%------------------------------------------------------------------------------
% File     : Metis---2.4
% Problem  : MED011+1 : TPTP v8.1.0. Released v4.0.0.
% Transfm  : none
% Format   : tptp:raw
% Command  : metis --show proof --show saturation %s

% Computer : n005.cluster.edu
% Model    : x86_64 x86_64
% CPU      : Intel(R) Xeon(R) CPU E5-2620 v4 2.10GHz
% Memory   : 8042.1875MB
% OS       : Linux 3.10.0-693.el7.x86_64
% CPULimit : 300s
% WCLimit  : 600s
% DateTime : Sun Jul 17 21:54:10 EDT 2022

% Result   : Satisfiable 207.76s 207.90s
% Output   : Saturation 224.99s
% Verified : 
% SZS Type : -

% Comments : 
%------------------------------------------------------------------------------
%----WARNING: Could not form TPTP format derivation
%------------------------------------------------------------------------------
%----ORIGINAL SYSTEM OUTPUT
% 0.12/0.12  % Problem  : MED011+1 : TPTP v8.1.0. Released v4.0.0.
% 0.12/0.13  % Command  : metis --show proof --show saturation %s
% 0.12/0.34  % Computer : n005.cluster.edu
% 0.12/0.34  % Model    : x86_64 x86_64
% 0.12/0.34  % CPU      : Intel(R) Xeon(R) CPU E5-2620 v4 @ 2.10GHz
% 0.12/0.34  % Memory   : 8042.1875MB
% 0.12/0.34  % OS       : Linux 3.10.0-693.el7.x86_64
% 0.12/0.34  % CPULimit : 300
% 0.12/0.34  % WCLimit  : 600
% 0.12/0.34  % DateTime : Tue Jul  5 01:52:37 EDT 2022
% 0.12/0.34  % CPUTime  : 
% 0.12/0.35  %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% 207.76/207.90  % SZS status Satisfiable for /export/starexec/sandbox/benchmark/theBenchmark.p
% 207.76/207.90  
% 207.76/207.90  SZS output start Saturation for /export/starexec/sandbox/benchmark/theBenchmark.p
% 207.76/207.90  |- rdf__type mesh__D003582sskos__Concept
% 207.76/207.90  |- mesh__recordAuthorizer mesh__D003582 sjn
% 207.76/207.90  |- mesh__dateEstablished mesh__D003582 1967-01-01
% 207.76/207.90  |- skos__annotation mesh__D003582
% 207.76/207.90       SPEC; avoid as coord: Manual 28.22.5;  /methods: consider CYTOGENETIC ANALYSIS: Manual 28.22.5.2; CYTOGENETIC ABERRATIONS see CHROMOSOME ABERRATIONS is also available%A%  
% 207.76/207.90  |- skos__related mesh__D003582smesh__D002869
% 207.76/207.90  |- skos__scopeNote mesh__D003582
% 207.76/207.90       A subdiscipline of genetics which deals with the cytological and molecular analysis of the CHROMOSOMES, and location of the GENES on chromosomes, and the movements of chromosomes during the CELL CYCLE.%A%    
% 207.76/207.90  |- skos__related mesh__D003582smesh__D025063
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D003582 2005
% 207.76/207.90  |- mesh__recordOriginator mesh__D003582 NLM
% 207.76/207.90  |- mesh__recordMaintainer mesh__D003582 nns
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D003582 2003
% 207.76/207.90  |- skos__related mesh__D003582smesh__D020732
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D003582 2006
% 207.76/207.90  |- mesh__publicMeSHNote mesh__D003582 67   
% 207.76/207.90  |- skos__hiddenLabel mesh__D003582 Cytogenetic
% 207.76/207.90  |- mesh__dateRevised mesh__D003582 2002-07-03
% 207.76/207.90  |- skos__related mesh__D003582smesh__D002874
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D003582 2004
% 207.76/207.90  |- mesh__dateCreated mesh__D003582 1999-01-01
% 207.76/207.90  |- skos__related mesh__D003582smesh__D007621
% 207.76/207.90  |- skos__broader mesh__D003582smesh__D005823
% 207.76/207.90  |- mesh__historyNote mesh__D003582 67   
% 207.76/207.90  |- skos__historyNote mesh__D003582 Genetics, Medical %28%1966%29%
% 207.76/207.90  |- skos__prefLabel mesh__D003582 Cytogenetics
% 207.76/207.90  |- skos__hiddenLabel mesh__D011216 Practice Managements, Medical
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D011216 2000
% 207.76/207.90  |- skos__altLabel mesh__D011216 Medical Practice Management
% 207.76/207.90  |- skos__scopeNote mesh__D011216
% 207.76/207.90       The organization and operation of the business aspects of a physician%27%s practice.%A%    
% 207.76/207.90  |- skos__historyNote mesh__D011216 Office Management %28%1966-1967%29%
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D011216 2005
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D011216 2001
% 207.76/207.90  |- skos__broader mesh__D011216smesh__D020399
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D011216 1999
% 207.76/207.90  |- mesh__historyNote mesh__D011216 68   
% 207.76/207.90  |- mesh__recordOriginator mesh__D011216 NLM
% 207.76/207.90  |- skos__hiddenLabel mesh__D011216 Managements, Medical Practice
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D011216 2006
% 207.76/207.90  |- mesh__recordMaintainer mesh__D011216 JLS
% 207.76/207.90  |- mesh__dateRevised mesh__D011216 1998-06-10
% 207.76/207.90  |- skos__prefLabel mesh__D011216 Practice Management, Medical
% 207.76/207.90  |- skos__altLabel mesh__D011216 Management, Medical Practice
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D011216 2003
% 207.76/207.90  |- mesh__publicMeSHNote mesh__D011216 68   
% 207.76/207.90  |- rdf__type mesh__D011216sskos__Concept
% 207.76/207.90  |- mesh__recordAuthorizer mesh__D011216 SJN
% 207.76/207.90  |- mesh__dateEstablished mesh__D011216 1968-01-01
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D011216 2002
% 207.76/207.90  |- mesh__dateCreated mesh__D011216 1999-01-01
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D011216 2004
% 207.76/207.90  |- skos__annotation mesh__D011216 DF: PRACTICE MANAGEMENT MED   
% 207.76/207.90  |- skos__hiddenLabel mesh__D011216 Medical Practice Managements
% 207.76/207.90  |- skos__hiddenLabel mesh__D007973 Leukorrheas
% 207.76/207.90  |- mesh__dateCreated mesh__D007973 1999-01-01
% 207.76/207.90  |- skos__scopeNote mesh__D007973
% 207.76/207.90       A clear or white discharge from the VAGINA, consisting mainly of MUCUS.%A%    
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D007973 2006
% 207.76/207.90  |- mesh__dateRevised mesh__D007973 2005-06-30
% 207.76/207.90  |- mesh__recordOriginator mesh__D007973 NLM
% 207.76/207.90  |- mesh__recordAuthorizer mesh__D007973 sjn
% 207.76/207.90  |- skos__prefLabel mesh__D007973 Leukorrhea
% 207.76/207.90  |- mesh__recordMaintainer mesh__D007973 lkt
% 207.76/207.90  |- skos__broader mesh__D007973smesh__D019522
% 207.76/207.90  |- rdf__type mesh__D007973sskos__Concept
% 207.76/207.90  |- skos__broader mesh__D029627smesh__D019685
% 207.76/207.90  |- skos__prefLabel mesh__D029627 Crassulaceae
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D029627 2006
% 207.76/207.90  |- mesh__publicMeSHNote mesh__D029627 2002   
% 207.76/207.90  |- mesh__recordOriginator mesh__D029627 ssb
% 207.76/207.90  |- mesh__recordAuthorizer mesh__D029627 sjn
% 207.76/207.90  |- mesh__dateEstablished mesh__D029627 2002-01-01
% 207.76/207.90  |- skos__annotation mesh__D029627
% 207.76/207.90       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.76/207.90  |- mesh__dateCreated mesh__D029627 2001-07-25
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D029627 2003
% 207.76/207.90  |- mesh__historyNote mesh__D029627 2002   
% 207.76/207.90  |- rdf__type mesh__D029627sskos__Concept
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D029627 2005
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D029627 2004
% 207.76/207.90  |- skos__scopeNote mesh__D029627
% 207.76/207.90       The stonecrop plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida that grow in warm, dry regions. The leaves are thick. The flower clusters are red, yellow, or white.%A%    
% 207.76/207.90  |- mesh__recordMaintainer mesh__D029627 ssb
% 207.76/207.90  |- mesh__dateRevised mesh__D029627 2002-07-03
% 207.76/207.90  |- skos__hiddenLabel mesh__D007175 Impulsive Behaviors
% 207.76/207.90  |- skos__historyNote mesh__D007175 Behavior %28%1966-1967%29%
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D007175 2004
% 207.76/207.90  |- skos__annotation mesh__D007175 use Cat F3 qualif   
% 207.76/207.90  |- skos__broader mesh__D007175smesh__D001519
% 207.76/207.90  |- mesh__recordOriginator mesh__D007175 NLM
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D007175 2003
% 207.76/207.90  |- skos__hiddenLabel mesh__D007175 Behaviors, Impulsive
% 207.76/207.90  |- mesh__recordMaintainer mesh__D007175 JLS
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D007175 2006
% 207.76/207.90  |- skos__prefLabel mesh__D007175 Impulsive Behavior
% 207.76/207.90  |- mesh__historyNote mesh__D007175 68   
% 207.76/207.90  |- mesh__dateRevised mesh__D007175 2002-07-02
% 207.76/207.90  |- skos__scopeNote mesh__D007175
% 207.76/207.90       An act performed without delay, reflection, voluntary direction or obvious control in response to a stimulus.%A%    
% 207.76/207.90  |- rdf__type mesh__D007175sskos__Concept
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D007175 2005
% 207.76/207.90  |- mesh__recordAuthorizer mesh__D007175 sjn
% 207.76/207.90  |- mesh__dateCreated mesh__D007175 1999-01-01
% 207.76/207.90  |- skos__hiddenLabel mesh__D007175 Behavior, Impulsive
% 207.76/207.90  |- mesh__publicMeSHNote mesh__D007175 68   
% 207.76/207.90  |- mesh__dateEstablished mesh__D007175 1968-01-01
% 207.76/207.90  |- skos__annotation mesh__D015607
% 207.76/207.90       do not use /util except by MeSH definition   
% 207.76/207.90  |- skos__scopeNote mesh__D015607
% 207.76/207.90       Devices that provide support for tubular structures that are being anastomosed or for body cavities during skin grafting.%A%    
% 207.76/207.90  |- mesh__dateEstablished mesh__D015607 1990-01-01
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D015607 2006
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D015607 1999
% 207.76/207.90  |- skos__prefLabel mesh__D015607 Stents
% 207.76/207.90  |- mesh__publicMeSHNote mesh__D015607 90   
% 207.76/207.90  |- mesh__dateCreated mesh__D015607 1989-04-13
% 207.76/207.90  |- skos__historyNote mesh__D015607 Catheters, Indwelling %28%1972-1989%29%
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D015607 2005
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D015607 1998
% 207.76/207.90  |- mesh__recordMaintainer mesh__D015607 PXP
% 207.76/207.90  |- skos__hiddenLabel mesh__D015607 Stent
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D015607 2002
% 207.76/207.90  |- rdf__type mesh__D015607sskos__Concept
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D015607 2004
% 207.76/207.90  |- skos__broader mesh__D015607smesh__D019736
% 207.76/207.90  |- skos__historyNote mesh__D015607 Splints %28%1966-1989%29%
% 207.76/207.90  |- mesh__historyNote mesh__D015607 90   
% 207.76/207.90  |- mesh__recordOriginator mesh__D015607 AGS
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D015607 2001
% 207.76/207.90  |- skos__historyNote mesh__D015607 Implants, Artificial %28%1972-1989%29%
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D015607 2003
% 207.76/207.90  |- mesh__dateRevised mesh__D015607 1997-06-20
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D015607 2000
% 207.76/207.90  |- skos__historyNote mesh__D015607 Prosthesis %28%1966-1989%29%
% 207.76/207.90  |- mesh__recordAuthorizer mesh__D015607 SJN
% 207.76/207.90  |- skos__historyNote mesh__D003583 Adenine %28%1973-1974%29%
% 207.76/207.90  |- skos__historyNote mesh__D003583
% 207.76/207.90       Plant Growth Regulators %28%1973-1974%29%
% 207.76/207.90  |- mesh__dateRevised mesh__D003583 2005-06-30
% 207.76/207.90  |- rdf__type mesh__D003583sskos__Concept
% 207.76/207.90  |- mesh__dateCreated mesh__D003583 1974-11-11
% 207.76/207.90  |- skos__broader mesh__D003583smesh__D000225
% 207.76/207.90  |- mesh__recordMaintainer mesh__D003583 ssb
% 207.76/207.90  |- mesh__recordAuthorizer mesh__D003583 sjn
% 207.76/207.90  |- mesh__dateEstablished mesh__D003583 1991-01-01
% 207.76/207.90  |- skos__prefLabel mesh__D003583 Cytokinins
% 207.76/207.90  |- mesh__publicMeSHNote mesh__D003583
% 207.76/207.90       91; was see under PLANT GROWTH REGULATORS 1975-90   
% 207.76/207.90  |- mesh__recordOriginator mesh__D003583 NLM
% 207.76/207.90  |- mesh__historyNote mesh__D003583
% 207.76/207.90       91%28%75%29%; was see under PLANT GROWTH REGULATORS 1975-90   
% 207.76/207.90  |- skos__scopeNote mesh__D003583
% 207.76/207.90       Plant hormones that promote the separation of daughter cells after mitotic division of a parent cell. Frequently they are purine derivatives.%A%    
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D003583 2006
% 207.76/207.90  |- mesh__recordAuthorizer mesh__D011217 sjn
% 207.76/207.90  |- skos__broader mesh__D011217smesh__D050198
% 207.76/207.90  |- mesh__publicMeSHNote mesh__D011217 74   
% 207.76/207.90  |- mesh__dateRevised mesh__D011217 2005-06-30
% 207.76/207.90  |- skos__scopeNote mesh__D011217
% 207.76/207.90       A beta-adrenergic antagonist that has been used in the emergency treatment of cardiac arrhythmias.%A%    
% 207.76/207.90  |- skos__hiddenLabel mesh__D011217 Practolol, Eralzdin
% 207.76/207.90  |- mesh__activeMeSHYear mesh__D011217 2006
% 207.76/207.90  |- skos__prefLabel mesh__D011217 Practolol
% 207.76/207.90  |- skos__broader mesh__D011217smesh__D000083
% 207.76/207.90  |- mesh__dateEstablished mesh__D011217 1974-01-01
% 207.76/207.90  |- rdf__type mesh__D011217sskos__Concept
% 207.76/207.90  |- skos__hiddenLabel mesh__D011217 ICI 50172
% 207.76/207.90  |- skos__hiddenLabel mesh__D011217 ICI50172
% 207.76/207.90  |- mesh__dateCreated mesh__D011217 1999-01-01
% 207.76/207.90  |- mesh__recordOriginator mesh__D011217 NLM
% 207.76/207.90  |- mesh__recordMaintainer mesh__D011217 ssb
% 207.76/207.90  |- mesh__historyNote mesh__D011217 74   
% 207.76/207.90  |- skos__broader mesh__D011217smesh__D011412
% 207.76/207.90  |- mesh__dateRevised mesh__D016700 2005-06-30
% 207.76/207.90  |- skos__broader mesh__D016700smesh__D000813
% 207.76/207.90  |- skos__prefLabel mesh__D016700 Encainide
% 207.76/207.90  |- skos__historyNote mesh__D016700 Anilides %28%1966-1991%29%
% 207.76/207.90  |- skos__hiddenLabel mesh__D016700 MJ9067
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D016700 2006
% 207.76/207.91  |- mesh__dateEstablished mesh__D016700 1992-01-01
% 207.76/207.91  |- mesh__recordAuthorizer mesh__D016700 sjn
% 207.76/207.91  |- mesh__dateCreated mesh__D016700 1991-02-11
% 207.76/207.91  |- mesh__publicMeSHNote mesh__D016700
% 207.76/207.91       92; ENCAINIDE was indexed under ANILIDES 1979-91   
% 207.76/207.91  |- skos__hiddenLabel mesh__D016700 MJ 9067
% 207.76/207.91  |- skos__hiddenLabel mesh__D016700
% 207.76/207.91       Bristol Myers Squibb Brand of Encainide Hydrochloride
% 207.76/207.91  |- mesh__historyNote mesh__D016700 92; was ENCAINIDE %28%NM%29% 1979-91   
% 207.76/207.91  |- skos__altLabel mesh__D016700
% 207.76/207.91       Bristol-Myers Squibb Brand of Encainide Hydrochloride
% 207.76/207.91  |- skos__altLabel mesh__D016700 Encainide Hydrochloride, %28%+-%29%-Isomer
% 207.76/207.91  |- rdf__type mesh__D016700sskos__Concept
% 207.76/207.91  |- skos__historyNote mesh__D016700 Anti-Arrhythmia Agents %28%1966-1991%29%
% 207.76/207.91  |- skos__scopeNote mesh__D016700
% 207.76/207.91       One of the ANTI-ARRHYTHMIA AGENTS, it blocks SODIUM CHANNELS and slows conduction within the His-Purkinje system and myocardium.%A%    
% 207.76/207.91  |- mesh__onlineNote mesh__D016700
% 207.76/207.91       use ENCAINIDE %28%NM%29% to search ENCAINIDE 1980-91   
% 207.76/207.91  |- mesh__recordOriginator mesh__D016700 RLS
% 207.76/207.91  |- mesh__recordMaintainer mesh__D016700 exl
% 207.76/207.91  |- skos__prefLabel mesh__D029628 Hydrangeaceae
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D029628 2002
% 207.76/207.91  |- mesh__dateEstablished mesh__D029628 2002-01-01
% 207.76/207.91  |- skos__broader mesh__D029628smesh__D019685
% 207.76/207.91  |- skos__annotation mesh__D029628
% 207.76/207.91       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D029628 2003
% 207.76/207.91  |- rdf__type mesh__D029628sskos__Concept
% 207.76/207.91  |- skos__scopeNote mesh__D029628
% 207.76/207.91       A plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida.%A%    
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D029628 2005
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D029628 2004
% 207.76/207.91  |- mesh__dateCreated mesh__D029628 2001-07-25
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D029628 2006
% 207.76/207.91  |- mesh__historyNote mesh__D029628 2002   
% 207.76/207.91  |- mesh__publicMeSHNote mesh__D029628 2002   
% 207.76/207.91  |- skos__altLabel mesh__D007176 In Vitro %5B%Publication Type%5D%
% 207.76/207.91  |- skos__prefLabel mesh__D007176 In Vitro
% 207.76/207.91  |- skos__broader mesh__D007176smesh__D052182
% 207.76/207.91  |- mesh__historyNote mesh__D007176 1966   
% 207.76/207.91  |- skos__altLabel mesh__D007176 In Vitro %5B%Pub Type%5D%
% 207.76/207.91  |- mesh__recordMaintainer mesh__D007176 jls
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D007176 2006
% 207.76/207.91  |- skos__annotation mesh__D007176 CATALOG: do not use   
% 207.76/207.91  |- mesh__recordOriginator mesh__D007176 NLM
% 207.76/207.91  |- rdf__type mesh__D007176sskos__Concept
% 207.76/207.91  |- mesh__dateRevised mesh__D007176 2005-06-30
% 207.76/207.91  |- mesh__dateCreated mesh__D007176 1999-01-01
% 207.76/207.91  |- skos__altLabel mesh__D007176 In Vitro %5B%PT%5D%
% 207.76/207.91  |- mesh__recordAuthorizer mesh__D007176 sjn
% 207.76/207.91  |- mesh__recordAuthorizer mesh__D015608 ags
% 207.76/207.91  |- skos__historyNote mesh__D015608 Vaccinia Virus %28%1967-1989%29%
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D015608 2006
% 207.76/207.91  |- mesh__historyNote mesh__D015608 90   
% 207.76/207.91  |- skos__annotation mesh__D015608 infection = COWPOX: see note there   
% 207.76/207.91  |- skos__altLabel mesh__D015608 Cow Pox Virus
% 207.76/207.91  |- skos__scopeNote mesh__D015608
% 207.76/207.91       A species of ORTHOPOXVIRUS that is the etiologic agent of COWPOX. It is closely related to but antigenically different from VACCINIA VIRUS.%A%    
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D015608 2006A
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D015608 2003
% 207.76/207.91  |- skos__prefLabel mesh__D015608 Cowpox virus
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D015608 2002
% 207.76/207.91  |- rdf__type mesh__D015608sskos__Concept
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D015608 2004
% 207.76/207.91  |- mesh__dateRevised mesh__D015608 2005-08-03
% 207.76/207.91  |- mesh__dateCreated mesh__D015608 1989-04-07
% 207.76/207.91  |- skos__hiddenLabel mesh__D015608 Cowpox viruses
% 207.76/207.91  |- skos__broader mesh__D015608smesh__D018155
% 207.76/207.91  |- mesh__recordMaintainer mesh__D015608 ags
% 207.76/207.91  |- mesh__recordOriginator mesh__D015608 PXP
% 207.76/207.91  |- mesh__dateEstablished mesh__D015608 1990-01-01
% 207.76/207.91  |- skos__hiddenLabel mesh__D015608 Cow Pox Viruses
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D015608 2005
% 207.76/207.91  |- mesh__publicMeSHNote mesh__D015608 90   
% 207.76/207.91  |- mesh__dateRevised mesh__D040001 2003-07-09
% 207.76/207.91  |- rdf__type mesh__D040001sskos__Concept
% 207.76/207.91  |- skos__scopeNote mesh__D040001
% 207.76/207.91       Species of American house dust mite, in the family PYROGLYPHIDAE.%A%    
% 207.76/207.91  |- skos__historyNote mesh__D040001 Mites %28%1968-2002%29%
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D040001 2005
% 207.76/207.91  |- mesh__dateEstablished mesh__D040001 2003-01-01
% 207.76/207.91  |- skos__altLabel mesh__D040001 American House Dust Mite
% 207.76/207.91  |- skos__prefLabel mesh__D040001 Dermatophagoides farinae
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D040001 2006
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D040001 2004
% 207.76/207.91  |- skos__broader mesh__D040001smesh__D039981
% 207.76/207.91  |- mesh__dateCreated mesh__D040001 2002-07-02
% 207.76/207.91  |- mesh__publicMeSHNote mesh__D040001 2003   
% 207.76/207.91  |- skos__altLabel mesh__D040001 House Dust Mite, American
% 207.76/207.91  |- mesh__historyNote mesh__D040001 2003   
% 207.76/207.91  |- mesh__dateRevised mesh__D012310 2004-07-07
% 207.76/207.91  |- mesh__dateCreated mesh__D012310 1999-01-01
% 207.76/207.91  |- mesh__publicMeSHNote mesh__D012310 RISTOMYCIN was heading 1965-93   
% 207.76/207.91  |- skos__broader mesh__D012310smesh__D006020
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D012310 2005
% 207.76/207.91  |- mesh__recordAuthorizer mesh__D012310 sjn
% 207.76/207.91  |- mesh__recordOriginator mesh__D012310 NLM
% 207.76/207.91  |- skos__prefLabel mesh__D012310 Ristocetin
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D012310 2006
% 207.76/207.91  |- mesh__recordMaintainer mesh__D012310 ssb
% 207.76/207.91  |- mesh__onlineNote mesh__D012310
% 207.76/207.91       use RISTOCETIN to search RISTOMYCIN 1966-93 %28%as Prov 1966-72%29%%A%  
% 207.76/207.91  |- rdf__type mesh__D012310sskos__Concept
% 207.76/207.91  |- mesh__historyNote mesh__D012310
% 207.76/207.91       RISTOMYCIN was heading 1965-93 %28%Prov 1965-72%29%   
% 207.76/207.91  |- skos__scopeNote mesh__D012310
% 207.76/207.91       An antibiotic mixture of two components, A and B, obtained from Nocardia lurida %28%or the same substance produced by any other means%29%. It is no longer used clinically because of its toxicity. It causes platelet agglutination and blood coagulation and is used to assay those functions in vitro.%A%    
% 207.76/207.91  |- mesh__onlineNote mesh__D003584
% 207.76/207.91       use CYTOLOGICAL TECHNIQUES to search CYTOLOGICAL TECHNICS 1973-90%A%  
% 207.76/207.91  |- mesh__publicMeSHNote mesh__D003584
% 207.76/207.91       91; was CYTOLOGICAL TECHNICS 1973-90   
% 207.76/207.91  |- skos__altLabel mesh__D003584 Technic, Cytological
% 207.76/207.91  |- rdf__type mesh__D003584sskos__Concept
% 207.76/207.91  |- mesh__dateEstablished mesh__D003584 1973-01-01
% 207.76/207.91  |- skos__hiddenLabel mesh__D003584 Cytologic Technic
% 207.76/207.91  |- skos__hiddenLabel mesh__D003584 Technics, Cytologic
% 207.76/207.91  |- skos__related mesh__D003584smesh__D003581
% 207.76/207.91  |- skos__broader mesh__D003584smesh__D019411
% 207.76/207.91  |- skos__altLabel mesh__D003584 Techniques, Cytological
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D003584 2002
% 207.76/207.91  |- skos__prefLabel mesh__D003584 Cytological Techniques
% 207.76/207.91  |- mesh__dateCreated mesh__D003584 1999-01-01
% 207.76/207.91  |- skos__altLabel mesh__D003584 Cytologic Technics
% 207.76/207.91  |- mesh__dateRevised mesh__D003584 2000-06-22
% 207.76/207.91  |- skos__altLabel mesh__D003584 Technique, Cytological
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D003584 2004
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D003584 2001
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D003584 2006
% 207.76/207.91  |- mesh__recordMaintainer mesh__D003584 kle
% 207.76/207.91  |- mesh__recordAuthorizer mesh__D003584 sjn
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D003584 2003
% 207.76/207.91  |- mesh__historyNote mesh__D003584 91; was CYTOLOGICAL TECHNICS 1973-90   
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D003584 2005
% 207.76/207.91  |- skos__hiddenLabel mesh__D003584 Technic, Cytologic
% 207.76/207.91  |- skos__altLabel mesh__D003584 Cytological Technique
% 207.76/207.91  |- skos__altLabel mesh__D003584 Cytological Technics
% 207.76/207.91  |- skos__altLabel mesh__D003584 Cytological Technic
% 207.76/207.91  |- skos__historyNote mesh__D003584 Cytology %28%1966-1972%29%
% 207.76/207.91  |- mesh__recordOriginator mesh__D003584 NLM
% 207.76/207.91  |- skos__altLabel mesh__D003584 Technics, Cytological
% 207.76/207.91  |- skos__annotation mesh__D003584 avoid: too general; usually NIM   
% 207.76/207.91  |- mesh__recordMaintainer mesh__D011218 lkt
% 207.76/207.91  |- skos__historyNote mesh__D011218
% 207.76/207.91       Abnormalities, Multiple %28%1968-1976%29%
% 207.76/207.91  |- skos__hiddenLabel mesh__D011218 Syndrome, Royer
% 207.76/207.91  |- mesh__dateEstablished mesh__D011218 1977-01-01
% 207.76/207.91  |- skos__related mesh__D011218smesh__D008607
% 207.76/207.91  |- skos__hiddenLabel mesh__D011218 Syndrome, Labhart-Willi
% 207.76/207.91  |- rdf__type mesh__D011218sskos__Concept
% 207.76/207.91  |- skos__altLabel mesh__D011218 Labhart-Willi Syndrome
% 207.76/207.91  |- mesh__dateCreated mesh__D011218 1976-04-13
% 207.76/207.91  |- skos__hiddenLabel mesh__D011218 Labhart Willi Syndrome
% 207.76/207.91  |- skos__altLabel mesh__D011218 Labhart-Willi-Prader-Fanconi Syndrome
% 207.76/207.91  |- mesh__recordOriginator mesh__D011218 EC
% 207.76/207.91  |- skos__altLabel mesh__D011218 Royer%27%s Syndrome
% 207.76/207.91  |- skos__broader mesh__D011218smesh__D025063
% 207.76/207.91  |- mesh__recordAuthorizer mesh__D011218 sjn
% 207.76/207.91  |- skos__scopeNote mesh__D011218
% 207.76/207.91       An autosomal dominant disorder caused by deletion of the proximal long arm of the paternal chromosome 15 %28%15q11-q13%29% or by inheritance of both of the pair of chromosomes 15 from the mother %28%UNIPARENTAL DISOMY%29% which are imprinted %28%GENETIC IMPRINTING%29% and hence silenced. Clinical manifestations include MENTAL RETARDATION; MUSCULAR HYPOTONIA; HYPERPHAGIA; OBESITY; short stature; HYPOGONADISM; STRABISMUS; and HYPERSOMNOLENCE.  %28%Menkes, Textbook of Child Neurology, 5th ed, p229%29%%A%    
% 207.76/207.91  |- skos__historyNote mesh__D011218 Obesity %28%1966-1976%29%
% 207.76/207.91  |- mesh__dateRevised mesh__D011218 2005-06-30
% 207.76/207.91  |- skos__historyNote mesh__D011218
% 207.76/207.91       Carbohydrate Metabolism, Inborn Errors %28%1969-1976%29%
% 207.76/207.91  |- skos__historyNote mesh__D011218 Mental Retardation %28%1966-1976%29%
% 207.76/207.91  |- mesh__historyNote mesh__D011218 77   
% 207.76/207.91  |- skos__broader mesh__D011218smesh__D008607
% 207.76/207.91  |- skos__hiddenLabel mesh__D011218 Royers Syndrome
% 207.76/207.91  |- skos__historyNote mesh__D011218 Hypogonadism %28%1966-1976%29%
% 207.76/207.91  |- skos__hiddenLabel mesh__D011218 Prader Willi Syndrome
% 207.76/207.91  |- skos__hiddenLabel mesh__D011218 Syndrome, Prader-Willi
% 207.76/207.91  |- skos__hiddenLabel mesh__D011218 Labhart Willi Prader Fanconi Syndrome
% 207.76/207.91  |- skos__prefLabel mesh__D011218 Prader-Willi Syndrome
% 207.76/207.91  |- skos__hiddenLabel mesh__D011218 Syndrome, Royer%27%s
% 207.76/207.91  |- skos__broader mesh__D011218smesh__D009765
% 207.76/207.91  |- skos__broader mesh__D011218smesh__D000015
% 207.76/207.91  |- skos__hiddenLabel mesh__D011218 Syndrome, Labhart-Willi-Prader-Fanconi
% 207.76/207.91  |- mesh__publicMeSHNote mesh__D011218 77   
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D011218 2006
% 207.76/207.91  |- mesh__recordOriginator mesh__D016701 TGC
% 207.76/207.91  |- skos__altLabel mesh__D016701 Guinea, Republic of
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D016701 2001
% 207.76/207.91  |- skos__altLabel mesh__D016701 French Guinea
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D016701 2006
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D016701 2002
% 207.76/207.91  |- skos__altLabel mesh__D016701 Guinea, French
% 207.76/207.91  |- mesh__recordAuthorizer mesh__D016701 SJN
% 207.76/207.91  |- rdf__type mesh__D016701sskos__Concept
% 207.76/207.91  |- mesh__onlineNote mesh__D016701
% 207.76/207.91       use AFRICA, WESTERN to search GUINEA %26% REPUBLIC OF GUINEA  1988-91; use GUINEA-BISSAU 1966-82%A%  
% 207.76/207.91  |- mesh__recordMaintainer mesh__D016701 TGC
% 207.76/207.91  |- skos__annotation mesh__D016701
% 207.76/207.91       a republic in western Africa; X ref FRENCH GUINEA was its former name; do not confuse with GUINEA-BISSAU %28%formerly Portuguese Guinea%29% or EQUATORIAL GUINEA %28%formerly Spanish Guinea%29%; do not confuse with GUYANA in So. Amer.%A%  
% 207.76/207.91  |- mesh__dateEstablished mesh__D016701 1992-01-01
% 207.76/207.91  |- skos__broader mesh__D016701smesh__D000354
% 207.76/207.91  |- mesh__dateRevised mesh__D016701 1997-06-20
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D016701 2003
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D016701 1998
% 207.76/207.91  |- skos__prefLabel mesh__D016701 Guinea
% 207.76/207.91  |- mesh__dateCreated mesh__D016701 1991-02-11
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D016701 2004
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D016701 1999
% 207.76/207.91  |- mesh__historyNote mesh__D016701
% 207.76/207.91       92; was REPUBLIC OF GUINEA see AFRICA, WESTERN 1988-91; was see GUINEA-BISSAU 1980-82; was heading 1966-79%A%  
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D016701 2000
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D016701 2005
% 207.76/207.91  |- skos__historyNote mesh__D016701 Africa, Western %28%1966-1991%29%
% 207.76/207.91  |- skos__scopeNote mesh__D016701
% 207.76/207.91       A republic in western Africa, south of SENEGAL and MALI, east of GUINEA-BISSAU. Its capital is Conakry. Its coastal region was proclaimed a French protectorate in 1849, was established as a separate colony called French Guinea in 1893, and gained its independence in 1958. This Guinea gave its name to the coin originally made out of gold coming from there. Guinea is from a Tuareg word aginaw, meaning black people. %28%From Webster%27%s New Geographical Dictionary, 1988, p474 %26% Room, Brewer%27%s Dictionary of Names, 1992, p222%29%%A%    
% 207.76/207.91  |- mesh__recordAuthorizer mesh__D007975 sjn
% 207.76/207.91  |- skos__altLabel mesh__D007975 Leukotriene B
% 207.76/207.91  |- skos__altLabel mesh__D007975 5,12-HETE
% 207.76/207.91  |- skos__historyNote mesh__D007975 Arachidonic Acids %28%1967-1982%29%
% 207.76/207.91  |- mesh__publicMeSHNote mesh__D007975
% 207.76/207.91       94; was LEUKOTRIENES B 1983-93; LEUKOTRIENE B4 was see LEUKOTRIENES B 1983-93%A%  
% 207.76/207.91  |- skos__hiddenLabel mesh__D007975 Leukotriene B 4
% 207.76/207.91  |- skos__broader mesh__D007975smesh__D015289
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D007975 2006
% 207.76/207.91  |- mesh__onlineNote mesh__D007975
% 207.76/207.91       use LEUKOTRIENE B4 to search LEUKOTRIENES B 1983-93   
% 207.76/207.91  |- skos__hiddenLabel mesh__D007975 5,12 HETE
% 207.76/207.91  |- mesh__historyNote mesh__D007975
% 207.76/207.91       94; was LEUKOTRIENES B 1983-93; LEUKOTRIENE B4 was see LEUKOTRIENES B 1983-93%A%  
% 207.76/207.91  |- skos__prefLabel mesh__D007975 Leukotriene B4
% 207.76/207.91  |- skos__altLabel mesh__D007975 LTB4
% 207.76/207.91  |- skos__altLabel mesh__D007975 Leukotriene B-4
% 207.76/207.91  |- mesh__recordMaintainer mesh__D007975 ssb
% 207.76/207.91  |- mesh__recordOriginator mesh__D007975 RLS
% 207.76/207.91  |- mesh__dateCreated mesh__D007975 1982-04-30
% 207.76/207.91  |- skos__hiddenLabel mesh__D007975 5,12 diHETE
% 207.76/207.91  |- mesh__dateEstablished mesh__D007975 1983-01-01
% 207.76/207.91  |- skos__annotation mesh__D007975
% 207.76/207.91       /biosyn /physiol permitted; DF: note short X ref   
% 207.76/207.91  |- skos__hiddenLabel mesh__D007975 B-4, Leukotriene
% 207.76/207.91  |- rdf__type mesh__D007975sskos__Concept
% 207.76/207.91  |- skos__scopeNote mesh__D007975
% 207.76/207.91       The major metabolite in neutrophil polymorphonuclear leukocytes. It stimulates polymorphonuclear cell function %28%degranulation, formation of oxygen-centered free radicals, arachidonic acid release, and metabolism%29%. %28%From Dictionary of Prostaglandins and Related Compounds, 1990%29%%A%    
% 207.76/207.91  |- mesh__dateRevised mesh__D007975 2005-06-30
% 207.76/207.91  |- skos__annotation mesh__D029629
% 207.76/207.91       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D029629 2003
% 207.76/207.91  |- mesh__dateCreated mesh__D029629 2001-07-25
% 207.76/207.91  |- rdf__type mesh__D029629sskos__Concept
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D029629 2005
% 207.76/207.91  |- mesh__historyNote mesh__D029629 2002   
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D029629 2004
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D029629 2002
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D029629 2006
% 207.76/207.91  |- skos__prefLabel mesh__D029629 Salicaceae
% 207.76/207.91  |- mesh__publicMeSHNote mesh__D029629 2002   
% 207.76/207.91  |- skos__scopeNote mesh__D029629
% 207.76/207.91       A plant family of the order Salicales, subclass Dilleniidae, class Magnoliopsida. The leaves are alternate and simple. Staminate %28%male%29% flowers consist of from one to many stamens. Pistillate %28%female%29% flowers consist of a one-chambered ovary with several to many ovules %28%potential silky seeds%29%.%A%    
% 207.76/207.91  |- skos__broader mesh__D029629smesh__D019684
% 207.76/207.91  |- mesh__dateEstablished mesh__D029629 2002-01-01
% 207.76/207.91  |- skos__historyNote mesh__D007177 Hyponatremia %28%1966-1978%29%
% 207.76/207.91  |- mesh__recordAuthorizer mesh__D007177 ags
% 207.76/207.91  |- skos__altLabel mesh__D007177
% 207.76/207.91       Antidiuretic Hormone, Inappropriate Secretion
% 207.76/207.91  |- skos__hiddenLabel mesh__D007177 Syndrome, Inappropriate ADH
% 207.76/207.91  |- rdf__type mesh__D007177sskos__Concept
% 207.76/207.91  |- mesh__recordOriginator mesh__D007177 VDK
% 207.76/207.91  |- skos__prefLabel mesh__D007177 Inappropriate ADH Syndrome
% 207.76/207.91  |- mesh__dateRevised mesh__D007177 2005-07-08
% 207.76/207.91  |- mesh__publicMeSHNote mesh__D007177 1979   
% 207.76/207.91  |- mesh__dateEstablished mesh__D007177 1979-01-01
% 207.76/207.91  |- mesh__recordMaintainer mesh__D007177 ags
% 207.76/207.91  |- skos__altLabel mesh__D007177
% 207.76/207.91       Syndrome of Inappropriate ADH %28%SIADH%29% Secretion
% 207.76/207.91  |- skos__altLabel mesh__D007177
% 207.76/207.91       Inappropriate Vasopressin Secretion Syndrome
% 207.76/207.91  |- skos__hiddenLabel mesh__D007177 Syndrome, Schwartz-Bartter
% 207.76/207.91  |- skos__scopeNote mesh__D007177
% 207.76/207.91       A condition of HYPONATREMIA and renal salt loss attributed to overexpansion of BODY FLUIDS resulting from sustained release of ANTIDIURETIC HORMONES which stimulates renal resorption of water. It is characterized by normal KIDNEY function, high urine OSMOLALITY, low serum osmolality, and neurological dysfunction. Etiologies include ADH-producing neoplasms, injuries or diseases involving the HYPOTHALAMUS, the PITUITARY GLAND, and the LUNG. This syndrome can also be drug-induced.%A%    
% 207.76/207.91  |- skos__historyNote mesh__D007177 Vasopressins %28%1966-1978%29%
% 207.76/207.91  |- skos__altLabel mesh__D007177 Schwartz-Bartter Syndrome
% 207.76/207.91  |- mesh__historyNote mesh__D007177 1979   
% 207.76/207.91  |- skos__hiddenLabel mesh__D007177 Schwartz Bartter Syndrome
% 207.76/207.91  |- skos__altLabel mesh__D007177 SIADH
% 207.76/207.91  |- skos__hiddenLabel mesh__D007177 ADH Syndrome, Inappropriate
% 207.76/207.91  |- skos__broader mesh__D007177smesh__D014883
% 207.76/207.91  |- skos__broader mesh__D007177smesh__D010900
% 207.76/207.91  |- mesh__dateCreated mesh__D007177 1977-12-06
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D007177 2006
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D007177 2006A
% 207.76/207.91  |- skos__annotation mesh__D015609 DF: ORGANOTECHNETIUM CPDS   
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D015609 2003
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D015609 1996
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D015609 2001
% 207.76/207.91  |- rdf__type mesh__D015609sskos__Concept
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D015609 2004
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D015609 1997
% 207.76/207.91  |- skos__hiddenLabel mesh__D015609 Compounds, Organotechnetium
% 207.76/207.91  |- skos__scopeNote mesh__D015609
% 207.76/207.91       Organic compounds that contain technetium as an integral part of the molecule. These compounds are often used as radionuclide imaging agents.%A%    
% 207.76/207.91  |- mesh__historyNote mesh__D015609 90   
% 207.76/207.91  |- mesh__recordOriginator mesh__D015609 RLS
% 207.76/207.91  |- skos__historyNote mesh__D015609 Technetium %28%1966-1989%29%
% 207.76/207.91  |- skos__historyNote mesh__D015609
% 207.76/207.91       Organometallic Compounds %28%1966-1989%29%
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D015609 2002
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D015609 1994
% 207.76/207.91  |- skos__broader mesh__D015609smesh__D009942
% 207.76/207.91  |- mesh__dateEstablished mesh__D015609 1990-01-01
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D015609 2005
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D015609 1998
% 207.76/207.91  |- mesh__recordAuthorizer mesh__D015609 PLS
% 207.76/207.91  |- mesh__publicMeSHNote mesh__D015609 90   
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D015609 1995
% 207.76/207.91  |- mesh__dateCreated mesh__D015609 1989-05-15
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D015609 2006
% 207.76/207.91  |- mesh__dateRevised mesh__D015609 1993-06-02
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D015609 1999
% 207.76/207.91  |- skos__prefLabel mesh__D015609 Organotechnetium Compounds
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D015609 2000
% 207.76/207.91  |- mesh__recordMaintainer mesh__D015609 TAP
% 207.76/207.91  |- skos__prefLabel mesh__D040002 Dermatophagoides pteronyssinus
% 207.76/207.91  |- rdf__type mesh__D040002sskos__Concept
% 207.76/207.91  |- skos__altLabel mesh__D040002 European House Dust Mite
% 207.76/207.91  |- mesh__historyNote mesh__D040002 2003   
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D040002 2005
% 207.76/207.91  |- skos__historyNote mesh__D040002 Mites %28%1966-2002%29%
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D040002 2006
% 207.76/207.91  |- skos__scopeNote mesh__D040002
% 207.76/207.91       Species of European house dust mite, in the family PYROGLYPHIDAE. It is the most commonly found house dust mite.%A%    
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D040002 2004
% 207.76/207.91  |- skos__broader mesh__D040002smesh__D039981
% 207.76/207.91  |- mesh__dateEstablished mesh__D040002 2003-01-01
% 207.76/207.91  |- mesh__dateCreated mesh__D040002 2002-07-03
% 207.76/207.91  |- mesh__publicMeSHNote mesh__D040002 2003   
% 207.76/207.91  |- skos__altLabel mesh__D040002 House Dust Mite, European
% 207.76/207.91  |- mesh__dateRevised mesh__D040002 2003-07-09
% 207.76/207.91  |- mesh__dateCreated mesh__D003585 1999-01-01
% 207.76/207.91  |- mesh__recordAuthorizer mesh__D003585 sjn
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D003585 2004
% 207.76/207.91  |- skos__related mesh__D003585smesh__D002477
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D003585 2006
% 207.76/207.91  |- mesh__recordOriginator mesh__D003585 NLM
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D003585 2003
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D003585 2005
% 207.76/207.91  |- skos__hiddenLabel mesh__D003585 Cytologies
% 207.76/207.91  |- skos__annotation mesh__D003585
% 207.76/207.91       SPEC only: prefer /cytol: Manual 19.7+, 19.8.20; SPEC qualif; DF: CYTOL%A%  
% 207.76/207.91  |- mesh__dateRevised mesh__D003585 2001-07-25
% 207.76/207.91  |- skos__prefLabel mesh__D003585 Cytology
% 207.76/207.91  |- rdf__type mesh__D003585sskos__Concept
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D003585 2002
% 207.76/207.91  |- mesh__recordMaintainer mesh__D003585 jls
% 207.76/207.91  |- skos__broader mesh__D003585smesh__D000715
% 207.76/207.91  |- skos__historyNote mesh__D011219 Rauwolfia %28%1966-1971%29%
% 207.76/207.91  |- skos__hiddenLabel mesh__D011219 Neo Gilurytmal
% 207.76/207.91  |- skos__hiddenLabel mesh__D011219 NeoGilurytmal
% 207.76/207.91  |- skos__altLabel mesh__D011219 N-Propylajmaline
% 207.76/207.91  |- skos__prefLabel mesh__D011219 Prajmaline
% 207.76/207.91  |- mesh__publicMeSHNote mesh__D011219 91; was see under AJMALINE 1980-90   
% 207.76/207.91  |- mesh__dateEstablished mesh__D011219 1991-01-01
% 207.76/207.91  |- skos__hiddenLabel mesh__D011219 N Propylajmaline
% 207.76/207.91  |- skos__hiddenLabel mesh__D011219 Bitartrate, Prajmalium
% 207.76/207.91  |- mesh__recordMaintainer mesh__D011219 ssb
% 207.76/207.91  |- skos__scopeNote mesh__D011219
% 207.76/207.91       A derivative of the rauwolfia alkaloid AJMALINE. It is an anti-arrhythmia agent, but may cause liver damage.%A%    
% 207.76/207.91  |- skos__altLabel mesh__D011219 Prajmalium
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D011219 2005
% 207.76/207.91  |- skos__historyNote mesh__D011219
% 207.76/207.91       Ajmaline %28%1971-1974%29% /analogs %26% derivatives %28%1975-1979%29%
% 207.76/207.91  |- skos__annotation mesh__D011219 /biosyn permitted if by plant   
% 207.76/207.91  |- mesh__recordAuthorizer mesh__D011219 sjn
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D011219 2006
% 207.76/207.91  |- mesh__historyNote mesh__D011219
% 207.76/207.91       91%28%80%29%; was see under AJMALINE 1980-90   
% 207.76/207.91  |- mesh__dateCreated mesh__D011219 1979-03-02
% 207.76/207.91  |- mesh__recordOriginator mesh__D011219 SH
% 207.76/207.91  |- mesh__dateRevised mesh__D011219 2004-07-07
% 207.76/207.91  |- skos__broader mesh__D011219smesh__D000404
% 207.76/207.91  |- rdf__type mesh__D011219sskos__Concept
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D008270 2001
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D008270 2000
% 207.76/207.91  |- skos__altLabel mesh__D008270 Malagasy Republic
% 207.76/207.91  |- skos__annotation mesh__D008270
% 207.76/207.91       the largest of the Indian Ocean Islands; X ref MALAGASY REPUBLIC was its former name%A%  
% 207.76/207.91  |- mesh__recordAuthorizer mesh__D008270 SJN
% 207.76/207.91  |- skos__scopeNote mesh__D008270
% 207.76/207.91       One of the Indian Ocean Islands off the southeast coast of Africa. Its capital is Antananarivo. It was formerly called the Malagasy Republic. Discovered by the Portuguese in 1500, its history has been tied predominantly to the French, becoming a French protectorate in 1882, a French colony in 1896, and a territory within the French union in 1946. The Malagasy Republic was established in the French Community in 1958 but it achieved independence in 1960. Its name was changed to Madagascar in 1975. %28%From Webster%27%s New Geographical Dictionary, 1988, p714%29%%A%    
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D008270 2004
% 207.76/207.91  |- mesh__recordMaintainer mesh__D008270 TGC
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D008270 2006
% 207.76/207.91  |- mesh__dateCreated mesh__D008270 1999-01-01
% 207.76/207.91  |- mesh__historyNote mesh__D008270 80; was MALAGASY REPUBLIC 1964-79   
% 207.76/207.91  |- mesh__recordOriginator mesh__D008270 NLM
% 207.76/207.91  |- skos__prefLabel mesh__D008270 Madagascar
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D008270 2003
% 207.76/207.91  |- mesh__onlineNote mesh__D008270
% 207.76/207.91       use MADAGASCAR to search MALAGASY REPUBLIC 1966-79   
% 207.76/207.91  |- rdf__type mesh__D008270sskos__Concept
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D008270 2005
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D008270 1999
% 207.76/207.91  |- skos__broader mesh__D008270smesh__D007195
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D008270 2002
% 207.76/207.91  |- mesh__dateRevised mesh__D008270 1997-06-20
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D008270 1998
% 207.76/207.91  |- mesh__recordMaintainer mesh__D007976 KEV
% 207.76/207.91  |- mesh__dateCreated mesh__D007976 1974-11-19
% 207.76/207.91  |- skos__scopeNote mesh__D007976
% 207.76/207.91       A group of acylated oligopeptides produced by Actinomycetes that function as protease inhibitors. They have been known to inhibit to varying degrees trypsin, plasmin, KALLIKREINS, papain and the cathepsins.%A%    
% 207.76/207.91  |- mesh__publicMeSHNote mesh__D007976
% 207.76/207.91       91; was see under OLIGOPEPTIDES 1975-90   
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D007976 2001
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D007976 2006
% 207.76/207.91  |- skos__annotation mesh__D007976 protease inhib   
% 207.76/207.91  |- mesh__dateEstablished mesh__D007976 1991-01-01
% 207.76/207.91  |- mesh__recordAuthorizer mesh__D007976 sjn
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D007976 2003
% 207.76/207.91  |- mesh__recordOriginator mesh__D007976 NLM
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D007976 2000
% 207.76/207.91  |- skos__prefLabel mesh__D007976 Leupeptins
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D007976 2005
% 207.76/207.91  |- skos__historyNote mesh__D007976 Oligopeptides %28%1973-1974%29%
% 207.76/207.91  |- rdf__type mesh__D007976sskos__Concept
% 207.76/207.91  |- mesh__historyNote mesh__D007976
% 207.76/207.91       91%28%75%29%; was see under OLIGOPEPTIDES 1975-90   
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D007976 2002
% 207.76/207.91  |- skos__broader mesh__D007976smesh__D009842
% 207.76/207.91  |- mesh__dateRevised mesh__D007976 1999-11-09
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D007976 2004
% 207.76/207.91  |- skos__hiddenLabel mesh__D007178 Backcrossings
% 207.76/207.91  |- mesh__recordOriginator mesh__D007178 NLM
% 207.76/207.91  |- skos__prefLabel mesh__D007178 Inbreeding
% 207.76/207.91  |- mesh__dateCreated mesh__D007178 1999-01-01
% 207.76/207.91  |- skos__broader mesh__D007178smesh__D001947
% 207.76/207.91  |- skos__historyNote mesh__D007178 Genetics %28%1966-1967%29%
% 207.76/207.91  |- skos__hiddenLabel mesh__D007178 Self Fertilization
% 207.76/207.91  |- mesh__publicMeSHNote mesh__D007178 68   
% 207.76/207.91  |- mesh__dateEstablished mesh__D007178 1968-01-01
% 207.76/207.91  |- skos__related mesh__D007178smesh__D003241
% 207.76/207.91  |- skos__scopeNote mesh__D007178
% 207.76/207.91       The mating of plants or non-human animals which are closely related genetically.%A%    
% 207.76/207.91  |- mesh__activeMeSHYear mesh__D007178 2004
% 207.76/207.91  |- skos__related mesh__D007178smesh__D017849
% 207.76/207.92  |- mesh__recordMaintainer mesh__D007178 lkt
% 207.76/207.92  |- skos__hiddenLabel mesh__D007178 Mating, Sib
% 207.76/207.92  |- skos__annotation mesh__D007178
% 207.76/207.92       animal only: for humans use CONSANGUINITY; no qualif; restrict to inbreeding as a genetic concept or a technique: not a routine term for inbred animals %28% = ANIMALS, INBRED STRAINS or specific%29%%A%  
% 207.76/207.92  |- mesh__historyNote mesh__D007178 68   
% 207.76/207.92  |- mesh__dateRevised mesh__D007178 2002-07-02
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007178 2003
% 207.76/207.92  |- skos__hiddenLabel mesh__D007178 Sib Matings
% 207.76/207.92  |- skos__hiddenLabel mesh__D007178 Matings, Sib
% 207.76/207.92  |- mesh__recordAuthorizer mesh__D007178 sjn
% 207.76/207.92  |- skos__hiddenLabel mesh__D007178 Half Sib Mating
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007178 2006
% 207.76/207.92  |- skos__hiddenLabel mesh__D007178 Half-Sib Matings
% 207.76/207.92  |- skos__historyNote mesh__D007178 Genetics, Population %28%1966-1967%29%
% 207.76/207.92  |- skos__hiddenLabel mesh__D007178 Self-Fertilizations
% 207.76/207.92  |- rdf__type mesh__D007178sskos__Concept
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007178 2005
% 207.76/207.92  |- skos__hiddenLabel mesh__D007178 Matings, Half-Sib
% 207.76/207.92  |- skos__hiddenLabel mesh__D007178 Mating, Half-Sib
% 207.76/207.92  |- mesh__recordMaintainer mesh__D012312 CCR
% 207.76/207.92  |- skos__scopeNote mesh__D012312
% 207.76/207.92       Adrenergic beta-agonist used to control premature labor.%A%    
% 207.76/207.92  |- skos__hiddenLabel mesh__D012312 Pre Par
% 207.76/207.92  |- skos__altLabel mesh__D012312 Pre-Par
% 207.76/207.92  |- mesh__dateCreated mesh__D012312 1974-11-19
% 207.76/207.92  |- skos__prefLabel mesh__D012312 Ritodrine
% 207.76/207.92  |- mesh__historyNote mesh__D012312
% 207.76/207.92       86%28%75%29%; was see under PROPANOLAMINES 1975-85   
% 207.76/207.92  |- skos__altLabel mesh__D012312 Janssen Brand of Ritodrine Hydrochloride
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D012312 2006
% 207.76/207.92  |- skos__altLabel mesh__D012312 Astra Brand of Ritodrine Hydrochloride
% 207.76/207.92  |- skos__historyNote mesh__D012312 Phenethylamines %28%1971-1974%29%
% 207.76/207.92  |- mesh__publicMeSHNote mesh__D012312
% 207.76/207.92       86; was see under PROPANOLAMINES 1975-85   
% 207.76/207.92  |- mesh__dateEstablished mesh__D012312 1986-01-01
% 207.76/207.92  |- skos__altLabel mesh__D012312 Solvay Brand of Ritodrine Hydrochloride
% 207.76/207.92  |- skos__hiddenLabel mesh__D012312 DU 21220
% 207.76/207.92  |- skos__broader mesh__D012312smesh__D010627
% 207.76/207.92  |- skos__hiddenLabel mesh__D012312 PrePar
% 207.76/207.92  |- skos__historyNote mesh__D012312 Phenols %28%1971-1974%29%
% 207.76/207.92  |- rdf__type mesh__D012312sskos__Concept
% 207.76/207.92  |- skos__hiddenLabel mesh__D012312 DU21220
% 207.76/207.92  |- mesh__dateRevised mesh__D012312 2005-06-30
% 207.76/207.92  |- skos__historyNote mesh__D012312 Propanolamines %28%1974%29%
% 207.76/207.92  |- mesh__recordAuthorizer mesh__D012312 sjn
% 207.76/207.92  |- mesh__recordOriginator mesh__D012312 NLM
% 207.76/207.92  |- skos__hiddenLabel mesh__D012312 Hydrochloride, Ritodrine
% 207.76/207.92  |- skos__broader mesh__D012312smesh__D011412
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003586 1998
% 207.76/207.92  |- mesh__recordAuthorizer mesh__D003586 PLS
% 207.76/207.92  |- mesh__onlineNote mesh__D003586
% 207.76/207.92       use CYTOMEGALOVIRUS INFECTIONS to search CYTOMEGALIC INCLUSION DISEASE 1966-93%A%  
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003586 2003
% 207.76/207.92  |- skos__hiddenLabel mesh__D003586 Cytomegalic Inclusion Diseases
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003586 2001
% 207.76/207.92  |- skos__altLabel mesh__D003586 Cytomegalic Inclusion Disease
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003586 1994
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003586 2005
% 207.76/207.92  |- skos__altLabel mesh__D003586 Salivary Gland Virus Disease
% 207.76/207.92  |- mesh__publicMeSHNote mesh__D003586
% 207.76/207.92       94; was CYTOMEGALIC INCLUSION DISEASE 1963-93; CYTOMEGALOVIRUS INFECTIONS was see CYTOMEGALIC INCLUSION DISEASE 1992-93%A%  
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003586 2000
% 207.76/207.92  |- skos__altLabel mesh__D003586 Inclusion Disease
% 207.76/207.92  |- skos__altLabel mesh__D003586 Infections, Cytomegalovirus
% 207.76/207.92  |- mesh__dateRevised mesh__D003586 1993-06-04
% 207.76/207.92  |- rdf__type mesh__D003586sskos__Concept
% 207.76/207.92  |- mesh__recordOriginator mesh__D003586 NLM
% 207.76/207.92  |- skos__hiddenLabel mesh__D003586 Inclusion Diseases
% 207.76/207.92  |- skos__hiddenLabel mesh__D003586 Cytomegalovirus Infection
% 207.76/207.92  |- skos__prefLabel mesh__D003586 Cytomegalovirus Infections
% 207.76/207.92  |- skos__hiddenLabel mesh__D003586 Inclusion Diseases, Cytomegalic
% 207.76/207.92  |- mesh__recordMaintainer mesh__D003586 AGS
% 207.76/207.92  |- skos__broader mesh__D003586smesh__D006566
% 207.76/207.92  |- skos__hiddenLabel mesh__D003586 Disease, Cytomegalic Inclusion
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003586 1997
% 207.76/207.92  |- skos__scopeNote mesh__D003586
% 207.76/207.92       Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults.%A%    
% 207.76/207.92  |- mesh__historyNote mesh__D003586
% 207.76/207.92       94; was CYTOMEGALIC INCLUSION DISEASE 1963-93; CYTOMEGALOVIRUS INFECTIONS was see CYTOMEGALIC INCLUSION DISEASE 1992-93%A%  
% 207.76/207.92  |- skos__hiddenLabel mesh__D003586 Inclusion Disease, Cytomegalic
% 207.76/207.92  |- mesh__dateCreated mesh__D003586 1999-01-01
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003586 1999
% 207.76/207.92  |- skos__annotation mesh__D003586
% 207.76/207.92       caused by a herpesvirus; GEN or unspecified; DF: note short X ref%A%  
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003586 2004
% 207.76/207.92  |- skos__hiddenLabel mesh__D003586 Infection, Cytomegalovirus
% 207.76/207.92  |- skos__hiddenLabel mesh__D003586 Diseases, Cytomegalic Inclusion
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003586 2002
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003586 1996
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003586 1995
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003586 2006
% 207.76/207.92  |- skos__broader mesh__D008271smesh__D009617
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D008271 2004
% 207.76/207.92  |- skos__hiddenLabel mesh__D008271 Maduromycoses
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D008271 2002
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D008271 2003
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D008271 2006
% 207.76/207.92  |- skos__hiddenLabel mesh__D008271 Mycetomas
% 207.76/207.92  |- skos__altLabel mesh__D008271 Madura Foot
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D008271 2001
% 207.76/207.92  |- mesh__dateCreated mesh__D008271 1999-01-01
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D008271 2005
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D008271 1997
% 207.76/207.92  |- mesh__dateRevised mesh__D008271 1994-02-08
% 207.76/207.92  |- skos__broader mesh__D008271smesh__D003881
% 207.76/207.92  |- skos__annotation mesh__D008271
% 207.76/207.92       caused by various fungi or bacteria; coord with causative organism %28%IM%29% or precoord organism/dis %28%IM%29% if pertinent%A%  
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D008271 2000
% 207.76/207.92  |- rdf__type mesh__D008271sskos__Concept
% 207.76/207.92  |- skos__altLabel mesh__D008271 Mycetoma
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D008271 1996
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D008271 1999
% 207.76/207.92  |- mesh__recordAuthorizer mesh__D008271 PLS
% 207.76/207.92  |- skos__prefLabel mesh__D008271 Maduromycosis
% 207.76/207.92  |- skos__broader mesh__D008271smesh__D017192
% 207.76/207.92  |- skos__scopeNote mesh__D008271
% 207.76/207.92       A disease caused by various fungi %28%Madurella mycetomi%29% or actinomycetes %28%Nocardia brasiliensis%29%. It usually affects the foot, hand, and legs with tissues becoming necrosed and swollen after infection.%A%    
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D008271 1995
% 207.76/207.92  |- mesh__recordMaintainer mesh__D008271 PXP
% 207.76/207.92  |- mesh__recordOriginator mesh__D008271 NLM
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D008271 1998
% 207.76/207.92  |- skos__hiddenLabel mesh__D008271 Foot, Madura
% 207.76/207.92  |- mesh__dateCreated mesh__D016703 1991-02-11
% 207.76/207.92  |- skos__scopeNote mesh__D016703
% 207.76/207.92       A republic in central Africa, north of GABON and bounded on the west by the Atlantic Ocean. Its capital is Malabo. Equatorial Guinea was discovered by the Portuguese in 1491 and ceded to Spain in 1778. The country gained independence in 1968. Equatorial refers to its location near the equator in the broad region long known as Guinea %28%from the Tuareg aginaw, black people%29%. %28%From Webster%27%s New Geographical Dictionary, 1988, p375 %26% Room, Brewer%27%s Dictionary of Names, 1992, p173, 222%29%%A%    
% 207.76/207.92  |- mesh__historyNote mesh__D016703 92; was see AFRICA, CENTRAL 1987-91   
% 207.76/207.92  |- mesh__onlineNote mesh__D016703
% 207.76/207.92       use AFRICA, CENTRAL to search EQUATORIAL GUINEA 1987-91   
% 207.76/207.92  |- skos__altLabel mesh__D016703 Guinea, Spanish
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D016703 2003
% 207.76/207.92  |- mesh__recordOriginator mesh__D016703 TGC
% 207.76/207.92  |- skos__historyNote mesh__D016703 Africa, Central %28%1966-1991%29%
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D016703 2004
% 207.76/207.92  |- skos__prefLabel mesh__D016703 Equatorial Guinea
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D016703 2002
% 207.76/207.92  |- skos__annotation mesh__D016703
% 207.76/207.92       a republic in central Africa; formerly Spanish Guinea; do not confuse with GUINEA %28%formerly French Guinea%29% or GUINEA-BISSAU %28%formerly Portuguese Guinea%29%; in titles %26% translations spell R%C3%%AD%o Muni with accent%A%  
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D016703 2005
% 207.76/207.92  |- mesh__recordMaintainer mesh__D016703 jls
% 207.76/207.92  |- mesh__dateRevised mesh__D016703 2001-08-13
% 207.76/207.92  |- skos__altLabel mesh__D016703 Spanish Guinea
% 207.76/207.92  |- mesh__recordAuthorizer mesh__D016703 sjn
% 207.76/207.92  |- mesh__dateEstablished mesh__D016703 1992-01-01
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D016703 2006
% 207.76/207.92  |- skos__broader mesh__D016703smesh__D000350
% 207.76/207.92  |- rdf__type mesh__D016703sskos__Concept
% 207.76/207.92  |- skos__scopeNote mesh__D007977
% 207.76/207.92       An opioid antagonist with properties similar to those of NALOXONE; in addition it also possesses some agonist properties. It should be used cautiously; levallorphan reverses severe opioid-induced respiratory depression but may exacerbate respiratory depression such as that induced by alcohol or other non-opioid central depressants. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p683%29%%A%    
% 207.76/207.92  |- mesh__dateCreated mesh__D007977 1999-01-01
% 207.76/207.92  |- mesh__dateEstablished mesh__D007977 1965-01-01
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007977 2002
% 207.76/207.92  |- rdf__type mesh__D007977sskos__Concept
% 207.76/207.92  |- mesh__recordMaintainer mesh__D007977 TWD
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007977 2001
% 207.76/207.92  |- skos__altLabel mesh__D007977 Naloxiphan
% 207.76/207.92  |- skos__broader mesh__D007977smesh__D009019
% 207.76/207.92  |- mesh__recordAuthorizer mesh__D007977 sjn
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007977 2004
% 207.76/207.92  |- mesh__recordOriginator mesh__D007977 NLM
% 207.76/207.92  |- mesh__dateRevised mesh__D007977 2000-06-22
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007977 2006
% 207.76/207.92  |- mesh__publicMeSHNote mesh__D007977
% 207.76/207.92       65; was see under NARCOTIC ANTAGONISTS 1963-64   
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007977 2003
% 207.76/207.92  |- mesh__historyNote mesh__D007977
% 207.76/207.92       65; was see under NARCOTIC ANTAGONISTS 1963-64   
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007977 2005
% 207.76/207.92  |- skos__prefLabel mesh__D007977 Levallorphan
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007179 1997
% 207.76/207.92  |- skos__prefLabel mesh__D007179 Incest
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007179 2000
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007179 2003
% 207.76/207.92  |- mesh__recordAuthorizer mesh__D007179 PLS
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007179 1998
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007179 2001
% 207.76/207.92  |- skos__annotation mesh__D007179 /ethnol /psychol permitted   
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007179 2004
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007179 1999
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007179 2002
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007179 2005
% 207.76/207.92  |- mesh__recordOriginator mesh__D007179 NLM
% 207.76/207.92  |- skos__scopeNote mesh__D007179
% 207.76/207.92       Sexual intercourse between persons so closely related that they are forbidden by law to marry.%A%    
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007179 1995
% 207.76/207.92  |- skos__historyNote mesh__D007179 Paraphilias %28%1966%29%
% 207.76/207.92  |- mesh__dateRevised mesh__D007179 1994-03-17
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007179 2006
% 207.76/207.92  |- mesh__dateEstablished mesh__D007179 1967-01-01
% 207.76/207.92  |- mesh__dateCreated mesh__D007179 1999-01-01
% 207.76/207.92  |- mesh__publicMeSHNote mesh__D007179 67   
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007179 1996
% 207.76/207.92  |- mesh__recordMaintainer mesh__D007179 PLS
% 207.76/207.92  |- skos__broader mesh__D007179smesh__D012940
% 207.76/207.92  |- mesh__historyNote mesh__D007179 67   
% 207.76/207.92  |- rdf__type mesh__D007179sskos__Concept
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D012313 2003
% 207.76/207.92  |- skos__altLabel mesh__D012313 RNA, Non-Polyadenylated
% 207.76/207.92  |- skos__altLabel mesh__D012313 Gene Products, RNA
% 207.76/207.92  |- mesh__onlineNote mesh__D012313
% 207.76/207.92       use RNA %28%NM%29% to search RNA, NON-POLYADENYLATED 1981-94   
% 207.76/207.92  |- skos__hiddenLabel mesh__D012313 RNA Gene Products
% 207.76/207.92  |- skos__altLabel mesh__D012313 Ribonucleic Acid
% 207.76/207.92  |- skos__hiddenLabel mesh__D012313 Acid, Ribonucleic
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D012313 2002
% 207.76/207.92  |- skos__annotation mesh__D012313
% 207.76/207.92       /immunol: consider also IMMUNE RNA MANIPULATION see IMMUNOTHERAPY, ACTIVE%A%  
% 207.76/207.92  |- skos__broader mesh__D012313smesh__D009696
% 207.76/207.92  |- skos__hiddenLabel mesh__D012313 Non Polyadenylated RNA
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D012313 2001
% 207.76/207.92  |- mesh__historyNote mesh__D012313
% 207.76/207.92       RNA, NON-POLYADENYLATED was NON-POLYADENYLATED RNA %28%NM%29% 1981-94%A%  
% 207.76/207.92  |- mesh__recordMaintainer mesh__D012313 nns
% 207.76/207.92  |- skos__scopeNote mesh__D012313
% 207.76/207.92       A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. %28%Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A%    
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D012313 2006
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D012313 2000
% 207.76/207.92  |- rdf__type mesh__D012313sskos__Concept
% 207.76/207.92  |- mesh__dateCreated mesh__D012313 1999-01-01
% 207.76/207.92  |- mesh__dateRevised mesh__D012313 1999-11-03
% 207.76/207.92  |- skos__hiddenLabel mesh__D012313 RNA, Non Polyadenylated
% 207.76/207.92  |- mesh__recordOriginator mesh__D012313 NLM
% 207.76/207.92  |- mesh__recordAuthorizer mesh__D012313 sjn
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D012313 2005
% 207.76/207.92  |- skos__related mesh__D012313smesh__D009562
% 207.76/207.92  |- mesh__publicMeSHNote mesh__D012313
% 207.76/207.92       NON-POLYADENYLATED RNA was indexed under RNA, NEOPLASM 1981-94%A%  
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D012313 2004
% 207.76/207.92  |- skos__prefLabel mesh__D012313 RNA
% 207.76/207.92  |- skos__altLabel mesh__D012313 Non-Polyadenylated RNA
% 207.76/207.92  |- mesh__dateEstablished mesh__D036761 2003-01-01
% 207.76/207.92  |- skos__hiddenLabel mesh__D036761
% 207.76/207.92       Transrectal High Intensity Focused Ultrasound
% 207.76/207.92  |- mesh__recordAuthorizer mesh__D036761 sjn
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D036761 2006
% 207.76/207.92  |- skos__historyNote mesh__D036761 Ultrasonic Therapy %28%1994-2002%29%
% 207.76/207.92  |- skos__annotation mesh__D036761 DF: TRANSRECTAL HIFU   
% 207.76/207.92  |- mesh__publicMeSHNote mesh__D036761 2003   
% 207.76/207.92  |- skos__scopeNote mesh__D036761
% 207.76/207.92       Tissue ablation of the PROSTATE performed by ultrasound from a transducer placed in the RECTUM. The procedure is used to treat prostate cancer %28%PROSTATIC NEOPLASMS%29% and benign prostatic hypertrophy %28%PROSTATIC HYPERPLASIA%29%.%A%    
% 207.76/207.92  |- skos__broader mesh__D036761smesh__D013521
% 207.76/207.92  |- mesh__recordOriginator mesh__D036761 ags
% 207.76/207.92  |- mesh__dateCreated mesh__D036761 2002-07-03
% 207.76/207.92  |- mesh__dateRevised mesh__D036761 2005-06-30
% 207.76/207.92  |- skos__prefLabel mesh__D036761
% 207.76/207.92       Ultrasound, High-Intensity Focused, Transrectal
% 207.76/207.92  |- skos__altLabel mesh__D036761
% 207.76/207.92       Transrectal High-Intensity Focused Ultrasound
% 207.76/207.92  |- rdf__type mesh__D036761sskos__Concept
% 207.76/207.92  |- mesh__recordMaintainer mesh__D036761 lkt
% 207.76/207.92  |- skos__broader mesh__D036761smesh__D014464
% 207.76/207.92  |- mesh__historyNote mesh__D036761 2003   
% 207.76/207.92  |- skos__hiddenLabel mesh__D003587 Cytomegaloviruses
% 207.76/207.92  |- mesh__publicMeSHNote mesh__D003587
% 207.76/207.92       94; was CYTOMEGALOVIRUSES 1966-93; SALIVARY GLAND VIRUSES was see under CYTOMEGALOVIRUSES 1966-78%A%  
% 207.76/207.92  |- mesh__dateEstablished mesh__D003587 1966-01-01
% 207.76/207.92  |- skos__altLabel mesh__D003587 Herpesvirus 5 %28%beta%29%, Human
% 207.76/207.92  |- skos__altLabel mesh__D003587 HHV 5
% 207.76/207.92  |- skos__scopeNote mesh__D003587
% 207.76/207.92       A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS.%A%    
% 207.76/207.92  |- skos__altLabel mesh__D003587 Human Herpesvirus 5
% 207.76/207.92  |- skos__hiddenLabel mesh__D003587 Viruses, Salivary Gland
% 207.76/207.92  |- mesh__dateCreated mesh__D003587 1999-01-01
% 207.76/207.92  |- mesh__historyNote mesh__D003587
% 207.76/207.92       94; was CYTOMEGALOVIRUSES 1966-93; SALIVARY GLAND VIRUSES was see under CYTOMEGALOVIRUSES 1966-78%A%  
% 207.76/207.92  |- rdf__type mesh__D003587sskos__Concept
% 207.76/207.92  |- skos__prefLabel mesh__D003587 Cytomegalovirus
% 207.76/207.92  |- skos__broader mesh__D003587smesh__D018141
% 207.76/207.92  |- mesh__recordAuthorizer mesh__D003587 sjn
% 207.76/207.92  |- skos__annotation mesh__D003587
% 207.76/207.92       infection = CYTOMEGALOVIRUS INFECTIONS; DF: HHV 5   
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003587 2003
% 207.76/207.92  |- mesh__onlineNote mesh__D003587
% 207.76/207.92       use CYTOMEGALOVIRUS to search CYTOMEGALOVIRUSES 1966-93 %26% SALIVARY GLAND VIRUSES 1966-78.%A%  
% 207.76/207.92  |- skos__hiddenLabel mesh__D003587 Salivary Gland Virus
% 207.76/207.92  |- mesh__dateRevised mesh__D003587 2001-07-25
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003587 2005
% 207.76/207.92  |- skos__altLabel mesh__D003587 Salivary Gland Viruses
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003587 2004
% 207.76/207.92  |- skos__hiddenLabel mesh__D003587 Virus, Salivary Gland
% 207.76/207.92  |- mesh__recordOriginator mesh__D003587 NLM
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003587 2002
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003587 2006
% 207.76/207.92  |- mesh__recordMaintainer mesh__D003587 ags
% 207.76/207.92  |- skos__altLabel mesh__D008272 Sanofi Winthrop Brand of Mafenide Acetate
% 207.76/207.92  |- mesh__recordMaintainer mesh__D008272 CCR
% 207.76/207.92  |- skos__broader mesh__D008272smesh__D013449
% 207.76/207.92  |- mesh__recordAuthorizer mesh__D008272 sjn
% 207.76/207.92  |- skos__altLabel mesh__D008272 4-Homosulfanilamide
% 207.76/207.92  |- mesh__historyNote mesh__D008272
% 207.76/207.92       91%28%75%29%; was see under SULFONAMIDES 1975-90   
% 207.76/207.92  |- skos__altLabel mesh__D008272 Bensulfamide
% 207.76/207.92  |- mesh__recordOriginator mesh__D008272 NLM
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D008272 2006
% 207.76/207.92  |- mesh__dateCreated mesh__D008272 1974-11-11
% 207.76/207.92  |- skos__altLabel mesh__D008272 Sulfabenzamine
% 207.76/207.92  |- skos__hiddenLabel mesh__D008272 4 Homosulfanilamide
% 207.76/207.92  |- skos__scopeNote mesh__D008272
% 207.76/207.92       A sulfonamide that inhibits the enzyme carbonic anhydrase and is used as topical anti-infective, especially in burn therapy.%A%    
% 207.76/207.92  |- skos__historyNote mesh__D008272 Tosyl Compounds %28%1973-1974%29%
% 207.76/207.92  |- skos__hiddenLabel mesh__D008272 Acetate, Mafenide
% 207.76/207.92  |- mesh__dateEstablished mesh__D008272 1991-01-01
% 207.76/207.92  |- rdf__type mesh__D008272sskos__Concept
% 207.76/207.92  |- skos__historyNote mesh__D008272 Sulfonamides %28%1970-1974%29%
% 207.76/207.92  |- skos__altLabel mesh__D008272 Maphenid
% 207.76/207.92  |- mesh__publicMeSHNote mesh__D008272
% 207.76/207.92       91; was see under SULFONAMIDES 1975-90   
% 207.76/207.92  |- skos__altLabel mesh__D008272 Bertek Brand of Mafenide Acetate
% 207.76/207.92  |- skos__prefLabel mesh__D008272 Mafenide
% 207.76/207.92  |- mesh__dateRevised mesh__D008272 2005-06-30
% 207.76/207.92  |- skos__historyNote mesh__D016704 Nerve Tissue Proteins %28%1966-1991%29%
% 207.76/207.92  |- mesh__dateEstablished mesh__D016704 1992-01-01
% 207.76/207.92  |- mesh__dateRevised mesh__D016704 2005-07-11
% 207.76/207.92  |- skos__prefLabel mesh__D016704 Synapsins
% 207.76/207.92  |- skos__broader mesh__D016704smesh__D009419
% 207.76/207.92  |- mesh__recordMaintainer mesh__D016704 ags
% 207.76/207.92  |- mesh__recordAuthorizer mesh__D016704 ags
% 207.76/207.92  |- mesh__historyNote mesh__D016704
% 207.76/207.92       1992; use SYNAPSINS %28%NM%29% 1981-1991   
% 207.76/207.92  |- skos__historyNote mesh__D016704 Phosphoproteins %28%1970-1991%29%
% 207.76/207.92  |- mesh__recordOriginator mesh__D016704 RLS
% 207.76/207.92  |- mesh__publicMeSHNote mesh__D016704 1992   
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D016704 2006
% 207.76/207.92  |- skos__broader mesh__D016704smesh__D010750
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D016704 2006A
% 207.76/207.92  |- mesh__dateCreated mesh__D016704 1991-07-12
% 207.76/207.92  |- rdf__type mesh__D016704sskos__Concept
% 207.76/207.92  |- skos__scopeNote mesh__D016704
% 207.76/207.92       A family of synaptic vesicle-associated proteins involved in the short-term regulation of NEUROTRANSMITTER release. Synapsin I, the predominant member of this family, links SYNAPTIC VESICLES to ACTIN FILAMENTS in the presynaptic nerve terminal. These interactions are modulated by the reversible PHOSPHORYLATION of synapsin I through various signal transduction pathways. The protein is also a substrate for cAMP- and CALCIUM-CALMODULIN DEPENDENT PROTEIN KINASES. It is believed that these functional properties are also shared by synapsin II.%A%    
% 207.76/207.92  |- skos__historyNote mesh__D016704 Neuropeptides %28%1987-1991%29%
% 207.76/207.92  |- mesh__dateCreated mesh__D007978 1999-01-01
% 207.76/207.92  |- skos__prefLabel mesh__D007978 Levamisole
% 207.76/207.92  |- skos__altLabel mesh__D007978 L-Tetramisole
% 207.76/207.92  |- rdf__type mesh__D007978sskos__Concept
% 207.76/207.92  |- skos__scopeNote mesh__D007978
% 207.76/207.92       An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. %28%From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6%29%%A%    
% 207.76/207.92  |- skos__altLabel mesh__D007978 Levotetramisole
% 207.76/207.92  |- skos__broader mesh__D007978smesh__D013844
% 207.76/207.92  |- mesh__recordMaintainer mesh__D007978 ssb
% 207.76/207.92  |- mesh__historyNote mesh__D007978 74   
% 207.76/207.92  |- mesh__publicMeSHNote mesh__D007978 74   
% 207.76/207.92  |- mesh__dateEstablished mesh__D007978 1974-01-01
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D007978 2006
% 207.76/207.92  |- skos__hiddenLabel mesh__D007978 Hydrochloride, Levamisole
% 207.76/207.92  |- skos__altLabel mesh__D007978 Decaris
% 207.76/207.92  |- mesh__dateRevised mesh__D007978 2005-06-30
% 207.76/207.92  |- mesh__recordAuthorizer mesh__D007978 sjn
% 207.76/207.92  |- mesh__recordOriginator mesh__D007978 NLM
% 207.76/207.92  |- skos__broader mesh__D007978smesh__D007093
% 207.76/207.92  |- mesh__dateRevised mesh__D004680 2001-07-25
% 207.76/207.92  |- skos__annotation mesh__D004680
% 207.76/207.92       do not confuse X ref MURINE ENCEPHALOMYELITIS VIRUS with THEILER%27%S MURINE ENCEPHALOMYELITIS VIRUS; infection: coord IM with CARDIOVIRUS INFECTIONS %28%IM%29%; DF: ENCEPH VIRUS MURINE%A%  
% 207.76/207.92  |- mesh__historyNote mesh__D004680
% 207.76/207.92       2002 %28%1963%29%; for MOUSE ELBERFELD VIRUS use ENCEPHALOMYOCARDITIS VIRUS 1997-2001%A%  
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D004680 2005
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D004680 2003
% 207.76/207.92  |- skos__scopeNote mesh__D004680
% 207.76/207.92       A strain of ENCEPHALOMYOCARDITIS VIRUS, a species of CARDIOVIRUS, usually causing an inapparent intestinal infection in mice. A small number of mice may show signs of flaccid paralysis.%A%    
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D004680 2006
% 207.76/207.92  |- mesh__dateEstablished mesh__D004680 1991-01-01
% 207.76/207.92  |- mesh__dateCreated mesh__D004680 1999-01-01
% 207.76/207.92  |- mesh__recordAuthorizer mesh__D004680 sjn
% 207.76/207.92  |- skos__altLabel mesh__D004680 Murine Encephalomyelitis Virus
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D004680 2004
% 207.76/207.92  |- skos__altLabel mesh__D004680 Mouse Elberfeld Virus
% 207.76/207.92  |- rdf__type mesh__D004680sskos__Concept
% 207.76/207.92  |- skos__altLabel mesh__D004680 Mouse Encephalomyelitis Virus
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D004680 2002
% 207.76/207.92  |- skos__altLabel mesh__D004680 Encephalomyelitis Virus, Murine
% 207.76/207.92  |- skos__broader mesh__D004680smesh__D004686
% 207.76/207.92  |- mesh__recordMaintainer mesh__D004680 ags
% 207.76/207.92  |- mesh__publicMeSHNote mesh__D004680
% 207.76/207.92       2002; see ENCEPHALOMYELITIS VIRUS, MURINE 1991-2001, see ENTEROVIRUSES 1975-1990, see ENTEROVIRUS 1967-1974, see POLIOVIRUS 1963-1966; for MOUSE ELBERFELD VIRUS see ENCEPHALOMYOCARDITIS VIRUS 1997-2001%A%  
% 207.76/207.92  |- mesh__recordOriginator mesh__D004680 NLM
% 207.76/207.92  |- skos__prefLabel mesh__D004680 Maus Elberfeld virus
% 207.76/207.92  |- skos__hiddenLabel mesh__D004680 Encephalomyelitis Virus, Mouse
% 207.76/207.92  |- skos__broader mesh__D005333Q000736smesh__D005333
% 207.76/207.92  |- mesh__preferredCombination mesh__D005333Q000736smesh__D016216
% 207.76/207.92  |- rdf__type mesh__D005333Q000736smesh__CompoundConcept
% 207.76/207.92  |- skos__scopeNote mesh__D012314
% 207.76/207.92       Analogs of RNA cap compounds which do not have a positive charge. These compounds inhibit the initiation of translation of both capped and uncapped messenger RNA.%A%    
% 207.76/207.92  |- mesh__dateRevised mesh__D012314 2005-06-30
% 207.76/207.92  |- skos__annotation mesh__D012314 IM; /drug eff /ultrastruct permitted   
% 207.76/207.92  |- mesh__recordMaintainer mesh__D012314 ags
% 207.76/207.92  |- mesh__publicMeSHNote mesh__D012314 91; was see under RNA CAPS 1980-90   
% 207.76/207.92  |- skos__hiddenLabel mesh__D012314 Analogs, RNA Cap
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D012314 2006
% 207.76/207.92  |- rdf__type mesh__D012314sskos__Concept
% 207.76/207.92  |- skos__hiddenLabel mesh__D012314 Analogues, RNA Cap
% 207.76/207.92  |- skos__broader mesh__D012314smesh__D012315
% 207.76/207.92  |- skos__altLabel mesh__D012314 RNA Cap Analogues
% 207.76/207.92  |- mesh__recordOriginator mesh__D012314 RLS
% 207.76/207.92  |- mesh__dateEstablished mesh__D012314 1991-01-01
% 207.76/207.92  |- skos__historyNote mesh__D012314 Guanine Nucleotides %28%1966-1979%29%
% 207.76/207.92  |- skos__historyNote mesh__D012314 RNA, Messenger %28%1966-1979%29%
% 207.76/207.92  |- mesh__dateCreated mesh__D012314 1979-05-25
% 207.76/207.92  |- skos__prefLabel mesh__D012314 RNA Cap Analogs
% 207.76/207.92  |- skos__historyNote mesh__D012314 Oligoribonucleotides %28%1976-1979%29%
% 207.76/207.92  |- skos__hiddenLabel mesh__D012314 Cap Analogues, RNA
% 207.76/207.92  |- mesh__recordAuthorizer mesh__D012314 sjn
% 207.76/207.92  |- skos__historyNote mesh__D012314 Ribonucleotides %28%1971-1975%29%
% 207.76/207.92  |- skos__hiddenLabel mesh__D012314 Cap Analogs, RNA
% 207.76/207.92  |- mesh__historyNote mesh__D012314
% 207.76/207.92       91%28%80%29%; was see under RNA CAPS 1980-90   
% 207.76/207.92  |- skos__broader mesh__D003588smesh__D003581
% 207.76/207.92  |- mesh__recordOriginator mesh__D003588 NLM
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003588 2002
% 207.76/207.92  |- skos__altLabel mesh__D003588 Viral Cytopathogenic Effect
% 207.76/207.92  |- skos__hiddenLabel mesh__D003588 Cytopathic Effects, Viral
% 207.76/207.92  |- mesh__dateCreated mesh__D003588 1999-01-01
% 207.76/207.92  |- rdf__type mesh__D003588sskos__Concept
% 207.76/207.92  |- mesh__publicMeSHNote mesh__D003588 68   
% 207.76/207.92  |- skos__related mesh__D003588smesh__D010948
% 207.76/207.92  |- skos__hiddenLabel mesh__D003588 Viral Cytopathogenic Effects
% 207.76/207.92  |- skos__hiddenLabel mesh__D003588 Cytopathogenic Effects, Viral
% 207.76/207.92  |- skos__hiddenLabel mesh__D003588 Effect, Viral Cytopathic
% 207.76/207.92  |- mesh__recordMaintainer mesh__D003588 PXP
% 207.76/207.92  |- skos__hiddenLabel mesh__D003588 Effects, Viral Cytopathogenic
% 207.76/207.92  |- mesh__recordAuthorizer mesh__D003588 SJN
% 207.76/207.92  |- skos__broader mesh__D003588smesh__D018406
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003588 1998
% 207.76/207.92  |- skos__annotation mesh__D003588
% 207.76/207.92       NIM; do not confuse with CELL TRANSFORMATION, VIRAL: see note there; DF: CPE or CPE VIRAL%A%  
% 207.76/207.92  |- skos__prefLabel mesh__D003588 Cytopathogenic Effect, Viral
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003588 2003
% 207.76/207.92  |- skos__altLabel mesh__D003588 Cytopathic Effect, Viral
% 207.76/207.92  |- mesh__dateRevised mesh__D003588 1997-06-20
% 207.76/207.92  |- skos__hiddenLabel mesh__D003588 Viral Cytopathic Effects
% 207.76/207.92  |- skos__hiddenLabel mesh__D003588 Effects, Viral Cytopathic
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003588 2000
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003588 2005
% 207.76/207.92  |- mesh__dateEstablished mesh__D003588 1968-01-01
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003588 1999
% 207.76/207.92  |- skos__hiddenLabel mesh__D003588 Effect, Viral Cytopathogenic
% 207.76/207.92  |- mesh__historyNote mesh__D003588 68%28%64%29%   
% 207.76/207.92  |- mesh__activeMeSHYear mesh__D003588 2004
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D003588 2001
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D003588 2006
% 207.76/207.93  |- skos__scopeNote mesh__D003588
% 207.76/207.93       Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses.%A%    
% 207.76/207.93  |- skos__hiddenLabel mesh__D003588 Viral Cytopathic Effect
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D008273 2006
% 207.76/207.93  |- skos__prefLabel mesh__D008273 Magic
% 207.76/207.93  |- skos__broader mesh__D008273smesh__D013483
% 207.76/207.93  |- mesh__recordAuthorizer mesh__D008273 sjn
% 207.76/207.93  |- rdf__type mesh__D008273sskos__Concept
% 207.76/207.93  |- mesh__recordOriginator mesh__D008273 NLM
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D008273 2002
% 207.76/207.93  |- skos__scopeNote mesh__D008273
% 207.76/207.93       Beliefs and practices concerned with producing desired results through supernatural forces or agents as with the manipulation of fetishes or rituals.%A%    
% 207.76/207.93  |- skos__broader mesh__D008273smesh__D026443
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D008273 2003
% 207.76/207.93  |- mesh__dateRevised mesh__D008273 2001-07-25
% 207.76/207.93  |- skos__annotation mesh__D008273 IM; consider also WITCHCRAFT   
% 207.76/207.93  |- mesh__dateCreated mesh__D008273 1999-01-01
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D008273 2005
% 207.76/207.93  |- skos__hiddenLabel mesh__D008273 Magics
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D008273 2004
% 207.76/207.93  |- mesh__recordMaintainer mesh__D008273 ssb
% 207.76/207.93  |- mesh__recordOriginator mesh__D000290 NLM
% 207.76/207.93  |- skos__scopeNote mesh__D000290
% 207.76/207.93       Appendages of the UTERUS which include the FALLOPIAN TUBES, the OVARY, and the supporting ligaments of the uterus %28%BROAD LIGAMENT; ROUND LIGAMENT%29%.%A%    
% 207.76/207.93  |- skos__annotation mesh__D000290
% 207.76/207.93       seen in titles more frequently in adjective form %22%adnexal%22%;  inflammation = ADNEXITIS%A%  
% 207.76/207.93  |- skos__prefLabel mesh__D000290 Adnexa Uteri
% 207.76/207.93  |- rdf__type mesh__D000290sskos__Concept
% 207.76/207.93  |- mesh__dateRevised mesh__D000290 2002-07-02
% 207.76/207.93  |- skos__hiddenLabel mesh__D000290 Appendages, Uterine
% 207.76/207.93  |- mesh__recordAuthorizer mesh__D000290 sjn
% 207.76/207.93  |- skos__hiddenLabel mesh__D000290 Uterine Appendage
% 207.76/207.93  |- skos__broader mesh__D000290smesh__D005836
% 207.76/207.93  |- mesh__recordMaintainer mesh__D000290 lkt
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D000290 2005
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D000290 2003
% 207.76/207.93  |- skos__hiddenLabel mesh__D000290 Appendage, Uterine
% 207.76/207.93  |- skos__altLabel mesh__D000290 Uterine Appendages
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D000290 2006
% 207.76/207.93  |- mesh__dateCreated mesh__D000290 1999-01-01
% 207.76/207.93  |- skos__related mesh__D000290smesh__D000291
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D000290 2004
% 207.76/207.93  |- rdf__type mesh__D007979sskos__Concept
% 207.76/207.93  |- skos__annotation mesh__D007979
% 207.76/207.93       heart in left hemithorax; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 207.76/207.93  |- skos__hiddenLabel mesh__D007979 Levocardias
% 207.76/207.93  |- skos__scopeNote mesh__D007979
% 207.76/207.93       Location of heart in left hemithorax with apex pointing to the left, but with situs inversus of other viscera and defects of the heart, or corrected transposition of great vessels.%A%    
% 207.76/207.93  |- mesh__dateRevised mesh__D007979 1999-11-03
% 207.76/207.93  |- skos__broader mesh__D007979smesh__D006330
% 207.76/207.93  |- skos__broader mesh__D007979smesh__D012857
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D007979 2002
% 207.76/207.93  |- mesh__recordMaintainer mesh__D007979 kle
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D007979 2004
% 207.76/207.93  |- mesh__publicMeSHNote mesh__D007979
% 207.76/207.93       91; was see under HEART DEFECTS, CONGENITAL 1975-90   
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D007979 2001
% 207.76/207.93  |- mesh__historyNote mesh__D007979
% 207.76/207.93       91%28%75%29%; was see under HEART DEFECTS, CONGENITAL 1975-90   
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D007979 2006
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D007979 2003
% 207.76/207.93  |- mesh__dateEstablished mesh__D007979 1991-01-01
% 207.76/207.93  |- skos__prefLabel mesh__D007979 Levocardia
% 207.76/207.93  |- mesh__recordOriginator mesh__D007979 NLM
% 207.76/207.93  |- mesh__recordAuthorizer mesh__D007979 sjn
% 207.76/207.93  |- mesh__dateCreated mesh__D007979 1974-12-12
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D007979 2000
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D007979 2005
% 207.76/207.93  |- mesh__recordOriginator mesh__D004681 NLM
% 207.76/207.93  |- skos__altLabel mesh__D004681 Autoimmune Encephalomyelitis, Experimental
% 207.76/207.93  |- skos__broader mesh__D004681smesh__D020278
% 207.76/207.93  |- skos__altLabel mesh__D004681 Experimental Allergic Encephalomyelitis
% 207.76/207.93  |- mesh__dateCreated mesh__D004681 1999-01-01
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D004681 2006
% 207.76/207.93  |- mesh__dateEstablished mesh__D004681 1966-01-01
% 207.76/207.93  |- skos__hiddenLabel mesh__D004681
% 207.76/207.93       Encephalomyelitis, Autoimmune Experimental
% 207.76/207.93  |- skos__altLabel mesh__D004681 Experimental Autoimmune Encephalomyelitis
% 207.76/207.93  |- rdf__type mesh__D004681sskos__Concept
% 207.76/207.93  |- skos__annotation mesh__D004681
% 207.76/207.93       coordinate with specific demyelinating disease if pertinent; DF: ENCEPH ALLERGIC%A%  
% 207.76/207.93  |- skos__altLabel mesh__D004681 Allergic Encephalomyelitis, Experimental
% 207.76/207.93  |- skos__hiddenLabel mesh__D004681 Encephalomyelitis, Experimental Allergic
% 207.76/207.93  |- mesh__dateRevised mesh__D004681 2004-07-07
% 207.76/207.93  |- skos__broader mesh__D004681smesh__D020721
% 207.76/207.93  |- skos__altLabel mesh__D004681 Autoimmune Experimental Encephalomyelitis
% 207.76/207.93  |- mesh__recordAuthorizer mesh__D004681 sjn
% 207.76/207.93  |- mesh__historyNote mesh__D004681 2005 %28%1964%29%   
% 207.76/207.93  |- skos__altLabel mesh__D004681 Allergic Encephalomyelitis
% 207.76/207.93  |- skos__altLabel mesh__D004681 Encephalomyelitis, Allergic
% 207.76/207.93  |- skos__altLabel mesh__D004681 Encephalomyelitis, Experimental Autoimmune
% 207.76/207.93  |- skos__scopeNote mesh__D004681
% 207.76/207.93       An experimental animal model for central nervous system demyelinating disease. Inoculation with a white matter emulsion combined with FREUND%27%S ADJUVANT, myelin basic protein, or purified central myelin triggers a T cell-mediated immune response directed towards central myelin. The pathologic features are similar to MULTIPLE SCLEROSIS, including perivascular and periventricular foci of inflammation and demyelination. Subpial demyelination underlying meningeal infiltrations also occurs, which is also a feature of ENCEPHALOMYELITIS, ACUTE DISSEMINATED. Passive immunization with T-cells from an afflicted animal to a normal animal also induces this condition. %28%From Immunol Res 1998;17%28%1-2%29%:217-27; Raine CS, Textbook of Neuropathology, 2nd ed, p604-5%29%%A%    
% 207.76/207.93  |- skos__prefLabel mesh__D004681
% 207.76/207.93       Encephalomyelitis, Autoimmune, Experimental
% 207.76/207.93  |- mesh__publicMeSHNote mesh__D004681
% 207.76/207.93       2005; see ENCEPHALOMYELITIS, EXPERIMENTAL AUTOIMMUNE 2000-2004, see ENCEPHALOMYELITIS, ALLERGIC 1964-1999%A%  
% 207.76/207.93  |- skos__hiddenLabel mesh__D004681
% 207.76/207.93       Experimental Encephalomyelitis, Autoimmune
% 207.76/207.93  |- mesh__recordMaintainer mesh__D004681 lkt
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D004681 2005
% 207.76/207.93  |- rdf__type mesh__D012315sskos__Concept
% 207.76/207.93  |- skos__hiddenLabel mesh__D012315 Caps, RNA
% 207.76/207.93  |- skos__broader mesh__D012315smesh__D006150
% 207.76/207.93  |- skos__historyNote mesh__D012315
% 207.76/207.93       Guanosine Triphosphate %28%1972-1974%29%/analogs %26% derivatives %28%1975-1979%29%
% 207.76/207.93  |- mesh__recordAuthorizer mesh__D012315 sjn
% 207.76/207.93  |- mesh__dateRevised mesh__D012315 2005-06-30
% 207.76/207.93  |- skos__historyNote mesh__D012315 Guanine Nucleotides %28%1966-1971%29%
% 207.76/207.93  |- skos__historyNote mesh__D012315 Oligoribonucleotides %28%1976-1979%29%
% 207.76/207.93  |- skos__broader mesh__D012315smesh__D012333
% 207.76/207.93  |- skos__altLabel mesh__D012315 5%27% Capped RNA
% 207.76/207.93  |- skos__prefLabel mesh__D012315 RNA Caps
% 207.76/207.93  |- skos__historyNote mesh__D012315 RNA, Messenger %28%1966-1979%29%
% 207.76/207.93  |- skos__scopeNote mesh__D012315
% 207.76/207.93       Nucleic acid structures found on the 5%27% end of eukaryotic cellular and viral messenger RNA and some heterogeneous nuclear RNAs. These structures, which are positively charged, protect the above specified RNAs at their termini against attack by phosphatases and other nucleases and promote mRNA function at the level of initiation of translation. Analogs of the RNA caps %28%RNA CAP ANALOGS%29%, which lack the positive charge, inhibit the initiation of protein synthesis.%A%    
% 207.76/207.93  |- skos__annotation mesh__D012315 IM; /drug eff /ultrastruct permitted   
% 207.76/207.93  |- skos__altLabel mesh__D012315 5%27% mRNA Cap Structure
% 207.76/207.93  |- skos__historyNote mesh__D012315 Ribonucleotides %28%1971-1975%29%
% 207.76/207.93  |- mesh__historyNote mesh__D012315 80   
% 207.76/207.93  |- skos__hiddenLabel mesh__D012315 RNA, 5%27% Capped
% 207.76/207.93  |- mesh__publicMeSHNote mesh__D012315 80   
% 207.76/207.93  |- mesh__dateEstablished mesh__D012315 1980-01-01
% 207.76/207.93  |- mesh__recordOriginator mesh__D012315 RLS
% 207.76/207.93  |- mesh__dateCreated mesh__D012315 1979-05-23
% 207.76/207.93  |- mesh__recordMaintainer mesh__D012315 ags
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D012315 2006
% 207.76/207.93  |- mesh__dateRevised mesh__D017000 2005-06-30
% 207.76/207.93  |- mesh__dateCreated mesh__D017000 1991-05-30
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D017000 2006
% 207.76/207.93  |- skos__broader mesh__D017000smesh__D002167
% 207.76/207.93  |- rdf__type mesh__D017000sskos__Concept
% 207.76/207.93  |- skos__historyNote mesh__D017000 Campylobacter %28%1983-1991%29%
% 207.76/207.93  |- mesh__historyNote mesh__D017000 92   
% 207.76/207.93  |- skos__annotation mesh__D017000
% 207.76/207.93       in intestines of man, swine %26% poultry; infection: coord IM with CAMPYLOBACTER INFECTIONS %28%IM%29%%A%  
% 207.76/207.93  |- skos__prefLabel mesh__D017000 Campylobacter coli
% 207.76/207.93  |- mesh__recordAuthorizer mesh__D017000 sjn
% 207.76/207.93  |- mesh__publicMeSHNote mesh__D017000 92   
% 207.76/207.93  |- mesh__recordOriginator mesh__D017000 PXP
% 207.76/207.93  |- mesh__dateEstablished mesh__D017000 1992-01-01
% 207.76/207.93  |- mesh__recordMaintainer mesh__D017000 SYSTEM
% 207.76/207.93  |- skos__scopeNote mesh__D017000
% 207.76/207.93       A species of gram-negative, rod-shaped bacteria isolated from the intestinal tract of swine, poultry, and man. It may be pathogenic.%A%    
% 207.76/207.93  |- mesh__dateRevised mesh__D003589 2005-06-30
% 207.76/207.93  |- skos__broader mesh__D003589smesh__D041964
% 207.76/207.93  |- mesh__recordAuthorizer mesh__D003589 sjn
% 207.76/207.93  |- mesh__recordMaintainer mesh__D003589 SYSTEM
% 207.76/207.93  |- skos__scopeNote mesh__D003589
% 207.76/207.93       A genus of gram-negative gliding bacteria found in SOIL; HUMUS; and FRESHWATER and marine habitats.%A%    
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D003589 2006
% 207.76/207.93  |- skos__annotation mesh__D003589
% 207.76/207.93       infection: coord IM with FLEXIBACTERACEAE INFECTIONS %28%IM%29%%A%  
% 207.76/207.93  |- mesh__recordOriginator mesh__D003589 NLM
% 207.76/207.93  |- mesh__dateCreated mesh__D003589 1999-01-01
% 207.76/207.93  |- rdf__type mesh__D003589sskos__Concept
% 207.76/207.93  |- skos__prefLabel mesh__D003589 Cytophaga
% 207.76/207.93  |- rdf__type mesh__D008274sskos__Concept
% 207.76/207.93  |- skos__broader mesh__D008274smesh__D008673
% 207.76/207.93  |- mesh__dateRevised mesh__D008274 2001-07-25
% 207.76/207.93  |- mesh__recordMaintainer mesh__D008274 jmp
% 207.76/207.93  |- skos__annotation mesh__D008274
% 207.76/207.93       Mg-24; /physiol permitted; Mg-25, 26 = MAGNESIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Mg-20, 21, 23, 27, 28 = MAGNESIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 207.76/207.93  |- skos__prefLabel mesh__D008274 Magnesium
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D008274 2003
% 207.76/207.93  |- mesh__dateCreated mesh__D008274 1999-01-01
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D008274 2005
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D008274 2004
% 207.76/207.93  |- skos__broader mesh__D008274smesh__D019565
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D008274 2006
% 207.76/207.93  |- mesh__recordAuthorizer mesh__D008274 sjn
% 207.76/207.93  |- skos__scopeNote mesh__D008274
% 207.76/207.93       A light, silvery, metallic element. It has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. Its salts are essential in nutrition, being required for the activity of many enzymes, especially those concerned with oxidative phosphorylation. It is a component of both intra- and extracellular fluids and is excreted in the urine and feces. Deficiency causes irritability of the nervous system with tetany, vasodilation, convulsions, tremors, depression, and psychotic behavior. %28%From Dorland, 27th ed%29%%A%    
% 207.76/207.93  |- mesh__recordOriginator mesh__D008274 NLM
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D008274 2002
% 207.76/207.93  |- skos__hiddenLabel mesh__D008274 Magnesium Level, Serum
% 207.76/207.93  |- skos__prefLabel mesh__D000291 Adnexal Diseases
% 207.76/207.93  |- skos__broader mesh__D000291smesh__D005831
% 207.76/207.93  |- mesh__recordOriginator mesh__D000291 NLM
% 207.76/207.93  |- skos__hiddenLabel mesh__D000291 Adnexal Disease
% 207.76/207.93  |- mesh__dateRevised mesh__D000291 2002-07-02
% 207.76/207.93  |- mesh__historyNote mesh__D000291 66   
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D000291 2005
% 207.76/207.93  |- skos__annotation mesh__D000291
% 207.76/207.93       inflamm dis = PELVIC INFLAMMATORY DISEASE   
% 207.76/207.93  |- mesh__dateEstablished mesh__D000291 1966-01-01
% 207.76/207.93  |- skos__hiddenLabel mesh__D000291 Disease, Adnexal
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D000291 2003
% 207.76/207.93  |- mesh__recordAuthorizer mesh__D000291 sjn
% 207.76/207.93  |- skos__hiddenLabel mesh__D000291 Diseases, Adnexal
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D000291 2006
% 207.76/207.93  |- mesh__dateCreated mesh__D000291 1999-01-01
% 207.76/207.93  |- mesh__publicMeSHNote mesh__D000291 66   
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D000291 2004
% 207.76/207.93  |- mesh__recordMaintainer mesh__D000291 lkt
% 207.76/207.93  |- skos__scopeNote mesh__D000291
% 207.76/207.93       Diseases of the uterine appendages %28%ADNEXA UTERI%29% including diseases involving the OVARY, the FALLOPIAN TUBES, and ligaments of the uterus %28%BROAD LIGAMENT; ROUND LIGAMENT%29%.%A%    
% 207.76/207.93  |- rdf__type mesh__D000291sskos__Concept
% 207.76/207.93  |- skos__hiddenLabel mesh__D016706 Still Disease, Adult Onset
% 207.76/207.93  |- skos__altLabel mesh__D016706 Adult-Onset Still Disease
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D016706 2000
% 207.76/207.93  |- mesh__historyNote mesh__D016706
% 207.76/207.93       92; STILL%27%S DISEASE was see ARTHRITIS, JUVENILE RHEUMATOID 1975-91%A%  
% 207.76/207.93  |- skos__scopeNote mesh__D016706
% 207.76/207.93       Systemic-onset rheumatoid arthritis in adults. It differs from classical rheumatoid arthritis in that it is more often marked by acute febrile onset, and generalized lymphadenopathy and hepatosplenomegaly are more prominent.%A%    
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D016706 2003
% 207.76/207.93  |- mesh__dateEstablished mesh__D016706 1992-01-01
% 207.76/207.93  |- mesh__recordOriginator mesh__D016706 AGS
% 207.76/207.93  |- mesh__recordMaintainer mesh__D016706 kle
% 207.76/207.93  |- skos__altLabel mesh__D016706 Still Disease, Adult-Onset
% 207.76/207.93  |- skos__historyNote mesh__D016706
% 207.76/207.93       Arthritis, Juvenile Rheumatoid %28%1966-1991%29%
% 207.76/207.93  |- skos__hiddenLabel mesh__D016706 Adult-Onset Stills Disease
% 207.76/207.93  |- skos__hiddenLabel mesh__D016706 Adult Onset Still Disease
% 207.76/207.93  |- mesh__publicMeSHNote mesh__D016706
% 207.76/207.93       92; STILL%27%S DISEASE was see ARTHRITIS, JUVENILE RHEUMATOID 1975-91%A%  
% 207.76/207.93  |- skos__broader mesh__D016706smesh__D001172
% 207.76/207.93  |- mesh__onlineNote mesh__D016706
% 207.76/207.93       use ARTHRITIS, JUVENILE RHEMUMATOID to search STILL%27%S DISEASE 1975-91%A%  
% 207.76/207.93  |- mesh__recordAuthorizer mesh__D016706 sjn
% 207.76/207.93  |- skos__hiddenLabel mesh__D016706 Still%27%s Disease, Adult Onset
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D016706 2006
% 207.76/207.93  |- skos__hiddenLabel mesh__D016706 Stills Disease, Adult-Onset
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D016706 2002
% 207.76/207.93  |- skos__annotation mesh__D016706
% 207.76/207.93       a type of rheum arthritis; do not confuse with STILL%27%S DISEASE, JUVENILE-ONSET see ARTHRITIS, JUVENILE RHEUMATOID%A%  
% 207.76/207.93  |- mesh__dateCreated mesh__D016706 1991-01-25
% 207.76/207.93  |- rdf__type mesh__D016706sskos__Concept
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D016706 2005
% 207.76/207.93  |- skos__hiddenLabel mesh__D016706 Adult Onset Still%27%s Disease
% 207.76/207.93  |- skos__altLabel mesh__D016706 Adult-Onset Still%27%s Disease
% 207.76/207.93  |- mesh__dateRevised mesh__D016706 1999-11-03
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D016706 2001
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D016706 2004
% 207.76/207.93  |- skos__prefLabel mesh__D016706 Still%27%s Disease, Adult-Onset
% 207.76/207.93  |- mesh__recordAuthorizer mesh__D004682 sjn
% 207.76/207.93  |- rdf__type mesh__D004682sskos__Concept
% 207.76/207.93  |- skos__altLabel mesh__D004682 Teschen Disease
% 207.76/207.93  |- mesh__dateEstablished mesh__D004682 1970-01-01
% 207.76/207.93  |- skos__historyNote mesh__D004682 Swine Diseases %28%1966-1969%29%
% 207.76/207.93  |- skos__altLabel mesh__D004682 Porcine Poliomyelitis
% 207.76/207.93  |- mesh__recordMaintainer mesh__D004682 ags
% 207.76/207.93  |- mesh__dateRevised mesh__D004682 2003-07-30
% 207.76/207.93  |- mesh__publicMeSHNote mesh__D004682 70   
% 207.76/207.93  |- skos__historyNote mesh__D004682 Enterovirus Infections %28%1966-1969%29%
% 207.76/207.93  |- skos__hiddenLabel mesh__D004682 Disease, Teschen
% 207.76/207.93  |- mesh__recordOriginator mesh__D004682 NLM
% 207.76/207.93  |- skos__altLabel mesh__D004682 Poliomyelitis, Porcine
% 207.76/207.93  |- skos__prefLabel mesh__D004682 Encephalomyelitis, Enzootic Porcine
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D004682 2005
% 207.76/207.93  |- skos__annotation mesh__D004682
% 207.76/207.93       caused by an enterovirus; don%27%t forget also SWINE %28%NIM%29% %26% check tag ANIMALS; DF: note short X ref%A%  
% 207.76/207.93  |- mesh__historyNote mesh__D004682 70   
% 207.76/207.93  |- skos__hiddenLabel mesh__D004682 Disease, Talfan
% 207.76/207.93  |- skos__hiddenLabel mesh__D004682 Enzootic Porcine Encephalomyelitis
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D004682 2006
% 207.76/207.93  |- skos__broader mesh__D004682smesh__D004769
% 207.76/207.93  |- mesh__dateCreated mesh__D004682 1999-01-01
% 207.76/207.93  |- skos__scopeNote mesh__D004682
% 207.76/207.93       A picornavirus infection producing symptoms similar to poliomyelitis in pigs.%A%    
% 207.76/207.93  |- skos__hiddenLabel mesh__D004682 Porcine Encephalomyelitis, Enzootic
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D004682 2004
% 207.76/207.93  |- skos__broader mesh__D004682smesh__D013553
% 207.76/207.93  |- skos__broader mesh__D009726Q000266smesh__D009726
% 207.76/207.93  |- mesh__preferredCombination mesh__D009726Q000266smesh__D006676
% 207.76/207.93  |- rdf__type mesh__D009726Q000266smesh__CompoundConcept
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D012316 2004
% 207.76/207.93  |- mesh__dateRevised mesh__D012316 2003-07-09
% 207.76/207.93  |- mesh__dateEstablished mesh__D012316 1968-01-01
% 207.76/207.93  |- skos__broader mesh__D012316smesh__D009713
% 207.76/207.93  |- mesh__recordOriginator mesh__D012316 NLM
% 207.76/207.93  |- skos__prefLabel mesh__D012316 RNA Nucleotidyltransferases
% 207.76/207.93  |- mesh__recordAuthorizer mesh__D012316 sjn
% 207.76/207.93  |- mesh__recordMaintainer mesh__D012316 ssb
% 207.76/207.93  |- skos__hiddenLabel mesh__D012316 Nucleotidyltransferases, RNA
% 207.76/207.93  |- skos__scopeNote mesh__D012316
% 207.76/207.93       Enzymes that catalyze the template-directed incorporation of ribonucleotides into an RNA chain. EC 2.7.7.-.%A%    
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D012316 2006
% 207.76/207.93  |- rdf__type mesh__D012316sskos__Concept
% 207.76/207.93  |- mesh__publicMeSHNote mesh__D012316 68   
% 207.76/207.93  |- mesh__historyNote mesh__D012316 68   
% 207.76/207.93  |- mesh__dateCreated mesh__D012316 1999-01-01
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D012316 2005
% 207.76/207.93  |- skos__historyNote mesh__D012316
% 207.76/207.93       Nucleotidyltransferases %28%1966-1967%29%
% 207.76/207.93  |- skos__broader mesh__D014125Q000662smesh__D014125
% 207.76/207.93  |- mesh__preferredCombination mesh__D014125Q000662smesh__D014124Q000151
% 207.76/207.93  |- rdf__type mesh__D014125Q000662smesh__CompoundConcept
% 207.76/207.93  |- skos__prefLabel mesh__D017001 Tooth Demineralization
% 207.76/207.93  |- mesh__recordAuthorizer mesh__D017001 SJN
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D017001 2006
% 207.76/207.93  |- skos__altLabel mesh__D017001 Tooth Hypomineralization
% 207.76/207.93  |- skos__related mesh__D017001smesh__D003731
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D017001 2001
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D017001 2003
% 207.76/207.93  |- rdf__type mesh__D017001sskos__Concept
% 207.76/207.93  |- skos__scopeNote mesh__D017001
% 207.76/207.93       A tooth%27%s loss of minerals, such as calcium in hydroxyapatite from the tooth matrix, caused by acidic exposure. An example of the occurrence of demineralization is in the formation of dental caries.%A%    
% 207.76/207.93  |- skos__altLabel mesh__D017001 Demineralization, Tooth
% 207.76/207.93  |- mesh__historyNote mesh__D017001 92   
% 207.76/207.93  |- skos__annotation mesh__D017001
% 207.76/207.93       a tooth dis; white spots or white lesions do not go here: note WHITE SPOTS see DENTAL CARIES%A%  
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D017001 2004
% 207.76/207.93  |- mesh__dateCreated mesh__D017001 1991-05-30
% 207.76/207.93  |- skos__broader mesh__D017001smesh__D014076
% 207.76/207.93  |- skos__hiddenLabel mesh__D017001 Tooth Hypomineralizations
% 207.76/207.93  |- mesh__recordMaintainer mesh__D017001 TGC
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D017001 2002
% 207.76/207.93  |- skos__altLabel mesh__D017001 Hypomineralization, Tooth
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D017001 1998
% 207.76/207.93  |- mesh__recordOriginator mesh__D017001 MXR
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D017001 1999
% 207.76/207.93  |- mesh__dateEstablished mesh__D017001 1992-01-01
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D017001 2005
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D017001 2000
% 207.76/207.93  |- mesh__publicMeSHNote mesh__D017001 92   
% 207.76/207.93  |- mesh__dateRevised mesh__D017001 1997-06-20
% 207.76/207.93  |- skos__hiddenLabel mesh__D017001 Hypomineralizations, Tooth
% 207.76/207.93  |- mesh__dateRevised mesh__D008275 2003-07-09
% 207.76/207.93  |- mesh__recordOriginator mesh__D008275 NLM
% 207.76/207.93  |- skos__broader mesh__D008275smesh__D003677
% 207.76/207.93  |- skos__hiddenLabel mesh__D008275 Deficiencies, Magnesium
% 207.76/207.93  |- skos__prefLabel mesh__D008275 Magnesium Deficiency
% 207.76/207.93  |- mesh__recordMaintainer mesh__D008275 lkt
% 207.76/207.93  |- mesh__dateCreated mesh__D008275 1999-01-01
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D008275 2004
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D008275 2005
% 207.76/207.93  |- skos__hiddenLabel mesh__D008275 Magnesium Deficiencies
% 207.76/207.93  |- skos__scopeNote mesh__D008275
% 207.76/207.93       A nutritional condition produced by a deficiency of magnesium in the diet, characterized by anorexia, nausea, vomiting, lethargy, and weakness. Symptoms are paresthesias, muscle cramps, irritability, decreased attention span, and mental confusion, possibly requiring months to appear. Deficiency of body magnesium can exist even when serum values are normal. In addition, magnesium deficiency may be organ-selective, since certain tissues become deficient before others. %28%Harrison%27%s Principles of Internal Medicine, 12th ed, p1936%29%%A%    
% 207.76/207.93  |- skos__altLabel mesh__D008275 Deficiency, Magnesium
% 207.76/207.93  |- skos__annotation mesh__D008275 DF: MAGNESIUM DEFIC   
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D008275 2006
% 207.76/207.93  |- rdf__type mesh__D008275sskos__Concept
% 207.76/207.93  |- mesh__recordAuthorizer mesh__D008275 sjn
% 207.76/207.93  |- skos__scopeNote mesh__D000292
% 207.76/207.93       A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus %28%ENDOMETRITIS%29%, the FALLOPIAN TUBES; %28%SALPINGITIS%29%; the ovaries %28%OOPHORITIS%29%, the supporting ligaments %28%PARAMETRITIS%29%, or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility.%A%    
% 207.76/207.93  |- skos__hiddenLabel mesh__D000292 Diseases, Inflammatory Pelvic
% 207.76/207.93  |- mesh__recordAuthorizer mesh__D000292 ags
% 207.76/207.93  |- skos__hiddenLabel mesh__D000292 Pelvic Inflammatory Diseases
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D000292 2005
% 207.76/207.93  |- skos__hiddenLabel mesh__D000292 Diseases, Pelvic Inflammatory
% 207.76/207.93  |- skos__altLabel mesh__D000292 Pelvic Disease, Inflammatory
% 207.76/207.93  |- rdf__type mesh__D000292sskos__Concept
% 207.76/207.93  |- skos__prefLabel mesh__D000292 Pelvic Inflammatory Disease
% 207.76/207.93  |- skos__hiddenLabel mesh__D000292 Inflammatory Pelvic Diseases
% 207.76/207.93  |- mesh__publicMeSHNote mesh__D000292 2003; see ADNEXITIS 1963-2002   
% 207.76/207.93  |- skos__broader mesh__D000292smesh__D034161
% 207.76/207.93  |- skos__hiddenLabel mesh__D000292 Pelvic Diseases, Inflammatory
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D000292 2006A
% 207.76/207.93  |- mesh__dateRevised mesh__D000292 2005-07-13
% 207.76/207.93  |- mesh__dateCreated mesh__D000292 1999-01-01
% 207.76/207.93  |- mesh__recordOriginator mesh__D000292 NLM
% 207.76/207.93  |- skos__annotation mesh__D000292
% 207.76/207.93       female only: note category; %22%male adnexitis%22%: index under GENITAL DISEASES, MALE or PELVIC INFECTION%A%  
% 207.76/207.93  |- skos__altLabel mesh__D000292 Inflammatory Pelvic Disease
% 207.76/207.93  |- mesh__recordMaintainer mesh__D000292 ags
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D000292 2004
% 207.76/207.93  |- skos__hiddenLabel mesh__D000292 Disease, Inflammatory Pelvic
% 207.76/207.93  |- skos__hiddenLabel mesh__D000292 Inflammatory Diseases, Pelvic
% 207.76/207.93  |- skos__altLabel mesh__D000292 Inflammatory Disease, Pelvic
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D000292 2006
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D000292 2003
% 207.76/207.93  |- skos__hiddenLabel mesh__D000292 Disease, Pelvic Inflammatory
% 207.76/207.93  |- mesh__historyNote mesh__D000292 2003 %28%1963%29%   
% 207.76/207.93  |- skos__broader mesh__D000292smesh__D000291
% 207.76/207.93  |- skos__prefLabel mesh__D016707 Tissue Fixation
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D016707 2002
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D016707 2006
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D016707 2001
% 207.76/207.93  |- mesh__recordMaintainer mesh__D016707 TAP
% 207.76/207.93  |- rdf__type mesh__D016707sskos__Concept
% 207.76/207.93  |- mesh__dateEstablished mesh__D016707 1992-01-01
% 207.76/207.93  |- mesh__dateRevised mesh__D016707 2000-06-22
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D016707 2005
% 207.76/207.93  |- skos__broader mesh__D016707smesh__D014021
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D016707 2004
% 207.76/207.93  |- mesh__recordOriginator mesh__D016707 MXR
% 207.76/207.93  |- mesh__historyNote mesh__D016707 92   
% 207.76/207.93  |- mesh__dateCreated mesh__D016707 1991-06-21
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D016707 2003
% 207.76/207.93  |- skos__scopeNote mesh__D016707
% 207.76/207.93       The technique of using FIXATIVES in the preparation of cytologic, histologic, or pathologic specimens for the purpose of maintaining the existing form and structure of all the constituent elements.%A%    
% 207.76/207.93  |- skos__related mesh__D016707smesh__D005404
% 207.76/207.93  |- mesh__recordAuthorizer mesh__D016707 sjn
% 207.76/207.93  |- skos__altLabel mesh__D016707 Fixation, Tissue
% 207.76/207.93  |- mesh__publicMeSHNote mesh__D016707 92   
% 207.76/207.93  |- skos__prefLabel mesh__D004683 Encephalomyelitis, Equine
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D004683 2000
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D004683 2001
% 207.76/207.93  |- mesh__recordAuthorizer mesh__D004683 sjn
% 207.76/207.93  |- skos__altLabel mesh__D004683 Infections, Equine Encephalomyelitis Virus
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D004683 2005
% 207.76/207.93  |- skos__scopeNote mesh__D004683
% 207.76/207.93       A group of ALPHAVIRUS INFECTIONS which affect horses and man, transmitted via the bites of mosquitoes. Disorders in this category are endemic to regions of South America and North America. In humans, clinical manifestations vary with the type of infection, and range from a mild influenza-like syndrome to a fulminant encephalitis. %28%From Joynt, Clinical Neurology, 1996, Ch26, pp8-10%29%%A%    
% 207.76/207.93  |- skos__broader mesh__D004683smesh__D001102
% 207.76/207.93  |- mesh__dateRevised mesh__D004683 1999-11-03
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D004683 2002
% 207.76/207.93  |- skos__broader mesh__D004683smesh__D004679
% 207.76/207.93  |- skos__altLabel mesh__D004683 Equine Encephalomyelitis Virus Infections
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D004683 2003
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D004683 2006
% 207.76/207.93  |- mesh__recordMaintainer mesh__D004683 KEV
% 207.76/207.93  |- mesh__dateCreated mesh__D004683 1999-01-01
% 207.76/207.93  |- skos__broader mesh__D004683smesh__D018792
% 207.76/207.93  |- skos__broader mesh__D004683smesh__D018354
% 207.76/207.93  |- mesh__recordOriginator mesh__D004683 NLM
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D004683 2004
% 207.76/207.93  |- skos__altLabel mesh__D004683 Equine Encephalitis
% 207.76/207.93  |- rdf__type mesh__D004683sskos__Concept
% 207.76/207.93  |- skos__altLabel mesh__D004683 Encephalitis, Equine
% 207.76/207.93  |- skos__altLabel mesh__D004683 Equine Encephalomyelitis Viral Infections
% 207.76/207.93  |- skos__annotation mesh__D004683
% 207.76/207.93       human %26% animal; if in horses, coord with HORSE DISEASES %28%IM%29% + HORSES %28%NIM%29% %26% use /vet; DF: ENCEPH EQUINE%A%  
% 207.76/207.93  |- skos__hiddenLabel mesh__D004683 Equine Encephalomyelitis
% 207.76/207.93  |- skos__hiddenLabel mesh__D012317 Bacteriophage, RNA
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D012317 2002
% 207.76/207.93  |- mesh__dateRevised mesh__D012317 2001-07-25
% 207.76/207.93  |- skos__annotation mesh__D012317 coord with specific bacterium /virol   
% 207.76/207.93  |- mesh__activeMeSHYear mesh__D012317 2004
% 207.76/207.93  |- mesh__historyNote mesh__D012317 80   
% 207.76/207.93  |- skos__altLabel mesh__D012317 Bacteriophages, RNA
% 207.76/207.93  |- skos__prefLabel mesh__D012317 RNA Phages
% 207.76/207.93  |- skos__historyNote mesh__D012317 Coliphages %28%1966-1979%29%
% 207.76/207.93  |- skos__historyNote mesh__D012317 Bacteriophages %28%1966-1979%29%
% 207.76/207.93  |- mesh__recordOriginator mesh__D012317 AEP
% 207.76/207.93  |- skos__hiddenLabel mesh__D012317 RNA Phage
% 207.76/207.93  |- skos__scopeNote mesh__D012317
% 207.76/207.93       Bacteriophages whose genetic material is RNA, which is single-stranded in all except the Pseudomonas phage phi 6 %28%BACTERIOPHAGE PHI 6%29%. All RNA phages infect their host bacteria via the host%27%s surface pili. Some frequently encountered RNA phages are: BF23, F2, R17, fr, PhiCb5, PhiCb12r, PhiCb8r, PhiCb23r, 7s, PP7, Q beta phage, MS2 phage, and BACTERIOPHAGE PHI 6.%A%    
% 207.76/207.93  |- mesh__dateEstablished mesh__D012317 1980-01-01
% 207.76/207.93  |- mesh__dateCreated mesh__D012317 1979-04-16
% 207.76/207.94  |- skos__hiddenLabel mesh__D012317 RNA Bacteriophage
% 207.76/207.94  |- skos__hiddenLabel mesh__D012317 Phage, RNA
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D012317 2005
% 207.76/207.94  |- mesh__recordMaintainer mesh__D012317 ags
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D012317 2006
% 207.76/207.94  |- rdf__type mesh__D012317sskos__Concept
% 207.76/207.94  |- mesh__recordAuthorizer mesh__D012317 sjn
% 207.76/207.94  |- skos__altLabel mesh__D012317 Phages, RNA
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D012317 2003
% 207.76/207.94  |- skos__hiddenLabel mesh__D012317 RNA Bacteriophages
% 207.76/207.94  |- skos__broader mesh__D012317smesh__D001435
% 207.76/207.94  |- mesh__publicMeSHNote mesh__D012317 80   
% 207.76/207.94  |- skos__hiddenLabel mesh__D017800 Potyviruses
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017800 2001
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017800 2005
% 207.76/207.94  |- skos__broader mesh__D017800smesh__D009029
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017800 2000
% 207.76/207.94  |- skos__prefLabel mesh__D017800 Potyvirus
% 207.76/207.94  |- mesh__recordMaintainer mesh__D017800 AGS
% 207.76/207.94  |- skos__broader mesh__D017800smesh__D019176
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017800 1997
% 207.76/207.94  |- mesh__historyNote mesh__D017800 94   
% 207.76/207.94  |- skos__hiddenLabel mesh__D017800 Potato Virus Ys
% 207.76/207.94  |- skos__historyNote mesh__D017800 Plant Viruses %28%1967-1993%29%
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017800 2004
% 207.76/207.94  |- mesh__dateCreated mesh__D017800 1993-06-04
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017800 2002
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017800 1999
% 207.76/207.94  |- mesh__recordOriginator mesh__D017800 AGS
% 207.76/207.94  |- mesh__dateEstablished mesh__D017800 1994-01-01
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017800 2003
% 207.76/207.94  |- skos__annotation mesh__D017800
% 207.76/207.94       a genus of mosaic viruses; from POTato virus Y %28%Y is one of a series, e.g., A, M, S, V, etc.%29%; coord IM with specific plant /virol %28%IM or NIM%29%%A%  
% 207.76/207.94  |- mesh__dateRevised mesh__D017800 1996-06-10
% 207.76/207.94  |- skos__historyNote mesh__D017800 Mosaic Viruses %28%1973-1993%29%
% 207.76/207.94  |- skos__hiddenLabel mesh__D017800 Virus Ys, Potato
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017800 2006
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017800 1998
% 207.76/207.94  |- skos__hiddenLabel mesh__D017800 Ys, Potato Virus
% 207.76/207.94  |- rdf__type mesh__D017800sskos__Concept
% 207.76/207.94  |- skos__scopeNote mesh__D017800
% 207.76/207.94       A large genus of plant viruses of the family POTYVIRIDAE which infect mainly plants of the Solanaceae. Transmission is primarily by aphids in a non-persistent manner. The type species is potato virus Y.%A%    
% 207.76/207.94  |- mesh__recordAuthorizer mesh__D017800 PLS
% 207.76/207.94  |- mesh__publicMeSHNote mesh__D017800 94   
% 207.76/207.94  |- skos__scopeNote mesh__D050436
% 207.76/207.94       Nucleotide sequences of a gene that are involved in the regulation of GENETIC TRANSCRIPTION.%A%    
% 207.76/207.94  |- mesh__publicMeSHNote mesh__D050436
% 207.76/207.94       2006; see GENES, REGULATOR 1991-2005   
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D050436 2006
% 207.76/207.94  |- skos__altLabel mesh__D050436 Elements, Transcriptional Regulatory
% 207.76/207.94  |- skos__altLabel mesh__D050436 Transcriptional Regulatory Elements
% 207.76/207.94  |- mesh__dateEstablished mesh__D050436 2006-01-01
% 207.76/207.94  |- rdf__type mesh__D050436sskos__Concept
% 207.76/207.94  |- mesh__recordOriginator mesh__D050436 nns
% 207.76/207.94  |- skos__prefLabel mesh__D050436 Regulatory Elements, Transcriptional
% 207.76/207.94  |- mesh__historyNote mesh__D050436 2006; use GENES, REGULATOR 1991-2005   
% 207.76/207.94  |- skos__altLabel mesh__D050436 Transcriptional Regulatory Element
% 207.76/207.94  |- mesh__dateCreated mesh__D050436 2005-06-30
% 207.76/207.94  |- skos__broader mesh__D050436smesh__D040461
% 207.76/207.94  |- mesh__recordMaintainer mesh__D050436 nns
% 207.76/207.94  |- skos__altLabel mesh__D050436 Element, Transcriptional Regulatory
% 207.76/207.94  |- mesh__recordAuthorizer mesh__D050436 sjn
% 207.76/207.94  |- skos__altLabel mesh__D050436 Regulatory Element, Transcriptional
% 207.76/207.94  |- mesh__publicMeSHNote mesh__D008276
% 207.76/207.94       91; was see under MAGNESIUM 1977-90   
% 207.76/207.94  |- rdf__type mesh__D008276sskos__Concept
% 207.76/207.94  |- skos__broader mesh__D008276smesh__D006878
% 207.76/207.94  |- skos__hiddenLabel mesh__D008276 Hydroxide, Magnesium
% 207.76/207.94  |- skos__broader mesh__D008276smesh__D017616
% 207.76/207.94  |- skos__prefLabel mesh__D008276 Magnesium Hydroxide
% 207.76/207.94  |- mesh__historyNote mesh__D008276
% 207.76/207.94       91%28%77%29%; was see under MAGNESIUM 1977-90   
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D008276 2004
% 207.76/207.94  |- mesh__recordAuthorizer mesh__D008276 sjn
% 207.76/207.94  |- skos__altLabel mesh__D008276 Magnesium Hydrate
% 207.76/207.94  |- mesh__dateRevised mesh__D008276 2001-07-25
% 207.76/207.94  |- mesh__dateCreated mesh__D008276 1976-04-13
% 207.76/207.94  |- mesh__dateEstablished mesh__D008276 1991-01-01
% 207.76/207.94  |- skos__scopeNote mesh__D008276
% 207.76/207.94       An inorganic compound that occurs in nature as the mineral brucite. It acts as an antacid with cathartic effects.%A%    
% 207.76/207.94  |- skos__historyNote mesh__D008276 Hydroxides %28%1966-1976%29%
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D008276 2003
% 207.76/207.94  |- skos__historyNote mesh__D008276 Magnesium %28%1966-1976%29%
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D008276 2006
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D008276 2002
% 207.76/207.94  |- mesh__recordOriginator mesh__D008276 RLS
% 207.76/207.94  |- skos__hiddenLabel mesh__D008276 Hydrate, Magnesium
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D008276 2005
% 207.76/207.94  |- mesh__recordMaintainer mesh__D008276 jmp
% 207.76/207.94  |- mesh__recordMaintainer mesh__D000293 jrf
% 207.76/207.94  |- mesh__dateRevised mesh__D000293 2002-07-02
% 207.76/207.94  |- skos__hiddenLabel mesh__D000293 Female Adolescents
% 207.76/207.94  |- skos__related mesh__D000293smesh__D033242
% 207.76/207.94  |- rdf__type mesh__D000293sskos__Concept
% 207.76/207.94  |- skos__altLabel mesh__D000293 Adolescents
% 207.76/207.94  |- skos__hiddenLabel mesh__D000293 Adolescent, Female
% 207.76/207.94  |- mesh__recordAuthorizer mesh__D000293 sjn
% 207.76/207.94  |- skos__hiddenLabel mesh__D000293 Female Adolescent
% 207.76/207.94  |- mesh__dateCreated mesh__D000293 1999-01-01
% 207.76/207.94  |- skos__scopeNote mesh__D000293 A person 13 to 18 years of age.     
% 207.76/207.94  |- skos__annotation mesh__D000293
% 207.76/207.94       age 13-18 yr; IM as psychol %26% sociol entity; check tag ADOLESCENT for NIM; Manual 18.5.12, 34.9.5%A%  
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D000293 2004
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D000293 2006
% 207.76/207.94  |- skos__hiddenLabel mesh__D000293 Teenager
% 207.76/207.94  |- skos__hiddenLabel mesh__D000293 Adolescent, Male
% 207.76/207.94  |- skos__prefLabel mesh__D000293 Adolescent
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D000293 2003
% 207.76/207.94  |- mesh__recordOriginator mesh__D000293 NLM
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D000293 2005
% 207.76/207.94  |- skos__broader mesh__D000293smesh__D009273
% 207.76/207.94  |- skos__hiddenLabel mesh__D000293 Youths
% 207.76/207.94  |- skos__altLabel mesh__D000293 Teenagers
% 207.76/207.94  |- skos__hiddenLabel mesh__D000293 Teen
% 207.76/207.94  |- skos__hiddenLabel mesh__D000293 Male Adolescents
% 207.76/207.94  |- skos__hiddenLabel mesh__D000293 Male Adolescent
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D016708 2006
% 207.76/207.94  |- mesh__dateRevised mesh__D016708 2005-06-30
% 207.76/207.94  |- skos__prefLabel mesh__D016708 Synaptophysin
% 207.76/207.94  |- skos__scopeNote mesh__D016708
% 207.76/207.94       A 38-kDa integral membrane glycoprotein of the presynaptic vesicles in neuron and neuroendocrine cells. It is expressed by a variety of normal and neoplastic neuroendocrine cells and is therefore used as an immunocytochemical marker for neuroendocrine differentiation in various tumors. In ALZHEIMER DISEASE and other dementing disorders, there is an important synapse loss due in part to a decrease of synaptophysin in the presynaptic vesicles.%A%    
% 207.76/207.94  |- skos__broader mesh__D016708smesh__D014408
% 207.76/207.94  |- rdf__type mesh__D016708sskos__Concept
% 207.76/207.94  |- mesh__recordAuthorizer mesh__D016708 sjn
% 207.76/207.94  |- skos__broader mesh__D016708smesh__D009419
% 207.76/207.94  |- mesh__publicMeSHNote mesh__D016708
% 207.76/207.94       92; SYNAPTOPHYSIN was indexed under MEMBRANE PROTEINS 1985-91%A%  
% 207.76/207.94  |- mesh__dateCreated mesh__D016708 1991-02-11
% 207.76/207.94  |- skos__altLabel mesh__D016708 P38 Membrane Protein, Synaptic Vesicle
% 207.76/207.94  |- mesh__recordOriginator mesh__D016708 RLS
% 207.76/207.94  |- mesh__onlineNote mesh__D016708
% 207.76/207.94       use SYNAPTOPHYSIN %28%NM%29% to search SYNAPTOPHYSIN 1985-91   
% 207.76/207.94  |- skos__historyNote mesh__D016708 Nerve Tissue Proteins %28%1966-1991%29%
% 207.76/207.94  |- mesh__dateEstablished mesh__D016708 1992-01-01
% 207.76/207.94  |- mesh__recordMaintainer mesh__D016708 ssb
% 207.76/207.94  |- mesh__historyNote mesh__D016708
% 207.76/207.94       92; was SYNAPTOPHYSIN %28%NM%29% 1985-91   
% 207.76/207.94  |- skos__historyNote mesh__D016708 Membrane Proteins %28%1977-1991%29%
% 207.76/207.94  |- skos__broader mesh__D016708smesh__D008562
% 207.76/207.94  |- skos__altLabel mesh__D016708 Protein P38, Synaptic Vesicle
% 207.76/207.94  |- skos__annotation mesh__D016708
% 207.76/207.94       /biosyn /drug eff /physiol /ultrastruct permitted   
% 207.76/207.94  |- mesh__dateEstablished mesh__D041101 2003-01-01
% 207.76/207.94  |- skos__scopeNote mesh__D041101
% 207.76/207.94       A species of gram-negative bacteria in the genus NEORICKETTSIA, family ANAPLASMATACEAE, causing Sennetsu fever and found in the FAR EAST and SOUTHEAST ASIA.%A%    
% 207.76/207.94  |- rdf__type mesh__D041101sskos__Concept
% 207.76/207.94  |- mesh__publicMeSHNote mesh__D041101 2003   
% 207.76/207.94  |- mesh__dateRevised mesh__D041101 2005-06-30
% 207.76/207.94  |- skos__prefLabel mesh__D041101 Neorickettsia sennetsu
% 207.76/207.94  |- skos__annotation mesh__D041101
% 207.76/207.94       infection: coord IM with ANAPLASMATACEAE INFECTIONS %28%IM%29%   
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D041101 2006
% 207.76/207.94  |- mesh__dateCreated mesh__D041101 2002-07-03
% 207.76/207.94  |- mesh__recordOriginator mesh__D041101 ags
% 207.76/207.94  |- mesh__recordAuthorizer mesh__D041101 sjn
% 207.76/207.94  |- skos__altLabel mesh__D041101 Ehrlichia sennetsu
% 207.76/207.94  |- skos__broader mesh__D041101smesh__D041102
% 207.76/207.94  |- skos__historyNote mesh__D041101 Ehrlichia %28%1985-2002%29%
% 207.76/207.94  |- mesh__historyNote mesh__D041101 2003   
% 207.76/207.94  |- mesh__recordMaintainer mesh__D041101 SYSTEM
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D013410 2002
% 207.76/207.94  |- skos__prefLabel mesh__D013410 Sulfachlorpyridazine
% 207.76/207.94  |- mesh__recordAuthorizer mesh__D013410 sjn
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D013410 2003
% 207.76/207.94  |- skos__broader mesh__D013410smesh__D013424
% 207.76/207.94  |- skos__historyNote mesh__D013410 Pyridazines %28%1974%29%
% 207.76/207.94  |- mesh__recordOriginator mesh__D013410 NLM
% 207.76/207.94  |- skos__altLabel mesh__D013410 Sulfachloropyridazine
% 207.76/207.94  |- mesh__dateRevised mesh__D013410 2000-06-22
% 207.76/207.94  |- skos__hiddenLabel mesh__D013410 Monosodium Salt Sulfachlorpyridazine
% 207.76/207.94  |- mesh__dateEstablished mesh__D013410 1991-01-01
% 207.76/207.94  |- mesh__historyNote mesh__D013410
% 207.76/207.94       91%28%75%29%; was see under SULFANILAMIDES 1975-90   
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D013410 2004
% 207.76/207.94  |- skos__historyNote mesh__D013410 Sulfanilamides %28%1974%29%
% 207.76/207.94  |- rdf__type mesh__D013410sskos__Concept
% 207.76/207.94  |- mesh__publicMeSHNote mesh__D013410
% 207.76/207.94       91; was see under SULFANILAMIDES 1975-90   
% 207.76/207.94  |- mesh__dateCreated mesh__D013410 1974-11-19
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D013410 2005
% 207.76/207.94  |- skos__altLabel mesh__D013410 Sulphachlorpyridazine
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D013410 2001
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D013410 2006
% 207.76/207.94  |- mesh__recordMaintainer mesh__D013410 CCR
% 207.76/207.94  |- skos__scopeNote mesh__D013410
% 207.76/207.94       A sulfonamide antimicrobial used for urinary tract infections and in veterinary medicine.%A%    
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684
% 207.76/207.94       Encephalomyelitides, Hemorrhagic Necrotizing
% 207.76/207.94  |- skos__altLabel mesh__D004684 Encephalomyelitis, Necrotizing Hemorrhagic
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684
% 207.76/207.94       Hemorrhagic Leukoencephalitides, Subacute
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D004684 2006
% 207.76/207.94  |- rdf__type mesh__D004684sskos__Concept
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684 Leukoencephalitides, Acute Hemorrhagic
% 207.76/207.94  |- skos__altLabel mesh__D004684
% 207.76/207.94       Encephalomyelitis, Acute Necrotizing Hemorrhagic
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D004684 2003
% 207.76/207.94  |- skos__annotation mesh__D004684 DF: LEUKOENCEPH ACUTE HEMOR   
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684 Subacute Hemorrhagic Leukoencephalitis
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684 Disease, Hurst%27%s
% 207.76/207.94  |- mesh__dateRevised mesh__D004684 1999-11-09
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684 Acute Necrotizing Encephalitis
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684 Encephalitides, Acute Necrotizing
% 207.76/207.94  |- skos__altLabel mesh__D004684 Hurst Disease
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D004684 2002
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684 Disease, Hurst
% 207.76/207.94  |- skos__altLabel mesh__D004684 Necrotizing Encephalomyelitis, Hemorrhagic
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684 Hemorrhagic Leukoencephalitides, Acute
% 207.76/207.94  |- skos__prefLabel mesh__D004684 Leukoencephalitis, Acute Hemorrhagic
% 207.76/207.94  |- skos__historyNote mesh__D004684 Encephalomyelitis %28%1966-1971%29%
% 207.76/207.94  |- mesh__historyNote mesh__D004684
% 207.76/207.94       1997; was ENCEPHALOMYELITIS, NECROTIZING HEMORRHAGIC 1991-1996 %28%see under ENCEPHALOMYELITIS 1972-1990%29%; HURST DISEASE was HURST%27%S DISEASE 1997%A%  
% 207.76/207.94  |- skos__broader mesh__D004684smesh__D004679
% 207.76/207.94  |- skos__broader mesh__D004684smesh__D020278
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D004684 2004
% 207.76/207.94  |- skos__altLabel mesh__D004684 Encephalomyelitis, Hemorrhagic Necrotizing
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684 Hemorrhagic Leukoencephalitis, Acute
% 207.76/207.94  |- mesh__dateEstablished mesh__D004684 1991-01-01
% 207.76/207.94  |- skos__scopeNote mesh__D004684
% 207.76/207.94       A fulminant and often fatal demyelinating disease of the brain which primarily affects young adults and children. Clinical features include the rapid onset of weakness, SEIZURES, and COMA. It may follow a viral illness or MYCOPLASMA PNEUMONIAE infections but in most instances there is no precipitating event. Pathologic examination reveals marked perivascular demyelination and necrosis of white matter with microhemorrhages. %28%Adams et al., Principles of Neurology, 6th ed, pp924-5%29%%A%    
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684
% 207.76/207.94       Necrotizing Hemorrhagic Encephalomyelitides
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684 Acute Hemorrhagic Leukoencephalitides
% 207.76/207.94  |- skos__altLabel mesh__D004684 Hemorrhagic Encephalomyelitis, Necrotizing
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684 Hemorrhagic Leukoencephalitis, Subacute
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684 Acute Hemorrhagic Leukoencephalitis
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684
% 207.76/207.94       Hemorrhagic Encephalomyelitides, Necrotizing
% 207.76/207.94  |- mesh__publicMeSHNote mesh__D004684
% 207.76/207.94       1997; was ENCEPHALOMYELITIS, NECROTIZING HEMORRHAGIC 1991-1996 %28%see under ENCEPHALOMYELITIS 1972-1990%29%; HURST DISEASE was HURST%27%S DISEASE 1997%A%  
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684 Hursts Disease
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684 Syndrome, Hurst
% 207.76/207.94  |- mesh__dateCreated mesh__D004684 1999-01-01
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684
% 207.76/207.94       Necrotizing Encephalomyelitides, Hemorrhagic
% 207.76/207.94  |- skos__altLabel mesh__D004684 Hurst Syndrome
% 207.76/207.94  |- mesh__recordMaintainer mesh__D004684 KEV
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D004684 2000
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684 Acute Necrotizing Encephalitides
% 207.76/207.94  |- skos__broader mesh__D004684smesh__D004660
% 207.76/207.94  |- skos__altLabel mesh__D004684 Leukoencephalitis Acuta Hemorrhagica
% 207.76/207.94  |- skos__broader mesh__D004684smesh__D020274
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684 Necrotizing Encephalitides, Acute
% 207.76/207.94  |- skos__altLabel mesh__D004684 Hemorrhagic Necrotizing Encephalomyelitis
% 207.76/207.94  |- skos__historyNote mesh__D004684 Demyelinating Diseases %28%1966-1971%29%
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684 Necrotizing Encephalitis, Acute
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D004684 2005
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684 Subacute Hemorrhagic Leukoencephalitides
% 207.76/207.94  |- mesh__recordOriginator mesh__D004684 NLM
% 207.76/207.94  |- skos__altLabel mesh__D004684 Hurst%27%s Disease
% 207.76/207.94  |- mesh__recordAuthorizer mesh__D004684 sjn
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D004684 2001
% 207.76/207.94  |- skos__hiddenLabel mesh__D004684
% 207.76/207.94       Leukoencephalitides, Subacute Hemorrhagic
% 207.76/207.94  |- skos__scopeNote mesh__D012318
% 207.76/207.94       A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. The enzyme functions in the nucleolar structure and transcribes DNA into RNA. It has different requirements for cations and salts than RNA polymerase II and III and is not inhibited by alpha-amanitin. EC 2.7.7.6.%A%    
% 207.76/207.94  |- mesh__recordAuthorizer mesh__D012318 sjn
% 207.76/207.94  |- skos__altLabel mesh__D012318 RNA Polymerase A
% 207.76/207.94  |- skos__hiddenLabel mesh__D012318 Polymerase I, RNA
% 207.76/207.94  |- skos__historyNote mesh__D012318 RNA Polymerases %28%1973-1976%29%
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D012318 2005
% 207.76/207.94  |- skos__hiddenLabel mesh__D012318 DNA Dependent RNA Polymerase I
% 207.76/207.94  |- skos__altLabel mesh__D012318 DNA-Dependent RNA Polymerase I
% 207.76/207.94  |- mesh__publicMeSHNote mesh__D012318
% 207.76/207.94       84; was see under RNA POLYMERASES 1977-83   
% 207.76/207.94  |- mesh__historyNote mesh__D012318
% 207.76/207.94       84%28%77%29%; was see under RNA POLYMERASES 1977-83   
% 207.76/207.94  |- skos__hiddenLabel mesh__D012318 A, RNA Polymerase
% 207.76/207.94  |- mesh__dateEstablished mesh__D012318 1984-01-01
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D012318 2006
% 207.76/207.94  |- skos__prefLabel mesh__D012318 RNA Polymerase I
% 207.76/207.94  |- rdf__type mesh__D012318sskos__Concept
% 207.76/207.94  |- skos__hiddenLabel mesh__D012318 Polymerase A, RNA
% 207.76/207.94  |- mesh__recordMaintainer mesh__D012318 ssb
% 207.76/207.94  |- skos__hiddenLabel mesh__D012318 I, RNA Polymerase
% 207.76/207.94  |- skos__broader mesh__D012318smesh__D012321
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D012318 2004
% 207.76/207.94  |- mesh__dateCreated mesh__D012318 1976-04-19
% 207.76/207.94  |- mesh__recordOriginator mesh__D012318 RLS
% 207.76/207.94  |- skos__historyNote mesh__D012318
% 207.76/207.94       RNA Nucleotidyltransferases %28%1968-1972%29%
% 207.76/207.94  |- mesh__dateRevised mesh__D012318 2003-07-09
% 207.76/207.94  |- mesh__recordAuthorizer mesh__D017801 PLS
% 207.76/207.94  |- skos__hiddenLabel mesh__D017801 Viruses, Plum Pox
% 207.76/207.94  |- skos__hiddenLabel mesh__D017801 Pox Viruses, Plum
% 207.76/207.94  |- mesh__dateRevised mesh__D017801 1996-06-10
% 207.76/207.94  |- skos__hiddenLabel mesh__D017801 Pox Virus, Plum
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017801 2000
% 207.76/207.94  |- skos__historyNote mesh__D017801 Plant Viruses %28%1969-1993%29%
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017801 1997
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017801 2003
% 207.76/207.94  |- mesh__publicMeSHNote mesh__D017801 94   
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017801 2001
% 207.76/207.94  |- mesh__historyNote mesh__D017801 94   
% 207.76/207.94  |- skos__scopeNote mesh__D017801
% 207.76/207.94       A species of the genus POTYVIRUS that affects many species of Prunus. It is transmitted by aphids and by infected rootstocks.%A%    
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017801 1998
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017801 2004
% 207.76/207.94  |- skos__hiddenLabel mesh__D017801 Virus, Plum Pox
% 207.76/207.94  |- mesh__dateCreated mesh__D017801 1993-06-04
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017801 2002
% 207.76/207.94  |- skos__broader mesh__D017801smesh__D017800
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017801 1999
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017801 2005
% 207.76/207.94  |- mesh__recordMaintainer mesh__D017801 AGS
% 207.76/207.94  |- mesh__recordOriginator mesh__D017801 AGS
% 207.76/207.94  |- skos__annotation mesh__D017801 a species of Potyvirus, a mosaic virus   
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017801 2006
% 207.76/207.94  |- rdf__type mesh__D017801sskos__Concept
% 207.76/207.94  |- mesh__dateEstablished mesh__D017801 1994-01-01
% 207.76/207.94  |- skos__hiddenLabel mesh__D017801 Plum Pox Viruses
% 207.76/207.94  |- skos__prefLabel mesh__D017801 Plum Pox Virus
% 207.76/207.94  |- skos__hiddenLabel mesh__D017003 Bovine toroviruses
% 207.76/207.94  |- mesh__dateRevised mesh__D017003 2001-07-25
% 207.76/207.94  |- skos__hiddenLabel mesh__D017003 torovirus, Bovine
% 207.76/207.94  |- mesh__dateCreated mesh__D017003 1991-05-30
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017003 2002
% 207.76/207.94  |- mesh__dateEstablished mesh__D017003 1992-01-01
% 207.76/207.94  |- skos__hiddenLabel mesh__D017003 toroviruses, Human
% 207.76/207.94  |- skos__hiddenLabel mesh__D017003 Equine toroviruses
% 207.76/207.94  |- mesh__recordOriginator mesh__D017003 AGS
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017003 2005
% 207.76/207.94  |- skos__hiddenLabel mesh__D017003 toroviruses, Bovine
% 207.76/207.94  |- skos__historyNote mesh__D017003 RNA Viruses %28%1984-1991%29%
% 207.76/207.94  |- skos__hiddenLabel mesh__D017003 torovirus, Human
% 207.76/207.94  |- skos__altLabel mesh__D017003 Toroviridae
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017003 2006
% 207.76/207.94  |- skos__hiddenLabel mesh__D017003 toroviruses, Equine
% 207.76/207.94  |- mesh__historyNote mesh__D017003
% 207.76/207.94       94; was TOROVIRIDAE 1992-93; TOROVIRUSES was see TOROVIRIDAE 1992-93%A%  
% 207.76/207.94  |- skos__hiddenLabel mesh__D017003 toroviruses, Porcine
% 207.76/207.94  |- mesh__recordAuthorizer mesh__D017003 sjn
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017003 2003
% 207.76/207.94  |- mesh__onlineNote mesh__D017003
% 207.76/207.94       use TOROVIRUS to search TOROVIRIDAE %26% TOROVIRUSES 1992-93%A%  
% 207.76/207.94  |- skos__annotation mesh__D017003
% 207.76/207.94       infection = TOROVIRUS INFECTIONS %28%IM%29%   
% 207.76/207.94  |- skos__altLabel mesh__D017003 Breda Virus
% 207.76/207.94  |- rdf__type mesh__D017003sskos__Concept
% 207.76/207.94  |- skos__hiddenLabel mesh__D017003 Human toroviruses
% 207.76/207.94  |- skos__scopeNote mesh__D017003
% 207.76/207.94       A genus of the family CORONAVIRIDAE characterized by enveloped, peplomer-bearing particles containing an elongated tubular nucleocapsid with helical symmetry. Toroviruses have been found in association with enteric infections in horses %28%Berne virus%29%, cattle %28%Breda virus%29%, swine, and humans. Transmission probably takes place via the fecal-oral route.%A%    
% 207.76/207.94  |- skos__hiddenLabel mesh__D017003 Porcine toroviruses
% 207.76/207.94  |- skos__altLabel mesh__D017003 Berne Virus
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D017003 2004
% 207.76/207.94  |- mesh__publicMeSHNote mesh__D017003
% 207.76/207.94       94; was TOROVIRIDAE 1992-93; TOROVIRUSES was see TOROVIRIDAE 1992-93%A%  
% 207.76/207.94  |- skos__hiddenLabel mesh__D017003 torovirus, Equine
% 207.76/207.94  |- mesh__recordMaintainer mesh__D017003 ags
% 207.76/207.94  |- skos__broader mesh__D017003smesh__D003332
% 207.76/207.94  |- skos__hiddenLabel mesh__D017003 Toroviruses
% 207.76/207.94  |- skos__hiddenLabel mesh__D017003 torovirus, Porcine
% 207.76/207.94  |- skos__prefLabel mesh__D017003 Torovirus
% 207.76/207.94  |- mesh__recordOriginator mesh__D050437 nns
% 207.76/207.94  |- mesh__publicMeSHNote mesh__D050437
% 207.76/207.94       2006; see GENES, STRUCTURAL 1988-2005   
% 207.76/207.94  |- mesh__recordMaintainer mesh__D050437 ags
% 207.76/207.94  |- skos__hiddenLabel mesh__D050437 Gene, Developmental
% 207.76/207.94  |- skos__scopeNote mesh__D050437
% 207.76/207.94       Genes that determine the fate of a cell or CELLS in a region of the EMBRYO during EMBRYONIC DEVELOPMENT.%A%    
% 207.76/207.94  |- skos__altLabel mesh__D050437 Developmental Genes
% 207.76/207.94  |- skos__related mesh__D050437smesh__D018507
% 207.76/207.94  |- mesh__dateEstablished mesh__D050437 2006-01-01
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D050437 2006A
% 207.76/207.94  |- mesh__dateRevised mesh__D050437 2005-11-09
% 207.76/207.94  |- skos__prefLabel mesh__D050437 Genes, Developmental
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D050437 2006
% 207.76/207.94  |- mesh__dateCreated mesh__D050437 2005-06-30
% 207.76/207.94  |- mesh__historyNote mesh__D050437 2006   
% 207.76/207.94  |- skos__broader mesh__D050437smesh__D005796
% 207.76/207.94  |- mesh__recordAuthorizer mesh__D050437 ags
% 207.76/207.94  |- skos__hiddenLabel mesh__D050437 Developmental Gene
% 207.76/207.94  |- rdf__type mesh__D050437sskos__Concept
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D008277 2002
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D008277 2004
% 207.76/207.94  |- skos__broader mesh__D008277smesh__D017616
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D008277 2003
% 207.76/207.94  |- skos__scopeNote mesh__D008277
% 207.76/207.94       Magnesium oxide %28%MgO%29%. An inorganic compound that occurs in nature as the mineral periclase. In aqueous media combines quickly with water to form magnesium hydroxide. It is used as an antacid and mild laxative and has many nonmedicinal uses.%A%    
% 207.76/207.94  |- skos__altLabel mesh__D008277 Magnesia
% 207.76/207.94  |- skos__broader mesh__D008277smesh__D010087
% 207.76/207.94  |- mesh__dateRevised mesh__D008277 1999-11-03
% 207.76/207.94  |- mesh__dateCreated mesh__D008277 1999-01-01
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D008277 2001
% 207.76/207.94  |- mesh__recordMaintainer mesh__D008277 adp
% 207.76/207.94  |- mesh__recordAuthorizer mesh__D008277 sjn
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D008277 2006
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D008277 2000
% 207.76/207.94  |- mesh__recordOriginator mesh__D008277 NLM
% 207.76/207.94  |- skos__annotation mesh__D008277 an antacid %26% cathartic   
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D008277 2005
% 207.76/207.94  |- rdf__type mesh__D008277sskos__Concept
% 207.76/207.94  |- skos__prefLabel mesh__D008277 Magnesium Oxide
% 207.76/207.94  |- skos__hiddenLabel mesh__D008277 Oxide, Magnesium
% 207.76/207.94  |- mesh__recordOriginator mesh__D000294 EC
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D000294 2004
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D000294 2006
% 207.76/207.94  |- skos__hiddenLabel mesh__D000294 Behaviors, Adolescent
% 207.76/207.94  |- mesh__dateCreated mesh__D000294 1980-05-07
% 207.76/207.94  |- skos__annotation mesh__D000294 check also tag ADOLESCENCE   
% 207.76/207.94  |- skos__related mesh__D000294smesh__D041923
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D000294 2005
% 207.76/207.94  |- mesh__historyNote mesh__D000294 81   
% 207.76/207.94  |- skos__historyNote mesh__D000294 Adolescent Psychology %28%1967-1980%29%
% 207.76/207.94  |- mesh__publicMeSHNote mesh__D000294 81   
% 207.76/207.94  |- mesh__dateRevised mesh__D000294 2003-07-09
% 207.76/207.94  |- skos__altLabel mesh__D000294 Behavior, Adolescent
% 207.76/207.94  |- mesh__recordAuthorizer mesh__D000294 sjn
% 207.76/207.94  |- skos__broader mesh__D000294smesh__D001519
% 207.76/207.94  |- rdf__type mesh__D000294sskos__Concept
% 207.76/207.94  |- skos__scopeNote mesh__D000294
% 207.76/207.94       Any observable response or action of an adolescent.     
% 207.76/207.94  |- mesh__dateEstablished mesh__D000294 1981-01-01
% 207.76/207.94  |- mesh__recordMaintainer mesh__D000294 lkt
% 207.76/207.94  |- skos__prefLabel mesh__D000294 Adolescent Behavior
% 207.76/207.94  |- skos__hiddenLabel mesh__D000294 Adolescent Behaviors
% 207.76/207.94  |- skos__broader mesh__D016709smesh__D008516
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D016709 2006
% 207.76/207.94  |- skos__related mesh__D016709smesh__D016710
% 207.76/207.94  |- skos__prefLabel mesh__D016709 Yin-Yang
% 207.76/207.94  |- rdf__type mesh__D016709sskos__Concept
% 207.76/207.94  |- skos__related mesh__D016709smesh__D019413
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D016709 2003
% 207.76/207.94  |- skos__hiddenLabel mesh__D016709 Yin Yang
% 207.76/207.94  |- mesh__activeMeSHYear mesh__D016709 2004
% 207.76/207.94  |- skos__scopeNote mesh__D016709
% 207.76/207.94       In Chinese philosophy and religion, two principles, one negative, dark, and feminine %28%yin%29% and one positive, bright, and masculine %28%yang%29%, from whose interaction all things are produced and all things are dissolved. As a concept the two polar elements referred originally to the shady and sunny sides of a valley or a hill but it developed into the relationship of any contrasting pair: those specified above %28%female-male, etc.%29% as well as cold-hot, wet-dry, weak-strong, etc. It is not a distinct system of thought by itself but permeates Chinese life and thought. A balance of yin and yang is essential to health. A deficiency of either principle can manifest as disease. %28%Encyclopedia Americana%29%%A%    
% 207.76/207.94  |- skos__broader mesh__D016709smesh__D010684
% 207.76/207.94  |- mesh__historyNote mesh__D016709 92   
% 207.76/207.94  |- skos__annotation mesh__D016709
% 207.76/207.94       yang exuberance syndrome can go here, defic syndromes: index YIN DEFICIENCY or YANG DEFICIENCY: see notes there%A%  
% 207.76/207.94  |- mesh__recordAuthorizer mesh__D016709 sjn
% 207.76/207.95  |- mesh__publicMeSHNote mesh__D016709 92   
% 207.76/207.95  |- skos__historyNote mesh__D016709
% 207.76/207.95       Medicine, Chinese Traditional %28%1968-1991%29%
% 207.76/207.95  |- mesh__recordMaintainer mesh__D016709 ssb
% 207.76/207.95  |- mesh__dateCreated mesh__D016709 1991-02-11
% 207.76/207.95  |- mesh__recordOriginator mesh__D016709 TGC
% 207.76/207.95  |- mesh__dateEstablished mesh__D016709 1992-01-01
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D016709 2005
% 207.76/207.95  |- skos__related mesh__D016709smesh__D016711
% 207.76/207.95  |- mesh__dateRevised mesh__D016709 2002-07-03
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D041102 2006
% 207.76/207.95  |- mesh__dateEstablished mesh__D041102 2003-01-01
% 207.76/207.95  |- skos__scopeNote mesh__D041102
% 207.76/207.95       Genus of gram-negative, intracytoplasmic bacteria that are found primarily in VACUOLES of MONOCYTES in the BLOOD and MACROPHAGES of lymphoid or other tissues of DOGS; HORSES, and humans. %28%From Int. J. Syst. Evol. Microbiol. %28%2001%29% 51:2145-2165%29%%A%    
% 207.76/207.95  |- skos__historyNote mesh__D041102 Rickettsiaceae %28%1969-2002%29%
% 207.76/207.95  |- mesh__dateRevised mesh__D041102 2005-06-30
% 207.76/207.95  |- mesh__publicMeSHNote mesh__D041102 2003, 1963-1981   
% 207.76/207.95  |- rdf__type mesh__D041102sskos__Concept
% 207.76/207.95  |- mesh__recordMaintainer mesh__D041102 SYSTEM
% 207.76/207.95  |- skos__broader mesh__D041102smesh__D000710
% 207.76/207.95  |- skos__annotation mesh__D041102
% 207.76/207.95       infection: coord IM with ANAPLASMATACEAE INFECTIONS %28%IM%29%   
% 207.76/207.95  |- skos__prefLabel mesh__D041102 Neorickettsia
% 207.76/207.95  |- mesh__historyNote mesh__D041102 2003, 1963-1981   
% 207.76/207.95  |- mesh__recordOriginator mesh__D041102 ags
% 207.76/207.95  |- mesh__dateCreated mesh__D041102 2002-07-03
% 207.76/207.95  |- mesh__recordAuthorizer mesh__D041102 sjn
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D013411 2003
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D013411 2004
% 207.76/207.95  |- rdf__type mesh__D013411sskos__Concept
% 207.76/207.95  |- skos__scopeNote mesh__D013411
% 207.76/207.95       One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.%A%    
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D013411 2005
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D013411 2002
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D013411 2006
% 207.76/207.95  |- skos__hiddenLabel mesh__D013411 Sulfadiazine, Zinc
% 207.76/207.95  |- mesh__recordMaintainer mesh__D013411 ssb
% 207.76/207.95  |- skos__altLabel mesh__D013411 Sulphadiazine
% 207.76/207.95  |- skos__prefLabel mesh__D013411 Sulfadiazine
% 207.76/207.95  |- mesh__dateCreated mesh__D013411 1999-01-01
% 207.76/207.95  |- skos__altLabel mesh__D013411 Sulfazine
% 207.76/207.95  |- mesh__recordAuthorizer mesh__D013411 sjn
% 207.76/207.95  |- skos__broader mesh__D013411smesh__D013424
% 207.76/207.95  |- mesh__recordOriginator mesh__D013411 NLM
% 207.76/207.95  |- skos__annotation mesh__D013411
% 207.76/207.95       note: METHYLSULFADIAZINE see SULFAMERAZINE   
% 207.76/207.95  |- mesh__dateRevised mesh__D013411 2001-07-25
% 207.76/207.95  |- mesh__dateEstablished mesh__D004685 1991-01-01
% 207.76/207.95  |- skos__prefLabel mesh__D004685 Encephalomyelitis, Venezuelan Equine
% 207.76/207.95  |- skos__altLabel mesh__D004685 Venezuelan Equine Encephalomyelitides
% 207.76/207.95  |- mesh__publicMeSHNote mesh__D004685
% 207.76/207.95       1991; was see under ENCEPHALOMYELITIS, EQUINE 1976-1990   
% 207.76/207.95  |- skos__scopeNote mesh__D004685
% 207.76/207.95       A form of arboviral encephalitis endemic to Central America and the northern latitudes of South America. The causative organism %28%ENCEPHALITIS VIRUS, VENEZUELAN EQUINE%29% is transmitted to humans and horses via the bite of several mosquito species. Human viral infection may be asymptomatic or remain restricted to a mild influenza-like illness. Encephalitis, usually not severe, occurs in a small percentage of cases and may rarely feature SEIZURES and COMA. %28%From Joynt, Clinical Neurology, 1996, Ch26, pp9-10%29%%A%    
% 207.76/207.95  |- mesh__recordOriginator mesh__D004685 FPG
% 207.76/207.95  |- skos__historyNote mesh__D004685
% 207.76/207.95       Encephalomyelitis, Equine %28%1966-1975%29%
% 207.76/207.95  |- skos__hiddenLabel mesh__D004685 Venezuelan Equine Encephalomyelitis
% 207.76/207.95  |- skos__hiddenLabel mesh__D004685 Equine Encephalomyelitis, Venezuelan
% 207.76/207.95  |- mesh__recordMaintainer mesh__D004685 sjn
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D004685 2006
% 207.76/207.95  |- mesh__dateCreated mesh__D004685 1975-07-25
% 207.76/207.95  |- skos__annotation mesh__D004685
% 207.76/207.95       human %26% animal; if in horses, coord with HORSE DISEASES %28%IM%29% + HORSES %28%NIM%29% %26% use /vet; DF: ENCEPH VENEZ EQUINE%A%  
% 207.76/207.95  |- mesh__historyNote mesh__D004685
% 207.76/207.95       1991%28%1976%29%; was see under ENCEPHALOMYELITIS, EQUINE 1976-1990%A%  
% 207.76/207.95  |- skos__altLabel mesh__D004685 Equine Encephalitis, Venezuelan
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D004685 2005
% 207.76/207.95  |- skos__altLabel mesh__D004685 Venezuelan Equine Encephalitis
% 207.76/207.95  |- skos__altLabel mesh__D004685 Encephalomyelitides, Venezuelan Equine
% 207.76/207.95  |- mesh__recordAuthorizer mesh__D004685 sjn
% 207.76/207.95  |- mesh__dateRevised mesh__D004685 2004-07-13
% 207.76/207.95  |- skos__broader mesh__D004685smesh__D004683
% 207.76/207.95  |- rdf__type mesh__D004685sskos__Concept
% 207.76/207.95  |- skos__altLabel mesh__D004685 Equine Encephalomyelitides, Venezuelan
% 207.76/207.95  |- skos__altLabel mesh__D004685 Encephalitis, Venezuelan Equine
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D037061 2006A
% 207.76/207.95  |- skos__historyNote mesh__D037061 Pain %28%1967-2002%29%
% 207.76/207.95  |- mesh__historyNote mesh__D037061 2003   
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D037061 2006
% 207.76/207.95  |- skos__broader mesh__D037061smesh__D010146
% 207.76/207.95  |- mesh__dateRevised mesh__D037061 2005-07-20
% 207.76/207.95  |- skos__broader mesh__D037061smesh__D007592
% 207.76/207.95  |- skos__broader mesh__D037061smesh__D005534
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D037061 2005
% 207.76/207.95  |- mesh__recordAuthorizer mesh__D037061 ags
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D037061 2004
% 207.76/207.95  |- skos__scopeNote mesh__D037061
% 207.76/207.95       Pain in the region of the METATARSUS. It can include pain in the METATARSAL BONES; METATARSOPHALANGEAL JOINT; and/or intermetatarsal joints %28%TARSAL JOINTS%29%.%A%    
% 207.76/207.95  |- skos__historyNote mesh__D037061 Metatarsus %28%1965-2002%29%
% 207.76/207.95  |- skos__prefLabel mesh__D037061 Metatarsalgia
% 207.76/207.95  |- mesh__publicMeSHNote mesh__D037061 2003   
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D037061 2003
% 207.76/207.95  |- rdf__type mesh__D037061sskos__Concept
% 207.76/207.95  |- mesh__dateCreated mesh__D037061 2002-07-03
% 207.76/207.95  |- mesh__recordOriginator mesh__D037061 ags
% 207.76/207.95  |- mesh__recordMaintainer mesh__D037061 ags
% 207.76/207.95  |- mesh__dateEstablished mesh__D037061 2003-01-01
% 207.76/207.95  |- skos__annotation mesh__D037061 coord with pertinent metatarsal term   
% 207.76/207.95  |- mesh__publicMeSHNote mesh__D012319
% 207.76/207.95       84; was see under RNA POLYMERASES 1977-83   
% 207.76/207.95  |- mesh__recordOriginator mesh__D012319 RLS
% 207.76/207.95  |- mesh__dateCreated mesh__D012319 1976-04-19
% 207.76/207.95  |- mesh__recordMaintainer mesh__D012319 ssb
% 207.76/207.95  |- skos__historyNote mesh__D012319
% 207.76/207.95       RNA Nucleotidyltransferases %28%1968-1972%29%
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D012319 2006
% 207.76/207.95  |- rdf__type mesh__D012319sskos__Concept
% 207.76/207.95  |- skos__prefLabel mesh__D012319 RNA Polymerase II
% 207.76/207.95  |- skos__hiddenLabel mesh__D012319 Polymerase B, RNA
% 207.76/207.95  |- skos__scopeNote mesh__D012319
% 207.76/207.95       A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6.%A%    
% 207.76/207.95  |- skos__hiddenLabel mesh__D012319 B, RNA Polymerase
% 207.76/207.95  |- skos__hiddenLabel mesh__D012319 DNA Dependent RNA Polymerase II
% 207.76/207.95  |- skos__hiddenLabel mesh__D012319 Polymerase II, RNA
% 207.76/207.95  |- skos__hiddenLabel mesh__D012319 II, RNA Polymerase
% 207.76/207.95  |- mesh__recordAuthorizer mesh__D012319 sjn
% 207.76/207.95  |- skos__broader mesh__D012319smesh__D012321
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D012319 2004
% 207.76/207.95  |- mesh__dateRevised mesh__D012319 2003-07-09
% 207.76/207.95  |- skos__altLabel mesh__D012319 RNA Polymerase B
% 207.76/207.95  |- skos__altLabel mesh__D012319 DNA-Dependent RNA Polymerase II
% 207.76/207.95  |- mesh__dateEstablished mesh__D012319 1984-01-01
% 207.76/207.95  |- skos__historyNote mesh__D012319 RNA Polymerases %28%1973-1976%29%
% 207.76/207.95  |- mesh__historyNote mesh__D012319
% 207.76/207.95       84%28%77%29%; was see under RNA POLYMERASES 1977-83   
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D012319 2005
% 207.76/207.95  |- skos__hiddenLabel mesh__D009370 Neoplasm Histological Types
% 207.76/207.95  |- mesh__historyNote mesh__D009370 98; use explode   
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D009370 2006
% 207.76/207.95  |- skos__altLabel mesh__D009370 Neoplasms by Histological Type
% 207.76/207.95  |- mesh__dateEstablished mesh__D009370 1998-01-01
% 207.76/207.95  |- skos__annotation mesh__D009370
% 207.76/207.95       to collect neopl by histol type; not used for indexing; policy: Manual section 24; also TN Suppl: Tumor Key for human %26% corresponding vet tumors %28%does not contain exper tumors%29%; TN 135: correct use of tissue type terms; restricted use: Manual 24.2.2.5; DF: NEOPL HISTOL TYPE      CATALOG: do not use%A%  
% 207.76/207.95  |- skos__scopeNote mesh__D009370
% 207.76/207.95       A collective term for the various histological types of NEOPLASMS. It is more likely to be used by searchers than by indexers and catalogers.%A%    
% 207.76/207.95  |- skos__broader mesh__D009370smesh__D009369
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D009370 2005
% 207.76/207.95  |- skos__altLabel mesh__D009370 Histological Type of Neoplasm
% 207.76/207.95  |- mesh__recordAuthorizer mesh__D009370 sjn
% 207.76/207.95  |- skos__hiddenLabel mesh__D009370 Neoplasm Histological Type
% 207.76/207.95  |- mesh__recordOriginator mesh__D009370 NLM
% 207.76/207.95  |- mesh__recordMaintainer mesh__D009370 sjn
% 207.76/207.95  |- rdf__type mesh__D009370sskos__Concept
% 207.76/207.95  |- skos__hiddenLabel mesh__D009370 Neoplasms Histological Type
% 207.76/207.95  |- mesh__dateCreated mesh__D009370 1999-01-01
% 207.76/207.95  |- mesh__publicMeSHNote mesh__D009370 98   
% 207.76/207.95  |- skos__altLabel mesh__D009370 Histological Types of Neoplasms
% 207.76/207.95  |- skos__prefLabel mesh__D009370 Neoplasms by Histologic Type
% 207.76/207.95  |- mesh__dateRevised mesh__D009370 2004-07-13
% 207.76/207.95  |- skos__hiddenLabel mesh__D009370 Neoplasms Histological Types
% 207.76/207.95  |- skos__altLabel mesh__D023041 Tumor Xenograft Assay
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D023041 2006
% 207.76/207.95  |- mesh__dateRevised mesh__D023041 2004-08-03
% 207.76/207.95  |- skos__altLabel mesh__D023041 Xenograft Antitumor Assays
% 207.76/207.95  |- skos__broader mesh__D023041smesh__D009368
% 207.76/207.95  |- rdf__type mesh__D023041sskos__Concept
% 207.76/207.95  |- skos__scopeNote mesh__D023041
% 207.76/207.95       In vivo methods of screening investigative anticancer drugs, biologic response modifiers or radiotherapies. Human tumor tissue or cells are transplanted into mice or rats followed by tumor treatment regimens. A variety of outcomes are monitored to assess antitumor effectiveness.%A%    
% 207.76/207.95  |- skos__hiddenLabel mesh__D023041 Xenograft Antitumor Assay
% 207.76/207.95  |- mesh__recordAuthorizer mesh__D023041 jls
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D023041 2005
% 207.76/207.95  |- skos__hiddenLabel mesh__D023041 Antitumor Assays, Xenograft
% 207.76/207.95  |- skos__hiddenLabel mesh__D023041 Assays, Xenograft Antitumor
% 207.76/207.95  |- mesh__recordOriginator mesh__D023041 nns
% 207.76/207.95  |- skos__altLabel mesh__D023041 Antitumor Assays, Xenograft Model
% 207.76/207.95  |- mesh__recordMaintainer mesh__D023041 jls
% 207.76/207.95  |- skos__hiddenLabel mesh__D023041 Assay, Xenograft Antitumor
% 207.76/207.95  |- skos__broader mesh__D023041smesh__D004354
% 207.76/207.95  |- skos__hiddenLabel mesh__D023041 Antitumor Assay, Xenograft
% 207.76/207.95  |- mesh__dateEstablished mesh__D023041 2001-01-01
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D023041 2005A
% 207.76/207.95  |- skos__prefLabel mesh__D023041 Xenograft Model Antitumor Assays
% 207.76/207.95  |- mesh__historyNote mesh__D023041
% 207.76/207.95       2001; for TUMOR XENOGRAFT ASSAY use SUBRENAL CAPSULE ASSAY %28%1988-2000%29%%A%  
% 207.76/207.95  |- mesh__dateCreated mesh__D023041 2000-06-21
% 207.76/207.95  |- mesh__publicMeSHNote mesh__D023041
% 207.76/207.95       2001; for TUMOR XENOGRAFT ASSAY see SUBRENAL CAPSULE ASSAY %28%1988-2000%29%%A%  
% 207.76/207.95  |- skos__altLabel mesh__D017004 Co-Dependency %28%Psychology%29%
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D017004 2005
% 207.76/207.95  |- skos__altLabel mesh__D017004 Co Dependency %28%Psychology%29%
% 207.76/207.95  |- skos__altLabel mesh__D017004 Co-Dependence %28%Psychology%29%
% 207.76/207.95  |- skos__historyNote mesh__D017004
% 207.76/207.95       Dependency %28%Psychology%29% %28%1987-1991%29%
% 207.76/207.95  |- mesh__recordOriginator mesh__D017004 MXR
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D017004 2006
% 207.76/207.95  |- skos__hiddenLabel mesh__D017004 Dependence, Co %28%Psychology%29%
% 207.76/207.95  |- skos__scopeNote mesh__D017004
% 207.76/207.95       A relational pattern in which a person attempts to derive a sense of purpose through relationships with others.%A%    
% 207.76/207.95  |- skos__hiddenLabel mesh__D017004 Dependency, Co %28%Psychology%29%
% 207.76/207.95  |- mesh__publicMeSHNote mesh__D017004
% 207.76/207.95       1998; see CO-DEPENDENCY %28%PSYCHOLOGY%29% 1992-1997   
% 207.76/207.95  |- mesh__dateEstablished mesh__D017004 1992-01-01
% 207.76/207.95  |- skos__hiddenLabel mesh__D017004 Codependencies %28%Psychology%29%
% 207.76/207.95  |- skos__hiddenLabel mesh__D017004 Dependences, Co %28%Psychology%29%
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D017004 2003
% 207.76/207.95  |- skos__hiddenLabel mesh__D017004 Co-Dependencies %28%Psychology%29%
% 207.76/207.95  |- skos__hiddenLabel mesh__D017004 Co Dependencies %28%Psychology%29%
% 207.76/207.95  |- skos__altLabel mesh__D017004 Codependence
% 207.76/207.95  |- rdf__type mesh__D017004sskos__Concept
% 207.76/207.95  |- skos__prefLabel mesh__D017004 Codependency %28%Psychology%29%
% 207.76/207.95  |- skos__hiddenLabel mesh__D017004 Co Dependences %28%Psychology%29%
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D017004 2004
% 207.76/207.95  |- skos__altLabel mesh__D017004 Co Dependence %28%Psychology%29%
% 207.76/207.95  |- mesh__recordMaintainer mesh__D017004 ags
% 207.76/207.95  |- skos__hiddenLabel mesh__D017004 Dependencies, Co %28%Psychology%29%
% 207.76/207.95  |- skos__broader mesh__D017004smesh__D001519
% 207.76/207.95  |- mesh__recordAuthorizer mesh__D017004 sjn
% 207.76/207.95  |- mesh__dateRevised mesh__D017004 2002-07-03
% 207.76/207.95  |- mesh__historyNote mesh__D017004 1998%28%1992%29%   
% 207.76/207.95  |- mesh__dateCreated mesh__D017004 1991-05-30
% 207.76/207.95  |- skos__hiddenLabel mesh__D017004 Co-Dependences %28%Psychology%29%
% 207.76/207.95  |- skos__annotation mesh__D017004
% 207.76/207.95       %22%dependency%22% is not restricted to substance dependence: can apply to family or workplace; DF: CODEPENDENCY%A%  
% 207.76/207.95  |- mesh__publicMeSHNote mesh__D050438
% 207.76/207.95       2006; see GENES, IMMUNOGLOBULIN 1987-2005   
% 207.76/207.95  |- mesh__historyNote mesh__D050438
% 207.76/207.95       2006; use GENES, IMMUNOGLOBULIN 1987-2005   
% 207.76/207.95  |- skos__altLabel mesh__D050438 Immunoglobulin VH Germ Line Genes
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D050438 2006
% 207.76/207.95  |- rdf__type mesh__D050438sskos__Concept
% 207.76/207.95  |- skos__scopeNote mesh__D050438
% 207.76/207.95       Genes and gene segments encoding the IMMUNOGLOBULIN HEAVY CHAINS. Gene segments of the heavy chain genes are symbolized V %28%variable%29%, D %28%diversity%29%, J %28%joining%29%, and C %28%constant%29%.%A%    
% 207.76/207.95  |- skos__altLabel mesh__D050438 Immunoglobulin Heavy Chain Genes
% 207.76/207.95  |- mesh__recordOriginator mesh__D050438 nns
% 207.76/207.95  |- skos__prefLabel mesh__D050438 Genes, Immunoglobulin Heavy Chain
% 207.76/207.95  |- skos__related mesh__D050438smesh__D007129
% 207.76/207.95  |- mesh__recordAuthorizer mesh__D050438 sjn
% 207.76/207.95  |- skos__broader mesh__D050438smesh__D005803
% 207.76/207.95  |- mesh__recordMaintainer mesh__D050438 nns
% 207.76/207.95  |- mesh__dateCreated mesh__D050438 2005-06-30
% 207.76/207.95  |- skos__related mesh__D050438smesh__D007143
% 207.76/207.95  |- mesh__dateEstablished mesh__D050438 2006-01-01
% 207.76/207.95  |- mesh__dateCreated mesh__D008278 1999-01-01
% 207.76/207.95  |- mesh__recordOriginator mesh__D008278 NLM
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D008278 2006
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D008278 2005
% 207.76/207.95  |- skos__prefLabel mesh__D008278 Magnesium Sulfate
% 207.76/207.95  |- rdf__type mesh__D008278sskos__Concept
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D008278 2002
% 207.76/207.95  |- skos__scopeNote mesh__D008278
% 207.76/207.95       A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. %28%From AMA Drug Evaluations Annual, 1992, p1083%29%%A%    
% 207.76/207.95  |- skos__broader mesh__D008278smesh__D013431
% 207.76/207.95  |- mesh__recordMaintainer mesh__D008278 CCR
% 207.76/207.95  |- skos__broader mesh__D008278smesh__D017616
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D008278 2004
% 207.76/207.95  |- skos__hiddenLabel mesh__D008278 Heptahydrate Magnesium Sulfate
% 207.76/207.95  |- mesh__recordAuthorizer mesh__D008278 sjn
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D008278 2003
% 207.76/207.95  |- skos__hiddenLabel mesh__D008278 Sulfate, Magnesium
% 207.76/207.95  |- mesh__dateRevised mesh__D008278 2001-07-25
% 207.76/207.95  |- mesh__dateCreated mesh__D000295 1979-05-29
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D000295 2006
% 207.76/207.95  |- mesh__dateRevised mesh__D000295 2002-07-03
% 207.76/207.95  |- mesh__historyNote mesh__D000295 80   
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D000295 2003
% 207.76/207.95  |- skos__scopeNote mesh__D000295
% 207.76/207.95       A branch of medicine pertaining to the diagnosis and treatment of diseases occurring during the period beginning with puberty until the cessation of somatic growth.%A%    
% 207.76/207.95  |- mesh__recordOriginator mesh__D000295 EC
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D000295 2005
% 207.76/207.95  |- skos__broader mesh__D000295smesh__D008511
% 207.76/207.95  |- skos__annotation mesh__D000295
% 207.76/207.95       SPEC; SPEC qualif; when permitted for %22%adolescent dis%22%: Manual 28.10.1; relation to ADOLESCENCE: Manual 28.10.1; DF: ADOLESCENT MED%A%  
% 207.76/207.95  |- skos__prefLabel mesh__D000295 Adolescent Medicine
% 207.76/207.95  |- skos__altLabel mesh__D000295 Medicine, Adolescent
% 207.76/207.95  |- rdf__type mesh__D000295sskos__Concept
% 207.76/207.95  |- skos__historyNote mesh__D000295 Adolescence %28%1966-1979%29%
% 207.76/207.95  |- mesh__recordMaintainer mesh__D000295 sjn
% 207.76/207.95  |- mesh__dateEstablished mesh__D000295 1980-01-01
% 207.76/207.95  |- mesh__recordAuthorizer mesh__D000295 sjn
% 207.76/207.95  |- mesh__publicMeSHNote mesh__D000295 80   
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D000295 2004
% 207.76/207.95  |- skos__annotation mesh__D041901
% 207.76/207.95       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.76/207.95  |- skos__prefLabel mesh__D041901 Stemonaceae
% 207.76/207.95  |- mesh__historyNote mesh__D041901 2004   
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D041901 2006
% 207.76/207.95  |- rdf__type mesh__D041901sskos__Concept
% 207.76/207.95  |- mesh__dateCreated mesh__D041901 2003-07-09
% 207.76/207.95  |- mesh__publicMeSHNote mesh__D041901 2004   
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D041901 2004
% 207.76/207.95  |- skos__broader mesh__D041901smesh__D019684
% 207.76/207.95  |- skos__scopeNote mesh__D041901
% 207.76/207.95       A small plant family of the order Liliales, subclass Liliidae, class Liliopsida %28%monocotyledons%29%.%A%    
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D041901 2005
% 207.76/207.95  |- mesh__dateEstablished mesh__D041901 2004-01-01
% 207.76/207.95  |- skos__prefLabel mesh__D041103 Neorickettsia risticii
% 207.76/207.95  |- mesh__recordOriginator mesh__D041103 ags
% 207.76/207.95  |- mesh__dateCreated mesh__D041103 2002-07-03
% 207.76/207.95  |- mesh__recordAuthorizer mesh__D041103 sjn
% 207.76/207.95  |- skos__broader mesh__D041103smesh__D041102
% 207.76/207.95  |- mesh__historyNote mesh__D041103 2003   
% 207.76/207.95  |- mesh__dateEstablished mesh__D041103 2003-01-01
% 207.76/207.95  |- skos__historyNote mesh__D041103 Ehrlichia %28%1986-2002%29%
% 207.76/207.95  |- rdf__type mesh__D041103sskos__Concept
% 207.76/207.95  |- mesh__recordMaintainer mesh__D041103 SYSTEM
% 207.76/207.95  |- skos__scopeNote mesh__D041103
% 207.76/207.95       A species of gram-negative bacteria in the genus NEORICKETTSIA, family ANAPLASMATACEAE.%A%    
% 207.76/207.95  |- mesh__publicMeSHNote mesh__D041103 2003   
% 207.76/207.95  |- skos__altLabel mesh__D041103 Ehrlichia risticii
% 207.76/207.95  |- mesh__dateRevised mesh__D041103 2005-06-30
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D041103 2006
% 207.76/207.95  |- skos__annotation mesh__D041103
% 207.76/207.95       infection: coord IM with ANAPLASMATACEAE INFECTIONS %28%IM%29%   
% 207.76/207.95  |- rdf__type mesh__D013412sskos__Concept
% 207.76/207.95  |- mesh__recordOriginator mesh__D013412 NLM
% 207.76/207.95  |- skos__broader mesh__D013412smesh__D013424
% 207.76/207.95  |- mesh__dateRevised mesh__D013412 2000-06-22
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D013412 2005
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D013412 2006
% 207.76/207.95  |- mesh__recordMaintainer mesh__D013412 CCR
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D013412 2001
% 207.76/207.95  |- mesh__dateCreated mesh__D013412 1999-01-01
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D013412 2002
% 207.76/207.95  |- skos__altLabel mesh__D013412 Sulphadimethoxine
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D013412 2003
% 207.76/207.95  |- skos__prefLabel mesh__D013412 Sulfadimethoxine
% 207.76/207.95  |- skos__scopeNote mesh__D013412
% 207.76/207.95       A sulfanilamide that is used as an anti-infective agent.%A%    
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D013412 2004
% 207.76/207.95  |- mesh__recordAuthorizer mesh__D013412 sjn
% 207.76/207.95  |- skos__broader mesh__D019926Q000031smesh__D019926
% 207.76/207.95  |- mesh__preferredCombination mesh__D019926Q000031smesh__D016213
% 207.76/207.95  |- rdf__type mesh__D019926Q000031smesh__CompoundConcept
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D004686 2004
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D004686 2006
% 207.76/207.95  |- mesh__recordAuthorizer mesh__D004686 sjn
% 207.76/207.95  |- skos__prefLabel mesh__D004686 Encephalomyocarditis virus
% 207.76/207.95  |- mesh__publicMeSHNote mesh__D004686
% 207.76/207.95       94; was ENCEPHALOMYOCARDITIS VIRUSES 1965-93   
% 207.76/207.95  |- skos__scopeNote mesh__D004686
% 207.76/207.95       The type species of CARDIOVIRUS causing encephalomyelitis and myocarditis in rodents, pigs, and monkeys. Infection in man has been reported with CNS involvement but without myocarditis.%A%    
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D004686 2003
% 207.76/207.95  |- mesh__recordMaintainer mesh__D004686 ags
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D004686 2005
% 207.76/207.95  |- skos__altLabel mesh__D004686 EMCV
% 207.76/207.95  |- rdf__type mesh__D004686sskos__Concept
% 207.76/207.95  |- skos__broader mesh__D004686smesh__D017943
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D004686 2002
% 207.76/207.95  |- mesh__recordOriginator mesh__D004686 NLM
% 207.76/207.95  |- skos__annotation mesh__D004686
% 207.76/207.95       infection: coord IM with CARDIOVIRUS INFECTIONS %28%IM%29%; DF: EMCV%A%  
% 207.76/207.95  |- mesh__historyNote mesh__D004686
% 207.76/207.95       94; was ENCEPHALOMYOCARDITIS VIRUSES 1965-93   
% 207.76/207.95  |- mesh__dateRevised mesh__D004686 2001-07-25
% 207.76/207.95  |- mesh__dateCreated mesh__D004686 1999-01-01
% 207.76/207.95  |- mesh__dateEstablished mesh__D004686 1965-01-01
% 207.76/207.95  |- mesh__onlineNote mesh__D004686
% 207.76/207.95       use ENCEPHALOMYOCARDITIS VIRUS to search ENCEPHALOMYOCARDITIS VIRUSES 1966-93%A%  
% 207.76/207.95  |- mesh__recordOriginator mesh__D009371 NLM
% 207.76/207.95  |- skos__scopeNote mesh__D009371
% 207.76/207.95       A collective term for precoordinated organ/neoplasm headings locating neoplasms by organ, as BRAIN NEOPLASMS; DUODENAL NEOPLASMS; LIVER NEOPLASMS; etc.%A%    
% 207.76/207.95  |- skos__annotation mesh__D009371
% 207.76/207.95       to collect neopl located by organ; not used for indexing; policy: Manual section 24; DF: NEOPL SITE      CATALOG: do not use%A%  
% 207.76/207.95  |- skos__altLabel mesh__D009371 Site, Neoplasm
% 207.76/207.95  |- skos__broader mesh__D009371smesh__D009369
% 207.76/207.95  |- skos__altLabel mesh__D009371 Neoplasms by Sites
% 207.76/207.95  |- skos__altLabel mesh__D009371 Sites, Neoplasm
% 207.76/207.95  |- mesh__publicMeSHNote mesh__D009371 98   
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D009371 2002
% 207.76/207.95  |- skos__hiddenLabel mesh__D009371 Neoplasm Sites
% 207.76/207.95  |- mesh__recordMaintainer mesh__D009371 mdb
% 207.76/207.95  |- rdf__type mesh__D009371sskos__Concept
% 207.76/207.95  |- mesh__dateEstablished mesh__D009371 1998-01-01
% 207.76/207.95  |- mesh__dateCreated mesh__D009371 1999-01-01
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D009371 2004
% 207.76/207.95  |- mesh__historyNote mesh__D009371 98; use explode   
% 207.76/207.95  |- skos__prefLabel mesh__D009371 Neoplasms by Site
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D009371 2003
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D009371 2006
% 207.76/207.95  |- mesh__recordAuthorizer mesh__D009371 sjn
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D009371 2005
% 207.76/207.95  |- skos__hiddenLabel mesh__D009371 Neoplasm Site
% 207.76/207.95  |- mesh__dateRevised mesh__D009371 2001-07-25
% 207.76/207.95  |- mesh__publicMeSHNote mesh__D017005 92   
% 207.76/207.95  |- skos__scopeNote mesh__D017005
% 207.76/207.95       Techniques used for removal of bonded orthodontic appliances, restorations, or fixed dentures from teeth.%A%    
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D017005 1994
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D017005 1993
% 207.76/207.95  |- mesh__recordMaintainer mesh__D017005 TAP
% 207.76/207.95  |- skos__historyNote mesh__D017005 Dental Bonding %28%1977-1991%29%
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D017005 2002
% 207.76/207.95  |- skos__prefLabel mesh__D017005 Dental Debonding
% 207.76/207.95  |- skos__annotation mesh__D017005 DF: DENT DEBONDING   
% 207.76/207.95  |- mesh__recordOriginator mesh__D017005 MXR
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D017005 1999
% 207.76/207.95  |- mesh__dateCreated mesh__D017005 1991-05-30
% 207.76/207.95  |- mesh__dateEstablished mesh__D017005 1992-01-01
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D017005 1998
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D017005 1997
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D017005 2006
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D017005 2001
% 207.76/207.95  |- skos__altLabel mesh__D017005 Debonding, Dental
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D017005 1996
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D017005 2005
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D017005 2004
% 207.76/207.95  |- mesh__recordAuthorizer mesh__D017005 PLS
% 207.76/207.95  |- mesh__historyNote mesh__D017005 92   
% 207.76/207.95  |- rdf__type mesh__D017005sskos__Concept
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D017005 2000
% 207.76/207.95  |- mesh__dateRevised mesh__D017005 1992-05-14
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D017005 2003
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D017005 1995
% 207.76/207.95  |- skos__broader mesh__D017005smesh__D003813
% 207.76/207.95  |- rdf__type mesh__D050439sskos__Concept
% 207.76/207.95  |- skos__altLabel mesh__D050439 Immunoglobulin Light Chain Genes
% 207.76/207.95  |- mesh__publicMeSHNote mesh__D050439
% 207.76/207.95       2006; see GENES, IMMUNOGLOBULIN 1988-2005   
% 207.76/207.95  |- mesh__recordOriginator mesh__D050439 nns
% 207.76/207.95  |- mesh__dateEstablished mesh__D050439 2006-01-01
% 207.76/207.95  |- skos__related mesh__D050439smesh__D007131
% 207.76/207.95  |- mesh__historyNote mesh__D050439
% 207.76/207.95       2006; use GENES, IMMUNOGLOBULIN 1988-2005   
% 207.76/207.95  |- skos__scopeNote mesh__D050439
% 207.76/207.95       Genes and gene segments encoding the IMMUNOGLOBULIN LIGHT CHAINS. Gene segments of the light chain genes are designated as V %28%variable%29%, J %28%joining%29%, and C %28%constant%29%.%A%    
% 207.76/207.95  |- mesh__recordAuthorizer mesh__D050439 sjn
% 207.76/207.95  |- skos__related mesh__D050439smesh__D007147
% 207.76/207.95  |- skos__prefLabel mesh__D050439 Genes, Immunoglobulin Light Chain
% 207.76/207.95  |- skos__broader mesh__D050439smesh__D005803
% 207.76/207.95  |- mesh__recordMaintainer mesh__D050439 nns
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D050439 2006
% 207.76/207.95  |- mesh__dateCreated mesh__D050439 2005-06-30
% 207.76/207.95  |- mesh__recordAuthorizer mesh__D047490 ags
% 207.76/207.95  |- mesh__historyNote mesh__D047490 2005   
% 207.76/207.95  |- mesh__dateCreated mesh__D047490 2004-07-07
% 207.76/207.95  |- skos__scopeNote mesh__D047490
% 207.76/207.95       A nuclear transcription factor. Heterodimerization with PPAR-GAMMA is important in regulation of GLUCOSE metabolism and CELL GROWTH PROCESSES.%A%    
% 207.76/207.95  |- skos__prefLabel mesh__D047490 Retinoid X Receptor alpha
% 207.76/207.95  |- skos__broader mesh__D047490smesh__D047488
% 207.76/207.95  |- rdf__type mesh__D047490sskos__Concept
% 207.76/207.95  |- mesh__activeMeSHYear mesh__D047490 2006A
% 207.76/207.95  |- skos__hiddenLabel mesh__D047490 Receptor, RXR alpha
% 207.76/207.95  |- mesh__recordMaintainer mesh__D047490 ags
% 207.76/207.95  |- skos__altLabel mesh__D047490 RXR alpha Receptor
% 207.76/207.95  |- skos__historyNote mesh__D047490
% 207.76/207.95       Receptors, Retinoic Acid %28%1993-2004%29%
% 207.76/207.96  |- mesh__dateRevised mesh__D047490 2005-07-12
% 207.76/207.96  |- mesh__publicMeSHNote mesh__D047490 2005   
% 207.76/207.96  |- mesh__recordOriginator mesh__D047490 ssb
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D047490 2005
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D047490 2006
% 207.76/207.96  |- mesh__dateEstablished mesh__D047490 2005-01-01
% 207.76/207.96  |- skos__broader mesh__D008279smesh__D003952
% 207.76/207.96  |- skos__hiddenLabel mesh__D008279 Imagings, Chemical Shift
% 207.76/207.96  |- mesh__dateRevised mesh__D008279 2000-06-22
% 207.76/207.96  |- mesh__publicMeSHNote mesh__D008279
% 207.76/207.96       1988; NMR TOMOGRAPHY %26% TOMOGRAPHY, NMR %26% TOMOGRAPHY, PROTON SPIN were see NUCLEAR MAGNETIC RESONANCE 1985-1987; for CHEMICAL SHIFT IMAGING see NUCLEAR MAGNETIC RESONANCE 1995-2000%A%  
% 207.76/207.96  |- mesh__recordAuthorizer mesh__D008279 sjn
% 207.76/207.96  |- skos__altLabel mesh__D008279 MR Tomography
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D008279 2005
% 207.76/207.96  |- skos__altLabel mesh__D008279 MRI, Functional
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D008279 2001
% 207.76/207.96  |- skos__prefLabel mesh__D008279 Magnetic Resonance Imaging
% 207.76/207.96  |- skos__hiddenLabel mesh__D008279 MRI Scan
% 207.76/207.96  |- skos__related mesh__D008279smesh__D019412
% 207.76/207.96  |- mesh__dateEstablished mesh__D008279 1988-01-01
% 207.76/207.96  |- skos__altLabel mesh__D008279 Tomography, MR
% 207.76/207.96  |- skos__altLabel mesh__D008279 Magnetic Resonance Imaging, Functional
% 207.76/207.96  |- skos__altLabel mesh__D008279 Proton Spin Tomography
% 207.76/207.96  |- skos__altLabel mesh__D008279 NMR Tomography
% 207.76/207.96  |- mesh__historyNote mesh__D008279
% 207.76/207.96       1988; for NMR TOMOGRAPHY %26% TOMOGRAPHY, NMR %26% TOMOGRAPHY, PROTON SPIN use MAGNETIC RESONANCE SPECTROSCOPY 1985-1987; for CHEMICAL SHIFT IMAGING use MAGNETIC RESONANCE SPECTROSCOPY 1995-2000%A%  
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D008279 2006
% 207.76/207.96  |- skos__hiddenLabel mesh__D008279 Imaging, Magnetic Resonance
% 207.76/207.96  |- skos__altLabel mesh__D008279 Chemical Shift Imaging
% 207.76/207.96  |- skos__broader mesh__D008279smesh__D014054
% 207.76/207.96  |- skos__hiddenLabel mesh__D008279 Functional MRI
% 207.76/207.96  |- skos__altLabel mesh__D008279 Zeugmatography
% 207.76/207.96  |- skos__hiddenLabel mesh__D008279 Shift Imagings, Chemical
% 207.76/207.96  |- skos__hiddenLabel mesh__D008279 Scan, MRI
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D008279 2002
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D008279 2003
% 207.76/207.96  |- skos__hiddenLabel mesh__D008279 Chemical Shift Imagings
% 207.76/207.96  |- skos__historyNote mesh__D008279
% 207.76/207.96       Nuclear Magnetic Resonance %28%1966-1987%29%
% 207.76/207.96  |- rdf__type mesh__D008279sskos__Concept
% 207.76/207.96  |- mesh__dateCreated mesh__D008279 1987-05-08
% 207.76/207.96  |- skos__related mesh__D008279smesh__D009682
% 207.76/207.96  |- skos__altLabel mesh__D008279 NMR Imaging
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D008279 2004
% 207.76/207.96  |- skos__scopeNote mesh__D008279
% 207.76/207.96       Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques.%A%    
% 207.76/207.96  |- skos__hiddenLabel mesh__D008279 MRIs, Functional
% 207.76/207.96  |- skos__annotation mesh__D008279
% 207.76/207.96       GEN or unspecified; prefer specifics; do not confuse with MAGNETIC RESONANCE SPECTROSCOPY: check text; coord with disease, organ or tissue using pertinent qualifs; DF: MRI%A%  
% 207.76/207.96  |- skos__hiddenLabel mesh__D008279 Shift Imaging, Chemical
% 207.76/207.96  |- skos__hiddenLabel mesh__D008279 Functional MRIs
% 207.76/207.96  |- mesh__recordMaintainer mesh__D008279 nns
% 207.76/207.96  |- skos__hiddenLabel mesh__D008279 Scans, MRI
% 207.76/207.96  |- mesh__recordOriginator mesh__D008279 SCD
% 207.76/207.96  |- skos__hiddenLabel mesh__D008279 Imaging, NMR
% 207.76/207.96  |- skos__historyNote mesh__D000296 Child Psychiatry %28%1966%29%
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D000296 2006
% 207.76/207.96  |- mesh__recordAuthorizer mesh__D000296 sjn
% 207.76/207.96  |- skos__hiddenLabel mesh__D000296 Psychiatry, Adolescent
% 207.76/207.96  |- mesh__dateCreated mesh__D000296 1999-01-01
% 207.76/207.96  |- mesh__publicMeSHNote mesh__D000296 67   
% 207.76/207.96  |- skos__annotation mesh__D000296
% 207.76/207.96       SPEC: SPEC qualif; not for mental disorders in adolescents %28% = MENTAL DISORDERS %28%IM%29% + ADOLESCENT %28%NIM%29% %29%: Manual 27.9%A%  
% 207.76/207.96  |- rdf__type mesh__D000296sskos__Concept
% 207.76/207.96  |- mesh__dateRevised mesh__D000296 2002-07-03
% 207.76/207.96  |- skos__historyNote mesh__D000296 Psychiatry %28%1966%29%
% 207.76/207.96  |- skos__broader mesh__D000296smesh__D011570
% 207.76/207.96  |- mesh__dateEstablished mesh__D000296 1967-01-01
% 207.76/207.96  |- skos__historyNote mesh__D000296 Psychoanalysis %28%1966%29%
% 207.76/207.96  |- mesh__historyNote mesh__D000296 67   
% 207.76/207.96  |- mesh__recordOriginator mesh__D000296 NLM
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D000296 2003
% 207.76/207.96  |- skos__prefLabel mesh__D000296 Adolescent Psychiatry
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D000296 2005
% 207.76/207.96  |- skos__scopeNote mesh__D000296
% 207.76/207.96       The medical science that deals with the origin, diagnosis, prevention, and treatment of mental disorders in individuals 13-18 years.%A%    
% 207.76/207.96  |- mesh__recordMaintainer mesh__D000296 sjn
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D000296 2004
% 207.76/207.96  |- mesh__dateCreated mesh__D041902 2003-07-09
% 207.76/207.96  |- mesh__publicMeSHNote mesh__D041902 2004   
% 207.76/207.96  |- mesh__dateEstablished mesh__D041902 2004-01-01
% 207.76/207.96  |- mesh__dateRevised mesh__D041902 2005-06-30
% 207.76/207.96  |- skos__broader mesh__D041902smesh__D020561
% 207.76/207.96  |- mesh__recordOriginator mesh__D041902 ags
% 207.76/207.96  |- mesh__recordAuthorizer mesh__D041902 sjn
% 207.76/207.96  |- mesh__recordMaintainer mesh__D041902 SYSTEM
% 207.76/207.96  |- mesh__historyNote mesh__D041902 2004   
% 207.76/207.96  |- skos__scopeNote mesh__D041902
% 207.76/207.96       A  family in the order Rhodobacterales, class ALPHAPROTEOBACTERIA.%A%    
% 207.76/207.96  |- skos__prefLabel mesh__D041902 Rhodobacteraceae
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D041902 2006
% 207.76/207.96  |- rdf__type mesh__D041902sskos__Concept
% 207.76/207.96  |- skos__broader mesh__D013413smesh__D013424
% 207.76/207.96  |- mesh__dateRevised mesh__D013413 2000-06-22
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D013413 2004
% 207.76/207.96  |- skos__altLabel mesh__D013413 Sulformetoxine
% 207.76/207.96  |- skos__historyNote mesh__D013413 Sulfonamides %28%1971-1974%29%
% 207.76/207.96  |- mesh__historyNote mesh__D013413
% 207.76/207.96       91%28%75%29%; was see under SULFANILAMIDES 1975-90   
% 207.76/207.96  |- skos__prefLabel mesh__D013413 Sulfadoxine
% 207.76/207.96  |- mesh__recordMaintainer mesh__D013413 CCR
% 207.76/207.96  |- mesh__publicMeSHNote mesh__D013413
% 207.76/207.96       91; was see under SULFANILAMIDES 1975-90   
% 207.76/207.96  |- skos__historyNote mesh__D013413 Pyrimidines %28%1971-1974%29%
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D013413 2005
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D013413 2001
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D013413 2006
% 207.76/207.96  |- skos__altLabel mesh__D013413 Sulforthomidine
% 207.76/207.96  |- skos__hiddenLabel mesh__D013413 Ro 4 4393
% 207.76/207.96  |- skos__scopeNote mesh__D013413
% 207.76/207.96       A long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary tract, and malarial infections.%A%    
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D013413 2002
% 207.76/207.96  |- skos__altLabel mesh__D013413 Sulphormetoxin
% 207.76/207.96  |- skos__altLabel mesh__D013413 Sulphorthodimethoxine
% 207.76/207.96  |- skos__altLabel mesh__D013413 Sulformethoxine
% 207.76/207.96  |- skos__hiddenLabel mesh__D013413 Ro 44393
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D013413 2003
% 207.76/207.96  |- mesh__recordAuthorizer mesh__D013413 sjn
% 207.76/207.96  |- mesh__recordOriginator mesh__D013413 NLM
% 207.76/207.96  |- rdf__type mesh__D013413sskos__Concept
% 207.76/207.96  |- mesh__dateCreated mesh__D013413 1974-11-19
% 207.76/207.96  |- mesh__dateEstablished mesh__D013413 1991-01-01
% 207.76/207.96  |- skos__hiddenLabel mesh__D004687 Multiple Enchondroses
% 207.76/207.96  |- skos__altLabel mesh__D004687 Ollier%27%s Disease
% 207.76/207.96  |- skos__hiddenLabel mesh__D004687 Multiple Enchondroma
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D004687 2006
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D004687 2002
% 207.76/207.96  |- rdf__type mesh__D004687sskos__Concept
% 207.76/207.96  |- mesh__recordOriginator mesh__D004687 RC
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D004687 2003
% 207.76/207.96  |- mesh__dateEstablished mesh__D004687 1991-01-01
% 207.76/207.96  |- mesh__recordAuthorizer mesh__D004687 PLS
% 207.76/207.96  |- mesh__dateCreated mesh__D004687 1984-04-06
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D004687 1998
% 207.76/207.96  |- skos__hiddenLabel mesh__D004687 Multiple Enchondrosis
% 207.76/207.96  |- mesh__onlineNote mesh__D004687
% 207.76/207.96       to search OLLIER%27%S DISEASE use OSTEOCHONDRODYSPLASIAS 1966-84%A%  
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D004687 2004
% 207.76/207.96  |- skos__annotation mesh__D004687
% 207.76/207.96       non-neoplastic; do not confuse X ref OLLIER%27%S DISEASE with Ollier%27%s disease as Ollier-Klippel-Trenaunay disease %28% = KLIPPEL-TRENAUNAY DISEASE%29%%A%  
% 207.76/207.96  |- skos__scopeNote mesh__D004687
% 207.76/207.96       Benign growths of cartilage in the metaphyses of several bones.%A%    
% 207.76/207.96  |- skos__broader mesh__D004687smesh__D010009
% 207.76/207.96  |- skos__hiddenLabel mesh__D004687 Disease, Ollier%27%s
% 207.76/207.96  |- skos__hiddenLabel mesh__D004687 Enchondromatoses
% 207.76/207.96  |- mesh__dateRevised mesh__D004687 1995-05-18
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D004687 1999
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D004687 1996
% 207.76/207.96  |- skos__hiddenLabel mesh__D004687 Disease, Ollier
% 207.76/207.96  |- skos__hiddenLabel mesh__D004687 Enchondromas, Multiple
% 207.76/207.96  |- skos__hiddenLabel mesh__D004687 Multiple Enchondromas
% 207.76/207.96  |- mesh__publicMeSHNote mesh__D004687
% 207.76/207.96       91; was see under OSTEOCHONDRODYSPLASIAS 1985-90; OLLIER%27%S DISEASE was see DYSCHONDROPLASIA 1963-84%A%  
% 207.76/207.96  |- skos__hiddenLabel mesh__D004687 Syndrome, Maffucci
% 207.76/207.96  |- skos__hiddenLabel mesh__D004687 Olliers Disease
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D004687 2000
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D004687 1997
% 207.76/207.96  |- skos__altLabel mesh__D004687 Enchondrosis, Multiple
% 207.76/207.96  |- mesh__recordMaintainer mesh__D004687 TAP
% 207.76/207.96  |- skos__altLabel mesh__D004687 Enchondroma, Multiple
% 207.76/207.96  |- skos__prefLabel mesh__D004687 Enchondromatosis
% 207.76/207.96  |- skos__hiddenLabel mesh__D004687 Enchondroses, Multiple
% 207.76/207.96  |- skos__altLabel mesh__D004687 Ollier Disease
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D004687 2005
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D004687 2001
% 207.76/207.96  |- mesh__historyNote mesh__D004687
% 207.76/207.96       91%28%85%29%; was see under OSTEOCHONDRODYSPLASIAS 1985-90; OLLIER%27%S DISEASE was see DYSCHONDROPLASIA 1963-84%A%  
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D009372 1998
% 207.76/207.96  |- skos__scopeNote mesh__D009372
% 207.76/207.96       Neoplasms composed of connective tissue, including elastic, mucous, reticular, osseous, and cartilaginous tissue. The concept does not refer to neoplasms located in connective tissue.%A%    
% 207.76/207.96  |- skos__related mesh__D009372smesh__D012983
% 207.76/207.96  |- skos__hiddenLabel mesh__D009372 Connective Tissue Neoplasm
% 207.76/207.96  |- rdf__type mesh__D009372sskos__Concept
% 207.76/207.96  |- mesh__recordOriginator mesh__D009372 NLM
% 207.76/207.96  |- skos__hiddenLabel mesh__D009372 Neoplasm, Connective Tissue
% 207.76/207.96  |- mesh__dateCreated mesh__D009372 1999-01-01
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D009372 2004
% 207.76/207.96  |- skos__prefLabel mesh__D009372 Neoplasms, Connective Tissue
% 207.76/207.96  |- skos__broader mesh__D009372smesh__D003240
% 207.76/207.96  |- mesh__dateRevised mesh__D009372 1995-06-08
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D009372 2002
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D009372 2003
% 207.76/207.96  |- skos__annotation mesh__D009372
% 207.76/207.96       neoplasms composed of connective tissue, NOT neoplasms located in connective tissue: TN 135; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; DF: NEOPL CONNECTIVE TISSUE%A%  
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D009372 2006
% 207.76/207.96  |- skos__altLabel mesh__D009372 Connective Tissue Neoplasms
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D009372 1997
% 207.76/207.96  |- skos__broader mesh__D009372smesh__D018204
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D009372 2001
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D009372 2005
% 207.76/207.96  |- mesh__recordAuthorizer mesh__D009372 PLS
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D009372 1996
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D009372 2000
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D009372 1999
% 207.76/207.96  |- mesh__recordMaintainer mesh__D009372 KEV
% 207.76/207.96  |- skos__scopeNote mesh__D017006
% 207.76/207.96       The musculotendinous sheath formed by the supraspinatus, infraspinatus, subscapularis, and teres minor muscles. These help stabilize the head of the HUMERUS in the glenoid fossa and allow for rotation of the SHOULDER JOINT about its longitudinal axis.%A%    
% 207.76/207.96  |- skos__related mesh__D017006smesh__D019534
% 207.76/207.96  |- skos__broader mesh__D017006smesh__D013711
% 207.76/207.96  |- skos__historyNote mesh__D017006 Shoulder Joint %28%1966-1991%29%
% 207.76/207.96  |- mesh__recordOriginator mesh__D017006 MXR
% 207.76/207.96  |- mesh__dateCreated mesh__D017006 1991-05-30
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D017006 2006
% 207.76/207.96  |- mesh__publicMeSHNote mesh__D017006 92   
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D017006 2002
% 207.76/207.96  |- skos__broader mesh__D017006smesh__D018482
% 207.76/207.96  |- mesh__recordAuthorizer mesh__D017006 sjn
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D017006 2004
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D017006 2005
% 207.76/207.96  |- skos__prefLabel mesh__D017006 Rotator Cuff
% 207.76/207.96  |- skos__historyNote mesh__D017006
% 207.76/207.96       Tendons, Para-Articular %28%1972-1991%29%
% 207.76/207.96  |- mesh__recordMaintainer mesh__D017006 nns
% 207.76/207.96  |- mesh__dateRevised mesh__D017006 2001-07-25
% 207.76/207.96  |- mesh__historyNote mesh__D017006 92   
% 207.76/207.96  |- rdf__type mesh__D017006sskos__Concept
% 207.76/207.96  |- mesh__dateEstablished mesh__D017006 1992-01-01
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D017006 2003
% 207.76/207.96  |- skos__altLabel mesh__D017006 Cuff, Rotator
% 207.76/207.96  |- skos__broader mesh__D047491smesh__D047488
% 207.76/207.96  |- rdf__type mesh__D047491sskos__Concept
% 207.76/207.96  |- mesh__dateEstablished mesh__D047491 2005-01-01
% 207.76/207.96  |- mesh__historyNote mesh__D047491 2005   
% 207.76/207.96  |- skos__altLabel mesh__D047491 RXR gamma Receptor
% 207.76/207.96  |- mesh__publicMeSHNote mesh__D047491 2005   
% 207.76/207.96  |- skos__hiddenLabel mesh__D047491 Receptor, RXR gamma
% 207.76/207.96  |- mesh__recordOriginator mesh__D047491 ssb
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D047491 2005
% 207.76/207.96  |- skos__prefLabel mesh__D047491 Retinoid X Receptor gamma
% 207.76/207.96  |- skos__scopeNote mesh__D047491
% 207.76/207.96       A nuclear transcription factor. Heterodimerization with PPAR ALPHA is important to metabolism of LIPIDS.%A%    
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D047491 2006
% 207.76/207.96  |- mesh__recordMaintainer mesh__D047491 ssb
% 207.76/207.96  |- mesh__recordAuthorizer mesh__D047491 sjn
% 207.76/207.96  |- mesh__dateCreated mesh__D047491 2004-07-07
% 207.76/207.96  |- skos__historyNote mesh__D047491
% 207.76/207.96       Receptors, Retinoic Acid %28%1993-2004%29%
% 207.76/207.96  |- mesh__dateRevised mesh__D000297 1996-06-10
% 207.76/207.96  |- mesh__recordAuthorizer mesh__D000297 PLS
% 207.76/207.96  |- mesh__dateCreated mesh__D000297 1999-01-01
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D000297 2002
% 207.76/207.96  |- mesh__publicMeSHNote mesh__D000297 67   
% 207.76/207.96  |- skos__broader mesh__D000297smesh__D011584
% 207.76/207.96  |- rdf__type mesh__D000297sskos__Concept
% 207.76/207.96  |- mesh__recordMaintainer mesh__D000297 TAP
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D000297 1998
% 207.76/207.96  |- skos__annotation mesh__D000297
% 207.76/207.96       SPEC but also the way a normal adolescent thinks %26% acts; when SPEC, SPEC qualif; Manual 27.11; DF: ADOLESCENT PSYCHOL%A%  
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D000297 2003
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D000297 1997
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D000297 2000
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D000297 2005
% 207.76/207.96  |- skos__altLabel mesh__D000297 Psychology, Adolescent
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D000297 1999
% 207.76/207.96  |- skos__scopeNote mesh__D000297
% 207.76/207.96       Field of psychology concerned with the normal and abnormal behavior of adolescents. It includes mental processes as well as observable responses.%A%    
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D000297 2004
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D000297 2001
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D000297 2006
% 207.76/207.96  |- mesh__historyNote mesh__D000297 67   
% 207.76/207.96  |- skos__prefLabel mesh__D000297 Adolescent Psychology
% 207.76/207.96  |- mesh__recordOriginator mesh__D000297 NLM
% 207.76/207.96  |- mesh__recordMaintainer mesh__D041903 SYSTEM
% 207.76/207.96  |- mesh__dateEstablished mesh__D041903 2004-01-01
% 207.76/207.96  |- mesh__dateRevised mesh__D041903 2005-06-30
% 207.76/207.96  |- skos__historyNote mesh__D041903 Rhodobacter %28%1996-2003%29%
% 207.76/207.96  |- skos__scopeNote mesh__D041903
% 207.76/207.96       A genus of facultatively or obligately anaerobic marine phototrophic bacteria, in the family RHODOBACTERACEAE.%A%    
% 207.76/207.96  |- mesh__recordOriginator mesh__D041903 ags
% 207.76/207.96  |- mesh__recordAuthorizer mesh__D041903 sjn
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D041903 2006
% 207.76/207.96  |- rdf__type mesh__D041903sskos__Concept
% 207.76/207.96  |- skos__broader mesh__D041903smesh__D041902
% 207.76/207.96  |- mesh__historyNote mesh__D041903 2004   
% 207.76/207.96  |- skos__broader mesh__D041903smesh__D006090
% 207.76/207.96  |- skos__prefLabel mesh__D041903 Rhodovulum
% 207.76/207.96  |- mesh__dateCreated mesh__D041903 2003-07-09
% 207.76/207.96  |- mesh__publicMeSHNote mesh__D041903 2004   
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D005780 2001
% 207.76/207.96  |- mesh__dateRevised mesh__D005780 2000-06-22
% 207.76/207.96  |- skos__prefLabel mesh__D005780 Gelatin
% 207.76/207.96  |- skos__scopeNote mesh__D005780
% 207.76/207.96       A product formed from skin, white connective tissue, or bone COLLAGEN. It is used as a protein food adjuvant, plasma substitute, hemostatic, suspending agent in pharmaceutical preparations, and in the manufacturing of capsules and suppositories.%A%    
% 207.76/207.96  |- mesh__dateCreated mesh__D005780 1999-01-01
% 207.76/207.96  |- mesh__recordAuthorizer mesh__D005780 sjn
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D005780 2006
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D005780 2004
% 207.76/207.96  |- mesh__recordOriginator mesh__D005780 NLM
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D005780 2005
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D005780 2002
% 207.76/207.96  |- mesh__recordMaintainer mesh__D005780 adp
% 207.76/207.96  |- rdf__type mesh__D005780sskos__Concept
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D005780 2003
% 207.76/207.96  |- skos__broader mesh__D005780smesh__D012596
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D013414 2004
% 207.76/207.96  |- mesh__historyNote mesh__D013414
% 207.76/207.96       91%28%63%29%; was see under GUANIDINES 1963-90   
% 207.76/207.96  |- skos__prefLabel mesh__D013414 Sulfaguanidine
% 207.76/207.96  |- rdf__type mesh__D013414sskos__Concept
% 207.76/207.96  |- skos__broader mesh__D013414smesh__D013424
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D013414 2003
% 207.76/207.96  |- mesh__dateRevised mesh__D013414 2000-06-22
% 207.76/207.96  |- mesh__recordAuthorizer mesh__D013414 sjn
% 207.76/207.96  |- mesh__dateCreated mesh__D013414 1999-01-01
% 207.76/207.96  |- mesh__recordOriginator mesh__D013414 NLM
% 207.76/207.96  |- mesh__recordMaintainer mesh__D013414 CCR
% 207.76/207.96  |- mesh__publicMeSHNote mesh__D013414
% 207.76/207.96       91; was see under GUANIDINES 1963-90   
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D013414 2002
% 207.76/207.96  |- skos__scopeNote mesh__D013414
% 207.76/207.96       A sulfanilamide antimicrobial agent that is used to treat enteric infections.%A%    
% 207.76/207.96  |- mesh__dateEstablished mesh__D013414 1991-01-01
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D013414 2001
% 207.76/207.96  |- skos__broader mesh__D013414smesh__D006146
% 207.76/207.96  |- skos__altLabel mesh__D013414 Sulphaguanidine
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D013414 2006
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D013414 2005
% 207.76/207.96  |- mesh__historyNote mesh__D004688 69%28%63%29%   
% 207.76/207.96  |- mesh__dateEstablished mesh__D004688 1969-01-01
% 207.76/207.96  |- rdf__type mesh__D004688sskos__Concept
% 207.76/207.96  |- mesh__recordOriginator mesh__D004688 NLM
% 207.76/207.96  |- mesh__dateCreated mesh__D004688 1999-01-01
% 207.76/207.96  |- skos__broader mesh__D004688smesh__D012817
% 207.76/207.96  |- mesh__dateRevised mesh__D004688 2002-07-03
% 207.76/207.96  |- skos__scopeNote mesh__D004688
% 207.76/207.96       Incontinence of feces not due to organic defect or illness.%A%    
% 207.76/207.96  |- skos__prefLabel mesh__D004688 Encopresis
% 207.76/207.96  |- mesh__recordMaintainer mesh__D004688 JLS
% 207.76/207.96  |- mesh__publicMeSHNote mesh__D004688 69   
% 207.76/207.96  |- skos__broader mesh__D004688smesh__D019960
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D004688 2003
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D004688 2005
% 207.76/207.96  |- mesh__recordAuthorizer mesh__D004688 sjn
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D004688 2004
% 207.76/207.96  |- skos__broader mesh__D004688smesh__D001526
% 207.76/207.96  |- skos__annotation mesh__D004688
% 207.76/207.96       of psychol origin: differentiate from FECAL INCONTINENCE, of organic origin%A%  
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D004688 2006
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D023842 2003
% 207.76/207.96  |- mesh__historyNote mesh__D023842 2002   
% 207.76/207.96  |- skos__prefLabel mesh__D023842 Rhinometry, Acoustic
% 207.76/207.96  |- skos__historyNote mesh__D023842 Acoustics %28%1991-2001%29%
% 207.76/207.96  |- skos__altLabel mesh__D023842 Acoustic Rhinometry
% 207.76/207.96  |- skos__broader mesh__D023842smesh__D003948
% 207.76/207.96  |- mesh__publicMeSHNote mesh__D023842 2002   
% 207.76/207.96  |- skos__historyNote mesh__D023842 Diagnosis %28%1989-2001%29%
% 207.76/207.96  |- skos__scopeNote mesh__D023842
% 207.76/207.96       Diagnostic measurement of the nose and its cavity through acoustic reflections. Used to measure nasal anatomical landmarks, nasal septal deviation, and nasal airway changes in response to allergen provocation tests %28%NASAL PROVOCATION TESTS%29%.%A%    
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D023842 2002
% 207.76/207.96  |- mesh__dateEstablished mesh__D023842 2002-01-01
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D023842 2006
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D023842 2004
% 207.76/207.96  |- rdf__type mesh__D023842sskos__Concept
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D023842 2005
% 207.76/207.96  |- mesh__dateCreated mesh__D023842 2001-07-25
% 207.76/207.96  |- skos__hiddenLabel mesh__D009373 Embryonal Cancer
% 207.76/207.96  |- skos__altLabel mesh__D009373 Germ Cell and Embryonic Neoplasms
% 207.76/207.96  |- skos__hiddenLabel mesh__D009373 Cancer, Germ Cell
% 207.76/207.96  |- skos__altLabel mesh__D009373 Embryonal Neoplasms
% 207.76/207.96  |- skos__hiddenLabel mesh__D009373 Neoplasm, Embryonal
% 207.76/207.96  |- skos__hiddenLabel mesh__D009373 Embryonal Cancers
% 207.76/207.96  |- skos__hiddenLabel mesh__D009373 Tumor, Germ Cell
% 207.76/207.96  |- rdf__type mesh__D009373sskos__Concept
% 207.76/207.96  |- skos__altLabel mesh__D009373 Germ Cell Neoplasms
% 207.76/207.96  |- skos__hiddenLabel mesh__D009373 Embryonal Neoplasm
% 207.76/207.96  |- skos__scopeNote mesh__D009373
% 207.76/207.96       Neoplasms composed of primordial GERM CELLS of embryonic GONADS or of elements of the germ layers of the EMBRYO. The concept does not refer to neoplasms located in the gonads or present in an embryo or FETUS.%A%    
% 207.76/207.96  |- skos__hiddenLabel mesh__D009373 Germ Cell Tumors
% 207.76/207.96  |- skos__hiddenLabel mesh__D009373 Cancers, Embryonal
% 207.76/207.96  |- skos__broader mesh__D009373smesh__D009370
% 207.76/207.96  |- skos__hiddenLabel mesh__D009373 Cancers, Germ Cell
% 207.76/207.96  |- mesh__recordAuthorizer mesh__D009373 sjn
% 207.76/207.96  |- skos__annotation mesh__D009373
% 207.76/207.96       neoplasms composed of germ cells or embryonic tissue, NOT neoplasms located in germ cells or embryonic tissue; coordinate IM with precoordinated organ/neoplasm term %28%IM%29%; DF: NEOPL GERM CELL%A%  
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D009373 2006
% 207.76/207.96  |- mesh__recordMaintainer mesh__D009373 ags
% 207.76/207.96  |- skos__altLabel mesh__D009373 Germ Cell Tumor
% 207.76/207.96  |- mesh__recordOriginator mesh__D009373 NLM
% 207.76/207.96  |- mesh__dateRevised mesh__D009373 2005-06-30
% 207.76/207.96  |- skos__hiddenLabel mesh__D009373 Germ Cell Cancers
% 207.76/207.96  |- skos__altLabel mesh__D009373 Germ Cell and Embryonal Neoplasms
% 207.76/207.96  |- skos__hiddenLabel mesh__D009373 Tumors, Germ Cell
% 207.76/207.96  |- skos__altLabel mesh__D009373 Neoplasms, Germ Cell and Embryonic
% 207.76/207.96  |- skos__prefLabel mesh__D009373 Neoplasms, Germ Cell and Embryonal
% 207.76/207.96  |- mesh__dateCreated mesh__D009373 1999-01-01
% 207.76/207.96  |- mesh__publicMeSHNote mesh__D009373
% 207.76/207.96       1994; see NEOPLASMS, EMBRYONAL AND MIXED 1963-1993; for GERM CELL TUMOR see GERMINOMA 1994-2005%A%  
% 207.76/207.96  |- mesh__historyNote mesh__D009373
% 207.76/207.96       1994 %28%1963%29%; for GERM CELL TUMOR use GERMINOMA 1994-2005   
% 207.76/207.96  |- skos__altLabel mesh__D001390 Bayer Brand of Azlocillin
% 207.76/207.96  |- skos__hiddenLabel mesh__D001390 Bay e 6905
% 207.76/207.96  |- skos__broader mesh__D001390smesh__D000667
% 207.76/207.96  |- skos__historyNote mesh__D001390 Penicillins %28%1966-1984%29%
% 207.76/207.96  |- mesh__publicMeSHNote mesh__D001390 85   
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D001390 2005
% 207.76/207.96  |- skos__prefLabel mesh__D001390 Azlocillin
% 207.76/207.96  |- mesh__dateEstablished mesh__D001390 1985-01-01
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D001390 2006
% 207.76/207.96  |- mesh__historyNote mesh__D001390 85   
% 207.76/207.96  |- mesh__recordOriginator mesh__D001390 SH
% 207.76/207.96  |- mesh__recordAuthorizer mesh__D001390 sjn
% 207.76/207.96  |- skos__scopeNote mesh__D001390
% 207.76/207.96       A semisynthetic ampicillin-derived acylureido penicillin.%A%    
% 207.76/207.96  |- mesh__recordMaintainer mesh__D001390 ssb
% 207.76/207.96  |- mesh__dateCreated mesh__D001390 1984-05-24
% 207.76/207.96  |- skos__hiddenLabel mesh__D001390 Azlocillin Bayer Brand
% 207.76/207.96  |- skos__hiddenLabel mesh__D001390 Baye 6905
% 207.76/207.96  |- rdf__type mesh__D001390sskos__Concept
% 207.76/207.96  |- skos__altLabel mesh__D001390 Bayer Brand of Azlocillin Sodium Salt
% 207.76/207.96  |- mesh__dateRevised mesh__D001390 2004-07-07
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D017805 2005
% 207.76/207.96  |- mesh__recordOriginator mesh__D017805 TGC
% 207.76/207.96  |- skos__altLabel mesh__D017805 Widowed
% 207.76/207.96  |- skos__historyNote mesh__D017805 Marriage %28%1966-1967%29%
% 207.76/207.96  |- mesh__historyNote mesh__D017805
% 207.76/207.96       94; WIDOWERS %26% WIDOWS were WIDOWER %26% WIDOW see SINGLE PERSON 1983-93%A%  
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D017805 2001
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D017805 1995
% 207.76/207.96  |- mesh__dateRevised mesh__D017805 1993-11-26
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D017805 1996
% 207.76/207.96  |- mesh__recordMaintainer mesh__D017805 PLS
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D017805 2006
% 207.76/207.96  |- skos__broader mesh__D017805smesh__D017533
% 207.76/207.96  |- skos__historyNote mesh__D017805 Single Person %28%1968-1993%29%
% 207.76/207.96  |- skos__hiddenLabel mesh__D017805 Widower
% 207.76/207.96  |- mesh__activeMeSHYear mesh__D017805 2002
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D017805 1997
% 207.76/207.97  |- skos__scopeNote mesh__D017805
% 207.76/207.97       The state of having lost a marital partner by death.     
% 207.76/207.97  |- mesh__dateEstablished mesh__D017805 1994-01-01
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D017805 2003
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D017805 1998
% 207.76/207.97  |- mesh__recordAuthorizer mesh__D017805 PLS
% 207.76/207.97  |- mesh__onlineNote mesh__D017805
% 207.76/207.97       use SINGLE PERSON to search WIDOWER %26% WIDOW 1983-93   
% 207.76/207.97  |- skos__prefLabel mesh__D017805 Widowhood
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D017805 2004
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D017805 1999
% 207.76/207.97  |- skos__hiddenLabel mesh__D017805 Widow
% 207.76/207.97  |- skos__annotation mesh__D017805
% 207.76/207.97       woman or man: note X refs; spousal bereavement: coord IM with BEREAVEMENT %28%IM%29%; coping behavior, coping strategy, coping style: coord IM with ADAPTATION, PSYCHOLOGICAL%A%  
% 207.76/207.97  |- mesh__publicMeSHNote mesh__D017805
% 207.76/207.97       94; WIDOWERS %26% WIDOWS were WIDOWER %26% WIDOW see SINGLE PERSON 1983-93%A%  
% 207.76/207.97  |- mesh__dateCreated mesh__D017805 1993-02-16
% 207.76/207.97  |- skos__historyNote mesh__D017805 Death %28%1966-1967%29%
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D017805 2000
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D017805 1994
% 207.76/207.97  |- rdf__type mesh__D017805sskos__Concept
% 207.76/207.97  |- skos__broader mesh__D017007smesh__D003219
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D017007 2004
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D017007 2005
% 207.76/207.97  |- skos__broader mesh__D017007smesh__D014342
% 207.76/207.97  |- mesh__historyNote mesh__D017007 92   
% 207.76/207.97  |- skos__related mesh__D017007smesh__D033002
% 207.76/207.97  |- rdf__type mesh__D017007sskos__Concept
% 207.76/207.97  |- skos__scopeNote mesh__D017007
% 207.76/207.97       A health professional%27%s obligation to breach patient CONFIDENTIALITY to warn third parties of the danger of their being assaulted or of contracting a serious infection.%A%    
% 207.76/207.97  |- skos__hiddenLabel mesh__D017007 Warn, Duty to
% 207.76/207.97  |- mesh__dateCreated mesh__D017007 1991-07-26
% 207.76/207.97  |- mesh__recordMaintainer mesh__D017007 jls
% 207.76/207.97  |- skos__related mesh__D017007smesh__D019221
% 207.76/207.97  |- skos__hiddenLabel mesh__D017007 to Warn, Duty
% 207.76/207.97  |- skos__prefLabel mesh__D017007 Duty to Warn
% 207.76/207.97  |- mesh__publicMeSHNote mesh__D017007 92   
% 207.76/207.97  |- skos__historyNote mesh__D017007 Confidentiality %28%1976-1991%29%
% 207.76/207.97  |- mesh__recordAuthorizer mesh__D017007 sjn
% 207.76/207.97  |- mesh__dateEstablished mesh__D017007 1992-01-01
% 207.76/207.97  |- skos__related mesh__D017007smesh__D003219
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D017007 2006
% 207.76/207.97  |- mesh__recordOriginator mesh__D017007 MXR
% 207.76/207.97  |- mesh__dateRevised mesh__D017007 2003-07-09
% 207.76/207.97  |- skos__hiddenLabel mesh__D047492 PPAR, NUC1
% 207.76/207.97  |- skos__related mesh__D047492smesh__D020025
% 207.76/207.97  |- skos__historyNote mesh__D047492 Transcription Factors %28%1993-2004%29%
% 207.76/207.97  |- skos__hiddenLabel mesh__D047492
% 207.76/207.97       Peroxisome Proliferator Activated Receptors
% 207.76/207.97  |- skos__altLabel mesh__D047492 PPAR
% 207.76/207.97  |- mesh__recordAuthorizer mesh__D047492 sjn
% 207.76/207.97  |- mesh__historyNote mesh__D047492 2005%28%1992%29%   
% 207.76/207.97  |- skos__broader mesh__D047492smesh__D018160
% 207.76/207.97  |- mesh__recordOriginator mesh__D047492 ssb
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D047492 2006
% 207.76/207.97  |- mesh__dateRevised mesh__D047492 2005-06-30
% 207.76/207.97  |- mesh__dateEstablished mesh__D047492 2005-01-01
% 207.76/207.97  |- mesh__recordMaintainer mesh__D047492 SYSTEM
% 207.76/207.97  |- mesh__dateCreated mesh__D047492 2004-07-07
% 207.76/207.97  |- mesh__publicMeSHNote mesh__D047492
% 207.76/207.97       2005; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR was indexed under TRANSCRIPTION FACTORS %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1994-2004, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993%A%  
% 207.76/207.97  |- skos__hiddenLabel mesh__D047492
% 207.76/207.97       Proliferator-Activated Receptors, Peroxisome
% 207.76/207.97  |- rdf__type mesh__D047492sskos__Concept
% 207.76/207.97  |- skos__prefLabel mesh__D047492
% 207.76/207.97       Peroxisome Proliferator-Activated Receptors
% 207.76/207.97  |- skos__annotation mesh__D047492 note specifics   
% 207.76/207.97  |- skos__hiddenLabel mesh__D047492
% 207.76/207.97       Receptors, Peroxisome Proliferator-Activated
% 207.76/207.97  |- skos__scopeNote mesh__D047492
% 207.76/207.97       TRANSCRIPTION FACTORS that are activated by ligands and heterodimerize with RETINOID X RECEPTORS and bind to peroxisome proliferator response elements in the promoter regions of target genes.%A%    
% 207.76/207.97  |- skos__broader mesh__D047492smesh__D014157
% 207.76/207.97  |- skos__annotation mesh__D000298
% 207.76/207.97       not for dis in adolescent in hosp for diag or ther: use only for hospitalized adolescents as a psychol, sociol or social entity; check also tag ADOLESCENT%A%  
% 207.76/207.97  |- mesh__historyNote mesh__D000298 83   
% 207.76/207.97  |- skos__hiddenLabel mesh__D000298 Hospitalized Adolescents
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D000298 2003
% 207.76/207.97  |- skos__hiddenLabel mesh__D000298 Adolescents, Hospitalized
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D000298 2005
% 207.76/207.97  |- skos__prefLabel mesh__D000298 Adolescent, Hospitalized
% 207.76/207.97  |- mesh__dateRevised mesh__D000298 2002-07-02
% 207.76/207.97  |- skos__historyNote mesh__D000298 Adolescence %28%1966-1982%29%
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D000298 2004
% 207.76/207.97  |- skos__hiddenLabel mesh__D000298 Hospitalized Adolescent
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D000298 2006
% 207.76/207.97  |- skos__scopeNote mesh__D000298
% 207.76/207.97       Adolescent hospitalized for short term care.     
% 207.76/207.97  |- mesh__recordMaintainer mesh__D000298 jls
% 207.76/207.97  |- skos__related mesh__D000298smesh__D000299
% 207.76/207.97  |- skos__historyNote mesh__D000298 Hospitalization %28%1966-1982%29%
% 207.76/207.97  |- skos__broader mesh__D000298smesh__D010361
% 207.76/207.97  |- mesh__recordAuthorizer mesh__D000298 sjn
% 207.76/207.97  |- mesh__recordOriginator mesh__D000298 EC
% 207.76/207.97  |- rdf__type mesh__D000298sskos__Concept
% 207.76/207.97  |- mesh__dateCreated mesh__D000298 1982-04-28
% 207.76/207.97  |- mesh__publicMeSHNote mesh__D000298 83   
% 207.76/207.97  |- mesh__dateEstablished mesh__D000298 1983-01-01
% 207.76/207.97  |- mesh__recordOriginator mesh__D041904 ags
% 207.76/207.97  |- mesh__historyNote mesh__D041904 2004   
% 207.76/207.97  |- mesh__publicMeSHNote mesh__D041904 2004   
% 207.76/207.97  |- mesh__dateEstablished mesh__D041904 2004-01-01
% 207.76/207.97  |- skos__broader mesh__D041904smesh__D006090
% 207.76/207.97  |- mesh__recordMaintainer mesh__D041904 SYSTEM
% 207.76/207.97  |- skos__prefLabel mesh__D041904 Roseobacter
% 207.76/207.97  |- mesh__dateRevised mesh__D041904 2005-06-30
% 207.76/207.97  |- skos__broader mesh__D041904smesh__D041902
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D041904 2006
% 207.76/207.97  |- rdf__type mesh__D041904sskos__Concept
% 207.76/207.97  |- mesh__dateCreated mesh__D041904 2003-07-09
% 207.76/207.97  |- mesh__recordAuthorizer mesh__D041904 sjn
% 207.76/207.97  |- skos__scopeNote mesh__D041904
% 207.76/207.97       A genus of obligately aerobic marine phototrophic and chemoorganotrophic bacteria, in the family RHODOBACTERACEAE.%A%    
% 207.76/207.97  |- mesh__publicMeSHNote mesh__D005781
% 207.76/207.97       78; was GELFOAM 1973-77, was GELFOAM see under HEMOSTATICS 1963-72%A%  
% 207.76/207.97  |- mesh__recordOriginator mesh__D005781 NLM
% 207.76/207.97  |- mesh__dateCreated mesh__D005781 1999-01-01
% 207.76/207.97  |- skos__hiddenLabel mesh__D005781 Gelatin Sponges, Absorbable
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D005781 2005
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D005781 2003
% 207.76/207.97  |- skos__hiddenLabel mesh__D005781 Sponge, Absorbable Gelatin
% 207.76/207.97  |- mesh__dateRevised mesh__D005781 2001-07-25
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D005781 2006
% 207.76/207.97  |- mesh__onlineNote mesh__D005781
% 207.76/207.97       use GELATIN SPONGE, ABSORBABLE to search GELFOAM 1966-77 %28%as Prov 1966-72%29%%A%  
% 207.76/207.97  |- mesh__historyNote mesh__D005781
% 207.76/207.97       78; was GELFOAM 1964-77 %28%Prov 1964-72%29%, was GELFOAM see under HEMOSTATICS 1963-72%A%  
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D005781 2004
% 207.76/207.97  |- skos__broader mesh__D005781smesh__D015503
% 207.76/207.97  |- mesh__recordMaintainer mesh__D005781 ssb
% 207.76/207.97  |- skos__hiddenLabel mesh__D005781 Absorbable Gelatin Sponges
% 207.76/207.97  |- skos__hiddenLabel mesh__D005781 Absorbable Gelatin Sponge
% 207.76/207.97  |- skos__prefLabel mesh__D005781 Gelatin Sponge, Absorbable
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D005781 2002
% 207.76/207.97  |- skos__scopeNote mesh__D005781
% 207.76/207.97       Sterile, gelatin-base surgical sponge applied topically as an adjunct to hemostasis when the control of bleeding by conventional procedures is ineffective to reduce capillary ooze or is impractical. %28%From AMA Drug Evaluations Annual, 1994, p797%29%%A%    
% 207.76/207.97  |- rdf__type mesh__D005781sskos__Concept
% 207.76/207.97  |- skos__hiddenLabel mesh__D005781 Sponges, Absorbable Gelatin
% 207.76/207.97  |- mesh__recordAuthorizer mesh__D005781 sjn
% 207.76/207.97  |- mesh__dateEstablished mesh__D005781 1973-01-01
% 207.76/207.97  |- skos__annotation mesh__D005781 D25-26 qualif   
% 207.76/207.97  |- skos__historyNote mesh__D013415 Pyrazines %28%1971-1974%29%
% 207.76/207.97  |- mesh__dateEstablished mesh__D013415 1991-01-01
% 207.76/207.97  |- skos__altLabel mesh__D013415 Longum
% 207.76/207.97  |- skos__altLabel mesh__D013415 Pharmacia Brand of Sulfalene
% 207.76/207.97  |- skos__historyNote mesh__D013415 Sulfonamides %28%1971-1974%29%
% 207.76/207.97  |- skos__altLabel mesh__D013415 Sulfamethopyrazine
% 207.76/207.97  |- skos__broader mesh__D013415smesh__D013424
% 207.76/207.97  |- skos__altLabel mesh__D013415 Sulphametopyrazine
% 207.76/207.97  |- skos__altLabel mesh__D013415 Sulfametopyrazine
% 207.76/207.97  |- mesh__publicMeSHNote mesh__D013415
% 207.76/207.97       91; was see under SULFANILAMIDES 1975-90   
% 207.76/207.97  |- mesh__dateRevised mesh__D013415 2005-06-30
% 207.76/207.97  |- mesh__recordMaintainer mesh__D013415 CCR
% 207.76/207.97  |- mesh__recordOriginator mesh__D013415 NLM
% 207.76/207.97  |- mesh__recordAuthorizer mesh__D013415 sjn
% 207.76/207.97  |- skos__altLabel mesh__D013415 Sulphalene
% 207.76/207.97  |- skos__altLabel mesh__D013415 Sulfapyrazinmethoxine
% 207.76/207.97  |- mesh__historyNote mesh__D013415
% 207.76/207.97       91%28%75%29%; was see under SULFANILAMIDES 1975-90   
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D013415 2006
% 207.76/207.97  |- mesh__dateCreated mesh__D013415 1974-11-19
% 207.76/207.97  |- skos__scopeNote mesh__D013415
% 207.76/207.97       Long-acting plasma-bound sulfonamide used for respiratory and urinary tract infections and also for malaria.%A%    
% 207.76/207.97  |- skos__prefLabel mesh__D013415 Sulfalene
% 207.76/207.97  |- skos__altLabel mesh__D013415 Sulfamethoxypyrazine
% 207.76/207.97  |- rdf__type mesh__D013415sskos__Concept
% 207.76/207.97  |- mesh__recordAuthorizer mesh__D018100 sjn
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D018100 2006
% 207.76/207.97  |- skos__broader mesh__D018100smesh__D011968
% 207.76/207.97  |- mesh__dateRevised mesh__D018100 2005-06-30
% 207.76/207.97  |- rdf__type mesh__D018100sskos__Concept
% 207.76/207.97  |- skos__altLabel mesh__D018100 Histamine H3 Receptors
% 207.76/207.97  |- mesh__publicMeSHNote mesh__D018100
% 207.76/207.97       94; HISTAMINE H3 RECEPTOR was indexed under RECEPTORS, HISTAMINE 1983-93%A%  
% 207.76/207.97  |- skos__scopeNote mesh__D018100
% 207.76/207.97       A class of histamine receptors discriminated by their pharmacology and mode of action. Histamine H3 receptors were first recognized as inhibitory autoreceptors on histamine-containing nerve terminals and have since been shown to regulate the release of several neurotransmitters in the central and peripheral nervous systems. %28%From Biochem Soc Trans 1992 Feb;20%28%1%29%:122-5%29%%A%    
% 207.76/207.97  |- skos__hiddenLabel mesh__D018100 H3 Receptors, Histamine
% 207.76/207.97  |- skos__prefLabel mesh__D018100 Receptors, Histamine H3
% 207.76/207.97  |- skos__hiddenLabel mesh__D018100 Receptor, Histamine H3
% 207.76/207.97  |- skos__altLabel mesh__D018100 H3 Receptors
% 207.76/207.97  |- skos__hiddenLabel mesh__D018100 H3 Receptor, Histamine
% 207.76/207.97  |- mesh__historyNote mesh__D018100
% 207.76/207.97       94; was HISTAMINE H3 RECEPTOR %28%NM%29% 1983-93   
% 207.76/207.97  |- skos__historyNote mesh__D018100 Receptors, Histamine %28%1983-1993%29%
% 207.76/207.97  |- mesh__onlineNote mesh__D018100
% 207.76/207.97       use RECEPTORS, HISTAMINE H3 %28%NM%29% to search HISTAMINE H3 RECEPTOR 1983-93%A%  
% 207.76/207.97  |- skos__hiddenLabel mesh__D018100 Receptors, H3
% 207.76/207.97  |- mesh__dateCreated mesh__D018100 1993-06-16
% 207.76/207.97  |- mesh__recordOriginator mesh__D018100 RAZ
% 207.76/207.97  |- mesh__dateEstablished mesh__D018100 1994-01-01
% 207.76/207.97  |- skos__altLabel mesh__D018100 Histamine H3 Receptor
% 207.76/207.97  |- skos__annotation mesh__D018100 DF: RECEPT H3   
% 207.76/207.97  |- mesh__recordMaintainer mesh__D018100 jmp
% 207.76/207.97  |- rdf__type mesh__D009374sskos__Concept
% 207.76/207.97  |- skos__hiddenLabel mesh__D009374 Experimental Neoplasm
% 207.76/207.97  |- skos__annotation mesh__D009374
% 207.76/207.97       IM general only; not a routine coordinate for specific neoplasms in experimental animals; policy: Manual 24.5+; /chem ind: Manual 24.5.6+; spontaneous: Manual 24.5.5; DF: NEOPL EXPER%A%  
% 207.76/207.97  |- skos__altLabel mesh__D009374 Experimental Neoplasms
% 207.76/207.97  |- mesh__dateRevised mesh__D009374 2004-07-13
% 207.76/207.97  |- skos__hiddenLabel mesh__D009374 Neoplasm, Experimental
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D009374 2005
% 207.76/207.97  |- skos__broader mesh__D009374smesh__D004195
% 207.76/207.97  |- skos__related mesh__D009374smesh__D014412
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D009374 2006
% 207.76/207.97  |- skos__scopeNote mesh__D009374
% 207.76/207.97       Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.%A%    
% 207.76/207.97  |- mesh__recordMaintainer mesh__D009374 sjn
% 207.76/207.97  |- skos__related mesh__D009374smesh__D009368
% 207.76/207.97  |- skos__prefLabel mesh__D009374 Neoplasms, Experimental
% 207.76/207.97  |- mesh__dateCreated mesh__D009374 1999-01-01
% 207.76/207.97  |- skos__broader mesh__D009374smesh__D009369
% 207.76/207.97  |- mesh__recordAuthorizer mesh__D009374 sjn
% 207.76/207.97  |- mesh__recordOriginator mesh__D009374 NLM
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D001391 2006
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D001391 2000
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D001391 1994
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D001391 2004
% 207.76/207.97  |- skos__broader mesh__D001391smesh__D009930
% 207.76/207.97  |- mesh__recordAuthorizer mesh__D001391 PLS
% 207.76/207.97  |- mesh__recordMaintainer mesh__D001391 TGC
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D001391 1995
% 207.76/207.97  |- mesh__dateRevised mesh__D001391 1992-05-07
% 207.76/207.97  |- rdf__type mesh__D001391sskos__Concept
% 207.76/207.97  |- mesh__recordOriginator mesh__D001391 NLM
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D001391 2001
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D001391 1993
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D001391 1998
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D001391 2002
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D001391 1996
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D001391 1999
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D001391 1997
% 207.76/207.97  |- skos__prefLabel mesh__D001391 Azo Compounds
% 207.76/207.97  |- mesh__dateCreated mesh__D001391 1999-01-01
% 207.76/207.97  |- skos__hiddenLabel mesh__D001391 Compounds, Azo
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D001391 2005
% 207.76/207.97  |- skos__annotation mesh__D001391
% 207.76/207.97       do not confuse with AZA COMPOUNDS; DF: AZO CPDS   
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D001391 2003
% 207.76/207.97  |- mesh__publicMeSHNote mesh__D017806 94   
% 207.76/207.97  |- skos__historyNote mesh__D017806 Plant Viruses %28%1966-1993%29%
% 207.76/207.97  |- rdf__type mesh__D017806sskos__Concept
% 207.76/207.97  |- mesh__dateCreated mesh__D017806 1993-06-04
% 207.76/207.97  |- mesh__recordOriginator mesh__D017806 AGS
% 207.76/207.97  |- mesh__dateEstablished mesh__D017806 1994-01-01
% 207.76/207.97  |- skos__scopeNote mesh__D017806
% 207.76/207.97       A genus of plant viruses, in the family TYMOVIRIDAE, possessing a narrow host range that includes CRUCIFERAE. Transmission occurs by BEETLES and mechanical inoculation.%A%    
% 207.76/207.97  |- mesh__recordAuthorizer mesh__D017806 sjn
% 207.76/207.97  |- skos__broader mesh__D017806smesh__D046830
% 207.76/207.97  |- mesh__recordMaintainer mesh__D017806 ags
% 207.76/207.97  |- skos__broader mesh__D017806smesh__D009029
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D017806 2006
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D017806 2005
% 207.76/207.97  |- skos__prefLabel mesh__D017806 Tymovirus
% 207.76/207.97  |- mesh__dateRevised mesh__D017806 2004-07-07
% 207.76/207.97  |- mesh__historyNote mesh__D017806 94   
% 207.76/207.97  |- skos__hiddenLabel mesh__D017806 Tymoviruses
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D017008 2003
% 207.76/207.97  |- skos__broader mesh__D017008smesh__D003142
% 207.76/207.97  |- skos__altLabel mesh__D017008 Arbitration
% 207.76/207.97  |- skos__broader mesh__D017008smesh__D003657
% 207.76/207.97  |- skos__broader mesh__D017008smesh__D010559
% 207.76/207.97  |- skos__prefLabel mesh__D017008 Negotiating
% 207.76/207.97  |- mesh__recordMaintainer mesh__D017008 jls
% 207.76/207.97  |- skos__altLabel mesh__D017008 Negotiation
% 207.76/207.97  |- skos__broader mesh__D017008smesh__D007398
% 207.76/207.97  |- skos__related mesh__D017008smesh__D003098
% 207.76/207.97  |- skos__annotation mesh__D017008
% 207.76/207.97       not restricted to labor unions: used also for interpersonal communications, personnel management, business transactions, etc.%A%  
% 207.76/207.97  |- skos__altLabel mesh__D017008 Mediation
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D017008 2006
% 207.76/207.97  |- mesh__recordOriginator mesh__D017008 MXR
% 207.76/207.97  |- mesh__dateCreated mesh__D017008 1991-05-30
% 207.76/207.97  |- mesh__dateRevised mesh__D017008 2002-07-02
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D017008 2004
% 207.76/207.97  |- skos__hiddenLabel mesh__D017008 Negotiations
% 207.76/207.97  |- mesh__publicMeSHNote mesh__D017008 92   
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D017008 2005
% 207.76/207.97  |- skos__scopeNote mesh__D017008
% 207.76/207.97       The process of bargaining in order to arrive at an agreement or compromise on a matter of importance to the parties involved. It also applies to the hearing and determination of a case by a third party chosen by the parties in controversy, as well as the interposing of a third party to reconcile the parties in controversy.%A%    
% 207.76/207.97  |- mesh__recordAuthorizer mesh__D017008 sjn
% 207.76/207.97  |- mesh__historyNote mesh__D017008 92   
% 207.76/207.97  |- rdf__type mesh__D017008sskos__Concept
% 207.76/207.97  |- mesh__dateEstablished mesh__D017008 1992-01-01
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D047493 2005
% 207.76/207.97  |- skos__scopeNote mesh__D047493
% 207.76/207.97       A nuclear transcription factor. Heterodimerization with RETINOID X RECEPTOR GAMMA is important to metabolism of LIPIDS. It is the target of FIBRATES to control HYPERLIPIDEMIA.%A%    
% 207.76/207.97  |- skos__broader mesh__D047493smesh__D047492
% 207.76/207.97  |- mesh__recordOriginator mesh__D047493 ssb
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D047493 2006
% 207.76/207.97  |- skos__altLabel mesh__D047493 PPARalpha
% 207.76/207.97  |- skos__prefLabel mesh__D047493 PPAR alpha
% 207.76/207.97  |- mesh__dateCreated mesh__D047493 2004-07-07
% 207.76/207.97  |- mesh__recordMaintainer mesh__D047493 ssb
% 207.76/207.97  |- mesh__recordAuthorizer mesh__D047493 sjn
% 207.76/207.97  |- rdf__type mesh__D047493sskos__Concept
% 207.76/207.97  |- mesh__historyNote mesh__D047493 2005%28%1992%29%   
% 207.76/207.97  |- skos__hiddenLabel mesh__D047493
% 207.76/207.97       Peroxisome Proliferator Activated Receptor alpha
% 207.76/207.97  |- mesh__dateEstablished mesh__D047493 2005-01-01
% 207.76/207.97  |- mesh__publicMeSHNote mesh__D047493
% 207.76/207.97       2005; PPAR ALPHA was indexed under TRANSCRIPTION FACTORS %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1994-2004, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993%A%  
% 207.76/207.97  |- skos__historyNote mesh__D047493 Transcription Factors %28%1993-2004%29%
% 207.76/207.97  |- skos__altLabel mesh__D047493
% 207.76/207.97       Peroxisome Proliferator-Activated Receptor alpha
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D000299 2005
% 207.76/207.97  |- skos__scopeNote mesh__D000299
% 207.76/207.97       An adolescent who is receiving long-term in-patient services or who resides in an institutional setting.%A%    
% 207.76/207.97  |- skos__historyNote mesh__D000299 Adolescence %28%1966-1982%29%
% 207.76/207.97  |- skos__hiddenLabel mesh__D000299 Institutionalized Adolescents
% 207.76/207.97  |- mesh__publicMeSHNote mesh__D000299 83   
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D000299 2004
% 207.76/207.97  |- mesh__dateEstablished mesh__D000299 1983-01-01
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D000299 2006
% 207.76/207.97  |- skos__prefLabel mesh__D000299 Adolescent, Institutionalized
% 207.76/207.97  |- skos__annotation mesh__D000299 check also tag ADOLESCENT   
% 207.76/207.97  |- mesh__dateRevised mesh__D000299 2002-07-02
% 207.76/207.97  |- skos__broader mesh__D000299smesh__D010361
% 207.76/207.97  |- skos__altLabel mesh__D000299 Institutionalized Adolescent
% 207.76/207.97  |- skos__hiddenLabel mesh__D000299 Adolescents, Institutionalized
% 207.76/207.97  |- rdf__type mesh__D000299sskos__Concept
% 207.76/207.97  |- mesh__dateCreated mesh__D000299 1982-04-28
% 207.76/207.97  |- mesh__recordMaintainer mesh__D000299 jls
% 207.76/207.97  |- mesh__historyNote mesh__D000299 83   
% 207.76/207.97  |- skos__historyNote mesh__D000299 Residential Facilities %28%1968-1982%29%
% 207.76/207.97  |- skos__historyNote mesh__D000299 Institutionalization %28%1979-1982%29%
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D000299 2003
% 207.76/207.97  |- mesh__recordOriginator mesh__D000299 EC
% 207.76/207.97  |- mesh__recordAuthorizer mesh__D000299 sjn
% 207.76/207.97  |- skos__hiddenLabel mesh__D041905 Cells, Erythroid
% 207.76/207.97  |- skos__hiddenLabel mesh__D041905 Cell, Erythroid
% 207.76/207.97  |- skos__prefLabel mesh__D041905 Erythroid Cells
% 207.76/207.97  |- mesh__historyNote mesh__D041905 2004   
% 207.76/207.97  |- mesh__dateEstablished mesh__D041905 2004-01-01
% 207.76/207.97  |- skos__broader mesh__D041905smesh__D002477
% 207.76/207.97  |- skos__scopeNote mesh__D041905
% 207.76/207.97       The series of cells in the red blood cell lineage at various stages of differentiation.%A%    
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D041905 2006
% 207.76/207.97  |- skos__hiddenLabel mesh__D041905 Erythroid Cell
% 207.76/207.97  |- mesh__dateCreated mesh__D041905 2003-07-09
% 207.76/207.97  |- rdf__type mesh__D041905sskos__Concept
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D041905 2004
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D041905 2005
% 207.76/207.97  |- mesh__publicMeSHNote mesh__D041905 2004   
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D005782 2005
% 207.76/207.97  |- skos__scopeNote mesh__D005782
% 207.76/207.97       Colloids with a solid continuous phase and liquid as the dispersed phase; gels may be unstable when, due to temperature or other cause, the solid phase liquefies; the resulting colloid is called a sol.%A%    
% 207.76/207.97  |- mesh__recordMaintainer mesh__D005782 jls
% 207.76/207.97  |- mesh__recordOriginator mesh__D005782 NLM
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D005782 2006
% 207.76/207.97  |- mesh__dateRevised mesh__D005782 2004-07-27
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D005782 2004
% 207.76/207.97  |- skos__annotation mesh__D005782
% 207.76/207.97       IM for general only, qualif permitted; NIM %28%no qualif%29% with specific drug IM %28%with qualif%29%%A%  
% 207.76/207.97  |- skos__broader mesh__D005782smesh__D003102
% 207.76/207.97  |- rdf__type mesh__D005782sskos__Concept
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D005782 2005A
% 207.76/207.97  |- skos__prefLabel mesh__D005782 Gels
% 207.76/207.97  |- mesh__dateCreated mesh__D005782 1999-01-01
% 207.76/207.97  |- mesh__recordAuthorizer mesh__D005782 jls
% 207.76/207.97  |- skos__scopeNote mesh__D013416
% 207.76/207.97       A sulfanilamide that is used as an antibacterial agent.%A%    
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D013416 2006
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D013416 2001
% 207.76/207.97  |- skos__prefLabel mesh__D013416 Sulfamerazine
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D013416 2005
% 207.76/207.97  |- skos__altLabel mesh__D013416 Methylsulfadiazine
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D013416 2004
% 207.76/207.97  |- rdf__type mesh__D013416sskos__Concept
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D013416 2003
% 207.76/207.97  |- mesh__dateCreated mesh__D013416 1999-01-01
% 207.76/207.97  |- mesh__recordMaintainer mesh__D013416 CCR
% 207.76/207.97  |- skos__broader mesh__D013416smesh__D013424
% 207.76/207.97  |- mesh__dateRevised mesh__D013416 2000-06-22
% 207.76/207.97  |- mesh__recordOriginator mesh__D013416 NLM
% 207.76/207.97  |- mesh__recordAuthorizer mesh__D013416 sjn
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D013416 2002
% 207.76/207.97  |- skos__broader mesh__D018101smesh__D008810
% 207.76/207.97  |- rdf__type mesh__D018101sskos__Concept
% 207.76/207.97  |- mesh__dateEstablished mesh__D018101 1994-01-01
% 207.76/207.97  |- skos__altLabel mesh__D018101 Mouse, Inbred mdx
% 207.76/207.97  |- skos__related mesh__D018101smesh__D009136
% 207.76/207.97  |- skos__hiddenLabel mesh__D018101 Inbred mdx Mice
% 207.76/207.97  |- mesh__recordAuthorizer mesh__D018101 sjn
% 207.76/207.97  |- skos__altLabel mesh__D018101 Mouse, mdx
% 207.76/207.97  |- mesh__dateCreated mesh__D018101 1993-06-03
% 207.76/207.97  |- skos__scopeNote mesh__D018101
% 207.76/207.97       A strain of mice arising from a spontaneous MUTATION %28%mdx%29% in inbred C57BL mice. This mutation is X chromosome-linked and produces viable homozygous animals that lack the muscle protein DYSTROPHIN, have high serum levels of muscle ENZYMES, and possess histological lesions similar to human MUSCULAR DYSTROPHY. The histological features, linkage, and map position of mdx make these mice a worthy animal model of DUCHENNE MUSCULAR DYSTROPHY.%A%    
% 207.76/207.97  |- skos__historyNote mesh__D018101 Mice, Mutant Strains %28%1984-1993%29%
% 207.76/207.97  |- skos__hiddenLabel mesh__D018101 mdx Mouse
% 207.76/207.97  |- skos__hiddenLabel mesh__D018101 mdx Mice, Inbred
% 207.76/207.97  |- mesh__dateRevised mesh__D018101 2005-06-30
% 207.76/207.97  |- mesh__historyNote mesh__D018101 94   
% 207.76/207.97  |- skos__hiddenLabel mesh__D018101 mdx Mouse, Inbred
% 207.76/207.97  |- skos__hiddenLabel mesh__D018101 mdx Mice
% 207.76/207.97  |- mesh__publicMeSHNote mesh__D018101 94   
% 207.76/207.97  |- skos__historyNote mesh__D018101 Mice, Inbred C57BL %28%1984-1993%29%
% 207.76/207.97  |- skos__altLabel mesh__D018101 Mice, mdx
% 207.76/207.97  |- mesh__recordOriginator mesh__D018101 PXP
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D018101 2006
% 207.76/207.97  |- skos__hiddenLabel mesh__D018101 Inbred mdx Mouse
% 207.76/207.97  |- skos__broader mesh__D018101smesh__D008817
% 207.76/207.97  |- mesh__recordMaintainer mesh__D018101 ags
% 207.76/207.97  |- skos__prefLabel mesh__D018101 Mice, Inbred mdx
% 207.76/207.97  |- skos__annotation mesh__D018101
% 207.76/207.97       NIM with no qualifiers when experimental animal; check the tag MICE%A%  
% 207.76/207.97  |- skos__hiddenLabel mesh__D009375 Glandular Epithelial Neoplasms
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D009375 1997
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D009375 1998
% 207.76/207.97  |- skos__broader mesh__D009375smesh__D009370
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D009375 2002
% 207.76/207.97  |- mesh__historyNote mesh__D009375
% 207.76/207.97       94; was NEOPLASMS, GLANDULAR EPITHELIAL 1963-93   
% 207.76/207.97  |- skos__hiddenLabel mesh__D009375 Neoplasm, Glandular Epithelial
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D009375 1999
% 207.76/207.97  |- mesh__recordMaintainer mesh__D009375 KEV
% 207.76/207.97  |- mesh__recordOriginator mesh__D009375 NLM
% 207.76/207.97  |- mesh__dateCreated mesh__D009375 1999-01-01
% 207.76/207.97  |- skos__hiddenLabel mesh__D009375 Neoplasm, Epithelial
% 207.76/207.97  |- skos__annotation mesh__D009375
% 207.76/207.97       neoplasms composed of glandular %26% epithelial tissue, NOT neoplasms located in various glands or epithelium: TN 135; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 207.76/207.97  |- skos__prefLabel mesh__D009375 Neoplasms, Glandular and Epithelial
% 207.76/207.97  |- skos__hiddenLabel mesh__D009375 Neoplasm, Glandular
% 207.76/207.97  |- mesh__recordAuthorizer mesh__D009375 PLS
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D009375 2000
% 207.76/207.97  |- skos__hiddenLabel mesh__D009375 Epithelial Neoplasm
% 207.76/207.97  |- skos__altLabel mesh__D009375 Neoplasms, Glandular
% 207.76/207.97  |- skos__altLabel mesh__D009375 Glandular and Epithelial Neoplasms
% 207.76/207.97  |- skos__hiddenLabel mesh__D009375 Epithelial Neoplasm, Glandular
% 207.76/207.97  |- skos__scopeNote mesh__D009375
% 207.76/207.97       Neoplasms composed of glandular tissue, an aggregation of epithelial cells that elaborate secretions, and of any type of epithelium itself. The concept does not refer to neoplasms located in the various glands or in epithelial tissue.%A%    
% 207.76/207.97  |- mesh__activeMeSHYear mesh__D009375 2003
% 207.76/207.97  |- skos__hiddenLabel mesh__D009375 Glandular Neoplasm
% 207.76/207.98  |- mesh__publicMeSHNote mesh__D009375
% 207.76/207.98       94; was NEOPLASMS, GLANDULAR EPITHELIAL 1963-93   
% 207.76/207.98  |- mesh__onlineNote mesh__D009375
% 207.76/207.98       use NEOPLASMS, GLANDULAR AND EPITHELIAL to search NEOPLASMS, GLANDULAR EPITHELIAL 1966-93%A%  
% 207.76/207.98  |- rdf__type mesh__D009375sskos__Concept
% 207.76/207.98  |- skos__altLabel mesh__D009375 Neoplasms, Glandular Epithelial
% 207.76/207.98  |- skos__hiddenLabel mesh__D009375 Epithelial Neoplasms, Glandular
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D009375 2001
% 207.76/207.98  |- skos__altLabel mesh__D009375 Epithelial Neoplasms
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D009375 2004
% 207.76/207.98  |- skos__hiddenLabel mesh__D009375 Glandular Epithelial Neoplasm
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D009375 2005
% 207.76/207.98  |- mesh__dateRevised mesh__D009375 1995-06-08
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D009375 1996
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D009375 2006
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D001392 1995
% 207.76/207.98  |- mesh__dateRevised mesh__D001392 1992-05-07
% 207.76/207.98  |- rdf__type mesh__D001392sskos__Concept
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D001392 1993
% 207.76/207.98  |- skos__prefLabel mesh__D001392 Azocines
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D001392 1998
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D001392 2000
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D001392 1996
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D001392 1999
% 207.76/207.98  |- mesh__recordAuthorizer mesh__D001392 PLS
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D001392 1997
% 207.76/207.98  |- mesh__recordOriginator mesh__D001392 NLM
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D001392 2001
% 207.76/207.98  |- mesh__dateCreated mesh__D001392 1999-01-01
% 207.76/207.98  |- mesh__historyNote mesh__D001392 66%28%64%29%   
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D001392 2005
% 207.76/207.98  |- mesh__publicMeSHNote mesh__D001392 66   
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D001392 2002
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D001392 2003
% 207.76/207.98  |- skos__broader mesh__D001392smesh__D006573
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D001392 2006
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D001392 1994
% 207.76/207.98  |- mesh__dateEstablished mesh__D001392 1966-01-01
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D001392 2004
% 207.76/207.98  |- mesh__recordMaintainer mesh__D001392 TAP
% 207.76/207.98  |- skos__broader mesh__D017009smesh__D011364
% 207.76/207.98  |- skos__scopeNote mesh__D017009
% 207.76/207.98       The quality or state of being independent and self-directing, especially in making decisions, enabling professionals to exercise judgment as they see fit during the performance of their jobs.%A%    
% 207.76/207.98  |- mesh__dateRevised mesh__D017009 2001-07-25
% 207.76/207.98  |- skos__hiddenLabel mesh__D017009 Professional Self Regulation
% 207.76/207.98  |- skos__hiddenLabel mesh__D017009 Regulation, Professional Self
% 207.76/207.98  |- mesh__dateEstablished mesh__D017009 1992-01-01
% 207.76/207.98  |- mesh__publicMeSHNote mesh__D017009 92   
% 207.76/207.98  |- mesh__recordMaintainer mesh__D017009 tjk
% 207.76/207.98  |- mesh__recordAuthorizer mesh__D017009 sjn
% 207.76/207.98  |- mesh__recordOriginator mesh__D017009 MXR
% 207.76/207.98  |- mesh__dateCreated mesh__D017009 1991-07-26
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D017009 2005
% 207.76/207.98  |- skos__prefLabel mesh__D017009 Professional Autonomy
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D017009 2006
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D017009 2003
% 207.76/207.98  |- skos__hiddenLabel mesh__D017009 Autonomy, Professional
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D017009 2004
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D017009 2002
% 207.76/207.98  |- skos__related mesh__D017009smesh__D026684
% 207.76/207.98  |- mesh__historyNote mesh__D017009 92   
% 207.76/207.98  |- rdf__type mesh__D017009sskos__Concept
% 207.76/207.98  |- skos__hiddenLabel mesh__D047494
% 207.76/207.98       Peroxisome Proliferator Activated Receptor delta
% 207.76/207.98  |- skos__altLabel mesh__D047494
% 207.76/207.98       Peroxisome Proliferator-Activated Receptor delta
% 207.76/207.98  |- mesh__dateCreated mesh__D047494 2004-07-07
% 207.76/207.98  |- skos__scopeNote mesh__D047494
% 207.76/207.98       A nuclear transcription factor. It is activated by PROSTACYCLIN.%A%    
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D047494 2006
% 207.76/207.98  |- skos__broader mesh__D047494smesh__D047492
% 207.76/207.98  |- mesh__recordMaintainer mesh__D047494 ssb
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D047494 2005
% 207.76/207.98  |- skos__altLabel mesh__D047494 PPARD protein
% 207.76/207.98  |- mesh__publicMeSHNote mesh__D047494
% 207.76/207.98       2005; PPAR DELTA was indexed under TRANSCRIPTION FACTORS %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1994-2004, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993%A%  
% 207.76/207.98  |- mesh__dateEstablished mesh__D047494 2005-01-01
% 207.76/207.98  |- mesh__recordOriginator mesh__D047494 ssb
% 207.76/207.98  |- rdf__type mesh__D047494sskos__Concept
% 207.76/207.98  |- skos__altLabel mesh__D047494 PPARdelta
% 207.76/207.98  |- skos__prefLabel mesh__D047494 PPAR delta
% 207.76/207.98  |- mesh__recordAuthorizer mesh__D047494 sjn
% 207.76/207.98  |- mesh__historyNote mesh__D047494 2005%28%1992%29%   
% 207.76/207.98  |- skos__historyNote mesh__D047494 Transcription Factors %28%1993-2004%29%
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D005783 2004
% 207.76/207.98  |- skos__altLabel mesh__D005783 Man%27%s Role
% 207.76/207.98  |- skos__hiddenLabel mesh__D005783 Woman%27%s Roles
% 207.76/207.98  |- skos__broader mesh__D005783smesh__D007062
% 207.76/207.98  |- skos__hiddenLabel mesh__D005783 Roles, Woman%27%s
% 207.76/207.98  |- skos__hiddenLabel mesh__D005783 Role, Women%27%s
% 207.76/207.98  |- skos__hiddenLabel mesh__D005783 Role, Sex
% 207.76/207.98  |- mesh__dateRevised mesh__D005783 2005-07-29
% 207.76/207.98  |- skos__hiddenLabel mesh__D005783 Role, Men%27%s
% 207.76/207.98  |- skos__hiddenLabel mesh__D005783 Gender Identities
% 207.76/207.98  |- skos__prefLabel mesh__D005783 Gender Identity
% 207.76/207.98  |- skos__historyNote mesh__D005783
% 207.76/207.98       Identification %28%Psychology%29% %28%1968-1975%29%
% 207.76/207.98  |- skos__hiddenLabel mesh__D005783 Role, Woman%27%s
% 207.76/207.98  |- rdf__type mesh__D005783sskos__Concept
% 207.76/207.98  |- mesh__publicMeSHNote mesh__D005783
% 207.76/207.98       1991; see IDENTIFICATION %28%PSYCHOLOGY%29% 1976-1990; for GENDER see SEX 1991-2003%A%  
% 207.76/207.98  |- mesh__dateEstablished mesh__D005783 1991-01-01
% 207.76/207.98  |- skos__altLabel mesh__D005783 Gender Role
% 207.76/207.98  |- skos__historyNote mesh__D005783 Sex %28%1968-1975%29%
% 207.76/207.98  |- skos__hiddenLabel mesh__D005783 Sex Roles
% 207.76/207.98  |- mesh__recordAuthorizer mesh__D005783 ags
% 207.76/207.98  |- skos__hiddenLabel mesh__D005783 Roles, Gender
% 207.76/207.98  |- mesh__recordMaintainer mesh__D005783 ags
% 207.76/207.98  |- skos__hiddenLabel mesh__D005783 Roles, Sex
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D005783 2005
% 207.76/207.98  |- skos__hiddenLabel mesh__D005783 Roles, Men%27%s
% 207.76/207.98  |- mesh__historyNote mesh__D005783
% 207.76/207.98       1991%28%1975%29%; for GENDER use SEX 1991-2003   
% 207.76/207.98  |- skos__broader mesh__D005783smesh__D011606
% 207.76/207.98  |- skos__hiddenLabel mesh__D005783 Roles, Women%27%s
% 207.76/207.98  |- mesh__dateCreated mesh__D005783 1975-07-21
% 207.76/207.98  |- skos__altLabel mesh__D005783 Women%27%s Role
% 207.76/207.98  |- skos__annotation mesh__D005783
% 207.76/207.98       psychological; do not confuse with SEX CHARACTERISTICS %28%physiological%29%; do not confuse with SEXUAL ORIENTATION see SEX BEHAVIOR: gender identity is knowing that one is male or female; sexual orientation is preferring heterosexual or homosexual behavior; no qualif%A%  
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D005783 2006A
% 207.76/207.98  |- skos__hiddenLabel mesh__D005783 Women%27%s Roles
% 207.76/207.98  |- skos__hiddenLabel mesh__D005783 Identity, Gender
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D005783 2006
% 207.76/207.98  |- skos__hiddenLabel mesh__D005783 Role, Man%27%s
% 207.76/207.98  |- skos__hiddenLabel mesh__D005783 Gender Roles
% 207.76/207.98  |- mesh__recordOriginator mesh__D005783 EC
% 207.76/207.98  |- skos__scopeNote mesh__D005783
% 207.76/207.98       A person%27%s concept of self as being male and masculine or female and feminine, or ambivalent, based in part on physical characteristics, parental responses, and psychological and social pressures. It is the internal experience of gender role.%A%    
% 207.76/207.98  |- mesh__recordAuthorizer mesh__D013417 sjn
% 207.76/207.98  |- skos__historyNote mesh__D013417 Sulfanilamides %28%1973-1974%29%
% 207.76/207.98  |- mesh__recordOriginator mesh__D013417 NLM
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D013417 2005
% 207.76/207.98  |- mesh__historyNote mesh__D013417
% 207.76/207.98       91%28%75%29%; was see under SULFANILAMIDES 1975-90   
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D013417 2002
% 207.76/207.98  |- skos__scopeNote mesh__D013417
% 207.76/207.98       Long acting sulfonamide used in leprosy, urinary, and respiratory tract infections.%A%    
% 207.76/207.98  |- mesh__dateCreated mesh__D013417 1974-12-12
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D013417 2004
% 207.76/207.98  |- skos__altLabel mesh__D013417 Sulfametoxydiazine
% 207.76/207.98  |- rdf__type mesh__D013417sskos__Concept
% 207.76/207.98  |- skos__altLabel mesh__D013417 Sulphamethoxydiazine
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D013417 2001
% 207.76/207.98  |- skos__historyNote mesh__D013417 Pyrimidines %28%1970-1974%29%
% 207.76/207.98  |- skos__altLabel mesh__D013417 Sulfametin
% 207.76/207.98  |- skos__altLabel mesh__D013417 Sulfametorinum
% 207.76/207.98  |- skos__altLabel mesh__D013417 Sulfamethoxydiazine
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D013417 2003
% 207.76/207.98  |- skos__altLabel mesh__D013417 Sulfamethoxydine
% 207.76/207.98  |- mesh__dateRevised mesh__D013417 2000-06-22
% 207.76/207.98  |- skos__altLabel mesh__D013417 Sulfametoxidine
% 207.76/207.98  |- mesh__dateEstablished mesh__D013417 1991-01-01
% 207.76/207.98  |- mesh__publicMeSHNote mesh__D013417
% 207.76/207.98       91; was see under SULFANILAMIDES 1975-90   
% 207.76/207.98  |- mesh__recordMaintainer mesh__D013417 CCR
% 207.76/207.98  |- skos__prefLabel mesh__D013417 Sulfameter
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D013417 2006
% 207.76/207.98  |- skos__broader mesh__D013417smesh__D013424
% 207.76/207.98  |- skos__scopeNote mesh__D018900
% 207.76/207.98       The most common of the microsatellite tandem repeats %28%MICROSATELLITE REPEATS%29% dispersed in the euchromatic arms of chromosomes. They consist of two nucleotides repeated in tandem; guanine and thymine, %28%GT%29%n, is the most frequently seen.%A%    
% 207.76/207.98  |- mesh__publicMeSHNote mesh__D018900 96   
% 207.76/207.98  |- mesh__historyNote mesh__D018900 96   
% 207.76/207.98  |- mesh__recordAuthorizer mesh__D018900 sjn
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D018900 2006
% 207.76/207.98  |- rdf__type mesh__D018900sskos__Concept
% 207.76/207.98  |- skos__broader mesh__D018900smesh__D018895
% 207.76/207.98  |- mesh__recordMaintainer mesh__D018900 nns
% 207.76/207.98  |- mesh__dateEstablished mesh__D018900 1996-01-01
% 207.76/207.98  |- skos__historyNote mesh__D018900
% 207.76/207.98       Repetitive Sequences, Nucleic Acid %28%1989-1995%29%
% 207.76/207.98  |- skos__prefLabel mesh__D018900 Dinucleotide Repeats
% 207.76/207.98  |- mesh__recordOriginator mesh__D018900 AGS
% 207.76/207.98  |- mesh__dateCreated mesh__D018900 1995-06-08
% 207.76/207.98  |- skos__hiddenLabel mesh__D018900 Dinucleotide Repeat
% 207.76/207.98  |- mesh__dateRevised mesh__D018900 2005-06-30
% 207.76/207.98  |- rdf__type mesh__D018102sskos__Concept
% 207.76/207.98  |- skos__historyNote mesh__D018102
% 207.76/207.98       Receptors, Cell Surface %28%1982-1984%29%
% 207.76/207.98  |- skos__scopeNote mesh__D018102
% 207.76/207.98       A class of cell surface leukotriene receptors with a preference for leukotriene B4. Leukotriene B4 receptor activation influences chemotaxis, chemokinesis, adherence, enzyme release, oxidative bursts, and degranulation in polymorphonuclear leukocytes. There are at least two subtypes of these receptors. Some actions are mediated through the inositol phosphate and diacylglycerol second messenger systems.%A%    
% 207.76/207.98  |- skos__annotation mesh__D018102 DF: RECEPT LEUKOTRIENE B4   
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D018102 2004
% 207.76/207.98  |- mesh__onlineNote mesh__D018102
% 207.76/207.98       use RECEPTORS, LEUKOTRIENE B4 %28%NM%29% to search LEUKOTRIENE B4 RECEPTOR 1982-93%A%  
% 207.76/207.98  |- skos__hiddenLabel mesh__D018102 Receptor, LTB4
% 207.76/207.98  |- mesh__dateEstablished mesh__D018102 1994-01-01
% 207.76/207.98  |- mesh__historyNote mesh__D018102
% 207.76/207.98       94; was LEUKOTRIENE B4 RECEPTOR %28%NM%29% 1982-93   
% 207.76/207.98  |- mesh__recordOriginator mesh__D018102 RAZ
% 207.76/207.98  |- mesh__dateCreated mesh__D018102 1993-06-16
% 207.76/207.98  |- skos__altLabel mesh__D018102 LTB4 Receptors
% 207.76/207.98  |- mesh__dateRevised mesh__D018102 2003-07-09
% 207.76/207.98  |- mesh__recordMaintainer mesh__D018102 jmp
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D018102 2005
% 207.76/207.98  |- mesh__recordAuthorizer mesh__D018102 sjn
% 207.76/207.98  |- skos__hiddenLabel mesh__D018102 Receptors, LTB4
% 207.76/207.98  |- skos__altLabel mesh__D018102 Leukotriene B4 Receptor
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D018102 2006
% 207.76/207.98  |- skos__broader mesh__D018102smesh__D018077
% 207.76/207.98  |- skos__prefLabel mesh__D018102 Receptors, Leukotriene B4
% 207.76/207.98  |- mesh__publicMeSHNote mesh__D018102
% 207.76/207.98       94; LEUKOTRIENE B4 RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1985-93, RECEPTORS, ENDOGENOUS SUBSTANCES 1982-84 %26% RECEPTORS, HORMONE 1982%A%  
% 207.76/207.98  |- skos__altLabel mesh__D018102 LTB4 Receptor
% 207.76/207.98  |- skos__hiddenLabel mesh__D018102 Receptor, Leukotriene B4
% 207.76/207.98  |- skos__altLabel mesh__D018102 Leukotriene B4 Receptors
% 207.76/207.98  |- skos__historyNote mesh__D018102 Receptors, Immunologic %28%1985-1993%29%
% 207.76/207.98  |- mesh__publicMeSHNote mesh__D051536 2006   
% 207.76/207.98  |- skos__annotation mesh__D051536 general; prefer specifics   
% 207.76/207.98  |- rdf__type mesh__D051536sskos__Concept
% 207.76/207.98  |- mesh__historyNote mesh__D051536 2006   
% 207.76/207.98  |- mesh__dateEstablished mesh__D051536 2006-01-01
% 207.76/207.98  |- skos__broader mesh__D051536smesh__D014157
% 207.76/207.98  |- skos__prefLabel mesh__D051536 Hepatocyte Nuclear Factors
% 207.76/207.98  |- mesh__dateCreated mesh__D051536 2005-06-30
% 207.76/207.98  |- skos__broader mesh__D051536smesh__D004268
% 207.76/207.98  |- skos__scopeNote mesh__D051536
% 207.76/207.98       Hepatocyte nuclear factors are a family of evolutionarily conserved transcription factors that are preferentially expressed in HEPATOCYTES. They play important roles in liver-specific transcription and are critical for CELL DIFFERENTIATION and METABOLISM.%A%    
% 207.76/207.98  |- skos__broader mesh__D051536smesh__D009687
% 207.76/207.98  |- mesh__recordOriginator mesh__D051536 DRC
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D051536 2006
% 207.76/207.98  |- mesh__recordMaintainer mesh__D051536 DRC
% 207.76/207.98  |- mesh__recordAuthorizer mesh__D051536 sjn
% 207.76/207.98  |- skos__hiddenLabel mesh__D009376 Neoplasms, Hormone Dependent
% 207.76/207.98  |- skos__broader mesh__D009376smesh__D009369
% 207.76/207.98  |- mesh__dateEstablished mesh__D009376 1979-01-01
% 207.76/207.98  |- mesh__recordAuthorizer mesh__D009376 sjn
% 207.76/207.98  |- skos__prefLabel mesh__D009376 Neoplasms, Hormone-Dependent
% 207.76/207.98  |- skos__hiddenLabel mesh__D009376 Hormone Dependent Neoplasms
% 207.76/207.98  |- mesh__dateRevised mesh__D009376 2004-07-07
% 207.76/207.98  |- rdf__type mesh__D009376sskos__Concept
% 207.76/207.98  |- mesh__recordOriginator mesh__D009376 VDK
% 207.76/207.98  |- skos__hiddenLabel mesh__D009376 Neoplasm, Hormone-Dependent
% 207.76/207.98  |- mesh__historyNote mesh__D009376 79   
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D009376 2005
% 207.76/207.98  |- skos__altLabel mesh__D009376 Hormone-Dependent Neoplasms
% 207.76/207.98  |- skos__hiddenLabel mesh__D009376 Hormone-Dependent Neoplasm
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D009376 2006
% 207.76/207.98  |- skos__scopeNote mesh__D009376
% 207.76/207.98       Certain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment.%A%    
% 207.76/207.98  |- mesh__recordMaintainer mesh__D009376 wdj
% 207.76/207.98  |- skos__related mesh__D009376smesh__D018931
% 207.76/207.98  |- mesh__dateCreated mesh__D009376 1978-05-19
% 207.76/207.98  |- skos__annotation mesh__D009376
% 207.76/207.98       /blood supply /chem /secret /ultrastruct permitted; /drug ther: consider also ANTINEOPLASTIC AGENTS, HORMONAL; coord IM with precoord organ/neopl term %28%IM%29% + histol type %28%IM%29% + specific hormone %28%IM%29%%A%  
% 207.76/207.98  |- mesh__publicMeSHNote mesh__D009376 79   
% 207.76/207.98  |- skos__broader mesh__D005167Q000172smesh__D005167
% 207.76/207.98  |- mesh__preferredCombination mesh__D005167Q000172smesh__D005168
% 207.76/207.98  |- rdf__type mesh__D005167Q000172smesh__CompoundConcept
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D001393 2006
% 207.76/207.98  |- skos__broader mesh__D001393smesh__D006573
% 207.76/207.98  |- mesh__recordMaintainer mesh__D001393 ssb
% 207.76/207.98  |- skos__scopeNote mesh__D001393
% 207.76/207.98       Five membered rings containing a NITROGEN atom.     
% 207.76/207.98  |- mesh__dateCreated mesh__D001393 1999-01-01
% 207.76/207.98  |- rdf__type mesh__D001393sskos__Concept
% 207.76/207.98  |- mesh__recordAuthorizer mesh__D001393 sjn
% 207.76/207.98  |- mesh__dateRevised mesh__D001393 2005-06-30
% 207.76/207.98  |- skos__prefLabel mesh__D001393 Azoles
% 207.76/207.98  |- mesh__recordOriginator mesh__D001393 NLM
% 207.76/207.98  |- mesh__recordOriginator mesh__D042201 ags
% 207.76/207.98  |- mesh__recordMaintainer mesh__D042201 ags
% 207.76/207.98  |- mesh__publicMeSHNote mesh__D042201 2004   
% 207.76/207.98  |- skos__scopeNote mesh__D042201
% 207.76/207.98       A genus of microaerophilic, gram-negative bacteria that forms crystals of the mineral magnetite.%A%    
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D042201 2006
% 207.76/207.98  |- mesh__recordAuthorizer mesh__D042201 sjn
% 207.76/207.98  |- rdf__type mesh__D042201sskos__Concept
% 207.76/207.98  |- mesh__historyNote mesh__D042201 2004   
% 207.76/207.98  |- skos__broader mesh__D042201smesh__D012244
% 207.76/207.98  |- mesh__dateEstablished mesh__D042201 2004-01-01
% 207.76/207.98  |- skos__prefLabel mesh__D042201 Magnetospirillum
% 207.76/207.98  |- mesh__dateCreated mesh__D042201 2003-07-09
% 207.76/207.98  |- mesh__dateRevised mesh__D042201 2005-06-30
% 207.76/207.98  |- mesh__recordAuthorizer mesh__D047495 ags
% 207.76/207.98  |- skos__altLabel mesh__D047495
% 207.76/207.98       Peroxisome Proliferator-Activated Receptor gamma
% 207.76/207.98  |- mesh__historyNote mesh__D047495 2005%28%1992%29%   
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D047495 2006
% 207.76/207.98  |- mesh__recordMaintainer mesh__D047495 ags
% 207.76/207.98  |- skos__scopeNote mesh__D047495
% 207.76/207.98       A nuclear transcription factor. Heterodimerization with RETINOID X RECEPTOR ALPHA is important in regulation of GLUCOSE metabolism and CELL GROWTH PROCESSES. It is a target of THIAZOLIDINEDIONES for control of DIABETES MELLITUS.%A%    
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D047495 2005
% 207.76/207.98  |- skos__altLabel mesh__D047495 PPARgamma
% 207.76/207.98  |- mesh__publicMeSHNote mesh__D047495
% 207.76/207.98       2005; PPAR GAMMA was indexed under TRANSCRIPTION FACTORS %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1994-2004, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993%A%  
% 207.76/207.98  |- skos__hiddenLabel mesh__D047495
% 207.76/207.98       Peroxisome Proliferator Activated Receptor gamma
% 207.76/207.98  |- mesh__dateRevised mesh__D047495 2005-07-13
% 207.76/207.98  |- mesh__recordOriginator mesh__D047495 ssb
% 207.76/207.98  |- rdf__type mesh__D047495sskos__Concept
% 207.76/207.98  |- skos__altLabel mesh__D047495 Thiazolidinedione Receptor
% 207.76/207.98  |- skos__broader mesh__D047495smesh__D047492
% 207.76/207.98  |- skos__historyNote mesh__D047495 Transcription Factors %28%1993-2004%29%
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D047495 2006B
% 207.76/207.98  |- mesh__dateCreated mesh__D047495 2004-07-07
% 207.76/207.98  |- skos__prefLabel mesh__D047495 PPAR gamma
% 207.76/207.98  |- skos__hiddenLabel mesh__D047495 Receptor, Thiazolidinedione
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D047495 2006A
% 207.76/207.98  |- mesh__dateEstablished mesh__D047495 2005-01-01
% 207.76/207.98  |- skos__scopeNote mesh__D014510
% 207.76/207.98       An enzyme that catalyzes the conversion of urea and water to carbon dioxide and ammonia. EC 3.5.1.5.%A%    
% 207.76/207.98  |- mesh__dateCreated mesh__D014510 1999-01-01
% 207.76/207.98  |- mesh__recordAuthorizer mesh__D014510 sjn
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D014510 2005
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D014510 2006
% 207.76/207.98  |- skos__hiddenLabel mesh__D014510 Amidohydrolase, Urea
% 207.76/207.98  |- mesh__recordOriginator mesh__D014510 NLM
% 207.76/207.98  |- skos__altLabel mesh__D014510 Urea Amidohydrolase
% 207.76/207.98  |- mesh__dateRevised mesh__D014510 2003-07-09
% 207.76/207.98  |- skos__prefLabel mesh__D014510 Urease
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D014510 2004
% 207.76/207.98  |- mesh__recordMaintainer mesh__D014510 ssb
% 207.76/207.98  |- skos__broader mesh__D014510smesh__D000581
% 207.76/207.98  |- rdf__type mesh__D014510sskos__Concept
% 207.76/207.98  |- skos__broader mesh__D001205Q000172smesh__D001205
% 207.76/207.98  |- mesh__preferredCombination mesh__D001205Q000172smesh__D001206
% 207.76/207.98  |- rdf__type mesh__D001205Q000172smesh__CompoundConcept
% 207.76/207.98  |- rdf__type mesh__D005784sskos__Concept
% 207.76/207.98  |- skos__annotation mesh__D005784
% 207.76/207.98       for physiol process only; for technique use NUCLEIC ACID AMPLIFICATION TECHNIQUES or specifics%A%  
% 207.76/207.98  |- skos__historyNote mesh__D005784 Plasmids %28%1975-1979%29%
% 207.76/207.98  |- skos__scopeNote mesh__D005784
% 207.76/207.98       A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication.%A%    
% 207.76/207.98  |- skos__broader mesh__D005784smesh__D009154
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D005784 2005
% 207.76/207.98  |- mesh__recordMaintainer mesh__D005784 NDW
% 207.76/207.98  |- skos__historyNote mesh__D005784 Genes, Structural %28%1968-1979%29%
% 207.76/207.98  |- skos__broader mesh__D005784smesh__D016296
% 207.76/207.98  |- mesh__dateCreated mesh__D005784 1979-04-17
% 207.76/207.98  |- mesh__publicMeSHNote mesh__D005784 80   
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D005784 2003
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D005784 2006
% 207.76/207.98  |- mesh__recordAuthorizer mesh__D005784 sjn
% 207.76/207.98  |- mesh__recordOriginator mesh__D005784 AEP
% 207.76/207.98  |- skos__historyNote mesh__D005784 Genes %28%1966-1967%29%
% 207.76/207.98  |- skos__related mesh__D005784smesh__D018628
% 207.76/207.98  |- skos__broader mesh__D005784smesh__D005786
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D005784 2004
% 207.76/207.98  |- mesh__dateEstablished mesh__D005784 1980-01-01
% 207.76/207.98  |- skos__hiddenLabel mesh__D005784 Amplification, Gene
% 207.76/207.98  |- skos__prefLabel mesh__D005784 Gene Amplification
% 207.76/207.98  |- skos__historyNote mesh__D005784
% 207.76/207.98       Nucleic Acid Hybridization %28%1971-1979%29%
% 207.76/207.98  |- mesh__historyNote mesh__D005784 80   
% 207.76/207.98  |- mesh__dateRevised mesh__D005784 2002-07-02
% 207.76/207.98  |- mesh__dateCreated mesh__D013418 1999-01-01
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D013418 2003
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D013418 2002
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D013418 2004
% 207.76/207.98  |- skos__prefLabel mesh__D013418 Sulfamethazine
% 207.76/207.98  |- mesh__recordMaintainer mesh__D013418 jmp
% 207.76/207.98  |- rdf__type mesh__D013418sskos__Concept
% 207.76/207.98  |- skos__broader mesh__D013418smesh__D013424
% 207.76/207.98  |- skos__altLabel mesh__D013418 Sulphamezathine
% 207.76/207.98  |- mesh__recordAuthorizer mesh__D013418 sjn
% 207.76/207.98  |- mesh__recordOriginator mesh__D013418 NLM
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D013418 2000
% 207.76/207.98  |- skos__altLabel mesh__D013418 Sulfadimidine
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D013418 2005
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D013418 2001
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D013418 2006
% 207.76/207.98  |- skos__altLabel mesh__D013418 Sulfadimezine
% 207.76/207.98  |- mesh__dateRevised mesh__D013418 1999-11-03
% 207.76/207.98  |- skos__scopeNote mesh__D013418
% 207.76/207.98       A sulfanilamide anti-infective agent. It has a spectrum of antimicrobial action similar to other sulfonamides.%A%    
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Dysfunctions, General Peroxisomal
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Dysfunctions, Single Peroxisomal
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Acidemias, Hyperpipecolic
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Peroxisomal Dysfunctions, Multiple
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Single Peroxisomal Dysfunctions
% 207.76/207.98  |- rdf__type mesh__D018901sskos__Concept
% 207.76/207.98  |- skos__prefLabel mesh__D018901 Peroxisomal Disorders
% 207.76/207.98  |- skos__scopeNote mesh__D018901
% 207.76/207.98       A heterogeneous group of inherited metabolic disorders marked by absent or dysfunctional PEROXISOMES. Peroxisomal enzymatic abnormalities may be single or multiple. Biosynthetic peroxisomal pathways are compromised, including the ability to synthesize ether lipids and to oxidize long-chain fatty acid precursors. Diseases in this category include ZELLWEGER SYNDROME; infantile Refsum disease; rhizomelic chondrodysplasia %28%CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC%29%; hyperpipecolic acidemia; neonatal adrenoleukodystrophy; and ADRENOLEUKODYSTROPHY %28%X-linked%29%. Neurologic dysfunction is a prominent feature of most peroxisomal disorders.%A%    
% 207.76/207.98  |- mesh__dateEstablished mesh__D018901 1996-01-01
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Single Peroxisomal Dysfunction
% 207.76/207.98  |- skos__broader mesh__D018901smesh__D020739
% 207.76/207.98  |- skos__altLabel mesh__D018901 Refsum%27%s Disease, Infantile
% 207.76/207.98  |- skos__broader mesh__D018901smesh__D008052
% 207.76/207.98  |- mesh__recordMaintainer mesh__D018901 nns
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Hyperpipecolic Acidemias
% 207.76/207.98  |- skos__annotation mesh__D018901
% 207.76/207.98       GEN or unspecified; prefer specifics; do not confuse X ref REFSUM DISEASE, INFANTILE with REFSUM DISEASE, a hered peripheral neuropathy; do not confuse X ref ADRENOLEUKODYSTROPHY, NEONATAL with ADRENOLEUKODYSTROPHY; do not use /in inf%A%  
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Peroxisomal Dysfunctions, General
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Refsums Disease, Infantile
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D018901 2005
% 207.76/207.98  |- mesh__dateRevised mesh__D018901 2001-07-25
% 207.76/207.98  |- mesh__recordAuthorizer mesh__D018901 sjn
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Multiple Peroxisomal Dysfunctions
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 General Peroxisomal Dysfunctions
% 207.76/207.98  |- skos__altLabel mesh__D018901 Infantile Refsum Disease
% 207.76/207.98  |- mesh__recordOriginator mesh__D018901 AGS
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D018901 2006
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Dysfunction, Single Peroxisomal
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Neonatal Adrenoleukodystrophy
% 207.76/207.98  |- skos__historyNote mesh__D018901
% 207.76/207.98       Metabolism, Inborn Errors %28%1988-1995%29%
% 207.76/207.98  |- skos__altLabel mesh__D018901 Infantile Refsum%27%s Disease
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Peroxisomal Disorder
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Dysfunction, General Peroxisomal
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D018901 2002
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Neonatal Adrenoleukodystrophies
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Dysfunctions, Multiple Peroxisomal
% 207.76/207.98  |- mesh__dateCreated mesh__D018901 1994-12-27
% 207.76/207.98  |- mesh__activeMeSHYear mesh__D018901 2003
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Multiple Peroxisomal Dysfunction
% 207.76/207.98  |- mesh__historyNote mesh__D018901 96   
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Infantile Refsums Disease
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Acidemia, Hyperpipecolic
% 207.76/207.98  |- mesh__publicMeSHNote mesh__D018901 96   
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Dysfunction, Multiple Peroxisomal
% 207.76/207.98  |- skos__historyNote mesh__D018901
% 207.76/207.98       Lipid Metabolism, Inborn Errors %28%1988-1995%29%
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Adrenoleukodystrophies, Neonatal
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 Peroxisomal Dysfunctions, Single
% 207.76/207.98  |- skos__hiddenLabel mesh__D018901 General Peroxisomal Dysfunction
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D018901 2004
% 207.76/207.99  |- skos__historyNote mesh__D018103 Paramyxoviridae %28%1983-1993%29%
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D018103 2004
% 207.76/207.99  |- mesh__publicMeSHNote mesh__D018103
% 207.76/207.99       94; MORBILLI VIRUS was see MEASLES VIRUS 1975-93   
% 207.76/207.99  |- skos__scopeNote mesh__D018103
% 207.76/207.99       A genus of the family PARAMYXOVIRIDAE %28%subfamily PARAMYXOVIRINAE%29% where the virions of most members have hemagglutinin but not neuraminidase activity. All members produce both cytoplasmic and intranuclear inclusion bodies. MEASLES VIRUS is the type species.%A%    
% 207.76/207.99  |- mesh__onlineNote mesh__D018103
% 207.76/207.99       use MEASLES VIRUS to search MORBILLI VIRUS 1975-93   
% 207.76/207.99  |- mesh__recordOriginator mesh__D018103 AGS
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D018103 2005
% 207.76/207.99  |- skos__historyNote mesh__D018103 specific Morbillivirus %28%1979-1993%29%
% 207.76/207.99  |- skos__altLabel mesh__D018103 Morbilli Virus
% 207.76/207.99  |- mesh__dateEstablished mesh__D018103 1994-01-01
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D018103 2002
% 207.76/207.99  |- mesh__dateRevised mesh__D018103 2001-08-03
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D018103 2006
% 207.76/207.99  |- skos__hiddenLabel mesh__D018103 Morbilliviruses
% 207.76/207.99  |- mesh__historyNote mesh__D018103
% 207.76/207.99       94; MORBILLI VIRUS was see MEASLES VIRUS 1975-93   
% 207.76/207.99  |- skos__annotation mesh__D018103
% 207.76/207.99       %22%morbilli virus%22% sometimes refers to the genus Morbillivirus %26% sometimes to MEASLES VIRUS: check text; infection = MORBILLIVIRUS INFECTIONS%A%  
% 207.76/207.99  |- mesh__recordMaintainer mesh__D018103 sjn
% 207.76/207.99  |- skos__broader mesh__D018103smesh__D018098
% 207.76/207.99  |- mesh__dateCreated mesh__D018103 1993-06-04
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D018103 2003
% 207.76/207.99  |- skos__prefLabel mesh__D018103 Morbillivirus
% 207.76/207.99  |- mesh__recordAuthorizer mesh__D018103 sjn
% 207.76/207.99  |- rdf__type mesh__D018103sskos__Concept
% 207.76/207.99  |- mesh__recordAuthorizer mesh__D010120 sjn
% 207.76/207.99  |- skos__altLabel mesh__D010120 Oxytocic Drugs
% 207.76/207.99  |- rdf__type mesh__D010120sskos__Concept
% 207.76/207.99  |- mesh__recordOriginator mesh__D010120 NLM
% 207.76/207.99  |- skos__hiddenLabel mesh__D010120 Drugs, Oxytocic
% 207.76/207.99  |- mesh__dateCreated mesh__D010120 1999-01-01
% 207.76/207.99  |- skos__hiddenLabel mesh__D010120 Agents, Oxytocic
% 207.76/207.99  |- skos__broader mesh__D010120smesh__D012102
% 207.76/207.99  |- skos__annotation mesh__D010120
% 207.76/207.99       no qualif for oxytocics when used to induce labor   
% 207.76/207.99  |- skos__hiddenLabel mesh__D010120 Stimulants, Uterine
% 207.76/207.99  |- skos__scopeNote mesh__D010120
% 207.76/207.99       Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions %28%ABORTIFACIENTS%29%. Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. %28%From AMA Drug Evaluations, 1994, p1157%29%%A%    
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D010120 2006
% 207.76/207.99  |- skos__altLabel mesh__D010120 Uterine Stimulants
% 207.76/207.99  |- skos__altLabel mesh__D010120 Oxytocic Agents
% 207.76/207.99  |- mesh__dateRevised mesh__D010120 2005-06-30
% 207.76/207.99  |- mesh__recordMaintainer mesh__D010120 ssb
% 207.76/207.99  |- skos__prefLabel mesh__D010120 Oxytocics
% 207.76/207.99  |- skos__altLabel mesh__D051537 Hepatic Nuclear Factor 1
% 207.76/207.99  |- mesh__recordMaintainer mesh__D051537 DRC
% 207.76/207.99  |- skos__prefLabel mesh__D051537 Hepatocyte Nuclear Factor 1
% 207.76/207.99  |- mesh__recordOriginator mesh__D051537 DRC
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D051537 2006
% 207.76/207.99  |- skos__scopeNote mesh__D051537
% 207.76/207.99       A transcription factor that regulates the expression of a large set of hepatic proteins including SERUM ALBUMIN; beta-fibrinogen; and ALPHA 1-ANTITRYPSIN. It is composed of hetero- or homo-dimers of HEPATOCYTE NUCLEAR FACTOR 1-ALPHA and HEPATOCYTE NUCLEAR FACTOR 1-BETA.%A%    
% 207.76/207.99  |- mesh__recordAuthorizer mesh__D051537 sjn
% 207.76/207.99  |- mesh__dateEstablished mesh__D051537 2006-01-01
% 207.76/207.99  |- skos__altLabel mesh__D051537 HNF-1 Protein
% 207.76/207.99  |- mesh__dateCreated mesh__D051537 2005-07-06
% 207.76/207.99  |- skos__hiddenLabel mesh__D051537 HNF 1 Protein
% 207.76/207.99  |- mesh__publicMeSHNote mesh__D051537
% 207.76/207.99       2006; HEPATOCYTE NUCLEAR FACTOR 1 was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1989-2005%A%  
% 207.76/207.99  |- skos__broader mesh__D051537smesh__D051536
% 207.76/207.99  |- rdf__type mesh__D051537sskos__Concept
% 207.76/207.99  |- skos__altLabel mesh__D051537 HNF1 Transcription Factor
% 207.76/207.99  |- mesh__historyNote mesh__D051537 2006%28%1989%29%   
% 207.76/207.99  |- skos__hiddenLabel mesh__D051537 Transcription Factor, HNF1
% 207.76/207.99  |- skos__hiddenLabel mesh__D009377 Adenopathy, Multiple Endocrine
% 207.76/207.99  |- skos__prefLabel mesh__D009377 Multiple Endocrine Neoplasia
% 207.76/207.99  |- skos__hiddenLabel mesh__D009377 Multiple Endocrine Adenomatoses
% 207.76/207.99  |- skos__altLabel mesh__D009377 Neoplasms, Multiple Endocrine
% 207.76/207.99  |- skos__hiddenLabel mesh__D009377 Endocrine Adenopathy, Multiple
% 207.76/207.99  |- skos__scopeNote mesh__D009377
% 207.76/207.99       A group of autosomal dominant diseases characterized by the combined occurrence of tumors involving two or more ENDOCRINE GLANDS that secrete PEPTIDE HORMONES or AMINES. These neoplasias are often benign but can be malignant. They are classified by the endocrine glands involved and the degree of aggressiveness. The two major forms are MEN1 and MEN2 with gene mutations on CHROMOSOME 11 and CHROMOSOME 10, respectively.%A%    
% 207.76/207.99  |- mesh__dateEstablished mesh__D009377 1965-01-01
% 207.76/207.99  |- skos__broader mesh__D009377smesh__D009378
% 207.76/207.99  |- mesh__publicMeSHNote mesh__D009377
% 207.76/207.99       95; was NEOPLASMS, MULTIPLE ENDOCRINE 1983-94; was ADENOMATOSIS, FAMILIAL ENDOCRINE 1965-82%A%  
% 207.76/207.99  |- skos__altLabel mesh__D009377 Multiple Endocrine Neoplasia Syndromes
% 207.76/207.99  |- skos__hiddenLabel mesh__D009377 Endocrine Adenopathies, Multiple
% 207.76/207.99  |- rdf__type mesh__D009377sskos__Concept
% 207.76/207.99  |- mesh__recordMaintainer mesh__D009377 lkt
% 207.76/207.99  |- skos__altLabel mesh__D009377 Endocrine Neoplasia, Multiple
% 207.76/207.99  |- skos__broader mesh__D009377smesh__D009386
% 207.76/207.99  |- skos__altLabel mesh__D009377 Multiple Endocrine Neoplasms
% 207.76/207.99  |- mesh__recordOriginator mesh__D009377 NLM
% 207.76/207.99  |- skos__altLabel mesh__D009377 Multiple Endocrine Adenopathy
% 207.76/207.99  |- skos__annotation mesh__D009377
% 207.76/207.99       general or unspecified; prefer specifics; coordinate IM with specific endocrine/neoplasm pre-coordinates %28%IM%29% + specific histological type %28%IM%29% if pertinent; DF MULTIPLE ENDOCRINE NEOPL%A%  
% 207.76/207.99  |- skos__hiddenLabel mesh__D009377 Endocrine Adenomatosis, Familial
% 207.76/207.99  |- mesh__dateRevised mesh__D009377 2005-06-30
% 207.76/207.99  |- mesh__recordAuthorizer mesh__D009377 sjn
% 207.76/207.99  |- mesh__dateCreated mesh__D009377 1999-01-01
% 207.76/207.99  |- skos__hiddenLabel mesh__D009377 Multiple Endocrine Adenopathies
% 207.76/207.99  |- skos__altLabel mesh__D009377 Neoplasia, Multiple Endocrine
% 207.76/207.99  |- skos__hiddenLabel mesh__D009377 Familial Endocrine Adenomatosis
% 207.76/207.99  |- skos__hiddenLabel mesh__D009377 Endocrine Adenomatoses, Multiple
% 207.76/207.99  |- skos__altLabel mesh__D009377 Adenomatosis, Familial Endocrine
% 207.76/207.99  |- skos__hiddenLabel mesh__D009377 Familial Endocrine Adenomatoses
% 207.76/207.99  |- skos__hiddenLabel mesh__D009377 Adenomatoses, Multiple Endocrine
% 207.76/207.99  |- skos__hiddenLabel mesh__D009377 Endocrine Neoplasms, Multiple
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D009377 2006
% 207.76/207.99  |- skos__hiddenLabel mesh__D009377 Endocrine Adenomatosis, Multiple
% 207.76/207.99  |- skos__hiddenLabel mesh__D009377 Multiple Endocrine Adenomatosis
% 207.76/207.99  |- skos__hiddenLabel mesh__D009377 Endocrine Adenomatoses, Familial
% 207.76/207.99  |- mesh__onlineNote mesh__D009377
% 207.76/207.99       use MULTIPLE ENDOCRINE NEOPLASIA to search NEOPLASMS, MULTIPLE ENDOCRINE 1983-94 %26% ADENOMATOSIS, FAMILIAL ENDOCRINE 1966-82%A%  
% 207.76/207.99  |- skos__hiddenLabel mesh__D009377 Adenomatoses, Familial Endocrine
% 207.76/207.99  |- skos__altLabel mesh__D009377 Adenomatosis, Multiple Endocrine
% 207.76/207.99  |- skos__hiddenLabel mesh__D009377 Adenopathies, Multiple Endocrine
% 207.76/207.99  |- mesh__historyNote mesh__D009377
% 207.76/207.99       95; was NEOPLASMS, MULTIPLE ENDOCRINE 1983-94; was ADENOMATOSIS, FAMILIAL ENDOCRINE 1965-82 %28%Prov 1964%29%%A%  
% 207.76/207.99  |- skos__broader mesh__D009377smesh__D004701
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D001394 2005
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D001394 2000
% 207.76/207.99  |- mesh__recordOriginator mesh__D001394 NLM
% 207.76/207.99  |- skos__broader mesh__D001394smesh__D001266
% 207.76/207.99  |- mesh__dateCreated mesh__D001394 1999-01-01
% 207.76/207.99  |- rdf__type mesh__D001394sskos__Concept
% 207.76/207.99  |- mesh__dateRevised mesh__D001394 1995-02-17
% 207.76/207.99  |- skos__prefLabel mesh__D001394 Azores
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D001394 1997
% 207.76/207.99  |- skos__scopeNote mesh__D001394
% 207.76/207.99       A group of nine islands and several islets belonging to Portugal in the north Atlantic Ocean off the coast of Portugal. The islands are named after the acores, the Portuguese for goshawks, living there in abundance. %28%Webster%27%s New Geographical Dictionary, 1988, p102 %26% Room, Brewer%27%s Dictionary of Names, 1992, p42%29%%A%    
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D001394 1999
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D001394 1996
% 207.76/207.99  |- skos__annotation mesh__D001394
% 207.76/207.99       a group of 9 Atlantic islands off the coast of Portugal   
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D001394 1998
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D001394 2002
% 207.76/207.99  |- mesh__recordMaintainer mesh__D001394 TGC
% 207.76/207.99  |- mesh__recordAuthorizer mesh__D001394 PLS
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D001394 2004
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D001394 2001
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D001394 2006
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D001394 2003
% 207.76/207.99  |- mesh__recordOriginator mesh__D017809 TGC
% 207.76/207.99  |- skos__prefLabel mesh__D017809 Fatal Outcome
% 207.76/207.99  |- mesh__dateRevised mesh__D017809 2004-07-07
% 207.76/207.99  |- mesh__historyNote mesh__D017809 94   
% 207.76/207.99  |- mesh__recordAuthorizer mesh__D017809 sjn
% 207.76/207.99  |- skos__hiddenLabel mesh__D017809 Outcomes, Fatal
% 207.76/207.99  |- mesh__recordMaintainer mesh__D017809 lkt
% 207.76/207.99  |- skos__hiddenLabel mesh__D017809 Fatal Outcomes
% 207.76/207.99  |- skos__broader mesh__D017809smesh__D009026
% 207.76/207.99  |- skos__scopeNote mesh__D017809
% 207.76/207.99       Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.%A%    
% 207.76/207.99  |- rdf__type mesh__D017809sskos__Concept
% 207.76/207.99  |- skos__related mesh__D017809smesh__D003643
% 207.76/207.99  |- skos__hiddenLabel mesh__D017809 Outcome, Fatal
% 207.76/207.99  |- skos__historyNote mesh__D017809 specific disease %28%1966-1993%29%
% 207.76/207.99  |- mesh__dateCreated mesh__D017809 1993-05-28
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D017809 2006
% 207.76/207.99  |- skos__annotation mesh__D017809
% 207.76/207.99       never IM; used only for individual fatalities: do not confuse with MORTALITY or /mortal, both epidemiological %26% statistical concepts, or with DEATH, a physiological process; do not use for animal toxicity studies %28% = /toxicity%29%; coordinate with specific disease or procedure with no qualifiers %28%IM%29%; index CASE REPORTS %5B%Publication Type%5D%%A%  
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D017809 2005
% 207.76/207.99  |- mesh__publicMeSHNote mesh__D017809 94   
% 207.76/207.99  |- skos__historyNote mesh__D017809 specific procedure %28%1966-1993%29%
% 207.76/207.99  |- mesh__dateEstablished mesh__D017809 1994-01-01
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D014511 2001
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D014511 2006
% 207.76/207.99  |- mesh__recordMaintainer mesh__D014511 RAZ
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D014511 2002
% 207.76/207.99  |- skos__hiddenLabel mesh__D014511 Azotemias
% 207.76/207.99  |- skos__prefLabel mesh__D014511 Uremia
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D014511 1996
% 207.76/207.99  |- mesh__recordAuthorizer mesh__D014511 PLS
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D014511 1997
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D014511 2003
% 207.76/207.99  |- skos__annotation mesh__D014511
% 207.76/207.99       azotemia in foreign lit means often UREMIA %26% often BLOOD UREA NITROGEN%A%  
% 207.76/207.99  |- mesh__recordOriginator mesh__D014511 NLM
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D014511 1998
% 207.76/207.99  |- skos__broader mesh__D014511smesh__D007674
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D014511 2004
% 207.76/207.99  |- rdf__type mesh__D014511sskos__Concept
% 207.76/207.99  |- mesh__dateRevised mesh__D014511 1995-06-09
% 207.76/207.99  |- mesh__dateCreated mesh__D014511 1999-01-01
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D014511 1999
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D014511 2000
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D014511 2005
% 207.76/207.99  |- skos__hiddenLabel mesh__D014511 Uremias
% 207.76/207.99  |- mesh__recordAuthorizer mesh__D005785 sjn
% 207.76/207.99  |- skos__hiddenLabel mesh__D005785 Polar Recombinations
% 207.76/207.99  |- skos__historyNote mesh__D005785 Mutation %28%1966-1979%29%
% 207.76/207.99  |- mesh__publicMeSHNote mesh__D005785 80   
% 207.76/207.99  |- skos__hiddenLabel mesh__D005785 Gene Conversions
% 207.76/207.99  |- skos__hiddenLabel mesh__D005785 Recombinations, Polar
% 207.76/207.99  |- skos__hiddenLabel mesh__D005785 Conversions, Gene
% 207.76/207.99  |- mesh__recordOriginator mesh__D005785 AEP
% 207.76/207.99  |- skos__hiddenLabel mesh__D005785 Recombination, Polar
% 207.76/207.99  |- skos__historyNote mesh__D005785 Recombination, Genetic %28%1968-1979%29%
% 207.76/207.99  |- skos__hiddenLabel mesh__D005785 Polarons
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D005785 2004
% 207.76/207.99  |- mesh__dateRevised mesh__D005785 2002-07-03
% 207.76/207.99  |- mesh__recordMaintainer mesh__D005785 KEV
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D005785 2006
% 207.76/207.99  |- mesh__dateCreated mesh__D005785 1979-05-23
% 207.76/207.99  |- mesh__historyNote mesh__D005785 80   
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D005785 2003
% 207.76/207.99  |- skos__scopeNote mesh__D005785
% 207.76/207.99       The asymmetrical segregation of genes during replication which leads to the production of non-reciprocal recombinant strands and the apparent conversion of one allele into another. Thus, e.g., the meiotic products of an Aa individual may be AAAa or aaaA instead of AAaa, i.e., the A allele has been converted into the a allele or vice versa.%A%    
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D005785 2005
% 207.76/207.99  |- rdf__type mesh__D005785sskos__Concept
% 207.76/207.99  |- skos__hiddenLabel mesh__D005785 Conversion, Gene
% 207.76/207.99  |- mesh__dateEstablished mesh__D005785 1980-01-01
% 207.76/207.99  |- skos__broader mesh__D005785smesh__D011995
% 207.76/207.99  |- skos__prefLabel mesh__D005785 Gene Conversion
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D038161 2004
% 207.76/207.99  |- mesh__dateCreated mesh__D038161 2002-07-03
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D038161 2003
% 207.76/207.99  |- mesh__dateEstablished mesh__D038161 2003-01-01
% 207.76/207.99  |- skos__broader mesh__D038161smesh__D013177
% 207.76/207.99  |- skos__prefLabel mesh__D038161 Snow Sports
% 207.76/207.99  |- rdf__type mesh__D038161sskos__Concept
% 207.76/207.99  |- skos__scopeNote mesh__D038161 Sports activities in the snow.     
% 207.76/207.99  |- skos__historyNote mesh__D038161 Skiing %28%1963-2002%29%
% 207.76/207.99  |- skos__hiddenLabel mesh__D038161 Sports, Snow
% 207.76/207.99  |- skos__hiddenLabel mesh__D038161 Sport, Snow
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D038161 2006
% 207.76/207.99  |- skos__annotation mesh__D038161
% 207.76/207.99       /inj: coord with specific injury %28%IM%29%   
% 207.76/207.99  |- mesh__publicMeSHNote mesh__D038161 2003   
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D038161 2005
% 207.76/207.99  |- mesh__historyNote mesh__D038161 2003   
% 207.76/207.99  |- skos__hiddenLabel mesh__D038161 Snow Sport
% 207.76/207.99  |- rdf__type mesh__D013419sskos__Concept
% 207.76/207.99  |- skos__altLabel mesh__D013419 Wyeth Brand of Sulfamethizole
% 207.76/207.99  |- skos__prefLabel mesh__D013419 Sulfamethizole
% 207.76/207.99  |- mesh__publicMeSHNote mesh__D013419
% 207.76/207.99       91; was see under SULFATHIAZOLES 1963-90   
% 207.76/207.99  |- skos__altLabel mesh__D013419 Sulphamethizole
% 207.76/207.99  |- skos__altLabel mesh__D013419 Urgo Brand of Sulfamethizole
% 207.76/207.99  |- mesh__historyNote mesh__D013419
% 207.76/207.99       91%28%63%29%; was see under SULFATHIAZOLES 1963-90   
% 207.76/207.99  |- mesh__recordAuthorizer mesh__D013419 sjn
% 207.76/207.99  |- mesh__dateRevised mesh__D013419 2005-06-30
% 207.76/207.99  |- mesh__recordMaintainer mesh__D013419 CCR
% 207.76/207.99  |- mesh__recordOriginator mesh__D013419 NLM
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D013419 2006
% 207.76/207.99  |- skos__altLabel mesh__D013419 FNA Brand of Sulfamethizole
% 207.76/207.99  |- mesh__dateCreated mesh__D013419 1999-01-01
% 207.76/207.99  |- skos__broader mesh__D013419smesh__D013432
% 207.76/207.99  |- skos__scopeNote mesh__D013419 A sulfathiazole antibacterial agent.     
% 207.76/207.99  |- skos__hiddenLabel mesh__D013419 FNA, Sulfamethizol
% 207.76/207.99  |- mesh__dateEstablished mesh__D013419 1991-01-01
% 207.76/207.99  |- skos__scopeNote mesh__D024141
% 207.76/207.99       A non-fibrillar collagen found in the structure of BASEMENT MEMBRANE. Collagen type IV molecules assemble to form a sheet-like network which is involved in maintaining the structural integrity of basement membranes.  The predominant form of the protein is comprised of two alpha1%28%IV%29% subunits and one alpha2%28%IV%29% subunit, however, at least six different alpha subunits can be incorporated into the heterotrimer.%A%    
% 207.76/207.99  |- skos__altLabel mesh__D024141 Type IV Collagen
% 207.76/207.99  |- skos__annotation mesh__D024141
% 207.76/207.99       precursors: coord IM with PROCOLLAGEN %28%IM%29%   
% 207.76/207.99  |- skos__historyNote mesh__D024141 Collagen %28%1978-2001%29%
% 207.76/207.99  |- mesh__historyNote mesh__D024141
% 207.76/207.99       2002; use COLLAGEN 1990-2001; for PROCOLLAGEN TYPE IV use PROCOLLAGEN 1982-2001; for 7S COLLAGEN use COLLAGEN 1982-2001%A%  
% 207.76/207.99  |- skos__altLabel mesh__D024141 Collagen Type IV, alpha2 Chain
% 207.76/207.99  |- mesh__publicMeSHNote mesh__D024141
% 207.76/207.99       2002; see COLLAGEN 1990-2001; for PROCOLLAGEN TYPE IV see PROCOLLAGEN 1982-2001; for 7S COLLAGEN see COLLAGEN 1982-2001%A%  
% 207.76/207.99  |- skos__hiddenLabel mesh__D024141 Collagen, Type IV
% 207.76/207.99  |- skos__hiddenLabel mesh__D024141 Collagen, 7S
% 207.76/207.99  |- skos__prefLabel mesh__D024141 Collagen Type IV
% 207.76/207.99  |- mesh__dateRevised mesh__D024141 2004-07-07
% 207.76/207.99  |- mesh__dateCreated mesh__D024141 2001-07-25
% 207.76/207.99  |- mesh__dateEstablished mesh__D024141 2002-01-01
% 207.76/207.99  |- skos__altLabel mesh__D024141 Type IV %28%Basement Membrane%29% Collagen
% 207.76/207.99  |- skos__altLabel mesh__D024141 alpha1%28%IV%29% collagen
% 207.76/207.99  |- rdf__type mesh__D024141sskos__Concept
% 207.76/207.99  |- skos__broader mesh__D024141smesh__D024041
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D024141 2006
% 207.76/207.99  |- skos__hiddenLabel mesh__D024141 Procollagen, Type IV
% 207.76/207.99  |- skos__altLabel mesh__D024141 Collagen alpha1%28%IV%29%
% 207.76/207.99  |- mesh__recordOriginator mesh__D024141 jmp
% 207.76/207.99  |- mesh__recordAuthorizer mesh__D024141 sjn
% 207.76/207.99  |- skos__altLabel mesh__D024141 Type IV Procollagen
% 207.76/207.99  |- skos__altLabel mesh__D024141 Collagen Type IV, alpha1 Chain
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D024141 2005
% 207.76/207.99  |- mesh__recordMaintainer mesh__D024141 jmp
% 207.76/207.99  |- skos__historyNote mesh__D018902
% 207.76/207.99       Chondrodysplasia Punctata %28%1971-1995%29%
% 207.76/207.99  |- skos__annotation mesh__D018902
% 207.76/207.99       a form of osteochondrodysplasia with stippled epiphyses; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D018902 2006
% 207.76/207.99  |- mesh__publicMeSHNote mesh__D018902 96   
% 207.76/207.99  |- skos__scopeNote mesh__D018902
% 207.76/207.99       An autosomal recessive form of CHONDRODYSPLASIA PUNCTATA characterized by defective plasmalogen biosynthesis and impaired peroxisomes. Patients have shortened proximal limbs and severely disturbed endochondral bone formation. The metabolic defects associated with the impaired peroxisomes are present only in the rhizomelic form of chondrodysplasia punctata. %28%From Scriver et al, Metabolic Basis of Inherited Disease, 6th ed, p1497%29%%A%    
% 207.76/207.99  |- mesh__recordMaintainer mesh__D018902 jls
% 207.76/207.99  |- skos__broader mesh__D018902smesh__D002806
% 207.76/207.99  |- mesh__recordAuthorizer mesh__D018902 sjn
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D018902 2005
% 207.76/207.99  |- skos__altLabel mesh__D018902 Rhizomelic Chondrodysplasia Punctata
% 207.76/207.99  |- mesh__dateRevised mesh__D018902 2004-07-19
% 207.76/207.99  |- skos__hiddenLabel mesh__D018902 Punctata, Rhizomelic Chondrodysplasia
% 207.76/207.99  |- mesh__dateEstablished mesh__D018902 1996-01-01
% 207.76/207.99  |- mesh__dateCreated mesh__D018902 1994-12-27
% 207.76/207.99  |- skos__broader mesh__D018902smesh__D018901
% 207.76/207.99  |- skos__prefLabel mesh__D018902 Chondrodysplasia Punctata, Rhizomelic
% 207.76/207.99  |- mesh__historyNote mesh__D018902 96   
% 207.76/207.99  |- mesh__recordOriginator mesh__D018902 AGS
% 207.76/207.99  |- rdf__type mesh__D018902sskos__Concept
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D018104 2005
% 207.76/207.99  |- skos__hiddenLabel mesh__D018104 Seal Distemper Viruses
% 207.76/207.99  |- skos__historyNote mesh__D018104 Paramyxoviridae %28%1989-1993%29%
% 207.76/207.99  |- skos__hiddenLabel mesh__D018104 Distemper Viruses, Seal
% 207.76/207.99  |- skos__hiddenLabel mesh__D018104 Distemper Virus, Seal
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D018104 2006
% 207.76/207.99  |- mesh__recordAuthorizer mesh__D018104 sjn
% 207.76/207.99  |- skos__hiddenLabel mesh__D018104 Phocid Distemper Virus
% 207.76/207.99  |- mesh__dateCreated mesh__D018104 1993-06-03
% 207.76/207.99  |- mesh__recordMaintainer mesh__D018104 ags
% 207.76/207.99  |- skos__hiddenLabel mesh__D018104 Phocine Distemper Viruses
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D018104 2003
% 207.76/207.99  |- mesh__dateRevised mesh__D018104 2001-07-25
% 207.76/207.99  |- rdf__type mesh__D018104sskos__Concept
% 207.76/207.99  |- skos__scopeNote mesh__D018104
% 207.76/207.99       A species of MORBILLIVIRUS causing distemper in seals.     
% 207.76/207.99  |- skos__hiddenLabel mesh__D018104 Distemper Viruses, Phocine
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D018104 2004
% 207.76/207.99  |- skos__altLabel mesh__D018104 Distemper Virus, Phocid
% 207.76/207.99  |- skos__altLabel mesh__D018104 Phocine distemper virus
% 207.76/207.99  |- skos__broader mesh__D018104smesh__D018103
% 207.76/207.99  |- mesh__dateEstablished mesh__D018104 1994-01-01
% 207.76/207.99  |- mesh__publicMeSHNote mesh__D018104 94   
% 207.76/207.99  |- mesh__recordOriginator mesh__D018104 AGS
% 207.76/207.99  |- mesh__historyNote mesh__D018104 94   
% 207.76/207.99  |- skos__annotation mesh__D018104
% 207.76/207.99       infection: coord IM with DISTEMPER %28%IM%29%; DISTEMPER VIRUS, CANINE is also available%A%  
% 207.76/207.99  |- skos__prefLabel mesh__D018104 Distemper Virus, Phocine
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D018104 2002
% 207.76/207.99  |- skos__hiddenLabel mesh__D018104 Distemper Viruses, Phocid
% 207.76/207.99  |- skos__hiddenLabel mesh__D018104 Phocid Distemper Viruses
% 207.76/207.99  |- skos__altLabel mesh__D018104 Seal Distemper Virus
% 207.76/207.99  |- skos__broader mesh__D010121smesh__D010909
% 207.76/207.99  |- skos__altLabel mesh__D010121 Ocytocin
% 207.76/207.99  |- mesh__dateRevised mesh__D010121 2005-06-30
% 207.76/207.99  |- mesh__recordMaintainer mesh__D010121 ssb
% 207.76/207.99  |- mesh__dateCreated mesh__D010121 1999-01-01
% 207.76/207.99  |- mesh__onlineNote mesh__D010121
% 207.76/207.99       use OXYTOCIN to search ALPHA-HYPOPHAMINE 1977-93 %26% ISOLEUCYL, LEUCYL VASOPRESSIN; VASOPRESSIN, ISOLEUCYL-LEUCYL; VASOTOCIN, LEUCYL, %26% 3-ISOLEUCINE,8-LEUCINE VASOPRESSIN 1983-93%A%  
% 207.76/207.99  |- skos__broader mesh__D010121smesh__D014667
% 207.76/207.99  |- mesh__recordAuthorizer mesh__D010121 sjn
% 207.76/207.99  |- mesh__publicMeSHNote mesh__D010121
% 207.76/207.99       ALPHA-HYPOPHAMINE was see OXYTOCIN 1977-93; ISOLEUCYL, LEUCYL VASOPRESSIN; VASOPRESSIN, ISOLEUCYL-LEUCYL; VASOTOCIN, LEUCYL, %26% 3-ISOLEUCINE,8-LEUCINE VASOPRESSIN were see OXYTOCIN 1983-93%A%  
% 207.76/207.99  |- skos__prefLabel mesh__D010121 Oxytocin
% 207.76/207.99  |- mesh__recordOriginator mesh__D010121 NLM
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D010121 2006
% 207.76/207.99  |- skos__scopeNote mesh__D010121
% 207.76/207.99       A nonapeptide posterior pituitary hormone that causes UTERINE CONTRACTIONS and stimulates MILK EJECTION.%A%    
% 207.76/207.99  |- skos__related mesh__D010121smesh__D018045
% 207.76/207.99  |- mesh__historyNote mesh__D010121
% 207.76/207.99       ALPHA-HYPOPHAMINE was see OXYTOCIN 1977-93; ISOLEUCYL, LEUCYL VASOPRESSIN; VASOPRESSIN, ISOLEUCYL-LEUCYL; VASOTOCIN, LEUCYL, %26% 3-ISOLEUCINE,8-LEUCINE VASOPRESSIN were see OXYTOCIN 1983-93%A%  
% 207.76/207.99  |- rdf__type mesh__D010121sskos__Concept
% 207.76/207.99  |- skos__altLabel mesh__D051538 Liver-Specific Transcription Factor LF-B1
% 207.76/207.99  |- mesh__recordOriginator mesh__D051538 DRC
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D051538 2006
% 207.76/207.99  |- mesh__dateCreated mesh__D051538 2005-06-30
% 207.76/207.99  |- skos__prefLabel mesh__D051538 Hepatocyte Nuclear Factor 1-alpha
% 207.76/207.99  |- skos__hiddenLabel mesh__D051538 Hepatocyte Nuclear Factor 1 alpha
% 207.76/207.99  |- mesh__recordMaintainer mesh__D051538 DRC
% 207.76/207.99  |- skos__hiddenLabel mesh__D051538
% 207.76/207.99       Liver Specific Transcription Factor LF B1
% 207.76/207.99  |- skos__broader mesh__D051538smesh__D051537
% 207.76/207.99  |- skos__hiddenLabel mesh__D051538 HNF 1alpha
% 207.76/207.99  |- skos__altLabel mesh__D051538 HNF-1alpha
% 207.76/207.99  |- rdf__type mesh__D051538sskos__Concept
% 207.76/207.99  |- skos__scopeNote mesh__D051538
% 207.76/207.99       Hepatocyte nuclear factor 1-alpha is a transcription factor found in the LIVER; PANCREAS; and KIDNEY that regulates HOMEOSTASIS of GLUCOSE.%A%    
% 207.76/207.99  |- mesh__recordAuthorizer mesh__D051538 sjn
% 207.76/207.99  |- mesh__publicMeSHNote mesh__D051538
% 207.76/207.99       2006; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1989-2005%A%  
% 207.76/207.99  |- skos__altLabel mesh__D051538 LFB1 Transcription Factor
% 207.76/207.99  |- skos__altLabel mesh__D051538 Hepatocyte Nuclear Factor 1alpha
% 207.76/207.99  |- mesh__dateEstablished mesh__D051538 2006-01-01
% 207.76/207.99  |- mesh__historyNote mesh__D051538 2006%28%1989%29%   
% 207.76/207.99  |- skos__altLabel mesh__D051538 Albumin Proximal Factor
% 207.76/207.99  |- skos__scopeNote mesh__D009378
% 207.76/207.99       Two or more abnormal growths of tissue occurring simultaneously. The neoplasms are histologically different and may be found in the same or different sites.%A%    
% 207.76/207.99  |- skos__altLabel mesh__D009378 Synchronous Multiple Primary Neoplasms
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D009378 1999
% 207.76/207.99  |- mesh__recordOriginator mesh__D009378 NLM
% 207.76/207.99  |- skos__hiddenLabel mesh__D009378 Synchronous Neoplasm
% 207.76/207.99  |- skos__related mesh__D009378smesh__D016609
% 207.76/207.99  |- skos__hiddenLabel mesh__D009378 Multiple Primary Neoplasm
% 207.76/207.99  |- skos__hiddenLabel mesh__D009378 Primary Neoplasms, Multiple
% 207.76/207.99  |- skos__hiddenLabel mesh__D009378 Primary Neoplasm, Multiple
% 207.76/207.99  |- skos__altLabel mesh__D009378 Synchronous Neoplasms
% 207.76/207.99  |- mesh__dateCreated mesh__D009378 1999-01-01
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D009378 1998
% 207.76/207.99  |- mesh__publicMeSHNote mesh__D009378 65   
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D009378 2002
% 207.76/207.99  |- skos__altLabel mesh__D009378 Multiple Primary Neoplasms
% 207.76/207.99  |- mesh__activeMeSHYear mesh__D009378 2004
% 207.76/207.99  |- mesh__dateRevised mesh__D009378 1996-06-10
% 207.76/207.99  |- rdf__type mesh__D009378sskos__Concept
% 207.76/208.00  |- skos__altLabel mesh__D009378 Neoplasms, Synchronous
% 207.76/208.00  |- mesh__recordMaintainer mesh__D009378 TGC
% 207.76/208.00  |- mesh__dateEstablished mesh__D009378 1965-01-01
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D009378 2003
% 207.76/208.00  |- skos__altLabel mesh__D009378 Neoplasms, Synchronous Multiple Primary
% 207.76/208.00  |- skos__prefLabel mesh__D009378 Neoplasms, Multiple Primary
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D009378 1997
% 207.76/208.00  |- skos__annotation mesh__D009378
% 207.76/208.00       2 or more neopl, histologically different, at same or different sites occurring simultaneously: do not confuse with NEOPLASMS, SECOND PRIMARY %28%a neopl following an earlier neopl but not its metastasis%29%; coord with each specific histol type %28%IM%29% %26% each precoord organ/neopl term %28%IM%29%; do not use /compl with specific multiple neopl terms to show multiplicity; differentiate from NEOPLASM METASTASIS %26% NEOPLASM RECURRENCE, LOCAL: Manual 24.4.1.5, 24.4.1.6; MULTIPLE ENDOCRINE NEOPLASIA %26% its specifics are also available; DF: NEOPL MULTIPLE PRIMARY%A%  
% 207.76/208.00  |- skos__altLabel mesh__D009378 Multiple Primary Neoplasms, Synchronous
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D009378 2001
% 207.76/208.00  |- mesh__historyNote mesh__D009378 65   
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D009378 2006
% 207.76/208.00  |- mesh__recordAuthorizer mesh__D009378 PLS
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D009378 2000
% 207.76/208.00  |- skos__hiddenLabel mesh__D009378 Neoplasm, Synchronous
% 207.76/208.00  |- skos__hiddenLabel mesh__D009378 Neoplasm, Multiple Primary
% 207.76/208.00  |- skos__broader mesh__D009378smesh__D009369
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D009378 2005
% 207.76/208.00  |- mesh__recordAuthorizer mesh__D001395 sjn
% 207.76/208.00  |- skos__scopeNote mesh__D001395
% 207.76/208.00       A genus of gram-negative, aerobic bacteria found in soil and water. Its organisms occur singly, in pairs or irregular clumps, and sometimes in chains of varying lengths.%A%    
% 207.76/208.00  |- skos__broader mesh__D001395smesh__D001396
% 207.76/208.00  |- mesh__dateRevised mesh__D001395 2005-06-30
% 207.76/208.00  |- skos__prefLabel mesh__D001395 Azotobacter
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D001395 2006
% 207.76/208.00  |- mesh__recordOriginator mesh__D001395 NLM
% 207.76/208.00  |- mesh__recordMaintainer mesh__D001395 SYSTEM
% 207.76/208.00  |- skos__annotation mesh__D001395 in soil %26% water   
% 207.76/208.00  |- rdf__type mesh__D001395sskos__Concept
% 207.76/208.00  |- mesh__dateCreated mesh__D001395 1999-01-01
% 207.76/208.00  |- mesh__recordOriginator mesh__D006080 NLM
% 207.76/208.00  |- skos__related mesh__D006080smesh__D010063
% 207.76/208.00  |- mesh__dateCreated mesh__D006080 1999-01-01
% 207.76/208.00  |- mesh__historyNote mesh__D006080 99   
% 207.76/208.00  |- mesh__dateRevised mesh__D006080 2005-06-30
% 207.76/208.00  |- skos__altLabel mesh__D006080 Ovarian Follicles
% 207.76/208.00  |- skos__hiddenLabel mesh__D006080 Atretic Follicles
% 207.76/208.00  |- mesh__recordMaintainer mesh__D006080 lkt
% 207.76/208.00  |- skos__hiddenLabel mesh__D006080 Graafian Follicles
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D006080 2006
% 207.76/208.00  |- skos__hiddenLabel mesh__D006080 Follicle, Ovarian
% 207.76/208.00  |- skos__annotation mesh__D006080
% 207.76/208.00       /cytol: consider also THECA CELLS; GRANULOSA CELLS; for follicular development use /physiol, not /growth%A%  
% 207.76/208.00  |- skos__broader mesh__D006080smesh__D010053
% 207.76/208.00  |- skos__related mesh__D006080smesh__D006107
% 207.76/208.00  |- rdf__type mesh__D006080sskos__Concept
% 207.76/208.00  |- skos__scopeNote mesh__D006080
% 207.76/208.00       An OOCYTE-containing structure in the cortex of the OVARY. The oocyte is enclosed by a layer of GRANULOSA CELLS providing a nourishing microenvironment %28%FOLLICULAR FLUID%29%. The number and size of follicles vary depending on the age and reproductive state of the female. The growing follicles are divided into five stages: primary, secondary, tertiary, Graafian, and atretic. Follicular growth and steroidogenesis depend on the presence of GONADOTROPINS.%A%    
% 207.76/208.00  |- skos__hiddenLabel mesh__D006080 Follicles, Graafian
% 207.76/208.00  |- skos__hiddenLabel mesh__D006080 Follicle, Graafian
% 207.76/208.00  |- mesh__publicMeSHNote mesh__D006080 99; see GRAAFIAN FOLLICLE 1966-98   
% 207.76/208.00  |- skos__hiddenLabel mesh__D006080 Follicles, Atretic
% 207.76/208.00  |- skos__hiddenLabel mesh__D006080 Follicle, Atretic
% 207.76/208.00  |- mesh__recordAuthorizer mesh__D006080 sjn
% 207.76/208.00  |- skos__related mesh__D006080smesh__D013799
% 207.76/208.00  |- skos__prefLabel mesh__D006080 Ovarian Follicle
% 207.76/208.00  |- skos__hiddenLabel mesh__D006080 Follicles, Ovarian
% 207.76/208.00  |- mesh__recordOriginator mesh__D014512 NLM
% 207.76/208.00  |- mesh__dateRevised mesh__D014512 2003-07-09
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D014512 2004
% 207.76/208.00  |- rdf__type mesh__D014512sskos__Concept
% 207.76/208.00  |- mesh__dateCreated mesh__D014512 1999-01-01
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D014512 2005
% 207.76/208.00  |- mesh__recordMaintainer mesh__D014512 ssb
% 207.76/208.00  |- skos__broader mesh__D014512smesh__D006867
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D014512 2006
% 207.76/208.00  |- mesh__recordAuthorizer mesh__D014512 sjn
% 207.76/208.00  |- skos__prefLabel mesh__D014512 Ureohydrolases
% 207.76/208.00  |- skos__related mesh__D005786smesh__D002454
% 207.76/208.00  |- skos__related mesh__D005786smesh__D002868
% 207.76/208.00  |- skos__prefLabel mesh__D005786 Gene Expression Regulation
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D005786 2004
% 207.76/208.00  |- mesh__dateEstablished mesh__D005786 1981-01-01
% 207.76/208.00  |- mesh__dateRevised mesh__D005786 2002-07-02
% 207.76/208.00  |- mesh__recordAuthorizer mesh__D005786 sjn
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D005786 2006
% 207.76/208.00  |- skos__scopeNote mesh__D005786
% 207.76/208.00       Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action at the level of transcription or translation. These processes include gene activation and genetic induction.%A%    
% 207.76/208.00  |- skos__historyNote mesh__D005786 Translation, Genetic %28%1973-1980%29%
% 207.76/208.00  |- skos__altLabel mesh__D005786 Gene Action Regulation
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D005786 2003
% 207.76/208.00  |- skos__historyNote mesh__D005786 Transcription, Genetic %28%1973-1980%29%
% 207.76/208.00  |- skos__altLabel mesh__D005786 Regulation, Gene Action
% 207.76/208.00  |- mesh__dateCreated mesh__D005786 1980-04-02
% 207.76/208.00  |- skos__historyNote mesh__D005786 Genes %28%1966-1980%29%
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D005786 2005
% 207.76/208.00  |- mesh__recordOriginator mesh__D005786 AEP
% 207.76/208.00  |- skos__altLabel mesh__D005786 Expression Regulation, Gene
% 207.76/208.00  |- rdf__type mesh__D005786sskos__Concept
% 207.76/208.00  |- skos__related mesh__D005786smesh__D014157
% 207.76/208.00  |- skos__annotation mesh__D005786
% 207.76/208.00       GEN or unspecified; prefer specifics; DF: GENE EXPRESSION REG%A%  
% 207.76/208.00  |- mesh__recordMaintainer mesh__D005786 NDW
% 207.76/208.00  |- skos__related mesh__D005786smesh__D015534
% 207.76/208.00  |- skos__altLabel mesh__D005786 Regulation of Gene Expression
% 207.76/208.00  |- skos__altLabel mesh__D005786 Genetic Induction
% 207.76/208.00  |- skos__hiddenLabel mesh__D005786 Activation, Gene
% 207.76/208.00  |- skos__historyNote mesh__D005786 Genes, Regulator %28%1973-1980%29%
% 207.76/208.00  |- skos__altLabel mesh__D005786 Regulation, Gene Expression
% 207.76/208.00  |- mesh__publicMeSHNote mesh__D005786 81   
% 207.76/208.00  |- skos__broader mesh__D005786smesh__D039361
% 207.76/208.00  |- mesh__historyNote mesh__D005786 81   
% 207.76/208.00  |- mesh__recordOriginator mesh__D024142 jmp
% 207.76/208.00  |- skos__annotation mesh__D024142
% 207.76/208.00       precursors: coord IM with PROCOLLAGEN %28%IM%29%   
% 207.76/208.00  |- mesh__recordAuthorizer mesh__D024142 sjn
% 207.76/208.00  |- skos__historyNote mesh__D024142 Collagen %28%1985-2001%29%
% 207.76/208.00  |- skos__scopeNote mesh__D024142
% 207.76/208.00       A non-fibrillar collagen that forms a network of MICROFIBRILS within the EXTRACELLULAR MATRIX of CONNECTIVE TISSUE. The alpha subunits of collagen type VI assemble into antiparallel, overlapping dimers which then align to form tetramers.%A%    
% 207.76/208.00  |- mesh__publicMeSHNote mesh__D024142 2002; see COLLAGEN 1990-2001   
% 207.76/208.00  |- skos__altLabel mesh__D024142 Collagen Type-VI, alpha2 Chain
% 207.76/208.00  |- skos__hiddenLabel mesh__D024142 Procollagen, Type VI
% 207.76/208.00  |- skos__altLabel mesh__D024142 Type VI %28%Intima%29% Collagen
% 207.76/208.00  |- mesh__dateRevised mesh__D024142 2004-07-07
% 207.76/208.00  |- mesh__dateEstablished mesh__D024142 2002-01-01
% 207.76/208.00  |- rdf__type mesh__D024142sskos__Concept
% 207.76/208.00  |- skos__altLabel mesh__D024142 Collagen alpha3%28%VI%29%
% 207.76/208.00  |- skos__altLabel mesh__D024142 Collagen alpha1%28%VI%29%
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D024142 2006
% 207.76/208.00  |- skos__altLabel mesh__D024142 Collagen Type VI, alpha3 Chain
% 207.76/208.00  |- skos__altLabel mesh__D024142 Type VI Procollagen
% 207.76/208.00  |- skos__hiddenLabel mesh__D024142 Collagen, Type VI
% 207.76/208.00  |- skos__hiddenLabel mesh__D024142 Collagen Type VI, alpha2 Chain
% 207.76/208.00  |- skos__altLabel mesh__D024142 Collagen alpha2%28%VI%29%
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D024142 2005
% 207.76/208.00  |- skos__prefLabel mesh__D024142 Collagen Type VI
% 207.76/208.00  |- skos__altLabel mesh__D024142 Type VI Collagen
% 207.76/208.00  |- mesh__recordMaintainer mesh__D024142 jmp
% 207.76/208.00  |- skos__altLabel mesh__D024142 Intima Collagen
% 207.76/208.00  |- mesh__dateCreated mesh__D024142 2001-07-25
% 207.76/208.00  |- skos__altLabel mesh__D024142 Collagen Type VI, alpha1 Chain
% 207.76/208.00  |- skos__hiddenLabel mesh__D024142 Collagen, Intima
% 207.76/208.00  |- skos__broader mesh__D024142smesh__D024041
% 207.76/208.00  |- mesh__historyNote mesh__D024142 2002; use COLLAGEN 1990-2001   
% 207.76/208.00  |- skos__altLabel mesh__D018903
% 207.76/208.00       Keratectomy, Phototherapeutic, Excimer Laser
% 207.76/208.00  |- skos__prefLabel mesh__D018903
% 207.76/208.00       Keratectomy, Photorefractive, Excimer Laser
% 207.76/208.00  |- skos__scopeNote mesh__D018903
% 207.76/208.00       A type of refractive surgery of the CORNEA to correct MYOPIA and ASTIGMATISM. An excimer laser is used directly on the surface of the EYE to remove the CORNEAL EPITHELIUM in order to reshape the anterior curvature of the cornea.%A%    
% 207.76/208.00  |- skos__historyNote mesh__D018903 Cornea/surgery %28%1983-1995%29%
% 207.76/208.00  |- skos__annotation mesh__D018903 DF: PRK   
% 207.76/208.00  |- skos__altLabel mesh__D018903 Keratectomy, Excimer Laser Photorefractive
% 207.76/208.00  |- mesh__dateRevised mesh__D018903 2004-07-07
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D018903 2006
% 207.76/208.00  |- skos__altLabel mesh__D018903 Photorefractive Keratectomy, Excimer Laser
% 207.76/208.00  |- mesh__recordMaintainer mesh__D018903 lkt
% 207.76/208.00  |- skos__historyNote mesh__D018903 Laser Surgery %28%1987-1995%29%
% 207.76/208.00  |- skos__altLabel mesh__D018903 Keratectomy, Excimer Laser
% 207.76/208.00  |- skos__broader mesh__D018903smesh__D048988
% 207.76/208.00  |- skos__hiddenLabel mesh__D018903 Excimer Laser Keratectomies
% 207.76/208.00  |- mesh__dateCreated mesh__D018903 1995-06-08
% 207.76/208.00  |- mesh__publicMeSHNote mesh__D018903 96   
% 207.76/208.00  |- skos__broader mesh__D018903smesh__D013508
% 207.76/208.00  |- mesh__recordAuthorizer mesh__D018903 sjn
% 207.76/208.00  |- mesh__recordOriginator mesh__D018903 TGC
% 207.76/208.00  |- mesh__dateEstablished mesh__D018903 1996-01-01
% 207.76/208.00  |- mesh__historyNote mesh__D018903 96   
% 207.76/208.00  |- rdf__type mesh__D018903sskos__Concept
% 207.76/208.00  |- skos__hiddenLabel mesh__D018903 Excimer Laser Keratectomy
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D018903 2005
% 207.76/208.00  |- mesh__recordOriginator mesh__D010920 NLM
% 207.76/208.00  |- skos__related mesh__D010920smesh__D021041
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D010920 2004
% 207.76/208.00  |- skos__hiddenLabel mesh__D010920 Placentomes
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D010920 2005
% 207.76/208.00  |- mesh__dateRevised mesh__D010920 2002-07-03
% 207.76/208.00  |- skos__broader mesh__D010920smesh__D004628
% 207.76/208.00  |- skos__scopeNote mesh__D010920
% 207.76/208.00       A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion %28%CHORIONIC VILLI%29% derived from TROPHOBLASTS and a maternal portion %28%DECIDUA%29% derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones %28%PLACENTAL HORMONES%29%.%A%    
% 207.76/208.00  |- skos__altLabel mesh__D010920 Placentome
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D010920 2006
% 207.76/208.00  |- skos__related mesh__D010920smesh__D008431
% 207.76/208.00  |- skos__altLabel mesh__D010920 Placentoma, Normal
% 207.76/208.00  |- mesh__dateCreated mesh__D010920 1999-01-01
% 207.76/208.00  |- skos__hiddenLabel mesh__D010920 Placentomas, Normal
% 207.76/208.00  |- mesh__recordMaintainer mesh__D010920 lkt
% 207.76/208.00  |- skos__prefLabel mesh__D010920 Placenta
% 207.76/208.00  |- rdf__type mesh__D010920sskos__Concept
% 207.76/208.00  |- skos__hiddenLabel mesh__D010920 Normal Placentoma
% 207.76/208.00  |- skos__hiddenLabel mesh__D010920 Placentas
% 207.76/208.00  |- skos__hiddenLabel mesh__D010920 Normal Placentomas
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D010920 2003
% 207.76/208.00  |- mesh__recordAuthorizer mesh__D010920 sjn
% 207.76/208.00  |- skos__annotation mesh__D010920
% 207.76/208.00       mammals only; check the tags FEMALE %26% PREGNANCY; /blood supply: consider PLACENTAL CIRCULATION; placental serum or placental blood = PLACENTA + BLOOD%A%  
% 207.76/208.00  |- skos__historyNote mesh__D018105 DNA, Circular %28%1973-1993%29%
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D018105 2006
% 207.76/208.00  |- mesh__dateRevised mesh__D018105 2000-06-22
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D018105 2002
% 207.76/208.00  |- skos__altLabel mesh__D018105 kDNA Maxicircles
% 207.76/208.00  |- mesh__historyNote mesh__D018105
% 207.76/208.00       94; was KINETOPLAST DNA %28%NM%29% 1987-93; KINETOPLAST DNA MAXICIRCLES was NM 1987-93; KINETOPLAST DNA MINICIRCLES was NM 1980-93%A%  
% 207.76/208.00  |- skos__annotation mesh__D018105
% 207.76/208.00       protozoan DNA; from Kinetoplastida, an order of flagellate protozoa; coord IM with specific protozoon %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D018105 2003
% 207.76/208.00  |- skos__broader mesh__D018105smesh__D004272
% 207.76/208.00  |- rdf__type mesh__D018105sskos__Concept
% 207.76/208.00  |- skos__broader mesh__D018105smesh__D016054
% 207.76/208.00  |- skos__scopeNote mesh__D018105
% 207.76/208.00       DNA of kinetoplasts which are specialized MITOCHONDRIA of trypanosomes and related parasitic protozoa within the order KINETOPLASTIDA. Kinetoplast DNA consists of a complex network of numerous catenated rings of two classes; the first being a large number of small DNA duplex rings, called minicircles, approximately 2000 base pairs in length, and the second being several dozen much larger rings, called maxicircles, approximately 37 kb in length.%A%    
% 207.76/208.00  |- mesh__recordMaintainer mesh__D018105 nns
% 207.76/208.00  |- skos__altLabel mesh__D018105 kDNA Minicircles
% 207.76/208.00  |- skos__historyNote mesh__D018105 DNA, Protozoan %28%1991-1993%29%
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D018105 2004
% 207.76/208.00  |- mesh__recordAuthorizer mesh__D018105 sjn
% 207.76/208.00  |- mesh__dateCreated mesh__D018105 1993-06-03
% 207.76/208.00  |- skos__hiddenLabel mesh__D018105 Maxicircles, Kinetoplast DNA
% 207.76/208.00  |- skos__hiddenLabel mesh__D018105 DNA Minicircles, Kinetoplast
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D018105 2001
% 207.76/208.00  |- mesh__onlineNote mesh__D018105
% 207.76/208.00       use DNA, KINETOPLAST %28%NM%29% to search KINETOPLAST DNA %26% KINETOPLAST DNA MAXICIRCLES 1987-93 %26% KINETOPLAST DNA MINICIRCLES 1980-93%A%  
% 207.76/208.00  |- skos__hiddenLabel mesh__D018105 Minicircles, kDNA
% 207.76/208.00  |- skos__prefLabel mesh__D018105 DNA, Kinetoplast
% 207.76/208.00  |- mesh__recordOriginator mesh__D018105 PXP
% 207.76/208.00  |- skos__hiddenLabel mesh__D018105 Minicircles, Kinetoplast DNA
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D018105 2005
% 207.76/208.00  |- mesh__publicMeSHNote mesh__D018105
% 207.76/208.00       94; KINETOPLAST DNA was indexed under DNA, CIRCULAR 1987-93; KINETOPLAST DNA MAXICIRCLES was indexed under DNA, CIRCULAR 1987-93; KINETOPLAST DNA MINICIRCLES was indexed under DNA, CIRCULAR 1980-93%A%  
% 207.76/208.00  |- skos__historyNote mesh__D018105 DNA %28%1969-1973%29%
% 207.76/208.00  |- skos__altLabel mesh__D018105 kDNA
% 207.76/208.00  |- skos__hiddenLabel mesh__D018105 Maxicircles, kDNA
% 207.76/208.00  |- skos__hiddenLabel mesh__D018105 DNA Maxicircles, Kinetoplast
% 207.76/208.00  |- mesh__dateEstablished mesh__D018105 1994-01-01
% 207.76/208.00  |- skos__altLabel mesh__D018105 Kinetoplast DNA
% 207.76/208.00  |- skos__altLabel mesh__D010122 Cystyl Aminopeptidase
% 207.76/208.00  |- skos__broader mesh__D010122smesh__D045727
% 207.76/208.00  |- skos__altLabel mesh__D010122 Cystidyl Aminopeptidase
% 207.76/208.00  |- rdf__type mesh__D010122sskos__Concept
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D010122 2004
% 207.76/208.00  |- skos__altLabel mesh__D010122 Cystinaminopeptidase
% 207.76/208.00  |- skos__altLabel mesh__D010122 Oxytocinase
% 207.76/208.00  |- mesh__recordMaintainer mesh__D010122 jmp
% 207.76/208.00  |- mesh__publicMeSHNote mesh__D010122
% 207.76/208.00       2000; see OXYTOCINASE 1991-1999; see AMINOPEPTIDASES 1973-1990%A%  
% 207.76/208.00  |- skos__altLabel mesh__D010122 Vasopressinase
% 207.76/208.00  |- skos__scopeNote mesh__D010122
% 207.76/208.00       A zinc-containing sialoglycoprotein that is used to study aminopeptidase activity in the pathogenesis of hypertension. EC 3.4.11.3.%A%    
% 207.76/208.00  |- mesh__dateEstablished mesh__D010122 1991-01-01
% 207.76/208.00  |- skos__altLabel mesh__D010122 Cystine Arylamidase
% 207.76/208.00  |- mesh__recordAuthorizer mesh__D010122 sjn
% 207.76/208.00  |- skos__altLabel mesh__D010122 Cystine Aminopeptidase
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D010122 2006
% 207.76/208.00  |- mesh__recordOriginator mesh__D010122 NLM
% 207.76/208.00  |- skos__broader mesh__D010122smesh__D000626
% 207.76/208.00  |- skos__prefLabel mesh__D010122 Cystinyl Aminopeptidase
% 207.76/208.00  |- mesh__historyNote mesh__D010122 2000%28%1973%29%   
% 207.76/208.00  |- mesh__dateRevised mesh__D010122 2003-07-09
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D010122 2005
% 207.76/208.00  |- mesh__dateCreated mesh__D010122 1999-01-01
% 207.76/208.00  |- skos__hiddenLabel mesh__D051539
% 207.76/208.00       Liver Specific Transcription Factor LF B3
% 207.76/208.00  |- mesh__dateCreated mesh__D051539 2005-07-06
% 207.76/208.00  |- skos__scopeNote mesh__D051539
% 207.76/208.00       A hepatocyte nuclear factor that is closely related to HEPATOCYTE NUCLEAR FACTOR 1-ALPHA but is only weakly expressed in the LIVER. Mutations in hepatocyte nuclear factor 1-beta are associated with renal CYSTS and MATURITY-ONSET DIABETES MELLITUS type 5.%A%    
% 207.76/208.00  |- mesh__publicMeSHNote mesh__D051539
% 207.76/208.00       2006; HEPATOCYTE NUCLEAR FACTOR 1-BETA was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1991-2005%A%  
% 207.76/208.00  |- skos__altLabel mesh__D051539 HNF-1beta
% 207.76/208.00  |- skos__altLabel mesh__D051539 Liver Specific Transcription Factor LF-B3
% 207.76/208.00  |- mesh__dateEstablished mesh__D051539 2006-01-01
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D051539 2006
% 207.76/208.00  |- mesh__recordMaintainer mesh__D051539 DRC
% 207.76/208.00  |- skos__hiddenLabel mesh__D051539 Hepatocyte Nuclear Factor 1beta
% 207.76/208.00  |- skos__hiddenLabel mesh__D051539 HNF 1beta
% 207.76/208.00  |- skos__hiddenLabel mesh__D051539 Hepatocyte Nuclear Factor 1 beta
% 207.76/208.00  |- skos__altLabel mesh__D051539 Variant Hepatic Nuclear Factor 1
% 207.76/208.00  |- rdf__type mesh__D051539sskos__Concept
% 207.76/208.00  |- skos__prefLabel mesh__D051539 Hepatocyte Nuclear Factor 1-beta
% 207.76/208.00  |- skos__broader mesh__D051539smesh__D051537
% 207.76/208.00  |- mesh__recordOriginator mesh__D051539 DRC
% 207.76/208.00  |- skos__altLabel mesh__D051539 Hepatocyte Nuclear Factor-1beta
% 207.76/208.00  |- mesh__recordAuthorizer mesh__D051539 sjn
% 207.76/208.00  |- mesh__historyNote mesh__D051539 2006%28%1991%29%   
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D009379 2004
% 207.76/208.00  |- skos__prefLabel mesh__D009379 Neoplasms, Muscle Tissue
% 207.76/208.00  |- skos__altLabel mesh__D009379 Muscle Tissue Neoplasms
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D009379 2001
% 207.76/208.00  |- skos__hiddenLabel mesh__D009379 Neoplasm, Muscle Tissue
% 207.76/208.00  |- mesh__dateRevised mesh__D009379 1995-06-08
% 207.76/208.00  |- mesh__publicMeSHNote mesh__D009379 MYOBLASTOMA was heading 1963-93   
% 207.76/208.00  |- rdf__type mesh__D009379sskos__Concept
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D009379 2003
% 207.76/208.00  |- mesh__recordAuthorizer mesh__D009379 PLS
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D009379 1997
% 207.76/208.00  |- skos__broader mesh__D009379smesh__D018204
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D009379 2000
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D009379 2006
% 207.76/208.00  |- skos__hiddenLabel mesh__D009379 Myoblastomas
% 207.76/208.00  |- mesh__recordMaintainer mesh__D009379 KEV
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D009379 1996
% 207.76/208.00  |- mesh__recordOriginator mesh__D009379 NLM
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D009379 2005
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D009379 1999
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D009379 2002
% 207.76/208.00  |- mesh__historyNote mesh__D009379 MYOBLASTOMA was heading 1963-93   
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D009379 1998
% 207.76/208.00  |- skos__annotation mesh__D009379
% 207.76/208.00       neoplasms composed of muscle tissue, NOT neoplasms located in muscles: TN 135; /blood supply /chem /secret /second /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; restricted use: Manual 24.2.2.5; DF: NEOPL MUSCLE TISSUE%A%  
% 207.76/208.00  |- skos__scopeNote mesh__D009379
% 207.76/208.00       Neoplasms composed of muscle tissue: skeletal, cardiac, or smooth. The concept does not refer to neoplasms located in muscles.%A%    
% 207.76/208.00  |- skos__hiddenLabel mesh__D009379 Myofibroblastomas
% 207.76/208.00  |- mesh__dateCreated mesh__D009379 1999-01-01
% 207.76/208.00  |- mesh__onlineNote mesh__D009379
% 207.76/208.00       use NEOPLASMS, MUSCLE TISSUE to search MYOBLASTOMA 1966-93%A%  
% 207.76/208.00  |- skos__hiddenLabel mesh__D009379 Muscle Tissue Neoplasm
% 207.76/208.00  |- mesh__publicMeSHNote mesh__D001396
% 207.76/208.00       75; AZOMONAS was heading 1976-81; AZOMONAS AGILIS was see under AZOMONAS 1976-81, was AZOTOBACTER AGILIS see under AZOTOBACTER 1975%A%  
% 207.76/208.00  |- skos__prefLabel mesh__D001396 Azotobacteraceae
% 207.76/208.00  |- mesh__historyNote mesh__D001396
% 207.76/208.00       75; AZOMONAS was heading 1976-81; AZOMONAS AGILIS was see under AZOMONAS 1976-81, was AZOTOBACTER AGILIS see under AZOTOBACTER 1975, was AZOTOBACTER AGILIS 1972-74 %28%Prov%29%%A%  
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D001396 2006
% 207.76/208.00  |- mesh__recordAuthorizer mesh__D001396 sjn
% 207.76/208.00  |- skos__historyNote mesh__D001396 Bacteria %28%1966-1974%29%
% 207.76/208.00  |- mesh__recordMaintainer mesh__D001396 SYSTEM
% 207.76/208.00  |- mesh__onlineNote mesh__D001396
% 207.76/208.00       use AZOTOBACTERACEAE to search AZOMONAS 1976-81 %26% AZOMONAS AGILIS 1972-81 %28%as Prov 1972-74%29%%A%  
% 207.76/208.00  |- mesh__dateRevised mesh__D001396 2005-06-30
% 207.76/208.00  |- skos__broader mesh__D001396smesh__D016946
% 207.76/208.00  |- rdf__type mesh__D001396sskos__Concept
% 207.76/208.00  |- mesh__dateCreated mesh__D001396 1999-01-01
% 207.76/208.00  |- skos__broader mesh__D001396smesh__D011548
% 207.76/208.00  |- skos__scopeNote mesh__D001396
% 207.76/208.00       A subfamily of motile, gram-negative bacteria found in SOIL and WATER and capable of fixing atmospheric nitrogen.%A%    
% 207.76/208.00  |- mesh__recordOriginator mesh__D001396 NLM
% 207.76/208.00  |- mesh__dateEstablished mesh__D001396 1975-01-01
% 207.76/208.00  |- skos__annotation mesh__D001396 in soil %26% water   
% 207.76/208.00  |- skos__related mesh__D014513smesh__D014547
% 207.76/208.00  |- mesh__recordMaintainer mesh__D014513 jls
% 207.76/208.00  |- skos__broader mesh__D014513smesh__D014551
% 207.76/208.00  |- mesh__dateRevised mesh__D014513 2001-08-13
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D014513 2003
% 207.76/208.00  |- rdf__type mesh__D014513sskos__Concept
% 207.76/208.00  |- mesh__dateCreated mesh__D014513 1999-01-01
% 207.76/208.00  |- skos__prefLabel mesh__D014513 Ureter
% 207.76/208.00  |- skos__related mesh__D014513smesh__D018666
% 207.76/208.00  |- skos__hiddenLabel mesh__D014513 Ureters
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D014513 2004
% 207.76/208.00  |- mesh__recordAuthorizer mesh__D014513 sjn
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D014513 2002
% 207.76/208.00  |- skos__related mesh__D014513smesh__D014519
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D014513 2005
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D014513 2006
% 207.76/208.00  |- mesh__recordOriginator mesh__D014513 NLM
% 207.76/208.00  |- skos__scopeNote mesh__D014513
% 207.76/208.00       One of a pair of thick-walled tubes that transports urine from the KIDNEY PELVIS to the BLADDER.%A%    
% 207.76/208.00  |- skos__annotation mesh__D014513
% 207.76/208.00       do not confuse with URETHRA, espec in Romance lang: uret%C3%%A8%re %28%French%29%, ur%C3%%A9%ter %28%Span%29%, uretere %28%Ital%29% = URETER, while ur%C3%%A8%tre %28%French%29%, uretra %28%Span%29%, uretra %28%Ital%29% = URETHRA; /surg: consider URETEROSTOMY %26% URINARY DIVERSION %28%TN 189: probably do not index under URETER%29%; ureteral catheterization: coord NIM with URINARY CATHETERIZATION %28%IM%29%%A%  
% 207.76/208.00  |- mesh__dateCreated mesh__D038961 2002-07-02
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D038961 2005
% 207.76/208.00  |- skos__prefLabel mesh__D038961 O-Acetyl-ADP-Ribose
% 207.76/208.00  |- skos__hiddenLabel mesh__D038961 O Acetyl Adenosine Diphosphate Ribose
% 207.76/208.00  |- rdf__type mesh__D038961sskos__Concept
% 207.76/208.00  |- skos__scopeNote mesh__D038961
% 207.76/208.00       An acetyl ester of ADENOSINE DIPHOSPHATE RIBOSE formed during NAD-dependent deacetylation of proteins by SIRTUINS. The acetate group resides on the ribose ring where nicotinamide was cleaved from NAD during the reaction. Several isomers of O-acetyl-ADP-ribose have been isolated from the reaction.%A%    
% 207.76/208.00  |- mesh__recordAuthorizer mesh__D038961 sjn
% 207.76/208.00  |- mesh__historyNote mesh__D038961
% 207.76/208.00       2003; use O-ACETYL-ADP-RIBOSE %28%NM%29% 2001-2002   
% 207.76/208.00  |- skos__altLabel mesh__D038961 O-Acetyl-Adenosine-Diphosphate-Ribose
% 207.76/208.00  |- skos__altLabel mesh__D038961 Adenosine-Diphosphate-Ribose, O-Acetyl-
% 207.76/208.00  |- skos__hiddenLabel mesh__D038961 Adenosine Diphosphate Ribose, O Acetyl 
% 207.76/208.00  |- mesh__recordOriginator mesh__D038961 nns
% 207.76/208.00  |- mesh__recordMaintainer mesh__D038961 ssb
% 207.76/208.00  |- mesh__dateRevised mesh__D038961 2004-07-07
% 207.76/208.00  |- mesh__publicMeSHNote mesh__D038961
% 207.76/208.00       2003; O-ACETYL-ADP-RIBOSE was indexed under ADENOSINE DIPHOSPHATE RIBOSE 2001-2002%A%  
% 207.76/208.00  |- skos__altLabel mesh__D038961 AADPR
% 207.76/208.00  |- skos__broader mesh__D038961smesh__D000246
% 207.76/208.00  |- skos__hiddenLabel mesh__D038961 O-Acetyl- Adenosine-Diphosphate-Ribose
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D038961 2006
% 207.76/208.00  |- mesh__dateEstablished mesh__D038961 2003-01-01
% 207.76/208.00  |- skos__hiddenLabel mesh__D038961 O Acetyl ADP Ribose
% 207.76/208.00  |- skos__scopeNote mesh__D005787
% 207.76/208.00       The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION.%A%    
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D005787 2003
% 207.76/208.00  |- mesh__dateEstablished mesh__D005787 1968-01-01
% 207.76/208.00  |- mesh__activeMeSHYear mesh__D005787 2005
% 207.76/208.00  |- skos__hiddenLabel mesh__D005787 Frequencies, Allele
% 207.76/208.00  |- rdf__type mesh__D005787sskos__Concept
% 207.76/208.00  |- mesh__publicMeSHNote mesh__D005787
% 207.76/208.00       1968; for GENETIC EQUILIBRIUM see GENETICS, POPULATION 1998-2002%A%  
% 207.76/208.00  |- mesh__recordMaintainer mesh__D005787 nns
% 207.76/208.00  |- skos__historyNote mesh__D005787 Genetics %28%1966-1967%29%
% 207.76/208.00  |- skos__hiddenLabel mesh__D005787 Frequency, Allele
% 207.76/208.00  |- mesh__recordOriginator mesh__D005787 NLM
% 207.76/208.00  |- skos__hiddenLabel mesh__D005787 Frequency, Gene
% 207.76/208.00  |- mesh__dateCreated mesh__D005787 1999-01-01
% 207.76/208.00  |- skos__historyNote mesh__D005787 Genetics, Population %28%1966-1967%29%
% 207.76/208.00  |- skos__prefLabel mesh__D005787 Gene Frequency
% 207.76/208.00  |- skos__hiddenLabel mesh__D005787 Allele Frequencies
% 207.76/208.00  |- skos__altLabel mesh__D005787 Equilibrium, Genetic
% 207.76/208.00  |- mesh__dateRevised mesh__D005787 2002-07-02
% 207.76/208.00  |- mesh__historyNote mesh__D005787
% 207.76/208.00       1968; for GENETIC EQUILIBRIUM use GENETICS, POPULATION 1998-2002%A%  
% 207.76/208.00  |- mesh__recordAuthorizer mesh__D005787 sjn
% 207.76/208.00  |- skos__hiddenLabel mesh__D005787 Gene Frequencies
% 207.76/208.00  |- skos__hiddenLabel mesh__D005787 Frequencies, Gene
% 207.76/208.01  |- skos__broader mesh__D005787smesh__D040341
% 207.76/208.01  |- skos__historyNote mesh__D005787 Genes %28%1966-1967%29%
% 207.76/208.01  |- skos__altLabel mesh__D005787 Allele Frequency
% 207.76/208.01  |- mesh__activeMeSHYear mesh__D005787 2004
% 207.76/208.01  |- mesh__activeMeSHYear mesh__D005787 2006
% 207.76/208.01  |- skos__prefLabel mesh__D024941 Starch Phosphorylase
% 207.76/208.01  |- mesh__recordMaintainer mesh__D024941 ssb
% 207.76/208.01  |- mesh__recordOriginator mesh__D024941 lkt
% 207.76/208.01  |- skos__broader mesh__D024941smesh__D006005
% 207.76/208.01  |- mesh__dateRevised mesh__D024941 2003-07-09
% 207.76/208.01  |- skos__historyNote mesh__D024941 Glucosyltransferases %28%1964-1972%29%
% 207.76/208.01  |- mesh__activeMeSHYear mesh__D024941 2004
% 207.76/208.01  |- skos__historyNote mesh__D024941 Phosphorylases %28%1973-2001%29%
% 207.76/208.01  |- mesh__dateEstablished mesh__D024941 2002-01-01
% 207.76/208.01  |- skos__altLabel mesh__D024941 Amylophosphorylase
% 207.76/208.01  |- skos__hiddenLabel mesh__D024941 Phosphorylase, Starch
% 207.76/208.01  |- mesh__historyNote mesh__D024941 2002   
% 207.76/208.01  |- skos__scopeNote mesh__D024941
% 207.76/208.01       An enzyme of the PHOSPHORYLASES family that catalyzes the degradation of starch, a mixture of unbranched AMYLOSE and branched AMYLOPECTIN compounds. This phosphorylase from plants is the counterpart of GLYCOGEN PHOSPHORYLASE in animals that catalyzes the reaction of inorganic phosphate on the terminal alpha-1,4-glycosidic bond at the non-reducing end of glucans resulting in the release of glucose-1-phosphate.%A%    
% 207.76/208.01  |- mesh__dateCreated mesh__D024941 2001-07-25
% 207.76/208.01  |- skos__hiddenLabel mesh__D024941 Phosphorylase a, Starch
% 207.76/208.01  |- mesh__activeMeSHYear mesh__D024941 2005
% 207.76/208.01  |- mesh__publicMeSHNote mesh__D024941 2002   
% 207.76/208.01  |- skos__hiddenLabel mesh__D024941 Phosphorylase b, Starch
% 207.76/208.01  |- rdf__type mesh__D024941sskos__Concept
% 207.76/208.01  |- mesh__activeMeSHYear mesh__D024941 2006
% 207.76/208.01  |- mesh__recordAuthorizer mesh__D024941 sjn
% 207.76/208.01  |- mesh__dateRevised mesh__D024143 2004-07-07
% 207.76/208.01  |- rdf__type mesh__D024143sskos__Concept
% 207.76/208.01  |- skos__broader mesh__D024143smesh__D024041
% 207.76/208.01  |- mesh__activeMeSHYear mesh__D024143 2006
% 207.76/208.01  |- skos__prefLabel mesh__D024143 Collagen Type VII
% 207.76/208.01  |- mesh__dateEstablished mesh__D024143 2002-01-01
% 207.76/208.01  |- skos__historyNote mesh__D024143 Collagen %28%1990-2001%29%
% 207.76/208.01  |- mesh__dateCreated mesh__D024143 2001-07-25
% 207.76/208.01  |- mesh__activeMeSHYear mesh__D024143 2005
% 207.76/208.01  |- skos__hiddenLabel mesh__D024143 Procollagen, Type VII
% 207.76/208.01  |- mesh__historyNote mesh__D024143 2002; use COLLAGEN 1990-2001   
% 207.76/208.01  |- mesh__recordOriginator mesh__D024143 jmp
% 207.76/208.01  |- mesh__recordAuthorizer mesh__D024143 sjn
% 207.76/208.01  |- mesh__recordMaintainer mesh__D024143 jmp
% 207.76/208.01  |- skos__altLabel mesh__D024143 Type VII Collagen
% 207.76/208.01  |- skos__scopeNote mesh__D024143
% 207.76/208.01       A non-fibrillar collagen involved in anchoring the epidermal BASEMENT MEMBRANE to underlying tissue. It is a homotrimer comprised of C-terminal and N-terminal globular domains connected by a central triple-helical region.%A%    
% 207.76/208.01  |- skos__altLabel mesh__D024143 Collagen alpha1%28%VII%29%
% 207.76/208.01  |- skos__annotation mesh__D024143
% 207.76/208.01       precursors: coord IM with PROCOLLAGEN %28%IM%29%   
% 207.76/208.01  |- skos__altLabel mesh__D024143 Collagen Type VII, alpha1 Chain
% 207.76/208.01  |- mesh__publicMeSHNote mesh__D024143 2002; see COLLAGEN 1990-2001   
% 207.76/208.01  |- skos__hiddenLabel mesh__D024143 Type VII, Procollagen
% 207.76/208.01  |- skos__altLabel mesh__D024143 Type VII Procollagen
% 207.76/208.01  |- skos__hiddenLabel mesh__D024143 Collagen, Type VII
% 207.76/208.01  |- mesh__dateCreated mesh__D010921 1999-01-01
% 207.76/208.01  |- skos__broader mesh__D010921smesh__D007744
% 207.76/208.01  |- mesh__dateRevised mesh__D010921 2005-06-30
% 207.76/208.01  |- skos__scopeNote mesh__D010921
% 207.76/208.01       Abnormal placentation in which all or parts of the PLACENTA are attached directly to the MYOMETRIUM due to a complete or partial absence of DECIDUA. It is associated with POSTPARTUM HEMORRHAGE because of the failure of placental separation.%A%    
% 207.76/208.01  |- mesh__recordAuthorizer mesh__D010921 sjn
% 207.76/208.01  |- rdf__type mesh__D010921sskos__Concept
% 207.76/208.01  |- skos__annotation mesh__D010921 check the tags FEMALE %26% PREGNANCY   
% 207.76/208.01  |- mesh__recordOriginator mesh__D010921 NLM
% 207.76/208.01  |- skos__broader mesh__D010921smesh__D010922
% 207.76/208.01  |- skos__hiddenLabel mesh__D010921 Accreta, Placenta
% 207.76/208.01  |- mesh__recordMaintainer mesh__D010921 lkt
% 207.76/208.01  |- skos__hiddenLabel mesh__D010921 Percreta, Placenta
% 207.76/208.01  |- mesh__activeMeSHYear mesh__D010921 2006
% 207.76/208.01  |- skos__prefLabel mesh__D010921 Placenta Accreta
% 207.76/208.01  |- skos__hiddenLabel mesh__D010921 Increta, Placenta
% 207.76/208.01  |- skos__scopeNote mesh__D018106
% 207.76/208.01       T-cell differentiation antigens that serve as the receptors for the B7 antigen %28%ANTIGENS, CD80%29% which modulates T-cell lymphokine production.%A%    
% 207.76/208.01  |- skos__historyNote mesh__D018106 Antigens, CD %28%1990-1993%29%
% 207.76/208.01  |- skos__historyNote mesh__D018106
% 207.76/208.01       Antigens, Differentiation, T-Lymphocyte %28%1986-1993%29%
% 207.76/208.01  |- mesh__dateEstablished mesh__D018106 1994-01-01
% 207.76/208.01  |- mesh__historyNote mesh__D018106
% 207.76/208.01       94; was CD28 ANTIGEN %28%NM%29% 1986-93   
% 207.76/208.01  |- skos__related mesh__D018106smesh__D018122
% 207.76/208.01  |- mesh__activeMeSHYear mesh__D018106 2006
% 207.76/208.01  |- skos__broader mesh__D018106smesh__D000945
% 207.76/208.01  |- mesh__dateCreated mesh__D018106 1993-06-21
% 207.76/208.01  |- skos__annotation mesh__D018106 T-lymphocyte differentiation antigens   
% 207.76/208.01  |- skos__altLabel mesh__D018106 CD28 Antigen
% 207.76/208.01  |- rdf__type mesh__D018106sskos__Concept
% 207.76/208.01  |- mesh__recordMaintainer mesh__D018106 ssb
% 207.76/208.01  |- skos__altLabel mesh__D018106 CD28 Antigens
% 207.76/208.01  |- skos__prefLabel mesh__D018106 Antigens, CD28
% 207.76/208.01  |- mesh__recordOriginator mesh__D018106 AGS
% 207.86/208.01  |- mesh__recordAuthorizer mesh__D018106 sjn
% 207.86/208.01  |- mesh__publicMeSHNote mesh__D018106
% 207.86/208.01       94; CD28 ANTIGEN was indexed under ANTIGENS, CD 1990-93 %26% ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1986-93%A%  
% 207.86/208.01  |- skos__broader mesh__D018106smesh__D011948
% 207.86/208.01  |- mesh__onlineNote mesh__D018106
% 207.86/208.01       use ANTIGENS, CD28 %28%NM%29% to search CD28 ANTIGEN 1986-93   
% 207.86/208.01  |- skos__hiddenLabel mesh__D018106 Antigen, CD28
% 207.86/208.01  |- skos__broader mesh__D018106smesh__D015703
% 207.86/208.01  |- mesh__dateRevised mesh__D018106 2005-06-30
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D010123 2001
% 207.86/208.01  |- skos__hiddenLabel mesh__D010123 Aspiculariases
% 207.86/208.01  |- skos__hiddenLabel mesh__D010123 Oxyuriases
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D010123 2003
% 207.86/208.01  |- mesh__publicMeSHNote mesh__D010123
% 207.86/208.01       ASPICULARIASIS was see NEMATODE INFECTIONS 1986-92; was heading 1968-85%A%  
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D010123 2000
% 207.86/208.01  |- mesh__dateRevised mesh__D010123 1997-06-20
% 207.86/208.01  |- mesh__recordMaintainer mesh__D010123 TGC
% 207.86/208.01  |- skos__annotation mesh__D010123
% 207.86/208.01       nematode infect caused by genera of the superfamily OXYUROIDEA; infect by Oxyuris species goes here but note X ref OXYURIS VERMICULARIS INFECTION see ENTEROBIASIS%A%  
% 207.86/208.01  |- skos__prefLabel mesh__D010123 Oxyuriasis
% 207.86/208.01  |- skos__broader mesh__D010123smesh__D017194
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D010123 2006
% 207.86/208.01  |- skos__scopeNote mesh__D010123
% 207.86/208.01       Infection with nematodes of the superfamily OXYUROIDEA.%A%    
% 207.86/208.01  |- mesh__historyNote mesh__D010123
% 207.86/208.01       ASPICULARIASIS was see NEMATODE INFECTIONS 1986-92; was heading 1968-85%A%  
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D010123 1999
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D010123 2005
% 207.86/208.01  |- mesh__dateCreated mesh__D010123 1999-01-01
% 207.86/208.01  |- mesh__onlineNote mesh__D010123
% 207.86/208.01       use NEMATODE INFECTIONS to search ASPICULARIASIS 1968-92   
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D010123 2002
% 207.86/208.01  |- mesh__recordAuthorizer mesh__D010123 SJN
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D010123 1998
% 207.86/208.01  |- rdf__type mesh__D010123sskos__Concept
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D010123 2004
% 207.86/208.01  |- mesh__recordOriginator mesh__D010123 NLM
% 207.86/208.01  |- skos__annotation mesh__D001397 a carcinogen   
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D001397 2005
% 207.86/208.01  |- mesh__recordMaintainer mesh__D001397 JRT
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D001397 2004
% 207.86/208.01  |- mesh__recordOriginator mesh__D001397 NLM
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D001397 2002
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D001397 2006
% 207.86/208.01  |- skos__scopeNote mesh__D001397
% 207.86/208.01       A potent carcinogen and neurotoxic compound. It is particularly effective in inducing colon carcinomas.%A%    
% 207.86/208.01  |- mesh__recordAuthorizer mesh__D001397 PLS
% 207.86/208.01  |- skos__broader mesh__D001397smesh__D001391
% 207.86/208.01  |- mesh__dateEstablished mesh__D001397 1991-01-01
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D001397 1996
% 207.86/208.01  |- mesh__dateCreated mesh__D001397 1974-11-11
% 207.86/208.01  |- skos__prefLabel mesh__D001397 Azoxymethane
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D001397 2000
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D001397 1998
% 207.86/208.01  |- rdf__type mesh__D001397sskos__Concept
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D001397 1997
% 207.86/208.01  |- mesh__publicMeSHNote mesh__D001397
% 207.86/208.01       91; was see under AZO COMPOUNDS 1975-90   
% 207.86/208.01  |- skos__historyNote mesh__D001397 Nitrogen Oxides %28%1973-1974%29%
% 207.86/208.01  |- skos__historyNote mesh__D001397 Azo Compounds %28%1973-1975%29%
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D001397 2001
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D001397 1999
% 207.86/208.01  |- mesh__dateRevised mesh__D001397 1995-06-08
% 207.86/208.01  |- mesh__historyNote mesh__D001397
% 207.86/208.01       91%28%75%29%; was see under AZO COMPOUNDS 1975-90   
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D001397 2003
% 207.86/208.01  |- mesh__historyNote mesh__D006880 75   
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006880 1999
% 207.86/208.01  |- rdf__type mesh__D006880sskos__Concept
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006880 1997
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006880 2002
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006880 1998
% 207.86/208.01  |- mesh__publicMeSHNote mesh__D006880 75   
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006880 1996
% 207.86/208.01  |- mesh__recordOriginator mesh__D006880 NLM
% 207.86/208.01  |- skos__broader mesh__D006880smesh__D002264
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006880 2006
% 207.86/208.01  |- skos__historyNote mesh__D006880 Fatty Acids %28%1966-1974%29%
% 207.86/208.01  |- mesh__dateRevised mesh__D006880 1992-05-19
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006880 2004
% 207.86/208.01  |- skos__prefLabel mesh__D006880 Hydroxy Acids
% 207.86/208.01  |- mesh__recordAuthorizer mesh__D006880 PLS
% 207.86/208.01  |- mesh__recordMaintainer mesh__D006880 TGC
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006880 2005
% 207.86/208.01  |- skos__historyNote mesh__D006880 Carboxylic Acids %28%1971-1974%29%
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006880 2001
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006880 1995
% 207.86/208.01  |- mesh__dateEstablished mesh__D006880 1975-09-01
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006880 2003
% 207.86/208.01  |- skos__hiddenLabel mesh__D006880 Acids, Hydroxy
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006880 1993
% 207.86/208.01  |- skos__scopeNote mesh__D006880
% 207.86/208.01       Organic compounds containing both the hydroxyl and carboxyl radicals.%A%    
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006880 2000
% 207.86/208.01  |- mesh__dateCreated mesh__D006880 1999-01-01
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006880 1994
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D020551 2002
% 207.86/208.01  |- skos__prefLabel mesh__D020551 Pulse Therapy, Drug
% 207.86/208.01  |- mesh__publicMeSHNote mesh__D020551 2000   
% 207.86/208.01  |- skos__scopeNote mesh__D020551
% 207.86/208.01       Administration of high doses of pharmaceuticals over short periods of time.%A%    
% 207.86/208.01  |- skos__altLabel mesh__D020551 Pulse Drug Therapy
% 207.86/208.01  |- skos__annotation mesh__D020551
% 207.86/208.01       coord NIM with drug /admin %28%IM%29%; DF: PULSE THER DRUG   
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D020551 2006
% 207.86/208.01  |- skos__broader mesh__D020551smesh__D004334
% 207.86/208.01  |- rdf__type mesh__D020551sskos__Concept
% 207.86/208.01  |- skos__hiddenLabel mesh__D020551 Pulse Therapies, Drug
% 207.86/208.01  |- mesh__historyNote mesh__D020551 2000   
% 207.86/208.01  |- skos__hiddenLabel mesh__D020551 Pulse Drug Therapies
% 207.86/208.01  |- skos__hiddenLabel mesh__D020551 Drug Therapies, Pulse
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D020551 2004
% 207.86/208.01  |- skos__historyNote mesh__D020551
% 207.86/208.01       Drug Administration Schedule %28%1978-1999%29%
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D020551 2005
% 207.86/208.01  |- skos__hiddenLabel mesh__D020551 Drug Pulse Therapies
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D020551 2001
% 207.86/208.01  |- skos__hiddenLabel mesh__D020551 Drug Therapy, Pulse
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D020551 2003
% 207.86/208.01  |- skos__hiddenLabel mesh__D020551 Therapy, Drug Pulse
% 207.86/208.01  |- skos__hiddenLabel mesh__D020551 Therapies, Pulse Drug
% 207.86/208.01  |- skos__altLabel mesh__D020551 Drug Pulse Therapy
% 207.86/208.01  |- mesh__dateCreated mesh__D020551 1999-11-05
% 207.86/208.01  |- skos__hiddenLabel mesh__D020551 Therapies, Drug Pulse
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D020551 2000
% 207.86/208.01  |- skos__hiddenLabel mesh__D020551 Therapy, Pulse Drug
% 207.86/208.01  |- mesh__dateEstablished mesh__D020551 2000-01-01
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006082 1993
% 207.86/208.01  |- skos__annotation mesh__D006082
% 207.86/208.01       to prevent graft rejection of normal or tumor tissue; do not coord with IMMUNOTHERAPY; DF: GRAFT ENHANCEMENT%A%  
% 207.86/208.01  |- skos__historyNote mesh__D006082
% 207.86/208.01       Transplantation, Homologous %28%1966-1979%29%
% 207.86/208.01  |- skos__hiddenLabel mesh__D006082 Graft Enhancements, Immunologic
% 207.86/208.01  |- rdf__type mesh__D006082sskos__Concept
% 207.86/208.01  |- skos__altLabel mesh__D006082 Immunologic Graft Enhancement
% 207.86/208.01  |- mesh__recordOriginator mesh__D006082 AEP
% 207.86/208.01  |- mesh__recordMaintainer mesh__D006082 TAP
% 207.86/208.01  |- skos__prefLabel mesh__D006082 Graft Enhancement, Immunologic
% 207.86/208.01  |- skos__hiddenLabel mesh__D006082 Immunologic Graft Enhancements
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006082 1998
% 207.86/208.01  |- mesh__publicMeSHNote mesh__D006082 80   
% 207.86/208.01  |- skos__hiddenLabel mesh__D006082 Graft Enhancements
% 207.86/208.01  |- mesh__dateCreated mesh__D006082 1979-05-29
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006082 1997
% 207.86/208.01  |- mesh__dateRevised mesh__D006082 1992-05-15
% 207.86/208.01  |- skos__hiddenLabel mesh__D006082 Immunological Graft Enhancements
% 207.86/208.01  |- skos__scopeNote mesh__D006082
% 207.86/208.01       The induction of prolonged survival and growth of allografts of either tumors or normal tissues which would ordinarily be rejected. It may be induced passively by introducing graft-specific antibodies from previously immunized donors, which bind to the graft%27%s surface antigens, masking them from recognition by T-cells; or actively by prior immunization of the recipient with graft antigens which evoke specific antibodies and form antigen-antibody complexes which bind to the antigen receptor sites of the T-cells and block their cytotoxic activity.%A%    
% 207.86/208.01  |- mesh__recordAuthorizer mesh__D006082 PLS
% 207.86/208.01  |- skos__historyNote mesh__D006082
% 207.86/208.01       Transplantation Immunology %28%1966-1979%29%
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006082 2001
% 207.86/208.01  |- skos__hiddenLabel mesh__D006082 Enhancement, Graft
% 207.86/208.01  |- skos__altLabel mesh__D006082 Immunologic Enhancement of Grafts
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006082 1996
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006082 2006
% 207.86/208.01  |- skos__altLabel mesh__D006082 Enhancement, Immunologic Graft
% 207.86/208.01  |- skos__broader mesh__D006082smesh__D007165
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006082 2000
% 207.86/208.01  |- skos__historyNote mesh__D006082 Graft Survival %28%1977-1979%29%
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006082 2005
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006082 2004
% 207.86/208.01  |- skos__hiddenLabel mesh__D006082 Enhancement, Immunological Graft
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006082 1995
% 207.86/208.01  |- skos__hiddenLabel mesh__D006082 Enhancements, Immunologic Graft
% 207.86/208.01  |- skos__hiddenLabel mesh__D006082 Enhancements, Graft
% 207.86/208.01  |- mesh__dateEstablished mesh__D006082 1980-01-01
% 207.86/208.01  |- skos__hiddenLabel mesh__D006082 Immunological Graft Enhancement
% 207.86/208.01  |- skos__hiddenLabel mesh__D006082 Graft Enhancements, Immunological
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006082 2003
% 207.86/208.01  |- skos__hiddenLabel mesh__D006082 Enhancements, Immunological Graft
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006082 1999
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006082 1994
% 207.86/208.01  |- skos__altLabel mesh__D006082 Graft Enhancement, Immunological
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D006082 2002
% 207.86/208.01  |- mesh__historyNote mesh__D006082 80   
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D014514 2003
% 207.86/208.01  |- mesh__onlineNote mesh__D014514
% 207.86/208.01       to search for chem composition of ureteral calculi, use URETERAL CALCULI/anal 1987-90 %26% URETERAL CALCULI/metab 1966-86%A%  
% 207.86/208.01  |- rdf__type mesh__D014514sskos__Concept
% 207.86/208.01  |- skos__hiddenLabel mesh__D014514 Ureteral Calculus
% 207.86/208.01  |- mesh__recordOriginator mesh__D014514 NLM
% 207.86/208.01  |- mesh__dateCreated mesh__D014514 1999-01-01
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D014514 2004
% 207.86/208.01  |- mesh__recordMaintainer mesh__D014514 ags
% 207.86/208.01  |- mesh__dateRevised mesh__D014514 2001-07-25
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D014514 2005
% 207.86/208.01  |- skos__prefLabel mesh__D014514 Ureteral Calculi
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D014514 2006
% 207.86/208.01  |- skos__scopeNote mesh__D014514
% 207.86/208.01       Calculi of the ureter, usually the result of the passage of one originating in the kidney. It occurs usually in mid-life, rarely in children; and is more frequent in males than females. %28%From CMIT, 5th ed%29%%A%    
% 207.86/208.01  |- mesh__recordAuthorizer mesh__D014514 sjn
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D014514 2002
% 207.86/208.01  |- skos__broader mesh__D014514smesh__D014545
% 207.86/208.01  |- skos__broader mesh__D014514smesh__D014515
% 207.86/208.01  |- skos__annotation mesh__D014514
% 207.86/208.01       chem composition of caclculi use /chem; /ultrastruct permitted%A%  
% 207.86/208.01  |- skos__altLabel mesh__D014514 Ureterolithiasis
% 207.86/208.01  |- skos__hiddenLabel mesh__D014514 Calculi, Ureteral
% 207.86/208.01  |- skos__hiddenLabel mesh__D014514 Calculus, Ureteral
% 207.86/208.01  |- mesh__recordOriginator mesh__D005788 AEP
% 207.86/208.01  |- skos__related mesh__D005788smesh__D018703
% 207.86/208.01  |- mesh__dateRevised mesh__D005788 2002-07-03
% 207.86/208.01  |- skos__historyNote mesh__D005788 Genetics, Population %28%1966-1977%29%
% 207.86/208.01  |- skos__hiddenLabel mesh__D005788 Gene Pools
% 207.86/208.01  |- mesh__dateCreated mesh__D005788 1977-03-02
% 207.86/208.01  |- mesh__recordMaintainer mesh__D005788 PXP
% 207.86/208.01  |- skos__annotation mesh__D005788 not for micro-organisms; no qualif   
% 207.86/208.01  |- skos__hiddenLabel mesh__D005788 Pool, Gene
% 207.86/208.01  |- mesh__publicMeSHNote mesh__D005788
% 207.86/208.01       91; was see under GENETICS, POPULATION 1978-90   
% 207.86/208.01  |- mesh__historyNote mesh__D005788
% 207.86/208.01       91%28%78%29%; was see under GENETICS, POPULATION 1978-90   
% 207.86/208.01  |- skos__prefLabel mesh__D005788 Gene Pool
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D005788 2004
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D005788 2006
% 207.86/208.01  |- skos__scopeNote mesh__D005788
% 207.86/208.01       The total genetic information possessed by the reproductive members of a POPULATION of sexually reproducing organisms.%A%    
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D005788 2003
% 207.86/208.01  |- mesh__dateEstablished mesh__D005788 1991-01-01
% 207.86/208.01  |- mesh__recordAuthorizer mesh__D005788 sjn
% 207.86/208.01  |- skos__historyNote mesh__D005788 Gene Frequency %28%1968-1977%29%
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D005788 2005
% 207.86/208.01  |- skos__broader mesh__D005788smesh__D040341
% 207.86/208.01  |- skos__hiddenLabel mesh__D005788 Pools, Gene
% 207.86/208.01  |- rdf__type mesh__D005788sskos__Concept
% 207.86/208.01  |- skos__broader mesh__D030181smesh__D020218
% 207.86/208.01  |- mesh__recordOriginator mesh__D030181 nns
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D030181 2006
% 207.86/208.01  |- mesh__dateEstablished mesh__D030181 2002-01-01
% 207.86/208.01  |- mesh__dateCreated mesh__D030181 2001-07-25
% 207.86/208.01  |- mesh__historyNote mesh__D030181
% 207.86/208.01       2002; was VITAMIN D-BINDING PROTEIN 1992-2001   
% 207.86/208.01  |- mesh__publicMeSHNote mesh__D030181
% 207.86/208.01       2002; 2002; see VITAMIN D-BINDING PROTEIN 1992-2001   
% 207.86/208.01  |- mesh__recordMaintainer mesh__D030181 nns
% 207.86/208.01  |- mesh__dateRevised mesh__D030181 2005-06-30
% 207.86/208.01  |- skos__altLabel mesh__D030181 Response Element, Vitamin D
% 207.86/208.01  |- skos__scopeNote mesh__D030181
% 207.86/208.01       A DNA sequence that is found in the promoter region of vitamin D regulated genes. Vitamin D receptor %28%RECEPTOR, CALCITRIOL%29% binds to and regulates the activity of genes containing this element.%A%    
% 207.86/208.01  |- skos__historyNote mesh__D030181 Receptors, Calcitriol %28%1989-2001%29%
% 207.86/208.01  |- skos__historyNote mesh__D030181 Vitamin D %28%1989-2001%29%
% 207.86/208.01  |- mesh__recordAuthorizer mesh__D030181 sjn
% 207.86/208.01  |- rdf__type mesh__D030181sskos__Concept
% 207.86/208.01  |- skos__prefLabel mesh__D030181 Vitamin D Response Element
% 207.86/208.01  |- skos__broader mesh__D002490smesh__D009420
% 207.86/208.01  |- skos__hiddenLabel mesh__D002490 Systems, Central Nervous
% 207.86/208.01  |- mesh__dateRevised mesh__D002490 2004-07-07
% 207.86/208.01  |- skos__hiddenLabel mesh__D002490 Central Nervous Systems
% 207.86/208.01  |- mesh__recordOriginator mesh__D002490 NLM
% 207.86/208.01  |- skos__hiddenLabel mesh__D002490 Nervous Systems, Central
% 207.86/208.01  |- rdf__type mesh__D002490sskos__Concept
% 207.86/208.01  |- mesh__recordMaintainer mesh__D002490 ags
% 207.86/208.01  |- mesh__onlineNote mesh__D002490
% 207.86/208.01       pre-explosion = CENTRAL NERVOUS SYSTEM %28%PX%29%   
% 207.86/208.01  |- mesh__dateCreated mesh__D002490 1999-01-01
% 207.86/208.01  |- skos__scopeNote mesh__D002490
% 207.86/208.01       The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.%A%    
% 207.86/208.01  |- skos__annotation mesh__D002490
% 207.86/208.01       text must discuss both brain %26% spinal cord; prefer BRAIN or SPINAL CORD; neural tube: index CENTRAL NERVOUS SYSTEM /embryol; %22%CNS effects%22% or %22%central effects%22% of drugs in texts usually means BRAIN /drug eff, not CNS /drug eff; /drug eff: consider terms in D14 %26% D15%A%  
% 207.86/208.01  |- skos__prefLabel mesh__D002490 Central Nervous System
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D002490 2005
% 207.86/208.01  |- skos__hiddenLabel mesh__D002490 Nervous System, Central
% 207.86/208.01  |- skos__hiddenLabel mesh__D002490 System, Central Nervous
% 207.86/208.01  |- mesh__recordAuthorizer mesh__D002490 sjn
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D002490 2006
% 207.86/208.01  |- skos__annotation mesh__D010922
% 207.86/208.01       check the tags FEMALE %26% PREGNANCY; FETAL MALNUTRITION is available%A%  
% 207.86/208.01  |- skos__historyNote mesh__D010922 Placenta %28%1966-1968%29%
% 207.86/208.01  |- rdf__type mesh__D010922sskos__Concept
% 207.86/208.01  |- skos__altLabel mesh__D010922 Placental Diseases
% 207.86/208.01  |- skos__hiddenLabel mesh__D010922 Disorder, Placenta
% 207.86/208.01  |- mesh__historyNote mesh__D010922
% 207.86/208.01       80; was PLACENTA DISORDERS 1969-79 %28%Prov 1969-72%29%   
% 207.86/208.01  |- skos__hiddenLabel mesh__D010922 Disease, Placenta
% 207.86/208.01  |- mesh__publicMeSHNote mesh__D010922 80; was PLACENTA DISORDERS 1973-79   
% 207.86/208.01  |- skos__hiddenLabel mesh__D010922 Placenta Disorder
% 207.86/208.01  |- mesh__dateRevised mesh__D010922 2005-06-30
% 207.86/208.01  |- skos__prefLabel mesh__D010922 Placenta Diseases
% 207.86/208.01  |- skos__historyNote mesh__D010922
% 207.86/208.01       Pregnancy Complications %28%1966-1968%29%
% 207.86/208.01  |- skos__hiddenLabel mesh__D010922 Disease, Placental
% 207.86/208.01  |- skos__broader mesh__D010922smesh__D011248
% 207.86/208.01  |- mesh__recordAuthorizer mesh__D010922 sjn
% 207.86/208.01  |- skos__scopeNote mesh__D010922
% 207.86/208.01       Pathological processes or abnormal functions of the PLACENTA.%A%    
% 207.86/208.01  |- mesh__recordOriginator mesh__D010922 NLM
% 207.86/208.01  |- skos__hiddenLabel mesh__D010922 Diseases, Placenta
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D010922 2006
% 207.86/208.01  |- skos__altLabel mesh__D010922 Placenta Disorders
% 207.86/208.01  |- mesh__dateCreated mesh__D010922 1999-01-01
% 207.86/208.01  |- mesh__onlineNote mesh__D010922
% 207.86/208.01       use PLACENTA DISEASES to search PLACENTA DISORDERS 1969-79 %28%as Prov 1969-72%29%%A%  
% 207.86/208.01  |- mesh__recordMaintainer mesh__D010922 lkt
% 207.86/208.01  |- mesh__dateEstablished mesh__D010922 1973-01-01
% 207.86/208.01  |- skos__hiddenLabel mesh__D010922 Diseases, Placental
% 207.86/208.01  |- skos__hiddenLabel mesh__D010922 Placental Disease
% 207.86/208.01  |- skos__hiddenLabel mesh__D010922 Placenta Disease
% 207.86/208.01  |- skos__hiddenLabel mesh__D010922 Disorders, Placenta
% 207.86/208.01  |- skos__historyNote mesh__D018107 Rinderpest Virus %28%1971-1993%29%
% 207.86/208.01  |- mesh__recordMaintainer mesh__D018107 ags
% 207.86/208.01  |- mesh__recordAuthorizer mesh__D018107 sjn
% 207.86/208.01  |- mesh__dateCreated mesh__D018107 1993-06-30
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D018107 2002
% 207.86/208.01  |- skos__hiddenLabel mesh__D018107 Peste des petits ruminants virus
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D018107 2004
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D018107 2005
% 207.86/208.01  |- rdf__type mesh__D018107sskos__Concept
% 207.86/208.01  |- mesh__dateEstablished mesh__D018107 1994-01-01
% 207.86/208.01  |- skos__annotation mesh__D018107
% 207.86/208.01       for foreign titles, do not translate the disease %22%peste des petits ruminants%22%; infection = PESTE-DES-PETITS-RUMINANTS%A%  
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D018107 2003
% 207.86/208.01  |- skos__prefLabel mesh__D018107 Peste-des-petits-ruminants virus
% 207.86/208.01  |- mesh__publicMeSHNote mesh__D018107 94   
% 207.86/208.01  |- mesh__historyNote mesh__D018107 94   
% 207.86/208.01  |- skos__scopeNote mesh__D018107
% 207.86/208.01       A species of MORBILLIVIRUS causing a severe, often fatal enteritis and pneumonia %28%PESTE-DES-PETITS-RUMINANTS%29% in sheep and goats.%A%    
% 207.86/208.01  |- skos__broader mesh__D018107smesh__D018103
% 207.86/208.01  |- mesh__dateRevised mesh__D018107 2001-07-25
% 207.86/208.01  |- mesh__recordOriginator mesh__D018107 AGS
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D018107 2006
% 207.86/208.01  |- mesh__publicMeSHNote mesh__D010124
% 207.86/208.01       SYPHACIA was see under OXYUROIDEA 1963-85   
% 207.86/208.01  |- mesh__activeMeSHYear mesh__D010124 2004
% 207.86/208.02  |- mesh__onlineNote mesh__D010124
% 207.86/208.02       use OXYUROIDEA to search SYPHACIA 1966-85   
% 207.86/208.02  |- mesh__recordMaintainer mesh__D010124 ags
% 207.86/208.02  |- mesh__historyNote mesh__D010124
% 207.86/208.02       SYPHACIA was see under OXYUROIDEA 1963-85   
% 207.86/208.02  |- skos__scopeNote mesh__D010124
% 207.86/208.02       A superfamily of parasitic nematodes consisting of several genera. ENTEROBIUS, which occurs in humans, and Oxyuris, which occurs in horses, are two of the most common. Other genera are: Skrjabinema, Passalurus, Dermatoxys, and Probstmayria.%A%    
% 207.86/208.02  |- skos__annotation mesh__D010124
% 207.86/208.02       a superfamily of nematodes; infection: coord IM with OXYURIASIS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 207.86/208.02  |- skos__prefLabel mesh__D010124 Oxyuroidea
% 207.86/208.02  |- mesh__dateCreated mesh__D010124 1999-01-01
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D010124 2006
% 207.86/208.02  |- mesh__recordAuthorizer mesh__D010124 sjn
% 207.86/208.02  |- skos__broader mesh__D010124smesh__D017167
% 207.86/208.02  |- mesh__recordOriginator mesh__D010124 NLM
% 207.86/208.02  |- rdf__type mesh__D010124sskos__Concept
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D010124 2005
% 207.86/208.02  |- mesh__dateRevised mesh__D010124 2003-07-09
% 207.86/208.02  |- skos__broader mesh__D001152Q000506smesh__D001152
% 207.86/208.02  |- mesh__preferredCombination mesh__D001152Q000506smesh__D020261
% 207.86/208.02  |- rdf__type mesh__D001152Q000506smesh__CompoundConcept
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D001398 2006
% 207.86/208.02  |- skos__hiddenLabel mesh__D001398 SQ 26,776
% 207.86/208.02  |- mesh__recordOriginator mesh__D001398 SH
% 207.86/208.02  |- skos__altLabel mesh__D001398 Azthreonam
% 207.86/208.02  |- skos__altLabel mesh__D001398 Squibb Brand of Aztreonam
% 207.86/208.02  |- skos__historyNote mesh__D001398 Antibiotics %28%1966-1982%29%
% 207.86/208.02  |- mesh__dateEstablished mesh__D001398 1986-01-01
% 207.86/208.02  |- skos__hiddenLabel mesh__D001398 Aztreonam Esteve Brand
% 207.86/208.02  |- skos__altLabel mesh__D001398 Az-threonam
% 207.86/208.02  |- mesh__publicMeSHNote mesh__D001398 86   
% 207.86/208.02  |- skos__historyNote mesh__D001398 Antibiotics, Lactam %28%1983-1985%29%
% 207.86/208.02  |- mesh__dateCreated mesh__D001398 1985-06-14
% 207.86/208.02  |- skos__altLabel mesh__D001398 Esteve Brand of Aztreonam
% 207.86/208.02  |- mesh__recordMaintainer mesh__D001398 ssb
% 207.86/208.02  |- mesh__dateRevised mesh__D001398 2004-07-07
% 207.86/208.02  |- skos__altLabel mesh__D001398 Bristol-Myers Squibb Brand of Aztreonam
% 207.86/208.02  |- rdf__type mesh__D001398sskos__Concept
% 207.86/208.02  |- skos__hiddenLabel mesh__D001398 Az threonam
% 207.86/208.02  |- skos__broader mesh__D001398smesh__D008997
% 207.86/208.02  |- skos__scopeNote mesh__D001398
% 207.86/208.02       A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.%A%    
% 207.86/208.02  |- skos__prefLabel mesh__D001398 Aztreonam
% 207.86/208.02  |- skos__hiddenLabel mesh__D001398 SQ26,776
% 207.86/208.02  |- skos__hiddenLabel mesh__D001398 Aztreonam Squibb Brand
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D001398 2005
% 207.86/208.02  |- skos__altLabel mesh__D001398 Sanofi Winthrop Brand of Aztreonam
% 207.86/208.02  |- mesh__recordAuthorizer mesh__D001398 sjn
% 207.86/208.02  |- skos__hiddenLabel mesh__D001398 Bristol Myers Squibb Brand of Aztreonam
% 207.86/208.02  |- mesh__historyNote mesh__D001398 86   
% 207.86/208.02  |- skos__annotation mesh__D001398
% 207.86/208.02       do not use /biosyn unless by living matter   
% 207.86/208.02  |- skos__broader mesh__D006881smesh__D015073
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D006881 2000
% 207.86/208.02  |- mesh__dateEstablished mesh__D006881 1991-01-01
% 207.86/208.02  |- mesh__recordMaintainer mesh__D006881 adp
% 207.86/208.02  |- skos__historyNote mesh__D006881 Hydroxamic Acids %28%1966-1974%29%
% 207.86/208.02  |- skos__prefLabel mesh__D006881 Hydroxyacetylaminofluorene
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D006881 2006
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D006881 2004
% 207.86/208.02  |- mesh__recordAuthorizer mesh__D006881 sjn
% 207.86/208.02  |- skos__historyNote mesh__D006881 Fluorenes %28%1966-1974%29%
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D006881 2005
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D006881 2002
% 207.86/208.02  |- skos__altLabel mesh__D006881 N-Hydroxy-2-acetamidofluorene
% 207.86/208.02  |- skos__scopeNote mesh__D006881
% 207.86/208.02       A N-hydroxylated derivative of 2-ACETYLAMINOFLUORENE that has demonstrated carcinogenic action.%A%    
% 207.86/208.02  |- mesh__historyNote mesh__D006881
% 207.86/208.02       91%28%75%29%; was see under 2-ACETYLAMINOFLUORENE 1980-90; was see under FLUORENES 1975-79%A%  
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D006881 2003
% 207.86/208.02  |- mesh__recordOriginator mesh__D006881 NLM
% 207.86/208.02  |- skos__hiddenLabel mesh__D006881 N Hydroxy 2 acetamidofluorene
% 207.86/208.02  |- mesh__dateCreated mesh__D006881 1974-11-11
% 207.86/208.02  |- rdf__type mesh__D006881sskos__Concept
% 207.86/208.02  |- mesh__dateRevised mesh__D006881 1999-11-03
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D006881 2001
% 207.86/208.02  |- skos__altLabel mesh__D006881 Hydroxyfluorenylacetamide
% 207.86/208.02  |- mesh__publicMeSHNote mesh__D006881
% 207.86/208.02       91; was see under 2-ACETYLAMINOFLUORENE 1980-90; was see under FLUORENES 1975-79%A%  
% 207.86/208.02  |- skos__hiddenLabel mesh__D020552 Assay, Comet
% 207.86/208.02  |- mesh__publicMeSHNote mesh__D020552 2000   
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D020552 2002
% 207.86/208.02  |- skos__hiddenLabel mesh__D020552
% 207.86/208.02       Alkaline Single Cell Gel Electrophoresis Assay
% 207.86/208.02  |- skos__broader mesh__D020552smesh__D009152
% 207.86/208.02  |- skos__prefLabel mesh__D020552 Comet Assay
% 207.86/208.02  |- skos__historyNote mesh__D020552 Mutagenicity Tests %28%1992-1999%29%
% 207.86/208.02  |- skos__hiddenLabel mesh__D020552 Assays, Comet
% 207.86/208.02  |- rdf__type mesh__D020552sskos__Concept
% 207.86/208.02  |- skos__scopeNote mesh__D020552
% 207.86/208.02       A genotoxicological technique for measuring DNA damage in an individual cell using single-cell gel electrophoresis. Cell DNA fragments assume a %22%comet with tail%22% formation on electrophoresis and are detected with an image analysis system. Alkaline assay conditions facilitate sensitive detection of single-strand damage.%A%    
% 207.86/208.02  |- skos__hiddenLabel mesh__D020552 Single-Cell Gel Electrophoreses
% 207.86/208.02  |- mesh__historyNote mesh__D020552 2000   
% 207.86/208.02  |- skos__altLabel mesh__D020552 Gel Electrophoresis, Single-Cell
% 207.86/208.02  |- mesh__dateCreated mesh__D020552 1999-11-03
% 207.86/208.02  |- skos__hiddenLabel mesh__D020552 Gel Electrophoresis, Single Cell
% 207.86/208.02  |- skos__hiddenLabel mesh__D020552 Comet Assays, Alkaline
% 207.86/208.02  |- skos__hiddenLabel mesh__D020552 Comet Assay, Alkaline
% 207.86/208.02  |- skos__hiddenLabel mesh__D020552 Assay, Alkaline Comet
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D020552 2006
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D020552 2001
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D020552 2004
% 207.86/208.02  |- skos__historyNote mesh__D020552
% 207.86/208.02       Electrophoresis, Agar Gel %28%1990-1999%29%
% 207.86/208.02  |- skos__broader mesh__D020552smesh__D004587
% 207.86/208.02  |- skos__hiddenLabel mesh__D020552 Comet Assays
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D020552 2005
% 207.86/208.02  |- skos__hiddenLabel mesh__D020552 Single-Cell Gel Electrophoresis
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D020552 2000
% 207.86/208.02  |- skos__historyNote mesh__D020552 Electrophoresis %28%1990-1999%29%
% 207.86/208.02  |- skos__altLabel mesh__D020552
% 207.86/208.02       Alkaline Single-Cell Gel Electrophoresis Assay
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D020552 2003
% 207.86/208.02  |- skos__hiddenLabel mesh__D020552 Assays, Alkaline Comet
% 207.86/208.02  |- skos__related mesh__D020552smesh__D004249
% 207.86/208.02  |- skos__hiddenLabel mesh__D020552 Gel Electrophoreses, Single-Cell
% 207.86/208.02  |- skos__hiddenLabel mesh__D020552 Alkaline Comet Assays
% 207.86/208.02  |- mesh__dateEstablished mesh__D020552 2000-01-01
% 207.86/208.02  |- skos__altLabel mesh__D020552 Electrophoresis, Gel, Single-Cell
% 207.86/208.02  |- skos__hiddenLabel mesh__D020552 Electrophoresis, Single-Cell Gel
% 207.86/208.02  |- skos__hiddenLabel mesh__D020552 Electrophoreses, Single-Cell Gel
% 207.86/208.02  |- skos__hiddenLabel mesh__D006083 Graft Restenoses, Vascular
% 207.86/208.02  |- skos__altLabel mesh__D006083 Graft Restenosis, Vascular
% 207.86/208.02  |- mesh__recordMaintainer mesh__D006083 KEV
% 207.86/208.02  |- skos__hiddenLabel mesh__D006083 Restenosis, Vascular Graft
% 207.86/208.02  |- mesh__dateRevised mesh__D006083 1999-11-03
% 207.86/208.02  |- skos__altLabel mesh__D006083 Vascular Graft Occlusion
% 207.86/208.02  |- mesh__recordOriginator mesh__D006083 VDK
% 207.86/208.02  |- skos__hiddenLabel mesh__D006083 Occlusion, Vascular Graft
% 207.86/208.02  |- mesh__historyNote mesh__D006083 85   
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D006083 2002
% 207.86/208.02  |- skos__related mesh__D006083smesh__D014654
% 207.86/208.02  |- rdf__type mesh__D006083sskos__Concept
% 207.86/208.02  |- mesh__publicMeSHNote mesh__D006083 85   
% 207.86/208.02  |- skos__broader mesh__D006083smesh__D011183
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D006083 2003
% 207.86/208.02  |- mesh__recordAuthorizer mesh__D006083 sjn
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D006083 2000
% 207.86/208.02  |- mesh__dateEstablished mesh__D006083 1985-01-01
% 207.86/208.02  |- skos__scopeNote mesh__D006083
% 207.86/208.02       Obstruction of flow in biological or prosthetic vascular grafts.%A%    
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D006083 2005
% 207.86/208.02  |- skos__altLabel mesh__D006083 Vascular Graft Restenosis
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D006083 2004
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D006083 2001
% 207.86/208.02  |- mesh__dateCreated mesh__D006083 1984-05-29
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D006083 2006
% 207.86/208.02  |- skos__prefLabel mesh__D006083 Graft Occlusion, Vascular
% 207.86/208.02  |- mesh__recordMaintainer mesh__D014515 jls
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D014515 2005
% 207.86/208.02  |- mesh__recordAuthorizer mesh__D014515 sjn
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D014515 2004
% 207.86/208.02  |- rdf__type mesh__D014515sskos__Concept
% 207.86/208.02  |- mesh__publicMeSHNote mesh__D014515 66   
% 207.86/208.02  |- skos__hiddenLabel mesh__D014515 Disease, Ureteral
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D014515 2003
% 207.86/208.02  |- mesh__dateRevised mesh__D014515 2001-08-13
% 207.86/208.02  |- mesh__recordOriginator mesh__D014515 NLM
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D014515 2002
% 207.86/208.02  |- skos__prefLabel mesh__D014515 Ureteral Diseases
% 207.86/208.02  |- skos__broader mesh__D014515smesh__D014570
% 207.86/208.02  |- skos__hiddenLabel mesh__D014515 Diseases, Ureteral
% 207.86/208.02  |- mesh__dateEstablished mesh__D014515 1966-01-01
% 207.86/208.02  |- mesh__historyNote mesh__D014515 66   
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D014515 2006
% 207.86/208.02  |- skos__annotation mesh__D014515
% 207.86/208.02       do not confuse with URETHRAL DISEASES, espec in Romance lang: ur%C3%%A9%t%C3%%A9%ral %28%French%29%, ureteral %28%Span%29%, ureterale %28%Ital%29% = %22%ureteral%22%, while ur%C3%%A9%tral %28%French%29%, uretral %28%Span%29%, uretrale %28%Ital%29% = %22%urethral%22%%A%  
% 207.86/208.02  |- mesh__dateCreated mesh__D014515 1999-01-01
% 207.86/208.02  |- skos__hiddenLabel mesh__D014515 Ureteral Disease
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D019200 1997
% 207.86/208.02  |- skos__broader mesh__D019200smesh__D012328
% 207.86/208.02  |- rdf__type mesh__D019200sskos__Concept
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D019200 2006
% 207.86/208.02  |- skos__scopeNote mesh__D019200
% 207.86/208.02       A family of RNA viruses with one genus: ASTROVIRUS. They cause gastroenteritis in humans and also infect other vertebrates.%A%    
% 207.86/208.02  |- skos__annotation mesh__D019200
% 207.86/208.02       a family of RNA viruses; infection = ASTROVIRIDAE INFECTIONS%A%  
% 207.86/208.02  |- mesh__dateEstablished mesh__D019200 1997-01-01
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D019200 2005
% 207.86/208.02  |- mesh__dateCreated mesh__D019200 1996-06-10
% 207.86/208.02  |- mesh__historyNote mesh__D019200 97   
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D019200 2002
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D019200 2004
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D019200 1999
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D019200 2001
% 207.86/208.02  |- mesh__publicMeSHNote mesh__D019200 97   
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D019200 2003
% 207.86/208.02  |- skos__prefLabel mesh__D019200 Astroviridae
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D019200 1998
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D019200 2000
% 207.86/208.02  |- skos__altLabel mesh__D005789 Geneology and Heraldry
% 207.86/208.02  |- mesh__recordMaintainer mesh__D005789 jls
% 207.86/208.02  |- mesh__dateRevised mesh__D005789 2004-07-07
% 207.86/208.02  |- mesh__recordAuthorizer mesh__D005789 sjn
% 207.86/208.02  |- skos__altLabel mesh__D005789 Heraldry and Geneology
% 207.86/208.02  |- skos__altLabel mesh__D005789 Heraldry and Genealogy
% 207.86/208.02  |- skos__prefLabel mesh__D005789 Genealogy and Heraldry
% 207.86/208.02  |- skos__altLabel mesh__D005789 Genealogy
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D005789 2005
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D005789 2006
% 207.86/208.02  |- skos__annotation mesh__D005789
% 207.86/208.02       IM; no qualif; do not confuse with GENEALOGICAL TREE see PEDIGREE; DF: GENEALOGY%A%  
% 207.86/208.02  |- mesh__dateCreated mesh__D005789 1999-01-01
% 207.86/208.02  |- skos__hiddenLabel mesh__D005789 Geneologies
% 207.86/208.02  |- skos__altLabel mesh__D005789 Genealogies
% 207.86/208.02  |- mesh__recordOriginator mesh__D005789 NLM
% 207.86/208.02  |- skos__related mesh__D005789smesh__D004616
% 207.86/208.02  |- skos__broader mesh__D005789smesh__D006664
% 207.86/208.02  |- rdf__type mesh__D005789sskos__Concept
% 207.86/208.02  |- skos__annotation mesh__D002491
% 207.86/208.02       GEN or unspecified; prefer specific groups or specific drugs; consider also CENTRAL NERVOUS SYSTEM /drug eff %26% BRAIN /drug eff; DF: CNS AGENTS%A%  
% 207.86/208.02  |- mesh__recordAuthorizer mesh__D002491 sjn
% 207.86/208.02  |- mesh__historyNote mesh__D002491 79; was NON MESH before 1979   
% 207.86/208.02  |- mesh__dateRevised mesh__D002491 2005-08-15
% 207.86/208.02  |- skos__broader mesh__D002491smesh__D045506
% 207.86/208.02  |- mesh__onlineNote mesh__D002491
% 207.86/208.02       consider also CENTRAL NERVOUS SYSTEM /DE %26% BRAIN /DE   
% 207.86/208.02  |- mesh__publicMeSHNote mesh__D002491 79   
% 207.86/208.02  |- rdf__type mesh__D002491sskos__Concept
% 207.86/208.02  |- mesh__recordMaintainer mesh__D002491 sjn
% 207.86/208.02  |- mesh__dateEstablished mesh__D002491 1979-01-01
% 207.86/208.02  |- mesh__dateCreated mesh__D002491 1999-01-01
% 207.86/208.02  |- skos__altLabel mesh__D002491 Central Nervous System Drugs
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D002491 2006A
% 207.86/208.02  |- mesh__recordOriginator mesh__D002491 NLM
% 207.86/208.02  |- skos__prefLabel mesh__D002491 Central Nervous System Agents
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D002491 2006
% 207.86/208.02  |- skos__scopeNote mesh__D002491
% 207.86/208.02       A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into %22%specific%22% agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and %22%nonspecific%22% agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with nonspecific mechanisms are generally further classed according to whether they produce behavioral depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. %28%From Gilman AG, et al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 8th ed, p252%29%%A%    
% 207.86/208.02  |- mesh__historyNote mesh__D018906 96   
% 207.86/208.02  |- rdf__type mesh__D018906sskos__Concept
% 207.86/208.02  |- mesh__dateCreated mesh__D018906 1995-05-26
% 207.86/208.02  |- skos__altLabel mesh__D018906 Alkylating Antineoplastic Drugs
% 207.86/208.02  |- skos__altLabel mesh__D018906 Antineoplastic Drugs, Alkylating
% 207.86/208.02  |- skos__historyNote mesh__D018906 Antineoplastic Agents %28%1966-1995%29%
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D018906 2006
% 207.86/208.02  |- mesh__dateRevised mesh__D018906 2005-06-30
% 207.86/208.02  |- mesh__publicMeSHNote mesh__D018906 96   
% 207.86/208.02  |- mesh__dateEstablished mesh__D018906 1996-01-01
% 207.86/208.02  |- skos__altLabel mesh__D018906 Antineoplastic Alkylating Agents
% 207.86/208.02  |- skos__altLabel mesh__D018906 Alkylating Antineoplastics
% 207.86/208.02  |- mesh__recordMaintainer mesh__D018906 ssb
% 207.86/208.02  |- mesh__recordAuthorizer mesh__D018906 sjn
% 207.86/208.02  |- skos__historyNote mesh__D018906 Alkylating Agents %28%1966-1995%29%
% 207.86/208.02  |- skos__prefLabel mesh__D018906 Antineoplastic Agents, Alkylating
% 207.86/208.02  |- skos__altLabel mesh__D018906 Alkylating Antineoplastic Agents
% 207.86/208.02  |- skos__altLabel mesh__D018906 Alkylating Agents, Antineoplastic
% 207.86/208.02  |- skos__altLabel mesh__D018906 Antineoplastics, Alkylating
% 207.86/208.02  |- skos__scopeNote mesh__D018906
% 207.86/208.02       A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. %28%From AMA, Drug Evaluations Annual, 1994, p2026%29%%A%    
% 207.86/208.02  |- skos__broader mesh__D018906smesh__D000477
% 207.86/208.02  |- skos__altLabel mesh__D018906 Alkylating Drugs, Antineoplastic
% 207.86/208.02  |- skos__hiddenLabel mesh__D018906 Antineoplastic Alkylating Drugs
% 207.86/208.02  |- skos__broader mesh__D018906smesh__D000970
% 207.86/208.02  |- mesh__recordOriginator mesh__D018906 JRT
% 207.86/208.02  |- skos__hiddenLabel mesh__D018906 Drugs, Antineoplastic Alkylating
% 207.86/208.02  |- mesh__recordOriginator mesh__D010923 NLM
% 207.86/208.02  |- mesh__publicMeSHNote mesh__D010923
% 207.86/208.02       2006; see PLACENTA PRAEVIA 1963-2005   
% 207.86/208.02  |- mesh__dateCreated mesh__D010923 1999-01-01
% 207.86/208.02  |- skos__prefLabel mesh__D010923 Placenta Previa
% 207.86/208.02  |- rdf__type mesh__D010923sskos__Concept
% 207.86/208.02  |- skos__scopeNote mesh__D010923
% 207.86/208.02       Abnormal placentation in which the PLACENTA implants in the lower segment of the UTERUS %28%the zone of dilation%29% and may cover part or all of the opening of the CERVIX. It is often associated with serious antepartum bleeding and PREMATURE LABOR.%A%    
% 207.86/208.02  |- mesh__historyNote mesh__D010923 2006 %28%1963%29%   
% 207.86/208.02  |- mesh__recordMaintainer mesh__D010923 lkt
% 207.86/208.02  |- skos__broader mesh__D010923smesh__D007744
% 207.86/208.02  |- skos__annotation mesh__D010923 check the tags FEMALE %26% PREGNANCY   
% 207.86/208.02  |- skos__broader mesh__D010923smesh__D010922
% 207.86/208.02  |- mesh__dateRevised mesh__D010923 2005-06-30
% 207.86/208.02  |- skos__altLabel mesh__D010923 Placenta Praevia
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D010923 2006
% 207.86/208.02  |- mesh__recordAuthorizer mesh__D010923 sjn
% 207.86/208.02  |- skos__annotation mesh__D018108 infection = RESPIROVIRUS INFECTIONS   
% 207.86/208.02  |- mesh__dateRevised mesh__D018108 2003-07-09
% 207.86/208.02  |- skos__historyNote mesh__D018108 Paramyxoviridae %28%1967-1993%29%
% 207.86/208.02  |- skos__scopeNote mesh__D018108
% 207.86/208.02       A genus of the family PARAMYXOVIRIDAE %28%subfamily PARAMYXOVIRINAE%29% where all the virions have both HEMAGGLUTININ and NEURAMINIDASE activities and encode a non-structural C protein. SENDAI VIRUS is the type species.%A%    
% 207.86/208.02  |- mesh__recordOriginator mesh__D018108 AGS
% 207.86/208.02  |- mesh__historyNote mesh__D018108 2002 %28%1994%29%   
% 207.86/208.02  |- mesh__recordAuthorizer mesh__D018108 sjn
% 207.86/208.02  |- mesh__publicMeSHNote mesh__D018108 2002; see PARAMYXOVIRUS 1994-2001   
% 207.86/208.02  |- skos__broader mesh__D018108smesh__D018098
% 207.86/208.02  |- mesh__dateEstablished mesh__D018108 1994-01-01
% 207.86/208.02  |- skos__prefLabel mesh__D018108 Respirovirus
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D018108 2006
% 207.86/208.02  |- skos__hiddenLabel mesh__D018108 Respiroviruses
% 207.86/208.02  |- mesh__recordMaintainer mesh__D018108 ags
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D018108 2004
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D018108 2005
% 207.86/208.02  |- rdf__type mesh__D018108sskos__Concept
% 207.86/208.02  |- mesh__dateCreated mesh__D018108 1993-06-04
% 207.86/208.02  |- mesh__recordMaintainer mesh__D010125 ags
% 207.86/208.02  |- skos__prefLabel mesh__D010125 Ostreidae
% 207.86/208.02  |- mesh__recordAuthorizer mesh__D010125 sjn
% 207.86/208.02  |- mesh__dateRevised mesh__D010125 2005-06-30
% 207.86/208.02  |- mesh__historyNote mesh__D010125 2006   
% 207.86/208.02  |- skos__annotation mesh__D010125
% 207.86/208.02       as animal %26% food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH %28%IM%29%; note entry term OYSTERS: oysters unspecified go here; OYSTERS, TRUE is also available%A%  
% 207.86/208.02  |- skos__historyNote mesh__D010125 Mollusca %28%1966-1971%29%
% 207.86/208.02  |- mesh__recordOriginator mesh__D010125 NLM
% 207.86/208.02  |- skos__scopeNote mesh__D010125
% 207.86/208.02       A family of marine mollusks in the class BIVALVIA, commonly known as oysters. They have a rough irregular shell closed by a single adductor muscle.%A%    
% 207.86/208.02  |- mesh__dateCreated mesh__D010125 1999-01-01
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D010125 2006
% 207.86/208.02  |- rdf__type mesh__D010125sskos__Concept
% 207.86/208.02  |- skos__broader mesh__D010125smesh__D049872
% 207.86/208.02  |- mesh__publicMeSHNote mesh__D010125 2006; see OYSTERS 1972-2006   
% 207.86/208.02  |- mesh__dateEstablished mesh__D010125 1972-01-01
% 207.86/208.02  |- skos__altLabel mesh__D010125 Oysters
% 207.86/208.02  |- rdf__type mesh__D001399sskos__Concept
% 207.86/208.02  |- mesh__dateEstablished mesh__D001399 1991-01-01
% 207.86/208.02  |- skos__historyNote mesh__D001399 Phenothiazines %28%1969-1975%29%
% 207.86/208.02  |- skos__hiddenLabel mesh__D001399 Stain, Giemsa
% 207.86/208.02  |- mesh__recordAuthorizer mesh__D001399 sjn
% 207.86/208.02  |- mesh__dateCreated mesh__D001399 1975-07-18
% 207.86/208.02  |- skos__historyNote mesh__D001399 Staining %28%1966-1975%29%
% 207.86/208.02  |- mesh__historyNote mesh__D001399
% 207.86/208.02       91%28%76%29%; was see under PHENOTHIAZINES 1976-90   
% 207.86/208.02  |- skos__historyNote mesh__D001399 Imines %28%1974-1975%29%
% 207.86/208.02  |- mesh__publicMeSHNote mesh__D001399
% 207.86/208.02       91; was see under PHENOTHIAZINES 1976-90   
% 207.86/208.02  |- mesh__dateRevised mesh__D001399 2005-06-30
% 207.86/208.02  |- skos__scopeNote mesh__D001399
% 207.86/208.02       PHENOTHIAZINES with an amino group at the 3-position that are green crystals or powder. They are used as biological stains.%A%    
% 207.86/208.02  |- skos__hiddenLabel mesh__D001399 Giemsa 11
% 207.86/208.02  |- mesh__recordOriginator mesh__D001399 RLS
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D001399 2006
% 207.86/208.02  |- skos__broader mesh__D001399smesh__D010640
% 207.86/208.02  |- mesh__recordMaintainer mesh__D001399 ssb
% 207.86/208.02  |- skos__historyNote mesh__D001399 Dimethylamines %28%1974-1975%29%
% 207.86/208.02  |- skos__hiddenLabel mesh__D001399 Stains, Azure
% 207.86/208.02  |- skos__prefLabel mesh__D001399 Azure Stains
% 207.86/208.02  |- mesh__recordOriginator mesh__D006882 NLM
% 207.86/208.02  |- rdf__type mesh__D006882sskos__Concept
% 207.86/208.02  |- mesh__publicMeSHNote mesh__D006882 75; was HYDROXYAPATITE 1967-74   
% 207.86/208.02  |- mesh__dateRevised mesh__D006882 2004-07-13
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D006882 2006
% 207.86/208.02  |- skos__prefLabel mesh__D006882 Hydroxyapatites
% 207.86/208.02  |- mesh__dateCreated mesh__D006882 1999-01-01
% 207.86/208.02  |- mesh__recordMaintainer mesh__D006882 sjn
% 207.86/208.02  |- mesh__dateEstablished mesh__D006882 1967-01-01
% 207.86/208.02  |- mesh__historyNote mesh__D006882
% 207.86/208.02       75; was HYDROXYAPATITE 1964-74 %28%Prov 1964-66%29%   
% 207.86/208.02  |- skos__broader mesh__D006882smesh__D001031
% 207.86/208.02  |- mesh__recordAuthorizer mesh__D006882 sjn
% 207.86/208.02  |- skos__scopeNote mesh__D006882
% 207.86/208.02       A group of compounds with the general formula M10%28%PO4%29%6%28%OH%29%2, where M is barium, strontium, or calcium. The compounds are the principal mineral in phosphorite deposits, biological tissue, human bones, and teeth. They are also used as an anticaking agent and polymer catalysts. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 207.86/208.02  |- mesh__onlineNote mesh__D006882
% 207.86/208.02       use HYDROXYAPATITES to search HYDROXYAPATITE 1964-74 %28%as Prov 1966%29%%A%  
% 207.86/208.02  |- skos__annotation mesh__D006882
% 207.86/208.02       in phosphorite deposits %26% biol tissue   
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D006882 2005
% 207.86/208.02  |- rdf__type mesh__D006084sskos__Concept
% 207.86/208.02  |- mesh__dateEstablished mesh__D006084 1973-01-01
% 207.86/208.02  |- mesh__recordMaintainer mesh__D006084 ags
% 207.86/208.02  |- skos__hiddenLabel mesh__D006084 Rejection, Transplantation
% 207.86/208.02  |- skos__hiddenLabel mesh__D006084 Transplant Rejections
% 207.86/208.02  |- skos__altLabel mesh__D006084 Transplantation Rejection
% 207.86/208.02  |- mesh__dateRevised mesh__D006084 2005-06-30
% 207.86/208.02  |- skos__altLabel mesh__D006084 Transplant Rejection
% 207.86/208.02  |- skos__altLabel mesh__D006084 Rejection, Transplant
% 207.86/208.02  |- skos__annotation mesh__D006084
% 207.86/208.02       may be used with transplanted neoplasms   
% 207.86/208.02  |- mesh__recordOriginator mesh__D006084 NLM
% 207.86/208.02  |- skos__hiddenLabel mesh__D006084 Rejections, Transplantation
% 207.86/208.02  |- mesh__publicMeSHNote mesh__D006084 73   
% 207.86/208.02  |- skos__hiddenLabel mesh__D006084 Rejection, Graft
% 207.86/208.02  |- skos__historyNote mesh__D006084
% 207.86/208.02       Transplantation Immunology %28%1966-1970%29%
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D006084 2006
% 207.86/208.02  |- skos__hiddenLabel mesh__D006084 Graft Rejections
% 207.86/208.02  |- skos__broader mesh__D006084smesh__D006789
% 207.86/208.02  |- skos__hiddenLabel mesh__D006084 Transplantation Rejections
% 207.86/208.02  |- skos__hiddenLabel mesh__D006084 Rejections, Graft
% 207.86/208.02  |- skos__scopeNote mesh__D006084
% 207.86/208.02       An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient.%A%    
% 207.86/208.02  |- skos__related mesh__D006084smesh__D051799
% 207.86/208.02  |- skos__prefLabel mesh__D006084 Graft Rejection
% 207.86/208.02  |- mesh__historyNote mesh__D006084 73%28%71%29%   
% 207.86/208.02  |- skos__hiddenLabel mesh__D006084 Rejections, Transplant
% 207.86/208.02  |- mesh__dateCreated mesh__D006084 1999-01-01
% 207.86/208.02  |- mesh__recordAuthorizer mesh__D006084 sjn
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D014516 2004
% 207.86/208.02  |- rdf__type mesh__D014516sskos__Concept
% 207.86/208.02  |- skos__hiddenLabel mesh__D014516 Ureter Neoplasm
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D014516 2000
% 207.86/208.02  |- skos__hiddenLabel mesh__D014516 Neoplasm, Ureter
% 207.86/208.02  |- skos__hiddenLabel mesh__D014516 Cancer, Ureter
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D014516 2003
% 207.86/208.02  |- mesh__recordMaintainer mesh__D014516 nns
% 207.86/208.02  |- skos__altLabel mesh__D014516 Ureter Cancer
% 207.86/208.02  |- mesh__recordAuthorizer mesh__D014516 sjn
% 207.86/208.02  |- skos__hiddenLabel mesh__D014516 Ureteral Cancers
% 207.86/208.02  |- skos__altLabel mesh__D014516 Ureter Neoplasms
% 207.86/208.02  |- skos__altLabel mesh__D014516 Neoplasms, Ureteral
% 207.86/208.02  |- skos__prefLabel mesh__D014516 Ureteral Neoplasms
% 207.86/208.02  |- skos__hiddenLabel mesh__D014516 Ureter Cancers
% 207.86/208.02  |- skos__hiddenLabel mesh__D014516 Cancers, Ureter
% 207.86/208.02  |- skos__hiddenLabel mesh__D014516 Neoplasms, Ureter
% 207.86/208.02  |- mesh__recordOriginator mesh__D014516 NLM
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D014516 2006
% 207.86/208.02  |- skos__annotation mesh__D014516
% 207.86/208.02       do not confuse with URETHRAL NEOPLASMS, espec in Romance lang: see note on %22%ureteral%22% %26% %22%urethral%22% under URETERAL DISEASES; coord IM with histol type of neopl %28%IM%29%%A%  
% 207.86/208.02  |- skos__hiddenLabel mesh__D014516 Cancers, Ureteral
% 207.86/208.02  |- mesh__dateCreated mesh__D014516 1999-01-01
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D014516 2002
% 207.86/208.02  |- skos__scopeNote mesh__D014516
% 207.86/208.02       Cancer or tumors of the URETER. Hematuria, which occurs in 75%25% of patients with ureteral carcinoma, is the most common presenting symptom. The most common site for the occurrence of a ureteral tumor is in the lower third of the URETER, with a lesser incidence higher up.%A%    
% 207.86/208.02  |- skos__altLabel mesh__D014516 Cancer of the Ureter
% 207.86/208.02  |- skos__broader mesh__D014516smesh__D014571
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D014516 2005
% 207.86/208.02  |- skos__broader mesh__D014516smesh__D014515
% 207.86/208.02  |- skos__hiddenLabel mesh__D014516 Ureteral Neoplasm
% 207.86/208.02  |- skos__hiddenLabel mesh__D014516 Neoplasm, Ureteral
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D014516 2001
% 207.86/208.02  |- mesh__dateRevised mesh__D014516 1999-11-03
% 207.86/208.02  |- skos__hiddenLabel mesh__D014516 Cancer, Ureteral
% 207.86/208.02  |- skos__altLabel mesh__D014516 Ureteral Cancer
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D019201 2002
% 207.86/208.02  |- skos__annotation mesh__D019201
% 207.86/208.02       a genus of the family Birnaviridae; infection: coord IM with BIRNAVIRIDAE INFECTIONS %28%IM%29%%A%  
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D019201 2005
% 207.86/208.02  |- mesh__historyNote mesh__D019201 97   
% 207.86/208.02  |- mesh__activeMeSHYear mesh__D019201 2001
% 207.86/208.02  |- mesh__publicMeSHNote mesh__D019201 97   
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D019201 2004
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D019201 1999
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D019201 2000
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D019201 2003
% 207.86/208.03  |- skos__scopeNote mesh__D019201
% 207.86/208.03       A genus of RNA viruses in the family BIRNAVIRIDAE infecting fish, mollusks, and crustaceans. It is transmitted both vertically and horizontally with no known vectors. The natural hosts are salmonids and the type species is INFECTIOUS PANCREATIC NECROSIS VIRUS.%A%    
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D019201 1998
% 207.86/208.03  |- skos__broader mesh__D019201smesh__D018059
% 207.86/208.03  |- skos__prefLabel mesh__D019201 Aquabirnavirus
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D019201 1997
% 207.86/208.03  |- skos__hiddenLabel mesh__D019201 Aquabirnaviruses
% 207.86/208.03  |- mesh__dateEstablished mesh__D019201 1997-01-01
% 207.86/208.03  |- rdf__type mesh__D019201sskos__Concept
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D019201 2006
% 207.86/208.03  |- mesh__dateCreated mesh__D019201 1996-06-10
% 207.86/208.03  |- skos__related mesh__D030981smesh__D010015
% 207.86/208.03  |- skos__altLabel mesh__D030981 Acroosteolysis Syndrome
% 207.86/208.03  |- skos__historyNote mesh__D030981 Osteolysis %28%1966-2002%29%
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D030981 2003
% 207.86/208.03  |- skos__broader mesh__D030981smesh__D010014
% 207.86/208.03  |- skos__historyNote mesh__D030981 Osteolysis, Essential %28%1972-2002%29%
% 207.86/208.03  |- skos__altLabel mesh__D030981 Acro-Osteolysis Syndromes
% 207.86/208.03  |- mesh__historyNote mesh__D030981 2003   
% 207.86/208.03  |- skos__broader mesh__D030981smesh__D001848
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D030981 2005
% 207.86/208.03  |- skos__hiddenLabel mesh__D030981 Acro Osteolysis
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D030981 2004
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D030981 2006
% 207.86/208.03  |- skos__hiddenLabel mesh__D030981 Acro-Osteolysis Syndrome
% 207.86/208.03  |- rdf__type mesh__D030981sskos__Concept
% 207.86/208.03  |- mesh__dateEstablished mesh__D030981 2003-01-01
% 207.86/208.03  |- skos__scopeNote mesh__D030981
% 207.86/208.03       A condition with congenital and acquired forms causing recurrent ulcers in the fingers and toes. The congenital form exhibits autosomal dominant inheritance; the acquired form is found in workers who handle VINYL CHLORIDE. When acro-osteolysis is accompanied by generalized OSTEOPOROSIS and skull deformations, it is called HAJDU-CHENEY SYNDROME.%A%    
% 207.86/208.03  |- skos__altLabel mesh__D030981 Acroosteolysis
% 207.86/208.03  |- skos__prefLabel mesh__D030981 Acro-Osteolysis
% 207.86/208.03  |- mesh__publicMeSHNote mesh__D030981 2003   
% 207.86/208.03  |- mesh__dateCreated mesh__D030981 2002-07-02
% 207.86/208.03  |- skos__altLabel mesh__D002492 CNS Depressants
% 207.86/208.03  |- mesh__dateEstablished mesh__D002492 1979-01-01
% 207.86/208.03  |- mesh__dateCreated mesh__D002492 1999-01-01
% 207.86/208.03  |- skos__prefLabel mesh__D002492 Central Nervous System Depressants
% 207.86/208.03  |- mesh__onlineNote mesh__D002492
% 207.86/208.03       consider also CENTRAL NERVOUS SYSTEM /DE + DEPRESSION, CHEMICAL or BRAIN /DE + DEPRESSION, CHEMICAL%A%  
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D002492 2006
% 207.86/208.03  |- skos__scopeNote mesh__D002492
% 207.86/208.03       A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anesthetics, hypnotics and sedatives, narcotics, and tranquilizing agents %28%antipsychotics and antianxiety agents%29%.%A%    
% 207.86/208.03  |- skos__annotation mesh__D002492
% 207.86/208.03       GEN or unspecified; prefer specific groups or specific drugs; consider also CENTRAL NERVOUS SYSTEM /drug eff or BRAIN /drug eff; DF: CNS DEPRESS%A%  
% 207.86/208.03  |- mesh__dateRevised mesh__D002492 2005-06-30
% 207.86/208.03  |- skos__broader mesh__D002492smesh__D002491
% 207.86/208.03  |- mesh__recordAuthorizer mesh__D002492 sjn
% 207.86/208.03  |- mesh__recordMaintainer mesh__D002492 ssb
% 207.86/208.03  |- skos__hiddenLabel mesh__D002492 Depressants, CNS
% 207.86/208.03  |- mesh__publicMeSHNote mesh__D002492 79   
% 207.86/208.03  |- skos__broader mesh__D002492smesh__D045505
% 207.86/208.03  |- mesh__historyNote mesh__D002492 79; was NON MESH before 1979   
% 207.86/208.03  |- rdf__type mesh__D002492sskos__Concept
% 207.86/208.03  |- mesh__recordOriginator mesh__D002492 NLM
% 207.86/208.03  |- skos__hiddenLabel mesh__D018907 Law 93-579, Public
% 207.86/208.03  |- skos__annotation mesh__D018907
% 207.86/208.03       a civil right to freedom from intrusion in one%27%s private affairs; note X ref, a Federal statute; privacy of patient data or records: index under CONFIDENTIALITY%A%  
% 207.86/208.03  |- skos__scopeNote mesh__D018907
% 207.86/208.03       The state of being free from intrusion or disturbance in one%27%s private life or affairs. %28%Random House Unabridged Dictionary, 2d ed, 1993%29%%A%    
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D018907 2003
% 207.86/208.03  |- skos__prefLabel mesh__D018907 Privacy
% 207.86/208.03  |- skos__hiddenLabel mesh__D018907 PL93 579
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D018907 2002
% 207.86/208.03  |- mesh__recordAuthorizer mesh__D018907 SJN
% 207.86/208.03  |- mesh__publicMeSHNote mesh__D018907
% 207.86/208.03       96; PRIVACY ACT was see CIVIL RIGHTS 1980-95   
% 207.86/208.03  |- mesh__dateCreated mesh__D018907 1994-12-27
% 207.86/208.03  |- rdf__type mesh__D018907sskos__Concept
% 207.86/208.03  |- skos__hiddenLabel mesh__D018907 Act, Privacy
% 207.86/208.03  |- mesh__recordMaintainer mesh__D018907 JLS
% 207.86/208.03  |- skos__related mesh__D018907smesh__D003219
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D018907 2001
% 207.86/208.03  |- skos__broader mesh__D018907smesh__D002961
% 207.86/208.03  |- skos__hiddenLabel mesh__D018907 Public Law 93 579
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D018907 2006
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D018907 2000
% 207.86/208.03  |- mesh__recordOriginator mesh__D018907 TGC
% 207.86/208.03  |- mesh__historyNote mesh__D018907
% 207.86/208.03       96; PRIVACY ACT was see CIVIL RIGHTS 1980-95   
% 207.86/208.03  |- skos__related mesh__D018907smesh__D012650
% 207.86/208.03  |- mesh__dateRevised mesh__D018907 1998-06-10
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D018907 1999
% 207.86/208.03  |- skos__hiddenLabel mesh__D018907 PL 93 579
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D018907 2005
% 207.86/208.03  |- skos__altLabel mesh__D018907 PL 93-579
% 207.86/208.03  |- mesh__dateEstablished mesh__D018907 1996-01-01
% 207.86/208.03  |- mesh__onlineNote mesh__D018907
% 207.86/208.03       use CIVIL RIGHTS to search PRIVACY 1980-95   
% 207.86/208.03  |- skos__related mesh__D018907smesh__D010550
% 207.86/208.03  |- skos__altLabel mesh__D018907 PL93-579
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D018907 2004
% 207.86/208.03  |- skos__annotation mesh__D010924
% 207.86/208.03       extracts of placenta or placental fractions; do not confuse with chemical substances %22%extracted%22% from the placenta, as %22%peptides extracted from the mouse placenta%22% %28% = PEPTIDES /anal + PLACENTA /chem%29%%A%  
% 207.86/208.03  |- mesh__dateCreated mesh__D010924 1999-01-01
% 207.86/208.03  |- mesh__recordAuthorizer mesh__D010924 sjn
% 207.86/208.03  |- rdf__type mesh__D010924sskos__Concept
% 207.86/208.03  |- mesh__recordOriginator mesh__D010924 NLM
% 207.86/208.03  |- skos__hiddenLabel mesh__D010924 Extracts, Placental
% 207.86/208.03  |- skos__broader mesh__D010924smesh__D014020
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D010924 2006
% 207.86/208.03  |- skos__scopeNote mesh__D010924
% 207.86/208.03       Extracts prepared from placental tissue; they may contain specific but uncharacterized factors or proteins with specific activities.%A%    
% 207.86/208.03  |- skos__prefLabel mesh__D010924 Placental Extracts
% 207.86/208.03  |- mesh__recordMaintainer mesh__D010924 ssb
% 207.86/208.03  |- mesh__dateRevised mesh__D010924 2005-06-30
% 207.86/208.03  |- skos__altLabel mesh__D018109 Paramyxoviruses, Avian
% 207.86/208.03  |- skos__hiddenLabel mesh__D018109 Avulaviruses
% 207.86/208.03  |- skos__hiddenLabel mesh__D018109 Avian Paramyxovirus
% 207.86/208.03  |- mesh__dateCreated mesh__D018109 1993-06-04
% 207.86/208.03  |- skos__altLabel mesh__D018109 Avian Paramyxoviruses
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D018109 2006
% 207.86/208.03  |- mesh__historyNote mesh__D018109 2004 %28%1994%29%   
% 207.86/208.03  |- skos__hiddenLabel mesh__D018109 Paramyxovirus, Avian
% 207.86/208.03  |- mesh__recordOriginator mesh__D018109 AGS
% 207.86/208.03  |- skos__scopeNote mesh__D018109
% 207.86/208.03       A genus in the subfamily PARAMYXOVIRINAE, family PARAMYXOVIRIDAE, causing disease in domestic fowl. There are many species, the most well-known being avian paramyxovirus 1 %28%NEWCASTLE DISEASE VIRUS%29%.%A%    
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D018109 2004
% 207.86/208.03  |- mesh__recordMaintainer mesh__D018109 ags
% 207.86/208.03  |- skos__prefLabel mesh__D018109 Avulavirus
% 207.86/208.03  |- skos__historyNote mesh__D018109 Paramyxoviridae %28%1975-1993%29%
% 207.86/208.03  |- mesh__recordAuthorizer mesh__D018109 sjn
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D018109 2005
% 207.86/208.03  |- skos__broader mesh__D018109smesh__D018098
% 207.86/208.03  |- rdf__type mesh__D018109sskos__Concept
% 207.86/208.03  |- mesh__dateEstablished mesh__D018109 1994-01-01
% 207.86/208.03  |- skos__annotation mesh__D018109
% 207.86/208.03       infection: coord IM with AVULAVIRUS INFECTIONS %28%IM%29%   
% 207.86/208.03  |- mesh__publicMeSHNote mesh__D018109
% 207.86/208.03       2004; see PARAMYXOVIRUSES, AVIAN 1994-2003   
% 207.86/208.03  |- mesh__dateRevised mesh__D018109 2003-07-09
% 207.86/208.03  |- skos__scopeNote mesh__D010126
% 207.86/208.03       An unstable triatomic form of oxygen, O3, that exists in the atmosphere in varying proportions. It is produced continuously in the outer layers of the atmosphere by the action of solar UV-radiation on the oxygen of the air.%A%    
% 207.86/208.03  |- skos__broader mesh__D010126smesh__D010100
% 207.86/208.03  |- mesh__dateCreated mesh__D010126 1999-01-01
% 207.86/208.03  |- skos__prefLabel mesh__D010126 Ozone
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D010126 2006
% 207.86/208.03  |- rdf__type mesh__D010126sskos__Concept
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D010126 2005
% 207.86/208.03  |- mesh__dateRevised mesh__D010126 2003-07-09
% 207.86/208.03  |- mesh__recordAuthorizer mesh__D010126 sjn
% 207.86/208.03  |- mesh__recordOriginator mesh__D010126 NLM
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D010126 2004
% 207.86/208.03  |- mesh__recordMaintainer mesh__D010126 ssb
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D006883 2006
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D006883 2004
% 207.86/208.03  |- mesh__recordOriginator mesh__D006883 NLM
% 207.86/208.03  |- skos__scopeNote mesh__D006883
% 207.86/208.03       Benzoic acid substituted by one or more hydroxy groups in any position on the benzene ring.%A%    
% 207.86/208.03  |- mesh__recordMaintainer mesh__D006883 ADP
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D006883 2000
% 207.86/208.03  |- skos__hiddenLabel mesh__D006883 Acids, Hydroxybenzoic
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D006883 2001
% 207.86/208.03  |- skos__broader mesh__D006883smesh__D020185
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D006883 1999
% 207.86/208.03  |- mesh__recordAuthorizer mesh__D006883 SJN
% 207.86/208.03  |- skos__historyNote mesh__D006883 Phenols %28%1966-1974%29%
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D006883 2002
% 207.86/208.03  |- mesh__historyNote mesh__D006883 75   
% 207.86/208.03  |- mesh__publicMeSHNote mesh__D006883
% 207.86/208.03       75; VANILLIC ACID was see under BENZOATES 1968-74   
% 207.86/208.03  |- mesh__dateCreated mesh__D006883 1974-11-19
% 207.86/208.03  |- mesh__dateEstablished mesh__D006883 1975-09-01
% 207.86/208.03  |- skos__broader mesh__D006883smesh__D010636
% 207.86/208.03  |- skos__broader mesh__D006883smesh__D006880
% 207.86/208.03  |- skos__prefLabel mesh__D006883 Hydroxybenzoic Acids
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D006883 2005
% 207.86/208.03  |- mesh__dateRevised mesh__D006883 1998-06-10
% 207.86/208.03  |- rdf__type mesh__D006883sskos__Concept
% 207.86/208.03  |- skos__historyNote mesh__D006883 Benzoates %28%1966-1974%29%
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D006883 2003
% 207.86/208.03  |- mesh__recordAuthorizer mesh__D020554 sjn
% 207.86/208.03  |- skos__hiddenLabel mesh__D020554 Injection, Intracytoplasmic Sperm
% 207.86/208.03  |- skos__broader mesh__D020554smesh__D005307
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D020554 2005
% 207.86/208.03  |- rdf__type mesh__D020554sskos__Concept
% 207.86/208.03  |- mesh__dateEstablished mesh__D020554 2000-01-01
% 207.86/208.03  |- mesh__recordOriginator mesh__D020554 ndw
% 207.86/208.03  |- skos__related mesh__D020554smesh__D007248
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D020554 2003
% 207.86/208.03  |- mesh__dateCreated mesh__D020554 1999-11-03
% 207.86/208.03  |- mesh__publicMeSHNote mesh__D020554 2000   
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D020554 2006
% 207.86/208.03  |- skos__hiddenLabel mesh__D020554 Injections, Intracytoplasmic Sperm
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D020554 2002
% 207.86/208.03  |- mesh__dateRevised mesh__D020554 2001-07-25
% 207.86/208.03  |- skos__historyNote mesh__D020554 Microinjections %28%1994-1999%29%
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D020554 2004
% 207.86/208.03  |- skos__hiddenLabel mesh__D020554 Sperm Injection, Intracytoplasmic
% 207.86/208.03  |- skos__hiddenLabel mesh__D020554 Intracytoplasmic Sperm Injection
% 207.86/208.03  |- mesh__recordMaintainer mesh__D020554 lkt
% 207.86/208.03  |- skos__altLabel mesh__D020554 ICSI
% 207.86/208.03  |- skos__historyNote mesh__D020554 Fertilization in Vitro %28%1994-1999%29%
% 207.86/208.03  |- mesh__historyNote mesh__D020554 2000   
% 207.86/208.03  |- skos__prefLabel mesh__D020554 Sperm Injections, Intracytoplasmic
% 207.86/208.03  |- skos__scopeNote mesh__D020554
% 207.86/208.03       An assisted fertilization technique consisting of the microinjection of a single viable sperm into an extracted ovum. It is used principally to overcome low sperm count, low sperm motility, inability of sperm to penetrate the egg, or other conditions related to male infertility %28%INFERTILITY, MALE%29%.%A%    
% 207.86/208.03  |- skos__altLabel mesh__D020554 Intracytoplasmic Sperm Injections
% 207.86/208.03  |- skos__altLabel mesh__D020554 Injections, Sperm, Intracytoplasmic
% 207.86/208.03  |- skos__hiddenLabel mesh__D006085 Graft Survivals
% 207.86/208.03  |- mesh__publicMeSHNote mesh__D006085 77   
% 207.86/208.03  |- skos__historyNote mesh__D006085
% 207.86/208.03       Transplantation Immunology %28%1966-1972%29%
% 207.86/208.03  |- mesh__recordAuthorizer mesh__D006085 sjn
% 207.86/208.03  |- skos__prefLabel mesh__D006085 Graft Survival
% 207.86/208.03  |- mesh__dateRevised mesh__D006085 2005-06-30
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D006085 2006
% 207.86/208.03  |- skos__annotation mesh__D006085
% 207.86/208.03       may be used with transplanted neoplasms   
% 207.86/208.03  |- mesh__historyNote mesh__D006085 77   
% 207.86/208.03  |- mesh__dateEstablished mesh__D006085 1977-01-01
% 207.86/208.03  |- skos__broader mesh__D006085smesh__D006789
% 207.86/208.03  |- skos__historyNote mesh__D006085 Graft Rejection %28%1971-1976%29%
% 207.86/208.03  |- rdf__type mesh__D006085sskos__Concept
% 207.86/208.03  |- skos__hiddenLabel mesh__D006085 Survivals, Graft
% 207.86/208.03  |- mesh__recordMaintainer mesh__D006085 ags
% 207.86/208.03  |- skos__hiddenLabel mesh__D006085 Survival, Graft
% 207.86/208.03  |- skos__scopeNote mesh__D006085
% 207.86/208.03       The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host.%A%    
% 207.86/208.03  |- skos__related mesh__D006085smesh__D023001
% 207.86/208.03  |- mesh__recordOriginator mesh__D006085 MM
% 207.86/208.03  |- mesh__dateCreated mesh__D006085 1976-05-19
% 207.86/208.03  |- skos__related mesh__D006085smesh__D051799
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D014517 1993
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D014517 1998
% 207.86/208.03  |- skos__annotation mesh__D014517
% 207.86/208.03       do not confuse with URETHRAL OBSTRUCTION, espec in Romance lang: see note on %22%ureteral%22% %26% %22%urethral%22% under URETERAL DISEASES%A%  
% 207.86/208.03  |- mesh__recordOriginator mesh__D014517 NLM
% 207.86/208.03  |- mesh__recordAuthorizer mesh__D014517 NLM
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D014517 2002
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D014517 1997
% 207.86/208.03  |- skos__hiddenLabel mesh__D014517 Ureteral Obstructions
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D014517 1992
% 207.86/208.03  |- skos__prefLabel mesh__D014517 Ureteral Obstruction
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D014517 2006
% 207.86/208.03  |- skos__broader mesh__D014517smesh__D014515
% 207.86/208.03  |- mesh__dateCreated mesh__D014517 1999-01-01
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D014517 2001
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D014517 1996
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D014517 2000
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D014517 2005
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D014517 1991
% 207.86/208.03  |- skos__hiddenLabel mesh__D014517 Obstructions, Ureteral
% 207.86/208.03  |- mesh__recordMaintainer mesh__D014517 PLS
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D014517 2004
% 207.86/208.03  |- rdf__type mesh__D014517sskos__Concept
% 207.86/208.03  |- skos__hiddenLabel mesh__D014517 Obstruction, Ureteral
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D014517 1995
% 207.86/208.03  |- mesh__dateRevised mesh__D014517 1990-05-29
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D014517 2003
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D014517 1999
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D014517 1994
% 207.86/208.03  |- skos__hiddenLabel mesh__D019202 Avibirnaviruses
% 207.86/208.03  |- mesh__historyNote mesh__D019202 97   
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D019202 1999
% 207.86/208.03  |- mesh__dateCreated mesh__D019202 1996-06-10
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D019202 2004
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D019202 2002
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D019202 1998
% 207.86/208.03  |- skos__broader mesh__D019202smesh__D018059
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D019202 2003
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D019202 2001
% 207.86/208.03  |- mesh__publicMeSHNote mesh__D019202 97   
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D019202 1997
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D019202 2000
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D019202 2006
% 207.86/208.03  |- skos__scopeNote mesh__D019202
% 207.86/208.03       A genus of RNA viruses in the family BIRNAVIRIDAE infecting birds. It is transmitted horizontally with no known vectors. The type species is INFECTIOUS BURSAL DISEASE VIRUS.%A%    
% 207.86/208.03  |- rdf__type mesh__D019202sskos__Concept
% 207.86/208.03  |- skos__annotation mesh__D019202
% 207.86/208.03       a genus of the family Birnaviridae; infection: coord IM with BIRNAVIRIDAE INFECTIONS %28%IM%29%%A%  
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D019202 2005
% 207.86/208.03  |- mesh__dateEstablished mesh__D019202 1997-01-01
% 207.86/208.03  |- skos__prefLabel mesh__D019202 Avibirnavirus
% 207.86/208.03  |- skos__hiddenLabel mesh__D002493 CNS Disease
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D002493 2003
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D002493 2006
% 207.86/208.03  |- mesh__recordOriginator mesh__D002493 NLM
% 207.86/208.03  |- mesh__dateRevised mesh__D002493 1999-11-03
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D002493 2004
% 207.86/208.03  |- skos__altLabel mesh__D002493 CNS Diseases
% 207.86/208.03  |- mesh__onlineNote mesh__D002493
% 207.86/208.03       pre-explosion = CENTRAL NERVOUS SYSTEM DISEASES %28%PX%29%   
% 207.86/208.03  |- skos__prefLabel mesh__D002493 Central Nervous System Diseases
% 207.86/208.03  |- skos__scopeNote mesh__D002493
% 207.86/208.03       Diseases of any component of the brain %28%including the cerebral hemispheres, diencephalon, brain stem, and cerebellum%29% or the spinal cord.%A%    
% 207.86/208.03  |- skos__annotation mesh__D002493 GEN: prefer specifics; DF: CNS DIS   
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D002493 2000
% 207.86/208.03  |- skos__broader mesh__D002493smesh__D009422
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D002493 2001
% 207.86/208.03  |- mesh__recordAuthorizer mesh__D002493 sjn
% 207.86/208.03  |- skos__altLabel mesh__D002493 Central Nervous System Disorders
% 207.86/208.03  |- rdf__type mesh__D002493sskos__Concept
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D002493 2005
% 207.86/208.03  |- mesh__dateCreated mesh__D002493 1999-01-01
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D002493 2002
% 207.86/208.03  |- mesh__recordMaintainer mesh__D002493 KEV
% 207.86/208.03  |- skos__annotation mesh__D018908
% 207.86/208.03       GEN or unspecified as a clin state or clin manifest: specific musc or neuromusc dis of which this is a manifest are also available; do not confuse %22%myasthenia%22% %28%my-, muscle + asthenia, weakness%29% in foreign titles with %22%muscle weakness%22%: it is more likely to refer to MYASTHENIA GRAVIS; do not confuse with MUSCLE HYPOTONIA or MUSCLE FATIGUE%A%  
% 207.86/208.03  |- mesh__dateEstablished mesh__D018908 1996-01-01
% 207.86/208.03  |- mesh__historyNote mesh__D018908 96   
% 207.86/208.03  |- mesh__recordAuthorizer mesh__D018908 sjn
% 207.86/208.03  |- mesh__dateCreated mesh__D018908 1994-12-27
% 207.86/208.03  |- rdf__type mesh__D018908sskos__Concept
% 207.86/208.03  |- skos__broader mesh__D018908smesh__D009135
% 207.86/208.03  |- mesh__dateRevised mesh__D018908 1999-11-03
% 207.86/208.03  |- skos__scopeNote mesh__D018908
% 207.86/208.03       A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. %28%From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251%29%%A%    
% 207.86/208.03  |- skos__hiddenLabel mesh__D018908 Weaknesses, Muscle
% 207.86/208.03  |- skos__hiddenLabel mesh__D018908 Muscle Weaknesses
% 207.86/208.03  |- skos__prefLabel mesh__D018908 Muscle Weakness
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D018908 2006
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D018908 2002
% 207.86/208.03  |- mesh__publicMeSHNote mesh__D018908 96   
% 207.86/208.03  |- skos__hiddenLabel mesh__D018908 Weakness, Muscular
% 207.86/208.03  |- skos__related mesh__D018908smesh__D001247
% 207.86/208.03  |- skos__broader mesh__D018908smesh__D020879
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D018908 2005
% 207.86/208.03  |- skos__hiddenLabel mesh__D018908 Muscular Weaknesses
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D018908 2001
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D018908 2004
% 207.86/208.03  |- skos__hiddenLabel mesh__D018908 Weaknesses, Muscular
% 207.86/208.03  |- skos__altLabel mesh__D018908 Muscular Weakness
% 207.86/208.03  |- mesh__recordMaintainer mesh__D018908 KEV
% 207.86/208.03  |- skos__broader mesh__D018908smesh__D010335
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D018908 2000
% 207.86/208.03  |- mesh__recordOriginator mesh__D018908 TGC
% 207.86/208.03  |- skos__historyNote mesh__D018908 Muscular Diseases %28%1966-1995%29%
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D018908 2003
% 207.86/208.03  |- skos__hiddenLabel mesh__D018908 Weakness, Muscle
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D010925 2000
% 207.86/208.03  |- skos__scopeNote mesh__D010925
% 207.86/208.03       Methods used for the assessment of placental function.     
% 207.86/208.03  |- mesh__recordAuthorizer mesh__D010925 SJN
% 207.86/208.03  |- skos__hiddenLabel mesh__D010925 Tests, Fetoplacental Function
% 207.86/208.03  |- skos__historyNote mesh__D010925
% 207.86/208.03       Fetal Diseases/diagnosis %28%1966-1974%29%
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D010925 2003
% 207.86/208.03  |- skos__historyNote mesh__D010925 Placenta %28%1966-1974%29%
% 207.86/208.03  |- skos__hiddenLabel mesh__D010925 Tests, Placental Function
% 207.86/208.03  |- mesh__dateRevised mesh__D010925 1997-06-20
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D010925 1999
% 207.86/208.03  |- skos__altLabel mesh__D010925 Fetoplacental Function Tests
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D010925 2006
% 207.86/208.03  |- skos__hiddenLabel mesh__D010925 Function Test, Placental
% 207.86/208.03  |- skos__historyNote mesh__D010925 Placenta Diseases %28%1969-1974%29%
% 207.86/208.03  |- mesh__dateCreated mesh__D010925 1974-11-19
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D010925 2002
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D010925 1998
% 207.86/208.03  |- skos__hiddenLabel mesh__D010925 Test, Fetoplacental Function
% 207.86/208.03  |- mesh__dateEstablished mesh__D010925 1975-09-01
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D010925 2005
% 207.86/208.03  |- skos__prefLabel mesh__D010925 Placental Function Tests
% 207.86/208.03  |- skos__hiddenLabel mesh__D010925 Fetoplacental Function Test
% 207.86/208.03  |- mesh__recordMaintainer mesh__D010925 PXP
% 207.86/208.03  |- skos__annotation mesh__D010925 NIM   
% 207.86/208.03  |- skos__broader mesh__D010925smesh__D003944
% 207.86/208.03  |- mesh__recordOriginator mesh__D010925 NLM
% 207.86/208.03  |- skos__hiddenLabel mesh__D010925 Test, Placental Function
% 207.86/208.03  |- mesh__publicMeSHNote mesh__D010925 75   
% 207.86/208.03  |- skos__hiddenLabel mesh__D010925 Function Tests, Placental
% 207.86/208.03  |- skos__hiddenLabel mesh__D010925 Function Test, Fetoplacental
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D010925 2001
% 207.86/208.03  |- rdf__type mesh__D010925sskos__Concept
% 207.86/208.03  |- skos__hiddenLabel mesh__D010925 Function Tests, Fetoplacental
% 207.86/208.03  |- mesh__historyNote mesh__D010925 75   
% 207.86/208.03  |- skos__hiddenLabel mesh__D010925 Placental Function Test
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D010925 2004
% 207.86/208.03  |- skos__broader mesh__D029630smesh__D019684
% 207.86/208.03  |- skos__scopeNote mesh__D029630
% 207.86/208.03       A plant family of the order Santalales, subclass Rosidae, class Magnoliopsida. They are parasites that form connections %28%haustoria%29% to their hosts to obtain water and nutrients. The one-seeded fruit may be surrounded by a brightly colored nut-like structure.%A%    
% 207.86/208.03  |- skos__altLabel mesh__D029630 Toadflax, Bastard
% 207.86/208.03  |- mesh__dateCreated mesh__D029630 2001-07-25
% 207.86/208.03  |- mesh__publicMeSHNote mesh__D029630 2002   
% 207.86/208.03  |- mesh__recordAuthorizer mesh__D029630 sjn
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D029630 2005
% 207.86/208.03  |- skos__prefLabel mesh__D029630 Santalaceae
% 207.86/208.03  |- mesh__historyNote mesh__D029630 2002   
% 207.86/208.03  |- mesh__recordOriginator mesh__D029630 ssb
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D029630 2003
% 207.86/208.03  |- rdf__type mesh__D029630sskos__Concept
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D029630 2006
% 207.86/208.03  |- skos__annotation mesh__D029630
% 207.86/208.03       X ref Toadflax, Bastard: Toadflax see LINARIA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.86/208.03  |- mesh__dateEstablished mesh__D029630 2002-01-01
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D029630 2004
% 207.86/208.03  |- mesh__recordMaintainer mesh__D029630 ssb
% 207.86/208.03  |- mesh__dateRevised mesh__D029630 2002-07-03
% 207.86/208.03  |- skos__annotation mesh__D010127
% 207.86/208.03       IM; coord with disease /blood %28%IM%29%, not /immunol nor /genet; TN 230%A%  
% 207.86/208.03  |- mesh__publicMeSHNote mesh__D010127
% 207.86/208.03       91; was see under BLOOD GROUPS 1976-90   
% 207.86/208.03  |- skos__hiddenLabel mesh__D010127 Blood-Group Systems, P
% 207.86/208.03  |- mesh__dateCreated mesh__D010127 1975-07-25
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D010127 2006
% 207.86/208.03  |- skos__scopeNote mesh__D010127
% 207.86/208.03       A blood group related to the ABO, Lewis and I systems. At least five different erythrocyte antigens are possible, some very rare, others almost universal. Multiple alleles are involved in this blood group.%A%    
% 207.86/208.03  |- mesh__dateEstablished mesh__D010127 1991-01-01
% 207.86/208.03  |- skos__hiddenLabel mesh__D010127 System, P Blood-Group
% 207.86/208.03  |- rdf__type mesh__D010127sskos__Concept
% 207.86/208.03  |- skos__hiddenLabel mesh__D010127 P Blood-Group Systems
% 207.86/208.03  |- mesh__historyNote mesh__D010127
% 207.86/208.03       91%28%76%29%; was see under BLOOD GROUPS 1976-90   
% 207.86/208.03  |- skos__historyNote mesh__D010127 Blood Groups %28%1966-1975%29%
% 207.86/208.03  |- skos__hiddenLabel mesh__D010127 Systems, P Blood-Group
% 207.86/208.03  |- skos__hiddenLabel mesh__D010127 Blood-Group System, P
% 207.86/208.03  |- mesh__recordOriginator mesh__D010127 SH
% 207.86/208.03  |- skos__prefLabel mesh__D010127 P Blood-Group System
% 207.86/208.03  |- mesh__recordAuthorizer mesh__D010127 sjn
% 207.86/208.03  |- mesh__dateRevised mesh__D010127 2005-06-30
% 207.86/208.03  |- mesh__recordMaintainer mesh__D010127 ssb
% 207.86/208.03  |- skos__broader mesh__D010127smesh__D001789
% 207.86/208.03  |- skos__hiddenLabel mesh__D010127 P Blood Group System
% 207.86/208.03  |- mesh__publicMeSHNote mesh__D015610 90   
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D015610 2005
% 207.86/208.03  |- skos__historyNote mesh__D015610
% 207.86/208.03       Microbial Sensitivity Tests %28%1972-1989%29%
% 207.86/208.03  |- mesh__recordAuthorizer mesh__D015610 jls
% 207.86/208.03  |- mesh__dateEstablished mesh__D015610 1990-01-01
% 207.86/208.03  |- skos__hiddenLabel mesh__D015610 Serum Bactericidal Tests
% 207.86/208.03  |- skos__scopeNote mesh__D015610
% 207.86/208.03       Method of measuring the bactericidal activity contained in a patient%27%s serum as a result of antimicrobial therapy. It is used to monitor the therapy in BACTERIAL ENDOCARDITIS; OSTEOMYELITIS and other serious bacterial infections. As commonly performed, the test is a variation of the broth dilution test. This test needs to be distinguished from testing of the naturally occurring BLOOD BACTERICIDAL ACTIVITY.%A%    
% 207.86/208.03  |- skos__hiddenLabel mesh__D015610 Tests, Serum Bactericidal
% 207.86/208.03  |- skos__hiddenLabel mesh__D015610 Test, Serum Bactericidal
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D015610 2005A
% 207.86/208.03  |- skos__hiddenLabel mesh__D015610 Test, Schlichter
% 207.86/208.03  |- rdf__type mesh__D015610sskos__Concept
% 207.86/208.03  |- mesh__activeMeSHYear mesh__D015610 2004
% 207.86/208.04  |- skos__hiddenLabel mesh__D015610 Bactericidal Tests, Serum
% 207.86/208.04  |- skos__annotation mesh__D015610
% 207.86/208.04       do not confuse with BLOOD BACTERICIDAL ACTIVITY, the natural bactericidal property of blood %28%Cat G%29%; MIC %28%Minimum Inhibitory Concentration%29% goes here if with regard to blood levels of drug or under MICROBIAL SENSITIVITY TESTS if on eff of drug on microorganism%A%  
% 207.86/208.04  |- mesh__recordMaintainer mesh__D015610 jls
% 207.86/208.04  |- mesh__historyNote mesh__D015610 90   
% 207.86/208.04  |- skos__prefLabel mesh__D015610 Serum Bactericidal Test
% 207.86/208.04  |- mesh__dateCreated mesh__D015610 1989-04-07
% 207.86/208.04  |- skos__broader mesh__D015610smesh__D008826
% 207.86/208.04  |- skos__historyNote mesh__D015610
% 207.86/208.04       Blood Bactericidal Activity %28%1972-1989%29%
% 207.86/208.04  |- skos__related mesh__D015610smesh__D001770
% 207.86/208.04  |- skos__hiddenLabel mesh__D015610 Bactericidal Test, Serum
% 207.86/208.04  |- skos__altLabel mesh__D015610 Schlichter Test
% 207.86/208.04  |- mesh__recordOriginator mesh__D015610 AGS
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D015610 2006
% 207.86/208.04  |- mesh__dateRevised mesh__D015610 2004-08-02
% 207.86/208.04  |- skos__prefLabel mesh__D006884 Hydroxybutyrate Dehydrogenase
% 207.86/208.04  |- mesh__historyNote mesh__D006884 65   
% 207.86/208.04  |- mesh__publicMeSHNote mesh__D006884 65   
% 207.86/208.04  |- skos__hiddenLabel mesh__D006884 Dehydrogenase, D-3-Hydroxybutyrate
% 207.86/208.04  |- skos__hiddenLabel mesh__D006884 3 Hydroxybutyrate Dehydrogenase
% 207.86/208.04  |- skos__hiddenLabel mesh__D006884 D 3 Hydroxybutyrate Dehydrogenase
% 207.86/208.04  |- rdf__type mesh__D006884sskos__Concept
% 207.86/208.04  |- skos__hiddenLabel mesh__D006884 Dehydrogenase, 3-Hydroxybutyrate
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006884 2005
% 207.86/208.04  |- skos__altLabel mesh__D006884 3-Hydroxybutyrate Dehydrogenase
% 207.86/208.04  |- mesh__recordAuthorizer mesh__D006884 sjn
% 207.86/208.04  |- skos__hiddenLabel mesh__D006884 D beta Hydroxybutyrate Dehydrogenase
% 207.86/208.04  |- mesh__recordMaintainer mesh__D006884 ssb
% 207.86/208.04  |- mesh__recordOriginator mesh__D006884 NLM
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006884 2006
% 207.86/208.04  |- mesh__dateRevised mesh__D006884 2003-07-09
% 207.86/208.04  |- skos__hiddenLabel mesh__D006884 Dehydrogenase, D-beta-Hydroxybutyrate
% 207.86/208.04  |- mesh__dateEstablished mesh__D006884 1965-01-01
% 207.86/208.04  |- mesh__dateCreated mesh__D006884 1999-01-01
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006884 2004
% 207.86/208.04  |- skos__hiddenLabel mesh__D006884 Dehydrogenase, Hydroxybutyrate
% 207.86/208.04  |- skos__altLabel mesh__D006884 D-beta-Hydroxybutyrate Dehydrogenase
% 207.86/208.04  |- skos__altLabel mesh__D006884 D-3-Hydroxybutyrate Dehydrogenase
% 207.86/208.04  |- skos__broader mesh__D006884smesh__D000429
% 207.86/208.04  |- skos__hiddenLabel mesh__D020555 Signaling Regulators, G-Protein
% 207.86/208.04  |- skos__altLabel mesh__D020555 Regulating Factors, G-Protein
% 207.86/208.04  |- skos__hiddenLabel mesh__D020555 Regulators, GTP-Binding Protein
% 207.86/208.04  |- mesh__dateRevised mesh__D020555 2005-06-30
% 207.86/208.04  |- skos__altLabel mesh__D020555 G-Protein Signaling Regulators
% 207.86/208.04  |- skos__hiddenLabel mesh__D020555 G Protein Signaling Regulators
% 207.86/208.04  |- mesh__recordOriginator mesh__D020555 jmp
% 207.86/208.04  |- skos__hiddenLabel mesh__D020555 Regulating Factors, GTP Binding Protein
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D020555 2006
% 207.86/208.04  |- skos__hiddenLabel mesh__D020555 Regulators, G Protein Signaling
% 207.86/208.04  |- skos__scopeNote mesh__D020555
% 207.86/208.04       Proteins that regulate the signaling activity of GTP-BINDING PROTEINS. They are divided into three categories depending upon whether they stimulate GTPase activity %28%GTPASE-ACTIVATING PROTEINS%29%, inhibit release of GDP; %28%GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS%29%; or exchange GTP for GDP; %28%GUANINE NUCLEOTIDE EXCHANGE FACTORS%29%.%A%    
% 207.86/208.04  |- skos__altLabel mesh__D020555 Regulating Factors, GTP-Binding Protein
% 207.86/208.04  |- mesh__recordAuthorizer mesh__D020555 sjn
% 207.86/208.04  |- skos__annotation mesh__D020555
% 207.86/208.04       Do not confuse with RGS proteins; DF: GTP BINDING PROTEIN REG%A%  
% 207.86/208.04  |- skos__hiddenLabel mesh__D020555 G Protein Regulating Factors
% 207.86/208.04  |- mesh__dateCreated mesh__D020555 1999-11-03
% 207.86/208.04  |- skos__altLabel mesh__D020555 G-Protein Regulating Factors
% 207.86/208.04  |- mesh__recordMaintainer mesh__D020555 SYSTEM
% 207.86/208.04  |- skos__broader mesh__D020555smesh__D011506
% 207.86/208.04  |- mesh__publicMeSHNote mesh__D020555 2000   
% 207.86/208.04  |- mesh__historyNote mesh__D020555 2000   
% 207.86/208.04  |- skos__historyNote mesh__D020555 Proteins %28%1978-1999%29%
% 207.86/208.04  |- skos__altLabel mesh__D020555 Regulators, G-Protein Signaling
% 207.86/208.04  |- skos__broader mesh__D020555smesh__D047908
% 207.86/208.04  |- rdf__type mesh__D020555sskos__Concept
% 207.86/208.04  |- skos__prefLabel mesh__D020555 GTP-Binding Protein Regulators
% 207.86/208.04  |- mesh__dateEstablished mesh__D020555 2000-01-01
% 207.86/208.04  |- skos__historyNote mesh__D020555 G-Proteins %28%1988-1999%29%
% 207.86/208.04  |- skos__hiddenLabel mesh__D020555 GTP Binding Protein Regulators
% 207.86/208.04  |- skos__hiddenLabel mesh__D006086 Disease, Graft-vs-Host
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006086 2006
% 207.86/208.04  |- mesh__historyNote mesh__D006086
% 207.86/208.04       84; was HOMOLOGOUS WASTING DISEASE 1964-83 %28%Prov 1964-66%29%%A%  
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006086 1994
% 207.86/208.04  |- skos__altLabel mesh__D006086 Graft-Versus-Host Disease
% 207.86/208.04  |- mesh__dateRevised mesh__D006086 1993-05-28
% 207.86/208.04  |- skos__hiddenLabel mesh__D006086 Disease, Graft-Versus-Host
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006086 2003
% 207.86/208.04  |- skos__broader mesh__D006086smesh__D007154
% 207.86/208.04  |- skos__altLabel mesh__D006086 Homologous Wasting Disease
% 207.86/208.04  |- mesh__recordMaintainer mesh__D006086 TGC
% 207.86/208.04  |- skos__altLabel mesh__D006086 Graft-vs-Host Disease
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006086 2002
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006086 1998
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006086 1995
% 207.86/208.04  |- skos__hiddenLabel mesh__D006086 Disease, Homologous Wasting
% 207.86/208.04  |- skos__prefLabel mesh__D006086 Graft vs Host Disease
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006086 2004
% 207.86/208.04  |- skos__hiddenLabel mesh__D006086 Diseases, Graft-vs-Host
% 207.86/208.04  |- mesh__recordAuthorizer mesh__D006086 PLS
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006086 1999
% 207.86/208.04  |- mesh__dateEstablished mesh__D006086 1967-01-01
% 207.86/208.04  |- skos__hiddenLabel mesh__D006086 Graft-Versus-Host Diseases
% 207.86/208.04  |- skos__hiddenLabel mesh__D006086 Disease, Runt
% 207.86/208.04  |- mesh__onlineNote mesh__D006086
% 207.86/208.04       use GRAFT VS HOST DISEASE to search HOMOLOGOUS WASTING DISEASE 1966-83 %28%as Prov 1966%29%%A%  
% 207.86/208.04  |- skos__hiddenLabel mesh__D006086 Diseases, Graft-Versus-Host
% 207.86/208.04  |- skos__scopeNote mesh__D006086
% 207.86/208.04       The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.%A%    
% 207.86/208.04  |- rdf__type mesh__D006086sskos__Concept
% 207.86/208.04  |- skos__annotation mesh__D006086
% 207.86/208.04       do not confuse with GRAFT VS HOST REACTION %28%Cat G%29%; DF: note short X ref%A%  
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006086 2000
% 207.86/208.04  |- mesh__dateCreated mesh__D006086 1999-01-01
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006086 1996
% 207.86/208.04  |- skos__altLabel mesh__D006086 Runt Disease
% 207.86/208.04  |- skos__hiddenLabel mesh__D006086 Graft Versus Host Disease
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006086 2005
% 207.86/208.04  |- mesh__publicMeSHNote mesh__D006086
% 207.86/208.04       84; was HOMOLOGOUS WASTING DISEASE 1967-83   
% 207.86/208.04  |- mesh__recordOriginator mesh__D006086 NLM
% 207.86/208.04  |- skos__hiddenLabel mesh__D006086 Graft-vs-Host Diseases
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006086 1997
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006086 2001
% 207.86/208.04  |- skos__prefLabel mesh__D014518 Ureterocele
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D014518 2006
% 207.86/208.04  |- mesh__dateCreated mesh__D014518 1999-01-01
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D014518 1996
% 207.86/208.04  |- mesh__dateRevised mesh__D014518 1993-06-03
% 207.86/208.04  |- mesh__publicMeSHNote mesh__D014518 68   
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D014518 2005
% 207.86/208.04  |- mesh__recordOriginator mesh__D014518 NLM
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D014518 2002
% 207.86/208.04  |- mesh__historyNote mesh__D014518 68%28%63%29%   
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D014518 2004
% 207.86/208.04  |- rdf__type mesh__D014518sskos__Concept
% 207.86/208.04  |- skos__broader mesh__D014518smesh__D014515
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D014518 1995
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D014518 2001
% 207.86/208.04  |- skos__annotation mesh__D014518 cystic dilat of ureter   
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D014518 2003
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D014518 2000
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D014518 1999
% 207.86/208.04  |- mesh__recordMaintainer mesh__D014518 TAP
% 207.86/208.04  |- mesh__recordAuthorizer mesh__D014518 PLS
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D014518 1994
% 207.86/208.04  |- skos__hiddenLabel mesh__D014518 Ureteroceles
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D014518 1998
% 207.86/208.04  |- mesh__dateEstablished mesh__D014518 1968-01-01
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D014518 1997
% 207.86/208.04  |- skos__scopeNote mesh__D014518
% 207.86/208.04       Cystic dilatation of the ureter with ballooning of the ureteral orifice into the lumen of the bladder.%A%    
% 207.86/208.04  |- mesh__historyNote mesh__D019203 97   
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D019203 1999
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D019203 2004
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D019203 2002
% 207.86/208.04  |- skos__broader mesh__D019203smesh__D018059
% 207.86/208.04  |- skos__scopeNote mesh__D019203
% 207.86/208.04       A genus of RNA viruses of the family BIRNAVIRIDAE infecting fruitflies. Transmission is horizontal and there are no known vectors. Drosophila melanogaster is the natural host and the type species is Drosophila X virus.%A%    
% 207.86/208.04  |- skos__annotation mesh__D019203
% 207.86/208.04       a genus of the family Birnaviridae; infection: coord IM with BIRNAVIRIDAE INFECTIONS %28%IM%29%%A%  
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D019203 2005
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D019203 1997
% 207.86/208.04  |- mesh__dateEstablished mesh__D019203 1997-01-01
% 207.86/208.04  |- mesh__dateCreated mesh__D019203 1996-06-10
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D019203 2000
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D019203 2006
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D019203 2001
% 207.86/208.04  |- skos__hiddenLabel mesh__D019203 Entomobirnaviruses
% 207.86/208.04  |- rdf__type mesh__D019203sskos__Concept
% 207.86/208.04  |- skos__prefLabel mesh__D019203 Entomobirnavirus
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D019203 1998
% 207.86/208.04  |- mesh__publicMeSHNote mesh__D019203 97   
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D019203 2003
% 207.86/208.04  |- mesh__recordOriginator mesh__D011220 NLM
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D011220 2001
% 207.86/208.04  |- skos__altLabel mesh__D011220 Pyridine Aldoxime Methyl Compounds
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D011220 2006
% 207.86/208.04  |- skos__broader mesh__D011220smesh__D010091
% 207.86/208.04  |- skos__hiddenLabel mesh__D011220 Compounds, Pralidoxime
% 207.86/208.04  |- mesh__dateRevised mesh__D011220 2000-06-22
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D011220 2002
% 207.86/208.04  |- skos__altLabel mesh__D011220 2-PAM Compounds
% 207.86/208.04  |- mesh__historyNote mesh__D011220 65%28%63%29%   
% 207.86/208.04  |- mesh__recordAuthorizer mesh__D011220 sjn
% 207.86/208.04  |- skos__hiddenLabel mesh__D011220 2 PAM Compounds
% 207.86/208.04  |- mesh__dateCreated mesh__D011220 1999-01-01
% 207.86/208.04  |- skos__annotation mesh__D011220 DF: PRALIDOXIME CPDS   
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D011220 2003
% 207.86/208.04  |- rdf__type mesh__D011220sskos__Concept
% 207.86/208.04  |- skos__hiddenLabel mesh__D011220 Compounds, 2-PAM
% 207.86/208.04  |- mesh__recordMaintainer mesh__D011220 CCR
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D011220 2004
% 207.86/208.04  |- skos__prefLabel mesh__D011220 Pralidoxime Compounds
% 207.86/208.04  |- skos__scopeNote mesh__D011220
% 207.86/208.04       Various salts of a quaternary ammonium oxime that reconstitute inactivated acetylcholinesterase, especially at the neuromuscular junction, and may cause neuromuscular blockade. They are used as antidotes to organophosphorus poisoning as chlorides, iodides, methanesulfonates %28%mesylates%29%, or other salts.%A%    
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D011220 2005
% 207.86/208.04  |- mesh__dateEstablished mesh__D011220 1965-01-01
% 207.86/208.04  |- mesh__publicMeSHNote mesh__D011220 65   
% 207.86/208.04  |- skos__broader mesh__D002494smesh__D002493
% 207.86/208.04  |- mesh__recordAuthorizer mesh__D002494 sjn
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D002494 2000
% 207.86/208.04  |- mesh__historyNote mesh__D002494 1998; use explode 1971-1997   
% 207.86/208.04  |- mesh__publicMeSHNote mesh__D002494 1998   
% 207.86/208.04  |- mesh__dateEstablished mesh__D002494 1998-01-01
% 207.86/208.04  |- mesh__recordMaintainer mesh__D002494 KEV
% 207.86/208.04  |- skos__historyNote mesh__D002494
% 207.86/208.04       Central Nervous System Diseases %28%1967-1997%29%
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D002494 2004
% 207.86/208.04  |- skos__historyNote mesh__D002494 Infection %28%1967-1997%29%
% 207.86/208.04  |- skos__prefLabel mesh__D002494 Central Nervous System Infections
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D002494 2006
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D002494 2003
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D002494 2005
% 207.86/208.04  |- mesh__dateCreated mesh__D002494 1999-01-01
% 207.86/208.04  |- skos__scopeNote mesh__D002494
% 207.86/208.04       Pathogenic infections of the brain, spinal cord, and meninges. DNA VIRUS INFECTIONS; RNA VIRUS INFECTIONS; BACTERIAL INFECTIONS; MYCOPLASMA INFECTIONS; SPIROCHAETALES INFECTIONS; fungal infections; PROTOZOAN INFECTIONS; HELMINTHIASIS; and PRION DISEASES may involve the central nervous system as a primary or secondary process.%A%    
% 207.86/208.04  |- mesh__recordOriginator mesh__D002494 NLM
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D002494 2002
% 207.86/208.04  |- skos__annotation mesh__D002494
% 207.86/208.04       GEN or unspecified; prefer specifics; coord IM with specific site/dis term %28%IM%29% if pertinent; DF: CNS INFECT%A%  
% 207.86/208.04  |- skos__altLabel mesh__D002494 Infections, Central Nervous System
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D002494 2001
% 207.86/208.04  |- skos__altLabel mesh__D002494 Central Nervous System Infection
% 207.86/208.04  |- skos__broader mesh__D002494smesh__D001423
% 207.86/208.04  |- rdf__type mesh__D002494sskos__Concept
% 207.86/208.04  |- mesh__dateRevised mesh__D002494 1999-11-04
% 207.86/208.04  |- skos__hiddenLabel mesh__D018909 Homology Domains, src
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D018909 2006
% 207.86/208.04  |- mesh__recordOriginator mesh__D018909 AGS
% 207.86/208.04  |- skos__historyNote mesh__D018909 Amino Acid Sequence %28%1989-1995%29%
% 207.86/208.04  |- skos__hiddenLabel mesh__D018909 SH2 Domains
% 207.86/208.04  |- mesh__dateRevised mesh__D018909 2004-07-07
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D018909 2005
% 207.86/208.04  |- skos__broader mesh__D018909smesh__D017434
% 207.86/208.04  |- skos__hiddenLabel mesh__D018909 src Homology Domain
% 207.86/208.04  |- mesh__dateEstablished mesh__D018909 1996-01-01
% 207.86/208.04  |- skos__altLabel mesh__D018909 SH Domains
% 207.86/208.04  |- skos__hiddenLabel mesh__D018909 SH Domain
% 207.86/208.04  |- skos__altLabel mesh__D018909 src Homology Region 2 Domain
% 207.86/208.04  |- skos__prefLabel mesh__D018909 src Homology Domains
% 207.86/208.04  |- skos__historyNote mesh__D018909
% 207.86/208.04       Sequence Homology, Amino Acid %28%1993-1995%29%
% 207.86/208.04  |- mesh__dateCreated mesh__D018909 1995-01-06
% 207.86/208.04  |- mesh__recordAuthorizer mesh__D018909 sjn
% 207.86/208.04  |- mesh__recordMaintainer mesh__D018909 nns
% 207.86/208.04  |- skos__hiddenLabel mesh__D018909 SH1 Domains
% 207.86/208.04  |- skos__scopeNote mesh__D018909
% 207.86/208.04       Regions of sequence similarity in the src family of cytoplasmic tyrosine kinases. The SH1 domain is a catalytic domain. SH2 and SH3 domains are protein-binding domains. SH2 usually binds phosphotyrosine-containing proteins and SH3 interacts with cytoskeletal proteins.%A%    
% 207.86/208.04  |- mesh__historyNote mesh__D018909 96   
% 207.86/208.04  |- rdf__type mesh__D018909sskos__Concept
% 207.86/208.04  |- skos__hiddenLabel mesh__D018909 Homology Domain, src
% 207.86/208.04  |- skos__hiddenLabel mesh__D018909 SH3 Domains
% 207.86/208.04  |- mesh__publicMeSHNote mesh__D018909 96   
% 207.86/208.04  |- skos__broader mesh__D010926smesh__D036361
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D010926 2006
% 207.86/208.04  |- mesh__recordMaintainer mesh__D010926 lkt
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D010926 2005
% 207.86/208.04  |- mesh__dateCreated mesh__D010926 1999-01-01
% 207.86/208.04  |- rdf__type mesh__D010926sskos__Concept
% 207.86/208.04  |- skos__broader mesh__D010926smesh__D006728
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D010926 2004
% 207.86/208.04  |- skos__prefLabel mesh__D010926 Placental Hormones
% 207.86/208.04  |- mesh__recordAuthorizer mesh__D010926 sjn
% 207.86/208.04  |- mesh__recordOriginator mesh__D010926 NLM
% 207.86/208.04  |- mesh__dateRevised mesh__D010926 2002-07-03
% 207.86/208.04  |- skos__scopeNote mesh__D010926
% 207.86/208.04       Hormones produced by the placenta include CHORIONIC GONADOTROPIN, and PLACENTAL LACTOGEN as well as steroids %28%ESTROGENS; PROGESTERONE%29%, and neuropeptide hormones similar to those found in the hypothalamus %28%HYPOTHALAMIC HORMONES%29%.%A%    
% 207.86/208.04  |- skos__hiddenLabel mesh__D010926 Hormones, Placental
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D010926 2003
% 207.86/208.04  |- mesh__recordMaintainer mesh__D029631 ssb
% 207.86/208.04  |- mesh__publicMeSHNote mesh__D029631 2002   
% 207.86/208.04  |- skos__prefLabel mesh__D029631 Sapindaceae
% 207.86/208.04  |- skos__broader mesh__D029631smesh__D019684
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D029631 2005
% 207.86/208.04  |- skos__annotation mesh__D029631
% 207.86/208.04       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.86/208.04  |- mesh__recordOriginator mesh__D029631 ssb
% 207.86/208.04  |- mesh__dateCreated mesh__D029631 2001-07-25
% 207.86/208.04  |- rdf__type mesh__D029631sskos__Concept
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D029631 2006
% 207.86/208.04  |- skos__scopeNote mesh__D029631
% 207.86/208.04       The soapberry plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida. Some members contain SAPONINS.%A%    
% 207.86/208.04  |- mesh__dateEstablished mesh__D029631 2002-01-01
% 207.86/208.04  |- mesh__recordAuthorizer mesh__D029631 sjn
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D029631 2004
% 207.86/208.04  |- mesh__dateRevised mesh__D029631 2003-07-09
% 207.86/208.04  |- mesh__historyNote mesh__D029631 2002   
% 207.86/208.04  |- skos__hiddenLabel mesh__D043302 Products, Cultured Milk
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D043302 2006
% 207.86/208.04  |- skos__hiddenLabel mesh__D043302 Milk Product, Cultured
% 207.86/208.04  |- skos__altLabel mesh__D043302 Milk Products, Cultured
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D043302 2004
% 207.86/208.04  |- mesh__publicMeSHNote mesh__D043302
% 207.86/208.04       2004; for BUTTERMILK and KEFIR see MILK 1998-2003   
% 207.86/208.04  |- skos__scopeNote mesh__D043302
% 207.86/208.04       Milk modified with controlled FERMENTATION. This should not be confused with KAFFIR LIME or with KAFFIR CORN.%A%    
% 207.86/208.04  |- skos__hiddenLabel mesh__D043302 Milk Products, Fermented
% 207.86/208.04  |- skos__hiddenLabel mesh__D043302 Fermented Milk Product
% 207.86/208.04  |- skos__prefLabel mesh__D043302 Cultured Milk Products
% 207.86/208.04  |- skos__historyNote mesh__D043302 Milk %28%1963-2003%29%
% 207.86/208.04  |- mesh__dateCreated mesh__D043302 2003-07-09
% 207.86/208.04  |- skos__hiddenLabel mesh__D043302 Milk Product, Fermented
% 207.86/208.04  |- mesh__historyNote mesh__D043302
% 207.86/208.04       2004; for BUTTERMILK and KEFIR use MILK 1998-2003   
% 207.86/208.04  |- mesh__recordOriginator mesh__D043302 ssb
% 207.86/208.04  |- mesh__recordAuthorizer mesh__D043302 sjn
% 207.86/208.04  |- mesh__dateEstablished mesh__D043302 2004-01-01
% 207.86/208.04  |- skos__altLabel mesh__D043302 Fermented Milk Products
% 207.86/208.04  |- skos__hiddenLabel mesh__D043302 Cultured Milk Product
% 207.86/208.04  |- mesh__recordMaintainer mesh__D043302 ssb
% 207.86/208.04  |- skos__broader mesh__D043302smesh__D008892
% 207.86/208.04  |- skos__hiddenLabel mesh__D043302 Product, Fermented Milk
% 207.86/208.04  |- skos__hiddenLabel mesh__D043302 Product, Cultured Milk
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D043302 2005
% 207.86/208.04  |- skos__hiddenLabel mesh__D043302 Products, Fermented Milk
% 207.86/208.04  |- rdf__type mesh__D043302sskos__Concept
% 207.86/208.04  |- rdf__type mesh__D010128sskos__Concept
% 207.86/208.04  |- mesh__recordAuthorizer mesh__D010128 NLM
% 207.86/208.04  |- skos__hiddenLabel mesh__D010128 para Aminoazobenzene
% 207.86/208.04  |- mesh__publicMeSHNote mesh__D010128
% 207.86/208.04       91; was see under AZO COMPOUNDS 1976-90   
% 207.86/208.04  |- mesh__historyNote mesh__D010128
% 207.86/208.04       91%28%76%29%; was see under AZO COMPOUNDS 1976-90   
% 207.86/208.04  |- skos__prefLabel mesh__D010128 p-Aminoazobenzene
% 207.86/208.04  |- skos__hiddenLabel mesh__D010128 p Aminoazobenzene
% 207.86/208.04  |- mesh__recordOriginator mesh__D010128 RLS
% 207.86/208.04  |- skos__historyNote mesh__D010128 Azo Compounds %28%1969-1975%29%
% 207.86/208.04  |- skos__altLabel mesh__D010128 para-Aminoazobenzene
% 207.86/208.04  |- skos__scopeNote mesh__D010128
% 207.86/208.04       Used in the form of its salts as a dye and as an intermediate in manufacture of Acid Yellow, diazo dyes, and indulines.%A%    
% 207.86/208.04  |- mesh__dateCreated mesh__D010128 1975-07-23
% 207.86/208.04  |- skos__annotation mesh__D010128 D25-26 qualif   
% 207.86/208.04  |- mesh__dateRevised mesh__D010128 2005-07-06
% 207.86/208.04  |- skos__historyNote mesh__D010128 Aniline Compounds %28%1973-1975%29%
% 207.86/208.04  |- skos__broader mesh__D010128smesh__D001391
% 207.86/208.04  |- mesh__recordMaintainer mesh__D010128 NLM
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D010128 2006
% 207.86/208.04  |- mesh__dateEstablished mesh__D010128 1991-01-01
% 207.86/208.04  |- mesh__recordOriginator mesh__D015611 PXP
% 207.86/208.04  |- mesh__recordAuthorizer mesh__D015611 sjn
% 207.86/208.04  |- mesh__historyNote mesh__D015611 90   
% 207.86/208.04  |- skos__altLabel mesh__D015611 DHBV
% 207.86/208.04  |- skos__historyNote mesh__D015611 Hepatitis B Virus %28%1981-1989%29%
% 207.86/208.04  |- skos__prefLabel mesh__D015611 Hepatitis B Virus, Duck
% 207.86/208.04  |- mesh__recordMaintainer mesh__D015611 sjn
% 207.86/208.04  |- skos__altLabel mesh__D015611 Duck hepatitis B virus
% 207.86/208.04  |- skos__altLabel mesh__D015611 Hepatitis B Viruses, Duck
% 207.86/208.04  |- rdf__type mesh__D015611sskos__Concept
% 207.86/208.04  |- mesh__dateRevised mesh__D015611 2004-07-13
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D015611 2005
% 207.86/208.04  |- skos__annotation mesh__D015611
% 207.86/208.04       do not confuse with HEPATITIS VIRUS, DUCK, an enterovirus; infection: coord IM with HEPADNAVIRIDAE INFECTIONS %28%IM%29% + HEPATITIS, VIRAL, ANIMAL %28%IM%29%%A%  
% 207.86/208.04  |- skos__altLabel mesh__D015611 Duck Hepatitis B Viruses
% 207.86/208.04  |- skos__broader mesh__D015611smesh__D017917
% 207.86/208.04  |- mesh__publicMeSHNote mesh__D015611 90   
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D015611 2006
% 207.86/208.04  |- skos__scopeNote mesh__D015611
% 207.86/208.04       A DNA virus that closely resembles human hepatitis B virus. It has been recovered from naturally infected ducks.%A%    
% 207.86/208.04  |- mesh__dateCreated mesh__D015611 1989-04-07
% 207.86/208.04  |- mesh__dateEstablished mesh__D015611 1990-01-01
% 207.86/208.04  |- rdf__type mesh__D006885sskos__Concept
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006885 2005
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006885 2006
% 207.86/208.04  |- mesh__dateRevised mesh__D006885 2003-07-09
% 207.86/208.04  |- mesh__dateCreated mesh__D006885 1999-01-01
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006885 2004
% 207.86/208.04  |- mesh__recordAuthorizer mesh__D006885 sjn
% 207.86/208.04  |- skos__broader mesh__D006885smesh__D020155
% 207.86/208.04  |- mesh__recordMaintainer mesh__D006885 ssb
% 207.86/208.04  |- mesh__recordOriginator mesh__D006885 NLM
% 207.86/208.04  |- skos__scopeNote mesh__D006885
% 207.86/208.04       Salts and esters of hydroxybutyric acid.     
% 207.86/208.04  |- skos__prefLabel mesh__D006885 Hydroxybutyrates
% 207.86/208.04  |- mesh__historyNote mesh__D020556 2000   
% 207.86/208.04  |- skos__broader mesh__D020556smesh__D007109
% 207.86/208.04  |- skos__prefLabel mesh__D020556 Neutrophil Infiltration
% 207.86/208.04  |- mesh__dateCreated mesh__D020556 1999-11-04
% 207.86/208.04  |- skos__scopeNote mesh__D020556
% 207.86/208.04       The diffusion or accumulation of neutrophils in tissues or cells in response to a wide variety of substances released at the sites of inflammatory reactions.%A%    
% 207.86/208.04  |- skos__related mesh__D020556smesh__D017254
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D020556 2000
% 207.86/208.04  |- rdf__type mesh__D020556sskos__Concept
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D020556 2005
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D020556 2003
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D020556 2006
% 207.86/208.04  |- mesh__dateEstablished mesh__D020556 2000-01-01
% 207.86/208.04  |- skos__hiddenLabel mesh__D020556 Recruitment, Neutrophil
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D020556 2001
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D020556 2004
% 207.86/208.04  |- skos__related mesh__D020556smesh__D002634
% 207.86/208.04  |- mesh__publicMeSHNote mesh__D020556 2000   
% 207.86/208.04  |- skos__altLabel mesh__D020556 Neutrophil Recruitment
% 207.86/208.04  |- skos__hiddenLabel mesh__D020556 Infiltration, Neutrophil
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D020556 2002
% 207.86/208.04  |- skos__historyNote mesh__D020556 Neutrophils %28%1969-1999%29%
% 207.86/208.04  |- mesh__recordOriginator mesh__D006087 NLM
% 207.86/208.04  |- mesh__dateEstablished mesh__D006087 1970-01-01
% 207.86/208.04  |- skos__historyNote mesh__D006087 Graft vs Host Disease %28%1966-1969%29%
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006087 1998
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006087 2003
% 207.86/208.04  |- skos__scopeNote mesh__D006087
% 207.86/208.04       An immunological attack mounted by a graft against the host because of tissue incompatibility when immunologically competent cells are transplanted to an immunologically incompetent host; the resulting clinical picture is that of GRAFT VS HOST DISEASE.%A%    
% 207.86/208.04  |- mesh__dateRevised mesh__D006087 1996-06-10
% 207.86/208.04  |- skos__historyNote mesh__D006087
% 207.86/208.04       Transplantation Immunology %28%1966-1969%29%
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006087 2001
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006087 2006
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006087 2000
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006087 1997
% 207.86/208.04  |- skos__related mesh__D006087smesh__D006086
% 207.86/208.04  |- skos__prefLabel mesh__D006087 Graft vs Host Reaction
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006087 2005
% 207.86/208.04  |- mesh__historyNote mesh__D006087 70   
% 207.86/208.04  |- skos__annotation mesh__D006087
% 207.86/208.04       do not confuse with HOST VS GRAFT REACTION nor with GRAFT VS HOST DISEASE%A%  
% 207.86/208.04  |- mesh__publicMeSHNote mesh__D006087 70   
% 207.86/208.04  |- rdf__type mesh__D006087sskos__Concept
% 207.86/208.04  |- skos__broader mesh__D006087smesh__D014181
% 207.86/208.04  |- mesh__recordAuthorizer mesh__D006087 PLS
% 207.86/208.04  |- mesh__dateCreated mesh__D006087 1999-01-01
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006087 2002
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006087 1999
% 207.86/208.04  |- mesh__recordMaintainer mesh__D006087 TGC
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D006087 2004
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D014519 2006
% 207.86/208.04  |- skos__annotation mesh__D014519
% 207.86/208.04       do not use /util except by MeSH definition   
% 207.86/208.04  |- mesh__dateEstablished mesh__D014519 1988-01-01
% 207.86/208.04  |- mesh__publicMeSHNote mesh__D014519 88   
% 207.86/208.04  |- mesh__dateCreated mesh__D014519 1987-03-20
% 207.86/208.04  |- mesh__activeMeSHYear mesh__D014519 2003
% 207.86/208.04  |- skos__scopeNote mesh__D014519
% 207.86/208.04       Surgical formation of an opening in the ureter for external drainage of the urine; cutaneous route utilizes a ureteral orifice emerging through the skin.%A%    
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D014519 2002
% 207.86/208.05  |- skos__broader mesh__D014519smesh__D010030
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D014519 2004
% 207.86/208.05  |- mesh__historyNote mesh__D014519 88   
% 207.86/208.05  |- rdf__type mesh__D014519sskos__Concept
% 207.86/208.05  |- skos__historyNote mesh__D014519 Ureter/surgery %28%1966-1987%29%
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D014519 1998
% 207.86/208.05  |- mesh__recordMaintainer mesh__D014519 PXP
% 207.86/208.05  |- mesh__recordAuthorizer mesh__D014519 SJN
% 207.86/208.05  |- mesh__recordOriginator mesh__D014519 SCD
% 207.86/208.05  |- skos__hiddenLabel mesh__D014519 Ureterostomies
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D014519 1999
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D014519 2000
% 207.86/208.05  |- skos__historyNote mesh__D014519 Urinary Diversion %28%1966-1987%29%
% 207.86/208.05  |- skos__prefLabel mesh__D014519 Ureterostomy
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D014519 2005
% 207.86/208.05  |- mesh__dateRevised mesh__D014519 1997-06-20
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D014519 2001
% 207.86/208.05  |- skos__broader mesh__D014519smesh__D014547
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D025241 2005
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D025241 2002
% 207.86/208.05  |- skos__prefLabel mesh__D025241 Spondylarthritis
% 207.86/208.05  |- mesh__dateCreated mesh__D025241 2001-07-25
% 207.86/208.05  |- skos__related mesh__D025241smesh__D013167
% 207.86/208.05  |- skos__annotation mesh__D025241
% 207.86/208.05       coord IM with specific vertebrae %28%IM%29%   
% 207.86/208.05  |- skos__broader mesh__D025241smesh__D013122
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D025241 2003
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D025241 2006
% 207.86/208.05  |- skos__historyNote mesh__D025241
% 207.86/208.05       Spondylitis, Ankylosing %28%1966-2001%29%
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D025241 2004
% 207.86/208.05  |- mesh__dateEstablished mesh__D025241 2002-01-01
% 207.86/208.05  |- skos__broader mesh__D025241smesh__D001168
% 207.86/208.05  |- skos__hiddenLabel mesh__D025241 Spondylarthritides
% 207.86/208.05  |- skos__scopeNote mesh__D025241
% 207.86/208.05       Arthritis of the spine, specifically involving the intervertebral articulations.%A%    
% 207.86/208.05  |- mesh__historyNote mesh__D025241 2002   
% 207.86/208.05  |- rdf__type mesh__D025241sskos__Concept
% 207.86/208.05  |- skos__altLabel mesh__D025241 Spinal Arthritis
% 207.86/208.05  |- skos__altLabel mesh__D025241 Arthritis, Spinal
% 207.86/208.05  |- mesh__publicMeSHNote mesh__D025241 2002   
% 207.86/208.05  |- skos__hiddenLabel mesh__D025241 Spinal Arthritides
% 207.86/208.05  |- skos__hiddenLabel mesh__D019204 Proteins, GTP-Regulatory
% 207.86/208.05  |- skos__altLabel mesh__D019204 GTP-Regulatory Proteins
% 207.86/208.05  |- skos__scopeNote mesh__D019204
% 207.86/208.05       Regulatory proteins that act as molecular switches. They control a wide range of biological processes including: receptor signaling, intracellular signal transduction pathways, and protein synthesis. Their activity is regulated by factors that control their ability to bind to and hydrolyze GTP to GDP. EC 3.6.1.-.%A%    
% 207.86/208.05  |- skos__hiddenLabel mesh__D019204 GTP Binding Protein
% 207.86/208.05  |- skos__altLabel mesh__D019204 Guanine Nucleotide Regulatory Proteins
% 207.86/208.05  |- skos__hiddenLabel mesh__D019204 G Protein
% 207.86/208.05  |- skos__altLabel mesh__D019204 GTP-Regulatory Protein
% 207.86/208.05  |- skos__altLabel mesh__D019204 G-Proteins
% 207.86/208.05  |- skos__altLabel mesh__D019204 G-Protein
% 207.86/208.05  |- skos__broader mesh__D019204smesh__D020558
% 207.86/208.05  |- mesh__recordOriginator mesh__D019204 TPW
% 207.86/208.05  |- mesh__publicMeSHNote mesh__D019204
% 207.86/208.05       1997; see G-PROTEINS 1985-1996; for G-PROTEINS see G-PROTEINS 1992-1999; for GUANINE NUCLEOTIDE REGULATORY PROTEINS see G-PROTEINS 1992-1996; for GTP-REGULATORY PROTEINS see G-PROTEINS 1985-1996%A%  
% 207.86/208.05  |- skos__hiddenLabel mesh__D019204 Proteins, GTP-Binding
% 207.86/208.05  |- skos__prefLabel mesh__D019204 GTP-Binding Proteins
% 207.86/208.05  |- skos__hiddenLabel mesh__D019204 Protein, GTP-Binding
% 207.86/208.05  |- skos__hiddenLabel mesh__D019204 G Proteins
% 207.86/208.05  |- skos__hiddenLabel mesh__D019204 GTP Regulatory Proteins
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D019204 2006
% 207.86/208.05  |- skos__broader mesh__D019204smesh__D002352
% 207.86/208.05  |- mesh__dateRevised mesh__D019204 2005-06-30
% 207.86/208.05  |- skos__altLabel mesh__D019204 GTP-Binding Protein
% 207.86/208.05  |- skos__hiddenLabel mesh__D019204 Protein, GTP-Regulatory
% 207.86/208.05  |- rdf__type mesh__D019204sskos__Concept
% 207.86/208.05  |- mesh__recordAuthorizer mesh__D019204 sjn
% 207.86/208.05  |- skos__annotation mesh__D019204
% 207.86/208.05       GEN or unspecified; prefer specifics; GTP stands for Guanosine TriPhosphate%A%  
% 207.86/208.05  |- mesh__recordMaintainer mesh__D019204 SYSTEM
% 207.86/208.05  |- mesh__dateEstablished mesh__D019204 1997-01-01
% 207.86/208.05  |- mesh__historyNote mesh__D019204 1997%28%1985%29%   
% 207.86/208.05  |- mesh__dateCreated mesh__D019204 1996-06-10
% 207.86/208.05  |- skos__hiddenLabel mesh__D019204 GTP Regulatory Protein
% 207.86/208.05  |- skos__hiddenLabel mesh__D019204 GTP Binding Proteins
% 207.86/208.05  |- skos__altLabel mesh__D019204 Guanine Nucleotide Coupling Protein
% 207.86/208.05  |- skos__annotation mesh__D011221
% 207.86/208.05       a rare earth metal; Pr-141; Pr-134-140, 142-148 = PRASEODYMIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 207.86/208.05  |- mesh__dateCreated mesh__D011221 1999-01-01
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D011221 2003
% 207.86/208.05  |- rdf__type mesh__D011221sskos__Concept
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D011221 2004
% 207.86/208.05  |- mesh__recordOriginator mesh__D011221 NLM
% 207.86/208.05  |- mesh__dateRevised mesh__D011221 2001-07-25
% 207.86/208.05  |- mesh__recordMaintainer mesh__D011221 jmp
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D011221 2005
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D011221 2002
% 207.86/208.05  |- skos__broader mesh__D011221smesh__D028581
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D011221 2006
% 207.86/208.05  |- skos__scopeNote mesh__D011221
% 207.86/208.05       Praseodymium. An element of the rare earth family of metals. It has the atomic symbol Pr, atomic number 59, and atomic weight 140.91.%A%    
% 207.86/208.05  |- mesh__recordAuthorizer mesh__D011221 sjn
% 207.86/208.05  |- skos__prefLabel mesh__D011221 Praseodymium
% 207.86/208.05  |- mesh__recordMaintainer mesh__D002495 KEV
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D002495 2004
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D002495 2001
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D002495 2006
% 207.86/208.05  |- skos__scopeNote mesh__D002495
% 207.86/208.05       Hospital department responsible for receiving, storing, and distributing medical and surgical supplies and equipment.%A%    
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D002495 2003
% 207.86/208.05  |- mesh__onlineNote mesh__D002495
% 207.86/208.05       use CENTRAL SUPPLY, HOSPITAL to search HOSPITAL CENTRAL SUPPLY 1968-77%A%  
% 207.86/208.05  |- skos__altLabel mesh__D002495 Supplies, Hospital Central
% 207.86/208.05  |- skos__altLabel mesh__D002495 Supply, Hospital Central
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D002495 2005
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D002495 2000
% 207.86/208.05  |- mesh__dateRevised mesh__D002495 1996-06-10
% 207.86/208.05  |- mesh__publicMeSHNote mesh__D002495
% 207.86/208.05       78; was HOSPITAL CENTRAL SUPPLY 1968-77   
% 207.86/208.05  |- mesh__dateCreated mesh__D002495 1999-01-01
% 207.86/208.05  |- skos__prefLabel mesh__D002495 Central Supply, Hospital
% 207.86/208.05  |- skos__broader mesh__D002495smesh__D006748
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D002495 1997
% 207.86/208.05  |- skos__annotation mesh__D002495
% 207.86/208.05       do not confuse with CENTRALIZED HOSPITAL SERVICES   
% 207.86/208.05  |- mesh__recordAuthorizer mesh__D002495 PLS
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D002495 1999
% 207.86/208.05  |- skos__hiddenLabel mesh__D002495 Central Supplies, Hospital
% 207.86/208.05  |- mesh__historyNote mesh__D002495
% 207.86/208.05       78; was HOSPITAL CENTRAL SUPPLY 1968-77   
% 207.86/208.05  |- rdf__type mesh__D002495sskos__Concept
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D002495 1998
% 207.86/208.05  |- mesh__dateEstablished mesh__D002495 1968-01-01
% 207.86/208.05  |- skos__altLabel mesh__D002495 Hospital Central Supply
% 207.86/208.05  |- mesh__recordOriginator mesh__D002495 NLM
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D002495 2002
% 207.86/208.05  |- skos__altLabel mesh__D002495 Hospital Central Supplies
% 207.86/208.05  |- rdf__type mesh__D043303sskos__Concept
% 207.86/208.05  |- skos__altLabel mesh__D043303 Paraoxonase
% 207.86/208.05  |- skos__broader mesh__D043303smesh__D044345
% 207.86/208.05  |- skos__altLabel mesh__D043303 Organophosphorus Acid Anhydrase
% 207.86/208.05  |- mesh__publicMeSHNote mesh__D043303
% 207.86/208.05       2004; ARYLDIALKYLPHOSPHATASE was indexed under ESTERASES 1994-2003; PHOSPHORIC MONOESTER HYRDOLASES 1990-1993; PHOSPHOMONOESTERASES 1982-1989%A%  
% 207.86/208.05  |- skos__altLabel mesh__D043303 Arylalkylphosphatase
% 207.86/208.05  |- skos__historyNote mesh__D043303 Esterases %28%1980-2003%29%
% 207.86/208.05  |- skos__altLabel mesh__D043303 Homocysteine Thiolactone Hydrolase
% 207.86/208.05  |- skos__hiddenLabel mesh__D043303 Phosphatase, Aryl-dialkyl
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D043303 2005
% 207.86/208.05  |- skos__hiddenLabel mesh__D043303 Paraoxonase 1
% 207.86/208.05  |- skos__hiddenLabel mesh__D043303 Anhydrase, OPA
% 207.86/208.05  |- skos__hiddenLabel mesh__D043303 Anhydrolase, Organophosphorus Acid
% 207.86/208.05  |- skos__hiddenLabel mesh__D043303 Aryl dialkyl Phosphatase
% 207.86/208.05  |- skos__hiddenLabel mesh__D043303 Thiolactone Hydrolase, Homocysteine
% 207.86/208.05  |- skos__scopeNote mesh__D043303
% 207.86/208.05       An enzyme which catalyzes the hydrolysis of an aryl-dialkyl phosphate to form dialkyl phosphate and an aryl alcohol. It can hydrolyze a broad spectrum of organophosphate substrates and a number of aromatic carboxylic acid esters. It may also mediate an enzymatic protection of LOW DENSITY LIPOPROTEINS against oxidative modification and the consequent series of events leading to ATHEROMA formation. The enzyme was previously regarded to be identical with Arylesterase %28%EC 3.1.1.2%29%.%A%    
% 207.86/208.05  |- skos__altLabel mesh__D043303 Organophosphorus Acid Hydrolase
% 207.86/208.05  |- mesh__recordMaintainer mesh__D043303 jmp
% 207.86/208.05  |- skos__hiddenLabel mesh__D043303 Paraoxonase 2
% 207.86/208.05  |- skos__prefLabel mesh__D043303 Aryldialkylphosphatase
% 207.86/208.05  |- mesh__recordAuthorizer mesh__D043303 sjn
% 207.86/208.05  |- skos__altLabel mesh__D043303 OPH Enzyme
% 207.86/208.05  |- skos__hiddenLabel mesh__D043303 Anhydrase, Organophosphorus Acid
% 207.86/208.05  |- skos__annotation mesh__D043303
% 207.86/208.05       X refs PARAOXONASE-1 and PARAOXONASE-2 see SCR for organism specific terms%A%  
% 207.86/208.05  |- mesh__historyNote mesh__D043303
% 207.86/208.05       2004; use ARYLDIALKYLPHOSPHATASE %28%NM%29% 1980 - 2003   
% 207.86/208.05  |- skos__hiddenLabel mesh__D043303 Hydrolase, Homocysteine Thiolactone
% 207.86/208.05  |- skos__altLabel mesh__D043303 Aryl-dialkyl Phosphatase
% 207.86/208.05  |- skos__altLabel mesh__D043303 Organophosphorus Hydrolase
% 207.86/208.05  |- skos__altLabel mesh__D043303 Organophosphorus Acid Anhydrolase
% 207.86/208.05  |- skos__hiddenLabel mesh__D043303 Enzyme, OPH
% 207.86/208.05  |- skos__hiddenLabel mesh__D043303 Acid Anhydrase, Organophosphorus
% 207.86/208.05  |- mesh__dateEstablished mesh__D043303 2004-01-01
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D043303 2004
% 207.86/208.05  |- skos__hiddenLabel mesh__D043303 Hydrolase, Organophosphorus
% 207.86/208.05  |- mesh__recordOriginator mesh__D043303 AKE
% 207.86/208.05  |- skos__hiddenLabel mesh__D043303 Acid Anhydrolase, Organophosphorus
% 207.86/208.05  |- mesh__dateCreated mesh__D043303 2003-07-09
% 207.86/208.05  |- skos__hiddenLabel mesh__D043303 Hydrolase, Organophosphorus Acid
% 207.86/208.05  |- skos__altLabel mesh__D043303 OPA Anhydrase
% 207.86/208.05  |- skos__hiddenLabel mesh__D043303 Acid Hydrolase, Organophosphorus
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D043303 2006
% 207.86/208.05  |- skos__scopeNote mesh__D010927
% 207.86/208.05       Failure of the PLACENTA to deliver an adequate supply of nutrients and OXYGEN to the FETUS.%A%    
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D010927 2006
% 207.86/208.05  |- mesh__historyNote mesh__D010927
% 207.86/208.05       91%28%75%29%; was see under PLACENTA DISEASES 1980-90; was see under PLACENTA DISORDERS 1975-79%A%  
% 207.86/208.05  |- mesh__recordAuthorizer mesh__D010927 sjn
% 207.86/208.05  |- mesh__recordOriginator mesh__D010927 NLM
% 207.86/208.05  |- skos__annotation mesh__D010927 check the tags FEMALE %26% PREGNANCY   
% 207.86/208.05  |- skos__prefLabel mesh__D010927 Placental Insufficiency
% 207.86/208.05  |- mesh__dateCreated mesh__D010927 1974-11-11
% 207.86/208.05  |- mesh__dateEstablished mesh__D010927 1991-01-01
% 207.86/208.05  |- skos__broader mesh__D010927smesh__D010922
% 207.86/208.05  |- rdf__type mesh__D010927sskos__Concept
% 207.86/208.05  |- mesh__recordMaintainer mesh__D010927 lkt
% 207.86/208.05  |- mesh__publicMeSHNote mesh__D010927
% 207.86/208.05       91; was see under PLACENTA DISEASES 1980-90; was see under PLACENTA DISORDERS 1975-79%A%  
% 207.86/208.05  |- skos__hiddenLabel mesh__D010927 Insufficiency, Placental
% 207.86/208.05  |- mesh__dateRevised mesh__D010927 2005-06-30
% 207.86/208.05  |- skos__prefLabel mesh__D029632 Sapotaceae
% 207.86/208.05  |- mesh__recordAuthorizer mesh__D029632 sjn
% 207.86/208.05  |- rdf__type mesh__D029632sskos__Concept
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D029632 2006
% 207.86/208.05  |- skos__annotation mesh__D029632
% 207.86/208.05       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.86/208.05  |- mesh__recordOriginator mesh__D029632 ssb
% 207.86/208.05  |- mesh__historyNote mesh__D029632 2002   
% 207.86/208.05  |- skos__broader mesh__D029632smesh__D019684
% 207.86/208.05  |- mesh__dateEstablished mesh__D029632 2002-01-01
% 207.86/208.05  |- mesh__recordMaintainer mesh__D029632 ssb
% 207.86/208.05  |- mesh__dateRevised mesh__D029632 2005-06-30
% 207.86/208.05  |- mesh__publicMeSHNote mesh__D029632 2002   
% 207.86/208.05  |- skos__scopeNote mesh__D029632
% 207.86/208.05       A plant family of the order Ebenales, subclass Dilleniidae, class Magnoliopsida that are tropical trees which have elongate latex cells. Several members bear sweet edible fruits and produce triterpenoid saponins.%A%    
% 207.86/208.05  |- mesh__dateCreated mesh__D029632 2001-07-25
% 207.86/208.05  |- skos__hiddenLabel mesh__D010129 para-Aminobenzoate, Magnesium
% 207.86/208.05  |- skos__scopeNote mesh__D010129
% 207.86/208.05       A member of the VITAMIN B COMPLEX. It used to be a common sunscreening agent until found to also be a sensitizer. The potassium salt is used therapeutically in fibrotic skin disorders.%A%    
% 207.86/208.05  |- mesh__publicMeSHNote mesh__D010129
% 207.86/208.05       90; was P-AMINOBENZOIC ACID see under AMINOBENZOIC ACIDS 1977-89; was PARA-AMINOBENZOIC ACID see under AMINOBENZOIC ACID 1965-76; was PARA-AMINOBENZOIC ACID 1963-64%A%  
% 207.86/208.05  |- skos__annotation mesh__D010129
% 207.86/208.05       deficiency: coordinate 4-AMINOBENZOIC ACID /defic %28%IM%29% with VITAMIN B DEFICIENCY %28%IM%29%%A%  
% 207.86/208.05  |- mesh__onlineNote mesh__D010129
% 207.86/208.05       use 4-AMINOBENZOIC ACID to search P-AMINOBENZOIC ACID 1977-89; search AMINOBENZOIC ACIDS 1966-76%A%  
% 207.86/208.05  |- skos__prefLabel mesh__D010129 4-Aminobenzoic Acid
% 207.86/208.05  |- skos__hiddenLabel mesh__D010129 p Aminobenzoic Acid
% 207.86/208.05  |- mesh__recordAuthorizer mesh__D010129 sjn
% 207.86/208.05  |- mesh__dateRevised mesh__D010129 2005-06-30
% 207.86/208.05  |- mesh__dateCreated mesh__D010129 1976-05-19
% 207.86/208.05  |- mesh__recordMaintainer mesh__D010129 ssb
% 207.86/208.05  |- skos__historyNote mesh__D010129 Aminobenzoic Acids %28%1966-1976%29%
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D010129 2006
% 207.86/208.05  |- skos__broader mesh__D010129smesh__D000610
% 207.86/208.05  |- skos__altLabel mesh__D010129 para-Aminobenzoic Acid
% 207.86/208.05  |- skos__altLabel mesh__D010129 Aminobenzoic Acid
% 207.86/208.05  |- mesh__recordOriginator mesh__D010129 RLS
% 207.86/208.05  |- rdf__type mesh__D010129sskos__Concept
% 207.86/208.05  |- mesh__historyNote mesh__D010129
% 207.86/208.05       90%28%77%29%; was P-AMINOBENZOIC ACID see under AMINOBENZOIC ACIDS 1977-89; was PARA-AMINOBENZOIC ACID see under AMINOBENZOIC ACID 1965-76; was PARA-AMINOBENZOIC ACID 1963-64%A%  
% 207.86/208.05  |- mesh__dateEstablished mesh__D010129 1990-01-01
% 207.86/208.05  |- skos__hiddenLabel mesh__D010129 4 Aminobenzoic Acid
% 207.86/208.05  |- skos__hiddenLabel mesh__D010129 para Aminobenzoic Acid
% 207.86/208.05  |- skos__altLabel mesh__D010129 PABA
% 207.86/208.05  |- skos__altLabel mesh__D010129 p-Aminobenzoic Acid
% 207.86/208.05  |- skos__hiddenLabel mesh__D007180 Incisors
% 207.86/208.05  |- mesh__recordAuthorizer mesh__D007180 sjn
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D007180 2004
% 207.86/208.05  |- mesh__recordMaintainer mesh__D007180 lkt
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D007180 2006
% 207.86/208.05  |- rdf__type mesh__D007180sskos__Concept
% 207.86/208.05  |- skos__scopeNote mesh__D007180
% 207.86/208.05       Any of the eight frontal teeth %28%four maxillary and four mandibular%29% having a sharp incisal edge for cutting food and a single root, which occurs in man both as a deciduous and a permanent tooth. %28%Jablonski, Dictionary of Dentistry, 1992, p820%29%%A%    
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D007180 2005
% 207.86/208.05  |- skos__broader mesh__D007180smesh__D014070
% 207.86/208.05  |- mesh__recordOriginator mesh__D007180 NLM
% 207.86/208.05  |- mesh__dateRevised mesh__D007180 2003-07-09
% 207.86/208.05  |- mesh__publicMeSHNote mesh__D007180 65   
% 207.86/208.05  |- mesh__dateCreated mesh__D007180 1999-01-01
% 207.86/208.05  |- skos__prefLabel mesh__D007180 Incisor
% 207.86/208.05  |- mesh__historyNote mesh__D007180 65   
% 207.86/208.05  |- mesh__dateEstablished mesh__D007180 1965-01-01
% 207.86/208.05  |- skos__annotation mesh__D007180
% 207.86/208.05       one of the 8 front teeth; NIM when merely locational; %22%incisive papilla%22%, a projection on the palate posterior to the central incisors: index under PALATE %26% do not add INCISOR%A%  
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D015612 1990
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D015612 1995
% 207.86/208.05  |- mesh__dateCreated mesh__D015612 1989-04-07
% 207.86/208.05  |- skos__annotation mesh__D015612
% 207.86/208.05       %22%use of ultrasound to increase percutaneous adsorption of drugs%22%; do not use /util except by MeSH definition%A%  
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D015612 2003
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D015612 1991
% 207.86/208.05  |- skos__scopeNote mesh__D015612
% 207.86/208.05       Use of ultrasound to increase the percutaneous adsorption of drugs.%A%    
% 207.86/208.05  |- rdf__type mesh__D015612sskos__Concept
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D015612 2004
% 207.86/208.05  |- mesh__historyNote mesh__D015612 90   
% 207.86/208.05  |- skos__broader mesh__D015612smesh__D014465
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D015612 1996
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D015612 2000
% 207.86/208.05  |- skos__hiddenLabel mesh__D015612 Phonophoreses
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D015612 2005
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D015612 1992
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D015612 1997
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D015612 2001
% 207.86/208.05  |- mesh__publicMeSHNote mesh__D015612 90   
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D015612 2006
% 207.86/208.05  |- skos__broader mesh__D015612smesh__D004333
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D015612 1993
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D015612 1998
% 207.86/208.05  |- skos__prefLabel mesh__D015612 Phonophoresis
% 207.86/208.05  |- mesh__dateEstablished mesh__D015612 1990-01-01
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D015612 2002
% 207.86/208.05  |- skos__historyNote mesh__D015612 Ultrasonics %28%1966-1989%29%
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D015612 1994
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D015612 1999
% 207.86/208.05  |- mesh__recordAuthorizer mesh__D006886 sjn
% 207.86/208.05  |- skos__altLabel mesh__D006886 Oxychlorochin
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D006886 2001
% 207.86/208.05  |- mesh__recordOriginator mesh__D006886 NLM
% 207.86/208.05  |- mesh__dateRevised mesh__D006886 2000-06-22
% 207.86/208.05  |- mesh__dateCreated mesh__D006886 1999-01-01
% 207.86/208.05  |- rdf__type mesh__D006886sskos__Concept
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D006886 2004
% 207.86/208.05  |- mesh__recordMaintainer mesh__D006886 TWD
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D006886 2006
% 207.86/208.05  |- skos__broader mesh__D006886smesh__D002738
% 207.86/208.05  |- skos__altLabel mesh__D006886 Oxychloroquine
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D006886 2003
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D006886 2005
% 207.86/208.05  |- skos__altLabel mesh__D006886 Hydroxychlorochin
% 207.86/208.05  |- skos__scopeNote mesh__D006886
% 207.86/208.05       A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. %28%From Gilman et al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 9th ed, p970%29%%A%    
% 207.86/208.05  |- skos__prefLabel mesh__D006886 Hydroxychloroquine
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D006886 2002
% 207.86/208.05  |- skos__altLabel mesh__D006886 Hydroxychloroquine Sulfate %28%1:1%29% Salt
% 207.86/208.05  |- skos__related mesh__D020557smesh__D011613
% 207.86/208.05  |- mesh__publicMeSHNote mesh__D020557 2000   
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D020557 2002
% 207.86/208.05  |- rdf__type mesh__D020557sskos__Concept
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D020557 2005
% 207.86/208.05  |- skos__prefLabel mesh__D020557 Neurolinguistic Programming
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D020557 2003
% 207.86/208.05  |- skos__scopeNote mesh__D020557
% 207.86/208.05       A set of models of how communication impacts and is impacted by subjective experience. Techniques are generated from these models by sequencing of various aspects of the models in order to change someone%27%s internal representations. Neurolinguistic programming is concerned with the patterns or programming created by the interactions among the brain, language, and the body, that produce both effective and ineffective behavior.%A%    
% 207.86/208.05  |- skos__hiddenLabel mesh__D020557 Programming, Neuro-linguistic
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D020557 2006
% 207.86/208.05  |- mesh__dateEstablished mesh__D020557 2000-01-01
% 207.86/208.05  |- skos__hiddenLabel mesh__D020557 Programming, Neurolinguistic
% 207.86/208.05  |- skos__broader mesh__D020557smesh__D008959
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D020557 2004
% 207.86/208.05  |- skos__broader mesh__D020557smesh__D007858
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D020557 2000
% 207.86/208.05  |- mesh__dateCreated mesh__D020557 1999-11-03
% 207.86/208.05  |- skos__broader mesh__D020557smesh__D011578
% 207.86/208.05  |- skos__broader mesh__D020557smesh__D008960
% 207.86/208.05  |- mesh__historyNote mesh__D020557 2000   
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D020557 2001
% 207.86/208.05  |- skos__altLabel mesh__D020557 Neuro-linguistic Programming
% 207.86/208.05  |- mesh__dateEstablished mesh__D039262 2003-01-01
% 207.86/208.05  |- skos__prefLabel mesh__D039262 Eriocaulaceae
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D039262 2006
% 207.86/208.05  |- mesh__publicMeSHNote mesh__D039262 2003   
% 207.86/208.05  |- skos__annotation mesh__D039262
% 207.86/208.05       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D039262 2005
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D039262 2004
% 207.86/208.05  |- mesh__historyNote mesh__D039262 2003   
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D039262 2003
% 207.86/208.05  |- mesh__dateCreated mesh__D039262 2002-07-03
% 207.86/208.05  |- rdf__type mesh__D039262sskos__Concept
% 207.86/208.05  |- skos__broader mesh__D039262smesh__D019684
% 207.86/208.05  |- skos__scopeNote mesh__D039262
% 207.86/208.05       A plant family of the order Commelinales, subclass Commelinidae, class Liliopsida %28%monocotyledons%29%.%A%    
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D006088 2006
% 207.86/208.05  |- skos__prefLabel mesh__D006088 Gram-Negative Aerobic Bacteria
% 207.86/208.05  |- mesh__historyNote mesh__D006088
% 207.86/208.05       76; ACHROMATIACEAE was heading 1975-96; ACHROMATIUM, LEPTOTHRIX, %26% SPHAEROTILUS were headings 1963-96; ACHROMOBACTERIACEAE was heading 1975-91 %28%was see under GRAM-NEGATIVE AEROBIC BACTERIA 1976-90%29%%A%  
% 207.86/208.05  |- mesh__recordAuthorizer mesh__D006088 sjn
% 207.86/208.05  |- mesh__onlineNote mesh__D006088
% 207.86/208.05       use GRAM-NEGATIVE AEROBIC BACTERIA to search ACHROMATIACEAE 1975-96; ACHROMATIUM, LEPTOTHRIX, %26% SPHAEROTILUS 1966-96, %26% ACHROMOBACTERIACEAE 1975-91%A%  
% 207.86/208.05  |- skos__altLabel mesh__D006088 Gram Negative Aerobic Bacteria
% 207.86/208.05  |- skos__broader mesh__D006088smesh__D006090
% 207.86/208.05  |- mesh__dateRevised mesh__D006088 2005-06-30
% 207.86/208.05  |- rdf__type mesh__D006088sskos__Concept
% 207.86/208.05  |- mesh__dateEstablished mesh__D006088 1976-01-01
% 207.86/208.05  |- skos__annotation mesh__D006088
% 207.86/208.05       GEN: avoid; prefer specifics; do not use as a routine coord for a gram-negative aerobic bact; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%; DF: GRAM NEG AEROBIC BACT%A%  
% 207.86/208.05  |- mesh__dateCreated mesh__D006088 1975-07-25
% 207.86/208.05  |- skos__scopeNote mesh__D006088
% 207.86/208.05       A large group of aerobic bacteria which show up as pink %28%negative%29% when treated by the gram-staining method. This is because the cell walls of gram-negative bacteria are low in peptidoglycan and thus have low affinity for  violet stain and high affinity for the pink dye safranine.%A%    
% 207.86/208.05  |- mesh__recordMaintainer mesh__D006088 SYSTEM
% 207.86/208.05  |- skos__historyNote mesh__D006088 Bacteria %28%1966-1975%29%
% 207.86/208.05  |- mesh__publicMeSHNote mesh__D006088
% 207.86/208.05       76; ACHROMATIACEAE was heading 1975-96; ACHROMATIUM, LEPTOTHRIX, %26% SPHAEROTILUS were headings 1963-96; ACHROMOBACTERIACEAE was heading 1975-91 %28%see under GRAM-NEGATIVE AEROBIC BACTERIA 1976-90%29%%A%  
% 207.86/208.05  |- mesh__recordOriginator mesh__D006088 JW
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D025242 2002
% 207.86/208.05  |- mesh__recordAuthorizer mesh__D025242 sjn
% 207.86/208.05  |- skos__scopeNote mesh__D025242
% 207.86/208.05       Heterogeneous group of arthritic diseases sharing clinical and radiologic features and presence of the HLA-B27 ANTIGEN.%A%    
% 207.86/208.05  |- rdf__type mesh__D025242sskos__Concept
% 207.86/208.05  |- skos__historyNote mesh__D025242
% 207.86/208.05       Spondylitis, Ankylosing %28%1977-2001%29%
% 207.86/208.05  |- skos__historyNote mesh__D025242 Spinal Diseases %28%1977-2001%29%
% 207.86/208.05  |- mesh__historyNote mesh__D025242 2002   
% 207.86/208.05  |- skos__annotation mesh__D025242
% 207.86/208.05       coord IM with specific vertebrae %28%IM%29%   
% 207.86/208.05  |- mesh__recordOriginator mesh__D025242 ags
% 207.86/208.05  |- mesh__recordMaintainer mesh__D025242 jls
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D025242 2004
% 207.86/208.05  |- mesh__dateCreated mesh__D025242 2001-08-03
% 207.86/208.05  |- mesh__dateEstablished mesh__D025242 2002-01-01
% 207.86/208.05  |- skos__altLabel mesh__D025242 Spondylarthropathy
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D025242 2006
% 207.86/208.05  |- mesh__publicMeSHNote mesh__D025242 2002   
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D025242 2003
% 207.86/208.05  |- skos__prefLabel mesh__D025242 Spondylarthropathies
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D025242 2005
% 207.86/208.05  |- skos__broader mesh__D025242smesh__D025241
% 207.86/208.05  |- mesh__historyNote mesh__D019205
% 207.86/208.05       2003%28%1997%29%; for STIMULATORY GTP-BINDING PROTEIN, ALPHA SUBUNIT use G-PROTEIN, GS FAMILY %28%NM%29% 1996-2003%A%  
% 207.86/208.05  |- mesh__recordAuthorizer mesh__D019205 sjn
% 207.86/208.05  |- skos__hiddenLabel mesh__D019205 Stimulatory G-Proteins, Gs
% 207.86/208.05  |- skos__hiddenLabel mesh__D019205 Gs alpha GTP Binding Protein Subunits
% 207.86/208.05  |- skos__hiddenLabel mesh__D019205 G-Proteins, Gs Stimulatory
% 207.86/208.05  |- skos__hiddenLabel mesh__D019205 Stimulatory Gs G-Protein
% 207.86/208.05  |- mesh__dateEstablished mesh__D019205 1997-01-01
% 207.86/208.05  |- skos__altLabel mesh__D019205
% 207.86/208.05       Stimulatory GTP-Binding Protein, alpha Subunit
% 207.86/208.05  |- skos__altLabel mesh__D019205 G-Protein, Stimulatory Gs
% 207.86/208.05  |- skos__altLabel mesh__D019205 Gs, Stimulatory G-Protein
% 207.86/208.05  |- skos__broader mesh__D019205smesh__D044385
% 207.86/208.05  |- skos__altLabel mesh__D019205 Ns Protein, Regulatory
% 207.86/208.05  |- skos__hiddenLabel mesh__D019205
% 207.86/208.05       Stimulatory GTP Binding Protein, alpha Subunit
% 207.86/208.05  |- skos__hiddenLabel mesh__D019205 Gs, Stimulatory G Protein
% 207.86/208.05  |- skos__altLabel mesh__D019205 alpha-Gs
% 207.86/208.05  |- skos__hiddenLabel mesh__D019205 G Protein, Gs alpha Family
% 207.86/208.05  |- mesh__publicMeSHNote mesh__D019205
% 207.86/208.05       2003; see G-PROTEIN, STIMULATORY GS 1997-2003; STIMULATORY GTP-BINDNG PROTEIN, ALPHA SUBUNIT was indexed under G-PROTEIN, STIMULATORY GS 1997-2003 %26% under G-PROTEINS 1996%A%  
% 207.86/208.05  |- skos__altLabel mesh__D019205 G%28%s%29%alpha
% 207.86/208.05  |- skos__altLabel mesh__D019205 Gs alpha GTP-Binding Protein Subunits
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D019205 2006
% 207.86/208.05  |- mesh__recordMaintainer mesh__D019205 jmp
% 207.86/208.05  |- skos__hiddenLabel mesh__D019205 Stimulatory G-Protein Gs
% 207.86/208.05  |- skos__scopeNote mesh__D019205
% 207.86/208.05       A family of heterotrimeric GTP-binding protein alpha subunits that activate ADENYLATE CYCLASE.%A%    
% 207.86/208.05  |- skos__hiddenLabel mesh__D019205 alpha Gs
% 207.86/208.05  |- skos__altLabel mesh__D019205 Gs Stimulatory G-Proteins
% 207.86/208.05  |- mesh__dateCreated mesh__D019205 1996-06-10
% 207.86/208.05  |- skos__annotation mesh__D019205 DF: G PROTEIN STIM GS   
% 207.86/208.05  |- skos__hiddenLabel mesh__D019205 GTP Binding Protein alpha Subunits, Gs
% 207.86/208.05  |- skos__hiddenLabel mesh__D019205 Gs G-Protein, Stimulatory
% 207.86/208.05  |- rdf__type mesh__D019205sskos__Concept
% 207.86/208.05  |- skos__hiddenLabel mesh__D019205 G Protein, Stimulatory Gs
% 207.86/208.05  |- skos__hiddenLabel mesh__D019205 Gs Stimulatory G Proteins
% 207.86/208.05  |- mesh__dateRevised mesh__D019205 2004-07-07
% 207.86/208.05  |- skos__prefLabel mesh__D019205 GTP-Binding Protein alpha Subunits, Gs
% 207.86/208.05  |- mesh__activeMeSHYear mesh__D019205 2005
% 207.86/208.05  |- skos__hiddenLabel mesh__D019205 Regulatory Ns Protein
% 207.86/208.05  |- skos__altLabel mesh__D019205 G-Protein, Gs alpha Family
% 207.86/208.05  |- skos__historyNote mesh__D019205 G-Proteins %28%1985-1996%29%
% 207.86/208.05  |- skos__hiddenLabel mesh__D019205 G-Protein Gs, Stimulatory
% 207.86/208.05  |- mesh__recordOriginator mesh__D019205 TPW
% 207.86/208.05  |- skos__altLabel mesh__D019205 G%28%s%29%, alpha Subunit
% 207.86/208.05  |- mesh__publicMeSHNote mesh__D011222 73   
% 207.86/208.06  |- rdf__type mesh__D011222sskos__Concept
% 207.86/208.06  |- skos__altLabel mesh__D011222 Demetrin
% 207.86/208.06  |- skos__scopeNote mesh__D011222
% 207.86/208.06       A benzodiazepine that is used in the treatment of ANXIETY DISORDERS.%A%    
% 207.86/208.06  |- skos__altLabel mesh__D011222 Mono Demetrin
% 207.86/208.06  |- skos__historyNote mesh__D011222 Benzazepines %28%1968-1971%29%
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D011222 2006
% 207.86/208.06  |- skos__altLabel mesh__D011222 Warner-Lambert Brand of Prazepam
% 207.86/208.06  |- skos__historyNote mesh__D011222
% 207.86/208.06       Muscle Relaxants, Central %28%1970-1971%29%
% 207.86/208.06  |- skos__altLabel mesh__D011222 Pfizer Brand of Prazepam
% 207.86/208.06  |- skos__altLabel mesh__D011222 Parke Davis Brand of Prazepam
% 207.86/208.06  |- mesh__recordOriginator mesh__D011222 NLM
% 207.86/208.06  |- skos__prefLabel mesh__D011222 Prazepam
% 207.86/208.06  |- mesh__recordMaintainer mesh__D011222 lkw
% 207.86/208.06  |- mesh__dateEstablished mesh__D011222 1973-01-01
% 207.86/208.06  |- mesh__historyNote mesh__D011222 73%28%72%29%   
% 207.86/208.06  |- mesh__dateCreated mesh__D011222 1999-01-01
% 207.86/208.06  |- skos__broader mesh__D011222smesh__D001570
% 207.86/208.06  |- mesh__dateRevised mesh__D011222 2005-06-30
% 207.86/208.06  |- skos__altLabel mesh__D011222 United Drug Brand of Prazepam
% 207.86/208.06  |- mesh__recordAuthorizer mesh__D011222 sjn
% 207.86/208.06  |- skos__broader mesh__D012067Q000523smesh__D012067
% 207.86/208.06  |- mesh__preferredCombination mesh__D012067Q000523smesh__D012069
% 207.86/208.06  |- rdf__type mesh__D012067Q000523smesh__CompoundConcept
% 207.86/208.06  |- skos__altLabel mesh__D049690 Ancient History of Medicine
% 207.86/208.06  |- skos__scopeNote mesh__D049690
% 207.86/208.06       The period of history before 500 of the common era.     
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D049690 2005
% 207.86/208.06  |- skos__hiddenLabel mesh__D049690 Ancient History Medicines
% 207.86/208.06  |- skos__hiddenLabel mesh__D049690 Ancient Histories %28%Medicine%29%
% 207.86/208.06  |- skos__broader mesh__D049690smesh__D006664
% 207.86/208.06  |- skos__altLabel mesh__D049690 Medicine, Ancient History
% 207.86/208.06  |- skos__altLabel mesh__D049690 Ancient History %28%Medicine%29%
% 207.86/208.06  |- skos__hiddenLabel mesh__D049690 Ancient History Medicine
% 207.86/208.06  |- skos__hiddenLabel mesh__D049690 Medicines, Ancient History
% 207.86/208.06  |- skos__hiddenLabel mesh__D049690 History, Ancient %28%Medicine%29%
% 207.86/208.06  |- skos__historyNote mesh__D049690
% 207.86/208.06       History of Medicine, Ancient %28%1966-2004%29%
% 207.86/208.06  |- skos__hiddenLabel mesh__D049690 Medicine Ancient History
% 207.86/208.06  |- mesh__historyNote mesh__D049690 2005   
% 207.86/208.06  |- skos__hiddenLabel mesh__D049690 History Medicine, Ancient
% 207.86/208.06  |- mesh__dateEstablished mesh__D049690 2005-01-01
% 207.86/208.06  |- skos__prefLabel mesh__D049690 History, Ancient
% 207.86/208.06  |- mesh__recordMaintainer mesh__D049690 jls
% 207.86/208.06  |- mesh__dateCreated mesh__D049690 2004-07-07
% 207.86/208.06  |- mesh__publicMeSHNote mesh__D049690
% 207.86/208.06       2005; see HISTORY OF MEDICINE, ANCIENT 1966-2004   
% 207.86/208.06  |- mesh__recordOriginator mesh__D049690 jls
% 207.86/208.06  |- skos__altLabel mesh__D049690 Ancient History
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D049690 2006
% 207.86/208.06  |- skos__hiddenLabel mesh__D049690 History Medicines, Ancient
% 207.86/208.06  |- skos__hiddenLabel mesh__D049690 Histories, Ancient %28%Medicine%29%
% 207.86/208.06  |- mesh__recordAuthorizer mesh__D049690 sjn
% 207.86/208.06  |- rdf__type mesh__D049690sskos__Concept
% 207.86/208.06  |- skos__annotation mesh__D049690
% 207.86/208.06       before 500 AD; IM general only; NIM as check tag; note ANCIENT LANDS in Category Z%A%  
% 207.86/208.06  |- skos__hiddenLabel mesh__D002496 Central Venous Pressures
% 207.86/208.06  |- mesh__dateCreated mesh__D002496 1999-01-01
% 207.86/208.06  |- skos__altLabel mesh__D002496 Venous Pressure, Central
% 207.86/208.06  |- mesh__dateRevised mesh__D002496 2003-07-09
% 207.86/208.06  |- skos__historyNote mesh__D002496 Veins %28%1966-1969%29%
% 207.86/208.06  |- mesh__recordMaintainer mesh__D002496 nns
% 207.86/208.06  |- mesh__recordOriginator mesh__D002496 NLM
% 207.86/208.06  |- skos__historyNote mesh__D002496 Blood Pressure %28%1966-1969%29%
% 207.86/208.06  |- rdf__type mesh__D002496sskos__Concept
% 207.86/208.06  |- mesh__historyNote mesh__D002496 70   
% 207.86/208.06  |- mesh__publicMeSHNote mesh__D002496 70   
% 207.86/208.06  |- mesh__dateEstablished mesh__D002496 1970-01-01
% 207.86/208.06  |- skos__hiddenLabel mesh__D002496 Venous Pressures, Central
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D002496 2004
% 207.86/208.06  |- skos__scopeNote mesh__D002496
% 207.86/208.06       The blood pressure in the central large VEINS of the body. It is distinguished from peripheral venous pressure which occurs in an extremity.%A%    
% 207.86/208.06  |- mesh__recordAuthorizer mesh__D002496 sjn
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D002496 2006
% 207.86/208.06  |- skos__prefLabel mesh__D002496 Central Venous Pressure
% 207.86/208.06  |- skos__broader mesh__D002496smesh__D014690
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D002496 2005
% 207.86/208.06  |- skos__hiddenLabel mesh__D002496 Pressures, Central Venous
% 207.86/208.06  |- skos__hiddenLabel mesh__D002496 Pressure, Central Venous
% 207.86/208.06  |- skos__related mesh__D010928smesh__D011986
% 207.86/208.06  |- skos__hiddenLabel mesh__D010928 Human Chorionic Somatomammotropin
% 207.86/208.06  |- skos__hiddenLabel mesh__D010928 Lactogen, Placental
% 207.86/208.06  |- mesh__dateEstablished mesh__D010928 1972-01-01
% 207.86/208.06  |- skos__altLabel mesh__D010928 Placental Luteotropin
% 207.86/208.06  |- mesh__dateRevised mesh__D010928 2004-07-07
% 207.86/208.06  |- skos__altLabel mesh__D010928 PAPP-D
% 207.86/208.06  |- mesh__historyNote mesh__D010928 72%28%68%29%   
% 207.86/208.06  |- mesh__publicMeSHNote mesh__D010928 72   
% 207.86/208.06  |- skos__hiddenLabel mesh__D010928 Luteotropin, Placental
% 207.86/208.06  |- skos__altLabel mesh__D010928 Somatomammotropin, Chorionic
% 207.86/208.06  |- mesh__recordAuthorizer mesh__D010928 sjn
% 207.86/208.06  |- skos__scopeNote mesh__D010928
% 207.86/208.06       A polypeptide hormone of approximately 25 kDa that is produced by the SYNCYTIOTROPHOBLASTS of the PLACENTA, also known as chorionic somatomammotropin. It has both GROWTH HORMONE and PROLACTIN activities on growth, lactation, and luteal steroid production. In women, placental lactogen secretion begins soon after implantation and increases to 1 g or more a day in late pregnancy. Placental lactogen is also an insulin antagonist.%A%    
% 207.86/208.06  |- rdf__type mesh__D010928sskos__Concept
% 207.86/208.06  |- mesh__recordOriginator mesh__D010928 NLM
% 207.86/208.06  |- skos__hiddenLabel mesh__D010928 Placental Lactogen, Human
% 207.86/208.06  |- skos__broader mesh__D010928smesh__D011257
% 207.86/208.06  |- skos__hiddenLabel mesh__D010928 Chorionic Somatomammotropin
% 207.86/208.06  |- skos__hiddenLabel mesh__D010928 Pregnancy Associated Plasma Protein D
% 207.86/208.06  |- skos__altLabel mesh__D010928 Choriomammotropin
% 207.86/208.06  |- skos__historyNote mesh__D010928 Placental Hormones %28%1966-1967%29%
% 207.86/208.06  |- skos__broader mesh__D010928smesh__D010926
% 207.86/208.06  |- skos__hiddenLabel mesh__D010928 Placental Mammotropic Hormone
% 207.86/208.06  |- skos__altLabel mesh__D010928 Lactogen Hormone, Placental
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D010928 2005
% 207.86/208.06  |- skos__altLabel mesh__D010928 HPL %28%Human Placental Lactogen%29%
% 207.86/208.06  |- skos__altLabel mesh__D010928 Choriomammotrophin
% 207.86/208.06  |- skos__altLabel mesh__D010928 Chorionic Somatomammotropin, Human
% 207.86/208.06  |- skos__prefLabel mesh__D010928 Placental Lactogen
% 207.86/208.06  |- skos__altLabel mesh__D010928 Pregnancy-Associated Plasma Protein D
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D010928 2006
% 207.86/208.06  |- mesh__dateCreated mesh__D010928 1999-01-01
% 207.86/208.06  |- skos__altLabel mesh__D010928
% 207.86/208.06       HCS %28%Human Chorionic Somatomammotropin%29%
% 207.86/208.06  |- mesh__recordMaintainer mesh__D010928 lkt
% 207.86/208.06  |- skos__altLabel mesh__D010928 Mammotropic Hormone, Placental
% 207.86/208.06  |- mesh__dateCreated mesh__D029633 2001-07-25
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D029633 2004
% 207.86/208.06  |- mesh__dateEstablished mesh__D029633 2002-01-01
% 207.86/208.06  |- skos__prefLabel mesh__D029633 Schisandraceae
% 207.86/208.06  |- mesh__historyNote mesh__D029633 2002   
% 207.86/208.06  |- skos__annotation mesh__D029633
% 207.86/208.06       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.86/208.06  |- mesh__publicMeSHNote mesh__D029633 2002   
% 207.86/208.06  |- skos__broader mesh__D029633smesh__D019684
% 207.86/208.06  |- skos__scopeNote mesh__D029633
% 207.86/208.06       A plant family of the order Illiciales, subclass Magnoliidae, class Magnoliopsida.%A%    
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D029633 2005
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D029633 2002
% 207.86/208.06  |- rdf__type mesh__D029633sskos__Concept
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D029633 2003
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D029633 2006
% 207.86/208.06  |- skos__hiddenLabel mesh__D007181 Inclusion Body, Viral
% 207.86/208.06  |- skos__altLabel mesh__D007181 Negri Bodies
% 207.86/208.06  |- mesh__dateRevised mesh__D007181 2005-06-30
% 207.86/208.06  |- skos__annotation mesh__D007181
% 207.86/208.06       A11 qualif except /cytol; /genet permitted; coord IM with specific virus %28%IM%29%%A%  
% 207.86/208.06  |- skos__hiddenLabel mesh__D007181 Bodies, Viral Inclusion
% 207.86/208.06  |- mesh__dateCreated mesh__D007181 1999-01-01
% 207.86/208.06  |- skos__broader mesh__D007181smesh__D018406
% 207.86/208.06  |- mesh__recordAuthorizer mesh__D007181 sjn
% 207.86/208.06  |- mesh__publicMeSHNote mesh__D007181 66   
% 207.86/208.06  |- skos__scopeNote mesh__D007181
% 207.86/208.06       An area showing altered staining behavior in the nucleus or cytoplasm of a virus-infected cell. Some inclusion bodies represent %22%virus factories%22% in which viral nucleic acid or protein is being synthesized; others are merely artifacts of fixation and staining. One example, Negri bodies, are found in the cytoplasm or processes of nerve cells in animals that have died from rabies.%A%    
% 207.86/208.06  |- mesh__historyNote mesh__D007181 66   
% 207.86/208.06  |- skos__prefLabel mesh__D007181 Inclusion Bodies, Viral
% 207.86/208.06  |- mesh__recordMaintainer mesh__D007181 nns
% 207.86/208.06  |- skos__broader mesh__D007181smesh__D002479
% 207.86/208.06  |- skos__altLabel mesh__D007181 Viral Inclusion Bodies
% 207.86/208.06  |- skos__hiddenLabel mesh__D007181 Viral Inclusion Body
% 207.86/208.06  |- mesh__dateEstablished mesh__D007181 1966-01-01
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D007181 2006
% 207.86/208.06  |- skos__hiddenLabel mesh__D007181 Body, Negri
% 207.86/208.06  |- mesh__recordOriginator mesh__D007181 NLM
% 207.86/208.06  |- rdf__type mesh__D007181sskos__Concept
% 207.86/208.06  |- skos__hiddenLabel mesh__D007181 Body, Viral Inclusion
% 207.86/208.06  |- skos__hiddenLabel mesh__D007181 Bodies, Negri
% 207.86/208.06  |- skos__hiddenLabel mesh__D015613 Hepadnavirus
% 207.86/208.06  |- mesh__recordAuthorizer mesh__D015613 sjn
% 207.86/208.06  |- skos__broader mesh__D015613smesh__D004267
% 207.86/208.06  |- mesh__dateCreated mesh__D015613 1989-04-07
% 207.86/208.06  |- rdf__type mesh__D015613sskos__Concept
% 207.86/208.06  |- mesh__historyNote mesh__D015613 90   
% 207.86/208.06  |- skos__altLabel mesh__D015613 Hepadnaviruses
% 207.86/208.06  |- mesh__publicMeSHNote mesh__D015613 90   
% 207.86/208.06  |- skos__historyNote mesh__D015613 Hepatitis B Virus %28%1982-1989%29%
% 207.86/208.06  |- mesh__dateRevised mesh__D015613 2004-07-13
% 207.86/208.06  |- mesh__dateEstablished mesh__D015613 1990-01-01
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D015613 2005
% 207.86/208.06  |- mesh__recordMaintainer mesh__D015613 sjn
% 207.86/208.06  |- skos__prefLabel mesh__D015613 Hepadnaviridae
% 207.86/208.06  |- mesh__recordOriginator mesh__D015613 PXP
% 207.86/208.06  |- skos__scopeNote mesh__D015613
% 207.86/208.06       A family of hepatotropic DNA viruses which contains double-stranded DNA genomes and causes hepatitis in humans and animals. There are two genera: AVIHEPADNAVIRUS and ORTHOHEPADNAVIRUS. Hepadnaviruses include HEPATITIS B VIRUS, duck hepatitis B virus %28%HEPATITIS B VIRUS, DUCK%29%, heron hepatitis B virus, ground squirrel hepatitis virus, and woodchuck hepatitis B virus %28%HEPATITIS B VIRUS, WOODCHUCK%29%.%A%    
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D015613 2006
% 207.86/208.06  |- skos__broader mesh__D015613smesh__D006518
% 207.86/208.06  |- skos__annotation mesh__D015613
% 207.86/208.06       a family of hepatitis viruses; from HEPAtotropic DNA viruses; infection = HEPADNAVIRIDAE INFECTIONS%A%  
% 207.86/208.06  |- mesh__recordMaintainer mesh__D006887 ssb
% 207.86/208.06  |- mesh__dateRevised mesh__D006887 2005-06-30
% 207.86/208.06  |- skos__altLabel mesh__D006887 Hydroxycholecalciferol
% 207.86/208.06  |- skos__broader mesh__D006887smesh__D002762
% 207.86/208.06  |- mesh__dateEstablished mesh__D006887 1973-01-01
% 207.86/208.06  |- mesh__recordAuthorizer mesh__D006887 sjn
% 207.86/208.06  |- mesh__dateCreated mesh__D006887 1999-01-01
% 207.86/208.06  |- rdf__type mesh__D006887sskos__Concept
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D006887 2006
% 207.86/208.06  |- mesh__recordOriginator mesh__D006887 NLM
% 207.86/208.06  |- mesh__historyNote mesh__D006887
% 207.86/208.06       75; was HYDROXYCHOLECALCIFEROL 1972-74 %28%Prov 1972%29%   
% 207.86/208.06  |- skos__scopeNote mesh__D006887
% 207.86/208.06       Hydroxy analogs of vitamin D 3; %28%CHOLECALCIFEROL%29%; including CALCIFEDIOL; CALCITRIOL; and 24,25-DIHYDROXYVITAMIN D 3.%A%    
% 207.86/208.06  |- skos__altLabel mesh__D006887 Hydroxyvitamins D
% 207.86/208.06  |- skos__hiddenLabel mesh__D006887 D, Hydroxyvitamins
% 207.86/208.06  |- skos__prefLabel mesh__D006887 Hydroxycholecalciferols
% 207.86/208.06  |- mesh__publicMeSHNote mesh__D006887
% 207.86/208.06       75; was HYDROXYCHOLECALCIFEROL 1973-74   
% 207.86/208.06  |- skos__annotation mesh__D006887
% 207.86/208.06       deficiency: coordinate HYDROXYCHOLECALCIFEROLS /defic %28%IM%29% with VITAMIN D DEFICIENCY %28%IM%29%%A%  
% 207.86/208.06  |- mesh__onlineNote mesh__D006887
% 207.86/208.06       use HYDROXYCHOLECALCIFEROLS to search HYDROXYCHOLECALCIFEROL 1972-74 %28%as Prov 1972%29%%A%  
% 207.86/208.06  |- skos__broader mesh__D020558smesh__D017766
% 207.86/208.06  |- skos__altLabel mesh__D020558 GTP Phosphohydrolase
% 207.86/208.06  |- skos__scopeNote mesh__D020558
% 207.86/208.06       Enzymes that hydrolyze GTP to GDP. EC 3.6.1.-.     
% 207.86/208.06  |- skos__prefLabel mesh__D020558 GTP Phosphohydrolases
% 207.86/208.06  |- mesh__historyNote mesh__D020558
% 207.86/208.06       2000; for GTP PHOSPHOHYDROLASE use GTP PHOSPHOHYDROLASES 1975-1999%A%  
% 207.86/208.06  |- skos__hiddenLabel mesh__D020558 Phosphohydrolases, GTP
% 207.86/208.06  |- skos__hiddenLabel mesh__D020558 Phosphohydrolase, GTP
% 207.86/208.06  |- skos__altLabel mesh__D020558 Guanosine Triphosphate Phosphohydrolases
% 207.86/208.06  |- mesh__publicMeSHNote mesh__D020558
% 207.86/208.06       2000; for GUANOSINE TRIPHOSPHATE PHOSPHOHYDROLASES, GTP PHOSPHOHYDROLASE AND GUANOSINETRIPHOSPHATASES see GTP PHOSPHOHYDROLASE %28%1975-1999%29%; for GTPASE see GTP PHOSPHOHYDROLASE %28%1977-1999%29%%A%  
% 207.86/208.06  |- skos__annotation mesh__D020558
% 207.86/208.06       GTP PHOSPHOHYDROLASE ACTIVATORS is available   
% 207.86/208.06  |- skos__altLabel mesh__D020558 GTPases
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D020558 2004
% 207.86/208.06  |- rdf__type mesh__D020558sskos__Concept
% 207.86/208.06  |- skos__altLabel mesh__D020558 GTPase
% 207.86/208.06  |- mesh__dateRevised mesh__D020558 2003-07-09
% 207.86/208.06  |- mesh__dateEstablished mesh__D020558 2000-01-01
% 207.86/208.06  |- skos__hiddenLabel mesh__D020558
% 207.86/208.06       Phosphohydrolases, Guanosine Triphosphate
% 207.86/208.06  |- skos__altLabel mesh__D020558 Guanosinetriphosphatases
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D020558 2006
% 207.86/208.06  |- mesh__dateCreated mesh__D020558 1999-11-03
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D020558 2005
% 207.86/208.06  |- skos__hiddenLabel mesh__D020558
% 207.86/208.06       Triphosphate Phosphohydrolases, Guanosine
% 207.86/208.06  |- skos__broader mesh__D006089smesh__D006090
% 207.86/208.06  |- skos__prefLabel mesh__D006089 Gram-Negative Anaerobic Bacteria
% 207.86/208.06  |- mesh__recordOriginator mesh__D006089 JW
% 207.86/208.06  |- skos__scopeNote mesh__D006089
% 207.86/208.06       A large group of anaerobic bacteria which show up as pink %28%negative%29% when treated by the Gram-staining method.%A%    
% 207.86/208.06  |- rdf__type mesh__D006089sskos__Concept
% 207.86/208.06  |- mesh__publicMeSHNote mesh__D006089 76   
% 207.86/208.06  |- mesh__historyNote mesh__D006089 76   
% 207.86/208.06  |- mesh__recordAuthorizer mesh__D006089 sjn
% 207.86/208.06  |- mesh__dateCreated mesh__D006089 1975-07-25
% 207.86/208.06  |- mesh__dateRevised mesh__D006089 2005-06-30
% 207.86/208.06  |- mesh__recordMaintainer mesh__D006089 SYSTEM
% 207.86/208.06  |- skos__historyNote mesh__D006089 Bacteria %28%1966-1975%29%
% 207.86/208.06  |- skos__altLabel mesh__D006089 Gram Negative Anaerobic Bacteria
% 207.86/208.06  |- mesh__dateEstablished mesh__D006089 1976-01-01
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D006089 2006
% 207.86/208.06  |- skos__annotation mesh__D006089
% 207.86/208.06       GEN: avoid; prefer specifics; do not use as a routine coord for a gram-negative anaerobic bact; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%; DF: GRAM NEG ANAEROBIC BACT%A%  
% 207.86/208.06  |- skos__hiddenLabel mesh__D025243 ATPases, Bacterial Proton-Translocating
% 207.86/208.06  |- mesh__publicMeSHNote mesh__D025243
% 207.86/208.06       2002; for E COLI COUPLING FACTOR see H%28%+%29%-TRANSPORTING ATP SYNTHASE 1993-2001, H%28%+%29%-TRANSPORTING ATPASE 1984-1992 %26% ADENOSINE TRIPHOSPHATASE F1 1983%A%  
% 207.86/208.06  |- skos__annotation mesh__D025243 coord with specific bacterium /enzymol   
% 207.86/208.06  |- skos__hiddenLabel mesh__D025243 F1F0-ATPase, E coli
% 207.86/208.06  |- skos__altLabel mesh__D025243 E coli F1F0-ATPase
% 207.86/208.06  |- skos__hiddenLabel mesh__D025243 Proton-Translocating ATPases, Bacterial
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D025243 2004
% 207.86/208.06  |- skos__altLabel mesh__D025243 E coli Coupling Factor
% 207.86/208.06  |- skos__altLabel mesh__D025243 Bacterial F%28%1%29%F%28%0%29% ATPases
% 207.86/208.06  |- skos__scopeNote mesh__D025243
% 207.86/208.06       Membrane-bound proton-translocating ATPases that serve two important physiological functions in bacteria. One function is to generate ADENOSINE TRIPHOSPHATE by utilizing the energy provided by an electrochemical gradient of protons across the cellular membrane. A second function is to counteract a loss of the transmembrane ion gradient by pumping protons at the expense of  adenosine triphosphate hydrolysis.%A%    
% 207.86/208.06  |- mesh__dateEstablished mesh__D025243 2002-01-01
% 207.86/208.06  |- skos__hiddenLabel mesh__D025243 Bacterial Proton Translocating ATPases
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D025243 2006
% 207.86/208.06  |- skos__historyNote mesh__D025243
% 207.86/208.06       Proton-Translocating ATPases %28%1983-2001%29%
% 207.86/208.06  |- skos__hiddenLabel mesh__D025243
% 207.86/208.06       Escherichia coli Proton Translocating ATPase
% 207.86/208.06  |- skos__hiddenLabel mesh__D025243 E Coli Proton Translocating ATPase
% 207.86/208.06  |- mesh__dateCreated mesh__D025243 2001-07-25
% 207.86/208.06  |- skos__prefLabel mesh__D025243 Bacterial Proton-Translocating ATPases
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D025243 2005
% 207.86/208.06  |- mesh__dateRevised mesh__D025243 2003-07-09
% 207.86/208.06  |- skos__broader mesh__D025243smesh__D006180
% 207.86/208.06  |- skos__altLabel mesh__D025243 E Coli Proton-Translocating ATPase
% 207.86/208.06  |- skos__hiddenLabel mesh__D025243 E coli F1F0 ATPase
% 207.86/208.06  |- mesh__historyNote mesh__D025243
% 207.86/208.06       2002; for E COLI COUPLING FACTOR use PROTON TRANSLOCATING ATPASES 1983-2001%A%  
% 207.86/208.06  |- rdf__type mesh__D025243sskos__Concept
% 207.86/208.06  |- skos__altLabel mesh__D019206 G%28%o%29% Protein
% 207.86/208.06  |- skos__altLabel mesh__D019206 Gi alpha Subunit
% 207.86/208.06  |- skos__altLabel mesh__D019206 Gi-Alpha Protein
% 207.86/208.06  |- mesh__recordAuthorizer mesh__D019206 sjn
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 G Protein, Go1 Subunit
% 207.86/208.06  |- skos__altLabel mesh__D019206 G-Protein, Gi Subunit
% 207.86/208.06  |- skos__annotation mesh__D019206 DF: G PROTEIN INHIB GI   
% 207.86/208.06  |- skos__broader mesh__D019206smesh__D044385
% 207.86/208.06  |- mesh__dateEstablished mesh__D019206 1997-01-01
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 alpha Subunit, Gi
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 Gi Go G Proteins
% 207.86/208.06  |- skos__altLabel mesh__D019206 G-Protein, Inhibitory Go
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 Go1 Subunit G-Protein
% 207.86/208.06  |- mesh__recordMaintainer mesh__D019206 DRC
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 G Protein, Inhibitory Gi
% 207.86/208.06  |- skos__altLabel mesh__D019206 G-Protein, Go1 Subunit
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 Inhibitory Gi G-Protein
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 Subunit G-Protein, Go1
% 207.86/208.06  |- skos__altLabel mesh__D019206 G-Protein, Go Subunit
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 GTP Binding Protein alpha Subunit, GoC
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 G Protein, Gi Go alpha Family
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 Inhibitory G-Protein Gi
% 207.86/208.06  |- skos__altLabel mesh__D019206 Gi-Go G-Proteins
% 207.86/208.06  |- skos__altLabel mesh__D019206 Go Alpha Subunit
% 207.86/208.06  |- skos__altLabel mesh__D019206 Gi, Inhibitory G-Protein
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D019206 2006
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 GTP Binding Protein alpha Subunit, Go
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 Inhibitory Go G-Protein
% 207.86/208.06  |- mesh__publicMeSHNote mesh__D019206
% 207.86/208.06       2004; see G-PROTEIN, INHBITORY GI 1997-2003; GUANINE NUCLEOTIDE-BINDING PROTEIN GO was indexed under HETEROTRIMERIC GTP-BINDING PROTEINS 2000-2003 %26% GTP-BINDING PROTEINS 1991-1999%A%  
% 207.86/208.06  |- skos__altLabel mesh__D019206 G-Protein, Gi-Go Subunits
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 GTP Binding Protein alpha Subunit, Go1
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 G Protein, Inhibitory Go
% 207.86/208.06  |- rdf__type mesh__D019206sskos__Concept
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 Gi-Go Subunits G-Protein
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 Guanine Nucleotide Binding Protein Go
% 207.86/208.06  |- mesh__dateCreated mesh__D019206 1996-06-10
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 Gi Subunit G-Protein
% 207.86/208.06  |- skos__altLabel mesh__D019206 G Protein Go
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 Subunits G-Protein, Gi-Go
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 Gi Alpha Protein
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 Go G-Protein, Inhibitory
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 Alpha Subunit, Go
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 Gi G-Protein, Inhibitory
% 207.86/208.06  |- skos__altLabel mesh__D019206 G%28%o1%29%alpha
% 207.86/208.06  |- skos__historyNote mesh__D019206 G-Proteins %28%1985-1996%29%
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 Gi, Inhibitory G Protein
% 207.86/208.06  |- mesh__historyNote mesh__D019206
% 207.86/208.06       2004%28%1997%29%; for GUANINE NUCLEOTIDE-BINDING PROTEIN GO use GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO %28%NM%29% 1997-2003%A%  
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 GTP Binding Protein alpha Subunit, Gi
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 G Protein, Gi Go Subunits
% 207.86/208.06  |- skos__altLabel mesh__D019206 G Protein Subunit alphaoA
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 G Protein, Go Subunit
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 Subunit G-Protein, Gi
% 207.86/208.06  |- skos__altLabel mesh__D019206 Ni Protein
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 GTP Binding Protein alpha Subunit, GoA
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 Subunit, Gi alpha
% 207.86/208.06  |- skos__altLabel mesh__D019206 G-Protein, Inhibitory Gi
% 207.86/208.06  |- mesh__dateRevised mesh__D019206 2005-06-30
% 207.86/208.06  |- skos__scopeNote mesh__D019206
% 207.86/208.06       A family of heterotrimeric GTP-binding protein alpha subunits that were originally identified by their ability to inhibit ADENYLATE CYCLASE. Members of this family can couple to beta and gamma G-protein subunits that activate POTASSIUM CHANNELS. The Gi-Go part of the name is also spelled Gi/Go.%A%    
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 Subunit G-Protein, Go
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206
% 207.86/208.06       GTP Binding Protein alpha Subunits, Gi Go
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 Subunit, Go Alpha
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 G-Proteins, Gi-Go
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 G Protein, Gi Subunit
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 Go, G Protein
% 207.86/208.06  |- skos__prefLabel mesh__D019206 GTP-Binding Protein alpha Subunits, Gi-Go
% 207.86/208.06  |- skos__altLabel mesh__D019206 G-Protein, Gi-Go alpha Family
% 207.86/208.06  |- skos__altLabel mesh__D019206 G Protein Subunit alphaoC
% 207.86/208.06  |- skos__hiddenLabel mesh__D019206 Go Subunit G-Protein
% 207.86/208.06  |- mesh__recordOriginator mesh__D019206 TPW
% 207.86/208.06  |- skos__altLabel mesh__D019206 Guanine Nucleotide-Binding Protein Go
% 207.86/208.06  |- skos__historyNote mesh__D011223 Pyrazines %28%1966-1979%29%
% 207.86/208.06  |- skos__altLabel mesh__D011223 Merck Brand of Praziquantel
% 207.86/208.06  |- mesh__publicMeSHNote mesh__D011223 86; see ISOQUINOLINES 1980-85   
% 207.86/208.06  |- mesh__dateEstablished mesh__D011223 1986-01-01
% 207.86/208.06  |- mesh__recordOriginator mesh__D011223 SH
% 207.86/208.06  |- skos__altLabel mesh__D011223 Cysticide
% 207.86/208.06  |- rdf__type mesh__D011223sskos__Concept
% 207.86/208.06  |- mesh__dateRevised mesh__D011223 2005-06-30
% 207.86/208.06  |- skos__altLabel mesh__D011223 Bayer Brand of Praziquantel
% 207.86/208.06  |- skos__altLabel mesh__D011223 Prasiquantel
% 207.86/208.06  |- mesh__recordAuthorizer mesh__D011223 sjn
% 207.86/208.06  |- skos__scopeNote mesh__D011223
% 207.86/208.06       An anthelmintic used in most schistosome and many cestode infestations.%A%    
% 207.86/208.06  |- skos__hiddenLabel mesh__D011223 8440, EMBAY
% 207.86/208.06  |- skos__historyNote mesh__D011223 Isoquinolines %28%1969-1979%29%
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D011223 2006
% 207.86/208.06  |- mesh__historyNote mesh__D011223 86%28%80%29%   
% 207.86/208.06  |- skos__broader mesh__D011223smesh__D007546
% 207.86/208.06  |- skos__prefLabel mesh__D011223 Praziquantel
% 207.86/208.06  |- skos__altLabel mesh__D011223 Cisticid
% 207.86/208.06  |- mesh__recordMaintainer mesh__D011223 lkw
% 207.86/208.06  |- skos__historyNote mesh__D011223 Quinolines %28%1966-1968%29%
% 207.86/208.06  |- mesh__dateCreated mesh__D011223 1979-05-30
% 207.86/208.06  |- skos__prefLabel mesh__D049691 History, Medieval
% 207.86/208.06  |- skos__hiddenLabel mesh__D049691 Histories, Medieval %28%Medicine%29%
% 207.86/208.06  |- mesh__recordAuthorizer mesh__D049691 sjn
% 207.86/208.06  |- skos__altLabel mesh__D049691 Medieval History %28%Medicine%29%
% 207.86/208.06  |- mesh__dateCreated mesh__D049691 2004-07-07
% 207.86/208.06  |- mesh__publicMeSHNote mesh__D049691
% 207.86/208.06       2005; see HISTORY OF MEDICINE, MEDIEVAL 1995-2004; for HISTORY OF MEDICINE, MEDIEVAL see HISTORY OF MEDICINE, MEDIEVAL 1966-2004%A%  
% 207.86/208.06  |- mesh__historyNote mesh__D049691 2005   
% 207.86/208.06  |- mesh__recordOriginator mesh__D049691 jls
% 207.86/208.06  |- skos__annotation mesh__D049691 IM general only; NIM as check tag   
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D049691 2006
% 207.86/208.06  |- mesh__dateEstablished mesh__D049691 2005-01-01
% 207.86/208.06  |- skos__altLabel mesh__D049691 Medieval History
% 207.86/208.06  |- skos__hiddenLabel mesh__D049691 Medieval History Medicine
% 207.86/208.06  |- skos__altLabel mesh__D049691 Medicine, Medieval History
% 207.86/208.06  |- rdf__type mesh__D049691sskos__Concept
% 207.86/208.06  |- skos__hiddenLabel mesh__D049691 Medieval Histories %28%Medicine%29%
% 207.86/208.06  |- skos__hiddenLabel mesh__D049691 History, Medieval %28%Medicine%29%
% 207.86/208.06  |- mesh__recordMaintainer mesh__D049691 jls
% 207.86/208.06  |- skos__scopeNote mesh__D049691
% 207.86/208.06       The period of history from the year 500 through 1450 of the common era.%A%    
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D049691 2005
% 207.86/208.06  |- skos__broader mesh__D049691smesh__D006664
% 207.86/208.06  |- skos__hiddenLabel mesh__D049691 History Medicine, Medieval
% 207.86/208.06  |- skos__altLabel mesh__D049691 Renaissance Medicine
% 207.86/208.06  |- skos__broader mesh__D004912Q000637smesh__D004912
% 207.86/208.06  |- mesh__preferredCombination mesh__D004912Q000637smesh__D017707
% 207.86/208.06  |- rdf__type mesh__D004912Q000637smesh__CompoundConcept
% 207.86/208.06  |- mesh__dateEstablished mesh__D002497 1991-01-01
% 207.86/208.06  |- mesh__recordAuthorizer mesh__D002497 PLS
% 207.86/208.06  |- mesh__recordOriginator mesh__D002497 EC
% 207.86/208.06  |- mesh__publicMeSHNote mesh__D002497
% 207.86/208.06       91; was see under HOSPITAL ADMINISTRATION Aug 1977-90   
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D002497 1996
% 207.86/208.06  |- rdf__type mesh__D002497sskos__Concept
% 207.86/208.06  |- skos__hiddenLabel mesh__D002497 Centralized Service, Hospital
% 207.86/208.06  |- skos__hiddenLabel mesh__D002497 Service, Centralized Hospital
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D002497 1998
% 207.86/208.06  |- skos__hiddenLabel mesh__D002497 Hospital Service, Centralized
% 207.86/208.06  |- mesh__dateCreated mesh__D002497 1977-05-19
% 207.86/208.06  |- skos__altLabel mesh__D002497 Hospital Services, Centralized
% 207.86/208.06  |- skos__broader mesh__D002497smesh__D006739
% 207.86/208.06  |- mesh__dateRevised mesh__D002497 1995-05-22
% 207.86/208.06  |- mesh__recordMaintainer mesh__D002497 KEV
% 207.86/208.06  |- skos__hiddenLabel mesh__D002497 Hospital Centralized Services
% 207.86/208.06  |- skos__hiddenLabel mesh__D002497 Centralized Hospital Service
% 207.86/208.06  |- skos__altLabel mesh__D002497 Centralized Services, Hospital
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D002497 2004
% 207.86/208.06  |- skos__scopeNote mesh__D002497
% 207.86/208.06       The coordination of services in one area of a facility to improve efficiency.%A%    
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D002497 2002
% 207.86/208.06  |- skos__altLabel mesh__D002497 Services, Centralized Hospital
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D002497 2006
% 207.86/208.06  |- skos__hiddenLabel mesh__D002497 Services, Hospital Centralized
% 207.86/208.06  |- skos__hiddenLabel mesh__D002497 Hospital Centralized Service
% 207.86/208.06  |- mesh__activeMeSHYear mesh__D002497 2003
% 207.86/208.07  |- skos__prefLabel mesh__D002497 Centralized Hospital Services
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D002497 2001
% 207.86/208.07  |- mesh__historyNote mesh__D002497
% 207.86/208.07       91%28%Aug 77%29%; was see under HOSPITAL ADMINISTRATION 1977-90%A%  
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D002497 2005
% 207.86/208.07  |- skos__annotation mesh__D002497
% 207.86/208.07       do not confuse with CENTRAL SUPPLY, HOSPITAL; DF: CENTRALIZED HOSP SERV%A%  
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D002497 1997
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D002497 2000
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D002497 1999
% 207.86/208.07  |- skos__hiddenLabel mesh__D002497 Service, Hospital Centralized
% 207.86/208.07  |- skos__hiddenLabel mesh__D010929 Placental Development, Hemochorial
% 207.86/208.07  |- rdf__type mesh__D010929sskos__Concept
% 207.86/208.07  |- mesh__recordMaintainer mesh__D010929 lkt
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D010929 2005
% 207.86/208.07  |- skos__historyNote mesh__D010929 Placenta %28%1966-1974%29%
% 207.86/208.07  |- skos__altLabel mesh__D010929 Placental Development
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D010929 2006
% 207.86/208.07  |- mesh__onlineNote mesh__D010929 76; was see under PLACENTA 1975   
% 207.86/208.07  |- skos__scopeNote mesh__D010929
% 207.86/208.07       The development of the PLACENTA, a highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products between mother and FETUS. The process begins at FERTILIZATION, through the development of CYTOTROPHOBLASTS and SYNCYTIOTROPHOBLASTS, the formation of CHORIONIC VILLI, to the progressive increase in BLOOD VESSELS to support the growing fetus.%A%    
% 207.86/208.07  |- skos__annotation mesh__D010929 check the tags FEMALE %26% PREGNANCY   
% 207.86/208.07  |- skos__prefLabel mesh__D010929 Placentation
% 207.86/208.07  |- mesh__recordAuthorizer mesh__D010929 sjn
% 207.86/208.07  |- mesh__historyNote mesh__D010929
% 207.86/208.07       76%28%75%29%; was see under PLACENTA 1975   
% 207.86/208.07  |- mesh__dateRevised mesh__D010929 2004-07-07
% 207.86/208.07  |- skos__broader mesh__D010929smesh__D011247
% 207.86/208.07  |- mesh__dateCreated mesh__D010929 1974-11-11
% 207.86/208.07  |- mesh__recordOriginator mesh__D010929 NLM
% 207.86/208.07  |- mesh__dateEstablished mesh__D010929 1976-01-01
% 207.86/208.07  |- skos__hiddenLabel mesh__D010929 Placentation, Hemochorial
% 207.86/208.07  |- skos__altLabel mesh__D010929 Hemochorial Placental Development
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D007980 2006
% 207.86/208.07  |- mesh__onlineNote mesh__D007980 search DOPA 1972-74   
% 207.86/208.07  |- skos__related mesh__D007980smesh__D004298
% 207.86/208.07  |- skos__altLabel mesh__D007980 Medphano Brand of Levodopa
% 207.86/208.07  |- skos__altLabel mesh__D007980 3-Hydroxy-L-tyrosine
% 207.86/208.07  |- mesh__dateCreated mesh__D007980 1999-01-01
% 207.86/208.07  |- skos__hiddenLabel mesh__D007980 3 Hydroxy L tyrosine
% 207.86/208.07  |- skos__hiddenLabel mesh__D007980 L Dopa
% 207.86/208.07  |- skos__altLabel mesh__D007980 L-3,4-Dihydroxyphenylalanine
% 207.86/208.07  |- mesh__dateRevised mesh__D007980 2005-06-30
% 207.86/208.07  |- mesh__recordAuthorizer mesh__D007980 sjn
% 207.86/208.07  |- mesh__recordOriginator mesh__D007980 NLM
% 207.86/208.07  |- skos__hiddenLabel mesh__D007980 L 3,4 Dihydroxyphenylalanine
% 207.86/208.07  |- mesh__publicMeSHNote mesh__D007980 75; was see DOPA 1972-74   
% 207.86/208.07  |- skos__altLabel mesh__D007980 Roberts Brand of Levodopa
% 207.86/208.07  |- skos__altLabel mesh__D007980 L-Dopa
% 207.86/208.07  |- rdf__type mesh__D007980sskos__Concept
% 207.86/208.07  |- skos__scopeNote mesh__D007980
% 207.86/208.07       The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system.%A%    
% 207.86/208.07  |- skos__prefLabel mesh__D007980 Levodopa
% 207.86/208.07  |- mesh__recordMaintainer mesh__D007980 ssb
% 207.86/208.07  |- skos__altLabel mesh__D007980 Roche Brand of Levodopa
% 207.86/208.07  |- mesh__historyNote mesh__D007980 75; was see DOPA 1972-74   
% 207.86/208.07  |- mesh__dateEstablished mesh__D007980 1975-01-01
% 207.86/208.07  |- skos__broader mesh__D007980smesh__D004295
% 207.86/208.07  |- skos__historyNote mesh__D007980 Dopa %28%1966-1974%29%
% 207.86/208.07  |- skos__scopeNote mesh__D007182
% 207.86/208.07       Revenues or receipts accruing from business enterprise, labor, or invested capital.%A%    
% 207.86/208.07  |- skos__hiddenLabel mesh__D007182 Incomes
% 207.86/208.07  |- skos__annotation mesh__D007182
% 207.86/208.07       includes income from salaries, annuities, stocks, etc.; does not include fees charged by a professional %28% = FEES AND CHARGES%29%%A%  
% 207.86/208.07  |- skos__prefLabel mesh__D007182 Income
% 207.86/208.07  |- skos__broader mesh__D007182smesh__D012959
% 207.86/208.07  |- mesh__publicMeSHNote mesh__D007182 68   
% 207.86/208.07  |- mesh__dateEstablished mesh__D007182 1968-01-01
% 207.86/208.07  |- mesh__recordOriginator mesh__D007182 NLM
% 207.86/208.07  |- mesh__recordMaintainer mesh__D007182 kle
% 207.86/208.07  |- mesh__dateCreated mesh__D007182 1999-01-01
% 207.86/208.07  |- skos__hiddenLabel mesh__D007182 Program, Income Generation
% 207.86/208.07  |- skos__hiddenLabel mesh__D007182 Income Generation Program
% 207.86/208.07  |- skos__hiddenLabel mesh__D007182 Distributions, Income
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D007182 2004
% 207.86/208.07  |- mesh__dateRevised mesh__D007182 1999-11-03
% 207.86/208.07  |- skos__hiddenLabel mesh__D007182 Distribution, Income
% 207.86/208.07  |- mesh__historyNote mesh__D007182 68   
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D007182 2002
% 207.86/208.07  |- skos__related mesh__D007182smesh__D012456
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D007182 2003
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D007182 2006
% 207.86/208.07  |- mesh__recordAuthorizer mesh__D007182 sjn
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D007182 2001
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D007182 2005
% 207.86/208.07  |- skos__hiddenLabel mesh__D007182 Income Distributions
% 207.86/208.07  |- rdf__type mesh__D007182sskos__Concept
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D007182 2000
% 207.86/208.07  |- skos__hiddenLabel mesh__D007182 Programs, Income Generation
% 207.86/208.07  |- skos__historyNote mesh__D007182 Social Conditions %28%1966-1967%29%
% 207.86/208.07  |- mesh__recordAuthorizer mesh__D015614 PLS
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D015614 1997
% 207.86/208.07  |- skos__broader mesh__D015614smesh__D012158
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D015614 2002
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D015614 2005
% 207.86/208.07  |- mesh__recordMaintainer mesh__D015614 TGC
% 207.86/208.07  |- mesh__publicMeSHNote mesh__D015614 90   
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D015614 1998
% 207.86/208.07  |- mesh__dateCreated mesh__D015614 1989-06-20
% 207.86/208.07  |- skos__scopeNote mesh__D015614
% 207.86/208.07       General term for the abnormal appearance of histiocytes in the blood. Based on the pathological features of the cells involved rather than on clinical findings, the histiocytic diseases are subdivided into three groups: HISTIOCYTOSIS, LANGERHANS CELL; HISTIOCYTOSIS, NON-LANGERHANS CELL; and HISTIOCYTIC DISORDERS, MALIGNANT.%A%    
% 207.86/208.07  |- skos__annotation mesh__D015614
% 207.86/208.07       %22%abnormal appearance of histiocytes in the blood%22% %28%usually in tissue%29%; GEN or unspecified only; prefer specifics; do not confuse with HISTIOCYTOSIS X see HISTIOCYTOSIS, LANGERHANS-CELL%A%  
% 207.86/208.07  |- mesh__recordOriginator mesh__D015614 AGS
% 207.86/208.07  |- mesh__dateEstablished mesh__D015614 1990-01-01
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D015614 2006
% 207.86/208.07  |- skos__hiddenLabel mesh__D015614 Histiocytoses
% 207.86/208.07  |- mesh__historyNote mesh__D015614 90   
% 207.86/208.07  |- skos__prefLabel mesh__D015614 Histiocytosis
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D015614 1999
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D015614 1994
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D015614 2000
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D015614 2003
% 207.86/208.07  |- rdf__type mesh__D015614sskos__Concept
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D015614 1995
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D015614 1996
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D015614 2001
% 207.86/208.07  |- mesh__dateRevised mesh__D015614 1993-06-02
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D015614 2004
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D006888 2006
% 207.86/208.07  |- skos__broader mesh__D006888smesh__D002784
% 207.86/208.07  |- mesh__historyNote mesh__D006888
% 207.86/208.07       78; was HYDROXYCHOLESTEROL see under CHOLESTEROL 1973-77   
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D006888 2005
% 207.86/208.07  |- mesh__dateRevised mesh__D006888 2003-07-09
% 207.86/208.07  |- skos__prefLabel mesh__D006888 Hydroxycholesterols
% 207.86/208.07  |- mesh__recordMaintainer mesh__D006888 ssb
% 207.86/208.07  |- skos__historyNote mesh__D006888 Cholesterol %28%1966-1977%29%
% 207.86/208.07  |- mesh__recordAuthorizer mesh__D006888 sjn
% 207.86/208.07  |- mesh__onlineNote mesh__D006888
% 207.86/208.07       use HYDROXYCHOLESTEROLS to search HYDROXYCHOLESTEROL 1975-77; use CHOLESTEROL 1973-74%A%  
% 207.86/208.07  |- mesh__publicMeSHNote mesh__D006888
% 207.86/208.07       78; was HYDROXYCHOLESTEROL see under CHOLESTEROL 1973-77   
% 207.86/208.07  |- mesh__recordOriginator mesh__D006888 NLM
% 207.86/208.07  |- rdf__type mesh__D006888sskos__Concept
% 207.86/208.07  |- mesh__dateCreated mesh__D006888 1999-01-01
% 207.86/208.07  |- mesh__dateEstablished mesh__D006888 1978-01-01
% 207.86/208.07  |- skos__scopeNote mesh__D006888
% 207.86/208.07       Cholesterol which is substituted by a hydroxy group in any position.%A%    
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D006888 2004
% 207.86/208.07  |- skos__hiddenLabel mesh__D020559 G-Proteins, Small
% 207.86/208.07  |- skos__broader mesh__D020559smesh__D047908
% 207.86/208.07  |- mesh__dateCreated mesh__D020559 1999-11-03
% 207.86/208.07  |- skos__broader mesh__D020559smesh__D019204
% 207.86/208.07  |- skos__hiddenLabel mesh__D020559 GTP Binding Proteins, Monomeric
% 207.86/208.07  |- skos__hiddenLabel mesh__D020559 Monomeric G Proteins
% 207.86/208.07  |- skos__hiddenLabel mesh__D020559 GTPases, Small
% 207.86/208.07  |- skos__altLabel mesh__D020559 G-Proteins, Monomeric
% 207.86/208.07  |- mesh__historyNote mesh__D020559 2000   
% 207.86/208.07  |- skos__altLabel mesh__D020559 GTP-Binding Proteins, Monomeric
% 207.86/208.07  |- skos__altLabel mesh__D020559 ras-Related G-Proteins
% 207.86/208.07  |- mesh__dateRevised mesh__D020559 2005-06-30
% 207.86/208.07  |- skos__hiddenLabel mesh__D020559 Monomeric GTP Binding Proteins
% 207.86/208.07  |- skos__historyNote mesh__D020559
% 207.86/208.07       Heterotrimeric GTP-Binding Proteins %28%1985-1996%29%
% 207.86/208.07  |- mesh__recordAuthorizer mesh__D020559 sjn
% 207.86/208.07  |- rdf__type mesh__D020559sskos__Concept
% 207.86/208.07  |- mesh__dateEstablished mesh__D020559 2000-01-01
% 207.86/208.07  |- skos__hiddenLabel mesh__D020559 GTPases, ras-Related
% 207.86/208.07  |- skos__scopeNote mesh__D020559
% 207.86/208.07       A class of monomeric, low molecular weight %28%20-25 kDa%29% GTP-binding proteins that regulate a variety of intracellular processes. The GTP bound form of the protein is active and limited by its inherent GTPase activity, which is controlled by an array of GTPase activators, GDP dissociation inhibitors, and guanine nucleotide exchange factors. This enzyme was formerly listed as EC 3.6.1.47%A%    
% 207.86/208.07  |- skos__hiddenLabel mesh__D020559 ras Related G Proteins
% 207.86/208.07  |- skos__hiddenLabel mesh__D020559 ras Related GTPases
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D020559 2006
% 207.86/208.07  |- skos__hiddenLabel mesh__D020559 Proteins, ras-Related GTP-Binding
% 207.86/208.07  |- skos__hiddenLabel mesh__D020559 GTP-Binding Proteins, ras-Related
% 207.86/208.07  |- skos__hiddenLabel mesh__D020559 G-Proteins, ras-Related
% 207.86/208.07  |- skos__altLabel mesh__D020559 ras-Related GTP-Binding Proteins
% 207.86/208.07  |- skos__altLabel mesh__D020559 Monomeric G-Proteins
% 207.86/208.07  |- mesh__recordMaintainer mesh__D020559 jmp
% 207.86/208.07  |- mesh__publicMeSHNote mesh__D020559 2000   
% 207.86/208.07  |- skos__hiddenLabel mesh__D020559 G Proteins, Monomeric
% 207.86/208.07  |- skos__altLabel mesh__D020559 Small GTPases
% 207.86/208.07  |- mesh__recordOriginator mesh__D020559 jmp
% 207.86/208.07  |- skos__prefLabel mesh__D020559 Monomeric GTP-Binding Proteins
% 207.86/208.07  |- skos__historyNote mesh__D020559 GTP-Binding Proteins %28%1997-1999%29%
% 207.86/208.07  |- skos__hiddenLabel mesh__D020559 Small G Proteins
% 207.86/208.07  |- skos__hiddenLabel mesh__D020559 ras Related GTP Binding Proteins
% 207.86/208.07  |- skos__altLabel mesh__D020559 Small G-Proteins
% 207.86/208.07  |- mesh__historyNote mesh__D031281 2003   
% 207.86/208.07  |- rdf__type mesh__D031281sskos__Concept
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D031281 2004
% 207.86/208.07  |- mesh__publicMeSHNote mesh__D031281 2003   
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D031281 2005
% 207.86/208.07  |- skos__broader mesh__D031281smesh__D031263
% 207.86/208.07  |- skos__altLabel mesh__D031281 Sea Buckthorn
% 207.86/208.07  |- skos__prefLabel mesh__D031281 Hippophae
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D031281 2006
% 207.86/208.07  |- mesh__dateCreated mesh__D031281 2002-07-02
% 207.86/208.07  |- mesh__dateEstablished mesh__D031281 2003-01-01
% 207.86/208.07  |- skos__altLabel mesh__D031281 Fructus Hippophae
% 207.86/208.07  |- skos__altLabel mesh__D031281 Buckthorn, Sea
% 207.86/208.07  |- skos__scopeNote mesh__D031281
% 207.86/208.07       A plant genus of the family ELAEAGNACEAE. Linoleic %28%18:2n-6%29% and alpha-linolenic acids %28%18:3n-3%29% comprised about 70%25% of seed oil fatty acids.  This is unrelated to %27%artificial sea buckthorn oil%27%.%A%    
% 207.86/208.07  |- skos__annotation mesh__D031281
% 207.86/208.07       unrelated to %22%artificial sea buckthorn oil%22%; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D031281 2003
% 207.86/208.07  |- skos__altLabel mesh__D019207 3M Brand of Betacarotene
% 207.86/208.07  |- skos__broader mesh__D019207smesh__D002338
% 207.86/208.07  |- skos__hiddenLabel mesh__D019207 Betacarotene Merck Brand
% 207.86/208.07  |- mesh__publicMeSHNote mesh__D019207
% 207.86/208.07       97; BETA-CAROTENE was indexed under CAROTENE 1980-96   
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D019207 2006
% 207.86/208.07  |- skos__hiddenLabel mesh__D019207 Betacarotene Hermal Brand
% 207.86/208.07  |- rdf__type mesh__D019207sskos__Concept
% 207.86/208.07  |- skos__hiddenLabel mesh__D019207 Betacarotene Solgar Brand
% 207.86/208.07  |- skos__scopeNote mesh__D019207
% 207.86/208.07       A carotenoid that is a precursor of VITAMIN A. It is administered to reduce the severity of photosensitivity reactions in patients with erythropoietic protoporphyria %28%PORPHYRIA, ERYTHROPOIETIC%29%. %28%From Reynolds JEF%28%Ed%29%: Martindale: The Extra Pharmacopoeia %28%electronic version%29%. Micromedex, Inc, Engewood, CO, 1995.%29%%A%    
% 207.86/208.07  |- skos__altLabel mesh__D019207 beta-Carotene
% 207.86/208.07  |- mesh__historyNote mesh__D019207
% 207.86/208.07       97; was BETA-CAROTENE %28%NM%29% 1980-96   
% 207.86/208.07  |- skos__prefLabel mesh__D019207 beta Carotene
% 207.86/208.07  |- skos__altLabel mesh__D019207 Merck Brand of Betacarotene
% 207.86/208.07  |- skos__hiddenLabel mesh__D019207 MaxCaro
% 207.86/208.07  |- skos__altLabel mesh__D019207 Hermal Brand of Betacarotene
% 207.86/208.07  |- skos__hiddenLabel mesh__D019207 Betacarotene 3M Brand
% 207.86/208.07  |- skos__hiddenLabel mesh__D019207 Max Caro
% 207.86/208.07  |- skos__altLabel mesh__D019207 Marlyn Brand of Betacarotene
% 207.86/208.07  |- skos__historyNote mesh__D019207 Carotene %28%1980-1996%29%
% 207.86/208.07  |- mesh__recordMaintainer mesh__D019207 ssb
% 207.86/208.07  |- mesh__recordOriginator mesh__D019207 TPW
% 207.86/208.07  |- mesh__dateRevised mesh__D019207 2005-06-30
% 207.86/208.07  |- skos__altLabel mesh__D019207 Solgar Brand of Betacarotene
% 207.86/208.07  |- mesh__recordAuthorizer mesh__D019207 sjn
% 207.86/208.07  |- skos__altLabel mesh__D019207 Roche Brand of Betacarotene
% 207.86/208.07  |- mesh__onlineNote mesh__D019207
% 207.86/208.07       use BETA CAROTENE %28%NM%29% to search BETA-CAROTENE 1980-96   
% 207.86/208.07  |- skos__altLabel mesh__D019207 Betacarotene
% 207.86/208.07  |- mesh__dateEstablished mesh__D019207 1997-01-01
% 207.86/208.07  |- skos__hiddenLabel mesh__D019207 Betacarotene Marlyn Brand
% 207.86/208.07  |- mesh__dateCreated mesh__D019207 1996-06-10
% 207.86/208.07  |- skos__hiddenLabel mesh__D019207 Carotene, beta
% 207.86/208.07  |- skos__hiddenLabel mesh__D019207 Betacarotene Roche Brand
% 207.86/208.07  |- mesh__recordOriginator mesh__D011224 SH
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D011224 2005
% 207.86/208.07  |- mesh__dateEstablished mesh__D011224 1986-01-01
% 207.86/208.07  |- skos__historyNote mesh__D011224 Piperazines %28%1974-1976%29%
% 207.86/208.07  |- mesh__dateCreated mesh__D011224 1976-04-13
% 207.86/208.07  |- mesh__publicMeSHNote mesh__D011224
% 207.86/208.07       86; was see under QUINAZOLINES 1977-85   
% 207.86/208.07  |- rdf__type mesh__D011224sskos__Concept
% 207.86/208.07  |- skos__broader mesh__D011224smesh__D011799
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D011224 2004
% 207.86/208.07  |- mesh__recordAuthorizer mesh__D011224 sjn
% 207.86/208.07  |- skos__scopeNote mesh__D011224
% 207.86/208.07       A selective adrenergic alpha-1 antagonist used in the treatment of heart failure, hypertension, pheochromocytoma, Raynaud%27%s syndrome, prostatic hypertrophy, and urinary retention.%A%    
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D011224 2003
% 207.86/208.07  |- mesh__recordMaintainer mesh__D011224 TWD
% 207.86/208.07  |- skos__altLabel mesh__D011224 Furazosin
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D011224 2002
% 207.86/208.07  |- skos__prefLabel mesh__D011224 Prazosin
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D011224 2001
% 207.86/208.07  |- mesh__historyNote mesh__D011224
% 207.86/208.07       86%28%77%29%; was see under QUINAZOLINES 1977-85   
% 207.86/208.07  |- skos__historyNote mesh__D011224 Quinazolines %28%1974-1976%29%
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D011224 2006
% 207.86/208.07  |- mesh__dateRevised mesh__D011224 2000-06-22
% 207.86/208.07  |- mesh__historyNote mesh__D049692 2005   
% 207.86/208.07  |- mesh__recordMaintainer mesh__D049692 jls
% 207.86/208.07  |- skos__hiddenLabel mesh__D049692 Modern Histories, Early %28%Medicine%29%
% 207.86/208.07  |- mesh__dateCreated mesh__D049692 2004-07-07
% 207.86/208.07  |- skos__hiddenLabel mesh__D049692 Early Modern Histories %28%Medicine%29%
% 207.86/208.07  |- skos__altLabel mesh__D049692 Early Modern History of Medicine
% 207.86/208.07  |- skos__prefLabel mesh__D049692 History, Early Modern 1451-1600
% 207.86/208.07  |- skos__scopeNote mesh__D049692
% 207.86/208.07       The period of history from 1451 through 1600 of the common era.%A%    
% 207.86/208.07  |- mesh__recordOriginator mesh__D049692 jls
% 207.86/208.07  |- skos__hiddenLabel mesh__D049692 Modern History, Early %28%Medicine%29%
% 207.86/208.07  |- skos__annotation mesh__D049692 not used for indexing   
% 207.86/208.07  |- skos__hiddenLabel mesh__D049692 Modern Medicine, Early
% 207.86/208.07  |- skos__hiddenLabel mesh__D049692 History, Early Modern 1451 1600
% 207.86/208.07  |- skos__hiddenLabel mesh__D049692 Modern History, Early
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D049692 2005
% 207.86/208.07  |- skos__hiddenLabel mesh__D049692 History, Early Modern %28%Medicine%29%
% 207.86/208.07  |- skos__altLabel mesh__D049692 Early Modern History
% 207.86/208.07  |- mesh__recordAuthorizer mesh__D049692 sjn
% 207.86/208.07  |- skos__altLabel mesh__D049692 History, Early Modern
% 207.86/208.07  |- skos__hiddenLabel mesh__D049692 Histories, Early Modern %28%Medicine%29%
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D049692 2006
% 207.86/208.07  |- mesh__publicMeSHNote mesh__D049692
% 207.86/208.07       2005; for HISTORY OF MEDICINE, EARLY MODERN see HISTORY OF MEDICINE, EARLY MODERN 1995-2004%A%  
% 207.86/208.07  |- rdf__type mesh__D049692sskos__Concept
% 207.86/208.07  |- skos__altLabel mesh__D049692 Early Modern History %28%Medicine%29%
% 207.86/208.07  |- mesh__dateEstablished mesh__D049692 2005-01-01
% 207.86/208.07  |- skos__broader mesh__D049692smesh__D006664
% 207.86/208.07  |- skos__altLabel mesh__D049692 Medicine, Early Modern
% 207.86/208.07  |- skos__annotation mesh__D002498
% 207.86/208.07       as a lab technique %26% to simulate gravitational eff in space; NIM%A%  
% 207.86/208.07  |- skos__related mesh__D002498smesh__D018471
% 207.86/208.07  |- skos__scopeNote mesh__D002498
% 207.86/208.07       Process of using a rotating machine to generate centrifugal force to separate substances of different densities, remove moisture, or simulate gravitational effects. It employs a large motor-driven apparatus with a long arm, at the end of which human and animal subjects, biological specimens, or equipment can be revolved and rotated at various speeds to study gravitational effects. %28%From Websters, 10th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 207.86/208.07  |- rdf__type mesh__D002498sskos__Concept
% 207.86/208.07  |- mesh__recordAuthorizer mesh__D002498 sjn
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D002498 2005
% 207.86/208.07  |- mesh__recordMaintainer mesh__D002498 sjn
% 207.86/208.07  |- mesh__dateCreated mesh__D002498 1999-01-01
% 207.86/208.07  |- mesh__dateRevised mesh__D002498 2004-07-13
% 207.86/208.07  |- skos__related mesh__D002498smesh__D018470
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D002498 2006
% 207.86/208.07  |- skos__broader mesh__D002498smesh__D008919
% 207.86/208.07  |- skos__prefLabel mesh__D002498 Centrifugation
% 207.86/208.07  |- skos__related mesh__D002498smesh__D014461
% 207.86/208.07  |- mesh__recordOriginator mesh__D002498 NLM
% 207.86/208.07  |- skos__hiddenLabel mesh__D007981 LevoDromoran
% 207.86/208.07  |- mesh__dateRevised mesh__D007981 2004-07-07
% 207.86/208.07  |- rdf__type mesh__D007981sskos__Concept
% 207.86/208.07  |- skos__hiddenLabel mesh__D007981 L Dromoran
% 207.86/208.07  |- mesh__publicMeSHNote mesh__D007981
% 207.86/208.07       65; was LEVORPHAN see under MORPHINE 1963-64   
% 207.86/208.07  |- skos__hiddenLabel mesh__D007981 Levo Dromoran
% 207.86/208.07  |- skos__hiddenLabel mesh__D007981 Tartrate, Levorphanol
% 207.86/208.07  |- skos__prefLabel mesh__D007981 Levorphanol
% 207.86/208.07  |- skos__altLabel mesh__D007981 Levodroman
% 207.86/208.07  |- skos__scopeNote mesh__D007981
% 207.86/208.07       A narcotic analgesic that may be habit-forming. It is nearly as effective orally as by injection.%A%    
% 207.86/208.07  |- skos__altLabel mesh__D007981 ICN Brand of Levorphanol Tartrate
% 207.86/208.07  |- skos__broader mesh__D007981smesh__D009019
% 207.86/208.07  |- skos__altLabel mesh__D007981 Levorphan
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D007981 2006
% 207.86/208.07  |- skos__hiddenLabel mesh__D007981 3 Hydroxy N methylmorphinan
% 207.86/208.07  |- mesh__historyNote mesh__D007981
% 207.86/208.07       65; was LEVORPHAN see under MORPHINE 1963-64   
% 207.86/208.07  |- mesh__recordAuthorizer mesh__D007981 sjn
% 207.86/208.07  |- mesh__recordOriginator mesh__D007981 NLM
% 207.86/208.07  |- mesh__dateEstablished mesh__D007981 1965-01-01
% 207.86/208.07  |- mesh__dateCreated mesh__D007981 1999-01-01
% 207.86/208.07  |- mesh__recordMaintainer mesh__D007981 CCR
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D007981 2005
% 207.86/208.07  |- mesh__dateRevised mesh__D007183 1999-11-03
% 207.86/208.07  |- mesh__recordAuthorizer mesh__D007183 sjn
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D007183 2001
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D007183 2003
% 207.86/208.07  |- skos__prefLabel mesh__D007183 Income Tax
% 207.86/208.07  |- skos__hiddenLabel mesh__D007183 Tax, Income
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D007183 2005
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D007183 2004
% 207.86/208.07  |- skos__scopeNote mesh__D007183
% 207.86/208.07       Tax on the net income of an individual, organization, or business.%A%    
% 207.86/208.07  |- skos__hiddenLabel mesh__D007183 Taxes, Income
% 207.86/208.07  |- mesh__recordOriginator mesh__D007183 NLM
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D007183 2002
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D007183 2006
% 207.86/208.07  |- mesh__recordMaintainer mesh__D007183 kle
% 207.86/208.07  |- skos__annotation mesh__D007183 IM; specify geog   
% 207.86/208.07  |- skos__altLabel mesh__D007183 Income Taxes
% 207.86/208.07  |- mesh__dateCreated mesh__D007183 1999-01-01
% 207.86/208.07  |- rdf__type mesh__D007183sskos__Concept
% 207.86/208.07  |- skos__broader mesh__D007183smesh__D013660
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D007183 2000
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D015615 2005
% 207.86/208.07  |- mesh__publicMeSHNote mesh__D015615 90   
% 207.86/208.07  |- skos__broader mesh__D015615smesh__D015619
% 207.86/208.07  |- skos__broader mesh__D015615smesh__D008171
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D015615 2001
% 207.86/208.07  |- mesh__dateEstablished mesh__D015615 1990-01-01
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D015615 2006
% 207.86/208.07  |- skos__prefLabel mesh__D015615
% 207.86/208.07       Cystic Adenomatoid Malformation of Lung, Congenital
% 207.86/208.07  |- mesh__recordMaintainer mesh__D015615 kle
% 207.86/208.07  |- skos__historyNote mesh__D015615 Lung/abnormalities %28%1966-1989%29%
% 207.86/208.07  |- skos__annotation mesh__D015615
% 207.86/208.07       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: CCAM%A%  
% 207.86/208.07  |- mesh__recordOriginator mesh__D015615 PXP
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D015615 2002
% 207.86/208.07  |- rdf__type mesh__D015615sskos__Concept
% 207.86/208.07  |- skos__altLabel mesh__D015615
% 207.86/208.07       Lung Malformation, Cystic Adenomatoid, Congenital
% 207.86/208.07  |- mesh__dateCreated mesh__D015615 1989-04-07
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D015615 2003
% 207.86/208.07  |- skos__scopeNote mesh__D015615
% 207.86/208.07       A developmental anomaly that usually becomes apparent in the neonatal period with progressive respiratory distress. This malformation is a focal pulmonary dysplasia characterized by a multicystic mass of terminal bronchiolar structures. CCAM is classified into 3 separate types %28%I, II, III%29% depending on cyst size.%A%    
% 207.86/208.07  |- mesh__historyNote mesh__D015615 90   
% 207.86/208.07  |- mesh__recordAuthorizer mesh__D015615 sjn
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D015615 2004
% 207.86/208.07  |- skos__altLabel mesh__D015615
% 207.86/208.07       Congenital Cystic Adenomatoid Malformation of Lung
% 207.86/208.07  |- mesh__dateRevised mesh__D015615 1999-11-03
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D015615 2000
% 207.86/208.07  |- skos__altLabel mesh__D015615 Cystic Adenomatoid Malformation of Lung
% 207.86/208.07  |- skos__altLabel mesh__D015615
% 207.86/208.07       Lung Malformation, Congenital Cystic Adenomatoid
% 207.86/208.07  |- mesh__recordOriginator mesh__D006889 NLM
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D006889 2005
% 207.86/208.07  |- skos__historyNote mesh__D006889 Glucocorticoids %28%1967-1971%29%
% 207.86/208.07  |- mesh__dateRevised mesh__D006889 2003-07-09
% 207.86/208.07  |- skos__historyNote mesh__D006889 Mineralocorticoids %28%1967-1971%29%
% 207.86/208.07  |- mesh__historyNote mesh__D006889 73%28%72%29%   
% 207.86/208.07  |- skos__scopeNote mesh__D006889
% 207.86/208.07       A group of corticosteroids carrying hydroxy groups, usually in the 11- or 17-positions. They comprise the bulk of the corticosteroids used systemically. As they are relatively insoluble in water, salts of various esterified forms are often used for injections or solutions.%A%    
% 207.86/208.07  |- skos__historyNote mesh__D006889
% 207.86/208.07       Adrenal Cortex Hormones %28%1966-1971%29%
% 207.86/208.07  |- mesh__recordMaintainer mesh__D006889 ssb
% 207.86/208.07  |- mesh__dateEstablished mesh__D006889 1973-01-01
% 207.86/208.07  |- mesh__dateCreated mesh__D006889 1999-01-01
% 207.86/208.07  |- rdf__type mesh__D006889sskos__Concept
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D006889 2004
% 207.86/208.07  |- mesh__recordAuthorizer mesh__D006889 sjn
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D006889 2006
% 207.86/208.07  |- skos__broader mesh__D006889smesh__D000305
% 207.86/208.07  |- skos__prefLabel mesh__D006889 Hydroxycorticosteroids
% 207.86/208.07  |- mesh__publicMeSHNote mesh__D006889 73   
% 207.86/208.07  |- mesh__publicMeSHNote mesh__D031282 2003   
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D031282 2005
% 207.86/208.07  |- mesh__historyNote mesh__D031282 2003   
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D031282 2006
% 207.86/208.07  |- mesh__dateCreated mesh__D031282 2002-07-03
% 207.86/208.07  |- skos__annotation mesh__D031282
% 207.86/208.07       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.86/208.07  |- skos__scopeNote mesh__D031282
% 207.86/208.07       A plant genus of the family ERICACEAE. The common name of %22%wintergreen%22% is also used for PYROLA and %22%snowberry%22% is also used for SYMPHORICARPOS.%A%    
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D031282 2003
% 207.86/208.07  |- skos__prefLabel mesh__D031282 Gaultheria
% 207.86/208.07  |- mesh__dateEstablished mesh__D031282 2003-01-01
% 207.86/208.07  |- rdf__type mesh__D031282sskos__Concept
% 207.86/208.07  |- skos__broader mesh__D031282smesh__D029791
% 207.86/208.07  |- mesh__activeMeSHYear mesh__D031282 2004
% 207.86/208.07  |- rdf__type mesh__D019208sskos__Concept
% 207.86/208.07  |- mesh__publicMeSHNote mesh__D019208
% 207.86/208.07       97; BRAIN-DERIVED NEUROTROPHIC FACTOR was indexed under NERVE TISSUE PROTEINS 1986-96%A%  
% 207.86/208.07  |- skos__hiddenLabel mesh__D019208 Factor, Brain-Derived Neurotrophic
% 207.86/208.07  |- mesh__historyNote mesh__D019208
% 207.86/208.07       97; was BRAIN-DERIVED NEUROTROPHIC FACTOR 1986-96   
% 207.86/208.07  |- mesh__dateEstablished mesh__D019208 1997-01-01
% 207.86/208.07  |- mesh__dateCreated mesh__D019208 1996-06-10
% 207.86/208.07  |- skos__annotation mesh__D019208
% 207.86/208.07       a nerve growth factor; DF: note short X ref   
% 207.86/208.07  |- skos__broader mesh__D019208smesh__D009414
% 207.86/208.07  |- mesh__onlineNote mesh__D019208
% 207.86/208.07       use BRAIN-DERIVED NEUROTROPHIC FACTOR %28%NM%29% to search BRAIN-DERIVED NEUROTROPHIC FACTOR 1986-96%A%  
% 207.86/208.07  |- mesh__recordMaintainer mesh__D019208 ssb
% 207.86/208.08  |- mesh__recordOriginator mesh__D019208 TPW
% 207.86/208.08  |- skos__scopeNote mesh__D019208
% 207.86/208.08       A member of the nerve growth factor family of trophic factors. In the brain BDNF has a trophic action on retinal, cholinergic, and dopaminergic neurons, and in the peripheral nervous system it acts on both motor and sensory neurons. %28%From Kendrew, The Encyclopedia of Molecular Biology, 1994%29%%A%    
% 207.86/208.08  |- skos__hiddenLabel mesh__D019208 Brain Derived Neurotrophic Factor
% 207.86/208.08  |- mesh__dateRevised mesh__D019208 2005-06-30
% 207.86/208.08  |- skos__prefLabel mesh__D019208 Brain-Derived Neurotrophic Factor
% 207.86/208.08  |- mesh__recordAuthorizer mesh__D019208 sjn
% 207.86/208.08  |- skos__hiddenLabel mesh__D019208 Neurotrophic Factor, Brain-Derived
% 207.86/208.08  |- skos__historyNote mesh__D019208 Nerve Tissue Proteins %28%1986-1996%29%
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D019208 2006
% 207.86/208.08  |- skos__altLabel mesh__D019208 BDNF
% 207.86/208.08  |- skos__broader mesh__D011225smesh__D046110
% 207.86/208.08  |- skos__altLabel mesh__D011225 EPH Complex
% 207.86/208.08  |- mesh__recordOriginator mesh__D011225 NLM
% 207.86/208.08  |- skos__hiddenLabel mesh__D011225 Proteinuria Edema Hypertension Gestosis
% 207.86/208.08  |- skos__hiddenLabel mesh__D011225 EPH Toxemia
% 207.86/208.08  |- skos__hiddenLabel mesh__D011225 Gestosis, Proteinuria-Edema-Hypertension
% 207.86/208.08  |- mesh__recordMaintainer mesh__D011225 lkt
% 207.86/208.08  |- skos__historyNote mesh__D011225 Pregnancy Toxemias %28%1966-1974%29%
% 207.86/208.08  |- mesh__publicMeSHNote mesh__D011225
% 207.86/208.08       1979; see PREGNANCY TOXEMIAS 1963-1978; for PREGNANCY TOXEMIAS see PREGNANCY TOXEMIAS 1963-2004; for EDEMA-PROTEINURIA-HYPERTENSION GESTOSIS see GESTOSIS, EPH 1989-2004%A%  
% 207.86/208.08  |- skos__altLabel mesh__D011225 Preeclampsia
% 207.86/208.08  |- skos__hiddenLabel mesh__D011225 Toxemia, EPH
% 207.86/208.08  |- skos__altLabel mesh__D011225 Proteinuria-Edema-Hypertension Gestosis
% 207.86/208.08  |- mesh__dateCreated mesh__D011225 1999-01-01
% 207.86/208.08  |- skos__altLabel mesh__D011225 Edema-Proteinuria-Hypertension Gestosis
% 207.86/208.08  |- skos__altLabel mesh__D011225 Pregnancy Toxemias
% 207.86/208.08  |- mesh__recordAuthorizer mesh__D011225 sjn
% 207.86/208.08  |- skos__hiddenLabel mesh__D011225 Edema Proteinuria Hypertension Gestosis
% 207.86/208.08  |- skos__hiddenLabel mesh__D011225 Hypertension Edema Proteinuria Gestosis
% 207.86/208.08  |- skos__altLabel mesh__D011225 Hypertension-Edema-Proteinuria Gestosis
% 207.86/208.08  |- skos__hiddenLabel mesh__D011225 Toxemias, EPH
% 207.86/208.08  |- skos__related mesh__D011225smesh__D014115
% 207.86/208.08  |- skos__altLabel mesh__D011225 EPH Gestosis
% 207.86/208.08  |- mesh__dateRevised mesh__D011225 2005-06-30
% 207.86/208.08  |- skos__hiddenLabel mesh__D011225 Pregnancy Toxemia
% 207.86/208.08  |- mesh__historyNote mesh__D011225 1979%28%1963%29%   
% 207.86/208.08  |- skos__prefLabel mesh__D011225 Pre-Eclampsia
% 207.86/208.08  |- skos__altLabel mesh__D011225 Toxemias, Pregnancy
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D011225 2006
% 207.86/208.08  |- mesh__dateEstablished mesh__D011225 1979-01-01
% 207.86/208.08  |- rdf__type mesh__D011225sskos__Concept
% 207.86/208.08  |- skos__hiddenLabel mesh__D011225 Pre Eclampsia
% 207.86/208.08  |- skos__scopeNote mesh__D011225
% 207.86/208.08       A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.%A%    
% 207.86/208.08  |- skos__hiddenLabel mesh__D011225 Toxemia, Pregnancy
% 207.86/208.08  |- skos__altLabel mesh__D011225 EPH Toxemias
% 207.86/208.08  |- skos__annotation mesh__D011225 check tags FEMALE %26% PREGNANCY   
% 207.86/208.08  |- skos__hiddenLabel mesh__D011225 Gestosis, Hypertension-Edema-Proteinuria
% 207.86/208.08  |- skos__altLabel mesh__D011225 Gestosis, EPH
% 207.86/208.08  |- skos__hiddenLabel mesh__D011225 Gestosis, Edema-Proteinuria-Hypertension
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D002499 2003
% 207.86/208.08  |- mesh__recordOriginator mesh__D002499 NLM
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D002499 2005
% 207.86/208.08  |- skos__broader mesh__D002499smesh__D014461
% 207.86/208.08  |- mesh__dateCreated mesh__D002499 1999-01-01
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D002499 2004
% 207.86/208.08  |- skos__hiddenLabel mesh__D002499 Density Gradient Centrifugations
% 207.86/208.08  |- skos__hiddenLabel mesh__D002499 Density Gradient Centrifugation
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D002499 2006
% 207.86/208.08  |- mesh__historyNote mesh__D002499 68%28%66%29%   
% 207.86/208.08  |- mesh__recordAuthorizer mesh__D002499 sjn
% 207.86/208.08  |- mesh__dateEstablished mesh__D002499 1968-01-01
% 207.86/208.08  |- skos__hiddenLabel mesh__D002499 Centrifugations, Density Gradient
% 207.86/208.08  |- skos__scopeNote mesh__D002499
% 207.86/208.08       Separation of particles according to density by employing a gradient of varying densities. At equilibrium each particle settles in the gradient at a point equal to its density. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 207.86/208.08  |- skos__annotation mesh__D002499
% 207.86/208.08       a type of ultracentrif; NIM; index sucrose density gradient centrif here but ignore SUCROSE%A%  
% 207.86/208.08  |- skos__hiddenLabel mesh__D002499 Gradient Centrifugation, Density
% 207.86/208.08  |- mesh__publicMeSHNote mesh__D002499 68   
% 207.86/208.08  |- skos__prefLabel mesh__D002499 Centrifugation, Density Gradient
% 207.86/208.08  |- mesh__dateRevised mesh__D002499 2002-07-03
% 207.86/208.08  |- mesh__recordMaintainer mesh__D002499 lkt
% 207.86/208.08  |- rdf__type mesh__D002499sskos__Concept
% 207.86/208.08  |- skos__hiddenLabel mesh__D002499 Gradient Centrifugations, Density
% 207.86/208.08  |- rdf__type mesh__D007982sskos__Concept
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007982 2001
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007982 1998
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007982 1997
% 207.86/208.08  |- mesh__recordMaintainer mesh__D007982 KEV
% 207.86/208.08  |- skos__broader mesh__D007982smesh__D007651
% 207.86/208.08  |- mesh__dateRevised mesh__D007982 1995-05-18
% 207.86/208.08  |- mesh__recordAuthorizer mesh__D007982 PLS
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007982 1996
% 207.86/208.08  |- skos__scopeNote mesh__D007982
% 207.86/208.08       Keto acids that are derivatives of 4-oxopentanoic acids %28%levulinic acid%29%.%A%    
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007982 2000
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007982 2006
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007982 2005
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007982 2004
% 207.86/208.08  |- mesh__publicMeSHNote mesh__D007982 75; was LEVULINIC ACID 1963-74   
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007982 2002
% 207.86/208.08  |- mesh__onlineNote mesh__D007982
% 207.86/208.08       use LEVULINIC ACIDS to search LEVULINIC ACID 1966-74   
% 207.86/208.08  |- mesh__dateCreated mesh__D007982 1999-01-01
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007982 2003
% 207.86/208.08  |- mesh__historyNote mesh__D007982 75; was LEVULINIC ACID 1963-74   
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007982 1999
% 207.86/208.08  |- skos__hiddenLabel mesh__D007982 Acids, Levulinic
% 207.86/208.08  |- skos__prefLabel mesh__D007982 Levulinic Acids
% 207.86/208.08  |- mesh__recordOriginator mesh__D007982 NLM
% 207.86/208.08  |- skos__altLabel mesh__D007184 Bloch-Sulzberger Syndrome
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007184 2005
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007184 2004
% 207.86/208.08  |- skos__prefLabel mesh__D007184 Incontinentia Pigmenti
% 207.86/208.08  |- mesh__publicMeSHNote mesh__D007184
% 207.86/208.08       91; was see under PIGMENTATION DISORDERS 1987-90   
% 207.86/208.08  |- skos__annotation mesh__D007184
% 207.86/208.08       multiple skin %26% other abnorm; do not confuse with INCONTINENTIA PIGMENTI ACHROMIANS see PIGMENTATION DISORDERS%A%  
% 207.86/208.08  |- mesh__dateCreated mesh__D007184 1986-04-03
% 207.86/208.08  |- mesh__recordAuthorizer mesh__D007184 sjn
% 207.86/208.08  |- skos__scopeNote mesh__D007184
% 207.86/208.08       A genodermatosis occurring mostly in females and characterized by skin changes in three phases - vesiculobullous, verrucous papillomatous, and macular melanodermic. Hyperpigmentation is bizarre and irregular. Sixty percent of patients have abnormalities of eyes, teeth, central nervous system, and skin appendages.%A%    
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007184 2006
% 207.86/208.08  |- mesh__dateEstablished mesh__D007184 1991-01-01
% 207.86/208.08  |- mesh__historyNote mesh__D007184
% 207.86/208.08       91%28%87%29%; was see under PIGMENTATION DISORDERS 1987-90   
% 207.86/208.08  |- mesh__recordMaintainer mesh__D007184 nns
% 207.86/208.08  |- skos__broader mesh__D007184smesh__D012873
% 207.86/208.08  |- skos__hiddenLabel mesh__D007184 Syndrome, Bloch-Sulzberger
% 207.86/208.08  |- skos__hiddenLabel mesh__D007184 Bloch Sulzberger Syndrome
% 207.86/208.08  |- rdf__type mesh__D007184sskos__Concept
% 207.86/208.08  |- mesh__dateRevised mesh__D007184 2001-07-25
% 207.86/208.08  |- skos__broader mesh__D007184smesh__D000015
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007184 2002
% 207.86/208.08  |- skos__historyNote mesh__D007184 Pigmentation Disorders %28%1966-1986%29%
% 207.86/208.08  |- skos__broader mesh__D007184smesh__D010859
% 207.86/208.08  |- mesh__recordOriginator mesh__D007184 RC
% 207.86/208.08  |- skos__broader mesh__D007184smesh__D012868
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007184 2003
% 207.86/208.08  |- skos__hiddenLabel mesh__D015616 Non-Langerhans-Cell Histiocytosis
% 207.86/208.08  |- mesh__recordAuthorizer mesh__D015616 sjn
% 207.86/208.08  |- skos__hiddenLabel mesh__D015616 Reticulohistiocytomas
% 207.86/208.08  |- skos__broader mesh__D015616smesh__D015614
% 207.86/208.08  |- mesh__dateEstablished mesh__D015616 1990-01-01
% 207.86/208.08  |- skos__scopeNote mesh__D015616
% 207.86/208.08       Group of disorders which feature accumulations of active HISTIOCYTES and LYMPHOCYTES, but where the histiocytes are not LANGERHANS CELLS. The group includes HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;  SINUS HISTIOCYTOSIS; xanthogranuloma; reticulohistiocytoma;  JUVENILE XANTHOGRANULOMA;  xanthoma disseminatum; as well as the lipid storage diseases %28%SEA-BLUE HISTIOCYTE SYNDROME; and NIEMANN-PICK DISEASES%29%.%A%    
% 207.86/208.08  |- mesh__dateCreated mesh__D015616 1989-04-07
% 207.86/208.08  |- mesh__publicMeSHNote mesh__D015616 90   
% 207.86/208.08  |- mesh__recordOriginator mesh__D015616 AGS
% 207.86/208.08  |- skos__annotation mesh__D015616
% 207.86/208.08       general or unspecified; prefer specifics   
% 207.86/208.08  |- skos__prefLabel mesh__D015616 Histiocytosis, Non-Langerhans-Cell
% 207.86/208.08  |- skos__historyNote mesh__D015616 Reticuloendotheliosis %28%1966-1989%29%
% 207.86/208.08  |- mesh__dateRevised mesh__D015616 2005-06-30
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D015616 2006
% 207.86/208.08  |- mesh__historyNote mesh__D015616 90   
% 207.86/208.08  |- skos__hiddenLabel mesh__D015616 Histiocytosis, Non Langerhans Cell
% 207.86/208.08  |- skos__hiddenLabel mesh__D015616 Disseminatum, Xanthoma
% 207.86/208.08  |- rdf__type mesh__D015616sskos__Concept
% 207.86/208.08  |- mesh__recordMaintainer mesh__D015616 ags
% 207.86/208.08  |- mesh__dateEstablished mesh__D031283 2003-01-01
% 207.86/208.08  |- skos__altLabel mesh__D031283 Du-zhong
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D031283 2003
% 207.86/208.08  |- skos__broader mesh__D031283smesh__D019684
% 207.86/208.08  |- rdf__type mesh__D031283sskos__Concept
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D031283 2004
% 207.86/208.08  |- mesh__publicMeSHNote mesh__D031283 2003   
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D031283 2005
% 207.86/208.08  |- mesh__historyNote mesh__D031283 2003   
% 207.86/208.08  |- skos__scopeNote mesh__D031283
% 207.86/208.08       A plant family of the order Eucommiales, subclass Hamamelidae, class Magnoliopsida %28%some botanists have classified this in the order Hamamelidales or Urticales%29%. Eucomia is an elmlike tree of central and eastern China. Leaves are alternate; deciduous flowers are solitary and unisexual and lack petals and sepals. The male flowers have 6 to 10 stamens and female flowers have one ovary of two carpels, one of which aborts during development so the fruit %28%a dry, winged structure%29% contains only one seed. The latex is a source of RUBBER.  Tochu tea is an aqueous extract of Eucommia ulmoides leaves and a popular beverage in Japan. %28%Mutat Res 1997 Jan 15;388%28%1%29%:7-20%29%.%A%    
% 207.86/208.08  |- mesh__dateCreated mesh__D031283 2002-07-03
% 207.86/208.08  |- skos__prefLabel mesh__D031283 Eucommiaceae
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D031283 2006
% 207.86/208.08  |- skos__annotation mesh__D031283
% 207.86/208.08       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.86/208.08  |- skos__scopeNote mesh__D003592
% 207.86/208.08       A method for the study of certain organic compounds within cells, in situ, by measuring the light intensities of the selectively stained areas of cytoplasm. The compounds studied and their locations in the cells are made to fluoresce and are observed under a microscope.%A%    
% 207.86/208.08  |- rdf__type mesh__D003592sskos__Concept
% 207.86/208.08  |- skos__historyNote mesh__D003592 Flow Cytometry %28%1982-1985%29%
% 207.86/208.08  |- skos__hiddenLabel mesh__D003592 Microfluorometries
% 207.86/208.08  |- skos__broader mesh__D003592smesh__D003584
% 207.86/208.08  |- mesh__recordMaintainer mesh__D003592 ssb
% 207.86/208.08  |- skos__hiddenLabel mesh__D003592 Cytophotometries
% 207.86/208.08  |- skos__broader mesh__D003592smesh__D005470
% 207.86/208.08  |- skos__altLabel mesh__D003592 Microfluorometry
% 207.86/208.08  |- mesh__publicMeSHNote mesh__D003592 86   
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D003592 2005
% 207.86/208.08  |- skos__historyNote mesh__D003592 Photometry %28%1966-1985%29%
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D003592 2006
% 207.86/208.08  |- mesh__recordOriginator mesh__D003592 SH
% 207.86/208.08  |- mesh__dateCreated mesh__D003592 1985-02-28
% 207.86/208.08  |- mesh__dateRevised mesh__D003592 2004-07-07
% 207.86/208.08  |- skos__prefLabel mesh__D003592 Cytophotometry
% 207.86/208.08  |- mesh__recordAuthorizer mesh__D003592 sjn
% 207.86/208.08  |- mesh__dateEstablished mesh__D003592 1986-01-01
% 207.86/208.08  |- mesh__historyNote mesh__D003592 86   
% 207.86/208.08  |- mesh__historyNote mesh__D019209 97; was TROPONIN C %28%NM%29% 1975-96   
% 207.86/208.08  |- mesh__dateRevised mesh__D019209 2005-06-30
% 207.86/208.08  |- skos__historyNote mesh__D019209 Troponin %28%1980-1996%29%
% 207.86/208.08  |- skos__broader mesh__D019209smesh__D002135
% 207.86/208.08  |- mesh__recordAuthorizer mesh__D019209 sjn
% 207.86/208.08  |- mesh__recordMaintainer mesh__D019209 DRC
% 207.86/208.08  |- mesh__publicMeSHNote mesh__D019209
% 207.86/208.08       97; TROPONIN C was indexed under TROPONIN 1980-96 %26% MUSCLE PROTEINS 1975-79%A%  
% 207.86/208.08  |- mesh__onlineNote mesh__D019209
% 207.86/208.08       use TROPONIN C %28%NM%29% to search TROPONIN C 1980-96   
% 207.86/208.08  |- skos__scopeNote mesh__D019209
% 207.86/208.08       One of the three polypeptide chains that make up the TROPONIN complex of skeletal muscle. It is a calcium-binding protein.%A%    
% 207.86/208.08  |- skos__altLabel mesh__D019209 Troponin-C
% 207.86/208.08  |- mesh__dateEstablished mesh__D019209 1997-01-01
% 207.86/208.08  |- skos__broader mesh__D019209smesh__D014336
% 207.86/208.08  |- skos__annotation mesh__D019209
% 207.86/208.08       TROPONIN I %26% TROPONIN T are also available   
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D019209 2006
% 207.86/208.08  |- mesh__dateCreated mesh__D019209 1996-06-10
% 207.86/208.08  |- rdf__type mesh__D019209sskos__Concept
% 207.86/208.08  |- skos__prefLabel mesh__D019209 Troponin C
% 207.86/208.08  |- mesh__recordOriginator mesh__D019209 TPW
% 207.86/208.08  |- skos__historyNote mesh__D019209 Muscle Proteins %28%1975-1979%29%
% 207.86/208.08  |- mesh__recordMaintainer mesh__D011226 ags
% 207.86/208.08  |- skos__historyNote mesh__D011226 Arrhythmia %28%1966-1985%29%
% 207.86/208.08  |- mesh__recordOriginator mesh__D011226 VDK
% 207.86/208.08  |- skos__historyNote mesh__D011226 Tachycardia %28%1966-1985%29%
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D011226 2002
% 207.86/208.08  |- skos__hiddenLabel mesh__D011226 Pre-Excitation Syndrome
% 207.86/208.08  |- mesh__publicMeSHNote mesh__D011226 86   
% 207.86/208.08  |- skos__hiddenLabel mesh__D011226 Pre Excitation Syndromes
% 207.86/208.08  |- mesh__dateRevised mesh__D011226 2005-07-27
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D011226 2006
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D011226 2001
% 207.86/208.08  |- skos__hiddenLabel mesh__D011226 Syndromes, Pre-Excitation
% 207.86/208.08  |- skos__broader mesh__D011226smesh__D001145
% 207.86/208.08  |- skos__scopeNote mesh__D011226
% 207.86/208.08       Conditions characterized by activation of the whole or some part of the ventricle by the atrial impulse earlier than would be expected if the impulse reached the ventricle by way of the normal specific conduction system only.%A%    
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D011226 2005
% 207.86/208.08  |- mesh__dateEstablished mesh__D011226 1986-01-01
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D011226 2000
% 207.86/208.08  |- skos__historyNote mesh__D011226
% 207.86/208.08       Heart Conduction System %28%1966-1985%29%
% 207.86/208.08  |- rdf__type mesh__D011226sskos__Concept
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D011226 2004
% 207.86/208.08  |- mesh__historyNote mesh__D011226 86   
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D011226 2006A
% 207.86/208.08  |- skos__annotation mesh__D011226
% 207.86/208.08       GEN: prefer specifics; long QT = LONG QT SYNDROME; normal PR-long QRS = PRE-EXCITATION, MAHAIM-TYPE; short PR-normal QRS = LOWN-GANONG-LEVINE SYNDROME; short PR, long QRS = WOLFF-PARKINSON-WHITE SYNDROME%A%  
% 207.86/208.08  |- mesh__dateCreated mesh__D011226 1985-03-20
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D011226 2003
% 207.86/208.08  |- skos__hiddenLabel mesh__D011226 Syndrome, Pre-Excitation
% 207.86/208.08  |- mesh__recordAuthorizer mesh__D011226 ags
% 207.86/208.08  |- skos__prefLabel mesh__D011226 Pre-Excitation Syndromes
% 207.86/208.08  |- skos__broader mesh__D005174Q000172smesh__D005174
% 207.86/208.08  |- mesh__preferredCombination mesh__D005174Q000172smesh__D005175
% 207.86/208.08  |- rdf__type mesh__D005174Q000172smesh__CompoundConcept
% 207.86/208.08  |- rdf__type mesh__D007983sskos__Concept
% 207.86/208.08  |- skos__hiddenLabel mesh__D007983 Blood-Group System, Lewis
% 207.86/208.08  |- mesh__dateEstablished mesh__D007983 1974-01-01
% 207.86/208.08  |- skos__hiddenLabel mesh__D007983 Antigens, Le
% 207.86/208.08  |- skos__annotation mesh__D007983
% 207.86/208.08       IM; coord with disease /blood, not /immunol nor /genet; TN 230%A%  
% 207.86/208.08  |- mesh__dateCreated mesh__D007983 1999-01-01
% 207.86/208.08  |- mesh__recordMaintainer mesh__D007983 ssb
% 207.86/208.08  |- skos__altLabel mesh__D007983 Le Antigens
% 207.86/208.08  |- mesh__historyNote mesh__D007983 74%28%63%29%   
% 207.86/208.08  |- mesh__dateRevised mesh__D007983 2005-06-30
% 207.86/208.08  |- mesh__recordOriginator mesh__D007983 NLM
% 207.86/208.08  |- mesh__recordAuthorizer mesh__D007983 sjn
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007983 2006
% 207.86/208.08  |- skos__scopeNote mesh__D007983
% 207.86/208.08       A group of dominantly and independently inherited antigens associated with the ABO blood factors. They are glycolipids present in plasma and secretions that may adhere to the erythrocytes. The phenotype Le%28%b%29% is the result of the interaction of the Le gene Le%28%a%29% with the genes for the ABO blood groups.%A%    
% 207.86/208.08  |- skos__altLabel mesh__D007983 Le%28%a%29% Blood Group System
% 207.86/208.08  |- skos__prefLabel mesh__D007983 Lewis Blood-Group System
% 207.86/208.08  |- skos__hiddenLabel mesh__D007983 Le Antigen
% 207.86/208.08  |- skos__hiddenLabel mesh__D007983 System, Lewis Blood-Group
% 207.86/208.08  |- mesh__publicMeSHNote mesh__D007983 74   
% 207.86/208.08  |- skos__broader mesh__D007983smesh__D001789
% 207.86/208.08  |- skos__altLabel mesh__D007983 Lewis System
% 207.86/208.08  |- skos__hiddenLabel mesh__D007983 Antigen, Le
% 207.86/208.08  |- skos__hiddenLabel mesh__D007983 Lewis Blood Group System
% 207.86/208.08  |- skos__hiddenLabel mesh__D007983 System, Lewis
% 207.86/208.08  |- mesh__recordAuthorizer mesh__D007185 SJN
% 207.86/208.08  |- mesh__historyNote mesh__D007185 73   
% 207.86/208.08  |- skos__annotation mesh__D007185
% 207.86/208.08       for eggs, microbial cultures, cell cultures, etc.; INCUBATORS, INFANT is also available%A%  
% 207.86/208.08  |- mesh__recordOriginator mesh__D007185 NLM
% 207.86/208.08  |- mesh__dateEstablished mesh__D007185 1973-01-01
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007185 2002
% 207.86/208.08  |- skos__hiddenLabel mesh__D007185 Incubator
% 207.86/208.08  |- rdf__type mesh__D007185sskos__Concept
% 207.86/208.08  |- mesh__dateCreated mesh__D007185 1999-01-01
% 207.86/208.08  |- skos__scopeNote mesh__D007185
% 207.86/208.08       Insulated enclosures in which temperature, humidity, and other environmental conditions can be regulated at levels optimal for growth, hatching, reproduction, or metabolic reactions.%A%    
% 207.86/208.08  |- skos__related mesh__D007185smesh__D004780
% 207.86/208.08  |- skos__prefLabel mesh__D007185 Incubators
% 207.86/208.08  |- mesh__dateRevised mesh__D007185 1997-06-20
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007185 1998
% 207.86/208.08  |- mesh__publicMeSHNote mesh__D007185 73   
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007185 2000
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007185 2003
% 207.86/208.08  |- mesh__recordMaintainer mesh__D007185 PXP
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007185 1999
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007185 2001
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007185 2005
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007185 2004
% 207.86/208.08  |- skos__related mesh__D007185smesh__D008021
% 207.86/208.08  |- skos__broader mesh__D007185smesh__D004864
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007185 2006
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D031284 2003
% 207.86/208.08  |- mesh__dateEstablished mesh__D031284 2003-01-01
% 207.86/208.08  |- rdf__type mesh__D031284sskos__Concept
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D031284 2004
% 207.86/208.08  |- mesh__dateCreated mesh__D031284 2002-07-02
% 207.86/208.08  |- mesh__publicMeSHNote mesh__D031284 2003   
% 207.86/208.08  |- skos__prefLabel mesh__D031284 Aleurites
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D031284 2005
% 207.86/208.08  |- skos__altLabel mesh__D031284 Tung
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D031284 2006
% 207.86/208.08  |- skos__broader mesh__D031284smesh__D019665
% 207.86/208.08  |- skos__annotation mesh__D031284
% 207.86/208.08       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.86/208.08  |- mesh__historyNote mesh__D031284 2003   
% 207.86/208.08  |- skos__scopeNote mesh__D031284
% 207.86/208.08       A plant genus of the family EUPHORBIACEAE that is the source of tung oil and a phorbol diester %28%PHORBOL ESTERS%29%.%A%    
% 207.86/208.08  |- skos__hiddenLabel mesh__D003593 Protoplasms
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D003593 2005
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D003593 2006
% 207.86/208.08  |- mesh__historyNote mesh__D003593
% 207.86/208.08       65%28%64%29%; PROTOPLASM was heading 1963-64   
% 207.86/208.08  |- mesh__recordAuthorizer mesh__D003593 sjn
% 207.86/208.08  |- skos__scopeNote mesh__D003593
% 207.86/208.08       The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. %28%Glick, Glossary of Biochemistry and Molecular Biology, 1990%29%%A%    
% 207.86/208.08  |- skos__broader mesh__D003593smesh__D042541
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D003593 2004
% 207.86/208.08  |- mesh__dateCreated mesh__D003593 1999-01-01
% 207.86/208.08  |- skos__prefLabel mesh__D003593 Cytoplasm
% 207.86/208.08  |- mesh__dateEstablished mesh__D003593 1965-01-01
% 207.86/208.08  |- mesh__dateRevised mesh__D003593 2003-07-09
% 207.86/208.08  |- mesh__recordOriginator mesh__D003593 NLM
% 207.86/208.08  |- rdf__type mesh__D003593sskos__Concept
% 207.86/208.08  |- mesh__recordMaintainer mesh__D003593 nns
% 207.86/208.08  |- skos__annotation mesh__D003593
% 207.86/208.08       A 11 qualif except /cytol; /genet permitted   
% 207.86/208.08  |- mesh__publicMeSHNote mesh__D003593 65; PROTOPLASM was heading 1963-64   
% 207.86/208.08  |- skos__hiddenLabel mesh__D003593 Cytoplasms
% 207.86/208.08  |- mesh__recordAuthorizer mesh__D011227 sjn
% 207.86/208.08  |- mesh__dateEstablished mesh__D011227 1991-01-01
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D011227 2006
% 207.86/208.08  |- mesh__recordMaintainer mesh__D011227 PLS
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D011227 2005
% 207.86/208.08  |- mesh__recordOriginator mesh__D011227 VDK
% 207.86/208.08  |- skos__hiddenLabel mesh__D011227 Mahaim Type Preexcitation
% 207.86/208.08  |- rdf__type mesh__D011227sskos__Concept
% 207.86/208.08  |- mesh__onlineNote mesh__D011227
% 207.86/208.08       use PRE-EXCITATION, MAHAIM-TYPE to search PRE-EXCITATION, MAHAIM TYPE 1986-91%A%  
% 207.86/208.08  |- skos__hiddenLabel mesh__D011227 Pre Excitation, Mahaim Type
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D011227 2002
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D011227 2004
% 207.86/208.08  |- skos__prefLabel mesh__D011227 Pre-Excitation, Mahaim-Type
% 207.86/208.08  |- skos__broader mesh__D011227smesh__D011226
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D011227 2001
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D011227 2003
% 207.86/208.08  |- mesh__historyNote mesh__D011227
% 207.86/208.08       92; was PRE-EXCITATION, MAHAIM TYPE 1986-91 %28%see under PRE-EXCITATION SYNDROMES 1986-90%29%%A%  
% 207.86/208.08  |- skos__hiddenLabel mesh__D011227 Preexcitation, Mahaim-Type
% 207.86/208.08  |- skos__altLabel mesh__D011227 Mahaim-Type Pre-Excitation
% 207.86/208.08  |- skos__annotation mesh__D011227
% 207.86/208.08       normal PR interval %26% long QRS interval with delta wave; SHORT PR NORMAL QRS COMPLEX SYNDROME see LOWN-GANONG-LEVINE SYNDROME is available%A%  
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D011227 2000
% 207.86/208.08  |- mesh__dateRevised mesh__D011227 1999-11-03
% 207.86/208.08  |- skos__scopeNote mesh__D011227
% 207.86/208.08       A form of pre-excitation characterized by a normal PR interval and a long QRS interval with a delta wave.%A%    
% 207.86/208.08  |- mesh__dateCreated mesh__D011227 1985-03-20
% 207.86/208.08  |- mesh__publicMeSHNote mesh__D011227
% 207.86/208.08       92; was PRE-EXCITATION, MAHAIM TYPE 1986-91 %28%see under PRE-EXCITATION SYNDROMES 1986-90%29%%A%  
% 207.86/208.08  |- skos__hiddenLabel mesh__D011227 Mahaim Type Pre Excitation
% 207.86/208.08  |- skos__altLabel mesh__D011227 Mahaim-Type Preexcitation
% 207.86/208.08  |- skos__altLabel mesh__D016710 Yinxu
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D016710 2005
% 207.86/208.08  |- skos__altLabel mesh__D016710 Yin Xu
% 207.86/208.08  |- mesh__recordAuthorizer mesh__D016710 sjn
% 207.86/208.08  |- mesh__dateCreated mesh__D016710 1991-02-11
% 207.86/208.08  |- mesh__dateRevised mesh__D016710 2002-07-03
% 207.86/208.08  |- mesh__dateEstablished mesh__D016710 1992-01-01
% 207.86/208.08  |- rdf__type mesh__D016710sskos__Concept
% 207.86/208.08  |- mesh__historyNote mesh__D016710 92   
% 207.86/208.08  |- skos__hiddenLabel mesh__D016710 Xu, Yin
% 207.86/208.08  |- skos__prefLabel mesh__D016710 Yin Deficiency
% 207.86/208.08  |- mesh__publicMeSHNote mesh__D016710 92   
% 207.86/208.08  |- mesh__recordMaintainer mesh__D016710 ssb
% 207.86/208.08  |- skos__altLabel mesh__D016710 Deficiency, Yin
% 207.86/208.08  |- skos__hiddenLabel mesh__D016710 Yin Deficiencies
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D016710 2004
% 207.86/208.08  |- mesh__recordOriginator mesh__D016710 TGC
% 207.86/208.08  |- skos__altLabel mesh__D016710 Yin Hsu
% 207.86/208.08  |- skos__hiddenLabel mesh__D016710 Hsu, Yin
% 207.86/208.08  |- skos__historyNote mesh__D016710
% 207.86/208.08       Medicine, Chinese Traditional %28%1983-1991%29%
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D016710 2003
% 207.86/208.08  |- skos__broader mesh__D016710smesh__D010335
% 207.86/208.08  |- skos__scopeNote mesh__D016710
% 207.86/208.08       In the YIN-YANG system of philosophy and medicine, an insufficiency of body fluid %28%called yinxu%29%, manifesting often as irritability, thirst, constipation, etc. %28%The Pinyin Chinese-English Dictionary, 1979%29%.%A%    
% 207.86/208.08  |- skos__related mesh__D016710smesh__D019413
% 207.86/208.08  |- skos__related mesh__D016710smesh__D016709
% 207.86/208.08  |- skos__annotation mesh__D016710
% 207.86/208.08       coord IM with clin manifest %28%IM%29% or precoord organ/dis term %28%IM%29%; DF: YIN DEFIC%A%  
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D016710 2006
% 207.86/208.08  |- mesh__dateCreated mesh__D007984 1999-01-01
% 207.86/208.08  |- skos__annotation mesh__D007984
% 207.86/208.08       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with TESTICULAR NEOPLASMS %28%IM%29% in male or OVARIAN NEOPLASMS %28%IM%29% if in female%A%  
% 207.86/208.08  |- skos__prefLabel mesh__D007984 Leydig Cell Tumor
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007984 2006
% 207.86/208.08  |- mesh__dateRevised mesh__D007984 2004-07-07
% 207.86/208.08  |- skos__hiddenLabel mesh__D007984 Tumor, Leydig Cell
% 207.86/208.08  |- skos__altLabel mesh__D007984 Interstitial Cell Tumor
% 207.86/208.08  |- mesh__recordOriginator mesh__D007984 NLM
% 207.86/208.08  |- skos__hiddenLabel mesh__D007984 Tumor, Interstitial Cell
% 207.86/208.08  |- mesh__recordAuthorizer mesh__D007984 sjn
% 207.86/208.08  |- skos__hiddenLabel mesh__D007984 Tumors, Interstitial Cell
% 207.86/208.08  |- skos__broader mesh__D007984smesh__D018310
% 207.86/208.08  |- skos__hiddenLabel mesh__D007984 Interstitial Cell Tumors
% 207.86/208.08  |- rdf__type mesh__D007984sskos__Concept
% 207.86/208.08  |- skos__scopeNote mesh__D007984
% 207.86/208.08       Gonadal interstitial or stromal cell neoplasm composed of only LEYDIG CELLS. These tumors may produce one or more of the steroid hormones such as ANDROGENS; ESTROGENS; and CORTICOSTEROIDS. Clinical symptoms include testicular swelling, GYNECOMASTIA, sexual precocity in children, or virilization %28%VIRILISM%29% in females.%A%    
% 207.86/208.08  |- mesh__recordMaintainer mesh__D007984 lkt
% 207.86/208.08  |- mesh__activeMeSHYear mesh__D007984 2005
% 207.86/208.08  |- mesh__dateCreated mesh__D007186 1999-01-01
% 207.86/208.08  |- rdf__type mesh__D007186sskos__Concept
% 207.86/208.08  |- skos__hiddenLabel mesh__D007186 Radiant Warmer, Infant
% 207.86/208.08  |- skos__hiddenLabel mesh__D007186 Infant Radiant Warmer
% 207.86/208.08  |- skos__hiddenLabel mesh__D007186 Infant Incubator
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007186 2002
% 207.86/208.09  |- mesh__recordOriginator mesh__D007186 NLM
% 207.86/208.09  |- skos__prefLabel mesh__D007186 Incubators, Infant
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007186 2003
% 207.86/208.09  |- mesh__dateEstablished mesh__D007186 1974-01-01
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007186 2004
% 207.86/208.09  |- skos__broader mesh__D007186smesh__D004865
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007186 2005
% 207.86/208.09  |- skos__scopeNote mesh__D007186
% 207.86/208.09       Electrically powered devices that are intended to assist in the maintenance of the thermal balance of infants, principally by controlling the air temperature and humidity in an enclosure. %28%from UMDNS, 1999%29%%A%    
% 207.86/208.09  |- skos__hiddenLabel mesh__D007186 Infant Incubators
% 207.86/208.09  |- skos__hiddenLabel mesh__D007186 Incubator, Infant
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007186 2000
% 207.86/208.09  |- skos__hiddenLabel mesh__D007186 Warmers, Infant Radiant
% 207.86/208.09  |- skos__altLabel mesh__D007186 Radiant Warmers, Infant
% 207.86/208.09  |- skos__hiddenLabel mesh__D007186 Warmer, Infant Radiant
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007186 2006
% 207.86/208.09  |- mesh__recordMaintainer mesh__D007186 KEV
% 207.86/208.09  |- mesh__publicMeSHNote mesh__D007186 74   
% 207.86/208.09  |- mesh__recordAuthorizer mesh__D007186 sjn
% 207.86/208.09  |- mesh__dateRevised mesh__D007186 1999-11-09
% 207.86/208.09  |- skos__broader mesh__D007186smesh__D007185
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007186 2001
% 207.86/208.09  |- mesh__historyNote mesh__D007186 74   
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D015618 2000
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D015618 2005
% 207.86/208.09  |- skos__broader mesh__D015618smesh__D015616
% 207.86/208.09  |- skos__hiddenLabel mesh__D015618 Disease, Rosai-Dorfman
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D015618 1998
% 207.86/208.09  |- skos__hiddenLabel mesh__D015618 Syndrome, Destombes-Rosai-Dorfman
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D015618 2004
% 207.86/208.09  |- skos__annotation mesh__D015618
% 207.86/208.09       a non-Langerhans cell histiocytosis; sinus refers to the lymphatic sinuses%A%  
% 207.86/208.09  |- rdf__type mesh__D015618sskos__Concept
% 207.86/208.09  |- skos__hiddenLabel mesh__D015618 Rosai Dorfman Disease
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D015618 1997
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D015618 2003
% 207.86/208.09  |- mesh__recordMaintainer mesh__D015618 TGC
% 207.86/208.09  |- skos__altLabel mesh__D015618 Destombes-Rosai-Dorfman Syndrome
% 207.86/208.09  |- skos__altLabel mesh__D015618 Rosai-Dorfman Disease
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D015618 1996
% 207.86/208.09  |- skos__hiddenLabel mesh__D015618 Sinus Histiocytosis
% 207.86/208.09  |- skos__hiddenLabel mesh__D015618 Histiocytoses, Sinus
% 207.86/208.09  |- mesh__dateCreated mesh__D015618 1989-04-07
% 207.86/208.09  |- skos__hiddenLabel mesh__D015618 Sinus Histiocytoses
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D015618 2002
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D015618 1995
% 207.86/208.09  |- skos__prefLabel mesh__D015618 Histiocytosis, Sinus
% 207.86/208.09  |- skos__historyNote mesh__D015618 Reticuloendotheliosis %28%1966-1989%29%
% 207.86/208.09  |- mesh__recordAuthorizer mesh__D015618 PLS
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D015618 2006
% 207.86/208.09  |- mesh__dateEstablished mesh__D015618 1990-01-01
% 207.86/208.09  |- skos__scopeNote mesh__D015618
% 207.86/208.09       Benign, non-Langerhans-cell, histiocytic proliferative disorder that primarily affects the lymph nodes. It is often referred to as sinus histiocytosis with massive lymphadenopathy.%A%    
% 207.86/208.09  |- mesh__historyNote mesh__D015618 90   
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D015618 2001
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D015618 1999
% 207.86/208.09  |- skos__historyNote mesh__D015618 Lymphatic Diseases %28%1966-1989%29%
% 207.86/208.09  |- mesh__publicMeSHNote mesh__D015618 90   
% 207.86/208.09  |- mesh__recordOriginator mesh__D015618 AGS
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D015618 1994
% 207.86/208.09  |- mesh__dateRevised mesh__D015618 1993-06-02
% 207.86/208.09  |- skos__hiddenLabel mesh__D015618 Destombes Rosai Dorfman Syndrome
% 207.86/208.09  |- skos__broader mesh__D012320smesh__D012321
% 207.86/208.09  |- mesh__recordAuthorizer mesh__D012320 sjn
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D012320 2004
% 207.86/208.09  |- skos__historyNote mesh__D012320 RNA Polymerases %28%1973-1976%29%
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D012320 2005
% 207.86/208.09  |- skos__hiddenLabel mesh__D012320 DNA Dependent RNA Polymerase III
% 207.86/208.09  |- skos__hiddenLabel mesh__D012320 Polymerase III, RNA
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D012320 2006
% 207.86/208.09  |- mesh__recordMaintainer mesh__D012320 ssb
% 207.86/208.09  |- mesh__dateCreated mesh__D012320 1976-04-19
% 207.86/208.09  |- skos__prefLabel mesh__D012320 RNA Polymerase III
% 207.86/208.09  |- skos__hiddenLabel mesh__D012320 III, RNA Polymerase
% 207.86/208.09  |- skos__scopeNote mesh__D012320
% 207.86/208.09       A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure where it transcribes DNA into RNA. It has specific requirements for cations and salt and has shown an intermediate sensitivity to alpha-amanitin in comparison to RNA polymerase I and II. EC 2.7.7.6.%A%    
% 207.86/208.09  |- skos__hiddenLabel mesh__D012320 Polymerase C, RNA
% 207.86/208.09  |- mesh__historyNote mesh__D012320
% 207.86/208.09       91%28%77%29%; was see under RNA POLYMERASES 1977-90   
% 207.86/208.09  |- skos__altLabel mesh__D012320 RNA Polymerase C
% 207.86/208.09  |- mesh__dateRevised mesh__D012320 2003-07-09
% 207.86/208.09  |- mesh__dateEstablished mesh__D012320 1991-01-01
% 207.86/208.09  |- skos__altLabel mesh__D012320 DNA-Dependent RNA Polymerase III
% 207.86/208.09  |- rdf__type mesh__D012320sskos__Concept
% 207.86/208.09  |- skos__historyNote mesh__D012320
% 207.86/208.09       RNA Nucleotidyltransferases %28%1968-1972%29%
% 207.86/208.09  |- mesh__recordOriginator mesh__D012320 RLS
% 207.86/208.09  |- mesh__publicMeSHNote mesh__D012320
% 207.86/208.09       91; was see under RNA POLYMERASES 1977-90   
% 207.86/208.09  |- skos__hiddenLabel mesh__D012320 C, RNA Polymerase
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D031285 2005
% 207.86/208.09  |- skos__annotation mesh__D031285
% 207.86/208.09       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D031285 2004
% 207.86/208.09  |- skos__scopeNote mesh__D031285
% 207.86/208.09       A plant genus of the family EUPHORBIACEAE. The trees contain hippomanin A %28%TANNINS%29% and the latex is a skin irritant.%A%    
% 207.86/208.09  |- skos__broader mesh__D031285smesh__D019665
% 207.86/208.09  |- skos__altLabel mesh__D031285 Manchincel
% 207.86/208.09  |- rdf__type mesh__D031285sskos__Concept
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D031285 2003
% 207.86/208.09  |- mesh__publicMeSHNote mesh__D031285 2003   
% 207.86/208.09  |- mesh__dateEstablished mesh__D031285 2003-01-01
% 207.86/208.09  |- mesh__historyNote mesh__D031285 2003   
% 207.86/208.09  |- mesh__dateCreated mesh__D031285 2002-07-03
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D031285 2006
% 207.86/208.09  |- skos__altLabel mesh__D031285 Manchineel
% 207.86/208.09  |- skos__prefLabel mesh__D031285 Hippomane
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D003594 2006
% 207.86/208.09  |- skos__broader mesh__D003594smesh__D022162
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D003594 2004
% 207.86/208.09  |- mesh__dateCreated mesh__D003594 1999-01-01
% 207.86/208.09  |- mesh__dateRevised mesh__D003594 2003-07-09
% 207.86/208.09  |- skos__annotation mesh__D003594
% 207.86/208.09       ZYMOGEN GRANULES see SECRETORY VESICLES is also available%A%  
% 207.86/208.09  |- rdf__type mesh__D003594sskos__Concept
% 207.86/208.09  |- mesh__recordAuthorizer mesh__D003594 sjn
% 207.86/208.09  |- skos__hiddenLabel mesh__D003594 Cytoplasmic Granule
% 207.86/208.09  |- mesh__historyNote mesh__D003594 65%28%64%29%   
% 207.86/208.09  |- mesh__publicMeSHNote mesh__D003594 65   
% 207.86/208.09  |- skos__broader mesh__D003594smesh__D022083
% 207.86/208.09  |- mesh__dateEstablished mesh__D003594 1965-01-01
% 207.86/208.09  |- skos__hiddenLabel mesh__D003594 Granules, Cytoplasmic
% 207.86/208.09  |- skos__prefLabel mesh__D003594 Cytoplasmic Granules
% 207.86/208.09  |- skos__hiddenLabel mesh__D003594 Granule, Cytoplasmic
% 207.86/208.09  |- mesh__recordOriginator mesh__D003594 NLM
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D003594 2005
% 207.86/208.09  |- skos__scopeNote mesh__D003594
% 207.86/208.09       Condensed areas of cellular material that may be bounded by a membrane.%A%    
% 207.86/208.09  |- mesh__recordMaintainer mesh__D003594 nns
% 207.86/208.09  |- skos__hiddenLabel mesh__D044402 Receptor, 5-HT2A
% 207.86/208.09  |- mesh__dateEstablished mesh__D044402 2004-01-01
% 207.86/208.09  |- skos__hiddenLabel mesh__D044402 2A Receptors, Serotonin
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D044402 2006
% 207.86/208.09  |- rdf__type mesh__D044402sskos__Concept
% 207.86/208.09  |- skos__broader mesh__D044402smesh__D044348
% 207.86/208.09  |- skos__scopeNote mesh__D044402
% 207.86/208.09       A serotonin receptor subtype found widely distributed in peripheral tissues where it mediates the contractile responses of variety of tissues that contain SMOOTH MUSCLE. Selective 5-HT2A receptor antagonists include KETANSERIN. The 5-HT2A subtype is also located in BASAL GANGLIA and CEREBRAL CORTEX of the BRAIN where it mediates the effects of HALLUCINOGENS such as LSD.%A%    
% 207.86/208.09  |- skos__altLabel mesh__D044402 Serotonin 2A Receptors
% 207.86/208.09  |- skos__altLabel mesh__D044402 5-HT%28%2A%29% Receptor
% 207.86/208.09  |- mesh__recordOriginator mesh__D044402 jmp
% 207.86/208.09  |- mesh__recordAuthorizer mesh__D044402 sjn
% 207.86/208.09  |- skos__altLabel mesh__D044402 Receptor, Serotonin 2A
% 207.86/208.09  |- skos__historyNote mesh__D044402 Receptors, Serotonin %28%1994-2003%29%
% 207.86/208.09  |- skos__hiddenLabel mesh__D044402 Receptors, Serotonin 2A
% 207.86/208.09  |- mesh__dateCreated mesh__D044402 2003-07-09
% 207.86/208.09  |- mesh__dateRevised mesh__D044402 2005-06-30
% 207.86/208.09  |- mesh__recordMaintainer mesh__D044402 DRC
% 207.86/208.09  |- skos__altLabel mesh__D044402 5-HT2A Receptor
% 207.86/208.09  |- mesh__historyNote mesh__D044402
% 207.86/208.09       2004; use RECEPTOR, SEROTONIN, 5-HT2A %28%NM%29% 1994-2003   
% 207.86/208.09  |- skos__hiddenLabel mesh__D044402 5 HT2A Receptor
% 207.86/208.09  |- skos__altLabel mesh__D044402 Serotonin 2A Receptor
% 207.86/208.09  |- skos__prefLabel mesh__D044402 Receptor, Serotonin, 5-HT2A
% 207.86/208.09  |- mesh__publicMeSHNote mesh__D044402
% 207.86/208.09       2004; SEROTONIN 2A RECEPTOR %28%now RECEPTOR, SEROTONIN, 5-HT2A%29% was indexed under RECEPTORS, SEROTONIN 1994-2003%A%  
% 207.86/208.09  |- skos__hiddenLabel mesh__D044402 2A Receptor, Serotonin
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D011228 2006
% 207.86/208.09  |- mesh__recordOriginator mesh__D011228 NLM
% 207.86/208.09  |- mesh__recordAuthorizer mesh__D011228 PLS
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D011228 1996
% 207.86/208.09  |- mesh__historyNote mesh__D011228
% 207.86/208.09       84%28%75%29%; was see under SERUM ALBUMIN 1975-83   
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D011228 2003
% 207.86/208.09  |- skos__historyNote mesh__D011228 Protein Precursors %28%1973-1974%29%
% 207.86/208.09  |- skos__scopeNote mesh__D011228
% 207.86/208.09       A tetrameric protein, molecular weight between 50,000 and 70,000, consisting of 4 equal chains, and migrating on electrophoresis in 3 fractions more mobile than serum albumin. Its concentration ranges from 7 to 33 per cent in the serum, but levels decrease in liver disease.%A%    
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D011228 1997
% 207.86/208.09  |- mesh__recordMaintainer mesh__D011228 KEV
% 207.86/208.09  |- rdf__type mesh__D011228sskos__Concept
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D011228 2002
% 207.86/208.09  |- skos__broader mesh__D011228smesh__D012709
% 207.86/208.09  |- skos__altLabel mesh__D011228 Transthyretin
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D011228 2004
% 207.86/208.09  |- skos__annotation mesh__D011228 /biosyn /drug eff /physiol permitted   
% 207.86/208.09  |- mesh__dateRevised mesh__D011228 1995-05-22
% 207.86/208.09  |- skos__altLabel mesh__D011228 Proalbumin
% 207.86/208.09  |- skos__prefLabel mesh__D011228 Prealbumin
% 207.86/208.09  |- mesh__dateEstablished mesh__D011228 1984-01-01
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D011228 2000
% 207.86/208.09  |- mesh__dateCreated mesh__D011228 1974-11-19
% 207.86/208.09  |- mesh__publicMeSHNote mesh__D011228
% 207.86/208.09       84; was see under SERUM ALBUMIN 1975-83   
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D011228 1998
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D011228 2005
% 207.86/208.09  |- skos__historyNote mesh__D011228 Serum Albumin %28%1972-1974%29%
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D011228 2001
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D011228 1999
% 207.86/208.09  |- skos__prefLabel mesh__D016711 Yang Deficiency
% 207.86/208.09  |- skos__scopeNote mesh__D016711
% 207.86/208.09       In the YIN-YANG system of philosophy and medicine, a lack of vital energy %28%called yangxu in Chinese%29%. It manifests itself in various systemic and organic diseases. %28%The Pinyin Chinese-English Dictionary, 1979%29%%A%    
% 207.86/208.09  |- skos__altLabel mesh__D016711 Yangxu
% 207.86/208.09  |- skos__broader mesh__D016711smesh__D010335
% 207.86/208.09  |- skos__related mesh__D016711smesh__D016709
% 207.86/208.09  |- skos__altLabel mesh__D016711 Yang Hsu
% 207.86/208.09  |- rdf__type mesh__D016711sskos__Concept
% 207.86/208.09  |- mesh__historyNote mesh__D016711 92   
% 207.86/208.09  |- skos__hiddenLabel mesh__D016711 Xu, Yang
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D016711 2004
% 207.86/208.09  |- mesh__recordAuthorizer mesh__D016711 sjn
% 207.86/208.09  |- skos__hiddenLabel mesh__D016711 Hsu, Yang
% 207.86/208.09  |- mesh__dateCreated mesh__D016711 1991-02-11
% 207.86/208.09  |- mesh__dateRevised mesh__D016711 2002-07-03
% 207.86/208.09  |- skos__annotation mesh__D016711
% 207.86/208.09       coord IM with clin manifest %28%IM%29% or precoord organ/dis term %28%IM%29%; DF: YANG DEFIC%A%  
% 207.86/208.09  |- mesh__dateEstablished mesh__D016711 1992-01-01
% 207.86/208.09  |- skos__historyNote mesh__D016711
% 207.86/208.09       Medicine, Chinese Traditional %28%1983-1991%29%
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D016711 2003
% 207.86/208.09  |- skos__related mesh__D016711smesh__D019413
% 207.86/208.09  |- mesh__publicMeSHNote mesh__D016711 92   
% 207.86/208.09  |- mesh__recordMaintainer mesh__D016711 ssb
% 207.86/208.09  |- skos__altLabel mesh__D016711 Yang Xu
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D016711 2006
% 207.86/208.09  |- mesh__recordOriginator mesh__D016711 TGC
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D016711 2005
% 207.86/208.09  |- skos__altLabel mesh__D016711 Deficiency, Yang
% 207.86/208.09  |- skos__broader mesh__D019793Q000031smesh__D019793
% 207.86/208.09  |- mesh__preferredCombination mesh__D019793Q000031smesh__D005452
% 207.86/208.09  |- rdf__type mesh__D019793Q000031smesh__CompoundConcept
% 207.86/208.09  |- skos__broader mesh__D007985smesh__D002477
% 207.86/208.09  |- mesh__dateEstablished mesh__D007985 1968-01-01
% 207.86/208.09  |- mesh__recordMaintainer mesh__D007985 ags
% 207.86/208.09  |- skos__hiddenLabel mesh__D007985 Testicular Interstitial Cell
% 207.86/208.09  |- mesh__historyNote mesh__D007985 68%28%64%29%   
% 207.86/208.09  |- skos__scopeNote mesh__D007985
% 207.86/208.09       Steroid-producing cells in the interstitial tissue of the TESTIS. They are under the regulation of PITUITARY HORMONES; LUTEINIZING HORMONE; or interstitial cell-stimulating hormone. TESTOSTERONE is the major androgen %28%ANDROGENS%29% produced.%A%    
% 207.86/208.09  |- skos__broader mesh__D007985smesh__D013737
% 207.86/208.09  |- skos__hiddenLabel mesh__D007985 Interstitial Cell, Testicular
% 207.86/208.09  |- rdf__type mesh__D007985sskos__Concept
% 207.86/208.09  |- skos__hiddenLabel mesh__D007985 Cells, Testicular Interstitial
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007985 2005
% 207.86/208.09  |- skos__hiddenLabel mesh__D007985 Cells, Leydig
% 207.86/208.09  |- skos__hiddenLabel mesh__D007985 Cell, Testicular Interstitial
% 207.86/208.09  |- skos__altLabel mesh__D007985 Interstitial Cells, Testicular
% 207.86/208.09  |- mesh__dateCreated mesh__D007985 1999-01-01
% 207.86/208.09  |- skos__annotation mesh__D007985
% 207.86/208.09       do not confuse X ref interstitial cells here with interstitial cells of connective tissue %28% = CONNECTIVE TISSUE CELLS%29%%A%  
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007985 2006A
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007985 2003
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007985 2006
% 207.86/208.09  |- mesh__dateRevised mesh__D007985 2005-07-27
% 207.86/208.09  |- skos__altLabel mesh__D007985 Testicular Interstitial Cells
% 207.86/208.09  |- mesh__publicMeSHNote mesh__D007985 68   
% 207.86/208.09  |- mesh__recordAuthorizer mesh__D007985 ags
% 207.86/208.09  |- skos__prefLabel mesh__D007985 Leydig Cells
% 207.86/208.09  |- mesh__recordOriginator mesh__D007985 NLM
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007985 2004
% 207.86/208.09  |- skos__prefLabel mesh__D007187 Incunabula
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007187 1994
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007187 2002
% 207.86/208.09  |- mesh__recordMaintainer mesh__D007187 sjn
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007187 2005
% 207.86/208.09  |- rdf__type mesh__D007187sskos__Concept
% 207.86/208.09  |- mesh__recordAuthorizer mesh__D007187 sjn
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007187 1997
% 207.86/208.09  |- skos__broader mesh__D007187smesh__D001877
% 207.86/208.09  |- mesh__dateCreated mesh__D007187 1999-01-01
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007187 1993
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007187 1990
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007187 1996
% 207.86/208.09  |- skos__annotation mesh__D007187 before 1501; IM; no qualif   
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007187 2004
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007187 2001
% 207.86/208.09  |- mesh__dateRevised mesh__D007187 2002-10-24
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007187 1992
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007187 2000
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007187 1999
% 207.86/208.09  |- mesh__recordOriginator mesh__D007187 NLM
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007187 2003
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007187 2003A
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007187 1995
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007187 1998
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007187 1991
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D007187 2006
% 207.86/208.09  |- skos__historyNote mesh__D015619
% 207.86/208.09       Respiratory System/abnormalities %28%1966-1997%29%
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D015619 2001
% 207.86/208.09  |- mesh__historyNote mesh__D015619 98; use explode 1990-97   
% 207.86/208.09  |- skos__altLabel mesh__D015619 Abnormalities, Respiratory System
% 207.86/208.09  |- mesh__dateRevised mesh__D015619 1999-11-03
% 207.86/208.09  |- mesh__dateEstablished mesh__D015619 1998-01-01
% 207.86/208.09  |- skos__annotation mesh__D015619
% 207.86/208.09       for congen struct abnorm only; GEN or unspecified; prefer specifics or specific organ /abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: RESPIRATORY SYSTEM ABNORM%A%  
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D015619 2003
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D015619 2000
% 207.86/208.09  |- skos__hiddenLabel mesh__D015619 Respiratory System Abnormality
% 207.86/208.09  |- mesh__publicMeSHNote mesh__D015619 98   
% 207.86/208.09  |- skos__broader mesh__D015619smesh__D012140
% 207.86/208.09  |- skos__prefLabel mesh__D015619 Respiratory System Abnormalities
% 207.86/208.09  |- skos__hiddenLabel mesh__D015619 System Abnormality, Respiratory
% 207.86/208.09  |- skos__scopeNote mesh__D015619
% 207.86/208.09       Congenital structural abnormalities of the respiratory system.%A%    
% 207.86/208.09  |- skos__hiddenLabel mesh__D015619 Abnormality, Respiratory System
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D015619 2006
% 207.86/208.09  |- skos__hiddenLabel mesh__D015619 System Abnormalities, Respiratory
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D015619 2005
% 207.86/208.09  |- mesh__recordMaintainer mesh__D015619 kle
% 207.86/208.09  |- mesh__recordOriginator mesh__D015619 PXP
% 207.86/208.09  |- mesh__dateCreated mesh__D015619 1989-04-07
% 207.86/208.09  |- mesh__recordAuthorizer mesh__D015619 sjn
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D015619 2002
% 207.86/208.09  |- skos__broader mesh__D015619smesh__D000013
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D015619 2004
% 207.86/208.09  |- rdf__type mesh__D015619sskos__Concept
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D026341 2002
% 207.86/208.09  |- skos__altLabel mesh__D026341 Transcription Factor MCM1
% 207.86/208.09  |- mesh__historyNote mesh__D026341
% 207.86/208.09       2002; use MCM1 PROTEIN %28%NM%29% 1992-2001   
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D026341 2005
% 207.86/208.09  |- skos__prefLabel mesh__D026341 MCM1 Protein
% 207.86/208.09  |- skos__historyNote mesh__D026341 Transcription Factors %28%1993-2001%29%
% 207.86/208.09  |- skos__historyNote mesh__D026341 DNA-Binding Proteins %28%1993-2001%29%
% 207.86/208.09  |- skos__altLabel mesh__D026341 Minichromosome Maintenance 1 Protein
% 207.86/208.09  |- skos__hiddenLabel mesh__D026341 MCM 1 Protein
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D026341 2003
% 207.86/208.09  |- mesh__publicMeSHNote mesh__D026341
% 207.86/208.09       2002; MCM1 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1993-2001 %26% FUNGAL PROTEINS 1992%A%  
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D026341 2006
% 207.86/208.09  |- skos__broader mesh__D026341smesh__D029701
% 207.86/208.09  |- skos__broader mesh__D026341smesh__D026161
% 207.86/208.09  |- mesh__dateCreated mesh__D026341 2001-07-25
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D026341 2004
% 207.86/208.09  |- skos__scopeNote mesh__D026341
% 207.86/208.09       A sequence-specific DNA-binding protein that plays an essential role as a global regulator of yeast cell cycle control. It contains a MADS-box domain within the N-terminal 56 amino acids. It is one of the four founder proteins that structurally define the superfamily of MADS DOMAIN PROTEINS.%A%    
% 207.86/208.09  |- skos__altLabel mesh__D026341 MCM-1 Protein
% 207.86/208.09  |- skos__historyNote mesh__D026341 Fungal Proteins %28%1992%29%
% 207.86/208.09  |- mesh__dateEstablished mesh__D026341 2002-01-01
% 207.86/208.09  |- rdf__type mesh__D026341sskos__Concept
% 207.86/208.09  |- skos__hiddenLabel mesh__D012321 Polymerases, RNA
% 207.86/208.09  |- skos__historyNote mesh__D012321
% 207.86/208.09       RNA Nucleotidyltransferases %28%1968-1972%29%
% 207.86/208.09  |- skos__altLabel mesh__D012321 Transcriptases
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D012321 2005
% 207.86/208.09  |- skos__hiddenLabel mesh__D012321 Polymerases, DNA-Dependent RNA
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D012321 2006
% 207.86/208.09  |- mesh__recordAuthorizer mesh__D012321 sjn
% 207.86/208.09  |- mesh__recordOriginator mesh__D012321 NLM
% 207.86/208.09  |- mesh__dateEstablished mesh__D012321 1973-01-01
% 207.86/208.09  |- skos__hiddenLabel mesh__D012321 Polymerases, DNA-Directed RNA
% 207.86/208.09  |- mesh__historyNote mesh__D012321 2003%28%1973%29%   
% 207.86/208.09  |- skos__prefLabel mesh__D012321 DNA-Directed RNA Polymerases
% 207.86/208.09  |- skos__altLabel mesh__D012321 RNA Polymerases
% 207.86/208.09  |- skos__altLabel mesh__D012321 RNA Polymerase
% 207.86/208.09  |- skos__altLabel mesh__D012321 DNA-Dependent RNA Polymerases
% 207.86/208.09  |- skos__scopeNote mesh__D012321
% 207.86/208.09       Enzymes that catalyze DNA template-directed extension of the 3%27%-end of an RNA strand one nucleotide at a time. They can initiate a chain de novo. In eukaryotes, three forms of the enzyme have been distinguished on the basis of sensitivity to alpha-amanitin, and the type of RNA synthesized. %28%From Enzyme Nomenclature, 1992%29%.%A%    
% 207.86/208.09  |- skos__altLabel mesh__D012321 DNA-Directed RNA Polymerase
% 207.86/208.09  |- skos__hiddenLabel mesh__D012321 Polymerase, DNA-Directed RNA
% 207.86/208.09  |- mesh__dateRevised mesh__D012321 2003-07-09
% 207.86/208.09  |- skos__hiddenLabel mesh__D012321 DNA Directed RNA Polymerases
% 207.86/208.09  |- skos__broader mesh__D012321smesh__D012316
% 207.86/208.09  |- rdf__type mesh__D012321sskos__Concept
% 207.86/208.09  |- mesh__publicMeSHNote mesh__D012321
% 207.86/208.09       2003; see DNA-DIRECTED RNA POLYMERASE 1998-2002, see RNA POLYMERASES 1977-1997, see RNA POLYMERASE 1973-1976%A%  
% 207.86/208.09  |- mesh__recordMaintainer mesh__D012321 ssb
% 207.86/208.09  |- skos__hiddenLabel mesh__D012321 Polymerase, RNA
% 207.86/208.09  |- skos__annotation mesh__D012321
% 207.86/208.09       GEN or unspecified; prefer specifics RNA POLYMERASE I, etc.%A%  
% 207.86/208.09  |- skos__hiddenLabel mesh__D012321 RNA Polymerases, DNA-Dependent
% 207.86/208.09  |- skos__hiddenLabel mesh__D012321 RNA Polymerases, DNA-Directed
% 207.86/208.09  |- skos__hiddenLabel mesh__D012321 DNA Directed RNA Polymerase
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D012321 2004
% 207.86/208.09  |- skos__hiddenLabel mesh__D012321 DNA Dependent RNA Polymerases
% 207.86/208.09  |- skos__hiddenLabel mesh__D012321 RNA Polymerase, DNA-Directed
% 207.86/208.09  |- mesh__dateCreated mesh__D012321 1999-01-01
% 207.86/208.09  |- skos__annotation mesh__D031286
% 207.86/208.09       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.86/208.09  |- mesh__dateCreated mesh__D031286 2002-07-03
% 207.86/208.09  |- skos__scopeNote mesh__D031286
% 207.86/208.09       A plant genus of the family EUPHORBIACEAE. Members contain jatrophone and other diterpenes.%A%    
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D031286 2004
% 207.86/208.09  |- skos__broader mesh__D031286smesh__D019665
% 207.86/208.09  |- skos__altLabel mesh__D031286 Nettlespurge
% 207.86/208.09  |- skos__prefLabel mesh__D031286 Jatropha
% 207.86/208.09  |- rdf__type mesh__D031286sskos__Concept
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D031286 2003
% 207.86/208.09  |- mesh__publicMeSHNote mesh__D031286 2003   
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D031286 2006
% 207.86/208.09  |- skos__altLabel mesh__D031286 Spurge, Nettle
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D031286 2005
% 207.86/208.09  |- mesh__dateEstablished mesh__D031286 2003-01-01
% 207.86/208.09  |- mesh__historyNote mesh__D031286 2003   
% 207.86/208.09  |- skos__hiddenLabel mesh__D050440 Subunits, Ig
% 207.86/208.09  |- mesh__recordAuthorizer mesh__D050440 ags
% 207.86/208.09  |- rdf__type mesh__D050440sskos__Concept
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D050440 2006A
% 207.86/208.09  |- skos__altLabel mesh__D050440 Immunoglobulin Polypeptide Chains
% 207.86/208.09  |- mesh__recordMaintainer mesh__D050440 ags
% 207.86/208.09  |- skos__scopeNote mesh__D050440
% 207.86/208.09       The PROTEIN SUBUNITS of the multimeric IMMUNOGLOBULIN proteins, such as IGA; IGD; IGE; IGG; and IGM. Included are the heavy and light chains which contain the specific ANTIGEN binding domains, as well as the accessory proteins that are part of the the secreted forms of IGM and IGA; %28%SECRETORY IGA%29%.%A%    
% 207.86/208.09  |- mesh__recordOriginator mesh__D050440 nns
% 207.86/208.09  |- mesh__dateEstablished mesh__D050440 2006-01-01
% 207.86/208.09  |- skos__altLabel mesh__D050440 Ig Subunits
% 207.86/208.09  |- skos__broader mesh__D050440smesh__D007136
% 207.86/208.09  |- mesh__publicMeSHNote mesh__D050440 2006   
% 207.86/208.09  |- skos__altLabel mesh__D050440 Ig Polypeptide Chains
% 207.86/208.09  |- skos__hiddenLabel mesh__D050440 Subunit, Ig
% 207.86/208.09  |- mesh__dateRevised mesh__D050440 2005-07-18
% 207.86/208.09  |- skos__altLabel mesh__D050440 Immunoglobulin Chains
% 207.86/208.09  |- mesh__historyNote mesh__D050440 2006   
% 207.86/208.09  |- skos__prefLabel mesh__D050440 Immunoglobulin Subunits
% 207.86/208.09  |- mesh__dateCreated mesh__D050440 2005-06-30
% 207.86/208.09  |- skos__altLabel mesh__D050440 Ig Subunit
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D050440 2006
% 207.86/208.09  |- skos__hiddenLabel mesh__D003595 Streamings, Protoplasmic
% 207.86/208.09  |- mesh__dateCreated mesh__D003595 1999-01-01
% 207.86/208.09  |- skos__hiddenLabel mesh__D003595 Streaming, Protoplasmic
% 207.86/208.09  |- mesh__recordOriginator mesh__D003595 NLM
% 207.86/208.09  |- mesh__publicMeSHNote mesh__D003595 70   
% 207.86/208.09  |- mesh__activeMeSHYear mesh__D003595 2006
% 207.86/208.09  |- mesh__historyNote mesh__D003595 70%28%67%29%   
% 207.86/208.09  |- skos__hiddenLabel mesh__D003595 Streamings, Cytoplasmic
% 207.86/208.09  |- skos__broader mesh__D003595smesh__D001692
% 207.86/208.10  |- skos__broader mesh__D003595smesh__D002468
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D003595 2005
% 207.86/208.10  |- skos__historyNote mesh__D003595 Cytoplasm %28%1966%29%
% 207.86/208.10  |- skos__hiddenLabel mesh__D003595 Cytoplasmic Streamings
% 207.86/208.10  |- skos__prefLabel mesh__D003595 Cytoplasmic Streaming
% 207.86/208.10  |- skos__hiddenLabel mesh__D003595 Streaming, Cytoplasmic
% 207.86/208.10  |- mesh__recordMaintainer mesh__D003595 nns
% 207.86/208.10  |- skos__annotation mesh__D003595
% 207.86/208.10       permitted for micro-organisms also; do not confuse with CYTOKINESIS or CELL MOVEMENT%A%  
% 207.86/208.10  |- mesh__dateRevised mesh__D003595 2004-07-07
% 207.86/208.10  |- skos__hiddenLabel mesh__D003595 Protoplasmic Streamings
% 207.86/208.10  |- skos__scopeNote mesh__D003595
% 207.86/208.10       The movement of CYTOPLASM within a CELL. It serves as an internal transport system for moving essential substances throughout the cell, and in single-celled organisms, such as the AMOEBA, it is responsible for the movement %28%CELL MOVEMENT%29% of the entire cell.%A%    
% 207.86/208.10  |- rdf__type mesh__D003595sskos__Concept
% 207.86/208.10  |- mesh__dateEstablished mesh__D003595 1970-01-01
% 207.86/208.10  |- mesh__recordAuthorizer mesh__D003595 sjn
% 207.86/208.10  |- skos__altLabel mesh__D044403 Receptor, Serotonin 2B
% 207.86/208.10  |- skos__prefLabel mesh__D044403 Receptor, Serotonin, 5-HT2B
% 207.86/208.10  |- mesh__historyNote mesh__D044403
% 207.86/208.10       2004; use RECEPTOR, SEROTONIN, 5-HT2B %28%NM%29% 1994-2003   
% 207.86/208.10  |- skos__scopeNote mesh__D044403
% 207.86/208.10       A serotonin receptor subtype found in the BRAIN; HEART; LUNGS; PLACENTA and DIGESTIVE SYSTEM organs. A number of functions have been attributed to the action of the 5-HT2B receptor including the development of cardiac myocytes %28%MYOCYTES, CARDIAC%29% and the contraction of SMOOTH MUSCLE.%A%    
% 207.86/208.10  |- mesh__dateRevised mesh__D044403 2005-06-30
% 207.86/208.10  |- skos__hiddenLabel mesh__D044403 5 Hydroxytryptamine 2B Receptor
% 207.86/208.10  |- skos__altLabel mesh__D044403 Serotonin 2B Receptor
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D044403 2006
% 207.86/208.10  |- skos__historyNote mesh__D044403 Receptors, Serotonin %28%1994-2003%29%
% 207.86/208.10  |- rdf__type mesh__D044403sskos__Concept
% 207.86/208.10  |- skos__hiddenLabel mesh__D044403 Receptor, 5-Hydroxytryptamine 2B
% 207.86/208.10  |- skos__hiddenLabel mesh__D044403 Receptor, 5-HT2B
% 207.86/208.10  |- skos__altLabel mesh__D044403 5-Hydroxytryptamine 2B Receptor
% 207.86/208.10  |- mesh__recordMaintainer mesh__D044403 jmp
% 207.86/208.10  |- mesh__dateEstablished mesh__D044403 2004-01-01
% 207.86/208.10  |- skos__hiddenLabel mesh__D044403 2B Receptor, 5-Hydroxytryptamine
% 207.86/208.10  |- mesh__dateCreated mesh__D044403 2003-07-09
% 207.86/208.10  |- skos__altLabel mesh__D044403 5-HT2B Receptor
% 207.86/208.10  |- skos__broader mesh__D044403smesh__D044348
% 207.86/208.10  |- skos__hiddenLabel mesh__D044403 5 HT2B Receptor
% 207.86/208.10  |- skos__altLabel mesh__D044403 %28%5-HT%29%2B Receptors
% 207.86/208.10  |- skos__hiddenLabel mesh__D044403 2B Receptor, Serotonin
% 207.86/208.10  |- skos__hiddenLabel mesh__D044403 2B Receptors, Serotonin
% 207.86/208.10  |- mesh__publicMeSHNote mesh__D044403
% 207.86/208.10       2004; SEROTONIN 2B RECEPTOR %28%now RECEPTOR, SEROTONIN, 5-HT2B%29% was indexed under RECEPTORS, SEROTONIN 1994-2003%A%  
% 207.86/208.10  |- mesh__recordOriginator mesh__D044403 jmp
% 207.86/208.10  |- mesh__recordAuthorizer mesh__D044403 sjn
% 207.86/208.10  |- skos__hiddenLabel mesh__D044403 Receptors, Serotonin 2B
% 207.86/208.10  |- skos__altLabel mesh__D044403 Serotonin 2B Receptors
% 207.86/208.10  |- mesh__recordMaintainer mesh__D011229 PLS
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D011229 1997
% 207.86/208.10  |- rdf__type mesh__D011229sskos__Concept
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D011229 2001
% 207.86/208.10  |- skos__prefLabel mesh__D011229 Preanesthetic Medication
% 207.86/208.10  |- mesh__dateCreated mesh__D011229 1999-01-01
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D011229 2004
% 207.86/208.10  |- skos__hiddenLabel mesh__D011229 Medication, Preanesthetic
% 207.86/208.10  |- mesh__recordOriginator mesh__D011229 NLM
% 207.86/208.10  |- mesh__recordAuthorizer mesh__D011229 PLS
% 207.86/208.10  |- skos__hiddenLabel mesh__D011229 Preanesthetic Medications
% 207.86/208.10  |- skos__annotation mesh__D011229
% 207.86/208.10       do not use /util except by MeSH definition   
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D011229 1994
% 207.86/208.10  |- skos__broader mesh__D011229smesh__D000760
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D011229 2002
% 207.86/208.10  |- mesh__dateRevised mesh__D011229 1993-05-03
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D011229 1998
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D011229 1995
% 207.86/208.10  |- skos__hiddenLabel mesh__D011229 Medications, Preanesthetic
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D011229 2005
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D011229 1999
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D011229 2006
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D011229 2000
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D011229 1996
% 207.86/208.10  |- skos__broader mesh__D011229smesh__D011300
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D011229 2003
% 207.86/208.10  |- mesh__dateRevised mesh__D008280 2005-06-30
% 207.86/208.10  |- skos__hiddenLabel mesh__D008280 Magnetometries
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D008280 2006
% 207.86/208.10  |- skos__broader mesh__D008280smesh__D010825
% 207.86/208.10  |- skos__annotation mesh__D008280
% 207.86/208.10       TRANSCRANIAL MAGNETIC STIMULATION and ELECTROMAGNETICS are also available%A%  
% 207.86/208.10  |- rdf__type mesh__D008280sskos__Concept
% 207.86/208.10  |- mesh__recordAuthorizer mesh__D008280 sjn
% 207.86/208.10  |- mesh__dateCreated mesh__D008280 1999-01-01
% 207.86/208.10  |- skos__prefLabel mesh__D008280 Magnetics
% 207.86/208.10  |- skos__scopeNote mesh__D008280
% 207.86/208.10       The study of magnetic phenomena and magnetic fields. Magnetism produced by electric currents is ELECTROMAGNETICS.%A%    
% 207.86/208.10  |- skos__hiddenLabel mesh__D008280 Magnetic
% 207.86/208.10  |- mesh__recordMaintainer mesh__D008280 ssb
% 207.86/208.10  |- mesh__recordOriginator mesh__D008280 NLM
% 207.86/208.10  |- skos__historyNote mesh__D016712 Fatty Acids %28%1966-1991%29%
% 207.86/208.10  |- mesh__dateRevised mesh__D016712 2003-07-09
% 207.86/208.10  |- skos__annotation mesh__D016712
% 207.86/208.10       do not use /biosyn unless by living matter   
% 207.86/208.10  |- rdf__type mesh__D016712sskos__Concept
% 207.86/208.10  |- mesh__dateCreated mesh__D016712 1991-07-12
% 207.86/208.10  |- skos__hiddenLabel mesh__D016712 BRL 4910A
% 207.86/208.10  |- skos__hiddenLabel mesh__D016712 14C-Labeled Mupirocin
% 207.86/208.10  |- mesh__recordOriginator mesh__D016712 RLS
% 207.86/208.10  |- skos__historyNote mesh__D016712 Antibiotics %28%1966-1991%29%
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D016712 2004
% 207.86/208.10  |- skos__scopeNote mesh__D016712
% 207.86/208.10       A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing.%A%    
% 207.86/208.10  |- skos__prefLabel mesh__D016712 Mupirocin
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D016712 2005
% 207.86/208.10  |- skos__altLabel mesh__D016712 Pseudomonic Acid A
% 207.86/208.10  |- mesh__recordMaintainer mesh__D016712 ssb
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D016712 2006
% 207.86/208.10  |- skos__broader mesh__D016712smesh__D005227
% 207.86/208.10  |- skos__hiddenLabel mesh__D016712 BRL4910A
% 207.86/208.10  |- skos__hiddenLabel mesh__D016712 Acid, Pseudomonic
% 207.86/208.10  |- mesh__recordAuthorizer mesh__D016712 sjn
% 207.86/208.10  |- mesh__dateEstablished mesh__D016712 1992-01-01
% 207.86/208.10  |- mesh__publicMeSHNote mesh__D016712
% 207.86/208.10       92; PSEUDOMONIC ACID was indexed under ANTIBIOTICS 1977-91%A%  
% 207.86/208.10  |- mesh__historyNote mesh__D016712
% 207.86/208.10       92; was PSEUDOMONIC ACID %28%NM%29% 1977-91   
% 207.86/208.10  |- mesh__onlineNote mesh__D016712
% 207.86/208.10       use MUPIROCIN %28%NM%29% to search PSEUDOMONIC ACID %28%NM%29% 1980-91%A%  
% 207.86/208.10  |- skos__hiddenLabel mesh__D016712 Mupirocin, 14C Labeled
% 207.86/208.10  |- skos__altLabel mesh__D016712 Pseudomonic Acid
% 207.86/208.10  |- skos__altLabel mesh__D007986 Luteoziman
% 207.86/208.10  |- skos__hiddenLabel mesh__D007986 Interstitial Cell Stimulating Hormone
% 207.86/208.10  |- skos__hiddenLabel mesh__D007986 Hormone, Luteinizing
% 207.86/208.10  |- mesh__recordAuthorizer mesh__D007986 sjn
% 207.86/208.10  |- skos__annotation mesh__D007986
% 207.86/208.10       do not confuse X ref LUTROPIN with LUTEOTROPIN see PLACENTAL LACTOGEN; for alpha subunit, coord with GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; LUTEINIZING HORMONE, BETA SUBUNIT is also available%A%  
% 207.86/208.10  |- mesh__dateRevised mesh__D007986 2002-07-03
% 207.86/208.10  |- rdf__type mesh__D007986sskos__Concept
% 207.86/208.10  |- mesh__recordOriginator mesh__D007986 NLM
% 207.86/208.10  |- skos__altLabel mesh__D007986 Interstitial Cell-Stimulating Hormone
% 207.86/208.10  |- skos__altLabel mesh__D007986 Lutropin
% 207.86/208.10  |- skos__broader mesh__D007986smesh__D006065
% 207.86/208.10  |- skos__altLabel mesh__D007986
% 207.86/208.10       ICSH %28%Interstitial Cell Stimulating Hormone%29%
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D007986 2005
% 207.86/208.10  |- mesh__dateCreated mesh__D007986 1999-01-01
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D007986 2006
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D007986 2003
% 207.86/208.10  |- skos__altLabel mesh__D007986 LH %28%Luteinizing Hormone%29%
% 207.86/208.10  |- skos__prefLabel mesh__D007986 Luteinizing Hormone
% 207.86/208.10  |- skos__hiddenLabel mesh__D007986 Hormone, Interstitial Cell-Stimulating
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D007986 2004
% 207.86/208.10  |- mesh__historyNote mesh__D007986 2003 %28%1968%29%; use ICSH 1963-1967   
% 207.86/208.10  |- skos__related mesh__D007986smesh__D011974
% 207.86/208.10  |- mesh__publicMeSHNote mesh__D007986
% 207.86/208.10       2003 %28%1968%29%; see ICSH 1963-1967   
% 207.86/208.10  |- mesh__recordMaintainer mesh__D007986 sjn
% 207.86/208.10  |- mesh__dateEstablished mesh__D007986 1968-01-01
% 207.86/208.10  |- skos__scopeNote mesh__D007986
% 207.86/208.10       A major gonadotropin secreted by the adenohypophysis %28%PITUITARY GLAND, ANTERIOR%29%. Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones %28%TSH, LH and FSH%29%, but the beta subunit is unique and confers its biological specificity.%A%    
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D007188 2005
% 207.86/208.10  |- rdf__type mesh__D007188sskos__Concept
% 207.86/208.10  |- skos__broader mesh__D007188smesh__D004429
% 207.86/208.10  |- mesh__dateEstablished mesh__D007188 1991-01-01
% 207.86/208.10  |- mesh__dateCreated mesh__D007188 1999-01-01
% 207.86/208.10  |- mesh__publicMeSHNote mesh__D007188
% 207.86/208.10       91; was see under EAR OSSICLES 1975-90   
% 207.86/208.10  |- mesh__onlineNote mesh__D007188 search EAR OSSICLES 1966-74   
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D007188 2002
% 207.86/208.10  |- skos__scopeNote mesh__D007188
% 207.86/208.10       One of three ossicles of the middle ear. It conducts sound vibrations from the MALLEUS to the STAPES.%A%    
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D007188 2004
% 207.86/208.10  |- skos__prefLabel mesh__D007188 Incus
% 207.86/208.10  |- mesh__dateRevised mesh__D007188 1999-11-03
% 207.86/208.10  |- mesh__recordAuthorizer mesh__D007188 sjn
% 207.86/208.10  |- mesh__recordMaintainer mesh__D007188 KEV
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D007188 2003
% 207.86/208.10  |- mesh__historyNote mesh__D007188
% 207.86/208.10       91%28%75%29%; was see under EAR OSSICLES 1975-90   
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D007188 2001
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D007188 2006
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D007188 2000
% 207.86/208.10  |- mesh__recordOriginator mesh__D007188 NLM
% 207.86/208.10  |- skos__historyNote mesh__D026342 Transcription Factors %28%1993-2001%29%
% 207.86/208.10  |- skos__scopeNote mesh__D026342
% 207.86/208.10       A plant homeotic protein involved in the development of stamens and carpels of Arabidopsis thaliana.  It is a DNA-binding protein that contains the MADS-box domain. It is one of the four founder proteins that structurally define the superfamily of MADS DOMAIN PROTEINS.%A%    
% 207.86/208.10  |- skos__altLabel mesh__D026342 AGAMOUS 1 Protein
% 207.86/208.10  |- mesh__recordMaintainer mesh__D026342 SYSTEM
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D026342 2006
% 207.86/208.10  |- mesh__recordAuthorizer mesh__D026342 sjn
% 207.86/208.10  |- mesh__dateRevised mesh__D026342 2005-06-30
% 207.86/208.10  |- skos__annotation mesh__D026342
% 207.86/208.10       AGAMOUS-LIKE PROTEINS see MADS DOMAIN PROTEINS is also available%A%  
% 207.86/208.10  |- mesh__publicMeSHNote mesh__D026342
% 207.86/208.10       2002; AGAMOUS PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1993-2001%A%  
% 207.86/208.10  |- skos__historyNote mesh__D026342 DNA-Binding Proteins %28%1993-2001%29%
% 207.86/208.10  |- mesh__historyNote mesh__D026342
% 207.86/208.10       2002; use AGAMOUS PROTEIN %28%NM%29% 1993-2001   
% 207.86/208.10  |- mesh__recordOriginator mesh__D026342 jmp
% 207.86/208.10  |- mesh__dateEstablished mesh__D026342 2002-01-01
% 207.86/208.10  |- rdf__type mesh__D026342sskos__Concept
% 207.86/208.10  |- skos__broader mesh__D026342smesh__D029681
% 207.86/208.10  |- skos__prefLabel mesh__D026342 AGAMOUS Protein, Arabidopsis
% 207.86/208.10  |- skos__broader mesh__D026342smesh__D026161
% 207.86/208.10  |- mesh__dateCreated mesh__D026342 2001-07-25
% 207.86/208.10  |- skos__hiddenLabel mesh__D026342 Arabidopsis AGAMOUS Protein
% 207.86/208.10  |- skos__historyNote mesh__D012322
% 207.86/208.10       Nucleic Acid Precursors %28%1975-1987%29%
% 207.86/208.10  |- rdf__type mesh__D012322sskos__Concept
% 207.86/208.10  |- skos__hiddenLabel mesh__D012322 Pre rRNA
% 207.86/208.10  |- skos__hiddenLabel mesh__D012322 Precursor, mRNA
% 207.86/208.10  |- skos__hiddenLabel mesh__D012322 Transcript, Primary RNA
% 207.86/208.10  |- skos__hiddenLabel mesh__D012322 RNA Transcript, Primary
% 207.86/208.10  |- mesh__dateRevised mesh__D012322 2002-07-03
% 207.86/208.10  |- mesh__recordAuthorizer mesh__D012322 sjn
% 207.86/208.10  |- mesh__publicMeSHNote mesh__D012322 88   
% 207.86/208.10  |- skos__hiddenLabel mesh__D012322 Pre snRNA
% 207.86/208.10  |- skos__hiddenLabel mesh__D012322 Pre tRNA
% 207.86/208.10  |- skos__historyNote mesh__D012322 Nucleic Acids %28%1966-1974%29%
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D012322 2006
% 207.86/208.10  |- skos__prefLabel mesh__D012322 RNA Precursors
% 207.86/208.10  |- skos__hiddenLabel mesh__D012322 Precursor, RNA
% 207.86/208.10  |- skos__altLabel mesh__D012322 tRNA Precursor
% 207.86/208.10  |- skos__annotation mesh__D012322 coord with specific RNA   
% 207.86/208.10  |- skos__altLabel mesh__D012322 snRNA Precursor
% 207.86/208.10  |- mesh__dateEstablished mesh__D012322 1988-01-01
% 207.86/208.10  |- skos__broader mesh__D012322smesh__D009694
% 207.86/208.10  |- skos__scopeNote mesh__D012322
% 207.86/208.10       RNA transcripts of the DNA that are in some unfinished stage of post-transcriptional processing %28%RNA PROCESSING, POST-TRANSCRIPTIONAL%29% required for function. RNA precursors may undergo several steps of RNA SPLICING during which the phosphodiester bonds at exon-intron boundaries are cleaved and the introns are excised. Consequently a new bond is formed between the ends of the exons. Resulting mature RNAs  can then be used; for example, mature mRNA %28%RNA, MESSENGER%29% is used as a template for protein production.%A%    
% 207.86/208.10  |- skos__altLabel mesh__D012322 Primary Transcript, RNA
% 207.86/208.10  |- skos__hiddenLabel mesh__D012322 Precursors, RNA
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D012322 2005
% 207.86/208.10  |- mesh__recordMaintainer mesh__D012322 nns
% 207.86/208.10  |- skos__hiddenLabel mesh__D012322 Pre mRNA
% 207.86/208.10  |- skos__hiddenLabel mesh__D012322 Precursor, snRNA
% 207.86/208.10  |- skos__altLabel mesh__D012322 Pre-snRNA
% 207.86/208.10  |- skos__hiddenLabel mesh__D012322 Precursor, rRNA
% 207.86/208.10  |- mesh__historyNote mesh__D012322 88   
% 207.86/208.10  |- skos__hiddenLabel mesh__D012322 Precursor, tRNA
% 207.86/208.10  |- skos__broader mesh__D012322smesh__D012313
% 207.86/208.10  |- skos__altLabel mesh__D012322 rRNA Precursor
% 207.86/208.10  |- skos__hiddenLabel mesh__D012322 RNA Primary Transcript
% 207.86/208.10  |- mesh__recordOriginator mesh__D012322 RLS
% 207.86/208.10  |- skos__hiddenLabel mesh__D012322 Transcript, RNA Primary
% 207.86/208.10  |- mesh__dateCreated mesh__D012322 1987-05-05
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D012322 2004
% 207.86/208.10  |- skos__altLabel mesh__D012322 Precursor RNA
% 207.86/208.10  |- skos__altLabel mesh__D012322 Pre-rRNA
% 207.86/208.10  |- skos__altLabel mesh__D012322 Pre-tRNA
% 207.86/208.10  |- skos__altLabel mesh__D012322 mRNA Precursor
% 207.86/208.10  |- skos__hiddenLabel mesh__D012322 RNA, Precursor
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D012322 2003
% 207.86/208.10  |- skos__altLabel mesh__D012322 Pre-mRNA
% 207.86/208.10  |- skos__scopeNote mesh__D031287
% 207.86/208.10       A plant genus of the family EUPHORBIACEAE that contains bukittinggine and PHORBOL ESTERS.%A%    
% 207.86/208.10  |- mesh__publicMeSHNote mesh__D031287 2003   
% 207.86/208.10  |- mesh__dateEstablished mesh__D031287 2003-01-01
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D031287 2006
% 207.86/208.10  |- mesh__historyNote mesh__D031287 2003   
% 207.86/208.10  |- mesh__dateCreated mesh__D031287 2002-07-03
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D031287 2005
% 207.86/208.10  |- skos__altLabel mesh__D031287 Tallow Tree, Chinese
% 207.86/208.10  |- skos__annotation mesh__D031287
% 207.86/208.10       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D031287 2004
% 207.86/208.10  |- skos__broader mesh__D031287smesh__D019665
% 207.86/208.10  |- rdf__type mesh__D031287sskos__Concept
% 207.86/208.10  |- skos__prefLabel mesh__D031287 Sapium
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D031287 2003
% 207.86/208.10  |- mesh__recordOriginator mesh__D050441 nns
% 207.86/208.10  |- mesh__historyNote mesh__D050441 2006   
% 207.86/208.10  |- mesh__dateCreated mesh__D050441 2005-06-30
% 207.86/208.10  |- skos__prefLabel mesh__D050441 VDJ Exons
% 207.86/208.10  |- mesh__recordAuthorizer mesh__D050441 sjn
% 207.86/208.10  |- skos__scopeNote mesh__D050441
% 207.86/208.10       Exons that are created in vivo during LYMPHOCYTE maturation from the V, D, and J gene segments of immunoglobulin superfamily genes %28%e.g., the IMMUNOGLOBULIN HEAVY CHAIN GENES, or the T-CELL RECEPTOR BETA GENES or T-CELL RECEPTOR GAMMA GENES %29% by the VDJ RECOMBINASE system.%A%    
% 207.86/208.10  |- mesh__publicMeSHNote mesh__D050441 2006   
% 207.86/208.10  |- skos__related mesh__D050441smesh__D045567
% 207.86/208.10  |- mesh__dateEstablished mesh__D050441 2006-01-01
% 207.86/208.10  |- skos__related mesh__D050441smesh__D019672
% 207.86/208.10  |- skos__hiddenLabel mesh__D050441 Exon, VDJ
% 207.86/208.10  |- skos__hiddenLabel mesh__D050441 Exons, VDJ
% 207.86/208.10  |- skos__related mesh__D050441smesh__D050438
% 207.86/208.10  |- skos__broader mesh__D050441smesh__D005091
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D050441 2006
% 207.86/208.10  |- rdf__type mesh__D050441sskos__Concept
% 207.86/208.10  |- mesh__recordMaintainer mesh__D050441 nns
% 207.86/208.10  |- skos__altLabel mesh__D050441 VDJ Exon
% 207.86/208.10  |- skos__scopeNote mesh__D003596
% 207.86/208.10       A pyrimidine base that is a fundamental unit of nucleic acids.%A%    
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D003596 2006
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D003596 1998
% 207.86/208.10  |- mesh__recordAuthorizer mesh__D003596 SJN
% 207.86/208.10  |- skos__prefLabel mesh__D003596 Cytosine
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D003596 2003
% 207.86/208.10  |- skos__broader mesh__D003596smesh__D011744
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D003596 2005
% 207.86/208.10  |- mesh__dateRevised mesh__D003596 1997-06-20
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D003596 2000
% 207.86/208.10  |- mesh__recordOriginator mesh__D003596 NLM
% 207.86/208.10  |- skos__annotation mesh__D003596 /biosyn /physiol permitted   
% 207.86/208.10  |- mesh__recordMaintainer mesh__D003596 TGC
% 207.86/208.10  |- rdf__type mesh__D003596sskos__Concept
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D003596 2002
% 207.86/208.10  |- mesh__dateCreated mesh__D003596 1999-01-01
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D003596 1999
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D003596 2004
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D003596 2001
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D044404 2006
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Pathogenicity Islet
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Islets, Genomic
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Islet, Genomic
% 207.86/208.10  |- rdf__type mesh__D044404sskos__Concept
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Islands, Pathogenicity
% 207.86/208.10  |- skos__scopeNote mesh__D044404
% 207.86/208.10       Distinct units in some bacterial, bacteriophage or plasmid GENOMES that are types of MOBILE GENETIC ELEMENTS. Encoded in them are a variety of fitness conferring genes, such as VIRULENCE FACTORS %28%in %22%pathogenicity islands or islets%22%%29%, ANTIBIOTIC RESISTANCE genes, or genes required for SYMBIOSIS %28%in %22%symbiosis islands or islets%22%%29%. They range in size from 10 - 500 kilobases, and their GC CONTENT and CODON usage differ from the rest of the genome. They typically contain an INTEGRASE gene, although in some cases this gene has been deleted resulting in %22%anchored genomic islands%22%.%A%    
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Island, Anchored Genomic
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Islets, Pathogenicity
% 207.86/208.10  |- mesh__recordAuthorizer mesh__D044404 sjn
% 207.86/208.10  |- skos__broader mesh__D044404smesh__D020071
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Islets, Symbiosis
% 207.86/208.10  |- skos__prefLabel mesh__D044404 Genomic Islands
% 207.86/208.10  |- mesh__dateRevised mesh__D044404 2005-06-30
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Symbiosis Islet
% 207.86/208.10  |- mesh__recordMaintainer mesh__D044404 nns
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Genomic Islands, Anchored
% 207.86/208.10  |- mesh__dateCreated mesh__D044404 2003-07-09
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Islands, Genomic
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Island, Genomic
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Island, Symbiosis
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Islands, Anchored Genomic
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Pathogenicity Island
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Islet, Symbiosis
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Islet, Pathogenicity
% 207.86/208.10  |- mesh__publicMeSHNote mesh__D044404 2004   
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Islands, Symbiosis
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Anchored Genomic Island
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Genomic Island
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Genomic Island, Anchored
% 207.86/208.10  |- mesh__dateEstablished mesh__D044404 2004-01-01
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Genomic Islet
% 207.86/208.10  |- mesh__historyNote mesh__D044404 2004   
% 207.86/208.10  |- mesh__recordOriginator mesh__D044404 nns
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Symbiosis Island
% 207.86/208.10  |- skos__hiddenLabel mesh__D044404 Island, Pathogenicity
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D008281 1999
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D008281 2006
% 207.86/208.10  |- rdf__type mesh__D008281sskos__Concept
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D008281 2003
% 207.86/208.10  |- mesh__recordOriginator mesh__D008281 NLM
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D008281 1998
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D008281 2005
% 207.86/208.10  |- mesh__dateCreated mesh__D008281 1999-01-01
% 207.86/208.10  |- mesh__dateRevised mesh__D008281 1997-06-20
% 207.86/208.10  |- skos__broader mesh__D008281smesh__D009511
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D008281 2002
% 207.86/208.10  |- mesh__recordMaintainer mesh__D008281 PXP
% 207.86/208.10  |- mesh__recordAuthorizer mesh__D008281 SJN
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D008281 2001
% 207.86/208.10  |- skos__prefLabel mesh__D008281 Maine
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D008281 2004
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D008281 2000
% 207.86/208.10  |- skos__historyNote mesh__D016713
% 207.86/208.10       Histamine H2 Receptor Blockaders %28%1977-1991%29%
% 207.86/208.10  |- rdf__type mesh__D016713sskos__Concept
% 207.86/208.10  |- mesh__publicMeSHNote mesh__D016713
% 207.86/208.10       92; RITANSERIN was indexed under PIPERIDINES 1985-91   
% 207.86/208.10  |- skos__prefLabel mesh__D016713 Ritanserin
% 207.86/208.10  |- mesh__dateRevised mesh__D016713 2003-07-09
% 207.86/208.10  |- skos__altLabel mesh__D016713
% 207.86/208.10       6-%28%2-%28%4-%28%Bis%28%4-fluorophenyl%29%methylene%29%-1-piperidinyl%29%ethyl%29%-7-methyl-5H-thiazolo%28%3,2-a%29%pyrimidin-5-one
% 207.86/208.10  |- skos__broader mesh__D016713smesh__D010880
% 207.86/208.10  |- skos__broader mesh__D016713smesh__D011744
% 207.86/208.10  |- mesh__historyNote mesh__D016713 92; was RITANSERIN %28%NM%29% 1985-91   
% 207.86/208.10  |- mesh__recordOriginator mesh__D016713 RLS
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D016713 2004
% 207.86/208.10  |- skos__hiddenLabel mesh__D016713 R 55667
% 207.86/208.10  |- skos__historyNote mesh__D016713 Piperidines %28%1966-1991%29%
% 207.86/208.10  |- mesh__recordMaintainer mesh__D016713 ssb
% 207.86/208.10  |- mesh__recordAuthorizer mesh__D016713 sjn
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D016713 2005
% 207.86/208.10  |- skos__scopeNote mesh__D016713
% 207.86/208.10       A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.%A%    
% 207.86/208.10  |- skos__hiddenLabel mesh__D016713 R55667
% 207.86/208.10  |- mesh__dateCreated mesh__D016713 1991-02-11
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D016713 2006
% 207.86/208.10  |- mesh__dateEstablished mesh__D016713 1992-01-01
% 207.86/208.10  |- mesh__onlineNote mesh__D016713
% 207.86/208.10       use RITANSERIN %28%NM%29% to search RITANSERIN 1985-91   
% 207.86/208.10  |- skos__altLabel mesh__D007987 LHRH
% 207.86/208.10  |- skos__hiddenLabel mesh__D007987 Acetate, Gonadorelin
% 207.86/208.10  |- skos__hiddenLabel mesh__D007987 Hormone, Gonadotropin-Releasing
% 207.86/208.10  |- skos__altLabel mesh__D007987 LHFSHRH
% 207.86/208.10  |- skos__broader mesh__D007987smesh__D009842
% 207.86/208.10  |- mesh__dateCreated mesh__D007987 1999-01-01
% 207.86/208.10  |- skos__altLabel mesh__D007987 LH-RH
% 207.86/208.10  |- skos__related mesh__D007987smesh__D011966
% 207.86/208.10  |- rdf__type mesh__D007987sskos__Concept
% 207.86/208.10  |- skos__hiddenLabel mesh__D007987 Hydrochloride, Gonadorelin
% 207.86/208.10  |- mesh__publicMeSHNote mesh__D007987
% 207.86/208.10       91; was LH-FSH RELEASING HORMONE 1974-90; GONADOTROPIN- RELEASING HORMONE was see PITUITARY HORMONE RELEASING HORMONES 1977-90%A%  
% 207.86/208.10  |- mesh__onlineNote mesh__D007987
% 207.86/208.10       use GONADORELIN to search LH-FSH RELEASING HORMONE 1974-90; use PITUITARY HORMONE RELEASING HORMONES to search GONADOTROPIN-RELEASING HORMONE 1977-90%A%  
% 207.86/208.10  |- skos__altLabel mesh__D007987 GnRH
% 207.86/208.10  |- mesh__recordMaintainer mesh__D007987 ssb
% 207.86/208.10  |- skos__altLabel mesh__D007987 Luteinizing Hormone-Releasing Hormone
% 207.86/208.10  |- skos__altLabel mesh__D007987 FSH-Releasing Hormone
% 207.86/208.10  |- skos__hiddenLabel mesh__D007987 Releasing Hormone, LH-FSH
% 207.86/208.10  |- skos__altLabel mesh__D007987 Gonadotropin-Releasing Hormone
% 207.86/208.10  |- skos__hiddenLabel mesh__D007987 Releasing Hormone, LHFSH
% 207.86/208.10  |- skos__hiddenLabel mesh__D007987 LH Releasing Hormone
% 207.86/208.10  |- skos__hiddenLabel mesh__D007987 Hormone, Luteinizing Hormone-Releasing
% 207.86/208.10  |- mesh__dateEstablished mesh__D007987 1974-01-01
% 207.86/208.10  |- skos__hiddenLabel mesh__D007987 Gonadotropin Releasing Hormone
% 207.86/208.10  |- skos__broader mesh__D007987smesh__D010906
% 207.86/208.10  |- skos__altLabel mesh__D007987 LH-FSH Releasing Hormone
% 207.86/208.10  |- mesh__dateRevised mesh__D007987 2005-06-30
% 207.86/208.10  |- mesh__historyNote mesh__D007987
% 207.86/208.10       91; was LH-FSH RELEASING HORMONE 1974-90; GONADOTROPIN- RELEASING HORMONE was see PITUITARY HORMONE RELEASING HORMONES 1977-90%A%  
% 207.86/208.10  |- mesh__recordOriginator mesh__D007987 NLM
% 207.86/208.10  |- skos__broader mesh__D007987smesh__D009479
% 207.86/208.10  |- skos__hiddenLabel mesh__D007987 Hormone, FSH-Releasing
% 207.86/208.10  |- mesh__activeMeSHYear mesh__D007987 2006
% 207.86/208.10  |- skos__altLabel mesh__D007987 Gonadoliberin
% 207.86/208.10  |- skos__hiddenLabel mesh__D007987 FSH Releasing Hormone
% 207.86/208.10  |- skos__prefLabel mesh__D007987 Gonadorelin
% 207.86/208.10  |- skos__altLabel mesh__D007987 LHFSH Releasing Hormone
% 207.86/208.11  |- skos__altLabel mesh__D007987 Gn-RH
% 207.86/208.11  |- mesh__recordAuthorizer mesh__D007987 sjn
% 207.86/208.11  |- skos__hiddenLabel mesh__D007987 LH FSH Releasing Hormone
% 207.86/208.11  |- skos__hiddenLabel mesh__D007987 Hormone, LH-Releasing
% 207.86/208.11  |- skos__hiddenLabel mesh__D007987 Hormone, LH-FSH Releasing
% 207.86/208.11  |- skos__altLabel mesh__D007987 LFRH
% 207.86/208.11  |- skos__altLabel mesh__D007987 Luliberin
% 207.86/208.11  |- skos__scopeNote mesh__D007987
% 207.86/208.11       A decapeptide hormone released by the hypothalamus. It stimulates the synthesis and secretion of both FOLLICLE STIMULATING HORMONE and luteinizing hormone %28%LH%29% from the pituitary gland.%A%    
% 207.86/208.11  |- skos__altLabel mesh__D007987 LH-Releasing Hormone
% 207.86/208.11  |- skos__hiddenLabel mesh__D007987 Hormone, LHFSH Releasing
% 207.86/208.11  |- mesh__recordMaintainer mesh__D007189 ssb
% 207.86/208.11  |- mesh__recordOriginator mesh__D007189 NLM
% 207.86/208.11  |- mesh__onlineNote mesh__D007189 search INDENES 1966-74   
% 207.86/208.11  |- skos__prefLabel mesh__D007189 Indans
% 207.86/208.11  |- mesh__publicMeSHNote mesh__D007189
% 207.86/208.11       91,63-67; was see under INDENES 1975-90; was heading 1963-67%A%  
% 207.86/208.11  |- mesh__activeMeSHYear mesh__D007189 2006
% 207.86/208.11  |- mesh__dateRevised mesh__D007189 2003-07-09
% 207.86/208.11  |- mesh__activeMeSHYear mesh__D007189 2005
% 207.86/208.11  |- rdf__type mesh__D007189sskos__Concept
% 207.86/208.11  |- skos__scopeNote mesh__D007189
% 207.86/208.11       Aryl CYCLOPENTANES that are a reduced %28%protonated%29% form of INDENES.%A%    
% 207.86/208.11  |- mesh__dateCreated mesh__D007189 1999-01-01
% 207.86/208.11  |- mesh__historyNote mesh__D007189
% 207.86/208.11       91%28%75%29%63-67; was see under INDENES 1975-90; was heading 1963-67%A%  
% 207.86/208.11  |- mesh__recordAuthorizer mesh__D007189 sjn
% 207.86/208.11  |- skos__broader mesh__D007189smesh__D007192
% 207.86/208.11  |- mesh__dateEstablished mesh__D007189 1991-01-01
% 207.86/208.11  |- mesh__activeMeSHYear mesh__D007189 2004
% 207.86/208.11  |- rdf__type mesh__D012323sskos__Concept
% 207.86/208.11  |- skos__annotation mesh__D012323
% 207.86/208.11       coord IM with specific RNA /metab %28%IM%29%; DF: RNA PROC POST TRANSCRIPTIONAL%A%  
% 207.86/208.11  |- skos__altLabel mesh__D012323 Posttranscriptional RNA Processing
% 207.86/208.11  |- mesh__historyNote mesh__D012323 83   
% 207.86/208.11  |- skos__broader mesh__D012323smesh__D005786
% 207.86/208.11  |- skos__historyNote mesh__D012323 RNA, Messenger %28%1966-1982%29%
% 207.86/208.11  |- skos__altLabel mesh__D012323 RNA Processing, Posttranscriptional
% 207.86/208.11  |- mesh__dateEstablished mesh__D012323 1983-01-01
% 207.86/208.11  |- mesh__recordMaintainer mesh__D012323 nns
% 207.86/208.11  |- mesh__dateRevised mesh__D012323 2004-07-07
% 207.86/208.11  |- skos__hiddenLabel mesh__D012323 Post Transcriptional RNA Modification
% 207.86/208.11  |- skos__scopeNote mesh__D012323
% 207.86/208.11       Post-transcriptional biological modification of messenger, transfer, or ribosomal RNAs or their precursors. It includes cleavage, methylation, thiolation, isopentenylation, pseudouridine formation, conformational changes, and association with ribosomal protein.%A%    
% 207.86/208.11  |- mesh__recordOriginator mesh__D012323 AEP
% 207.86/208.11  |- mesh__publicMeSHNote mesh__D012323 83   
% 207.86/208.11  |- skos__historyNote mesh__D012323 Transcription, Genetic %28%1973-1982%29%
% 207.86/208.11  |- skos__hiddenLabel mesh__D012323 RNA Modifications, Post-Transcriptional
% 207.86/208.11  |- mesh__activeMeSHYear mesh__D012323 2005
% 207.86/208.11  |- mesh__dateCreated mesh__D012323 1982-04-23
% 207.86/208.11  |- skos__altLabel mesh__D012323 Post-Transcriptional RNA Modification
% 207.86/208.11  |- skos__broader mesh__D012323smesh__D008660
% 207.86/208.11  |- skos__hiddenLabel mesh__D012323 Modification, Post-Transcriptional RNA
% 207.86/208.11  |- skos__hiddenLabel mesh__D012323 Modifications, Post-Transcriptional RNA
% 207.86/208.11  |- skos__historyNote mesh__D012323
% 207.86/208.11       Nucleic Acid Precursors %28%1975-1982%29%
% 207.86/208.11  |- mesh__activeMeSHYear mesh__D012323 2006
% 207.86/208.11  |- skos__hiddenLabel mesh__D012323 Processing, Posttranscriptional RNA
% 207.86/208.11  |- skos__altLabel mesh__D012323 RNA Processing, Post Transcriptional
% 207.86/208.11  |- skos__prefLabel mesh__D012323 RNA Processing, Post-Transcriptional
% 207.86/208.11  |- skos__hiddenLabel mesh__D012323 Post Transcriptional RNA Processing
% 207.86/208.11  |- skos__altLabel mesh__D012323 Post-Transcriptional RNA Processing
% 207.86/208.11  |- mesh__recordAuthorizer mesh__D012323 sjn
% 207.86/208.11  |- skos__hiddenLabel mesh__D012323 RNA Modification, Post-Transcriptional
% 207.86/208.11  |- skos__hiddenLabel mesh__D012323 Post-Transcriptional RNA Modifications
% 207.86/208.11  |- skos__altLabel mesh__D031288 Pea, Partridge
% 207.86/208.11  |- mesh__publicMeSHNote mesh__D031288 2003   
% 207.86/208.11  |- mesh__recordAuthorizer mesh__D031288 ags
% 207.86/208.11  |- mesh__dateEstablished mesh__D031288 2003-01-01
% 207.86/208.11  |- mesh__recordOriginator mesh__D031288 ssb
% 207.86/208.11  |- skos__broader mesh__D031288smesh__D007887
% 207.86/208.11  |- mesh__dateRevised mesh__D031288 2005-07-29
% 207.86/208.11  |- skos__altLabel mesh__D031288 Pea, Sensitive
% 207.86/208.11  |- mesh__activeMeSHYear mesh__D031288 2006
% 207.86/208.11  |- mesh__historyNote mesh__D031288 2003   
% 207.86/208.11  |- mesh__dateCreated mesh__D031288 2002-07-03
% 207.86/208.11  |- skos__scopeNote mesh__D031288
% 207.86/208.11       A plant genus of the family FABACEAE. Some species were reclassified from CASSIA and Senna.%A%    
% 207.86/208.11  |- mesh__recordMaintainer mesh__D031288 ags
% 207.86/208.11  |- mesh__activeMeSHYear mesh__D031288 2005
% 207.86/208.11  |- skos__annotation mesh__D031288
% 207.86/208.11       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.86/208.11  |- rdf__type mesh__D031288sskos__Concept
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D031288 2004
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D031288 2006A
% 207.97/208.11  |- skos__altLabel mesh__D031288 Partridgepea
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D031288 2003
% 207.97/208.11  |- skos__prefLabel mesh__D031288 Chamaecrista
% 207.97/208.11  |- skos__hiddenLabel mesh__D003597 Nucleotides, Cytosine
% 207.97/208.11  |- skos__broader mesh__D003597smesh__D011742
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D003597 2002
% 207.97/208.11  |- rdf__type mesh__D003597sskos__Concept
% 207.97/208.11  |- skos__annotation mesh__D003597 /biosyn /physiol permitted   
% 207.97/208.11  |- mesh__dateRevised mesh__D003597 1992-05-11
% 207.97/208.11  |- mesh__recordAuthorizer mesh__D003597 PLS
% 207.97/208.11  |- mesh__recordMaintainer mesh__D003597 TGC
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D003597 2001
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D003597 1997
% 207.97/208.11  |- mesh__dateCreated mesh__D003597 1999-01-01
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D003597 1999
% 207.97/208.11  |- skos__hiddenLabel mesh__D003597 Phosphates, Cytidine
% 207.97/208.11  |- skos__broader mesh__D003597smesh__D012265
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D003597 2004
% 207.97/208.11  |- skos__altLabel mesh__D003597 Cytidine Phosphates
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D003597 1993
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D003597 2006
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D003597 2000
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D003597 1996
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D003597 1995
% 207.97/208.11  |- skos__prefLabel mesh__D003597 Cytosine Nucleotides
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D003597 1998
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D003597 2003
% 207.97/208.11  |- mesh__recordOriginator mesh__D003597 NLM
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D003597 1994
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D003597 2005
% 207.97/208.11  |- mesh__dateEstablished mesh__D044405 2004-01-01
% 207.97/208.11  |- skos__hiddenLabel mesh__D044405 Receptor, Serotonin 2C
% 207.97/208.11  |- mesh__historyNote mesh__D044405
% 207.97/208.11       2004; use RECEPTOR, SEROTONIN, 5-HT2C %28%NM%29% 1994-2003   
% 207.97/208.11  |- skos__altLabel mesh__D044405 Serotonin 2C Receptor
% 207.97/208.11  |- mesh__dateCreated mesh__D044405 2003-07-09
% 207.97/208.11  |- mesh__recordMaintainer mesh__D044405 jmp
% 207.97/208.11  |- skos__prefLabel mesh__D044405 Receptor, Serotonin, 5-HT2C
% 207.97/208.11  |- skos__broader mesh__D044405smesh__D044348
% 207.97/208.11  |- mesh__publicMeSHNote mesh__D044405
% 207.97/208.11       2004; SEROTONIN 2C RECEPTOR %28%now RECEPTOR, SEROTONIN, 5-HTC%29% was indexed under RECEPTORS, SEROTONIN 1994-2003%A%  
% 207.97/208.11  |- skos__hiddenLabel mesh__D044405 5 HT2C Receptor
% 207.97/208.11  |- skos__hiddenLabel mesh__D044405 Receptor, 5-HT2C
% 207.97/208.11  |- skos__altLabel mesh__D044405 Receptor, 5-Hydroxytryptamine Type 2C
% 207.97/208.11  |- mesh__recordAuthorizer mesh__D044405 sjn
% 207.97/208.11  |- skos__scopeNote mesh__D044405
% 207.97/208.11       A serotonin receptor subtype found primarily in the CENTRAL NERVOUS SYSTEM and the CHOROID PLEXUS. This receptor subtype is believed to mediate the anorectic action of SEROTONIN, while selective antagonists of the 5-HT2C receptor appear to induce ANXIETY. Several isoforms of this receptor subtype exist, due to adenine deaminase editing of the receptor mRNA.%A%    
% 207.97/208.11  |- skos__hiddenLabel mesh__D044405 5 Hydroxytryptamine Type 2C Receptors
% 207.97/208.11  |- skos__altLabel mesh__D044405 5-HT2C Receptor
% 207.97/208.11  |- mesh__recordOriginator mesh__D044405 jmp
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D044405 2006
% 207.97/208.11  |- skos__altLabel mesh__D044405 5-HT%28%2C%29% Receptor
% 207.97/208.11  |- rdf__type mesh__D044405sskos__Concept
% 207.97/208.11  |- skos__historyNote mesh__D044405 Receptors, Serotonin %28%1994-2003%29%
% 207.97/208.11  |- mesh__dateRevised mesh__D044405 2005-06-30
% 207.97/208.11  |- skos__hiddenLabel mesh__D044405 5 Hydroxytryptamine Type 2C Receptor
% 207.97/208.11  |- skos__altLabel mesh__D044405 5-Hydroxytryptamine Type 2C Receptor
% 207.97/208.11  |- skos__altLabel mesh__D044405 5-Hydroxytryptamine Type 2C Receptors
% 207.97/208.11  |- skos__hiddenLabel mesh__D044405 2C Receptor, Serotonin
% 207.97/208.11  |- skos__hiddenLabel mesh__D044405 Receptor, 5 Hydroxytryptamine Type 2C
% 207.97/208.11  |- skos__hiddenLabel mesh__D008282 Mainstreamings %28%Education%29%
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D008282 1994
% 207.97/208.11  |- skos__broader mesh__D008282smesh__D004519
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D008282 2002
% 207.97/208.11  |- mesh__dateRevised mesh__D008282 1992-05-14
% 207.97/208.11  |- mesh__dateEstablished mesh__D008282 1987-01-01
% 207.97/208.11  |- mesh__dateCreated mesh__D008282 1986-04-15
% 207.97/208.11  |- skos__scopeNote mesh__D008282
% 207.97/208.11       Most frequently refers to the integration of a physically or mentally disabled child into the regular class of normal peers and provision of the appropriately determined educational program.%A%    
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D008282 2001
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D008282 2004
% 207.97/208.11  |- skos__historyNote mesh__D008282
% 207.97/208.11       Education, Special/trends %28%1968-1986%29%
% 207.97/208.11  |- skos__annotation mesh__D008282 DF: MAINSTREAMING   
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D008282 2000
% 207.97/208.11  |- mesh__recordMaintainer mesh__D008282 TGC
% 207.97/208.11  |- mesh__historyNote mesh__D008282 87   
% 207.97/208.11  |- skos__broader mesh__D008282smesh__D003479
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D008282 2003
% 207.97/208.11  |- mesh__recordOriginator mesh__D008282 EC
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D008282 2006
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D008282 1997
% 207.97/208.11  |- mesh__publicMeSHNote mesh__D008282 87   
% 207.97/208.11  |- skos__hiddenLabel mesh__D008282 Mainstreamings
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D008282 1993
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D008282 2005
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D008282 1996
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D008282 1999
% 207.97/208.11  |- rdf__type mesh__D008282sskos__Concept
% 207.97/208.11  |- skos__prefLabel mesh__D008282 Mainstreaming %28%Education%29%
% 207.97/208.11  |- mesh__recordAuthorizer mesh__D008282 PLS
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D008282 1995
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D008282 1998
% 207.97/208.11  |- skos__altLabel mesh__D008282 Mainstreaming
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D007988 1997
% 207.97/208.11  |- mesh__dateCreated mesh__D007988 1999-01-01
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D007988 1999
% 207.97/208.11  |- mesh__recordAuthorizer mesh__D007988 PLS
% 207.97/208.11  |- rdf__type mesh__D007988sskos__Concept
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D007988 1996
% 207.97/208.11  |- skos__annotation mesh__D007988 a republic in western Africa   
% 207.97/208.11  |- skos__scopeNote mesh__D007988
% 207.97/208.11       A republic in western Africa, south of GUINEA and east of COTE D%27%IVOIRE. Its capital is Monrovia, named for the U.S. President James Monroe. Liberia was projected as a settlement of freed American slaves by the American Colonization Society in 1817 and hence named from the Latin liber, free. In 1847 it was established as the Free and Independent Republic of Liberia. Liberia is the only black African state never to have been subjected to colonial rule. %28%From Webster%27%s New Geographical Dictionary, 1988, p668 %26% Room, Brewer%27%s Dictionary of Names, 1992, p307%29%%A%    
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D007988 2002
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D007988 1998
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D007988 2004
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D007988 2001
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D007988 2006
% 207.97/208.11  |- mesh__recordOriginator mesh__D007988 NLM
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D007988 2003
% 207.97/208.11  |- mesh__dateRevised mesh__D007988 1995-02-21
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D007988 2000
% 207.97/208.11  |- skos__prefLabel mesh__D007988 Liberia
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D007988 2005
% 207.97/208.11  |- skos__broader mesh__D007988smesh__D000354
% 207.97/208.11  |- mesh__recordMaintainer mesh__D007988 TGC
% 207.97/208.11  |- skos__annotation mesh__D032381
% 207.97/208.11       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.97/208.11  |- skos__scopeNote mesh__D032381
% 207.97/208.11       A plant genus of the family TILIACEAE. Members contain cycloartane saponins and CARDENOLIDES.%A%    
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D032381 2006
% 207.97/208.11  |- skos__prefLabel mesh__D032381 Corchorus
% 207.97/208.11  |- skos__broader mesh__D032381smesh__D029646
% 207.97/208.11  |- mesh__dateCreated mesh__D032381 2002-07-03
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D032381 2005
% 207.97/208.11  |- mesh__publicMeSHNote mesh__D032381 2003   
% 207.97/208.11  |- rdf__type mesh__D032381sskos__Concept
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D032381 2004
% 207.97/208.11  |- mesh__dateEstablished mesh__D032381 2003-01-01
% 207.97/208.11  |- mesh__historyNote mesh__D032381 2003   
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D032381 2003
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D004690 2006
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D004690 2004
% 207.97/208.11  |- mesh__recordAuthorizer mesh__D004690 sjn
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D004690 2005
% 207.97/208.11  |- rdf__type mesh__D004690sskos__Concept
% 207.97/208.11  |- skos__scopeNote mesh__D004690
% 207.97/208.11       Works containing information articles on subjects in every field of knowledge, usually arranged in alphabetical order, or a similar work limited to a special field or subject. %28%From The ALA Glossary of Library and Information Science, 1983%29%%A%    
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D004690 2001
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D004690 2003
% 207.97/208.11  |- mesh__dateCreated mesh__D004690 1999-01-01
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D004690 2000
% 207.97/208.11  |- skos__hiddenLabel mesh__D004690 Encyclopedia
% 207.97/208.11  |- skos__prefLabel mesh__D004690 Encyclopedias
% 207.97/208.11  |- mesh__dateRevised mesh__D004690 1999-11-03
% 207.97/208.11  |- skos__annotation mesh__D004690
% 207.97/208.11       do not confuse with Publication Type ENCYCLOPEDIAS; no qualif%A%  
% 207.97/208.11  |- skos__broader mesh__D004690smesh__D012013
% 207.97/208.11  |- mesh__recordMaintainer mesh__D004690 kle
% 207.97/208.11  |- mesh__recordOriginator mesh__D004690 NLM
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D004690 2002
% 207.97/208.11  |- mesh__dateEstablished mesh__D012324 1991-01-01
% 207.97/208.11  |- mesh__dateRevised mesh__D012324 2003-07-09
% 207.97/208.11  |- skos__hiddenLabel mesh__D012324 Replicase, RNA
% 207.97/208.11  |- mesh__recordMaintainer mesh__D012324 ssb
% 207.97/208.11  |- mesh__dateCreated mesh__D012324 1974-11-19
% 207.97/208.11  |- skos__historyNote mesh__D012324
% 207.97/208.11       RNA Nucleotidyltransferases %28%1969-1974%29%
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D012324 2004
% 207.97/208.11  |- skos__hiddenLabel mesh__D012324 RNA Dependent RNA Polymerase
% 207.97/208.11  |- skos__prefLabel mesh__D012324 RNA Replicase
% 207.97/208.11  |- mesh__historyNote mesh__D012324
% 207.97/208.11       91%28%75%29%; was see under RNA NUCLEOTIDYLTRANSFERASES 1975-90%A%  
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D012324 2005
% 207.97/208.11  |- mesh__publicMeSHNote mesh__D012324
% 207.97/208.11       91; was see under RNA NUCLEOTIDYLTRANSFERASES 1975-90   
% 207.97/208.11  |- skos__altLabel mesh__D012324 RNA-Dependent RNA Polymerase
% 207.97/208.11  |- skos__hiddenLabel mesh__D012324 RNA Polymerase, RNA-Directed
% 207.97/208.11  |- mesh__recordOriginator mesh__D012324 NLM
% 207.97/208.11  |- skos__hiddenLabel mesh__D012324 RNA Polymerase, RNA-Dependent
% 207.97/208.11  |- mesh__recordAuthorizer mesh__D012324 sjn
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D012324 2006
% 207.97/208.11  |- skos__hiddenLabel mesh__D012324 RNA Directed RNA Polymerase
% 207.97/208.11  |- skos__scopeNote mesh__D012324
% 207.97/208.11       An enzyme that catalyses RNA-template-directed extension of the 3%27%- end of an RNA strand by one nucleotide at a time, and can initiate a chain de novo. %28%Enzyme Nomenclature, 1992, p293%29%%A%    
% 207.97/208.11  |- skos__altLabel mesh__D012324 RNA-Directed RNA Polymerase
% 207.97/208.11  |- rdf__type mesh__D012324sskos__Concept
% 207.97/208.11  |- skos__broader mesh__D012324smesh__D012316
% 207.97/208.11  |- skos__altLabel mesh__D031289 Albizia
% 207.97/208.11  |- skos__broader mesh__D031289smesh__D007887
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D031289 2006
% 207.97/208.11  |- mesh__dateCreated mesh__D031289 2002-07-02
% 207.97/208.11  |- skos__prefLabel mesh__D031289 Albizzia
% 207.97/208.11  |- mesh__dateEstablished mesh__D031289 2003-01-01
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D031289 2005
% 207.97/208.11  |- skos__annotation mesh__D031289
% 207.97/208.11       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.97/208.11  |- skos__altLabel mesh__D031289 Silktree
% 207.97/208.11  |- skos__scopeNote mesh__D031289
% 207.97/208.11       A plant genus of the family FABACEAE that contains julibroside %28%triterpenoid saponins%29%.%A%    
% 207.97/208.11  |- rdf__type mesh__D031289sskos__Concept
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D031289 2004
% 207.97/208.11  |- mesh__historyNote mesh__D031289 2003   
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D031289 2003
% 207.97/208.11  |- mesh__publicMeSHNote mesh__D031289 2003   
% 207.97/208.11  |- rdf__type mesh__D003598sskos__Concept
% 207.97/208.11  |- mesh__dateCreated mesh__D003598 1984-06-11
% 207.97/208.11  |- skos__historyNote mesh__D003598 Cytoplasm %28%1966-1979%29%
% 207.97/208.11  |- mesh__recordOriginator mesh__D003598 RLS
% 207.97/208.11  |- mesh__dateEstablished mesh__D003598 1985-01-01
% 207.97/208.11  |- skos__broader mesh__D003598smesh__D011506
% 207.97/208.11  |- skos__annotation mesh__D003598
% 207.97/208.11       /biosyn /drug eff /physiol permitted; do not use /analogs%A%  
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D003598 2006
% 207.97/208.11  |- skos__prefLabel mesh__D003598 Cytoskeletal Proteins
% 207.97/208.11  |- mesh__dateRevised mesh__D003598 2005-06-30
% 207.97/208.11  |- skos__scopeNote mesh__D003598
% 207.97/208.11       Major constituent of the cytoskeleton found in the cytoplasm of eukaryotic cells. They form a flexible framework for the cell, provide attachment points for organelles and formed bodies, and make communication between parts of the cell possible.%A%    
% 207.97/208.11  |- mesh__publicMeSHNote mesh__D003598 85   
% 207.97/208.11  |- mesh__historyNote mesh__D003598 85   
% 207.97/208.11  |- skos__hiddenLabel mesh__D003598 Proteins, Cytoskeletal
% 207.97/208.11  |- mesh__recordAuthorizer mesh__D003598 sjn
% 207.97/208.11  |- skos__historyNote mesh__D003598 Cytoskeleton %28%1977-1984%29%
% 207.97/208.11  |- mesh__recordMaintainer mesh__D003598 SYSTEM
% 207.97/208.11  |- skos__historyNote mesh__D003598
% 207.97/208.11       Proteins or specific proteins %28%1966-1984%29%
% 207.97/208.11  |- skos__prefLabel mesh__D044406 Receptors, Serotonin, 5-HT3
% 207.97/208.11  |- mesh__recordMaintainer mesh__D044406 jmp
% 207.97/208.11  |- skos__altLabel mesh__D044406 5-HT3B Receptor
% 207.97/208.11  |- skos__broader mesh__D044406smesh__D011985
% 207.97/208.11  |- skos__hiddenLabel mesh__D044406 Receptor, 5-HT3A
% 207.97/208.11  |- mesh__historyNote mesh__D044406
% 207.97/208.11       2004; use RECEPTORS, SEROTONIN, 5-HT3 %28%NM%29% 1995-2003   
% 207.97/208.11  |- skos__hiddenLabel mesh__D044406 5 HT3A Receptor
% 207.97/208.11  |- mesh__dateEstablished mesh__D044406 2004-01-01
% 207.97/208.11  |- skos__altLabel mesh__D044406 5-Hydroxytryptamine-3 Receptor
% 207.97/208.11  |- skos__scopeNote mesh__D044406
% 207.97/208.11       A subclass of serotonin receptors that form cation channels and mediate signal transduction by depolarizing the cell membrane. The cation channels are formed from 5 receptor subunits. When stimulated the receptors and allow the selective passage of SODIUM; POTASSIUM; and CALCIUM.%A%    
% 207.97/208.11  |- mesh__publicMeSHNote mesh__D044406
% 207.97/208.11       2004; SEROTONIN 3 RECEPTOR %28%now RECEPTORS, SEROTONIN, 5-HT3%29% was indexed under RECEPTORS, SEROTONIN 1995-2003%A%  
% 207.97/208.11  |- skos__hiddenLabel mesh__D044406 Receptors, Serotonin 3
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D044406 2006
% 207.97/208.11  |- rdf__type mesh__D044406sskos__Concept
% 207.97/208.11  |- skos__hiddenLabel mesh__D044406 5 HT3 Receptor
% 207.97/208.11  |- skos__altLabel mesh__D044406 Receptor, Serotonin 3
% 207.97/208.11  |- skos__hiddenLabel mesh__D044406 Receptor, 5-Hydroxytryptamine-3
% 207.97/208.11  |- skos__altLabel mesh__D044406 5-HT3A Receptor
% 207.97/208.11  |- skos__hiddenLabel mesh__D044406 Receptor, 5-HT3
% 207.97/208.11  |- skos__altLabel mesh__D044406 5-HT3 Receptor
% 207.97/208.11  |- mesh__recordAuthorizer mesh__D044406 sjn
% 207.97/208.11  |- skos__hiddenLabel mesh__D044406 5 Hydroxytryptamine 3 Receptor
% 207.97/208.11  |- skos__altLabel mesh__D044406 Serotonin 3 Receptor
% 207.97/208.11  |- mesh__recordOriginator mesh__D044406 jmp
% 207.97/208.11  |- skos__historyNote mesh__D044406 Receptors, Serotonin %28%1995-2003%29%
% 207.97/208.11  |- skos__altLabel mesh__D044406 Serotonin 3 Receptors
% 207.97/208.11  |- mesh__dateRevised mesh__D044406 2005-06-30
% 207.97/208.11  |- mesh__dateCreated mesh__D044406 2003-07-09
% 207.97/208.11  |- skos__hiddenLabel mesh__D044406 Receptor, 5-HT3B
% 207.97/208.11  |- skos__hiddenLabel mesh__D044406 5 HT3B Receptor
% 207.97/208.11  |- skos__annotation mesh__D008283
% 207.97/208.11       %22%upkeep of property or equipment%22%; NIM   
% 207.97/208.11  |- mesh__dateEstablished mesh__D008283 1973-01-01
% 207.97/208.11  |- mesh__publicMeSHNote mesh__D008283 73   
% 207.97/208.11  |- mesh__recordAuthorizer mesh__D008283 sjn
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D008283 2004
% 207.97/208.11  |- skos__hiddenLabel mesh__D008283 Maintenances
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D008283 2002
% 207.97/208.11  |- mesh__recordMaintainer mesh__D008283 TGC
% 207.97/208.11  |- skos__scopeNote mesh__D008283 The upkeep of property or equipment.     
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D008283 2003
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D008283 2006
% 207.97/208.11  |- skos__prefLabel mesh__D008283 Maintenance
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D008283 2001
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D008283 2005
% 207.97/208.11  |- mesh__dateRevised mesh__D008283 1999-11-05
% 207.97/208.11  |- mesh__historyNote mesh__D008283 73   
% 207.97/208.11  |- rdf__type mesh__D008283sskos__Concept
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D008283 2000
% 207.97/208.11  |- skos__broader mesh__D008283smesh__D005159
% 207.97/208.11  |- mesh__dateCreated mesh__D008283 1999-01-01
% 207.97/208.11  |- mesh__recordOriginator mesh__D008283 NLM
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D016715 2002
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D016715 2005
% 207.97/208.11  |- skos__historyNote mesh__D016715 Neurofibromatosis 1 %28%1979-1990%29%
% 207.97/208.11  |- skos__broader mesh__D016715smesh__D009378
% 207.97/208.11  |- mesh__recordAuthorizer mesh__D016715 sjn
% 207.97/208.11  |- mesh__dateCreated mesh__D016715 1991-06-21
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D016715 2006
% 207.97/208.11  |- mesh__dateEstablished mesh__D016715 1992-01-01
% 207.97/208.11  |- skos__prefLabel mesh__D016715 Proteus Syndrome
% 207.97/208.11  |- mesh__dateRevised mesh__D016715 1999-11-03
% 207.97/208.11  |- skos__broader mesh__D016715smesh__D000015
% 207.97/208.11  |- rdf__type mesh__D016715sskos__Concept
% 207.97/208.11  |- mesh__recordMaintainer mesh__D016715 kle
% 207.97/208.11  |- mesh__recordOriginator mesh__D016715 AGS
% 207.97/208.11  |- skos__historyNote mesh__D016715
% 207.97/208.11       Abnormalities, Multiple %28%1979-1991%29%
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D016715 2000
% 207.97/208.11  |- skos__broader mesh__D016715smesh__D017880
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D016715 2003
% 207.97/208.11  |- skos__broader mesh__D016715smesh__D006222
% 207.97/208.11  |- mesh__historyNote mesh__D016715 92   
% 207.97/208.11  |- mesh__publicMeSHNote mesh__D016715 92   
% 207.97/208.11  |- skos__scopeNote mesh__D016715
% 207.97/208.11       Hamartoneoplastic malformation syndrome of uncertain etiology characterized by partial gigantism of the hands and/or feet, asymmetry of the limbs, plantar hyperplasia, hemangiomas, lipomas, lymphangiomas, epidermal nevi, macrocephaly, cranial hyperostoses, and long-bone overgrowth. Joseph Merrick, the so-called %22%elephant man%22%, apparently suffered from Proteus syndrome and not neurofibromatosis, a disorder with similar characteristics.%A%    
% 207.97/208.11  |- skos__broader mesh__D016715smesh__D001848
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D016715 2001
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D016715 2004
% 207.97/208.11  |- skos__historyNote mesh__D016715
% 207.97/208.11       Neoplasms, Multiple Primary %28%1986-1991%29%
% 207.97/208.11  |- skos__annotation mesh__D016715
% 207.97/208.11       hamartomas %26% multiple abnorm; %22%Proteus%22% refers to the sea god in Greek mythol who could assume many forms; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 207.97/208.11  |- skos__altLabel mesh__D016715 Elephant Man Disease
% 207.97/208.11  |- mesh__dateRevised mesh__D007989 1992-03-25
% 207.97/208.11  |- mesh__historyNote mesh__D007989 68   
% 207.97/208.11  |- mesh__recordOriginator mesh__D007989 NLM
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D007989 1994
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D007989 2004
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D007989 2000
% 207.97/208.11  |- mesh__activeMeSHYear mesh__D007989 2006
% 207.97/208.11  |- mesh__recordMaintainer mesh__D007989 PLS
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D007989 2003
% 207.97/208.12  |- skos__scopeNote mesh__D007989
% 207.97/208.12       The psychic drive or energy associated with sexual instinct in the broad sense %28%pleasure and love-object seeking%29%. It may also connote the psychic energy associated with instincts in general that motivate behavior.%A%    
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D007989 2005
% 207.97/208.12  |- skos__prefLabel mesh__D007989 Libido
% 207.97/208.12  |- mesh__recordAuthorizer mesh__D007989 PLS
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D007989 1997
% 207.97/208.12  |- skos__hiddenLabel mesh__D007989 Libido, Increased
% 207.97/208.12  |- skos__hiddenLabel mesh__D007989 Libido, Decreased
% 207.97/208.12  |- mesh__dateCreated mesh__D007989 1999-01-01
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D007989 2002
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D007989 1999
% 207.97/208.12  |- mesh__publicMeSHNote mesh__D007989 68   
% 207.97/208.12  |- skos__broader mesh__D007989smesh__D011574
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D007989 1993
% 207.97/208.12  |- rdf__type mesh__D007989sskos__Concept
% 207.97/208.12  |- mesh__dateEstablished mesh__D007989 1968-01-01
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D007989 1996
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D007989 1995
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D007989 2001
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D007989 1998
% 207.97/208.12  |- skos__annotation mesh__D032382
% 207.97/208.12       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.97/208.12  |- mesh__dateEstablished mesh__D032382 2003-01-01
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D032382 2006
% 207.97/208.12  |- skos__broader mesh__D032382smesh__D029646
% 207.97/208.12  |- mesh__historyNote mesh__D032382 2003   
% 207.97/208.12  |- mesh__publicMeSHNote mesh__D032382 2003   
% 207.97/208.12  |- rdf__type mesh__D032382sskos__Concept
% 207.97/208.12  |- skos__prefLabel mesh__D032382 Grewia
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D032382 2003
% 207.97/208.12  |- mesh__dateCreated mesh__D032382 2002-07-03
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D032382 2004
% 207.97/208.12  |- skos__altLabel mesh__D032382 Dhaman Tree
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D032382 2005
% 207.97/208.12  |- skos__scopeNote mesh__D032382
% 207.97/208.12       A plant genus of the family TILIACEAE. Members contain lupeol and betulin TRITERPENES.%A%    
% 207.97/208.12  |- rdf__type mesh__D004691sskos__Concept
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004691 2005
% 207.97/208.12  |- mesh__publicMeSHNote mesh__D004691 67   
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004691 2002
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004691 2003
% 207.97/208.12  |- mesh__dateRevised mesh__D004691 1997-06-20
% 207.97/208.12  |- mesh__dateCreated mesh__D004691 1999-01-01
% 207.97/208.12  |- skos__annotation mesh__D004691
% 207.97/208.12       do not use /util except by MeSH definition   
% 207.97/208.12  |- skos__broader mesh__D004691smesh__D014656
% 207.97/208.12  |- mesh__dateEstablished mesh__D004691 1967-01-01
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004691 2001
% 207.97/208.12  |- mesh__recordMaintainer mesh__D004691 PXP
% 207.97/208.12  |- skos__related mesh__D004691smesh__D017073
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004691 2000
% 207.97/208.12  |- skos__prefLabel mesh__D004691 Endarterectomy
% 207.97/208.12  |- skos__hiddenLabel mesh__D004691 Endarterectomies
% 207.97/208.12  |- skos__related mesh__D004691smesh__D017130
% 207.97/208.12  |- skos__scopeNote mesh__D004691
% 207.97/208.12       Surgical excision, performed under general anesthesia, of the atheromatous tunica intima of an artery. When reconstruction of an artery is performed as an endovascular procedure through a catheter, it is called ATHERECTOMY.%A%    
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004691 1999
% 207.97/208.12  |- skos__hiddenLabel mesh__D004691 Thromboendarterectomies
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004691 2006
% 207.97/208.12  |- mesh__historyNote mesh__D004691 67%28%65%29%   
% 207.97/208.12  |- mesh__recordAuthorizer mesh__D004691 SJN
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004691 2004
% 207.97/208.12  |- mesh__recordOriginator mesh__D004691 NLM
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004691 1998
% 207.97/208.12  |- mesh__dateRevised mesh__D017010 1992-05-18
% 207.97/208.12  |- skos__hiddenLabel mesh__D017010 Reminder System
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D017010 2006
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D017010 1998
% 207.97/208.12  |- skos__scopeNote mesh__D017010
% 207.97/208.12       Systems used to prompt or aid the memory. The systems can be computerized reminders, color coding, telephone calls, or devices such as letters and postcards.%A%    
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D017010 1997
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D017010 2005
% 207.97/208.12  |- skos__prefLabel mesh__D017010 Reminder Systems
% 207.97/208.12  |- rdf__type mesh__D017010sskos__Concept
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D017010 2002
% 207.97/208.12  |- mesh__publicMeSHNote mesh__D017010 92   
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D017010 2004
% 207.97/208.12  |- mesh__historyNote mesh__D017010 92   
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D017010 1996
% 207.97/208.12  |- mesh__recordMaintainer mesh__D017010 TAP
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D017010 1995
% 207.97/208.12  |- skos__broader mesh__D017010smesh__D003142
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D017010 2001
% 207.97/208.12  |- mesh__recordAuthorizer mesh__D017010 PLS
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D017010 2003
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D017010 2000
% 207.97/208.12  |- mesh__dateEstablished mesh__D017010 1992-01-01
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D017010 1994
% 207.97/208.12  |- mesh__recordOriginator mesh__D017010 MXR
% 207.97/208.12  |- mesh__dateCreated mesh__D017010 1991-05-30
% 207.97/208.12  |- skos__broader mesh__D017010smesh__D007256
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D017010 1993
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D017010 1999
% 207.97/208.12  |- skos__hiddenLabel mesh__D017010 System, Reminder
% 207.97/208.12  |- skos__hiddenLabel mesh__D017010 Systems, Reminder
% 207.97/208.12  |- mesh__dateRevised mesh__D003599 2003-07-09
% 207.97/208.12  |- mesh__historyNote mesh__D003599
% 207.97/208.12       86; was CYTOPLASMIC FILAMENTS 1980-85; was MICROFILAMENTS see under CYTOPLASM 1977-79%A%  
% 207.97/208.12  |- skos__hiddenLabel mesh__D003599 Filament, Cytoskeletal
% 207.97/208.12  |- mesh__recordAuthorizer mesh__D003599 sjn
% 207.97/208.12  |- mesh__onlineNote mesh__D003599
% 207.97/208.12       use CYTOSKELETON to search CYTOPLASMIC FILAMENTS 1977-85   
% 207.97/208.12  |- skos__broader mesh__D003599smesh__D022083
% 207.97/208.12  |- skos__hiddenLabel mesh__D003599 Cytoplasmic Filament
% 207.97/208.12  |- skos__hiddenLabel mesh__D003599 Filaments, Cytoplasmic
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D003599 2005
% 207.97/208.12  |- skos__hiddenLabel mesh__D003599 Filaments, Cytoskeletal
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D003599 2004
% 207.97/208.12  |- mesh__dateCreated mesh__D003599 1976-05-19
% 207.97/208.12  |- skos__historyNote mesh__D003599 Cellular Inclusions %28%1970-1976%29%
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D003599 2006
% 207.97/208.12  |- mesh__recordMaintainer mesh__D003599 nns
% 207.97/208.12  |- skos__hiddenLabel mesh__D003599 Lattice, Microtrabecular
% 207.97/208.12  |- skos__historyNote mesh__D003599 Organoids %28%1966-1976%29%
% 207.97/208.12  |- skos__hiddenLabel mesh__D003599 Filament, Cytoplasmic
% 207.97/208.12  |- mesh__dateEstablished mesh__D003599 1980-01-01
% 207.97/208.12  |- skos__annotation mesh__D003599
% 207.97/208.12       A 11 qualif except /cytol; /genet permitted   
% 207.97/208.12  |- skos__historyNote mesh__D003599 Cytoplasm %28%1966-1976%29%
% 207.97/208.12  |- mesh__publicMeSHNote mesh__D003599
% 207.97/208.12       86; was CYTOPLASMIC FILAMENTS 1980-85; was MICROFILAMENTS see under CYTOPLASM 1977-79%A%  
% 207.97/208.12  |- skos__scopeNote mesh__D003599
% 207.97/208.12       The network of filaments, tubules, and interconnecting filamentous bridges which give shape, structure, and organization to the cytoplasm.%A%    
% 207.97/208.12  |- mesh__recordOriginator mesh__D003599 VDK
% 207.97/208.12  |- skos__hiddenLabel mesh__D003599 Microtrabecular Lattices
% 207.97/208.12  |- skos__hiddenLabel mesh__D003599 Lattices, Microtrabecular
% 207.97/208.12  |- skos__related mesh__D003599smesh__D003598
% 207.97/208.12  |- skos__prefLabel mesh__D003599 Cytoskeleton
% 207.97/208.12  |- rdf__type mesh__D003599sskos__Concept
% 207.97/208.12  |- skos__hiddenLabel mesh__D003599 Cytoskeletons
% 207.97/208.12  |- skos__hiddenLabel mesh__D003599 Cytoskeletal Filament
% 207.97/208.12  |- mesh__recordAuthorizer mesh__D008284 PLS
% 207.97/208.12  |- mesh__recordMaintainer mesh__D008284 TGC
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D008284 2005
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D008284 1996
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D008284 2004
% 207.97/208.12  |- mesh__recordOriginator mesh__D008284 NLM
% 207.97/208.12  |- skos__prefLabel mesh__D008284 Maintenance and Engineering, Hospital
% 207.97/208.12  |- mesh__historyNote mesh__D008284
% 207.97/208.12       80; was MAINTENANCE, HOSPITAL 1978-79; was HOSPITAL MAINTENANCE 1963-77%A%  
% 207.97/208.12  |- skos__broader mesh__D008284smesh__D006748
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D008284 2002
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D008284 1998
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D008284 2006
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D008284 1997
% 207.97/208.12  |- mesh__dateCreated mesh__D008284 1999-01-01
% 207.97/208.12  |- skos__altLabel mesh__D008284 Engineering, Hospital
% 207.97/208.12  |- skos__altLabel mesh__D008284 Hospital Landscaping
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D008284 1994
% 207.97/208.12  |- skos__annotation mesh__D008284
% 207.97/208.12       DF: MAINTENANCE HOSP or MAINTENANCE HOSPITAL   
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D008284 1993
% 207.97/208.12  |- skos__altLabel mesh__D008284 Groundskeeping, Hospital
% 207.97/208.12  |- rdf__type mesh__D008284sskos__Concept
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D008284 1999
% 207.97/208.12  |- mesh__onlineNote mesh__D008284
% 207.97/208.12       use MAINTENANCE AND ENGINEERING, HOSPITAL to search MAINTENANCE, HOSPITAL 1978-79 %26% HOSPITAL MAINTENANCE 1966-77%A%  
% 207.97/208.12  |- skos__scopeNote mesh__D008284
% 207.97/208.12       Hospital department whose primary function is the upkeep and supervision of the buildings and grounds and the maintenance of hospital physical plant and equipment which requires engineering expertise.%A%    
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D008284 2000
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D008284 1995
% 207.97/208.12  |- skos__altLabel mesh__D008284 Hospital Maintenance and Engineering
% 207.97/208.12  |- mesh__dateRevised mesh__D008284 1992-05-14
% 207.97/208.12  |- skos__broader mesh__D008284smesh__D008283
% 207.97/208.12  |- skos__altLabel mesh__D008284 Maintenance, Hospital
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D008284 2001
% 207.97/208.12  |- mesh__publicMeSHNote mesh__D008284
% 207.97/208.12       80; was MAINTENANCE, HOSPITAL 1978-79; was HOSPITAL MAINTENANCE 1963-77%A%  
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D008284 2003
% 207.97/208.12  |- skos__scopeNote mesh__D016716
% 207.97/208.12       A CELL LINE derived from a PHEOCHROMOCYTOMA of the rat ADRENAL MEDULLA. PC12 cells stop dividing and undergo terminal differentiation when treated with NERVE GROWTH FACTOR, making the line a useful model system for NERVE CELL differentiation.%A%    
% 207.97/208.12  |- skos__altLabel mesh__D016716 Pheochromocytoma Cell Line
% 207.97/208.12  |- skos__broader mesh__D016716smesh__D045744
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D016716 2006
% 207.97/208.12  |- skos__hiddenLabel mesh__D016716 Cell Lines, Pheochromocytoma
% 207.97/208.12  |- rdf__type mesh__D016716sskos__Concept
% 207.97/208.12  |- skos__historyNote mesh__D016716 Cell Line %28%1976-1991%29%
% 207.97/208.12  |- skos__historyNote mesh__D016716 Tumor Cells, Cultured %28%1987-1991%29%
% 207.97/208.12  |- skos__hiddenLabel mesh__D016716 Cell Line, Pheochromocytoma
% 207.97/208.12  |- skos__historyNote mesh__D016716 Clone Cells %28%1977-1987%29%
% 207.97/208.12  |- skos__hiddenLabel mesh__D016716 Pheochromocytoma Cell Lines
% 207.97/208.12  |- mesh__dateRevised mesh__D016716 2003-07-09
% 207.97/208.12  |- mesh__recordAuthorizer mesh__D016716 sjn
% 207.97/208.12  |- mesh__dateEstablished mesh__D016716 1992-01-01
% 207.97/208.12  |- mesh__historyNote mesh__D016716 92   
% 207.97/208.12  |- skos__annotation mesh__D016716
% 207.97/208.12       PC stands for PheochromoCytoma; almost always NIM with no subheadings; check ANIMAL; %26% RATS; do not routinely add PHEOCHROMOCYTOMA or ADRENAL GLAND NEOPLASMS%A%  
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D016716 2004
% 207.97/208.12  |- skos__prefLabel mesh__D016716 PC12 Cells
% 207.97/208.12  |- mesh__dateCreated mesh__D016716 1991-02-11
% 207.97/208.12  |- mesh__recordOriginator mesh__D016716 AGS
% 207.97/208.12  |- mesh__recordMaintainer mesh__D016716 nns
% 207.97/208.12  |- skos__broader mesh__D016716smesh__D019439
% 207.97/208.12  |- skos__hiddenLabel mesh__D016716 PC12 Cell
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D016716 2005
% 207.97/208.12  |- mesh__publicMeSHNote mesh__D016716 92   
% 207.97/208.12  |- skos__scopeNote mesh__D032383
% 207.97/208.12       Striated muscle cells found in the heart. They are derived from cardiac myoblasts %28%MYOBLASTS, CARDIAC%29%.%A%    
% 207.97/208.12  |- skos__hiddenLabel mesh__D032383 Cells, Heart Muscle
% 207.97/208.12  |- skos__hiddenLabel mesh__D032383 Cells, Cardiac Muscle
% 207.97/208.12  |- skos__hiddenLabel mesh__D032383 Muscle Cell, Heart
% 207.97/208.12  |- skos__hiddenLabel mesh__D032383 Cardiac Myocytes
% 207.97/208.12  |- skos__hiddenLabel mesh__D032383 Heart Muscle Cells
% 207.97/208.12  |- skos__hiddenLabel mesh__D032383 Myocyte, Cardiac
% 207.97/208.12  |- mesh__dateEstablished mesh__D032383 2003-01-01
% 207.97/208.12  |- skos__hiddenLabel mesh__D032383 Cell, Heart Muscle
% 207.97/208.12  |- mesh__publicMeSHNote mesh__D032383 2003   
% 207.97/208.12  |- rdf__type mesh__D032383sskos__Concept
% 207.97/208.12  |- skos__altLabel mesh__D032383 Muscle Cells, Cardiac
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D032383 2003
% 207.97/208.12  |- skos__related mesh__D032383smesh__D009210
% 207.97/208.12  |- mesh__historyNote mesh__D032383 2003   
% 207.97/208.12  |- skos__altLabel mesh__D032383 Muscle Cells, Heart
% 207.97/208.12  |- skos__hiddenLabel mesh__D032383 Heart Muscle Cell
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D032383 2004
% 207.97/208.12  |- skos__hiddenLabel mesh__D032383 Muscle Cell, Cardiac
% 207.97/208.12  |- skos__hiddenLabel mesh__D032383 Cardiac Muscle Cell
% 207.97/208.12  |- skos__hiddenLabel mesh__D032383 Cell, Cardiac Muscle
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D032383 2005
% 207.97/208.12  |- skos__historyNote mesh__D032383 Myocardium/cytology %28%1968-2002%29%
% 207.97/208.12  |- skos__hiddenLabel mesh__D032383 Cardiac Myocyte
% 207.97/208.12  |- skos__hiddenLabel mesh__D032383 Cardiac Muscle Cells
% 207.97/208.12  |- skos__broader mesh__D032383smesh__D032342
% 207.97/208.12  |- skos__related mesh__D032383smesh__D032386
% 207.97/208.12  |- skos__prefLabel mesh__D032383 Myocytes, Cardiac
% 207.97/208.12  |- mesh__dateCreated mesh__D032383 2002-07-03
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D032383 2006
% 207.97/208.12  |- rdf__type mesh__D004692sskos__Concept
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004692 2002
% 207.97/208.12  |- skos__scopeNote mesh__D004692
% 207.97/208.12       Inflammation of the tunica intima of an artery. %28%Dorland, 27th ed%29%%A%    
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004692 1994
% 207.97/208.12  |- mesh__recordOriginator mesh__D004692 NLM
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004692 1995
% 207.97/208.12  |- skos__hiddenLabel mesh__D004692 Endarteritides
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004692 1998
% 207.97/208.12  |- skos__annotation mesh__D004692 inflamm of the intima of an artery   
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004692 2000
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004692 2005
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004692 1996
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004692 2003
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004692 1999
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004692 2006
% 207.97/208.12  |- mesh__dateCreated mesh__D004692 1999-01-01
% 207.97/208.12  |- skos__prefLabel mesh__D004692 Endarteritis
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004692 1997
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004692 2004
% 207.97/208.12  |- mesh__recordMaintainer mesh__D004692 TAP
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004692 2001
% 207.97/208.12  |- mesh__dateRevised mesh__D004692 1993-06-02
% 207.97/208.12  |- mesh__recordAuthorizer mesh__D004692 PLS
% 207.97/208.12  |- skos__broader mesh__D004692smesh__D001167
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D012326 2005
% 207.97/208.12  |- skos__historyNote mesh__D012326 Base Sequence %28%1976-1981%29%
% 207.97/208.12  |- skos__historyNote mesh__D012326 RNA, Messenger %28%1976-1981%29%
% 207.97/208.12  |- skos__hiddenLabel mesh__D012326 RNA Splicings
% 207.97/208.12  |- skos__scopeNote mesh__D012326
% 207.97/208.12       The ultimate exclusion of nonsense sequences or intervening sequences %28%introns%29% before the final RNA transcript is sent to the cytoplasm.%A%    
% 207.97/208.12  |- mesh__dateEstablished mesh__D012326 1982-01-01
% 207.97/208.12  |- mesh__recordMaintainer mesh__D012326 nns
% 207.97/208.12  |- mesh__historyNote mesh__D012326 82   
% 207.97/208.12  |- skos__annotation mesh__D012326
% 207.97/208.12       note category: a physiol process taking place within the cell nucleus; do not confuse with DNA, RECOMBINANT; CLONING, MOLECULAR or GENETIC INTERVENTION%A%  
% 207.97/208.12  |- mesh__publicMeSHNote mesh__D012326 82   
% 207.97/208.12  |- mesh__recordAuthorizer mesh__D012326 sjn
% 207.97/208.12  |- skos__related mesh__D012326smesh__D012322
% 207.97/208.12  |- skos__related mesh__D012326smesh__D017381
% 207.97/208.12  |- skos__historyNote mesh__D012326
% 207.97/208.12       Nucleic Acid Precursors %28%1976-1981%29%
% 207.97/208.12  |- mesh__dateRevised mesh__D012326 2004-07-07
% 207.97/208.12  |- skos__prefLabel mesh__D012326 RNA Splicing
% 207.97/208.12  |- skos__altLabel mesh__D012326 Splicing, RNA
% 207.97/208.12  |- skos__hiddenLabel mesh__D012326 Splicings, RNA
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D012326 2006
% 207.97/208.12  |- mesh__recordOriginator mesh__D012326 AEP
% 207.97/208.12  |- skos__broader mesh__D012326smesh__D012323
% 207.97/208.12  |- rdf__type mesh__D012326sskos__Concept
% 207.97/208.12  |- mesh__dateCreated mesh__D012326 1981-05-20
% 207.97/208.12  |- skos__historyNote mesh__D012326 Transcription, Genetic %28%1976-1981%29%
% 207.97/208.12  |- mesh__historyNote mesh__D017011 92   
% 207.97/208.12  |- skos__annotation mesh__D017011
% 207.97/208.12       pathogenic for swine; infection: coord IM with STREPTOCOCCAL INFECTIONS %28%IM%29%; DF: STREP SUIS%A%  
% 207.97/208.12  |- mesh__dateRevised mesh__D017011 2005-06-30
% 207.97/208.12  |- mesh__recordOriginator mesh__D017011 PXP
% 207.97/208.12  |- mesh__recordMaintainer mesh__D017011 SYSTEM
% 207.97/208.12  |- skos__broader mesh__D017011smesh__D013291
% 207.97/208.12  |- skos__prefLabel mesh__D017011 Streptococcus suis
% 207.97/208.12  |- mesh__dateCreated mesh__D017011 1991-05-30
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D017011 2006
% 207.97/208.12  |- mesh__recordAuthorizer mesh__D017011 sjn
% 207.97/208.12  |- mesh__publicMeSHNote mesh__D017011 92   
% 207.97/208.12  |- skos__historyNote mesh__D017011 Streptococcus %28%1966-1991%29%
% 207.97/208.12  |- skos__scopeNote mesh__D017011
% 207.97/208.12       A species of STREPTOCOCCUS isolated from pigs. It is a pathogen of swine but rarely occurs in humans.%A%    
% 207.97/208.12  |- mesh__dateEstablished mesh__D017011 1992-01-01
% 207.97/208.12  |- rdf__type mesh__D017011sskos__Concept
% 207.97/208.12  |- skos__broader mesh__D016718Q000031smesh__D016718
% 207.97/208.12  |- mesh__preferredCombination mesh__D016718Q000031smesh__D001095
% 207.97/208.12  |- rdf__type mesh__D016718Q000031smesh__CompoundConcept
% 207.97/208.12  |- skos__altLabel mesh__D008285 Histocompatibility Complex
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D008285 2006A
% 207.97/208.12  |- mesh__recordMaintainer mesh__D008285 ags
% 207.97/208.12  |- mesh__historyNote mesh__D008285 79   
% 207.97/208.12  |- skos__broader mesh__D008285smesh__D007125
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D008285 2006
% 207.97/208.12  |- skos__annotation mesh__D008285 DF: MHC   
% 207.97/208.12  |- mesh__recordOriginator mesh__D008285 AEP
% 207.97/208.12  |- skos__hiddenLabel mesh__D008285 Complices, Major Histocompatibility
% 207.97/208.12  |- skos__broader mesh__D008285smesh__D005796
% 207.97/208.12  |- rdf__type mesh__D008285sskos__Concept
% 207.97/208.12  |- skos__hiddenLabel mesh__D008285 Complices, Histocompatibility
% 207.97/208.12  |- skos__hiddenLabel mesh__D008285 Complex, Histocompatibility
% 207.97/208.12  |- skos__related mesh__D008285smesh__D005805
% 207.97/208.12  |- mesh__dateRevised mesh__D008285 2005-07-18
% 207.97/208.12  |- skos__scopeNote mesh__D008285
% 207.97/208.12       The genetic region which contains the loci of genes which determine the structure of the serologically defined %28%SD%29% and lymphocyte-defined %28%LD%29% TRANSPLANTATION ANTIGENS, genes which control the structure of the IMMUNE RESPONSE-ASSOCIATED ANTIGENS, HUMAN; the IMMUNE RESPONSE GENES which control the ability of an animal to respond immunologically to antigenic stimuli, and genes which determine the structure and/or level of the first four components of complement.%A%    
% 207.97/208.12  |- skos__hiddenLabel mesh__D008285 Histocompatibility Complices, Major
% 207.97/208.12  |- skos__hiddenLabel mesh__D008285 Histocompatibility Complices
% 207.97/208.12  |- skos__historyNote mesh__D008285 HLA Antigens %28%1975-1978%29%
% 207.97/208.12  |- mesh__dateCreated mesh__D008285 1978-03-20
% 207.97/208.12  |- skos__historyNote mesh__D008285
% 207.97/208.12       Histocompatibility Antigens %28%1973-1978%29%
% 207.97/208.12  |- skos__hiddenLabel mesh__D008285 Complex, Major Histocompatibility
% 207.97/208.12  |- skos__hiddenLabel mesh__D008285 Histocompatibility Complex, Major
% 207.97/208.12  |- mesh__dateEstablished mesh__D008285 1979-01-01
% 207.97/208.12  |- skos__prefLabel mesh__D008285 Major Histocompatibility Complex
% 207.97/208.12  |- mesh__recordAuthorizer mesh__D008285 ags
% 207.97/208.12  |- mesh__publicMeSHNote mesh__D008285 79   
% 207.97/208.12  |- skos__hiddenLabel mesh__D008285 Major Histocompatibility Complices
% 207.97/208.12  |- skos__altLabel mesh__D016717 Endoscopic Sphincterotomy
% 207.97/208.12  |- mesh__dateCreated mesh__D016717 1991-02-11
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D016717 2001
% 207.97/208.12  |- mesh__dateRevised mesh__D016717 1999-11-03
% 207.97/208.12  |- skos__historyNote mesh__D016717
% 207.97/208.12       Sphincterotomy, Transhepatic %28%1986-1991%29%
% 207.97/208.12  |- skos__historyNote mesh__D016717
% 207.97/208.12       Oddi%27%s Sphincter/surgery %28%1974-1991%29%
% 207.97/208.12  |- skos__altLabel mesh__D016717 Endoscopic Papillotomy
% 207.97/208.12  |- skos__broader mesh__D016717smesh__D001662
% 207.97/208.12  |- skos__hiddenLabel mesh__D016717 Sphincterotomies, Endoscopic
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D016717 2006
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D016717 2000
% 207.97/208.12  |- skos__hiddenLabel mesh__D016717 Papillotomies, Endoscopic
% 207.97/208.12  |- skos__prefLabel mesh__D016717 Sphincterotomy, Endoscopic
% 207.97/208.12  |- skos__historyNote mesh__D016717
% 207.97/208.12       Vater%27%s Ampulla/surgery %28%1974-1991%29%
% 207.97/208.12  |- skos__hiddenLabel mesh__D016717 Endoscopic Sphincterotomies
% 207.97/208.12  |- skos__altLabel mesh__D016717 Papillotomy, Endoscopic
% 207.97/208.12  |- skos__historyNote mesh__D016717 Endoscopy %28%1974-1991%29%
% 207.97/208.12  |- skos__annotation mesh__D016717
% 207.97/208.12       refers to Oddi%27%s sphincter or Vater%27%s ampulla only; coord with disease /surg, not /diag; /instrum is probably DUODENOSCOPES%A%  
% 207.97/208.12  |- rdf__type mesh__D016717sskos__Concept
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D016717 2005
% 207.97/208.12  |- mesh__dateEstablished mesh__D016717 1992-01-01
% 207.97/208.12  |- mesh__recordMaintainer mesh__D016717 nns
% 207.97/208.12  |- mesh__recordOriginator mesh__D016717 AGS
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D016717 2004
% 207.97/208.12  |- skos__related mesh__D016717smesh__D002760
% 207.97/208.12  |- mesh__historyNote mesh__D016717 92   
% 207.97/208.12  |- skos__scopeNote mesh__D016717
% 207.97/208.12       Incision of Oddi%27%s sphincter or Vater%27%s ampulla performed by inserting a sphincterotome through an endoscope %28%DUODENOSCOPE%29% often following retrograde cholangiography %28%CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE%29%. Endoscopic treatment by sphincterotomy is the preferred method of treatment for patients with retained or recurrent bile duct stones post-cholecystectomy, and for poor-surgical-risk patients that have the gallbladder still present.%A%    
% 207.97/208.12  |- mesh__recordAuthorizer mesh__D016717 sjn
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D016717 2003
% 207.97/208.12  |- mesh__publicMeSHNote mesh__D016717 92   
% 207.97/208.12  |- skos__hiddenLabel mesh__D016717 Endoscopic Papillotomies
% 207.97/208.12  |- skos__broader mesh__D016717smesh__D016099
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D016717 2002
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D032384 2003
% 207.97/208.12  |- skos__altLabel mesh__D032384 Linden
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D032384 2004
% 207.97/208.12  |- skos__scopeNote mesh__D032384
% 207.97/208.12       A plant genus of the family TILIACEAE. Some species in this genus are called Limetree which is nearly the same as the common name for lime %28%CITRUS AURANTIIFOLIA%29%. Some people are allergic to the POLLEN.%A%    
% 207.97/208.12  |- skos__altLabel mesh__D032384 Basswood
% 207.97/208.12  |- skos__annotation mesh__D032384
% 207.97/208.12       Lime citrus fruit see CITRUS AURANTIIFOLIA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D032384 2005
% 207.97/208.12  |- mesh__dateEstablished mesh__D032384 2003-01-01
% 207.97/208.12  |- skos__prefLabel mesh__D032384 Tilia
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D032384 2006
% 207.97/208.12  |- skos__broader mesh__D032384smesh__D029646
% 207.97/208.12  |- mesh__dateCreated mesh__D032384 2002-07-02
% 207.97/208.12  |- mesh__historyNote mesh__D032384 2003   
% 207.97/208.12  |- mesh__publicMeSHNote mesh__D032384 2003   
% 207.97/208.12  |- rdf__type mesh__D032384sskos__Concept
% 207.97/208.12  |- skos__altLabel mesh__D004693 Endo-1,3-beta-Glucanase
% 207.97/208.12  |- mesh__recordAuthorizer mesh__D004693 sjn
% 207.97/208.12  |- skos__prefLabel mesh__D004693 Glucan Endo-1,3-beta-D-Glucosidase
% 207.97/208.12  |- mesh__dateCreated mesh__D004693 1974-11-19
% 207.97/208.12  |- skos__annotation mesh__D004693 DF: ENDO GLUCANASE   
% 207.97/208.12  |- skos__historyNote mesh__D004693 Glycoside Hydrolases %28%1969-1974%29%
% 207.97/208.12  |- skos__hiddenLabel mesh__D004693 Glucan Endo 1,3 beta D Glucosidase
% 207.97/208.12  |- skos__hiddenLabel mesh__D004693 Endo 1,3 beta Glucanase
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004693 2005
% 207.97/208.12  |- skos__hiddenLabel mesh__D004693 Oligo 1,3 Glucosidase
% 207.97/208.12  |- mesh__historyNote mesh__D004693
% 207.97/208.12       97; was ENDO-1,3-BETA-GLUCANASE 1975-96 %28%see under GLYCOSIDE HYDROLASES 1975-90%29%%A%  
% 207.97/208.12  |- skos__altLabel mesh__D004693 Oligo-1,3-Glucosidase
% 207.97/208.12  |- skos__hiddenLabel mesh__D004693 Endo-1,3-beta-D-Glucosidase, Glucan
% 207.97/208.12  |- mesh__recordOriginator mesh__D004693 NLM
% 207.97/208.12  |- mesh__activeMeSHYear mesh__D004693 2006
% 207.97/208.12  |- skos__historyNote mesh__D004693 Polysaccharides %28%1969-1974%29%
% 207.97/208.13  |- skos__scopeNote mesh__D004693
% 207.97/208.13       An endocellulase with specificity for the hydrolysis of 1,3-beta-D-glucosidic linkages in 1,3-beta-D-glucans including laminarin, paramylon, and pachyman.%A%    
% 207.97/208.13  |- mesh__recordMaintainer mesh__D004693 jmp
% 207.97/208.13  |- skos__broader mesh__D004693smesh__D044602
% 207.97/208.13  |- mesh__dateEstablished mesh__D004693 1991-01-01
% 207.97/208.13  |- mesh__publicMeSHNote mesh__D004693
% 207.97/208.13       97; was ENDO-1,3-BETA-GLUCANASE 1975-96 %28%see under GLYCOSIDE HYDROLASES 1975-90%29%%A%  
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D004693 2004
% 207.97/208.13  |- mesh__dateRevised mesh__D004693 2003-07-09
% 207.97/208.13  |- rdf__type mesh__D004693sskos__Concept
% 207.97/208.13  |- skos__altLabel mesh__D004693 Zymolase
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012327 1999
% 207.97/208.13  |- skos__altLabel mesh__D012327 Infections, RNA Virus
% 207.97/208.13  |- mesh__recordAuthorizer mesh__D012327 SJN
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012327 1998
% 207.97/208.13  |- skos__prefLabel mesh__D012327 RNA Virus Infections
% 207.97/208.13  |- skos__hiddenLabel mesh__D012327 RNA Virus Infection
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012327 2002
% 207.97/208.13  |- mesh__publicMeSHNote mesh__D012327 98   
% 207.97/208.13  |- skos__broader mesh__D012327smesh__D014777
% 207.97/208.13  |- skos__historyNote mesh__D012327 RNA Viruses %28%1975-1997%29%
% 207.97/208.13  |- skos__hiddenLabel mesh__D012327 Virus Infections, RNA
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012327 2006
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012327 2001
% 207.97/208.13  |- mesh__historyNote mesh__D012327 98; use explode 1975-97   
% 207.97/208.13  |- rdf__type mesh__D012327sskos__Concept
% 207.97/208.13  |- mesh__dateCreated mesh__D012327 1999-01-01
% 207.97/208.13  |- mesh__dateRevised mesh__D012327 1997-06-20
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012327 2005
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012327 2000
% 207.97/208.13  |- mesh__dateEstablished mesh__D012327 1998-01-01
% 207.97/208.13  |- mesh__recordOriginator mesh__D012327 NLM
% 207.97/208.13  |- skos__hiddenLabel mesh__D012327 Virus Infection, RNA
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012327 2004
% 207.97/208.13  |- skos__historyNote mesh__D012327 Virus Diseases %28%1975-1997%29%
% 207.97/208.13  |- skos__hiddenLabel mesh__D012327 Infection, RNA Virus
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012327 2003
% 207.97/208.13  |- skos__annotation mesh__D012327
% 207.97/208.13       GEN or unspecified; prefer specifics; DF: RNA VIRUS INFECT%A%  
% 207.97/208.13  |- mesh__recordMaintainer mesh__D012327 TGC
% 207.97/208.13  |- mesh__publicMeSHNote mesh__D017012 92   
% 207.97/208.13  |- skos__scopeNote mesh__D017012
% 207.97/208.13       An order of anaerobic, coccoid to rod-shaped methanogens, in the kingdom EURYARCHAEOTA. They are nonmotile, do not catabolize carbohydrates, proteinaceous material, or organic compounds other than formate or carbon monoxide, and are widely distributed in nature.%A%    
% 207.97/208.13  |- mesh__recordOriginator mesh__D017012 PXP
% 207.97/208.13  |- mesh__dateEstablished mesh__D017012 1992-01-01
% 207.97/208.13  |- mesh__recordMaintainer mesh__D017012 SYSTEM
% 207.97/208.13  |- skos__broader mesh__D017012smesh__D019605
% 207.97/208.13  |- mesh__dateCreated mesh__D017012 1991-05-30
% 207.97/208.13  |- skos__prefLabel mesh__D017012 Methanobacteriales
% 207.97/208.13  |- mesh__dateRevised mesh__D017012 2005-06-30
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D017012 2006
% 207.97/208.13  |- rdf__type mesh__D017012sskos__Concept
% 207.97/208.13  |- mesh__historyNote mesh__D017012 92   
% 207.97/208.13  |- skos__annotation mesh__D017012
% 207.97/208.13       an order of methanogens found throughout nature   
% 207.97/208.13  |- mesh__recordAuthorizer mesh__D017012 sjn
% 207.97/208.13  |- mesh__publicMeSHNote mesh__D008286
% 207.97/208.13       65; MALABSORPTION SYNDROME was see SPRUE 1963-64; MALABSORPTION SYNDROME, CHILDHOOD was see CELIAC DISEASE 1963-64%A%  
% 207.97/208.13  |- skos__scopeNote mesh__D008286
% 207.97/208.13       General term for a group of MALNUTRITION syndromes caused by failure of normal INTESTINAL ABSORPTION of nutrients.%A%    
% 207.97/208.13  |- mesh__recordAuthorizer mesh__D008286 sjn
% 207.97/208.13  |- skos__broader mesh__D008286smesh__D007410
% 207.97/208.13  |- skos__hiddenLabel mesh__D008286 Syndrome, Malabsorption
% 207.97/208.13  |- skos__broader mesh__D008286smesh__D008659
% 207.97/208.13  |- skos__hiddenLabel mesh__D008286 Syndromes, Malabsorption
% 207.97/208.13  |- mesh__recordMaintainer mesh__D008286 lkt
% 207.97/208.13  |- skos__hiddenLabel mesh__D008286 Malabsorption Syndrome
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D008286 2004
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D008286 2005
% 207.97/208.13  |- mesh__historyNote mesh__D008286
% 207.97/208.13       65; MALABSORPTION SYNDROME was see SPRUE 1963-64; MALABSORPTION SYNDROME, CHILDHOOD was see CELIAC DISEASE 1963-64%A%  
% 207.97/208.13  |- mesh__dateEstablished mesh__D008286 1965-01-01
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D008286 2006
% 207.97/208.13  |- mesh__dateCreated mesh__D008286 1999-01-01
% 207.97/208.13  |- mesh__dateRevised mesh__D008286 2003-07-09
% 207.97/208.13  |- mesh__recordOriginator mesh__D008286 NLM
% 207.97/208.13  |- skos__prefLabel mesh__D008286 Malabsorption Syndromes
% 207.97/208.13  |- rdf__type mesh__D008286sskos__Concept
% 207.97/208.13  |- mesh__recordAuthorizer mesh__D016718 sjn
% 207.97/208.13  |- skos__historyNote mesh__D016718 Arachidonic Acids %28%1975-1991%29%
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D016718 2006
% 207.97/208.13  |- skos__altLabel mesh__D016718
% 207.97/208.13       %28%all-Z%29%-5,8,11,14-Eicosatetraenoic acid
% 207.97/208.13  |- mesh__recordMaintainer mesh__D016718 sjn
% 207.97/208.13  |- mesh__dateCreated mesh__D016718 1991-02-08
% 207.97/208.13  |- skos__broader mesh__D016718smesh__D001095
% 207.97/208.13  |- skos__hiddenLabel mesh__D016718 Arachidonate, Sodium
% 207.97/208.13  |- rdf__type mesh__D016718sskos__Concept
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D016718 2005
% 207.97/208.13  |- skos__prefLabel mesh__D016718 Arachidonic Acid
% 207.97/208.13  |- skos__annotation mesh__D016718 do not confuse with ARACHIDONIC ACIDS   
% 207.97/208.13  |- mesh__publicMeSHNote mesh__D016718
% 207.97/208.13       92; ARACHIDONIC ACID was indexed under ARACHIDONIC ACIDS 1981-91%A%  
% 207.97/208.13  |- mesh__historyNote mesh__D016718
% 207.97/208.13       92; was ARACHIDONIC ACID %28%NM%29% 1981-91   
% 207.97/208.13  |- skos__altLabel mesh__D016718 Vitamin F
% 207.97/208.13  |- skos__altLabel mesh__D016718 Sodium Arachidonate
% 207.97/208.13  |- mesh__recordOriginator mesh__D016718 RLS
% 207.97/208.13  |- mesh__onlineNote mesh__D016718
% 207.97/208.13       use ARACHIDONIC ACID %28%NM%29% to search ARACHIDONIC ACID 1977-91%A%  
% 207.97/208.13  |- skos__scopeNote mesh__D016718
% 207.97/208.13       An unsaturated, essential fatty acid. It is found in animal and human fat as well as in the liver, brain, and glandular organs, and is a constituent of animal phosphatides. It is formed by the synthesis from dietary linoleic acid and is a precursor in the biosynthesis of prostaglandins, thromboxanes, and leukotrienes.%A%    
% 207.97/208.13  |- mesh__dateEstablished mesh__D016718 1992-01-01
% 207.97/208.13  |- mesh__dateRevised mesh__D016718 2004-07-13
% 207.97/208.13  |- skos__prefLabel mesh__D013420 Sulfamethoxazole
% 207.97/208.13  |- mesh__dateCreated mesh__D013420 1999-01-01
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D013420 2004
% 207.97/208.13  |- mesh__recordMaintainer mesh__D013420 jmp
% 207.97/208.13  |- mesh__recordAuthorizer mesh__D013420 sjn
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D013420 2002
% 207.97/208.13  |- skos__broader mesh__D013420smesh__D013424
% 207.97/208.13  |- rdf__type mesh__D013420sskos__Concept
% 207.97/208.13  |- mesh__recordOriginator mesh__D013420 NLM
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D013420 2003
% 207.97/208.13  |- skos__altLabel mesh__D013420 Sulfamethylisoxazole
% 207.97/208.13  |- mesh__dateEstablished mesh__D013420 1968-01-01
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D013420 2006
% 207.97/208.13  |- mesh__publicMeSHNote mesh__D013420 68   
% 207.97/208.13  |- skos__annotation mesh__D013420 a sulfanilamide anti-infective   
% 207.97/208.13  |- skos__altLabel mesh__D013420 Sulfisomezole
% 207.97/208.13  |- skos__scopeNote mesh__D013420
% 207.97/208.13       A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p208%29%%A%    
% 207.97/208.13  |- skos__altLabel mesh__D013420 Sulphamethoxazole
% 207.97/208.13  |- mesh__dateRevised mesh__D013420 2001-07-25
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D013420 2005
% 207.97/208.13  |- mesh__historyNote mesh__D013420 68%28%63%29%   
% 207.97/208.13  |- mesh__historyNote mesh__D032385 2003   
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D032385 2005
% 207.97/208.13  |- skos__annotation mesh__D032385
% 207.97/208.13       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D032385 2006
% 207.97/208.13  |- skos__prefLabel mesh__D032385 Triumfetta
% 207.97/208.13  |- skos__broader mesh__D032385smesh__D029646
% 207.97/208.13  |- skos__scopeNote mesh__D032385
% 207.97/208.13       A plant genus of the family TILIACEAE. The common name of burweed is also used for AMSINCKIA.  Triumfetta semitriloba is considered a noxious weed.%A%    
% 207.97/208.13  |- mesh__dateCreated mesh__D032385 2002-07-03
% 207.97/208.13  |- mesh__dateEstablished mesh__D032385 2003-01-01
% 207.97/208.13  |- mesh__publicMeSHNote mesh__D032385 2003   
% 207.97/208.13  |- rdf__type mesh__D032385sskos__Concept
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D032385 2003
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D032385 2004
% 207.97/208.13  |- skos__broader mesh__D005530Q000151smesh__D005530
% 207.97/208.13  |- mesh__preferredCombination mesh__D005530Q000151smesh__D005532
% 207.97/208.13  |- rdf__type mesh__D005530Q000151smesh__CompoundConcept
% 207.97/208.13  |- skos__hiddenLabel mesh__D004694 Ostium Primum, Persistent
% 207.97/208.13  |- skos__hiddenLabel mesh__D004694 Endocardial Cushion Defect
% 207.97/208.13  |- skos__annotation mesh__D004694
% 207.97/208.13       a heart septal defect; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 207.97/208.13  |- skos__hiddenLabel mesh__D004694 Cushion Defect, Endocardial
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D004694 2003
% 207.97/208.13  |- skos__historyNote mesh__D004694
% 207.97/208.13       Heart Defects, Congenital %28%1966-1982%29%
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D004694 2006
% 207.97/208.13  |- skos__hiddenLabel mesh__D004694 Cushion Defects, Endocardial
% 207.97/208.13  |- skos__prefLabel mesh__D004694 Endocardial Cushion Defects
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D004694 2000
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D004694 2004
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D004694 2001
% 207.97/208.13  |- skos__broader mesh__D004694smesh__D006343
% 207.97/208.13  |- mesh__dateEstablished mesh__D004694 1991-01-01
% 207.97/208.13  |- mesh__recordAuthorizer mesh__D004694 sjn
% 207.97/208.13  |- rdf__type mesh__D004694sskos__Concept
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D004694 2002
% 207.97/208.13  |- mesh__dateRevised mesh__D004694 1999-11-03
% 207.97/208.13  |- skos__hiddenLabel mesh__D004694 Primum, Persistent Ostium
% 207.97/208.13  |- mesh__recordOriginator mesh__D004694 AEP
% 207.97/208.13  |- mesh__recordMaintainer mesh__D004694 kle
% 207.97/208.13  |- mesh__publicMeSHNote mesh__D004694
% 207.97/208.13       91; was see under HEART SEPTAL DEFECTS 1983-90   
% 207.97/208.13  |- skos__scopeNote mesh__D004694
% 207.97/208.13       A spectrum of septal defects associated with persistence of the embryonic atrioventricular canal due to incomplete growth and fusion of the endocardial cushion.%A%    
% 207.97/208.13  |- skos__hiddenLabel mesh__D004694 Defect, Endocardial Cushion
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D004694 2005
% 207.97/208.13  |- mesh__dateCreated mesh__D004694 1982-04-23
% 207.97/208.13  |- mesh__historyNote mesh__D004694
% 207.97/208.13       91%28%83%29%; was see under HEART SEPTAL DEFECTS 1983-90   
% 207.97/208.13  |- skos__hiddenLabel mesh__D004694 Defects, Endocardial Cushion
% 207.97/208.13  |- mesh__publicMeSHNote mesh__D045502 2004   
% 207.97/208.13  |- mesh__recordOriginator mesh__D045502 ags
% 207.97/208.13  |- skos__prefLabel mesh__D045502 Helicobacter mustelae
% 207.97/208.13  |- skos__annotation mesh__D045502
% 207.97/208.13       infection: coord IM with HELICOBACTER INFECTIONS %28%IM%29%   
% 207.97/208.13  |- skos__broader mesh__D045502smesh__D016998
% 207.97/208.13  |- mesh__recordAuthorizer mesh__D045502 sjn
% 207.97/208.13  |- rdf__type mesh__D045502sskos__Concept
% 207.97/208.13  |- mesh__dateRevised mesh__D045502 2005-06-30
% 207.97/208.13  |- skos__historyNote mesh__D045502 Helicobacter %28%1992-2003%29%
% 207.97/208.13  |- mesh__dateEstablished mesh__D045502 2004-01-01
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D045502 2006
% 207.97/208.13  |- mesh__historyNote mesh__D045502 2004   
% 207.97/208.13  |- mesh__dateCreated mesh__D045502 2003-07-09
% 207.97/208.13  |- skos__scopeNote mesh__D045502
% 207.97/208.13       A species of HELICOBACTER commonly associated with STOMACH DISEASES in FERRETS.%A%    
% 207.97/208.13  |- mesh__recordMaintainer mesh__D045502 SYSTEM
% 207.97/208.13  |- skos__hiddenLabel mesh__D012328 Virus, RNA
% 207.97/208.13  |- skos__prefLabel mesh__D012328 RNA Viruses
% 207.97/208.13  |- skos__broader mesh__D012328smesh__D014780
% 207.97/208.13  |- skos__hiddenLabel mesh__D012328 Viruses, RNA
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012328 2006
% 207.97/208.13  |- skos__scopeNote mesh__D012328
% 207.97/208.13       Viruses whose genetic material is RNA.     
% 207.97/208.13  |- mesh__dateCreated mesh__D012328 1999-01-01
% 207.97/208.13  |- mesh__recordAuthorizer mesh__D012328 SJN
% 207.97/208.13  |- rdf__type mesh__D012328sskos__Concept
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012328 2005
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012328 2002
% 207.97/208.13  |- mesh__historyNote mesh__D012328
% 207.97/208.13       66; RNA RODENT VIRUSES was heading 1975-93   
% 207.97/208.13  |- mesh__publicMeSHNote mesh__D012328
% 207.97/208.13       66; RNA RODENT VIRUSES was heading 1975-93   
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012328 2004
% 207.97/208.13  |- skos__hiddenLabel mesh__D012328 RNA Rodent Virus
% 207.97/208.13  |- skos__annotation mesh__D012328
% 207.97/208.13       avoid: too general; prefer specifics; infection = RNA VIRUS INFECTIONS%A%  
% 207.97/208.13  |- mesh__onlineNote mesh__D012328
% 207.97/208.13       use RNA VIRUSES to search RNA RODENT VIRUSES 1975-93   
% 207.97/208.13  |- skos__broader mesh__D012328smesh__D014712
% 207.97/208.13  |- skos__hiddenLabel mesh__D012328 Viruses, RNA Rodent
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012328 2001
% 207.97/208.13  |- mesh__dateRevised mesh__D012328 1997-06-20
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012328 2003
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012328 1999
% 207.97/208.13  |- mesh__recordMaintainer mesh__D012328 TGC
% 207.97/208.13  |- mesh__dateEstablished mesh__D012328 1966-01-01
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012328 2000
% 207.97/208.13  |- skos__hiddenLabel mesh__D012328 Rodent Viruses, RNA
% 207.97/208.13  |- skos__hiddenLabel mesh__D012328 Virus, RNA Rodent
% 207.97/208.13  |- skos__hiddenLabel mesh__D012328 RNA Virus
% 207.97/208.13  |- mesh__recordOriginator mesh__D012328 NLM
% 207.97/208.13  |- skos__hiddenLabel mesh__D012328 Rodent Virus, RNA
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012328 1998
% 207.97/208.13  |- skos__prefLabel mesh__D017013 Methanobacteriaceae
% 207.97/208.13  |- mesh__dateEstablished mesh__D017013 1992-01-01
% 207.97/208.13  |- skos__broader mesh__D017013smesh__D017012
% 207.97/208.13  |- mesh__publicMeSHNote mesh__D017013 92   
% 207.97/208.13  |- mesh__recordAuthorizer mesh__D017013 sjn
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D017013 2006
% 207.97/208.13  |- mesh__recordMaintainer mesh__D017013 SYSTEM
% 207.97/208.13  |- mesh__recordOriginator mesh__D017013 PXP
% 207.97/208.13  |- mesh__historyNote mesh__D017013 92   
% 207.97/208.13  |- rdf__type mesh__D017013sskos__Concept
% 207.97/208.13  |- skos__scopeNote mesh__D017013
% 207.97/208.13       A family of anaerobic, coccoid to rod-shaped METHANOBACTERIALES. Cell membranes are composed mainly of polyisoprenoid hydrocarbons ether-linked to glycerol. Its organisms are found in anaerobic habitats throughout nature.%A%    
% 207.97/208.13  |- mesh__dateCreated mesh__D017013 1991-05-30
% 207.97/208.13  |- mesh__dateRevised mesh__D017013 2005-06-30
% 207.97/208.13  |- mesh__recordOriginator mesh__D008287 NLM
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D008287 2002
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D008287 2003
% 207.97/208.13  |- mesh__dateEstablished mesh__D008287 1973-01-01
% 207.97/208.13  |- mesh__publicMeSHNote mesh__D008287 73   
% 207.97/208.13  |- mesh__recordMaintainer mesh__D008287 KEV
% 207.97/208.13  |- mesh__recordAuthorizer mesh__D008287 sjn
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D008287 2004
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D008287 2005
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D008287 2000
% 207.97/208.13  |- skos__hiddenLabel mesh__D008287 Malacoplakias
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D008287 2006
% 207.97/208.13  |- mesh__dateCreated mesh__D008287 1999-01-01
% 207.97/208.13  |- skos__prefLabel mesh__D008287 Malacoplakia
% 207.97/208.13  |- mesh__historyNote mesh__D008287 73%28%65%29%   
% 207.97/208.13  |- mesh__dateRevised mesh__D008287 1999-11-03
% 207.97/208.13  |- skos__broader mesh__D008287smesh__D010335
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D008287 2001
% 207.97/208.13  |- rdf__type mesh__D008287sskos__Concept
% 207.97/208.13  |- skos__scopeNote mesh__D008287
% 207.97/208.13       The formation of soft patches on the mucous membrane of a hollow organ, such as the urogenital tract or digestive tract.%A%    
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D016719 2004
% 207.97/208.13  |- mesh__recordMaintainer mesh__D016719 TPW
% 207.97/208.13  |- skos__altLabel mesh__D016719 Radiolabelled Immunoscintigraphy
% 207.97/208.13  |- mesh__dateRevised mesh__D016719 1997-06-20
% 207.97/208.13  |- mesh__recordOriginator mesh__D016719 AGS
% 207.97/208.13  |- skos__altLabel mesh__D016719 Immunoscintigraphy, Radiolabeled
% 207.97/208.13  |- mesh__historyNote mesh__D016719 92   
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D016719 1999
% 207.97/208.13  |- skos__annotation mesh__D016719
% 207.97/208.13       uses radiolabeled antibodies for diag imaging; do not use /util except by MeSH definition; coord IM or NIM with dis /radionuclide %28%IM%29%, not /diag, not /radiogr %26% not /immunol, + specific radioisotope /diag use %28%IM or NIM%29%%A%  
% 207.97/208.13  |- skos__altLabel mesh__D016719 Immunoscintigraphy, Radiolabelled
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D016719 2003
% 207.97/208.13  |- skos__broader mesh__D016719smesh__D007158
% 207.97/208.13  |- skos__hiddenLabel mesh__D016719 Radiolabeled Immunoscintigraphies
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D016719 1998
% 207.97/208.13  |- mesh__publicMeSHNote mesh__D016719 92   
% 207.97/208.13  |- skos__historyNote mesh__D016719
% 207.97/208.13       Antibodies, Monoclonal/diagnostic use %28%1980-1991%29%
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D016719 2002
% 207.97/208.13  |- skos__broader mesh__D016719smesh__D011877
% 207.97/208.13  |- skos__hiddenLabel mesh__D016719 Radioimmunoscintigraphies
% 207.97/208.13  |- skos__altLabel mesh__D016719 Radioimmunoimaging
% 207.97/208.13  |- skos__altLabel mesh__D016719 Radiolabeled Immunoscintigraphy
% 207.97/208.13  |- mesh__dateCreated mesh__D016719 1991-02-11
% 207.97/208.13  |- skos__hiddenLabel mesh__D016719 Immunoscintigraphies, Radiolabeled
% 207.97/208.13  |- skos__historyNote mesh__D016719 Radionuclide Imaging %28%1980-1991%29%
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D016719 2006
% 207.97/208.13  |- skos__prefLabel mesh__D016719 Radioimmunodetection
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D016719 2001
% 207.97/208.13  |- skos__hiddenLabel mesh__D016719 Radioimmunoimagings
% 207.97/208.13  |- skos__scopeNote mesh__D016719
% 207.97/208.13       Use of radiolabeled antibodies for diagnostic imaging of neoplasms. Antitumor antibodies are labeled with diverse radionuclides including iodine-131, iodine-123, indium-111, or technetium-99m and injected into the patient. Images are obtained by a scintillation camera.%A%    
% 207.97/208.13  |- rdf__type mesh__D016719sskos__Concept
% 207.97/208.13  |- skos__historyNote mesh__D016719 Antibodies, Neoplasm %28%1980-1986%29%
% 207.97/208.13  |- skos__hiddenLabel mesh__D016719 Radiolabelled Immunoscintigraphies
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D016719 2000
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D016719 2005
% 207.97/208.13  |- mesh__dateEstablished mesh__D016719 1992-01-01
% 207.97/208.13  |- skos__hiddenLabel mesh__D016719 Radioimmunodetections
% 207.97/208.13  |- skos__hiddenLabel mesh__D016719 Immunoscintigraphies, Radiolabelled
% 207.97/208.13  |- mesh__recordAuthorizer mesh__D016719 SJN
% 207.97/208.13  |- skos__altLabel mesh__D016719 Radioimmunoscintigraphy
% 207.97/208.13  |- mesh__dateEstablished mesh__D027441 2002-01-01
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D027441 2006
% 207.97/208.13  |- mesh__dateCreated mesh__D027441 2001-07-25
% 207.97/208.13  |- skos__scopeNote mesh__D027441
% 207.97/208.13       A plant genus in the LAURACEAE family. The tree bark has been used medicinally.%A%    
% 207.97/208.13  |- mesh__historyNote mesh__D027441 2002; use LAURACEAE 1996-2001   
% 207.97/208.13  |- skos__prefLabel mesh__D027441 Sassafras
% 207.97/208.13  |- rdf__type mesh__D027441sskos__Concept
% 207.97/208.13  |- mesh__recordOriginator mesh__D027441 ssb
% 207.97/208.13  |- mesh__recordMaintainer mesh__D027441 ssb
% 207.97/208.13  |- skos__annotation mesh__D027441
% 207.97/208.13       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.97/208.13  |- mesh__publicMeSHNote mesh__D027441 2002; see LAURACEAE 1996-2001   
% 207.97/208.13  |- mesh__recordAuthorizer mesh__D027441 sjn
% 207.97/208.13  |- skos__broader mesh__D027441smesh__D019770
% 207.97/208.13  |- mesh__dateRevised mesh__D027441 2004-07-07
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D027441 2005
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D013421 2003
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D013421 2001
% 207.97/208.13  |- mesh__dateRevised mesh__D013421 2000-06-22
% 207.97/208.13  |- mesh__recordMaintainer mesh__D013421 CCR
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D013421 2004
% 207.97/208.13  |- skos__prefLabel mesh__D013421 Sulfamethoxypyridazine
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D013421 2002
% 207.97/208.13  |- skos__altLabel mesh__D013421 Sulphamethoxypyridazine
% 207.97/208.13  |- rdf__type mesh__D013421sskos__Concept
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D013421 2005
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D013421 2006
% 207.97/208.13  |- mesh__recordAuthorizer mesh__D013421 sjn
% 207.97/208.13  |- skos__broader mesh__D013421smesh__D013424
% 207.97/208.13  |- mesh__recordOriginator mesh__D013421 NLM
% 207.97/208.13  |- mesh__dateCreated mesh__D013421 1999-01-01
% 207.97/208.13  |- skos__altLabel mesh__D013421 Sulfapyridazine
% 207.97/208.13  |- skos__scopeNote mesh__D013421 A sulfanilamide antibacterial agent.     
% 207.97/208.13  |- mesh__historyNote mesh__D032386 2003   
% 207.97/208.13  |- skos__related mesh__D032386smesh__D032383
% 207.97/208.13  |- mesh__dateEstablished mesh__D032386 2003-01-01
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D032386 2003
% 207.97/208.13  |- skos__hiddenLabel mesh__D032386 Cardiac Myoblast
% 207.97/208.13  |- skos__historyNote mesh__D032386 Myocardium %28%1969-2002%29%
% 207.97/208.13  |- skos__hiddenLabel mesh__D032386 Cardiac Myoblasts
% 207.97/208.13  |- mesh__dateCreated mesh__D032386 2002-07-03
% 207.97/208.13  |- skos__prefLabel mesh__D032386 Myoblasts, Cardiac
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D032386 2006
% 207.97/208.13  |- skos__scopeNote mesh__D032386
% 207.97/208.13       Precursor cells destined to differentiate into cardiac myocytes %28%MYOCYTES, CARDIAC%29%.%A%    
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D032386 2005
% 207.97/208.13  |- skos__broader mesh__D032386smesh__D032446
% 207.97/208.13  |- skos__hiddenLabel mesh__D032386 Myoblast, Cardiac
% 207.97/208.13  |- rdf__type mesh__D032386sskos__Concept
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D032386 2004
% 207.97/208.13  |- mesh__publicMeSHNote mesh__D032386 2003   
% 207.97/208.13  |- mesh__recordAuthorizer mesh__D051540 sjn
% 207.97/208.13  |- rdf__type mesh__D051540sskos__Concept
% 207.97/208.13  |- skos__broader mesh__D051540smesh__D014157
% 207.97/208.13  |- skos__hiddenLabel mesh__D051540 Transcription Factors, Winged-Helix
% 207.97/208.13  |- mesh__dateEstablished mesh__D051540 2006-01-01
% 207.97/208.13  |- mesh__historyNote mesh__D051540 2006   
% 207.97/208.13  |- skos__prefLabel mesh__D051540 Winged-Helix Transcription Factors
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D051540 2006
% 207.97/208.13  |- mesh__recordMaintainer mesh__D051540 DRC
% 207.97/208.13  |- skos__broader mesh__D051540smesh__D004268
% 207.97/208.13  |- mesh__dateCreated mesh__D051540 2005-06-30
% 207.97/208.13  |- skos__scopeNote mesh__D051540
% 207.97/208.13       A subfamily of HELIX-TURN-HELIX DNA-binding proteins that contain a variable length loop adjacent to the HTH motif. The loop connects two anti-parallel strands and forms a wing when bound to DNA.%A%    
% 207.97/208.13  |- mesh__recordOriginator mesh__D051540 DRC
% 207.97/208.13  |- skos__hiddenLabel mesh__D051540 Winged Helix Transcription Factors
% 207.97/208.13  |- mesh__publicMeSHNote mesh__D051540 2006   
% 207.97/208.13  |- mesh__dateCreated mesh__D004695 1999-01-01
% 207.97/208.13  |- skos__hiddenLabel mesh__D004695 Fibroelastosis, Endocardial
% 207.97/208.13  |- mesh__recordOriginator mesh__D004695 NLM
% 207.97/208.13  |- mesh__dateRevised mesh__D004695 2005-07-15
% 207.97/208.13  |- rdf__type mesh__D004695sskos__Concept
% 207.97/208.13  |- skos__hiddenLabel mesh__D004695 Endocardial Fibroelastoses
% 207.97/208.13  |- skos__hiddenLabel mesh__D004695 Fibroelastoses, Endocardial
% 207.97/208.13  |- skos__scopeNote mesh__D004695
% 207.97/208.13       A condition characterized by the thickening of ENDOCARDIUM due to proliferation of fibrous and elastic tissue, usually in the left ventricle leading to impaired cardiac function %28%CARDIOMYOPATHY, RESTRICTIVE%29%. It is most commonly seen in young children and rarely in adults. It is often associated with congenital heart anomalies %28%HEART DEFECTS,CONGENITAL;%29% INFECTION; or gene mutation. Defects in the tafazzin protein, encoded by TAZ gene, result in a form of autosomal dominant familial endocardial fibroelastosis.%A%    
% 207.97/208.13  |- mesh__recordMaintainer mesh__D004695 ags
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D004695 2006A
% 207.97/208.13  |- skos__broader mesh__D004695smesh__D009202
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D004695 2005
% 207.97/208.13  |- mesh__recordAuthorizer mesh__D004695 ags
% 207.97/208.13  |- skos__prefLabel mesh__D004695 Endocardial Fibroelastosis
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D004695 2006
% 207.97/208.13  |- skos__broader mesh__D045503smesh__D001473
% 207.97/208.13  |- rdf__type mesh__D045503sskos__Concept
% 207.97/208.13  |- skos__historyNote mesh__D045503 Bartonella %28%1966-2003%29%
% 207.97/208.13  |- skos__annotation mesh__D045503
% 207.97/208.13       infection: coord IM with BARTONELLA INFECTIONS %28%IM%29%   
% 207.97/208.13  |- mesh__recordOriginator mesh__D045503 ags
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D045503 2006
% 207.97/208.13  |- mesh__recordAuthorizer mesh__D045503 sjn
% 207.97/208.13  |- skos__scopeNote mesh__D045503
% 207.97/208.13       The type species of the genus BARTONELLA, a gram-negative bacteria found in humans. It is found in the mountain valleys of Peru, Ecuador, and Southwest Columbia where the sandfly %28%see PHLEBOTOMUS%29% vector is present. It causes OROYA FEVER and VERRUGA PERUANA.%A%    
% 207.97/208.13  |- mesh__dateRevised mesh__D045503 2005-06-30
% 207.97/208.13  |- mesh__dateCreated mesh__D045503 2003-07-09
% 207.97/208.13  |- mesh__dateEstablished mesh__D045503 2004-01-01
% 207.97/208.13  |- skos__prefLabel mesh__D045503 Bartonella bacilliformis
% 207.97/208.13  |- mesh__recordMaintainer mesh__D045503 SYSTEM
% 207.97/208.13  |- mesh__publicMeSHNote mesh__D045503 2004   
% 207.97/208.13  |- mesh__historyNote mesh__D045503 2004   
% 207.97/208.13  |- mesh__recordMaintainer mesh__D012329 JRT
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012329 2005
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012329 1997
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012329 2001
% 207.97/208.13  |- skos__scopeNote mesh__D012329
% 207.97/208.13       Ribonucleic acid in bacteria having regulatory and catalytic roles as well as involvement in protein synthesis.%A%    
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012329 2006
% 207.97/208.13  |- rdf__type mesh__D012329sskos__Concept
% 207.97/208.13  |- mesh__recordOriginator mesh__D012329 NLM
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012329 2003
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012329 2002
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012329 2004
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012329 1998
% 207.97/208.13  |- mesh__dateRevised mesh__D012329 1995-03-20
% 207.97/208.13  |- mesh__recordAuthorizer mesh__D012329 PLS
% 207.97/208.13  |- skos__broader mesh__D012329smesh__D012313
% 207.97/208.13  |- skos__annotation mesh__D012329
% 207.97/208.13       IM; coord with specific bacterium %28%IM%29%; /drug eff /ultrastruct permitted; DF: RNA BACT%A%  
% 207.97/208.13  |- mesh__activeMeSHYear mesh__D012329 1999
% 207.97/208.14  |- skos__prefLabel mesh__D012329 RNA, Bacterial
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D012329 2000
% 207.97/208.14  |- mesh__dateCreated mesh__D012329 1999-01-01
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D012329 1996
% 207.97/208.14  |- skos__altLabel mesh__D012329 Bacterial RNA
% 207.97/208.14  |- skos__altLabel mesh__D009380 Nerve Tissue Neoplasms
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D009380 2001
% 207.97/208.14  |- rdf__type mesh__D009380sskos__Concept
% 207.97/208.14  |- skos__hiddenLabel mesh__D009380 Nervous Tissue Neoplasm
% 207.97/208.14  |- skos__prefLabel mesh__D009380 Neoplasms, Nerve Tissue
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D009380 2002
% 207.97/208.14  |- mesh__recordAuthorizer mesh__D009380 PLS
% 207.97/208.14  |- skos__scopeNote mesh__D009380
% 207.97/208.14       Neoplasms composed of nerve tissue. This concept does not refer to neoplasms located in the nervous system or its component nerves.%A%    
% 207.97/208.14  |- skos__annotation mesh__D009380
% 207.97/208.14       neoplasms composed of nerve tissue, NOT neoplasms located in the nervous system or nerves %28% = NERVOUS SYSTEM NEOPLASMS%29%: TN 135; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D009380 2005
% 207.97/208.14  |- mesh__recordMaintainer mesh__D009380 KEV
% 207.97/208.14  |- mesh__recordOriginator mesh__D009380 NLM
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D009380 1998
% 207.97/208.14  |- skos__broader mesh__D009380smesh__D009370
% 207.97/208.14  |- skos__altLabel mesh__D009380 Nervous Tissue Neoplasms
% 207.97/208.14  |- skos__altLabel mesh__D009380 Neoplasms, Nervous Tissue
% 207.97/208.14  |- mesh__dateCreated mesh__D009380 1999-01-01
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D009380 2006
% 207.97/208.14  |- mesh__historyNote mesh__D009380
% 207.97/208.14       94; was NEOPLASMS, NERVOUS TISSUE 1963-93   
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D009380 2003
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D009380 1999
% 207.97/208.14  |- mesh__dateRevised mesh__D009380 1995-06-08
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D009380 1996
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D009380 2004
% 207.97/208.14  |- mesh__publicMeSHNote mesh__D009380
% 207.97/208.14       94; was NEOPLASMS, NERVOUS TISSUE 1963-93   
% 207.97/208.14  |- skos__hiddenLabel mesh__D009380 Neoplasm, Nerve Tissue
% 207.97/208.14  |- mesh__onlineNote mesh__D009380
% 207.97/208.14       use NEOPLASMS, NERVE TISSUE to search NEOPLASMS, NERVOUS TISSUE 1966-93%A%  
% 207.97/208.14  |- skos__hiddenLabel mesh__D009380 Neoplasm, Nervous Tissue
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D009380 1997
% 207.97/208.14  |- skos__hiddenLabel mesh__D009380 Nerve Tissue Neoplasm
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D009380 2000
% 207.97/208.14  |- mesh__dateCreated mesh__D017812 1993-02-16
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D017812 2004
% 207.97/208.14  |- skos__hiddenLabel mesh__D017812 Water Moccasins
% 207.97/208.14  |- skos__broader mesh__D017812smesh__D012911
% 207.97/208.14  |- skos__hiddenLabel mesh__D017812 Water Snakes
% 207.97/208.14  |- skos__hiddenLabel mesh__D017812 Snakes, King
% 207.97/208.14  |- skos__hiddenLabel mesh__D017812 Snakes, Garter
% 207.97/208.14  |- skos__altLabel mesh__D017812 Garter Snake
% 207.97/208.14  |- skos__prefLabel mesh__D017812 Colubridae
% 207.97/208.14  |- skos__altLabel mesh__D017812 Natrix
% 207.97/208.14  |- mesh__recordOriginator mesh__D017812 TGC
% 207.97/208.14  |- skos__annotation mesh__D017812
% 207.97/208.14       the largest family of snakes; its venom: coord IM with SNAKE VENOMS %28%IM%29%%A%  
% 207.97/208.14  |- mesh__dateEstablished mesh__D017812 1994-01-01
% 207.97/208.14  |- mesh__recordMaintainer mesh__D017812 ags
% 207.97/208.14  |- rdf__type mesh__D017812sskos__Concept
% 207.97/208.14  |- skos__hiddenLabel mesh__D017812 King Snakes
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D017812 2006
% 207.97/208.14  |- skos__hiddenLabel mesh__D017812 Snake, Garter
% 207.97/208.14  |- mesh__recordAuthorizer mesh__D017812 sjn
% 207.97/208.14  |- skos__hiddenLabel mesh__D017812 Snakes, Water
% 207.97/208.14  |- skos__scopeNote mesh__D017812
% 207.97/208.14       The largest family of snakes, comprising five subfamilies: Colubrinae, Natricinae, Homalopsinae, Lycodontinae, and Xenodontinae. They show a great diversity of eating habits, some eating almost anything, others having a specialized diet. They can be oviparous, ovoviviparous, or viviparous. The majority of North American snakes are colubrines. Among the colubrids are king snakes, water moccasins, water snakes, and garter snakes. Some genera are poisonous. %28%Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, pp321-29%29%%A%    
% 207.97/208.14  |- skos__hiddenLabel mesh__D017812 Mocassins, Water
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D017812 2005
% 207.97/208.14  |- skos__historyNote mesh__D017812 Snakes %28%1968-1993%29%
% 207.97/208.14  |- skos__altLabel mesh__D017812 King Snake
% 207.97/208.14  |- skos__hiddenLabel mesh__D017812 Water Mocassins
% 207.97/208.14  |- skos__hiddenLabel mesh__D017812 Moccasins, Water
% 207.97/208.14  |- skos__hiddenLabel mesh__D017812 Moccasin, Water
% 207.97/208.14  |- skos__hiddenLabel mesh__D017812 Garter Snakes
% 207.97/208.14  |- mesh__historyNote mesh__D017812 94   
% 207.97/208.14  |- mesh__publicMeSHNote mesh__D017812 94   
% 207.97/208.14  |- skos__hiddenLabel mesh__D017812 Snake, King
% 207.97/208.14  |- mesh__dateRevised mesh__D017812 2003-07-09
% 207.97/208.14  |- skos__hiddenLabel mesh__D017812 Mocassin, Water
% 207.97/208.14  |- skos__hiddenLabel mesh__D017812 Snake, Water
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D017014 2006A
% 207.97/208.14  |- skos__prefLabel mesh__D017014 Methanobacterium
% 207.97/208.14  |- skos__scopeNote mesh__D017014
% 207.97/208.14       A genus of anaerobic, rod-shaped METHANOBACTERIACEAE. Its organisms are nonmotile and use ammonia as the sole source of nitrogen. These methanogens are found in aquatic sediments, soil, sewage, and the gastrointestinal tract of animals.%A%    
% 207.97/208.14  |- mesh__dateRevised mesh__D017014 2005-07-20
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D017014 2006
% 207.97/208.14  |- skos__historyNote mesh__D017014 Methanogens %28%1979-1991%29%
% 207.97/208.14  |- mesh__recordOriginator mesh__D017014 PXP
% 207.97/208.14  |- mesh__dateEstablished mesh__D017014 1992-01-01
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D017014 2006B
% 207.97/208.14  |- mesh__publicMeSHNote mesh__D017014 92   
% 207.97/208.14  |- mesh__historyNote mesh__D017014 92   
% 207.97/208.14  |- mesh__recordMaintainer mesh__D017014 ags
% 207.97/208.14  |- rdf__type mesh__D017014sskos__Concept
% 207.97/208.14  |- mesh__dateCreated mesh__D017014 1991-05-30
% 207.97/208.14  |- skos__historyNote mesh__D017014 Bacteria %28%1968-1978%29%
% 207.97/208.14  |- skos__annotation mesh__D017014
% 207.97/208.14       a genus of methanogens found throughout nature %26% in gastrointestinal tract of animals: do not confuse with plural see ref METHANOBACTERIA see EURYARCHAEOTA; DF: METHANOBACT%A%  
% 207.97/208.14  |- mesh__recordAuthorizer mesh__D017014 ags
% 207.97/208.14  |- skos__broader mesh__D017014smesh__D017013
% 207.97/208.14  |- skos__altLabel mesh__D008288 Marsh Fever
% 207.97/208.14  |- skos__scopeNote mesh__D008288
% 207.97/208.14       A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia.%A%    
% 207.97/208.14  |- skos__hiddenLabel mesh__D008288 Fever, Remittent
% 207.97/208.14  |- skos__hiddenLabel mesh__D008288 Fever, Marsh
% 207.97/208.14  |- mesh__dateRevised mesh__D008288 2005-06-30
% 207.97/208.14  |- skos__prefLabel mesh__D008288 Malaria
% 207.97/208.14  |- skos__altLabel mesh__D008288 Paludism
% 207.97/208.14  |- skos__altLabel mesh__D008288 Remittent Fever
% 207.97/208.14  |- mesh__publicMeSHNote mesh__D008288
% 207.97/208.14       MALARIA CONTROL was heading 1963-66   
% 207.97/208.14  |- skos__altLabel mesh__D008288 Plasmodium Infections
% 207.97/208.14  |- mesh__recordOriginator mesh__D008288 NLM
% 207.97/208.14  |- skos__broader mesh__D008288smesh__D003048
% 207.97/208.14  |- skos__related mesh__D008288smesh__D000962
% 207.97/208.14  |- skos__altLabel mesh__D008288 Infections, Plasmodium
% 207.97/208.14  |- skos__hiddenLabel mesh__D008288 Plasmodium Infection
% 207.97/208.14  |- mesh__historyNote mesh__D008288 MALARIA CONTROL was heading 1963-66   
% 207.97/208.14  |- skos__hiddenLabel mesh__D008288 Infection, Plasmodium
% 207.97/208.14  |- mesh__recordAuthorizer mesh__D008288 sjn
% 207.97/208.14  |- mesh__recordMaintainer mesh__D008288 ags
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D008288 2006
% 207.97/208.14  |- mesh__onlineNote mesh__D008288
% 207.97/208.14       use MALARIA to search MALARIA CONTROL 1966   
% 207.97/208.14  |- mesh__dateCreated mesh__D008288 1999-01-01
% 207.97/208.14  |- skos__annotation mesh__D008288
% 207.97/208.14       GEN or unspecified; specify Plasmodium species IM if possible but note P. falciparum malaria = MALARIA, FALCIPARUM; P. vivax malaria = MALARIA, VIVAX; tertian malaria = MALARIA, VIVAX, quartan malaria: coord IM with PLASMODIUM MALARIAE %28%IM%29%; malariotherapy = HYPERTHERMIA, INDUCED: do not confuse with MALARIA /ther; /drug ther: consider also ANTIMALARIALS%A%  
% 207.97/208.14  |- rdf__type mesh__D008288sskos__Concept
% 207.97/208.14  |- skos__annotation mesh__D027442
% 207.97/208.14       do not confuse X ref BAY LAUREL with BAY LAUREL, CALIFORNIA see UMBELLULARIA; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.97/208.14  |- mesh__recordMaintainer mesh__D027442 ssb
% 207.97/208.14  |- skos__historyNote mesh__D027442 Lauraceae %28%1998-2001%29%
% 207.97/208.14  |- mesh__recordAuthorizer mesh__D027442 sjn
% 207.97/208.14  |- mesh__recordOriginator mesh__D027442 ssb
% 207.97/208.14  |- mesh__historyNote mesh__D027442 2002; use LAURACEAE 1998-2001   
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D027442 2005
% 207.97/208.14  |- mesh__dateCreated mesh__D027442 2001-07-25
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D027442 2003
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D027442 2006
% 207.97/208.14  |- skos__prefLabel mesh__D027442 Laurus
% 207.97/208.14  |- mesh__publicMeSHNote mesh__D027442 2002; see LAURACEAE 1998-2001   
% 207.97/208.14  |- skos__scopeNote mesh__D027442
% 207.97/208.14       A plant genus in the LAURACEAE family.  Laurus nobilis L. leaves are known for use in SPICES, having a similar flavor as UMBELLULARIA.%A%    
% 207.97/208.14  |- skos__altLabel mesh__D027442 Bay Laurel
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D027442 2004
% 207.97/208.14  |- mesh__dateEstablished mesh__D027442 2002-01-01
% 207.97/208.14  |- mesh__dateRevised mesh__D027442 2002-07-02
% 207.97/208.14  |- skos__broader mesh__D027442smesh__D019770
% 207.97/208.14  |- rdf__type mesh__D027442sskos__Concept
% 207.97/208.14  |- mesh__dateEstablished mesh__D013422 1991-01-01
% 207.97/208.14  |- skos__scopeNote mesh__D013422
% 207.97/208.14       Long acting sulfonamide antibacterial agent.     
% 207.97/208.14  |- mesh__historyNote mesh__D013422
% 207.97/208.14       91%28%75%29%; was see under SULFANILAMIDES 1975-90   
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D013422 2004
% 207.97/208.14  |- rdf__type mesh__D013422sskos__Concept
% 207.97/208.14  |- mesh__publicMeSHNote mesh__D013422
% 207.97/208.14       91; was see under SULFANILAMIDES 1975-90   
% 207.97/208.14  |- mesh__dateCreated mesh__D013422 1974-11-19
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D013422 2005
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D013422 2001
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D013422 2006
% 207.97/208.14  |- mesh__recordMaintainer mesh__D013422 CCR
% 207.97/208.14  |- skos__historyNote mesh__D013422 Pyrimidines %28%1972-1974%29%
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D013422 2002
% 207.97/208.14  |- mesh__recordAuthorizer mesh__D013422 sjn
% 207.97/208.14  |- skos__prefLabel mesh__D013422 Sulfamonomethoxine
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D013422 2003
% 207.97/208.14  |- skos__broader mesh__D013422smesh__D013424
% 207.97/208.14  |- mesh__recordOriginator mesh__D013422 NLM
% 207.97/208.14  |- skos__historyNote mesh__D013422 Sulfonamides %28%1969-1974%29%
% 207.97/208.14  |- mesh__dateRevised mesh__D013422 2000-06-22
% 207.97/208.14  |- skos__prefLabel mesh__D032387 Tropaeolaceae
% 207.97/208.14  |- skos__broader mesh__D032387smesh__D019684
% 207.97/208.14  |- mesh__historyNote mesh__D032387 2003   
% 207.97/208.14  |- skos__annotation mesh__D032387
% 207.97/208.14       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.97/208.14  |- mesh__dateEstablished mesh__D032387 2003-01-01
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D032387 2006
% 207.97/208.14  |- mesh__dateCreated mesh__D032387 2002-07-03
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D032387 2005
% 207.97/208.14  |- rdf__type mesh__D032387sskos__Concept
% 207.97/208.14  |- mesh__publicMeSHNote mesh__D032387 2003   
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D032387 2004
% 207.97/208.14  |- skos__scopeNote mesh__D032387
% 207.97/208.14       A plant family of the order Geraniales, subclass Rosidae, class Magnoliopsida.%A%    
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D032387 2003
% 207.97/208.14  |- skos__hiddenLabel mesh__D051541
% 207.97/208.14       Hepatocyte Enriched Transcription Factor HNF 3A
% 207.97/208.14  |- skos__hiddenLabel mesh__D051541 HNF 3alpha Protein
% 207.97/208.14  |- mesh__publicMeSHNote mesh__D051541
% 207.97/208.14       2006; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005%A%  
% 207.97/208.14  |- mesh__dateCreated mesh__D051541 2005-06-30
% 207.97/208.14  |- skos__altLabel mesh__D051541
% 207.97/208.14       Hepatocyte-Enriched Transcription Factor HNF-3A
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D051541 2006
% 207.97/208.14  |- skos__altLabel mesh__D051541 HNF-3A Transcription Factor
% 207.97/208.14  |- skos__hiddenLabel mesh__D051541 Hepatocyte Nuclear Factor 3 alpha
% 207.97/208.14  |- mesh__recordAuthorizer mesh__D051541 sjn
% 207.97/208.14  |- mesh__recordOriginator mesh__D051541 DRC
% 207.97/208.14  |- mesh__dateEstablished mesh__D051541 2006-01-01
% 207.97/208.14  |- skos__hiddenLabel mesh__D051541 HNF 3A Transcription Factor
% 207.97/208.14  |- skos__broader mesh__D051541smesh__D051858
% 207.97/208.14  |- rdf__type mesh__D051541sskos__Concept
% 207.97/208.14  |- skos__altLabel mesh__D051541 HNF-3alpha Protein
% 207.97/208.14  |- skos__altLabel mesh__D051541 Forkhead Box A1 Protein
% 207.97/208.14  |- skos__scopeNote mesh__D051541
% 207.97/208.14       A forkhead transcription factor that is an essential activator of GLUCAGON gene expression.%A%    
% 207.97/208.14  |- mesh__recordMaintainer mesh__D051541 DRC
% 207.97/208.14  |- skos__altLabel mesh__D051541 Hepatocyte Nuclear Factor 3alpha
% 207.97/208.14  |- mesh__historyNote mesh__D051541 2006%28%1990%29%   
% 207.97/208.14  |- skos__broader mesh__D051541smesh__D051536
% 207.97/208.14  |- skos__prefLabel mesh__D051541 Hepatocyte Nuclear Factor 3-alpha
% 207.97/208.14  |- skos__hiddenLabel mesh__D051541 Transcription Factor, HNF-3A
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004696 2000
% 207.97/208.14  |- mesh__dateRevised mesh__D004696 1993-06-02
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004696 2004
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004696 1997
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004696 2006
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004696 1999
% 207.97/208.14  |- mesh__recordMaintainer mesh__D004696 PLS
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004696 2003
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004696 1996
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004696 1995
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004696 2005
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004696 1998
% 207.97/208.14  |- skos__prefLabel mesh__D004696 Endocarditis
% 207.97/208.14  |- mesh__recordOriginator mesh__D004696 NLM
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004696 1994
% 207.97/208.14  |- skos__broader mesh__D004696smesh__D006331
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004696 2002
% 207.97/208.14  |- rdf__type mesh__D004696sskos__Concept
% 207.97/208.14  |- skos__hiddenLabel mesh__D004696 Endocarditides
% 207.97/208.14  |- skos__scopeNote mesh__D004696
% 207.97/208.14       Exudative and proliferative inflammatory alterations of the endocardium, characterized by the presence of vegetations on the surface of the endocardium or in the endocardium itself, and most commonly involving a heart valve, but sometimes affecting the inner lining of the cardiac chambers or the endocardium elsewhere. It may occur as a primary disorder or as a complication of or in association with another disease. %28%Dorland, 27th ed%29%%A%    
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004696 2001
% 207.97/208.14  |- mesh__recordAuthorizer mesh__D004696 PLS
% 207.97/208.14  |- skos__annotation mesh__D004696
% 207.97/208.14       inflamm of endocardium but read MeSH definition; rheumatic endocarditis: index under RHEUMATIC HEART DISEASE %28%IM%29% + ENDOCARDITIS %28%IM%29%%A%  
% 207.97/208.14  |- mesh__dateCreated mesh__D004696 1999-01-01
% 207.97/208.14  |- skos__annotation mesh__D045504 not used for indexing or cataloging   
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D045504 2005
% 207.97/208.14  |- rdf__type mesh__D045504sskos__Concept
% 207.97/208.14  |- mesh__dateEstablished mesh__D045504 2004-01-01
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D045504 2006
% 207.97/208.14  |- mesh__historyNote mesh__D045504 2004   
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D045504 2004
% 207.97/208.14  |- skos__related mesh__D045504smesh__D011506
% 207.97/208.14  |- mesh__dateCreated mesh__D045504 2003-07-09
% 207.97/208.14  |- skos__prefLabel mesh__D045504 Molecular Mechanisms of Action
% 207.97/208.14  |- skos__related mesh__D045504smesh__D007155
% 207.97/208.14  |- mesh__publicMeSHNote mesh__D045504 2004   
% 207.97/208.14  |- skos__broader mesh__D045504smesh__D020228
% 207.97/208.14  |- skos__scopeNote mesh__D045504
% 207.97/208.14       Activities at the molecular level of exogenous compounds affecting normal biochemical pathways, including the actions of PROTEINS; CELL SURFACE RECEPTORS; NEUROTRANSMITTERS; and inhibitors.%A%    
% 207.97/208.14  |- skos__related mesh__D045504smesh__D004798
% 207.97/208.14  |- skos__hiddenLabel mesh__D009381 Neoplasm, Radiation-Induced
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D009381 2003
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D009381 2002
% 207.97/208.14  |- skos__broader mesh__D009381smesh__D009369
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D009381 2005
% 207.97/208.14  |- skos__hiddenLabel mesh__D009381 Radiation-Induced Cancers
% 207.97/208.14  |- skos__hiddenLabel mesh__D009381 Radiation Induced Neoplasms
% 207.97/208.14  |- skos__prefLabel mesh__D009381 Neoplasms, Radiation-Induced
% 207.97/208.14  |- skos__annotation mesh__D009381
% 207.97/208.14       IM; coord with specific histol type %28%IM%29% + organ/neopl term %28%IM%29%; Manual 24.4.3.2+; DF: NEOPL RAD IND%A%  
% 207.97/208.14  |- skos__related mesh__D009381smesh__D007953
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D009381 2001
% 207.97/208.14  |- skos__hiddenLabel mesh__D009381 Cancers, Radiation-Induced
% 207.97/208.14  |- skos__altLabel mesh__D009381 Cancer, Radiation-Induced
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D009381 2000
% 207.97/208.14  |- mesh__dateCreated mesh__D009381 1999-01-01
% 207.97/208.14  |- rdf__type mesh__D009381sskos__Concept
% 207.97/208.14  |- skos__hiddenLabel mesh__D009381 Radiation Induced Cancer
% 207.97/208.14  |- mesh__dateRevised mesh__D009381 1999-11-03
% 207.97/208.14  |- skos__hiddenLabel mesh__D009381 Neoplasms, Radiation Induced
% 207.97/208.14  |- skos__altLabel mesh__D009381 Radiation-Induced Neoplasms
% 207.97/208.14  |- mesh__recordMaintainer mesh__D009381 nns
% 207.97/208.14  |- skos__scopeNote mesh__D009381
% 207.97/208.14       Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation.%A%    
% 207.97/208.14  |- mesh__recordAuthorizer mesh__D009381 sjn
% 207.97/208.14  |- skos__hiddenLabel mesh__D009381 Cancer, Radiation Induced
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D009381 2004
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D009381 2006
% 207.97/208.14  |- skos__related mesh__D009381smesh__D016609
% 207.97/208.14  |- skos__broader mesh__D009381smesh__D011832
% 207.97/208.14  |- mesh__recordOriginator mesh__D009381 NLM
% 207.97/208.14  |- skos__hiddenLabel mesh__D009381 Radiation-Induced Neoplasm
% 207.97/208.14  |- skos__prefLabel mesh__D017015 Methanococcales
% 207.97/208.14  |- mesh__recordAuthorizer mesh__D017015 sjn
% 207.97/208.14  |- mesh__recordMaintainer mesh__D017015 SYSTEM
% 207.97/208.14  |- mesh__historyNote mesh__D017015 92   
% 207.97/208.14  |- mesh__recordOriginator mesh__D017015 PXP
% 207.97/208.14  |- rdf__type mesh__D017015sskos__Concept
% 207.97/208.14  |- skos__scopeNote mesh__D017015
% 207.97/208.14       An order of anaerobic methanogens in the kingdom EURYARCHAEOTA. They are pseudosarcina, coccoid or sheathed rod-shaped and catabolize methyl groups. The cell wall is composed of protein. The order includes one family, METHANOCOCCACEAE. %28%From Bergey%27%s Manual of Systemic Bacteriology, 1989%29%%A%    
% 207.97/208.14  |- mesh__dateRevised mesh__D017015 2005-06-30
% 207.97/208.14  |- mesh__dateCreated mesh__D017015 1991-05-30
% 207.97/208.14  |- skos__broader mesh__D017015smesh__D019605
% 207.97/208.14  |- mesh__dateEstablished mesh__D017015 1992-01-01
% 207.97/208.14  |- skos__annotation mesh__D017015 an order of methanogens   
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D017015 2006
% 207.97/208.14  |- mesh__publicMeSHNote mesh__D017015 92   
% 207.97/208.14  |- skos__broader mesh__D011942Q000037smesh__D011942
% 207.97/208.14  |- mesh__preferredCombination mesh__D011942Q000037smesh__D000317
% 207.97/208.14  |- rdf__type mesh__D011942Q000037smesh__CompoundConcept
% 207.97/208.14  |- skos__annotation mesh__D008289
% 207.97/208.14       coord with BIRDS %28%NIM%29% or specific bird or fowl %28%IM%29%   
% 207.97/208.14  |- skos__broader mesh__D008289smesh__D008288
% 207.97/208.14  |- skos__hiddenLabel mesh__D008289 Avian Malaria
% 207.97/208.14  |- mesh__recordMaintainer mesh__D008289 sjn
% 207.97/208.14  |- skos__prefLabel mesh__D008289 Malaria, Avian
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D008289 2006
% 207.97/208.14  |- mesh__recordOriginator mesh__D008289 NLM
% 207.97/208.14  |- mesh__dateRevised mesh__D008289 2004-07-13
% 207.97/208.14  |- mesh__dateCreated mesh__D008289 1999-01-01
% 207.97/208.14  |- rdf__type mesh__D008289sskos__Concept
% 207.97/208.14  |- skos__broader mesh__D008289smesh__D001715
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D008289 2005
% 207.97/208.14  |- skos__scopeNote mesh__D008289
% 207.97/208.14       Any of a group of infections of fowl caused by protozoa of the genera PLASMODIUM, Leucocytozoon, and Haemoproteus. The life cycles of these parasites and the disease produced bears strong resemblance to those observed in human malaria.%A%    
% 207.97/208.14  |- skos__hiddenLabel mesh__D008289 Malarias, Avian
% 207.97/208.14  |- mesh__recordAuthorizer mesh__D008289 sjn
% 207.97/208.14  |- skos__hiddenLabel mesh__D008289 Avian Malarias
% 207.97/208.14  |- mesh__recordOriginator mesh__D027443 ssb
% 207.97/208.14  |- skos__annotation mesh__D027443
% 207.97/208.14       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.97/208.14  |- mesh__historyNote mesh__D027443 2002   
% 207.97/208.14  |- skos__scopeNote mesh__D027443
% 207.97/208.14       A plant genus in the LAURACEAE family.  Lindera benzoin is a source of a balsamic resin called benzoin which is up to 1/3 BENZOIC ACID.  This should not be confused with the chemical BENZOIN or the plant STYRAX BENZOIDES.%A%    
% 207.97/208.14  |- skos__broader mesh__D027443smesh__D019770
% 207.97/208.14  |- skos__prefLabel mesh__D027443 Lindera
% 207.97/208.14  |- mesh__recordMaintainer mesh__D027443 ssb
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D027443 2005
% 207.97/208.14  |- mesh__recordAuthorizer mesh__D027443 sjn
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D027443 2003
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D027443 2006
% 207.97/208.14  |- skos__altLabel mesh__D027443 Wild Allspice
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D027443 2004
% 207.97/208.14  |- mesh__dateEstablished mesh__D027443 2002-01-01
% 207.97/208.14  |- mesh__dateRevised mesh__D027443 2002-07-03
% 207.97/208.14  |- rdf__type mesh__D027443sskos__Concept
% 207.97/208.14  |- mesh__dateCreated mesh__D027443 2001-07-25
% 207.97/208.14  |- mesh__publicMeSHNote mesh__D027443 2002   
% 207.97/208.14  |- skos__related mesh__D027443smesh__D019817
% 207.97/208.14  |- skos__altLabel mesh__D027443 Spicebush
% 207.97/208.14  |- mesh__dateCreated mesh__D013423 1999-01-01
% 207.97/208.14  |- mesh__recordAuthorizer mesh__D013423 sjn
% 207.97/208.14  |- skos__broader mesh__D013423smesh__D013424
% 207.97/208.14  |- mesh__recordOriginator mesh__D013423 NLM
% 207.97/208.14  |- skos__scopeNote mesh__D013423 A sulfanilamide antibacterial agent.     
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D013423 2003
% 207.97/208.14  |- skos__altLabel mesh__D013423 Sulphamoxole
% 207.97/208.14  |- mesh__recordMaintainer mesh__D013423 CCR
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D013423 2004
% 207.97/208.14  |- rdf__type mesh__D013423sskos__Concept
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D013423 2001
% 207.97/208.14  |- mesh__dateRevised mesh__D013423 2000-06-22
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D013423 2005
% 207.97/208.14  |- skos__prefLabel mesh__D013423 Sulfamoxole
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D013423 2002
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D013423 2006
% 207.97/208.14  |- skos__scopeNote mesh__D032388
% 207.97/208.14       A plant genus of the family TROPAEOLACEAE. The common nasturtium is a plant that grows 2.4-3.6 m %28%8-12 feet%29% tall and has funnel-shaped flowers that are commonly yellow-orange with red spots or stripes and have a long spur that contains sweet nectar. Some species in this genus are called watercress which is also a common name for RORIPPA and NASTURTIUM.%A%    
% 207.97/208.14  |- mesh__recordAuthorizer mesh__D032388 jls
% 207.97/208.14  |- skos__broader mesh__D032388smesh__D032387
% 207.97/208.14  |- skos__altLabel mesh__D032388 Cress, Indian
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D032388 2005A
% 207.97/208.14  |- mesh__dateRevised mesh__D032388 2004-08-02
% 207.97/208.14  |- mesh__historyNote mesh__D032388 2003   
% 207.97/208.14  |- mesh__dateEstablished mesh__D032388 2003-01-01
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D032388 2006
% 207.97/208.14  |- mesh__recordMaintainer mesh__D032388 jls
% 207.97/208.14  |- mesh__dateCreated mesh__D032388 2002-07-03
% 207.97/208.14  |- mesh__recordOriginator mesh__D032388 ssb
% 207.97/208.14  |- rdf__type mesh__D032388sskos__Concept
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D032388 2005
% 207.97/208.14  |- skos__altLabel mesh__D032388 Nasturtium, Garden
% 207.97/208.14  |- skos__annotation mesh__D032388
% 207.97/208.14       X ref NASTURTIUM, GARDEN: the genus NASTURTIUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D032388 2004
% 207.97/208.14  |- mesh__publicMeSHNote mesh__D032388 2003   
% 207.97/208.14  |- skos__prefLabel mesh__D032388 Tropaeolum
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D032388 2003
% 207.97/208.14  |- mesh__recordMaintainer mesh__D051542 DRC
% 207.97/208.14  |- mesh__publicMeSHNote mesh__D051542
% 207.97/208.14       2006; HEPATOCYTE NUCLEAR FACTOR 3-BETA was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1991-2005%A%  
% 207.97/208.14  |- skos__hiddenLabel mesh__D051542 HNF 3beta Protein
% 207.97/208.14  |- mesh__recordOriginator mesh__D051542 DRC
% 207.97/208.14  |- skos__hiddenLabel mesh__D051542 Hepatocyte Nuclear Factor 3 beta
% 207.97/208.14  |- mesh__dateCreated mesh__D051542 2005-06-30
% 207.97/208.14  |- skos__altLabel mesh__D051542 Forkhead Box A2 Protein
% 207.97/208.14  |- skos__prefLabel mesh__D051542 Hepatocyte Nuclear Factor 3-beta
% 207.97/208.14  |- skos__broader mesh__D051542smesh__D051858
% 207.97/208.14  |- rdf__type mesh__D051542sskos__Concept
% 207.97/208.14  |- skos__altLabel mesh__D051542 HNF-3beta Protein
% 207.97/208.14  |- mesh__recordAuthorizer mesh__D051542 sjn
% 207.97/208.14  |- skos__altLabel mesh__D051542 Hepatocyte Nuclear Factor 3beta
% 207.97/208.14  |- mesh__dateEstablished mesh__D051542 2006-01-01
% 207.97/208.14  |- skos__broader mesh__D051542smesh__D051536
% 207.97/208.14  |- mesh__historyNote mesh__D051542 2006%28%1991%29%   
% 207.97/208.14  |- skos__scopeNote mesh__D051542
% 207.97/208.14       A forkhead transcription factor that regulates expression of metabolic GENES and is involved in EMBRYONIC DEVELOPMENT. Mutations in HNF-3beta have been associated with PERSISTENT HYPERINSULINEMIA HYPOGLYCEMIA OF INFANCY.%A%    
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D051542 2006
% 207.97/208.14  |- mesh__recordAuthorizer mesh__D004697 PLS
% 207.97/208.14  |- mesh__dateRevised mesh__D004697 1991-06-27
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004697 1993
% 207.97/208.14  |- skos__altLabel mesh__D004697 Endocarditides, Bacterial
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004697 2003
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004697 1996
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004697 1995
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004697 2000
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004697 2005
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004697 1998
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004697 1992
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004697 1994
% 207.97/208.14  |- rdf__type mesh__D004697sskos__Concept
% 207.97/208.14  |- mesh__recordMaintainer mesh__D004697 TGC
% 207.97/208.14  |- skos__broader mesh__D004697smesh__D001424
% 207.97/208.14  |- skos__altLabel mesh__D004697 Bacterial Endocarditides
% 207.97/208.14  |- skos__related mesh__D004697smesh__D000785
% 207.97/208.14  |- mesh__recordOriginator mesh__D004697 NLM
% 207.97/208.14  |- mesh__dateCreated mesh__D004697 1999-01-01
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004697 2002
% 207.97/208.14  |- skos__annotation mesh__D004697
% 207.97/208.14       coord with specific bacterium /infections heading %28%IM%29% if pertinent; DF: ENDOCARDITIS BACT%A%  
% 207.97/208.14  |- skos__altLabel mesh__D004697 Bacterial Endocarditis
% 207.97/208.14  |- skos__prefLabel mesh__D004697 Endocarditis, Bacterial
% 207.97/208.14  |- mesh__activeMeSHYear mesh__D004697 2004
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D004697 1997
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D004697 2001
% 207.97/208.15  |- skos__broader mesh__D004697smesh__D004696
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D004697 2006
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D004697 1999
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D045505 2006
% 207.97/208.15  |- skos__scopeNote mesh__D045505
% 207.97/208.15       Activities which affect organs and systemic functions without regard to a particular disease.%A%    
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D045505 2004
% 207.97/208.15  |- skos__prefLabel mesh__D045505 Physiological Effects of Drugs
% 207.97/208.15  |- skos__annotation mesh__D045505 not used for indexing or cataloging   
% 207.97/208.15  |- skos__altLabel mesh__D045505 Drug Effects on Physiology
% 207.97/208.15  |- mesh__dateEstablished mesh__D045505 2004-01-01
% 207.97/208.15  |- mesh__dateCreated mesh__D045505 2003-07-09
% 207.97/208.15  |- mesh__historyNote mesh__D045505 2004   
% 207.97/208.15  |- mesh__publicMeSHNote mesh__D045505 2004   
% 207.97/208.15  |- skos__hiddenLabel mesh__D045505 Effects, Drug Physiological
% 207.97/208.15  |- skos__hiddenLabel mesh__D045505 Physiological Effects, Drug
% 207.97/208.15  |- skos__altLabel mesh__D045505 Drug Physiological Effects
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D045505 2005
% 207.97/208.15  |- rdf__type mesh__D045505sskos__Concept
% 207.97/208.15  |- skos__broader mesh__D045505smesh__D020228
% 207.97/208.15  |- mesh__publicMeSHNote mesh__D009382 87   
% 207.97/208.15  |- mesh__recordAuthorizer mesh__D009382 sjn
% 207.97/208.15  |- mesh__dateRevised mesh__D009382 2000-06-22
% 207.97/208.15  |- skos__annotation mesh__D009382
% 207.97/208.15       IM; do not use /second; coord IM with organ/neopl term with /second %28%IM%29% + histol type /second %28%IM%29%; Manual 24.4.1.8%A%  
% 207.97/208.15  |- skos__hiddenLabel mesh__D009382 Tumors, Unknown Primary
% 207.97/208.15  |- skos__hiddenLabel mesh__D009382 Primary Tumors, Unknown
% 207.97/208.15  |- skos__hiddenLabel mesh__D009382 Unknown Primary Tumor
% 207.97/208.15  |- skos__hiddenLabel mesh__D009382 Occult Primary Neoplasm
% 207.97/208.15  |- skos__scopeNote mesh__D009382
% 207.97/208.15       Metastases in which the tissue of origin is unknown.     
% 207.97/208.15  |- skos__altLabel mesh__D009382 Unknown Primary Neoplasm Metastasis
% 207.97/208.15  |- mesh__dateEstablished mesh__D009382 1987-01-01
% 207.97/208.15  |- mesh__recordOriginator mesh__D009382 VDK
% 207.97/208.15  |- skos__hiddenLabel mesh__D009382 Unknown Primary Neoplasm
% 207.97/208.15  |- mesh__dateCreated mesh__D009382 1986-04-18
% 207.97/208.15  |- skos__hiddenLabel mesh__D009382 Primary Neoplasms, Unknown
% 207.97/208.15  |- rdf__type mesh__D009382sskos__Concept
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D009382 2002
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D009382 2004
% 207.97/208.15  |- skos__hiddenLabel mesh__D009382 Primary Tumor, Unknown
% 207.97/208.15  |- skos__hiddenLabel mesh__D009382 Tumor, Unknown Primary
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D009382 2001
% 207.97/208.15  |- skos__hiddenLabel mesh__D009382 Neoplasm, Unknown Primary
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D009382 2003
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D009382 2006
% 207.97/208.15  |- skos__prefLabel mesh__D009382 Neoplasms, Unknown Primary
% 207.97/208.15  |- mesh__historyNote mesh__D009382 87   
% 207.97/208.15  |- skos__hiddenLabel mesh__D009382 Neoplasm, Occult Primary
% 207.97/208.15  |- skos__altLabel mesh__D009382 Occult Primary Neoplasms
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D009382 2005
% 207.97/208.15  |- skos__hiddenLabel mesh__D009382 Primary Neoplasm, Unknown
% 207.97/208.15  |- skos__hiddenLabel mesh__D009382 Primary Neoplasm, Occult
% 207.97/208.15  |- skos__broader mesh__D009382smesh__D009362
% 207.97/208.15  |- skos__altLabel mesh__D009382 Unknown Primary Neoplasms
% 207.97/208.15  |- skos__altLabel mesh__D009382 Neoplasms, Occult Primary
% 207.97/208.15  |- mesh__recordMaintainer mesh__D009382 KEV
% 207.97/208.15  |- skos__hiddenLabel mesh__D009382 Primary Neoplasms, Occult
% 207.97/208.15  |- mesh__recordOriginator mesh__D017016 PXP
% 207.97/208.15  |- rdf__type mesh__D017016sskos__Concept
% 207.97/208.15  |- mesh__publicMeSHNote mesh__D017016 92   
% 207.97/208.15  |- mesh__recordAuthorizer mesh__D017016 sjn
% 207.97/208.15  |- mesh__dateCreated mesh__D017016 1991-05-30
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D017016 2006
% 207.97/208.15  |- skos__broader mesh__D017016smesh__D017015
% 207.97/208.15  |- mesh__dateRevised mesh__D017016 2005-06-30
% 207.97/208.15  |- skos__prefLabel mesh__D017016 Methanococcaceae
% 207.97/208.15  |- mesh__dateEstablished mesh__D017016 1992-01-01
% 207.97/208.15  |- skos__scopeNote mesh__D017016
% 207.97/208.15       A family of anaerobic METHANOCOCCALES whose organisms are motile by means of flagella. These methanogens use carbon dioxide as an electron acceptor.%A%    
% 207.97/208.15  |- mesh__recordMaintainer mesh__D017016 SYSTEM
% 207.97/208.15  |- mesh__historyNote mesh__D017016 92   
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D033481 2004
% 207.97/208.15  |- mesh__dateEstablished mesh__D033481 2003-01-01
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D033481 2003
% 207.97/208.15  |- skos__prefLabel mesh__D033481 Chromosomes, Mammalian
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D033481 2006
% 207.97/208.15  |- skos__historyNote mesh__D033481 Chromosomes %28%1965-2002%29%
% 207.97/208.15  |- skos__hiddenLabel mesh__D033481 Mammalian Chromosomes
% 207.97/208.15  |- skos__scopeNote mesh__D033481
% 207.97/208.15       Complex nucleoprotein structures which contain the genomic DNA and are part of the CELL NUCLEUS of MAMMALS.%A%    
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D033481 2005
% 207.97/208.15  |- skos__hiddenLabel mesh__D033481 Mammalian Chromosome
% 207.97/208.15  |- mesh__publicMeSHNote mesh__D033481 2003   
% 207.97/208.15  |- mesh__dateCreated mesh__D033481 2002-07-03
% 207.97/208.15  |- skos__hiddenLabel mesh__D033481 Chromosome, Mammalian
% 207.97/208.15  |- skos__broader mesh__D033481smesh__D002875
% 207.97/208.15  |- mesh__historyNote mesh__D033481 2003   
% 207.97/208.15  |- rdf__type mesh__D033481sskos__Concept
% 207.97/208.15  |- mesh__recordOriginator mesh__D005790 NLM
% 207.97/208.15  |- mesh__dateEstablished mesh__D005790 1991-01-01
% 207.97/208.15  |- mesh__onlineNote mesh__D005790
% 207.97/208.15       search STRESS %26% ADAPTATION, PHYSIOLOGICAL 1966-74   
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D005790 2006
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D005790 2002
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D005790 2004
% 207.97/208.15  |- mesh__recordAuthorizer mesh__D005790 sjn
% 207.97/208.15  |- mesh__dateCreated mesh__D005790 1999-01-01
% 207.97/208.15  |- rdf__type mesh__D005790sskos__Concept
% 207.97/208.15  |- skos__hiddenLabel mesh__D005790 Adaptation Syndromes, General
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D005790 2005
% 207.97/208.15  |- skos__hiddenLabel mesh__D005790 General Adaptation Syndromes
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D005790 2003
% 207.97/208.15  |- skos__prefLabel mesh__D005790 General Adaptation Syndrome
% 207.97/208.15  |- skos__scopeNote mesh__D005790
% 207.97/208.15       The sum of all nonspecific systemic reactions of the body to long-continued exposure to systemic stress.%A%    
% 207.97/208.15  |- mesh__historyNote mesh__D005790
% 207.97/208.15       91%28%75%29%; was see under STRESS 1975-90; was see under STRESS %26% ADAPTATION, PHYSIOLOGICAL 1963-74%A%  
% 207.97/208.15  |- skos__hiddenLabel mesh__D005790 Adaptation Syndrome, General
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D005790 2001
% 207.97/208.15  |- skos__broader mesh__D005790smesh__D012920
% 207.97/208.15  |- skos__hiddenLabel mesh__D005790 Syndromes, General Adaptation
% 207.97/208.15  |- skos__annotation mesh__D005790
% 207.97/208.15       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D005790 2000
% 207.97/208.15  |- mesh__dateRevised mesh__D005790 1999-11-08
% 207.97/208.15  |- mesh__publicMeSHNote mesh__D005790
% 207.97/208.15       91; was see under STRESS 1975-90; was see under STRESS %26% ADAPTATION, PHYSIOLOGICAL 1963-74%A%  
% 207.97/208.15  |- skos__hiddenLabel mesh__D005790 Syndrome, General Adaptation
% 207.97/208.15  |- mesh__recordMaintainer mesh__D005790 KEV
% 207.97/208.15  |- skos__broader mesh__D027444smesh__D019770
% 207.97/208.15  |- rdf__type mesh__D027444sskos__Concept
% 207.97/208.15  |- skos__prefLabel mesh__D027444 Ocotea
% 207.97/208.15  |- mesh__dateRevised mesh__D027444 2002-07-03
% 207.97/208.15  |- mesh__recordMaintainer mesh__D027444 ssb
% 207.97/208.15  |- skos__annotation mesh__D027444
% 207.97/208.15       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.97/208.15  |- skos__scopeNote mesh__D027444
% 207.97/208.15       A plant genus in the LAURACEAE family. The common name of stinkwood is also used for Zieria %28%RUTACEAE%29%.%A%    
% 207.97/208.15  |- mesh__historyNote mesh__D027444 2002   
% 207.97/208.15  |- mesh__publicMeSHNote mesh__D027444 2002   
% 207.97/208.15  |- mesh__recordOriginator mesh__D027444 ssb
% 207.97/208.15  |- mesh__dateEstablished mesh__D027444 2002-01-01
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D027444 2004
% 207.97/208.15  |- mesh__recordAuthorizer mesh__D027444 sjn
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D027444 2006
% 207.97/208.15  |- mesh__dateCreated mesh__D027444 2001-07-25
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D027444 2003
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D027444 2005
% 207.97/208.15  |- mesh__dateCreated mesh__D013424 1999-01-01
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D013424 2006
% 207.97/208.15  |- mesh__recordOriginator mesh__D013424 NLM
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D013424 1996
% 207.97/208.15  |- skos__annotation mesh__D013424
% 207.97/208.15       anti-infectives; GEN; prefer specific sulfanilamide anti-infective%A%  
% 207.97/208.15  |- skos__prefLabel mesh__D013424 Sulfanilamides
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D013424 1997
% 207.97/208.15  |- mesh__recordAuthorizer mesh__D013424 PLS
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D013424 2000
% 207.97/208.15  |- mesh__onlineNote mesh__D013424
% 207.97/208.15       use SULFANILAMIDES to search SULFANILAMIDE 1966-74   
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D013424 2003
% 207.97/208.15  |- mesh__publicMeSHNote mesh__D013424 75; was SULFANILAMIDE 1963-74   
% 207.97/208.15  |- mesh__recordMaintainer mesh__D013424 JRT
% 207.97/208.15  |- rdf__type mesh__D013424sskos__Concept
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D013424 1998
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D013424 2001
% 207.97/208.15  |- mesh__historyNote mesh__D013424 75; was SULFANILAMIDE 1963-74   
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D013424 2004
% 207.97/208.15  |- mesh__dateRevised mesh__D013424 1995-06-08
% 207.97/208.15  |- skos__broader mesh__D013424smesh__D013449
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D013424 1999
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D013424 2002
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D013424 2005
% 207.97/208.15  |- skos__scopeNote mesh__D032389
% 207.97/208.15       Non-striated, elongated, spindle-shaped cells found lining the digestive tract, uterus, and blood vessels. They are derived from specialized myoblasts %28%MYOBLASTS, SMOOTH MUSCLE%29%.%A%    
% 207.97/208.15  |- skos__hiddenLabel mesh__D032389 Smooth Muscle Cell
% 207.97/208.15  |- skos__prefLabel mesh__D032389 Myocytes, Smooth Muscle
% 207.97/208.15  |- skos__hiddenLabel mesh__D032389 Cell, Smooth Muscle
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D032389 2006
% 207.97/208.15  |- skos__hiddenLabel mesh__D032389 Myocyte, Smooth Muscle
% 207.97/208.15  |- skos__historyNote mesh__D032389
% 207.97/208.15       Muscle, Smooth/cytology %28%1964-2002%29%
% 207.97/208.15  |- skos__related mesh__D032389smesh__D032390
% 207.97/208.15  |- rdf__type mesh__D032389sskos__Concept
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D032389 2005
% 207.97/208.15  |- skos__hiddenLabel mesh__D032389 Cells, Smooth Muscle
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D032389 2004
% 207.97/208.15  |- mesh__publicMeSHNote mesh__D032389 2003   
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D032389 2003
% 207.97/208.15  |- mesh__dateEstablished mesh__D032389 2003-01-01
% 207.97/208.15  |- skos__broader mesh__D032389smesh__D032342
% 207.97/208.15  |- mesh__historyNote mesh__D032389 2003   
% 207.97/208.15  |- skos__altLabel mesh__D032389 Smooth Muscle Cells
% 207.97/208.15  |- skos__hiddenLabel mesh__D032389 Smooth Muscle Myocytes
% 207.97/208.15  |- skos__hiddenLabel mesh__D032389 Smooth Muscle Myocyte
% 207.97/208.15  |- mesh__dateCreated mesh__D032389 2002-07-03
% 207.97/208.15  |- skos__prefLabel mesh__D051543 Hepatocyte Nuclear Factor 3-gamma
% 207.97/208.15  |- skos__altLabel mesh__D051543 HNF-3gamma Protein
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D051543 2006
% 207.97/208.15  |- mesh__dateEstablished mesh__D051543 2006-01-01
% 207.97/208.15  |- skos__broader mesh__D051543smesh__D051858
% 207.97/208.15  |- mesh__recordMaintainer mesh__D051543 DRC
% 207.97/208.15  |- skos__altLabel mesh__D051543 Forkhead Box A3 Protein
% 207.97/208.15  |- mesh__historyNote mesh__D051543 2006%28%1991%29%   
% 207.97/208.15  |- skos__hiddenLabel mesh__D051543 HNF 3gamma Protein
% 207.97/208.15  |- skos__scopeNote mesh__D051543
% 207.97/208.15       A winged-helix transcription factor that regulates GENE expression in metabolic tissues. It plays a role in HOMEOSTASIS of GLUCOSE and controls expression of GLUT2 PROTEIN.%A%    
% 207.97/208.15  |- skos__hiddenLabel mesh__D051543 Hepatocyte Nuclear Factor 3 gamma
% 207.97/208.15  |- mesh__recordOriginator mesh__D051543 DRC
% 207.97/208.15  |- mesh__dateCreated mesh__D051543 2005-06-30
% 207.97/208.15  |- rdf__type mesh__D051543sskos__Concept
% 207.97/208.15  |- skos__broader mesh__D051543smesh__D051536
% 207.97/208.15  |- mesh__publicMeSHNote mesh__D051543
% 207.97/208.15       2006; HEPATOCYTE NUCLEAR FACTOR 3-GAMMA was indexed under DNA-BINDING PROTINS %26% NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1991-2005%A%  
% 207.97/208.15  |- skos__altLabel mesh__D051543 Hepatocyte Nuclear Factor 3gamma
% 207.97/208.15  |- mesh__recordAuthorizer mesh__D051543 sjn
% 207.97/208.15  |- mesh__dateRevised mesh__D004698 1991-06-12
% 207.97/208.15  |- mesh__recordOriginator mesh__D004698 NLM
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D004698 2002
% 207.97/208.15  |- skos__altLabel mesh__D004698 Bacterial Endocarditides, Subacute
% 207.97/208.15  |- skos__altLabel mesh__D004698 Bacterial Endocarditis, Subacute
% 207.97/208.15  |- mesh__dateCreated mesh__D004698 1999-01-01
% 207.97/208.15  |- skos__broader mesh__D004698smesh__D013290
% 207.97/208.15  |- skos__altLabel mesh__D004698 Subacute Bacterial Endocarditides
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D004698 2001
% 207.97/208.15  |- mesh__recordAuthorizer mesh__D004698 PLS
% 207.97/208.15  |- skos__prefLabel mesh__D004698 Endocarditis, Subacute Bacterial
% 207.97/208.15  |- skos__annotation mesh__D004698
% 207.97/208.15       coord with specific bacterium /infections heading %28%IM%29%; DF: ENDOCARDITIS SUBACUTE BACT%A%  
% 207.97/208.15  |- skos__altLabel mesh__D004698 Subacute Bacterial Endocarditis
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D004698 2004
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D004698 1997
% 207.97/208.15  |- mesh__recordMaintainer mesh__D004698 PXP
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D004698 2000
% 207.97/208.15  |- skos__broader mesh__D004698smesh__D004697
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D004698 2006
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D004698 1999
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D004698 1993
% 207.97/208.15  |- skos__scopeNote mesh__D004698
% 207.97/208.15       Infection of the endocardium caused by species of STREPTOCOCCUS. This condition does not produce metastatic foci and if untreated may take up to a year to be fatal.%A%    
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D004698 2003
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D004698 1996
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D004698 1995
% 207.97/208.15  |- skos__altLabel mesh__D004698 Endocarditides, Subacute Bacterial
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D004698 2005
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D004698 1998
% 207.97/208.15  |- skos__altLabel mesh__D004698 Endocarditis Lenta
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D004698 1992
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D004698 1994
% 207.97/208.15  |- rdf__type mesh__D004698sskos__Concept
% 207.97/208.15  |- mesh__dateCreated mesh__D045506 2003-07-09
% 207.97/208.15  |- mesh__publicMeSHNote mesh__D045506 2004   
% 207.97/208.15  |- skos__broader mesh__D045506smesh__D020228
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D045506 2005
% 207.97/208.15  |- rdf__type mesh__D045506sskos__Concept
% 207.97/208.15  |- skos__hiddenLabel mesh__D045506 Uses, Therapeutic
% 207.97/208.15  |- skos__scopeNote mesh__D045506
% 207.97/208.15       Uses of chemicals which affect the course of conditions, diseases, syndromes or pathology to benefit the health of an individual.%A%    
% 207.97/208.15  |- mesh__dateEstablished mesh__D045506 2004-01-01
% 207.97/208.15  |- skos__annotation mesh__D045506 not used for indexing or cataloging   
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D045506 2006
% 207.97/208.15  |- skos__prefLabel mesh__D045506 Therapeutic Uses
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D045506 2004
% 207.97/208.15  |- mesh__historyNote mesh__D045506 2004   
% 207.97/208.15  |- rdf__type mesh__D009383sskos__Concept
% 207.97/208.15  |- skos__altLabel mesh__D009383 Blood Vessel Tumors
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D009383 2004
% 207.97/208.15  |- mesh__recordAuthorizer mesh__D009383 PLS
% 207.97/208.15  |- skos__scopeNote mesh__D009383
% 207.97/208.15       Neoplasms composed of vascular tissue. This concept does not refer to neoplasms located in blood vessels.%A%    
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D009383 2000
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D009383 2003
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D009383 2006
% 207.97/208.15  |- skos__hiddenLabel mesh__D009383 Tumors, Blood Vessel
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D009383 1997
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D009383 2005
% 207.97/208.15  |- mesh__recordMaintainer mesh__D009383 TGC
% 207.97/208.15  |- skos__altLabel mesh__D009383 Vascular Tissue Neoplasms
% 207.97/208.15  |- skos__hiddenLabel mesh__D009383 Blood Vessel Tumor
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D009383 1999
% 207.97/208.15  |- skos__annotation mesh__D009383
% 207.97/208.15       neoplasms composed of vascular tissue, NOT neoplasms located in vascular tissue %28% = VASCULAR NEOPLASMS%29%: TN 135; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; restricted use: Manual 24.2.2.5%A%  
% 207.97/208.15  |- skos__hiddenLabel mesh__D009383 Neoplasm, Vascular Tissue
% 207.97/208.15  |- mesh__recordOriginator mesh__D009383 NLM
% 207.97/208.15  |- skos__prefLabel mesh__D009383 Neoplasms, Vascular Tissue
% 207.97/208.15  |- skos__hiddenLabel mesh__D009383 Vascular Tissue Neoplasm
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D009383 1998
% 207.97/208.15  |- mesh__dateRevised mesh__D009383 1996-06-10
% 207.97/208.15  |- skos__broader mesh__D009383smesh__D009370
% 207.97/208.15  |- skos__hiddenLabel mesh__D009383 Tumor, Blood Vessel
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D009383 2002
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D009383 2001
% 207.97/208.15  |- mesh__dateCreated mesh__D009383 1999-01-01
% 207.97/208.15  |- skos__related mesh__D017815smesh__D004546
% 207.97/208.15  |- skos__altLabel mesh__D017815 Dendroaspis
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D017815 2005
% 207.97/208.15  |- skos__hiddenLabel mesh__D017815 Coral Snakes
% 207.97/208.15  |- skos__annotation mesh__D017815 a family of very venomous snakes   
% 207.97/208.15  |- skos__historyNote mesh__D017815 Snakes %28%1966-1993%29%
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D017815 2006
% 207.97/208.15  |- skos__hiddenLabel mesh__D017815 Snakes, Coral
% 207.97/208.15  |- skos__hiddenLabel mesh__D017815 Snake, Coral
% 207.97/208.15  |- skos__hiddenLabel mesh__D017815 Mambas
% 207.97/208.15  |- mesh__publicMeSHNote mesh__D017815 94   
% 207.97/208.15  |- mesh__historyNote mesh__D017815 94   
% 207.97/208.15  |- skos__prefLabel mesh__D017815 Elapidae
% 207.97/208.15  |- skos__scopeNote mesh__D017815
% 207.97/208.15       A family of extremely venomous snakes, comprising coral snakes, cobras, mambas, kraits, and sea snakes. They are widely distributed, being found in the southern United States, South America, Africa, southern Asia, Australia, and the Pacific Islands. The elapids include three subfamilies: Elapinae, Hydrophiinae, and Lauticaudinae. Like the viperids, they have venom fangs in the front part of the upper jaw. The mambas of Africa are the most dangerous of all snakes by virtue of their size, speed, and highly toxic venom. %28%Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, p329-33%29%%A%    
% 207.97/208.15  |- mesh__dateEstablished mesh__D017815 1994-01-01
% 207.97/208.15  |- mesh__recordOriginator mesh__D017815 TGC
% 207.97/208.15  |- mesh__dateCreated mesh__D017815 1993-02-16
% 207.97/208.15  |- mesh__dateRevised mesh__D017815 2003-07-09
% 207.97/208.15  |- skos__broader mesh__D017815smesh__D012911
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D017815 2004
% 207.97/208.15  |- mesh__recordMaintainer mesh__D017815 ags
% 207.97/208.15  |- mesh__recordAuthorizer mesh__D017815 sjn
% 207.97/208.15  |- rdf__type mesh__D017815sskos__Concept
% 207.97/208.15  |- skos__altLabel mesh__D017815 Coral Snake
% 207.97/208.15  |- mesh__dateRevised mesh__D017017 2005-06-30
% 207.97/208.15  |- skos__broader mesh__D017017smesh__D017016
% 207.97/208.15  |- mesh__recordOriginator mesh__D017017 PXP
% 207.97/208.15  |- mesh__historyNote mesh__D017017 92   
% 207.97/208.15  |- rdf__type mesh__D017017sskos__Concept
% 207.97/208.15  |- mesh__recordMaintainer mesh__D017017 SYSTEM
% 207.97/208.15  |- mesh__publicMeSHNote mesh__D017017 92   
% 207.97/208.15  |- skos__prefLabel mesh__D017017 Methanococcus
% 207.97/208.15  |- skos__historyNote mesh__D017017 Bacteria %28%1977-1978%29%
% 207.97/208.15  |- mesh__recordAuthorizer mesh__D017017 sjn
% 207.97/208.15  |- skos__annotation mesh__D017017
% 207.97/208.15       a genus of methanogens found in aquatic environments %26% in animal intestine%A%  
% 207.97/208.15  |- mesh__dateCreated mesh__D017017 1991-05-30
% 207.97/208.15  |- skos__scopeNote mesh__D017017
% 207.97/208.15       A genus of anaerobic coccoid METHANOCOCCACEAE whose organisms are motile by means of polar tufts of flagella. These methanogens are found in salt marshes, marine and estuarine sediments, and the intestinal tract of animals.%A%    
% 207.97/208.15  |- mesh__dateEstablished mesh__D017017 1992-01-01
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D017017 2006
% 207.97/208.15  |- skos__historyNote mesh__D017017 Methanogens %28%1979-1991%29%
% 207.97/208.15  |- rdf__type mesh__D005791sskos__Concept
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D005791 2005
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D005791 2001
% 207.97/208.15  |- skos__hiddenLabel mesh__D005791 Care, Patient
% 207.97/208.15  |- mesh__dateEstablished mesh__D005791 1998-01-01
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D005791 2003
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D005791 2000
% 207.97/208.15  |- skos__historyNote mesh__D005791 Nursing Care %28%1966-1997%29%
% 207.97/208.15  |- skos__annotation mesh__D005791
% 207.97/208.15       by professional %26% non-professional; GEN or unspecified; prefer specifics; not a synonym for NURSING CARE: nursing care is only one type of patient care%A%  
% 207.97/208.15  |- mesh__recordOriginator mesh__D005791 NLM
% 207.97/208.15  |- mesh__dateRevised mesh__D005791 1999-11-03
% 207.97/208.15  |- skos__historyNote mesh__D005791 Patient Care Planning %28%1993-1997%29%
% 207.97/208.15  |- skos__prefLabel mesh__D005791 Patient Care
% 207.97/208.15  |- mesh__historyNote mesh__D005791 98; use explode 1975-97   
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D005791 2002
% 207.97/208.15  |- skos__broader mesh__D005791smesh__D013812
% 207.97/208.15  |- skos__scopeNote mesh__D005791
% 207.97/208.15       The services rendered by members of the health profession and non-professionals under their supervision for the benefit of the patient. %28%From Dorland, 28th ed, p269%29%%A%    
% 207.97/208.15  |- mesh__recordAuthorizer mesh__D005791 sjn
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D005791 2006
% 207.97/208.15  |- mesh__recordMaintainer mesh__D005791 kle
% 207.97/208.15  |- mesh__publicMeSHNote mesh__D005791 98   
% 207.97/208.15  |- skos__broader mesh__D005791smesh__D006296
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D005791 2004
% 207.97/208.15  |- mesh__dateCreated mesh__D005791 1999-01-01
% 207.97/208.15  |- skos__historyNote mesh__D013425 Benzenesulfonates %28%1974%29%
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D013425 2002
% 207.97/208.15  |- skos__broader mesh__D013425smesh__D017739
% 207.97/208.15  |- skos__historyNote mesh__D013425 Amines %28%1974%29%
% 207.97/208.15  |- skos__scopeNote mesh__D013425
% 207.97/208.15       Aminobenzenesulfonic acids. Organic acids that are used in the manufacture of dyes and organic chemicals and as reagents.%A%    
% 207.97/208.15  |- skos__altLabel mesh__D013425 Anilinesulfonic Acids
% 207.97/208.15  |- mesh__historyNote mesh__D013425
% 207.97/208.15       91%28%83%29%; was see under BENZENESULFONATES 1983-90; was SULFANILIC ACID see under BENZENESULFONATES 1975-82%A%  
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D013425 2003
% 207.97/208.15  |- mesh__recordAuthorizer mesh__D013425 sjn
% 207.97/208.15  |- skos__broader mesh__D013425smesh__D001555
% 207.97/208.15  |- mesh__recordOriginator mesh__D013425 NLM
% 207.97/208.15  |- rdf__type mesh__D013425sskos__Concept
% 207.97/208.15  |- skos__hiddenLabel mesh__D013425 Acids, Sulfanilic
% 207.97/208.15  |- mesh__dateEstablished mesh__D013425 1991-01-01
% 207.97/208.15  |- mesh__dateCreated mesh__D013425 1974-11-19
% 207.97/208.15  |- skos__prefLabel mesh__D013425 Sulfanilic Acids
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D013425 2004
% 207.97/208.15  |- skos__related mesh__D013425smesh__D007202
% 207.97/208.15  |- skos__altLabel mesh__D013425 Aminobenzenesulfonic Acids
% 207.97/208.15  |- mesh__recordMaintainer mesh__D013425 CCR
% 207.97/208.15  |- mesh__dateRevised mesh__D013425 2000-06-21
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D013425 2005
% 207.97/208.15  |- skos__hiddenLabel mesh__D013425 Acids, Anilinesulfonic
% 207.97/208.15  |- skos__hiddenLabel mesh__D013425 Acids, Aminobenzenesulfonic
% 207.97/208.15  |- mesh__onlineNote mesh__D013425
% 207.97/208.15       use SULFANILIC ACIDS to search SULFANILIC ACID 1975-82   
% 207.97/208.15  |- mesh__publicMeSHNote mesh__D013425
% 207.97/208.15       91; was see under BENZENESULFONATES 1983-90; was SULFANILIC ACID see under BENZENESULFONATES 1975-82%A%  
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D013425 2001
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D013425 2006
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D018110 2002
% 207.97/208.15  |- mesh__historyNote mesh__D018110
% 207.97/208.15       94; was LIPOPROTEIN RECEPTOR %28%NM%29% 1981-93   
% 207.97/208.15  |- skos__hiddenLabel mesh__D018110 Lipoproteins Receptors
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D018110 2006
% 207.97/208.15  |- skos__annotation mesh__D018110
% 207.97/208.15       GEN; RECEPTORS, LDL is available; DF: RECEPT LIPOPROTEIN   
% 207.97/208.15  |- skos__broader mesh__D018110smesh__D011956
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D018110 1999
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D018110 2001
% 207.97/208.15  |- mesh__onlineNote mesh__D018110
% 207.97/208.15       use RECEPTORS, LIPOPROTEIN %28%NM%29% to search LIPOPROTEIN RECEPTOR 1981-93%A%  
% 207.97/208.15  |- mesh__dateRevised mesh__D018110 1995-06-08
% 207.97/208.15  |- rdf__type mesh__D018110sskos__Concept
% 207.97/208.15  |- mesh__publicMeSHNote mesh__D018110
% 207.97/208.15       94; LIPOPROTEIN RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-93%A%  
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D018110 2000
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D018110 2005
% 207.97/208.15  |- skos__altLabel mesh__D018110 Lipoprotein Receptor
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D018110 1998
% 207.97/208.15  |- mesh__dateCreated mesh__D018110 1993-06-21
% 207.97/208.15  |- skos__altLabel mesh__D018110 Receptors, Lipoproteins
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D018110 2004
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D018110 1997
% 207.97/208.15  |- mesh__recordAuthorizer mesh__D018110 PLS
% 207.97/208.15  |- skos__hiddenLabel mesh__D018110 Receptor, Lipoprotein
% 207.97/208.15  |- skos__historyNote mesh__D018110
% 207.97/208.15       Receptors, Cell Surface %28%1981-1993%29%
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D018110 2003
% 207.97/208.15  |- skos__prefLabel mesh__D018110 Receptors, Lipoprotein
% 207.97/208.15  |- skos__historyNote mesh__D018110 Lipoproteins %28%1981-1993%29%
% 207.97/208.15  |- mesh__recordMaintainer mesh__D018110 KEV
% 207.97/208.15  |- mesh__recordOriginator mesh__D018110 RAZ
% 207.97/208.15  |- mesh__activeMeSHYear mesh__D018110 1996
% 207.97/208.15  |- skos__altLabel mesh__D018110 Lipoprotein Receptors
% 207.97/208.15  |- mesh__dateEstablished mesh__D018110 1994-01-01
% 207.97/208.15  |- skos__scopeNote mesh__D018110
% 207.97/208.15       Cell surface proteins that bind lipoproteins with high affinity. Lipoprotein receptors in the liver and peripheral tissues mediate the regulation of plasma and cellular cholesterol metabolism and concentration. The receptors generally recognize the apolipoproteins of the lipoprotein complex, and binding is often a trigger for endocytosis.%A%    
% 207.97/208.15  |- skos__altLabel mesh__D051544 Erythromycin N-Demethylase
% 207.97/208.15  |- skos__hiddenLabel mesh__D051544 Cytochrome P 450 CYP3A
% 207.97/208.16  |- skos__altLabel mesh__D051544 Cytochrome P-450IIIA
% 207.97/208.16  |- mesh__recordMaintainer mesh__D051544 AKE
% 207.97/208.16  |- mesh__recordAuthorizer mesh__D051544 sjn
% 207.97/208.16  |- mesh__recordOriginator mesh__D051544 AKE
% 207.97/208.16  |- skos__hiddenLabel mesh__D051544 Erythromycin N Demethylase
% 207.97/208.16  |- skos__hiddenLabel mesh__D051544 Cytochrome P 450IIIA
% 207.97/208.16  |- skos__hiddenLabel mesh__D051544 P-450IIIA, Cytochrome
% 207.97/208.16  |- skos__broader mesh__D051544smesh__D010089
% 207.97/208.16  |- skos__scopeNote mesh__D051544
% 207.97/208.16       A cytochrome P-450 monooxygenase that is involved in an NADPH-dependent electron transport pathway by oxidizing a variety of structurally unrelated compounds, including STEROIDS; FATTY ACIDS; and XENOBIOTICS. This enzyme has clinical significance due to its ability to metabolize a diverse array of clinically important drugs such as CYCLOSPORINE; VERAPAMIL; and MIDAZOLAM. This enzyme also catalyzes the N-demethylation of ERYTHROMYCIN.%A%    
% 207.97/208.16  |- skos__hiddenLabel mesh__D051544 N-Demethylase, Erythromycin
% 207.97/208.16  |- rdf__type mesh__D051544sskos__Concept
% 207.97/208.16  |- skos__hiddenLabel mesh__D051544 P450 3A, Cytochrome
% 207.97/208.16  |- mesh__dateEstablished mesh__D051544 2006-01-01
% 207.97/208.16  |- skos__prefLabel mesh__D051544 Cytochrome P-450 CYP3A
% 207.97/208.16  |- mesh__historyNote mesh__D051544 2006%28%1980%29%   
% 207.97/208.16  |- skos__hiddenLabel mesh__D051544 P-450 CYP3A, Cytochrome
% 207.97/208.16  |- mesh__dateCreated mesh__D051544 2005-06-30
% 207.97/208.16  |- mesh__publicMeSHNote mesh__D051544
% 207.97/208.16       2006; CYTOCHROME P-450 CYP3A was indexed under ARYL HYDROCARBON HYDROXYLASES %26% OXIDOREDUCTASES, N-DEMETHYLATING 1980-2005%A%  
% 207.97/208.16  |- skos__broader mesh__D051544smesh__D001189
% 207.97/208.16  |- skos__altLabel mesh__D051544 Cytochrome P450 3A
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D051544 2006
% 207.97/208.16  |- skos__altLabel mesh__D051544 CYP3A
% 207.97/208.16  |- skos__hiddenLabel mesh__D004699 Endocardiums
% 207.97/208.16  |- mesh__dateCreated mesh__D004699 1999-01-01
% 207.97/208.16  |- skos__broader mesh__D004699smesh__D006321
% 207.97/208.16  |- skos__annotation mesh__D004699
% 207.97/208.16       inflammation = ENDOCARDITIS %26% its specifics   
% 207.97/208.16  |- mesh__recordOriginator mesh__D004699 NLM
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D004699 2004
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D004699 1997
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D004699 2002
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D004699 2006
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D004699 1999
% 207.97/208.16  |- mesh__dateRevised mesh__D004699 1992-05-15
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D004699 1993
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D004699 2003
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D004699 1996
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D004699 1995
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D004699 2001
% 207.97/208.16  |- skos__scopeNote mesh__D004699
% 207.97/208.16       The innermost layer of the heart, comprised of endothelial cells.%A%    
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D004699 2005
% 207.97/208.16  |- mesh__recordAuthorizer mesh__D004699 PLS
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D004699 1998
% 207.97/208.16  |- rdf__type mesh__D004699sskos__Concept
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D004699 1994
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D004699 2000
% 207.97/208.16  |- mesh__recordMaintainer mesh__D004699 TAP
% 207.97/208.16  |- skos__prefLabel mesh__D004699 Endocardium
% 207.97/208.16  |- skos__historyNote mesh__D009384 Hormones, Ectopic %28%1968-1972%29%
% 207.97/208.16  |- skos__prefLabel mesh__D009384 Paraneoplastic Endocrine Syndromes
% 207.97/208.16  |- skos__related mesh__D009384smesh__D000182
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D009384 2006
% 207.97/208.16  |- mesh__dateRevised mesh__D009384 2004-07-07
% 207.97/208.16  |- mesh__dateEstablished mesh__D009384 1973-01-01
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D009384 2005
% 207.97/208.16  |- skos__broader mesh__D009384smesh__D010257
% 207.97/208.16  |- mesh__publicMeSHNote mesh__D009384
% 207.97/208.16       2005; see NEOPLASTIC ENDOCRINE-LIKE SYNDROMES 1973-2004   
% 207.97/208.16  |- mesh__historyNote mesh__D009384 2005 %28%1973%29%   
% 207.97/208.16  |- skos__hiddenLabel mesh__D009384 Endocrine Syndrome, Paraneoplastic
% 207.97/208.16  |- skos__scopeNote mesh__D009384
% 207.97/208.16       Syndromes resulting from inappropriate production of HORMONES or hormone-like materials by NEOPLASMS in non-endocrine tissues or not by the usual ENDOCRINE GLANDS. Such hormone outputs are called ectopic hormone %28%HORMONES, ECTOPIC%29% secretion.%A%    
% 207.97/208.16  |- skos__altLabel mesh__D009384 Ectopic Hormone Syndromes
% 207.97/208.16  |- mesh__recordMaintainer mesh__D009384 lkt
% 207.97/208.16  |- mesh__recordAuthorizer mesh__D009384 sjn
% 207.97/208.16  |- skos__related mesh__D009384smesh__D006729
% 207.97/208.16  |- skos__hiddenLabel mesh__D009384 Syndrome, Ectopic Hormone
% 207.97/208.16  |- skos__hiddenLabel mesh__D009384 Paraneoplastic Endocrine Syndrome
% 207.97/208.16  |- rdf__type mesh__D009384sskos__Concept
% 207.97/208.16  |- mesh__recordOriginator mesh__D009384 NLM
% 207.97/208.16  |- mesh__dateCreated mesh__D009384 1999-01-01
% 207.97/208.16  |- skos__hiddenLabel mesh__D009384 Syndromes, Ectopic Hormone
% 207.97/208.16  |- skos__annotation mesh__D009384
% 207.97/208.16       coordinate IM with pre-coordinated organ/neoplasm term with /secret %28%IM%29% + histological type of neoplasm /secret %28%IM%29% + specific hormone /secret %28%IM%29%; but ACTH SYNDROME, ECTOPIC is also available%A%  
% 207.97/208.16  |- skos__broader mesh__D009384smesh__D004701
% 207.97/208.16  |- skos__hiddenLabel mesh__D009384 Ectopic Hormone Syndrome
% 207.97/208.16  |- skos__hiddenLabel mesh__D009384 Syndrome, Paraneoplastic Endocrine
% 207.97/208.16  |- skos__hiddenLabel mesh__D009384 Syndromes, Paraneoplastic Endocrine
% 207.97/208.16  |- mesh__recordOriginator mesh__D017018 PXP
% 207.97/208.16  |- mesh__historyNote mesh__D017018 92   
% 207.97/208.16  |- rdf__type mesh__D017018sskos__Concept
% 207.97/208.16  |- mesh__dateEstablished mesh__D017018 1992-01-01
% 207.97/208.16  |- mesh__recordMaintainer mesh__D017018 SYSTEM
% 207.97/208.16  |- mesh__dateRevised mesh__D017018 2005-06-30
% 207.97/208.16  |- skos__scopeNote mesh__D017018
% 207.97/208.16       An order of anaerobic, highly specialized methanogens, in the kingdom EURYARCHAEOTA. Its organisms are nonmotile or motile, with cells occurring as coccoid bodies, pseudosarcina, or rods. Families include METHANOMICROBIACEAE, Methanocorpusculaceae, and  Methanospirillaceae.%A%    
% 207.97/208.16  |- skos__broader mesh__D017018smesh__D019605
% 207.97/208.16  |- mesh__dateCreated mesh__D017018 1991-05-30
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D017018 2006
% 207.97/208.16  |- mesh__publicMeSHNote mesh__D017018 92   
% 207.97/208.16  |- mesh__recordAuthorizer mesh__D017018 sjn
% 207.97/208.16  |- skos__prefLabel mesh__D017018 Methanomicrobiales
% 207.97/208.16  |- skos__broader mesh__D005792smesh__D003813
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005792 1999
% 207.97/208.16  |- mesh__dateEstablished mesh__D005792 1967-01-01
% 207.97/208.16  |- mesh__recordAuthorizer mesh__D005792 PLS
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005792 1997
% 207.97/208.16  |- mesh__historyNote mesh__D005792 67   
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005792 1998
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005792 2001
% 207.97/208.16  |- skos__historyNote mesh__D005792 Dentistry %28%1966%29%
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005792 1996
% 207.97/208.16  |- skos__scopeNote mesh__D005792
% 207.97/208.16       Nonspecialized dental practice which is concerned with providing primary and continuing dental care.%A%    
% 207.97/208.16  |- skos__prefLabel mesh__D005792 General Practice, Dental
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005792 2000
% 207.97/208.16  |- mesh__dateRevised mesh__D005792 1990-05-29
% 207.97/208.16  |- mesh__publicMeSHNote mesh__D005792 67   
% 207.97/208.16  |- skos__altLabel mesh__D005792 Practice, Dental General
% 207.97/208.16  |- skos__altLabel mesh__D005792 Dental General Practice
% 207.97/208.16  |- skos__altLabel mesh__D005792 General Practices, Dental
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005792 2006
% 207.97/208.16  |- mesh__recordOriginator mesh__D005792 NLM
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005792 2004
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005792 1995
% 207.97/208.16  |- skos__annotation mesh__D005792
% 207.97/208.16       SPEC: SPEC qualif; %22%extraction in general practice in dentistry%22% is GENERAL PRACTICE, DENTAL %28%NIM%29% if indexed there at all; DF: GENERAL PRACTICE DENT%A%  
% 207.97/208.16  |- skos__altLabel mesh__D005792 Practices, Dental General
% 207.97/208.16  |- skos__altLabel mesh__D005792 Dental General Practices
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005792 1993
% 207.97/208.16  |- mesh__dateCreated mesh__D005792 1999-01-01
% 207.97/208.16  |- mesh__recordMaintainer mesh__D005792 TAP
% 207.97/208.16  |- rdf__type mesh__D005792sskos__Concept
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005792 2005
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005792 2002
% 207.97/208.16  |- skos__historyNote mesh__D005792 Family Practice %28%1966%29%
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005792 1991
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005792 2003
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005792 1994
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005792 1992
% 207.97/208.16  |- skos__altLabel mesh__D013426 Sulphaphenazole
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D013426 2001
% 207.97/208.16  |- skos__altLabel mesh__D013426 Phenylsulfapyrazole
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D013426 2006
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D013426 2005
% 207.97/208.16  |- skos__altLabel mesh__D013426 Sulfaphenylpyrazol
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D013426 2004
% 207.97/208.16  |- skos__broader mesh__D013426smesh__D013424
% 207.97/208.16  |- rdf__type mesh__D013426sskos__Concept
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D013426 2003
% 207.97/208.16  |- skos__scopeNote mesh__D013426 A sulfonilamide anti-infective agent.     
% 207.97/208.16  |- mesh__recordAuthorizer mesh__D013426 sjn
% 207.97/208.16  |- mesh__dateCreated mesh__D013426 1999-01-01
% 207.97/208.16  |- mesh__dateRevised mesh__D013426 2000-06-22
% 207.97/208.16  |- mesh__recordOriginator mesh__D013426 NLM
% 207.97/208.16  |- mesh__recordMaintainer mesh__D013426 CCR
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D013426 2002
% 207.97/208.16  |- skos__prefLabel mesh__D013426 Sulfaphenazole
% 207.97/208.16  |- skos__historyNote mesh__D018111 Paramyxoviridae %28%1985-1993%29%
% 207.97/208.16  |- mesh__recordAuthorizer mesh__D018111 sjn
% 207.97/208.16  |- rdf__type mesh__D018111sskos__Concept
% 207.97/208.16  |- skos__scopeNote mesh__D018111
% 207.97/208.16       A genus of the family PARAMYXOVIRIDAE %28%subfamily PNEUMOVIRINAE%29% where the human and bovine virions have neither hemagglutinin nor neuraminidase activity. RESPIRATORY SYNCYTIAL VIRUS, HUMAN is the type species.%A%    
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D018111 2005
% 207.97/208.16  |- skos__annotation mesh__D018111 infection = PNEUMOVIRUS INFECTIONS   
% 207.97/208.16  |- mesh__recordOriginator mesh__D018111 AGS
% 207.97/208.16  |- mesh__dateEstablished mesh__D018111 1994-01-01
% 207.97/208.16  |- mesh__dateCreated mesh__D018111 1993-06-04
% 207.97/208.16  |- mesh__recordMaintainer mesh__D018111 sjn
% 207.97/208.16  |- mesh__historyNote mesh__D018111 94   
% 207.97/208.16  |- skos__prefLabel mesh__D018111 Pneumovirus
% 207.97/208.16  |- mesh__publicMeSHNote mesh__D018111 94   
% 207.97/208.16  |- skos__broader mesh__D018111smesh__D018099
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D018111 2006
% 207.97/208.16  |- mesh__dateRevised mesh__D018111 2004-07-13
% 207.97/208.16  |- skos__altLabel mesh__D051545 Cyclooxygenase-1
% 207.97/208.16  |- rdf__type mesh__D051545sskos__Concept
% 207.97/208.16  |- mesh__historyNote mesh__D051545 2006%28%1996%29%   
% 207.97/208.16  |- mesh__publicMeSHNote mesh__D051545
% 207.97/208.16       2006; CYCLOOXYGENASE 1 was indexed under ISOENZYMES, %26% PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1996-2005%A%  
% 207.97/208.16  |- skos__hiddenLabel mesh__D051545 Cyclo Oxygenase I
% 207.97/208.16  |- skos__hiddenLabel mesh__D051545 Prostaglandin Synthase, COX-1
% 207.97/208.16  |- mesh__dateCreated mesh__D051545 2005-06-30
% 207.97/208.16  |- skos__altLabel mesh__D051545 Cyclo-Oxygenase I
% 207.97/208.16  |- skos__hiddenLabel mesh__D051545 Prostaglandin H Synthase 1
% 207.97/208.16  |- mesh__recordOriginator mesh__D051545 AKE
% 207.97/208.16  |- skos__broader mesh__D051545smesh__D011451
% 207.97/208.16  |- skos__altLabel mesh__D051545 Prostaglandin H Synthase-1
% 207.97/208.16  |- skos__hiddenLabel mesh__D051545 COX 1 Prostaglandin Synthase
% 207.97/208.16  |- mesh__recordAuthorizer mesh__D051545 sjn
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D051545 2006
% 207.97/208.16  |- skos__prefLabel mesh__D051545 Cyclooxygenase 1
% 207.97/208.16  |- mesh__dateEstablished mesh__D051545 2006-01-01
% 207.97/208.16  |- mesh__recordMaintainer mesh__D051545 AKE
% 207.97/208.16  |- skos__scopeNote mesh__D051545
% 207.97/208.16       A constitutively-expressed subtype of prostaglandin-endoperoxide synthase. It plays an important role in many cellular processes.%A%    
% 207.97/208.16  |- skos__altLabel mesh__D051545 COX-1 Prostaglandin Synthase
% 207.97/208.16  |- skos__hiddenLabel mesh__D051545 Synthase, COX-1 Prostaglandin
% 207.97/208.16  |- mesh__recordMaintainer mesh__D009385 TGC
% 207.97/208.16  |- mesh__recordAuthorizer mesh__D009385 sjn
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D009385 2002
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D009385 2006
% 207.97/208.16  |- mesh__dateRevised mesh__D009385 2000-06-22
% 207.97/208.16  |- skos__scopeNote mesh__D009385
% 207.97/208.16       The pathological mechanisms and forms taken by tissue during degeneration into a neoplasm and its subsequent activity.%A%    
% 207.97/208.16  |- skos__prefLabel mesh__D009385 Neoplastic Processes
% 207.97/208.16  |- mesh__dateCreated mesh__D009385 1981-05-19
% 207.97/208.16  |- mesh__publicMeSHNote mesh__D009385 98   
% 207.97/208.16  |- mesh__recordOriginator mesh__D009385 VDK
% 207.97/208.16  |- mesh__dateEstablished mesh__D009385 1998-01-01
% 207.97/208.16  |- skos__broader mesh__D009385smesh__D009369
% 207.97/208.16  |- skos__annotation mesh__D009385
% 207.97/208.16       GEN or unspecified; prefer specifics; for neopl process in general, coord NIM when precoord organ/neopl %28%with /pathol%29% or histol type %28%with /pathol%29% is IM; DF: NEOPL PROCESSES%A%  
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D009385 2001
% 207.97/208.16  |- mesh__historyNote mesh__D009385 98; use explode 1982-97   
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D009385 2003
% 207.97/208.16  |- skos__altLabel mesh__D009385 Processes, Neoplastic
% 207.97/208.16  |- rdf__type mesh__D009385sskos__Concept
% 207.97/208.16  |- skos__broader mesh__D009385smesh__D010335
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D009385 2005
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D009385 2004
% 207.97/208.16  |- skos__historyNote mesh__D009385
% 207.97/208.16       specific neoplastic process %28%1966-1997%29%
% 207.97/208.16  |- mesh__publicMeSHNote mesh__D017817 94   
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D017817 2003
% 207.97/208.16  |- mesh__dateEstablished mesh__D017817 1994-01-01
% 207.97/208.16  |- skos__altLabel mesh__D017817 Nasal Washings
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D017817 2004
% 207.97/208.16  |- skos__historyNote mesh__D017817 Irrigation %28%1971-1993%29%
% 207.97/208.16  |- skos__broader mesh__D017817smesh__D001826
% 207.97/208.16  |- rdf__type mesh__D017817sskos__Concept
% 207.97/208.16  |- skos__hiddenLabel mesh__D017817 Nasal Washing
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D017817 2000
% 207.97/208.16  |- skos__prefLabel mesh__D017817 Nasal Lavage Fluid
% 207.97/208.16  |- mesh__recordAuthorizer mesh__D017817 sjn
% 207.97/208.16  |- skos__hiddenLabel mesh__D017817 Nasal Lavage Fluids
% 207.97/208.16  |- skos__hiddenLabel mesh__D017817 Washing, Nasal
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D017817 2005
% 207.97/208.16  |- mesh__recordOriginator mesh__D017817 JLS
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D017817 2001
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D017817 2006
% 207.97/208.16  |- skos__hiddenLabel mesh__D017817 Lavage Fluid, Nasal
% 207.97/208.16  |- skos__scopeNote mesh__D017817
% 207.97/208.16       Fluid obtained by irrigation or washout of the nasal cavity and NASAL MUCOSA. The resulting fluid is used in cytologic and immunologic assays of the nasal mucosa such as with the NASAL PROVOCATION TEST in the diagnosis of nasal hypersensitivity.%A%    
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D017817 2002
% 207.97/208.16  |- mesh__dateCreated mesh__D017817 1993-06-04
% 207.97/208.16  |- mesh__recordMaintainer mesh__D017817 KEV
% 207.97/208.16  |- skos__hiddenLabel mesh__D017817 Fluid, Nasal Lavage
% 207.97/208.16  |- mesh__dateRevised mesh__D017817 1999-11-09
% 207.97/208.16  |- mesh__historyNote mesh__D017817 94   
% 207.97/208.16  |- mesh__recordMaintainer mesh__D017019 SYSTEM
% 207.97/208.16  |- mesh__publicMeSHNote mesh__D017019 92   
% 207.97/208.16  |- mesh__recordAuthorizer mesh__D017019 sjn
% 207.97/208.16  |- mesh__dateEstablished mesh__D017019 1992-01-01
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D017019 2006
% 207.97/208.16  |- mesh__dateCreated mesh__D017019 1991-05-30
% 207.97/208.16  |- skos__broader mesh__D017019smesh__D019640
% 207.97/208.16  |- skos__annotation mesh__D017019
% 207.97/208.16       a family of methanogens %22%found in any anaerobic environment%22%%A%  
% 207.97/208.16  |- skos__scopeNote mesh__D017019
% 207.97/208.16       A family of anaerobic METHANOSARCINALES whose cells are mesophilic or thermophilic and appear as irregular spheroid bodies or sheathed rods. These methanogens are found in any anaerobic environment including aquatic sediments, anaerobic sewage digesters and gastrointestinal tracts. There are four genera: METHANOSARCINA, Methanolobus, Methanothrix, and Methanococcoides.%A%    
% 207.97/208.16  |- mesh__historyNote mesh__D017019 92   
% 207.97/208.16  |- rdf__type mesh__D017019sskos__Concept
% 207.97/208.16  |- mesh__dateRevised mesh__D017019 2005-06-30
% 207.97/208.16  |- mesh__recordOriginator mesh__D017019 PXP
% 207.97/208.16  |- skos__prefLabel mesh__D017019 Methanosarcinaceae
% 207.97/208.16  |- skos__hiddenLabel mesh__D005793 Generalizations %28%Psychology%29%
% 207.97/208.16  |- mesh__recordOriginator mesh__D005793 NLM
% 207.97/208.16  |- mesh__publicMeSHNote mesh__D005793
% 207.97/208.16       65; was GENERALIZATION LEARNING 1963-64   
% 207.97/208.16  |- skos__altLabel mesh__D005793 Generalization
% 207.97/208.16  |- skos__annotation mesh__D005793 DF: GENERALIZATION   
% 207.97/208.16  |- mesh__recordMaintainer mesh__D005793 TAP
% 207.97/208.16  |- mesh__historyNote mesh__D005793
% 207.97/208.16       65; was GENERALIZATION LEARNING 1963-64   
% 207.97/208.16  |- mesh__recordAuthorizer mesh__D005793 PLS
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005793 1997
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005793 2005
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005793 1994
% 207.97/208.16  |- mesh__dateCreated mesh__D005793 1999-01-01
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005793 2000
% 207.97/208.16  |- skos__broader mesh__D005793smesh__D007858
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005793 2006
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005793 2003
% 207.97/208.16  |- mesh__dateRevised mesh__D005793 1992-05-15
% 207.97/208.16  |- mesh__dateEstablished mesh__D005793 1965-01-01
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005793 2001
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005793 1995
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005793 2004
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005793 1998
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005793 1993
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005793 2002
% 207.97/208.16  |- skos__scopeNote mesh__D005793
% 207.97/208.16       The phenomenon of an organism%27%s responding to all situations similar to one in which it has been conditioned.%A%    
% 207.97/208.16  |- skos__hiddenLabel mesh__D005793 Generalizations
% 207.97/208.16  |- skos__prefLabel mesh__D005793 Generalization %28%Psychology%29%
% 207.97/208.16  |- rdf__type mesh__D005793sskos__Concept
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005793 1996
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D005793 1999
% 207.97/208.16  |- mesh__historyNote mesh__D013427
% 207.97/208.16       91%28%75%29%; was see under SULFANILAMIDES 1975-90   
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D013427 2002
% 207.97/208.16  |- skos__altLabel mesh__D013427 Sulphapyridin
% 207.97/208.16  |- mesh__dateCreated mesh__D013427 1974-11-19
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D013427 2005
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D013427 2001
% 207.97/208.16  |- skos__scopeNote mesh__D013427
% 207.97/208.16       Antibacterial, potentially toxic, used to treat certain skin diseases.%A%    
% 207.97/208.16  |- skos__historyNote mesh__D013427 Pyridines %28%1974%29%
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D013427 2004
% 207.97/208.16  |- rdf__type mesh__D013427sskos__Concept
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D013427 2003
% 207.97/208.16  |- mesh__dateRevised mesh__D013427 2000-06-22
% 207.97/208.16  |- skos__altLabel mesh__D013427 Sulphapyridine
% 207.97/208.16  |- mesh__dateEstablished mesh__D013427 1991-01-01
% 207.97/208.16  |- skos__broader mesh__D013427smesh__D013424
% 207.97/208.16  |- skos__prefLabel mesh__D013427 Sulfapyridine
% 207.97/208.16  |- mesh__publicMeSHNote mesh__D013427
% 207.97/208.16       91; was see under SULFANILAMIDES 1975-90   
% 207.97/208.16  |- mesh__recordAuthorizer mesh__D013427 sjn
% 207.97/208.16  |- skos__historyNote mesh__D013427 Sulfanilamides %28%1974%29%
% 207.97/208.16  |- mesh__recordOriginator mesh__D013427 NLM
% 207.97/208.16  |- mesh__recordMaintainer mesh__D013427 CCR
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D013427 2006
% 207.97/208.16  |- skos__hiddenLabel mesh__D018910 Games, Video
% 207.97/208.16  |- mesh__dateCreated mesh__D018910 1994-12-27
% 207.97/208.16  |- skos__annotation mesh__D018910 /adv eff /psychol permitted   
% 207.97/208.16  |- mesh__recordAuthorizer mesh__D018910 sjn
% 207.97/208.16  |- skos__hiddenLabel mesh__D018910 Game, Video
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D018910 2006
% 207.97/208.16  |- mesh__recordMaintainer mesh__D018910 jls
% 207.97/208.16  |- rdf__type mesh__D018910sskos__Concept
% 207.97/208.16  |- skos__broader mesh__D018910smesh__D010988
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D018910 2005
% 207.97/208.16  |- mesh__dateEstablished mesh__D018910 1996-01-01
% 207.97/208.16  |- mesh__publicMeSHNote mesh__D018910
% 207.97/208.16       96; was see PLAY AND PLAYTHINGS 1984-95   
% 207.97/208.16  |- mesh__recordOriginator mesh__D018910 AGS
% 207.97/208.16  |- mesh__onlineNote mesh__D018910
% 207.97/208.16       use PLAY AND PLAYTHINGS to search VIDEO GAMES 1984-95   
% 207.97/208.16  |- skos__prefLabel mesh__D018910 Video Games
% 207.97/208.16  |- mesh__dateRevised mesh__D018910 2004-07-07
% 207.97/208.16  |- mesh__historyNote mesh__D018910
% 207.97/208.16       96; was see PLAY AND PLAYTHINGS 1984-95   
% 207.97/208.16  |- skos__broader mesh__D018910smesh__D012984
% 207.97/208.16  |- skos__historyNote mesh__D018910 Play and Playthings %28%1983-1995%29%
% 207.97/208.16  |- skos__scopeNote mesh__D018910
% 207.97/208.16       A form of interactive entertainment in which the player controls electronically generated images that appear on a video display screen. This includes video games played in the home on special machines or home computers, and those played in arcades. %28%McGraw Hill Encyclopedia of Science %26% Technology, 7th ed, v19, p223%29%%A%    
% 207.97/208.16  |- skos__hiddenLabel mesh__D018910 Video Game
% 207.97/208.16  |- skos__historyNote mesh__D018112
% 207.97/208.16       Respiratory Syncytial Viruses %28%1968-1993%29%
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D018112 2003
% 207.97/208.16  |- mesh__historyNote mesh__D018112 94   
% 207.97/208.16  |- skos__broader mesh__D018112smesh__D012136
% 207.97/208.16  |- skos__annotation mesh__D018112
% 207.97/208.16       infection: coord IM with RESPIRATORY SYNCYTIAL VIRUS INFECTIONS %28%IM%29%%A%  
% 207.97/208.16  |- skos__altLabel mesh__D018112 Bovine respiratory syncytial virus
% 207.97/208.16  |- mesh__dateRevised mesh__D018112 2001-07-25
% 207.97/208.16  |- mesh__dateEstablished mesh__D018112 1994-01-01
% 207.97/208.16  |- mesh__recordAuthorizer mesh__D018112 sjn
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D018112 2006
% 207.97/208.16  |- mesh__recordOriginator mesh__D018112 AGS
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D018112 2002
% 207.97/208.16  |- skos__scopeNote mesh__D018112
% 207.97/208.16       A species of PNEUMOVIRUS causing an important respiratory infection in cattle. Symptoms include fever, conjunctivitis, and respiratory distress.%A%    
% 207.97/208.16  |- mesh__recordMaintainer mesh__D018112 ags
% 207.97/208.16  |- mesh__dateCreated mesh__D018112 1993-06-04
% 207.97/208.16  |- rdf__type mesh__D018112sskos__Concept
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D018112 2005
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D018112 2004
% 207.97/208.16  |- skos__prefLabel mesh__D018112 Respiratory Syncytial Virus, Bovine
% 207.97/208.16  |- mesh__publicMeSHNote mesh__D018112 94   
% 207.97/208.16  |- skos__hiddenLabel mesh__D051546 Prostaglandin H Synthase 2
% 207.97/208.16  |- skos__hiddenLabel mesh__D051546 Cyclo Oxygenase II
% 207.97/208.16  |- skos__altLabel mesh__D051546 Prostaglandin H Synthase-2
% 207.97/208.16  |- skos__altLabel mesh__D051546 Cyclo-Oxygenase II
% 207.97/208.16  |- mesh__historyNote mesh__D051546 2006%28%1996%29%   
% 207.97/208.16  |- skos__broader mesh__D051546smesh__D011451
% 207.97/208.16  |- mesh__publicMeSHNote mesh__D051546
% 207.97/208.16       2006; CYCLOOXYGENASE 2 was indexed under ISOENZYMES, under PEROXIDASES %26% PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1996-2005%A%  
% 207.97/208.16  |- skos__altLabel mesh__D051546 PGHS-2
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D051546 2006
% 207.97/208.16  |- skos__scopeNote mesh__D051546
% 207.97/208.16       An inducibly-expressed subtype of prostaglandin-endoperoxide synthase. It plays an important role in many cellular processes and INFLAMMATION. It is the target of COX2 INHIBITORS.%A%    
% 207.97/208.16  |- mesh__dateCreated mesh__D051546 2005-06-30
% 207.97/208.16  |- skos__prefLabel mesh__D051546 Cyclooxygenase 2
% 207.97/208.16  |- skos__altLabel mesh__D051546 Cyclooxygenase-2
% 207.97/208.16  |- skos__hiddenLabel mesh__D051546 Prostaglandin Synthase, COX-2
% 207.97/208.16  |- mesh__recordMaintainer mesh__D051546 AKE
% 207.97/208.16  |- skos__hiddenLabel mesh__D051546 COX 2 Prostaglandin Synthase
% 207.97/208.16  |- mesh__recordOriginator mesh__D051546 AKE
% 207.97/208.16  |- skos__altLabel mesh__D051546 PTGS2
% 207.97/208.16  |- skos__altLabel mesh__D051546 COX-2 Prostaglandin Synthase
% 207.97/208.16  |- mesh__recordAuthorizer mesh__D051546 sjn
% 207.97/208.16  |- rdf__type mesh__D051546sskos__Concept
% 207.97/208.16  |- mesh__dateEstablished mesh__D051546 2006-01-01
% 207.97/208.16  |- skos__hiddenLabel mesh__D051546 Synthase, COX-2 Prostaglandin
% 207.97/208.16  |- skos__broader mesh__D009386smesh__D030342
% 207.97/208.16  |- mesh__recordAuthorizer mesh__D009386 sjn
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D009386 2002
% 207.97/208.16  |- skos__broader mesh__D009386smesh__D009369
% 207.97/208.16  |- skos__hiddenLabel mesh__D009386 Syndrome, Hereditary Cancer
% 207.97/208.16  |- skos__prefLabel mesh__D009386 Neoplastic Syndromes, Hereditary
% 207.97/208.16  |- mesh__dateCreated mesh__D009386 1986-06-23
% 207.97/208.16  |- skos__hiddenLabel mesh__D009386 Syndrome, Hereditary Neoplastic
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D009386 2003
% 207.97/208.16  |- rdf__type mesh__D009386sskos__Concept
% 207.97/208.16  |- mesh__historyNote mesh__D009386 87   
% 207.97/208.16  |- mesh__dateEstablished mesh__D009386 1987-01-01
% 207.97/208.16  |- mesh__recordOriginator mesh__D009386 VDK
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D009386 2004
% 207.97/208.16  |- skos__hiddenLabel mesh__D009386 Syndromes, Hereditary Cancer
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D009386 2005
% 207.97/208.16  |- skos__hiddenLabel mesh__D009386 Hereditary Cancer Syndrome
% 207.97/208.16  |- skos__altLabel mesh__D009386 Hereditary Neoplastic Syndromes
% 207.97/208.16  |- skos__altLabel mesh__D009386 Hereditary Cancer Syndromes
% 207.97/208.16  |- skos__scopeNote mesh__D009386
% 207.97/208.16       The condition of a pattern of malignancies within a family, but not every individual%27%s necessarily having the same neoplasm. Characteristically the tumor tends to occur at an earlier than average age, individuals may have more than one primary tumor, the tumors may be multicentric, usually more than 25 percent of the individuals in direct lineal descent from the proband are affected, and the cancer predisposition in these families behaves as an autosomal dominant trait with about 60 percent penetrance.%A%    
% 207.97/208.16  |- skos__hiddenLabel mesh__D009386 Syndromes, Hereditary Neoplastic
% 207.97/208.16  |- mesh__activeMeSHYear mesh__D009386 2006
% 207.97/208.16  |- mesh__publicMeSHNote mesh__D009386 87   
% 207.97/208.16  |- mesh__recordMaintainer mesh__D009386 nns
% 207.97/208.16  |- skos__hiddenLabel mesh__D009386 Cancer Syndrome, Hereditary
% 207.97/208.16  |- mesh__dateRevised mesh__D009386 2001-07-25
% 207.97/208.16  |- skos__hiddenLabel mesh__D009386 Hereditary Neoplastic Syndrome
% 207.97/208.16  |- skos__hiddenLabel mesh__D009386 Neoplastic Syndrome, Hereditary
% 207.97/208.16  |- skos__altLabel mesh__D009386 Cancer Syndromes, Hereditary
% 207.97/208.16  |- skos__annotation mesh__D009386
% 207.97/208.16       do not use /blood supply /chem /second /secret /ultrastruct; coord IM with specific hereditary organ/neopl term %28%IM%29% or specific hereditary histol type %28%IM%29%%A%  
% 207.97/208.17  |- mesh__recordOriginator mesh__D014520 NLM
% 207.97/208.17  |- skos__altLabel mesh__D014520 Ethyl Carbamate
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D014520 2004
% 207.97/208.17  |- mesh__recordMaintainer mesh__D014520 adp
% 207.97/208.17  |- rdf__type mesh__D014520sskos__Concept
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D014520 2001
% 207.97/208.17  |- skos__altLabel mesh__D014520 Urethan
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D014520 2003
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D014520 2000
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D014520 2006
% 207.97/208.17  |- skos__broader mesh__D014520smesh__D002219
% 207.97/208.17  |- skos__prefLabel mesh__D014520 Urethane
% 207.97/208.17  |- skos__annotation mesh__D014520 POLYURETHANES is available   
% 207.97/208.17  |- mesh__recordAuthorizer mesh__D014520 sjn
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D014520 2005
% 207.97/208.17  |- skos__scopeNote mesh__D014520
% 207.97/208.17       Antineoplastic agent that is also used as a veterinary anesthetic. It has also been used as an intermediate in organic synthesis. Urethane is suspected to be a carcinogen.%A%    
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D014520 2002
% 207.97/208.17  |- mesh__dateRevised mesh__D014520 1999-11-03
% 207.97/208.17  |- mesh__dateCreated mesh__D014520 1999-01-01
% 207.97/208.17  |- skos__hiddenLabel mesh__D014520 Carbamate, Ethyl
% 207.97/208.17  |- skos__hiddenLabel mesh__D000500 Allylestrenol Organon Brand
% 207.97/208.17  |- mesh__dateEstablished mesh__D000500 1991-01-01
% 207.97/208.17  |- skos__historyNote mesh__D000500 Estranes %28%1970-1974%29%
% 207.97/208.17  |- mesh__dateRevised mesh__D000500 2003-07-09
% 207.97/208.17  |- mesh__recordAuthorizer mesh__D000500 sjn
% 207.97/208.17  |- skos__scopeNote mesh__D000500
% 207.97/208.17       A synthetic steroid with progestational activity.     
% 207.97/208.17  |- skos__historyNote mesh__D000500 Hydroxysteroids %28%1973-1974%29%
% 207.97/208.17  |- skos__prefLabel mesh__D000500 Allylestrenol
% 207.97/208.17  |- rdf__type mesh__D000500sskos__Concept
% 207.97/208.17  |- skos__broader mesh__D000500smesh__D004963
% 207.97/208.17  |- skos__altLabel mesh__D000500 Allyloestrenol
% 207.97/208.17  |- mesh__recordMaintainer mesh__D000500 lkt
% 207.97/208.17  |- skos__altLabel mesh__D000500 Gestanin
% 207.97/208.17  |- skos__altLabel mesh__D000500 Organon Brand of Allylestrenol
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D000500 2006
% 207.97/208.17  |- mesh__dateCreated mesh__D000500 1974-11-11
% 207.97/208.17  |- mesh__recordOriginator mesh__D000500 NLM
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D000500 2004
% 207.97/208.17  |- mesh__historyNote mesh__D000500
% 207.97/208.17       91%28%75%29%; was see under ESTRENES 1975-90   
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D000500 2005
% 207.97/208.17  |- mesh__publicMeSHNote mesh__D000500 91; was see under ESTRENES 1975-90   
% 207.97/208.17  |- skos__historyNote mesh__D000500 Allyl Compounds %28%1973-1974%29%
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005794 2002
% 207.97/208.17  |- skos__hiddenLabel mesh__D005794 Response Generalization
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005794 2005
% 207.97/208.17  |- skos__broader mesh__D005794smesh__D005793
% 207.97/208.17  |- mesh__dateEstablished mesh__D005794 1969-01-01
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005794 1994
% 207.97/208.17  |- mesh__dateCreated mesh__D005794 1999-01-01
% 207.97/208.17  |- mesh__recordOriginator mesh__D005794 NLM
% 207.97/208.17  |- mesh__recordMaintainer mesh__D005794 TAP
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005794 2003
% 207.97/208.17  |- mesh__recordAuthorizer mesh__D005794 PLS
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005794 2006
% 207.97/208.17  |- skos__hiddenLabel mesh__D005794 Response Generalizations
% 207.97/208.17  |- mesh__publicMeSHNote mesh__D005794 69   
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005794 1995
% 207.97/208.17  |- skos__scopeNote mesh__D005794
% 207.97/208.17       The principle that after an organism learns to respond in a particular manner to a stimulus, that stimulus is effective in eliciting similar responses.%A%    
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005794 2004
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005794 1998
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005794 1993
% 207.97/208.17  |- rdf__type mesh__D005794sskos__Concept
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005794 2000
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005794 1996
% 207.97/208.17  |- mesh__dateRevised mesh__D005794 1992-05-15
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005794 1999
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005794 2001
% 207.97/208.17  |- skos__hiddenLabel mesh__D005794 Generalizations, Response
% 207.97/208.17  |- skos__prefLabel mesh__D005794 Generalization, Response
% 207.97/208.17  |- mesh__historyNote mesh__D005794 69%28%65%29%   
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005794 1997
% 207.97/208.17  |- rdf__type mesh__D013428sskos__Concept
% 207.97/208.17  |- mesh__publicMeSHNote mesh__D013428
% 207.97/208.17       91; was see under SULFANILAMIDES 1975-90   
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D013428 2003
% 207.97/208.17  |- mesh__recordMaintainer mesh__D013428 CCR
% 207.97/208.17  |- skos__broader mesh__D013428smesh__D013424
% 207.97/208.17  |- mesh__recordAuthorizer mesh__D013428 sjn
% 207.97/208.17  |- mesh__dateRevised mesh__D013428 2000-06-22
% 207.97/208.17  |- mesh__dateCreated mesh__D013428 1974-11-19
% 207.97/208.17  |- mesh__recordOriginator mesh__D013428 NLM
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D013428 2002
% 207.97/208.17  |- mesh__dateEstablished mesh__D013428 1991-01-01
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D013428 2006
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D013428 2001
% 207.97/208.17  |- skos__altLabel mesh__D013428 Sulfachinoxalin
% 207.97/208.17  |- skos__historyNote mesh__D013428 Sulfanilamides %28%1974%29%
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D013428 2005
% 207.97/208.17  |- skos__altLabel mesh__D013428 Sulfabenzpyrazine
% 207.97/208.17  |- mesh__historyNote mesh__D013428
% 207.97/208.17       91%28%75%29%; was see under SULFANILAMIDES 1975-90   
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D013428 2004
% 207.97/208.17  |- skos__prefLabel mesh__D013428 Sulfaquinoxaline
% 207.97/208.17  |- skos__scopeNote mesh__D013428
% 207.97/208.17       An antiprotozoal agent used to combat coccidial infections of swine, cattle, fowl, and other veterinary animals. Also used in controlling outbreaks of fowl typhoid and fowl cholera and in treatment of infectious enteritis.%A%    
% 207.97/208.17  |- skos__historyNote mesh__D013428 Quinoxalines %28%1974%29%
% 207.97/208.17  |- skos__hiddenLabel mesh__D018911 Repeat, Triplet
% 207.97/208.17  |- mesh__historyNote mesh__D018911 96   
% 207.97/208.17  |- skos__hiddenLabel mesh__D018911 Repeats, Trinucleotide
% 207.97/208.17  |- mesh__dateRevised mesh__D018911 2005-06-30
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D018911 2006
% 207.97/208.17  |- skos__hiddenLabel mesh__D018911 Triplet Repeat
% 207.97/208.17  |- rdf__type mesh__D018911sskos__Concept
% 207.97/208.17  |- mesh__publicMeSHNote mesh__D018911 96   
% 207.97/208.17  |- skos__historyNote mesh__D018911
% 207.97/208.17       Repetitive Sequences, Nucleic Acid %28%1989-1995%29%
% 207.97/208.17  |- skos__broader mesh__D018911smesh__D018895
% 207.97/208.17  |- mesh__recordAuthorizer mesh__D018911 sjn
% 207.97/208.17  |- skos__hiddenLabel mesh__D018911 Repeats, Triplet
% 207.97/208.17  |- skos__hiddenLabel mesh__D018911 Trinucleotide Repeat
% 207.97/208.17  |- skos__altLabel mesh__D018911 Triplet Repeats
% 207.97/208.17  |- skos__prefLabel mesh__D018911 Trinucleotide Repeats
% 207.97/208.17  |- mesh__recordMaintainer mesh__D018911 nns
% 207.97/208.17  |- mesh__dateCreated mesh__D018911 1995-06-08
% 207.97/208.17  |- mesh__dateEstablished mesh__D018911 1996-01-01
% 207.97/208.17  |- skos__hiddenLabel mesh__D018911 Repeat, Trinucleotide
% 207.97/208.17  |- skos__scopeNote mesh__D018911
% 207.97/208.17       Microsatellite repeats consisting of three nucleotides dispersed in the euchromatic arms of chromosomes.%A%    
% 207.97/208.17  |- mesh__recordOriginator mesh__D018911 AGS
% 207.97/208.17  |- skos__broader mesh__D018113smesh__D012136
% 207.97/208.17  |- skos__scopeNote mesh__D018113
% 207.97/208.17       The type species of PNEUMOVIRUS and an important cause of lower respiratory disease in infants and young children. It frequently presents with bronchitis and bronchopneumonia and is further characterized by fever, cough, dyspnea, wheezing, and pallor.%A%    
% 207.97/208.17  |- mesh__publicMeSHNote mesh__D018113 94   
% 207.97/208.17  |- skos__historyNote mesh__D018113
% 207.97/208.17       Respiratory Syncytial Viruses %28%1966-1993%29%
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D018113 2006
% 207.97/208.17  |- mesh__dateRevised mesh__D018113 2001-07-25
% 207.97/208.17  |- skos__annotation mesh__D018113
% 207.97/208.17       infection: coord IM with RESPIRATORY SYNCYTIAL VIRUS INFECTIONS %28%IM%29%%A%  
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D018113 2005
% 207.97/208.17  |- mesh__recordMaintainer mesh__D018113 ags
% 207.97/208.17  |- mesh__dateEstablished mesh__D018113 1994-01-01
% 207.97/208.17  |- rdf__type mesh__D018113sskos__Concept
% 207.97/208.17  |- skos__altLabel mesh__D018113 Human respiratory syncytial virus
% 207.97/208.17  |- mesh__recordOriginator mesh__D018113 AGS
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D018113 2004
% 207.97/208.17  |- mesh__recordAuthorizer mesh__D018113 sjn
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D018113 2002
% 207.97/208.17  |- skos__prefLabel mesh__D018113 Respiratory Syncytial Virus, Human
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D018113 2003
% 207.97/208.17  |- mesh__historyNote mesh__D018113 94   
% 207.97/208.17  |- mesh__dateCreated mesh__D018113 1993-06-04
% 207.97/208.17  |- skos__hiddenLabel mesh__D010130 Sodium, Aminohippurate
% 207.97/208.17  |- skos__hiddenLabel mesh__D010130 p Aminohippurate
% 207.97/208.17  |- skos__hiddenLabel mesh__D010130 Para-Aminohippurate, Sodium
% 207.97/208.17  |- skos__prefLabel mesh__D010130 p-Aminohippuric Acid
% 207.97/208.17  |- mesh__dateCreated mesh__D010130 1976-05-19
% 207.97/208.17  |- skos__altLabel mesh__D010130 para-Aminohippuric Acid
% 207.97/208.17  |- skos__historyNote mesh__D010130 Aminohippuric Acids %28%1966-1976%29%
% 207.97/208.17  |- mesh__dateEstablished mesh__D010130 1991-01-01
% 207.97/208.17  |- rdf__type mesh__D010130sskos__Concept
% 207.97/208.17  |- skos__hiddenLabel mesh__D010130 p Aminohippuric Acid
% 207.97/208.17  |- skos__broader mesh__D010130smesh__D000618
% 207.97/208.17  |- skos__altLabel mesh__D010130 Sodium Para-Aminohippurate
% 207.97/208.17  |- mesh__recordOriginator mesh__D010130 RLS
% 207.97/208.17  |- mesh__onlineNote mesh__D010130
% 207.97/208.17       use P-AMINOHIPPURIC ACID to search PARA-AMINOHIPPURIC ACID 1975-76; use AMINOHIPPURIC ACIDS 1966-74%A%  
% 207.97/208.17  |- mesh__historyNote mesh__D010130
% 207.97/208.17       91%28%77%29%; was see under AMINOHIPPURIC ACIDS 1977-90; was PARA-AMINOHIPPURIC ACID see under AMINOHIPPURIC ACID 1965-76; was PARA-AMINOHIPPURIC ACID 1963-64%A%  
% 207.97/208.17  |- mesh__recordMaintainer mesh__D010130 CCR
% 207.97/208.17  |- skos__hiddenLabel mesh__D010130 para Aminohippuric Acid
% 207.97/208.17  |- skos__hiddenLabel mesh__D010130 Sodium Para Aminohippurate
% 207.97/208.17  |- skos__altLabel mesh__D010130 Aminohippuric Acid
% 207.97/208.17  |- skos__hiddenLabel mesh__D010130 4 Aminohippuric Acid
% 207.97/208.17  |- mesh__dateRevised mesh__D010130 2005-06-30
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D010130 2006
% 207.97/208.17  |- skos__altLabel mesh__D010130 4-Aminohippuric Acid
% 207.97/208.17  |- skos__scopeNote mesh__D010130
% 207.97/208.17       The glycine amide of 4-aminobenzoic acid. Its sodium salt is used as a diagnostic aid to measure effective renal plasma flow %28%ERPF%29% and excretory capacity.%A%    
% 207.97/208.17  |- mesh__recordAuthorizer mesh__D010130 sjn
% 207.97/208.17  |- mesh__publicMeSHNote mesh__D010130
% 207.97/208.17       91; was see under AMINOHIPPURIC ACIDS 1977-90; was PARA-AMINOHIPPURIC ACID see under AMINOHIPPURIC ACID 1965-76; was PARA-AMINOHIPPURIC ACID 1963-64%A%  
% 207.97/208.17  |- skos__historyNote mesh__D051547
% 207.97/208.17       Heme Oxygenase %28%Decyclizing%29% %28%1997-2005%29%
% 207.97/208.17  |- skos__broader mesh__D051547smesh__D006419
% 207.97/208.17  |- mesh__recordOriginator mesh__D051547 AKE
% 207.97/208.17  |- mesh__recordAuthorizer mesh__D051547 sjn
% 207.97/208.17  |- skos__altLabel mesh__D051547 Hemeoxygenase 1
% 207.97/208.17  |- mesh__historyNote mesh__D051547 2006%28%1997%29%   
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D051547 2006
% 207.97/208.17  |- skos__hiddenLabel mesh__D051547 Oxygenase-1, Heme
% 207.97/208.17  |- skos__hiddenLabel mesh__D051547 Heme Oxygenase 1
% 207.97/208.17  |- mesh__recordMaintainer mesh__D051547 AKE
% 207.97/208.17  |- mesh__dateEstablished mesh__D051547 2006-01-01
% 207.97/208.17  |- skos__prefLabel mesh__D051547 Heme Oxygenase-1
% 207.97/208.17  |- skos__scopeNote mesh__D051547
% 207.97/208.17       A ubiquitous stress-responsive enzyme that catalyzes the oxidative cleavage of HEME to yield IRON; CARBON MONOXIDE; and BILIVERDIN.%A%    
% 207.97/208.17  |- mesh__dateCreated mesh__D051547 2005-06-30
% 207.97/208.17  |- rdf__type mesh__D051547sskos__Concept
% 207.97/208.17  |- mesh__publicMeSHNote mesh__D051547
% 207.97/208.17       2006; HEME OXYGENASE-1 was indexed under HEME OXYGENASE %28%DECYCLIZING%29% 1997-200%A%  
% 207.97/208.17  |- skos__historyNote mesh__D009387 Polymers %28%1971-1974%29%
% 207.97/208.17  |- skos__altLabel mesh__D009387 Chloroprene Polymer
% 207.97/208.17  |- skos__historyNote mesh__D009387 Hydrocarbons, Chlorinated %28%1974%29%
% 207.97/208.17  |- mesh__dateRevised mesh__D009387 2004-07-07
% 207.97/208.17  |- rdf__type mesh__D009387sskos__Concept
% 207.97/208.17  |- skos__prefLabel mesh__D009387 Neoprene
% 207.97/208.17  |- skos__broader mesh__D009387smesh__D011090
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D009387 2005
% 207.97/208.17  |- mesh__recordMaintainer mesh__D009387 jmp
% 207.97/208.17  |- skos__hiddenLabel mesh__D009387 Polychloroprenes
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D009387 2006
% 207.97/208.17  |- skos__altLabel mesh__D009387 Polychloroprene
% 207.97/208.17  |- mesh__dateCreated mesh__D009387 1974-11-19
% 207.97/208.17  |- skos__altLabel mesh__D009387 Duprene
% 207.97/208.17  |- skos__scopeNote mesh__D009387
% 207.97/208.17       An oil-resistant synthetic rubber made by the polymerization of chloroprene.%A%    
% 207.97/208.17  |- mesh__recordAuthorizer mesh__D009387 sjn
% 207.97/208.17  |- mesh__historyNote mesh__D009387
% 207.97/208.17       91%28%75%29%; was see under POLYENES 1975-90   
% 207.97/208.17  |- mesh__recordOriginator mesh__D009387 NLM
% 207.97/208.17  |- mesh__publicMeSHNote mesh__D009387 91; was see under POLYENES 1975-90   
% 207.97/208.17  |- skos__historyNote mesh__D009387 Butadienes %28%1971-1974%29%
% 207.97/208.17  |- mesh__dateEstablished mesh__D009387 1991-01-01
% 207.97/208.17  |- skos__hiddenLabel mesh__D009387 Chloroprene Polymers
% 207.97/208.17  |- skos__broader mesh__D009387smesh__D012408
% 207.97/208.17  |- mesh__dateEstablished mesh__D017819 1994-01-01
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D017819 2004
% 207.97/208.17  |- mesh__recordAuthorizer mesh__D017819 sjn
% 207.97/208.17  |- mesh__publicMeSHNote mesh__D017819 94   
% 207.97/208.17  |- skos__altLabel mesh__D017819 European Adder
% 207.97/208.17  |- skos__scopeNote mesh__D017819
% 207.97/208.17       A family of snakes comprising three subfamilies: Azemiopinae %28%the mountain viper, the sole member of this subfamily%29%, Viperinae %28%true vipers%29%, and Crotalinae %28%pit vipers%29%. They are widespread throughout the world, being found in the United States, Central and South America, Europe, Asia and Africa. Their venoms act on the blood %28%hemotoxic%29% as compared to the venom of elapids which act on the nervous system %28%neurotoxic%29%. %28%Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, pp333-36%29%%A%    
% 207.97/208.17  |- skos__hiddenLabel mesh__D017819 Vipers, European
% 207.97/208.17  |- skos__hiddenLabel mesh__D017819 Gaboon Vipers
% 207.97/208.17  |- skos__hiddenLabel mesh__D017819 Vipers, True
% 207.97/208.17  |- rdf__type mesh__D017819sskos__Concept
% 207.97/208.17  |- skos__hiddenLabel mesh__D017819 Crotalid
% 207.97/208.17  |- skos__hiddenLabel mesh__D017819 Asps
% 207.97/208.17  |- skos__hiddenLabel mesh__D017819 Adder, European
% 207.97/208.17  |- mesh__dateCreated mesh__D017819 1993-05-07
% 207.97/208.17  |- skos__prefLabel mesh__D017819 Viperidae
% 207.97/208.17  |- skos__historyNote mesh__D017819 Snakes %28%1968-1993%29%
% 207.97/208.17  |- skos__hiddenLabel mesh__D017819 Bushmasters
% 207.97/208.17  |- skos__broader mesh__D017819smesh__D012911
% 207.97/208.17  |- skos__hiddenLabel mesh__D017819 Viper, European
% 207.97/208.17  |- skos__annotation mesh__D017819
% 207.97/208.17       mountain viper, true vipers %26% pit vipers   
% 207.97/208.17  |- mesh__dateRevised mesh__D017819 2003-07-09
% 207.97/208.17  |- mesh__recordOriginator mesh__D017819 TGC
% 207.97/208.17  |- skos__hiddenLabel mesh__D017819 Adders, European
% 207.97/208.17  |- skos__hiddenLabel mesh__D017819 Viper, True
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D017819 2006
% 207.97/208.17  |- skos__hiddenLabel mesh__D017819 European Vipers
% 207.97/208.17  |- skos__related mesh__D017819smesh__D014757
% 207.97/208.17  |- skos__hiddenLabel mesh__D017819 True Viper
% 207.97/208.17  |- skos__hiddenLabel mesh__D017819 Vipers, Gaboon
% 207.97/208.17  |- skos__altLabel mesh__D017819 True Vipers
% 207.97/208.17  |- mesh__recordMaintainer mesh__D017819 ags
% 207.97/208.17  |- skos__hiddenLabel mesh__D017819 European Adders
% 207.97/208.17  |- skos__hiddenLabel mesh__D017819 Viper, Gaboon
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D017819 2005
% 207.97/208.17  |- mesh__historyNote mesh__D017819 94   
% 207.97/208.17  |- skos__scopeNote mesh__D014521
% 207.97/208.17       A tube that transports URINE from the BLADDER to the outside of the body in both the sexes. It also has a reproductive function in the male by providing a passage for SPERM.%A%    
% 207.97/208.17  |- skos__hiddenLabel mesh__D014521 Urethras
% 207.97/208.17  |- skos__broader mesh__D014521smesh__D010413
% 207.97/208.17  |- rdf__type mesh__D014521sskos__Concept
% 207.97/208.17  |- mesh__recordMaintainer mesh__D014521 lkt
% 207.97/208.17  |- mesh__recordOriginator mesh__D014521 NLM
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D014521 2006
% 207.97/208.17  |- mesh__dateRevised mesh__D014521 2005-06-30
% 207.97/208.17  |- skos__prefLabel mesh__D014521 Urethra
% 207.97/208.17  |- mesh__dateCreated mesh__D014521 1999-01-01
% 207.97/208.17  |- skos__broader mesh__D014521smesh__D014551
% 207.97/208.17  |- mesh__recordAuthorizer mesh__D014521 sjn
% 207.97/208.17  |- skos__annotation mesh__D014521
% 207.97/208.17       do not confuse with URETER, especially in Romance language: see note on URETER; inflammation = URETHRITIS%A%  
% 207.97/208.17  |- mesh__recordOriginator mesh__D000501 RLS
% 207.97/208.17  |- skos__scopeNote mesh__D000501
% 207.97/208.17       An inhibitor of glutamate decarboxylase and an antagonist of GAMMA-AMINOBUTYRIC ACID. It is used to induce convulsions in experimental animals.%A%    
% 207.97/208.17  |- skos__historyNote mesh__D000501
% 207.97/208.17       Glycine %28%1966-1974%29% /antagonists %26% inhibitors %28%1975-1979%29%
% 207.97/208.17  |- skos__altLabel mesh__D000501 2-Amino-4-Pentenoic Acid
% 207.97/208.17  |- rdf__type mesh__D000501sskos__Concept
% 207.97/208.17  |- mesh__publicMeSHNote mesh__D000501 91; was see under GLYCINE 1980-90   
% 207.97/208.17  |- skos__historyNote mesh__D000501 Analeptics %28%1966-1974%29%
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D000501 2002
% 207.97/208.17  |- skos__historyNote mesh__D000501 Allyl Compounds %28%1971-1975%29%
% 207.97/208.17  |- mesh__recordAuthorizer mesh__D000501 sjn
% 207.97/208.17  |- skos__historyNote mesh__D000501 Convulsants %28%1974-1979%29%
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D000501 2006
% 207.97/208.17  |- mesh__historyNote mesh__D000501
% 207.97/208.17       91%28%80%29%; was see under GLYCINE 1980-90   
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D000501 2004
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D000501 2005
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D000501 2003
% 207.97/208.17  |- mesh__dateRevised mesh__D000501 2001-08-03
% 207.97/208.17  |- mesh__dateCreated mesh__D000501 1979-05-23
% 207.97/208.17  |- mesh__recordMaintainer mesh__D000501 sjn
% 207.97/208.17  |- skos__broader mesh__D000501smesh__D000498
% 207.97/208.17  |- mesh__dateEstablished mesh__D000501 1991-01-01
% 207.97/208.17  |- skos__broader mesh__D000501smesh__D005998
% 207.97/208.17  |- skos__prefLabel mesh__D000501 Allylglycine
% 207.97/208.17  |- mesh__publicMeSHNote mesh__D005795 69   
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005795 1995
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005795 2000
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005795 2004
% 207.97/208.17  |- mesh__dateRevised mesh__D005795 1992-05-15
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005795 1998
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005795 2001
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005795 1993
% 207.97/208.17  |- skos__scopeNote mesh__D005795
% 207.97/208.17       The tendency to react to stimuli that are different from, but somewhat similar to, the stimulus used as a conditioned stimulus.%A%    
% 207.97/208.17  |- rdf__type mesh__D005795sskos__Concept
% 207.97/208.17  |- mesh__historyNote mesh__D005795 69%28%65%29%   
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005795 1996
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005795 1999
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005795 2002
% 207.97/208.17  |- skos__hiddenLabel mesh__D005795 Stimulus Generalization
% 207.97/208.17  |- skos__hiddenLabel mesh__D005795 Generalizations, Stimulus
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005795 1997
% 207.97/208.17  |- skos__prefLabel mesh__D005795 Generalization, Stimulus
% 207.97/208.17  |- mesh__recordOriginator mesh__D005795 NLM
% 207.97/208.17  |- mesh__recordMaintainer mesh__D005795 TAP
% 207.97/208.17  |- skos__broader mesh__D005795smesh__D005793
% 207.97/208.17  |- mesh__recordAuthorizer mesh__D005795 PLS
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005795 2005
% 207.97/208.17  |- mesh__dateEstablished mesh__D005795 1969-01-01
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005795 1994
% 207.97/208.17  |- mesh__dateCreated mesh__D005795 1999-01-01
% 207.97/208.17  |- skos__hiddenLabel mesh__D005795 Stimulus Generalizations
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005795 2003
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D005795 2006
% 207.97/208.17  |- mesh__recordMaintainer mesh__D013429 ssb
% 207.97/208.17  |- skos__prefLabel mesh__D013429 Sulfatases
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D013429 2006
% 207.97/208.17  |- mesh__dateRevised mesh__D013429 2003-07-09
% 207.97/208.17  |- mesh__recordAuthorizer mesh__D013429 sjn
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D013429 2005
% 207.97/208.17  |- mesh__recordOriginator mesh__D013429 NLM
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D013429 2004
% 207.97/208.17  |- rdf__type mesh__D013429sskos__Concept
% 207.97/208.17  |- mesh__dateCreated mesh__D013429 1999-01-01
% 207.97/208.17  |- skos__broader mesh__D013429smesh__D004950
% 207.97/208.17  |- skos__hiddenLabel mesh__D018912 Palestinian
% 207.97/208.17  |- skos__scopeNote mesh__D018912
% 207.97/208.17       Members of a Semitic people inhabiting the Arabian peninsula or other countries of the Middle East and North Africa. The term may be used with reference to ancient, medieval, or modern ethnic or cultural groups. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D018912 2004A
% 207.97/208.17  |- skos__broader mesh__D018912smesh__D005006
% 207.97/208.17  |- skos__hiddenLabel mesh__D018912 Bedouin
% 207.97/208.17  |- skos__annotation mesh__D018912 specify geog if relevant   
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D018912 2004
% 207.97/208.17  |- skos__related mesh__D018912smesh__D007514
% 207.97/208.17  |- mesh__dateRevised mesh__D018912 2003-10-30
% 207.97/208.17  |- mesh__recordAuthorizer mesh__D018912 jls
% 207.97/208.17  |- mesh__publicMeSHNote mesh__D018912 96   
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D018912 2004B
% 207.97/208.17  |- mesh__historyNote mesh__D018912 96   
% 207.97/208.17  |- mesh__dateCreated mesh__D018912 1995-01-06
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D018912 2006
% 207.97/208.17  |- mesh__recordMaintainer mesh__D018912 jls
% 207.97/208.17  |- mesh__recordOriginator mesh__D018912 TGC
% 207.97/208.17  |- rdf__type mesh__D018912sskos__Concept
% 207.97/208.17  |- skos__hiddenLabel mesh__D018912 Arab
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D018912 2005
% 207.97/208.17  |- mesh__dateEstablished mesh__D018912 1996-01-01
% 207.97/208.17  |- skos__prefLabel mesh__D018912 Arabs
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D018114 2005
% 207.97/208.17  |- mesh__recordAuthorizer mesh__D018114 sjn
% 207.97/208.17  |- skos__hiddenLabel mesh__D018114 lyssavirus, Australian bat
% 207.97/208.17  |- skos__hiddenLabel mesh__D018114 Lyssaviruses
% 207.97/208.17  |- mesh__recordMaintainer mesh__D018114 ags
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D018114 2006
% 207.97/208.17  |- mesh__dateRevised mesh__D018114 2001-07-25
% 207.97/208.17  |- skos__hiddenLabel mesh__D018114 lyssaviruses, Australian bat
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D018114 2003
% 207.97/208.17  |- skos__broader mesh__D018114smesh__D012209
% 207.97/208.17  |- rdf__type mesh__D018114sskos__Concept
% 207.97/208.17  |- skos__annotation mesh__D018114
% 207.97/208.17       infection: coord IM with RHABDOVIRIDAE INFECTIONS %28%IM%29%   
% 207.97/208.17  |- mesh__publicMeSHNote mesh__D018114 94   
% 207.97/208.17  |- skos__scopeNote mesh__D018114
% 207.97/208.17       A genus of the family RHABDOVIRIDAE that includes RABIES VIRUS and other rabies-like viruses.%A%    
% 207.97/208.17  |- skos__historyNote mesh__D018114 Rhabdoviridae %28%1978-1993%29%
% 207.97/208.17  |- skos__prefLabel mesh__D018114 Lyssavirus
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D018114 2004
% 207.97/208.17  |- mesh__recordOriginator mesh__D018114 AGS
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D018114 2002
% 207.97/208.17  |- mesh__dateEstablished mesh__D018114 1994-01-01
% 207.97/208.17  |- mesh__historyNote mesh__D018114 94   
% 207.97/208.17  |- skos__hiddenLabel mesh__D018114 Australian bat lyssaviruses
% 207.97/208.17  |- mesh__dateCreated mesh__D018114 1993-06-04
% 207.97/208.17  |- mesh__dateEstablished mesh__D010131 1991-01-01
% 207.97/208.17  |- skos__hiddenLabel mesh__D010131 p Aminosalicylic Acid Monolithium Salt
% 207.97/208.17  |- skos__hiddenLabel mesh__D010131 p Aminosalicylic Acid Monosodium Salt
% 207.97/208.17  |- skos__prefLabel mesh__D010131 p-Aminosalicylic Acid
% 207.97/208.17  |- rdf__type mesh__D010131sskos__Concept
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D010131 2003
% 207.97/208.17  |- skos__altLabel mesh__D010131 4-Aminosalicylic Acid
% 207.97/208.17  |- mesh__recordAuthorizer mesh__D010131 sjn
% 207.97/208.17  |- skos__historyNote mesh__D010131 Aminosalicylic Acids %28%1966-1976%29%
% 207.97/208.17  |- skos__hiddenLabel mesh__D010131 Alumino 4 Aminosalicylic Acid
% 207.97/208.17  |- mesh__onlineNote mesh__D010131
% 207.97/208.17       use P-AMINOSALICYLIC ACID to search PARA-AMINOSALICYLIC ACID 1975-76; use AMINOSALICYLIC ACIDS to search PARA-AMINOSALICYLIC ACID 1966-74 %26% PAS 1966-67%A%  
% 207.97/208.17  |- skos__annotation mesh__D010131 AMINOSALICYLIC ACIDS is also available   
% 207.97/208.17  |- skos__altLabel mesh__D010131 para-Aminosalicylic Acid
% 207.97/208.17  |- skos__broader mesh__D010131smesh__D000636
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D010131 2004
% 207.97/208.17  |- mesh__dateCreated mesh__D010131 1976-05-19
% 207.97/208.17  |- skos__hiddenLabel mesh__D010131 4 Aminosalicylic Acid
% 207.97/208.17  |- mesh__historyNote mesh__D010131
% 207.97/208.17       91%28%77%29%; was see under AMINOSALICYLIC ACIDS 1977-90; was PARA-AMINOSALICYLIC ACID see under AMINOSALICYLIC ACID 1963-76; PAS was see under AMINOSALICYLIC ACID 1963-67%A%  
% 207.97/208.17  |- skos__hiddenLabel mesh__D010131 para Aminosalicylic Acid
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D010131 2005
% 207.97/208.17  |- skos__hiddenLabel mesh__D010131 p Aminosalicylic Acid Monopotassium Salt
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D010131 2001
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D010131 2006
% 207.97/208.17  |- mesh__dateRevised mesh__D010131 2000-06-21
% 207.97/208.17  |- mesh__recordOriginator mesh__D010131 RLS
% 207.97/208.17  |- mesh__publicMeSHNote mesh__D010131
% 207.97/208.17       91; was see under AMINOSALICYLIC ACIDS 1977-90; was PARA-AMINOSALICYLIC ACID see under AMINOSALICYLIC ACID 1963-76; PAS was see under AMINOSALICYCLIC ACID 1963-67%A%  
% 207.97/208.17  |- mesh__activeMeSHYear mesh__D010131 2002
% 207.97/208.17  |- skos__hiddenLabel mesh__D010131 p Aminosalicylic Acid
% 207.97/208.17  |- mesh__recordMaintainer mesh__D010131 CCR
% 207.97/208.18  |- skos__scopeNote mesh__D010131
% 207.97/208.18       An antitubercular agent often administered in association with ISONIAZID. The sodium salt of the drug is better tolerated than the free acid.%A%    
% 207.97/208.18  |- skos__altLabel mesh__D010131 PAS
% 207.97/208.18  |- mesh__dateCreated mesh__D051548 2005-06-30
% 207.97/208.18  |- mesh__publicMeSHNote mesh__D051548
% 207.97/208.18       2006; HISTONE ACETYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1981-2005, HISTONES 1973-1980%A%  
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D051548 2006
% 207.97/208.18  |- mesh__historyNote mesh__D051548
% 207.97/208.18       2006%28%1980%29% use HISTONES 1973-1979   
% 207.97/208.18  |- mesh__recordMaintainer mesh__D051548 AKE
% 207.97/208.18  |- skos__hiddenLabel mesh__D051548 Acetyltransferase, Histone
% 207.97/208.18  |- skos__broader mesh__D051548smesh__D000123
% 207.97/208.18  |- skos__hiddenLabel mesh__D051548 Acetyltransferases, Histone
% 207.97/208.18  |- mesh__recordOriginator mesh__D051548 AKE
% 207.97/208.18  |- skos__hiddenLabel mesh__D051548 Acetylase, Histone
% 207.97/208.18  |- mesh__recordAuthorizer mesh__D051548 sjn
% 207.97/208.18  |- skos__prefLabel mesh__D051548 Histone Acetyltransferases
% 207.97/208.18  |- skos__altLabel mesh__D051548 Histone Acetyltransferase
% 207.97/208.18  |- mesh__dateEstablished mesh__D051548 2006-01-01
% 207.97/208.18  |- rdf__type mesh__D051548sskos__Concept
% 207.97/208.18  |- skos__scopeNote mesh__D051548
% 207.97/208.18       Enzymes that catalyze acyl group transfer from ACETYL-CoA to HISTONES forming CoA and acetyl-histones.%A%    
% 207.97/208.18  |- skos__altLabel mesh__D051548 Histone Acetylase
% 207.97/208.18  |- skos__hiddenLabel mesh__D009388 Bromide, Neostigmine
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D009388 2006
% 207.97/208.18  |- skos__altLabel mesh__D009388 Prozerin
% 207.97/208.18  |- skos__broader mesh__D009388smesh__D000644
% 207.97/208.18  |- skos__broader mesh__D009388smesh__D050338
% 207.97/208.18  |- skos__prefLabel mesh__D009388 Neostigmine
% 207.97/208.18  |- skos__hiddenLabel mesh__D009388 Methylsulfate, Neostigmine
% 207.97/208.18  |- mesh__dateCreated mesh__D009388 1999-01-01
% 207.97/208.18  |- skos__altLabel mesh__D009388 Synstigmin
% 207.97/208.18  |- skos__scopeNote mesh__D009388
% 207.97/208.18       A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.%A%    
% 207.97/208.18  |- skos__altLabel mesh__D009388 Prostigmin
% 207.97/208.18  |- mesh__recordMaintainer mesh__D009388 ssb
% 207.97/208.18  |- skos__altLabel mesh__D009388 Proserine
% 207.97/208.18  |- mesh__recordAuthorizer mesh__D009388 sjn
% 207.97/208.18  |- mesh__dateRevised mesh__D009388 2005-06-30
% 207.97/208.18  |- rdf__type mesh__D009388sskos__Concept
% 207.97/208.18  |- mesh__recordOriginator mesh__D009388 NLM
% 207.97/208.18  |- mesh__dateRevised mesh__D006090 2005-06-30
% 207.97/208.18  |- skos__altLabel mesh__D006090 Gram Negative Bacteria
% 207.97/208.18  |- mesh__historyNote mesh__D006090 84,73-75   
% 207.97/208.18  |- mesh__recordMaintainer mesh__D006090 SYSTEM
% 207.97/208.18  |- mesh__dateEstablished mesh__D006090 1984-01-01
% 207.97/208.18  |- skos__annotation mesh__D006090
% 207.97/208.18       GEN: avoid; prefer specifics; do not use as a routine coord for a gram-negative bact; infection = GRAM-NEGATIVE BACTERIAL INFECTIONS; DF: GRAM NEG BACT%A%  
% 207.97/208.18  |- mesh__recordOriginator mesh__D006090 RC
% 207.97/208.18  |- skos__broader mesh__D006090smesh__D001419
% 207.97/208.18  |- mesh__publicMeSHNote mesh__D006090 84,73-75   
% 207.97/208.18  |- mesh__dateCreated mesh__D006090 1983-06-03
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D006090 2006
% 207.97/208.18  |- mesh__recordAuthorizer mesh__D006090 sjn
% 207.97/208.18  |- skos__prefLabel mesh__D006090 Gram-Negative Bacteria
% 207.97/208.18  |- skos__scopeNote mesh__D006090
% 207.97/208.18       Bacteria which lose crystal violet stain but are stained pink when treated by Gram%27%s method.%A%    
% 207.97/208.18  |- mesh__onlineNote mesh__D006090 search BACTERIA 1973-75   
% 207.97/208.18  |- rdf__type mesh__D006090sskos__Concept
% 207.97/208.18  |- skos__historyNote mesh__D006090 Bacteria %28%1966-1983%29%
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014522 2004
% 207.97/208.18  |- rdf__type mesh__D014522sskos__Concept
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014522 1996
% 207.97/208.18  |- mesh__dateRevised mesh__D014522 1990-05-29
% 207.97/208.18  |- skos__hiddenLabel mesh__D014522 Disease, Urethral
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014522 2002
% 207.97/208.18  |- skos__prefLabel mesh__D014522 Urethral Diseases
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014522 2005
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014522 1992
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014522 1997
% 207.97/208.18  |- mesh__dateEstablished mesh__D014522 1966-01-01
% 207.97/208.18  |- skos__annotation mesh__D014522
% 207.97/208.18       do not confuse with URETERAL DISEASES, espec in Romance lang: see note on %22%ureteral%22% %26% %22%urethral%22% under URETERAL DISEASES; inflamm dis = URETHRITIS%A%  
% 207.97/208.18  |- skos__hiddenLabel mesh__D014522 Diseases, Urethral
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014522 2006
% 207.97/208.18  |- mesh__dateCreated mesh__D014522 1999-01-01
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014522 1993
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014522 1998
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014522 1991
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014522 1994
% 207.97/208.18  |- mesh__publicMeSHNote mesh__D014522 66   
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014522 1999
% 207.97/208.18  |- mesh__recordAuthorizer mesh__D014522 NLM
% 207.97/208.18  |- skos__broader mesh__D014522smesh__D014570
% 207.97/208.18  |- mesh__recordOriginator mesh__D014522 NLM
% 207.97/208.18  |- mesh__recordMaintainer mesh__D014522 PLS
% 207.97/208.18  |- mesh__historyNote mesh__D014522 66   
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014522 1995
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014522 2000
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014522 2003
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014522 2001
% 207.97/208.18  |- skos__hiddenLabel mesh__D014522 Urethral Disease
% 207.97/208.18  |- skos__scopeNote mesh__D000502
% 207.97/208.18       An allylic compound that acts as a suicide inactivator of CYTOCHROME P450 by covalently binding to its heme moiety or surrounding protein.%A%    
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D000502 2006
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D000502 1999
% 207.97/208.18  |- skos__hiddenLabel mesh__D000502 2 Isopropyl 4 Pentenamide
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D000502 2001
% 207.97/208.18  |- mesh__historyNote mesh__D000502
% 207.97/208.18       91%28%73%29%; was see under ACETAMIDES 1973-90   
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D000502 2004
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D000502 2005
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D000502 2000
% 207.97/208.18  |- mesh__publicMeSHNote mesh__D000502
% 207.97/208.18       91; was see under ACETAMIDES 1973-90   
% 207.97/208.18  |- mesh__recordOriginator mesh__D000502 NLM
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D000502 2003
% 207.97/208.18  |- mesh__dateRevised mesh__D000502 1998-06-10
% 207.97/208.18  |- skos__broader mesh__D000502smesh__D000498
% 207.97/208.18  |- skos__prefLabel mesh__D000502 Allylisopropylacetamide
% 207.97/208.18  |- mesh__recordAuthorizer mesh__D000502 SJN
% 207.97/208.18  |- mesh__dateEstablished mesh__D000502 1991-01-01
% 207.97/208.18  |- mesh__dateCreated mesh__D000502 1999-01-01
% 207.97/208.18  |- mesh__recordMaintainer mesh__D000502 ADP
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D000502 2002
% 207.97/208.18  |- rdf__type mesh__D000502sskos__Concept
% 207.97/208.18  |- skos__broader mesh__D000502smesh__D000081
% 207.97/208.18  |- skos__altLabel mesh__D000502 2-Isopropyl-4-Pentenamide
% 207.97/208.18  |- skos__hiddenLabel mesh__D005796 Material, Genetic
% 207.97/208.18  |- skos__related mesh__D005796smesh__D016678
% 207.97/208.18  |- rdf__type mesh__D005796sskos__Concept
% 207.97/208.18  |- mesh__recordMaintainer mesh__D005796 ags
% 207.97/208.18  |- mesh__dateEstablished mesh__D005796 1965-01-01
% 207.97/208.18  |- skos__prefLabel mesh__D005796 Genes
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D005796 2006A
% 207.97/208.18  |- skos__hiddenLabel mesh__D005796 Materials, Genetic
% 207.97/208.18  |- mesh__publicMeSHNote mesh__D005796
% 207.97/208.18       1965; see CHROMOSOMES 1963-1964; for CISTRON see GENES, STRUCTURAL 1980-2005%A%  
% 207.97/208.18  |- skos__annotation mesh__D005796
% 207.97/208.18       locus = CHROMOSOME MAPPING; restorer genes: index under SUPPRESSION, GENETIC and probably PLANT INFERTILITY; repressor genes = GENES, REGULATOR but also consider REPRESSOR PROTEINS; lac gene = LAC OPERON but consider also LAC FACTORS or LAC REPRESSORS %28%see note on REPRESSOR PROTEINS%29%; split genes = EXONS or INTRONS%A%  
% 207.97/208.18  |- mesh__recordAuthorizer mesh__D005796 ags
% 207.97/208.18  |- skos__hiddenLabel mesh__D005796 Cistrons
% 207.97/208.18  |- mesh__historyNote mesh__D005796
% 207.97/208.18       1965; %28%1963%29%; for CISTRON use GENES, STRUCTURAL 1980-2005%A%  
% 207.97/208.18  |- skos__altLabel mesh__D005796 Gene
% 207.97/208.18  |- mesh__dateCreated mesh__D005796 1999-01-01
% 207.97/208.18  |- skos__hiddenLabel mesh__D005796 Genetic Material
% 207.97/208.18  |- skos__related mesh__D005796smesh__D015698
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D005796 2006
% 207.97/208.18  |- mesh__dateRevised mesh__D005796 2005-07-27
% 207.97/208.18  |- skos__related mesh__D005796smesh__D001483
% 207.97/208.18  |- mesh__recordOriginator mesh__D005796 NLM
% 207.97/208.18  |- skos__scopeNote mesh__D005796
% 207.97/208.18       Specific sequences of nucleotides along a molecule of DNA %28%or, in the case of some viruses, RNA%29% which represent functional units of HEREDITY. Most eukaryotic genes contain a set of coding regions %28%EXONS%29% that are spliced together in the transcript, after removal of intervening sequence %28%INTRONS%29% and are therefore labeled split genes.%A%    
% 207.97/208.18  |- skos__broader mesh__D005796smesh__D040481
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D018913 2002
% 207.97/208.18  |- skos__scopeNote mesh__D018913
% 207.97/208.18       A late-appearing component of the event-related potential. P stands for positive voltage potential and 300 represents 300 millisecond poststimulus. Its amplitude increases with unpredictable, unlikely, or highly significant stimuli and thereby constitutes an index of mental activity. %28%From Campbell, Psychiatric Dictionary, 6th ed%29%%A%    
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D018913 2005
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D018913 1998
% 207.97/208.18  |- mesh__dateCreated mesh__D018913 1994-12-27
% 207.97/208.18  |- skos__historyNote mesh__D018913
% 207.97/208.18       specific Evoked Potentials %28%1980-1995%29%
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D018913 2001
% 207.97/208.18  |- skos__hiddenLabel mesh__D018913 Event Related Potentials, P300
% 207.97/208.18  |- skos__hiddenLabel mesh__D018913 P300 Event Related Potentials
% 207.97/208.18  |- skos__altLabel mesh__D018913 Evoked Potentials, P300 Component
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D018913 2004
% 207.97/208.18  |- skos__hiddenLabel mesh__D018913 P300 Event-Related Potential
% 207.97/208.18  |- mesh__publicMeSHNote mesh__D018913 96   
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D018913 1997
% 207.97/208.18  |- mesh__historyNote mesh__D018913 96   
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D018913 2000
% 207.97/208.18  |- skos__prefLabel mesh__D018913 Event-Related Potentials, P300
% 207.97/208.18  |- skos__altLabel mesh__D018913 P300 Component
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D018913 2003
% 207.97/208.18  |- rdf__type mesh__D018913sskos__Concept
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D018913 1996
% 207.97/208.18  |- skos__hiddenLabel mesh__D018913 P300 Components
% 207.97/208.18  |- skos__altLabel mesh__D018913 P300 Event-Related Potentials
% 207.97/208.18  |- skos__annotation mesh__D018913
% 207.97/208.18       an evoked potential; DF: P300 COMPONENT   
% 207.97/208.18  |- skos__broader mesh__D018913smesh__D005071
% 207.97/208.18  |- skos__hiddenLabel mesh__D018913 Event-Related Potential, P300
% 207.97/208.18  |- skos__historyNote mesh__D018913 Evoked Potentials %28%1975-1995%29%
% 207.97/208.18  |- mesh__dateEstablished mesh__D018913 1996-01-01
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D018913 2006
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D018913 1999
% 207.97/208.18  |- mesh__dateRevised mesh__D010930 2002-07-03
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D010930 2006
% 207.97/208.18  |- mesh__recordMaintainer mesh__D010930 sjn
% 207.97/208.18  |- skos__hiddenLabel mesh__D010930 Plague, Meningeal
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D010930 2005
% 207.97/208.18  |- skos__hiddenLabel mesh__D010930 Plagues, Pulmonic
% 207.97/208.18  |- skos__hiddenLabel mesh__D010930 Meningeal Plagues
% 207.97/208.18  |- skos__hiddenLabel mesh__D010930 Plague, Pneumonic
% 207.97/208.18  |- skos__prefLabel mesh__D010930 Plague
% 207.97/208.18  |- skos__hiddenLabel mesh__D010930 Pulmonic Plagues
% 207.97/208.18  |- skos__hiddenLabel mesh__D010930 Plagues, Pneumonic
% 207.97/208.18  |- skos__hiddenLabel mesh__D010930 Plague, Pulmonic
% 207.97/208.18  |- rdf__type mesh__D010930sskos__Concept
% 207.97/208.18  |- mesh__dateCreated mesh__D010930 1999-01-01
% 207.97/208.18  |- skos__annotation mesh__D010930
% 207.97/208.18       Pasteurella pestis or Yersinia pestis infection only; swine plague = HEMORRHAGIC SEPTICEMIA /vet %28%IM%29% + SWINE DISEASES %28%IM%29% but do not confuse with African swine plague %28% = AFRICAN SWINE FEVER%29%%A%  
% 207.97/208.18  |- skos__hiddenLabel mesh__D010930 Plagues, Meningeal
% 207.97/208.18  |- skos__broader mesh__D010930smesh__D015009
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D010930 2004
% 207.97/208.18  |- skos__scopeNote mesh__D010930
% 207.97/208.18       An acute infectious disease caused by YERSINIA PESTIS that affects humans, wild rodents, and their ectoparasites. This condition persists due to its firm entrenchment in sylvatic rodent-flea ecosystems throughout the world. Bubonic plague is the most common form.%A%    
% 207.97/208.18  |- mesh__recordOriginator mesh__D010930 NLM
% 207.97/208.18  |- mesh__recordAuthorizer mesh__D010930 sjn
% 207.97/208.18  |- skos__hiddenLabel mesh__D010930 Pneumonic Plagues
% 207.97/208.18  |- skos__hiddenLabel mesh__D010930 Plague, Bubonic
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D010930 2003
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D018115 2002
% 207.97/208.18  |- mesh__dateEstablished mesh__D018115 1994-01-01
% 207.97/208.18  |- skos__historyNote mesh__D018115 Rhabdoviridae %28%1977-1993%29%
% 207.97/208.18  |- mesh__recordMaintainer mesh__D018115 ags
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D018115 2006
% 207.97/208.18  |- mesh__dateCreated mesh__D018115 1993-06-04
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D018115 2003
% 207.97/208.18  |- mesh__recordAuthorizer mesh__D018115 sjn
% 207.97/208.18  |- rdf__type mesh__D018115sskos__Concept
% 207.97/208.18  |- skos__historyNote mesh__D018115 RNA Viruses %28%1969-1978%29%
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D018115 2004
% 207.97/208.18  |- mesh__dateRevised mesh__D018115 2001-07-25
% 207.97/208.18  |- skos__annotation mesh__D018115
% 207.97/208.18       infection = EPHEMERAL FEVER: see note there   
% 207.97/208.18  |- skos__scopeNote mesh__D018115
% 207.97/208.18       The type species of EPHEMEROVIRUS causing disease in cattle. Transmission is by hematophagous arthropods and the virus has been isolated from both culicoides and mosquitoes.%A%    
% 207.97/208.18  |- skos__prefLabel mesh__D018115 Ephemeral Fever Virus, Bovine
% 207.97/208.18  |- mesh__historyNote mesh__D018115 94   
% 207.97/208.18  |- mesh__publicMeSHNote mesh__D018115 94   
% 207.97/208.18  |- skos__broader mesh__D018115smesh__D019235
% 207.97/208.18  |- skos__altLabel mesh__D018115 Bovine ephemeral fever virus
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D018115 2005
% 207.97/208.18  |- mesh__recordOriginator mesh__D018115 AGS
% 207.97/208.18  |- skos__hiddenLabel mesh__D010132 p Azobenzenearsonate
% 207.97/208.18  |- skos__scopeNote mesh__D010132
% 207.97/208.18       A hapten capable of eliciting both antibody formation and delayed hypersensitivity when bound to aromatic amino acids, polypeptides or proteins. It is used as an immunologic research tool.%A%    
% 207.97/208.18  |- skos__historyNote mesh__D010132 Azo Compounds %28%1972-1975%29%
% 207.97/208.18  |- skos__altLabel mesh__D010132 para-Azobenzenearsonate
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D010132 2006
% 207.97/208.18  |- mesh__publicMeSHNote mesh__D010132
% 207.97/208.18       91; was see under AZO COMPOUNDS 1976-90   
% 207.97/208.18  |- skos__hiddenLabel mesh__D010132 para Azobenzenearsonate
% 207.97/208.18  |- skos__broader mesh__D010132smesh__D001391
% 207.97/208.18  |- mesh__dateRevised mesh__D010132 2005-06-30
% 207.97/208.18  |- mesh__recordMaintainer mesh__D010132 ssb
% 207.97/208.18  |- mesh__recordAuthorizer mesh__D010132 sjn
% 207.97/208.18  |- mesh__historyNote mesh__D010132
% 207.97/208.18       91%28%76%29%; was see under AZO COMPOUNDS 1976-90   
% 207.97/208.18  |- skos__broader mesh__D010132smesh__D001152
% 207.97/208.18  |- rdf__type mesh__D010132sskos__Concept
% 207.97/208.18  |- mesh__recordOriginator mesh__D010132 SH
% 207.97/208.18  |- mesh__dateEstablished mesh__D010132 1991-01-01
% 207.97/208.18  |- skos__prefLabel mesh__D010132 p-Azobenzenearsonate
% 207.97/208.18  |- skos__historyNote mesh__D010132 Arsenicals %28%1972-1975%29%
% 207.97/208.18  |- skos__broader mesh__D010132smesh__D006241
% 207.97/208.18  |- mesh__dateCreated mesh__D010132 1975-07-18
% 207.97/208.18  |- skos__scopeNote mesh__D051549
% 207.97/208.18       A glutathione transferase that catalyzes the conjugation of electrophilic substrates to GLUTATHIONE. This enzyme has been shown to provide cellular protection against redox-mediated damage by FREE RADICALS.%A%    
% 207.97/208.18  |- skos__hiddenLabel mesh__D051549 GST Class phi
% 207.97/208.18  |- skos__broader mesh__D051549smesh__D005982
% 207.97/208.18  |- rdf__type mesh__D051549sskos__Concept
% 207.97/208.18  |- skos__hiddenLabel mesh__D051549 Glutathione D-Transferase, GSTP1
% 207.97/208.18  |- skos__hiddenLabel mesh__D051549 Glutathione S Transferase pi
% 207.97/208.18  |- mesh__dateCreated mesh__D051549 2005-06-30
% 207.97/208.18  |- skos__altLabel mesh__D051549 GST Class-phi
% 207.97/208.18  |- skos__hiddenLabel mesh__D051549 Class-phi, GST
% 207.97/208.18  |- skos__hiddenLabel mesh__D051549 D-Transferase, GSTP1 Glutathione
% 207.97/208.18  |- mesh__recordOriginator mesh__D051549 AKE
% 207.97/208.18  |- skos__hiddenLabel mesh__D051549 Transferase P1-1, Glutathione
% 207.97/208.18  |- skos__hiddenLabel mesh__D051549 GSTP1 Glutathione D Transferase
% 207.97/208.18  |- mesh__publicMeSHNote mesh__D051549
% 207.97/208.18       2006; GLUTATHIONE S-TRANSFERASE PI was indexed under GLUTATHIONE TRANSFERASE %26% ISOENZYMES 1997-2005%A%  
% 207.97/208.18  |- skos__altLabel mesh__D051549 GSTP1 Glutathione D-Transferase
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D051549 2006
% 207.97/208.18  |- mesh__historyNote mesh__D051549 2006%28%1997%29%   
% 207.97/208.18  |- skos__prefLabel mesh__D051549 Glutathione S-Transferase pi
% 207.97/208.18  |- mesh__recordMaintainer mesh__D051549 AKE
% 207.97/208.18  |- mesh__recordAuthorizer mesh__D051549 sjn
% 207.97/208.18  |- mesh__dateEstablished mesh__D051549 2006-01-01
% 207.97/208.18  |- skos__hiddenLabel mesh__D051549 Glutathione Transferase P1 1
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D009389 2004
% 207.97/208.18  |- mesh__onlineNote mesh__D009389
% 207.97/208.18       use NEOVASCULARIZATION, PATHOLOGIC to search NEOVASCULARIZATION %26% ANGIOGENESIS 1980-95%A%  
% 207.97/208.18  |- skos__altLabel mesh__D009389 Angiogenesis, Pathological
% 207.97/208.18  |- mesh__historyNote mesh__D009389
% 207.97/208.18       96; was NEOVASCULARIZATION 1980-95; ANGIOGENESIS, PATHOLOGIC was ANGIOGENESIS 1980-85; was in Cat G 1980-82%A%  
% 207.97/208.18  |- rdf__type mesh__D009389sskos__Concept
% 207.97/208.18  |- skos__altLabel mesh__D009389 Pathologic Angiogenesis
% 207.97/208.18  |- mesh__recordAuthorizer mesh__D009389 sjn
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D009389 2003
% 207.97/208.18  |- skos__altLabel mesh__D009389 Pathologic Neovascularization
% 207.97/208.18  |- skos__related mesh__D009389smesh__D018919
% 207.97/208.18  |- skos__scopeNote mesh__D009389
% 207.97/208.18       A pathologic process consisting in proliferation of blood vessels in abnormal tissues or in abnormal positions.%A%    
% 207.97/208.18  |- skos__hiddenLabel mesh__D009389 Pathological Angiogenesis
% 207.97/208.18  |- skos__prefLabel mesh__D009389 Neovascularization, Pathologic
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D009389 2006
% 207.97/208.18  |- mesh__recordMaintainer mesh__D009389 nns
% 207.97/208.18  |- mesh__dateEstablished mesh__D009389 1980-01-01
% 207.97/208.18  |- mesh__dateRevised mesh__D009389 2002-07-02
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D009389 2005
% 207.97/208.18  |- skos__altLabel mesh__D009389 Angiogenesis, Pathologic
% 207.97/208.18  |- mesh__recordOriginator mesh__D009389 VDK
% 207.97/208.18  |- mesh__publicMeSHNote mesh__D009389
% 207.97/208.18       96; was NEOVASCULARIZATION 1980-95; ANGIOGENESIS, PATHOLOGIC was ANGIOGENESIS 1980-85%A%  
% 207.97/208.18  |- mesh__dateCreated mesh__D009389 1979-04-23
% 207.97/208.18  |- skos__altLabel mesh__D009389 Neovascularization, Pathological
% 207.97/208.18  |- skos__annotation mesh__D009389
% 207.97/208.18       note category: a pathol process; do not confuse with NEOVASCULARIZATION, PHYSIOLOGIC, a physiol phenomenon; coord IM or NIM with organ /blood supply %28%IM%29%; DF: NEOVASC PATHOL%A%  
% 207.97/208.18  |- skos__hiddenLabel mesh__D009389 Pathological Neovascularization
% 207.97/208.18  |- skos__broader mesh__D009389smesh__D008679
% 207.97/208.18  |- mesh__recordAuthorizer mesh__D020560 sjn
% 207.97/208.18  |- mesh__publicMeSHNote mesh__D020560 2000   
% 207.97/208.18  |- skos__altLabel mesh__D020560 Purple Bacteria
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D020560 2006
% 207.97/208.18  |- mesh__historyNote mesh__D020560 2000   
% 207.97/208.18  |- rdf__type mesh__D020560sskos__Concept
% 207.97/208.18  |- skos__altLabel mesh__D020560 Bacteria, Purple
% 207.97/208.18  |- mesh__recordOriginator mesh__D020560 ndw
% 207.97/208.18  |- skos__annotation mesh__D020560 DF: PROTEOBACT   
% 207.97/208.18  |- mesh__dateEstablished mesh__D020560 2000-01-01
% 207.97/208.18  |- skos__broader mesh__D020560smesh__D001419
% 207.97/208.18  |- mesh__dateRevised mesh__D020560 2005-06-30
% 207.97/208.18  |- mesh__recordMaintainer mesh__D020560 SYSTEM
% 207.97/208.18  |- mesh__dateCreated mesh__D020560 1999-11-03
% 207.97/208.18  |- skos__prefLabel mesh__D020560 Proteobacteria
% 207.97/208.18  |- skos__scopeNote mesh__D020560
% 207.97/208.18       A phylum of bacteria consisting of the purple bacteria and their relatives which form a branch of the eubacterial tree. This group of predominantly gram-negative bacteria is classified based on homology of equivalent nucleotide sequences of 16S ribosomal RNA or by hybridization of ribosomal RNA or DNA with 16S and 23S ribosomal RNA.%A%    
% 207.97/208.18  |- skos__historyNote mesh__D006091 Bacteria %28%1966-1972%29%
% 207.97/208.18  |- skos__annotation mesh__D006091
% 207.97/208.18       GEN: avoid; prefer specifics; do not use as a routine coord for a gram-negative chemolithotrophic bact; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%; DF: note short X ref%A%  
% 207.97/208.18  |- mesh__dateCreated mesh__D006091 1975-07-25
% 207.97/208.18  |- mesh__recordOriginator mesh__D006091 JW
% 207.97/208.18  |- mesh__dateRevised mesh__D006091 2005-06-30
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D006091 2006
% 207.97/208.18  |- mesh__dateEstablished mesh__D006091 1976-01-01
% 207.97/208.18  |- mesh__publicMeSHNote mesh__D006091
% 207.97/208.18       76; THIOBACTERIACEAE was heading 1975-91 %28%see under GRAM-NEGATIVE CHEMOLITHOTROPHIC BACTERIA 1976-90%29%%A%  
% 207.97/208.18  |- skos__broader mesh__D006091smesh__D006088
% 207.97/208.18  |- skos__scopeNote mesh__D006091
% 207.97/208.18       A large group of bacteria including those which oxidize ammonia or nitrite, metabolize sulfur and sulfur compounds, or deposit iron and/or manganese oxides.%A%    
% 207.97/208.18  |- mesh__onlineNote mesh__D006091
% 207.97/208.18       use GRAM-NEGATIVE CHEMOLITHOTROPHIC BACTERIA to search THIOBACTERIACEAE 1975-91%A%  
% 207.97/208.18  |- skos__prefLabel mesh__D006091 Gram-Negative Chemolithotrophic Bacteria
% 207.97/208.18  |- rdf__type mesh__D006091sskos__Concept
% 207.97/208.18  |- skos__historyNote mesh__D006091 Schizomycetes %28%1973-1974%29%
% 207.97/208.18  |- mesh__recordAuthorizer mesh__D006091 sjn
% 207.97/208.18  |- mesh__recordMaintainer mesh__D006091 SYSTEM
% 207.97/208.18  |- mesh__historyNote mesh__D006091
% 207.97/208.18       76; THIOBACTERIACEAE was heading 1975-91 %28%see under GRAM-NEGATIVE CHEMOLITHOTROPHIC BACTERIA 1976-90%29%%A%  
% 207.97/208.18  |- skos__altLabel mesh__D006091 Gram Negative Chemolithotrophic Bacteria
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014523 2005
% 207.97/208.18  |- skos__hiddenLabel mesh__D014523 Urethra Cancers
% 207.97/208.18  |- skos__altLabel mesh__D014523 Urethral Cancer
% 207.97/208.18  |- skos__hiddenLabel mesh__D014523 Cancer, Urethra
% 207.97/208.18  |- skos__annotation mesh__D014523
% 207.97/208.18       do not confuse with URETERAL NEOPLASMS, espec in Romance lang: see note on %22%ureteral%22% %26% %22%urethral%22% under URETERAL DISEASES; coord IM with histol type of neopl %28%IM%29%%A%  
% 207.97/208.18  |- skos__hiddenLabel mesh__D014523 Neoplasm, Urethra
% 207.97/208.18  |- skos__altLabel mesh__D014523 Neoplasms, Urethral
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014523 2001
% 207.97/208.18  |- mesh__dateCreated mesh__D014523 1999-01-01
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014523 2006
% 207.97/208.18  |- skos__hiddenLabel mesh__D014523 Urethral Neoplasm
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014523 2002
% 207.97/208.18  |- skos__hiddenLabel mesh__D014523 Neoplasms, Urethra
% 207.97/208.18  |- skos__hiddenLabel mesh__D014523 Neoplasm, Urethral
% 207.97/208.18  |- skos__altLabel mesh__D014523 Urethra Cancer
% 207.97/208.18  |- skos__broader mesh__D014523smesh__D014571
% 207.97/208.18  |- skos__hiddenLabel mesh__D014523 Urethral Cancers
% 207.97/208.18  |- mesh__recordAuthorizer mesh__D014523 sjn
% 207.97/208.18  |- skos__altLabel mesh__D014523 Urethra Neoplasms
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014523 2003
% 207.97/208.18  |- skos__hiddenLabel mesh__D014523 Urethra Neoplasm
% 207.97/208.18  |- skos__broader mesh__D014523smesh__D014522
% 207.97/208.18  |- skos__scopeNote mesh__D014523
% 207.97/208.18       Cancer or tumors of the URETHRA. This condition is relatively uncommon and is the only cancer of the urinary system that has a higher incidence rate in females than males. Squamous cell carcinoma is the most frequent histologic type.%A%    
% 207.97/208.18  |- skos__altLabel mesh__D014523 Cancer of the Urethra
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014523 2004
% 207.97/208.18  |- mesh__recordOriginator mesh__D014523 NLM
% 207.97/208.18  |- mesh__recordMaintainer mesh__D014523 nns
% 207.97/208.18  |- rdf__type mesh__D014523sskos__Concept
% 207.97/208.18  |- mesh__dateRevised mesh__D014523 1999-11-03
% 207.97/208.18  |- skos__prefLabel mesh__D014523 Urethral Neoplasms
% 207.97/208.18  |- skos__hiddenLabel mesh__D014523 Cancers, Urethral
% 207.97/208.18  |- skos__hiddenLabel mesh__D014523 Cancers, Urethra
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D014523 2000
% 207.97/208.18  |- skos__hiddenLabel mesh__D014523 Cancer, Urethral
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D000503 2005
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D000503 1998
% 207.97/208.18  |- skos__prefLabel mesh__D000503 Almanacs
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D000503 2003
% 207.97/208.18  |- skos__hiddenLabel mesh__D000503 Almanac
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D000503 2001
% 207.97/208.18  |- mesh__recordAuthorizer mesh__D000503 PLS
% 207.97/208.18  |- mesh__dateCreated mesh__D000503 1999-01-01
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D000503 2000
% 207.97/208.18  |- rdf__type mesh__D000503sskos__Concept
% 207.97/208.18  |- skos__annotation mesh__D000503
% 207.97/208.18       for med almanacs, do not coord with MEDICINE; do not confuse with Publication Type ALMANACS%A%  
% 207.97/208.18  |- mesh__recordOriginator mesh__D000503 NLM
% 207.97/208.18  |- skos__scopeNote mesh__D000503
% 207.97/208.18       Publications, usually annual, containing a calendar for the coming year, the times of such events and phenomena as anniversaries, sunrises, sunsets, phases of the moon, tides, meteorological, and other statistical information and related topics. Almanacs are also annual reference books of useful and interesting facts relating to countries of the world, sports, entertainment, population groups, etc. %28%Random House Unabridged Dictionary, 2d ed%29%%A%    
% 207.97/208.18  |- mesh__recordMaintainer mesh__D000503 TGC
% 207.97/208.18  |- skos__broader mesh__D000503smesh__D012013
% 207.97/208.18  |- mesh__dateRevised mesh__D000503 1996-06-10
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D000503 2006
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D000503 1999
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D000503 2002
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D000503 2004
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D000503 1997
% 207.97/208.18  |- skos__annotation mesh__D005797
% 207.97/208.18       araC stands for %22%arabinose C%22% where C is 3d of a sequence araA, araB, etc.%A%  
% 207.97/208.18  |- skos__historyNote mesh__D005797 Genes, Regulator %28%1971-1987%29%
% 207.97/208.18  |- rdf__type mesh__D005797sskos__Concept
% 207.97/208.18  |- skos__altLabel mesh__D005797 araC Genes
% 207.97/208.18  |- mesh__recordMaintainer mesh__D005797 nns
% 207.97/208.18  |- skos__prefLabel mesh__D005797 Genes, araC
% 207.97/208.18  |- skos__historyNote mesh__D005797 Arabinose %28%1971-1987%29%
% 207.97/208.18  |- skos__broader mesh__D005797smesh__D005809
% 207.97/208.18  |- mesh__recordAuthorizer mesh__D005797 sjn
% 207.97/208.18  |- skos__altLabel mesh__D005797 Locus, araC Regulator
% 207.97/208.18  |- mesh__historyNote mesh__D005797
% 207.97/208.18       91%28%88%29%; was see under GENES, REGULATOR 1988-90   
% 207.97/208.18  |- skos__altLabel mesh__D005797 araC Regulator Locus
% 207.97/208.18  |- skos__hiddenLabel mesh__D005797 araC Gene
% 207.97/208.18  |- mesh__dateCreated mesh__D005797 1987-05-09
% 207.97/208.18  |- mesh__dateRevised mesh__D005797 2005-06-30
% 207.97/208.18  |- mesh__recordOriginator mesh__D005797 SCD
% 207.97/208.18  |- skos__scopeNote mesh__D005797
% 207.97/208.18       Regulatory genes which encode a cyclic AMP receptor protein required for L-arabinose utilization in E. coli. It is an example of positive control or regulation of gene expression in the bacterial operon.%A%    
% 207.97/208.18  |- mesh__dateEstablished mesh__D005797 1991-01-01
% 207.97/208.18  |- skos__historyNote mesh__D005797 Operon %28%1971-1987%29%
% 207.97/208.18  |- skos__hiddenLabel mesh__D005797 Gene, araC
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D005797 2006
% 207.97/208.18  |- mesh__publicMeSHNote mesh__D005797
% 207.97/208.18       91; was see under GENES, REGULATOR 1988-90   
% 207.97/208.18  |- mesh__dateCreated mesh__D018914 1995-01-06
% 207.97/208.18  |- skos__altLabel mesh__D018914 Immobilized Cells
% 207.97/208.18  |- mesh__dateEstablished mesh__D018914 1996-01-01
% 207.97/208.18  |- skos__scopeNote mesh__D018914
% 207.97/208.18       Microbial, plant, or animal cells which are immobilized by attachment to solid structures, usually a column matrix. A common use of immobilized cells is in biotechnology for the bioconversion of a substrate to a particular product. %28%From Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed%29%%A%    
% 207.97/208.18  |- skos__prefLabel mesh__D018914 Cells, Immobilized
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D018914 2002
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D018914 2004
% 207.97/208.18  |- mesh__activeMeSHYear mesh__D018914 1997
% 207.97/208.18  |- mesh__historyNote mesh__D018914 96   
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018914 2003
% 207.97/208.19  |- rdf__type mesh__D018914sskos__Concept
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018914 1996
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018914 2001
% 207.97/208.19  |- skos__broader mesh__D018914smesh__D002477
% 207.97/208.19  |- skos__hiddenLabel mesh__D018914 Cell, Immobilized
% 207.97/208.19  |- skos__hiddenLabel mesh__D018914 Immobilized Cell
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018914 2006
% 207.97/208.19  |- mesh__publicMeSHNote mesh__D018914 96   
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018914 2000
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018914 1999
% 207.97/208.19  |- skos__annotation mesh__D018914
% 207.97/208.19       NIM; specify cell if relevant, probably NIM; A 11 qualif   
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018914 2005
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018914 1998
% 207.97/208.19  |- mesh__dateRevised mesh__D010931 2005-06-30
% 207.97/208.19  |- skos__scopeNote mesh__D010931
% 207.97/208.19       A suspension of killed Yersinia pestis used for immunizing people in enzootic plague areas.%A%    
% 207.97/208.19  |- skos__prefLabel mesh__D010931 Plague Vaccine
% 207.97/208.19  |- mesh__dateCreated mesh__D010931 1999-01-01
% 207.97/208.19  |- mesh__recordAuthorizer mesh__D010931 sjn
% 207.97/208.19  |- mesh__recordOriginator mesh__D010931 NLM
% 207.97/208.19  |- mesh__recordMaintainer mesh__D010931 ssb
% 207.97/208.19  |- rdf__type mesh__D010931sskos__Concept
% 207.97/208.19  |- skos__hiddenLabel mesh__D010931 Vaccine, Plague
% 207.97/208.19  |- skos__broader mesh__D010931smesh__D001428
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D010931 2006
% 207.97/208.19  |- rdf__type mesh__D018116sskos__Concept
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018116 2004
% 207.97/208.19  |- skos__broader mesh__D018116smesh__D012209
% 207.97/208.19  |- mesh__publicMeSHNote mesh__D018116 94   
% 207.97/208.19  |- mesh__dateEstablished mesh__D018116 1994-01-01
% 207.97/208.19  |- skos__hiddenLabel mesh__D018116 Vesiculoviruses
% 207.97/208.19  |- mesh__recordOriginator mesh__D018116 AGS
% 207.97/208.19  |- mesh__historyNote mesh__D018116 94   
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018116 2002
% 207.97/208.19  |- skos__historyNote mesh__D018116 Rhabdoviridae %28%1979-1993%29%
% 207.97/208.19  |- skos__scopeNote mesh__D018116
% 207.97/208.19       A genus of the family RHABDOVIRIDAE that infects a wide range of vertebrates and invertebrates. The type species is VESICULAR STOMATITIS-INDIANA VIRUS.%A%    
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018116 2005
% 207.97/208.19  |- mesh__dateCreated mesh__D018116 1993-06-04
% 207.97/208.19  |- skos__prefLabel mesh__D018116 Vesiculovirus
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018116 2006
% 207.97/208.19  |- mesh__recordAuthorizer mesh__D018116 sjn
% 207.97/208.19  |- mesh__recordMaintainer mesh__D018116 ags
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018116 2003
% 207.97/208.19  |- mesh__dateRevised mesh__D018116 2001-07-25
% 207.97/208.19  |- skos__annotation mesh__D018116
% 207.97/208.19       infection: coord IM with RHABDOVIRIDAE INFECTIONS %28%IM%29%   
% 207.97/208.19  |- skos__hiddenLabel mesh__D010133 Ly 123362
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D010133 2006
% 207.97/208.19  |- skos__broader mesh__D010133smesh__D000662
% 207.97/208.19  |- skos__altLabel mesh__D010133 p-Chloramphetamine
% 207.97/208.19  |- mesh__publicMeSHNote mesh__D010133
% 207.97/208.19       91; was see under AMPHETAMINES 1975-90   
% 207.97/208.19  |- skos__hiddenLabel mesh__D010133 p Chloramphetamine
% 207.97/208.19  |- skos__historyNote mesh__D010133 Amphetamine %28%1966-1974%29%
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D010133 2001
% 207.97/208.19  |- skos__historyNote mesh__D010133 Chlorine %28%1966-1974%29%
% 207.97/208.19  |- mesh__recordMaintainer mesh__D010133 CCR
% 207.97/208.19  |- skos__prefLabel mesh__D010133 p-Chloroamphetamine
% 207.97/208.19  |- skos__hiddenLabel mesh__D010133 LY121860
% 207.97/208.19  |- skos__hiddenLabel mesh__D010133 p Chloroamphetamine
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D010133 2002
% 207.97/208.19  |- rdf__type mesh__D010133sskos__Concept
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D010133 2003
% 207.97/208.19  |- mesh__dateCreated mesh__D010133 1974-11-19
% 207.97/208.19  |- mesh__historyNote mesh__D010133
% 207.97/208.19       91%28%75%29%; was see under AMPHETAMINES 1975-90   
% 207.97/208.19  |- skos__hiddenLabel mesh__D010133 LY 121860
% 207.97/208.19  |- mesh__dateEstablished mesh__D010133 1991-01-01
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D010133 2004
% 207.97/208.19  |- mesh__recordAuthorizer mesh__D010133 sjn
% 207.97/208.19  |- skos__hiddenLabel mesh__D010133 para Chloroamphetamine
% 207.97/208.19  |- skos__scopeNote mesh__D010133
% 207.97/208.19       Chlorinated analog of AMPHETAMINE. Potent neurotoxin that causes release and eventually depletion of serotonin in the CNS. It is used as a research tool.%A%    
% 207.97/208.19  |- skos__hiddenLabel mesh__D010133 Ly123362
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D010133 2005
% 207.97/208.19  |- skos__altLabel mesh__D010133 para-Chloroamphetamine
% 207.97/208.19  |- skos__altLabel mesh__D010133 Parachloroamphetamine
% 207.97/208.19  |- mesh__recordOriginator mesh__D010133 NLM
% 207.97/208.19  |- mesh__dateRevised mesh__D010133 2000-06-22
% 207.97/208.19  |- mesh__publicMeSHNote mesh__D034581 2003   
% 207.97/208.19  |- mesh__dateCreated mesh__D034581 2002-07-02
% 207.97/208.19  |- mesh__dateEstablished mesh__D034581 2003-01-01
% 207.97/208.19  |- skos__hiddenLabel mesh__D034581 Bighorn Sheep
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D034581 2004
% 207.97/208.19  |- skos__altLabel mesh__D034581 Ovis canadensis
% 207.97/208.19  |- rdf__type mesh__D034581sskos__Concept
% 207.97/208.19  |- skos__broader mesh__D034581smesh__D012756
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D034581 2006
% 207.97/208.19  |- skos__scopeNote mesh__D034581
% 207.97/208.19       A species of sheep, Ovis canadensis, characterized by massive brown horns. There are at least four subspecies and they are all endangered or threatened.%A%    
% 207.97/208.19  |- skos__historyNote mesh__D034581 Sheep %28%1965-2002%29%
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D034581 2005
% 207.97/208.19  |- mesh__dateRevised mesh__D034581 2003-07-09
% 207.97/208.19  |- skos__prefLabel mesh__D034581 Sheep, Bighorn
% 207.97/208.19  |- mesh__historyNote mesh__D034581 2003   
% 207.97/208.19  |- mesh__dateRevised mesh__D020561 2005-06-30
% 207.97/208.19  |- mesh__recordMaintainer mesh__D020561 SYSTEM
% 207.97/208.19  |- skos__scopeNote mesh__D020561
% 207.97/208.19       A class in the phylum PROTEOBACTERIA comprised mostly of two major phenotypes: purple non-sulfur bacteria and aerobic bacteriochlorophyll-containing bacteria.%A%    
% 207.97/208.19  |- mesh__recordOriginator mesh__D020561 ndw
% 207.97/208.19  |- skos__broader mesh__D020561smesh__D020560
% 207.97/208.19  |- mesh__dateCreated mesh__D020561 1999-11-03
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D020561 2006
% 207.97/208.19  |- mesh__recordAuthorizer mesh__D020561 sjn
% 207.97/208.19  |- skos__annotation mesh__D020561 DF: ALPHAPROTEOBACT   
% 207.97/208.19  |- rdf__type mesh__D020561sskos__Concept
% 207.97/208.19  |- skos__altLabel mesh__D020561 alpha Proteobacteria
% 207.97/208.19  |- mesh__dateEstablished mesh__D020561 2000-01-01
% 207.97/208.19  |- skos__prefLabel mesh__D020561 Alphaproteobacteria
% 207.97/208.19  |- mesh__publicMeSHNote mesh__D020561
% 207.97/208.19       2004; see ALPHA PROTEOBACTERIA 2000-2003   
% 207.97/208.19  |- mesh__historyNote mesh__D020561 2004 %28%2000%29%   
% 207.97/208.19  |- skos__altLabel mesh__D020561 Proteobacteria alpha
% 207.97/208.19  |- mesh__historyNote mesh__D006092
% 207.97/208.19       92; was GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS %28%NON MESH%29% 1976-91%A%  
% 207.97/208.19  |- skos__altLabel mesh__D006092 Gram Negative Facultatively Anaerobic Rods
% 207.97/208.19  |- mesh__recordAuthorizer mesh__D006092 sjn
% 207.97/208.19  |- rdf__type mesh__D006092sskos__Concept
% 207.97/208.19  |- skos__scopeNote mesh__D006092
% 207.97/208.19       A large group of facultatively anaerobic, rod-shaped bacteria that show up as pink %28%negative%29% when treated by the gram-staining method.%A%    
% 207.97/208.19  |- skos__historyNote mesh__D006092 Gram-Negative Bacteria %28%1973-1975%29%
% 207.97/208.19  |- skos__broader mesh__D006092smesh__D006090
% 207.97/208.19  |- mesh__dateEstablished mesh__D006092 1992-01-01
% 207.97/208.19  |- mesh__recordOriginator mesh__D006092 JW
% 207.97/208.19  |- mesh__dateRevised mesh__D006092 2005-06-30
% 207.97/208.19  |- mesh__recordMaintainer mesh__D006092 SYSTEM
% 207.97/208.19  |- mesh__dateCreated mesh__D006092 1975-07-25
% 207.97/208.19  |- skos__annotation mesh__D006092
% 207.97/208.19       GEN: avoid; prefer specifics; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 207.97/208.19  |- skos__historyNote mesh__D006092 Bacteria %28%1966-1972%29%
% 207.97/208.19  |- mesh__publicMeSHNote mesh__D006092 92   
% 207.97/208.19  |- skos__prefLabel mesh__D006092 Gram-Negative Facultatively Anaerobic Rods
% 207.97/208.19  |- skos__historyNote mesh__D006092
% 207.97/208.19       Gram-Negative Anaerobic Bacteria %28%1976-1991%29%
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D006092 2006
% 207.97/208.19  |- skos__annotation mesh__D014524
% 207.97/208.19       do not confuse with URETERAL OBSTRUCTION, espec in Romance lang: see note on %22%ureteral%22% %26% %22%urethral%22% under URETERAL DISEASES; URETHRAL STRICTURE is also available%A%  
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014524 2001
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014524 1998
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014524 2005
% 207.97/208.19  |- skos__historyNote mesh__D014524 Urethral Diseases %28%1966-1978%29%
% 207.97/208.19  |- mesh__recordAuthorizer mesh__D014524 PLS
% 207.97/208.19  |- mesh__dateRevised mesh__D014524 1996-06-10
% 207.97/208.19  |- mesh__recordOriginator mesh__D014524 SMH
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014524 2002
% 207.97/208.19  |- skos__hiddenLabel mesh__D014524 Urethral Obstructions
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014524 2006
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014524 1999
% 207.97/208.19  |- mesh__publicMeSHNote mesh__D014524 79   
% 207.97/208.19  |- skos__hiddenLabel mesh__D014524 Obstruction, Urethral
% 207.97/208.19  |- skos__historyNote mesh__D014524 Urethral Stricture %28%1966-1978%29%
% 207.97/208.19  |- mesh__dateCreated mesh__D014524 1977-11-23
% 207.97/208.19  |- mesh__historyNote mesh__D014524 79   
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014524 2003
% 207.97/208.19  |- mesh__dateEstablished mesh__D014524 1979-01-01
% 207.97/208.19  |- skos__scopeNote mesh__D014524
% 207.97/208.19       Obstruction anywhere along the urethra.     
% 207.97/208.19  |- rdf__type mesh__D014524sskos__Concept
% 207.97/208.19  |- skos__hiddenLabel mesh__D014524 Obstructions, Urethral
% 207.97/208.19  |- skos__broader mesh__D014524smesh__D014522
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014524 2000
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014524 2004
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014524 1997
% 207.97/208.19  |- skos__prefLabel mesh__D014524 Urethral Obstruction
% 207.97/208.19  |- mesh__recordMaintainer mesh__D014524 TGC
% 207.97/208.19  |- mesh__recordOriginator mesh__D000504 NLM
% 207.97/208.19  |- mesh__dateCreated mesh__D000504 1999-01-01
% 207.97/208.19  |- skos__broader mesh__D000504smesh__D019684
% 207.97/208.19  |- mesh__publicMeSHNote mesh__D000504
% 207.97/208.19       91,63-77; was see under PLANTS, MEDICINAL 1978-90; was heading 1963-77%A%  
% 207.97/208.19  |- mesh__historyNote mesh__D000504
% 207.97/208.19       91%28%78%29%63; was see under PLANTS, MEDICINAL 1978-90; was heading 1963-77; was in Cat B %26% D 1963-77%A%  
% 207.97/208.19  |- skos__scopeNote mesh__D000504
% 207.97/208.19       A plant genus of the family Aloeaceae, order Liliales %28%or Asphodelaceae, Asparagales in APG system%29% which is used medicinally.  It contains anthraquinone glycosides such as aloin-emodin or aloe-emodin %28%EMODIN%29%.%A%    
% 207.97/208.19  |- mesh__recordAuthorizer mesh__D000504 sjn
% 207.97/208.19  |- rdf__type mesh__D000504sskos__Concept
% 207.97/208.19  |- mesh__dateRevised mesh__D000504 2002-07-02
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D000504 2005
% 207.97/208.19  |- skos__prefLabel mesh__D000504 Aloe
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D000504 2003
% 207.97/208.19  |- mesh__recordMaintainer mesh__D000504 ssb
% 207.97/208.19  |- mesh__dateEstablished mesh__D000504 1964-01-01
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D000504 2006
% 207.97/208.19  |- skos__annotation mesh__D000504
% 207.97/208.19       for HESPERALOE see AGAVACEAE is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D000504 2004
% 207.97/208.19  |- rdf__type mesh__D005798sskos__Concept
% 207.97/208.19  |- skos__scopeNote mesh__D005798
% 207.97/208.19       The functional hereditary units of BACTERIA.     
% 207.97/208.19  |- skos__altLabel mesh__D005798 Gene, Bacterial
% 207.97/208.19  |- skos__prefLabel mesh__D005798 Genes, Bacterial
% 207.97/208.19  |- mesh__dateEstablished mesh__D005798 1982-01-01
% 207.97/208.19  |- skos__annotation mesh__D005798
% 207.97/208.19       coordinate IM with specific bacterium /genet %28%IM%29%; DF: GENES BACT%A%  
% 207.97/208.19  |- mesh__publicMeSHNote mesh__D005798 82   
% 207.97/208.19  |- mesh__dateCreated mesh__D005798 1981-02-23
% 207.97/208.19  |- skos__broader mesh__D005798smesh__D016680
% 207.97/208.19  |- mesh__historyNote mesh__D005798 82   
% 207.97/208.19  |- skos__historyNote mesh__D005798 Genes %28%1966-1981%29%
% 207.97/208.19  |- mesh__recordMaintainer mesh__D005798 nns
% 207.97/208.19  |- skos__altLabel mesh__D005798 Bacterial Genes
% 207.97/208.19  |- skos__altLabel mesh__D005798 Bacterial Gene
% 207.97/208.19  |- mesh__recordAuthorizer mesh__D005798 sjn
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D005798 2006
% 207.97/208.19  |- skos__related mesh__D005798smesh__D016680
% 207.97/208.19  |- skos__historyNote mesh__D005798 specific bacterium/GE %28%1978-1981%29%
% 207.97/208.19  |- skos__broader mesh__D005798smesh__D005796
% 207.97/208.19  |- mesh__recordOriginator mesh__D005798 AEP
% 207.97/208.19  |- mesh__dateRevised mesh__D005798 2005-06-30
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018915 2001
% 207.97/208.19  |- mesh__recordMaintainer mesh__D018915 TGC
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018915 2003
% 207.97/208.19  |- skos__hiddenLabel mesh__D018915 Root Canal Preparations
% 207.97/208.19  |- skos__scopeNote mesh__D018915
% 207.97/208.19       Preparatory activities in ROOT CANAL THERAPY by partial or complete extirpation of diseased pulp, cleaning and sterilization of the empty canal, enlarging and shaping the canal to receive the sealing material. The cavity may be prepared by mechanical, sonic, chemical, or other means. %28%From Dorland, 28th ed, p1700%29%%A%    
% 207.97/208.19  |- mesh__dateCreated mesh__D018915 1995-06-08
% 207.97/208.19  |- mesh__publicMeSHNote mesh__D018915 96   
% 207.97/208.19  |- mesh__dateRevised mesh__D018915 1996-06-10
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018915 2002
% 207.97/208.19  |- mesh__recordOriginator mesh__D018915 TGC
% 207.97/208.19  |- skos__historyNote mesh__D018915 Root Canal Therapy %28%1966-1995%29%
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018915 2004
% 207.97/208.19  |- skos__hiddenLabel mesh__D018915 Preparation, Root Canal
% 207.97/208.19  |- mesh__dateEstablished mesh__D018915 1996-01-01
% 207.97/208.19  |- skos__annotation mesh__D018915
% 207.97/208.19       preparatory activities leading to treatment of pulp dis %28% = ROOT CANAL THERAPY%29%; do not use /util except by MeSH definition; /instrum: reamers %26% broaches go here%A%  
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018915 1997
% 207.97/208.19  |- mesh__historyNote mesh__D018915 96   
% 207.97/208.19  |- skos__broader mesh__D018915smesh__D019246
% 207.97/208.19  |- skos__hiddenLabel mesh__D018915 Canal Preparation, Root
% 207.97/208.19  |- rdf__type mesh__D018915sskos__Concept
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018915 2005
% 207.97/208.19  |- mesh__recordAuthorizer mesh__D018915 PLS
% 207.97/208.19  |- skos__broader mesh__D018915smesh__D012390
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018915 1998
% 207.97/208.19  |- skos__hiddenLabel mesh__D018915 Preparations, Root Canal
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018915 2006
% 207.97/208.19  |- skos__hiddenLabel mesh__D018915 Canal Preparations, Root
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018915 1999
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018915 2000
% 207.97/208.19  |- skos__prefLabel mesh__D018915 Root Canal Preparation
% 207.97/208.19  |- mesh__onlineNote mesh__D010932 search TURBELLARIA 1966-74   
% 207.97/208.19  |- mesh__dateRevised mesh__D010932 2003-07-09
% 207.97/208.19  |- mesh__dateEstablished mesh__D010932 1991-01-01
% 207.97/208.19  |- skos__broader mesh__D010932smesh__D014419
% 207.97/208.19  |- rdf__type mesh__D010932sskos__Concept
% 207.97/208.19  |- mesh__recordAuthorizer mesh__D010932 sjn
% 207.97/208.19  |- skos__annotation mesh__D010932
% 207.97/208.19       non-parasitic flatworms used in regeneration experiments   
% 207.97/208.19  |- mesh__recordOriginator mesh__D010932 NLM
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D010932 2004
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D010932 2005
% 207.97/208.19  |- mesh__recordMaintainer mesh__D010932 ags
% 207.97/208.19  |- mesh__historyNote mesh__D010932
% 207.97/208.19       91%28%75%29%; was see under TURBELLARIA 1975-90   
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D010932 2006
% 207.97/208.19  |- mesh__publicMeSHNote mesh__D010932
% 207.97/208.19       91; was see under TURBELLARIA 1975-90   
% 207.97/208.19  |- mesh__dateCreated mesh__D010932 1999-01-01
% 207.97/208.19  |- skos__prefLabel mesh__D010932 Planarians
% 207.97/208.19  |- skos__scopeNote mesh__D010932
% 207.97/208.19       Nonparasitic free-living flatworms of the class Turbellaria. The most common genera are Dugesia, formerly Planaria, which lives in water, and Bipalium, which lives on land. Geoplana occurs in South America and California.%A%    
% 207.97/208.19  |- skos__scopeNote mesh__D018117
% 207.97/208.19       A genus of the family ORTHOMYXOVIRIDAE comprising tick-borne viruses occasionally infecting humans. Dhori and Thogoto viruses were formerly thought to be members of BUNYAVIRIDAE. Thogoto virus is the type species.%A%    
% 207.97/208.19  |- skos__annotation mesh__D018117
% 207.97/208.19       infection: coordinate IM with INFLUENZA, HUMAN %28%IM%29% in humans or ORTHOMYXOVIRIDAE INFECTIONS %28%IM%29% in animals%A%  
% 207.97/208.19  |- skos__historyNote mesh__D018117 Orthomyxoviridae %28%1987-1993%29%
% 207.97/208.19  |- skos__altLabel mesh__D018117 Influenza Viruses Type D
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018117 2006A
% 207.97/208.19  |- skos__altLabel mesh__D018117 Influenzavirus D
% 207.97/208.19  |- mesh__recordAuthorizer mesh__D018117 ags
% 207.97/208.19  |- skos__hiddenLabel mesh__D018117 Thogoto-Like Virus
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018117 2005
% 207.97/208.19  |- mesh__dateEstablished mesh__D018117 1994-01-01
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018117 2006
% 207.97/208.19  |- skos__altLabel mesh__D018117 Thogoto-Like Viruses
% 207.97/208.19  |- skos__broader mesh__D018117smesh__D009975
% 207.97/208.19  |- mesh__publicMeSHNote mesh__D018117
% 207.97/208.19       2002; see THOGOTO-LIKE VIRUSES 1997-2001, see ORTHOMYXOVIRUSES TYPE D 1994-1996%A%  
% 207.97/208.19  |- skos__altLabel mesh__D018117 Orthomyxoviruses Type D
% 207.97/208.19  |- mesh__recordOriginator mesh__D018117 AGS
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018117 2002
% 207.97/208.19  |- skos__hiddenLabel mesh__D018117 Thogotoviruses
% 207.97/208.19  |- skos__historyNote mesh__D018117 Bunyaviridae %28%1985-1989%29%
% 207.97/208.19  |- mesh__recordMaintainer mesh__D018117 ags
% 207.97/208.19  |- mesh__dateRevised mesh__D018117 2005-11-10
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018117 2003
% 207.97/208.19  |- mesh__dateCreated mesh__D018117 1993-06-04
% 207.97/208.19  |- rdf__type mesh__D018117sskos__Concept
% 207.97/208.19  |- mesh__historyNote mesh__D018117 2002 %28%1994%29%   
% 207.97/208.19  |- skos__hiddenLabel mesh__D018117 Thogoto Like Viruses
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D018117 2004
% 207.97/208.19  |- skos__historyNote mesh__D018117 Arboviruses %28%1970-1987%29%
% 207.97/208.19  |- skos__prefLabel mesh__D018117 Thogotovirus
% 207.97/208.19  |- mesh__historyNote mesh__D010134 93%28%71%29%   
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D010134 2002
% 207.97/208.19  |- mesh__recordAuthorizer mesh__D010134 sjn
% 207.97/208.19  |- mesh__dateEstablished mesh__D010134 1973-01-01
% 207.97/208.19  |- skos__broader mesh__D010134smesh__D010649
% 207.97/208.19  |- skos__hiddenLabel mesh__D010134 Hydrochloride, Fenclonine
% 207.97/208.19  |- skos__prefLabel mesh__D010134 Fenclonine
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D010134 2006
% 207.97/208.19  |- skos__hiddenLabel mesh__D010134 Hydrobromide, Fenclonine
% 207.97/208.19  |- mesh__recordOriginator mesh__D010134 NLM
% 207.97/208.19  |- skos__scopeNote mesh__D010134
% 207.97/208.19       A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin %28%5-HYDROXYTRYPTAMINE%29%. Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.%A%    
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D010134 2005
% 207.97/208.19  |- mesh__dateCreated mesh__D010134 1999-01-01
% 207.97/208.19  |- skos__historyNote mesh__D010134 Phenylalanine %28%1966-1970%29%
% 207.97/208.19  |- skos__altLabel mesh__D010134 para-Chlorophenylalanine
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D010134 2004
% 207.97/208.19  |- skos__hiddenLabel mesh__D010134 para Chlorophenylalanine
% 207.97/208.19  |- skos__altLabel mesh__D010134 Fenclonin
% 207.97/208.19  |- rdf__type mesh__D010134sskos__Concept
% 207.97/208.19  |- skos__altLabel mesh__D010134 DL-3-%28%4-Chlorophenyl%29%alanine
% 207.97/208.19  |- mesh__publicMeSHNote mesh__D010134
% 207.97/208.19       93; see P-CHLOROPHENYLALANINE 1973-92; for FENCLONINE see P-CHLOROPHENYLALANINE 1978-92%A%  
% 207.97/208.19  |- skos__altLabel mesh__D010134 p-Chlorophenylalanine
% 207.97/208.19  |- mesh__recordMaintainer mesh__D010134 nns
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D010134 2003
% 207.97/208.19  |- mesh__dateRevised mesh__D010134 2001-07-25
% 207.97/208.19  |- rdf__type mesh__D034582sskos__Concept
% 207.97/208.19  |- mesh__runningHead mesh__D034582 A17 - ANATOMY-INTEGUMENTARY SYSTEM   
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D034582 2003
% 207.97/208.19  |- skos__hiddenLabel mesh__D034582 Integumentary Systems
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D034582 2006
% 207.97/208.19  |- skos__hiddenLabel mesh__D034582 Systems, Integumentary
% 207.97/208.19  |- mesh__historyNote mesh__D034582 2003   
% 207.97/208.19  |- skos__hiddenLabel mesh__D034582 System, Integumentary
% 207.97/208.19  |- skos__prefLabel mesh__D034582 Integumentary System
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D034582 2005
% 207.97/208.19  |- mesh__dateEstablished mesh__D034582 2003-01-01
% 207.97/208.19  |- mesh__publicMeSHNote mesh__D034582 2003   
% 207.97/208.19  |- mesh__dateCreated mesh__D034582 2002-07-03
% 207.97/208.19  |- skos__scopeNote mesh__D034582
% 207.97/208.19       The outer covering of the body composed of the SKIN and the skin appendages, which are the HAIR, the NAILS; and the SEBACEOUS GLANDS and the SWEAT GLANDS and their ducts.%A%    
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D034582 2004
% 207.97/208.19  |- mesh__historyNote mesh__D020562 2004 %28%2000%29%   
% 207.97/208.19  |- mesh__publicMeSHNote mesh__D020562
% 207.97/208.19       2004; see BETA PROTEOBACTERIA 2000-2003   
% 207.97/208.19  |- mesh__recordOriginator mesh__D020562 ndw
% 207.97/208.19  |- skos__prefLabel mesh__D020562 Betaproteobacteria
% 207.97/208.19  |- skos__broader mesh__D020562smesh__D020560
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D020562 2006
% 207.97/208.19  |- mesh__dateRevised mesh__D020562 2005-06-30
% 207.97/208.19  |- rdf__type mesh__D020562sskos__Concept
% 207.97/208.19  |- skos__scopeNote mesh__D020562
% 207.97/208.19       A class in the phylum PROTEOBACTERIA comprised of chemoheterotrophs and chemoautotrophs which derive nutrients from decomposition of organic material.%A%    
% 207.97/208.19  |- mesh__dateEstablished mesh__D020562 2000-01-01
% 207.97/208.19  |- mesh__dateCreated mesh__D020562 1999-11-03
% 207.97/208.19  |- mesh__recordAuthorizer mesh__D020562 sjn
% 207.97/208.19  |- skos__altLabel mesh__D020562 beta Proteobacteria
% 207.97/208.19  |- skos__altLabel mesh__D020562 Proteobacteria beta
% 207.97/208.19  |- skos__annotation mesh__D020562 DF: BETAPROTEOBACT   
% 207.97/208.19  |- mesh__recordMaintainer mesh__D020562 SYSTEM
% 207.97/208.19  |- rdf__type mesh__D006093sskos__Concept
% 207.97/208.19  |- mesh__onlineNote mesh__D006093 indexed under BACTERIA 1976-83   
% 207.97/208.19  |- skos__scopeNote mesh__D006093
% 207.97/208.19       A gram-positive, non-spore-forming group of bacteria comprising organisms that have morphological and physiological characteristics in common.%A%    
% 207.97/208.19  |- skos__broader mesh__D006093smesh__D016987
% 207.97/208.19  |- skos__altLabel mesh__D006093 Gram-Positive Non-Spore-Forming Rods
% 207.97/208.19  |- mesh__dateEstablished mesh__D006093 1990-01-01
% 207.97/208.19  |- skos__annotation mesh__D006093
% 207.97/208.19       GEN: avoid; prefer specifics; do not use as a routine coord for a gram-positive asporogenous bact; infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 207.97/208.19  |- mesh__recordMaintainer mesh__D006093 SYSTEM
% 207.97/208.19  |- mesh__recordAuthorizer mesh__D006093 sjn
% 207.97/208.19  |- mesh__dateCreated mesh__D006093 1975-07-25
% 207.97/208.19  |- mesh__publicMeSHNote mesh__D006093 90   
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D006093 2006
% 207.97/208.19  |- mesh__dateRevised mesh__D006093 2005-06-30
% 207.97/208.19  |- skos__altLabel mesh__D006093 Gram Positive Non Spore Forming Rods
% 207.97/208.19  |- skos__altLabel mesh__D006093 Gram Positive Asporogenous Rods
% 207.97/208.19  |- mesh__historyNote mesh__D006093 90; was NON MESH before 1990   
% 207.97/208.19  |- mesh__recordOriginator mesh__D006093 JW
% 207.97/208.19  |- skos__prefLabel mesh__D006093 Gram-Positive Asporogenous Rods
% 207.97/208.19  |- skos__prefLabel mesh__D014525 Urethral Stricture
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014525 1994
% 207.97/208.19  |- mesh__recordOriginator mesh__D014525 NLM
% 207.97/208.19  |- skos__hiddenLabel mesh__D014525 Urethral Stenoses
% 207.97/208.19  |- skos__hiddenLabel mesh__D014525 Stenoses, Urethral
% 207.97/208.19  |- skos__hiddenLabel mesh__D014525 Strictures, Urethral
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014525 2000
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014525 1995
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014525 1996
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014525 2003
% 207.97/208.19  |- rdf__type mesh__D014525sskos__Concept
% 207.97/208.19  |- skos__altLabel mesh__D014525 Urethral Stenosis
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014525 2001
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014525 1997
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014525 2004
% 207.97/208.19  |- mesh__recordAuthorizer mesh__D014525 PLS
% 207.97/208.19  |- skos__broader mesh__D014525smesh__D014524
% 207.97/208.19  |- mesh__dateCreated mesh__D014525 1999-01-01
% 207.97/208.19  |- skos__hiddenLabel mesh__D014525 Urethral Strictures
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014525 2002
% 207.97/208.19  |- mesh__dateRevised mesh__D014525 1992-05-22
% 207.97/208.19  |- skos__hiddenLabel mesh__D014525 Stricture, Urethral
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014525 1998
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014525 2005
% 207.97/208.19  |- mesh__recordMaintainer mesh__D014525 TGC
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014525 1993
% 207.97/208.19  |- skos__hiddenLabel mesh__D014525 Stenosis, Urethral
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014525 1999
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D014525 2006
% 207.97/208.19  |- skos__annotation mesh__D014525
% 207.97/208.19       do not confuse with URETHRAL OBSTRUCTION   
% 207.97/208.19  |- skos__altLabel mesh__D000505 Male Pattern Baldness
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D000505 2002
% 207.97/208.19  |- mesh__recordOriginator mesh__D000505 NLM
% 207.97/208.19  |- skos__broader mesh__D000505smesh__D007039
% 207.97/208.19  |- skos__scopeNote mesh__D000505
% 207.97/208.19       Absence of hair from areas where it is normally present.%A%    
% 207.97/208.19  |- skos__altLabel mesh__D000505 Baldness
% 207.97/208.19  |- rdf__type mesh__D000505sskos__Concept
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D000505 2005
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D000505 2003
% 207.97/208.19  |- mesh__recordAuthorizer mesh__D000505 sjn
% 207.97/208.19  |- skos__broader mesh__D000505smesh__D020763
% 207.97/208.19  |- skos__hiddenLabel mesh__D000505 Baldness, Male Pattern
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D000505 2006
% 207.97/208.19  |- skos__prefLabel mesh__D000505 Alopecia
% 207.97/208.19  |- skos__altLabel mesh__D000505 Alopecia, Male Pattern
% 207.97/208.19  |- mesh__activeMeSHYear mesh__D000505 2004
% 207.97/208.19  |- skos__hiddenLabel mesh__D000505 Male Pattern Alopecia
% 207.97/208.19  |- skos__altLabel mesh__D000505 Alopecia, Androgenetic
% 207.97/208.19  |- mesh__dateRevised mesh__D000505 2001-07-25
% 207.97/208.19  |- mesh__dateCreated mesh__D000505 1999-01-01
% 207.97/208.19  |- mesh__recordMaintainer mesh__D000505 lkt
% 207.97/208.19  |- skos__historyNote mesh__D019210 Muscle Proteins %28%1975-1978%29%
% 207.97/208.20  |- mesh__dateEstablished mesh__D019210 1997-01-01
% 207.97/208.20  |- skos__historyNote mesh__D019210 Troponin %28%1979-1996%29%
% 207.97/208.20  |- mesh__dateRevised mesh__D019210 2005-06-30
% 207.97/208.20  |- mesh__recordAuthorizer mesh__D019210 sjn
% 207.97/208.20  |- mesh__dateCreated mesh__D019210 1996-06-10
% 207.97/208.20  |- skos__scopeNote mesh__D019210
% 207.97/208.20       One of the three polypeptide chains that make up the TROPONIN complex. It inhibits F-actin-myosin interactions.%A%    
% 207.97/208.20  |- mesh__onlineNote mesh__D019210
% 207.97/208.20       use TROPONIN I %28%NM%29% to search TROPONIN I 1980-96   
% 207.97/208.20  |- mesh__publicMeSHNote mesh__D019210
% 207.97/208.20       97; TROPONIN I was indexed under TROPONIN 1979-96 %26% MUSCLE PROTEINS 1975-78%A%  
% 207.97/208.20  |- mesh__recordOriginator mesh__D019210 TPW
% 207.97/208.20  |- mesh__recordMaintainer mesh__D019210 DRC
% 207.97/208.20  |- skos__annotation mesh__D019210
% 207.97/208.20       a muscle protein; /biosyn /physiol permitted; TROPONIN C %26% TROPONIN T are also available%A%  
% 207.97/208.20  |- mesh__historyNote mesh__D019210 97; was TROPONIN I %28%NM%29% 1975-96   
% 207.97/208.20  |- skos__broader mesh__D019210smesh__D014336
% 207.97/208.20  |- skos__prefLabel mesh__D019210 Troponin I
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D019210 2006
% 207.97/208.20  |- skos__altLabel mesh__D019210 Troponin-I
% 207.97/208.20  |- rdf__type mesh__D019210sskos__Concept
% 207.97/208.20  |- mesh__recordAuthorizer mesh__D005799 sjn
% 207.97/208.20  |- skos__scopeNote mesh__D005799
% 207.97/208.20       Genes that influence the PHENOTYPE both in the homozygous and the heterozygous state.%A%    
% 207.97/208.20  |- skos__historyNote mesh__D005799 Genes %28%1966-1967%29%
% 207.97/208.20  |- mesh__historyNote mesh__D005799 68   
% 207.97/208.20  |- skos__hiddenLabel mesh__D005799 Dominant Genetic Condition
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D005799 2006
% 207.97/208.20  |- mesh__dateRevised mesh__D005799 2005-06-30
% 207.97/208.20  |- skos__hiddenLabel mesh__D005799 Genetic Condition, Dominant
% 207.97/208.20  |- skos__broader mesh__D005799smesh__D005796
% 207.97/208.20  |- skos__hiddenLabel mesh__D005799 Gene, Dominant
% 207.97/208.20  |- skos__prefLabel mesh__D005799 Genes, Dominant
% 207.97/208.20  |- mesh__dateEstablished mesh__D005799 1968-01-01
% 207.97/208.20  |- skos__hiddenLabel mesh__D005799 Dominant Genes
% 207.97/208.20  |- skos__broader mesh__D005799smesh__D040582
% 207.97/208.20  |- rdf__type mesh__D005799sskos__Concept
% 207.97/208.20  |- mesh__recordMaintainer mesh__D005799 nns
% 207.97/208.20  |- mesh__publicMeSHNote mesh__D005799 68   
% 207.97/208.20  |- skos__hiddenLabel mesh__D005799 Condition, Dominant Genetic
% 207.97/208.20  |- mesh__recordOriginator mesh__D005799 NLM
% 207.97/208.20  |- mesh__dateCreated mesh__D005799 1999-01-01
% 207.97/208.20  |- skos__hiddenLabel mesh__D005799 Dominant Gene
% 207.97/208.20  |- skos__altLabel mesh__D005799 Dominant Genetic Conditions
% 207.97/208.20  |- skos__altLabel mesh__D005799 Conditions, Dominant Genetic
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D018916 2004
% 207.97/208.20  |- skos__hiddenLabel mesh__D018916 Barrier, Aqueous-Blood
% 207.97/208.20  |- mesh__historyNote mesh__D018916 96   
% 207.97/208.20  |- rdf__type mesh__D018916sskos__Concept
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D018916 2005
% 207.97/208.20  |- mesh__dateRevised mesh__D018916 2003-07-09
% 207.97/208.20  |- mesh__publicMeSHNote mesh__D018916 96   
% 207.97/208.20  |- skos__broader mesh__D018916smesh__D002319
% 207.97/208.20  |- mesh__recordAuthorizer mesh__D018916 sjn
% 207.97/208.20  |- mesh__recordOriginator mesh__D018916 TGC
% 207.97/208.20  |- skos__historyNote mesh__D018916 Aqueous Humor %28%1966-1995%29%
% 207.97/208.20  |- mesh__recordMaintainer mesh__D018916 nns
% 207.97/208.20  |- skos__hiddenLabel mesh__D018916 Barrier, Blood-Aqueous
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D018916 2006
% 207.97/208.20  |- mesh__dateEstablished mesh__D018916 1996-01-01
% 207.97/208.20  |- skos__hiddenLabel mesh__D018916 Blood-Aqueous Barriers
% 207.97/208.20  |- skos__hiddenLabel mesh__D018916 Blood Aqueous Barrier
% 207.97/208.20  |- skos__hiddenLabel mesh__D018916 Barriers, Aqueous-Blood
% 207.97/208.20  |- skos__scopeNote mesh__D018916
% 207.97/208.20       The selectively permeable barrier, in the EYE, formed by the nonpigmented layer of the EPITHELIUM of the CILIARY BODY, and the ENDOTHELIUM of the BLOOD VESSELS of the IRIS. TIGHT JUNCTIONS joining adjacent cells keep the barrier between cells continuous.%A%    
% 207.97/208.20  |- skos__related mesh__D018916smesh__D002199
% 207.97/208.20  |- skos__hiddenLabel mesh__D018916 Barriers, Blood-Aqueous
% 207.97/208.20  |- skos__annotation mesh__D018916
% 207.97/208.20       coord IM with endogenous substance /metab %28%IM%29% or exogenous substance /pharmacokin %28%IM%29%%A%  
% 207.97/208.20  |- skos__hiddenLabel mesh__D018916 Aqueous-Blood Barriers
% 207.97/208.20  |- mesh__dateCreated mesh__D018916 1995-01-06
% 207.97/208.20  |- skos__altLabel mesh__D018916 Aqueous-Blood Barrier
% 207.97/208.20  |- skos__prefLabel mesh__D018916 Blood-Aqueous Barrier
% 207.97/208.20  |- skos__broader mesh__D018916smesh__D014602
% 207.97/208.20  |- skos__hiddenLabel mesh__D018916 Aqueous Blood Barrier
% 207.97/208.20  |- skos__broader mesh__D010933smesh__D007448
% 207.97/208.20  |- skos__scopeNote mesh__D010933
% 207.97/208.20       Community of tiny aquatic organisms, both PLANTS and ANIMALS, that are either free-floating or suspended in the water, with little or no power of locomotion. They are divided into PHYTOPLANKTON and ZOOPLANKTON.%A%    
% 207.97/208.20  |- mesh__recordAuthorizer mesh__D010933 ags
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D010933 2006A
% 207.97/208.20  |- skos__annotation mesh__D010933
% 207.97/208.20       coord with specific organism; PHYTOPLANKTON and ZOOPLANKTON are also available; non-phototrophic bacterioplankton: index PLANKTON + BACTERIA or specific; phototrophic bacterioplankton: index PHYTOPLANKTON + BACTERIA or specific%A%  
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D010933 2006
% 207.97/208.20  |- skos__broader mesh__D010933smesh__D010944
% 207.97/208.20  |- mesh__recordMaintainer mesh__D010933 ags
% 207.97/208.20  |- mesh__dateRevised mesh__D010933 2005-07-27
% 207.97/208.20  |- mesh__dateCreated mesh__D010933 1999-01-01
% 207.97/208.20  |- skos__related mesh__D010933smesh__D005068
% 207.97/208.20  |- rdf__type mesh__D010933sskos__Concept
% 207.97/208.20  |- mesh__recordOriginator mesh__D010933 NLM
% 207.97/208.20  |- skos__prefLabel mesh__D010933 Plankton
% 207.97/208.20  |- rdf__type mesh__D018118sskos__Concept
% 207.97/208.20  |- skos__broader mesh__D018118smesh__D007473
% 207.97/208.20  |- skos__historyNote mesh__D018118 Chlorides %28%1979-1993%29%
% 207.97/208.20  |- skos__prefLabel mesh__D018118 Chloride Channels
% 207.97/208.20  |- skos__scopeNote mesh__D018118
% 207.97/208.20       Cell membrane glycoproteins selective for chloride ions.%A%    
% 207.97/208.20  |- mesh__historyNote mesh__D018118
% 207.97/208.20       94; was CHLORIDE CHANNELS %28%NM%29% 1988-93   
% 207.97/208.20  |- mesh__publicMeSHNote mesh__D018118
% 207.97/208.20       94; CHLORIDE CHANNELS was indexed under MEMBRANE PROTEINS 1988-93%A%  
% 207.97/208.20  |- skos__hiddenLabel mesh__D018118 Channel, Chloride
% 207.97/208.20  |- skos__altLabel mesh__D018118 Chloride Ion Channels
% 207.97/208.20  |- mesh__recordAuthorizer mesh__D018118 sjn
% 207.97/208.20  |- mesh__onlineNote mesh__D018118
% 207.97/208.20       use CHLORIDE CHANNELS %28%NM%29% to search CHLORIDE CHANNELS 1988-93%A%  
% 207.97/208.20  |- mesh__recordOriginator mesh__D018118 TPW
% 207.97/208.20  |- skos__historyNote mesh__D018118 Membrane Proteins %28%1988-1993%29%
% 207.97/208.20  |- skos__altLabel mesh__D018118 Chloride Channel
% 207.97/208.20  |- mesh__dateRevised mesh__D018118 2005-06-30
% 207.97/208.20  |- skos__hiddenLabel mesh__D018118 Channels, Chloride Ion
% 207.97/208.20  |- skos__altLabel mesh__D018118 Ion Channel, Chloride
% 207.97/208.20  |- skos__annotation mesh__D018118
% 207.97/208.20       /biosyn /drug eff /physiol /rad eff /ultrastruct permitted; DF: CL CHANNELS%A%  
% 207.97/208.20  |- skos__hiddenLabel mesh__D018118 Chloride Ion Channel
% 207.97/208.20  |- mesh__dateEstablished mesh__D018118 1994-01-01
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D018118 2006
% 207.97/208.20  |- skos__hiddenLabel mesh__D018118 Channel, Chloride Ion
% 207.97/208.20  |- mesh__dateCreated mesh__D018118 1993-06-04
% 207.97/208.20  |- mesh__recordMaintainer mesh__D018118 SYSTEM
% 207.97/208.20  |- skos__historyNote mesh__D018118 Ion Channels %28%1979-1993%29%
% 207.97/208.20  |- skos__altLabel mesh__D018118 Ion Channels, Chloride
% 207.97/208.20  |- skos__hiddenLabel mesh__D018118 Channels, Chloride
% 207.97/208.20  |- mesh__recordAuthorizer mesh__D010135 sjn
% 207.97/208.20  |- mesh__dateRevised mesh__D010135 2001-07-25
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D010135 2002
% 207.97/208.20  |- skos__hiddenLabel mesh__D010135 para Fluorophenylalanine
% 207.97/208.20  |- skos__scopeNote mesh__D010135 3-%28%p-Fluorophenyl%29%-alanine.     
% 207.97/208.20  |- mesh__recordOriginator mesh__D010135 NLM
% 207.97/208.20  |- skos__broader mesh__D010135smesh__D010649
% 207.97/208.20  |- skos__prefLabel mesh__D010135 p-Fluorophenylalanine
% 207.97/208.20  |- mesh__historyNote mesh__D010135
% 207.97/208.20       91%28%75%29%; was see under PHENYLALANINE 1975-90   
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D010135 2006
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D010135 2005
% 207.97/208.20  |- rdf__type mesh__D010135sskos__Concept
% 207.97/208.20  |- skos__altLabel mesh__D010135 p Fluorophenylalanine
% 207.97/208.20  |- skos__historyNote mesh__D010135 Fluorine %28%1972-1974%29%
% 207.97/208.20  |- skos__hiddenLabel mesh__D010135 Fluorophenylalanine, p
% 207.97/208.20  |- skos__hiddenLabel mesh__D010135 4 Fluorophenylalanine
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D010135 2004
% 207.97/208.20  |- mesh__publicMeSHNote mesh__D010135
% 207.97/208.20       91; was see under PHENYLALANINE 1975-90   
% 207.97/208.20  |- skos__historyNote mesh__D010135 Phenylalanine %28%1972-1974%29%
% 207.97/208.20  |- mesh__recordMaintainer mesh__D010135 nns
% 207.97/208.20  |- skos__altLabel mesh__D010135 para-Fluorophenylalanine
% 207.97/208.20  |- mesh__dateCreated mesh__D010135 1974-11-19
% 207.97/208.20  |- mesh__dateEstablished mesh__D010135 1991-01-01
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D010135 2003
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D006892 2004
% 207.97/208.20  |- mesh__dateRevised mesh__D006892 1994-05-24
% 207.97/208.20  |- mesh__recordAuthorizer mesh__D006892 PLS
% 207.97/208.20  |- mesh__publicMeSHNote mesh__D006892 82; was HYDROXYDOPAMINE 1973-81   
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D006892 2005
% 207.97/208.20  |- skos__prefLabel mesh__D006892 Hydroxydopamines
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D006892 1995
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D006892 2001
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D006892 2003
% 207.97/208.20  |- skos__historyNote mesh__D006892 Phenethylamines %28%1966-1972%29%
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D006892 2000
% 207.97/208.20  |- mesh__dateCreated mesh__D006892 1999-01-01
% 207.97/208.20  |- mesh__onlineNote mesh__D006892
% 207.97/208.20       use HYDROXYDOPAMINES to search HYDROXYDOPAMINE 1973-81   
% 207.97/208.20  |- skos__broader mesh__D006892smesh__D004298
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D006892 1999
% 207.97/208.20  |- mesh__recordMaintainer mesh__D006892 RAZ
% 207.97/208.20  |- mesh__historyNote mesh__D006892 82; was HYDROXYDOPAMINE 1973-81   
% 207.97/208.20  |- skos__scopeNote mesh__D006892
% 207.97/208.20       Dopamines with a hydroxy group substituted in one or more positions.%A%    
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D006892 1997
% 207.97/208.20  |- rdf__type mesh__D006892sskos__Concept
% 207.97/208.20  |- skos__historyNote mesh__D006892 Dopamine %28%1966-1972%29%
% 207.97/208.20  |- mesh__dateEstablished mesh__D006892 1973-01-01
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D006892 2002
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D006892 1998
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D006892 1996
% 207.97/208.20  |- mesh__recordOriginator mesh__D006892 NLM
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D006892 2006
% 207.97/208.20  |- mesh__recordMaintainer mesh__D020563 SYSTEM
% 207.97/208.20  |- mesh__historyNote mesh__D020563 2004 %28%2000%29%   
% 207.97/208.20  |- skos__altLabel mesh__D020563 Proteobacteria gamma
% 207.97/208.20  |- mesh__recordOriginator mesh__D020563 ndw
% 207.97/208.20  |- rdf__type mesh__D020563sskos__Concept
% 207.97/208.20  |- skos__broader mesh__D020563smesh__D020560
% 207.97/208.20  |- mesh__dateRevised mesh__D020563 2005-06-30
% 207.97/208.20  |- mesh__publicMeSHNote mesh__D020563
% 207.97/208.20       2004; use GAMMA PROTEOBACTERIA 2000-2003   
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D020563 2006
% 207.97/208.20  |- skos__prefLabel mesh__D020563 Gammaproteobacteria
% 207.97/208.20  |- mesh__recordAuthorizer mesh__D020563 sjn
% 207.97/208.20  |- mesh__dateEstablished mesh__D020563 2000-01-01
% 207.97/208.20  |- skos__altLabel mesh__D020563 gamma Proteobacteria
% 207.97/208.20  |- mesh__dateCreated mesh__D020563 1999-11-03
% 207.97/208.20  |- skos__annotation mesh__D020563 DF: GAMMAPROTEOBACT   
% 207.97/208.20  |- skos__scopeNote mesh__D020563
% 207.97/208.20       A group of the proteobacteria comprised of facultatively anaerobic and fermentative gram-negative bacteria.%A%    
% 207.97/208.20  |- mesh__recordOriginator mesh__D006094 RC
% 207.97/208.20  |- mesh__dateRevised mesh__D006094 2005-06-30
% 207.97/208.20  |- rdf__type mesh__D006094sskos__Concept
% 207.97/208.20  |- skos__historyNote mesh__D006094 Bacteria %28%1966-1983%29%
% 207.97/208.20  |- mesh__publicMeSHNote mesh__D006094 84,73-75   
% 207.97/208.20  |- skos__altLabel mesh__D006094 Gram Positive Bacteria
% 207.97/208.20  |- skos__broader mesh__D006094smesh__D001419
% 207.97/208.20  |- skos__scopeNote mesh__D006094
% 207.97/208.20       Bacteria which retain the crystal violet stain when treated by Gram%27%s method.%A%    
% 207.97/208.20  |- skos__annotation mesh__D006094
% 207.97/208.20       GEN: avoid; prefer specifics; do not use as a routine coord for a gram-positive bact; infection = GRAM-POSITIVE BACTERIAL INFECTIONS; DF: GRAM POS BACT%A%  
% 207.97/208.20  |- mesh__onlineNote mesh__D006094 search BACTERIA 1973-75   
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D006094 2006
% 207.97/208.20  |- mesh__dateCreated mesh__D006094 1983-06-03
% 207.97/208.20  |- skos__prefLabel mesh__D006094 Gram-Positive Bacteria
% 207.97/208.20  |- mesh__recordMaintainer mesh__D006094 SYSTEM
% 207.97/208.20  |- mesh__recordAuthorizer mesh__D006094 sjn
% 207.97/208.20  |- mesh__dateEstablished mesh__D006094 1984-01-01
% 207.97/208.20  |- mesh__historyNote mesh__D006094 84,73-75   
% 207.97/208.20  |- mesh__recordMaintainer mesh__D014526 TAP
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D014526 1995
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D014526 1996
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D014526 2003
% 207.97/208.20  |- skos__scopeNote mesh__D014526
% 207.97/208.20       Inflammation of the urethra. %28%Dorland, 27th ed%29%     
% 207.97/208.20  |- rdf__type mesh__D014526sskos__Concept
% 207.97/208.20  |- skos__broader mesh__D014526smesh__D014522
% 207.97/208.20  |- mesh__dateRevised mesh__D014526 1993-06-03
% 207.97/208.20  |- mesh__recordOriginator mesh__D014526 NLM
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D014526 1997
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D014526 2004
% 207.97/208.20  |- mesh__dateCreated mesh__D014526 1999-01-01
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D014526 2000
% 207.97/208.20  |- skos__hiddenLabel mesh__D014526 Urethritides
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D014526 1998
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D014526 2005
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D014526 2001
% 207.97/208.20  |- skos__prefLabel mesh__D014526 Urethritis
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D014526 1999
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D014526 2006
% 207.97/208.20  |- mesh__recordAuthorizer mesh__D014526 PLS
% 207.97/208.20  |- skos__annotation mesh__D014526 inflamm of the urethra   
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D014526 1994
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D014526 2002
% 207.97/208.20  |- mesh__recordAuthorizer mesh__D000506 sjn
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D000506 2005
% 207.97/208.20  |- skos__annotation mesh__D000506 baldness in defined areas   
% 207.97/208.20  |- mesh__recordMaintainer mesh__D000506 lkt
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D000506 2003
% 207.97/208.20  |- mesh__dateRevised mesh__D000506 2001-07-25
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D000506 2006
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D000506 2004
% 207.97/208.20  |- mesh__dateCreated mesh__D000506 1999-01-01
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D000506 2002
% 207.97/208.20  |- mesh__recordOriginator mesh__D000506 NLM
% 207.97/208.20  |- skos__scopeNote mesh__D000506
% 207.97/208.20       A microscopically inflammatory, usually reversible, patchy hair loss occurring in sharply defined areas and usually involving the beard or scalp. %28%Dorland, 27th ed%29%%A%    
% 207.97/208.20  |- skos__broader mesh__D000506smesh__D000505
% 207.97/208.20  |- rdf__type mesh__D000506sskos__Concept
% 207.97/208.20  |- skos__prefLabel mesh__D000506 Alopecia Areata
% 207.97/208.20  |- skos__hiddenLabel mesh__D019211 Guinea pig cytomegaloviruses
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D019211 2006
% 207.97/208.20  |- skos__prefLabel mesh__D019211 Roseolovirus
% 207.97/208.20  |- rdf__type mesh__D019211sskos__Concept
% 207.97/208.20  |- mesh__recordMaintainer mesh__D019211 sjn
% 207.97/208.20  |- mesh__publicMeSHNote mesh__D019211 97   
% 207.97/208.20  |- mesh__recordOriginator mesh__D019211 AGS
% 207.97/208.20  |- skos__annotation mesh__D019211 infection = ROSEOLOVIRUS INFECTIONS   
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D019211 2005
% 207.97/208.20  |- mesh__historyNote mesh__D019211 97   
% 207.97/208.20  |- skos__broader mesh__D019211smesh__D018141
% 207.97/208.20  |- skos__hiddenLabel mesh__D019211 cytomegalovirus, Guinea pig
% 207.97/208.20  |- skos__hiddenLabel mesh__D019211 cytomegaloviruses, Guinea pig
% 207.97/208.20  |- mesh__dateRevised mesh__D019211 2004-07-13
% 207.97/208.20  |- skos__hiddenLabel mesh__D019211 Roseoloviruses
% 207.97/208.20  |- skos__hiddenLabel mesh__D019211 herpesvirus 2, Caviid
% 207.97/208.20  |- skos__altLabel mesh__D019211 Guinea pig cytomegalovirus
% 207.97/208.20  |- mesh__recordAuthorizer mesh__D019211 sjn
% 207.97/208.20  |- skos__scopeNote mesh__D019211
% 207.97/208.20       A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, whose viruses have been isolated from lymphocytes. HERPESVIRUS 6, HUMAN is the type species.%A%    
% 207.97/208.20  |- mesh__dateEstablished mesh__D019211 1997-01-01
% 207.97/208.20  |- mesh__dateCreated mesh__D019211 1996-06-10
% 207.97/208.20  |- skos__hiddenLabel mesh__D046608 Synkineses
% 207.97/208.20  |- mesh__recordAuthorizer mesh__D046608 sjn
% 207.97/208.20  |- mesh__historyNote mesh__D046608 2005   
% 207.97/208.20  |- skos__broader mesh__D046608smesh__D020820
% 207.97/208.20  |- mesh__recordMaintainer mesh__D046608 ags
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D046608 2005
% 207.97/208.20  |- rdf__type mesh__D046608sskos__Concept
% 207.97/208.20  |- skos__prefLabel mesh__D046608 Synkinesis
% 207.97/208.20  |- skos__historyNote mesh__D046608
% 207.97/208.20       Neurologic Manifestations %28%1966-2004%29%
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D046608 2006
% 207.97/208.20  |- skos__scopeNote mesh__D046608
% 207.97/208.20       An involuntary movement accompanying a volitional movement. It often refers to facial movements that accompany FACIAL PARALYSIS.%A%    
% 207.97/208.20  |- mesh__dateEstablished mesh__D046608 2005-01-01
% 207.97/208.20  |- mesh__dateCreated mesh__D046608 2004-07-07
% 207.97/208.20  |- mesh__recordOriginator mesh__D046608 ags
% 207.97/208.20  |- mesh__publicMeSHNote mesh__D046608 2005   
% 207.97/208.20  |- skos__hiddenLabel mesh__D018917 Ischemic Optic Neuropathies
% 207.97/208.20  |- mesh__recordMaintainer mesh__D018917 ags
% 207.97/208.20  |- mesh__dateCreated mesh__D018917 1995-01-06
% 207.97/208.20  |- skos__altLabel mesh__D018917 Optic Neuropathy, Anterior Ischemic
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D018917 2006
% 207.97/208.20  |- skos__scopeNote mesh__D018917
% 207.97/208.20       Ischemic injury to the optic nerve which usually affects the optic disk %28%optic neuropathy, anterior ischemic%29% and less frequently the retrobulbar portion of the nerve %28%optic neuropathy, posterior ischemic%29%. The injury results from occlusion of arterial blood supply which may result from TEMPORAL ARTERITIS; ATHEROSCLEROSIS; COLLAGEN DISEASES; EMBOLISM; DIABETES MELLITUS; and other conditions. The disease primarily occurs in the sixth decade or later and presents with the sudden onset of painless and usually severe monocular visual loss. Anterior ischemic optic neuropathy also features optic disk edema with microhemorrhages. The optic disk appears normal in posterior ischemic optic neuropathy. %28%Glaser, Neuro-Ophthalmology, 2nd ed, p135%29%%A%    
% 207.97/208.20  |- mesh__recordAuthorizer mesh__D018917 ags
% 207.97/208.20  |- skos__historyNote mesh__D018917 Optic Nerve Diseases %28%1976-1995%29%
% 207.97/208.20  |- mesh__dateRevised mesh__D018917 2005-07-13
% 207.97/208.20  |- skos__altLabel mesh__D018917 Optic Neuropathy, Posterior Ischemic
% 207.97/208.20  |- skos__hiddenLabel mesh__D018917 Nerve Ischemias, Optic
% 207.97/208.20  |- skos__hiddenLabel mesh__D018917 Optic Neuropathies, Ischemic
% 207.97/208.20  |- skos__hiddenLabel mesh__D018917 Neuropathies, Ischemic Optic
% 207.97/208.20  |- skos__altLabel mesh__D018917 Ischemic Optic Neuropathy
% 207.97/208.20  |- skos__broader mesh__D018917smesh__D009901
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D018917 2000
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D018917 2003
% 207.97/208.20  |- skos__hiddenLabel mesh__D018917 Ischemia, Optic Nerve
% 207.97/208.20  |- skos__prefLabel mesh__D018917 Optic Neuropathy, Ischemic
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D018917 2006A
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D018917 2001
% 207.97/208.20  |- mesh__activeMeSHYear mesh__D018917 2004
% 207.97/208.20  |- skos__hiddenLabel mesh__D018917 Ischemias, Optic Nerve
% 207.97/208.20  |- mesh__dateEstablished mesh__D018917 1996-01-01
% 207.97/208.20  |- skos__hiddenLabel mesh__D018917 Nerve Ischemia, Optic
% 208.06/208.20  |- mesh__publicMeSHNote mesh__D018917 96   
% 208.06/208.20  |- skos__hiddenLabel mesh__D018917 Neuropathy, Ischemic Optic
% 208.06/208.20  |- mesh__historyNote mesh__D018917 96   
% 208.06/208.20  |- mesh__activeMeSHYear mesh__D018917 2002
% 208.06/208.20  |- mesh__recordOriginator mesh__D018917 TGC
% 208.06/208.20  |- rdf__type mesh__D018917sskos__Concept
% 208.06/208.20  |- skos__historyNote mesh__D018917 Optic Nerve %28%1966-1975%29%
% 208.06/208.20  |- mesh__activeMeSHYear mesh__D018917 2005
% 208.06/208.20  |- skos__hiddenLabel mesh__D018917 Optic Nerve Ischemias
% 208.06/208.20  |- skos__broader mesh__D018917smesh__D007511
% 208.06/208.20  |- skos__altLabel mesh__D018917 Optic Nerve Ischemia
% 208.06/208.20  |- mesh__activeMeSHYear mesh__D010934 1999
% 208.06/208.20  |- skos__scopeNote mesh__D010934
% 208.06/208.20       Procedures, strategies, and theories of planning.     
% 208.06/208.20  |- mesh__dateEstablished mesh__D010934 1980-01-01
% 208.06/208.20  |- skos__related mesh__D010934smesh__D006285
% 208.06/208.20  |- skos__hiddenLabel mesh__D010934 Techniques, Planning
% 208.06/208.20  |- mesh__activeMeSHYear mesh__D010934 2000
% 208.06/208.20  |- skos__altLabel mesh__D010934 Methodology, Planning
% 208.06/208.20  |- mesh__activeMeSHYear mesh__D010934 2006
% 208.06/208.20  |- mesh__dateCreated mesh__D010934 1979-06-01
% 208.06/208.20  |- mesh__activeMeSHYear mesh__D010934 1998
% 208.06/208.20  |- skos__hiddenLabel mesh__D010934 Theory, Planning
% 208.06/208.20  |- skos__hiddenLabel mesh__D010934 Planning Methodologies
% 208.06/208.20  |- mesh__activeMeSHYear mesh__D010934 1997
% 208.06/208.20  |- skos__hiddenLabel mesh__D010934 Methodologies, Planning
% 208.06/208.20  |- mesh__activeMeSHYear mesh__D010934 2005
% 208.06/208.20  |- mesh__activeMeSHYear mesh__D010934 2004
% 208.06/208.20  |- skos__hiddenLabel mesh__D010934 Planning Theory
% 208.06/208.20  |- mesh__dateRevised mesh__D010934 1995-05-23
% 208.06/208.20  |- skos__altLabel mesh__D010934 Planning Technic
% 208.06/208.20  |- mesh__activeMeSHYear mesh__D010934 1996
% 208.06/208.20  |- mesh__activeMeSHYear mesh__D010934 2002
% 208.06/208.20  |- skos__annotation mesh__D010934 NIM; no qualif   
% 208.06/208.20  |- mesh__recordAuthorizer mesh__D010934 PLS
% 208.06/208.20  |- skos__hiddenLabel mesh__D010934 Planning Technique
% 208.06/208.20  |- mesh__activeMeSHYear mesh__D010934 2003
% 208.06/208.20  |- rdf__type mesh__D010934sskos__Concept
% 208.06/208.20  |- skos__hiddenLabel mesh__D010934 Planning Technics
% 208.06/208.20  |- skos__hiddenLabel mesh__D010934 Technic, Planning
% 208.06/208.20  |- mesh__historyNote mesh__D010934 91; was PLANNING TECHNICS 1980-90   
% 208.06/208.20  |- skos__hiddenLabel mesh__D010934 Technics, Planning
% 208.06/208.20  |- mesh__recordOriginator mesh__D010934 EC
% 208.06/208.20  |- skos__prefLabel mesh__D010934 Planning Techniques
% 208.06/208.20  |- mesh__onlineNote mesh__D010934
% 208.06/208.20       use PLANNING TECHNIQUES to search PLANNING TECHNICS 1980-90%A%  
% 208.06/208.20  |- skos__hiddenLabel mesh__D010934 Technique, Planning
% 208.06/208.20  |- skos__broader mesh__D010934smesh__D009934
% 208.06/208.20  |- mesh__activeMeSHYear mesh__D010934 2001
% 208.06/208.20  |- skos__related mesh__D010934smesh__D012939
% 208.06/208.20  |- skos__hiddenLabel mesh__D010934 Theories, Planning
% 208.06/208.20  |- skos__altLabel mesh__D010934 Planning Methodology
% 208.06/208.20  |- mesh__recordMaintainer mesh__D010934 KEV
% 208.06/208.20  |- mesh__publicMeSHNote mesh__D010934 91; was PLANNING TECHNICS 1980-90   
% 208.06/208.20  |- mesh__onlineNote mesh__D018119
% 208.06/208.20       use STAVUDINE %28%NM%29% to search STAVUDINE 1987-93   
% 208.06/208.20  |- mesh__publicMeSHNote mesh__D018119
% 208.06/208.20       94; STAVUDINE was indexed under DIDEOXYNUCLEOSIDES 1988-93 %26% THYMIDINE/*ANALOGS %26% DERIVATIVES 1987-88%A%  
% 208.06/208.20  |- skos__prefLabel mesh__D018119 Stavudine
% 208.06/208.20  |- skos__altLabel mesh__D018119
% 208.06/208.20       2%27%,3%27%-Didehydro-2%27%,3%27%-dideoxythmidine
% 208.06/208.20  |- skos__broader mesh__D018119smesh__D015224
% 208.06/208.20  |- skos__historyNote mesh__D018119 Dideoxynucleosides %28%1989-1993%29%
% 208.06/208.20  |- skos__altLabel mesh__D018119 Bristol-Myers Squibb Brand of Stavudine
% 208.06/208.20  |- skos__scopeNote mesh__D018119
% 208.06/208.20       A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV.%A%    
% 208.06/208.20  |- mesh__historyNote mesh__D018119 94; was STAVUDINE %28%NM%29% 1987-93   
% 208.06/208.20  |- skos__hiddenLabel mesh__D018119 BMY27857
% 208.06/208.20  |- mesh__recordMaintainer mesh__D018119 CCR
% 208.06/208.20  |- skos__annotation mesh__D018119 DF: note short X ref   
% 208.06/208.20  |- skos__altLabel mesh__D018119 D4T
% 208.06/208.20  |- mesh__activeMeSHYear mesh__D018119 2006
% 208.06/208.20  |- mesh__recordAuthorizer mesh__D018119 sjn
% 208.06/208.20  |- skos__altLabel mesh__D018119 2%27%,3%27%-Didehydro-3%27%-deoxythymidine
% 208.06/208.20  |- mesh__recordOriginator mesh__D018119 TPW
% 208.06/208.20  |- skos__hiddenLabel mesh__D018119
% 208.06/208.20       2%27%,3%27% Didehydro 3%27% deoxythymidine
% 208.06/208.20  |- skos__historyNote mesh__D018119
% 208.06/208.20       Thymidine/analogs %26% derivatives %28%1987-1988%29%
% 208.06/208.20  |- mesh__dateRevised mesh__D018119 2005-06-30
% 208.06/208.20  |- skos__hiddenLabel mesh__D018119 BMY 27857
% 208.06/208.20  |- rdf__type mesh__D018119sskos__Concept
% 208.06/208.20  |- mesh__dateEstablished mesh__D018119 1994-01-01
% 208.06/208.20  |- skos__altLabel mesh__D018119 Bristol-Myers Brand of Stavudine
% 208.06/208.20  |- skos__broader mesh__D018119smesh__D013936
% 208.06/208.20  |- mesh__dateCreated mesh__D018119 1993-06-04
% 208.06/208.20  |- mesh__publicMeSHNote mesh__D010136
% 208.06/208.20       91; was see under AMPHETAMINES 1975-90   
% 208.06/208.20  |- skos__altLabel mesh__D010136 Oxyamphetamine
% 208.06/208.20  |- mesh__dateRevised mesh__D010136 2004-07-07
% 208.06/208.20  |- mesh__dateCreated mesh__D010136 1974-11-19
% 208.06/208.20  |- skos__broader mesh__D010136smesh__D000662
% 208.06/208.20  |- mesh__historyNote mesh__D010136
% 208.06/208.20       91%28%75%29%; was see under AMPHETAMINES 1975-90   
% 208.06/208.20  |- mesh__activeMeSHYear mesh__D010136 2006
% 208.06/208.20  |- mesh__recordAuthorizer mesh__D010136 sjn
% 208.06/208.20  |- skos__altLabel mesh__D010136 Hydroxyamphetamin
% 208.06/208.20  |- skos__historyNote mesh__D010136 Amphetamine %28%1973-1974%29%
% 208.06/208.20  |- mesh__recordOriginator mesh__D010136 NLM
% 208.06/208.21  |- skos__scopeNote mesh__D010136
% 208.06/208.21       Amphetamine metabolite with sympathomimetic effects. It is sometimes called alpha-methyltyramine, which may also refer to the meta isomer, gepefrine.%A%    
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D010136 2005
% 208.06/208.21  |- rdf__type mesh__D010136sskos__Concept
% 208.06/208.21  |- skos__altLabel mesh__D010136 Hydroxyamfetamine
% 208.06/208.21  |- skos__altLabel mesh__D010136 Norpholedrin
% 208.06/208.21  |- skos__hiddenLabel mesh__D010136 para Hydroxyamphetamine
% 208.06/208.21  |- skos__altLabel mesh__D010136 Hydroxyamphetamine
% 208.06/208.21  |- skos__altLabel mesh__D010136 Hydroxyphenylisopropylamine
% 208.06/208.21  |- skos__prefLabel mesh__D010136 p-Hydroxyamphetamine
% 208.06/208.21  |- mesh__dateEstablished mesh__D010136 1991-01-01
% 208.06/208.21  |- mesh__recordMaintainer mesh__D010136 ssb
% 208.06/208.21  |- skos__hiddenLabel mesh__D010136 p Hydroxyamphetamine
% 208.06/208.21  |- skos__historyNote mesh__D010136 Phenols %28%1968-1974%29%
% 208.06/208.21  |- skos__hiddenLabel mesh__D010136 Hydrobromide, Hydroxyamphetamine
% 208.06/208.21  |- skos__altLabel mesh__D010136 para-Hydroxyamphetamine
% 208.06/208.21  |- skos__historyNote mesh__D006893 Arachidonic Acids %28%1967-1984%29%
% 208.06/208.21  |- skos__altLabel mesh__D006893 HETE
% 208.06/208.21  |- skos__scopeNote mesh__D006893
% 208.06/208.21       Eicosatetraenoic acids substituted in any position by one or more hydroxy groups. They are important intermediates in a series of biosynthetic processes leading from arachidonic acid to a number of biologically active compounds such as prostaglandins, thromboxanes, and leukotrienes.%A%    
% 208.06/208.21  |- skos__prefLabel mesh__D006893 Hydroxyeicosatetraenoic Acids
% 208.06/208.21  |- mesh__recordOriginator mesh__D006893 RLS
% 208.06/208.21  |- mesh__publicMeSHNote mesh__D006893 85   
% 208.06/208.21  |- skos__broader mesh__D006893smesh__D001095
% 208.06/208.21  |- mesh__dateCreated mesh__D006893 1984-05-30
% 208.06/208.21  |- mesh__recordMaintainer mesh__D006893 ssb
% 208.06/208.21  |- rdf__type mesh__D006893sskos__Concept
% 208.06/208.21  |- mesh__historyNote mesh__D006893 85   
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D006893 2006
% 208.06/208.21  |- mesh__dateRevised mesh__D006893 2003-07-09
% 208.06/208.21  |- skos__hiddenLabel mesh__D006893 Acids, Hydroxyeicosatetraenoic
% 208.06/208.21  |- mesh__dateEstablished mesh__D006893 1985-01-01
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D006893 2005
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D006893 2004
% 208.06/208.21  |- mesh__recordAuthorizer mesh__D006893 sjn
% 208.06/208.21  |- skos__historyNote mesh__D006893 Fatty Acids, Essential %28%1966%29%
% 208.06/208.21  |- mesh__recordOriginator mesh__D020564 ndw
% 208.06/208.21  |- skos__altLabel mesh__D020564 delta Proteobacteria
% 208.06/208.21  |- mesh__dateEstablished mesh__D020564 2000-01-01
% 208.06/208.21  |- mesh__historyNote mesh__D020564 2004 %28%2000%29%   
% 208.06/208.21  |- skos__annotation mesh__D020564 DF: DELTAPROTEOBACT   
% 208.06/208.21  |- mesh__publicMeSHNote mesh__D020564
% 208.06/208.21       2004; see delta Proteobacteria 2000-2003   
% 208.06/208.21  |- mesh__dateRevised mesh__D020564 2005-06-30
% 208.06/208.21  |- skos__altLabel mesh__D020564 Proteobacteria delta
% 208.06/208.21  |- mesh__dateCreated mesh__D020564 1999-11-03
% 208.06/208.21  |- rdf__type mesh__D020564sskos__Concept
% 208.06/208.21  |- skos__broader mesh__D020564smesh__D020560
% 208.06/208.21  |- mesh__recordAuthorizer mesh__D020564 sjn
% 208.06/208.21  |- mesh__recordMaintainer mesh__D020564 SYSTEM
% 208.06/208.21  |- skos__prefLabel mesh__D020564 Deltaproteobacteria
% 208.06/208.21  |- skos__scopeNote mesh__D020564
% 208.06/208.21       A group of PROTEOBACTERIA represented by morphologically diverse, anaerobic sulfidogens. Some members of this group are considered bacterial predators, having bacteriolytic properties.%A%    
% 208.06/208.21  |- skos__historyNote mesh__D020564
% 208.06/208.21       Gram-negative Anaerobic Bacteria %28%1995-1999%29%
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D020564 2006
% 208.06/208.21  |- skos__historyNote mesh__D006095 Bacteria %28%1966-1983%29%
% 208.06/208.21  |- mesh__recordAuthorizer mesh__D006095 sjn
% 208.06/208.21  |- mesh__historyNote mesh__D006095
% 208.06/208.21       92; was GRAM-POSITIVE COCCI %28%NON MESH%29% 1976-91   
% 208.06/208.21  |- mesh__dateRevised mesh__D006095 2005-06-30
% 208.06/208.21  |- skos__scopeNote mesh__D006095
% 208.06/208.21       Coccus-shaped bacteria that retain the crystal violet stain when treated by Gram%27%s method.%A%    
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D006095 2006
% 208.06/208.21  |- skos__historyNote mesh__D006095 Gram-Positive Bacteria %28%1973-1991%29%
% 208.06/208.21  |- mesh__recordOriginator mesh__D006095 JW
% 208.06/208.21  |- mesh__publicMeSHNote mesh__D006095 92   
% 208.06/208.21  |- skos__altLabel mesh__D006095 Gram Positive Cocci
% 208.06/208.21  |- mesh__recordMaintainer mesh__D006095 SYSTEM
% 208.06/208.21  |- skos__prefLabel mesh__D006095 Gram-Positive Cocci
% 208.06/208.21  |- skos__broader mesh__D006095smesh__D006094
% 208.06/208.21  |- rdf__type mesh__D006095sskos__Concept
% 208.06/208.21  |- skos__annotation mesh__D006095
% 208.06/208.21       gram-positive bacteria; infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS %28%IM%29%; DF: GRAM POS COCCI%A%  
% 208.06/208.21  |- mesh__dateCreated mesh__D006095 1975-07-25
% 208.06/208.21  |- mesh__dateEstablished mesh__D006095 1992-01-01
% 208.06/208.21  |- mesh__recordMaintainer mesh__D014527 jmp
% 208.06/208.21  |- skos__broader mesh__D014527smesh__D014970
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D014527 2005
% 208.06/208.21  |- skos__hiddenLabel mesh__D014527 Urate, Sodium Acid
% 208.06/208.21  |- skos__hiddenLabel mesh__D014527 Monohydrate, Sodium Urate
% 208.06/208.21  |- skos__hiddenLabel mesh__D014527 Urate, Potassium
% 208.06/208.21  |- skos__hiddenLabel mesh__D014527 Acid Urate, Sodium
% 208.06/208.21  |- mesh__dateCreated mesh__D014527 1999-01-01
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D014527 2004
% 208.06/208.21  |- skos__hiddenLabel mesh__D014527 Acid, Uric
% 208.06/208.21  |- skos__hiddenLabel mesh__D014527 Acid Urate, Ammonium
% 208.06/208.21  |- rdf__type mesh__D014527sskos__Concept
% 208.06/208.21  |- skos__altLabel mesh__D014527 Trioxopurine
% 208.06/208.21  |- mesh__recordAuthorizer mesh__D014527 sjn
% 208.06/208.21  |- skos__hiddenLabel mesh__D014527 Urate, Sodium
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D014527 2003
% 208.06/208.21  |- skos__altLabel mesh__D014527 Sodium Acid Urate
% 208.06/208.21  |- skos__hiddenLabel mesh__D014527 Urate, Monosodium
% 208.06/208.21  |- skos__hiddenLabel mesh__D014527 Urate, Ammonium Acid
% 208.06/208.21  |- skos__hiddenLabel mesh__D014527 Monohydrate, Monosodium Urate
% 208.06/208.21  |- skos__hiddenLabel mesh__D014527 Urate Monohydrate, Sodium
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D014527 2002
% 208.06/208.21  |- mesh__recordOriginator mesh__D014527 NLM
% 208.06/208.21  |- mesh__dateRevised mesh__D014527 2001-07-25
% 208.06/208.21  |- skos__altLabel mesh__D014527 2,6,8-Trihydroxypurine
% 208.06/208.21  |- skos__altLabel mesh__D014527 Monosodium Urate
% 208.06/208.21  |- skos__altLabel mesh__D014527 Monosodium Urate Monohydrate
% 208.06/208.21  |- skos__hiddenLabel mesh__D014527 Urate Monohydrate, Monosodium
% 208.06/208.21  |- skos__altLabel mesh__D014527 Sodium Urate
% 208.06/208.21  |- skos__altLabel mesh__D014527 Sodium Acid Urate Monohydrate
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D014527 2006
% 208.06/208.21  |- skos__prefLabel mesh__D014527 Uric Acid
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D000507 2003
% 208.06/208.21  |- skos__broader mesh__D000507smesh__D000505
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D000507 2006
% 208.06/208.21  |- mesh__publicMeSHNote mesh__D000507
% 208.06/208.21       93; was ALOPECIA MUCINOSA 1965-92 %28%see under ALOPECIA 1965-90%29%%A%  
% 208.06/208.21  |- skos__hiddenLabel mesh__D000507 Follicular Mucinosis
% 208.06/208.21  |- mesh__onlineNote mesh__D000507
% 208.06/208.21       use MUCINOSIS, FOLLICULAR to search ALOPECIA MUCINOSA 1966-92%A%  
% 208.06/208.21  |- skos__hiddenLabel mesh__D000507 Follicular Mucinoses
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D000507 2004
% 208.06/208.21  |- skos__broader mesh__D000507smesh__D012625
% 208.06/208.21  |- mesh__recordAuthorizer mesh__D000507 sjn
% 208.06/208.21  |- mesh__dateEstablished mesh__D000507 1991-01-01
% 208.06/208.21  |- skos__hiddenLabel mesh__D000507 Mucinoses, Follicular
% 208.06/208.21  |- mesh__dateRevised mesh__D000507 2001-07-25
% 208.06/208.21  |- skos__altLabel mesh__D000507 Alopecia Mucinosa
% 208.06/208.21  |- mesh__dateCreated mesh__D000507 1999-01-01
% 208.06/208.21  |- mesh__recordMaintainer mesh__D000507 lkt
% 208.06/208.21  |- skos__broader mesh__D000507smesh__D017520
% 208.06/208.21  |- mesh__historyNote mesh__D000507
% 208.06/208.21       93; was ALOPECIA MUCINOSA 1965-92 %28%see under ALOPECIA 1965-90%29%%A%  
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D000507 2002
% 208.06/208.21  |- skos__scopeNote mesh__D000507
% 208.06/208.21       A disease of the pilosebaceous unit, presenting clinically as grouped follicular papules or plaques with associated hair loss. It is caused by mucinous infiltration of tissues, and usually involving the scalp, face, and neck. It may be primary %28%idiopathic%29% or secondary to mycosis fungoides or reticulosis.%A%    
% 208.06/208.21  |- rdf__type mesh__D000507sskos__Concept
% 208.06/208.21  |- mesh__recordOriginator mesh__D000507 NLM
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D000507 2005
% 208.06/208.21  |- skos__annotation mesh__D000507 a sebaceous gland dis   
% 208.06/208.21  |- skos__prefLabel mesh__D000507 Mucinosis, Follicular
% 208.06/208.21  |- mesh__recordOriginator mesh__D019212 JLS
% 208.06/208.21  |- mesh__dateCreated mesh__D019212 1996-06-13
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D019212 2005
% 208.06/208.21  |- mesh__dateEstablished mesh__D019212 1997-01-01
% 208.06/208.21  |- mesh__historyNote mesh__D019212 97   
% 208.06/208.21  |- mesh__recordMaintainer mesh__D019212 ags
% 208.06/208.21  |- mesh__dateRevised mesh__D019212 2004-07-07
% 208.06/208.21  |- mesh__publicMeSHNote mesh__D019212 97   
% 208.06/208.21  |- skos__broader mesh__D019212smesh__D001296
% 208.06/208.21  |- skos__altLabel mesh__D019212 Multimedium
% 208.06/208.21  |- skos__prefLabel mesh__D019212 Multimedia
% 208.06/208.21  |- skos__scopeNote mesh__D019212
% 208.06/208.21       Materials, frequently computer applications, that combine some or all of text, sound, graphics, animation, and video into integrated packages. %28%Thesaurus of ERIC Descriptors, 1994%29%%A%    
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D019212 2006
% 208.06/208.21  |- rdf__type mesh__D019212sskos__Concept
% 208.06/208.21  |- mesh__recordAuthorizer mesh__D019212 sjn
% 208.06/208.21  |- skos__historyNote mesh__D019212
% 208.06/208.21       Computer-Assisted Instruction %28%1993-1996%29%
% 208.06/208.21  |- skos__annotation mesh__D019212
% 208.06/208.21       restrict to a combination of audiovisual aids: do not use for a multiplicity of media such as newspapers, radio, TV%A%  
% 208.06/208.21  |- skos__broader mesh__D046609smesh__D009862
% 208.06/208.21  |- skos__hiddenLabel mesh__D046609 Library, Digital
% 208.06/208.21  |- skos__hiddenLabel mesh__D046609 Virtual Library
% 208.06/208.21  |- mesh__historyNote mesh__D046609 2005   
% 208.06/208.21  |- mesh__publicMeSHNote mesh__D046609 2005   
% 208.06/208.21  |- skos__broader mesh__D046609smesh__D007990
% 208.06/208.21  |- mesh__recordOriginator mesh__D046609 ags
% 208.06/208.21  |- skos__hiddenLabel mesh__D046609 Virtual Libraries
% 208.06/208.21  |- skos__scopeNote mesh__D046609
% 208.06/208.21       Libraries in which a major proportion of the resources are available in machine-readable format, rather than on paper or MICROFORM.%A%    
% 208.06/208.21  |- mesh__recordAuthorizer mesh__D046609 sjn
% 208.06/208.21  |- mesh__dateCreated mesh__D046609 2004-07-07
% 208.06/208.21  |- rdf__type mesh__D046609sskos__Concept
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D046609 2006
% 208.06/208.21  |- mesh__dateEstablished mesh__D046609 2005-01-01
% 208.06/208.21  |- skos__hiddenLabel mesh__D046609 Digital Library
% 208.06/208.21  |- mesh__recordMaintainer mesh__D046609 ags
% 208.06/208.21  |- skos__hiddenLabel mesh__D046609 Library, Virtual
% 208.06/208.21  |- skos__prefLabel mesh__D046609 Libraries, Digital
% 208.06/208.21  |- skos__altLabel mesh__D046609 Digital Libraries
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D046609 2005
% 208.06/208.21  |- mesh__recordOriginator mesh__D018918 TGC
% 208.06/208.21  |- skos__historyNote mesh__D018918 Cataract Extraction %28%1970-1995%29%
% 208.06/208.21  |- mesh__dateCreated mesh__D018918 1995-01-06
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D018918 2003
% 208.06/208.21  |- skos__hiddenLabel mesh__D018918 Phacoemulsifications
% 208.06/208.21  |- mesh__recordMaintainer mesh__D018918 PXP
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D018918 2004
% 208.06/208.21  |- skos__annotation mesh__D018918
% 208.06/208.21       a type of cataract extraction; do not use /util except by MeSH definition%A%  
% 208.06/208.21  |- skos__prefLabel mesh__D018918 Phacoemulsification
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D018918 2000
% 208.06/208.21  |- mesh__historyNote mesh__D018918 96   
% 208.06/208.21  |- rdf__type mesh__D018918sskos__Concept
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D018918 2005
% 208.06/208.21  |- skos__broader mesh__D018918smesh__D002387
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D018918 1998
% 208.06/208.21  |- mesh__recordAuthorizer mesh__D018918 SJN
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D018918 2001
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D018918 2006
% 208.06/208.21  |- skos__scopeNote mesh__D018918
% 208.06/208.21       A procedure for removal of the crystalline lens in cataract surgery in which an anterior capsulectomy is performed by means of a needle inserted through a small incision at the temporal limbus, allowing the lens contents to fall through the dilated pupil into the anterior chamber where they are broken up by the use of ultrasound and aspirated out of the eye through the incision. The small incision allows the surgeon to use very few or even no stitches to close the tiny wound. There is usually no need for hospitalization and patients may resume most activities within days. %28%Cline, et al., Dictionary of Visual Science, 4th ed %26% In Focus 1993;1%28%1%29%:1%29%%A%    
% 208.06/208.21  |- mesh__dateEstablished mesh__D018918 1996-01-01
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D018918 1999
% 208.06/208.21  |- mesh__publicMeSHNote mesh__D018918 96   
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D018918 2002
% 208.06/208.21  |- mesh__dateRevised mesh__D018918 1997-06-20
% 208.06/208.21  |- skos__hiddenLabel mesh__D010935 Diseases, Plant
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D010935 2004
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D010935 2003
% 208.06/208.21  |- skos__broader mesh__D010935smesh__D018521
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D010935 2002
% 208.06/208.21  |- mesh__dateEstablished mesh__D010935 1968-01-01
% 208.06/208.21  |- skos__hiddenLabel mesh__D010935 Disease, Plant
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D010935 2006
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D010935 1999
% 208.06/208.21  |- mesh__publicMeSHNote mesh__D010935 68   
% 208.06/208.21  |- skos__scopeNote mesh__D010935 Diseases of plants.     
% 208.06/208.21  |- mesh__dateRevised mesh__D010935 1998-06-10
% 208.06/208.21  |- mesh__recordOriginator mesh__D010935 NLM
% 208.06/208.21  |- skos__hiddenLabel mesh__D010935 Plant Disease
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D010935 2005
% 208.06/208.21  |- skos__prefLabel mesh__D010935 Plant Diseases
% 208.06/208.21  |- skos__annotation mesh__D010935
% 208.06/208.21       coord with specific causative organism if pertinent but not with infection term%A%  
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D010935 2001
% 208.06/208.21  |- mesh__historyNote mesh__D010935 68   
% 208.06/208.21  |- mesh__dateCreated mesh__D010935 1999-01-01
% 208.06/208.21  |- skos__historyNote mesh__D010935 Plants %28%1966-1967%29%
% 208.06/208.21  |- mesh__recordMaintainer mesh__D010935 JLS
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D010935 2000
% 208.06/208.21  |- rdf__type mesh__D010935sskos__Concept
% 208.06/208.21  |- mesh__recordAuthorizer mesh__D010935 SJN
% 208.06/208.21  |- skos__prefLabel mesh__D010137 p-Hydroxynorephedrine
% 208.06/208.21  |- mesh__publicMeSHNote mesh__D010137
% 208.06/208.21       91; was see under PHENYLPROPANOLAMINE 1975-90   
% 208.06/208.21  |- skos__broader mesh__D010137smesh__D010665
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D010137 2004
% 208.06/208.21  |- skos__hiddenLabel mesh__D010137 para Hydroxynorephedrine
% 208.06/208.21  |- skos__altLabel mesh__D010137 p Hydroxynorephedrine
% 208.06/208.21  |- mesh__dateCreated mesh__D010137 1974-11-19
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D010137 2003
% 208.06/208.21  |- skos__historyNote mesh__D010137 Phenols %28%1972-1974%29%
% 208.06/208.21  |- skos__altLabel mesh__D010137 para-Hydroxynorephedrine
% 208.06/208.21  |- skos__hiddenLabel mesh__D010137 Hydroxynorephedrine, p
% 208.06/208.21  |- mesh__dateEstablished mesh__D010137 1991-01-01
% 208.06/208.21  |- skos__historyNote mesh__D010137 Phenylpropanolamine %28%1972-1974%29%
% 208.06/208.21  |- mesh__recordMaintainer mesh__D010137 CCR
% 208.06/208.21  |- mesh__recordAuthorizer mesh__D010137 sjn
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D010137 2002
% 208.06/208.21  |- mesh__recordOriginator mesh__D010137 NLM
% 208.06/208.21  |- mesh__dateRevised mesh__D010137 2000-06-22
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D010137 2006
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D010137 2001
% 208.06/208.21  |- skos__scopeNote mesh__D010137
% 208.06/208.21       Parahydroxy analog of phenylpropanolamine with properties as a sympathomimetic.%A%    
% 208.06/208.21  |- mesh__historyNote mesh__D010137
% 208.06/208.21       91%28%75%29%; was see under PHENYLPROPANOLAMINE 1975-90   
% 208.06/208.21  |- rdf__type mesh__D010137sskos__Concept
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D010137 2005
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D015620 1996
% 208.06/208.21  |- mesh__dateEstablished mesh__D015620 1990-01-01
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D015620 2000
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D015620 2005
% 208.06/208.21  |- skos__prefLabel mesh__D015620 Histiocytic Disorders, Malignant
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D015620 1999
% 208.06/208.21  |- mesh__dateRevised mesh__D015620 1995-06-08
% 208.06/208.21  |- skos__hiddenLabel mesh__D015620 Histiocytic Disorder, Malignant
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D015620 1998
% 208.06/208.21  |- mesh__recordAuthorizer mesh__D015620 PLS
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D015620 2002
% 208.06/208.21  |- skos__hiddenLabel mesh__D015620 Disorder, Malignant Histiocytic
% 208.06/208.21  |- skos__annotation mesh__D015620
% 208.06/208.21       GEN or unspecified; prefer specifics; do not use /blood supply /chem /second /secret /ultrastruct; do not confuse with HISTIOCYTOSIS, MALIGNANT%A%  
% 208.06/208.21  |- skos__hiddenLabel mesh__D015620 Malignant Histiocytic Disorder
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D015620 2004
% 208.06/208.21  |- rdf__type mesh__D015620sskos__Concept
% 208.06/208.21  |- mesh__historyNote mesh__D015620 90   
% 208.06/208.21  |- mesh__recordOriginator mesh__D015620 AGS
% 208.06/208.21  |- skos__hiddenLabel mesh__D015620 Disorders, Malignant Histiocytic
% 208.06/208.21  |- skos__broader mesh__D015620smesh__D015614
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D015620 2003
% 208.06/208.21  |- skos__broader mesh__D015620smesh__D009370
% 208.06/208.21  |- skos__hiddenLabel mesh__D015620 Malignant Histiocytic Disorders
% 208.06/208.21  |- mesh__recordMaintainer mesh__D015620 KEV
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D015620 2001
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D015620 1997
% 208.06/208.21  |- mesh__dateCreated mesh__D015620 1989-06-20
% 208.06/208.21  |- mesh__publicMeSHNote mesh__D015620 90   
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D015620 2006
% 208.06/208.21  |- skos__scopeNote mesh__D015620
% 208.06/208.21       Distinctive neoplastic disorders of histiocytes. Included are acute monocytic leukemias, malignant histiocytosis %28%HISTIOCYTOSIS, MALIGNANT%29%, and true histiocytic lymphomas.%A%    
% 208.06/208.21  |- skos__prefLabel mesh__D001600 Berberine Alkaloids
% 208.06/208.21  |- mesh__dateEstablished mesh__D001600 1969-01-01
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D001600 2005
% 208.06/208.21  |- mesh__historyNote mesh__D001600 2001%28%1969%29%   
% 208.06/208.21  |- skos__broader mesh__D001600smesh__D006576
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D001600 2002
% 208.06/208.21  |- skos__broader mesh__D001600smesh__D000470
% 208.06/208.21  |- mesh__recordOriginator mesh__D001600 NLM
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D001600 2006
% 208.06/208.21  |- skos__scopeNote mesh__D001600
% 208.06/208.21       A group of related plant alkaloids that contain the BERBERINE heterocyclic ring structure.%A%    
% 208.06/208.21  |- skos__historyNote mesh__D001600 Alkaloids %28%1966-1968%29%
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D001600 2003
% 208.06/208.21  |- skos__hiddenLabel mesh__D001600 Alkaloids, Berberine
% 208.06/208.21  |- mesh__recordMaintainer mesh__D001600 jmp
% 208.06/208.21  |- mesh__publicMeSHNote mesh__D001600 2001; see BERBINES 1969-2000   
% 208.06/208.21  |- rdf__type mesh__D001600sskos__Concept
% 208.06/208.21  |- mesh__recordAuthorizer mesh__D001600 sjn
% 208.06/208.21  |- skos__altLabel mesh__D001600 Berbines
% 208.06/208.21  |- mesh__dateRevised mesh__D001600 2000-06-21
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D001600 2004
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D001600 2001
% 208.06/208.21  |- mesh__dateCreated mesh__D001600 1999-01-01
% 208.06/208.21  |- mesh__recordMaintainer mesh__D006894 lkt
% 208.06/208.21  |- mesh__dateEstablished mesh__D006894 1991-01-01
% 208.06/208.21  |- mesh__publicMeSHNote mesh__D006894 91; was see under ESTRONE 1977-90   
% 208.06/208.21  |- skos__scopeNote mesh__D006894
% 208.06/208.21       Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.%A%    
% 208.06/208.21  |- mesh__recordAuthorizer mesh__D006894 sjn
% 208.06/208.21  |- skos__historyNote mesh__D006894 Hydroxysteroids %28%1972-1975%29%
% 208.06/208.21  |- mesh__historyNote mesh__D006894
% 208.06/208.21       91%28%77%29%; was see under ESTRONE 1977-90   
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D006894 2005
% 208.06/208.21  |- rdf__type mesh__D006894sskos__Concept
% 208.06/208.21  |- skos__historyNote mesh__D006894 Estrone %28%1972-1976%29%
% 208.06/208.21  |- skos__broader mesh__D006894smesh__D002393
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D006894 2006
% 208.06/208.21  |- skos__broader mesh__D006894smesh__D004970
% 208.06/208.21  |- mesh__dateRevised mesh__D006894 2003-07-09
% 208.06/208.21  |- mesh__dateCreated mesh__D006894 1976-04-27
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D006894 2004
% 208.06/208.21  |- mesh__recordOriginator mesh__D006894 RLS
% 208.06/208.21  |- skos__prefLabel mesh__D006894 Hydroxyestrones
% 208.06/208.21  |- mesh__dateCreated mesh__D020565 1999-11-03
% 208.06/208.21  |- mesh__recordAuthorizer mesh__D020565 sjn
% 208.06/208.21  |- mesh__dateEstablished mesh__D020565 2000-01-01
% 208.06/208.21  |- skos__prefLabel mesh__D020565 Epsilonproteobacteria
% 208.06/208.21  |- skos__scopeNote mesh__D020565
% 208.06/208.21       A group of proteobacteria consisting of chemoorganotrophs usually associated with the DIGESTIVE SYSTEM of humans and animals.%A%    
% 208.06/208.21  |- skos__altLabel mesh__D020565 epsilon Proteobacteria
% 208.06/208.21  |- rdf__type mesh__D020565sskos__Concept
% 208.06/208.21  |- skos__broader mesh__D020565smesh__D020560
% 208.06/208.21  |- mesh__recordMaintainer mesh__D020565 SYSTEM
% 208.06/208.21  |- skos__altLabel mesh__D020565 Proteobacteria epsilon
% 208.06/208.21  |- mesh__historyNote mesh__D020565 2004 %28%2000%29%   
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D020565 2006
% 208.06/208.21  |- mesh__recordOriginator mesh__D020565 ndw
% 208.06/208.21  |- skos__annotation mesh__D020565 DF: EPSILONPROTEOBACT   
% 208.06/208.21  |- mesh__publicMeSHNote mesh__D020565
% 208.06/208.21       2004; see episilon Proteobacteria 2000-2004   
% 208.06/208.21  |- skos__historyNote mesh__D020565
% 208.06/208.21       Bacteria/classification %28%1994-1999%29%
% 208.06/208.21  |- mesh__dateRevised mesh__D020565 2005-06-30
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D006096 2006
% 208.06/208.21  |- skos__altLabel mesh__D006096 Gramicidins
% 208.06/208.21  |- mesh__dateEstablished mesh__D006096 1974-01-01
% 208.06/208.21  |- skos__hiddenLabel mesh__D006096 Gramicidin, Linear
% 208.06/208.21  |- skos__broader mesh__D006096smesh__D014449
% 208.06/208.21  |- mesh__publicMeSHNote mesh__D006096
% 208.06/208.21       96; was GRAMICIDINS 1963-95 %28%see under TYROTHRICIN 1963-73%29%%A%  
% 208.06/208.21  |- mesh__dateCreated mesh__D006096 1999-01-01
% 208.06/208.21  |- rdf__type mesh__D006096sskos__Concept
% 208.06/208.21  |- mesh__historyNote mesh__D006096
% 208.06/208.21       96; was GRAMICIDINS 1963-95 %28%see under TYROTHRICIN 1963-73%29%%A%  
% 208.06/208.21  |- skos__prefLabel mesh__D006096 Gramicidin
% 208.06/208.21  |- skos__altLabel mesh__D006096 Gramicidin Dubos
% 208.06/208.21  |- mesh__recordMaintainer mesh__D006096 ags
% 208.06/208.21  |- skos__altLabel mesh__D006096 Gramicidin D
% 208.06/208.21  |- mesh__onlineNote mesh__D006096 search TYROTHRICIN 1966-73   
% 208.06/208.21  |- mesh__recordOriginator mesh__D006096 NLM
% 208.06/208.21  |- mesh__dateRevised mesh__D006096 2005-07-22
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D006096 2005
% 208.06/208.21  |- mesh__recordAuthorizer mesh__D006096 ags
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D006096 2004
% 208.06/208.21  |- skos__scopeNote mesh__D006096
% 208.06/208.21       A group of peptide antibiotics from BACILLUS brevis. Gramicidin C or S is a cyclic, ten-amino acid polypeptide and gramicidins A, B, D are linear. Gramicidin is one of the two principal components of TYROTHRICIN which is used topically for gram-positive organisms. It is toxic to blood, liver, kidneys, meninges, and the olfactory apparatus.%A%    
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D006096 2006A
% 208.06/208.21  |- skos__scopeNote mesh__D014528
% 208.06/208.21       Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma.%A%    
% 208.06/208.21  |- mesh__dateCreated mesh__D014528 1999-01-01
% 208.06/208.21  |- rdf__type mesh__D014528sskos__Concept
% 208.06/208.21  |- skos__broader mesh__D014528smesh__D006074
% 208.06/208.21  |- mesh__recordMaintainer mesh__D014528 ssb
% 208.06/208.21  |- mesh__dateRevised mesh__D014528 2005-06-30
% 208.06/208.21  |- skos__prefLabel mesh__D014528 Uricosuric Agents
% 208.06/208.21  |- mesh__historyNote mesh__D014528 64   
% 208.06/208.21  |- mesh__dateEstablished mesh__D014528 1964-01-01
% 208.06/208.21  |- mesh__recordAuthorizer mesh__D014528 sjn
% 208.06/208.21  |- skos__hiddenLabel mesh__D014528 Agents, Uricosuric
% 208.06/208.21  |- mesh__publicMeSHNote mesh__D014528 64   
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D014528 2006
% 208.06/208.21  |- mesh__recordOriginator mesh__D014528 NLM
% 208.06/208.21  |- skos__broader mesh__D014528smesh__D012076
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D019213 2003
% 208.06/208.21  |- skos__hiddenLabel mesh__D019213 Rubulaviruses
% 208.06/208.21  |- skos__prefLabel mesh__D019213 Rubulavirus
% 208.06/208.21  |- mesh__dateEstablished mesh__D019213 1997-01-01
% 208.06/208.21  |- mesh__historyNote mesh__D019213 1997   
% 208.06/208.21  |- mesh__recordAuthorizer mesh__D019213 sjn
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D019213 2006
% 208.06/208.21  |- mesh__dateCreated mesh__D019213 1996-06-10
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D019213 2002
% 208.06/208.21  |- rdf__type mesh__D019213sskos__Concept
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D019213 2005
% 208.06/208.21  |- mesh__dateRevised mesh__D019213 2001-07-25
% 208.06/208.21  |- mesh__recordOriginator mesh__D019213 AGS
% 208.06/208.21  |- skos__broader mesh__D019213smesh__D018098
% 208.06/208.21  |- mesh__activeMeSHYear mesh__D019213 2004
% 208.06/208.21  |- mesh__publicMeSHNote mesh__D019213 1997   
% 208.06/208.21  |- skos__scopeNote mesh__D019213
% 208.06/208.21       A genus of the family PARAMYXOVIRIDAE %28%subfamily PARAMYXOVIRINAE%29% where all the species have hemagglutinin and neuraminidase activities but lack a C protein. MUMPS VIRUS is the type species.%A%    
% 208.06/208.21  |- skos__annotation mesh__D019213
% 208.06/208.21       do not confuse with RUBELLA VIRUS, a rubivirus; infection = RUBULAVIRUS INFECTIONS%A%  
% 208.06/208.21  |- mesh__recordMaintainer mesh__D019213 ags
% 208.06/208.21  |- skos__scopeNote mesh__D000508
% 208.06/208.21       A genus of the subfamily ALOUATTINAE, family CEBIDAE, composed of six species. They are A. belzebul %28%black and red howler%29%, A. caraya %28%black howler%29%, A. fusca %28%brown howler%29%, A. palliata %28%mantled howler%29%, A. seniculus %28%red howler%29%, and A. villosa %28%also known as A. pigra; Guatemalan howler%29%. They inhabit the forests of Central and South America. Howlers travel in groups and define their territories by howling accompanied by vigorously shaking and breaking branches.%A%    
% 208.06/208.21  |- mesh__recordMaintainer mesh__D000508 ags
% 208.06/208.21  |- rdf__type mesh__D000508sskos__Concept
% 208.06/208.22  |- mesh__publicMeSHNote mesh__D000508
% 208.06/208.22       91; was see under CEBIDAE 1981-90; was HOWLER MONKEYS see under MONKEYS 1975-80%A%  
% 208.06/208.22  |- mesh__onlineNote mesh__D000508
% 208.06/208.22       use ALOUATTA to search HOWLER MONKEYS 1975-80   
% 208.06/208.22  |- mesh__recordOriginator mesh__D000508 NLM
% 208.06/208.22  |- skos__altLabel mesh__D000508 Howler Monkeys
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D000508 2006
% 208.06/208.22  |- skos__hiddenLabel mesh__D000508 Alouattas
% 208.06/208.22  |- skos__hiddenLabel mesh__D000508 Monkeys, Howler
% 208.06/208.22  |- skos__altLabel mesh__D000508 Monkey, Howler
% 208.06/208.22  |- skos__prefLabel mesh__D000508 Alouatta
% 208.06/208.22  |- mesh__dateCreated mesh__D000508 1974-11-11
% 208.06/208.22  |- mesh__recordAuthorizer mesh__D000508 sjn
% 208.06/208.22  |- mesh__dateEstablished mesh__D000508 1991-01-01
% 208.06/208.22  |- skos__broader mesh__D000508smesh__D016661
% 208.06/208.22  |- skos__hiddenLabel mesh__D000508 Howler Monkey
% 208.06/208.22  |- skos__annotation mesh__D000508
% 208.06/208.22       New World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 208.06/208.22  |- mesh__dateRevised mesh__D000508 2005-06-30
% 208.06/208.22  |- mesh__historyNote mesh__D000508
% 208.06/208.22       91%28%81%29%; was see under CEBIDAE 1981-90; was HOWLER MONKEYS see under MONKEYS 1975-80%A%  
% 208.06/208.22  |- skos__hiddenLabel mesh__D011230 Conditions, Precancerous
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D011230 2000
% 208.06/208.22  |- rdf__type mesh__D011230sskos__Concept
% 208.06/208.22  |- skos__hiddenLabel mesh__D011230 Precancerous Condition
% 208.06/208.22  |- skos__altLabel mesh__D011230 Preneoplastic Conditions
% 208.06/208.22  |- mesh__dateEstablished mesh__D011230 1968-01-01
% 208.06/208.22  |- skos__scopeNote mesh__D011230
% 208.06/208.22       Pathological processes that tend eventually to become malignant. %28%From Dorland, 27th ed%29%%A%    
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D011230 1997
% 208.06/208.22  |- skos__hiddenLabel mesh__D011230 Condition, Precancerous
% 208.06/208.22  |- mesh__dateCreated mesh__D011230 1999-01-01
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D011230 2004
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D011230 2002
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D011230 1996
% 208.06/208.22  |- mesh__historyNote mesh__D011230 68   
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D011230 2003
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D011230 1999
% 208.06/208.22  |- mesh__publicMeSHNote mesh__D011230 68   
% 208.06/208.22  |- skos__prefLabel mesh__D011230 Precancerous Conditions
% 208.06/208.22  |- skos__altLabel mesh__D011230 Conditions, Preneoplastic
% 208.06/208.22  |- mesh__recordMaintainer mesh__D011230 KEV
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D011230 2006
% 208.06/208.22  |- mesh__dateRevised mesh__D011230 1995-05-24
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D011230 1998
% 208.06/208.22  |- skos__annotation mesh__D011230
% 208.06/208.22       IM; do not use /compl for develop into cancer: use /pathol; coord IM with organ/neopl term %28%IM%29%; Manual 24.4.1.13%A%  
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D011230 2001
% 208.06/208.22  |- skos__broader mesh__D011230smesh__D009369
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D011230 2005
% 208.06/208.22  |- mesh__recordAuthorizer mesh__D011230 PLS
% 208.06/208.22  |- skos__altLabel mesh__D011230 Preneoplastic Condition
% 208.06/208.22  |- mesh__recordOriginator mesh__D011230 NLM
% 208.06/208.22  |- skos__broader mesh__D014803Q000172smesh__D014803
% 208.06/208.22  |- mesh__preferredCombination mesh__D014803Q000172smesh__D014804
% 208.06/208.22  |- rdf__type mesh__D014803Q000172smesh__CompoundConcept
% 208.06/208.22  |- mesh__recordMaintainer mesh__D018919 lkt
% 208.06/208.22  |- skos__altLabel mesh__D018919 Angiogenesis, Physiologic
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D018919 2006
% 208.06/208.22  |- mesh__recordOriginator mesh__D018919 TGC
% 208.06/208.22  |- skos__altLabel mesh__D018919 Physiologic Angiogenesis
% 208.06/208.22  |- skos__hiddenLabel mesh__D018919 Physiological Neovascularization
% 208.06/208.22  |- skos__annotation mesh__D018919
% 208.06/208.22       do not confuse with NEOVASCULARIZATION, PATHOLOGIC; coord IM or NIM with organ /blood supply %28%IM%29%; do not confuse with COLLATERAL CIRCULATION: physiol neovasc is formation of new blood vessels in tissue, collat circ is circ through secondary channels after obstruct of principal vessel supplying a part; DF: NEOVASC PHYSIOL%A%  
% 208.06/208.22  |- mesh__dateRevised mesh__D018919 2004-07-07
% 208.06/208.22  |- skos__altLabel mesh__D018919 Angiogenesis, Physiological
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D018919 2005
% 208.06/208.22  |- skos__altLabel mesh__D018919 Physiologic Neovascularization
% 208.06/208.22  |- mesh__recordAuthorizer mesh__D018919 sjn
% 208.06/208.22  |- mesh__dateEstablished mesh__D018919 1996-01-01
% 208.06/208.22  |- skos__related mesh__D018919smesh__D003097
% 208.06/208.22  |- skos__prefLabel mesh__D018919 Neovascularization, Physiologic
% 208.06/208.22  |- mesh__dateCreated mesh__D018919 1995-01-06
% 208.06/208.22  |- skos__broader mesh__D018919smesh__D045125
% 208.06/208.22  |- skos__altLabel mesh__D018919 Neovascularization, Physiological
% 208.06/208.22  |- skos__scopeNote mesh__D018919
% 208.06/208.22       The development of new BLOOD VESSELS in restoration of BLOOD CIRCULATION during the healing process.%A%    
% 208.06/208.22  |- skos__related mesh__D018919smesh__D009389
% 208.06/208.22  |- mesh__historyNote mesh__D018919 96   
% 208.06/208.22  |- skos__hiddenLabel mesh__D018919 Physiological Angiogenesis
% 208.06/208.22  |- mesh__publicMeSHNote mesh__D018919 96   
% 208.06/208.22  |- rdf__type mesh__D018919sskos__Concept
% 208.06/208.22  |- skos__hiddenLabel mesh__D010936 Extracts, Plant
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D010936 2006
% 208.06/208.22  |- mesh__dateEstablished mesh__D010936 1976-01-01
% 208.06/208.22  |- skos__broader mesh__D010936smesh__D028321
% 208.06/208.22  |- skos__annotation mesh__D010936
% 208.06/208.22       IM GEN only; NIM when specific plant term is IM; /ther use: coord with disease /drug ther, not /ther; extracts of medicinal plants in Chinese med = PLANT EXTRACTS, CHINESE see DRUGS, CHINESE HERBAL: TN J%A%  
% 208.06/208.22  |- mesh__publicMeSHNote mesh__D010936 76; was see under PLANTS 1975   
% 208.06/208.22  |- mesh__recordMaintainer mesh__D010936 ssb
% 208.06/208.22  |- skos__prefLabel mesh__D010936 Plant Extracts
% 208.06/208.22  |- mesh__dateRevised mesh__D010936 2005-06-30
% 208.06/208.22  |- mesh__dateCreated mesh__D010936 1999-01-01
% 208.06/208.22  |- skos__related mesh__D010936smesh__D008517
% 208.06/208.22  |- skos__broader mesh__D010936smesh__D004364
% 208.06/208.22  |- mesh__recordAuthorizer mesh__D010936 sjn
% 208.06/208.22  |- mesh__recordOriginator mesh__D010936 NLM
% 208.06/208.22  |- rdf__type mesh__D010936sskos__Concept
% 208.06/208.22  |- skos__historyNote mesh__D010936 Plants %28%1966%29%
% 208.06/208.22  |- mesh__historyNote mesh__D010936
% 208.06/208.22       76%28%67%29%; was see under PLANTS 1975   
% 208.06/208.22  |- skos__scopeNote mesh__D010936
% 208.06/208.22       Concentrated pharmaceutical preparations of plants obtained by removing  active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard.%A%    
% 208.06/208.22  |- skos__prefLabel mesh__D029641 Simaroubaceae
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D029641 2006
% 208.06/208.22  |- skos__broader mesh__D029641smesh__D019684
% 208.06/208.22  |- rdf__type mesh__D029641sskos__Concept
% 208.06/208.22  |- skos__scopeNote mesh__D029641
% 208.06/208.22       A plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida. Leaves are alternate and compound. Most have small flowers, bitter bark, and fleshy fruits that are sometimes winged. Members contain QUASSINS.%A%    
% 208.06/208.22  |- skos__annotation mesh__D029641
% 208.06/208.22       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.22  |- mesh__recordMaintainer mesh__D029641 ssb
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D029641 2005
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D029641 2004
% 208.06/208.22  |- mesh__recordAuthorizer mesh__D029641 sjn
% 208.06/208.22  |- mesh__dateRevised mesh__D029641 2003-07-09
% 208.06/208.22  |- mesh__recordOriginator mesh__D029641 ssb
% 208.06/208.22  |- mesh__dateCreated mesh__D029641 2001-07-25
% 208.06/208.22  |- mesh__historyNote mesh__D029641 2002   
% 208.06/208.22  |- mesh__publicMeSHNote mesh__D029641 2002   
% 208.06/208.22  |- mesh__dateEstablished mesh__D029641 2002-01-01
% 208.06/208.22  |- skos__hiddenLabel mesh__D010138 Cardiac Pacemakers, Artificial
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D010138 2001
% 208.06/208.22  |- skos__hiddenLabel mesh__D010138 Pacemakers, Artificial Cardiac
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D010138 2003
% 208.06/208.22  |- skos__broader mesh__D010138smesh__D001187
% 208.06/208.22  |- skos__hiddenLabel mesh__D010138 Artificial Cardiac Pacemaker
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D010138 2000
% 208.06/208.22  |- mesh__dateRevised mesh__D010138 1997-06-20
% 208.06/208.22  |- skos__scopeNote mesh__D010138
% 208.06/208.22       A device designed to stimulate, by electric impulses, contraction of the heart muscles. It may be temporary %28%external%29% or permanent %28%internal or internal-external%29%.%A%    
% 208.06/208.22  |- skos__hiddenLabel mesh__D010138 Artificial Pacemakers
% 208.06/208.22  |- skos__hiddenLabel mesh__D010138 Artificial Pacemaker
% 208.06/208.22  |- skos__hiddenLabel mesh__D010138 Artificial Cardiac Pacemakers
% 208.06/208.22  |- skos__prefLabel mesh__D010138 Pacemaker, Artificial
% 208.06/208.22  |- mesh__dateCreated mesh__D010138 1999-01-01
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D010138 1999
% 208.06/208.22  |- skos__hiddenLabel mesh__D010138 Pacemaker, Artificial Cardiac
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D010138 2006
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D010138 1998
% 208.06/208.22  |- rdf__type mesh__D010138sskos__Concept
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D010138 2005
% 208.06/208.22  |- mesh__recordAuthorizer mesh__D010138 SJN
% 208.06/208.22  |- skos__altLabel mesh__D010138 Cardiac Pacemaker, Artificial
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D010138 2002
% 208.06/208.22  |- skos__annotation mesh__D010138
% 208.06/208.22       may be temporary %28%external%29% or permanent %28%internal or internal-external%29%; coord dis with /ther, not /surg for treatment with pacemaker%A%  
% 208.06/208.22  |- mesh__recordOriginator mesh__D010138 NLM
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D010138 2004
% 208.06/208.22  |- skos__hiddenLabel mesh__D010138 Pacemakers, Artificial
% 208.06/208.22  |- mesh__recordMaintainer mesh__D010138 PXP
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D001601 2002
% 208.06/208.22  |- mesh__recordAuthorizer mesh__D001601 PLS
% 208.06/208.22  |- mesh__publicMeSHNote mesh__D001601 88   
% 208.06/208.22  |- mesh__dateRevised mesh__D001601 1991-06-20
% 208.06/208.22  |- skos__annotation mesh__D001601 human %26% animal; no qualif   
% 208.06/208.22  |- skos__hiddenLabel mesh__D001601 Bereavements
% 208.06/208.22  |- mesh__dateEstablished mesh__D001601 1988-01-01
% 208.06/208.22  |- mesh__recordMaintainer mesh__D001601 TGC
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D001601 1995
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D001601 1993
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D001601 2001
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D001601 1999
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D001601 1994
% 208.06/208.22  |- skos__scopeNote mesh__D001601
% 208.06/208.22       Refers to the whole process of grieving and mourning and is associated with a deep sense of loss and sadness.%A%    
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D001601 1997
% 208.06/208.22  |- skos__related mesh__D001601smesh__D006117
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D001601 1992
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D001601 2006
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D001601 2000
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D001601 1998
% 208.06/208.22  |- mesh__dateCreated mesh__D001601 1987-03-14
% 208.06/208.22  |- skos__historyNote mesh__D001601 Grief %28%1968-1987%29%
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D001601 2004
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D001601 1996
% 208.06/208.22  |- rdf__type mesh__D001601sskos__Concept
% 208.06/208.22  |- skos__prefLabel mesh__D001601 Bereavement
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D001601 2005
% 208.06/208.22  |- mesh__recordOriginator mesh__D001601 EC
% 208.06/208.22  |- skos__broader mesh__D001601smesh__D004644
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D001601 2003
% 208.06/208.22  |- mesh__historyNote mesh__D001601 88   
% 208.06/208.22  |- skos__historyNote mesh__D006895 Alcohol, Ethyl %28%1971-1974%29%
% 208.06/208.22  |- skos__altLabel mesh__D006895 Fresenius Brand of Pentastarch
% 208.06/208.22  |- skos__broader mesh__D006895smesh__D013213
% 208.06/208.22  |- mesh__dateCreated mesh__D006895 1974-11-19
% 208.06/208.22  |- skos__altLabel mesh__D006895 Hydroxyethyl Starch
% 208.06/208.22  |- rdf__type mesh__D006895sskos__Concept
% 208.06/208.22  |- mesh__recordMaintainer mesh__D006895 lkw
% 208.06/208.22  |- skos__historyNote mesh__D006895 Starch %28%1971-1974%29%
% 208.06/208.22  |- mesh__historyNote mesh__D006895
% 208.06/208.22       96; was HYDROXYETHYL STARCH 1975-95 %28%see under STARCH 1975-90%29%%A%  
% 208.06/208.22  |- skos__altLabel mesh__D006895 Pentastarch
% 208.06/208.22  |- mesh__dateRevised mesh__D006895 2005-06-30
% 208.06/208.22  |- skos__hiddenLabel mesh__D006895 Starch, Hydroxyethyl
% 208.06/208.22  |- mesh__publicMeSHNote mesh__D006895
% 208.06/208.22       96; was HYDROXYETHYL STARCH 1975-95 %28%see under STARCH 1975-90%29%%A%  
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D006895 2006
% 208.06/208.22  |- mesh__recordAuthorizer mesh__D006895 sjn
% 208.06/208.22  |- mesh__recordOriginator mesh__D006895 NLM
% 208.06/208.22  |- skos__altLabel mesh__D006895 Braun Brand of Pentastarch
% 208.06/208.22  |- skos__prefLabel mesh__D006895 Hetastarch
% 208.06/208.22  |- skos__scopeNote mesh__D006895
% 208.06/208.22       A derivative of STARCH used as a plasma substitute in the treatment of hemorrhage.%A%    
% 208.06/208.22  |- mesh__dateEstablished mesh__D006895 1991-01-01
% 208.06/208.22  |- skos__altLabel mesh__D006895 Bristol-Myers Squibb Brand of Pentastarch
% 208.06/208.22  |- skos__altLabel mesh__D006895
% 208.06/208.22       Rh%C3%%B4%ne-Poulenc Rorer Brand of Pentastarch
% 208.06/208.22  |- skos__broader mesh__D020566smesh__D000938
% 208.06/208.22  |- skos__hiddenLabel mesh__D020566 Dendritic Cell, Follicular
% 208.06/208.22  |- skos__scopeNote mesh__D020566
% 208.06/208.22       Cells with extensive dendritic processes found in the B-cell areas %28%primary follicles and germinal centers%29% of lymphoid tissue. They are unrelated to the DENDRITIC CELLS associated with T-cells. Follicular dendritic cells have Fc receptors %28%RECEPTORS, FC%29% and C3b receptors %28%RECEPTORS, COMPLEMENT 3B%29%, but unlike other dendritic cells, they do not process or present antigen in a way that allows recognition by T-cells. Instead, they hold antigen in the form of immune complexes on their surfaces for long periods and can present antigen to B-cells during an immune response. %28%From Herbert et al., Dictionary of Immunology, 4th ed%29%%A%    
% 208.06/208.22  |- mesh__recordOriginator mesh__D020566 ags
% 208.06/208.22  |- skos__hiddenLabel mesh__D020566 Follicular Dendritic Cell
% 208.06/208.22  |- skos__broader mesh__D020566smesh__D018858
% 208.06/208.22  |- mesh__dateRevised mesh__D020566 2003-07-09
% 208.06/208.22  |- skos__altLabel mesh__D020566 Follicular Dendritic Cells
% 208.06/208.22  |- mesh__publicMeSHNote mesh__D020566
% 208.06/208.22       2000; see DENDRITIC CELLS 1987-1999   
% 208.06/208.22  |- mesh__recordAuthorizer mesh__D020566 sjn
% 208.06/208.22  |- skos__historyNote mesh__D020566 Lymph Nodes %28%1980-1986%29%
% 208.06/208.22  |- skos__prefLabel mesh__D020566 Dendritic Cells, Follicular
% 208.06/208.22  |- mesh__historyNote mesh__D020566 2000; use  DENDRITIC CELLS 1987-1999   
% 208.06/208.22  |- mesh__dateEstablished mesh__D020566 2000-01-01
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D020566 2005
% 208.06/208.22  |- skos__annotation mesh__D020566 DENDRITIC CELLS is also available   
% 208.06/208.22  |- mesh__dateCreated mesh__D020566 1999-11-03
% 208.06/208.22  |- rdf__type mesh__D020566sskos__Concept
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D020566 2006
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D020566 2004
% 208.06/208.22  |- skos__historyNote mesh__D020566 Dendritic Cells %28%1987-1999%29%
% 208.06/208.22  |- mesh__recordMaintainer mesh__D020566 jmp
% 208.06/208.22  |- mesh__recordMaintainer mesh__D006097 KEV
% 208.06/208.22  |- mesh__dateCreated mesh__D006097 1999-01-01
% 208.06/208.22  |- skos__hiddenLabel mesh__D006097 Tissue, Granulation
% 208.06/208.22  |- rdf__type mesh__D006097sskos__Concept
% 208.06/208.22  |- mesh__dateRevised mesh__D006097 2002-07-03
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D006097 2003
% 208.06/208.22  |- skos__broader mesh__D006097smesh__D003238
% 208.06/208.22  |- skos__prefLabel mesh__D006097 Granulation Tissue
% 208.06/208.22  |- skos__hiddenLabel mesh__D006097 Tissues, Granulation
% 208.06/208.22  |- skos__hiddenLabel mesh__D006097 Granulation Tissues
% 208.06/208.22  |- mesh__recordAuthorizer mesh__D006097 sjn
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D006097 2004
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D006097 2005
% 208.06/208.22  |- skos__scopeNote mesh__D006097
% 208.06/208.22       A vascular connective tissue formed on the surface of a healing wound, ulcer, or inflamed tissue. It consists of new capillaries and an infiltrate containing lymphoid cells, macrophages, and plasma cells.%A%    
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D006097 2006
% 208.06/208.22  |- mesh__recordOriginator mesh__D006097 NLM
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D014529 1991
% 208.06/208.22  |- mesh__recordAuthorizer mesh__D014529 NLM
% 208.06/208.22  |- skos__broader mesh__D014529smesh__D011741
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D014529 1995
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D014529 2002
% 208.06/208.22  |- skos__altLabel mesh__D014529 Allo-Uridine
% 208.06/208.22  |- mesh__recordOriginator mesh__D014529 NLM
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D014529 1999
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D014529 2006
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D014529 1994
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D014529 2001
% 208.06/208.22  |- skos__broader mesh__D014529smesh__D012263
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D014529 1993
% 208.06/208.22  |- skos__prefLabel mesh__D014529 Uridine
% 208.06/208.22  |- mesh__publicMeSHNote mesh__D014529
% 208.06/208.22       66; was see under NUCLEOSIDES 1963-65; ARABINOFURANOSYLURACIL was see under PYRIMIDINE NUCLEOSIDES 1976-77%A%  
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D014529 2000
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D014529 1998
% 208.06/208.22  |- mesh__dateEstablished mesh__D014529 1966-01-01
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D014529 2005
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D014529 1997
% 208.06/208.22  |- mesh__recordMaintainer mesh__D014529 PLS
% 208.06/208.22  |- mesh__dateCreated mesh__D014529 1999-01-01
% 208.06/208.22  |- skos__annotation mesh__D014529 /biosyn /physiol permitted   
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D014529 2004
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D014529 1992
% 208.06/208.22  |- skos__hiddenLabel mesh__D014529 Allo Uridine
% 208.06/208.22  |- rdf__type mesh__D014529sskos__Concept
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D014529 1996
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D014529 2003
% 208.06/208.22  |- mesh__dateRevised mesh__D014529 1990-05-30
% 208.06/208.22  |- mesh__historyNote mesh__D014529
% 208.06/208.22       66%28%64%29%; was see under NUCLEOSIDES 1963-65   
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D019214 1997
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D019214 2000
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D019214 2006
% 208.06/208.22  |- skos__broader mesh__D019214smesh__D005882
% 208.06/208.22  |- skos__hiddenLabel mesh__D019214 Overgrowth, Gingival
% 208.06/208.22  |- rdf__type mesh__D019214sskos__Concept
% 208.06/208.22  |- skos__historyNote mesh__D019214 Gingival Hypertrophy %28%1992-1996%29%
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D019214 2005
% 208.06/208.22  |- skos__hiddenLabel mesh__D019214 Gingival Overgrowths
% 208.06/208.22  |- mesh__dateEstablished mesh__D019214 1997-01-01
% 208.06/208.22  |- skos__hiddenLabel mesh__D019214 Overgrowths, Gingival
% 208.06/208.22  |- mesh__historyNote mesh__D019214 97   
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D019214 1999
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D019214 2004
% 208.06/208.22  |- skos__annotation mesh__D019214
% 208.06/208.22       GEN or unspecified; prefer GINGIVAL HYPERTROPHY or GINGIVAL HYPERPLASIA%A%  
% 208.06/208.22  |- mesh__dateCreated mesh__D019214 1996-06-10
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D019214 2002
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D019214 1998
% 208.06/208.22  |- skos__prefLabel mesh__D019214 Gingival Overgrowth
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D019214 2003
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D019214 2001
% 208.06/208.22  |- skos__scopeNote mesh__D019214
% 208.06/208.22       Excessive growth of the gingiva either by an increase in the size of the constituent cells %28%GINGIVAL HYPERTROPHY%29% or by an increase in their number %28%GINGIVAL HYPERPLASIA%29%. %28%From Jablonski%27%s Dictionary of Dentistry, 1992, p574%29%%A%    
% 208.06/208.22  |- skos__historyNote mesh__D019214 Gingival Hyperplasia %28%1978-1996%29%
% 208.06/208.22  |- mesh__publicMeSHNote mesh__D019214 97   
% 208.06/208.22  |- skos__scopeNote mesh__D000509
% 208.06/208.22       The first alpha-globulins to appear in mammalian sera during development of the embryo and the dominant serum proteins in early embryonic life. They reappear in the adult serum during certain pathologic states, primarily hepatocellular carcinoma. They may also be elevated in the amniotic fluid and maternal serum during pregnancy in ANENCEPHALY.%A%    
% 208.06/208.22  |- mesh__dateEstablished mesh__D000509 1977-01-01
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D000509 2006
% 208.06/208.22  |- skos__hiddenLabel mesh__D000509 alpha Fetoprotein
% 208.06/208.22  |- mesh__dateRevised mesh__D000509 2005-06-30
% 208.06/208.22  |- mesh__onlineNote mesh__D000509
% 208.06/208.22       use ALPHA-FETOPROTEINS to search ALPHA FETOPROTEINS 1975-95%A%  
% 208.06/208.22  |- mesh__historyNote mesh__D000509
% 208.06/208.22       96; was ALPHA FETOPROTEINS 1975-95 %28%see under FETAL GLOBULINS 1975-76%29%%A%  
% 208.06/208.22  |- skos__annotation mesh__D000509 /biosyn /physiol permitted   
% 208.06/208.22  |- skos__altLabel mesh__D000509 Fetuin
% 208.06/208.22  |- skos__prefLabel mesh__D000509 alpha-Fetoproteins
% 208.06/208.22  |- skos__broader mesh__D000509smesh__D014408
% 208.06/208.22  |- skos__historyNote mesh__D000509 Fetal Proteins %28%1970-1974%29%
% 208.06/208.22  |- mesh__dateCreated mesh__D000509 1974-11-11
% 208.06/208.22  |- skos__altLabel mesh__D000509 alpha-Fetoprotein
% 208.06/208.22  |- mesh__recordOriginator mesh__D000509 NLM
% 208.06/208.22  |- skos__hiddenLabel mesh__D000509 alpha Fetoproteins
% 208.06/208.22  |- skos__altLabel mesh__D000509 AFP
% 208.06/208.22  |- skos__altLabel mesh__D000509 Fetuins
% 208.06/208.22  |- mesh__publicMeSHNote mesh__D000509
% 208.06/208.22       96; was ALPHA FETOPROTEINS 1975-95 %28%see under FETAL GLOBULINS 1975-76%29%%A%  
% 208.06/208.22  |- skos__broader mesh__D000509smesh__D005326
% 208.06/208.22  |- mesh__recordAuthorizer mesh__D000509 sjn
% 208.06/208.22  |- rdf__type mesh__D000509sskos__Concept
% 208.06/208.22  |- skos__related mesh__D000509smesh__D000757
% 208.06/208.22  |- mesh__recordMaintainer mesh__D000509 ssb
% 208.06/208.22  |- skos__broader mesh__D011231smesh__D004493
% 208.06/208.22  |- skos__hiddenLabel mesh__D011231 Preceptorships
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D011231 2000
% 208.06/208.22  |- mesh__historyNote mesh__D011231 75   
% 208.06/208.22  |- skos__historyNote mesh__D011231 Education, Dental %28%1966-1974%29%
% 208.06/208.22  |- rdf__type mesh__D011231sskos__Concept
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D011231 2003
% 208.06/208.22  |- skos__prefLabel mesh__D011231 Preceptorship
% 208.06/208.22  |- mesh__dateRevised mesh__D011231 1999-11-03
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D011231 2001
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D011231 2004
% 208.06/208.22  |- mesh__recordOriginator mesh__D011231 NLM
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D011231 2002
% 208.06/208.22  |- skos__historyNote mesh__D011231 Education, Medical %28%1966-1974%29%
% 208.06/208.22  |- mesh__dateEstablished mesh__D011231 1975-09-01
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D011231 2005
% 208.06/208.22  |- mesh__recordAuthorizer mesh__D011231 sjn
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D011231 2006
% 208.06/208.22  |- mesh__publicMeSHNote mesh__D011231 75   
% 208.06/208.22  |- mesh__recordMaintainer mesh__D011231 jls
% 208.06/208.22  |- mesh__dateCreated mesh__D011231 1974-11-11
% 208.06/208.22  |- skos__scopeNote mesh__D011231
% 208.06/208.22       Practical experience in medical and health-related services that occurs as part of an educational program wherein the professionally-trained student works outside the academic environment under the supervision of an established professional in the particular field.%A%    
% 208.06/208.22  |- skos__hiddenLabel mesh__D010937 Hormones, Plant
% 208.06/208.22  |- mesh__recordOriginator mesh__D010937 NLM
% 208.06/208.22  |- mesh__recordAuthorizer mesh__D010937 sjn
% 208.06/208.22  |- skos__altLabel mesh__D010937 Plant Hormones
% 208.06/208.22  |- mesh__dateCreated mesh__D010937 1999-01-01
% 208.06/208.22  |- skos__annotation mesh__D010937 DF: PLANT GROWTH REG   
% 208.06/208.22  |- skos__scopeNote mesh__D010937
% 208.06/208.22       Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins.%A%    
% 208.06/208.22  |- skos__altLabel mesh__D010937 Regulators, Plant Growth
% 208.06/208.22  |- rdf__type mesh__D010937sskos__Concept
% 208.06/208.22  |- skos__prefLabel mesh__D010937 Plant Growth Regulators
% 208.06/208.22  |- skos__broader mesh__D010937smesh__D006133
% 208.06/208.22  |- skos__altLabel mesh__D010937 Growth Regulators, Plant
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D010937 2006
% 208.06/208.22  |- mesh__recordMaintainer mesh__D010937 ssb
% 208.06/208.22  |- skos__altLabel mesh__D010937 Phytohormones
% 208.06/208.22  |- mesh__dateRevised mesh__D010937 2005-06-30
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D029642 2005
% 208.06/208.22  |- mesh__historyNote mesh__D029642 2002   
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D029642 2003
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D029642 2006
% 208.06/208.22  |- rdf__type mesh__D029642sskos__Concept
% 208.06/208.22  |- mesh__dateEstablished mesh__D029642 2002-01-01
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D029642 2004
% 208.06/208.22  |- skos__broader mesh__D029642smesh__D019684
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D029642 2002
% 208.06/208.22  |- skos__scopeNote mesh__D029642
% 208.06/208.22       A plant family of the order Liliales, subclass Liliidae, class Liliopsida %28%monocotyledon%29%.%A%    
% 208.06/208.22  |- skos__prefLabel mesh__D029642 Smilacaceae
% 208.06/208.22  |- skos__annotation mesh__D029642
% 208.06/208.22       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.22  |- mesh__dateCreated mesh__D029642 2001-07-25
% 208.06/208.22  |- mesh__publicMeSHNote mesh__D029642 2002   
% 208.06/208.22  |- mesh__dateCreated mesh__D010139 1999-01-01
% 208.06/208.22  |- mesh__recordAuthorizer mesh__D010139 sjn
% 208.06/208.22  |- skos__annotation mesh__D010139
% 208.06/208.22       includes MELANESIA; MICRONESIA %26% POLYNESIA: see notes under each %26% indentions in trees%A%  
% 208.06/208.22  |- mesh__recordOriginator mesh__D010139 NLM
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D010139 2005
% 208.06/208.22  |- skos__prefLabel mesh__D010139 Pacific Islands
% 208.06/208.22  |- skos__broader mesh__D010139smesh__D005842
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D010139 2006
% 208.06/208.22  |- skos__broader mesh__D010139smesh__D044362
% 208.06/208.22  |- rdf__type mesh__D010139sskos__Concept
% 208.06/208.22  |- mesh__dateRevised mesh__D010139 2003-07-09
% 208.06/208.22  |- mesh__onlineNote mesh__D010139
% 208.06/208.22       use PACIFIC ISLANDS to search SOUTH PACIFIC ISLANDS 1967-77%A%  
% 208.06/208.22  |- mesh__recordMaintainer mesh__D010139 jls
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D010139 2004
% 208.06/208.22  |- skos__scopeNote mesh__D010139
% 208.06/208.22       The islands of the Pacific Ocean divided into MICRONESIA; MELANESIA; and POLYNESIA %28%including NEW ZEALAND%29%. The collective name Oceania includes the aforenamed islands, adding AUSTRALIA; NEW ZEALAND; and the Malay Archipelago %28%INDONESIA%29%. %28%Webster%27%s New Geographical Dictionary, 1988, p910, 880%29%%A%    
% 208.06/208.22  |- mesh__historyNote mesh__D010139 78; was SOUTH PACIFIC ISLANDS 1967-77   
% 208.06/208.22  |- skos__broader mesh__D007190smesh__D007211
% 208.06/208.22  |- skos__historyNote mesh__D007190 Diuretics, Sulfamyl %28%1974%29%
% 208.06/208.22  |- skos__hiddenLabel mesh__D007190 SE1520
% 208.06/208.22  |- skos__altLabel mesh__D007190 Metindamide
% 208.06/208.22  |- skos__hiddenLabel mesh__D007190 S 1520
% 208.06/208.22  |- skos__scopeNote mesh__D007190
% 208.06/208.22       A benzamide-sulfonamide-indole. It is called a thiazide-like diuretic but structure is different enough %28%lacking the thiazo-ring%29% so it is not clear that the mechanism is comparable.%A%    
% 208.06/208.22  |- skos__historyNote mesh__D007190 Indoles %28%1974%29%
% 208.06/208.22  |- skos__historyNote mesh__D007190 Benzamides %28%1974%29%
% 208.06/208.22  |- skos__hiddenLabel mesh__D007190 S1520
% 208.06/208.22  |- mesh__recordOriginator mesh__D007190 NLM
% 208.06/208.22  |- mesh__recordMaintainer mesh__D007190 ssb
% 208.06/208.22  |- mesh__publicMeSHNote mesh__D007190
% 208.06/208.22       91; was see under DIURETICS, SULFAMYL 1975-90   
% 208.06/208.22  |- mesh__dateCreated mesh__D007190 1974-11-19
% 208.06/208.22  |- mesh__activeMeSHYear mesh__D007190 2006
% 208.06/208.22  |- skos__hiddenLabel mesh__D007190 SE 1520
% 208.06/208.23  |- mesh__historyNote mesh__D007190
% 208.06/208.23       91%28%75%29%; was see under DIURETICS, SULFAMYL 1975-90   
% 208.06/208.23  |- mesh__dateRevised mesh__D007190 2005-06-30
% 208.06/208.23  |- mesh__dateEstablished mesh__D007190 1991-01-01
% 208.06/208.23  |- rdf__type mesh__D007190sskos__Concept
% 208.06/208.23  |- skos__prefLabel mesh__D007190 Indapamide
% 208.06/208.23  |- skos__altLabel mesh__D007190 SE-1520
% 208.06/208.23  |- skos__broader mesh__D007190smesh__D013449
% 208.06/208.23  |- mesh__recordAuthorizer mesh__D007190 sjn
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D015622 2004
% 208.06/208.23  |- rdf__type mesh__D015622sskos__Concept
% 208.06/208.23  |- skos__historyNote mesh__D015622 Epithelium %28%1966-1989%29%
% 208.06/208.23  |- mesh__historyNote mesh__D015622 90   
% 208.06/208.23  |- mesh__recordAuthorizer mesh__D015622 sjn
% 208.06/208.23  |- skos__prefLabel mesh__D015622 Epithelioid Cells
% 208.06/208.23  |- mesh__dateCreated mesh__D015622 1989-03-29
% 208.06/208.23  |- skos__related mesh__D015622smesh__D015726
% 208.06/208.23  |- mesh__recordOriginator mesh__D015622 AGS
% 208.06/208.23  |- skos__annotation mesh__D015622
% 208.06/208.23       a type of macrophage; A 11 qualif; do not confuse with EPITHELIAL CELLS%A%  
% 208.06/208.23  |- skos__historyNote mesh__D015622 Macrophages %28%1966-1989%29%
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D015622 2006
% 208.06/208.23  |- mesh__publicMeSHNote mesh__D015622 90   
% 208.06/208.23  |- skos__hiddenLabel mesh__D015622 Cell, Epithelioid
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D015622 2005
% 208.06/208.23  |- skos__broader mesh__D015622smesh__D008264
% 208.06/208.23  |- mesh__dateRevised mesh__D015622 2003-07-09
% 208.06/208.23  |- skos__hiddenLabel mesh__D015622 Epithelioid Cell
% 208.06/208.23  |- mesh__dateEstablished mesh__D015622 1990-01-01
% 208.06/208.23  |- mesh__recordMaintainer mesh__D015622 nns
% 208.06/208.23  |- skos__scopeNote mesh__D015622
% 208.06/208.23       Characteristic cells of granulomatous hypersensitivity. They appear as large, flattened cells with increased endoplasmic reticulum. They are believed to be activated macrophages that have differentiated as a result of prolonged antigenic stimulation. Further differentiation or fusion of epithelioid cells is thought to produce multinucleated giant cells %28%GIANT CELLS%29%.%A%    
% 208.06/208.23  |- skos__hiddenLabel mesh__D015622 Cells, Epithelioid
% 208.06/208.23  |- mesh__dateCreated mesh__D001602 1999-01-01
% 208.06/208.23  |- mesh__recordAuthorizer mesh__D001602 sjn
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D001602 2006
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D001602 2004
% 208.06/208.23  |- rdf__type mesh__D001602sskos__Concept
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D001602 2005
% 208.06/208.23  |- skos__broader mesh__D001602smesh__D013832
% 208.06/208.23  |- mesh__dateRevised mesh__D001602 2003-07-09
% 208.06/208.23  |- skos__annotation mesh__D001602 caused by THIAMINE DEFICIENCY   
% 208.06/208.23  |- mesh__recordMaintainer mesh__D001602 lkt
% 208.06/208.23  |- skos__prefLabel mesh__D001602 Beriberi
% 208.06/208.23  |- mesh__recordOriginator mesh__D001602 NLM
% 208.06/208.23  |- skos__scopeNote mesh__D001602
% 208.06/208.23       A disease caused by a deficiency of thiamine %28%vitamin B1%29% and characterized by polyneuritis, cardiac pathology, and edema. The epidemic form is found primarily in areas in which white %28%polished%29% rice is the staple food, as in Japan, China, the Philippines, India, and other countries of southeast Asia. %28%Dorland, 27th ed%29%%A%    
% 208.06/208.23  |- skos__prefLabel mesh__D006896 Hydroxyethylrutoside
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006896 2006
% 208.06/208.23  |- mesh__recordMaintainer mesh__D006896 ssb
% 208.06/208.23  |- mesh__recordOriginator mesh__D006896 NLM
% 208.06/208.23  |- mesh__publicMeSHNote mesh__D006896 91; was see under RUTIN 1975-90   
% 208.06/208.23  |- skos__historyNote mesh__D006896 Rutin %28%1972-1974%29%
% 208.06/208.23  |- skos__hiddenLabel mesh__D006896 beta Hydroxyethylrutoside
% 208.06/208.23  |- skos__hiddenLabel mesh__D006896 0 beta Hydroxyethylrutoside
% 208.06/208.23  |- mesh__dateCreated mesh__D006896 1974-11-19
% 208.06/208.23  |- skos__altLabel mesh__D006896 beta-Hydroxyethylrutoside
% 208.06/208.23  |- mesh__dateEstablished mesh__D006896 1991-01-01
% 208.06/208.23  |- skos__scopeNote mesh__D006896
% 208.06/208.23       Monohydroxyethyl derivative of rutin. Peripheral circulation stimulant used in treatment of venous disorders.%A%    
% 208.06/208.23  |- mesh__historyNote mesh__D006896
% 208.06/208.23       91%28%75%29%; was see under RUTIN 1975-90   
% 208.06/208.23  |- mesh__dateRevised mesh__D006896 2005-06-30
% 208.06/208.23  |- skos__historyNote mesh__D006896 Alcohol, Ethyl %28%1972-1974%29%
% 208.06/208.23  |- rdf__type mesh__D006896sskos__Concept
% 208.06/208.23  |- skos__altLabel mesh__D006896 0-beta-Hydroxyethylrutoside
% 208.06/208.23  |- mesh__recordAuthorizer mesh__D006896 sjn
% 208.06/208.23  |- skos__broader mesh__D006896smesh__D012431
% 208.06/208.23  |- skos__broader mesh__D020567smesh__D001835
% 208.06/208.23  |- skos__broader mesh__D020567smesh__D047109
% 208.06/208.23  |- mesh__historyNote mesh__D020567 2000   
% 208.06/208.23  |- skos__scopeNote mesh__D020567
% 208.06/208.23       The weight of the FETUS in utero. It is usually estimated by various formulas based on measurements made during PRENATAL ULTRASONOGRAPHY.%A%    
% 208.06/208.23  |- skos__historyNote mesh__D020567 Body Weight %28%1965-1999%29%
% 208.06/208.23  |- skos__related mesh__D020567smesh__D001724
% 208.06/208.23  |- skos__hiddenLabel mesh__D020567 Fetal Body Weights
% 208.06/208.23  |- mesh__recordMaintainer mesh__D020567 lkt
% 208.06/208.23  |- skos__hiddenLabel mesh__D020567 Body Weights, Fetal
% 208.06/208.23  |- mesh__dateEstablished mesh__D020567 2000-01-01
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D020567 2005
% 208.06/208.23  |- skos__altLabel mesh__D020567 Body Weight, Fetal
% 208.06/208.23  |- rdf__type mesh__D020567sskos__Concept
% 208.06/208.23  |- skos__hiddenLabel mesh__D020567 Weights, Fetal
% 208.06/208.23  |- mesh__recordOriginator mesh__D020567 ags
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D020567 2006
% 208.06/208.23  |- skos__prefLabel mesh__D020567 Fetal Weight
% 208.06/208.23  |- skos__hiddenLabel mesh__D020567 Fetal Weights
% 208.06/208.23  |- mesh__recordAuthorizer mesh__D020567 sjn
% 208.06/208.23  |- skos__hiddenLabel mesh__D020567 Fetal Body Weight
% 208.06/208.23  |- skos__hiddenLabel mesh__D020567 Weight, Fetal
% 208.06/208.23  |- skos__historyNote mesh__D020567 Fetus %28%1965-1999%29%
% 208.06/208.23  |- mesh__dateCreated mesh__D020567 1999-11-03
% 208.06/208.23  |- mesh__dateRevised mesh__D020567 2004-07-07
% 208.06/208.23  |- mesh__publicMeSHNote mesh__D020567 2000   
% 208.06/208.23  |- skos__annotation mesh__D020567 mammalian only   
% 208.06/208.23  |- skos__scopeNote mesh__D006098
% 208.06/208.23       Leukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS.%A%    
% 208.06/208.23  |- mesh__recordAuthorizer mesh__D006098 sjn
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006098 2006
% 208.06/208.23  |- skos__prefLabel mesh__D006098 Granulocytes
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006098 2005
% 208.06/208.23  |- mesh__recordOriginator mesh__D006098 NLM
% 208.06/208.23  |- mesh__onlineNote mesh__D006098 search LEUKOCYTES 1968-74   
% 208.06/208.23  |- skos__broader mesh__D006098smesh__D007962
% 208.06/208.23  |- skos__broader mesh__D006098smesh__D001854
% 208.06/208.23  |- rdf__type mesh__D006098sskos__Concept
% 208.06/208.23  |- mesh__dateCreated mesh__D006098 1999-01-01
% 208.06/208.23  |- mesh__dateRevised mesh__D006098 2003-07-09
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006098 2004
% 208.06/208.23  |- mesh__recordMaintainer mesh__D006098 nns
% 208.06/208.23  |- mesh__historyNote mesh__D006098
% 208.06/208.23       79%28%75%29%; was see under LEUKOCYTES 1968-78   
% 208.06/208.23  |- mesh__publicMeSHNote mesh__D006098
% 208.06/208.23       79; was see under LEUKOCYTES 1968-78   
% 208.06/208.23  |- skos__hiddenLabel mesh__D006098 Granulocyte
% 208.06/208.23  |- mesh__dateEstablished mesh__D006098 1979-01-01
% 208.06/208.23  |- skos__historyNote mesh__D006098 Leukocytes %28%1966-1974%29%
% 208.06/208.23  |- skos__broader mesh__D006098smesh__D022423
% 208.06/208.23  |- skos__altLabel mesh__D019215 Historical Biography
% 208.06/208.23  |- mesh__dateRevised mesh__D019215 2005-07-22
% 208.06/208.23  |- mesh__dateEstablished mesh__D019215 1997-01-01
% 208.06/208.23  |- skos__related mesh__D019215smesh__D020493
% 208.06/208.23  |- skos__annotation mesh__D019215
% 208.06/208.23       publication type only; check appropriate century tags; add also HISTORICAL ARTICLE %5B%Publication Type%5D%; Manual 32.16+, 32.17+; obituaries go here; biography as a subject is indexed under the main heading BIOGRAPHY; CATALOG: use for individual and collective biographies. For autobiographies, use PERSONAL NARRATIVES %5B%PUBLICATION TYPE%5D%.%A%  
% 208.06/208.23  |- mesh__historyNote mesh__D019215
% 208.06/208.23       1997; CURRENT BIOG-OBIT was Publication Type 1991-1996, was Citation Type 1966-1990; HISTORICAL BIOGRAPHY was Publication Type 1991-1996, was Citation Type 1966-1990%A%  
% 208.06/208.23  |- skos__related mesh__D019215smesh__D020467
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D019215 2006
% 208.06/208.23  |- rdf__type mesh__D019215sskos__Concept
% 208.06/208.23  |- mesh__recordAuthorizer mesh__D019215 ags
% 208.06/208.23  |- mesh__recordOriginator mesh__D019215 TGC
% 208.06/208.23  |- skos__broader mesh__D019215smesh__D052181
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D019215 2006A
% 208.06/208.23  |- skos__historyNote mesh__D019215
% 208.06/208.23       Historical Biography %5B%Publication Type%5D% %28%1966-1996%29%
% 208.06/208.23  |- mesh__recordMaintainer mesh__D019215 ags
% 208.06/208.23  |- skos__scopeNote mesh__D019215
% 208.06/208.23       Works consisting of an account of the events, works, and achievements, personal and professional, during a person%27%s life. It includes articles on the activities and accomplishments of living persons as well as the presentation of an obituary.%A%    
% 208.06/208.23  |- skos__prefLabel mesh__D019215 Biography %5B%Publication Type%5D%
% 208.06/208.23  |- skos__altLabel mesh__D019215 Current Biog-Obit
% 208.06/208.23  |- mesh__dateCreated mesh__D019215 1996-06-21
% 208.06/208.23  |- skos__historyNote mesh__D019215
% 208.06/208.23       Current Biog-Obit %5B%Publication Type%5D% %28%1966-1996%29%
% 208.06/208.23  |- skos__broader mesh__D019215smesh__D052180
% 208.06/208.23  |- skos__broader mesh__D019215smesh__D016456
% 208.06/208.23  |- skos__altLabel mesh__D019215 Biography %28%PT%29%
% 208.06/208.23  |- rdf__type mesh__D011232sskos__Concept
% 208.06/208.23  |- mesh__publicMeSHNote mesh__D011232 66   
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D011232 2003
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D011232 1992
% 208.06/208.23  |- mesh__dateEstablished mesh__D011232 1966-01-01
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D011232 1997
% 208.06/208.23  |- mesh__recordAuthorizer mesh__D011232 PLS
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D011232 2004
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D011232 1998
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D011232 1993
% 208.06/208.23  |- skos__annotation mesh__D011232 NIM; no qualif   
% 208.06/208.23  |- mesh__historyNote mesh__D011232 66%28%64%29%   
% 208.06/208.23  |- skos__prefLabel mesh__D011232 Precipitation
% 208.06/208.23  |- skos__broader mesh__D011232smesh__D002627
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D011232 2000
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D011232 2005
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D011232 1994
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D011232 1999
% 208.06/208.23  |- mesh__recordMaintainer mesh__D011232 TGC
% 208.06/208.23  |- skos__hiddenLabel mesh__D011232 Precipitations
% 208.06/208.23  |- mesh__dateRevised mesh__D011232 1989-05-16
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D011232 2001
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D011232 1990
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D011232 2006
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D011232 1995
% 208.06/208.23  |- mesh__recordOriginator mesh__D011232 NLM
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D011232 2002
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D011232 1991
% 208.06/208.23  |- mesh__dateCreated mesh__D011232 1999-01-01
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D011232 1996
% 208.06/208.23  |- skos__historyNote mesh__D010938 Oils %28%1966-1986%29%
% 208.06/208.23  |- mesh__dateCreated mesh__D010938 1986-06-03
% 208.06/208.23  |- mesh__dateRevised mesh__D010938 2005-06-30
% 208.06/208.23  |- mesh__recordMaintainer mesh__D010938 DRC
% 208.06/208.23  |- rdf__type mesh__D010938sskos__Concept
% 208.06/208.23  |- skos__altLabel mesh__D010938 Vegetable Oils
% 208.06/208.23  |- mesh__recordAuthorizer mesh__D010938 sjn
% 208.06/208.23  |- mesh__recordOriginator mesh__D010938 RLS
% 208.06/208.23  |- skos__annotation mesh__D010938
% 208.06/208.23       D25-26 qualif; coord IM with specific plant source of oil %28%IM or NIM%29% but not PLANTS; %22%yusho poisoning%22%: see note on RICE%A%  
% 208.06/208.23  |- mesh__dateEstablished mesh__D010938 1987-01-01
% 208.06/208.23  |- mesh__historyNote mesh__D010938 87   
% 208.06/208.23  |- mesh__publicMeSHNote mesh__D010938 87; SESAME OIL was heading 1963-86   
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D010938 2006
% 208.06/208.23  |- skos__broader mesh__D010938smesh__D009821
% 208.06/208.23  |- skos__altLabel mesh__D010938 Oils, Plant
% 208.06/208.23  |- skos__broader mesh__D010938smesh__D028321
% 208.06/208.23  |- skos__scopeNote mesh__D010938
% 208.06/208.23       Oils derived from plants or plant products.     
% 208.06/208.23  |- skos__prefLabel mesh__D010938 Plant Oils
% 208.06/208.23  |- mesh__dateCreated mesh__D029643 2001-07-25
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D029643 2006
% 208.06/208.23  |- rdf__type mesh__D029643sskos__Concept
% 208.06/208.23  |- mesh__dateEstablished mesh__D029643 2002-01-01
% 208.06/208.23  |- mesh__recordAuthorizer mesh__D029643 sjn
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D029643 2004
% 208.06/208.23  |- skos__scopeNote mesh__D029643
% 208.06/208.23       A plant family of the order Malvales, subclass Dilleniidae, class Magnoliopsida. The leaves of Sterculiaceae are alternate and simple or palmately compound. Flowers have three to five sepals and five or no petals.%A%    
% 208.06/208.23  |- mesh__historyNote mesh__D029643 2002   
% 208.06/208.23  |- mesh__dateRevised mesh__D029643 2003-07-09
% 208.06/208.23  |- mesh__recordMaintainer mesh__D029643 ssb
% 208.06/208.23  |- mesh__publicMeSHNote mesh__D029643 2002   
% 208.06/208.23  |- skos__broader mesh__D029643smesh__D019684
% 208.06/208.23  |- skos__prefLabel mesh__D029643 Sterculiaceae
% 208.06/208.23  |- skos__annotation mesh__D029643
% 208.06/208.23       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D029643 2005
% 208.06/208.23  |- mesh__recordOriginator mesh__D029643 ssb
% 208.06/208.23  |- mesh__historyNote mesh__D007191
% 208.06/208.23       91%28%71%29%; was see under PYRAZOLES 1971-90   
% 208.06/208.23  |- rdf__type mesh__D007191sskos__Concept
% 208.06/208.23  |- mesh__dateRevised mesh__D007191 2005-06-30
% 208.06/208.23  |- mesh__dateEstablished mesh__D007191 1991-01-01
% 208.06/208.23  |- mesh__recordAuthorizer mesh__D007191 sjn
% 208.06/208.23  |- mesh__dateCreated mesh__D007191 1999-01-01
% 208.06/208.23  |- mesh__recordMaintainer mesh__D007191 ssb
% 208.06/208.23  |- skos__historyNote mesh__D007191 Pyrazoles %28%1966-1970%29%
% 208.06/208.23  |- mesh__recordOriginator mesh__D007191 NLM
% 208.06/208.23  |- mesh__publicMeSHNote mesh__D007191
% 208.06/208.23       91; was see under PYRAZOLES 1971-90   
% 208.06/208.23  |- skos__broader mesh__D007191smesh__D006574
% 208.06/208.23  |- skos__prefLabel mesh__D007191 Indazoles
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D007191 2006
% 208.06/208.23  |- skos__broader mesh__D007191smesh__D011720
% 208.06/208.23  |- rdf__type mesh__D015623sskos__Concept
% 208.06/208.23  |- skos__scopeNote mesh__D015623
% 208.06/208.23       An approach to nutrition based on whole cereal grains, beans, cooked vegetables and the Chinese YIN-YANG principle. It advocates a diet consisting of organic and locally grown foods, seasonal vegetables, complex carbohydrates, and fewer fats, sugars, and chemically processed foods.%A%    
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D015623 2005
% 208.06/208.23  |- skos__prefLabel mesh__D015623 Diet, Macrobiotic
% 208.06/208.23  |- skos__hiddenLabel mesh__D015623 Macrobiotic Diet
% 208.06/208.23  |- mesh__publicMeSHNote mesh__D015623 90   
% 208.06/208.23  |- mesh__recordOriginator mesh__D015623 AGS
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D015623 2006
% 208.06/208.23  |- mesh__dateRevised mesh__D015623 2002-07-03
% 208.06/208.23  |- mesh__dateCreated mesh__D015623 1989-04-07
% 208.06/208.23  |- skos__broader mesh__D015623smesh__D014676
% 208.06/208.23  |- mesh__dateEstablished mesh__D015623 1990-01-01
% 208.06/208.23  |- mesh__recordMaintainer mesh__D015623 TAP
% 208.06/208.23  |- mesh__recordAuthorizer mesh__D015623 sjn
% 208.06/208.23  |- mesh__historyNote mesh__D015623 90   
% 208.06/208.23  |- skos__hiddenLabel mesh__D015623 Macrobiotic Diets
% 208.06/208.23  |- skos__hiddenLabel mesh__D015623 Diets, Macrobiotic
% 208.06/208.23  |- skos__annotation mesh__D015623 coord with specific disease /diet ther   
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D015623 2003
% 208.06/208.23  |- skos__historyNote mesh__D015623 Diet Fads %28%1966-1989%29%
% 208.06/208.23  |- skos__historyNote mesh__D015623 Diet %28%1986-1989%29%
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D015623 2004
% 208.06/208.23  |- skos__broader mesh__D001603smesh__D008671
% 208.06/208.23  |- mesh__dateRevised mesh__D001603 2005-06-30
% 208.06/208.23  |- mesh__recordMaintainer mesh__D001603 jmp
% 208.06/208.23  |- rdf__type mesh__D001603sskos__Concept
% 208.06/208.23  |- mesh__recordOriginator mesh__D001603 NLM
% 208.06/208.23  |- skos__broader mesh__D001603smesh__D019216
% 208.06/208.23  |- mesh__recordAuthorizer mesh__D001603 sjn
% 208.06/208.23  |- mesh__dateCreated mesh__D001603 1999-01-01
% 208.06/208.23  |- skos__annotation mesh__D001603 man-made radioactive element; IM   
% 208.06/208.23  |- skos__scopeNote mesh__D001603
% 208.06/208.23       Berkelium. A man-made radioactive actinide with atomic symbol Bk, atomic number 97, and atomic weight 247. Its valence can be +3 or +4. Twelve isotopes have been produced with mass numbers 240-251.%A%    
% 208.06/208.23  |- skos__prefLabel mesh__D001603 Berkelium
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D001603 2006
% 208.06/208.23  |- skos__hiddenLabel mesh__D006897 Acid, 5-Hydroxyindolamine Acetic
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006897 2004
% 208.06/208.23  |- mesh__dateCreated mesh__D006897 1999-01-01
% 208.06/208.23  |- mesh__dateEstablished mesh__D006897 1966-01-01
% 208.06/208.23  |- mesh__recordAuthorizer mesh__D006897 PLS
% 208.06/208.23  |- skos__hiddenLabel mesh__D006897 Acetic Acid, 5-Hydroxyindolamine
% 208.06/208.23  |- skos__altLabel mesh__D006897 5-Hydroxyindolamine Acetic Acid
% 208.06/208.23  |- skos__hiddenLabel mesh__D006897 5 Hydroxyindolamine Acetic Acid
% 208.06/208.23  |- mesh__publicMeSHNote mesh__D006897 66   
% 208.06/208.23  |- mesh__dateRevised mesh__D006897 1995-05-31
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006897 1998
% 208.06/208.23  |- mesh__recordOriginator mesh__D006897 NLM
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006897 2000
% 208.06/208.23  |- skos__hiddenLabel mesh__D006897 5 Hydroxy 3 Indoleacetic Acid
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006897 1999
% 208.06/208.23  |- mesh__recordMaintainer mesh__D006897 TPW
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006897 1996
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006897 2001
% 208.06/208.23  |- skos__altLabel mesh__D006897 5-HIAA
% 208.06/208.23  |- rdf__type mesh__D006897sskos__Concept
% 208.06/208.23  |- mesh__historyNote mesh__D006897 66%28%64%29%   
% 208.06/208.23  |- skos__annotation mesh__D006897 DF: HIAA   
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006897 1997
% 208.06/208.23  |- skos__hiddenLabel mesh__D006897 Acid, 5-Hydroxy-3-Indoleacetic
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006897 2005
% 208.06/208.23  |- skos__prefLabel mesh__D006897 Hydroxyindoleacetic Acid
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006897 2002
% 208.06/208.23  |- skos__broader mesh__D006897smesh__D007210
% 208.06/208.23  |- skos__hiddenLabel mesh__D006897 Acid, Hydroxyindoleacetic
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006897 2006
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006897 2003
% 208.06/208.23  |- skos__altLabel mesh__D006897 5-Hydroxy-3-Indoleacetic Acid
% 208.06/208.23  |- rdf__type mesh__D031290sskos__Concept
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D031290 2004
% 208.06/208.23  |- mesh__publicMeSHNote mesh__D031290 2003   
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D031290 2003
% 208.06/208.23  |- mesh__dateCreated mesh__D031290 2002-07-02
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D031290 2006
% 208.06/208.23  |- mesh__dateEstablished mesh__D031290 2003-01-01
% 208.06/208.23  |- mesh__historyNote mesh__D031290 2003   
% 208.06/208.23  |- skos__annotation mesh__D031290
% 208.06/208.23       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.23  |- skos__broader mesh__D031290smesh__D007887
% 208.06/208.23  |- skos__prefLabel mesh__D031290 Butea
% 208.06/208.23  |- skos__scopeNote mesh__D031290
% 208.06/208.23       A plant genus of the family FABACEAE that contains butrin and isobutrin.%A%    
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D031290 2005
% 208.06/208.23  |- skos__scopeNote mesh__D006099
% 208.06/208.23       A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents.%A%    
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006099 2005
% 208.06/208.23  |- skos__related mesh__D006099smesh__D014375
% 208.06/208.23  |- mesh__recordAuthorizer mesh__D006099 sjn
% 208.06/208.23  |- rdf__type mesh__D006099sskos__Concept
% 208.06/208.23  |- mesh__dateCreated mesh__D006099 1999-01-01
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006099 2002
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006099 2004
% 208.06/208.23  |- mesh__recordOriginator mesh__D006099 NLM
% 208.06/208.23  |- skos__annotation mesh__D006099
% 208.06/208.23       GEN: prefer specifics; coord IM with organ/dis %28%IM%29%; malignant of nose = GRANULOMA, LETHAL MIDLINE; central giant cell granuloma %26% giant cell granuloma = GRANULOMA, GIANT CELL; granulomatous dis or granulomatous dis of childhood = GRANULOMATOUS DISEASE, CHRONIC; cholesterol granuloma = GRANULOMA, FOREIGN BODY %28%IM%29% + CHOLESTEROL %28%IM%29%; talc granuloma = GRANULOMA, FOREIGN BODY /etiol %28%not/chem ind%29% + TALC /adv eff; xanthogranuloma = XANTHOMATOSIS %28%IM%29% + GRANULOMA %28%IM%29% but XANTHOGRANULOMA, JUVENILE is available%A%  
% 208.06/208.23  |- skos__altLabel mesh__D006099 Granulomas
% 208.06/208.23  |- skos__prefLabel mesh__D006099 Granuloma
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006099 2003
% 208.06/208.23  |- mesh__recordMaintainer mesh__D006099 KEV
% 208.06/208.23  |- skos__broader mesh__D006099smesh__D010335
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006099 2001
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006099 2006
% 208.06/208.23  |- mesh__dateRevised mesh__D006099 1999-11-03
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D006099 2000
% 208.06/208.23  |- skos__broader mesh__D006099smesh__D008232
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D019216 2006
% 208.06/208.23  |- mesh__dateCreated mesh__D019216 1996-06-20
% 208.06/208.23  |- mesh__dateRevised mesh__D019216 1997-06-20
% 208.06/208.23  |- skos__broader mesh__D019216smesh__D004602
% 208.06/208.23  |- rdf__type mesh__D019216sskos__Concept
% 208.06/208.23  |- mesh__recordOriginator mesh__D019216 JLS
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D019216 1998
% 208.06/208.23  |- skos__historyNote mesh__D019216 Metals or specifics %28%1966-1996%29%
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D019216 2003
% 208.06/208.23  |- mesh__dateEstablished mesh__D019216 1997-01-01
% 208.06/208.23  |- skos__broader mesh__D019216smesh__D008670
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D019216 2000
% 208.06/208.23  |- skos__scopeNote mesh__D019216
% 208.06/208.23       Metals with high specific gravity, typically larger than 5. They have complex spectra, form colored salts and double salts, have a low electrode potential, are mainly amphoteric, yield weak bases and weak acids, and are oxidizing or reducing agents %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 208.06/208.23  |- mesh__historyNote mesh__D019216 97   
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D019216 1999
% 208.06/208.23  |- mesh__recordAuthorizer mesh__D019216 SJN
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D019216 2004
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D019216 2001
% 208.06/208.23  |- mesh__publicMeSHNote mesh__D019216 97   
% 208.06/208.23  |- skos__prefLabel mesh__D019216 Metals, Heavy
% 208.06/208.23  |- mesh__recordMaintainer mesh__D019216 TGC
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D019216 2005
% 208.06/208.23  |- skos__altLabel mesh__D019216 Heavy Metals
% 208.06/208.23  |- mesh__onlineNote mesh__D019216
% 208.06/208.23       pre-explosion - METALS, HEAVY %28%PX%29%   
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D019216 2002
% 208.06/208.23  |- skos__annotation mesh__D019216 GEN: prefer specifics   
% 208.06/208.23  |- mesh__recordOriginator mesh__D011233 NLM
% 208.06/208.23  |- skos__broader mesh__D011233smesh__D047468
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D011233 2006
% 208.06/208.23  |- skos__prefLabel mesh__D011233 Precipitin Tests
% 208.06/208.23  |- mesh__recordAuthorizer mesh__D011233 sjn
% 208.06/208.23  |- skos__hiddenLabel mesh__D011233 Test, Precipitin
% 208.06/208.23  |- mesh__dateCreated mesh__D011233 1999-01-01
% 208.06/208.23  |- skos__hiddenLabel mesh__D011233 Tests, Precipitin
% 208.06/208.23  |- mesh__recordMaintainer mesh__D011233 nns
% 208.06/208.23  |- rdf__type mesh__D011233sskos__Concept
% 208.06/208.23  |- skos__broader mesh__D011233smesh__D012698
% 208.06/208.23  |- skos__hiddenLabel mesh__D011233 Precipitin Test
% 208.06/208.23  |- mesh__dateRevised mesh__D011233 2004-07-07
% 208.06/208.23  |- skos__scopeNote mesh__D011233
% 208.06/208.23       Serologic tests in which a positive reaction manifested by visible precipitation occurs when a soluble ANTIGEN reacts with its ANTIBODIES.%A%    
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D011233 2005
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D035681 2006
% 208.06/208.23  |- skos__annotation mesh__D035681
% 208.06/208.23       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D035681 2005
% 208.06/208.23  |- mesh__publicMeSHNote mesh__D035681 2003   
% 208.06/208.23  |- mesh__dateEstablished mesh__D035681 2003-01-01
% 208.06/208.23  |- skos__prefLabel mesh__D035681 Adiantum
% 208.06/208.23  |- mesh__dateCreated mesh__D035681 2002-07-02
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D035681 2004
% 208.06/208.23  |- skos__broader mesh__D035681smesh__D029625
% 208.06/208.23  |- rdf__type mesh__D035681sskos__Concept
% 208.06/208.23  |- skos__scopeNote mesh__D035681
% 208.06/208.23       A plant genus of the family Pteridaceae. Members contain TRITERPENES. Some species in this genus are called maidenhair fern which is also a common name occasionally used for Lygodium %28%FERNS%29% and POLYPODIUM.%A%    
% 208.06/208.23  |- mesh__historyNote mesh__D035681 2003   
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D035681 2003
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D029644 2002
% 208.06/208.23  |- skos__annotation mesh__D029644
% 208.06/208.23       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.23  |- mesh__publicMeSHNote mesh__D029644 2002   
% 208.06/208.23  |- skos__prefLabel mesh__D029644 Styracaceae
% 208.06/208.23  |- mesh__dateCreated mesh__D029644 2001-07-25
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D029644 2005
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D029644 2003
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D029644 2006
% 208.06/208.23  |- rdf__type mesh__D029644sskos__Concept
% 208.06/208.23  |- mesh__historyNote mesh__D029644 2002   
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D029644 2004
% 208.06/208.23  |- skos__broader mesh__D029644smesh__D019684
% 208.06/208.23  |- skos__scopeNote mesh__D029644
% 208.06/208.23       A plant family of the order Ebenales, subclass Dilleniidae, class Magnoliopsida.%A%    
% 208.06/208.23  |- mesh__dateEstablished mesh__D029644 2002-01-01
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D010939 2003
% 208.06/208.23  |- mesh__recordMaintainer mesh__D010939 TGC
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D010939 2002
% 208.06/208.23  |- skos__prefLabel mesh__D010939 Plant Poisoning
% 208.06/208.23  |- skos__altLabel mesh__D010939 Poisoning, Plant
% 208.06/208.23  |- rdf__type mesh__D010939sskos__Concept
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D010939 2004
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D010939 2005
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D010939 1998
% 208.06/208.23  |- skos__broader mesh__D010939smesh__D011041
% 208.06/208.23  |- skos__annotation mesh__D010939
% 208.06/208.23       human %26% animal; coord IM with specific plant %28%IM%29% + specific dis /etiol %28%IM%29%; do not coord with food plants in Cat J: index under specific Cat J2 food plant /pois %28%IM%29%, as FRUIT /pois or GARLIC /pois but not also here; Jamaican vomiting sickness: index PLANT POISONING + HYPOGLYCINS /pois%A%  
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D010939 2006
% 208.06/208.23  |- mesh__dateCreated mesh__D010939 1999-01-01
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D010939 1999
% 208.06/208.23  |- skos__scopeNote mesh__D010939
% 208.06/208.23       Poisoning by the ingestion of plants or its leaves, berries, roots or stalks. The manifestations in both humans and animals vary in severity from mild to life threatening. In animals, especially domestic animals, it is usually the result of ingesting moldy or fermented forage.%A%    
% 208.06/208.23  |- skos__hiddenLabel mesh__D010939 Poisonings, Plant
% 208.06/208.23  |- mesh__recordOriginator mesh__D010939 NLM
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D010939 2000
% 208.06/208.23  |- mesh__recordAuthorizer mesh__D010939 SJN
% 208.06/208.23  |- mesh__activeMeSHYear mesh__D010939 2001
% 208.06/208.24  |- mesh__dateRevised mesh__D010939 1997-06-20
% 208.06/208.24  |- skos__hiddenLabel mesh__D010939 Plant Poisonings
% 208.06/208.24  |- skos__prefLabel mesh__D007990 Libraries
% 208.06/208.24  |- rdf__type mesh__D007990sskos__Concept
% 208.06/208.24  |- skos__scopeNote mesh__D007990
% 208.06/208.24       Collections of organized information for study and reference.%A%    
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007990 2001
% 208.06/208.24  |- mesh__recordAuthorizer mesh__D007990 sjn
% 208.06/208.24  |- mesh__recordOriginator mesh__D007990 NLM
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007990 2005
% 208.06/208.24  |- skos__broader mesh__D007990smesh__D007253
% 208.06/208.24  |- skos__annotation mesh__D007990 IM; specify geog or other site   
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007990 2006
% 208.06/208.24  |- mesh__dateCreated mesh__D007990 1999-01-01
% 208.06/208.24  |- mesh__recordMaintainer mesh__D007990 kle
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007990 2002
% 208.06/208.24  |- skos__hiddenLabel mesh__D007990 Library
% 208.06/208.24  |- mesh__dateRevised mesh__D007990 1999-11-03
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007990 2003
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007990 2004
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007990 2000
% 208.06/208.24  |- skos__hiddenLabel mesh__D021661 Organization, Management Service
% 208.06/208.24  |- mesh__dateCreated mesh__D021661 2000-06-22
% 208.06/208.24  |- skos__hiddenLabel mesh__D021661 Management Service Organization
% 208.06/208.24  |- rdf__type mesh__D021661sskos__Concept
% 208.06/208.24  |- skos__broader mesh__D021661smesh__D011364
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D021661 2006
% 208.06/208.24  |- mesh__recordMaintainer mesh__D021661 jls
% 208.06/208.24  |- mesh__dateRevised mesh__D021661 2004-07-28
% 208.06/208.24  |- mesh__dateEstablished mesh__D021661 2001-01-01
% 208.06/208.24  |- mesh__recordAuthorizer mesh__D021661 jls
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D021661 2002
% 208.06/208.24  |- skos__hiddenLabel mesh__D021661 Service Organizations, Management
% 208.06/208.24  |- skos__scopeNote mesh__D021661
% 208.06/208.24       Voluntarily-formed groups of healthcare professionals who join for common management services and other benefits such as collective bargaining agreements with reimbursement agents. The physical assets of a practice are controlled by the MSO which also provides billing, collections, and similar services. The practitioner retains control of patient records and management of patient care.%A%    
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D021661 2003
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D021661 2005A
% 208.06/208.24  |- mesh__recordOriginator mesh__D021661 jls
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D021661 2004
% 208.06/208.24  |- skos__altLabel mesh__D021661 Organizations, Management Service
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D021661 2005B
% 208.06/208.24  |- skos__prefLabel mesh__D021661 Management Service Organizations
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D021661 2001
% 208.06/208.24  |- skos__hiddenLabel mesh__D021661 Service Organization, Management
% 208.06/208.24  |- mesh__historyNote mesh__D021661
% 208.06/208.24       2001; use HOSPITAL-PHYSICIAN JOINT VENTURES 1996-2000   
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D021661 2005
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007192 1997
% 208.06/208.24  |- skos__annotation mesh__D007192 aromatic hydrocarbons   
% 208.06/208.24  |- mesh__dateEstablished mesh__D007192 1968-01-01
% 208.06/208.24  |- mesh__dateCreated mesh__D007192 1999-01-01
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007192 2002
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007192 1999
% 208.06/208.24  |- mesh__publicMeSHNote mesh__D007192 68   
% 208.06/208.24  |- mesh__dateRevised mesh__D007192 1993-06-03
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007192 1996
% 208.06/208.24  |- mesh__recordMaintainer mesh__D007192 PLS
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007192 2001
% 208.06/208.24  |- skos__prefLabel mesh__D007192 Indenes
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007192 1998
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007192 2004
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007192 1995
% 208.06/208.24  |- mesh__historyNote mesh__D007192 68   
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007192 2000
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007192 2006
% 208.06/208.24  |- mesh__recordAuthorizer mesh__D007192 PLS
% 208.06/208.24  |- skos__scopeNote mesh__D007192
% 208.06/208.24       A family of fused-ring hydrocarbons isolated from coal tar that act as intermediates in various chemical reactions and are used in the production of coumarone-indene resins.%A%    
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007192 2003
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007192 1994
% 208.06/208.24  |- rdf__type mesh__D007192sskos__Concept
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007192 2005
% 208.06/208.24  |- skos__broader mesh__D007192smesh__D011084
% 208.06/208.24  |- mesh__recordOriginator mesh__D007192 NLM
% 208.06/208.24  |- skos__hiddenLabel mesh__D015624
% 208.06/208.24       Eaton-Lambert Myopathic-Myasthenic Syndromes
% 208.06/208.24  |- skos__hiddenLabel mesh__D015624
% 208.06/208.24       Eaton-Lambert Myopathic-Myasthenic Syndrome
% 208.06/208.24  |- skos__altLabel mesh__D015624
% 208.06/208.24       Myopathic-Myasthenic Syndrome of Lambert-Eaton
% 208.06/208.24  |- skos__broader mesh__D015624smesh__D020511
% 208.06/208.24  |- skos__historyNote mesh__D015624 Muscular Diseases %28%1967-1988%29%
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D015624 2004
% 208.06/208.24  |- skos__hiddenLabel mesh__D015624
% 208.06/208.24       Lambert-Eaton Myopathic-Myasthenic Syndromes
% 208.06/208.24  |- skos__historyNote mesh__D015624 Myasthenia Gravis %28%1980-1989%29%
% 208.06/208.24  |- mesh__recordMaintainer mesh__D015624 KEV
% 208.06/208.24  |- skos__altLabel mesh__D015624 Eaton-Lambert Myasthenic Syndrome
% 208.06/208.24  |- skos__broader mesh__D015624smesh__D020274
% 208.06/208.24  |- skos__altLabel mesh__D015624 Myasthenic Syndrome, Lambert-Eaton
% 208.06/208.24  |- mesh__publicMeSHNote mesh__D015624 1990   
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D015624 2003
% 208.06/208.24  |- skos__hiddenLabel mesh__D015624 Eaton Lambert Myasthenic Syndrome
% 208.06/208.24  |- mesh__dateCreated mesh__D015624 1989-04-07
% 208.06/208.24  |- skos__hiddenLabel mesh__D015624 Syndrome, Eaton-Lambert
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D015624 2002
% 208.06/208.24  |- skos__hiddenLabel mesh__D015624
% 208.06/208.24       Myasthenic Myopathic Syndrome of Eaton Lambert
% 208.06/208.24  |- skos__broader mesh__D015624smesh__D001327
% 208.06/208.24  |- skos__hiddenLabel mesh__D015624 Myasthenic Syndrome, Lambert Eaton
% 208.06/208.24  |- skos__broader mesh__D015624smesh__D020361
% 208.06/208.24  |- skos__hiddenLabel mesh__D015624
% 208.06/208.24       Eaton-Lambert Myasthenic-Myopathic Syndrome
% 208.06/208.24  |- skos__hiddenLabel mesh__D015624 Myasthenic Syndrome, Eaton-Lambert
% 208.06/208.24  |- mesh__historyNote mesh__D015624 1990   
% 208.06/208.24  |- skos__historyNote mesh__D015624 Neuromuscular Diseases %28%1980-1989%29%
% 208.06/208.24  |- skos__hiddenLabel mesh__D015624
% 208.06/208.24       Lambert-Eaton Myasthenic-Myopathic Syndromes
% 208.06/208.24  |- skos__hiddenLabel mesh__D015624
% 208.06/208.24       Lambert-Eaton Myopathic-Myasthenic Syndrome
% 208.06/208.24  |- skos__hiddenLabel mesh__D015624 Syndrome, Lambert-Eaton Myasthenic
% 208.06/208.24  |- mesh__recordAuthorizer mesh__D015624 sjn
% 208.06/208.24  |- skos__altLabel mesh__D015624 Eaton-Lambert Syndrome
% 208.06/208.24  |- skos__hiddenLabel mesh__D015624 Eaton Lambert Syndrome
% 208.06/208.24  |- mesh__dateEstablished mesh__D015624 1990-01-01
% 208.06/208.24  |- mesh__dateRevised mesh__D015624 1999-11-03
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D015624 2001
% 208.06/208.24  |- skos__altLabel mesh__D015624
% 208.06/208.24       Myasthenic-Myopathic Syndrome of Eaton-Lambert
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D015624 2006
% 208.06/208.24  |- skos__hiddenLabel mesh__D015624 Lambert Eaton Syndrome
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D015624 2000
% 208.06/208.24  |- skos__hiddenLabel mesh__D015624
% 208.06/208.24       Lambert-Eaton Myasthenic-Myopathic Syndrome
% 208.06/208.24  |- skos__hiddenLabel mesh__D015624 Syndrome, Lambert-Eaton
% 208.06/208.24  |- skos__prefLabel mesh__D015624 Lambert-Eaton Myasthenic Syndrome
% 208.06/208.24  |- skos__hiddenLabel mesh__D015624
% 208.06/208.24       Myopathic Myasthenic Syndrome of Eaton Lambert
% 208.06/208.24  |- skos__scopeNote mesh__D015624
% 208.06/208.24       An autoimmune disease characterized by weakness and fatigability of proximal muscles, particularly of the pelvic girdle, lower extremities, trunk, and shoulder girdle. There is relative sparing of extraocular and bulbar muscles. CARCINOMA, SMALL CELL of the lung is a frequently associated condition, although other malignancies and autoimmune diseases may be associated. Muscular weakness results from impaired impulse transmission at the NEUROMUSCULAR JUNCTION. Presynaptic calcium channel dysfunction leads to a reduced amount of acetylcholine being released in response to stimulation of the nerve. %28%From Adams et al., Principles of Neurology, 6th ed, pp 1471%29%%A%    
% 208.06/208.24  |- rdf__type mesh__D015624sskos__Concept
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D015624 2005
% 208.06/208.24  |- skos__altLabel mesh__D015624 Lambert-Eaton Syndrome
% 208.06/208.24  |- skos__altLabel mesh__D015624
% 208.06/208.24       Myasthenic-Myopathic Syndrome of Lambert-Eaton
% 208.06/208.24  |- skos__hiddenLabel mesh__D015624 Syndrome, Eaton-Lambert Myasthenic
% 208.06/208.24  |- skos__altLabel mesh__D015624
% 208.06/208.24       Myopathic-Myasthenic Syndrome of Eaton-Lambert
% 208.06/208.24  |- mesh__recordOriginator mesh__D015624 PXP
% 208.06/208.24  |- skos__hiddenLabel mesh__D015624
% 208.06/208.24       Myasthenic Myopathic Syndrome of Lambert Eaton
% 208.06/208.24  |- skos__hiddenLabel mesh__D015624 Lambert Eaton Myasthenic Syndrome
% 208.06/208.24  |- skos__historyNote mesh__D015624 Neuromuscular Junction %28%1980-1986%29%
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001604 2005
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001604 2003
% 208.06/208.24  |- skos__broader mesh__D001604smesh__D002947
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001604 2001
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001604 2000
% 208.06/208.24  |- mesh__dateRevised mesh__D001604 1989-07-13
% 208.06/208.24  |- mesh__recordMaintainer mesh__D001604 PLS
% 208.06/208.24  |- mesh__dateCreated mesh__D001604 1999-01-01
% 208.06/208.24  |- skos__prefLabel mesh__D001604 Berlin
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001604 1995
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001604 1991
% 208.06/208.24  |- mesh__recordOriginator mesh__D001604 NLM
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001604 1993
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001604 1999
% 208.06/208.24  |- skos__annotation mesh__D001604
% 208.06/208.24       includes East or West Berlin; for historical or modern Berlin%A%  
% 208.06/208.24  |- skos__broader mesh__D001604smesh__D005858
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001604 1994
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001604 1997
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001604 2006
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001604 2002
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001604 1992
% 208.06/208.24  |- mesh__recordAuthorizer mesh__D001604 PLS
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001604 1998
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001604 2004
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001604 1996
% 208.06/208.24  |- rdf__type mesh__D001604sskos__Concept
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001604 1990
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D006898 2004
% 208.06/208.24  |- skos__prefLabel mesh__D006898 Hydroxylamines
% 208.06/208.24  |- mesh__dateRevised mesh__D006898 1997-06-20
% 208.06/208.24  |- mesh__dateCreated mesh__D006898 1999-01-01
% 208.06/208.24  |- skos__broader mesh__D006898smesh__D000588
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D006898 2006
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D006898 2003
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D006898 2005
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D006898 2002
% 208.06/208.24  |- mesh__recordMaintainer mesh__D006898 ADP
% 208.06/208.24  |- mesh__recordAuthorizer mesh__D006898 SJN
% 208.06/208.24  |- skos__scopeNote mesh__D006898
% 208.06/208.24       Organic compounds that contain the %28%-NH2OH%29% radical.     
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D006898 2001
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D006898 1999
% 208.06/208.24  |- mesh__recordOriginator mesh__D006898 NLM
% 208.06/208.24  |- rdf__type mesh__D006898sskos__Concept
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D006898 2000
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D006898 1998
% 208.06/208.24  |- skos__hiddenLabel mesh__D020569 Proteins, c-rel
% 208.06/208.24  |- mesh__dateEstablished mesh__D020569 2000-01-01
% 208.06/208.24  |- skos__hiddenLabel mesh__D020569 rel Proto Oncogene Product p68
% 208.06/208.24  |- skos__hiddenLabel mesh__D020569 Protein, c-rel
% 208.06/208.24  |- mesh__dateCreated mesh__D020569 1999-11-08
% 208.06/208.24  |- skos__hiddenLabel mesh__D020569 c-rel, Proto-Oncogene Proteins
% 208.06/208.24  |- skos__hiddenLabel mesh__D020569 Proto Oncogene Proteins c rel
% 208.06/208.24  |- skos__altLabel mesh__D020569 Proto-Oncogene Proteins rel
% 208.06/208.24  |- skos__hiddenLabel mesh__D020569 Proto Oncogene Proteins rel
% 208.06/208.24  |- skos__hiddenLabel mesh__D020569 Proto-Oncogene Proteins, rel
% 208.06/208.24  |- skos__altLabel mesh__D020569 p68 c-rel
% 208.06/208.24  |- skos__hiddenLabel mesh__D020569 rel Proto Oncogene Proteins
% 208.06/208.24  |- mesh__recordAuthorizer mesh__D020569 sjn
% 208.06/208.24  |- skos__altLabel mesh__D020569 p68%28%c-rel%29%
% 208.06/208.24  |- skos__hiddenLabel mesh__D020569 c-rel, Proto-Oncogene Protein
% 208.06/208.24  |- skos__scopeNote mesh__D020569
% 208.06/208.24       Cellular DNA-binding proteins encoded by the rel gene %28%GENES, REL%29%. They are expressed predominately in hematopoietic cells and may play a role in lymphocyte differentiation. Rel frequently combines with other related proteins %28%NF-KAPPA B, I-kappa B, relA%29% to form heterodimers that regulate transcription. Rearrangement or overexpression of c-rel can cause tumorigenesis.%A%    
% 208.06/208.24  |- skos__hiddenLabel mesh__D020569 c-rel, p68
% 208.06/208.24  |- skos__historyNote mesh__D020569
% 208.06/208.24       Proto-Oncogene Proteins %28%1988-1999%29%
% 208.06/208.24  |- mesh__historyNote mesh__D020569
% 208.06/208.24       2000; use PROTO-ONCOGENE PROTEINS C-REL %28%NM%29% 1988-1999   
% 208.06/208.24  |- skos__hiddenLabel mesh__D020569 Proto Oncogene Products c rel
% 208.06/208.24  |- skos__broader mesh__D020569smesh__D014157
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D020569 2006
% 208.06/208.24  |- skos__hiddenLabel mesh__D020569 p68 c rel
% 208.06/208.24  |- skos__altLabel mesh__D020569 rel Proto-Oncogene Proteins
% 208.06/208.24  |- skos__altLabel mesh__D020569 c-rel Protein
% 208.06/208.24  |- skos__hiddenLabel mesh__D020569 c rel Protein
% 208.06/208.24  |- skos__prefLabel mesh__D020569 Proto-Oncogene Proteins c-rel
% 208.06/208.24  |- skos__hiddenLabel mesh__D020569 c-rel, Proto-Oncogene Products
% 208.06/208.24  |- mesh__dateRevised mesh__D020569 2005-06-30
% 208.06/208.24  |- skos__related mesh__D020569smesh__D020573
% 208.06/208.24  |- skos__related mesh__D020569smesh__D020672
% 208.06/208.24  |- mesh__recordOriginator mesh__D020569 ags
% 208.06/208.24  |- skos__hiddenLabel mesh__D020569 Proto Oncogene Protein c rel
% 208.06/208.24  |- mesh__recordMaintainer mesh__D020569 DRC
% 208.06/208.24  |- skos__broader mesh__D020569smesh__D004268
% 208.06/208.24  |- mesh__publicMeSHNote mesh__D020569
% 208.06/208.24       2000; PROTO-ONCOGENE PROTEIN C-REL was indexed under PROTO-ONCOGENE PROTEINS 1988-1999%A%  
% 208.06/208.24  |- skos__altLabel mesh__D020569 Proto-Oncogene Protein c-rel
% 208.06/208.24  |- skos__altLabel mesh__D020569 rel Proto-Oncogene Product p68
% 208.06/208.24  |- skos__broader mesh__D020569smesh__D009687
% 208.06/208.24  |- skos__broader mesh__D020569smesh__D011518
% 208.06/208.24  |- skos__hiddenLabel mesh__D020569 c rel Proteins
% 208.06/208.24  |- skos__altLabel mesh__D020569 c-rel Proteins
% 208.06/208.24  |- skos__altLabel mesh__D020569 Proto-Oncogene Products c-rel
% 208.06/208.24  |- rdf__type mesh__D020569sskos__Concept
% 208.06/208.24  |- mesh__dateCreated mesh__D031291 2002-07-03
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D031291 2006
% 208.06/208.24  |- skos__annotation mesh__D031291
% 208.06/208.24       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.24  |- skos__broader mesh__D031291smesh__D007887
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D031291 2005
% 208.06/208.24  |- mesh__dateEstablished mesh__D031291 2003-01-01
% 208.06/208.24  |- rdf__type mesh__D031291sskos__Concept
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D031291 2004
% 208.06/208.24  |- skos__prefLabel mesh__D031291 Castanospermum
% 208.06/208.24  |- skos__scopeNote mesh__D031291
% 208.06/208.24       A plant genus of the family FABACEAE that contains castanospermines, swainsonine, and triterpenoid saponins.%A%    
% 208.06/208.24  |- mesh__publicMeSHNote mesh__D031291 2003   
% 208.06/208.24  |- mesh__historyNote mesh__D031291 2003   
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D031291 2003
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D019217 2004
% 208.06/208.24  |- skos__historyNote mesh__D019217 Tooth Abrasion %28%1966-1996%29%
% 208.06/208.24  |- skos__broader mesh__D019217smesh__D014076
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D019217 2002
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D019217 1997
% 208.06/208.24  |- mesh__onlineNote mesh__D019217
% 208.06/208.24       use TOOTH ABRASION to search DENTAL ATTRITION 1976-96   
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D019217 2005
% 208.06/208.24  |- mesh__dateEstablished mesh__D019217 1997-01-01
% 208.06/208.24  |- skos__annotation mesh__D019217
% 208.06/208.24       result of tooth-to-tooth contact as in mastication: do not confuse with TOOTH EROSION %28%result of chem action without bact action%29% or TOOTH ABRASION %28%loss of substance from friction like bruxism%29%: read MeSH definitions%A%  
% 208.06/208.24  |- skos__scopeNote mesh__D019217
% 208.06/208.24       The wearing away of a tooth as a result of tooth-to-tooth contact, as in mastication, occurring only on the occlusal, incisal, and proximal surfaces. It is chiefly associated with aging. It is differentiated from TOOTH ABRASION %28%the pathologic wearing away of the tooth substance by friction, as brushing, bruxism, clenching, and other mechanical causes%29% and from TOOTH EROSION %28%the loss of substance caused by chemical action without bacterial action%29%. %28%Jablonski, Dictionary of Dentistry, 1992, p86%29%%A%    
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D019217 2006
% 208.06/208.24  |- mesh__dateCreated mesh__D019217 1996-06-10
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D019217 2000
% 208.06/208.24  |- rdf__type mesh__D019217sskos__Concept
% 208.06/208.24  |- skos__altLabel mesh__D019217 Dental Attrition
% 208.06/208.24  |- mesh__publicMeSHNote mesh__D019217
% 208.06/208.24       97; DENTAL ATTRITION was see TOOTH ABRASION 1976-96   
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D019217 1998
% 208.06/208.24  |- skos__altLabel mesh__D019217 Attrition, Dental
% 208.06/208.24  |- skos__prefLabel mesh__D019217 Tooth Attrition
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D019217 2003
% 208.06/208.24  |- skos__hiddenLabel mesh__D019217 Attrition, Tooth
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D019217 2001
% 208.06/208.24  |- mesh__historyNote mesh__D019217
% 208.06/208.24       97; DENTAL ATTRITION was see TOOTH ABRASION 1976-96   
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D019217 1999
% 208.06/208.24  |- skos__hiddenLabel mesh__D011234 Precipitates, Immune
% 208.06/208.24  |- mesh__dateCreated mesh__D011234 1999-01-01
% 208.06/208.24  |- mesh__recordOriginator mesh__D011234 NLM
% 208.06/208.24  |- skos__prefLabel mesh__D011234 Precipitins
% 208.06/208.24  |- rdf__type mesh__D011234sskos__Concept
% 208.06/208.24  |- mesh__recordAuthorizer mesh__D011234 sjn
% 208.06/208.24  |- mesh__dateRevised mesh__D011234 2005-06-30
% 208.06/208.24  |- skos__scopeNote mesh__D011234
% 208.06/208.24       Antibodies which elicit IMMUNOPRECIPITATION when combined with antigen.%A%    
% 208.06/208.24  |- skos__broader mesh__D011234smesh__D000906
% 208.06/208.24  |- mesh__recordMaintainer mesh__D011234 ssb
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D011234 2006
% 208.06/208.24  |- mesh__dateCreated mesh__D035682 2002-07-03
% 208.06/208.24  |- skos__prefLabel mesh__D035682 Gnetophyta
% 208.06/208.24  |- mesh__publicMeSHNote mesh__D035682 2003; see GYMNOSPERMS 1998-2002   
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D035682 2004
% 208.06/208.24  |- rdf__type mesh__D035682sskos__Concept
% 208.06/208.24  |- skos__broader mesh__D035682smesh__D019681
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D035682 2003
% 208.06/208.24  |- mesh__dateEstablished mesh__D035682 2003-01-01
% 208.06/208.24  |- mesh__historyNote mesh__D035682 2003; use GYMNOSPERMS 1998-2002   
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D035682 2006
% 208.06/208.24  |- skos__historyNote mesh__D035682 Gymnosperms %28%1998-2002%29%
% 208.06/208.24  |- skos__annotation mesh__D035682
% 208.06/208.24       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.24  |- skos__scopeNote mesh__D035682
% 208.06/208.24       A plant division of seed plants containing only a few members.%A%    
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D035682 2005
% 208.06/208.24  |- skos__broader mesh__D007991smesh__D007990
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007991 2003
% 208.06/208.24  |- mesh__dateRevised mesh__D007991 1999-11-03
% 208.06/208.24  |- rdf__type mesh__D007991sskos__Concept
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007991 2002
% 208.06/208.24  |- skos__altLabel mesh__D007991 Dental Libraries
% 208.06/208.24  |- mesh__historyNote mesh__D007991 65   
% 208.06/208.24  |- skos__altLabel mesh__D007991 Dental Library
% 208.06/208.24  |- mesh__recordOriginator mesh__D007991 NLM
% 208.06/208.24  |- mesh__recordAuthorizer mesh__D007991 sjn
% 208.06/208.24  |- skos__altLabel mesh__D007991 Library, Dental
% 208.06/208.24  |- skos__prefLabel mesh__D007991 Libraries, Dental
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007991 2006
% 208.06/208.24  |- skos__annotation mesh__D007991
% 208.06/208.24       IM; specify geog or other site; DF: LIBRARIES DENT   
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007991 2004
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007991 2001
% 208.06/208.24  |- mesh__dateCreated mesh__D007991 1999-01-01
% 208.06/208.24  |- mesh__dateEstablished mesh__D007991 1965-01-01
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007991 2005
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007991 2000
% 208.06/208.24  |- mesh__recordMaintainer mesh__D007991 kle
% 208.06/208.24  |- mesh__publicMeSHNote mesh__D007991 65   
% 208.06/208.24  |- mesh__publicMeSHNote mesh__D029645 2002   
% 208.06/208.24  |- skos__broader mesh__D029645smesh__D019684
% 208.06/208.24  |- mesh__recordMaintainer mesh__D029645 ssb
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D029645 2005
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D029645 2006
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D029645 2003
% 208.06/208.24  |- rdf__type mesh__D029645sskos__Concept
% 208.06/208.24  |- mesh__recordOriginator mesh__D029645 ssb
% 208.06/208.24  |- skos__annotation mesh__D029645
% 208.06/208.24       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.24  |- mesh__dateCreated mesh__D029645 2001-07-25
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D029645 2004
% 208.06/208.24  |- mesh__dateRevised mesh__D029645 2002-07-02
% 208.06/208.24  |- skos__prefLabel mesh__D029645 Thymelaeaceae
% 208.06/208.24  |- mesh__dateEstablished mesh__D029645 2002-01-01
% 208.06/208.24  |- mesh__recordAuthorizer mesh__D029645 sjn
% 208.06/208.24  |- skos__scopeNote mesh__D029645
% 208.06/208.24       A plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. They are mainly trees and shrubs. Many members contain mucilage and COUMARINS.%A%    
% 208.06/208.24  |- mesh__historyNote mesh__D029645 2002   
% 208.06/208.24  |- skos__altLabel mesh__D007193 Association, Individual Practice
% 208.06/208.24  |- skos__hiddenLabel mesh__D007193
% 208.06/208.24       IPAs %28%Independent Practice Association%29%
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007193 1996
% 208.06/208.24  |- skos__altLabel mesh__D007193 Individual Practice Associations
% 208.06/208.24  |- skos__altLabel mesh__D007193 IPA %28%Individual Practice Association%29%
% 208.06/208.24  |- skos__altLabel mesh__D007193 Practice Association, Individual
% 208.06/208.24  |- skos__prefLabel mesh__D007193 Independent Practice Associations
% 208.06/208.24  |- mesh__dateRevised mesh__D007193 1994-05-12
% 208.06/208.24  |- skos__scopeNote mesh__D007193
% 208.06/208.24       A partnership, corporation, association, or other legal entity that enters into an arrangement for the provision of services with persons who are licensed to practice medicine, osteopathy, and dentistry, and with other care personnel. Under an IPA arrangement, licensed professional persons provide services through the entity in accordance with a mutually accepted compensation arrangement, while retaining their private practices. Services under the IPA are marketed through a prepaid health plan. %28%From Facts on File Dictionary of Health Care Management, 1988%29%%A%    
% 208.06/208.24  |- rdf__type mesh__D007193sskos__Concept
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007193 2001
% 208.06/208.24  |- skos__hiddenLabel mesh__D007193 Practice Associations, Individual
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007193 2005
% 208.06/208.24  |- mesh__dateCreated mesh__D007193 1987-05-02
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007193 1997
% 208.06/208.24  |- skos__hiddenLabel mesh__D007193 Independent Practice Association
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007193 2002
% 208.06/208.24  |- skos__broader mesh__D007193smesh__D011331
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007193 2006
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007193 2003
% 208.06/208.24  |- mesh__historyNote mesh__D007193
% 208.06/208.24       92; was INDEPENDENT PRACTICE ASSOCIATION 1988-91 %28%see under PRIVATE PRACTICE 1988-90%29%%A%  
% 208.06/208.24  |- skos__hiddenLabel mesh__D007193
% 208.06/208.24       IPAs %28%Individual Practice Association%29%
% 208.06/208.24  |- mesh__recordAuthorizer mesh__D007193 PLS
% 208.06/208.24  |- mesh__recordOriginator mesh__D007193 EC
% 208.06/208.24  |- skos__altLabel mesh__D007193 Practice Association, Independent
% 208.06/208.24  |- skos__altLabel mesh__D007193 Association, Independent Practice
% 208.06/208.24  |- skos__hiddenLabel mesh__D007193 Individual Practice Association
% 208.06/208.24  |- mesh__onlineNote mesh__D007193
% 208.06/208.24       use INDEPENDENT PRACTICE ASSOCIATIONS to search INDEPENDENT PRACTICE ASSOCIATION 1988-91%A%  
% 208.06/208.24  |- skos__annotation mesh__D007193 DF: IPA   
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007193 2004
% 208.06/208.24  |- skos__broader mesh__D007193smesh__D006123
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007193 1998
% 208.06/208.24  |- skos__altLabel mesh__D007193
% 208.06/208.24       IPA %28%Independent Practice Association%29%
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007193 1995
% 208.06/208.24  |- skos__hiddenLabel mesh__D007193 Associations, Independent Practice
% 208.06/208.24  |- mesh__dateEstablished mesh__D007193 1991-01-01
% 208.06/208.24  |- skos__broader mesh__D007193smesh__D008329
% 208.06/208.24  |- skos__hiddenLabel mesh__D007193 Associations, Individual Practice
% 208.06/208.24  |- skos__hiddenLabel mesh__D007193 Practice Associations, Independent
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007193 2000
% 208.06/208.24  |- mesh__recordMaintainer mesh__D007193 PLS
% 208.06/208.24  |- mesh__publicMeSHNote mesh__D007193
% 208.06/208.24       92; was INDEPENDENT PRACTICE ASSOCIATION 1988-91 %28%see under PRIVATE PRACTICE 1988-90%29%%A%  
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D007193 1999
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D015625 2001
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D015625 2005
% 208.06/208.24  |- mesh__dateEstablished mesh__D015625 1990-01-01
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D015625 1998
% 208.06/208.24  |- skos__hiddenLabel mesh__D015625 Expander, Tissue
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D015625 2002
% 208.06/208.24  |- skos__broader mesh__D015625smesh__D013523
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D015625 2006
% 208.06/208.24  |- skos__hiddenLabel mesh__D015625 Expanders, Tissue
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D015625 1999
% 208.06/208.24  |- mesh__dateRevised mesh__D015625 1997-06-20
% 208.06/208.24  |- mesh__recordOriginator mesh__D015625 AGS
% 208.06/208.24  |- skos__broader mesh__D015625smesh__D019736
% 208.06/208.24  |- mesh__recordMaintainer mesh__D015625 PXP
% 208.06/208.24  |- skos__hiddenLabel mesh__D015625 Tissue Expander
% 208.06/208.24  |- skos__historyNote mesh__D015625 Implants, Artificial %28%1983-1989%29%
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D015625 2003
% 208.06/208.24  |- mesh__dateCreated mesh__D015625 1989-04-07
% 208.06/208.24  |- mesh__recordAuthorizer mesh__D015625 SJN
% 208.06/208.24  |- skos__scopeNote mesh__D015625
% 208.06/208.24       Inflatable reservoirs, usually made of silicone, which are implanted subcutaneously in order to generate tissue needed for surgical reconstruction. After implantation, the reservoir is inflated over several weeks by percutaneous injection of fluid. Once the tissue has grown, the expander is surgically removed and the expanded skin is used to cover the area being reconstructed.%A%    
% 208.06/208.24  |- rdf__type mesh__D015625sskos__Concept
% 208.06/208.24  |- mesh__historyNote mesh__D015625 90   
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D015625 2000
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D015625 2004
% 208.06/208.24  |- mesh__publicMeSHNote mesh__D015625 90   
% 208.06/208.24  |- skos__prefLabel mesh__D015625 Tissue Expanders
% 208.06/208.24  |- skos__annotation mesh__D015625
% 208.06/208.24       do not use /util except by MeSH definition   
% 208.06/208.24  |- skos__scopeNote mesh__D001605
% 208.06/208.24       A British colony in the western North Atlantic Ocean about 640 miles east southeast of Cape Hatteras, North Carolina. It comprises a group of about 300 islands of which only about 20 are inhabited. It is called also the Bermuda Islands or the Bermudas. It was named for the Spanish explorer Juan Bermudez who visited the islands in 1515. %28%From Webster%27%s New Geographical Dictionary, 1988, p140 %26% Room, Brewer%27%s Dictionary of Names, 1992, p61%29%%A%    
% 208.06/208.24  |- mesh__dateCreated mesh__D001605 1999-01-01
% 208.06/208.24  |- skos__annotation mesh__D001605 a British colony in the North Atlantic   
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001605 2000
% 208.06/208.24  |- mesh__recordMaintainer mesh__D001605 TGC
% 208.06/208.24  |- skos__prefLabel mesh__D001605 Bermuda
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001605 1998
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001605 1996
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001605 2005
% 208.06/208.24  |- mesh__activeMeSHYear mesh__D001605 1999
% 208.06/208.24  |- skos__broader mesh__D001605smesh__D001266
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D001605 2001
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D001605 2003
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D001605 1997
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D001605 2006
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D001605 2002
% 208.06/208.25  |- mesh__dateRevised mesh__D001605 1995-02-17
% 208.06/208.25  |- mesh__recordAuthorizer mesh__D001605 PLS
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D001605 2004
% 208.06/208.25  |- mesh__recordOriginator mesh__D001605 NLM
% 208.06/208.25  |- rdf__type mesh__D001605sskos__Concept
% 208.06/208.25  |- mesh__recordOriginator mesh__D006899 NLM
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D006899 2005
% 208.06/208.25  |- skos__annotation mesh__D006899 do not confuse with HYDRO-LYASES   
% 208.06/208.25  |- skos__altLabel mesh__D006899 Monooxygenases
% 208.06/208.25  |- skos__prefLabel mesh__D006899 Mixed Function Oxygenases
% 208.06/208.25  |- skos__hiddenLabel mesh__D006899 Oxygenases, Mixed Function
% 208.06/208.25  |- skos__hiddenLabel mesh__D006899 Oxidases, Mixed Function
% 208.06/208.25  |- mesh__historyNote mesh__D006899 2003 %28%1966%29%   
% 208.06/208.25  |- skos__broader mesh__D006899smesh__D010105
% 208.06/208.25  |- mesh__recordMaintainer mesh__D006899 ssb
% 208.06/208.25  |- skos__scopeNote mesh__D006899
% 208.06/208.25       Widely distributed enzymes that carry out oxidation-reduction reactions in which one atom of the oxygen molecule is incorporated into the organic substrate; the other oxygen atom is reduced and combined with hydrogen ions to form water. They are also known as monooxygenases or hydroxylases. These reactions require two substrates as reductants for each of the two oxygen atoms. There are different classes of monooxygenases depending on the type of hydrogen-providing cosubstrate %28%COENZYMES%29% required in the mixed-function oxidation.%A%    
% 208.06/208.25  |- skos__altLabel mesh__D006899 Hydroxylases
% 208.06/208.25  |- skos__altLabel mesh__D006899 Mixed Function Oxidases
% 208.06/208.25  |- rdf__type mesh__D006899sskos__Concept
% 208.06/208.25  |- mesh__recordAuthorizer mesh__D006899 sjn
% 208.06/208.25  |- mesh__dateRevised mesh__D006899 2004-07-07
% 208.06/208.25  |- mesh__dateCreated mesh__D006899 1999-01-01
% 208.06/208.25  |- mesh__publicMeSHNote mesh__D006899 2003 %28%1966%29%   
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D006899 2006
% 208.06/208.25  |- skos__prefLabel mesh__D031292 Clitoria
% 208.06/208.25  |- skos__annotation mesh__D031292
% 208.06/208.25       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.25  |- skos__broader mesh__D031292smesh__D007887
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D031292 2005
% 208.06/208.25  |- mesh__historyNote mesh__D031292 2003   
% 208.06/208.25  |- mesh__dateCreated mesh__D031292 2002-07-03
% 208.06/208.25  |- rdf__type mesh__D031292sskos__Concept
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D031292 2004
% 208.06/208.25  |- mesh__publicMeSHNote mesh__D031292 2003   
% 208.06/208.25  |- skos__scopeNote mesh__D031292
% 208.06/208.25       A plant genus of the family FABACEAE that contains ternatins %28%anthocyanins%29% and preternatins, antifungal proteins, stigmast-4-ene-3,6-dione, and clitoriacetal %28%ROTENONE%29%.%A%    
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D031292 2003
% 208.06/208.25  |- mesh__dateEstablished mesh__D031292 2003-01-01
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D031292 2006
% 208.06/208.25  |- skos__annotation mesh__D019218
% 208.06/208.25       infection: coord IM with PARVOVIRIDAE INFECTIONS %28%IM%29%   
% 208.06/208.25  |- mesh__dateRevised mesh__D019218 2004-07-27
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D019218 2005A
% 208.06/208.25  |- mesh__publicMeSHNote mesh__D019218 97   
% 208.06/208.25  |- skos__broader mesh__D019218smesh__D019219
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D019218 2005
% 208.06/208.25  |- mesh__recordAuthorizer mesh__D019218 jls
% 208.06/208.25  |- skos__altLabel mesh__D019218 Parvovirus, Simian
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D019218 2006
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D019218 2002
% 208.06/208.25  |- rdf__type mesh__D019218sskos__Concept
% 208.06/208.25  |- skos__prefLabel mesh__D019218 Erythrovirus
% 208.06/208.25  |- mesh__dateEstablished mesh__D019218 1997-01-01
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D019218 2003
% 208.06/208.25  |- mesh__historyNote mesh__D019218 97   
% 208.06/208.25  |- mesh__recordOriginator mesh__D019218 AGS
% 208.06/208.25  |- skos__hiddenLabel mesh__D019218 Erythroviruses
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D019218 2004
% 208.06/208.25  |- mesh__dateCreated mesh__D019218 1996-06-10
% 208.06/208.25  |- mesh__recordMaintainer mesh__D019218 jls
% 208.06/208.25  |- skos__scopeNote mesh__D019218
% 208.06/208.25       A genus of the family PARVOVIRIDAE, subfamily PARVOVIRINAE, and containing the type species PARVOVIRUS B19, HUMAN.%A%    
% 208.06/208.25  |- mesh__recordMaintainer mesh__D011235 TAP
% 208.06/208.25  |- mesh__recordOriginator mesh__D011235 NLM
% 208.06/208.25  |- skos__annotation mesh__D011235 animal only   
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D011235 2006
% 208.06/208.25  |- skos__broader mesh__D011235smesh__D001070
% 208.06/208.25  |- skos__prefLabel mesh__D011235 Predatory Behavior
% 208.06/208.25  |- skos__scopeNote mesh__D011235
% 208.06/208.25       Instinctual behavior pattern in which food is obtained by killing and consuming other species.%A%    
% 208.06/208.25  |- rdf__type mesh__D011235sskos__Concept
% 208.06/208.25  |- skos__broader mesh__D011235smesh__D003259
% 208.06/208.25  |- skos__hiddenLabel mesh__D011235 Predatory Behaviors
% 208.06/208.25  |- mesh__recordAuthorizer mesh__D011235 sjn
% 208.06/208.25  |- mesh__historyNote mesh__D011235
% 208.06/208.25       91%28%75%29%; was see under APPETITIVE BEHAVIOR 1975-90   
% 208.06/208.25  |- skos__hiddenLabel mesh__D011235 Behavior, Predatory
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D011235 2003
% 208.06/208.25  |- mesh__dateEstablished mesh__D011235 1991-01-01
% 208.06/208.25  |- skos__hiddenLabel mesh__D011235 Behaviors, Predatory
% 208.06/208.25  |- mesh__dateCreated mesh__D011235 1974-12-12
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D011235 2004
% 208.06/208.25  |- mesh__dateRevised mesh__D011235 2002-07-02
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D011235 2005
% 208.06/208.25  |- mesh__publicMeSHNote mesh__D011235
% 208.06/208.25       91; was see under APPETITIVE BEHAVIOR 1975-90   
% 208.06/208.25  |- skos__historyNote mesh__D035683 RNA, Untranslated %28%2001-2002%29%
% 208.06/208.25  |- skos__altLabel mesh__D035683 Micro RNA
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D035683 2004
% 208.06/208.25  |- mesh__historyNote mesh__D035683
% 208.06/208.25       2003; use MICRORNAS %28%NM%29% 2001-2002   
% 208.06/208.25  |- skos__altLabel mesh__D035683 miRNA
% 208.06/208.25  |- rdf__type mesh__D035683sskos__Concept
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D035683 2003
% 208.06/208.25  |- mesh__dateCreated mesh__D035683 2002-07-03
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D035683 2006
% 208.06/208.25  |- skos__scopeNote mesh__D035683
% 208.06/208.25       Small regulatory, ANTISENSE RNAs, 21-25 nucleotides in length that repress the translation %28%TRANSLATION, GENETIC%29% of homologous target RNA. The process by which they are generated is related to the process that produces small interfering RNAs %28%RNA, SMALL INTERFERING%29%. The small temporal RNAs %28%stRNAs%29%, let-7 and lin-4, from C. elegans are a class of miRNAs%A%    
% 208.06/208.25  |- skos__prefLabel mesh__D035683 MicroRNAs
% 208.06/208.25  |- skos__altLabel mesh__D035683 miRNAs
% 208.06/208.25  |- skos__hiddenLabel mesh__D035683 Temporal RNA, Small
% 208.06/208.25  |- skos__altLabel mesh__D035683 Small Temporal RNA
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D035683 2005
% 208.06/208.25  |- skos__historyNote mesh__D035683 RNA, Antisense %28%2001-2002%29%
% 208.06/208.25  |- skos__broader mesh__D035683smesh__D022661
% 208.06/208.25  |- skos__hiddenLabel mesh__D035683 RNA, Micro
% 208.06/208.25  |- skos__altLabel mesh__D035683 stRNA
% 208.06/208.25  |- skos__broader mesh__D035683smesh__D016372
% 208.06/208.25  |- mesh__publicMeSHNote mesh__D035683
% 208.06/208.25       2003; MICRORNAS was indexed under RNA, UNTRANSLATED and RNA, ANTISENSE 2001-2002%A%  
% 208.06/208.25  |- mesh__dateEstablished mesh__D035683 2003-01-01
% 208.06/208.25  |- skos__altLabel mesh__D035683 MicroRNA
% 208.06/208.25  |- skos__related mesh__D035683smesh__D034741
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007992 2001
% 208.06/208.25  |- rdf__type mesh__D007992sskos__Concept
% 208.06/208.25  |- skos__broader mesh__D007992smesh__D006739
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007992 2000
% 208.06/208.25  |- mesh__recordMaintainer mesh__D007992 kle
% 208.06/208.25  |- skos__scopeNote mesh__D007992
% 208.06/208.25       Information centers primarily serving the needs of hospital medical staff and sometimes also providing patient education and other services.%A%    
% 208.06/208.25  |- skos__annotation mesh__D007992
% 208.06/208.25       IM; specify geog or other site; DF: LIBRARIES HOSP   
% 208.06/208.25  |- skos__broader mesh__D007992smesh__D007990
% 208.06/208.25  |- mesh__dateRevised mesh__D007992 1999-11-03
% 208.06/208.25  |- skos__altLabel mesh__D007992 Library, Hospital
% 208.06/208.25  |- skos__altLabel mesh__D007992 Hospital Library
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007992 2006
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007992 2002
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007992 2004
% 208.06/208.25  |- mesh__dateCreated mesh__D007992 1999-01-01
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007992 2005
% 208.06/208.25  |- skos__altLabel mesh__D007992 Hospital Libraries
% 208.06/208.25  |- skos__prefLabel mesh__D007992 Libraries, Hospital
% 208.06/208.25  |- mesh__recordOriginator mesh__D007992 NLM
% 208.06/208.25  |- mesh__recordAuthorizer mesh__D007992 sjn
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007992 2003
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D029646 2002
% 208.06/208.25  |- skos__prefLabel mesh__D029646 Tiliaceae
% 208.06/208.25  |- mesh__historyNote mesh__D029646 2002   
% 208.06/208.25  |- skos__annotation mesh__D029646
% 208.06/208.25       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.25  |- skos__broader mesh__D029646smesh__D019684
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D029646 2004
% 208.06/208.25  |- mesh__dateCreated mesh__D029646 2001-07-25
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D029646 2006
% 208.06/208.25  |- mesh__dateEstablished mesh__D029646 2002-01-01
% 208.06/208.25  |- rdf__type mesh__D029646sskos__Concept
% 208.06/208.25  |- mesh__publicMeSHNote mesh__D029646 2002   
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D029646 2003
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D029646 2005
% 208.06/208.25  |- skos__scopeNote mesh__D029646
% 208.06/208.25       A plant family of the order Malvales, subclass Dilleniidae, class Magnoliopsida.%A%    
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007194 1998
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007194 2002
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007194 2003
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007194 2006
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007194 1990
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007194 1994
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007194 2001
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007194 2005
% 208.06/208.25  |- skos__annotation mesh__D007194
% 208.06/208.25       Indians are of CAUCASOID RACE unless otherwise specified   
% 208.06/208.25  |- skos__broader mesh__D007194smesh__D001211
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007194 2000
% 208.06/208.25  |- rdf__type mesh__D007194sskos__Concept
% 208.06/208.25  |- mesh__recordAuthorizer mesh__D007194 PLS
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007194 1989
% 208.06/208.25  |- mesh__recordOriginator mesh__D007194 NLM
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007194 1997
% 208.06/208.25  |- mesh__dateCreated mesh__D007194 1999-01-01
% 208.06/208.25  |- mesh__recordMaintainer mesh__D007194 PLS
% 208.06/208.25  |- skos__prefLabel mesh__D007194 India
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007194 1993
% 208.06/208.25  |- mesh__dateRevised mesh__D007194 1991-11-14
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007194 1996
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007194 1999
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007194 2004
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007194 1991
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007194 1992
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007194 1995
% 208.06/208.25  |- mesh__recordAuthorizer mesh__D015626 SJN
% 208.06/208.25  |- skos__historyNote mesh__D015626 Surgical Flaps %28%1983-1989%29%
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D015626 2000
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D015626 2003
% 208.06/208.25  |- rdf__type mesh__D015626sskos__Concept
% 208.06/208.25  |- skos__prefLabel mesh__D015626 Tissue Expansion
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D015626 2001
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D015626 2004
% 208.06/208.25  |- skos__broader mesh__D015626smesh__D019651
% 208.06/208.25  |- skos__annotation mesh__D015626
% 208.06/208.25       do not use /util except by MeSH definition   
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D015626 2002
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D015626 2005
% 208.06/208.25  |- skos__hiddenLabel mesh__D015626 Expansions, Tissue
% 208.06/208.25  |- mesh__publicMeSHNote mesh__D015626 90   
% 208.06/208.25  |- skos__hiddenLabel mesh__D015626 Expansion, Tissue
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D015626 1998
% 208.06/208.25  |- mesh__dateRevised mesh__D015626 1997-06-20
% 208.06/208.25  |- skos__hiddenLabel mesh__D015626 Tissue Expansions
% 208.06/208.25  |- skos__historyNote mesh__D015626 Surgery, Plastic %28%1980-1989%29%
% 208.06/208.25  |- mesh__recordOriginator mesh__D015626 AGS
% 208.06/208.25  |- mesh__dateCreated mesh__D015626 1989-04-07
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D015626 2006
% 208.06/208.25  |- mesh__recordMaintainer mesh__D015626 PXP
% 208.06/208.25  |- mesh__historyNote mesh__D015626 90   
% 208.06/208.25  |- mesh__dateEstablished mesh__D015626 1990-01-01
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D015626 1999
% 208.06/208.25  |- skos__scopeNote mesh__D015626
% 208.06/208.25       Process whereby tissue adjacent to a soft tissue defect is expanded by means of a subcutaneously implanted reservoir. The procedure is used in reconstructive surgery for injuries caused by trauma, burns, or ablative surgery.%A%    
% 208.06/208.25  |- skos__broader mesh__D016226Q000737smesh__D016226
% 208.06/208.25  |- mesh__preferredCombination mesh__D016226Q000737smesh__D010758Q000737
% 208.06/208.25  |- rdf__type mesh__D016226Q000737smesh__CompoundConcept
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D001606 2002
% 208.06/208.25  |- skos__historyNote mesh__D001606
% 208.06/208.25       Blood Platelet Disorders %28%1967-1985%29%
% 208.06/208.25  |- mesh__dateCreated mesh__D001606 1985-03-11
% 208.06/208.25  |- mesh__recordOriginator mesh__D001606 VDK
% 208.06/208.25  |- skos__hiddenLabel mesh__D001606 Bernard Soulier Syndrome
% 208.06/208.25  |- mesh__dateRevised mesh__D001606 2001-07-25
% 208.06/208.25  |- skos__broader mesh__D001606smesh__D025861
% 208.06/208.25  |- mesh__historyNote mesh__D001606
% 208.06/208.25       91%28%86%29%; was see under BLOOD PLATELET DISORDERS 1986-90   
% 208.06/208.25  |- skos__scopeNote mesh__D001606
% 208.06/208.25       A familial coagulation disorder characterized by a prolonged bleeding time, unusually large platelets, and impaired prothrombin consumption.%A%    
% 208.06/208.25  |- skos__prefLabel mesh__D001606 Bernard-Soulier Syndrome
% 208.06/208.25  |- mesh__publicMeSHNote mesh__D001606
% 208.06/208.25       91; was see under BLOOD PLATELET DISORDERS 1986-90   
% 208.06/208.25  |- skos__altLabel mesh__D001606 Giant Platelet Syndrome
% 208.06/208.25  |- mesh__recordAuthorizer mesh__D001606 sjn
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D001606 2005
% 208.06/208.25  |- mesh__recordMaintainer mesh__D001606 nns
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D001606 2003
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D001606 2006
% 208.06/208.25  |- skos__broader mesh__D001606smesh__D006474
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D001606 2004
% 208.06/208.25  |- skos__hiddenLabel mesh__D001606 Syndrome, Giant Platelet
% 208.06/208.25  |- rdf__type mesh__D001606sskos__Concept
% 208.06/208.25  |- skos__broader mesh__D001606smesh__D001791
% 208.06/208.25  |- mesh__dateEstablished mesh__D001606 1991-01-01
% 208.06/208.25  |- skos__annotation mesh__D001606 a familial blood platelet disord   
% 208.06/208.25  |- skos__hiddenLabel mesh__D001606 Syndrome, Bernard-Soulier
% 208.06/208.25  |- skos__scopeNote mesh__D031293
% 208.06/208.25       A plant genus of the family FABACEAE that is the source of guar gum.%A%    
% 208.06/208.25  |- skos__annotation mesh__D031293
% 208.06/208.25       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.25  |- mesh__dateEstablished mesh__D031293 2003-01-01
% 208.06/208.25  |- skos__prefLabel mesh__D031293 Cyamopsis
% 208.06/208.25  |- mesh__recordMaintainer mesh__D031293 ssb
% 208.06/208.25  |- mesh__recordAuthorizer mesh__D031293 sjn
% 208.06/208.25  |- mesh__dateRevised mesh__D031293 2003-07-09
% 208.06/208.25  |- mesh__historyNote mesh__D031293 2003   
% 208.06/208.25  |- rdf__type mesh__D031293sskos__Concept
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D031293 2004
% 208.06/208.25  |- mesh__dateCreated mesh__D031293 2002-07-03
% 208.06/208.25  |- mesh__publicMeSHNote mesh__D031293 2003   
% 208.06/208.25  |- skos__broader mesh__D031293smesh__D007887
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D031293 2005
% 208.06/208.25  |- skos__altLabel mesh__D031293 Guar
% 208.06/208.25  |- skos__altLabel mesh__D031293 Cyamposis
% 208.06/208.25  |- mesh__recordOriginator mesh__D031293 ssb
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D031293 2006
% 208.06/208.25  |- skos__broader mesh__D047708smesh__D009372
% 208.06/208.25  |- mesh__publicMeSHNote mesh__D047708 2005; see LEIOMYOMA 1994-2004   
% 208.06/208.25  |- mesh__recordMaintainer mesh__D047708 ags
% 208.06/208.25  |- mesh__historyNote mesh__D047708 2005; use LEIOMYOMA 1994-2004   
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D047708 2005
% 208.06/208.25  |- mesh__dateEstablished mesh__D047708 2005-01-01
% 208.06/208.25  |- skos__scopeNote mesh__D047708
% 208.06/208.25       A benign tumor that consists chiefly of fibrous CONNECTIVE TISSUE, with variable numbers of MUSCLE CELLS forming portions of the neoplasm %28%From Stedman%27%s, 27th ed%29%.%A%    
% 208.06/208.25  |- skos__hiddenLabel mesh__D047708 Myofibromas
% 208.06/208.25  |- mesh__recordAuthorizer mesh__D047708 sjn
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D047708 2006
% 208.06/208.25  |- mesh__dateCreated mesh__D047708 2004-07-07
% 208.06/208.25  |- skos__prefLabel mesh__D047708 Myofibroma
% 208.06/208.25  |- mesh__recordOriginator mesh__D047708 ags
% 208.06/208.25  |- rdf__type mesh__D047708sskos__Concept
% 208.06/208.25  |- skos__annotation mesh__D047708
% 208.06/208.25       coordinate IM with organ/neoplasm term %28%IM%29%   
% 208.06/208.25  |- skos__historyNote mesh__D047708 Leiomyoma %28%1963-2004%29%
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D019219 2003
% 208.06/208.25  |- skos__annotation mesh__D019219
% 208.06/208.25       a subfamily of the family Parvoviridae; infection: coord IM with PARVOVIRIDAE INFECTIONS %28%IM%29%%A%  
% 208.06/208.25  |- mesh__recordAuthorizer mesh__D019219 sjn
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D019219 2002
% 208.06/208.25  |- skos__broader mesh__D019219smesh__D010321
% 208.06/208.25  |- mesh__dateEstablished mesh__D019219 1997-01-01
% 208.06/208.25  |- mesh__dateCreated mesh__D019219 1996-06-10
% 208.06/208.25  |- mesh__recordOriginator mesh__D019219 AGS
% 208.06/208.25  |- mesh__publicMeSHNote mesh__D019219 97   
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D019219 2006
% 208.06/208.25  |- skos__prefLabel mesh__D019219 Parvovirinae
% 208.06/208.25  |- mesh__dateRevised mesh__D019219 2001-07-25
% 208.06/208.25  |- skos__scopeNote mesh__D019219
% 208.06/208.25       A subfamily of DNA vertebrate viruses, in the family PARVOVIRIDAE. There are three genera: PARVOVIRUS; ERYTHROVIRUS; and DEPENDOVIRUS.%A%    
% 208.06/208.25  |- rdf__type mesh__D019219sskos__Concept
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D019219 2004
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D019219 2005
% 208.06/208.25  |- mesh__recordMaintainer mesh__D019219 mdb
% 208.06/208.25  |- mesh__historyNote mesh__D019219 97   
% 208.06/208.25  |- skos__related mesh__D011236smesh__D006943
% 208.06/208.25  |- mesh__dateRevised mesh__D011236 2004-07-07
% 208.06/208.25  |- mesh__recordMaintainer mesh__D011236 lkt
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D011236 2006
% 208.06/208.25  |- mesh__recordOriginator mesh__D011236 NLM
% 208.06/208.25  |- skos__annotation mesh__D011236
% 208.06/208.25       do not use /compl for development into diabetes mellitus; coordinate IM with specific type of diabetes mellitus %28%IM%29% if pertinent%A%  
% 208.06/208.25  |- skos__broader mesh__D011236smesh__D003920
% 208.06/208.25  |- rdf__type mesh__D011236sskos__Concept
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D011236 2005
% 208.06/208.25  |- mesh__publicMeSHNote mesh__D011236 68   
% 208.06/208.25  |- skos__altLabel mesh__D011236 Prediabetes
% 208.06/208.25  |- skos__scopeNote mesh__D011236
% 208.06/208.25       The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes %28%DIABETES MELLITUS, TYPE 2%29%.%A%    
% 208.06/208.25  |- mesh__recordAuthorizer mesh__D011236 sjn
% 208.06/208.25  |- mesh__historyNote mesh__D011236 68%28%65%29%   
% 208.06/208.25  |- skos__hiddenLabel mesh__D011236 State, Prediabetic
% 208.06/208.25  |- mesh__dateEstablished mesh__D011236 1968-01-01
% 208.06/208.25  |- mesh__dateCreated mesh__D011236 1999-01-01
% 208.06/208.25  |- skos__hiddenLabel mesh__D011236 States, Prediabetic
% 208.06/208.25  |- skos__hiddenLabel mesh__D011236 Prediabetic States
% 208.06/208.25  |- skos__prefLabel mesh__D011236 Prediabetic State
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D035684 2003
% 208.06/208.25  |- mesh__dateEstablished mesh__D035684 2003-01-01
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D035684 2006
% 208.06/208.25  |- skos__scopeNote mesh__D035684
% 208.06/208.25       A plant genus of the family Gnetaceae, order Gnetales class Gnetopsida, division GNETOPHYTA. Members contain STILBENES and benzylisoquinoline alkaloids.%A%    
% 208.06/208.25  |- skos__annotation mesh__D035684
% 208.06/208.25       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D035684 2005
% 208.06/208.25  |- mesh__publicMeSHNote mesh__D035684 2003   
% 208.06/208.25  |- skos__broader mesh__D035684smesh__D035682
% 208.06/208.25  |- skos__prefLabel mesh__D035684 Gnetum
% 208.06/208.25  |- mesh__dateCreated mesh__D035684 2002-07-03
% 208.06/208.25  |- mesh__historyNote mesh__D035684 2003   
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D035684 2004
% 208.06/208.25  |- rdf__type mesh__D035684sskos__Concept
% 208.06/208.25  |- skos__hiddenLabel mesh__D007993 Science Library, Health
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007993 2006
% 208.06/208.25  |- skos__altLabel mesh__D007993 Library, Medical
% 208.06/208.25  |- mesh__recordOriginator mesh__D007993 NLM
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007993 2005
% 208.06/208.25  |- mesh__recordAuthorizer mesh__D007993 sjn
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007993 2004
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007993 2001
% 208.06/208.25  |- mesh__dateCreated mesh__D007993 1999-01-01
% 208.06/208.25  |- skos__broader mesh__D007993smesh__D007990
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007993 2003
% 208.06/208.25  |- skos__hiddenLabel mesh__D007993 Library, Health Science
% 208.06/208.25  |- mesh__recordMaintainer mesh__D007993 kle
% 208.06/208.25  |- mesh__dateRevised mesh__D007993 1999-11-03
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007993 2000
% 208.06/208.25  |- skos__hiddenLabel mesh__D007993 Health Science Libraries
% 208.06/208.25  |- skos__annotation mesh__D007993
% 208.06/208.25       private %26% public libraries; includes private collections of books; IM; specify geog or other site; DF: LIBRARIES MED%A%  
% 208.06/208.25  |- skos__hiddenLabel mesh__D007993 Science Libraries, Health
% 208.06/208.25  |- rdf__type mesh__D007993sskos__Concept
% 208.06/208.25  |- skos__altLabel mesh__D007993 Medical Libraries
% 208.06/208.25  |- skos__altLabel mesh__D007993 Medical Library
% 208.06/208.25  |- skos__prefLabel mesh__D007993 Libraries, Medical
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007993 2002
% 208.06/208.25  |- skos__hiddenLabel mesh__D007993 Health Science Library
% 208.06/208.25  |- skos__scopeNote mesh__D029647
% 208.06/208.25       A plant genus of the family Turneraceae, order Violales, subclass Dilleniidae, class Magnoliopsida.%A%    
% 208.06/208.25  |- skos__annotation mesh__D029647
% 208.06/208.25       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D029647 2002
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D029647 2004
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D029647 2006
% 208.06/208.25  |- mesh__dateEstablished mesh__D029647 2002-01-01
% 208.06/208.25  |- rdf__type mesh__D029647sskos__Concept
% 208.06/208.25  |- mesh__historyNote mesh__D029647 2002   
% 208.06/208.25  |- mesh__publicMeSHNote mesh__D029647 2002   
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D029647 2003
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D029647 2005
% 208.06/208.25  |- skos__broader mesh__D029647smesh__D019684
% 208.06/208.25  |- skos__prefLabel mesh__D029647 Turnera
% 208.06/208.25  |- mesh__dateCreated mesh__D029647 2001-07-25
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007195 2002
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007195 2006
% 208.06/208.25  |- mesh__recordMaintainer mesh__D007195 TGC
% 208.06/208.25  |- skos__scopeNote mesh__D007195
% 208.06/208.25       Numerous islands in the Indian Ocean situated east of Madagascar, north to the Arabian Sea and east to Sri Lanka. Included are COMOROS %28%republic%29%, MADAGASCAR %28%republic%29%, Maldives %28%republic%29%, MAURITIUS %28%parliamentary democracy%29%, Pemba %28%administered by Tanzania%29%, REUNION %28%a department of France%29%, and SEYCHELLES %28%republic%29%.%A%    
% 208.06/208.25  |- mesh__dateCreated mesh__D007195 1999-01-01
% 208.06/208.25  |- rdf__type mesh__D007195sskos__Concept
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007195 2000
% 208.06/208.25  |- mesh__recordAuthorizer mesh__D007195 PLS
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007195 1996
% 208.06/208.25  |- mesh__dateRevised mesh__D007195 1995-02-17
% 208.06/208.25  |- skos__broader mesh__D007195smesh__D005842
% 208.06/208.25  |- skos__prefLabel mesh__D007195 Indian Ocean Islands
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007195 2001
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007195 1998
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007195 1997
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007195 2003
% 208.06/208.25  |- skos__annotation mesh__D007195
% 208.06/208.25       in addition to indentions here, includes Maldives, Pemba %26% Cocos %28%Keeling%29% Islands%A%  
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007195 1999
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007195 2005
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D007195 2004
% 208.06/208.25  |- mesh__recordOriginator mesh__D007195 NLM
% 208.06/208.25  |- skos__broader mesh__D005224Q000737smesh__D005224
% 208.06/208.25  |- rdf__type mesh__D005224Q000737smesh__CompoundConcept
% 208.06/208.25  |- skos__hiddenLabel mesh__D001607 Beryllioses
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D001607 1999
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D001607 2000
% 208.06/208.25  |- skos__historyNote mesh__D001607 Lung Diseases %28%1966-1978%29%
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D001607 2003
% 208.06/208.25  |- skos__prefLabel mesh__D001607 Berylliosis
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D001607 2006
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D001607 2001
% 208.06/208.25  |- skos__broader mesh__D001607smesh__D011009
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D001607 1997
% 208.06/208.25  |- mesh__recordOriginator mesh__D001607 VDK
% 208.06/208.25  |- mesh__dateRevised mesh__D001607 1993-03-03
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D001607 2004
% 208.06/208.25  |- mesh__recordMaintainer mesh__D001607 PLS
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D001607 2002
% 208.06/208.25  |- skos__historyNote mesh__D001607 Pneumoconiosis %28%1966-1978%29%
% 208.06/208.25  |- rdf__type mesh__D001607sskos__Concept
% 208.06/208.25  |- mesh__recordAuthorizer mesh__D001607 PLS
% 208.06/208.25  |- mesh__dateCreated mesh__D001607 1978-05-19
% 208.06/208.25  |- mesh__activeMeSHYear mesh__D001607 1994
% 208.06/208.25  |- skos__scopeNote mesh__D001607
% 208.06/208.25       A lung disease caused by exposure to metallic beryllium or its soluble salts.%A%    
% 208.06/208.25  |- mesh__historyNote mesh__D001607 79   
% 208.06/208.26  |- mesh__dateEstablished mesh__D001607 1979-01-01
% 208.06/208.26  |- mesh__publicMeSHNote mesh__D001607 79   
% 208.06/208.26  |- skos__annotation mesh__D001607
% 208.06/208.26       pneumoconiosis from beryllium; do not coord with OCCUPATIONAL DISEASES%A%  
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D001607 1998
% 208.06/208.26  |- skos__altLabel mesh__D001607 Beryllium Disease
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D001607 1995
% 208.06/208.26  |- skos__hiddenLabel mesh__D001607 Disease, Beryllium
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D001607 2005
% 208.06/208.26  |- skos__historyNote mesh__D001607 Occupational Diseases %28%1966-1978%29%
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D001607 1996
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D031294 2003
% 208.06/208.26  |- mesh__dateEstablished mesh__D031294 2003-01-01
% 208.06/208.26  |- skos__prefLabel mesh__D031294 Dolichos
% 208.06/208.26  |- rdf__type mesh__D031294sskos__Concept
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D031294 2004
% 208.06/208.26  |- mesh__publicMeSHNote mesh__D031294 2003   
% 208.06/208.26  |- skos__broader mesh__D031294smesh__D007887
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D031294 2005
% 208.06/208.26  |- skos__scopeNote mesh__D031294
% 208.06/208.26       A plant genus of the family FABACEAE that contains LECTINS. Many members have been reclassified into other genera of the FABACEAE family.%A%    
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D031294 2006
% 208.06/208.26  |- mesh__historyNote mesh__D031294 2003   
% 208.06/208.26  |- mesh__dateCreated mesh__D031294 2002-07-03
% 208.06/208.26  |- skos__annotation mesh__D031294
% 208.06/208.26       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.26  |- skos__prefLabel mesh__D047709 Hirudo medicinalis
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D047709 2005
% 208.06/208.26  |- mesh__historyNote mesh__D047709 2005; use LEECHES 2002-2004   
% 208.06/208.26  |- mesh__publicMeSHNote mesh__D047709 2005; see LEECHES 2002-2004   
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D047709 2006
% 208.06/208.26  |- mesh__dateCreated mesh__D047709 2004-07-07
% 208.06/208.26  |- skos__broader mesh__D047709smesh__D007865
% 208.06/208.26  |- rdf__type mesh__D047709sskos__Concept
% 208.06/208.26  |- mesh__dateEstablished mesh__D047709 2005-01-01
% 208.06/208.26  |- mesh__recordAuthorizer mesh__D047709 sjn
% 208.06/208.26  |- skos__scopeNote mesh__D047709
% 208.06/208.26       A species of European freshwater LEECHES used for BLOODLETTING in ancient times and also for LEECHING in modern times.%A%    
% 208.06/208.26  |- mesh__recordOriginator mesh__D047709 ags
% 208.06/208.26  |- skos__historyNote mesh__D047709 Leeches %28%1965-2004%29%
% 208.06/208.26  |- mesh__recordMaintainer mesh__D047709 ags
% 208.06/208.26  |- skos__broader mesh__D011237smesh__D012680
% 208.06/208.26  |- skos__prefLabel mesh__D011237 Predictive Value of Tests
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D011237 2006
% 208.06/208.26  |- skos__scopeNote mesh__D011237
% 208.06/208.26       In screening and diagnostic tests, the probability that a person with a positive test is a true positive %28%i.e., has the disease%29%, is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.%A%    
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D011237 2002
% 208.06/208.26  |- rdf__type mesh__D011237sskos__Concept
% 208.06/208.26  |- mesh__dateRevised mesh__D011237 2001-07-25
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D011237 2005
% 208.06/208.26  |- skos__related mesh__D011237smesh__D005188
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D011237 2004
% 208.06/208.26  |- mesh__dateCreated mesh__D011237 1986-03-25
% 208.06/208.26  |- mesh__recordOriginator mesh__D011237 EC
% 208.06/208.26  |- skos__related mesh__D011237smesh__D005189
% 208.06/208.26  |- mesh__publicMeSHNote mesh__D011237 87   
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D011237 2003
% 208.06/208.26  |- skos__annotation mesh__D011237
% 208.06/208.26       IM GEN only; coord NIM with specific disease %28%IM%29%; no qualif; specify geog if pertinent%A%  
% 208.06/208.26  |- mesh__historyNote mesh__D011237 87   
% 208.06/208.26  |- mesh__dateEstablished mesh__D011237 1987-01-01
% 208.06/208.26  |- skos__broader mesh__D011237smesh__D011336
% 208.06/208.26  |- mesh__recordMaintainer mesh__D011237 ags
% 208.06/208.26  |- mesh__recordAuthorizer mesh__D011237 sjn
% 208.06/208.26  |- skos__scopeNote mesh__D016720
% 208.06/208.26       Infections with species in the genus PNEUMOCYSTIS, a fungus causing interstitial plasma cell pneumonia %28%PNEUMONIA, PNEUMOCYSTIS%29% and other infections in humans and other MAMMALS. Immunocompromised patients, especially those with AIDS, are particularly susceptible to these infections. Extrapulmonary sites are rare but seen occasionally.%A%    
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D016720 2006
% 208.06/208.26  |- mesh__recordAuthorizer mesh__D016720 sjn
% 208.06/208.26  |- mesh__publicMeSHNote mesh__D016720
% 208.06/208.26       2004; see PNEUMOCYSTIS CARINII INFECTIONS 1992-2003   
% 208.06/208.26  |- mesh__historyNote mesh__D016720 2004 %28%1992%29%   
% 208.06/208.26  |- mesh__dateCreated mesh__D016720 1991-02-11
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D016720 2005
% 208.06/208.26  |- skos__historyNote mesh__D016720 Mycoses %28%1989-1991%29%
% 208.06/208.26  |- skos__hiddenLabel mesh__D016720 Infection, Pneumocystis
% 208.06/208.26  |- mesh__dateEstablished mesh__D016720 1992-01-01
% 208.06/208.26  |- mesh__dateRevised mesh__D016720 2003-07-09
% 208.06/208.26  |- rdf__type mesh__D016720sskos__Concept
% 208.06/208.26  |- skos__hiddenLabel mesh__D016720 Pneumocystis carinii Infection
% 208.06/208.26  |- skos__annotation mesh__D016720
% 208.06/208.26       coord IM with precoord organ/dis term %28%IM%29% but consider more commonly PNEUMONIA, PNEUMOCYSTIS%A%  
% 208.06/208.26  |- skos__hiddenLabel mesh__D016720 Infections, Pneumocystis
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D016720 2004
% 208.06/208.26  |- skos__historyNote mesh__D016720
% 208.06/208.26       Pneumonia, Pneumocystis carinii %28%1966-1991%29%
% 208.06/208.26  |- mesh__recordMaintainer mesh__D016720 ags
% 208.06/208.26  |- mesh__recordOriginator mesh__D016720 AGS
% 208.06/208.26  |- skos__broader mesh__D016720smesh__D009181
% 208.06/208.26  |- skos__historyNote mesh__D016720 Protozoan Infections %28%1985-1988%29%
% 208.06/208.26  |- skos__hiddenLabel mesh__D016720 Pneumocystis Infection
% 208.06/208.26  |- skos__prefLabel mesh__D016720 Pneumocystis Infections
% 208.06/208.26  |- skos__altLabel mesh__D016720 Pneumocystis carinii Infections
% 208.06/208.26  |- mesh__historyNote mesh__D035685 2003   
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D035685 2005
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D035685 2006
% 208.06/208.26  |- skos__annotation mesh__D035685
% 208.06/208.26       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.26  |- mesh__dateEstablished mesh__D035685 2003-01-01
% 208.06/208.26  |- mesh__dateCreated mesh__D035685 2002-07-02
% 208.06/208.26  |- skos__scopeNote mesh__D035685
% 208.06/208.26       A plant genus of the family ACANTHACEAE. Members contain andrographolide and other DITERPENES and androechin, a CHALCONE.%A%    
% 208.06/208.26  |- mesh__publicMeSHNote mesh__D035685 2003   
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D035685 2003
% 208.06/208.26  |- skos__broader mesh__D035685smesh__D027901
% 208.06/208.26  |- skos__prefLabel mesh__D035685 Andrographis
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D035685 2004
% 208.06/208.26  |- rdf__type mesh__D035685sskos__Concept
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D002700 2003
% 208.06/208.26  |- mesh__recordAuthorizer mesh__D002700 sjn
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D002700 2004
% 208.06/208.26  |- rdf__type mesh__D002700sskos__Concept
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D002700 2002
% 208.06/208.26  |- mesh__recordMaintainer mesh__D002700 CCR
% 208.06/208.26  |- mesh__dateCreated mesh__D002700 1999-01-01
% 208.06/208.26  |- skos__prefLabel mesh__D002700 Chloramines
% 208.06/208.26  |- skos__broader mesh__D002700smesh__D013449
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D002700 2005
% 208.06/208.26  |- mesh__dateRevised mesh__D002700 2000-06-22
% 208.06/208.26  |- skos__altLabel mesh__D002700 Chloroamines
% 208.06/208.26  |- mesh__recordOriginator mesh__D002700 NLM
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D002700 2006
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D002700 2001
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007994 2005
% 208.06/208.26  |- mesh__dateEstablished mesh__D007994 1967-01-01
% 208.06/208.26  |- skos__annotation mesh__D007994
% 208.06/208.26       IM; specify geog or other site; DF: LIBRARIES NURS   
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007994 2004
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007994 2002
% 208.06/208.26  |- mesh__dateCreated mesh__D007994 1999-01-01
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007994 2003
% 208.06/208.26  |- skos__hiddenLabel mesh__D007994 Nursing Library
% 208.06/208.26  |- mesh__recordOriginator mesh__D007994 NLM
% 208.06/208.26  |- mesh__recordAuthorizer mesh__D007994 sjn
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007994 2001
% 208.06/208.26  |- mesh__publicMeSHNote mesh__D007994 67   
% 208.06/208.26  |- rdf__type mesh__D007994sskos__Concept
% 208.06/208.26  |- skos__broader mesh__D007994smesh__D007990
% 208.06/208.26  |- skos__prefLabel mesh__D007994 Libraries, Nursing
% 208.06/208.26  |- skos__hiddenLabel mesh__D007994 Library, Nursing
% 208.06/208.26  |- mesh__dateRevised mesh__D007994 1999-11-03
% 208.06/208.26  |- mesh__recordMaintainer mesh__D007994 kle
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007994 2000
% 208.06/208.26  |- mesh__historyNote mesh__D007994 67%28%65%29%   
% 208.06/208.26  |- skos__altLabel mesh__D007994 Nursing Libraries
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007994 2006
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D029648 2006
% 208.06/208.26  |- rdf__type mesh__D029648sskos__Concept
% 208.06/208.26  |- skos__scopeNote mesh__D029648
% 208.06/208.26       A plant family of the order Lamiales, subclass Asteridae, class Magnoliopsida. The leaves are opposite or whorled. The flowers are aggregated in spikes, clusters, or racemes.%A%    
% 208.06/208.26  |- mesh__publicMeSHNote mesh__D029648 2002   
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D029648 2003
% 208.06/208.26  |- mesh__dateCreated mesh__D029648 2001-07-25
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D029648 2005
% 208.06/208.26  |- mesh__dateEstablished mesh__D029648 2002-01-01
% 208.06/208.26  |- skos__prefLabel mesh__D029648 Verbenaceae
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D029648 2002
% 208.06/208.26  |- skos__annotation mesh__D029648
% 208.06/208.26       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.26  |- skos__broader mesh__D029648smesh__D019684
% 208.06/208.26  |- mesh__historyNote mesh__D029648 2002   
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D029648 2004
% 208.06/208.26  |- mesh__dateCreated mesh__D007196 1999-01-01
% 208.06/208.26  |- mesh__recordAuthorizer mesh__D007196 SJN
% 208.06/208.26  |- rdf__type mesh__D007196sskos__Concept
% 208.06/208.26  |- mesh__recordOriginator mesh__D007196 NLM
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007196 2002
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007196 1998
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007196 2003
% 208.06/208.26  |- mesh__dateRevised mesh__D007196 1997-06-20
% 208.06/208.26  |- skos__broader mesh__D007196smesh__D006114
% 208.06/208.26  |- skos__broader mesh__D007196smesh__D015146
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007196 2000
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007196 1999
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007196 2005
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007196 2004
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007196 2001
% 208.06/208.26  |- mesh__recordMaintainer mesh__D007196 PXP
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007196 2006
% 208.06/208.26  |- skos__prefLabel mesh__D007196 Indiana
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D040021 2006
% 208.06/208.26  |- skos__historyNote mesh__D040021 Mites %28%1965-2002%29%
% 208.06/208.26  |- mesh__historyNote mesh__D040021 2003   
% 208.06/208.26  |- skos__prefLabel mesh__D040021 Sarcoptidae
% 208.06/208.26  |- skos__scopeNote mesh__D040021
% 208.06/208.26       Family of MITES, in the superfamily Sarcoptoidea, order Astigmata. They are slow moving, obligate PARASITES that infect MAMMALS and BIRDS. The species SARCOPTIDAE SCABIEI causes SCABIES.%A%    
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D040021 2004
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D040021 2005
% 208.06/208.26  |- mesh__publicMeSHNote mesh__D040021 2003   
% 208.06/208.26  |- mesh__dateCreated mesh__D040021 2002-07-03
% 208.06/208.26  |- skos__annotation mesh__D040021
% 208.06/208.26       infestation: coord IM with MITE INFESTATIONS %28%IM%29%   
% 208.06/208.26  |- skos__broader mesh__D040021smesh__D008925
% 208.06/208.26  |- mesh__dateRevised mesh__D040021 2003-07-09
% 208.06/208.26  |- mesh__dateEstablished mesh__D040021 2003-01-01
% 208.06/208.26  |- rdf__type mesh__D040021sskos__Concept
% 208.06/208.26  |- mesh__recordAuthorizer mesh__D001608 sjn
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D001608 2004
% 208.06/208.26  |- mesh__recordMaintainer mesh__D001608 jmp
% 208.06/208.26  |- rdf__type mesh__D001608sskos__Concept
% 208.06/208.26  |- skos__broader mesh__D001608smesh__D008673
% 208.06/208.26  |- mesh__dateCreated mesh__D001608 1999-01-01
% 208.06/208.26  |- skos__broader mesh__D001608smesh__D019565
% 208.06/208.26  |- skos__scopeNote mesh__D001608
% 208.06/208.26       Beryllium. An element with the atomic symbol Be, atomic number 4, and atomic weight 9.01218. Short exposure to this element can lead to a type of poisoning known as BERYLLIOSIS.%A%    
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D001608 2002
% 208.06/208.26  |- mesh__dateRevised mesh__D001608 2001-07-25
% 208.06/208.26  |- skos__annotation mesh__D001608
% 208.06/208.26       Be-9; Be-6-8, 10, 11 = BERYLLIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%; /adv eff /tox permitted but /pois = BERYLLIOSIS%A%  
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D001608 2005
% 208.06/208.26  |- mesh__recordOriginator mesh__D001608 NLM
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D001608 2003
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D001608 2006
% 208.06/208.26  |- skos__prefLabel mesh__D001608 Beryllium
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D012330 2003
% 208.06/208.26  |- skos__hiddenLabel mesh__D012330 RNA, Double Stranded
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D012330 1995
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D012330 1998
% 208.06/208.26  |- skos__prefLabel mesh__D012330 RNA, Double-Stranded
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D012330 2000
% 208.06/208.26  |- skos__altLabel mesh__D012330 Double-Stranded RNA
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D012330 2006
% 208.06/208.26  |- skos__historyNote mesh__D012330 RNA %28%1966-1979%29%
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D012330 1994
% 208.06/208.26  |- mesh__publicMeSHNote mesh__D012330 80   
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D012330 2005
% 208.06/208.26  |- mesh__dateEstablished mesh__D012330 1980-01-01
% 208.06/208.26  |- mesh__historyNote mesh__D012330 80   
% 208.06/208.26  |- mesh__recordAuthorizer mesh__D012330 PLS
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D012330 2002
% 208.06/208.26  |- rdf__type mesh__D012330sskos__Concept
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D012330 1997
% 208.06/208.26  |- mesh__recordOriginator mesh__D012330 RLS
% 208.06/208.26  |- skos__scopeNote mesh__D012330
% 208.06/208.26       RNA consisting of two strands as opposed to the more prevalent single-stranded RNA. Most of the double-stranded segments are formed from transcription of DNA by intramolecular base-pairing of inverted complementary sequences separated by a single-stranded loop. Some double-stranded segments of RNA are normal in all organisms.%A%    
% 208.06/208.26  |- mesh__dateCreated mesh__D012330 1979-05-25
% 208.06/208.26  |- skos__hiddenLabel mesh__D012330 Double Stranded RNA
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D012330 1996
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D012330 1993
% 208.06/208.26  |- mesh__dateRevised mesh__D012330 1992-05-20
% 208.06/208.26  |- skos__broader mesh__D012330smesh__D012313
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D012330 2004
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D012330 2001
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D012330 1999
% 208.06/208.26  |- skos__annotation mesh__D012330
% 208.06/208.26       IM; /drug eff /ultrastruct permitted; DF: DSRNA   
% 208.06/208.26  |- mesh__recordMaintainer mesh__D012330 TGC
% 208.06/208.26  |- skos__broader mesh__D031295smesh__D007887
% 208.06/208.26  |- mesh__publicMeSHNote mesh__D031295 2003   
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D031295 2005
% 208.06/208.26  |- mesh__historyNote mesh__D031295 2003   
% 208.06/208.26  |- mesh__dateCreated mesh__D031295 2002-07-03
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D031295 2006
% 208.06/208.26  |- skos__annotation mesh__D031295
% 208.06/208.26       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.26  |- mesh__dateEstablished mesh__D031295 2003-01-01
% 208.06/208.26  |- skos__scopeNote mesh__D031295
% 208.06/208.26       A plant genus of the family FABACEAE. Members contain Griffonia simplicifolia agglutin-I and griffonin.%A%    
% 208.06/208.26  |- skos__prefLabel mesh__D031295 Griffonia
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D031295 2003
% 208.06/208.26  |- rdf__type mesh__D031295sskos__Concept
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D031295 2004
% 208.06/208.26  |- mesh__historyNote mesh__D011238
% 208.06/208.26       91%28%80%29%; was see under CHLORAMBUCIL 1980-90   
% 208.06/208.26  |- skos__broader mesh__D011238smesh__D002699
% 208.06/208.26  |- skos__altLabel mesh__D011238 Sterecyt
% 208.06/208.26  |- skos__prefLabel mesh__D011238 Prednimustine
% 208.06/208.26  |- mesh__recordMaintainer mesh__D011238 lkw
% 208.06/208.26  |- skos__historyNote mesh__D011238
% 208.06/208.26       Chlorambucil %28%1966-1974%29% /analogs %26% derivatives %28%1975-1979%29%
% 208.06/208.26  |- mesh__dateCreated mesh__D011238 1979-05-30
% 208.06/208.26  |- skos__hiddenLabel mesh__D011238 Leo1031
% 208.06/208.26  |- skos__historyNote mesh__D011238
% 208.06/208.26       Prednisolone %28%1966-1974%29% /analogs %26% derivatives %28%1975-1979%29%
% 208.06/208.26  |- skos__hiddenLabel mesh__D011238 NSC134087
% 208.06/208.26  |- mesh__recordAuthorizer mesh__D011238 sjn
% 208.06/208.26  |- skos__broader mesh__D011238smesh__D011239
% 208.06/208.26  |- mesh__dateEstablished mesh__D011238 1991-01-01
% 208.06/208.26  |- skos__scopeNote mesh__D011238
% 208.06/208.26       Ester of CHLORAMBUCIL and PREDNISOLONE used as a combination alkylating agent and synthetic steroid to treat various leukemias and other neoplasms. It causes gastrointestinal and bone marrow toxicity.%A%    
% 208.06/208.26  |- skos__hiddenLabel mesh__D011238 NSC 134087
% 208.06/208.26  |- skos__hiddenLabel mesh__D011238 Leo 1031
% 208.06/208.26  |- mesh__dateRevised mesh__D011238 2005-06-30
% 208.06/208.26  |- skos__altLabel mesh__D011238 St%C3%%A9%r%C3%%A9%ocyt
% 208.06/208.26  |- mesh__recordOriginator mesh__D011238 SH
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D011238 2006
% 208.06/208.26  |- rdf__type mesh__D011238sskos__Concept
% 208.06/208.26  |- mesh__publicMeSHNote mesh__D011238
% 208.06/208.26       91; was see under CHLORAMBUCIL 1980-90   
% 208.06/208.26  |- skos__altLabel mesh__D011238 Pharmacia Brand of Prednimustine
% 208.06/208.26  |- skos__historyNote mesh__D016721 Retroviridae %28%1966-1987%29%
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D016721 2005
% 208.06/208.26  |- skos__hiddenLabel mesh__D016721 Leukemia Virus, Radiation
% 208.06/208.26  |- mesh__dateCreated mesh__D016721 1991-06-21
% 208.06/208.26  |- skos__altLabel mesh__D016721 RadLV
% 208.06/208.26  |- skos__prefLabel mesh__D016721 Radiation Leukemia Virus
% 208.06/208.26  |- mesh__historyNote mesh__D016721 92   
% 208.06/208.26  |- mesh__recordAuthorizer mesh__D016721 sjn
% 208.06/208.26  |- skos__broader mesh__D016721smesh__D009052
% 208.06/208.26  |- rdf__type mesh__D016721sskos__Concept
% 208.06/208.26  |- skos__scopeNote mesh__D016721
% 208.06/208.26       A strain of Murine leukemia virus %28%LEUKEMIA VIRUS, MURINE%29% isolated from radiation-induced lymphomas in C57BL mice. It is leukemogenic, thymotrophic, can be transmitted vertically, and replicates only in vivo.%A%    
% 208.06/208.26  |- mesh__dateRevised mesh__D016721 2002-07-03
% 208.06/208.26  |- skos__hiddenLabel mesh__D016721 Radiation Leukemia Viruses
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D016721 2004
% 208.06/208.26  |- mesh__recordMaintainer mesh__D016721 ags
% 208.06/208.26  |- mesh__publicMeSHNote mesh__D016721 92   
% 208.06/208.26  |- mesh__dateEstablished mesh__D016721 1992-01-01
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D016721 2003
% 208.06/208.26  |- skos__historyNote mesh__D016721 Mouse Leukemia Viruses %28%1966-1991%29%
% 208.06/208.26  |- skos__hiddenLabel mesh__D016721 Leukemia Viruses, Radiation
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D016721 2006
% 208.06/208.26  |- skos__annotation mesh__D016721
% 208.06/208.26       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% + LEUKEMIA, EXPERIMENTAL %28%IM%29% or LEUKEMIA %28%IM%29% %28%for spontaneous leukemia%29%%A%  
% 208.06/208.26  |- mesh__recordOriginator mesh__D016721 AGS
% 208.06/208.26  |- skos__prefLabel mesh__D002701 Chloramphenicol
% 208.06/208.26  |- rdf__type mesh__D002701sskos__Concept
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D002701 2004
% 208.06/208.26  |- mesh__recordOriginator mesh__D002701 NLM
% 208.06/208.26  |- mesh__recordAuthorizer mesh__D002701 NLM
% 208.06/208.26  |- mesh__dateRevised mesh__D002701 2003-07-30
% 208.06/208.26  |- skos__altLabel mesh__D002701 Cloranfenicol
% 208.06/208.26  |- mesh__dateCreated mesh__D002701 1999-01-01
% 208.06/208.26  |- skos__altLabel mesh__D002701 Kloramfenikol
% 208.06/208.26  |- mesh__recordMaintainer mesh__D002701 SYSTEM
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D002701 2005
% 208.06/208.26  |- skos__scopeNote mesh__D002701
% 208.06/208.26       An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. %28%From Martindale, The Extra Pharmacopoeia, 29th ed, p106%29%%A%    
% 208.06/208.26  |- skos__annotation mesh__D002701 an antibiotic   
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D002701 2006
% 208.06/208.26  |- skos__broader mesh__D002701smesh__D009578
% 208.06/208.26  |- skos__broader mesh__D002701smesh__D011409
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007995 1992
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007995 2004
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007995 1995
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007995 1990
% 208.06/208.26  |- skos__hiddenLabel mesh__D007995 Administrations, Library
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007995 2002
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007995 1998
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007995 1993
% 208.06/208.26  |- skos__scopeNote mesh__D007995
% 208.06/208.26       Planning, organizing, staffing, direction, and control of libraries.%A%    
% 208.06/208.26  |- skos__prefLabel mesh__D007995 Library Administration
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007995 1991
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007995 1996
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007995 1999
% 208.06/208.26  |- skos__broader mesh__D007995smesh__D007998
% 208.06/208.26  |- skos__annotation mesh__D007995 SPEC: SPEC qualif   
% 208.06/208.26  |- rdf__type mesh__D007995sskos__Concept
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007995 1997
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007995 2005
% 208.06/208.26  |- mesh__recordAuthorizer mesh__D007995 PLS
% 208.06/208.26  |- skos__altLabel mesh__D007995 Administration, Library
% 208.06/208.26  |- mesh__dateCreated mesh__D007995 1999-01-01
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007995 2000
% 208.06/208.26  |- mesh__recordOriginator mesh__D007995 NLM
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007995 2003
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007995 1994
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007995 2006
% 208.06/208.26  |- mesh__recordMaintainer mesh__D007995 PLS
% 208.06/208.26  |- mesh__dateRevised mesh__D007995 1989-06-26
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007995 2001
% 208.06/208.26  |- skos__hiddenLabel mesh__D007995 Library Administrations
% 208.06/208.26  |- rdf__type mesh__D029649sskos__Concept
% 208.06/208.26  |- skos__broader mesh__D029649smesh__D019684
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D029649 2004
% 208.06/208.26  |- skos__scopeNote mesh__D029649
% 208.06/208.26       A plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida.%A%    
% 208.06/208.26  |- mesh__historyNote mesh__D029649 2002   
% 208.06/208.26  |- mesh__dateEstablished mesh__D029649 2002-01-01
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D029649 2006
% 208.06/208.26  |- mesh__dateCreated mesh__D029649 2001-07-25
% 208.06/208.26  |- mesh__publicMeSHNote mesh__D029649 2002   
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D029649 2005
% 208.06/208.26  |- mesh__recordAuthorizer mesh__D029649 sjn
% 208.06/208.26  |- mesh__recordMaintainer mesh__D029649 ssb
% 208.06/208.26  |- skos__prefLabel mesh__D029649 Violaceae
% 208.06/208.26  |- skos__annotation mesh__D029649
% 208.06/208.26       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.26  |- mesh__dateRevised mesh__D029649 2003-07-09
% 208.06/208.26  |- mesh__recordOriginator mesh__D029649 ssb
% 208.06/208.26  |- skos__hiddenLabel mesh__D007197 Central American Indians
% 208.06/208.26  |- skos__hiddenLabel mesh__D007197 Central American Indian
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007197 2004A
% 208.06/208.26  |- skos__historyNote mesh__D007197
% 208.06/208.26       Indians, South American %28%1966-1977%29%
% 208.06/208.26  |- skos__prefLabel mesh__D007197 Indians, Central American
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007197 2004
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007197 2005
% 208.06/208.26  |- skos__hiddenLabel mesh__D007197 American Indian, Central
% 208.06/208.26  |- skos__hiddenLabel mesh__D007197 American Indians, Central
% 208.06/208.26  |- mesh__dateEstablished mesh__D007197 1978-01-01
% 208.06/208.26  |- skos__hiddenLabel mesh__D007197 Central American Amerinds
% 208.06/208.26  |- skos__hiddenLabel mesh__D007197 Amerind, Central American
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007197 2006
% 208.06/208.26  |- mesh__dateRevised mesh__D007197 2003-10-30
% 208.06/208.26  |- skos__hiddenLabel mesh__D007197 Indian, Central American
% 208.06/208.26  |- mesh__recordAuthorizer mesh__D007197 jls
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D007197 2004B
% 208.06/208.26  |- mesh__recordOriginator mesh__D007197 EC
% 208.06/208.26  |- skos__broader mesh__D007197smesh__D044467
% 208.06/208.26  |- mesh__recordMaintainer mesh__D007197 jls
% 208.06/208.26  |- skos__scopeNote mesh__D007197
% 208.06/208.26       Individual members of Central American ethnic groups with ancient historic ancestral origins in Asia. Mexican Indians are not included.%A%    
% 208.06/208.26  |- skos__hiddenLabel mesh__D007197 American Amerind, Central
% 208.06/208.26  |- skos__annotation mesh__D007197
% 208.06/208.26       specify geog if possible; not for Indians of Mexico %28% = INDIANS, NORTH AMERICAN + MEXICO%29%%A%  
% 208.06/208.26  |- skos__altLabel mesh__D007197 Amerinds, Central American
% 208.06/208.26  |- rdf__type mesh__D007197sskos__Concept
% 208.06/208.26  |- skos__hiddenLabel mesh__D007197 American Amerinds, Central
% 208.06/208.26  |- skos__hiddenLabel mesh__D007197 Central American Amerind
% 208.06/208.26  |- mesh__publicMeSHNote mesh__D007197 78   
% 208.06/208.26  |- mesh__dateCreated mesh__D007197 1977-05-13
% 208.06/208.26  |- mesh__historyNote mesh__D007197 78   
% 208.06/208.26  |- skos__hiddenLabel mesh__D001609 Beta Globulin
% 208.06/208.26  |- skos__altLabel mesh__D001609 Beta-Globulin
% 208.06/208.26  |- mesh__activeMeSHYear mesh__D001609 2006
% 208.06/208.26  |- mesh__recordOriginator mesh__D001609 NLM
% 208.06/208.26  |- mesh__publicMeSHNote mesh__D001609 75; was BETA GLOBULIN 1965-74   
% 208.06/208.26  |- skos__hiddenLabel mesh__D001609 Beta Globulins
% 208.06/208.26  |- mesh__historyNote mesh__D001609
% 208.06/208.26       75; was BETA GLOBULIN 1963-74 %28%Prov 1963-64%29%   
% 208.06/208.26  |- rdf__type mesh__D001609sskos__Concept
% 208.06/208.26  |- skos__annotation mesh__D001609
% 208.06/208.26       GEN or unspecified; prefer specifics; do not confuse with beta 2 A-globulin or beta 2 M-globulin %28% = BETA 2-MICROGLOBULIN%29%%A%  
% 208.06/208.26  |- mesh__dateRevised mesh__D001609 2005-07-01
% 208.06/208.27  |- mesh__dateCreated mesh__D001609 1999-01-01
% 208.06/208.27  |- mesh__recordMaintainer mesh__D001609 sjn
% 208.06/208.27  |- skos__broader mesh__D001609smesh__D012712
% 208.06/208.27  |- mesh__recordAuthorizer mesh__D001609 sjn
% 208.06/208.27  |- mesh__dateEstablished mesh__D001609 1965-01-01
% 208.06/208.27  |- skos__prefLabel mesh__D001609 Beta-Globulins
% 208.06/208.27  |- skos__scopeNote mesh__D001609
% 208.06/208.27       Serum proteins with an electrophoretic mobility that falls between ALPHA-GLOBULINS and GAMMA-GLOBULINS.%A%    
% 208.06/208.27  |- mesh__onlineNote mesh__D001609
% 208.06/208.27       use BETA-GLOBULINS to search BETA GLOBULIN 1966-74   
% 208.06/208.27  |- skos__scopeNote mesh__D012331
% 208.06/208.27       Ribonucleic acid in fungi having regulatory and catalytic roles as well as involvement in protein synthesis.%A%    
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012331 2001
% 208.06/208.27  |- mesh__dateRevised mesh__D012331 1995-06-08
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012331 2005
% 208.06/208.27  |- mesh__dateEstablished mesh__D012331 1980-01-01
% 208.06/208.27  |- mesh__historyNote mesh__D012331 80   
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012331 2000
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012331 1997
% 208.06/208.27  |- skos__historyNote mesh__D012331 RNA %28%1966-1979%29%
% 208.06/208.27  |- rdf__type mesh__D012331sskos__Concept
% 208.06/208.27  |- mesh__dateCreated mesh__D012331 1979-05-25
% 208.06/208.27  |- mesh__publicMeSHNote mesh__D012331 80   
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012331 1996
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012331 2004
% 208.06/208.27  |- mesh__recordAuthorizer mesh__D012331 PLS
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012331 2002
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012331 1999
% 208.06/208.27  |- skos__prefLabel mesh__D012331 RNA, Fungal
% 208.06/208.27  |- skos__annotation mesh__D012331
% 208.06/208.27       IM; coord with specific fungus %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 208.06/208.27  |- skos__altLabel mesh__D012331 Fungal RNA
% 208.06/208.27  |- mesh__recordMaintainer mesh__D012331 KEV
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012331 2003
% 208.06/208.27  |- mesh__recordOriginator mesh__D012331 RLS
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012331 1998
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012331 2006
% 208.06/208.27  |- skos__broader mesh__D012331smesh__D012313
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D031296 2006
% 208.06/208.27  |- skos__altLabel mesh__D031296 Cytisus laburnum
% 208.06/208.27  |- skos__scopeNote mesh__D031296
% 208.06/208.27       A plant genus of the family FABACEAE named after the drooping clusters of flowers.%A%    
% 208.06/208.27  |- skos__annotation mesh__D031296
% 208.06/208.27       INDIAN LABURNUM see CASSIA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.27  |- mesh__historyNote mesh__D031296 2003   
% 208.06/208.27  |- mesh__dateCreated mesh__D031296 2002-07-03
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D031296 2003
% 208.06/208.27  |- skos__altLabel mesh__D031296 Golden Chain
% 208.06/208.27  |- mesh__dateEstablished mesh__D031296 2003-01-01
% 208.06/208.27  |- rdf__type mesh__D031296sskos__Concept
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D031296 2004
% 208.06/208.27  |- skos__broader mesh__D031296smesh__D007887
% 208.06/208.27  |- mesh__publicMeSHNote mesh__D031296 2003   
% 208.06/208.27  |- skos__prefLabel mesh__D031296 Laburnum
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D031296 2005
% 208.06/208.27  |- mesh__dateCreated mesh__D011239 1999-01-01
% 208.06/208.27  |- mesh__historyNote mesh__D011239
% 208.06/208.27       /therapeutic use was PREDNISOLONE, THERAPEUTIC 1965   
% 208.06/208.27  |- skos__prefLabel mesh__D011239 Prednisolone
% 208.06/208.27  |- mesh__recordOriginator mesh__D011239 NLM
% 208.06/208.27  |- mesh__dateRevised mesh__D011239 2003-07-09
% 208.06/208.27  |- skos__hiddenLabel mesh__D011239 Di Adreson F
% 208.06/208.27  |- skos__broader mesh__D011239smesh__D011246
% 208.06/208.27  |- skos__hiddenLabel mesh__D011239 DiAdresonF
% 208.06/208.27  |- mesh__recordAuthorizer mesh__D011239 sjn
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D011239 2006
% 208.06/208.27  |- mesh__recordMaintainer mesh__D011239 ssb
% 208.06/208.27  |- rdf__type mesh__D011239sskos__Concept
% 208.06/208.27  |- skos__scopeNote mesh__D011239
% 208.06/208.27       A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.%A%    
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D011239 2005
% 208.06/208.27  |- mesh__publicMeSHNote mesh__D011239
% 208.06/208.27       /therapeutic use was PREDNISOLONE, THERAPEUTIC 1965   
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D011239 2004
% 208.06/208.27  |- skos__broader mesh__D008290smesh__D003904
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D008290 2006A
% 208.06/208.27  |- mesh__dateCreated mesh__D008290 1999-01-01
% 208.06/208.27  |- skos__scopeNote mesh__D008290
% 208.06/208.27       A mitosporic fungal genus that causes a variety of skin disorders. Malassezia furfur %28%Pityrosporum orbiculare%29% causes TINEA VERSICOLOR.%A%    
% 208.06/208.27  |- mesh__recordMaintainer mesh__D008290 ags
% 208.06/208.27  |- skos__altLabel mesh__D008290 Pityrosporum
% 208.06/208.27  |- skos__prefLabel mesh__D008290 Malassezia
% 208.06/208.27  |- skos__altLabel mesh__D008290 Pityrosporum orbiculare
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D008290 2006
% 208.06/208.27  |- mesh__recordAuthorizer mesh__D008290 ags
% 208.06/208.27  |- rdf__type mesh__D008290sskos__Concept
% 208.06/208.27  |- skos__annotation mesh__D008290
% 208.06/208.27       infection: coord IM with DERMATOMYCOSES %28%IM%29% or TINEA VERSICOLOR %28%IM%29%%A%  
% 208.06/208.27  |- mesh__recordOriginator mesh__D008290 NLM
% 208.06/208.27  |- skos__broader mesh__D008290smesh__D015003
% 208.06/208.27  |- mesh__dateRevised mesh__D008290 2005-08-03
% 208.06/208.27  |- mesh__recordAuthorizer mesh__D016722 SJN
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D016722 2004
% 208.06/208.27  |- skos__annotation mesh__D016722
% 208.06/208.27       cermet stands for %22%CERamic%22% %26% %22%METal%22%; D25-26 qualif   
% 208.06/208.27  |- skos__historyNote mesh__D016722 Dental Alloys %28%1988-1991%29%
% 208.06/208.27  |- mesh__dateRevised mesh__D016722 1997-06-20
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D016722 2001
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D016722 1999
% 208.06/208.27  |- skos__broader mesh__D016722smesh__D005899
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D016722 2003
% 208.06/208.27  |- skos__prefLabel mesh__D016722 Cermet Cements
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D016722 2000
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D016722 1998
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D016722 2006
% 208.06/208.27  |- skos__hiddenLabel mesh__D016722 Cements, Cermet
% 208.06/208.27  |- skos__hiddenLabel mesh__D016722 KetacSilver
% 208.06/208.27  |- skos__historyNote mesh__D016722 Glass Ionomer Cements %28%1985-1991%29%
% 208.06/208.27  |- skos__altLabel mesh__D016722 Cermet
% 208.06/208.27  |- mesh__recordMaintainer mesh__D016722 ADP
% 208.06/208.27  |- skos__scopeNote mesh__D016722
% 208.06/208.27       Fluoride-releasing restorative materials made by the sintering of metal %28%usually silver%29% particles to glass ionomer powder. Glass ionomers are fluoride-releasing cements that are not very durable. Sintering of the metal particles is a means of improving those physical properties that will make the glass ionomer cement more durable.%A%    
% 208.06/208.27  |- mesh__recordOriginator mesh__D016722 MXR
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D016722 2005
% 208.06/208.27  |- skos__hiddenLabel mesh__D016722 Ketac Silver
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D016722 2002
% 208.06/208.27  |- mesh__dateEstablished mesh__D016722 1992-01-01
% 208.06/208.27  |- mesh__dateCreated mesh__D016722 1991-04-29
% 208.06/208.27  |- mesh__historyNote mesh__D016722 92   
% 208.06/208.27  |- skos__historyNote mesh__D016722 Dental Cements %28%1988-1991%29%
% 208.06/208.27  |- rdf__type mesh__D016722sskos__Concept
% 208.06/208.27  |- skos__historyNote mesh__D016722 Silver %28%1988-1991%29%
% 208.06/208.27  |- skos__broader mesh__D016722smesh__D016876
% 208.06/208.27  |- mesh__publicMeSHNote mesh__D016722 92   
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D002702 2004
% 208.06/208.27  |- skos__scopeNote mesh__D002702
% 208.06/208.27       Nonsusceptibility of bacteria to the action of CHLORAMPHENICOL, a potent inhibitor of protein synthesis in the 50S ribosomal subunit where amino acids are added to nascent bacterial polypeptides.%A%    
% 208.06/208.27  |- mesh__recordMaintainer mesh__D002702 ssb
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D002702 2005
% 208.06/208.27  |- skos__historyNote mesh__D002702
% 208.06/208.27       Drug Resistance, Microbial %28%1966-1987%29%
% 208.06/208.27  |- rdf__type mesh__D002702sskos__Concept
% 208.06/208.27  |- skos__historyNote mesh__D002702 Chloramphenicol %28%1966-1987%29%
% 208.06/208.27  |- skos__hiddenLabel mesh__D002702 Chloramphenicol Resistances
% 208.06/208.27  |- mesh__recordOriginator mesh__D002702 SCD
% 208.06/208.27  |- mesh__publicMeSHNote mesh__D002702 1988   
% 208.06/208.27  |- mesh__recordAuthorizer mesh__D002702 sjn
% 208.06/208.27  |- skos__broader mesh__D002702smesh__D024881
% 208.06/208.27  |- mesh__dateCreated mesh__D002702 1987-05-09
% 208.06/208.27  |- skos__prefLabel mesh__D002702 Chloramphenicol Resistance
% 208.06/208.27  |- mesh__historyNote mesh__D002702 1988   
% 208.06/208.27  |- mesh__dateEstablished mesh__D002702 1988-01-01
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D002702 2006
% 208.06/208.27  |- mesh__dateRevised mesh__D002702 2003-07-09
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007996 2000
% 208.06/208.27  |- mesh__recordAuthorizer mesh__D007996 sjn
% 208.06/208.27  |- skos__annotation mesh__D007996
% 208.06/208.27       med libr assoc: do not coord with MEDICINE; DF: LIBRARY ASSOC%A%  
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007996 2001
% 208.06/208.27  |- skos__broader mesh__D007996smesh__D007998
% 208.06/208.27  |- mesh__recordMaintainer mesh__D007996 kle
% 208.06/208.27  |- rdf__type mesh__D007996sskos__Concept
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007996 2002
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007996 2005
% 208.06/208.27  |- skos__altLabel mesh__D007996 Associations, Library
% 208.06/208.27  |- mesh__dateRevised mesh__D007996 1999-11-03
% 208.06/208.27  |- mesh__dateCreated mesh__D007996 1999-01-01
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007996 2003
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007996 2006
% 208.06/208.27  |- skos__hiddenLabel mesh__D007996 Association, Library
% 208.06/208.27  |- skos__hiddenLabel mesh__D007996 Library Association
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007996 2004
% 208.06/208.27  |- skos__prefLabel mesh__D007996 Library Associations
% 208.06/208.27  |- mesh__recordOriginator mesh__D007996 NLM
% 208.06/208.27  |- skos__hiddenLabel mesh__D007198 American Indians, North
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007198 2004
% 208.06/208.27  |- skos__altLabel mesh__D007198 Amerinds, North American
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007198 2005
% 208.06/208.27  |- skos__hiddenLabel mesh__D007198 Amerind, North American
% 208.06/208.27  |- skos__hiddenLabel mesh__D007198 North American Amerind
% 208.06/208.27  |- skos__hiddenLabel mesh__D007198 American, Native
% 208.06/208.27  |- skos__hiddenLabel mesh__D007198 Indian, North American
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007198 2006
% 208.06/208.27  |- skos__hiddenLabel mesh__D007198 Americans, Native
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007198 2004A
% 208.06/208.27  |- mesh__dateCreated mesh__D007198 1999-01-01
% 208.06/208.27  |- skos__hiddenLabel mesh__D007198 North American Indian
% 208.06/208.27  |- rdf__type mesh__D007198sskos__Concept
% 208.06/208.27  |- skos__hiddenLabel mesh__D007198 Indians, American
% 208.06/208.27  |- skos__related mesh__D007198smesh__D016549
% 208.06/208.27  |- skos__hiddenLabel mesh__D007198 North American Amerinds
% 208.06/208.27  |- mesh__dateRevised mesh__D007198 2003-10-30
% 208.06/208.27  |- skos__hiddenLabel mesh__D007198 North American Indians
% 208.06/208.27  |- mesh__recordAuthorizer mesh__D007198 jls
% 208.06/208.27  |- skos__hiddenLabel mesh__D007198 American Indian
% 208.06/208.27  |- skos__prefLabel mesh__D007198 Indians, North American
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007198 2004B
% 208.06/208.27  |- mesh__recordOriginator mesh__D007198 NLM
% 208.06/208.27  |- skos__broader mesh__D007198smesh__D044467
% 208.06/208.27  |- skos__annotation mesh__D007198
% 208.06/208.27       specify geog if possible; in titles capitalize both Native and American%A%  
% 208.06/208.27  |- mesh__recordMaintainer mesh__D007198 jls
% 208.06/208.27  |- skos__hiddenLabel mesh__D007198 Native American
% 208.06/208.27  |- skos__hiddenLabel mesh__D007198 Indian, American
% 208.06/208.27  |- skos__scopeNote mesh__D007198
% 208.06/208.27       Individual members of North American ethnic groups with ancient historic ancestral origins in Asia.%A%    
% 208.06/208.27  |- skos__hiddenLabel mesh__D007198 American Indian, North
% 208.06/208.27  |- skos__scopeNote mesh__D040821
% 208.06/208.27       The fundamental dispositions and traits of humans. %28%Merriam-Webster%27%s Collegiate Dictionary, 10th ed%29%%A%    
% 208.06/208.27  |- skos__altLabel mesh__D040821 Human Nature
% 208.06/208.27  |- skos__related mesh__D040821smesh__D010551
% 208.06/208.27  |- mesh__dateEstablished mesh__D040821 2003-01-01
% 208.06/208.27  |- skos__hiddenLabel mesh__D040821 Nature, Human
% 208.06/208.27  |- skos__hiddenLabel mesh__D040821 Characteristic, Human
% 208.06/208.27  |- skos__hiddenLabel mesh__D040821 Characteristics, Human
% 208.06/208.27  |- rdf__type mesh__D040821sskos__Concept
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D040821 2006
% 208.06/208.27  |- mesh__publicMeSHNote mesh__D040821 2003   
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D040821 2005
% 208.06/208.27  |- skos__hiddenLabel mesh__D040821 Human Characteristic
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D040821 2004
% 208.06/208.27  |- skos__related mesh__D040821smesh__D028723
% 208.06/208.27  |- skos__broader mesh__D040821smesh__D001520
% 208.06/208.27  |- skos__prefLabel mesh__D040821 Human Characteristics
% 208.06/208.27  |- mesh__historyNote mesh__D040821 2003   
% 208.06/208.27  |- mesh__dateCreated mesh__D040821 2002-07-03
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D040821 2003
% 208.06/208.27  |- mesh__historyNote mesh__D012332 79   
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012332 1996
% 208.06/208.27  |- skos__annotation mesh__D012332
% 208.06/208.27       IM; /drug eff /ultrastruct permitted; DF: HNRNA   
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012332 2000
% 208.06/208.27  |- mesh__dateEstablished mesh__D012332 1979-01-01
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012332 1997
% 208.06/208.27  |- mesh__dateRevised mesh__D012332 1992-05-20
% 208.06/208.27  |- rdf__type mesh__D012332sskos__Concept
% 208.06/208.27  |- mesh__dateCreated mesh__D012332 1978-03-15
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012332 2003
% 208.06/208.27  |- mesh__recordOriginator mesh__D012332 RLS
% 208.06/208.27  |- skos__broader mesh__D012332smesh__D015138
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012332 2001
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012332 1998
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012332 1993
% 208.06/208.27  |- mesh__recordMaintainer mesh__D012332 TGC
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012332 2004
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012332 2002
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012332 1994
% 208.06/208.27  |- mesh__recordAuthorizer mesh__D012332 PLS
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012332 1999
% 208.06/208.27  |- skos__scopeNote mesh__D012332
% 208.06/208.27       Nuclear nonribosomal RNA larger than about 1000 nucleotides, the mass of which is rapidly synthesized and degraded within the cell nucleus. Some heterogeneous nuclear RNA may be a precursor to mRNA. However, the great bulk of total hnRNA hybridizes with nuclear DNA rather than with mRNA.%A%    
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012332 2005
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012332 1995
% 208.06/208.27  |- skos__prefLabel mesh__D012332 RNA, Heterogeneous Nuclear
% 208.06/208.27  |- skos__historyNote mesh__D012332 RNA %28%1966-1978%29%
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012332 2006
% 208.06/208.27  |- mesh__publicMeSHNote mesh__D012332 79   
% 208.06/208.27  |- skos__hiddenLabel mesh__D012332 Nuclear RNA, Heterogeneous
% 208.06/208.27  |- skos__altLabel mesh__D012332 Heterogeneous Nuclear RNA
% 208.06/208.27  |- skos__scopeNote mesh__D031297
% 208.06/208.27       A plant genus of the family FABACEAE that is a source of SPARTEINE, lupanine and other lupin alkaloids.%A%    
% 208.06/208.27  |- mesh__publicMeSHNote mesh__D031297 2003   
% 208.06/208.27  |- mesh__dateEstablished mesh__D031297 2003-01-01
% 208.06/208.27  |- skos__altLabel mesh__D031297 Lupine
% 208.06/208.27  |- skos__broader mesh__D031297smesh__D007887
% 208.06/208.27  |- mesh__historyNote mesh__D031297 2003   
% 208.06/208.27  |- mesh__dateCreated mesh__D031297 2002-07-03
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D031297 2006
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D031297 2005
% 208.06/208.27  |- skos__annotation mesh__D031297
% 208.06/208.27       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.27  |- skos__prefLabel mesh__D031297 Lupinus
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D031297 2004
% 208.06/208.27  |- rdf__type mesh__D031297sskos__Concept
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D031297 2003
% 208.06/208.27  |- skos__hiddenLabel mesh__D008291 Dehydrogenase, NAD-Malate
% 208.06/208.27  |- mesh__recordOriginator mesh__D008291 NLM
% 208.06/208.27  |- mesh__dateCreated mesh__D008291 1999-01-01
% 208.06/208.27  |- skos__prefLabel mesh__D008291 Malate Dehydrogenase
% 208.06/208.27  |- mesh__dateRevised mesh__D008291 2003-07-09
% 208.06/208.27  |- mesh__publicMeSHNote mesh__D008291
% 208.06/208.27       MALIC ENZYME was see MALATE DEHYDROGENASE 1983-93   
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D008291 2005
% 208.06/208.27  |- skos__hiddenLabel mesh__D008291 NAD Malate Dehydrogenase
% 208.06/208.27  |- skos__scopeNote mesh__D008291
% 208.06/208.27       An enzyme that catalyzes the conversion of %28%S%29%-malate and NAD+ to oxaloacetate and NADH. EC 1.1.1.37.%A%    
% 208.06/208.27  |- skos__altLabel mesh__D008291 Malic Dehydrogenase
% 208.06/208.27  |- mesh__recordMaintainer mesh__D008291 ssb
% 208.06/208.27  |- mesh__recordAuthorizer mesh__D008291 sjn
% 208.06/208.27  |- mesh__onlineNote mesh__D008291
% 208.06/208.27       use MALATE DEHYDROGENASE to search MALIC ENZYME 1983-93   
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D008291 2006
% 208.06/208.27  |- skos__hiddenLabel mesh__D008291 Dehydrogenase, Malic
% 208.06/208.27  |- rdf__type mesh__D008291sskos__Concept
% 208.06/208.27  |- mesh__historyNote mesh__D008291
% 208.06/208.27       MALIC ENZYME was see MALATE DEHYDROGENASE 1983-93   
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D008291 2004
% 208.06/208.27  |- skos__hiddenLabel mesh__D008291 Dehydrogenase, Malate
% 208.06/208.27  |- skos__broader mesh__D008291smesh__D000429
% 208.06/208.27  |- skos__altLabel mesh__D008291 NAD-Malate Dehydrogenase
% 208.06/208.27  |- mesh__dateEstablished mesh__D016723 1992-01-01
% 208.06/208.27  |- mesh__publicMeSHNote mesh__D016723 92   
% 208.06/208.27  |- skos__scopeNote mesh__D016723
% 208.06/208.27       The continuous turnover of bone matrix and mineral that involves first, an increase in resorption %28%osteoclastic activity%29% and later, reactive bone formation %28%osteoblastic activity%29%. The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium homeostasis. An imbalance in the regulation of bone remodeling%27%s two contrasting events, bone resorption and bone formation, results in many of the metabolic bone diseases, such as OSTEOPOROSIS.%A%    
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D016723 2006
% 208.06/208.27  |- skos__prefLabel mesh__D016723 Bone Remodeling
% 208.06/208.27  |- skos__hiddenLabel mesh__D016723 Remodeling, Bone
% 208.06/208.27  |- skos__historyNote mesh__D016723 Bone Regeneration %28%1967-1991%29%
% 208.06/208.27  |- skos__annotation mesh__D016723
% 208.06/208.27       note category: an aspect of bone physiol   
% 208.06/208.27  |- mesh__recordOriginator mesh__D016723 MXR
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D016723 2005
% 208.06/208.27  |- mesh__recordMaintainer mesh__D016723 nns
% 208.06/208.27  |- skos__broader mesh__D016723smesh__D043702
% 208.06/208.27  |- skos__broader mesh__D016723smesh__D012038
% 208.06/208.27  |- mesh__dateCreated mesh__D016723 1991-04-29
% 208.06/208.27  |- mesh__historyNote mesh__D016723 92   
% 208.06/208.27  |- skos__historyNote mesh__D016723 Bone Resorption %28%1967-1991%29%
% 208.06/208.27  |- mesh__dateRevised mesh__D016723 2003-07-09
% 208.06/208.27  |- rdf__type mesh__D016723sskos__Concept
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D016723 2004
% 208.06/208.27  |- mesh__recordAuthorizer mesh__D016723 sjn
% 208.06/208.27  |- skos__historyNote mesh__D016723 Bone Development %28%1967-1991%29%
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D002703 2003
% 208.06/208.27  |- skos__altLabel mesh__D002703 Tetrachloro-1,4-benzoquinone
% 208.06/208.27  |- rdf__type mesh__D002703sskos__Concept
% 208.06/208.27  |- mesh__recordOriginator mesh__D002703 RLS
% 208.06/208.27  |- skos__broader mesh__D002703smesh__D016227
% 208.06/208.27  |- mesh__dateEstablished mesh__D002703 1991-01-01
% 208.06/208.27  |- mesh__publicMeSHNote mesh__D002703 91; was see under QUINONES 1976-90   
% 208.06/208.27  |- skos__prefLabel mesh__D002703 Chloranil
% 208.06/208.27  |- mesh__dateRevised mesh__D002703 2000-06-22
% 208.06/208.27  |- mesh__recordMaintainer mesh__D002703 CCR
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D002703 2002
% 208.06/208.27  |- skos__scopeNote mesh__D002703
% 208.06/208.27       A quinone fungicide used for treatment of seeds and foliage.%A%    
% 208.06/208.27  |- skos__altLabel mesh__D002703 2,3,5,6-Tetrachloro-1,4-benzoquinone
% 208.06/208.27  |- skos__historyNote mesh__D002703 Chlorine %28%1974-1975%29%
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D002703 2006
% 208.06/208.27  |- mesh__dateCreated mesh__D002703 1975-07-18
% 208.06/208.27  |- mesh__historyNote mesh__D002703
% 208.06/208.27       91%28%76%29%; was see under QUINONES 1976-90   
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D002703 2004
% 208.06/208.27  |- mesh__recordAuthorizer mesh__D002703 sjn
% 208.06/208.27  |- skos__hiddenLabel mesh__D002703 Tetrachloro 1,4 benzoquinone
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D002703 2005
% 208.06/208.27  |- skos__historyNote mesh__D002703 Quinones %28%1968-1975%29%
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D002703 2001
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007997 2005
% 208.06/208.27  |- skos__hiddenLabel mesh__D007997 School, Library
% 208.06/208.27  |- mesh__dateCreated mesh__D007997 1999-01-01
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007997 2006
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007997 2003
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007997 2000
% 208.06/208.27  |- skos__hiddenLabel mesh__D007997 Library School
% 208.06/208.27  |- skos__altLabel mesh__D007997 Schools, Library
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007997 2004
% 208.06/208.27  |- mesh__recordAuthorizer mesh__D007997 sjn
% 208.06/208.27  |- mesh__recordOriginator mesh__D007997 NLM
% 208.06/208.27  |- skos__annotation mesh__D007997 specify geog if pertinent   
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007997 2001
% 208.06/208.27  |- skos__scopeNote mesh__D007997
% 208.06/208.27       Educational institutions for individuals specializing in the field of library science or information.%A%    
% 208.06/208.27  |- skos__prefLabel mesh__D007997 Library Schools
% 208.06/208.27  |- mesh__recordMaintainer mesh__D007997 kle
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007997 2002
% 208.06/208.27  |- mesh__dateRevised mesh__D007997 1999-11-03
% 208.06/208.27  |- skos__broader mesh__D007997smesh__D012574
% 208.06/208.27  |- skos__broader mesh__D007997smesh__D007998
% 208.06/208.27  |- rdf__type mesh__D007997sskos__Concept
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D032390 2004
% 208.06/208.27  |- skos__related mesh__D032390smesh__D032389
% 208.06/208.27  |- skos__prefLabel mesh__D032390 Myoblasts, Smooth Muscle
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D032390 2003
% 208.06/208.27  |- skos__scopeNote mesh__D032390
% 208.06/208.27       Precursor cells destined to differentiate into smooth muscle myocytes %28%MYOCYTES, SMOOTH MUSCLE%29%.%A%    
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D032390 2006
% 208.06/208.27  |- skos__broader mesh__D032390smesh__D032446
% 208.06/208.27  |- skos__altLabel mesh__D032390 Smooth Muscle Myoblasts
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D032390 2005
% 208.06/208.27  |- mesh__historyNote mesh__D032390 2003   
% 208.06/208.27  |- skos__hiddenLabel mesh__D032390 Myoblast, Smooth Muscle
% 208.06/208.27  |- skos__hiddenLabel mesh__D032390 Smooth Muscle Myoblast
% 208.06/208.27  |- rdf__type mesh__D032390sskos__Concept
% 208.06/208.27  |- mesh__dateEstablished mesh__D032390 2003-01-01
% 208.06/208.27  |- mesh__publicMeSHNote mesh__D032390 2003   
% 208.06/208.27  |- mesh__dateCreated mesh__D032390 2002-07-03
% 208.06/208.27  |- skos__hiddenLabel mesh__D007199 South American Indian
% 208.06/208.27  |- mesh__recordMaintainer mesh__D007199 jls
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007199 2004
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007199 2004A
% 208.06/208.27  |- skos__hiddenLabel mesh__D007199 South American Amerinds
% 208.06/208.27  |- mesh__recordOriginator mesh__D007199 NLM
% 208.06/208.27  |- skos__broader mesh__D007199smesh__D044467
% 208.06/208.27  |- skos__annotation mesh__D007199
% 208.06/208.27       specify geog if possible; in titles capitalize both Native and American%A%  
% 208.06/208.27  |- skos__hiddenLabel mesh__D007199 Amerind, South American
% 208.06/208.27  |- mesh__recordAuthorizer mesh__D007199 jls
% 208.06/208.27  |- skos__scopeNote mesh__D007199
% 208.06/208.27       Individual members of South American ethnic groups with historic ancestral origins in Asia.%A%    
% 208.06/208.27  |- skos__hiddenLabel mesh__D007199 Indian, South American
% 208.06/208.27  |- skos__hiddenLabel mesh__D007199 American Amerind, South
% 208.06/208.27  |- skos__prefLabel mesh__D007199 Indians, South American
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007199 2006
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007199 2005A
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007199 2004B
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D007199 2005
% 208.06/208.27  |- mesh__dateRevised mesh__D007199 2004-07-28
% 208.06/208.27  |- skos__altLabel mesh__D007199 Amerinds, South American
% 208.06/208.27  |- rdf__type mesh__D007199sskos__Concept
% 208.06/208.27  |- skos__hiddenLabel mesh__D007199 American Amerinds, South
% 208.06/208.27  |- skos__hiddenLabel mesh__D007199 American Indians, South
% 208.06/208.27  |- skos__hiddenLabel mesh__D007199 South American Amerind
% 208.06/208.27  |- mesh__dateCreated mesh__D007199 1999-01-01
% 208.06/208.27  |- skos__hiddenLabel mesh__D007199 American Indian, South
% 208.06/208.27  |- skos__hiddenLabel mesh__D007199 South American Indians
% 208.06/208.27  |- skos__annotation mesh__D012333
% 208.06/208.27       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 208.06/208.27  |- mesh__historyNote mesh__D012333
% 208.06/208.27       65%28%64%29%; MRNA, NON-POLYADENYLATED was NON-POLYADENYLATED MRNA %28%NM%29% 1981-94; MRNA, POLYADENYLATED was POLYADENYLATED MRNA %28%NM%29% 1980-94; POLY%28%A%29%+ RNA was SY to POLY%28%A%29% RNA %28%NM%29% 1980-94%A%  
% 208.06/208.27  |- rdf__type mesh__D012333sskos__Concept
% 208.06/208.27  |- skos__scopeNote mesh__D012333
% 208.06/208.27       RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3%27% end, referred to as the poly%28%A%29% tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.%A%    
% 208.06/208.27  |- mesh__onlineNote mesh__D012333
% 208.06/208.27       use RNA, MESSENGER %28%NM%29% to search MRNA, NON-POLYADENYLATED 1981-94, MRNA, POLYADENYLATED 1980-94, %26% POLY%28%A%29%+ RNA 1980-94%A%  
% 208.06/208.27  |- skos__altLabel mesh__D012333 RNA, Messenger, Polyadenylated
% 208.06/208.27  |- mesh__recordMaintainer mesh__D012333 ags
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012333 2003
% 208.06/208.27  |- skos__hiddenLabel mesh__D012333 mRNA, Non Polyadenylated
% 208.06/208.27  |- skos__hiddenLabel mesh__D012333 Polyadenylated RNA
% 208.06/208.27  |- skos__hiddenLabel mesh__D012333 Polyadenylated Messenger RNA
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012333 2004
% 208.06/208.27  |- mesh__dateCreated mesh__D012333 1999-01-01
% 208.06/208.27  |- skos__broader mesh__D012333smesh__D012313
% 208.06/208.27  |- skos__altLabel mesh__D012333 Polyadenylated mRNA
% 208.06/208.27  |- skos__altLabel mesh__D012333 Poly%28%A%29%+ mRNA
% 208.06/208.27  |- skos__altLabel mesh__D012333 Messenger RNA
% 208.06/208.27  |- mesh__dateRevised mesh__D012333 2002-07-03
% 208.06/208.27  |- mesh__activeMeSHYear mesh__D012333 2005
% 208.06/208.27  |- mesh__dateEstablished mesh__D012333 1965-01-01
% 208.06/208.28  |- skos__hiddenLabel mesh__D012333 RNA, Polyadenylated Messenger
% 208.06/208.28  |- skos__altLabel mesh__D012333 mRNA
% 208.06/208.28  |- skos__altLabel mesh__D012333 Poly%28%A%29%+ RNA
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D012333 2006
% 208.06/208.28  |- skos__altLabel mesh__D012333 Poly%28%A%29% RNA
% 208.06/208.28  |- skos__hiddenLabel mesh__D012333 Non Polyadenylated mRNA
% 208.06/208.28  |- mesh__recordAuthorizer mesh__D012333 sjn
% 208.06/208.28  |- skos__altLabel mesh__D012333 Non-Polyadenylated mRNA
% 208.06/208.28  |- mesh__recordOriginator mesh__D012333 NLM
% 208.06/208.28  |- mesh__publicMeSHNote mesh__D012333
% 208.06/208.28       65; NON-POLYADENYLATED MRNA was indexed under RNA, MESSENGER 1981-94; POLYADENYLATED MRNA %26% POLY%28%A%29% RNA were indexed under POLY A %26% RNA, MESSENGER 1980-94%A%  
% 208.06/208.28  |- skos__altLabel mesh__D012333 Messenger RNA, Polyadenylated
% 208.06/208.28  |- skos__prefLabel mesh__D012333 RNA, Messenger
% 208.06/208.28  |- skos__broader mesh__D031298smesh__D007887
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D031298 2006
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D031298 2005
% 208.06/208.28  |- mesh__dateEstablished mesh__D031298 2003-01-01
% 208.06/208.28  |- mesh__dateCreated mesh__D031298 2002-07-03
% 208.06/208.28  |- mesh__historyNote mesh__D031298 2003   
% 208.06/208.28  |- skos__annotation mesh__D031298
% 208.06/208.28       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.28  |- skos__scopeNote mesh__D031298
% 208.06/208.28       A plant genus of the family FABACEAE that contains kukulkanin, a CHALCONE.%A%    
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D031298 2004
% 208.06/208.28  |- skos__prefLabel mesh__D031298 Mimosa
% 208.06/208.28  |- rdf__type mesh__D031298sskos__Concept
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D031298 2003
% 208.06/208.28  |- mesh__publicMeSHNote mesh__D031298 2003   
% 208.06/208.28  |- skos__altLabel mesh__D036781 Pilins
% 208.06/208.28  |- mesh__publicMeSHNote mesh__D036781
% 208.06/208.28       2003; PILIN %28%now FIMBRIAE PROTEINS%29% was indexed under MEMBRANE PROTEINS 1977-2002; PROPILIN %28%now FIMBRIAE PROTEINS%29% was indexed under BACTERIAL OUTER MEMBRANE PROTEINS %26% PROTEIN PRECURSORS 1989-2002%A%  
% 208.06/208.28  |- skos__altLabel mesh__D036781 Propilin
% 208.06/208.28  |- skos__altLabel mesh__D036781 Pilin
% 208.06/208.28  |- mesh__dateCreated mesh__D036781 2002-07-03
% 208.06/208.28  |- rdf__type mesh__D036781sskos__Concept
% 208.06/208.28  |- skos__related mesh__D036781smesh__D018933
% 208.06/208.28  |- skos__hiddenLabel mesh__D036781 Precusors, Fimbriae Protein
% 208.06/208.28  |- mesh__recordOriginator mesh__D036781 jmp
% 208.06/208.28  |- skos__altLabel mesh__D036781 Pre-Pilin
% 208.06/208.28  |- mesh__historyNote mesh__D036781
% 208.06/208.28       2003; use FIMBRIAE PROTEINS %28%NM%29% 1977-2002   
% 208.06/208.28  |- skos__annotation mesh__D036781
% 208.06/208.28       Coordinate with PILI, SEX  if involved in BACTERIAL CONJUGATION, otherwise coordinate with FIMBRIAE, BACTERIAL%A%  
% 208.06/208.28  |- skos__hiddenLabel mesh__D036781 Precursors, Pilin
% 208.06/208.28  |- skos__altLabel mesh__D036781 Pilin Precursors
% 208.06/208.28  |- skos__scopeNote mesh__D036781
% 208.06/208.28       Proteins that are structural components of bacterial fimbriae %28%FIMBRIAE, BACTERIAL%29% or sex pili %28%PILI, SEX%29%.%A%    
% 208.06/208.28  |- skos__related mesh__D036781smesh__D010861
% 208.06/208.28  |- skos__prefLabel mesh__D036781 Fimbriae Proteins
% 208.06/208.28  |- skos__altLabel mesh__D036781 Pili Structural Proteins
% 208.06/208.28  |- mesh__dateRevised mesh__D036781 2005-06-30
% 208.06/208.28  |- mesh__recordMaintainer mesh__D036781 SYSTEM
% 208.06/208.28  |- mesh__dateEstablished mesh__D036781 2003-01-01
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D036781 2006
% 208.06/208.28  |- skos__hiddenLabel mesh__D036781 Pre Pilin
% 208.06/208.28  |- skos__hiddenLabel mesh__D036781 Protein Precusors, Fimbriae
% 208.06/208.28  |- skos__broader mesh__D036781smesh__D001425
% 208.06/208.28  |- mesh__recordAuthorizer mesh__D036781 sjn
% 208.06/208.28  |- skos__altLabel mesh__D022761 Horizontal Gene Transfer
% 208.06/208.28  |- skos__prefLabel mesh__D022761 Gene Transfer, Horizontal
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D022761 2005
% 208.06/208.28  |- mesh__publicMeSHNote mesh__D022761 2001   
% 208.06/208.28  |- mesh__recordAuthorizer mesh__D022761 jls
% 208.06/208.28  |- mesh__dateEstablished mesh__D022761 2001-01-01
% 208.06/208.28  |- skos__hiddenLabel mesh__D022761 Lateral Gene Transfers
% 208.06/208.28  |- skos__hiddenLabel mesh__D022761 Interspecific Recombination
% 208.06/208.28  |- skos__broader mesh__D022761smesh__D011995
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D022761 2006
% 208.06/208.28  |- mesh__recordOriginator mesh__D022761 nns
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D022761 2005B
% 208.06/208.28  |- skos__altLabel mesh__D022761 Lateral Gene Transfer
% 208.06/208.28  |- skos__annotation mesh__D022761
% 208.06/208.28       note category: do not confuse with GENE TRANSFER TECHNIQUES%A%  
% 208.06/208.28  |- mesh__recordMaintainer mesh__D022761 jls
% 208.06/208.28  |- skos__altLabel mesh__D022761 Recombination, Interspecific
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D022761 2005C
% 208.06/208.28  |- rdf__type mesh__D022761sskos__Concept
% 208.06/208.28  |- skos__altLabel mesh__D022761 Gene Transfer, Lateral
% 208.06/208.28  |- mesh__historyNote mesh__D022761 2001   
% 208.06/208.28  |- skos__hiddenLabel mesh__D022761 Gene Transfers, Lateral
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D022761 2004
% 208.06/208.28  |- skos__scopeNote mesh__D022761
% 208.06/208.28       The naturally occurring transmission of genetic information between organisms, related or unrelated, circumventing parent-to-offspring transmission. Horizontal gene transfer may occur via a variety of naturally occurring processes such as GENETIC CONJUGATION; GENETIC TRANSDUCTION; and TRANSFECTION. It may result in a change of the recipient organism%27%s genetic composition %28%TRANSFORMATION, GENETIC%29%.%A%    
% 208.06/208.28  |- skos__hiddenLabel mesh__D022761 Interspecies Recombination
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D022761 2005A
% 208.06/208.28  |- mesh__dateRevised mesh__D022761 2004-07-27
% 208.06/208.28  |- mesh__dateCreated mesh__D022761 2000-07-06
% 208.06/208.28  |- mesh__dateCreated mesh__D008292 1976-04-16
% 208.06/208.28  |- skos__prefLabel mesh__D008292 Malate Synthase
% 208.06/208.28  |- skos__altLabel mesh__D008292 Malate Condensing Enzyme
% 208.06/208.28  |- mesh__recordMaintainer mesh__D008292 jmp
% 208.06/208.28  |- skos__hiddenLabel mesh__D008292 Transacetylase, Glyoxylate
% 208.06/208.28  |- skos__hiddenLabel mesh__D008292 Synthase, Malate
% 208.06/208.28  |- mesh__recordOriginator mesh__D008292 RLS
% 208.06/208.28  |- mesh__dateEstablished mesh__D008292 1991-01-01
% 208.06/208.28  |- mesh__dateRevised mesh__D008292 2005-06-30
% 208.06/208.28  |- skos__historyNote mesh__D008292 Malates %28%1973-1976%29%
% 208.06/208.28  |- skos__broader mesh__D008292smesh__D000217
% 208.06/208.28  |- skos__historyNote mesh__D008292 Ketoacid-Lyases %28%1973-1976%29%
% 208.06/208.28  |- skos__altLabel mesh__D008292 Glyoxylate Transacetylase
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D008292 2006
% 208.06/208.28  |- skos__hiddenLabel mesh__D008292 Condensing Enzyme, Malate
% 208.06/208.28  |- skos__hiddenLabel mesh__D008292 Enzyme, Malate Condensing
% 208.06/208.28  |- skos__scopeNote mesh__D008292
% 208.06/208.28       An important enzyme in the glyoxylic acid cycle which reversibly catalyzes the synthesis of L-malate from acetyl-CoA and glyoxylate. This enzyme was formerly listed as EC 4.1.3.2.%A%    
% 208.06/208.28  |- mesh__recordAuthorizer mesh__D008292 sjn
% 208.06/208.28  |- rdf__type mesh__D008292sskos__Concept
% 208.06/208.28  |- skos__altLabel mesh__D008292 Malate Synthetase
% 208.06/208.28  |- mesh__publicMeSHNote mesh__D008292
% 208.06/208.28       91; was see under KETOACID-LYASES 1977-90   
% 208.06/208.28  |- skos__hiddenLabel mesh__D008292 Synthetase, Malate
% 208.06/208.28  |- mesh__historyNote mesh__D008292
% 208.06/208.28       91%28%77%29%; was see under KETOACID-LYASES 1977-90   
% 208.06/208.28  |- skos__hiddenLabel mesh__D016724 Thoracic Empyema
% 208.06/208.28  |- mesh__recordMaintainer mesh__D016724 PLS
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D016724 2003
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D016724 1998
% 208.06/208.28  |- mesh__onlineNote mesh__D016724
% 208.06/208.28       use EMPYEMA to search EMPYEMA, PLEURAL %26% PYOTHORAX 1984-91%A%  
% 208.06/208.28  |- mesh__dateRevised mesh__D016724 1994-05-27
% 208.06/208.28  |- mesh__dateEstablished mesh__D016724 1992-01-01
% 208.06/208.28  |- skos__altLabel mesh__D016724 Pyothorax
% 208.06/208.28  |- skos__broader mesh__D016724smesh__D012141
% 208.06/208.28  |- skos__hiddenLabel mesh__D016724 Thoracic Empyemas
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D016724 2001
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D016724 1995
% 208.06/208.28  |- mesh__recordOriginator mesh__D016724 TGC
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D016724 2006
% 208.06/208.28  |- skos__broader mesh__D016724smesh__D010995
% 208.06/208.28  |- mesh__publicMeSHNote mesh__D016724
% 208.06/208.28       92; was see EMPYEMA 1984-91; PYOTHORAX was see EMPYEMA 1984-91%A%  
% 208.06/208.28  |- mesh__recordAuthorizer mesh__D016724 PLS
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D016724 2000
% 208.06/208.28  |- skos__annotation mesh__D016724 if tuberculous = EMPYEMA, TUBERCULOUS   
% 208.06/208.28  |- skos__historyNote mesh__D016724 Empyema %28%1966-1991%29%
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D016724 1997
% 208.06/208.28  |- skos__hiddenLabel mesh__D016724 Empyemas, Thoracic
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D016724 2005
% 208.06/208.28  |- skos__hiddenLabel mesh__D016724 Pleural Empyema
% 208.06/208.28  |- rdf__type mesh__D016724sskos__Concept
% 208.06/208.28  |- skos__scopeNote mesh__D016724
% 208.06/208.28       Suppurative inflammation of the pleural space.     
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D016724 1996
% 208.06/208.28  |- mesh__historyNote mesh__D016724
% 208.06/208.28       92; was see EMPYEMA 1984-91; PYOTHORAX was see EMPYEMA 1984-91%A%  
% 208.06/208.28  |- skos__altLabel mesh__D016724 Empyema, Thoracic
% 208.06/208.28  |- skos__hiddenLabel mesh__D016724 Empyemas, Pleural
% 208.06/208.28  |- skos__broader mesh__D016724smesh__D004653
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D016724 2002
% 208.06/208.28  |- skos__prefLabel mesh__D016724 Empyema, Pleural
% 208.06/208.28  |- skos__hiddenLabel mesh__D016724 Pleural Empyemas
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D016724 2004
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D016724 1999
% 208.06/208.28  |- mesh__dateCreated mesh__D016724 1991-02-11
% 208.06/208.28  |- mesh__recordOriginator mesh__D002704 NLM
% 208.06/208.28  |- mesh__dateCreated mesh__D002704 1999-01-01
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D002704 1995
% 208.06/208.28  |- skos__broader mesh__D002704smesh__D017606
% 208.06/208.28  |- skos__broader mesh__D002704smesh__D000838
% 208.06/208.28  |- mesh__recordMaintainer mesh__D002704 TPW
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D002704 2006
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D002704 1999
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D002704 2004
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D002704 2001
% 208.06/208.28  |- mesh__dateEstablished mesh__D002704 1973-01-01
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D002704 1994
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D002704 1997
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D002704 2000
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D002704 2005
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D002704 1998
% 208.06/208.28  |- mesh__dateRevised mesh__D002704 1993-06-04
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D002704 2003
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D002704 1996
% 208.06/208.28  |- skos__historyNote mesh__D002704 Chlorine %28%1966-1970%29%
% 208.06/208.28  |- rdf__type mesh__D002704sskos__Concept
% 208.06/208.28  |- mesh__recordAuthorizer mesh__D002704 PLS
% 208.06/208.28  |- mesh__publicMeSHNote mesh__D002704 73   
% 208.06/208.28  |- skos__scopeNote mesh__D002704
% 208.06/208.28       Inorganic salts of chloric acid that contain the ClO3- ion.%A%    
% 208.06/208.28  |- skos__prefLabel mesh__D002704 Chlorates
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D002704 2002
% 208.06/208.28  |- mesh__historyNote mesh__D002704 73%28%71%29%   
% 208.06/208.28  |- skos__broader mesh__D019817Q000031smesh__D019817
% 208.06/208.28  |- mesh__preferredCombination mesh__D019817Q000031smesh__D020185
% 208.06/208.28  |- rdf__type mesh__D019817Q000031smesh__CompoundConcept
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007998 2006
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007998 1991
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007998 2003
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007998 1994
% 208.06/208.28  |- mesh__dateRevised mesh__D007998 1990-05-07
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007998 2004
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007998 1992
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007998 1995
% 208.06/208.28  |- skos__hiddenLabel mesh__D007998 Sciences, Library
% 208.06/208.28  |- skos__hiddenLabel mesh__D007998 Library Sciences
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007998 1993
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007998 1998
% 208.06/208.28  |- mesh__recordAuthorizer mesh__D007998 PLS
% 208.06/208.28  |- skos__annotation mesh__D007998
% 208.06/208.28       SPEC: SPEC qualif; med librarianship: do not coord with MEDICINE%A%  
% 208.06/208.28  |- mesh__recordMaintainer mesh__D007998 PLS
% 208.06/208.28  |- skos__broader mesh__D007998smesh__D007254
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007998 2000
% 208.06/208.28  |- skos__prefLabel mesh__D007998 Library Science
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007998 1999
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007998 1996
% 208.06/208.28  |- mesh__recordOriginator mesh__D007998 NLM
% 208.06/208.28  |- rdf__type mesh__D007998sskos__Concept
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007998 2001
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007998 1997
% 208.06/208.28  |- skos__hiddenLabel mesh__D007998 Science, Library
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007998 2005
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007998 2002
% 208.06/208.28  |- mesh__dateCreated mesh__D007998 1999-01-01
% 208.06/208.28  |- skos__scopeNote mesh__D007998
% 208.06/208.28       Study of the principles and practices of library administration and services.%A%    
% 208.06/208.28  |- skos__prefLabel mesh__D048008 TNF Receptor-Associated Factor 3
% 208.06/208.28  |- skos__hiddenLabel mesh__D048008 LAP 1 Protein
% 208.06/208.28  |- skos__hiddenLabel mesh__D048008 CD40 Receptor Associated Factor 1
% 208.06/208.28  |- mesh__dateCreated mesh__D048008 2004-07-07
% 208.06/208.28  |- skos__scopeNote mesh__D048008
% 208.06/208.28       A signal transducing tumor necrosis factor receptor associated factor that is involved in regulation of NF-KAPPA B signaling and activation of MITOGEN-ACTIVATED PROTEIN KINASES.%A%    
% 208.06/208.28  |- mesh__recordOriginator mesh__D048008 jmp
% 208.06/208.28  |- mesh__recordAuthorizer mesh__D048008 sjn
% 208.06/208.28  |- mesh__historyNote mesh__D048008 2005%28%1995%29%   
% 208.06/208.28  |- skos__historyNote mesh__D048008 Proteins %28%1995-2004%29%
% 208.06/208.28  |- skos__altLabel mesh__D048008 TRAF-3
% 208.06/208.28  |- skos__broader mesh__D048008smesh__D047988
% 208.06/208.28  |- skos__altLabel mesh__D048008 CRAF1 Protein
% 208.06/208.28  |- mesh__publicMeSHNote mesh__D048008
% 208.06/208.28       2005; TNF RECEPTOR-ASSOCIATED FACTOR 3 was indexed under PROTEINS 1995-2004%A%  
% 208.06/208.28  |- skos__altLabel mesh__D048008 CD40bp Protein
% 208.06/208.28  |- skos__altLabel mesh__D048008 LAP-1 Protein
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D048008 2005
% 208.06/208.28  |- skos__hiddenLabel mesh__D048008 TNF Receptor Associated Factor 3
% 208.06/208.28  |- skos__altLabel mesh__D048008 CD40 Receptor-Associated Factor 1
% 208.06/208.28  |- mesh__dateEstablished mesh__D048008 2005-01-01
% 208.06/208.28  |- mesh__recordMaintainer mesh__D048008 jmp
% 208.06/208.28  |- rdf__type mesh__D048008sskos__Concept
% 208.06/208.28  |- skos__altLabel mesh__D048008 TRAF3
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D048008 2006
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D012334 2004
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D012334 2001
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D012334 1999
% 208.06/208.28  |- mesh__dateCreated mesh__D012334 1999-01-01
% 208.06/208.28  |- mesh__recordMaintainer mesh__D012334 TGC
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D012334 2005
% 208.06/208.28  |- skos__prefLabel mesh__D012334 RNA, Neoplasm
% 208.06/208.28  |- mesh__recordOriginator mesh__D012334 NLM
% 208.06/208.28  |- skos__annotation mesh__D012334
% 208.06/208.28       IM; /drug eff /ultrastruct permitted; coord with required neopl term%28%s%29% %28%IM%29%; Manual 24.4.4.2; DF: RNA NEOPL%A%  
% 208.06/208.28  |- skos__altLabel mesh__D012334 Neoplasm RNA
% 208.06/208.28  |- mesh__recordAuthorizer mesh__D012334 PLS
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D012334 2002
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D012334 2006
% 208.06/208.28  |- mesh__dateRevised mesh__D012334 1995-03-20
% 208.06/208.28  |- skos__scopeNote mesh__D012334 RNA present in neoplastic tissue.     
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D012334 1996
% 208.06/208.28  |- rdf__type mesh__D012334sskos__Concept
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D012334 1997
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D012334 2003
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D012334 1998
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D012334 2000
% 208.06/208.28  |- skos__broader mesh__D012334smesh__D012313
% 208.06/208.28  |- skos__prefLabel mesh__D031299 Mucuna
% 208.06/208.28  |- mesh__publicMeSHNote mesh__D031299 2003   
% 208.06/208.28  |- mesh__dateCreated mesh__D031299 2002-07-02
% 208.06/208.28  |- skos__altLabel mesh__D031299 Bean, Velvet
% 208.06/208.28  |- skos__broader mesh__D031299smesh__D007887
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D031299 2006
% 208.06/208.28  |- skos__annotation mesh__D031299
% 208.06/208.28       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D031299 2005
% 208.06/208.28  |- mesh__dateEstablished mesh__D031299 2003-01-01
% 208.06/208.28  |- mesh__historyNote mesh__D031299 2003   
% 208.06/208.28  |- skos__scopeNote mesh__D031299
% 208.06/208.28       A plant genus of the family FABACEAE that is the source of mucuna gum.%A%    
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D031299 2004
% 208.06/208.28  |- skos__altLabel mesh__D031299 Cowitch
% 208.06/208.28  |- rdf__type mesh__D031299sskos__Concept
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D031299 2003
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D022762 2006
% 208.06/208.28  |- skos__hiddenLabel mesh__D022762 C-EBP, Nuclear Protein
% 208.06/208.28  |- skos__hiddenLabel mesh__D022762 CAAT Enhancer Binding Proteins
% 208.06/208.28  |- skos__altLabel mesh__D022762 Nuclear Protein C-EBP
% 208.06/208.28  |- skos__altLabel mesh__D022762 C-EBP Proteins
% 208.06/208.28  |- skos__altLabel mesh__D022762 CAAT-Enhancer Binding Protein
% 208.06/208.28  |- skos__altLabel mesh__D022762 C-EBP Protein
% 208.06/208.28  |- skos__altLabel mesh__D022762 CCAAT-Enhancer-Binding Protein
% 208.06/208.28  |- skos__hiddenLabel mesh__D022762 CCAAT Enhancer Binding Proteins
% 208.06/208.28  |- skos__hiddenLabel mesh__D022762 C EBP Nuclear Protein
% 208.06/208.28  |- skos__scopeNote mesh__D022762
% 208.06/208.28       A class of proteins that were originally identified by their ability to bind the DNA sequence CCAAT. The typical CCAAT-enhancer binding protein forms dimers and consists of an activation domain, a DNA-binding basic region, and a leucine-rich dimerization domain %28%LEUCINE ZIPPERS%29%. CCAAT-BINDING FACTOR is structurally distinct type of CCAAT-enhancer binding protein consisting of a trimer of three different subunits.%A%    
% 208.06/208.28  |- skos__historyNote mesh__D022762 DNA-Binding Proteins %28%1991-2000%29%
% 208.06/208.28  |- skos__hiddenLabel mesh__D022762 C EBP Proteins
% 208.06/208.28  |- skos__historyNote mesh__D022762 Nuclear Proteins %28%1991-2000%29%
% 208.06/208.28  |- rdf__type mesh__D022762sskos__Concept
% 208.06/208.28  |- skos__hiddenLabel mesh__D022762 Nuclear Protein, C-EBP
% 208.06/208.28  |- skos__altLabel mesh__D022762 CAAT-Enhancer-Binding Proteins
% 208.06/208.28  |- skos__altLabel mesh__D022762
% 208.06/208.28       CCAAT Sequence-Specific DNA-Binding Proteins
% 208.06/208.28  |- skos__hiddenLabel mesh__D022762 Binding Protein, CAAT-Enhancer
% 208.06/208.28  |- skos__broader mesh__D022762smesh__D009687
% 208.06/208.28  |- mesh__dateRevised mesh__D022762 2005-06-30
% 208.06/208.28  |- mesh__dateCreated mesh__D022762 2000-06-21
% 208.06/208.28  |- mesh__publicMeSHNote mesh__D022762
% 208.06/208.28       2001; C-EBP NUCLEAR PROTEIN was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS 1989-2000; CCAAT SEQUENCE-SPECIFIC DNA-BINDING PROTEINS was indexed under DNA-BINDING PROTEINS 1988-2000%A%  
% 208.06/208.28  |- skos__broader mesh__D022762smesh__D050976
% 208.06/208.28  |- skos__hiddenLabel mesh__D022762 C EBP Protein
% 208.06/208.28  |- mesh__recordMaintainer mesh__D022762 DRC
% 208.06/208.28  |- mesh__historyNote mesh__D022762
% 208.06/208.28       2001; for C-EBP NUCLEAR PROTEIN use CCAAT-ENHANCER-BINDING PROTEINS %28%NM%29% 1989-2000; for CCAAT SEQUENCE-SPECIFIC DNA-BINDING PROTEINS use CCAAT-ENHANCER BINDING PROTEINS 1988-2000%A%  
% 208.06/208.28  |- skos__hiddenLabel mesh__D022762
% 208.06/208.28       CCAAT Sequence Specific DNA Binding Proteins
% 208.06/208.28  |- mesh__recordOriginator mesh__D022762 jmp
% 208.06/208.28  |- skos__altLabel mesh__D022762 C-EBP Nuclear Protein
% 208.06/208.28  |- skos__annotation mesh__D022762 GEN: prefer specifics   
% 208.06/208.28  |- skos__prefLabel mesh__D022762 CCAAT-Enhancer-Binding Proteins
% 208.06/208.28  |- skos__hiddenLabel mesh__D022762 CAAT Enhancer Binding Protein
% 208.06/208.28  |- skos__hiddenLabel mesh__D022762 Nuclear Protein C EBP
% 208.06/208.28  |- mesh__dateEstablished mesh__D022762 2001-01-01
% 208.06/208.28  |- skos__hiddenLabel mesh__D022762 CCAAT Enhancer Binding Protein
% 208.06/208.28  |- mesh__recordAuthorizer mesh__D022762 sjn
% 208.06/208.28  |- skos__prefLabel mesh__D008293 Malates
% 208.06/208.28  |- skos__broader mesh__D008293smesh__D006880
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D008293 2002
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D008293 2004
% 208.06/208.28  |- mesh__dateRevised mesh__D008293 1992-05-18
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D008293 2001
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D008293 2003
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D008293 2006
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D008293 1997
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D008293 2000
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D008293 2005
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D008293 1996
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D008293 1993
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D008293 1999
% 208.06/208.28  |- rdf__type mesh__D008293sskos__Concept
% 208.06/208.28  |- mesh__recordOriginator mesh__D008293 NLM
% 208.06/208.28  |- skos__broader mesh__D008293smesh__D003998
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D008293 1995
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D008293 1998
% 208.06/208.28  |- mesh__dateCreated mesh__D008293 1999-01-01
% 208.06/208.28  |- skos__annotation mesh__D008293 do not confuse with MALEATES   
% 208.06/208.28  |- mesh__recordAuthorizer mesh__D008293 PLS
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D008293 1994
% 208.06/208.28  |- mesh__recordMaintainer mesh__D008293 TAP
% 208.06/208.28  |- skos__broader mesh__D001769Q000737smesh__D001769
% 208.06/208.28  |- mesh__preferredCombination mesh__D001769Q000737smesh__D001774
% 208.06/208.28  |- rdf__type mesh__D001769Q000737smesh__CompoundConcept
% 208.06/208.28  |- mesh__historyNote mesh__D007999 76; was NON MESH before 1976   
% 208.06/208.28  |- skos__broader mesh__D007999smesh__D007255
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007999 2000
% 208.06/208.28  |- skos__annotation mesh__D007999 IM; DF: LIBRARY SERV   
% 208.06/208.28  |- skos__altLabel mesh__D007999 Services, Library
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007999 2004
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007999 2006
% 208.06/208.28  |- mesh__dateEstablished mesh__D007999 1976-01-01
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007999 2003
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007999 2005
% 208.06/208.28  |- skos__hiddenLabel mesh__D007999 Service, Library
% 208.06/208.28  |- mesh__dateRevised mesh__D007999 1999-11-03
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007999 2002
% 208.06/208.28  |- mesh__recordMaintainer mesh__D007999 kle
% 208.06/208.28  |- skos__broader mesh__D007999smesh__D007998
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D007999 2001
% 208.06/208.28  |- mesh__publicMeSHNote mesh__D007999 76   
% 208.06/208.28  |- skos__hiddenLabel mesh__D007999 Library Service
% 208.06/208.28  |- skos__prefLabel mesh__D007999 Library Services
% 208.06/208.28  |- rdf__type mesh__D007999sskos__Concept
% 208.06/208.28  |- skos__scopeNote mesh__D007999
% 208.06/208.28       Services offered to the library user. They include reference and circulation.%A%    
% 208.06/208.28  |- mesh__recordOriginator mesh__D007999 SMH
% 208.06/208.28  |- mesh__dateCreated mesh__D007999 1975-07-25
% 208.06/208.28  |- skos__historyNote mesh__D007999
% 208.06/208.28       specific library or library science heading %28%1966-1975%29%
% 208.06/208.28  |- mesh__recordAuthorizer mesh__D007999 sjn
% 208.06/208.28  |- skos__broader mesh__D002802Q000037smesh__D002802
% 208.06/208.28  |- mesh__preferredCombination mesh__D002802Q000037smesh__D002800
% 208.06/208.28  |- rdf__type mesh__D002802Q000037smesh__CompoundConcept
% 208.06/208.28  |- mesh__dateRevised mesh__D048009 2005-06-30
% 208.06/208.28  |- mesh__recordOriginator mesh__D048009 ags
% 208.06/208.28  |- rdf__type mesh__D048009sskos__Concept
% 208.06/208.28  |- skos__prefLabel mesh__D048009 Clostridium symbiosum
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D048009 2006
% 208.06/208.28  |- skos__historyNote mesh__D048009 Clostridium %28%1985-2004%29%
% 208.06/208.28  |- mesh__recordMaintainer mesh__D048009 SYSTEM
% 208.06/208.28  |- skos__scopeNote mesh__D048009
% 208.06/208.28       A species of gram-positive bacteria in the family Clostridiaceae. Its GLUTAMATE DEHYDROGENASE is commonly used in research.%A%    
% 208.06/208.28  |- mesh__recordAuthorizer mesh__D048009 sjn
% 208.06/208.28  |- skos__broader mesh__D048009smesh__D003013
% 208.06/208.28  |- mesh__publicMeSHNote mesh__D048009 2005   
% 208.06/208.28  |- mesh__dateCreated mesh__D048009 2004-07-07
% 208.06/208.28  |- mesh__historyNote mesh__D048009 2005   
% 208.06/208.28  |- mesh__dateEstablished mesh__D048009 2005-01-01
% 208.06/208.28  |- mesh__activeMeSHYear mesh__D012335 2001
% 208.15/208.28  |- skos__annotation mesh__D012335
% 208.15/208.28       IM; /drug eff /ultrastruct permitted; RRNA OPERON is also available%A%  
% 208.15/208.28  |- mesh__activeMeSHYear mesh__D012335 1999
% 208.15/208.28  |- mesh__recordOriginator mesh__D012335 NLM
% 208.15/208.28  |- mesh__activeMeSHYear mesh__D012335 2004
% 208.15/208.28  |- mesh__recordAuthorizer mesh__D012335 PLS
% 208.15/208.28  |- mesh__recordMaintainer mesh__D012335 KEV
% 208.15/208.28  |- mesh__dateEstablished mesh__D012335 1972-01-01
% 208.15/208.28  |- skos__scopeNote mesh__D012335
% 208.15/208.28       The most abundant form of RNA. Together with proteins, it forms the ribosomes, playing a structural role and also a role in ribosomal binding of mRNA and tRNAs. Individual chains are conventionally designated by their sedimentation coefficients. In eukaryotes, four large chains exist, synthesized in the nucleolus and constituting about 50%25% of the ribosome. %28%Dorland, 28th ed%29%%A%    
% 208.15/208.28  |- mesh__activeMeSHYear mesh__D012335 2002
% 208.15/208.28  |- mesh__historyNote mesh__D012335 72%28%71%29%   
% 208.15/208.28  |- mesh__activeMeSHYear mesh__D012335 2005
% 208.15/208.28  |- skos__altLabel mesh__D012335 Ribosomal RNA
% 208.15/208.28  |- mesh__dateRevised mesh__D012335 1995-06-08
% 208.15/208.28  |- mesh__activeMeSHYear mesh__D012335 1996
% 208.15/208.28  |- skos__historyNote mesh__D012335 Ribosomes %28%1966-1970%29%
% 208.15/208.28  |- mesh__activeMeSHYear mesh__D012335 2006
% 208.15/208.28  |- skos__prefLabel mesh__D012335 RNA, Ribosomal
% 208.15/208.28  |- skos__hiddenLabel mesh__D012335 RNA, 15S
% 208.15/208.28  |- mesh__activeMeSHYear mesh__D012335 1997
% 208.15/208.28  |- rdf__type mesh__D012335sskos__Concept
% 208.15/208.28  |- mesh__activeMeSHYear mesh__D012335 2000
% 208.15/208.28  |- mesh__activeMeSHYear mesh__D012335 1998
% 208.15/208.29  |- mesh__publicMeSHNote mesh__D012335 72   
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012335 2003
% 208.15/208.29  |- skos__historyNote mesh__D012335 RNA %28%1966-1970%29%
% 208.15/208.29  |- skos__broader mesh__D012335smesh__D012313
% 208.15/208.29  |- mesh__dateCreated mesh__D012335 1999-01-01
% 208.15/208.29  |- mesh__recordAuthorizer mesh__D017020 sjn
% 208.15/208.29  |- mesh__dateEstablished mesh__D017020 1992-01-01
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D017020 2006
% 208.15/208.29  |- mesh__recordOriginator mesh__D017020 PXP
% 208.15/208.29  |- skos__broader mesh__D017020smesh__D017019
% 208.15/208.29  |- mesh__dateRevised mesh__D017020 2005-06-30
% 208.15/208.29  |- skos__historyNote mesh__D017020 Sarcina %28%1966-1974%29%
% 208.15/208.29  |- rdf__type mesh__D017020sskos__Concept
% 208.15/208.29  |- skos__historyNote mesh__D017020 Methanogens %28%1979-1991%29%
% 208.15/208.29  |- mesh__dateCreated mesh__D017020 1991-05-30
% 208.15/208.29  |- skos__historyNote mesh__D017020 Bacteria %28%1973-1978%29%
% 208.15/208.29  |- mesh__historyNote mesh__D017020 92   
% 208.15/208.29  |- skos__annotation mesh__D017020
% 208.15/208.29       a genus of methanogens found in aquatic environments   
% 208.15/208.29  |- mesh__publicMeSHNote mesh__D017020 92   
% 208.15/208.29  |- skos__scopeNote mesh__D017020
% 208.15/208.29       A genus of anaerobic, irregular spheroid-shaped METHANOSARCINALES whose organisms are nonmotile. Endospores are not formed. These archaea derive energy via formation of methane from acetate, methanol, mono-, di-, and trimethylamine, and possibly, carbon monoxide. Organisms are isolated from freshwater and marine environments.%A%    
% 208.15/208.29  |- skos__prefLabel mesh__D017020 Methanosarcina
% 208.15/208.29  |- mesh__recordMaintainer mesh__D017020 SYSTEM
% 208.15/208.29  |- rdf__type mesh__D003000sskos__Concept
% 208.15/208.29  |- mesh__recordOriginator mesh__D003000 NLM
% 208.15/208.29  |- skos__historyNote mesh__D003000
% 208.15/208.29       Antihypertensive Agents %28%1966-1971%29%
% 208.15/208.29  |- mesh__historyNote mesh__D003000 73%28%72%29%   
% 208.15/208.29  |- skos__altLabel mesh__D003000 Clofelin
% 208.15/208.29  |- skos__hiddenLabel mesh__D003000 ST 155
% 208.15/208.29  |- skos__hiddenLabel mesh__D003000 Monohydrobromide, Clonidine
% 208.15/208.29  |- mesh__dateCreated mesh__D003000 1999-01-01
% 208.15/208.29  |- skos__altLabel mesh__D003000 Catapressan
% 208.15/208.29  |- mesh__recordAuthorizer mesh__D003000 sjn
% 208.15/208.29  |- skos__hiddenLabel mesh__D003000 Monohydrochloride, Clonidine
% 208.15/208.29  |- skos__altLabel mesh__D003000 Clopheline
% 208.15/208.29  |- skos__hiddenLabel mesh__D003000 ST155
% 208.15/208.29  |- skos__hiddenLabel mesh__D003000 Hydrochloride, Clonidine
% 208.15/208.29  |- skos__hiddenLabel mesh__D003000 M5041T
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D003000 2006
% 208.15/208.29  |- mesh__recordMaintainer mesh__D003000 ssb
% 208.15/208.29  |- mesh__dateRevised mesh__D003000 2005-06-30
% 208.15/208.29  |- skos__hiddenLabel mesh__D003000 Dihydrochloride, Clonidine
% 208.15/208.29  |- skos__prefLabel mesh__D003000 Clonidine
% 208.15/208.29  |- skos__altLabel mesh__D003000 Klofenil
% 208.15/208.29  |- skos__altLabel mesh__D003000 Clofenil
% 208.15/208.29  |- skos__broader mesh__D003000smesh__D048288
% 208.15/208.29  |- skos__historyNote mesh__D003000 Imidazoles %28%1966-1971%29%
% 208.15/208.29  |- skos__altLabel mesh__D003000 Catapresan
% 208.15/208.29  |- skos__scopeNote mesh__D003000
% 208.15/208.29       An alpha-2 adrenergic agonist that crosses the blood-brain barrier. Clonidine acts centrally by reducing sympathetic tone, resulting in a fall in diastolic and systolic blood pressure and a reduction in heart rate. It also acts peripherally, and this peripheral activity may be responsible for the transient increase in blood pressure seen during rapid intravenous administration. %28%From Martindale, the Extra Pharmacopoeia, 30th ed, p350%29%%A%    
% 208.15/208.29  |- skos__hiddenLabel mesh__D003000 M 5041T
% 208.15/208.29  |- mesh__dateEstablished mesh__D003000 1973-01-01
% 208.15/208.29  |- mesh__publicMeSHNote mesh__D003000 73   
% 208.15/208.29  |- skos__altLabel mesh__D022763 C-EBP alpha
% 208.15/208.29  |- skos__historyNote mesh__D022763 DNA-Binding Proteins %28%1990-2000%29%
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D022763 2006
% 208.15/208.29  |- rdf__type mesh__D022763sskos__Concept
% 208.15/208.29  |- skos__broader mesh__D022763smesh__D022762
% 208.15/208.29  |- skos__scopeNote mesh__D022763
% 208.15/208.29       A CCAAT-enhancer-binding protein found in LIVER; ADIPOSE TISSUE; INTESTINES; LUNG; ADRENAL GLANDS; PLACENTA; OVARY and peripheral blood mononuclear cells %28%LEUKOCYTES, MONONUCLEAR%29%. Experiments with knock-out mice have demonstrated that CCAAT-enhancer binding protein-alpha is essential for the functioning and differentiation of HEPATOCYTES and ADIPOCYTES.%A%    
% 208.15/208.29  |- mesh__historyNote mesh__D022763
% 208.15/208.29       2001; C-EBPALPHA use CCAAT-ENHANCER-BINDING PROTEINS %28%NM%29% 1996-2000%A%  
% 208.15/208.29  |- mesh__dateCreated mesh__D022763 2000-06-21
% 208.15/208.29  |- skos__hiddenLabel mesh__D022763 CCAAT Enhancer Binding Protein alpha
% 208.15/208.29  |- skos__historyNote mesh__D022763 Nuclear Proteins %28%1990-2000%29%
% 208.15/208.29  |- skos__hiddenLabel mesh__D022763 C EBPalpha
% 208.15/208.29  |- mesh__dateRevised mesh__D022763 2005-06-30
% 208.15/208.29  |- mesh__dateEstablished mesh__D022763 2001-01-01
% 208.15/208.29  |- mesh__recordOriginator mesh__D022763 jmp
% 208.15/208.29  |- mesh__recordMaintainer mesh__D022763 DRC
% 208.15/208.29  |- mesh__recordAuthorizer mesh__D022763 sjn
% 208.15/208.29  |- skos__altLabel mesh__D022763 C-EBPalpha
% 208.15/208.29  |- skos__prefLabel mesh__D022763 CCAAT-Enhancer-Binding Protein-alpha
% 208.15/208.29  |- skos__hiddenLabel mesh__D022763 C EBP alpha
% 208.15/208.29  |- mesh__publicMeSHNote mesh__D022763
% 208.15/208.29       2001; C-EBPALPHA was indexed under NUCLEAR PROTEINS %26% DNA-BINDING PROTEINS 1996-2000%A%  
% 208.15/208.29  |- skos__altLabel mesh__D008294 Carbafos
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D008294 2006
% 208.15/208.29  |- skos__historyNote mesh__D008294 Phosphoric Acids %28%1968-1971%29%
% 208.15/208.29  |- skos__altLabel mesh__D008294 Karbofos
% 208.15/208.29  |- mesh__dateEstablished mesh__D008294 1972-01-01
% 208.15/208.29  |- mesh__publicMeSHNote mesh__D008294 72   
% 208.15/208.29  |- skos__altLabel mesh__D008294 Carbophos
% 208.15/208.29  |- mesh__recordOriginator mesh__D008294 NLM
% 208.15/208.29  |- mesh__recordMaintainer mesh__D008294 ssb
% 208.15/208.29  |- skos__historyNote mesh__D008294 Thiomalates %28%1966-1971%29%
% 208.15/208.29  |- rdf__type mesh__D008294sskos__Concept
% 208.15/208.29  |- mesh__recordAuthorizer mesh__D008294 sjn
% 208.15/208.29  |- skos__prefLabel mesh__D008294 Malathion
% 208.15/208.29  |- mesh__dateCreated mesh__D008294 1999-01-01
% 208.15/208.29  |- skos__scopeNote mesh__D008294
% 208.15/208.29       A wide spectrum aliphatic organophosphate insecticide widely used for both domestic and commercial agricultural purposes.%A%    
% 208.15/208.29  |- skos__broader mesh__D008294smesh__D009946
% 208.15/208.29  |- skos__historyNote mesh__D008294 Phosphates %28%1966-1971%29%
% 208.15/208.29  |- mesh__historyNote mesh__D008294 72   
% 208.15/208.29  |- skos__altLabel mesh__D008294 Carbofos
% 208.15/208.29  |- mesh__dateRevised mesh__D008294 2005-06-30
% 208.15/208.29  |- skos__altLabel mesh__D016726 Pseudotumor, Inflammatory, Pulmonary
% 208.15/208.29  |- skos__hiddenLabel mesh__D016726 Pseudotumors, Inflammatory Pulmonary
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D016726 2004
% 208.15/208.29  |- skos__hiddenLabel mesh__D016726 Inflammatory Pseudotumors, Pulmonary
% 208.15/208.29  |- skos__hiddenLabel mesh__D016726 Lung Inflammatory Pseudotumor
% 208.15/208.29  |- skos__altLabel mesh__D016726 Pulmonary Granuloma, Plasma Cell
% 208.15/208.29  |- skos__hiddenLabel mesh__D016726 Pseudotumors, Pulmonary Inflammatory
% 208.15/208.29  |- rdf__type mesh__D016726sskos__Concept
% 208.15/208.29  |- skos__altLabel mesh__D016726 Plasma Cell Granuloma, Pulmonary
% 208.15/208.29  |- skos__altLabel mesh__D016726 Pulmonary Inflammatory Pseudotumor
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D016726 2003
% 208.15/208.29  |- skos__altLabel mesh__D016726 Pulmonary Pseudotumor, Inflammatory
% 208.15/208.29  |- mesh__recordMaintainer mesh__D016726 jls
% 208.15/208.29  |- mesh__recordAuthorizer mesh__D016726 sjn
% 208.15/208.29  |- mesh__dateRevised mesh__D016726 1999-11-08
% 208.15/208.29  |- skos__altLabel mesh__D016726 Inflammatory Pseudotumor, Pulmonary
% 208.15/208.29  |- mesh__dateEstablished mesh__D016726 1992-01-01
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D016726 2002
% 208.15/208.29  |- skos__scopeNote mesh__D016726
% 208.15/208.29       A pseudotumor of the lung composed of inflammatory cells and showing complete maturity of fibroblastic components with a striking lack of mitosis. It is also called postinflammatory pseudotumor and pseudoneoplastic pneumonitis. %28%Surg Gynecol Obstet 1983 Jan;156%28%1%29%:89-96%29%%A%    
% 208.15/208.29  |- skos__hiddenLabel mesh__D016726 Pseudotumor, Inflammatory Pulmonary
% 208.15/208.29  |- skos__altLabel mesh__D016726 Pseudotumor, Pulmonary Inflammatory
% 208.15/208.29  |- skos__altLabel mesh__D016726 Inflammatory Pseudotumor of Lung
% 208.15/208.29  |- skos__hiddenLabel mesh__D016726 Lung Inflammatory Pseudotumors
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D016726 2001
% 208.15/208.29  |- mesh__historyNote mesh__D016726 92   
% 208.15/208.29  |- skos__broader mesh__D016726smesh__D008171
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D016726 2006
% 208.15/208.29  |- mesh__recordOriginator mesh__D016726 TGC
% 208.15/208.29  |- skos__hiddenLabel mesh__D016726 Pulmonary Inflammatory Pseudotumors
% 208.15/208.29  |- skos__historyNote mesh__D016726 Lung Diseases %28%1966-1991%29%
% 208.15/208.29  |- skos__hiddenLabel mesh__D016726 Inflammatory Pulmonary Pseudotumors
% 208.15/208.29  |- skos__altLabel mesh__D016726 Pulmonary Plasma Cell Granuloma
% 208.15/208.29  |- skos__hiddenLabel mesh__D016726 Pulmonary Pseudotumors, Inflammatory
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D016726 2000
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D016726 2005
% 208.15/208.29  |- skos__prefLabel mesh__D016726 Granuloma, Plasma Cell, Pulmonary
% 208.15/208.29  |- mesh__dateCreated mesh__D016726 1991-02-11
% 208.15/208.29  |- skos__annotation mesh__D016726
% 208.15/208.29       non-neoplastic; DF: GRANULOMA PLASMA CELL PULM   
% 208.15/208.29  |- mesh__publicMeSHNote mesh__D016726 92   
% 208.15/208.29  |- skos__broader mesh__D016726smesh__D006104
% 208.15/208.29  |- skos__altLabel mesh__D016726 Inflammatory Pulmonary Pseudotumor
% 208.15/208.29  |- skos__hiddenLabel mesh__D002706 gamma Chlordane
% 208.15/208.29  |- skos__broader mesh__D002706smesh__D006843
% 208.15/208.29  |- skos__prefLabel mesh__D002706 Chlordan
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D002706 2006
% 208.15/208.29  |- mesh__dateRevised mesh__D002706 2004-07-07
% 208.15/208.29  |- rdf__type mesh__D002706sskos__Concept
% 208.15/208.29  |- skos__altLabel mesh__D002706 gamma-Chlordane
% 208.15/208.29  |- mesh__dateCreated mesh__D002706 1999-01-01
% 208.15/208.29  |- skos__scopeNote mesh__D002706
% 208.15/208.29       A highly poisonous organochlorine insecticide. The EPA has cancelled registrations of pesticides containing this compound with the exception of its use through subsurface ground insertion for termite control and the dipping of roots or tops of non-food plants. %28%From Merck Index, 11th ed%29%%A%    
% 208.15/208.29  |- mesh__recordOriginator mesh__D002706 NLM
% 208.15/208.29  |- mesh__recordAuthorizer mesh__D002706 sjn
% 208.15/208.29  |- mesh__recordMaintainer mesh__D002706 ssb
% 208.15/208.29  |- skos__altLabel mesh__D002706 Chlordane
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D002706 2005
% 208.15/208.29  |- skos__annotation mesh__D002706 TN 111 for eff on insects   
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012336 2000
% 208.15/208.29  |- skos__altLabel mesh__D012336 16S Ribosomal RNA
% 208.15/208.29  |- skos__annotation mesh__D012336
% 208.15/208.29       IM; /drug eff /ultrastruct permitted; DF: 16S RRNA   
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012336 2005
% 208.15/208.29  |- mesh__publicMeSHNote mesh__D012336
% 208.15/208.29       91; was see under RNA, RIBOSOMAL 1988-90   
% 208.15/208.29  |- mesh__recordOriginator mesh__D012336 RLS
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012336 1996
% 208.15/208.29  |- skos__prefLabel mesh__D012336 RNA, Ribosomal, 16S
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012336 2001
% 208.15/208.29  |- skos__hiddenLabel mesh__D012336 RNA, 16S Ribosomal
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012336 2006
% 208.15/208.29  |- mesh__recordAuthorizer mesh__D012336 PLS
% 208.15/208.29  |- skos__broader mesh__D012336smesh__D012335
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012336 1997
% 208.15/208.29  |- rdf__type mesh__D012336sskos__Concept
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012336 2002
% 208.15/208.29  |- mesh__dateRevised mesh__D012336 1995-05-22
% 208.15/208.29  |- skos__scopeNote mesh__D012336
% 208.15/208.29       Constituent of 30S subunit prokaryotic ribosomes containing 1600 nucleotides and 21 proteins. 16S rRNA is involved in initiation of polypeptide synthesis.%A%    
% 208.15/208.29  |- mesh__dateEstablished mesh__D012336 1991-01-01
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012336 1998
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012336 2003
% 208.15/208.29  |- skos__historyNote mesh__D012336 RNA %28%1966-1970%29%
% 208.15/208.29  |- mesh__dateCreated mesh__D012336 1987-05-09
% 208.15/208.29  |- skos__hiddenLabel mesh__D012336 Ribosomal RNA, 16S
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012336 1999
% 208.15/208.29  |- skos__historyNote mesh__D012336 RNA, Ribosomal %28%1971-1987%29%
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012336 2004
% 208.15/208.29  |- mesh__recordMaintainer mesh__D012336 KEV
% 208.15/208.29  |- mesh__historyNote mesh__D012336
% 208.15/208.29       91%28%88%29%; was see under RNA, RIBOSOMAL 1988-90   
% 208.15/208.29  |- mesh__dateEstablished mesh__D017021 1992-01-01
% 208.15/208.29  |- skos__prefLabel mesh__D017021 Methanosarcina barkeri
% 208.15/208.29  |- mesh__recordOriginator mesh__D017021 PXP
% 208.15/208.29  |- mesh__recordAuthorizer mesh__D017021 sjn
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D017021 2006
% 208.15/208.29  |- mesh__dateCreated mesh__D017021 1991-05-30
% 208.15/208.29  |- skos__scopeNote mesh__D017021
% 208.15/208.29       A species of halophilic archaea whose organisms are nonmotile. Habitats include freshwater and marine mud, animal-waste lagoons, and the rumens of ungulates.%A%    
% 208.15/208.29  |- mesh__publicMeSHNote mesh__D017021 92   
% 208.15/208.29  |- skos__broader mesh__D017021smesh__D017020
% 208.15/208.29  |- rdf__type mesh__D017021sskos__Concept
% 208.15/208.29  |- skos__historyNote mesh__D017021 Methanogens %28%1979-1991%29%
% 208.15/208.29  |- mesh__dateRevised mesh__D017021 2005-06-30
% 208.15/208.29  |- skos__annotation mesh__D017021
% 208.15/208.29       a gram-pos methanogen found in mud %26% ungulate rumens   
% 208.15/208.29  |- mesh__recordMaintainer mesh__D017021 SYSTEM
% 208.15/208.29  |- skos__historyNote mesh__D017021 Sarcina %28%1966-1968%29%
% 208.15/208.29  |- mesh__historyNote mesh__D017021 92   
% 208.15/208.29  |- mesh__dateEstablished mesh__D003001 1980-01-01
% 208.15/208.29  |- skos__scopeNote mesh__D003001
% 208.15/208.29       The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.%A%    
% 208.15/208.29  |- mesh__recordMaintainer mesh__D003001 nns
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D003001 2001
% 208.15/208.29  |- skos__historyNote mesh__D003001 DNA, Recombinant %28%1977-1979%29%
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D003001 2005
% 208.15/208.29  |- skos__related mesh__D003001smesh__D011993
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D003001 2002
% 208.15/208.29  |- mesh__dateRevised mesh__D003001 2000-06-22
% 208.15/208.29  |- mesh__recordOriginator mesh__D003001 AEP
% 208.15/208.29  |- skos__related mesh__D003001smesh__D005818
% 208.15/208.29  |- mesh__historyNote mesh__D003001 80   
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D003001 2003
% 208.15/208.29  |- mesh__publicMeSHNote mesh__D003001 80   
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D003001 2006
% 208.15/208.29  |- skos__historyNote mesh__D003001 DNA %28%1966-1976%29%
% 208.15/208.29  |- skos__altLabel mesh__D003001 Molecular Cloning
% 208.15/208.29  |- skos__broader mesh__D003001smesh__D005821
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D003001 2004
% 208.15/208.29  |- mesh__recordAuthorizer mesh__D003001 sjn
% 208.15/208.29  |- rdf__type mesh__D003001sskos__Concept
% 208.15/208.29  |- mesh__dateCreated mesh__D003001 1978-12-21
% 208.15/208.29  |- skos__related mesh__D003001smesh__D019976
% 208.15/208.29  |- skos__annotation mesh__D003001
% 208.15/208.29       differentiate from CLONE CELLS and CLONING, ORGANISM; %22%clonal analysis%22%: index under CLONE CELLS; DF: CLONING MOL or MOL CLONING%A%  
% 208.15/208.29  |- skos__historyNote mesh__D003001 Plasmids %28%1975-1979%29%
% 208.15/208.29  |- skos__related mesh__D003001smesh__D004274
% 208.15/208.29  |- skos__prefLabel mesh__D003001 Cloning, Molecular
% 208.15/208.29  |- skos__broader mesh__D013339Q000193smesh__D013339
% 208.15/208.29  |- mesh__preferredCombination mesh__D013339Q000193smesh__D004512
% 208.15/208.29  |- rdf__type mesh__D013339Q000193smesh__CompoundConcept
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D008295 2005
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D008295 1999
% 208.15/208.29  |- rdf__type mesh__D008295sskos__Concept
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D008295 2000
% 208.15/208.29  |- skos__annotation mesh__D008295
% 208.15/208.29       a republic in southern Africa; X ref NYASALAND was its former name%A%  
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D008295 1998
% 208.15/208.29  |- mesh__dateCreated mesh__D008295 1999-01-01
% 208.15/208.29  |- mesh__recordOriginator mesh__D008295 NLM
% 208.15/208.29  |- skos__scopeNote mesh__D008295
% 208.15/208.29       A republic in southern Africa east of ZAMBIA. Its capital is Lilongwe. It was formerly called Nyasaland. This region was visited by Livingstone in 1859. It became a British protectorate in 1891, part of the Federation of Rhodesia and Nyasaland in 1953, and independent in 1964. It takes its name from the Malavi people whose name means flames, possibly referring to the reflection of the rising sun on Lake Malawi. Its former name Nyasaland is from the Malawi word for lake. %28%Webster%27%s New Geographical Dictionary, 1988, p715 %26% Room, Brewer%27%s Dictionary of Names, 1992, p326, 386%29%%A%    
% 208.15/208.29  |- skos__broader mesh__D008295smesh__D000353
% 208.15/208.29  |- skos__altLabel mesh__D008295 Nyasaland
% 208.15/208.29  |- mesh__dateRevised mesh__D008295 1997-06-20
% 208.15/208.29  |- skos__prefLabel mesh__D008295 Malawi
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D008295 2004
% 208.15/208.29  |- mesh__recordMaintainer mesh__D008295 TGC
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D008295 2002
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D008295 2003
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D008295 2006
% 208.15/208.29  |- mesh__recordAuthorizer mesh__D008295 SJN
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D008295 2001
% 208.15/208.29  |- mesh__dateRevised mesh__D016727 1999-11-03
% 208.15/208.29  |- skos__altLabel mesh__D016727 Orbital Granuloma, Plasma Cell
% 208.15/208.29  |- skos__broader mesh__D016727smesh__D006104
% 208.15/208.29  |- mesh__recordAuthorizer mesh__D016727 sjn
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D016727 2004
% 208.15/208.29  |- skos__altLabel mesh__D016727 Myositis, Orbital
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D016727 2002
% 208.15/208.29  |- mesh__recordMaintainer mesh__D016727 KEV
% 208.15/208.29  |- skos__hiddenLabel mesh__D016727 Orbit Inflammatory Pseudotumors
% 208.15/208.29  |- rdf__type mesh__D016727sskos__Concept
% 208.15/208.29  |- skos__historyNote mesh__D016727 Orbit %28%1966-1980%29%
% 208.15/208.29  |- skos__hiddenLabel mesh__D016727 Pseudotumors, Orbital Inflammatory
% 208.15/208.29  |- skos__hiddenLabel mesh__D016727 Orbital Inflammatory Pseudotumors
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D016727 2003
% 208.15/208.29  |- skos__altLabel mesh__D016727 Inflammatory Pseudotumor of Orbit
% 208.15/208.29  |- mesh__dateEstablished mesh__D016727 1992-01-01
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D016727 2001
% 208.15/208.29  |- skos__scopeNote mesh__D016727
% 208.15/208.29       A chronic neoplasm-like inflammatory reaction, usually affecting the orbital tissues of both eyes, also known as orbital myositis.%A%    
% 208.15/208.29  |- skos__hiddenLabel mesh__D016727 Inflammatory Pseudotumors, Orbital
% 208.15/208.29  |- mesh__recordOriginator mesh__D016727 TGC
% 208.15/208.29  |- skos__annotation mesh__D016727 non-neoplastic   
% 208.15/208.29  |- skos__altLabel mesh__D016727 Orbital Myositis
% 208.15/208.29  |- skos__altLabel mesh__D016727 Pseudotumor, Inflammatory, Orbital
% 208.15/208.29  |- skos__altLabel mesh__D016727 Pseudotumor, Orbital Inflammatory
% 208.15/208.29  |- skos__hiddenLabel mesh__D016727 Orbital Myositides
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D016727 2000
% 208.15/208.29  |- skos__altLabel mesh__D016727 Plasma Cell Granuloma, Orbital
% 208.15/208.29  |- mesh__dateCreated mesh__D016727 1991-02-11
% 208.15/208.29  |- mesh__publicMeSHNote mesh__D016727 92   
% 208.15/208.29  |- skos__hiddenLabel mesh__D016727 Orbit Inflammatory Pseudotumor
% 208.15/208.29  |- mesh__historyNote mesh__D016727 92   
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D016727 2006
% 208.15/208.29  |- skos__historyNote mesh__D016727 Orbital Diseases %28%1981-1991%29%
% 208.15/208.29  |- skos__altLabel mesh__D016727 Orbital Inflammatory Pseudotumor
% 208.15/208.29  |- skos__altLabel mesh__D016727 Inflammatory Pseudotumor, Orbital
% 208.15/208.29  |- skos__hiddenLabel mesh__D016727 Myositides, Orbital
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D016727 2005
% 208.15/208.29  |- skos__historyNote mesh__D016727 Granuloma %28%1966-1991%29%
% 208.15/208.29  |- skos__broader mesh__D016727smesh__D009916
% 208.15/208.29  |- skos__prefLabel mesh__D016727 Granuloma, Plasma Cell, Orbital
% 208.15/208.29  |- mesh__recordAuthorizer mesh__D002707 sjn
% 208.15/208.29  |- mesh__dateRevised mesh__D002707 2004-07-19
% 208.15/208.29  |- skos__hiddenLabel mesh__D002707 Monohydrochloride, Chlordiazepoxide
% 208.15/208.29  |- rdf__type mesh__D002707sskos__Concept
% 208.15/208.29  |- skos__scopeNote mesh__D002707
% 208.15/208.29       An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal.%A%    
% 208.15/208.29  |- mesh__dateCreated mesh__D002707 1999-01-01
% 208.15/208.29  |- skos__altLabel mesh__D002707 Methaminodiazepoxide
% 208.15/208.29  |- skos__hiddenLabel mesh__D002707 Hydrobromide, Chlordiazepoxide
% 208.15/208.29  |- skos__altLabel mesh__D002707
% 208.15/208.29       7-Chloro-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-amine 4-oxide
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D002707 2005
% 208.15/208.29  |- skos__hiddenLabel mesh__D002707 Perchlorate, Chlordiazepoxide
% 208.15/208.29  |- skos__hiddenLabel mesh__D002707 Hydrochloride, Chlordiazepoxide
% 208.15/208.29  |- mesh__recordMaintainer mesh__D002707 jls
% 208.15/208.29  |- skos__altLabel mesh__D002707 Chlordiazepoxide Monohydrochloride
% 208.15/208.29  |- skos__hiddenLabel mesh__D002707
% 208.15/208.29       7 Chloro N methyl 5 phenyl 3H 1,4 benzodiazepin 2 amine 4 oxide
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D002707 2006
% 208.15/208.29  |- mesh__recordOriginator mesh__D002707 NLM
% 208.15/208.29  |- skos__broader mesh__D002707smesh__D001569
% 208.15/208.29  |- skos__prefLabel mesh__D002707 Chlordiazepoxide
% 208.15/208.29  |- mesh__historyNote mesh__D048809 2005%28%1978%29%   
% 208.15/208.29  |- skos__hiddenLabel mesh__D048809
% 208.15/208.29       alpha D N Acetyl Galactosaminyloligosaccharidase
% 208.15/208.29  |- skos__altLabel mesh__D048809 N-Acetyl-alpha-D-Galactosaminidase
% 208.15/208.29  |- skos__historyNote mesh__D048809 Hexosaminidases %28%1978-2004%29%
% 208.15/208.29  |- skos__hiddenLabel mesh__D048809 alpha N Acetyl D galactosaminidase
% 208.15/208.29  |- mesh__recordOriginator mesh__D048809 jmp
% 208.15/208.29  |- skos__hiddenLabel mesh__D048809
% 208.15/208.29       alpha D N Acetylgalactosaminyloligosaccharidase
% 208.15/208.29  |- skos__altLabel mesh__D048809 endo-alpha-N-Acetylgalactosaminidase
% 208.15/208.29  |- skos__altLabel mesh__D048809
% 208.15/208.29       alpha-D-N-Acetyl-Galactosaminyloligosaccharidase
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D048809 2005
% 208.15/208.29  |- skos__prefLabel mesh__D048809 alpha-N-Acetylgalactosaminidase
% 208.15/208.29  |- mesh__dateCreated mesh__D048809 2004-07-07
% 208.15/208.29  |- skos__hiddenLabel mesh__D048809 alpha Galactosidase B
% 208.15/208.29  |- skos__hiddenLabel mesh__D048809 endo alpha N Acetylgalactosaminidase
% 208.15/208.29  |- mesh__recordMaintainer mesh__D048809 jmp
% 208.15/208.29  |- skos__altLabel mesh__D048809 alpha-N-Acetyl-D-galactosaminidase
% 208.15/208.29  |- mesh__dateEstablished mesh__D048809 2005-01-01
% 208.15/208.29  |- skos__altLabel mesh__D048809
% 208.15/208.29       alpha-D-N-Acetylgalactosaminyloligosaccharidase
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D048809 2006
% 208.15/208.29  |- skos__hiddenLabel mesh__D048809 N Acetyl alpha D Galactosaminidase
% 208.15/208.29  |- mesh__publicMeSHNote mesh__D048809
% 208.15/208.29       2005; ALPHA-N-ACETYL-D-GALATOSAMINIDASE was indexed under GALATOSAMINIDASE 1982-2004 %26% ACETYLGALACTOSAMINE 1978-1981%A%  
% 208.15/208.29  |- skos__scopeNote mesh__D048809
% 208.15/208.29       A hexosaminidase with specificity for terminal non-reducing N-acetyl-D-galactosamine residues in N-acetyl-alpha-D-galactosaminides.%A%    
% 208.15/208.29  |- skos__hiddenLabel mesh__D048809 endo N Acetyl alpha D Galactosamidase
% 208.15/208.29  |- skos__altLabel mesh__D048809 alpha-Galactosidase B
% 208.15/208.29  |- skos__hiddenLabel mesh__D048809 alpha N Acetylgalactosaminidase
% 208.15/208.29  |- skos__broader mesh__D048809smesh__D006596
% 208.15/208.29  |- mesh__recordAuthorizer mesh__D048809 sjn
% 208.15/208.29  |- rdf__type mesh__D048809sskos__Concept
% 208.15/208.29  |- skos__altLabel mesh__D048809 endo-N-Acetyl-alpha-D-Galactosamidase
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012337 2003
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012337 1999
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012337 2002
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012337 1998
% 208.15/208.29  |- mesh__historyNote mesh__D012337
% 208.15/208.29       91%28%88%29%; was see under RNA, RIBOSOMAL 1988-90   
% 208.15/208.29  |- skos__hiddenLabel mesh__D012337 Ribosomal RNA, 18S
% 208.15/208.29  |- mesh__recordAuthorizer mesh__D012337 PLS
% 208.15/208.29  |- mesh__dateCreated mesh__D012337 1987-05-07
% 208.15/208.29  |- mesh__recordMaintainer mesh__D012337 KEV
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012337 2001
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012337 1997
% 208.15/208.29  |- skos__hiddenLabel mesh__D012337 RNA, 18S Ribosomal
% 208.15/208.29  |- mesh__recordOriginator mesh__D012337 RLS
% 208.15/208.29  |- mesh__dateRevised mesh__D012337 1995-05-22
% 208.15/208.29  |- skos__broader mesh__D012337smesh__D012335
% 208.15/208.29  |- skos__historyNote mesh__D012337 RNA %28%1966-1970%29%
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012337 2006
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012337 2000
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012337 1996
% 208.15/208.29  |- rdf__type mesh__D012337sskos__Concept
% 208.15/208.29  |- skos__historyNote mesh__D012337 RNA, Ribosomal %28%1971-1987%29%
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012337 2005
% 208.15/208.29  |- skos__prefLabel mesh__D012337 RNA, Ribosomal, 18S
% 208.15/208.29  |- skos__annotation mesh__D012337
% 208.15/208.29       IM; /drug eff /ultrastruct permitted; DF: 18S RRNA   
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D012337 2004
% 208.15/208.29  |- skos__scopeNote mesh__D012337
% 208.15/208.29       Constituent of the 40S subunit of eukaryotic ribosomes. 18S rRNA is involved in the initiation of polypeptide synthesis in eukaryotes.%A%    
% 208.15/208.29  |- mesh__publicMeSHNote mesh__D012337
% 208.15/208.29       91; was see under RNA, RIBOSOMAL 1988-90   
% 208.15/208.29  |- mesh__dateEstablished mesh__D012337 1991-01-01
% 208.15/208.29  |- skos__altLabel mesh__D012337 18S Ribosomal RNA
% 208.15/208.29  |- mesh__recordMaintainer mesh__D050456 ags
% 208.15/208.29  |- mesh__publicMeSHNote mesh__D050456 2006   
% 208.15/208.29  |- skos__broader mesh__D050456smesh__D004197
% 208.15/208.29  |- mesh__recordOriginator mesh__D050456 ags
% 208.15/208.29  |- mesh__historyNote mesh__D050456 2006   
% 208.15/208.29  |- mesh__dateCreated mesh__D050456 2005-06-30
% 208.15/208.29  |- mesh__recordAuthorizer mesh__D050456 sjn
% 208.15/208.29  |- skos__scopeNote mesh__D050456
% 208.15/208.29       Inanimate objects  that carry pathogenic microorganisms and thus can serve as the source of infection. Microorganisms typically survive on fomites for minutes or hours. Common fomites include CLOTHING, tissue paper, hairbrushes, and COOKING AND EATING UTENSILS.%A%    
% 208.15/208.29  |- skos__hiddenLabel mesh__D050456 Fomite
% 208.15/208.29  |- skos__related mesh__D050456smesh__D004866
% 208.15/208.29  |- skos__related mesh__D050456smesh__D018562
% 208.15/208.29  |- skos__prefLabel mesh__D050456 Fomites
% 208.15/208.29  |- mesh__activeMeSHYear mesh__D050456 2006
% 208.15/208.30  |- mesh__dateEstablished mesh__D050456 2006-01-01
% 208.15/208.30  |- rdf__type mesh__D050456sskos__Concept
% 208.15/208.30  |- skos__hiddenLabel mesh__D017022 Analyses, Flow Injection
% 208.15/208.30  |- mesh__recordOriginator mesh__D017022 MXR
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017022 1995
% 208.15/208.30  |- skos__hiddenLabel mesh__D017022 Flow Injection Analyses
% 208.15/208.30  |- skos__hiddenLabel mesh__D017022 Injection Analysis, Flow
% 208.15/208.30  |- mesh__dateEstablished mesh__D017022 1992-01-01
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017022 2006
% 208.15/208.30  |- skos__broader mesh__D017022smesh__D002623
% 208.15/208.30  |- mesh__dateCreated mesh__D017022 1991-05-30
% 208.15/208.30  |- skos__prefLabel mesh__D017022 Flow Injection Analysis
% 208.15/208.30  |- mesh__recordMaintainer mesh__D017022 TGC
% 208.15/208.30  |- skos__annotation mesh__D017022
% 208.15/208.30       an anal chem technique; NIM; DF: FLOW INJECT ANAL   
% 208.15/208.30  |- skos__scopeNote mesh__D017022
% 208.15/208.30       The analysis of a chemical substance by inserting a sample into a carrier stream of reagent using a sample injection valve that propels the sample downstream where mixing occurs in a coiled tube, then passes into a flow-through detector and a recorder or other data handling device.%A%    
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017022 1999
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017022 2005
% 208.15/208.30  |- rdf__type mesh__D017022sskos__Concept
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017022 2002
% 208.15/208.30  |- mesh__recordAuthorizer mesh__D017022 PLS
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017022 2004
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017022 1998
% 208.15/208.30  |- skos__hiddenLabel mesh__D017022 Injection Analyses, Flow
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017022 2001
% 208.15/208.30  |- skos__altLabel mesh__D017022 Analysis, Flow Injection
% 208.15/208.30  |- mesh__historyNote mesh__D017022 92   
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017022 1997
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017022 2003
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017022 2000
% 208.15/208.30  |- mesh__publicMeSHNote mesh__D017022 92   
% 208.15/208.30  |- mesh__dateRevised mesh__D017022 1994-05-12
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017022 1996
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003800 1996
% 208.15/208.30  |- skos__altLabel mesh__D003800 Technician, Dental
% 208.15/208.30  |- mesh__historyNote mesh__D003800 65   
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003800 1993
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003800 2002
% 208.15/208.30  |- mesh__dateEstablished mesh__D003800 1965-01-01
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003800 1997
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003800 2005
% 208.15/208.30  |- skos__broader mesh__D003800smesh__D003727
% 208.15/208.30  |- skos__altLabel mesh__D003800 Technicians, Dental
% 208.15/208.30  |- mesh__dateRevised mesh__D003800 1992-05-14
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003800 2006
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003800 2000
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003800 2003
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003800 1994
% 208.15/208.30  |- mesh__dateCreated mesh__D003800 1999-01-01
% 208.15/208.30  |- mesh__publicMeSHNote mesh__D003800 65   
% 208.15/208.30  |- mesh__recordMaintainer mesh__D003800 TAP
% 208.15/208.30  |- mesh__recordAuthorizer mesh__D003800 PLS
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003800 1998
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003800 2001
% 208.15/208.30  |- skos__annotation mesh__D003800
% 208.15/208.30       executes dentists%27% prescripts for mechanical fabrication of dental appliances; DF: DENT TECHNICIANS%A%  
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003800 1995
% 208.15/208.30  |- rdf__type mesh__D003800sskos__Concept
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003800 2004
% 208.15/208.30  |- mesh__recordOriginator mesh__D003800 NLM
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003800 1999
% 208.15/208.30  |- skos__prefLabel mesh__D003800 Dental Technicians
% 208.15/208.30  |- skos__scopeNote mesh__D003800
% 208.15/208.30       Individuals responsible for fabrication of dental appliances.%A%    
% 208.15/208.30  |- skos__altLabel mesh__D003800 Dental Technician
% 208.15/208.30  |- skos__broader mesh__D014810Q000172smesh__D014810
% 208.15/208.30  |- mesh__preferredCombination mesh__D014810Q000172smesh__D014811
% 208.15/208.30  |- rdf__type mesh__D014810Q000172smesh__CompoundConcept
% 208.15/208.30  |- mesh__recordAuthorizer mesh__D003002 sjn
% 208.15/208.30  |- rdf__type mesh__D003002sskos__Concept
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003002 2002
% 208.15/208.30  |- skos__broader mesh__D003002smesh__D009539
% 208.15/208.30  |- mesh__dateCreated mesh__D003002 1974-11-19
% 208.15/208.30  |- skos__historyNote mesh__D003002 Toluidines %28%1973-1974%29%
% 208.15/208.30  |- skos__hiddenLabel mesh__D003002 CBA 93626
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003002 2001
% 208.15/208.30  |- mesh__recordMaintainer mesh__D003002 TWD
% 208.15/208.30  |- skos__scopeNote mesh__D003002 Anti-inflammatory analgesic.     
% 208.15/208.30  |- mesh__dateEstablished mesh__D003002 1991-01-01
% 208.15/208.30  |- mesh__dateRevised mesh__D003002 2000-06-22
% 208.15/208.30  |- skos__hiddenLabel mesh__D003002 Sch10304
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003002 2004
% 208.15/208.30  |- mesh__recordOriginator mesh__D003002 NLM
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003002 2006
% 208.15/208.30  |- skos__hiddenLabel mesh__D003002 CBA93626
% 208.15/208.30  |- skos__hiddenLabel mesh__D003002 Sch 10304
% 208.15/208.30  |- skos__prefLabel mesh__D003002 Clonixin
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003002 2003
% 208.15/208.30  |- mesh__historyNote mesh__D003002
% 208.15/208.30       91%28%75%29%; was see under NICOTINIC ACIDS 1975-90   
% 208.15/208.30  |- mesh__publicMeSHNote mesh__D003002
% 208.15/208.30       91; was see under NICOTINIC ACIDS 1975-90   
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003002 2005
% 208.15/208.30  |- skos__historyNote mesh__D003002 Nicotinic Acids %28%1971-1974%29%
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D008296 1999
% 208.15/208.30  |- rdf__type mesh__D008296sskos__Concept
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D008296 2000
% 208.15/208.30  |- skos__prefLabel mesh__D008296 Malaysia
% 208.15/208.30  |- skos__annotation mesh__D008296
% 208.15/208.30       a monarchy in southeast Asia; note X refs but Malay Archipelago = INDONESIA; Malaysians are of MONGOLOID RACE unless otherwise specified%A%  
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D008296 2001
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D008296 2003
% 208.15/208.30  |- skos__altLabel mesh__D008296 Federation of Malaya
% 208.15/208.30  |- skos__scopeNote mesh__D008296
% 208.15/208.30       A parliamentary democracy with a constitutional monarch in southeast Asia, consisting of 11 states %28%West Malaysia%29% on the Malay Peninsula and two states %28%East Malaysia%29% on the island of BORNEO. It is also called the Federation of Malaysia. Its capital is Kuala Lumpur. Before 1963 it was the Union of Malaya. It reorganized in 1948 as the Federation of Malaya, becoming independent from British Malaya in 1957 and becoming Malaysia in 1963 as a federation of Malaya, Sabah, Sarawak, and Singapore %28%which seceded in 1965%29%. The form Malay- probably derives from the Tamil malay, mountain, with reference to its geography. %28%From Webster%27%s New Geographical Dictionary, 1988, p715 %26% Room, Brewer%27%s Dictionary of Names, 1992, p329%29%%A%    
% 208.15/208.30  |- skos__altLabel mesh__D008296 Malay Federation
% 208.15/208.30  |- mesh__recordMaintainer mesh__D008296 TGC
% 208.15/208.30  |- mesh__dateRevised mesh__D008296 1997-06-20
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D008296 2005
% 208.15/208.30  |- skos__altLabel mesh__D008296 Malaya
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D008296 2004
% 208.15/208.30  |- mesh__recordOriginator mesh__D008296 NLM
% 208.15/208.30  |- skos__altLabel mesh__D008296 Malaya Federation
% 208.15/208.30  |- skos__broader mesh__D008296smesh__D001210
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D008296 2002
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D008296 1998
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D008296 2006
% 208.15/208.30  |- mesh__dateCreated mesh__D008296 1999-01-01
% 208.15/208.30  |- mesh__recordAuthorizer mesh__D008296 SJN
% 208.15/208.30  |- mesh__historyNote mesh__D016728 92   
% 208.15/208.30  |- skos__hiddenLabel mesh__D016728 Behavior, Self-Injurious
% 208.15/208.30  |- mesh__dateRevised mesh__D016728 2003-07-09
% 208.15/208.30  |- skos__altLabel mesh__D016728 Deliberate Self-Harm
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D016728 2004
% 208.15/208.30  |- skos__scopeNote mesh__D016728
% 208.15/208.30       Behavior in which persons hurt or harm themselves without the motive of suicide or of sexual deviation.%A%    
% 208.15/208.30  |- skos__hiddenLabel mesh__D016728 Self Injurious Behavior
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D016728 2005
% 208.15/208.30  |- skos__hiddenLabel mesh__D016728 Behavior, Self-Destructive
% 208.15/208.30  |- skos__hiddenLabel mesh__D016728 Self Destructive Behavior
% 208.15/208.30  |- mesh__recordOriginator mesh__D016728 MXR
% 208.15/208.30  |- mesh__dateCreated mesh__D016728 1991-04-29
% 208.15/208.30  |- mesh__publicMeSHNote mesh__D016728 92   
% 208.15/208.30  |- skos__broader mesh__D016728smesh__D001526
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D016728 2006
% 208.15/208.30  |- skos__annotation mesh__D016728
% 208.15/208.30       SELF MUTILATION is also available; DF: SELF INJ BEHAVIOR   
% 208.15/208.30  |- rdf__type mesh__D016728sskos__Concept
% 208.15/208.30  |- mesh__recordMaintainer mesh__D016728 ssb
% 208.15/208.30  |- skos__prefLabel mesh__D016728 Self-Injurious Behavior
% 208.15/208.30  |- skos__hiddenLabel mesh__D016728 Self-Harm, Deliberate
% 208.15/208.30  |- mesh__recordAuthorizer mesh__D016728 sjn
% 208.15/208.30  |- skos__historyNote mesh__D016728 Self Mutilation %28%1968-1991%29%
% 208.15/208.30  |- skos__hiddenLabel mesh__D016728 Deliberate Self Harm
% 208.15/208.30  |- mesh__dateEstablished mesh__D016728 1992-01-01
% 208.15/208.30  |- mesh__dateEstablished mesh__D041121 2003-01-01
% 208.15/208.30  |- mesh__dateRevised mesh__D041121 2005-06-30
% 208.15/208.30  |- skos__historyNote mesh__D041121 Klebsiella %28%1970-2002%29%
% 208.15/208.30  |- skos__annotation mesh__D041121
% 208.15/208.30       infection: coord IM with KLEBSIELLA INFECTIONS %28%IM%29%   
% 208.15/208.30  |- skos__scopeNote mesh__D041121
% 208.15/208.30       A species of gram-negative bacteria causing URINARY TRACT INFECTIONS and SEPTICEMIA.%A%    
% 208.15/208.30  |- mesh__dateCreated mesh__D041121 2002-07-03
% 208.15/208.30  |- rdf__type mesh__D041121sskos__Concept
% 208.15/208.30  |- skos__prefLabel mesh__D041121 Klebsiella oxytoca
% 208.15/208.30  |- mesh__publicMeSHNote mesh__D041121 2003   
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D041121 2006
% 208.15/208.30  |- mesh__historyNote mesh__D041121 2003   
% 208.15/208.30  |- mesh__recordOriginator mesh__D041121 ags
% 208.15/208.30  |- mesh__recordAuthorizer mesh__D041121 sjn
% 208.15/208.30  |- skos__broader mesh__D041121smesh__D007709
% 208.15/208.30  |- mesh__recordMaintainer mesh__D041121 SYSTEM
% 208.15/208.30  |- mesh__dateEstablished mesh__D002708 1974-01-01
% 208.15/208.30  |- mesh__dateCreated mesh__D002708 1999-01-01
% 208.15/208.30  |- skos__broader mesh__D002708smesh__D000460
% 208.15/208.30  |- skos__annotation mesh__D002708 a unicellular green alga   
% 208.15/208.30  |- mesh__publicMeSHNote mesh__D002708 74   
% 208.15/208.30  |- mesh__recordMaintainer mesh__D002708 SYSTEM
% 208.15/208.30  |- mesh__recordOriginator mesh__D002708 NLM
% 208.15/208.30  |- skos__prefLabel mesh__D002708 Chlorella
% 208.15/208.30  |- mesh__historyNote mesh__D002708 74%28%72%29%   
% 208.15/208.30  |- mesh__recordAuthorizer mesh__D002708 sjn
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D002708 2006
% 208.15/208.30  |- mesh__dateRevised mesh__D002708 2005-06-30
% 208.15/208.30  |- skos__historyNote mesh__D002708 Algae, Green %28%1970-1971%29%
% 208.15/208.30  |- rdf__type mesh__D002708sskos__Concept
% 208.15/208.30  |- skos__scopeNote mesh__D002708
% 208.15/208.30       Nonmotile unicellular green algae potentially valuable as a source of high-grade protein and B-complex vitamins.%A%    
% 208.15/208.30  |- skos__hiddenLabel mesh__D002708 Chlorellas
% 208.15/208.30  |- skos__altLabel mesh__D013430 Sulfurylase
% 208.15/208.30  |- skos__scopeNote mesh__D013430
% 208.15/208.30       An enzyme that catalyzes the activation of sulfate ions by ATP to form adenosine-5%27%-phosphosulfate and pyrophosphate. This reaction constitutes the first enzymatic step in sulfate utilization following the uptake of sulfate. EC 2.7.7.4.%A%    
% 208.15/208.30  |- skos__historyNote mesh__D013430 Transferases %28%1966-1967%29%
% 208.15/208.30  |- mesh__recordAuthorizer mesh__D013430 sjn
% 208.15/208.30  |- skos__hiddenLabel mesh__D013430 Adenylyltransferase, Sulfate
% 208.15/208.30  |- skos__hiddenLabel mesh__D013430 Sulfurylase, ATP
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D013430 2004
% 208.15/208.30  |- skos__historyNote mesh__D013430
% 208.15/208.30       Nucleotidyltransferases %28%1966-1978%29%
% 208.15/208.30  |- skos__broader mesh__D013430smesh__D009713
% 208.15/208.30  |- mesh__recordMaintainer mesh__D013430 ssb
% 208.15/208.30  |- rdf__type mesh__D013430sskos__Concept
% 208.15/208.30  |- mesh__dateRevised mesh__D013430 2003-07-09
% 208.15/208.30  |- skos__historyNote mesh__D013430 Sulfates %28%1966-1978%29%
% 208.15/208.30  |- mesh__historyNote mesh__D013430
% 208.15/208.30       91%28%79%29%; was see under NUCLEOTIDYLTRANSFERASES 1979-90   
% 208.15/208.30  |- mesh__dateCreated mesh__D013430 1978-03-16
% 208.15/208.30  |- skos__historyNote mesh__D013430 Adenosine Triphosphate %28%1966-1978%29%
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D013430 2006
% 208.15/208.30  |- mesh__recordOriginator mesh__D013430 RLS
% 208.15/208.30  |- mesh__dateEstablished mesh__D013430 1991-01-01
% 208.15/208.30  |- skos__altLabel mesh__D013430 ATP Sulfurylase
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D013430 2005
% 208.15/208.30  |- skos__prefLabel mesh__D013430 Sulfate Adenylyltransferase
% 208.15/208.30  |- mesh__publicMeSHNote mesh__D013430
% 208.15/208.30       91; was see under NUCLEOTIDYLTRANSFERASES 1979-90   
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D012338 1998
% 208.15/208.30  |- skos__annotation mesh__D012338
% 208.15/208.30       IM; /drug eff /ultrastruct permitted; DF: 23S RRNA   
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D012338 1993
% 208.15/208.30  |- skos__hiddenLabel mesh__D012338 Ribosomal RNA, 23S
% 208.15/208.30  |- skos__hiddenLabel mesh__D012338 RNA, 23S Ribosomal
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D012338 1997
% 208.15/208.30  |- mesh__dateRevised mesh__D012338 1992-05-20
% 208.15/208.30  |- skos__historyNote mesh__D012338 RNA %28%1966-1970%29%
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D012338 2006
% 208.15/208.30  |- skos__altLabel mesh__D012338 23S Ribosomal RNA
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D012338 1996
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D012338 2002
% 208.15/208.30  |- skos__prefLabel mesh__D012338 RNA, Ribosomal, 23S
% 208.15/208.30  |- rdf__type mesh__D012338sskos__Concept
% 208.15/208.30  |- mesh__historyNote mesh__D012338
% 208.15/208.30       91%28%88%29%; was see under RNA, RIBOSOMAL 1988-90   
% 208.15/208.30  |- skos__historyNote mesh__D012338 RNA, Ribosomal %28%1971-1987%29%
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D012338 2005
% 208.15/208.30  |- mesh__recordAuthorizer mesh__D012338 PLS
% 208.15/208.30  |- mesh__dateCreated mesh__D012338 1987-05-07
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D012338 2001
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D012338 2004
% 208.15/208.30  |- mesh__recordMaintainer mesh__D012338 TGC
% 208.15/208.30  |- skos__broader mesh__D012338smesh__D012335
% 208.15/208.30  |- mesh__recordOriginator mesh__D012338 RLS
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D012338 2000
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D012338 1995
% 208.15/208.30  |- mesh__dateEstablished mesh__D012338 1991-01-01
% 208.15/208.30  |- mesh__publicMeSHNote mesh__D012338
% 208.15/208.30       91; was see under RNA, RIBOSOMAL 1988-90   
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D012338 2003
% 208.15/208.30  |- skos__scopeNote mesh__D012338
% 208.15/208.30       Constituent of 50S subunit of prokaryotic ribosomes containing about 3200 nucleotides. 23S rRNA is involved in the initiation of polypeptide synthesis.%A%    
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D012338 1999
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D012338 1994
% 208.15/208.30  |- mesh__recordAuthorizer mesh__D017821 sjn
% 208.15/208.30  |- mesh__dateEstablished mesh__D017821 1994-01-01
% 208.15/208.30  |- skos__historyNote mesh__D017821 Snakes %28%1966-1993%29%
% 208.15/208.30  |- mesh__dateRevised mesh__D017821 2003-07-09
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017821 2004
% 208.15/208.30  |- mesh__dateCreated mesh__D017821 1993-02-16
% 208.15/208.30  |- skos__hiddenLabel mesh__D017821 Anacondas
% 208.15/208.30  |- skos__scopeNote mesh__D017821
% 208.15/208.30       A family of snakes comprising the boas, anacondas, and pythons. They occupy a variety of habitats through the tropics and subtropics and are arboreal, aquatic or fossorial %28%burrowing%29%. Some are oviparous, others ovoviviparous. Contrary to popular opinion, they do not crush the bones of their victims: their coils exert enough pressure to stop a prey%27%s breathing, thus suffocating it. There are five subfamilies: Boinae, Bolyerinae, Erycinae, Pythoninae, and Tropidophiinae. %28%Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, p315-320%29%%A%    
% 208.15/208.30  |- mesh__recordMaintainer mesh__D017821 ags
% 208.15/208.30  |- mesh__publicMeSHNote mesh__D017821 94   
% 208.15/208.30  |- skos__hiddenLabel mesh__D017821 Boas
% 208.15/208.30  |- rdf__type mesh__D017821sskos__Concept
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017821 2006
% 208.15/208.30  |- skos__hiddenLabel mesh__D017821 Pythons
% 208.15/208.30  |- skos__broader mesh__D017821smesh__D012911
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017821 2005
% 208.15/208.30  |- skos__prefLabel mesh__D017821 Boidae
% 208.15/208.30  |- skos__annotation mesh__D017821 a family of snakes; note X refs   
% 208.15/208.30  |- mesh__historyNote mesh__D017821 94   
% 208.15/208.30  |- mesh__recordOriginator mesh__D017821 TGC
% 208.15/208.30  |- mesh__recordOriginator mesh__D017023 AGS
% 208.15/208.30  |- mesh__dateRevised mesh__D017023 1997-06-20
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017023 1999
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017023 2005
% 208.15/208.30  |- rdf__type mesh__D017023sskos__Concept
% 208.15/208.30  |- mesh__dateCreated mesh__D017023 1991-05-30
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017023 2001
% 208.15/208.30  |- skos__broader mesh__D017023smesh__D000792
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017023 2004
% 208.15/208.30  |- skos__scopeNote mesh__D017023
% 208.15/208.30       Radiography of the vascular system of the heart muscle after injection of a contrast medium.%A%    
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017023 2000
% 208.15/208.30  |- mesh__publicMeSHNote mesh__D017023 92   
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017023 1998
% 208.15/208.30  |- skos__hiddenLabel mesh__D017023 Angiographies, Coronary
% 208.15/208.30  |- skos__broader mesh__D017023smesh__D006334
% 208.15/208.30  |- skos__historyNote mesh__D017023
% 208.15/208.30       Coronary Vessels/radiography %28%1966-1991%29%
% 208.15/208.30  |- mesh__historyNote mesh__D017023 92   
% 208.15/208.30  |- skos__annotation mesh__D017023
% 208.15/208.30       /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: CORONARY ANGIOGR%A%  
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017023 2003
% 208.15/208.30  |- skos__hiddenLabel mesh__D017023 Coronary Angiographies
% 208.15/208.30  |- mesh__dateEstablished mesh__D017023 1992-01-01
% 208.15/208.30  |- skos__historyNote mesh__D017023 Angiography %28%1966-1991%29%
% 208.15/208.30  |- skos__altLabel mesh__D017023 Angiography, Coronary
% 208.15/208.30  |- skos__prefLabel mesh__D017023 Coronary Angiography
% 208.15/208.30  |- mesh__recordMaintainer mesh__D017023 PXP
% 208.15/208.30  |- mesh__recordAuthorizer mesh__D017023 SJN
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017023 2006
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D017023 2002
% 208.15/208.30  |- mesh__recordAuthorizer mesh__D003801 PLS
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003801 2006
% 208.15/208.30  |- skos__altLabel mesh__D003801 Veneers, Dental
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003801 2001
% 208.15/208.30  |- skos__historyNote mesh__D003801 Crowns %28%1966-1983%29%
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003801 2003
% 208.15/208.30  |- mesh__dateRevised mesh__D003801 1996-06-10
% 208.15/208.30  |- skos__altLabel mesh__D003801 Laminate, Dental
% 208.15/208.30  |- mesh__dateCreated mesh__D003801 1983-02-09
% 208.15/208.30  |- skos__historyNote mesh__D003801 Dental Prosthesis %28%1966-1969%29%
% 208.15/208.30  |- mesh__recordOriginator mesh__D003801 RC
% 208.15/208.30  |- skos__altLabel mesh__D003801 Dental Veneer
% 208.15/208.30  |- skos__altLabel mesh__D003801 Laminates, Dental
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003801 1998
% 208.15/208.30  |- skos__altLabel mesh__D003801 Dental Laminate
% 208.15/208.30  |- rdf__type mesh__D003801sskos__Concept
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003801 2004
% 208.15/208.30  |- mesh__historyNote mesh__D003801 84   
% 208.15/208.30  |- skos__historyNote mesh__D003801
% 208.15/208.30       Dental Prosthesis Design %28%1970-1983%29%
% 208.15/208.30  |- mesh__recordMaintainer mesh__D003801 TGC
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003801 1999
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003801 2002
% 208.15/208.30  |- skos__altLabel mesh__D003801 Dental Laminates
% 208.15/208.30  |- skos__broader mesh__D003801smesh__D017266
% 208.15/208.30  |- mesh__publicMeSHNote mesh__D003801 84   
% 208.15/208.30  |- skos__broader mesh__D003801smesh__D003793
% 208.15/208.30  |- skos__altLabel mesh__D003801 Veneer, Dental
% 208.15/208.30  |- skos__scopeNote mesh__D003801
% 208.15/208.30       The use of a layer of tooth-colored material, usually porcelain or acrylic resin, applied to the surface of natural teeth, crowns, or pontics by fusion, cementation, or mechanical retention.%A%    
% 208.15/208.30  |- mesh__dateEstablished mesh__D003801 1984-01-01
% 208.15/208.30  |- skos__annotation mesh__D003801
% 208.15/208.30       IM; coord with specific material %28%IM%29% if pertinent; DF: DENT VENEERS%A%  
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003801 1997
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003801 2005
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003801 2000
% 208.15/208.30  |- skos__prefLabel mesh__D003801 Dental Veneers
% 208.15/208.30  |- skos__historyNote mesh__D003801 Dental Porcelain %28%1966-1983%29%
% 208.15/208.30  |- skos__broader mesh__D007501Q000172smesh__D007501
% 208.15/208.30  |- rdf__type mesh__D007501Q000172smesh__CompoundConcept
% 208.15/208.30  |- mesh__recordMaintainer mesh__D003003 TGC
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003003 2002
% 208.15/208.30  |- mesh__dateRevised mesh__D003003 1996-06-10
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003003 1997
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003003 2004
% 208.15/208.30  |- mesh__recordAuthorizer mesh__D003003 PLS
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003003 2001
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003003 1999
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003003 2006
% 208.15/208.30  |- skos__annotation mesh__D003003
% 208.15/208.30       trematode infect caused by CLONORCHIS SINENSIS; OPISTHORCHIS SINENSIS infection = CLONORCHIASIS, not OPISTHORCHIASIS which is Opisthorchis infect by Opisthorchis species other than O. sinensis%A%  
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003003 2003
% 208.15/208.30  |- skos__broader mesh__D003003smesh__D014201
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003003 2005
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003003 2000
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D003003 1998
% 208.15/208.30  |- skos__hiddenLabel mesh__D003003 Clonorchiases
% 208.15/208.30  |- mesh__dateCreated mesh__D003003 1999-01-01
% 208.15/208.30  |- rdf__type mesh__D003003sskos__Concept
% 208.15/208.30  |- skos__scopeNote mesh__D003003
% 208.15/208.30       Infection of the biliary passages with CLONORCHIS SINENSIS, also called Opisthorchis sinensis. It may lead to inflammation of the biliary tract, proliferation of biliary epithelium, progressive portal fibrosis, and sometimes bile duct carcinoma. Extension to the liver may lead to fatty changes and cirrhosis. %28%From Dorland, 27th ed%29%%A%    
% 208.15/208.30  |- mesh__recordOriginator mesh__D003003 NLM
% 208.15/208.30  |- skos__prefLabel mesh__D003003 Clonorchiasis
% 208.15/208.30  |- mesh__recordAuthorizer mesh__D008297 sjn
% 208.15/208.30  |- skos__altLabel mesh__D008297 Males
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D008297 2006
% 208.15/208.30  |- mesh__dateCreated mesh__D008297 1999-01-01
% 208.15/208.30  |- mesh__recordMaintainer mesh__D008297 ags
% 208.15/208.30  |- mesh__dateRevised mesh__D008297 2005-06-30
% 208.15/208.30  |- mesh__historyNote mesh__D008297 1966; for MALES use MEN 1979-2005   
% 208.15/208.30  |- skos__prefLabel mesh__D008297 Male
% 208.15/208.30  |- skos__annotation mesh__D008297
% 208.15/208.30       check tag only for male organs, diseases, physiol processes, genetics, etc.; do not confuse with MEN as a social, cultural, political, economic force; Manual 18.9+, 35.6.2      CATALOG: do not use: for indexers only%A%  
% 208.15/208.30  |- mesh__recordOriginator mesh__D008297 NLM
% 208.15/208.30  |- mesh__dateCreated mesh__D016729 1991-05-30
% 208.15/208.30  |- rdf__type mesh__D016729sskos__Concept
% 208.15/208.30  |- skos__hiddenLabel mesh__D016729 A 43818
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D016729 2004
% 208.15/208.30  |- skos__altLabel mesh__D016729 Leuprorelin
% 208.15/208.30  |- mesh__historyNote mesh__D016729 92; was LEUPROLIDE %28%NM%29% 1975-91   
% 208.15/208.30  |- mesh__recordMaintainer mesh__D016729 WXM
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D016729 2003
% 208.15/208.30  |- mesh__recordAuthorizer mesh__D016729 sjn
% 208.15/208.30  |- mesh__dateRevised mesh__D016729 2001-07-25
% 208.15/208.30  |- skos__broader mesh__D016729smesh__D007987
% 208.15/208.30  |- skos__hiddenLabel mesh__D016729 TAP 144
% 208.15/208.30  |- skos__historyNote mesh__D016729
% 208.15/208.30       Gonadorelin/analogs %26% derivatives %28%1980-1991%29%
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D016729 2002
% 208.15/208.30  |- skos__hiddenLabel mesh__D016729 TAP144
% 208.15/208.30  |- mesh__recordOriginator mesh__D016729 PXP
% 208.15/208.30  |- skos__hiddenLabel mesh__D016729 Monoacetate, Leuprolide
% 208.15/208.30  |- skos__scopeNote mesh__D016729
% 208.15/208.30       A potent and long acting analog of naturally occurring gonadotropin-releasing hormone %28%GONADORELIN%29%. Its action is similar to gonadorelin, which regulates the synthesis and release of pituitary gonadotropins.%A%    
% 208.15/208.30  |- skos__hiddenLabel mesh__D016729 A43818
% 208.15/208.30  |- mesh__publicMeSHNote mesh__D016729
% 208.15/208.30       92; LEUPROLIDE was indexed under PEPTIDES 1975-76 %26% GONADORELIN/analogs %26% derivatives 1977-91%A%  
% 208.15/208.30  |- mesh__onlineNote mesh__D016729
% 208.15/208.30       use LEUPROLIDE %28%NM%29% to search LEUPROLIDE 1980-91   
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D016729 2006
% 208.15/208.30  |- skos__hiddenLabel mesh__D016729 Acetate, Leuprolide
% 208.15/208.30  |- skos__historyNote mesh__D016729 Antineoplastic Agents %28%1984-1991%29%
% 208.15/208.30  |- skos__prefLabel mesh__D016729 Leuprolide
% 208.15/208.30  |- mesh__dateEstablished mesh__D016729 1992-01-01
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D016729 2005
% 208.15/208.30  |- skos__broader mesh__D041122smesh__D010961
% 208.15/208.30  |- mesh__dateEstablished mesh__D041122 2003-01-01
% 208.15/208.30  |- skos__prefLabel mesh__D041122 Plasmodium ovale
% 208.15/208.30  |- rdf__type mesh__D041122sskos__Concept
% 208.15/208.30  |- skos__historyNote mesh__D041122 Plasmodium %28%1966-2002%29%
% 208.15/208.30  |- mesh__dateRevised mesh__D041122 2003-07-09
% 208.15/208.30  |- mesh__dateCreated mesh__D041122 2002-07-03
% 208.15/208.30  |- skos__scopeNote mesh__D041122
% 208.15/208.30       A species of protozoan parasite causing MALARIA. It is the rarest of the four species of PLASMODIUM infecting humans, but is common in West African countries and neighboring areas.%A%    
% 208.15/208.30  |- mesh__publicMeSHNote mesh__D041122 2003   
% 208.15/208.30  |- skos__annotation mesh__D041122
% 208.15/208.30       infection: coord IM with MALARIA %28%IM%29%; coord with specific protozoan terms %28%ANTIGENS, PROTOZOAN, etc%29% if pertinent%A%  
% 208.15/208.30  |- mesh__historyNote mesh__D041122 2003   
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D041122 2006
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D041122 2004
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D041122 2005
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D002709 2005
% 208.15/208.30  |- skos__altLabel mesh__D002709 Clofenvinfos
% 208.15/208.30  |- mesh__activeMeSHYear mesh__D002709 2006
% 208.15/208.30  |- skos__historyNote mesh__D002709 Vinyl Compounds %28%1971-1974%29%
% 208.15/208.30  |- skos__historyNote mesh__D002709 Insecticides %28%1966-1972%29%
% 208.15/208.30  |- skos__scopeNote mesh__D002709
% 208.15/208.30       An organophosphorus cholinesterase inhibitor that is used as an insecticide and an acaricide.%A%    
% 208.15/208.30  |- mesh__historyNote mesh__D002709
% 208.15/208.30       91%28%80%29%; was see under INSECTICIDES, ORGANOPHOSPHATE 1980-90%A%  
% 208.15/208.31  |- mesh__publicMeSHNote mesh__D002709
% 208.15/208.31       91; was see under INSECTICIDES, ORGANOPHOSPHATE 1980-90   
% 208.15/208.31  |- mesh__dateRevised mesh__D002709 2004-07-08
% 208.15/208.31  |- mesh__dateCreated mesh__D002709 1979-05-23
% 208.15/208.31  |- skos__annotation mesh__D002709 TN 111 for eff on insects   
% 208.15/208.31  |- mesh__recordAuthorizer mesh__D002709 sjn
% 208.15/208.31  |- rdf__type mesh__D002709sskos__Concept
% 208.15/208.31  |- mesh__recordOriginator mesh__D002709 RLS
% 208.15/208.31  |- mesh__recordMaintainer mesh__D002709 ssb
% 208.15/208.31  |- mesh__dateEstablished mesh__D002709 1991-01-01
% 208.15/208.31  |- skos__historyNote mesh__D002709 Phosphoric Acids %28%1966-1970%29%
% 208.15/208.31  |- skos__altLabel mesh__D002709 Chlorphenvinphos
% 208.15/208.31  |- skos__prefLabel mesh__D002709 Chlorfenvinphos
% 208.15/208.31  |- skos__historyNote mesh__D002709
% 208.15/208.31       Organophosphorus Compounds %28%1971-1979%29%
% 208.15/208.31  |- skos__broader mesh__D002709smesh__D009943
% 208.15/208.31  |- skos__historyNote mesh__D002709
% 208.15/208.31       Insecticides, Organophosphate %28%1973-1979%29%
% 208.15/208.31  |- skos__altLabel mesh__D013431 Inorganic Sulfates
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D013431 2001
% 208.15/208.31  |- rdf__type mesh__D013431sskos__Concept
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D013431 1996
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D013431 2003
% 208.15/208.31  |- skos__prefLabel mesh__D013431 Sulfates
% 208.15/208.31  |- mesh__recordAuthorizer mesh__D013431 PLS
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D013431 2000
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D013431 1999
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D013431 2006
% 208.15/208.31  |- mesh__dateRevised mesh__D013431 1993-06-04
% 208.15/208.31  |- skos__scopeNote mesh__D013431 Inorganic salts of sulfuric acid.     
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D013431 1995
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D013431 1998
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D013431 2005
% 208.15/208.31  |- skos__altLabel mesh__D013431 Sulfates, Inorganic
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D013431 2002
% 208.15/208.31  |- mesh__recordMaintainer mesh__D013431 TPW
% 208.15/208.31  |- skos__broader mesh__D013431smesh__D013464
% 208.15/208.31  |- mesh__recordOriginator mesh__D013431 NLM
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D013431 1994
% 208.15/208.31  |- skos__broader mesh__D013431smesh__D000838
% 208.15/208.31  |- mesh__dateCreated mesh__D013431 1999-01-01
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D013431 1997
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D013431 2004
% 208.15/208.31  |- skos__hiddenLabel mesh__D051550 Essential Modifier, NF-kappaB
% 208.15/208.31  |- skos__hiddenLabel mesh__D051550 NF kappaB Essential Modifier
% 208.15/208.31  |- skos__altLabel mesh__D051550 IKK 2 Kinase
% 208.15/208.31  |- skos__hiddenLabel mesh__D051550
% 208.15/208.31       I Kappa B alpha Associated Protein Kinase
% 208.15/208.31  |- skos__altLabel mesh__D051550 IkappaB Kinase
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D051550 2006
% 208.15/208.31  |- skos__scopeNote mesh__D051550
% 208.15/208.31       A protein serine-threonine kinase that catalyzes the PHOSPHORYLATION of I KAPPA B PROTEINS. This enzyme also activates the transcription factor NF-KAPPA B and is composed of alpha and beta catalytic subunits, which are protein kinases and gamma, a regulatory subunit.%A%    
% 208.15/208.31  |- skos__hiddenLabel mesh__D051550 Kinase epsilon, IkappaB
% 208.15/208.31  |- skos__prefLabel mesh__D051550 I-kappa B Kinase
% 208.15/208.31  |- mesh__historyNote mesh__D051550 2006%28%1997%29%   
% 208.15/208.31  |- mesh__publicMeSHNote mesh__D051550
% 208.15/208.31       2006; I-KAPPA B KINASE was indexed under PROTEIN-SERINE-THREONINE KINASES 1997-2005%A%  
% 208.15/208.31  |- skos__altLabel mesh__D051550 I kappa B Kinase
% 208.15/208.31  |- skos__hiddenLabel mesh__D051550 Kinase alpha, IkappaB
% 208.15/208.31  |- skos__hiddenLabel mesh__D051550 B Kinase, I-kappa
% 208.15/208.31  |- skos__hiddenLabel mesh__D051550 Kinase beta, IkappaB
% 208.15/208.31  |- skos__hiddenLabel mesh__D051550 NK kappa B Activating Kinase NAK
% 208.15/208.31  |- skos__altLabel mesh__D051550 CHUK Kinase
% 208.15/208.31  |- skos__broader mesh__D051550smesh__D017346
% 208.15/208.31  |- skos__altLabel mesh__D051550 IKK epsilon
% 208.15/208.31  |- skos__altLabel mesh__D051550 NK-kappa B-Activating Kinase NAK
% 208.15/208.31  |- mesh__recordOriginator mesh__D051550 AKE
% 208.15/208.31  |- mesh__dateCreated mesh__D051550 2005-06-30
% 208.15/208.31  |- skos__altLabel mesh__D051550 NF-kappaB Essential Modifier
% 208.15/208.31  |- skos__altLabel mesh__D051550 IkappaBalpha Kinase
% 208.15/208.31  |- skos__altLabel mesh__D051550 IKBKB
% 208.15/208.31  |- skos__altLabel mesh__D051550 IKK gamma
% 208.15/208.31  |- skos__altLabel mesh__D051550
% 208.15/208.31       Conserved Helix-Loop-Helix Ubiquitous Kinase
% 208.15/208.31  |- skos__altLabel mesh__D051550 IKKepsilon
% 208.15/208.31  |- skos__hiddenLabel mesh__D051550 Kinase, I-kappa B
% 208.15/208.31  |- rdf__type mesh__D051550sskos__Concept
% 208.15/208.31  |- skos__altLabel mesh__D051550 IKK beta
% 208.15/208.31  |- skos__altLabel mesh__D051550 IKK alpha
% 208.15/208.31  |- mesh__recordAuthorizer mesh__D051550 sjn
% 208.15/208.31  |- mesh__recordMaintainer mesh__D051550 AKE
% 208.15/208.31  |- skos__altLabel mesh__D051550 IKK 1 Kinase
% 208.15/208.31  |- skos__broader mesh__D051550smesh__D036341
% 208.15/208.31  |- mesh__dateEstablished mesh__D051550 2006-01-01
% 208.15/208.31  |- skos__hiddenLabel mesh__D051550
% 208.15/208.31       Conserved Helix Loop Helix Ubiquitous Kinase
% 208.15/208.31  |- skos__hiddenLabel mesh__D051550 Kinase, IkappaB
% 208.15/208.31  |- skos__altLabel mesh__D051550 I Kappa B alpha-Associated Protein Kinase
% 208.15/208.31  |- skos__related mesh__D051550smesh__D020672
% 208.15/208.31  |- skos__broader mesh__D051550smesh__D047908
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D037081 2003
% 208.15/208.31  |- mesh__dateCreated mesh__D037081 2002-07-03
% 208.15/208.31  |- mesh__publicMeSHNote mesh__D037081 2003   
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D037081 2004
% 208.15/208.31  |- skos__hiddenLabel mesh__D037081 Dysfunction, Tibialis Posterior
% 208.15/208.31  |- skos__historyNote mesh__D037081 Flatfoot %28%1991-2002%29%
% 208.15/208.31  |- rdf__type mesh__D037081sskos__Concept
% 208.15/208.31  |- skos__altLabel mesh__D037081 Tibialis Posterior Dysfunction
% 208.15/208.31  |- skos__historyNote mesh__D037081 Tendons %28%1989-2002%29%
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D037081 2005
% 208.15/208.31  |- mesh__historyNote mesh__D037081 2003   
% 208.15/208.31  |- skos__scopeNote mesh__D037081
% 208.15/208.31       A condition characterized by a broad range of progressive disorders ranging from TENOSYNOVITIS to tendon rupture with or without hindfoot collapse to a fixed, rigid, FLATFOOT deformity. Pathologic changes can involve associated tendons, ligaments, joint structures of the ANKLE, hindfoot, and midfoot. Posterior tibial tendon dysfunction is the most common cause of acquired flatfoot deformity in adults.%A%    
% 208.15/208.31  |- skos__broader mesh__D037081smesh__D005534
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D037081 2006
% 208.15/208.31  |- skos__historyNote mesh__D037081 Muscular Diseases %28%1989-2002%29%
% 208.15/208.31  |- skos__altLabel mesh__D037081 Tibial Tendon Dysfunction, Posterior
% 208.15/208.31  |- skos__related mesh__D037081smesh__D005413
% 208.15/208.31  |- mesh__dateEstablished mesh__D037081 2003-01-01
% 208.15/208.31  |- skos__prefLabel mesh__D037081 Posterior Tibial Tendon Dysfunction
% 208.15/208.31  |- rdf__type mesh__D012339sskos__Concept
% 208.15/208.31  |- skos__broader mesh__D012339smesh__D012335
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D012339 2000
% 208.15/208.31  |- mesh__dateRevised mesh__D012339 1995-05-22
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D012339 2005
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D012339 2004
% 208.15/208.31  |- skos__historyNote mesh__D012339 RNA, Ribosomal %28%1971-1987%29%
% 208.15/208.31  |- mesh__publicMeSHNote mesh__D012339
% 208.15/208.31       91; was see under RNA, RIBOSOMAL 1988-90   
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D012339 1999
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D012339 2003
% 208.15/208.31  |- skos__altLabel mesh__D012339 28S Ribosomal RNA
% 208.15/208.31  |- mesh__dateEstablished mesh__D012339 1991-01-01
% 208.15/208.31  |- skos__hiddenLabel mesh__D012339 Ribosomal RNA, 28S
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D012339 1998
% 208.15/208.31  |- skos__prefLabel mesh__D012339 RNA, Ribosomal, 28S
% 208.15/208.31  |- skos__scopeNote mesh__D012339
% 208.15/208.31       Constituent of the 60S subunit of eukaryotic ribosomes. 28S rRNA is involved in the initiation of polypeptide synthesis in eukaryotes.%A%    
% 208.15/208.31  |- skos__hiddenLabel mesh__D012339 RNA, 28S Ribosomal
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D012339 2002
% 208.15/208.31  |- mesh__recordMaintainer mesh__D012339 KEV
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D012339 1997
% 208.15/208.31  |- mesh__historyNote mesh__D012339
% 208.15/208.31       91%28%88%29%; was see under RNA, RIBOSOMAL 1988-90   
% 208.15/208.31  |- skos__annotation mesh__D012339
% 208.15/208.31       IM; /drug eff /ultrastruct permitted; DF: 28S RRNA   
% 208.15/208.31  |- mesh__dateCreated mesh__D012339 1987-05-09
% 208.15/208.31  |- mesh__recordAuthorizer mesh__D012339 PLS
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D012339 2006
% 208.15/208.31  |- mesh__recordOriginator mesh__D012339 RLS
% 208.15/208.31  |- skos__historyNote mesh__D012339 RNA %28%1966-1970%29%
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D012339 2001
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D012339 1996
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D009390 2001
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D009390 2002
% 208.15/208.31  |- mesh__recordAuthorizer mesh__D009390 PLS
% 208.15/208.31  |- rdf__type mesh__D009390sskos__Concept
% 208.15/208.31  |- mesh__recordOriginator mesh__D009390 NLM
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D009390 1994
% 208.15/208.31  |- mesh__recordMaintainer mesh__D009390 PLS
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D009390 2005
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D009390 1998
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D009390 1995
% 208.15/208.31  |- mesh__dateCreated mesh__D009390 1999-01-01
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D009390 2006
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D009390 2003
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D009390 1999
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D009390 1996
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D009390 2000
% 208.15/208.31  |- skos__prefLabel mesh__D009390 Nepal
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D009390 2004
% 208.15/208.31  |- skos__broader mesh__D009390smesh__D001211
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D009390 1997
% 208.15/208.31  |- mesh__dateRevised mesh__D009390 1993-06-03
% 208.15/208.31  |- skos__altLabel mesh__D023061 Gene Position
% 208.15/208.31  |- skos__hiddenLabel mesh__D023061 Order, Gene
% 208.15/208.31  |- mesh__dateCreated mesh__D023061 2000-06-21
% 208.15/208.31  |- skos__hiddenLabel mesh__D023061 Arrangement, Gene
% 208.15/208.31  |- skos__hiddenLabel mesh__D023061 Position, Gene
% 208.15/208.31  |- skos__related mesh__D023061smesh__D008040
% 208.15/208.31  |- skos__prefLabel mesh__D023061 Gene Order
% 208.15/208.31  |- skos__hiddenLabel mesh__D023061 Gene Positions
% 208.15/208.31  |- skos__hiddenLabel mesh__D023061 Gene Arrangements
% 208.15/208.31  |- mesh__dateRevised mesh__D023061 2002-07-02
% 208.15/208.31  |- skos__hiddenLabel mesh__D023061 Arrangements, Gene
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D023061 2005
% 208.15/208.31  |- skos__scopeNote mesh__D023061
% 208.15/208.31       The sequential location of genes on a chromosome.     
% 208.15/208.31  |- skos__broader mesh__D023061smesh__D040341
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D023061 2003
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D023061 2006
% 208.15/208.31  |- mesh__dateEstablished mesh__D023061 2001-01-01
% 208.15/208.31  |- mesh__historyNote mesh__D023061 2001   
% 208.15/208.31  |- rdf__type mesh__D023061sskos__Concept
% 208.15/208.31  |- skos__historyNote mesh__D023061 Chromosome Mapping %28%1965-2000%29%
% 208.15/208.31  |- skos__altLabel mesh__D023061 Gene Arrangement
% 208.15/208.31  |- mesh__publicMeSHNote mesh__D023061 2001   
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D023061 2004
% 208.15/208.31  |- skos__hiddenLabel mesh__D023061 Positions, Gene
% 208.15/208.31  |- skos__scopeNote mesh__D017024
% 208.15/208.31       Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.%A%    
% 208.15/208.31  |- skos__altLabel mesh__D017024 Adjuvant Drug Therapy
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017024 2004
% 208.15/208.31  |- skos__broader mesh__D017024smesh__D003131
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017024 2002
% 208.15/208.31  |- mesh__historyNote mesh__D017024 92   
% 208.15/208.31  |- skos__altLabel mesh__D017024 Drug Therapy, Adjuvant
% 208.15/208.31  |- mesh__recordOriginator mesh__D017024 AGS
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017024 2003
% 208.15/208.31  |- mesh__recordAuthorizer mesh__D017024 PLS
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017024 2001
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017024 1997
% 208.15/208.31  |- skos__annotation mesh__D017024
% 208.15/208.31       almost never IM; coordinate with dis /drug ther + specific drug or drugs /ther use + other form of ther to which this is adjuvant; Manual 24.4.2.2.1; DF: CHEMOTHER ADJUVANT%A%  
% 208.15/208.31  |- mesh__publicMeSHNote mesh__D017024 92   
% 208.15/208.31  |- skos__broader mesh__D017024smesh__D004358
% 208.15/208.31  |- skos__historyNote mesh__D017024
% 208.15/208.31       Drug Therapy, Combination %28%1974-1983%29%
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017024 1996
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017024 1995
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017024 2000
% 208.15/208.31  |- mesh__dateEstablished mesh__D017024 1992-01-01
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017024 2006
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017024 1994
% 208.15/208.31  |- skos__hiddenLabel mesh__D017024 Adjuvant Chemotherapy
% 208.15/208.31  |- skos__historyNote mesh__D017024
% 208.15/208.31       specific drug/therapeutic use %28%1966-1991%29%
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017024 2005
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017024 1999
% 208.15/208.31  |- mesh__dateRevised mesh__D017024 1993-06-29
% 208.15/208.31  |- skos__historyNote mesh__D017024
% 208.15/208.31       Combined Modality Therapy %28%1984-1991%29%
% 208.15/208.31  |- skos__prefLabel mesh__D017024 Chemotherapy, Adjuvant
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017024 1998
% 208.15/208.31  |- mesh__dateCreated mesh__D017024 1991-05-30
% 208.15/208.31  |- mesh__recordMaintainer mesh__D017024 TGC
% 208.15/208.31  |- rdf__type mesh__D017024sskos__Concept
% 208.15/208.31  |- skos__prefLabel mesh__D003802 Dentifrices
% 208.15/208.31  |- skos__altLabel mesh__D003802 Polishes, Dental
% 208.15/208.31  |- skos__annotation mesh__D003802 D25-26 qualif   
% 208.15/208.31  |- rdf__type mesh__D003802sskos__Concept
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D003802 2004
% 208.15/208.31  |- skos__broader mesh__D003802smesh__D003358
% 208.15/208.31  |- mesh__recordOriginator mesh__D003802 NLM
% 208.15/208.31  |- skos__scopeNote mesh__D003802
% 208.15/208.31       Any preparations used for cleansing teeth; they usually contain an abrasive, detergent, binder and flavoring agent and may exist in the form of liquid, paste or powder; may also contain medicaments and caries preventives.%A%    
% 208.15/208.31  |- mesh__dateRevised mesh__D003802 2003-07-09
% 208.15/208.31  |- mesh__recordMaintainer mesh__D003802 ssb
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D003802 2005
% 208.15/208.31  |- mesh__recordAuthorizer mesh__D003802 sjn
% 208.15/208.31  |- skos__related mesh__D003802smesh__D009067
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D003802 2006
% 208.15/208.31  |- mesh__dateCreated mesh__D003802 1999-01-01
% 208.15/208.31  |- skos__broader mesh__D003802smesh__D001697
% 208.15/208.31  |- skos__broader mesh__D001285Q000031smesh__D001285
% 208.15/208.31  |- mesh__preferredCombination mesh__D001285Q000031smesh__D001286
% 208.15/208.31  |- rdf__type mesh__D001285Q000031smesh__CompoundConcept
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D003004 2004
% 208.15/208.31  |- mesh__historyNote mesh__D003004
% 208.15/208.31       72; was see under OPISTHORCHIS 1963-71   
% 208.15/208.31  |- mesh__dateEstablished mesh__D003004 1972-01-01
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D003004 2006
% 208.15/208.31  |- skos__scopeNote mesh__D003004
% 208.15/208.31       A species of trematode flukes of the family Opisthorchidae. Many authorities consider this genus belonging to Opisthorchis. It is common in China and other Asiatic countries. Snails and fish are the intermediate hosts.%A%    
% 208.15/208.31  |- skos__broader mesh__D003004smesh__D009890
% 208.15/208.31  |- skos__prefLabel mesh__D003004 Clonorchis sinensis
% 208.15/208.31  |- skos__altLabel mesh__D003004 Opisthorchis sinensis
% 208.15/208.31  |- mesh__publicMeSHNote mesh__D003004
% 208.15/208.31       72; was see under OPISTHORCHIS 1963-71   
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D003004 2005
% 208.15/208.31  |- mesh__recordOriginator mesh__D003004 NLM
% 208.15/208.31  |- mesh__dateCreated mesh__D003004 1999-01-01
% 208.15/208.31  |- rdf__type mesh__D003004sskos__Concept
% 208.15/208.31  |- mesh__onlineNote mesh__D003004 search OPISTHORCHIS 1966-71   
% 208.15/208.31  |- mesh__recordAuthorizer mesh__D003004 sjn
% 208.15/208.31  |- skos__historyNote mesh__D003004 Opisthorchis %28%1966-1971%29%
% 208.15/208.31  |- skos__annotation mesh__D003004
% 208.15/208.31       infection = CLONORCHIASIS; note X ref: OPISTHORCHIS SINENSIS infection = CLONORCHIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 208.15/208.31  |- mesh__dateRevised mesh__D003004 2003-07-09
% 208.15/208.31  |- mesh__recordMaintainer mesh__D003004 ags
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D008298 2004
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D008298 2005
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D008298 1996
% 208.15/208.31  |- mesh__recordAuthorizer mesh__D008298 PLS
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D008298 2006
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D008298 1997
% 208.15/208.31  |- mesh__dateCreated mesh__D008298 1999-01-01
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D008298 1998
% 208.15/208.31  |- skos__broader mesh__D008298smesh__D003998
% 208.15/208.31  |- mesh__recordOriginator mesh__D008298 NLM
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D008298 2002
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D008298 1994
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D008298 1993
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D008298 1999
% 208.15/208.31  |- skos__prefLabel mesh__D008298 Maleates
% 208.15/208.31  |- rdf__type mesh__D008298sskos__Concept
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D008298 1995
% 208.15/208.31  |- mesh__recordMaintainer mesh__D008298 TAP
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D008298 2000
% 208.15/208.31  |- mesh__dateRevised mesh__D008298 1992-05-18
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D008298 2003
% 208.15/208.31  |- skos__annotation mesh__D008298 do not confuse with MALATES   
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D008298 2001
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D041921 2006
% 208.15/208.31  |- mesh__historyNote mesh__D041921 2004   
% 208.15/208.31  |- skos__prefLabel mesh__D041921 Hyphomicrobiaceae
% 208.15/208.31  |- mesh__publicMeSHNote mesh__D041921 2004   
% 208.15/208.31  |- mesh__dateCreated mesh__D041921 2003-07-09
% 208.15/208.31  |- skos__broader mesh__D041921smesh__D020561
% 208.15/208.31  |- mesh__dateRevised mesh__D041921 2005-06-30
% 208.15/208.31  |- skos__scopeNote mesh__D041921
% 208.15/208.31       A family in the order Rhizobiales, class ALPHAPROTEOBACTERIA comprised of many genera of budding or appendaged bacteria.%A%    
% 208.15/208.31  |- mesh__recordAuthorizer mesh__D041921 sjn
% 208.15/208.31  |- mesh__dateEstablished mesh__D041921 2004-01-01
% 208.15/208.31  |- mesh__recordOriginator mesh__D041921 ags
% 208.15/208.31  |- rdf__type mesh__D041921sskos__Concept
% 208.15/208.31  |- mesh__recordMaintainer mesh__D041921 SYSTEM
% 208.15/208.31  |- skos__broader mesh__D013432smesh__D013844
% 208.15/208.31  |- mesh__recordMaintainer mesh__D013432 ssb
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D013432 2006
% 208.15/208.31  |- mesh__dateRevised mesh__D013432 2005-06-30
% 208.15/208.31  |- skos__prefLabel mesh__D013432 Sulfathiazoles
% 208.15/208.31  |- mesh__dateCreated mesh__D013432 1999-01-01
% 208.15/208.31  |- mesh__recordAuthorizer mesh__D013432 sjn
% 208.15/208.31  |- mesh__recordOriginator mesh__D013432 NLM
% 208.15/208.31  |- skos__annotation mesh__D013432 sulfanilamide anti-infectives   
% 208.15/208.31  |- rdf__type mesh__D013432sskos__Concept
% 208.15/208.31  |- skos__broader mesh__D013432smesh__D013424
% 208.15/208.31  |- mesh__publicMeSHNote mesh__D009391
% 208.15/208.31       81; was TURBIDIMETRY see under PHOTOMETRY 1975-80; was TURBIDIMETRY see under DENSITOMETRY 1969-74%A%  
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D009391 2005
% 208.15/208.31  |- mesh__dateRevised mesh__D009391 2002-07-03
% 208.15/208.31  |- mesh__dateCreated mesh__D009391 1999-01-01
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D009391 2006
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D009391 2003
% 208.15/208.31  |- mesh__onlineNote mesh__D009391
% 208.15/208.31       use NEPHELOMETRY AND TURBIDIMETRY to search TURBIDIMETRY 1975-80; use DENSITOMETRY 1969-74%A%  
% 208.15/208.31  |- mesh__dateEstablished mesh__D009391 1981-01-01
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D009391 2004
% 208.15/208.31  |- skos__annotation mesh__D009391 NIM; DF: NEPHELOMETRY   
% 208.15/208.31  |- skos__broader mesh__D009391smesh__D010783
% 208.15/208.31  |- skos__hiddenLabel mesh__D009391 Turbidimetry and Nephelometry
% 208.15/208.31  |- mesh__recordAuthorizer mesh__D009391 sjn
% 208.15/208.31  |- mesh__historyNote mesh__D009391
% 208.15/208.31       81; was TURBIDIMETRY see under PHOTOMETRY 1975-80; was TURBIDIMETRY see under DENSITOMETRY 1969-74%A%  
% 208.15/208.31  |- skos__scopeNote mesh__D009391
% 208.15/208.31       Chemical analysis based on the phenomenon whereby light, passing through a medium with dispersed particles of a different refractive index from that of the medium, is attenuated in intensity by scattering. In turbidimetry, the intensity of light transmitted through the medium, the unscattered light, is measured. In nephelometry, the intensity of the scattered light is measured, usually, but not necessarily, at right angles to the incident light beam.%A%    
% 208.15/208.31  |- mesh__recordOriginator mesh__D009391 NLM
% 208.15/208.31  |- skos__prefLabel mesh__D009391 Nephelometry and Turbidimetry
% 208.15/208.31  |- mesh__recordMaintainer mesh__D009391 lkt
% 208.15/208.31  |- rdf__type mesh__D009391sskos__Concept
% 208.15/208.31  |- skos__hiddenLabel mesh__D023062 IL 8A Receptors
% 208.15/208.31  |- skos__altLabel mesh__D023062 CXC Chemokine Receptor 1
% 208.15/208.31  |- mesh__recordAuthorizer mesh__D023062 sjn
% 208.15/208.31  |- skos__altLabel mesh__D023062 IL-8A Receptors
% 208.15/208.31  |- skos__hiddenLabel mesh__D023062 Receptor, Interleukin 8A
% 208.15/208.31  |- skos__hiddenLabel mesh__D023062 IL 8Ralpha
% 208.15/208.31  |- skos__altLabel mesh__D023062 IL-8A Receptor
% 208.15/208.31  |- skos__hiddenLabel mesh__D023062 Receptor, IL-8A
% 208.15/208.31  |- skos__hiddenLabel mesh__D023062 Receptor, NAP-1
% 208.15/208.31  |- skos__altLabel mesh__D023062 CXCR1 Protein
% 208.15/208.31  |- mesh__dateEstablished mesh__D023062 2001-01-01
% 208.15/208.31  |- skos__hiddenLabel mesh__D023062 Receptor, Interleukin 8
% 208.15/208.31  |- mesh__dateCreated mesh__D023062 2000-06-23
% 208.15/208.31  |- mesh__recordOriginator mesh__D023062 ags
% 208.15/208.31  |- skos__historyNote mesh__D023062 Antigens, CD %28%1993-2000%29%
% 208.15/208.31  |- skos__altLabel mesh__D023062 Interleukin 8A Receptor
% 208.15/208.31  |- skos__historyNote mesh__D023062 Receptors, Immunologic %28%1989-1993%29%
% 208.15/208.31  |- mesh__historyNote mesh__D023062
% 208.15/208.31       2001; use RECEPTORS, INTERLEUKIN-8A %28%NM%29% to search INTERLEUKIN 8 RECEPTOR 1989-2000%A%  
% 208.15/208.31  |- skos__hiddenLabel mesh__D023062 Receptors, MDNCF
% 208.15/208.31  |- rdf__type mesh__D023062sskos__Concept
% 208.15/208.31  |- skos__broader mesh__D023062smesh__D018123
% 208.15/208.31  |- skos__annotation mesh__D023062 DF: IL8RA   
% 208.15/208.31  |- skos__historyNote mesh__D023062 Receptors, Interleukin %28%1994-2000%29%
% 208.15/208.31  |- skos__altLabel mesh__D023062 IL8RA
% 208.15/208.31  |- skos__altLabel mesh__D023062 Receptors, CXCR1
% 208.15/208.31  |- skos__altLabel mesh__D023062 IL-8Ralpha
% 208.15/208.31  |- skos__altLabel mesh__D023062 CXCR1 Receptor
% 208.15/208.31  |- skos__hiddenLabel mesh__D023062 Receptors, Interleukin 8A
% 208.15/208.31  |- mesh__recordMaintainer mesh__D023062 ssb
% 208.15/208.31  |- skos__hiddenLabel mesh__D023062 IL 8A Receptor
% 208.15/208.31  |- skos__broader mesh__D023062smesh__D043562
% 208.15/208.31  |- skos__hiddenLabel mesh__D023062 Receptor, CXCR1
% 208.15/208.31  |- skos__altLabel mesh__D023062 IL-8RA
% 208.15/208.31  |- skos__hiddenLabel mesh__D023062 Interleukin 8A Receptors
% 208.15/208.31  |- skos__altLabel mesh__D023062 Antigens, CDw128a
% 208.15/208.31  |- skos__scopeNote mesh__D023062
% 208.15/208.31       High-affinity receptors for INTERLEUKIN-8 present on neutrophils, monocytes, and basophils.%A%    
% 208.15/208.31  |- skos__altLabel mesh__D023062 MDNCF Receptors
% 208.15/208.31  |- skos__hiddenLabel mesh__D023062 Receptors, IL-8A
% 208.15/208.31  |- skos__prefLabel mesh__D023062 Receptors, Interleukin-8A
% 208.15/208.31  |- skos__broader mesh__D023062smesh__D015703
% 208.15/208.31  |- skos__altLabel mesh__D023062 Interleukin-8A Receptors
% 208.15/208.31  |- skos__altLabel mesh__D023062 CDw128a Antigens
% 208.15/208.31  |- mesh__publicMeSHNote mesh__D023062
% 208.15/208.31       2001; INTERLEUKIN 8 RECEPTOR was indexed under RECEPTORS, INTERLEUKIN 1994-2000, ANTIGENS, CD 1989-2000, %26% RECEPTORS,  IMMUNOLOGIC 1989-1993%A%  
% 208.15/208.31  |- skos__hiddenLabel mesh__D023062 NAP 1 Receptor
% 208.15/208.31  |- skos__broader mesh__D023062smesh__D019707
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D023062 2006
% 208.15/208.31  |- skos__altLabel mesh__D023062 Interleukin 8 Receptor Type A
% 208.15/208.31  |- mesh__dateRevised mesh__D023062 2005-06-30
% 208.15/208.31  |- skos__altLabel mesh__D023062 CXCR1 Receptors
% 208.15/208.31  |- skos__altLabel mesh__D023062 NAP-1 Receptor
% 208.15/208.31  |- skos__altLabel mesh__D023062 Interleukin 8 Receptor
% 208.15/208.31  |- rdf__type mesh__D017823sskos__Concept
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017823 2000
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017823 2006
% 208.15/208.31  |- mesh__publicMeSHNote mesh__D017823 94   
% 208.15/208.31  |- skos__broader mesh__D017823smesh__D010510
% 208.15/208.31  |- skos__hiddenLabel mesh__D017823 Defect, Furcation
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017823 2005
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017823 1997
% 208.15/208.31  |- skos__prefLabel mesh__D017823 Furcation Defects
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017823 2002
% 208.15/208.31  |- mesh__historyNote mesh__D017823 94   
% 208.15/208.31  |- mesh__dateCreated mesh__D017823 1993-06-04
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017823 1996
% 208.15/208.31  |- skos__hiddenLabel mesh__D017823 Defects, Furcation
% 208.15/208.31  |- mesh__dateEstablished mesh__D017823 1994-01-01
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017823 1999
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017823 2004
% 208.15/208.31  |- skos__annotation mesh__D017823 a periodontal dis   
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017823 1995
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017823 2001
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017823 1998
% 208.15/208.31  |- skos__historyNote mesh__D017823 Tooth Root %28%1966-1993%29%
% 208.15/208.31  |- skos__scopeNote mesh__D017823
% 208.15/208.31       Conditions in which a bifurcation or trifurcation of the molar tooth root becomes denuded as a result of periodontal disease. It may be followed by tooth mobility, temperature sensitivity, pain, and alveolar bone resorption.%A%    
% 208.15/208.31  |- skos__hiddenLabel mesh__D017823 Furcation Defect
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017823 2003
% 208.15/208.31  |- mesh__activeMeSHYear mesh__D017823 1994
% 208.15/208.32  |- skos__hiddenLabel mesh__D003803 Cyst, Dentigerous
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D003803 2006
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D003803 2000
% 208.15/208.32  |- mesh__dateRevised mesh__D003803 1990-06-05
% 208.15/208.32  |- skos__hiddenLabel mesh__D003803 Dentigerous Cysts
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D003803 2004
% 208.15/208.32  |- mesh__recordAuthorizer mesh__D003803 PLS
% 208.15/208.32  |- skos__annotation mesh__D003803
% 208.15/208.32       non-neoplastic; /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/dis term %28%IM%29%%A%  
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D003803 2005
% 208.15/208.32  |- mesh__dateCreated mesh__D003803 1999-01-01
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D003803 2003
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D003803 1995
% 208.15/208.32  |- rdf__type mesh__D003803sskos__Concept
% 208.15/208.32  |- skos__prefLabel mesh__D003803 Dentigerous Cyst
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D003803 1993
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D003803 2002
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D003803 1999
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D003803 1994
% 208.15/208.32  |- mesh__recordMaintainer mesh__D003803 TAP
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D003803 1997
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D003803 1992
% 208.15/208.32  |- skos__hiddenLabel mesh__D003803 Cysts, Dentigerous
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D003803 1998
% 208.15/208.32  |- skos__scopeNote mesh__D003803
% 208.15/208.32       Most common follicular odontogenic cyst. Occurs in relation to a partially erupted or unerupted tooth with at least the crown of the tooth to which the cyst is attached protruding into the cystic cavity. May give rise to an ameloblastoma and, in rare instances, undergo malignant transformation.%A%    
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D003803 1991
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D003803 1996
% 208.15/208.32  |- skos__broader mesh__D003803smesh__D009807
% 208.15/208.32  |- mesh__recordOriginator mesh__D003803 NLM
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D003803 2001
% 208.15/208.32  |- mesh__dateEstablished mesh__D003005 1974-01-01
% 208.15/208.32  |- mesh__dateRevised mesh__D003005 2005-06-30
% 208.15/208.32  |- mesh__dateCreated mesh__D003005 1999-01-01
% 208.15/208.32  |- rdf__type mesh__D003005sskos__Concept
% 208.15/208.32  |- mesh__historyNote mesh__D003005 74%28%64%29%   
% 208.15/208.32  |- skos__scopeNote mesh__D003005
% 208.15/208.32       A sulfamoylbenzamide piperidine. It is considered a thiazide-like diuretic.%A%    
% 208.15/208.32  |- skos__broader mesh__D003005smesh__D010880
% 208.15/208.32  |- mesh__recordOriginator mesh__D003005 NLM
% 208.15/208.32  |- mesh__publicMeSHNote mesh__D003005 74   
% 208.15/208.32  |- skos__prefLabel mesh__D003005 Clopamide
% 208.15/208.32  |- mesh__recordMaintainer mesh__D003005 ssb
% 208.15/208.32  |- mesh__recordAuthorizer mesh__D003005 sjn
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D003005 2006
% 208.15/208.32  |- skos__broader mesh__D003005smesh__D013449
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D008299 2006
% 208.15/208.32  |- skos__broader mesh__D008299smesh__D005663
% 208.15/208.32  |- skos__broader mesh__D008299smesh__D000812
% 208.15/208.32  |- skos__hiddenLabel mesh__D008299 2,5 Furandiones
% 208.15/208.32  |- mesh__recordOriginator mesh__D008299 RLS
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D008299 2001
% 208.15/208.32  |- mesh__publicMeSHNote mesh__D008299
% 208.15/208.32       91; was see under FURANS 1979-90; was MALEIC ANHYDRIDE see under FURANS 1977-78%A%  
% 208.15/208.32  |- mesh__onlineNote mesh__D008299
% 208.15/208.32       use MALEIC ANHYDRIDES to search MALEIC ANHYDRIDE 1977-78   
% 208.15/208.32  |- rdf__type mesh__D008299sskos__Concept
% 208.15/208.32  |- skos__scopeNote mesh__D008299
% 208.15/208.32       Used in copolymerization reactions, in the Diels-Alder%28%diene%29%synthesis, in the preparation of resins, pharmaceuticals and agricultural chemicals. It is a powerful irritant and causes burns.%A%    
% 208.15/208.32  |- skos__historyNote mesh__D008299 Furans %28%1966-1976%29%
% 208.15/208.32  |- skos__prefLabel mesh__D008299 Maleic Anhydrides
% 208.15/208.32  |- skos__historyNote mesh__D008299 Anhydrides %28%1966-1976%29%
% 208.15/208.32  |- mesh__dateCreated mesh__D008299 1976-05-19
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D008299 2002
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D008299 2003
% 208.15/208.32  |- mesh__dateEstablished mesh__D008299 1991-01-01
% 208.15/208.32  |- mesh__historyNote mesh__D008299
% 208.15/208.32       91%28%79%29%; was see under FURANS 1979-90; was MALEIC ANHYDRIDE see under FURANS 1977-78%A%  
% 208.15/208.32  |- skos__historyNote mesh__D008299 Maleates %28%1966-1976%29%
% 208.15/208.32  |- skos__hiddenLabel mesh__D008299 Anhydride, Maleic
% 208.15/208.32  |- mesh__recordAuthorizer mesh__D008299 sjn
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D008299 2004
% 208.15/208.32  |- mesh__dateRevised mesh__D008299 2000-06-21
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D008299 2005
% 208.15/208.32  |- mesh__recordMaintainer mesh__D008299 TWD
% 208.15/208.32  |- skos__altLabel mesh__D008299 2,5-Furandiones
% 208.15/208.32  |- skos__hiddenLabel mesh__D008299 Anhydrides, Maleic
% 208.15/208.32  |- mesh__recordMaintainer mesh__D013433 ssb
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D013433 2006
% 208.15/208.32  |- skos__scopeNote mesh__D013433
% 208.15/208.32       GLYCOSPHINGOLIPIDS with a sulfate group esterified to one of the sugar groups.%A%    
% 208.15/208.32  |- mesh__recordAuthorizer mesh__D013433 sjn
% 208.15/208.32  |- mesh__recordOriginator mesh__D013433 NLM
% 208.15/208.32  |- mesh__dateRevised mesh__D013433 2004-07-07
% 208.15/208.32  |- skos__historyNote mesh__D013433 Cerebrosides %28%1966-1970%29%
% 208.15/208.32  |- mesh__dateCreated mesh__D013433 1999-01-01
% 208.15/208.32  |- mesh__dateEstablished mesh__D013433 1973-01-01
% 208.15/208.32  |- mesh__publicMeSHNote mesh__D013433 99; see SULFATIDES 1971-98   
% 208.15/208.32  |- mesh__historyNote mesh__D013433 99%28%71%29%   
% 208.15/208.32  |- skos__altLabel mesh__D013433 Sulfatides
% 208.15/208.32  |- skos__altLabel mesh__D013433 Sulfatoglycosphingolipids
% 208.15/208.32  |- skos__broader mesh__D013433smesh__D020384
% 208.15/208.32  |- rdf__type mesh__D013433sskos__Concept
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D013433 2005
% 208.15/208.32  |- skos__prefLabel mesh__D013433 Sulfoglycosphingolipids
% 208.15/208.32  |- mesh__publicMeSHNote mesh__D037881 2003; see FETUS 1978-2002   
% 208.15/208.32  |- skos__historyNote mesh__D037881 Fetus %28%1968-2002%29%
% 208.15/208.32  |- mesh__historyNote mesh__D037881 2003; use FETUS 1978-2002   
% 208.15/208.32  |- skos__hiddenLabel mesh__D037881 Fetuses, Aborted
% 208.15/208.32  |- rdf__type mesh__D037881sskos__Concept
% 208.15/208.32  |- skos__hiddenLabel mesh__D037881 Aborted Embryos
% 208.15/208.32  |- skos__altLabel mesh__D037881 Aborted Fetuses
% 208.15/208.32  |- skos__related mesh__D037881smesh__D000022
% 208.15/208.32  |- mesh__dateCreated mesh__D037881 2002-07-02
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D037881 2003
% 208.15/208.32  |- skos__prefLabel mesh__D037881 Aborted Fetus
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D037881 2005
% 208.15/208.32  |- mesh__dateEstablished mesh__D037881 2003-01-01
% 208.15/208.32  |- skos__altLabel mesh__D037881 Fetus, Aborted
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D037881 2004
% 208.15/208.32  |- skos__altLabel mesh__D037881 Aborted Embryo
% 208.15/208.32  |- skos__broader mesh__D037881smesh__D005333
% 208.15/208.32  |- skos__related mesh__D037881smesh__D000028
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D037881 2006
% 208.15/208.32  |- skos__scopeNote mesh__D037881
% 208.15/208.32       A mammalian fetus expelled by INDUCED ABORTION or SPONTANEOUS ABORTION.%A%    
% 208.15/208.32  |- skos__hiddenLabel mesh__D037881 Embryo, Aborted
% 208.15/208.32  |- skos__hiddenLabel mesh__D037881 Embryos, Aborted
% 208.15/208.32  |- skos__hiddenLabel mesh__D051552 beta Adrenergic Receptor Kinase
% 208.15/208.32  |- skos__altLabel mesh__D051552 beta-AR Kinase
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D051552 2006
% 208.15/208.32  |- skos__broader mesh__D051552smesh__D017868
% 208.15/208.32  |- mesh__dateCreated mesh__D051552 2005-06-30
% 208.15/208.32  |- mesh__recordMaintainer mesh__D051552 ags
% 208.15/208.32  |- skos__hiddenLabel mesh__D051552 beta AR Kinase
% 208.15/208.32  |- skos__prefLabel mesh__D051552 beta-Adrenergic Receptor Kinase
% 208.15/208.32  |- mesh__recordOriginator mesh__D051552 AKE
% 208.15/208.32  |- rdf__type mesh__D051552sskos__Concept
% 208.15/208.32  |- mesh__dateRevised mesh__D051552 2005-07-14
% 208.15/208.32  |- mesh__publicMeSHNote mesh__D051552
% 208.15/208.32       2006; BETA-ADRENERGIC RECEPTOR KINASE was indexed PROTEIN KINASES 1987-1993, %26% CYCLIC AMP-DEPENDENT PROTEIN KINASES 1992-2005%A%  
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D051552 2006A
% 208.15/208.32  |- skos__hiddenLabel mesh__D051552 Receptor Kinase, beta-Adrenergic
% 208.15/208.32  |- mesh__dateEstablished mesh__D051552 2006-01-01
% 208.15/208.32  |- mesh__historyNote mesh__D051552 2006   
% 208.15/208.32  |- mesh__recordAuthorizer mesh__D051552 ags
% 208.15/208.32  |- skos__scopeNote mesh__D051552
% 208.15/208.32       A cyclic-AMP protein kinase that mediates agonist-dependent PHOSPHORYLATION and desensitization of G-PROTEIN-COUPLED RECEPTORS.%A%    
% 208.15/208.32  |- skos__prefLabel mesh__D023861 Photography, Dental
% 208.15/208.32  |- mesh__dateCreated mesh__D023861 2001-07-25
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D023861 2006
% 208.15/208.32  |- skos__scopeNote mesh__D023861
% 208.15/208.32       Photographic techniques used in ORTHODONTICS; DENTAL ESTHETICS; and PATIENT EDUCATION.%A%    
% 208.15/208.32  |- skos__hiddenLabel mesh__D023861 Intraoral Photographies
% 208.15/208.32  |- skos__broader mesh__D023861smesh__D003945
% 208.15/208.32  |- skos__historyNote mesh__D023861 Photography %28%1969-1999%29%
% 208.15/208.32  |- mesh__publicMeSHNote mesh__D023861
% 208.15/208.32       2002; for PHOTOGRAPHY, INTRAORAL see PHOTOGRAPHY, INTRAORAL %28%2000-2001%29%%A%  
% 208.15/208.32  |- mesh__recordAuthorizer mesh__D023861 sjn
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D023861 2004
% 208.15/208.32  |- rdf__type mesh__D023861sskos__Concept
% 208.15/208.32  |- skos__hiddenLabel mesh__D023861 Photographies, Intraoral
% 208.15/208.32  |- skos__broader mesh__D023861smesh__D010781
% 208.15/208.32  |- mesh__dateRevised mesh__D023861 2003-07-09
% 208.15/208.32  |- skos__altLabel mesh__D023861 Intraoral Photography
% 208.15/208.32  |- skos__hiddenLabel mesh__D023861 Orthodontic Photography
% 208.15/208.32  |- skos__hiddenLabel mesh__D023861 Dental Photography
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D023861 2005
% 208.15/208.32  |- mesh__recordOriginator mesh__D023861 lkt
% 208.15/208.32  |- mesh__historyNote mesh__D023861 2002   
% 208.15/208.32  |- mesh__recordMaintainer mesh__D023861 lkt
% 208.15/208.32  |- mesh__dateEstablished mesh__D023861 2002-01-01
% 208.15/208.32  |- mesh__recordAuthorizer mesh__D009392 SJN
% 208.15/208.32  |- skos__prefLabel mesh__D009392 Nephrectomy
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009392 1998
% 208.15/208.32  |- mesh__recordOriginator mesh__D009392 NLM
% 208.15/208.32  |- skos__scopeNote mesh__D009392
% 208.15/208.32       Excision of a kidney. %28%Dorland, 28th ed%29%     
% 208.15/208.32  |- mesh__dateCreated mesh__D009392 1999-01-01
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009392 2006
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009392 2003
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009392 1999
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009392 2004
% 208.15/208.32  |- mesh__recordMaintainer mesh__D009392 PXP
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009392 2000
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009392 2001
% 208.15/208.32  |- skos__hiddenLabel mesh__D009392 Nephrectomies
% 208.15/208.32  |- mesh__dateRevised mesh__D009392 1997-06-20
% 208.15/208.32  |- skos__broader mesh__D009392smesh__D013520
% 208.15/208.32  |- rdf__type mesh__D009392sskos__Concept
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009392 2002
% 208.15/208.32  |- skos__annotation mesh__D009392
% 208.15/208.32       do not use /util except by MeSH definition   
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009392 2005
% 208.15/208.32  |- skos__altLabel mesh__D023063 Interleukin-8 Receptors Type B
% 208.15/208.32  |- skos__altLabel mesh__D023063 Interleukin-8 Receptors B
% 208.15/208.32  |- mesh__historyNote mesh__D023063
% 208.15/208.32       2001; use RECEPTORS, INTERLEUKIN-8B %28%NM%29% to search INTERLEUKIN-8 RECEPTOR TYPE B 1994-2000%A%  
% 208.15/208.32  |- skos__hiddenLabel mesh__D023063 Receptor, Interleukin-8B
% 208.15/208.32  |- skos__altLabel mesh__D023063 CDw128b Antigens
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D023063 2005
% 208.15/208.32  |- mesh__recordAuthorizer mesh__D023063 sjn
% 208.15/208.32  |- skos__prefLabel mesh__D023063 Receptors, Interleukin-8B
% 208.15/208.32  |- mesh__dateEstablished mesh__D023063 2001-01-01
% 208.15/208.32  |- skos__hiddenLabel mesh__D023063 Interleukin 8 Receptors Type B
% 208.15/208.32  |- skos__hiddenLabel mesh__D023063 Interleukin 8 Receptors B
% 208.15/208.32  |- mesh__publicMeSHNote mesh__D023063
% 208.15/208.32       2001; INTERLEUKIN-8 RECEPTOR TYPE B was indexed under RECEPTORS, CHEMOKINE 1998-2000 %26% RECEPTORS, INTERLEUKIN 1994-2000%A%  
% 208.15/208.32  |- skos__altLabel mesh__D023063 IL8RB
% 208.15/208.32  |- mesh__dateCreated mesh__D023063 2000-06-23
% 208.15/208.32  |- skos__hiddenLabel mesh__D023063 IL 8Rbeta
% 208.15/208.32  |- mesh__recordOriginator mesh__D023063 ags
% 208.15/208.32  |- skos__altLabel mesh__D023063 Receptors, CXCR2
% 208.15/208.32  |- skos__historyNote mesh__D023063 Receptors, Interleukin %28%1994-2000%29%
% 208.15/208.32  |- rdf__type mesh__D023063sskos__Concept
% 208.15/208.32  |- mesh__recordMaintainer mesh__D023063 jmp
% 208.15/208.32  |- skos__altLabel mesh__D023063 Interleukin-8 Receptor Type B
% 208.15/208.32  |- skos__altLabel mesh__D023063 Interleukin-8B Receptor
% 208.15/208.32  |- skos__broader mesh__D023063smesh__D018123
% 208.15/208.32  |- skos__hiddenLabel mesh__D023063 Interleukin 8B Receptor
% 208.15/208.32  |- skos__hiddenLabel mesh__D023063 IL 8RB
% 208.15/208.32  |- skos__altLabel mesh__D023063 IL-8Rbeta
% 208.15/208.32  |- skos__broader mesh__D023063smesh__D043562
% 208.15/208.32  |- skos__altLabel mesh__D023063 Antigens, CDw128b
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D023063 2004
% 208.15/208.32  |- skos__altLabel mesh__D023063 Interleukin-8B Receptors
% 208.15/208.32  |- skos__historyNote mesh__D023063 Receptors, Chemokine %28%1997-2000%29%
% 208.15/208.32  |- skos__altLabel mesh__D023063 CXCR2 Protein
% 208.15/208.32  |- skos__hiddenLabel mesh__D023063 Receptors, Interleukin 8B
% 208.15/208.32  |- skos__altLabel mesh__D023063 CXC Chemokine Receptor 2
% 208.15/208.32  |- skos__annotation mesh__D023063 DF: IL8RB   
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D023063 2006
% 208.15/208.32  |- skos__hiddenLabel mesh__D023063 Interleukin 8B Receptors
% 208.15/208.32  |- skos__altLabel mesh__D023063 CXCR2 Receptors
% 208.15/208.32  |- mesh__dateRevised mesh__D023063 2003-07-09
% 208.15/208.32  |- skos__altLabel mesh__D023063 IL-8RB
% 208.15/208.32  |- skos__scopeNote mesh__D023063
% 208.15/208.32       Low-affinity receptors for INTERLEUKIN-8 present on neutrophils, monocytes, basophils, and T-cells. These receptors also bind GRO and NAP-2.%A%    
% 208.15/208.32  |- skos__hiddenLabel mesh__D023063 Interleukin 8 Receptor Type B
% 208.15/208.32  |- skos__hiddenLabel mesh__D017824 Bone Cyst, Aneurysmal
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017824 1994
% 208.15/208.32  |- mesh__publicMeSHNote mesh__D017824 94   
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017824 1997
% 208.15/208.32  |- mesh__dateCreated mesh__D017824 1993-06-03
% 208.15/208.32  |- skos__annotation mesh__D017824
% 208.15/208.32       non-neoplastic; nothing to do with %22%aneurysm%22%: see MeSH definition; /blood supply /chem /secret /ultrastruct permitted; coord IM with precord organ/diseases term %28%IM%29% %28%but not BONE DISEASES%29%%A%  
% 208.15/208.32  |- skos__hiddenLabel mesh__D017824 Aneurysmal Bone Cysts
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017824 2006
% 208.15/208.32  |- skos__broader mesh__D017824smesh__D001845
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017824 1996
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017824 2002
% 208.15/208.32  |- skos__hiddenLabel mesh__D017824 Cysts, Aneurysmal Bone
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017824 2005
% 208.15/208.32  |- skos__prefLabel mesh__D017824 Bone Cysts, Aneurysmal
% 208.15/208.32  |- mesh__historyNote mesh__D017824 94   
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017824 1999
% 208.15/208.32  |- mesh__dateEstablished mesh__D017824 1994-01-01
% 208.15/208.32  |- skos__hiddenLabel mesh__D017824 Aneurysmal Bone Cyst
% 208.15/208.32  |- skos__scopeNote mesh__D017824
% 208.15/208.32       Solitary lesions of bone that typically cause a bulging of the overlying cortex bearing some resemblance to the saccular protrusion of the aortic wall in aortic aneurysm, hence the name. %28%Dorland, 27th ed%29%%A%    
% 208.15/208.32  |- skos__hiddenLabel mesh__D017824 Cyst, Aneurysmal Bone
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017824 2001
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017824 1998
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017824 2004
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017824 2000
% 208.15/208.32  |- rdf__type mesh__D017824sskos__Concept
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017824 1995
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017824 2003
% 208.15/208.32  |- mesh__recordMaintainer mesh__D017026 TWD
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017026 2005
% 208.15/208.32  |- mesh__dateRevised mesh__D017026 2000-06-22
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017026 2002
% 208.15/208.32  |- mesh__publicMeSHNote mesh__D017026
% 208.15/208.32       92; SWAINSONINE was indexed under ALKALOIDS 1981-91   
% 208.15/208.32  |- mesh__recordOriginator mesh__D017026 AGS
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017026 2006
% 208.15/208.32  |- mesh__dateCreated mesh__D017026 1991-07-12
% 208.15/208.32  |- skos__prefLabel mesh__D017026 Swainsonine
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017026 2003
% 208.15/208.32  |- mesh__onlineNote mesh__D017026
% 208.15/208.32       use SWAINSONINE %28%NM%29% to search SWAINSONINE 1981-91   
% 208.15/208.32  |- skos__historyNote mesh__D017026 Alkaloids %28%1980-1991%29%
% 208.15/208.32  |- mesh__historyNote mesh__D017026
% 208.15/208.32       92; was SWAINSONINE %28%NM%29% 1981-91   
% 208.15/208.32  |- rdf__type mesh__D017026sskos__Concept
% 208.15/208.32  |- skos__broader mesh__D017026smesh__D000470
% 208.15/208.32  |- skos__scopeNote mesh__D017026
% 208.15/208.32       An indolizidine alkaloid from the plant Swainsona canescens that is a potent alpha-mannosidase inhibitor. Swainsonine also exhibits antimetastatic, antiproliferative, and immunomodulatory activity.%A%    
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017026 2004
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017026 2001
% 208.15/208.32  |- mesh__recordAuthorizer mesh__D017026 sjn
% 208.15/208.32  |- mesh__dateEstablished mesh__D017026 1992-01-01
% 208.15/208.32  |- mesh__recordOriginator mesh__D003804 NLM
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D003804 2005
% 208.15/208.32  |- mesh__dateCreated mesh__D003804 1999-01-01
% 208.15/208.32  |- skos__related mesh__D003804smesh__D003810
% 208.15/208.32  |- rdf__type mesh__D003804sskos__Concept
% 208.15/208.32  |- skos__prefLabel mesh__D003804 Dentin
% 208.15/208.32  |- mesh__dateRevised mesh__D003804 2003-07-09
% 208.15/208.32  |- mesh__recordAuthorizer mesh__D003804 sjn
% 208.15/208.32  |- skos__scopeNote mesh__D003804
% 208.15/208.32       The hard portion of the tooth surrounding the pulp, covered by enamel on the crown and cementum on the root, which is harder and denser than bone but softer than enamel, and is thus readily abraded when left unprotected. %28%From Jablonski, Dictionary of Dentistry, 1992%29%%A%    
% 208.15/208.32  |- skos__annotation mesh__D003804
% 208.15/208.32       /embryol: consider also DENTINOGENESIS; reparative dentin = DENTIN, SECONDARY; dentin bridge = DENTIN, SECONDARY%A%  
% 208.15/208.32  |- skos__broader mesh__D003804smesh__D019589
% 208.15/208.32  |- skos__related mesh__D003804smesh__D009804
% 208.15/208.32  |- skos__altLabel mesh__D003804 Dentine
% 208.15/208.32  |- skos__hiddenLabel mesh__D003804 Dentines
% 208.15/208.32  |- skos__hiddenLabel mesh__D003804 Dentins
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D003804 2006
% 208.15/208.32  |- mesh__recordMaintainer mesh__D003804 lkt
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D003804 2004
% 208.15/208.32  |- skos__hiddenLabel mesh__D003006 alpha Clopenthixol
% 208.15/208.32  |- mesh__recordAuthorizer mesh__D003006 sjn
% 208.15/208.32  |- rdf__type mesh__D003006sskos__Concept
% 208.15/208.32  |- mesh__dateEstablished mesh__D003006 1991-01-01
% 208.15/208.32  |- mesh__publicMeSHNote mesh__D003006
% 208.15/208.32       91; was see under THIOXANTHENES 1975-90; was see under TRANQUILIZING AGENTS 1967-74%A%  
% 208.15/208.32  |- skos__prefLabel mesh__D003006 Clopenthixol
% 208.15/208.32  |- mesh__recordMaintainer mesh__D003006 jmp
% 208.15/208.32  |- skos__broader mesh__D003006smesh__D013892
% 208.15/208.32  |- skos__altLabel mesh__D003006 alpha-Clopenthixol
% 208.15/208.32  |- mesh__dateRevised mesh__D003006 2005-06-30
% 208.15/208.32  |- mesh__dateCreated mesh__D003006 1999-01-01
% 208.15/208.32  |- skos__scopeNote mesh__D003006
% 208.15/208.32       A thioxanthene with therapeutic actions similar to the phenothiazine antipsychotics. It is an antagonist at D1 and D2 dopamine receptors.%A%    
% 208.15/208.32  |- mesh__historyNote mesh__D003006
% 208.15/208.32       91%28%63%29%; was see under THIOXANTHENES 1975-90; was see under TRANQUILIZING AGENTS 1967-74%A%  
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D003006 2006
% 208.15/208.32  |- mesh__recordOriginator mesh__D003006 NLM
% 208.15/208.32  |- mesh__recordMaintainer mesh__D041923 lkt
% 208.15/208.32  |- skos__prefLabel mesh__D041923 Adolescent Development
% 208.15/208.32  |- mesh__recordOriginator mesh__D041923 lkt
% 208.15/208.32  |- mesh__dateRevised mesh__D041923 2004-07-07
% 208.15/208.32  |- mesh__dateEstablished mesh__D041923 2004-01-01
% 208.15/208.32  |- skos__related mesh__D041923smesh__D000294
% 208.15/208.32  |- mesh__recordAuthorizer mesh__D041923 sjn
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D041923 2006
% 208.15/208.32  |- rdf__type mesh__D041923sskos__Concept
% 208.15/208.32  |- skos__historyNote mesh__D041923 Adolescence %28%1965-2003%29%
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D041923 2005
% 208.15/208.32  |- mesh__dateCreated mesh__D041923 2003-07-09
% 208.15/208.32  |- mesh__publicMeSHNote mesh__D041923 2004   
% 208.15/208.32  |- mesh__historyNote mesh__D041923 2004   
% 208.15/208.32  |- skos__hiddenLabel mesh__D041923 Development, Adolescent
% 208.15/208.32  |- skos__scopeNote mesh__D041923
% 208.15/208.32       The continuous sequential physiological and psychological changes during ADOLESCENCE, approximately between the age of 13 and 18.%A%    
% 208.15/208.32  |- skos__broader mesh__D041923smesh__D006803
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D049108 2005
% 208.15/208.32  |- mesh__historyNote mesh__D049108 2005   
% 208.15/208.32  |- mesh__dateCreated mesh__D049108 2004-07-07
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D049108 2006
% 208.15/208.32  |- skos__hiddenLabel mesh__D049108 Growth, Cell Size
% 208.15/208.32  |- mesh__recordMaintainer mesh__D049108 nns
% 208.15/208.32  |- skos__prefLabel mesh__D049108 Cell Enlargement
% 208.15/208.32  |- skos__hiddenLabel mesh__D049108 Size Growth, Cell
% 208.15/208.32  |- skos__hiddenLabel mesh__D049108 Growths, Cell Size
% 208.15/208.32  |- skos__altLabel mesh__D049108 Cell Size Growth
% 208.15/208.32  |- mesh__recordAuthorizer mesh__D049108 sjn
% 208.15/208.32  |- skos__broader mesh__D049108smesh__D048708
% 208.15/208.32  |- skos__altLabel mesh__D049108 Cell Growth in Size
% 208.15/208.32  |- mesh__publicMeSHNote mesh__D049108 2005   
% 208.15/208.32  |- skos__scopeNote mesh__D049108
% 208.15/208.32       Growth processes that result in an increase in CELL SIZE.%A%    
% 208.15/208.32  |- mesh__dateEstablished mesh__D049108 2005-01-01
% 208.15/208.32  |- skos__hiddenLabel mesh__D049108 Enlargement, Cell
% 208.15/208.32  |- mesh__recordOriginator mesh__D049108 nns
% 208.15/208.32  |- skos__related mesh__D049108smesh__D006984
% 208.15/208.32  |- rdf__type mesh__D049108sskos__Concept
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D013434 2002
% 208.15/208.32  |- skos__broader mesh__D013434smesh__D013456
% 208.15/208.32  |- mesh__dateCreated mesh__D013434 1999-01-01
% 208.15/208.32  |- mesh__recordMaintainer mesh__D013434 TPW
% 208.15/208.32  |- skos__scopeNote mesh__D013434
% 208.15/208.32       Oxy acids of sulfur with the general formula RSOH, where R is an alkyl or aryl group such as CH3. They are often encountered as esters and halides. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D013434 2003
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D013434 1996
% 208.15/208.32  |- mesh__recordOriginator mesh__D013434 NLM
% 208.15/208.32  |- mesh__historyNote mesh__D013434 68   
% 208.15/208.32  |- mesh__dateEstablished mesh__D013434 1968-01-01
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D013434 1997
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D013434 2004
% 208.15/208.32  |- skos__prefLabel mesh__D013434 Sulfenic Acids
% 208.15/208.32  |- rdf__type mesh__D013434sskos__Concept
% 208.15/208.32  |- mesh__recordAuthorizer mesh__D013434 PLS
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D013434 2000
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D013434 1998
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D013434 2005
% 208.15/208.32  |- skos__hiddenLabel mesh__D013434 Acids, Sulfenic
% 208.15/208.32  |- mesh__dateRevised mesh__D013434 1993-06-04
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D013434 1994
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D013434 2001
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D013434 1999
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D013434 2006
% 208.15/208.32  |- mesh__publicMeSHNote mesh__D013434 68   
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D013434 1995
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009393 2000
% 208.15/208.32  |- skos__hiddenLabel mesh__D009393 Nephritides
% 208.15/208.32  |- mesh__recordAuthorizer mesh__D009393 PLS
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009393 2004
% 208.15/208.32  |- skos__prefLabel mesh__D009393 Nephritis
% 208.15/208.32  |- skos__broader mesh__D009393smesh__D007674
% 208.15/208.32  |- mesh__dateCreated mesh__D009393 1999-01-01
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009393 2003
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009393 2006
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009393 2005
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009393 1997
% 208.15/208.32  |- mesh__recordOriginator mesh__D009393 NLM
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009393 1996
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009393 2002
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009393 1999
% 208.15/208.32  |- skos__scopeNote mesh__D009393
% 208.15/208.32       Inflammation of the kidney. It is a focal or diffuse proliferative or destructive process which may involve the glomerulus, tubule, or interstitial renal tissue. %28%Dorland, 27th ed%29%%A%    
% 208.15/208.32  |- skos__annotation mesh__D009393
% 208.15/208.32       inflamm of kidney; familial: consider also NEPHRITIS, HEREDITARY%A%  
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009393 2001
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009393 1995
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009393 1998
% 208.15/208.32  |- mesh__dateRevised mesh__D009393 1993-06-02
% 208.15/208.32  |- mesh__recordMaintainer mesh__D009393 TAP
% 208.15/208.32  |- rdf__type mesh__D009393sskos__Concept
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D009393 1994
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017825 2006
% 208.15/208.32  |- skos__altLabel mesh__D017825 Canavan-van Bogaert-Bertrand Disease
% 208.15/208.32  |- skos__annotation mesh__D017825
% 208.15/208.32       do not confuse X ref CANAVAN-VAN BOGAERT-BERTRAND SYNDROME with VAN BOGAERT%27%S LEUKOENCEPHALITIS see SUBACUTE SCLEROSING PANENCEPHALITIS; DF: CANAVAN DIS%A%  
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017825 2002
% 208.15/208.32  |- skos__prefLabel mesh__D017825 Canavan Disease
% 208.15/208.32  |- mesh__publicMeSHNote mesh__D017825 94   
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017825 2003
% 208.15/208.32  |- skos__altLabel mesh__D017825 Neonatal Canavan Disease
% 208.15/208.32  |- mesh__historyNote mesh__D017825 94   
% 208.15/208.32  |- skos__altLabel mesh__D017825 Canavan Disease, Type I
% 208.15/208.32  |- skos__hiddenLabel mesh__D017825 Aspartoacylase Deficiency Disease
% 208.15/208.32  |- skos__altLabel mesh__D017825 Deficiency Disease, Aspartoacylase
% 208.15/208.32  |- skos__altLabel mesh__D017825 Spongy Degeneration of Infancy
% 208.15/208.32  |- skos__altLabel mesh__D017825 Infantile Canavan Disease
% 208.15/208.32  |- mesh__activeMeSHYear mesh__D017825 2004
% 208.15/208.33  |- skos__altLabel mesh__D017825 Leukodystrophy, Spongiform
% 208.15/208.33  |- skos__altLabel mesh__D017825 Type III Canavan Disease
% 208.15/208.33  |- skos__hiddenLabel mesh__D017825 Bogaert-Bertrand Disease, Canavan-van
% 208.15/208.33  |- skos__altLabel mesh__D017825 Sporadic Form of Canavan Disease
% 208.15/208.33  |- skos__hiddenLabel mesh__D017825 Spongiform Leukodystrophies
% 208.15/208.33  |- mesh__recordMaintainer mesh__D017825 ags
% 208.15/208.33  |- skos__hiddenLabel mesh__D017825 Aspartoacylase Deficiency Diseases
% 208.15/208.33  |- skos__hiddenLabel mesh__D017825 Diseases, Aspartoacylase Deficiency
% 208.15/208.33  |- skos__altLabel mesh__D017825 Spongy Disease of Central Nervous System
% 208.15/208.33  |- skos__scopeNote mesh__D017825
% 208.15/208.33       A rare neurodegenerative condition of infancy or childhood characterized by white matter vacuolization and demeylination that gives rise to a spongy appearance. Aspartoacylase deficiency leads to an accumulation of N-acetylaspartate in astrocytes. Inheritance may be autosomal recessive or the illness may occur sporadically. This illness occurs more frequently in individuals of Ashkenazic Jewish descent. The neonatal form features the onset of hypotonia and lethargy at birth, rapidly progressing to coma and death. The infantile form features developmental delay, DYSKINESIAS, hypotonia, spasticity, blindness, and megalencephaly. The juvenile form is characterized by ATAXIA; OPTIC ATROPHY; and DEMENTIA. %28%From Adams et al., Principles of Neurology, 6th ed, p944; Am J Med Genet 1988 Feb;29%28%2%29%:463-71%29%%A%    
% 208.15/208.33  |- mesh__recordOriginator mesh__D017825 TGC
% 208.15/208.33  |- mesh__dateRevised mesh__D017825 2005-07-11
% 208.15/208.33  |- mesh__dateEstablished mesh__D017825 1994-01-01
% 208.15/208.33  |- skos__hiddenLabel mesh__D017825 Leukodystrophies, Spongiform
% 208.15/208.33  |- skos__altLabel mesh__D017825 Familial Form of Canavan Disease
% 208.15/208.33  |- skos__hiddenLabel mesh__D017825 Spongiform Leukodystrophy
% 208.15/208.33  |- skos__hiddenLabel mesh__D017825 Deficiency Diseases, Aspartoacylase
% 208.15/208.33  |- skos__broader mesh__D017825smesh__D020271
% 208.15/208.33  |- skos__altLabel mesh__D017825 Canavan Disease, Type III
% 208.15/208.33  |- skos__altLabel mesh__D017825 Juvenile Canavan Disease
% 208.15/208.33  |- skos__altLabel mesh__D017825 Type I Canavan Disease
% 208.15/208.33  |- skos__hiddenLabel mesh__D017825 Disease, Aspartoacylase Deficiency
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D017825 2006A
% 208.15/208.33  |- mesh__recordAuthorizer mesh__D017825 ags
% 208.15/208.33  |- skos__historyNote mesh__D017825 Demyelinating Diseases %28%1967-1993%29%
% 208.15/208.33  |- skos__altLabel mesh__D017825 Type II Canavan Disease
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D017825 2005
% 208.15/208.33  |- rdf__type mesh__D017825sskos__Concept
% 208.15/208.33  |- skos__historyNote mesh__D017825
% 208.15/208.33       Cerebral Sclerosis, Diffuse %28%1981-1993%29%
% 208.15/208.33  |- mesh__dateCreated mesh__D017825 1993-02-16
% 208.15/208.33  |- skos__altLabel mesh__D017825 Spongy Disease of White Matter
% 208.15/208.33  |- skos__broader mesh__D017825smesh__D020279
% 208.15/208.33  |- skos__hiddenLabel mesh__D017825 Canavan van Bogaert Bertrand Disease
% 208.15/208.33  |- skos__altLabel mesh__D017825 Canavan Disease, Type II
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D017027 2006
% 208.15/208.33  |- skos__prefLabel mesh__D017027 Protein-Tyrosine-Phosphatase
% 208.15/208.33  |- mesh__dateRevised mesh__D017027 2003-07-09
% 208.15/208.33  |- skos__broader mesh__D017027smesh__D010749
% 208.15/208.33  |- skos__hiddenLabel mesh__D017027 Phosphoprotein Phosphatase, Tyrosyl
% 208.15/208.33  |- skos__hiddenLabel mesh__D017027 Phosphatase, Phosphotyrosyl Histone
% 208.15/208.33  |- mesh__dateEstablished mesh__D017027 1992-01-01
% 208.15/208.33  |- skos__annotation mesh__D017027 DF: note short X ref   
% 208.15/208.33  |- mesh__onlineNote mesh__D017027
% 208.15/208.33       use PROTEIN-TYROSINE-PHOSPHATASE %28%NM%29% to search PROTEIN-TYROSINE PHOSPHATASE 1985-91%A%  
% 208.15/208.33  |- skos__altLabel mesh__D017027 Tyrosyl Phosphoprotein Phosphatase
% 208.15/208.33  |- skos__hiddenLabel mesh__D017027 Phosphatase, Phosphotyrosine
% 208.15/208.33  |- mesh__recordAuthorizer mesh__D017027 sjn
% 208.15/208.33  |- rdf__type mesh__D017027sskos__Concept
% 208.15/208.33  |- skos__scopeNote mesh__D017027
% 208.15/208.33       An enzyme group that specifically dephosphorylates phosphotyrosyl residues in selected proteins. Together with PROTEIN-TYROSINE KINASE, it regulates tyrosine phosphorylation and dephosphorylation in cellular signal transduction and may play a role in cell growth control and carcinogenesis. EC 3.1.3.48.%A%    
% 208.15/208.33  |- skos__hiddenLabel mesh__D017027 Phosphatase, Phosphotyrosyl Protein
% 208.15/208.33  |- mesh__recordMaintainer mesh__D017027 ssb
% 208.15/208.33  |- skos__altLabel mesh__D017027 Protein-Tyrosine Phosphatase
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D017027 2004
% 208.15/208.33  |- skos__hiddenLabel mesh__D017027 Protein Phosphatase, Phosphotyrosyl
% 208.15/208.33  |- skos__altLabel mesh__D017027 Tyrosine Phosphatase
% 208.15/208.33  |- skos__hiddenLabel mesh__D017027 Protein Tyrosine Phosphatase
% 208.15/208.33  |- skos__hiddenLabel mesh__D017027 Phosphatase, Tyrosyl Phosphoprotein
% 208.15/208.33  |- skos__hiddenLabel mesh__D017027 Phosphatase, Protein-Tyrosine
% 208.15/208.33  |- skos__altLabel mesh__D017027 Phosphotyrosine Phosphatase
% 208.15/208.33  |- skos__altLabel mesh__D017027 Phosphotyrosyl Protein Phosphatase
% 208.15/208.33  |- skos__altLabel mesh__D017027 PTPase
% 208.15/208.33  |- skos__historyNote mesh__D017027
% 208.15/208.33       Phosphoprotein Phosphatases %28%1985-1991%29%
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D017027 2005
% 208.15/208.33  |- skos__hiddenLabel mesh__D017027 Phosphatase, Tyrosine
% 208.15/208.33  |- mesh__publicMeSHNote mesh__D017027
% 208.15/208.33       92; PROTEIN-TYROSINE PHOSPHATASE  was indexed under PHOSPHOPROTEIN PHOSPHATASES 1985-91%A%  
% 208.15/208.33  |- mesh__historyNote mesh__D017027
% 208.15/208.33       92; was PROTEIN-TYROSINE PHOSPHATASE %28%NM%29% 1985-91   
% 208.15/208.33  |- mesh__recordOriginator mesh__D017027 PLS
% 208.15/208.33  |- skos__hiddenLabel mesh__D017027 Histone Phosphatase, Phosphotyrosyl
% 208.15/208.33  |- mesh__dateCreated mesh__D017027 1991-05-30
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003805 2002
% 208.15/208.33  |- mesh__historyNote mesh__D003805 65   
% 208.15/208.33  |- skos__hiddenLabel mesh__D003805 Dysplasias, Dentin
% 208.15/208.33  |- mesh__recordMaintainer mesh__D003805 kle
% 208.15/208.33  |- skos__hiddenLabel mesh__D003805 Dentin Dysplasias
% 208.15/208.33  |- mesh__recordOriginator mesh__D003805 NLM
% 208.15/208.33  |- mesh__dateRevised mesh__D003805 1999-11-03
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003805 2006
% 208.15/208.33  |- skos__broader mesh__D003805smesh__D014071
% 208.15/208.33  |- skos__scopeNote mesh__D003805
% 208.15/208.33       An apparently hereditary disorder of dentin formation, marked by a normal appearance of coronal dentin associated with pulpal obliteration, faulty root formation, and a tendency for peripheral lesions without obvious cause. %28%From Dorland, 27th ed%29%%A%    
% 208.15/208.33  |- skos__hiddenLabel mesh__D003805 Dysplasia, Dentin
% 208.15/208.33  |- skos__prefLabel mesh__D003805 Dentin Dysplasia
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003805 2001
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003805 2004
% 208.15/208.33  |- mesh__dateEstablished mesh__D003805 1965-01-01
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003805 2000
% 208.15/208.33  |- mesh__recordAuthorizer mesh__D003805 sjn
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003805 2005
% 208.15/208.33  |- mesh__dateCreated mesh__D003805 1999-01-01
% 208.15/208.33  |- rdf__type mesh__D003805sskos__Concept
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003805 2003
% 208.15/208.33  |- mesh__publicMeSHNote mesh__D003805 65   
% 208.15/208.33  |- skos__annotation mesh__D003805
% 208.15/208.33       a tooth abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003007 2006
% 208.15/208.33  |- mesh__dateEstablished mesh__D003007 1991-01-01
% 208.15/208.33  |- rdf__type mesh__D003007sskos__Concept
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003007 2000
% 208.15/208.33  |- mesh__historyNote mesh__D003007
% 208.15/208.33       91%28%75%29%; was see under PYRIDINES 1975-90   
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003007 2001
% 208.15/208.33  |- skos__broader mesh__D003007smesh__D011725
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003007 1996
% 208.15/208.33  |- skos__annotation mesh__D003007 a coccidiostat   
% 208.15/208.33  |- skos__altLabel mesh__D003007 3,5-Dichloro-2,6-dimethyl-4-pyridinol
% 208.15/208.33  |- mesh__recordMaintainer mesh__D003007 JRT
% 208.15/208.33  |- mesh__dateRevised mesh__D003007 1995-06-08
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003007 2003
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003007 1998
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003007 1997
% 208.15/208.33  |- mesh__publicMeSHNote mesh__D003007
% 208.15/208.33       91; was see under PYRIDINES 1975-90   
% 208.15/208.33  |- skos__altLabel mesh__D003007 Meticlorpindol
% 208.15/208.33  |- mesh__recordOriginator mesh__D003007 NLM
% 208.15/208.33  |- skos__scopeNote mesh__D003007
% 208.15/208.33       A very effective anticoccidial agent used in poultry.     
% 208.15/208.33  |- skos__prefLabel mesh__D003007 Clopidol
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003007 2005
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003007 2002
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003007 1999
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003007 2004
% 208.15/208.33  |- mesh__recordAuthorizer mesh__D003007 PLS
% 208.15/208.33  |- skos__historyNote mesh__D003007 Pyridines %28%1973-1974%29%
% 208.15/208.33  |- mesh__dateCreated mesh__D003007 1974-11-19
% 208.15/208.33  |- skos__altLabel mesh__D003007 Clopindol
% 208.15/208.33  |- skos__hiddenLabel mesh__D049109 Multiplication, Cell
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D049109 2006
% 208.15/208.33  |- skos__hiddenLabel mesh__D049109 Proliferation, Cell
% 208.15/208.33  |- skos__hiddenLabel mesh__D049109 Growth, Cell Number
% 208.15/208.33  |- mesh__historyNote mesh__D049109 2005   
% 208.15/208.33  |- skos__altLabel mesh__D049109 Cell Number Growth
% 208.15/208.33  |- skos__altLabel mesh__D049109 Cell Multiplication
% 208.15/208.33  |- skos__hiddenLabel mesh__D049109 Number Growth, Cell
% 208.15/208.33  |- mesh__publicMeSHNote mesh__D049109 2005   
% 208.15/208.33  |- skos__historyNote mesh__D049109 Cell Division %28%1966-2004%29%
% 208.15/208.33  |- skos__related mesh__D049109smesh__D006965
% 208.15/208.33  |- mesh__recordMaintainer mesh__D049109 nns
% 208.15/208.33  |- mesh__recordOriginator mesh__D049109 nns
% 208.15/208.33  |- skos__altLabel mesh__D049109 Cellular Proliferation
% 208.15/208.33  |- skos__prefLabel mesh__D049109 Cell Proliferation
% 208.15/208.33  |- mesh__recordAuthorizer mesh__D049109 sjn
% 208.15/208.33  |- skos__broader mesh__D049109smesh__D048708
% 208.15/208.33  |- rdf__type mesh__D049109sskos__Concept
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D049109 2005
% 208.15/208.33  |- skos__hiddenLabel mesh__D049109 Proliferation, Cellular
% 208.15/208.33  |- mesh__dateCreated mesh__D049109 2004-07-07
% 208.15/208.33  |- skos__altLabel mesh__D049109 Cell Growth in Number
% 208.15/208.33  |- skos__scopeNote mesh__D049109
% 208.15/208.33       All of the processes involved in increasing in CELL NUMBER. These processes include more than CELL DIVISION which is part of the CELL CYCLE.%A%    
% 208.15/208.33  |- mesh__dateEstablished mesh__D049109 2005-01-01
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013435 2006
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013435 1995
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013435 1996
% 208.15/208.33  |- mesh__recordOriginator mesh__D013435 NLM
% 208.15/208.33  |- skos__prefLabel mesh__D013435 Sulfhemoglobin
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013435 2003
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013435 1997
% 208.15/208.33  |- mesh__dateRevised mesh__D013435 1992-05-18
% 208.15/208.33  |- rdf__type mesh__D013435sskos__Concept
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013435 2000
% 208.15/208.33  |- mesh__recordAuthorizer mesh__D013435 PLS
% 208.15/208.33  |- mesh__historyNote mesh__D013435 65%28%63%29%   
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013435 2004
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013435 1998
% 208.15/208.33  |- mesh__publicMeSHNote mesh__D013435 65   
% 208.15/208.33  |- mesh__recordMaintainer mesh__D013435 TAP
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013435 1993
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013435 2001
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013435 2005
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013435 1999
% 208.15/208.33  |- mesh__dateEstablished mesh__D013435 1965-01-01
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013435 1994
% 208.15/208.33  |- mesh__dateCreated mesh__D013435 1999-01-01
% 208.15/208.33  |- skos__broader mesh__D013435smesh__D006454
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013435 2002
% 208.15/208.33  |- mesh__dateRevised mesh__D018120 2005-06-30
% 208.15/208.33  |- skos__altLabel mesh__D018120 Merck Brand 2 of Finasteride
% 208.15/208.33  |- skos__historyNote mesh__D018120 Androstenes %28%1988-1993%29%
% 208.15/208.33  |- mesh__recordMaintainer mesh__D018120 CCR
% 208.15/208.33  |- skos__altLabel mesh__D018120 Lipha Brand of Finasteride
% 208.15/208.33  |- skos__altLabel mesh__D018120 Cahill May Roberts Brand of Finasteride
% 208.15/208.33  |- skos__altLabel mesh__D018120
% 208.15/208.33       Merck Sharp %26% Dhome Brand 2 of Finasteride
% 208.15/208.33  |- mesh__recordOriginator mesh__D018120 TPW
% 208.15/208.33  |- skos__altLabel mesh__D018120 MSD Brand of Finasteride
% 208.15/208.33  |- skos__scopeNote mesh__D018120
% 208.15/208.33       An orally active TESTOSTERONE 5-ALPHA-REDUCTASE inhibitor. It is used as a surgical alternative for treatment of benign prostatic hyperplasia.%A%    
% 208.15/208.33  |- skos__altLabel mesh__D018120 Merck Brand 1 of Finasteride
% 208.15/208.33  |- skos__broader mesh__D018120smesh__D000736
% 208.15/208.33  |- skos__altLabel mesh__D018120 Frosst Iberica Brand of Finasteride
% 208.15/208.33  |- skos__hiddenLabel mesh__D018120 MK906
% 208.15/208.33  |- skos__hiddenLabel mesh__D018120 Chibro Proscar
% 208.15/208.33  |- skos__prefLabel mesh__D018120 Finasteride
% 208.15/208.33  |- skos__broader mesh__D018120smesh__D001378
% 208.15/208.33  |- skos__hiddenLabel mesh__D018120 MK 906
% 208.15/208.33  |- skos__altLabel mesh__D018120 Merck Frosst Brand 1 of Finasteride
% 208.15/208.33  |- mesh__dateCreated mesh__D018120 1993-06-18
% 208.15/208.33  |- mesh__dateEstablished mesh__D018120 1994-01-01
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D018120 2006
% 208.15/208.33  |- skos__altLabel mesh__D018120 MSD Chibropharm Brand of Finasteride
% 208.15/208.33  |- mesh__recordAuthorizer mesh__D018120 sjn
% 208.15/208.33  |- skos__historyNote mesh__D018120 Azasteroids %28%1988-1993%29%
% 208.15/208.33  |- skos__altLabel mesh__D018120 Merck Frosst Brand 2 of Finasteride
% 208.15/208.33  |- mesh__onlineNote mesh__D018120
% 208.15/208.33       use FINASTERIDE %28%NM%29% to search FINASTERIDE 1988-93   
% 208.15/208.33  |- skos__altLabel mesh__D018120
% 208.15/208.33       Merck Sharp %26% Dohme Brand 1 of Finasteride
% 208.15/208.33  |- rdf__type mesh__D018120sskos__Concept
% 208.15/208.33  |- mesh__publicMeSHNote mesh__D018120
% 208.15/208.33       94; FINASTERIDE was indexed under ANDROSTENES %26% AZASTEROIDS 1988-93%A%  
% 208.15/208.33  |- skos__altLabel mesh__D018120 Propeshia
% 208.15/208.33  |- mesh__historyNote mesh__D018120
% 208.15/208.33       94; was FINASTERIDE %28%NM%29% 1988-93   
% 208.15/208.33  |- skos__annotation mesh__D004100
% 208.15/208.33       deficiency: coordinate DIHYDROXYCHOLECALCIFEROLS /defic %28%IM%29% with VITAMIN D DEFICIENCY %28%IM%29%%A%  
% 208.15/208.33  |- mesh__recordAuthorizer mesh__D004100 sjn
% 208.15/208.33  |- mesh__dateEstablished mesh__D004100 1983-01-01
% 208.15/208.33  |- mesh__historyNote mesh__D004100
% 208.15/208.33       83%28%73%29%; was see under HYDROXYCHOLECALCIFEROLS 1975-82   
% 208.15/208.33  |- skos__altLabel mesh__D004100 Dihydroxyvitamins D
% 208.15/208.33  |- skos__scopeNote mesh__D004100
% 208.15/208.33       Cholecalciferols substituted with two hydroxy groups in any position.%A%    
% 208.15/208.33  |- mesh__dateRevised mesh__D004100 2005-06-30
% 208.15/208.33  |- skos__broader mesh__D004100smesh__D006887
% 208.15/208.33  |- mesh__publicMeSHNote mesh__D004100
% 208.15/208.33       83; was see under HYDROXYCHOLECALCIFEROLS 1975-82   
% 208.15/208.33  |- rdf__type mesh__D004100sskos__Concept
% 208.15/208.33  |- mesh__recordOriginator mesh__D004100 NLM
% 208.15/208.33  |- mesh__dateCreated mesh__D004100 1999-01-01
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D004100 2006
% 208.15/208.33  |- skos__prefLabel mesh__D004100 Dihydroxycholecalciferols
% 208.15/208.33  |- mesh__recordMaintainer mesh__D004100 ssb
% 208.15/208.33  |- mesh__publicMeSHNote mesh__D009394
% 208.15/208.33       77; was ALPORT%27%S SYNDROME 1970-76   
% 208.15/208.33  |- skos__hiddenLabel mesh__D009394 Hereditary Nephritides
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D009394 2006
% 208.15/208.33  |- skos__altLabel mesh__D009394 Nephritis, Familial
% 208.15/208.33  |- skos__prefLabel mesh__D009394 Nephritis, Hereditary
% 208.15/208.33  |- skos__broader mesh__D009394smesh__D009393
% 208.15/208.33  |- skos__hiddenLabel mesh__D009394 Nephritides, Hereditary
% 208.15/208.33  |- mesh__onlineNote mesh__D009394
% 208.15/208.33       use NEPHRITIS, HEREDITARY to search ALPORT%27%S SYNDROME 1966-76 %28%as Prov 1966-69%29%%A%  
% 208.15/208.33  |- skos__scopeNote mesh__D009394
% 208.15/208.33       A group of inherited conditions characterized initially by HEMATURIA and slowly progressing to RENAL INSUFFICIENCY. The most common form is the Alport syndrome %28%hereditary nephritis with HEARING LOSS%29% which is caused by mutations in genes for TYPE IV COLLAGEN and defective GLOMERULAR BASEMENT MEMBRANE.%A%    
% 208.15/208.33  |- mesh__recordAuthorizer mesh__D009394 sjn
% 208.15/208.33  |- mesh__dateRevised mesh__D009394 2005-06-30
% 208.15/208.33  |- skos__hiddenLabel mesh__D009394 Syndrome, X-Linked Alport
% 208.15/208.33  |- skos__hiddenLabel mesh__D009394 Familial Nephritis
% 208.15/208.33  |- skos__altLabel mesh__D009394 Alport%27%s Syndrome
% 208.15/208.33  |- skos__broader mesh__D009394smesh__D014564
% 208.15/208.33  |- skos__hiddenLabel mesh__D009394 Familial Nephritides
% 208.15/208.33  |- rdf__type mesh__D009394sskos__Concept
% 208.15/208.33  |- mesh__recordOriginator mesh__D009394 NLM
% 208.15/208.33  |- mesh__dateEstablished mesh__D009394 1970-01-01
% 208.15/208.33  |- skos__hiddenLabel mesh__D009394 Hereditary Nephritis
% 208.15/208.33  |- skos__hiddenLabel mesh__D009394 Nephritides, Familial
% 208.15/208.33  |- mesh__recordMaintainer mesh__D009394 lkt
% 208.15/208.33  |- mesh__historyNote mesh__D009394
% 208.15/208.33       77; was ALPORT%27%S SYNDROME 1964-76 %28%Prov 1964-69%29%   
% 208.15/208.33  |- skos__hiddenLabel mesh__D009394 X-Linked Alport Syndrome
% 208.15/208.33  |- skos__hiddenLabel mesh__D009394 Alport Syndrome, X Linked
% 208.15/208.33  |- mesh__dateCreated mesh__D009394 1999-01-01
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D017028 2003
% 208.15/208.33  |- mesh__recordOriginator mesh__D017028 TGC
% 208.15/208.33  |- skos__hiddenLabel mesh__D017028 Caregiver, Family
% 208.15/208.33  |- rdf__type mesh__D017028sskos__Concept
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D017028 2004
% 208.15/208.33  |- mesh__historyNote mesh__D017028 92   
% 208.15/208.33  |- skos__hiddenLabel mesh__D017028 Caregiver, Spouse
% 208.15/208.33  |- skos__hiddenLabel mesh__D017028 Caregivers, Family
% 208.15/208.33  |- mesh__dateEstablished mesh__D017028 1992-01-01
% 208.15/208.33  |- skos__prefLabel mesh__D017028 Caregivers
% 208.15/208.33  |- skos__hiddenLabel mesh__D017028 Spouse Caregiver
% 208.15/208.33  |- skos__scopeNote mesh__D017028
% 208.15/208.33       Persons who provide care to those who need supervision or assistance in illness or disability. They may provide the care in the home, in a hospital, or in an institution. Although caregivers include trained medical, nursing, and other health personnel, the concept also refers to parents, spouses, or other family members, friends, members of the clergy, teachers, social workers, fellow patients, etc.%A%    
% 208.15/208.33  |- mesh__recordAuthorizer mesh__D017028 sjn
% 208.15/208.33  |- skos__hiddenLabel mesh__D017028 Caregiver
% 208.15/208.33  |- mesh__publicMeSHNote mesh__D017028 92   
% 208.15/208.33  |- mesh__dateRevised mesh__D017028 2001-07-25
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D017028 2005
% 208.15/208.33  |- skos__annotation mesh__D017028
% 208.15/208.33       GEN or unspecified: prefer specific caregiver as NURSES; PHYSICIANS; etc.; IM; coord with specific field if pertinent %28%IM%29%: %22%the teacher as caregiver%22% = CAREGIVERS %28%IM%29% + TEACHING %28%IM%29%%A%  
% 208.15/208.33  |- skos__hiddenLabel mesh__D017028 Caregivers, Spouse
% 208.15/208.33  |- skos__hiddenLabel mesh__D017028 Care Giver
% 208.15/208.33  |- skos__hiddenLabel mesh__D017028 Family Caregiver
% 208.15/208.33  |- mesh__dateCreated mesh__D017028 1991-05-30
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D017028 2006
% 208.15/208.33  |- skos__broader mesh__D017028smesh__D009272
% 208.15/208.33  |- mesh__recordMaintainer mesh__D017028 mdb
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D017028 2002
% 208.15/208.33  |- skos__broader mesh__D017028smesh__D006282
% 208.15/208.33  |- skos__altLabel mesh__D017028 Care Givers
% 208.15/208.33  |- mesh__recordAuthorizer mesh__D003806 PLS
% 208.15/208.33  |- skos__broader mesh__D003806smesh__D014088
% 208.15/208.33  |- mesh__dateEstablished mesh__D003806 1991-01-01
% 208.15/208.33  |- skos__scopeNote mesh__D003806
% 208.15/208.33       The property of dentin that permits passage of light, heat, cold, and chemical substances. It does not include penetration by microorganisms.%A%    
% 208.15/208.33  |- mesh__publicMeSHNote mesh__D003806
% 208.15/208.33       91; was see under TOOTH PERMEABILITY 1975-90   
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003806 2006
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003806 2002
% 208.15/208.33  |- mesh__historyNote mesh__D003806
% 208.15/208.33       91%28%75%29%; was see under TOOTH PERMEABILITY 1975-90   
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003806 2004
% 208.15/208.33  |- skos__hiddenLabel mesh__D003806 Dentin Permeabilities
% 208.15/208.33  |- mesh__recordMaintainer mesh__D003806 TGC
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003806 2005
% 208.15/208.33  |- mesh__dateCreated mesh__D003806 1999-01-01
% 208.15/208.33  |- mesh__dateRevised mesh__D003806 1996-06-13
% 208.15/208.33  |- rdf__type mesh__D003806sskos__Concept
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003806 2003
% 208.15/208.33  |- mesh__recordOriginator mesh__D003806 NLM
% 208.15/208.33  |- skos__hiddenLabel mesh__D003806 Permeabilities, Dentin
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003806 1999
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003806 2001
% 208.15/208.33  |- skos__hiddenLabel mesh__D003806 Permeability, Dentin
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003806 1997
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003806 2000
% 208.15/208.33  |- skos__annotation mesh__D003806
% 208.15/208.33       IM; coord with permeating substance %28%IM%29% if relevant   
% 208.15/208.33  |- mesh__onlineNote mesh__D003806 search TOOTH PERMEABILITY 1966-74   
% 208.15/208.33  |- skos__prefLabel mesh__D003806 Dentin Permeability
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003806 1998
% 208.15/208.33  |- skos__hiddenLabel mesh__D003008 Sodium, Cloprostenol
% 208.15/208.33  |- skos__prefLabel mesh__D003008 Cloprostenol
% 208.15/208.33  |- skos__historyNote mesh__D003008 Prostaglandins F %28%1975-1977%29%
% 208.15/208.33  |- mesh__recordOriginator mesh__D003008 RLS
% 208.15/208.33  |- skos__scopeNote mesh__D003008
% 208.15/208.33       A synthetic prostaglandin F2alpha analog. The compound has luteolytic effects and is used for the synchronization of estrus in cattle.%A%    
% 208.15/208.33  |- skos__hiddenLabel mesh__D003008 ICI80,966
% 208.15/208.33  |- skos__historyNote mesh__D003008 Prostaglandins F, Synthetic %28%1978%29%
% 208.15/208.33  |- mesh__recordAuthorizer mesh__D003008 sjn
% 208.15/208.33  |- skos__hiddenLabel mesh__D003008 ICI 80,966
% 208.15/208.33  |- skos__altLabel mesh__D003008 Cloprostenol Monosodium Salt
% 208.15/208.33  |- mesh__dateCreated mesh__D003008 1977-12-09
% 208.15/208.33  |- mesh__historyNote mesh__D003008
% 208.15/208.33       91%28%79%29%; was see under PROSTAGLANDINS F, SYNTHETIC 1979-90%A%  
% 208.15/208.33  |- mesh__dateRevised mesh__D003008 2005-06-30
% 208.15/208.33  |- mesh__recordMaintainer mesh__D003008 ssb
% 208.15/208.33  |- skos__broader mesh__D003008smesh__D011461
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D003008 2006
% 208.15/208.33  |- mesh__publicMeSHNote mesh__D003008
% 208.15/208.33       91; was see under PROSTAGLANDINS F, SYNTHETIC 1979-90   
% 208.15/208.33  |- rdf__type mesh__D003008sskos__Concept
% 208.15/208.33  |- mesh__dateEstablished mesh__D003008 1991-01-01
% 208.15/208.33  |- skos__hiddenLabel mesh__D003008 Monosodium Salt, Cloprostenol
% 208.15/208.33  |- skos__hiddenLabel mesh__D003008 Salt, Cloprostenol Monosodium
% 208.15/208.33  |- mesh__dateEstablished mesh__D013436 1965-01-01
% 208.15/208.33  |- mesh__publicMeSHNote mesh__D013436 65   
% 208.15/208.33  |- mesh__recordMaintainer mesh__D013436 TGC
% 208.15/208.33  |- rdf__type mesh__D013436sskos__Concept
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013436 2001
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013436 2004
% 208.15/208.33  |- mesh__historyNote mesh__D013436 65   
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013436 1998
% 208.15/208.33  |- mesh__dateRevised mesh__D013436 1993-06-03
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013436 2002
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013436 2005
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013436 1999
% 208.15/208.33  |- skos__prefLabel mesh__D013436 Sulfhemoglobinemia
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013436 1994
% 208.15/208.33  |- mesh__dateCreated mesh__D013436 1999-01-01
% 208.15/208.33  |- skos__annotation mesh__D013436
% 208.15/208.33       sulfmethemoglobin %28%see Dorland%29% in the blood   
% 208.15/208.33  |- mesh__recordOriginator mesh__D013436 NLM
% 208.15/208.33  |- skos__hiddenLabel mesh__D013436 Sulfhemoglobinemias
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013436 2006
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013436 1995
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013436 1996
% 208.15/208.33  |- skos__scopeNote mesh__D013436
% 208.15/208.33       A morbid condition due to the presence of sulfmethemoglobin in the blood. It is marked by persistent cyanosis, but the blood count does not reveal any special abnormality in the blood. It is thought to be caused by the action of hydrogen sulfide absorbed from the intestine. %28%Stedman, 25th ed%29%%A%    
% 208.15/208.33  |- skos__broader mesh__D013436smesh__D006402
% 208.15/208.33  |- mesh__recordAuthorizer mesh__D013436 PLS
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013436 2000
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013436 2003
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D013436 1997
% 208.15/208.33  |- skos__broader mesh__D018121smesh__D011971
% 208.15/208.33  |- mesh__dateCreated mesh__D018121 1993-06-21
% 208.15/208.33  |- skos__altLabel mesh__D018121 Receptors, Cytokines
% 208.15/208.33  |- skos__scopeNote mesh__D018121
% 208.15/208.33       Cell surface proteins that bind cytokines and trigger intracellular changes influencing the behavior of cells.%A%    
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D018121 2005
% 208.15/208.33  |- skos__altLabel mesh__D018121 Cytokine Receptor
% 208.15/208.33  |- skos__prefLabel mesh__D018121 Receptors, Cytokine
% 208.15/208.33  |- mesh__recordMaintainer mesh__D018121 jmp
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D018121 2006
% 208.15/208.33  |- skos__hiddenLabel mesh__D018121 Cytokines Receptors
% 208.15/208.33  |- skos__historyNote mesh__D018121 Receptors, Immunologic %28%1980-1993%29%
% 208.15/208.33  |- mesh__recordOriginator mesh__D018121 RAZ
% 208.15/208.33  |- rdf__type mesh__D018121sskos__Concept
% 208.15/208.33  |- skos__annotation mesh__D018121 DF: RECEPT CYTOKINE   
% 208.15/208.33  |- skos__hiddenLabel mesh__D018121 Receptor, Cytokine
% 208.15/208.33  |- mesh__dateEstablished mesh__D018121 1994-01-01
% 208.15/208.33  |- skos__altLabel mesh__D018121 Cytokine Receptors
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D018121 2004
% 208.15/208.33  |- mesh__recordAuthorizer mesh__D018121 sjn
% 208.15/208.33  |- mesh__historyNote mesh__D018121 94   
% 208.15/208.33  |- mesh__dateRevised mesh__D018121 2003-07-09
% 208.15/208.33  |- mesh__publicMeSHNote mesh__D018121 94   
% 208.15/208.33  |- skos__broader mesh__D004101smesh__D001580
% 208.15/208.33  |- mesh__recordOriginator mesh__D004101 RLS
% 208.15/208.33  |- mesh__dateRevised mesh__D004101 1999-11-03
% 208.15/208.33  |- skos__prefLabel mesh__D004101 Dihydroxydihydrobenzopyrenes
% 208.15/208.33  |- mesh__dateCreated mesh__D004101 1986-04-09
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D004101 2005
% 208.15/208.33  |- rdf__type mesh__D004101sskos__Concept
% 208.15/208.33  |- mesh__publicMeSHNote mesh__D004101 87   
% 208.15/208.33  |- mesh__recordMaintainer mesh__D004101 adp
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D004101 2003
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D004101 2006
% 208.15/208.33  |- skos__scopeNote mesh__D004101
% 208.15/208.33       Benzopyrenes saturated in any two adjacent positions and substituted with two hydroxyl groups in any position. The majority of these compounds have carcinogenic or mutagenic activity.%A%    
% 208.15/208.33  |- skos__altLabel mesh__D004101 Dihydrodiolbenzopyrenes
% 208.15/208.33  |- skos__hiddenLabel mesh__D004101 Dihydrodiols, Benzopyrene
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D004101 2000
% 208.15/208.33  |- mesh__recordAuthorizer mesh__D004101 sjn
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D004101 2004
% 208.15/208.33  |- skos__hiddenLabel mesh__D004101 Diols, Dihydrobenzopyrene
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D004101 2001
% 208.15/208.33  |- skos__altLabel mesh__D004101 Dihydrobenzopyrene Diols
% 208.15/208.33  |- mesh__historyNote mesh__D004101 87   
% 208.15/208.33  |- skos__altLabel mesh__D004101 Benzopyrene Dihydrodiols
% 208.15/208.33  |- skos__annotation mesh__D004101 carcinogens; D25-26 qualif; DF: DDBPS   
% 208.15/208.33  |- mesh__dateEstablished mesh__D004101 1987-01-01
% 208.15/208.33  |- mesh__activeMeSHYear mesh__D004101 2002
% 208.15/208.33  |- skos__historyNote mesh__D004101 Benzopyrenes %28%1966-1986%29%
% 208.15/208.34  |- skos__hiddenLabel mesh__D009395 Nephritides, Tubulointerstitial
% 208.15/208.34  |- skos__prefLabel mesh__D009395 Nephritis, Interstitial
% 208.15/208.34  |- mesh__recordMaintainer mesh__D009395 KEV
% 208.15/208.34  |- mesh__dateEstablished mesh__D009395 1964-01-01
% 208.15/208.34  |- mesh__recordOriginator mesh__D009395 NLM
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D009395 2002
% 208.15/208.34  |- rdf__type mesh__D009395sskos__Concept
% 208.15/208.34  |- mesh__dateRevised mesh__D009395 1999-11-03
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D009395 2001
% 208.15/208.34  |- skos__broader mesh__D009395smesh__D009393
% 208.15/208.34  |- skos__scopeNote mesh__D009395
% 208.15/208.34       Diffuse or local inflammation and edema of the interstitial tissue of the kidney, including the tubules.%A%    
% 208.15/208.34  |- skos__altLabel mesh__D009395 Interstitial Nephritis
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D009395 2004
% 208.15/208.34  |- mesh__dateCreated mesh__D009395 1999-01-01
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D009395 2000
% 208.15/208.34  |- mesh__historyNote mesh__D009395 64   
% 208.15/208.34  |- skos__hiddenLabel mesh__D009395 Tubulointerstitial Nephritides
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D009395 2003
% 208.15/208.34  |- mesh__publicMeSHNote mesh__D009395 64   
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D009395 2006
% 208.15/208.34  |- skos__altLabel mesh__D009395 Tubulointerstitial Nephritis
% 208.15/208.34  |- skos__hiddenLabel mesh__D009395 Interstitial Nephritides
% 208.15/208.34  |- skos__hiddenLabel mesh__D009395 Nephritides, Interstitial
% 208.15/208.34  |- mesh__recordAuthorizer mesh__D009395 sjn
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D009395 2005
% 208.15/208.34  |- skos__altLabel mesh__D017827 Joseph Disease
% 208.15/208.34  |- skos__hiddenLabel mesh__D017827 Machado Joseph Disease Type I
% 208.15/208.34  |- mesh__historyNote mesh__D017827
% 208.15/208.34       94; was see SPINOCEREBELLAR DEGENERATION 1987-93   
% 208.15/208.34  |- skos__hiddenLabel mesh__D017827 Disease, Joseph Azorean
% 208.15/208.34  |- skos__scopeNote mesh__D017827
% 208.15/208.34       A dominantly-inherited ATAXIA first described in people of Azorean and Portuguese descent, and subsequently identified in Brazil, Japan, China, and Australia. This disorder is classified as one of the SPINOCEREBELLAR ATAXIAS %28%Type 3%29% and has been associated with a mutation of the MJD1 gene on chromosome 14. Clinical features include progressive ataxia, DYSARTHRIA, postural instability, nystagmus, eyelid retraction, and facial FASCICULATIONS. DYSTONIA is prominent in younger patients %28%referred to as Type I Machado-Joseph Disease%29%. Type II features ataxia and ocular signs; Type III features MUSCULAR ATROPHY and a sensorimotor neuropathy; and Type IV features extrapyramidal signs combined with a sensorimotor neuropathy. %28%From Clin Neurosci 1995;3%28%1%29%:17-22; Ann Neurol 1998 Mar;43%28%3%29%:288-96%29%%A%    
% 208.15/208.34  |- mesh__onlineNote mesh__D017827
% 208.15/208.34       use SPINOCEREBELLAR DEGENERATION to search MACHADO-JOSEPH DISEASE 1987-93%A%  
% 208.15/208.34  |- skos__hiddenLabel mesh__D017827 Machado Joseph Disease Type II
% 208.15/208.34  |- skos__hiddenLabel mesh__D017827 Type III Machado Joseph Disease
% 208.15/208.34  |- skos__hiddenLabel mesh__D017827 Type II Machado Joseph Disease
% 208.15/208.34  |- skos__altLabel mesh__D017827 Type 3 Spinocerebellar Ataxia
% 208.15/208.34  |- skos__altLabel mesh__D017827 Joseph Azorean Disease
% 208.15/208.34  |- skos__hiddenLabel mesh__D017827 Diseases, Azorean %28%Machado-Joseph%29%
% 208.15/208.34  |- skos__altLabel mesh__D017827 Azorean Disease
% 208.15/208.34  |- skos__altLabel mesh__D017827 Nervous System Azorean Disease
% 208.15/208.34  |- skos__altLabel mesh__D017827 Azorean Disease %28%Machado-Joseph%29%
% 208.15/208.34  |- skos__hiddenLabel mesh__D017827 Machado Joseph Disease Type III
% 208.15/208.34  |- skos__hiddenLabel mesh__D017827 Disease, Azorean %28%Machado-Joseph%29%
% 208.15/208.34  |- mesh__recordMaintainer mesh__D017827 nns
% 208.15/208.34  |- skos__hiddenLabel mesh__D017827 Disease, Machado-Joseph Azorean
% 208.15/208.34  |- skos__broader mesh__D017827smesh__D020754
% 208.15/208.34  |- mesh__publicMeSHNote mesh__D017827
% 208.15/208.34       94; was see SPINOCEREBELLAR DEGENERATION 1987-93   
% 208.15/208.34  |- skos__historyNote mesh__D017827
% 208.15/208.34       Spinocerebellar Degeneration %28%1986-1993%29%
% 208.15/208.34  |- skos__hiddenLabel mesh__D017827 Type IV Machado Joseph Disease
% 208.15/208.34  |- skos__altLabel mesh__D017827 Type I Machado-Joseph Disease
% 208.15/208.34  |- skos__historyNote mesh__D017827 Cerebellar Ataxia %28%1980-1986%29%
% 208.15/208.34  |- mesh__dateRevised mesh__D017827 2005-06-30
% 208.15/208.34  |- skos__altLabel mesh__D017827
% 208.15/208.34       Striatonigral Degeneration, Autosomal Dominant
% 208.15/208.34  |- skos__hiddenLabel mesh__D017827 Azorean Diseases %28%Machado-Joseph%29%
% 208.15/208.34  |- skos__hiddenLabel mesh__D017827 Disease, Joseph
% 208.15/208.34  |- skos__altLabel mesh__D017827 Azorean Disease, Nervous System
% 208.15/208.34  |- mesh__recordOriginator mesh__D017827 TGC
% 208.15/208.34  |- rdf__type mesh__D017827sskos__Concept
% 208.15/208.34  |- skos__altLabel mesh__D017827
% 208.15/208.34       Autosomal Dominant Striatonigral Degeneration
% 208.15/208.34  |- skos__hiddenLabel mesh__D017827 Machado Joseph Disease
% 208.15/208.34  |- mesh__dateCreated mesh__D017827 1993-02-16
% 208.15/208.34  |- skos__altLabel mesh__D017827 Type III Machado-Joseph Disease
% 208.15/208.34  |- skos__prefLabel mesh__D017827 Machado-Joseph Disease
% 208.15/208.34  |- skos__hiddenLabel mesh__D017827 Type I Machado Joseph Disease
% 208.15/208.34  |- skos__hiddenLabel mesh__D017827 Spinocerebellar Ataxia 3
% 208.15/208.34  |- skos__hiddenLabel mesh__D017827 Machado Joseph Disease Type IV
% 208.15/208.34  |- skos__hiddenLabel mesh__D017827 Azorean Disease %28%Machado Joseph%29%
% 208.15/208.34  |- skos__altLabel mesh__D017827 Spinocerebellar Ataxia Type 3
% 208.15/208.34  |- mesh__recordAuthorizer mesh__D017827 sjn
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D017827 2006
% 208.15/208.34  |- skos__hiddenLabel mesh__D017827 Disease, Machado-Joseph
% 208.15/208.34  |- skos__hiddenLabel mesh__D017827 Disease, Azorean
% 208.15/208.34  |- skos__altLabel mesh__D017827 Spinocerebellar Ataxia-3
% 208.15/208.34  |- mesh__dateEstablished mesh__D017827 1994-01-01
% 208.15/208.34  |- skos__altLabel mesh__D017827 Type II Machado-Joseph Disease
% 208.15/208.34  |- skos__hiddenLabel mesh__D017827 Machado Joseph Azorean Disease
% 208.15/208.34  |- skos__altLabel mesh__D017827 Type IV Machado-Joseph Disease
% 208.15/208.34  |- skos__altLabel mesh__D017827 Machado-Joseph Azorean Disease
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D017029 2006
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D017029 2001
% 208.15/208.34  |- skos__altLabel mesh__D017029 Disorder, Complex Partial Seizures
% 208.15/208.34  |- skos__altLabel mesh__D017029 Symptomatic Partial Complex Epilepsy
% 208.15/208.34  |- mesh__dateCreated mesh__D017029 1991-05-30
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D017029 2004
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D017029 2005
% 208.15/208.34  |- skos__altLabel mesh__D017029 Complex Partial Epilepsy
% 208.15/208.34  |- skos__altLabel mesh__D017029 Epilepsy, Cryptogenic, Partial Complex
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D017029 2000
% 208.15/208.34  |- skos__historyNote mesh__D017029
% 208.15/208.34       Epilepsy, Temporal Lobe %28%1979-1991%29%
% 208.15/208.34  |- mesh__dateEstablished mesh__D017029 1992-01-01
% 208.15/208.34  |- skos__altLabel mesh__D017029 Complex Partial Seizure Disorder
% 208.15/208.34  |- rdf__type mesh__D017029sskos__Concept
% 208.15/208.34  |- skos__altLabel mesh__D017029 Partial Complex Epilepsy, Cryptogenic
% 208.15/208.34  |- mesh__publicMeSHNote mesh__D017029
% 208.15/208.34       1992; see EPILEPSY, TEMPORAL LOBE 1977-1991; for EPILEPSY, PSYCHIC EQUIVALENT see EPILEPSY, TEMPORAL LOBE 1975-1991; for EPILEPSY, PSYCHOMOTOR see EPILEPSY, TEMPORAL LOBE 1964-1991%A%  
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D017029 2003
% 208.15/208.34  |- mesh__recordAuthorizer mesh__D017029 ags
% 208.15/208.34  |- skos__altLabel mesh__D017029 Seizure Disorder, Complex Partial
% 208.15/208.34  |- mesh__dateRevised mesh__D017029 1999-12-09
% 208.15/208.34  |- skos__altLabel mesh__D017029 Partial Complex Epilepsy, Symptomatic
% 208.15/208.34  |- mesh__historyNote mesh__D017029
% 208.15/208.34       1992; use EPILEPSY, TEMPORAL LOBE 1977-1991; for EPILEPSY, PSYCHIC EQUIVALENT use EPILEPSY, TEMPORAL LOBE 1975-1991; for EPILEPSY, PSYCHOMOTOR use EPILEPSY, TEMPORAL LOBE 1964-1991%A%  
% 208.15/208.34  |- skos__annotation mesh__D017029
% 208.15/208.34       do not confuse with EPILEPSY, SIMPLE PARTIAL see EPILEPSIES, PARTIAL%A%  
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D017029 2002
% 208.15/208.34  |- skos__hiddenLabel mesh__D017029 Psychomotor Epilepsy
% 208.15/208.34  |- skos__prefLabel mesh__D017029 Epilepsy, Complex Partial
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D017029 2000A
% 208.15/208.34  |- skos__hiddenLabel mesh__D017029 Partial Epilepsy, Complex
% 208.15/208.34  |- skos__hiddenLabel mesh__D017029 Psychic Equivalent Epilepsy
% 208.15/208.34  |- skos__scopeNote mesh__D017029
% 208.15/208.34       A disorder characterized by recurrent partial seizures marked by impairment of cognition. During the seizure the individual may experience a wide variety of psychic phenomenon including formed hallucinations, illusions, deja vu, intense emotional feelings, confusion, and spatial disorientation. Focal motor activity, sensory alterations and AUTOMATISM may also occur. Complex partial seizures often originate from foci in one or both temporal lobes. The etiology may be idiopathic %28%cryptogenic partial complex epilepsy%29% or occur as a secondary manifestation of a focal cortical lesion %28%symptomatic partial complex epilepsy%29%. %28%From Adams et al., Principles of Neurology, 6th ed, pp317-8%29%%A%    
% 208.15/208.34  |- skos__broader mesh__D017029smesh__D004828
% 208.15/208.34  |- skos__altLabel mesh__D017029 Epilepsy, Psychomotor
% 208.15/208.34  |- skos__altLabel mesh__D017029 Epilepsy, Psychic Equivalent
% 208.15/208.34  |- mesh__recordOriginator mesh__D017029 MXR
% 208.15/208.34  |- mesh__recordMaintainer mesh__D017029 ags
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003807 2005
% 208.15/208.34  |- mesh__publicMeSHNote mesh__D003807 65   
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003807 2001
% 208.15/208.34  |- mesh__recordOriginator mesh__D003807 NLM
% 208.15/208.34  |- skos__hiddenLabel mesh__D003807 Hypersensitivity, Dentin
% 208.15/208.34  |- skos__broader mesh__D003807smesh__D014076
% 208.15/208.34  |- skos__hiddenLabel mesh__D003807 Dentin Hypersensitivities
% 208.15/208.34  |- mesh__dateCreated mesh__D003807 1999-01-01
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003807 2003
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003807 2006
% 208.15/208.34  |- mesh__recordMaintainer mesh__D003807 TGC
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003807 2002
% 208.15/208.34  |- skos__hiddenLabel mesh__D003807 Sensitivities, Dentin
% 208.15/208.34  |- skos__hiddenLabel mesh__D003807 Sensitivity, Dentin
% 208.15/208.34  |- mesh__dateEstablished mesh__D003807 1965-01-01
% 208.15/208.34  |- skos__altLabel mesh__D003807 Dentin Hypersensitivity
% 208.15/208.34  |- skos__annotation mesh__D003807 note category   
% 208.15/208.34  |- skos__hiddenLabel mesh__D003807 Hypersensitivities, Dentin
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003807 2004
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003807 1998
% 208.15/208.34  |- mesh__recordAuthorizer mesh__D003807 SJN
% 208.15/208.34  |- rdf__type mesh__D003807sskos__Concept
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003807 1999
% 208.15/208.34  |- skos__prefLabel mesh__D003807 Dentin Sensitivity
% 208.15/208.34  |- mesh__historyNote mesh__D003807 65   
% 208.15/208.34  |- skos__hiddenLabel mesh__D003807 Dentin Sensitivities
% 208.15/208.34  |- mesh__dateRevised mesh__D003807 1997-06-20
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003807 2000
% 208.15/208.34  |- mesh__dateCreated mesh__D003009 1974-11-11
% 208.15/208.34  |- skos__hiddenLabel mesh__D003009 Chlorazepate, Dipotassium
% 208.15/208.34  |- skos__broader mesh__D003009smesh__D001569
% 208.15/208.34  |- skos__scopeNote mesh__D003009
% 208.15/208.34       A water-soluble benzodiazepine derivative effective in the treatment of anxiety. It has also muscle relaxant and anticonvulsant actions.%A%    
% 208.15/208.34  |- skos__altLabel mesh__D003009 Dipotassium Chlorazepate
% 208.15/208.34  |- mesh__recordMaintainer mesh__D003009 ssb
% 208.15/208.34  |- skos__hiddenLabel mesh__D003009 Monopotassium, Clorazepate
% 208.15/208.34  |- skos__historyNote mesh__D003009 Benzazepines %28%1971-1974%29%
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003009 2005
% 208.15/208.34  |- mesh__dateRevised mesh__D003009 2003-07-09
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003009 2004
% 208.15/208.34  |- skos__historyNote mesh__D003009 Carboxylic Acids %28%1971-1974%29%
% 208.15/208.34  |- mesh__historyNote mesh__D003009
% 208.15/208.34       91%28%75%29%; was see under BENZODIAZEPINE TRANQUILIZERS 1975-90%A%  
% 208.15/208.34  |- mesh__recordOriginator mesh__D003009 NLM
% 208.15/208.34  |- skos__prefLabel mesh__D003009 Clorazepate Dipotassium
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003009 2006
% 208.15/208.34  |- rdf__type mesh__D003009sskos__Concept
% 208.15/208.34  |- mesh__publicMeSHNote mesh__D003009
% 208.15/208.34       91; was see under BENZODIAZEPINE TRANQUILIZERS 1975-90   
% 208.15/208.34  |- mesh__recordAuthorizer mesh__D003009 sjn
% 208.15/208.34  |- mesh__dateEstablished mesh__D003009 1991-01-01
% 208.15/208.34  |- skos__hiddenLabel mesh__D003009 Dipotassium, Clorazepate
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D013437 2004
% 208.15/208.34  |- mesh__dateEstablished mesh__D013437 1991-01-01
% 208.15/208.34  |- skos__broader mesh__D013437smesh__D008190
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D013437 2005
% 208.15/208.34  |- mesh__dateRevised mesh__D013437 2003-07-09
% 208.15/208.34  |- mesh__historyNote mesh__D013437 98%28%75%29%   
% 208.15/208.34  |- skos__hiddenLabel mesh__D013437 Carbon Sulfur Lyases
% 208.15/208.34  |- mesh__dateCreated mesh__D013437 1999-01-01
% 208.15/208.34  |- skos__altLabel mesh__D013437 Sulfhydrases
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D013437 2006
% 208.15/208.34  |- skos__hiddenLabel mesh__D013437 Lyases, Carbon-Sulfur
% 208.15/208.34  |- mesh__recordMaintainer mesh__D013437 ssb
% 208.15/208.34  |- skos__annotation mesh__D013437 DF: C S LYASES   
% 208.15/208.34  |- mesh__publicMeSHNote mesh__D013437
% 208.15/208.34       98; see SULFHYDRASES 1991-97, see LYASES 1975-90   
% 208.15/208.34  |- mesh__recordOriginator mesh__D013437 NLM
% 208.15/208.34  |- mesh__recordAuthorizer mesh__D013437 sjn
% 208.15/208.34  |- skos__prefLabel mesh__D013437 Carbon-Sulfur Lyases
% 208.15/208.34  |- skos__scopeNote mesh__D013437
% 208.15/208.34       Enzymes that catalyze the cleavage of a carbon-sulfur bond by means other than hydrolysis or oxidation. EC 4.4.%A%    
% 208.15/208.34  |- rdf__type mesh__D013437sskos__Concept
% 208.15/208.34  |- skos__annotation mesh__D018920
% 208.15/208.34       NIM; specify cell or tissue %26% infecting organism if relevant, probably NIM%A%  
% 208.15/208.34  |- mesh__recordAuthorizer mesh__D018920 sjn
% 208.15/208.34  |- skos__altLabel mesh__D018920 Co-culture
% 208.15/208.34  |- mesh__dateRevised mesh__D018920 2004-07-13
% 208.15/208.34  |- mesh__historyNote mesh__D018920 2005 %28%1996%29%   
% 208.15/208.34  |- skos__historyNote mesh__D018920 Cells, Cultured %28%1979-1995%29%
% 208.15/208.34  |- skos__hiddenLabel mesh__D018920 Cocultivations
% 208.15/208.34  |- skos__prefLabel mesh__D018920 Coculture Techniques
% 208.15/208.34  |- skos__altLabel mesh__D018920 Cocultivation
% 208.15/208.34  |- mesh__recordOriginator mesh__D018920 AGS
% 208.15/208.34  |- skos__hiddenLabel mesh__D018920 Co culture
% 208.15/208.34  |- mesh__publicMeSHNote mesh__D018920 2005; see COCULTURE 1996-2004   
% 208.15/208.34  |- skos__related mesh__D018920smesh__D002478
% 208.15/208.34  |- skos__broader mesh__D018920smesh__D046508
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D018920 2005
% 208.15/208.34  |- skos__historyNote mesh__D018920 Tissue Culture %28%1974-1995%29%
% 208.15/208.34  |- mesh__dateCreated mesh__D018920 1995-01-06
% 208.15/208.34  |- rdf__type mesh__D018920sskos__Concept
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D018920 2006
% 208.15/208.34  |- skos__related mesh__D018920smesh__D014407
% 208.15/208.34  |- skos__hiddenLabel mesh__D018920 Coculture Technique
% 208.15/208.34  |- skos__hiddenLabel mesh__D018920 Co-cultures
% 208.15/208.34  |- skos__altLabel mesh__D018920 Coculture
% 208.15/208.34  |- skos__hiddenLabel mesh__D018920 Cocultures
% 208.15/208.34  |- mesh__dateEstablished mesh__D018920 1996-01-01
% 208.15/208.34  |- skos__scopeNote mesh__D018920
% 208.15/208.34       A technique of culturing mixed cell types in vitro to allow their synergistic or antagonistic interactions, such as on CELL DIFFERENTIATION or APOPTOSIS. Coculture can be of different types of cells, tissues, or organs from normal or disease states.%A%    
% 208.15/208.34  |- mesh__recordMaintainer mesh__D018920 sjn
% 208.15/208.34  |- skos__prefLabel mesh__D018122 Antigens, CD80
% 208.15/208.34  |- skos__scopeNote mesh__D018122
% 208.15/208.34       The natural ligand for the T-cell antigen CD28; %28%ANTIGENS, CD28%29%; mediating T- and B-cell adhesion. CD80 is expressed on activated B-cells and gamma-interferon-stimulated monocytes. The binding of CD80 to CD28 and CTLA-4 provides a co-stimulatory signal to T-cells and leads to greatly upregulated lymphokine production.%A%    
% 208.15/208.34  |- skos__altLabel mesh__D018122 Antigen, B7-1
% 208.15/208.34  |- skos__altLabel mesh__D018122 B7-1 Costimulatory Molecule
% 208.15/208.34  |- skos__altLabel mesh__D018122 B-Cell Activation Antigen
% 208.15/208.34  |- skos__broader mesh__D018122smesh__D015703
% 208.15/208.34  |- skos__altLabel mesh__D018122 CD80 Antigens
% 208.15/208.34  |- mesh__onlineNote mesh__D018122
% 208.15/208.34       use ANTIGENS, CD80 %28%NM%29% to search B7-1 PROTEIN 1994-95 %26% B CELL ACTIVATION ANTIGEN B7 1991-93%A%  
% 208.15/208.34  |- mesh__recordAuthorizer mesh__D018122 sjn
% 208.15/208.34  |- skos__altLabel mesh__D018122 B7 Antigen
% 208.15/208.34  |- skos__altLabel mesh__D018122 CD80 Antigen
% 208.15/208.34  |- mesh__recordOriginator mesh__D018122 AGS
% 208.15/208.34  |- skos__hiddenLabel mesh__D018122 B7 1 Costimulatory Molecule
% 208.15/208.34  |- mesh__dateEstablished mesh__D018122 1994-01-01
% 208.15/208.34  |- mesh__publicMeSHNote mesh__D018122
% 208.15/208.34       96; was B-CELL ACTIVATION ANTIGEN 1994-95; B7-1 PROTEIN was indexed under B-CELL ACTIVATION ANTIGEN 1994-95; B CELL ACTIVATION ANTIGEN B7 was indexed under ANTIGENS, SURFACE 1991-93%A%  
% 208.15/208.34  |- mesh__dateRevised mesh__D018122 2005-06-30
% 208.15/208.34  |- skos__historyNote mesh__D018122 Antigens, Surface %28%1991-1993%29%
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D018122 2006
% 208.15/208.34  |- mesh__dateCreated mesh__D018122 1993-06-04
% 208.15/208.34  |- skos__hiddenLabel mesh__D018122 B7 1 Antigen
% 208.15/208.34  |- skos__hiddenLabel mesh__D018122 B Cell Activation Antigen
% 208.15/208.34  |- mesh__historyNote mesh__D018122
% 208.15/208.34       96; was B-CELL ACTIVATION ANTIGEN 1994-95; was B CELL ACTIVATION ANTIGEN B7 %28%NM%29% 1991-93; B7-1 COSTIMULATORY MOLECULE was B7-1 PROTEIN %28%NM%29% 1994-95%A%  
% 208.15/208.34  |- mesh__recordMaintainer mesh__D018122 ssb
% 208.15/208.34  |- rdf__type mesh__D018122sskos__Concept
% 208.15/208.34  |- skos__hiddenLabel mesh__D018122 Costimulatory Molecule, B7-1
% 208.15/208.34  |- skos__hiddenLabel mesh__D018122 Antigen, B7 1
% 208.15/208.34  |- skos__altLabel mesh__D018122 B7-1 Antigen
% 208.15/208.34  |- mesh__recordMaintainer mesh__D004900 nns
% 208.15/208.34  |- mesh__publicMeSHNote mesh__D004900
% 208.15/208.34       84; was see under ERYTHROCYTES 1975-83   
% 208.15/208.34  |- skos__scopeNote mesh__D004900
% 208.15/208.34       Immature, nucleated ERYTHROCYTES occupying the stage of ERYTHROPOIESIS that follows formation of ERYTHROID PROGENITOR CELLS and precedes formation of RETICULOCYTES. Popularly called normoblasts.%A%    
% 208.15/208.34  |- skos__hiddenLabel mesh__D004900 Erythrocyte, Nucleated
% 208.15/208.34  |- skos__hiddenLabel mesh__D004900 Erythroblast
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D004900 2005
% 208.15/208.34  |- skos__hiddenLabel mesh__D004900 Normoblast
% 208.15/208.34  |- mesh__dateCreated mesh__D004900 1974-11-11
% 208.15/208.34  |- mesh__recordOriginator mesh__D004900 NLM
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D004900 2006
% 208.15/208.34  |- mesh__recordAuthorizer mesh__D004900 sjn
% 208.15/208.34  |- skos__altLabel mesh__D004900 Erythrocytes, Nucleated
% 208.15/208.34  |- skos__hiddenLabel mesh__D004900 Nucleated Erythrocytes
% 208.15/208.34  |- skos__hiddenLabel mesh__D004900 Proerythroblast
% 208.15/208.34  |- skos__prefLabel mesh__D004900 Erythroblasts
% 208.15/208.34  |- skos__historyNote mesh__D004900 Erythrocytes %28%1966-1974%29%
% 208.15/208.34  |- rdf__type mesh__D004900sskos__Concept
% 208.15/208.34  |- skos__broader mesh__D004900smesh__D015672
% 208.15/208.34  |- skos__hiddenLabel mesh__D004900 Pronormoblast
% 208.15/208.34  |- mesh__historyNote mesh__D004900
% 208.15/208.34       84%28%75%29%; was see under ERYTHROCYTES 1975-83   
% 208.15/208.34  |- skos__hiddenLabel mesh__D004900 Nucleated Erythrocyte
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D004900 2004
% 208.15/208.34  |- skos__altLabel mesh__D004900 Normoblasts
% 208.15/208.34  |- skos__altLabel mesh__D004900 Pronormoblasts
% 208.15/208.34  |- mesh__dateRevised mesh__D004900 2003-07-09
% 208.15/208.34  |- mesh__dateEstablished mesh__D004900 1984-01-01
% 208.15/208.34  |- skos__hiddenLabel mesh__D051556 Hyperbilirubinemia, Neonatal Direct
% 208.15/208.34  |- mesh__recordMaintainer mesh__D051556 lkt
% 208.15/208.34  |- skos__scopeNote mesh__D051556
% 208.15/208.34       Accumulation of BILIRUBIN, a breakdown product of HEME PROTEINS, in the BLOOD during the first weeks of life. This may lead to NEONATAL JAUNDICE. The excess bilirubin may exist in the unconjugated %28%indirect%29% or the conjugated %28%direct%29% form. The condition may be self-limiting %28%PHYSIOLOGICAL NEONATAL JAUNDICE%29% or pathological with toxic levels of bilirubin.%A%    
% 208.15/208.34  |- mesh__historyNote mesh__D051556
% 208.15/208.34       2006; use JAUNDICE, NEONATAL 1976-2005   
% 208.15/208.34  |- skos__annotation mesh__D051556 check the tag, INFANT, NEWBORN   
% 208.15/208.34  |- skos__broader mesh__D051556smesh__D006932
% 208.15/208.34  |- mesh__dateCreated mesh__D051556 2005-06-30
% 208.15/208.34  |- skos__broader mesh__D051556smesh__D007232
% 208.15/208.34  |- skos__related mesh__D051556smesh__D007567
% 208.15/208.34  |- skos__hiddenLabel mesh__D051556 Hyperbilirubinemia, Neonatal Indirect
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D051556 2006
% 208.15/208.34  |- skos__hiddenLabel mesh__D051556 Neonatal Indirect Hyperbilirubinemia
% 208.15/208.34  |- skos__hiddenLabel mesh__D051556 Neonatal Direct Hyperbilirubinemia
% 208.15/208.34  |- mesh__publicMeSHNote mesh__D051556
% 208.15/208.34       2006; see JAUNDICE, NEONATAL 1976-2005   
% 208.15/208.34  |- mesh__recordAuthorizer mesh__D051556 sjn
% 208.15/208.34  |- skos__prefLabel mesh__D051556 Hyperbilirubinemia, Neonatal
% 208.15/208.34  |- mesh__recordOriginator mesh__D051556 lkt
% 208.15/208.34  |- mesh__dateEstablished mesh__D051556 2006-01-01
% 208.15/208.34  |- skos__altLabel mesh__D051556 Neonatal Hyperbilirubinemia
% 208.15/208.34  |- rdf__type mesh__D051556sskos__Concept
% 208.15/208.34  |- skos__historyNote mesh__D051556 Jaundice, Neonatal %28%1965-2005%29%
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D004102 2002
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D004102 1998
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D004102 2003
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D004102 2006
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D004102 1996
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D004102 1999
% 208.15/208.34  |- mesh__publicMeSHNote mesh__D004102 78   
% 208.15/208.34  |- skos__historyNote mesh__D004102 Tryptamines %28%1966-1977%29%
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D004102 2004
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D004102 1997
% 208.15/208.34  |- skos__broader mesh__D004102smesh__D014363
% 208.15/208.34  |- mesh__dateRevised mesh__D004102 1994-05-24
% 208.15/208.34  |- mesh__recordMaintainer mesh__D004102 TPW
% 208.15/208.34  |- mesh__dateEstablished mesh__D004102 1978-01-01
% 208.15/208.34  |- skos__scopeNote mesh__D004102
% 208.15/208.34       Tryptamine substituted with two hydroxyl groups in any position. Some are cytotoxic serotonin analogs that are preferentially taken up by serotonergic neurons and then destroy those neurons.%A%    
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D004102 2000
% 208.15/208.34  |- mesh__recordOriginator mesh__D004102 SH
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D004102 2001
% 208.15/208.34  |- mesh__historyNote mesh__D004102 78   
% 208.15/208.34  |- mesh__recordAuthorizer mesh__D004102 PLS
% 208.15/208.34  |- mesh__dateCreated mesh__D004102 1977-04-22
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D004102 1995
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D004102 2005
% 208.15/208.34  |- skos__prefLabel mesh__D004102 Dihydroxytryptamines
% 208.15/208.34  |- rdf__type mesh__D004102sskos__Concept
% 208.15/208.34  |- skos__hiddenLabel mesh__D009396 Wilm Tumor
% 208.15/208.34  |- mesh__recordAuthorizer mesh__D009396 sjn
% 208.15/208.34  |- skos__hiddenLabel mesh__D009396 Wilm%27%s Tumor
% 208.15/208.34  |- mesh__dateRevised mesh__D009396 2005-06-30
% 208.15/208.34  |- rdf__type mesh__D009396sskos__Concept
% 208.15/208.34  |- skos__broader mesh__D009396smesh__D018193
% 208.15/208.34  |- skos__annotation mesh__D009396
% 208.15/208.34       coordinate IM with KIDNEY NEOPLASMS %28%IM%29%; /genet: consider also GENES, WILMS TUMOR%A%  
% 208.15/208.34  |- mesh__recordMaintainer mesh__D009396 lkt
% 208.15/208.34  |- mesh__recordOriginator mesh__D009396 NLM
% 208.15/208.34  |- mesh__dateCreated mesh__D009396 1999-01-01
% 208.15/208.34  |- skos__hiddenLabel mesh__D009396 Tumor, Wilms
% 208.15/208.34  |- skos__hiddenLabel mesh__D009396 Nephroblastomas
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D009396 2006
% 208.15/208.34  |- skos__related mesh__D009396smesh__D016162
% 208.15/208.34  |- skos__altLabel mesh__D009396 Wilms%27% Tumor
% 208.15/208.34  |- skos__related mesh__D009396smesh__D025721
% 208.15/208.34  |- mesh__historyNote mesh__D009396 2006 %28%1963%29%   
% 208.15/208.34  |- skos__altLabel mesh__D009396 Nephroblastoma
% 208.15/208.34  |- skos__broader mesh__D009396smesh__D009386
% 208.15/208.34  |- skos__broader mesh__D009396smesh__D007680
% 208.15/208.34  |- skos__hiddenLabel mesh__D009396 Tumor, Wilms%27%
% 208.15/208.34  |- skos__prefLabel mesh__D009396 Wilms Tumor
% 208.15/208.34  |- skos__scopeNote mesh__D009396
% 208.15/208.34       A malignant kidney tumor, caused by the uncontrolled multiplication of renal stem %28%blastemal%29%, stromal %28%STROMAL CELLS%29%, and epithelial %28%EPITHELIAL CELLS%29% elements. However, not all three are present in every case. Several genes or chromosomal areas have been associated with Wilms tumor which is usually found in childhood as a firm lump in a child%27%s side or ABDOMEN.%A%    
% 208.15/208.34  |- mesh__publicMeSHNote mesh__D009396
% 208.15/208.34       2006; see NEPHROBLASTOMA 1994-2005, WILMS%27% TUMOR 1991-1993, see NEPHROBLASTOMA 1963-1990%A%  
% 208.15/208.34  |- skos__altLabel mesh__D017828 Gr%C3%%BC%nenthal Brand of Rifabutin
% 208.15/208.34  |- rdf__type mesh__D017828sskos__Concept
% 208.15/208.34  |- mesh__dateCreated mesh__D017828 1993-06-04
% 208.15/208.34  |- mesh__publicMeSHNote mesh__D017828
% 208.15/208.34       94; RIFABUTINE was indexed under RIFAMYCINS 1981-93   
% 208.15/208.34  |- skos__prefLabel mesh__D017828 Rifabutin
% 208.15/208.34  |- mesh__recordOriginator mesh__D017828 TPW
% 208.15/208.34  |- skos__historyNote mesh__D017828 Rifamycins %28%1981-1993%29%
% 208.15/208.34  |- skos__broader mesh__D017828smesh__D012294
% 208.15/208.34  |- mesh__onlineNote mesh__D017828
% 208.15/208.34       use RIFABUTIN %28%NM%29% to search RIFABUTINE 1981-93   
% 208.15/208.34  |- skos__altLabel mesh__D017828 Pharmacia Brand of Rifabutin
% 208.15/208.34  |- skos__hiddenLabel mesh__D017828 LM427
% 208.15/208.34  |- skos__scopeNote mesh__D017828
% 208.15/208.34       A broad-spectrum antibiotic that is being used as prophylaxis against disseminated Mycobacterium avium complex infection in HIV-positive patients.%A%    
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D017828 2006
% 208.15/208.34  |- skos__hiddenLabel mesh__D017828 LM 427
% 208.15/208.34  |- skos__altLabel mesh__D017828 Ansatipine
% 208.15/208.34  |- mesh__dateEstablished mesh__D017828 1994-01-01
% 208.15/208.34  |- mesh__dateRevised mesh__D017828 2005-06-30
% 208.15/208.34  |- mesh__recordMaintainer mesh__D017828 CCR
% 208.15/208.34  |- mesh__historyNote mesh__D017828 94; was RIFABUTINE %28%NM%29% 1981-93   
% 208.15/208.34  |- mesh__recordAuthorizer mesh__D017828 sjn
% 208.15/208.34  |- skos__altLabel mesh__D017828 Kenfarma Brand of Rifabutin
% 208.15/208.34  |- skos__altLabel mesh__D017828 Ansamycin
% 208.15/208.34  |- skos__altLabel mesh__D017828 Rifabutine
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003808 2003
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003808 2006
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003808 1994
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003808 2000
% 208.15/208.34  |- skos__hiddenLabel mesh__D003808 Dentin Solubilities
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003808 2004
% 208.15/208.34  |- mesh__publicMeSHNote mesh__D003808 65   
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003808 2001
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003808 1998
% 208.15/208.34  |- mesh__recordOriginator mesh__D003808 NLM
% 208.15/208.34  |- mesh__recordAuthorizer mesh__D003808 PLS
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003808 1995
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003808 1996
% 208.15/208.34  |- rdf__type mesh__D003808sskos__Concept
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003808 1999
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003808 2002
% 208.15/208.34  |- mesh__historyNote mesh__D003808 65   
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003808 1993
% 208.15/208.34  |- skos__hiddenLabel mesh__D003808 Solubilities, Dentin
% 208.15/208.34  |- mesh__dateEstablished mesh__D003808 1965-01-01
% 208.15/208.34  |- skos__broader mesh__D003808smesh__D009063
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003808 1997
% 208.15/208.34  |- skos__prefLabel mesh__D003808 Dentin Solubility
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D003808 2005
% 208.15/208.34  |- mesh__dateRevised mesh__D003808 1992-05-14
% 208.15/208.34  |- mesh__recordMaintainer mesh__D003808 TAP
% 208.15/208.34  |- skos__hiddenLabel mesh__D003808 Solubility, Dentin
% 208.15/208.34  |- mesh__dateCreated mesh__D003808 1999-01-01
% 208.15/208.34  |- skos__scopeNote mesh__D014530
% 208.15/208.34       A uracil nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety.%A%    
% 208.15/208.34  |- mesh__dateRevised mesh__D014530 1999-11-08
% 208.15/208.34  |- skos__broader mesh__D014530smesh__D014500
% 208.15/208.34  |- mesh__dateEstablished mesh__D014530 1991-01-01
% 208.15/208.34  |- mesh__recordMaintainer mesh__D014530 adp
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D014530 2001
% 208.15/208.34  |- mesh__publicMeSHNote mesh__D014530
% 208.15/208.34       91; was see under URACIL NUCLEOTIDES 1978-90   
% 208.15/208.34  |- mesh__historyNote mesh__D014530
% 208.15/208.34       91%28%78%29%; was see under URACIL NUCLEOTIDES 1978-90   
% 208.15/208.34  |- mesh__activeMeSHYear mesh__D014530 2004
% 208.15/208.35  |- skos__prefLabel mesh__D014530 Uridine Diphosphate
% 208.15/208.35  |- skos__historyNote mesh__D014530 Uracil Nucleotides %28%1966-1977%29%
% 208.15/208.35  |- mesh__recordOriginator mesh__D014530 RLS
% 208.15/208.35  |- rdf__type mesh__D014530sskos__Concept
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D014530 2000
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D014530 2003
% 208.15/208.35  |- skos__hiddenLabel mesh__D014530 Diphosphate, Uridine
% 208.15/208.35  |- mesh__dateCreated mesh__D014530 1977-04-22
% 208.15/208.35  |- skos__altLabel mesh__D014530 Uridine Pyrophosphate
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D014530 2006
% 208.15/208.35  |- mesh__recordAuthorizer mesh__D014530 sjn
% 208.15/208.35  |- skos__altLabel mesh__D014530 UDP
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D014530 2002
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D014530 2005
% 208.15/208.35  |- skos__hiddenLabel mesh__D014530 Pyrophosphate, Uridine
% 208.15/208.35  |- skos__hiddenLabel mesh__D000510 Alpha Globulins
% 208.15/208.35  |- mesh__historyNote mesh__D000510
% 208.15/208.35       75; was ALPHA GLOBULIN 1964-74 %28%Prov 1964%29%   
% 208.15/208.35  |- mesh__recordAuthorizer mesh__D000510 sjn
% 208.15/208.35  |- mesh__onlineNote mesh__D000510
% 208.15/208.35       use ALPHA-GLOBULINS to search ALPHA GLOBULIN 1966-74   
% 208.15/208.35  |- mesh__dateRevised mesh__D000510 2000-06-21
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D000510 2006
% 208.15/208.35  |- skos__prefLabel mesh__D000510 Alpha-Globulins
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D000510 2001
% 208.15/208.35  |- skos__altLabel mesh__D000510 Alpha-Globulin
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D000510 2003
% 208.15/208.35  |- skos__broader mesh__D000510smesh__D012712
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D000510 2004
% 208.15/208.35  |- skos__scopeNote mesh__D000510
% 208.15/208.35       Serum proteins that have the most rapid migration during ELECTROPHORESIS. This subgroup of globulins is divided into faster and slower alpha%28%1%29%- and alpha%28%2%29%-globulins.%A%    
% 208.15/208.35  |- mesh__dateCreated mesh__D000510 1999-01-01
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D000510 2002
% 208.15/208.35  |- mesh__recordOriginator mesh__D000510 NLM
% 208.15/208.35  |- mesh__publicMeSHNote mesh__D000510 75; was ALPHA GLOBULIN 1965-74   
% 208.15/208.35  |- skos__hiddenLabel mesh__D000510 Alpha Globulin
% 208.15/208.35  |- mesh__dateEstablished mesh__D000510 1965-01-01
% 208.15/208.35  |- rdf__type mesh__D000510sskos__Concept
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D000510 2005
% 208.15/208.35  |- mesh__recordMaintainer mesh__D000510 adp
% 208.15/208.35  |- skos__annotation mesh__D000510 GEN or unspecified; prefer specifics   
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D013438 2004
% 208.15/208.35  |- skos__annotation mesh__D013438
% 208.15/208.35       do not confuse with SULFHYDRYL REAGENTS; /physiol permitted with only endogenous SH cpds; DF: SULFHYDRYL CPDS%A%  
% 208.15/208.35  |- mesh__recordAuthorizer mesh__D013438 PLS
% 208.15/208.35  |- rdf__type mesh__D013438sskos__Concept
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D013438 2003
% 208.15/208.35  |- mesh__recordOriginator mesh__D013438 NLM
% 208.15/208.35  |- mesh__dateCreated mesh__D013438 1999-01-01
% 208.15/208.35  |- skos__broader mesh__D013438smesh__D013457
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D013438 2002
% 208.15/208.35  |- skos__prefLabel mesh__D013438 Sulfhydryl Compounds
% 208.15/208.35  |- skos__hiddenLabel mesh__D013438 Compounds, Sulfhydryl
% 208.15/208.35  |- skos__hiddenLabel mesh__D013438 Compounds, Mercapto
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D013438 1999
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D013438 2001
% 208.15/208.35  |- mesh__recordMaintainer mesh__D013438 PXP
% 208.15/208.35  |- skos__altLabel mesh__D013438 Mercaptans
% 208.15/208.35  |- skos__scopeNote mesh__D013438 Compounds containing the -SH radical.     
% 208.15/208.35  |- skos__altLabel mesh__D013438 Mercapto Compounds
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D013438 1998
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D013438 2006
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D013438 2000
% 208.15/208.35  |- skos__altLabel mesh__D013438 Thiols
% 208.15/208.35  |- mesh__dateRevised mesh__D013438 1995-05-31
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D013438 1997
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D013438 2005
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D013438 1996
% 208.15/208.35  |- mesh__publicMeSHNote mesh__D018921 96   
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D018921 2002
% 208.15/208.35  |- mesh__dateEstablished mesh__D018921 1996-01-01
% 208.15/208.35  |- skos__prefLabel mesh__D018921 Leukostasis
% 208.15/208.35  |- skos__hiddenLabel mesh__D018921 Syndrome, Leukostasis
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D018921 2003
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D018921 2005
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D018921 2004
% 208.15/208.35  |- mesh__historyNote mesh__D018921 96   
% 208.15/208.35  |- rdf__type mesh__D018921sskos__Concept
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D018921 2006
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D018921 2000
% 208.15/208.35  |- skos__altLabel mesh__D018921 Leukostasis Syndrome
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D018921 1996
% 208.15/208.35  |- skos__annotation mesh__D018921
% 208.15/208.35       note category: abnorm intravasc leukocyte aggreg   
% 208.15/208.35  |- skos__hiddenLabel mesh__D018921 Syndromes, Leukostasis
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D018921 2001
% 208.15/208.35  |- skos__broader mesh__D018921smesh__D007960
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D018921 1998
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D018921 1997
% 208.15/208.35  |- skos__hiddenLabel mesh__D018921 Leukostasis Syndromes
% 208.15/208.35  |- mesh__dateCreated mesh__D018921 1995-01-06
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D018921 1999
% 208.15/208.35  |- skos__scopeNote mesh__D018921
% 208.15/208.35       Abnormal intravascular leukocyte aggregation and clumping often seen in leukemia patients. The brain and lungs are the two most commonly affected organs. This acute syndrome requires aggressive cytoreductive modalities including chemotherapy and/or leukophoresis. It is differentiated from LEUKEMIC INFILTRATION which is a neoplastic process where leukemic cells invade organs.%A%    
% 208.15/208.35  |- skos__hiddenLabel mesh__D018921 Leukostases
% 208.15/208.35  |- skos__altLabel mesh__D018123 Interleukin Receptors
% 208.15/208.35  |- mesh__historyNote mesh__D018123 94   
% 208.15/208.35  |- mesh__publicMeSHNote mesh__D018123 94   
% 208.15/208.35  |- skos__scopeNote mesh__D018123
% 208.15/208.35       Cell surface proteins that bind interleukins and trigger intracellular changes influencing the behavior of cells.%A%    
% 208.15/208.35  |- mesh__recordMaintainer mesh__D018123 jmp
% 208.15/208.35  |- mesh__dateCreated mesh__D018123 1993-06-21
% 208.15/208.35  |- mesh__dateRevised mesh__D018123 2003-07-09
% 208.15/208.35  |- skos__hiddenLabel mesh__D018123 Interleukins Receptors
% 208.15/208.35  |- skos__hiddenLabel mesh__D018123 Receptor, Interleukin
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D018123 2006
% 208.15/208.35  |- mesh__recordOriginator mesh__D018123 RAZ
% 208.15/208.35  |- skos__historyNote mesh__D018123 Receptors, Immunologic %28%1980-1993%29%
% 208.15/208.35  |- skos__broader mesh__D018123smesh__D018121
% 208.15/208.35  |- skos__altLabel mesh__D018123 Interleukin Receptor
% 208.15/208.35  |- mesh__recordAuthorizer mesh__D018123 sjn
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D018123 2005
% 208.15/208.35  |- rdf__type mesh__D018123sskos__Concept
% 208.15/208.35  |- mesh__dateEstablished mesh__D018123 1994-01-01
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D018123 2004
% 208.15/208.35  |- skos__annotation mesh__D018123
% 208.15/208.35       GEN; prefer specific; DF: RECEPT INTERLEUKIN   
% 208.15/208.35  |- skos__prefLabel mesh__D018123 Receptors, Interleukin
% 208.15/208.35  |- skos__altLabel mesh__D018123 Receptors, Interleukins
% 208.15/208.35  |- mesh__recordOriginator mesh__D010140 RC
% 208.15/208.35  |- rdf__type mesh__D010140sskos__Concept
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D010140 1994
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D010140 2004
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D010140 2001
% 208.15/208.35  |- skos__prefLabel mesh__D010140 Pacific Ocean
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D010140 2003
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D010140 1997
% 208.15/208.35  |- mesh__dateEstablished mesh__D010140 1987-01-01
% 208.15/208.35  |- mesh__dateCreated mesh__D010140 1986-04-02
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D010140 2000
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D010140 2006
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D010140 1993
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D010140 1996
% 208.15/208.35  |- mesh__historyNote mesh__D010140 87   
% 208.15/208.35  |- skos__broader mesh__D010140smesh__D009792
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D010140 2005
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D010140 1999
% 208.15/208.35  |- mesh__recordMaintainer mesh__D010140 TGC
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D010140 2002
% 208.15/208.35  |- mesh__dateRevised mesh__D010140 1992-05-15
% 208.15/208.35  |- mesh__recordAuthorizer mesh__D010140 PLS
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D010140 1995
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D010140 1998
% 208.15/208.35  |- skos__annotation mesh__D010140 no qualif   
% 208.15/208.35  |- mesh__dateCreated mesh__D004901 1974-11-11
% 208.15/208.35  |- skos__altLabel mesh__D004901 Monkey, Red
% 208.15/208.35  |- skos__altLabel mesh__D004901 Patas Monkey
% 208.15/208.35  |- mesh__dateRevised mesh__D004901 2005-06-30
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D004901 2006
% 208.15/208.35  |- skos__scopeNote mesh__D004901
% 208.15/208.35       A species of the genus ERYTHROCEBUS, subfamily CERCOPITHECINAE, family CERCOPITHECIDAE. It inhabits the flat open arid country of Africa. It is also known as the patas monkey or the red monkey.%A%    
% 208.15/208.35  |- skos__hiddenLabel mesh__D004901 patas, Erythrocebus
% 208.15/208.35  |- rdf__type mesh__D004901sskos__Concept
% 208.15/208.35  |- mesh__onlineNote mesh__D004901
% 208.15/208.35       use ERYTHROCEBUS PATAS to search PATAS MONKEYS 1975-80   
% 208.15/208.35  |- mesh__dateEstablished mesh__D004901 1991-01-01
% 208.15/208.35  |- mesh__recordOriginator mesh__D004901 NLM
% 208.15/208.35  |- mesh__recordMaintainer mesh__D004901 ags
% 208.15/208.35  |- skos__prefLabel mesh__D004901 Erythrocebus patas
% 208.15/208.35  |- skos__altLabel mesh__D004901 Monkey, Patas
% 208.15/208.35  |- mesh__recordAuthorizer mesh__D004901 sjn
% 208.15/208.35  |- mesh__publicMeSHNote mesh__D004901
% 208.15/208.35       91; was see under CERCOPITHECIDAE 1981-90; was PATAS MONKEYS see under MONKEYS 1975-80%A%  
% 208.15/208.35  |- mesh__historyNote mesh__D004901
% 208.15/208.35       91%28%81%29%; was see under CERCOPITHECIDAE 1981-90; was PATAS MONKEYS see under MONKEYS 1975-80%A%  
% 208.15/208.35  |- skos__altLabel mesh__D004901 Red Monkey
% 208.15/208.35  |- skos__hiddenLabel mesh__D004901 Patas Monkeys
% 208.15/208.35  |- skos__annotation mesh__D004901
% 208.15/208.35       Old World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 208.15/208.35  |- skos__broader mesh__D004901smesh__D016669
% 208.15/208.35  |- skos__hiddenLabel mesh__D004901 Red Monkeys
% 208.15/208.35  |- skos__hiddenLabel mesh__D004901 Monkeys, Red
% 208.15/208.35  |- skos__hiddenLabel mesh__D004901 Monkeys, Patas
% 208.15/208.35  |- skos__broader mesh__D051557smesh__D051536
% 208.15/208.35  |- skos__hiddenLabel mesh__D051557 Hepatocyte Nuclear Factor 4 beta
% 208.15/208.35  |- skos__hiddenLabel mesh__D051557 Transcription Factor, HNF4
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D051557 2006
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D051557 2006B
% 208.15/208.35  |- mesh__dateEstablished mesh__D051557 2006-01-01
% 208.15/208.35  |- mesh__publicMeSHNote mesh__D051557
% 208.15/208.35       2006; HEPATOCYTE NUCLEAR FACTOR 4 was indexed under DNA-BINDING PROTEINS, PHOSPHOPROTEINS %26% TRANSCRIPTION FACTORS 1991-2005%A%  
% 208.15/208.35  |- skos__hiddenLabel mesh__D051557
% 208.15/208.35       Hepatocyte Nuclear Factor Forkhead Homolog 4
% 208.15/208.35  |- skos__hiddenLabel mesh__D051557 Hepatocyte Nuclear Factor 4 alpha
% 208.15/208.35  |- mesh__recordAuthorizer mesh__D051557 ags
% 208.15/208.35  |- skos__scopeNote mesh__D051557
% 208.15/208.35       A subfamily of nuclear receptors that regulate GENETIC TRANSCRIPTION of a diverse group of GENES involved in the synthesis of BLOOD COAGULATION FACTORS; and in GLUCOSE; CHOLESTEROL; and FATTY ACIDS metabolism.%A%    
% 208.15/208.35  |- skos__broader mesh__D051557smesh__D018160
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D051557 2006A
% 208.15/208.35  |- mesh__recordOriginator mesh__D051557 DRC
% 208.15/208.35  |- rdf__type mesh__D051557sskos__Concept
% 208.15/208.35  |- mesh__recordMaintainer mesh__D051557 ags
% 208.15/208.35  |- skos__altLabel mesh__D051557
% 208.15/208.35       Hepatocyte Nuclear Factor-Forkhead Homolog 4
% 208.15/208.35  |- mesh__dateCreated mesh__D051557 2005-06-30
% 208.15/208.35  |- skos__hiddenLabel mesh__D051557 Hepatocyte Nuclear Factor 4 gamma
% 208.15/208.35  |- mesh__historyNote mesh__D051557 2006 %28%1991%29%   
% 208.15/208.35  |- mesh__dateRevised mesh__D051557 2005-08-03
% 208.15/208.35  |- skos__prefLabel mesh__D051557 Hepatocyte Nuclear Factor 4
% 208.15/208.35  |- skos__altLabel mesh__D051557 HNF4 Transcription Factor
% 208.15/208.35  |- mesh__recordAuthorizer mesh__D004103 sjn
% 208.15/208.35  |- mesh__publicMeSHNote mesh__D004103
% 208.15/208.35       91; was DIIODOHYDROXYQUIN 1963-91 %28%see under HYDROXYQUINOLINES 1983-90%29%%A%  
% 208.15/208.35  |- rdf__type mesh__D004103sskos__Concept
% 208.15/208.35  |- mesh__dateCreated mesh__D004103 1999-01-01
% 208.15/208.35  |- skos__scopeNote mesh__D004103
% 208.15/208.35       One of the halogenated 8-quinolinols widely used as an intestinal antiseptic, especially as an antiamebic agent. It is also used topically in other infections and may cause CNS and eye damage. It is known by very many similar trade names world-wide.%A%    
% 208.15/208.35  |- skos__altLabel mesh__D004103 Summers Brand of Iodoquinol
% 208.15/208.35  |- skos__altLabel mesh__D004103 Searle Brand of Iodoquinol
% 208.15/208.35  |- skos__altLabel mesh__D004103 Diiodohydroxyquin
% 208.15/208.35  |- mesh__dateRevised mesh__D004103 2005-06-30
% 208.15/208.35  |- skos__altLabel mesh__D004103 CMC Brand of Iodoquinol
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D004103 2006
% 208.15/208.35  |- skos__altLabel mesh__D004103 Diodoxyquinoline
% 208.15/208.35  |- mesh__recordMaintainer mesh__D004103 exl
% 208.15/208.35  |- skos__altLabel mesh__D004103 Diiodohydroxyquinoline
% 208.15/208.35  |- skos__altLabel mesh__D004103 Diba Brand of Iodoquinol
% 208.15/208.35  |- skos__altLabel mesh__D004103 Glenwood Brand of Iodoquinol
% 208.15/208.35  |- mesh__dateEstablished mesh__D004103 1963-01-01
% 208.15/208.35  |- skos__altLabel mesh__D004103 Serral Brand of Iodoquinol
% 208.15/208.35  |- mesh__recordOriginator mesh__D004103 NLM
% 208.15/208.35  |- skos__prefLabel mesh__D004103 Iodoquinol
% 208.15/208.35  |- mesh__onlineNote mesh__D004103
% 208.15/208.35       use IODOQUINOL to search DIIODOHYDROXYQUIN 1966-90   
% 208.15/208.35  |- mesh__historyNote mesh__D004103
% 208.15/208.35       91%28%83%29%63; was DIIODOHYDROXYQUIN 1963-91 %28%see under HYDROXYQUINOLINES 1983-90%29%%A%  
% 208.15/208.35  |- skos__broader mesh__D004103smesh__D015125
% 208.15/208.35  |- skos__altLabel mesh__D004103 Diodoquin
% 208.15/208.35  |- skos__broader mesh__D018821Q000172smesh__D018821
% 208.15/208.35  |- mesh__preferredCombination mesh__D018821Q000172smesh__D018370
% 208.15/208.35  |- rdf__type mesh__D018821Q000172smesh__CompoundConcept
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D009397 2001
% 208.15/208.35  |- rdf__type mesh__D009397sskos__Concept
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D009397 2003
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D009397 2004
% 208.15/208.35  |- skos__broader mesh__D009397smesh__D007674
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D009397 2005
% 208.15/208.35  |- mesh__recordMaintainer mesh__D009397 TGC
% 208.15/208.35  |- skos__scopeNote mesh__D009397
% 208.15/208.35       A condition characterized by precipitation of calcium phosphate in the tubules of the kidney, with resultant renal insufficiency. %28%Dorland, 27th ed%29%%A%    
% 208.15/208.35  |- skos__annotation mesh__D009397
% 208.15/208.35       calcium phosphate deposition in kidney tubules   
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D009397 2006
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D009397 2002
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D009397 1996
% 208.15/208.35  |- skos__prefLabel mesh__D009397 Nephrocalcinosis
% 208.15/208.35  |- skos__hiddenLabel mesh__D009397 Nephrocalcinoses
% 208.15/208.35  |- mesh__dateRevised mesh__D009397 1993-06-02
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D009397 1997
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D009397 1998
% 208.15/208.35  |- mesh__recordOriginator mesh__D009397 NLM
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D009397 2000
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D009397 1994
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D009397 1999
% 208.15/208.35  |- mesh__recordAuthorizer mesh__D009397 PLS
% 208.15/208.35  |- skos__broader mesh__D009397smesh__D002114
% 208.15/208.35  |- mesh__dateCreated mesh__D009397 1999-01-01
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D009397 1995
% 208.15/208.35  |- mesh__recordMaintainer mesh__D017829 ssb
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D017829 2006
% 208.15/208.35  |- skos__hiddenLabel mesh__D017829 BRL 43694A
% 208.15/208.35  |- mesh__publicMeSHNote mesh__D017829
% 208.15/208.35       94; GRANISETRON was indexed under INDAZOLES 1988-93   
% 208.15/208.35  |- skos__prefLabel mesh__D017829 Granisetron
% 208.15/208.35  |- skos__hiddenLabel mesh__D017829 BRL43694
% 208.15/208.35  |- mesh__dateCreated mesh__D017829 1993-06-04
% 208.15/208.35  |- mesh__historyNote mesh__D017829
% 208.15/208.35       94; was GRANISETRON %28%NM%29% 1988-93   
% 208.15/208.35  |- mesh__recordOriginator mesh__D017829 TPW
% 208.15/208.35  |- skos__hiddenLabel mesh__D017829 BRL 43694
% 208.15/208.35  |- skos__hiddenLabel mesh__D017829 Monohydrochloride, Granisetron
% 208.15/208.35  |- skos__hiddenLabel mesh__D017829 BRL43694A
% 208.15/208.35  |- skos__scopeNote mesh__D017829
% 208.15/208.35       A serotonin receptor %28%5HT-3 selective%29% antagonist that has been used as an antiemetic for cancer chemotherapy patients.%A%    
% 208.15/208.35  |- skos__altLabel mesh__D017829
% 208.15/208.35       1-Methyl-N-%28%endo-9-Methyl-9-Azabicyclo%28%3.3.1%29%non-3-yl%29%-1H-Indazole-3-Carboxamide
% 208.15/208.35  |- skos__broader mesh__D017829smesh__D007191
% 208.15/208.35  |- mesh__dateRevised mesh__D017829 2005-06-30
% 208.15/208.35  |- mesh__dateEstablished mesh__D017829 1994-01-01
% 208.15/208.35  |- skos__hiddenLabel mesh__D017829 Hydrochloride, Granisetron
% 208.15/208.35  |- mesh__onlineNote mesh__D017829
% 208.15/208.35       use GRANISETRON %28%NM%29% to search GRANISETRON 1988-93   
% 208.15/208.35  |- skos__altLabel mesh__D017829 BRL-43694
% 208.15/208.35  |- skos__altLabel mesh__D017829 Granisetron Monohydrochloride
% 208.15/208.35  |- rdf__type mesh__D017829sskos__Concept
% 208.15/208.35  |- skos__historyNote mesh__D017829 Indazoles %28%1988-1993%29%
% 208.15/208.35  |- mesh__recordAuthorizer mesh__D017829 sjn
% 208.15/208.35  |- mesh__dateRevised mesh__D003809 2003-07-09
% 208.15/208.35  |- rdf__type mesh__D003809sskos__Concept
% 208.15/208.35  |- skos__altLabel mesh__D003809 Secondary Dentin
% 208.15/208.35  |- mesh__historyNote mesh__D003809 65   
% 208.15/208.35  |- skos__hiddenLabel mesh__D003809 Secondary Dentins
% 208.15/208.35  |- mesh__recordMaintainer mesh__D003809 lkt
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D003809 2005
% 208.15/208.35  |- skos__broader mesh__D003809smesh__D003804
% 208.15/208.35  |- mesh__dateCreated mesh__D003809 1999-01-01
% 208.15/208.35  |- skos__scopeNote mesh__D003809
% 208.15/208.35       Dentin formed by normal pulp after completion of root end formation.%A%    
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D003809 2006
% 208.15/208.35  |- mesh__publicMeSHNote mesh__D003809 65   
% 208.15/208.35  |- mesh__recordOriginator mesh__D003809 NLM
% 208.15/208.35  |- mesh__dateEstablished mesh__D003809 1965-01-01
% 208.15/208.35  |- skos__prefLabel mesh__D003809 Dentin, Secondary
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D003809 2004
% 208.15/208.35  |- skos__broader mesh__D003809smesh__D003788
% 208.15/208.35  |- skos__hiddenLabel mesh__D003809 Dentins, Secondary
% 208.15/208.35  |- mesh__recordAuthorizer mesh__D003809 sjn
% 208.15/208.35  |- skos__scopeNote mesh__D014531
% 208.15/208.35       A nucleoside diphosphate sugar which can be epimerized into UDPglucose for entry into the mainstream of carbohydrate metabolism. Serves as a source of galactose in the synthesis of lipopolysaccharides, cerebrosides, and lactose.%A%    
% 208.15/208.35  |- skos__hiddenLabel mesh__D014531 Galactose, Uridine Diphosphate
% 208.15/208.35  |- mesh__publicMeSHNote mesh__D014531
% 208.15/208.35       91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90   
% 208.15/208.35  |- skos__altLabel mesh__D014531 UDPGal
% 208.15/208.35  |- mesh__recordOriginator mesh__D014531 NLM
% 208.15/208.35  |- rdf__type mesh__D014531sskos__Concept
% 208.15/208.35  |- mesh__recordMaintainer mesh__D014531 ssb
% 208.15/208.35  |- skos__hiddenLabel mesh__D014531 Pyrophosphogalactose, Uridine
% 208.15/208.35  |- skos__hiddenLabel mesh__D014531 Galactose, UDP
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D014531 2006
% 208.15/208.35  |- skos__hiddenLabel mesh__D014531 Diphosphate Galactose, Uridine
% 208.15/208.35  |- mesh__dateCreated mesh__D014531 1974-11-19
% 208.15/208.35  |- skos__altLabel mesh__D014531 Uridine Diphosphogalactose
% 208.15/208.35  |- skos__historyNote mesh__D014531
% 208.15/208.35       Uridine Diphosphate Sugars %28%1973-1974%29%
% 208.15/208.35  |- skos__hiddenLabel mesh__D014531 Diphosphogalactose, Uridine
% 208.15/208.35  |- skos__altLabel mesh__D014531 UDP Galactose
% 208.15/208.35  |- skos__altLabel mesh__D014531 Uridine Pyrophosphogalactose
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D014531 2005
% 208.15/208.35  |- mesh__dateRevised mesh__D014531 2004-07-07
% 208.15/208.35  |- skos__broader mesh__D014531smesh__D014539
% 208.15/208.35  |- mesh__recordAuthorizer mesh__D014531 sjn
% 208.15/208.35  |- skos__prefLabel mesh__D014531 Uridine Diphosphate Galactose
% 208.15/208.35  |- mesh__historyNote mesh__D014531
% 208.15/208.35       91%28%75%29%; was see under URIDINE DIPHOSPHATE SUGARS 1975-90   
% 208.15/208.35  |- mesh__dateEstablished mesh__D014531 1991-01-01
% 208.15/208.35  |- skos__historyNote mesh__D014531 Galactose %28%1973-1974%29%
% 208.15/208.35  |- skos__historyNote mesh__D000511 Macroglobulins %28%1973-1975%29%
% 208.15/208.35  |- mesh__recordAuthorizer mesh__D000511 PLS
% 208.15/208.35  |- skos__hiddenLabel mesh__D000511 alpha Macrofetoproteins
% 208.15/208.35  |- skos__hiddenLabel mesh__D000511 alpha 2-Macroglobulins, Slow
% 208.15/208.35  |- skos__altLabel mesh__D000511 alpha 2-Acute Phase Globulin
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D000511 1996
% 208.15/208.35  |- skos__hiddenLabel mesh__D000511 Slow alpha 2 Globulin
% 208.15/208.35  |- skos__altLabel mesh__D000511 alpha 2-Glucoprotein
% 208.15/208.35  |- mesh__onlineNote mesh__D000511
% 208.15/208.35       use ALPHA-MACROGLOBULINS to search ALPHA MACROGLOBULINS 1976-95%A%  
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D000511 2006
% 208.15/208.35  |- skos__hiddenLabel mesh__D000511 alpha 2 Glucoproteins
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D000511 2001
% 208.15/208.35  |- mesh__dateEstablished mesh__D000511 1976-01-01
% 208.15/208.35  |- skos__altLabel mesh__D000511 alpha-Macrofetoproteins
% 208.15/208.35  |- mesh__dateRevised mesh__D000511 1995-03-16
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D000511 1999
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D000511 2005
% 208.15/208.35  |- mesh__dateCreated mesh__D000511 1975-07-18
% 208.15/208.35  |- skos__hiddenLabel mesh__D000511 alpha 1-Protein, Acute-Phase
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D000511 2000
% 208.15/208.35  |- skos__broader mesh__D000511smesh__D008259
% 208.15/208.35  |- skos__hiddenLabel mesh__D000511 Acute Phase alpha 1 Protein
% 208.15/208.35  |- mesh__historyNote mesh__D000511 96; was ALPHA MACROGLOBULINS 1976-95   
% 208.15/208.35  |- skos__hiddenLabel mesh__D000511 alpha2 Macroglobulin
% 208.15/208.35  |- skos__broader mesh__D000511smesh__D000209
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D000511 1998
% 208.15/208.35  |- skos__hiddenLabel mesh__D000511 RNP, 45S
% 208.15/208.35  |- skos__hiddenLabel mesh__D000511 alpha 1 Acute Phase Globulin
% 208.15/208.35  |- mesh__publicMeSHNote mesh__D000511
% 208.15/208.35       96; was ALPHA MACROGLOBULINS 1976-95   
% 208.15/208.35  |- skos__historyNote mesh__D000511 alpha Globulins %28%1974-1975%29%
% 208.15/208.35  |- skos__hiddenLabel mesh__D000511 alpha 2 Acute Phase Globulin
% 208.15/208.35  |- skos__altLabel mesh__D000511 Acute-Phase alpha 1-Protein
% 208.15/208.35  |- skos__hiddenLabel mesh__D000511 alpha 1 Acute Phase Protein
% 208.15/208.35  |- mesh__recordOriginator mesh__D000511 RLS
% 208.15/208.35  |- skos__altLabel mesh__D000511 alpha2-Macroglobulin
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D000511 2004
% 208.15/208.35  |- mesh__recordMaintainer mesh__D000511 PLS
% 208.15/208.35  |- skos__hiddenLabel mesh__D000511 alpha Macroglobulins
% 208.15/208.35  |- skos__hiddenLabel mesh__D000511 alpha 2 Acute Phase Globulins
% 208.15/208.35  |- skos__hiddenLabel mesh__D000511 alpha 2-Globulin, Slow
% 208.15/208.35  |- skos__altLabel mesh__D000511 Slow alpha 2-Globulin
% 208.15/208.35  |- skos__broader mesh__D000511smesh__D000510
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D000511 2002
% 208.15/208.35  |- skos__hiddenLabel mesh__D000511 alpha 2 Macroglobulin
% 208.15/208.35  |- skos__hiddenLabel mesh__D000511 Slow alpha 2 Macroglobulins
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D000511 1997
% 208.15/208.35  |- skos__scopeNote mesh__D000511
% 208.15/208.35       Glycoproteins with a molecular weight of approximately 620,000 to 680,000. Precipitation by electrophoresis is in the alpha region. They include alpha 1-macroglobulins and alpha 2-macroglobulins. These proteins exhibit trypsin-, chymotrypsin-, thrombin-, and plasmin-binding activity and function as hormonal transporters.%A%    
% 208.15/208.35  |- skos__hiddenLabel mesh__D000511 alpha 1 Macroglobulin
% 208.15/208.35  |- skos__altLabel mesh__D000511 45S RNP
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D000511 2003
% 208.15/208.35  |- rdf__type mesh__D000511sskos__Concept
% 208.15/208.35  |- skos__hiddenLabel mesh__D000511 alpha 2 Glucoprotein
% 208.15/208.35  |- skos__prefLabel mesh__D000511 alpha-Macroglobulins
% 208.15/208.35  |- skos__hiddenLabel mesh__D000511 alpha Macrofetoprotein
% 208.15/208.35  |- skos__altLabel mesh__D000511 alpha 2-Macroglobulin
% 208.15/208.35  |- skos__altLabel mesh__D038181 NADH-Flavin Oxidoreductase
% 208.15/208.35  |- skos__hiddenLabel mesh__D038181 Reductase, Flavin Mononucleotide
% 208.15/208.35  |- skos__hiddenLabel mesh__D038181 Oxidoreductase, FMN
% 208.15/208.35  |- skos__hiddenLabel mesh__D038181 Reductase, FMN
% 208.15/208.35  |- mesh__dateEstablished mesh__D038181 2003-01-01
% 208.15/208.35  |- skos__altLabel mesh__D038181 FMN Oxidoreductase
% 208.15/208.35  |- mesh__activeMeSHYear mesh__D038181 2006
% 208.15/208.35  |- skos__hiddenLabel mesh__D038181 NADPH Flavin Reductase
% 208.15/208.35  |- mesh__dateCreated mesh__D038181 2002-07-03
% 208.15/208.35  |- mesh__recordAuthorizer mesh__D038181 sjn
% 208.15/208.35  |- skos__altLabel mesh__D038181 NADH-FMN Oxidoreductase
% 208.15/208.35  |- skos__hiddenLabel mesh__D038181 NADH FMN Oxidoreductase
% 208.15/208.35  |- skos__hiddenLabel mesh__D038181 Reductase, NADPH-Flavin
% 208.15/208.35  |- skos__hiddenLabel mesh__D038181 Mononucleotide Reductase, Flavin
% 208.15/208.35  |- skos__altLabel mesh__D038181 Flavin Mononucleotide Reductase
% 208.15/208.35  |- mesh__historyNote mesh__D038181 2006%28%1975%29%   
% 208.15/208.35  |- mesh__dateRevised mesh__D038181 2005-06-30
% 208.15/208.35  |- skos__altLabel mesh__D038181 NAD%28%P%29%H Dehydrogenase %28%FMN%29%
% 208.15/208.35  |- skos__prefLabel mesh__D038181 FMN Reductase
% 208.15/208.35  |- skos__altLabel mesh__D038181 NAD%28%P%29%H-Flavin Oxidoreductase
% 208.15/208.35  |- skos__historyNote mesh__D038181
% 208.15/208.35       NADH, NADPH Oxidoreductases %28%1981-2002%29%
% 208.15/208.35  |- skos__hiddenLabel mesh__D038181 Oxidoreductase, NADH-Flavin
% 208.15/208.35  |- skos__altLabel mesh__D038181 NAD%28%P%29%H-FMN Oxidoreductase
% 208.15/208.35  |- mesh__recordMaintainer mesh__D038181 AKE
% 208.15/208.35  |- mesh__recordOriginator mesh__D038181 jmp
% 208.15/208.35  |- skos__broader mesh__D038181smesh__D000587
% 208.15/208.35  |- skos__historyNote mesh__D038181 Flavin Mononucleotide %28%1975-1980%29%
% 208.15/208.35  |- skos__scopeNote mesh__D038181
% 208.15/208.35       An enzyme that utilizes NADH or NADPH to reduce FLAVINS. It is involved in a number of biological processes that require reduced flavin for their functions such as bacterial bioluminescence. Formerly listed as EC 1.6.8.1%A%    
% 208.15/208.35  |- skos__hiddenLabel mesh__D038181 Oxidoreductase, NADH-FMN
% 208.15/208.35  |- mesh__publicMeSHNote mesh__D038181
% 208.15/208.35       2006; see FLAVIN MONONUCLEOTIDE REDUCTASE 2003-2005; FLAVIN MONONUCLEOTIDE REDUCTASE%28%now FMN REDUCTASE%29% was indexed under NADH, NADPH OXIDOREDUCTASES 1981-2002 %26% under FMN 1975-1980%A%  
% 208.15/208.36  |- rdf__type mesh__D038181sskos__Concept
% 208.15/208.36  |- skos__altLabel mesh__D038181 NADPH-Flavin Reductase
% 208.15/208.36  |- skos__hiddenLabel mesh__D013439 Inhibitors, Sulfhydryl Compound
% 208.15/208.36  |- skos__hiddenLabel mesh__D013439 Reagents, Sulfhydryl
% 208.15/208.36  |- skos__hiddenLabel mesh__D013439 Compound Antagonists, Sulfhydryl
% 208.15/208.36  |- skos__hiddenLabel mesh__D013439 SH Reagents
% 208.15/208.36  |- skos__hiddenLabel mesh__D013439 Reagents, Thiol
% 208.15/208.36  |- mesh__publicMeSHNote mesh__D013439
% 208.15/208.36       99; for SULFHYDRYL COMPOUND ANTAGONISTS see SULFHYDRYL COMPOUNDS ANTAGONISTS 1978-98; for SULFHYDRYL COMPOUND INHIBITORS see SULFHYDRYL COMPOUNDS INHIBITORS 1978-98%A%  
% 208.15/208.36  |- mesh__historyNote mesh__D013439 99%28%72%29%   
% 208.15/208.36  |- mesh__recordAuthorizer mesh__D013439 sjn
% 208.15/208.36  |- skos__broader mesh__D013439smesh__D007202
% 208.15/208.36  |- skos__related mesh__D013439smesh__D004791
% 208.15/208.36  |- skos__hiddenLabel mesh__D013439 Antagonists, Sulfhydryl Compounds
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D013439 2006
% 208.15/208.36  |- mesh__recordOriginator mesh__D013439 NLM
% 208.15/208.36  |- skos__altLabel mesh__D013439 Sulfhydryl Compound Inhibitors
% 208.15/208.36  |- skos__prefLabel mesh__D013439 Sulfhydryl Reagents
% 208.15/208.36  |- mesh__dateEstablished mesh__D013439 1972-01-01
% 208.15/208.36  |- mesh__dateRevised mesh__D013439 2003-07-09
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D013439 2005
% 208.15/208.36  |- skos__altLabel mesh__D013439 SH-Reagents
% 208.15/208.36  |- skos__historyNote mesh__D013439
% 208.15/208.36       Sulfhydryl Compounds/antagonists %26% inhibitors %28%1968-1970%29%
% 208.15/208.36  |- skos__altLabel mesh__D013439 Sulfhydryl Compounds Antagonists
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D013439 2004
% 208.15/208.36  |- rdf__type mesh__D013439sskos__Concept
% 208.15/208.36  |- skos__hiddenLabel mesh__D013439 Compound Inhibitors, Sulfhydryl
% 208.15/208.36  |- mesh__recordMaintainer mesh__D013439 ssb
% 208.15/208.36  |- skos__scopeNote mesh__D013439
% 208.15/208.36       Chemical agents that react with SH groups. This is a chemically diverse group that is used for a variety of purposes. Among these are enzyme inhibition, enzyme reactivation or protection, and labelling.%A%    
% 208.15/208.36  |- skos__hiddenLabel mesh__D013439 Antagonists, Sulfhydryl Compound
% 208.15/208.36  |- skos__hiddenLabel mesh__D013439 Inhibitors, Sulfhydryl Compounds
% 208.15/208.36  |- mesh__dateCreated mesh__D013439 1999-01-01
% 208.15/208.36  |- skos__altLabel mesh__D013439 Thiol Reagents
% 208.15/208.36  |- skos__annotation mesh__D013439
% 208.15/208.36       do not confuse with SULFHYDRYL COMPOUNDS   
% 208.15/208.36  |- skos__hiddenLabel mesh__D024161 Collagen Type XI, alpha2 Chain
% 208.15/208.36  |- mesh__dateRevised mesh__D024161 2004-07-07
% 208.15/208.36  |- skos__altLabel mesh__D024161 Collagen alpha3%28%XI%29%
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D024161 2005
% 208.15/208.36  |- skos__prefLabel mesh__D024161 Collagen Type XI
% 208.15/208.36  |- mesh__recordOriginator mesh__D024161 jmp
% 208.15/208.36  |- rdf__type mesh__D024161sskos__Concept
% 208.15/208.36  |- skos__altLabel mesh__D024161 Type XI Collagen
% 208.15/208.36  |- skos__hiddenLabel mesh__D024161 Collagen, Type XI
% 208.15/208.36  |- skos__hiddenLabel mesh__D024161 Collagen Type XI, alpha1 Chain
% 208.15/208.36  |- mesh__dateEstablished mesh__D024161 2002-01-01
% 208.15/208.36  |- skos__hiddenLabel mesh__D024161 Collagen Type XI, alpha3 Chain
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D024161 2006
% 208.15/208.36  |- mesh__publicMeSHNote mesh__D024161 2002; see COLLAGEN 1992-2001   
% 208.15/208.36  |- mesh__recordMaintainer mesh__D024161 jmp
% 208.15/208.36  |- mesh__recordAuthorizer mesh__D024161 sjn
% 208.15/208.36  |- skos__altLabel mesh__D024161 Collagen Type-XI, alpha3 Chain
% 208.15/208.36  |- skos__altLabel mesh__D024161 Collagen Type-XI, alpha1 Chain
% 208.15/208.36  |- mesh__historyNote mesh__D024161 2002; use COLLAGEN 1992-2001   
% 208.15/208.36  |- skos__hiddenLabel mesh__D024161 Procollagen, Type XI
% 208.15/208.36  |- skos__altLabel mesh__D024161 Type XI Procollagen
% 208.15/208.36  |- skos__altLabel mesh__D024161 Collagen alpha1%28%XI%29%
% 208.15/208.36  |- mesh__dateCreated mesh__D024161 2001-07-25
% 208.15/208.36  |- skos__historyNote mesh__D024161 Collagen %28%1992-2001%29%
% 208.15/208.36  |- skos__scopeNote mesh__D024161
% 208.15/208.36       A fibrillar collagen found primarily in interstitial CARTILAGE. Collagen type XI is heterotrimer containing alpha1%28%XI%29%, alpha2%28%XI%29% and alpha3%28%XI%29% subunits.%A%    
% 208.15/208.36  |- skos__broader mesh__D024161smesh__D024022
% 208.15/208.36  |- skos__altLabel mesh__D024161 Collagen Type-XI, alpha2 Chain
% 208.15/208.36  |- skos__annotation mesh__D024161
% 208.15/208.36       precursors: coord IM with PROCOLLAGEN %28%IM%29%   
% 208.15/208.36  |- skos__altLabel mesh__D024161 Collagen alpha2%28%XI%29%
% 208.15/208.36  |- skos__prefLabel mesh__D018922 HL-60 Cells
% 208.15/208.36  |- mesh__dateEstablished mesh__D018922 1996-01-01
% 208.15/208.36  |- mesh__recordMaintainer mesh__D018922 sjn
% 208.15/208.36  |- skos__broader mesh__D018922smesh__D045744
% 208.15/208.36  |- mesh__recordOriginator mesh__D018922 AGS
% 208.15/208.36  |- skos__historyNote mesh__D018922 Cell Line %28%1979-1995%29%
% 208.15/208.36  |- skos__broader mesh__D018922smesh__D042381
% 208.15/208.36  |- mesh__dateCreated mesh__D018922 1995-06-08
% 208.15/208.36  |- skos__historyNote mesh__D018922 Tumor Cells, Cultured %28%1987-1995%29%
% 208.15/208.36  |- skos__hiddenLabel mesh__D018922 Cell, HL60
% 208.15/208.36  |- skos__altLabel mesh__D018922 HL60 Cells
% 208.15/208.36  |- mesh__publicMeSHNote mesh__D018922 96   
% 208.15/208.36  |- skos__scopeNote mesh__D018922
% 208.15/208.36       A promyelocytic cell line derived from a patient with ACUTE PROMYELOCYTIC LEUKEMIA. HL-60 cells lack specific markers for LYMPHOID CELLS but express surface receptors for FC FRAGMENTS and COMPLEMENT SYSTEM PROTEINS. They also exhibit phagocytic activity and responsiveness to chemotactic stimuli. %28%From Hay et al., American Type Culture Collection, 7th ed, pp127-8%29%%A%    
% 208.15/208.36  |- mesh__recordAuthorizer mesh__D018922 sjn
% 208.15/208.36  |- skos__hiddenLabel mesh__D018922 Cells, HL60
% 208.15/208.36  |- rdf__type mesh__D018922sskos__Concept
% 208.15/208.36  |- mesh__historyNote mesh__D018922 96   
% 208.15/208.36  |- skos__hiddenLabel mesh__D018922 HL-60 Cell
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D018922 2006
% 208.15/208.36  |- skos__hiddenLabel mesh__D018922 HL 60 Cells
% 208.15/208.36  |- mesh__dateRevised mesh__D018922 2005-07-01
% 208.15/208.36  |- skos__hiddenLabel mesh__D018922 HL60 Cell
% 208.15/208.36  |- skos__annotation mesh__D018922
% 208.15/208.36       almost always NIM with no subheadings; check HUMAN; do not routinely add LEUKEMIA, PROMYELOCYTIC, ACUTE%A%  
% 208.15/208.36  |- skos__altLabel mesh__D018124 TNF Receptors
% 208.15/208.36  |- mesh__recordAuthorizer mesh__D018124 sjn
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D018124 2005
% 208.15/208.36  |- skos__altLabel mesh__D018124 Receptors, TNF
% 208.15/208.36  |- rdf__type mesh__D018124sskos__Concept
% 208.15/208.36  |- skos__altLabel mesh__D018124 Receptors, Cachectin
% 208.15/208.36  |- skos__historyNote mesh__D018124
% 208.15/208.36       Receptors, Cell Surface %28%1985-1993%29%
% 208.15/208.36  |- mesh__publicMeSHNote mesh__D018124
% 208.15/208.36       94; TUMOR NECROSIS FACTOR RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1985-93%A%  
% 208.15/208.36  |- skos__prefLabel mesh__D018124 Receptors, Tumor Necrosis Factor
% 208.15/208.36  |- skos__altLabel mesh__D018124 Cachectin Receptors
% 208.15/208.36  |- mesh__onlineNote mesh__D018124
% 208.15/208.36       use RECEPTORS, TUMOR NECROSIS FACTOR %28%NM%29% to search TUMOR NECROSIS FACTOR RECEPTOR 1985-93%A%  
% 208.15/208.36  |- mesh__dateCreated mesh__D018124 1993-06-21
% 208.15/208.36  |- skos__annotation mesh__D018124 general; prefer specifics   
% 208.15/208.36  |- skos__altLabel mesh__D018124 Tumor Necrosis Factor Receptors
% 208.15/208.36  |- skos__broader mesh__D018124smesh__D018121
% 208.15/208.36  |- mesh__historyNote mesh__D018124
% 208.15/208.36       94; was TUMOR NECROSIS FACTOR RECEPTOR %28%NM%29% 1985-93   
% 208.15/208.36  |- skos__altLabel mesh__D018124 TNF Receptor
% 208.15/208.36  |- skos__scopeNote mesh__D018124
% 208.15/208.36       Cell surface receptors that bind TUMOR NECROSIS FACTORS and trigger changes which influence the behavior of cells.%A%    
% 208.15/208.36  |- mesh__recordOriginator mesh__D018124 RAZ
% 208.15/208.36  |- skos__hiddenLabel mesh__D018124 Receptor, TNF
% 208.15/208.36  |- skos__altLabel mesh__D018124 Tumor Necrosis Factor Receptor
% 208.15/208.36  |- mesh__dateRevised mesh__D018124 2004-07-07
% 208.15/208.36  |- mesh__dateEstablished mesh__D018124 1994-01-01
% 208.15/208.36  |- mesh__recordMaintainer mesh__D018124 jmp
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D018124 2006
% 208.15/208.36  |- mesh__onlineNote mesh__D010141
% 208.15/208.36       search MECHANORECEPTORS 1972-74 %26% NERVE ENDINGS 1966-71   
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010141 2002
% 208.15/208.36  |- mesh__recordAuthorizer mesh__D010141 PLS
% 208.15/208.36  |- mesh__recordOriginator mesh__D010141 NLM
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010141 2003
% 208.15/208.36  |- mesh__publicMeSHNote mesh__D010141
% 208.15/208.36       91; was see under MECHANORECEPTORS 1972-90; was see under NERVE ENDINGS 1963-71%A%  
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010141 1997
% 208.15/208.36  |- skos__hiddenLabel mesh__D010141 Corpuscles, Pacinian
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010141 2006
% 208.15/208.36  |- mesh__dateCreated mesh__D010141 1999-01-01
% 208.15/208.36  |- mesh__dateRevised mesh__D010141 1993-06-30
% 208.15/208.36  |- mesh__recordMaintainer mesh__D010141 RAZ
% 208.15/208.36  |- mesh__dateEstablished mesh__D010141 1991-01-01
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010141 1996
% 208.15/208.36  |- skos__broader mesh__D010141smesh__D008465
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010141 2001
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010141 2005
% 208.15/208.36  |- skos__annotation mesh__D010141 mechanoreceptors   
% 208.15/208.36  |- skos__prefLabel mesh__D010141 Pacinian Corpuscles
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010141 1999
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010141 1995
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010141 2000
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010141 1998
% 208.15/208.36  |- mesh__historyNote mesh__D010141
% 208.15/208.36       91%28%75%29%; was see under MECHANORECEPTORS 1972-90; was see under NERVE ENDINGS 1963-71%A%  
% 208.15/208.36  |- rdf__type mesh__D010141sskos__Concept
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010141 1994
% 208.15/208.36  |- skos__scopeNote mesh__D010141
% 208.15/208.36       Rapidly adapting mechanoreceptors found in subcutaneous tissue beneath both hairy and glabrous skin. Pacinian corpuscles contain an afferent nerve fiber surrounded by a capsule with multiple concentric layers. They have large receptive fields and are most sensitive to high-frequency stimuli, such as vibration.%A%    
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010141 2004
% 208.15/208.36  |- skos__prefLabel mesh__D004902 Erythrocruorins
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D004902 1996
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D004902 1993
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D004902 2004
% 208.15/208.36  |- mesh__recordMaintainer mesh__D004902 TAP
% 208.15/208.36  |- mesh__publicMeSHNote mesh__D004902
% 208.15/208.36       91; was see under HEMOGLOBINS 1977-90   
% 208.15/208.36  |- mesh__dateEstablished mesh__D004902 1991-01-01
% 208.15/208.36  |- skos__annotation mesh__D004902
% 208.15/208.36       in plasma of various annelids %26% mollusks   
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D004902 2002
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D004902 1997
% 208.15/208.36  |- mesh__recordAuthorizer mesh__D004902 PLS
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D004902 2005
% 208.15/208.36  |- mesh__historyNote mesh__D004902
% 208.15/208.36       91%28%77%29%; was see under HEMOGLOBINS 1977-90   
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D004902 2000
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D004902 1994
% 208.15/208.36  |- skos__broader mesh__D004902smesh__D006454
% 208.15/208.36  |- mesh__dateCreated mesh__D004902 1976-04-27
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D004902 1998
% 208.15/208.36  |- skos__scopeNote mesh__D004902
% 208.15/208.36       High molecular weight %28%1,500,000 to 3,000,000%29% hemoglobins found in the plasma of many polychete and oligochete annelid worms and various mollusks. They bind one mole of oxygen per heme and function as oxygen carriers.%A%    
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D004902 2006
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D004902 2001
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D004902 1995
% 208.15/208.36  |- mesh__dateRevised mesh__D004902 1992-05-19
% 208.15/208.36  |- mesh__recordOriginator mesh__D004902 RLS
% 208.15/208.36  |- skos__historyNote mesh__D004902 Hemeproteins %28%1973-1976%29%
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D004902 2003
% 208.15/208.36  |- rdf__type mesh__D004902sskos__Concept
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D004902 1999
% 208.15/208.36  |- skos__hiddenLabel mesh__D051558 Transcription Factors, Onecut
% 208.15/208.36  |- mesh__recordOriginator mesh__D051558 DRC
% 208.15/208.36  |- mesh__publicMeSHNote mesh__D051558 2006   
% 208.15/208.36  |- mesh__recordAuthorizer mesh__D051558 sjn
% 208.15/208.36  |- mesh__dateEstablished mesh__D051558 2006-01-01
% 208.15/208.36  |- rdf__type mesh__D051558sskos__Concept
% 208.15/208.36  |- skos__scopeNote mesh__D051558
% 208.15/208.36       A family of transcription factors that contain a single cut domain and a divergent homeodomain. They regulate gene networks by controlling the expression of other transcription factors and they play an important role in CELL DIFFERENTIATION and METABOLISM.%A%    
% 208.15/208.36  |- mesh__recordMaintainer mesh__D051558 DRC
% 208.15/208.36  |- skos__broader mesh__D051558smesh__D018398
% 208.15/208.36  |- skos__altLabel mesh__D051558 Onecut Homeodomain Proteins
% 208.15/208.36  |- mesh__historyNote mesh__D051558 2006   
% 208.15/208.36  |- skos__prefLabel mesh__D051558 Onecut Transcription Factors
% 208.15/208.36  |- skos__broader mesh__D051558smesh__D014157
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D051558 2006
% 208.15/208.36  |- mesh__dateCreated mesh__D051558 2005-06-30
% 208.15/208.36  |- skos__hiddenLabel mesh__D051558 Homeodomain Proteins, Onecut
% 208.15/208.36  |- skos__prefLabel mesh__D004104 Diiodothyronines
% 208.15/208.36  |- mesh__historyNote mesh__D004104
% 208.15/208.36       91%28%79%29%; was see under THYRONINES 1979-90   
% 208.15/208.36  |- skos__broader mesh__D004104smesh__D013970
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D004104 2006
% 208.15/208.36  |- mesh__recordAuthorizer mesh__D004104 sjn
% 208.15/208.36  |- mesh__dateEstablished mesh__D004104 1991-01-01
% 208.15/208.36  |- mesh__dateCreated mesh__D004104 1978-05-16
% 208.15/208.36  |- mesh__dateRevised mesh__D004104 2005-06-30
% 208.15/208.36  |- mesh__publicMeSHNote mesh__D004104
% 208.15/208.36       91; was see under THYRONINES 1979-90   
% 208.15/208.36  |- mesh__recordMaintainer mesh__D004104 SYSTEM
% 208.15/208.36  |- mesh__recordOriginator mesh__D004104 RLS
% 208.15/208.36  |- skos__historyNote mesh__D004104 Thyronines %28%1966-1978%29%
% 208.15/208.36  |- skos__scopeNote mesh__D004104
% 208.15/208.36       These metabolites of THYROXINE are formed by the deiodination of T3 or reverse T3.%A%    
% 208.15/208.36  |- rdf__type mesh__D004104sskos__Concept
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D009398 2000
% 208.15/208.36  |- mesh__publicMeSHNote mesh__D009398 80   
% 208.15/208.36  |- skos__broader mesh__D009398smesh__D007388
% 208.15/208.36  |- mesh__recordAuthorizer mesh__D009398 PLS
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D009398 2004
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D009398 2005
% 208.15/208.36  |- mesh__recordOriginator mesh__D009398 EC
% 208.15/208.36  |- mesh__dateEstablished mesh__D009398 1980-01-01
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D009398 2001
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D009398 2006
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D009398 1996
% 208.15/208.36  |- skos__prefLabel mesh__D009398 Nephrology
% 208.15/208.36  |- skos__scopeNote mesh__D009398
% 208.15/208.36       A subspecialty of internal medicine concerned with the anatomy, physiology, and pathology of the kidney.%A%    
% 208.15/208.36  |- skos__related mesh__D009398smesh__D007674
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D009398 1997
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D009398 1998
% 208.15/208.36  |- skos__annotation mesh__D009398 SPEC; SPEC qualif; DF: NEPHROL   
% 208.15/208.36  |- mesh__recordMaintainer mesh__D009398 JLS
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D009398 1994
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D009398 1999
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D009398 2002
% 208.15/208.36  |- mesh__dateCreated mesh__D009398 1979-05-29
% 208.15/208.36  |- skos__historyNote mesh__D009398 Kidney Diseases %28%1966-1979%29%
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D009398 1995
% 208.15/208.36  |- mesh__historyNote mesh__D009398 80   
% 208.15/208.36  |- rdf__type mesh__D009398sskos__Concept
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D009398 2003
% 208.15/208.36  |- mesh__dateRevised mesh__D009398 1993-06-04
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D014532 2006
% 208.15/208.36  |- skos__prefLabel mesh__D014532 Uridine Diphosphate Glucose
% 208.15/208.36  |- skos__broader mesh__D014532smesh__D014539
% 208.15/208.36  |- mesh__recordAuthorizer mesh__D014532 sjn
% 208.15/208.36  |- skos__hiddenLabel mesh__D014532 Diphosphoglucose, Uridine
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D014532 2005
% 208.15/208.36  |- mesh__historyNote mesh__D014532
% 208.15/208.36       91%28%75%29%; was see under URIDINE DIPHOSPHATE SUGARS 1975-90   
% 208.15/208.36  |- mesh__dateRevised mesh__D014532 2004-07-07
% 208.15/208.36  |- skos__historyNote mesh__D014532
% 208.15/208.36       Uridine Diphosphate Sugars %28%1973-1974%29%
% 208.15/208.36  |- mesh__recordOriginator mesh__D014532 NLM
% 208.15/208.36  |- mesh__recordMaintainer mesh__D014532 ssb
% 208.15/208.36  |- skos__hiddenLabel mesh__D014532 Glucose, UDP
% 208.15/208.36  |- mesh__dateEstablished mesh__D014532 1991-01-01
% 208.15/208.36  |- mesh__dateCreated mesh__D014532 1974-11-19
% 208.15/208.36  |- skos__hiddenLabel mesh__D014532 Diphosphate Glucose, Uridine
% 208.15/208.36  |- skos__altLabel mesh__D014532 UDPG
% 208.15/208.36  |- mesh__publicMeSHNote mesh__D014532
% 208.15/208.36       91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90   
% 208.15/208.36  |- skos__hiddenLabel mesh__D014532 Glucose, Uridine Diphosphate
% 208.15/208.36  |- skos__altLabel mesh__D014532 Uridine Diphosphoglucose
% 208.15/208.36  |- rdf__type mesh__D014532sskos__Concept
% 208.15/208.36  |- skos__altLabel mesh__D014532 UDP Glucose
% 208.15/208.36  |- skos__historyNote mesh__D014532 Glucose %28%1973-1974%29%
% 208.15/208.36  |- skos__scopeNote mesh__D014532
% 208.15/208.36       A key intermediate in carbohydrate metabolism. Serves as a precursor of glycogen, can be metabolized into UDPgalactose and UDPglucuronic acid which can then be incorporated into polysaccharides as galactose and glucuronic acid. Also serves as a precursor of sucrose lipopolysaccharides, and glycosphingolipids.%A%    
% 208.15/208.36  |- skos__broader mesh__D000512smesh__D009686
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D000512 2001
% 208.15/208.36  |- skos__altLabel mesh__D000512 Radiation, Alpha
% 208.15/208.36  |- skos__scopeNote mesh__D000512
% 208.15/208.36       Positively charged particles composed of two protons and two neutrons, i.e., helium nuclei, emitted during disintegration of very heavy isotopes; a beam of alpha particles or an alpha ray has very strong ionizing power, but weak penetrability.%A%    
% 208.15/208.36  |- skos__hiddenLabel mesh__D000512 Particles, Alpha
% 208.15/208.36  |- skos__altLabel mesh__D000512 Alpha Radiation
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D000512 2006
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D000512 2000
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D000512 1999
% 208.15/208.36  |- skos__hiddenLabel mesh__D000512 Alpha Radiations
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D000512 2004
% 208.15/208.36  |- mesh__recordMaintainer mesh__D000512 TPW
% 208.15/208.36  |- mesh__historyNote mesh__D000512 66   
% 208.15/208.36  |- mesh__recordOriginator mesh__D000512 NLM
% 208.15/208.36  |- mesh__dateRevised mesh__D000512 1997-06-20
% 208.15/208.36  |- skos__hiddenLabel mesh__D000512 Alpha Ray
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D000512 2005
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D000512 1998
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D000512 2003
% 208.15/208.36  |- mesh__recordAuthorizer mesh__D000512 SJN
% 208.15/208.36  |- skos__annotation mesh__D000512
% 208.15/208.36       ionizing; radiation policy: see Manual index under RADIATION %26% entries following%A%  
% 208.15/208.36  |- skos__hiddenLabel mesh__D000512 Ray, Alpha
% 208.15/208.36  |- skos__broader mesh__D000512smesh__D011839
% 208.15/208.36  |- mesh__publicMeSHNote mesh__D000512 66   
% 208.15/208.36  |- skos__hiddenLabel mesh__D000512 Particle, Alpha
% 208.15/208.36  |- skos__hiddenLabel mesh__D000512 Alpha Particle
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D000512 2002
% 208.15/208.36  |- skos__hiddenLabel mesh__D000512 Radiations, Alpha
% 208.15/208.36  |- mesh__dateEstablished mesh__D000512 1966-01-01
% 208.15/208.36  |- skos__prefLabel mesh__D000512 Alpha Particles
% 208.15/208.36  |- mesh__dateCreated mesh__D000512 1999-01-01
% 208.15/208.36  |- skos__hiddenLabel mesh__D000512 Rays, Alpha
% 208.15/208.36  |- rdf__type mesh__D000512sskos__Concept
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D024162 2003
% 208.15/208.36  |- mesh__dateEstablished mesh__D024162 2002-01-01
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D024162 2006
% 208.15/208.36  |- skos__altLabel mesh__D024162 Surgery, Second-Look
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D024162 2004
% 208.15/208.36  |- skos__broader mesh__D024162smesh__D013514
% 208.15/208.36  |- skos__scopeNote mesh__D024162
% 208.15/208.36       A followup operation to examine the outcome of the previous surgery and other treatments, such as chemotherapy or radiation therapy.%A%    
% 208.15/208.36  |- skos__prefLabel mesh__D024162 Second-Look Surgery
% 208.15/208.36  |- mesh__historyNote mesh__D024162 2002   
% 208.15/208.36  |- mesh__publicMeSHNote mesh__D024162 2002   
% 208.15/208.36  |- skos__historyNote mesh__D024162 Reoperation %28%1983-2001%29%
% 208.15/208.36  |- skos__hiddenLabel mesh__D024162 Second Look Surgery
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D024162 2002
% 208.15/208.36  |- skos__related mesh__D024162smesh__D012086
% 208.15/208.36  |- skos__hiddenLabel mesh__D024162 Surgery, Second Look
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D024162 2005
% 208.15/208.36  |- rdf__type mesh__D024162sskos__Concept
% 208.15/208.36  |- mesh__dateCreated mesh__D024162 2001-07-25
% 208.15/208.36  |- skos__hiddenLabel mesh__D018923 Syndrome, Persian Gulf
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D018923 2002
% 208.15/208.36  |- skos__prefLabel mesh__D018923 Persian Gulf Syndrome
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D018923 2004
% 208.15/208.36  |- skos__broader mesh__D018923smesh__D009784
% 208.15/208.36  |- skos__altLabel mesh__D018923 Gulf War Syndrome
% 208.15/208.36  |- mesh__dateEstablished mesh__D018923 1996-01-01
% 208.15/208.36  |- skos__annotation mesh__D018923
% 208.15/208.36       coord IM with specific dis or manifest %28%IM%29%   
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D018923 2003
% 208.15/208.36  |- mesh__dateCreated mesh__D018923 1994-12-27
% 208.15/208.36  |- rdf__type mesh__D018923sskos__Concept
% 208.15/208.36  |- skos__scopeNote mesh__D018923
% 208.15/208.36       Unexplained symptoms reported by veterans of the Persian Gulf War with Iraq in 1991. The symptoms reported include fatigue, skin rash, muscle and joint pain, headaches, loss of memory, shortness of breath, gastrointestinal and respiratory symptoms, and extreme sensitivity to commonly occurring chemicals. %28%Nature 1994 May 5;369%28%6475%29%:8%29%%A%    
% 208.15/208.36  |- mesh__historyNote mesh__D018923 96   
% 208.15/208.36  |- skos__hiddenLabel mesh__D018923 Syndrome, Gulf War
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D018923 2001
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D018923 2006
% 208.15/208.36  |- mesh__publicMeSHNote mesh__D018923 96   
% 208.15/208.36  |- mesh__dateRevised mesh__D018923 1999-11-03
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D018923 2000
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D018923 2005
% 208.15/208.36  |- mesh__recordAuthorizer mesh__D018923 sjn
% 208.15/208.36  |- mesh__recordOriginator mesh__D018923 TGC
% 208.15/208.36  |- mesh__recordMaintainer mesh__D018923 MCC
% 208.15/208.36  |- skos__scopeNote mesh__D010940
% 208.15/208.36       Proteins found in plants %28%flowers, herbs, shrubs, trees, etc.%29%. The concept does not include proteins found in vegetables for which VEGETABLE PROTEINS is available.%A%    
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010940 2006
% 208.15/208.36  |- skos__annotation mesh__D010940
% 208.15/208.36       dietary plant proteins: coord IM with specific plant %28%IM%29% + specific protein %28%IM%29% + DIETARY PROTEINS %28%IM%29% but note that VEGETABLE PROTEINS is available %28%see note there%29%; nutritive value of plant proteins: coord IM with specific protein %28%IM%29% + NUTRITIVE VALUE %28%NIM%29% but not also DIETARY PROTEINS%A%  
% 208.15/208.36  |- skos__related mesh__D010940smesh__D010944
% 208.15/208.36  |- rdf__type mesh__D010940sskos__Concept
% 208.15/208.36  |- mesh__dateRevised mesh__D010940 2005-06-30
% 208.15/208.36  |- mesh__dateCreated mesh__D010940 1999-01-01
% 208.15/208.36  |- skos__prefLabel mesh__D010940 Plant Proteins
% 208.15/208.36  |- mesh__recordMaintainer mesh__D010940 SYSTEM
% 208.15/208.36  |- mesh__recordAuthorizer mesh__D010940 sjn
% 208.15/208.36  |- mesh__recordOriginator mesh__D010940 NLM
% 208.15/208.36  |- skos__broader mesh__D010940smesh__D011506
% 208.15/208.36  |- skos__hiddenLabel mesh__D010940 Proteins, Plant
% 208.15/208.36  |- skos__altLabel mesh__D018125 Transforming Growth Factor beta Receptor
% 208.15/208.36  |- skos__altLabel mesh__D018125 Receptors, TGF-beta
% 208.15/208.36  |- mesh__recordOriginator mesh__D018125 RAZ
% 208.15/208.36  |- skos__hiddenLabel mesh__D018125 TGF beta Receptors
% 208.15/208.36  |- mesh__dateEstablished mesh__D018125 1994-01-01
% 208.15/208.36  |- rdf__type mesh__D018125sskos__Concept
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D018125 2004
% 208.15/208.36  |- mesh__recordAuthorizer mesh__D018125 sjn
% 208.15/208.36  |- mesh__onlineNote mesh__D018125
% 208.15/208.36       use RECEPTORS, TRANSFORMING GROWTH FACTOR BETA %28%NM%29% to search TRANSFORMING GROWTH FACTOR RECEPTOR, BETA 1986-93%A%  
% 208.15/208.36  |- skos__hiddenLabel mesh__D018125 Receptors, TGF beta
% 208.15/208.36  |- skos__historyNote mesh__D018125
% 208.15/208.36       Receptors, Cell Surface %28%1986-1993%29%
% 208.15/208.36  |- skos__hiddenLabel mesh__D018125 Receptor, TGF-beta
% 208.15/208.36  |- skos__scopeNote mesh__D018125
% 208.15/208.36       Cell-surface proteins that bind transforming growth factor beta and trigger changes influencing the behavior of cells. Two types of transforming growth factor receptors have been recognized. They differ in affinity for different members of the transforming growth factor beta family and in cellular mechanisms of action.%A%    
% 208.15/208.36  |- mesh__publicMeSHNote mesh__D018125
% 208.15/208.36       94; TRANSFORMING GROWTH FACTOR RECEPTOR, BETA 1986-93 was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1986-93%A%  
% 208.15/208.36  |- skos__hiddenLabel mesh__D018125 TGF beta Receptor
% 208.15/208.36  |- skos__broader mesh__D018125smesh__D017978
% 208.15/208.36  |- skos__altLabel mesh__D018125 Transforming Growth Factor beta Receptors
% 208.15/208.36  |- mesh__dateRevised mesh__D018125 2003-07-09
% 208.15/208.36  |- skos__annotation mesh__D018125 DF: RECEPT TGF BETA   
% 208.15/208.36  |- mesh__dateCreated mesh__D018125 1993-06-21
% 208.15/208.36  |- mesh__recordMaintainer mesh__D018125 jmp
% 208.15/208.36  |- mesh__historyNote mesh__D018125
% 208.15/208.36       94; was TRANSFORMING GROWTH FACTOR RECEPTOR, BETA %28%NM%29% 1986-93%A%  
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D018125 2006
% 208.15/208.36  |- skos__prefLabel mesh__D018125 Receptors, Transforming Growth Factor beta
% 208.15/208.36  |- skos__broader mesh__D018125smesh__D018121
% 208.15/208.36  |- skos__altLabel mesh__D018125 TGF-beta Receptor
% 208.15/208.36  |- skos__altLabel mesh__D018125 TGF-beta Receptors
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D018125 2005
% 208.15/208.36  |- mesh__historyNote mesh__D010142
% 208.15/208.36       91%28%75%29%; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90%A%  
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010142 2002
% 208.15/208.36  |- mesh__dateRevised mesh__D010142 1998-06-10
% 208.15/208.36  |- skos__historyNote mesh__D010142
% 208.15/208.36       Antibiotics, Antineoplastic %28%1972-1974%29%
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010142 2005
% 208.15/208.36  |- skos__prefLabel mesh__D010142 Pactamycin
% 208.15/208.36  |- skos__broader mesh__D010142smesh__D006883
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010142 2006
% 208.15/208.36  |- skos__scopeNote mesh__D010142
% 208.15/208.36       Antibiotic produced by Streptomyces pactum used as an antineoplastic agent. It is also used as a tool in biochemistry because it inhibits certain steps in protein synthesis.%A%    
% 208.15/208.36  |- mesh__dateCreated mesh__D010142 1974-11-19
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010142 1999
% 208.15/208.36  |- mesh__publicMeSHNote mesh__D010142
% 208.15/208.36       91; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90   
% 208.15/208.36  |- mesh__recordOriginator mesh__D010142 NLM
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010142 2000
% 208.15/208.36  |- mesh__dateEstablished mesh__D010142 1991-01-01
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010142 2003
% 208.15/208.36  |- rdf__type mesh__D010142sskos__Concept
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010142 2001
% 208.15/208.36  |- mesh__recordAuthorizer mesh__D010142 SJN
% 208.15/208.36  |- mesh__recordMaintainer mesh__D010142 ADP
% 208.15/208.36  |- mesh__activeMeSHYear mesh__D010142 2004
% 208.15/208.36  |- mesh__publicMeSHNote mesh__D004903
% 208.15/208.36       1976; for ERYTHROCYTE AGGREGATION, INTRAVASCULAR see ERYTHROCYTE AGGREGATION, INTRAVASCULAR 1964-2003; for INTRAVASCULAR AGGLUTINATION see ERYTHROCYTE AGGREGATION, INTRAVASCULAR 1976-2003%A%  
% 208.15/208.36  |- mesh__recordAuthorizer mesh__D004903 sjn
% 208.15/208.36  |- skos__hiddenLabel mesh__D004903 Erythrocyte Rouleaux Formations
% 208.15/208.36  |- mesh__dateRevised mesh__D004903 2003-07-09
% 208.15/208.36  |- skos__related mesh__D004903smesh__D018056
% 208.15/208.36  |- skos__hiddenLabel mesh__D004903 Erythrocyte Rouleaux Formation
% 208.15/208.36  |- skos__hiddenLabel mesh__D004903 Aggregation, Erythrocyte
% 208.15/208.36  |- skos__altLabel mesh__D004903 Intravascular Agglutination
% 208.15/208.37  |- skos__hiddenLabel mesh__D004903 Rouleaux Formations, Erythrocyte
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004903 2005
% 208.15/208.37  |- skos__broader mesh__D004903smesh__D045123
% 208.15/208.37  |- skos__scopeNote mesh__D004903
% 208.15/208.37       The formation of clumps of  RED BLOOD CELLS under low or non-flow conditions, resulting from the attraction forces between the red blood cells. The cells adhere to each other in rouleaux aggregates. Slight mechanical force, such as occurs in the circulation, is enough to disperse these aggregates. Stronger or weaker than normal aggregation may result from a variety of effects in the ERYTHROCYTE MEMBRANE or in BLOOD PLASMA. The degree of aggregation is affected by ERYTHROCYTE DEFORMABILITY, erythrocyte membrane sialylation, masking of negative surface charge by plasma proteins, etc. BLOOD VISCOSITY and the ERYTHROCYTE SEDIMENTATION RATE are affected by the amount of erythrocyte aggregation and are parameters used to measure the aggregation.%A%    
% 208.15/208.37  |- skos__hiddenLabel mesh__D004903 Aggregations, Intravascular Erythrocyte
% 208.15/208.37  |- skos__hiddenLabel mesh__D004903 Agglutinations, Intravascular
% 208.15/208.37  |- skos__hiddenLabel mesh__D004903 Erythrocyte Aggregations, Intravascular
% 208.15/208.37  |- skos__hiddenLabel mesh__D004903 Intravascular Agglutinations
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004903 2006
% 208.15/208.37  |- skos__altLabel mesh__D004903 Intravascular Erythrocyte Aggregation
% 208.15/208.37  |- skos__historyNote mesh__D004903 Erythrocytes %28%1966-1975%29%
% 208.15/208.37  |- skos__hiddenLabel mesh__D004903 Erythrocyte Aggregations
% 208.15/208.37  |- mesh__dateCreated mesh__D004903 1975-07-25
% 208.15/208.37  |- rdf__type mesh__D004903sskos__Concept
% 208.15/208.37  |- mesh__recordMaintainer mesh__D004903 nns
% 208.15/208.37  |- skos__hiddenLabel mesh__D004903 Formations, Erythrocyte Rouleaux
% 208.15/208.37  |- mesh__recordOriginator mesh__D004903 SMB
% 208.15/208.37  |- skos__broader mesh__D004903smesh__D006403
% 208.15/208.37  |- skos__annotation mesh__D004903
% 208.15/208.37       coord with disease /blood, not disease /physiopathol; do not confuse with DISSEMINATED INTRAVASCULAR COAGULATION; DF: ERYTHROCYTE AGGREGATION INTRAVASC%A%  
% 208.15/208.37  |- skos__hiddenLabel mesh__D004903 Formation, Erythrocyte Rouleaux
% 208.15/208.37  |- skos__hiddenLabel mesh__D004903 Aggregations, Erythrocyte
% 208.15/208.37  |- skos__hiddenLabel mesh__D004903 Aggregation, Intravascular Erythrocyte
% 208.15/208.37  |- mesh__dateEstablished mesh__D004903 1976-01-01
% 208.15/208.37  |- mesh__historyNote mesh__D004903 1976   
% 208.15/208.37  |- skos__prefLabel mesh__D004903 Erythrocyte Aggregation
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004903 2004
% 208.15/208.37  |- skos__hiddenLabel mesh__D004903 Intravascular Erythrocyte Aggregations
% 208.15/208.37  |- mesh__publicMeSHNote mesh__D051559
% 208.15/208.37       2006; HEPATOCYTE NUCLEAR FACTOR 6 was indexed under TRANS-ACTIVATORS %26% HOMEODOMAIN PROTEINS 1996-2005%A%  
% 208.15/208.37  |- skos__hiddenLabel mesh__D051559 Hepatocyte Nuclear Factor 6 Alpha
% 208.15/208.37  |- skos__broader mesh__D051559smesh__D051536
% 208.15/208.37  |- mesh__dateCreated mesh__D051559 2005-06-30
% 208.15/208.37  |- skos__altLabel mesh__D051559 HNF6alpha Transcription Factor
% 208.15/208.37  |- skos__broader mesh__D051559smesh__D051558
% 208.15/208.37  |- skos__scopeNote mesh__D051559
% 208.15/208.37       A onecut transcription factor that regulates expression of GENES involved in EMBRYONIC DEVELOPMENT of the PANCREAS and LIVER.%A%    
% 208.15/208.37  |- rdf__type mesh__D051559sskos__Concept
% 208.15/208.37  |- skos__hiddenLabel mesh__D051559 Transcription Factor, HNF6
% 208.15/208.37  |- skos__hiddenLabel mesh__D051559 Transcription Factor, HNF6beta
% 208.15/208.37  |- mesh__recordMaintainer mesh__D051559 DRC
% 208.15/208.37  |- skos__altLabel mesh__D051559 HNF6 Transcription Factor
% 208.15/208.37  |- mesh__recordAuthorizer mesh__D051559 sjn
% 208.15/208.37  |- mesh__historyNote mesh__D051559 2006%28%1996%29%   
% 208.15/208.37  |- skos__prefLabel mesh__D051559 Hepatocyte Nuclear Factor 6
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D051559 2006
% 208.15/208.37  |- skos__hiddenLabel mesh__D051559 Transcription Factor, HNF6alpha
% 208.15/208.37  |- skos__hiddenLabel mesh__D051559 Hepatocyte Nuclear Factor 6 Beta
% 208.15/208.37  |- skos__altLabel mesh__D051559 HNF6beta Transcription Factor
% 208.15/208.37  |- mesh__recordOriginator mesh__D051559 DRC
% 208.15/208.37  |- mesh__dateEstablished mesh__D051559 2006-01-01
% 208.15/208.37  |- skos__scopeNote mesh__D004105
% 208.15/208.37       A product from the iodination of MONOIODOTYROSINE.  In the biosynthesis of thyroid hormones, diiodotyrosine residues are coupled with other  monoiodotyrosine or diiodotyrosine residues to form T4 or T3 thyroid hormones %28%THYROXINE and TRIIODOTHYRONINE%29%.%A%    
% 208.15/208.37  |- mesh__recordMaintainer mesh__D004105 nns
% 208.15/208.37  |- skos__broader mesh__D004105smesh__D013963
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004105 2002
% 208.15/208.37  |- mesh__recordOriginator mesh__D004105 NLM
% 208.15/208.37  |- skos__broader mesh__D004105smesh__D014443
% 208.15/208.37  |- rdf__type mesh__D004105sskos__Concept
% 208.15/208.37  |- mesh__dateCreated mesh__D004105 1999-01-01
% 208.15/208.37  |- skos__altLabel mesh__D004105 Iodogorgoic Acid
% 208.15/208.37  |- skos__hiddenLabel mesh__D004105 Acid, Iodogorgoic
% 208.15/208.37  |- skos__related mesh__D004105smesh__D011988
% 208.15/208.37  |- mesh__dateRevised mesh__D004105 2001-07-25
% 208.15/208.37  |- mesh__recordAuthorizer mesh__D004105 sjn
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004105 2004
% 208.15/208.37  |- skos__prefLabel mesh__D004105 Diiodotyrosine
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004105 2006
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004105 2003
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004105 2005
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D009399 1992
% 208.15/208.37  |- mesh__dateRevised mesh__D009399 1991-01-07
% 208.15/208.37  |- mesh__publicMeSHNote mesh__D009399 79; was see under KIDNEY 1975-78   
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D009399 2002
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D009399 1997
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D009399 1998
% 208.15/208.37  |- skos__historyNote mesh__D009399 Kidney %28%1966-1972%29%
% 208.15/208.37  |- skos__hiddenLabel mesh__D009399 Nephron
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D009399 1993
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D009399 1994
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D009399 1999
% 208.15/208.37  |- skos__prefLabel mesh__D009399 Nephrons
% 208.15/208.37  |- mesh__recordOriginator mesh__D009399 NLM
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D009399 2000
% 208.15/208.37  |- mesh__dateCreated mesh__D009399 1999-01-01
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D009399 1995
% 208.15/208.37  |- mesh__dateEstablished mesh__D009399 1979-01-01
% 208.15/208.37  |- mesh__recordAuthorizer mesh__D009399 PLS
% 208.15/208.37  |- rdf__type mesh__D009399sskos__Concept
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D009399 2003
% 208.15/208.37  |- mesh__historyNote mesh__D009399
% 208.15/208.37       79%28%73%29%; was see under KIDNEY 1975-78   
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D009399 2001
% 208.15/208.37  |- skos__broader mesh__D009399smesh__D007668
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D009399 2004
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D009399 2005
% 208.15/208.37  |- skos__scopeNote mesh__D009399
% 208.15/208.37       The functional units of the kidney, consisting of the glomerulus and the attached tubule.%A%    
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D009399 2006
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D009399 1996
% 208.15/208.37  |- mesh__recordMaintainer mesh__D009399 TGC
% 208.15/208.37  |- skos__hiddenLabel mesh__D020570 Proto-Oncogenes, c-myb
% 208.15/208.37  |- skos__hiddenLabel mesh__D020570 v-myb Gene
% 208.15/208.37  |- skos__hiddenLabel mesh__D020570 c myb Genes
% 208.15/208.37  |- skos__altLabel mesh__D020570 myb Genes
% 208.15/208.37  |- skos__prefLabel mesh__D020570 Genes, myb
% 208.15/208.37  |- skos__hiddenLabel mesh__D020570 Oncogenes, v-myb
% 208.15/208.37  |- skos__broader mesh__D020570smesh__D011519
% 208.15/208.37  |- skos__hiddenLabel mesh__D020570 Oncogene, v-myb
% 208.15/208.37  |- skos__hiddenLabel mesh__D020570 Proto-Oncogene, c-myb
% 208.15/208.37  |- skos__altLabel mesh__D020570 myb Oncogene
% 208.15/208.37  |- mesh__dateCreated mesh__D020570 1999-11-03
% 208.15/208.37  |- skos__hiddenLabel mesh__D020570 v myb Oncogenes
% 208.15/208.37  |- skos__hiddenLabel mesh__D020570 Gene, c-myb
% 208.15/208.37  |- skos__hiddenLabel mesh__D020570 c myb Proto Oncogenes
% 208.15/208.37  |- skos__hiddenLabel mesh__D020570 myb Oncogenes
% 208.15/208.37  |- skos__historyNote mesh__D020570 Genes, Viral %28%1983-1999%29%
% 208.15/208.37  |- mesh__dateRevised mesh__D020570 2005-06-30
% 208.15/208.37  |- skos__altLabel mesh__D020570 v-myb Oncogenes
% 208.15/208.37  |- skos__hiddenLabel mesh__D020570 Oncogenes, myb
% 208.15/208.37  |- skos__hiddenLabel mesh__D020570 Genes, c-myb
% 208.15/208.37  |- skos__hiddenLabel mesh__D020570 Gene, myb
% 208.15/208.37  |- mesh__recordMaintainer mesh__D020570 nns
% 208.15/208.37  |- mesh__recordAuthorizer mesh__D020570 sjn
% 208.15/208.37  |- skos__hiddenLabel mesh__D020570 c-myb Gene
% 208.15/208.37  |- skos__hiddenLabel mesh__D020570 myb Gene
% 208.15/208.37  |- skos__altLabel mesh__D020570 c-myb Proto-Oncogenes
% 208.15/208.37  |- skos__historyNote mesh__D020570 Oncogenes %28%1983-1999%29%
% 208.15/208.37  |- skos__hiddenLabel mesh__D020570 v-myb Oncogene
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D020570 2006
% 208.15/208.37  |- skos__hiddenLabel mesh__D020570 v myb Genes
% 208.15/208.37  |- skos__scopeNote mesh__D020570
% 208.15/208.37       Retrovirus-associated DNA sequences %28%v-myb%29% originally isolated from the avian myeloblastosis and E26 leukemia viruses. The proto-oncogene c-myb codes for a nuclear protein involved in transcriptional regulation and appears to be essential for hematopoietic cell proliferation. The human myb gene is located at 6q22-23 on the short arm of chromosome 6. This is the point of break in translocations involved in T-cell acute lymphatic leukemia and in some ovarian cancers and melanomas. %28%From Ibelgaufts, Dictionary of Cytokines, 1995%29%.%A%    
% 208.15/208.37  |- mesh__historyNote mesh__D020570 2000; use ONCOGENES 1985-1999   
% 208.15/208.37  |- rdf__type mesh__D020570sskos__Concept
% 208.15/208.37  |- skos__hiddenLabel mesh__D020570 Gene, v-myb
% 208.15/208.37  |- mesh__dateEstablished mesh__D020570 2000-01-01
% 208.15/208.37  |- skos__hiddenLabel mesh__D020570 Oncogene, myb
% 208.15/208.37  |- skos__hiddenLabel mesh__D020570 c-myb Proto-Oncogene
% 208.15/208.37  |- skos__hiddenLabel mesh__D020570 Genes, v-myb
% 208.15/208.37  |- mesh__recordOriginator mesh__D020570 ags
% 208.15/208.37  |- mesh__publicMeSHNote mesh__D020570 2000; use ONCOGENES 1985-1999   
% 208.15/208.37  |- skos__scopeNote mesh__D014533
% 208.15/208.37       An enzyme that catalyzes the oxidation of UDPglucose to UDPglucuronate in the presence of NAD+. EC 1.1.1.22.%A%    
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D014533 2005
% 208.15/208.37  |- skos__historyNote mesh__D014533 Glucose %28%1973-1974%29%
% 208.15/208.37  |- skos__historyNote mesh__D014533
% 208.15/208.37       Uridine Diphosphate Sugars %28%1973-1974%29%
% 208.15/208.37  |- mesh__dateRevised mesh__D014533 2003-07-09
% 208.15/208.37  |- skos__annotation mesh__D014533 DF: note short X ref   
% 208.15/208.37  |- mesh__publicMeSHNote mesh__D014533
% 208.15/208.37       91; was see under CARBOHYDRATE DEHYDROGENASES 1978-90; was see under ALCOHOL OXIDOREDUCTASES 1975-77%A%  
% 208.15/208.37  |- skos__hiddenLabel mesh__D014533 Dehydrogenase, UDP Glucose
% 208.15/208.37  |- skos__broader mesh__D014533smesh__D002237
% 208.15/208.37  |- skos__altLabel mesh__D014533 UDPG Dehydrogenase
% 208.15/208.37  |- mesh__recordAuthorizer mesh__D014533 sjn
% 208.15/208.37  |- mesh__dateEstablished mesh__D014533 1991-01-01
% 208.15/208.37  |- mesh__historyNote mesh__D014533
% 208.15/208.37       91%28%75%29%; was see under CARBOHYDRATE DEHYDROGENASES 1978-90; was see under ALCOHOL OXIDOREDUCTASES 1975-77%A%  
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D014533 2004
% 208.15/208.37  |- skos__prefLabel mesh__D014533 Uridine Diphosphate Glucose Dehydrogenase
% 208.15/208.37  |- rdf__type mesh__D014533sskos__Concept
% 208.15/208.37  |- skos__altLabel mesh__D014533 UDP Glucose Dehydrogenase
% 208.15/208.37  |- mesh__recordOriginator mesh__D014533 NLM
% 208.15/208.37  |- skos__historyNote mesh__D014533
% 208.15/208.37       Alcohol Oxidoreductases %28%1973-1974%29%
% 208.15/208.37  |- skos__hiddenLabel mesh__D014533 Glucose Dehydrogenase, UDP
% 208.15/208.37  |- skos__hiddenLabel mesh__D014533 Dehydrogenase, UDPG
% 208.15/208.37  |- mesh__recordMaintainer mesh__D014533 ssb
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D014533 2006
% 208.15/208.37  |- mesh__dateCreated mesh__D014533 1974-11-19
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D000513 2006
% 208.15/208.37  |- skos__prefLabel mesh__D000513 Alpha Rhythm
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D000513 2004
% 208.15/208.37  |- skos__hiddenLabel mesh__D000513 Alpha Rhythms
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D000513 2005
% 208.15/208.37  |- skos__hiddenLabel mesh__D000513 Alpha Rhythm Electroencephalography
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D000513 2001
% 208.15/208.37  |- mesh__dateRevised mesh__D000513 1999-11-03
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D000513 2003
% 208.15/208.37  |- mesh__recordMaintainer mesh__D000513 KEV
% 208.15/208.37  |- skos__scopeNote mesh__D000513
% 208.15/208.37       One of four types of brain waves characterized by a relatively high voltage or amplitude and a frequency of 8-13 Hz.  They constitute the majority of waves recorded by EEG registering the activity of the parietal and occipital lobes when the individual is awake, but relaxed with the eyes closed.%A%    
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D000513 2000
% 208.15/208.37  |- skos__annotation mesh__D000513 in EEG   
% 208.15/208.37  |- skos__hiddenLabel mesh__D000513 Encephalography, Alpha Rhythm
% 208.15/208.37  |- mesh__publicMeSHNote mesh__D000513 74   
% 208.15/208.37  |- mesh__recordOriginator mesh__D000513 NLM
% 208.15/208.37  |- mesh__dateEstablished mesh__D000513 1974-01-01
% 208.15/208.37  |- skos__historyNote mesh__D000513 Electroencephalography %28%1966-1971%29%
% 208.15/208.37  |- mesh__dateCreated mesh__D000513 1999-01-01
% 208.15/208.37  |- rdf__type mesh__D000513sskos__Concept
% 208.15/208.37  |- skos__hiddenLabel mesh__D000513 Rhythm, Alpha
% 208.15/208.37  |- skos__hiddenLabel mesh__D000513 Rhythms, Alpha
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D000513 2002
% 208.15/208.37  |- mesh__historyNote mesh__D000513 74%28%72%29%   
% 208.15/208.37  |- skos__altLabel mesh__D000513 Alpha Rhythm Encephalography
% 208.15/208.37  |- mesh__recordAuthorizer mesh__D000513 sjn
% 208.15/208.37  |- skos__broader mesh__D000513smesh__D004569
% 208.15/208.37  |- mesh__recordAuthorizer mesh__D038981 sjn
% 208.15/208.37  |- skos__altLabel mesh__D038981 Collagen Receptor
% 208.15/208.37  |- skos__broader mesh__D038981smesh__D011956
% 208.15/208.37  |- mesh__historyNote mesh__D038981
% 208.15/208.37       2003; use  RECEPTORS, COLLAGEN %28%NM%29% 1983-2002   
% 208.15/208.37  |- mesh__recordOriginator mesh__D038981 MDJ
% 208.15/208.37  |- skos__scopeNote mesh__D038981
% 208.15/208.37       Collagen receptors are cell surface receptors that modulate signal transduction between cells and the EXTRACELLULAR MATRIX.  They are found in many cell types and are involved in the maintenance and regulation of cell shape and behavior, including PLATELET ACTIVATION and aggregation, through many different signaling pathways and differences in their affinities for collagen isoforms.  Collagen receptors include discoidin domain receptors, INTEGRINS, and glycoprotein VI.%A%    
% 208.15/208.37  |- mesh__dateRevised mesh__D038981 2005-06-30
% 208.15/208.37  |- mesh__dateEstablished mesh__D038981 2003-01-01
% 208.15/208.37  |- skos__altLabel mesh__D038981 Collagen Receptors
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D038981 2006
% 208.15/208.37  |- skos__historyNote mesh__D038981 Integrins %28%1983-2002%29%
% 208.15/208.37  |- skos__hiddenLabel mesh__D038981 Receptor, Collagen
% 208.15/208.37  |- rdf__type mesh__D038981sskos__Concept
% 208.15/208.37  |- mesh__recordMaintainer mesh__D038981 jmp
% 208.15/208.37  |- mesh__publicMeSHNote mesh__D038981
% 208.15/208.37       2003; COLLAGEN RECEPTOR was indexed under INTEGRINS 1983-2002%A%  
% 208.15/208.37  |- mesh__dateCreated mesh__D038981 2002-07-03
% 208.15/208.37  |- skos__prefLabel mesh__D038981 Receptors, Collagen
% 208.15/208.37  |- skos__historyNote mesh__D018924 Vascular Resistance %28%1967-1995%29%
% 208.15/208.37  |- skos__prefLabel mesh__D018924 Vascular Capacitance
% 208.15/208.37  |- mesh__dateEstablished mesh__D018924 1996-01-01
% 208.15/208.37  |- skos__scopeNote mesh__D018924
% 208.15/208.37       The measure of a BLOOD VESSEL%27%s ability to increase the volume of BLOOD it holds without a large increase in BLOOD PRESSURE. The vascular capacitance is equal to the change in volume divided by the change in pressure.%A%    
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D018924 2004
% 208.15/208.37  |- skos__broader mesh__D018924smesh__D045472
% 208.15/208.37  |- rdf__type mesh__D018924sskos__Concept
% 208.15/208.37  |- skos__hiddenLabel mesh__D018924 Capacitance, Vascular
% 208.15/208.37  |- mesh__historyNote mesh__D018924 96   
% 208.15/208.37  |- mesh__dateCreated mesh__D018924 1995-02-22
% 208.15/208.37  |- mesh__publicMeSHNote mesh__D018924 96   
% 208.15/208.37  |- mesh__dateRevised mesh__D018924 2003-07-09
% 208.15/208.37  |- skos__related mesh__D018924smesh__D014655
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D018924 2006
% 208.15/208.37  |- skos__annotation mesh__D018924
% 208.15/208.37       do not confuse with VASCULAR RESISTANCE, opposition to blood flow in a vasc bed%A%  
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D018924 2005
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D010941 2002
% 208.15/208.37  |- skos__altLabel mesh__D010941 Crown Gall
% 208.15/208.37  |- mesh__recordOriginator mesh__D010941 NLM
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D010941 2001
% 208.15/208.37  |- rdf__type mesh__D010941sskos__Concept
% 208.15/208.37  |- mesh__dateCreated mesh__D010941 1999-01-01
% 208.15/208.37  |- skos__prefLabel mesh__D010941 Plant Tumors
% 208.15/208.37  |- skos__broader mesh__D010941smesh__D010935
% 208.15/208.37  |- skos__hiddenLabel mesh__D010941 Tumor, Plant
% 208.15/208.37  |- skos__hiddenLabel mesh__D010941 Plant Tumor
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D010941 2000
% 208.15/208.37  |- mesh__recordMaintainer mesh__D010941 JLS
% 208.15/208.37  |- skos__altLabel mesh__D010941 Plant Galls
% 208.15/208.37  |- mesh__recordAuthorizer mesh__D010941 SJN
% 208.15/208.37  |- skos__scopeNote mesh__D010941
% 208.15/208.37       A localized proliferation of plant tissue forming a swelling or outgrowth, commonly with a characteristic shape and unlike any organ of the normal plant. Plant tumors or galls usually form in response to the action of a pathogen or a pest. %28%Holliday, P., A Dictionary of Plant Pathology, 1989, p330%29%%A%    
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D010941 2004
% 208.15/208.37  |- skos__hiddenLabel mesh__D010941 Galls, Crown
% 208.15/208.37  |- skos__hiddenLabel mesh__D010941 Gall, Plant
% 208.15/208.37  |- mesh__dateRevised mesh__D010941 1997-06-20
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D010941 2003
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D010941 2006
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D010941 1999
% 208.15/208.37  |- skos__hiddenLabel mesh__D010941 Tumors, Plant
% 208.15/208.37  |- skos__hiddenLabel mesh__D010941 Plant Gall
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D010941 2005
% 208.15/208.37  |- skos__hiddenLabel mesh__D010941 Gall, Crown
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D010941 1998
% 208.15/208.37  |- skos__hiddenLabel mesh__D010941 Crown Galls
% 208.15/208.37  |- skos__altLabel mesh__D010941 Galls, Plant
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D018126 2003
% 208.15/208.37  |- skos__altLabel mesh__D018126 Odontogenic Dysplasia
% 208.15/208.37  |- skos__hiddenLabel mesh__D018126 Odontodysplasias
% 208.15/208.37  |- rdf__type mesh__D018126sskos__Concept
% 208.15/208.37  |- skos__hiddenLabel mesh__D018126 Tooth, Ghost
% 208.15/208.37  |- skos__hiddenLabel mesh__D018126 Teeth, Ghost
% 208.15/208.37  |- skos__prefLabel mesh__D018126 Odontodysplasia
% 208.15/208.37  |- mesh__historyNote mesh__D018126
% 208.15/208.37       94; ODONTOGENESIS IMPERFECTA was heading 1965-93   
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D018126 2004
% 208.15/208.37  |- skos__altLabel mesh__D018126 Ghost Teeth
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D018126 2002
% 208.15/208.37  |- mesh__dateEstablished mesh__D018126 1994-01-01
% 208.15/208.37  |- skos__broader mesh__D018126smesh__D014071
% 208.15/208.37  |- skos__hiddenLabel mesh__D018126 Odontogenic Dysplasias
% 208.15/208.37  |- mesh__recordOriginator mesh__D018126 TGC
% 208.15/208.37  |- skos__scopeNote mesh__D018126
% 208.15/208.37       A localized arrested tooth development which appears to involve most commonly the anterior teeth, usually on one side of the midline, most often the maxillary central and lateral incisors. Roentgenographically, the teeth have a ghostlike appearance. Calcification and bits of prismatic enamel may be found in the pulp and the enamel is thin and absent in part. %28%Jablonski, Illustrated Dictionary of Dentistry, 1982%29%%A%    
% 208.15/208.37  |- skos__hiddenLabel mesh__D018126 Dysplasia, Odontogenic
% 208.15/208.37  |- mesh__recordMaintainer mesh__D018126 kle
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D018126 2005
% 208.15/208.37  |- skos__annotation mesh__D018126
% 208.15/208.37       an abnorm of tooth develop; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 208.15/208.37  |- mesh__recordAuthorizer mesh__D018126 sjn
% 208.15/208.37  |- mesh__dateCreated mesh__D018126 1993-06-03
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D018126 2000
% 208.15/208.37  |- mesh__onlineNote mesh__D018126
% 208.15/208.37       use ODONTODYSPLASIA to search ODONTOGENESIS IMPERFECTA 1966-93%A%  
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D018126 2006
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D018126 2001
% 208.15/208.37  |- skos__altLabel mesh__D018126 Ghost Tooth
% 208.15/208.37  |- mesh__publicMeSHNote mesh__D018126
% 208.15/208.37       94; ODONTOGENESIS IMPERFECTA was heading 1965-93   
% 208.15/208.37  |- skos__hiddenLabel mesh__D018126 Dysplasias, Odontogenic
% 208.15/208.37  |- mesh__dateRevised mesh__D018126 1999-11-03
% 208.15/208.37  |- skos__scopeNote mesh__D010143
% 208.15/208.37       A mitosporic fungal genus occasionally causing human diseases such as pulmonary infections, mycotic keratitis, endocarditis, and opportunistic infections. Its teleomorph is Byssochlamys.%A%    
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D010143 2006
% 208.15/208.37  |- mesh__publicMeSHNote mesh__D010143 91; see HYPHOMYCETES 1986-90   
% 208.15/208.37  |- mesh__recordOriginator mesh__D010143 RC
% 208.15/208.37  |- mesh__historyNote mesh__D010143 91%28%86%29%   
% 208.15/208.37  |- skos__broader mesh__D010143smesh__D003904
% 208.15/208.37  |- mesh__recordMaintainer mesh__D010143 SYSTEM
% 208.15/208.37  |- skos__prefLabel mesh__D010143 Paecilomyces
% 208.15/208.37  |- mesh__dateRevised mesh__D010143 2005-06-30
% 208.15/208.37  |- mesh__dateEstablished mesh__D010143 1991-01-01
% 208.15/208.37  |- rdf__type mesh__D010143sskos__Concept
% 208.15/208.37  |- mesh__recordAuthorizer mesh__D010143 sjn
% 208.15/208.37  |- mesh__dateCreated mesh__D010143 1985-02-12
% 208.15/208.37  |- skos__annotation mesh__D010143
% 208.15/208.37       infection: coord IM with MYCOSES %28%IM%29% or specific mycosis %28%IM%29%%A%  
% 208.15/208.37  |- skos__historyNote mesh__D010143 Hyphomycetes %28%1966-1985%29%
% 208.15/208.37  |- mesh__dateEstablished mesh__D004106 1976-01-01
% 208.15/208.37  |- skos__broader mesh__D004106smesh__D008919
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004106 1994
% 208.15/208.37  |- skos__scopeNote mesh__D004106 The act of dilating.     
% 208.15/208.37  |- rdf__type mesh__D004106sskos__Concept
% 208.15/208.37  |- mesh__historyNote mesh__D004106
% 208.15/208.37       76%28%68%29%; was in Cat C %26% E 1968-75 %28%Prov 1968-74%29%; was see under PATHOLOGY 1975%A%  
% 208.15/208.37  |- mesh__dateCreated mesh__D004106 1999-01-01
% 208.15/208.37  |- mesh__dateRevised mesh__D004106 1992-05-14
% 208.15/208.37  |- skos__related mesh__D004106smesh__D001451
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004106 2004
% 208.15/208.37  |- mesh__publicMeSHNote mesh__D004106 76; was see under PATHOLOGY 1975   
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004106 2002
% 208.15/208.37  |- mesh__recordOriginator mesh__D004106 NLM
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004106 2006
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004106 1997
% 208.15/208.37  |- skos__hiddenLabel mesh__D004106 Dilatations
% 208.15/208.37  |- skos__prefLabel mesh__D004106 Dilatation
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004106 2003
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004106 1999
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004106 2001
% 208.15/208.37  |- mesh__recordMaintainer mesh__D004106 TAP
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004106 1993
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004106 2005
% 208.15/208.37  |- mesh__recordAuthorizer mesh__D004106 PLS
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004106 1996
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004106 1995
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004106 1998
% 208.15/208.37  |- skos__annotation mesh__D004106 note category   
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D004106 2000
% 208.15/208.37  |- rdf__type mesh__D020571sskos__Concept
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 sis Oncogenes
% 208.15/208.37  |- skos__altLabel mesh__D020571 sis Oncogene
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 Gene, c-sis
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 v sis Oncogenes
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 Genes, v-sis
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 v-sis Gene
% 208.15/208.37  |- mesh__publicMeSHNote mesh__D020571 2000; see ONCOGENES 1988-1999   
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 c-sis Gene
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 Gene, v-sis
% 208.15/208.37  |- mesh__historyNote mesh__D020571 2000; use ONCOGENES 1988-1999   
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 c sis Proto Oncogenes
% 208.15/208.37  |- skos__broader mesh__D020571smesh__D011519
% 208.15/208.37  |- skos__altLabel mesh__D020571 Genes, PDGFB
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 Proto-Oncogenes, c-sis
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 c sis Genes
% 208.15/208.37  |- skos__related mesh__D020571smesh__D020574
% 208.15/208.37  |- mesh__dateRevised mesh__D020571 2005-06-30
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 sis Gene
% 208.15/208.37  |- skos__altLabel mesh__D020571 c-sis Proto-Oncogenes
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 v-sis Oncogene
% 208.15/208.37  |- mesh__recordAuthorizer mesh__D020571 sjn
% 208.15/208.37  |- skos__altLabel mesh__D020571 sis Genes
% 208.15/208.37  |- skos__historyNote mesh__D020571 Oncogenes %28%1983-1999%29%
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 Oncogenes, v-sis
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 Genes, c-sis
% 208.15/208.37  |- skos__scopeNote mesh__D020571
% 208.15/208.37       Retrovirus-associated DNA sequences %28%v-sis%29% originally isolated from the simian sarcoma virus %28%SSV%29%. The proto-oncogene c-sis codes for a growth factor which is the B chain of PLATELET-DERIVED GROWTH FACTOR. v-sis or overexpression of c-sis causes tumorigenesis. The human sis gene is located at 22q12.3-13.1 on the long arm of chromosome 22.%A%    
% 208.15/208.37  |- mesh__dateCreated mesh__D020571 1999-11-03
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 Proto-Oncogene, c-sis
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 Gene, sis
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 v sis Genes
% 208.15/208.37  |- skos__related mesh__D020571smesh__D020575
% 208.15/208.37  |- skos__prefLabel mesh__D020571 Genes, sis
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 PDGFB Genes
% 208.15/208.37  |- mesh__recordMaintainer mesh__D020571 nns
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 c-sis Proto-Oncogene
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 Oncogene, v-sis
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 Oncogenes, sis
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 Gene, PDGFB
% 208.15/208.37  |- mesh__recordOriginator mesh__D020571 ags
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D020571 2006
% 208.15/208.37  |- mesh__dateEstablished mesh__D020571 2000-01-01
% 208.15/208.37  |- skos__altLabel mesh__D020571 v-sis Oncogenes
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 Oncogene, sis
% 208.15/208.37  |- skos__hiddenLabel mesh__D020571 PDGFB Gene
% 208.15/208.37  |- skos__hiddenLabel mesh__D014534 Epimerase, UDP Galactose
% 208.15/208.37  |- skos__hiddenLabel mesh__D014534 4-Epimerase, UDPglucose
% 208.15/208.37  |- skos__historyNote mesh__D014534
% 208.15/208.37       Carbohydrate Isomerases %28%1973-1974%29%
% 208.15/208.37  |- skos__historyNote mesh__D014534 Glucose %28%1973-1974%29%
% 208.15/208.37  |- mesh__recordOriginator mesh__D014534 NLM
% 208.15/208.37  |- mesh__dateRevised mesh__D014534 2003-07-09
% 208.15/208.37  |- skos__hiddenLabel mesh__D014534 UDP Glucose 4 Epimerase
% 208.15/208.37  |- mesh__publicMeSHNote mesh__D014534
% 208.15/208.37       98; see URIDINE DIPHOSPHATE GLUCOSE EPIMERASE 1991-97, see CARBOHYDRATE ISOMERASES 1975-90; UDPGALACTOSE 4-EPIMERASE %26% UPD-GALACTOSE 4-EPIMERASE were indexed under CARBOHYDRATE ISOMERASES 1977-96, GALACTOSE 1977-82, and UDPGLUCOSE 4-EPIMERASE 1977-98,%A%  
% 208.15/208.37  |- skos__hiddenLabel mesh__D014534 UDPglucose 4 Epimerase
% 208.15/208.37  |- skos__altLabel mesh__D014534 UDP-Glucose 4-Epimerase
% 208.15/208.37  |- skos__hiddenLabel mesh__D014534 4-Epimerase, UDP-Galactose
% 208.15/208.37  |- skos__hiddenLabel mesh__D014534 UDP Galactose 4 Epimerase
% 208.15/208.37  |- skos__altLabel mesh__D014534 UDP Galactose Epimerase
% 208.15/208.37  |- skos__hiddenLabel mesh__D014534 Epimerase, UDP Glucose
% 208.15/208.37  |- skos__broader mesh__D014534smesh__D002238
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D014534 2004
% 208.15/208.37  |- skos__historyNote mesh__D014534 Galactose %28%1973-1974%29%
% 208.15/208.37  |- skos__altLabel mesh__D014534 UDP-Galactose 4-Epimerase
% 208.15/208.37  |- skos__hiddenLabel mesh__D014534 Galactose Epimerase, UDP
% 208.15/208.37  |- rdf__type mesh__D014534sskos__Concept
% 208.15/208.37  |- skos__related mesh__D014534smesh__D005693
% 208.15/208.37  |- skos__hiddenLabel mesh__D014534 Glucose Epimerase, UDP
% 208.15/208.37  |- skos__hiddenLabel mesh__D014534 UDPgalactose 4 Epimerase
% 208.15/208.37  |- skos__altLabel mesh__D014534 Uridine Diphosphate Glucose Epimerase
% 208.15/208.37  |- mesh__activeMeSHYear mesh__D014534 2005
% 208.15/208.37  |- skos__prefLabel mesh__D014534 UDPglucose 4-Epimerase
% 208.15/208.38  |- skos__scopeNote mesh__D014534
% 208.15/208.38       A necessary enzyme in the metabolism of galactose. It reversibly catalyzes the conversion of UDPglucose to UDPgalactose. NAD+ is an essential component for enzymatic activity. EC 5.1.3.2.%A%    
% 208.15/208.38  |- mesh__dateCreated mesh__D014534 1974-11-11
% 208.15/208.38  |- skos__altLabel mesh__D014534 UDPgalactose 4-Epimerase
% 208.15/208.38  |- mesh__recordAuthorizer mesh__D014534 sjn
% 208.15/208.38  |- mesh__activeMeSHYear mesh__D014534 2006
% 208.15/208.38  |- mesh__recordMaintainer mesh__D014534 ssb
% 208.15/208.38  |- skos__hiddenLabel mesh__D014534 4-Epimerase, UDPgalactose
% 208.15/208.38  |- mesh__dateEstablished mesh__D014534 1991-01-01
% 208.15/208.38  |- skos__historyNote mesh__D014534
% 208.15/208.38       Uridine Diphosphate Sugars %28%1973-1974%29%
% 208.15/208.38  |- skos__hiddenLabel mesh__D014534 4-Epimerase, UDP-Glucose
% 208.15/208.38  |- skos__altLabel mesh__D014534 UDP Glucose Epimerase
% 208.15/208.38  |- mesh__historyNote mesh__D014534
% 208.15/208.38       98%28%75%29%; for UDPGALACTOSE 4-EPIMERASE use GALACTOSE EPIMERASE %28%NM%29% 1977-98; for UDP-GALACTOSE 4-EPIPMERASE use GALACTOSE EPIMERASE %28%NM%29% 1977-98%A%  
% 208.15/208.38  |- mesh__publicMeSHNote mesh__D000514 87   
% 208.15/208.38  |- mesh__dateCreated mesh__D000514 1986-04-14
% 208.15/208.38  |- mesh__historyNote mesh__D000514 87   
% 208.15/208.38  |- skos__scopeNote mesh__D000514
% 208.15/208.38       Glycoprotein found in alpha%28%1%29%-globulin region in human serum. It inhibits chymotrypsin-like proteinases in vivo and has cytotoxic killer-cell activity in vitro. The protein also has a role as an acute-phase protein and is active in the control of immunologic and inflammatory processes, and as a tumor marker. It is a member of the serpin superfamily.%A%    
% 208.15/208.38  |- skos__broader mesh__D000514smesh__D006023
% 208.15/208.38  |- skos__historyNote mesh__D000514
% 208.15/208.38       Chymotrypsin/antagonists %26% inhibitors %28%1968-1986%29%
% 208.15/208.38  |- skos__prefLabel mesh__D000514 alpha 1-Antichymotrypsin
% 208.15/208.38  |- skos__broader mesh__D000514smesh__D000510
% 208.15/208.38  |- rdf__type mesh__D000514sskos__Concept
% 208.15/208.38  |- skos__historyNote mesh__D000514 Glycoproteins %28%1966-1986%29%
% 208.15/208.38  |- mesh__recordAuthorizer mesh__D000514 sjn
% 208.15/208.38  |- skos__hiddenLabel mesh__D000514 gp68, Glycoprotein
% 208.15/208.38  |- mesh__dateEstablished mesh__D000514 1987-01-01
% 208.15/208.38  |- mesh__dateRevised mesh__D000514 2004-07-13
% 208.15/208.38  |- mesh__recordMaintainer mesh__D000514 sjn
% 208.15/208.38  |- skos__altLabel mesh__D000514 alpha%28%1%29%-Antichymotrypsin
% 208.15/208.38  |- mesh__activeMeSHYear mesh__D000514 2006
% 208.15/208.38  |- skos__broader mesh__D000514smesh__D015843
% 208.15/208.38  |- skos__annotation mesh__D000514
% 208.15/208.38       a serpin %26% acute phase protein; /biosyn /physiol permitted%A%  
% 208.15/208.38  |- skos__broader mesh__D000514smesh__D000209
% 208.15/208.38  |- skos__historyNote mesh__D000514 Protease Inhibitors %28%1979-1986%29%
% 208.15/208.38  |- mesh__recordOriginator mesh__D000514 RLS
% 208.15/208.38  |- mesh__activeMeSHYear mesh__D000514 2005
% 208.15/208.38  |- skos__hiddenLabel mesh__D000514 1-Antichymotrypsin, alpha
% 208.15/208.38  |- skos__hiddenLabel mesh__D000514 alpha 1 Antichymotrypsin
% 208.15/208.38  |- mesh__activeMeSHYear mesh__D038982 2006
% 208.15/208.38  |- mesh__publicMeSHNote mesh__D038982
% 208.15/208.38       2003; INTEGRIN ALPHA2BETA1 was indexed under INTEGRINS 1994-2002%A%  
% 208.15/208.38  |- skos__altLabel mesh__D038982 alpha2beta1Integrin
% 208.15/208.38  |- skos__broader mesh__D038982smesh__D038981
% 208.15/208.38  |- skos__hiddenLabel mesh__D038982 Late Antigen-2, Very
% 208.15/208.38  |- skos__altLabel mesh__D038982 CD49b-CD29
% 208.15/208.38  |- skos__hiddenLabel mesh__D038982 VLA 2
% 208.15/208.38  |- skos__altLabel mesh__D038982
% 208.15/208.38       Platelet Membrane Glycoprotein Heterodimer Ia-IIa
% 208.15/208.38  |- skos__broader mesh__D038982smesh__D017469
% 208.15/208.38  |- skos__prefLabel mesh__D038982 Integrin alpha2beta1
% 208.15/208.38  |- rdf__type mesh__D038982sskos__Concept
% 208.15/208.38  |- skos__altLabel mesh__D038982 Very Late Antigen-2
% 208.15/208.38  |- skos__broader mesh__D038982smesh__D017474
% 208.15/208.38  |- skos__historyNote mesh__D038982 Integrins %28%1994-2002%29%
% 208.15/208.38  |- mesh__recordAuthorizer mesh__D038982 sjn
% 208.15/208.38  |- skos__hiddenLabel mesh__D038982 CD49b CD29
% 208.15/208.38  |- mesh__dateCreated mesh__D038982 2002-07-02
% 208.15/208.38  |- mesh__dateEstablished mesh__D038982 2003-01-01
% 208.15/208.38  |- skos__hiddenLabel mesh__D038982
% 208.15/208.38       Platelet Membrane Glycoprotein Heterodimer Ia IIa
% 208.15/208.38  |- mesh__historyNote mesh__D038982
% 208.15/208.38       2003; for VLA-2 use COLLAGEN RECEPTORS %28%NM%29% 1991-2002; for PLATELET MEMBRANE GLYCOPROTEIN HETERODIMER IA-IIA use COLLAGEN RECEPTORS %28%NM%29% 1992-2000; for INTEGRIN ALPHA2BETA1 %26% CD49B-CD29 use COLLAGEN RECEPTORS %28%NM%29% 1994-2002; for ALPHA2BETA1INTEGRIN use COLLAGEN RECEPTORS %28%NM%29% 2001-2002%A%  
% 208.15/208.38  |- mesh__recordMaintainer mesh__D038982 jmp
% 208.15/208.38  |- skos__scopeNote mesh__D038982
% 208.15/208.38       An integrin found on fibroblasts, platelets, endothelial and epithelial cells, and lymphocytes where it functions as a receptor for COLLAGEN and LAMININ. Although originally referred to as the collagen receptor, it is one of several receptors for collagen. Ligand binding to integrin alpha2beta1 triggers a cascade of intracellular signaling, including activation of p38 MAP kinase.%A%    
% 208.15/208.38  |- skos__hiddenLabel mesh__D038982 alpha2beta1, Integrin
% 208.15/208.38  |- skos__broader mesh__D038982smesh__D016029
% 208.15/208.38  |- skos__altLabel mesh__D038982 VLA-2
% 208.15/208.38  |- mesh__recordOriginator mesh__D038982 MDJ
% 208.15/208.38  |- mesh__dateRevised mesh__D038982 2005-06-30
% 208.15/208.38  |- skos__hiddenLabel mesh__D038982 Glycoprotein Ia IIa
% 208.15/208.38  |- skos__broader mesh__D038982smesh__D010980
% 208.15/208.38  |- skos__hiddenLabel mesh__D038982 Very Late Antigen 2
% 208.15/208.38  |- skos__historyNote mesh__D038982 Collagen Receptors %28%1991-2002%29%
% 208.15/208.38  |- skos__altLabel mesh__D038982 Glycoprotein Ia-IIa
% 208.15/208.38  |- rdf__type mesh__D018925sskos__Concept
% 208.15/208.38  |- mesh__recordAuthorizer mesh__D018925 sjn
% 208.15/208.38  |- mesh__historyNote mesh__D018925 96   
% 208.15/208.38  |- skos__broader mesh__D018925smesh__D002630
% 208.15/208.38  |- skos__annotation mesh__D018925
% 208.15/208.38       a class of cytokines that attract %26% activate leukocytes; chemokines stands for CHEMOtactic cytoKINES; GEN or unspecified; prefer specifics%A%  
% 208.15/208.38  |- skos__prefLabel mesh__D018925 Chemokines
% 208.15/208.38  |- mesh__activeMeSHYear mesh__D018925 2006
% 208.15/208.38  |- mesh__dateEstablished mesh__D018925 1996-01-01
% 208.15/208.38  |- mesh__recordMaintainer mesh__D018925 ssb
% 208.15/208.38  |- skos__altLabel mesh__D018925 Intercrines
% 208.15/208.38  |- skos__altLabel mesh__D018925 Chemotactic Cytokines
% 208.15/208.38  |- skos__historyNote mesh__D018925 Cytokines %28%1992-1995%29%
% 208.15/208.38  |- skos__historyNote mesh__D018925 Chemotactic Factors %28%1992-1995%29%
% 208.15/208.38  |- skos__altLabel mesh__D018925 Cytokines, Chemotactic
% 208.15/208.38  |- mesh__recordOriginator mesh__D018925 AGS
% 208.15/208.38  |- skos__broader mesh__D018925smesh__D016207
% 208.15/208.38  |- skos__related mesh__D018925smesh__D002634
% 208.15/208.38  |- skos__broader mesh__D018925smesh__D018836
% 208.15/208.38  |- mesh__dateCreated mesh__D018925 1995-02-17
% 208.15/208.38  |- mesh__dateRevised mesh__D018925 2005-06-30
% 208.15/208.38  |- skos__scopeNote mesh__D018925
% 208.15/208.38       Class of pro-inflammatory cytokines that have the ability to attract and activate leukocytes. They can be divided into at least three structural branches: C; %28%CHEMOKINES, C%29%; CC; %28%CHEMOKINES, CC%29%; and CXC; %28%CHEMOKINES, CXC%29%; according to variations in a shared cysteine motif.%A%    
% 208.15/208.38  |- mesh__publicMeSHNote mesh__D018925 96   
% 208.15/208.38  |- rdf__type mesh__D010942sskos__Concept
% 208.24/208.38  |- mesh__historyNote mesh__D010942
% 208.24/208.38       PHYTOPHAGINEAE was see under PLANT VIRUSES 1963-78   
% 208.24/208.38  |- skos__hiddenLabel mesh__D010942 Virus, Plant
% 208.24/208.38  |- mesh__dateRevised mesh__D010942 1995-03-13
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010942 2002
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010942 2004
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010942 1997
% 208.24/208.38  |- skos__altLabel mesh__D010942 Phytophagineae
% 208.24/208.38  |- mesh__recordAuthorizer mesh__D010942 PLS
% 208.24/208.38  |- skos__annotation mesh__D010942
% 208.24/208.38       GEN or unspecified; prefer specifics; coord IM with specific plant /virol %28%IM or NIM%29%%A%  
% 208.24/208.38  |- skos__hiddenLabel mesh__D010942 Viruses, Plant
% 208.24/208.38  |- skos__prefLabel mesh__D010942 Plant Viruses
% 208.24/208.38  |- skos__hiddenLabel mesh__D010942 Plant Virus
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010942 2001
% 208.24/208.38  |- mesh__recordOriginator mesh__D010942 NLM
% 208.24/208.38  |- mesh__recordMaintainer mesh__D010942 TGC
% 208.24/208.38  |- mesh__publicMeSHNote mesh__D010942
% 208.24/208.38       PHYTOPHAGINEAE was see under PLANT VIRUSES 1963-78   
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010942 2006
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010942 2003
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010942 1999
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010942 1996
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010942 2000
% 208.24/208.38  |- skos__scopeNote mesh__D010942
% 208.24/208.38       Viruses parasitic on plants higher than bacteria.     
% 208.24/208.38  |- skos__broader mesh__D010942smesh__D014780
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010942 2005
% 208.24/208.38  |- mesh__onlineNote mesh__D010942
% 208.24/208.38       use PLANT VIRUSES to search PHYTOPHAGINEAE 1966-78   
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010942 1998
% 208.24/208.38  |- mesh__dateCreated mesh__D010942 1999-01-01
% 208.24/208.38  |- skos__historyNote mesh__D018127 Antigens, CD %28%1989-1993%29%
% 208.24/208.38  |- skos__broader mesh__D018127smesh__D018124
% 208.24/208.38  |- skos__broader mesh__D018127smesh__D000945
% 208.24/208.38  |- skos__hiddenLabel mesh__D018127 Antigen, T-Cell Activation
% 208.24/208.38  |- mesh__dateRevised mesh__D018127 2005-06-30
% 208.24/208.38  |- skos__hiddenLabel mesh__D018127 Activation Antigen, T-Cell
% 208.24/208.38  |- skos__altLabel mesh__D018127 Antigen, CD27
% 208.24/208.38  |- skos__hiddenLabel mesh__D018127 Receptor, TNFRSF7
% 208.24/208.38  |- mesh__recordOriginator mesh__D018127 AGS
% 208.24/208.38  |- skos__altLabel mesh__D018127 T-Cell Activation Antigen
% 208.24/208.38  |- mesh__publicMeSHNote mesh__D018127
% 208.24/208.38       94; CD27 ANTIGEN was indexed under ANTIGENS, CD %26% ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1989-93; T-CELL ACTIVATION ANTIGEN was indexed under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1983-93%A%  
% 208.24/208.38  |- skos__hiddenLabel mesh__D018127 T Cell Activation Antigen
% 208.24/208.38  |- mesh__dateEstablished mesh__D018127 1994-01-01
% 208.24/208.38  |- skos__prefLabel mesh__D018127 Antigens, CD27
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D018127 2006
% 208.24/208.38  |- mesh__historyNote mesh__D018127
% 208.24/208.38       94; was CD27 ANTIGEN %28%NM%29% 1989-93; T-CELL ACTIVATION ANTIGEN was T CELL ACTIVATION ANTIGEN %28%NM%29% 1983-93%A%  
% 208.24/208.38  |- skos__historyNote mesh__D018127
% 208.24/208.38       Antigens, Differentiation, T-Lymphocyte %28%1989-1993%29%
% 208.24/208.38  |- skos__broader mesh__D018127smesh__D015703
% 208.24/208.38  |- mesh__dateCreated mesh__D018127 1993-06-04
% 208.24/208.38  |- skos__hiddenLabel mesh__D018127 CD27 Antigen
% 208.24/208.38  |- skos__altLabel mesh__D018127 TNFRSF7 Receptor
% 208.24/208.38  |- mesh__onlineNote mesh__D018127
% 208.24/208.38       use ANTIGENS, CD27 %28%NM%29% to search CD27 ANTIGEN 1989-93 and T CELL ACTIVATION ANTIGEN 1983-93%A%  
% 208.24/208.38  |- mesh__recordAuthorizer mesh__D018127 sjn
% 208.24/208.38  |- skos__altLabel mesh__D018127
% 208.24/208.38       Tumor Necrosis Factor Receptor Superfamily, Member 7
% 208.24/208.38  |- mesh__recordMaintainer mesh__D018127 ssb
% 208.24/208.38  |- skos__scopeNote mesh__D018127
% 208.24/208.38       A member of the tumor necrosis factor receptor superfamily found on most T-LYMPHOCYTES.  Activation of T-cells by the receptor increases CD27 surface expression and T cell expansion.%A%    
% 208.24/208.38  |- rdf__type mesh__D018127sskos__Concept
% 208.24/208.38  |- skos__altLabel mesh__D018127 CD27 Antigens
% 208.24/208.38  |- skos__broader mesh__D018100Q000819smesh__D018100
% 208.24/208.38  |- mesh__preferredCombination mesh__D018100Q000819smesh__D017442
% 208.24/208.38  |- rdf__type mesh__D018100Q000819smesh__CompoundConcept
% 208.24/208.38  |- skos__altLabel mesh__D010144 Mammary Paget%27%s Disease
% 208.24/208.38  |- skos__prefLabel mesh__D010144 Paget%27%s Disease, Mammary
% 208.24/208.38  |- skos__hiddenLabel mesh__D010144 Pagets Disease, Mammary
% 208.24/208.38  |- mesh__recordOriginator mesh__D010144 NLM
% 208.24/208.38  |- skos__altLabel mesh__D010144 Mammary Paget Disease
% 208.24/208.38  |- rdf__type mesh__D010144sskos__Concept
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010144 2003
% 208.24/208.38  |- skos__scopeNote mesh__D010144
% 208.24/208.38       An intraductal carcinoma of the breast extending to involve the nipple and areola, characterized clinically by eczema-like inflammatory skin changes and histologically by infiltration of the dermis by malignant cells %28%Paget%27%s cells%29%. %28%Dorland, 27th ed%29%%A%    
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010144 2000
% 208.24/208.38  |- mesh__dateCreated mesh__D010144 1999-01-01
% 208.24/208.38  |- skos__altLabel mesh__D010144 Paget Disease, Mammary
% 208.24/208.38  |- mesh__historyNote mesh__D010144
% 208.24/208.38       94; was PAGET%27%S DISEASE OF BREAST 1975-93 %28%see under CARCINOMA, DUCTAL 1975-90%29%%A%  
% 208.24/208.38  |- skos__hiddenLabel mesh__D010144 Disease, Mammary Paget%27%s
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010144 2004
% 208.24/208.38  |- mesh__dateEstablished mesh__D010144 1991-01-01
% 208.24/208.38  |- skos__altLabel mesh__D010144 Paget Disease of Breast
% 208.24/208.38  |- skos__annotation mesh__D010144
% 208.24/208.38       neoplastic; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with BREAST NEOPLASMS %28%IM%29%%A%  
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010144 1996
% 208.24/208.38  |- mesh__dateRevised mesh__D010144 1995-06-08
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010144 2001
% 208.24/208.38  |- mesh__onlineNote mesh__D010144
% 208.24/208.38       use PAGET%27%S DISEASE, MAMMARY to search PAGET%27%S DISEASE OF BREAST 1975-93; search CARCINOMA, INTRADUCTAL, NONINFILTRATING 1966-74%A%  
% 208.24/208.38  |- skos__altLabel mesh__D010144 Paget%27%s Disease of Breast
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010144 2005
% 208.24/208.38  |- mesh__recordMaintainer mesh__D010144 KEV
% 208.24/208.38  |- skos__hiddenLabel mesh__D010144 Pagets Disease, Breast
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010144 1997
% 208.24/208.38  |- skos__hiddenLabel mesh__D010144 Mammary Pagets Disease
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010144 2002
% 208.24/208.38  |- mesh__recordAuthorizer mesh__D010144 PLS
% 208.24/208.38  |- skos__hiddenLabel mesh__D010144 Paget Disease, Breast
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010144 2006
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010144 1998
% 208.24/208.38  |- skos__hiddenLabel mesh__D010144 Disease, Mammary Paget
% 208.24/208.38  |- mesh__publicMeSHNote mesh__D010144
% 208.24/208.38       94; was PAGET%27%S DISEASE OF BREAST 1975-93 %28%see under CARCINOMA, DUCTAL 1975-90%29%%A%  
% 208.24/208.38  |- skos__broader mesh__D010144smesh__D002285
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D010144 1999
% 208.24/208.38  |- mesh__recordMaintainer mesh__D004905 nns
% 208.24/208.38  |- mesh__dateEstablished mesh__D004905 1967-01-01
% 208.24/208.38  |- skos__broader mesh__D004905smesh__D045123
% 208.24/208.38  |- skos__annotation mesh__D004905
% 208.24/208.38       coord with disease /blood, not /physiopathol   
% 208.24/208.38  |- mesh__historyNote mesh__D004905 67%28%65%29%   
% 208.24/208.38  |- skos__prefLabel mesh__D004905 Erythrocyte Aging
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D004905 2006
% 208.24/208.38  |- mesh__recordOriginator mesh__D004905 NLM
% 208.24/208.38  |- skos__hiddenLabel mesh__D004905 Survival, Erythrocyte
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D004905 2004
% 208.24/208.38  |- rdf__type mesh__D004905sskos__Concept
% 208.24/208.38  |- mesh__dateCreated mesh__D004905 1999-01-01
% 208.24/208.38  |- skos__scopeNote mesh__D004905
% 208.24/208.38       The senescence of RED BLOOD CELLS. Lacking the organelles that make protein synthesis possible, the mature erythrocyte is incapable of self-repair, reproduction, and carrying out certain functions performed by other cells. This limits the average life span of an erythrocyte to 120 days.%A%    
% 208.24/208.38  |- mesh__recordAuthorizer mesh__D004905 sjn
% 208.24/208.38  |- skos__hiddenLabel mesh__D004905 Aging, Erythrocyte
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D004905 2005
% 208.24/208.38  |- skos__broader mesh__D004905smesh__D016922
% 208.24/208.38  |- mesh__publicMeSHNote mesh__D004905 67   
% 208.24/208.38  |- mesh__dateRevised mesh__D004905 2003-07-09
% 208.24/208.38  |- skos__altLabel mesh__D004107 Dilatation %26% Curettage
% 208.24/208.38  |- skos__prefLabel mesh__D004107 Dilatation and Curettage
% 208.24/208.38  |- rdf__type mesh__D004107sskos__Concept
% 208.24/208.38  |- skos__broader mesh__D004107smesh__D013509
% 208.24/208.38  |- skos__scopeNote mesh__D004107
% 208.24/208.38       Dilatation of the cervix uteri followed by a scraping of the endometrium with a curette.%A%    
% 208.24/208.38  |- mesh__publicMeSHNote mesh__D004107 75   
% 208.24/208.38  |- mesh__historyNote mesh__D004107 75   
% 208.24/208.38  |- mesh__recordOriginator mesh__D004107 NLM
% 208.24/208.38  |- mesh__recordMaintainer mesh__D004107 PXP
% 208.24/208.38  |- mesh__dateRevised mesh__D004107 1997-06-20
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D004107 2002
% 208.24/208.38  |- mesh__dateCreated mesh__D004107 1974-11-19
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D004107 2004
% 208.24/208.38  |- mesh__recordAuthorizer mesh__D004107 SJN
% 208.24/208.38  |- skos__broader mesh__D004107smesh__D003475
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D004107 2001
% 208.24/208.38  |- skos__altLabel mesh__D004107 Curettage and Dilatation
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D004107 1999
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D004107 2003
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D004107 2006
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D004107 2000
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D004107 1998
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D004107 2005
% 208.24/208.38  |- skos__historyNote mesh__D004107 Curettage %28%1966-1974%29%
% 208.24/208.38  |- skos__altLabel mesh__D004107 D%26%C
% 208.24/208.38  |- skos__annotation mesh__D004107
% 208.24/208.38       do not use /util except by MeSH definition; DF: D %26% C   
% 208.24/208.38  |- mesh__dateEstablished mesh__D004107 1975-09-01
% 208.24/208.38  |- skos__altLabel mesh__D020572 v-rel Proteins
% 208.24/208.38  |- skos__broader mesh__D020572smesh__D015682
% 208.24/208.38  |- skos__hiddenLabel mesh__D020572 Oncogene Products v rel
% 208.24/208.38  |- skos__altLabel mesh__D020572 Oncogene Protein rel
% 208.24/208.38  |- mesh__dateEstablished mesh__D020572 2000-01-01
% 208.24/208.38  |- skos__hiddenLabel mesh__D020572 rel, Oncogene Proteins
% 208.24/208.38  |- skos__historyNote mesh__D020572
% 208.24/208.38       Retroviridae Proteins, Oncogenic %28%1990-1999%29%
% 208.24/208.38  |- skos__hiddenLabel mesh__D020572 Oncogene Proteins, rel
% 208.24/208.38  |- mesh__recordOriginator mesh__D020572 ags
% 208.24/208.38  |- mesh__historyNote mesh__D020572
% 208.24/208.38       2000; use ONCOGENE PROTEINS V-REL %28%NM%29% 1988-1999   
% 208.24/208.38  |- mesh__dateRevised mesh__D020572 2005-06-30
% 208.24/208.38  |- mesh__recordMaintainer mesh__D020572 SYSTEM
% 208.24/208.38  |- skos__historyNote mesh__D020572
% 208.24/208.38       Oncogene Proteins, Viral %28%1986-1987%29%
% 208.24/208.38  |- skos__altLabel mesh__D020572 rel Oncogene Proteins
% 208.24/208.38  |- mesh__dateCreated mesh__D020572 1999-11-03
% 208.24/208.38  |- skos__prefLabel mesh__D020572 Oncogene Proteins v-rel
% 208.24/208.38  |- skos__scopeNote mesh__D020572
% 208.24/208.38       Transforming proteins coded by rel oncogenes. The v-rel protein competes with rel-related proteins and probably transforms cells by acting as a dominant negative version of c-rel. This results in the induction of a broad range of leukemias and lymphomas.%A%    
% 208.24/208.38  |- mesh__recordAuthorizer mesh__D020572 sjn
% 208.24/208.38  |- skos__altLabel mesh__D020572 Oncogene Products v-rel
% 208.24/208.38  |- skos__related mesh__D020572smesh__D020573
% 208.24/208.38  |- mesh__publicMeSHNote mesh__D020572
% 208.24/208.38       2000; ONCOGENE PROTEIN REL was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-1999 %26% RETROVIRIDAE PROTEINS 1988-1989%A%  
% 208.24/208.38  |- skos__hiddenLabel mesh__D020572 Proteins, v-rel
% 208.24/208.38  |- skos__altLabel mesh__D020572 v-rel Protein
% 208.24/208.38  |- skos__altLabel mesh__D020572 Oncogene Proteins rel
% 208.24/208.38  |- skos__altLabel mesh__D020572 pp59%28%v-rel%29%
% 208.24/208.38  |- skos__hiddenLabel mesh__D020572 v-rel, Oncogene Proteins
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D020572 2006
% 208.24/208.38  |- skos__hiddenLabel mesh__D020572 v rel Protein
% 208.24/208.38  |- skos__altLabel mesh__D020572 Oncogene Protein pp59%28%v-rel%29%
% 208.24/208.38  |- skos__hiddenLabel mesh__D020572 v rel Proteins
% 208.24/208.38  |- rdf__type mesh__D020572sskos__Concept
% 208.24/208.38  |- skos__historyNote mesh__D020572 Retroviridae Proteins %28%1988-1989%29%
% 208.24/208.38  |- skos__hiddenLabel mesh__D020572 rel, Oncogene Protein
% 208.24/208.38  |- skos__hiddenLabel mesh__D020572 Protein, v-rel
% 208.24/208.38  |- skos__hiddenLabel mesh__D020572 v-rel, Oncogene Products
% 208.24/208.38  |- skos__hiddenLabel mesh__D020572 Oncogene Proteins v rel
% 208.24/208.38  |- skos__hiddenLabel mesh__D014535 Acid, Uridine Diphosphoglucuronic
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D014535 2006
% 208.24/208.38  |- mesh__dateCreated mesh__D014535 1974-11-19
% 208.24/208.38  |- mesh__publicMeSHNote mesh__D014535
% 208.24/208.38       91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90   
% 208.24/208.38  |- skos__hiddenLabel mesh__D014535 Acid, UDP Glucuronic
% 208.24/208.38  |- skos__altLabel mesh__D014535 UDPGA
% 208.24/208.38  |- rdf__type mesh__D014535sskos__Concept
% 208.24/208.38  |- skos__hiddenLabel mesh__D014535 Diphosphoglucuronic Acid, Uridine
% 208.24/208.38  |- skos__historyNote mesh__D014535 Glucuronates %28%1973-1974%29%
% 208.24/208.38  |- skos__altLabel mesh__D014535 Uridine Diphosphoglucuronic Acid
% 208.24/208.38  |- skos__related mesh__D014535smesh__D020719
% 208.24/208.38  |- skos__hiddenLabel mesh__D014535 Glucuronic Acid, UDP
% 208.24/208.38  |- skos__prefLabel mesh__D014535 Uridine Diphosphate Glucuronic Acid
% 208.24/208.38  |- mesh__recordAuthorizer mesh__D014535 sjn
% 208.24/208.38  |- skos__altLabel mesh__D014535 UDP Glucuronic Acid
% 208.24/208.38  |- mesh__recordMaintainer mesh__D014535 ssb
% 208.24/208.38  |- mesh__historyNote mesh__D014535
% 208.24/208.38       91%28%75%29%; was see under URIDINE DIPHOSPHATE SUGARS 1975-90   
% 208.24/208.38  |- skos__historyNote mesh__D014535
% 208.24/208.38       Uridine Diphosphate Sugars %28%1973-1974%29%
% 208.24/208.38  |- mesh__dateRevised mesh__D014535 2004-07-07
% 208.24/208.38  |- mesh__dateEstablished mesh__D014535 1991-01-01
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D014535 2005
% 208.24/208.38  |- skos__scopeNote mesh__D014535
% 208.24/208.38       A nucleoside diphosphate sugar which serves as a source of glucuronic acid for polysaccharide biosynthesis. It may also be epimerized to UDP iduronic acid, which donates iduronic acid to polysaccharides. In animals, UDP glucuronic acid is used for formation of many glucosiduronides with various aglycones.%A%    
% 208.24/208.38  |- skos__broader mesh__D014535smesh__D014539
% 208.24/208.38  |- mesh__recordOriginator mesh__D014535 NLM
% 208.24/208.38  |- skos__hiddenLabel mesh__D000515 alpha 1 Proteinase Inhibitor
% 208.24/208.38  |- skos__hiddenLabel mesh__D000515 1-Antiproteinase, alpha
% 208.24/208.38  |- rdf__type mesh__D000515sskos__Concept
% 208.24/208.38  |- mesh__publicMeSHNote mesh__D000515 74   
% 208.24/208.38  |- mesh__recordOriginator mesh__D000515 NLM
% 208.24/208.38  |- skos__altLabel mesh__D000515 alpha 1-Proteinase Inhibitor
% 208.24/208.38  |- skos__hiddenLabel mesh__D000515 Antiprotease, alpha 1
% 208.24/208.38  |- skos__hiddenLabel mesh__D000515 alpha 1 Proteinase Inhibitor S
% 208.24/208.38  |- skos__scopeNote mesh__D000515
% 208.24/208.38       Plasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES. Commonly referred to as alpha 1-proteinase inhibitor %28%A1PI%29%, it exists in over 30 different biochemical variant forms known collectively as the Pi %28%protease inhibitor%29% system. Hereditary A1PI deficiency is associated with PULMONARY EMPHYSEMA.%A%    
% 208.24/208.38  |- skos__hiddenLabel mesh__D000515 Trypsin Inhibitor, alpha 1 Antitrypsin
% 208.24/208.38  |- skos__hiddenLabel mesh__D000515 Inhibitor, alpha 1-Protease
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D000515 2006
% 208.24/208.38  |- skos__prefLabel mesh__D000515 alpha 1-Antitrypsin
% 208.24/208.38  |- skos__related mesh__D000515smesh__D019896
% 208.24/208.38  |- skos__broader mesh__D000515smesh__D015843
% 208.24/208.38  |- skos__hiddenLabel mesh__D000515 Inhibitor, alpha 1-Proteinase
% 208.24/208.38  |- skos__altLabel mesh__D000515 A1PI
% 208.24/208.38  |- skos__broader mesh__D000515smesh__D000510
% 208.24/208.38  |- mesh__historyNote mesh__D000515 74   
% 208.24/208.38  |- mesh__recordAuthorizer mesh__D000515 sjn
% 208.24/208.38  |- mesh__dateRevised mesh__D000515 2004-07-07
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D000515 2005
% 208.24/208.38  |- skos__altLabel mesh__D000515 alpha 1-Antiproteinase
% 208.24/208.38  |- skos__hiddenLabel mesh__D000515 alpha 1 Antiproteinase
% 208.24/208.38  |- skos__broader mesh__D000515smesh__D000209
% 208.24/208.38  |- skos__altLabel mesh__D000515 alpha 1-Protease Inhibitor
% 208.24/208.38  |- skos__altLabel mesh__D000515 alpha 1 Antiprotease
% 208.24/208.38  |- skos__hiddenLabel mesh__D000515 alpha 1 Proteinase Inhibitor F
% 208.24/208.38  |- mesh__recordMaintainer mesh__D000515 jmp
% 208.24/208.38  |- mesh__dateEstablished mesh__D000515 1974-01-01
% 208.24/208.38  |- skos__hiddenLabel mesh__D000515 alpha 1 Protease Inhibitor
% 208.24/208.38  |- mesh__dateCreated mesh__D000515 1999-01-01
% 208.24/208.38  |- skos__altLabel mesh__D000515 Trypsin Inhibitor, alpha 1-Antitrypsin
% 208.24/208.38  |- skos__hiddenLabel mesh__D000515 alpha 1 Antitrypsin
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D019220 2002
% 208.24/208.38  |- skos__altLabel mesh__D019220 HESW
% 208.24/208.38  |- skos__hiddenLabel mesh__D019220 Shock Wave, High-Energy
% 208.24/208.38  |- mesh__dateEstablished mesh__D019220 1997-01-01
% 208.24/208.38  |- skos__related mesh__D019220smesh__D008096
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D019220 1998
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D019220 2003
% 208.24/208.38  |- skos__hiddenLabel mesh__D019220 Shock Waves, High Energy
% 208.24/208.38  |- skos__annotation mesh__D019220
% 208.24/208.38       a form of non-ionizing radiation; DF: note short X ref   
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D019220 1999
% 208.24/208.38  |- skos__hiddenLabel mesh__D019220 High-Energy Shock Wave
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D019220 2004
% 208.24/208.38  |- skos__hiddenLabel mesh__D019220 Wave, High-Energy Shock
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D019220 2000
% 208.24/208.38  |- mesh__historyNote mesh__D019220 97   
% 208.24/208.38  |- skos__historyNote mesh__D019220 Lithotripsy %28%1993-1996%29%
% 208.24/208.38  |- skos__scopeNote mesh__D019220
% 208.24/208.38       Compression waves of large amplitude, across which density, pressure, and particle velocity change drastically. %28%From McGraw Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%    
% 208.24/208.38  |- mesh__publicMeSHNote mesh__D019220 97   
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D019220 2005
% 208.24/208.38  |- skos__broader mesh__D019220smesh__D011840
% 208.24/208.38  |- skos__altLabel mesh__D019220 High Energy Shock Waves
% 208.24/208.38  |- skos__hiddenLabel mesh__D019220 Waves, High-Energy Shock
% 208.24/208.38  |- skos__altLabel mesh__D019220 Shock Waves, High-Energy
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D019220 2001
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D019220 2006
% 208.24/208.38  |- mesh__dateCreated mesh__D019220 1996-06-13
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D019220 1997
% 208.24/208.38  |- skos__prefLabel mesh__D019220 High-Energy Shock Waves
% 208.24/208.38  |- rdf__type mesh__D019220sskos__Concept
% 208.24/208.38  |- mesh__recordMaintainer mesh__D038983 ssb
% 208.24/208.38  |- mesh__publicMeSHNote mesh__D038983
% 208.24/208.38       2003; GALACTOLIPIDS was indexed under GLYCOLIPIDS 1976-2002%A%  
% 208.24/208.38  |- rdf__type mesh__D038983sskos__Concept
% 208.24/208.38  |- mesh__historyNote mesh__D038983
% 208.24/208.38       2003; use GALACTOLIPIDS %28%NM%29% 1976-2002   
% 208.24/208.38  |- skos__scopeNote mesh__D038983
% 208.24/208.38       A group of GLYCOLIPIDS in which the sugar group is GALACTOSE. They are distinguished from GLYCOSPHINGOLIPIDS in lacking nitrogen. They constitute the majority of MEMBRANE LIPIDS in PLANTS.%A%    
% 208.24/208.38  |- mesh__dateRevised mesh__D038983 2004-07-07
% 208.24/208.38  |- skos__prefLabel mesh__D038983 Galactolipids
% 208.24/208.38  |- mesh__dateCreated mesh__D038983 2002-07-03
% 208.24/208.38  |- mesh__recordOriginator mesh__D038983 ssb
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D038983 2005
% 208.24/208.38  |- mesh__recordAuthorizer mesh__D038983 sjn
% 208.24/208.38  |- skos__historyNote mesh__D038983 Glycolipids %28%1976-2002%29%
% 208.24/208.38  |- mesh__dateEstablished mesh__D038983 2003-01-01
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D038983 2006
% 208.24/208.38  |- skos__broader mesh__D038983smesh__D006017
% 208.24/208.38  |- mesh__dateCreated mesh__D005200 1974-11-19
% 208.24/208.38  |- mesh__activeMeSHYear mesh__D005200 2006
% 208.24/208.38  |- skos__historyNote mesh__D005200 Thiazoles %28%1970-1974%29%
% 208.24/208.39  |- mesh__publicMeSHNote mesh__D005200
% 208.24/208.39       91; was see under THIAZOLES 1975-90   
% 208.24/208.39  |- skos__historyNote mesh__D005200 Nitrofurans %28%1972-1974%29%
% 208.24/208.39  |- skos__prefLabel mesh__D005200 FANFT
% 208.24/208.39  |- skos__annotation mesh__D005200 D25-26 qualif   
% 208.24/208.39  |- mesh__recordMaintainer mesh__D005200 ssb
% 208.24/208.39  |- skos__scopeNote mesh__D005200
% 208.24/208.39       A potent nitrofuran derivative tumor initiator. It causes bladder tumors in all animals studied and is mutagenic to many bacteria.%A%    
% 208.24/208.39  |- skos__broader mesh__D005200smesh__D009581
% 208.24/208.39  |- skos__historyNote mesh__D005200 Formamides %28%1972-1974%29%
% 208.24/208.39  |- mesh__dateEstablished mesh__D005200 1991-01-01
% 208.24/208.39  |- mesh__recordOriginator mesh__D005200 NLM
% 208.24/208.39  |- rdf__type mesh__D005200sskos__Concept
% 208.24/208.39  |- skos__altLabel mesh__D005200
% 208.24/208.39       N-4-%28%5-Nitro-2-furyl%29%-2-thiazolylformamide
% 208.24/208.39  |- mesh__recordAuthorizer mesh__D005200 sjn
% 208.24/208.39  |- mesh__dateRevised mesh__D005200 2005-06-30
% 208.24/208.39  |- mesh__historyNote mesh__D005200
% 208.24/208.39       91%28%75%29%; was see under THIAZOLES 1975-90   
% 208.24/208.39  |- skos__broader mesh__D005200smesh__D013844
% 208.24/208.39  |- skos__broader mesh__D005492Q000037smesh__D005492
% 208.24/208.39  |- mesh__preferredCombination mesh__D005492Q000037smesh__D005493
% 208.24/208.39  |- rdf__type mesh__D005492Q000037smesh__CompoundConcept
% 208.24/208.39  |- skos__hiddenLabel mesh__D018926 Anti Allergics
% 208.24/208.39  |- mesh__dateRevised mesh__D018926 2005-06-30
% 208.24/208.39  |- mesh__recordOriginator mesh__D018926 JRT
% 208.24/208.39  |- skos__historyNote mesh__D018926
% 208.24/208.39       Histamine H1 Antagonists %28%1966-1995%29%
% 208.24/208.39  |- mesh__activeMeSHYear mesh__D018926 2006
% 208.24/208.39  |- mesh__publicMeSHNote mesh__D018926 96   
% 208.24/208.39  |- skos__altLabel mesh__D018926 Antiallergic Agents
% 208.24/208.39  |- skos__related mesh__D018926smesh__D006634
% 208.24/208.39  |- mesh__recordAuthorizer mesh__D018926 sjn
% 208.24/208.39  |- skos__hiddenLabel mesh__D018926 Anti Allergic Agents
% 208.24/208.39  |- skos__altLabel mesh__D018926 Antiallergics
% 208.24/208.39  |- skos__hiddenLabel mesh__D018926 Agents, Antiallergic
% 208.24/208.39  |- skos__altLabel mesh__D018926 Antiallergic Drugs
% 208.24/208.39  |- skos__annotation mesh__D018926
% 208.24/208.39       consider also HYPERSENSITIVITY /drug ther   
% 208.24/208.39  |- skos__hiddenLabel mesh__D018926 Agents, Antiallergy
% 208.24/208.39  |- skos__hiddenLabel mesh__D018926 Drugs, Anti-Allergy
% 208.24/208.39  |- skos__hiddenLabel mesh__D018926 Anti Allergy Drugs
% 208.24/208.39  |- skos__altLabel mesh__D018926 Antiallergy Agents
% 208.24/208.39  |- skos__hiddenLabel mesh__D018926 Agents, Anti-Allergic
% 208.24/208.39  |- skos__altLabel mesh__D018926 Anti-Allergy Drugs
% 208.24/208.39  |- mesh__recordMaintainer mesh__D018926 ssb
% 208.24/208.39  |- mesh__dateEstablished mesh__D018926 1996-01-01
% 208.24/208.39  |- skos__altLabel mesh__D018926 Anti-Allergics
% 208.24/208.39  |- skos__prefLabel mesh__D018926 Anti-Allergic Agents
% 208.24/208.39  |- skos__scopeNote mesh__D018926
% 208.24/208.39       Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. %28%From AMA Drug Evaluations Annual, 1994, p475%29%%A%    
% 208.24/208.39  |- skos__hiddenLabel mesh__D018926 Drugs, Antiallergic
% 208.24/208.39  |- mesh__dateCreated mesh__D018926 1995-05-26
% 208.24/208.39  |- rdf__type mesh__D018926sskos__Concept
% 208.24/208.39  |- mesh__historyNote mesh__D018926 96   
% 208.24/208.39  |- skos__broader mesh__D018926smesh__D045506
% 208.24/208.39  |- mesh__recordOriginator mesh__D010943 SH
% 208.24/208.39  |- mesh__historyNote mesh__D010943
% 208.24/208.39       91%28%78%29%; was see under PLANTS, MEDICINAL 1978-90; was see PSYLLIUM 1963-77 %28%Cat B %26% D heading%29%%A%  
% 208.24/208.39  |- mesh__activeMeSHYear mesh__D010943 2003
% 208.24/208.39  |- skos__historyNote mesh__D010943 Psyllium %28%1966-1977%29%
% 208.24/208.39  |- mesh__activeMeSHYear mesh__D010943 2004
% 208.24/208.39  |- mesh__activeMeSHYear mesh__D010943 2005
% 208.24/208.39  |- skos__annotation mesh__D010943
% 208.24/208.39       Xref PLANTAIN: for the banana-like fruit or green plantain flour use MUSA; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.24/208.39  |- mesh__activeMeSHYear mesh__D010943 2006
% 208.24/208.39  |- mesh__onlineNote mesh__D010943
% 208.24/208.39       search PSYLLIUM 1966-77 %28%as Cat B %26% D heading%29%   
% 208.24/208.39  |- mesh__recordAuthorizer mesh__D010943 sjn
% 208.24/208.39  |- skos__broader mesh__D010943smesh__D019684
% 208.24/208.39  |- skos__scopeNote mesh__D010943
% 208.24/208.39       A plant genus of the family Plantaginaceae, order Plantaginales, subclass Asteridae, class Magnoliopsida. The small plants usually have a dense tuft of basal leaves and long, leafless stalks bearing a terminal spike of small flowers. The seeds, known as PSYLLIUM, swell in water and are used as laxatives.  The leaves have been used medicinally.%A%    
% 208.24/208.39  |- skos__altLabel mesh__D010943 Plantain
% 208.24/208.39  |- mesh__publicMeSHNote mesh__D010943
% 208.24/208.39       91; was see under PLANTS, MEDICINAL 1978-90; was see PSYLLIUM 1963-77 %28%Cat B %26% D heading%29%%A%  
% 208.24/208.39  |- mesh__dateEstablished mesh__D010943 1991-01-01
% 208.24/208.39  |- mesh__dateCreated mesh__D010943 1977-03-29
% 208.24/208.39  |- mesh__recordMaintainer mesh__D010943 ssb
% 208.24/208.39  |- mesh__dateRevised mesh__D010943 2002-07-03
% 208.24/208.39  |- skos__prefLabel mesh__D010943 Plantago
% 208.24/208.39  |- rdf__type mesh__D010943sskos__Concept
% 208.24/208.39  |- skos__related mesh__D010943smesh__D011620
% 208.24/208.39  |- skos__prefLabel mesh__D010145 Paget%27%s Disease, Extramammary
% 208.24/208.39  |- skos__broader mesh__D010145smesh__D000230
% 208.24/208.39  |- skos__hiddenLabel mesh__D010145 Paget Disease, Extra Mammary
% 208.24/208.39  |- skos__hiddenLabel mesh__D010145 Disease, Extra-Mammary Paget
% 208.24/208.39  |- mesh__activeMeSHYear mesh__D010145 2005
% 208.24/208.39  |- mesh__activeMeSHYear mesh__D010145 1997
% 208.24/208.39  |- skos__altLabel mesh__D010145 Extra-Mammary Paget%27%s Disease
% 208.24/208.39  |- skos__scopeNote mesh__D010145
% 208.24/208.39       A rare cutaneous neoplasm that occurs in the elderly. It develops more frequently in women and predominantly involves apocrine gland-bearing areas, especially the vulva, scrotum, and perianal areas. The lesions develop as erythematous scaly patches that progress to crusted, pruritic, erythematous plaques. The clinical differential diagnosis includes squamous cell carcinoma in situ and superficial fungal infection. It is generally thought to be an adenocarcinoma of the epidermis, from which it extends into the contiguous epithelium of hair follicles and eccrine sweat ducts. %28%DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1478%29%%A%    
% 208.24/208.39  |- skos__annotation mesh__D010145
% 208.24/208.39       neoplastic; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 208.24/208.39  |- skos__hiddenLabel mesh__D010145 Extra-Mammary Pagets Disease
% 208.24/208.39  |- skos__hiddenLabel mesh__D010145 Extra Mammary Paget%27%s Disease
% 208.24/208.39  |- skos__altLabel mesh__D010145 Paget%27%s Disease, Extra-Mammary
% 208.24/208.39  |- mesh__onlineNote mesh__D010145
% 208.24/208.39       use PAGET%27%S DISEASE, EXTAMAMMARY to search PAGET%27%S DISEASE, EXTRA-MAMMARY 1966-93%A%  
% 208.24/208.39  |- skos__broader mesh__D010145smesh__D018299
% 208.24/208.39  |- skos__hiddenLabel mesh__D010145 Extramammary Pagets Disease
% 208.24/208.39  |- mesh__recordMaintainer mesh__D010145 KEV
% 208.24/208.39  |- skos__hiddenLabel mesh__D010145 Disease, Extramammary Paget
% 208.24/208.39  |- mesh__activeMeSHYear mesh__D010145 2004
% 208.24/208.39  |- mesh__activeMeSHYear mesh__D010145 1996
% 208.24/208.39  |- mesh__dateCreated mesh__D010145 1999-01-01
% 208.24/208.39  |- mesh__historyNote mesh__D010145
% 208.24/208.39       94; was PAGET%27%S DISEASE, EXTRA-MAMMARY 1963-93   
% 208.24/208.39  |- skos__altLabel mesh__D010145 Paget Disease, Extra-Mammary
% 208.24/208.39  |- mesh__activeMeSHYear mesh__D010145 2002
% 208.24/208.39  |- skos__altLabel mesh__D010145 Paget Disease, Extramammary
% 208.24/208.39  |- mesh__activeMeSHYear mesh__D010145 2003
% 208.24/208.39  |- rdf__type mesh__D010145sskos__Concept
% 208.24/208.39  |- mesh__dateRevised mesh__D010145 1995-06-08
% 208.24/208.39  |- skos__altLabel mesh__D010145 Extramammary Paget Disease
% 208.24/208.39  |- skos__altLabel mesh__D010145 Extra-Mammary Paget Disease
% 208.24/208.39  |- skos__hiddenLabel mesh__D010145 Disease, Extra-Mammary Paget%27%s
% 208.24/208.39  |- mesh__activeMeSHYear mesh__D010145 1999
% 208.24/208.39  |- skos__hiddenLabel mesh__D010145 Pagets Disease, Extra-Mammary
% 208.24/208.39  |- mesh__activeMeSHYear mesh__D010145 2001
% 208.24/208.39  |- skos__hiddenLabel mesh__D010145 Paget%27%s Disease, Extra Mammary
% 208.24/208.39  |- mesh__recordOriginator mesh__D010145 NLM
% 208.24/208.39  |- skos__hiddenLabel mesh__D010145 Pagets Disease, Extramammary
% 208.24/208.39  |- mesh__recordAuthorizer mesh__D010145 PLS
% 208.24/208.39  |- skos__hiddenLabel mesh__D010145 Extra Mammary Paget Disease
% 208.24/208.39  |- mesh__publicMeSHNote mesh__D010145
% 208.24/208.39       94; was PAGET%27%S DISEASE, EXTRA-MAMMARY 1963-93   
% 208.24/208.39  |- skos__hiddenLabel mesh__D010145 Disease, Extramammary Paget%27%s
% 208.24/208.39  |- mesh__activeMeSHYear mesh__D010145 2006
% 208.24/208.39  |- skos__altLabel mesh__D010145 Extramammary Paget%27%s Disease
% 208.24/208.39  |- mesh__activeMeSHYear mesh__D010145 1998
% 208.24/208.39  |- mesh__activeMeSHYear mesh__D010145 2000
% 208.24/208.39  |- mesh__recordOriginator mesh__D004906 NLM
% 208.24/208.39  |- skos__altLabel mesh__D004906 Blood Cell Count, Red
% 208.24/208.39  |- skos__hiddenLabel mesh__D004906 Count, Erythrocyte
% 208.24/208.39  |- skos__scopeNote mesh__D004906
% 208.24/208.39       The number of RED BLOOD CELLS per unit volume in a sample of venous BLOOD.%A%    
% 208.24/208.39  |- mesh__recordAuthorizer mesh__D004906 sjn
% 208.24/208.39  |- mesh__activeMeSHYear mesh__D004906 2006
% 208.24/208.39  |- mesh__recordMaintainer mesh__D004906 nns
% 208.24/208.39  |- mesh__activeMeSHYear mesh__D004906 2004
% 208.24/208.39  |- rdf__type mesh__D004906sskos__Concept
% 208.24/208.39  |- mesh__dateCreated mesh__D004906 1999-01-01
% 208.24/208.39  |- mesh__activeMeSHYear mesh__D004906 2005
% 208.24/208.39  |- skos__altLabel mesh__D004906 Red Blood Cell Count
% 208.24/208.39  |- skos__altLabel mesh__D004906 Erythrocyte Number
% 208.24/208.39  |- skos__annotation mesh__D004906
% 208.24/208.39       usually NIM; coord with disease /blood, not /physiopathol%A%  
% 208.24/208.39  |- mesh__dateRevised mesh__D004906 2003-07-09
% 208.24/208.39  |- skos__prefLabel mesh__D004906 Erythrocyte Count
% 208.24/208.39  |- skos__hiddenLabel mesh__D004906 Counts, Erythrocyte
% 208.24/208.39  |- skos__hiddenLabel mesh__D004906 Erythrocyte Counts
% 208.24/208.39  |- skos__broader mesh__D004906smesh__D001772
% 208.24/208.39  |- skos__hiddenLabel mesh__D004906 Erythrocyte Numbers
% 208.24/208.39  |- skos__scopeNote mesh__D004108
% 208.24/208.39       The condition of an anatomical structure%27%s being dilated beyond normal dimensions.%A%    
% 208.24/208.39  |- mesh__publicMeSHNote mesh__D004108
% 208.24/208.39       76; was included in DILATATION see under PATHOLOGY 1975   
% 208.24/208.39  |- mesh__activeMeSHYear mesh__D004108 2001
% 208.25/208.39  |- mesh__dateEstablished mesh__D004108 1976-01-01
% 208.25/208.39  |- mesh__dateCreated mesh__D004108 1975-07-25
% 208.25/208.39  |- mesh__recordAuthorizer mesh__D004108 sjn
% 208.25/208.39  |- rdf__type mesh__D004108sskos__Concept
% 208.25/208.39  |- skos__altLabel mesh__D004108 Ectasia
% 208.25/208.39  |- mesh__historyNote mesh__D004108
% 208.25/208.39       76; was included in DILATATION 1968-75 %28%Prov 1968-74, Cat C %26% E heading 1968-75%29%%A%  
% 208.25/208.39  |- skos__annotation mesh__D004108 never IM; DF: DILATATION PATHOL   
% 208.25/208.39  |- skos__hiddenLabel mesh__D004108 Pathological Dilatations
% 208.25/208.39  |- skos__prefLabel mesh__D004108 Dilatation, Pathologic
% 208.25/208.39  |- skos__historyNote mesh__D004108 Dilatation %28%1968-1975%29%
% 208.25/208.39  |- skos__altLabel mesh__D004108 Pathologic Dilatation
% 208.25/208.39  |- skos__altLabel mesh__D004108 Pathologic Dilatations
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D004108 2003
% 208.25/208.39  |- skos__altLabel mesh__D004108 Dilatations, Pathological
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D004108 2002
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D004108 2005
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D004108 2004
% 208.25/208.39  |- mesh__dateRevised mesh__D004108 1999-11-08
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D004108 2006
% 208.25/208.39  |- skos__altLabel mesh__D004108 Dilatations, Pathologic
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D004108 2000
% 208.25/208.39  |- mesh__recordOriginator mesh__D004108 SMH
% 208.25/208.39  |- skos__hiddenLabel mesh__D004108 Pathological Dilatation
% 208.25/208.39  |- skos__broader mesh__D004108smesh__D020763
% 208.25/208.39  |- mesh__recordMaintainer mesh__D004108 KEV
% 208.25/208.39  |- mesh__onlineNote mesh__D004108
% 208.25/208.39       search DILATATION 1968-75 %28%as Prov 1968-74, as Cat C %26% E heading 1968-75%29%%A%  
% 208.25/208.39  |- skos__altLabel mesh__D004108 Dilatation, Pathological
% 208.25/208.39  |- skos__hiddenLabel mesh__D020573 Genes, c-rel
% 208.25/208.39  |- skos__hiddenLabel mesh__D020573 c-rel Proto-Oncogene
% 208.25/208.39  |- skos__hiddenLabel mesh__D020573 Gene, c-rel
% 208.25/208.39  |- skos__altLabel mesh__D020573 rel Oncogene
% 208.25/208.39  |- skos__broader mesh__D020573smesh__D011519
% 208.25/208.39  |- skos__hiddenLabel mesh__D020573 c rel Proto Oncogenes
% 208.25/208.39  |- mesh__dateCreated mesh__D020573 1999-11-03
% 208.25/208.39  |- skos__related mesh__D020573smesh__D020572
% 208.25/208.39  |- skos__hiddenLabel mesh__D020573 Proto-Oncogene, c-rel
% 208.25/208.39  |- skos__hiddenLabel mesh__D020573 rel Gene
% 208.25/208.39  |- mesh__dateRevised mesh__D020573 2005-06-30
% 208.25/208.39  |- skos__altLabel mesh__D020573 c-rel Proto-Oncogenes
% 208.25/208.39  |- skos__related mesh__D020573smesh__D020569
% 208.25/208.39  |- skos__altLabel mesh__D020573 v-rel Oncogenes
% 208.25/208.39  |- mesh__dateEstablished mesh__D020573 2000-01-01
% 208.25/208.39  |- mesh__recordAuthorizer mesh__D020573 sjn
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D020573 2006
% 208.25/208.39  |- skos__hiddenLabel mesh__D020573 rel Oncogenes
% 208.25/208.39  |- skos__hiddenLabel mesh__D020573 Gene, rel
% 208.25/208.39  |- skos__hiddenLabel mesh__D020573 v rel Oncogenes
% 208.25/208.39  |- skos__altLabel mesh__D020573 rel Genes
% 208.25/208.39  |- skos__hiddenLabel mesh__D020573 c-rel Gene
% 208.25/208.39  |- skos__hiddenLabel mesh__D020573 Oncogenes, rel
% 208.25/208.39  |- skos__scopeNote mesh__D020573
% 208.25/208.39       Family of retrovirus-associated DNA sequences %28%v-rel%29% originally isolated from an avian reticuloendotheliosis virus strain. The proto-oncogene rel %28%c-rel%29% codes for a subcellular %28%nuclear and cytoplasmic%29% transcription factor that has a role in lymphocyte differentiation. Translocation or overexpression of c-rel or competition from v-rel causes oncogenesis. The human rel gene is located at 2p12-13 on the short arm of chromosome 2.%A%    
% 208.25/208.39  |- rdf__type mesh__D020573sskos__Concept
% 208.25/208.39  |- skos__prefLabel mesh__D020573 Genes, rel
% 208.25/208.39  |- skos__hiddenLabel mesh__D020573 Gene, v-rel
% 208.25/208.39  |- skos__hiddenLabel mesh__D020573 Oncogenes, v-rel
% 208.25/208.39  |- mesh__publicMeSHNote mesh__D020573 2000; see ONCOGENES 1988-1999   
% 208.25/208.39  |- mesh__recordOriginator mesh__D020573 ags
% 208.25/208.39  |- mesh__historyNote mesh__D020573 2000; use ONCOGENES 1988-1999   
% 208.25/208.39  |- mesh__recordMaintainer mesh__D020573 nns
% 208.25/208.39  |- skos__hiddenLabel mesh__D020573 v-rel Oncogene
% 208.25/208.39  |- skos__hiddenLabel mesh__D020573 c rel Genes
% 208.25/208.39  |- skos__hiddenLabel mesh__D020573 Proto-Oncogenes, c-rel
% 208.25/208.39  |- skos__hiddenLabel mesh__D020573 Genes, v-rel
% 208.25/208.39  |- skos__hiddenLabel mesh__D020573 Oncogene, rel
% 208.25/208.39  |- skos__historyNote mesh__D020573 Genes, Viral %28%1983-1999%29%
% 208.25/208.39  |- skos__hiddenLabel mesh__D020573 v-rel Gene
% 208.25/208.39  |- skos__hiddenLabel mesh__D020573 Oncogene, v-rel
% 208.25/208.39  |- skos__hiddenLabel mesh__D020573 v rel Genes
% 208.25/208.39  |- skos__historyNote mesh__D020573 Oncogenes %28%1983-1999%29%
% 208.25/208.39  |- skos__hiddenLabel mesh__D014536
% 208.25/208.39       Diphosphate N-Acetylgalactosamine, Uridine
% 208.25/208.39  |- skos__scopeNote mesh__D014536
% 208.25/208.39       A nucleoside diphosphate sugar which serves as a source of N-acetylgalactosamine for glycoproteins, sulfatides and cerebrosides.%A%    
% 208.25/208.39  |- mesh__recordOriginator mesh__D014536 NLM
% 208.25/208.39  |- skos__hiddenLabel mesh__D014536 Acetylgalactosamine, UDP
% 208.25/208.39  |- skos__broader mesh__D014536smesh__D014539
% 208.25/208.39  |- mesh__dateCreated mesh__D014536 1974-11-19
% 208.25/208.39  |- rdf__type mesh__D014536sskos__Concept
% 208.25/208.39  |- skos__altLabel mesh__D014536 Uridine Diphosphate N Acetylgalactosamine
% 208.25/208.39  |- skos__historyNote mesh__D014536
% 208.25/208.39       Uridine Diphosphate Sugars %28%1973-1974%29%
% 208.25/208.39  |- skos__altLabel mesh__D014536 UDP Acetylgalactosamine
% 208.25/208.39  |- mesh__dateRevised mesh__D014536 2004-07-07
% 208.25/208.39  |- mesh__dateEstablished mesh__D014536 1991-01-01
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D014536 2005
% 208.25/208.39  |- skos__hiddenLabel mesh__D014536
% 208.25/208.39       N-Acetylgalactosamine, Uridine Diphosphate
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D014536 2006
% 208.25/208.39  |- skos__prefLabel mesh__D014536 Uridine Diphosphate N-Acetylgalactosamine
% 208.25/208.39  |- mesh__recordAuthorizer mesh__D014536 sjn
% 208.25/208.39  |- mesh__historyNote mesh__D014536
% 208.25/208.39       91%28%75%29%; was see under URIDINE DIPHOSPHATE SUGARS 1975-90   
% 208.25/208.39  |- mesh__recordMaintainer mesh__D014536 ssb
% 208.25/208.39  |- mesh__publicMeSHNote mesh__D014536
% 208.25/208.39       91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90   
% 208.25/208.39  |- skos__historyNote mesh__D014536 Galactosamine %28%1973-1974%29%
% 208.25/208.39  |- rdf__type mesh__D000516sskos__Concept
% 208.25/208.39  |- skos__hiddenLabel mesh__D000516 alpha Amylase 2
% 208.25/208.39  |- mesh__publicMeSHNote mesh__D000516 84; was see under AMYLASES 1978-83   
% 208.25/208.39  |- skos__broader mesh__D000516smesh__D000681
% 208.25/208.39  |- skos__hiddenLabel mesh__D000516 alpha 1,4 D Glucanglucanohydrolase
% 208.25/208.39  |- mesh__dateCreated mesh__D000516 1977-04-15
% 208.25/208.39  |- mesh__dateRevised mesh__D000516 2005-06-30
% 208.25/208.39  |- skos__hiddenLabel mesh__D000516 TakaAmylase A
% 208.25/208.39  |- skos__altLabel mesh__D000516 Sanofi Synthelabo Brand of alpha-Amylase
% 208.25/208.39  |- mesh__recordMaintainer mesh__D000516 lkw
% 208.25/208.39  |- skos__scopeNote mesh__D000516
% 208.25/208.39       An enzyme that catalyzes the endohydrolysis of 1,4-alpha-glycosidic linkages in starch, glycogen, and related polysaccharides and oligosaccharides containing 3 or more 1,4-alpha-linked D-glucose units. EC 3.2.1.1.%A%    
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D000516 2006
% 208.25/208.39  |- skos__historyNote mesh__D000516 Amylases %28%1966-1977%29%
% 208.25/208.39  |- skos__altLabel mesh__D000516 Bayer Brand of alpha-Amylase
% 208.25/208.39  |- skos__hiddenLabel mesh__D000516 Alpha Amylase Bayer
% 208.25/208.39  |- mesh__recordOriginator mesh__D000516 RLS
% 208.25/208.39  |- mesh__dateEstablished mesh__D000516 1984-01-01
% 208.25/208.39  |- mesh__historyNote mesh__D000516
% 208.25/208.39       84%28%78%29%; was see under AMYLASES 1978-83   
% 208.25/208.39  |- skos__altLabel mesh__D000516 Leurquin Brand of alpha-Amylase
% 208.25/208.39  |- skos__hiddenLabel mesh__D000516 alpha Amylase
% 208.25/208.39  |- skos__prefLabel mesh__D000516 alpha-Amylase
% 208.25/208.39  |- skos__hiddenLabel mesh__D000516 AlphaAmylase Bayer
% 208.25/208.39  |- skos__altLabel mesh__D000516 alpha-1,4-D-Glucanglucanohydrolase
% 208.25/208.39  |- skos__hiddenLabel mesh__D000516 Taka Amylase A
% 208.25/208.39  |- mesh__recordAuthorizer mesh__D000516 sjn
% 208.25/208.39  |- skos__hiddenLabel mesh__D019221 Reporting, Abuse
% 208.25/208.39  |- mesh__recordMaintainer mesh__D019221 jls
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D019221 2004
% 208.25/208.39  |- skos__broader mesh__D019221smesh__D037141
% 208.25/208.39  |- mesh__publicMeSHNote mesh__D019221 97   
% 208.25/208.39  |- mesh__recordOriginator mesh__D019221 JLS
% 208.25/208.39  |- mesh__historyNote mesh__D019221 97   
% 208.25/208.39  |- skos__related mesh__D019221smesh__D018563
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D019221 2003A
% 208.25/208.39  |- mesh__dateEstablished mesh__D019221 1997-01-01
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D019221 2005
% 208.25/208.39  |- skos__related mesh__D019221smesh__D035622
% 208.25/208.39  |- skos__broader mesh__D019221smesh__D030881
% 208.25/208.39  |- mesh__dateRevised mesh__D019221 2002-10-31
% 208.25/208.39  |- skos__historyNote mesh__D019221
% 208.25/208.39       Elder Abuse/legislation %26% jurisprudence %28%1984-1996%29%
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D019221 2006
% 208.25/208.39  |- mesh__recordAuthorizer mesh__D019221 jls
% 208.25/208.39  |- rdf__type mesh__D019221sskos__Concept
% 208.25/208.39  |- skos__prefLabel mesh__D019221 Mandatory Reporting
% 208.25/208.39  |- mesh__dateCreated mesh__D019221 1996-06-10
% 208.25/208.39  |- skos__hiddenLabel mesh__D019221 Reporting, Mandatory
% 208.25/208.39  |- skos__historyNote mesh__D019221
% 208.25/208.39       Child Abuse/legislation %26% jurisprudence %28%1966-1996%29%
% 208.25/208.39  |- skos__scopeNote mesh__D019221
% 208.25/208.39       A legal requirement that designated types of information acquired by professionals or institutions in the course of their work be reported to appropriate authorities.%A%    
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D019221 2003
% 208.25/208.39  |- skos__broader mesh__D019221smesh__D007603
% 208.25/208.39  |- skos__hiddenLabel mesh__D005201 Daydream
% 208.25/208.39  |- mesh__publicMeSHNote mesh__D005201 68   
% 208.25/208.39  |- skos__altLabel mesh__D005201 Daydreams
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D005201 2004
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D005201 1997
% 208.25/208.39  |- mesh__recordAuthorizer mesh__D005201 PLS
% 208.25/208.39  |- mesh__dateEstablished mesh__D005201 1968-01-01
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D005201 2000
% 208.25/208.39  |- mesh__historyNote mesh__D005201
% 208.25/208.39       68; DAY DREAMS was see under FANTASY 1968-78   
% 208.25/208.39  |- mesh__recordMaintainer mesh__D005201 PLS
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D005201 2001
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D005201 1994
% 208.25/208.39  |- skos__broader mesh__D005201smesh__D003674
% 208.25/208.39  |- mesh__onlineNote mesh__D005201
% 208.25/208.39       use FANTASY to search DAY DREAMS 1968-78   
% 208.25/208.39  |- skos__annotation mesh__D005201 no qualif   
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D005201 1992
% 208.25/208.39  |- rdf__type mesh__D005201sskos__Concept
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D005201 2002
% 208.25/208.39  |- skos__prefLabel mesh__D005201 Fantasy
% 208.25/208.39  |- mesh__dateCreated mesh__D005201 1999-01-01
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D005201 1995
% 208.25/208.39  |- skos__broader mesh__D005201smesh__D007092
% 208.25/208.39  |- skos__historyNote mesh__D005201 Imagination %28%1966-1967%29%
% 208.25/208.39  |- skos__scopeNote mesh__D005201
% 208.25/208.39       An imagined sequence of events or mental images, e.g., daydreams.%A%    
% 208.25/208.39  |- skos__hiddenLabel mesh__D005201 Dream, Day
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D005201 2005
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D005201 1998
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D005201 1993
% 208.25/208.39  |- skos__hiddenLabel mesh__D005201 Dreams, Day
% 208.25/208.39  |- skos__hiddenLabel mesh__D005201 Fantasies
% 208.25/208.39  |- skos__hiddenLabel mesh__D005201 Day Dream
% 208.25/208.39  |- mesh__dateRevised mesh__D005201 1991-06-11
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D005201 2006
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D005201 2003
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D005201 1996
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D005201 1999
% 208.25/208.39  |- mesh__recordOriginator mesh__D005201 NLM
% 208.25/208.39  |- skos__hiddenLabel mesh__D018927 Anti Asthmatics
% 208.25/208.39  |- skos__altLabel mesh__D018927 Antiasthmatic Drugs
% 208.25/208.39  |- skos__prefLabel mesh__D018927 Anti-Asthmatic Agents
% 208.25/208.39  |- mesh__recordOriginator mesh__D018927 JRT
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D018927 2006
% 208.25/208.39  |- skos__scopeNote mesh__D018927 Drugs that are used to treat asthma.     
% 208.25/208.39  |- skos__annotation mesh__D018927 consider also ASTHMA /drug ther   
% 208.25/208.39  |- skos__hiddenLabel mesh__D018927 Anti Asthmatic Agents
% 208.25/208.39  |- skos__broader mesh__D018927smesh__D019141
% 208.25/208.39  |- skos__altLabel mesh__D018927 Antiasthmatics
% 208.25/208.39  |- skos__altLabel mesh__D018927 Antiasthmatic Agents
% 208.25/208.39  |- skos__altLabel mesh__D018927 Anti-Asthmatics
% 208.25/208.39  |- mesh__dateRevised mesh__D018927 2005-06-30
% 208.25/208.39  |- skos__historyNote mesh__D018927 Asthma/drug therapy %28%1966-1995%29%
% 208.25/208.39  |- mesh__publicMeSHNote mesh__D018927 96   
% 208.25/208.39  |- mesh__recordMaintainer mesh__D018927 ssb
% 208.25/208.39  |- mesh__recordAuthorizer mesh__D018927 sjn
% 208.25/208.39  |- mesh__dateCreated mesh__D018927 1995-05-26
% 208.25/208.39  |- rdf__type mesh__D018927sskos__Concept
% 208.25/208.39  |- mesh__dateEstablished mesh__D018927 1996-01-01
% 208.25/208.39  |- skos__hiddenLabel mesh__D018927 Drugs, Antiasthmatic
% 208.25/208.39  |- mesh__historyNote mesh__D018927 96   
% 208.25/208.39  |- skos__hiddenLabel mesh__D018927 Agents, Antiasthmatic
% 208.25/208.39  |- skos__hiddenLabel mesh__D018927 Drugs, Anti-Asthmatic
% 208.25/208.39  |- skos__hiddenLabel mesh__D018927 Anti Asthmatic Drugs
% 208.25/208.39  |- skos__hiddenLabel mesh__D018927 Agents, Anti-Asthmatic
% 208.25/208.39  |- skos__altLabel mesh__D018927 Anti-Asthmatic Drugs
% 208.25/208.39  |- mesh__runningHead mesh__D010944 B6 - ORGANISMS-PLANTS   
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D010944 2004
% 208.25/208.39  |- mesh__publicMeSHNote mesh__D010944 PYRETHRUM was heading 1963-85   
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D010944 2005
% 208.25/208.39  |- skos__annotation mesh__D010944
% 208.25/208.39       GEN only: prefer specific groups or specific plants; plants or %22%plant tissue%22%: Manual 31.10; /anat: consider also PLANT COMPONENTS; /embryol: consider also SEEDS; policy 22.30, 36.25; plants used in therapy = PHYTOTHERAPY: Manual 26.29%A%  
% 208.25/208.39  |- skos__related mesh__D010944smesh__D010940
% 208.25/208.39  |- mesh__onlineNote mesh__D010944 use PLANTS to search PYRETHRUM 1966-85   
% 208.25/208.39  |- skos__related mesh__D010944smesh__D012639
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D010944 2006
% 208.25/208.39  |- mesh__recordAuthorizer mesh__D010944 jls
% 208.25/208.39  |- skos__related mesh__D010944smesh__D011058
% 208.25/208.39  |- mesh__dateCreated mesh__D010944 1999-01-01
% 208.25/208.39  |- mesh__recordMaintainer mesh__D010944 jls
% 208.25/208.39  |- skos__prefLabel mesh__D010944 Plants
% 208.25/208.39  |- skos__related mesh__D010944smesh__D006540
% 208.25/208.39  |- mesh__dateRevised mesh__D010944 2004-07-30
% 208.25/208.39  |- skos__scopeNote mesh__D010944
% 208.25/208.39       Multicellular, eukaryotic life forms of the kingdom Plantae. They are characterized by a mainly photosynthetic mode of nutrition; essentially unlimited growth at localized regions of cell divisions %28%MERISTEMS%29%; cellulose within cells providing rigidity; the absence of organs of locomotion; absence of nervous and sensory systems; and an alteration of haploid and diploid generations.%A%    
% 208.25/208.39  |- rdf__type mesh__D010944sskos__Concept
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D010944 2005A
% 208.25/208.39  |- mesh__activeMeSHYear mesh__D010944 2003
% 208.25/208.39  |- mesh__recordOriginator mesh__D010944 NLM
% 208.25/208.39  |- mesh__historyNote mesh__D010944 PYRETHRUM was heading 1963-85   
% 208.25/208.39  |- skos__hiddenLabel mesh__D018129 Phosphates, Phosphatidyl Inositol
% 208.25/208.39  |- mesh__publicMeSHNote mesh__D018129
% 208.25/208.39       94; POLYPHOSPHOINOSITIDES was indexed under PHOSPHOINOSITIDES 1983-93 %26% POLYMERS 1978-82; PHOSPHATIDYLINOSITOL PHOSPHATES was see PHOSPHOINOSITIDES 1977-93%A%  
% 208.25/208.39  |- skos__altLabel mesh__D018129 Polyphosphoinositide
% 208.25/208.39  |- skos__hiddenLabel mesh__D018129 Phosphates, Phosphatidylinositol
% 208.25/208.39  |- mesh__dateCreated mesh__D018129 1993-06-04
% 208.25/208.39  |- mesh__recordOriginator mesh__D018129 TPW
% 208.25/208.39  |- rdf__type mesh__D018129sskos__Concept
% 208.25/208.40  |- skos__scopeNote mesh__D018129
% 208.25/208.40       Phosphatidylinositols in which one or more alcohol group of the inositol has been substituted with a phosphate group.%A%    
% 208.25/208.40  |- mesh__recordAuthorizer mesh__D018129 sjn
% 208.25/208.40  |- skos__altLabel mesh__D018129 Polyphosphoinositides
% 208.25/208.40  |- mesh__dateRevised mesh__D018129 2004-07-07
% 208.25/208.40  |- skos__historyNote mesh__D018129 Phosphatidylinositols %28%1977-1993%29%
% 208.25/208.40  |- skos__prefLabel mesh__D018129 Phosphatidylinositol Phosphates
% 208.25/208.40  |- mesh__historyNote mesh__D018129
% 208.25/208.40       94; was POLYPHOSPHOINOSITIDES %28%NM%29% 1978-93; PHOSPHATIDYLINOSITOL PHOSPHATES was see PHOSPHOINOSITIDES 1977-93%A%  
% 208.25/208.40  |- skos__altLabel mesh__D018129 Phosphatidyl Inositol Phosphates
% 208.25/208.40  |- skos__historyNote mesh__D018129 Polymers %28%1978-1982%29%
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D018129 2005
% 208.25/208.40  |- skos__hiddenLabel mesh__D018129 Inositol Phosphates, Phosphatidyl
% 208.25/208.40  |- skos__broader mesh__D018129smesh__D010716
% 208.25/208.40  |- mesh__onlineNote mesh__D018129
% 208.25/208.40       use PHOSPHATIDYLINOSITOL PHOSPHATES %28%NM%29% to search POLYPHOSPHOINOSITIDES 1980-93; use PHOSPHATIDYLINOSITOLS to search PHOSPHATIDYLINOSITOL PHOSPHATES 1977-93%A%  
% 208.25/208.40  |- mesh__recordMaintainer mesh__D018129 jmp
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D018129 2006
% 208.25/208.40  |- mesh__dateEstablished mesh__D018129 1994-01-01
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D010146 2006
% 208.25/208.40  |- skos__related mesh__D010146smesh__D000700
% 208.25/208.40  |- skos__related mesh__D010146smesh__D000698
% 208.25/208.40  |- skos__broader mesh__D010146smesh__D012677
% 208.25/208.40  |- skos__hiddenLabel mesh__D010146 Pains, Splitting
% 208.25/208.40  |- mesh__recordAuthorizer mesh__D010146 sjn
% 208.25/208.40  |- mesh__dateRevised mesh__D010146 1999-11-03
% 208.25/208.40  |- skos__hiddenLabel mesh__D010146 Crushing Pain
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D010146 2005
% 208.25/208.40  |- skos__hiddenLabel mesh__D010146 Aches
% 208.25/208.40  |- skos__hiddenLabel mesh__D010146 Physical Suffering
% 208.25/208.40  |- skos__hiddenLabel mesh__D010146 Radiating Pain
% 208.25/208.40  |- skos__related mesh__D010146smesh__D000699
% 208.25/208.40  |- mesh__recordMaintainer mesh__D010146 KEV
% 208.25/208.40  |- skos__hiddenLabel mesh__D010146 Splitting Pains
% 208.25/208.40  |- mesh__dateCreated mesh__D010146 1999-01-01
% 208.25/208.40  |- skos__hiddenLabel mesh__D010146 Migratory Pain
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D010146 2004
% 208.25/208.40  |- skos__hiddenLabel mesh__D010146 Pains, Radiating
% 208.25/208.40  |- skos__annotation mesh__D010146
% 208.25/208.40       IM, GEN only; prefer precoord locational pain terms, like ABDOMINAL PAIN, CHEST PAIN, etc.; /diag: consider also PAIN MEASUREMENT but PAIN /diag is probably PAIN /etiol; /ther: consider also PALLIATIVE CARE %28% = pain relief without cure%29%; /physiopathol: PAIN THRESHOLD is also available; chronic pain = PAIN %28%IM%29% + CHRONIC DISEASE %28%NIM%29%: do not equate with PAIN, INTRACTABLE; congen absence of pain = PAIN INSENSITIVITY, CONGENITAL; excessive sensitivity to pain = HYPERALGESIA; policy: Manual 23.17+%A%  
% 208.25/208.40  |- skos__hiddenLabel mesh__D010146 Physical Sufferings
% 208.25/208.40  |- skos__broader mesh__D010146smesh__D012816
% 208.25/208.40  |- skos__hiddenLabel mesh__D010146 Splitting Pain
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D010146 2002
% 208.25/208.40  |- rdf__type mesh__D010146sskos__Concept
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D010146 2003
% 208.25/208.40  |- skos__broader mesh__D010146smesh__D009461
% 208.25/208.40  |- skos__hiddenLabel mesh__D010146 Sufferings, Physical
% 208.25/208.40  |- skos__hiddenLabel mesh__D010146 Pains, Crushing
% 208.25/208.40  |- skos__hiddenLabel mesh__D010146 Pains, Migratory
% 208.25/208.40  |- mesh__recordOriginator mesh__D010146 NLM
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D010146 2001
% 208.25/208.40  |- skos__scopeNote mesh__D010146
% 208.25/208.40       An unpleasant sensation induced by noxious stimuli and generally received by specialized nerve endings.%A%    
% 208.25/208.40  |- skos__related mesh__D010146smesh__D010166
% 208.25/208.40  |- skos__hiddenLabel mesh__D010146 Migratory Pains
% 208.25/208.40  |- skos__prefLabel mesh__D010146 Pain
% 208.25/208.40  |- skos__hiddenLabel mesh__D010146 Crushing Pains
% 208.25/208.40  |- skos__related mesh__D010146smesh__D006930
% 208.25/208.40  |- skos__hiddenLabel mesh__D010146 Burning Pains
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D010146 2000
% 208.25/208.40  |- skos__hiddenLabel mesh__D010146 Burning Pain
% 208.25/208.40  |- skos__hiddenLabel mesh__D010146 Radiating Pains
% 208.25/208.40  |- skos__hiddenLabel mesh__D010146 Pains, Burning
% 208.25/208.40  |- skos__historyNote mesh__D004907 Erythrocytes, Abnormal %28%1968-1984%29%
% 208.25/208.40  |- skos__annotation mesh__D004907
% 208.25/208.40       note category: do not confuse with ERYTHROCYTES, ABNORMAL: deformability is a normal desirable characteristic of erythrocytes; coord with disease /blood, not /physiopathol%A%  
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D004907 2005
% 208.25/208.40  |- skos__hiddenLabel mesh__D004907 Deformability, Erythrocyte
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D004907 2004
% 208.25/208.40  |- rdf__type mesh__D004907sskos__Concept
% 208.25/208.40  |- mesh__dateCreated mesh__D004907 1984-05-30
% 208.25/208.40  |- mesh__dateRevised mesh__D004907 2003-07-09
% 208.25/208.40  |- mesh__historyNote mesh__D004907 85   
% 208.25/208.40  |- skos__historyNote mesh__D004907 Erythrocytes %28%1966-1984%29%
% 208.25/208.40  |- mesh__recordMaintainer mesh__D004907 nns
% 208.25/208.40  |- mesh__recordAuthorizer mesh__D004907 sjn
% 208.25/208.40  |- skos__prefLabel mesh__D004907 Erythrocyte Deformability
% 208.25/208.40  |- mesh__recordOriginator mesh__D004907 VDK
% 208.25/208.40  |- skos__broader mesh__D004907smesh__D045122
% 208.25/208.40  |- skos__scopeNote mesh__D004907
% 208.25/208.40       Ability of ERYTHROCYTES to change shape as they pass through narrow spaces, such as the microvasculature.%A%    
% 208.25/208.40  |- mesh__publicMeSHNote mesh__D004907 85   
% 208.25/208.40  |- skos__hiddenLabel mesh__D004907 Filterability, Erythrocyte
% 208.25/208.40  |- mesh__dateEstablished mesh__D004907 1985-01-01
% 208.25/208.40  |- skos__altLabel mesh__D004907 Erythrocyte Filterability
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D004907 2006
% 208.25/208.40  |- skos__related mesh__D004907smesh__D018056
% 208.25/208.40  |- skos__hiddenLabel mesh__D004109 4898, Asta C
% 208.25/208.40  |- mesh__recordMaintainer mesh__D004109 TWD
% 208.25/208.40  |- mesh__historyNote mesh__D004109
% 208.25/208.40       91%28%75%29%; was see under AZEPINES 1975-90   
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D004109 2003
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D004109 2001
% 208.25/208.40  |- mesh__recordAuthorizer mesh__D004109 sjn
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D004109 2005
% 208.25/208.40  |- skos__prefLabel mesh__D004109 Dilazep
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D004109 2004
% 208.25/208.40  |- mesh__publicMeSHNote mesh__D004109 91; was see under AZEPINES 1975-90   
% 208.25/208.40  |- skos__historyNote mesh__D004109 Benzoates %28%1972-1974%29%
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D004109 2006
% 208.25/208.40  |- mesh__dateRevised mesh__D004109 2000-06-21
% 208.25/208.40  |- skos__altLabel mesh__D004109 Biopropazepan Trimethoxybenzoate
% 208.25/208.40  |- skos__scopeNote mesh__D004109
% 208.25/208.40       Coronary vasodilator with some antiarrhythmic activity.%A%    
% 208.25/208.40  |- skos__hiddenLabel mesh__D004109 C 4898, Asta
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D004109 2002
% 208.25/208.40  |- mesh__dateCreated mesh__D004109 1974-11-27
% 208.25/208.40  |- skos__broader mesh__D004109smesh__D001381
% 208.25/208.40  |- skos__hiddenLabel mesh__D004109 Trimethoxybenzoate, Biopropazepan
% 208.25/208.40  |- rdf__type mesh__D004109sskos__Concept
% 208.25/208.40  |- skos__historyNote mesh__D004109 Azepines %28%1972-1974%29%
% 208.25/208.40  |- mesh__dateEstablished mesh__D004109 1991-01-01
% 208.25/208.40  |- mesh__recordOriginator mesh__D004109 NLM
% 208.25/208.40  |- skos__altLabel mesh__D020574 c-sis Proteins
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D020574 2006
% 208.25/208.40  |- skos__hiddenLabel mesh__D020574 sis Proto Oncogene Proteins
% 208.25/208.40  |- skos__scopeNote mesh__D020574
% 208.25/208.40       Cellular DNA-binding proteins encoded by the sis gene %28%GENES, SIS%29%. c-sis proteins make up the B chain of PLATELET-DERIVED GROWTH FACTOR. Overexpression of c-sis causes tumorigenesis.%A%    
% 208.25/208.40  |- mesh__recordMaintainer mesh__D020574 DRC
% 208.25/208.40  |- skos__hiddenLabel mesh__D020574 Proto Oncogene Protein sis
% 208.25/208.40  |- skos__prefLabel mesh__D020574 Proto-Oncogene Proteins c-sis
% 208.25/208.40  |- skos__altLabel mesh__D020574 Proto-Oncogene Proteins sis
% 208.25/208.40  |- skos__hiddenLabel mesh__D020574 sis, Proto-Oncogene Protein
% 208.25/208.40  |- skos__broader mesh__D020574smesh__D010982
% 208.25/208.40  |- mesh__dateEstablished mesh__D020574 2000-01-01
% 208.25/208.40  |- skos__altLabel mesh__D020574 Platelet-Derived Growth Factor B
% 208.25/208.40  |- skos__altLabel mesh__D020574 PDGFB
% 208.25/208.40  |- skos__historyNote mesh__D020574
% 208.25/208.40       Platelet-Derived Growth Factor %28%1990-1999%29%
% 208.25/208.40  |- mesh__historyNote mesh__D020574
% 208.25/208.40       2000; use PROTO-ONCOGENE PROTEINS C-SIS %28%NM%29% 1987-1999   
% 208.25/208.40  |- skos__related mesh__D020574smesh__D020571
% 208.25/208.40  |- skos__hiddenLabel mesh__D020574 Platelet Derived Growth Factor B
% 208.25/208.40  |- skos__historyNote mesh__D020574
% 208.25/208.40       Proto-Oncogene Proteins %28%1987-1999%29%
% 208.25/208.40  |- skos__hiddenLabel mesh__D020574 Proto Oncogene Proteins c sis
% 208.25/208.40  |- skos__broader mesh__D020574smesh__D004268
% 208.25/208.40  |- skos__altLabel mesh__D020574 Proto-Oncogene Protein sis
% 208.25/208.40  |- skos__broader mesh__D020574smesh__D011518
% 208.25/208.40  |- mesh__recordOriginator mesh__D020574 ags
% 208.25/208.40  |- skos__altLabel mesh__D020574 sis Proto-Oncogene Proteins
% 208.25/208.40  |- skos__hiddenLabel mesh__D020574 c sis Proteins
% 208.25/208.40  |- skos__hiddenLabel mesh__D020574 Proto-Oncogene Proteins, sis
% 208.25/208.40  |- mesh__dateRevised mesh__D020574 2005-06-30
% 208.25/208.40  |- skos__altLabel mesh__D020574 Proto-Oncogene Products c-sis
% 208.25/208.40  |- mesh__recordAuthorizer mesh__D020574 sjn
% 208.25/208.40  |- skos__hiddenLabel mesh__D020574 sis, Proto-Oncogene Proteins
% 208.25/208.40  |- skos__hiddenLabel mesh__D020574 Proto Oncogene Proteins sis
% 208.25/208.40  |- skos__hiddenLabel mesh__D020574 Proto Oncogene Products c sis
% 208.25/208.40  |- mesh__publicMeSHNote mesh__D020574
% 208.25/208.40       2000; PROTO-ONCOGENE PROTEIN SIS was indexed under PROTO-ONCOGENE PROTEINS 1987-1999 %26% PLATELET-DERIVED GROWTH FACTOR 1990-1999%A%  
% 208.25/208.40  |- mesh__dateCreated mesh__D020574 1999-11-03
% 208.25/208.40  |- rdf__type mesh__D020574sskos__Concept
% 208.25/208.40  |- skos__broader mesh__D007717Q000293smesh__D007717
% 208.25/208.40  |- mesh__preferredCombination mesh__D007717Q000293smesh__D007718
% 208.25/208.40  |- rdf__type mesh__D007717Q000293smesh__CompoundConcept
% 208.25/208.40  |- skos__historyNote mesh__D014537 Uridine Diphosphate Sugars %28%1974%29%
% 208.25/208.40  |- skos__altLabel mesh__D014537 Uridine Pyrophosphoacetylglucosamine
% 208.25/208.40  |- skos__hiddenLabel mesh__D014537 N-Acetylglucosamine, Uridine Diphosphate
% 208.25/208.40  |- skos__altLabel mesh__D014537 Uridine Diphospho-N-Acetylglucosamine
% 208.25/208.40  |- skos__hiddenLabel mesh__D014537 Acetylglucosamine, UDP
% 208.25/208.40  |- skos__scopeNote mesh__D014537
% 208.25/208.40       Serves as the biological precursor of insect chitin, of muramic acid in bacterial cell walls, and of sialic acids in mammalian glycoproteins.%A%    
% 208.25/208.40  |- mesh__dateRevised mesh__D014537 2004-07-07
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D014537 2005
% 208.25/208.40  |- skos__historyNote mesh__D014537 Glucosamine %28%1974%29%
% 208.25/208.40  |- mesh__recordAuthorizer mesh__D014537 sjn
% 208.25/208.40  |- mesh__recordMaintainer mesh__D014537 ssb
% 208.25/208.40  |- mesh__historyNote mesh__D014537
% 208.25/208.40       91%28%75%29%; was see under URIDINE DIPHOSPHATE SUGARS 1975-90   
% 208.25/208.40  |- skos__altLabel mesh__D014537 Uridine Diphosphate N Acetylglucosamine
% 208.25/208.40  |- mesh__dateEstablished mesh__D014537 1991-01-01
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D014537 2006
% 208.25/208.40  |- mesh__dateCreated mesh__D014537 1974-11-19
% 208.25/208.40  |- skos__hiddenLabel mesh__D014537 Diphospho-N-Acetylglucosamine, Uridine
% 208.25/208.40  |- mesh__recordOriginator mesh__D014537 NLM
% 208.25/208.40  |- skos__broader mesh__D014537smesh__D014539
% 208.25/208.40  |- mesh__publicMeSHNote mesh__D014537
% 208.25/208.40       91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90   
% 208.25/208.40  |- skos__hiddenLabel mesh__D014537 Diphosphate N-Acetylglucosamine, Uridine
% 208.25/208.40  |- skos__altLabel mesh__D014537 UDPGNAc
% 208.25/208.40  |- skos__prefLabel mesh__D014537 Uridine Diphosphate N-Acetylglucosamine
% 208.25/208.40  |- skos__hiddenLabel mesh__D014537 Uridine Diphospho N Acetylglucosamine
% 208.25/208.40  |- skos__altLabel mesh__D014537 UDP Acetylglucosamine
% 208.25/208.40  |- skos__hiddenLabel mesh__D014537 Pyrophosphoacetylglucosamine, Uridine
% 208.25/208.40  |- rdf__type mesh__D014537sskos__Concept
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D000517 2005
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D000517 2003
% 208.25/208.40  |- mesh__recordAuthorizer mesh__D000517 sjn
% 208.25/208.40  |- mesh__dateEstablished mesh__D000517 1991-01-01
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D000517 2006
% 208.25/208.40  |- skos__altLabel mesh__D000517 alpha-Chlorhydrin
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D000517 2004
% 208.25/208.40  |- skos__broader mesh__D000517smesh__D011409
% 208.25/208.40  |- skos__historyNote mesh__D000517 Chlorine %28%1972-1974%29%
% 208.25/208.40  |- skos__hiddenLabel mesh__D000517 U 5897
% 208.25/208.40  |- skos__prefLabel mesh__D000517 alpha-Chlorohydrin
% 208.25/208.40  |- skos__altLabel mesh__D000517 3-Chloropropanediol
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D000517 2001
% 208.25/208.40  |- mesh__historyNote mesh__D000517
% 208.25/208.40       91%28%75%29%; was see under CHLOROHYDRINS 1975-90   
% 208.25/208.40  |- skos__altLabel mesh__D000517 Glycerol alpha-Monochlorohydrin
% 208.25/208.40  |- mesh__publicMeSHNote mesh__D000517
% 208.25/208.40       91; was see under CHLOROHYDRINS 1975-90   
% 208.25/208.40  |- mesh__recordMaintainer mesh__D000517 CCR
% 208.25/208.40  |- skos__historyNote mesh__D000517 Propanediols %28%1969-1974%29%
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D000517 2002
% 208.25/208.40  |- skos__hiddenLabel mesh__D000517 3 Chloropropanediol
% 208.25/208.40  |- skos__hiddenLabel mesh__D000517 3 Chloro 1,2 propanediol
% 208.25/208.40  |- skos__hiddenLabel mesh__D000517 alpha Chlorohydrin
% 208.25/208.40  |- skos__hiddenLabel mesh__D000517 Glycerol alpha Monochlorohydrin
% 208.25/208.40  |- mesh__recordOriginator mesh__D000517 NLM
% 208.25/208.40  |- mesh__dateRevised mesh__D000517 2000-06-21
% 208.25/208.40  |- mesh__dateCreated mesh__D000517 1974-11-14
% 208.25/208.40  |- skos__hiddenLabel mesh__D000517 U5897
% 208.25/208.40  |- skos__hiddenLabel mesh__D000517 alpha Chlorhydrin
% 208.25/208.40  |- rdf__type mesh__D000517sskos__Concept
% 208.25/208.40  |- skos__hiddenLabel mesh__D000517 alpha-Monochlorohydrin, Glycerol
% 208.25/208.40  |- skos__altLabel mesh__D000517 3-Chloro-1,2-propanediol
% 208.25/208.40  |- skos__broader mesh__D000517smesh__D002728
% 208.25/208.40  |- skos__scopeNote mesh__D000517
% 208.25/208.40       A chlorinated propanediol compound that has shown anti-fertility activity in males and has been used as a chemosterilant in rodents.%A%    
% 208.25/208.40  |- skos__broader mesh__D019222smesh__D008606
% 208.25/208.40  |- skos__hiddenLabel mesh__D019222
% 208.25/208.40       Mind Body Relationship %28%Non Physiology%29%
% 208.25/208.40  |- mesh__historyNote mesh__D019222 97   
% 208.25/208.40  |- mesh__dateRevised mesh__D019222 2001-07-25
% 208.25/208.40  |- skos__hiddenLabel mesh__D019222 Relations, Mind-Body %28%Metaphysics%29%
% 208.25/208.40  |- skos__related mesh__D019222smesh__D011603
% 208.25/208.40  |- skos__hiddenLabel mesh__D019222 Relation, Mind-Body %28%Metaphysics%29%
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D019222 2005
% 208.25/208.40  |- skos__altLabel mesh__D019222
% 208.25/208.40       Mind-Body Relationship %28%Non-Physiology%29%
% 208.25/208.40  |- skos__hiddenLabel mesh__D019222 Mind-Body Relation %28%Metaphysics%29%
% 208.25/208.40  |- skos__hiddenLabel mesh__D019222
% 208.25/208.40       Mind Body Relations %28%Non Physiology%29%
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D019222 2006
% 208.25/208.40  |- mesh__publicMeSHNote mesh__D019222 97   
% 208.25/208.40  |- skos__hiddenLabel mesh__D019222
% 208.25/208.40       Relations, Mind-Body %28%Non-Physiology%29%
% 208.25/208.40  |- skos__prefLabel mesh__D019222 Mind-Body Relations %28%Metaphysics%29%
% 208.25/208.40  |- rdf__type mesh__D019222sskos__Concept
% 208.25/208.40  |- mesh__recordOriginator mesh__D019222 TGC
% 208.25/208.40  |- mesh__dateEstablished mesh__D019222 1997-01-01
% 208.25/208.40  |- skos__hiddenLabel mesh__D019222
% 208.25/208.40       Relationship, Mind-Body %28%Non-Physiology%29%
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D019222 2002
% 208.25/208.40  |- skos__scopeNote mesh__D019222
% 208.25/208.40       The relation between the mind and the body in a religious, social, spiritual, behavioral, and metaphysical context. This concept is significant in the field of alternative medicine. It differs from the relationship between physiologic processes and behavior where the emphasis is on the body%27%s physiology %28% = PSYCHOPHYSIOLOGY%29%.%A%    
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D019222 2003
% 208.25/208.40  |- mesh__recordMaintainer mesh__D019222 ssb
% 208.25/208.40  |- skos__hiddenLabel mesh__D019222
% 208.25/208.40       Relationships, Mind-Body %28%Non-Physiology%29%
% 208.25/208.40  |- mesh__recordAuthorizer mesh__D019222 sjn
% 208.25/208.40  |- mesh__dateCreated mesh__D019222 1996-06-10
% 208.25/208.40  |- skos__hiddenLabel mesh__D019222
% 208.25/208.40       Mind-Body Relation %28%Non-Physiology%29%
% 208.25/208.40  |- skos__hiddenLabel mesh__D019222 Mind Body Relations %28%Metaphysics%29%
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D019222 2004
% 208.25/208.40  |- skos__hiddenLabel mesh__D019222
% 208.25/208.40       Relation, Mind-Body %28%Non-Physiology%29%
% 208.25/208.40  |- skos__annotation mesh__D019222
% 208.25/208.40       important in alternative med; do not confuse with MIND-BODY RELATIONS %28%PHYSIOLOGY%29% see PSYCHOPHYSIOLOGY where emphasis is on physiol; DF: MIND BODY RELAT METAPHYSICS%A%  
% 208.25/208.40  |- skos__hiddenLabel mesh__D019222
% 208.25/208.40       Mind-Body Relationships %28%Non-Physiology%29%
% 208.25/208.40  |- skos__broader mesh__D019222smesh__D026441
% 208.25/208.40  |- skos__altLabel mesh__D019222 Mind-Body Relations %28%Non-Physiology%29%
% 208.25/208.40  |- skos__broader mesh__D005202smesh__D001208
% 208.25/208.40  |- skos__annotation mesh__D005202
% 208.25/208.40       a geog area of east %26% southeast Asia; prefer specific countries%A%  
% 208.25/208.40  |- mesh__dateEstablished mesh__D005202 1963-01-01
% 208.25/208.40  |- rdf__type mesh__D005202sskos__Concept
% 208.25/208.40  |- skos__altLabel mesh__D005202 Eastern Asia
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D005202 2005
% 208.25/208.40  |- mesh__dateRevised mesh__D005202 2001-07-25
% 208.25/208.40  |- mesh__recordOriginator mesh__D005202 CAB
% 208.25/208.40  |- mesh__recordAuthorizer mesh__D005202 sjn
% 208.25/208.40  |- skos__prefLabel mesh__D005202 Far East
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D005202 2003
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D005202 2006
% 208.25/208.40  |- skos__altLabel mesh__D005202 East Asia
% 208.25/208.40  |- mesh__recordMaintainer mesh__D005202 mdb
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D005202 2004
% 208.25/208.40  |- mesh__dateCreated mesh__D005202 1975-06-19
% 208.25/208.40  |- skos__scopeNote mesh__D005202
% 208.25/208.40       A geographic area of east and southeast Asia encompassing CHINA; HONG KONG; JAPAN; KOREA; MACAO; MONGOLIA; and TAIWAN.%A%    
% 208.25/208.40  |- mesh__historyNote mesh__D005202 67   
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D005202 2002
% 208.25/208.40  |- mesh__dateRevised mesh__D018928 2001-08-03
% 208.25/208.40  |- mesh__dateCreated mesh__D018928 1995-02-17
% 208.25/208.40  |- mesh__dateEstablished mesh__D018928 1996-01-01
% 208.25/208.40  |- mesh__recordOriginator mesh__D018928 AGS
% 208.25/208.40  |- skos__hiddenLabel mesh__D018928 Mucosal Immune Responses
% 208.25/208.40  |- mesh__recordMaintainer mesh__D018928 sjn
% 208.25/208.40  |- skos__hiddenLabel mesh__D018928 Mucosal Immune Response
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D018928 2003
% 208.25/208.40  |- skos__related mesh__D018928smesh__D007071
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D018928 2004
% 208.25/208.40  |- rdf__type mesh__D018928sskos__Concept
% 208.25/208.40  |- skos__historyNote mesh__D018928
% 208.25/208.40       Mucous Membrane/immunology %28%1970-1995%29%
% 208.25/208.40  |- skos__scopeNote mesh__D018928
% 208.25/208.40       Nonsusceptibility to the pathogenic effects of foreign microorganisms or antigenic substances as a result of antibody secretions of the mucous membranes. Mucosal epithelia in the gastrointestinal, respiratory, and reproductive tracts produce a form of IgA %28%IMMUNOGLOBULIN A, SECRETORY%29% that serves to protect these ports of entry into the body.%A%    
% 208.25/208.40  |- skos__hiddenLabel mesh__D018928 Immune Responses, Mucosal
% 208.25/208.40  |- mesh__historyNote mesh__D018928 96   
% 208.25/208.40  |- skos__prefLabel mesh__D018928 Immunity, Mucosal
% 208.25/208.40  |- skos__broader mesh__D018928smesh__D007109
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D018928 2005
% 208.25/208.40  |- skos__annotation mesh__D018928
% 208.25/208.40       IM general only, NIM with specific disease /immunol %28%IM%29%   
% 208.25/208.40  |- mesh__publicMeSHNote mesh__D018928 96   
% 208.25/208.40  |- mesh__recordAuthorizer mesh__D018928 sjn
% 208.25/208.40  |- skos__historyNote mesh__D018928
% 208.25/208.40       Intestinal Mucosa/immunology %28%1976-1995%29%
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D018928 2002
% 208.25/208.40  |- skos__altLabel mesh__D018928 Mucosal Immunity
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D018928 2006
% 208.25/208.40  |- mesh__dateCreated mesh__D010945 1999-01-01
% 208.25/208.40  |- skos__altLabel mesh__D010945 Food Plants
% 208.25/208.40  |- skos__scopeNote mesh__D010945
% 208.25/208.40       An organism of the vegetable kingdom suitable by nature for use as a food, especially by human beings. Not all parts of any given plant are edible but all parts of edible plants have been known to figure as raw or cooked food: leaves, roots, tubers, stems, seeds, buds, fruits, and flowers. The most commonly edible parts of plants are FRUIT, usually sweet, fleshy, and succulent. Most edible plants are commonly cultivated for their nutritional value and are referred to as VEGETABLES.%A%    
% 208.25/208.40  |- mesh__recordMaintainer mesh__D010945 sjn
% 208.25/208.40  |- skos__annotation mesh__D010945
% 208.25/208.40       as plants %26% food; prefer FRUIT %28%J%29% or VEGETABLES %28%J%29% if ascertainable; specify geog if pertinent; use qualif available to PLANTS with discretion%A%  
% 208.25/208.40  |- mesh__dateRevised mesh__D010945 2004-07-13
% 208.25/208.40  |- skos__prefLabel mesh__D010945 Plants, Edible
% 208.25/208.40  |- mesh__recordAuthorizer mesh__D010945 sjn
% 208.25/208.40  |- rdf__type mesh__D010945sskos__Concept
% 208.25/208.40  |- mesh__recordOriginator mesh__D010945 NLM
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D010945 2005
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D010945 2006
% 208.25/208.40  |- skos__broader mesh__D010945smesh__D010944
% 208.25/208.40  |- mesh__dateEstablished mesh__D029650 2002-01-01
% 208.25/208.40  |- skos__historyNote mesh__D029650 Enterovirus %28%1965-2001%29%
% 208.25/208.40  |- skos__annotation mesh__D029650
% 208.25/208.40       infection: coord IM with ENTEROVIRUS INFECTIONS %28%IM%29%   
% 208.25/208.40  |- mesh__publicMeSHNote mesh__D029650 2002   
% 208.25/208.40  |- mesh__recordOriginator mesh__D029650 ags
% 208.25/208.40  |- skos__altLabel mesh__D029650 Bovine enterovirus
% 208.25/208.40  |- mesh__recordAuthorizer mesh__D029650 sjn
% 208.25/208.40  |- mesh__dateCreated mesh__D029650 2001-07-25
% 208.25/208.40  |- skos__broader mesh__D029650smesh__D004770
% 208.25/208.40  |- rdf__type mesh__D029650sskos__Concept
% 208.25/208.40  |- skos__hiddenLabel mesh__D029650 Enteroviruses, Bovine
% 208.25/208.40  |- mesh__recordMaintainer mesh__D029650 ags
% 208.25/208.40  |- mesh__historyNote mesh__D029650 2002   
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D029650 2006
% 208.25/208.40  |- skos__prefLabel mesh__D029650 Enterovirus, Bovine
% 208.25/208.40  |- skos__scopeNote mesh__D029650
% 208.25/208.40       A species in the family ENTEROVIRUS infecting cattle.     
% 208.25/208.40  |- skos__hiddenLabel mesh__D029650 Bovine Enteroviruses
% 208.25/208.40  |- mesh__dateRevised mesh__D029650 2005-06-30
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Measurements, Pain
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Scale, Analogue Pain
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Analogue Pain Scales
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Tests, Tourniquet Pain
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Tests, Analgesia
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Scale, Visual Analog
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D010147 1998
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Test, Tourniquet Pain
% 208.25/208.40  |- mesh__dateEstablished mesh__D010147 1987-01-01
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Analogue Scale, Visual
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D010147 2004
% 208.25/208.40  |- rdf__type mesh__D010147sskos__Concept
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Pain Scales, Analog
% 208.25/208.40  |- mesh__recordMaintainer mesh__D010147 PXP
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Visual Analogue Scales
% 208.25/208.40  |- skos__altLabel mesh__D010147 Visual Analogue Pain Scale
% 208.25/208.40  |- mesh__recordOriginator mesh__D010147 SH
% 208.25/208.40  |- skos__altLabel mesh__D010147 Nociception Tests
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Test, Analgesia
% 208.25/208.40  |- skos__broader mesh__D010147smesh__D009460
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Visual Analog Scales
% 208.25/208.40  |- skos__altLabel mesh__D010147 Analgesia Tests
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Scale, McGill Pain
% 208.25/208.40  |- mesh__publicMeSHNote mesh__D010147 87   
% 208.25/208.40  |- mesh__recordAuthorizer mesh__D010147 SJN
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Pain Scale, Analogue
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Assessments, Pain
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D010147 1999
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Scale, Analog Pain
% 208.25/208.40  |- mesh__dateRevised mesh__D010147 1997-06-20
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Measurement, Pain
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Pain Measurements
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Pain Test, Tourniquet
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Test, Nociception
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Formalin Tests
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D010147 2005
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Analog Pain Scales
% 208.25/208.40  |- mesh__dateCreated mesh__D010147 1986-03-25
% 208.25/208.40  |- skos__altLabel mesh__D010147 Visual Analog Pain Scale
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Pain Assessments
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Pain Scale, McGill
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Scales, Analogue Pain
% 208.25/208.40  |- skos__altLabel mesh__D010147 McGill Pain Scale
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Scales, Analog Pain
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Analgesia Test
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D010147 2000
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Pain Questionnaire, McGill
% 208.25/208.40  |- mesh__historyNote mesh__D010147 87   
% 208.25/208.40  |- mesh__activeMeSHYear mesh__D010147 2006
% 208.25/208.40  |- skos__altLabel mesh__D010147 Assessment, Pain
% 208.25/208.40  |- skos__altLabel mesh__D010147 Pain Assessment
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Questionnaire, McGill Pain
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Tourniquet Pain Tests
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Scales, Visual Analog
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Pain Tests, Tourniquet
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Scale, Visual Analogue
% 208.25/208.40  |- skos__historyNote mesh__D010147 Pain %28%1966-1986%29%
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Pain Scale, Analog
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Pain Scales, Analogue
% 208.25/208.40  |- skos__hiddenLabel mesh__D010147 Scales, Visual Analogue
% 208.25/208.40  |- skos__annotation mesh__D010147 /drug eff /rad eff permitted   
% 208.25/208.41  |- mesh__activeMeSHYear mesh__D010147 2001
% 208.25/208.41  |- skos__related mesh__D010147smesh__D017288
% 208.25/208.41  |- skos__scopeNote mesh__D010147
% 208.25/208.41       Scales, questionnaires, tests, and other methods used to assess pain severity and duration in patients or experimental animals to aid in diagnosis, therapy, and physiological studies.%A%    
% 208.25/208.41  |- skos__prefLabel mesh__D010147 Pain Measurement
% 208.25/208.41  |- skos__hiddenLabel mesh__D010147 Tests, Nociception
% 208.25/208.41  |- skos__hiddenLabel mesh__D010147 Nociception Test
% 208.25/208.41  |- skos__hiddenLabel mesh__D010147 Test, Formalin
% 208.25/208.41  |- skos__related mesh__D010147smesh__D012684
% 208.25/208.41  |- skos__hiddenLabel mesh__D010147 Analogue Scales, Visual
% 208.25/208.41  |- skos__hiddenLabel mesh__D010147 Tests, Formalin
% 208.25/208.41  |- mesh__activeMeSHYear mesh__D010147 2003
% 208.25/208.41  |- skos__altLabel mesh__D010147 Analog Pain Scale
% 208.25/208.41  |- skos__altLabel mesh__D010147 Visual Analogue Scale
% 208.25/208.41  |- mesh__activeMeSHYear mesh__D010147 2002
% 208.25/208.41  |- mesh__recordMaintainer mesh__D004908 TGC
% 208.25/208.41  |- mesh__activeMeSHYear mesh__D004908 2004
% 208.25/208.41  |- rdf__type mesh__D004908sskos__Concept
% 208.25/208.41  |- mesh__dateEstablished mesh__D004908 1991-01-01
% 208.25/208.41  |- skos__hiddenLabel mesh__D004908 Inclusion, Erythrocyte
% 208.25/208.41  |- mesh__dateCreated mesh__D004908 1975-02-04
% 208.25/208.41  |- skos__hiddenLabel mesh__D004908 Howell Jolly Bodies
% 208.25/208.41  |- skos__scopeNote mesh__D004908
% 208.25/208.41       Pathologic inclusions occurring in erythrocytes.     
% 208.25/208.41  |- skos__hiddenLabel mesh__D004908 Bodies, Howell-Jolly
% 208.25/208.41  |- skos__prefLabel mesh__D004908 Erythrocyte Inclusions
% 208.25/208.41  |- skos__hiddenLabel mesh__D004908 Inclusions, Erythrocyte
% 208.25/208.41  |- skos__annotation mesh__D004908 A 11 qualif except /cytol   
% 208.25/208.41  |- mesh__onlineNote mesh__D004908 search ERYTHROCYTES, ABNORMAL 1968-74   
% 208.25/208.41  |- skos__broader mesh__D004908smesh__D002479
% 208.25/208.41  |- mesh__recordOriginator mesh__D004908 NLM
% 208.25/208.41  |- mesh__activeMeSHYear mesh__D004908 2005
% 208.25/208.41  |- skos__broader mesh__D004908smesh__D004913
% 208.25/208.41  |- mesh__activeMeSHYear mesh__D004908 2001
% 208.25/208.41  |- mesh__publicMeSHNote mesh__D004908
% 208.25/208.41       91; was see under ERYTHROCYTES, ABNORMAL 1975-90   
% 208.25/208.41  |- mesh__historyNote mesh__D004908
% 208.25/208.41       91%28%75%29%; was see under ERYTHROCYTES, ABNORMAL 1975-90   
% 208.25/208.41  |- mesh__dateRevised mesh__D004908 2000-06-22
% 208.25/208.41  |- skos__hiddenLabel mesh__D004908 Erythrocyte Inclusion
% 208.25/208.41  |- mesh__recordAuthorizer mesh__D004908 sjn
% 208.25/208.41  |- mesh__activeMeSHYear mesh__D004908 2003
% 208.25/208.41  |- mesh__activeMeSHYear mesh__D004908 2006
% 208.25/208.41  |- mesh__activeMeSHYear mesh__D004908 2002
% 208.25/208.41  |- rdf__type mesh__D001610sskos__Concept
% 208.25/208.41  |- skos__hiddenLabel mesh__D001610 Cathode Ray
% 208.25/208.41  |- mesh__activeMeSHYear mesh__D001610 2006
% 208.25/208.41  |- skos__historyNote mesh__D001610 Elementary Particles %28%1970-1984%29%
% 208.25/208.41  |- skos__altLabel mesh__D001610 Beta Radiation
% 208.25/208.41  |- skos__hiddenLabel mesh__D001610 Beta Particle
% 208.25/208.41  |- mesh__recordOriginator mesh__D001610 SH
% 208.25/208.41  |- mesh__activeMeSHYear mesh__D001610 1997
% 208.25/208.41  |- mesh__activeMeSHYear mesh__D001610 2005
% 208.25/208.41  |- skos__annotation mesh__D001610 NIM   
% 208.25/208.41  |- skos__altLabel mesh__D001610 Beta Particles
% 208.25/208.41  |- skos__broader mesh__D001610smesh__D009686
% 208.25/208.41  |- mesh__recordAuthorizer mesh__D001610 PLS
% 208.25/208.41  |- mesh__activeMeSHYear mesh__D001610 2001
% 208.25/208.41  |- mesh__activeMeSHYear mesh__D001610 1996
% 208.25/208.41  |- skos__hiddenLabel mesh__D001610 Beta Ray
% 208.25/208.41  |- mesh__dateRevised mesh__D001610 1994-06-30
% 208.25/208.41  |- skos__hiddenLabel mesh__D001610 Radiations, Beta
% 208.25/208.41  |- mesh__onlineNote mesh__D001610
% 208.25/208.41       use BETA RAYS to search CATHODE RAYS 1976-84, RADIATION 1966-75%A%  
% 208.25/208.41  |- mesh__activeMeSHYear mesh__D001610 2000
% 208.25/208.41  |- skos__hiddenLabel mesh__D001610 Rays, Beta
% 208.25/208.41  |- mesh__dateCreated mesh__D001610 1984-02-24
% 208.25/208.41  |- mesh__activeMeSHYear mesh__D001610 1999
% 208.25/208.41  |- mesh__activeMeSHYear mesh__D001610 2004
% 208.25/208.41  |- skos__hiddenLabel mesh__D001610 Ray, Cathode
% 208.25/208.41  |- skos__historyNote mesh__D001610 Radiation %28%1966-1984%29%
% 208.25/208.41  |- skos__broader mesh__D001610smesh__D011839
% 208.25/208.41  |- mesh__historyNote mesh__D001610
% 208.25/208.41       85; CATHODE RAYS was see under RADIATION, IONIZING 1976-84, was see under RADIATION 1963-75%A%  
% 208.25/208.41  |- mesh__dateEstablished mesh__D001610 1985-01-01
% 208.25/208.41  |- skos__hiddenLabel mesh__D001610 Beta Radiations
% 208.25/208.41  |- skos__hiddenLabel mesh__D001610 Particle, Beta
% 208.26/208.41  |- skos__hiddenLabel mesh__D001610 Rays, Cathode
% 208.26/208.41  |- skos__prefLabel mesh__D001610 Beta Rays
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D001610 1995
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D001610 1998
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D001610 2003
% 208.26/208.41  |- skos__altLabel mesh__D001610 Radiation, Beta
% 208.26/208.41  |- mesh__publicMeSHNote mesh__D001610
% 208.26/208.41       85; CATHODE RAYS was see under RADIATION, IONIZING 1976-84, was see under RADIATION 1963-75%A%  
% 208.26/208.41  |- mesh__recordMaintainer mesh__D001610 TGC
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D001610 2002
% 208.26/208.41  |- skos__hiddenLabel mesh__D001610 Ray, Beta
% 208.26/208.41  |- skos__hiddenLabel mesh__D001610 Particles, Beta
% 208.26/208.41  |- skos__scopeNote mesh__D001610
% 208.26/208.41       A stream of positive or negative electrons ejected with high energy from a disintegrating atomic nucleus; most biomedically used isotopes emit negative particles %28%electrons or negatrons, rather than positrons%29%. Cathode rays are low-energy negative electrons produced in cathode ray tubes, also called television tubes or oscilloscopes.%A%    
% 208.26/208.41  |- skos__historyNote mesh__D001610 Electrons %28%1966-1984%29%
% 208.26/208.41  |- skos__hiddenLabel mesh__D020575 Oncogene Proteins v sis
% 208.26/208.41  |- mesh__dateEstablished mesh__D020575 2000-01-01
% 208.26/208.41  |- skos__altLabel mesh__D020575 Oncogene Products v-sis
% 208.26/208.41  |- skos__prefLabel mesh__D020575 Oncogene Proteins v-sis
% 208.26/208.41  |- mesh__dateCreated mesh__D020575 1999-11-03
% 208.26/208.41  |- skos__scopeNote mesh__D020575
% 208.26/208.41       Transforming proteins coded by sis oncogenes. Transformation of cells by v-sis is related to its interaction with the PDGF receptor and also its ability to alter other transcription factors.%A%    
% 208.26/208.41  |- skos__related mesh__D020575smesh__D020571
% 208.26/208.41  |- skos__hiddenLabel mesh__D020575 v-sis, Oncogene Products
% 208.26/208.41  |- skos__altLabel mesh__D020575 v-sis Proteins
% 208.26/208.41  |- skos__historyNote mesh__D020575 Viral Proteins %28%1983-1985%29%
% 208.26/208.41  |- skos__hiddenLabel mesh__D020575 Proteins, v-sis
% 208.26/208.41  |- skos__hiddenLabel mesh__D020575 v-sis, Oncogene Proteins
% 208.26/208.41  |- skos__altLabel mesh__D020575 p28%28%v-sis%29%
% 208.26/208.41  |- mesh__historyNote mesh__D020575
% 208.26/208.41       2000; use ONCOGENE PROTEINS V-SIS %28%NM%29% 1983-1999   
% 208.26/208.41  |- skos__broader mesh__D020575smesh__D015682
% 208.26/208.41  |- mesh__publicMeSHNote mesh__D020575
% 208.26/208.41       2000; ONCOGENE PROTEINS SIS was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-1999; RETROVIRIDAE PROTEINS 1986-1989; %26% VIRAL PROTEINS 1983-1985%A%  
% 208.26/208.41  |- skos__hiddenLabel mesh__D020575 v sis Proteins
% 208.26/208.41  |- skos__hiddenLabel mesh__D020575 Oncogene Products v sis
% 208.26/208.41  |- mesh__recordMaintainer mesh__D020575 SYSTEM
% 208.26/208.41  |- rdf__type mesh__D020575sskos__Concept
% 208.26/208.41  |- skos__historyNote mesh__D020575
% 208.26/208.41       Retroviridae Proteins, Oncogenic %28%1990-1999%29%
% 208.26/208.41  |- skos__historyNote mesh__D020575 Retroviridae Proteins %28%1986-1989%29%
% 208.26/208.41  |- skos__altLabel mesh__D020575 sis Oncogene Proteins
% 208.26/208.41  |- mesh__recordOriginator mesh__D020575 ags
% 208.26/208.41  |- skos__altLabel mesh__D020575 Oncogene Proteins sis
% 208.26/208.41  |- skos__altLabel mesh__D020575 Oncogene Protein p28%28%v-sis%29%
% 208.26/208.41  |- skos__hiddenLabel mesh__D020575 Oncogene Proteins, sis
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D020575 2006
% 208.26/208.41  |- mesh__dateRevised mesh__D020575 2005-06-30
% 208.26/208.41  |- skos__hiddenLabel mesh__D020575 sis, Oncogene Proteins
% 208.26/208.41  |- mesh__recordAuthorizer mesh__D020575 sjn
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D014538 2005
% 208.26/208.41  |- skos__altLabel mesh__D014538 Uridine Diphosphate N Acetylmuramic Acid
% 208.26/208.41  |- skos__historyNote mesh__D014538
% 208.26/208.41       Uridine Diphosphate Sugars %28%1973-1974%29%
% 208.26/208.41  |- mesh__dateEstablished mesh__D014538 1991-01-01
% 208.26/208.41  |- skos__historyNote mesh__D014538 Muramic Acid %28%1973-1974%29%
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D014538 2006
% 208.26/208.41  |- skos__altLabel mesh__D014538 UDP Acetylmuramic Acid
% 208.26/208.41  |- mesh__publicMeSHNote mesh__D014538
% 208.26/208.41       91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90   
% 208.26/208.41  |- skos__prefLabel mesh__D014538 Uridine Diphosphate N-Acetylmuramic Acid
% 208.26/208.41  |- mesh__recordAuthorizer mesh__D014538 sjn
% 208.26/208.41  |- mesh__recordMaintainer mesh__D014538 ssb
% 208.26/208.41  |- mesh__historyNote mesh__D014538
% 208.26/208.41       91%28%75%29%; was see under URIDINE DIPHOSPHATE SUGARS 1975-90   
% 208.26/208.41  |- mesh__dateCreated mesh__D014538 1974-11-19
% 208.26/208.41  |- rdf__type mesh__D014538sskos__Concept
% 208.26/208.41  |- skos__hiddenLabel mesh__D014538 Acetylmuramic Acid, UDP
% 208.26/208.41  |- skos__scopeNote mesh__D014538
% 208.26/208.41       A nucleoside diphosphate sugar which is formed from UDP-N-acetylglucosamine and phosphoenolpyruvate. It serves as the building block upon which peptidoglycan is formed.%A%    
% 208.26/208.41  |- skos__hiddenLabel mesh__D014538 Acid, UDP Acetylmuramic
% 208.26/208.41  |- mesh__recordOriginator mesh__D014538 NLM
% 208.26/208.41  |- skos__broader mesh__D014538smesh__D014539
% 208.26/208.41  |- mesh__dateRevised mesh__D014538 2004-07-07
% 208.26/208.41  |- mesh__onlineNote mesh__D000518
% 208.26/208.41       use EFLORNITHINE to search ALPHA-DIFLUOROMETHYLORNITHINE 1987-90%A%  
% 208.26/208.41  |- skos__hiddenLabel mesh__D000518 MDL71,782 A
% 208.26/208.41  |- skos__hiddenLabel mesh__D000518 alpha Difluoromethylornithine
% 208.26/208.41  |- mesh__historyNote mesh__D000518
% 208.26/208.41       91; was ALPHA-DIFLUOROMETHYLORNITHINE 1987-90   
% 208.26/208.41  |- skos__hiddenLabel mesh__D000518 DL alpha Difluoromethylornithine
% 208.26/208.41  |- skos__hiddenLabel mesh__D000518 Ornithine, alpha-Difluoromethyl
% 208.26/208.41  |- mesh__recordMaintainer mesh__D000518 exl
% 208.26/208.41  |- skos__altLabel mesh__D000518 alpha-Difluoromethylornithine
% 208.26/208.41  |- skos__historyNote mesh__D000518
% 208.26/208.41       Ornithine/analogs %26% derivatives %28%1975-1986%29%
% 208.26/208.41  |- skos__altLabel mesh__D000518
% 208.26/208.41       Women First Brand of Eflornithine Hydrochloride
% 208.26/208.41  |- mesh__dateCreated mesh__D000518 1986-06-03
% 208.26/208.41  |- mesh__publicMeSHNote mesh__D000518
% 208.26/208.41       91; was ALPHA-DIFLUOROMETHYLORNITHINE 1987-90   
% 208.26/208.41  |- skos__hiddenLabel mesh__D000518 MDL 71,782 A
% 208.26/208.41  |- skos__hiddenLabel mesh__D000518 alpha Difluoromethyl Ornithine
% 208.26/208.41  |- skos__hiddenLabel mesh__D000518
% 208.26/208.41       Monohydrochloride, Monohydrate Eflornithine
% 208.26/208.41  |- rdf__type mesh__D000518sskos__Concept
% 208.26/208.41  |- skos__hiddenLabel mesh__D000518 Hydrochloride, Eflornithine
% 208.26/208.41  |- skos__annotation mesh__D000518 DF:DFMO   
% 208.26/208.41  |- mesh__recordAuthorizer mesh__D000518 sjn
% 208.26/208.41  |- skos__historyNote mesh__D000518 Ornithine %28%1966-1974%29%
% 208.26/208.41  |- mesh__dateEstablished mesh__D000518 1987-01-01
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D000518 2006
% 208.26/208.41  |- skos__scopeNote mesh__D000518
% 208.26/208.41       An inhibitor of ornithine decarboxylase, the rate limiting enzyme of the polyamine biosynthetic pathway.%A%    
% 208.26/208.41  |- skos__altLabel mesh__D000518 alpha-Difluoromethyl Ornithine
% 208.26/208.41  |- skos__altLabel mesh__D000518 Eflornithine Monohydrochloride, Monohydrate
% 208.26/208.41  |- skos__altLabel mesh__D000518 DL-alpha-Difluoromethylornithine
% 208.26/208.41  |- mesh__dateRevised mesh__D000518 2005-06-30
% 208.26/208.41  |- skos__broader mesh__D000518smesh__D009952
% 208.26/208.41  |- mesh__recordOriginator mesh__D000518 RLS
% 208.26/208.41  |- skos__hiddenLabel mesh__D000518 71782, RMI
% 208.26/208.41  |- skos__prefLabel mesh__D000518 Eflornithine
% 208.26/208.41  |- skos__annotation mesh__D019223
% 208.26/208.41       coord IM with specific arthropod /virol or insect /virol %28%IM%29%; do not confuse X ref INFECTIOUS HYPODERMAL AND HEMATOPOIETIC NECROSIS VIRUS see DENSOVIRINAE with INFECTIOUS HEMATOPOIETIC NECROSIS VIRUS%A%  
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D019223 2003
% 208.26/208.41  |- mesh__recordAuthorizer mesh__D019223 sjn
% 208.26/208.41  |- skos__broader mesh__D019223smesh__D010321
% 208.26/208.41  |- mesh__dateEstablished mesh__D019223 1997-01-01
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D019223 2002
% 208.26/208.41  |- mesh__dateCreated mesh__D019223 1996-06-10
% 208.26/208.41  |- skos__hiddenLabel mesh__D019223 densovirus, Aedes aegypti
% 208.26/208.41  |- skos__scopeNote mesh__D019223
% 208.26/208.41       A subfamily of DNA arthropod viruses, in the family PARVOVIRIDAE. The host range includes members of Dictyoptera, DIPTERA, LEPIDOPTERA, Odonata, and ORTHOPTERA. There are three genera: DENSOVIRUS, Iteravirus, and Brevidensovirus. Densovirus-like viruses also infect and multiply in crabs and shrimp.%A%    
% 208.26/208.41  |- skos__altLabel mesh__D019223 IHHNV
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D019223 2006
% 208.26/208.41  |- skos__prefLabel mesh__D019223 Densovirinae
% 208.26/208.41  |- skos__hiddenLabel mesh__D019223 Brevidensoviruses
% 208.26/208.41  |- rdf__type mesh__D019223sskos__Concept
% 208.26/208.41  |- mesh__dateRevised mesh__D019223 2001-07-25
% 208.26/208.41  |- mesh__publicMeSHNote mesh__D019223 97   
% 208.26/208.41  |- mesh__recordOriginator mesh__D019223 AGS
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D019223 2005
% 208.26/208.41  |- skos__hiddenLabel mesh__D019223 Contraviruses
% 208.26/208.41  |- mesh__historyNote mesh__D019223 97   
% 208.26/208.41  |- skos__hiddenLabel mesh__D019223 Iteraviruses
% 208.26/208.41  |- skos__hiddenLabel mesh__D019223 Aedes aegypti densoviruses
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D019223 2004
% 208.26/208.41  |- mesh__recordMaintainer mesh__D019223 ags
% 208.26/208.41  |- skos__broader mesh__D019223smesh__D007304
% 208.26/208.41  |- skos__altLabel mesh__D019223 Contravirus
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D005203 2005
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D005203 2002
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D005203 1998
% 208.26/208.41  |- skos__annotation mesh__D005203
% 208.26/208.41       caused by bacteria Micropolyspora %26% Thermoactinomyces %28%see MICROMONOSPORACEAE%29%%A%  
% 208.26/208.41  |- mesh__recordMaintainer mesh__D005203 TGC
% 208.26/208.41  |- mesh__dateEstablished mesh__D005203 1965-01-01
% 208.26/208.41  |- skos__hiddenLabel mesh__D005203 Lung, Farmer%27%s
% 208.26/208.41  |- skos__broader mesh__D005203smesh__D000382
% 208.26/208.41  |- skos__hiddenLabel mesh__D005203 Farmer%27%s Lungs
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D005203 2006
% 208.26/208.41  |- mesh__publicMeSHNote mesh__D005203 65   
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D005203 1999
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D005203 2003
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D005203 1996
% 208.26/208.41  |- mesh__historyNote mesh__D005203 65%28%63%29%   
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D005203 2004
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D005203 1997
% 208.26/208.41  |- skos__prefLabel mesh__D005203 Farmer%27%s Lung
% 208.26/208.41  |- skos__hiddenLabel mesh__D005203 Farmer Lung
% 208.26/208.41  |- skos__hiddenLabel mesh__D005203 Lungs, Farmer%27%s
% 208.26/208.41  |- mesh__recordOriginator mesh__D005203 NLM
% 208.26/208.41  |- skos__hiddenLabel mesh__D005203 Farmers Lung
% 208.26/208.41  |- mesh__dateRevised mesh__D005203 1994-04-16
% 208.26/208.41  |- mesh__recordAuthorizer mesh__D005203 PLS
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D005203 2000
% 208.26/208.41  |- skos__broader mesh__D005203smesh__D000542
% 208.26/208.41  |- rdf__type mesh__D005203sskos__Concept
% 208.26/208.41  |- skos__scopeNote mesh__D005203
% 208.26/208.41       Systemic and pulmonary reactions resulting from inhalation of dust from moldy hay, threshing dust, or moldy straw, by persons who have become hypersensitive to antigens in the dust. It is most often associated with inhalation of spores of Micromonospora faeni or Thermoactinomyces vulgaris. %28%From Dorland, 27th ed%29%%A%    
% 208.26/208.41  |- mesh__dateCreated mesh__D005203 1999-01-01
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D005203 1995
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D005203 2001
% 208.26/208.41  |- skos__hiddenLabel mesh__D018929 Cell Cultures, Primary
% 208.26/208.41  |- skos__hiddenLabel mesh__D018929 Cell Culture, Primary
% 208.26/208.41  |- skos__scopeNote mesh__D018929
% 208.26/208.41       A technique for maintaining or growing CELLS in vitro. Cultures of dispersed cells derived directly from fresh TISSUES are called primary cell cultures. Cultures may also derive from established CELL LINE usually stored frozen.%A%    
% 208.26/208.41  |- mesh__publicMeSHNote mesh__D018929 2005; see CELL CULTURE 1996-2004   
% 208.26/208.41  |- skos__hiddenLabel mesh__D018929 Culture Technique, Cell
% 208.26/208.41  |- rdf__type mesh__D018929sskos__Concept
% 208.26/208.41  |- skos__historyNote mesh__D018929 Tissue Culture %28%1966-1995%29%
% 208.26/208.41  |- mesh__recordAuthorizer mesh__D018929 sjn
% 208.26/208.41  |- skos__hiddenLabel mesh__D018929 Primary Cell Cultures
% 208.26/208.41  |- mesh__dateEstablished mesh__D018929 1996-01-01
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D018929 2005
% 208.26/208.41  |- mesh__dateRevised mesh__D018929 2004-07-07
% 208.26/208.41  |- mesh__dateCreated mesh__D018929 1995-01-06
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D018929 2006
% 208.26/208.41  |- mesh__recordOriginator mesh__D018929 AGS
% 208.26/208.41  |- mesh__historyNote mesh__D018929 2005 %28%1996%29%   
% 208.26/208.41  |- skos__altLabel mesh__D018929 Cell Culture
% 208.26/208.41  |- skos__annotation mesh__D018929
% 208.26/208.41       note category: do not confuse with CELLS, CULTURED %28%Cat A%29%; NIM%A%  
% 208.26/208.41  |- skos__related mesh__D018929smesh__D002478
% 208.26/208.41  |- skos__hiddenLabel mesh__D018929 Cell Culture Technique
% 208.26/208.41  |- skos__hiddenLabel mesh__D018929 Cell Cultures
% 208.26/208.41  |- skos__hiddenLabel mesh__D018929 Culture Techniques, Cell
% 208.26/208.41  |- mesh__recordMaintainer mesh__D018929 lkt
% 208.26/208.41  |- skos__prefLabel mesh__D018929 Cell Culture Techniques
% 208.26/208.41  |- skos__broader mesh__D018929smesh__D046508
% 208.26/208.41  |- mesh__historyNote mesh__D010946
% 208.26/208.41       AESCULUS, CASTANEA, CHELIDONIUM, CHENOPODIUM, COLCHICUM, COLOCYNTH, CRATAEGUS, CUBEB, ECHINACEA, GELSEMIUM, GENTIAN, HYDRASTIS, LITHOSPERMUM, MARRUBIUM, MYRICA,  RAUWOLFIA, ROSA, SARSAPARILLA, SALIX %26% TAMARIND were headings 1963-85; ADONIS, ASPIDIUM %26% OLEANDER were see under PLANTS, MEDICINAL 1978-85 and headings 1963-77; AMMI was see under PLANTS, MEDICINAL 1977-85%A%  
% 208.26/208.41  |- skos__related mesh__D010946smesh__D008517
% 208.26/208.41  |- skos__related mesh__D010946smesh__D010936
% 208.26/208.41  |- skos__altLabel mesh__D010946 Herbs, Medicinal
% 208.26/208.41  |- skos__broader mesh__D010946smesh__D010944
% 208.26/208.41  |- rdf__type mesh__D010946sskos__Concept
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D010946 2003
% 208.26/208.41  |- skos__prefLabel mesh__D010946 Plants, Medicinal
% 208.26/208.41  |- skos__altLabel mesh__D010946 Medicinal Plants
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D010946 2005
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D010946 2004
% 208.26/208.41  |- mesh__publicMeSHNote mesh__D010946
% 208.26/208.41       AESCULUS, ARECA, CASTANEA, CHELIDONIUM, CHENOPODIUM, COCA, COLCHICUM, COLOCYNTH, CRATAEGUS, CUBEB, ECHINACEA, ERYTHRINA, GELSEMIUM, GENTIAN, HYDRASTIS, LITHOSPERMUM, MARRUBIUM, MYRICA, PAPAVER, RAUWOLFIA, ROSA, SARSAPARILLA, SALIX, TAMARIND %26% VALERIAN were headings 1963-85; ADONIS, ASPIDIUM %26% OLEANDER were see under PLANTS, MEDICINAL 1978-85 and headings 1963-77; AMMI was see under PLANTS, MEDICINAL 1977-85; ALOE %26% RHUBARB were headings 1963-77; PLANTAGO was see PSYLLIUM 1963-77%A%  
% 208.26/208.41  |- mesh__recordAuthorizer mesh__D010946 sjn
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D010946 2006
% 208.26/208.41  |- mesh__recordOriginator mesh__D010946 NLM
% 208.26/208.41  |- mesh__dateRevised mesh__D010946 2002-07-03
% 208.26/208.41  |- mesh__onlineNote mesh__D010946
% 208.26/208.41       use PLANTS, MEDICINAL to search AESCULUS, ASPIDIUM, CASTANEA, CHELIDONIUM, CHENOPODIUM, COLOCYNTH, CRATAEGUS, CUBEB, ECHINACEA, GELSEMIUM, GENTIAN, HYDRASTIS, LITHOSPERMUM, MARRUBIUM, MYRICA, RAUWOLFIA, ROSA, SARSAPARILLA, SALIX %26% TAMARIND 1966-85%A%  
% 208.26/208.41  |- mesh__recordMaintainer mesh__D010946 ssb
% 208.26/208.41  |- mesh__dateCreated mesh__D010946 1999-01-01
% 208.26/208.41  |- skos__scopeNote mesh__D010946
% 208.26/208.41       Plants whose roots, leaves, seeds, bark, or other constituent possess therapeutic, tonic, purgative, or other pharmacologic activity when administered to higher animals.%A%    
% 208.26/208.41  |- skos__annotation mesh__D010946 IM GEN only; spec geog if pertinent;   
% 208.26/208.41  |- mesh__historyNote mesh__D043322
% 208.26/208.41       2004; use LACTASE %28%NM%29% 1990-2003   
% 208.26/208.41  |- mesh__dateCreated mesh__D043322 2003-07-09
% 208.26/208.41  |- mesh__dateEstablished mesh__D043322 2004-01-01
% 208.26/208.41  |- skos__prefLabel mesh__D043322 Lactase
% 208.26/208.41  |- skos__scopeNote mesh__D043322
% 208.26/208.41       An enzyme which catalyzes the hydrolysis of LACTOSE to D-GALACTOSE and D-GLUCOSE. Defects in the enzyme cause LACTOSE INTOLERANCE.%A%    
% 208.26/208.41  |- skos__related mesh__D043322smesh__D007787
% 208.26/208.41  |- skos__hiddenLabel mesh__D043322 Galactohydrolase, Lactose
% 208.26/208.41  |- skos__altLabel mesh__D043322 Lactose Galactohydrolase
% 208.26/208.41  |- skos__historyNote mesh__D043322 beta-Galactosidase %28%1990-2003%29%
% 208.26/208.41  |- skos__broader mesh__D043322smesh__D001616
% 208.26/208.41  |- mesh__publicMeSHNote mesh__D043322
% 208.26/208.41       2004; LACTASE was indexed under BETA-GALACTOSIDASE 1990-2003%A%  
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D043322 2006
% 208.26/208.41  |- rdf__type mesh__D043322sskos__Concept
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D043322 2004
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D043322 2005
% 208.26/208.41  |- skos__scopeNote mesh__D010148
% 208.26/208.41       Persistent pain that is refractory to some or all forms of treatment.%A%    
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D010148 2004
% 208.26/208.41  |- skos__annotation mesh__D010148
% 208.26/208.41       IM; usually chronic so do not coord with CHRONIC DISEASE but chronic pain = PAIN %28%IM%29% + CHRONIC DISEASE %28%NIM%29%%A%  
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D010148 2000
% 208.26/208.41  |- mesh__recordAuthorizer mesh__D010148 ags
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D010148 2003
% 208.26/208.41  |- mesh__historyNote mesh__D010148 1974   
% 208.26/208.41  |- mesh__recordMaintainer mesh__D010148 ags
% 208.26/208.41  |- skos__hiddenLabel mesh__D010148 Pains, Intractable
% 208.26/208.41  |- skos__prefLabel mesh__D010148 Pain, Intractable
% 208.26/208.41  |- skos__hiddenLabel mesh__D010148 Pain, Refractory
% 208.26/208.41  |- skos__altLabel mesh__D010148 Refractory Pain
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D010148 2000A
% 208.26/208.41  |- mesh__dateEstablished mesh__D010148 1974-01-01
% 208.26/208.41  |- mesh__dateCreated mesh__D010148 1999-01-01
% 208.26/208.41  |- skos__hiddenLabel mesh__D010148 Pains, Refractory
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D010148 2006
% 208.26/208.41  |- mesh__dateRevised mesh__D010148 1999-12-08
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D010148 2002
% 208.26/208.41  |- mesh__recordOriginator mesh__D010148 NLM
% 208.26/208.41  |- mesh__publicMeSHNote mesh__D010148 1974   
% 208.26/208.41  |- skos__hiddenLabel mesh__D010148 Refractory Pains
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D010148 2005
% 208.26/208.41  |- rdf__type mesh__D010148sskos__Concept
% 208.26/208.41  |- skos__hiddenLabel mesh__D010148 Intractable Pains
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D010148 2001
% 208.26/208.41  |- skos__hiddenLabel mesh__D010148 Intractable Pain
% 208.26/208.41  |- skos__broader mesh__D010148smesh__D010146
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D004909 2006
% 208.26/208.41  |- skos__hiddenLabel mesh__D004909 Erythrocyte Size Determinations
% 208.26/208.41  |- skos__altLabel mesh__D004909 Mean Cell Volume
% 208.26/208.41  |- skos__hiddenLabel mesh__D004909 Determinations, Erythrocyte Size
% 208.26/208.41  |- skos__broader mesh__D004909smesh__D045122
% 208.26/208.41  |- mesh__dateCreated mesh__D004909 1978-12-19
% 208.26/208.41  |- skos__hiddenLabel mesh__D004909 Diameter, Erythrocyte
% 208.26/208.41  |- skos__historyNote mesh__D004909 Erythrocyte Volume %28%1978-1979%29%
% 208.26/208.41  |- mesh__recordMaintainer mesh__D004909 nns
% 208.26/208.41  |- mesh__historyNote mesh__D004909 80   
% 208.26/208.41  |- skos__hiddenLabel mesh__D004909 Indexes, Red Cell
% 208.26/208.41  |- skos__annotation mesh__D004909
% 208.26/208.41       coord with disease /blood, not /physiopathol   
% 208.26/208.41  |- mesh__activeMeSHYear mesh__D004909 2005
% 208.27/208.41  |- skos__hiddenLabel mesh__D004909 Volumes, Mean Corpuscular
% 208.27/208.41  |- skos__hiddenLabel mesh__D004909 Size Determination, Erythrocyte
% 208.27/208.41  |- mesh__recordAuthorizer mesh__D004909 sjn
% 208.27/208.41  |- rdf__type mesh__D004909sskos__Concept
% 208.27/208.41  |- skos__hiddenLabel mesh__D004909 Mean Cell Volumes
% 208.27/208.41  |- skos__historyNote mesh__D004909 Erythrocyte Count %28%1966-1979%29%
% 208.27/208.41  |- skos__hiddenLabel mesh__D004909 Corpuscular Volumes, Mean
% 208.27/208.41  |- skos__hiddenLabel mesh__D004909 Erythrocyte Diameters
% 208.27/208.41  |- skos__altLabel mesh__D004909 Red Cell Index
% 208.27/208.41  |- skos__hiddenLabel mesh__D004909 Size Determinations, Erythrocyte
% 208.27/208.41  |- skos__hiddenLabel mesh__D004909 Volume, Mean Corpuscular
% 208.27/208.41  |- mesh__dateRevised mesh__D004909 2003-07-25
% 208.27/208.41  |- skos__hiddenLabel mesh__D004909 Cell Volumes, Mean
% 208.27/208.41  |- skos__broader mesh__D004909smesh__D006403
% 208.27/208.41  |- skos__hiddenLabel mesh__D004909 Mean Corpuscular Hemoglobins
% 208.27/208.41  |- skos__altLabel mesh__D004909 Mean Cell Hemoglobin Concentration
% 208.27/208.41  |- skos__hiddenLabel mesh__D004909 Index, Red Cell
% 208.27/208.41  |- skos__historyNote mesh__D004909 Erythrocytes %28%1966-1979%29%
% 208.27/208.41  |- skos__hiddenLabel mesh__D004909 Indices, Red Cell
% 208.27/208.41  |- skos__altLabel mesh__D004909 Erythrocyte Hemoglobin, Mean Cell
% 208.27/208.41  |- skos__hiddenLabel mesh__D004909 Hemoglobin, Mean Corpuscular
% 208.27/208.41  |- skos__hiddenLabel mesh__D004909 Mean Corpuscular Volumes
% 208.27/208.41  |- skos__hiddenLabel mesh__D004909 Index, Erythrocyte
% 208.27/208.41  |- skos__altLabel mesh__D004909 Hemoglobin, Erythrocyte, Mean Cell
% 208.27/208.41  |- skos__hiddenLabel mesh__D004909 Volume, Mean Cell
% 208.27/208.41  |- skos__altLabel mesh__D004909 Erythrocyte Indexes
% 208.27/208.41  |- skos__hiddenLabel mesh__D004909 Determination, Erythrocyte Size
% 208.27/208.41  |- mesh__publicMeSHNote mesh__D004909 80   
% 208.27/208.41  |- mesh__dateEstablished mesh__D004909 1980-01-01
% 208.27/208.41  |- skos__scopeNote mesh__D004909
% 208.27/208.41       ERYTHROCYTE size and HEMOGLOBIN content or concentration, usually derived from ERYTHROCYTE COUNT; BLOOD hemoglobin concentration; and HEMATOCRIT. The indices include the mean corpuscular volume %28%MCV%29%, the mean corpuscular hemoglobin %28%MCH%29%, and the mean corpuscular hemoglobin concentration %28%MCHC%29%.%A%    
% 208.27/208.41  |- mesh__activeMeSHYear mesh__D004909 2004
% 208.27/208.41  |- mesh__recordOriginator mesh__D004909 SMH
% 208.27/208.41  |- skos__hiddenLabel mesh__D004909 Diameters, Erythrocyte
% 208.27/208.41  |- skos__historyNote mesh__D004909 Hematocrit %28%1966-1979%29%
% 208.27/208.41  |- skos__altLabel mesh__D004909 Erythrocyte Index
% 208.27/208.41  |- skos__altLabel mesh__D004909 Red Cell Indexes
% 208.27/208.41  |- skos__hiddenLabel mesh__D004909 Hemoglobins, Mean Corpuscular
% 208.27/208.41  |- skos__altLabel mesh__D004909 Red Cell Indices
% 208.27/208.41  |- skos__historyNote mesh__D004909 Erythrocytes, Abnormal %28%1968-1979%29%
% 208.27/208.41  |- skos__hiddenLabel mesh__D004909 Volumes, Mean Cell
% 208.27/208.41  |- skos__hiddenLabel mesh__D004909 Indices, Erythrocyte
% 208.27/208.41  |- skos__altLabel mesh__D004909 Erythrocyte Volume, Mean Cell
% 208.27/208.42  |- skos__prefLabel mesh__D004909 Erythrocyte Indices
% 208.27/208.42  |- skos__hiddenLabel mesh__D004909 Indexes, Erythrocyte
% 208.27/208.42  |- skos__historyNote mesh__D004909 Hemoglobins %28%1966-1979%29%
% 208.27/208.42  |- skos__hiddenLabel mesh__D004909 Thickness, Erythrocyte
% 208.27/208.42  |- mesh__dateCreated mesh__D001611 1974-12-12
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D001611 2006
% 208.27/208.42  |- skos__prefLabel mesh__D001611 Beta Rhythm
% 208.27/208.42  |- skos__hiddenLabel mesh__D001611 Beta Rhythms
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D001611 2001
% 208.27/208.42  |- rdf__type mesh__D001611sskos__Concept
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D001611 2003
% 208.27/208.42  |- skos__scopeNote mesh__D001611
% 208.27/208.42       Brain waves with frequency greater than 13 Hz seen on EEG during wakefulness.%A%    
% 208.27/208.42  |- skos__annotation mesh__D001611 /drug eff /rad eff permitted   
% 208.27/208.42  |- mesh__dateRevised mesh__D001611 1999-11-03
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D001611 2004
% 208.27/208.42  |- skos__altLabel mesh__D001611 Electroencephalography, Beta Rhythm
% 208.27/208.42  |- skos__hiddenLabel mesh__D001611 Rhythms, Beta
% 208.27/208.42  |- mesh__historyNote mesh__D001611
% 208.27/208.42       91%28%75%29%; was see under ELECTROENCEPHALOGRAPHY 1975-90   
% 208.27/208.42  |- skos__hiddenLabel mesh__D001611 Rhythm, Beta
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D001611 2002
% 208.27/208.42  |- mesh__dateEstablished mesh__D001611 1991-01-01
% 208.27/208.42  |- mesh__recordOriginator mesh__D001611 NLM
% 208.27/208.42  |- mesh__recordMaintainer mesh__D001611 KEV
% 208.27/208.42  |- mesh__publicMeSHNote mesh__D001611
% 208.27/208.42       91; was see under ELECTROENCEPHALOGRAPHY 1975-90   
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D001611 2005
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D001611 2000
% 208.27/208.42  |- mesh__recordAuthorizer mesh__D001611 sjn
% 208.27/208.42  |- skos__broader mesh__D001611smesh__D004569
% 208.27/208.42  |- mesh__publicMeSHNote mesh__D020576 2000   
% 208.27/208.42  |- skos__scopeNote mesh__D020576
% 208.27/208.42       A genus of gram-negative, rod-shaped to ellipsoidal bacteria occurring singly or in pairs and found in flowers, soil, honey bees, fruits, cider, beer, wine, and vinegar. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 208.27/208.42  |- skos__prefLabel mesh__D020576 Gluconobacter
% 208.27/208.42  |- mesh__dateRevised mesh__D020576 2005-06-30
% 208.27/208.42  |- skos__broader mesh__D020576smesh__D016947
% 208.27/208.42  |- mesh__dateCreated mesh__D020576 1999-11-03
% 208.27/208.42  |- rdf__type mesh__D020576sskos__Concept
% 208.27/208.42  |- mesh__recordAuthorizer mesh__D020576 sjn
% 208.27/208.42  |- skos__annotation mesh__D020576
% 208.27/208.42       do not confuse X ref GLUCONOBACTER SUBOXYDANS with GLUCONOBACTER OXYDANS%A%  
% 208.27/208.42  |- mesh__historyNote mesh__D020576 2000   
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D020576 2006
% 208.27/208.42  |- mesh__recordOriginator mesh__D020576 ndw
% 208.27/208.42  |- mesh__recordMaintainer mesh__D020576 ags
% 208.27/208.42  |- mesh__dateEstablished mesh__D020576 2000-01-01
% 208.27/208.42  |- mesh__dateEstablished mesh__D039281 2003-01-01
% 208.27/208.42  |- mesh__dateCreated mesh__D039281 2002-07-02
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D039281 2003
% 208.27/208.42  |- rdf__type mesh__D039281sskos__Concept
% 208.27/208.42  |- skos__scopeNote mesh__D039281
% 208.27/208.42       A plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida.%A%    
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D039281 2004
% 208.27/208.42  |- skos__prefLabel mesh__D039281 Nyctaginaceae
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D039281 2005
% 208.27/208.42  |- skos__annotation mesh__D039281
% 208.27/208.42       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.27/208.42  |- skos__broader mesh__D039281smesh__D019684
% 208.27/208.42  |- mesh__publicMeSHNote mesh__D039281 2003   
% 208.27/208.42  |- skos__altLabel mesh__D039281 Boerhaavia
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D039281 2006
% 208.27/208.42  |- mesh__historyNote mesh__D039281 2003   
% 208.27/208.42  |- skos__altLabel mesh__D014539 UDP Sugars
% 208.27/208.42  |- skos__hiddenLabel mesh__D014539 Sugars, UDP
% 208.27/208.42  |- mesh__recordOriginator mesh__D014539 NLM
% 208.27/208.42  |- mesh__historyNote mesh__D014539 73   
% 208.27/208.42  |- mesh__dateRevised mesh__D014539 2004-07-07
% 208.27/208.42  |- mesh__dateEstablished mesh__D014539 1973-01-01
% 208.27/208.42  |- mesh__publicMeSHNote mesh__D014539 73   
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D014539 2006
% 208.27/208.42  |- mesh__recordMaintainer mesh__D014539 ssb
% 208.27/208.42  |- skos__broader mesh__D014539smesh__D009702
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D014539 2005
% 208.27/208.42  |- mesh__dateCreated mesh__D014539 1999-01-01
% 208.27/208.42  |- skos__historyNote mesh__D014539 specific carbohydrate %28%1966-1972%29%
% 208.27/208.42  |- skos__broader mesh__D014539smesh__D014530
% 208.27/208.42  |- skos__hiddenLabel mesh__D014539 Sugars, Uridine Diphosphate
% 208.27/208.42  |- mesh__recordAuthorizer mesh__D014539 sjn
% 208.27/208.42  |- rdf__type mesh__D014539sskos__Concept
% 208.27/208.42  |- skos__prefLabel mesh__D014539 Uridine Diphosphate Sugars
% 208.27/208.42  |- skos__hiddenLabel mesh__D014539 Diphosphate Sugars, Uridine
% 208.27/208.42  |- skos__historyNote mesh__D014539 Uracil Nucleotides %28%1966-1972%29%
% 208.27/208.42  |- skos__altLabel mesh__D025261 Mitochondrial F%28%1%29%F%28%0%29% ATPase
% 208.27/208.42  |- skos__hiddenLabel mesh__D025261
% 208.27/208.42       Mitochondrial Proton Translocating ATPases
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D025261 2006
% 208.27/208.42  |- skos__scopeNote mesh__D025261
% 208.27/208.42       Proton-translocating ATPases responsible for ADENOSINE TRIPHOSPHATE synthesis in the MITOCHONDRIA. They derive energy from the respiratory chain-driven reactions that develop high concentrations of protons within the intermembranous space of the mitochondria.%A%    
% 208.27/208.42  |- mesh__dateRevised mesh__D025261 2003-07-09
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D025261 2004
% 208.27/208.42  |- mesh__dateCreated mesh__D025261 2001-07-25
% 208.27/208.42  |- skos__prefLabel mesh__D025261 Mitochondrial Proton-Translocating ATPases
% 208.27/208.42  |- skos__hiddenLabel mesh__D025261
% 208.27/208.42       ATPases, Mitochondrial Proton-Translocating
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D025261 2005
% 208.27/208.42  |- rdf__type mesh__D025261sskos__Concept
% 208.27/208.42  |- skos__hiddenLabel mesh__D025261 ATP Synthases, Mitochondrial
% 208.27/208.42  |- skos__altLabel mesh__D025261 Mitochondrial ATP Synthase
% 208.27/208.42  |- mesh__dateEstablished mesh__D025261 2002-01-01
% 208.27/208.42  |- skos__broader mesh__D025261smesh__D006180
% 208.27/208.42  |- mesh__historyNote mesh__D025261 2002   
% 208.27/208.42  |- skos__historyNote mesh__D025261
% 208.27/208.42       Proton-Translocating ATPases %28%1979-2001%29%
% 208.27/208.42  |- skos__hiddenLabel mesh__D025261
% 208.27/208.42       Proton-Translocating ATPases, Mitochondrial
% 208.27/208.42  |- skos__hiddenLabel mesh__D025261 ATP Synthase, Mitochondrial
% 208.27/208.42  |- skos__altLabel mesh__D025261 Mitochondrial ATP Synthases
% 208.27/208.42  |- mesh__publicMeSHNote mesh__D025261 2002   
% 208.27/208.42  |- skos__hiddenLabel mesh__D019224 Joint Disks, Temporomandibular
% 208.27/208.42  |- skos__broader mesh__D019224smesh__D013704
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D019224 1997
% 208.27/208.42  |- skos__hiddenLabel mesh__D019224 Disk, Temporomandibular Articular
% 208.27/208.42  |- skos__scopeNote mesh__D019224
% 208.27/208.42       A plate of fibrous tissue that divides the temporomandibular joint into an upper and lower cavity. The disk is attached to the articular capsule and moves forward with the condyle in free opening and protrusion. %28%Boucher%27%s Clinical Dental Terminology, 4th ed, p92%29%%A%    
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D019224 2006
% 208.27/208.42  |- skos__hiddenLabel mesh__D019224 Disks, Temporomandibular Joint
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D019224 2005
% 208.27/208.42  |- rdf__type mesh__D019224sskos__Concept
% 208.27/208.42  |- mesh__dateEstablished mesh__D019224 1997-01-01
% 208.27/208.42  |- skos__hiddenLabel mesh__D019224 Articular Disks, Temporomandibular
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D019224 2002
% 208.27/208.42  |- mesh__dateCreated mesh__D019224 1996-06-10
% 208.27/208.42  |- skos__hiddenLabel mesh__D019224 Temporomandibular Articular Disks
% 208.27/208.42  |- mesh__historyNote mesh__D019224 97   
% 208.27/208.42  |- skos__annotation mesh__D019224
% 208.27/208.42       disk displacement: coord IM with DISLOCATIONS %28%IM%29%; DF: TMJ DISK%A%  
% 208.27/208.42  |- skos__hiddenLabel mesh__D019224 Temporomandibular Articular Disk
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D019224 2004
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D019224 2001
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D019224 1999
% 208.27/208.42  |- skos__altLabel mesh__D019224 Articular Disk, Temporomandibular
% 208.27/208.42  |- skos__hiddenLabel mesh__D019224 Temporomandibular Joint Disks
% 208.27/208.42  |- skos__historyNote mesh__D019224
% 208.27/208.42       Temporomandibular Joint %28%1966-1996%29%
% 208.27/208.42  |- skos__hiddenLabel mesh__D019224 Disks, Temporomandibular Articular
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D019224 2003
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D019224 1998
% 208.27/208.42  |- skos__prefLabel mesh__D019224 Temporomandibular Joint Disk
% 208.27/208.42  |- skos__altLabel mesh__D019224 Disk, Temporomandibular Joint
% 208.27/208.42  |- mesh__publicMeSHNote mesh__D019224 97   
% 208.27/208.42  |- skos__hiddenLabel mesh__D019224 Joint Disk, Temporomandibular
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D019224 2000
% 208.27/208.42  |- mesh__dateRevised mesh__D000519 2003-07-09
% 208.27/208.42  |- mesh__recordOriginator mesh__D000519 RLS
% 208.27/208.42  |- mesh__publicMeSHNote mesh__D000519
% 208.27/208.42       94; was ALPHA-GALACTOSIDASES 1978-93 %28%see under GALACTOSIDASES 1978-90%29%; MELIBIASES was see ALPHA-GALACTOSIDASE 1978-93; MELIBIASE was see GALACTOSIDASES 1975-78, was see GALACTOSIDASE 1963-74%A%  
% 208.27/208.42  |- mesh__recordMaintainer mesh__D000519 ssb
% 208.27/208.42  |- skos__hiddenLabel mesh__D000519 alpha Galactosidase A
% 208.27/208.42  |- skos__altLabel mesh__D000519 alpha-Galactosidases
% 208.27/208.42  |- skos__historyNote mesh__D000519 Galactosidases %28%1966-1978%29%
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D000519 2005
% 208.27/208.42  |- rdf__type mesh__D000519sskos__Concept
% 208.27/208.42  |- skos__broader mesh__D000519smesh__D005696
% 208.27/208.42  |- skos__hiddenLabel mesh__D000519 alpha Galactosidases
% 208.27/208.42  |- skos__scopeNote mesh__D000519
% 208.27/208.42       An enzyme that catalyzes the hydrolysis of terminal, non-reducing alpha-D-galactose residues in alpha-galactosides including galactose oligosaccharides, galactomannans, and galactolipids. EC 3.2.1.22.%A%    
% 208.27/208.42  |- mesh__dateCreated mesh__D000519 1977-04-15
% 208.27/208.42  |- skos__altLabel mesh__D000519 alpha-Galactosidase A
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D000519 2006
% 208.27/208.42  |- mesh__onlineNote mesh__D000519
% 208.27/208.42       use ALPHA-GALACTOSIDASE to search ALPHA-GALACTOSIDASES %26% MELIBIASES 1978-93; use GALACTOSIDASES to search MELIBIASE 1966-78%A%  
% 208.27/208.42  |- mesh__historyNote mesh__D000519
% 208.27/208.42       94; was ALPHA-GALACTOSIDASES 1978-93 %28%see under GALACTOSIDASES 1978-90%29%; MELIBIASES was see ALPHA-GALACTOSIDASES 1978-93;  MELIBIASE was see GALACTOSIDASES 1975-78, was see GALACTOSIDASE 1963-74%A%  
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D000519 2004
% 208.27/208.42  |- mesh__recordAuthorizer mesh__D000519 sjn
% 208.27/208.42  |- mesh__dateEstablished mesh__D000519 1991-01-01
% 208.27/208.42  |- skos__hiddenLabel mesh__D000519 alpha Galactosidase
% 208.27/208.42  |- skos__altLabel mesh__D000519 Melibiase
% 208.27/208.42  |- skos__prefLabel mesh__D000519 alpha-Galactosidase
% 208.27/208.42  |- skos__altLabel mesh__D011241 Lichtenstein Brand of Prednisone
% 208.27/208.42  |- skos__altLabel mesh__D011241 delta-Cortisone
% 208.27/208.42  |- skos__altLabel mesh__D011241 GALENpharma Brand of Prednisone
% 208.27/208.42  |- skos__altLabel mesh__D011241 acis Brand of Prednisone
% 208.27/208.42  |- mesh__dateCreated mesh__D011241 1999-01-01
% 208.27/208.42  |- skos__altLabel mesh__D011241 Trommsdorff Brand of Prednisone
% 208.27/208.42  |- skos__altLabel mesh__D011241 Merck Brand of Prednisone
% 208.27/208.42  |- skos__altLabel mesh__D011241 Hoechst Brand of Prednisone
% 208.27/208.42  |- skos__altLabel mesh__D011241 mibe Brand of Prednisone
% 208.27/208.42  |- skos__prefLabel mesh__D011241 Prednisone
% 208.27/208.42  |- mesh__recordOriginator mesh__D011241 NLM
% 208.27/208.42  |- skos__altLabel mesh__D011241 Diba Brand of Prednisone
% 208.27/208.42  |- skos__altLabel mesh__D011241 ICN Brand of Prednisone
% 208.27/208.42  |- skos__altLabel mesh__D011241 Dehydrocortisone
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D011241 2006
% 208.27/208.42  |- mesh__publicMeSHNote mesh__D011241
% 208.27/208.42       /adverse effects /poisoning /toxicity were PREDNISONE TOXICOLOGY 1963-65; /therapeutic use was PREDNISONE, THERAPEUTIC 1965%A%  
% 208.27/208.42  |- skos__altLabel mesh__D011241 Seatrace Brand of Prednisone
% 208.27/208.42  |- skos__scopeNote mesh__D011241
% 208.27/208.42       A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.%A%    
% 208.27/208.42  |- skos__altLabel mesh__D011241 Panafcort
% 208.27/208.42  |- mesh__recordAuthorizer mesh__D011241 sjn
% 208.27/208.42  |- skos__altLabel mesh__D011241 Aventis Brand of Prednisone
% 208.27/208.42  |- mesh__historyNote mesh__D011241
% 208.27/208.42       /adv eff-pois-tox was PREDNISONE TOXICOLOGY 1963-65; /ther use was PREDNISONE, THERAPEUTIC 1965%A%  
% 208.27/208.42  |- skos__altLabel mesh__D011241 Schering-Plough Brand of Prednisone
% 208.27/208.42  |- skos__annotation mesh__D011241
% 208.27/208.42       do not confuse trade name Decortin %28%Merck%29% with DESOXYCORTICOSTERONE tradename Decortin %28%Schieffelin%29%%A%  
% 208.27/208.42  |- skos__altLabel mesh__D011241 Decortin Brand of Prednisone
% 208.27/208.42  |- mesh__dateRevised mesh__D011241 2005-06-30
% 208.27/208.42  |- skos__altLabel mesh__D011241 Pharmacia Brand of Prednisone
% 208.27/208.42  |- skos__broader mesh__D011241smesh__D011244
% 208.27/208.42  |- skos__altLabel mesh__D011241 Hexal Brand of Prednisone
% 208.27/208.42  |- skos__altLabel mesh__D011241 Ferring Brand of Prednisone
% 208.27/208.42  |- skos__altLabel mesh__D011241 Merz Brand of Prednisone
% 208.27/208.42  |- skos__altLabel mesh__D011241 Fawns %26% McAllan Brand of Prednisone
% 208.27/208.42  |- skos__altLabel mesh__D011241 Encorton
% 208.27/208.42  |- skos__altLabel mesh__D011241 Halsey Drug Brand of Prednisone
% 208.27/208.42  |- skos__altLabel mesh__D011241 Apotex Brand of Prednisone
% 208.27/208.42  |- mesh__recordMaintainer mesh__D011241 lkw
% 208.27/208.42  |- rdf__type mesh__D011241sskos__Concept
% 208.27/208.42  |- skos__altLabel mesh__D011241 Solvay Brand of Prednisone
% 208.27/208.42  |- mesh__publicMeSHNote mesh__D005204 68   
% 208.27/208.42  |- skos__broader mesh__D005204smesh__D012717
% 208.27/208.42  |- skos__scopeNote mesh__D005204
% 208.27/208.42       A colorless liquid extracted from oils of plants such as citronella, neroli, cyclamen, and tuberose. It is an intermediate step in the biological synthesis of cholesterol from mevalonic acid in vertebrates. It has a delicate odor and is used in perfumery. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%    
% 208.27/208.42  |- skos__broader mesh__D005204smesh__D005233
% 208.27/208.42  |- mesh__dateEstablished mesh__D005204 1968-01-01
% 208.27/208.42  |- rdf__type mesh__D005204sskos__Concept
% 208.27/208.42  |- mesh__historyNote mesh__D005204
% 208.27/208.42       68; was FARNESYL COMPOUNDS 1965-67 %28%Prov%29%   
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005204 2004
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005204 2006
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005204 2005A
% 208.27/208.42  |- mesh__dateRevised mesh__D005204 2004-07-27
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005204 2005
% 208.27/208.42  |- mesh__recordMaintainer mesh__D005204 jls
% 208.27/208.42  |- mesh__onlineNote mesh__D005204
% 208.27/208.42       use FARNESOL to search FARNESYL COMPOUNDS 1966-67 %28%as Prov%29%%A%  
% 208.27/208.42  |- mesh__dateCreated mesh__D005204 1999-01-01
% 208.27/208.42  |- skos__prefLabel mesh__D005204 Farnesol
% 208.27/208.42  |- mesh__recordAuthorizer mesh__D005204 jls
% 208.27/208.42  |- mesh__recordOriginator mesh__D005204 NLM
% 208.27/208.42  |- skos__broader mesh__D010947smesh__D010944
% 208.27/208.42  |- skos__altLabel mesh__D010947 Plants, Poisonous
% 208.27/208.42  |- skos__annotation mesh__D010947 IM general only   
% 208.27/208.42  |- mesh__dateCreated mesh__D010947 1975-07-23
% 208.27/208.42  |- skos__related mesh__D010947smesh__D010939
% 208.27/208.42  |- mesh__historyNote mesh__D010947 1976; was NON MESH before 1976;   
% 208.27/208.42  |- mesh__recordOriginator mesh__D010947 JW
% 208.27/208.42  |- rdf__type mesh__D010947sskos__Concept
% 208.27/208.42  |- skos__prefLabel mesh__D010947 Plants, Toxic
% 208.27/208.42  |- mesh__dateEstablished mesh__D010947 1976-01-01
% 208.27/208.42  |- skos__scopeNote mesh__D010947
% 208.27/208.42       Plants or plant parts which are harmful to man or other animals.%A%    
% 208.27/208.42  |- mesh__recordMaintainer mesh__D010947 ssb
% 208.27/208.42  |- mesh__dateRevised mesh__D010947 2005-06-30
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D010947 2006
% 208.27/208.42  |- mesh__publicMeSHNote mesh__D010947 1976   
% 208.27/208.42  |- skos__historyNote mesh__D010947 Plants %28%1966-1975%29%
% 208.27/208.42  |- mesh__recordAuthorizer mesh__D010947 sjn
% 208.27/208.42  |- skos__altLabel mesh__D043323 Neutral alpha-Mannosidase
% 208.27/208.42  |- mesh__dateCreated mesh__D043323 2003-07-09
% 208.27/208.42  |- skos__prefLabel mesh__D043323 alpha-Mannosidase
% 208.27/208.42  |- skos__hiddenLabel mesh__D043323 Neutral alpha Mannosidase
% 208.27/208.42  |- skos__hiddenLabel mesh__D043323 alpha D Mannoside Mannohydrolase
% 208.27/208.42  |- skos__annotation mesh__D043323
% 208.27/208.42       /DEFIC: consider also ALPHA-MANNOSIDOSIS   
% 208.27/208.42  |- skos__altLabel mesh__D043323 LAMAN
% 208.27/208.42  |- skos__altLabel mesh__D043323 alpha Mannosidase B
% 208.27/208.42  |- skos__hiddenLabel mesh__D043323 alpha D Mannosidase
% 208.27/208.42  |- skos__broader mesh__D043323smesh__D008361
% 208.27/208.42  |- mesh__dateEstablished mesh__D043323 2004-01-01
% 208.27/208.42  |- skos__hiddenLabel mesh__D043323 alpha-Mannosidase, Neutral
% 208.27/208.42  |- mesh__historyNote mesh__D043323
% 208.27/208.42       2004; use ALPHA-MANNOSIDASE %28%NM%29% 1980-2003   
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D043323 2006
% 208.27/208.42  |- rdf__type mesh__D043323sskos__Concept
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D043323 2004
% 208.27/208.42  |- skos__hiddenLabel mesh__D043323 Mannosidase B, alpha
% 208.27/208.42  |- skos__altLabel mesh__D043323 alpha-D-Mannoside Mannohydrolase
% 208.27/208.42  |- skos__hiddenLabel mesh__D043323 alpha Mannosidase
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D043323 2005
% 208.27/208.42  |- skos__scopeNote mesh__D043323
% 208.27/208.42       An enzyme that catalyzes the HYDROLYSIS of terminal, non-reducing alpha-D-mannose residues in alpha-D-mannosides. The enzyme plays a role in the processing of newly formed N-glycans and in degradation of mature GLYCOPROTEINS. There are multiple isoforms of alpha-mannosidase, each having its own specific cellular location and pH optimum. Defects in the lysosomal form of the enzyme results in a buildup of mannoside intermediate metabolites and the disease ALPHA-MANNOSIDOSIS.%A%    
% 208.27/208.42  |- skos__hiddenLabel mesh__D043323 alpha-Mannosidase, Lysosomal
% 208.27/208.42  |- skos__hiddenLabel mesh__D043323 Mannohydrolase, alpha-D-Mannoside
% 208.27/208.42  |- skos__historyNote mesh__D043323 Mannosidases %28%1980-2003%29%
% 208.27/208.42  |- skos__altLabel mesh__D043323 alpha-D-Mannosidase
% 208.27/208.42  |- skos__related mesh__D043323smesh__D008363
% 208.27/208.42  |- skos__hiddenLabel mesh__D043323 Lysosomal alpha Mannosidase
% 208.27/208.42  |- mesh__publicMeSHNote mesh__D043323
% 208.27/208.42       2004; ALPHA-MANNOSIDASE was indexed under MANNOSIDASES 1980-2003%A%  
% 208.27/208.42  |- skos__hiddenLabel mesh__D010149 Postoperative Pains
% 208.27/208.42  |- mesh__historyNote mesh__D010149 74   
% 208.27/208.42  |- mesh__recordAuthorizer mesh__D010149 sjn
% 208.27/208.42  |- mesh__dateRevised mesh__D010149 1999-11-03
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D010149 2002
% 208.27/208.42  |- skos__scopeNote mesh__D010149 Pain during the period after surgery.     
% 208.27/208.42  |- mesh__recordOriginator mesh__D010149 NLM
% 208.27/208.42  |- skos__annotation mesh__D010149 DF: PAIN POSTOP or POSTOP PAIN   
% 208.27/208.42  |- mesh__recordMaintainer mesh__D010149 KEV
% 208.27/208.42  |- mesh__dateCreated mesh__D010149 1999-01-01
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D010149 2006
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D010149 2001
% 208.27/208.42  |- skos__broader mesh__D010149smesh__D010146
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D010149 2005
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D010149 2000
% 208.27/208.42  |- rdf__type mesh__D010149sskos__Concept
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D010149 2004
% 208.27/208.42  |- mesh__publicMeSHNote mesh__D010149 74   
% 208.27/208.42  |- skos__broader mesh__D010149smesh__D011183
% 208.27/208.42  |- skos__altLabel mesh__D010149 Postoperative Pain
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D010149 2003
% 208.27/208.42  |- mesh__dateEstablished mesh__D010149 1974-01-01
% 208.27/208.42  |- skos__prefLabel mesh__D010149 Pain, Postoperative
% 208.27/208.42  |- mesh__recordAuthorizer mesh__D015632 sjn
% 208.27/208.42  |- mesh__dateRevised mesh__D015632 2005-06-30
% 208.27/208.42  |- mesh__recordMaintainer mesh__D015632 ssb
% 208.27/208.42  |- skos__altLabel mesh__D015632
% 208.27/208.42       N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
% 208.27/208.42  |- skos__altLabel mesh__D015632 MPTP
% 208.27/208.42  |- mesh__publicMeSHNote mesh__D015632 90   
% 208.27/208.42  |- mesh__historyNote mesh__D015632 90   
% 208.27/208.42  |- skos__historyNote mesh__D015632 Pyridines %28%1966-1989%29%
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D015632 2006
% 208.27/208.42  |- mesh__recordOriginator mesh__D015632 RLS
% 208.27/208.42  |- mesh__dateEstablished mesh__D015632 1990-01-01
% 208.27/208.42  |- mesh__dateCreated mesh__D015632 1989-05-25
% 208.27/208.42  |- skos__prefLabel mesh__D015632
% 208.27/208.42       1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
% 208.27/208.42  |- skos__scopeNote mesh__D015632
% 208.27/208.42       A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.%A%    
% 208.27/208.42  |- skos__broader mesh__D015632smesh__D011725
% 208.27/208.42  |- rdf__type mesh__D015632sskos__Concept
% 208.27/208.42  |- rdf__type mesh__D020577sskos__Concept
% 208.27/208.42  |- mesh__recordMaintainer mesh__D020577 SYSTEM
% 208.27/208.42  |- mesh__historyNote mesh__D020577 2000   
% 208.27/208.42  |- mesh__publicMeSHNote mesh__D020577 2000   
% 208.27/208.42  |- skos__scopeNote mesh__D020577
% 208.27/208.42       A genus of bacteria comprised of a heterogenous group of gram-negative small rods and coccoid forms associated with arthropods. %28%From Bergey%27%s Manual of Systematic Bacteriology, vol 1, 1984%29%%A%    
% 208.27/208.42  |- skos__historyNote mesh__D020577 Rickettsiaceae %28%1976-1999%29%
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D020577 2006
% 208.27/208.42  |- mesh__recordOriginator mesh__D020577 ndw
% 208.27/208.42  |- mesh__dateRevised mesh__D020577 2005-06-30
% 208.27/208.42  |- skos__prefLabel mesh__D020577 Wolbachia
% 208.27/208.42  |- mesh__dateCreated mesh__D020577 1999-11-03
% 208.27/208.42  |- skos__broader mesh__D020577smesh__D012287
% 208.27/208.42  |- mesh__recordAuthorizer mesh__D020577 sjn
% 208.27/208.42  |- mesh__dateEstablished mesh__D020577 2000-01-01
% 208.27/208.42  |- mesh__dateCreated mesh__D039282 2002-07-03
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D039282 2003
% 208.27/208.42  |- rdf__type mesh__D039282sskos__Concept
% 208.27/208.42  |- mesh__historyNote mesh__D039282 2003   
% 208.27/208.42  |- mesh__dateEstablished mesh__D039282 2003-01-01
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D039282 2004
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D039282 2005
% 208.27/208.42  |- skos__scopeNote mesh__D039282
% 208.27/208.42       A plant genus of the family NYCTAGINACEAE. Members contain Mirabilis antiviral protein %28%a ribosome-inactivating protein%29%.%A%    
% 208.27/208.42  |- mesh__publicMeSHNote mesh__D039282 2003   
% 208.27/208.42  |- skos__broader mesh__D039282smesh__D039281
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D039282 2006
% 208.27/208.42  |- skos__annotation mesh__D039282
% 208.27/208.42       do not confuse with PROTEUS MIRABILIS; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.27/208.42  |- skos__prefLabel mesh__D039282 Mirabilis
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D025262 2005
% 208.27/208.42  |- skos__hiddenLabel mesh__D025262 Lysosomal Proton Translocating ATPases
% 208.27/208.42  |- skos__altLabel mesh__D025262 Vacuolar F%28%1%29%F%28%0%29% ATPases
% 208.27/208.42  |- mesh__recordMaintainer mesh__D025262 ssb
% 208.27/208.42  |- skos__altLabel mesh__D025262 Lysosomal Proton-Translocating ATPases
% 208.27/208.42  |- skos__historyNote mesh__D025262
% 208.27/208.42       Proton-Translocating ATPases %28%1984-2001%29%
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D025262 2006
% 208.27/208.42  |- mesh__recordOriginator mesh__D025262 jmp
% 208.27/208.42  |- mesh__dateRevised mesh__D025262 2003-07-09
% 208.27/208.42  |- skos__scopeNote mesh__D025262
% 208.27/208.42       Proton-translocating ATPases that are involved in acidification of a variety of intracellular compartments.%A%    
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D025262 2004
% 208.27/208.42  |- skos__altLabel mesh__D025262 Lysosomal F%28%1%29%F%28%0%29% ATPase
% 208.27/208.42  |- mesh__dateCreated mesh__D025262 2001-07-25
% 208.27/208.42  |- skos__altLabel mesh__D025262 Vacuolar F%28%1%29%F%28%0%29% ATPase
% 208.27/208.42  |- skos__hiddenLabel mesh__D025262 ATPases, Lysosomal Proton-Translocating
% 208.27/208.42  |- rdf__type mesh__D025262sskos__Concept
% 208.27/208.42  |- skos__prefLabel mesh__D025262 Vacuolar Proton-Translocating ATPases
% 208.27/208.42  |- skos__hiddenLabel mesh__D025262 Proton-Translocating ATPases, Lysosomal
% 208.27/208.42  |- mesh__recordAuthorizer mesh__D025262 sjn
% 208.27/208.42  |- mesh__publicMeSHNote mesh__D025262 2002   
% 208.27/208.42  |- mesh__historyNote mesh__D025262 2002   
% 208.27/208.42  |- mesh__dateEstablished mesh__D025262 2002-01-01
% 208.27/208.42  |- skos__broader mesh__D025262smesh__D006180
% 208.27/208.42  |- rdf__type mesh__D005205sskos__Concept
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005205 1989
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005205 2002
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005205 2004
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005205 1997
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005205 1991
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005205 2001
% 208.27/208.42  |- skos__prefLabel mesh__D005205 Fascia
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005205 2006
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005205 1999
% 208.27/208.42  |- skos__hiddenLabel mesh__D005205 Fascias
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005205 1993
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005205 2003
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005205 1996
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005205 1995
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005205 1990
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005205 2000
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005205 2005
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005205 1998
% 208.27/208.42  |- mesh__dateCreated mesh__D005205 1999-01-01
% 208.27/208.42  |- skos__broader mesh__D005205smesh__D009141
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005205 1992
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D005205 1994
% 208.27/208.42  |- skos__scopeNote mesh__D010948
% 208.27/208.42       Method for measuring viral infectivity and multiplication in cultured cells. Clear lysed areas or plaques develop as the viral particles are released from the infected cells during incubation. With some viruses, the cells are killed by a cytopathic effect; with others, the infected cells are not killed but can be detected by their hemadsorptive ability. Sometimes the plaque cells contain viral antigens which can be measured by immunofluorescence.%A%    
% 208.27/208.42  |- mesh__dateEstablished mesh__D010948 1973-01-01
% 208.27/208.42  |- mesh__dateCreated mesh__D010948 1999-01-01
% 208.27/208.42  |- mesh__publicMeSHNote mesh__D010948 73   
% 208.27/208.42  |- mesh__recordAuthorizer mesh__D010948 sjn
% 208.27/208.42  |- mesh__recordOriginator mesh__D010948 NLM
% 208.27/208.42  |- rdf__type mesh__D010948sskos__Concept
% 208.27/208.42  |- skos__historyNote mesh__D010948 Virus Cultivation %28%1966-1972%29%
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D010948 2004
% 208.27/208.42  |- mesh__activeMeSHYear mesh__D010948 2001
% 208.27/208.43  |- skos__broader mesh__D010948smesh__D014776
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D010948 2003
% 208.27/208.43  |- mesh__dateRevised mesh__D010948 2000-06-21
% 208.27/208.43  |- mesh__recordMaintainer mesh__D010948 TAP
% 208.27/208.43  |- skos__hiddenLabel mesh__D010948 Assay, Plaque
% 208.27/208.43  |- mesh__historyNote mesh__D010948 73   
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D010948 2006
% 208.27/208.43  |- skos__prefLabel mesh__D010948 Plaque Assay
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D010948 2005
% 208.27/208.43  |- skos__hiddenLabel mesh__D010948 Plaque Assays
% 208.27/208.43  |- skos__annotation mesh__D010948
% 208.27/208.43       for viruses; coord IM or NIM with specific virus /growth %28%IM%29%; do not confuse with HEMOLYTIC PLAQUE TECHNIQUE in immunol%A%  
% 208.27/208.43  |- skos__hiddenLabel mesh__D010948 Assays, Plaque
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D010948 2002
% 208.27/208.43  |- skos__prefLabel mesh__D043324 beta-Fructofuranosidase
% 208.27/208.43  |- skos__hiddenLabel mesh__D043324 beta Fructofuranosidase
% 208.27/208.43  |- mesh__historyNote mesh__D043324
% 208.27/208.43       2004; use BETA-FRUCTOFURANOSIDASE %28%NM%29% 1980-2003   
% 208.27/208.43  |- skos__altLabel mesh__D043324 beta-Fructosidase
% 208.27/208.43  |- mesh__recordMaintainer mesh__D043324 AKE
% 208.27/208.43  |- rdf__type mesh__D043324sskos__Concept
% 208.27/208.43  |- skos__historyNote mesh__D043324 Glycoside Hydrolases %28%1983-2003%29%
% 208.27/208.43  |- skos__historyNote mesh__D043324 Fructose %28%1979-1981%29%
% 208.27/208.43  |- skos__scopeNote mesh__D043324
% 208.27/208.43       A glycoside hydrolase found primarily in PLANTS and YEASTS. It has specificity for beta-D-fructofuranosides such as SUCROSE.%A%    
% 208.27/208.43  |- skos__hiddenLabel mesh__D043324 beta Fructosidase
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D043324 2006
% 208.27/208.43  |- skos__altLabel mesh__D043324 beta-D-Fructofuranosidase
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D043324 2004
% 208.27/208.43  |- skos__hiddenLabel mesh__D043324 Hydrolase, Sucrose 6-Phosphate
% 208.27/208.43  |- skos__altLabel mesh__D043324 Saccharase
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D043324 2005
% 208.27/208.43  |- skos__altLabel mesh__D043324 Sucrose 6-Phosphate Hydrolase
% 208.27/208.43  |- skos__hiddenLabel mesh__D043324 Sucrose 6 Phosphate Hydrolase
% 208.27/208.43  |- mesh__recordOriginator mesh__D043324 AKE
% 208.27/208.43  |- skos__hiddenLabel mesh__D043324 beta D Fructofuranosidase
% 208.27/208.43  |- mesh__dateCreated mesh__D043324 2003-07-09
% 208.27/208.43  |- skos__historyNote mesh__D043324 Sucrase %28%1979-2003%29%
% 208.27/208.43  |- skos__hiddenLabel mesh__D043324 6-Phosphate Hydrolase, Sucrose
% 208.27/208.43  |- mesh__dateEstablished mesh__D043324 2004-01-01
% 208.27/208.43  |- skos__broader mesh__D043324smesh__D006026
% 208.27/208.43  |- skos__altLabel mesh__D043324 Invertase
% 208.27/208.43  |- mesh__recordAuthorizer mesh__D043324 sjn
% 208.27/208.43  |- mesh__publicMeSHNote mesh__D043324
% 208.27/208.43       2004; BETA-FRUCTOFURANOSIDASE was indexed under GLYCOSIDE HYDROLASES 1983-2003, under SUCRASE 1979-1982, %26% under FRUCTOSE 1979-1981%A%  
% 208.27/208.43  |- skos__hiddenLabel mesh__D043324 Invertase, Acid
% 208.27/208.43  |- skos__altLabel mesh__D043324 Acid Invertase
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D015633 2006
% 208.27/208.43  |- mesh__recordMaintainer mesh__D015633 nns
% 208.27/208.43  |- skos__annotation mesh__D015633 DF: EVLW   
% 208.27/208.43  |- mesh__publicMeSHNote mesh__D015633 90   
% 208.27/208.43  |- skos__hiddenLabel mesh__D015633 Water, Extravascular Lung
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D015633 2005
% 208.27/208.43  |- mesh__dateEstablished mesh__D015633 1990-01-01
% 208.27/208.43  |- skos__historyNote mesh__D015633 Body Water %28%1972-1989%29%
% 208.27/208.43  |- skos__historyNote mesh__D015633 Extracellular Space %28%1978-1989%29%
% 208.27/208.43  |- mesh__dateRevised mesh__D015633 2003-07-09
% 208.27/208.43  |- skos__scopeNote mesh__D015633
% 208.27/208.43       Water present within the lungs; its volume is roughly equal to, or a little less than, the intracellular blood volume of the lungs. Accumulations of extravascular lung water result in pulmonary edema.%A%    
% 208.27/208.43  |- mesh__recordAuthorizer mesh__D015633 sjn
% 208.27/208.43  |- skos__prefLabel mesh__D015633 Extravascular Lung Water
% 208.27/208.43  |- skos__altLabel mesh__D015633 Lung Water, Extra Vascular
% 208.27/208.43  |- mesh__historyNote mesh__D015633 90   
% 208.27/208.43  |- skos__altLabel mesh__D015633 Extra Vascular Lung Water
% 208.27/208.43  |- skos__altLabel mesh__D015633 Lung Water, Extravascular
% 208.27/208.43  |- rdf__type mesh__D015633sskos__Concept
% 208.27/208.43  |- mesh__dateCreated mesh__D015633 1989-04-07
% 208.27/208.43  |- skos__broader mesh__D015633smesh__D045604
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D015633 2004
% 208.27/208.43  |- skos__historyNote mesh__D015633 Lung %28%1969-1989%29%
% 208.27/208.43  |- skos__broader mesh__D015633smesh__D008168
% 208.27/208.43  |- mesh__recordOriginator mesh__D015633 PXP
% 208.27/208.43  |- mesh__historyNote mesh__D001613
% 208.27/208.43       91%28%75%29%; was BETA 2 MICROGLOBULIN 1984-90; was see under BETA GLOBULINS 1975-83%A%  
% 208.27/208.43  |- mesh__onlineNote mesh__D001613
% 208.27/208.43       use BETA 2-MICROGLOBULIN tosearch BETA 2 MICROGLOBULIN 1984-90%A%  
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D001613 2006
% 208.27/208.43  |- skos__hiddenLabel mesh__D001613 2-Microglobulin, beta
% 208.27/208.43  |- mesh__recordMaintainer mesh__D001613 jmp
% 208.27/208.43  |- rdf__type mesh__D001613sskos__Concept
% 208.27/208.43  |- skos__scopeNote mesh__D001613
% 208.27/208.43       An 11-kDa protein associated with the outer membrane of many cells including lymphocytes. It is the small subunit of the MHC class I molecule. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, csf, and urine of normal people, and to a much greater degree in the urine and plasma of patients with tubular proteinemia, renal failure, or kidney transplants.%A%    
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D001613 2005
% 208.27/208.43  |- mesh__recordOriginator mesh__D001613 NLM
% 208.27/208.43  |- skos__annotation mesh__D001613 /biosyn /physiol /blood permitted   
% 208.27/208.43  |- skos__prefLabel mesh__D001613 beta 2-Microglobulin
% 208.27/208.43  |- mesh__publicMeSHNote mesh__D001613
% 208.27/208.43       91; was BETA 2 MICROGLOBULIN 1984-90; was see under BETA GLOBULINS 1975-83%A%  
% 208.27/208.43  |- mesh__recordAuthorizer mesh__D001613 sjn
% 208.27/208.43  |- mesh__dateCreated mesh__D001613 1974-11-19
% 208.27/208.43  |- skos__hiddenLabel mesh__D001613 beta 2 Microglobulin
% 208.27/208.43  |- mesh__dateEstablished mesh__D001613 1984-01-01
% 208.27/208.43  |- skos__broader mesh__D001613smesh__D001609
% 208.27/208.43  |- skos__altLabel mesh__D001613 Thymotaxin
% 208.27/208.43  |- mesh__dateRevised mesh__D001613 2004-07-07
% 208.27/208.43  |- skos__historyNote mesh__D001613 Beta Globulins %28%1973-1974%29%
% 208.27/208.43  |- mesh__dateEstablished mesh__D020578 2000-01-01
% 208.27/208.43  |- skos__prefLabel mesh__D020578 Sphingomonas
% 208.27/208.43  |- rdf__type mesh__D020578sskos__Concept
% 208.27/208.43  |- mesh__recordOriginator mesh__D020578 ndw
% 208.27/208.43  |- mesh__dateCreated mesh__D020578 1999-11-03
% 208.27/208.43  |- skos__scopeNote mesh__D020578
% 208.27/208.43       A genus of gram-negative, aerobic, rod-shaped bacteria characterized by an outer membrane that contains glycosphingolipids but lacks lipopolysaccharide. They have the ability to degrade a broad range of substituted aromatic compounds.%A%    
% 208.27/208.43  |- mesh__publicMeSHNote mesh__D020578 2000   
% 208.27/208.43  |- skos__broader mesh__D020578smesh__D042301
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D020578 2006
% 208.27/208.43  |- mesh__recordMaintainer mesh__D020578 SYSTEM
% 208.27/208.43  |- skos__broader mesh__D020578smesh__D016946
% 208.27/208.43  |- mesh__historyNote mesh__D020578 2000   
% 208.27/208.43  |- skos__annotation mesh__D020578
% 208.27/208.43       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 208.27/208.43  |- mesh__dateRevised mesh__D020578 2005-06-30
% 208.27/208.43  |- mesh__recordAuthorizer mesh__D020578 sjn
% 208.27/208.43  |- mesh__historyNote mesh__D019226 97   
% 208.27/208.43  |- skos__related mesh__D019226smesh__D009625
% 208.27/208.43  |- skos__hiddenLabel mesh__D019226 Mouth Ulcers
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D019226 2004
% 208.27/208.43  |- skos__annotation mesh__D019226
% 208.27/208.43       coord IM with cause %28%IM%29% if pertinent; not a synonym for STOMATITIS, APHTHOUS%A%  
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D019226 2002
% 208.27/208.43  |- mesh__recordAuthorizer mesh__D019226 ags
% 208.27/208.43  |- skos__hiddenLabel mesh__D019226 Ulcers, Oral
% 208.27/208.43  |- mesh__dateCreated mesh__D019226 1996-06-10
% 208.27/208.43  |- skos__historyNote mesh__D019226 Ulcer %28%1966-1996%29%
% 208.27/208.43  |- skos__hiddenLabel mesh__D019226 Ulcers, Mouth
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D019226 2003
% 208.27/208.43  |- mesh__recordMaintainer mesh__D019226 ags
% 208.27/208.43  |- skos__scopeNote mesh__D019226
% 208.27/208.43       A loss of mucous substance of the mouth showing local excavation of the surface, resulting from the sloughing of inflammatory necrotic tissue. It is the result of a variety of causes, e.g., denture irritation, aphthous stomatitis %28%STOMATITIS, APHTHOUS%29%; NOMA; necrotizing gingivitis %28%GINGIVITIS, NECROTIZING ULCERATIVE%29%; TOOTHBRUSHING; and various irritants. %28%From Jablonski, Dictionary of Dentistry, 1992, p842%29%%A%    
% 208.27/208.43  |- skos__historyNote mesh__D019226 Mouth Diseases %28%1966-1996%29%
% 208.27/208.43  |- skos__historyNote mesh__D019226 Stomatitis %28%1966-1996%29%
% 208.27/208.43  |- mesh__recordOriginator mesh__D019226 TGC
% 208.27/208.43  |- mesh__publicMeSHNote mesh__D019226 97   
% 208.27/208.43  |- skos__related mesh__D019226smesh__D005892
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D019226 2006A
% 208.27/208.43  |- mesh__dateRevised mesh__D019226 2005-07-15
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D019226 2006
% 208.27/208.43  |- skos__broader mesh__D019226smesh__D009059
% 208.27/208.43  |- skos__related mesh__D019226smesh__D013281
% 208.27/208.43  |- skos__hiddenLabel mesh__D019226 Ulcer, Mouth
% 208.27/208.43  |- rdf__type mesh__D019226sskos__Concept
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D019226 2005
% 208.27/208.43  |- skos__historyNote mesh__D019226 Stomatitis, Aphthous %28%1966-1996%29%
% 208.27/208.43  |- skos__prefLabel mesh__D019226 Oral Ulcer
% 208.27/208.43  |- mesh__dateEstablished mesh__D019226 1997-01-01
% 208.27/208.43  |- skos__hiddenLabel mesh__D019226 Oral Ulcers
% 208.27/208.43  |- skos__altLabel mesh__D019226 Mouth Ulcer
% 208.27/208.43  |- skos__hiddenLabel mesh__D019226 Ulcer, Oral
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D011243 2005
% 208.27/208.43  |- mesh__recordAuthorizer mesh__D011243 sjn
% 208.27/208.43  |- skos__hiddenLabel mesh__D011243 Organization, Preferred Provider
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D011243 2006
% 208.27/208.43  |- mesh__recordMaintainer mesh__D011243 kle
% 208.27/208.43  |- skos__prefLabel mesh__D011243 Preferred Provider Organizations
% 208.27/208.43  |- skos__altLabel mesh__D011243 Organizations, Preferred Provider
% 208.27/208.43  |- skos__broader mesh__D011243smesh__D008329
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D011243 2000
% 208.27/208.43  |- mesh__dateEstablished mesh__D011243 1991-01-01
% 208.27/208.43  |- rdf__type mesh__D011243sskos__Concept
% 208.27/208.43  |- skos__scopeNote mesh__D011243
% 208.27/208.43       Arrangements negotiated between a third-party payer %28%often a self-insured company or union trust fund%29% and a group of health-care providers %28%hospitals and physicians%29% who furnish services at lower than usual fees, and, in return, receive prompt payment and an expectation of an increased volume of patients.%A%    
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D011243 2003
% 208.27/208.43  |- mesh__dateCreated mesh__D011243 1984-04-13
% 208.27/208.43  |- mesh__onlineNote mesh__D011243
% 208.27/208.43       use INSURANCE, HEALTH to search PREFERRED PROVIDER ORGANIZATIONS 1984%A%  
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D011243 2001
% 208.27/208.43  |- mesh__dateRevised mesh__D011243 1999-11-03
% 208.27/208.43  |- skos__historyNote mesh__D011243 Insurance, Health %28%1966-1984%29%
% 208.27/208.43  |- mesh__recordOriginator mesh__D011243 EC
% 208.27/208.43  |- mesh__publicMeSHNote mesh__D011243
% 208.27/208.43       91; was see under MANAGED CARE PROGRAMS 1990; was see under INSURANCE, HEALTH 1985-89; was see INSURANCE, HEALTH 1984%A%  
% 208.27/208.43  |- mesh__historyNote mesh__D011243
% 208.27/208.43       91%28%85%29%; was see under MANAGED CARE PROGRAMS 1990; was see under INSURANCE, HEALTH 1985-89; was see INSURANCE, HEALTH 1984%A%  
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D011243 2004
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D011243 2002
% 208.27/208.43  |- skos__annotation mesh__D011243 specify geog if possible; DF: PPO   
% 208.27/208.43  |- skos__altLabel mesh__D011243 Preferred Provider Organization
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005206 1993
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005206 2003
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005206 1996
% 208.27/208.43  |- mesh__dateEstablished mesh__D005206 1991-01-01
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005206 1995
% 208.27/208.43  |- skos__broader mesh__D005206smesh__D005205
% 208.27/208.43  |- skos__historyNote mesh__D005206 Thigh %28%1966-1971%29%
% 208.27/208.43  |- mesh__dateRevised mesh__D005206 1990-04-13
% 208.27/208.43  |- skos__hiddenLabel mesh__D005206 Latas, Fascia
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005206 2005
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005206 1998
% 208.27/208.43  |- mesh__dateCreated mesh__D005206 1999-01-01
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005206 1992
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005206 1994
% 208.27/208.43  |- mesh__recordAuthorizer mesh__D005206 PLS
% 208.27/208.43  |- skos__hiddenLabel mesh__D005206 Lata, Fascia
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005206 2002
% 208.27/208.43  |- mesh__historyNote mesh__D005206
% 208.27/208.43       91%28%72%29%; was see under FASCIA 1972-90   
% 208.27/208.43  |- mesh__recordOriginator mesh__D005206 NLM
% 208.27/208.43  |- rdf__type mesh__D005206sskos__Concept
% 208.27/208.43  |- mesh__recordMaintainer mesh__D005206 NLM
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005206 1991
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005206 2001
% 208.27/208.43  |- skos__historyNote mesh__D005206 Fascia %28%1966-1971%29%
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005206 2004
% 208.27/208.43  |- skos__prefLabel mesh__D005206 Fascia Lata
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005206 1997
% 208.27/208.43  |- skos__hiddenLabel mesh__D005206 Fascia Latas
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005206 2000
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005206 2006
% 208.27/208.43  |- mesh__publicMeSHNote mesh__D005206 91; was see under FASCIA 1972-90   
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005206 1999
% 208.27/208.43  |- skos__hiddenLabel mesh__D010949 Plasmas
% 208.27/208.43  |- skos__hiddenLabel mesh__D010949 Plasmas, Fresh Frozen
% 208.27/208.43  |- skos__hiddenLabel mesh__D010949 Plasma, Fresh Frozen
% 208.27/208.43  |- skos__hiddenLabel mesh__D010949 Plasmas, Blood
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D010949 2006
% 208.27/208.43  |- mesh__dateRevised mesh__D010949 2003-07-09
% 208.27/208.43  |- skos__hiddenLabel mesh__D010949 Plasma, Blood
% 208.27/208.43  |- skos__hiddenLabel mesh__D010949 Frozen Plasmas, Fresh
% 208.27/208.43  |- skos__hiddenLabel mesh__D010949 Fresh Frozen Plasmas
% 208.27/208.43  |- skos__altLabel mesh__D010949 Blood Plasma
% 208.27/208.43  |- skos__annotation mesh__D010949
% 208.27/208.43       restrict to plasma for transfusions or plasma when compared with serum or blood cells or whole blood; substances in plasma = /blood, not PLASMA; policy: Manual 21.47, 25.14.5; for X ref FRESH FROZEN PLASMA do not coord with FREEZING nor BLOOD PRESERVATION%A%  
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D010949 2005
% 208.27/208.43  |- mesh__recordAuthorizer mesh__D010949 sjn
% 208.27/208.43  |- mesh__recordOriginator mesh__D010949 NLM
% 208.27/208.43  |- skos__hiddenLabel mesh__D010949 Blood Plasmas
% 208.27/208.43  |- mesh__dateCreated mesh__D010949 1999-01-01
% 208.27/208.43  |- skos__scopeNote mesh__D010949
% 208.27/208.43       The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION.%A%    
% 208.27/208.43  |- skos__related mesh__D010949smesh__D044967
% 208.27/208.43  |- skos__hiddenLabel mesh__D010949 Frozen Plasma, Fresh
% 208.27/208.43  |- mesh__recordMaintainer mesh__D010949 lkt
% 208.27/208.43  |- skos__prefLabel mesh__D010949 Plasma
% 208.27/208.43  |- rdf__type mesh__D010949sskos__Concept
% 208.27/208.43  |- skos__broader mesh__D010949smesh__D045604
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D010949 2004
% 208.27/208.43  |- skos__broader mesh__D010949smesh__D001769
% 208.27/208.43  |- rdf__type mesh__D043325sskos__Concept
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D043325 2006
% 208.27/208.43  |- mesh__recordAuthorizer mesh__D043325 sjn
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D043325 2004
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D043325 2005
% 208.27/208.43  |- skos__hiddenLabel mesh__D043325 Endo-1,3-beta-Xylosidase, Xylan
% 208.27/208.43  |- skos__scopeNote mesh__D043325
% 208.27/208.43       A xylosidase that catalyses the random hydrolysis of 1,3-beta-D-xylosidic linkages in 1,3-beta-D-xylans.%A%    
% 208.27/208.43  |- skos__hiddenLabel mesh__D043325 Endo 1,3 beta Xylanase
% 208.27/208.43  |- skos__broader mesh__D043325smesh__D014995
% 208.27/208.43  |- mesh__dateCreated mesh__D043325 2003-07-09
% 208.27/208.43  |- skos__historyNote mesh__D043325 Xylans %28%1979-1982%29%
% 208.27/208.43  |- skos__historyNote mesh__D043325 Glycoside Hydrolases %28%1975-1994%29%
% 208.27/208.43  |- skos__historyNote mesh__D043325 Xylosidases %28%1995-2003%29%
% 208.27/208.43  |- mesh__recordOriginator mesh__D043325 AKE
% 208.27/208.43  |- mesh__publicMeSHNote mesh__D043325
% 208.27/208.43       2004; XYLAN ENDO-1,3-BETA-XYLOSIDASE was indexed under XYLOSIDASES 1995-2003, under GYCOSIDE HYDROLASES 1975-1994, under XYLANS 1979-1982 %26% under XYLOSE 1975-1979%A%  
% 208.27/208.43  |- mesh__historyNote mesh__D043325
% 208.27/208.43       2004; use XYLAN ENDO-1,3-BETA-XYLOSIDASE %28%NM%29% 1980-2003   
% 208.27/208.43  |- skos__historyNote mesh__D043325 Xylose %28%1975-1979%29%
% 208.27/208.43  |- skos__prefLabel mesh__D043325 Xylan Endo-1,3-beta-Xylosidase
% 208.27/208.43  |- skos__related mesh__D043325smesh__D014990
% 208.27/208.43  |- skos__hiddenLabel mesh__D043325 Xylan Endo 1,3 beta Xylosidase
% 208.27/208.43  |- skos__altLabel mesh__D043325 Endo-1,3-beta-Xylanase
% 208.27/208.43  |- mesh__recordMaintainer mesh__D043325 AKE
% 208.27/208.43  |- mesh__dateEstablished mesh__D043325 2004-01-01
% 208.27/208.43  |- mesh__publicMeSHNote mesh__D048010 2005   
% 208.27/208.43  |- mesh__recordMaintainer mesh__D048010 SYSTEM
% 208.27/208.43  |- mesh__recordAuthorizer mesh__D048010 sjn
% 208.27/208.43  |- mesh__dateEstablished mesh__D048010 2005-01-01
% 208.27/208.43  |- skos__historyNote mesh__D048010 Clostridium %28%1963-2004%29%
% 208.27/208.43  |- mesh__dateRevised mesh__D048010 2005-06-30
% 208.27/208.43  |- skos__prefLabel mesh__D048010 Clostridium tertium
% 208.27/208.43  |- skos__annotation mesh__D048010
% 208.27/208.43       infection: coordinate IM with CLOSTRIDIUM INFECTIONS %28%IM%29%%A%  
% 208.27/208.43  |- mesh__historyNote mesh__D048010 2005   
% 208.27/208.43  |- skos__broader mesh__D048010smesh__D003013
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D048010 2006
% 208.27/208.43  |- mesh__dateCreated mesh__D048010 2004-07-07
% 208.27/208.43  |- mesh__recordOriginator mesh__D048010 ags
% 208.27/208.43  |- rdf__type mesh__D048010sskos__Concept
% 208.27/208.43  |- skos__scopeNote mesh__D048010
% 208.27/208.43       A species of gram-positive bacteria in the family Clostridiaceae, causing BACTEREMIA in humans and ANIMALS.%A%    
% 208.27/208.43  |- skos__scopeNote mesh__D001614
% 208.27/208.43       An enzyme that catalyzes the hydrolysis of 1,4-alpha-glycosidic linkages in starch, glycogen, and related polysaccharides and oligosaccharides so as to remove successive beta-maltose units from the non-reducing ends of the chains. EC 3.2.1.2.%A%    
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D001614 2005
% 208.27/208.43  |- mesh__dateRevised mesh__D001614 2003-07-09
% 208.27/208.43  |- mesh__recordMaintainer mesh__D001614 ssb
% 208.27/208.43  |- mesh__recordOriginator mesh__D001614 RLS
% 208.27/208.43  |- mesh__publicMeSHNote mesh__D001614 91; was see under AMYLASES 1978-90   
% 208.27/208.43  |- skos__prefLabel mesh__D001614 beta-Amylase
% 208.27/208.43  |- mesh__dateEstablished mesh__D001614 1991-01-01
% 208.27/208.43  |- mesh__recordAuthorizer mesh__D001614 sjn
% 208.27/208.43  |- mesh__dateCreated mesh__D001614 1977-04-15
% 208.27/208.43  |- mesh__historyNote mesh__D001614
% 208.27/208.43       91%28%78%29%; was see under AMYLASES 1978-90   
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D001614 2006
% 208.27/208.43  |- skos__broader mesh__D001614smesh__D000681
% 208.27/208.43  |- skos__historyNote mesh__D001614 Amylases %28%1966-1977%29%
% 208.27/208.43  |- rdf__type mesh__D001614sskos__Concept
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D001614 2004
% 208.27/208.43  |- skos__hiddenLabel mesh__D001614 beta Amylase
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D020579 2006
% 208.27/208.43  |- mesh__dateRevised mesh__D020579 2005-06-30
% 208.27/208.43  |- skos__prefLabel mesh__D020579 Sinorhizobium
% 208.27/208.43  |- mesh__recordAuthorizer mesh__D020579 sjn
% 208.27/208.43  |- skos__scopeNote mesh__D020579
% 208.27/208.43       A genus of gram-negative, aerobic, nonsporeforming rods which usually contain granules of poly-beta-hydroxybutyrate. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 208.27/208.43  |- mesh__dateCreated mesh__D020579 1999-11-03
% 208.27/208.43  |- mesh__publicMeSHNote mesh__D020579 2000   
% 208.27/208.43  |- mesh__recordMaintainer mesh__D020579 SYSTEM
% 208.27/208.43  |- skos__broader mesh__D020579smesh__D012230
% 208.27/208.43  |- mesh__historyNote mesh__D020579 2000   
% 208.27/208.43  |- mesh__dateEstablished mesh__D020579 2000-01-01
% 208.27/208.43  |- rdf__type mesh__D020579sskos__Concept
% 208.27/208.43  |- mesh__recordOriginator mesh__D020579 ndw
% 208.27/208.43  |- skos__broader mesh__D019227smesh__D014092
% 208.27/208.43  |- skos__scopeNote mesh__D019227
% 208.27/208.43       The tip or terminal end of the root of a tooth. %28%Jablonski, Dictionary of Dentistry, 1992, p62%29%%A%    
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D019227 2004
% 208.27/208.43  |- mesh__historyNote mesh__D019227
% 208.27/208.43       97; was see TOOTH ROOT 1975-96; was see under TOOTH ROOT 1969-74%A%  
% 208.27/208.43  |- skos__hiddenLabel mesh__D019227 Foramen, Apical
% 208.27/208.43  |- mesh__onlineNote mesh__D019227
% 208.27/208.43       use TOOTH ROOT to search TOOTH APEX 1969-96   
% 208.27/208.43  |- skos__hiddenLabel mesh__D019227 Apex, Tooth
% 208.27/208.43  |- mesh__recordAuthorizer mesh__D019227 sjn
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D019227 2005
% 208.27/208.43  |- mesh__dateEstablished mesh__D019227 1997-01-01
% 208.27/208.43  |- mesh__publicMeSHNote mesh__D019227
% 208.27/208.43       97; was see TOOTH ROOT 1975-96; was see under TOOTH ROOT 1969-74%A%  
% 208.27/208.43  |- skos__altLabel mesh__D019227 Tooth Apices
% 208.27/208.43  |- skos__prefLabel mesh__D019227 Tooth Apex
% 208.27/208.43  |- mesh__dateCreated mesh__D019227 1996-06-10
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D019227 2006
% 208.27/208.43  |- mesh__dateRevised mesh__D019227 2003-07-09
% 208.27/208.43  |- skos__hiddenLabel mesh__D019227 Apices, Tooth
% 208.27/208.43  |- skos__annotation mesh__D019227
% 208.27/208.43       dis: coord IM with TOOTH DISEASES %28%IM%29%; /surg: consider also APICOECTOMY; apical foramen goes here%A%  
% 208.27/208.43  |- mesh__recordMaintainer mesh__D019227 lkt
% 208.27/208.43  |- rdf__type mesh__D019227sskos__Concept
% 208.27/208.43  |- mesh__recordOriginator mesh__D019227 TGC
% 208.27/208.43  |- skos__related mesh__D019227smesh__D001047
% 208.27/208.43  |- skos__historyNote mesh__D019227 Tooth Root %28%1975-1996%29%
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D011244 2001
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D011244 2006
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D011244 1995
% 208.27/208.43  |- mesh__recordOriginator mesh__D011244 NLM
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D011244 2002
% 208.27/208.43  |- mesh__dateEstablished mesh__D011244 1974-01-01
% 208.27/208.43  |- mesh__dateCreated mesh__D011244 1999-01-01
% 208.27/208.43  |- mesh__historyNote mesh__D011244 74   
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D011244 1996
% 208.27/208.43  |- mesh__publicMeSHNote mesh__D011244 74   
% 208.27/208.43  |- skos__scopeNote mesh__D011244
% 208.27/208.43       Doubly unsaturated pregnane derivatives with two hydroxy groups substituted anywhere on the rings or side chains.%A%    
% 208.27/208.43  |- rdf__type mesh__D011244sskos__Concept
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D011244 2003
% 208.27/208.43  |- mesh__dateRevised mesh__D011244 1993-06-03
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D011244 1997
% 208.27/208.43  |- mesh__recordAuthorizer mesh__D011244 PLS
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D011244 2004
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D011244 1998
% 208.27/208.43  |- skos__broader mesh__D011244smesh__D011245
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D011244 2000
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D011244 2005
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D011244 1994
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D011244 1999
% 208.27/208.43  |- skos__prefLabel mesh__D011244 Pregnadienediols
% 208.27/208.43  |- mesh__recordMaintainer mesh__D011244 PLS
% 208.27/208.43  |- skos__altLabel mesh__D011244 Dihydroxypregnadienes
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005207 2001
% 208.27/208.43  |- skos__hiddenLabel mesh__D005207 Muscle Fasciculations, Skeletal
% 208.27/208.43  |- skos__hiddenLabel mesh__D005207 Muscular Fasciculation
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005207 2005
% 208.27/208.43  |- skos__hiddenLabel mesh__D005207 Neural Fasciculations
% 208.27/208.43  |- skos__altLabel mesh__D005207 Fasciculation, Muscular
% 208.27/208.43  |- mesh__publicMeSHNote mesh__D005207
% 208.27/208.43       1987; see NEUROLOGIC MANIFESTATIONS 1982-86, see MOVEMENT DISORDERS 1979-81%A%  
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005207 2002
% 208.27/208.43  |- skos__hiddenLabel mesh__D005207 Benign Fasciculations
% 208.27/208.43  |- mesh__historyNote mesh__D005207 1987%28%1979%29%   
% 208.27/208.43  |- skos__hiddenLabel mesh__D005207 Skeletal Muscle Fasciculation
% 208.27/208.43  |- skos__prefLabel mesh__D005207 Fasciculation
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005207 2006
% 208.27/208.43  |- skos__hiddenLabel mesh__D005207 Muscular Fasciculations
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005207 2003
% 208.27/208.43  |- skos__hiddenLabel mesh__D005207 Benign Fasciculation
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005207 2000A
% 208.27/208.43  |- mesh__recordAuthorizer mesh__D005207 ags
% 208.27/208.43  |- skos__hiddenLabel mesh__D005207 Skeletal Muscle Fasciculations
% 208.27/208.43  |- skos__annotation mesh__D005207
% 208.27/208.43       note category: do not confuse with axonal fasciculation %28%index under AXONS /physiol%29%%A%  
% 208.27/208.43  |- skos__hiddenLabel mesh__D005207 Fasciculations
% 208.27/208.43  |- skos__hiddenLabel mesh__D005207 Fasciculations, Muscular
% 208.27/208.43  |- mesh__dateCreated mesh__D005207 1978-05-22
% 208.27/208.43  |- rdf__type mesh__D005207sskos__Concept
% 208.27/208.43  |- skos__broader mesh__D005207smesh__D020879
% 208.27/208.43  |- skos__hiddenLabel mesh__D005207 Fasciculations, Benign
% 208.27/208.43  |- mesh__dateRevised mesh__D005207 1999-12-03
% 208.27/208.43  |- skos__hiddenLabel mesh__D005207 Tongue Fasciculation
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005207 2004
% 208.27/208.43  |- skos__hiddenLabel mesh__D005207 Muscle Fasciculation, Skeletal
% 208.27/208.43  |- skos__hiddenLabel mesh__D005207 Tongue Fasciculations
% 208.27/208.43  |- skos__scopeNote mesh__D005207
% 208.27/208.43       Involuntary contraction of the muscle fibers innervated by a motor unit. Fasciculations can often by visualized and take the form of a muscle twitch or dimpling under the skin, but usually do not generate sufficient force to move a limb. They may represent a benign condition or occur as a manifestation of MOTOR NEURON DISEASE or PERIPHERAL NERVOUS SYSTEM DISEASES. %28%Adams et al., Principles of Neurology, 6th ed, p1294%29%%A%    
% 208.27/208.43  |- skos__hiddenLabel mesh__D005207 Fasciculations, Tongue
% 208.27/208.43  |- mesh__recordOriginator mesh__D005207 RC
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D005207 2000
% 208.27/208.43  |- skos__hiddenLabel mesh__D005207 Fasciculations, Skeletal Muscle
% 208.27/208.43  |- skos__hiddenLabel mesh__D005207 Neural Fasciculation
% 208.27/208.43  |- skos__altLabel mesh__D005207 Fasciculation, Neural
% 208.27/208.43  |- mesh__dateEstablished mesh__D005207 1987-01-01
% 208.27/208.43  |- mesh__recordMaintainer mesh__D005207 ags
% 208.27/208.43  |- skos__hiddenLabel mesh__D005207 Fasciculations, Neural
% 208.27/208.43  |- rdf__type mesh__D043326sskos__Concept
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D043326 2005A
% 208.27/208.43  |- mesh__dateRevised mesh__D043326 2004-07-27
% 208.27/208.43  |- mesh__activeMeSHYear mesh__D043326 2004
% 208.27/208.43  |- mesh__publicMeSHNote mesh__D043326
% 208.27/208.43       2004; GLUCAN 1,3-BETA-GLUCOSIDASE was indexed under BETA-GLUCOSIDASE 1979-2003%A%  
% 208.27/208.43  |- skos__hiddenLabel mesh__D043326 1,3-beta-Glucosidase, Glucan
% 208.27/208.43  |- mesh__recordAuthorizer mesh__D043326 jls
% 208.27/208.43  |- skos__historyNote mesh__D043326 beta-Glucosidase %28%1979-2003%29%
% 208.27/208.43  |- mesh__recordOriginator mesh__D043326 AKE
% 208.27/208.43  |- skos__hiddenLabel mesh__D043326 Beta 1,3 Glucanase Type II
% 208.27/208.43  |- skos__hiddenLabel mesh__D043326 beta-D-Glucosidase, Exo-1,3
% 208.27/208.43  |- skos__scopeNote mesh__D043326
% 208.27/208.43       An exocellulase with specificity for 1,3-beta-D-glucasidic linkages. It catalyzes hydrolysis of beta-D-glucose units from the non-reducing ends of 1,3-beta-D-glucans, releasing GLUCOSE.%A%    
% 208.27/208.44  |- skos__hiddenLabel mesh__D043326 Glucan 1,3 beta Glucosidase
% 208.27/208.44  |- skos__hiddenLabel mesh__D043326 1,3 beta Glucanase
% 208.27/208.44  |- skos__broader mesh__D043326smesh__D044602
% 208.27/208.44  |- mesh__dateCreated mesh__D043326 2003-07-09
% 208.27/208.44  |- mesh__dateEstablished mesh__D043326 2004-01-01
% 208.27/208.44  |- mesh__historyNote mesh__D043326
% 208.27/208.44       2004; use GLUCAN 1,3-BETA-GLUCOSIDASE %28%NM%29% 1979-2003   
% 208.27/208.44  |- mesh__recordMaintainer mesh__D043326 jls
% 208.27/208.44  |- skos__hiddenLabel mesh__D043326 Exo 1,3 beta D Glucosidase
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D043326 2005
% 208.27/208.44  |- skos__prefLabel mesh__D043326 Glucan 1,3-beta-Glucosidase
% 208.27/208.44  |- skos__altLabel mesh__D043326 1,3-beta-Glucanase
% 208.27/208.44  |- skos__altLabel mesh__D043326 Exo-1,3 beta-D-Glucosidase
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D043326 2006
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015635 2000
% 208.27/208.44  |- mesh__dateCreated mesh__D015635 1989-06-19
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015635 1999
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015635 2005
% 208.27/208.44  |- rdf__type mesh__D015635sskos__Concept
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015635 1998
% 208.27/208.44  |- skos__broader mesh__D015635smesh__D011875
% 208.27/208.44  |- skos__historyNote mesh__D015635
% 208.27/208.44       Heart/radionuclide imaging %28%1977-1989%29%
% 208.27/208.44  |- skos__historyNote mesh__D015635
% 208.27/208.44       Heart Ventricle/radionuclide imaging %28%1977-1989%29%
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015635 2002
% 208.27/208.44  |- mesh__historyNote mesh__D015635 90   
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015635 2004
% 208.27/208.44  |- skos__annotation mesh__D015635
% 208.27/208.44       %22%ventriculo-%22% refers to the heart, not the cerebral ventricles; NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: RADIONUCLIDE VENTRICULOGR%A%  
% 208.27/208.44  |- mesh__dateRevised mesh__D015635 1997-06-20
% 208.27/208.44  |- mesh__recordMaintainer mesh__D015635 PXP
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015635 2003
% 208.27/208.44  |- mesh__publicMeSHNote mesh__D015635 90   
% 208.27/208.44  |- skos__scopeNote mesh__D015635
% 208.27/208.44       Imaging of a ventricle of the heart after the injection of a radioactive contrast medium. The technique is less invasive than cardiac catheterization and is used to assess ventricular function.%A%    
% 208.27/208.44  |- mesh__recordOriginator mesh__D015635 AGS
% 208.27/208.44  |- mesh__recordAuthorizer mesh__D015635 SJN
% 208.27/208.44  |- skos__broader mesh__D015635smesh__D006334
% 208.27/208.44  |- mesh__dateEstablished mesh__D015635 1990-01-01
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015635 2001
% 208.27/208.44  |- skos__prefLabel mesh__D015635 Radionuclide Ventriculography
% 208.27/208.44  |- skos__altLabel mesh__D015635 Ventriculography, Radionuclide
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015635 2006
% 208.27/208.44  |- mesh__dateEstablished mesh__D001615 1988-01-01
% 208.27/208.44  |- skos__altLabel mesh__D001615 Lipotropin C Fragment
% 208.27/208.44  |- skos__hiddenLabel mesh__D001615 Endorphin, C-Fragment
% 208.27/208.44  |- mesh__recordAuthorizer mesh__D001615 sjn
% 208.27/208.44  |- skos__hiddenLabel mesh__D001615 C Fragment Endorphin
% 208.27/208.44  |- skos__broader mesh__D001615smesh__D004723
% 208.27/208.44  |- skos__hiddenLabel mesh__D001615 C Fragment, beta-Lipotropin
% 208.27/208.44  |- skos__altLabel mesh__D001615 beta-LPH %28%61-91%29%
% 208.27/208.44  |- skos__hiddenLabel mesh__D001615 beta Endorphin
% 208.27/208.44  |- skos__hiddenLabel mesh__D001615 beta Lipotropin C Fragment
% 208.27/208.44  |- skos__hiddenLabel mesh__D001615 Fragment, beta-Lipotropin C
% 208.27/208.44  |- skos__altLabel mesh__D001615 Lipotropin Fragment C
% 208.27/208.44  |- mesh__dateCreated mesh__D001615 1987-05-04
% 208.27/208.44  |- skos__hiddenLabel mesh__D001615 Fragment, Lipotropin C
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D001615 2006
% 208.27/208.44  |- skos__scopeNote mesh__D001615
% 208.27/208.44       A peptide consisting of amino acid sequence 61-91 of the endogenous pituitary hormone BETA-LIPOTROPIN. The first four amino acids show a common tetrapeptide sequence with METHIONINE- and LEUCINE ENKEPHALIN. The compound shows opiate-like activity. Injection of beta-endorphin induces a profound analgesia of the whole body for several hours. This action is reversed after administration of naloxone.%A%    
% 208.27/208.44  |- skos__hiddenLabel mesh__D001615 Lipotropin 61 91
% 208.27/208.44  |- mesh__dateRevised mesh__D001615 2005-06-30
% 208.27/208.44  |- rdf__type mesh__D001615sskos__Concept
% 208.27/208.44  |- mesh__recordOriginator mesh__D001615 RLS
% 208.27/208.44  |- skos__prefLabel mesh__D001615 beta-Endorphin
% 208.27/208.44  |- mesh__recordMaintainer mesh__D001615 ssb
% 208.27/208.44  |- skos__altLabel mesh__D001615 beta-Lipotropin C Fragment
% 208.27/208.44  |- skos__hiddenLabel mesh__D001615 C Fragment, Lipotropin
% 208.27/208.44  |- skos__altLabel mesh__D001615 Lipotropin 61-91
% 208.27/208.44  |- skos__historyNote mesh__D001615 Endorphins %28%1978-1987%29%
% 208.27/208.44  |- skos__altLabel mesh__D001615 C-Fragment Endorphin
% 208.27/208.44  |- skos__historyNote mesh__D001615 Peptides %28%1966-1977%29%
% 208.27/208.44  |- mesh__publicMeSHNote mesh__D001615 88   
% 208.27/208.44  |- mesh__historyNote mesh__D001615 88   
% 208.27/208.44  |- skos__hiddenLabel mesh__D001615 Fragment C, Lipotropin
% 208.27/208.44  |- skos__altLabel mesh__D001615 Endorphin, beta
% 208.27/208.44  |- skos__hiddenLabel mesh__D006300 Misuses, Health Services
% 208.27/208.44  |- skos__scopeNote mesh__D006300
% 208.27/208.44       Excessive or unnecessary utilization of health services by patients or physicians.%A%    
% 208.27/208.44  |- skos__prefLabel mesh__D006300 Health Services Misuse
% 208.27/208.44  |- rdf__type mesh__D006300sskos__Concept
% 208.27/208.44  |- mesh__recordMaintainer mesh__D006300 KEV
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D006300 2001
% 208.27/208.44  |- skos__altLabel mesh__D006300 Misuse, Health Services
% 208.27/208.44  |- skos__altLabel mesh__D006300 Misuse of Health Services
% 208.27/208.44  |- mesh__recordAuthorizer mesh__D006300 PLS
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D006300 1999
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D006300 2000
% 208.27/208.44  |- mesh__dateCreated mesh__D006300 1977-05-12
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D006300 1998
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D006300 1997
% 208.27/208.44  |- skos__hiddenLabel mesh__D006300 Health Services Abuses
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D006300 2006
% 208.27/208.44  |- mesh__historyNote mesh__D006300
% 208.27/208.44       91%28%Aug 77%29%; was see under HEALTH SERVICES 1977-90   
% 208.27/208.44  |- skos__altLabel mesh__D006300 Overutilization of Health Services
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D006300 1996
% 208.27/208.44  |- skos__broader mesh__D006300smesh__D006296
% 208.27/208.44  |- mesh__dateEstablished mesh__D006300 1991-01-01
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D006300 2005
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D006300 2004
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D006300 2002
% 208.27/208.44  |- skos__hiddenLabel mesh__D006300 Health Services Misuses
% 208.27/208.44  |- mesh__publicMeSHNote mesh__D006300
% 208.27/208.44       91; was see under HEALTH SERVICES Aug 1977-90   
% 208.27/208.44  |- skos__broader mesh__D006300smesh__D001294
% 208.27/208.44  |- skos__annotation mesh__D006300
% 208.27/208.44       misuse, overuse or abuse by patient or physician; DF: HEALTH SERV MISUSE%A%  
% 208.27/208.44  |- skos__hiddenLabel mesh__D006300 Overutilization, Health Services
% 208.27/208.44  |- skos__hiddenLabel mesh__D006300 Health Services Abuse
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D006300 2003
% 208.27/208.44  |- mesh__dateRevised mesh__D006300 1995-05-22
% 208.27/208.44  |- mesh__recordOriginator mesh__D006300 EC
% 208.27/208.44  |- mesh__recordOriginator mesh__D019228 TGC
% 208.27/208.44  |- mesh__recordMaintainer mesh__D019228 lkt
% 208.27/208.44  |- skos__hiddenLabel mesh__D019228 Crowns, Tooth
% 208.27/208.44  |- mesh__publicMeSHNote mesh__D019228 97   
% 208.27/208.44  |- skos__prefLabel mesh__D019228 Tooth Crown
% 208.27/208.44  |- skos__hiddenLabel mesh__D019228 Crown, Tooth
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D019228 2005
% 208.27/208.44  |- skos__hiddenLabel mesh__D019228 Tooth Crowns
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D019228 2006
% 208.27/208.44  |- mesh__dateRevised mesh__D019228 2003-07-09
% 208.27/208.44  |- mesh__recordAuthorizer mesh__D019228 sjn
% 208.27/208.44  |- skos__annotation mesh__D019228
% 208.27/208.44       anatomical crown: do not confuse with CROWNS or its X ref DENTAL CROWNS %28%Cat E6%29%, prosthetic restorations; coord IM with specific tooth %28%IM%29% if pertinent%A%  
% 208.27/208.44  |- rdf__type mesh__D019228sskos__Concept
% 208.27/208.44  |- mesh__dateEstablished mesh__D019228 1997-01-01
% 208.27/208.44  |- skos__historyNote mesh__D019228 specific tooth %28%1966-1996%29%
% 208.27/208.44  |- skos__scopeNote mesh__D019228
% 208.27/208.44       The upper part of the tooth, which joins the lower part of the tooth %28%TOOTH ROOT%29% at the cervix %28%TOOTH CERVIX%29% at a line called the cementoenamel junction. The entire surface of the crown is covered with enamel which is thicker at the extremity and becomes progressively thinner toward the cervix. %28%From Jablonski, Dictionary of Dentistry, 1992, p216%29%%A%    
% 208.27/208.44  |- skos__historyNote mesh__D019228 Tooth %28%1966-1996%29%
% 208.27/208.44  |- mesh__dateCreated mesh__D019228 1996-06-10
% 208.27/208.44  |- mesh__historyNote mesh__D019228 97   
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D019228 2004
% 208.27/208.44  |- skos__broader mesh__D019228smesh__D019589
% 208.27/208.44  |- skos__prefLabel mesh__D011245 Pregnadienes
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011245 1996
% 208.27/208.44  |- mesh__recordAuthorizer mesh__D011245 PLS
% 208.27/208.44  |- rdf__type mesh__D011245sskos__Concept
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011245 2003
% 208.27/208.44  |- mesh__recordMaintainer mesh__D011245 PLS
% 208.27/208.44  |- mesh__historyNote mesh__D011245 73   
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011245 1997
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011245 2000
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011245 2004
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011245 1998
% 208.27/208.44  |- skos__broader mesh__D011245smesh__D011278
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011245 2001
% 208.27/208.44  |- skos__scopeNote mesh__D011245
% 208.27/208.44       Pregnane derivatives containing two double bonds anywhere within the ring structures.%A%    
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011245 2005
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011245 1994
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011245 1999
% 208.27/208.44  |- mesh__recordOriginator mesh__D011245 NLM
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011245 2002
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011245 2006
% 208.27/208.44  |- skos__historyNote mesh__D011245 Pregnanes %28%1966-1972%29%
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011245 1995
% 208.27/208.44  |- mesh__dateEstablished mesh__D011245 1973-01-01
% 208.27/208.44  |- mesh__publicMeSHNote mesh__D011245 73   
% 208.27/208.44  |- mesh__dateCreated mesh__D011245 1999-01-01
% 208.27/208.44  |- mesh__dateRevised mesh__D011245 1993-06-03
% 208.27/208.44  |- skos__historyNote mesh__D005208 Necrosis %28%1966-1980%29%
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D005208 2005
% 208.27/208.44  |- skos__historyNote mesh__D005208 Eosinophils %28%1966-1980%29%
% 208.27/208.44  |- mesh__dateCreated mesh__D005208 1980-04-09
% 208.27/208.44  |- skos__historyNote mesh__D005208 Fascia %28%1966-1980%29%
% 208.27/208.44  |- skos__historyNote mesh__D005208 Eosinophilia %28%1966-1980%29%
% 208.27/208.44  |- rdf__type mesh__D005208sskos__Concept
% 208.27/208.44  |- skos__prefLabel mesh__D005208 Fasciitis
% 208.27/208.44  |- mesh__recordOriginator mesh__D005208 RC
% 208.27/208.44  |- skos__historyNote mesh__D005208 Inflammation %28%1966-1980%29%
% 208.27/208.44  |- mesh__dateRevised mesh__D005208 2004-07-07
% 208.27/208.44  |- mesh__recordAuthorizer mesh__D005208 sjn
% 208.27/208.44  |- mesh__historyNote mesh__D005208 81   
% 208.27/208.44  |- skos__scopeNote mesh__D005208
% 208.27/208.44       Inflammation of the fascia. There are three major types: 1, Eosinophilic fasciitis, an inflammatory reaction with eosinophilia, producing hard thickened skin with an orange-peel configuration suggestive of scleroderma and considered by some a variant of scleroderma; 2, Necrotizing fasciitis %28%FASCIITIS, NECROTIZING%29%, a serious fulminating infection %28%usually by a beta hemolytic streptococcus%29% causing extensive necrosis of superficial fascia; 3, Nodular/Pseudosarcomatous /Proliferative fasciitis, characterized by a rapid growth of fibroblasts with mononuclear inflammatory cells and proliferating capillaries in soft tissue, often the forearm; it is not malignant but is sometimes mistaken for fibrosarcoma.%A%    
% 208.27/208.44  |- skos__hiddenLabel mesh__D005208 Fasciitides
% 208.27/208.44  |- skos__hiddenLabel mesh__D005208 Fascitides
% 208.27/208.44  |- skos__annotation mesh__D005208
% 208.27/208.44       see MeSH definition for major types; eosinophilic fasciitis: coord IM with EOSINOPHILIA %28%IM%29%; FASCIITIS, NECROTIZING is available%A%  
% 208.27/208.44  |- skos__broader mesh__D005208smesh__D009140
% 208.27/208.44  |- mesh__publicMeSHNote mesh__D005208 81   
% 208.27/208.44  |- mesh__dateEstablished mesh__D005208 1981-01-01
% 208.27/208.44  |- skos__altLabel mesh__D005208 Fascitis
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D005208 2006
% 208.27/208.44  |- mesh__recordMaintainer mesh__D005208 wdj
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015636 2000
% 208.27/208.44  |- skos__broader mesh__D015636smesh__D017616
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015636 1999
% 208.27/208.44  |- mesh__historyNote mesh__D015636 90   
% 208.27/208.44  |- skos__annotation mesh__D015636 used as a source of magnesium ions   
% 208.27/208.44  |- rdf__type mesh__D015636sskos__Concept
% 208.27/208.44  |- skos__historyNote mesh__D015636 Magnesium %28%1966-1989%29%
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015636 2001
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015636 2003
% 208.27/208.44  |- mesh__dateCreated mesh__D015636 1989-05-25
% 208.27/208.44  |- skos__broader mesh__D015636smesh__D002712
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015636 2002
% 208.27/208.44  |- mesh__publicMeSHNote mesh__D015636 90   
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015636 2004
% 208.27/208.44  |- mesh__recordMaintainer mesh__D015636 TPW
% 208.27/208.44  |- mesh__recordOriginator mesh__D015636 RLS
% 208.27/208.44  |- skos__prefLabel mesh__D015636 Magnesium Chloride
% 208.27/208.44  |- mesh__dateEstablished mesh__D015636 1990-01-01
% 208.27/208.44  |- skos__altLabel mesh__D015636 MgCl2
% 208.27/208.44  |- mesh__dateRevised mesh__D015636 1997-06-20
% 208.27/208.44  |- skos__scopeNote mesh__D015636
% 208.27/208.44       Magnesium chloride. An inorganic compound consisting of one magnesium and two chloride ions. The compound is used in medicine as a source of magnesium ions, which are essential for many cellular activities. It has also been used as a cathartic and in alloys.%A%    
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015636 2005
% 208.27/208.44  |- mesh__recordAuthorizer mesh__D015636 SJN
% 208.27/208.44  |- skos__hiddenLabel mesh__D015636 Chloride, Magnesium
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015636 1998
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015636 2006
% 208.27/208.44  |- mesh__dateCreated mesh__D048012 2004-07-07
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D048012 2006
% 208.27/208.44  |- mesh__dateRevised mesh__D048012 2005-06-30
% 208.27/208.44  |- skos__broader mesh__D048012smesh__D003013
% 208.27/208.44  |- mesh__historyNote mesh__D048012 2005   
% 208.27/208.44  |- rdf__type mesh__D048012sskos__Concept
% 208.27/208.44  |- mesh__recordOriginator mesh__D048012 ags
% 208.27/208.44  |- mesh__publicMeSHNote mesh__D048012 2005   
% 208.27/208.44  |- skos__scopeNote mesh__D048012
% 208.27/208.44       A species of gram-positive bacteria in the family Clostridiaceae. Its glutamate mutase is commonly used in research.%A%    
% 208.27/208.44  |- mesh__dateEstablished mesh__D048012 2005-01-01
% 208.27/208.44  |- mesh__recordMaintainer mesh__D048012 SYSTEM
% 208.27/208.44  |- skos__historyNote mesh__D048012 Clostridium %28%1965-2004%29%
% 208.27/208.44  |- skos__prefLabel mesh__D048012 Clostridium tetanomorphum
% 208.27/208.44  |- mesh__recordAuthorizer mesh__D048012 sjn
% 208.27/208.44  |- skos__broader mesh__D001554Q000031smesh__D001554
% 208.27/208.44  |- mesh__preferredCombination mesh__D001554Q000031smesh__D001555
% 208.27/208.44  |- rdf__type mesh__D001554Q000031smesh__CompoundConcept
% 208.27/208.44  |- mesh__recordAuthorizer mesh__D001616 ags
% 208.27/208.44  |- skos__annotation mesh__D001616
% 208.27/208.44       /defic: consider also LACTOSE INTOLERANCE and GANGLIOSIDOSIS GM1%A%  
% 208.27/208.44  |- mesh__dateCreated mesh__D001616 1977-04-15
% 208.27/208.44  |- mesh__dateEstablished mesh__D001616 1991-01-01
% 208.27/208.44  |- skos__altLabel mesh__D001616 Sunrise Brand of beta-Galactosidase
% 208.27/208.44  |- mesh__onlineNote mesh__D001616
% 208.27/208.44       use BETA-GALACTOSIDASE to search BETA-GALACTOSIDASES 1978-91%A%  
% 208.27/208.44  |- skos__hiddenLabel mesh__D001616 beta Galactosidase A3
% 208.27/208.44  |- skos__altLabel mesh__D001616 McNeil Brand of beta-Galactosidase
% 208.27/208.44  |- skos__hiddenLabel mesh__D001616 beta Galactosidases
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D001616 2006
% 208.27/208.44  |- rdf__type mesh__D001616sskos__Concept
% 208.27/208.44  |- skos__hiddenLabel mesh__D001616 Tanta Brand of beta Galactosidase
% 208.27/208.44  |- skos__historyNote mesh__D001616 Galactosidases %28%1966-1977%29%
% 208.27/208.44  |- mesh__dateRevised mesh__D001616 2005-07-14
% 208.27/208.44  |- skos__prefLabel mesh__D001616 beta-Galactosidase
% 208.27/208.44  |- skos__hiddenLabel mesh__D001616 beta Galactosidase
% 208.27/208.44  |- skos__altLabel mesh__D001616 Rivex Brand of beta-Galactosidase
% 208.27/208.44  |- skos__broader mesh__D001616smesh__D005696
% 208.27/208.44  |- mesh__historyNote mesh__D001616
% 208.27/208.44       92; was BETA-GALACTOSIDASES 1978-91 %28%see under GALACTOSIDASES 1978-90%29%%A%  
% 208.27/208.44  |- mesh__recordMaintainer mesh__D001616 ags
% 208.27/208.44  |- skos__hiddenLabel mesh__D001616 Protein, lac Z
% 208.27/208.44  |- skos__hiddenLabel mesh__D001616 Rivex Brand of beta Galactosidase
% 208.27/208.44  |- skos__hiddenLabel mesh__D001616 beta Galactosidase A2
% 208.27/208.44  |- mesh__recordOriginator mesh__D001616 RLS
% 208.27/208.44  |- skos__hiddenLabel mesh__D001616 beta Galactosidase A1
% 208.27/208.44  |- skos__hiddenLabel mesh__D001616 Thompson Brand of beta Galactosidase
% 208.27/208.44  |- skos__altLabel mesh__D001616 Thompson Brand of beta-Galactosidase
% 208.27/208.44  |- skos__altLabel mesh__D001616 lac Z Protein
% 208.27/208.44  |- skos__altLabel mesh__D001616 beta-D-Galactosidase
% 208.27/208.44  |- skos__related mesh__D001616smesh__D016537
% 208.27/208.44  |- skos__hiddenLabel mesh__D001616 beta D Galactosidase
% 208.27/208.44  |- skos__altLabel mesh__D001616 beta-Galactosidases
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D001616 2006A
% 208.27/208.44  |- mesh__publicMeSHNote mesh__D001616
% 208.27/208.44       92; was BETA-GALACTOSIDASES 1978-91 %28%see under GALACTOSIDASES 1978-90%29%%A%  
% 208.27/208.44  |- skos__scopeNote mesh__D001616
% 208.27/208.44       A group of enzymes that catalyzes the hydrolysis of terminal, non-reducing beta-D-galactose residues in beta-galactosides. Deficiency of beta-Galactosidase A1 may cause GANGLIOSIDOSIS GM1.%A%    
% 208.27/208.44  |- skos__hiddenLabel mesh__D001616 Sunrise Brand of beta Galactosidase
% 208.27/208.44  |- skos__altLabel mesh__D001616 Tanta Brand of beta-Galactosidase
% 208.27/208.44  |- skos__altLabel mesh__D001616 Lactases
% 208.27/208.44  |- mesh__dateRevised mesh__D006301 1999-11-03
% 208.27/208.44  |- mesh__recordMaintainer mesh__D006301 kle
% 208.27/208.44  |- mesh__recordAuthorizer mesh__D006301 sjn
% 208.27/208.44  |- mesh__dateEstablished mesh__D006301 1991-01-01
% 208.27/208.44  |- rdf__type mesh__D006301sskos__Concept
% 208.27/208.44  |- mesh__recordOriginator mesh__D006301 EC
% 208.27/208.44  |- skos__broader mesh__D006301smesh__D003695
% 208.27/208.44  |- skos__prefLabel mesh__D006301 Health Services Needs and Demand
% 208.27/208.44  |- skos__hiddenLabel mesh__D006301 Health Services Need
% 208.27/208.44  |- mesh__historyNote mesh__D006301
% 208.27/208.44       91%28%Aug 77%29%; was see under HEALTH SERVICES RESEARCH 1980-90; was see under HEALTH PLANNING 1979; was see under HEALTH AND WELFARE PLANNING 1977-78%A%  
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D006301 2005
% 208.27/208.44  |- skos__altLabel mesh__D006301 Needs and Demand, Health Services
% 208.27/208.44  |- mesh__publicMeSHNote mesh__D006301
% 208.27/208.44       91; was see under HEALTH SERVICES RESEARCH 1980-90; was see under HEALTH PLANNING 1979; was see under HEALTH AND WELFARE PLANNING Aug 1977-78%A%  
% 208.27/208.44  |- skos__scopeNote mesh__D006301
% 208.27/208.44       Health services required by a population or community as well as the health services that the population or community is able and willing to pay for.%A%    
% 208.27/208.44  |- skos__hiddenLabel mesh__D006301 Need, Health Services
% 208.27/208.44  |- mesh__dateCreated mesh__D006301 1977-05-12
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D006301 2000
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D006301 2003
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D006301 2006
% 208.27/208.44  |- skos__hiddenLabel mesh__D006301 Population, Target
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D006301 2001
% 208.27/208.44  |- skos__annotation mesh__D006301 specify geog; DF: HEALTH SERV NEEDS   
% 208.27/208.44  |- skos__hiddenLabel mesh__D006301 Target Populations
% 208.27/208.44  |- skos__hiddenLabel mesh__D006301 Needs, Health Services
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D006301 2004
% 208.27/208.44  |- skos__hiddenLabel mesh__D006301 Populations, Target
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D006301 2002
% 208.27/208.44  |- skos__broader mesh__D006301smesh__D006302
% 208.27/208.44  |- skos__broader mesh__D006321Q000736smesh__D006321
% 208.27/208.44  |- mesh__preferredCombination mesh__D006321Q000736smesh__D004452
% 208.27/208.44  |- rdf__type mesh__D006321Q000736smesh__CompoundConcept
% 208.27/208.44  |- skos__hiddenLabel mesh__D019229 Permanent Dentition
% 208.27/208.44  |- skos__altLabel mesh__D019229 Dentition, Adult
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D019229 2006
% 208.27/208.44  |- skos__altLabel mesh__D019229 Dentition, Secondary
% 208.27/208.44  |- mesh__dateRevised mesh__D019229 2003-07-09
% 208.27/208.44  |- skos__prefLabel mesh__D019229 Dentition, Permanent
% 208.27/208.44  |- mesh__dateCreated mesh__D019229 1996-06-10
% 208.27/208.44  |- skos__scopeNote mesh__D019229
% 208.27/208.44       The 32 teeth of adulthood that either replace or are added to the complement of deciduous teeth. %28%Boucher%27%s Clinical Dental Terminology, 4th ed%29%%A%    
% 208.27/208.44  |- skos__historyNote mesh__D019229 Dentition %28%1966-1996%29%
% 208.27/208.44  |- rdf__type mesh__D019229sskos__Concept
% 208.27/208.44  |- skos__hiddenLabel mesh__D019229 Adult Dentition
% 208.27/208.44  |- mesh__recordMaintainer mesh__D019229 lkt
% 208.27/208.44  |- mesh__recordOriginator mesh__D019229 JLS
% 208.27/208.44  |- mesh__historyNote mesh__D019229 97   
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D019229 2004
% 208.27/208.44  |- mesh__publicMeSHNote mesh__D019229 97   
% 208.27/208.44  |- skos__annotation mesh__D019229 see note at DENTITION; no qualif   
% 208.27/208.44  |- skos__hiddenLabel mesh__D019229 Secondary Dentition
% 208.27/208.44  |- mesh__dateEstablished mesh__D019229 1997-01-01
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D019229 2005
% 208.27/208.44  |- mesh__recordAuthorizer mesh__D019229 sjn
% 208.27/208.44  |- skos__broader mesh__D019229smesh__D003817
% 208.27/208.44  |- rdf__type mesh__D011246sskos__Concept
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011246 1997
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011246 2000
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011246 2003
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011246 1998
% 208.27/208.44  |- skos__scopeNote mesh__D011246
% 208.27/208.44       Doubly unsaturated pregnane derivatives substituted with three hydroxy groups anywhere within the ring structure or side chains.%A%    
% 208.27/208.44  |- mesh__recordMaintainer mesh__D011246 PLS
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011246 2001
% 208.27/208.44  |- mesh__dateEstablished mesh__D011246 1974-01-01
% 208.27/208.44  |- mesh__recordOriginator mesh__D011246 NLM
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011246 2004
% 208.27/208.44  |- skos__broader mesh__D011246smesh__D011245
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011246 1999
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011246 2002
% 208.27/208.44  |- skos__prefLabel mesh__D011246 Pregnadienetriols
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011246 2005
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011246 1994
% 208.27/208.44  |- mesh__dateCreated mesh__D011246 1999-01-01
% 208.27/208.44  |- mesh__publicMeSHNote mesh__D011246 74   
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011246 2006
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011246 1995
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D011246 1996
% 208.27/208.44  |- mesh__dateRevised mesh__D011246 1993-06-03
% 208.27/208.44  |- mesh__recordAuthorizer mesh__D011246 PLS
% 208.27/208.44  |- mesh__historyNote mesh__D011246 74   
% 208.27/208.44  |- skos__altLabel mesh__D011246 Trihydroxypregnadienes
% 208.27/208.44  |- mesh__recordAuthorizer mesh__D005209 sjn
% 208.27/208.44  |- skos__prefLabel mesh__D005209 Fasciola
% 208.27/208.44  |- rdf__type mesh__D005209sskos__Concept
% 208.27/208.44  |- skos__broader mesh__D005209smesh__D005212
% 208.27/208.44  |- mesh__dateRevised mesh__D005209 2003-07-09
% 208.27/208.44  |- mesh__dateCreated mesh__D005209 1999-01-01
% 208.27/208.44  |- mesh__recordMaintainer mesh__D005209 ags
% 208.27/208.44  |- skos__scopeNote mesh__D005209
% 208.27/208.44       A genus of trematode liver flukes of the family Fasciolidae. Two species of this genus are F. hepatica and F. gigantica. The parasites are found in the liver and gallbladder and associated ducts in mammals and occasionally man. F. gigantica occurs rarely in man.%A%    
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D005209 2005
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D005209 2004
% 208.27/208.44  |- skos__annotation mesh__D005209
% 208.27/208.44       infection = FASCIOLIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D005209 2006
% 208.27/208.44  |- mesh__recordOriginator mesh__D005209 NLM
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637 Blood-Pool Scintigraphy, Gated
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637 Blood-Pool Scintigraphies
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015637 2002
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637 Gated Blood-Pool Imagings
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637 Gated Radionuclide Angiographies
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015637 1999
% 208.27/208.44  |- skos__altLabel mesh__D015637 Blood-Pool Scintigraphy
% 208.27/208.44  |- mesh__dateEstablished mesh__D015637 1990-01-01
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637 Scintigraphy, Blood-Pool
% 208.27/208.44  |- skos__annotation mesh__D015637
% 208.27/208.44       a type of radionuclide ventriculography usually for the left heart: for the right heart VENTRICULOGRAPHY, FIRST-PASS is usually preferred; /drug eff /rad eff permitted; do not use /util except by MeSH definition%A%  
% 208.27/208.44  |- mesh__dateRevised mesh__D015637 1997-06-20
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637
% 208.27/208.44       Radionuclide Ventriculography, Equilibrium
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637 Gated Radionuclide Angiography
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015637 2001
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637 Radionuclide Angiographies, Gated
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015637 2006
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637 Gated Blood Pool Imaging
% 208.27/208.44  |- skos__altLabel mesh__D015637 Equilibrium Radionuclide Angiocardiography
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015637 1998
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637 Gated Radionuclide Ventriculography
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637 Angiographies, Equilibrium Radionuclide
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637
% 208.27/208.44       Ventriculographies, Equilibrium Radionuclide
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637 Scintigraphy, Gated Blood-Pool
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015637 2000
% 208.27/208.44  |- mesh__recordAuthorizer mesh__D015637 SJN
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637 Equilibrium Scintigraphy
% 208.27/208.44  |- skos__prefLabel mesh__D015637 Gated Blood-Pool Imaging
% 208.27/208.44  |- mesh__dateCreated mesh__D015637 1989-05-02
% 208.27/208.44  |- mesh__recordMaintainer mesh__D015637 PXP
% 208.27/208.44  |- rdf__type mesh__D015637sskos__Concept
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637
% 208.27/208.44       Angiocardiography, Equilibrium Radionuclide
% 208.27/208.44  |- mesh__activeMeSHYear mesh__D015637 2005
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637 Radionuclide Ventriculographies, Gated
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637 Angiographies, Gated Radionuclide
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637 Gated Blood Pool Scintigraphy
% 208.27/208.44  |- skos__altLabel mesh__D015637 Gated Equilibrium Blood-Pool Scintigraphy
% 208.27/208.44  |- skos__altLabel mesh__D015637 Gated Equilibrium Blood Pool Scintigraphy
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637 Gated Radionuclide Ventriculographies
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637
% 208.27/208.44       Angiocardiographies, Equilibrium Radionuclide
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637 Scintigraphies, Blood-Pool
% 208.27/208.44  |- mesh__recordOriginator mesh__D015637 AGS
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637
% 208.27/208.44       Radionuclide Ventriculographies, Equilibrium
% 208.27/208.44  |- skos__hiddenLabel mesh__D015637 Ventriculographies, Gated Radionuclide
% 208.27/208.45  |- mesh__publicMeSHNote mesh__D015637 90   
% 208.27/208.45  |- skos__altLabel mesh__D015637 Equilibrium Radionuclide Angiography
% 208.27/208.45  |- skos__hiddenLabel mesh__D015637 Imaging, Gated Blood-Pool
% 208.27/208.45  |- skos__hiddenLabel mesh__D015637
% 208.27/208.45       Radionuclide Angiocardiographies, Equilibrium
% 208.27/208.45  |- skos__hiddenLabel mesh__D015637 Gated Blood-Pool Scintigraphies
% 208.27/208.45  |- skos__hiddenLabel mesh__D015637 Blood-Pool Scintigraphies, Gated
% 208.27/208.45  |- skos__altLabel mesh__D015637 Radionuclide Ventriculography, Gated
% 208.27/208.45  |- skos__hiddenLabel mesh__D015637 Angiography, Equilibrium Radionuclide
% 208.27/208.45  |- skos__altLabel mesh__D015637 Ventriculography, Gated Radionuclide
% 208.27/208.45  |- skos__hiddenLabel mesh__D015637 Imagings, Gated Blood-Pool
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D015637 2004
% 208.27/208.45  |- mesh__historyNote mesh__D015637 90   
% 208.27/208.45  |- skos__hiddenLabel mesh__D015637 Scintigraphies, Gated Blood-Pool
% 208.27/208.45  |- skos__hiddenLabel mesh__D015637 Scintigraphies, Equilibrium
% 208.27/208.45  |- skos__altLabel mesh__D015637 Equilibrium Radionuclide Ventriculography
% 208.27/208.45  |- skos__altLabel mesh__D015637 Gated Blood-Pool Scintigraphy
% 208.27/208.45  |- skos__altLabel mesh__D015637 Scintigraphy, Equilibrium
% 208.27/208.45  |- skos__altLabel mesh__D015637 Radionuclide Angiography, Gated
% 208.27/208.45  |- skos__altLabel mesh__D015637 Ventriculography, Equilibrium Radionuclide
% 208.27/208.45  |- skos__hiddenLabel mesh__D015637 Equilibrium Scintigraphies
% 208.27/208.45  |- skos__hiddenLabel mesh__D015637 Radionuclide Angiography, Equilibrium
% 208.27/208.45  |- skos__scopeNote mesh__D015637
% 208.27/208.45       Radionuclide ventriculography where scintigraphic data is acquired during repeated cardiac cycles at specific times in the cycle, using an electrocardiographic synchronizer or gating device. Analysis of right ventricular function is difficult with this technique; that is best evaluated by first-pass ventriculography %28%VENTRICULOGRAPHY, FIRST-PASS%29%.%A%    
% 208.27/208.45  |- skos__hiddenLabel mesh__D015637 Blood-Pool Imaging, Gated
% 208.27/208.45  |- skos__hiddenLabel mesh__D015637 Radionuclide Angiographies, Equilibrium
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D015637 2003
% 208.27/208.45  |- skos__hiddenLabel mesh__D015637
% 208.27/208.45       Equilibrium Radionuclide Ventriculographies
% 208.27/208.45  |- skos__hiddenLabel mesh__D015637 Equilibrium Radionuclide Angiographies
% 208.27/208.45  |- skos__hiddenLabel mesh__D015637 Blood-Pool Imagings, Gated
% 208.27/208.45  |- skos__hiddenLabel mesh__D015637
% 208.27/208.45       Equilibrium Radionuclide Angiocardiographies
% 208.27/208.45  |- skos__broader mesh__D015637smesh__D015635
% 208.27/208.45  |- skos__altLabel mesh__D015637 Angiography, Gated Radionuclide
% 208.27/208.45  |- skos__hiddenLabel mesh__D015637
% 208.27/208.45       Radionuclide Angiocardiography, Equilibrium
% 208.27/208.45  |- skos__hiddenLabel mesh__D015637 Blood Pool Scintigraphy
% 208.27/208.45  |- skos__scopeNote mesh__D048013
% 208.27/208.45       A species of gram-positive, thermophilic, cellulolytic bacteria in the family Clostridaceae. It degrades and ferments CELLOBIOSE and CELLULOSE to ETHANOL in the CELLULOSOME.%A%    
% 208.27/208.45  |- mesh__recordAuthorizer mesh__D048013 sjn
% 208.27/208.45  |- skos__historyNote mesh__D048013 Clostridium %28%1968-2004%29%
% 208.27/208.45  |- rdf__type mesh__D048013sskos__Concept
% 208.27/208.45  |- mesh__publicMeSHNote mesh__D048013 2005   
% 208.27/208.45  |- mesh__dateRevised mesh__D048013 2005-06-30
% 208.27/208.45  |- skos__prefLabel mesh__D048013 Clostridium thermocellum
% 208.27/208.45  |- mesh__recordMaintainer mesh__D048013 SYSTEM
% 208.27/208.45  |- mesh__historyNote mesh__D048013 2005   
% 208.27/208.45  |- mesh__recordOriginator mesh__D048013 ags
% 208.27/208.45  |- mesh__dateEstablished mesh__D048013 2005-01-01
% 208.27/208.45  |- skos__broader mesh__D048013smesh__D003013
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D048013 2006
% 208.27/208.45  |- mesh__dateCreated mesh__D048013 2004-07-07
% 208.27/208.45  |- skos__altLabel mesh__D001617 Cellobiases
% 208.27/208.45  |- skos__altLabel mesh__D001617 Amygdalase
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D001617 2005
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D001617 2006
% 208.27/208.45  |- rdf__type mesh__D001617sskos__Concept
% 208.27/208.45  |- mesh__recordOriginator mesh__D001617 RLS
% 208.27/208.45  |- mesh__recordMaintainer mesh__D001617 jmp
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D001617 2004
% 208.27/208.45  |- skos__hiddenLabel mesh__D001617 beta-D-Glucosidase, Emulsion
% 208.27/208.45  |- skos__altLabel mesh__D001617 Cellobiase
% 208.27/208.45  |- skos__historyNote mesh__D001617 Glucosidases %28%1966-1977%29%
% 208.27/208.45  |- skos__altLabel mesh__D001617 Gentiobiase
% 208.27/208.45  |- mesh__dateEstablished mesh__D001617 1991-01-01
% 208.27/208.45  |- skos__hiddenLabel mesh__D001617 beta Glucosidase
% 208.27/208.45  |- mesh__dateRevised mesh__D001617 2003-07-09
% 208.27/208.45  |- mesh__recordAuthorizer mesh__D001617 sjn
% 208.27/208.45  |- mesh__dateCreated mesh__D001617 1977-04-15
% 208.27/208.45  |- skos__scopeNote mesh__D001617
% 208.27/208.45       An exocellulase with specificity for a variety of beta-D-glycoside substrates. It catalyzes the hydrolysis of terminal non-reducing residues in beta-D-glucosides with release of GLUCOSE.%A%    
% 208.27/208.45  |- mesh__publicMeSHNote mesh__D001617
% 208.27/208.45       92; was BETA-GLUCOSIDASES 1978-91 %28%see under GLUCOSIDASES 1978-90%29%%A%  
% 208.27/208.45  |- mesh__historyNote mesh__D001617
% 208.27/208.45       92; was BETA-GLUCOSIDASES 1978-91 %28%see under GLUCOSIDASES 1978-90%29%%A%  
% 208.27/208.45  |- skos__hiddenLabel mesh__D001617 Emulsion beta D Glucosidase
% 208.27/208.45  |- skos__prefLabel mesh__D001617 beta-Glucosidase
% 208.27/208.45  |- mesh__onlineNote mesh__D001617
% 208.27/208.45       use BETA-GLUCOSIDASE to search BETA-GLUCOSIDASES 1978-91   
% 208.27/208.45  |- skos__broader mesh__D001617smesh__D044602
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D006302 2002
% 208.27/208.45  |- skos__altLabel mesh__D006302 Health Care Research
% 208.27/208.45  |- skos__altLabel mesh__D006302 Medical Care Research
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D006302 2005
% 208.27/208.45  |- mesh__recordMaintainer mesh__D006302 jls
% 208.27/208.45  |- skos__hiddenLabel mesh__D006302 Health Services Evaluations
% 208.27/208.45  |- skos__prefLabel mesh__D006302 Health Services Research
% 208.27/208.45  |- skos__hiddenLabel mesh__D006302 Research, Healthcare
% 208.27/208.45  |- skos__hiddenLabel mesh__D006302 Research, Health Care
% 208.27/208.45  |- skos__altLabel mesh__D006302 Research, Health Services
% 208.27/208.45  |- skos__broader mesh__D006302smesh__D017530
% 208.27/208.45  |- mesh__recordAuthorizer mesh__D006302 sjn
% 208.27/208.45  |- skos__hiddenLabel mesh__D006302 Evaluations, Health Services
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D006302 2003
% 208.27/208.45  |- skos__broader mesh__D006302smesh__D006285
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D006302 2006
% 208.27/208.45  |- mesh__recordOriginator mesh__D006302 EC
% 208.27/208.45  |- skos__historyNote mesh__D006302 Research %28%1966-1979%29%
% 208.27/208.45  |- skos__historyNote mesh__D006302 Health Services %28%1974-1979%29%
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D006302 2004
% 208.27/208.45  |- mesh__publicMeSHNote mesh__D006302 80   
% 208.27/208.45  |- skos__hiddenLabel mesh__D006302 Research, Action
% 208.27/208.45  |- skos__annotation mesh__D006302 IM; DF: HEALTH SERV RESEARCH   
% 208.27/208.45  |- skos__altLabel mesh__D006302 Health Services Evaluation
% 208.27/208.45  |- mesh__historyNote mesh__D006302 80   
% 208.27/208.45  |- skos__altLabel mesh__D006302 Healthcare Research
% 208.27/208.45  |- mesh__dateEstablished mesh__D006302 1980-01-01
% 208.27/208.45  |- skos__hiddenLabel mesh__D006302 Evaluation, Health Services
% 208.27/208.45  |- mesh__dateCreated mesh__D006302 1979-06-01
% 208.27/208.45  |- skos__altLabel mesh__D006302 Research, Medical Care
% 208.27/208.45  |- rdf__type mesh__D006302sskos__Concept
% 208.27/208.45  |- skos__scopeNote mesh__D006302
% 208.27/208.45       The integration of epidemiologic, sociological, economic, and other analytic sciences in the study of health services. Health services research is usually concerned with relationships between need, demand, supply, use, and outcome of health services. The aim of the research is evaluation, particularly in terms of structure, process, output, and outcome. %28%From Last, Dictionary of Epidemiology, 2d ed%29%%A%    
% 208.27/208.45  |- mesh__dateRevised mesh__D006302 2001-07-25
% 208.27/208.45  |- skos__broader mesh__D006321Q000737smesh__D006321
% 208.27/208.45  |- mesh__preferredCombination mesh__D006321Q000737smesh__D009206Q000737
% 208.27/208.45  |- rdf__type mesh__D006321Q000737smesh__CompoundConcept
% 208.27/208.45  |- skos__altLabel mesh__D011247 Gestation
% 208.27/208.45  |- mesh__recordMaintainer mesh__D011247 ags
% 208.27/208.45  |- skos__related mesh__D011247smesh__D011295
% 208.27/208.45  |- mesh__historyNote mesh__D011247 1963   
% 208.27/208.45  |- skos__scopeNote mesh__D011247
% 208.27/208.45       The status during which female mammals carry their developing young %28%EMBRYOS or FETUSES%29% in utero before birth, beginning from FERTILIZATION to BIRTH.%A%    
% 208.27/208.45  |- mesh__publicMeSHNote mesh__D011247 1963   
% 208.27/208.45  |- skos__prefLabel mesh__D011247 Pregnancy
% 208.27/208.45  |- skos__hiddenLabel mesh__D011247 Pregnancies
% 208.27/208.45  |- mesh__dateCreated mesh__D011247 1999-01-01
% 208.27/208.45  |- mesh__dateRevised mesh__D011247 2005-07-22
% 208.27/208.45  |- skos__broader mesh__D011247smesh__D012098
% 208.27/208.45  |- mesh__recordOriginator mesh__D011247 NLM
% 208.27/208.45  |- skos__related mesh__D011247smesh__D008098
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D011247 2006
% 208.27/208.45  |- mesh__recordAuthorizer mesh__D011247 ags
% 208.27/208.45  |- skos__related mesh__D011247smesh__D033261
% 208.27/208.45  |- skos__annotation mesh__D011247
% 208.27/208.45       IM for articles on normal pregn, NIM as check tag; policy: Manual 18.4+, 28.16+; in children or adolescents, see note under PREGNANCY IN ADOLESCENCE; check tag FEMALE also; molar pregn = HYDATIDIFORM MOLE; surrogate pregnancy = SURROGATE MOTHERS; heterotopic pregnancy: see note under PREGNANCY, ECTOPIC; for %22%pregnancy%22% in non-placental organisms: use OVIPARITY; OVOVIVIPARITY; or VIVIPARITY, NON-MAMMALIAN; DF: PREGN%A%  
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D011247 2006A
% 208.27/208.45  |- skos__related mesh__D011247smesh__D011555
% 208.27/208.45  |- rdf__type mesh__D011247sskos__Concept
% 208.27/208.45  |- skos__related mesh__D011247smesh__D037841
% 208.27/208.45  |- skos__hiddenLabel mesh__D016730 Program Description
% 208.27/208.45  |- mesh__recordAuthorizer mesh__D016730 sjn
% 208.27/208.45  |- rdf__type mesh__D016730sskos__Concept
% 208.27/208.45  |- skos__hiddenLabel mesh__D016730 Field Reports
% 208.27/208.45  |- mesh__dateRevised mesh__D016730 2003-07-25
% 208.27/208.45  |- skos__scopeNote mesh__D016730
% 208.27/208.45       The process of formulating, improving, and expanding educational, managerial, or service-oriented work plans %28%excluding computer program development%29%.%A%    
% 208.27/208.45  |- skos__hiddenLabel mesh__D016730 Development, Program
% 208.27/208.45  |- skos__hiddenLabel mesh__D016730 Report, Progress
% 208.27/208.45  |- skos__hiddenLabel mesh__D016730 Description, Program
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D016730 2005
% 208.27/208.45  |- mesh__recordMaintainer mesh__D016730 sjn
% 208.27/208.45  |- mesh__publicMeSHNote mesh__D016730 92   
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D016730 2004
% 208.27/208.45  |- skos__hiddenLabel mesh__D016730 Progress Reports
% 208.27/208.45  |- skos__hiddenLabel mesh__D016730 Reports, Field
% 208.27/208.45  |- skos__hiddenLabel mesh__D016730 Report, Field
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D016730 2006
% 208.27/208.45  |- skos__annotation mesh__D016730
% 208.27/208.45       coord IM with specific subject %28%IM%29%; not for computer programs%A%  
% 208.27/208.45  |- skos__hiddenLabel mesh__D016730 Reports, Progress
% 208.27/208.45  |- mesh__recordOriginator mesh__D016730 MXR
% 208.27/208.45  |- skos__broader mesh__D016730smesh__D009934
% 208.27/208.45  |- mesh__dateCreated mesh__D016730 1991-04-29
% 208.27/208.45  |- mesh__dateEstablished mesh__D016730 1992-01-01
% 208.27/208.45  |- skos__prefLabel mesh__D016730 Program Development
% 208.27/208.45  |- skos__hiddenLabel mesh__D016730 Descriptions, Program
% 208.27/208.45  |- mesh__historyNote mesh__D016730 92   
% 208.27/208.45  |- mesh__dateCreated mesh__D030401 2001-07-25
% 208.27/208.45  |- skos__hiddenLabel mesh__D030401 Cytochrome Oxidase Deficiencies
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D030401 2006
% 208.27/208.45  |- skos__hiddenLabel mesh__D030401 Oxidase Deficiency, Cytochrome
% 208.27/208.45  |- mesh__dateEstablished mesh__D030401 2002-01-01
% 208.27/208.45  |- skos__hiddenLabel mesh__D030401 Cytochrome c Oxidase Deficiency
% 208.27/208.45  |- mesh__recordOriginator mesh__D030401 nns
% 208.27/208.45  |- mesh__publicMeSHNote mesh__D030401 2002   
% 208.27/208.45  |- skos__hiddenLabel mesh__D030401 Deficiency, Cytochrome c Oxidase
% 208.27/208.45  |- skos__hiddenLabel mesh__D030401 Cytochrome-c Oxidase Deficiencies
% 208.27/208.45  |- skos__hiddenLabel mesh__D030401 Deficiencies, Cytochrome-c Oxidase
% 208.27/208.45  |- mesh__dateRevised mesh__D030401 2003-07-25
% 208.27/208.45  |- rdf__type mesh__D030401sskos__Concept
% 208.27/208.45  |- skos__scopeNote mesh__D030401
% 208.27/208.45       A disease that results from a congenital defect in ELECTRON TRANSPORT COMPLEX IV. Defects in ELECTRON TRANSPORT COMPLEX IV can be caused by mutations in the SURF1, SCO2, COX10, or SCO1 genes. ELECTRON TRANSPORT COMPLEX IV deficiency caused by mutation in SURF1 manifests itself as LEIGH DISEASE; that caused by mutation in SCO2 as fatal infantile cardioencephalomyopathy; that caused by mutation in COX10 as tubulopathy and leukodystrophy; and that caused by mutation in SCO1 as early-onset hepatic failure and neurologic disorder. %28%from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim, MIM%23%220110, May 17, 2001%29%%A%    
% 208.27/208.45  |- skos__historyNote mesh__D030401 Leigh Disease %28%1997-2001%29%
% 208.27/208.45  |- mesh__recordMaintainer mesh__D030401 sjn
% 208.27/208.45  |- skos__hiddenLabel mesh__D030401 Deficiency, Cytochrome Oxidase
% 208.27/208.45  |- mesh__recordAuthorizer mesh__D030401 sjn
% 208.27/208.45  |- skos__historyNote mesh__D030401
% 208.27/208.45       Cytochrome-c Oxidase/deficiency %28%1976-2001%29%
% 208.27/208.45  |- skos__broader mesh__D030401smesh__D008661
% 208.27/208.45  |- skos__altLabel mesh__D030401 Deficiency, Cytochrome-c Oxidase
% 208.27/208.45  |- skos__hiddenLabel mesh__D030401 Deficiencies, Cytochrome Oxidase
% 208.27/208.45  |- skos__related mesh__D030401smesh__D003576
% 208.27/208.45  |- skos__hiddenLabel mesh__D030401 Oxidase Deficiencies, Cytochrome-c
% 208.27/208.45  |- skos__altLabel mesh__D030401 Cytochrome Oxidase Deficiency
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D030401 2004
% 208.27/208.45  |- skos__hiddenLabel mesh__D030401 Oxidase Deficiencies, Cytochrome
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D030401 2005
% 208.27/208.45  |- skos__broader mesh__D030401smesh__D028361
% 208.27/208.45  |- skos__hiddenLabel mesh__D030401 Oxidase Deficiency, Cytochrome-c
% 208.27/208.45  |- skos__prefLabel mesh__D030401 Cytochrome-c Oxidase Deficiency
% 208.27/208.45  |- mesh__historyNote mesh__D030401 2002   
% 208.27/208.45  |- skos__historyNote mesh__D002710 Chlorobenzenes %28%1974%29%
% 208.27/208.45  |- mesh__dateCreated mesh__D002710 1974-11-11
% 208.27/208.45  |- skos__hiddenLabel mesh__D002710 MK412A
% 208.27/208.45  |- skos__hiddenLabel mesh__D002710 Acetate, Chlorhexidine
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D002710 2003
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D002710 2002
% 208.27/208.45  |- mesh__historyNote mesh__D002710
% 208.27/208.45       80%28%75%29%; was see under BIGUANIDES 1975-79   
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D002710 2004
% 208.27/208.45  |- mesh__publicMeSHNote mesh__D002710
% 208.27/208.45       80; was see under BIGUANIDES 1975-79   
% 208.27/208.45  |- skos__hiddenLabel mesh__D002710 MK 412A
% 208.27/208.45  |- rdf__type mesh__D002710sskos__Concept
% 208.27/208.45  |- skos__hiddenLabel mesh__D002710 Hydrochloride, Chlorhexidine
% 208.27/208.45  |- mesh__dateRevised mesh__D002710 2001-07-25
% 208.27/208.45  |- skos__scopeNote mesh__D002710
% 208.27/208.45       A disinfectant and topical anti-infective agent used also as mouthwash to prevent oral plaque.%A%    
% 208.27/208.45  |- skos__prefLabel mesh__D002710 Chlorhexidine
% 208.27/208.45  |- mesh__dateEstablished mesh__D002710 1980-01-01
% 208.27/208.45  |- skos__hiddenLabel mesh__D002710 A, Sebidin
% 208.27/208.45  |- skos__historyNote mesh__D002710 Biguanides %28%1968-1974%29%
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D002710 2005
% 208.27/208.45  |- mesh__recordOriginator mesh__D002710 NLM
% 208.27/208.45  |- mesh__recordMaintainer mesh__D002710 ssb
% 208.27/208.45  |- mesh__recordAuthorizer mesh__D002710 sjn
% 208.27/208.45  |- skos__broader mesh__D002710smesh__D001645
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D002710 2006
% 208.27/208.45  |- mesh__recordMaintainer mesh__D015638 ssb
% 208.27/208.45  |- mesh__publicMeSHNote mesh__D015638 90   
% 208.27/208.45  |- skos__broader mesh__D015638smesh__D003572
% 208.27/208.45  |- mesh__dateEstablished mesh__D015638 1990-01-01
% 208.27/208.45  |- skos__scopeNote mesh__D015638
% 208.27/208.45       A fungal metabolite that blocks cytoplasmic cleavage by blocking formation of contractile microfilament structures resulting in multinucleated cell formation, reversible inhibition of cell movement, and the induction of cellular extrusion. Additional reported effects include the inhibition of actin polymerization, DNA synthesis, sperm motility, glucose transport, thyroid secretion, and growth hormone release.%A%    
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D015638 2006
% 208.27/208.45  |- mesh__recordAuthorizer mesh__D015638 sjn
% 208.27/208.45  |- mesh__historyNote mesh__D015638 90   
% 208.27/208.45  |- skos__prefLabel mesh__D015638 Cytochalasin D
% 208.27/208.45  |- rdf__type mesh__D015638sskos__Concept
% 208.27/208.45  |- mesh__dateRevised mesh__D015638 2005-06-30
% 208.27/208.45  |- skos__historyNote mesh__D015638 Cytochalasins %28%1973-1989%29%
% 208.27/208.45  |- mesh__dateCreated mesh__D015638 1989-05-15
% 208.27/208.45  |- mesh__recordOriginator mesh__D015638 RLS
% 208.27/208.45  |- mesh__recordOriginator mesh__D048014 ags
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D048014 2006
% 208.27/208.45  |- skos__broader mesh__D048014smesh__D003013
% 208.27/208.45  |- mesh__dateEstablished mesh__D048014 2005-01-01
% 208.27/208.45  |- rdf__type mesh__D048014sskos__Concept
% 208.27/208.45  |- skos__historyNote mesh__D048014 Clostridium %28%1969-2004%29%
% 208.27/208.45  |- mesh__recordAuthorizer mesh__D048014 sjn
% 208.27/208.45  |- mesh__publicMeSHNote mesh__D048014 2005   
% 208.27/208.45  |- mesh__historyNote mesh__D048014 2005   
% 208.27/208.45  |- mesh__dateCreated mesh__D048014 2004-07-07
% 208.27/208.45  |- mesh__recordMaintainer mesh__D048014 SYSTEM
% 208.27/208.45  |- skos__prefLabel mesh__D048014 Clostridium tyrobutyricum
% 208.27/208.45  |- skos__scopeNote mesh__D048014
% 208.27/208.45       A species of gram-positive bacteria in the family Clostridiaceae responsible for spoilage of some CHEESE via FERMENTATION of BUTYRIC ACID.%A%    
% 208.27/208.45  |- mesh__dateRevised mesh__D048014 2005-06-30
% 208.27/208.45  |- skos__hiddenLabel mesh__D001618 beta Lactamase
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D001618 2006
% 208.27/208.45  |- mesh__recordMaintainer mesh__D001618 ssb
% 208.27/208.45  |- rdf__type mesh__D001618sskos__Concept
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D001618 2004
% 208.27/208.45  |- mesh__dateRevised mesh__D001618 2003-07-09
% 208.27/208.45  |- mesh__recordOriginator mesh__D001618 RLS
% 208.27/208.45  |- skos__altLabel mesh__D001618 beta-Lactamase
% 208.27/208.45  |- skos__broader mesh__D001618smesh__D000581
% 208.27/208.45  |- mesh__dateEstablished mesh__D001618 1979-01-01
% 208.27/208.45  |- skos__scopeNote mesh__D001618
% 208.27/208.45       Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. EC 3.5.2.6.%A%    
% 208.27/208.45  |- skos__historyNote mesh__D001618 Amidohydrolases %28%1966-1978%29%
% 208.27/208.45  |- skos__historyNote mesh__D001618 Cephalosporinase %28%1975-1978%29%
% 208.27/208.45  |- skos__historyNote mesh__D001618 Penicillinase %28%1966-1978%29%
% 208.27/208.45  |- mesh__historyNote mesh__D001618 79   
% 208.27/208.45  |- skos__prefLabel mesh__D001618 beta-Lactamases
% 208.27/208.45  |- skos__hiddenLabel mesh__D001618 beta Lactamases
% 208.27/208.45  |- mesh__publicMeSHNote mesh__D001618 79   
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D001618 2005
% 208.27/208.45  |- mesh__recordAuthorizer mesh__D001618 sjn
% 208.27/208.45  |- mesh__dateCreated mesh__D001618 1978-05-16
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D012340 2000
% 208.27/208.45  |- mesh__dateEstablished mesh__D012340 1991-01-01
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D012340 1999
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D012340 2003
% 208.27/208.45  |- mesh__recordMaintainer mesh__D012340 KEV
% 208.27/208.45  |- skos__hiddenLabel mesh__D012340 Ribosomal RNA, 5.8S
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D012340 1998
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D012340 2006
% 208.27/208.45  |- skos__historyNote mesh__D012340 RNA %28%1966-1970%29%
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D012340 2002
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D012340 2005
% 208.27/208.45  |- mesh__dateRevised mesh__D012340 1995-05-22
% 208.27/208.45  |- skos__altLabel mesh__D012340 5.8S Ribosomal RNA
% 208.27/208.45  |- mesh__recordAuthorizer mesh__D012340 PLS
% 208.27/208.45  |- rdf__type mesh__D012340sskos__Concept
% 208.27/208.45  |- mesh__publicMeSHNote mesh__D012340
% 208.27/208.45       91; was see under RNA, RIBOSOMAL 1988-90   
% 208.27/208.45  |- mesh__recordOriginator mesh__D012340 RLS
% 208.27/208.45  |- skos__scopeNote mesh__D012340
% 208.27/208.45       Constituent of the 60S subunit of eukaryotic ribosomes. 5.8S rRNA is involved in the initiation of polypeptide synthesis in eukaryotes.%A%    
% 208.27/208.45  |- skos__hiddenLabel mesh__D012340 RNA, 5.8S Ribosomal
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D012340 1997
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D012340 2001
% 208.27/208.45  |- skos__annotation mesh__D012340
% 208.27/208.45       IM; /drug eff /ultrastruct permitted; DF: 58S RRNA   
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D012340 2004
% 208.27/208.45  |- mesh__historyNote mesh__D012340
% 208.27/208.45       91%28%88%29%; was see under RNA, RIBOSOMAL 1988-90   
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D012340 1996
% 208.27/208.45  |- mesh__dateCreated mesh__D012340 1987-05-07
% 208.27/208.45  |- skos__prefLabel mesh__D012340 RNA, Ribosomal, 5.8S
% 208.27/208.45  |- skos__broader mesh__D012340smesh__D012335
% 208.27/208.45  |- skos__historyNote mesh__D012340 RNA, Ribosomal %28%1971-1987%29%
% 208.27/208.45  |- skos__hiddenLabel mesh__D006303 Service, Health Indigenous
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D006303 2000
% 208.27/208.45  |- skos__hiddenLabel mesh__D006303 Services, Health Indigenous
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D006303 2004
% 208.27/208.45  |- mesh__dateEstablished mesh__D006303 1981-01-01
% 208.27/208.45  |- skos__hiddenLabel mesh__D006303 Health Indigenous Services
% 208.27/208.45  |- skos__scopeNote mesh__D006303
% 208.27/208.45       Health care provided to specific cultural or tribal peoples which incorporates local customs, beliefs, and taboos.%A%    
% 208.27/208.45  |- skos__prefLabel mesh__D006303 Health Services, Indigenous
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D006303 2001
% 208.27/208.45  |- mesh__publicMeSHNote mesh__D006303
% 208.27/208.45       81; was see under HEALTH SERVICES 1977-80   
% 208.27/208.45  |- mesh__historyNote mesh__D006303
% 208.27/208.45       81%28%Aug 77%29%; was see under HEALTH SERVICES Aug 1977-80   
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D006303 2002
% 208.27/208.45  |- skos__annotation mesh__D006303
% 208.27/208.45       %22%health care provided to specific cultural or tribal peoples which incorporates local customs, beliefs %26% taboos%22%; specify ethnic group %28%IM%29% + geog; DF: HEALTH SERV INDIGENOUS%A%  
% 208.27/208.45  |- mesh__dateRevised mesh__D006303 1999-11-03
% 208.27/208.45  |- skos__hiddenLabel mesh__D006303 Indigenous Health Service
% 208.27/208.45  |- skos__hiddenLabel mesh__D006303 Service, Indigenous Health
% 208.27/208.45  |- rdf__type mesh__D006303sskos__Concept
% 208.27/208.45  |- mesh__recordOriginator mesh__D006303 EC
% 208.27/208.45  |- mesh__recordAuthorizer mesh__D006303 sjn
% 208.27/208.45  |- mesh__recordMaintainer mesh__D006303 kle
% 208.27/208.45  |- skos__broader mesh__D006303smesh__D006296
% 208.27/208.45  |- skos__altLabel mesh__D006303 Services, Indigenous Health
% 208.27/208.45  |- skos__altLabel mesh__D006303 Indigenous Services, Health
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D006303 2005
% 208.27/208.45  |- skos__hiddenLabel mesh__D006303 Health Service, Indigenous
% 208.27/208.45  |- mesh__dateCreated mesh__D006303 1977-05-12
% 208.27/208.45  |- skos__hiddenLabel mesh__D006303 Indigenous Service, Health
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D006303 2006
% 208.27/208.45  |- skos__altLabel mesh__D006303 Indigenous Health Services
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D006303 2003
% 208.27/208.45  |- skos__hiddenLabel mesh__D006303 Health Indigenous Service
% 208.27/208.45  |- skos__prefLabel mesh__D044422 Receptors, Serotonin, 5-HT4
% 208.27/208.45  |- skos__hiddenLabel mesh__D044422 5 HT4 Receptor
% 208.27/208.45  |- skos__hiddenLabel mesh__D044422 Receptor, 5-HT4L
% 208.27/208.45  |- skos__hiddenLabel mesh__D044422 5 HT4L Receptor
% 208.27/208.45  |- skos__altLabel mesh__D044422 Serotonin 4 Receptors
% 208.27/208.45  |- skos__hiddenLabel mesh__D044422 5 HT4S Receptor
% 208.27/208.45  |- mesh__recordAuthorizer mesh__D044422 sjn
% 208.27/208.45  |- skos__hiddenLabel mesh__D044422 5 Hydroxytryptamine 4 Receptor
% 208.27/208.45  |- mesh__recordOriginator mesh__D044422 jmp
% 208.27/208.45  |- mesh__dateCreated mesh__D044422 2003-07-09
% 208.27/208.45  |- mesh__dateRevised mesh__D044422 2005-06-30
% 208.27/208.45  |- skos__altLabel mesh__D044422 Receptor, Serotonin 4
% 208.27/208.45  |- skos__broader mesh__D044422smesh__D011985
% 208.27/208.45  |- skos__historyNote mesh__D044422 Receptors, Serotonin %28%1995-2003%29%
% 208.27/208.45  |- mesh__recordMaintainer mesh__D044422 jmp
% 208.27/208.45  |- skos__altLabel mesh__D044422 Serotonin 4 Receptor
% 208.27/208.45  |- skos__altLabel mesh__D044422 5-HT4 Receptor
% 208.27/208.45  |- mesh__historyNote mesh__D044422
% 208.27/208.45       2004; use RECEPTORS, SEROTININ, 5HT4 %28%NM%29% 1995-2003   
% 208.27/208.45  |- skos__hiddenLabel mesh__D044422 Receptor, 5-HT4S
% 208.27/208.45  |- mesh__dateEstablished mesh__D044422 2004-01-01
% 208.27/208.45  |- skos__hiddenLabel mesh__D044422 Receptor, 5-HT4
% 208.27/208.45  |- rdf__type mesh__D044422sskos__Concept
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D044422 2006
% 208.27/208.45  |- skos__hiddenLabel mesh__D044422 Receptor, 5-Hydroxytryptamine-4
% 208.27/208.45  |- skos__hiddenLabel mesh__D044422 Receptors, Serotonin 4
% 208.27/208.45  |- skos__altLabel mesh__D044422 5-HT4L Receptor
% 208.27/208.45  |- skos__altLabel mesh__D044422 5-Hydroxytryptamine-4 Receptor
% 208.27/208.45  |- skos__scopeNote mesh__D044422
% 208.27/208.45       A subtype of G-protein-coupled SEROTONIN receptors that preferentially couple to GS STIMULATORY G-PROTEINS resulting in increased intracellular CYCLIC AMP. Several isoforms of the receptor exist due to ALTERNATIVE SPLICING of its mRNA.%A%    
% 208.27/208.45  |- mesh__publicMeSHNote mesh__D044422
% 208.27/208.45       2004; SEROTONIN 4 RECEPTOR %28%now RECEPTORS, SEROTININ, 5HT4%29% was indexed under RECEPTORS, SEROTONIN 1995-2003%A%  
% 208.27/208.45  |- skos__altLabel mesh__D044422 5-HT4S Receptor
% 208.27/208.45  |- rdf__type mesh__D011248sskos__Concept
% 208.27/208.45  |- skos__annotation mesh__D011248
% 208.27/208.45       coord IM with dis %28%IM%29%; /surg: consider also OBSTETRIC SURGICAL PROCEDURES; do not use for heterotopic pregn: see note at PREGNANCY, ECTOPIC; check tags FEMALE %26% PREGNANCY; Manual 18.4.7; DF: PREGN COMPL%A%  
% 208.27/208.45  |- mesh__recordAuthorizer mesh__D011248 sjn
% 208.27/208.45  |- skos__scopeNote mesh__D011248
% 208.27/208.45       Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases.%A%    
% 208.27/208.45  |- mesh__dateCreated mesh__D011248 1999-01-01
% 208.27/208.45  |- skos__prefLabel mesh__D011248 Pregnancy Complications
% 208.27/208.45  |- mesh__dateRevised mesh__D011248 2005-06-30
% 208.27/208.45  |- skos__altLabel mesh__D011248 Complications, Pregnancy
% 208.27/208.45  |- mesh__recordMaintainer mesh__D011248 lkt
% 208.27/208.45  |- skos__related mesh__D011248smesh__D011273
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D011248 2006
% 208.27/208.45  |- skos__hiddenLabel mesh__D011248 Pregnancy Complication
% 208.27/208.45  |- skos__broader mesh__D011248smesh__D005261
% 208.27/208.45  |- mesh__recordOriginator mesh__D011248 NLM
% 208.27/208.45  |- skos__hiddenLabel mesh__D011248 Complication, Pregnancy
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D016731 2005
% 208.27/208.45  |- skos__scopeNote mesh__D016731
% 208.27/208.45       Contagious infection with human B19 Parvovirus most commonly seen in school age children and characterized by fever, headache, and rashes of the face, trunk, and extremities. It is often confused with rubella.%A%    
% 208.27/208.45  |- mesh__recordAuthorizer mesh__D016731 sjn
% 208.27/208.45  |- skos__historyNote mesh__D016731
% 208.27/208.45       Skin Diseases, Infectious %28%1972-1991%29%
% 208.27/208.45  |- mesh__activeMeSHYear mesh__D016731 2006
% 208.27/208.45  |- skos__historyNote mesh__D016731 Virus Diseases %28%1966-1982%29%
% 208.27/208.45  |- skos__historyNote mesh__D016731 Parvovirus Infections %28%1986-1991%29%
% 208.27/208.45  |- mesh__recordOriginator mesh__D016731 AGS
% 208.27/208.45  |- skos__prefLabel mesh__D016731 Erythema Infectiosum
% 208.27/208.45  |- mesh__publicMeSHNote mesh__D016731 92   
% 208.27/208.45  |- mesh__recordMaintainer mesh__D016731 sjn
% 208.27/208.45  |- mesh__dateCreated mesh__D016731 1991-04-29
% 208.27/208.45  |- mesh__dateRevised mesh__D016731 2004-07-13
% 208.27/208.45  |- mesh__historyNote mesh__D016731 92   
% 208.27/208.45  |- skos__annotation mesh__D016731
% 208.27/208.45       caused by Parvovirus B19 but do not index under PARVOVIRUS B19, HUMAN unless particularly discussed%A%  
% 208.27/208.45  |- skos__broader mesh__D016731smesh__D004890
% 208.27/208.45  |- skos__broader mesh__D016731smesh__D017193
% 208.27/208.45  |- rdf__type mesh__D016731sskos__Concept
% 208.27/208.45  |- skos__broader mesh__D016731smesh__D010322
% 208.27/208.45  |- skos__altLabel mesh__D016731 Fifth Disease
% 208.27/208.45  |- mesh__dateEstablished mesh__D016731 1992-01-01
% 208.27/208.45  |- mesh__recordMaintainer mesh__D002711 ssb
% 208.27/208.45  |- mesh__dateEstablished mesh__D002711 1991-01-01
% 208.27/208.45  |- skos__broader mesh__D002711smesh__D010544
% 208.27/208.46  |- mesh__dateRevised mesh__D002711 2003-07-09
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D002711 2004
% 208.27/208.46  |- mesh__recordAuthorizer mesh__D002711 sjn
% 208.27/208.46  |- rdf__type mesh__D002711sskos__Concept
% 208.27/208.46  |- skos__prefLabel mesh__D002711 Chloride Peroxidase
% 208.27/208.46  |- mesh__recordOriginator mesh__D002711 RLS
% 208.27/208.46  |- mesh__dateCreated mesh__D002711 1975-07-23
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D002711 2005
% 208.27/208.46  |- skos__altLabel mesh__D002711 Chloroperoxidase
% 208.27/208.46  |- skos__historyNote mesh__D002711 Chlorine %28%1973-1975%29%
% 208.27/208.46  |- mesh__publicMeSHNote mesh__D002711
% 208.27/208.46       91; was see under PEROXIDASES 1976-90   
% 208.27/208.46  |- skos__hiddenLabel mesh__D002711 Peroxidase, Chloride
% 208.27/208.46  |- skos__historyNote mesh__D002711 Peroxidases %28%1973-1975%29%
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D002711 2006
% 208.27/208.46  |- mesh__historyNote mesh__D002711
% 208.27/208.46       91%28%76%29%; was see under PEROXIDASES 1976-90   
% 208.27/208.46  |- skos__scopeNote mesh__D002711
% 208.27/208.46       An enzyme that catalyzes the chlorination of a range of organic molecules, forming stable carbon-chloride bonds. EC 1.11.1.10.%A%    
% 208.27/208.46  |- skos__broader mesh__D026361smesh__D009603
% 208.27/208.46  |- skos__altLabel mesh__D026361 Nitrogen Species, Reactive
% 208.27/208.46  |- skos__broader mesh__D026361smesh__D017672
% 208.27/208.46  |- mesh__dateEstablished mesh__D026361 2002-01-01
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D026361 2002
% 208.27/208.46  |- mesh__recordMaintainer mesh__D026361 ags
% 208.27/208.46  |- skos__scopeNote mesh__D026361
% 208.27/208.46       Nitrogenous products of NITRIC OXIDE synthases, ranging from NITRIC OXIDE to NITRATES. These reactive nitrogen intermediates also include the inorganic PEROXYNITROUS ACID and the organic S-NITROSOTHIOLS.%A%    
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D026361 2006
% 208.27/208.46  |- mesh__recordOriginator mesh__D026361 lkt
% 208.27/208.46  |- skos__historyNote mesh__D026361 Nitrogen Oxides %28%1976-2001%29%
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D026361 2004
% 208.27/208.46  |- mesh__recordAuthorizer mesh__D026361 ags
% 208.27/208.46  |- mesh__publicMeSHNote mesh__D026361 2002   
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D026361 2005
% 208.27/208.46  |- mesh__dateRevised mesh__D026361 2005-07-21
% 208.27/208.46  |- skos__historyNote mesh__D026361 Nitroso Compounds %28%1992-2001%29%
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D026361 2003
% 208.27/208.46  |- rdf__type mesh__D026361sskos__Concept
% 208.27/208.46  |- skos__hiddenLabel mesh__D026361 Species, Reactive Nitrogen
% 208.27/208.46  |- mesh__dateCreated mesh__D026361 2001-07-25
% 208.27/208.46  |- skos__prefLabel mesh__D026361 Reactive Nitrogen Species
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D026361 2006A
% 208.27/208.46  |- mesh__historyNote mesh__D026361 2002   
% 208.27/208.46  |- mesh__publicMeSHNote mesh__D048015
% 208.27/208.46       2005; TNF RECEPTOR-ASSOCIATED FACTOR 5 was indexed under PROTEINS 1999-2004, under CARRIER PROTEINS 1996-1998%A%  
% 208.27/208.46  |- skos__historyNote mesh__D048015 Proteins %28%1999-2004%29%
% 208.27/208.46  |- rdf__type mesh__D048015sskos__Concept
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D048015 2005
% 208.27/208.46  |- mesh__dateRevised mesh__D048015 2005-07-12
% 208.27/208.46  |- mesh__dateCreated mesh__D048015 2004-07-07
% 208.27/208.46  |- skos__historyNote mesh__D048015 Carrier Proteins %28%1996-1998%29%
% 208.27/208.46  |- mesh__recordMaintainer mesh__D048015 ags
% 208.27/208.46  |- skos__altLabel mesh__D048015 TRAF5
% 208.27/208.46  |- mesh__dateEstablished mesh__D048015 2005-01-01
% 208.27/208.46  |- mesh__recordOriginator mesh__D048015 jmp
% 208.27/208.46  |- mesh__recordAuthorizer mesh__D048015 ags
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D048015 2006A
% 208.27/208.46  |- skos__prefLabel mesh__D048015 TNF Receptor-Associated Factor 5
% 208.27/208.46  |- mesh__historyNote mesh__D048015 2005%28%1996%29%   
% 208.27/208.46  |- skos__broader mesh__D048015smesh__D047988
% 208.27/208.46  |- skos__hiddenLabel mesh__D048015 TNF Receptor Associated Factor 5
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D048015 2006
% 208.27/208.46  |- skos__scopeNote mesh__D048015
% 208.27/208.46       A signal transducing tumor necrosis factor receptor associated factor that mediates signaling from CD27 ANTIGENS; CD40 ANTIGENS; and the lymphotoxin beta-specific receptor. It is involved in regulation of NF-KAPPA B signalling.%A%    
% 208.27/208.46  |- skos__altLabel mesh__D001619 Hex A
% 208.27/208.46  |- mesh__recordMaintainer mesh__D001619 ags
% 208.27/208.46  |- mesh__dateRevised mesh__D001619 2005-07-15
% 208.27/208.46  |- skos__related mesh__D001619smesh__D013661
% 208.27/208.46  |- skos__altLabel mesh__D001619 beta-N-Acetylhexosaminidase A
% 208.27/208.46  |- skos__hiddenLabel mesh__D001619 beta N Acetyl hexosaminidase
% 208.27/208.46  |- mesh__publicMeSHNote mesh__D001619 87   
% 208.27/208.46  |- skos__historyNote mesh__D001619 Glycoside Hydrolases %28%1966-1970%29%
% 208.27/208.46  |- mesh__historyNote mesh__D001619 87   
% 208.27/208.46  |- skos__hiddenLabel mesh__D001619 beta N Acetylhexosaminidase
% 208.27/208.46  |- skos__hiddenLabel mesh__D001619 beta Hexosaminidase
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D001619 2005
% 208.27/208.46  |- mesh__dateEstablished mesh__D001619 1987-01-01
% 208.27/208.46  |- skos__prefLabel mesh__D001619 beta-N-Acetylhexosaminidase
% 208.27/208.46  |- mesh__dateCreated mesh__D001619 1986-06-02
% 208.27/208.46  |- skos__hiddenLabel mesh__D001619 N Acetyl beta D hexosaminidase
% 208.27/208.46  |- skos__altLabel mesh__D001619 beta-N-Acetyl-hexosaminidase
% 208.27/208.46  |- skos__altLabel mesh__D001619 Hex B
% 208.27/208.46  |- skos__historyNote mesh__D001619 Hexosaminidases %28%1971-1986%29%
% 208.27/208.46  |- skos__hiddenLabel mesh__D001619 beta N Acetyl D hexosaminidase
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D001619 2006
% 208.27/208.46  |- skos__altLabel mesh__D001619 beta-N-Acetyl-D-hexosaminidase
% 208.27/208.46  |- mesh__recordOriginator mesh__D001619 RLS
% 208.27/208.46  |- skos__scopeNote mesh__D001619
% 208.27/208.46       An enzyme hydrolyzing terminal non-reducing N-acetyl-D-hexosamine residues in N-acetyl-beta-D-hexosaminides. It acts on GLUCOSIDES; GALACTOSIDES; and several OLIGOSACCHARIDES. Hexosaminidase A cleaves GM2, GA2, globosides, and hexosamine oligosaccharides. Hexosaminidase B cleaves all the above substrates except GM2. Deficiency of Hexosaminidase A causes TAY-SACHS DISEASE, while deficiency of both A and B isozymes causes SANDHOFF DISEASE. The enzyme has also been used as a tumor marker to distinguish between malignant and benign disease.%A%    
% 208.27/208.46  |- skos__broader mesh__D001619smesh__D006596
% 208.27/208.46  |- skos__altLabel mesh__D001619 beta-Hexosaminidase
% 208.27/208.46  |- skos__hiddenLabel mesh__D001619 beta N Acetylhexosaminidase A
% 208.27/208.46  |- skos__related mesh__D001619smesh__D012497
% 208.27/208.46  |- rdf__type mesh__D001619sskos__Concept
% 208.27/208.46  |- skos__altLabel mesh__D001619 N-Acetyl-beta-D-hexosaminidase
% 208.27/208.46  |- skos__annotation mesh__D001619
% 208.27/208.46       do not confuse with ACETYLGLUCOSAMINIDASE; /defic: consider also TAY SACHS DISEASE and SANDHOFF DISEASE; coord with ISOENZYMES if discussed%A%  
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D001619 2006A
% 208.27/208.46  |- mesh__recordAuthorizer mesh__D001619 ags
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D012341 1998
% 208.27/208.46  |- mesh__dateCreated mesh__D012341 1987-05-09
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D012341 2006
% 208.27/208.46  |- mesh__historyNote mesh__D012341
% 208.27/208.46       91%28%88%29%; was see under RNA, RIBOSOMAL 1988-90   
% 208.27/208.46  |- skos__historyNote mesh__D012341 RNA %28%1966-1970%29%
% 208.27/208.46  |- skos__altLabel mesh__D012341 5S Ribosomal RNA
% 208.27/208.46  |- skos__broader mesh__D012341smesh__D012335
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D012341 2005
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D012341 2000
% 208.27/208.46  |- rdf__type mesh__D012341sskos__Concept
% 208.27/208.46  |- mesh__publicMeSHNote mesh__D012341
% 208.27/208.46       91; was see under RNA, RIBOSOMAL 1988-90   
% 208.27/208.46  |- skos__prefLabel mesh__D012341 RNA, Ribosomal, 5S
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D012341 1997
% 208.27/208.46  |- skos__scopeNote mesh__D012341
% 208.27/208.46       Constituent of the 50S subunit of prokaryotic ribosomes containing about 120 nucleotides and 34 proteins. It is also a constituent of the 60S subunit of eukaryotic ribosomes. 5S rRNA is involved in initiation of polypeptide synthesis.%A%    
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D012341 2002
% 208.27/208.46  |- skos__hiddenLabel mesh__D012341 RNA, 5S Ribosomal
% 208.27/208.46  |- mesh__dateRevised mesh__D012341 1995-05-22
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D012341 1996
% 208.27/208.46  |- mesh__recordAuthorizer mesh__D012341 PLS
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D012341 2004
% 208.27/208.46  |- skos__hiddenLabel mesh__D012341 Ribosomal RNA, 5S
% 208.27/208.46  |- mesh__recordOriginator mesh__D012341 RLS
% 208.27/208.46  |- skos__historyNote mesh__D012341 RNA, Ribosomal %28%1971-1987%29%
% 208.27/208.46  |- mesh__dateEstablished mesh__D012341 1991-01-01
% 208.27/208.46  |- skos__annotation mesh__D012341
% 208.27/208.46       IM; /drug eff /ultrastruct permitted; DF: 5S RRNA   
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D012341 1999
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D012341 2003
% 208.27/208.46  |- mesh__recordMaintainer mesh__D012341 KEV
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D012341 2001
% 208.27/208.46  |- mesh__recordAuthorizer mesh__D006304 PLS
% 208.27/208.46  |- skos__historyNote mesh__D006304 Health Surveys %28%1966-1979%29%
% 208.27/208.46  |- skos__historyNote mesh__D006304
% 208.27/208.46       Health Status Indicators %28%1975-1979%29%
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D006304 1995
% 208.27/208.46  |- skos__prefLabel mesh__D006304 Health Status
% 208.27/208.46  |- skos__broader mesh__D006304smesh__D003710
% 208.27/208.46  |- mesh__historyNote mesh__D006304
% 208.27/208.46       90%28%80%29%; was see under HEALTH 1980-89   
% 208.27/208.46  |- mesh__dateEstablished mesh__D006304 1990-01-01
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D006304 2000
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D006304 1998
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D006304 1993
% 208.27/208.46  |- mesh__dateCreated mesh__D006304 1979-06-01
% 208.27/208.46  |- rdf__type mesh__D006304sskos__Concept
% 208.27/208.46  |- mesh__publicMeSHNote mesh__D006304 90; was see under HEALTH 1980-89   
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D006304 2001
% 208.27/208.46  |- mesh__dateRevised mesh__D006304 1992-05-20
% 208.27/208.46  |- skos__scopeNote mesh__D006304
% 208.27/208.46       The level of health of the individual, group, or population as subjectively assessed by the individual or by more objective measures.%A%    
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D006304 1999
% 208.27/208.46  |- skos__historyNote mesh__D006304 Health %28%1966-1979%29%
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D006304 1996
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D006304 2005
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D006304 2002
% 208.27/208.46  |- skos__hiddenLabel mesh__D006304 Health Level
% 208.27/208.46  |- skos__hiddenLabel mesh__D006304 Status, Health
% 208.27/208.46  |- skos__hiddenLabel mesh__D006304 Health Levels
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D006304 1997
% 208.27/208.46  |- skos__altLabel mesh__D006304 Level of Health
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D006304 2006
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D006304 2003
% 208.27/208.46  |- mesh__recordOriginator mesh__D006304 EC
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D006304 2004
% 208.27/208.46  |- skos__annotation mesh__D006304 no qualif   
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D006304 1994
% 208.27/208.46  |- mesh__recordMaintainer mesh__D006304 PLS
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D044423 2006
% 208.27/208.46  |- skos__scopeNote mesh__D044423
% 208.27/208.46       Large, robust forms of brown algae %28%PHAEOPHYCEAE%29% in the order Laminariales. They are a major component of the lower intertidal and sublittoral zones on rocky coasts in temperate and polar waters. Kelp, a kind of SEAWEED, usually refers to species in the genera LAMINARIA or MACROCYSTIS, but the term may also be used for species in FUCUS or Nereocystis.%A%    
% 208.27/208.46  |- skos__broader mesh__D044423smesh__D012624
% 208.27/208.46  |- skos__historyNote mesh__D044423 Algae %28%1965-2003%29%
% 208.27/208.46  |- mesh__publicMeSHNote mesh__D044423 2004; see SEAWEED 2000-2003   
% 208.27/208.46  |- skos__hiddenLabel mesh__D044423 Kelps
% 208.27/208.46  |- mesh__dateCreated mesh__D044423 2003-07-09
% 208.27/208.46  |- mesh__historyNote mesh__D044423 2004; use SEAWEED 2000-2003   
% 208.27/208.46  |- mesh__recordMaintainer mesh__D044423 SYSTEM
% 208.27/208.46  |- mesh__dateEstablished mesh__D044423 2004-01-01
% 208.27/208.46  |- skos__historyNote mesh__D044423 Seaweed %28%1971-2003%29%
% 208.27/208.46  |- mesh__recordOriginator mesh__D044423 ags
% 208.27/208.46  |- mesh__recordAuthorizer mesh__D044423 sjn
% 208.27/208.46  |- skos__broader mesh__D044423smesh__D000459
% 208.27/208.46  |- mesh__dateRevised mesh__D044423 2005-06-30
% 208.27/208.46  |- skos__prefLabel mesh__D044423 Kelp
% 208.27/208.46  |- skos__annotation mesh__D044423 coord with specific alga if pertinent   
% 208.27/208.46  |- rdf__type mesh__D044423sskos__Concept
% 208.27/208.46  |- mesh__publicMeSHNote mesh__D011249 64   
% 208.27/208.46  |- skos__annotation mesh__D011249
% 208.27/208.46       coordinate IM with specific cardiovascular disease %28%IM%29%; check the tags FEMALE %26% PREGNANCY; hemorrhage during pregnancy goes here, not PREGNANCY COMPLICATIONS, HEMATOLOGIC; Manual 18.4.7; DF: PREGN COMPL CARDIOVASC%A%  
% 208.27/208.46  |- mesh__recordOriginator mesh__D011249 NLM
% 208.27/208.46  |- mesh__dateCreated mesh__D011249 1999-01-01
% 208.27/208.46  |- skos__altLabel mesh__D011249 Cardiovascular Pregnancy Complications
% 208.27/208.46  |- skos__prefLabel mesh__D011249 Pregnancy Complications, Cardiovascular
% 208.27/208.46  |- skos__hiddenLabel mesh__D011249 Cardiovascular Pregnancy Complication
% 208.27/208.46  |- skos__hiddenLabel mesh__D011249 Pregnancy Complication, Cardiovascular
% 208.27/208.46  |- skos__scopeNote mesh__D011249
% 208.27/208.46       The co-occurrence of pregnancy and a cardiovascular disease. The disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS.%A%    
% 208.27/208.46  |- skos__hiddenLabel mesh__D011249 Complication, Cardiovascular Pregnancy
% 208.27/208.46  |- mesh__recordAuthorizer mesh__D011249 sjn
% 208.27/208.46  |- mesh__dateEstablished mesh__D011249 1964-01-01
% 208.27/208.46  |- skos__altLabel mesh__D011249 Complications, Cardiovascular Pregnancy
% 208.27/208.46  |- skos__altLabel mesh__D011249 Pregnancy, Cardiovascular Complications
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D011249 2006
% 208.27/208.46  |- skos__broader mesh__D011249smesh__D011248
% 208.27/208.46  |- mesh__dateRevised mesh__D011249 2005-06-30
% 208.27/208.46  |- mesh__historyNote mesh__D011249 64   
% 208.27/208.46  |- skos__hiddenLabel mesh__D011249
% 208.27/208.46       Pregnancies, Cardiovascular Complications
% 208.27/208.46  |- rdf__type mesh__D011249sskos__Concept
% 208.27/208.46  |- skos__broader mesh__D011249smesh__D002318
% 208.27/208.46  |- mesh__recordMaintainer mesh__D011249 lkt
% 208.27/208.46  |- skos__related mesh__D016732smesh__D016731
% 208.27/208.46  |- rdf__type mesh__D016732sskos__Concept
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D016732 2004
% 208.27/208.46  |- skos__scopeNote mesh__D016732
% 208.27/208.46       The type species of ERYTHROVIRUS and the etiological agent of ERYTHEMA INFECTIOSUM, a disease most commonly seen in school-age children.%A%    
% 208.27/208.46  |- mesh__recordOriginator mesh__D016732 AGS
% 208.27/208.46  |- mesh__recordMaintainer mesh__D016732 ags
% 208.27/208.46  |- skos__prefLabel mesh__D016732 Parvovirus B19, Human
% 208.27/208.46  |- skos__broader mesh__D016732smesh__D019218
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D016732 2003
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D016732 2006
% 208.27/208.46  |- mesh__dateRevised mesh__D016732 2001-07-25
% 208.27/208.46  |- mesh__recordAuthorizer mesh__D016732 sjn
% 208.27/208.46  |- skos__historyNote mesh__D016732 Parvoviridae %28%1981-1991%29%
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D016732 2002
% 208.27/208.46  |- skos__hiddenLabel mesh__D016732 B19 viruses
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D016732 2005
% 208.27/208.46  |- skos__altLabel mesh__D016732 Human Parvovirus B19
% 208.27/208.46  |- skos__annotation mesh__D016732
% 208.27/208.46       infection = probably ERYTHEMA INFECTIOSUM but if not so specified, coord IM with PARVOVIRIDAE INFECTIONS %28%IM%29%%A%  
% 208.27/208.46  |- mesh__publicMeSHNote mesh__D016732 92   
% 208.27/208.46  |- skos__altLabel mesh__D016732 B19 virus
% 208.27/208.46  |- mesh__dateCreated mesh__D016732 1991-04-29
% 208.27/208.46  |- mesh__dateEstablished mesh__D016732 1992-01-01
% 208.27/208.46  |- mesh__historyNote mesh__D016732 92   
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D002712 1994
% 208.27/208.46  |- skos__prefLabel mesh__D002712 Chlorides
% 208.27/208.46  |- mesh__dateCreated mesh__D002712 1999-01-01
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D002712 2005
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D002712 2000
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D002712 1998
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D002712 1995
% 208.27/208.46  |- mesh__recordMaintainer mesh__D002712 TPW
% 208.27/208.46  |- mesh__dateRevised mesh__D002712 1993-06-04
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D002712 2006
% 208.27/208.46  |- mesh__recordOriginator mesh__D002712 NLM
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D002712 2001
% 208.27/208.46  |- mesh__recordAuthorizer mesh__D002712 PLS
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D002712 1999
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D002712 2003
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D002712 1996
% 208.27/208.46  |- skos__broader mesh__D002712smesh__D006851
% 208.27/208.46  |- skos__scopeNote mesh__D002712
% 208.27/208.46       Inorganic compounds derived from hydrochloric acid that contain the Cl- ion.%A%    
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D002712 2004
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D002712 1997
% 208.27/208.46  |- rdf__type mesh__D002712sskos__Concept
% 208.27/208.46  |- skos__hiddenLabel mesh__D002712 Ion Level, Chloride
% 208.27/208.46  |- skos__annotation mesh__D002712
% 208.27/208.46       only for inorganic cpds or chloride ion; /physiol permitted%A%  
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D002712 2002
% 208.27/208.46  |- skos__hiddenLabel mesh__D002712 Level, Chloride Ion
% 208.27/208.46  |- skos__broader mesh__D002712smesh__D000838
% 208.27/208.46  |- mesh__dateCreated mesh__D026362 2001-07-25
% 208.27/208.46  |- skos__altLabel mesh__D026362 p67-SRF
% 208.27/208.46  |- mesh__recordMaintainer mesh__D026362 jmp
% 208.27/208.46  |- mesh__recordAuthorizer mesh__D026362 sjn
% 208.27/208.46  |- skos__hiddenLabel mesh__D026362 c fos Serum Response Factor
% 208.27/208.46  |- skos__historyNote mesh__D026362 Nuclear Proteins %28%1988-2001%29%
% 208.27/208.46  |- mesh__publicMeSHNote mesh__D026362
% 208.27/208.46       2002; SERUM RESPONSE FACTOR was indexed under NUCLEAR PROTEINS 1988-2001 %26% DNA-BINDING PROTEINS 1992-2001%A%  
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D026362 2006
% 208.27/208.46  |- skos__scopeNote mesh__D026362
% 208.27/208.46       A MADS domain-containing transcription factor that binds to the SERUM RESPONSE ELEMENT in the promoter-enhancer region of many genes. It is one of the four founder proteins that structurally define the superfamily of MADS DOMAIN PROTEINS.%A%    
% 208.27/208.46  |- skos__altLabel mesh__D026362 Serum Response Factor, p67
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D026362 2004
% 208.27/208.46  |- skos__historyNote mesh__D026362 DNA-Binding Proteins %28%1992-2001%29%
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D026362 2005
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D026362 2002
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D026362 2003
% 208.27/208.46  |- mesh__historyNote mesh__D026362
% 208.27/208.46       2002; use SERUM RESPONSE FACTOR %28%NM%29% 1988-2001   
% 208.27/208.46  |- rdf__type mesh__D026362sskos__Concept
% 208.27/208.46  |- mesh__recordOriginator mesh__D026362 jmp
% 208.27/208.46  |- skos__broader mesh__D026362smesh__D026161
% 208.27/208.46  |- skos__altLabel mesh__D026362 c-fos Serum Response Factor
% 208.27/208.46  |- skos__hiddenLabel mesh__D026362 Response Factor, Serum
% 208.27/208.46  |- skos__altLabel mesh__D026362 Transcription Factor SRF
% 208.27/208.46  |- mesh__dateEstablished mesh__D026362 2002-01-01
% 208.27/208.46  |- skos__prefLabel mesh__D026362 Serum Response Factor
% 208.27/208.46  |- mesh__recordAuthorizer mesh__D048016 sjn
% 208.27/208.46  |- skos__historyNote mesh__D048016 Sea Cucumbers %28%1989-2004%29%
% 208.27/208.46  |- mesh__historyNote mesh__D048016 2005   
% 208.27/208.46  |- skos__broader mesh__D048016smesh__D012616
% 208.27/208.46  |- mesh__recordMaintainer mesh__D048016 ags
% 208.27/208.46  |- skos__prefLabel mesh__D048016 Cucumaria
% 208.27/208.46  |- skos__scopeNote mesh__D048016
% 208.27/208.46       A genus of large SEA CUCUMBERS possessing the primitive radial configuration of podia in all five ambulacral areas.%A%    
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D048016 2006
% 208.27/208.46  |- mesh__recordOriginator mesh__D048016 ags
% 208.27/208.46  |- rdf__type mesh__D048016sskos__Concept
% 208.27/208.46  |- mesh__dateEstablished mesh__D048016 2005-01-01
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D048016 2005
% 208.27/208.46  |- skos__historyNote mesh__D048016 Echinodermata %28%1970-1988%29%
% 208.27/208.46  |- mesh__publicMeSHNote mesh__D048016 2005   
% 208.27/208.46  |- mesh__dateCreated mesh__D048016 2004-07-07
% 208.27/208.46  |- mesh__recordOriginator mesh__D012342 RLS
% 208.27/208.46  |- skos__altLabel mesh__D012342 snRNA
% 208.27/208.46  |- mesh__dateRevised mesh__D012342 2000-06-22
% 208.27/208.46  |- skos__altLabel mesh__D012342 Small Molecular Weight RNA
% 208.27/208.46  |- skos__broader mesh__D012342smesh__D015138
% 208.27/208.46  |- skos__historyNote mesh__D012342 RNA, Messenger %28%1966-1985%29%
% 208.27/208.46  |- skos__hiddenLabel mesh__D012342 RNA, Chromatin-Associated
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D012342 2004
% 208.27/208.46  |- mesh__recordMaintainer mesh__D012342 nns
% 208.27/208.46  |- mesh__publicMeSHNote mesh__D012342 86   
% 208.27/208.46  |- skos__annotation mesh__D012342 DF: SNRNA   
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D012342 2001
% 208.27/208.46  |- mesh__dateCreated mesh__D012342 1985-04-25
% 208.27/208.46  |- mesh__historyNote mesh__D012342 86   
% 208.27/208.46  |- mesh__recordAuthorizer mesh__D012342 sjn
% 208.27/208.46  |- mesh__dateEstablished mesh__D012342 1986-01-01
% 208.27/208.46  |- skos__altLabel mesh__D012342 Small Nuclear RNA
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D012342 2003
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D012342 2006
% 208.27/208.46  |- skos__historyNote mesh__D012342 RNA %28%1966-1985%29%
% 208.27/208.46  |- skos__prefLabel mesh__D012342 RNA, Small Nuclear
% 208.27/208.46  |- skos__broader mesh__D012342smesh__D022661
% 208.27/208.46  |- skos__altLabel mesh__D012342 Low Molecular Weight Nuclear RNA
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D012342 2005
% 208.27/208.46  |- skos__hiddenLabel mesh__D012342 Chromatin Associated RNA
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D012342 2002
% 208.27/208.46  |- rdf__type mesh__D012342sskos__Concept
% 208.27/208.46  |- skos__scopeNote mesh__D012342
% 208.27/208.46       Short chains of RNA %28%100-300 nucleotides long%29% that are abundant in the nucleus and usually complexed with proteins in snRNPs %28%RIBONUCLEOPROTEINS, SMALL NUCLEAR%29%. Many function in the processing of messenger RNA precursors. Others, the snoRNAs %28%RNA, SMALL NUCLEOLAR%29%, are involved with the processing of ribosomal RNA precursors.%A%    
% 208.27/208.46  |- skos__hiddenLabel mesh__D006305 Indicators, Health Status
% 208.27/208.46  |- skos__hiddenLabel mesh__D006305 Appraisals, Health Risk
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D006305 2003
% 208.27/208.46  |- skos__hiddenLabel mesh__D006305 Indicator, Health Status
% 208.27/208.46  |- skos__hiddenLabel mesh__D006305 Indices, Health Status
% 208.27/208.46  |- mesh__dateRevised mesh__D006305 1999-11-03
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D006305 2005
% 208.27/208.46  |- mesh__recordAuthorizer mesh__D006305 sjn
% 208.27/208.46  |- skos__hiddenLabel mesh__D006305 Indexes, Health Status
% 208.27/208.46  |- skos__hiddenLabel mesh__D006305 Appraisal, Health Risk
% 208.27/208.46  |- skos__hiddenLabel mesh__D006305 Health Status Indicator
% 208.27/208.46  |- mesh__dateEstablished mesh__D006305 1990-01-01
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D006305 2002
% 208.27/208.46  |- skos__hiddenLabel mesh__D006305 Risk Appraisal, Health
% 208.27/208.46  |- mesh__publicMeSHNote mesh__D006305
% 208.27/208.46       90; was see under HEALTH SURVEYS 1975-89   
% 208.27/208.46  |- skos__hiddenLabel mesh__D006305 Health Risk Appraisals
% 208.27/208.46  |- mesh__dateCreated mesh__D006305 1974-11-11
% 208.27/208.46  |- skos__hiddenLabel mesh__D006305 Index, Health Status
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D006305 2001
% 208.27/208.46  |- rdf__type mesh__D006305sskos__Concept
% 208.27/208.46  |- skos__broader mesh__D006305smesh__D006306
% 208.27/208.46  |- skos__hiddenLabel mesh__D006305 Health Status Indices
% 208.27/208.46  |- skos__altLabel mesh__D006305 Health Status Indexes
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D006305 2000
% 208.27/208.46  |- mesh__historyNote mesh__D006305
% 208.27/208.46       90%28%75%29%; was see under HEALTH SURVEYS 1975-89   
% 208.27/208.46  |- skos__altLabel mesh__D006305 Health Status Index
% 208.27/208.46  |- mesh__recordOriginator mesh__D006305 NLM
% 208.27/208.46  |- mesh__recordMaintainer mesh__D006305 kle
% 208.27/208.46  |- skos__scopeNote mesh__D006305
% 208.27/208.46       The measurement of the health status for a given population using a variety of indices, including morbidity, mortality, and available health resources.%A%    
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D006305 2004
% 208.27/208.46  |- skos__prefLabel mesh__D006305 Health Status Indicators
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D006305 2006
% 208.27/208.46  |- skos__annotation mesh__D006305 no qualif   
% 208.27/208.46  |- skos__hiddenLabel mesh__D006305 Risk Appraisals, Health
% 208.27/208.46  |- mesh__dateRevised mesh__D044424 2005-06-30
% 208.27/208.46  |- skos__scopeNote mesh__D044424
% 208.27/208.46       A genus of primitive ALGAE in the family Cyanophoraceae, class Glaucocystophyceae. They contain pigmented prokaryotic endosymbionts called cyanelles, which have characteristics of both CYANOBACTERIA and CHLOROPLASTS.%A%    
% 208.27/208.46  |- mesh__dateCreated mesh__D044424 2003-07-09
% 208.27/208.46  |- mesh__recordMaintainer mesh__D044424 SYSTEM
% 208.27/208.46  |- skos__broader mesh__D044424smesh__D000456
% 208.27/208.46  |- skos__hiddenLabel mesh__D044424 paradoxa, Cyanophora
% 208.27/208.46  |- mesh__historyNote mesh__D044424 2004; use ALGAE 1998-2003   
% 208.27/208.46  |- skos__hiddenLabel mesh__D044424 paradoxas, Cyanophora
% 208.27/208.46  |- skos__annotation mesh__D044424
% 208.27/208.46       do not confuse CYANOPHORA with the group CYANOBACTERIA   
% 208.27/208.46  |- skos__hiddenLabel mesh__D044424 Cyanophora paradoxas
% 208.27/208.46  |- mesh__publicMeSHNote mesh__D044424 2004; see ALGAE 1998-2003   
% 208.27/208.46  |- mesh__dateEstablished mesh__D044424 2004-01-01
% 208.27/208.46  |- skos__historyNote mesh__D044424 Cyanobacteria %28%1980-1988%29%
% 208.27/208.46  |- skos__hiddenLabel mesh__D044424 Cyanophoras
% 208.27/208.46  |- rdf__type mesh__D044424sskos__Concept
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D044424 2006
% 208.27/208.46  |- mesh__recordOriginator mesh__D044424 ags
% 208.27/208.46  |- skos__prefLabel mesh__D044424 Cyanophora
% 208.27/208.46  |- skos__historyNote mesh__D044424 Algae %28%1989-2003%29%
% 208.27/208.46  |- mesh__recordAuthorizer mesh__D044424 sjn
% 208.27/208.46  |- skos__broader mesh__D016733smesh__D003748
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D016733 1999
% 208.27/208.46  |- mesh__dateRevised mesh__D016733 1992-04-21
% 208.27/208.46  |- mesh__publicMeSHNote mesh__D016733 92   
% 208.27/208.46  |- skos__historyNote mesh__D016733
% 208.27/208.46       Dentistry, Operative/instrumentation %28%1977-1991%29%
% 208.27/208.46  |- mesh__dateEstablished mesh__D016733 1992-01-01
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D016733 2003
% 208.27/208.46  |- skos__historyNote mesh__D016733 Dental Materials %28%1966-1977%29%
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D016733 1995
% 208.27/208.46  |- skos__hiddenLabel mesh__D016733 Rubber Dam
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D016733 2001
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D016733 1998
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D016733 2006
% 208.27/208.46  |- mesh__recordOriginator mesh__D016733 MXR
% 208.27/208.46  |- skos__scopeNote mesh__D016733
% 208.27/208.46       Sheets of latex rubber punched and placed over the teeth during dental procedures to isolate the field of operation from the rest of the oral cavity %28%Jablonski; Illustrated Dictionary of Dentistry, 1982%29%. Rubber dams are useful in preventing the swallowing of instruments or restorations during dental work.%A%    
% 208.27/208.46  |- mesh__recordMaintainer mesh__D016733 NLM
% 208.27/208.46  |- skos__hiddenLabel mesh__D016733 Dam, Rubber
% 208.27/208.46  |- mesh__activeMeSHYear mesh__D016733 1994
% 208.27/208.46  |- skos__hiddenLabel mesh__D016733 Dams, Rubber
% 208.27/208.47  |- mesh__recordAuthorizer mesh__D016733 PLS
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016733 2000
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016733 2005
% 208.27/208.47  |- skos__prefLabel mesh__D016733 Rubber Dams
% 208.27/208.47  |- skos__altLabel mesh__D016733 Rubberdam
% 208.27/208.47  |- mesh__dateCreated mesh__D016733 1991-04-29
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016733 1997
% 208.27/208.47  |- mesh__historyNote mesh__D016733 92   
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016733 2002
% 208.27/208.47  |- rdf__type mesh__D016733sskos__Concept
% 208.27/208.47  |- skos__annotation mesh__D016733
% 208.27/208.47       to isolate operative field during dent proced; do not use /util except by MeSH definition%A%  
% 208.27/208.47  |- skos__hiddenLabel mesh__D016733 Rubberdams
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016733 1993
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016733 1996
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016733 2004
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D002713 2002
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D002713 2003A
% 208.27/208.47  |- skos__prefLabel mesh__D002713 Chlorine
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D002713 2006
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D002713 2003B
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D002713 2003
% 208.27/208.47  |- skos__annotation mesh__D002713
% 208.27/208.47       Cl-35; Cl-37 = CHLORINE %28%IM%29% + ISOTOPES %28%NIM%29%; Cl-34, 36, 38-40 = CHLORINE %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D002713 2004
% 208.27/208.47  |- rdf__type mesh__D002713sskos__Concept
% 208.27/208.47  |- mesh__recordOriginator mesh__D002713 NLM
% 208.27/208.47  |- mesh__dateRevised mesh__D002713 2003-03-21
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D002713 2001
% 208.27/208.47  |- mesh__recordAuthorizer mesh__D002713 ags
% 208.27/208.47  |- skos__broader mesh__D002713smesh__D005740
% 208.27/208.47  |- skos__broader mesh__D002713smesh__D006219
% 208.27/208.47  |- mesh__dateCreated mesh__D002713 1999-01-01
% 208.27/208.47  |- mesh__recordMaintainer mesh__D002713 ags
% 208.27/208.47  |- skos__scopeNote mesh__D002713
% 208.27/208.47       A greenish-yellow, diatomic gas that is a member of the halogen family of elements. It has the atomic symbol Cl, atomic number 17, and atomic weight 70.906. It is a powerful irritant that can cause fatal pulmonary edema. Chlorine is used in manufacturing, as a reagent in synthetic chemistry, for water purification, and in the production of chlorinated lime, which is used in fabric bleaching.%A%    
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D002713 2005
% 208.27/208.47  |- mesh__dateEstablished mesh__D012343 1972-01-01
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012343 2004
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012343 2002
% 208.27/208.47  |- skos__altLabel mesh__D012343 Transfer RNA, Suppressor
% 208.27/208.47  |- mesh__dateRevised mesh__D012343 2001-07-25
% 208.27/208.47  |- skos__hiddenLabel mesh__D012343 RNA, Suppressor Transfer
% 208.27/208.47  |- skos__altLabel mesh__D012343 tRNA
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012343 2003
% 208.27/208.47  |- mesh__onlineNote mesh__D012343
% 208.27/208.47       use RNA, TRANSFER to search RNA, SOLUBLE 1966-71   
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012343 2006
% 208.27/208.47  |- skos__altLabel mesh__D012343 Suppressor Transfer RNA
% 208.27/208.47  |- mesh__recordMaintainer mesh__D012343 nns
% 208.27/208.47  |- skos__scopeNote mesh__D012343
% 208.27/208.47       The small RNA molecules, 73-80 nucleotides long, that  function during translation %28%TRANSLATION, GENETIC%29% to align AMINO ACIDS at the RIBOSOMES in a sequence determined by  the mRNA %28%RNA, MESSENGER%29%. There are about 30 different transfer RNAs. Each recognizes a specific CODON set on the mRNA through its own ANTICODON and as aminoacyl tRNAs %28%RNA, TRANSFER, AMINO ACYL%29%, each carries a specific amino acid to the ribosome to add to the elongating peptide chains.%A%    
% 208.27/208.47  |- skos__broader mesh__D012343smesh__D012313
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012343 2005
% 208.27/208.47  |- mesh__recordAuthorizer mesh__D012343 sjn
% 208.27/208.47  |- mesh__dateCreated mesh__D012343 1999-01-01
% 208.27/208.47  |- skos__annotation mesh__D012343
% 208.27/208.47       GEN; prefer specifics; for suppressor transfer RNA coord with GENES, SUPPRESSOR or SUPPRESSION, GENETIC%A%  
% 208.27/208.47  |- rdf__type mesh__D012343sskos__Concept
% 208.27/208.47  |- skos__altLabel mesh__D012343 Transfer RNA
% 208.27/208.47  |- skos__prefLabel mesh__D012343 RNA, Transfer
% 208.27/208.47  |- mesh__recordOriginator mesh__D012343 NLM
% 208.27/208.47  |- mesh__historyNote mesh__D012343 72; was RNA, SOLUBLE 1965-71   
% 208.27/208.47  |- mesh__publicMeSHNote mesh__D012343 72; was RNA, SOLUBLE 1965-71   
% 208.27/208.47  |- mesh__recordOriginator mesh__D006306 NLM
% 208.27/208.47  |- skos__hiddenLabel mesh__D006306 Survey, Health
% 208.27/208.47  |- skos__broader mesh__D006306smesh__D003625
% 208.27/208.47  |- skos__hiddenLabel mesh__D006306 Surveys, Health
% 208.27/208.47  |- skos__annotation mesh__D006306
% 208.27/208.47       do not confuse with HEALTH CARE SURVEYS: health surveys are on health statist, health care surveys are on health services provided; no qualif; TN 97: misuse of %22%surveys%22%; specify geog if pertinent%A%  
% 208.27/208.47  |- rdf__type mesh__D006306sskos__Concept
% 208.27/208.47  |- mesh__recordAuthorizer mesh__D006306 sjn
% 208.27/208.47  |- mesh__onlineNote mesh__D006306
% 208.27/208.47       use HEALTH SURVEYS to search SANITARY SURVEYS 1966   
% 208.27/208.47  |- skos__prefLabel mesh__D006306 Health Surveys
% 208.27/208.47  |- mesh__dateRevised mesh__D006306 2004-07-13
% 208.27/208.47  |- mesh__recordMaintainer mesh__D006306 sjn
% 208.27/208.47  |- skos__hiddenLabel mesh__D006306 Survey, Abortion
% 208.27/208.47  |- mesh__dateCreated mesh__D006306 1999-01-01
% 208.27/208.47  |- skos__scopeNote mesh__D006306
% 208.27/208.47       A systematic collection of factual data pertaining to health and disease in a human population within a given geographic area.%A%    
% 208.27/208.47  |- skos__hiddenLabel mesh__D006306 Surveys, Abortion
% 208.27/208.47  |- mesh__publicMeSHNote mesh__D006306
% 208.27/208.47       SANITARY SURVEYS was heading 1963-66   
% 208.27/208.47  |- skos__hiddenLabel mesh__D006306 Health Survey
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D006306 2006
% 208.27/208.47  |- skos__hiddenLabel mesh__D006306 Abortion Survey
% 208.27/208.47  |- mesh__historyNote mesh__D006306 SANITARY SURVEYS was heading 1963-66   
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D006306 2005
% 208.27/208.47  |- mesh__recordOriginator mesh__D016734 MXR
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016734 2005
% 208.27/208.47  |- skos__hiddenLabel mesh__D016734 Clasp, Denture
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016734 2002
% 208.27/208.47  |- skos__altLabel mesh__D016734 Clasps, Dental
% 208.27/208.47  |- mesh__dateCreated mesh__D016734 1991-04-29
% 208.27/208.47  |- skos__historyNote mesh__D016734
% 208.27/208.47       Denture, Partial, Removable %28%1966-1991%29%
% 208.27/208.47  |- mesh__dateEstablished mesh__D016734 1992-01-01
% 208.27/208.47  |- mesh__historyNote mesh__D016734 92   
% 208.27/208.47  |- skos__annotation mesh__D016734
% 208.27/208.47       for any prosthesis; do not confuse X ref DENTURE CLASPS with DENTURE PRECISION ATTACHMENT, a special type of precision device for use with partial dentures; do not use for orthodontic clasps; DF: DENT CLASPS%A%  
% 208.27/208.47  |- rdf__type mesh__D016734sskos__Concept
% 208.27/208.47  |- skos__altLabel mesh__D016734 Dental Clasp
% 208.27/208.47  |- skos__altLabel mesh__D016734 Denture Clasps
% 208.27/208.47  |- mesh__publicMeSHNote mesh__D016734 92   
% 208.27/208.47  |- mesh__recordAuthorizer mesh__D016734 SJN
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016734 2004
% 208.27/208.47  |- skos__prefLabel mesh__D016734 Dental Clasps
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016734 2001
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016734 1999
% 208.27/208.47  |- mesh__dateRevised mesh__D016734 1997-06-20
% 208.27/208.47  |- skos__scopeNote mesh__D016734
% 208.27/208.47       Metal devices for fastening together two or more parts of dental prostheses for stabilizing or retaining them by attachment to abutment teeth. For a precision attachment for a partial denture DENTURE PRECISION ATTACHMENT is available.%A%    
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016734 2003
% 208.27/208.47  |- skos__altLabel mesh__D016734 Clasp, Dental
% 208.27/208.47  |- mesh__recordMaintainer mesh__D016734 PXP
% 208.27/208.47  |- skos__hiddenLabel mesh__D016734 Denture Clasp
% 208.27/208.47  |- skos__broader mesh__D016734smesh__D017266
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016734 2000
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016734 1998
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016734 2006
% 208.27/208.47  |- skos__hiddenLabel mesh__D016734 Clasps, Denture
% 208.27/208.47  |- skos__hiddenLabel mesh__D002714 Chloride, Chlorisondamine
% 208.27/208.47  |- mesh__recordOriginator mesh__D002714 NLM
% 208.27/208.47  |- mesh__recordAuthorizer mesh__D002714 sjn
% 208.27/208.47  |- mesh__dateRevised mesh__D002714 2005-06-30
% 208.27/208.47  |- mesh__dateCreated mesh__D002714 1999-01-01
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D002714 2006
% 208.27/208.47  |- skos__broader mesh__D002714smesh__D007211
% 208.27/208.47  |- mesh__recordMaintainer mesh__D002714 ssb
% 208.27/208.47  |- skos__prefLabel mesh__D002714 Chlorisondamine
% 208.27/208.47  |- skos__altLabel mesh__D002714 Chlorisondamine Dichloride
% 208.27/208.47  |- rdf__type mesh__D002714sskos__Concept
% 208.27/208.47  |- skos__scopeNote mesh__D002714
% 208.27/208.47       A nicotinic antagonist used primarily as a ganglionic blocker in animal research. It has been used as an antihypertensive agent but has been supplanted by more specific drugs in most clinical applications.%A%    
% 208.27/208.47  |- skos__hiddenLabel mesh__D002714 Dichloride, Chlorisondamine
% 208.27/208.47  |- skos__broader mesh__D002714smesh__D050337
% 208.27/208.47  |- skos__broader mesh__D002714smesh__D000644
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012344 1998
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012344 2004
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012344 2002
% 208.27/208.47  |- skos__hiddenLabel mesh__D012344 tRNA, Alanine-Specific
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012344 1999
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012344 2005
% 208.27/208.47  |- mesh__recordAuthorizer mesh__D012344 PLS
% 208.27/208.47  |- mesh__dateRevised mesh__D012344 1996-06-10
% 208.27/208.47  |- skos__altLabel mesh__D012344 Transfer RNA, Ala
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012344 2006
% 208.27/208.47  |- skos__prefLabel mesh__D012344 RNA, Transfer, Ala
% 208.27/208.47  |- skos__broader mesh__D012344smesh__D012345
% 208.27/208.47  |- mesh__publicMeSHNote mesh__D012344
% 208.27/208.47       91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.27/208.47  |- skos__hiddenLabel mesh__D012344 Alanine Specific tRNA
% 208.27/208.47  |- skos__altLabel mesh__D012344 tRNA%28%Ala%29%
% 208.27/208.47  |- skos__hiddenLabel mesh__D012344 RNA, Ala Transfer
% 208.27/208.47  |- skos__hiddenLabel mesh__D012344 Ala Transfer RNA
% 208.27/208.47  |- rdf__type mesh__D012344sskos__Concept
% 208.27/208.47  |- skos__historyNote mesh__D012344 RNA, Transfer %28%1966-1987%29%
% 208.27/208.47  |- skos__scopeNote mesh__D012344
% 208.27/208.47       A transfer RNA which is specific for carrying alanine to sites on the ribosomes in preparation for protein synthesis.%A%    
% 208.27/208.47  |- skos__historyNote mesh__D012344 Amino Acyl T RNA %28%1978-1987%29%
% 208.27/208.47  |- mesh__dateCreated mesh__D012344 1987-05-07
% 208.27/208.47  |- skos__annotation mesh__D012344
% 208.27/208.47       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 208.27/208.47  |- mesh__recordOriginator mesh__D012344 RLS
% 208.27/208.47  |- skos__altLabel mesh__D012344 tRNAAla
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012344 2000
% 208.27/208.47  |- mesh__dateEstablished mesh__D012344 1991-01-01
% 208.27/208.47  |- mesh__historyNote mesh__D012344
% 208.27/208.47       91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.27/208.47  |- skos__altLabel mesh__D012344 Alanine-Specific tRNA
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012344 1997
% 208.27/208.47  |- mesh__recordMaintainer mesh__D012344 TGC
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012344 2003
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012344 2001
% 208.27/208.47  |- skos__broader mesh__D014466Q000627smesh__D014466
% 208.27/208.47  |- mesh__preferredCombination mesh__D014466Q000627smesh__D014467
% 208.27/208.47  |- rdf__type mesh__D014466Q000627smesh__CompoundConcept
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D006307 2005
% 208.27/208.47  |- skos__historyNote mesh__D006307 Health Planning %28%1968-1977%29%
% 208.27/208.47  |- mesh__recordAuthorizer mesh__D006307 sjn
% 208.27/208.47  |- rdf__type mesh__D006307sskos__Concept
% 208.27/208.47  |- skos__prefLabel mesh__D006307 Health Systems Agencies
% 208.27/208.47  |- mesh__recordOriginator mesh__D006307 EC
% 208.27/208.47  |- mesh__publicMeSHNote mesh__D006307 78   
% 208.27/208.47  |- skos__hiddenLabel mesh__D006307 Health Systems Agency
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D006307 2002
% 208.27/208.47  |- mesh__dateRevised mesh__D006307 1999-11-03
% 208.27/208.47  |- mesh__dateCreated mesh__D006307 1977-05-05
% 208.27/208.47  |- skos__annotation mesh__D006307
% 208.27/208.47       Public Law 93-641; specify geog %26% add UNITED STATES also   
% 208.27/208.47  |- skos__hiddenLabel mesh__D006307 Systems Agency, Health
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D006307 2001
% 208.27/208.47  |- skos__hiddenLabel mesh__D006307 Agencies, Health Systems
% 208.27/208.47  |- mesh__historyNote mesh__D006307 78   
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D006307 2004
% 208.27/208.47  |- skos__hiddenLabel mesh__D006307 Systems Agencies, Health
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D006307 2000
% 208.27/208.47  |- mesh__dateEstablished mesh__D006307 1978-01-01
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D006307 2003
% 208.27/208.47  |- skos__scopeNote mesh__D006307
% 208.27/208.47       Health planning and resources development agencies which function in each health service area of the United States %28%PL 93-641%29%.%A%    
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D006307 2006
% 208.27/208.47  |- skos__broader mesh__D006307smesh__D013220
% 208.27/208.47  |- skos__hiddenLabel mesh__D006307 Agency, Health Systems
% 208.27/208.47  |- mesh__recordMaintainer mesh__D006307 kle
% 208.27/208.47  |- skos__broader mesh__D007074Q000172smesh__D007074
% 208.27/208.47  |- mesh__preferredCombination mesh__D007074Q000172smesh__D017099
% 208.27/208.47  |- rdf__type mesh__D007074Q000172smesh__CompoundConcept
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016735 2006
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016735 2002
% 208.27/208.47  |- skos__scopeNote mesh__D016735
% 208.27/208.47       A phenomenon in which symptoms of a disease are fabricated by an individual other than the patient causing unnecessary, and often painful, physical examinations and treatments. This syndrome is considered a form of CHILD ABUSE, since another individual, usually a parent, is the source of the fabrication of symptoms and presents the child for medical care.%A%    
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016735 2005
% 208.27/208.47  |- skos__historyNote mesh__D016735 Munchausen Syndrome %28%1977-1991%29%
% 208.27/208.47  |- rdf__type mesh__D016735sskos__Concept
% 208.27/208.47  |- mesh__dateCreated mesh__D016735 1991-04-29
% 208.27/208.47  |- mesh__recordAuthorizer mesh__D016735 SJN
% 208.27/208.47  |- mesh__dateEstablished mesh__D016735 1992-01-01
% 208.27/208.47  |- mesh__historyNote mesh__D016735 92   
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016735 2001
% 208.27/208.47  |- mesh__publicMeSHNote mesh__D016735 92   
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016735 2004
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016735 1999
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016735 2000
% 208.27/208.47  |- mesh__dateRevised mesh__D016735 1997-06-24
% 208.27/208.47  |- skos__broader mesh__D016735smesh__D002649
% 208.27/208.47  |- mesh__recordMaintainer mesh__D016735 TGC
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016735 2003
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016735 1998
% 208.27/208.47  |- skos__prefLabel mesh__D016735 Munchausen Syndrome by Proxy
% 208.27/208.47  |- mesh__recordOriginator mesh__D016735 MXR
% 208.27/208.47  |- skos__annotation mesh__D016735
% 208.27/208.47       dis symptoms fabricated by person other than patient, usually a parent for a child%A%  
% 208.27/208.47  |- mesh__dateCreated mesh__D002715 1999-01-01
% 208.27/208.47  |- skos__broader mesh__D002715smesh__D013258
% 208.27/208.47  |- skos__hiddenLabel mesh__D002715 Acetate, Chlormadinon
% 208.27/208.47  |- skos__scopeNote mesh__D002715
% 208.27/208.47       An orally active synthetic progestational hormone used often in combinations as an oral contraceptive.%A%    
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D002715 2006
% 208.27/208.47  |- mesh__recordOriginator mesh__D002715 NLM
% 208.27/208.47  |- skos__hiddenLabel mesh__D002715 Neo Eunomin
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D002715 2004
% 208.27/208.47  |- mesh__recordAuthorizer mesh__D002715 sjn
% 208.27/208.47  |- mesh__dateRevised mesh__D002715 2003-07-09
% 208.27/208.47  |- mesh__dateEstablished mesh__D002715 1966-01-01
% 208.27/208.47  |- skos__altLabel mesh__D002715 Chlormadinon Acetate
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D002715 2005
% 208.27/208.47  |- mesh__publicMeSHNote mesh__D002715 96; was CHLORMADINONE 1966-1995   
% 208.27/208.47  |- skos__hiddenLabel mesh__D002715 Acetate, Chlormadinone
% 208.27/208.47  |- skos__hiddenLabel mesh__D002715 NeoEunomin
% 208.27/208.47  |- mesh__recordMaintainer mesh__D002715 lkt
% 208.27/208.47  |- rdf__type mesh__D002715sskos__Concept
% 208.27/208.47  |- skos__prefLabel mesh__D002715 Chlormadinone Acetate
% 208.27/208.47  |- skos__broader mesh__D002715smesh__D011245
% 208.27/208.47  |- mesh__historyNote mesh__D002715
% 208.27/208.47       96; was CHLORMADINONE 1964-1995 %28%Prov 1964-65%29%   
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D007400 2003
% 208.27/208.47  |- mesh__dateEstablished mesh__D007400 1965-01-01
% 208.27/208.47  |- mesh__publicMeSHNote mesh__D007400 65   
% 208.27/208.47  |- mesh__dateRevised mesh__D007400 2002-10-31
% 208.27/208.47  |- mesh__dateCreated mesh__D007400 1999-01-01
% 208.27/208.47  |- rdf__type mesh__D007400sskos__Concept
% 208.27/208.47  |- skos__broader mesh__D007400smesh__D007398
% 208.27/208.47  |- skos__scopeNote mesh__D007400
% 208.27/208.47       The reciprocal interaction of two or more professional individuals.%A%    
% 208.27/208.47  |- skos__altLabel mesh__D007400 Medical Etiquette
% 208.27/208.47  |- skos__related mesh__D007400smesh__D033183
% 208.27/208.47  |- skos__prefLabel mesh__D007400 Interprofessional Relations
% 208.27/208.47  |- mesh__recordOriginator mesh__D007400 NLM
% 208.27/208.47  |- skos__hiddenLabel mesh__D007400 Relations, Interprofessional
% 208.27/208.47  |- mesh__recordMaintainer mesh__D007400 jls
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D007400 2006
% 208.27/208.47  |- mesh__recordAuthorizer mesh__D007400 jls
% 208.27/208.47  |- mesh__historyNote mesh__D007400 65   
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D007400 2005
% 208.27/208.47  |- skos__annotation mesh__D007400
% 208.27/208.47       coord IM with med or other spec %28%IM%29% if pertinent; INTERDISCIPLINARY COMMUNICATION is also available%A%  
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D007400 2004
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D007400 2003A
% 208.27/208.47  |- skos__altLabel mesh__D012345 Amino Acid-Specific tRNA
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012345 2000
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012345 1999
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012345 2005
% 208.27/208.47  |- mesh__dateEstablished mesh__D012345 1988-01-01
% 208.27/208.47  |- skos__hiddenLabel mesh__D012345 Transfer RNA, Amino Acid Specific
% 208.27/208.47  |- skos__historyNote mesh__D012345 RNA, Transfer %28%1972-1987%29%
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012345 2001
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012345 2006
% 208.27/208.47  |- skos__hiddenLabel mesh__D012345 Acid, tRNA-Amino
% 208.27/208.47  |- skos__scopeNote mesh__D012345
% 208.27/208.47       A group of transfer RNAs which are specific for carrying each one of the 20 amino acids to the ribosome in preparation for protein synthesis.%A%    
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012345 2002
% 208.27/208.47  |- mesh__historyNote mesh__D012345 88   
% 208.27/208.47  |- skos__hiddenLabel mesh__D012345 Amino Acid Specific Transfer RNA
% 208.27/208.47  |- skos__hiddenLabel mesh__D012345 Amino Acid Specific tRNA
% 208.27/208.47  |- skos__altLabel mesh__D012345 tRNA-Amino Acid
% 208.27/208.47  |- skos__altLabel mesh__D012345 Amino Acid-Specific Transfer RNA
% 208.27/208.47  |- mesh__recordAuthorizer mesh__D012345 PLS
% 208.27/208.47  |- rdf__type mesh__D012345sskos__Concept
% 208.27/208.47  |- mesh__dateCreated mesh__D012345 1987-05-05
% 208.27/208.47  |- mesh__publicMeSHNote mesh__D012345 88   
% 208.27/208.47  |- skos__prefLabel mesh__D012345 RNA, Transfer, Amino Acid-Specific
% 208.27/208.47  |- mesh__dateRevised mesh__D012345 1996-06-10
% 208.27/208.47  |- skos__broader mesh__D012345smesh__D012343
% 208.27/208.47  |- skos__historyNote mesh__D012345 Amino Acids %28%1966-1987%29%
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012345 1997
% 208.27/208.47  |- mesh__recordMaintainer mesh__D012345 TGC
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012345 2003
% 208.27/208.47  |- skos__annotation mesh__D012345
% 208.27/208.47       GEN or unspecified; prefer available tRNA terms naming the specific amino acids; /drug eff /ultrastruct permitted; DF: TRNA AA SPECIFIC%A%  
% 208.27/208.47  |- skos__hiddenLabel mesh__D012345 tRNA Amino Acid
% 208.27/208.47  |- skos__altLabel mesh__D012345 Transfer RNA, Amino Acid-Specific
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012345 1998
% 208.27/208.47  |- skos__hiddenLabel mesh__D012345 tRNA, Amino Acid-Specific
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D012345 2004
% 208.27/208.47  |- skos__hiddenLabel mesh__D012345 Acid-Specific tRNA, Amino
% 208.27/208.47  |- skos__altLabel mesh__D012345 RNA, Transfer, Amino Acid Specific
% 208.27/208.47  |- skos__historyNote mesh__D012345 Amino Acyl T RNA %28%1978-1987%29%
% 208.27/208.47  |- skos__altLabel mesh__D012345 tRNA %28%Amino Acid%29%
% 208.27/208.47  |- mesh__recordOriginator mesh__D012345 RLS
% 208.27/208.47  |- skos__broader mesh__D000418Q000652smesh__D000418
% 208.27/208.47  |- mesh__preferredCombination mesh__D000418Q000652smesh__D000419
% 208.27/208.47  |- rdf__type mesh__D000418Q000652smesh__CompoundConcept
% 208.27/208.47  |- mesh__dateCreated mesh__D006308 1979-06-01
% 208.27/208.47  |- mesh__publicMeSHNote mesh__D006308
% 208.27/208.47       91; was see under REGIONAL HEALTH PLANNING 1981-90; was see under STATE HEALTH PLANS 1980%A%  
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D006308 2001
% 208.27/208.47  |- skos__broader mesh__D006308smesh__D012040
% 208.27/208.47  |- mesh__historyNote mesh__D006308
% 208.27/208.47       91%28%80%29%; was see under REGIONAL HEALTH PLANNING 1981-90; was see under STATE HEALTH PLANS 1980%A%  
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D006308 2000
% 208.27/208.47  |- skos__prefLabel mesh__D006308 Health Systems Plans
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D006308 2004
% 208.27/208.47  |- mesh__recordMaintainer mesh__D006308 kle
% 208.27/208.47  |- mesh__dateEstablished mesh__D006308 1991-01-01
% 208.27/208.47  |- skos__scopeNote mesh__D006308
% 208.27/208.47       Statements of goals for the delivery of health services pertaining to the Health Systems Agency service area, established under PL 93-641, and consistent with national guidelines for health planning.%A%    
% 208.27/208.47  |- skos__hiddenLabel mesh__D006308 Health Systems Plan
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D006308 2003
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D006308 2006
% 208.27/208.47  |- mesh__recordOriginator mesh__D006308 EC
% 208.27/208.47  |- skos__hiddenLabel mesh__D006308 Plans, Health Systems
% 208.27/208.47  |- mesh__recordAuthorizer mesh__D006308 sjn
% 208.27/208.47  |- mesh__dateRevised mesh__D006308 1999-11-03
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D006308 2005
% 208.27/208.47  |- skos__annotation mesh__D006308
% 208.27/208.47       Public Law 93-641; specify geog %26% add UNITED STATES also   
% 208.27/208.47  |- skos__hiddenLabel mesh__D006308 Plan, Health Systems
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D006308 2002
% 208.27/208.47  |- rdf__type mesh__D006308sskos__Concept
% 208.27/208.47  |- skos__historyNote mesh__D003010 Propylamines %28%1970-1974%29%
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D003010 2002
% 208.27/208.47  |- skos__historyNote mesh__D003010 Phenyl Ethers %28%1974%29%
% 208.27/208.47  |- mesh__recordOriginator mesh__D003010 NLM
% 208.27/208.47  |- mesh__dateEstablished mesh__D003010 1991-01-01
% 208.27/208.47  |- rdf__type mesh__D003010sskos__Concept
% 208.27/208.47  |- skos__altLabel mesh__D003010 Clorgilin
% 208.27/208.47  |- skos__altLabel mesh__D003010 Chlorgyline
% 208.27/208.47  |- mesh__historyNote mesh__D003010
% 208.27/208.47       91%28%75%29%; was see under PROPYLAMINES 1975-90   
% 208.27/208.47  |- skos__broader mesh__D003010smesh__D011437
% 208.27/208.47  |- mesh__recordAuthorizer mesh__D003010 sjn
% 208.27/208.47  |- skos__altLabel mesh__D003010 Clorgiline
% 208.27/208.47  |- mesh__dateRevised mesh__D003010 2000-06-22
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D003010 2005
% 208.27/208.47  |- skos__historyNote mesh__D003010 Alkynes %28%1972-1974%29%
% 208.27/208.47  |- mesh__dateCreated mesh__D003010 1974-11-19
% 208.27/208.47  |- skos__prefLabel mesh__D003010 Clorgyline
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D003010 2003
% 208.27/208.47  |- skos__scopeNote mesh__D003010
% 208.27/208.47       An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.%A%    
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D003010 2006
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D003010 2001
% 208.27/208.47  |- mesh__publicMeSHNote mesh__D003010
% 208.27/208.47       91; was see under PROPYLAMINES 1975-90   
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D003010 2004
% 208.27/208.47  |- mesh__recordMaintainer mesh__D003010 CCR
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D049910 2006
% 208.27/208.47  |- mesh__recordOriginator mesh__D049910 ags
% 208.27/208.47  |- skos__broader mesh__D049910smesh__D049897
% 208.27/208.47  |- skos__historyNote mesh__D049910 Mollusca %28%1965-2005%29%
% 208.27/208.47  |- rdf__type mesh__D049910sskos__Concept
% 208.27/208.47  |- mesh__dateEstablished mesh__D049910 2006-01-01
% 208.27/208.47  |- mesh__recordMaintainer mesh__D049910 ags
% 208.27/208.47  |- skos__prefLabel mesh__D049910 Pecten
% 208.27/208.47  |- mesh__historyNote mesh__D049910 2006   
% 208.27/208.47  |- mesh__dateCreated mesh__D049910 2005-06-30
% 208.27/208.47  |- skos__scopeNote mesh__D049910
% 208.27/208.47       A genus of scallops in the family PECTINIDAE, class BIVALVIA. The shell is usually radially ribbed.%A%    
% 208.27/208.47  |- mesh__recordAuthorizer mesh__D049910 sjn
% 208.27/208.47  |- mesh__publicMeSHNote mesh__D049910 2006   
% 208.27/208.47  |- skos__annotation mesh__D049910
% 208.27/208.47       as animal %26% food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH %28%IM%29%%A%  
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016736 2004
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016736 1998
% 208.27/208.47  |- skos__hiddenLabel mesh__D016736 Anti Phospholipid Syndrome
% 208.27/208.47  |- mesh__recordOriginator mesh__D016736 TGC
% 208.27/208.47  |- skos__scopeNote mesh__D016736
% 208.27/208.47       The presence of antibodies directed against phospholipids %28%ANTIBODIES, ANTIPHOSPHOLIPID%29%. The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies %28%ANTIBODIES, ANTICARDIOLIPIN%29%. Present also are high levels of lupus anticoagulant %28%LUPUS COAGULATION INHIBITOR%29%.%A%    
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016736 1995
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016736 2000
% 208.27/208.47  |- skos__altLabel mesh__D016736 Antiphospholipid Antibody Syndrome
% 208.27/208.47  |- skos__hiddenLabel mesh__D016736 Syndrome, Antiphospholipid
% 208.27/208.47  |- mesh__historyNote mesh__D016736
% 208.27/208.47       92; PHOSPHOLIPID ANTIBODY SYNDROME was see ANTIPHOSPHOLIPID SYNDROME 1992%A%  
% 208.27/208.47  |- mesh__publicMeSHNote mesh__D016736
% 208.27/208.47       92; PHOSPHOLIPID ANTIBODY SYNDROME was see ANTIPHOSPHOLIPID SYNDROME 1992%A%  
% 208.27/208.47  |- skos__historyNote mesh__D016736
% 208.27/208.47       Phospholipids/immunology %28%1977-1991%29%
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016736 1993
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016736 1999
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016736 2001
% 208.27/208.47  |- skos__prefLabel mesh__D016736 Antiphospholipid Syndrome
% 208.27/208.47  |- mesh__activeMeSHYear mesh__D016736 2005
% 208.27/208.47  |- skos__hiddenLabel mesh__D016736 Antiphospholipid Antibody Syndromes
% 208.27/208.47  |- skos__hiddenLabel mesh__D016736 Antibody Syndrome, Antiphospholipid
% 208.27/208.48  |- mesh__dateCreated mesh__D016736 1991-04-29
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D016736 1996
% 208.27/208.48  |- skos__hiddenLabel mesh__D016736 Syndrome, Anti-Phospholipid
% 208.27/208.48  |- mesh__dateEstablished mesh__D016736 1992-01-01
% 208.27/208.48  |- skos__altLabel mesh__D016736 Anti-Phospholipid Antibody Syndrome
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D016736 2006
% 208.27/208.48  |- skos__altLabel mesh__D016736 Anti-Phospholipid Syndrome
% 208.27/208.48  |- mesh__onlineNote mesh__D016736
% 208.27/208.48       use ANTIPHOSPHOLIPID SYNDROME to search PHOSPHOLIPID ANTIBODY SYNDROME 1992%A%  
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D016736 1997
% 208.27/208.48  |- skos__hiddenLabel mesh__D016736 Syndrome, Antiphospholipid Antibody
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D016736 2002
% 208.27/208.48  |- mesh__dateRevised mesh__D016736 1992-05-07
% 208.27/208.48  |- mesh__recordAuthorizer mesh__D016736 PLS
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D016736 2003
% 208.27/208.48  |- skos__hiddenLabel mesh__D016736 Syndrome, Anti-Phospholipid Antibody
% 208.27/208.48  |- skos__hiddenLabel mesh__D016736 Antibody Syndrome, Anti-Phospholipid
% 208.27/208.48  |- rdf__type mesh__D016736sskos__Concept
% 208.27/208.48  |- skos__hiddenLabel mesh__D016736 Anti Phospholipid Antibody Syndrome
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D016736 1994
% 208.27/208.48  |- skos__annotation mesh__D016736 an autoimmune dis, not a metab dis   
% 208.27/208.48  |- mesh__recordMaintainer mesh__D016736 AGS
% 208.27/208.48  |- skos__broader mesh__D016736smesh__D001327
% 208.27/208.48  |- mesh__historyNote mesh__D002716
% 208.27/208.48       91%28%72%29%; was see under AMMONIUM COMPOUNDS 1972-90   
% 208.27/208.48  |- rdf__type mesh__D002716sskos__Concept
% 208.27/208.48  |- mesh__recordMaintainer mesh__D002716 ssb
% 208.27/208.48  |- skos__historyNote mesh__D002716
% 208.27/208.48       Plant Growth Regulators %28%1966-1971%29%
% 208.27/208.48  |- mesh__publicMeSHNote mesh__D002716
% 208.27/208.48       91; was see under AMMONIUM COMPOUNDS 1972-90   
% 208.27/208.48  |- skos__broader mesh__D002716smesh__D050337
% 208.27/208.48  |- skos__broader mesh__D002716smesh__D000644
% 208.27/208.48  |- mesh__recordOriginator mesh__D002716 NLM
% 208.27/208.48  |- mesh__dateEstablished mesh__D002716 1991-01-01
% 208.27/208.48  |- mesh__dateCreated mesh__D002716 1999-01-01
% 208.27/208.48  |- skos__historyNote mesh__D002716 Ammonium Compounds %28%1966-1971%29%
% 208.27/208.48  |- mesh__recordAuthorizer mesh__D002716 sjn
% 208.27/208.48  |- skos__prefLabel mesh__D002716 Chlormequat
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D002716 2006
% 208.27/208.48  |- mesh__dateRevised mesh__D002716 2005-06-30
% 208.27/208.48  |- skos__hiddenLabel mesh__D002716 Chloride, Chlorocholine
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007401 1989
% 208.27/208.48  |- mesh__historyNote mesh__D007401
% 208.27/208.48       89%28%75%29%; was see under ADRENAL GLANDS 1969-88   
% 208.27/208.48  |- skos__hiddenLabel mesh__D007401 Interrenal Glands
% 208.27/208.48  |- skos__hiddenLabel mesh__D007401 Glands, Interrenal
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007401 2001
% 208.27/208.48  |- mesh__dateRevised mesh__D007401 1988-06-11
% 208.27/208.48  |- skos__scopeNote mesh__D007401
% 208.27/208.48       Structures in fishes homologous to the cortical tissue of the mammalian adrenal gland; they are in close proximity to or imbedded in the kidney.%A%    
% 208.27/208.48  |- skos__broader mesh__D007401smesh__D000825
% 208.27/208.48  |- skos__hiddenLabel mesh__D007401 Gland, Interrenal
% 208.27/208.48  |- skos__annotation mesh__D007401 also called interrenal body; in fish   
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007401 1995
% 208.27/208.48  |- mesh__recordAuthorizer mesh__D007401 MED
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007401 2000
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007401 1994
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007401 1993
% 208.27/208.48  |- mesh__publicMeSHNote mesh__D007401
% 208.27/208.48       89; was see under ADRENAL GLANDS 1969-88   
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007401 1991
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007401 2006
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007401 1992
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007401 1999
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007401 2005
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007401 2004
% 208.27/208.48  |- mesh__recordMaintainer mesh__D007401 FES
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007401 2002
% 208.27/208.48  |- mesh__recordOriginator mesh__D007401 NLM
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007401 1998
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007401 1997
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007401 2003
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007401 1990
% 208.27/208.48  |- rdf__type mesh__D007401sskos__Concept
% 208.27/208.48  |- mesh__dateCreated mesh__D007401 1999-01-01
% 208.27/208.48  |- mesh__dateEstablished mesh__D007401 1989-01-01
% 208.27/208.48  |- skos__prefLabel mesh__D007401 Interrenal Gland
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007401 1996
% 208.27/208.48  |- skos__hiddenLabel mesh__D012346 Acyl tRNA, Amino
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D012346 2001
% 208.27/208.48  |- mesh__recordOriginator mesh__D012346 RLS
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D012346 2005
% 208.27/208.48  |- mesh__publicMeSHNote mesh__D012346 88; was AMINO ACYL T RNA 1978-87   
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D012346 2002
% 208.27/208.48  |- mesh__recordAuthorizer mesh__D012346 PLS
% 208.27/208.48  |- skos__altLabel mesh__D012346 Transfer RNA, Amino Acyl
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D012346 2006
% 208.27/208.48  |- rdf__type mesh__D012346sskos__Concept
% 208.27/208.48  |- skos__historyNote mesh__D012346 Amino Acids %28%1966-1977%29%
% 208.27/208.48  |- mesh__dateRevised mesh__D012346 1996-06-10
% 208.27/208.48  |- skos__altLabel mesh__D012346 Amino Acyl T RNA
% 208.27/208.48  |- skos__scopeNote mesh__D012346
% 208.27/208.48       Intermediates in protein biosynthesis. The compounds are formed from amino acids, ATP and transfer RNA, a reaction catalyzed by aminoacyl tRNA synthetase. They are key compounds in the genetic translation process.%A%    
% 208.27/208.48  |- mesh__onlineNote mesh__D012346
% 208.27/208.48       use RNA, TRANSFER, AMINO ACYL to search AMINO ACYL T RNA 1978-87%A%  
% 208.27/208.48  |- skos__hiddenLabel mesh__D012346 tRNA Amino Acyl
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D012346 1997
% 208.27/208.48  |- mesh__historyNote mesh__D012346 88; was AMINO ACYL T RNA 1978-87   
% 208.27/208.48  |- skos__hiddenLabel mesh__D012346 Acyl, tRNA-Amino
% 208.27/208.48  |- mesh__dateEstablished mesh__D012346 1978-01-01
% 208.27/208.48  |- skos__altLabel mesh__D012346 Amino Acyl tRNA
% 208.27/208.48  |- skos__broader mesh__D012346smesh__D000596
% 208.27/208.48  |- skos__annotation mesh__D012346
% 208.27/208.48       IM; /drug eff /ultrastruct permitted; DF: TRNA AMINO ACYL%A%  
% 208.27/208.48  |- skos__hiddenLabel mesh__D012346 tRNA, Amino Acyl
% 208.27/208.48  |- skos__altLabel mesh__D012346 tRNA-Amino Acyl
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D012346 2003
% 208.27/208.48  |- skos__broader mesh__D012346smesh__D012343
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D012346 1998
% 208.27/208.48  |- skos__historyNote mesh__D012346 RNA, Transfer %28%1966-1977%29%
% 208.27/208.48  |- mesh__dateCreated mesh__D012346 1977-05-20
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D012346 2000
% 208.27/208.48  |- skos__prefLabel mesh__D012346 RNA, Transfer, Amino Acyl
% 208.27/208.48  |- mesh__recordMaintainer mesh__D012346 TGC
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D012346 2004
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D012346 1999
% 208.27/208.48  |- skos__related mesh__D006309smesh__D000161
% 208.27/208.48  |- skos__related mesh__D006309smesh__D001844
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D006309 2002
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D006309 2004
% 208.27/208.48  |- skos__hiddenLabel mesh__D006309 Hearings
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D006309 2001
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D006309 2003
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D006309 2006
% 208.27/208.48  |- skos__annotation mesh__D006309
% 208.27/208.48       differentiate from AUDITORY PERCEPTION: aud percept takes place in the brain, hearing takes place in the ear: TN 98; PSYCHOACOUSTICS is also available; AMERICAN SPEECH-LANGUAGE-HEARING ASSOCIATION is available%A%  
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D006309 2000
% 208.27/208.48  |- mesh__recordOriginator mesh__D006309 NLM
% 208.27/208.48  |- skos__related mesh__D006309smesh__D001307
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D006309 2005
% 208.27/208.48  |- mesh__considerAlso mesh__D006309
% 208.27/208.48       consider also terms at ACOUSTIC and AUDIO-   
% 208.27/208.48  |- skos__scopeNote mesh__D006309 The sensation of sound.     
% 208.27/208.48  |- mesh__recordMaintainer mesh__D006309 kle
% 208.27/208.48  |- rdf__type mesh__D006309sskos__Concept
% 208.27/208.48  |- skos__broader mesh__D006309smesh__D012677
% 208.27/208.48  |- mesh__recordAuthorizer mesh__D006309 sjn
% 208.27/208.48  |- mesh__dateRevised mesh__D006309 1999-11-03
% 208.27/208.48  |- skos__prefLabel mesh__D006309 Hearing
% 208.27/208.48  |- mesh__dateCreated mesh__D006309 1999-01-01
% 208.27/208.48  |- mesh__dateRevised mesh__D003011 2003-07-09
% 208.27/208.48  |- skos__hiddenLabel mesh__D003011 Volume, Closing
% 208.27/208.48  |- skos__annotation mesh__D003011 NIM   
% 208.27/208.48  |- mesh__recordMaintainer mesh__D003011 nns
% 208.27/208.48  |- mesh__publicMeSHNote mesh__D003011
% 208.27/208.48       91; was see under LUNG VOLUME MEASUREMENTS 1978-90   
% 208.27/208.48  |- skos__hiddenLabel mesh__D003011 Volumes, Closing
% 208.27/208.48  |- skos__broader mesh__D003011smesh__D014109
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D003011 2005
% 208.27/208.48  |- skos__historyNote mesh__D003011
% 208.27/208.48       Lung Volume Measurements %28%1975-1977%29%
% 208.27/208.48  |- mesh__historyNote mesh__D003011
% 208.27/208.48       91%28%78%29%; was see under LUNG VOLUME MEASUREMENTS 1978-90   
% 208.27/208.48  |- skos__prefLabel mesh__D003011 Closing Volume
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D003011 2006
% 208.27/208.48  |- mesh__recordAuthorizer mesh__D003011 sjn
% 208.27/208.48  |- skos__historyNote mesh__D003011
% 208.27/208.48       Respiratory Function Tests %28%1966-1974%29%
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D003011 2004
% 208.27/208.48  |- mesh__dateEstablished mesh__D003011 1991-01-01
% 208.27/208.48  |- rdf__type mesh__D003011sskos__Concept
% 208.27/208.48  |- skos__scopeNote mesh__D003011
% 208.27/208.48       The lung volume at which the dependent lung zones cease to ventilate presumably as a result of airway closure.%A%    
% 208.27/208.48  |- mesh__recordOriginator mesh__D003011 VDK
% 208.27/208.48  |- skos__hiddenLabel mesh__D003011 Closing Volumes
% 208.27/208.48  |- mesh__dateCreated mesh__D003011 1977-04-27
% 208.27/208.48  |- mesh__recordOriginator mesh__D049911 ags
% 208.27/208.48  |- skos__scopeNote mesh__D049911
% 208.27/208.48       A genus of pearl oysters in the family Pteriidae, class BIVALVIA. Both cultured and natural pearls are obtained from species in the genus. They are distinct from the distantly related, edible true oysters of the family OSTREIDAE.%A%    
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D049911 2006
% 208.27/208.48  |- rdf__type mesh__D049911sskos__Concept
% 208.27/208.48  |- skos__altLabel mesh__D049911 Pearl Oyster
% 208.27/208.48  |- mesh__dateEstablished mesh__D049911 2006-01-01
% 208.27/208.48  |- mesh__recordMaintainer mesh__D049911 ags
% 208.27/208.48  |- mesh__historyNote mesh__D049911 2006   
% 208.27/208.48  |- skos__prefLabel mesh__D049911 Pinctada
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D049911 2006A
% 208.27/208.48  |- mesh__dateRevised mesh__D049911 2005-07-08
% 208.27/208.48  |- skos__historyNote mesh__D049911 Ostreidae %28%1969-2005%29%
% 208.27/208.48  |- mesh__publicMeSHNote mesh__D049911 2006   
% 208.27/208.48  |- skos__altLabel mesh__D049911 Oysters, Pearl
% 208.27/208.48  |- skos__broader mesh__D049911smesh__D049872
% 208.27/208.48  |- mesh__dateCreated mesh__D049911 2005-06-30
% 208.27/208.48  |- mesh__recordAuthorizer mesh__D049911 ags
% 208.27/208.48  |- skos__related mesh__D016737smesh__D019449
% 208.27/208.48  |- mesh__dateRevised mesh__D016737 2002-07-03
% 208.27/208.48  |- rdf__type mesh__D016737sskos__Concept
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D016737 2003
% 208.27/208.48  |- mesh__publicMeSHNote mesh__D016737 92   
% 208.27/208.48  |- skos__broader mesh__D016737smesh__D003082
% 208.27/208.48  |- mesh__historyNote mesh__D016737 92   
% 208.27/208.48  |- skos__hiddenLabel mesh__D016737 Restorative Proctocolectomy
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D016737 2004
% 208.27/208.48  |- mesh__recordMaintainer mesh__D016737 ags
% 208.27/208.48  |- skos__hiddenLabel mesh__D016737 Proctocolectomies, Restorative
% 208.27/208.48  |- mesh__recordOriginator mesh__D016737 MXR
% 208.27/208.48  |- skos__scopeNote mesh__D016737
% 208.27/208.48       A surgical procedure involving the excision of the COLON and RECTUM and the formation of an ILEOANAL RESERVOIR %28%pouch%29%. In patients with intestinal diseases, such as ulcerative colitis, this procedure avoids the need for an OSTOMY by allowing for transanal defecation.%A%    
% 208.27/208.48  |- skos__historyNote mesh__D016737 Colectomy %28%1981-1991%29%
% 208.27/208.48  |- skos__hiddenLabel mesh__D016737 Restorative Coloproctectomy
% 208.27/208.48  |- skos__prefLabel mesh__D016737 Proctocolectomy, Restorative
% 208.27/208.48  |- mesh__recordAuthorizer mesh__D016737 sjn
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D016737 2005
% 208.27/208.48  |- mesh__dateCreated mesh__D016737 1991-04-29
% 208.27/208.48  |- skos__altLabel mesh__D016737 Coloproctectomy, Restorative
% 208.27/208.48  |- skos__related mesh__D016737smesh__D039021
% 208.27/208.48  |- skos__hiddenLabel mesh__D016737 Restorative Proctocolectomies
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D016737 2006
% 208.27/208.48  |- skos__hiddenLabel mesh__D016737 Coloproctectomies, Restorative
% 208.27/208.48  |- mesh__dateEstablished mesh__D016737 1992-01-01
% 208.27/208.48  |- skos__hiddenLabel mesh__D016737 Restorative Coloproctectomies
% 208.27/208.48  |- skos__scopeNote mesh__D002717
% 208.27/208.48       A mercurial compound that has been used as a diuretic but is now superseded by more potent and less toxic drugs. The radiolabeled form has been used as a diagnostic and research tool.%A%    
% 208.27/208.48  |- skos__hiddenLabel mesh__D002717 3 Chloromercuri 2 methoxypropylurea
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D002717 2001
% 208.27/208.48  |- skos__altLabel mesh__D002717 3-Chloromercuri-2-methoxypropylurea
% 208.27/208.48  |- skos__altLabel mesh__D002717 Promeran
% 208.27/208.48  |- skos__altLabel mesh__D002717 Chlormeroprin
% 208.27/208.48  |- mesh__recordMaintainer mesh__D002717 CCR
% 208.27/208.48  |- mesh__dateCreated mesh__D002717 1999-01-01
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D002717 2006
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D002717 2002
% 208.27/208.48  |- mesh__dateRevised mesh__D002717 2000-06-22
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D002717 2004
% 208.27/208.48  |- mesh__dateEstablished mesh__D002717 1966-01-01
% 208.27/208.48  |- mesh__historyNote mesh__D002717
% 208.27/208.48       66%28%64%29%; was see under DIURETICS, MERCURIAL 1963-65   
% 208.27/208.48  |- skos__broader mesh__D002717smesh__D000479
% 208.27/208.48  |- mesh__recordOriginator mesh__D002717 NLM
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D002717 2005
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D002717 2003
% 208.27/208.48  |- mesh__recordAuthorizer mesh__D002717 sjn
% 208.27/208.48  |- skos__prefLabel mesh__D002717 Chlormerodrin
% 208.27/208.48  |- mesh__publicMeSHNote mesh__D002717
% 208.27/208.48       66; was see under DIURETICS, MERCURIAL 1963-65   
% 208.27/208.48  |- rdf__type mesh__D002717sskos__Concept
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007402 1994
% 208.27/208.48  |- skos__broader mesh__D007402smesh__D003872
% 208.27/208.48  |- mesh__recordOriginator mesh__D007402 NLM
% 208.27/208.48  |- skos__broader mesh__D007402smesh__D017443
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007402 2005
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007402 1995
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007402 1998
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007402 2000
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007402 1993
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007402 2003
% 208.27/208.48  |- mesh__recordAuthorizer mesh__D007402 PLS
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007402 2006
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007402 2001
% 208.27/208.48  |- mesh__dateCreated mesh__D007402 1999-01-01
% 208.27/208.48  |- skos__prefLabel mesh__D007402 Intertrigo
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007402 1996
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007402 1999
% 208.27/208.48  |- mesh__dateRevised mesh__D007402 1992-05-20
% 208.27/208.48  |- mesh__recordMaintainer mesh__D007402 PLS
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007402 2004
% 208.27/208.48  |- skos__annotation mesh__D007402 a dermatitis of skin folds   
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007402 2002
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D007402 1997
% 208.27/208.48  |- skos__scopeNote mesh__D007402
% 208.27/208.48       A superficial dermatitis occurring on skin surfaces in contact with each other, such as the axillae, neck creases, intergluteal fold, between the toes, etc. Obesity is a predisposing factor. The condition is caused by moisture and friction and is characterized by erythema, maceration, burning, and exudation.%A%    
% 208.27/208.48  |- rdf__type mesh__D007402sskos__Concept
% 208.27/208.48  |- rdf__type mesh__D012347sskos__Concept
% 208.27/208.48  |- skos__scopeNote mesh__D012347
% 208.27/208.48       A transfer RNA which is specific for carrying arginine to sites on the ribosomes in preparation for protein synthesis.%A%    
% 208.27/208.48  |- skos__annotation mesh__D012347
% 208.27/208.48       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 208.27/208.48  |- skos__altLabel mesh__D012347 Transfer RNA, Arg
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D012347 1997
% 208.27/208.48  |- skos__historyNote mesh__D012347 Amino Acyl T RNA %28%1978-1987%29%
% 208.27/208.48  |- skos__historyNote mesh__D012347 RNA, Transfer %28%1966-1987%29%
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D012347 2000
% 208.27/208.48  |- mesh__dateEstablished mesh__D012347 1991-01-01
% 208.27/208.48  |- mesh__recordOriginator mesh__D012347 RLS
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D012347 2003
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D012347 1998
% 208.27/208.48  |- mesh__historyNote mesh__D012347
% 208.27/208.48       91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D012347 2001
% 208.27/208.48  |- skos__hiddenLabel mesh__D012347 tRNA, Arginine-Specific
% 208.27/208.48  |- skos__altLabel mesh__D012347 tRNA%28%Arg%29%
% 208.27/208.48  |- mesh__dateCreated mesh__D012347 1987-05-06
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D012347 2004
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D012347 1999
% 208.27/208.48  |- skos__hiddenLabel mesh__D012347 Arginine Specific tRNA
% 208.27/208.48  |- skos__altLabel mesh__D012347 tRNAArg
% 208.27/208.48  |- mesh__recordMaintainer mesh__D012347 TGC
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D012347 2002
% 208.27/208.48  |- skos__prefLabel mesh__D012347 RNA, Transfer, Arg
% 208.27/208.48  |- mesh__recordAuthorizer mesh__D012347 PLS
% 208.27/208.48  |- skos__hiddenLabel mesh__D012347 Arg Transfer RNA
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D012347 2005
% 208.27/208.48  |- mesh__dateRevised mesh__D012347 1996-06-10
% 208.27/208.48  |- skos__hiddenLabel mesh__D012347 RNA, Arg Transfer
% 208.27/208.48  |- skos__altLabel mesh__D012347 Arginine-Specific tRNA
% 208.27/208.48  |- mesh__publicMeSHNote mesh__D012347
% 208.27/208.48       91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.27/208.48  |- skos__broader mesh__D012347smesh__D012345
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D012347 2006
% 208.27/208.48  |- skos__annotation mesh__D017830 D25-26 qualif   
% 208.27/208.48  |- skos__altLabel mesh__D017830 Octylphenoxy Polyethoxyethanol
% 208.27/208.48  |- skos__historyNote mesh__D017830 Polyethylene Glycols %28%1974-1993%29%
% 208.27/208.48  |- skos__hiddenLabel mesh__D017830 Triton X 45
% 208.27/208.48  |- mesh__dateEstablished mesh__D017830 1994-01-01
% 208.27/208.48  |- mesh__recordOriginator mesh__D017830 TPW
% 208.27/208.48  |- mesh__dateCreated mesh__D017830 1993-07-12
% 208.27/208.48  |- skos__prefLabel mesh__D017830 Octoxynol
% 208.27/208.48  |- skos__hiddenLabel mesh__D017830 Octoxynol 9
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D017830 2005
% 208.27/208.48  |- mesh__onlineNote mesh__D017830
% 208.27/208.48       use OCTOXYNOL %28%NM%29% to search OCTOXYNOL 1980-93   
% 208.27/208.48  |- mesh__dateRevised mesh__D017830 2004-07-07
% 208.27/208.48  |- skos__hiddenLabel mesh__D017830 Triton X100
% 208.27/208.48  |- skos__broader mesh__D017830smesh__D011092
% 208.27/208.48  |- skos__scopeNote mesh__D017830
% 208.27/208.48       Nonionic surfactant mixtures varying in the number of repeating ethoxy %28%oxy-1,2-ethanediyl%29% groups. They are used as detergents, emulsifiers, wetting agents, defoaming agents, etc. Octoxynol-9, the compound with 9 repeating ethoxy groups, is a spermatocide.%A%    
% 208.27/208.48  |- skos__altLabel mesh__D017830 Octoxinol
% 208.27/208.48  |- rdf__type mesh__D017830sskos__Concept
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D017830 2006
% 208.27/208.48  |- skos__hiddenLabel mesh__D017830 Triton X 305
% 208.27/208.48  |- skos__historyNote mesh__D017830 Phenyl Ethers %28%1975-1976%29%
% 208.27/208.48  |- skos__altLabel mesh__D017830 Octylphenoxypolyethoxyethanols
% 208.27/208.48  |- mesh__recordAuthorizer mesh__D017830 sjn
% 208.27/208.48  |- mesh__publicMeSHNote mesh__D017830
% 208.27/208.48       94; OCTOXYNOL was indexed under POLYETHYLENE GLYCOLS 1983-94 %26% 1974-79, TRITONS 1979-82 %26% PHENYL ETHERS 1975-76%A%  
% 208.27/208.48  |- mesh__historyNote mesh__D017830 94; was OCTOXYNOL %28%NM%29% 1974-93   
% 208.27/208.48  |- skos__hiddenLabel mesh__D017830 Polyethoxyethanol, Octylphenoxy
% 208.27/208.48  |- skos__hiddenLabel mesh__D017830 Triton X45
% 208.27/208.48  |- skos__altLabel mesh__D017830 Octoxinols
% 208.27/208.48  |- skos__altLabel mesh__D017830 Octoxynols
% 208.27/208.48  |- mesh__recordMaintainer mesh__D017830 jmp
% 208.27/208.48  |- skos__hiddenLabel mesh__D017830 Triton X 100
% 208.27/208.48  |- skos__hiddenLabel mesh__D017830 Triton X305
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D031501 2003
% 208.27/208.48  |- skos__altLabel mesh__D031501 Fagara horrida
% 208.27/208.48  |- mesh__publicMeSHNote mesh__D031501 2003   
% 208.27/208.48  |- skos__scopeNote mesh__D031501
% 208.27/208.48       A plant genus of the family FABACEAE that contains gleditsiosides %28%triterpenoid SAPONINS%29%.%A%    
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D031501 2004
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D031501 2005
% 208.27/208.48  |- mesh__dateCreated mesh__D031501 2002-07-03
% 208.27/208.48  |- skos__broader mesh__D031501smesh__D007887
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D031501 2006
% 208.27/208.48  |- mesh__dateEstablished mesh__D031501 2003-01-01
% 208.27/208.48  |- skos__prefLabel mesh__D031501 Gleditsia
% 208.27/208.48  |- skos__annotation mesh__D031501
% 208.27/208.48       X ref FAGARA HORRIDA: FAGARA, unspecified index RUTACEAE; for other species check plant taxonomy reference: Manual 22.37; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.27/208.48  |- mesh__historyNote mesh__D031501 2003   
% 208.27/208.48  |- rdf__type mesh__D031501sskos__Concept
% 208.27/208.48  |- mesh__recordAuthorizer mesh__D003810 sjn
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D003810 2006
% 208.27/208.48  |- mesh__historyNote mesh__D003810 65   
% 208.27/208.48  |- skos__annotation mesh__D003810
% 208.27/208.48       formation of primary dentin; formation of secondary dentin = DENTIN, SECONDARY /growth; AMELOGENESIS, formation of dent enamel, is also available%A%  
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D003810 2005
% 208.27/208.48  |- mesh__recordMaintainer mesh__D003810 lkt
% 208.27/208.48  |- skos__broader mesh__D003810smesh__D009805
% 208.27/208.48  |- rdf__type mesh__D003810sskos__Concept
% 208.27/208.48  |- mesh__dateCreated mesh__D003810 1999-01-01
% 208.27/208.48  |- mesh__dateRevised mesh__D003810 2004-07-07
% 208.27/208.48  |- mesh__recordOriginator mesh__D003810 NLM
% 208.27/208.48  |- skos__scopeNote mesh__D003810
% 208.27/208.48       The formation of dentin. Dentin first appears in the layer between the ameloblasts and odontoblasts and becomes calcified immediately. Formation progresses from the tip of the papilla over its slope to form a calcified cap becoming thicker by the apposition of new layers pulpward. A layer of uncalcified dentin intervenes between the calcified tissue and the odontoblast and its processes. %28%From Jablonski, Dictionary of Dentistry, 1992%29%%A%    
% 208.27/208.48  |- skos__prefLabel mesh__D003810 Dentinogenesis
% 208.27/208.48  |- mesh__dateEstablished mesh__D003810 1965-01-01
% 208.27/208.48  |- mesh__publicMeSHNote mesh__D003810 65   
% 208.27/208.48  |- skos__hiddenLabel mesh__D003810 Dentinogeneses
% 208.27/208.48  |- skos__prefLabel mesh__D003012 Microbial Collagenase
% 208.27/208.48  |- mesh__historyNote mesh__D003012
% 208.27/208.48       94; was CLOSTRIDIUM HISTOLYTICUM COLLAGENASE 1991-93; was CLOSTRIDIOPEPTIDASE A 1963-90%A%  
% 208.27/208.48  |- skos__hiddenLabel mesh__D003012 Collagenase, Clostridium histolyticum
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D003012 2006
% 208.27/208.48  |- skos__altLabel mesh__D003012 Clostridium histolyticum Collagenase
% 208.27/208.48  |- skos__broader mesh__D003012smesh__D017364
% 208.27/208.48  |- skos__altLabel mesh__D003012 Collalysine
% 208.27/208.48  |- mesh__publicMeSHNote mesh__D003012
% 208.27/208.48       94; was CLOSTRIDIUM HISTOLYTICUM COLLAGENASE 1991-93; was CLOSTRIDIOPEPTIDASE A 1963-90%A%  
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D003012 2004
% 208.27/208.48  |- mesh__onlineNote mesh__D003012
% 208.27/208.48       use MICROBIAL COLLAGENASE to search CLOSTRIDIUM HISTOLYTICUM COLLAGENASE 1991-93 %26% CLOSTRIDIOPEPTIDASE A 1966-90%A%  
% 208.27/208.48  |- rdf__type mesh__D003012sskos__Concept
% 208.27/208.48  |- skos__hiddenLabel mesh__D003012 Peptidase, Collagenase-Like
% 208.27/208.48  |- skos__altLabel mesh__D003012 Clostridiopeptidase A
% 208.27/208.48  |- skos__altLabel mesh__D003012 Nucleolysin
% 208.27/208.48  |- mesh__recordOriginator mesh__D003012 NLM
% 208.27/208.48  |- skos__hiddenLabel mesh__D003012 Collagenase Like Peptidase
% 208.27/208.48  |- skos__altLabel mesh__D003012 Collagenase, Microbial
% 208.27/208.48  |- mesh__dateRevised mesh__D003012 2003-07-09
% 208.27/208.48  |- mesh__recordMaintainer mesh__D003012 jmp
% 208.27/208.48  |- mesh__dateEstablished mesh__D003012 1966-01-01
% 208.27/208.48  |- mesh__dateCreated mesh__D003012 1999-01-01
% 208.27/208.48  |- skos__scopeNote mesh__D003012
% 208.27/208.48       A metalloproteinase which degrades helical regions of native collagen to small fragments. Preferred cleavage is -Gly in the sequence -Pro-Xaa-Gly-Pro-. Six forms %28%or 2 classes%29% have been isolated from Clostridium histolyticum that are immunologically cross-reactive but possess different sequences and different specificities. Other variants have been isolated from Bacillus cereus, Empedobacter collagenolyticum, Pseudomonas marinoglutinosa, and species of Vibrio and Streptomyces. EC 3.4.24.3.%A%    
% 208.27/208.48  |- skos__annotation mesh__D003012
% 208.27/208.48       coord IM with specific bacterium /enzymol %28%IM or NIM%29% if pertinent%A%  
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D003012 2005
% 208.27/208.48  |- mesh__recordAuthorizer mesh__D003012 sjn
% 208.27/208.48  |- skos__broader mesh__D049912smesh__D000236
% 208.27/208.48  |- mesh__historyNote mesh__D049912 2006   
% 208.27/208.48  |- mesh__recordAuthorizer mesh__D049912 sjn
% 208.27/208.48  |- mesh__dateEstablished mesh__D049912 2006-01-01
% 208.27/208.48  |- mesh__activeMeSHYear mesh__D049912 2006
% 208.27/208.48  |- skos__altLabel mesh__D049912 Somatotroph Adenoma
% 208.27/208.48  |- rdf__type mesh__D049912sskos__Concept
% 208.27/208.48  |- skos__scopeNote mesh__D049912
% 208.27/208.48       A pituitary tumor that secretes GROWTH HORMONE. In humans, excess HUMAN GROWTH HORMONE leads to ACROMEGALY.%A%    
% 208.27/208.48  |- skos__hiddenLabel mesh__D049912 Adenoma, Somatotroph
% 208.27/208.48  |- skos__hiddenLabel mesh__D049912 Adenomas, Somatotroph
% 208.27/208.48  |- mesh__recordOriginator mesh__D049912 lkt
% 208.27/208.48  |- mesh__dateCreated mesh__D049912 2005-06-30
% 208.27/208.48  |- skos__prefLabel mesh__D049912 Growth Hormone-Secreting Pituitary Adenoma
% 208.27/208.48  |- skos__hiddenLabel mesh__D049912 Pituitary Adenoma, GH Secreting
% 208.27/208.48  |- skos__annotation mesh__D049912 coordinate IM with ADENOMA %28%IM%29%   
% 208.27/208.48  |- skos__hiddenLabel mesh__D049912 GH Secreting Pituitary Adenoma
% 208.27/208.48  |- skos__hiddenLabel mesh__D049912
% 208.27/208.48       Pituitary Growth Hormone Secreting Adenoma
% 208.27/208.48  |- skos__hiddenLabel mesh__D049912 GH-Secreting Pituitary Adenomas
% 208.27/208.48  |- mesh__recordMaintainer mesh__D049912 lkt
% 208.27/208.48  |- skos__hiddenLabel mesh__D049912 Somatotroph Adenomas
% 208.27/208.48  |- skos__historyNote mesh__D049912 Pituitary Neoplasms %28%1981-2005%29%
% 208.27/208.48  |- skos__broader mesh__D049912smesh__D010911
% 208.27/208.48  |- skos__altLabel mesh__D049912 GH-Secreting Pituitary Adenoma
% 208.27/208.48  |- mesh__publicMeSHNote mesh__D049912 2006   
% 208.27/208.48  |- skos__hiddenLabel mesh__D049912 Pituitary Adenomas, GH-Secreting
% 208.27/208.48  |- skos__altLabel mesh__D049912 Pituitary Adenoma, GH-Secreting
% 208.27/208.48  |- skos__altLabel mesh__D049912 Pituitary Growth Hormone-Secreting Adenoma
% 208.27/208.48  |- skos__broader mesh__D016738smesh__D000015
% 208.27/208.48  |- skos__scopeNote mesh__D016738
% 208.27/208.48       An autosomal dominant MUTATION involving CHROMOSOME 20. It is characterized by the almost normal LIVER that has few or no intrahepatic bile ducts %28%BILE DUCTS, INTRAHEPATIC%29%. Other extrahepatic malformations include those in the heart, the eyes, the vertebral column, and the facies. Major clinical features include JAUNDICE, and congenital heart disease with peripheral PULMONARY STENOSIS.%A%    
% 208.27/208.49  |- skos__historyNote mesh__D016738
% 208.27/208.49       Bile Ducts, Intrahepatic/abnormalities %28%1980-1991%29%
% 208.27/208.49  |- skos__altLabel mesh__D016738 Dysplasia, Arteriohepatic
% 208.27/208.49  |- skos__historyNote mesh__D016738
% 208.27/208.49       Abnormalities, Multiple %28%1981-1991%29%
% 208.27/208.49  |- skos__hiddenLabel mesh__D016738 Syndrome, Alagille
% 208.27/208.49  |- mesh__dateEstablished mesh__D016738 1992-01-01
% 208.27/208.49  |- mesh__historyNote mesh__D016738 92   
% 208.27/208.49  |- mesh__dateRevised mesh__D016738 2003-07-09
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D016738 2004
% 208.27/208.49  |- skos__hiddenLabel mesh__D016738 Arteriohepatic Dysplasias
% 208.27/208.49  |- mesh__recordMaintainer mesh__D016738 lkt
% 208.27/208.49  |- skos__hiddenLabel mesh__D016738 Alagille Watson Syndrome
% 208.27/208.49  |- mesh__recordOriginator mesh__D016738 TGC
% 208.27/208.49  |- mesh__publicMeSHNote mesh__D016738 92   
% 208.27/208.49  |- skos__altLabel mesh__D016738
% 208.27/208.49       Cholestasis with Peripheral Pulmonary Stenosis
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D016738 2005
% 208.27/208.49  |- skos__hiddenLabel mesh__D016738 Syndrome, Alagille-Watson
% 208.27/208.49  |- skos__altLabel mesh__D016738 Alagille-Watson Syndrome
% 208.27/208.49  |- skos__altLabel mesh__D016738 Arteriohepatic Dysplasia
% 208.27/208.49  |- mesh__dateCreated mesh__D016738 1991-04-29
% 208.27/208.49  |- skos__historyNote mesh__D016738
% 208.27/208.49       Pulmonary Artery/abnormalities %28%1988-1991%29%
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D016738 2006
% 208.27/208.49  |- skos__broader mesh__D016738smesh__D006330
% 208.27/208.49  |- skos__altLabel mesh__D016738 Hepatic Ductular Hypoplasia, Syndromatic
% 208.27/208.49  |- skos__historyNote mesh__D016738
% 208.27/208.49       Cholestasis, Intrahepatic %28%1979-1991%29%
% 208.27/208.49  |- skos__broader mesh__D016738smesh__D002780
% 208.27/208.49  |- mesh__recordAuthorizer mesh__D016738 sjn
% 208.27/208.49  |- rdf__type mesh__D016738sskos__Concept
% 208.27/208.49  |- skos__prefLabel mesh__D016738 Alagille Syndrome
% 208.27/208.49  |- skos__hiddenLabel mesh__D016738 Dysplasias, Arteriohepatic
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013440 2004
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013440 1997
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013440 1994
% 208.27/208.49  |- mesh__recordOriginator mesh__D013440 NLM
% 208.27/208.49  |- skos__scopeNote mesh__D013440
% 208.27/208.49       Chemical groups containing the covalent sulfur bonds -S-. The sulfur atom can be bound to inorganic or organic moieties.%A%    
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013440 2006
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013440 1999
% 208.27/208.49  |- mesh__recordAuthorizer mesh__D013440 PLS
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013440 2000
% 208.27/208.49  |- skos__broader mesh__D013440smesh__D013457
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013440 2001
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013440 1995
% 208.27/208.49  |- skos__broader mesh__D013440smesh__D000838
% 208.27/208.49  |- skos__broader mesh__D013440smesh__D006862
% 208.27/208.49  |- skos__prefLabel mesh__D013440 Sulfides
% 208.27/208.49  |- skos__hiddenLabel mesh__D013440 Ethers, Sulfur
% 208.27/208.49  |- mesh__dateRevised mesh__D013440 1993-06-03
% 208.27/208.49  |- mesh__recordMaintainer mesh__D013440 TPW
% 208.27/208.49  |- mesh__dateCreated mesh__D013440 1999-01-01
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013440 2002
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013440 1996
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013440 2003
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013440 1998
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013440 2005
% 208.27/208.49  |- rdf__type mesh__D013440sskos__Concept
% 208.27/208.49  |- mesh__dateRevised mesh__D007403 2005-06-30
% 208.27/208.49  |- skos__hiddenLabel mesh__D007403 Discs, Intervertebral
% 208.27/208.49  |- skos__hiddenLabel mesh__D007403 Intervertebral Discs
% 208.27/208.49  |- skos__altLabel mesh__D007403 Disc, Intervertebral
% 208.27/208.49  |- skos__annotation mesh__D007403
% 208.27/208.49       coord IM with specific vertebrae %28%IM%29%; diseases: probably DISCITIS or INTERVERTEBRAL DISK DISPLACEMENT but if not, index as INTERVERTEBRAL DISK %28%IM%29% + SPINAL DISEASES %28%IM%29%; chemonucleolysis = INTERVERTEBRAL DISK CHEMOLYSIS%A%  
% 208.27/208.49  |- mesh__recordMaintainer mesh__D007403 ags
% 208.27/208.49  |- skos__hiddenLabel mesh__D007403 Disks, Intervertebral
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D007403 2006
% 208.27/208.49  |- skos__broader mesh__D007403smesh__D051445
% 208.27/208.49  |- mesh__dateCreated mesh__D007403 1999-01-01
% 208.27/208.49  |- mesh__recordOriginator mesh__D007403 NLM
% 208.27/208.49  |- skos__hiddenLabel mesh__D007403 Intervertebral Disc
% 208.27/208.49  |- mesh__recordAuthorizer mesh__D007403 sjn
% 208.27/208.49  |- skos__hiddenLabel mesh__D007403 Intervertebral Disks
% 208.27/208.49  |- skos__related mesh__D007403smesh__D017586
% 208.27/208.49  |- skos__altLabel mesh__D007403 Disk, Intervertebral
% 208.27/208.49  |- rdf__type mesh__D007403sskos__Concept
% 208.27/208.49  |- skos__broader mesh__D007403smesh__D013131
% 208.27/208.49  |- skos__prefLabel mesh__D007403 Intervertebral Disk
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D045522 2006
% 208.27/208.49  |- mesh__recordAuthorizer mesh__D045522 sjn
% 208.27/208.49  |- mesh__publicMeSHNote mesh__D045522
% 208.27/208.49       2004; RECOMBINASE was indexed under DNA NUCLEOTIDYLTRANSFERASES 1986-2003; RESOLVASE was indexed under TRANSPOSASES 1997-2003, under DNA NUCLEOTIDYLTRANSFERASES 1992-1997 %26% under NUCLEOTIDYLTRANSFERASES 1981-1995%A%  
% 208.27/208.49  |- mesh__dateEstablished mesh__D045522 2004-01-01
% 208.27/208.49  |- skos__altLabel mesh__D045522 Resolvase
% 208.27/208.49  |- mesh__recordMaintainer mesh__D045522 jmp
% 208.27/208.49  |- skos__broader mesh__D045522smesh__D004798
% 208.27/208.49  |- mesh__dateCreated mesh__D045522 2003-07-25
% 208.27/208.49  |- skos__prefLabel mesh__D045522 Recombinases
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D045522 2004
% 208.27/208.49  |- skos__altLabel mesh__D045522 Recombinase
% 208.27/208.49  |- mesh__recordOriginator mesh__D045522 jmp
% 208.27/208.49  |- skos__scopeNote mesh__D045522
% 208.27/208.49       A broad category of enzymes that are involved in the process of GENETIC RECOMBINATION.%A%    
% 208.27/208.49  |- skos__historyNote mesh__D045522
% 208.27/208.49       DNA Nucleotidyltransferases %28%1986-2003%29%
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D045522 2005
% 208.27/208.49  |- rdf__type mesh__D045522sskos__Concept
% 208.27/208.49  |- mesh__historyNote mesh__D045522
% 208.27/208.49       2004; use RECOMBINASES %28%NM%29% 1986-2003; for RESOLVASE use RECOMBINASES %28%NM%29% 1981-2003%A%  
% 208.27/208.49  |- skos__altLabel mesh__D012348 tRNAAsn
% 208.27/208.49  |- mesh__dateRevised mesh__D012348 1996-06-10
% 208.27/208.49  |- skos__scopeNote mesh__D012348
% 208.27/208.49       A transfer RNA which is specific for carrying asparagine to sites on the ribosomes in preparation for protein synthesis.%A%    
% 208.27/208.49  |- skos__historyNote mesh__D012348 RNA, Transfer %28%1966-1987%29%
% 208.27/208.49  |- mesh__dateEstablished mesh__D012348 1991-01-01
% 208.27/208.49  |- skos__hiddenLabel mesh__D012348 RNA, Asn Transfer
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D012348 2003
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D012348 1998
% 208.27/208.49  |- skos__hiddenLabel mesh__D012348 Asn Transfer RNA
% 208.27/208.49  |- skos__hiddenLabel mesh__D012348 tRNA, Asparagine-Specific
% 208.27/208.49  |- skos__altLabel mesh__D012348 Asparagine-Specific tRNA
% 208.27/208.49  |- skos__altLabel mesh__D012348 Transfer RNA, Asn
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D012348 2004
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D012348 1999
% 208.27/208.49  |- skos__historyNote mesh__D012348 Amino Acyl T RNA %28%1978-1987%29%
% 208.27/208.49  |- mesh__recordMaintainer mesh__D012348 TGC
% 208.27/208.49  |- mesh__dateCreated mesh__D012348 1987-05-07
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D012348 2000
% 208.27/208.49  |- mesh__recordOriginator mesh__D012348 RLS
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D012348 2005
% 208.27/208.49  |- skos__altLabel mesh__D012348 tRNA%28%Asn%29%
% 208.27/208.49  |- mesh__historyNote mesh__D012348
% 208.27/208.49       91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.27/208.49  |- skos__broader mesh__D012348smesh__D012345
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D012348 2001
% 208.27/208.49  |- mesh__publicMeSHNote mesh__D012348
% 208.27/208.49       91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.27/208.49  |- rdf__type mesh__D012348sskos__Concept
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D012348 2006
% 208.27/208.49  |- skos__prefLabel mesh__D012348 RNA, Transfer, Asn
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D012348 2002
% 208.27/208.49  |- skos__annotation mesh__D012348
% 208.27/208.49       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 208.27/208.49  |- skos__hiddenLabel mesh__D012348 Asparagine Specific tRNA
% 208.27/208.49  |- mesh__recordAuthorizer mesh__D012348 PLS
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D012348 1997
% 208.27/208.49  |- skos__hiddenLabel mesh__D017831 Dual Diagnosis %28%Psychiatry%29%
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D017831 2000
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D017831 1994
% 208.27/208.49  |- mesh__publicMeSHNote mesh__D017831 94   
% 208.27/208.49  |- skos__historyNote mesh__D017831
% 208.27/208.49       specific substance abuse disorder/diagnosis %28%1989-1993%29%
% 208.27/208.49  |- skos__hiddenLabel mesh__D017831 Dual Psychiatric Diagnoses
% 208.27/208.49  |- skos__annotation mesh__D017831
% 208.27/208.49       restrict to substance abuse with ment disord; IM GEN only; coord NIM with specific addiction %28%IM%29% + specific ment disord %28%IM%29%; DF: DUAL DIAG%A%  
% 208.27/208.49  |- skos__prefLabel mesh__D017831 Diagnosis, Dual %28%Psychiatry%29%
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D017831 2006
% 208.27/208.49  |- skos__altLabel mesh__D017831 Psychiatric Diagnosis, Dual
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D017831 1998
% 208.27/208.49  |- skos__hiddenLabel mesh__D017831 Dual Diagnoses %28%Psychiatry%29%
% 208.27/208.49  |- skos__altLabel mesh__D017831 Dual Diagnosis, Psychiatric
% 208.27/208.49  |- skos__hiddenLabel mesh__D017831 Diagnosis, Psychiatric Dual
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D017831 1997
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D017831 2005
% 208.27/208.49  |- skos__hiddenLabel mesh__D017831 Diagnoses, Psychiatric Dual
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D017831 2004
% 208.27/208.49  |- skos__hiddenLabel mesh__D017831 Dual Psychiatric Diagnosis
% 208.27/208.49  |- skos__hiddenLabel mesh__D017831 Diagnoses, Dual
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D017831 2002
% 208.27/208.49  |- skos__hiddenLabel mesh__D017831 Diagnosis, Dual
% 208.27/208.49  |- skos__altLabel mesh__D017831 Psychiatric Dual Diagnosis
% 208.27/208.49  |- skos__hiddenLabel mesh__D017831 Psychiatric Diagnoses, Dual
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D017831 1996
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D017831 2003
% 208.27/208.49  |- skos__altLabel mesh__D017831 Dual Diagnosis
% 208.27/208.49  |- skos__hiddenLabel mesh__D017831 Psychiatric Dual Diagnoses
% 208.27/208.49  |- skos__broader mesh__D017831smesh__D003933
% 208.27/208.49  |- rdf__type mesh__D017831sskos__Concept
% 208.27/208.49  |- mesh__dateCreated mesh__D017831 1993-02-16
% 208.27/208.49  |- skos__hiddenLabel mesh__D017831 Diagnosis, Dual Psychiatric
% 208.27/208.49  |- mesh__historyNote mesh__D017831 94   
% 208.27/208.49  |- mesh__dateEstablished mesh__D017831 1994-01-01
% 208.27/208.49  |- skos__hiddenLabel mesh__D017831 Diagnoses, Dual Psychiatric
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D017831 2001
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D017831 1995
% 208.27/208.49  |- skos__scopeNote mesh__D017831
% 208.27/208.49       The co-existence of a substance abuse disorder with a psychiatric disorder. The diagnostic principle is based on the fact that it has been found often that chemically dependent patients also have psychiatric problems of various degrees of severity.%A%    
% 208.27/208.49  |- skos__hiddenLabel mesh__D017831 Dual Diagnoses, Psychiatric
% 208.27/208.49  |- skos__hiddenLabel mesh__D017831 Dual Diagnoses
% 208.27/208.49  |- skos__historyNote mesh__D017831
% 208.27/208.49       specific mental disorder/diagnosis %28%1989-1993%29%
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D017831 1999
% 208.27/208.49  |- skos__hiddenLabel mesh__D017831 Diagnoses, Dual %28%Psychiatry%29%
% 208.27/208.49  |- skos__historyNote mesh__D017033 Algae %28%1966-1969%29%
% 208.27/208.49  |- mesh__publicMeSHNote mesh__D017033 92   
% 208.27/208.49  |- rdf__type mesh__D017033sskos__Concept
% 208.27/208.49  |- skos__historyNote mesh__D017033 Cyanobacteria %28%1970-1991%29%
% 208.27/208.49  |- mesh__dateRevised mesh__D017033 2005-06-30
% 208.27/208.49  |- mesh__recordMaintainer mesh__D017033 SYSTEM
% 208.27/208.49  |- mesh__historyNote mesh__D017033 92   
% 208.27/208.49  |- skos__broader mesh__D017033smesh__D000458
% 208.27/208.49  |- skos__scopeNote mesh__D017033
% 208.27/208.49       A genus of CYANOBACTERIA consisting of trichomes that are untapered with conspicuous constrictions at cross-walls. A firm individual sheath is absent, but a soft covering is often present. Many species are known worldwide as major components of freshwater PLANKTON and also of many saline lakes. The species ANABAENA FLOS-AQUAE is responsible for acute poisonings of various animals.%A%    
% 208.27/208.49  |- mesh__dateEstablished mesh__D017033 1992-01-01
% 208.27/208.49  |- skos__prefLabel mesh__D017033 Anabaena
% 208.27/208.49  |- skos__annotation mesh__D017033
% 208.27/208.49       general or unspecified; prefer specifics   
% 208.27/208.49  |- mesh__recordOriginator mesh__D017033 PXP
% 208.27/208.49  |- mesh__recordAuthorizer mesh__D017033 sjn
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D017033 2006
% 208.27/208.49  |- mesh__dateCreated mesh__D017033 1991-05-30
% 208.27/208.49  |- skos__hiddenLabel mesh__D003811 Imperfectas, Dentinogenesis
% 208.27/208.49  |- mesh__recordOriginator mesh__D003811 NLM
% 208.27/208.49  |- skos__broader mesh__D003811smesh__D014071
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D003811 2006
% 208.27/208.49  |- mesh__recordMaintainer mesh__D003811 kle
% 208.27/208.49  |- skos__hiddenLabel mesh__D003811 Opalescent Dentin, Hereditary
% 208.27/208.49  |- mesh__dateCreated mesh__D003811 1999-01-01
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D003811 2003
% 208.27/208.49  |- mesh__dateRevised mesh__D003811 1999-11-03
% 208.27/208.49  |- skos__prefLabel mesh__D003811 Dentinogenesis Imperfecta
% 208.27/208.49  |- mesh__recordAuthorizer mesh__D003811 sjn
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D003811 2002
% 208.27/208.49  |- skos__hiddenLabel mesh__D003811 Imperfecta, Dentinogenesis
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D003811 2004
% 208.27/208.49  |- skos__hiddenLabel mesh__D003811 Dentins, Hereditary Opalescent
% 208.27/208.49  |- rdf__type mesh__D003811sskos__Concept
% 208.27/208.49  |- skos__hiddenLabel mesh__D003811 Hereditary Opalescent Dentins
% 208.27/208.49  |- skos__hiddenLabel mesh__D003811 Opalescent Dentins, Hereditary
% 208.27/208.49  |- skos__hiddenLabel mesh__D003811 Dentin, Hereditary Opalescent
% 208.27/208.49  |- skos__annotation mesh__D003811
% 208.27/208.49       a dentin abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D003811 2000
% 208.27/208.49  |- mesh__historyNote mesh__D003811 65   
% 208.27/208.49  |- mesh__publicMeSHNote mesh__D003811 65   
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D003811 2005
% 208.27/208.49  |- skos__scopeNote mesh__D003811
% 208.27/208.49       An autosomal dominant disorder of tooth development characterized by opalescent dentin resulting in discoloration of the teeth, ranging from dusky blue to brownish. The dentin is poorly formed with an abnormally low mineral content; the pulp canal is obliterated, but the enamel is normal. The teeth usually wear down rapidly, leaving short, brown stumps. %28%Dorland, 27th ed%29%%A%    
% 208.27/208.49  |- skos__hiddenLabel mesh__D003811 Dentinogenesis Imperfectas
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D003811 2001
% 208.27/208.49  |- mesh__recordAuthorizer mesh__D003013 sjn
% 208.27/208.49  |- skos__broader mesh__D003013smesh__D016937
% 208.27/208.49  |- skos__scopeNote mesh__D003013
% 208.27/208.49       A genus of motile or nonmotile gram-positive bacteria of the family Clostridiaceae. Many species have been identified with some being pathogenic. They occur in water, soil, and in the intestinal tract of humans and lower animals.%A%    
% 208.27/208.49  |- rdf__type mesh__D003013sskos__Concept
% 208.27/208.49  |- mesh__dateRevised mesh__D003013 2005-06-30
% 208.27/208.49  |- mesh__recordMaintainer mesh__D003013 SYSTEM
% 208.27/208.49  |- mesh__dateCreated mesh__D003013 1999-01-01
% 208.27/208.49  |- skos__prefLabel mesh__D003013 Clostridium
% 208.27/208.49  |- mesh__recordOriginator mesh__D003013 NLM
% 208.27/208.49  |- skos__annotation mesh__D003013
% 208.27/208.49       GEN or unspecified; prefer specifics; infection = CLOSTRIDIUM INFECTIONS or its specifics%A%  
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D003013 2006
% 208.27/208.49  |- skos__altLabel mesh__D049913 Pituitary Corticotropin-Secreting Adenoma
% 208.27/208.49  |- skos__altLabel mesh__D049913 Pituitary Adenoma, ACTH-Secreting
% 208.27/208.49  |- skos__altLabel mesh__D049913 ACTH-Producing Pituitary Adenoma
% 208.27/208.49  |- skos__historyNote mesh__D049913 Pituitary Neoplasms %28%1981-2005%29%
% 208.27/208.49  |- skos__broader mesh__D049913smesh__D010911
% 208.27/208.49  |- skos__hiddenLabel mesh__D049913 ACTH Secreting Pituitary Adenoma
% 208.27/208.49  |- mesh__recordOriginator mesh__D049913 lkt
% 208.27/208.49  |- skos__hiddenLabel mesh__D049913 ACTH Producing Pituitary Adenoma
% 208.27/208.49  |- skos__broader mesh__D049913smesh__D000236
% 208.27/208.49  |- skos__scopeNote mesh__D049913
% 208.27/208.49       A pituitary adenoma which secretes ADRENOCORTICOTROPIN, leading to CUSHING DISEASE.%A%    
% 208.27/208.49  |- mesh__historyNote mesh__D049913 2006   
% 208.27/208.49  |- skos__annotation mesh__D049913 coordinate IM with ADENOMA %28%IM%29%   
% 208.27/208.49  |- mesh__recordAuthorizer mesh__D049913 sjn
% 208.27/208.49  |- mesh__dateEstablished mesh__D049913 2006-01-01
% 208.27/208.49  |- skos__hiddenLabel mesh__D049913
% 208.27/208.49       Corticotropin-Secreting Adenoma, Pituitary
% 208.27/208.49  |- skos__hiddenLabel mesh__D049913 Pituitary Adenomas, ACTH-Producing
% 208.27/208.49  |- skos__hiddenLabel mesh__D049913 Pituitary Adenomas, ACTH-Secreting
% 208.27/208.49  |- skos__hiddenLabel mesh__D049913
% 208.27/208.49       Pituitary Corticotropin Secreting Adenoma
% 208.27/208.49  |- mesh__dateCreated mesh__D049913 2005-06-30
% 208.27/208.49  |- skos__hiddenLabel mesh__D049913 Corticotroph Adenomas
% 208.27/208.49  |- skos__altLabel mesh__D049913 Corticotroph Adenoma
% 208.27/208.49  |- skos__hiddenLabel mesh__D049913 Adenoma, Corticotroph
% 208.27/208.49  |- mesh__publicMeSHNote mesh__D049913 2006   
% 208.27/208.49  |- skos__hiddenLabel mesh__D049913
% 208.27/208.49       Pituitary Corticotropin-Secreting Adenomas
% 208.27/208.49  |- skos__prefLabel mesh__D049913 ACTH-Secreting Pituitary Adenoma
% 208.27/208.49  |- skos__hiddenLabel mesh__D049913 Pituitary Adenoma, ACTH Secreting
% 208.27/208.49  |- skos__hiddenLabel mesh__D049913
% 208.27/208.49       Corticotropin-Secreting Adenomas, Pituitary
% 208.27/208.49  |- mesh__recordMaintainer mesh__D049913 lkt
% 208.27/208.49  |- skos__hiddenLabel mesh__D049913 Pituitary Adenoma, ACTH-Producing
% 208.27/208.49  |- rdf__type mesh__D049913sskos__Concept
% 208.27/208.49  |- skos__hiddenLabel mesh__D049913 Adenomas, Corticotroph
% 208.27/208.49  |- skos__hiddenLabel mesh__D049913 ACTH-Secreting Pituitary Adenomas
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D049913 2006
% 208.27/208.49  |- skos__hiddenLabel mesh__D049913 ACTH-Producing Pituitary Adenomas
% 208.27/208.49  |- skos__annotation mesh__D016739 use Cat F3 qualif   
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D016739 2005
% 208.27/208.49  |- mesh__recordMaintainer mesh__D016739 JLS
% 208.27/208.49  |- mesh__dateRevised mesh__D016739 2002-07-02
% 208.27/208.49  |- mesh__recordOriginator mesh__D016739 MXR
% 208.27/208.49  |- mesh__dateCreated mesh__D016739 1991-04-29
% 208.27/208.49  |- mesh__recordAuthorizer mesh__D016739 sjn
% 208.27/208.49  |- skos__historyNote mesh__D016739 Behavior %28%1974-1991%29%
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D016739 2006
% 208.27/208.49  |- mesh__dateEstablished mesh__D016739 1992-01-01
% 208.27/208.49  |- skos__prefLabel mesh__D016739 Behavior, Addictive
% 208.27/208.49  |- skos__scopeNote mesh__D016739
% 208.27/208.49       The observable, measurable, and often pathological activity of an organism that portrays its inability to overcome a habit resulting in an insatiable craving for a substance or for performing certain acts. The addictive behavior includes the emotional and physical overdependence on the object of habit in increasing amount or frequency.%A%    
% 208.27/208.49  |- skos__broader mesh__D016739smesh__D003192
% 208.27/208.49  |- skos__historyNote mesh__D016739 Substance Abuse %28%1980-1991%29%
% 208.27/208.49  |- rdf__type mesh__D016739sskos__Concept
% 208.27/208.49  |- skos__altLabel mesh__D016739 Addictive Behavior
% 208.27/208.49  |- skos__related mesh__D016739smesh__D019966
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D016739 2003
% 208.27/208.49  |- skos__historyNote mesh__D016739 Substance Dependence %28%1974-1991%29%
% 208.27/208.49  |- skos__hiddenLabel mesh__D016739 Addictive Behaviors
% 208.27/208.49  |- mesh__historyNote mesh__D016739 92   
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D016739 2004
% 208.27/208.49  |- mesh__publicMeSHNote mesh__D016739 92   
% 208.27/208.49  |- skos__hiddenLabel mesh__D016739 Behaviors, Addictive
% 208.27/208.49  |- mesh__dateRevised mesh__D027461 2004-07-07
% 208.27/208.49  |- skos__annotation mesh__D027461
% 208.27/208.49       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.27/208.49  |- rdf__type mesh__D027461sskos__Concept
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D027461 2005
% 208.27/208.49  |- skos__broader mesh__D027461smesh__D019663
% 208.27/208.49  |- mesh__historyNote mesh__D027461 2002; use CHENOPODIACEAE 1998-2001   
% 208.27/208.49  |- mesh__dateEstablished mesh__D027461 2002-01-01
% 208.27/208.49  |- mesh__dateCreated mesh__D027461 2001-07-25
% 208.27/208.49  |- skos__prefLabel mesh__D027461 Beta vulgaris
% 208.27/208.49  |- mesh__recordAuthorizer mesh__D027461 sjn
% 208.27/208.49  |- mesh__recordOriginator mesh__D027461 ssb
% 208.27/208.49  |- mesh__recordMaintainer mesh__D027461 ssb
% 208.27/208.49  |- skos__historyNote mesh__D027461 Chenopodiaceae %28%1998-2001%29%
% 208.27/208.49  |- skos__scopeNote mesh__D027461
% 208.27/208.49       A species of the Beta genus. Cultivars are used as a source of beets %28%root%29% or chard %28%leaves%29%.%A%    
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D027461 2006
% 208.27/208.49  |- mesh__publicMeSHNote mesh__D027461 2002; see CHENOPODIACEAE 1998-2001   
% 208.27/208.49  |- skos__historyNote mesh__D002719
% 208.27/208.49       Hypnotics and Sedatives %28%1966-1967%29%
% 208.27/208.49  |- skos__broader mesh__D002719smesh__D013844
% 208.27/208.49  |- mesh__publicMeSHNote mesh__D002719
% 208.27/208.49       68; CHLORETHIAZOLE was see CHLORMETHAZOLE 1975-95   
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D002719 2006
% 208.27/208.49  |- skos__historyNote mesh__D002719 Thiazoles %28%1966-1967%29%
% 208.27/208.49  |- skos__prefLabel mesh__D002719 Chlormethiazole
% 208.27/208.49  |- mesh__recordOriginator mesh__D002719 NLM
% 208.27/208.49  |- skos__altLabel mesh__D002719 Clomethiazole
% 208.27/208.49  |- mesh__recordAuthorizer mesh__D002719 sjn
% 208.27/208.49  |- mesh__historyNote mesh__D002719
% 208.27/208.49       68; CHLORETHIAZOLE was see CHLORMETHAZOLE 1975-95   
% 208.27/208.49  |- mesh__dateRevised mesh__D002719 2005-06-30
% 208.27/208.49  |- mesh__recordMaintainer mesh__D002719 ssb
% 208.27/208.49  |- mesh__dateEstablished mesh__D002719 1968-01-01
% 208.27/208.49  |- rdf__type mesh__D002719sskos__Concept
% 208.27/208.49  |- skos__scopeNote mesh__D002719
% 208.27/208.49       A sedative and anticonvulsant often used in the treatment of alcohol withdrawal. Chlormethiazole has also been proposed as a neuroprotective agent. The mechanism of its therapeutic activity is not entirely clear, but it does potentiate GAMMA-AMINOBUTYRIC ACID receptors response and it may also affect glycine receptors.%A%    
% 208.27/208.49  |- mesh__dateCreated mesh__D002719 1999-01-01
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013441 1997
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013441 2004
% 208.27/208.49  |- mesh__dateEstablished mesh__D013441 1965-01-01
% 208.27/208.49  |- mesh__recordAuthorizer mesh__D013441 PLS
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013441 2000
% 208.27/208.49  |- rdf__type mesh__D013441sskos__Concept
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013441 1996
% 208.27/208.49  |- skos__prefLabel mesh__D013441 Sulfinic Acids
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013441 2003
% 208.27/208.49  |- mesh__dateRevised mesh__D013441 1993-06-04
% 208.27/208.49  |- mesh__publicMeSHNote mesh__D013441 65   
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013441 1999
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013441 2006
% 208.27/208.49  |- skos__annotation mesh__D013441 do not confuse with SULFONIC ACIDS   
% 208.27/208.49  |- mesh__recordOriginator mesh__D013441 NLM
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013441 2002
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013441 1995
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013441 1998
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013441 2005
% 208.27/208.49  |- skos__scopeNote mesh__D013441
% 208.27/208.49       Any of the monobasic inorganic or organic acids of sulfur with the general formula RSO%28%OH%29%. %28%From McGraw Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 208.27/208.49  |- mesh__historyNote mesh__D013441 65   
% 208.27/208.49  |- mesh__recordMaintainer mesh__D013441 TPW
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013441 1994
% 208.27/208.49  |- skos__hiddenLabel mesh__D013441 Acids, Sulfinic
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D013441 2001
% 208.27/208.49  |- skos__broader mesh__D013441smesh__D013456
% 208.27/208.49  |- mesh__dateCreated mesh__D013441 1999-01-01
% 208.27/208.49  |- skos__hiddenLabel mesh__D007404 Intervertebral Disk Chemolyses
% 208.27/208.49  |- skos__hiddenLabel mesh__D007404 Chemonucleolyses
% 208.27/208.49  |- mesh__recordMaintainer mesh__D007404 lkt
% 208.27/208.49  |- skos__altLabel mesh__D007404 Chemonucleolysis
% 208.27/208.49  |- skos__broader mesh__D007404smesh__D019637
% 208.27/208.49  |- skos__hiddenLabel mesh__D007404 Nucleolyses, Intervertebral Disk
% 208.27/208.49  |- rdf__type mesh__D007404sskos__Concept
% 208.27/208.49  |- skos__historyNote mesh__D007404
% 208.27/208.49       Intervertebral Disk Displacement %28%1966-1986%29%
% 208.27/208.49  |- skos__hiddenLabel mesh__D007404 Disk Chemolyses, Intervertebral
% 208.27/208.49  |- skos__historyNote mesh__D007404 Chymopapain %28%1975-1986%29%
% 208.27/208.49  |- skos__hiddenLabel mesh__D007404 Disk Chemolysis, Intervertebral
% 208.27/208.49  |- skos__altLabel mesh__D007404 Discolysis
% 208.27/208.49  |- skos__prefLabel mesh__D007404 Intervertebral Disk Chemolysis
% 208.27/208.49  |- skos__hiddenLabel mesh__D007404 Intervertebral Disk Nucleolyses
% 208.27/208.49  |- skos__annotation mesh__D007404
% 208.27/208.49       coordinate IM with specific substance /ther use %28%usually CHYMOPAPAIN%29% if particularly discussed%A%  
% 208.27/208.49  |- mesh__publicMeSHNote mesh__D007404 87   
% 208.27/208.49  |- skos__related mesh__D007404smesh__D002917
% 208.27/208.49  |- skos__scopeNote mesh__D007404
% 208.27/208.49       The dissolving of the nucleus pulposus, the semi-gelatinous tissue of a displaced INTERVERTEBRAL DISK. It is usually achieved by the direct injection of a proteolytic enzyme, especially CHYMOPAPAIN, into the herniated disk.%A%    
% 208.27/208.49  |- mesh__dateRevised mesh__D007404 2005-06-30
% 208.27/208.49  |- mesh__recordOriginator mesh__D007404 SH
% 208.27/208.49  |- mesh__dateCreated mesh__D007404 1986-06-20
% 208.27/208.49  |- skos__altLabel mesh__D007404 Chemolysis, Intervertebral Disk
% 208.27/208.49  |- skos__hiddenLabel mesh__D007404 Intervertebral Disk Nucleolysis
% 208.27/208.49  |- skos__hiddenLabel mesh__D007404 Discolyses
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D007404 2006
% 208.27/208.49  |- mesh__recordAuthorizer mesh__D007404 sjn
% 208.27/208.49  |- skos__hiddenLabel mesh__D007404 Chemolyses, Intervertebral Disk
% 208.27/208.49  |- skos__altLabel mesh__D007404 Nucleolysis, Intervertebral Disk
% 208.27/208.49  |- mesh__dateEstablished mesh__D007404 1987-01-01
% 208.27/208.49  |- skos__hiddenLabel mesh__D007404 Disk Nucleolyses, Intervertebral
% 208.27/208.49  |- mesh__historyNote mesh__D007404 87   
% 208.27/208.49  |- skos__hiddenLabel mesh__D007404 Disk Nucleolysis, Intervertebral
% 208.27/208.49  |- mesh__recordMaintainer mesh__D051560 DRC
% 208.27/208.49  |- skos__altLabel mesh__D051560 c-bcl-6 Proto-Oncogene Proteins
% 208.27/208.49  |- skos__hiddenLabel mesh__D051560 Proto-Oncogene Proteins, c-bcl-6
% 208.27/208.49  |- skos__hiddenLabel mesh__D051560 Proto Oncogene Proteins c bcl 6
% 208.27/208.49  |- mesh__dateEstablished mesh__D051560 2006-01-01
% 208.27/208.49  |- skos__hiddenLabel mesh__D051560 c bcl 6 Protein
% 208.27/208.49  |- skos__hiddenLabel mesh__D051560 Proto Oncogene Protein c bcl 6
% 208.27/208.49  |- mesh__historyNote mesh__D051560 2006%28%1993%29%   
% 208.27/208.49  |- mesh__recordAuthorizer mesh__D051560 sjn
% 208.27/208.49  |- skos__scopeNote mesh__D051560
% 208.27/208.49       A DNA-binding protein that represses GENETIC TRANSCRIPTION of target genes by recruiting HISTONE DEACETYLASES. Aberrant Blc-6 expression is associated with certain types of human B-CELL LYMPHOMA.%A%    
% 208.27/208.49  |- skos__hiddenLabel mesh__D051560 B Cell Lymphoma 6 Protein
% 208.27/208.49  |- skos__altLabel mesh__D051560 B-Cell Lymphoma 6 Protein
% 208.27/208.49  |- mesh__publicMeSHNote mesh__D051560
% 208.27/208.49       2006; PROTO-ONCOGENE PROTEIN C-BCL-6 was indexed under DNA-BINDING PROTEINS %26% PROTO-ONCOGENE PROTEINS %26% TRANSCRIPTION FACTORS 1993-2005%A%  
% 208.27/208.49  |- skos__altLabel mesh__D051560 bcl-6 Proto-Oncogene Proteins
% 208.27/208.49  |- skos__hiddenLabel mesh__D051560 Proto-Oncogene Proteins, bcl-6
% 208.27/208.49  |- rdf__type mesh__D051560sskos__Concept
% 208.27/208.49  |- skos__broader mesh__D051560smesh__D014157
% 208.27/208.49  |- skos__hiddenLabel mesh__D051560 bcl 6 Proto Oncogene Proteins
% 208.27/208.49  |- skos__altLabel mesh__D051560 Zinc Finger Protein 51
% 208.27/208.49  |- mesh__recordOriginator mesh__D051560 DRC
% 208.27/208.49  |- mesh__dateCreated mesh__D051560 2005-06-30
% 208.27/208.49  |- skos__altLabel mesh__D051560 c-bcl-6 Protein
% 208.27/208.49  |- mesh__activeMeSHYear mesh__D051560 2006
% 208.27/208.49  |- skos__broader mesh__D051560smesh__D011518
% 208.27/208.50  |- skos__broader mesh__D051560smesh__D004268
% 208.27/208.50  |- skos__hiddenLabel mesh__D051560 c-bcl-6, Proto-Oncogene Proteins
% 208.27/208.50  |- skos__hiddenLabel mesh__D051560 c bcl 6 Proto Oncogene Proteins
% 208.27/208.50  |- skos__hiddenLabel mesh__D051560 bcl-6, Proto-Oncogene Protein
% 208.27/208.50  |- skos__hiddenLabel mesh__D051560 Proto Oncogene Protein bcl 6
% 208.27/208.50  |- skos__altLabel mesh__D051560 Proto-Oncogene Protein c-bcl-6
% 208.27/208.50  |- skos__prefLabel mesh__D051560 Proto-Oncogene Proteins c-bcl-6
% 208.27/208.50  |- skos__altLabel mesh__D051560 Proto-Oncogene Protein bcl-6
% 208.27/208.50  |- rdf__type mesh__D012349sskos__Concept
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D012349 2006
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D012349 2000
% 208.27/208.50  |- skos__hiddenLabel mesh__D012349 RNA, Asp Transfer
% 208.27/208.50  |- skos__broader mesh__D012349smesh__D012345
% 208.27/208.50  |- skos__historyNote mesh__D012349 Amino Acyl T RNA %28%1978-1987%29%
% 208.27/208.50  |- skos__altLabel mesh__D012349 tRNA%28%Asp%29%
% 208.27/208.50  |- skos__scopeNote mesh__D012349
% 208.27/208.50       A transfer RNA which is specific for carrying aspartic acid to sites on the ribosomes in preparation for protein synthesis.%A%    
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D012349 2005
% 208.27/208.50  |- skos__prefLabel mesh__D012349 RNA, Transfer, Asp
% 208.27/208.50  |- mesh__dateRevised mesh__D012349 1996-06-10
% 208.27/208.50  |- skos__altLabel mesh__D012349 Transfer RNA, Asp
% 208.27/208.50  |- skos__altLabel mesh__D012349 tRNAAsp
% 208.27/208.50  |- mesh__recordMaintainer mesh__D012349 TGC
% 208.27/208.50  |- skos__annotation mesh__D012349
% 208.27/208.50       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D012349 2004
% 208.27/208.50  |- skos__hiddenLabel mesh__D012349 Acid-Specific tRNA, Aspartic
% 208.27/208.50  |- mesh__historyNote mesh__D012349
% 208.27/208.50       91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.27/208.50  |- skos__hiddenLabel mesh__D012349 Aspartic Acid Specific tRNA
% 208.27/208.50  |- mesh__dateEstablished mesh__D012349 1991-01-01
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D012349 2003
% 208.27/208.50  |- mesh__publicMeSHNote mesh__D012349
% 208.27/208.50       91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.27/208.50  |- skos__altLabel mesh__D012349 Aspartic Acid-Specific tRNA
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D012349 1999
% 208.27/208.50  |- skos__historyNote mesh__D012349 RNA, Transfer %28%1966-1987%29%
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D012349 2002
% 208.27/208.50  |- skos__hiddenLabel mesh__D012349 tRNA, Aspartic Acid-Specific
% 208.27/208.50  |- skos__hiddenLabel mesh__D012349 Asp Transfer RNA
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D012349 1998
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D012349 2001
% 208.27/208.50  |- mesh__recordOriginator mesh__D012349 RLS
% 208.27/208.50  |- mesh__dateCreated mesh__D012349 1987-05-07
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D012349 1997
% 208.27/208.50  |- mesh__recordAuthorizer mesh__D012349 PLS
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D017034 2001
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D017034 2003
% 208.27/208.50  |- skos__hiddenLabel mesh__D017034 Opercular Epilepsy
% 208.27/208.50  |- skos__hiddenLabel mesh__D017034 Epilepsies, Orbito-Frontal
% 208.27/208.50  |- skos__altLabel mesh__D017034 Benign Frontal Childhood Epilepsy
% 208.27/208.50  |- skos__hiddenLabel mesh__D017034 Epilepsies, Cingulate
% 208.27/208.50  |- skos__hiddenLabel mesh__D017034 Orbito-Frontal Epilepsies
% 208.27/208.50  |- skos__hiddenLabel mesh__D017034 Opercular Epilepsies
% 208.27/208.50  |- skos__altLabel mesh__D017034 Epilepsy, Benign Frontal, Childhood
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D017034 2002
% 208.27/208.50  |- skos__historyNote mesh__D017034 Epilepsy %28%1966-1988%29%
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D017034 2004
% 208.27/208.50  |- skos__hiddenLabel mesh__D017034 Supplementary Motor Epilepsies
% 208.27/208.50  |- mesh__dateRevised mesh__D017034 1999-12-09
% 208.27/208.50  |- skos__altLabel mesh__D017034 Frontal Lobe Epilepsy
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D017034 2000A
% 208.27/208.50  |- skos__hiddenLabel mesh__D017034 Frontal Lobe Epilepsies
% 208.27/208.50  |- mesh__recordAuthorizer mesh__D017034 ags
% 208.27/208.50  |- rdf__type mesh__D017034sskos__Concept
% 208.27/208.50  |- mesh__recordMaintainer mesh__D017034 ags
% 208.27/208.50  |- mesh__recordOriginator mesh__D017034 MXR
% 208.27/208.50  |- skos__hiddenLabel mesh__D017034 Cingulate Epilepsy
% 208.27/208.50  |- skos__historyNote mesh__D017034
% 208.27/208.50       Epilepsy, Temporal Lobe %28%1966-1991%29%
% 208.27/208.50  |- skos__hiddenLabel mesh__D017034 Cingulate Epilepsies
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D017034 2005
% 208.27/208.50  |- skos__hiddenLabel mesh__D017034 Fronto-Polar Epilepsy, Anterior
% 208.27/208.50  |- skos__hiddenLabel mesh__D017034 Supplementary Motor Epilepsy
% 208.27/208.50  |- mesh__dateEstablished mesh__D017034 1992-01-01
% 208.27/208.50  |- mesh__historyNote mesh__D017034 1992   
% 208.27/208.50  |- skos__hiddenLabel mesh__D017034 Epilepsies, Anterior Fronto-Polar
% 208.27/208.50  |- skos__hiddenLabel mesh__D017034 Orbito-Frontal Epilepsy
% 208.27/208.50  |- skos__hiddenLabel mesh__D017034 Anterior Fronto-Polar Epilepsies
% 208.27/208.50  |- mesh__dateCreated mesh__D017034 1991-05-30
% 208.27/208.50  |- skos__hiddenLabel mesh__D017034 Motor Epilepsies, Supplementary
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D017034 2006
% 208.27/208.50  |- skos__hiddenLabel mesh__D017034 Epilepsy, Orbito Frontal
% 208.27/208.50  |- skos__altLabel mesh__D017034 Childhood Benign Frontal Epilepsy
% 208.27/208.50  |- skos__prefLabel mesh__D017034 Epilepsy, Frontal Lobe
% 208.27/208.50  |- skos__scopeNote mesh__D017034
% 208.27/208.50       A localization-related %28%focal%29% form of epilepsy characterized by seizures which arise in the frontal lobe. A variety of clinical syndromes exist depending on the exact location of the seizure focus. Simple or complex motor movements may occur, and most commonly involve the face and upper extremities. Seizures in the anterior frontal regions may be associated with head and eye turning, typically away from the side of origin of the seizure. Frontal lobe seizures may be idiopathic %28%cryptogenic%29% or caused by an identifiable disease process such as traumatic injuries, neoplasms, or other macroscopic or microscopic lesions of the frontal lobes %28%symptomatic frontal lobe seizures%29%. %28%From Adams et al., Principles of Neurology, 6th ed, pp318-9%29%%A%    
% 208.27/208.50  |- skos__hiddenLabel mesh__D017034 Anterior Fronto-Polar Epilepsy
% 208.27/208.50  |- mesh__publicMeSHNote mesh__D017034 1992   
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D017034 2000
% 208.27/208.50  |- skos__hiddenLabel mesh__D017034 Fronto-Polar Epilepsies, Anterior
% 208.27/208.50  |- skos__broader mesh__D017034smesh__D004828
% 208.27/208.50  |- skos__hiddenLabel mesh__D017034 Epilepsy, Anterior Fronto Polar
% 208.27/208.50  |- skos__hiddenLabel mesh__D017034 Epilepsies, Supplementary Motor
% 208.27/208.50  |- skos__historyNote mesh__D017034 Epilepsy, Partial %28%1980-1991%29%
% 208.27/208.50  |- mesh__dateCreated mesh__D003812 1999-01-01
% 208.27/208.50  |- skos__hiddenLabel mesh__D003812 Dentist Patient Relationship
% 208.27/208.50  |- mesh__publicMeSHNote mesh__D003812 65   
% 208.27/208.50  |- skos__annotation mesh__D003812 DF: DENTIST PATIENT RELAT   
% 208.27/208.50  |- mesh__dateRevised mesh__D003812 2005-06-30
% 208.27/208.50  |- mesh__recordOriginator mesh__D003812 NLM
% 208.27/208.50  |- rdf__type mesh__D003812sskos__Concept
% 208.27/208.50  |- mesh__recordMaintainer mesh__D003812 ssb
% 208.27/208.50  |- skos__hiddenLabel mesh__D003812 Relation, Dentist-Patient
% 208.27/208.50  |- skos__altLabel mesh__D003812 Dentist-Patient Relationship
% 208.27/208.50  |- skos__hiddenLabel mesh__D003812 Relationship, Dentist-Patient
% 208.27/208.50  |- mesh__historyNote mesh__D003812 65   
% 208.27/208.50  |- skos__hiddenLabel mesh__D003812 Dentist Patient Relations
% 208.27/208.50  |- mesh__recordAuthorizer mesh__D003812 sjn
% 208.27/208.50  |- skos__broader mesh__D003812smesh__D011369
% 208.27/208.50  |- mesh__dateEstablished mesh__D003812 1965-01-01
% 208.27/208.50  |- skos__scopeNote mesh__D003812
% 208.27/208.50       The psychological relations between the dentist and patient.%A%    
% 208.27/208.50  |- skos__prefLabel mesh__D003812 Dentist-Patient Relations
% 208.27/208.50  |- skos__hiddenLabel mesh__D003812 Dentist-Patient Relation
% 208.27/208.50  |- skos__hiddenLabel mesh__D003812 Relationships, Dentist-Patient
% 208.27/208.50  |- skos__hiddenLabel mesh__D003812 Relations, Dentist-Patient
% 208.27/208.50  |- skos__hiddenLabel mesh__D003812 Dentist-Patient Relationships
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D003812 2006
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D003014 2006
% 208.27/208.50  |- skos__related mesh__D003014smesh__D001905
% 208.27/208.50  |- mesh__recordOriginator mesh__D003014 NLM
% 208.27/208.50  |- skos__prefLabel mesh__D003014 Clostridium botulinum
% 208.27/208.50  |- skos__broader mesh__D003014smesh__D003013
% 208.27/208.50  |- mesh__dateCreated mesh__D003014 1999-01-01
% 208.27/208.50  |- mesh__recordAuthorizer mesh__D003014 sjn
% 208.27/208.50  |- mesh__recordMaintainer mesh__D003014 SYSTEM
% 208.27/208.50  |- rdf__type mesh__D003014sskos__Concept
% 208.27/208.50  |- mesh__dateRevised mesh__D003014 2005-06-30
% 208.27/208.50  |- skos__annotation mesh__D003014
% 208.27/208.50       note specific types; infection = BOTULISM   
% 208.27/208.50  |- skos__scopeNote mesh__D003014
% 208.27/208.50       A species of anaerobic, gram-positive, rod-shaped bacteria in the family Clostridiaceae that produces proteins with characteristic neurotoxicity. It is the etiologic agent of BOTULISM in humans, wild fowl, HORSES; and CATTLE. Seven subtypes %28%sometimes called antigenic types, or strains%29% exist, each producing a different botulinum toxin %28%BOTULINUM TOXINS%29%. The organism and its spores are widely distributed in nature.%A%    
% 208.27/208.50  |- skos__hiddenLabel mesh__D049914 DNA Repair-Deficiencies
% 208.27/208.50  |- skos__hiddenLabel mesh__D049914 DNA Repair-Deficiency Disorder
% 208.27/208.50  |- skos__hiddenLabel mesh__D049914 Disorder, DNA Repair-Deficiency
% 208.27/208.50  |- skos__hiddenLabel mesh__D049914 Syndromes, Chromosome Instability
% 208.27/208.50  |- skos__hiddenLabel mesh__D049914 Repair, Defic DNA
% 208.27/208.50  |- skos__broader mesh__D049914smesh__D008659
% 208.27/208.50  |- skos__hiddenLabel mesh__D049914 Disorders, DNA Repair-Deficiency
% 208.27/208.50  |- skos__related mesh__D049914smesh__D045643
% 208.27/208.50  |- skos__annotation mesh__D049914 general; prefer specifics   
% 208.27/208.50  |- mesh__publicMeSHNote mesh__D049914 2006   
% 208.27/208.50  |- mesh__recordMaintainer mesh__D049914 nns
% 208.27/208.50  |- skos__scopeNote mesh__D049914
% 208.27/208.50       Disorders resulting from defective DNA REPAIR processes or the associated cellular responses to DNA DAMAGE.%A%    
% 208.27/208.50  |- skos__hiddenLabel mesh__D049914 DNA Repair Deficiency Disorders
% 208.27/208.50  |- mesh__recordOriginator mesh__D049914 nns
% 208.27/208.50  |- skos__hiddenLabel mesh__D049914 Syndrome, Chromosome Instability
% 208.27/208.50  |- skos__hiddenLabel mesh__D049914 Chromosome Instability Syndrome
% 208.27/208.50  |- skos__altLabel mesh__D049914 Defic DNA Repair
% 208.27/208.50  |- skos__historyNote mesh__D049914 DNA Repair %28%1977-2005%29%
% 208.27/208.50  |- mesh__dateEstablished mesh__D049914 2006-01-01
% 208.27/208.50  |- skos__related mesh__D049914smesh__D018816
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D049914 2006
% 208.27/208.50  |- rdf__type mesh__D049914sskos__Concept
% 208.27/208.50  |- mesh__historyNote mesh__D049914 2006   
% 208.27/208.50  |- skos__hiddenLabel mesh__D049914 DNA Repairs, Defic
% 208.27/208.50  |- mesh__recordAuthorizer mesh__D049914 sjn
% 208.27/208.50  |- skos__hiddenLabel mesh__D049914 DNA Repair Deficiency
% 208.27/208.50  |- skos__hiddenLabel mesh__D049914 Defic DNA Repairs
% 208.27/208.50  |- mesh__dateCreated mesh__D049914 2005-06-30
% 208.27/208.50  |- skos__prefLabel mesh__D049914 DNA Repair-Deficiency Disorders
% 208.27/208.50  |- skos__hiddenLabel mesh__D049914 Repairs, Defic DNA
% 208.27/208.50  |- skos__hiddenLabel mesh__D049914 DNA Repair, Defic
% 208.27/208.50  |- skos__scopeNote mesh__D027462
% 208.27/208.50       A plant genus in the CHENOPODIACEAE family.     
% 208.27/208.50  |- mesh__dateEstablished mesh__D027462 2002-01-01
% 208.27/208.50  |- mesh__recordMaintainer mesh__D027462 ssb
% 208.27/208.50  |- mesh__historyNote mesh__D027462
% 208.27/208.50       2002; for GOOSEFOOT use CHENOPODIACEAE 1998-2001   
% 208.27/208.50  |- mesh__publicMeSHNote mesh__D027462
% 208.27/208.50       2002; for GOOSEFOOT see CHENOPODIACEAE 1998-2001   
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D027462 2002
% 208.27/208.50  |- mesh__recordOriginator mesh__D027462 ssb
% 208.27/208.50  |- skos__broader mesh__D027462smesh__D019663
% 208.27/208.50  |- skos__prefLabel mesh__D027462 Chenopodium
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D027462 2006
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D027462 2004
% 208.27/208.50  |- skos__annotation mesh__D027462
% 208.27/208.50       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.27/208.50  |- mesh__dateCreated mesh__D027462 2001-07-25
% 208.27/208.50  |- rdf__type mesh__D027462sskos__Concept
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D027462 2005
% 208.27/208.50  |- mesh__recordAuthorizer mesh__D027462 sjn
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D027462 2003
% 208.27/208.50  |- skos__hiddenLabel mesh__D013442 Nu Sulfinpyrazone
% 208.27/208.50  |- skos__hiddenLabel mesh__D013442 Apo Sulfinpyrazone
% 208.27/208.50  |- skos__hiddenLabel mesh__D013442 Nu Pharm Brand of Sulfinpyrazone
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D013442 2006
% 208.27/208.50  |- skos__altLabel mesh__D013442 Sulfoxyphenylpyrazolidin
% 208.27/208.50  |- mesh__historyNote mesh__D013442 65%28%64%29%   
% 208.27/208.50  |- skos__altLabel mesh__D013442 Apotex Brand of Sulfinpyrazone
% 208.27/208.50  |- skos__altLabel mesh__D013442 Sulphinpyrazone
% 208.27/208.50  |- mesh__dateEstablished mesh__D013442 1965-01-01
% 208.27/208.50  |- skos__altLabel mesh__D013442 Nu-Pharm Brand of Sulfinpyrazone
% 208.27/208.50  |- skos__altLabel mesh__D013442 Anturan
% 208.27/208.50  |- skos__prefLabel mesh__D013442 Sulfinpyrazone
% 208.27/208.50  |- skos__scopeNote mesh__D013442
% 208.27/208.50       A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.%A%    
% 208.27/208.50  |- skos__altLabel mesh__D013442 Novartis Brand of Sulfinpyrazone
% 208.27/208.50  |- mesh__dateRevised mesh__D013442 2005-06-30
% 208.27/208.50  |- skos__broader mesh__D013442smesh__D010653
% 208.27/208.50  |- mesh__publicMeSHNote mesh__D013442 65   
% 208.27/208.50  |- mesh__recordAuthorizer mesh__D013442 sjn
% 208.27/208.50  |- skos__annotation mesh__D013442 a uricosuric   
% 208.27/208.50  |- mesh__recordOriginator mesh__D013442 NLM
% 208.27/208.50  |- mesh__dateCreated mesh__D013442 1999-01-01
% 208.27/208.50  |- mesh__recordMaintainer mesh__D013442 ssb
% 208.27/208.50  |- rdf__type mesh__D013442sskos__Concept
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D007405 2000
% 208.27/208.50  |- skos__related mesh__D007405smesh__D012585
% 208.27/208.50  |- mesh__recordMaintainer mesh__D007405 RAZ
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Disk, Slipped
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D007405 1997
% 208.27/208.50  |- mesh__dateRevised mesh__D007405 1995-06-09
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Discs, Herniated
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Displacements, Intervertebral Disk
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Disk, Prolapsed
% 208.27/208.50  |- skos__altLabel mesh__D007405 Slipped Disk
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Intervertebral Disc Displacements
% 208.27/208.50  |- skos__altLabel mesh__D007405 Herniated Disc
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Slipped Disks
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Herniated Disk
% 208.27/208.50  |- skos__broader mesh__D007405smesh__D013122
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Intervertebral Disk Displacements
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Disc, Herniated
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D007405 1996
% 208.27/208.50  |- skos__related mesh__D007405smesh__D007404
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D007405 2004
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D007405 1999
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Disk Displacements, Intervertebral
% 208.27/208.50  |- mesh__recordOriginator mesh__D007405 NLM
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Displacement, Intervertebral Disk
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Prolapsed Disks
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Disk Displacement, Intervertebral
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Herniated Discs
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Disks, Slipped
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Displacement, Intervertebral Disc
% 208.27/208.50  |- skos__altLabel mesh__D007405 Prolapsed Disk
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D007405 2002
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D007405 2003
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D007405 1998
% 208.27/208.50  |- mesh__recordAuthorizer mesh__D007405 PLS
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Prolapses, Disk
% 208.27/208.50  |- mesh__dateCreated mesh__D007405 1999-01-01
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D007405 2006
% 208.27/208.50  |- skos__altLabel mesh__D007405 Intervertebral Disc Displacement
% 208.27/208.50  |- skos__altLabel mesh__D007405 Disk Prolapse
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Disc Displacement, Intervertebral
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Disks, Herniated
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Prolapse, Disk
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D007405 2001
% 208.27/208.50  |- skos__scopeNote mesh__D007405
% 208.27/208.50       An intervertebral disk in which the nucleus pulposus has protruded through surrounding fibrocartilage. This occurs most frequently in the lower lumbar region.%A%    
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Disc Displacements, Intervertebral
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Disks, Prolapsed
% 208.27/208.50  |- skos__annotation mesh__D007405
% 208.27/208.50       = herniation or prolapse; coord IM with specific vertebrae %28%IM%29%; ther by chemonucleolysis = INTERVERTEBRAL DISK CHEMOLYSIS: see note there%A%  
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D007405 2005
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Herniated Disks
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Disk Prolapses
% 208.27/208.50  |- skos__hiddenLabel mesh__D007405 Displacements, Intervertebral Disc
% 208.27/208.50  |- skos__prefLabel mesh__D007405 Intervertebral Disk Displacement
% 208.27/208.50  |- rdf__type mesh__D007405sskos__Concept
% 208.27/208.50  |- skos__altLabel mesh__D051561
% 208.27/208.50       Complement 3 Convertase, Alternative Pathway
% 208.27/208.50  |- mesh__recordAuthorizer mesh__D051561 sjn
% 208.27/208.50  |- skos__scopeNote mesh__D051561
% 208.27/208.50       A serine protease that is the complex of COMPLEMENT C3B and COMPLEMENT FACTOR BB. It cleaves multiple COMPLEMENT C3 into COMPLEMENT C3A %28%anaphylatoxin%29% and COMPLEMENT C3B in the ALTERNATIVE COMPLEMENT ACTIVATION PATHWAY.%A%    
% 208.27/208.50  |- mesh__dateEstablished mesh__D051561 2006-01-01
% 208.27/208.50  |- skos__altLabel mesh__D051561 C3 Convertase %28%C3bBb%29%
% 208.27/208.50  |- mesh__recordOriginator mesh__D051561 lkt
% 208.27/208.50  |- mesh__recordMaintainer mesh__D051561 lkt
% 208.27/208.50  |- skos__altLabel mesh__D051561 Alternative Pathway C3 Convertase
% 208.27/208.50  |- skos__altLabel mesh__D051561 C3 Convertase, Alternative Pathway
% 208.27/208.50  |- mesh__historyNote mesh__D051561
% 208.27/208.50       2006 %28%1989%29%; for CVFBB use COMPLEMENT FACTOR B 1985-2005   
% 208.27/208.50  |- rdf__type mesh__D051561sskos__Concept
% 208.27/208.50  |- skos__prefLabel mesh__D051561
% 208.27/208.50       Complement C3 Convertase, Alternative Pathway
% 208.27/208.50  |- skos__historyNote mesh__D051561 Esterases %28%1976-2005%29%
% 208.27/208.50  |- mesh__publicMeSHNote mesh__D051561
% 208.27/208.50       2006; was indexed under COMPLEMENT 3B 1989-2005; for CVFBB see COMPLEMENT FACTOR B 1985-2005%A%  
% 208.27/208.50  |- skos__altLabel mesh__D051561
% 208.27/208.50       Complement 3b-Associated Factor B-fragment Bb
% 208.27/208.50  |- skos__historyNote mesh__D051561 Complement C3 %28%1976-2005%29%
% 208.27/208.50  |- skos__altLabel mesh__D051561 CVFBb
% 208.27/208.50  |- skos__hiddenLabel mesh__D051561
% 208.27/208.50       Complement 3b Associated Factor B fragment Bb
% 208.27/208.50  |- mesh__dateCreated mesh__D051561 2005-06-30
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D051561 2006
% 208.27/208.50  |- skos__broader mesh__D051561smesh__D050578
% 208.27/208.50  |- mesh__recordOriginator mesh__D045524 jmp
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D045524 2006
% 208.27/208.50  |- mesh__dateEstablished mesh__D045524 2004-01-01
% 208.27/208.50  |- mesh__historyNote mesh__D045524
% 208.27/208.50       2004; use PHYCOBILISOMES %28%NM%29% 1980-2003; use PROTEINS 1978-1979%A%  
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D045524 2005
% 208.27/208.50  |- mesh__dateCreated mesh__D045524 2003-07-09
% 208.27/208.50  |- skos__prefLabel mesh__D045524 Phycobilisomes
% 208.27/208.50  |- skos__related mesh__D045524smesh__D045342
% 208.27/208.50  |- mesh__recordMaintainer mesh__D045524 ags
% 208.27/208.50  |- mesh__publicMeSHNote mesh__D045524
% 208.27/208.50       2004; PHYCOBILISOMES was indexed under PROTEINS 1978-2003%A%  
% 208.27/208.50  |- mesh__recordAuthorizer mesh__D045524 sjn
% 208.27/208.50  |- skos__broader mesh__D045524smesh__D021961
% 208.27/208.50  |- skos__scopeNote mesh__D045524
% 208.27/208.50       Light energy harvesting structures attached to the THYLAKOID MEMBRANES of CYANOBACTERIA and red algae %28%ALGAE, RED%29%. These multiprotein complexes contain pigments %28%PHYCOBILIPROTEINS%29% that transfer light energy to chlorophyll a.%A%    
% 208.27/208.50  |- rdf__type mesh__D045524sskos__Concept
% 208.27/208.50  |- skos__historyNote mesh__D045524 Proteins %28%1978-2003%29%
% 208.27/208.50  |- skos__broader mesh__D045524smesh__D045342
% 208.27/208.50  |- skos__hiddenLabel mesh__D045524 Phycobilisome
% 208.27/208.50  |- mesh__dateRevised mesh__D045524 2004-07-07
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D017833 2003
% 208.27/208.50  |- skos__hiddenLabel mesh__D017833 Afferents, Visceral
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D017833 1994
% 208.27/208.50  |- mesh__activeMeSHYear mesh__D017833 2006
% 208.27/208.50  |- rdf__type mesh__D017833sskos__Concept
% 208.36/208.50  |- skos__hiddenLabel mesh__D017833 Visceral Afferent
% 208.36/208.50  |- mesh__activeMeSHYear mesh__D017833 2002
% 208.36/208.50  |- mesh__activeMeSHYear mesh__D017833 2005
% 208.36/208.50  |- mesh__activeMeSHYear mesh__D017833 1997
% 208.36/208.50  |- skos__scopeNote mesh__D017833
% 208.36/208.50       The sensory fibers innervating the viscera.     
% 208.36/208.50  |- skos__historyNote mesh__D017833 Viscera/innervation %28%1986-1993%29%
% 208.36/208.50  |- skos__hiddenLabel mesh__D017833 Afferent, Visceral
% 208.36/208.50  |- mesh__historyNote mesh__D017833 94   
% 208.36/208.50  |- mesh__activeMeSHYear mesh__D017833 1996
% 208.36/208.50  |- mesh__activeMeSHYear mesh__D017833 2001
% 208.36/208.50  |- mesh__dateEstablished mesh__D017833 1994-01-01
% 208.36/208.50  |- mesh__dateCreated mesh__D017833 1993-06-21
% 208.36/208.50  |- mesh__activeMeSHYear mesh__D017833 1999
% 208.36/208.50  |- mesh__activeMeSHYear mesh__D017833 2004
% 208.36/208.50  |- skos__prefLabel mesh__D017833 Visceral Afferents
% 208.36/208.50  |- mesh__activeMeSHYear mesh__D017833 1995
% 208.36/208.50  |- mesh__activeMeSHYear mesh__D017833 2000
% 208.36/208.50  |- skos__broader mesh__D017833smesh__D000344
% 208.36/208.50  |- mesh__publicMeSHNote mesh__D017833 94   
% 208.36/208.50  |- mesh__activeMeSHYear mesh__D017833 1998
% 208.36/208.50  |- skos__altLabel mesh__D017035 Linson Pharma Brand of Pravastatin Sodium
% 208.36/208.50  |- skos__prefLabel mesh__D017035 Pravastatin
% 208.36/208.50  |- skos__hiddenLabel mesh__D017035 RMS 431
% 208.36/208.50  |- skos__hiddenLabel mesh__D017035 Lin Pravastatin
% 208.36/208.50  |- mesh__recordAuthorizer mesh__D017035 sjn
% 208.36/208.50  |- skos__altLabel mesh__D017035 Eptastatin
% 208.36/208.50  |- skos__hiddenLabel mesh__D017035 RMS431
% 208.36/208.50  |- skos__hiddenLabel mesh__D017035 Sodium Salt, Pravastatin
% 208.36/208.50  |- skos__hiddenLabel mesh__D017035 Apo Pravastatin
% 208.36/208.50  |- skos__altLabel mesh__D017035 Mevalotin
% 208.36/208.50  |- skos__altLabel mesh__D017035 Nu-Pharma Brand of Pravastatin Sodium
% 208.36/208.50  |- skos__altLabel mesh__D017035 Selektine
% 208.36/208.50  |- skos__altLabel mesh__D017035 Pravacol
% 208.36/208.50  |- skos__hiddenLabel mesh__D017035 CS514
% 208.36/208.50  |- skos__altLabel mesh__D017035 Apotex Brand of Pravastatin Sodium
% 208.36/208.50  |- skos__hiddenLabel mesh__D017035 Nu Pravastatin
% 208.36/208.50  |- skos__hiddenLabel mesh__D017035 SQ 31,000
% 208.36/208.50  |- skos__hiddenLabel mesh__D017035 Pravastatin tert Octylamine Salt
% 208.36/208.50  |- skos__broader mesh__D017035smesh__D009281
% 208.36/208.50  |- skos__hiddenLabel mesh__D017035 SQ31000
% 208.36/208.50  |- rdf__type mesh__D017035sskos__Concept
% 208.36/208.50  |- mesh__dateEstablished mesh__D017035 1992-01-01
% 208.36/208.50  |- skos__altLabel mesh__D017035 Esteve Brand of Pravastatin Sodium
% 208.36/208.50  |- mesh__publicMeSHNote mesh__D017035
% 208.36/208.50       92; PRAVASTATIN was indexed under NAPHTHALENES %26% HEPTANOIC ACIDS 1986-91%A%  
% 208.36/208.50  |- skos__altLabel mesh__D017035 Juste Brand of Pravastatin Sodium
% 208.36/208.50  |- skos__altLabel mesh__D017035 SQ-31,000
% 208.36/208.50  |- mesh__recordMaintainer mesh__D017035 lkw
% 208.36/208.50  |- skos__scopeNote mesh__D017035
% 208.36/208.50       An antilipemic fungal metabolite isolated from cultures of Nocardia autotrophica. It acts as a competitive inhibitor of HMG CoA reductase %28%HYDROXYMETHYLGLUTARYL COA REDUCTASES%29%.%A%    
% 208.36/208.50  |- mesh__dateRevised mesh__D017035 2005-06-30
% 208.36/208.50  |- skos__altLabel mesh__D017035 Pravasin
% 208.36/208.50  |- skos__altLabel mesh__D017035 Sankyo Brand of Pravastatin Sodium
% 208.36/208.50  |- skos__altLabel mesh__D017035 Elisor
% 208.36/208.50  |- skos__altLabel mesh__D017035 Pravastatin Sodium Salt
% 208.36/208.50  |- mesh__activeMeSHYear mesh__D017035 2006
% 208.36/208.50  |- skos__altLabel mesh__D017035
% 208.36/208.50       Bristol-Myers Squibb Brand of Pravastatin Sodium
% 208.36/208.50  |- skos__hiddenLabel mesh__D017035 SQ31,000
% 208.36/208.50  |- skos__altLabel mesh__D017035 Lipostat
% 208.36/208.50  |- mesh__historyNote mesh__D017035
% 208.36/208.50       92; was PRAVASTATIN %28%NM%29% 1986-91   
% 208.36/208.50  |- skos__hiddenLabel mesh__D017035 CS 514
% 208.36/208.50  |- mesh__dateCreated mesh__D017035 1991-07-12
% 208.36/208.50  |- mesh__recordOriginator mesh__D017035 PLS
% 208.36/208.50  |- skos__altLabel mesh__D017035 Aventis Brand of Pravastatin Sodium
% 208.36/208.50  |- mesh__onlineNote mesh__D017035
% 208.36/208.50       use PRAVASTATIN %28%NM%29% to search PRAVASTATIN 1986-91   
% 208.36/208.50  |- skos__hiddenLabel mesh__D017035 SQ 31000
% 208.36/208.50  |- skos__altLabel mesh__D017035 Squibb Brand of Pravastatin Sodium
% 208.36/208.50  |- skos__related mesh__D003813smesh__D007879
% 208.36/208.50  |- mesh__recordAuthorizer mesh__D003813 sjn
% 208.36/208.50  |- mesh__onlineNote mesh__D003813 pre-explosion = DENTISTRY %28%PX%29%   
% 208.36/208.50  |- skos__annotation mesh__D003813
% 208.36/208.50       specialty; /instrum = DENTAL INSTRUMENTS; DENTAL EQUIPMENT or other specifics; /legislation %26% jurisprudence = LEGISLATION, DENTAL or DENTISTRY %28%IM%29% + JURISPRUDENCE %28%IM%29% or FORENSIC DENTISTRY; /man permissible but consider also DENTISTS /supply; veterinary dentistry = DENTISTRY /vet %28%IM%29% + VETERINARY MEDICINE %28%IM%29%%A%  
% 208.36/208.50  |- skos__related mesh__D003813smesh__D004468
% 208.36/208.50  |- skos__related mesh__D003813smesh__D003748
% 208.36/208.50  |- mesh__historyNote mesh__D003813
% 208.36/208.50       AVIATION DENTISTRY was heading 1965-79   
% 208.36/208.50  |- skos__related mesh__D003813smesh__D019242
% 208.36/208.50  |- skos__related mesh__D003813smesh__D006665
% 208.36/208.50  |- skos__related mesh__D003813smesh__D004497
% 208.36/208.50  |- mesh__activeMeSHYear mesh__D003813 2005
% 208.36/208.50  |- mesh__recordMaintainer mesh__D003813 jls
% 208.36/208.50  |- skos__related mesh__D003813smesh__D003762
% 208.36/208.50  |- skos__prefLabel mesh__D003813 Dentistry
% 208.36/208.50  |- mesh__dateRevised mesh__D003813 2003-07-14
% 208.36/208.50  |- mesh__activeMeSHYear mesh__D003813 2006
% 208.36/208.50  |- mesh__publicMeSHNote mesh__D003813
% 208.36/208.50       AVIATION DENTISTRY was heading 1965-79   
% 208.36/208.50  |- mesh__dateCreated mesh__D003813 1999-01-01
% 208.36/208.50  |- mesh__recordOriginator mesh__D003813 NLM
% 208.36/208.50  |- mesh__runningHead mesh__D003813 E6 - PROCEDURES AND TECHNIQUES-DENTAL   
% 208.36/208.50  |- skos__scopeNote mesh__D003813
% 208.36/208.50       The profession concerned with the teeth, oral cavity, and associated structures, and the diagnosis and treatment of their diseases including prevention and the restoration of defective and missing tissue.%A%    
% 208.36/208.50  |- mesh__activeMeSHYear mesh__D003813 2004
% 208.36/208.50  |- rdf__type mesh__D003813sskos__Concept
% 208.36/208.50  |- skos__broader mesh__D003015smesh__D016908
% 208.36/208.50  |- skos__hiddenLabel mesh__D003015 Clostridium Infection
% 208.36/208.50  |- mesh__activeMeSHYear mesh__D003015 2005
% 208.36/208.50  |- mesh__dateEstablished mesh__D003015 1968-01-01
% 208.36/208.50  |- mesh__dateCreated mesh__D003015 1999-01-01
% 208.36/208.51  |- skos__scopeNote mesh__D003015
% 208.36/208.51       Infections with bacteria of the genus CLOSTRIDIUM.     
% 208.36/208.51  |- rdf__type mesh__D003015sskos__Concept
% 208.36/208.51  |- skos__historyNote mesh__D003015 Clostridium %28%1966-1967%29%
% 208.36/208.51  |- mesh__recordOriginator mesh__D003015 NLM
% 208.36/208.51  |- skos__prefLabel mesh__D003015 Clostridium Infections
% 208.36/208.51  |- mesh__historyNote mesh__D003015
% 208.36/208.51       68; HEMOGLOBINURIA, BACILLARY was heading 1968-81   
% 208.36/208.51  |- mesh__publicMeSHNote mesh__D003015
% 208.36/208.51       68; HEMOGLOBINURIA, BACILLARY was heading 1968-81   
% 208.36/208.51  |- skos__hiddenLabel mesh__D003015 Infection, Clostridium
% 208.36/208.51  |- skos__annotation mesh__D003015
% 208.36/208.51       gram-pos bact infect; GEN: prefer specifics   
% 208.36/208.51  |- mesh__recordAuthorizer mesh__D003015 sjn
% 208.36/208.51  |- mesh__recordMaintainer mesh__D003015 ags
% 208.36/208.51  |- mesh__onlineNote mesh__D003015
% 208.36/208.51       use CLOSTRIDIUM INFECTIONS /VE to search HEMOGLOBINURIA, BACILLARY 1968-81%A%  
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003015 2004
% 208.36/208.51  |- mesh__dateRevised mesh__D003015 2003-07-09
% 208.36/208.51  |- skos__altLabel mesh__D003015 Infections, Clostridium
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003015 2006
% 208.36/208.51  |- skos__prefLabel mesh__D049915 Ipomoea nil
% 208.36/208.51  |- mesh__publicMeSHNote mesh__D049915 2006   
% 208.36/208.51  |- mesh__recordOriginator mesh__D049915 ssb
% 208.36/208.51  |- mesh__dateCreated mesh__D049915 2005-06-30
% 208.36/208.51  |- skos__historyNote mesh__D049915 Ipomoea %28%2001-2005%29%
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D049915 2006
% 208.36/208.51  |- mesh__recordMaintainer mesh__D049915 ssb
% 208.36/208.51  |- rdf__type mesh__D049915sskos__Concept
% 208.36/208.51  |- skos__annotation mesh__D049915
% 208.36/208.51       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.36/208.51  |- skos__scopeNote mesh__D049915
% 208.36/208.51       A plant species of the genus IPOMOEA, family CONVOLVULACEAE. An abundance of spontaneous mutants makes it useful in study of PLANT DNA and GENETICS.%A%    
% 208.36/208.51  |- skos__broader mesh__D049915smesh__D027741
% 208.36/208.51  |- mesh__dateEstablished mesh__D049915 2006-01-01
% 208.36/208.51  |- skos__altLabel mesh__D049915 Japanese Morning Glory
% 208.36/208.51  |- mesh__historyNote mesh__D049915 2006   
% 208.36/208.51  |- mesh__recordAuthorizer mesh__D049915 sjn
% 208.36/208.51  |- skos__altLabel mesh__D049915 Pharbitis nil
% 208.36/208.51  |- skos__scopeNote mesh__D027463
% 208.36/208.51       A plant species in the CHENOPODIUM genus known for edible greens.%A%    
% 208.36/208.51  |- mesh__recordAuthorizer mesh__D027463 sjn
% 208.36/208.51  |- mesh__recordOriginator mesh__D027463 ssb
% 208.36/208.51  |- skos__historyNote mesh__D027463 Chenopodiaceae %28%1998-2001%29%
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D027463 2006
% 208.36/208.51  |- skos__annotation mesh__D027463
% 208.36/208.51       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.36/208.51  |- mesh__recordMaintainer mesh__D027463 ssb
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D027463 2005
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D027463 2004
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D027463 2002
% 208.36/208.51  |- mesh__publicMeSHNote mesh__D027463 2002   
% 208.36/208.51  |- rdf__type mesh__D027463sskos__Concept
% 208.36/208.51  |- skos__altLabel mesh__D027463 Lamb%27%s Quarters
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D027463 2003
% 208.36/208.51  |- skos__broader mesh__D027463smesh__D027462
% 208.36/208.51  |- skos__prefLabel mesh__D027463 Chenopodium album
% 208.36/208.51  |- skos__altLabel mesh__D027463 Lambsquarters
% 208.36/208.51  |- mesh__dateCreated mesh__D027463 2001-07-25
% 208.36/208.51  |- mesh__historyNote mesh__D027463 2002   
% 208.36/208.51  |- mesh__dateEstablished mesh__D027463 2002-01-01
% 208.36/208.51  |- mesh__recordAuthorizer mesh__D013443 sjn
% 208.36/208.51  |- skos__altLabel mesh__D013443 Optima Brand of Sulfisomidine
% 208.36/208.51  |- mesh__recordOriginator mesh__D013443 NLM
% 208.36/208.51  |- skos__broader mesh__D013443smesh__D013424
% 208.36/208.51  |- skos__prefLabel mesh__D013443 Sulfisomidine
% 208.36/208.51  |- skos__hiddenLabel mesh__D013443 Augensalbe, Aristamid
% 208.36/208.51  |- skos__hiddenLabel mesh__D013443 Sodium, Sulfisomidine
% 208.36/208.51  |- mesh__dateCreated mesh__D013443 1999-01-01
% 208.36/208.51  |- mesh__recordMaintainer mesh__D013443 CCR
% 208.36/208.51  |- rdf__type mesh__D013443sskos__Concept
% 208.36/208.51  |- skos__scopeNote mesh__D013443 A sulfanilamide antibacterial agent.     
% 208.36/208.51  |- skos__altLabel mesh__D013443 Optima Brand of Sulfisomidine Sodium
% 208.36/208.51  |- skos__altLabel mesh__D013443 Sulphasomidine
% 208.36/208.51  |- skos__altLabel mesh__D013443 Sulfaisodimidine
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D013443 2006
% 208.36/208.51  |- skos__hiddenLabel mesh__D013443 Augentropfen, Aristamid
% 208.36/208.51  |- mesh__dateRevised mesh__D013443 2005-06-30
% 208.36/208.51  |- skos__altLabel mesh__D007406 Psychological Interview
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D007406 2005
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D007406 1993
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D007406 1996
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D007406 1995
% 208.36/208.51  |- skos__hiddenLabel mesh__D007406 Psychologic Interviews
% 208.36/208.51  |- mesh__dateRevised mesh__D007406 1992-05-14
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D007406 1998
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D007406 2002
% 208.36/208.51  |- mesh__recordAuthorizer mesh__D007406 PLS
% 208.36/208.51  |- skos__scopeNote mesh__D007406
% 208.36/208.51       A directed conversation aimed at eliciting information for psychiatric diagnosis, evaluation, treatment planning, etc. The interview may be conducted by a social worker or psychologist.%A%    
% 208.36/208.51  |- skos__altLabel mesh__D007406 Interview, Psychologic
% 208.36/208.51  |- rdf__type mesh__D007406sskos__Concept
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D007406 1994
% 208.36/208.51  |- mesh__recordOriginator mesh__D007406 NLM
% 208.36/208.51  |- skos__prefLabel mesh__D007406 Interview, Psychological
% 208.36/208.51  |- mesh__dateEstablished mesh__D007406 1968-01-01
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D007406 2001
% 208.36/208.51  |- mesh__dateCreated mesh__D007406 1999-01-01
% 208.36/208.51  |- mesh__recordMaintainer mesh__D007406 TAP
% 208.36/208.51  |- skos__broader mesh__D007406smesh__D011580
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D007406 2000
% 208.36/208.51  |- mesh__historyNote mesh__D007406 68%28%65%29%   
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D007406 2004
% 208.36/208.51  |- skos__hiddenLabel mesh__D007406 Psychologic Interview
% 208.36/208.51  |- skos__hiddenLabel mesh__D007406 Interviews, Psychologic
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D007406 2006
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D007406 1997
% 208.36/208.51  |- skos__altLabel mesh__D007406 Psychological Interviews
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D007406 2003
% 208.36/208.51  |- mesh__publicMeSHNote mesh__D007406 68   
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D007406 1999
% 208.36/208.51  |- skos__altLabel mesh__D007406 Interviews, Psychological
% 208.36/208.51  |- skos__hiddenLabel mesh__D051562 Proto-Oncogene Proteins, bcr
% 208.36/208.51  |- mesh__dateCreated mesh__D051562 2005-06-30
% 208.36/208.51  |- skos__hiddenLabel mesh__D051562 c bcr Proto Oncogene Proteins
% 208.36/208.51  |- skos__altLabel mesh__D051562 Breakpoint Cluster Region Protein
% 208.36/208.51  |- mesh__recordMaintainer mesh__D051562 DRC
% 208.36/208.51  |- rdf__type mesh__D051562sskos__Concept
% 208.36/208.51  |- skos__hiddenLabel mesh__D051562 Proteins, c-bcr
% 208.36/208.51  |- skos__altLabel mesh__D051562 c-bcr Proto-Oncogene Proteins
% 208.36/208.51  |- mesh__recordAuthorizer mesh__D051562 sjn
% 208.36/208.51  |- skos__hiddenLabel mesh__D051562 c-bcr, Proto-Oncogene Proteins
% 208.36/208.51  |- mesh__publicMeSHNote mesh__D051562
% 208.36/208.51       2006; PROTO-ONCOGENE PROTEIN C-BCR  was indexed under PROTEIN-TYROSINE KINASE %26% PROTO-ONCOGENE PROTEINS 1988-2005%A%  
% 208.36/208.51  |- mesh__dateEstablished mesh__D051562 2006-01-01
% 208.36/208.51  |- mesh__historyNote mesh__D051562 2006%28%1988%29%   
% 208.36/208.51  |- mesh__recordOriginator mesh__D051562 DRC
% 208.36/208.51  |- skos__hiddenLabel mesh__D051562 Proto Oncogene Protein c bcr
% 208.36/208.51  |- skos__hiddenLabel mesh__D051562 Proto Oncogene Proteins c bcr
% 208.36/208.51  |- skos__hiddenLabel mesh__D051562 Proto Oncogene Protein bcr
% 208.36/208.51  |- skos__hiddenLabel mesh__D051562 c bcr Proteins
% 208.36/208.51  |- skos__prefLabel mesh__D051562 Proto-Oncogene Proteins c-bcr
% 208.36/208.51  |- skos__altLabel mesh__D051562 Proto-Oncogene Protein bcr
% 208.36/208.51  |- skos__broader mesh__D051562smesh__D011518
% 208.36/208.51  |- skos__altLabel mesh__D051562 c-bcr Proteins
% 208.36/208.51  |- skos__scopeNote mesh__D051562
% 208.36/208.51       Proto-oncogene protein bcr is a serine-threonine kinase that functions as a negative regulator of CELL PROLIFERATION and NEOPLASTIC CELL TRANSFORMATION. It is commonly fused with cellular abl protein to form BCR-ABL FUSION PROTEINS in PHILADELPHIA CHROMOSOME positive LEUKEMIA patients.%A%    
% 208.36/208.51  |- skos__hiddenLabel mesh__D051562 Proto-Oncogene Proteins, c-bcr
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D051562 2006
% 208.36/208.51  |- skos__hiddenLabel mesh__D051562 bcr Proto Oncogene Proteins
% 208.36/208.51  |- skos__altLabel mesh__D051562 bcr Proto-Oncogene Proteins
% 208.36/208.51  |- skos__altLabel mesh__D051562 Proto-Oncogene Protein c-bcr
% 208.36/208.51  |- skos__hiddenLabel mesh__D051562 c-bcr, Proto-Oncogene Protein
% 208.36/208.51  |- skos__broader mesh__D051562smesh__D017346
% 208.36/208.51  |- skos__altLabel mesh__D017036 Kojewnikow Syndrome
% 208.36/208.51  |- skos__hiddenLabel mesh__D017036 Syndrome, Kojewnikow%27%s
% 208.36/208.51  |- skos__hiddenLabel mesh__D017036 Epilepsy, Kojewnikov%27%s
% 208.36/208.51  |- skos__hiddenLabel mesh__D017036 Kojevnikov Epilepsy
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D017036 2002
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D017036 2003
% 208.36/208.51  |- skos__hiddenLabel mesh__D017036 Syndrome, Kojewnikow
% 208.36/208.51  |- skos__broader mesh__D017036smesh__D013226
% 208.36/208.51  |- mesh__recordMaintainer mesh__D017036 ags
% 208.36/208.51  |- skos__altLabel mesh__D017036 Kozhevnikow Syndrome, Progressive Variant
% 208.36/208.51  |- mesh__recordOriginator mesh__D017036 MXR
% 208.36/208.51  |- skos__altLabel mesh__D017036
% 208.36/208.51       Epilepsia Partialis Continua, Chronic Progressive
% 208.36/208.51  |- skos__hiddenLabel mesh__D017036 Epilepsies, Kojevnikov%27%s
% 208.36/208.51  |- skos__historyNote mesh__D017036
% 208.36/208.51       Epilepsy, Temporal Lobe %28%1966-1991%29%
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D017036 2004
% 208.36/208.51  |- mesh__dateRevised mesh__D017036 1999-12-09
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D017036 2000A
% 208.36/208.51  |- mesh__historyNote mesh__D017036 1992   
% 208.36/208.51  |- skos__hiddenLabel mesh__D017036 Syndrome, Kozhevnikov
% 208.36/208.51  |- mesh__recordAuthorizer mesh__D017036 ags
% 208.36/208.51  |- mesh__dateCreated mesh__D017036 1991-05-30
% 208.36/208.51  |- rdf__type mesh__D017036sskos__Concept
% 208.36/208.51  |- skos__altLabel mesh__D017036 Kojewnikov%27%s Epilepsy
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D017036 2005
% 208.36/208.51  |- skos__hiddenLabel mesh__D017036 Kojevnikov%27%s Epilepsies
% 208.36/208.51  |- mesh__dateEstablished mesh__D017036 1992-01-01
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D017036 2000B
% 208.36/208.51  |- skos__altLabel mesh__D017036 Kojevnikov%27%s Epilepsy
% 208.36/208.51  |- skos__altLabel mesh__D017036 Kojewnikow%27%s Syndrome
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D017036 2000
% 208.36/208.51  |- skos__historyNote mesh__D017036 Epilepsy %28%1966-1991%29%
% 208.36/208.51  |- skos__hiddenLabel mesh__D017036 Kojewnikov Epilepsy
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D017036 2006
% 208.36/208.51  |- skos__scopeNote mesh__D017036
% 208.36/208.51       A variant of epilepsy characterized by continuous focal jerking of a body part over a period of hours, days, or even years without spreading to other body regions. Contractions may be aggravated by movement and are reduced, but not abolished during sleep. ELECTROENCEPHALOGRAPHY demonstrates epileptiform %28%spike and wave%29% discharges over the hemisphere opposite to the affected limb in most instances. The repetitive movements may originate from the CEREBRAL CORTEX or from subcortical structures %28%e.g., BRAIN STEM; BASAL GANGLIA%29%. This condition is associated with Russian Spring and Summer encephalitis %28%see ENCEPHALITIS, TICK BORNE%29%; Rasmussen syndrome %28%see ENCEPHALITIS%29%; MULTIPLE SCLEROSIS; DIABETES MELLITUS; BRAIN NEOPLASMS; and CEREBROVASCULAR DISORDERS. %28%From Brain, 1996 April;119%28%pt2%29%:393-407; Epilepsia 1993;34;Suppl 1:S29-S36; and Adams et al., Principles of Neurology, 6th ed, p319%29%%A%    
% 208.36/208.51  |- skos__hiddenLabel mesh__D017036 Epilepsy, Kojevnikov%27%s
% 208.36/208.51  |- skos__altLabel mesh__D017036 Kozhevnikov%27%s Syndrome
% 208.36/208.51  |- mesh__publicMeSHNote mesh__D017036 1992   
% 208.36/208.51  |- skos__altLabel mesh__D017036 Progressive Variant of Kozhevnikow Syndrome
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D017036 2001
% 208.36/208.51  |- skos__altLabel mesh__D017036 Kozhevnikov Syndrome
% 208.36/208.51  |- skos__historyNote mesh__D017036 Epilepsy, Partial %28%1977-1991%29%
% 208.36/208.51  |- skos__prefLabel mesh__D017036 Epilepsia Partialis Continua
% 208.36/208.51  |- skos__hiddenLabel mesh__D017036 Syndrome, Kozhevnikov%27%s
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003814 1996
% 208.36/208.51  |- mesh__dateEstablished mesh__D003814 1965-01-01
% 208.36/208.51  |- skos__annotation mesh__D003814
% 208.36/208.51       SPEC; SPEC qualif; to restore tooth function %28%filling, inlay, etc.%29%; do not confuse with SURGERY, ORAL %28%surg ther of dis, inj or defects of soft tissues of mouth or of jaws%29%; DF: DENT OPERATIVE%A%  
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003814 2005
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003814 1997
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003814 2002
% 208.36/208.51  |- mesh__dateRevised mesh__D003814 1995-03-13
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003814 2006
% 208.36/208.51  |- mesh__historyNote mesh__D003814 65; was in Cat E only 1972-79   
% 208.36/208.51  |- mesh__dateCreated mesh__D003814 1999-01-01
% 208.36/208.51  |- skos__altLabel mesh__D003814 Operative Dentistry
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003814 2003
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003814 2000
% 208.36/208.51  |- skos__prefLabel mesh__D003814 Dentistry, Operative
% 208.36/208.51  |- skos__broader mesh__D003814smesh__D003813
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003814 2004
% 208.36/208.51  |- rdf__type mesh__D003814sskos__Concept
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003814 1998
% 208.36/208.51  |- mesh__recordAuthorizer mesh__D003814 PLS
% 208.36/208.51  |- mesh__publicMeSHNote mesh__D003814 65   
% 208.36/208.51  |- skos__scopeNote mesh__D003814
% 208.36/208.51       That phase of clinical dentistry concerned with the restoration of parts of existing teeth that are defective through disease, trauma, or abnormal development, to the state of normal function, health, and esthetics, including preventive, diagnostic, biological, mechanical, and therapeutic techniques, as well as material and instrument science and application. %28%Jablonski%27%s Dictionary of Dentistry, 2d ed, p237%29%%A%    
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003814 2001
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003814 1999
% 208.36/208.51  |- mesh__recordMaintainer mesh__D003814 TGC
% 208.36/208.51  |- mesh__recordOriginator mesh__D003814 NLM
% 208.36/208.51  |- mesh__recordMaintainer mesh__D003016 SYSTEM
% 208.36/208.51  |- mesh__recordAuthorizer mesh__D003016 sjn
% 208.36/208.51  |- skos__annotation mesh__D003016
% 208.36/208.51       infection = GAS GANGRENE if in text; otherwise coord IM with CLOSTRIDIUM INFECTIONS %28%IM%29%%A%  
% 208.36/208.51  |- skos__altLabel mesh__D003016 Clostridium welchii
% 208.36/208.51  |- mesh__dateRevised mesh__D003016 2005-06-30
% 208.36/208.51  |- skos__scopeNote mesh__D003016
% 208.36/208.51       The most common etiologic agent of GAS GANGRENE. It is differentiable into several distinct types based on the distribution of twelve different toxins.%A%    
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003016 2006
% 208.36/208.51  |- skos__broader mesh__D003016smesh__D003013
% 208.36/208.51  |- mesh__recordOriginator mesh__D003016 NLM
% 208.36/208.51  |- skos__prefLabel mesh__D003016 Clostridium perfringens
% 208.36/208.51  |- mesh__dateCreated mesh__D003016 1999-01-01
% 208.36/208.51  |- rdf__type mesh__D003016sskos__Concept
% 208.36/208.51  |- skos__broader mesh__D049916smesh__D008974
% 208.36/208.51  |- mesh__historyNote mesh__D049916 2006   
% 208.36/208.51  |- mesh__recordAuthorizer mesh__D049916 sjn
% 208.36/208.51  |- mesh__publicMeSHNote mesh__D049916 2006   
% 208.36/208.51  |- mesh__dateEstablished mesh__D049916 2006-01-01
% 208.36/208.51  |- skos__historyNote mesh__D049916 Mollusca %28%1967-2005%29%
% 208.36/208.51  |- skos__prefLabel mesh__D049916 Polyplacophora
% 208.36/208.51  |- mesh__dateCreated mesh__D049916 2005-06-30
% 208.36/208.51  |- skos__scopeNote mesh__D049916
% 208.36/208.51       A class in the phylum MOLLUSCA comprised of flattened, elongated marine mollusks, commonly called chitons. They are unique in that they possess seven or eight separate shell plates.%A%    
% 208.36/208.51  |- skos__altLabel mesh__D049916 Chitons
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D049916 2006
% 208.36/208.51  |- rdf__type mesh__D049916sskos__Concept
% 208.36/208.51  |- mesh__recordOriginator mesh__D049916 ags
% 208.36/208.51  |- mesh__recordMaintainer mesh__D049916 ags
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D027464 2005
% 208.36/208.51  |- skos__prefLabel mesh__D027464 Chenopodium ambrosioides
% 208.36/208.51  |- skos__scopeNote mesh__D027464
% 208.36/208.51       A plant species of the genus Chenopodium known for toxicity to intestinal worms and other simple organisms.%A%    
% 208.36/208.51  |- skos__broader mesh__D027464smesh__D027462
% 208.36/208.51  |- skos__altLabel mesh__D027464 Epazote
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D027464 2003
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D027464 2006
% 208.36/208.51  |- mesh__historyNote mesh__D027464 2002   
% 208.36/208.51  |- mesh__dateEstablished mesh__D027464 2002-01-01
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D027464 2004
% 208.36/208.51  |- skos__annotation mesh__D027464
% 208.36/208.51       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D027464 2002
% 208.36/208.51  |- mesh__publicMeSHNote mesh__D027464 2002   
% 208.36/208.51  |- rdf__type mesh__D027464sskos__Concept
% 208.36/208.51  |- skos__altLabel mesh__D027464 Wormseed
% 208.36/208.51  |- mesh__dateCreated mesh__D027464 2001-07-25
% 208.36/208.51  |- skos__hiddenLabel mesh__D013444 TL azole
% 208.36/208.51  |- skos__scopeNote mesh__D013444
% 208.36/208.51       A short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms.%A%    
% 208.36/208.51  |- mesh__dateRevised mesh__D013444 2005-06-30
% 208.36/208.51  |- mesh__dateCreated mesh__D013444 1999-01-01
% 208.36/208.51  |- skos__altLabel mesh__D013444 Sulfadimethyloxazole
% 208.36/208.51  |- skos__hiddenLabel mesh__D013444 Ammonium Salt Sulfisoxazole
% 208.36/208.51  |- mesh__recordAuthorizer mesh__D013444 sjn
% 208.36/208.51  |- skos__hiddenLabel mesh__D013444 Monolithium Salt Sulfisoxazole
% 208.36/208.51  |- skos__hiddenLabel mesh__D013444 V Sul
% 208.36/208.51  |- skos__hiddenLabel mesh__D013444 Diolamine, Sulfisoxazole
% 208.36/208.51  |- mesh__recordOriginator mesh__D013444 NLM
% 208.36/208.51  |- skos__altLabel mesh__D013444 Zenith Brand of Sulfisoxazole
% 208.36/208.51  |- skos__broader mesh__D013444smesh__D013424
% 208.36/208.51  |- rdf__type mesh__D013444sskos__Concept
% 208.36/208.51  |- skos__hiddenLabel mesh__D013444 Monosodium Salt Sulfisoxazole
% 208.36/208.51  |- skos__altLabel mesh__D013444 Sulfasoxizole
% 208.36/208.51  |- skos__altLabel mesh__D013444 Sulfafurazole
% 208.36/208.51  |- skos__altLabel mesh__D013444 Vangard Brand of Sulfisoxazole
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D013444 2006
% 208.36/208.51  |- mesh__recordMaintainer mesh__D013444 CCR
% 208.36/208.51  |- skos__prefLabel mesh__D013444 Sulfisoxazole
% 208.36/208.51  |- skos__altLabel mesh__D013444 FNA Brand of Sulfisoxazole
% 208.36/208.51  |- skos__hiddenLabel mesh__D013444 Triammonium Salt Sulfisoxazole
% 208.36/208.51  |- mesh__historyNote mesh__D007407 80   
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D007407 2006
% 208.36/208.51  |- mesh__dateRevised mesh__D007407 2001-07-25
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D007407 2002
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D007407 2005
% 208.36/208.51  |- rdf__type mesh__D007407sskos__Concept
% 208.36/208.51  |- skos__scopeNote mesh__D007407
% 208.36/208.51       Conversations with an individual or individuals held in order to obtain information about their background and other personal biographical data, their attitudes and opinions, etc. It includes school admission or job interviews.%A%    
% 208.36/208.51  |- mesh__publicMeSHNote mesh__D007407 80   
% 208.36/208.51  |- mesh__recordAuthorizer mesh__D007407 sjn
% 208.36/208.51  |- mesh__dateCreated mesh__D007407 1979-05-30
% 208.36/208.51  |- skos__hiddenLabel mesh__D007407 Interview, Group
% 208.36/208.51  |- skos__hiddenLabel mesh__D007407 Interviews, Group
% 208.36/208.51  |- skos__broader mesh__D007407smesh__D003625
% 208.36/208.51  |- skos__prefLabel mesh__D007407 Interviews
% 208.36/208.51  |- skos__hiddenLabel mesh__D007407 Telephone Interview
% 208.36/208.51  |- skos__hiddenLabel mesh__D007407 Group Interview
% 208.36/208.51  |- skos__hiddenLabel mesh__D007407 Interviewer
% 208.36/208.51  |- mesh__recordOriginator mesh__D007407 SMH
% 208.36/208.51  |- skos__hiddenLabel mesh__D007407 Interview, Telephone
% 208.36/208.51  |- mesh__dateEstablished mesh__D007407 1980-01-01
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D007407 2004
% 208.36/208.51  |- mesh__recordMaintainer mesh__D007407 lkt
% 208.36/208.51  |- skos__annotation mesh__D007407
% 208.36/208.51       for articles on how to conduct interviews, their value, behavior of participants, etc.: do not confuse with Publication Type INTERVIEW %28%Manual 17.64+%29%%A%  
% 208.36/208.51  |- skos__hiddenLabel mesh__D007407 Telephone Interviews
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D007407 2003
% 208.36/208.51  |- mesh__publicMeSHNote mesh__D017835
% 208.36/208.51       94; NEDOCROMIL was indexed under QUINOLINONES 1989-93 %26% QUINOLINES 1984-88%A%  
% 208.36/208.51  |- skos__scopeNote mesh__D017835
% 208.36/208.51       A pyranoquinolone derivative that inhibits activation of inflammatory cells which are associated with ASTHMA, including eosinophils, neutrophils, macrophages, mast cells, monocytes, and platelets.%A%    
% 208.36/208.51  |- skos__altLabel mesh__D017835 Nedocromil, Disodium Salt
% 208.36/208.51  |- skos__altLabel mesh__D017835 ASTA Medica Brand of Nedocromil Sodium
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D017835 2006
% 208.36/208.51  |- mesh__onlineNote mesh__D017835
% 208.36/208.51       use NEDOCROMIL %28%NM%29% to search NEDOCROMIL 1984-93   
% 208.36/208.51  |- mesh__recordMaintainer mesh__D017835 lkw
% 208.36/208.51  |- skos__altLabel mesh__D017835
% 208.36/208.51       Rh%C3%%B4%ne-Poulenc Rorer Brand of Nedocromil Sodium
% 208.36/208.51  |- skos__historyNote mesh__D017835 Quinolines %28%1984-1988%29%
% 208.36/208.51  |- mesh__historyNote mesh__D017835 94; was NEDOCROMIL %28%NM%29% 1984-93   
% 208.36/208.51  |- mesh__recordOriginator mesh__D017835 TPW
% 208.36/208.51  |- mesh__dateRevised mesh__D017835 2005-06-30
% 208.36/208.51  |- mesh__dateCreated mesh__D017835 1993-06-04
% 208.36/208.51  |- skos__hiddenLabel mesh__D017835 FPL59002
% 208.36/208.51  |- skos__altLabel mesh__D017835 Tilavist
% 208.36/208.51  |- skos__hiddenLabel mesh__D017835 Sodium, Nedocromil
% 208.36/208.51  |- skos__altLabel mesh__D017835 Tilad
% 208.36/208.51  |- skos__altLabel mesh__D017835 Allergan Brand of Nedocromil Sodium
% 208.36/208.51  |- skos__altLabel mesh__D017835 Aventis Brand of Nedocromil Sodium
% 208.36/208.51  |- skos__altLabel mesh__D017835 Aventis Behring Brand of Nedocromil Sodium
% 208.36/208.51  |- skos__hiddenLabel mesh__D017835 FPL 59002
% 208.36/208.51  |- skos__altLabel mesh__D017835 Tilaire
% 208.36/208.51  |- skos__altLabel mesh__D017835 Lesvi Brand of Nedocromil Sodium
% 208.36/208.51  |- mesh__recordAuthorizer mesh__D017835 sjn
% 208.36/208.51  |- skos__altLabel mesh__D017835 Fisons Brand of Nedocromil Sodium
% 208.36/208.51  |- skos__altLabel mesh__D017835 Vita Brand of Nedocromil Sodium
% 208.36/208.51  |- skos__altLabel mesh__D017835 Rapitil
% 208.36/208.51  |- rdf__type mesh__D017835sskos__Concept
% 208.36/208.51  |- skos__altLabel mesh__D017835 Irtan
% 208.36/208.51  |- skos__altLabel mesh__D017835 Nedocromil, Calcium Salt %28%1:1%29%
% 208.36/208.51  |- skos__prefLabel mesh__D017835 Nedocromil
% 208.36/208.51  |- skos__historyNote mesh__D017835 Quinolones %28%1989-1993%29%
% 208.36/208.51  |- mesh__dateEstablished mesh__D017835 1994-01-01
% 208.36/208.51  |- skos__broader mesh__D017835smesh__D042462
% 208.36/208.51  |- skos__altLabel mesh__D017835
% 208.36/208.51       9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano%28%3,2-g%29%quinoline-2,8-dicarboxylic acid
% 208.36/208.51  |- skos__hiddenLabel mesh__D017835 Calcium, Nedocromil
% 208.36/208.51  |- skos__altLabel mesh__D017835 Pantheon Brand of Nedocromil Sodium
% 208.36/208.51  |- mesh__onlineNote mesh__D017037
% 208.36/208.51       use DINITROGENASE REDUCTASE %28%NM%29% to search AZOFERREDOXIN %28%NM%29% 1985-91%A%  
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D017037 2006
% 208.36/208.51  |- mesh__publicMeSHNote mesh__D017037
% 208.36/208.51       92; AZOFERREDOXIN %28%NM%29% was indexed under FERREDOXINS 1985-91; AZOFERREDOXIN was see under FERREDOXINS 1977-85%A%  
% 208.36/208.51  |- mesh__dateRevised mesh__D017037 2003-07-09
% 208.36/208.51  |- mesh__recordAuthorizer mesh__D017037 sjn
% 208.36/208.51  |- mesh__dateEstablished mesh__D017037 1992-01-01
% 208.36/208.51  |- mesh__recordMaintainer mesh__D017037 ssb
% 208.36/208.51  |- skos__broader mesh__D017037smesh__D009591
% 208.36/208.51  |- rdf__type mesh__D017037sskos__Concept
% 208.36/208.51  |- skos__prefLabel mesh__D017037 Dinitrogenase Reductase
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D017037 2004
% 208.36/208.51  |- skos__hiddenLabel mesh__D017037 Reductase, Dinitrogenase
% 208.36/208.51  |- skos__historyNote mesh__D017037 Ferredoxins %28%1977-1991%29%
% 208.36/208.51  |- mesh__recordOriginator mesh__D017037 AGS
% 208.36/208.51  |- mesh__dateCreated mesh__D017037 1991-07-12
% 208.36/208.51  |- mesh__historyNote mesh__D017037
% 208.36/208.51       92; was AZOFERREDOXIN %28%NM%29% 1985-91; AZOFERREDOXIN was see under FERREDOXINS 1977-85%A%  
% 208.36/208.51  |- skos__scopeNote mesh__D017037
% 208.36/208.51       A non-heme iron-sulfur protein isolated from Clostridium pasteurianum and other bacteria. It is a component of NITROGENASE along with molybdoferredoxin and is active in nitrogen fixation.%A%    
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D017037 2005
% 208.36/208.51  |- skos__altLabel mesh__D017037 Azoferredoxin
% 208.36/208.51  |- skos__annotation mesh__D017037 from bacteria   
% 208.36/208.51  |- skos__prefLabel mesh__D003815 Dentists
% 208.36/208.51  |- skos__broader mesh__D003815smesh__D006282
% 208.36/208.51  |- skos__scopeNote mesh__D003815
% 208.36/208.51       Individuals licensed to practice dentistry.     
% 208.36/208.51  |- mesh__recordOriginator mesh__D003815 NLM
% 208.36/208.51  |- mesh__recordMaintainer mesh__D003815 kle
% 208.36/208.51  |- mesh__historyNote mesh__D003815 65   
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003815 2001
% 208.36/208.51  |- mesh__dateRevised mesh__D003815 1999-11-03
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003815 2006
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003815 2000
% 208.36/208.51  |- mesh__recordAuthorizer mesh__D003815 sjn
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003815 2004
% 208.36/208.51  |- mesh__dateEstablished mesh__D003815 1965-01-01
% 208.36/208.51  |- skos__hiddenLabel mesh__D003815 Dentist
% 208.36/208.51  |- mesh__publicMeSHNote mesh__D003815 65   
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003815 2005
% 208.36/208.51  |- mesh__dateCreated mesh__D003815 1999-01-01
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003815 2003
% 208.36/208.51  |- rdf__type mesh__D003815sskos__Concept
% 208.36/208.51  |- skos__annotation mesh__D003815 /educ = EDUCATION, DENTAL or specific   
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003815 2002
% 208.36/208.51  |- skos__annotation mesh__D003017 infection = TETANUS   
% 208.36/208.51  |- mesh__recordAuthorizer mesh__D003017 sjn
% 208.36/208.51  |- skos__scopeNote mesh__D003017
% 208.36/208.51       The cause of TETANUS in humans and domestic animals. It is a common inhabitant of human and horse intestines as well as soil. Two components make up its potent exotoxin activity, a neurotoxin and a hemolytic toxin.%A%    
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D003017 2006
% 208.36/208.51  |- skos__broader mesh__D003017smesh__D003013
% 208.36/208.51  |- mesh__dateRevised mesh__D003017 2005-06-30
% 208.36/208.51  |- mesh__dateCreated mesh__D003017 1999-01-01
% 208.36/208.51  |- rdf__type mesh__D003017sskos__Concept
% 208.36/208.51  |- skos__prefLabel mesh__D003017 Clostridium tetani
% 208.36/208.51  |- mesh__recordMaintainer mesh__D003017 SYSTEM
% 208.36/208.51  |- skos__related mesh__D003017smesh__D013744
% 208.36/208.51  |- mesh__recordOriginator mesh__D003017 NLM
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D008500 1994
% 208.36/208.51  |- mesh__activeMeSHYear mesh__D008500 1993
% 208.36/208.52  |- mesh__publicMeSHNote mesh__D008500
% 208.36/208.52       91; was see under HOSPITAL DEPARTMENTS Aug 1977-90   
% 208.36/208.52  |- skos__hiddenLabel mesh__D008500 Departments, Medical Records
% 208.36/208.52  |- skos__prefLabel mesh__D008500 Medical Records Department, Hospital
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D008500 1999
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D008500 2006
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D008500 2002
% 208.36/208.52  |- mesh__dateCreated mesh__D008500 1977-05-19
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D008500 2005
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D008500 1998
% 208.36/208.52  |- mesh__dateEstablished mesh__D008500 1991-01-01
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D008500 1997
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D008500 2004
% 208.36/208.52  |- skos__hiddenLabel mesh__D008500 Department, Medical Records
% 208.36/208.52  |- skos__scopeNote mesh__D008500
% 208.36/208.52       Hospital department responsible for the creating, care, storage and retrieval of medical records. It also provides statistical information for the medical and administrative staff.%A%    
% 208.36/208.52  |- skos__altLabel mesh__D008500 Medical Records Department
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D008500 2003
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D008500 1996
% 208.36/208.52  |- mesh__dateRevised mesh__D008500 1992-05-14
% 208.36/208.52  |- rdf__type mesh__D008500sskos__Concept
% 208.36/208.52  |- skos__hiddenLabel mesh__D008500 Records Department, Medical
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D008500 2001
% 208.36/208.52  |- skos__hiddenLabel mesh__D008500 Records Departments, Medical
% 208.36/208.52  |- skos__broader mesh__D008500smesh__D006748
% 208.36/208.52  |- mesh__historyNote mesh__D008500
% 208.36/208.52       91%28%Aug 77%29%; was see under HOSPITAL DEPARTMENTS 1977-90   
% 208.36/208.52  |- skos__annotation mesh__D008500 DF: MED REC DEP   
% 208.36/208.52  |- mesh__recordOriginator mesh__D008500 EC
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D008500 1995
% 208.36/208.52  |- mesh__recordMaintainer mesh__D008500 TGC
% 208.36/208.52  |- skos__altLabel mesh__D008500 Hospital Medical Records Department
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D008500 2000
% 208.36/208.52  |- skos__hiddenLabel mesh__D008500 Medical Records Departments
% 208.36/208.52  |- mesh__recordAuthorizer mesh__D008500 PLS
% 208.36/208.52  |- mesh__recordOriginator mesh__D049917 ssb
% 208.36/208.52  |- mesh__publicMeSHNote mesh__D049917 2006   
% 208.36/208.52  |- skos__scopeNote mesh__D049917
% 208.36/208.52       A plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida. It is sometimes called the teasel family.%A%    
% 208.36/208.52  |- skos__annotation mesh__D049917
% 208.36/208.52       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.36/208.52  |- skos__prefLabel mesh__D049917 Dipsacaceae
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D049917 2006
% 208.36/208.52  |- mesh__historyNote mesh__D049917 2006   
% 208.36/208.52  |- rdf__type mesh__D049917sskos__Concept
% 208.36/208.52  |- mesh__recordAuthorizer mesh__D049917 sjn
% 208.36/208.52  |- skos__broader mesh__D049917smesh__D019684
% 208.36/208.52  |- mesh__dateEstablished mesh__D049917 2006-01-01
% 208.36/208.52  |- mesh__recordMaintainer mesh__D049917 ssb
% 208.36/208.52  |- skos__altLabel mesh__D049917 Teasel
% 208.36/208.52  |- mesh__dateCreated mesh__D049917 2005-06-30
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D027465 2006
% 208.36/208.52  |- mesh__dateCreated mesh__D027465 2001-07-25
% 208.36/208.52  |- mesh__dateEstablished mesh__D027465 2002-01-01
% 208.36/208.52  |- skos__scopeNote mesh__D027465
% 208.36/208.52       A species of the Chenopodium genus which is the source of edible seed called quinoa. It contains makisterone A and other STEROIDS, some having ECDYSTEROID activity on insects.%A%    
% 208.36/208.52  |- mesh__publicMeSHNote mesh__D027465 2002   
% 208.36/208.52  |- mesh__recordOriginator mesh__D027465 ssb
% 208.36/208.52  |- rdf__type mesh__D027465sskos__Concept
% 208.36/208.52  |- skos__broader mesh__D027465smesh__D027462
% 208.36/208.52  |- mesh__dateRevised mesh__D027465 2005-06-30
% 208.36/208.52  |- mesh__historyNote mesh__D027465 2002   
% 208.36/208.52  |- mesh__recordMaintainer mesh__D027465 ssb
% 208.36/208.52  |- mesh__recordAuthorizer mesh__D027465 sjn
% 208.36/208.52  |- skos__prefLabel mesh__D027465 Chenopodium quinoa
% 208.36/208.52  |- skos__annotation mesh__D027465
% 208.36/208.52       coordinate with specific PLANT COMPONENTS term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.36/208.52  |- rdf__type mesh__D007408sskos__Concept
% 208.36/208.52  |- mesh__recordMaintainer mesh__D007408 lkt
% 208.36/208.52  |- mesh__publicMeSHNote mesh__D007408 65   
% 208.36/208.52  |- skos__broader mesh__D007408smesh__D000042
% 208.36/208.52  |- mesh__dateCreated mesh__D007408 1999-01-01
% 208.36/208.52  |- skos__altLabel mesh__D007408 Absorption, Intestinal
% 208.36/208.52  |- mesh__dateRevised mesh__D007408 2005-06-30
% 208.36/208.52  |- mesh__recordOriginator mesh__D007408 NLM
% 208.36/208.52  |- mesh__recordAuthorizer mesh__D007408 sjn
% 208.36/208.52  |- mesh__dateEstablished mesh__D007408 1965-01-01
% 208.36/208.52  |- skos__broader mesh__D007408smesh__D004068
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D007408 2006
% 208.36/208.52  |- mesh__historyNote mesh__D007408 65   
% 208.36/208.52  |- skos__prefLabel mesh__D007408 Intestinal Absorption
% 208.36/208.52  |- skos__scopeNote mesh__D007408
% 208.36/208.52       Uptake of substances through the lining of the INTESTINES.%A%    
% 208.36/208.52  |- skos__related mesh__D007408smesh__D008286
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D018130 2000
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D018130 2003
% 208.36/208.52  |- skos__scopeNote mesh__D018130
% 208.36/208.52       Diamond. A crystalline form of carbon that occurs as hard, colorless or tinted isomeric crystals. It is used as a precious stone, for cutting glass, and as bearings for delicate mechanisms. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D018130 1996
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D018130 2001
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D018130 2004
% 208.36/208.52  |- skos__historyNote mesh__D018130 Carbon %28%1980-1993%29%
% 208.36/208.52  |- mesh__publicMeSHNote mesh__D018130
% 208.36/208.52       94; DIAMOND was indexed under CARBON 1980-93   
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D018130 1997
% 208.36/208.52  |- skos__broader mesh__D018130smesh__D002244
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D018130 2002
% 208.36/208.52  |- mesh__dateCreated mesh__D018130 1993-06-04
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D018130 2005
% 208.36/208.52  |- skos__annotation mesh__D018130 a form of carbon   
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D018130 1998
% 208.36/208.52  |- mesh__historyNote mesh__D018130 94; was DIAMOND %28%NM%29% 1980-93   
% 208.36/208.52  |- mesh__dateEstablished mesh__D018130 1994-01-01
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D018130 2006
% 208.36/208.52  |- skos__prefLabel mesh__D018130 Diamond
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D018130 1994
% 208.36/208.52  |- rdf__type mesh__D018130sskos__Concept
% 208.36/208.52  |- skos__altLabel mesh__D018130 Diamonds
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D018130 1999
% 208.36/208.52  |- mesh__onlineNote mesh__D018130
% 208.36/208.52       use DIAMOND %28%NM%29% to search DIAMOND 1980-93   
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D018130 1995
% 208.36/208.52  |- mesh__recordMaintainer mesh__D004110 ssb
% 208.36/208.52  |- mesh__dateRevised mesh__D004110 2001-07-25
% 208.36/208.52  |- mesh__recordOriginator mesh__D004110 SH
% 208.36/208.52  |- mesh__dateCreated mesh__D004110 1974-11-19
% 208.36/208.52  |- rdf__type mesh__D004110sskos__Concept
% 208.36/208.52  |- skos__hiddenLabel mesh__D004110 CRD401
% 208.36/208.52  |- skos__hiddenLabel mesh__D004110 Malate, Diltiazem
% 208.36/208.52  |- skos__historyNote mesh__D004110 Benzazepines %28%1971-1974%29%
% 208.36/208.52  |- skos__scopeNote mesh__D004110
% 208.36/208.52       A benzothiazepine derivative with vasodilating action due to its antagonism of the actions of the calcium ion in membrane functions. It is also teratogenic.%A%    
% 208.36/208.52  |- mesh__dateEstablished mesh__D004110 1987-01-01
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D004110 2006
% 208.36/208.52  |- skos__broader mesh__D004110smesh__D001552
% 208.36/208.52  |- skos__historyNote mesh__D004110 Anisoles %28%1973-1974%29%
% 208.36/208.52  |- skos__hiddenLabel mesh__D004110 Hydrochloride, Diltiazem
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D004110 2005
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D004110 2004
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D004110 2002
% 208.36/208.52  |- skos__historyNote mesh__D004110 Dimethylamines %28%1973-1974%29%
% 208.36/208.52  |- mesh__historyNote mesh__D004110
% 208.36/208.52       87%28%79%29%; was see under BENZAZEPINES 1979-86; was CRD 401 see under BENZAZEPINES 1975-78%A%  
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D004110 2003
% 208.36/208.52  |- mesh__onlineNote mesh__D004110
% 208.36/208.52       use DILTIAZEM to search CRD 401 1975-78   
% 208.36/208.52  |- mesh__publicMeSHNote mesh__D004110
% 208.36/208.52       87; was see under BENZAZEPINES 1979-86; was CRD 401 see under BENZAZEPINES 1975-78%A%  
% 208.36/208.52  |- skos__hiddenLabel mesh__D004110 CRD 401
% 208.36/208.52  |- skos__prefLabel mesh__D004110 Diltiazem
% 208.36/208.52  |- mesh__recordAuthorizer mesh__D004110 sjn
% 208.36/208.52  |- skos__scopeNote mesh__D017836
% 208.36/208.52       A genus of venomous snakes of the subfamily Crotalinae. Twelve species of this genus are found in North and Central America and Asia. Agkistrodon contortrix is the copperhead, A. piscivorus, the cottonmouth. The former is named for its russet or orange-brown color, the latter for the white interior of its mouth. %28%Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, p336; Moore, Poisonous Snakes of the World, 1980, p75%29%%A%    
% 208.36/208.52  |- mesh__recordAuthorizer mesh__D017836 sjn
% 208.36/208.52  |- mesh__dateEstablished mesh__D017836 1994-01-01
% 208.36/208.52  |- mesh__dateCreated mesh__D017836 1993-02-16
% 208.36/208.52  |- skos__altLabel mesh__D017836 Ancistrodon
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D017836 2004
% 208.36/208.52  |- skos__historyNote mesh__D017836 Snakes %28%1966-1993%29%
% 208.36/208.52  |- mesh__dateRevised mesh__D017836 2003-07-09
% 208.36/208.52  |- rdf__type mesh__D017836sskos__Concept
% 208.36/208.52  |- skos__hiddenLabel mesh__D017836 Copperheads
% 208.36/208.52  |- mesh__recordMaintainer mesh__D017836 ags
% 208.36/208.52  |- mesh__publicMeSHNote mesh__D017836 94   
% 208.36/208.52  |- skos__annotation mesh__D017836
% 208.36/208.52       a genus of vipers; note X refs; its venom: coord IM with CROTALID VENOMS %28%IM%29%%A%  
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D017836 2006
% 208.36/208.52  |- skos__prefLabel mesh__D017836 Agkistrodon
% 208.36/208.52  |- skos__broader mesh__D017836smesh__D017819
% 208.36/208.52  |- skos__hiddenLabel mesh__D017836 Cottonmouths
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D017836 2005
% 208.36/208.52  |- mesh__historyNote mesh__D017836 94   
% 208.36/208.52  |- mesh__recordOriginator mesh__D017836 TGC
% 208.36/208.52  |- mesh__historyNote mesh__D017038
% 208.36/208.52       1992 %28%1979%29%; for ENDOGLUCOSAMINIDASE F use GLUCOSAMINIDASE 1987-2004; for ENDOGLUCOSAMINIDASE H use GLUCOSAMINIDASE 1983-2004; for ENDOGLYCOSIDASE D use GLUCOSAMINIDASE 1980-2004%A%  
% 208.36/208.52  |- skos__altLabel mesh__D017038 Peptide N-Glycosidase F
% 208.36/208.52  |- skos__altLabel mesh__D017038 Endo D Endoglucosaminidase
% 208.36/208.52  |- skos__broader mesh__D017038smesh__D006596
% 208.36/208.52  |- skos__hiddenLabel mesh__D017038 Endo beta Acetylglucosaminidase
% 208.36/208.52  |- rdf__type mesh__D017038sskos__Concept
% 208.36/208.52  |- skos__hiddenLabel mesh__D017038 Endo beta N Acetylglucosaminidase H
% 208.36/208.52  |- skos__hiddenLabel mesh__D017038 Endo N Acetyl beta d glucosaminidase
% 208.36/208.52  |- skos__altLabel mesh__D017038 Endoglycosidase D
% 208.36/208.52  |- skos__altLabel mesh__D017038 Endo-N-Acetyl-beta-d-glucosaminidase
% 208.36/208.52  |- skos__altLabel mesh__D017038 Endo F Endoglucosaminidase
% 208.36/208.52  |- skos__scopeNote mesh__D017038
% 208.36/208.52       A group of related enzymes responsible for the endohydrolysis of the di-N-acetylchitobiosyl unit in high-mannose-content glycopeptides and GLYCOPROTEINS.%A%    
% 208.36/208.52  |- mesh__recordAuthorizer mesh__D017038 sjn
% 208.36/208.52  |- skos__hiddenLabel mesh__D017038 Endo beta N Acetylglucosaminidase D
% 208.36/208.52  |- skos__altLabel mesh__D017038 Endoglucosaminidase H
% 208.36/208.52  |- mesh__dateEstablished mesh__D017038 1992-01-01
% 208.36/208.52  |- skos__altLabel mesh__D017038 Endoglycosidase F
% 208.36/208.52  |- mesh__dateRevised mesh__D017038 2004-07-07
% 208.36/208.52  |- skos__hiddenLabel mesh__D017038
% 208.36/208.52       Endo-beta-N-Acetylglucosaminidase, Mannosyl-Glycoprotein
% 208.36/208.52  |- mesh__publicMeSHNote mesh__D017038
% 208.36/208.52       1992;  for ENDOGLUCOSAMINIDASE F use GLUCOSAMINIDASE 1987-2004, for ENDOGLUCOSAMINIDASE H use GLUCOSAMINIDASE 1983-2004; for ENDOGLYCOSIDASE D use GLUCOSAMINIDASE 1980-2004; ENDO-BETA-ACETYLGLUCOSAMINIDASE was indexed under ACETYLGLUCOSAMINIDASE 1986-1991 %26% under GLYCOSIDE HYDROLASES 1979-1985; ENDOGLYCOSIDASE F was indexed under GLYCOSIDE HYDROLASES 1983-1991; ENDOHEXOSAMINIDASE H was indexed under HEXOSAMINIDASES 1982-1992%A%  
% 208.36/208.52  |- skos__hiddenLabel mesh__D017038
% 208.36/208.52       beta-N-Acetylglucosaminidase, Di-N-Acetylchitobiosyl
% 208.36/208.52  |- skos__altLabel mesh__D017038 Endoglucosaminidase F
% 208.36/208.52  |- skos__altLabel mesh__D017038 Endo H Endoglucosaminidase
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D017038 2005
% 208.36/208.52  |- skos__altLabel mesh__D017038 Endoglucosaminidase D
% 208.36/208.52  |- skos__hiddenLabel mesh__D017038 Peptide N Glycosidase F
% 208.36/208.52  |- skos__hiddenLabel mesh__D017038 Endo beta N Acetylglucosaminidase F
% 208.36/208.52  |- skos__prefLabel mesh__D017038
% 208.36/208.52       Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase
% 208.36/208.52  |- skos__altLabel mesh__D017038 Endo-beta-Acetylglucosaminidase
% 208.36/208.52  |- skos__historyNote mesh__D017038 Glycoside Hydrolases %28%1979-1985%29%
% 208.36/208.52  |- skos__hiddenLabel mesh__D017038
% 208.36/208.52       Mannosyl Glycoprotein Endo beta N Acetylglucosaminidase
% 208.36/208.52  |- mesh__recordOriginator mesh__D017038 AGS
% 208.36/208.52  |- skos__altLabel mesh__D017038
% 208.36/208.52       Di-N-Acetylchitobiosyl beta-N-Acetylglucosaminidase
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D017038 2006
% 208.36/208.52  |- skos__historyNote mesh__D017038 Acetylglucosaminidase %28%1986-1991%29%
% 208.36/208.52  |- mesh__dateCreated mesh__D017038 1991-07-12
% 208.36/208.52  |- skos__altLabel mesh__D017038 Endoglucosidase H
% 208.36/208.52  |- skos__hiddenLabel mesh__D017038
% 208.36/208.52       Di N Acetylchitobiosyl beta N Acetylglucosaminidase
% 208.36/208.52  |- mesh__recordMaintainer mesh__D017038 jmp
% 208.36/208.52  |- skos__prefLabel mesh__D003816 Dentists, Women
% 208.36/208.52  |- mesh__historyNote mesh__D003816 65   
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D003816 2002
% 208.36/208.52  |- skos__annotation mesh__D003816
% 208.36/208.52       /educ = EDUCATION, DENTAL or specific; Manual 34.11.3   
% 208.36/208.52  |- skos__altLabel mesh__D003816 Woman Dentist
% 208.36/208.52  |- skos__hiddenLabel mesh__D003816 Dentist, Woman
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D003816 2006
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D003816 2004
% 208.36/208.52  |- mesh__recordOriginator mesh__D003816 NLM
% 208.36/208.52  |- mesh__recordMaintainer mesh__D003816 kle
% 208.36/208.52  |- skos__scopeNote mesh__D003816 Female dentists.     
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D003816 2005
% 208.36/208.52  |- mesh__dateCreated mesh__D003816 1999-01-01
% 208.36/208.52  |- skos__broader mesh__D003816smesh__D014930
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D003816 2001
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D003816 2003
% 208.36/208.52  |- rdf__type mesh__D003816sskos__Concept
% 208.36/208.52  |- mesh__dateRevised mesh__D003816 1999-11-03
% 208.36/208.52  |- skos__hiddenLabel mesh__D003816 Woman Dentists
% 208.36/208.52  |- skos__broader mesh__D003816smesh__D003815
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D003816 2000
% 208.36/208.52  |- mesh__recordAuthorizer mesh__D003816 sjn
% 208.36/208.52  |- skos__hiddenLabel mesh__D003816 Women Dentists
% 208.36/208.52  |- mesh__dateEstablished mesh__D003816 1965-01-01
% 208.36/208.52  |- skos__hiddenLabel mesh__D003816 Dentists, Woman
% 208.36/208.52  |- mesh__publicMeSHNote mesh__D003816 65   
% 208.36/208.52  |- skos__hiddenLabel mesh__D003018 Retraction, Clot
% 208.36/208.52  |- mesh__recordAuthorizer mesh__D003018 sjn
% 208.36/208.52  |- skos__prefLabel mesh__D003018 Clot Retraction
% 208.36/208.52  |- skos__broader mesh__D003018smesh__D015539
% 208.36/208.52  |- mesh__historyNote mesh__D003018 73%28%64%29%   
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D003018 2004
% 208.36/208.52  |- mesh__dateRevised mesh__D003018 2003-07-09
% 208.36/208.52  |- skos__scopeNote mesh__D003018
% 208.36/208.52       Retraction of a clot resulting from contraction of PLATELET pseudopods attached to FIBRIN strands. The retraction is dependent on the contractile protein thrombosthenin. Clot retraction is used as a measure of platelet function.%A%    
% 208.36/208.52  |- skos__hiddenLabel mesh__D003018 Clot Retractions
% 208.36/208.52  |- mesh__dateCreated mesh__D003018 1999-01-01
% 208.36/208.52  |- mesh__publicMeSHNote mesh__D003018 73   
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D003018 2006
% 208.36/208.52  |- skos__broader mesh__D003018smesh__D010979
% 208.36/208.52  |- rdf__type mesh__D003018sskos__Concept
% 208.36/208.52  |- mesh__dateEstablished mesh__D003018 1973-01-01
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D003018 2005
% 208.36/208.52  |- skos__hiddenLabel mesh__D003018 Retractions, Clot
% 208.36/208.52  |- mesh__recordOriginator mesh__D003018 NLM
% 208.36/208.52  |- mesh__recordMaintainer mesh__D003018 nns
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D008501 2005
% 208.36/208.52  |- skos__altLabel mesh__D008501 Records, Problem-Oriented Medical
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D008501 2004
% 208.36/208.52  |- mesh__publicMeSHNote mesh__D008501
% 208.36/208.52       91; was see under MEDICAL RECORDS 1975-90; was MEDICAL RECORDS, PROBLEM ORIENTED 1975-89%A%  
% 208.36/208.52  |- skos__hiddenLabel mesh__D008501 Problem Oriented Medical Records
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D008501 2001
% 208.36/208.52  |- skos__scopeNote mesh__D008501
% 208.36/208.52       A system of record keeping in which a list of the patient%27%s problems is made and all history, physical findings, laboratory data, etc. pertinent to each problem are placed under that heading.%A%    
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D008501 2003
% 208.36/208.52  |- mesh__recordAuthorizer mesh__D008501 sjn
% 208.36/208.52  |- mesh__dateEstablished mesh__D008501 1991-01-01
% 208.36/208.52  |- skos__altLabel mesh__D008501 Record, Problem-Oriented Medical
% 208.36/208.52  |- rdf__type mesh__D008501sskos__Concept
% 208.36/208.52  |- skos__altLabel mesh__D008501 Problem-Oriented Medical Records
% 208.36/208.52  |- skos__altLabel mesh__D008501 Medical Record, Problem-Oriented
% 208.36/208.52  |- skos__hiddenLabel mesh__D008501 Records, Problem Oriented Medical
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D008501 2000
% 208.36/208.52  |- skos__broader mesh__D008501smesh__D008499
% 208.36/208.52  |- skos__hiddenLabel mesh__D008501 Record, Problem Oriented Medical
% 208.36/208.52  |- skos__altLabel mesh__D008501 Medical Records, Problem Oriented
% 208.36/208.52  |- mesh__onlineNote mesh__D008501
% 208.36/208.52       use MEDICAL RECORDS, PROBLEM-ORIENTED to search MEDICAL RECORDS, PROBLEM ORIENTED 1975-89%A%  
% 208.36/208.52  |- mesh__recordMaintainer mesh__D008501 jls
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D008501 2002
% 208.36/208.52  |- mesh__recordOriginator mesh__D008501 NLM
% 208.36/208.52  |- mesh__dateRevised mesh__D008501 1999-11-03
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D008501 2006
% 208.36/208.52  |- skos__prefLabel mesh__D008501 Medical Records, Problem-Oriented
% 208.36/208.52  |- skos__annotation mesh__D008501 DF: POMR   
% 208.36/208.52  |- mesh__historyNote mesh__D008501
% 208.36/208.52       91%28%89%29%; was see under MEDICAL RECORDS 1975-90; was MEDICAL RECORDS, PROBLEM ORIENTED 1975-89%A%  
% 208.36/208.52  |- skos__hiddenLabel mesh__D008501 Problem-Oriented Medical Record
% 208.36/208.52  |- mesh__dateCreated mesh__D008501 1974-11-11
% 208.36/208.52  |- skos__hiddenLabel mesh__D008501 Medical Record, Problem Oriented
% 208.36/208.52  |- skos__prefLabel mesh__D049918 Salacia
% 208.36/208.52  |- rdf__type mesh__D049918sskos__Concept
% 208.36/208.52  |- mesh__dateCreated mesh__D049918 2005-06-30
% 208.36/208.52  |- mesh__publicMeSHNote mesh__D049918 2006   
% 208.36/208.52  |- skos__broader mesh__D049918smesh__D029753
% 208.36/208.52  |- mesh__dateEstablished mesh__D049918 2006-01-01
% 208.36/208.52  |- mesh__historyNote mesh__D049918 2006   
% 208.36/208.52  |- mesh__recordOriginator mesh__D049918 ssb
% 208.36/208.52  |- mesh__recordAuthorizer mesh__D049918 sjn
% 208.36/208.52  |- skos__annotation mesh__D049918
% 208.36/208.52       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.36/208.52  |- skos__scopeNote mesh__D049918
% 208.36/208.52       A plant genus of the family CELASTRACEAE. Members contain friedelane-type TRITERPENES and SESQUITERPENES, EUDESMANE.%A%    
% 208.36/208.52  |- mesh__recordMaintainer mesh__D049918 ssb
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D049918 2006
% 208.36/208.52  |- rdf__type mesh__D027466sskos__Concept
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D027466 2002
% 208.36/208.52  |- skos__prefLabel mesh__D027466 Atriplex
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D027466 2005
% 208.36/208.52  |- mesh__dateCreated mesh__D027466 2001-07-25
% 208.36/208.52  |- skos__broader mesh__D027466smesh__D019663
% 208.36/208.52  |- skos__altLabel mesh__D027466 Saltbush
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D027466 2003
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D027466 2006
% 208.36/208.52  |- skos__scopeNote mesh__D027466
% 208.36/208.52       A plant genus in the CHENOPODIACEAE family.     
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D027466 2004
% 208.36/208.52  |- skos__annotation mesh__D027466
% 208.36/208.52       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.36/208.52  |- mesh__historyNote mesh__D027466 2002   
% 208.36/208.52  |- mesh__publicMeSHNote mesh__D027466 2002   
% 208.36/208.52  |- mesh__dateEstablished mesh__D027466 2002-01-01
% 208.36/208.52  |- skos__broader mesh__D007409smesh__D004065
% 208.36/208.52  |- skos__altLabel mesh__D007409 Atresia, Intestinal
% 208.36/208.52  |- skos__scopeNote mesh__D007409
% 208.36/208.52       Congenital obliteration of the lumen of the intestine, with the ILEUM involved in 50%25% of the cases and the JEJUNUM and DUODENUM following in frequency. It is the most frequent cause of INTESTINAL OBSTRUCTION in NEWBORNS. %28%From Stedman, 25th ed%29%%A%    
% 208.36/208.52  |- mesh__recordMaintainer mesh__D007409 lkt
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D007409 2004
% 208.36/208.52  |- skos__annotation mesh__D007409
% 208.36/208.52       coord IM with specific intestine /abnorm except for duodenum: index duodenal atresia as DUODENAL OBSTRUCTION /congen %28%IM%29% + INTESTINAL ATRESIA %28%IM%29%%A%  
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D007409 2006
% 208.36/208.52  |- rdf__type mesh__D007409sskos__Concept
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D007409 2005
% 208.36/208.52  |- mesh__recordOriginator mesh__D007409 NLM
% 208.36/208.52  |- skos__prefLabel mesh__D007409 Intestinal Atresia
% 208.36/208.52  |- mesh__dateRevised mesh__D007409 2003-07-09
% 208.36/208.52  |- mesh__dateCreated mesh__D007409 1999-01-01
% 208.36/208.52  |- skos__broader mesh__D007409smesh__D007410
% 208.36/208.52  |- mesh__recordAuthorizer mesh__D007409 sjn
% 208.36/208.52  |- mesh__dateCreated mesh__D004111 1999-01-01
% 208.36/208.52  |- skos__hiddenLabel mesh__D004111 Lichtenstein, Dimen
% 208.36/208.52  |- skos__altLabel mesh__D004111 Uriach Brand of Dimenhydrinate
% 208.36/208.52  |- skos__altLabel mesh__D004111 Republic Drug Brand of Dimenhydrinate
% 208.36/208.52  |- mesh__recordOriginator mesh__D004111 NLM
% 208.36/208.52  |- skos__altLabel mesh__D004111 Hyrex Brand of Dimenhydrinate
% 208.36/208.52  |- skos__broader mesh__D004111smesh__D004155
% 208.36/208.52  |- skos__altLabel mesh__D004111 RubiePharm Brand of Dimenhydrinate
% 208.36/208.52  |- skos__hiddenLabel mesh__D004111 Vertigo Vomex
% 208.36/208.52  |- skos__hiddenLabel mesh__D004111 Motion Aid
% 208.36/208.52  |- skos__altLabel mesh__D004111 Whitehall-Much Brand of Dimenhydrinate
% 208.36/208.52  |- skos__altLabel mesh__D004111 Del Brand of Dimenhydrinate
% 208.36/208.52  |- skos__hiddenLabel mesh__D004111 Reisetabletten ratiopharm
% 208.36/208.52  |- skos__altLabel mesh__D004111 Lichtenstein Brand of Dimenhydrinate
% 208.36/208.52  |- skos__altLabel mesh__D004111 Apotex Brand of Dimenhydrinate
% 208.36/208.52  |- skos__altLabel mesh__D004111 Brothier Brand of Dimenhydrinate
% 208.36/208.52  |- skos__altLabel mesh__D004111 Carter Horner Brand of Dimenhydrinate
% 208.36/208.52  |- skos__altLabel mesh__D004111 Stada Brand of Dimenhydrinate
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D004111 2006
% 208.36/208.52  |- skos__altLabel mesh__D004111 Gr%C3%%BC%nwalder Brand of Dimenhydrinate
% 208.36/208.52  |- skos__hiddenLabel mesh__D004111 L%C3%%BC%nopharm, Reisetabletten
% 208.36/208.52  |- skos__altLabel mesh__D004111 Vomex A
% 208.36/208.52  |- skos__hiddenLabel mesh__D004111 Calm X
% 208.36/208.52  |- skos__scopeNote mesh__D004111
% 208.36/208.52       A drug combination that contains DIPHENHYDRAMINE and THEOPHYLLINE. It is used for treating vertigo, motion sickness, and nausea associated with pregnancy. It is not effective in the treatment of nausea associated with cancer chemotherapy.%A%    
% 208.36/208.52  |- skos__altLabel mesh__D004111 Vangard Brand of Dimenhydrinate
% 208.36/208.52  |- mesh__recordMaintainer mesh__D004111 exl
% 208.36/208.52  |- skos__prefLabel mesh__D004111 Dimenhydrinate
% 208.36/208.52  |- skos__altLabel mesh__D004111 Roberts Brand of Dimenhydrinate
% 208.36/208.52  |- skos__altLabel mesh__D004111 Yamanouchi Brand of Dimenhydrinate
% 208.36/208.52  |- skos__hiddenLabel mesh__D004111 Apo Dimenhydrinate
% 208.36/208.52  |- skos__altLabel mesh__D004111 Diphenhydramine Theoclate
% 208.36/208.52  |- skos__altLabel mesh__D004111 ratiopharm Brand of Dimenhydrinate
% 208.36/208.52  |- skos__altLabel mesh__D004111 Vortech Brand of Dimenhydrinate
% 208.36/208.52  |- rdf__type mesh__D004111sskos__Concept
% 208.36/208.52  |- skos__altLabel mesh__D004111 Farmalider Brand of Dimenhydrinate
% 208.36/208.52  |- skos__altLabel mesh__D004111 Jones Brand of Dimenhydrinate
% 208.36/208.52  |- skos__altLabel mesh__D004111 Pasadena Brand of Dimenhydrinate
% 208.36/208.52  |- skos__altLabel mesh__D004111 Pharmacia Brand of Dimenhydrinate
% 208.36/208.52  |- skos__hiddenLabel mesh__D004111 Theoclate, Diphenhydramine
% 208.36/208.52  |- skos__altLabel mesh__D004111 Cinfa Brand of Dimenhydrinate
% 208.36/208.52  |- skos__altLabel mesh__D004111 Alra Brand of Dimenhydrinate
% 208.36/208.52  |- skos__altLabel mesh__D004111 Torrens Brand of Dimenhydrinate
% 208.36/208.52  |- skos__altLabel mesh__D004111 Heumann Brand of Dimenhydrinate
% 208.36/208.52  |- mesh__dateRevised mesh__D004111 2005-06-30
% 208.36/208.52  |- skos__hiddenLabel mesh__D004111 Stada, Reisetabletten
% 208.36/208.52  |- skos__altLabel mesh__D004111 Hexal Brand of Dimenhydrinate
% 208.36/208.52  |- skos__altLabel mesh__D004111 Wallace Brand of Dimenhydrinate
% 208.36/208.52  |- skos__altLabel mesh__D004111 Hermes Brand of Dimenhydrinate
% 208.36/208.52  |- skos__broader mesh__D004111smesh__D013806
% 208.36/208.52  |- skos__altLabel mesh__D004111 Rayere Brand of Dimenhydrinate
% 208.36/208.52  |- mesh__recordAuthorizer mesh__D004111 sjn
% 208.36/208.52  |- skos__hiddenLabel mesh__D004111 Heumann, Dimen
% 208.36/208.52  |- skos__altLabel mesh__D004111 Seatrace Brand of Dimenhydrinate
% 208.36/208.52  |- skos__hiddenLabel mesh__D004111 Whitehall Much Brand of Dimenhydrinate
% 208.36/208.52  |- skos__altLabel mesh__D004111 Lunopharm Brand of Dimenhydrinate
% 208.36/208.52  |- skos__scopeNote mesh__D017837
% 208.36/208.52       A genus of poisonous snakes of the VIPERIDAE family. About 50 species are known and all are found in tropical America and southern South America. Bothrops atrox is the fer-de-lance and B. jararaca is the jararaca. %28%Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, p336%29%%A%    
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D017837 2004
% 208.36/208.52  |- skos__historyNote mesh__D017837 Snakes %28%1966-1993%29%
% 208.36/208.52  |- mesh__dateRevised mesh__D017837 2003-07-09
% 208.36/208.52  |- mesh__recordOriginator mesh__D017837 TGC
% 208.36/208.52  |- skos__hiddenLabel mesh__D017837 Fer de Lance
% 208.36/208.52  |- skos__altLabel mesh__D017837 Jararaca
% 208.36/208.52  |- rdf__type mesh__D017837sskos__Concept
% 208.36/208.52  |- mesh__recordAuthorizer mesh__D017837 sjn
% 208.36/208.52  |- skos__prefLabel mesh__D017837 Bothrops
% 208.36/208.52  |- mesh__dateEstablished mesh__D017837 1994-01-01
% 208.36/208.52  |- mesh__recordMaintainer mesh__D017837 ags
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D017837 2006
% 208.36/208.52  |- skos__annotation mesh__D017837
% 208.36/208.52       a genus of vipers; its venom: coord IM with CROTALID VENOMS %28%IM%29%%A%  
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D017837 2005
% 208.36/208.52  |- skos__hiddenLabel mesh__D017837 Fer-de-Lances
% 208.36/208.52  |- mesh__publicMeSHNote mesh__D017837 94   
% 208.36/208.52  |- mesh__historyNote mesh__D017837 94   
% 208.36/208.52  |- skos__broader mesh__D017837smesh__D017819
% 208.36/208.52  |- mesh__dateCreated mesh__D017837 1993-02-16
% 208.36/208.52  |- skos__scopeNote mesh__D003817
% 208.36/208.52       The teeth collectively in the dental arch. Dentition ordinarily refers to the natural teeth in position in their alveoli. Dentition referring to the deciduous teeth is DENTITION, PRIMARY; to the permanent teeth, DENTITION, PERMANENT. %28%From Jablonski, Dictionary of Dentistry, 1992%29%%A%    
% 208.36/208.52  |- mesh__recordMaintainer mesh__D003817 ags
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D003817 2004
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D003817 2005
% 208.36/208.52  |- mesh__dateRevised mesh__D003817 2005-07-13
% 208.36/208.52  |- mesh__dateCreated mesh__D003817 1999-01-01
% 208.36/208.52  |- skos__broader mesh__D003817smesh__D009055
% 208.36/208.52  |- skos__annotation mesh__D003817
% 208.36/208.52       GEN or unspecified; prefer DENTITION, PRIMARY; DENTITION, PERMANENT; or DENTITION, MIXED; differentiate from TOOTH%A%  
% 208.36/208.52  |- mesh__activeMeSHYear mesh__D003817 2006A
% 208.36/208.52  |- rdf__type mesh__D003817sskos__Concept
% 208.36/208.52  |- skos__hiddenLabel mesh__D003817 Dentitions
% 208.36/208.52  |- mesh__recordOriginator mesh__D003817 NLM
% 208.36/208.52  |- skos__prefLabel mesh__D003817 Dentition
% 208.36/208.53  |- mesh__recordAuthorizer mesh__D003817 ags
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D003817 2006
% 208.36/208.53  |- rdf__type mesh__D008502sskos__Concept
% 208.36/208.53  |- mesh__recordMaintainer mesh__D008502 TAP
% 208.36/208.53  |- skos__scopeNote mesh__D008502
% 208.36/208.53       Individuals responsible for various duties pertaining to the medical office routine.%A%    
% 208.36/208.53  |- skos__altLabel mesh__D008502 Medical Secretary
% 208.36/208.53  |- mesh__dateRevised mesh__D008502 1992-05-14
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008502 2001
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008502 1995
% 208.36/208.53  |- skos__altLabel mesh__D008502 Secretary, Medical
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008502 1994
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008502 1993
% 208.36/208.53  |- skos__prefLabel mesh__D008502 Medical Secretaries
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008502 2000
% 208.36/208.53  |- mesh__recordAuthorizer mesh__D008502 PLS
% 208.36/208.53  |- skos__broader mesh__D008502smesh__D000488
% 208.36/208.53  |- mesh__dateCreated mesh__D008502 1999-01-01
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008502 1999
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008502 2006
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008502 1998
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008502 2005
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008502 1997
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008502 2004
% 208.36/208.53  |- skos__altLabel mesh__D008502 Secretaries, Medical
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008502 2002
% 208.36/208.53  |- mesh__recordOriginator mesh__D008502 NLM
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008502 1996
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008502 2003
% 208.36/208.53  |- mesh__recordAuthorizer mesh__D049919 sjn
% 208.36/208.53  |- skos__altLabel mesh__D049919 Fleabane
% 208.36/208.53  |- skos__prefLabel mesh__D049919 Erigeron
% 208.36/208.53  |- skos__historyNote mesh__D049919 Asteraceae %28%2001-2005%29%
% 208.36/208.53  |- mesh__dateCreated mesh__D049919 2005-06-30
% 208.36/208.53  |- mesh__recordMaintainer mesh__D049919 ssb
% 208.36/208.53  |- skos__broader mesh__D049919smesh__D019659
% 208.36/208.53  |- mesh__publicMeSHNote mesh__D049919 2006   
% 208.36/208.53  |- mesh__recordOriginator mesh__D049919 ssb
% 208.36/208.53  |- skos__annotation mesh__D049919
% 208.36/208.53       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.36/208.53  |- skos__scopeNote mesh__D049919
% 208.36/208.53       A plant genus of the family ASTERACEAE that is similar to CONYZA. Members contain SESQUITERPENES.%A%    
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D049919 2006
% 208.36/208.53  |- rdf__type mesh__D049919sskos__Concept
% 208.36/208.53  |- mesh__historyNote mesh__D049919 2006   
% 208.36/208.53  |- mesh__dateEstablished mesh__D049919 2006-01-01
% 208.36/208.53  |- mesh__historyNote mesh__D027467 2002   
% 208.36/208.53  |- mesh__dateCreated mesh__D027467 2001-08-03
% 208.36/208.53  |- skos__altLabel mesh__D027467 Burningbush %28%Bassia%29%
% 208.36/208.53  |- skos__prefLabel mesh__D027467 Bassia scoparia
% 208.36/208.53  |- mesh__recordAuthorizer mesh__D027467 sjn
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D027467 2005
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D027467 2002
% 208.36/208.53  |- skos__altLabel mesh__D027467 Summer cypress
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D027467 2006
% 208.36/208.53  |- mesh__recordMaintainer mesh__D027467 jls
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D027467 2003
% 208.36/208.53  |- skos__altLabel mesh__D027467 Fireweed
% 208.36/208.53  |- skos__altLabel mesh__D027467 Kochia scoparia
% 208.36/208.53  |- skos__altLabel mesh__D027467 Firebrush
% 208.36/208.53  |- skos__annotation mesh__D027467
% 208.36/208.53       do not confuse X ref BURNINGBUSH %28%BASSIA%29% with BURNINGBUSH %28%EUONYMUS%29% see EUONYMUS; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D027467 2004
% 208.36/208.53  |- mesh__publicMeSHNote mesh__D027467 2002   
% 208.36/208.53  |- mesh__dateEstablished mesh__D027467 2002-01-01
% 208.36/208.53  |- rdf__type mesh__D027467sskos__Concept
% 208.36/208.53  |- skos__broader mesh__D027467smesh__D019663
% 208.36/208.53  |- mesh__recordOriginator mesh__D027467 ssb
% 208.36/208.53  |- skos__scopeNote mesh__D027467
% 208.36/208.53       A plant species of the family CHENOPODIACEAE.  It is a source of furonaphthoquinones.  The common name of burning bush is also used with the unrelated EUONYMUS sieboldianus.%A%    
% 208.36/208.53  |- mesh__recordAuthorizer mesh__D013447 PLS
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D013447 2000
% 208.36/208.53  |- rdf__type mesh__D013447sskos__Concept
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D013447 2004
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D013447 1998
% 208.36/208.53  |- skos__prefLabel mesh__D013447 Sulfites
% 208.36/208.53  |- skos__broader mesh__D013447smesh__D013457
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D013447 2001
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D013447 2005
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D013447 1999
% 208.36/208.53  |- skos__broader mesh__D013447smesh__D000838
% 208.36/208.53  |- mesh__dateRevised mesh__D013447 1993-06-03
% 208.36/208.53  |- mesh__dateCreated mesh__D013447 1999-01-01
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D013447 1994
% 208.36/208.53  |- skos__altLabel mesh__D013447 Sulfites, Inorganic
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D013447 2002
% 208.36/208.53  |- skos__scopeNote mesh__D013447 Inorganic salts of sulfurous acid.     
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D013447 2006
% 208.36/208.53  |- mesh__recordMaintainer mesh__D013447 TPW
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D013447 1995
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D013447 1996
% 208.36/208.53  |- mesh__recordOriginator mesh__D013447 NLM
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D013447 2003
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D013447 1997
% 208.36/208.53  |- skos__altLabel mesh__D013447 Inorganic Sulfites
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D032601 2006
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D032601 2003
% 208.36/208.53  |- skos__scopeNote mesh__D032601
% 208.36/208.53       A plant genus of the family BRASSICACEAE. Some members contain CARDIAC GLYCOSIDES.%A%    
% 208.36/208.53  |- rdf__type mesh__D032601sskos__Concept
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D032601 2005
% 208.36/208.53  |- mesh__dateCreated mesh__D032601 2002-07-03
% 208.36/208.53  |- mesh__publicMeSHNote mesh__D032601 2003   
% 208.36/208.53  |- mesh__historyNote mesh__D032601 2003   
% 208.36/208.53  |- skos__annotation mesh__D032601
% 208.36/208.53       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.36/208.53  |- mesh__dateEstablished mesh__D032601 2003-01-01
% 208.36/208.53  |- skos__altLabel mesh__D032601 Wallflower
% 208.36/208.53  |- skos__broader mesh__D032601smesh__D019607
% 208.36/208.53  |- skos__prefLabel mesh__D032601 Erysimum
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D032601 2004
% 208.36/208.53  |- mesh__dateCreated mesh__D018132 1993-06-04
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D018132 2006
% 208.36/208.53  |- mesh__recordMaintainer mesh__D018132 sjn
% 208.36/208.53  |- mesh__recordOriginator mesh__D018132 AGS
% 208.36/208.53  |- mesh__historyNote mesh__D018132 94; was see RUBELLA VIRUS 1981-93   
% 208.36/208.53  |- mesh__dateEstablished mesh__D018132 1994-01-01
% 208.36/208.53  |- rdf__type mesh__D018132sskos__Concept
% 208.36/208.53  |- mesh__recordAuthorizer mesh__D018132 sjn
% 208.36/208.53  |- skos__hiddenLabel mesh__D018132 Rubiviruses
% 208.36/208.53  |- mesh__dateRevised mesh__D018132 2001-08-03
% 208.36/208.53  |- mesh__publicMeSHNote mesh__D018132 94; was see RUBELLA VIRUS 1981-93   
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D018132 2003
% 208.36/208.53  |- mesh__onlineNote mesh__D018132
% 208.36/208.53       use RUBELLA VIRUS to search RUBIVIRUS 1981-93   
% 208.36/208.53  |- skos__broader mesh__D018132smesh__D014035
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D018132 2004
% 208.36/208.53  |- skos__annotation mesh__D018132
% 208.36/208.53       a genus of the family Togaviridae; from Latin rub-, red, with reference to the type species RUBELLA VIRUS %28%Latin rubella, reddish, a disease showing a generalized reddish rash%29%; infection = RUBIVIRUS INFECTIONS%A%  
% 208.36/208.53  |- skos__prefLabel mesh__D018132 Rubivirus
% 208.36/208.53  |- skos__scopeNote mesh__D018132
% 208.36/208.53       A genus of the family TOGAVIRIDAE containing only one recognized species, RUBELLA VIRUS. Transmission is primarily by aerosolization.%A%    
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D018132 2005
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D018132 2002
% 208.36/208.53  |- skos__hiddenLabel mesh__D004910 Red Cell Ghosts
% 208.36/208.53  |- skos__hiddenLabel mesh__D004910 Cytoskeleton, Erythrocyte
% 208.36/208.53  |- skos__altLabel mesh__D004910 Erythrocyte Ghost
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D004910 2006
% 208.36/208.53  |- mesh__recordMaintainer mesh__D004910 lkt
% 208.36/208.53  |- mesh__dateEstablished mesh__D004910 1984-01-01
% 208.36/208.53  |- skos__hiddenLabel mesh__D004910 Erythrocyte Membranes
% 208.36/208.53  |- skos__hiddenLabel mesh__D004910 Membranes, Erythrocyte
% 208.36/208.53  |- skos__broader mesh__D004910smesh__D002462
% 208.36/208.53  |- rdf__type mesh__D004910sskos__Concept
% 208.36/208.53  |- skos__prefLabel mesh__D004910 Erythrocyte Membrane
% 208.36/208.53  |- mesh__recordOriginator mesh__D004910 VDK
% 208.36/208.53  |- skos__hiddenLabel mesh__D004910 Ghost, Erythrocyte
% 208.36/208.53  |- mesh__recordAuthorizer mesh__D004910 sjn
% 208.36/208.53  |- skos__hiddenLabel mesh__D004910 Ghost, Red Cell
% 208.36/208.53  |- skos__hiddenLabel mesh__D004910 Cytoskeletons, Erythrocyte
% 208.36/208.53  |- mesh__dateCreated mesh__D004910 1976-05-19
% 208.36/208.53  |- skos__broader mesh__D004910smesh__D004912
% 208.36/208.53  |- skos__hiddenLabel mesh__D004910 Ghosts, Erythrocyte
% 208.36/208.53  |- skos__altLabel mesh__D004910 Erythrocyte Cytoskeleton
% 208.36/208.53  |- skos__hiddenLabel mesh__D004910 Erythrocyte Cytoskeletons
% 208.36/208.53  |- skos__scopeNote mesh__D004910
% 208.36/208.53       The semi-permeable outer structure of a red blood cell. It is known as a red cell %27%ghost%27% after HEMOLYSIS.%A%    
% 208.36/208.53  |- skos__historyNote mesh__D004910 Erythrocytes %28%1966-1976%29%
% 208.36/208.53  |- skos__hiddenLabel mesh__D004910 Membrane, Erythrocyte
% 208.36/208.53  |- skos__hiddenLabel mesh__D004910 Erythrocyte Ghosts
% 208.36/208.53  |- mesh__historyNote mesh__D004910
% 208.36/208.53       84%28%77%29%; was see under ERYTHROCYTES 1977-83   
% 208.36/208.53  |- mesh__dateRevised mesh__D004910 2005-06-30
% 208.36/208.53  |- mesh__publicMeSHNote mesh__D004910
% 208.36/208.53       84; was see under ERYTHROCYTES 1977-83   
% 208.36/208.53  |- skos__hiddenLabel mesh__D004910 Ghosts, Red Cell
% 208.36/208.53  |- skos__broader mesh__D051566smesh__D050578
% 208.36/208.53  |- skos__altLabel mesh__D051566 Alternative Pathway C5 Convertase
% 208.36/208.53  |- skos__prefLabel mesh__D051566
% 208.36/208.53       Complement C5 Convertase, Alternative Pathway
% 208.36/208.53  |- skos__historyNote mesh__D051566 Complement C5 %28%1976-2005%29%
% 208.36/208.53  |- skos__historyNote mesh__D051566
% 208.36/208.53       Complement Activating Enzymes %28%1978-2005%29%
% 208.36/208.53  |- mesh__dateCreated mesh__D051566 2005-06-30
% 208.36/208.53  |- mesh__recordOriginator mesh__D051566 lkt
% 208.36/208.53  |- mesh__publicMeSHNote mesh__D051566 2006   
% 208.36/208.53  |- rdf__type mesh__D051566sskos__Concept
% 208.36/208.53  |- skos__altLabel mesh__D051566 C5 Convertase %28%C3bBb3b%29%
% 208.36/208.53  |- mesh__recordAuthorizer mesh__D051566 sjn
% 208.36/208.53  |- mesh__dateEstablished mesh__D051566 2006-01-01
% 208.36/208.53  |- mesh__recordMaintainer mesh__D051566 lkt
% 208.36/208.53  |- skos__altLabel mesh__D051566 C5 Convertase, Alternative Pathway
% 208.36/208.53  |- skos__scopeNote mesh__D051566
% 208.36/208.53       A serine protease that cleaves multiple COMPLEMENT C5 into COMPLEMENT C5A %28%anaphylatoxin%29% and COMPLEMENT C5B in the ALTERNATIVE COMPLEMENT ACTIVATION PATHWAY. It is the complex of ALTERNATIVE PATHWAY C3 CONVERTASE %28%C3bBb%29% with an additional COMPLEMENT C3B, or C3bBb3b.%A%    
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D051566 2006
% 208.36/208.53  |- mesh__historyNote mesh__D051566 2006   
% 208.36/208.53  |- skos__hiddenLabel mesh__D004112 Anti-Lewisite, British
% 208.36/208.53  |- skos__scopeNote mesh__D004112
% 208.36/208.53       An anti-gas warfare agent that is effective against Lewisite %28%dichloro%28%2-chlorovinyl%29%arsine%29% and formerly known as British Anti-Lewisite or BAL. It acts as a chelating agent and is used in the treatment of arsenic, gold, and other heavy metal poisoning.%A%    
% 208.36/208.53  |- mesh__recordMaintainer mesh__D004112 exl
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D004112 2006
% 208.36/208.53  |- mesh__recordOriginator mesh__D004112 NLM
% 208.36/208.53  |- mesh__dateCreated mesh__D004112 1999-01-01
% 208.36/208.53  |- skos__altLabel mesh__D004112 2,3-Dithiopropan-1-o1
% 208.36/208.53  |- skos__altLabel mesh__D004112 2,3-Dimercaptopropanol
% 208.36/208.53  |- skos__annotation mesh__D004112 a chelating agent; D25-26 qualif   
% 208.36/208.53  |- skos__hiddenLabel mesh__D004112 Cadmium 2,3 Dimercaptopropanol
% 208.36/208.53  |- skos__altLabel mesh__D004112 British Anti-Lewisite
% 208.36/208.53  |- skos__hiddenLabel mesh__D004112 2,3 Dithiopropan 1 o1
% 208.36/208.53  |- mesh__recordAuthorizer mesh__D004112 sjn
% 208.36/208.53  |- skos__hiddenLabel mesh__D004112 British Anti Lewisite Agent
% 208.36/208.53  |- skos__altLabel mesh__D004112 British Anti-Lewisite Agent
% 208.36/208.53  |- skos__hiddenLabel mesh__D004112 2,3-Dimercaptopropanol, Cadmium
% 208.36/208.53  |- skos__prefLabel mesh__D004112 Dimercaprol
% 208.36/208.53  |- skos__altLabel mesh__D004112 Taylor Brand of Dimercaprol
% 208.36/208.53  |- skos__hiddenLabel mesh__D004112 2,3 Dimercaptopropanol
% 208.36/208.53  |- mesh__dateRevised mesh__D004112 2005-06-30
% 208.36/208.53  |- skos__broader mesh__D004112smesh__D013438
% 208.36/208.53  |- skos__hiddenLabel mesh__D004112 British Anti Lewisite
% 208.36/208.53  |- skos__hiddenLabel mesh__D004112 Anti-Lewisite Agent, British
% 208.36/208.53  |- skos__altLabel mesh__D004112 Knoll Brand of Dimercaprol
% 208.36/208.53  |- rdf__type mesh__D004112sskos__Concept
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D017838 2004
% 208.36/208.53  |- mesh__dateRevised mesh__D017838 2003-07-09
% 208.36/208.53  |- mesh__recordMaintainer mesh__D017838 ags
% 208.36/208.53  |- mesh__publicMeSHNote mesh__D017838 94   
% 208.36/208.53  |- rdf__type mesh__D017838sskos__Concept
% 208.36/208.53  |- skos__scopeNote mesh__D017838
% 208.36/208.53       A genus of poisonous snakes of the subfamily Elapinae of the family ELAPIDAE. They comprise the kraits. Twelve species are recognized and all inhabit southeast Asia. They are considered extremely dangerous. %28%Moore: Poisonous Snakes of the World, 1980, p120%29%%A%    
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D017838 2005
% 208.36/208.53  |- skos__altLabel mesh__D017838 Krait
% 208.36/208.53  |- skos__hiddenLabel mesh__D017838 Kraits
% 208.36/208.53  |- skos__historyNote mesh__D017838 Snakes %28%1966-1993%29%
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D017838 2006
% 208.36/208.53  |- skos__related mesh__D017838smesh__D002038
% 208.36/208.53  |- mesh__dateEstablished mesh__D017838 1994-01-01
% 208.36/208.53  |- mesh__recordOriginator mesh__D017838 TGC
% 208.36/208.53  |- skos__broader mesh__D017838smesh__D017815
% 208.36/208.53  |- mesh__recordAuthorizer mesh__D017838 sjn
% 208.36/208.53  |- skos__prefLabel mesh__D017838 Bungarus
% 208.36/208.53  |- mesh__historyNote mesh__D017838 94   
% 208.36/208.53  |- skos__annotation mesh__D017838 a genus of poisonous snakes   
% 208.36/208.53  |- mesh__dateCreated mesh__D017838 1993-02-16
% 208.36/208.53  |- skos__annotation mesh__D003818
% 208.36/208.53       some deciduous teeth, some permanent; see note at DENTITION; no qualif%A%  
% 208.36/208.53  |- mesh__dateCreated mesh__D003818 1999-01-01
% 208.36/208.53  |- mesh__recordOriginator mesh__D003818 NLM
% 208.36/208.53  |- mesh__dateRevised mesh__D003818 2003-07-09
% 208.36/208.53  |- skos__scopeNote mesh__D003818
% 208.36/208.53       The complement of teeth in the jaws after the eruption of some of the permanent teeth but before all the deciduous teeth are absent. %28%Boucher%27%s Clinical Dental Terminology, 4th ed%29%%A%    
% 208.36/208.53  |- skos__related mesh__D003818smesh__D012690
% 208.36/208.53  |- rdf__type mesh__D003818sskos__Concept
% 208.36/208.53  |- skos__hiddenLabel mesh__D003818 Mixed Dentition
% 208.36/208.53  |- skos__hiddenLabel mesh__D003818 Transitional Dentition
% 208.36/208.53  |- skos__hiddenLabel mesh__D003818 Dentitions, Mixed
% 208.36/208.53  |- mesh__recordAuthorizer mesh__D003818 sjn
% 208.36/208.53  |- mesh__publicMeSHNote mesh__D003818 73   
% 208.36/208.53  |- skos__prefLabel mesh__D003818 Dentition, Mixed
% 208.36/208.53  |- skos__hiddenLabel mesh__D003818 Mixed Dentitions
% 208.36/208.53  |- skos__hiddenLabel mesh__D003818 Transitional Dentitions
% 208.36/208.53  |- skos__historyNote mesh__D003818 Dentition %28%1966-1970%29%
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D003818 2006
% 208.36/208.53  |- mesh__dateEstablished mesh__D003818 1973-01-01
% 208.36/208.53  |- mesh__recordMaintainer mesh__D003818 lkt
% 208.36/208.53  |- skos__hiddenLabel mesh__D003818 Dentitions, Transitional
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D003818 2005
% 208.36/208.53  |- skos__altLabel mesh__D003818 Dentition, Transitional
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D003818 2004
% 208.36/208.53  |- skos__broader mesh__D003818smesh__D003817
% 208.36/208.53  |- mesh__historyNote mesh__D003818 73%28%71%29%   
% 208.36/208.53  |- skos__scopeNote mesh__D014540
% 208.36/208.53       The decarboxylation product of UDPglucuronic acid, which is used for formation of the xylosides of seryl hydroxyl groups in mucoprotein synthesis. Also forms plant xylans.%A%    
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D014540 2006
% 208.36/208.53  |- mesh__dateRevised mesh__D014540 2004-07-07
% 208.36/208.53  |- mesh__recordMaintainer mesh__D014540 ssb
% 208.36/208.53  |- mesh__historyNote mesh__D014540
% 208.36/208.53       91%28%75%29%; was see under URIDINE DIPHOSPHATE SUGARS 1975-90   
% 208.36/208.53  |- skos__hiddenLabel mesh__D014540 Diphosphate Xylose, Uridine
% 208.36/208.53  |- mesh__dateEstablished mesh__D014540 1991-01-01
% 208.36/208.53  |- skos__broader mesh__D014540smesh__D014539
% 208.36/208.53  |- skos__hiddenLabel mesh__D014540 Xylose, UDP
% 208.36/208.53  |- mesh__recordAuthorizer mesh__D014540 sjn
% 208.36/208.53  |- skos__hiddenLabel mesh__D014540 Xylose, Uridine Diphosphate
% 208.36/208.53  |- skos__historyNote mesh__D014540 Xylose %28%1973-1974%29%
% 208.36/208.53  |- mesh__dateCreated mesh__D014540 1974-11-19
% 208.36/208.53  |- mesh__publicMeSHNote mesh__D014540
% 208.36/208.53       91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90   
% 208.36/208.53  |- skos__historyNote mesh__D014540
% 208.36/208.53       Uridine Diphosphate Sugars %28%1973-1974%29%
% 208.36/208.53  |- mesh__recordOriginator mesh__D014540 NLM
% 208.36/208.53  |- skos__prefLabel mesh__D014540 Uridine Diphosphate Xylose
% 208.36/208.53  |- rdf__type mesh__D014540sskos__Concept
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D014540 2005
% 208.36/208.53  |- skos__altLabel mesh__D014540 UDP Xylose
% 208.36/208.53  |- rdf__type mesh__D008503sskos__Concept
% 208.36/208.53  |- skos__altLabel mesh__D008503 Staffs, Medical
% 208.36/208.53  |- skos__broader mesh__D008503smesh__D006282
% 208.36/208.53  |- mesh__dateCreated mesh__D008503 1999-01-01
% 208.36/208.53  |- skos__prefLabel mesh__D008503 Medical Staff
% 208.36/208.53  |- mesh__historyNote mesh__D008503 73   
% 208.36/208.53  |- skos__annotation mesh__D008503
% 208.36/208.53       other than in hosp; in hosp = MEDICAL STAFF, HOSPITAL; coord IM with med milieu %28%IM%29%%A%  
% 208.36/208.53  |- skos__altLabel mesh__D008503 Staff, Medical
% 208.36/208.53  |- mesh__publicMeSHNote mesh__D008503 73   
% 208.36/208.53  |- mesh__recordMaintainer mesh__D008503 KEV
% 208.36/208.53  |- mesh__recordOriginator mesh__D008503 NLM
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008503 1998
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008503 2005
% 208.36/208.53  |- skos__altLabel mesh__D008503 Medical Staffs
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008503 2000
% 208.36/208.53  |- mesh__recordAuthorizer mesh__D008503 PLS
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008503 1999
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008503 2006
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008503 1996
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008503 2003
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008503 2001
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008503 1997
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008503 2004
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D008503 2002
% 208.36/208.53  |- mesh__dateEstablished mesh__D008503 1973-01-01
% 208.36/208.53  |- skos__scopeNote mesh__D008503
% 208.36/208.53       Professional medical personnel who provide care to patients in an organized facility, institution or agency.%A%    
% 208.36/208.53  |- mesh__dateRevised mesh__D008503 1995-05-23
% 208.36/208.53  |- skos__broader mesh__D000520smesh__D005959
% 208.36/208.53  |- skos__hiddenLabel mesh__D000520 Maltase Glucoamylase
% 208.36/208.53  |- mesh__dateCreated mesh__D000520 1977-04-15
% 208.36/208.53  |- skos__hiddenLabel mesh__D000520 alpha-Glucosidase, Neutral
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D000520 2004
% 208.36/208.53  |- mesh__recordAuthorizer mesh__D000520 sjn
% 208.36/208.53  |- skos__hiddenLabel mesh__D000520 Neutral alpha Glucosidase
% 208.36/208.53  |- mesh__dateEstablished mesh__D000520 1987-01-01
% 208.36/208.53  |- skos__annotation mesh__D000520
% 208.36/208.53       defic/: consider also GLYCOGEN STORAGE DISEASE TYPE II   
% 208.36/208.53  |- mesh__recordOriginator mesh__D000520 RLS
% 208.36/208.53  |- mesh__recordMaintainer mesh__D000520 ssb
% 208.36/208.53  |- skos__altLabel mesh__D000520 Maltases
% 208.36/208.53  |- skos__historyNote mesh__D000520 Glucosidases %28%1966-1977%29%
% 208.36/208.53  |- skos__prefLabel mesh__D000520 alpha-Glucosidases
% 208.36/208.53  |- skos__altLabel mesh__D000520 Maltase-Glucoamylase
% 208.36/208.53  |- mesh__historyNote mesh__D000520
% 208.36/208.53       87%28%78%29%; was see under GLUCOSIDASES 1978-86   
% 208.36/208.53  |- skos__hiddenLabel mesh__D000520 alpha Glucosidases
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D000520 2005
% 208.36/208.53  |- mesh__dateRevised mesh__D000520 2003-07-09
% 208.36/208.53  |- skos__related mesh__D000520smesh__D006009
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D000520 2006
% 208.36/208.53  |- rdf__type mesh__D000520sskos__Concept
% 208.36/208.53  |- skos__scopeNote mesh__D000520
% 208.36/208.53       Enzymes that catalyze the exohydrolysis of 1,4-alpha-glucosidic linkages with release of alpha-glucose. Deficiency of alpha-1,4-glucosidase may cause GLYCOGEN STORAGE DISEASE TYPE II. EC 3.2.1.20.%A%    
% 208.36/208.53  |- skos__hiddenLabel mesh__D000520 Maltase, Neutral
% 208.36/208.53  |- mesh__publicMeSHNote mesh__D000520
% 208.36/208.53       87; was see under GLUCOSIDASES 1978-86   
% 208.36/208.53  |- rdf__type mesh__D027468sskos__Concept
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D027468 2002
% 208.36/208.53  |- skos__broader mesh__D027468smesh__D019659
% 208.36/208.53  |- skos__annotation mesh__D027468
% 208.36/208.53       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.36/208.53  |- skos__scopeNote mesh__D027468
% 208.36/208.53       A plant genus in the ASTERACEAE family.     
% 208.36/208.53  |- skos__prefLabel mesh__D027468 Crepis
% 208.36/208.53  |- mesh__publicMeSHNote mesh__D027468
% 208.36/208.53       2002; see ASTERACEAE 1998-2001, see HERBS 1995-1997   
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D027468 2004
% 208.36/208.53  |- mesh__dateEstablished mesh__D027468 2002-01-01
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D027468 2006
% 208.36/208.53  |- mesh__dateCreated mesh__D027468 2001-07-25
% 208.36/208.53  |- skos__altLabel mesh__D027468 Hawk%27%s Beard
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D027468 2003
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D027468 2005
% 208.36/208.53  |- mesh__historyNote mesh__D027468
% 208.36/208.53       2002; use ASTERACEAE 1998-2001, use HERBS 1995-1997   
% 208.36/208.53  |- mesh__dateCreated mesh__D013448 1999-01-01
% 208.36/208.53  |- skos__hiddenLabel mesh__D013448 Disodium, Sulfobromophthalein
% 208.36/208.53  |- mesh__recordOriginator mesh__D013448 NLM
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D013448 2006
% 208.36/208.53  |- skos__broader mesh__D013448smesh__D010635
% 208.36/208.53  |- skos__annotation mesh__D013448
% 208.36/208.53       usually /diag use in LIVER FUNCTION TESTS   
% 208.36/208.53  |- skos__altLabel mesh__D013448 Sulfobromophthalein Disodium
% 208.36/208.53  |- skos__scopeNote mesh__D013448
% 208.36/208.53       A phenolphthalein that is used as a diagnostic aid in hepatic function determination.%A%    
% 208.36/208.53  |- skos__altLabel mesh__D013448 Bromosulfophthalein
% 208.36/208.53  |- mesh__recordMaintainer mesh__D013448 NLM
% 208.36/208.53  |- mesh__recordAuthorizer mesh__D013448 NLM
% 208.36/208.53  |- skos__hiddenLabel mesh__D013448 Sodium, Sulfobromophthalein
% 208.36/208.53  |- mesh__dateRevised mesh__D013448 2005-07-06
% 208.36/208.53  |- rdf__type mesh__D013448sskos__Concept
% 208.36/208.53  |- skos__prefLabel mesh__D013448 Sulfobromophthalein
% 208.36/208.53  |- skos__altLabel mesh__D013448 Bromosulphthalein
% 208.36/208.53  |- skos__altLabel mesh__D018931 Antineoplastic Hormonal Agents
% 208.36/208.53  |- mesh__recordAuthorizer mesh__D018931 sjn
% 208.36/208.53  |- skos__altLabel mesh__D018931 Hormonal Antineoplastics
% 208.36/208.53  |- skos__hiddenLabel mesh__D018931 Hormonal Drugs, Antineoplastic
% 208.36/208.53  |- skos__hiddenLabel mesh__D018931 Agents, Antineoplastic Hormonal
% 208.36/208.53  |- skos__altLabel mesh__D018931 Antineoplastics, Hormonal
% 208.36/208.53  |- mesh__recordOriginator mesh__D018931 JRT
% 208.36/208.53  |- mesh__dateEstablished mesh__D018931 1996-01-01
% 208.36/208.53  |- skos__scopeNote mesh__D018931
% 208.36/208.53       Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. %28%From AMA Drug Evaluations Annual 1994, p2079%29%%A%    
% 208.36/208.53  |- skos__altLabel mesh__D018931 Hormonal Antineoplastic Drugs
% 208.36/208.53  |- skos__broader mesh__D018931smesh__D000970
% 208.36/208.53  |- skos__hiddenLabel mesh__D018931 Drugs, Antineoplastic Hormonal
% 208.36/208.53  |- skos__altLabel mesh__D018931 Antineoplastic Drugs, Hormonal
% 208.36/208.53  |- mesh__dateCreated mesh__D018931 1995-05-26
% 208.36/208.53  |- skos__altLabel mesh__D018931 Hormonal Agents, Antineoplastic
% 208.36/208.53  |- rdf__type mesh__D018931sskos__Concept
% 208.36/208.53  |- mesh__historyNote mesh__D018931 96   
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D018931 2006
% 208.36/208.53  |- skos__altLabel mesh__D018931 Hormonal Antineoplastic Agents
% 208.36/208.53  |- skos__prefLabel mesh__D018931 Antineoplastic Agents, Hormonal
% 208.36/208.53  |- mesh__dateRevised mesh__D018931 2005-06-30
% 208.36/208.53  |- skos__annotation mesh__D018931
% 208.36/208.53       consider also NEOPLASMS, HORMONE-DEPENDENT /drug ther   
% 208.36/208.53  |- skos__historyNote mesh__D018931 Antineoplastic Agents %28%1966-1995%29%
% 208.36/208.53  |- mesh__recordMaintainer mesh__D018931 ssb
% 208.36/208.53  |- skos__altLabel mesh__D018931 Antineoplastic Hormonal Drugs
% 208.36/208.53  |- mesh__publicMeSHNote mesh__D018931 96   
% 208.36/208.53  |- mesh__historyNote mesh__D032602 2003   
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D032602 2006
% 208.36/208.53  |- skos__altLabel mesh__D032602 Peashrub
% 208.36/208.53  |- skos__scopeNote mesh__D032602
% 208.36/208.53       A plant genus of the family FABACEAE. Members contain STILBENES.%A%    
% 208.36/208.53  |- skos__prefLabel mesh__D032602 Caragana
% 208.36/208.53  |- rdf__type mesh__D032602sskos__Concept
% 208.36/208.53  |- mesh__publicMeSHNote mesh__D032602 2003   
% 208.36/208.53  |- skos__annotation mesh__D032602
% 208.36/208.53       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.36/208.53  |- skos__broader mesh__D032602smesh__D007887
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D032602 2003
% 208.36/208.53  |- mesh__dateCreated mesh__D032602 2002-07-03
% 208.36/208.53  |- mesh__dateEstablished mesh__D032602 2003-01-01
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D032602 2004
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D032602 2005
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D010150 2001
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D010150 1994
% 208.36/208.53  |- rdf__type mesh__D010150sskos__Concept
% 208.36/208.53  |- skos__hiddenLabel mesh__D010150 Paints
% 208.36/208.53  |- mesh__recordMaintainer mesh__D010150 sjn
% 208.36/208.53  |- mesh__activeMeSHYear mesh__D010150 2004
% 208.36/208.54  |- skos__broader mesh__D010150smesh__D008420
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010150 2000
% 208.36/208.54  |- mesh__onlineNote mesh__D010150 use PAINT to search VARNISH 1966-78   
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010150 2003
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010150 1997
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010150 2003A
% 208.36/208.54  |- mesh__dateCreated mesh__D010150 1999-01-01
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010150 2006
% 208.36/208.54  |- mesh__historyNote mesh__D010150 VARNISH was see under PAINT 1963-78   
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010150 1996
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010150 1993
% 208.36/208.54  |- skos__prefLabel mesh__D010150 Paint
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010150 2002
% 208.36/208.54  |- mesh__recordAuthorizer mesh__D010150 sjn
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010150 2005
% 208.36/208.54  |- mesh__dateRevised mesh__D010150 2002-10-23
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010150 1999
% 208.36/208.54  |- mesh__recordOriginator mesh__D010150 NLM
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010150 1995
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010150 1998
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D004911 2005
% 208.36/208.54  |- rdf__type mesh__D004911sskos__Concept
% 208.36/208.54  |- skos__hiddenLabel mesh__D004911 Mass, Red Cell
% 208.36/208.54  |- skos__related mesh__D004911smesh__D006400
% 208.36/208.54  |- skos__hiddenLabel mesh__D004911 Volume, Erythrocyte
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D004911 2004
% 208.36/208.54  |- skos__broader mesh__D004911smesh__D001810
% 208.36/208.54  |- skos__historyNote mesh__D004911 Erythrocytes %28%1966-1977%29%
% 208.36/208.54  |- mesh__recordMaintainer mesh__D004911 nns
% 208.36/208.54  |- mesh__recordOriginator mesh__D004911 VDK
% 208.36/208.54  |- mesh__recordAuthorizer mesh__D004911 sjn
% 208.36/208.54  |- mesh__dateRevised mesh__D004911 2003-07-09
% 208.36/208.54  |- skos__hiddenLabel mesh__D004911 Erythrocyte Volumes
% 208.36/208.54  |- mesh__publicMeSHNote mesh__D004911 78   
% 208.36/208.54  |- mesh__dateEstablished mesh__D004911 1978-01-01
% 208.36/208.54  |- mesh__dateCreated mesh__D004911 1977-04-27
% 208.36/208.54  |- skos__annotation mesh__D004911
% 208.36/208.54       restrict to total amt of circulating erythrocytes: do not use for size of individual erythrocytes %28%use ERYTHROCYTES /cytol%29%; ERYTHROCYTE VOLUME, PACKED %26% ERYTHROCYTE INDICES are also available; coord with disease /blood, not /physiopathol%A%  
% 208.36/208.54  |- skos__hiddenLabel mesh__D004911 Volumes, Erythrocyte
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D004911 2006
% 208.36/208.54  |- skos__scopeNote mesh__D004911
% 208.36/208.54       Volume of circulating ERYTHROCYTES . It is usually measured by RADIOISOTOPE DILUTION TECHNIQUE.%A%    
% 208.36/208.54  |- skos__hiddenLabel mesh__D004911 Masses, Red Cell
% 208.36/208.54  |- skos__hiddenLabel mesh__D004911 Red Cell Masses
% 208.36/208.54  |- mesh__historyNote mesh__D004911 78   
% 208.36/208.54  |- skos__prefLabel mesh__D004911 Erythrocyte Volume
% 208.36/208.54  |- skos__scopeNote mesh__D051567
% 208.36/208.54       Proto-oncogene proteins that are guanine nucleotide exchange factors for RHO GTPASES. They also function as signal transducing adaptor proteins.%A%    
% 208.36/208.54  |- skos__hiddenLabel mesh__D051567 Proto Oncogene Protein c vav
% 208.36/208.54  |- skos__altLabel mesh__D051567 Proto-Oncogene Protein vav1
% 208.36/208.54  |- skos__hiddenLabel mesh__D051567 Proto Oncogene Protein vav
% 208.36/208.54  |- skos__hiddenLabel mesh__D051567 Proteins c-vav, Proto-Oncogene
% 208.36/208.54  |- skos__hiddenLabel mesh__D051567 vav, Proto-Oncogene Protein
% 208.36/208.54  |- skos__altLabel mesh__D051567 Proto-Oncogene Protein vav
% 208.36/208.54  |- skos__broader mesh__D051567smesh__D020662
% 208.36/208.54  |- skos__altLabel mesh__D051567 vav Proto-Oncogene Protein
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D051567 2006
% 208.36/208.54  |- skos__hiddenLabel mesh__D051567 c-vav, Proto-Oncogene Protein
% 208.36/208.54  |- skos__hiddenLabel mesh__D051567 c vav Protein
% 208.36/208.54  |- mesh__dateEstablished mesh__D051567 2006-01-01
% 208.36/208.54  |- skos__prefLabel mesh__D051567 Proto-Oncogene Proteins c-vav
% 208.36/208.54  |- mesh__recordMaintainer mesh__D051567 DRC
% 208.36/208.54  |- skos__altLabel mesh__D051567 Proto-Oncogene Protein c-vav
% 208.36/208.54  |- skos__hiddenLabel mesh__D051567 Proto-Oncogene Protein, vav
% 208.36/208.54  |- skos__hiddenLabel mesh__D051567 c-vav, Proto-Oncogene Proteins
% 208.36/208.54  |- mesh__historyNote mesh__D051567 2006%28%1991%29%   
% 208.36/208.54  |- skos__hiddenLabel mesh__D051567 Proto Oncogene Protein vav1
% 208.36/208.54  |- mesh__publicMeSHNote mesh__D051567
% 208.36/208.54       2006; PROTO-ONCOGENE PROTEIN C-VAV  was indexed under PROTO-ONCOGENE PROTEINS %26% CELL CYCLE PROTEINS 2004-2005, %26% under ONCOGENE PROTEINS 1991-2004%A%  
% 208.36/208.54  |- skos__hiddenLabel mesh__D051567 vav Proto Oncogene Protein
% 208.36/208.54  |- skos__altLabel mesh__D051567 c-vav Protein
% 208.36/208.54  |- skos__broader mesh__D051567smesh__D048868
% 208.36/208.54  |- mesh__recordOriginator mesh__D051567 DRC
% 208.36/208.54  |- rdf__type mesh__D051567sskos__Concept
% 208.36/208.54  |- mesh__dateCreated mesh__D051567 2005-06-30
% 208.36/208.54  |- skos__broader mesh__D051567smesh__D011518
% 208.36/208.54  |- skos__hiddenLabel mesh__D051567 vav Guanine Nucleotide Exchange Factor
% 208.36/208.54  |- skos__hiddenLabel mesh__D051567 Proto Oncogene Proteins c vav
% 208.36/208.54  |- skos__hiddenLabel mesh__D051567 vav1, Proto-Oncogene Protein
% 208.36/208.54  |- skos__altLabel mesh__D051567 vav Guanine-Nucleotide Exchange Factor
% 208.36/208.54  |- mesh__recordAuthorizer mesh__D051567 sjn
% 208.36/208.54  |- skos__broader mesh__D019855Q000031smesh__D019855
% 208.36/208.54  |- mesh__preferredCombination mesh__D019855Q000031smesh__D005026
% 208.36/208.54  |- rdf__type mesh__D019855Q000031smesh__CompoundConcept
% 208.36/208.54  |- skos__hiddenLabel mesh__D004113 Tin Salt Succimer
% 208.36/208.54  |- skos__altLabel mesh__D004113 SERB Brand of Succimer
% 208.36/208.54  |- skos__altLabel mesh__D004113 Sanofi Brand of Succimer
% 208.36/208.54  |- skos__prefLabel mesh__D004113 Succimer
% 208.36/208.54  |- mesh__dateRevised mesh__D004113 2005-06-30
% 208.36/208.54  |- skos__broader mesh__D004113smesh__D013438
% 208.36/208.54  |- mesh__historyNote mesh__D004113
% 208.36/208.54       94; was DIMERCAPTOSUCCINIC ACID 1979-93 %28%see under SULFHYDRYL COMPOUNDS 1979-90%29%; SUCCIMER was see DIMERCAPTOSUCCINIC ACID 1979-93%A%  
% 208.36/208.54  |- skos__historyNote mesh__D004113 Succinates %28%1966-1978%29%
% 208.36/208.54  |- skos__altLabel mesh__D004113 2,3-Dimercaptosuccinic Acid
% 208.36/208.54  |- skos__hiddenLabel mesh__D004113 meso Dimercaptosuccinic Acid
% 208.36/208.54  |- mesh__publicMeSHNote mesh__D004113
% 208.36/208.54       94; was DIMERCAPTOSUCCINIC ACID 1979-93 %28%see under SULFHYDRYL COMPOUNDS 1979-90%29%; SUCCIMER was see DIMERCAPTOSUCCINIC ACID 1979-93%A%  
% 208.36/208.54  |- skos__altLabel mesh__D004113 DMSA
% 208.36/208.54  |- mesh__dateCreated mesh__D004113 1978-02-07
% 208.36/208.54  |- skos__hiddenLabel mesh__D004113 Ro17977
% 208.36/208.54  |- skos__broader mesh__D004113smesh__D019822
% 208.36/208.54  |- skos__hiddenLabel mesh__D004113 Monosodium Salt Succimer
% 208.36/208.54  |- mesh__recordOriginator mesh__D004113 SH
% 208.36/208.54  |- skos__annotation mesh__D004113 D25-26 qualif   
% 208.36/208.54  |- rdf__type mesh__D004113sskos__Concept
% 208.36/208.54  |- skos__historyNote mesh__D004113 Sulfhydryl Compounds %28%1966-1978%29%
% 208.36/208.54  |- skos__hiddenLabel mesh__D004113 Dimercaptosuccinate, Tin
% 208.36/208.54  |- mesh__recordMaintainer mesh__D004113 CCR
% 208.36/208.54  |- skos__hiddenLabel mesh__D004113 2,3 Dimercaptosuccinic Acid
% 208.36/208.54  |- skos__hiddenLabel mesh__D004113 Rhenium Salt Succimer
% 208.36/208.54  |- mesh__dateEstablished mesh__D004113 1991-01-01
% 208.36/208.54  |- skos__altLabel mesh__D004113 Tin Dimercaptosuccinate
% 208.36/208.54  |- skos__hiddenLabel mesh__D004113 Disodium Salt Succimer
% 208.36/208.54  |- skos__hiddenLabel mesh__D004113 Dipotassium Salt Succimer
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D004113 2006
% 208.36/208.54  |- skos__scopeNote mesh__D004113
% 208.36/208.54       A mercaptodicarboxylic acid used as an antidote to heavy metal poisoning because it forms strong chelates with them.%A%    
% 208.36/208.54  |- mesh__onlineNote mesh__D004113
% 208.36/208.54       use SUCCIMER to search DIMERCAPTOSUCCINIC ACID 1979-93   
% 208.36/208.54  |- skos__altLabel mesh__D004113 meso-Dimercaptosuccinic Acid
% 208.36/208.54  |- skos__hiddenLabel mesh__D004113 Ro 1 7977
% 208.36/208.54  |- mesh__recordAuthorizer mesh__D004113 sjn
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D017839 2005
% 208.36/208.54  |- skos__broader mesh__D017839smesh__D017819
% 208.36/208.54  |- skos__altLabel mesh__D017839 Rattlesnake
% 208.36/208.54  |- skos__historyNote mesh__D017839 Snakes %28%1966-1993%29%
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D017839 2006
% 208.36/208.54  |- mesh__publicMeSHNote mesh__D017839 94   
% 208.36/208.54  |- skos__annotation mesh__D017839
% 208.36/208.54       a genus of pit vipers; note X ref; its venom: coord IM with CROTALID VENOMS %28%IM%29%%A%  
% 208.36/208.54  |- skos__hiddenLabel mesh__D017839 Rattlesnakes
% 208.36/208.54  |- mesh__historyNote mesh__D017839 94   
% 208.36/208.54  |- mesh__recordOriginator mesh__D017839 TGC
% 208.36/208.54  |- mesh__dateEstablished mesh__D017839 1994-01-01
% 208.36/208.54  |- mesh__dateCreated mesh__D017839 1993-02-16
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D017839 2004
% 208.36/208.54  |- mesh__recordAuthorizer mesh__D017839 sjn
% 208.36/208.54  |- mesh__dateRevised mesh__D017839 2003-07-09
% 208.36/208.54  |- skos__scopeNote mesh__D017839
% 208.36/208.54       A genus of snakes of the family VIPERIDAE, one of the pit vipers, so-called from the pit hollowing out the maxillary bone, opening between the eye and the nostril. They are distinctively American serpents. Most of the 25 recognized species are found in the southwestern United States and northern Mexico. Several species are found as far north as Canada and east of the Mississippi, including southern Appalachia. They are named for the jointed rattle %28%Greek krotalon%29% at the tip of their tail. %28%Goin, Goin, and Zug: Introduction to Herpetology, 3d ed; Moore: Poisonous Snakes of the World, 1980, p335%29%%A%    
% 208.36/208.54  |- skos__prefLabel mesh__D017839 Crotalus
% 208.36/208.54  |- mesh__recordMaintainer mesh__D017839 ags
% 208.36/208.54  |- rdf__type mesh__D017839sskos__Concept
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D028561 2005
% 208.36/208.54  |- mesh__historyNote mesh__D028561 2002   
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D028561 2003
% 208.36/208.54  |- mesh__dateCreated mesh__D028561 2001-07-25
% 208.36/208.54  |- skos__annotation mesh__D028561 GEN or unspecified; prefer specifics   
% 208.36/208.54  |- skos__hiddenLabel mesh__D028561 Elements, Transition
% 208.36/208.54  |- skos__broader mesh__D028561smesh__D004602
% 208.36/208.54  |- mesh__publicMeSHNote mesh__D028561 2002   
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D028561 2002
% 208.36/208.54  |- mesh__dateEstablished mesh__D028561 2002-01-01
% 208.36/208.54  |- skos__scopeNote mesh__D028561
% 208.36/208.54       Elements with partially filled d orbitals. They constitute groups 3-12 of the periodic table of elements.%A%    
% 208.36/208.54  |- skos__prefLabel mesh__D028561 Transition Elements
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D028561 2006
% 208.36/208.54  |- rdf__type mesh__D028561sskos__Concept
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D028561 2004
% 208.36/208.54  |- mesh__recordAuthorizer mesh__D003819 SJN
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D003819 1998
% 208.36/208.54  |- skos__scopeNote mesh__D003819
% 208.36/208.54       The part of a denture that overlies the soft tissue and supports the supplied teeth and is supported in turn by abutment teeth or the residual alveolar ridge. It is usually made of resins or metal or their combination.%A%    
% 208.36/208.54  |- skos__hiddenLabel mesh__D003819 Denture Base
% 208.36/208.54  |- skos__prefLabel mesh__D003819 Denture Bases
% 208.36/208.54  |- rdf__type mesh__D003819sskos__Concept
% 208.36/208.54  |- mesh__recordMaintainer mesh__D003819 PXP
% 208.36/208.54  |- skos__annotation mesh__D003819
% 208.36/208.54       coord IM with specific denture term %28%IM or NIM%29%   
% 208.36/208.54  |- mesh__historyNote mesh__D003819 65   
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D003819 1999
% 208.36/208.54  |- skos__hiddenLabel mesh__D003819 Base, Denture
% 208.36/208.54  |- skos__hiddenLabel mesh__D003819 Bases, Denture
% 208.36/208.54  |- mesh__dateRevised mesh__D003819 1997-06-20
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D003819 2000
% 208.36/208.54  |- skos__broader mesh__D003819smesh__D003778
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D003819 2005
% 208.36/208.54  |- mesh__recordOriginator mesh__D003819 NLM
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D003819 2001
% 208.36/208.54  |- mesh__publicMeSHNote mesh__D003819 65   
% 208.36/208.54  |- mesh__dateCreated mesh__D003819 1999-01-01
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D003819 2003
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D003819 2006
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D003819 2002
% 208.36/208.54  |- mesh__dateEstablished mesh__D003819 1965-01-01
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D003819 2004
% 208.36/208.54  |- skos__hiddenLabel mesh__D014541 Kinase, Uridine
% 208.36/208.54  |- mesh__dateCreated mesh__D014541 1974-11-11
% 208.36/208.54  |- mesh__dateEstablished mesh__D014541 1991-01-01
% 208.36/208.54  |- skos__scopeNote mesh__D014541
% 208.36/208.54       An enzyme that catalyzes the phosphorylation of uridine and cytidine to uridine 5%27%-phosphate and cytidine 5%27%-phosphate, respectively. ATP, dUTP, dGTP, and dATP are effective phosphate donors. EC 2.7.1.48.%A%    
% 208.36/208.54  |- mesh__historyNote mesh__D014541
% 208.36/208.54       91%28%75%29%; was see under PHOSPHOTRANSFERASES, ATP 1975-90   
% 208.36/208.54  |- mesh__recordMaintainer mesh__D014541 ssb
% 208.36/208.54  |- mesh__dateRevised mesh__D014541 2003-07-09
% 208.36/208.54  |- skos__altLabel mesh__D014541 Cytidine Kinase
% 208.36/208.54  |- skos__historyNote mesh__D014541 Uridine %28%1974%29%
% 208.36/208.54  |- skos__hiddenLabel mesh__D014541 Kinase, Uridine-Cytidine
% 208.36/208.54  |- rdf__type mesh__D014541sskos__Concept
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D014541 2005
% 208.36/208.54  |- skos__hiddenLabel mesh__D014541 Kinase, Cytidine
% 208.36/208.54  |- mesh__recordAuthorizer mesh__D014541 sjn
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D014541 2004
% 208.36/208.54  |- skos__prefLabel mesh__D014541 Uridine Kinase
% 208.36/208.54  |- mesh__publicMeSHNote mesh__D014541
% 208.36/208.54       91; was see under PHOSPHOTRANSFERASES, ATP 1975-90   
% 208.36/208.54  |- skos__altLabel mesh__D014541 Uridine-Cytidine Kinase
% 208.36/208.54  |- skos__historyNote mesh__D014541 Phosphotransferases, ATP %28%1974%29%
% 208.36/208.54  |- skos__broader mesh__D014541smesh__D017853
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D014541 2006
% 208.36/208.54  |- skos__hiddenLabel mesh__D014541 Uridine Cytidine Kinase
% 208.36/208.54  |- mesh__recordOriginator mesh__D014541 NLM
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D008504 1995
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D008504 2002
% 208.36/208.54  |- mesh__historyNote mesh__D008504
% 208.36/208.54       91%28%Aug 77%29%; was see under MEDICAL STAFF, HOSPITAL 1977-90%A%  
% 208.36/208.54  |- skos__altLabel mesh__D008504 Staff Privileges, Medical
% 208.36/208.54  |- mesh__dateEstablished mesh__D008504 1991-01-01
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D008504 1998
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D008504 2005
% 208.36/208.54  |- skos__hiddenLabel mesh__D008504 Privileges, Medical Staff
% 208.36/208.54  |- skos__historyNote mesh__D008504
% 208.36/208.54       Medical Staff, Hospital %28%1966-Jul 1977%29%
% 208.36/208.54  |- skos__hiddenLabel mesh__D008504 Privilege, Medical Staff
% 208.36/208.54  |- mesh__dateRevised mesh__D008504 1994-04-19
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D008504 2006
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D008504 1999
% 208.36/208.54  |- skos__prefLabel mesh__D008504 Medical Staff Privileges
% 208.36/208.54  |- mesh__dateCreated mesh__D008504 1977-05-11
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D008504 1996
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D008504 2003
% 208.36/208.54  |- skos__annotation mesh__D008504 DF: MED STAFF PRIVILEGES   
% 208.36/208.54  |- mesh__recordMaintainer mesh__D008504 JLS
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D008504 1997
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D008504 2004
% 208.36/208.54  |- skos__historyNote mesh__D008504
% 208.36/208.54       Hospital Administration %28%1966-Jul 1977%29%
% 208.36/208.54  |- mesh__recordOriginator mesh__D008504 EC
% 208.36/208.54  |- skos__hiddenLabel mesh__D008504 Staff Privilege, Medical
% 208.36/208.54  |- mesh__publicMeSHNote mesh__D008504
% 208.36/208.54       91; was see under MEDICAL STAFF, HOSPITAL Aug 1977-90   
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D008504 2000
% 208.36/208.54  |- mesh__recordAuthorizer mesh__D008504 PLS
% 208.36/208.54  |- rdf__type mesh__D008504sskos__Concept
% 208.36/208.54  |- skos__scopeNote mesh__D008504
% 208.36/208.54       Those rights or activities which are specific to members of the institution%27%s medical staff, including the right to admit private patients.%A%    
% 208.36/208.54  |- skos__hiddenLabel mesh__D008504 Medical Staff Privilege
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D008504 2001
% 208.36/208.54  |- skos__broader mesh__D008504smesh__D018578
% 208.36/208.54  |- mesh__dateEstablished mesh__D000521 1988-01-01
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D000521 2006
% 208.36/208.54  |- mesh__publicMeSHNote mesh__D000521 1988   
% 208.36/208.54  |- skos__prefLabel mesh__D000521 alpha-MSH
% 208.36/208.54  |- mesh__recordAuthorizer mesh__D000521 sjn
% 208.36/208.54  |- skos__historyNote mesh__D000521 MSH %28%1966-1987%29%
% 208.36/208.54  |- mesh__recordMaintainer mesh__D000521 ssb
% 208.36/208.54  |- mesh__dateRevised mesh__D000521 2005-06-30
% 208.36/208.54  |- skos__scopeNote mesh__D000521
% 208.36/208.54       A 13-amino acid peptide derived from the ANTERIOR PITUITARY GLAND in man and from the pars intermedia in lower vertebrates. Its amino acid sequence is identical to the first 13 amino acids of ACTH. It influences the formation of deposition of MELANIN in the body.%A%    
% 208.36/208.54  |- skos__hiddenLabel mesh__D000521 alpha MSH
% 208.36/208.54  |- mesh__recordOriginator mesh__D000521 RLS
% 208.36/208.54  |- skos__altLabel mesh__D000521 MSH, alpha
% 208.36/208.54  |- mesh__historyNote mesh__D000521 1988   
% 208.36/208.54  |- skos__altLabel mesh__D000521 alpha-Melanocyte-Stimulating Hormone
% 208.36/208.54  |- skos__hiddenLabel mesh__D000521 alpha Melanotropin
% 208.36/208.54  |- rdf__type mesh__D000521sskos__Concept
% 208.36/208.54  |- skos__hiddenLabel mesh__D000521 alpha Melanocyte Stimulating Hormone
% 208.36/208.54  |- skos__hiddenLabel mesh__D000521 Melanocortin 1
% 208.36/208.54  |- skos__broader mesh__D000521smesh__D009074
% 208.36/208.54  |- skos__altLabel mesh__D000521 alpha-Melanotropin
% 208.36/208.54  |- mesh__dateCreated mesh__D000521 1987-05-05
% 208.36/208.54  |- skos__broader mesh__D000521smesh__D000324
% 208.36/208.54  |- skos__altLabel mesh__D000521 Melanocortin-1
% 208.36/208.54  |- mesh__onlineNote mesh__D013449
% 208.36/208.54       use SULFONAMIDES to search SULFONAMIDE MIXTURES 1966-79   
% 208.36/208.54  |- skos__broader mesh__D013449smesh__D013450
% 208.36/208.54  |- mesh__recordMaintainer mesh__D013449 ssb
% 208.36/208.54  |- mesh__recordAuthorizer mesh__D013449 sjn
% 208.36/208.54  |- mesh__recordOriginator mesh__D013449 NLM
% 208.36/208.54  |- mesh__dateRevised mesh__D013449 2005-06-30
% 208.36/208.54  |- mesh__historyNote mesh__D013449
% 208.36/208.54       SULFONAMIDE MIXTURES was heading 1963-79   
% 208.36/208.54  |- rdf__type mesh__D013449sskos__Concept
% 208.36/208.54  |- skos__prefLabel mesh__D013449 Sulfonamides
% 208.36/208.54  |- skos__scopeNote mesh__D013449
% 208.36/208.54       A group of compounds that contain the structure SO2NH2. Members of this group, also known as sulfa drugs, are derivatives of sulfanilamide, which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. They have been largely supplanted by more effective and less toxic antibiotics. %28%From Dorland, 28th ed%29%%A%    
% 208.36/208.54  |- skos__broader mesh__D013449smesh__D000577
% 208.36/208.54  |- skos__hiddenLabel mesh__D013449 Mixtures, Sulfonamide
% 208.36/208.54  |- mesh__publicMeSHNote mesh__D013449
% 208.36/208.54       SULFONAMIDE MIXTURES was heading 1963-79   
% 208.36/208.54  |- mesh__dateCreated mesh__D013449 1999-01-01
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D013449 2006
% 208.36/208.54  |- skos__hiddenLabel mesh__D018932 Chemoattractant Protein-1, Monocyte
% 208.36/208.54  |- skos__scopeNote mesh__D018932
% 208.36/208.54       A chemokine that is a chemoattractant for human MONOCYTES and may also cause cellular activation of specific functions related to host defense. It is produced by LEUKOCYTES of both monocyte and lymphocyte lineage and by FIBROBLASTS during tissue injury.%A%    
% 208.36/208.54  |- mesh__dateCreated mesh__D018932 1995-02-21
% 208.36/208.54  |- mesh__dateRevised mesh__D018932 2005-06-30
% 208.36/208.54  |- skos__altLabel mesh__D018932 CCL2
% 208.36/208.54  |- rdf__type mesh__D018932sskos__Concept
% 208.36/208.54  |- skos__hiddenLabel mesh__D018932 Chemotactic Protein-1, Monocyte
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D018932 2006
% 208.36/208.54  |- mesh__recordMaintainer mesh__D018932 ssb
% 208.36/208.54  |- skos__prefLabel mesh__D018932 Monocyte Chemoattractant Protein-1
% 208.36/208.54  |- mesh__dateEstablished mesh__D018932 1996-01-01
% 208.36/208.54  |- mesh__recordAuthorizer mesh__D018932 sjn
% 208.36/208.54  |- mesh__historyNote mesh__D018932
% 208.36/208.54       96; was MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR %28%NM%29% 1989-95%A%  
% 208.36/208.54  |- mesh__recordOriginator mesh__D018932 AGS
% 208.36/208.54  |- skos__hiddenLabel mesh__D018932 Monocyte Chemoattractant Protein 1
% 208.36/208.54  |- skos__altLabel mesh__D018932 Monocyte Chemotactic and Activating Factor
% 208.36/208.54  |- skos__broader mesh__D018932smesh__D018945
% 208.36/208.54  |- skos__hiddenLabel mesh__D018932 Monocyte Chemotactic Protein 1
% 208.36/208.54  |- skos__historyNote mesh__D018932 Chemotactic Factors %28%1989-1995%29%
% 208.36/208.54  |- mesh__publicMeSHNote mesh__D018932
% 208.36/208.54       96; MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR was indexed under CHEMOTACTIC FACTORS 1991-95 %26% GLYCOPROTEINS 1988-90%A%  
% 208.36/208.54  |- skos__historyNote mesh__D018932 Glycoproteins %28%1988-1990%29%
% 208.36/208.54  |- skos__altLabel mesh__D018932 Monocyte Chemotactic Protein-1
% 208.36/208.54  |- mesh__dateCreated mesh__D032603 2002-07-03
% 208.36/208.54  |- rdf__type mesh__D032603sskos__Concept
% 208.36/208.54  |- mesh__dateEstablished mesh__D032603 2003-01-01
% 208.36/208.54  |- skos__prefLabel mesh__D032603 Scopolia
% 208.36/208.54  |- mesh__historyNote mesh__D032603 2003   
% 208.36/208.54  |- mesh__publicMeSHNote mesh__D032603 2003   
% 208.36/208.54  |- skos__annotation mesh__D032603
% 208.36/208.54       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.36/208.54  |- skos__broader mesh__D032603smesh__D019657
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D032603 2003
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D032603 2004
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D032603 2005
% 208.36/208.54  |- skos__scopeNote mesh__D032603
% 208.36/208.54       A plant genus of the family SOLANACEAE after which the compound SCOPOLAMINE got its name.%A%    
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D032603 2006
% 208.36/208.54  |- mesh__recordMaintainer mesh__D010151 TAP
% 208.36/208.54  |- mesh__recordOriginator mesh__D010151 NLM
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010151 2004
% 208.36/208.54  |- mesh__historyNote mesh__D010151
% 208.36/208.54       91%28%75%29%; was see under ART 1975-90   
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010151 2003
% 208.36/208.54  |- mesh__dateEstablished mesh__D010151 1991-01-01
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010151 1997
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010151 2001
% 208.36/208.54  |- skos__hiddenLabel mesh__D010151 Painting
% 208.36/208.54  |- mesh__dateCreated mesh__D010151 1999-01-01
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010151 2006
% 208.36/208.54  |- mesh__publicMeSHNote mesh__D010151 91; was see under ART 1975-90   
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010151 1996
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010151 1993
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010151 2005
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010151 2000
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010151 1999
% 208.36/208.54  |- skos__prefLabel mesh__D010151 Paintings
% 208.36/208.54  |- mesh__onlineNote mesh__D010151 search ART 1966-74   
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010151 1995
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010151 1998
% 208.36/208.54  |- skos__broader mesh__D010151smesh__D001154
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010151 2002
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D010151 1994
% 208.36/208.54  |- mesh__dateRevised mesh__D010151 1992-05-15
% 208.36/208.54  |- rdf__type mesh__D010151sskos__Concept
% 208.36/208.54  |- mesh__recordAuthorizer mesh__D010151 PLS
% 208.36/208.54  |- rdf__type mesh__D004912sskos__Concept
% 208.36/208.54  |- skos__altLabel mesh__D004912 Red Blood Cells
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D004912 2004
% 208.36/208.54  |- skos__altLabel mesh__D004912 Blood Cells, Red
% 208.36/208.54  |- skos__hiddenLabel mesh__D004912 Erythrocyte
% 208.36/208.54  |- skos__hiddenLabel mesh__D004912 Red Blood Cell
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D004912 2005
% 208.36/208.54  |- mesh__dateRevised mesh__D004912 2003-07-25
% 208.36/208.54  |- skos__prefLabel mesh__D004912 Erythrocytes
% 208.36/208.54  |- mesh__recordOriginator mesh__D004912 NLM
% 208.36/208.54  |- skos__broader mesh__D004912smesh__D001773
% 208.36/208.54  |- skos__scopeNote mesh__D004912
% 208.36/208.54       Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN.%A%    
% 208.36/208.54  |- skos__hiddenLabel mesh__D004912 Blood Cell, Red
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D004912 2006
% 208.36/208.54  |- mesh__dateCreated mesh__D004912 1999-01-01
% 208.36/208.54  |- mesh__recordAuthorizer mesh__D004912 sjn
% 208.36/208.54  |- skos__broader mesh__D004912smesh__D041905
% 208.36/208.54  |- mesh__recordMaintainer mesh__D004912 sjn
% 208.36/208.54  |- skos__annotation mesh__D004912
% 208.36/208.54       vertebrates only; for invertebrates index under HEMOCYTES; /cytol: consider also ERYTHROCYTE INDICES; do not equate /pathol with ERYTHROCYTES, ABNORMAL; nucleated erythrocytes in circulating blood = ERYTHROCYTES /pathol; ERYTHROCYTE DEFORMABILITY is available; erythrocyte antibodies: index BLOOD GROUP ANTIGENS /immunol + ISOANTIBODIES %26% do not index under ERYTHROCYTES%A%  
% 208.36/208.54  |- mesh__dateCreated mesh__D004114 1974-11-19
% 208.36/208.54  |- skos__broader mesh__D004114smesh__D010080
% 208.36/208.54  |- skos__altLabel mesh__D004114 5,5-Dimethyl-2,4-oxazolidinedione
% 208.36/208.54  |- mesh__recordAuthorizer mesh__D004114 sjn
% 208.36/208.54  |- skos__altLabel mesh__D004114 Dimethyloxazolidinedione
% 208.36/208.54  |- rdf__type mesh__D004114sskos__Concept
% 208.36/208.54  |- mesh__recordOriginator mesh__D004114 SH
% 208.36/208.54  |- skos__prefLabel mesh__D004114 Dimethadione
% 208.36/208.54  |- mesh__dateRevised mesh__D004114 2005-06-30
% 208.36/208.54  |- skos__historyNote mesh__D004114 Oxazoles %28%1970-1974%29%
% 208.36/208.54  |- skos__altLabel mesh__D004114 5,5-Dimethyloxazolidine-2,4-dione
% 208.36/208.54  |- mesh__dateEstablished mesh__D004114 1991-01-01
% 208.36/208.54  |- mesh__publicMeSHNote mesh__D004114 91; was see under OXAZOLES 1975-90   
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D004114 2006
% 208.36/208.54  |- skos__scopeNote mesh__D004114
% 208.36/208.54       An anticonvulsant that is the active metabolite of TRIMETHADIONE.%A%    
% 208.36/208.54  |- mesh__historyNote mesh__D004114
% 208.36/208.54       91%28%75%29%; was see under OXAZOLES 1975-90   
% 208.36/208.54  |- mesh__recordMaintainer mesh__D004114 ssb
% 208.36/208.54  |- skos__broader mesh__D008511Q000191smesh__D008511
% 208.36/208.54  |- mesh__preferredCombination mesh__D008511Q000191smesh__D004470
% 208.36/208.54  |- rdf__type mesh__D008511Q000191smesh__CompoundConcept
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D014542 2003
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D014542 1997
% 208.36/208.54  |- skos__altLabel mesh__D014542 Uridine 5%27%-Monophosphate
% 208.36/208.54  |- skos__altLabel mesh__D014542 Uridylic Acids
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D014542 2006
% 208.36/208.54  |- skos__historyNote mesh__D014542 Uracil Nucleotides %28%1966-1974%29%
% 208.36/208.54  |- skos__prefLabel mesh__D014542 Uridine Monophosphate
% 208.36/208.54  |- mesh__recordMaintainer mesh__D014542 TAP
% 208.36/208.54  |- mesh__publicMeSHNote mesh__D014542
% 208.36/208.54       91; was see under URACIL NUCLEOTIDES 1978-90; was URIDYLIC ACIDS see under URACIL NUCLEOTIDES 1963-77%A%  
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D014542 2002
% 208.36/208.54  |- mesh__recordAuthorizer mesh__D014542 PLS
% 208.36/208.54  |- mesh__dateRevised mesh__D014542 1995-05-18
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D014542 1996
% 208.36/208.54  |- skos__altLabel mesh__D014542 UMP
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D014542 2005
% 208.36/208.54  |- skos__scopeNote mesh__D014542
% 208.36/208.54       5%27%-Uridylic acid. A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2%27%, 3%27% or 5%27% position.%A%    
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D014542 1999
% 208.36/208.54  |- skos__hiddenLabel mesh__D014542 Monophosphate, Uridine
% 208.36/208.54  |- mesh__recordOriginator mesh__D014542 NLM
% 208.36/208.54  |- mesh__dateCreated mesh__D014542 1999-01-01
% 208.36/208.54  |- skos__altLabel mesh__D014542 Uridylic Acid
% 208.36/208.54  |- mesh__activeMeSHYear mesh__D014542 1998
% 208.36/208.54  |- skos__hiddenLabel mesh__D014542 Uridine 5%27% Monophosphate
% 208.36/208.54  |- skos__hiddenLabel mesh__D014542 Acids, Uridylic
% 208.36/208.54  |- mesh__dateEstablished mesh__D014542 1991-01-01
% 208.36/208.55  |- skos__broader mesh__D014542smesh__D014500
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D014542 2001
% 208.36/208.55  |- mesh__historyNote mesh__D014542
% 208.36/208.55       91%28%78%29%; was see under URACIL NUCLEOTIDES 1978-90; was URIDYLIC ACIDS see under URACIL NUCLEOTIDES 1963-77%A%  
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D014542 2004
% 208.36/208.55  |- mesh__onlineNote mesh__D014542
% 208.36/208.55       to search URIDYLIC ACIDS use URIDINE MONOPHOSPHATE 1975-77 %26% URACIL NUCLEOTIDES 1966-74%A%  
% 208.36/208.55  |- skos__hiddenLabel mesh__D014542 5%27%-Monophosphate, Uridine
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D014542 2000
% 208.36/208.55  |- skos__hiddenLabel mesh__D014542 Acid, Uridylic
% 208.36/208.55  |- rdf__type mesh__D014542sskos__Concept
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D008505 2006
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D008505 2003
% 208.36/208.55  |- skos__hiddenLabel mesh__D008505 Staff, Hospital Medical
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D008505 2000
% 208.36/208.55  |- mesh__dateRevised mesh__D008505 1997-06-20
% 208.36/208.55  |- skos__altLabel mesh__D008505 Hospital Medical Staff
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D008505 2004
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D008505 2001
% 208.36/208.55  |- mesh__recordAuthorizer mesh__D008505 SJN
% 208.36/208.55  |- skos__altLabel mesh__D008505 Hospital Attending Physician
% 208.36/208.55  |- skos__hiddenLabel mesh__D008505 Registrar, Hospital
% 208.36/208.55  |- skos__broader mesh__D008505smesh__D008503
% 208.36/208.55  |- skos__altLabel mesh__D008505 Attending Physician, Hospital
% 208.36/208.55  |- skos__hiddenLabel mesh__D008505 Hospital Registrars
% 208.36/208.55  |- skos__hiddenLabel mesh__D008505 Staffs, Hospital Medical
% 208.36/208.55  |- skos__altLabel mesh__D008505 Hospital Attending Physicians
% 208.36/208.55  |- rdf__type mesh__D008505sskos__Concept
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D008505 2002
% 208.36/208.55  |- skos__annotation mesh__D008505
% 208.36/208.55       hosp only: non-hosp med staff = MEDICAL STAFF; X ref REGISTRARS, HOSPITAL refers to British hosp; DF: MED STAFF HOSP%A%  
% 208.36/208.55  |- mesh__dateCreated mesh__D008505 1999-01-01
% 208.36/208.55  |- skos__hiddenLabel mesh__D008505 Junior Physician
% 208.36/208.55  |- skos__hiddenLabel mesh__D008505 Junior Physicians
% 208.36/208.55  |- mesh__historyNote mesh__D008505
% 208.36/208.55       78; was HOSPITAL MEDICAL STAFF 1963-77   
% 208.36/208.55  |- skos__scopeNote mesh__D008505
% 208.36/208.55       Professional medical personnel approved to provide care to patients in a hospital.%A%    
% 208.36/208.55  |- mesh__publicMeSHNote mesh__D008505
% 208.36/208.55       78; was HOSPITAL MEDICAL STAFF 1963-77   
% 208.36/208.55  |- skos__altLabel mesh__D008505 Hospital Medical Staffs
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D008505 2005
% 208.36/208.55  |- mesh__recordMaintainer mesh__D008505 TGC
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D008505 1998
% 208.36/208.55  |- skos__prefLabel mesh__D008505 Medical Staff, Hospital
% 208.36/208.55  |- skos__broader mesh__D008505smesh__D010564
% 208.36/208.55  |- skos__hiddenLabel mesh__D008505 Physician, Junior
% 208.36/208.55  |- mesh__onlineNote mesh__D008505
% 208.36/208.55       use MEDICAL STAFF, HOSPITAL to search HOSPITAL MEDICAL STAFF 1966-77%A%  
% 208.36/208.55  |- mesh__recordOriginator mesh__D008505 NLM
% 208.36/208.55  |- skos__altLabel mesh__D008505 Medical Staffs, Hospital
% 208.36/208.55  |- skos__hiddenLabel mesh__D008505 Hospital Registrar
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D008505 1999
% 208.36/208.55  |- skos__prefLabel mesh__D000522 Alphaprodine
% 208.36/208.55  |- mesh__dateCreated mesh__D000522 1999-01-01
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D000522 2002
% 208.36/208.55  |- mesh__recordOriginator mesh__D000522 NLM
% 208.36/208.55  |- skos__hiddenLabel mesh__D000522 Hydrochloride, Alphaprodine
% 208.36/208.55  |- mesh__publicMeSHNote mesh__D000522 65   
% 208.36/208.55  |- mesh__dateEstablished mesh__D000522 1965-01-01
% 208.36/208.55  |- mesh__recordMaintainer mesh__D000522 TWD
% 208.36/208.55  |- mesh__historyNote mesh__D000522 65%28%64%29%   
% 208.36/208.55  |- rdf__type mesh__D000522sskos__Concept
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D000522 2005
% 208.36/208.55  |- mesh__recordAuthorizer mesh__D000522 sjn
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D000522 2006
% 208.36/208.55  |- mesh__dateRevised mesh__D000522 2000-06-21
% 208.36/208.55  |- skos__scopeNote mesh__D000522
% 208.36/208.55       An opioid analgesic chemically related to and with an action resembling that of MEPERIDINE, but more rapid in onset and of shorter duration. It has been used in obstetrics, as pre-operative medication, for minor surgical procedures, and for dental procedures. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1067%29%%A%    
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D000522 2001
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D000522 2003
% 208.36/208.55  |- skos__broader mesh__D000522smesh__D010880
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D000522 2004
% 208.36/208.55  |- rdf__type mesh__D018933sskos__Concept
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D018933 2006
% 208.36/208.55  |- skos__historyNote mesh__D018933 Fimbriae, Bacterial %28%1980-1994%29%
% 208.36/208.55  |- mesh__historyNote mesh__D018933 95   
% 208.36/208.55  |- mesh__publicMeSHNote mesh__D018933 95   
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D018933 2001
% 208.36/208.55  |- mesh__recordMaintainer mesh__D018933 PLS
% 208.36/208.55  |- mesh__dateEstablished mesh__D018933 1995-01-01
% 208.36/208.55  |- skos__related mesh__D018933smesh__D003227
% 208.36/208.55  |- mesh__dateCreated mesh__D018933 1994-10-25
% 208.36/208.55  |- skos__broader mesh__D018933smesh__D022081
% 208.36/208.55  |- skos__hiddenLabel mesh__D018933 Pilus, Conjugative
% 208.36/208.55  |- skos__altLabel mesh__D018933 Pili, Conjugative
% 208.36/208.55  |- skos__altLabel mesh__D018933 Sex Pili
% 208.36/208.55  |- skos__altLabel mesh__D018933 Conjugative Pili
% 208.36/208.55  |- mesh__dateRevised mesh__D018933 2000-06-22
% 208.36/208.55  |- skos__scopeNote mesh__D018933
% 208.36/208.55       Filamentous or elongated proteinaceous structures which extend from the cell surface in gram-negative bacteria that contain certain types of conjugative plasmid. These pili are the organs associated with genetic transfer and have essential roles in conjugation. Normally, only one or a few pili occur on a given donor cell. %28%From Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed, p675%29% This preferred use of %22%pili%22% refers to the sexual appendage, to be distinguished from bacterial fimbriae %28%FIMBRIAE, BACTERIAL%29%, also known as common pili, which are usually concerned with adhesion.%A%    
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D018933 2002
% 208.36/208.55  |- skos__prefLabel mesh__D018933 Pili, Sex
% 208.36/208.55  |- skos__hiddenLabel mesh__D018933 Pilus, Sex
% 208.36/208.55  |- mesh__recordAuthorizer mesh__D018933 sjn
% 208.36/208.55  |- mesh__recordOriginator mesh__D018933 PLS
% 208.36/208.55  |- skos__hiddenLabel mesh__D018933 Conjugative Pilus
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D018933 2003
% 208.36/208.55  |- skos__historyNote mesh__D018933
% 208.36/208.55       specific bacteria/ultrastructure %28%1975-1979%29%
% 208.36/208.55  |- skos__annotation mesh__D018933
% 208.36/208.55       note X refs: do not confuse with COMMON PILI see FIMBRIAE, BACTERIAL; coord IM with specific bacterium %28%IM%29%; A 11 qualif except /cytol; /genet permitted%A%  
% 208.36/208.55  |- skos__historyNote mesh__D018933
% 208.36/208.55       specific bacteria/cytology %28%1969-1974%29%
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D018933 2005
% 208.36/208.55  |- skos__altLabel mesh__D018933 Sex Pilus
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D018933 2004
% 208.36/208.55  |- rdf__type mesh__D010950sskos__Concept
% 208.36/208.55  |- skos__hiddenLabel mesh__D010950 Cell, Plasma
% 208.36/208.55  |- skos__broader mesh__D010950smesh__D001402
% 208.36/208.55  |- mesh__recordMaintainer mesh__D010950 jmp
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010950 2005
% 208.36/208.55  |- mesh__dateCreated mesh__D010950 1999-01-01
% 208.36/208.55  |- skos__hiddenLabel mesh__D010950 Plasma Cell
% 208.36/208.55  |- skos__altLabel mesh__D010950 Plasmacytes
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010950 2006
% 208.36/208.55  |- mesh__dateRevised mesh__D010950 2003-07-09
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010950 2004
% 208.36/208.55  |- skos__hiddenLabel mesh__D010950 Plasmacyte
% 208.36/208.55  |- mesh__recordAuthorizer mesh__D010950 sjn
% 208.36/208.55  |- mesh__recordOriginator mesh__D010950 NLM
% 208.36/208.55  |- skos__hiddenLabel mesh__D010950 Cells, Plasma
% 208.36/208.55  |- skos__prefLabel mesh__D010950 Plasma Cells
% 208.36/208.55  |- skos__scopeNote mesh__D010950
% 208.36/208.55       Specialized forms of antibody-producing B-LYMPHOCYTES. They synthesize and secrete immunoglobulin. They are found only in lymphoid organs and at sites of immune responses and normally do not circulate in the blood or lymph. %28%Rosen et al., Dictionary of Immunology, 1989, p169 %26% Abbas et al., Cellular and Molecular Immunology, 2d ed, p20%29%%A%    
% 208.36/208.55  |- skos__annotation mesh__D010950
% 208.36/208.55       not for BLOOD CELLS: they are antibody-producing cells; A 11 qualif%A%  
% 208.36/208.55  |- skos__annotation mesh__D032604
% 208.36/208.55       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D032604 2003
% 208.36/208.55  |- mesh__dateEstablished mesh__D032604 2003-01-01
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D032604 2004
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D032604 2005
% 208.36/208.55  |- skos__prefLabel mesh__D032604 Alangiaceae
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D032604 2006
% 208.36/208.55  |- mesh__historyNote mesh__D032604 2003   
% 208.36/208.55  |- mesh__dateCreated mesh__D032604 2002-07-02
% 208.36/208.55  |- rdf__type mesh__D032604sskos__Concept
% 208.36/208.55  |- skos__scopeNote mesh__D032604
% 208.36/208.55       A plant family of the order Cornales, subclass Rosidae, class Magnoliopsida, consisting of slow-growing evergreen trees common in tropical forests of south India and Burma. Members contain tetrahydroisoquinoline-monoterpene and iridoid glycosides.%A%    
% 208.36/208.55  |- skos__broader mesh__D032604smesh__D019684
% 208.36/208.55  |- mesh__publicMeSHNote mesh__D032604 2003   
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010152 2006
% 208.36/208.55  |- mesh__dateEstablished mesh__D010152 1991-01-01
% 208.36/208.55  |- skos__scopeNote mesh__D010152
% 208.36/208.55       In animals, the social relationship established between a male and female for reproduction. It may include raising of young.%A%    
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010152 2005
% 208.36/208.55  |- skos__altLabel mesh__D010152 Bond, Pair
% 208.36/208.55  |- mesh__dateCreated mesh__D010152 1974-11-11
% 208.36/208.55  |- skos__hiddenLabel mesh__D010152 Pair Bonds
% 208.36/208.55  |- mesh__recordMaintainer mesh__D010152 PLS
% 208.36/208.55  |- skos__hiddenLabel mesh__D010152 Bonds, Pair
% 208.36/208.55  |- mesh__historyNote mesh__D010152
% 208.36/208.55       91%28%75%29%; was see under SEX BEHAVIOR, ANIMAL 1975-90   
% 208.36/208.55  |- skos__prefLabel mesh__D010152 Pair Bond
% 208.36/208.55  |- mesh__recordAuthorizer mesh__D010152 sjn
% 208.36/208.55  |- mesh__recordOriginator mesh__D010152 NLM
% 208.36/208.55  |- rdf__type mesh__D010152sskos__Concept
% 208.36/208.55  |- mesh__dateRevised mesh__D010152 2002-07-02
% 208.36/208.55  |- skos__annotation mesh__D010152 animal only; no qualif   
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010152 2004
% 208.36/208.55  |- mesh__publicMeSHNote mesh__D010152
% 208.36/208.55       91; was see under SEX BEHAVIOR, ANIMAL 1975-90   
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010152 2003
% 208.36/208.55  |- skos__broader mesh__D010152smesh__D012726
% 208.36/208.55  |- mesh__recordAuthorizer mesh__D004913 sjn
% 208.36/208.55  |- mesh__historyNote mesh__D004913 68   
% 208.36/208.55  |- mesh__publicMeSHNote mesh__D004913 68   
% 208.36/208.55  |- skos__broader mesh__D004913smesh__D004912
% 208.36/208.55  |- skos__hiddenLabel mesh__D004913 Erythrocyte, Abnormal
% 208.36/208.55  |- mesh__dateRevised mesh__D004913 2003-07-09
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D004913 2005
% 208.36/208.55  |- skos__altLabel mesh__D004913 Abnormal Erythrocytes
% 208.36/208.55  |- skos__hiddenLabel mesh__D004913 Abnormal Erythrocyte
% 208.36/208.55  |- skos__prefLabel mesh__D004913 Erythrocytes, Abnormal
% 208.36/208.55  |- skos__historyNote mesh__D004913 Erythrocytes %28%1966-1967%29%
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D004913 2006
% 208.36/208.55  |- mesh__dateCreated mesh__D004913 1999-01-01
% 208.36/208.55  |- skos__annotation mesh__D004913
% 208.36/208.55       = abnorm of size %26% shape; do not equate with ERYTHROCYTES /pathol; do not confuse with ERYTHROCYTE DEFORMABILITY which is the %22%ability of erythrocytes to change shape as they pass through narrow spaces, such as the microvasculature%22%; A 11 qualif; coord with disease /blood, not /compl%A%  
% 208.36/208.55  |- mesh__recordMaintainer mesh__D004913 nns
% 208.36/208.55  |- mesh__dateEstablished mesh__D004913 1968-01-01
% 208.36/208.55  |- rdf__type mesh__D004913sskos__Concept
% 208.36/208.55  |- mesh__recordOriginator mesh__D004913 NLM
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D004913 2004
% 208.36/208.55  |- skos__broader mesh__D004115smesh__D011725
% 208.36/208.55  |- skos__altLabel mesh__D004115 Dimethpyrindene
% 208.36/208.55  |- mesh__recordOriginator mesh__D004115 NLM
% 208.36/208.55  |- skos__hiddenLabel mesh__D004115 Maleate, Dimethindene
% 208.36/208.55  |- skos__prefLabel mesh__D004115 Dimethindene
% 208.36/208.55  |- mesh__recordAuthorizer mesh__D004115 sjn
% 208.36/208.55  |- skos__scopeNote mesh__D004115
% 208.36/208.55       A histamine H1 antagonist. It is used in hypersensitivity reactions, in rhinitis, for pruritus, and in some common cold remedies.%A%    
% 208.36/208.55  |- mesh__dateCreated mesh__D004115 1999-01-01
% 208.36/208.55  |- rdf__type mesh__D004115sskos__Concept
% 208.36/208.55  |- skos__altLabel mesh__D004115 Forhistal
% 208.36/208.55  |- mesh__dateRevised mesh__D004115 2005-06-30
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D004115 2006
% 208.36/208.55  |- skos__altLabel mesh__D004115 Novartis Brand of Dimethindene Maleate
% 208.36/208.55  |- skos__altLabel mesh__D004115 Dimetindene
% 208.36/208.55  |- mesh__recordMaintainer mesh__D004115 exl
% 208.36/208.55  |- skos__broader mesh__D004115smesh__D007192
% 208.36/208.55  |- rdf__type mesh__D020580sskos__Concept
% 208.36/208.55  |- skos__historyNote mesh__D020580 Methylococcaceae %28%1977-1991%29%
% 208.36/208.55  |- mesh__recordOriginator mesh__D020580 ndw
% 208.36/208.55  |- skos__annotation mesh__D020580
% 208.36/208.55       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%; DF: METHYLOBACT%A%  
% 208.36/208.55  |- skos__historyNote mesh__D020580 Methylococcaceae %28%1998-1999%29%
% 208.36/208.55  |- mesh__publicMeSHNote mesh__D020580 2000   
% 208.36/208.55  |- mesh__historyNote mesh__D020580 2000   
% 208.36/208.55  |- mesh__dateRevised mesh__D020580 2005-06-30
% 208.36/208.55  |- skos__historyNote mesh__D020580
% 208.36/208.55       Gram-Negative Aerobic Bacteria %28%1992-1997%29%
% 208.36/208.55  |- skos__prefLabel mesh__D020580 Methylobacterium
% 208.36/208.55  |- mesh__recordMaintainer mesh__D020580 DRC
% 208.36/208.55  |- mesh__dateCreated mesh__D020580 1999-11-03
% 208.36/208.55  |- skos__broader mesh__D020580smesh__D042082
% 208.36/208.55  |- skos__scopeNote mesh__D020580
% 208.36/208.55       A genus of gram-negative, aerobic, facultatively methylotrophic rods occurring singly or occasionally in rosettes. Members of this genus are usually motile and are isolated from soil, dust, fresh water, lake sediments, leaf surfaces, rice, air, and hospital environments. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 208.36/208.55  |- mesh__recordAuthorizer mesh__D020580 sjn
% 208.36/208.55  |- mesh__dateEstablished mesh__D020580 2000-01-01
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D020580 2006
% 208.36/208.55  |- mesh__dateCreated mesh__D014543 1974-11-19
% 208.36/208.55  |- skos__historyNote mesh__D014543 Phosphates %28%1973-1974%29%
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D014543 2005
% 208.36/208.55  |- mesh__recordAuthorizer mesh__D014543 sjn
% 208.36/208.55  |- mesh__dateRevised mesh__D014543 2003-07-09
% 208.36/208.55  |- mesh__publicMeSHNote mesh__D014543
% 208.36/208.55       91; was see under PENTOSYLTRANSFERASES 1975-90   
% 208.36/208.55  |- skos__scopeNote mesh__D014543
% 208.36/208.55       An enzyme that catalyzes the transfer of ribose from uridine to orthophosphate, forming uracil and ribose 1-phosphate. EC 2.4.2.3.%A%    
% 208.36/208.55  |- skos__broader mesh__D014543smesh__D010430
% 208.36/208.55  |- mesh__historyNote mesh__D014543
% 208.36/208.55       91%28%75%29%; was see under PENTOSYLTRANSFERASES 1975-90   
% 208.36/208.55  |- mesh__dateEstablished mesh__D014543 1991-01-01
% 208.36/208.55  |- skos__historyNote mesh__D014543 Uridine %28%1973-1974%29%
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D014543 2004
% 208.36/208.55  |- mesh__recordOriginator mesh__D014543 NLM
% 208.36/208.55  |- mesh__recordMaintainer mesh__D014543 ssb
% 208.36/208.55  |- skos__hiddenLabel mesh__D014543
% 208.36/208.55       5 Fluoro 2%27% deoxyuridine Phosphorylase
% 208.36/208.55  |- rdf__type mesh__D014543sskos__Concept
% 208.36/208.55  |- skos__prefLabel mesh__D014543 Uridine Phosphorylase
% 208.36/208.55  |- skos__hiddenLabel mesh__D014543
% 208.36/208.55       Phosphorylase, 5-Fluoro-2%27%-deoxyuridine
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D014543 2006
% 208.36/208.55  |- skos__historyNote mesh__D014543 Pentosyltransferases %28%1973-1974%29%
% 208.36/208.55  |- skos__hiddenLabel mesh__D014543 Phosphorylase, Uridine
% 208.36/208.55  |- mesh__recordOriginator mesh__D008506 EC
% 208.36/208.55  |- skos__altLabel mesh__D008506 Waste, Medical
% 208.36/208.55  |- skos__broader mesh__D008506smesh__D014866
% 208.36/208.55  |- mesh__historyNote mesh__D008506
% 208.36/208.55       91%28%78%29%; was see under WASTE PRODUCTS 1978-90   
% 208.36/208.55  |- rdf__type mesh__D008506sskos__Concept
% 208.36/208.55  |- mesh__dateCreated mesh__D008506 1977-05-13
% 208.36/208.55  |- skos__historyNote mesh__D008506 Refuse Disposal %28%1966-1977%29%
% 208.36/208.55  |- skos__hiddenLabel mesh__D008506 Medical Wastes
% 208.36/208.55  |- skos__hiddenLabel mesh__D008506 Wastes, Pathological
% 208.36/208.55  |- skos__prefLabel mesh__D008506 Medical Waste
% 208.36/208.55  |- mesh__dateRevised mesh__D008506 2005-06-30
% 208.36/208.55  |- skos__hiddenLabel mesh__D008506 Wastes, Medical
% 208.36/208.55  |- skos__hiddenLabel mesh__D008506 Pathological Wastes
% 208.36/208.55  |- mesh__recordAuthorizer mesh__D008506 sjn
% 208.36/208.55  |- skos__altLabel mesh__D008506 Pathological Waste
% 208.36/208.55  |- mesh__publicMeSHNote mesh__D008506
% 208.36/208.55       91; was see under WASTE PRODUCTS 1978-90   
% 208.36/208.55  |- mesh__dateEstablished mesh__D008506 1991-01-01
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D008506 2006
% 208.36/208.55  |- skos__related mesh__D008506smesh__D017848
% 208.36/208.55  |- skos__scopeNote mesh__D008506
% 208.36/208.55       Blood, mucus, tissue removed at surgery or autopsy, soiled surgical dressings, and other materials requiring special disposal procedures.%A%    
% 208.36/208.55  |- skos__annotation mesh__D008506
% 208.36/208.55       note next heading; DENTAL WASTE is also available; DF: MED WASTE%A%  
% 208.36/208.55  |- mesh__recordMaintainer mesh__D008506 ssb
% 208.36/208.55  |- rdf__type mesh__D000523sskos__Concept
% 208.36/208.55  |- skos__annotation mesh__D000523 a synthetic progestational hormone   
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D000523 2005
% 208.36/208.55  |- mesh__dateRevised mesh__D000523 2003-07-09
% 208.36/208.55  |- mesh__historyNote mesh__D000523
% 208.36/208.55       91%28%75%29%; was ALPHASONE see under ALGESTONE ACETOPHENIDE/analogs %26% derivatives 1975-90; was ALPHASONE see under ALGESTONE ACETOPHENIDE 1974; DIHYDROXYPROGESTERONE was see ALGESTONE ACETOPHENIDE 1975-76, was see under ALGESTONE ACETOPHENIDE 1974, was heading 1964-73 %28%Prov%29%%A%  
% 208.36/208.55  |- mesh__recordOriginator mesh__D000523 NLM
% 208.36/208.55  |- skos__prefLabel mesh__D000523 Algestone
% 208.36/208.55  |- skos__altLabel mesh__D000523 Alphasone
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D000523 2006
% 208.36/208.55  |- mesh__dateEstablished mesh__D000523 1991-01-01
% 208.36/208.55  |- mesh__onlineNote mesh__D000523
% 208.36/208.55       use ALGESTONE to search ALPHASONE 1974-90; use ALGESTONE to search DIHYDROXYPROGESTERONE 1977-present %26% use ALGESTONE ACETOPHENIDE 1966-76 %28%as Prov 1966-73%29%%A%  
% 208.36/208.55  |- skos__scopeNote mesh__D000523
% 208.36/208.55       16 alpha,17-Dihydroxypregn-4-ene-3,20-dione. Progestational dihydroxy derivative of PROGESTERONE. Its acetonide possesses anti-inflammatory properties.%A%    
% 208.36/208.55  |- mesh__publicMeSHNote mesh__D000523
% 208.36/208.55       91; was ALPHASONE see under ALGESTONE ACETOPHENIDE/analogs %26% derivatives 1975-90; was ALPHASONE see under ALGESTONE ACETOPHENIDE 1974; DIHYDROXYPROGESTERONE was see ALGESTONE ACETOPHENIDE 1975-76, was see under ALGESTONE ACETOPHENIDE 1974%A%  
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D000523 2004
% 208.36/208.55  |- skos__altLabel mesh__D000523 Dihydroxyprogesterone
% 208.36/208.55  |- mesh__recordAuthorizer mesh__D000523 sjn
% 208.36/208.55  |- skos__broader mesh__D000523smesh__D011374
% 208.36/208.55  |- mesh__recordMaintainer mesh__D000523 lkt
% 208.36/208.55  |- mesh__dateCreated mesh__D000523 1999-01-01
% 208.36/208.55  |- mesh__recordAuthorizer mesh__D018934 ags
% 208.36/208.55  |- mesh__publicMeSHNote mesh__D018934
% 208.36/208.55       2000; see FOURNIER%27%S GANGRENE 1996-1999   
% 208.36/208.55  |- skos__broader mesh__D018934smesh__D014569
% 208.36/208.55  |- mesh__recordMaintainer mesh__D018934 ags
% 208.36/208.55  |- mesh__dateCreated mesh__D018934 1995-02-17
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D018934 2000
% 208.36/208.55  |- skos__broader mesh__D018934smesh__D001424
% 208.36/208.55  |- skos__altLabel mesh__D018934 Fournier%27%s Gangrene
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D018934 2003
% 208.36/208.55  |- mesh__recordOriginator mesh__D018934 TGC
% 208.36/208.55  |- skos__altLabel mesh__D018934 Fournier%27%s Disease
% 208.36/208.55  |- rdf__type mesh__D018934sskos__Concept
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D018934 2006
% 208.36/208.55  |- skos__hiddenLabel mesh__D018934 Fourniers Disease
% 208.36/208.55  |- skos__scopeNote mesh__D018934
% 208.36/208.55       An acute infective gangrene involving the scrotum, penis, or perineum caused by gram-positive organisms, enteric bacilli, and anaerobes, usually resulting from local trauma, operative procedures, or urinary tract disease.%A%    
% 208.36/208.55  |- skos__hiddenLabel mesh__D018934 Fournier Gangrenes
% 208.36/208.55  |- skos__historyNote mesh__D018934 Gangrene %28%1966-1995%29%
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D018934 2002
% 208.36/208.55  |- skos__altLabel mesh__D018934 Fournier Disease
% 208.36/208.55  |- skos__hiddenLabel mesh__D018934 Gangrene, Fournier%27%s
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D018934 2005
% 208.36/208.55  |- mesh__historyNote mesh__D018934 2000%28%1996%29%   
% 208.36/208.55  |- skos__hiddenLabel mesh__D018934 Gangrene, Fournier
% 208.36/208.55  |- skos__prefLabel mesh__D018934 Fournier Gangrene
% 208.36/208.55  |- mesh__dateRevised mesh__D018934 2000-01-21
% 208.36/208.55  |- mesh__dateEstablished mesh__D018934 1996-01-01
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D018934 2000A
% 208.36/208.55  |- skos__hiddenLabel mesh__D018934 Fourniers Gangrene
% 208.36/208.55  |- skos__annotation mesh__D018934
% 208.36/208.55       coord IM with specific site or organ/diseases term %28%NIM%29% or with specific bact infect %28%NIM%29% only if particularly discussed; usually in male%A%  
% 208.36/208.55  |- skos__hiddenLabel mesh__D018934 Gangrenes, Fournier
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D018934 2001
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D018934 2004
% 208.36/208.55  |- skos__prefLabel mesh__D010951 Plasma Exchange
% 208.36/208.55  |- skos__historyNote mesh__D010951
% 208.36/208.55       Exchange Transfusion, Whole Blood %28%1968-1980%29%
% 208.36/208.55  |- mesh__dateRevised mesh__D010951 1989-05-16
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010951 1993
% 208.36/208.55  |- mesh__historyNote mesh__D010951 81   
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010951 1998
% 208.36/208.55  |- mesh__recordOriginator mesh__D010951 SMH
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010951 2004
% 208.36/208.55  |- mesh__dateEstablished mesh__D010951 1981-01-01
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010951 1992
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010951 1995
% 208.36/208.55  |- skos__scopeNote mesh__D010951
% 208.36/208.55       Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions %28%PPF%29%, albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions.%A%    
% 208.36/208.55  |- skos__hiddenLabel mesh__D010951 Plasma Exchanges
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010951 2003
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010951 2006
% 208.36/208.55  |- mesh__dateCreated mesh__D010951 1980-05-12
% 208.36/208.55  |- skos__broader mesh__D010951smesh__D001803
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010951 1991
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010951 1994
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010951 2002
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010951 2005
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010951 1990
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010951 2001
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010951 1997
% 208.36/208.55  |- mesh__publicMeSHNote mesh__D010951 81   
% 208.36/208.55  |- rdf__type mesh__D010951sskos__Concept
% 208.36/208.55  |- skos__annotation mesh__D010951
% 208.36/208.55       do not use /util except by MeSH definition   
% 208.36/208.55  |- mesh__recordMaintainer mesh__D010951 TGC
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010951 2000
% 208.36/208.55  |- mesh__recordAuthorizer mesh__D010951 PLS
% 208.36/208.55  |- skos__hiddenLabel mesh__D010951 Exchanges, Plasma
% 208.36/208.55  |- skos__historyNote mesh__D010951 Plasmapheresis %28%1968-1980%29%
% 208.36/208.55  |- skos__historyNote mesh__D010951 Blood Transfusion %28%1968-1980%29%
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010951 1996
% 208.36/208.55  |- skos__hiddenLabel mesh__D010951 Exchange, Plasma
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010951 1999
% 208.36/208.55  |- skos__broader mesh__D018136smesh__D004267
% 208.36/208.55  |- skos__prefLabel mesh__D018136 Circoviridae
% 208.36/208.55  |- mesh__historyNote mesh__D018136 94   
% 208.36/208.55  |- mesh__dateRevised mesh__D018136 2004-07-07
% 208.36/208.55  |- mesh__dateEstablished mesh__D018136 1994-01-01
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D018136 2006
% 208.36/208.55  |- mesh__recordAuthorizer mesh__D018136 sjn
% 208.36/208.55  |- skos__scopeNote mesh__D018136
% 208.36/208.55       A family of very small viruses containing circular, single-stranded DNA and possessing no envelope. The modes of transmission are not known.%A%    
% 208.36/208.55  |- mesh__recordOriginator mesh__D018136 AGS
% 208.36/208.55  |- mesh__recordMaintainer mesh__D018136 ags
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D018136 2005
% 208.36/208.55  |- rdf__type mesh__D018136sskos__Concept
% 208.36/208.55  |- mesh__dateCreated mesh__D018136 1993-06-04
% 208.36/208.55  |- skos__annotation mesh__D018136 infection = CIRCOVIRIDAE INFECTIONS   
% 208.36/208.55  |- mesh__publicMeSHNote mesh__D018136 94   
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010153 1999
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010153 1995
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010153 2000
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010153 1998
% 208.36/208.55  |- skos__broader mesh__D010153smesh__D014706
% 208.36/208.55  |- skos__hiddenLabel mesh__D010153 Paired Associate Learning
% 208.36/208.55  |- skos__hiddenLabel mesh__D010153 Learnings, Paired-Associate
% 208.36/208.55  |- skos__prefLabel mesh__D010153 Paired-Associate Learning
% 208.36/208.55  |- rdf__type mesh__D010153sskos__Concept
% 208.36/208.55  |- skos__scopeNote mesh__D010153
% 208.36/208.55       Learning in which the subject must respond with one word or syllable when presented with another word or syllable.%A%    
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010153 1994
% 208.36/208.55  |- skos__hiddenLabel mesh__D010153 Paired-Associate Learnings
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010153 2004
% 208.36/208.55  |- skos__hiddenLabel mesh__D010153 Learning, Paired-Associate
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010153 2002
% 208.36/208.55  |- mesh__dateRevised mesh__D010153 1992-05-15
% 208.36/208.55  |- mesh__recordAuthorizer mesh__D010153 PLS
% 208.36/208.55  |- mesh__recordMaintainer mesh__D010153 TAP
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010153 2003
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010153 1997
% 208.36/208.55  |- mesh__recordOriginator mesh__D010153 NLM
% 208.36/208.55  |- mesh__dateCreated mesh__D010153 1999-01-01
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010153 2006
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010153 1993
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010153 1996
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010153 2001
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D010153 2005
% 208.36/208.55  |- mesh__publicMeSHNote mesh__D004116 73   
% 208.36/208.55  |- skos__broader mesh__D004116smesh__D011283
% 208.36/208.55  |- skos__hiddenLabel mesh__D004116 Monohydrate, Dimethisterone
% 208.36/208.55  |- rdf__type mesh__D004116sskos__Concept
% 208.36/208.55  |- mesh__dateCreated mesh__D004116 1999-01-01
% 208.36/208.55  |- mesh__historyNote mesh__D004116 73%28%65%29%   
% 208.36/208.55  |- mesh__recordOriginator mesh__D004116 NLM
% 208.36/208.55  |- mesh__dateRevised mesh__D004116 2003-07-09
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D004116 2004
% 208.36/208.55  |- mesh__dateEstablished mesh__D004116 1973-01-01
% 208.36/208.55  |- skos__prefLabel mesh__D004116 Dimethisterone
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D004116 2006
% 208.36/208.55  |- mesh__recordAuthorizer mesh__D004116 sjn
% 208.36/208.55  |- skos__scopeNote mesh__D004116
% 208.36/208.55       A synthetic progestational hormone without significant estrogenic or androgenic properties. It was formerly used as the progestational component in oral sequential contraceptives.%A%    
% 208.36/208.55  |- mesh__activeMeSHYear mesh__D004116 2005
% 208.36/208.55  |- mesh__recordMaintainer mesh__D004116 lkt
% 208.36/208.55  |- skos__broader mesh__D008511Q000193smesh__D008511
% 208.36/208.55  |- mesh__preferredCombination mesh__D008511Q000193smesh__D004501
% 208.36/208.55  |- rdf__type mesh__D008511Q000193smesh__CompoundConcept
% 208.36/208.56  |- rdf__type mesh__D020581sskos__Concept
% 208.36/208.56  |- skos__broader mesh__D020581smesh__D006090
% 208.36/208.56  |- skos__scopeNote mesh__D020581
% 208.36/208.56       A genus of gram-negative rods which form exospores and are obligate methanotrophs.%A%    
% 208.36/208.56  |- mesh__recordOriginator mesh__D020581 ndw
% 208.36/208.56  |- mesh__recordAuthorizer mesh__D020581 sjn
% 208.36/208.56  |- mesh__dateEstablished mesh__D020581 2000-01-01
% 208.36/208.56  |- mesh__dateCreated mesh__D020581 1999-11-03
% 208.36/208.56  |- mesh__publicMeSHNote mesh__D020581 2000   
% 208.36/208.56  |- mesh__recordMaintainer mesh__D020581 SYSTEM
% 208.36/208.56  |- skos__broader mesh__D020581smesh__D042083
% 208.36/208.56  |- skos__prefLabel mesh__D020581 Methylosinus
% 208.36/208.56  |- skos__historyNote mesh__D020581 Methylococcaceae %28%1975-1999%29%
% 208.36/208.56  |- mesh__dateRevised mesh__D020581 2005-06-30
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D020581 2006
% 208.36/208.56  |- mesh__historyNote mesh__D020581 2000   
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D014544 1998
% 208.36/208.56  |- skos__hiddenLabel mesh__D014544 UTP, Magnesium
% 208.36/208.56  |- skos__broader mesh__D014544smesh__D014500
% 208.36/208.56  |- skos__altLabel mesh__D014544 Magnesium Uridine Triphosphate
% 208.36/208.56  |- mesh__dateEstablished mesh__D014544 1990-01-01
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D014544 1994
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D014544 2004
% 208.36/208.56  |- skos__hiddenLabel mesh__D014544 Mg UTP
% 208.36/208.56  |- skos__altLabel mesh__D014544 Magnesium UTP
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D014544 2001
% 208.36/208.56  |- skos__historyNote mesh__D014544 Uracil Nucleotides %28%1966-1977%29%
% 208.36/208.56  |- rdf__type mesh__D014544sskos__Concept
% 208.36/208.56  |- mesh__recordOriginator mesh__D014544 RLS
% 208.36/208.56  |- mesh__historyNote mesh__D014544
% 208.36/208.56       90%28%78%29%; was see under URACIL NUCLEOTIDES 1978-89   
% 208.36/208.56  |- skos__hiddenLabel mesh__D014544 Triphosphate, Magnesium Uridine
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D014544 2003
% 208.36/208.56  |- mesh__recordMaintainer mesh__D014544 TGC
% 208.36/208.56  |- skos__altLabel mesh__D014544 UTP
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D014544 1997
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D014544 2000
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D014544 2006
% 208.36/208.56  |- mesh__dateCreated mesh__D014544 1977-04-22
% 208.36/208.56  |- skos__scopeNote mesh__D014544
% 208.36/208.56       Uridine 5%27%-%28%tetrahydrogen triphosphate%29%. A uracil nucleotide containing three phosphate groups esterified to the sugar moiety.%A%    
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D014544 1993
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D014544 1996
% 208.36/208.56  |- mesh__publicMeSHNote mesh__D014544
% 208.36/208.56       90; was see under URACIL NUCLEOTIDES 1978-89   
% 208.36/208.56  |- skos__hiddenLabel mesh__D014544 Triphosphate, Uridine
% 208.36/208.56  |- skos__prefLabel mesh__D014544 Uridine Triphosphate
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D014544 2005
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D014544 1999
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D014544 2002
% 208.36/208.56  |- mesh__recordAuthorizer mesh__D014544 PLS
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D014544 1995
% 208.36/208.56  |- mesh__dateRevised mesh__D014544 1992-05-20
% 208.36/208.56  |- skos__broader mesh__D004194Q000628smesh__D004194
% 208.36/208.56  |- mesh__preferredCombination mesh__D004194Q000628smesh__D013812
% 208.36/208.56  |- rdf__type mesh__D004194Q000628smesh__CompoundConcept
% 208.36/208.56  |- mesh__recordOriginator mesh__D008507 EC
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D008507 2004
% 208.36/208.56  |- skos__hiddenLabel mesh__D008507 Underserved Areas, Medically
% 208.36/208.56  |- skos__hiddenLabel mesh__D008507 Areas, Physician Shortage
% 208.36/208.56  |- rdf__type mesh__D008507sskos__Concept
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D008507 2000
% 208.36/208.56  |- mesh__historyNote mesh__D008507 78   
% 208.36/208.56  |- skos__hiddenLabel mesh__D008507 Medically Underserved Areas
% 208.36/208.56  |- mesh__dateEstablished mesh__D008507 1978-01-01
% 208.36/208.56  |- mesh__dateRevised mesh__D008507 1999-11-08
% 208.36/208.56  |- skos__hiddenLabel mesh__D008507 Physician Shortage Areas
% 208.36/208.56  |- skos__broader mesh__D008507smesh__D012040
% 208.36/208.56  |- skos__altLabel mesh__D008507 Health Service Corps, National
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D008507 2001
% 208.36/208.56  |- skos__prefLabel mesh__D008507 Medically Underserved Area
% 208.36/208.56  |- mesh__recordAuthorizer mesh__D008507 sjn
% 208.36/208.56  |- mesh__dateCreated mesh__D008507 1977-05-12
% 208.36/208.56  |- skos__altLabel mesh__D008507 Area, Medically Underserved
% 208.36/208.56  |- mesh__recordMaintainer mesh__D008507 KEV
% 208.36/208.56  |- skos__hiddenLabel mesh__D008507 Underserved Area, Medically
% 208.36/208.56  |- skos__hiddenLabel mesh__D008507 Shortage Areas, Physician
% 208.36/208.56  |- skos__related mesh__D008507smesh__D006297
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D008507 2002
% 208.36/208.56  |- skos__broader mesh__D008507smesh__D006301
% 208.36/208.56  |- skos__annotation mesh__D008507
% 208.36/208.56       no qualif; specify geog; DF: MED UNDERSERV AREA   
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D008507 2005
% 208.36/208.56  |- mesh__publicMeSHNote mesh__D008507 78   
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D008507 2003
% 208.36/208.56  |- skos__hiddenLabel mesh__D008507 Shortage Area, Physician
% 208.36/208.56  |- skos__hiddenLabel mesh__D008507 Area, Physician Shortage
% 208.36/208.56  |- skos__hiddenLabel mesh__D008507 Areas, Medically Underserved
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D008507 2006
% 208.36/208.56  |- skos__scopeNote mesh__D008507
% 208.36/208.56       A geographic location which has insufficient health resources %28%manpower and/or facilities%29% to meet the medical needs of the resident population.%A%    
% 208.36/208.56  |- mesh__dateEstablished mesh__D000524 1981-01-01
% 208.36/208.56  |- mesh__publicMeSHNote mesh__D000524
% 208.36/208.56       94; was ALPHAVIRUSES 1981-93; ALPHAVIRUSES was see ARBOVIRUSES 1978-80%A%  
% 208.36/208.56  |- skos__altLabel mesh__D000524 Alphaviruses
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D000524 2002
% 208.36/208.56  |- skos__hiddenLabel mesh__D000524 Group A Arbovirus
% 208.36/208.56  |- skos__hiddenLabel mesh__D000524 Alpha Viruses
% 208.36/208.56  |- mesh__recordAuthorizer mesh__D000524 sjn
% 208.36/208.56  |- mesh__recordOriginator mesh__D000524 RC
% 208.36/208.56  |- skos__broader mesh__D000524smesh__D014035
% 208.36/208.56  |- skos__hiddenLabel mesh__D000524 Group A Arboviruses
% 208.36/208.56  |- rdf__type mesh__D000524sskos__Concept
% 208.36/208.56  |- mesh__dateCreated mesh__D000524 1980-05-14
% 208.36/208.56  |- skos__altLabel mesh__D000524 Arboviruses, Group A
% 208.36/208.56  |- mesh__historyNote mesh__D000524
% 208.36/208.56       94; was ALPHAVIRUSES 1981-93; ALPHAVIRUSES was see ARBOVIRUSES 1978-80%A%  
% 208.36/208.56  |- skos__historyNote mesh__D000524 Arboviruses %28%1966-1980%29%
% 208.36/208.56  |- mesh__onlineNote mesh__D000524
% 208.36/208.56       use ALPHAVIRUS to search ALPHAVIRUSES 1981-93; use ARBOVIRUSES 1978-80%A%  
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D000524 2006
% 208.36/208.56  |- skos__prefLabel mesh__D000524 Alphavirus
% 208.36/208.56  |- skos__hiddenLabel mesh__D000524 Arbovirus, Group A
% 208.36/208.56  |- skos__scopeNote mesh__D000524
% 208.36/208.56       A genus of TOGAVIRIDAE, also known as Group A arboviruses, serologically related to each other but not to other Togaviridae. The viruses are transmitted by mosquitoes. The type species is the SINDBIS VIRUS.%A%    
% 208.36/208.56  |- mesh__dateRevised mesh__D000524 2001-07-25
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D000524 2004
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D000524 2005
% 208.36/208.56  |- mesh__recordMaintainer mesh__D000524 ags
% 208.36/208.56  |- skos__annotation mesh__D000524 infection = ALPHAVIRUS INFECTIONS   
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D000524 2003
% 208.36/208.56  |- skos__altLabel mesh__D000524 Alpha Virus
% 208.36/208.56  |- skos__hiddenLabel mesh__D010952 Expanders, Blood
% 208.36/208.56  |- skos__scopeNote mesh__D010952
% 208.36/208.56       Any liquid used to replace blood plasma, usually a saline solution, often with serum albumins, dextrans or other preparations. These substances do not enhance the oxygen- carrying capacity of blood, but merely replace the volume. They are also used to treat dehydration.%A%    
% 208.36/208.56  |- mesh__recordMaintainer mesh__D010952 ssb
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D010952 2006
% 208.36/208.56  |- skos__hiddenLabel mesh__D010952 Expanders, Plasma Volume
% 208.36/208.56  |- skos__hiddenLabel mesh__D010952 Substitutes, Plasma
% 208.36/208.56  |- skos__related mesh__D010952smesh__D001802
% 208.36/208.56  |- skos__altLabel mesh__D010952 Plasma Volume Expanders
% 208.36/208.56  |- mesh__recordAuthorizer mesh__D010952 sjn
% 208.36/208.56  |- skos__prefLabel mesh__D010952 Plasma Substitutes
% 208.36/208.56  |- rdf__type mesh__D010952sskos__Concept
% 208.36/208.56  |- mesh__dateRevised mesh__D010952 2005-06-30
% 208.36/208.56  |- skos__hiddenLabel mesh__D010952 Volume Expanders, Plasma
% 208.36/208.56  |- skos__altLabel mesh__D010952 Blood Expanders
% 208.36/208.56  |- skos__broader mesh__D010952smesh__D001802
% 208.36/208.56  |- mesh__dateCreated mesh__D010952 1999-01-01
% 208.36/208.56  |- skos__annotation mesh__D010952
% 208.36/208.56       do not confuse with BLOOD SUBSTITUTES which carry O2 to %26% CO2 from tissue; D25-26 qualif%A%  
% 208.36/208.56  |- mesh__recordOriginator mesh__D010952 NLM
% 208.36/208.56  |- mesh__recordMaintainer mesh__D010154 PLS
% 208.36/208.56  |- skos__prefLabel mesh__D010154 Pakistan
% 208.36/208.56  |- mesh__recordOriginator mesh__D010154 NLM
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D010154 1995
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D010154 2000
% 208.36/208.56  |- skos__broader mesh__D010154smesh__D001211
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D010154 2003
% 208.36/208.56  |- rdf__type mesh__D010154sskos__Concept
% 208.36/208.56  |- mesh__dateRevised mesh__D010154 1993-06-03
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D010154 2001
% 208.36/208.56  |- mesh__dateCreated mesh__D010154 1999-01-01
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D010154 2004
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D010154 2002
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D010154 1996
% 208.36/208.56  |- mesh__recordAuthorizer mesh__D010154 PLS
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D010154 2005
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D010154 1997
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D010154 2006
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D010154 1998
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D010154 1994
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D010154 1999
% 208.36/208.56  |- skos__hiddenLabel mesh__D004915 Leukemias, Acute Erythroblastic
% 208.36/208.56  |- mesh__recordMaintainer mesh__D004915 sjn
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D004915 2002
% 208.36/208.56  |- skos__historyNote mesh__D004915 Erythremic Myelosis %28%1966-1967%29%
% 208.36/208.56  |- skos__broader mesh__D004915smesh__D015470
% 208.36/208.56  |- mesh__dateCreated mesh__D004915 1999-01-01
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D004915 2003
% 208.36/208.56  |- mesh__recordAuthorizer mesh__D004915 sjn
% 208.36/208.56  |- skos__altLabel mesh__D004915 Myeloid Leukemia, Acute, M6
% 208.36/208.56  |- skos__hiddenLabel mesh__D004915 Myeloses, Erythremic
% 208.36/208.56  |- mesh__dateEstablished mesh__D004915 1973-01-01
% 208.36/208.56  |- skos__altLabel mesh__D004915 Erythroblastic Leukemia, Acute
% 208.36/208.56  |- rdf__type mesh__D004915sskos__Concept
% 208.36/208.56  |- mesh__onlineNote mesh__D004915
% 208.36/208.56       use LEUKEMIA, ERYTHROBLASTIC, ACUTE to search ERYTHROLEUKEMIA 1973-88 %28%as Prov 1968-72%29% %26% ERYTHREMIC MYELOSIS 1966-83%A%  
% 208.36/208.56  |- skos__hiddenLabel mesh__D004915 Di Guglielmos Disease
% 208.36/208.56  |- skos__annotation mesh__D004915
% 208.36/208.56       do not use /blood supply /chem /second /secret /ultrastruct; Friend erythroleukemia cells: coord IM with FRIEND MURINE LEUKEMIA VIRUS %28%IM%29% + TUMOR CELLS, CULTURED %28%NIM%29%%A%  
% 208.36/208.56  |- skos__altLabel mesh__D004915 Di Guglielmo Disease
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D004915 2006
% 208.36/208.56  |- skos__scopeNote mesh__D004915
% 208.36/208.56       A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.%A%    
% 208.36/208.56  |- skos__hiddenLabel mesh__D004915 Myelosis, Erythremic
% 208.36/208.56  |- skos__hiddenLabel mesh__D004915 Disease, Di Guglielmo
% 208.36/208.56  |- skos__hiddenLabel mesh__D004915 Acute Erythroblastic Leukemias
% 208.36/208.56  |- skos__altLabel mesh__D004915 Erythroleukemia
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D004915 2005
% 208.36/208.56  |- mesh__publicMeSHNote mesh__D004915
% 208.36/208.56       89; ERYTHROLEUKEMIA was heading 1973-88; ERYTHREMIC MYELOSIS was heading 1963-83%A%  
% 208.36/208.56  |- skos__altLabel mesh__D004915 Leukemia, Myeloid, Acute, M6
% 208.36/208.56  |- mesh__historyNote mesh__D004915
% 208.36/208.56       89; ERYTHROLEUKEMIA was heading 1973-88 %28%Prov 1968-72%29%; ERYTHREMIC MYELOSIS was heading 1963-83%A%  
% 208.36/208.56  |- skos__hiddenLabel mesh__D004915 Disease, Di Guglielmo%27%s
% 208.36/208.56  |- skos__hiddenLabel mesh__D004915 Erythroblastic Leukemias, Acute
% 208.36/208.56  |- skos__hiddenLabel mesh__D004915 Leukemia, Acute Erythroblastic
% 208.36/208.56  |- mesh__recordOriginator mesh__D004915 NLM
% 208.36/208.56  |- skos__hiddenLabel mesh__D004915 Erythremic Myeloses
% 208.36/208.56  |- skos__prefLabel mesh__D004915 Leukemia, Erythroblastic, Acute
% 208.36/208.56  |- skos__altLabel mesh__D004915 Di Guglielmo%27%s Disease
% 208.36/208.56  |- skos__hiddenLabel mesh__D004915 Acute Erythroblastic Leukemia
% 208.36/208.56  |- skos__hiddenLabel mesh__D004915 Erythroleukemias
% 208.36/208.56  |- skos__broader mesh__D004915smesh__D009196
% 208.36/208.56  |- skos__altLabel mesh__D004915 Erythremic Myelosis
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D004915 2004
% 208.36/208.56  |- mesh__dateRevised mesh__D004915 2001-08-03
% 208.36/208.56  |- mesh__dateCreated mesh__D004117 1999-01-01
% 208.36/208.56  |- mesh__publicMeSHNote mesh__D004117 74   
% 208.36/208.56  |- skos__scopeNote mesh__D004117
% 208.36/208.56       An organothiophosphorus cholinesterase inhibitor that is used as a systemic and contact insecticide.%A%    
% 208.36/208.56  |- mesh__recordAuthorizer mesh__D004117 sjn
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D004117 2006
% 208.36/208.56  |- mesh__dateRevised mesh__D004117 2005-06-30
% 208.36/208.56  |- skos__hiddenLabel mesh__D004117 Bi 58
% 208.36/208.56  |- skos__altLabel mesh__D004117 Phosphamide
% 208.36/208.56  |- mesh__recordMaintainer mesh__D004117 ssb
% 208.36/208.56  |- skos__prefLabel mesh__D004117 Dimethoate
% 208.36/208.56  |- skos__hiddenLabel mesh__D004117 Bi58
% 208.36/208.56  |- skos__historyNote mesh__D004117 Insecticides %28%1966-1971%29%
% 208.36/208.56  |- skos__annotation mesh__D004117 TN 111 for eff on insects   
% 208.36/208.56  |- mesh__historyNote mesh__D004117 74%28%72%29%   
% 208.36/208.56  |- mesh__recordOriginator mesh__D004117 NLM
% 208.36/208.56  |- skos__broader mesh__D004117smesh__D009946
% 208.36/208.56  |- mesh__dateEstablished mesh__D004117 1974-01-01
% 208.36/208.56  |- rdf__type mesh__D004117sskos__Concept
% 208.36/208.56  |- mesh__dateCreated mesh__D009600 1974-11-11
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D009600 2001
% 208.36/208.56  |- mesh__recordOriginator mesh__D009600 NLM
% 208.36/208.56  |- skos__broader mesh__D009600smesh__D011804
% 208.36/208.56  |- mesh__recordAuthorizer mesh__D009600 PLS
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D009600 2005
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D009600 1995
% 208.36/208.56  |- mesh__dateEstablished mesh__D009600 1975-09-01
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D009600 2004
% 208.36/208.56  |- skos__scopeNote mesh__D009600
% 208.36/208.56       Quinolines substituted in any position by one or more nitro groups.%A%    
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D009600 2000
% 208.36/208.56  |- mesh__dateRevised mesh__D009600 1992-05-19
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D009600 1993
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D009600 1994
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D009600 2003
% 208.36/208.56  |- rdf__type mesh__D009600sskos__Concept
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D009600 1999
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D009600 2002
% 208.36/208.56  |- mesh__recordMaintainer mesh__D009600 TAP
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D009600 1998
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D009600 1997
% 208.36/208.56  |- mesh__historyNote mesh__D009600 75   
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D009600 1996
% 208.36/208.56  |- mesh__publicMeSHNote mesh__D009600 75   
% 208.36/208.56  |- skos__prefLabel mesh__D009600 Nitroquinolines
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D009600 2006
% 208.36/208.56  |- skos__historyNote mesh__D009600 Quinolines %28%1966-1974%29%
% 208.36/208.56  |- skos__broader mesh__D009600smesh__D009574
% 208.36/208.56  |- mesh__dateEstablished mesh__D020582 2000-01-01
% 208.36/208.56  |- skos__scopeNote mesh__D020582
% 208.36/208.56       A genus of rod-shaped, oval, or bean-shaped bacteria found in soil and fresh water. Polar prosthecae are present and cells reproduce by budding at the tips of the prosthecae. Cells of this genus are aerobic and grow best with one-carbon compounds. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 208.36/208.56  |- mesh__recordMaintainer mesh__D020582 SYSTEM
% 208.36/208.56  |- skos__historyNote mesh__D020582
% 208.36/208.56       Budding and Appendaged Bacteria %28%1998-1999%29%
% 208.36/208.56  |- mesh__recordAuthorizer mesh__D020582 sjn
% 208.36/208.56  |- skos__broader mesh__D020582smesh__D041921
% 208.36/208.56  |- mesh__dateCreated mesh__D020582 1999-11-03
% 208.36/208.56  |- skos__historyNote mesh__D020582 Bacteria %28%1966-1997%29%
% 208.36/208.56  |- mesh__publicMeSHNote mesh__D020582 2000   
% 208.36/208.56  |- skos__prefLabel mesh__D020582 Hyphomicrobium
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D020582 2006
% 208.36/208.56  |- mesh__historyNote mesh__D020582 2000   
% 208.36/208.56  |- rdf__type mesh__D020582sskos__Concept
% 208.36/208.56  |- mesh__recordOriginator mesh__D020582 ndw
% 208.36/208.56  |- mesh__dateRevised mesh__D020582 2005-06-30
% 208.36/208.56  |- skos__broader mesh__D014545smesh__D002137
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D014545 2004
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D014545 2002
% 208.36/208.56  |- skos__hiddenLabel mesh__D014545 Stones, Urinary
% 208.36/208.56  |- skos__broader mesh__D014545smesh__D014570
% 208.36/208.56  |- rdf__type mesh__D014545sskos__Concept
% 208.36/208.56  |- skos__hiddenLabel mesh__D014545 Calculus, Urinary
% 208.36/208.56  |- skos__annotation mesh__D014545
% 208.36/208.56       GEN or unspecified; consider BLADDER CALCULI; KIDNEY CALCULI; URETERAL CALCULI; chem composition of calculi: use /chem; /ultrastruct permitted%A%  
% 208.36/208.56  |- mesh__dateRevised mesh__D014545 2001-07-25
% 208.36/208.56  |- skos__hiddenLabel mesh__D014545 Urinary Tract Stone
% 208.36/208.56  |- skos__hiddenLabel mesh__D014545 Tract Stone, Urinary
% 208.36/208.56  |- mesh__recordOriginator mesh__D014545 NLM
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D014545 2003
% 208.36/208.56  |- skos__hiddenLabel mesh__D014545 Stone, Urinary
% 208.36/208.56  |- skos__hiddenLabel mesh__D014545 Urinary Calculus
% 208.36/208.56  |- mesh__onlineNote mesh__D014545
% 208.36/208.56       to search for chem composition of urinary calculi, use URINARY CALCULI/anal 1987-90 %26% URINARY CALCULI/metab 1966-86%A%  
% 208.36/208.56  |- skos__hiddenLabel mesh__D014545 Stone, Urinary Tract
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D014545 2006
% 208.36/208.56  |- skos__altLabel mesh__D014545 Urinary Tract Stones
% 208.36/208.56  |- skos__hiddenLabel mesh__D014545 Stones, Urinary Tract
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D014545 2005
% 208.36/208.56  |- skos__scopeNote mesh__D014545
% 208.36/208.56       Calculi in any part of the urinary tract. According to their composition or pattern of chemical composition distribution, urinary calculi types may include alternating or combination, cystine, decubitus, encysted, fibrin, hemp seed, matrix, mulberry, oxalate, struvite, urostealith, and xanthic calculi.%A%    
% 208.36/208.56  |- skos__prefLabel mesh__D014545 Urinary Calculi
% 208.36/208.56  |- mesh__dateCreated mesh__D014545 1999-01-01
% 208.36/208.56  |- skos__hiddenLabel mesh__D014545 Calculi, Urinary
% 208.36/208.56  |- skos__altLabel mesh__D014545 Urinary Stones
% 208.36/208.56  |- mesh__recordMaintainer mesh__D014545 mdb
% 208.36/208.56  |- skos__hiddenLabel mesh__D014545 Tract Stones, Urinary
% 208.36/208.56  |- mesh__recordAuthorizer mesh__D014545 sjn
% 208.36/208.56  |- skos__hiddenLabel mesh__D014545 Urinary Stone
% 208.36/208.56  |- mesh__recordMaintainer mesh__D008508 jls
% 208.36/208.56  |- mesh__recordOriginator mesh__D008508 NLM
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D008508 2001
% 208.36/208.56  |- mesh__dateRevised mesh__D008508 1999-11-03
% 208.36/208.56  |- skos__annotation mesh__D008508
% 208.36/208.56       IM; coord with specific dis /drug ther %28%IM%29% %26% specific drug /ther use %28%IM%29%; DF: MEDICATION ERR%A%  
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D008508 2000
% 208.36/208.56  |- skos__scopeNote mesh__D008508
% 208.36/208.56       Errors in prescribing, dispensing, or administering medication with the result that the patient fails to receive the correct drug or the indicated proper drug dosage.%A%    
% 208.36/208.56  |- skos__broader mesh__D008508smesh__D019300
% 208.36/208.56  |- skos__hiddenLabel mesh__D008508 Error, Medication
% 208.36/208.56  |- skos__broader mesh__D008508smesh__D004358
% 208.36/208.56  |- mesh__dateEstablished mesh__D008508 1967-01-01
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D008508 2004
% 208.36/208.56  |- skos__prefLabel mesh__D008508 Medication Errors
% 208.36/208.56  |- mesh__publicMeSHNote mesh__D008508 67   
% 208.36/208.56  |- skos__altLabel mesh__D008508 Errors, Medication
% 208.36/208.56  |- mesh__historyNote mesh__D008508 67%28%66%29%   
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D008508 2003
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D008508 2006
% 208.36/208.56  |- rdf__type mesh__D008508sskos__Concept
% 208.36/208.56  |- skos__hiddenLabel mesh__D008508 Medication Error
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D008508 2002
% 208.36/208.56  |- mesh__dateCreated mesh__D008508 1999-01-01
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D008508 2005
% 208.36/208.56  |- mesh__recordAuthorizer mesh__D008508 sjn
% 208.36/208.56  |- skos__hiddenLabel mesh__D000525 Alprazolam Orion Brand
% 208.36/208.56  |- mesh__historyNote mesh__D000525 87   
% 208.36/208.56  |- skos__altLabel mesh__D000525 Nu-Pharm Brand of Alprazolam
% 208.36/208.56  |- skos__altLabel mesh__D000525 Alphapharm Brand of Alprazolam
% 208.36/208.56  |- mesh__recordAuthorizer mesh__D000525 sjn
% 208.36/208.56  |- skos__hiddenLabel mesh__D000525 NuAlpraz
% 208.36/208.56  |- skos__altLabel mesh__D000525 Esparon
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D000525 2004
% 208.36/208.56  |- skos__altLabel mesh__D000525 Temmler Brand of Alprazolam
% 208.36/208.56  |- skos__historyNote mesh__D000525 Benzazepines %28%1968-1973%29%
% 208.36/208.56  |- skos__historyNote mesh__D000525 Benzodiazepines %28%1975-1986%29%
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D000525 2005
% 208.36/208.56  |- skos__altLabel mesh__D000525 Kenral Brand of Alprazolam
% 208.36/208.56  |- skos__hiddenLabel mesh__D000525 D65MT
% 208.36/208.56  |- skos__altLabel mesh__D000525
% 208.36/208.56       Arzneimittelwerk Dresden Brand of Alprazolam
% 208.36/208.56  |- skos__altLabel mesh__D000525 Pharmacia Brand of Alprazolam
% 208.36/208.56  |- mesh__dateEstablished mesh__D000525 1987-01-01
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D000525 2006
% 208.36/208.56  |- skos__altLabel mesh__D000525 Apotex Brand of Alprazolam
% 208.36/208.56  |- skos__altLabel mesh__D000525 Novopharm Brand of Alprazolam
% 208.36/208.56  |- skos__hiddenLabel mesh__D000525 Alprazolam Pharmacia Brand
% 208.36/208.56  |- skos__hiddenLabel mesh__D000525 U31,889
% 208.36/208.56  |- skos__hiddenLabel mesh__D000525 ApoAlpraz
% 208.36/208.56  |- skos__hiddenLabel mesh__D000525 Alprazolam Alphapharm Brand
% 208.36/208.56  |- skos__hiddenLabel mesh__D000525 Apo Alpraz
% 208.36/208.56  |- mesh__recordOriginator mesh__D000525 RLS
% 208.36/208.56  |- skos__broader mesh__D000525smesh__D001569
% 208.36/208.56  |- skos__altLabel mesh__D000525 Upjohn Brand of Alprazolam
% 208.36/208.56  |- skos__hiddenLabel mesh__D000525 Alprazolam Temmler Brand
% 208.36/208.56  |- mesh__publicMeSHNote mesh__D000525 87   
% 208.36/208.56  |- skos__hiddenLabel mesh__D000525 Alprazolam Nu-Pharm Brand
% 208.36/208.56  |- mesh__dateCreated mesh__D000525 1986-06-16
% 208.36/208.56  |- skos__hiddenLabel mesh__D000525 Nu Pharm Brand of Alprazolam
% 208.36/208.56  |- skos__hiddenLabel mesh__D000525 Alprazolam Upjohn Brand
% 208.36/208.56  |- skos__hiddenLabel mesh__D000525 Nu Alpraz
% 208.36/208.56  |- skos__historyNote mesh__D000525 Azepines %28%1966-1967%29%
% 208.36/208.56  |- skos__hiddenLabel mesh__D000525 Novo Alprazol
% 208.36/208.56  |- skos__altLabel mesh__D000525 Orion Brand of Alprazolam
% 208.36/208.56  |- skos__hiddenLabel mesh__D000525 Alprazolam Novopharm Brand
% 208.36/208.56  |- skos__altLabel mesh__D000525 Trankimazin
% 208.36/208.56  |- skos__prefLabel mesh__D000525 Alprazolam
% 208.36/208.56  |- skos__hiddenLabel mesh__D000525 Alprazolam Apotex Brand
% 208.36/208.56  |- skos__altLabel mesh__D000525 Tafil
% 208.36/208.56  |- rdf__type mesh__D000525sskos__Concept
% 208.36/208.56  |- mesh__recordMaintainer mesh__D000525 ssb
% 208.36/208.56  |- skos__hiddenLabel mesh__D000525 NovoAlprazol
% 208.36/208.56  |- skos__altLabel mesh__D000525 Alprazolan
% 208.36/208.56  |- skos__scopeNote mesh__D000525
% 208.36/208.56       A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. %28%From AMA Drug Evaluations Annual, 1994, p238%29%%A%    
% 208.36/208.56  |- mesh__dateRevised mesh__D000525 2003-07-09
% 208.36/208.56  |- skos__hiddenLabel mesh__D000525 Alprazolam Kenral Brand
% 208.36/208.56  |- skos__altLabel mesh__D019230 Audit, Dental
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D019230 1999
% 208.36/208.56  |- skos__historyNote mesh__D019230 Medical Audit %28%1980-1996%29%
% 208.36/208.56  |- skos__prefLabel mesh__D019230 Dental Audit
% 208.36/208.56  |- mesh__dateCreated mesh__D019230 1996-06-10
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D019230 2004
% 208.36/208.56  |- skos__broader mesh__D019230smesh__D011787
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D019230 1998
% 208.36/208.56  |- skos__scopeNote mesh__D019230
% 208.36/208.56       A detailed review and evaluation of selected clinical records by qualified professional personnel for evaluating quality of dental care.%A%    
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D019230 2002
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D019230 2003
% 208.36/208.56  |- mesh__historyNote mesh__D019230 97   
% 208.36/208.56  |- skos__altLabel mesh__D019230 Audits, Dental
% 208.36/208.56  |- skos__annotation mesh__D019230 DF: DENT AUDIT   
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D019230 2006
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D019230 1997
% 208.36/208.56  |- mesh__publicMeSHNote mesh__D019230 97   
% 208.36/208.56  |- skos__broader mesh__D019230smesh__D011785
% 208.36/208.56  |- rdf__type mesh__D019230sskos__Concept
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D019230 2001
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D019230 2005
% 208.36/208.56  |- mesh__dateEstablished mesh__D019230 1997-01-01
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D019230 2000
% 208.36/208.56  |- skos__altLabel mesh__D019230 Dental Audits
% 208.36/208.56  |- skos__annotation mesh__D005210
% 208.36/208.56       infection = FASCIOLIASIS %26% do not bother to coord with FASCIOLA HEPATICA unless particularly discussed %28%index IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D005210 2004
% 208.36/208.56  |- mesh__dateRevised mesh__D005210 2003-07-09
% 208.36/208.56  |- skos__altLabel mesh__D005210 Liver Fluke
% 208.36/208.56  |- skos__scopeNote mesh__D005210
% 208.36/208.56       A species of helminth commonly called the sheep liver fluke. It occurs in the biliary passages, liver, and gallbladder during various stages of development. Snails and aquatic vegetation are the intermediate hosts. Occasionally seen in man, it is most common in sheep and cattle.%A%    
% 208.36/208.56  |- mesh__recordMaintainer mesh__D005210 ags
% 208.36/208.56  |- skos__prefLabel mesh__D005210 Fasciola hepatica
% 208.36/208.56  |- rdf__type mesh__D005210sskos__Concept
% 208.36/208.56  |- mesh__recordOriginator mesh__D005210 NLM
% 208.36/208.56  |- mesh__recordAuthorizer mesh__D005210 sjn
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D005210 2006
% 208.36/208.56  |- mesh__dateCreated mesh__D005210 1999-01-01
% 208.36/208.56  |- skos__broader mesh__D005210smesh__D005209
% 208.36/208.56  |- mesh__activeMeSHYear mesh__D005210 2005
% 208.36/208.57  |- skos__scopeNote mesh__D018936
% 208.36/208.57       Antigens of the virions of HEPACIVIRUS, their surface, core, or other associated antigens.%A%    
% 208.36/208.57  |- skos__prefLabel mesh__D018936 Hepatitis C Antigens
% 208.36/208.57  |- mesh__dateRevised mesh__D018936 2005-06-30
% 208.36/208.57  |- skos__broader mesh__D018936smesh__D018963
% 208.36/208.57  |- mesh__recordAuthorizer mesh__D018936 sjn
% 208.36/208.57  |- mesh__onlineNote mesh__D018936
% 208.36/208.57       use HEPATITIS C ANTIGENS %28%NM%29% to search HEPATITIS NON-A, NON-B ANTIGEN 1984-95%A%  
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D018936 2006
% 208.36/208.57  |- skos__historyNote mesh__D018936 Antigens, Viral %28%1984-1995%29%
% 208.36/208.57  |- mesh__publicMeSHNote mesh__D018936
% 208.36/208.57       96; HEPATITIS NON-A, NON-B ANTIGEN was indexed under ANTIGENS, VIRAL 1984-95%A%  
% 208.36/208.57  |- mesh__recordMaintainer mesh__D018936 ssb
% 208.36/208.57  |- mesh__dateEstablished mesh__D018936 1996-01-01
% 208.36/208.57  |- mesh__dateCreated mesh__D018936 1995-02-17
% 208.36/208.57  |- skos__hiddenLabel mesh__D018936 Hepatitis Non A, Non B Antigen
% 208.36/208.57  |- mesh__recordOriginator mesh__D018936 AGS
% 208.36/208.57  |- skos__altLabel mesh__D018936 Hepatitis C Antigen
% 208.36/208.57  |- mesh__historyNote mesh__D018936
% 208.36/208.57       96; was HEPATITIS NON-A, NON-B ANTIGEN %28%NM%29% 1984-95   
% 208.36/208.57  |- rdf__type mesh__D018936sskos__Concept
% 208.36/208.57  |- mesh__recordMaintainer mesh__D010953 nns
% 208.36/208.57  |- mesh__dateEstablished mesh__D010953 1970-01-01
% 208.36/208.57  |- skos__broader mesh__D010953smesh__D001810
% 208.36/208.57  |- rdf__type mesh__D010953sskos__Concept
% 208.36/208.57  |- skos__altLabel mesh__D010953 Blood Plasma Volume
% 208.36/208.57  |- skos__hiddenLabel mesh__D010953 Blood Plasma Volumes
% 208.36/208.57  |- skos__hiddenLabel mesh__D010953 Volume, Plasma
% 208.36/208.57  |- skos__hiddenLabel mesh__D010953 Volume, Blood Plasma
% 208.36/208.57  |- mesh__dateRevised mesh__D010953 2003-07-09
% 208.36/208.57  |- mesh__publicMeSHNote mesh__D010953 70   
% 208.36/208.57  |- mesh__recordOriginator mesh__D010953 NLM
% 208.36/208.57  |- skos__prefLabel mesh__D010953 Plasma Volume
% 208.36/208.57  |- mesh__dateCreated mesh__D010953 1999-01-01
% 208.36/208.57  |- skos__scopeNote mesh__D010953
% 208.36/208.57       Volume of PLASMA in the circulation. It is usually measured by INDICATOR DILUTION TECHNIQUES.%A%    
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D010953 2004
% 208.36/208.57  |- mesh__historyNote mesh__D010953 70%28%66%29%   
% 208.36/208.57  |- skos__related mesh__D010953smesh__D018495
% 208.36/208.57  |- skos__hiddenLabel mesh__D010953 Volumes, Plasma
% 208.36/208.57  |- skos__hiddenLabel mesh__D010953 Plasma Volumes
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D010953 2006
% 208.36/208.57  |- skos__hiddenLabel mesh__D010953 Volumes, Blood Plasma
% 208.36/208.57  |- skos__annotation mesh__D010953
% 208.36/208.57       coord IM with disease /physiopathol, not /blood   
% 208.36/208.57  |- mesh__recordAuthorizer mesh__D010953 sjn
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D010953 2005
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D018138 2005
% 208.36/208.57  |- mesh__recordAuthorizer mesh__D018138 ags
% 208.36/208.57  |- mesh__dateCreated mesh__D018138 1993-06-04
% 208.36/208.57  |- mesh__recordMaintainer mesh__D018138 ags
% 208.36/208.57  |- skos__broader mesh__D018138smesh__D006564
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D018138 2006
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D018138 2006A
% 208.36/208.57  |- rdf__type mesh__D018138sskos__Concept
% 208.36/208.57  |- skos__scopeNote mesh__D018138
% 208.36/208.57       A subfamily of HERPESVIRIDAE characterized by a short replication cycle. The genera include: SIMPLEXVIRUS; VARICELLOVIRUS; MAREK%27%S DISEASE-LIKE VIRUSES; and INFECTIOUS LARYNGOTRACHEITIS-LIKE VIRUSES.%A%    
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D018138 2003
% 208.36/208.57  |- skos__prefLabel mesh__D018138 Alphaherpesvirinae
% 208.36/208.57  |- mesh__publicMeSHNote mesh__D018138 94   
% 208.36/208.57  |- mesh__dateRevised mesh__D018138 2005-07-29
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D018138 2004
% 208.36/208.57  |- skos__historyNote mesh__D018138 Herpesviridae %28%1988-1993%29%
% 208.36/208.57  |- mesh__recordOriginator mesh__D018138 AGS
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D018138 2002
% 208.36/208.57  |- mesh__dateEstablished mesh__D018138 1994-01-01
% 208.36/208.57  |- skos__annotation mesh__D018138
% 208.36/208.57       infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29%   
% 208.36/208.57  |- mesh__historyNote mesh__D018138 94   
% 208.36/208.57  |- skos__historyNote mesh__D010155 Palate %28%1966-1972%29%
% 208.36/208.57  |- rdf__type mesh__D010155sskos__Concept
% 208.36/208.57  |- mesh__onlineNote mesh__D010155
% 208.36/208.57       use PALATAL EXPANSION TECHNIQUE to search PALATAL EXPANSION TECHNIC 1973-90%A%  
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D010155 2003
% 208.36/208.57  |- skos__hiddenLabel mesh__D010155 Palatal Expansion Techniques
% 208.36/208.57  |- mesh__recordAuthorizer mesh__D010155 sjn
% 208.36/208.57  |- mesh__dateRevised mesh__D010155 1999-11-03
% 208.36/208.57  |- mesh__dateCreated mesh__D010155 1999-01-01
% 208.36/208.57  |- skos__hiddenLabel mesh__D010155 Technique, Palatal Expansion
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D010155 2004
% 208.36/208.57  |- skos__altLabel mesh__D010155 Palatal Expansion Technic
% 208.36/208.57  |- skos__hiddenLabel mesh__D010155 Technic, Palatal Expansion
% 208.36/208.57  |- mesh__recordOriginator mesh__D010155 NLM
% 208.36/208.57  |- mesh__recordMaintainer mesh__D010155 kle
% 208.36/208.57  |- skos__hiddenLabel mesh__D010155 Expansion Technic, Palatal
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D010155 2000
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D010155 2005
% 208.36/208.57  |- mesh__dateEstablished mesh__D010155 1973-01-01
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D010155 2001
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D010155 2006
% 208.36/208.57  |- skos__hiddenLabel mesh__D010155 Expansion Technique, Palatal
% 208.36/208.57  |- skos__broader mesh__D010155smesh__D009971
% 208.36/208.57  |- skos__historyNote mesh__D010155
% 208.36/208.57       Orthodontics, Corrective %28%1966-1972%29%
% 208.36/208.57  |- skos__hiddenLabel mesh__D010155 Palatal Expansion Technics
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D010155 2002
% 208.36/208.57  |- skos__hiddenLabel mesh__D010155 Expansion Techniques, Palatal
% 208.36/208.57  |- mesh__historyNote mesh__D010155
% 208.36/208.57       91; was PALATAL EXPANSION TECHNIC 1973-90   
% 208.36/208.57  |- skos__prefLabel mesh__D010155 Palatal Expansion Technique
% 208.36/208.57  |- skos__hiddenLabel mesh__D010155 Expansion, Maxillary
% 208.36/208.57  |- mesh__publicMeSHNote mesh__D010155
% 208.36/208.57       91; was PALATAL EXPANSION TECHNIC 1973-90   
% 208.36/208.57  |- skos__scopeNote mesh__D010155
% 208.36/208.57       An orthodontic method used for correcting narrow or collapsed maxillary arches and functional cross-bite. %28%From Jablonski%27%s Dictionary of Dentistry%29%,%A%    
% 208.36/208.57  |- skos__hiddenLabel mesh__D010155 Expansion Technics, Palatal
% 208.36/208.57  |- skos__hiddenLabel mesh__D004916 Erythromelalgias
% 208.36/208.57  |- mesh__dateRevised mesh__D004916 1993-06-02
% 208.36/208.57  |- mesh__recordAuthorizer mesh__D004916 PLS
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004916 2001
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004916 2006
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004916 2000
% 208.36/208.57  |- mesh__recordMaintainer mesh__D004916 TAP
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004916 1995
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004916 2004
% 208.36/208.57  |- mesh__dateCreated mesh__D004916 1999-01-01
% 208.36/208.57  |- rdf__type mesh__D004916sskos__Concept
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004916 1999
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004916 2005
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004916 1994
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004916 1997
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004916 2003
% 208.36/208.57  |- skos__prefLabel mesh__D004916 Erythromelalgia
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004916 1998
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004916 2002
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004916 1996
% 208.36/208.57  |- skos__broader mesh__D004916smesh__D014652
% 208.36/208.57  |- skos__annotation mesh__D004916 painful burning %26% redness of limbs   
% 208.36/208.57  |- skos__altLabel mesh__D004916 Erythermalgia
% 208.36/208.57  |- skos__scopeNote mesh__D004916
% 208.36/208.57       Disease marked by paroxysmal, bilateral vasodilatation, particularly of the extremities, with burning pain, and increased skin temperature and redness.%A%    
% 208.36/208.57  |- skos__hiddenLabel mesh__D004916 Erythermalgias
% 208.36/208.57  |- mesh__recordOriginator mesh__D004916 NLM
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004118 2000
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004118 1997
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004118 2004
% 208.36/208.57  |- mesh__recordMaintainer mesh__D004118 TGC
% 208.36/208.57  |- mesh__onlineNote mesh__D004118 search PHENETHYLAMINES 1968-74   
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004118 1996
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004118 1999
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004118 2003
% 208.36/208.57  |- mesh__dateEstablished mesh__D004118 1991-01-01
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004118 2006
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004118 1998
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004118 1993
% 208.36/208.57  |- skos__prefLabel mesh__D004118 Dimethoxyphenylethylamine
% 208.36/208.57  |- mesh__historyNote mesh__D004118
% 208.36/208.57       91%28%75%29%; was see under PHENETHYLAMINES 1975-90   
% 208.36/208.57  |- mesh__dateRevised mesh__D004118 1992-05-13
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004118 2005
% 208.36/208.57  |- mesh__recordOriginator mesh__D004118 NLM
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004118 1995
% 208.36/208.57  |- mesh__publicMeSHNote mesh__D004118
% 208.36/208.57       91; was see under PHENETHYLAMINES 1975-90   
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004118 2002
% 208.36/208.57  |- skos__broader mesh__D004118smesh__D010627
% 208.36/208.57  |- mesh__dateCreated mesh__D004118 1999-01-01
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004118 1994
% 208.36/208.57  |- rdf__type mesh__D004118sskos__Concept
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D004118 2001
% 208.36/208.57  |- mesh__recordAuthorizer mesh__D004118 PLS
% 208.36/208.57  |- mesh__publicMeSHNote mesh__D009601
% 208.36/208.57       91; was see under OXIDOREDUCTASES 1987-90   
% 208.36/208.57  |- skos__broader mesh__D009601smesh__D010088
% 208.36/208.57  |- mesh__dateRevised mesh__D009601 2005-06-30
% 208.36/208.57  |- rdf__type mesh__D009601sskos__Concept
% 208.36/208.57  |- skos__historyNote mesh__D009601 Oxidoreductases %28%1966-1986%29%
% 208.36/208.57  |- mesh__recordMaintainer mesh__D009601 jmp
% 208.36/208.57  |- mesh__historyNote mesh__D009601
% 208.36/208.57       91%28%87%29%; was see under OXIDOREDUCTASES 1987-90   
% 208.36/208.57  |- skos__prefLabel mesh__D009601 Nitroreductases
% 208.36/208.57  |- mesh__dateEstablished mesh__D009601 1991-01-01
% 208.36/208.57  |- skos__scopeNote mesh__D009601
% 208.36/208.57       Enzymes which reduce nitro groups %28%NITRO COMPOUNDS%29% and other nitrogenous compounds.%A%    
% 208.36/208.57  |- skos__altLabel mesh__D009601
% 208.36/208.57       Oxidoreductases Acting on other Nitrogenous Compounds as Donors
% 208.36/208.57  |- mesh__recordOriginator mesh__D009601 RLS
% 208.36/208.57  |- mesh__recordAuthorizer mesh__D009601 sjn
% 208.36/208.57  |- mesh__dateCreated mesh__D009601 1986-06-02
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D009601 2006
% 208.36/208.57  |- skos__annotation mesh__D009601 general; prefer specifics   
% 208.36/208.57  |- mesh__recordMaintainer mesh__D020583 SYSTEM
% 208.36/208.57  |- skos__broader mesh__D020583smesh__D016946
% 208.36/208.57  |- skos__scopeNote mesh__D020583
% 208.36/208.57       A genus of gram-negative, rod-shaped, obligate aerobes which are motile by peritrichous flagella on solid medium and one lateral flagellum in liquid medium. Under microaerobic conditions Azorhizobium fixes nitrogen. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 208.36/208.57  |- skos__prefLabel mesh__D020583 Azorhizobium
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D020583 2006
% 208.36/208.57  |- mesh__historyNote mesh__D020583 2000   
% 208.36/208.57  |- mesh__dateRevised mesh__D020583 2005-06-30
% 208.36/208.57  |- rdf__type mesh__D020583sskos__Concept
% 208.36/208.57  |- skos__historyNote mesh__D020583 Rhizobiaceae/genetics %28%1988-1996%29%
% 208.36/208.57  |- skos__historyNote mesh__D020583 Rhizobiaceae %28%1997-1999%29%
% 208.36/208.57  |- mesh__recordOriginator mesh__D020583 ndw
% 208.36/208.57  |- mesh__dateCreated mesh__D020583 1999-11-03
% 208.36/208.57  |- skos__broader mesh__D020583smesh__D041921
% 208.36/208.57  |- mesh__recordAuthorizer mesh__D020583 sjn
% 208.36/208.57  |- mesh__dateEstablished mesh__D020583 2000-01-01
% 208.36/208.57  |- mesh__publicMeSHNote mesh__D020583 2000   
% 208.36/208.57  |- rdf__type mesh__D014546sskos__Concept
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D014546 2002
% 208.36/208.57  |- mesh__recordOriginator mesh__D014546 NLM
% 208.36/208.57  |- mesh__recordMaintainer mesh__D014546 PXP
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D014546 2004
% 208.36/208.57  |- skos__altLabel mesh__D014546 Catheterization, Urinary
% 208.36/208.57  |- mesh__dateRevised mesh__D014546 1997-06-20
% 208.36/208.57  |- skos__hiddenLabel mesh__D014546 Catheterizations, Urinary
% 208.36/208.57  |- skos__annotation mesh__D014546
% 208.36/208.57       do not use /util except by MeSH definition; coord IM with specific site %28%NIM%29% if pertinent; DF: URINARY CATH%A%  
% 208.36/208.57  |- skos__hiddenLabel mesh__D014546 Urethral Catheterizations
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D014546 2003
% 208.36/208.57  |- mesh__recordAuthorizer mesh__D014546 SJN
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D014546 2001
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D014546 2006
% 208.36/208.57  |- skos__hiddenLabel mesh__D014546 Ureteral Catheterizations
% 208.36/208.57  |- mesh__dateCreated mesh__D014546 1999-01-01
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D014546 1999
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D014546 2000
% 208.36/208.57  |- skos__scopeNote mesh__D014546
% 208.36/208.57       Employment or passage of a catheter into the bladder %28%urethral c.%29% or kidney %28%ureteral c.%29% for therapeutic or diagnostic purposes.%A%    
% 208.36/208.57  |- skos__hiddenLabel mesh__D014546 Catheterizations, Ureteral
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D014546 2005
% 208.36/208.57  |- skos__broader mesh__D014546smesh__D002404
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D014546 1998
% 208.36/208.57  |- skos__hiddenLabel mesh__D014546 Urinary Catheterizations
% 208.36/208.57  |- skos__hiddenLabel mesh__D014546 Catheterizations, Urethral
% 208.36/208.57  |- skos__altLabel mesh__D014546 Urethral Catheterization
% 208.36/208.57  |- skos__altLabel mesh__D014546 Ureteral Catheterization
% 208.36/208.57  |- skos__prefLabel mesh__D014546 Urinary Catheterization
% 208.36/208.57  |- skos__broader mesh__D014546smesh__D003950
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D008509 1998
% 208.36/208.57  |- skos__hiddenLabel mesh__D008509 Medication System
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D008509 2002
% 208.36/208.57  |- mesh__dateRevised mesh__D008509 1996-06-10
% 208.36/208.57  |- skos__annotation mesh__D008509
% 208.36/208.57       an organizational concept in patient care for providing medication; do not confuse with DRUG DELIVERY SYSTEMS for admin of a drug to a patient or animal for %22%controlled delivery so that an optimum amount reaches the target site%22%; MEDICATION SYSTEMS, HOSPITAL is also available%A%  
% 208.36/208.57  |- mesh__recordOriginator mesh__D008509 NLM
% 208.36/208.57  |- skos__hiddenLabel mesh__D008509 Systems, Medication
% 208.36/208.57  |- mesh__recordAuthorizer mesh__D008509 PLS
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D008509 2001
% 208.36/208.57  |- skos__prefLabel mesh__D008509 Medication Systems
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D008509 2004
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D008509 2000
% 208.36/208.57  |- skos__broader mesh__D008509smesh__D009934
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D008509 2003
% 208.36/208.57  |- rdf__type mesh__D008509sskos__Concept
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D008509 2006
% 208.36/208.57  |- mesh__recordMaintainer mesh__D008509 TGC
% 208.36/208.57  |- mesh__dateEstablished mesh__D008509 1973-01-01
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D008509 1997
% 208.36/208.57  |- mesh__dateCreated mesh__D008509 1999-01-01
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D008509 2005
% 208.36/208.57  |- skos__hiddenLabel mesh__D008509 System, Medication
% 208.36/208.57  |- skos__scopeNote mesh__D008509
% 208.36/208.57       Overall systems, traditional or automated, to provide medication to patients.%A%    
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D008509 1999
% 208.36/208.57  |- mesh__publicMeSHNote mesh__D008509 73   
% 208.36/208.57  |- mesh__historyNote mesh__D008509 73   
% 208.36/208.57  |- skos__hiddenLabel mesh__D000526 H5628
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D000526 2006
% 208.36/208.57  |- skos__altLabel mesh__D000526 Astra Brand of Alprenolol Hydrochloride
% 208.36/208.57  |- mesh__dateRevised mesh__D000526 2005-06-30
% 208.36/208.57  |- skos__altLabel mesh__D000526 Alfeprol
% 208.36/208.57  |- skos__altLabel mesh__D000526
% 208.36/208.57       1-%28%o-Allylphenoxy%29%-3-%28%isopropylamino%29%-2-propanol
% 208.36/208.57  |- skos__broader mesh__D000526smesh__D011412
% 208.36/208.57  |- skos__scopeNote mesh__D000526
% 208.36/208.57       One of the ADRENERGIC BETA-ANTAGONISTS used as an antihypertensive, anti-anginal, and anti-arrhythmic agent.%A%    
% 208.36/208.57  |- skos__hiddenLabel mesh__D000526 Aptin Duriles
% 208.36/208.57  |- mesh__recordOriginator mesh__D000526 NLM
% 208.36/208.57  |- skos__historyNote mesh__D000526 Sympatholytics %28%1966-1971%29%
% 208.36/208.57  |- mesh__historyNote mesh__D000526 73%28%72%29%   
% 208.36/208.57  |- skos__prefLabel mesh__D000526 Alprenolol
% 208.36/208.57  |- skos__altLabel mesh__D000526 Aptin-Duriles
% 208.36/208.57  |- mesh__recordMaintainer mesh__D000526 ssb
% 208.36/208.57  |- mesh__publicMeSHNote mesh__D000526 73   
% 208.36/208.57  |- mesh__dateCreated mesh__D000526 1999-01-01
% 208.36/208.57  |- skos__hiddenLabel mesh__D000526 H 56 28
% 208.36/208.57  |- skos__altLabel mesh__D000526 Made Brand of Alprenolol Hydrochloride
% 208.36/208.57  |- skos__hiddenLabel mesh__D000526 AptinDuriles
% 208.36/208.57  |- mesh__recordAuthorizer mesh__D000526 sjn
% 208.36/208.57  |- rdf__type mesh__D000526sskos__Concept
% 208.36/208.57  |- skos__historyNote mesh__D000526 Amino Alcohols %28%1966-1971%29%
% 208.36/208.57  |- skos__altLabel mesh__D000526 Astra Brand of Alprenolol Benzoate
% 208.36/208.57  |- mesh__dateEstablished mesh__D000526 1973-01-01
% 208.36/208.57  |- skos__broader mesh__D000526smesh__D050198
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D019231 1999
% 208.36/208.57  |- skos__hiddenLabel mesh__D019231 Prosthodontic Tooth Preparations
% 208.36/208.57  |- skos__hiddenLabel mesh__D019231 Preparations, Prosthodontic Tooth
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D019231 2004
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D019231 2001
% 208.36/208.57  |- skos__annotation mesh__D019231
% 208.36/208.57       restrict to prep procedures for prostheses; DENTAL CAVITY PREPARATION %28%for fillings %26% inlays%29% %26% ROOT CANAL PREPARATION are also available%A%  
% 208.36/208.57  |- skos__hiddenLabel mesh__D019231 Preparation, Prosthodontic Tooth
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D019231 2002
% 208.36/208.57  |- mesh__historyNote mesh__D019231 97   
% 208.36/208.57  |- skos__related mesh__D019231smesh__D003737
% 208.36/208.57  |- skos__historyNote mesh__D019231
% 208.36/208.57       Dental Cavity Preparation %28%1966-1996%29%
% 208.36/208.57  |- skos__prefLabel mesh__D019231 Tooth Preparation, Prosthodontic
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D019231 2005
% 208.36/208.57  |- mesh__dateEstablished mesh__D019231 1997-01-01
% 208.36/208.57  |- mesh__dateCreated mesh__D019231 1996-06-10
% 208.36/208.57  |- skos__hiddenLabel mesh__D019231 Tooth Preparations, Prosthodontic
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D019231 2006
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D019231 1997
% 208.36/208.57  |- rdf__type mesh__D019231sskos__Concept
% 208.36/208.57  |- skos__broader mesh__D019231smesh__D019246
% 208.36/208.57  |- skos__historyNote mesh__D019231
% 208.36/208.57       specific dental procedure %28%1966-1996%29%
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D019231 1998
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D019231 2000
% 208.36/208.57  |- skos__hiddenLabel mesh__D019231 Prosthodontic Tooth Preparation
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D019231 2003
% 208.36/208.57  |- mesh__publicMeSHNote mesh__D019231 97   
% 208.36/208.57  |- skos__scopeNote mesh__D019231
% 208.36/208.57       The selected form given to a natural tooth when it is reduced by instrumentation to receive a prosthesis %28%e.g., artificial crown or a retainer for a fixed or removable prosthesis%29%. The selection of the form is guided by clinical circumstances and physical properties of the materials that make up the prosthesis. %28%Boucher%27%s Clinical Dental Terminology, 4th ed, p239%29%%A%    
% 208.36/208.57  |- skos__broader mesh__D005211smesh__D014201
% 208.36/208.57  |- mesh__recordMaintainer mesh__D005211 lkt
% 208.36/208.57  |- skos__prefLabel mesh__D005211 Fascioliasis
% 208.36/208.57  |- rdf__type mesh__D005211sskos__Concept
% 208.36/208.57  |- mesh__dateRevised mesh__D005211 2004-07-07
% 208.36/208.57  |- skos__annotation mesh__D005211
% 208.36/208.57       do not confuse with FASCIOLOIDIASIS %28%caused by Fascioloides%29% or FASCIOLOPSIASIS %28%caused by Fasciolopsis%29%%A%  
% 208.36/208.57  |- skos__hiddenLabel mesh__D005211 Fascioliases
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D005211 2006
% 208.36/208.57  |- mesh__dateCreated mesh__D005211 1999-01-01
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D005211 2005
% 208.36/208.57  |- skos__broader mesh__D005211smesh__D008109
% 208.36/208.57  |- mesh__recordAuthorizer mesh__D005211 sjn
% 208.36/208.57  |- mesh__recordOriginator mesh__D005211 NLM
% 208.36/208.57  |- skos__scopeNote mesh__D005211
% 208.36/208.57       Liver disease caused by infections with parasitic flukes of the genus FASCIOLA, such as FASCIOLA HEPATICA.%A%    
% 208.36/208.57  |- mesh__recordMaintainer mesh__D046628 ags
% 208.36/208.57  |- rdf__type mesh__D046628sskos__Concept
% 208.36/208.57  |- skos__broader mesh__D046628smesh__D001657
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D046628 2006
% 208.36/208.57  |- skos__historyNote mesh__D046628
% 208.36/208.57       Sphincter of Oddi/pathophysiology %28%1974-2004%29%
% 208.36/208.57  |- skos__scopeNote mesh__D046628
% 208.36/208.57       Organic or functional motility disorder involving the SPHINCTER OF ODDI and associated with biliary COLIC. Pathological changes are most often seen in the COMMON BILE DUCT sphincter, and less commonly the PANCREATIC DUCT sphincter.%A%    
% 208.36/208.57  |- skos__historyNote mesh__D046628
% 208.36/208.57       Common Bile Duct Diseases %28%1985-2004%29%
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D046628 2005
% 208.36/208.57  |- mesh__recordOriginator mesh__D046628 ags
% 208.36/208.57  |- mesh__publicMeSHNote mesh__D046628 2005   
% 208.36/208.57  |- mesh__dateEstablished mesh__D046628 2005-01-01
% 208.36/208.57  |- mesh__recordAuthorizer mesh__D046628 sjn
% 208.36/208.57  |- skos__prefLabel mesh__D046628 Sphincter of Oddi Dysfunction
% 208.36/208.57  |- mesh__dateCreated mesh__D046628 2004-07-07
% 208.36/208.57  |- mesh__historyNote mesh__D046628 2005   
% 208.36/208.57  |- mesh__publicMeSHNote mesh__D018937
% 208.36/208.57       96; HEPATITIS C VIRUS ANTIBODIES was indexed under HEPATITIS ANTIBODIES 1992-95%A%  
% 208.36/208.57  |- mesh__recordOriginator mesh__D018937 AGS
% 208.36/208.57  |- mesh__historyNote mesh__D018937
% 208.36/208.57       96; was HEPATITIS C VIRUS ANTIBODIES %28%NM%29% 1992-95   
% 208.36/208.57  |- mesh__onlineNote mesh__D018937
% 208.36/208.57       use HEPATITIS C ANTIBODIES %28%NM%29% to search HEPATITIS C VIRUS ANTIBODIES 1992-95%A%  
% 208.36/208.57  |- skos__hiddenLabel mesh__D018937 Anti HCV Antibodies
% 208.36/208.57  |- mesh__dateCreated mesh__D018937 1995-02-17
% 208.36/208.57  |- skos__broader mesh__D018937smesh__D006508
% 208.36/208.57  |- skos__altLabel mesh__D018937 Hepatitis C Virus Antibodies
% 208.36/208.57  |- mesh__dateRevised mesh__D018937 2005-06-30
% 208.36/208.57  |- skos__altLabel mesh__D018937 HCV Antibodies
% 208.36/208.57  |- rdf__type mesh__D018937sskos__Concept
% 208.36/208.57  |- mesh__recordAuthorizer mesh__D018937 sjn
% 208.36/208.57  |- skos__altLabel mesh__D018937 Anti-Hepatitis C Virus Antibodies
% 208.36/208.57  |- skos__historyNote mesh__D018937 Hepatitis Antibodies %28%1992-1995%29%
% 208.36/208.57  |- skos__altLabel mesh__D018937 Anti-HCV Antibodies
% 208.36/208.57  |- skos__hiddenLabel mesh__D018937 Anti Hepatitis C Virus Antibodies
% 208.36/208.57  |- skos__scopeNote mesh__D018937
% 208.36/208.57       Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins.%A%    
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D018937 2006
% 208.36/208.57  |- skos__prefLabel mesh__D018937 Hepatitis C Antibodies
% 208.36/208.57  |- mesh__dateEstablished mesh__D018937 1996-01-01
% 208.36/208.57  |- mesh__recordMaintainer mesh__D018937 ssb
% 208.36/208.57  |- skos__scopeNote mesh__D010954
% 208.36/208.57       Any discrete, presumably solitary, mass of neoplastic plasma cells either in bone marrow or various extramedullary sites.%A%    
% 208.36/208.57  |- mesh__recordAuthorizer mesh__D010954 SJN
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D010954 1999
% 208.36/208.57  |- skos__prefLabel mesh__D010954 Plasmacytoma
% 208.36/208.57  |- mesh__recordMaintainer mesh__D010954 TGC
% 208.36/208.57  |- skos__hiddenLabel mesh__D010954 Plasma Cell Tumors
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D010954 2002
% 208.36/208.57  |- mesh__dateCreated mesh__D010954 1999-01-01
% 208.36/208.57  |- skos__hiddenLabel mesh__D010954 Plasmacytomas
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D010954 1998
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D010954 2004
% 208.36/208.57  |- mesh__dateEstablished mesh__D010954 1965-01-01
% 208.36/208.57  |- mesh__publicMeSHNote mesh__D010954 65; was PLASMOCYTOMA 1963-64   
% 208.36/208.57  |- skos__annotation mesh__D010954
% 208.36/208.57       solitary = PLASMACYTOMA; multiple = MULTIPLE MYELOMA; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D010954 2001
% 208.36/208.57  |- skos__hiddenLabel mesh__D010954 Tumors, Plasma Cell
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D010954 2006
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D010954 2003
% 208.36/208.57  |- skos__altLabel mesh__D010954 Plasma Cell Tumor
% 208.36/208.57  |- mesh__historyNote mesh__D010954 65; was PLASMOCYTOMA 1963-64   
% 208.36/208.57  |- mesh__recordOriginator mesh__D010954 NLM
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D010954 2000
% 208.36/208.57  |- skos__hiddenLabel mesh__D010954 Tumor, Plasma Cell
% 208.36/208.57  |- skos__hiddenLabel mesh__D010954 Plasmocytomas
% 208.36/208.57  |- mesh__dateRevised mesh__D010954 1997-06-20
% 208.36/208.57  |- skos__broader mesh__D010954smesh__D008223
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D010954 2005
% 208.36/208.57  |- skos__altLabel mesh__D010954 Plasmocytoma
% 208.36/208.57  |- rdf__type mesh__D010954sskos__Concept
% 208.36/208.57  |- skos__altLabel mesh__D018139 Herpesvirus 1, Saimirine
% 208.36/208.57  |- skos__hiddenLabel mesh__D018139 Herpes-T Viruses
% 208.36/208.57  |- skos__hiddenLabel mesh__D018139 Simplexviruses
% 208.36/208.57  |- skos__hiddenLabel mesh__D018139 Saimirine Herpesvirus 1
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D018139 2003
% 208.36/208.57  |- skos__altLabel mesh__D018139 Herpesvirus papio 2
% 208.36/208.57  |- skos__broader mesh__D018139smesh__D018138
% 208.36/208.57  |- mesh__recordOriginator mesh__D018139 AGS
% 208.36/208.57  |- skos__scopeNote mesh__D018139
% 208.36/208.57       A genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE, consisting of herpes simplex-like viruses. The type species is HERPESVIRUS 1, HUMAN.%A%    
% 208.36/208.57  |- skos__altLabel mesh__D018139 Cercopithecine herpesvirus 16
% 208.36/208.57  |- mesh__dateCreated mesh__D018139 1993-06-04
% 208.36/208.57  |- skos__hiddenLabel mesh__D018139 Herpes labialis Viruses
% 208.36/208.57  |- skos__hiddenLabel mesh__D018139 Marmoset Herpesviruses
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D018139 2006
% 208.36/208.57  |- skos__altLabel mesh__D018139 Herpes-T Virus
% 208.36/208.57  |- skos__hiddenLabel mesh__D018139 Herpes Simplex Viruses
% 208.36/208.57  |- skos__altLabel mesh__D018139 Marmoset Virus
% 208.36/208.57  |- skos__altLabel mesh__D018139 Herpes labialis Virus
% 208.36/208.57  |- mesh__recordAuthorizer mesh__D018139 sjn
% 208.36/208.57  |- rdf__type mesh__D018139sskos__Concept
% 208.36/208.57  |- mesh__onlineNote mesh__D018139
% 208.36/208.57       use SIMPLEXVIRUS to search FEVER BLISTER VIRUS 1976-93, MARMOSET VIRUS, HERPES-T VIRUS, %26% HERPESVIRUS PLATYRHINAE 1975-93, and HERPES SIMPLEX VIRUS %26% HERPESVIRUS HOMINIS 1966-93%A%  
% 208.36/208.57  |- mesh__activeMeSHYear mesh__D018139 2005
% 208.36/208.57  |- skos__annotation mesh__D018139
% 208.36/208.57       note X ref HERPES SIMPLEX VIRUS: HERPES SIMPLEX VIRUS 1 and HERPES SIMPLEX VIRUS 2 are also available; do not confuse X ref HERPESVIRUS 1, SAIMIRINE with HERPESVIRUS 2, SAIMIRINE; infection = HERPES SIMPLEX or its indentions%A%  
% 208.36/208.57  |- skos__altLabel mesh__D018139 Saimiriine herpesvirus 1
% 208.36/208.57  |- skos__altLabel mesh__D018139 Herpesvirus 1 %28%alpha%29%, Saimirine
% 208.36/208.57  |- skos__altLabel mesh__D018139 Herpesvirus platyrhinae
% 208.36/208.57  |- skos__hiddenLabel mesh__D018139 Marmoset Viruses
% 208.36/208.57  |- skos__hiddenLabel mesh__D018139 Herpesviruses, Marmoset
% 208.36/208.58  |- mesh__historyNote mesh__D018139
% 208.36/208.58       94; MARMOSET VIRUS was heading 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%; HERPESVIRUS HOMINIS was heading 1963-93; HERPES-T VIRUS %26% HERPESVIRUS PLATYRHINAE were see MARMOSET VIRUS 1975-93; FEVER BLISTER VIRUS was see HERPESVIRUS HOMINIS 1976-93; HERPES SIMPLEX VIRUS was see HERPESVIRUS HOMINIS 1963-93%A%  
% 208.36/208.58  |- mesh__recordMaintainer mesh__D018139 mdb
% 208.36/208.58  |- skos__hiddenLabel mesh__D018139 Herpesvirus, Marmoset
% 208.36/208.58  |- mesh__dateEstablished mesh__D018139 1994-01-01
% 208.36/208.58  |- skos__prefLabel mesh__D018139 Simplexvirus
% 208.36/208.58  |- skos__hiddenLabel mesh__D018139 Herpes T Virus
% 208.36/208.58  |- skos__altLabel mesh__D018139 Marmoset Herpesvirus
% 208.36/208.58  |- mesh__dateRevised mesh__D018139 2002-07-03
% 208.36/208.58  |- skos__altLabel mesh__D018139 Herpesvirus hominis
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D018139 2004
% 208.36/208.58  |- skos__altLabel mesh__D018139 Herpes Simplex Virus
% 208.36/208.58  |- mesh__publicMeSHNote mesh__D018139
% 208.36/208.58       94; MARMOSET VIRUS was heading 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%; HERPESVIRUS HOMINIS was heading 1963-93; HERPES-T VIRUS %26% HERPESVIRUS PLATYRHINAE were see MARMOSET VIRUS 1975-93; FEVER BLISTER VIRUS was see HERPESVIRUS HOMINIS 1976-93; HERPES SIMPLEX VIRUS was see HERPESVIRUS HOMINIS 1963-93;%A%  
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D010156 2005
% 208.36/208.58  |- mesh__dateCreated mesh__D010156 1978-05-19
% 208.36/208.58  |- skos__prefLabel mesh__D010156 Palatal Muscles
% 208.36/208.58  |- skos__broader mesh__D010156smesh__D018482
% 208.36/208.58  |- skos__hiddenLabel mesh__D010156 Palatal Muscle
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D010156 2006
% 208.36/208.58  |- skos__historyNote mesh__D010156 Muscles %28%1966-1978%29%
% 208.36/208.58  |- skos__hiddenLabel mesh__D010156 Muscles, Palatal
% 208.36/208.58  |- mesh__recordMaintainer mesh__D010156 lkt
% 208.36/208.58  |- mesh__dateRevised mesh__D010156 2003-07-09
% 208.36/208.58  |- skos__scopeNote mesh__D010156
% 208.36/208.58       The muscles of the palate are the glossopalatine, palatoglossus, levator palati%28%ni%29%, musculus uvulae, palatopharyngeus, and tensor palati%28%ni%29%.%A%    
% 208.36/208.58  |- mesh__recordOriginator mesh__D010156 RC
% 208.36/208.58  |- mesh__publicMeSHNote mesh__D010156 91; was see under MUSCLES 1979-90   
% 208.36/208.58  |- skos__broader mesh__D010156smesh__D010159
% 208.36/208.58  |- mesh__historyNote mesh__D010156
% 208.36/208.58       91%28%79%29%; was see under MUSCLES 1979-90   
% 208.36/208.58  |- mesh__recordAuthorizer mesh__D010156 sjn
% 208.36/208.58  |- skos__annotation mesh__D010156
% 208.36/208.58       /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 208.36/208.58  |- skos__hiddenLabel mesh__D010156 Muscle, Palatal
% 208.36/208.58  |- rdf__type mesh__D010156sskos__Concept
% 208.36/208.58  |- skos__historyNote mesh__D010156 Palate %28%1966-1978%29%
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D010156 2004
% 208.36/208.58  |- mesh__dateEstablished mesh__D010156 1991-01-01
% 208.36/208.58  |- skos__hiddenLabel mesh__D004917 TStat
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D004917 2006
% 208.36/208.58  |- skos__hiddenLabel mesh__D004917 Phosphate, Erythromycin
% 208.36/208.58  |- skos__altLabel mesh__D004917 Erythromycin A
% 208.36/208.58  |- mesh__recordOriginator mesh__D004917 NLM
% 208.36/208.58  |- mesh__dateCreated mesh__D004917 1999-01-01
% 208.36/208.58  |- skos__hiddenLabel mesh__D004917 Lactate, Erythromycin
% 208.36/208.58  |- rdf__type mesh__D004917sskos__Concept
% 208.36/208.58  |- mesh__recordAuthorizer mesh__D004917 sjn
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D004917 2005
% 208.36/208.58  |- skos__hiddenLabel mesh__D004917 C, Erythromycin
% 208.36/208.58  |- skos__prefLabel mesh__D004917 Erythromycin
% 208.36/208.58  |- skos__hiddenLabel mesh__D004917 T Stat
% 208.36/208.58  |- mesh__dateRevised mesh__D004917 2004-07-07
% 208.36/208.58  |- mesh__recordMaintainer mesh__D004917 ssb
% 208.36/208.58  |- skos__scopeNote mesh__D004917
% 208.36/208.58       A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.%A%    
% 208.36/208.58  |- skos__broader mesh__D004917smesh__D018942
% 208.36/208.58  |- skos__altLabel mesh__D004119 Dimethyl Adipinamidate
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D004119 2004
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D004119 2001
% 208.36/208.58  |- mesh__recordAuthorizer mesh__D004119 sjn
% 208.36/208.58  |- mesh__historyNote mesh__D004119
% 208.36/208.58       91%28%78%29%; was see under IMIDOESTERS 1980-90; was see under IMIDES 1978-79%A%  
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D004119 2003
% 208.36/208.58  |- mesh__dateEstablished mesh__D004119 1991-01-01
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D004119 2006
% 208.36/208.58  |- skos__broader mesh__D004119smesh__D000272
% 208.36/208.58  |- skos__prefLabel mesh__D004119 Dimethyl Adipimidate
% 208.36/208.58  |- skos__hiddenLabel mesh__D004119 Adipimate, Dimethyl
% 208.36/208.58  |- skos__historyNote mesh__D004119 Imides %28%1966-1977%29%
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D004119 2005
% 208.36/208.58  |- skos__altLabel mesh__D004119 Dimethyl Adipimate
% 208.36/208.58  |- mesh__publicMeSHNote mesh__D004119
% 208.36/208.58       91; was see under IMIDOESTERS 1980-90; was see under IMIDES 1978-79%A%  
% 208.36/208.58  |- skos__hiddenLabel mesh__D004119 Adipinamidate, Dimethyl
% 208.36/208.58  |- mesh__dateRevised mesh__D004119 2000-06-21
% 208.36/208.58  |- mesh__recordMaintainer mesh__D004119 CCR
% 208.36/208.58  |- skos__broader mesh__D004119smesh__D007096
% 208.36/208.58  |- skos__historyNote mesh__D004119 Adipic Acids %28%1966-1977%29%
% 208.36/208.58  |- mesh__dateCreated mesh__D004119 1977-04-22
% 208.36/208.58  |- rdf__type mesh__D004119sskos__Concept
% 208.36/208.58  |- mesh__recordOriginator mesh__D004119 SH
% 208.36/208.58  |- skos__annotation mesh__D004119 D25-26 qualif   
% 208.36/208.58  |- skos__hiddenLabel mesh__D004119 Adipimidate, Dimethyl
% 208.36/208.58  |- skos__scopeNote mesh__D004119
% 208.36/208.58       Bifunctional cross-linking agent that links covalently free amino groups of proteins or polypeptides, including those in cell membranes. It is used as reagent or fixative in immunohistochemistry and is a proposed antisickling agent.%A%    
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D004119 2002
% 208.36/208.58  |- mesh__recordAuthorizer mesh__D009602 sjn
% 208.36/208.58  |- skos__scopeNote mesh__D009602
% 208.36/208.58       A class of compounds that contain a -NH2 and a -NO radical. Many members of this group have carcinogenic and mutagenic properties.%A%    
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D009602 2002
% 208.36/208.58  |- mesh__dateCreated mesh__D009602 1999-01-01
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D009602 2006
% 208.36/208.58  |- skos__broader mesh__D009602smesh__D009603
% 208.36/208.58  |- mesh__dateRevised mesh__D009602 1999-11-03
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D009602 2005
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D009602 2004
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D009602 2001
% 208.36/208.58  |- mesh__recordMaintainer mesh__D009602 adp
% 208.36/208.58  |- mesh__recordOriginator mesh__D009602 NLM
% 208.36/208.58  |- skos__annotation mesh__D009602 carcinogens   
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D009602 2003
% 208.36/208.58  |- rdf__type mesh__D009602sskos__Concept
% 208.36/208.58  |- skos__prefLabel mesh__D009602 Nitrosamines
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D009602 2000
% 208.36/208.58  |- mesh__recordAuthorizer mesh__D020584 sjn
% 208.36/208.58  |- mesh__publicMeSHNote mesh__D020584 2000   
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D020584 2006
% 208.36/208.58  |- mesh__historyNote mesh__D020584 2000   
% 208.36/208.58  |- rdf__type mesh__D020584sskos__Concept
% 208.36/208.58  |- skos__broader mesh__D020584smesh__D016946
% 208.36/208.58  |- skos__prefLabel mesh__D020584 Xanthobacter
% 208.36/208.58  |- mesh__recordOriginator mesh__D020584 ndw
% 208.36/208.58  |- skos__scopeNote mesh__D020584
% 208.36/208.58       A genus of gram-negative, aerobic, rod-shaped bacteria found in wet soil containing decaying organic material and in water. Cells tend to be pleomorphic if grown on media containing succinate or coccoid if grown in the presence of an alcohol as the sole carbon source. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 208.36/208.58  |- mesh__dateRevised mesh__D020584 2005-06-30
% 208.36/208.58  |- mesh__dateEstablished mesh__D020584 2000-01-01
% 208.36/208.58  |- mesh__recordMaintainer mesh__D020584 SYSTEM
% 208.36/208.58  |- skos__historyNote mesh__D020584
% 208.36/208.58       Gram-Negative Aerobic Bacteria %28%1985-1999%29%
% 208.36/208.58  |- mesh__dateCreated mesh__D020584 1999-11-03
% 208.36/208.58  |- skos__broader mesh__D020584smesh__D041921
% 208.36/208.58  |- skos__scopeNote mesh__D014547
% 208.36/208.58       Temporary or permanent diversion of the flow of urine through the ureter away from the bladder in the presence of a bladder disease or after cystectomy. There is a variety of techniques: direct anastomosis of ureter and bowel, cutaneous ureterostomy, ileal, jejunal or colon conduit, ureterosigmoidostomy, etc. %28%From Campbell%27%s Urology, 6th ed, p2654%29%%A%    
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D014547 2002
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D014547 2004
% 208.36/208.58  |- mesh__recordMaintainer mesh__D014547 PXP
% 208.36/208.58  |- skos__prefLabel mesh__D014547 Urinary Diversion
% 208.36/208.58  |- mesh__dateRevised mesh__D014547 1997-06-20
% 208.36/208.58  |- skos__hiddenLabel mesh__D014547 Conduit, Ileal
% 208.36/208.58  |- mesh__dateCreated mesh__D014547 1999-01-01
% 208.36/208.58  |- skos__broader mesh__D014547smesh__D013520
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D014547 2005
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D014547 1998
% 208.36/208.58  |- skos__hiddenLabel mesh__D014547 Conduits, Ileal
% 208.36/208.58  |- mesh__recordAuthorizer mesh__D014547 SJN
% 208.36/208.58  |- mesh__recordOriginator mesh__D014547 NLM
% 208.36/208.58  |- skos__annotation mesh__D014547
% 208.36/208.58       GEN or unspecified; note specifics in tree; if not in tree, coord IM with organ /surg %28%NIM%29%; TN 189: do not coord with URETER; Manual 26.17.1; do not use /util except by MeSH defintion%A%  
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D014547 2006
% 208.36/208.58  |- skos__hiddenLabel mesh__D014547 Diversions, Urinary
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D014547 1999
% 208.36/208.58  |- skos__hiddenLabel mesh__D014547 Diversion, Urinary
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D014547 2000
% 208.36/208.58  |- skos__hiddenLabel mesh__D014547 Urinary Diversions
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D014547 2001
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D014547 2003
% 208.36/208.58  |- skos__hiddenLabel mesh__D014547 Ileal Conduits
% 208.36/208.58  |- rdf__type mesh__D014547sskos__Concept
% 208.36/208.58  |- mesh__dateEstablished mesh__D033701 2003-01-01
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D033701 2006A
% 208.36/208.58  |- skos__annotation mesh__D033701 GEN only; prefer specifics   
% 208.36/208.58  |- mesh__recordOriginator mesh__D033701 jmp
% 208.36/208.58  |- skos__prefLabel mesh__D033701
% 208.36/208.58       Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins
% 208.36/208.58  |- skos__scopeNote mesh__D033701
% 208.36/208.58       A broad class of proteins involved in the transport of nucleobases, NUCLEOSIDES; NUCLEOTIDES; and NUCLEIC ACIDS; across membranes.%A%    
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D033701 2006
% 208.36/208.58  |- mesh__dateRevised mesh__D033701 2005-07-21
% 208.36/208.58  |- mesh__recordAuthorizer mesh__D033701 ags
% 208.36/208.58  |- mesh__historyNote mesh__D033701 2003   
% 208.36/208.58  |- mesh__publicMeSHNote mesh__D033701 2003   
% 208.36/208.58  |- rdf__type mesh__D033701sskos__Concept
% 208.36/208.58  |- mesh__recordMaintainer mesh__D033701 ags
% 208.36/208.58  |- mesh__dateCreated mesh__D033701 2002-07-03
% 208.36/208.58  |- skos__broader mesh__D033701smesh__D026901
% 208.36/208.58  |- skos__hiddenLabel mesh__D000527 Lipo PGE1
% 208.36/208.58  |- mesh__dateRevised mesh__D000527 2005-06-30
% 208.36/208.58  |- skos__altLabel mesh__D000527 Prostavasin
% 208.36/208.58  |- skos__altLabel mesh__D000527 PGE1alpha
% 208.36/208.58  |- skos__historyNote mesh__D000527 Prostaglandins %28%1966-1974%29%
% 208.36/208.58  |- skos__annotation mesh__D000527
% 208.36/208.58       /biosyn /physiol permitted; DF: note short X ref   
% 208.36/208.58  |- skos__broader mesh__D000527smesh__D005229
% 208.36/208.58  |- skos__altLabel mesh__D000527 Viridal
% 208.36/208.58  |- skos__prefLabel mesh__D000527 Alprostadil
% 208.36/208.58  |- skos__altLabel mesh__D000527 Sugiran
% 208.36/208.58  |- skos__altLabel mesh__D000527 Astra Brand of Alprostadil
% 208.36/208.58  |- skos__altLabel mesh__D000527 Prostaglandin E1alpha
% 208.36/208.58  |- skos__broader mesh__D000527smesh__D011458
% 208.36/208.58  |- mesh__recordMaintainer mesh__D000527 lkw
% 208.36/208.58  |- skos__altLabel mesh__D000527 Pharmacia Brand 2 of Alprostadil
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D000527 2006
% 208.36/208.58  |- mesh__dateEstablished mesh__D000527 1986-01-01
% 208.36/208.58  |- skos__altLabel mesh__D000527 Hoyer Brand of Alprostadil
% 208.36/208.58  |- skos__altLabel mesh__D000527 AstraZeneca Brand of Alprostadil
% 208.36/208.58  |- skos__altLabel mesh__D000527 Vivus Brand of Alprostadil
% 208.36/208.58  |- mesh__historyNote mesh__D000527
% 208.36/208.58       86; see VASOPROSTAN %28%NM%29% 1995-97   
% 208.36/208.58  |- skos__altLabel mesh__D000527 Minprog
% 208.36/208.58  |- skos__altLabel mesh__D000527 Prostaglandin E1
% 208.36/208.58  |- mesh__recordOriginator mesh__D000527 RLS
% 208.36/208.58  |- skos__altLabel mesh__D000527 Abbott Brand of Alprostadil
% 208.36/208.58  |- skos__altLabel mesh__D000527 Janssen Brand of Alprostadil
% 208.36/208.58  |- skos__historyNote mesh__D000527 Prostaglandins E %28%1975-1985%29%
% 208.36/208.58  |- skos__altLabel mesh__D000527 Muse
% 208.36/208.58  |- mesh__dateCreated mesh__D000527 1985-03-08
% 208.36/208.58  |- skos__altLabel mesh__D000527 Schwarz Brand of Alprostadil
% 208.36/208.58  |- skos__altLabel mesh__D000527 Paladin Brand of Alprostadil
% 208.36/208.58  |- skos__altLabel mesh__D000527 Prostine VR
% 208.36/208.58  |- rdf__type mesh__D000527sskos__Concept
% 208.36/208.58  |- skos__altLabel mesh__D000527 PGE1
% 208.36/208.58  |- skos__altLabel mesh__D000527 Lipo-PGE1
% 208.36/208.58  |- skos__altLabel mesh__D000527 Allphar Brand of Alprostadil
% 208.36/208.58  |- mesh__publicMeSHNote mesh__D000527
% 208.36/208.58       86; VASOPROSTAN %28%now ALPROSTADIL%29% was indexed under VASODILATOR AGENTS 1995-97%A%  
% 208.36/208.58  |- mesh__recordAuthorizer mesh__D000527 sjn
% 208.36/208.58  |- skos__altLabel mesh__D000527 Pharmacia Brand 1 of Alprostadil
% 208.36/208.58  |- skos__scopeNote mesh__D000527
% 208.36/208.58       A potent vasodilator agent that increases peripheral blood flow. It inhibits platelet aggregation and has many other biological effects such as bronchodilation, mediation of inflammation, etc.%A%    
% 208.36/208.58  |- skos__prefLabel mesh__D019232 Dental Restoration Failure
% 208.36/208.58  |- skos__broader mesh__D019232smesh__D003814
% 208.36/208.58  |- skos__broader mesh__D019232smesh__D017266
% 208.36/208.58  |- skos__annotation mesh__D019232
% 208.36/208.58       failure of a filling, inlay, crown, bridge, implant, any type of denture, etc.; coord IM with specific type of dent restoration or prosthesis %28%IM%29%; DF: DENT RESTORATION FAILURE%A%  
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D019232 2000
% 208.36/208.58  |- skos__scopeNote mesh__D019232
% 208.36/208.58       Inability or inadequacy of a dental restoration or prosthesis to perform as expected.%A%    
% 208.36/208.58  |- mesh__historyNote mesh__D019232 97   
% 208.36/208.58  |- skos__altLabel mesh__D019232 Failure, Dental Prosthesis
% 208.36/208.58  |- mesh__publicMeSHNote mesh__D019232 97   
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D019232 2005
% 208.36/208.58  |- skos__altLabel mesh__D019232 Dental Prosthesis Failures
% 208.36/208.58  |- skos__altLabel mesh__D019232 Prosthesis Failure, Dental
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D019232 2001
% 208.36/208.58  |- skos__altLabel mesh__D019232 Dental Restoration Failures
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D019232 2006
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D019232 1997
% 208.36/208.58  |- skos__altLabel mesh__D019232 Prosthesis Failures, Dental
% 208.36/208.58  |- skos__altLabel mesh__D019232 Failure, Dental Restoration
% 208.36/208.58  |- rdf__type mesh__D019232sskos__Concept
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D019232 2002
% 208.36/208.58  |- mesh__dateEstablished mesh__D019232 1997-01-01
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D019232 1998
% 208.36/208.58  |- mesh__dateCreated mesh__D019232 1996-06-10
% 208.36/208.58  |- skos__altLabel mesh__D019232 Failures, Dental Restoration
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D019232 2003
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D019232 1999
% 208.36/208.58  |- skos__altLabel mesh__D019232 Restoration Failures, Dental
% 208.36/208.58  |- skos__altLabel mesh__D019232 Failures, Dental Prosthesis
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D019232 2004
% 208.36/208.58  |- skos__altLabel mesh__D019232 Restoration Failure, Dental
% 208.36/208.58  |- skos__historyNote mesh__D005212 Trematoda %28%1966-1981%29%
% 208.36/208.58  |- mesh__publicMeSHNote mesh__D005212
% 208.36/208.58       82; FASCIOLOPSIS was heading 1963-81   
% 208.36/208.58  |- mesh__recordAuthorizer mesh__D005212 sjn
% 208.36/208.58  |- rdf__type mesh__D005212sskos__Concept
% 208.36/208.58  |- skos__prefLabel mesh__D005212 Fasciolidae
% 208.36/208.58  |- skos__broader mesh__D005212smesh__D014200
% 208.36/208.58  |- skos__annotation mesh__D005212
% 208.36/208.58       a family of trematodes; infection: coord IM with TREMATODE INFECTIONS %28%IM%29% but note specific FASCIOL- disease terms; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 208.36/208.58  |- skos__scopeNote mesh__D005212
% 208.36/208.58       A family of flukes of the class Trematoda occurring primarily in the liver of animals and man. There are six genera: Fasciola, Fasciolopsis, Fascioloides, Tenuifasciola, Parafasciolopsis, and Protofasciola. The adult form of Fasciolopsis occurs in the intestines of pigs and man.%A%    
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D005212 2005
% 208.36/208.58  |- mesh__dateCreated mesh__D005212 1981-05-15
% 208.36/208.58  |- mesh__dateEstablished mesh__D005212 1982-01-01
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D005212 2006
% 208.36/208.58  |- mesh__recordOriginator mesh__D005212 EC
% 208.36/208.58  |- mesh__historyNote mesh__D005212 82; FASCIOLOPSIS was heading 1963-81   
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D005212 2004
% 208.36/208.58  |- mesh__onlineNote mesh__D005212
% 208.36/208.58       use FASCIOLIDAE to search FASCIOLOPSIS 1966-80   
% 208.36/208.58  |- mesh__recordMaintainer mesh__D005212 ags
% 208.36/208.58  |- mesh__dateRevised mesh__D005212 2003-07-09
% 208.36/208.58  |- skos__broader mesh__D018938smesh__D004847
% 208.36/208.58  |- mesh__recordMaintainer mesh__D018938 nns
% 208.36/208.58  |- skos__hiddenLabel mesh__D018938 Cell, Caco-2
% 208.36/208.58  |- skos__annotation mesh__D018938
% 208.36/208.58       Caco stands for adenoCArcinoma of the COlon; almost always NIM with no subheadings; check HUMAN; do not routinely add ADENOCARCINOMA or COLONIC NEOPLASMS%A%  
% 208.36/208.58  |- skos__hiddenLabel mesh__D018938 Cells, Caco-2
% 208.36/208.58  |- mesh__dateEstablished mesh__D018938 1996-01-01
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D018938 2004
% 208.36/208.58  |- skos__hiddenLabel mesh__D018938 Caco 2 Cells
% 208.36/208.58  |- skos__broader mesh__D018938smesh__D045744
% 208.36/208.58  |- rdf__type mesh__D018938sskos__Concept
% 208.36/208.58  |- mesh__historyNote mesh__D018938 96   
% 208.36/208.58  |- skos__historyNote mesh__D018938 Tumor Cells, Cultured %28%1988-1995%29%
% 208.36/208.58  |- mesh__dateCreated mesh__D018938 1995-05-24
% 208.36/208.58  |- skos__prefLabel mesh__D018938 Caco-2 Cells
% 208.36/208.58  |- mesh__dateRevised mesh__D018938 2003-07-09
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D018938 2006
% 208.36/208.58  |- mesh__publicMeSHNote mesh__D018938 96   
% 208.36/208.58  |- skos__historyNote mesh__D018938 Cell Line %28%1984-1995%29%
% 208.36/208.58  |- mesh__recordAuthorizer mesh__D018938 sjn
% 208.36/208.58  |- mesh__recordOriginator mesh__D018938 PXP
% 208.36/208.58  |- skos__hiddenLabel mesh__D018938 Caco-2 Cell
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D018938 2005
% 208.36/208.58  |- skos__scopeNote mesh__D018938
% 208.36/208.58       Human colonic ADENOCARCINOMA cells that are able to express differentiation features characteristic of mature intestinal cells, such as ENTEROCYTES. These cells are valuable in vitro tools for studies related to intestinal cell function and differentiation.%A%    
% 208.36/208.58  |- mesh__recordMaintainer mesh__D010955 ags
% 208.36/208.58  |- mesh__dateRevised mesh__D010955 2005-07-15
% 208.36/208.58  |- skos__hiddenLabel mesh__D010955 Phospholipids, Alkenyl Ether
% 208.36/208.58  |- skos__prefLabel mesh__D010955 Plasmalogens
% 208.36/208.58  |- skos__hiddenLabel mesh__D010955 Ether Phospholipids, Alkenyl
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D010955 2006A
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D010955 2004
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D010955 2005
% 208.36/208.58  |- skos__hiddenLabel mesh__D010955 Compounds, Phosphatidal
% 208.36/208.58  |- skos__scopeNote mesh__D010955
% 208.36/208.58       GLYCEROPHOSPHOLIPIDS in which one of the two acyl chains is attached to glycerol with an ether alkenyl linkage instead of an ester as with the other glycerophospholipids.%A%    
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D010955 2006
% 208.36/208.58  |- skos__annotation mesh__D010955
% 208.36/208.58       do not confuse X ref here with specific phosphatidyl compounds in MeSH%A%  
% 208.36/208.58  |- mesh__recordAuthorizer mesh__D010955 ags
% 208.36/208.58  |- skos__broader mesh__D010955smesh__D010742
% 208.36/208.58  |- mesh__dateCreated mesh__D010955 1999-01-01
% 208.36/208.58  |- rdf__type mesh__D010955sskos__Concept
% 208.36/208.58  |- mesh__recordOriginator mesh__D010955 NLM
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D010157 2002
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D010157 2005
% 208.36/208.58  |- mesh__dateRevised mesh__D010157 2000-06-22
% 208.36/208.58  |- skos__prefLabel mesh__D010157 Palatal Neoplasms
% 208.36/208.58  |- skos__annotation mesh__D010157
% 208.36/208.58       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%  
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D010157 2006
% 208.36/208.58  |- mesh__recordAuthorizer mesh__D010157 sjn
% 208.36/208.58  |- skos__broader mesh__D010157smesh__D009062
% 208.36/208.58  |- mesh__recordOriginator mesh__D010157 NLM
% 208.36/208.58  |- skos__broader mesh__D010157smesh__D007573
% 208.36/208.58  |- rdf__type mesh__D010157sskos__Concept
% 208.36/208.58  |- skos__hiddenLabel mesh__D010157 Palatal Neoplasm
% 208.36/208.58  |- mesh__dateCreated mesh__D010157 1999-01-01
% 208.36/208.58  |- skos__hiddenLabel mesh__D010157 Neoplasms, Palatal
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D010157 2003
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D010157 2001
% 208.36/208.58  |- mesh__recordMaintainer mesh__D010157 nns
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D010157 2004
% 208.36/208.58  |- skos__hiddenLabel mesh__D010157 Neoplasm, Palatal
% 208.36/208.58  |- skos__scopeNote mesh__D010157
% 208.36/208.58       Tumors or cancer of the PALATE, including those of the hard palate, soft palate and UVULA.%A%    
% 208.36/208.58  |- skos__historyNote mesh__D004918 Propionates %28%1974%29%
% 208.36/208.58  |- skos__prefLabel mesh__D004918 Erythromycin Estolate
% 208.36/208.58  |- mesh__recordMaintainer mesh__D004918 ssb
% 208.36/208.58  |- mesh__dateRevised mesh__D004918 2004-07-07
% 208.36/208.58  |- mesh__historyNote mesh__D004918
% 208.36/208.58       91%28%75%29%; was see under ERYTHROMYCIN 1975-90   
% 208.36/208.58  |- skos__historyNote mesh__D004918 Sodium Dodecyl Sulfate %28%1974%29%
% 208.36/208.58  |- mesh__dateEstablished mesh__D004918 1991-01-01
% 208.36/208.58  |- mesh__publicMeSHNote mesh__D004918
% 208.36/208.58       91; was see under ERYTHROMYCIN 1975-90   
% 208.36/208.58  |- skos__historyNote mesh__D004918 Erythromycin %28%1970-1974%29%
% 208.36/208.58  |- mesh__recordOriginator mesh__D004918 NLM
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D004918 2006
% 208.36/208.58  |- skos__altLabel mesh__D004918 Erythromycin Propionate Lauryl Sulfate
% 208.36/208.58  |- mesh__recordAuthorizer mesh__D004918 sjn
% 208.36/208.58  |- skos__altLabel mesh__D004918 Erythromycin Propionate Monododecyl Sulfate
% 208.36/208.58  |- skos__altLabel mesh__D004918 Erythromycin Propionate Dodecyl Sulfate
% 208.36/208.58  |- skos__scopeNote mesh__D004918
% 208.36/208.58       A macrolide antibiotic, produced by Streptomyces erythreus. It is the lauryl sulfate salt of the propionic ester of erythromycin. This erythromycin salt acts primarily as a bacteriostatic agent. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.%A%    
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D004918 2005
% 208.36/208.58  |- skos__hiddenLabel mesh__D004918 Estolate, Erythromycin
% 208.36/208.58  |- skos__broader mesh__D004918smesh__D004917
% 208.36/208.58  |- rdf__type mesh__D004918sskos__Concept
% 208.36/208.58  |- mesh__dateCreated mesh__D004918 1974-11-19
% 208.36/208.58  |- skos__broader mesh__D015640smesh__D015398
% 208.36/208.58  |- skos__broader mesh__D015640smesh__D002468
% 208.36/208.58  |- skos__historyNote mesh__D015640 Electrophysiology %28%1966-1989%29%
% 208.36/208.58  |- rdf__type mesh__D015640sskos__Concept
% 208.36/208.58  |- mesh__recordOriginator mesh__D015640 AGS
% 208.36/208.58  |- mesh__recordMaintainer mesh__D015640 AGS
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D015640 2003
% 208.36/208.58  |- skos__altLabel mesh__D015640 Gating, Ion Channel
% 208.36/208.58  |- mesh__dateRevised mesh__D015640 1996-06-10
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D015640 2005
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D015640 2000
% 208.36/208.58  |- skos__prefLabel mesh__D015640 Ion Channel Gating
% 208.36/208.58  |- mesh__historyNote mesh__D015640 90   
% 208.36/208.58  |- mesh__dateCreated mesh__D015640 1989-06-19
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D015640 2004
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D015640 2001
% 208.36/208.58  |- skos__scopeNote mesh__D015640
% 208.36/208.58       The opening and closing of ion channels due to a stimulus. The stimulus can be a change in membrane potential %28%voltage-gated%29%, drugs or chemical transmitters %28%ligand-gated%29%, or a mechanical deformation. Gating is thought to involve conformational changes of the ion channel which alters selective permeability.%A%    
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D015640 2006
% 208.36/208.58  |- skos__annotation mesh__D015640
% 208.36/208.58       %22%opening %26% closing of ion channels%22% after various types of stimulation; DF: GATING%A%  
% 208.36/208.58  |- skos__historyNote mesh__D015640 Electric Conductivity %28%1966-1989%29%
% 208.36/208.58  |- mesh__dateEstablished mesh__D015640 1990-01-01
% 208.36/208.58  |- skos__hiddenLabel mesh__D015640 Gatings, Ion Channel
% 208.36/208.58  |- mesh__publicMeSHNote mesh__D015640 90   
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D015640 1998
% 208.36/208.58  |- skos__historyNote mesh__D015640 Membrane Potentials %28%1966-1989%29%
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D015640 1997
% 208.36/208.58  |- mesh__recordAuthorizer mesh__D015640 PLS
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D015640 1999
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D015640 2002
% 208.36/208.58  |- skos__hiddenLabel mesh__D015640 Ion Channel Gatings
% 208.36/208.58  |- skos__historyNote mesh__D015640 Ion Channels %28%1979-1989%29%
% 208.36/208.58  |- skos__annotation mesh__D009603 DF: NITROSO CPDS   
% 208.36/208.58  |- skos__prefLabel mesh__D009603 Nitroso Compounds
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D009603 2000
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D009603 1996
% 208.36/208.58  |- mesh__dateCreated mesh__D009603 1999-01-01
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D009603 2006
% 208.36/208.58  |- skos__hiddenLabel mesh__D009603 Compounds, Nitroso
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D009603 1995
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D009603 2004
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D009603 2005
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D009603 2002
% 208.36/208.58  |- mesh__recordMaintainer mesh__D009603 TAP
% 208.36/208.58  |- mesh__dateRevised mesh__D009603 1992-05-19
% 208.36/208.58  |- mesh__activeMeSHYear mesh__D009603 1993
% 208.44/208.58  |- mesh__activeMeSHYear mesh__D009603 1994
% 208.44/208.58  |- rdf__type mesh__D009603sskos__Concept
% 208.44/208.58  |- mesh__activeMeSHYear mesh__D009603 2003
% 208.44/208.58  |- mesh__activeMeSHYear mesh__D009603 1999
% 208.44/208.58  |- skos__broader mesh__D009603smesh__D009930
% 208.44/208.58  |- mesh__activeMeSHYear mesh__D009603 2001
% 208.44/208.58  |- mesh__activeMeSHYear mesh__D009603 1997
% 208.44/208.58  |- mesh__activeMeSHYear mesh__D009603 1998
% 208.44/208.58  |- mesh__recordOriginator mesh__D009603 NLM
% 208.44/208.58  |- mesh__recordAuthorizer mesh__D009603 PLS
% 208.44/208.58  |- skos__hiddenLabel mesh__D001620 Thromboglobulin, beta-2
% 208.44/208.58  |- skos__broader mesh__D001620smesh__D018925
% 208.44/208.58  |- mesh__dateEstablished mesh__D001620 1987-01-01
% 208.44/208.58  |- mesh__recordOriginator mesh__D001620 RLS
% 208.44/208.58  |- skos__historyNote mesh__D001620 Beta Globulins %28%1966-1979%29%
% 208.44/208.58  |- mesh__dateCreated mesh__D001620 1979-05-23
% 208.44/208.58  |- mesh__dateRevised mesh__D001620 2005-06-30
% 208.44/208.58  |- skos__broader mesh__D001620smesh__D001779
% 208.44/208.58  |- skos__broader mesh__D001620smesh__D001609
% 208.44/208.58  |- rdf__type mesh__D001620sskos__Concept
% 208.44/208.58  |- mesh__historyNote mesh__D001620
% 208.44/208.58       87%28%80%29%; was see under BETA GLOBULINS 1980-86   
% 208.44/208.58  |- skos__hiddenLabel mesh__D001620 beta 2 Thromboglobulin
% 208.44/208.58  |- skos__hiddenLabel mesh__D001620 beta Thromboglobulin
% 208.44/208.59  |- skos__prefLabel mesh__D001620 beta-Thromboglobulin
% 208.44/208.59  |- skos__annotation mesh__D001620
% 208.44/208.59       /biosyn /physiol permitted; DF: BETA TG   
% 208.44/208.59  |- mesh__publicMeSHNote mesh__D001620
% 208.44/208.59       87; was see under BETA GLOBULINS 1980-86   
% 208.44/208.59  |- mesh__recordMaintainer mesh__D001620 ssb
% 208.44/208.59  |- mesh__recordAuthorizer mesh__D001620 sjn
% 208.44/208.59  |- skos__scopeNote mesh__D001620
% 208.44/208.59       A platelet-specific protein which is released when platelets aggregate. Elevated plasma levels have been reported after deep venous thrombosis, pre-eclampsia, myocardial infarction with mural thrombosis, and myeloproliferative disorders. Measurement of beta-thromboglobulin in biological fluids by radioimmunoassay is used for the diagnosis and assessment of progress of thromboembolic disorders.%A%    
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D001620 2006
% 208.44/208.59  |- mesh__recordMaintainer mesh__D020585 SYSTEM
% 208.44/208.59  |- mesh__publicMeSHNote mesh__D020585 2000   
% 208.44/208.59  |- mesh__historyNote mesh__D020585 2000   
% 208.44/208.59  |- skos__prefLabel mesh__D020585 Comamonas
% 208.44/208.59  |- rdf__type mesh__D020585sskos__Concept
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D020585 2006
% 208.44/208.59  |- skos__annotation mesh__D020585
% 208.44/208.59       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 208.44/208.59  |- mesh__recordOriginator mesh__D020585 ndw
% 208.44/208.59  |- mesh__dateRevised mesh__D020585 2005-06-30
% 208.44/208.59  |- mesh__dateEstablished mesh__D020585 2000-01-01
% 208.44/208.59  |- skos__broader mesh__D020585smesh__D042621
% 208.44/208.59  |- mesh__recordAuthorizer mesh__D020585 sjn
% 208.44/208.59  |- skos__scopeNote mesh__D020585
% 208.44/208.59       A genus of gram-negative, straight or slightly curved rods which are motile by polar flagella and which accumulate poly-beta-hydroxybutyrate within the cells.%A%    
% 208.44/208.59  |- mesh__dateCreated mesh__D020585 1999-11-03
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D014548 2001
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D014548 2005
% 208.44/208.59  |- skos__hiddenLabel mesh__D014548 Fistula, Urinary
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D014548 2002
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D014548 2006
% 208.44/208.59  |- mesh__recordAuthorizer mesh__D014548 sjn
% 208.44/208.59  |- mesh__dateRevised mesh__D014548 1999-11-08
% 208.44/208.59  |- mesh__recordOriginator mesh__D014548 NLM
% 208.44/208.59  |- skos__prefLabel mesh__D014548 Urinary Fistula
% 208.44/208.59  |- skos__hiddenLabel mesh__D014548 Fistulas, Urinary
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D014548 2003
% 208.44/208.59  |- skos__scopeNote mesh__D014548
% 208.44/208.59       An abnormal passage in any organ of the urinary tract or between urinary organs and other organs.%A%    
% 208.44/208.59  |- rdf__type mesh__D014548sskos__Concept
% 208.44/208.59  |- skos__annotation mesh__D014548
% 208.44/208.59       GEN or unspecified; coord IM with pre-coord urinary organ/diseases %28%IM%29%; fistula policy: Manual 23.19+; BLADDER FISTULA %26% VESICOVAGINAL FISTULA are available%A%  
% 208.44/208.59  |- mesh__recordMaintainer mesh__D014548 KEV
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D014548 2000
% 208.44/208.59  |- skos__hiddenLabel mesh__D014548 Urinary Fistulas
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D014548 2004
% 208.44/208.59  |- skos__broader mesh__D014548smesh__D014570
% 208.44/208.59  |- skos__broader mesh__D014548smesh__D005402
% 208.44/208.59  |- mesh__dateCreated mesh__D014548 1999-01-01
% 208.44/208.59  |- mesh__dateCreated mesh__D033702 2002-07-03
% 208.44/208.59  |- mesh__dateRevised mesh__D033702 2005-06-30
% 208.44/208.59  |- skos__scopeNote mesh__D033702
% 208.44/208.59       Proteins involved in the transport of nucleobases such as PYRIMIDINES and PURINES across membranes.%A%    
% 208.44/208.59  |- skos__broader mesh__D033702smesh__D033701
% 208.44/208.59  |- mesh__dateEstablished mesh__D033702 2003-01-01
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D033702 2006
% 208.44/208.59  |- skos__hiddenLabel mesh__D033702 Transport Proteins, Nucleobase
% 208.44/208.59  |- mesh__publicMeSHNote mesh__D033702 2003   
% 208.44/208.59  |- mesh__recordAuthorizer mesh__D033702 sjn
% 208.44/208.59  |- mesh__recordOriginator mesh__D033702 jmp
% 208.44/208.59  |- skos__prefLabel mesh__D033702 Nucleobase Transport Proteins
% 208.44/208.59  |- rdf__type mesh__D033702sskos__Concept
% 208.44/208.59  |- mesh__recordMaintainer mesh__D033702 SYSTEM
% 208.44/208.59  |- mesh__historyNote mesh__D033702 2003   
% 208.44/208.59  |- mesh__recordAuthorizer mesh__D019233 sjn
% 208.44/208.59  |- skos__broader mesh__D019233smesh__D013812
% 208.44/208.59  |- skos__prefLabel mesh__D019233 Retreatment
% 208.44/208.59  |- rdf__type mesh__D019233sskos__Concept
% 208.44/208.59  |- mesh__dateCreated mesh__D019233 1996-06-10
% 208.44/208.59  |- skos__related mesh__D019233smesh__D012086
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D019233 2003
% 208.44/208.59  |- mesh__recordMaintainer mesh__D019233 jls
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D019233 2004
% 208.44/208.59  |- mesh__publicMeSHNote mesh__D019233 97   
% 208.44/208.59  |- mesh__dateRevised mesh__D019233 2000-06-22
% 208.44/208.59  |- mesh__historyNote mesh__D019233 97   
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D019233 2001
% 208.44/208.59  |- mesh__recordOriginator mesh__D019233 TGC
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D019233 2005
% 208.44/208.59  |- mesh__dateEstablished mesh__D019233 1997-01-01
% 208.44/208.59  |- skos__hiddenLabel mesh__D019233 Retreatments
% 208.44/208.59  |- skos__annotation mesh__D019233
% 208.44/208.59       NIM; coord with specific type of ther %28%IM%29% + specific disease /ther %28%or other ther qualif%29% %28%IM%29%%A%  
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D019233 2002
% 208.44/208.59  |- skos__scopeNote mesh__D019233
% 208.44/208.59       The therapy of the same disease in a patient, with the same agent or procedure repeated after initial treatment, or with an additional or alternate measure or follow-up. It does not include therapy which requires more than one administration of a therapeutic agent or regimen. Retreatment is often used with reference to a different modality when the original one was inadequate, harmful, or unsuccessful.%A%    
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D019233 2006
% 208.44/208.59  |- skos__broader mesh__D000528smesh__D003904
% 208.44/208.59  |- mesh__publicMeSHNote mesh__D000528
% 208.44/208.59       91; see HYPHOMYCETES 1986-90, see MONILIALES 1975-85   
% 208.44/208.59  |- skos__annotation mesh__D000528
% 208.44/208.59       infection: coord IM with MYCOSES %28%IM%29% or specific mycosis %28%IM%29%%A%  
% 208.44/208.59  |- mesh__recordAuthorizer mesh__D000528 sjn
% 208.44/208.59  |- rdf__type mesh__D000528sskos__Concept
% 208.44/208.59  |- mesh__dateCreated mesh__D000528 1974-12-12
% 208.44/208.59  |- skos__scopeNote mesh__D000528
% 208.44/208.59       A mitosporic Loculoascomycetes fungal genus including several plant pathogens and at least one species which produces a highly phytotoxic antibiotic. Its teleomorph is Lewia.%A%    
% 208.44/208.59  |- mesh__dateRevised mesh__D000528 2005-06-30
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D000528 2006
% 208.44/208.59  |- mesh__historyNote mesh__D000528 91%28%75%29%   
% 208.44/208.59  |- mesh__dateEstablished mesh__D000528 1991-01-01
% 208.44/208.59  |- mesh__recordMaintainer mesh__D000528 SYSTEM
% 208.44/208.59  |- mesh__recordOriginator mesh__D000528 NLM
% 208.44/208.59  |- skos__prefLabel mesh__D000528 Alternaria
% 208.44/208.59  |- mesh__recordAuthorizer mesh__D011250 sjn
% 208.44/208.59  |- skos__prefLabel mesh__D011250 Pregnancy Complications, Hematologic
% 208.44/208.59  |- skos__altLabel mesh__D011250 Complications, Hematologic Pregnancy
% 208.44/208.59  |- mesh__recordMaintainer mesh__D011250 lkt
% 208.44/208.59  |- skos__hiddenLabel mesh__D011250 Hematologic Pregnancy Complication
% 208.44/208.59  |- skos__altLabel mesh__D011250 Hematologic Pregnancy Complications
% 208.44/208.59  |- mesh__dateRevised mesh__D011250 2005-06-30
% 208.44/208.59  |- skos__hiddenLabel mesh__D011250 Complications, Hematological Pregnancy
% 208.44/208.59  |- skos__altLabel mesh__D011250 Pregnancy Complications, Hematological
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D011250 2006
% 208.44/208.59  |- skos__scopeNote mesh__D011250
% 208.44/208.59       The co-occurrence of pregnancy and a blood disease %28%HEMATOLOGIC DISEASES%29% which involves BLOOD CELLS or COAGULATION FACTORS. The hematologic disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS.%A%    
% 208.44/208.59  |- skos__hiddenLabel mesh__D011250 Complication, Hematological Pregnancy
% 208.44/208.59  |- mesh__dateEstablished mesh__D011250 1964-01-01
% 208.44/208.59  |- mesh__publicMeSHNote mesh__D011250 64   
% 208.44/208.59  |- skos__annotation mesh__D011250
% 208.44/208.59       for disorders of formed elements or coagulation processes of blood in pregnancy, not for excess or deficiency of substances in the blood %28%as HYPOKALEMIA + PREGNANCY COMPLICATIONS not PREGNANCY COMPLICATIONS, HEMATOLOGIC%29%; coordinate IM with specific hematologic disease %28%IM%29%; check the tags FEMALE %26% PREGNANCY; hemorrhage during pregnancy goes under PREGNANCY COMPLICATIONS, CARDIOVASCULAR, not here; Manual 18.4.7; DF: PREGN COMPL HEMATOL%A%  
% 208.44/208.59  |- skos__hiddenLabel mesh__D011250 Pregnancies, Hematologic Complications
% 208.44/208.59  |- skos__hiddenLabel mesh__D011250 Pregnancy Complication, Hematological
% 208.44/208.59  |- skos__hiddenLabel mesh__D011250 Pregnancy Complication, Hematologic
% 208.44/208.59  |- skos__hiddenLabel mesh__D011250 Hematological Pregnancy Complication
% 208.44/208.59  |- skos__hiddenLabel mesh__D011250 Complication, Hematologic Pregnancy
% 208.44/208.59  |- mesh__recordOriginator mesh__D011250 NLM
% 208.44/208.59  |- mesh__dateCreated mesh__D011250 1999-01-01
% 208.44/208.59  |- skos__hiddenLabel mesh__D011250 Hematological Pregnancy Complications
% 208.44/208.59  |- skos__broader mesh__D011250smesh__D006402
% 208.44/208.59  |- rdf__type mesh__D011250sskos__Concept
% 208.44/208.59  |- mesh__historyNote mesh__D011250 64   
% 208.44/208.59  |- skos__broader mesh__D011250smesh__D011248
% 208.44/208.59  |- skos__altLabel mesh__D011250 Pregnancy, Hematologic Complications
% 208.44/208.59  |- mesh__dateCreated mesh__D005213 1999-01-01
% 208.44/208.59  |- rdf__type mesh__D005213sskos__Concept
% 208.44/208.59  |- skos__broader mesh__D005213smesh__D006374
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D005213 2005
% 208.44/208.59  |- mesh__dateRevised mesh__D005213 2003-07-30
% 208.44/208.59  |- mesh__historyNote mesh__D005213 68   
% 208.44/208.59  |- skos__historyNote mesh__D005213 Trematode Infections %28%1966-1967%29%
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D005213 2006
% 208.44/208.59  |- skos__hiddenLabel mesh__D005213 Fascioloidiases
% 208.44/208.59  |- mesh__recordOriginator mesh__D005213 NLM
% 208.44/208.59  |- mesh__publicMeSHNote mesh__D005213 68   
% 208.44/208.59  |- mesh__recordAuthorizer mesh__D005213 sjn
% 208.44/208.59  |- skos__scopeNote mesh__D005213
% 208.44/208.59       Infection of cattle and other herbivores with the giant liver fluke Fascioloides magna. It is characterized by extensive destruction of the liver parenchyma.%A%    
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D005213 2004
% 208.44/208.59  |- mesh__recordMaintainer mesh__D005213 ags
% 208.44/208.59  |- skos__annotation mesh__D005213
% 208.44/208.59       trematode infect; usually animal; check tag ANIMALS; caused by FASCIOLOIDES; do not confuse with FASCIOLIASIS %28%caused by FASCIOLA%29% or FASCIOLOPSIASIS %28%caused by FASCIOLOPSIS%29%%A%  
% 208.44/208.59  |- mesh__dateEstablished mesh__D005213 1968-01-01
% 208.44/208.59  |- skos__broader mesh__D005213smesh__D014201
% 208.44/208.59  |- skos__prefLabel mesh__D005213 Fascioloidiasis
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D018939 2003
% 208.44/208.59  |- skos__broader mesh__D018939smesh__D010687
% 208.44/208.59  |- mesh__publicMeSHNote mesh__D018939 96   
% 208.44/208.59  |- skos__historyNote mesh__D018939 Holistic Health %28%1980-1995%29%
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D018939 2002
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D018939 1996
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D018939 2004
% 208.44/208.59  |- rdf__type mesh__D018939sskos__Concept
% 208.44/208.59  |- mesh__dateEstablished mesh__D018939 1996-01-01
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D018939 1997
% 208.44/208.59  |- skos__scopeNote mesh__D018939
% 208.44/208.59       A philosophy of nursing practice that takes into account total patient care, considering the physical, emotional, social, economic, and spiritual needs of patients, their response to their illnesses, and the effect of illness on patients%27% abilities to meet self-care needs. %28%From Mosby%27%s Medical, Nursing, %26% Allied Health Dictionary, 4th ed, p745%29%%A%    
% 208.44/208.59  |- mesh__historyNote mesh__D018939 96   
% 208.44/208.59  |- skos__broader mesh__D018939smesh__D009732
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D018939 2005
% 208.44/208.59  |- skos__broader mesh__D018939smesh__D013041
% 208.44/208.59  |- skos__prefLabel mesh__D018939 Holistic Nursing
% 208.44/208.59  |- skos__historyNote mesh__D018939 Nursing Care %28%1971-1995%29%
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D018939 1998
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D018939 2006
% 208.44/208.59  |- mesh__dateCreated mesh__D018939 1995-02-17
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D018939 2000
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D018939 1999
% 208.44/208.59  |- skos__annotation mesh__D018939 SPEC; SPEC qualif; DF: HOLISTIC NURS   
% 208.44/208.59  |- skos__altLabel mesh__D018939 Nursing, Holistic
% 208.44/208.59  |- skos__historyNote mesh__D018939 Philosophy, Nursing %28%1971-1995%29%
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D018939 2001
% 208.44/208.59  |- mesh__recordMaintainer mesh__D010956 lkt
% 208.44/208.59  |- mesh__recordOriginator mesh__D010956 NLM
% 208.44/208.59  |- skos__broader mesh__D010956smesh__D016060
% 208.44/208.59  |- skos__prefLabel mesh__D010956 Plasmapheresis
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D010956 2006
% 208.44/208.59  |- mesh__publicMeSHNote mesh__D010956 68   
% 208.44/208.59  |- skos__hiddenLabel mesh__D010956 Plasmaphereses
% 208.44/208.59  |- mesh__historyNote mesh__D010956 68%28%65%29%   
% 208.44/208.59  |- mesh__recordAuthorizer mesh__D010956 sjn
% 208.44/208.59  |- rdf__type mesh__D010956sskos__Concept
% 208.44/208.59  |- mesh__dateCreated mesh__D010956 1999-01-01
% 208.44/208.59  |- mesh__dateEstablished mesh__D010956 1968-01-01
% 208.44/208.59  |- skos__annotation mesh__D010956
% 208.44/208.59       do not use /util except by MeSH definition   
% 208.44/208.59  |- skos__scopeNote mesh__D010956
% 208.44/208.59       Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use.%A%    
% 208.44/208.59  |- mesh__dateRevised mesh__D010956 2005-06-30
% 208.44/208.59  |- skos__broader mesh__D010956smesh__D001781
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D029661 2003
% 208.44/208.59  |- mesh__dateCreated mesh__D029661 2001-07-25
% 208.44/208.59  |- mesh__dateEstablished mesh__D029661 2002-01-01
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D029661 2004
% 208.44/208.59  |- skos__annotation mesh__D029661
% 208.44/208.59       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.44/208.59  |- mesh__historyNote mesh__D029661 2002   
% 208.44/208.59  |- mesh__publicMeSHNote mesh__D029661 2002   
% 208.44/208.59  |- rdf__type mesh__D029661sskos__Concept
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D029661 2005
% 208.44/208.59  |- skos__broader mesh__D029661smesh__D029401
% 208.44/208.59  |- skos__scopeNote mesh__D029661
% 208.44/208.59       A plant genus of the family BETULACEAE that is distinguished from birch %28%BETULA%29% by its usually stalked winter buds and by cones that remain on the branches after the small, winged nutlets are released.%A%    
% 208.44/208.59  |- skos__prefLabel mesh__D029661 Alnus
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D029661 2006
% 208.44/208.59  |- skos__altLabel mesh__D029661 Alder
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D029661 2002
% 208.44/208.59  |- mesh__dateEstablished mesh__D010158 1966-01-01
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D010158 2001
% 208.44/208.59  |- mesh__recordAuthorizer mesh__D010158 SJN
% 208.44/208.59  |- mesh__onlineNote mesh__D010158
% 208.44/208.59       use PALATAL OBTURATORS to search CLEFT PALATE PROSTHESIS 1966-82%A%  
% 208.44/208.59  |- skos__hiddenLabel mesh__D010158 Prosthesis, Cleft Palate
% 208.44/208.59  |- skos__hiddenLabel mesh__D010158 Prostheses, Cleft Palate
% 208.44/208.59  |- skos__hiddenLabel mesh__D010158 Palatal Obturator
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D010158 2006
% 208.44/208.59  |- skos__hiddenLabel mesh__D010158 Palate Prosthesis, Cleft
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D010158 1999
% 208.44/208.59  |- skos__hiddenLabel mesh__D010158 Obturator, Palatal
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D010158 2002
% 208.44/208.59  |- skos__annotation mesh__D010158
% 208.44/208.59       do not use /util except by MeSH definition   
% 208.44/208.59  |- rdf__type mesh__D010158sskos__Concept
% 208.44/208.59  |- mesh__publicMeSHNote mesh__D010158
% 208.44/208.59       83; was CLEFT PALATE PROSTHESIS 1966-82   
% 208.44/208.59  |- mesh__dateCreated mesh__D010158 1999-01-01
% 208.44/208.59  |- mesh__dateRevised mesh__D010158 1997-06-20
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D010158 2003
% 208.44/208.59  |- skos__altLabel mesh__D010158 Obturators, Palatal
% 208.44/208.59  |- skos__scopeNote mesh__D010158
% 208.44/208.59       Appliances that close a cleft or fissure of the palate.%A%    
% 208.44/208.59  |- skos__prefLabel mesh__D010158 Palatal Obturators
% 208.44/208.59  |- mesh__historyNote mesh__D010158
% 208.44/208.59       83; was CLEFT PALATE PROSTHESIS 1966-82   
% 208.44/208.59  |- skos__hiddenLabel mesh__D010158 Cleft Palate Prostheses
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D010158 2004
% 208.44/208.59  |- mesh__recordMaintainer mesh__D010158 PXP
% 208.44/208.59  |- mesh__recordOriginator mesh__D010158 NLM
% 208.44/208.59  |- skos__broader mesh__D010158smesh__D017266
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D010158 2000
% 208.44/208.59  |- skos__hiddenLabel mesh__D010158 Palate Prostheses, Cleft
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D010158 2005
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D010158 1998
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D004919 2000
% 208.44/208.59  |- mesh__recordMaintainer mesh__D004919 TPW
% 208.44/208.59  |- skos__hiddenLabel mesh__D004919 Erythroplasias
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D004919 2006
% 208.44/208.59  |- skos__prefLabel mesh__D004919 Erythroplasia
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D004919 2002
% 208.44/208.59  |- mesh__dateRevised mesh__D004919 1997-06-20
% 208.44/208.59  |- skos__broader mesh__D004919smesh__D011230
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D004919 2005
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D004919 1999
% 208.44/208.59  |- skos__scopeNote mesh__D004919
% 208.44/208.59       A condition of the mucous membrane characterized by erythematous papular lesions. %28%Dorland, 27th ed%29%%A%    
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D004919 2004
% 208.44/208.59  |- mesh__dateCreated mesh__D004919 1999-01-01
% 208.44/208.59  |- rdf__type mesh__D004919sskos__Concept
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D004919 1998
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D004919 2003
% 208.44/208.59  |- mesh__recordOriginator mesh__D004919 NLM
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D004919 2001
% 208.44/208.59  |- skos__annotation mesh__D004919
% 208.44/208.59       precancerous dis of the mucous membranes   
% 208.44/208.59  |- mesh__recordAuthorizer mesh__D004919 SJN
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D015641 2004
% 208.44/208.59  |- skos__annotation mesh__D015641
% 208.44/208.59       do not use /util except by MeSH definition; DF: RADIOGR INTERVENTIONAL%A%  
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D015641 2006
% 208.44/208.59  |- skos__broader mesh__D015641smesh__D002404
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D015641 1998
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D015641 2002
% 208.44/208.59  |- mesh__dateCreated mesh__D015641 1989-04-07
% 208.44/208.59  |- mesh__dateEstablished mesh__D015641 1990-01-01
% 208.44/208.59  |- mesh__dateRevised mesh__D015641 1997-06-20
% 208.44/208.59  |- mesh__publicMeSHNote mesh__D015641 90   
% 208.44/208.59  |- skos__historyNote mesh__D015641 Catheterization %28%1972-1989%29%
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D015641 1999
% 208.44/208.59  |- mesh__recordAuthorizer mesh__D015641 SJN
% 208.44/208.59  |- skos__historyNote mesh__D015641 Radiology  %28%1977-1989%29%
% 208.44/208.59  |- mesh__recordOriginator mesh__D015641 AGS
% 208.44/208.59  |- mesh__historyNote mesh__D015641 90   
% 208.44/208.59  |- skos__historyNote mesh__D015641 Technology, Radiologic %28%1972-1989%29%
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D015641 2000
% 208.44/208.59  |- rdf__type mesh__D015641sskos__Concept
% 208.44/208.59  |- skos__broader mesh__D015641smesh__D011859
% 208.44/208.59  |- skos__historyNote mesh__D015641 Radiography %28%1972-1989%29%
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D015641 2003
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D015641 2001
% 208.44/208.59  |- skos__prefLabel mesh__D015641 Radiography, Interventional
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D015641 2005
% 208.44/208.59  |- skos__altLabel mesh__D015641 Interventional Radiography
% 208.44/208.59  |- skos__scopeNote mesh__D015641
% 208.44/208.59       Diagnostic and therapeutic procedures that are invasive or surgical in nature, and require the expertise of a specially trained radiologist. In general, they are more invasive than diagnostic imaging but less invasive than major surgery. They often involve catheterization, fluoroscopy, or computed tomography. Some examples include percutaneous transhepatic cholangiography, percutaneous transthoracic biopsy, balloon angioplasty, and arterial embolization.%A%    
% 208.44/208.59  |- mesh__recordMaintainer mesh__D015641 PXP
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D009604 2000
% 208.44/208.59  |- skos__historyNote mesh__D009604 Guanidines %28%1966-1970%29%
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D009604 1994
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D009604 2006
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D009604 2003
% 208.44/208.59  |- mesh__historyNote mesh__D009604 73%28%71%29%   
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D009604 2001
% 208.44/208.59  |- mesh__recordOriginator mesh__D009604 NLM
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D009604 1995
% 208.44/208.59  |- skos__historyNote mesh__D009604 Carcinogens %28%1966-1970%29%
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D009604 2004
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D009604 2002
% 208.44/208.59  |- mesh__dateRevised mesh__D009604 1992-05-19
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D009604 1993
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D009604 1998
% 208.44/208.59  |- rdf__type mesh__D009604sskos__Concept
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D009604 1999
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D009604 1996
% 208.44/208.59  |- skos__broader mesh__D009604smesh__D006146
% 208.44/208.59  |- mesh__dateCreated mesh__D009604 1999-01-01
% 208.44/208.59  |- skos__historyNote mesh__D009604 Nitroso Compounds %28%1966-1970%29%
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D009604 1997
% 208.44/208.59  |- mesh__recordMaintainer mesh__D009604 TAP
% 208.44/208.59  |- skos__broader mesh__D009604smesh__D009603
% 208.44/208.59  |- mesh__dateEstablished mesh__D009604 1973-01-01
% 208.44/208.59  |- mesh__recordAuthorizer mesh__D009604 PLS
% 208.44/208.59  |- mesh__publicMeSHNote mesh__D009604 73   
% 208.44/208.59  |- skos__prefLabel mesh__D009604 Nitrosoguanidines
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D009604 2005
% 208.44/208.59  |- skos__altLabel mesh__D001621 Betahistine Biphar
% 208.44/208.59  |- skos__hiddenLabel mesh__D001621 Methanesulfonate, Betahistine
% 208.44/208.59  |- mesh__historyNote mesh__D001621
% 208.44/208.59       91%28%67%29%; was see under PYRIDINES 1967-90   
% 208.44/208.59  |- skos__altLabel mesh__D001621 Solvay Brand of Betahistine Hydrochloride
% 208.44/208.59  |- skos__hiddenLabel mesh__D001621 Betahistin ratiopharm
% 208.44/208.59  |- skos__altLabel mesh__D001621 Unimed Brand of Betahistine Hydrochloride
% 208.44/208.59  |- mesh__publicMeSHNote mesh__D001621
% 208.44/208.59       91; was see under PYRIDINES 1967-90   
% 208.44/208.59  |- skos__altLabel mesh__D001621
% 208.44/208.59       Fides Ecopharma Brand of Betahistine Hydrochloride
% 208.44/208.59  |- skos__hiddenLabel mesh__D001621 By Vertin
% 208.44/208.59  |- skos__altLabel mesh__D001621 Stadapharm Brand of Betahistine Mesylate
% 208.44/208.59  |- skos__hiddenLabel mesh__D001621 PT 9
% 208.44/208.59  |- skos__altLabel mesh__D001621 Bouchara Brand of Betahistine Hydrochloride
% 208.44/208.59  |- skos__altLabel mesh__D001621 Betaserc
% 208.44/208.59  |- skos__altLabel mesh__D001621 Betahistine Dihydrochloride
% 208.44/208.59  |- skos__altLabel mesh__D001621 Eurim Brand of Betahistine Hydrochloride
% 208.44/208.59  |- skos__hiddenLabel mesh__D001621 Hydrochloride, Betahistine
% 208.44/208.59  |- mesh__recordMaintainer mesh__D001621 CCR
% 208.44/208.59  |- skos__altLabel mesh__D001621 Vasomotal
% 208.44/208.59  |- mesh__recordOriginator mesh__D001621 NLM
% 208.44/208.59  |- skos__altLabel mesh__D001621 ratiopharm Brand of Betahistine Mesylate
% 208.44/208.59  |- rdf__type mesh__D001621sskos__Concept
% 208.44/208.59  |- skos__prefLabel mesh__D001621 Betahistine
% 208.44/208.59  |- skos__scopeNote mesh__D001621
% 208.44/208.59       A histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in Meniere%27%s disease and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers.%A%    
% 208.44/208.59  |- skos__altLabel mesh__D001621 Hennig Brand of Betahistine Mesylate
% 208.44/208.59  |- skos__hiddenLabel mesh__D001621 Dihydrobromide, Betahistine
% 208.44/208.59  |- mesh__dateEstablished mesh__D001621 1991-01-01
% 208.44/208.59  |- skos__altLabel mesh__D001621 Ergha Brand of Betahistine Hydrochloride
% 208.44/208.59  |- skos__hiddenLabel mesh__D001621 PT9
% 208.44/208.59  |- mesh__dateRevised mesh__D001621 2005-06-30
% 208.44/208.59  |- skos__altLabel mesh__D001621 Aliud Brand of Betahistine Mesylate
% 208.44/208.59  |- skos__hiddenLabel mesh__D001621 Mesylate, Betahistine
% 208.44/208.59  |- skos__altLabel mesh__D001621
% 208.44/208.59       Byk Gulden Brand of Betahistine Hydrochloride
% 208.44/208.59  |- skos__broader mesh__D001621smesh__D011725
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D001621 2006
% 208.44/208.59  |- skos__altLabel mesh__D001621 Betahistine Methanesulfonate
% 208.44/208.59  |- skos__altLabel mesh__D001621 Betahistine Methanesulphonate
% 208.44/208.59  |- skos__altLabel mesh__D001621 Dexo Brand of Betahistine Mesylate
% 208.44/208.59  |- skos__hiddenLabel mesh__D001621 Dihydrochloride, Betahistine
% 208.44/208.59  |- skos__altLabel mesh__D001621 Medopharm Brand of Betahistine Mesylate
% 208.44/208.59  |- skos__altLabel mesh__D001621 Gerard Brand of Betahistine Hydrochloride
% 208.44/208.59  |- skos__hiddenLabel mesh__D001621 Methanesulphonate, Betahistine
% 208.44/208.59  |- skos__altLabel mesh__D001621 Altana Pharma Brand of Betahistine Mesylate
% 208.44/208.59  |- mesh__dateCreated mesh__D001621 1999-01-01
% 208.44/208.59  |- mesh__recordAuthorizer mesh__D001621 sjn
% 208.44/208.59  |- mesh__publicMeSHNote mesh__D020586 2000   
% 208.44/208.59  |- mesh__dateRevised mesh__D020586 2005-06-30
% 208.44/208.59  |- skos__historyNote mesh__D020586 Chromatiaceae %28%1988-1999%29%
% 208.44/208.59  |- skos__broader mesh__D020586smesh__D002841
% 208.44/208.59  |- mesh__recordAuthorizer mesh__D020586 sjn
% 208.44/208.59  |- skos__prefLabel mesh__D020586 Thiocapsa
% 208.44/208.59  |- rdf__type mesh__D020586sskos__Concept
% 208.44/208.59  |- mesh__historyNote mesh__D020586 2000   
% 208.44/208.59  |- mesh__recordOriginator mesh__D020586 ndw
% 208.44/208.59  |- mesh__recordMaintainer mesh__D020586 SYSTEM
% 208.44/208.59  |- mesh__dateCreated mesh__D020586 1999-11-03
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D020586 2006
% 208.44/208.59  |- skos__broader mesh__D020586smesh__D016964
% 208.44/208.59  |- mesh__dateEstablished mesh__D020586 2000-01-01
% 208.44/208.59  |- skos__scopeNote mesh__D020586
% 208.44/208.59       A genus of anoxygenic, photosynthetic, nonmotile, spherical to slightly ovoid bacterial cells occurring singly, or in aggregates of two or four, and usually surrounded with slime. It is found in stagnant water, mud of ponds, estuaries, and microbial mats of salt marshes. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 208.44/208.59  |- mesh__recordOriginator mesh__D014549 NLM
% 208.44/208.59  |- skos__broader mesh__D014549smesh__D014555
% 208.44/208.59  |- skos__related mesh__D014549smesh__D016496
% 208.44/208.59  |- mesh__dateRevised mesh__D014549 2004-07-08
% 208.44/208.59  |- skos__related mesh__D014549smesh__D016741
% 208.44/208.59  |- rdf__type mesh__D014549sskos__Concept
% 208.44/208.59  |- skos__hiddenLabel mesh__D014549 Incontinence, Urinary
% 208.44/208.59  |- skos__prefLabel mesh__D014549 Urinary Incontinence
% 208.44/208.59  |- mesh__dateCreated mesh__D014549 1999-01-01
% 208.44/208.59  |- skos__scopeNote mesh__D014549
% 208.44/208.59       Inability to control the passage of URINE.     
% 208.44/208.59  |- mesh__activeMeSHYear mesh__D014549 2005
% 208.44/208.59  |- mesh__recordMaintainer mesh__D014549 ssb
% 208.44/208.59  |- skos__altLabel mesh__D014549 Bladder, Overactive
% 208.44/208.59  |- mesh__recordAuthorizer mesh__D014549 sjn
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D014549 2006
% 208.44/208.60  |- skos__hiddenLabel mesh__D014549 Incontinence, Urge
% 208.44/208.60  |- mesh__publicMeSHNote mesh__D033703
% 208.44/208.60       2003; NUCLEOSIDE TRANSPORTER %28%now NUCLEOSIDE TRANSPORT PROTEINS%29% was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1983-2002%A%  
% 208.44/208.60  |- mesh__recordMaintainer mesh__D033703 SYSTEM
% 208.44/208.60  |- skos__historyNote mesh__D033703 Membrane Proteins %28%1983-2002%29%
% 208.44/208.60  |- skos__hiddenLabel mesh__D033703 Transporter, Nucleoside
% 208.44/208.60  |- mesh__historyNote mesh__D033703
% 208.44/208.60       2003; use NUCLEOSIDE TRANSPORT PROTEINS %28%NM%29% 1983-2002   
% 208.44/208.60  |- skos__prefLabel mesh__D033703 Nucleoside Transport Proteins
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D033703 2006
% 208.44/208.60  |- mesh__dateCreated mesh__D033703 2002-07-03
% 208.44/208.60  |- skos__hiddenLabel mesh__D033703 Transport Proteins, Nucleoside
% 208.44/208.60  |- mesh__dateEstablished mesh__D033703 2003-01-01
% 208.44/208.60  |- rdf__type mesh__D033703sskos__Concept
% 208.44/208.60  |- skos__scopeNote mesh__D033703
% 208.44/208.60       Proteins involved in the transport of NUCLEOSIDES across cellular membranes.%A%    
% 208.44/208.60  |- mesh__dateRevised mesh__D033703 2005-06-30
% 208.44/208.60  |- skos__historyNote mesh__D033703 Carrier Proteins %28%1983-2002%29%
% 208.44/208.60  |- skos__broader mesh__D033703smesh__D033701
% 208.44/208.60  |- mesh__recordOriginator mesh__D033703 jmp
% 208.44/208.60  |- mesh__recordAuthorizer mesh__D033703 sjn
% 208.44/208.60  |- skos__altLabel mesh__D033703 Nucleoside Transporter
% 208.44/208.60  |- skos__historyNote mesh__D019234 Dentin %28%1966-1996%29%
% 208.44/208.60  |- mesh__dateEstablished mesh__D019234 1997-01-01
% 208.44/208.60  |- skos__hiddenLabel mesh__D019234 Fluid, Dentinal
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D019234 1998
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D019234 2002
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D019234 2003
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D019234 1999
% 208.44/208.60  |- skos__prefLabel mesh__D019234 Dentinal Fluid
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D019234 2004
% 208.44/208.60  |- skos__scopeNote mesh__D019234
% 208.44/208.60       The lymph or fluid of dentin. It is a transudate of extracellular fluid, mainly cytoplasm of odontoblastic processes, from the dental pulp via the dentinal tubules. It is also called dental lymph. %28%From Stedman, 26th ed, p665%29%%A%    
% 208.44/208.60  |- skos__annotation mesh__D019234 dentin lymph or transudate   
% 208.44/208.60  |- mesh__historyNote mesh__D019234 97   
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D019234 2005
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D019234 2000
% 208.44/208.60  |- skos__broader mesh__D019234smesh__D005122
% 208.44/208.60  |- skos__hiddenLabel mesh__D019234 Dentinal Fluids
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D019234 2006
% 208.44/208.60  |- mesh__publicMeSHNote mesh__D019234 97   
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D019234 1997
% 208.44/208.60  |- rdf__type mesh__D019234sskos__Concept
% 208.44/208.60  |- skos__hiddenLabel mesh__D019234 Fluids, Dentinal
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D019234 2001
% 208.44/208.60  |- mesh__dateCreated mesh__D019234 1996-06-18
% 208.44/208.60  |- mesh__recordMaintainer mesh__D000529 ssb
% 208.44/208.60  |- skos__hiddenLabel mesh__D000529 Therapies, Complementary
% 208.44/208.60  |- skos__altLabel mesh__D000529 Therapy, Alternative
% 208.44/208.60  |- skos__hiddenLabel mesh__D000529 Therapies, Alternative
% 208.44/208.60  |- skos__prefLabel mesh__D000529 Complementary Therapies
% 208.44/208.60  |- mesh__publicMeSHNote mesh__D000529
% 208.44/208.60       2002; see ALTERNATIVE MEDICINE %28%1986-2001%29%   
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D000529 2005
% 208.44/208.60  |- rdf__type mesh__D000529sskos__Concept
% 208.44/208.60  |- skos__annotation mesh__D000529
% 208.44/208.60       General or unspecified; prefer specifics; not for %22%alternative health care delivery system%22% %28%= DELIVERY OF HEALTH CARE%29% or specific health service.%A%  
% 208.44/208.60  |- mesh__recordOriginator mesh__D000529 EC
% 208.44/208.60  |- mesh__dateRevised mesh__D000529 2004-07-07
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D000529 2006
% 208.44/208.60  |- mesh__recordAuthorizer mesh__D000529 sjn
% 208.44/208.60  |- skos__broader mesh__D000529smesh__D013812
% 208.44/208.60  |- mesh__historyNote mesh__D000529 2002%28%1986%29%   
% 208.44/208.60  |- skos__scopeNote mesh__D000529
% 208.44/208.60       Therapeutic practices which are not currently considered an integral part of conventional allopathic medical practice.  They may lack biomedical explanations but as they become better researched some %28%PHYSICAL THERAPY; DIET; ACUPUNCTURE%29% become widely accepted whereas others %28%humors, radium therapy%29% quietly fade away, yet are important historical footnotes. Therapies are termed as Complementary when used in addition to conventional treatments and as Alternative when used instead of conventional treatment.%A%    
% 208.44/208.60  |- skos__altLabel mesh__D000529 Therapy, Complementary
% 208.44/208.60  |- skos__altLabel mesh__D000529 Medicine, Complementary
% 208.44/208.60  |- mesh__dateCreated mesh__D000529 1985-02-25
% 208.44/208.60  |- skos__altLabel mesh__D000529 Medicine, Alternative
% 208.44/208.60  |- mesh__dateEstablished mesh__D000529 1986-01-01
% 208.44/208.60  |- rdf__type mesh__D011251sskos__Concept
% 208.44/208.60  |- skos__annotation mesh__D011251
% 208.44/208.60       bacterial, fungal or viral infections: PREGNANCY COMPLICATIONS, PARASITIC is also available; coordinate IM with specific infectious disease %28%IM%29%; check the tags FEMALE %26% PREGNANCY; Manual 18.4.7; DF: PREGN COMPL INFECT%A%  
% 208.44/208.60  |- skos__hiddenLabel mesh__D011251 Pregnancy Complication, Infectious
% 208.44/208.60  |- mesh__dateCreated mesh__D011251 1999-01-01
% 208.44/208.60  |- mesh__recordOriginator mesh__D011251 NLM
% 208.44/208.60  |- mesh__historyNote mesh__D011251 64   
% 208.44/208.60  |- skos__broader mesh__D011251smesh__D011248
% 208.44/208.60  |- mesh__publicMeSHNote mesh__D011251 64   
% 208.44/208.60  |- mesh__recordAuthorizer mesh__D011251 sjn
% 208.44/208.60  |- skos__scopeNote mesh__D011251
% 208.44/208.60       The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION.%A%    
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D011251 2006
% 208.44/208.60  |- skos__prefLabel mesh__D011251 Pregnancy Complications, Infectious
% 208.44/208.60  |- skos__broader mesh__D011251smesh__D007239
% 208.44/208.60  |- skos__hiddenLabel mesh__D011251 Pregnancies, Infectious Complications
% 208.44/208.60  |- skos__hiddenLabel mesh__D011251 Infectious Pregnancy Complication
% 208.44/208.60  |- mesh__dateEstablished mesh__D011251 1964-01-01
% 208.44/208.60  |- skos__altLabel mesh__D011251 Complications, Infectious Pregnancy
% 208.44/208.60  |- mesh__dateRevised mesh__D011251 2005-06-30
% 208.44/208.60  |- mesh__recordMaintainer mesh__D011251 lkt
% 208.44/208.60  |- skos__hiddenLabel mesh__D011251 Complication, Infectious Pregnancy
% 208.44/208.60  |- skos__altLabel mesh__D011251 Infectious Pregnancy Complications
% 208.44/208.60  |- skos__altLabel mesh__D011251 Pregnancy, Infectious Complications
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D005214 1999
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D005214 2003
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D005214 1996
% 208.44/208.60  |- mesh__dateRevised mesh__D005214 1993-05-28
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D005214 2000
% 208.44/208.60  |- skos__broader mesh__D005214smesh__D009502
% 208.44/208.60  |- skos__hiddenLabel mesh__D005214 Neutron, Fast
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D005214 2004
% 208.44/208.60  |- skos__prefLabel mesh__D005214 Fast Neutrons
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D005214 1997
% 208.44/208.60  |- skos__hiddenLabel mesh__D005214 Neutrons, Fast
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D005214 2001
% 208.44/208.60  |- skos__historyNote mesh__D005214 Neutrons %28%1966-1970%29%
% 208.44/208.60  |- mesh__publicMeSHNote mesh__D005214 91; was see under NEUTRONS 1971-90   
% 208.44/208.60  |- skos__hiddenLabel mesh__D005214 Fast Neutron
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D005214 2002
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D005214 1994
% 208.44/208.60  |- mesh__historyNote mesh__D005214
% 208.44/208.60       91%28%71%29%; was see under NEUTRONS 1971-90   
% 208.44/208.60  |- skos__annotation mesh__D005214 elementary particles; IM   
% 208.44/208.60  |- mesh__dateCreated mesh__D005214 1999-01-01
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D005214 1995
% 208.44/208.60  |- rdf__type mesh__D005214sskos__Concept
% 208.44/208.60  |- mesh__dateEstablished mesh__D005214 1991-01-01
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D005214 2005
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D005214 1998
% 208.44/208.60  |- skos__scopeNote mesh__D005214
% 208.44/208.60       Neutrons, the energy of which exceeds some arbitrary level, usually around one million electron volts.%A%    
% 208.44/208.60  |- mesh__recordMaintainer mesh__D005214 TGC
% 208.44/208.60  |- mesh__recordOriginator mesh__D005214 NLM
% 208.44/208.60  |- mesh__recordAuthorizer mesh__D005214 PLS
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D005214 2006
% 208.44/208.60  |- skos__annotation mesh__D010957 GEN; prefer specifics   
% 208.44/208.60  |- skos__historyNote mesh__D010957 Genetics %28%1966-1967%29%
% 208.44/208.60  |- skos__scopeNote mesh__D010957
% 208.44/208.60       Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS.%A%    
% 208.44/208.60  |- mesh__dateRevised mesh__D010957 2004-07-30
% 208.44/208.60  |- skos__historyNote mesh__D010957
% 208.44/208.60       Extrachromosomal Inheritance %28%1968-1974%29%
% 208.44/208.60  |- mesh__recordMaintainer mesh__D010957 jls
% 208.44/208.60  |- skos__broader mesh__D010957smesh__D040342
% 208.44/208.60  |- rdf__type mesh__D010957sskos__Concept
% 208.44/208.60  |- skos__related mesh__D010957smesh__D005111
% 208.44/208.60  |- mesh__recordAuthorizer mesh__D010957 jls
% 208.44/208.60  |- mesh__onlineNote mesh__D010957
% 208.44/208.60       use PLASMIDS to search EPISOMES 1975-77   
% 208.44/208.60  |- skos__altLabel mesh__D010957 Episome
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D010957 2005A
% 208.44/208.60  |- mesh__recordOriginator mesh__D010957 NLM
% 208.44/208.60  |- skos__related mesh__D010957smesh__D005822
% 208.44/208.60  |- mesh__historyNote mesh__D010957
% 208.44/208.60       78%28%75%29%; was see under EXTRACHROMOSOMAL INHERITANCE 1975-77; EPISOMES was see under EXTRACHROMOSOMAL INHERITANCE 1975-77%A%  
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D010957 2005
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D010957 2004
% 208.44/208.60  |- mesh__dateEstablished mesh__D010957 1978-01-01
% 208.44/208.60  |- mesh__publicMeSHNote mesh__D010957
% 208.44/208.60       78; was see under EXTRACHROMOSOMAL INHERITANCE 1975-77; EPISOMES was see under EXTRACHROMOSOMAL INHERITANCE 1975-77%A%  
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D010957 2006
% 208.44/208.60  |- skos__altLabel mesh__D010957 Plasmid
% 208.44/208.60  |- skos__prefLabel mesh__D010957 Plasmids
% 208.44/208.60  |- mesh__dateCreated mesh__D010957 1974-11-11
% 208.44/208.60  |- mesh__dateCreated mesh__D029662 2001-08-03
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D029662 2006
% 208.44/208.60  |- skos__broader mesh__D029662smesh__D029401
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D029662 2004
% 208.44/208.60  |- skos__scopeNote mesh__D029662
% 208.44/208.60       A plant genus of the family BETULACEAE. The tree has smooth, resinous, varicolored or white bark, marked by horizontal pores %28%lenticels%29%, which usually peels horizontally in thin sheets.%A%    
% 208.44/208.60  |- skos__prefLabel mesh__D029662 Betula
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D029662 2005
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D029662 2003
% 208.44/208.60  |- skos__annotation mesh__D029662
% 208.44/208.60       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.44/208.60  |- mesh__recordOriginator mesh__D029662 ssb
% 208.44/208.60  |- mesh__dateEstablished mesh__D029662 2002-01-01
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D029662 2002
% 208.44/208.60  |- mesh__recordAuthorizer mesh__D029662 sjn
% 208.44/208.60  |- mesh__recordMaintainer mesh__D029662 jls
% 208.44/208.60  |- mesh__publicMeSHNote mesh__D029662 2002   
% 208.44/208.60  |- skos__altLabel mesh__D029662 Birch
% 208.44/208.60  |- rdf__type mesh__D029662sskos__Concept
% 208.44/208.60  |- mesh__historyNote mesh__D029662 2002   
% 208.44/208.60  |- skos__hiddenLabel mesh__D010159 Papilla, Incisive
% 208.44/208.60  |- mesh__recordMaintainer mesh__D010159 lkt
% 208.44/208.60  |- mesh__recordOriginator mesh__D010159 NLM
% 208.44/208.60  |- skos__prefLabel mesh__D010159 Palate
% 208.44/208.60  |- mesh__dateCreated mesh__D010159 1999-01-01
% 208.44/208.60  |- skos__broader mesh__D010159smesh__D009055
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D010159 2006
% 208.44/208.60  |- skos__hiddenLabel mesh__D010159 Papillas, Incisive
% 208.44/208.60  |- skos__broader mesh__D010159smesh__D007568
% 208.44/208.60  |- skos__hiddenLabel mesh__D010159 Incisive Papillas
% 208.44/208.60  |- skos__hiddenLabel mesh__D010159 Palates
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D010159 2005
% 208.44/208.60  |- rdf__type mesh__D010159sskos__Concept
% 208.44/208.60  |- mesh__dateRevised mesh__D010159 2003-07-09
% 208.44/208.60  |- skos__scopeNote mesh__D010159
% 208.44/208.60       The structure that forms the roof of the mouth. It consists of the anterior hard palate %28%PALATE, HARD%29% and the posterior soft palate %28%PALATE, SOFT%29%.%A%    
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D010159 2004
% 208.44/208.60  |- skos__annotation mesh__D010159
% 208.44/208.60       X ref INCISIVE PAPILLA, a projection on the palate posterior to the central incisors: do not add INCISOR; PALATE, HARD and PALATE, SOFT are also available%A%  
% 208.44/208.60  |- mesh__recordAuthorizer mesh__D010159 sjn
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D015642 2001
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D015642 1998
% 208.44/208.60  |- mesh__dateEstablished mesh__D015642 1990-01-01
% 208.44/208.60  |- mesh__recordAuthorizer mesh__D015642 jls
% 208.44/208.60  |- skos__historyNote mesh__D015642 Radiology %28%1977-1989%29%
% 208.44/208.60  |- mesh__publicMeSHNote mesh__D015642 90   
% 208.44/208.60  |- skos__altLabel mesh__D015642 Interventional Radiology
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D015642 1999
% 208.44/208.60  |- mesh__recordMaintainer mesh__D015642 jls
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D015642 2002
% 208.44/208.60  |- mesh__dateCreated mesh__D015642 1989-04-07
% 208.44/208.60  |- rdf__type mesh__D015642sskos__Concept
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D015642 2003
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D015642 2005
% 208.44/208.60  |- skos__broader mesh__D015642smesh__D011871
% 208.44/208.60  |- mesh__dateRevised mesh__D015642 2004-08-02
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D015642 2005A
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D015642 2004
% 208.44/208.60  |- mesh__historyNote mesh__D015642 90   
% 208.44/208.60  |- mesh__recordOriginator mesh__D015642 AGS
% 208.44/208.60  |- skos__annotation mesh__D015642
% 208.44/208.60       SPEC: SPEC qualif; for diag use RADIOGRAPHY, INTERVENTIONAL; DF: RADIOL INTERVENTIONAL%A%  
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D015642 2006
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D015642 2000
% 208.44/208.60  |- skos__prefLabel mesh__D015642 Radiology, Interventional
% 208.44/208.60  |- skos__scopeNote mesh__D015642
% 208.44/208.60       Subspecialty of radiology that combines organ system radiography, catheter techniques and sectional imaging.%A%    
% 208.44/208.60  |- skos__scopeNote mesh__D009605
% 208.44/208.60       An alkylating carcinogen that produces gastrointestinal and probably lung and nervous system tumors.%A%    
% 208.44/208.60  |- mesh__historyNote mesh__D009605
% 208.44/208.60       91%28%75%29%; was see under URETHANE 1975-90   
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D009605 2004
% 208.44/208.60  |- mesh__dateEstablished mesh__D009605 1991-01-01
% 208.44/208.60  |- skos__prefLabel mesh__D009605 Nitrosomethylurethane
% 208.44/208.60  |- rdf__type mesh__D009605sskos__Concept
% 208.44/208.60  |- mesh__dateCreated mesh__D009605 1974-11-19
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D009605 2001
% 208.44/208.60  |- mesh__recordOriginator mesh__D009605 NLM
% 208.44/208.60  |- skos__altLabel mesh__D009605 Methylnitrosourethane
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D009605 2002
% 208.44/208.60  |- skos__broader mesh__D009605smesh__D009603
% 208.44/208.60  |- mesh__recordMaintainer mesh__D009605 CCR
% 208.44/208.60  |- skos__broader mesh__D009605smesh__D014520
% 208.44/208.60  |- skos__historyNote mesh__D009605 Urethane %28%1972-1974%29%
% 208.44/208.60  |- skos__historyNote mesh__D009605 Nitroso Compounds %28%1972-1974%29%
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D009605 2005
% 208.44/208.60  |- skos__annotation mesh__D009605 D26-26 qualif   
% 208.44/208.60  |- mesh__publicMeSHNote mesh__D009605 91; was see under URETHANE 1975-90   
% 208.44/208.60  |- mesh__recordAuthorizer mesh__D009605 sjn
% 208.44/208.60  |- mesh__dateRevised mesh__D009605 2000-06-22
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D009605 2006
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D009605 2003
% 208.44/208.60  |- skos__broader mesh__D001622smesh__D000644
% 208.44/208.60  |- rdf__type mesh__D001622sskos__Concept
% 208.44/208.60  |- skos__altLabel mesh__D001622 Logeais Brand of Betaine Cyclobutyrate
% 208.44/208.60  |- skos__altLabel mesh__D001622 Beaufour Brand of Betaine Citrate
% 208.44/208.60  |- skos__hiddenLabel mesh__D001622 Betaine, Glycine
% 208.44/208.60  |- skos__hiddenLabel mesh__D001622 AcidinPepsin
% 208.44/208.60  |- skos__altLabel mesh__D001622 Orphan Brand of Betaine
% 208.44/208.60  |- skos__altLabel mesh__D001622
% 208.44/208.60       Fournier Brand of Betaine Ascorbate and Hydrate
% 208.44/208.60  |- skos__altLabel mesh__D001622 Citrate de B%C3%%A9%ta%C3%%AF%ne Beaufour
% 208.44/208.60  |- skos__altLabel mesh__D001622 Byk Brand of Betaine Phosphate
% 208.44/208.60  |- skos__altLabel mesh__D001622 Boizot Brand of Betaine Aspartate
% 208.44/208.60  |- skos__hiddenLabel mesh__D001622 Acidin Pepsin
% 208.44/208.60  |- skos__broader mesh__D001622smesh__D050337
% 208.44/208.60  |- skos__altLabel mesh__D001622 Glycine Betaine
% 208.44/208.60  |- skos__scopeNote mesh__D001622
% 208.44/208.60       A naturally occurring compound that has been of interest for its role in osmoregulation. As a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. Betaine has also been used in the treatment of liver disorders, for hyperkalemia, for homocystinuria, and for gastrointestinal disturbances. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1341%29%%A%    
% 208.44/208.60  |- mesh__dateEstablished mesh__D001622 1968-01-01
% 208.44/208.60  |- skos__hiddenLabel mesh__D001622 Betaine Orphan Brand
% 208.44/208.60  |- mesh__dateRevised mesh__D001622 2005-06-30
% 208.44/208.60  |- skos__hiddenLabel mesh__D001622 Scorbob%C3%%A9%ta%C3%%AF%ne
% 208.44/208.60  |- skos__hiddenLabel mesh__D001622 Scorbo b%C3%%A9%ta%C3%%AF%ne
% 208.44/208.60  |- skos__prefLabel mesh__D001622 Betaine
% 208.44/208.60  |- mesh__dateCreated mesh__D001622 1999-01-01
% 208.44/208.60  |- skos__hiddenLabel mesh__D001622 Stea16
% 208.44/208.60  |- mesh__historyNote mesh__D001622 68%28%64%29%   
% 208.44/208.60  |- skos__altLabel mesh__D001622 Lycine
% 208.44/208.60  |- mesh__recordOriginator mesh__D001622 NLM
% 208.44/208.60  |- skos__altLabel mesh__D001622 Oxyneurine
% 208.44/208.60  |- skos__altLabel mesh__D001622 UPSA Brand of Betaine Citrate
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D001622 2006
% 208.44/208.60  |- mesh__recordMaintainer mesh__D001622 ssb
% 208.44/208.60  |- mesh__publicMeSHNote mesh__D001622 68   
% 208.44/208.60  |- skos__hiddenLabel mesh__D001622 Hydrochloride, Betaine
% 208.44/208.60  |- mesh__recordAuthorizer mesh__D001622 sjn
% 208.44/208.60  |- mesh__dateCreated mesh__D020587 1999-11-05
% 208.44/208.60  |- rdf__type mesh__D020587sskos__Concept
% 208.44/208.60  |- mesh__recordMaintainer mesh__D020587 ags
% 208.44/208.60  |- mesh__recordOriginator mesh__D020587 ndw
% 208.44/208.60  |- mesh__historyNote mesh__D020587 2000   
% 208.44/208.60  |- mesh__publicMeSHNote mesh__D020587 2000   
% 208.44/208.60  |- mesh__dateRevised mesh__D020587 2005-06-30
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D020587 2006
% 208.44/208.60  |- skos__scopeNote mesh__D020587
% 208.44/208.60       A genus of vibrioid or rod-shaped cells which are motile by polar flagella. Internal photosynthetic membranes are present as lamellar stacks and contain bacteriochlorophyll a or b and carotenoids. Growth occurs photoautotrophically under anaerobic conditions. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 208.44/208.60  |- skos__broader mesh__D020587smesh__D042001
% 208.44/208.60  |- mesh__recordAuthorizer mesh__D020587 sjn
% 208.44/208.60  |- mesh__dateEstablished mesh__D020587 2000-01-01
% 208.44/208.60  |- skos__prefLabel mesh__D020587 Ectothiorhodospira
% 208.44/208.60  |- skos__prefLabel mesh__D033704 Nucleotide Transport Proteins
% 208.44/208.60  |- mesh__recordOriginator mesh__D033704 jmp
% 208.44/208.60  |- mesh__recordAuthorizer mesh__D033704 sjn
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D033704 2006
% 208.44/208.60  |- skos__altLabel mesh__D033704 Nucleotide Translocase
% 208.44/208.60  |- skos__scopeNote mesh__D033704
% 208.44/208.60       Proteins involved in the transport of NUCLEOTIDES across cellular membranes.%A%    
% 208.44/208.60  |- rdf__type mesh__D033704sskos__Concept
% 208.44/208.60  |- skos__hiddenLabel mesh__D033704 Transport Proteins, Nucleotide
% 208.44/208.60  |- mesh__dateCreated mesh__D033704 2002-07-03
% 208.44/208.60  |- mesh__dateEstablished mesh__D033704 2003-01-01
% 208.44/208.60  |- skos__historyNote mesh__D033704
% 208.44/208.60       Mitochondrial ADP, ATP Translocases %28%1982-2002%29%
% 208.44/208.60  |- mesh__dateRevised mesh__D033704 2005-06-30
% 208.44/208.60  |- mesh__recordMaintainer mesh__D033704 SYSTEM
% 208.44/208.60  |- skos__broader mesh__D033704smesh__D033701
% 208.44/208.60  |- mesh__historyNote mesh__D033704
% 208.44/208.60       2003; use MITOCHONDRIAL ADP, ATP TRANSLOCASES 1982-2002   
% 208.44/208.60  |- mesh__publicMeSHNote mesh__D033704
% 208.44/208.60       2003; see ADENINE NUCLEOTIDE TRANSLOCASE 1982-2002   
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D019235 2001
% 208.44/208.60  |- skos__prefLabel mesh__D019235 Ephemerovirus
% 208.44/208.60  |- skos__annotation mesh__D019235
% 208.44/208.60       a genus of the family Rhabdoviridae, primarily infecting cattle; infection = RHABDOVIRIDAE INFECTIONS%A%  
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D019235 2005
% 208.44/208.60  |- rdf__type mesh__D019235sskos__Concept
% 208.44/208.60  |- mesh__publicMeSHNote mesh__D019235 97   
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D019235 2000
% 208.44/208.60  |- mesh__historyNote mesh__D019235 97   
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D019235 2004
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D019235 1999
% 208.44/208.60  |- skos__broader mesh__D019235smesh__D012209
% 208.44/208.60  |- skos__hiddenLabel mesh__D019235 Ephemeroviruses
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D019235 2003
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D019235 1998
% 208.44/208.60  |- skos__scopeNote mesh__D019235
% 208.44/208.60       A genus of the family RHABDOVIRIDAE which primarily infect cattle. EPHEMERAL FEVER VIRUS, BOVINE is the type species.%A%    
% 208.44/208.60  |- mesh__dateEstablished mesh__D019235 1997-01-01
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D019235 2002
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D019235 1997
% 208.44/208.60  |- mesh__dateCreated mesh__D019235 1996-06-10
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D019235 2006
% 208.44/208.60  |- skos__altLabel mesh__D011252 Neoplastic Pregnancy Complications
% 208.44/208.60  |- skos__hiddenLabel mesh__D011252 Complication, Neoplastic Pregnancy
% 208.44/208.60  |- skos__altLabel mesh__D011252 Pregnancy, Neoplastic Complications
% 208.44/208.60  |- skos__prefLabel mesh__D011252 Pregnancy Complications, Neoplastic
% 208.44/208.60  |- skos__historyNote mesh__D011252 specific neoplasms %28%1966-1982%29%
% 208.44/208.60  |- skos__historyNote mesh__D011252
% 208.44/208.60       Pregnancy Complications %28%1966-1982%29%
% 208.44/208.60  |- mesh__publicMeSHNote mesh__D011252 83   
% 208.44/208.60  |- skos__scopeNote mesh__D011252
% 208.44/208.60       The co-occurrence of pregnancy and NEOPLASMS. The neoplastic disease may precede or follow FERTILIZATION.%A%    
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D011252 2006
% 208.44/208.60  |- skos__annotation mesh__D011252
% 208.44/208.60       coordinate IM with specific histologic type %28%IM%29% + precoordinated organ/neopl term %28%IM%29%; check the tags FEMALE %26% PREGNANCY; Manual 18.4.7; DF: PREGN COMPL NEOPL%A%  
% 208.44/208.60  |- mesh__historyNote mesh__D011252 83   
% 208.44/208.60  |- skos__broader mesh__D011252smesh__D011248
% 208.44/208.60  |- skos__hiddenLabel mesh__D011252 Neoplastic Pregnancy Complication
% 208.44/208.60  |- skos__broader mesh__D011252smesh__D009369
% 208.44/208.60  |- skos__hiddenLabel mesh__D011252 Pregnancies, Neoplastic Complications
% 208.44/208.60  |- mesh__recordOriginator mesh__D011252 VDK
% 208.44/208.60  |- mesh__recordAuthorizer mesh__D011252 sjn
% 208.44/208.60  |- skos__hiddenLabel mesh__D011252 Pregnancy Complication, Neoplastic
% 208.44/208.60  |- mesh__dateRevised mesh__D011252 2005-06-30
% 208.44/208.60  |- rdf__type mesh__D011252sskos__Concept
% 208.44/208.60  |- mesh__dateEstablished mesh__D011252 1983-01-01
% 208.44/208.60  |- skos__altLabel mesh__D011252 Complications, Neoplastic Pregnancy
% 208.44/208.60  |- mesh__recordMaintainer mesh__D011252 lkt
% 208.44/208.60  |- mesh__dateCreated mesh__D011252 1982-04-26
% 208.44/208.60  |- mesh__recordAuthorizer mesh__D005215 sjn
% 208.44/208.60  |- mesh__recordOriginator mesh__D005215 NLM
% 208.44/208.60  |- skos__annotation mesh__D005215
% 208.44/208.60       human %26% animal; differs from STARVATION in matter of degree: TN 80; FOOD DEPRIVATION is also available%A%  
% 208.44/208.60  |- mesh__recordMaintainer mesh__D005215 TAP
% 208.44/208.60  |- skos__broader mesh__D005215smesh__D004032
% 208.44/208.60  |- skos__scopeNote mesh__D005215 Abstaining from all food.     
% 208.44/208.60  |- mesh__dateRevised mesh__D005215 2002-07-03
% 208.44/208.60  |- skos__broader mesh__D005215smesh__D005247
% 208.44/208.60  |- mesh__dateCreated mesh__D005215 1999-01-01
% 208.44/208.60  |- rdf__type mesh__D005215sskos__Concept
% 208.44/208.60  |- skos__related mesh__D005215smesh__D013217
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D005215 2005
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D005215 2006
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D005215 2003
% 208.44/208.60  |- skos__related mesh__D005215smesh__D006815
% 208.44/208.60  |- skos__prefLabel mesh__D005215 Fasting
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D005215 2004
% 208.44/208.60  |- skos__altLabel mesh__D010958 Glutamyl Plasminogen
% 208.44/208.60  |- skos__altLabel mesh__D010958 Profibrinolysin
% 208.44/208.60  |- mesh__publicMeSHNote mesh__D010958 65   
% 208.44/208.60  |- skos__scopeNote mesh__D010958
% 208.44/208.60       Precursor of fibrinolysin %28%plasmin%29%. It is a single-chain beta-globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. It is used in wound debriding and has been investigated as a thrombolytic agent.%A%    
% 208.44/208.60  |- skos__hiddenLabel mesh__D010958 1-Plasminogen, Glutamic Acid
% 208.44/208.60  |- skos__broader mesh__D010958smesh__D001609
% 208.44/208.60  |- mesh__dateCreated mesh__D010958 1999-01-01
% 208.44/208.60  |- mesh__dateRevised mesh__D010958 2003-07-09
% 208.44/208.60  |- rdf__type mesh__D010958sskos__Concept
% 208.44/208.60  |- mesh__recordAuthorizer mesh__D010958 sjn
% 208.44/208.60  |- skos__altLabel mesh__D010958 Glutamic Acid 1-Plasminogen
% 208.44/208.60  |- mesh__historyNote mesh__D010958 65%28%63%29%   
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D010958 2005
% 208.44/208.60  |- skos__broader mesh__D010958smesh__D004792
% 208.44/208.60  |- mesh__recordMaintainer mesh__D010958 ssb
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D010958 2004
% 208.44/208.60  |- mesh__dateEstablished mesh__D010958 1965-01-01
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D010958 2006
% 208.44/208.60  |- skos__hiddenLabel mesh__D010958 Glu Plasminogen
% 208.44/208.60  |- skos__hiddenLabel mesh__D010958 Glutamic Acid 1 Plasminogen
% 208.44/208.60  |- mesh__recordOriginator mesh__D010958 NLM
% 208.44/208.60  |- skos__hiddenLabel mesh__D010958 Plasminogen, Glutamyl
% 208.44/208.60  |- skos__prefLabel mesh__D010958 Plasminogen
% 208.44/208.60  |- skos__annotation mesh__D010958
% 208.44/208.60       an enzyme precursor %26% fibrinolytic agent; /antag: do not confuse with PLASMINOGEN INACTIVATORS which modulate PLASMINOGEN ACTIVATORS, not PLASMINOGEN%A%  
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D029663 2004
% 208.44/208.60  |- mesh__historyNote mesh__D029663 2002   
% 208.44/208.60  |- skos__scopeNote mesh__D029663
% 208.44/208.60       A plant genus of the family BIGNONIACEAE that is a source of lapachol.%A%    
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D029663 2003
% 208.44/208.60  |- mesh__dateCreated mesh__D029663 2001-07-25
% 208.44/208.60  |- skos__annotation mesh__D029663
% 208.44/208.60       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.44/208.60  |- mesh__dateEstablished mesh__D029663 2002-01-01
% 208.44/208.60  |- skos__broader mesh__D029663smesh__D029402
% 208.44/208.60  |- mesh__publicMeSHNote mesh__D029663 2002   
% 208.44/208.60  |- skos__prefLabel mesh__D029663 Tabebuia
% 208.44/208.60  |- rdf__type mesh__D029663sskos__Concept
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D029663 2006
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D029663 2002
% 208.44/208.60  |- skos__altLabel mesh__D029663 Pau d%27%arco
% 208.44/208.60  |- mesh__activeMeSHYear mesh__D029663 2005
% 208.44/208.60  |- skos__hiddenLabel mesh__D015643 Succinate, Eyrthromycin Ethyl
% 208.44/208.60  |- skos__altLabel mesh__D015643 Eyrthromycin Ethyl Succinate
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D015643 2006
% 208.44/208.61  |- mesh__dateEstablished mesh__D015643 1990-01-01
% 208.44/208.61  |- mesh__dateCreated mesh__D015643 1989-05-25
% 208.44/208.61  |- mesh__recordAuthorizer mesh__D015643 sjn
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D015643 2005
% 208.44/208.61  |- mesh__recordMaintainer mesh__D015643 ssb
% 208.44/208.61  |- mesh__dateRevised mesh__D015643 2004-07-07
% 208.44/208.61  |- skos__broader mesh__D015643smesh__D004917
% 208.44/208.61  |- skos__scopeNote mesh__D015643
% 208.44/208.61       A macrolide antibiotic, produced by Streptomyces erythreus. This compound is an ester of erythromycin base and succinic acid. It acts primarily as a bacteriostatic agent. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.%A%    
% 208.44/208.61  |- mesh__historyNote mesh__D015643 90   
% 208.44/208.61  |- skos__historyNote mesh__D015643 Erythromycin %28%1966-1989%29%
% 208.44/208.61  |- rdf__type mesh__D015643sskos__Concept
% 208.44/208.61  |- skos__prefLabel mesh__D015643 Erythromycin Ethylsuccinate
% 208.44/208.61  |- skos__hiddenLabel mesh__D015643 Ethyl Succinate, Eyrthromycin
% 208.44/208.61  |- mesh__recordOriginator mesh__D015643 RLS
% 208.44/208.61  |- skos__hiddenLabel mesh__D015643 Ethylsuccinate, Erythromycin
% 208.44/208.61  |- skos__hiddenLabel mesh__D015643 EMycin E
% 208.44/208.61  |- mesh__publicMeSHNote mesh__D015643 90   
% 208.44/208.61  |- mesh__dateCreated mesh__D009606 1999-01-01
% 208.44/208.61  |- skos__scopeNote mesh__D009606
% 208.44/208.61       A genus of gram-negative, ellipsoidal or rod-shaped bacteria whose major source of energy and reducing power is from the oxidation of ammonia to nitrite. Its species occur in soils, oceans, lakes, rivers, and sewage disposal systems.%A%    
% 208.44/208.61  |- mesh__recordAuthorizer mesh__D009606 sjn
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D009606 2006
% 208.44/208.61  |- mesh__dateRevised mesh__D009606 2005-06-30
% 208.44/208.61  |- skos__broader mesh__D009606smesh__D043369
% 208.44/208.61  |- skos__prefLabel mesh__D009606 Nitrosomonas
% 208.44/208.61  |- mesh__recordOriginator mesh__D009606 NLM
% 208.44/208.61  |- rdf__type mesh__D009606sskos__Concept
% 208.44/208.61  |- mesh__recordMaintainer mesh__D009606 SYSTEM
% 208.44/208.61  |- mesh__dateRevised mesh__D001623 2003-07-09
% 208.44/208.61  |- skos__prefLabel mesh__D001623 Betamethasone
% 208.44/208.61  |- mesh__recordOriginator mesh__D001623 NLM
% 208.44/208.61  |- mesh__dateCreated mesh__D001623 1999-01-01
% 208.44/208.61  |- skos__altLabel mesh__D001623 Flubenisolone
% 208.44/208.61  |- skos__scopeNote mesh__D001623
% 208.44/208.61       A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p724%29%%A%    
% 208.44/208.61  |- mesh__historyNote mesh__D001623 64%28%63%29%   
% 208.44/208.61  |- mesh__recordMaintainer mesh__D001623 ssb
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D001623 2005
% 208.44/208.61  |- mesh__recordAuthorizer mesh__D001623 sjn
% 208.44/208.61  |- mesh__dateEstablished mesh__D001623 1964-01-01
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D001623 2006
% 208.44/208.61  |- skos__broader mesh__D001623smesh__D013259
% 208.44/208.61  |- rdf__type mesh__D001623sskos__Concept
% 208.44/208.61  |- mesh__publicMeSHNote mesh__D001623 64   
% 208.44/208.61  |- skos__broader mesh__D001623smesh__D011246
% 208.44/208.61  |- skos__altLabel mesh__D001623 Betadexamethasone
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D001623 2004
% 208.44/208.61  |- mesh__recordMaintainer mesh__D020588 SYSTEM
% 208.44/208.61  |- skos__historyNote mesh__D020588 Xanthomonas %28%1993-1999%29%
% 208.44/208.61  |- skos__prefLabel mesh__D020588 Stenotrophomonas
% 208.44/208.61  |- mesh__dateEstablished mesh__D020588 2000-01-01
% 208.44/208.61  |- skos__broader mesh__D020588smesh__D044166
% 208.44/208.61  |- mesh__publicMeSHNote mesh__D020588 2000   
% 208.44/208.61  |- mesh__dateRevised mesh__D020588 2005-06-30
% 208.44/208.61  |- rdf__type mesh__D020588sskos__Concept
% 208.44/208.61  |- mesh__historyNote mesh__D020588 2000   
% 208.44/208.61  |- mesh__recordAuthorizer mesh__D020588 sjn
% 208.44/208.61  |- skos__scopeNote mesh__D020588
% 208.44/208.61       A genus of gram-negative, aerobic, motile, rod-shaped bacteria formerly classified as part of the genus XANTHOMONAS.%A%    
% 208.44/208.61  |- mesh__dateCreated mesh__D020588 1999-11-03
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D020588 2006
% 208.44/208.61  |- skos__annotation mesh__D020588
% 208.44/208.61       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 208.44/208.61  |- mesh__recordOriginator mesh__D020588 ndw
% 208.44/208.61  |- skos__prefLabel mesh__D033705
% 208.44/208.61       Equilibrative Nucleoside Transport Proteins
% 208.44/208.61  |- rdf__type mesh__D033705sskos__Concept
% 208.44/208.61  |- mesh__dateCreated mesh__D033705 2002-07-03
% 208.44/208.61  |- skos__altLabel mesh__D033705 Equilibrative Nucleoside Transport Protein
% 208.44/208.61  |- skos__broader mesh__D033705smesh__D033703
% 208.44/208.61  |- mesh__dateRevised mesh__D033705 2005-06-30
% 208.44/208.61  |- skos__scopeNote mesh__D033705
% 208.44/208.61       A class of sodium-independent nucleoside transporters that mediate the facilitative transport of NUCLEOSIDES.%A%    
% 208.44/208.61  |- mesh__recordOriginator mesh__D033705 jmp
% 208.44/208.61  |- skos__historyNote mesh__D033705 Carrier Proteins %28%1997-2002%29%
% 208.44/208.61  |- mesh__historyNote mesh__D033705
% 208.44/208.61       2003; use EQUILIBRATIVE NUCLEOSIDE TRANSPORT PROTEINS %28%NM%29% 1997-2002%A%  
% 208.44/208.61  |- mesh__recordAuthorizer mesh__D033705 sjn
% 208.44/208.61  |- mesh__recordMaintainer mesh__D033705 SYSTEM
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D033705 2006
% 208.44/208.61  |- mesh__dateEstablished mesh__D033705 2003-01-01
% 208.44/208.61  |- mesh__publicMeSHNote mesh__D033705
% 208.44/208.61       2003; EQUILIBRATIVE NUCLEOSIDE TRANSPORT PROTEIN was indexed under CARRIER PROTEINS 1997-2002%A%  
% 208.44/208.61  |- mesh__recordAuthorizer mesh__D011253 sjn
% 208.44/208.61  |- skos__altLabel mesh__D011253 Pregnancy, Adolescent
% 208.44/208.61  |- mesh__historyNote mesh__D011253 79   
% 208.44/208.61  |- skos__hiddenLabel mesh__D011253 Pregnancies, Teen
% 208.44/208.61  |- skos__hiddenLabel mesh__D011253 Adolescent Pregnancies
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D011253 2005
% 208.44/208.61  |- skos__hiddenLabel mesh__D011253 Pregnancies, Preteen
% 208.44/208.61  |- skos__hiddenLabel mesh__D011253 Pregnancies, Teenage
% 208.44/208.61  |- skos__historyNote mesh__D011253 Adolescence %28%1966-1978%29%
% 208.44/208.61  |- skos__broader mesh__D011253smesh__D008423
% 208.44/208.61  |- skos__hiddenLabel mesh__D011253 Pregnancies, Adolescent
% 208.44/208.61  |- mesh__recordMaintainer mesh__D011253 sjn
% 208.44/208.61  |- mesh__recordOriginator mesh__D011253 AEP
% 208.44/208.61  |- skos__historyNote mesh__D011253 Pregnancy %28%1966-1978%29%
% 208.44/208.61  |- mesh__publicMeSHNote mesh__D011253 79   
% 208.44/208.61  |- rdf__type mesh__D011253sskos__Concept
% 208.44/208.61  |- skos__hiddenLabel mesh__D011253 Adolescence, Pregnancy in
% 208.44/208.61  |- skos__annotation mesh__D011253
% 208.44/208.61       IM; use only for pregnancy as a social, cultural, or psychological problem in adolescents; for other aspects of PREGNANCY %28%IM%29% in adolescents, use PREGNANCY %28%IM%29% + ADOLESCENT %28%check tag%29%; includes pregnancy in children under 13; check tags HUMAN; FEMALE; PREGNANCY %26% ADOLESCENT or CHILD if under 13%A%  
% 208.44/208.61  |- skos__hiddenLabel mesh__D011253 Preteen Pregnancies
% 208.44/208.61  |- skos__hiddenLabel mesh__D011253 Teen Pregnancies
% 208.44/208.61  |- mesh__dateEstablished mesh__D011253 1979-01-01
% 208.44/208.61  |- skos__hiddenLabel mesh__D011253 Teenage Pregnancies
% 208.44/208.61  |- mesh__dateRevised mesh__D011253 2004-07-13
% 208.44/208.61  |- mesh__dateCreated mesh__D011253 1978-03-20
% 208.44/208.61  |- skos__scopeNote mesh__D011253
% 208.44/208.61       Pregnancy in human adolescent females under the age of 19.%A%    
% 208.44/208.61  |- skos__altLabel mesh__D011253 Teenage Pregnancy
% 208.44/208.61  |- skos__prefLabel mesh__D011253 Pregnancy in Adolescence
% 208.44/208.61  |- skos__altLabel mesh__D011253 Adolescent Pregnancy
% 208.44/208.61  |- skos__hiddenLabel mesh__D011253 Pregnancy, Teen
% 208.44/208.61  |- skos__hiddenLabel mesh__D011253 Pregnancy, Preteen
% 208.44/208.61  |- skos__altLabel mesh__D011253 Teen Pregnancy
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D011253 2006
% 208.44/208.61  |- skos__altLabel mesh__D011253 Pregnancy, Teenage
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D005216 2006
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D005216 1998
% 208.44/208.61  |- mesh__recordOriginator mesh__D005216 VDK
% 208.44/208.61  |- mesh__recordAuthorizer mesh__D005216 PLS
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D005216 1992
% 208.44/208.61  |- skos__hiddenLabel mesh__D005216 Body, Fat
% 208.44/208.61  |- skos__broader mesh__D005216smesh__D000825
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D005216 2003
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D005216 1994
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D005216 2005
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D005216 1991
% 208.44/208.61  |- mesh__recordMaintainer mesh__D005216 TGC
% 208.44/208.61  |- skos__prefLabel mesh__D005216 Fat Body
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D005216 2002
% 208.44/208.61  |- mesh__publicMeSHNote mesh__D005216
% 208.44/208.61       89; was see under ADIPOSE TISSUE 1980-88   
% 208.44/208.61  |- mesh__dateCreated mesh__D005216 1979-05-24
% 208.44/208.61  |- mesh__historyNote mesh__D005216
% 208.44/208.61       89%28%80%29%; was see under ADIPOSE TISSUE 1980-88   
% 208.44/208.61  |- mesh__dateRevised mesh__D005216 1989-03-14
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D005216 1990
% 208.44/208.61  |- rdf__type mesh__D005216sskos__Concept
% 208.44/208.61  |- skos__hiddenLabel mesh__D005216 Bodies, Fat
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D005216 2001
% 208.44/208.61  |- mesh__dateEstablished mesh__D005216 1989-01-01
% 208.44/208.61  |- skos__hiddenLabel mesh__D005216 Fat Bodies
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D005216 1997
% 208.44/208.61  |- skos__annotation mesh__D005216 in amphibia %26% insects   
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D005216 2000
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D005216 1999
% 208.44/208.61  |- skos__historyNote mesh__D005216 Adipose Tissue %28%1966-1979%29%
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D005216 1993
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D005216 2004
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D005216 1996
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D005216 1995
% 208.44/208.61  |- skos__scopeNote mesh__D005216
% 208.44/208.61       A nutritional reservoir of fatty tissue found mainly in insects and amphibians.%A%    
% 208.44/208.61  |- skos__historyNote mesh__D010959 Plasminogen Activators %28%1976-1985%29%
% 208.44/208.61  |- skos__broader mesh__D010959smesh__D010960
% 208.44/208.61  |- skos__historyNote mesh__D010959 Enzyme Activation %28%1974-1975%29%
% 208.44/208.61  |- skos__broader mesh__D010959smesh__D001779
% 208.44/208.61  |- skos__altLabel mesh__D010959 Genentech Brand of Alteplase
% 208.44/208.61  |- skos__hiddenLabel mesh__D010959 Alteplase Genentech Brand
% 208.44/208.61  |- skos__hiddenLabel mesh__D010959 Plasminogen Activator, Tissue
% 208.44/208.61  |- skos__hiddenLabel mesh__D010959 Alteplase Promeco Brand
% 208.44/208.61  |- skos__altLabel mesh__D010959 Lysatec rt-PA
% 208.44/208.61  |- skos__altLabel mesh__D010959 Hoffmann-La Roche Brand of Alteplase
% 208.44/208.61  |- mesh__recordMaintainer mesh__D010959 ssb
% 208.44/208.61  |- mesh__publicMeSHNote mesh__D010959
% 208.44/208.61       98; see ALTEPLASE 1992-97; see PLASMINOGEN ACTIVATOR, TISSUE-TYPE 1986-91%A%  
% 208.44/208.61  |- skos__hiddenLabel mesh__D010959 Plasminogen Activator, Tissue Type
% 208.44/208.61  |- skos__hiddenLabel mesh__D010959 Lysatec rt PA
% 208.44/208.61  |- skos__hiddenLabel mesh__D010959 Tissue Activator D 44
% 208.44/208.61  |- skos__altLabel mesh__D010959 Promeco Brand of Alteplase
% 208.44/208.61  |- skos__hiddenLabel mesh__D010959 Tissue Type Plasminogen Activator
% 208.44/208.61  |- skos__prefLabel mesh__D010959 Tissue Plasminogen Activator
% 208.44/208.61  |- skos__broader mesh__D010959smesh__D012697
% 208.44/208.61  |- skos__altLabel mesh__D010959 Tissue-Type Plasminogen Activator
% 208.44/208.61  |- skos__altLabel mesh__D010959 T-Plasminogen Activator
% 208.44/208.61  |- skos__altLabel mesh__D010959 Tissue Activator D-44
% 208.44/208.61  |- mesh__dateEstablished mesh__D010959 1986-01-01
% 208.44/208.61  |- skos__scopeNote mesh__D010959
% 208.44/208.61       A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to PLASMIN. It has fibrin-binding activity and is immunologically different from URINARY PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. EC 3.4.21.68.%A%    
% 208.44/208.61  |- skos__hiddenLabel mesh__D010959 T Plasminogen Activator
% 208.44/208.61  |- skos__hiddenLabel mesh__D010959 Hoffmann La Roche Brand of Alteplase
% 208.44/208.61  |- mesh__dateRevised mesh__D010959 2005-06-30
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D010959 2006
% 208.44/208.61  |- skos__altLabel mesh__D010959 Alteplase
% 208.44/208.61  |- skos__historyNote mesh__D010959 Peptide Hydrolases %28%1975%29%
% 208.44/208.61  |- skos__hiddenLabel mesh__D010959 Lysatec rtPA
% 208.44/208.61  |- skos__annotation mesh__D010959 DF: TTPA   
% 208.44/208.61  |- skos__hiddenLabel mesh__D010959 Activator, Tissue Plasminogen
% 208.44/208.61  |- mesh__recordOriginator mesh__D010959 RLS
% 208.44/208.61  |- rdf__type mesh__D010959sskos__Concept
% 208.44/208.61  |- skos__hiddenLabel mesh__D010959 Activator, T-Plasminogen
% 208.44/208.61  |- skos__hiddenLabel mesh__D010959 Activator, Tissue-Type Plasminogen
% 208.44/208.61  |- mesh__dateCreated mesh__D010959 1985-06-12
% 208.44/208.61  |- skos__altLabel mesh__D010959 TTPA
% 208.44/208.61  |- mesh__recordAuthorizer mesh__D010959 sjn
% 208.44/208.61  |- skos__altLabel mesh__D010959 Boehringer Ingelheim Brand of Alteplase
% 208.44/208.61  |- mesh__historyNote mesh__D010959 98%28%86%29%   
% 208.44/208.61  |- skos__altLabel mesh__D010959 Plasminogen Activator, Tissue-Type
% 208.44/208.61  |- skos__broader mesh__D021681smesh__D003904
% 208.44/208.61  |- skos__altLabel mesh__D021681 Monosporium apiospermum
% 208.44/208.61  |- skos__scopeNote mesh__D021681
% 208.44/208.61       A mitosporic fungal genus previously called Monosporium. Teleomorphs include PSEUDALLESCHERIA.%A%    
% 208.44/208.61  |- skos__historyNote mesh__D021681 Mitosporic Fungi %28%1981-2000%29%
% 208.44/208.61  |- mesh__dateRevised mesh__D021681 2005-06-30
% 208.44/208.61  |- mesh__dateCreated mesh__D021681 2000-06-22
% 208.44/208.61  |- skos__prefLabel mesh__D021681 Scedosporium
% 208.44/208.61  |- skos__altLabel mesh__D021681 Monosporium
% 208.44/208.61  |- mesh__historyNote mesh__D021681 2001   
% 208.44/208.61  |- mesh__recordAuthorizer mesh__D021681 sjn
% 208.44/208.61  |- mesh__publicMeSHNote mesh__D021681
% 208.44/208.61       2001; for MONOSPORIUM APIOSPERMUM see PSEUDALLESCHERIA 1986-2000%A%  
% 208.44/208.61  |- mesh__recordMaintainer mesh__D021681 SYSTEM
% 208.44/208.61  |- skos__annotation mesh__D021681
% 208.44/208.61       infection: coord IM with probably MADUROMYCOSIS %28%IM%29% or other mycosis %28%IM%29%%A%  
% 208.44/208.61  |- skos__historyNote mesh__D021681 Pseudallescheria %28%1982-2000%29%
% 208.44/208.61  |- mesh__recordOriginator mesh__D021681 ags
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D021681 2006
% 208.44/208.61  |- mesh__dateEstablished mesh__D021681 2001-01-01
% 208.44/208.61  |- rdf__type mesh__D021681sskos__Concept
% 208.44/208.61  |- skos__altLabel mesh__D015644 Myocamicin
% 208.44/208.61  |- skos__prefLabel mesh__D015644 Miocamycin
% 208.44/208.61  |- skos__annotation mesh__D015644
% 208.44/208.61       do not use /biosyn unless by living matter   
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D015644 2005
% 208.44/208.61  |- mesh__dateCreated mesh__D015644 1989-10-17
% 208.44/208.61  |- skos__hiddenLabel mesh__D015644 PM 88908
% 208.44/208.61  |- skos__altLabel mesh__D015644 9,3%27%%27%-Di-O-Acetylmidecamycin
% 208.44/208.61  |- mesh__dateRevised mesh__D015644 2004-07-07
% 208.44/208.61  |- skos__hiddenLabel mesh__D015644 PM88908
% 208.44/208.61  |- skos__altLabel mesh__D015644 9,3%27%%27%-Diacetylmidecamycin
% 208.44/208.61  |- rdf__type mesh__D015644sskos__Concept
% 208.44/208.61  |- skos__scopeNote mesh__D015644
% 208.44/208.61       A macrolide antibiotic that has a wide antimicrobial spectrum and is particularly effective in respiratory and genital infections.%A%    
% 208.44/208.61  |- skos__hiddenLabel mesh__D015644 9,3%27%%27% Diacetylmidecamycin
% 208.44/208.61  |- mesh__recordAuthorizer mesh__D015644 sjn
% 208.44/208.61  |- mesh__recordMaintainer mesh__D015644 ssb
% 208.44/208.61  |- skos__historyNote mesh__D015644 Leucomycins %28%1981-1989%29%
% 208.44/208.61  |- skos__altLabel mesh__D015644 Miokamycin
% 208.44/208.61  |- mesh__publicMeSHNote mesh__D015644 90   
% 208.44/208.61  |- mesh__historyNote mesh__D015644 90   
% 208.44/208.61  |- skos__broader mesh__D015644smesh__D018942
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D015644 2006
% 208.44/208.61  |- skos__hiddenLabel mesh__D015644 9,3%27%%27% Di O Acetylmidecamycin
% 208.44/208.61  |- skos__altLabel mesh__D015644 Ponsinomycin
% 208.44/208.61  |- mesh__recordOriginator mesh__D015644 RLS
% 208.44/208.61  |- skos__altLabel mesh__D015644 Miocamycine
% 208.44/208.61  |- mesh__dateEstablished mesh__D015644 1990-01-01
% 208.44/208.61  |- mesh__dateCreated mesh__D009607 1999-01-01
% 208.44/208.61  |- mesh__dateRevised mesh__D009607 1992-05-19
% 208.44/208.61  |- skos__annotation mesh__D009607 DF: NITROSOUREA CPDS   
% 208.44/208.61  |- skos__historyNote mesh__D009607 Urea %28%1966-1970%29%
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D009607 1997
% 208.44/208.61  |- skos__historyNote mesh__D009607 Nitroso Compounds %28%1966-1970%29%
% 208.44/208.61  |- mesh__recordMaintainer mesh__D009607 TAP
% 208.44/208.61  |- mesh__dateEstablished mesh__D009607 1973-01-01
% 208.44/208.61  |- mesh__recordAuthorizer mesh__D009607 PLS
% 208.44/208.61  |- skos__broader mesh__D009607smesh__D009603
% 208.44/208.61  |- skos__hiddenLabel mesh__D009607 Compounds, Nitrosourea
% 208.44/208.61  |- mesh__publicMeSHNote mesh__D009607 73   
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D009607 2005
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D009607 2000
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D009607 2003
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D009607 1994
% 208.44/208.61  |- mesh__recordOriginator mesh__D009607 NLM
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D009607 2006
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D009607 2001
% 208.44/208.61  |- rdf__type mesh__D009607sskos__Concept
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D009607 2004
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D009607 1998
% 208.44/208.61  |- mesh__historyNote mesh__D009607 73%28%71%29%   
% 208.44/208.61  |- skos__broader mesh__D009607smesh__D014508
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D009607 1995
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D009607 1996
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D009607 1993
% 208.44/208.61  |- skos__prefLabel mesh__D009607 Nitrosourea Compounds
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D009607 2002
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D009607 1999
% 208.44/208.61  |- skos__broader mesh__D001624smesh__D001623
% 208.44/208.61  |- mesh__publicMeSHNote mesh__D001624
% 208.44/208.61       91; was see under BETAMETHASONE 1976-90   
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D001624 2005
% 208.44/208.61  |- skos__historyNote mesh__D001624
% 208.44/208.61       Betamethasone %28%1974%29% /AA %28%1975%29%
% 208.44/208.61  |- mesh__historyNote mesh__D001624
% 208.44/208.61       91%28%76%29%; was see under BETAMETHASONE 1976-90   
% 208.44/208.61  |- skos__historyNote mesh__D001624 Valerates %28%1974-1975%29%
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D001624 2006
% 208.44/208.61  |- rdf__type mesh__D001624sskos__Concept
% 208.44/208.61  |- mesh__dateCreated mesh__D001624 1975-07-21
% 208.44/208.61  |- mesh__recordMaintainer mesh__D001624 ssb
% 208.44/208.61  |- skos__hiddenLabel mesh__D001624 Betamethasone 17 Valerate
% 208.44/208.61  |- mesh__recordAuthorizer mesh__D001624 sjn
% 208.44/208.61  |- skos__scopeNote mesh__D001624
% 208.44/208.61       The 17-valerate derivative of BETAMETHASONE. It has substantial topical anti-inflammatory activity and relatively low systemic anti-inflammatory activity.%A%    
% 208.44/208.61  |- skos__hiddenLabel mesh__D001624 17-Valerate, Betamethasone
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D001624 2004
% 208.44/208.61  |- skos__altLabel mesh__D001624 Flubenisolonvalerate
% 208.44/208.61  |- skos__prefLabel mesh__D001624 Betamethasone 17-Valerate
% 208.44/208.61  |- mesh__recordOriginator mesh__D001624 RLS
% 208.44/208.61  |- mesh__dateEstablished mesh__D001624 1991-01-01
% 208.44/208.61  |- mesh__dateRevised mesh__D001624 2003-07-09
% 208.44/208.61  |- mesh__recordAuthorizer mesh__D020589 sjn
% 208.44/208.61  |- mesh__dateCreated mesh__D020589 1999-11-03
% 208.44/208.61  |- mesh__dateEstablished mesh__D020589 2000-01-01
% 208.44/208.61  |- skos__broader mesh__D020589smesh__D009346
% 208.44/208.61  |- skos__broader mesh__D020589smesh__D006088
% 208.44/208.61  |- skos__prefLabel mesh__D020589 Vitreoscilla
% 208.44/208.61  |- rdf__type mesh__D020589sskos__Concept
% 208.44/208.61  |- skos__scopeNote mesh__D020589
% 208.44/208.61       A genus of gram-negative, aerobic or microaerophilic, colorless filaments. It is nonfruiting, motile by gliding, and found in freshwater sediments and cow dung. One species %28%V. stercoraria%29% is considered morphologically to be a streptobacillus. That species is strictly aerobic and produces a homodimeric bacterial hemoglobin, especially under oxygen-limited growth conditions. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 208.44/208.61  |- mesh__historyNote mesh__D020589 2000   
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D020589 2006
% 208.44/208.61  |- mesh__publicMeSHNote mesh__D020589 2000   
% 208.44/208.61  |- mesh__dateRevised mesh__D020589 2005-06-30
% 208.44/208.61  |- mesh__recordOriginator mesh__D020589 ndw
% 208.44/208.61  |- mesh__recordMaintainer mesh__D020589 SYSTEM
% 208.44/208.61  |- skos__altLabel mesh__D019237 CEJ
% 208.44/208.61  |- skos__scopeNote mesh__D019237
% 208.44/208.61       The constricted part of the tooth at the junction of the crown and root or roots. It is often referred to as the cementoenamel junction %28%CEJ%29%, the line at which the cementum covering the root of a tooth and the enamel of the tooth meet. %28%Jablonski, Dictionary of Dentistry, 1992, p530, p433%29%%A%    
% 208.44/208.61  |- mesh__dateEstablished mesh__D019237 1997-01-01
% 208.44/208.61  |- skos__broader mesh__D019237smesh__D019589
% 208.44/208.61  |- skos__hiddenLabel mesh__D019237 Junctions, Cementoenamel
% 208.44/208.61  |- skos__hiddenLabel mesh__D019237 Junction, Cementoenamel
% 208.44/208.61  |- mesh__recordAuthorizer mesh__D019237 sjn
% 208.44/208.61  |- skos__prefLabel mesh__D019237 Tooth Cervix
% 208.44/208.61  |- skos__annotation mesh__D019237
% 208.44/208.61       IM; coord with specific tooth %28%IM%29% if pertinent; DF: note short X ref%A%  
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D019237 2006
% 208.44/208.61  |- mesh__dateRevised mesh__D019237 2003-07-09
% 208.44/208.61  |- mesh__recordMaintainer mesh__D019237 lkt
% 208.44/208.61  |- mesh__dateCreated mesh__D019237 1996-06-10
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D019237 2005
% 208.44/208.61  |- rdf__type mesh__D019237sskos__Concept
% 208.44/208.61  |- skos__hiddenLabel mesh__D019237 Cementoenamel Junctions
% 208.44/208.61  |- skos__hiddenLabel mesh__D019237 Cervix, Tooth
% 208.44/208.61  |- skos__altLabel mesh__D019237 Cervix Dentis
% 208.44/208.61  |- mesh__historyNote mesh__D019237 97   
% 208.44/208.61  |- mesh__recordOriginator mesh__D019237 TGC
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D019237 2004
% 208.44/208.61  |- skos__altLabel mesh__D019237 Cementoenamel Junction
% 208.44/208.61  |- mesh__publicMeSHNote mesh__D019237 97   
% 208.44/208.61  |- skos__broader mesh__D011254smesh__D011248
% 208.44/208.61  |- skos__hiddenLabel mesh__D011254 Pregnancy in Diabete
% 208.44/208.61  |- skos__hiddenLabel mesh__D011254 Pregnancy in Diabetic
% 208.44/208.61  |- skos__annotation mesh__D011254
% 208.44/208.61       DIABETES MELLITUS, not DIABETES INSIPIDUS; coordinate IM with specific type of diabetes mellitus %28%IM%29% if pertinent; DF: PREGN IN DIABETES%A%  
% 208.44/208.61  |- mesh__recordAuthorizer mesh__D011254 sjn
% 208.44/208.61  |- rdf__type mesh__D011254sskos__Concept
% 208.44/208.61  |- mesh__dateCreated mesh__D011254 1999-01-01
% 208.44/208.61  |- mesh__recordMaintainer mesh__D011254 lkt
% 208.44/208.61  |- skos__altLabel mesh__D011254 Pregnancy in Diabetes
% 208.44/208.61  |- mesh__dateRevised mesh__D011254 2005-06-30
% 208.44/208.61  |- skos__prefLabel mesh__D011254 Pregnancy in Diabetics
% 208.44/208.61  |- mesh__historyNote mesh__D011254 2001%28%1965%29%   
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D011254 2006
% 208.44/208.61  |- skos__related mesh__D011254smesh__D016640
% 208.44/208.61  |- mesh__publicMeSHNote mesh__D011254
% 208.44/208.61       2001; see PREGNANCY IN DIABETICS 1965-2000   
% 208.44/208.61  |- skos__scopeNote mesh__D011254
% 208.44/208.61       The state of PREGNANCY in women with DIABETES MELLITUS. This does not include either symptomatic diabetes or GLUCOSE INTOLERANCE induced by pregnancy %28%DIABETES, GESTATIONAL%29% which resolves at the end of pregnancy.%A%    
% 208.44/208.61  |- mesh__recordOriginator mesh__D011254 NLM
% 208.44/208.61  |- skos__broader mesh__D005217smesh__D004655
% 208.44/208.61  |- skos__scopeNote mesh__D005217
% 208.44/208.61       Emulsions of fats or lipids used primarily in parenteral feeding.%A%    
% 208.44/208.61  |- skos__historyNote mesh__D005217 Oils %28%1966-1978%29%
% 208.44/208.61  |- mesh__historyNote mesh__D005217 79   
% 208.44/208.61  |- mesh__recordOriginator mesh__D005217 RLS
% 208.44/208.61  |- skos__historyNote mesh__D005217 Lipids %28%1966-1978%29%
% 208.44/208.61  |- skos__historyNote mesh__D005217 Fats %28%1966-1978%29%
% 208.44/208.61  |- rdf__type mesh__D005217sskos__Concept
% 208.44/208.61  |- skos__hiddenLabel mesh__D005217 Emulsions, Intravenous Lipid
% 208.44/208.61  |- mesh__dateEstablished mesh__D005217 1979-01-01
% 208.44/208.61  |- skos__hiddenLabel mesh__D005217 Intravenous Fat Emulsions
% 208.44/208.61  |- skos__prefLabel mesh__D005217 Fat Emulsions, Intravenous
% 208.44/208.61  |- mesh__recordAuthorizer mesh__D005217 sjn
% 208.44/208.61  |- mesh__publicMeSHNote mesh__D005217 79   
% 208.44/208.61  |- skos__hiddenLabel mesh__D005217 Intravenous Lipid Emulsions
% 208.44/208.61  |- skos__broader mesh__D005217smesh__D004041
% 208.44/208.61  |- mesh__dateCreated mesh__D005217 1977-12-09
% 208.44/208.61  |- skos__altLabel mesh__D005217 Lipid Emulsions, Intravenous
% 208.44/208.61  |- skos__historyNote mesh__D005217 Dietary Fats %28%1966-1978%29%
% 208.44/208.61  |- skos__annotation mesh__D005217 coordinate with disease /ther   
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D005217 2006
% 208.44/208.61  |- skos__hiddenLabel mesh__D005217 Emulsions, Intravenous Fat
% 208.44/208.61  |- mesh__recordMaintainer mesh__D005217 ssb
% 208.44/208.61  |- mesh__dateRevised mesh__D005217 2005-06-30
% 208.44/208.61  |- skos__broader mesh__D003813Q000266smesh__D003813
% 208.44/208.61  |- mesh__preferredCombination mesh__D003813Q000266smesh__D006665
% 208.44/208.61  |- rdf__type mesh__D003813Q000266smesh__CompoundConcept
% 208.44/208.61  |- skos__historyNote mesh__D015645 Antibiotics %28%1966-1980%29%
% 208.44/208.61  |- rdf__type mesh__D015645sskos__Concept
% 208.44/208.61  |- mesh__recordOriginator mesh__D015645 RLS
% 208.44/208.61  |- skos__annotation mesh__D015645
% 208.44/208.61       do not use /biosyn unless by living matter   
% 208.44/208.61  |- skos__altLabel mesh__D015645 Tylosine
% 208.44/208.61  |- skos__altLabel mesh__D015645 Fradizine
% 208.44/208.61  |- mesh__onlineNote mesh__D015645
% 208.44/208.61       use ANTIBIOTICS to search TYLOSIN 1966-80; use LEUCOMYCINS 1981-89%A%  
% 208.44/208.61  |- skos__prefLabel mesh__D015645 Tylosin
% 208.44/208.61  |- skos__broader mesh__D015645smesh__D018942
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D015645 2006
% 208.44/208.61  |- skos__historyNote mesh__D015645 Leucomycins %28%1981-1989%29%
% 208.44/208.61  |- skos__scopeNote mesh__D015645
% 208.44/208.61       Macrolide antibiotic obtained from cultures of Streptomyces fradiae. The drug is effective against many microorganisms in animals but not in humans.%A%    
% 208.44/208.61  |- skos__hiddenLabel mesh__D015645 Hydrochloride, Tylosin
% 208.44/208.61  |- mesh__dateCreated mesh__D015645 1989-05-25
% 208.44/208.61  |- mesh__publicMeSHNote mesh__D015645
% 208.44/208.61       90; was see LEUCOMYCINS 1981-89; was see under ANTIBIOTICS 1964-80%A%  
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D015645 2005
% 208.44/208.61  |- mesh__dateEstablished mesh__D015645 1990-01-01
% 208.44/208.61  |- mesh__dateRevised mesh__D015645 2004-07-07
% 208.44/208.61  |- mesh__recordAuthorizer mesh__D015645 sjn
% 208.44/208.61  |- mesh__recordMaintainer mesh__D015645 ssb
% 208.44/208.61  |- mesh__historyNote mesh__D015645
% 208.44/208.61       90; was see LEUCOMYCINS 1981-89; was see under ANTIBIOTICS 1964-80%A%  
% 208.44/208.61  |- skos__scopeNote mesh__D009608
% 208.44/208.61       Nitrous acid %28%HNO2%29%. A weak acid that exists only in solution. It can form water-soluble nitrites and stable esters. %28%From Merck Index, 11th ed%29%%A%    
% 208.44/208.61  |- skos__hiddenLabel mesh__D009608 Acid, Nitrous
% 208.44/208.61  |- mesh__dateRevised mesh__D009608 1993-06-04
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D009608 2002
% 208.44/208.61  |- mesh__activeMeSHYear mesh__D009608 2005
% 208.44/208.62  |- skos__broader mesh__D009608smesh__D017672
% 208.44/208.62  |- skos__prefLabel mesh__D009608 Nitrous Acid
% 208.44/208.62  |- skos__annotation mesh__D009608 do not confuse with NITRIC ACID   
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D009608 2003
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D009608 1994
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D009608 2006
% 208.44/208.62  |- mesh__recordAuthorizer mesh__D009608 PLS
% 208.44/208.62  |- rdf__type mesh__D009608sskos__Concept
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D009608 1998
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D009608 2004
% 208.44/208.62  |- mesh__dateEstablished mesh__D009608 1991-01-01
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D009608 1995
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D009608 1996
% 208.44/208.62  |- skos__broader mesh__D009608smesh__D000148
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D009608 2000
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D009608 1999
% 208.44/208.62  |- mesh__historyNote mesh__D009608
% 208.44/208.62       91%28%75%29%; was see under NITRITES 1975-90   
% 208.44/208.62  |- mesh__dateCreated mesh__D009608 1999-01-01
% 208.44/208.62  |- mesh__publicMeSHNote mesh__D009608 91; was see under NITRITES 1975-90   
% 208.44/208.62  |- mesh__recordOriginator mesh__D009608 NLM
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D009608 1997
% 208.44/208.62  |- mesh__recordMaintainer mesh__D009608 TPW
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D009608 2001
% 208.44/208.62  |- mesh__onlineNote mesh__D009608 search NITRITES 1966-74   
% 208.44/208.62  |- skos__broader mesh__D001625smesh__D011720
% 208.44/208.62  |- mesh__dateCreated mesh__D001625 1974-11-19
% 208.44/208.62  |- skos__scopeNote mesh__D001625
% 208.44/208.62       A histamine H2 agonist used clinically to test gastric secretory function.%A%    
% 208.44/208.62  |- skos__hiddenLabel mesh__D001625 Monohydrochloride, Betazole
% 208.44/208.62  |- skos__altLabel mesh__D001625 Ametazole
% 208.44/208.62  |- mesh__dateEstablished mesh__D001625 1991-01-01
% 208.44/208.62  |- mesh__publicMeSHNote mesh__D001625
% 208.44/208.62       91; was see under PYRAZOLES 1975-90   
% 208.44/208.62  |- skos__historyNote mesh__D001625 Ethylamines %28%1972-1974%29%
% 208.44/208.62  |- skos__hiddenLabel mesh__D001625 96791, Lilly
% 208.44/208.62  |- mesh__dateRevised mesh__D001625 2005-06-30
% 208.44/208.62  |- mesh__recordMaintainer mesh__D001625 ssb
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D001625 2006
% 208.44/208.62  |- skos__historyNote mesh__D001625 Pyrazoles %28%1968-1974%29%
% 208.44/208.62  |- rdf__type mesh__D001625sskos__Concept
% 208.44/208.62  |- mesh__historyNote mesh__D001625
% 208.44/208.62       91%28%75%29%; was see under PYRAZOLES 1975-90   
% 208.44/208.62  |- skos__hiddenLabel mesh__D001625 Dihydrochloride, Betazole
% 208.44/208.62  |- skos__prefLabel mesh__D001625 Betazole
% 208.44/208.62  |- mesh__recordOriginator mesh__D001625 NLM
% 208.44/208.62  |- mesh__recordAuthorizer mesh__D001625 sjn
% 208.44/208.62  |- rdf__type mesh__D034001sskos__Concept
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D034001 2004
% 208.44/208.62  |- mesh__publicMeSHNote mesh__D034001 2003   
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D034001 2003
% 208.44/208.62  |- skos__altLabel mesh__D034001 Adaptor Protein Subunits
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D034001 2006
% 208.44/208.62  |- skos__prefLabel mesh__D034001 Adaptor Protein Complex Subunits
% 208.44/208.62  |- skos__scopeNote mesh__D034001
% 208.44/208.62       The subunits that make up the large, medium and small chains of adaptor proteins.%A%    
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D034001 2005
% 208.44/208.62  |- mesh__dateCreated mesh__D034001 2002-07-02
% 208.44/208.62  |- mesh__dateEstablished mesh__D034001 2003-01-01
% 208.44/208.62  |- skos__broader mesh__D034001smesh__D033942
% 208.44/208.62  |- mesh__historyNote mesh__D034001 2003   
% 208.44/208.62  |- skos__hiddenLabel mesh__D006310 Ear Mold
% 208.44/208.62  |- mesh__recordOriginator mesh__D006310 NLM
% 208.44/208.62  |- skos__hiddenLabel mesh__D006310 Mold, Ear
% 208.44/208.62  |- mesh__dateCreated mesh__D006310 1999-01-01
% 208.44/208.62  |- rdf__type mesh__D006310sskos__Concept
% 208.44/208.62  |- skos__scopeNote mesh__D006310
% 208.44/208.62       Wearable sound-amplifying devices that are intended to compensate for impaired hearing. These generic devices include air-conduction hearing aids and bone-conduction hearing aids. %28%UMDNS, 1999%29%%A%    
% 208.44/208.62  |- skos__broader mesh__D006310smesh__D012682
% 208.44/208.62  |- mesh__recordAuthorizer mesh__D006310 sjn
% 208.44/208.62  |- skos__hiddenLabel mesh__D006310 Hearing Aid
% 208.44/208.62  |- skos__hiddenLabel mesh__D006310 Molds, Ear
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D006310 2006
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D006310 2002
% 208.44/208.62  |- skos__annotation mesh__D006310
% 208.44/208.62       %22%hearing aid%22% is correct translation for %22%proth%C3%%A8%se auditive%22%, not %22%auditory prosthesis%22% unless you mean COCHLEAR IMPLANT%A%  
% 208.44/208.62  |- mesh__recordMaintainer mesh__D006310 jls
% 208.44/208.62  |- mesh__dateRevised mesh__D006310 2001-08-13
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D006310 2005
% 208.44/208.62  |- skos__prefLabel mesh__D006310 Hearing Aids
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D006310 2004
% 208.44/208.62  |- skos__hiddenLabel mesh__D006310 Aid, Hearing
% 208.44/208.62  |- skos__hiddenLabel mesh__D006310 Aids, Hearing
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D006310 2003
% 208.44/208.62  |- mesh__publicMeSHNote mesh__D011255
% 208.44/208.62       80; was see under PREGNANCY 1975-79   
% 208.44/208.62  |- skos__hiddenLabel mesh__D011255 Pregnancy Maintenances
% 208.44/208.62  |- skos__scopeNote mesh__D011255
% 208.44/208.62       Physiological mechanisms that sustain the state of PREGNANCY.%A%    
% 208.44/208.62  |- skos__annotation mesh__D011255
% 208.44/208.62       check tags FEMALE %26% PREGNANCY; DF: PREGN MAINTENANCE   
% 208.44/208.62  |- rdf__type mesh__D011255sskos__Concept
% 208.44/208.62  |- skos__prefLabel mesh__D011255 Pregnancy Maintenance
% 208.44/208.62  |- mesh__recordOriginator mesh__D011255 NLM
% 208.44/208.62  |- skos__hiddenLabel mesh__D011255 Maintenance, Pregnancy
% 208.44/208.62  |- mesh__dateRevised mesh__D011255 2004-07-07
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D011255 2005
% 208.44/208.62  |- skos__broader mesh__D011255smesh__D011247
% 208.44/208.62  |- mesh__recordAuthorizer mesh__D011255 sjn
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D011255 2006
% 208.44/208.62  |- mesh__historyNote mesh__D011255
% 208.44/208.62       80%28%75%29%; was see under PREGNANCY 1975-79   
% 208.44/208.62  |- mesh__dateCreated mesh__D011255 1974-11-11
% 208.44/208.62  |- skos__hiddenLabel mesh__D011255 Maintenances, Pregnancy
% 208.44/208.62  |- mesh__recordMaintainer mesh__D011255 lkt
% 208.44/208.62  |- mesh__dateEstablished mesh__D011255 1980-01-01
% 208.44/208.62  |- skos__scopeNote mesh__D005218
% 208.44/208.62       A condition in which the death of adipose tissue results in neutral fats being split into fatty acids and glycerol.%A%    
% 208.44/208.62  |- skos__altLabel mesh__D005218 Steatonecrosis
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D005218 2005
% 208.44/208.62  |- mesh__recordOriginator mesh__D005218 VDK
% 208.44/208.62  |- skos__hiddenLabel mesh__D005218 Fat Necroses
% 208.44/208.62  |- rdf__type mesh__D005218sskos__Concept
% 208.44/208.62  |- mesh__publicMeSHNote mesh__D005218 91; was see under NECROSIS 1977-90   
% 208.44/208.62  |- mesh__dateEstablished mesh__D005218 1991-01-01
% 208.44/208.62  |- mesh__recordAuthorizer mesh__D005218 sjn
% 208.44/208.62  |- skos__historyNote mesh__D005218 Necrosis %28%1966-1976%29%
% 208.44/208.62  |- skos__hiddenLabel mesh__D005218 Steatonecroses
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D005218 2002
% 208.44/208.62  |- mesh__dateCreated mesh__D005218 1976-04-27
% 208.44/208.62  |- mesh__dateRevised mesh__D005218 1999-11-03
% 208.44/208.62  |- skos__prefLabel mesh__D005218 Fat Necrosis
% 208.44/208.62  |- mesh__historyNote mesh__D005218
% 208.44/208.62       91%28%77%29%; was see under NECROSIS 1977-90   
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D005218 2001
% 208.44/208.62  |- mesh__recordMaintainer mesh__D005218 KEV
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D005218 2004
% 208.44/208.62  |- skos__broader mesh__D005218smesh__D009336
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D005218 2000
% 208.44/208.62  |- skos__hiddenLabel mesh__D005218 Necrosis, Fat
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D005218 2003
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D005218 2006
% 208.44/208.62  |- skos__hiddenLabel mesh__D015646
% 208.44/208.62       Ventriculographies, First-Pass Radionuclide
% 208.44/208.62  |- skos__historyNote mesh__D015646 Heart %28%1977-1989%29%
% 208.44/208.62  |- skos__hiddenLabel mesh__D015646
% 208.44/208.62       First-Pass Radionuclide Ventriculographies
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D015646 2005
% 208.44/208.62  |- skos__annotation mesh__D015646
% 208.44/208.62       %22%ventriculo-%22% refers to the heart, not the cerebral ventricles; used for the right or left ventricle but is preferred for right: for the left ventricle GATED BLOOD-POOL IMAGING is preferred; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: VENTRICULOGR FIRST PASS%A%  
% 208.44/208.62  |- skos__historyNote mesh__D015646
% 208.44/208.62       Radionuclide Angiography %28%1983-1989%29%
% 208.44/208.62  |- mesh__dateRevised mesh__D015646 1997-06-20
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D015646 1999
% 208.44/208.62  |- rdf__type mesh__D015646sskos__Concept
% 208.44/208.62  |- skos__broader mesh__D015646smesh__D015635
% 208.44/208.62  |- skos__hiddenLabel mesh__D015646 First Pass Ventriculography
% 208.44/208.62  |- skos__hiddenLabel mesh__D015646 Ventriculography, First Pass
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D015646 2006
% 208.44/208.62  |- skos__hiddenLabel mesh__D015646 Radionuclide Angiography, First Pass
% 208.44/208.62  |- skos__hiddenLabel mesh__D015646 Radionuclide Angiographies, First-Pass
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D015646 2002
% 208.44/208.62  |- skos__related mesh__D015646smesh__D015637
% 208.44/208.62  |- mesh__recordAuthorizer mesh__D015646 SJN
% 208.44/208.62  |- skos__hiddenLabel mesh__D015646
% 208.44/208.62       Ventriculography, First-Pass Radionuclide
% 208.44/208.62  |- mesh__publicMeSHNote mesh__D015646 90   
% 208.44/208.62  |- skos__altLabel mesh__D015646 Radionuclide Ventriculography, First-Pass
% 208.44/208.62  |- skos__hiddenLabel mesh__D015646 Angiographies, First-Pass Radionuclide
% 208.44/208.62  |- skos__hiddenLabel mesh__D015646 First Pass Radionuclide Angiography
% 208.44/208.62  |- mesh__dateCreated mesh__D015646 1989-06-19
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D015646 2003
% 208.44/208.62  |- skos__historyNote mesh__D015646 Heart Ventricle %28%1977-1989%29%
% 208.44/208.62  |- mesh__historyNote mesh__D015646 90   
% 208.44/208.62  |- skos__altLabel mesh__D015646 First-Pass Ventriculography
% 208.44/208.62  |- mesh__dateEstablished mesh__D015646 1990-01-01
% 208.44/208.62  |- skos__scopeNote mesh__D015646
% 208.44/208.62       Radionuclide ventriculography where a bolus of radionuclide is injected and data are recorded from one pass through the heart ventricle. Left and right ventricular function can be analyzed independently during this technique. First-pass ventriculography is preferred over GATED BLOOD-POOL IMAGING for assessing right ventricular function.%A%    
% 208.44/208.62  |- skos__hiddenLabel mesh__D015646
% 208.44/208.62       Radionuclide Ventriculography, First Pass
% 208.44/208.62  |- skos__prefLabel mesh__D015646 Ventriculography, First-Pass
% 208.44/208.62  |- skos__hiddenLabel mesh__D015646 First-Pass Ventriculographies
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D015646 2004
% 208.44/208.62  |- skos__hiddenLabel mesh__D015646
% 208.44/208.62       Radionuclide Ventriculographies, First-Pass
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D015646 2000
% 208.44/208.62  |- skos__hiddenLabel mesh__D015646 First-Pass Radionuclide Ventriculography
% 208.44/208.62  |- mesh__recordMaintainer mesh__D015646 PXP
% 208.44/208.62  |- mesh__recordOriginator mesh__D015646 AGS
% 208.44/208.62  |- skos__altLabel mesh__D015646 First-Pass Radionuclide Angiography
% 208.44/208.62  |- skos__hiddenLabel mesh__D015646 Angiography, First-Pass Radionuclide
% 208.44/208.62  |- skos__hiddenLabel mesh__D015646 First-Pass Radionuclide Angiographies
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D015646 1998
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D015646 2001
% 208.44/208.62  |- skos__altLabel mesh__D015646 Radionuclide Angiography, First-Pass
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D009609 2001
% 208.44/208.62  |- skos__prefLabel mesh__D009609 Nitrous Oxide
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D009609 2000
% 208.44/208.62  |- mesh__recordOriginator mesh__D009609 NLM
% 208.44/208.62  |- skos__scopeNote mesh__D009609
% 208.44/208.62       Nitrogen oxide %28%N2O%29%. A colorless, odorless gas that is used as an anesthetic and analgesic. High concentrations cause a narcotic effect and may replace oxygen, causing death by asphyxia. It is also used as a food aerosol in the preparation of whipping cream.%A%    
% 208.44/208.62  |- mesh__recordMaintainer mesh__D009609 adp
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D009609 2004
% 208.44/208.62  |- mesh__dateRevised mesh__D009609 1999-11-03
% 208.44/208.62  |- skos__hiddenLabel mesh__D009609 Gas, Laughing
% 208.44/208.62  |- mesh__dateCreated mesh__D009609 1999-01-01
% 208.44/208.62  |- skos__annotation mesh__D009609
% 208.44/208.62       an inhalation anesthetic %26% nonnarcotic analgesic   
% 208.44/208.62  |- mesh__recordAuthorizer mesh__D009609 sjn
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D009609 2003
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D009609 2006
% 208.44/208.62  |- skos__altLabel mesh__D009609 Laughing Gas
% 208.44/208.62  |- skos__broader mesh__D009609smesh__D009589
% 208.44/208.62  |- rdf__type mesh__D009609sskos__Concept
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D009609 2002
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D009609 2005
% 208.44/208.62  |- skos__hiddenLabel mesh__D009609 Oxide, Nitrous
% 208.44/208.62  |- skos__annotation mesh__D001626
% 208.44/208.62       ammonium cpds; BETHANECHOL is available; DF: BETHANECHOL CPDS%A%  
% 208.44/208.62  |- mesh__recordOriginator mesh__D001626 NLM
% 208.44/208.62  |- mesh__recordAuthorizer mesh__D001626 sjn
% 208.44/208.62  |- mesh__dateCreated mesh__D001626 1999-01-01
% 208.44/208.62  |- mesh__dateEstablished mesh__D001626 1968-01-01
% 208.44/208.62  |- skos__prefLabel mesh__D001626 Bethanechol Compounds
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D001626 2006
% 208.44/208.62  |- mesh__publicMeSHNote mesh__D001626 68   
% 208.44/208.62  |- rdf__type mesh__D001626sskos__Concept
% 208.44/208.62  |- skos__broader mesh__D001626smesh__D050337
% 208.44/208.62  |- mesh__dateRevised mesh__D001626 2005-06-30
% 208.44/208.62  |- skos__hiddenLabel mesh__D001626 Compounds, Bethanechol
% 208.44/208.62  |- mesh__recordMaintainer mesh__D001626 ssb
% 208.44/208.62  |- skos__broader mesh__D001626smesh__D000644
% 208.44/208.62  |- mesh__historyNote mesh__D001626
% 208.44/208.62       68; was BETHANECHOL 1964-67 %28%Prov%29%; URECHOLINE was URECHOLINE CHLORIDE see under BETHANECHOL COMPOUNDS 1968-76%A%  
% 208.44/208.62  |- mesh__onlineNote mesh__D001626
% 208.44/208.62       use BETHANECHOL COMPOUNDS to search BETHANECHOL 1966-67 %28%as Prov 1966-67%29% %26% URECHOLINE CHLORIDE 1968-76%A%  
% 208.44/208.62  |- mesh__dateCreated mesh__D034002 2002-07-02
% 208.44/208.62  |- mesh__dateEstablished mesh__D034002 2003-01-01
% 208.44/208.62  |- mesh__publicMeSHNote mesh__D034002 2003   
% 208.44/208.62  |- mesh__recordOriginator mesh__D034002 jmp
% 208.44/208.62  |- mesh__historyNote mesh__D034002 2003   
% 208.44/208.62  |- skos__prefLabel mesh__D034002 Adaptor Protein Complex sigma Subunits
% 208.44/208.62  |- skos__historyNote mesh__D034002 Adaptor Proteins %28%1995-2002%29%
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D034002 2006
% 208.44/208.62  |- skos__hiddenLabel mesh__D034002 Sigma Adaptins
% 208.44/208.62  |- skos__altLabel mesh__D034002
% 208.44/208.62       Clathrin Assembly Protein Complex sigma Subunit
% 208.44/208.62  |- skos__scopeNote mesh__D034002
% 208.44/208.62       A family of small adaptin protein complex subunits of approximately 19 KDa in size.%A%    
% 208.44/208.62  |- mesh__recordMaintainer mesh__D034002 jmp
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D034002 2005
% 208.44/208.62  |- mesh__recordAuthorizer mesh__D034002 sjn
% 208.44/208.62  |- mesh__dateRevised mesh__D034002 2004-07-07
% 208.44/208.62  |- skos__broader mesh__D034002smesh__D034001
% 208.44/208.62  |- skos__altLabel mesh__D034002 Sigma-Adaptins
% 208.44/208.62  |- rdf__type mesh__D034002sskos__Concept
% 208.44/208.62  |- skos__altLabel mesh__D006311 Paracusis
% 208.44/208.62  |- skos__broader mesh__D006311smesh__D004427
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D006311 2006
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D006311 2005
% 208.44/208.62  |- skos__related mesh__D006311smesh__D019986
% 208.44/208.62  |- skos__prefLabel mesh__D006311 Hearing Disorders
% 208.44/208.62  |- mesh__recordOriginator mesh__D006311 NLM
% 208.44/208.62  |- mesh__recordMaintainer mesh__D006311 lkt
% 208.44/208.62  |- mesh__dateRevised mesh__D006311 2004-07-07
% 208.44/208.62  |- skos__broader mesh__D006311smesh__D012678
% 208.44/208.62  |- skos__annotation mesh__D006311
% 208.44/208.62       GEN or unspecified; consider also DEAFNESS and HEARING LOSS and its indentations%A%  
% 208.44/208.62  |- skos__scopeNote mesh__D006311
% 208.44/208.62       Conditions that impair the transmission of auditory impulses and information from the level of the ear to the temporal cortices, including the sensorineural pathways.%A%    
% 208.44/208.62  |- skos__hiddenLabel mesh__D006311 Hearing, Distorted
% 208.44/208.62  |- mesh__dateCreated mesh__D006311 1999-01-01
% 208.44/208.62  |- skos__hiddenLabel mesh__D006311 Hearing Disorder
% 208.44/208.62  |- rdf__type mesh__D006311sskos__Concept
% 208.44/208.62  |- mesh__recordAuthorizer mesh__D006311 sjn
% 208.44/208.62  |- skos__hiddenLabel mesh__D047728 Progressive Myopia
% 208.44/208.62  |- mesh__historyNote mesh__D047728 2005   
% 208.44/208.62  |- skos__hiddenLabel mesh__D047728 Pathological Myopias
% 208.44/208.62  |- skos__hiddenLabel mesh__D047728 Progressive Myopias
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D047728 2006
% 208.44/208.62  |- skos__historyNote mesh__D047728 Myopia %28%1965-2004%29%
% 208.44/208.62  |- rdf__type mesh__D047728sskos__Concept
% 208.44/208.62  |- skos__altLabel mesh__D047728 Myopia, Pathological
% 208.44/208.62  |- mesh__dateEstablished mesh__D047728 2005-01-01
% 208.44/208.62  |- mesh__recordOriginator mesh__D047728 ags
% 208.44/208.62  |- mesh__recordMaintainer mesh__D047728 jls
% 208.44/208.62  |- skos__hiddenLabel mesh__D047728 Degenerative Myopia
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D047728 2005
% 208.44/208.62  |- skos__prefLabel mesh__D047728 Myopia, Degenerative
% 208.44/208.62  |- skos__broader mesh__D047728smesh__D009216
% 208.44/208.62  |- skos__hiddenLabel mesh__D047728 Myopias, Pathological
% 208.44/208.62  |- mesh__dateRevised mesh__D047728 2004-07-29
% 208.44/208.62  |- skos__hiddenLabel mesh__D047728 Pathological Myopia
% 208.44/208.62  |- skos__hiddenLabel mesh__D047728 Degenerative Myopias
% 208.44/208.62  |- skos__hiddenLabel mesh__D047728 Myopias, Progressive
% 208.44/208.62  |- mesh__dateCreated mesh__D047728 2004-07-07
% 208.44/208.62  |- mesh__publicMeSHNote mesh__D047728 2005   
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D047728 2005A
% 208.44/208.62  |- skos__scopeNote mesh__D047728
% 208.44/208.62       Excessive axial myopia associated with complications %28%especially posterior staphyloma and CHOROIDAL NEOVASCULARIZATION%29% that can lead to BLINDNESS.%A%    
% 208.44/208.62  |- mesh__recordAuthorizer mesh__D047728 jls
% 208.44/208.62  |- skos__hiddenLabel mesh__D047728 Myopias, Degenerative
% 208.44/208.62  |- skos__altLabel mesh__D019239 Practice Patterns, Dental
% 208.44/208.62  |- mesh__dateRevised mesh__D019239 1999-11-03
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D019239 2000
% 208.44/208.62  |- skos__hiddenLabel mesh__D019239 Practice Patterns, Dentist%27%s
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D019239 2006
% 208.44/208.62  |- skos__broader mesh__D019239smesh__D003695
% 208.44/208.62  |- skos__hiddenLabel mesh__D019239 Pattern, Dentist%27%s Practice
% 208.44/208.62  |- skos__hiddenLabel mesh__D019239 Dentists Practice Patterns
% 208.44/208.62  |- skos__altLabel mesh__D019239 Dental Practice Pattern
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D019239 2001
% 208.44/208.62  |- skos__annotation mesh__D019239
% 208.44/208.62       practice in dentistry related to diag %26% treatment   
% 208.44/208.62  |- skos__hiddenLabel mesh__D019239 Practice Pattern, Dentist%27%s
% 208.44/208.62  |- skos__broader mesh__D019239smesh__D010346
% 208.44/208.62  |- rdf__type mesh__D019239sskos__Concept
% 208.44/208.62  |- mesh__recordOriginator mesh__D019239 TGC
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D019239 2003
% 208.44/208.62  |- mesh__publicMeSHNote mesh__D019239 97   
% 208.44/208.62  |- mesh__dateCreated mesh__D019239 1996-06-13
% 208.44/208.62  |- skos__historyNote mesh__D019239 Professional Practice %28%1987-1995%29%
% 208.44/208.62  |- mesh__historyNote mesh__D019239 97   
% 208.44/208.62  |- skos__altLabel mesh__D019239 Pattern, Dental Practice
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D019239 2004
% 208.44/208.62  |- skos__altLabel mesh__D019239 Practice Pattern, Dental
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D019239 2002
% 208.44/208.62  |- skos__historyNote mesh__D019239
% 208.44/208.62       Physician%27%s Practice Patterns %28%1990-1996%29%
% 208.44/208.62  |- mesh__recordMaintainer mesh__D019239 kle
% 208.44/208.62  |- skos__hiddenLabel mesh__D019239 Dentist%27%s Practice Pattern
% 208.44/208.62  |- skos__altLabel mesh__D019239 Dental Practice Patterns
% 208.44/208.62  |- skos__prefLabel mesh__D019239 Dentist%27%s Practice Patterns
% 208.44/208.62  |- skos__hiddenLabel mesh__D019239 Patterns, Dentist%27%s Practice
% 208.44/208.62  |- skos__altLabel mesh__D019239 Patterns, Dental Practice
% 208.44/208.62  |- mesh__recordAuthorizer mesh__D019239 sjn
% 208.44/208.62  |- skos__hiddenLabel mesh__D019239 Dentist Practice Patterns
% 208.44/208.62  |- skos__scopeNote mesh__D019239
% 208.44/208.62       Patterns of practice in dentistry related to diagnosis and treatment.%A%    
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D019239 2005
% 208.44/208.62  |- mesh__dateEstablished mesh__D019239 1997-01-01
% 208.44/208.62  |- mesh__dateRevised mesh__D011256 2005-06-30
% 208.44/208.62  |- rdf__type mesh__D011256sskos__Concept
% 208.44/208.62  |- mesh__historyNote mesh__D011256 88   
% 208.44/208.62  |- mesh__publicMeSHNote mesh__D011256 88   
% 208.44/208.62  |- skos__historyNote mesh__D011256 Pregnancy %28%1966-1987%29%
% 208.44/208.62  |- mesh__recordMaintainer mesh__D011256 lkt
% 208.44/208.62  |- skos__prefLabel mesh__D011256 Pregnancy Outcome
% 208.44/208.62  |- skos__altLabel mesh__D011256 Pregnancy Outcomes
% 208.44/208.62  |- skos__broader mesh__D011256smesh__D011379
% 208.44/208.62  |- skos__annotation mesh__D011256
% 208.44/208.62       general or unspecified: prefer specific outcome; DF: PREGN OUTCOME%A%  
% 208.44/208.62  |- mesh__recordOriginator mesh__D011256 EC
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D011256 2006
% 208.44/208.62  |- skos__altLabel mesh__D011256 Outcomes, Pregnancy
% 208.44/208.62  |- mesh__dateCreated mesh__D011256 1987-03-23
% 208.44/208.62  |- mesh__dateEstablished mesh__D011256 1988-01-01
% 208.44/208.62  |- skos__historyNote mesh__D011256
% 208.44/208.62       Pregnancy Complications %28%1966-1987%29%
% 208.44/208.62  |- skos__broader mesh__D011256smesh__D011247
% 208.44/208.62  |- mesh__recordAuthorizer mesh__D011256 sjn
% 208.44/208.62  |- skos__altLabel mesh__D011256 Outcome, Pregnancy
% 208.44/208.62  |- skos__scopeNote mesh__D011256
% 208.44/208.62       Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; SPONTANEOUS ABORTION; INDUCED ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO.%A%    
% 208.44/208.62  |- skos__hiddenLabel mesh__D005219 Relationship, Father-Child
% 208.44/208.62  |- mesh__dateEstablished mesh__D005219 1968-01-01
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D005219 2001
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D005219 1996
% 208.44/208.62  |- mesh__recordMaintainer mesh__D005219 TAP
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D005219 1999
% 208.44/208.62  |- skos__hiddenLabel mesh__D005219 Relationships, Father-Child
% 208.44/208.62  |- mesh__publicMeSHNote mesh__D005219 68   
% 208.44/208.62  |- skos__altLabel mesh__D005219 Father-Child Relationship
% 208.44/208.62  |- skos__hiddenLabel mesh__D005219 Father Child Relationship
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D005219 2000
% 208.44/208.62  |- skos__hiddenLabel mesh__D005219 Relations, Father-Child
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D005219 1998
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D005219 1993
% 208.44/208.62  |- skos__historyNote mesh__D005219 Parent-Child Relations %28%1966-1967%29%
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D005219 2004
% 208.44/208.62  |- skos__annotation mesh__D005219 human only; DF: FATHER CHILD RELAT   
% 208.44/208.62  |- mesh__dateCreated mesh__D005219 1999-01-01
% 208.44/208.62  |- mesh__recordAuthorizer mesh__D005219 PLS
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D005219 1995
% 208.44/208.62  |- skos__prefLabel mesh__D005219 Father-Child Relations
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D005219 2003
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D005219 2006
% 208.44/208.62  |- mesh__dateRevised mesh__D005219 1992-05-15
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D005219 1994
% 208.44/208.62  |- skos__hiddenLabel mesh__D005219 Father-Child Relation
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D005219 2005
% 208.44/208.62  |- mesh__historyNote mesh__D005219 68   
% 208.44/208.62  |- skos__broader mesh__D005219smesh__D010287
% 208.44/208.62  |- skos__hiddenLabel mesh__D005219 Father Child Relations
% 208.44/208.62  |- skos__scopeNote mesh__D005219
% 208.44/208.62       Interaction between the father and the child.     
% 208.44/208.62  |- skos__hiddenLabel mesh__D005219 Father-Child Relationships
% 208.44/208.62  |- rdf__type mesh__D005219sskos__Concept
% 208.44/208.62  |- skos__hiddenLabel mesh__D005219 Relation, Father-Child
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D005219 2002
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D005219 1997
% 208.44/208.62  |- mesh__recordOriginator mesh__D005219 NLM
% 208.44/208.62  |- skos__altLabel mesh__D015647 SKF38393
% 208.44/208.62  |- skos__altLabel mesh__D015647 SKF-38393
% 208.44/208.62  |- mesh__recordMaintainer mesh__D015647 ssb
% 208.44/208.62  |- skos__prefLabel mesh__D015647
% 208.44/208.62       2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
% 208.44/208.62  |- skos__historyNote mesh__D015647 Benzazepines %28%1966-1989%29%
% 208.44/208.62  |- skos__altLabel mesh__D015647 SKF 38393-A
% 208.44/208.62  |- skos__hiddenLabel mesh__D015647 SK%26%F 38393
% 208.44/208.62  |- skos__hiddenLabel mesh__D015647 SK%26%F38393
% 208.44/208.62  |- skos__altLabel mesh__D015647 R-SK%26%F 38393
% 208.44/208.62  |- mesh__dateEstablished mesh__D015647 1990-01-01
% 208.44/208.62  |- skos__hiddenLabel mesh__D015647 SKF 38393A
% 208.44/208.62  |- skos__altLabel mesh__D015647
% 208.44/208.62       1H-3-Benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D015647 2006
% 208.44/208.62  |- mesh__publicMeSHNote mesh__D015647 2005; see SK%26%F-38393 1989-2004   
% 208.44/208.62  |- skos__historyNote mesh__D015647 Dopaminergic Agents %28%1989%29%
% 208.44/208.62  |- mesh__recordOriginator mesh__D015647 RLS
% 208.44/208.62  |- mesh__historyNote mesh__D015647 2005%28%1990%29%   
% 208.44/208.62  |- skos__hiddenLabel mesh__D015647 RSK%26%F 38393
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D015647 2005
% 208.44/208.62  |- mesh__dateRevised mesh__D015647 2004-07-07
% 208.44/208.62  |- skos__scopeNote mesh__D015647
% 208.44/208.62       A selective D1 dopamine receptor agonist used primarily as a research tool.%A%    
% 208.44/208.62  |- rdf__type mesh__D015647sskos__Concept
% 208.44/208.62  |- skos__hiddenLabel mesh__D015647 SKF 38393
% 208.44/208.62  |- skos__broader mesh__D015647smesh__D001552
% 208.44/208.62  |- mesh__dateCreated mesh__D015647 1989-09-01
% 208.44/208.62  |- mesh__recordAuthorizer mesh__D015647 sjn
% 208.44/208.62  |- skos__hiddenLabel mesh__D015647 SKF 38393 A
% 208.44/208.62  |- rdf__type mesh__D034801sskos__Concept
% 208.44/208.62  |- skos__historyNote mesh__D034801 Mastocytosis %28%1985-2002%29%
% 208.44/208.62  |- mesh__recordOriginator mesh__D034801 lkt
% 208.44/208.62  |- mesh__activeMeSHYear mesh__D034801 2005
% 208.44/208.62  |- mesh__publicMeSHNote mesh__D034801
% 208.44/208.62       2003;  for MASTOCYTOMA BENIGN see MASTOCYTOSIS 1987-2002   
% 208.44/208.62  |- skos__annotation mesh__D034801
% 208.44/208.62       unifocal lesion only; multi-focal lesions use MASTOCYTOSIS, CUTANEOUS%A%  
% 208.44/208.62  |- skos__broader mesh__D034801smesh__D008415
% 208.44/208.63  |- mesh__recordAuthorizer mesh__D034801 sjn
% 208.44/208.63  |- skos__altLabel mesh__D034801 Mastocytoma, Skin
% 208.44/208.63  |- skos__altLabel mesh__D034801 Skin Mastocytoma
% 208.44/208.63  |- mesh__dateCreated mesh__D034801 2002-07-02
% 208.44/208.63  |- skos__altLabel mesh__D034801 Benign Mastocytoma
% 208.44/208.63  |- mesh__dateEstablished mesh__D034801 2003-01-01
% 208.44/208.63  |- mesh__historyNote mesh__D034801
% 208.44/208.63       2003; for MASTOCYTOMA BENIGN use MASTOCYTOSIS 1987-2002   
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D034801 2004
% 208.44/208.63  |- skos__scopeNote mesh__D034801
% 208.44/208.63       A solid tumor consisting of a dense infiltration of MAST CELLS. It is generally benign.%A%    
% 208.44/208.63  |- mesh__recordMaintainer mesh__D034801 lkt
% 208.44/208.63  |- skos__prefLabel mesh__D034801 Mastocytoma
% 208.44/208.63  |- skos__hiddenLabel mesh__D034801 Cutaneous Mastocytoma
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D034801 2006
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D034801 2003
% 208.44/208.63  |- rdf__type mesh__D001627sskos__Concept
% 208.44/208.63  |- skos__prefLabel mesh__D001627 Bethanidine
% 208.44/208.63  |- mesh__publicMeSHNote mesh__D001627
% 208.44/208.63       91; was see under GUANIDINES 1975-90   
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D001627 2005
% 208.44/208.63  |- skos__altLabel mesh__D001627 Wellcome Brand of Betanidine Sulfate
% 208.44/208.63  |- skos__historyNote mesh__D001627 Benzyl Compounds %28%1972-1974%29%
% 208.44/208.63  |- skos__altLabel mesh__D001627 Betanidine
% 208.44/208.63  |- mesh__recordOriginator mesh__D001627 NLM
% 208.44/208.63  |- mesh__dateCreated mesh__D001627 1974-11-19
% 208.44/208.63  |- mesh__recordAuthorizer mesh__D001627 sjn
% 208.44/208.63  |- mesh__historyNote mesh__D001627
% 208.44/208.63       91%28%75%29%; was see under GUANIDINES 1975-90   
% 208.44/208.63  |- skos__altLabel mesh__D001627 Bethanidine, Sulfate %28%2:1%29%
% 208.44/208.63  |- skos__hiddenLabel mesh__D001627 Sulfate, Bethanidine
% 208.44/208.63  |- skos__broader mesh__D001627smesh__D006146
% 208.44/208.63  |- mesh__dateRevised mesh__D001627 2004-07-07
% 208.44/208.63  |- mesh__dateEstablished mesh__D001627 1991-01-01
% 208.44/208.63  |- mesh__recordMaintainer mesh__D001627 mdb
% 208.44/208.63  |- skos__scopeNote mesh__D001627
% 208.44/208.63       A guanidinium antihypertensive agent that acts by blocking adrenergic transmission. The precise mode of action is not clear.%A%    
% 208.44/208.63  |- skos__historyNote mesh__D001627 Guanidines %28%1968-1974%29%
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D001627 2006
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D006312 2006
% 208.44/208.63  |- skos__historyNote mesh__D006312 Deafness %28%1966-1978%29%
% 208.44/208.63  |- mesh__recordAuthorizer mesh__D006312 sjn
% 208.44/208.63  |- skos__hiddenLabel mesh__D006312 Loss, Bilateral Hearing
% 208.44/208.63  |- skos__hiddenLabel mesh__D006312 Hearing Losses, Bilateral
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D006312 2005
% 208.44/208.63  |- mesh__dateEstablished mesh__D006312 1991-01-01
% 208.44/208.63  |- skos__hiddenLabel mesh__D006312 Bilateral Hearing Loss
% 208.44/208.63  |- skos__hiddenLabel mesh__D006312 Bilateral Hearing Losses
% 208.44/208.63  |- skos__scopeNote mesh__D006312 Partial hearing loss in both ears.     
% 208.44/208.63  |- mesh__dateRevised mesh__D006312 2004-07-07
% 208.44/208.63  |- skos__annotation mesh__D006312
% 208.44/208.63       differentiate from DEAFNESS, total hearing loss in both ears%A%  
% 208.44/208.63  |- skos__broader mesh__D006312smesh__D034381
% 208.44/208.63  |- mesh__historyNote mesh__D006312
% 208.44/208.63       91%28%79%29%; was see under HEARING LOSS, PARTIAL 1979-90   
% 208.44/208.63  |- rdf__type mesh__D006312sskos__Concept
% 208.44/208.63  |- skos__hiddenLabel mesh__D006312 Losses, Bilateral Hearing
% 208.44/208.63  |- mesh__recordMaintainer mesh__D006312 lkt
% 208.44/208.63  |- mesh__recordOriginator mesh__D006312 RC
% 208.44/208.63  |- mesh__publicMeSHNote mesh__D006312
% 208.44/208.63       91; was see under HEARING LOSS, PARTIAL 1979-90   
% 208.44/208.63  |- skos__prefLabel mesh__D006312 Hearing Loss, Bilateral
% 208.44/208.63  |- mesh__dateCreated mesh__D006312 1978-05-22
% 208.44/208.63  |- skos__hiddenLabel mesh__D011257 Proteins, Pregnancy
% 208.44/208.63  |- mesh__dateRevised mesh__D011257 2005-06-30
% 208.44/208.63  |- skos__historyNote mesh__D011257 Pregnancy %28%1966-1979%29%
% 208.44/208.63  |- skos__historyNote mesh__D011257 Placental Hormones %28%1966-1979%29%
% 208.44/208.63  |- skos__historyNote mesh__D011257 Proteins %28%1966-1979%29%
% 208.44/208.63  |- skos__historyNote mesh__D011257 Placenta %28%1966-1979%29%
% 208.44/208.63  |- skos__prefLabel mesh__D011257 Pregnancy Proteins
% 208.44/208.63  |- skos__scopeNote mesh__D011257
% 208.44/208.63       Proteins produced by organs of the mother or the PLACENTA during PREGNANCY. These proteins may be pregnancy-specific %28%present only during pregnancy%29% or pregnancy-associated %28%present during pregnancy or under other conditions such as hormone therapy or certain malignancies.%29%%A%    
% 208.44/208.63  |- skos__historyNote mesh__D011257 specific protein
% 208.44/208.63  |- skos__altLabel mesh__D011257 Placental Proteins
% 208.44/208.63  |- skos__hiddenLabel mesh__D011257 Proteins, Placental
% 208.44/208.63  |- mesh__dateCreated mesh__D011257 1979-02-22
% 208.44/208.63  |- skos__broader mesh__D011257smesh__D011506
% 208.44/208.63  |- skos__annotation mesh__D011257
% 208.44/208.63       GEN; prefer specifics; DF: PREGN PROTEINS   
% 208.44/208.63  |- mesh__dateEstablished mesh__D011257 1980-01-01
% 208.44/208.63  |- mesh__recordMaintainer mesh__D011257 SYSTEM
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D011257 2006
% 208.44/208.63  |- mesh__recordAuthorizer mesh__D011257 sjn
% 208.44/208.63  |- mesh__historyNote mesh__D011257 80   
% 208.44/208.63  |- mesh__recordOriginator mesh__D011257 RLS
% 208.44/208.63  |- mesh__publicMeSHNote mesh__D011257 80   
% 208.44/208.63  |- rdf__type mesh__D011257sskos__Concept
% 208.44/208.63  |- rdf__type mesh__D016740sskos__Concept
% 208.44/208.63  |- skos__altLabel mesh__D016740 Jingluo
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D016740 2003
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D016740 2005
% 208.44/208.63  |- mesh__publicMeSHNote mesh__D016740 92   
% 208.44/208.63  |- mesh__dateRevised mesh__D016740 2001-07-25
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D016740 2004
% 208.44/208.63  |- mesh__recordMaintainer mesh__D016740 ssb
% 208.44/208.63  |- skos__broader mesh__D016740smesh__D015670
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D016740 2002
% 208.44/208.63  |- mesh__dateCreated mesh__D016740 1991-05-31
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D016740 2006
% 208.44/208.63  |- skos__scopeNote mesh__D016740
% 208.44/208.63       Classical loci in acupuncture. They are main and collateral channels, regarded as a network of passages, through which vital energy circulates and along which acupoints %28%ACUPUNCTURE POINTS%29% are distributed. The meridians are a series of 14 lines upon which more than 400 acupoints are located on the body. %28%The Pinyin Chinese-English Dictionary, p. 359; Dr. Wu Lancheng, Academy of Traditional Chinese Medicine, Beijing%29%%A%    
% 208.44/208.63  |- skos__altLabel mesh__D016740 Ching Lo
% 208.44/208.63  |- mesh__dateEstablished mesh__D016740 1992-01-01
% 208.44/208.63  |- skos__prefLabel mesh__D016740 Meridians
% 208.44/208.63  |- skos__annotation mesh__D016740
% 208.44/208.63       classical loci in acupuncture; not for meridians in ophthalmology: index under OPTICS %28%IM%29% + EYE; CORNEA; VISUAL FIELD or other applicable ophthalmol term %28%IM%29%%A%  
% 208.44/208.63  |- mesh__historyNote mesh__D016740 92   
% 208.44/208.63  |- skos__hiddenLabel mesh__D016740 Luo, Jing
% 208.44/208.63  |- skos__historyNote mesh__D016740 Acupuncture %28%1968-1991%29%
% 208.44/208.63  |- mesh__recordAuthorizer mesh__D016740 sjn
% 208.44/208.63  |- skos__altLabel mesh__D016740 Jing Luo
% 208.44/208.63  |- mesh__recordOriginator mesh__D016740 TGC
% 208.44/208.63  |- skos__broader mesh__D002720smesh__D013843
% 208.44/208.63  |- skos__annotation mesh__D002720
% 208.44/208.63       an anti-anxiety agent %26% central muscle relaxant   
% 208.44/208.63  |- mesh__recordAuthorizer mesh__D002720 sjn
% 208.44/208.63  |- mesh__recordOriginator mesh__D002720 NLM
% 208.44/208.63  |- mesh__dateRevised mesh__D002720 2005-06-30
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D002720 2006
% 208.44/208.63  |- mesh__recordMaintainer mesh__D002720 ssb
% 208.44/208.63  |- skos__prefLabel mesh__D002720 Chlormezanone
% 208.44/208.63  |- mesh__dateCreated mesh__D002720 1999-01-01
% 208.44/208.63  |- skos__scopeNote mesh__D002720
% 208.44/208.63       A non-benzodiazepine that is used in the management of anxiety. It has been suggested for use in the treatment of muscle spasm.%A%    
% 208.44/208.63  |- skos__altLabel mesh__D002720 Chlormethazanone
% 208.44/208.63  |- rdf__type mesh__D002720sskos__Concept
% 208.44/208.63  |- skos__scopeNote mesh__D040041
% 208.44/208.63       Family of MITES, in the superfamily Acaroidea, order Astigmata. They are frequently found in cereal-based foodstuffs including GRAIN and FLOUR.%A%    
% 208.44/208.63  |- skos__broader mesh__D040041smesh__D008925
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D040041 2005
% 208.44/208.63  |- mesh__dateCreated mesh__D040041 2002-07-02
% 208.44/208.63  |- mesh__dateEstablished mesh__D040041 2003-01-01
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D040041 2006
% 208.44/208.63  |- mesh__recordOriginator mesh__D040041 ags
% 208.44/208.63  |- mesh__dateRevised mesh__D040041 2003-07-09
% 208.44/208.63  |- mesh__recordAuthorizer mesh__D040041 sjn
% 208.44/208.63  |- rdf__type mesh__D040041sskos__Concept
% 208.44/208.63  |- skos__historyNote mesh__D040041 Mites %28%1967-2002%29%
% 208.44/208.63  |- mesh__publicMeSHNote mesh__D040041 2003   
% 208.44/208.63  |- skos__altLabel mesh__D040041 Mites, Storage
% 208.44/208.63  |- mesh__recordMaintainer mesh__D040041 ags
% 208.44/208.63  |- skos__altLabel mesh__D040041 Storage Mites
% 208.44/208.63  |- mesh__historyNote mesh__D040041 2003   
% 208.44/208.63  |- skos__altLabel mesh__D040041 Mites, Store Product
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D040041 2004
% 208.44/208.63  |- skos__prefLabel mesh__D040041 Acaridae
% 208.44/208.63  |- skos__hiddenLabel mesh__D034802 EWS Proto Oncogene Protein
% 208.44/208.63  |- skos__hiddenLabel mesh__D034802 Proto-Oncogene Protein, EWS
% 208.44/208.63  |- skos__altLabel mesh__D034802 Ewing Sarcoma Breakpointregion 1 Protein
% 208.44/208.63  |- mesh__publicMeSHNote mesh__D034802
% 208.44/208.63       2003; EWS PROTEIN was indexed under RIBONUCLEOPROTEINS 1995-2002%A%  
% 208.44/208.63  |- skos__broader mesh__D034802smesh__D034441
% 208.44/208.63  |- mesh__recordOriginator mesh__D034802 jmp
% 208.44/208.63  |- skos__scopeNote mesh__D034802
% 208.44/208.63       A ubiquitous hnRNP protein found in the CELL NUCLEUS and the CYTOPLASM. Translocations that result in the formation of fusion proteins containing parts of RNA-binding protein EWS may play a role in neoplastic processes such as Ewing Sarcoma %28%SARCOMA, EWING%27%S%29%.%A%    
% 208.44/208.63  |- skos__hiddenLabel mesh__D034802 RNA Binding Protein EWS
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D034802 2004
% 208.44/208.63  |- skos__hiddenLabel mesh__D034802 EWS, RNA-Binding Protein
% 208.44/208.63  |- skos__altLabel mesh__D034802 EWS Protein
% 208.44/208.63  |- mesh__dateCreated mesh__D034802 2002-07-03
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D034802 2006A
% 208.44/208.63  |- mesh__recordMaintainer mesh__D034802 ags
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D034802 2006
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D034802 2003
% 208.44/208.63  |- rdf__type mesh__D034802sskos__Concept
% 208.44/208.63  |- mesh__dateRevised mesh__D034802 2005-07-21
% 208.44/208.63  |- skos__altLabel mesh__D034802 EWS Proto-Oncogene Protein
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D034802 2005
% 208.44/208.63  |- mesh__historyNote mesh__D034802
% 208.44/208.63       2003; for EWS PROTEIN use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS 1995-2002%A%  
% 208.44/208.63  |- mesh__recordAuthorizer mesh__D034802 ags
% 208.44/208.63  |- mesh__dateEstablished mesh__D034802 2003-01-01
% 208.44/208.63  |- skos__broader mesh__D034802smesh__D011518
% 208.44/208.63  |- skos__historyNote mesh__D034802 Ribonucleoproteins %28%1995-2002%29%
% 208.44/208.63  |- skos__prefLabel mesh__D034802 RNA-Binding Protein EWS
% 208.44/208.63  |- skos__hiddenLabel mesh__D001628 Tea, Medicinal
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D001628 2003
% 208.44/208.63  |- skos__hiddenLabel mesh__D001628 Herbal Tea
% 208.44/208.63  |- mesh__recordMaintainer mesh__D001628 ags
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D001628 2001
% 208.44/208.63  |- skos__altLabel mesh__D001628 Herbal Teas
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D001628 2006A
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D001628 2000
% 208.44/208.63  |- mesh__dateRevised mesh__D001628 2005-07-12
% 208.44/208.63  |- skos__broader mesh__D001628smesh__D019602
% 208.44/208.63  |- skos__annotation mesh__D001628
% 208.44/208.63       orange %26% grapefruit juices: coord IM with CITRUS FRUIT %28%IM%29%; ALCOHOLIC BEVERAGES %26% specifics %26% CARBONATED BEVERAGES are also available%A%  
% 208.44/208.63  |- mesh__recordAuthorizer mesh__D001628 ags
% 208.44/208.63  |- skos__hiddenLabel mesh__D001628 Beverage
% 208.44/208.63  |- mesh__dateCreated mesh__D001628 1999-01-01
% 208.44/208.63  |- skos__scopeNote mesh__D001628
% 208.44/208.63       Liquids that are suitable for drinking. %28%From Merriam Webster Collegiate Dictionary, 10th ed%29%%A%    
% 208.44/208.63  |- mesh__recordOriginator mesh__D001628 NLM
% 208.44/208.63  |- skos__hiddenLabel mesh__D001628 Tea, Herbal
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D001628 1999
% 208.44/208.63  |- skos__hiddenLabel mesh__D001628 Medicinal Teas
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D001628 2006
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D001628 2002
% 208.44/208.63  |- rdf__type mesh__D001628sskos__Concept
% 208.44/208.63  |- skos__hiddenLabel mesh__D001628 Medicinal Tea
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D001628 2004
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D001628 1998
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D001628 2005
% 208.44/208.63  |- skos__prefLabel mesh__D001628 Beverages
% 208.44/208.63  |- rdf__type mesh__D012350sskos__Concept
% 208.44/208.63  |- mesh__recordOriginator mesh__D012350 RLS
% 208.44/208.63  |- skos__historyNote mesh__D012350 Amino Acyl T RNA %28%1978-1987%29%
% 208.44/208.63  |- mesh__dateCreated mesh__D012350 1987-05-07
% 208.44/208.63  |- skos__scopeNote mesh__D012350
% 208.44/208.63       A transfer RNA which is specific for carrying cysteine to sites on the ribosomes in preparation for protein synthesis.%A%    
% 208.44/208.63  |- skos__hiddenLabel mesh__D012350 RNA, Cys Transfer
% 208.44/208.63  |- skos__hiddenLabel mesh__D012350 Cys Transfer RNA
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D012350 2000
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D012350 1998
% 208.44/208.63  |- mesh__dateEstablished mesh__D012350 1991-01-01
% 208.44/208.63  |- skos__annotation mesh__D012350
% 208.44/208.63       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 208.44/208.63  |- skos__prefLabel mesh__D012350 RNA, Transfer, Cys
% 208.44/208.63  |- skos__hiddenLabel mesh__D012350 tRNA, Cysteine-Specific
% 208.44/208.63  |- skos__altLabel mesh__D012350 Cysteine-Specific tRNA
% 208.44/208.63  |- skos__altLabel mesh__D012350 tRNACys
% 208.44/208.63  |- skos__altLabel mesh__D012350 tRNA%28%Cys%29%
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D012350 2003
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D012350 2001
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D012350 1997
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D012350 2005
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D012350 1999
% 208.44/208.63  |- mesh__historyNote mesh__D012350
% 208.44/208.63       91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D012350 2004
% 208.44/208.63  |- skos__hiddenLabel mesh__D012350 Cysteine Specific tRNA
% 208.44/208.63  |- mesh__recordMaintainer mesh__D012350 TGC
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D012350 2006
% 208.44/208.63  |- mesh__recordAuthorizer mesh__D012350 PLS
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D012350 2002
% 208.44/208.63  |- skos__altLabel mesh__D012350 Transfer RNA, Cys
% 208.44/208.63  |- mesh__dateRevised mesh__D012350 1996-06-10
% 208.44/208.63  |- skos__broader mesh__D012350smesh__D012345
% 208.44/208.63  |- mesh__publicMeSHNote mesh__D012350
% 208.44/208.63       91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.44/208.63  |- skos__historyNote mesh__D012350 RNA, Transfer %28%1966-1987%29%
% 208.44/208.63  |- mesh__dateRevised mesh__D006313 2004-07-07
% 208.44/208.63  |- skos__altLabel mesh__D006313 Central Hearing Loss
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D006313 2006
% 208.44/208.63  |- skos__scopeNote mesh__D006313
% 208.44/208.63       Hearing loss due to disease of the AUDITORY PATHWAYS %28%in the CENTRAL NERVOUS SYSTEM%29% which originate in the COCHLEAR NUCLEI of the PONS and then ascend bilaterally to the MIDBRAIN, the THALAMUS, and then the AUDITORY CORTEX in the TEMPORAL LOBE. Bilateral lesions of the auditory pathways are usually required to cause central hearing loss. Cortical deafness refers to loss of hearing due to bilateral auditory cortex lesions. Unilateral BRAIN STEM lesions involving the cochlear nuclei may result in unilateral hearing loss.%A%    
% 208.44/208.63  |- skos__broader mesh__D006313smesh__D006319
% 208.44/208.63  |- mesh__recordMaintainer mesh__D006313 lkt
% 208.44/208.63  |- mesh__recordOriginator mesh__D006313 RC
% 208.44/208.63  |- skos__broader mesh__D006313smesh__D001304
% 208.44/208.63  |- mesh__dateCreated mesh__D006313 1978-05-22
% 208.44/208.63  |- skos__annotation mesh__D006313
% 208.44/208.63       coord IM with VESTIBULOCOCHLEAR NERVE DISEASES %28%IM%29% for hearing loss due to cochlear nerve dis%A%  
% 208.44/208.63  |- skos__altLabel mesh__D006313 Deafness, Cortical
% 208.44/208.63  |- skos__historyNote mesh__D006313 Deafness %28%1966-1978%29%
% 208.44/208.63  |- mesh__recordAuthorizer mesh__D006313 sjn
% 208.44/208.63  |- mesh__dateEstablished mesh__D006313 1991-01-01
% 208.44/208.63  |- rdf__type mesh__D006313sskos__Concept
% 208.44/208.63  |- skos__prefLabel mesh__D006313 Hearing Loss, Central
% 208.44/208.63  |- mesh__historyNote mesh__D006313
% 208.44/208.63       91%28%79%29%; was see under HEARING LOSS, SENSORINEURAL 1979-90%A%  
% 208.44/208.63  |- mesh__publicMeSHNote mesh__D006313
% 208.44/208.63       91; was see under HEARING LOSS, SENSORINEURAL 1979-90   
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D006313 2005
% 208.44/208.63  |- skos__related mesh__D006313smesh__D000160
% 208.44/208.63  |- skos__altLabel mesh__D011258 Test, Pregnancy
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D011258 2002
% 208.44/208.63  |- skos__scopeNote mesh__D011258
% 208.44/208.63       Tests to determine whether or not an individual is pregnant.%A%    
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D011258 1999
% 208.44/208.63  |- mesh__recordAuthorizer mesh__D011258 SJN
% 208.44/208.63  |- skos__broader mesh__D011258smesh__D003942
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D011258 2005
% 208.44/208.63  |- skos__altLabel mesh__D011258 Tests, Pregnancy
% 208.44/208.63  |- mesh__dateCreated mesh__D011258 1999-01-01
% 208.44/208.63  |- mesh__dateRevised mesh__D011258 1997-06-20
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D011258 2006
% 208.44/208.63  |- rdf__type mesh__D011258sskos__Concept
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D011258 2000
% 208.44/208.63  |- skos__broader mesh__D011258smesh__D003944
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D011258 2003
% 208.44/208.63  |- mesh__recordMaintainer mesh__D011258 PXP
% 208.44/208.63  |- skos__annotation mesh__D011258
% 208.44/208.63       human %26% animal; check tags FEMALE %26% PREGNANCY; DF: PREGN TESTS%A%  
% 208.44/208.63  |- mesh__recordOriginator mesh__D011258 NLM
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D011258 2001
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D011258 1998
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D011258 2004
% 208.44/208.63  |- skos__altLabel mesh__D011258 Pregnancy Test
% 208.44/208.63  |- skos__prefLabel mesh__D011258 Pregnancy Tests
% 208.44/208.63  |- skos__hiddenLabel mesh__D016741 Urinary Sphincters, Artificial
% 208.44/208.63  |- mesh__dateRevised mesh__D016741 1997-06-20
% 208.44/208.63  |- mesh__recordAuthorizer mesh__D016741 SJN
% 208.44/208.63  |- mesh__recordMaintainer mesh__D016741 PXP
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D016741 2003
% 208.44/208.63  |- skos__historyNote mesh__D016741 Implants, Artificial %28%1976-1991%29%
% 208.44/208.63  |- skos__hiddenLabel mesh__D016741 Sphincters, Artificial Genitourinary
% 208.44/208.63  |- skos__hiddenLabel mesh__D016741 Artificial Urinary Sphincter
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D016741 2005
% 208.44/208.63  |- mesh__recordOriginator mesh__D016741 TGC
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D016741 2000
% 208.44/208.63  |- skos__hiddenLabel mesh__D016741 Sphincter, Artificial Genitourinary
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D016741 2004
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D016741 2001
% 208.44/208.63  |- mesh__dateCreated mesh__D016741 1991-05-02
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D016741 2006
% 208.44/208.63  |- skos__historyNote mesh__D016741
% 208.44/208.63       Urinary Incontinence/surgery %28%1969-1991%29%
% 208.44/208.63  |- skos__hiddenLabel mesh__D016741 Sphincter, Artificial Urinary
% 208.44/208.63  |- skos__altLabel mesh__D016741 Genitourinary Sphincter, Artificial
% 208.44/208.63  |- mesh__publicMeSHNote mesh__D016741 92   
% 208.44/208.63  |- skos__hiddenLabel mesh__D016741 Genitourinary Sphincters, Artificial
% 208.44/208.63  |- mesh__historyNote mesh__D016741 92   
% 208.44/208.63  |- skos__hiddenLabel mesh__D016741 Sphincters, Artificial Urinary
% 208.44/208.63  |- skos__hiddenLabel mesh__D016741 Artificial Genitourinary Sphincters
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D016741 1998
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D016741 2002
% 208.44/208.63  |- skos__broader mesh__D016741smesh__D001187
% 208.44/208.63  |- rdf__type mesh__D016741sskos__Concept
% 208.44/208.63  |- skos__hiddenLabel mesh__D016741 Artificial Urinary Sphincters
% 208.44/208.63  |- skos__annotation mesh__D016741 /psychol permitted   
% 208.44/208.63  |- mesh__dateEstablished mesh__D016741 1992-01-01
% 208.44/208.63  |- skos__broader mesh__D016741smesh__D019736
% 208.44/208.63  |- skos__prefLabel mesh__D016741 Urinary Sphincter, Artificial
% 208.44/208.63  |- skos__hiddenLabel mesh__D016741 Artificial Genitourinary Sphincter
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D016741 1999
% 208.44/208.63  |- skos__scopeNote mesh__D016741
% 208.44/208.63       An artifical implanted device, usually in the form of an inflatable silicone cuff, inserted in or around the bladder neck in the surgical treatment of urinary incontinence caused by sphincter weakness. Often it is placed around the bulbous urethra in adult males. The artificial urinary sphincter is considered an alternative to urinary diversion.%A%    
% 208.44/208.63  |- mesh__recordOriginator mesh__D002721 NLM
% 208.44/208.63  |- skos__hiddenLabel mesh__D002721 omega Chloroacetophenone
% 208.44/208.63  |- skos__hiddenLabel mesh__D002721 alpha Chloroacetophenone
% 208.44/208.63  |- mesh__recordMaintainer mesh__D002721 jmp
% 208.44/208.63  |- skos__altLabel mesh__D002721 alpha-Chloroacetophenone
% 208.44/208.63  |- mesh__publicMeSHNote mesh__D002721 91; was CHLOROACETOPHENONE 1963-90   
% 208.44/208.63  |- skos__hiddenLabel mesh__D002721 2 Chloroacetophenone
% 208.44/208.63  |- mesh__dateRevised mesh__D002721 2000-06-21
% 208.44/208.63  |- skos__broader mesh__D002721smesh__D000098
% 208.44/208.63  |- skos__scopeNote mesh__D002721
% 208.44/208.63       A potent eye, throat, and skin irritant. One of its uses is as a riot control agent.%A%    
% 208.44/208.63  |- mesh__onlineNote mesh__D002721
% 208.44/208.63       use OMEGA-CHLOROACETOPHENONE to search CHLOROACETOPHENONE 1966-90%A%  
% 208.44/208.63  |- mesh__dateCreated mesh__D002721 1999-01-01
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D002721 2006
% 208.44/208.63  |- skos__prefLabel mesh__D002721 omega-Chloroacetophenone
% 208.44/208.63  |- mesh__historyNote mesh__D002721 91; was CHLOROACETOPHENONE 1963-90   
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D002721 2005
% 208.44/208.63  |- skos__altLabel mesh__D002721 2-Chloro-1-phenylethanone
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D002721 2002
% 208.44/208.63  |- rdf__type mesh__D002721sskos__Concept
% 208.44/208.63  |- skos__hiddenLabel mesh__D002721 2 Chloro 1 phenylethanone
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D002721 2004
% 208.44/208.63  |- skos__altLabel mesh__D002721 Chloracetophenone
% 208.44/208.63  |- skos__annotation mesh__D002721 D25-26 qualif   
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D002721 2001
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D002721 2003
% 208.44/208.63  |- skos__altLabel mesh__D002721 2-Chloroacetophenone
% 208.44/208.63  |- mesh__recordAuthorizer mesh__D002721 sjn
% 208.44/208.63  |- skos__broader mesh__D015649smesh__D003070
% 208.44/208.63  |- mesh__publicMeSHNote mesh__D015649
% 208.44/208.63       90; CO-VIDARABINE %28%now PENTOSTATIN%29% was indexed under VIDARABINE/*analogs %26% derivatives 1976-97%A%  
% 208.44/208.63  |- skos__historyNote mesh__D015649
% 208.44/208.63       Coformycin/analogs %26% derivatives %28%1979-1989%29%
% 208.44/208.63  |- skos__hiddenLabel mesh__D015649 2%27% Deoxycoformycin
% 208.44/208.63  |- skos__altLabel mesh__D015649 Wyeth Brand of Pentostatin
% 208.44/208.63  |- mesh__recordOriginator mesh__D015649 RLS
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D015649 2006
% 208.44/208.63  |- skos__altLabel mesh__D015649 Warner-Lambert Brand of Pentostatin
% 208.44/208.63  |- mesh__historyNote mesh__D015649
% 208.44/208.63       90; for CO-VIDARABINE use PENTOSTATIN 1982-97   
% 208.44/208.63  |- skos__historyNote mesh__D015649 Deoxyribonucleosides %28%1971-1978%29%
% 208.44/208.63  |- skos__hiddenLabel mesh__D015649 CI825
% 208.44/208.63  |- skos__prefLabel mesh__D015649 Pentostatin
% 208.44/208.63  |- skos__broader mesh__D015649smesh__D003853
% 208.44/208.63  |- skos__hiddenLabel mesh__D015649 Co vidarabine
% 208.44/208.63  |- rdf__type mesh__D015649sskos__Concept
% 208.44/208.63  |- skos__historyNote mesh__D015649 Azepines %28%1966-1978%29%
% 208.44/208.63  |- mesh__recordAuthorizer mesh__D015649 sjn
% 208.44/208.63  |- skos__altLabel mesh__D015649 Supergen Brand of Pentostatin
% 208.44/208.63  |- skos__hiddenLabel mesh__D015649 NSC 218321
% 208.44/208.63  |- skos__hiddenLabel mesh__D015649 NSC218321
% 208.44/208.63  |- skos__scopeNote mesh__D015649
% 208.44/208.63       A potent inhibitor of adenosine deaminase. The drug is effective in the treatment of many lymphoproliferative malignancies, particularly hairy-cell leukemia. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity.%A%    
% 208.44/208.63  |- mesh__dateCreated mesh__D015649 1989-05-25
% 208.44/208.63  |- skos__altLabel mesh__D015649 Deoxycoformycin
% 208.44/208.63  |- skos__hiddenLabel mesh__D015649 Covidarabine
% 208.44/208.63  |- mesh__dateRevised mesh__D015649 2005-06-30
% 208.44/208.63  |- mesh__recordMaintainer mesh__D015649 lkw
% 208.44/208.63  |- skos__hiddenLabel mesh__D015649 CI 825
% 208.44/208.63  |- skos__altLabel mesh__D015649 Lederle Brand of Pentostatin
% 208.44/208.63  |- skos__altLabel mesh__D015649 2%27%-Deoxycoformycin
% 208.44/208.63  |- skos__altLabel mesh__D015649 Prasfarma Brand of Pentostatin
% 208.44/208.63  |- mesh__dateEstablished mesh__D015649 1990-01-01
% 208.44/208.63  |- skos__scopeNote mesh__D040042
% 208.44/208.63       Family of parasitic MITES, in the superfamily Sarcoptoidea, order Astigmata. Genera include Psoroptes and Chorioptes.%A%    
% 208.44/208.63  |- skos__prefLabel mesh__D040042 Psoroptidae
% 208.44/208.63  |- mesh__historyNote mesh__D040042 2003   
% 208.44/208.63  |- mesh__dateEstablished mesh__D040042 2003-01-01
% 208.44/208.63  |- mesh__dateRevised mesh__D040042 2003-07-09
% 208.44/208.63  |- skos__altLabel mesh__D040042 Mites, Sheep Scab
% 208.44/208.63  |- mesh__dateCreated mesh__D040042 2002-07-03
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D040042 2006
% 208.44/208.63  |- skos__annotation mesh__D040042
% 208.44/208.63       infestation: coord IM with MITE INFESTATIONS %28%IM%29%   
% 208.44/208.63  |- rdf__type mesh__D040042sskos__Concept
% 208.44/208.63  |- skos__historyNote mesh__D040042 Mites %28%1966-2002%29%
% 208.44/208.63  |- skos__broader mesh__D040042smesh__D008925
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D040042 2004
% 208.44/208.63  |- mesh__activeMeSHYear mesh__D040042 2005
% 208.44/208.63  |- mesh__publicMeSHNote mesh__D040042 2003   
% 208.44/208.63  |- skos__hiddenLabel mesh__D001629 Berlin Chemie Brand of Bezafibrate
% 208.44/208.63  |- skos__hiddenLabel mesh__D001629 BM 15.075
% 208.44/208.64  |- skos__altLabel mesh__D001629 B%C3%%A9%fizal
% 208.44/208.64  |- skos__altLabel mesh__D001629 Betapharm Brand of Bezafibrate
% 208.44/208.64  |- skos__altLabel mesh__D001629 Lakeside Brand of Bezafibrate
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 BezaLande
% 208.44/208.64  |- skos__broader mesh__D001629smesh__D002087
% 208.44/208.64  |- skos__altLabel mesh__D001629 Roche Brand of Bezafibrate
% 208.44/208.64  |- skos__historyNote mesh__D001629 Phenylbutyrates %28%1977-1978%29%
% 208.44/208.64  |- skos__historyNote mesh__D001629
% 208.44/208.64       Clofibrate/analogs %26% derivatives %28%1978-1983%29%
% 208.44/208.64  |- mesh__publicMeSHNote mesh__D001629 84   
% 208.44/208.64  |- skos__altLabel mesh__D001629 Eulitop
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 BezaPuren
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D001629 2006
% 208.44/208.64  |- skos__altLabel mesh__D001629 Isis Brand of Bezafibrate
% 208.44/208.64  |- skos__altLabel mesh__D001629 Hexal Brand of Bezafibrate
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 Bezafibrate Isis Brand
% 208.44/208.64  |- skos__altLabel mesh__D001629 Teva Brand of Bezafibrate
% 208.44/208.64  |- skos__prefLabel mesh__D001629 Bezafibrate
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 Bezafibrate Roche Brand
% 208.44/208.64  |- mesh__dateCreated mesh__D001629 1983-03-17
% 208.44/208.64  |- skos__historyNote mesh__D001629 Benzamides %28%1977-1978%29%
% 208.44/208.64  |- mesh__recordOriginator mesh__D001629 RLS
% 208.44/208.64  |- skos__altLabel mesh__D001629 Merckle Brand of Bezafibrate
% 208.44/208.64  |- skos__altLabel mesh__D001629 durabezur
% 208.44/208.64  |- skos__broader mesh__D001629smesh__D002995
% 208.44/208.64  |- skos__altLabel mesh__D001629 Difaterol
% 208.44/208.64  |- skos__altLabel mesh__D001629 Boehringer Mannheim Brand of Bezafibrate
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D001629 2005
% 208.44/208.64  |- mesh__dateEstablished mesh__D001629 1984-01-01
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 Bezafibrate Azupharma Brand
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 Bezafibrate Merckle Brand
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 Bezafibrate Hennig Brand
% 208.44/208.64  |- skos__altLabel mesh__D001629 TAD Brand of Bezafibrate
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 Bezafibrate Elfar Brand
% 208.44/208.64  |- skos__altLabel mesh__D001629 Berlin-Chemie Brand of Bezafibrate
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 Bezafibrate Lakeside Brand
% 208.44/208.64  |- skos__altLabel mesh__D001629 Cryopharma Brand of Bezafibrate
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 Bezafibrate TAD Brand
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 Bezafibrate Berlin-Chemie Brand
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 Bezafibrate Bayer Brand
% 208.44/208.64  |- mesh__recordMaintainer mesh__D001629 mdb
% 208.44/208.64  |- mesh__recordAuthorizer mesh__D001629 sjn
% 208.44/208.64  |- skos__altLabel mesh__D001629 Hennig Brand of Bezafibrate
% 208.44/208.64  |- mesh__historyNote mesh__D001629 84   
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 Bezafibrate Teva Brand
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 Bezafibrate Synthelabo Brand
% 208.44/208.64  |- mesh__dateRevised mesh__D001629 2004-07-07
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 Bezafibrate Betapharm Brand
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 Bezafibrate Cryopharma Brand
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 Beza Puren
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 Bezafibrate Hexal Brand
% 208.44/208.64  |- skos__altLabel mesh__D001629 Elfar Brand of Bezafibrate
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 BM15.075
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 PB, Bezafibrat
% 208.44/208.64  |- rdf__type mesh__D001629sskos__Concept
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 B, Regadrin
% 208.44/208.64  |- skos__altLabel mesh__D001629 Synthelabo Brand of Bezafibrate
% 208.44/208.64  |- skos__altLabel mesh__D001629 Azupharma Brand of Bezafibrate
% 208.44/208.64  |- skos__scopeNote mesh__D001629
% 208.44/208.64       Antilipemic agent that lowers cholesterol and triglycerides. It decreases low density lipoproteins and increases high density lipoproteins.%A%    
% 208.44/208.64  |- skos__hiddenLabel mesh__D001629 Beza Lande
% 208.44/208.64  |- skos__altLabel mesh__D001629 Bayer Brand of Bezafibrate
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D012351 2002
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D012351 1998
% 208.44/208.64  |- mesh__dateRevised mesh__D012351 1996-06-10
% 208.44/208.64  |- mesh__dateEstablished mesh__D012351 1991-01-01
% 208.44/208.64  |- skos__annotation mesh__D012351
% 208.44/208.64       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 208.44/208.64  |- skos__hiddenLabel mesh__D012351 tRNA, Glutamine-Specific
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D012351 2003
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D012351 1997
% 208.44/208.64  |- mesh__recordOriginator mesh__D012351 RLS
% 208.44/208.64  |- skos__altLabel mesh__D012351 Glutamine-Specific tRNA
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D012351 2005
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D012351 1999
% 208.44/208.64  |- skos__historyNote mesh__D012351 Amino Acyl T RNA %28%1978-1987%29%
% 208.44/208.64  |- skos__hiddenLabel mesh__D012351 Gln Transfer RNA
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D012351 2004
% 208.44/208.64  |- mesh__recordMaintainer mesh__D012351 TGC
% 208.44/208.64  |- mesh__dateCreated mesh__D012351 1987-05-07
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D012351 2006
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D012351 2000
% 208.44/208.64  |- skos__altLabel mesh__D012351 tRNA%28%Gln%29%
% 208.44/208.64  |- skos__scopeNote mesh__D012351
% 208.44/208.64       A transfer RNA which is specific for carrying glutamine to sites on the ribosomes in preparation for protein synthesis.%A%    
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D012351 2001
% 208.44/208.64  |- skos__altLabel mesh__D012351 tRNAGln
% 208.44/208.64  |- skos__hiddenLabel mesh__D012351 RNA, Gln Transfer
% 208.44/208.64  |- skos__prefLabel mesh__D012351 RNA, Transfer, Gln
% 208.44/208.64  |- skos__broader mesh__D012351smesh__D012345
% 208.44/208.64  |- mesh__publicMeSHNote mesh__D012351
% 208.44/208.64       91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.44/208.64  |- skos__historyNote mesh__D012351 RNA, Transfer %28%1966-1987%29%
% 208.44/208.64  |- skos__hiddenLabel mesh__D012351 Glutamine Specific tRNA
% 208.44/208.64  |- mesh__historyNote mesh__D012351
% 208.44/208.64       91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.44/208.64  |- rdf__type mesh__D012351sskos__Concept
% 208.44/208.64  |- skos__altLabel mesh__D012351 Transfer RNA, Gln
% 208.44/208.64  |- mesh__recordAuthorizer mesh__D012351 PLS
% 208.44/208.64  |- mesh__historyNote mesh__D006314
% 208.44/208.64       91%28%79%29%; was see under HEARING LOSS, PARTIAL 1979-90   
% 208.44/208.64  |- skos__broader mesh__D006314smesh__D034381
% 208.44/208.64  |- mesh__publicMeSHNote mesh__D006314
% 208.44/208.64       91; was see under HEARING LOSS, PARTIAL 1979-90   
% 208.44/208.64  |- mesh__dateCreated mesh__D006314 1978-05-22
% 208.44/208.64  |- mesh__recordOriginator mesh__D006314 RC
% 208.44/208.64  |- mesh__recordAuthorizer mesh__D006314 ags
% 208.44/208.64  |- skos__historyNote mesh__D006314 Deafness %28%1966-1978%29%
% 208.44/208.64  |- mesh__dateRevised mesh__D006314 2005-07-13
% 208.44/208.64  |- mesh__recordMaintainer mesh__D006314 ags
% 208.44/208.64  |- mesh__dateEstablished mesh__D006314 1991-01-01
% 208.44/208.64  |- rdf__type mesh__D006314sskos__Concept
% 208.44/208.64  |- skos__annotation mesh__D006314
% 208.44/208.64       HEARING LOSS, MIXED CONDUCTIVE-SENSORINEURAL is also available.%A%  
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D006314 2005
% 208.44/208.64  |- skos__prefLabel mesh__D006314 Hearing Loss, Conductive
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D006314 2006A
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D006314 2006
% 208.44/208.64  |- skos__altLabel mesh__D006314 Conductive Hearing Loss
% 208.44/208.64  |- skos__scopeNote mesh__D006314
% 208.44/208.64       Hearing loss due to interference with the mechanical reception or amplification of sound to the COCHLEA. The interference is in the outer or middle ear involving the EAR CANAL; TYMPANIC MEMBRANE; or EAR OSSICLES.%A%    
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D011259 2001
% 208.44/208.64  |- mesh__dateCreated mesh__D011259 1999-01-01
% 208.44/208.64  |- skos__broader mesh__D011259smesh__D007159
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D011259 2006
% 208.44/208.64  |- skos__historyNote mesh__D011259 Pregnancy Tests %28%1966-1972%29%
% 208.44/208.64  |- skos__altLabel mesh__D011259 Immunologic Pregnancy Tests
% 208.44/208.64  |- skos__altLabel mesh__D011259 Tests, Immunological Pregnancy
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D011259 2002
% 208.44/208.64  |- skos__altLabel mesh__D011259 Pregnancy Tests, Immunological
% 208.44/208.64  |- mesh__recordAuthorizer mesh__D011259 SJN
% 208.44/208.64  |- skos__altLabel mesh__D011259 Pregnancy Test, Immunologic
% 208.44/208.64  |- rdf__type mesh__D011259sskos__Concept
% 208.44/208.64  |- skos__altLabel mesh__D011259 Tests, Immunologic Pregnancy
% 208.44/208.64  |- skos__altLabel mesh__D011259 Test, Immunologic Pregnancy
% 208.44/208.64  |- mesh__publicMeSHNote mesh__D011259 73   
% 208.44/208.64  |- skos__prefLabel mesh__D011259 Pregnancy Tests, Immunologic
% 208.44/208.64  |- mesh__dateRevised mesh__D011259 1997-06-20
% 208.44/208.64  |- skos__broader mesh__D011259smesh__D011258
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D011259 2003
% 208.44/208.64  |- mesh__historyNote mesh__D011259 73   
% 208.44/208.64  |- skos__hiddenLabel mesh__D011259 Test, Immunological Pregnancy
% 208.44/208.64  |- skos__annotation mesh__D011259
% 208.44/208.64       human %26% animal; check tags FEMALE %26% PREGNANCY; DF: PREGN TESTS IMMUNOL%A%  
% 208.44/208.64  |- mesh__dateEstablished mesh__D011259 1973-01-01
% 208.44/208.64  |- skos__hiddenLabel mesh__D011259 Immunological Pregnancy Test
% 208.44/208.64  |- skos__altLabel mesh__D011259 Immunological Pregnancy Tests
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D011259 1998
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D011259 2004
% 208.44/208.64  |- skos__hiddenLabel mesh__D011259 Pregnancy Test, Immunological
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D011259 2000
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D011259 1999
% 208.44/208.64  |- mesh__recordMaintainer mesh__D011259 PXP
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D011259 2005
% 208.44/208.64  |- skos__altLabel mesh__D011259 Immunologic Pregnancy Test
% 208.44/208.64  |- mesh__recordOriginator mesh__D011259 NLM
% 208.44/208.64  |- mesh__dateEstablished mesh__D016742 1992-01-01
% 208.44/208.64  |- mesh__recordOriginator mesh__D016742 MXR
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D016742 2002
% 208.44/208.64  |- skos__scopeNote mesh__D016742
% 208.44/208.64       An organized and comprehensive program of health care that identifies and reduces a woman%27%s reproductive risks before conception through risk assessment, health promotion, and interventions. Preconception care programs may be designed to include the male partner in providing counseling and educational information in preparation for fatherhood, such as genetic counseling and testing, financial and family planning, etc. This concept is different from PRENATAL CARE, which occurs during pregnancy.%A%    
% 208.44/208.64  |- mesh__historyNote mesh__D016742 92   
% 208.44/208.64  |- skos__annotation mesh__D016742
% 208.44/208.64       may refer to prospective mother or father   
% 208.44/208.64  |- skos__related mesh__D016742smesh__D011295
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D016742 1998
% 208.44/208.64  |- skos__broader mesh__D016742smesh__D014932
% 208.44/208.64  |- mesh__dateRevised mesh__D016742 1997-06-20
% 208.44/208.64  |- mesh__recordAuthorizer mesh__D016742 SJN
% 208.44/208.64  |- rdf__type mesh__D016742sskos__Concept
% 208.44/208.64  |- skos__broader mesh__D016742smesh__D005791
% 208.44/208.64  |- mesh__recordMaintainer mesh__D016742 PXP
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D016742 1999
% 208.44/208.64  |- mesh__dateCreated mesh__D016742 1991-05-07
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D016742 2000
% 208.44/208.64  |- skos__hiddenLabel mesh__D016742 Care, Preconception
% 208.44/208.64  |- skos__prefLabel mesh__D016742 Preconception Care
% 208.44/208.64  |- mesh__activeMeSHYear mesh__D016742 2003
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D016742 2001
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D016742 2005
% 208.74/208.95  |- skos__historyNote mesh__D016742 Pregnancy %28%1981-1991%29%
% 208.74/208.95  |- skos__broader mesh__D016742smesh__D008427
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D016742 2004
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D016742 2006
% 208.74/208.95  |- mesh__publicMeSHNote mesh__D016742 92   
% 208.74/208.95  |- mesh__dateCreated mesh__D002722 1999-01-01
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002722 1998
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002722 2000
% 208.74/208.95  |- mesh__dateRevised mesh__D002722 1992-05-11
% 208.74/208.95  |- mesh__recordMaintainer mesh__D002722 TGC
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002722 1995
% 208.74/208.95  |- mesh__recordAuthorizer mesh__D002722 PLS
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002722 2005
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002722 1999
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002722 2001
% 208.74/208.95  |- mesh__publicMeSHNote mesh__D002722 74   
% 208.74/208.95  |- mesh__dateEstablished mesh__D002722 1974-01-01
% 208.74/208.95  |- mesh__historyNote mesh__D002722 74   
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002722 1996
% 208.74/208.95  |- skos__prefLabel mesh__D002722 Chlorobenzenes
% 208.74/208.95  |- mesh__recordOriginator mesh__D002722 NLM
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002722 1993
% 208.74/208.95  |- skos__broader mesh__D002722smesh__D006843
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002722 2006
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002722 2003
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002722 1997
% 208.74/208.95  |- rdf__type mesh__D002722sskos__Concept
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002722 2002
% 208.74/208.95  |- skos__broader mesh__D002722smesh__D001555
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002722 2004
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002722 1994
% 208.74/208.95  |- skos__broader mesh__D040841smesh__D004467
% 208.74/208.95  |- mesh__historyNote mesh__D040841 2003   
% 208.74/208.95  |- mesh__publicMeSHNote mesh__D040841 2003   
% 208.74/208.95  |- skos__hiddenLabel mesh__D040841 Resources Allocation
% 208.74/208.95  |- skos__prefLabel mesh__D040841 Resource Allocation
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D040841 2003
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D040841 2004
% 208.74/208.95  |- skos__hiddenLabel mesh__D040841 Resource Allocations
% 208.74/208.95  |- mesh__dateCreated mesh__D040841 2002-07-02
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D040841 2005
% 208.74/208.95  |- skos__annotation mesh__D040841
% 208.74/208.95       for health care resource allocation, use HEALTH CARE RATIONING; use both terms only when a discussion of health care resource allocation is accompanied by a more theoretical discussion of the concept of equity in the distribution of limited resources%A%  
% 208.74/208.95  |- skos__altLabel mesh__D040841 Allocation of Resources
% 208.74/208.95  |- skos__hiddenLabel mesh__D040841 Allocation, Resource
% 208.74/208.95  |- rdf__type mesh__D040841sskos__Concept
% 208.74/208.95  |- skos__hiddenLabel mesh__D040841 Allocations, Resource
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D040841 2006
% 208.74/208.95  |- mesh__dateEstablished mesh__D040841 2003-01-01
% 208.74/208.95  |- skos__scopeNote mesh__D040841
% 208.74/208.95       Societal or individual decisions about the equitable distribution of available resources.%A%    
% 208.74/208.95  |- skos__historyNote mesh__D012352 Amino Acyl T RNA %28%1978-1987%29%
% 208.74/208.95  |- rdf__type mesh__D012352sskos__Concept
% 208.74/208.95  |- skos__altLabel mesh__D012352 tRNAGlu
% 208.74/208.95  |- mesh__recordOriginator mesh__D012352 RLS
% 208.74/208.95  |- skos__hiddenLabel mesh__D012352 RNA, Glu Transfer
% 208.74/208.95  |- skos__broader mesh__D012352smesh__D012345
% 208.74/208.95  |- mesh__publicMeSHNote mesh__D012352
% 208.74/208.95       91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D012352 1997
% 208.74/208.95  |- mesh__recordMaintainer mesh__D012352 TGC
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D012352 2001
% 208.74/208.95  |- skos__hiddenLabel mesh__D012352 Acid-Specific tRNA, Glutamic
% 208.74/208.95  |- skos__historyNote mesh__D012352 RNA, Transfer %28%1966-1987%29%
% 208.74/208.95  |- skos__hiddenLabel mesh__D012352 Glu Transfer RNA
% 208.74/208.95  |- skos__prefLabel mesh__D012352 RNA, Transfer, Glu
% 208.74/208.95  |- mesh__dateCreated mesh__D012352 1987-05-07
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D012352 2004
% 208.74/208.95  |- skos__hiddenLabel mesh__D012352 tRNA, Glutamic Acid-Specific
% 208.74/208.95  |- skos__annotation mesh__D012352
% 208.74/208.95       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 208.74/208.95  |- skos__altLabel mesh__D012352 Transfer RNA, Glu
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D012352 2000
% 208.74/208.95  |- mesh__dateEstablished mesh__D012352 1991-01-01
% 208.74/208.95  |- skos__scopeNote mesh__D012352
% 208.74/208.95       A transfer RNA which is specific for carrying glutamic acid to sites on the ribosomes in preparation for protein synthesis.%A%    
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D012352 1999
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D012352 2003
% 208.74/208.95  |- mesh__historyNote mesh__D012352
% 208.74/208.95       91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.74/208.95  |- skos__altLabel mesh__D012352 Glutamic Acid-Specific tRNA
% 208.74/208.95  |- skos__altLabel mesh__D012352 tRNA%28%Glu%29%
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D012352 1998
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D012352 2006
% 208.74/208.95  |- mesh__dateRevised mesh__D012352 1996-06-10
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D012352 2002
% 208.74/208.95  |- skos__hiddenLabel mesh__D012352 Glutamic Acid Specific tRNA
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D012352 2005
% 208.74/208.95  |- mesh__recordAuthorizer mesh__D012352 PLS
% 208.74/208.95  |- rdf__type mesh__D006315sskos__Concept
% 208.74/208.95  |- mesh__recordAuthorizer mesh__D006315 sjn
% 208.74/208.95  |- skos__historyNote mesh__D006315 Deafness %28%1966-1978%29%
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D006315 2005
% 208.74/208.95  |- mesh__dateEstablished mesh__D006315 1991-01-01
% 208.74/208.95  |- mesh__historyNote mesh__D006315
% 208.74/208.95       91%28%79%29%; was see under HEARING LOSS, PARTIAL 1979-90   
% 208.74/208.95  |- skos__broader mesh__D006315smesh__D034381
% 208.74/208.95  |- mesh__dateRevised mesh__D006315 2004-07-07
% 208.74/208.95  |- mesh__publicMeSHNote mesh__D006315
% 208.74/208.95       91; was see under HEARING LOSS, PARTIAL 1979-90   
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D006315 2006
% 208.74/208.95  |- skos__altLabel mesh__D006315 Hearing Loss, Psychogenic
% 208.74/208.95  |- skos__hiddenLabel mesh__D006315 Psychogenic Hearing Loss
% 208.74/208.95  |- skos__hiddenLabel mesh__D006315 Nonorganic Hearing Loss
% 208.74/208.95  |- skos__scopeNote mesh__D006315
% 208.74/208.95       Hearing loss without a physical basis. Often observed in patients with psychological or behavioral disorders.%A%    
% 208.74/208.95  |- skos__broader mesh__D006315smesh__D001526
% 208.74/208.95  |- mesh__recordMaintainer mesh__D006315 lkt
% 208.74/208.95  |- mesh__dateCreated mesh__D006315 1978-05-22
% 208.74/208.95  |- mesh__recordOriginator mesh__D006315 RC
% 208.74/208.95  |- skos__hiddenLabel mesh__D006315 Functional Hearing Loss
% 208.74/208.95  |- skos__altLabel mesh__D006315 Hearing Loss, Nonorganic
% 208.74/208.95  |- skos__prefLabel mesh__D006315 Hearing Loss, Functional
% 208.74/208.95  |- skos__related mesh__D016743smesh__D007298
% 208.74/208.95  |- mesh__historyNote mesh__D016743 92   
% 208.74/208.95  |- skos__altLabel mesh__D016743 Competency, Mental
% 208.74/208.95  |- skos__annotation mesh__D016743
% 208.74/208.95       in mental retard or organic or psychiat mental disord; coord IM with concomitant disord /psychol %28%IM%29%; competency to consent: coord IM with INFORMED CONSENT %28%IM%29%%A%  
% 208.74/208.95  |- skos__broader mesh__D016743smesh__D011579
% 208.74/208.95  |- skos__altLabel mesh__D016743 Mental Competence
% 208.74/208.95  |- mesh__publicMeSHNote mesh__D016743 92   
% 208.74/208.95  |- skos__related mesh__D016743smesh__D016312
% 208.74/208.95  |- rdf__type mesh__D016743sskos__Concept
% 208.74/208.95  |- skos__prefLabel mesh__D016743 Mental Competency
% 208.74/208.95  |- skos__hiddenLabel mesh__D016743 Mental Incompetence
% 208.74/208.95  |- mesh__dateEstablished mesh__D016743 1992-01-01
% 208.74/208.95  |- skos__altLabel mesh__D016743 Incompetence, Mental
% 208.74/208.95  |- skos__related mesh__D016743smesh__D007258
% 208.74/208.95  |- skos__broader mesh__D016743smesh__D001520
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D016743 2003
% 208.74/208.95  |- skos__hiddenLabel mesh__D016743 Competence, Mental
% 208.74/208.95  |- mesh__recordMaintainer mesh__D016743 jrf
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D016743 2005
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D016743 2004
% 208.74/208.95  |- mesh__recordAuthorizer mesh__D016743 sjn
% 208.74/208.95  |- skos__historyNote mesh__D016743 Mental Disorders %28%1966-1991%29%
% 208.74/208.95  |- skos__related mesh__D016743smesh__D032882
% 208.74/208.95  |- skos__historyNote mesh__D016743 Forensic Psychiatry %28%1966-1991%29%
% 208.74/208.95  |- skos__hiddenLabel mesh__D016743 Mental Incompetency
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D016743 2006
% 208.74/208.95  |- mesh__recordOriginator mesh__D016743 TGC
% 208.74/208.95  |- skos__scopeNote mesh__D016743
% 208.74/208.95       The ability to understand the nature and effect of the act in which the individual is engaged. %28%From Black%27%s Law Dictionary, 6th ed%29%.%A%    
% 208.74/208.95  |- skos__related mesh__D016743smesh__D007872
% 208.74/208.95  |- mesh__dateRevised mesh__D016743 2002-07-03
% 208.74/208.95  |- skos__broader mesh__D016743smesh__D007603
% 208.74/208.95  |- mesh__dateCreated mesh__D016743 1991-07-26
% 208.74/208.95  |- skos__historyNote mesh__D016743 Mental Retardation %28%1966-1991%29%
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002723 2005
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002723 1999
% 208.74/208.95  |- mesh__dateEstablished mesh__D002723 1975-09-01
% 208.74/208.95  |- skos__broader mesh__D002723smesh__D001565
% 208.74/208.95  |- mesh__dateCreated mesh__D002723 1974-11-11
% 208.74/208.95  |- mesh__recordAuthorizer mesh__D002723 SJN
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002723 2006
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002723 2000
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002723 2003
% 208.74/208.95  |- mesh__dateRevised mesh__D002723 1998-06-10
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002723 2001
% 208.74/208.95  |- rdf__type mesh__D002723sskos__Concept
% 208.74/208.95  |- mesh__recordOriginator mesh__D002723 NLM
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002723 2004
% 208.74/208.95  |- skos__historyNote mesh__D002723 Benzoates %28%1966-1974%29%
% 208.74/208.95  |- mesh__publicMeSHNote mesh__D002723 75   
% 208.74/208.95  |- mesh__recordMaintainer mesh__D002723 ADP
% 208.74/208.95  |- mesh__historyNote mesh__D002723 75   
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D002723 2002
% 208.74/208.95  |- skos__prefLabel mesh__D002723 Chlorobenzoates
% 208.74/208.95  |- skos__scopeNote mesh__D002723
% 208.74/208.95       Benzoic acid or benzoic acid esters substituted with one or more chlorine atoms.%A%    
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D012353 2002
% 208.74/208.95  |- mesh__recordMaintainer mesh__D012353 TGC
% 208.74/208.95  |- skos__altLabel mesh__D012353 tRNAGly
% 208.74/208.95  |- skos__historyNote mesh__D012353 RNA, Transfer %28%1966-1987%29%
% 208.74/208.95  |- skos__altLabel mesh__D012353 Iso tRNA%28%Gly%29%
% 208.74/208.95  |- skos__hiddenLabel mesh__D012353 Gly Transfer RNA
% 208.74/208.95  |- mesh__recordAuthorizer mesh__D012353 PLS
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D012353 2004
% 208.74/208.95  |- skos__prefLabel mesh__D012353 RNA, Transfer, Gly
% 208.74/208.95  |- skos__historyNote mesh__D012353 Amino Acyl T RNA %28%1978-1987%29%
% 208.74/208.95  |- mesh__dateEstablished mesh__D012353 1991-01-01
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D012353 1999
% 208.74/208.95  |- skos__annotation mesh__D012353
% 208.74/208.95       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 208.74/208.95  |- mesh__recordOriginator mesh__D012353 RLS
% 208.74/208.95  |- skos__hiddenLabel mesh__D012353 RNA, Gly Transfer
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D012353 2003
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D012353 2001
% 208.74/208.95  |- skos__scopeNote mesh__D012353
% 208.74/208.95       A transfer RNA which is specific for carrying glycine to sites on the ribosomes in preparation for protein synthesis.%A%    
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D012353 2006
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D012353 1998
% 208.74/208.95  |- skos__hiddenLabel mesh__D012353 tRNA, Glycine-Specific
% 208.74/208.95  |- skos__altLabel mesh__D012353 tRNA%28%Gly%29%
% 208.74/208.95  |- mesh__dateCreated mesh__D012353 1987-05-07
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D012353 2000
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D012353 2005
% 208.74/208.95  |- mesh__historyNote mesh__D012353
% 208.74/208.95       91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.74/208.95  |- skos__hiddenLabel mesh__D012353 Glycine Specific tRNA
% 208.74/208.95  |- rdf__type mesh__D012353sskos__Concept
% 208.74/208.95  |- skos__altLabel mesh__D012353 Glycine-Specific tRNA
% 208.74/208.95  |- mesh__dateRevised mesh__D012353 1996-06-10
% 208.74/208.95  |- mesh__publicMeSHNote mesh__D012353
% 208.74/208.95       91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.74/208.95  |- skos__altLabel mesh__D012353 Transfer RNA, Gly
% 208.74/208.95  |- skos__broader mesh__D012353smesh__D012345
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D012353 1997
% 208.74/208.95  |- mesh__dateEstablished mesh__D006316 1991-01-01
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D006316 2005
% 208.74/208.95  |- skos__scopeNote mesh__D006316
% 208.74/208.95       Hearing loss in frequencies above 1000 hertz.     
% 208.74/208.95  |- mesh__dateRevised mesh__D006316 2004-07-07
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D006316 2006
% 208.74/208.95  |- skos__hiddenLabel mesh__D006316 High-Frequency Hearing Loss
% 208.74/208.95  |- mesh__recordAuthorizer mesh__D006316 sjn
% 208.74/208.95  |- mesh__historyNote mesh__D006316
% 208.74/208.95       91%28%79%29%; was see under HEARING LOSS, PARTIAL 1979-90   
% 208.74/208.95  |- skos__broader mesh__D006316smesh__D034381
% 208.74/208.95  |- skos__hiddenLabel mesh__D006316 Hearing Loss, High Frequency
% 208.74/208.95  |- mesh__recordOriginator mesh__D006316 RC
% 208.74/208.95  |- mesh__publicMeSHNote mesh__D006316
% 208.74/208.95       91; was see under HEARING LOSS, PARTIAL 1979-90   
% 208.74/208.95  |- mesh__dateCreated mesh__D006316 1978-05-22
% 208.74/208.95  |- rdf__type mesh__D006316sskos__Concept
% 208.74/208.95  |- skos__prefLabel mesh__D006316 Hearing Loss, High-Frequency
% 208.74/208.95  |- skos__historyNote mesh__D006316 Deafness %28%1966-1978%29%
% 208.74/208.95  |- mesh__recordMaintainer mesh__D006316 lkt
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D022781 2006
% 208.74/208.95  |- skos__hiddenLabel mesh__D022781 Hepatic Cell
% 208.74/208.95  |- mesh__activeMeSHYear mesh__D022781 2002
% 208.74/208.95  |- skos__prefLabel mesh__D022781 Hepatocytes
% 208.74/208.96  |- skos__hiddenLabel mesh__D022781 Cells, Hepatic
% 208.74/208.96  |- mesh__publicMeSHNote mesh__D022781 2001   
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D022781 2005
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D022781 2001
% 208.74/208.96  |- skos__altLabel mesh__D022781 Liver Cells
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D022781 2004
% 208.74/208.96  |- rdf__type mesh__D022781sskos__Concept
% 208.74/208.96  |- skos__scopeNote mesh__D022781
% 208.74/208.96       The main structural component of the LIVER. They are specialized EPITHELIAL CELLS that are organized into interconnected plates called lobules.%A%    
% 208.74/208.96  |- skos__hiddenLabel mesh__D022781 Cells, Liver
% 208.74/208.96  |- skos__hiddenLabel mesh__D022781 Cell, Hepatic
% 208.74/208.96  |- skos__hiddenLabel mesh__D022781 Liver Cell
% 208.74/208.96  |- skos__historyNote mesh__D022781 Liver %28%1966-2000%29%
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D022781 2003
% 208.74/208.96  |- skos__broader mesh__D022781smesh__D004847
% 208.74/208.96  |- skos__altLabel mesh__D022781 Hepatic Cells
% 208.74/208.96  |- skos__hiddenLabel mesh__D022781 Cell, Liver
% 208.74/208.96  |- mesh__dateCreated mesh__D022781 2000-06-22
% 208.74/208.96  |- skos__hiddenLabel mesh__D022781 Hepatocyte
% 208.74/208.96  |- mesh__dateEstablished mesh__D022781 2001-01-01
% 208.74/208.96  |- mesh__historyNote mesh__D022781 2001   
% 208.74/208.96  |- mesh__dateRevised mesh__D016744 2005-06-30
% 208.74/208.96  |- mesh__recordAuthorizer mesh__D016744 sjn
% 208.74/208.96  |- skos__altLabel mesh__D016744 M Locus
% 208.74/208.96  |- mesh__recordMaintainer mesh__D016744 nns
% 208.74/208.96  |- skos__broader mesh__D016744smesh__D005796
% 208.74/208.96  |- skos__scopeNote mesh__D016744
% 208.74/208.96       Genetic loci responsible for the encoding of minor lymphocyte stimulatory antigens. There are at least two unlinked loci %28%in the mouse%29% and they appear to be separate from the MAJOR HISTOCOMPATIBILITY COMPLEX and MINOR HISTOCOMPATIBILITY LOCI. The mouse mammary tumor virus %28%see MAMMARY TUMOR VIRUS, MOUSE%29% has the ability to integrate into these loci. The antigens induce strong T-cell proliferative responses in mixed lymphocyte reactions.%A%    
% 208.74/208.96  |- skos__hiddenLabel mesh__D016744 Locus, M
% 208.74/208.96  |- skos__hiddenLabel mesh__D016744 Locus, Mls
% 208.74/208.96  |- mesh__dateEstablished mesh__D016744 1992-01-01
% 208.74/208.96  |- skos__altLabel mesh__D016744 Lymphocyte Stimulatory Loci, Minor
% 208.74/208.96  |- mesh__historyNote mesh__D016744 92   
% 208.74/208.96  |- skos__altLabel mesh__D016744 Mls Loci
% 208.74/208.96  |- skos__hiddenLabel mesh__D016744 Mls Locus
% 208.74/208.96  |- skos__broader mesh__D016744smesh__D007125
% 208.74/208.96  |- rdf__type mesh__D016744sskos__Concept
% 208.74/208.96  |- skos__hiddenLabel mesh__D016744 Loci, Mls
% 208.74/208.96  |- skos__prefLabel mesh__D016744 Minor Lymphocyte Stimulatory Loci
% 208.74/208.96  |- mesh__recordOriginator mesh__D016744 AGS
% 208.74/208.96  |- skos__related mesh__D016744smesh__D016747
% 208.74/208.96  |- mesh__dateCreated mesh__D016744 1991-04-29
% 208.74/208.96  |- mesh__publicMeSHNote mesh__D016744 92   
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016744 2006
% 208.74/208.96  |- mesh__recordAuthorizer mesh__D002724 sjn
% 208.74/208.96  |- skos__broader mesh__D002724smesh__D000440
% 208.74/208.96  |- rdf__type mesh__D002724sskos__Concept
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D002724 2004
% 208.74/208.96  |- mesh__dateRevised mesh__D002724 2003-07-09
% 208.74/208.96  |- skos__scopeNote mesh__D002724
% 208.74/208.96       A colorless to white crystalline compound with a camphoraceous odor and taste. It is a widely used preservative in various pharmaceutical solutions, especially injectables. Also, it is an active ingredient in certain oral sedatives and topical anesthetics.%A%    
% 208.74/208.96  |- skos__altLabel mesh__D002724 Trichlorbutanol
% 208.74/208.96  |- skos__broader mesh__D002724smesh__D002728
% 208.74/208.96  |- mesh__dateCreated mesh__D002724 1999-01-01
% 208.74/208.96  |- skos__altLabel mesh__D002724 Acetonchloroform
% 208.74/208.96  |- skos__prefLabel mesh__D002724 Chlorobutanol
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D002724 2005
% 208.74/208.96  |- mesh__recordMaintainer mesh__D002724 ssb
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D002724 2006
% 208.74/208.96  |- skos__altLabel mesh__D002724 Chlorbutol
% 208.74/208.96  |- mesh__recordOriginator mesh__D002724 NLM
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D048028 2006
% 208.74/208.96  |- mesh__recordOriginator mesh__D048028 ags
% 208.74/208.96  |- rdf__type mesh__D048028sskos__Concept
% 208.74/208.96  |- mesh__dateEstablished mesh__D048028 2005-01-01
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D048028 2005
% 208.74/208.96  |- skos__scopeNote mesh__D048028
% 208.74/208.96       Deoxyribonucleic acid that makes up the genetic material of ALGAE.%A%    
% 208.74/208.96  |- mesh__publicMeSHNote mesh__D048028 2005   
% 208.74/208.96  |- mesh__dateCreated mesh__D048028 2004-07-07
% 208.74/208.96  |- skos__broader mesh__D048028smesh__D004247
% 208.74/208.96  |- mesh__recordAuthorizer mesh__D048028 sjn
% 208.74/208.96  |- skos__altLabel mesh__D048028 Algal DNA
% 208.74/208.96  |- mesh__historyNote mesh__D048028 2005   
% 208.74/208.96  |- mesh__recordMaintainer mesh__D048028 ags
% 208.74/208.96  |- skos__prefLabel mesh__D048028 DNA, Algal
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D012354 2000
% 208.74/208.96  |- mesh__dateEstablished mesh__D012354 1991-01-01
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D012354 2006
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D012354 1998
% 208.74/208.96  |- mesh__historyNote mesh__D012354
% 208.74/208.96       91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.74/208.96  |- skos__hiddenLabel mesh__D012354 RNA, His Transfer
% 208.74/208.96  |- skos__altLabel mesh__D012354 Histidine-Specific tRNA
% 208.74/208.96  |- mesh__dateRevised mesh__D012354 1996-06-10
% 208.74/208.96  |- skos__altLabel mesh__D012354 tRNA%28%His%29%
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D012354 2005
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D012354 2002
% 208.74/208.96  |- skos__scopeNote mesh__D012354
% 208.74/208.96       A transfer RNA which is specific for carrying histidine to sites on the ribosomes in preparation for protein synthesis.%A%    
% 208.74/208.96  |- rdf__type mesh__D012354sskos__Concept
% 208.74/208.96  |- skos__broader mesh__D012354smesh__D012345
% 208.74/208.96  |- skos__hiddenLabel mesh__D012354 tRNA, Histidine-Specific
% 208.74/208.96  |- skos__hiddenLabel mesh__D012354 Histidine Specific tRNA
% 208.74/208.96  |- skos__altLabel mesh__D012354 tRNAHis
% 208.74/208.96  |- mesh__recordOriginator mesh__D012354 RLS
% 208.74/208.96  |- mesh__recordAuthorizer mesh__D012354 PLS
% 208.74/208.96  |- mesh__publicMeSHNote mesh__D012354
% 208.74/208.96       91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.74/208.96  |- skos__prefLabel mesh__D012354 RNA, Transfer, His
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D012354 1997
% 208.74/208.96  |- skos__historyNote mesh__D012354 Amino Acyl T RNA %28%1978-1987%29%
% 208.74/208.96  |- skos__altLabel mesh__D012354 Transfer RNA, His
% 208.74/208.96  |- skos__hiddenLabel mesh__D012354 His Transfer RNA
% 208.74/208.96  |- skos__historyNote mesh__D012354 RNA, Transfer %28%1966-1987%29%
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D012354 2004
% 208.74/208.96  |- mesh__dateCreated mesh__D012354 1987-05-07
% 208.74/208.96  |- mesh__recordMaintainer mesh__D012354 TGC
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D012354 2001
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D012354 1999
% 208.74/208.96  |- skos__annotation mesh__D012354
% 208.74/208.96       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D012354 2003
% 208.74/208.96  |- skos__scopeNote mesh__D006317
% 208.74/208.96       Hearing loss due to exposure to explosive loud noise or chronic exposure to sound level greater than 85 dB. The hearing loss is often in the frequency range 4000-6000 hertz.%A%    
% 208.74/208.96  |- rdf__type mesh__D006317sskos__Concept
% 208.74/208.96  |- mesh__publicMeSHNote mesh__D006317 79; was ACOUSTIC TRAUMA 1963-78   
% 208.74/208.96  |- mesh__onlineNote mesh__D006317
% 208.74/208.96       use HEARING LOSS, NOISE-INDUCED to search ACOUSTIC TRAUMA 1966-78%A%  
% 208.74/208.96  |- skos__broader mesh__D006317smesh__D006319
% 208.74/208.96  |- mesh__dateCreated mesh__D006317 1999-01-01
% 208.74/208.96  |- mesh__recordOriginator mesh__D006317 NLM
% 208.74/208.96  |- skos__historyNote mesh__D006317 Deafness %28%1966-1978%29%
% 208.74/208.96  |- skos__historyNote mesh__D006317 Acoustic Trauma %28%1966-1978%29%
% 208.74/208.96  |- skos__hiddenLabel mesh__D006317 Hearing Loss, Noise Induced
% 208.74/208.96  |- skos__prefLabel mesh__D006317 Hearing Loss, Noise-Induced
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D006317 2006
% 208.74/208.96  |- mesh__recordMaintainer mesh__D006317 lkt
% 208.74/208.96  |- skos__historyNote mesh__D006317 Noise %28%1966-1978%29%
% 208.74/208.96  |- mesh__dateRevised mesh__D006317 2004-07-07
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D006317 2005
% 208.74/208.96  |- mesh__recordAuthorizer mesh__D006317 sjn
% 208.74/208.96  |- skos__hiddenLabel mesh__D006317 Noise-Induced Hearing Loss
% 208.74/208.96  |- mesh__historyNote mesh__D006317 79; was ACOUSTIC TRAUMA 1963-78   
% 208.74/208.96  |- skos__hiddenLabel mesh__D022782 IL 6 Dependent DNA Binding Protein
% 208.74/208.96  |- skos__hiddenLabel mesh__D022782 Transcription Factor, LAP
% 208.74/208.96  |- skos__altLabel mesh__D022782 Liver-Enriched Inhibitory Protein, LIP
% 208.74/208.96  |- mesh__dateCreated mesh__D022782 2000-06-23
% 208.74/208.96  |- mesh__recordOriginator mesh__D022782 jmp
% 208.74/208.96  |- skos__altLabel mesh__D022782 C-EBP beta
% 208.74/208.96  |- skos__hiddenLabel mesh__D022782 Transcription Factor, AGP-EBP
% 208.74/208.96  |- mesh__recordAuthorizer mesh__D022782 ags
% 208.74/208.96  |- skos__scopeNote mesh__D022782
% 208.74/208.96       A CCAAT-enhancer-binding protein found in LIVER; INTESTINES; LUNG and ADIPOSE TISSUE. It is an important mediator of INTERLEUKIN-6 signaling.%A%    
% 208.74/208.96  |- mesh__dateEstablished mesh__D022782 2001-01-01
% 208.74/208.96  |- skos__hiddenLabel mesh__D022782 C EBP beta
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D022782 2006A
% 208.74/208.96  |- skos__altLabel mesh__D022782 IL-6-Dependent DNA Binding Protein
% 208.74/208.96  |- mesh__publicMeSHNote mesh__D022782
% 208.74/208.96       2001; C-EBP BETA %28%now CCAAT-ENHANCER-BINDING PROTEIN-BETA%29% was indexed under DNA-BINDING PROTEINS and NUCLEAR PROTEINS 1994-2000; LIVER-ENRICHED INHIBITING PROTEIN was indexed under REPRESSOR PROTEINS 1995-2000%A%  
% 208.74/208.96  |- skos__hiddenLabel mesh__D022782 Inhibiting Protein, Liver-Enriched
% 208.74/208.96  |- skos__historyNote mesh__D022782 Nuclear Proteins %28%1994-2000%29%
% 208.74/208.96  |- skos__altLabel mesh__D022782 IL-6 DBP
% 208.74/208.96  |- skos__hiddenLabel mesh__D022782 C EBPbeta
% 208.74/208.96  |- skos__hiddenLabel mesh__D022782 C EBP Related Protein 2
% 208.74/208.96  |- skos__hiddenLabel mesh__D022782 Liver Enriched Inhibiting Protein
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D022782 2006
% 208.74/208.96  |- skos__altLabel mesh__D022782 40-C-EBP Protein
% 208.74/208.96  |- skos__hiddenLabel mesh__D022782 AGP EBP Transcription Factor
% 208.74/208.96  |- skos__altLabel mesh__D022782 C-EBPbeta
% 208.74/208.96  |- skos__hiddenLabel mesh__D022782 2, C-EBP-Related Protein
% 208.74/208.96  |- skos__hiddenLabel mesh__D022782 Interleukin 6 Nuclear Factor
% 208.74/208.96  |- skos__hiddenLabel mesh__D022782 Liver Enriched Inhibitory Protein, LIP
% 208.74/208.96  |- skos__altLabel mesh__D022782 AGP-EBP Transcription Factor
% 208.74/208.96  |- skos__historyNote mesh__D022782 DNA-Binding Proteins %28%1994-2000%29%
% 208.74/208.96  |- skos__prefLabel mesh__D022782 CCAAT-Enhancer-Binding Protein-beta
% 208.74/208.96  |- skos__altLabel mesh__D022782 CRP2 Protein
% 208.74/208.96  |- skos__altLabel mesh__D022782 Interleukin-6 Nuclear Factor
% 208.74/208.96  |- skos__altLabel mesh__D022782 C-EBP-Related Protein 2
% 208.74/208.96  |- skos__altLabel mesh__D022782 C-EBP-beta
% 208.74/208.96  |- rdf__type mesh__D022782sskos__Concept
% 208.74/208.96  |- skos__altLabel mesh__D022782 NF-IL6
% 208.74/208.96  |- mesh__historyNote mesh__D022782
% 208.74/208.96       2001; use CCAAT-ENHANCER-BINDING PROTEINS %28%NM%29% 1994-2000; for LIVER-ENRICHED INHIBITING PROTEIN use CCAAT-ENHANCER-BINDING PROTEIN-BETA %28%NM%29% 1995-2000;%A%  
% 208.74/208.96  |- skos__altLabel mesh__D022782 23-C-EBP Protein
% 208.74/208.96  |- skos__broader mesh__D022782smesh__D022762
% 208.74/208.96  |- skos__hiddenLabel mesh__D022782 Protein-beta, CCAAT-Enhancer-Binding
% 208.74/208.96  |- skos__hiddenLabel mesh__D022782 Nuclear Factor, Interleukin-6
% 208.74/208.96  |- skos__altLabel mesh__D022782 LAP Transcription Factor
% 208.74/208.96  |- skos__hiddenLabel mesh__D022782 CCAAT Enhancer Binding Protein beta
% 208.74/208.96  |- mesh__recordMaintainer mesh__D022782 ags
% 208.74/208.96  |- mesh__dateRevised mesh__D022782 2005-07-11
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016745 1997
% 208.74/208.96  |- skos__historyNote mesh__D016745 Tooth Root %28%1966-1991%29%
% 208.74/208.96  |- skos__scopeNote mesh__D016745
% 208.74/208.96       A procedure for smoothing of the roughened root surface or cementum of a tooth after subgingival curettage or scaling, as part of periodontal therapy.%A%    
% 208.74/208.96  |- mesh__historyNote mesh__D016745 92   
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016745 1993
% 208.74/208.96  |- rdf__type mesh__D016745sskos__Concept
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016745 1996
% 208.74/208.96  |- skos__broader mesh__D016745smesh__D013357
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016745 2002
% 208.74/208.96  |- skos__annotation mesh__D016745
% 208.74/208.96       in periodontal ther to smooth root surface or cementum; do not use /util except by MeSH definition; do not confuse with ROOT SCALING see DENTAL SCALING%A%  
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016745 1999
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016745 1992
% 208.74/208.96  |- mesh__dateCreated mesh__D016745 1991-04-29
% 208.74/208.96  |- skos__prefLabel mesh__D016745 Root Planing
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016745 2004
% 208.74/208.96  |- mesh__dateEstablished mesh__D016745 1992-01-01
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016745 1995
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016745 1998
% 208.74/208.96  |- skos__broader mesh__D016745smesh__D012534
% 208.74/208.96  |- skos__hiddenLabel mesh__D016745 Root Planings
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016745 2003
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016745 1994
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016745 2001
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016745 2006
% 208.74/208.96  |- mesh__publicMeSHNote mesh__D016745 92   
% 208.74/208.96  |- skos__hiddenLabel mesh__D016745 Planings, Root
% 208.74/208.96  |- skos__hiddenLabel mesh__D016745 Planing, Root
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016745 2000
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016745 2005
% 208.74/208.96  |- mesh__recordAuthorizer mesh__D002725 sjn
% 208.74/208.96  |- mesh__dateCreated mesh__D002725 1999-01-01
% 208.74/208.96  |- mesh__recordOriginator mesh__D002725 NLM
% 208.74/208.96  |- mesh__dateRevised mesh__D002725 2004-07-19
% 208.74/208.96  |- mesh__recordMaintainer mesh__D002725 jls
% 208.74/208.96  |- skos__scopeNote mesh__D002725
% 208.74/208.96       A commonly used laboratory solvent. It was previously used as an anesthetic, but was banned from use in the U.S. due to its suspected carcinogenicity.%A%    
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D002725 2005
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D002725 2006
% 208.74/208.96  |- skos__broader mesh__D002725smesh__D006843
% 208.74/208.96  |- skos__prefLabel mesh__D002725 Chloroform
% 208.74/208.96  |- skos__broader mesh__D002725smesh__D022882
% 208.74/208.96  |- rdf__type mesh__D002725sskos__Concept
% 208.74/208.96  |- skos__altLabel mesh__D002725 Trichloromethane
% 208.74/208.96  |- skos__prefLabel mesh__D007410 Intestinal Diseases
% 208.74/208.96  |- mesh__onlineNote mesh__D007410
% 208.74/208.96       search INTESTINAL MICROORGANISMS under INTESTINES 1966-67%A%  
% 208.74/208.96  |- mesh__historyNote mesh__D007410
% 208.74/208.96       INTESTINAL MICROORGANISMS was heading 1963-67; general or unspecified inflamm dis was indexed under ENTERITIS or INTESTINAL DISEASES 1966-79%A%  
% 208.74/208.96  |- mesh__dateCreated mesh__D007410 1999-01-01
% 208.74/208.96  |- skos__hiddenLabel mesh__D007410 Disease, Intestinal
% 208.74/208.96  |- rdf__type mesh__D007410sskos__Concept
% 208.74/208.96  |- skos__annotation mesh__D007410
% 208.74/208.96       GEN: prefer specifics; inflamm dis = GASTROENTERITIS or specifics; consider also INFLAMMATORY BOWEL DISEASE; gas cysts = PNEUMATOSIS CYSTOIDES INTESTINALIS%A%  
% 208.74/208.96  |- mesh__publicMeSHNote mesh__D007410
% 208.74/208.96       INTESTINAL MICROORGANISMS was heading 1963-67; general or unspecified inflammatory disease is indexed here, was indexed under INTESTINAL DISEASES or ENTERITIS 1963-79%A%  
% 208.74/208.96  |- skos__hiddenLabel mesh__D007410 Intestinal Disease
% 208.74/208.96  |- mesh__recordOriginator mesh__D007410 NLM
% 208.74/208.96  |- mesh__recordAuthorizer mesh__D007410 sjn
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D007410 2006
% 208.74/208.96  |- skos__broader mesh__D007410smesh__D005767
% 208.74/208.96  |- skos__hiddenLabel mesh__D007410 Diseases, Intestinal
% 208.74/208.96  |- mesh__dateRevised mesh__D007410 2003-07-09
% 208.74/208.96  |- skos__scopeNote mesh__D007410
% 208.74/208.96       Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.%A%    
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D007410 2005
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D007410 2004
% 208.74/208.96  |- mesh__recordMaintainer mesh__D007410 lkt
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D048029 2005
% 208.74/208.96  |- skos__altLabel mesh__D048029 TRAF6
% 208.74/208.96  |- skos__historyNote mesh__D048029 Proteins %28%1996-2004%29%
% 208.74/208.96  |- mesh__dateCreated mesh__D048029 2004-07-07
% 208.74/208.96  |- mesh__publicMeSHNote mesh__D048029
% 208.74/208.96       2005; TNF RECEPTOR-ASSOCIATED FACTOR 6 was indexed under PROTEINS 1996-2004%A%  
% 208.74/208.96  |- skos__altLabel mesh__D048029 TRAF-6 Protein
% 208.74/208.96  |- skos__hiddenLabel mesh__D048029 TNF Receptor Associated Factor 6
% 208.74/208.96  |- mesh__dateEstablished mesh__D048029 2005-01-01
% 208.74/208.96  |- skos__hiddenLabel mesh__D048029 TRAF 6 Protein
% 208.74/208.96  |- mesh__recordOriginator mesh__D048029 jmp
% 208.74/208.96  |- mesh__historyNote mesh__D048029 2005%28%1996%29%   
% 208.74/208.96  |- skos__scopeNote mesh__D048029
% 208.74/208.96       A signal transducing tumor necrosis factor receptor associated factor that is involved in regulation of NF-KAPPA B signalling and activation of JNK MITOGEN-ACTIVATED PROTEIN KINASES.%A%    
% 208.74/208.96  |- skos__prefLabel mesh__D048029 TNF Receptor-Associated Factor 6
% 208.74/208.96  |- mesh__recordAuthorizer mesh__D048029 sjn
% 208.74/208.96  |- skos__broader mesh__D048029smesh__D047988
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D048029 2006
% 208.74/208.96  |- mesh__recordMaintainer mesh__D048029 jmp
% 208.74/208.96  |- rdf__type mesh__D048029sskos__Concept
% 208.74/208.96  |- skos__hiddenLabel mesh__D012355 RNA, Ile Transfer
% 208.74/208.96  |- mesh__dateCreated mesh__D012355 1987-05-07
% 208.74/208.96  |- skos__scopeNote mesh__D012355
% 208.74/208.96       A transfer RNA which is specific for carrying isoleucine to sites on the ribosomes in preparation for protein synthesis.%A%    
% 208.74/208.96  |- skos__hiddenLabel mesh__D012355 Isoleucine Specific tRNA
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D012355 2001
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D012355 2005
% 208.74/208.96  |- skos__prefLabel mesh__D012355 RNA, Transfer, Ile
% 208.74/208.96  |- rdf__type mesh__D012355sskos__Concept
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D012355 2000
% 208.74/208.96  |- skos__broader mesh__D012355smesh__D012345
% 208.74/208.96  |- mesh__publicMeSHNote mesh__D012355
% 208.74/208.96       91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.74/208.96  |- mesh__historyNote mesh__D012355
% 208.74/208.96       91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.74/208.96  |- skos__altLabel mesh__D012355 Isoleucine-Specific tRNA
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D012355 1997
% 208.74/208.96  |- skos__altLabel mesh__D012355 tRNAIle
% 208.74/208.96  |- skos__hiddenLabel mesh__D012355 Ile Transfer RNA
% 208.74/208.96  |- skos__altLabel mesh__D012355 Transfer RNA, Ile
% 208.74/208.96  |- mesh__dateRevised mesh__D012355 1996-06-10
% 208.74/208.96  |- skos__historyNote mesh__D012355 RNA, Transfer %28%1966-1987%29%
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D012355 2004
% 208.74/208.96  |- mesh__recordMaintainer mesh__D012355 TGC
% 208.74/208.96  |- skos__hiddenLabel mesh__D012355 tRNA, Isoleucine-Specific
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D012355 2002
% 208.74/208.96  |- skos__annotation mesh__D012355
% 208.74/208.96       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 208.74/208.96  |- mesh__recordOriginator mesh__D012355 RLS
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D012355 1999
% 208.74/208.96  |- skos__altLabel mesh__D012355 tRNA%28%Ile%29%
% 208.74/208.96  |- mesh__recordAuthorizer mesh__D012355 PLS
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D012355 2003
% 208.74/208.96  |- skos__historyNote mesh__D012355 Amino Acyl T RNA %28%1978-1987%29%
% 208.74/208.96  |- mesh__dateEstablished mesh__D012355 1991-01-01
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D012355 2006
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D012355 1998
% 208.74/208.96  |- skos__hiddenLabel mesh__D003020 Clothings
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D003020 2002
% 208.74/208.96  |- mesh__dateCreated mesh__D003020 1999-01-01
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D003020 2006
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D003020 1999
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D003020 2004
% 208.74/208.96  |- mesh__dateRevised mesh__D003020 1997-06-20
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D003020 2005
% 208.74/208.96  |- skos__broader mesh__D003020smesh__D008420
% 208.74/208.96  |- rdf__type mesh__D003020sskos__Concept
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D003020 2001
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D003020 1998
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D003020 2003
% 208.74/208.96  |- mesh__recordOriginator mesh__D003020 NLM
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D003020 2000
% 208.74/208.96  |- mesh__recordAuthorizer mesh__D003020 SJN
% 208.74/208.96  |- skos__prefLabel mesh__D003020 Clothing
% 208.74/208.96  |- mesh__recordMaintainer mesh__D003020 JLS
% 208.74/208.96  |- mesh__dateCreated mesh__D022783 2000-06-22
% 208.74/208.96  |- mesh__publicMeSHNote mesh__D022783
% 208.74/208.96       2006; see TRANSFUSION-ASSOCIATED VIRUS 2001-2005   
% 208.74/208.96  |- mesh__recordMaintainer mesh__D022783 ags
% 208.74/208.96  |- mesh__recordAuthorizer mesh__D022783 sjn
% 208.74/208.96  |- rdf__type mesh__D022783sskos__Concept
% 208.74/208.96  |- skos__altLabel mesh__D022783 SEN-V
% 208.74/208.96  |- mesh__recordOriginator mesh__D022783 ags
% 208.74/208.96  |- skos__annotation mesh__D022783
% 208.74/208.96       a specific virus, not any virus transmitted by transfusion; infection: coord IM with DNA VIRUS INFECTIONS %28%IM%29%%A%  
% 208.74/208.96  |- skos__hiddenLabel mesh__D022783 Virus, TT
% 208.74/208.96  |- mesh__historyNote mesh__D022783 2006 %28%2001%29%   
% 208.74/208.96  |- skos__broader mesh__D022783smesh__D049811
% 208.74/208.96  |- skos__hiddenLabel mesh__D022783 Virus, Transfusion-Transmitted
% 208.74/208.96  |- skos__hiddenLabel mesh__D022783 Viruses, TT
% 208.74/208.96  |- skos__hiddenLabel mesh__D022783 TT Viruses
% 208.74/208.96  |- mesh__dateEstablished mesh__D022783 2001-01-01
% 208.74/208.96  |- skos__altLabel mesh__D022783 TT Virus
% 208.74/208.96  |- skos__prefLabel mesh__D022783 Torque teno virus
% 208.74/208.96  |- skos__hiddenLabel mesh__D022783 Transfusion Transmitted Virus
% 208.74/208.96  |- skos__hiddenLabel mesh__D022783 SEN viruses
% 208.74/208.96  |- skos__hiddenLabel mesh__D022783 virus, SEN
% 208.74/208.96  |- skos__historyNote mesh__D022783 DNA Viruses %28%1998-2000%29%
% 208.74/208.96  |- skos__altLabel mesh__D022783 Transfusion-Transmitted Virus
% 208.74/208.96  |- skos__historyNote mesh__D022783 Hepatitis Viruses %28%1998-1999%29%
% 208.74/208.96  |- skos__hiddenLabel mesh__D022783 viruses, SEN
% 208.74/208.96  |- skos__scopeNote mesh__D022783
% 208.74/208.96       A species of non-enveloped DNA virus in the genus ANELLOVIRUS, associated with BLOOD TRANSFUSIONS; and HEPATITIS. However, no etiological role has been found for TTV in hepatitis.%A%    
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D022783 2006
% 208.74/208.96  |- skos__altLabel mesh__D022783 SENV
% 208.74/208.96  |- mesh__dateRevised mesh__D022783 2005-06-30
% 208.74/208.96  |- skos__hiddenLabel mesh__D022783 Torque teno viruses
% 208.74/208.96  |- skos__historyNote mesh__D049920
% 208.74/208.96       Gram-Negative Aerobic Rods and Cocci %28%1995-2000%29%
% 208.74/208.96  |- mesh__recordOriginator mesh__D049920 ags
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D049920 2006
% 208.74/208.96  |- skos__prefLabel mesh__D049920 Ralstonia pickettii
% 208.74/208.96  |- skos__annotation mesh__D049920
% 208.74/208.96       infection: coordinate IM with GRAM NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 208.74/208.96  |- mesh__publicMeSHNote mesh__D049920 2006; see RALSTONIA 2002-2005   
% 208.74/208.96  |- rdf__type mesh__D049920sskos__Concept
% 208.74/208.96  |- mesh__recordMaintainer mesh__D049920 ags
% 208.74/208.96  |- skos__broader mesh__D049920smesh__D043367
% 208.74/208.96  |- skos__historyNote mesh__D049920 Ralstonia %28%2004-2005%29%
% 208.74/208.96  |- skos__scopeNote mesh__D049920
% 208.74/208.96       The type species in the genus RALSTONIA. It is often found in the hospital ward as a contaminant of antiseptic and disinfectant solutions.%A%    
% 208.74/208.96  |- mesh__dateEstablished mesh__D049920 2006-01-01
% 208.74/208.96  |- skos__historyNote mesh__D049920 Betaproteobacteria %28%1995-2004%29%
% 208.74/208.96  |- mesh__dateCreated mesh__D049920 2005-06-30
% 208.74/208.96  |- mesh__recordAuthorizer mesh__D049920 sjn
% 208.74/208.96  |- mesh__historyNote mesh__D049920 2006; use RALSTONIA 2002-2005   
% 208.74/208.96  |- skos__scopeNote mesh__D016746
% 208.74/208.96       A nursing specialty created to answer the need for developing a global perspective in the practice of nursing in a world of interdependent nations and people. The focus of this nursing discipline is on the integration of international and transcultural content into the training. Courses include study in the area of cultural differences, nursing in other countries, and international health issues and organizations, as an example.%A%    
% 208.74/208.96  |- rdf__type mesh__D016746sskos__Concept
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016746 2005
% 208.74/208.96  |- mesh__recordAuthorizer mesh__D016746 sjn
% 208.74/208.96  |- mesh__historyNote mesh__D016746 92   
% 208.74/208.96  |- mesh__recordMaintainer mesh__D016746 kle
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016746 2002
% 208.74/208.96  |- skos__historyNote mesh__D016746 Nursing Care %28%1975-1991%29%
% 208.74/208.96  |- mesh__dateCreated mesh__D016746 1991-04-29
% 208.74/208.96  |- mesh__dateRevised mesh__D016746 1999-11-03
% 208.74/208.96  |- skos__prefLabel mesh__D016746 Transcultural Nursing
% 208.74/208.96  |- skos__broader mesh__D016746smesh__D013041
% 208.74/208.96  |- skos__annotation mesh__D016746
% 208.74/208.96       SPEC: SPEC qualif; on an international or cultural level only; coord IM with nurs specialty %28%IM%29% if pertinent + culture or ethnic group %28%IM%29% if pertinent; specify geog; DF: TRANSCULTURAL NURS%A%  
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016746 2004
% 208.74/208.96  |- mesh__recordOriginator mesh__D016746 MXR
% 208.74/208.96  |- mesh__dateEstablished mesh__D016746 1992-01-01
% 208.74/208.96  |- skos__historyNote mesh__D016746 Primary Nursing Care %28%1977-1991%29%
% 208.74/208.96  |- skos__historyNote mesh__D016746 Nursing %28%1977-1991%29%
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016746 2001
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016746 2003
% 208.74/208.96  |- skos__altLabel mesh__D016746 Nursing, Transcultural
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016746 2000
% 208.74/208.96  |- mesh__publicMeSHNote mesh__D016746 92   
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D016746 2006
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D002726 2005
% 208.74/208.96  |- skos__hiddenLabel mesh__D002726 Acid, Chlorogenic
% 208.74/208.96  |- rdf__type mesh__D002726sskos__Concept
% 208.74/208.96  |- skos__prefLabel mesh__D002726 Chlorogenic Acid
% 208.74/208.96  |- skos__broader mesh__D002726smesh__D002934
% 208.74/208.96  |- mesh__recordAuthorizer mesh__D002726 sjn
% 208.74/208.96  |- skos__altLabel mesh__D002726 3-Caffeoylquinic Acid
% 208.74/208.96  |- skos__hiddenLabel mesh__D002726 3 Caffeoylquinic Acid
% 208.74/208.96  |- mesh__dateCreated mesh__D002726 1999-01-01
% 208.74/208.96  |- mesh__dateRevised mesh__D002726 2004-07-19
% 208.74/208.96  |- mesh__recordMaintainer mesh__D002726 jls
% 208.74/208.96  |- mesh__recordOriginator mesh__D002726 NLM
% 208.74/208.96  |- skos__broader mesh__D002726smesh__D003509
% 208.74/208.96  |- skos__scopeNote mesh__D002726
% 208.74/208.96       A naturally occurring phenolic acid which is a carcinogenic inhibitor. It has also been shown to prevent paraquat-induced oxidative stress in rats. %28%From J Chromatogr A 1996;741%28%2%29%:223-31; Biosci Biotechnol Biochem 1996;60%28%5%29%:765-68%29%.%A%    
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D002726 2006
% 208.74/208.96  |- skos__hiddenLabel mesh__D002726 Acid, 3-Caffeoylquinic
% 208.74/208.96  |- rdf__type mesh__D007411sskos__Concept
% 208.74/208.96  |- skos__altLabel mesh__D007411 Parasitic Intestinal Diseases
% 208.74/208.96  |- skos__hiddenLabel mesh__D007411 Diseases, Parasitic Intestinal
% 208.74/208.96  |- skos__broader mesh__D007411smesh__D010272
% 208.74/208.96  |- skos__hiddenLabel mesh__D007411 Disease, Parasitic Intestinal
% 208.74/208.96  |- skos__scopeNote mesh__D007411
% 208.74/208.96       Infections of the INTESTINES with PARASITES, commonly involving PROTOZOA or PARASITIC WORMS. Infections with roundworms %28%NEMATODE INFECTIONS%29% and tapeworms %28%CESTODE INFECTIONS%29% are also known as HELMINTHIASIS.%A%    
% 208.74/208.96  |- mesh__recordMaintainer mesh__D007411 ags
% 208.74/208.96  |- skos__prefLabel mesh__D007411 Intestinal Diseases, Parasitic
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D007411 2006
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D007411 2006A
% 208.74/208.96  |- skos__hiddenLabel mesh__D007411 Parasitic Intestinal Disease
% 208.74/208.96  |- mesh__recordOriginator mesh__D007411 NLM
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D007411 2005
% 208.74/208.96  |- mesh__activeMeSHYear mesh__D007411 2004
% 208.74/208.97  |- mesh__recordAuthorizer mesh__D007411 ags
% 208.74/208.97  |- skos__hiddenLabel mesh__D007411 Intestinal Disease, Parasitic
% 208.74/208.97  |- skos__annotation mesh__D007411
% 208.74/208.97       GEN; prefer specific indentations; otherwise coord IM with specific parasitic disease %28%IM%29% + specific precoord intestinal disease %28%IM%29%%A%  
% 208.74/208.97  |- mesh__dateRevised mesh__D007411 2005-08-02
% 208.74/208.97  |- skos__broader mesh__D007411smesh__D007410
% 208.74/208.97  |- mesh__dateCreated mesh__D007411 1999-01-01
% 208.74/208.97  |- skos__prefLabel mesh__D048828 beta-N-Acetyl-Galactosaminidase
% 208.74/208.97  |- skos__historyNote mesh__D048828 Acetic Acids %28%1973-1978%29%
% 208.74/208.97  |- mesh__recordAuthorizer mesh__D048828 sjn
% 208.74/208.97  |- mesh__recordMaintainer mesh__D048828 jmp
% 208.74/208.97  |- skos__hiddenLabel mesh__D048828 beta N Acetyl Galactosaminidase
% 208.74/208.97  |- mesh__publicMeSHNote mesh__D048828
% 208.74/208.97       2005; BETA-N-ACETYL-GALACTOAMINIDASE was indexed under GALACTOSAMINIDASE 1982-2004, under ACETYLGALACTOSAMINE 1978-1981, %26% under ACETAMIDES %26% ACETIC ACIDS 1973-1978%A%  
% 208.74/208.97  |- mesh__activeMeSHYear mesh__D048828 2006
% 208.74/208.97  |- skos__scopeNote mesh__D048828
% 208.74/208.97       A hexosiminidase that specifically hydrolyzes terminal non-reducing N-acetyl-D-galactosamine residues in N-acetyl-beta-D-galactosaminides.%A%    
% 208.74/208.97  |- rdf__type mesh__D048828sskos__Concept
% 208.74/208.97  |- skos__altLabel mesh__D048828 N-Acetyl-beta-Galactosaminidase
% 208.74/208.97  |- skos__historyNote mesh__D048828 Acetylgalactosamine %28%1978-1981%29%
% 208.74/208.97  |- mesh__activeMeSHYear mesh__D048828 2005
% 208.74/208.97  |- mesh__recordOriginator mesh__D048828 jmp
% 208.74/208.97  |- mesh__dateEstablished mesh__D048828 2005-01-01
% 208.74/208.97  |- skos__broader mesh__D048828smesh__D006596
% 208.74/208.97  |- skos__historyNote mesh__D048828 Hexosaminidases %28%1982-2004%29%
% 208.74/208.97  |- skos__historyNote mesh__D048828 Acetamides %28%1973-1978%29%
% 208.74/208.97  |- skos__hiddenLabel mesh__D048828 N Acetyl beta Galactosaminidase
% 208.74/208.97  |- mesh__historyNote mesh__D048828 2005%28%1973%29%   
% 208.74/208.97  |- skos__hiddenLabel mesh__D048828 beta N Acetylgalactosaminidase
% 208.74/208.97  |- skos__altLabel mesh__D048828 beta-N-Acetylgalactosaminidase
% 208.74/208.97  |- mesh__dateCreated mesh__D048828 2004-07-08
% 208.74/208.97  |- skos__altLabel mesh__D012356 Transfer RNA, Leu
% 208.74/208.97  |- skos__altLabel mesh__D012356 tRNALeu
% 208.74/208.97  |- skos__historyNote mesh__D012356 RNA, Transfer %28%1966-1987%29%
% 208.74/208.97  |- rdf__type mesh__D012356sskos__Concept
% 208.74/208.97  |- mesh__dateCreated mesh__D012356 1987-05-07
% 208.74/208.97  |- skos__historyNote mesh__D012356 Amino Acyl T RNA %28%1978-1987%29%
% 208.74/208.97  |- mesh__activeMeSHYear mesh__D012356 2000
% 208.74/208.97  |- mesh__dateEstablished mesh__D012356 1991-01-01
% 208.74/208.97  |- mesh__recordOriginator mesh__D012356 RLS
% 208.74/208.97  |- skos__altLabel mesh__D012356 Leucine-Specific tRNA
% 208.74/208.97  |- skos__annotation mesh__D012356
% 208.74/208.97       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 208.74/208.97  |- mesh__historyNote mesh__D012356
% 208.74/208.97       91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.74/208.97  |- skos__altLabel mesh__D012356 tRNA%28%Leu%29%
% 208.74/208.97  |- mesh__activeMeSHYear mesh__D012356 1997
% 208.74/208.97  |- mesh__recordMaintainer mesh__D012356 TGC
% 208.74/208.97  |- mesh__activeMeSHYear mesh__D012356 2003
% 208.74/208.97  |- mesh__activeMeSHYear mesh__D012356 2001
% 208.74/208.97  |- mesh__activeMeSHYear mesh__D012356 1998
% 208.74/208.97  |- mesh__activeMeSHYear mesh__D012356 2004
% 208.74/208.97  |- mesh__activeMeSHYear mesh__D012356 2002
% 208.74/208.97  |- skos__prefLabel mesh__D012356 RNA, Transfer, Leu
% 208.74/208.97  |- mesh__activeMeSHYear mesh__D012356 1999
% 208.74/208.97  |- mesh__activeMeSHYear mesh__D012356 2005
% 208.74/208.97  |- skos__hiddenLabel mesh__D012356 Leu Transfer RNA
% 208.74/208.97  |- mesh__recordAuthorizer mesh__D012356 PLS
% 208.74/208.97  |- skos__hiddenLabel mesh__D012356 Leucine Specific tRNA
% 208.74/208.97  |- skos__hiddenLabel mesh__D012356 tRNA, Leucine-Specific
% 208.74/208.97  |- skos__hiddenLabel mesh__D012356 RNA, Leu Transfer
% 208.74/208.97  |- skos__scopeNote mesh__D012356
% 208.74/208.97       A transfer RNA which is specific for carrying leucine to sites on the ribosomes in preparation for protein synthesis.%A%    
% 208.74/208.97  |- mesh__activeMeSHYear mesh__D012356 2006
% 208.74/208.97  |- mesh__dateRevised mesh__D012356 1996-06-10
% 208.74/208.97  |- skos__broader mesh__D012356smesh__D012345
% 208.74/208.97  |- mesh__publicMeSHNote mesh__D012356
% 208.74/208.97       91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.74/208.97  |- skos__historyNote mesh__D006319 Deafness %28%1966-1978%29%
% 208.74/208.97  |- mesh__publicMeSHNote mesh__D006319 79   
% 208.74/208.97  |- mesh__dateCreated mesh__D006319 1978-05-22
% 208.74/208.97  |- skos__altLabel mesh__D006319 Sensorineural Hearing Loss
% 208.74/208.97  |- skos__annotation mesh__D006319
% 208.74/208.97       HEARING LOSS, MIXED CONDUCTIVE-SENSORINEURAL is also available%A%  
% 208.74/208.97  |- mesh__dateEstablished mesh__D006319 1979-01-01
% 208.74/208.97  |- skos__prefLabel mesh__D006319 Hearing Loss, Sensorineural
% 208.74/208.97  |- mesh__activeMeSHYear mesh__D006319 2006
% 208.74/208.97  |- mesh__dateRevised mesh__D006319 2004-07-07
% 208.74/208.97  |- skos__scopeNote mesh__D006319
% 208.74/208.97       Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.%A%    
% 208.74/208.97  |- mesh__activeMeSHYear mesh__D006319 2005
% 208.74/208.97  |- mesh__recordOriginator mesh__D006319 RC
% 208.74/208.97  |- skos__altLabel mesh__D006319 Cochlear Hearing Loss
% 208.74/208.97  |- mesh__recordMaintainer mesh__D006319 lkt
% 208.74/208.97  |- mesh__recordAuthorizer mesh__D006319 sjn
% 208.74/208.97  |- mesh__historyNote mesh__D006319 79   
% 208.74/208.97  |- rdf__type mesh__D006319sskos__Concept
% 208.74/208.97  |- skos__broader mesh__D006319smesh__D034381
% 208.74/208.97  |- mesh__activeMeSHYear mesh__D017041 2006
% 208.74/208.97  |- mesh__recordMaintainer mesh__D017041 jrf
% 208.74/208.97  |- skos__hiddenLabel mesh__D017041 Ethics Committees, Institutional
% 208.74/208.97  |- mesh__recordAuthorizer mesh__D017041 sjn
% 208.74/208.97  |- skos__hiddenLabel mesh__D017041 Ethics Committee
% 208.74/208.97  |- mesh__dateCreated mesh__D017041 1991-07-26
% 208.74/208.97  |- rdf__type mesh__D017041sskos__Concept
% 208.74/208.97  |- skos__related mesh__D017041smesh__D026724
% 208.74/208.97  |- mesh__activeMeSHYear mesh__D017041 2003
% 208.74/208.97  |- mesh__dateEstablished mesh__D017041 1992-01-01
% 208.74/208.97  |- skos__hiddenLabel mesh__D017041 Committees, Institutional Ethics
% 208.74/208.97  |- mesh__historyNote mesh__D017041 92   
% 208.74/208.97  |- skos__hiddenLabel mesh__D017041 Regional Ethics Committee
% 208.74/208.97  |- skos__hiddenLabel mesh__D017041 Institutional Ethics Committee
% 208.74/208.97  |- mesh__activeMeSHYear mesh__D017041 2004
% 208.74/208.97  |- mesh__recordOriginator mesh__D017041 PLS
% 208.74/208.97  |- skos__hiddenLabel mesh__D017041 Committee, Regional Ethics
% 208.74/208.97  |- skos__hiddenLabel mesh__D017041 Committee, Ethics
% 208.74/208.97  |- skos__related mesh__D017041smesh__D026683
% 208.74/208.97  |- skos__hiddenLabel mesh__D017041 Ethics Committee, Institutional
% 208.74/208.97  |- skos__hiddenLabel mesh__D017041 Committees, Ethics
% 208.74/208.97  |- skos__broader mesh__D017041smesh__D011367
% 208.74/208.97  |- skos__broader mesh__D017041smesh__D004989
% 208.74/208.97  |- skos__scopeNote mesh__D017041
% 208.74/208.97       Committees established by professional societies, health facilities, or other institutions to consider decisions that have bioethical implications. The role of these committees may include consultation, education, mediation, and/or review of policies and practices. Committees that consider the ethical dimensions of patient care are ETHICS COMMITTEES, CLINICAL; committees established to protect the welfare of research subjects are ETHICS COMMITTEES, RESEARCH.%A%    
% 208.74/208.97  |- skos__historyNote mesh__D017041
% 208.74/208.97       Professional Staff Committees %28%1975-1991%29%
% 208.74/208.97  |- skos__hiddenLabel mesh__D017041 Ethics Committees, Regional
% 208.74/208.97  |- skos__hiddenLabel mesh__D017041 Committees, Regional Ethics
% 208.74/208.97  |- mesh__activeMeSHYear mesh__D017041 2005
% 208.74/208.97  |- skos__hiddenLabel mesh__D017041 Ethics Committee, Regional
% 208.74/208.97  |- skos__hiddenLabel mesh__D017041 Committee, Institutional Ethics
% 208.74/208.97  |- skos__related mesh__D017041smesh__D035661
% 208.74/208.97  |- skos__prefLabel mesh__D017041 Ethics Committees
% 208.82/208.97  |- skos__historyNote mesh__D017041 Ethics, Medical %28%1966-1991%29%
% 208.82/208.97  |- mesh__publicMeSHNote mesh__D017041 92   
% 208.82/208.97  |- mesh__dateRevised mesh__D017041 2002-07-03
% 208.82/208.97  |- mesh__historyNote mesh__D049921 2006   
% 208.82/208.97  |- mesh__dateCreated mesh__D049921 2005-06-30
% 208.82/208.97  |- mesh__recordAuthorizer mesh__D049921 sjn
% 208.82/208.97  |- skos__broader mesh__D049921smesh__D043365
% 208.82/208.97  |- mesh__recordMaintainer mesh__D049921 ags
% 208.82/208.97  |- skos__prefLabel mesh__D049921 Wautersia
% 208.82/208.97  |- mesh__publicMeSHNote mesh__D049921 2006   
% 208.82/208.97  |- mesh__recordOriginator mesh__D049921 ags
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D049921 2006
% 208.82/208.97  |- mesh__dateEstablished mesh__D049921 2006-01-01
% 208.82/208.97  |- skos__scopeNote mesh__D049921
% 208.82/208.97       A genus of gram-negative, aerobic, rod-shaped bacteria, in the family RALSTONIACEAE, that are mobile by means of peritrichous FLAGELLA. Species in this genus were formerly in the genus RALSTONIA.%A%    
% 208.82/208.97  |- rdf__type mesh__D049921sskos__Concept
% 208.82/208.97  |- skos__altLabel mesh__D016747 Minor Lymphocyte Stimulatory Determinants
% 208.82/208.97  |- mesh__recordOriginator mesh__D016747 AGS
% 208.82/208.97  |- skos__scopeNote mesh__D016747
% 208.82/208.97       Endogenous superantigens responsible for inducing strong proliferative responses in T-cells in mixed lymphocyte reactions %28%see LYMPHOCYTE CULTURE TEST, MIXED%29%. They are encoded by mouse mammary tumor viruses that have integrated into the germ line as DNA proviruses %28%MINOR LYMPHOCYTE STIMULATORY LOCI%29%.%A%    
% 208.82/208.97  |- skos__hiddenLabel mesh__D016747 Minor Lymphocyte Stimulating Antigens
% 208.82/208.97  |- skos__broader mesh__D016747smesh__D018089
% 208.82/208.97  |- skos__hiddenLabel mesh__D016747
% 208.82/208.97       Determinants, Minor Lymphocyte-Stimulating
% 208.82/208.97  |- mesh__onlineNote mesh__D016747
% 208.82/208.97       use MINOR LYMPHOCYTE STIMULATORY ANTIGENS %28%NM%29% to search MLS ANTIGENS 1987-91%A%  
% 208.82/208.97  |- skos__hiddenLabel mesh__D016747 Lymphocyte-Stimulating Antigens, Minor
% 208.82/208.97  |- skos__altLabel mesh__D016747 Lymphocyte Stimulatory Antigens, Minor
% 208.82/208.97  |- skos__hiddenLabel mesh__D016747 Antigens, Minor Lymphocyte-Stimulating
% 208.82/208.97  |- skos__hiddenLabel mesh__D016747
% 208.82/208.97       Lymphocyte-Stimulating Determinants, Minor
% 208.82/208.97  |- skos__hiddenLabel mesh__D016747 Antigens, Mls
% 208.82/208.97  |- mesh__recordAuthorizer mesh__D016747 sjn
% 208.82/208.97  |- skos__hiddenLabel mesh__D016747
% 208.82/208.97       Minor Lymphocyte Stimulating Determinants
% 208.82/208.97  |- skos__prefLabel mesh__D016747 Minor Lymphocyte Stimulatory Antigens
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D016747 2006
% 208.82/208.97  |- rdf__type mesh__D016747sskos__Concept
% 208.82/208.97  |- skos__hiddenLabel mesh__D016747 Lymphocyte Activating Determinants
% 208.82/208.97  |- skos__hiddenLabel mesh__D016747 Determinants, Mls
% 208.82/208.97  |- skos__altLabel mesh__D016747 Minor Lymphocyte-Stimulating Determinants
% 208.82/208.97  |- skos__annotation mesh__D016747 DF: note short X ref   
% 208.82/208.97  |- skos__altLabel mesh__D016747 Mls Antigens
% 208.82/208.97  |- mesh__historyNote mesh__D016747
% 208.82/208.97       92; was MLS ANTIGENS %28%NM%29% 1987-91   
% 208.82/208.97  |- mesh__publicMeSHNote mesh__D016747
% 208.82/208.97       92; MLS ANTIGENS was indexed under ANTIGENS, SURFACE 1987-91%A%  
% 208.82/208.97  |- skos__hiddenLabel mesh__D016747 Determinants, Lymphocyte-Activating
% 208.82/208.97  |- skos__altLabel mesh__D016747 Mls Determinants
% 208.82/208.97  |- mesh__dateRevised mesh__D016747 2005-06-30
% 208.82/208.97  |- skos__altLabel mesh__D016747 Minor Lymphocyte-Stimulating Antigens
% 208.82/208.97  |- skos__altLabel mesh__D016747 Lymphocyte-Activating Determinants
% 208.82/208.97  |- mesh__dateEstablished mesh__D016747 1992-01-01
% 208.82/208.97  |- mesh__recordMaintainer mesh__D016747 ssb
% 208.82/208.97  |- skos__broader mesh__D016747smesh__D000954
% 208.82/208.97  |- mesh__dateCreated mesh__D016747 1991-07-12
% 208.82/208.97  |- skos__altLabel mesh__D016747 Antigens, Minor Lymphocyte Stimulatory
% 208.82/208.97  |- skos__prefLabel mesh__D035901 Hypocrea
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D035901 2006
% 208.82/208.97  |- mesh__dateRevised mesh__D035901 2005-06-30
% 208.82/208.97  |- mesh__dateCreated mesh__D035901 2002-07-03
% 208.82/208.97  |- skos__altLabel mesh__D035901 Gliocladium virens
% 208.82/208.97  |- mesh__recordAuthorizer mesh__D035901 sjn
% 208.82/208.97  |- mesh__publicMeSHNote mesh__D035901 2003   
% 208.82/208.97  |- mesh__dateEstablished mesh__D035901 2003-01-01
% 208.82/208.97  |- mesh__recordMaintainer mesh__D035901 SYSTEM
% 208.82/208.97  |- skos__historyNote mesh__D035901 Hypocreales %28%1993-2002%29%
% 208.82/208.97  |- rdf__type mesh__D035901sskos__Concept
% 208.82/208.97  |- mesh__recordOriginator mesh__D035901 ags
% 208.82/208.97  |- mesh__historyNote mesh__D035901 2003   
% 208.82/208.97  |- skos__scopeNote mesh__D035901
% 208.82/208.97       A genus of fungus in the family Hypocreaceae, order HYPOCREALES. Anamorphs include TRICHODERMA.%A%    
% 208.82/208.97  |- skos__broader mesh__D035901smesh__D006999
% 208.82/208.97  |- skos__altLabel mesh__D002727 Astra Brand of Chloroguanide Hydrochloride
% 208.82/208.97  |- mesh__dateRevised mesh__D002727 2005-06-30
% 208.82/208.97  |- skos__altLabel mesh__D002727 Proguanil Hydrochloride
% 208.82/208.97  |- skos__hiddenLabel mesh__D002727 Hydrochloride, Proguanil
% 208.82/208.97  |- mesh__dateCreated mesh__D002727 1999-01-01
% 208.82/208.97  |- skos__altLabel mesh__D002727 Paludrin
% 208.82/208.97  |- mesh__recordMaintainer mesh__D002727 lkw
% 208.82/208.97  |- skos__prefLabel mesh__D002727 Chloroguanide
% 208.82/208.97  |- skos__broader mesh__D002727smesh__D001645
% 208.82/208.97  |- skos__hiddenLabel mesh__D002727 Hydrochloride, Chloroguanide
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D002727 2006
% 208.82/208.97  |- skos__altLabel mesh__D002727 Chlorguanid
% 208.82/208.97  |- mesh__recordAuthorizer mesh__D002727 sjn
% 208.82/208.97  |- mesh__recordOriginator mesh__D002727 NLM
% 208.82/208.97  |- skos__scopeNote mesh__D002727
% 208.82/208.97       A biguanide compound which has little antimalarial activity until metabolized in the body  to the active antimalarial agent cycloguanil. The usefulness of proguanil is limited by the rapid development of drug resistance by the malarial parasite. The hydrochloride is used for the casual prophylaxis of falciparum malaria, to suppress other forms of malaria, and to reduce transmission of infection %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p405%29%%A%    
% 208.82/208.97  |- skos__altLabel mesh__D002727
% 208.82/208.97       AstraZeneca Brand of Chloroguanide Hydrochloride
% 208.82/208.97  |- rdf__type mesh__D002727sskos__Concept
% 208.82/208.97  |- skos__altLabel mesh__D002727 Proguanil
% 208.82/208.97  |- skos__altLabel mesh__D002727 Zeneca Brand of Chloroguanide Hydrochloride
% 208.82/208.97  |- skos__broader mesh__D009206Q000378smesh__D009206
% 208.82/208.97  |- rdf__type mesh__D009206Q000378smesh__CompoundConcept
% 208.82/208.97  |- mesh__recordOriginator mesh__D007412 NLM
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D007412 2006
% 208.82/208.97  |- mesh__recordAuthorizer mesh__D007412 sjn
% 208.82/208.97  |- mesh__dateRevised mesh__D007412 2003-07-09
% 208.82/208.97  |- mesh__recordMaintainer mesh__D007412 lkt
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D007412 2005
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D007412 2004
% 208.82/208.97  |- skos__prefLabel mesh__D007412 Intestinal Fistula
% 208.82/208.97  |- skos__hiddenLabel mesh__D007412 Fistula, Colovesical
% 208.82/208.97  |- skos__broader mesh__D007412smesh__D007410
% 208.82/208.97  |- skos__annotation mesh__D007412
% 208.82/208.97       fistula policy: Manual 23.19+; RECTAL FISTULA %26% RECTOVAGINAL FISTULA are also available%A%  
% 208.82/208.97  |- skos__hiddenLabel mesh__D007412 Fistula, Cholecystoduodenal
% 208.82/208.97  |- mesh__dateCreated mesh__D007412 1999-01-01
% 208.82/208.97  |- skos__hiddenLabel mesh__D007412 Fistula, Intestinal
% 208.82/208.97  |- rdf__type mesh__D007412sskos__Concept
% 208.82/208.97  |- skos__hiddenLabel mesh__D007412 Fistula, Enterocutaneous
% 208.82/208.97  |- skos__broader mesh__D007412smesh__D016154
% 208.82/208.97  |- skos__scopeNote mesh__D007412
% 208.82/208.97       An abnormal anatomical passage between the INTESTINE, and another segment of the intestine or other organs. External intestinal fistula is connected to the SKIN %28%enterocutaneous fistula%29%. Internal intestinal fistula can be connected to a number of organs, such as STOMACH %28%gastrocolic fistula%29%, the BILIARY TRACT %28%cholecystoduodenal fistula%29%, or the BLADDER of the URINARY TRACT %28%colovesical fistula%29%. Risk factors include inflammatory processes, cancer, radiation treatment, and surgical misadventures %28%MEDICAL ERRORS%29%.%A%    
% 208.82/208.97  |- skos__broader mesh__D012357smesh__D012345
% 208.82/208.97  |- skos__prefLabel mesh__D012357 RNA, Transfer, Lys
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D012357 2006
% 208.82/208.97  |- skos__altLabel mesh__D012357 tRNA%28%Lys%29%
% 208.82/208.97  |- rdf__type mesh__D012357sskos__Concept
% 208.82/208.97  |- skos__historyNote mesh__D012357 Amino Acyl T RNA %28%1978-1987%29%
% 208.82/208.97  |- skos__hiddenLabel mesh__D012357 tRNA, Lysine-Specific
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D012357 2000
% 208.82/208.97  |- mesh__dateEstablished mesh__D012357 1991-01-01
% 208.82/208.97  |- skos__altLabel mesh__D012357 Transfer RNA, Lys
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D012357 1997
% 208.82/208.97  |- skos__annotation mesh__D012357
% 208.82/208.97       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 208.82/208.97  |- mesh__historyNote mesh__D012357
% 208.82/208.97       91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.82/208.97  |- skos__historyNote mesh__D012357 RNA, Transfer %28%1966-1987%29%
% 208.82/208.97  |- mesh__dateCreated mesh__D012357 1987-05-07
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D012357 2001
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D012357 2003
% 208.82/208.97  |- mesh__recordOriginator mesh__D012357 RLS
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D012357 1998
% 208.82/208.97  |- skos__hiddenLabel mesh__D012357 RNA, Lys Transfer
% 208.82/208.97  |- skos__altLabel mesh__D012357 Lysine-Specific tRNA
% 208.82/208.97  |- mesh__recordMaintainer mesh__D012357 TGC
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D012357 2002
% 208.82/208.97  |- skos__altLabel mesh__D012357 tRNALys
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D012357 2004
% 208.82/208.97  |- mesh__recordAuthorizer mesh__D012357 PLS
% 208.82/208.97  |- skos__hiddenLabel mesh__D012357 Lys Transfer RNA
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D012357 1999
% 208.82/208.97  |- mesh__dateRevised mesh__D012357 1996-06-10
% 208.82/208.97  |- skos__scopeNote mesh__D012357
% 208.82/208.97       A transfer RNA which is specific for carrying lysine to sites on the ribosomes in preparation for protein synthesis.%A%    
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D012357 2005
% 208.82/208.97  |- skos__hiddenLabel mesh__D012357 Lysine Specific tRNA
% 208.82/208.97  |- mesh__publicMeSHNote mesh__D012357
% 208.82/208.97       91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.82/208.97  |- mesh__dateRevised mesh__D017840 2003-07-09
% 208.82/208.97  |- skos__broader mesh__D017840smesh__D017819
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D017840 2004
% 208.82/208.97  |- skos__hiddenLabel mesh__D017840 Russell Viper
% 208.82/208.97  |- mesh__dateEstablished mesh__D017840 1994-01-01
% 208.82/208.97  |- mesh__recordMaintainer mesh__D017840 ags
% 208.82/208.97  |- mesh__recordOriginator mesh__D017840 TGC
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D017840 2006
% 208.82/208.97  |- skos__historyNote mesh__D017840 Snakes %28%1966-1993%29%
% 208.82/208.97  |- rdf__type mesh__D017840sskos__Concept
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D017840 2005
% 208.82/208.97  |- skos__annotation mesh__D017840
% 208.82/208.97       a genus of vipers; its venom: coord IM with VIPER VENOMS %28%IM%29%%A%  
% 208.82/208.97  |- skos__altLabel mesh__D017840 Vipera russelii
% 208.82/208.97  |- mesh__recordAuthorizer mesh__D017840 sjn
% 208.82/208.97  |- skos__hiddenLabel mesh__D017840 russelii, Vipera
% 208.82/208.97  |- mesh__historyNote mesh__D017840 94   
% 208.82/208.97  |- skos__scopeNote mesh__D017840
% 208.82/208.97       A genus of snakes of the family VIPERIDAE. It is distributed in West Pakistan, most of India, Burma, Ceylon, Thailand, southeast China, Taiwan, and a few islands of Indonesia. It hisses loudly when disturbed and strikes with great force and speed. Very prolific, it gives birth to 20-60 young. This viper is the leading cause of snakebite in India and Burma. %28%Moore: Poisonous Snakes of the World, 1980, p127%29%%A%    
% 208.82/208.97  |- mesh__publicMeSHNote mesh__D017840 94   
% 208.82/208.97  |- skos__hiddenLabel mesh__D017840 Viper, Russell%27%s
% 208.82/208.97  |- skos__hiddenLabel mesh__D017840 Russells Viper
% 208.82/208.97  |- skos__prefLabel mesh__D017840 Russell%27%s Viper
% 208.82/208.97  |- mesh__dateCreated mesh__D017840 1993-02-16
% 208.82/208.97  |- mesh__dateCreated mesh__D017042 1991-05-30
% 208.82/208.97  |- skos__annotation mesh__D017042
% 208.82/208.97       check the tags PREGNANCY %26% FEMALE; consider also PHENYLALANINE HYDROXYLASE /defic; DF: PKU MATERNAL%A%  
% 208.82/208.97  |- skos__altLabel mesh__D017042 Maternal Phenylketonuria
% 208.82/208.97  |- mesh__publicMeSHNote mesh__D017042 1992   
% 208.82/208.97  |- rdf__type mesh__D017042sskos__Concept
% 208.82/208.97  |- skos__altLabel mesh__D017042 Pregnancy in Phenylketonuria
% 208.82/208.97  |- mesh__historyNote mesh__D017042 1992   
% 208.82/208.97  |- skos__altLabel mesh__D017042
% 208.82/208.97       Phenylalanine-Hydroxylase Deficiency Disease, Maternal
% 208.82/208.97  |- skos__altLabel mesh__D017042 PKU, Maternal
% 208.82/208.97  |- skos__hiddenLabel mesh__D017042 Pregnancy in Phenylketonurias
% 208.82/208.97  |- skos__historyNote mesh__D017042 Phenylketonuria %28%1966-1991%29%
% 208.82/208.97  |- skos__altLabel mesh__D017042
% 208.82/208.97       Maternal Phenylalanine Hydroxylase Deficiency Disease
% 208.82/208.97  |- mesh__recordAuthorizer mesh__D017042 sjn
% 208.82/208.97  |- mesh__recordOriginator mesh__D017042 PLS
% 208.82/208.97  |- skos__hiddenLabel mesh__D017042 in Phenylketonurias, Pregnancy
% 208.82/208.97  |- skos__hiddenLabel mesh__D017042 Phenylketonuria, Pregnancy in
% 208.82/208.97  |- skos__broader mesh__D017042smesh__D010661
% 208.82/208.97  |- skos__hiddenLabel mesh__D017042 in Phenylketonuria, Pregnancy
% 208.82/208.97  |- mesh__dateEstablished mesh__D017042 1992-01-01
% 208.82/208.97  |- skos__prefLabel mesh__D017042 Phenylketonuria, Maternal
% 208.82/208.97  |- skos__hiddenLabel mesh__D017042 Phenylketonurias, Pregnancy in
% 208.82/208.97  |- mesh__recordMaintainer mesh__D017042 lkt
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D017042 2006
% 208.82/208.97  |- mesh__dateRevised mesh__D017042 2005-06-30
% 208.82/208.97  |- skos__broader mesh__D017042smesh__D011248
% 208.82/208.97  |- skos__scopeNote mesh__D017042
% 208.82/208.97       A condition occurring in untreated or partially treated females with PHENYLKETONURIA when they become pregnant. This may result in damages to the FETUS, including MICROCEPHALY; MENTAL RETARDATION; congenital heart disease; FETAL GROWTH RETARDATION; and CRANIOFACIAL ABNORMALITIES. %28%From Am J Med Genet 1997 Mar 3;69%28%1%29%:89-95%29%%A%    
% 208.82/208.97  |- skos__related mesh__D017042smesh__D010651
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D003820 1996
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D003820 1995
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D003820 2004
% 208.82/208.97  |- skos__annotation mesh__D003820
% 208.82/208.97       D25-26 qualif; includes sonic-action cleansers   
% 208.82/208.97  |- skos__broader mesh__D003820smesh__D003802
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D003820 2000
% 208.82/208.97  |- skos__historyNote mesh__D003820 Oral Hygiene %28%1973-1978%29%
% 208.82/208.97  |- mesh__publicMeSHNote mesh__D003820
% 208.82/208.97       91; was see under DENTIFRICES 1979-90   
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D003820 1994
% 208.82/208.97  |- skos__historyNote mesh__D003820 Dental Prosthesis %28%1966-1978%29%
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D003820 2003
% 208.82/208.97  |- mesh__recordAuthorizer mesh__D003820 PLS
% 208.82/208.97  |- mesh__dateCreated mesh__D003820 1977-12-08
% 208.82/208.97  |- rdf__type mesh__D003820sskos__Concept
% 208.82/208.97  |- skos__scopeNote mesh__D003820
% 208.82/208.97       Substances used to clean dentures; they are usually alkaline peroxides or hypochlorites, may contain enzymes and release oxygen. Use also for sonic action cleaners.%A%    
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D003820 1999
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D003820 1993
% 208.82/208.97  |- skos__historyNote mesh__D003820 Dentifrices %28%1966-1978%29%
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D003820 1998
% 208.82/208.97  |- skos__altLabel mesh__D003820 Cleansers, Denture
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D003820 2006
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D003820 1992
% 208.82/208.97  |- mesh__recordOriginator mesh__D003820 SH
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D003820 2002
% 208.82/208.97  |- mesh__dateRevised mesh__D003820 1991-06-26
% 208.82/208.97  |- mesh__historyNote mesh__D003820
% 208.82/208.97       91%28%79%29%; was see under DENTIFRICES 1979-90   
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D003820 1997
% 208.82/208.97  |- mesh__recordMaintainer mesh__D003820 TAP
% 208.82/208.97  |- mesh__dateEstablished mesh__D003820 1991-01-01
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D003820 2005
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D003820 2001
% 208.82/208.97  |- skos__prefLabel mesh__D003820 Denture Cleansers
% 208.82/208.97  |- mesh__dateCreated mesh__D050476 2005-06-30
% 208.82/208.97  |- skos__altLabel mesh__D050476 Bowman%27%s Capsule
% 208.82/208.97  |- mesh__historyNote mesh__D050476 2006   
% 208.82/208.97  |- mesh__publicMeSHNote mesh__D050476 2006   
% 208.82/208.97  |- mesh__recordMaintainer mesh__D050476 lkt
% 208.82/208.97  |- mesh__recordAuthorizer mesh__D050476 sjn
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D050476 2006
% 208.82/208.97  |- rdf__type mesh__D050476sskos__Concept
% 208.82/208.97  |- skos__historyNote mesh__D050476 Kidney Tubules %28%1967-2005%29%
% 208.82/208.97  |- skos__hiddenLabel mesh__D050476 Capsule, Bowman
% 208.82/208.97  |- skos__prefLabel mesh__D050476 Bowman Capsule
% 208.82/208.97  |- skos__broader mesh__D050476smesh__D007684
% 208.82/208.97  |- skos__hiddenLabel mesh__D050476 Bowmans Capsule
% 208.82/208.97  |- mesh__dateEstablished mesh__D050476 2006-01-01
% 208.82/208.97  |- skos__scopeNote mesh__D050476
% 208.82/208.97       A double-walled epithelial capsule that is the bulbous closed proximal end of the kidney tubular system. It surrounds the cluster of convoluted capillaries of KIDNEY GLOMERULUS and is continuous with the convoluted PROXIMAL KIDNEY TUBULE.%A%    
% 208.82/208.97  |- mesh__recordOriginator mesh__D050476 lkt
% 208.82/208.97  |- skos__hiddenLabel mesh__D050476 Capsule, Bowman%27%s
% 208.82/208.97  |- skos__historyNote mesh__D050476 Kidney Glomerulus %28%1966-2005%29%
% 208.82/208.97  |- skos__prefLabel mesh__D003022 Clotrimazole
% 208.82/208.97  |- mesh__recordMaintainer mesh__D003022 ssb
% 208.82/208.97  |- mesh__dateRevised mesh__D003022 2005-06-30
% 208.82/208.97  |- skos__hiddenLabel mesh__D003022 b 5097, Bay
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D003022 2006
% 208.82/208.97  |- skos__altLabel mesh__D003022 Kanesten
% 208.82/208.97  |- skos__altLabel mesh__D003022 Klotrimazole
% 208.82/208.97  |- skos__hiddenLabel mesh__D003022 5097, Bay b
% 208.82/208.97  |- skos__hiddenLabel mesh__D003022 b 5097, FB
% 208.82/208.97  |- mesh__historyNote mesh__D003022
% 208.82/208.97       91%28%75%29%; was see under IMIDAZOLES 1975-90   
% 208.82/208.97  |- mesh__publicMeSHNote mesh__D003022
% 208.82/208.97       91; was see under IMIDAZOLES 1975-90   
% 208.82/208.97  |- skos__scopeNote mesh__D003022
% 208.82/208.97       An imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal cell membranes. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane.%A%    
% 208.82/208.97  |- mesh__recordOriginator mesh__D003022 NLM
% 208.82/208.97  |- skos__historyNote mesh__D003022 Trityl Compounds %28%1974%29%
% 208.82/208.97  |- rdf__type mesh__D003022sskos__Concept
% 208.82/208.97  |- mesh__dateEstablished mesh__D003022 1991-01-01
% 208.82/208.97  |- skos__hiddenLabel mesh__D003022 5097, FB b
% 208.82/208.97  |- mesh__recordAuthorizer mesh__D003022 sjn
% 208.82/208.97  |- mesh__dateCreated mesh__D003022 1974-11-11
% 208.82/208.97  |- skos__broader mesh__D003022smesh__D007093
% 208.82/208.97  |- skos__historyNote mesh__D003022 Imidazoles %28%1971-1974%29%
% 208.82/208.97  |- mesh__recordOriginator mesh__D016748 TGC
% 208.82/208.97  |- skos__scopeNote mesh__D016748
% 208.82/208.97       Creation of a small incised opening in a vein to permit the passage of a needle or cannula for withdrawal of blood, administration of medication, or in diagnostic or therapeutic catheterization. %28%Dorland, 28th ed.; Stedman, 26th ed.%29%%A%    
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D016748 2003
% 208.82/208.97  |- skos__hiddenLabel mesh__D016748 Venostomies
% 208.82/208.97  |- skos__annotation mesh__D016748
% 208.82/208.97       usually for insertion of a catheter; do not use /util except by MeSH definition%A%  
% 208.82/208.97  |- mesh__activeMeSHYear mesh__D016748 2001
% 208.82/208.97  |- mesh__dateRevised mesh__D016748 1997-06-20
% 208.82/208.97  |- mesh__recordAuthorizer mesh__D016748 SJN
% 208.82/208.97  |- skos__altLabel mesh__D016748 Cutdown, Venous
% 208.82/208.97  |- skos__hiddenLabel mesh__D016748 Vein Cutdowns
% 208.82/208.98  |- skos__altLabel mesh__D016748 Venostomy
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D016748 2006
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D016748 2000
% 208.82/208.98  |- rdf__type mesh__D016748sskos__Concept
% 208.82/208.98  |- mesh__publicMeSHNote mesh__D016748 92   
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D016748 2005
% 208.82/208.98  |- skos__hiddenLabel mesh__D016748 Cutdowns, Vein
% 208.82/208.98  |- mesh__historyNote mesh__D016748 92   
% 208.82/208.98  |- mesh__recordMaintainer mesh__D016748 PXP
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D016748 1999
% 208.82/208.98  |- skos__hiddenLabel mesh__D016748 Venous Cutdowns
% 208.82/208.98  |- skos__hiddenLabel mesh__D016748 Cutdowns, Venous
% 208.82/208.98  |- mesh__dateCreated mesh__D016748 1991-04-29
% 208.82/208.98  |- skos__broader mesh__D016748smesh__D014656
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D016748 2002
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D016748 1998
% 208.82/208.98  |- skos__altLabel mesh__D016748 Vein Cutdown
% 208.82/208.98  |- skos__hiddenLabel mesh__D016748 Cutdown, Vein
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D016748 2004
% 208.82/208.98  |- skos__prefLabel mesh__D016748 Venous Cutdown
% 208.82/208.98  |- mesh__dateEstablished mesh__D016748 1992-01-01
% 208.82/208.98  |- skos__broader mesh__D041141smesh__D012281
% 208.82/208.98  |- mesh__dateRevised mesh__D041141 2005-06-30
% 208.82/208.98  |- skos__scopeNote mesh__D041141
% 208.82/208.98       A species of gram-negative bacteria that causes rickettsialpox. The vector is a mouse mite and the reservoirs are mites and mice.%A%    
% 208.82/208.98  |- skos__prefLabel mesh__D041141 Rickettsia akari
% 208.82/208.98  |- mesh__recordMaintainer mesh__D041141 SYSTEM
% 208.82/208.98  |- mesh__publicMeSHNote mesh__D041141 2003   
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D041141 2006
% 208.82/208.98  |- rdf__type mesh__D041141sskos__Concept
% 208.82/208.98  |- mesh__dateCreated mesh__D041141 2002-07-03
% 208.82/208.98  |- skos__annotation mesh__D041141
% 208.82/208.98       infection: coord IM with RICKETTSIA INFECTIONS %28%IM%29%   
% 208.82/208.98  |- mesh__historyNote mesh__D041141 2003   
% 208.82/208.98  |- mesh__recordAuthorizer mesh__D041141 sjn
% 208.82/208.98  |- mesh__recordOriginator mesh__D041141 ags
% 208.82/208.98  |- mesh__dateEstablished mesh__D041141 2003-01-01
% 208.82/208.98  |- skos__historyNote mesh__D041141 Rickettsia %28%1972-2002%29%
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D002728 1999
% 208.82/208.98  |- mesh__recordMaintainer mesh__D002728 ADP
% 208.82/208.98  |- mesh__recordOriginator mesh__D002728 NLM
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D002728 2006
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D002728 1998
% 208.82/208.98  |- mesh__dateCreated mesh__D002728 1974-11-11
% 208.82/208.98  |- skos__scopeNote mesh__D002728
% 208.82/208.98       Any of the compounds derived from a group of glycols or polyhydroxy alcohols by chlorine substitution for part of the hydroxyl groups. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%    
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D002728 2001
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D002728 2004
% 208.82/208.98  |- mesh__recordAuthorizer mesh__D002728 SJN
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D002728 2000
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D002728 2005
% 208.82/208.98  |- skos__altLabel mesh__D002728 Chlorhydrins
% 208.82/208.98  |- skos__prefLabel mesh__D002728 Chlorohydrins
% 208.82/208.98  |- rdf__type mesh__D002728sskos__Concept
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D002728 2003
% 208.82/208.98  |- mesh__publicMeSHNote mesh__D002728 75   
% 208.82/208.98  |- mesh__historyNote mesh__D002728 75   
% 208.82/208.98  |- mesh__dateEstablished mesh__D002728 1975-09-01
% 208.82/208.98  |- skos__broader mesh__D002728smesh__D000438
% 208.82/208.98  |- mesh__dateRevised mesh__D002728 1997-06-20
% 208.82/208.98  |- skos__historyNote mesh__D002728 Alcohols %28%1966-1974%29%
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D002728 2002
% 208.82/208.98  |- skos__prefLabel mesh__D013450 Sulfones
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D013450 1996
% 208.82/208.98  |- mesh__recordMaintainer mesh__D013450 TGC
% 208.82/208.98  |- mesh__dateRevised mesh__D013450 1992-05-20
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D013450 1998
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D013450 2002
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D013450 1997
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D013450 1994
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D013450 1999
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D013450 1993
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D013450 2003
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D013450 1995
% 208.82/208.98  |- mesh__dateCreated mesh__D013450 1999-01-01
% 208.82/208.98  |- rdf__type mesh__D013450sskos__Concept
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D013450 2005
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D013450 2000
% 208.82/208.98  |- mesh__recordOriginator mesh__D013450 NLM
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D013450 2004
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D013450 2001
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D013450 2006
% 208.82/208.98  |- mesh__recordAuthorizer mesh__D013450 PLS
% 208.82/208.98  |- skos__broader mesh__D013450smesh__D013457
% 208.82/208.98  |- skos__broader mesh__D007413smesh__D007422
% 208.82/208.98  |- skos__related mesh__D007413smesh__D007419
% 208.82/208.98  |- skos__hiddenLabel mesh__D007413 Gland, Intestinal
% 208.82/208.98  |- mesh__publicMeSHNote mesh__D007413 67   
% 208.82/208.98  |- mesh__recordOriginator mesh__D007413 NLM
% 208.82/208.98  |- skos__scopeNote mesh__D007413
% 208.82/208.98       Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells %28%ENTEROCYTES%29% with MICROVILLI.%A%    
% 208.82/208.98  |- skos__annotation mesh__D007413
% 208.82/208.98       /cytol: consider also specific cell types available in MeSH; for X ref INTESTINAL EPITHELIUM, do not routinely coordinate with EPITHELIUM unless it is specifically discussed%A%  
% 208.82/208.98  |- skos__hiddenLabel mesh__D007413 Epithelium, Intestinal
% 208.82/208.98  |- mesh__recordAuthorizer mesh__D007413 sjn
% 208.82/208.98  |- mesh__dateCreated mesh__D007413 1999-01-01
% 208.82/208.98  |- rdf__type mesh__D007413sskos__Concept
% 208.82/208.98  |- mesh__recordMaintainer mesh__D007413 lkt
% 208.82/208.98  |- skos__hiddenLabel mesh__D007413 Mucosa, Intestinal
% 208.82/208.98  |- skos__broader mesh__D007413smesh__D009092
% 208.82/208.98  |- skos__hiddenLabel mesh__D007413 Intestinal Gland
% 208.82/208.98  |- skos__prefLabel mesh__D007413 Intestinal Mucosa
% 208.82/208.98  |- mesh__dateEstablished mesh__D007413 1967-01-01
% 208.82/208.98  |- skos__hiddenLabel mesh__D007413 Glands, Intestinal
% 208.82/208.98  |- mesh__activeMeSHYear mesh__D007413 2006
% 208.83/208.98  |- mesh__historyNote mesh__D007413 67%28%65%29%   
% 208.83/208.98  |- mesh__dateRevised mesh__D007413 2005-06-30
% 208.83/208.98  |- skos__hiddenLabel mesh__D012358 RNA, Met Transfer
% 208.83/208.98  |- skos__annotation mesh__D012358
% 208.83/208.98       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 208.83/208.98  |- skos__historyNote mesh__D012358 RNA, Transfer %28%1966-1987%29%
% 208.83/208.98  |- skos__altLabel mesh__D012358 Methionine-Specific tRNA
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D012358 2003
% 208.83/208.98  |- skos__altLabel mesh__D012358 tRNA%28%Met%29%
% 208.83/208.98  |- skos__altLabel mesh__D012358 Initiator tRNA
% 208.83/208.98  |- mesh__recordMaintainer mesh__D012358 nns
% 208.83/208.98  |- skos__historyNote mesh__D012358 Amino Acyl T RNA %28%1978-1987%29%
% 208.83/208.98  |- skos__hiddenLabel mesh__D012358 tRNA, Initiator
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D012358 2004
% 208.83/208.98  |- skos__altLabel mesh__D012358 Transfer RNA, Met
% 208.83/208.98  |- mesh__historyNote mesh__D012358
% 208.83/208.98       91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.83/208.98  |- mesh__dateCreated mesh__D012358 1987-05-07
% 208.83/208.98  |- skos__prefLabel mesh__D012358 RNA, Transfer, Met
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D012358 2001
% 208.83/208.98  |- mesh__recordAuthorizer mesh__D012358 sjn
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D012358 2005
% 208.83/208.98  |- mesh__recordOriginator mesh__D012358 RLS
% 208.83/208.98  |- mesh__dateRevised mesh__D012358 2000-06-22
% 208.83/208.98  |- skos__hiddenLabel mesh__D012358 tRNAm, Methionine-Specific
% 208.83/208.98  |- skos__altLabel mesh__D012358 tRNAMet
% 208.83/208.98  |- skos__altLabel mesh__D012358 Methionine-Specific tRNAm
% 208.83/208.98  |- skos__hiddenLabel mesh__D012358 Methionine Specific tRNA
% 208.83/208.98  |- skos__broader mesh__D012358smesh__D012345
% 208.83/208.98  |- mesh__publicMeSHNote mesh__D012358
% 208.83/208.98       91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D012358 2002
% 208.83/208.98  |- skos__hiddenLabel mesh__D012358 tRNA, Methionine-Specific
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D012358 2006
% 208.83/208.98  |- rdf__type mesh__D012358sskos__Concept
% 208.83/208.98  |- skos__hiddenLabel mesh__D012358 Met Transfer RNA
% 208.83/208.98  |- skos__scopeNote mesh__D012358
% 208.83/208.98       A transfer RNA which is specific for carrying methionine to sites on the ribosomes. During initiation of protein synthesis, tRNA%28%f%29%Met in prokaryotic cells and tRNA%28%i%29%Met in eukaryotic cells binds to the start codon %28%CODON, INITIATOR%29%.%A%    
% 208.83/208.98  |- mesh__dateEstablished mesh__D012358 1991-01-01
% 208.83/208.98  |- skos__hiddenLabel mesh__D012358 Methionine Specific tRNAm
% 208.83/208.98  |- mesh__dateRevised mesh__D017841 2003-07-09
% 208.83/208.98  |- skos__annotation mesh__D017841
% 208.83/208.98       a genus of vipers; its venom: coord IM with CROTALID VENOMS %28%IM%29%%A%  
% 208.83/208.98  |- skos__broader mesh__D017841smesh__D017819
% 208.83/208.98  |- skos__hiddenLabel mesh__D017841 Habus
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D017841 2004
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D017841 2006
% 208.83/208.98  |- mesh__publicMeSHNote mesh__D017841 94   
% 208.83/208.98  |- rdf__type mesh__D017841sskos__Concept
% 208.83/208.98  |- mesh__dateEstablished mesh__D017841 1994-01-01
% 208.83/208.98  |- mesh__historyNote mesh__D017841 94   
% 208.83/208.98  |- mesh__recordOriginator mesh__D017841 TGC
% 208.83/208.98  |- skos__scopeNote mesh__D017841
% 208.83/208.98       A genus of snakes of the family VIPERIDAE. About 30 species are currently recognized, found in southeast Asia and adjacent island chains. The Okinawa habu frequently enters dwellings in search of rats and mice; the Chinese habu is often found in suburban and agricultural areas. They are quite irritable. %28%Moore: Poisonous Snakes of the World, 1980, p136%29%%A%    
% 208.83/208.98  |- skos__historyNote mesh__D017841 Snakes %28%1966-1993%29%
% 208.83/208.98  |- skos__altLabel mesh__D017841 Habu
% 208.83/208.98  |- skos__prefLabel mesh__D017841 Trimeresurus
% 208.83/208.98  |- mesh__dateCreated mesh__D017841 1993-02-16
% 208.83/208.98  |- mesh__recordAuthorizer mesh__D017841 sjn
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D017841 2005
% 208.83/208.98  |- mesh__recordMaintainer mesh__D017841 ags
% 208.83/208.98  |- skos__altLabel mesh__D017043 Meibomian Cyst
% 208.83/208.98  |- mesh__recordOriginator mesh__D017043 PLS
% 208.83/208.98  |- mesh__dateRevised mesh__D017043 1999-11-03
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D017043 2001
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D017043 2005
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D017043 2002
% 208.83/208.98  |- skos__historyNote mesh__D017043 Meibomian Glands %28%1975-1990%29%
% 208.83/208.98  |- skos__scopeNote mesh__D017043
% 208.83/208.98       A non-neoplastic cyst of the MEIBOMIAN GLANDS of the eyelid.%A%    
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D017043 2006
% 208.83/208.98  |- skos__hiddenLabel mesh__D017043 Cyst, Meibomian
% 208.83/208.98  |- skos__historyNote mesh__D017043 Cysts %28%1966-1991%29%
% 208.83/208.98  |- skos__historyNote mesh__D017043 Eyelid Diseases %28%1970-1991%29%
% 208.83/208.98  |- mesh__publicMeSHNote mesh__D017043 92   
% 208.83/208.98  |- skos__prefLabel mesh__D017043 Chalazion
% 208.83/208.98  |- rdf__type mesh__D017043sskos__Concept
% 208.83/208.98  |- skos__broader mesh__D017043smesh__D003560
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D017043 2003
% 208.83/208.98  |- mesh__dateCreated mesh__D017043 1991-05-30
% 208.83/208.98  |- mesh__recordAuthorizer mesh__D017043 sjn
% 208.83/208.98  |- mesh__dateEstablished mesh__D017043 1992-01-01
% 208.83/208.98  |- skos__hiddenLabel mesh__D017043 Chalazions
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D017043 2000
% 208.83/208.98  |- mesh__historyNote mesh__D017043 92   
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D017043 2004
% 208.83/208.98  |- skos__broader mesh__D017043smesh__D005141
% 208.83/208.98  |- mesh__recordMaintainer mesh__D017043 KEV
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D003821 2005
% 208.83/208.98  |- mesh__dateRevised mesh__D003821 1992-05-18
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D003821 2000
% 208.83/208.98  |- skos__prefLabel mesh__D003821 Denture Identification Marking
% 208.83/208.98  |- mesh__recordMaintainer mesh__D003821 MXR
% 208.83/208.98  |- skos__hiddenLabel mesh__D003821 Identification Marking, Denture
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D003821 2004
% 208.83/208.98  |- mesh__recordAuthorizer mesh__D003821 PLS
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D003821 1995
% 208.83/208.98  |- rdf__type mesh__D003821sskos__Concept
% 208.83/208.98  |- skos__hiddenLabel mesh__D003821 Denture Identification Markings
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D003821 2003
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D003821 1999
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D003821 1994
% 208.83/208.98  |- mesh__recordOriginator mesh__D003821 RC
% 208.83/208.98  |- skos__hiddenLabel mesh__D003821 Marking, Denture Identification
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D003821 1998
% 208.83/208.98  |- skos__hiddenLabel mesh__D003821 Identification Markings, Denture
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D003821 1993
% 208.83/208.98  |- skos__broader mesh__D003821smesh__D013674
% 208.83/208.98  |- mesh__dateCreated mesh__D003821 1983-04-21
% 208.83/208.98  |- skos__annotation mesh__D003821 marking of dentures or dent prostheses   
% 208.83/208.98  |- mesh__historyNote mesh__D003821 84   
% 208.83/208.98  |- skos__hiddenLabel mesh__D003821 Markings, Denture Identification
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D003821 1997
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D003821 2002
% 208.83/208.98  |- skos__historyNote mesh__D003821 Denture, Complete %28%1966-1983%29%
% 208.83/208.98  |- skos__historyNote mesh__D003821 Forensic Dentistry %28%1966-1983%29%
% 208.83/208.98  |- mesh__publicMeSHNote mesh__D003821 84   
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D003821 2006
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D003821 1996
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D003821 2001
% 208.83/208.98  |- mesh__dateEstablished mesh__D003821 1984-01-01
% 208.83/208.98  |- skos__scopeNote mesh__D003821
% 208.83/208.98       Any system of defining ownership of dentures or dental prostheses.%A%    
% 208.83/208.98  |- skos__hiddenLabel mesh__D050477 Urinary Human FSH
% 208.83/208.98  |- skos__historyNote mesh__D050477 Menotropins %28%1998-2005%29%
% 208.83/208.98  |- skos__hiddenLabel mesh__D050477 FSH, Urinary Human
% 208.83/208.98  |- skos__altLabel mesh__D050477 Follicle-Stimulating Hormone, Human Urine
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D050477 2006
% 208.83/208.98  |- skos__hiddenLabel mesh__D050477
% 208.83/208.98       Follicle Stimulating Hormone, Human Urine
% 208.83/208.98  |- skos__historyNote mesh__D050477
% 208.83/208.98       Follicle Stimulating Hormone %28%1993-2005%29%
% 208.83/208.98  |- rdf__type mesh__D050477sskos__Concept
% 208.83/208.98  |- mesh__dateCreated mesh__D050477 2005-06-30
% 208.83/208.98  |- skos__scopeNote mesh__D050477
% 208.83/208.98       A protein extract of human menopausal urine in which LUTEINIZING HORMONE has been partially or completely removed. Urofollitropin represents FOLLICLE STIMULATING HORMONE from the urine. In highly purified preparations, LH and other urinary proteins are removed.%A%    
% 208.83/208.98  |- mesh__recordMaintainer mesh__D050477 lkt
% 208.83/208.98  |- mesh__historyNote mesh__D050477 2006; use MENOTROPINS 1998-2005   
% 208.83/208.98  |- mesh__recordOriginator mesh__D050477 lkt
% 208.83/208.98  |- mesh__recordAuthorizer mesh__D050477 sjn
% 208.83/208.98  |- mesh__publicMeSHNote mesh__D050477 2006; see MENOTROPINS 1998-2005   
% 208.83/208.98  |- skos__prefLabel mesh__D050477 Urofollitropin
% 208.83/208.98  |- skos__broader mesh__D050477smesh__D008596
% 208.83/208.98  |- mesh__dateEstablished mesh__D050477 2006-01-01
% 208.83/208.98  |- skos__altLabel mesh__D050477 Human FSH, Urinary
% 208.83/208.98  |- skos__altLabel mesh__D003023 Chloroxacillin
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D003023 2006
% 208.83/208.98  |- mesh__recordAuthorizer mesh__D003023 sjn
% 208.83/208.98  |- skos__broader mesh__D003023smesh__D010068
% 208.83/208.98  |- skos__hiddenLabel mesh__D003023 Cloxacillin, Sodium
% 208.83/208.98  |- mesh__recordMaintainer mesh__D003023 ssb
% 208.83/208.98  |- mesh__dateEstablished mesh__D003023 1967-01-01
% 208.83/208.98  |- skos__prefLabel mesh__D003023 Cloxacillin
% 208.83/208.98  |- mesh__historyNote mesh__D003023 67%28%65%29%   
% 208.83/208.98  |- skos__hiddenLabel mesh__D003023 Sodium, Cloxacillin
% 208.83/208.98  |- rdf__type mesh__D003023sskos__Concept
% 208.83/208.98  |- mesh__recordOriginator mesh__D003023 NLM
% 208.83/208.98  |- skos__scopeNote mesh__D003023
% 208.83/208.98       A semi-synthetic antibiotic that is a chlorinated derivative of OXACILLIN.%A%    
% 208.83/208.98  |- mesh__dateCreated mesh__D003023 1999-01-01
% 208.83/208.98  |- mesh__dateRevised mesh__D003023 2004-07-07
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D003023 2005
% 208.83/208.98  |- skos__altLabel mesh__D003023 Sodium Cloxacillin
% 208.83/208.98  |- mesh__publicMeSHNote mesh__D003023 67   
% 208.83/208.98  |- skos__scopeNote mesh__D016749
% 208.83/208.98       A databank established by the Health Care Quality Improvement Act of 1986 authorizing the Department of Health and Human Services to collect and release information on the professional competence and conduct of physicians, dentists, nurses, and other health care practitioners. The data include adverse actions on physicians%27% malpractice, licensure, hospital privileges, concealing of pertinent information, and the like.%A%    
% 208.83/208.98  |- skos__historyNote mesh__D016749 Malpractice %28%1989-1991%29%
% 208.83/208.98  |- mesh__recordAuthorizer mesh__D016749 sjn
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D016749 2005
% 208.83/208.98  |- mesh__dateEstablished mesh__D016749 1992-01-01
% 208.83/208.98  |- skos__annotation mesh__D016749
% 208.83/208.98       add UNITED STATES %28%NIM%29%      CATALOG: use NAF entry   
% 208.83/208.98  |- skos__hiddenLabel mesh__D016749 Databank, National Practitioner
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D016749 2006
% 208.83/208.98  |- mesh__dateCreated mesh__D016749 1991-04-29
% 208.83/208.98  |- skos__hiddenLabel mesh__D016749 National Practitioner Databanks
% 208.83/208.98  |- skos__hiddenLabel mesh__D016749 Databanks, National Practitioner
% 208.83/208.98  |- mesh__recordOriginator mesh__D016749 TGC
% 208.83/208.98  |- skos__hiddenLabel mesh__D016749 Practitioner Databank, National
% 208.83/208.98  |- rdf__type mesh__D016749sskos__Concept
% 208.83/208.98  |- skos__hiddenLabel mesh__D016749 Practitioner Databanks, National
% 208.83/208.98  |- mesh__historyNote mesh__D016749 92   
% 208.83/208.98  |- mesh__dateRevised mesh__D016749 2004-07-13
% 208.83/208.98  |- skos__historyNote mesh__D016749 Information Systems %28%1989-1991%29%
% 208.83/208.98  |- skos__altLabel mesh__D016749 National Practitioner Databank
% 208.83/208.98  |- mesh__recordMaintainer mesh__D016749 sjn
% 208.83/208.98  |- skos__broader mesh__D016749smesh__D016208
% 208.83/208.98  |- mesh__publicMeSHNote mesh__D016749 92   
% 208.83/208.98  |- skos__prefLabel mesh__D016749 National Practitioner Data Bank
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D002729 2006
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D002729 2002
% 208.83/208.98  |- mesh__publicMeSHNote mesh__D002729 66   
% 208.83/208.98  |- mesh__dateRevised mesh__D002729 1998-06-10
% 208.83/208.98  |- mesh__dateEstablished mesh__D002729 1966-01-01
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D002729 2005
% 208.83/208.98  |- skos__annotation mesh__D002729
% 208.83/208.98       P-CHLOROMERCURIBENZOIC ACID is available   
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D002729 2004
% 208.83/208.98  |- skos__prefLabel mesh__D002729 Chloromercuribenzoates
% 208.83/208.98  |- mesh__historyNote mesh__D002729 66%28%64%29%   
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D002729 2003
% 208.83/208.98  |- rdf__type mesh__D002729sskos__Concept
% 208.83/208.98  |- mesh__recordOriginator mesh__D002729 NLM
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D002729 2001
% 208.83/208.98  |- skos__scopeNote mesh__D002729
% 208.83/208.98       Chloride and mercury-containing derivatives of benzoic acid.%A%    
% 208.83/208.98  |- skos__historyNote mesh__D002729 Benzoates %28%1966%29%
% 208.83/208.98  |- mesh__recordAuthorizer mesh__D002729 SJN
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D002729 2000
% 208.83/208.98  |- skos__broader mesh__D002729smesh__D008626
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D002729 1999
% 208.83/208.98  |- mesh__dateCreated mesh__D002729 1999-01-01
% 208.83/208.98  |- mesh__recordMaintainer mesh__D002729 ADP
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D013451 2000
% 208.83/208.98  |- mesh__recordOriginator mesh__D013451 NLM
% 208.83/208.98  |- rdf__type mesh__D013451sskos__Concept
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D013451 2003
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D013451 1995
% 208.83/208.98  |- mesh__dateCreated mesh__D013451 1999-01-01
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D013451 2001
% 208.83/208.98  |- skos__prefLabel mesh__D013451 Sulfonic Acids
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D013451 2005
% 208.83/208.98  |- skos__annotation mesh__D013451 do not confuse with SULFINIC ACIDS   
% 208.83/208.98  |- mesh__recordAuthorizer mesh__D013451 PLS
% 208.83/208.98  |- skos__scopeNote mesh__D013451
% 208.83/208.98       Inorganic or organic oxy acids of sulfur which contain the RSO2%28%OH%29% radical.%A%    
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D013451 2004
% 208.83/208.98  |- skos__hiddenLabel mesh__D013451 Acids, Sulfonic
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D013451 2006
% 208.83/208.98  |- mesh__dateRevised mesh__D013451 1993-06-04
% 208.83/208.98  |- mesh__recordMaintainer mesh__D013451 TPW
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D013451 2002
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D013451 1996
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D013451 1998
% 208.83/208.98  |- skos__broader mesh__D013451smesh__D013456
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D013451 1997
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D013451 1994
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D013451 1999
% 208.83/208.98  |- skos__hiddenLabel mesh__D007414 Intestinal Cancers
% 208.83/208.98  |- skos__altLabel mesh__D007414 Neoplasms, Intestinal
% 208.83/208.98  |- mesh__dateRevised mesh__D007414 2003-07-09
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D007414 2004
% 208.83/208.98  |- skos__hiddenLabel mesh__D007414 Neoplasm, Intestines
% 208.83/208.98  |- mesh__recordMaintainer mesh__D007414 lkt
% 208.83/208.98  |- skos__hiddenLabel mesh__D007414 Intestines Cancers
% 208.83/208.98  |- skos__scopeNote mesh__D007414 Tumors or cancer of the INTESTINES.     
% 208.83/208.98  |- skos__hiddenLabel mesh__D007414 Cancer, Intestinal
% 208.83/208.98  |- skos__broader mesh__D007414smesh__D007410
% 208.83/208.98  |- rdf__type mesh__D007414sskos__Concept
% 208.83/208.98  |- skos__annotation mesh__D007414
% 208.83/208.98       GEN: prefer specific precoord; coord IM with histol type of neopl %28%IM%29%%A%  
% 208.83/208.98  |- skos__broader mesh__D007414smesh__D005770
% 208.83/208.98  |- skos__hiddenLabel mesh__D007414 Neoplasm, Intestinal
% 208.83/208.98  |- skos__hiddenLabel mesh__D007414 Intestinal Neoplasm
% 208.83/208.98  |- skos__hiddenLabel mesh__D007414 Cancers, Intestinal
% 208.83/208.98  |- skos__altLabel mesh__D007414 Cancer of the Intestines
% 208.83/208.98  |- skos__hiddenLabel mesh__D007414 Intestines Neoplasm
% 208.83/208.98  |- skos__altLabel mesh__D007414 Intestines Neoplasms
% 208.83/208.98  |- skos__hiddenLabel mesh__D007414 Cancers, Intestines
% 208.83/208.98  |- mesh__recordOriginator mesh__D007414 NLM
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D007414 2005
% 208.83/208.98  |- mesh__recordAuthorizer mesh__D007414 sjn
% 208.83/208.98  |- skos__hiddenLabel mesh__D007414 Neoplasms, Intestines
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D007414 2006
% 208.83/208.98  |- skos__prefLabel mesh__D007414 Intestinal Neoplasms
% 208.83/208.98  |- skos__altLabel mesh__D007414 Intestinal Cancer
% 208.83/208.98  |- skos__altLabel mesh__D007414 Intestines Cancer
% 208.83/208.98  |- skos__hiddenLabel mesh__D007414 Cancer, Intestines
% 208.83/208.98  |- mesh__dateCreated mesh__D007414 1999-01-01
% 208.83/208.98  |- skos__altLabel mesh__D012359 T RNA Methyltransferases
% 208.83/208.98  |- mesh__recordAuthorizer mesh__D012359 sjn
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D012359 2004
% 208.83/208.98  |- mesh__dateCreated mesh__D012359 1999-01-01
% 208.83/208.98  |- mesh__recordOriginator mesh__D012359 NLM
% 208.83/208.98  |- mesh__publicMeSHNote mesh__D012359
% 208.83/208.98       98; see RNA, TRANSFER, METHYLTRANSFERASES 1974-97   
% 208.83/208.98  |- skos__scopeNote mesh__D012359
% 208.83/208.98       Enzymes that catalyze the S-adenosyl-L-methionine-dependent methylation of ribonucleotide bases within a transfer RNA molecule. EC 2.1.1.%A%    
% 208.83/208.98  |- skos__annotation mesh__D012359 DF: note short X ref   
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D012359 2005
% 208.83/208.98  |- skos__hiddenLabel mesh__D012359 Methyltransferases, tRNA
% 208.83/208.98  |- skos__altLabel mesh__D012359 RNA Methylases
% 208.83/208.98  |- mesh__historyNote mesh__D012359 98%28%74%29%   
% 208.83/208.98  |- mesh__recordMaintainer mesh__D012359 ssb
% 208.83/208.98  |- mesh__activeMeSHYear mesh__D012359 2006
% 208.83/208.98  |- rdf__type mesh__D012359sskos__Concept
% 208.83/208.98  |- skos__broader mesh__D012359smesh__D008780
% 208.83/208.98  |- skos__altLabel mesh__D012359 RNA, Transfer, Methyltransferases
% 208.83/208.98  |- mesh__dateRevised mesh__D012359 2003-07-09
% 208.83/208.98  |- skos__prefLabel mesh__D012359 tRNA Methyltransferases
% 208.83/208.98  |- skos__hiddenLabel mesh__D012359 RNA Methyltransferases, T
% 208.83/208.98  |- skos__hiddenLabel mesh__D012359 Methylases, RNA
% 208.83/208.98  |- mesh__dateEstablished mesh__D012359 1974-01-01
% 208.83/208.98  |- skos__hiddenLabel mesh__D012359 Methyltransferases, T RNA
% 208.83/208.98  |- skos__hiddenLabel mesh__D023081 CBF Protein, CCAAT Binding
% 208.83/208.98  |- skos__altLabel mesh__D023081 CCAAT-Binding-Factor
% 208.83/208.99  |- skos__altLabel mesh__D023081 CBF-B Protein, CCAAT-Binding
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 CCAAT-Binding CBF-A Protein
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 CBF C Protein, CCAAT Binding
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 CCAAT-Binding CBF Protein
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 CCAAT Binding Factor, A Subunit
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 CCAAT Binding Transcription Factor
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 CCAAT-Binding CBF-C Protein
% 208.83/208.99  |- skos__altLabel mesh__D023081 CBF Protein, CCAAT-Binding
% 208.83/208.99  |- skos__altLabel mesh__D023081 CBF-C Protein, CCAAT-Binding
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 Transcription Factor, CCAAT-Binding
% 208.83/208.99  |- mesh__historyNote mesh__D023081
% 208.83/208.99       2001; use CCAAT-ENHANCER-BINDING PROTEINS %28%NM%29% 1988-2000   
% 208.83/208.99  |- skos__altLabel mesh__D023081 CBF-A Protein, CCAAT-Binding
% 208.83/208.99  |- mesh__recordOriginator mesh__D023081 jmp
% 208.83/208.99  |- skos__historyNote mesh__D023081 DNA-Binding Proteins %28%1988-2000%29%
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 CBF B Protein, CCAAT Binding
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 CCAAT Binding Factor, B Subunit
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D023081 2006
% 208.83/208.99  |- mesh__dateRevised mesh__D023081 2005-06-30
% 208.83/208.99  |- skos__prefLabel mesh__D023081 CCAAT-Binding Factor
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 Factor, A-Subunit CCAAT-Binding
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 CBF A Protein, CCAAT Binding
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 CCAAT-Binding CBF-B Protein
% 208.83/208.99  |- rdf__type mesh__D023081sskos__Concept
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 NF Y Protein
% 208.83/208.99  |- skos__altLabel mesh__D023081 CCAAT-Binding Protein, CP1
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 Factor, C-Subunit CCAAT-Binding
% 208.83/208.99  |- skos__altLabel mesh__D023081 CCAAT-Binding Transcription Factor
% 208.83/208.99  |- skos__broader mesh__D023081smesh__D022762
% 208.83/208.99  |- mesh__dateCreated mesh__D023081 2000-06-23
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 Protein, NF-Y
% 208.83/208.99  |- mesh__recordAuthorizer mesh__D023081 sjn
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 CCAAT Binding Factor, C Subunit
% 208.83/208.99  |- skos__scopeNote mesh__D023081
% 208.83/208.99       A heterotrimeric DNA-binding protein that binds to CCAAT motifs in the promoters of eukaryotic genes. It is composed of three subunits: A, B and C.%A%    
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 CCAAT Binding Protein, CP1
% 208.83/208.99  |- mesh__publicMeSHNote mesh__D023081
% 208.83/208.99       2001; CCAAT-BINDING FACTOR was indexed under DNA-BINDING PROTEINS 1988-2000%A%  
% 208.83/208.99  |- mesh__recordMaintainer mesh__D023081 DRC
% 208.83/208.99  |- mesh__dateEstablished mesh__D023081 2001-01-01
% 208.83/208.99  |- skos__altLabel mesh__D023081 NF-Y Protein
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 Factor, B-Subunit CCAAT-Binding
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 CP1 CCAAT-Binding Protein
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 Protein, CCAAT-Binding CBF-A
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 Protein, CCAAT-Binding CBF-B
% 208.83/208.99  |- skos__hiddenLabel mesh__D023081 CCAAT Binding Factor
% 208.83/208.99  |- skos__hiddenLabel mesh__D017842 Cobra, Asiatic
% 208.83/208.99  |- rdf__type mesh__D017842sskos__Concept
% 208.83/208.99  |- mesh__recordAuthorizer mesh__D017842 sjn
% 208.83/208.99  |- skos__broader mesh__D017842smesh__D017815
% 208.83/208.99  |- skos__related mesh__D017842smesh__D003040
% 208.83/208.99  |- skos__hiddenLabel mesh__D017842 Cobra, Water
% 208.83/208.99  |- skos__altLabel mesh__D017842 Egyptian Cobra
% 208.83/208.99  |- skos__scopeNote mesh__D017842
% 208.83/208.99       A genus of poisonous snakes of the subfamily Elapinae of the family ELAPIDAE. There are six recognized species, all inhabiting Africa except the Asiatic %28%Indian%29% cobra, Naja naja. Some species %22%spit%22% their venom into the eyes of their %22%enemies%22%. So-called spitting cobras show a high degree of accuracy in aiming for the eyes. The ringhals, the most highly specialized of the spitting cobras, is limited to southern Africa. Its spray destroys eye tissue and can cause blindness; its bite can cause death. %28%Moore: Poisonous Snakes of the World, 1980, p80%29%%A%    
% 208.83/208.99  |- mesh__historyNote mesh__D017842 94   
% 208.83/208.99  |- skos__prefLabel mesh__D017842 Cobra
% 208.83/208.99  |- skos__hiddenLabel mesh__D017842 Cobras
% 208.83/208.99  |- mesh__publicMeSHNote mesh__D017842 94   
% 208.83/208.99  |- skos__historyNote mesh__D017842 Snakes %28%1966-1993%29%
% 208.83/208.99  |- skos__altLabel mesh__D017842 Asiatic Cobra
% 208.83/208.99  |- skos__altLabel mesh__D017842 Haemachatus
% 208.83/208.99  |- skos__hiddenLabel mesh__D017842 Water Cobras
% 208.83/208.99  |- mesh__dateEstablished mesh__D017842 1994-01-01
% 208.83/208.99  |- skos__hiddenLabel mesh__D017842 Egyptian Cobras
% 208.83/208.99  |- skos__hiddenLabel mesh__D017842 Cobras, Egyptian
% 208.83/208.99  |- skos__hiddenLabel mesh__D017842 Cobras, Asiatic
% 208.83/208.99  |- skos__hiddenLabel mesh__D017842 Cobra, Egyptian
% 208.83/208.99  |- mesh__dateCreated mesh__D017842 1993-02-16
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D017842 2005
% 208.83/208.99  |- mesh__recordOriginator mesh__D017842 TGC
% 208.83/208.99  |- skos__annotation mesh__D017842 a genus of poisonous snakes   
% 208.83/208.99  |- mesh__recordMaintainer mesh__D017842 ags
% 208.83/208.99  |- mesh__dateRevised mesh__D017842 2003-07-09
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D017842 2004
% 208.83/208.99  |- skos__hiddenLabel mesh__D017842 Asiatic Cobras
% 208.83/208.99  |- skos__altLabel mesh__D017842 Water Cobra
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D017842 2006
% 208.83/208.99  |- skos__hiddenLabel mesh__D017842 Cobras, Water
% 208.83/208.99  |- skos__altLabel mesh__D017842 Ringhals
% 208.83/208.99  |- mesh__recordAuthorizer mesh__D017044 sjn
% 208.83/208.99  |- mesh__dateEstablished mesh__D017044 1992-01-01
% 208.83/208.99  |- skos__altLabel mesh__D017044 ARPKD
% 208.83/208.99  |- skos__altLabel mesh__D017044
% 208.83/208.99       Autosomal Recessive Polycystic Kidney Disease
% 208.83/208.99  |- mesh__recordMaintainer mesh__D017044 lkt
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D017044 2006
% 208.83/208.99  |- skos__altLabel mesh__D017044
% 208.83/208.99       Polycystic Kidney Disease, Infantile, Type I
% 208.83/208.99  |- mesh__publicMeSHNote mesh__D017044
% 208.83/208.99       1992; see KIDNEY, POLYCYCSTIC, AUTOSOMAL RECESSIVE 1992-2000%A%  
% 208.83/208.99  |- skos__broader mesh__D017044smesh__D007690
% 208.83/208.99  |- skos__altLabel mesh__D017044 Autosomal Recessive Polycystic Kidney
% 208.83/208.99  |- skos__scopeNote mesh__D017044
% 208.83/208.99       A genetic disorder with autosomal recessive inheritance, characterized by multiple CYSTS in both KIDNEYS and associated LIVER lesions. Serious manifestations are usually present at BIRTH with high PERINATAL MORTALITY.%A%    
% 208.83/208.99  |- mesh__dateRevised mesh__D017044 2005-06-30
% 208.83/208.99  |- rdf__type mesh__D017044sskos__Concept
% 208.83/208.99  |- skos__prefLabel mesh__D017044 Polycystic Kidney, Autosomal Recessive
% 208.83/208.99  |- mesh__dateCreated mesh__D017044 1991-05-30
% 208.83/208.99  |- mesh__recordOriginator mesh__D017044 AGS
% 208.83/208.99  |- skos__historyNote mesh__D017044 Kidney, Polycystic %28%1966-1991%29%
% 208.83/208.99  |- mesh__historyNote mesh__D017044 1992   
% 208.83/208.99  |- skos__altLabel mesh__D017044
% 208.83/208.99       Polycystic Kidney and Hepatic Disease 1 %28%Autosomal Recessive%29%
% 208.83/208.99  |- skos__altLabel mesh__D017044 Kidney, Polycystic, Autosomal Recessive
% 208.83/208.99  |- skos__hiddenLabel mesh__D003822 Liners, Denture
% 208.83/208.99  |- rdf__type mesh__D003822sskos__Concept
% 208.83/208.99  |- skos__related mesh__D003822smesh__D012826
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003822 2001
% 208.83/208.99  |- mesh__dateCreated mesh__D003822 1999-01-01
% 208.83/208.99  |- mesh__recordMaintainer mesh__D003822 PXP
% 208.83/208.99  |- skos__hiddenLabel mesh__D003822 Denture Liner
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003822 2003
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003822 1999
% 208.83/208.99  |- skos__broader mesh__D003822smesh__D003778
% 208.83/208.99  |- mesh__recordOriginator mesh__D003822 NLM
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003822 2000
% 208.83/208.99  |- skos__scopeNote mesh__D003822
% 208.83/208.99       Material applied to the tissue side of a denture to provide a soft lining to the parts of a denture coming in contact with soft tissue. It cushions contact of the denture with the tissues.%A%    
% 208.83/208.99  |- mesh__dateRevised mesh__D003822 1997-06-20
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003822 1998
% 208.83/208.99  |- mesh__dateEstablished mesh__D003822 1965-01-01
% 208.83/208.99  |- mesh__publicMeSHNote mesh__D003822 65   
% 208.83/208.99  |- skos__prefLabel mesh__D003822 Denture Liners
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003822 2006
% 208.83/208.99  |- skos__altLabel mesh__D003822 Cushion Liners
% 208.83/208.99  |- mesh__historyNote mesh__D003822 65   
% 208.83/208.99  |- skos__annotation mesh__D003822
% 208.83/208.99       coord IM with specific denture term %28%IM or NIM%29%   
% 208.83/208.99  |- skos__hiddenLabel mesh__D003822 Liner, Denture
% 208.83/208.99  |- skos__hiddenLabel mesh__D003822 Liners, Cushion
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003822 2005
% 208.83/208.99  |- mesh__recordAuthorizer mesh__D003822 SJN
% 208.83/208.99  |- skos__hiddenLabel mesh__D003822 Liner, Cushion
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003822 2002
% 208.83/208.99  |- skos__hiddenLabel mesh__D003822 Cushion Liner
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003822 2004
% 208.83/208.99  |- mesh__publicMeSHNote mesh__D003024
% 208.83/208.99       91; was see under DIBENZAZEPINES 1975-90   
% 208.83/208.99  |- rdf__type mesh__D003024sskos__Concept
% 208.83/208.99  |- mesh__recordOriginator mesh__D003024 NLM
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003024 2002
% 208.83/208.99  |- skos__scopeNote mesh__D003024
% 208.83/208.99       A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent.%A%    
% 208.83/208.99  |- mesh__dateEstablished mesh__D003024 1991-01-01
% 208.83/208.99  |- skos__broader mesh__D003024smesh__D003984
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003024 2005
% 208.83/208.99  |- mesh__recordAuthorizer mesh__D003024 sjn
% 208.83/208.99  |- skos__prefLabel mesh__D003024 Clozapine
% 208.83/208.99  |- skos__historyNote mesh__D003024 Dibenzazepines %28%1971-1974%29%
% 208.83/208.99  |- mesh__recordMaintainer mesh__D003024 TWD
% 208.83/208.99  |- mesh__dateCreated mesh__D003024 1974-11-19
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003024 2003
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003024 2006
% 208.83/208.99  |- skos__historyNote mesh__D003024 Piperazines %28%1971-1974%29%
% 208.83/208.99  |- mesh__dateRevised mesh__D003024 2000-06-21
% 208.83/208.99  |- mesh__historyNote mesh__D003024
% 208.83/208.99       91%28%75%29%; was see under DIBENZAZEPINES 1975-90   
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003024 2004
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003024 2001
% 208.83/208.99  |- mesh__dateCreated mesh__D041941 2003-07-09
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D041941 2004
% 208.83/208.99  |- skos__broader mesh__D041941smesh__D001628
% 208.83/208.99  |- skos__hiddenLabel mesh__D041941 Milk Substitute
% 208.83/208.99  |- skos__scopeNote mesh__D041941
% 208.83/208.99       Food BEVERAGES that are used as nutritional substitutes for MILK.%A%    
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D041941 2005
% 208.83/208.99  |- mesh__dateEstablished mesh__D041941 2004-01-01
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D041941 2006
% 208.83/208.99  |- skos__prefLabel mesh__D041941 Milk Substitutes
% 208.83/208.99  |- rdf__type mesh__D041941sskos__Concept
% 208.83/208.99  |- mesh__historyNote mesh__D041941 2004; use MILK 1998-2003   
% 208.83/208.99  |- mesh__publicMeSHNote mesh__D041941 2004; see MILK 1998-2003   
% 208.83/208.99  |- skos__historyNote mesh__D041941 Milk %28%1968-2003%29%
% 208.83/208.99  |- skos__prefLabel mesh__D013452 Sulfonium Compounds
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D013452 2005
% 208.83/208.99  |- skos__scopeNote mesh__D013452
% 208.83/208.99       Sulfur compounds in which the sulfur atom is attached to three organic radicals and an electronegative element or radical.%A%    
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D013452 2004
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D013452 2006
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D013452 2000
% 208.83/208.99  |- mesh__historyNote mesh__D013452
% 208.83/208.99       91%28%75%29%; was see under ONIUM COMPOUNDS 1975-90   
% 208.83/208.99  |- skos__historyNote mesh__D013452 Onium Compounds %28%1968-1974%29%
% 208.83/208.99  |- mesh__dateEstablished mesh__D013452 1991-01-01
% 208.83/208.99  |- mesh__recordOriginator mesh__D013452 NLM
% 208.83/208.99  |- skos__hiddenLabel mesh__D013452 Compounds, Sulfine
% 208.83/208.99  |- mesh__publicMeSHNote mesh__D013452
% 208.83/208.99       91; was see under ONIUM COMPOUNDS 1975-90   
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D013452 2001
% 208.83/208.99  |- skos__hiddenLabel mesh__D013452 Compounds, Sulfonium
% 208.83/208.99  |- mesh__recordAuthorizer mesh__D013452 PLS
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D013452 1996
% 208.83/208.99  |- skos__broader mesh__D013452smesh__D013457
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D013452 1998
% 208.83/208.99  |- mesh__recordMaintainer mesh__D013452 TGC
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D013452 1997
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D013452 1994
% 208.83/208.99  |- mesh__dateRevised mesh__D013452 1992-05-20
% 208.83/208.99  |- skos__annotation mesh__D013452 DF: SULFONIUM CPDS   
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D013452 1999
% 208.83/208.99  |- skos__broader mesh__D013452smesh__D009861
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D013452 2002
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D013452 1993
% 208.83/208.99  |- rdf__type mesh__D013452sskos__Concept
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D013452 1995
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D013452 2003
% 208.83/208.99  |- mesh__dateCreated mesh__D013452 1974-11-11
% 208.83/208.99  |- skos__broader mesh__D007415smesh__D007410
% 208.83/208.99  |- rdf__type mesh__D007415sskos__Concept
% 208.83/208.99  |- mesh__dateRevised mesh__D007415 2005-07-01
% 208.83/208.99  |- skos__annotation mesh__D007415
% 208.83/208.99       coord IM with specific precoord intestinal dis %28%IM%29%; INTESTINAL PSEUDO-OBSTRUCTION is also available%A%  
% 208.83/208.99  |- skos__hiddenLabel mesh__D007415 Obstruction, Intestinal
% 208.83/208.99  |- skos__prefLabel mesh__D007415 Intestinal Obstruction
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D007415 2006
% 208.83/208.99  |- mesh__dateCreated mesh__D007415 1999-01-01
% 208.83/208.99  |- skos__hiddenLabel mesh__D007415 Intestinal Obstructions
% 208.83/208.99  |- mesh__recordMaintainer mesh__D007415 sjn
% 208.83/208.99  |- mesh__recordOriginator mesh__D007415 NLM
% 208.83/208.99  |- mesh__recordAuthorizer mesh__D007415 sjn
% 208.83/208.99  |- skos__scopeNote mesh__D007415
% 208.83/208.99       Any impairment, arrest, or reversal of the normal flow of INTESTINAL CONTENTS toward the ANAL CANAL.%A%    
% 208.83/208.99  |- skos__broader mesh__D051571smesh__D011493
% 208.83/208.99  |- mesh__recordMaintainer mesh__D051571 ags
% 208.83/208.99  |- skos__altLabel mesh__D051571 Protein Kinase C%28%alpha%29%
% 208.83/208.99  |- mesh__dateRevised mesh__D051571 2005-07-18
% 208.83/208.99  |- mesh__recordAuthorizer mesh__D051571 ags
% 208.83/208.99  |- mesh__publicMeSHNote mesh__D051571
% 208.83/208.99       2006; PROTEIN KINASE C ALPHA was indexed under PROTEIN KINASE C 2004-2006, %26% under ISOENZYMES 1999-2003%A%  
% 208.83/208.99  |- mesh__recordOriginator mesh__D051571 AKE
% 208.83/208.99  |- skos__scopeNote mesh__D051571
% 208.83/208.99       A cytoplasmic serine threonine kinase involved in regulating CELL DIFFERENTIATION and CELLULAR PROLIFERATION. Overexpression of this enzyme has been shown to promote PHOSPHORYLATION of BCL-2 PROTO-ONCOGENE PROTEINS and chemoresistance in human acute leukemia cells.%A%    
% 208.83/208.99  |- skos__altLabel mesh__D051571 Protein Kinase C alpha
% 208.83/208.99  |- skos__altLabel mesh__D051571 PKC-alpha Serine-Threonine Kinase
% 208.83/208.99  |- rdf__type mesh__D051571sskos__Concept
% 208.83/208.99  |- skos__hiddenLabel mesh__D051571 Serine-Threonine Kinase, PKC-alpha
% 208.83/208.99  |- skos__prefLabel mesh__D051571 Protein Kinase C-alpha
% 208.83/208.99  |- mesh__dateEstablished mesh__D051571 2006-01-01
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D051571 2006A
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D051571 2006
% 208.83/208.99  |- mesh__historyNote mesh__D051571 2006%28%1999%29%   
% 208.83/208.99  |- mesh__dateCreated mesh__D051571 2005-06-30
% 208.83/208.99  |- skos__hiddenLabel mesh__D051571 PKC alpha Serine Threonine Kinase
% 208.83/208.99  |- skos__historyNote mesh__D023082 Proteins %28%1998-2000%29%
% 208.83/208.99  |- mesh__dateEstablished mesh__D023082 2001-01-01
% 208.83/208.99  |- skos__broader mesh__D023082smesh__D023181
% 208.83/208.99  |- mesh__recordMaintainer mesh__D023082 jmp
% 208.83/208.99  |- skos__prefLabel mesh__D023082 Defensins
% 208.83/208.99  |- mesh__publicMeSHNote mesh__D023082
% 208.83/208.99       2001; DEFENSINS was indexed under PROTEINS %28%1999-2000%29% %26% BLOOD PROTEINS %28%1985-1998%29%%A%  
% 208.83/208.99  |- mesh__recordOriginator mesh__D023082 ags
% 208.83/208.99  |- skos__historyNote mesh__D023082 Blood Proteins %28%1985-1998%29%
% 208.83/208.99  |- skos__scopeNote mesh__D023082
% 208.83/208.99       Family of antimicrobial peptides that have been identified in humans, animals, and plants. They are thought to play a role in host defenses against infections, inflammation, wound repair, and acquired immunity.%A%    
% 208.83/208.99  |- mesh__historyNote mesh__D023082
% 208.83/208.99       2001; use DEFENSINS %28%NM%29% to search DEFENSINS 1985-2000   
% 208.83/208.99  |- mesh__dateRevised mesh__D023082 2005-06-30
% 208.83/208.99  |- mesh__recordAuthorizer mesh__D023082 sjn
% 208.83/208.99  |- mesh__dateCreated mesh__D023082 2000-06-22
% 208.83/208.99  |- rdf__type mesh__D023082sskos__Concept
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D023082 2006
% 208.83/208.99  |- skos__altLabel mesh__D017843 Ligamenta Flava
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D017843 2000
% 208.83/208.99  |- mesh__recordOriginator mesh__D017843 TGC
% 208.83/208.99  |- skos__broader mesh__D017843smesh__D008023
% 208.83/208.99  |- skos__historyNote mesh__D017843 Ligaments %28%1966-1993%29%
% 208.83/208.99  |- mesh__recordMaintainer mesh__D017843 KEV
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D017843 2003
% 208.83/208.99  |- mesh__dateRevised mesh__D017843 1999-11-03
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D017843 2001
% 208.83/208.99  |- mesh__dateCreated mesh__D017843 1993-02-16
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D017843 2005
% 208.83/208.99  |- skos__hiddenLabel mesh__D017843 Ligaments, Flaval
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D017843 2004
% 208.83/208.99  |- mesh__recordAuthorizer mesh__D017843 sjn
% 208.83/208.99  |- skos__hiddenLabel mesh__D017843 Flaval Ligaments
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D017843 2006
% 208.83/208.99  |- rdf__type mesh__D017843sskos__Concept
% 208.83/208.99  |- skos__prefLabel mesh__D017843 Ligamentum Flavum
% 208.83/208.99  |- skos__altLabel mesh__D017843 Flaval Ligament
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D017843 2002
% 208.83/208.99  |- skos__scopeNote mesh__D017843
% 208.83/208.99       The paired bands of yellow elastic tissue that connect adjoining laminae of the vertebrae. With the laminae, it forms the posterior wall of the spinal canal and helps hold the body erect.%A%    
% 208.83/208.99  |- mesh__dateEstablished mesh__D017843 1994-01-01
% 208.83/208.99  |- mesh__publicMeSHNote mesh__D017843 94   
% 208.83/208.99  |- skos__hiddenLabel mesh__D017843 Ligament, Flaval
% 208.83/208.99  |- mesh__historyNote mesh__D017843 94   
% 208.83/208.99  |- skos__scopeNote mesh__D017045
% 208.83/208.99       A genus of gram-positive, coccoid bacteria mainly isolated from milk and milk products. These bacteria are also found in plants and nonsterile frozen and dry foods. Previously thought to be a member of the genus STREPTOCOCCUS %28%group N%29%, it is now recognized as a separate genus.%A%    
% 208.83/208.99  |- skos__annotation mesh__D017045
% 208.83/208.99       usually non-pathogenic; in milk %26% milk products   
% 208.83/208.99  |- skos__historyNote mesh__D017045 Gram-Positive Bacteria %28%1988%29%
% 208.83/208.99  |- skos__historyNote mesh__D017045 Streptococcus %28%1988-1991%29%
% 208.83/208.99  |- mesh__recordAuthorizer mesh__D017045 sjn
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D017045 2006
% 208.83/208.99  |- mesh__recordOriginator mesh__D017045 PXP
% 208.83/208.99  |- mesh__dateCreated mesh__D017045 1991-05-30
% 208.83/208.99  |- mesh__publicMeSHNote mesh__D017045 92   
% 208.83/208.99  |- skos__broader mesh__D017045smesh__D013289
% 208.83/208.99  |- skos__prefLabel mesh__D017045 Lactococcus
% 208.83/208.99  |- rdf__type mesh__D017045sskos__Concept
% 208.83/208.99  |- mesh__recordMaintainer mesh__D017045 SYSTEM
% 208.83/208.99  |- mesh__dateRevised mesh__D017045 2005-06-30
% 208.83/208.99  |- mesh__historyNote mesh__D017045 92   
% 208.83/208.99  |- mesh__dateEstablished mesh__D017045 1992-01-01
% 208.83/208.99  |- rdf__type mesh__D003823sskos__Concept
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003823 1995
% 208.83/208.99  |- skos__prefLabel mesh__D003823 Denture Rebasing
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003823 1999
% 208.83/208.99  |- skos__hiddenLabel mesh__D003823 Rebasing, Denture
% 208.83/208.99  |- skos__hiddenLabel mesh__D003823 Relinings, Denture
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003823 2000
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003823 1996
% 208.83/208.99  |- skos__annotation mesh__D003823
% 208.83/208.99       coord IM with specific denture term %28%IM or NIM%29%   
% 208.83/208.99  |- mesh__historyNote mesh__D003823 65   
% 208.83/208.99  |- skos__hiddenLabel mesh__D003823 Relining, Denture
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003823 1993
% 208.83/208.99  |- skos__hiddenLabel mesh__D003823 Denture Relinings
% 208.83/208.99  |- skos__hiddenLabel mesh__D003823 Denture Rebasings
% 208.83/208.99  |- mesh__publicMeSHNote mesh__D003823 65   
% 208.83/208.99  |- mesh__recordAuthorizer mesh__D003823 PLS
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003823 2005
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003823 2001
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003823 1997
% 208.83/208.99  |- skos__scopeNote mesh__D003823
% 208.83/208.99       The process of refitting a denture by replacing the denture base material without changing the occlusal relations of the teeth. Rebasing may include adding to the denture base to compensate for resorptive changes to subjacent structures.%A%    
% 208.83/208.99  |- skos__broader mesh__D003823smesh__D003778
% 208.83/208.99  |- mesh__recordOriginator mesh__D003823 NLM
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003823 2006
% 208.83/208.99  |- mesh__dateCreated mesh__D003823 1999-01-01
% 208.83/208.99  |- mesh__recordMaintainer mesh__D003823 MXR
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003823 2003
% 208.83/208.99  |- mesh__dateRevised mesh__D003823 1992-05-11
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003823 1994
% 208.83/208.99  |- skos__hiddenLabel mesh__D003823 Rebasings, Denture
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003823 2002
% 208.83/208.99  |- mesh__dateEstablished mesh__D003823 1965-01-01
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003823 1998
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003823 2004
% 208.83/208.99  |- skos__broader mesh__D003823smesh__D013674
% 208.83/208.99  |- mesh__publicMeSHNote mesh__D050479 2006   
% 208.83/208.99  |- mesh__recordOriginator mesh__D050479 DRC
% 208.83/208.99  |- skos__hiddenLabel mesh__D050479 Transport Proteins, Neurotransmitter
% 208.83/208.99  |- skos__hiddenLabel mesh__D050479 Transporter Proteins, Neurotransmitter
% 208.83/208.99  |- skos__broader mesh__D050479smesh__D026901
% 208.83/208.99  |- mesh__recordAuthorizer mesh__D050479 sjn
% 208.83/208.99  |- skos__hiddenLabel mesh__D050479 Transporters, Neurotransmitter
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D050479 2006
% 208.83/208.99  |- rdf__type mesh__D050479sskos__Concept
% 208.83/208.99  |- mesh__recordMaintainer mesh__D050479 DRC
% 208.83/208.99  |- skos__prefLabel mesh__D050479 Neurotransmitter Transport Proteins
% 208.83/208.99  |- skos__altLabel mesh__D050479 Neurotransmitter Transporters
% 208.83/208.99  |- mesh__dateEstablished mesh__D050479 2006-01-01
% 208.83/208.99  |- skos__scopeNote mesh__D050479
% 208.83/208.99       Membrane transport proteins found predominately in NEURONS and neuroendocrine cells that facilitate neurotransmitter transport. They include two distinct families of proteins that transport NEUROTRANSMITTERS across the PLASMA MEMBRANE and that transport NEUROTRANSMITTERS into SECRETORY VESICLES.%A%    
% 208.83/208.99  |- mesh__dateCreated mesh__D050479 2005-06-30
% 208.83/208.99  |- mesh__historyNote mesh__D050479 2006   
% 208.83/208.99  |- skos__altLabel mesh__D050479 Neurotransmitter Transporter Proteins
% 208.83/208.99  |- mesh__dateCreated mesh__D003025 1999-01-01
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003025 2005
% 208.83/208.99  |- mesh__recordOriginator mesh__D003025 NLM
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003025 2006
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003025 2003
% 208.83/208.99  |- skos__altLabel mesh__D003025 Talipes Equinovarus
% 208.83/208.99  |- mesh__recordMaintainer mesh__D003025 kle
% 208.83/208.99  |- skos__altLabel mesh__D003025 Equinovarus
% 208.83/208.99  |- skos__prefLabel mesh__D003025 Clubfoot
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D003025 2004
% 208.83/208.99  |- mesh__recordAuthorizer mesh__D003025 sjn
% 208.83/208.99  |- skos__broader mesh__D003025smesh__D005532
% 208.83/208.99  |- skos__annotation mesh__D003025
% 208.83/208.99       X ref EQUINOVARUS: do not confuse with EQUINUS DEFORMITY; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 208.83/208.99  |- mesh__dateRevised mesh__D003025 2002-07-03
% 208.83/208.99  |- rdf__type mesh__D003025sskos__Concept
% 208.83/208.99  |- skos__scopeNote mesh__D003025
% 208.83/208.99       A deformed foot in which the foot is plantarflexed, inverted and adducted.%A%    
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D041942 2006
% 208.83/208.99  |- rdf__type mesh__D041942sskos__Concept
% 208.83/208.99  |- mesh__historyNote mesh__D041942 2004   
% 208.83/208.99  |- skos__broader mesh__D041942smesh__D041941
% 208.83/208.99  |- skos__historyNote mesh__D041942 Milk %28%1965-2003%29%
% 208.83/208.99  |- skos__scopeNote mesh__D041942 A beverage prepared from SOYBEANS.     
% 208.83/208.99  |- mesh__dateCreated mesh__D041942 2003-07-09
% 208.83/208.99  |- mesh__dateEstablished mesh__D041942 2004-01-01
% 208.83/208.99  |- skos__prefLabel mesh__D041942 Soy Milk
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D041942 2004
% 208.83/208.99  |- skos__hiddenLabel mesh__D041942 Beverages, Soy
% 208.83/208.99  |- skos__broader mesh__D041942smesh__D045730
% 208.83/208.99  |- skos__altLabel mesh__D041942 Soy Beverage
% 208.83/208.99  |- mesh__publicMeSHNote mesh__D041942 2004   
% 208.83/208.99  |- skos__hiddenLabel mesh__D041942 Soy Beverages
% 208.83/208.99  |- skos__altLabel mesh__D041942 Milk, Soy
% 208.83/208.99  |- skos__hiddenLabel mesh__D041942 Beverage, Soy
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D041942 2005
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D013453 2001
% 208.83/208.99  |- mesh__dateEstablished mesh__D013453 1972-01-01
% 208.83/208.99  |- skos__prefLabel mesh__D013453 Sulfonylurea Compounds
% 208.83/208.99  |- skos__hiddenLabel mesh__D013453 Compounds, Sulfonylurea
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D013453 2004
% 208.83/208.99  |- mesh__recordMaintainer mesh__D013453 jmp
% 208.83/208.99  |- mesh__recordAuthorizer mesh__D013453 sjn
% 208.83/208.99  |- rdf__type mesh__D013453sskos__Concept
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D013453 2000
% 208.83/208.99  |- mesh__dateCreated mesh__D013453 1999-01-01
% 208.83/208.99  |- mesh__historyNote mesh__D013453 72   
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D013453 2003
% 208.83/208.99  |- mesh__publicMeSHNote mesh__D013453 72   
% 208.83/208.99  |- skos__broader mesh__D013453smesh__D013450
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D013453 2006
% 208.83/208.99  |- mesh__dateRevised mesh__D013453 1999-11-03
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D013453 2002
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D013453 2005
% 208.83/208.99  |- skos__broader mesh__D013453smesh__D014508
% 208.83/208.99  |- mesh__recordOriginator mesh__D013453 NLM
% 208.83/208.99  |- skos__historyNote mesh__D013453 Hypoglycemic Agents %28%1966-1971%29%
% 208.83/208.99  |- skos__annotation mesh__D013453 hypoglycemics; DF: SULFONYLUREA CPDS   
% 208.83/208.99  |- skos__hiddenLabel mesh__D007416 Perforations, Intestinal
% 208.83/208.99  |- mesh__activeMeSHYear mesh__D007416 2005
% 208.83/208.99  |- skos__hiddenLabel mesh__D007416 Perforation, Intestinal
% 208.83/208.99  |- skos__annotation mesh__D007416
% 208.83/208.99       caused by dis or inj; coord IM with specific intestine %28%IM%29% or specific precoord intestinal dis %28%IM%29%; intestinal rupture does not go here: index with INTESTINES /inj or specific intestine /inj %28%IM%29% + RUPTURE %28%NIM%29% or specific intestine %28%IM%29% or specific precoord intestinal dis %28%IM%29% + RUPTURE, SPONTANEOUS %28%NIM%29%%A%  
% 208.83/208.99  |- mesh__recordOriginator mesh__D007416 NLM
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D007416 2006
% 208.83/209.00  |- mesh__recordAuthorizer mesh__D007416 sjn
% 208.83/209.00  |- mesh__dateCreated mesh__D007416 1999-01-01
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D007416 2004
% 208.83/209.00  |- mesh__dateRevised mesh__D007416 2003-07-09
% 208.83/209.00  |- mesh__recordMaintainer mesh__D007416 lkt
% 208.83/209.00  |- skos__prefLabel mesh__D007416 Intestinal Perforation
% 208.83/209.00  |- skos__broader mesh__D007416smesh__D007410
% 208.83/209.00  |- skos__scopeNote mesh__D007416
% 208.83/209.00       Opening or penetration through the wall of the INTESTINES.%A%    
% 208.83/209.00  |- rdf__type mesh__D007416sskos__Concept
% 208.83/209.00  |- skos__hiddenLabel mesh__D007416 Intestinal Perforations
% 208.83/209.00  |- mesh__publicMeSHNote mesh__D051572
% 208.83/209.00       2006; PROTO-ONCOGENE PROTEIN C-HCK was indexed under PROTEIN-TYROSINE KINASE %26% PROTO-ONCOGENE PROTEINS 1991-2005%A%  
% 208.83/209.00  |- mesh__dateCreated mesh__D051572 2005-06-30
% 208.83/209.00  |- skos__prefLabel mesh__D051572 Proto-Oncogene Proteins c-hck
% 208.83/209.00  |- rdf__type mesh__D051572sskos__Concept
% 208.83/209.00  |- skos__hiddenLabel mesh__D051572 Proto Oncogene Proteins c hck
% 208.83/209.00  |- skos__hiddenLabel mesh__D051572 c hck Proteins
% 208.83/209.00  |- skos__hiddenLabel mesh__D051572 Proto Oncogene Protein c hck
% 208.83/209.00  |- skos__hiddenLabel mesh__D051572 hck Proto Oncogene Proteins
% 208.83/209.00  |- mesh__recordAuthorizer mesh__D051572 sjn
% 208.83/209.00  |- skos__altLabel mesh__D051572 c-hck Proteins
% 208.83/209.00  |- skos__altLabel mesh__D051572 Proto-Oncogene Protein hck
% 208.83/209.00  |- skos__scopeNote mesh__D051572
% 208.83/209.00       Members of the src-family tyrosine kinase family that are strongly expressed in MYELOID CELLS and B-LYMPHOCYTES.%A%    
% 208.83/209.00  |- skos__altLabel mesh__D051572 hck Proto-Oncogene Proteins
% 208.83/209.00  |- mesh__historyNote mesh__D051572 2006%28%1991%29%   
% 208.83/209.00  |- mesh__recordMaintainer mesh__D051572 DRC
% 208.83/209.00  |- mesh__recordOriginator mesh__D051572 DRC
% 208.83/209.00  |- skos__altLabel mesh__D051572 c-hck Proto-Oncogene Proteins
% 208.83/209.00  |- mesh__dateEstablished mesh__D051572 2006-01-01
% 208.83/209.00  |- skos__broader mesh__D051572smesh__D011518
% 208.83/209.00  |- skos__altLabel mesh__D051572 Proto-Oncogene Protein c-hck
% 208.83/209.00  |- skos__hiddenLabel mesh__D051572 Tyrosine Protein Kinase HCK
% 208.83/209.00  |- skos__broader mesh__D051572smesh__D019061
% 208.83/209.00  |- skos__hiddenLabel mesh__D051572 Proto Oncogene Protein hck
% 208.83/209.00  |- skos__hiddenLabel mesh__D051572 Proto-Oncogene Proteins, hck
% 208.83/209.00  |- skos__hiddenLabel mesh__D051572 c hck Proto Oncogene Proteins
% 208.83/209.00  |- skos__altLabel mesh__D051572 Tyrosine-Protein Kinase HCK
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D051572 2006
% 208.83/209.00  |- skos__hiddenLabel mesh__D051572 c-hck, Proto-Oncogene Protein
% 208.83/209.00  |- skos__hiddenLabel mesh__D051572 Proto-Oncogene Proteins, c-hck
% 208.83/209.00  |- skos__altLabel mesh__D051572 Hematopoietic Cell Kinase
% 208.83/209.00  |- skos__prefLabel mesh__D023881 Colonography, Computed Tomographic
% 208.83/209.00  |- skos__related mesh__D023881smesh__D003113
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D023881 2005
% 208.83/209.00  |- skos__broader mesh__D023881smesh__D014057
% 208.83/209.00  |- skos__historyNote mesh__D023881
% 208.83/209.00       Colonic Diseases/radiography %28%1994-2001%29%
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D023881 2002
% 208.83/209.00  |- mesh__dateEstablished mesh__D023881 2002-01-01
% 208.83/209.00  |- skos__altLabel mesh__D023881 CT Colonography
% 208.83/209.00  |- skos__related mesh__D023881smesh__D014057
% 208.83/209.00  |- skos__historyNote mesh__D023881 Colon/radiography %28%1994-2001%29%
% 208.83/209.00  |- rdf__type mesh__D023881sskos__Concept
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D023881 2004
% 208.83/209.00  |- mesh__dateCreated mesh__D023881 2001-07-25
% 208.83/209.00  |- skos__broader mesh__D023881smesh__D003938
% 208.83/209.00  |- skos__altLabel mesh__D023881 Virtual Colonoscopy
% 208.83/209.00  |- skos__altLabel mesh__D023881 Computed Tomographic Colonography
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D023881 2003
% 208.83/209.00  |- mesh__historyNote mesh__D023881 2002   
% 208.83/209.00  |- skos__historyNote mesh__D023881
% 208.83/209.00       Tomography, X-Ray Computed %28%1994-2001%29%
% 208.83/209.00  |- skos__scopeNote mesh__D023881
% 208.83/209.00       A non-invasive imaging method that uses computed tomographic data combined with specialized imaging software to examine the colon.%A%    
% 208.83/209.00  |- mesh__publicMeSHNote mesh__D023881 2002   
% 208.83/209.00  |- skos__annotation mesh__D023881 DF: CT Colonography   
% 208.83/209.00  |- skos__historyNote mesh__D023881 Colonoscopy/methods %28%1994-2001%29%
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D023881 2006
% 208.83/209.00  |- skos__altLabel mesh__D023881 Colonoscopy, Virtual
% 208.83/209.00  |- skos__hiddenLabel mesh__D023881 Colonography, CT
% 208.83/209.00  |- skos__scopeNote mesh__D023083
% 208.83/209.00       DEFENSINS found mainly in epithelial cells.     
% 208.83/209.00  |- skos__historyNote mesh__D023083 Proteins %28%1993-2000%29%
% 208.83/209.00  |- mesh__historyNote mesh__D023083 2001   
% 208.83/209.00  |- skos__broader mesh__D023083smesh__D023082
% 208.83/209.00  |- mesh__recordMaintainer mesh__D023083 ssb
% 208.83/209.00  |- mesh__dateCreated mesh__D023083 2000-06-22
% 208.83/209.00  |- mesh__publicMeSHNote mesh__D023083 2001   
% 208.83/209.00  |- mesh__recordOriginator mesh__D023083 ags
% 208.83/209.00  |- rdf__type mesh__D023083sskos__Concept
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D023083 2006
% 208.83/209.00  |- mesh__dateRevised mesh__D023083 2005-06-30
% 208.83/209.00  |- skos__prefLabel mesh__D023083 beta-Defensins
% 208.83/209.00  |- mesh__recordAuthorizer mesh__D023083 sjn
% 208.83/209.00  |- mesh__dateEstablished mesh__D023083 2001-01-01
% 208.83/209.00  |- skos__hiddenLabel mesh__D023083 beta Defensins
% 208.83/209.00  |- mesh__dateEstablished mesh__D017844 1994-01-01
% 208.83/209.00  |- mesh__recordAuthorizer mesh__D017844 jls
% 208.83/209.00  |- mesh__publicMeSHNote mesh__D017844 94   
% 208.83/209.00  |- skos__hiddenLabel mesh__D017844 Ligaments, Ankle Lateral
% 208.83/209.00  |- skos__altLabel mesh__D017844 Ankle Lateral Ligament
% 208.83/209.00  |- skos__altLabel mesh__D017844
% 208.83/209.00       Ligamentum Laterale Articulationis Talocruralis
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017844 2003
% 208.83/209.00  |- mesh__dateCreated mesh__D017844 1993-02-16
% 208.83/209.00  |- skos__scopeNote mesh__D017844
% 208.83/209.00       There are two lateral ligaments of the ankle - internal and external. The internal lateral ligament is attached to the apex and anterior and posterior bodies of the inner malleolus and inserted into the navicular bone, the inferior calcaneo-navicular ligament, the sustentaculum tali of the os calcis, and the inner side of the astragalus. The external lateral ligament, also called the lateral collateral ligament, consists of three distinct fasciculi - the calcaneofibular, the anterior talofibular, and the posterior talofibular.%A%    
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017844 2005
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017844 2004
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017844 2006
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017844 2005A
% 208.83/209.00  |- mesh__recordOriginator mesh__D017844 TGC
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017844 2000
% 208.83/209.00  |- rdf__type mesh__D017844sskos__Concept
% 208.83/209.00  |- skos__hiddenLabel mesh__D017844 Ankle Lateral Ligaments
% 208.83/209.00  |- skos__historyNote mesh__D017844 Ligaments %28%1966-1993%29%
% 208.83/209.00  |- skos__hiddenLabel mesh__D017844 Lateral Ligaments, Ankle
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017844 2001
% 208.83/209.00  |- skos__historyNote mesh__D017844 Ligaments, Articular %28%1966-1993%29%
% 208.83/209.00  |- mesh__dateRevised mesh__D017844 2004-07-28
% 208.83/209.00  |- mesh__historyNote mesh__D017844 94   
% 208.83/209.00  |- skos__broader mesh__D017844smesh__D017885
% 208.83/209.00  |- mesh__recordMaintainer mesh__D017844 jls
% 208.83/209.00  |- skos__hiddenLabel mesh__D017844 Ligament, Ankle Lateral
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017844 2002
% 208.83/209.00  |- skos__prefLabel mesh__D017844 Lateral Ligament, Ankle
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017046 1996
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017046 1995
% 208.83/209.00  |- mesh__dateEstablished mesh__D017046 1992-01-01
% 208.83/209.00  |- mesh__recordOriginator mesh__D017046 PLS
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017046 2006
% 208.83/209.00  |- mesh__dateCreated mesh__D017046 1991-06-20
% 208.83/209.00  |- skos__scopeNote mesh__D017046
% 208.83/209.00       Reductions in all or any portion of the costs of providing goods or services. Savings may be incurred by the provider or the consumer.%A%    
% 208.83/209.00  |- mesh__recordMaintainer mesh__D017046 PLS
% 208.83/209.00  |- mesh__recordAuthorizer mesh__D017046 NLM
% 208.83/209.00  |- skos__hiddenLabel mesh__D017046 Cost Saving
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017046 2005
% 208.83/209.00  |- skos__broader mesh__D017046smesh__D003363
% 208.83/209.00  |- skos__prefLabel mesh__D017046 Cost Savings
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017046 2002
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017046 1999
% 208.83/209.00  |- skos__historyNote mesh__D017046 Cost Control %28%1979-1991%29%
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017046 2004
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017046 2001
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017046 1998
% 208.83/209.00  |- rdf__type mesh__D017046sskos__Concept
% 208.83/209.00  |- mesh__historyNote mesh__D017046 92   
% 208.83/209.00  |- skos__hiddenLabel mesh__D017046 Saving, Cost
% 208.83/209.00  |- skos__annotation mesh__D017046
% 208.83/209.00       a saving for the provider of goods or services or for the recipient or consumer%A%  
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017046 2003
% 208.83/209.00  |- mesh__publicMeSHNote mesh__D017046 92   
% 208.83/209.00  |- skos__hiddenLabel mesh__D017046 Savings, Cost
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017046 2000
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017046 1997
% 208.83/209.00  |- mesh__dateRevised mesh__D017046 1993-09-16
% 208.83/209.00  |- mesh__recordAuthorizer mesh__D003824 SJN
% 208.83/209.00  |- mesh__historyNote mesh__D003824 65   
% 208.83/209.00  |- skos__annotation mesh__D003824
% 208.83/209.00       labeling for ownership or identification = DENTURE IDENTIFICATION MARKING%A%  
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003824 2002
% 208.83/209.00  |- mesh__dateEstablished mesh__D003824 1965-01-01
% 208.83/209.00  |- skos__prefLabel mesh__D003824 Denture, Complete
% 208.83/209.00  |- skos__hiddenLabel mesh__D003824 Dentures, Complete
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003824 2005
% 208.83/209.00  |- skos__hiddenLabel mesh__D003824 Complete Denture
% 208.83/209.00  |- mesh__recordMaintainer mesh__D003824 PXP
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003824 2006
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003824 2000
% 208.83/209.00  |- mesh__dateRevised mesh__D003824 1997-06-20
% 208.83/209.00  |- mesh__dateCreated mesh__D003824 1999-01-01
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003824 2003
% 208.83/209.00  |- mesh__publicMeSHNote mesh__D003824 65   
% 208.83/209.00  |- skos__hiddenLabel mesh__D003824 Complete Dentures
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003824 2001
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003824 1998
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003824 2004
% 208.83/209.00  |- skos__broader mesh__D003824smesh__D003778
% 208.83/209.00  |- mesh__recordOriginator mesh__D003824 NLM
% 208.83/209.00  |- rdf__type mesh__D003824sskos__Concept
% 208.83/209.00  |- skos__scopeNote mesh__D003824
% 208.83/209.00       A denture replacing all natural teeth and associated structures in both the maxilla and mandible.%A%    
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003824 1999
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003026 2002
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003026 1994
% 208.83/209.00  |- rdf__type mesh__D003026sskos__Concept
% 208.83/209.00  |- mesh__historyNote mesh__D003026
% 208.83/209.00       91%28%75%29%; was see under PROTAMINES 1975-90   
% 208.83/209.00  |- mesh__onlineNote mesh__D003026 search PROTAMINES 1966-74   
% 208.83/209.00  |- mesh__recordAuthorizer mesh__D003026 PLS
% 208.83/209.00  |- mesh__publicMeSHNote mesh__D003026
% 208.83/209.00       91; was see under PROTAMINES 1975-90   
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003026 2001
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003026 2000
% 208.83/209.00  |- mesh__dateEstablished mesh__D003026 1991-01-01
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003026 2004
% 208.83/209.00  |- skos__prefLabel mesh__D003026 Clupeine
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003026 1997
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003026 2006
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003026 1999
% 208.83/209.00  |- mesh__recordOriginator mesh__D003026 NLM
% 208.83/209.00  |- mesh__dateRevised mesh__D003026 1992-05-11
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003026 2003
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003026 1993
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003026 2005
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003026 1996
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003026 1995
% 208.83/209.00  |- mesh__recordMaintainer mesh__D003026 TAP
% 208.83/209.00  |- skos__broader mesh__D003026smesh__D011479
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003026 1998
% 208.83/209.00  |- mesh__dateCreated mesh__D003026 1999-01-01
% 208.83/209.00  |- skos__broader mesh__D041943smesh__D007225
% 208.83/209.00  |- skos__historyNote mesh__D041943 Infant Nutrition %28%1968-2003%29%
% 208.83/209.00  |- skos__hiddenLabel mesh__D041943 Formulas, Infant
% 208.83/209.00  |- skos__related mesh__D041943smesh__D007225
% 208.83/209.00  |- skos__hiddenLabel mesh__D041943 Formula, Infant
% 208.83/209.00  |- skos__broader mesh__D041943smesh__D008892
% 208.83/209.00  |- mesh__historyNote mesh__D041943 2004   
% 208.83/209.00  |- skos__broader mesh__D041943smesh__D041941
% 208.83/209.00  |- skos__hiddenLabel mesh__D041943 Formula, Baby
% 208.83/209.00  |- skos__historyNote mesh__D041943 Milk %28%1969-2003%29%
% 208.83/209.00  |- skos__scopeNote mesh__D041943
% 208.83/209.00       Liquid formulations for the nutrition of INFANTS, useful for those with special needs or MILK HYPERSENSITIVITY or those whose mothers are unable to breastfeed %28%BREAST FEEDING%29%.%A%    
% 208.83/209.00  |- mesh__dateCreated mesh__D041943 2003-07-09
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D041943 2004
% 208.83/209.00  |- skos__altLabel mesh__D041943 Baby Formula
% 208.83/209.00  |- skos__annotation mesh__D041943 coordinate with major ingredient   
% 208.83/209.00  |- skos__hiddenLabel mesh__D041943 Infant Formulas
% 208.83/209.00  |- skos__hiddenLabel mesh__D041943 Baby Formulas
% 208.83/209.00  |- mesh__publicMeSHNote mesh__D041943 2004   
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D041943 2005
% 208.83/209.00  |- skos__prefLabel mesh__D041943 Infant Formula
% 208.83/209.00  |- mesh__dateEstablished mesh__D041943 2004-01-01
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D041943 2006
% 208.83/209.00  |- skos__broader mesh__D041943smesh__D005526
% 208.83/209.00  |- rdf__type mesh__D041943sskos__Concept
% 208.83/209.00  |- skos__hiddenLabel mesh__D041943 Formulas, Baby
% 208.83/209.00  |- mesh__publicMeSHNote mesh__D049128
% 208.83/209.00       2005; SPHINGOLIPID ACTIVATOR PROTEINS was indexed under GLYCOPROTEINS 1977-2004%A%  
% 208.83/209.00  |- skos__broader mesh__D049128smesh__D003067
% 208.83/209.00  |- mesh__dateEstablished mesh__D049128 2005-01-01
% 208.83/209.00  |- mesh__historyNote mesh__D049128 2005%28%1977%29%   
% 208.83/209.00  |- mesh__dateRevised mesh__D049128 2005-06-30
% 208.83/209.00  |- skos__altLabel mesh__D049128 G%28%M1%29% Activator Protein
% 208.83/209.00  |- rdf__type mesh__D049128sskos__Concept
% 208.83/209.00  |- mesh__recordAuthorizer mesh__D049128 sjn
% 208.83/209.00  |- mesh__recordOriginator mesh__D049128 jmp
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D049128 2006
% 208.83/209.00  |- skos__altLabel mesh__D049128 Ganglioside Degradation Activator Protein
% 208.83/209.00  |- skos__prefLabel mesh__D049128 Sphingolipid Activator Proteins
% 208.83/209.00  |- skos__altLabel mesh__D049128 Hexosaminidase Activating Factor
% 208.83/209.00  |- skos__scopeNote mesh__D049128
% 208.83/209.00       A family of glycoprotein cofactors that are required for the efficient catabolization of SPHINGOLIPIDS by specific acid hydrolases such as GLUCOSYLCERAMIDASE; GALACTOCEREBROSIDASE; BETA-N-ACETYLHEXOSAMINIDASE; and CEREBROSIDE-SULFATASE.%A%    
% 208.83/209.00  |- mesh__recordMaintainer mesh__D049128 SYSTEM
% 208.83/209.00  |- mesh__dateCreated mesh__D049128 2004-07-07
% 208.83/209.00  |- skos__historyNote mesh__D049128 Glycoproteins %28%1977-2004%29%
% 208.83/209.00  |- skos__altLabel mesh__D049128 GM1 Activator Protein
% 208.83/209.00  |- mesh__dateCreated mesh__D013454 1999-01-01
% 208.83/209.00  |- mesh__historyNote mesh__D013454 66   
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D013454 2003
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D013454 1994
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D013454 2001
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D013454 2006
% 208.83/209.00  |- skos__prefLabel mesh__D013454 Sulfoxides
% 208.83/209.00  |- mesh__recordMaintainer mesh__D013454 TPW
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D013454 2000
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D013454 2005
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D013454 1997
% 208.83/209.00  |- skos__scopeNote mesh__D013454
% 208.83/209.00       Organic compounds that have the general formula R-SO-R. They are obtained by oxidation of mercaptans %28%analogous to the ketones%29%. %28%From Hackh%27%s Chemical Dictionary, 4th ed%29%%A%    
% 208.83/209.00  |- mesh__recordAuthorizer mesh__D013454 PLS
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D013454 1996
% 208.83/209.00  |- mesh__dateEstablished mesh__D013454 1966-01-01
% 208.83/209.00  |- skos__broader mesh__D013454smesh__D013457
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D013454 2002
% 208.83/209.00  |- mesh__publicMeSHNote mesh__D013454 66   
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D013454 1999
% 208.83/209.00  |- mesh__dateRevised mesh__D013454 1993-06-04
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D013454 2004
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D013454 1995
% 208.83/209.00  |- mesh__recordOriginator mesh__D013454 NLM
% 208.83/209.00  |- rdf__type mesh__D013454sskos__Concept
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D013454 1998
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D007417 2006
% 208.83/209.00  |- skos__scopeNote mesh__D007417
% 208.83/209.00       Discrete abnormal tissue masses that protrude into the lumen of the INTESTINE. A polyp is attached to the intestinal wall either by a stalk, pedunculus, or by a broad base.%A%    
% 208.83/209.00  |- skos__annotation mesh__D007417 INTESTINAL POLYPOSIS is also available   
% 208.83/209.00  |- skos__hiddenLabel mesh__D007417 Polyps, Intestinal
% 208.83/209.00  |- mesh__dateEstablished mesh__D007417 1968-01-01
% 208.83/209.00  |- mesh__dateCreated mesh__D007417 1977-12-06
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D007417 2004
% 208.83/209.00  |- mesh__dateRevised mesh__D007417 2003-07-09
% 208.83/209.00  |- mesh__historyNote mesh__D007417 68   
% 208.83/209.00  |- mesh__recordAuthorizer mesh__D007417 sjn
% 208.83/209.00  |- rdf__type mesh__D007417sskos__Concept
% 208.83/209.00  |- skos__historyNote mesh__D007417 Polyps %28%1966-1967%29%
% 208.83/209.00  |- skos__hiddenLabel mesh__D007417 Intestinal Polyp
% 208.83/209.00  |- skos__prefLabel mesh__D007417 Intestinal Polyps
% 208.83/209.00  |- skos__historyNote mesh__D007417 Intestinal Diseases %28%1966-1967%29%
% 208.83/209.00  |- mesh__recordMaintainer mesh__D007417 lkt
% 208.83/209.00  |- mesh__publicMeSHNote mesh__D007417 68   
% 208.83/209.00  |- mesh__recordOriginator mesh__D007417 SMH
% 208.83/209.00  |- skos__broader mesh__D007417smesh__D011127
% 208.83/209.00  |- skos__hiddenLabel mesh__D007417 Polyp, Intestinal
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D007417 2005
% 208.83/209.00  |- skos__altLabel mesh__D051573 Pim-1 Kinase
% 208.83/209.00  |- skos__altLabel mesh__D051573 Proto-Oncogene Protein c-pim-1
% 208.83/209.00  |- mesh__recordOriginator mesh__D051573 DRC
% 208.83/209.00  |- mesh__historyNote mesh__D051573 2006%28%1988%29%   
% 208.83/209.00  |- skos__altLabel mesh__D051573 pim-1 Proto-Oncogene Protein
% 208.83/209.00  |- mesh__publicMeSHNote mesh__D051573
% 208.83/209.00       2006; PROTO-ONCOGENE PROTEIN C-PIM-1 was indexed under PROTO-ONCOGENE PROTEINS 1988-2005, %26% under PROTEIN-SERINE-THREONINE KINASES 1989-2005, %26% under PROTEIN-TYROSINE KINASE 1988%A%  
% 208.83/209.00  |- skos__hiddenLabel mesh__D051573 c pim 1 Protein
% 208.83/209.00  |- skos__hiddenLabel mesh__D051573 pim-1, Proto-Oncogene Protein
% 208.83/209.00  |- skos__altLabel mesh__D051573 Proto-Oncogene Protein pim-1
% 208.83/209.00  |- skos__hiddenLabel mesh__D051573 c-pim-1, Proto-Oncogene Protein
% 208.83/209.00  |- skos__broader mesh__D051573smesh__D011518
% 208.83/209.00  |- mesh__dateCreated mesh__D051573 2005-06-30
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D051573 2006
% 208.83/209.00  |- skos__hiddenLabel mesh__D051573 Kinase, Pim-1
% 208.83/209.00  |- skos__hiddenLabel mesh__D051573 c-pim-1, Proto-Oncogene Proteins
% 208.83/209.00  |- skos__hiddenLabel mesh__D051573 Proto Oncogene Protein pim 1
% 208.83/209.00  |- skos__hiddenLabel mesh__D051573 Pim 1 Kinase
% 208.83/209.00  |- mesh__recordMaintainer mesh__D051573 DRC
% 208.83/209.00  |- skos__altLabel mesh__D051573 c-pim-1 Protein
% 208.83/209.00  |- mesh__recordAuthorizer mesh__D051573 sjn
% 208.83/209.00  |- mesh__dateEstablished mesh__D051573 2006-01-01
% 208.83/209.00  |- skos__prefLabel mesh__D051573 Proto-Oncogene Proteins c-pim-1
% 208.83/209.00  |- skos__broader mesh__D051573smesh__D017346
% 208.83/209.00  |- skos__hiddenLabel mesh__D051573 pim 1 Proto Oncogene Protein
% 208.83/209.00  |- rdf__type mesh__D051573sskos__Concept
% 208.83/209.00  |- skos__hiddenLabel mesh__D051573 Proto Oncogene Protein c pim 1
% 208.83/209.00  |- skos__scopeNote mesh__D051573
% 208.83/209.00       Serine-threonine protein kinases that relay signals from CYTOKINE RECEPTORS and are involved in control of CELL GROWTH PROCESSES; CELL DIFFERENTIATION; and APOPTOSIS.%A%    
% 208.83/209.00  |- skos__hiddenLabel mesh__D051573 Proto Oncogene Proteins c pim 1
% 208.83/209.00  |- mesh__historyNote mesh__D023882 2002   
% 208.83/209.00  |- skos__altLabel mesh__D023882 Eye Dominance
% 208.83/209.00  |- mesh__dateRevised mesh__D023882 2003-07-09
% 208.83/209.00  |- skos__broader mesh__D023882smesh__D043722
% 208.83/209.00  |- mesh__publicMeSHNote mesh__D023882 2002   
% 208.83/209.00  |- skos__scopeNote mesh__D023882
% 208.83/209.00       The functional superiority and preferential use of one eye over the other. The term is usually applied to superiority in sighting %28%VISUAL PERCEPTION%29% or motor task but not difference in VISUAL ACUITY or dysfunction of one of the eyes. Ocular dominance can be modified by visual input and neurotrophic factors.%A%    
% 208.83/209.00  |- skos__historyNote mesh__D023882 Dominance, Cerebral %28%1967-2001%29%
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D023882 2006
% 208.83/209.00  |- skos__hiddenLabel mesh__D023882 Ocular Dominance
% 208.83/209.00  |- skos__broader mesh__D023882smesh__D009424
% 208.83/209.00  |- skos__hiddenLabel mesh__D023882 Dominance, Eye
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D023882 2005
% 208.83/209.00  |- mesh__dateCreated mesh__D023882 2001-07-25
% 208.83/209.00  |- rdf__type mesh__D023882sskos__Concept
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D023882 2004
% 208.83/209.00  |- mesh__dateEstablished mesh__D023882 2002-01-01
% 208.83/209.00  |- skos__prefLabel mesh__D023882 Dominance, Ocular
% 208.83/209.00  |- mesh__recordOriginator mesh__D023084 ags
% 208.83/209.00  |- mesh__recordMaintainer mesh__D023084 ssb
% 208.83/209.00  |- mesh__dateCreated mesh__D023084 2000-06-21
% 208.83/209.00  |- mesh__dateRevised mesh__D023084 2005-06-30
% 208.83/209.00  |- mesh__recordAuthorizer mesh__D023084 sjn
% 208.83/209.00  |- skos__hiddenLabel mesh__D023084 Peptides, Neutrophil Antimicrobial
% 208.83/209.00  |- skos__historyNote mesh__D023084 Anti-Infective Agents %28%1997-2000%29%
% 208.83/209.00  |- skos__hiddenLabel mesh__D023084 alpha Defensins
% 208.83/209.00  |- mesh__publicMeSHNote mesh__D023084 2001   
% 208.83/209.00  |- mesh__historyNote mesh__D023084 2001   
% 208.83/209.00  |- skos__broader mesh__D023084smesh__D023082
% 208.83/209.00  |- skos__hiddenLabel mesh__D023084 Neutrophil Antimicrobial Peptides
% 208.83/209.00  |- rdf__type mesh__D023084sskos__Concept
% 208.83/209.00  |- skos__scopeNote mesh__D023084
% 208.83/209.00       DEFENSINS found in azurophilic granules of neutrophils and in the secretory granules of  intestinal PANETH CELLS.%A%    
% 208.83/209.00  |- mesh__dateEstablished mesh__D023084 2001-01-01
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D023084 2006
% 208.83/209.00  |- skos__prefLabel mesh__D023084 alpha-Defensins
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017047 2001
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017047 1999
% 208.83/209.00  |- skos__hiddenLabel mesh__D017047 Insurance, Cost-Sharing
% 208.83/209.00  |- skos__annotation mesh__D017047
% 208.83/209.00       restrict to insurance: sharing of costs by both insured %26% insurer%A%  
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017047 2004
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017047 1998
% 208.83/209.00  |- rdf__type mesh__D017047sskos__Concept
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017047 2000
% 208.83/209.00  |- mesh__dateRevised mesh__D017047 1993-09-16
% 208.83/209.00  |- mesh__dateEstablished mesh__D017047 1992-01-01
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017047 2003
% 208.83/209.00  |- skos__prefLabel mesh__D017047 Cost Sharing
% 208.83/209.00  |- mesh__recordMaintainer mesh__D017047 PLS
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017047 1997
% 208.83/209.00  |- mesh__publicMeSHNote mesh__D017047
% 208.83/209.00       92; COST SHARING INSURANCE was see DEDUCTIBLES AND COINSURANCE 1978-91%A%  
% 208.83/209.00  |- skos__related mesh__D017047smesh__D006264
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017047 1996
% 208.83/209.00  |- skos__broader mesh__D017047smesh__D003365
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017047 1995
% 208.83/209.00  |- mesh__recordOriginator mesh__D017047 PLS
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017047 2006
% 208.83/209.00  |- mesh__onlineNote mesh__D017047
% 208.83/209.00       use DEDUCTIBLES AND COINSURANCE to search COST SHARING INSURANCE 1978-91%A%  
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017047 2002
% 208.83/209.00  |- mesh__recordAuthorizer mesh__D017047 NLM
% 208.83/209.00  |- skos__hiddenLabel mesh__D017047 Sharing, Cost
% 208.83/209.00  |- skos__broader mesh__D017047smesh__D007341
% 208.83/209.00  |- skos__scopeNote mesh__D017047
% 208.83/209.00       Provisions of an insurance policy that require the insured to pay some portion of covered expenses. Several forms of sharing are in use, e.g., deductibles, coinsurance, and copayments. Cost sharing does not refer to or include amounts paid in premiums for the coverage. %28%From Dictionary of Health Services Management, 2d ed%29%%A%    
% 208.83/209.00  |- mesh__historyNote mesh__D017047
% 208.83/209.00       92; COST SHARING INSURANCE was see DEDUCTIBLES AND COINSURANCE 1978-91%A%  
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D017047 2005
% 208.83/209.00  |- skos__related mesh__D017047smesh__D008329
% 208.83/209.00  |- mesh__dateCreated mesh__D017047 1991-06-20
% 208.83/209.00  |- skos__hiddenLabel mesh__D017047 Cost Sharing Insurance
% 208.83/209.00  |- skos__historyNote mesh__D017047
% 208.83/209.00       Deductibles and Coinsurance %28%1968-1991%29%
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003825 2006
% 208.83/209.00  |- mesh__publicMeSHNote mesh__D003825 65   
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003825 2001
% 208.83/209.00  |- mesh__dateCreated mesh__D003825 1999-01-01
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003825 2003
% 208.83/209.00  |- mesh__recordOriginator mesh__D003825 NLM
% 208.83/209.00  |- skos__prefLabel mesh__D003825 Denture, Complete, Immediate
% 208.83/209.00  |- skos__broader mesh__D003825smesh__D003824
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003825 2004
% 208.83/209.00  |- mesh__dateEstablished mesh__D003825 1965-01-01
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003825 1998
% 208.83/209.00  |- rdf__type mesh__D003825sskos__Concept
% 208.83/209.00  |- mesh__recordAuthorizer mesh__D003825 SJN
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003825 2002
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003825 1999
% 208.83/209.00  |- mesh__historyNote mesh__D003825 65   
% 208.83/209.00  |- mesh__recordMaintainer mesh__D003825 PXP
% 208.83/209.00  |- skos__scopeNote mesh__D003825
% 208.83/209.00       A complete denture constructed for replacement of natural teeth immediately after their removal. It does not fit the mouth perfectly and is intended only for functional and cosmetic purposes during the healing process after total extraction. It is to be replaced by the fitted permanent denture.%A%    
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003825 2000
% 208.83/209.00  |- mesh__activeMeSHYear mesh__D003825 2005
% 208.83/209.00  |- mesh__dateRevised mesh__D003825 1997-06-20
% 208.83/209.00  |- skos__prefLabel mesh__D036201 Receptor, EphB5
% 208.83/209.00  |- skos__altLabel mesh__D036201 Receptor Tyrosine Kinase Cek9
% 208.83/209.00  |- mesh__recordMaintainer mesh__D036201 jmp
% 208.83/209.00  |- skos__altLabel mesh__D036201 Cek9 Kinase
% 208.83/209.01  |- mesh__activeMeSHYear mesh__D036201 2006
% 208.83/209.01  |- skos__historyNote mesh__D036201
% 208.83/209.01       Receptor Protein-Tyrosine Kinases %28%1993-2002%29%
% 208.83/209.01  |- mesh__dateRevised mesh__D036201 2005-06-30
% 208.83/209.01  |- mesh__publicMeSHNote mesh__D036201
% 208.83/209.01       2003; RECEPTOR TYROSINE KINASE CEK9 %28%now RECEPTOR, EPHB5 %29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1996-2002%A%  
% 208.83/209.01  |- skos__altLabel mesh__D036201 EphB5 Receptor
% 208.83/209.01  |- skos__broader mesh__D036201smesh__D036081
% 208.83/209.01  |- skos__scopeNote mesh__D036201
% 208.83/209.01       An eph family receptor found at high levels in adult THYMUS and RETINA. In embryonic tissues it is found in many developing organs.%A%    
% 208.83/209.01  |- mesh__recordAuthorizer mesh__D036201 sjn
% 208.83/209.01  |- mesh__dateEstablished mesh__D036201 2003-01-01
% 208.83/209.01  |- mesh__historyNote mesh__D036201
% 208.83/209.01       2003; use RECEPTOR, EPHB5 %28%NM%29% 1996-2002, for EPHB5 RECEPTOR use EPHB2 RECEPTOR %28%NM%29% 1999-2002%A%  
% 208.86/209.01  |- mesh__dateCreated mesh__D036201 2002-07-03
% 208.86/209.01  |- rdf__type mesh__D036201sskos__Concept
% 208.86/209.01  |- mesh__recordOriginator mesh__D036201 jmp
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Cephalgia, Histamine
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Syndrome, Horton%27%s
% 208.86/209.01  |- skos__altLabel mesh__D003027 Neuralgic Migraine
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Headache, Chronic Cluster
% 208.86/209.01  |- mesh__dateEstablished mesh__D003027 1991-01-01
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Neuralgic Migraines
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Cluster Headache Syndromes
% 208.86/209.01  |- skos__altLabel mesh__D003027 Ciliary Neuralgia
% 208.86/209.01  |- skos__altLabel mesh__D003027 Histamine Cephalgia
% 208.86/209.01  |- rdf__type mesh__D003027sskos__Concept
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Syndrome, Horton
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Hortons Syndrome
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Headache Syndrome, Cluster
% 208.86/209.01  |- skos__scopeNote mesh__D003027
% 208.86/209.01       A primary headache disorder that is characterized by severe, strictly unilateral PAIN which is orbital, supraorbital, temporal or in any combination of these sites, lasting 15-180 min. occurring 1 to 8 times a day. The attacks are associated with one or more of the following, all of which are ipsilateral: conjunctival injection, lacrimation, nasal congestion, rhinorrhea, facial SWEATING, eyelid EDEMA, and miosis. %28%International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1%29%%A%    
% 208.86/209.01  |- mesh__historyNote mesh__D003027 1991%28%1978%29%   
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Headache, Episodic Cluster
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Cluster Headaches, Episodic
% 208.86/209.01  |- skos__altLabel mesh__D003027 Chronic Cluster Headache
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Headache Syndromes, Cluster
% 208.86/209.01  |- skos__broader mesh__D003027smesh__D051303
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Cluster Headaches, Atypical
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Syndromes, Cluster Headache
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Neuralgias, Ciliary
% 208.86/209.01  |- skos__historyNote mesh__D003027 Headache %28%1966-1977%29%
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Atypical Cluster Headaches
% 208.86/209.01  |- mesh__publicMeSHNote mesh__D003027
% 208.86/209.01       1991; see VASCULAR HEADACHE 1978-1990   
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Headaches, Atypical Cluster
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Migraine, Neuralgic
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Ciliary Neuralgias
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Headaches, Chronic Cluster
% 208.86/209.01  |- mesh__dateCreated mesh__D003027 1977-05-13
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Episodic Cluster Headaches
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Headaches, Cluster
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Cephalgias, Histamine
% 208.86/209.01  |- skos__altLabel mesh__D003027 Headache, Cluster
% 208.86/209.01  |- mesh__recordOriginator mesh__D003027 AEP
% 208.86/209.01  |- skos__altLabel mesh__D003027 Horton Syndrome
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Headache, Atypical Cluster
% 208.86/209.01  |- mesh__dateRevised mesh__D003027 2005-06-30
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Neuralgia, Ciliary
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D003027 2006
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Cluster Headache, Episodic
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Syndrome, Cluster Headache
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Headaches, Episodic Cluster
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Cluster Headache, Chronic
% 208.86/209.01  |- skos__historyNote mesh__D003027 Vascular Headache %28%1966-1977%29%
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Histamine Cephalgias
% 208.86/209.01  |- skos__altLabel mesh__D003027 Cluster Headache Syndrome
% 208.86/209.01  |- mesh__recordMaintainer mesh__D003027 lkt
% 208.86/209.01  |- skos__prefLabel mesh__D003027 Cluster Headache
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Cluster Headaches
% 208.86/209.01  |- mesh__recordAuthorizer mesh__D003027 sjn
% 208.86/209.01  |- skos__altLabel mesh__D003027 Horton%27%s Syndrome
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Chronic Cluster Headaches
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Migraines, Neuralgic
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Cluster Headache, Atypical
% 208.86/209.01  |- skos__hiddenLabel mesh__D003027 Cluster Headaches, Chronic
% 208.86/209.01  |- skos__related mesh__D008510smesh__D016303
% 208.86/209.01  |- skos__historyNote mesh__D008510
% 208.86/209.01       Pharmacy Service, Hospital %28%1966-1967%29%
% 208.86/209.01  |- skos__prefLabel mesh__D008510 Medication Systems, Hospital
% 208.86/209.01  |- skos__related mesh__D008510smesh__D050316
% 208.86/209.01  |- skos__altLabel mesh__D008510 Hospital Unit Dose Drug Distribution System
% 208.86/209.01  |- skos__scopeNote mesh__D008510
% 208.86/209.01       Overall systems, traditional or automated, to provide medication to patients in hospitals. Elements of the system are: handling the physician%27%s order, transcription of the order by nurse and/or pharmacist, filling the medication order, transfer to the nursing unit, and administration to the patient.%A%    
% 208.86/209.01  |- skos__altLabel mesh__D008510 Medication System, Hospital
% 208.86/209.01  |- skos__hiddenLabel mesh__D008510 System, Medication Hospital
% 208.86/209.01  |- skos__altLabel mesh__D008510 Hospital Drug Distribution Systems
% 208.86/209.01  |- mesh__dateCreated mesh__D008510 1999-01-01
% 208.86/209.01  |- skos__altLabel mesh__D008510 System Hospital Medication
% 208.86/209.01  |- skos__annotation mesh__D008510
% 208.86/209.01       an organizational concept in hospital patient care for providing medication; do not confuse with DRUG DELIVERY SYSTEMS; DF: MEDICATION SYSTEMS HOSP%A%  
% 208.86/209.01  |- skos__broader mesh__D008510smesh__D008509
% 208.86/209.01  |- skos__altLabel mesh__D008510
% 208.86/209.01       Hospital Unit Dose Drug Distribution Systems
% 208.86/209.01  |- skos__altLabel mesh__D008510 Drug Distribution Systems, Hospital
% 208.86/209.01  |- skos__altLabel mesh__D008510 Systems, Medication Hospital
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D008510 2006
% 208.86/209.01  |- skos__hiddenLabel mesh__D008510 Systems, Hospital Medication
% 208.86/209.01  |- skos__altLabel mesh__D008510 Hospital Medication Systems
% 208.86/209.01  |- skos__hiddenLabel mesh__D008510 Medication Hospital System
% 208.86/209.01  |- skos__altLabel mesh__D008510 Drug Distribution System, Hospital
% 208.86/209.01  |- skos__hiddenLabel mesh__D008510 Hospital System, Medication
% 208.86/209.01  |- skos__hiddenLabel mesh__D008510 Hospital Medications, System
% 208.86/209.01  |- skos__hiddenLabel mesh__D008510 Hospital Medication, System
% 208.86/209.01  |- mesh__dateRevised mesh__D008510 2005-06-30
% 208.86/209.01  |- mesh__recordMaintainer mesh__D008510 ags
% 208.86/209.01  |- skos__broader mesh__D008510smesh__D006739
% 208.86/209.01  |- mesh__onlineNote mesh__D008510
% 208.86/209.01       use MEDICATION SYSTEMS, HOSPITAL to search HOSPITAL MEDICATION SYSTEMS 1968-77%A%  
% 208.86/209.01  |- skos__hiddenLabel mesh__D008510 Hospital Systems, Medication
% 208.86/209.01  |- mesh__recordOriginator mesh__D008510 NLM
% 208.86/209.01  |- skos__hiddenLabel mesh__D008510 System Hospital Medications
% 208.86/209.01  |- skos__hiddenLabel mesh__D008510 System, Hospital Medication
% 208.86/209.01  |- rdf__type mesh__D008510sskos__Concept
% 208.86/209.01  |- skos__altLabel mesh__D008510 Hospital Medication System
% 208.86/209.01  |- mesh__recordAuthorizer mesh__D008510 sjn
% 208.86/209.01  |- skos__hiddenLabel mesh__D008510 Medication, System Hospital
% 208.86/209.01  |- mesh__historyNote mesh__D008510
% 208.86/209.01       78; was HOSPITAL MEDICATION SYSTEMS 1968-77   
% 208.86/209.01  |- mesh__publicMeSHNote mesh__D008510
% 208.86/209.01       78; was HOSPITAL MEDICATION SYSTEMS 1968-77   
% 208.86/209.01  |- skos__hiddenLabel mesh__D008510 Medications, System Hospital
% 208.86/209.01  |- skos__hiddenLabel mesh__D008510 Medication Hospital Systems
% 208.86/209.01  |- mesh__dateEstablished mesh__D008510 1968-01-01
% 208.86/209.01  |- skos__annotation mesh__D013455 S-32   
% 208.86/209.01  |- mesh__recordAuthorizer mesh__D013455 SJN
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D013455 2005
% 208.86/209.01  |- skos__related mesh__D013455smesh__D013462
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D013455 2002
% 208.86/209.01  |- mesh__recordOriginator mesh__D013455 NLM
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D013455 1999
% 208.86/209.01  |- skos__scopeNote mesh__D013455
% 208.86/209.01       An element that is a member of the chalcogen family. It has an atomic symbol S, atomic number 16, and atomic weight 32.066. It is found in the amino acids cysteine and methionine.%A%    
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D013455 2004
% 208.86/209.01  |- rdf__type mesh__D013455sskos__Concept
% 208.86/209.01  |- skos__related mesh__D013455smesh__D013460
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D013455 2001
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D013455 1998
% 208.86/209.01  |- mesh__dateRevised mesh__D013455 1997-06-20
% 208.86/209.01  |- skos__prefLabel mesh__D013455 Sulfur
% 208.86/209.01  |- mesh__dateCreated mesh__D013455 1999-01-01
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D013455 2003
% 208.86/209.01  |- mesh__recordMaintainer mesh__D013455 ADP
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D013455 2000
% 208.86/209.01  |- skos__broader mesh__D013455smesh__D018011
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D013455 2006
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D007418 2005
% 208.86/209.01  |- skos__hiddenLabel mesh__D007418 Pseudo-Obstructions, Intestinal
% 208.86/209.01  |- skos__prefLabel mesh__D007418 Intestinal Pseudo-Obstruction
% 208.86/209.01  |- skos__hiddenLabel mesh__D007418 Intestinal Pseudoobstructions
% 208.86/209.01  |- skos__hiddenLabel mesh__D007418 Ileus, Paralytic
% 208.86/209.01  |- skos__hiddenLabel mesh__D007418 Myopathy, Visceral
% 208.86/209.01  |- skos__altLabel mesh__D007418 Intestinal Pseudoobstruction
% 208.86/209.01  |- skos__hiddenLabel mesh__D007418
% 208.86/209.01       Pseudo-Obstruction, Idiopathic Intestinal
% 208.86/209.01  |- skos__hiddenLabel mesh__D007418 Visceral Myopathies
% 208.86/209.01  |- skos__hiddenLabel mesh__D007418
% 208.86/209.01       Intestinal Pseudo-Obstructions, Idiopathic
% 208.86/209.01  |- mesh__publicMeSHNote mesh__D007418
% 208.86/209.01       87; was INTESTINAL PSEUDO-OBSTRUCTION, IDIOPATHIC see under INTESTINAL OBSTRUCTION 1981-86; PARALYTIC ILEUS was see under INTESTINAL OBSTRUCTION 1975-86%A%  
% 208.86/209.01  |- skos__hiddenLabel mesh__D007418 Intestinal Pseudo-Obstructions
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D007418 2006
% 208.86/209.01  |- skos__hiddenLabel mesh__D007418 Pseudoobstruction, Intestinal
% 208.86/209.01  |- skos__hiddenLabel mesh__D007418 Myopathies, Visceral
% 208.86/209.01  |- skos__hiddenLabel mesh__D007418
% 208.86/209.01       Intestinal Pseudo Obstruction, Idiopathic
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D007418 2004
% 208.86/209.01  |- skos__altLabel mesh__D007418 Intestinal Pseudo-Obstruction, Idiopathic
% 208.86/209.01  |- mesh__dateEstablished mesh__D007418 1987-01-01
% 208.86/209.01  |- mesh__recordAuthorizer mesh__D007418 sjn
% 208.86/209.01  |- mesh__dateRevised mesh__D007418 2003-07-09
% 208.86/209.01  |- rdf__type mesh__D007418sskos__Concept
% 208.86/209.01  |- mesh__historyNote mesh__D007418
% 208.86/209.01       87; was INTESTINAL PSEUDO-OBSTRUCTION, IDIOPATHIC see under INTESTINAL OBSTRUCTION 1981-86; PARALYTIC ILEUS was see under INTESTINAL OBSTRUCTION 1975-86, was Prov 1971-74%A%  
% 208.86/209.01  |- skos__hiddenLabel mesh__D007418 Pseudoobstructions, Intestinal
% 208.86/209.01  |- skos__hiddenLabel mesh__D007418
% 208.86/209.01       Idiopathic Intestinal Pseudo-Obstructions
% 208.86/209.01  |- skos__hiddenLabel mesh__D007418 Idiopathic Intestinal Pseudo-Obstruction
% 208.86/209.01  |- skos__scopeNote mesh__D007418
% 208.86/209.01       A type of ILEUS, a functional not mechanical obstruction of the INTESTINES. This syndrome is caused by a large number of disorders involving the smooth muscles %28%MUSCLE, SMOOTH%29% or the NERVOUS SYSTEM.%A%    
% 208.86/209.01  |- skos__annotation mesh__D007418
% 208.86/209.01       coord IM with specific precoord intestinal dis %28%IM%29%; INTESTINAL OBSTRUCTION and ILEUS are also available%A%  
% 208.86/209.01  |- skos__altLabel mesh__D007418 Pseudo-Obstruction, Intestinal
% 208.86/209.01  |- skos__hiddenLabel mesh__D007418 Intestinal Pseudo Obstruction
% 208.86/209.01  |- skos__historyNote mesh__D007418 Intestinal Obstruction %28%1966-1980%29%
% 208.86/209.01  |- skos__hiddenLabel mesh__D007418 Pseudo Obstruction, Intestinal
% 208.86/209.01  |- mesh__dateCreated mesh__D007418 1980-04-07
% 208.86/209.01  |- mesh__recordMaintainer mesh__D007418 lkt
% 208.86/209.01  |- mesh__onlineNote mesh__D007418
% 208.86/209.01       use INTESTINAL PSEUDO-OBSTRUCTION to search INTESTINAL PSEUDO-OBSTRUCTION, IDIOPATHIC 1981-86 %26% PARALYTIC ILEUS 1971-86 %28%as Prov 1971-74%29%%A%  
% 208.86/209.01  |- skos__hiddenLabel mesh__D007418
% 208.86/209.01       Pseudo-Obstructions, Idiopathic Intestinal
% 208.86/209.01  |- skos__broader mesh__D007418smesh__D045823
% 208.86/209.01  |- mesh__recordOriginator mesh__D007418 RC
% 208.86/209.01  |- skos__broader mesh__D018140smesh__D018138
% 208.86/209.01  |- mesh__publicMeSHNote mesh__D018140 1994   
% 208.86/209.01  |- skos__altLabel mesh__D018140 Goat herpesvirus
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D018140 2003
% 208.86/209.01  |- skos__altLabel mesh__D018140 Caprine herpesvirus 1
% 208.86/209.01  |- skos__hiddenLabel mesh__D018140 herpesviruses, Goat
% 208.86/209.01  |- skos__hiddenLabel mesh__D018140 Varicelloviruses
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D018140 2006
% 208.86/209.01  |- skos__scopeNote mesh__D018140
% 208.86/209.01       A genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE. Its species include those causing CHICKENPOX and HERPES ZOSTER in humans %28%HERPESVIRUS 3, HUMAN%29%, as well as several animal viruses.%A%    
% 208.86/209.01  |- mesh__dateRevised mesh__D018140 2001-07-25
% 208.86/209.01  |- rdf__type mesh__D018140sskos__Concept
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D018140 2005
% 208.86/209.01  |- mesh__recordAuthorizer mesh__D018140 sjn
% 208.86/209.01  |- skos__hiddenLabel mesh__D018140 herpesvirus, Goat
% 208.86/209.01  |- skos__annotation mesh__D018140
% 208.86/209.01       infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29%   
% 208.86/209.01  |- mesh__recordOriginator mesh__D018140 AGS
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D018140 2002
% 208.86/209.01  |- mesh__dateCreated mesh__D018140 1993-06-04
% 208.86/209.01  |- mesh__dateEstablished mesh__D018140 1994-01-01
% 208.86/209.01  |- skos__hiddenLabel mesh__D018140 Goat herpesviruses
% 208.86/209.01  |- mesh__recordMaintainer mesh__D018140 ags
% 208.86/209.01  |- skos__prefLabel mesh__D018140 Varicellovirus
% 208.86/209.01  |- mesh__historyNote mesh__D018140 1994   
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D018140 2004
% 208.86/209.01  |- skos__broader mesh__D051574smesh__D050579
% 208.86/209.01  |- skos__altLabel mesh__D051574 Classical Pathway C3 Convertase
% 208.86/209.01  |- mesh__recordMaintainer mesh__D051574 lkt
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D051574 2006
% 208.86/209.01  |- skos__historyNote mesh__D051574
% 208.86/209.01       Complement C3-C5 Convertases %28%1979-2005%29%
% 208.86/209.01  |- skos__scopeNote mesh__D051574
% 208.86/209.01       A serine protease that cleaves multiple COMPLEMENT 3 into COMPLEMENT 3A %28%anaphylatoxin%29% and COMPLEMENT 3B in the CLASSICAL COMPLEMENT ACTIVATION PATHWAY. It is a complex of COMPLEMENT 4B and COMPLEMENT 2A %28%C4b2a%29%.%A%    
% 208.86/209.01  |- mesh__historyNote mesh__D051574 2006   
% 208.86/209.01  |- skos__historyNote mesh__D051574
% 208.86/209.01       Complement Pathway, Classical %28%1980-2005%29%
% 208.86/209.01  |- mesh__recordOriginator mesh__D051574 lkt
% 208.86/209.01  |- mesh__publicMeSHNote mesh__D051574 2006   
% 208.86/209.01  |- rdf__type mesh__D051574sskos__Concept
% 208.86/209.01  |- mesh__dateCreated mesh__D051574 2005-06-30
% 208.86/209.01  |- skos__altLabel mesh__D051574 Classical C3 Convertase
% 208.86/209.01  |- skos__altLabel mesh__D051574 C3 Convertase %28%C4b2a%29%
% 208.86/209.01  |- mesh__recordAuthorizer mesh__D051574 sjn
% 208.86/209.01  |- skos__prefLabel mesh__D051574
% 208.86/209.01       Complement C3 Convertase, Classical Pathway
% 208.86/209.01  |- mesh__dateEstablished mesh__D051574 2006-01-01
% 208.86/209.01  |- skos__hiddenLabel mesh__D051574 C3 Convertase, Classical
% 208.86/209.01  |- skos__broader mesh__D004120smesh__D007096
% 208.86/209.01  |- skos__scopeNote mesh__D004120
% 208.86/209.01       The methyl imidoester of suberic acid used to produce cross links in proteins. Each end of the imidoester will react with an amino group in the protein molecule to form an amidine.%A%    
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D004120 2001
% 208.86/209.01  |- skos__historyNote mesh__D004120 Imides %28%1973-1974%29%
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D004120 2000
% 208.86/209.01  |- mesh__dateRevised mesh__D004120 1998-06-10
% 208.86/209.01  |- rdf__type mesh__D004120sskos__Concept
% 208.86/209.01  |- mesh__historyNote mesh__D004120
% 208.86/209.01       91%28%75%29%; was see under IMIDOESTERS 1980-90; was see under IMIDES 1975-79%A%  
% 208.86/209.01  |- skos__historyNote mesh__D004120 Dicarboxylic Acids %28%1974%29%
% 208.86/209.01  |- mesh__dateCreated mesh__D004120 1974-11-19
% 208.86/209.01  |- skos__altLabel mesh__D004120 Dimethylsuberimidate
% 208.86/209.01  |- mesh__recordAuthorizer mesh__D004120 SJN
% 208.86/209.01  |- skos__altLabel mesh__D004120 Bismethyl Suberimidate
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D004120 2006
% 208.86/209.01  |- mesh__dateEstablished mesh__D004120 1991-01-01
% 208.86/209.01  |- mesh__recordOriginator mesh__D004120 NLM
% 208.86/209.01  |- skos__prefLabel mesh__D004120 Dimethyl Suberimidate
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D004120 2002
% 208.86/209.01  |- mesh__recordMaintainer mesh__D004120 JAG
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D004120 2004
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D004120 1999
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D004120 2005
% 208.86/209.01  |- mesh__publicMeSHNote mesh__D004120
% 208.86/209.01       91; was see under IMIDOESTERS 1980-90; was see under IMIDES 1975-79%A%  
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D004120 2003
% 208.86/209.01  |- skos__hiddenLabel mesh__D004120 Suberimidate, Bismethyl
% 208.86/209.01  |- skos__hiddenLabel mesh__D004120 Suberimidate, Dimethyl
% 208.86/209.01  |- skos__historyNote mesh__D017846 Ligaments, Articular %28%1968-1993%29%
% 208.86/209.01  |- skos__hiddenLabel mesh__D017846 Posterior Longitudinal Ligaments
% 208.86/209.01  |- mesh__historyNote mesh__D017846 94   
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017846 2001
% 208.86/209.01  |- skos__prefLabel mesh__D017846 Longitudinal Ligaments
% 208.86/209.01  |- skos__scopeNote mesh__D017846
% 208.86/209.01       Two extensive fibrous bands running the length of the vertebral column. The anterior longitudinal ligament %28%ligamentum longitudinale anterius; lacertus medius%29% interconnects the anterior surfaces of the vertebral bodies; the posterior longitudinal ligament %28%ligamentum longitudinale posterius%29% interconnects the posterior surfaces. The commonest clinical consideration is OSSIFICATION OF POSTERIOR LONGITUDINAL LIGAMENT. %28%From Stedman, 25th ed%29%%A%    
% 208.86/209.01  |- skos__annotation mesh__D017846
% 208.86/209.01       spinal ligaments; LIGAMENTUM FLAVUM, a vertebral ligament, is also available%A%  
% 208.86/209.01  |- skos__historyNote mesh__D017846 Ligaments %28%1967-1993%29%
% 208.86/209.01  |- skos__hiddenLabel mesh__D017846 Ligaments, Longitudinal
% 208.86/209.01  |- skos__hiddenLabel mesh__D017846 Anterior Longitudinal Ligaments
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017846 1999
% 208.86/209.01  |- skos__hiddenLabel mesh__D017846 Longitudinal Ligaments, Posterior
% 208.86/209.01  |- mesh__dateEstablished mesh__D017846 1994-01-01
% 208.86/209.01  |- skos__altLabel mesh__D017846 Ligamentum Longitudinale
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017846 2000
% 208.86/209.01  |- skos__hiddenLabel mesh__D017846 Ligament, Longitudinal
% 208.86/209.01  |- mesh__dateCreated mesh__D017846 1993-02-16
% 208.86/209.01  |- skos__hiddenLabel mesh__D017846 Ligament, Anterior Longitudinal
% 208.86/209.01  |- skos__hiddenLabel mesh__D017846 Longitudinal Ligament, Posterior
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017846 2004
% 208.86/209.01  |- skos__hiddenLabel mesh__D017846 Ligament, Posterior Longitudinal
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017846 1998
% 208.86/209.01  |- skos__hiddenLabel mesh__D017846 Longitudinal Ligament
% 208.86/209.01  |- mesh__publicMeSHNote mesh__D017846 94   
% 208.86/209.01  |- skos__broader mesh__D017846smesh__D008023
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017846 2003
% 208.86/209.01  |- rdf__type mesh__D017846sskos__Concept
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017846 1995
% 208.86/209.01  |- skos__hiddenLabel mesh__D017846 Ligaments, Anterior Longitudinal
% 208.86/209.01  |- skos__related mesh__D017846smesh__D017887
% 208.86/209.01  |- skos__hiddenLabel mesh__D017846 Longitudinal Ligament, Anterior
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017846 2002
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017846 1994
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017846 2006
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017846 1997
% 208.86/209.01  |- skos__hiddenLabel mesh__D017846 Ligaments, Posterior Longitudinal
% 208.86/209.01  |- skos__hiddenLabel mesh__D017846 Longitudinal Ligaments, Anterior
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017846 2005
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017846 1996
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017048 2004
% 208.86/209.01  |- skos__hiddenLabel mesh__D017048 Treatment Cost
% 208.86/209.01  |- mesh__recordAuthorizer mesh__D017048 SJN
% 208.86/209.01  |- skos__hiddenLabel mesh__D017048 Cost, Treatment
% 208.86/209.01  |- mesh__publicMeSHNote mesh__D017048 92   
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017048 1999
% 208.86/209.01  |- skos__hiddenLabel mesh__D017048 Costs, Healthcare
% 208.86/209.01  |- mesh__historyNote mesh__D017048 92   
% 208.86/209.01  |- skos__scopeNote mesh__D017048
% 208.86/209.01       The actual costs of providing services related to the delivery of health care, including the costs of procedures, therapies, and medications. It is differentiated from HEALTH EXPENDITURES, which refers to the amount of money paid for the services, and from fees, which refers to the amount charged, regardless of cost.%A%    
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017048 2005
% 208.86/209.01  |- mesh__recordOriginator mesh__D017048 PLS
% 208.86/209.01  |- skos__hiddenLabel mesh__D017048 Cost, Health Care
% 208.86/209.01  |- skos__broader mesh__D017048smesh__D003695
% 208.86/209.01  |- skos__hiddenLabel mesh__D017048 Cost, Healthcare
% 208.86/209.01  |- skos__hiddenLabel mesh__D017048 Costs, Health Care
% 208.86/209.01  |- skos__hiddenLabel mesh__D017048 Costs, Treatment
% 208.86/209.01  |- skos__historyNote mesh__D017048
% 208.86/209.01       Costs and Cost Analysis %28%1966-1991%29%
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017048 2000
% 208.86/209.01  |- skos__hiddenLabel mesh__D017048 Medical Care Cost
% 208.86/209.01  |- skos__historyNote mesh__D017048 Health Expenditures %28%1968-1991%29%
% 208.86/209.01  |- skos__hiddenLabel mesh__D017048 Healthcare Cost
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017048 2006
% 208.86/209.01  |- skos__hiddenLabel mesh__D017048 Costs, Health
% 208.86/209.01  |- skos__prefLabel mesh__D017048 Health Care Costs
% 208.86/209.01  |- mesh__dateRevised mesh__D017048 1997-06-20
% 208.86/209.01  |- skos__hiddenLabel mesh__D017048 Health Cost
% 208.86/209.01  |- mesh__recordMaintainer mesh__D017048 TPW
% 208.86/209.01  |- skos__altLabel mesh__D017048 Health Costs
% 208.86/209.01  |- skos__altLabel mesh__D017048 Costs, Medical Care
% 208.86/209.01  |- mesh__dateCreated mesh__D017048 1991-06-20
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017048 2001
% 208.86/209.01  |- mesh__dateEstablished mesh__D017048 1992-01-01
% 208.86/209.01  |- skos__hiddenLabel mesh__D017048 Cost, Medical Care
% 208.86/209.01  |- skos__broader mesh__D017048smesh__D003365
% 208.86/209.01  |- skos__annotation mesh__D017048
% 208.86/209.01       actual cost of providing care: do not confuse with HEALTH EXPENDITURES %28%the amount paid for the service%29% or with FEES AND CHARGES %28%the amount charged regardless of cost%29%; do not confuse with COST OF ILLNESS which is a personal cost %28%psychol, social, etc.%29% as well as a monetary cost for services%A%  
% 208.86/209.01  |- skos__altLabel mesh__D017048 Healthcare Costs
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017048 2002
% 208.86/209.01  |- rdf__type mesh__D017048sskos__Concept
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017048 2003
% 208.86/209.01  |- skos__hiddenLabel mesh__D017048 Health Care Cost
% 208.86/209.01  |- skos__related mesh__D017048smesh__D005102
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D017048 1998
% 208.86/209.01  |- skos__hiddenLabel mesh__D017048 Cost, Health
% 208.86/209.01  |- skos__prefLabel mesh__D003826 Denture, Complete, Lower
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D003826 2000
% 208.86/209.01  |- mesh__dateRevised mesh__D003826 1997-06-20
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D003826 2004
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D003826 1998
% 208.86/209.01  |- rdf__type mesh__D003826sskos__Concept
% 208.86/209.01  |- skos__scopeNote mesh__D003826
% 208.86/209.01       A complete denture replacing all the natural mandibular teeth and associated structures. It is completely supported by the oral tissue and underlying mandibular bone.%A%    
% 208.86/209.01  |- mesh__publicMeSHNote mesh__D003826 65   
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D003826 2001
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D003826 1999
% 208.86/209.01  |- mesh__recordOriginator mesh__D003826 NLM
% 208.86/209.01  |- skos__broader mesh__D003826smesh__D003824
% 208.86/209.01  |- mesh__historyNote mesh__D003826 65   
% 208.86/209.01  |- mesh__dateEstablished mesh__D003826 1965-01-01
% 208.86/209.01  |- mesh__recordAuthorizer mesh__D003826 SJN
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D003826 2005
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D003826 2002
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D003826 2006
% 208.86/209.01  |- mesh__recordMaintainer mesh__D003826 PXP
% 208.86/209.01  |- mesh__dateCreated mesh__D003826 1999-01-01
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D003826 2003
% 208.86/209.01  |- mesh__dateEstablished mesh__D003028 1991-01-01
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D003028 2006
% 208.86/209.01  |- mesh__dateRevised mesh__D003028 2000-06-22
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D003028 2003
% 208.86/209.01  |- skos__hiddenLabel mesh__D003028 Carbodiimide, CME
% 208.86/209.01  |- mesh__historyNote mesh__D003028
% 208.86/209.01       91%28%75%29%; was see under CARBODIIMIDES 1975-90   
% 208.86/209.01  |- mesh__publicMeSHNote mesh__D003028
% 208.86/209.01       91; was see under CARBODIIMIDES 1975-90   
% 208.86/209.01  |- skos__altLabel mesh__D003028 CMEC
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D003028 2005
% 208.86/209.01  |- skos__historyNote mesh__D003028 Morpholines %28%1974%29%
% 208.86/209.01  |- skos__historyNote mesh__D003028 Tosyl Compounds %28%1974%29%
% 208.86/209.01  |- rdf__type mesh__D003028sskos__Concept
% 208.86/209.01  |- mesh__recordMaintainer mesh__D003028 CCR
% 208.86/209.01  |- mesh__recordOriginator mesh__D003028 MEG
% 208.86/209.01  |- mesh__recordAuthorizer mesh__D003028 sjn
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D003028 2002
% 208.86/209.01  |- mesh__dateCreated mesh__D003028 1974-11-19
% 208.86/209.01  |- skos__prefLabel mesh__D003028 CME-Carbodiimide
% 208.86/209.01  |- skos__historyNote mesh__D003028 Carbodiimides %28%1974%29%
% 208.86/209.01  |- skos__broader mesh__D003028smesh__D002234
% 208.86/209.01  |- skos__altLabel mesh__D003028
% 208.86/209.01       4-%28%2-%28%%28%Cyclohexylimidocarbonyl%29%amino%29%ethyl%29%-4-methylmorpholinium
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D003028 2001
% 208.86/209.01  |- skos__altLabel mesh__D003028 CME Carbodiimide
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D003028 2004
% 208.86/209.01  |- skos__related mesh__D008511smesh__D004501
% 208.86/209.01  |- mesh__recordMaintainer mesh__D008511 sjn
% 208.86/209.01  |- skos__broader mesh__D008511smesh__D006281
% 208.86/209.01  |- skos__scopeNote mesh__D008511
% 208.86/209.01       The art and science of preventing, diagnosing, and treating disease, as well as the maintenance of health.%A%    
% 208.86/209.01  |- skos__related mesh__D008511smesh__D006666
% 208.86/209.01  |- mesh__recordAuthorizer mesh__D008511 sjn
% 208.86/209.01  |- skos__prefLabel mesh__D008511 Medicine
% 208.86/209.01  |- mesh__recordOriginator mesh__D008511 NLM
% 208.86/209.01  |- mesh__dateRevised mesh__D008511 2004-07-13
% 208.86/209.01  |- skos__annotation mesh__D008511
% 208.86/209.01       medicine only as a field, profession or discipline: differentiate from DELIVERY OF HEALTH CARE where the patient is emphasized %28%see MeSH definition there%29%; very general; avoid; it is divided broadly into experimental medicine %28% = BIOMEDICAL RESEARCH%29% %26% CLINICAL MEDICINE, a specialty devoted to the diag %26% management of human patients; /legislation %26% jurisprudence = LEGISLATION, MEDICAL or JURISPRUDENCE or FORENSIC MEDICINE; legal med = FORENSIC MEDICINE or JURISPRUDENCE%A%  
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D008511 2006
% 208.86/209.01  |- mesh__activeMeSHYear mesh__D008511 2005
% 208.86/209.01  |- mesh__dateCreated mesh__D008511 1999-01-01
% 208.86/209.01  |- skos__related mesh__D008511smesh__D004470
% 208.86/209.02  |- skos__related mesh__D008511smesh__D007883
% 208.86/209.02  |- rdf__type mesh__D008511sskos__Concept
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D013456 2000
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D013456 1996
% 208.86/209.02  |- mesh__recordMaintainer mesh__D013456 PLS
% 208.86/209.02  |- skos__prefLabel mesh__D013456 Sulfur Acids
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D013456 1999
% 208.86/209.02  |- skos__hiddenLabel mesh__D013456 Acids, Sulfur
% 208.86/209.02  |- mesh__dateEstablished mesh__D013456 1994-01-01
% 208.86/209.02  |- skos__annotation mesh__D013456 do not confuse with SULFURIC ACIDS   
% 208.86/209.02  |- mesh__recordAuthorizer mesh__D013456 PLS
% 208.86/209.02  |- mesh__historyNote mesh__D013456
% 208.86/209.02       94; was NON MESH 1971-93; SULFUROUS ACIDS was heading 1968-93%A%  
% 208.86/209.02  |- skos__broader mesh__D013456smesh__D013457
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D013456 2004
% 208.86/209.02  |- rdf__type mesh__D013456sskos__Concept
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D013456 2002
% 208.86/209.02  |- mesh__dateRevised mesh__D013456 1995-06-29
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D013456 1998
% 208.86/209.02  |- skos__scopeNote mesh__D013456
% 208.86/209.02       Inorganic or organic acids that contain sulfur as an integral part of the molecule.%A%    
% 208.86/209.02  |- skos__broader mesh__D013456smesh__D000148
% 208.86/209.02  |- mesh__dateCreated mesh__D013456 1999-01-01
% 208.86/209.02  |- mesh__onlineNote mesh__D013456
% 208.86/209.02       use SULFUR ACIDS to search SULFUROUS ACIDS 1968-93   
% 208.86/209.02  |- mesh__recordOriginator mesh__D013456 NLM
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D013456 2003
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D013456 2006
% 208.86/209.02  |- mesh__publicMeSHNote mesh__D013456
% 208.86/209.02       94; SULFUROUS ACIDS was heading 1968-93   
% 208.86/209.02  |- skos__hiddenLabel mesh__D013456 Acids, Sulfurous
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D013456 2001
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D013456 2005
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D013456 1997
% 208.86/209.02  |- mesh__recordAuthorizer mesh__D007419 SJN
% 208.86/209.02  |- skos__hiddenLabel mesh__D007419 Secretions, Intestinal
% 208.86/209.02  |- skos__hiddenLabel mesh__D007419 Intestinal Secretion
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D007419 2004
% 208.86/209.02  |- skos__hiddenLabel mesh__D007419 Secretion, Intestinal
% 208.86/209.02  |- skos__prefLabel mesh__D007419 Intestinal Secretions
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D007419 2003
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D007419 2006
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D007419 1999
% 208.86/209.02  |- mesh__recordOriginator mesh__D007419 NLM
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D007419 2005
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D007419 2002
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D007419 1998
% 208.86/209.02  |- mesh__dateRevised mesh__D007419 1997-06-20
% 208.86/209.02  |- rdf__type mesh__D007419sskos__Concept
% 208.86/209.02  |- skos__broader mesh__D007419smesh__D012634
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D007419 2001
% 208.86/209.02  |- skos__related mesh__D007419smesh__D005768
% 208.86/209.02  |- mesh__recordMaintainer mesh__D007419 PXP
% 208.86/209.02  |- mesh__dateCreated mesh__D007419 1999-01-01
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D007419 2000
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D018141 2006
% 208.86/209.02  |- skos__broader mesh__D018141smesh__D006564
% 208.86/209.02  |- mesh__dateRevised mesh__D018141 2005-07-13
% 208.86/209.02  |- rdf__type mesh__D018141sskos__Concept
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D018141 2005
% 208.86/209.02  |- skos__prefLabel mesh__D018141 Betaherpesvirinae
% 208.86/209.02  |- skos__scopeNote mesh__D018141
% 208.86/209.02       A subfamily of HERPESVIRIDAE characterized by a relatively long replication cycle. Genera include: CYTOMEGALOVIRUS; MUROMEGALOVIRUS; and ROSEOLOVIRUS.%A%    
% 208.86/209.02  |- mesh__recordMaintainer mesh__D018141 ags
% 208.86/209.02  |- mesh__publicMeSHNote mesh__D018141 94   
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D018141 2004
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D018141 2006A
% 208.86/209.02  |- mesh__historyNote mesh__D018141 94   
% 208.86/209.02  |- skos__annotation mesh__D018141
% 208.86/209.02       infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29%   
% 208.86/209.02  |- mesh__recordAuthorizer mesh__D018141 ags
% 208.86/209.02  |- mesh__recordOriginator mesh__D018141 AGS
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D018141 2002
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D018141 2003
% 208.86/209.02  |- mesh__dateCreated mesh__D018141 1993-06-04
% 208.86/209.02  |- mesh__dateEstablished mesh__D018141 1994-01-01
% 208.86/209.02  |- mesh__recordMaintainer mesh__D051575 DRC
% 208.86/209.02  |- mesh__historyNote mesh__D051575 2006%28%1987%29%   
% 208.86/209.02  |- mesh__dateCreated mesh__D051575 2005-06-30
% 208.86/209.02  |- skos__broader mesh__D051575smesh__D019061
% 208.86/209.02  |- skos__hiddenLabel mesh__D051575 Proto Oncogene Protein yes
% 208.86/209.02  |- mesh__publicMeSHNote mesh__D051575
% 208.86/209.02       2006; PROTO-ONCOGENE PROTEIN C-YES was indexed under SCR-FAMILY KINASES 2005, %26% under PROTO-ONCOGENE PROTEINS 1987-2005, %26% under PROTEIN-TYROSINE KINASE 1987-2004%A%  
% 208.86/209.02  |- skos__hiddenLabel mesh__D051575 c-yes, Proto-Oncogene Protein
% 208.86/209.02  |- skos__altLabel mesh__D051575 yes Proto-Oncogene Protein
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D051575 2006
% 208.86/209.02  |- skos__hiddenLabel mesh__D051575 yes Proto Oncogene Protein
% 208.86/209.02  |- skos__altLabel mesh__D051575 Proto-Oncogene Protein c-yes
% 208.86/209.02  |- mesh__recordAuthorizer mesh__D051575 sjn
% 208.86/209.02  |- skos__hiddenLabel mesh__D051575 yes, Proto-Oncogene Protein
% 208.86/209.02  |- mesh__recordOriginator mesh__D051575 DRC
% 208.86/209.02  |- skos__scopeNote mesh__D051575
% 208.86/209.02       Members of the src-family tyrosine kinases that are activated during the transition from G2 PHASE to M PHASE of the CELL CYCLE. It is highly homologous to PROTO-ONCOGENE PROTEIN PP60%28%C-SRC%29%.%A%    
% 208.86/209.02  |- skos__hiddenLabel mesh__D051575 Proto Oncogene Proteins c yes
% 208.86/209.02  |- skos__hiddenLabel mesh__D051575 c yes Protein
% 208.86/209.02  |- mesh__dateEstablished mesh__D051575 2006-01-01
% 208.86/209.02  |- skos__broader mesh__D051575smesh__D011518
% 208.86/209.02  |- rdf__type mesh__D051575sskos__Concept
% 208.86/209.02  |- skos__altLabel mesh__D051575 Proto-Oncogene Protein yes
% 208.86/209.02  |- skos__altLabel mesh__D051575 c-yes Proto-Oncogene Protein
% 208.86/209.02  |- skos__hiddenLabel mesh__D051575 c-yes, Proto-Oncogene Proteins
% 208.86/209.02  |- skos__hiddenLabel mesh__D051575 Proto Oncogene Protein c yes
% 208.86/209.02  |- skos__prefLabel mesh__D051575 Proto-Oncogene Proteins c-yes
% 208.86/209.02  |- skos__altLabel mesh__D051575 c-yes Protein
% 208.86/209.02  |- skos__hiddenLabel mesh__D051575 Proto-Oncogene Protein, yes
% 208.86/209.02  |- skos__hiddenLabel mesh__D051575 Proto-Oncogene Protein, c-yes
% 208.86/209.02  |- skos__altLabel mesh__D004121 Dimethylsulfoxide
% 208.86/209.02  |- mesh__historyNote mesh__D004121 65%28%64%29%   
% 208.86/209.02  |- mesh__publicMeSHNote mesh__D004121 65   
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D004121 2006
% 208.86/209.02  |- mesh__recordMaintainer mesh__D004121 exl
% 208.86/209.02  |- skos__hiddenLabel mesh__D004121 Sulphoxide, Dimethyl
% 208.86/209.02  |- skos__altLabel mesh__D004121 Shire Brand of Dimethyl Sulfoxide
% 208.86/209.02  |- skos__broader mesh__D004121smesh__D013454
% 208.86/209.02  |- skos__altLabel mesh__D004121 Dimethylsulphinyl
% 208.86/209.02  |- mesh__recordAuthorizer mesh__D004121 sjn
% 208.86/209.02  |- skos__altLabel mesh__D004121 Dimethyl Sulphoxide
% 208.86/209.02  |- skos__altLabel mesh__D004121 DMSO
% 208.86/209.02  |- skos__altLabel mesh__D004121
% 208.86/209.02       Research Ind. Corp. Brand 1 of Dimethyl Sulfoxide
% 208.86/209.02  |- skos__prefLabel mesh__D004121 Dimethyl Sulfoxide
% 208.86/209.02  |- skos__altLabel mesh__D004121 Merckle Brand of Dimethyl Sulfoxide
% 208.86/209.02  |- mesh__dateRevised mesh__D004121 2005-06-30
% 208.86/209.02  |- skos__scopeNote mesh__D004121
% 208.86/209.02       A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during cryopreservation. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.%A%    
% 208.86/209.02  |- skos__altLabel mesh__D004121 Sulfinylbis%28%methane%29%
% 208.86/209.02  |- mesh__dateCreated mesh__D004121 1999-01-01
% 208.86/209.02  |- skos__altLabel mesh__D004121 Dimethylsulphoxide
% 208.86/209.02  |- mesh__dateEstablished mesh__D004121 1965-01-01
% 208.86/209.02  |- skos__hiddenLabel mesh__D004121 Sulfoxide, Dimethyl
% 208.86/209.02  |- rdf__type mesh__D004121sskos__Concept
% 208.86/209.02  |- skos__altLabel mesh__D004121
% 208.86/209.02       Research Ind. Corp. Brand 2 of Dimethyl Sulfoxide
% 208.86/209.02  |- mesh__recordOriginator mesh__D004121 NLM
% 208.86/209.02  |- skos__scopeNote mesh__D017847
% 208.86/209.02       The central portion of the common tendon of the QUADRICEPS FEMORIS. It is attached to the apex of the PATELLA and to the lower part of the tubercle of the TIBIA.%A%    
% 208.86/209.02  |- mesh__dateCreated mesh__D017847 1993-02-16
% 208.86/209.02  |- mesh__recordOriginator mesh__D017847 TGC
% 208.86/209.02  |- skos__annotation mesh__D017847
% 208.86/209.02       an artic ligament between patella %26% tibia: do not confuse with MEDIAL COLLATERAL LIGAMENT, KNEE, between tibia %26% femur%A%  
% 208.86/209.02  |- mesh__recordAuthorizer mesh__D017847 sjn
% 208.86/209.02  |- skos__prefLabel mesh__D017847 Patellar Ligament
% 208.86/209.02  |- mesh__recordMaintainer mesh__D017847 ags
% 208.86/209.02  |- rdf__type mesh__D017847sskos__Concept
% 208.86/209.02  |- mesh__dateEstablished mesh__D017847 1994-01-01
% 208.86/209.02  |- skos__historyNote mesh__D017847 Ligaments %28%1968-1993%29%
% 208.86/209.02  |- skos__altLabel mesh__D017847 Ligamentum Patellae
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D017847 2006
% 208.86/209.02  |- skos__related mesh__D017847smesh__D016119
% 208.86/209.02  |- mesh__publicMeSHNote mesh__D017847 94   
% 208.86/209.02  |- skos__broader mesh__D017847smesh__D008023
% 208.86/209.02  |- skos__related mesh__D017847smesh__D017888
% 208.86/209.02  |- skos__historyNote mesh__D017847 Ligaments, Articular %28%1968-1993%29%
% 208.86/209.02  |- skos__hiddenLabel mesh__D017847 Ligaments, Patellar
% 208.86/209.02  |- mesh__historyNote mesh__D017847 94   
% 208.86/209.02  |- skos__hiddenLabel mesh__D017847 Ligament, Patellar
% 208.86/209.02  |- skos__related mesh__D017847smesh__D016118
% 208.86/209.02  |- mesh__dateRevised mesh__D017847 2005-06-30
% 208.86/209.02  |- skos__hiddenLabel mesh__D017847 Patellar Ligaments
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D017049 2004
% 208.86/209.02  |- mesh__historyNote mesh__D017049 92   
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D017049 2002
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D017049 1996
% 208.86/209.02  |- skos__hiddenLabel mesh__D017049 Health Cost, Employer
% 208.86/209.02  |- mesh__dateCreated mesh__D017049 1991-06-20
% 208.86/209.02  |- mesh__recordMaintainer mesh__D017049 PLS
% 208.86/209.02  |- mesh__recordAuthorizer mesh__D017049 NLM
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D017049 1997
% 208.86/209.02  |- skos__altLabel mesh__D017049 Health Costs, Employer
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D017049 2005
% 208.86/209.02  |- skos__historyNote mesh__D017049 Health Expenditures %28%1968-1991%29%
% 208.86/209.02  |- skos__scopeNote mesh__D017049
% 208.86/209.02       That portion of total HEALTH CARE COSTS borne by an individual%27%s or group%27%s employing organization.%A%    
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D017049 2000
% 208.86/209.02  |- mesh__recordOriginator mesh__D017049 PLS
% 208.86/209.02  |- mesh__dateRevised mesh__D017049 1993-09-16
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D017049 1995
% 208.86/209.02  |- skos__hiddenLabel mesh__D017049 Employer Health Cost
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D017049 2006
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D017049 2001
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D017049 1998
% 208.86/209.02  |- skos__broader mesh__D017049smesh__D017048
% 208.86/209.02  |- mesh__dateEstablished mesh__D017049 1992-01-01
% 208.86/209.02  |- skos__annotation mesh__D017049 health care cost paid by employer   
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D017049 2003
% 208.86/209.02  |- mesh__publicMeSHNote mesh__D017049 92   
% 208.86/209.02  |- skos__prefLabel mesh__D017049 Employer Health Costs
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D017049 1999
% 208.86/209.02  |- skos__historyNote mesh__D017049
% 208.86/209.02       Costs and Cost Analysis %28%1966-1991%29%
% 208.86/209.02  |- rdf__type mesh__D017049sskos__Concept
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D003827 2006
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D003827 2000
% 208.86/209.02  |- mesh__dateRevised mesh__D003827 1997-06-20
% 208.86/209.02  |- skos__scopeNote mesh__D003827
% 208.86/209.02       A complete denture replacing all the natural maxillary teeth and associated maxillary structures. It is completely supported by the oral tissue and underlying maxillary bone.%A%    
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D003827 2004
% 208.86/209.02  |- mesh__dateEstablished mesh__D003827 1965-01-01
% 208.86/209.02  |- skos__broader mesh__D003827smesh__D003824
% 208.86/209.02  |- mesh__publicMeSHNote mesh__D003827 65   
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D003827 2005
% 208.86/209.02  |- mesh__dateCreated mesh__D003827 1999-01-01
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D003827 2003
% 208.86/209.02  |- rdf__type mesh__D003827sskos__Concept
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D003827 2002
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D003827 1999
% 208.86/209.02  |- mesh__recordAuthorizer mesh__D003827 SJN
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D003827 1998
% 208.86/209.02  |- mesh__recordOriginator mesh__D003827 NLM
% 208.86/209.02  |- skos__prefLabel mesh__D003827 Denture, Complete, Upper
% 208.86/209.02  |- mesh__historyNote mesh__D003827 65   
% 208.86/209.02  |- mesh__recordMaintainer mesh__D003827 PXP
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D003827 2001
% 208.86/209.02  |- mesh__dateRevised mesh__D003029 2005-06-30
% 208.86/209.02  |- mesh__recordOriginator mesh__D003029 NLM
% 208.86/209.02  |- skos__scopeNote mesh__D003029
% 208.86/209.02       Exogenous substances used to promote blood coagulation. The endogenous BLOOD COAGULATION FACTORS are considered to be coagulants only when administered as drugs.%A%    
% 208.86/209.02  |- mesh__dateCreated mesh__D003029 1999-01-01
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D003029 2006
% 208.86/209.02  |- rdf__type mesh__D003029sskos__Concept
% 208.86/209.02  |- skos__prefLabel mesh__D003029 Coagulants
% 208.86/209.02  |- mesh__recordMaintainer mesh__D003029 ssb
% 208.86/209.02  |- mesh__historyNote mesh__D003029 75; was see under HEMOSTATICS 1963-74   
% 208.86/209.02  |- mesh__recordAuthorizer mesh__D003029 sjn
% 208.86/209.02  |- skos__historyNote mesh__D003029 Hemostatics %28%1966-1974%29%
% 208.86/209.02  |- mesh__publicMeSHNote mesh__D003029
% 208.86/209.02       75; was see under HEMOSTATICS 1963-74   
% 208.86/209.02  |- mesh__onlineNote mesh__D003029 search HEMOSTATICS 1966-74   
% 208.86/209.02  |- skos__broader mesh__D003029smesh__D006401
% 208.86/209.02  |- skos__related mesh__D003029smesh__D013917
% 208.86/209.02  |- skos__related mesh__D003029smesh__D001779
% 208.86/209.02  |- skos__annotation mesh__D003029
% 208.86/209.02       consider also BLOOD COAGULATION /drug eff   
% 208.86/209.02  |- mesh__dateEstablished mesh__D003029 1975-09-01
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D008512 2000
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D008512 1998
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D008512 1997
% 208.86/209.02  |- skos__hiddenLabel mesh__D008512 Medicine in Arts
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D008512 1996
% 208.86/209.02  |- mesh__recordAuthorizer mesh__D008512 PLS
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D008512 2006
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D008512 2002
% 208.86/209.02  |- skos__hiddenLabel mesh__D008512 in Arts, Medicine
% 208.86/209.02  |- skos__annotation mesh__D008512
% 208.86/209.02       no qualif; coord IM with med aspect %28%IM%29% + specific art heading %28%IM%29%; DF: MED ART%A%  
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D008512 2005
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D008512 2004
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D008512 1995
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D008512 1991
% 208.86/209.02  |- mesh__dateCreated mesh__D008512 1999-01-01
% 208.86/209.02  |- mesh__recordOriginator mesh__D008512 NLM
% 208.86/209.02  |- rdf__type mesh__D008512sskos__Concept
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D008512 2003
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D008512 1993
% 208.86/209.02  |- mesh__recordMaintainer mesh__D008512 TGC
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D008512 1994
% 208.86/209.02  |- skos__hiddenLabel mesh__D008512 Art, Medicine in
% 208.86/209.02  |- skos__hiddenLabel mesh__D008512 in Art, Medicine
% 208.86/209.02  |- skos__prefLabel mesh__D008512 Medicine in Art
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D008512 2001
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D008512 1992
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D008512 1999
% 208.86/209.02  |- skos__broader mesh__D008512smesh__D001154
% 208.86/209.02  |- skos__hiddenLabel mesh__D008512 Arts, Medicine in
% 208.86/209.02  |- mesh__dateRevised mesh__D008512 1990-05-17
% 208.86/209.02  |- mesh__recordAuthorizer mesh__D013457 SJN
% 208.86/209.02  |- skos__scopeNote mesh__D013457
% 208.86/209.02       Inorganic or organic compounds that contain sulfur as an integral part of the molecule.%A%    
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D013457 1999
% 208.86/209.02  |- mesh__publicMeSHNote mesh__D013457 98   
% 208.86/209.02  |- skos__prefLabel mesh__D013457 Sulfur Compounds
% 208.86/209.02  |- rdf__type mesh__D013457sskos__Concept
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D013457 2002
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D013457 1998
% 208.86/209.02  |- mesh__dateCreated mesh__D013457 1999-01-01
% 208.86/209.02  |- mesh__recordOriginator mesh__D013457 NLM
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D013457 2004
% 208.86/209.02  |- skos__annotation mesh__D013457
% 208.86/209.02       GEN or unspecified; prefer specific groups or specific drugs; DF: SULFUR CPDS%A%  
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D013457 2003
% 208.86/209.02  |- skos__broader mesh__D013457smesh__D009930
% 208.86/209.02  |- skos__hiddenLabel mesh__D013457 Compounds, Sulfur
% 208.86/209.02  |- mesh__recordMaintainer mesh__D013457 ADP
% 208.86/209.02  |- mesh__dateRevised mesh__D013457 1997-06-20
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D013457 2001
% 208.86/209.02  |- mesh__dateEstablished mesh__D013457 1998-01-01
% 208.86/209.02  |- mesh__historyNote mesh__D013457 98; use explode 1968-97   
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D013457 2006
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D013457 2000
% 208.86/209.02  |- skos__broader mesh__D013457smesh__D007287
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D013457 2005
% 208.86/209.02  |- mesh__publicMeSHNote mesh__D018940 1996   
% 208.86/209.02  |- skos__hiddenLabel mesh__D018940 Elasmobranch
% 208.86/209.02  |- mesh__dateEstablished mesh__D018940 1996-01-01
% 208.86/209.02  |- skos__scopeNote mesh__D018940
% 208.86/209.02       A subclass of cartilaginous fish comprising the SHARKS; rays; skates %28%SKATES %28%FISH%29%;%29%, and sawfish. Elasmobranchs are typically predaceous, relying more on smell %28%the olfactory capsules are relatively large%29% than sight %28%the eyes are relatively small%29% for obtaining their food.%A%    
% 208.86/209.02  |- mesh__recordAuthorizer mesh__D018940 ags
% 208.86/209.02  |- mesh__recordOriginator mesh__D018940 PXP
% 208.86/209.02  |- mesh__dateCreated mesh__D018940 1995-06-05
% 208.86/209.02  |- skos__prefLabel mesh__D018940 Elasmobranchii
% 208.86/209.02  |- skos__altLabel mesh__D018940 Elasmobranchs
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D018940 2006A
% 208.86/209.02  |- mesh__dateRevised mesh__D018940 2005-07-29
% 208.86/209.02  |- mesh__historyNote mesh__D018940 1996   
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D018940 2004
% 208.86/209.02  |- mesh__recordMaintainer mesh__D018940 ags
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D018940 2006
% 208.86/209.02  |- rdf__type mesh__D018940sskos__Concept
% 208.86/209.02  |- skos__annotation mesh__D018940
% 208.86/209.02       GEN or unspecified; SHARKS; DOGFISH; SKATES %28%FISH%29% are also available%A%  
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D018940 2005
% 208.86/209.02  |- skos__historyNote mesh__D018940 Fishes %28%1966-1995%29%
% 208.86/209.02  |- skos__hiddenLabel mesh__D018940 Elasmobranchius
% 208.86/209.02  |- skos__broader mesh__D018940smesh__D005399
% 208.86/209.02  |- skos__hiddenLabel mesh__D018142 Lymphoproliferative Virus
% 208.86/209.02  |- skos__prefLabel mesh__D018142 Gammaherpesvirinae
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D018142 2006
% 208.86/209.02  |- mesh__recordAuthorizer mesh__D018142 sjn
% 208.86/209.02  |- mesh__dateCreated mesh__D018142 1993-06-18
% 208.86/209.02  |- mesh__publicMeSHNote mesh__D018142 94   
% 208.86/209.02  |- mesh__dateEstablished mesh__D018142 1994-01-01
% 208.86/209.02  |- rdf__type mesh__D018142sskos__Concept
% 208.86/209.02  |- skos__hiddenLabel mesh__D018142 Viruses, Lymphoproliferative
% 208.86/209.02  |- mesh__recordMaintainer mesh__D018142 ags
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D018142 2003
% 208.86/209.02  |- skos__scopeNote mesh__D018142
% 208.86/209.02       A subfamily of HERPESVIRIDAE characterized by variable reproductive cycles. The genera include:  LYMPHOCRYPTOVIRUS and RHADINOVIRUS.%A%    
% 208.86/209.02  |- skos__hiddenLabel mesh__D018142 Virus, Lymphoproliferative
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D018142 2004
% 208.86/209.02  |- mesh__dateRevised mesh__D018142 2001-07-25
% 208.86/209.02  |- skos__broader mesh__D018142smesh__D004263
% 208.86/209.02  |- mesh__historyNote mesh__D018142 94   
% 208.86/209.02  |- skos__broader mesh__D018142smesh__D006564
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D018142 2002
% 208.86/209.02  |- skos__annotation mesh__D018142
% 208.86/209.02       infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29%; if discussed as tumor viruses, add TUMOR VIRUS INFECTIONS %28%IM%29%%A%  
% 208.86/209.02  |- mesh__recordOriginator mesh__D018142 AGS
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D018142 2005
% 208.86/209.02  |- skos__altLabel mesh__D018142 Lymphoproliferative Viruses
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D004920 2006A
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D004920 2004
% 208.86/209.02  |- rdf__type mesh__D004920sskos__Concept
% 208.86/209.02  |- skos__scopeNote mesh__D004920
% 208.86/209.02       The production of red blood cells %28%ERYTHROCYTES%29%. In humans, erythrocytes are produced by the YOLK SAC in the first trimester; by the liver in the second trimester; by the BONE MARROW in the third trimester and after birth. In normal individuals, the erythrocyte count in the peripheral blood remains relatively constant implying a balance between the rate of erythrocyte production and rate of destruction.%A%    
% 208.86/209.02  |- mesh__recordMaintainer mesh__D004920 ags
% 208.86/209.02  |- mesh__recordOriginator mesh__D004920 NLM
% 208.86/209.02  |- mesh__dateCreated mesh__D004920 1999-01-01
% 208.86/209.02  |- mesh__recordAuthorizer mesh__D004920 ags
% 208.86/209.02  |- skos__broader mesh__D004920smesh__D006410
% 208.86/209.02  |- skos__hiddenLabel mesh__D004920 Erythropoieses
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D004920 2006
% 208.86/209.02  |- mesh__dateRevised mesh__D004920 2005-07-08
% 208.86/209.02  |- skos__prefLabel mesh__D004920 Erythropoiesis
% 208.86/209.02  |- mesh__activeMeSHYear mesh__D004920 2005
% 208.86/209.02  |- skos__hiddenLabel mesh__D004122 Phosphate Synthetase, Dolichyl
% 208.86/209.02  |- mesh__publicMeSHNote mesh__D004122
% 208.86/209.02       97; was DIMETHYLALLYLTRANSFERASE 1979-96 %28%see under TRANSFERASES 1979-90%29%%A%  
% 208.88/209.02  |- mesh__activeMeSHYear mesh__D004122 2005
% 208.88/209.02  |- mesh__activeMeSHYear mesh__D004122 2004
% 208.88/209.02  |- mesh__dateEstablished mesh__D004122 1991-01-01
% 208.88/209.02  |- skos__historyNote mesh__D004122 Transferases %28%1966-1978%29%
% 208.88/209.02  |- skos__hiddenLabel mesh__D004122 Pyrophosphate Synthetase, Geranylgeranyl
% 208.88/209.02  |- skos__hiddenLabel mesh__D004122 Synthetase, Dolichyl Phosphate
% 208.88/209.02  |- skos__hiddenLabel mesh__D004122 Synthetase, Nerylpyrophosphate
% 208.88/209.02  |- mesh__recordAuthorizer mesh__D004122 sjn
% 208.88/209.02  |- mesh__dateRevised mesh__D004122 2003-07-09
% 208.88/209.02  |- mesh__historyNote mesh__D004122
% 208.88/209.02       97; was DIMETHYLALLYLTRANSFERASE 1979-96 %28%see under TRANSFERASES 1979-90%29%%A%  
% 208.88/209.02  |- skos__altLabel mesh__D004122 Geranylpyrophosphate Synthetase
% 208.88/209.02  |- skos__prefLabel mesh__D004122 Dimethylallyltranstransferase
% 208.88/209.02  |- mesh__recordMaintainer mesh__D004122 ssb
% 208.88/209.02  |- rdf__type mesh__D004122sskos__Concept
% 208.88/209.02  |- skos__scopeNote mesh__D004122
% 208.88/209.02       An enzyme that, in the pathway of cholesterol biosynthesis, catalyzes the condensation of isopentenyl pyrophosphate and dimethylallylpyrophosphate to yield pyrophosphate and geranylpyrophosphate. The enzyme then catalyzes the condensation of the latter compound with another molecule of isopentenyl pyrophosphate to yield pyrophosphate and farnesylpyrophosphate. EC 2.5.1.1.%A%    
% 208.88/209.02  |- skos__altLabel mesh__D004122 Prenyltransferase
% 208.88/209.02  |- skos__historyNote mesh__D004122 Allyl Compounds %28%1971-1978%29%
% 208.88/209.02  |- skos__hiddenLabel mesh__D004122 Synthetase, Geranylgeranyl Pyrophosphate
% 208.88/209.02  |- skos__altLabel mesh__D004122 Geranylgeranyl Pyrophosphate Synthetase
% 208.88/209.02  |- skos__altLabel mesh__D004122 Dimethylallyltransferase
% 208.88/209.02  |- skos__altLabel mesh__D004122 Nerylpyrophosphate Synthetase
% 208.88/209.02  |- skos__altLabel mesh__D004122 Dolichyl Phosphate Synthetase
% 208.88/209.02  |- skos__broader mesh__D004122smesh__D019883
% 208.88/209.02  |- mesh__dateCreated mesh__D004122 1978-05-18
% 208.88/209.02  |- skos__hiddenLabel mesh__D004122 Synthetase, Geranylpyrophosphate
% 208.88/209.02  |- skos__hiddenLabel mesh__D004122 Synthetase, Farnesylpyrophosphate
% 208.88/209.02  |- mesh__activeMeSHYear mesh__D004122 2006
% 208.88/209.02  |- mesh__recordOriginator mesh__D004122 RLS
% 208.88/209.02  |- skos__altLabel mesh__D004122 Farnesylpyrophosphate Synthetase
% 208.88/209.02  |- skos__prefLabel mesh__D017848 Blood-Borne Pathogens
% 208.88/209.02  |- mesh__activeMeSHYear mesh__D017848 2006A
% 208.88/209.02  |- mesh__publicMeSHNote mesh__D017848 94   
% 208.88/209.02  |- mesh__recordMaintainer mesh__D017848 ags
% 208.88/209.02  |- mesh__activeMeSHYear mesh__D017848 2006
% 208.88/209.02  |- skos__annotation mesh__D017848
% 208.88/209.02       coord with specific pathogen %28%IM%29% if pertinent; do not routinely add as a coordinate for infections in the blood %28%VIREMIA; BACTEREMIA; FUNGEMIA; PARASITEMIA%29%%A%  
% 208.88/209.02  |- mesh__activeMeSHYear mesh__D017848 2005
% 208.88/209.02  |- skos__broader mesh__D017848smesh__D000456
% 208.88/209.02  |- skos__broader mesh__D017848smesh__D005658
% 208.88/209.02  |- mesh__historyNote mesh__D017848 94   
% 208.88/209.02  |- mesh__recordOriginator mesh__D017848 TGC
% 208.88/209.02  |- skos__scopeNote mesh__D017848
% 208.88/209.02       Infectious organisms in the BLOOD, of which the predominant medical interest is their contamination of blood-soiled linens, towels, gowns, BANDAGES, other items from individuals in risk categories, NEEDLES and other sharp objects, MEDICAL WASTE and DENTAL WASTE, all of which health workers are exposed to. This concept is differentiated from the clinical conditions of BACTEREMIA; VIREMIA; and FUNGEMIA where the organism is present in the blood of a patient as the result of a natural infectious process.%A%    
% 208.88/209.02  |- skos__broader mesh__D017848smesh__D011527
% 208.88/209.02  |- skos__related mesh__D017848smesh__D016635
% 208.88/209.02  |- skos__altLabel mesh__D017848 Bloodborne Pathogens
% 208.88/209.02  |- mesh__dateEstablished mesh__D017848 1994-01-01
% 208.88/209.02  |- skos__broader mesh__D017848smesh__D001419
% 208.88/209.02  |- mesh__dateCreated mesh__D017848 1993-02-16
% 208.88/209.02  |- skos__broader mesh__D017848smesh__D014712
% 208.88/209.02  |- skos__broader mesh__D017848smesh__D001105
% 208.88/209.02  |- mesh__dateRevised mesh__D017848 2005-08-03
% 208.88/209.02  |- skos__altLabel mesh__D017848 Pathogens, Blood-Borne
% 208.88/209.02  |- mesh__activeMeSHYear mesh__D017848 2004
% 208.88/209.02  |- mesh__recordAuthorizer mesh__D017848 ags
% 208.88/209.02  |- rdf__type mesh__D017848sskos__Concept
% 208.88/209.02  |- skos__historyNote mesh__D017848 specific organism %28%1987-1993%29%
% 208.88/209.02  |- skos__broader mesh__D042241smesh__D003933
% 208.88/209.02  |- mesh__activeMeSHYear mesh__D042241 2006
% 208.88/209.02  |- skos__annotation mesh__D042241
% 208.88/209.02       IM general only; index NIM if discussed   
% 208.88/209.02  |- rdf__type mesh__D042241sskos__Concept
% 208.88/209.02  |- skos__hiddenLabel mesh__D042241 Early Diagnoses
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D042241 2004
% 208.88/209.03  |- mesh__historyNote mesh__D042241 2004   
% 208.88/209.03  |- skos__hiddenLabel mesh__D042241 Diagnosis, Early
% 208.88/209.03  |- mesh__publicMeSHNote mesh__D042241 2004   
% 208.88/209.03  |- mesh__dateCreated mesh__D042241 2003-07-09
% 208.88/209.03  |- skos__prefLabel mesh__D042241 Early Diagnosis
% 208.88/209.03  |- skos__scopeNote mesh__D042241
% 208.88/209.03       Methods to determine in patients the nature of a disease or disorder at its early stage of progression. Generally, early diagnosis improves PROGNOSIS and TREATMENT OUTCOME.%A%    
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D042241 2005
% 208.88/209.03  |- mesh__dateEstablished mesh__D042241 2004-01-01
% 208.88/209.03  |- skos__hiddenLabel mesh__D042241 Diagnoses, Early
% 208.88/209.03  |- mesh__publicMeSHNote mesh__D003828
% 208.88/209.03       74; TELESCOPIC PROSTHESIS was see DENTURE, OVERLAY 1974-92%A%  
% 208.88/209.03  |- mesh__recordOriginator mesh__D003828 NLM
% 208.88/209.03  |- skos__hiddenLabel mesh__D003828 Dentures, Overlay
% 208.88/209.03  |- skos__altLabel mesh__D003828 Overdenture
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D003828 2005
% 208.88/209.03  |- mesh__dateCreated mesh__D003828 1999-01-01
% 208.88/209.03  |- mesh__recordMaintainer mesh__D003828 PXP
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D003828 2001
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D003828 2003
% 208.88/209.03  |- skos__hiddenLabel mesh__D003828 Overlay Dentures
% 208.88/209.03  |- rdf__type mesh__D003828sskos__Concept
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D003828 2000
% 208.88/209.03  |- mesh__dateRevised mesh__D003828 1997-06-20
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D003828 1999
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D003828 1998
% 208.88/209.03  |- skos__annotation mesh__D003828
% 208.88/209.03       coord IM with specific denture term %28%IM or NIM%29%   
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D003828 2002
% 208.88/209.03  |- skos__prefLabel mesh__D003828 Denture, Overlay
% 208.88/209.03  |- skos__hiddenLabel mesh__D003828 Overdentures
% 208.88/209.03  |- skos__scopeNote mesh__D003828
% 208.88/209.03       Removable prosthesis constructed over natural teeth or implanted studs.%A%    
% 208.88/209.03  |- skos__hiddenLabel mesh__D003828 Overlay Denture
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D003828 2006
% 208.88/209.03  |- mesh__recordAuthorizer mesh__D003828 SJN
% 208.88/209.03  |- mesh__dateEstablished mesh__D003828 1974-01-01
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D003828 2004
% 208.88/209.03  |- mesh__onlineNote mesh__D003828
% 208.88/209.03       use DENTURE, OVERLAY to search TELESCOPIC PROSTHESIS 1974-92%A%  
% 208.88/209.03  |- mesh__historyNote mesh__D003828
% 208.88/209.03       74; TELESCOPIC PROSTHESIS was see DENTURE, OVERLAY 1974-92%A%  
% 208.88/209.03  |- skos__broader mesh__D003828smesh__D003778
% 208.88/209.03  |- rdf__type mesh__D014550sskos__Concept
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014550 2004
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014550 1996
% 208.88/209.03  |- mesh__recordMaintainer mesh__D014550 TGC
% 208.88/209.03  |- skos__prefLabel mesh__D014550 Urinary Incontinence, Stress
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014550 2002
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014550 2006
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014550 1998
% 208.88/209.03  |- skos__hiddenLabel mesh__D014550 Stress Incontinence, Urinary
% 208.88/209.03  |- skos__annotation mesh__D014550
% 208.88/209.03       stress refers to coughing, sneezing %26% other forces   
% 208.88/209.03  |- mesh__dateRevised mesh__D014550 1993-06-03
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014550 1997
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014550 1994
% 208.88/209.03  |- mesh__dateCreated mesh__D014550 1999-01-01
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014550 1999
% 208.88/209.03  |- skos__hiddenLabel mesh__D014550 Incontinence, Urinary Stress
% 208.88/209.03  |- skos__altLabel mesh__D014550 Urinary Stress Incontinence
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014550 2000
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014550 1995
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014550 2001
% 208.88/209.03  |- mesh__recordOriginator mesh__D014550 NLM
% 208.88/209.03  |- skos__scopeNote mesh__D014550
% 208.88/209.03       The involuntary discharge of urine as a result of anatomic displacement which exerts an opening pull on the bladder orifice. It often occurs during coughing or other forceful stresses. %28%From Dorland, 27th ed%29%%A%    
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014550 2003
% 208.88/209.03  |- skos__broader mesh__D014550smesh__D014549
% 208.88/209.03  |- mesh__recordAuthorizer mesh__D014550 PLS
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014550 2005
% 208.88/209.03  |- skos__hiddenLabel mesh__D008513 Literature, Medicine in
% 208.88/209.03  |- skos__prefLabel mesh__D008513 Medicine in Literature
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D008513 2005
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D008513 2004
% 208.88/209.03  |- mesh__dateCreated mesh__D008513 1999-01-01
% 208.88/209.03  |- rdf__type mesh__D008513sskos__Concept
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D008513 2003
% 208.88/209.03  |- mesh__dateRevised mesh__D008513 2001-07-25
% 208.88/209.03  |- mesh__recordMaintainer mesh__D008513 mdb
% 208.88/209.03  |- skos__hiddenLabel mesh__D008513 in Literature, Medicine
% 208.88/209.03  |- skos__broader mesh__D008513smesh__D008091
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D008513 2002
% 208.88/209.03  |- mesh__recordAuthorizer mesh__D008513 sjn
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D008513 2006
% 208.88/209.03  |- mesh__recordOriginator mesh__D008513 NLM
% 208.88/209.03  |- skos__annotation mesh__D008513
% 208.88/209.03       no qualif; coord IM with med aspect %28%IM%29% + specific lit heading %28%IM%29% + literary type if pertinent %28%as POETRY; DRAMA, etc.%29% %28%IM%29%; DF: MED LIT%A%  
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D000530 2004
% 208.88/209.03  |- mesh__historyNote mesh__D000530 2001%28%1975%29%   
% 208.88/209.03  |- mesh__dateCreated mesh__D000530 1974-11-11
% 208.88/209.03  |- skos__historyNote mesh__D000530 Drug Combinations %28%1974%29%
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D000530 2003
% 208.88/209.03  |- mesh__recordMaintainer mesh__D000530 sjn
% 208.88/209.03  |- mesh__recordAuthorizer mesh__D000530 sjn
% 208.88/209.03  |- mesh__publicMeSHNote mesh__D000530
% 208.88/209.03       2000; see ALTHESIN 1980-2000 %26% PREGNANEDIONES 1975-79   
% 208.88/209.03  |- skos__prefLabel mesh__D000530 Alfaxalone Alfadolone Mixture
% 208.88/209.03  |- skos__scopeNote mesh__D000530
% 208.88/209.03       A 3:1 mixture of alfaxalone with alfadolone acetate that previously had been used as a general anesthetic. It is no longer actively marketed. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1445%29%%A%    
% 208.88/209.03  |- skos__historyNote mesh__D000530 Hydroxysteroids %28%1974%29%
% 208.88/209.03  |- skos__hiddenLabel mesh__D000530 CT 1341
% 208.88/209.03  |- mesh__dateEstablished mesh__D000530 1980-01-01
% 208.88/209.03  |- skos__hiddenLabel mesh__D000530 Alfadolone Mixture, Alfaxalone
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D000530 2006
% 208.88/209.03  |- rdf__type mesh__D000530sskos__Concept
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D000530 2005
% 208.88/209.03  |- mesh__dateRevised mesh__D000530 2002-07-24
% 208.88/209.03  |- skos__historyNote mesh__D000530 Pregnanediones %28%1974%29%
% 208.88/209.03  |- mesh__recordOriginator mesh__D000530 NLM
% 208.88/209.03  |- skos__broader mesh__D000530smesh__D011277
% 208.88/209.03  |- skos__hiddenLabel mesh__D000530 CT1341
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D013458 2001
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D013458 2003
% 208.88/209.03  |- skos__prefLabel mesh__D013458 Sulfur Dioxide
% 208.88/209.03  |- mesh__dateEstablished mesh__D013458 1966-01-01
% 208.88/209.03  |- mesh__recordAuthorizer mesh__D013458 sjn
% 208.88/209.03  |- rdf__type mesh__D013458sskos__Concept
% 208.88/209.03  |- skos__broader mesh__D013458smesh__D013461
% 208.88/209.03  |- mesh__publicMeSHNote mesh__D013458 66   
% 208.88/209.03  |- skos__altLabel mesh__D013458 Sulfurous Anhydride
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D013458 2002
% 208.88/209.03  |- skos__scopeNote mesh__D013458
% 208.88/209.03       A highly toxic, colorless, nonflammable gas. It is used as a pharmaceutical aid and antioxidant. It is also an environmental air pollutant.%A%    
% 208.88/209.03  |- skos__hiddenLabel mesh__D013458 Anhydride, Sulfurous
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D013458 2004
% 208.88/209.03  |- mesh__dateRevised mesh__D013458 1999-11-09
% 208.88/209.03  |- skos__annotation mesh__D013458 an air pollutant   
% 208.88/209.03  |- mesh__recordMaintainer mesh__D013458 adp
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D013458 2005
% 208.88/209.03  |- mesh__recordOriginator mesh__D013458 NLM
% 208.88/209.03  |- skos__broader mesh__D013458smesh__D005740
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D013458 2006
% 208.88/209.03  |- mesh__historyNote mesh__D013458 66%28%64%29%   
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D013458 2000
% 208.88/209.03  |- skos__hiddenLabel mesh__D013458 Dioxide, Sulfur
% 208.88/209.03  |- mesh__dateCreated mesh__D013458 1999-01-01
% 208.88/209.03  |- skos__historyNote mesh__D018941
% 208.88/209.03       Antigens, Differentiation, B-Lymphocyte %28%1988-1995%29%
% 208.88/209.03  |- mesh__recordAuthorizer mesh__D018941 sjn
% 208.88/209.03  |- mesh__recordMaintainer mesh__D018941 ssb
% 208.88/209.03  |- skos__scopeNote mesh__D018941
% 208.88/209.03       Differentiation antigens expressed on B-lymphocytes and B-cell precursors. They are involved in regulation of B-cell proliferation.%A%    
% 208.88/209.03  |- skos__historyNote mesh__D018941 Antigens, CD %28%1990-1995%29%
% 208.88/209.03  |- mesh__dateCreated mesh__D018941 1995-05-26
% 208.88/209.03  |- mesh__historyNote mesh__D018941
% 208.88/209.03       96; was B CELL ANTIGEN CD19 %28%NM%29% 1987-95   
% 208.88/209.03  |- skos__altLabel mesh__D018941 CD19 Antigen
% 208.88/209.03  |- skos__altLabel mesh__D018941 B Cell Antigen CD19
% 208.88/209.03  |- mesh__dateEstablished mesh__D018941 1996-01-01
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D018941 2006
% 208.88/209.03  |- rdf__type mesh__D018941sskos__Concept
% 208.88/209.03  |- mesh__onlineNote mesh__D018941
% 208.88/209.03       use ANTIGENS, CD19 %28%NM%29% to search B CELL ANTIGEN CD19 1987-95%A%  
% 208.88/209.03  |- mesh__publicMeSHNote mesh__D018941
% 208.88/209.03       96; B CELL ANTIGEN CD19 was indexed under ANTIGENS, CD 1990-95; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1988-95; %26% ANTIGENS, SURFACE 1987-88%A%  
% 208.88/209.03  |- skos__historyNote mesh__D018941 Antigens, Surface %28%1987-1988%29%
% 208.88/209.03  |- skos__broader mesh__D018941smesh__D000944
% 208.88/209.03  |- skos__prefLabel mesh__D018941 Antigens, CD19
% 208.88/209.03  |- skos__altLabel mesh__D018941 CD19 Antigens
% 208.88/209.03  |- skos__hiddenLabel mesh__D018941 Antigen, CD19
% 208.88/209.03  |- skos__broader mesh__D018941smesh__D015703
% 208.88/209.03  |- mesh__recordOriginator mesh__D018941 AGS
% 208.88/209.03  |- mesh__dateRevised mesh__D018941 2005-06-30
% 208.88/209.03  |- skos__annotation mesh__D018941 B-lymphocyte differentiation antigens   
% 208.88/209.03  |- rdf__type mesh__D051577sskos__Concept
% 208.88/209.03  |- skos__historyNote mesh__D051577
% 208.88/209.03       Complement Pathway, Classical %28%1983-2005%29%
% 208.88/209.03  |- mesh__recordMaintainer mesh__D051577 lkt
% 208.88/209.03  |- mesh__historyNote mesh__D051577 2006   
% 208.88/209.03  |- skos__broader mesh__D051577smesh__D050579
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D051577 2006
% 208.88/209.03  |- mesh__dateCreated mesh__D051577 2005-06-30
% 208.88/209.03  |- skos__historyNote mesh__D051577
% 208.88/209.03       Complement Activating Enzymes %28%1983-2005%29%
% 208.88/209.03  |- skos__hiddenLabel mesh__D051577 C5 Convertase, Classical
% 208.88/209.03  |- skos__prefLabel mesh__D051577
% 208.88/209.03       Complement C5 Convertase, Classical Pathway
% 208.88/209.03  |- skos__altLabel mesh__D051577 Classical Pathway C5 Convertase
% 208.88/209.03  |- skos__altLabel mesh__D051577 C5 Convertase %28%C4b2a3b%29%
% 208.88/209.03  |- mesh__recordAuthorizer mesh__D051577 sjn
% 208.88/209.03  |- mesh__dateEstablished mesh__D051577 2006-01-01
% 208.88/209.03  |- skos__altLabel mesh__D051577 Classical C5 Convertase
% 208.88/209.03  |- mesh__recordOriginator mesh__D051577 lkt
% 208.88/209.03  |- skos__scopeNote mesh__D051577
% 208.88/209.03       A serine protease that cleaves multiple COMPLEMENT 5 into COMPLEMENT 5A %28%anaphylatoxin%29% and COMPLEMENT 5B in the CLASSICAL COMPLEMENT ACTIVATION PATHWAY. It is a complex of CLASSICAL PATHWAY C3 CONVERTASE %28%C4b2a%29% with an additional COMPLEMENT C3B, or C4b2a3b.%A%    
% 208.88/209.03  |- mesh__publicMeSHNote mesh__D051577 2006   
% 208.88/209.03  |- skos__annotation mesh__D018143
% 208.88/209.03       infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%%A%  
% 208.88/209.03  |- rdf__type mesh__D018143sskos__Concept
% 208.88/209.03  |- mesh__dateCreated mesh__D018143 1993-06-04
% 208.88/209.03  |- mesh__recordOriginator mesh__D018143 AGS
% 208.88/209.03  |- skos__scopeNote mesh__D018143
% 208.88/209.03       A genus of the family HERPESVIRIDAE, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans and new world primates. The type species human herpesvirus 4 %28%HERPESVIRUS 4, HUMAN%29% is better known as the Epstein-Barr virus.%A%    
% 208.88/209.03  |- skos__broader mesh__D018143smesh__D018142
% 208.88/209.03  |- mesh__recordMaintainer mesh__D018143 sjn
% 208.88/209.03  |- mesh__recordAuthorizer mesh__D018143 sjn
% 208.88/209.03  |- mesh__publicMeSHNote mesh__D018143 94   
% 208.88/209.03  |- mesh__dateEstablished mesh__D018143 1994-01-01
% 208.88/209.03  |- skos__hiddenLabel mesh__D018143 Lymphocryptoviruses
% 208.88/209.03  |- mesh__historyNote mesh__D018143 94   
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D018143 2005
% 208.88/209.03  |- mesh__dateRevised mesh__D018143 2004-07-13
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D018143 2006
% 208.88/209.03  |- skos__prefLabel mesh__D018143 Lymphocryptovirus
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D010160 2006
% 208.88/209.03  |- mesh__recordMaintainer mesh__D010160 lkt
% 208.88/209.03  |- mesh__dateCreated mesh__D010160 1978-05-19
% 208.88/209.03  |- skos__prefLabel mesh__D010160 Palate, Soft
% 208.88/209.03  |- mesh__recordOriginator mesh__D010160 RC
% 208.88/209.03  |- skos__hiddenLabel mesh__D010160 Palatinum, Velum
% 208.88/209.03  |- mesh__dateRevised mesh__D010160 2003-07-09
% 208.88/209.03  |- skos__altLabel mesh__D010160 Velum Palatinum
% 208.88/209.03  |- mesh__publicMeSHNote mesh__D010160 79   
% 208.88/209.03  |- skos__broader mesh__D010160smesh__D010159
% 208.88/209.03  |- skos__hiddenLabel mesh__D010160 Palates, Soft
% 208.88/209.03  |- rdf__type mesh__D010160sskos__Concept
% 208.88/209.03  |- mesh__recordAuthorizer mesh__D010160 sjn
% 208.88/209.03  |- mesh__historyNote mesh__D010160 79   
% 208.88/209.03  |- mesh__dateEstablished mesh__D010160 1979-01-01
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D010160 2005
% 208.88/209.03  |- skos__historyNote mesh__D010160 Palate %28%1966-1978%29%
% 208.88/209.03  |- skos__scopeNote mesh__D010160
% 208.88/209.03       A movable fold suspended from the posterior border of the hard palate. The uvula hangs from the middle of the lower border.%A%    
% 208.88/209.03  |- skos__altLabel mesh__D010160 Soft Palate
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D010160 2004
% 208.88/209.03  |- rdf__type mesh__D004921sskos__Concept
% 208.88/209.03  |- skos__prefLabel mesh__D004921 Erythropoietin
% 208.88/209.03  |- mesh__recordOriginator mesh__D004921 NLM
% 208.88/209.03  |- mesh__dateCreated mesh__D004921 1999-01-01
% 208.88/209.03  |- skos__scopeNote mesh__D004921
% 208.88/209.03       Glycoprotein hormone, secreted chiefly by the kidney in the adult and the liver in the fetus, that acts on erythroid stem cells of the bone marrow to stimulate proliferation and differentiation.%A%    
% 208.88/209.03  |- mesh__recordAuthorizer mesh__D004921 sjn
% 208.88/209.03  |- mesh__recordMaintainer mesh__D004921 ssb
% 208.88/209.03  |- skos__broader mesh__D004921smesh__D003115
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D004921 2006
% 208.88/209.03  |- mesh__dateRevised mesh__D004921 2005-06-30
% 208.88/209.03  |- skos__related mesh__D004921smesh__D017467
% 208.88/209.03  |- skos__annotation mesh__D004921 /biosyn /physiol permitted   
% 208.88/209.03  |- skos__broader mesh__D018100Q000037smesh__D018100
% 208.88/209.03  |- mesh__preferredCombination mesh__D018100Q000037smesh__D006633
% 208.88/209.03  |- rdf__type mesh__D018100Q000037smesh__CompoundConcept
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D004123 1996
% 208.88/209.03  |- mesh__dateCreated mesh__D004123 1999-01-01
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D004123 1999
% 208.88/209.03  |- mesh__dateRevised mesh__D004123 1992-05-13
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D004123 2004
% 208.88/209.03  |- skos__broader mesh__D004123smesh__D008744
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D004123 2002
% 208.88/209.03  |- mesh__recordAuthorizer mesh__D004123 PLS
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D004123 1997
% 208.88/209.03  |- mesh__publicMeSHNote mesh__D004123 74   
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D004123 1994
% 208.88/209.03  |- mesh__recordOriginator mesh__D004123 NLM
% 208.88/209.03  |- rdf__type mesh__D004123sskos__Concept
% 208.88/209.03  |- skos__historyNote mesh__D004123 METHYLAMINES %28%1972-1973%29%
% 208.88/209.03  |- mesh__dateEstablished mesh__D004123 1974-01-01
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D004123 2005
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D004123 1995
% 208.88/209.03  |- skos__prefLabel mesh__D004123 Dimethylamines
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D004123 2000
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D004123 1998
% 208.88/209.03  |- mesh__recordMaintainer mesh__D004123 TGC
% 208.88/209.03  |- mesh__historyNote mesh__D004123 74%28%72%29%   
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D004123 2003
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D004123 2006
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D004123 1993
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D004123 2001
% 208.88/209.03  |- skos__broader mesh__D017849smesh__D000830
% 208.88/209.03  |- skos__scopeNote mesh__D017849
% 208.88/209.03       Animals produced by the mating of littermates or siblings over multiple generations. The resultant strain of animals is virtually identical genotypically. Highly inbred animal lines allow the study of certain traits in a relatively pure form. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 208.88/209.03  |- skos__hiddenLabel mesh__D017849 Animal Inbred Strain
% 208.88/209.03  |- skos__hiddenLabel mesh__D017849 Animal, Inbred Strains
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D017849 2005
% 208.88/209.03  |- skos__hiddenLabel mesh__D017849 Strain, Inbred Animal
% 208.88/209.03  |- skos__hiddenLabel mesh__D017849 Strains, Inbred Animal
% 208.88/209.03  |- skos__hiddenLabel mesh__D017849 Inbred Strains Animal
% 208.88/209.03  |- skos__hiddenLabel mesh__D017849 Animal Strains, Inbred
% 208.88/209.03  |- mesh__publicMeSHNote mesh__D017849 94   
% 208.88/209.03  |- mesh__historyNote mesh__D017849 94   
% 208.88/209.03  |- skos__hiddenLabel mesh__D017849 Inbred Animal Strain
% 208.88/209.03  |- skos__altLabel mesh__D017849 Inbred Strain of Animal
% 208.88/209.03  |- skos__hiddenLabel mesh__D017849 Animals Inbred Strain
% 208.88/209.03  |- skos__hiddenLabel mesh__D017849 Animal Inbred Strains
% 208.88/209.03  |- skos__altLabel mesh__D017849 Inbred Strains of Animals
% 208.88/209.03  |- mesh__recordMaintainer mesh__D017849 nns
% 208.88/209.03  |- skos__hiddenLabel mesh__D017849 Strains Animal, Inbred
% 208.88/209.03  |- mesh__dateCreated mesh__D017849 1993-02-16
% 208.88/209.03  |- skos__hiddenLabel mesh__D017849 Inbred Strain, Animal
% 208.88/209.03  |- skos__annotation mesh__D017849
% 208.88/209.03       IM GEN or unspecified; coord NIM with specific exper animal %28%NIM%29%; when IM, qualif permitted; do not forget also to check tag ANIMALS%A%  
% 208.88/209.03  |- skos__hiddenLabel mesh__D017849 Animals Inbred Strains
% 208.88/209.03  |- skos__hiddenLabel mesh__D017849 Animal Strain, Inbred
% 208.88/209.03  |- skos__altLabel mesh__D017849 Inbred Animal Strains
% 208.88/209.03  |- skos__historyNote mesh__D017849 Inbreeding %28%1970-1993%29%
% 208.88/209.03  |- skos__hiddenLabel mesh__D017849 Strains, Animal Inbred
% 208.88/209.03  |- skos__hiddenLabel mesh__D017849 Strains Animals, Inbred
% 208.88/209.03  |- mesh__recordOriginator mesh__D017849 TGC
% 208.88/209.03  |- skos__hiddenLabel mesh__D017849 Inbred Strains Animals
% 208.88/209.03  |- rdf__type mesh__D017849sskos__Concept
% 208.88/209.03  |- skos__prefLabel mesh__D017849 Animals, Inbred Strains
% 208.88/209.03  |- mesh__recordAuthorizer mesh__D017849 sjn
% 208.88/209.03  |- mesh__dateEstablished mesh__D017849 1994-01-01
% 208.88/209.03  |- skos__altLabel mesh__D017849 Inbred Strains, Animal
% 208.88/209.03  |- mesh__dateRevised mesh__D017849 2004-07-07
% 208.88/209.03  |- skos__hiddenLabel mesh__D017849 Strain, Animal Inbred
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D017849 2006
% 208.88/209.03  |- skos__broader mesh__D017849smesh__D000828
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D003829 2002
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D003829 1998
% 208.88/209.03  |- skos__altLabel mesh__D003829 Bridgeworks, Dental
% 208.88/209.03  |- skos__hiddenLabel mesh__D003829 Dentures, Partial
% 208.88/209.03  |- mesh__recordAuthorizer mesh__D003829 SJN
% 208.88/209.03  |- skos__broader mesh__D003829smesh__D003778
% 208.88/209.03  |- skos__hiddenLabel mesh__D003829 Partial Dentures
% 208.88/209.03  |- skos__altLabel mesh__D003829 Dental Bridgework
% 208.88/209.03  |- skos__prefLabel mesh__D003829 Denture, Partial
% 208.88/209.03  |- skos__annotation mesh__D003829
% 208.88/209.03       labeling for ownership or identification = DENTURE IDENTIFICATION MARKING%A%  
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D003829 2006
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D003829 2001
% 208.88/209.03  |- mesh__recordOriginator mesh__D003829 NLM
% 208.88/209.03  |- skos__scopeNote mesh__D003829
% 208.88/209.03       A denture replacing one or more %28%but not all%29% natural teeth. It is supported and retained by underlying tissue and some or all of the remaining teeth.%A%    
% 208.88/209.03  |- mesh__dateEstablished mesh__D003829 1965-01-01
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D003829 2005
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D003829 2004
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D003829 2000
% 208.88/209.03  |- mesh__recordMaintainer mesh__D003829 TGC
% 208.88/209.03  |- skos__altLabel mesh__D003829 Dental Bridgeworks
% 208.88/209.03  |- mesh__dateRevised mesh__D003829 1997-06-20
% 208.88/209.03  |- mesh__dateCreated mesh__D003829 1999-01-01
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D003829 2003
% 208.88/209.03  |- mesh__publicMeSHNote mesh__D003829
% 208.88/209.03       65; CROWN AND BRIDGEWORK was heading 1963-64   
% 208.88/209.03  |- skos__hiddenLabel mesh__D003829 Partial Denture
% 208.88/209.03  |- mesh__historyNote mesh__D003829
% 208.88/209.03       65; CROWN AND BRIDGEWORK was heading 1963-64   
% 208.88/209.03  |- rdf__type mesh__D003829sskos__Concept
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D003829 1999
% 208.88/209.03  |- skos__altLabel mesh__D003829 Bridgework, Dental
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014551 2006
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014551 1998
% 208.88/209.03  |- skos__hiddenLabel mesh__D014551 Tract, Urinary
% 208.88/209.03  |- mesh__historyNote mesh__D014551 72   
% 208.88/209.03  |- skos__related mesh__D014551smesh__D014567
% 208.88/209.03  |- skos__hiddenLabel mesh__D014551 Tracts, Urinary
% 208.88/209.03  |- mesh__dateCreated mesh__D014551 1999-01-01
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014551 1999
% 208.88/209.03  |- skos__prefLabel mesh__D014551 Urinary Tract
% 208.88/209.03  |- skos__broader mesh__D014551smesh__D014566
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014551 2002
% 208.88/209.03  |- mesh__dateRevised mesh__D014551 1997-06-20
% 208.88/209.03  |- skos__annotation mesh__D014551
% 208.88/209.03       GEN: prefer specific organ; /radiogr = UROGRAPHY but for general only: prefer /radiogr with specific organs of the urinary tract; /surg: consider also UROLOGIC SURGICAL PROCEDURES; dis = UROLOGIC DISEASES; neopl = UROLOGIC NEOPLASMS but prefer specifics%A%  
% 208.88/209.03  |- mesh__dateEstablished mesh__D014551 1972-01-01
% 208.88/209.03  |- mesh__recordAuthorizer mesh__D014551 SJN
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014551 2003
% 208.88/209.03  |- rdf__type mesh__D014551sskos__Concept
% 208.88/209.03  |- skos__hiddenLabel mesh__D014551 Urinary Tracts
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014551 2005
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014551 2000
% 208.88/209.03  |- mesh__publicMeSHNote mesh__D014551 72   
% 208.88/209.03  |- skos__historyNote mesh__D014551 Urogenital System %28%1966-1971%29%
% 208.88/209.03  |- mesh__recordOriginator mesh__D014551 NLM
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014551 2004
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D014551 2001
% 208.88/209.03  |- mesh__recordMaintainer mesh__D014551 TGC
% 208.88/209.03  |- skos__broader mesh__D004194Q000635smesh__D004194
% 208.88/209.03  |- mesh__preferredCombination mesh__D004194Q000635smesh__D018562
% 208.88/209.03  |- rdf__type mesh__D004194Q000635smesh__CompoundConcept
% 208.88/209.03  |- rdf__type mesh__D008514sskos__Concept
% 208.88/209.03  |- skos__broader mesh__D008514smesh__D008519
% 208.88/209.03  |- mesh__recordAuthorizer mesh__D008514 sjn
% 208.88/209.03  |- mesh__recordOriginator mesh__D008514 NLM
% 208.88/209.03  |- mesh__recordMaintainer mesh__D008514 jls
% 208.88/209.03  |- skos__altLabel mesh__D008514 Arabic Medicine
% 208.88/209.03  |- skos__prefLabel mesh__D008514 Medicine, Arabic
% 208.88/209.03  |- skos__broader mesh__D008514smesh__D006666
% 208.88/209.03  |- skos__annotation mesh__D008514
% 208.88/209.03       is not medicine in Arab countries %28% = MEDICINE + specific country%29%; no qualif; Manual 32.13; Avicenna %28%also called Ibn Sina%29% is indexed as Avicenna in field 15 + check tags BIOGRAPHY + HISTORY OF MEDICINE, MEDIEVAL: TN 12; DF: MED ARABIC%A%  
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D008514 2006
% 208.88/209.03  |- mesh__dateRevised mesh__D008514 2004-07-07
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D008514 2005
% 208.88/209.03  |- mesh__dateCreated mesh__D008514 1999-01-01
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D000531 2002
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D000531 1996
% 208.88/209.03  |- skos__related mesh__D000531smesh__D009051
% 208.88/209.03  |- mesh__recordOriginator mesh__D000531 NLM
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D000531 1997
% 208.88/209.03  |- mesh__dateCreated mesh__D000531 1999-01-01
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D000531 1994
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D000531 2005
% 208.88/209.03  |- mesh__recordAuthorizer mesh__D000531 PLS
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D000531 2000
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D000531 1995
% 208.88/209.03  |- skos__annotation mesh__D000531
% 208.88/209.03       no qualif; consider also ATMOSPHERIC PRESSURE; /adv eff = probably ALTITUDE SICKNESS%A%  
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D000531 2006
% 208.88/209.03  |- skos__prefLabel mesh__D000531 Altitude
% 208.88/209.03  |- mesh__recordMaintainer mesh__D000531 PLS
% 208.88/209.03  |- skos__hiddenLabel mesh__D000531 Altitudes
% 208.88/209.03  |- rdf__type mesh__D000531sskos__Concept
% 208.88/209.03  |- mesh__dateRevised mesh__D000531 1991-11-02
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D000531 2001
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D000531 1998
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D000531 1992
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D000531 2003
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D000531 1999
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D000531 1993
% 208.88/209.03  |- skos__broader mesh__D000531smesh__D004777
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D000531 2004
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D000531 1991
% 208.88/209.03  |- skos__historyNote mesh__D013459 Fluorides %28%1966-1979%29%
% 208.88/209.03  |- rdf__type mesh__D013459sskos__Concept
% 208.88/209.03  |- skos__scopeNote mesh__D013459
% 208.88/209.03       Sulfur hexafluoride. An inert gas used mainly as a test gas in respiratory physiology. Other uses include its injection in vitreoretinal surgery to restore the vitreous chamber and as a tracer in monitoring the dispersion and deposition of air pollutants.%A%    
% 208.88/209.03  |- mesh__recordOriginator mesh__D013459 RLS
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D013459 1994
% 208.88/209.03  |- mesh__activeMeSHYear mesh__D013459 2000
% 208.88/209.04  |- mesh__dateEstablished mesh__D013459 1991-01-01
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D013459 2004
% 208.88/209.04  |- mesh__publicMeSHNote mesh__D013459
% 208.88/209.04       91; was see under FLUORIDES 1980-90   
% 208.88/209.04  |- mesh__dateCreated mesh__D013459 1979-05-25
% 208.88/209.04  |- skos__broader mesh__D013459smesh__D005459
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D013459 1995
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D013459 1996
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D013459 2001
% 208.88/209.04  |- mesh__recordAuthorizer mesh__D013459 PLS
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D013459 2005
% 208.88/209.04  |- skos__broader mesh__D013459smesh__D013457
% 208.88/209.04  |- mesh__recordMaintainer mesh__D013459 TPW
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D013459 1997
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D013459 2002
% 208.88/209.04  |- skos__broader mesh__D013459smesh__D005740
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D013459 2006
% 208.88/209.04  |- skos__prefLabel mesh__D013459 Sulfur Hexafluoride
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D013459 1998
% 208.88/209.04  |- skos__annotation mesh__D013459
% 208.88/209.04       an inert gas used in resp physiol studies   
% 208.88/209.04  |- mesh__dateRevised mesh__D013459 1993-06-03
% 208.88/209.04  |- skos__historyNote mesh__D013459 Gases %28%1966-1979%29%
% 208.88/209.04  |- skos__hiddenLabel mesh__D013459 Hexafluoride, Sulfur
% 208.88/209.04  |- skos__historyNote mesh__D013459 Sulfur %28%1966-1979%29%
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D013459 1999
% 208.88/209.04  |- mesh__historyNote mesh__D013459
% 208.88/209.04       91%28%80%29%; was see under FLUORIDES 1980-90   
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D013459 2003
% 208.88/209.04  |- rdf__type mesh__D024181sskos__Concept
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D024181 2006
% 208.88/209.04  |- skos__hiddenLabel mesh__D024181 Collagen, Type XIII
% 208.88/209.04  |- mesh__historyNote mesh__D024181 2002; use COLLAGEN %28%1992-2001%29%   
% 208.88/209.04  |- skos__annotation mesh__D024181
% 208.88/209.04       precursors: coord IM with PROCOLLAGEN %28%IM%29%   
% 208.88/209.04  |- mesh__dateRevised mesh__D024181 2004-07-07
% 208.88/209.04  |- skos__broader mesh__D024181smesh__D024041
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D024181 2005
% 208.88/209.04  |- mesh__recordMaintainer mesh__D024181 jmp
% 208.88/209.04  |- mesh__recordAuthorizer mesh__D024181 sjn
% 208.88/209.04  |- skos__altLabel mesh__D024181 Collagen Type XIII, alpha1 Chain
% 208.88/209.04  |- mesh__dateEstablished mesh__D024181 2002-01-01
% 208.88/209.04  |- mesh__publicMeSHNote mesh__D024181
% 208.88/209.04       2002; see COLLAGEN %28%1992-2001%29%   
% 208.88/209.04  |- skos__historyNote mesh__D024181 Collagen %28%1992-2001%29%
% 208.88/209.04  |- skos__scopeNote mesh__D024181
% 208.88/209.04       A non-fibrillar collagen found as a ubiquitously expressed membrane- associated protein. Type XIII collagen contains both collagenous and non-collagenous domains along with a transmembrane domain within its N-terminal region.%A%    
% 208.88/209.04  |- skos__prefLabel mesh__D024181 Collagen Type XIII
% 208.88/209.04  |- skos__altLabel mesh__D024181 Collagen alpha1%28%XIII%29%
% 208.88/209.04  |- skos__hiddenLabel mesh__D024181 Procollagen, Type XIII
% 208.88/209.04  |- skos__altLabel mesh__D024181 Type XIII Procollagen
% 208.88/209.04  |- mesh__dateCreated mesh__D024181 2001-07-25
% 208.88/209.04  |- mesh__recordOriginator mesh__D024181 jmp
% 208.88/209.04  |- skos__altLabel mesh__D024181 Type XIII Collagen
% 208.88/209.04  |- skos__broader mesh__D018942smesh__D047028
% 208.88/209.04  |- mesh__recordMaintainer mesh__D018942 ags
% 208.88/209.04  |- mesh__dateRevised mesh__D018942 2005-07-27
% 208.88/209.04  |- mesh__dateCreated mesh__D018942 1995-05-26
% 208.88/209.04  |- mesh__publicMeSHNote mesh__D018942 96   
% 208.88/209.04  |- skos__hiddenLabel mesh__D018942 Polyketides, Macrolide
% 208.88/209.04  |- skos__hiddenLabel mesh__D018942 Ketolides, Macrolide
% 208.88/209.04  |- skos__prefLabel mesh__D018942 Macrolides
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D018942 2006
% 208.88/209.04  |- mesh__historyNote mesh__D018942 96   
% 208.88/209.04  |- rdf__type mesh__D018942sskos__Concept
% 208.88/209.04  |- mesh__recordOriginator mesh__D018942 JRT
% 208.88/209.04  |- skos__altLabel mesh__D018942 Polyketide Macrolides
% 208.88/209.04  |- mesh__dateEstablished mesh__D018942 1996-01-01
% 208.88/209.04  |- mesh__recordAuthorizer mesh__D018942 ags
% 208.88/209.04  |- skos__broader mesh__D018942smesh__D007783
% 208.88/209.04  |- skos__hiddenLabel mesh__D018942 Macrolides, Polyketide
% 208.88/209.04  |- skos__altLabel mesh__D018942 Macrolide Ketolides
% 208.88/209.04  |- skos__scopeNote mesh__D018942
% 208.88/209.04       A group of macrocyclic compounds formed by chain extension of multiple PROPIONATES and cyclized into a large %28%typically 12, 14, 16%29% membered lactone.  They are often glycosylated. Many of them are ANTIBIOTICS.%A%    
% 208.88/209.04  |- skos__broader mesh__D018942smesh__D006027
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D018942 2006A
% 208.88/209.04  |- skos__hiddenLabel mesh__D018144 Rhadinoviruses
% 208.88/209.04  |- skos__scopeNote mesh__D018144
% 208.88/209.04       A genus of the family HERPESVIRIDAE, subfamily GAMMAHERPESVIRINAE, infecting New World primates and other species. HERPESVIRUS 2, SAIMIRIINE is the type species.%A%    
% 208.88/209.04  |- skos__hiddenLabel mesh__D018144 ateles, Herpesvirus
% 208.88/209.04  |- skos__prefLabel mesh__D018144 Rhadinovirus
% 208.88/209.04  |- skos__hiddenLabel mesh__D018144 Herpesvirus 2, Equine
% 208.88/209.04  |- mesh__recordMaintainer mesh__D018144 ags
% 208.88/209.04  |- skos__altLabel mesh__D018144 Murine herpesvirus 68
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D018144 2004
% 208.88/209.04  |- mesh__historyNote mesh__D018144 94   
% 208.88/209.04  |- skos__altLabel mesh__D018144 Equine Herpesvirus 2
% 208.88/209.04  |- skos__altLabel mesh__D018144 Equid herpesvirus 2
% 208.88/209.04  |- mesh__dateRevised mesh__D018144 2001-07-25
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D018144 2005
% 208.88/209.04  |- skos__altLabel mesh__D018144 Murid herpesvirus 4
% 208.88/209.04  |- skos__broader mesh__D018144smesh__D018142
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D018144 2002
% 208.88/209.04  |- mesh__recordOriginator mesh__D018144 AGS
% 208.88/209.04  |- mesh__dateCreated mesh__D018144 1993-06-04
% 208.88/209.04  |- skos__altLabel mesh__D018144 Mouse herpesvirus strain 68
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D018144 2006
% 208.88/209.04  |- mesh__dateEstablished mesh__D018144 1994-01-01
% 208.88/209.04  |- skos__annotation mesh__D018144
% 208.88/209.04       infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%%A%  
% 208.88/209.04  |- rdf__type mesh__D018144sskos__Concept
% 208.88/209.04  |- mesh__recordAuthorizer mesh__D018144 sjn
% 208.88/209.04  |- skos__altLabel mesh__D018144 Herpesvirus ateles
% 208.88/209.04  |- mesh__publicMeSHNote mesh__D018144 94   
% 208.88/209.04  |- skos__altLabel mesh__D018144 Ateline herpesvirus 2
% 208.88/209.04  |- skos__hiddenLabel mesh__D018144 herpesvirus 68, Murine
% 208.88/209.04  |- skos__altLabel mesh__D018144 Herpesvirus 2 %28%gamma%29%, Ateline
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D018144 2003
% 208.88/209.04  |- mesh__recordAuthorizer mesh__D010161 PLS
% 208.88/209.04  |- mesh__recordOriginator mesh__D010161 NLM
% 208.88/209.04  |- mesh__recordMaintainer mesh__D010161 TGC
% 208.88/209.04  |- rdf__type mesh__D010161sskos__Concept
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010161 2002
% 208.88/209.04  |- skos__broader mesh__D010161smesh__D010163
% 208.88/209.04  |- skos__annotation mesh__D010161
% 208.88/209.04       IM; SPEC: SPEC qualif; as NIM coord, no qualif; check tags HISTORICAL ARTICLE %26% ANCIENT or MEDIEVAL; for prehist, ANCIENT tag is all right; paleodontology is for pre-Columbian, nothing later; DF: PALEODONTOL%A%  
% 208.88/209.04  |- skos__scopeNote mesh__D010161
% 208.88/209.04       The study of the teeth of early forms of life through fossil remains.%A%    
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010161 2003
% 208.88/209.04  |- mesh__dateCreated mesh__D010161 1999-01-01
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010161 1996
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010161 2005
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010161 1998
% 208.88/209.04  |- mesh__dateRevised mesh__D010161 1994-04-11
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010161 2004
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010161 1997
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010161 2006
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010161 2000
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010161 1999
% 208.88/209.04  |- skos__prefLabel mesh__D010161 Paleodontology
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010161 2001
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010161 1995
% 208.88/209.04  |- skos__hiddenLabel mesh__D051578 Feline Sarcoma Proto Oncogene Protein
% 208.88/209.04  |- skos__hiddenLabel mesh__D051578 fes, Proto-Oncogene Protein
% 208.88/209.04  |- mesh__recordAuthorizer mesh__D051578 sjn
% 208.88/209.04  |- skos__altLabel mesh__D051578 fes Proto-Oncogene Proteins
% 208.88/209.04  |- mesh__dateEstablished mesh__D051578 2006-01-01
% 208.88/209.04  |- skos__altLabel mesh__D051578 c-fes Proteins
% 208.88/209.04  |- skos__hiddenLabel mesh__D051578 c-fes, Proto-Oncogene Proteins
% 208.88/209.04  |- skos__altLabel mesh__D051578 Proto-Oncogene Protein fes
% 208.88/209.04  |- skos__hiddenLabel mesh__D051578 Proto-Oncogene Proteins, fes
% 208.88/209.04  |- skos__hiddenLabel mesh__D051578 fps Proto Oncogene Protein
% 208.88/209.04  |- skos__hiddenLabel mesh__D051578 Proteins, c-fes
% 208.88/209.04  |- mesh__publicMeSHNote mesh__D051578
% 208.88/209.04       2006; PROTO-ONCOGENE PROTEIN C-FES was indexed under PROTEIN-TYROSINE KINASE %26% PROTO-ONCOGENE PROTEINS 1986-2005%A%  
% 208.88/209.04  |- skos__altLabel mesh__D051578 c-fes Proto-Oncogene Proteins
% 208.88/209.04  |- skos__hiddenLabel mesh__D051578 Proto-Oncogene Protein, fps
% 208.88/209.04  |- skos__prefLabel mesh__D051578 Proto-Oncogene Proteins c-fes
% 208.88/209.04  |- skos__broader mesh__D051578smesh__D011505
% 208.88/209.04  |- skos__hiddenLabel mesh__D051578 Proto Oncogene Protein fes
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D051578 2006
% 208.88/209.04  |- skos__hiddenLabel mesh__D051578 Tyrosine Kinase, c-fes
% 208.88/209.04  |- skos__hiddenLabel mesh__D051578 Proto Oncogene Proteins c fes
% 208.88/209.04  |- mesh__historyNote mesh__D051578 2006%28%1986%29%   
% 208.88/209.04  |- skos__altLabel mesh__D051578 fps Proto-Oncogene Protein
% 208.88/209.04  |- skos__hiddenLabel mesh__D051578 Proto-Oncogene Proteins, c-fes
% 208.88/209.04  |- skos__altLabel mesh__D051578 Proto-Oncogene Protein c-fes
% 208.88/209.04  |- mesh__recordMaintainer mesh__D051578 DRC
% 208.88/209.04  |- mesh__recordOriginator mesh__D051578 DRC
% 208.88/209.04  |- skos__hiddenLabel mesh__D051578 c fes Tyrosine Kinase
% 208.88/209.04  |- skos__altLabel mesh__D051578 c-fes Tyrosine Kinase
% 208.88/209.04  |- skos__hiddenLabel mesh__D051578 c fes Proto Oncogene Proteins
% 208.88/209.04  |- skos__hiddenLabel mesh__D051578 c fes Proteins
% 208.88/209.04  |- rdf__type mesh__D051578sskos__Concept
% 208.88/209.04  |- skos__hiddenLabel mesh__D051578 Kinase, c-fes Tyrosine
% 208.88/209.04  |- mesh__dateCreated mesh__D051578 2005-06-30
% 208.88/209.04  |- skos__altLabel mesh__D051578 Feline Sarcoma Proto-Oncogene Protein
% 208.88/209.04  |- skos__scopeNote mesh__D051578
% 208.88/209.04       Proto-oncogene proteins fes are protein-tyrosine kinases with a central SH2 DOMAIN. It has been implicated in SIGNAL TRANSDUCTION PATHWAYS for CELL DIFFERENTIATION of a variety of cell types including MYELOID PROGENITOR CELLS. Fes proto-oncogene proteins also bind TUBULIN and promotes MICROTUBULE assembly.%A%    
% 208.88/209.04  |- skos__hiddenLabel mesh__D051578 fes Proto Oncogene Proteins
% 208.88/209.04  |- skos__hiddenLabel mesh__D051578 Proto Oncogene Protein c fes
% 208.88/209.04  |- skos__hiddenLabel mesh__D051578 c-fes, Proto-Oncogene Protein
% 208.88/209.04  |- skos__broader mesh__D051578smesh__D011518
% 208.88/209.04  |- mesh__historyNote mesh__D004124
% 208.88/209.04       92; was DIMETHYLAMINOAZOBENZENE 1963-91   
% 208.88/209.04  |- skos__annotation mesh__D004124
% 208.88/209.04       usually NIM in DAB-induced exper cancer: no qualif; when IM, D25-26 qualif; DF: note short X ref%A%  
% 208.88/209.04  |- skos__scopeNote mesh__D004124
% 208.88/209.04       A reagent used mainly to induce experimental liver cancer. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, p. 89%29% published in 1985, this compound %22%may reasonably be anticipated to be a carcinogen.%22% %28%Merck, 11th ed%29%%A%    
% 208.88/209.04  |- skos__altLabel mesh__D004124 Methyl Yellow
% 208.88/209.04  |- skos__hiddenLabel mesh__D004124 p Dimethylaminoazobenzene
% 208.88/209.04  |- skos__hiddenLabel mesh__D004124 4 Dimethylaminoazobenzene
% 208.88/209.04  |- skos__altLabel mesh__D004124 4-Dimethylaminoazobenzene
% 208.88/209.04  |- skos__broader mesh__D004124smesh__D000814
% 208.88/209.04  |- mesh__recordAuthorizer mesh__D004124 NLM
% 208.88/209.04  |- mesh__onlineNote mesh__D004124
% 208.88/209.04       use P-DIMETHYLAMINOAZOBENZENE to search DIMETHYLAMINOAZOBENZENE 1966-91%A%  
% 208.88/209.04  |- rdf__type mesh__D004124sskos__Concept
% 208.88/209.04  |- skos__prefLabel mesh__D004124 p-Dimethylaminoazobenzene
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D004124 2006
% 208.88/209.04  |- mesh__recordOriginator mesh__D004124 NLM
% 208.88/209.04  |- skos__altLabel mesh__D004124 Butter Yellow
% 208.88/209.04  |- mesh__publicMeSHNote mesh__D004124
% 208.88/209.04       92; was DIMETHYLAMINOAZOBENZENE 1963-91   
% 208.88/209.04  |- mesh__dateCreated mesh__D004124 1999-01-01
% 208.88/209.04  |- mesh__dateRevised mesh__D004124 2005-07-06
% 208.88/209.04  |- mesh__recordMaintainer mesh__D004124 NLM
% 208.88/209.04  |- skos__hiddenLabel mesh__D014552 Urinary Tract Infection
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D014552 1995
% 208.88/209.04  |- skos__broader mesh__D014552smesh__D007239
% 208.88/209.04  |- skos__hiddenLabel mesh__D014552 Infections, Urinary Tract
% 208.88/209.04  |- skos__hiddenLabel mesh__D014552 Tract Infections, Urinary
% 208.88/209.04  |- skos__broader mesh__D014552smesh__D014570
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D014552 2000
% 208.88/209.04  |- skos__annotation mesh__D014552
% 208.88/209.04       infection in any organ of the urinary tract; GEN or unspecified; prefer specific organ/diseases coord with infection term; /drug ther: consider also ANTI-INFECTIVE AGENTS, URINARY%A%  
% 208.88/209.04  |- skos__hiddenLabel mesh__D014552 Infection, Urinary Tract
% 208.88/209.04  |- mesh__recordOriginator mesh__D014552 NLM
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D014552 2003
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D014552 2001
% 208.88/209.04  |- skos__scopeNote mesh__D014552
% 208.88/209.04       Infections affecting those structures of the body which participate in the secretion and elimination of urine, i.e., the kidney, the ureters, the urinary bladder, and the urethra.%A%    
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D014552 2005
% 208.88/209.04  |- rdf__type mesh__D014552sskos__Concept
% 208.88/209.04  |- skos__prefLabel mesh__D014552 Urinary Tract Infections
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D014552 2004
% 208.88/209.04  |- mesh__recordAuthorizer mesh__D014552 PLS
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D014552 1996
% 208.88/209.04  |- skos__hiddenLabel mesh__D014552 Tract Infection, Urinary
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D014552 2006
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D014552 1998
% 208.88/209.04  |- mesh__recordMaintainer mesh__D014552 TGC
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D014552 2002
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D014552 1997
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D014552 1994
% 208.88/209.04  |- mesh__dateCreated mesh__D014552 1999-01-01
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D014552 1999
% 208.88/209.04  |- mesh__dateRevised mesh__D014552 1993-06-03
% 208.88/209.04  |- skos__related mesh__D014552smesh__D000892
% 208.88/209.04  |- skos__broader mesh__D008515smesh__D008519
% 208.88/209.04  |- mesh__recordMaintainer mesh__D008515 ssb
% 208.88/209.04  |- skos__hiddenLabel mesh__D008515 Medicine, Siddha
% 208.88/209.04  |- mesh__dateRevised mesh__D008515 2003-07-09
% 208.88/209.04  |- skos__scopeNote mesh__D008515
% 208.88/209.04       The traditional Hindu system of medicine which is based on customs, beliefs, and practices of the Hindu culture. Ayurveda means %22%the science of Life%22%: veda - science, ayur - life.%A%    
% 208.88/209.04  |- mesh__recordAuthorizer mesh__D008515 sjn
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D008515 2005
% 208.88/209.04  |- skos__prefLabel mesh__D008515 Medicine, Ayurvedic
% 208.88/209.04  |- mesh__dateCreated mesh__D008515 1999-01-01
% 208.88/209.04  |- mesh__recordOriginator mesh__D008515 NLM
% 208.88/209.04  |- skos__annotation mesh__D008515 Manual 32.13; DF: MED AYURVEDIC   
% 208.88/209.04  |- mesh__historyNote mesh__D008515 81; was MEDICINE, HINDU 1964-80   
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D008515 2006
% 208.88/209.04  |- mesh__publicMeSHNote mesh__D008515 81; was MEDICINE, HINDU 1964-80   
% 208.88/209.04  |- mesh__onlineNote mesh__D008515
% 208.88/209.04       use MEDICINE, AYURVEDIC to search MEDICINE, HINDU 1966-80%A%  
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D008515 2004
% 208.88/209.04  |- rdf__type mesh__D008515sskos__Concept
% 208.88/209.04  |- skos__altLabel mesh__D008515 Medicine, Hindu
% 208.88/209.04  |- skos__altLabel mesh__D008515 Ayurvedic Medicine
% 208.88/209.04  |- mesh__dateEstablished mesh__D008515 1964-01-01
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D000532 2002
% 208.88/209.04  |- skos__hiddenLabel mesh__D000532 Sicknesses, Mountain
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D000532 2004
% 208.88/209.04  |- mesh__publicMeSHNote mesh__D000532 91; was see under ANOXIA 1975-90   
% 208.88/209.04  |- mesh__recordOriginator mesh__D000532 NLM
% 208.88/209.04  |- mesh__dateCreated mesh__D000532 1999-01-01
% 208.88/209.04  |- skos__hiddenLabel mesh__D000532 Altitude Sicknesses
% 208.88/209.04  |- skos__hiddenLabel mesh__D000532 Sicknesses, Altitude
% 208.88/209.04  |- mesh__recordMaintainer mesh__D000532 KEV
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D000532 2000
% 208.88/209.04  |- skos__hiddenLabel mesh__D000532 Sickness, Altitude
% 208.88/209.04  |- skos__altLabel mesh__D000532 Mountain Sickness
% 208.88/209.04  |- rdf__type mesh__D000532sskos__Concept
% 208.88/209.04  |- skos__scopeNote mesh__D000532
% 208.88/209.04       A morbid condition of ANOXIA caused by the reduced available oxygen at high altitudes.%A%    
% 208.88/209.04  |- mesh__recordAuthorizer mesh__D000532 sjn
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D000532 2005
% 208.88/209.04  |- skos__hiddenLabel mesh__D000532 Sickness, Mountain
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D000532 2001
% 208.88/209.04  |- skos__broader mesh__D000532smesh__D000860
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D000532 2006
% 208.88/209.04  |- mesh__dateEstablished mesh__D000532 1991-01-01
% 208.88/209.04  |- mesh__historyNote mesh__D000532
% 208.88/209.04       91%28%75%29%; was see under ANOXIA 1975-90   
% 208.88/209.04  |- mesh__dateRevised mesh__D000532 1999-11-03
% 208.88/209.04  |- mesh__onlineNote mesh__D000532 search ANOXIA 1966-74   
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D000532 2003
% 208.88/209.04  |- skos__hiddenLabel mesh__D000532 Mountain Sicknesses
% 208.88/209.04  |- skos__prefLabel mesh__D000532 Altitude Sickness
% 208.88/209.04  |- skos__hiddenLabel mesh__D024182 Heterodisomy, Uniparental
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D024182 2005
% 208.88/209.04  |- mesh__dateCreated mesh__D024182 2001-07-25
% 208.88/209.04  |- mesh__publicMeSHNote mesh__D024182 2002   
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D024182 2003
% 208.88/209.04  |- mesh__historyNote mesh__D024182 2002   
% 208.88/209.04  |- skos__altLabel mesh__D024182 Disomy, Uniparental
% 208.88/209.04  |- skos__historyNote mesh__D024182 Chromosome Aberrations %28%1989-2001%29%
% 208.88/209.04  |- skos__hiddenLabel mesh__D024182 Uniparental Heterodisomies
% 208.88/209.04  |- skos__hiddenLabel mesh__D024182 Isodisomies, Uniparental
% 208.88/209.04  |- mesh__dateEstablished mesh__D024182 2002-01-01
% 208.88/209.04  |- skos__scopeNote mesh__D024182
% 208.88/209.04       The presence in a cell of two paired chromosomes from the same parent, with no chromosome of that pair from the other parent. This chromosome composition stems from non-disjunction %28%NONDISJUNCTION, GENETIC%29% events during MEIOSIS. The disomy may be composed of both homologous chromosomes from one parent %28%heterodisomy%29% or a duplicate of one chromosome %28%isodisomy%29%.%A%    
% 208.88/209.04  |- skos__prefLabel mesh__D024182 Uniparental Disomy
% 208.88/209.04  |- mesh__recordAuthorizer mesh__D024182 sjn
% 208.88/209.04  |- skos__hiddenLabel mesh__D024182 Heterodisomies, Uniparental
% 208.88/209.04  |- mesh__recordOriginator mesh__D024182 nns
% 208.88/209.04  |- skos__hiddenLabel mesh__D024182 Disomies, Uniparental
% 208.88/209.04  |- skos__broader mesh__D024182smesh__D002869
% 208.88/209.04  |- skos__hiddenLabel mesh__D024182 Uniparental Isodisomies
% 208.88/209.04  |- mesh__recordMaintainer mesh__D024182 nns
% 208.88/209.04  |- rdf__type mesh__D024182sskos__Concept
% 208.88/209.04  |- skos__hiddenLabel mesh__D024182 Uniparental Disomies
% 208.88/209.04  |- skos__historyNote mesh__D024182
% 208.88/209.04       Chromosome Abnormalities %28%1980-2001%29%
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D024182 2006
% 208.88/209.04  |- mesh__dateRevised mesh__D024182 2002-07-03
% 208.88/209.04  |- skos__historyNote mesh__D024182 Aneuploidy %28%1980-2001%29%
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D024182 2004
% 208.88/209.04  |- skos__broader mesh__D024182smesh__D009630
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D018943 2006
% 208.88/209.04  |- mesh__historyNote mesh__D018943 96   
% 208.88/209.04  |- skos__prefLabel mesh__D018943 Anthracyclines
% 208.88/209.04  |- rdf__type mesh__D018943sskos__Concept
% 208.88/209.04  |- mesh__recordMaintainer mesh__D018943 ssb
% 208.88/209.04  |- mesh__publicMeSHNote mesh__D018943 96   
% 208.88/209.04  |- mesh__dateRevised mesh__D018943 2004-07-07
% 208.88/209.04  |- skos__scopeNote mesh__D018943
% 208.88/209.04       Organic compounds that have a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.%A%    
% 208.88/209.04  |- mesh__dateCreated mesh__D018943 1995-06-05
% 208.88/209.04  |- skos__broader mesh__D018943smesh__D009279
% 208.88/209.04  |- mesh__recordAuthorizer mesh__D018943 sjn
% 208.88/209.04  |- mesh__recordOriginator mesh__D018943 JRT
% 208.88/209.04  |- mesh__dateEstablished mesh__D018943 1996-01-01
% 208.88/209.04  |- skos__broader mesh__D018943smesh__D000617
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D018943 2005
% 208.88/209.04  |- skos__historyNote mesh__D010960 Peptide Hydrolases %28%1975%29%
% 208.88/209.04  |- mesh__publicMeSHNote mesh__D010960 76   
% 208.88/209.04  |- mesh__dateCreated mesh__D010960 1975-07-25
% 208.88/209.04  |- skos__historyNote mesh__D010960 Enzyme Activation %28%1974-1975%29%
% 208.88/209.04  |- skos__broader mesh__D010960smesh__D012697
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010960 2006
% 208.88/209.04  |- skos__prefLabel mesh__D010960 Plasminogen Activators
% 208.88/209.04  |- mesh__dateEstablished mesh__D010960 1976-01-01
% 208.88/209.04  |- skos__altLabel mesh__D010960 Plasminogen Activator
% 208.88/209.04  |- mesh__historyNote mesh__D010960 76   
% 208.88/209.04  |- skos__historyNote mesh__D010960 Plasminogen %28%1974-1975%29%
% 208.88/209.04  |- skos__broader mesh__D010960smesh__D001779
% 208.88/209.04  |- skos__hiddenLabel mesh__D010960 Uterine Tissue Plasminogen Activator
% 208.88/209.04  |- rdf__type mesh__D010960sskos__Concept
% 208.88/209.04  |- mesh__recordAuthorizer mesh__D010960 sjn
% 208.88/209.04  |- mesh__recordMaintainer mesh__D010960 ssb
% 208.88/209.04  |- skos__scopeNote mesh__D010960
% 208.88/209.04       A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to PLASMIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation.%A%    
% 208.88/209.04  |- mesh__recordOriginator mesh__D010960 RLS
% 208.88/209.04  |- skos__annotation mesh__D010960
% 208.88/209.04       /antag: consider also PLASMINOGEN INACTIVATORS   
% 208.88/209.04  |- mesh__dateRevised mesh__D010960 2005-06-30
% 208.88/209.04  |- mesh__onlineNote mesh__D018145
% 208.88/209.04       use PAPILLOMAVIRUSES to search INFECTIOUS HUMAN WART VIRUS 1975-93%A%  
% 208.88/209.04  |- mesh__dateRevised mesh__D018145 2003-07-09
% 208.88/209.04  |- skos__prefLabel mesh__D018145 Papillomavirus, Human
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D018145 2005
% 208.88/209.04  |- skos__hiddenLabel mesh__D018145 Human Papilloma Viruses
% 208.88/209.04  |- skos__hiddenLabel mesh__D018145 Papillomaviruses, Human
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D018145 2006
% 208.88/209.04  |- skos__altLabel mesh__D018145 Papilloma Virus, Human
% 208.88/209.04  |- skos__hiddenLabel mesh__D018145 Human Papilloma Virus
% 208.88/209.04  |- skos__broader mesh__D018145smesh__D010213
% 208.88/209.04  |- skos__altLabel mesh__D018145 Human Wart Virus, Infectious
% 208.88/209.04  |- mesh__publicMeSHNote mesh__D018145
% 208.88/209.04       94; INFECTIOUS HUMAN WART VIRUS was see PAPILLOMAVIRUSES 1975-93%A%  
% 208.88/209.04  |- rdf__type mesh__D018145sskos__Concept
% 208.88/209.04  |- skos__annotation mesh__D018145
% 208.88/209.04       infection: coord IM with PAPILLOMAVIRUS INFECTIONS %28%IM%29%; consider also WARTS%A%  
% 208.88/209.04  |- skos__historyNote mesh__D018145 Papillomavirus %28%1975-1993%29%
% 208.88/209.04  |- skos__altLabel mesh__D018145 Infectious Human Wart Virus
% 208.88/209.04  |- skos__scopeNote mesh__D018145
% 208.88/209.04       A species of PAPILLOMAVIRUS causing WARTS in humans. These benign, squamous EPITHELIAL NEOPLASMS can sometimes progress to malignancy.%A%    
% 208.88/209.04  |- skos__altLabel mesh__D018145 Human papillomavirus
% 208.88/209.04  |- mesh__historyNote mesh__D018145
% 208.88/209.04       94; INFECTIOUS HUMAN WART VIRUS was see PAPILLOMAVIRUSES 1975-93%A%  
% 208.88/209.04  |- mesh__recordOriginator mesh__D018145 AGS
% 208.88/209.04  |- mesh__dateCreated mesh__D018145 1993-06-04
% 208.88/209.04  |- mesh__dateEstablished mesh__D018145 1994-01-01
% 208.88/209.04  |- skos__hiddenLabel mesh__D018145 Papilloma Viruses, Human
% 208.88/209.04  |- skos__hiddenLabel mesh__D018145 Human Papillomaviruses
% 208.88/209.04  |- mesh__recordMaintainer mesh__D018145 ags
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D018145 2004
% 208.88/209.04  |- mesh__recordAuthorizer mesh__D018145 sjn
% 208.88/209.04  |- skos__scopeNote mesh__D010162
% 208.88/209.04       The study of ancient inscriptions and modes of writing. It includes the deciphering of manuscripts and other forms to determine their date, provenance, etc. %28%Webster%27%s 1st ed%29%%A%    
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010162 2006
% 208.88/209.04  |- mesh__recordMaintainer mesh__D010162 TGC
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010162 1999
% 208.88/209.04  |- mesh__dateRevised mesh__D010162 1994-04-21
% 208.88/209.04  |- mesh__recordAuthorizer mesh__D010162 PLS
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010162 2002
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010162 1995
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010162 2005
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010162 1998
% 208.88/209.04  |- mesh__recordOriginator mesh__D010162 NLM
% 208.88/209.04  |- rdf__type mesh__D010162sskos__Concept
% 208.88/209.04  |- skos__annotation mesh__D010162
% 208.88/209.04       study of manuscripts %26% inscriptions; IM; med paleography: do not coord with MEDICINE; DF: PALEOGR%A%  
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010162 2001
% 208.88/209.04  |- skos__broader mesh__D010162smesh__D006236
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010162 2004
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010162 1997
% 208.88/209.04  |- skos__prefLabel mesh__D010162 Paleography
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010162 2000
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010162 2003
% 208.88/209.04  |- mesh__dateCreated mesh__D010162 1999-01-01
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D010162 1996
% 208.88/209.04  |- mesh__recordOriginator mesh__D004923 SH
% 208.88/209.04  |- skos__prefLabel mesh__D004923 Erythrosine
% 208.88/209.04  |- skos__scopeNote mesh__D004923
% 208.88/209.04       A tetraiodofluorescein used as a red coloring in some foods %28%cherries, fish%29%, as a disclosure of DENTAL PLAQUE, and as a stain of some cell types. It has structural similarity to THYROXINE.%A%    
% 208.88/209.04  |- mesh__recordMaintainer mesh__D004923 ssb
% 208.88/209.04  |- mesh__dateEstablished mesh__D004923 1991-01-01
% 208.88/209.04  |- skos__historyNote mesh__D004923 Fluoresceins %28%1966-1978%29%
% 208.88/209.04  |- mesh__historyNote mesh__D004923
% 208.88/209.04       91%28%79%29%; was see under FLUORESCEINS 1979-90   
% 208.88/209.04  |- skos__annotation mesh__D004923
% 208.88/209.04       do not confuse with Erythrocin, a brand of ERYTHROMYCIN   
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D004923 2006
% 208.88/209.04  |- skos__altLabel mesh__D004923 FDC Red No. 3
% 208.88/209.04  |- skos__altLabel mesh__D004923 Erythrosin
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D004923 2005
% 208.88/209.04  |- rdf__type mesh__D004923sskos__Concept
% 208.88/209.04  |- mesh__dateCreated mesh__D004923 1978-02-07
% 208.88/209.04  |- mesh__dateRevised mesh__D004923 2002-07-03
% 208.88/209.04  |- skos__altLabel mesh__D004923 Erythrosine B
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D004923 2004
% 208.88/209.04  |- skos__altLabel mesh__D004923 FD %26% C Red No. 3
% 208.88/209.04  |- skos__altLabel mesh__D004923 Erythrosin B
% 208.88/209.04  |- skos__altLabel mesh__D004923 F D %26% C %23%3
% 208.88/209.04  |- mesh__activeMeSHYear mesh__D004923 2003
% 208.88/209.04  |- skos__broader mesh__D004923smesh__D005452
% 208.88/209.04  |- mesh__publicMeSHNote mesh__D004923
% 208.88/209.04       91; was see under FLUORESCEINS 1979-90   
% 208.88/209.04  |- skos__altLabel mesh__D004923
% 208.88/209.04       2%27%,4%27%,5%27%,7%27%-Tetraiodofluorescein
% 208.88/209.04  |- mesh__recordAuthorizer mesh__D004923 sjn
% 208.88/209.04  |- mesh__recordOriginator mesh__D051579 DRC
% 208.88/209.04  |- rdf__type mesh__D051579sskos__Concept
% 208.88/209.04  |- mesh__publicMeSHNote mesh__D051579
% 208.88/209.04       2006; NEUROGRANIN was indexed under CALMODULIN-BINDING PROTEINS %26% NERVE TISSUE PROTEINS 1991-2005%A%  
% 208.88/209.04  |- skos__broader mesh__D051579smesh__D009419
% 208.88/209.04  |- mesh__dateCreated mesh__D051579 2005-06-30
% 208.88/209.04  |- skos__scopeNote mesh__D051579
% 208.88/209.04       A BRAIN-specific substrate for PROTEIN KINASE C that binds CALMODULIN and is involved in regulation of CALCIUM SIGNALING.%A%    
% 208.88/209.05  |- mesh__recordAuthorizer mesh__D051579 sjn
% 208.88/209.05  |- skos__prefLabel mesh__D051579 Neurogranin
% 208.88/209.05  |- skos__altLabel mesh__D051579 P17 Protein Kinase C Substrate
% 208.88/209.05  |- skos__broader mesh__D051579smesh__D002148
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D051579 2006
% 208.88/209.05  |- mesh__dateEstablished mesh__D051579 2006-01-01
% 208.88/209.05  |- skos__altLabel mesh__D051579 RC3 Protein %28%Neurogranin%29%
% 208.88/209.05  |- mesh__recordMaintainer mesh__D051579 DRC
% 208.88/209.05  |- mesh__historyNote mesh__D051579 2006%28%1991%29%   
% 208.88/209.05  |- mesh__publicMeSHNote mesh__D004125
% 208.88/209.05       91; was see under THIOCARBAMATES 1975-90   
% 208.88/209.05  |- rdf__type mesh__D004125sskos__Concept
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004125 1995
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004125 2005
% 208.88/209.05  |- mesh__dateEstablished mesh__D004125 1991-01-01
% 208.88/209.05  |- mesh__recordOriginator mesh__D004125 NLM
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004125 2006
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004125 1998
% 208.88/209.05  |- skos__prefLabel mesh__D004125 Dimethyldithiocarbamate
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004125 2003
% 208.88/209.05  |- mesh__historyNote mesh__D004125
% 208.88/209.05       91%28%75%29%; was see under THIOCARBAMATES 1975-90   
% 208.88/209.05  |- mesh__dateCreated mesh__D004125 1974-11-19
% 208.88/209.05  |- skos__broader mesh__D004125smesh__D013859
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004125 2000
% 208.88/209.05  |- skos__historyNote mesh__D004125 Thiocarbamates %28%1966-1974%29%
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004125 1999
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004125 1996
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004125 2004
% 208.88/209.05  |- mesh__dateRevised mesh__D004125 1993-06-04
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004125 2001
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004125 1997
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004125 2002
% 208.88/209.05  |- mesh__recordAuthorizer mesh__D004125 PLS
% 208.88/209.05  |- skos__scopeNote mesh__D004125
% 208.88/209.05       A chemical that acts as a dopamine beta-hydroxylase inhibitor. Its salts are agricultural fungicides. It is inferior to diethyldithiocarbamate as a chelating agent.%A%    
% 208.88/209.05  |- mesh__recordMaintainer mesh__D004125 TPW
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004125 1994
% 208.88/209.05  |- skos__hiddenLabel mesh__D014553 Physiologies, Urinary Tract
% 208.88/209.05  |- skos__prefLabel mesh__D014553 Urinary Tract Physiology
% 208.88/209.05  |- skos__annotation mesh__D014553
% 208.88/209.05       avoid: too general; DF: URINARY TRACT PHYSIOL   
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D014553 2005
% 208.88/209.05  |- mesh__recordAuthorizer mesh__D014553 sjn
% 208.88/209.05  |- rdf__type mesh__D014553sskos__Concept
% 208.88/209.05  |- skos__scopeNote mesh__D014553
% 208.88/209.05       Functions and activities of the urinary tract as a whole or of any of its parts.%A%    
% 208.88/209.05  |- skos__hiddenLabel mesh__D014553 Tract Physiologies, Urinary
% 208.88/209.05  |- mesh__recordMaintainer mesh__D014553 lkt
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D014553 2006
% 208.88/209.05  |- skos__altLabel mesh__D014553 Physiology, Urinary Tract
% 208.88/209.05  |- mesh__publicMeSHNote mesh__D014553 98   
% 208.88/209.05  |- skos__broader mesh__D014553smesh__D012101
% 208.88/209.05  |- mesh__recordOriginator mesh__D014553 NLM
% 208.88/209.05  |- mesh__dateRevised mesh__D014553 2004-07-07
% 208.88/209.05  |- skos__historyNote mesh__D014553
% 208.88/209.05       Urinary Tract/physiology %28%1969-1997%29%
% 208.88/209.05  |- mesh__dateCreated mesh__D014553 1999-01-01
% 208.88/209.05  |- mesh__historyNote mesh__D014553 98; use explode 1970-97   
% 208.88/209.05  |- skos__hiddenLabel mesh__D014553 Tract Physiology, Urinary
% 208.88/209.05  |- mesh__dateEstablished mesh__D014553 1998-01-01
% 208.88/209.05  |- skos__hiddenLabel mesh__D014553 Urinary Tract Physiologies
% 208.88/209.05  |- skos__altLabel mesh__D008516 Zhong Yi Xue
% 208.88/209.05  |- mesh__onlineNote mesh__D008516
% 208.88/209.05       to search MEDICINE, CHINESE %26% CHINESE MEDICINE use MEDICINE, CHINESE TRADITIONAL 1975-83 %26% MEDICINE, ORIENTAL TRADITIONAL 1967-74%A%  
% 208.88/209.05  |- skos__related mesh__D008516smesh__D015670
% 208.88/209.05  |- mesh__recordMaintainer mesh__D008516 ssb
% 208.88/209.05  |- skos__related mesh__D008516smesh__D004365
% 208.88/209.05  |- mesh__dateRevised mesh__D008516 2002-07-03
% 208.88/209.05  |- skos__related mesh__D008516smesh__D016711
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D008516 2005
% 208.88/209.05  |- mesh__dateCreated mesh__D008516 1999-01-01
% 208.88/209.05  |- skos__broader mesh__D008516smesh__D008518
% 208.88/209.05  |- skos__altLabel mesh__D008516 Chinese Medicine, Traditional
% 208.88/209.05  |- skos__altLabel mesh__D008516 Traditional Chinese Medicine
% 208.88/209.05  |- skos__hiddenLabel mesh__D008516 Hsueh, Chung I
% 208.88/209.05  |- skos__altLabel mesh__D008516 Chung I Hsueh
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D008516 2006
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D008516 2003
% 208.88/209.05  |- skos__scopeNote mesh__D008516
% 208.88/209.05       A system of traditional medicine which is based on the beliefs and practices of the Chinese culture.%A%    
% 208.88/209.05  |- skos__annotation mesh__D008516
% 208.88/209.05       is not medicine in China %28% = MEDICINE + CHINA%29%; Manual 32.13; medicinal plants in Chinese med: consider DRUGS, CHINESE HERBAL; index differentiation of signs %26% symptoms %28%bianzheng shizhi%29% under MEDICINE, CHINESE TRADITIONAL %28%IM%29% + DIAGNOSIS, DIFFERENTIAL %28%IM%29%; Oriental taking of pulses = PULSE + appropriate acupuncture or Oriental medicine terms; DF: MED CHINESE TRADITIONAL%A%  
% 208.88/209.05  |- skos__related mesh__D008516smesh__D016710
% 208.88/209.05  |- skos__prefLabel mesh__D008516 Medicine, Chinese Traditional
% 208.88/209.05  |- mesh__recordAuthorizer mesh__D008516 sjn
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D008516 2004
% 208.88/209.05  |- skos__related mesh__D008516smesh__D038861
% 208.88/209.05  |- mesh__publicMeSHNote mesh__D008516
% 208.88/209.05       88; was see under MEDICINE, ORIENTAL TRADITIONAL 1984-87; was MEDICINE, CHINESE see under MEDICINE, ORIENTAL 1981-83; was CHINESE MEDICINE see under MEDICINE, ORIENTAL 1967-80%A%  
% 208.88/209.05  |- mesh__historyNote mesh__D008516
% 208.88/209.05       88%28%84%29%; was see under MEDICINE, ORIENTAL TRADITIONAL 1984-87; was MEDICINE, CHINESE see under MEDICINE, ORIENTAL 1981-83; was CHINESE MEDICINE see under MEDICINE, ORIENTAL 1967-80%A%  
% 208.88/209.05  |- skos__altLabel mesh__D008516 Traditional Medicine, Chinese
% 208.88/209.05  |- mesh__recordOriginator mesh__D008516 NLM
% 208.88/209.05  |- rdf__type mesh__D008516sskos__Concept
% 208.88/209.05  |- skos__altLabel mesh__D008516 Chinese Traditional Medicine
% 208.88/209.05  |- mesh__dateEstablished mesh__D008516 1988-01-01
% 208.88/209.05  |- mesh__dateEstablished mesh__D000533 1978-01-01
% 208.88/209.05  |- skos__related mesh__D000533smesh__D026686
% 208.88/209.05  |- skos__annotation mesh__D000533 no qualif   
% 208.88/209.05  |- mesh__publicMeSHNote mesh__D000533 78   
% 208.88/209.05  |- rdf__type mesh__D000533sskos__Concept
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D000533 2005
% 208.88/209.05  |- skos__scopeNote mesh__D000533
% 208.88/209.05       Consideration and concern for others, as opposed to self-love or egoism, which can be a motivating influence.%A%    
% 208.88/209.05  |- skos__historyNote mesh__D000533 Social Behavior %28%1969-1977%29%
% 208.88/209.05  |- mesh__historyNote mesh__D000533 78   
% 208.88/209.05  |- mesh__recordMaintainer mesh__D000533 hjn
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D000533 2006
% 208.88/209.05  |- mesh__dateRevised mesh__D000533 2002-07-02
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D000533 2003
% 208.88/209.05  |- mesh__recordOriginator mesh__D000533 EC
% 208.88/209.05  |- mesh__recordAuthorizer mesh__D000533 sjn
% 208.88/209.05  |- skos__broader mesh__D000533smesh__D012919
% 208.88/209.05  |- skos__related mesh__D000533smesh__D037921
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D000533 2004
% 208.88/209.05  |- skos__prefLabel mesh__D000533 Altruism
% 208.88/209.05  |- mesh__dateCreated mesh__D000533 1977-04-22
% 208.88/209.05  |- mesh__dateEstablished mesh__D024981 2002-01-01
% 208.88/209.05  |- skos__historyNote mesh__D024981 Glucosyltransferases %28%1965-1971%29%
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D024981 2005
% 208.88/209.05  |- rdf__type mesh__D024981sskos__Concept
% 208.88/209.05  |- skos__scopeNote mesh__D024981
% 208.88/209.05       An enzyme that catalyzes the degradation of GLYCOGEN in animals by releasing glucose-1-phosphate from the terminal alpha-1,4-glycosidic bond. This enzyme exists in two forms: an active phosphorylated form %28% PHOSPHORYLASE A%29% and an inactive un-phosphorylated form %28%PHOSPHORYLASE B%29%. Both a and b forms of  phosphorylase exist as homodimers. In mammals, the major isozymes of glycogen phosphorylase are found in muscle, liver and brain tissue.%A%    
% 208.88/209.05  |- mesh__historyNote mesh__D024981 2002   
% 208.88/209.05  |- skos__broader mesh__D024981smesh__D006005
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D024981 2004
% 208.88/209.05  |- skos__altLabel mesh__D024981 Phosphorylase ab
% 208.88/209.05  |- skos__annotation mesh__D024981 GEN or unspecified; prefer specifics   
% 208.88/209.05  |- skos__historyNote mesh__D024981 Phosphorylases %28%1972-2001%29%
% 208.88/209.05  |- mesh__publicMeSHNote mesh__D024981 2002   
% 208.88/209.05  |- mesh__dateRevised mesh__D024981 2003-07-09
% 208.88/209.05  |- mesh__dateCreated mesh__D024981 2001-07-25
% 208.88/209.05  |- skos__hiddenLabel mesh__D024981 Phosphorylase, Glycogen
% 208.88/209.05  |- skos__prefLabel mesh__D024981 Glycogen Phosphorylase
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D024981 2006
% 208.88/209.05  |- skos__scopeNote mesh__D010961
% 208.88/209.05       A genus of coccidian protozoa that comprise the malaria parasites of mammals. Four species infect humans %28%although occasional infections with primate malarias may occur%29%. These are PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE, and PLASMODIUM VIVAX. Species causing infection in vertebrates other than man include: PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; P. vinckei, and PLASMODIUM YOELII in rodents; P. brasilianum, PLASMODIUM CYNOMOLGI; and PLASMODIUM KNOWLESI in monkeys; and PLASMODIUM GALLINACEUM in chickens.%A%    
% 208.88/209.05  |- mesh__recordMaintainer mesh__D010961 ags
% 208.88/209.05  |- mesh__dateRevised mesh__D010961 2003-07-09
% 208.88/209.05  |- skos__broader mesh__D010961smesh__D016787
% 208.88/209.05  |- mesh__recordAuthorizer mesh__D010961 sjn
% 208.88/209.05  |- skos__prefLabel mesh__D010961 Plasmodium
% 208.88/209.05  |- rdf__type mesh__D010961sskos__Concept
% 208.88/209.05  |- skos__related mesh__D010961smesh__D000962
% 208.88/209.05  |- skos__annotation mesh__D010961
% 208.88/209.05       GEN: prefer specifics; infection = MALARIA; coord with specific protozoan terms %28%ANTIGENS, PROTOZOAN, etc%29% if pertinent%A%  
% 208.88/209.05  |- mesh__onlineNote mesh__D010961
% 208.88/209.05       use PLASMODIUM to search HAEMAMOEBA 1976-91   
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D010961 2005
% 208.88/209.05  |- mesh__recordOriginator mesh__D010961 NLM
% 208.88/209.05  |- mesh__historyNote mesh__D010961 HAEMAMOEBA was see PLASMODIUM 1976-91   
% 208.88/209.05  |- mesh__publicMeSHNote mesh__D010961
% 208.88/209.05       HAEMAMOEBA was see PLASMODIUM 1976-91   
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D010961 2006
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D010961 2004
% 208.88/209.05  |- mesh__dateCreated mesh__D010961 1999-01-01
% 208.88/209.05  |- skos__broader mesh__D017293Q000172smesh__D017293
% 208.88/209.05  |- mesh__preferredCombination mesh__D017293Q000172smesh__D018455
% 208.88/209.05  |- rdf__type mesh__D017293Q000172smesh__CompoundConcept
% 208.88/209.05  |- skos__hiddenLabel mesh__D018146 Cytomegalovirus, Rat
% 208.88/209.05  |- skos__altLabel mesh__D018146 Herpesvirus 1 %28%beta%29%, Murid
% 208.88/209.05  |- skos__historyNote mesh__D018146 Cytomegalovirus %28%1966-1993%29%
% 208.88/209.05  |- skos__hiddenLabel mesh__D018146 Muromegaloviruses
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D018146 2003
% 208.88/209.05  |- skos__broader mesh__D018146smesh__D018141
% 208.88/209.05  |- skos__hiddenLabel mesh__D018146 Cytomegalovirus, Mouse
% 208.88/209.05  |- skos__annotation mesh__D018146
% 208.88/209.05       infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29%   
% 208.88/209.05  |- mesh__historyNote mesh__D018146 94   
% 208.88/209.05  |- skos__hiddenLabel mesh__D018146 Cytomegaloviruses, Murine
% 208.88/209.05  |- skos__hiddenLabel mesh__D018146 Rat Cytomegaloviruses
% 208.88/209.05  |- mesh__recordAuthorizer mesh__D018146 sjn
% 208.88/209.05  |- skos__altLabel mesh__D018146 Murine Cytomegalovirus
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D018146 2002
% 208.88/209.05  |- mesh__recordOriginator mesh__D018146 AGS
% 208.88/209.05  |- skos__altLabel mesh__D018146 Mouse Cytomegalovirus
% 208.88/209.05  |- skos__altLabel mesh__D018146 Murid herpesvirus 2
% 208.88/209.05  |- mesh__recordMaintainer mesh__D018146 ags
% 208.88/209.05  |- skos__prefLabel mesh__D018146 Muromegalovirus
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D018146 2006
% 208.88/209.05  |- mesh__dateEstablished mesh__D018146 1994-01-01
% 208.88/209.05  |- skos__scopeNote mesh__D018146
% 208.88/209.05       A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, causing infection involving several organs in mice and rats. Murid herpesvirus is the type species.%A%    
% 208.88/209.05  |- mesh__onlineNote mesh__D018146 search CYTOMEGALOVIRUS 1966-93   
% 208.88/209.05  |- skos__hiddenLabel mesh__D018146 Mouse Cytomegaloviruses
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D018146 2005
% 208.88/209.05  |- skos__hiddenLabel mesh__D018146 Cytomegaloviruses, Rat
% 208.88/209.05  |- skos__altLabel mesh__D018146 Murid herpesvirus 1
% 208.88/209.05  |- skos__hiddenLabel mesh__D018146 Cytomegaloviruses, Mouse
% 208.88/209.05  |- rdf__type mesh__D018146sskos__Concept
% 208.88/209.05  |- skos__altLabel mesh__D018146 Rat Cytomegalovirus
% 208.88/209.05  |- mesh__dateCreated mesh__D018146 1993-06-04
% 208.88/209.05  |- skos__hiddenLabel mesh__D018146 Murine Cytomegaloviruses
% 208.88/209.05  |- mesh__publicMeSHNote mesh__D018146 94   
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D018146 2004
% 208.88/209.05  |- mesh__dateRevised mesh__D018146 2001-07-25
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D010163 1995
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D010163 2005
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D010163 1998
% 208.88/209.05  |- skos__broader mesh__D010163smesh__D000885
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D010163 2000
% 208.88/209.05  |- skos__related mesh__D010163smesh__D009106
% 208.88/209.05  |- skos__prefLabel mesh__D010163 Paleontology
% 208.88/209.05  |- skos__scopeNote mesh__D010163
% 208.88/209.05       The study of early forms of life through fossil remains.%A%    
% 208.88/209.05  |- mesh__recordAuthorizer mesh__D010163 PLS
% 208.88/209.05  |- rdf__type mesh__D010163sskos__Concept
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D010163 2002
% 208.88/209.05  |- skos__annotation mesh__D010163
% 208.88/209.05       IM; SPEC: SPEC qualif; as NIM coord, no qualif; do not routinely check tags HISTORICAL ARTICLE %26% ANCIENT or MEDIEVAL: check only when the hist %26% ancient or medieval med aspects are particularly discussed; for prehist, ANCIENT tag is all right; paleontology is for pre-Columbian, nothing later; DF: PALEONTOL%A%  
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D010163 2004
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D010163 1997
% 208.88/209.05  |- mesh__recordOriginator mesh__D010163 NLM
% 208.88/209.05  |- mesh__dateRevised mesh__D010163 1994-04-11
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D010163 2003
% 208.88/209.05  |- mesh__dateCreated mesh__D010163 1999-01-01
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D010163 1996
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D010163 2001
% 208.88/209.05  |- mesh__recordMaintainer mesh__D010163 TGC
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D010163 2006
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D010163 1999
% 208.88/209.05  |- mesh__dateRevised mesh__D004924 2002-07-03
% 208.88/209.05  |- skos__hiddenLabel mesh__D004924 Flight Reactions
% 208.88/209.05  |- skos__broader mesh__D004924smesh__D001519
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004924 2005
% 208.88/209.05  |- skos__annotation mesh__D004924 human %26% animal   
% 208.88/209.05  |- mesh__recordOriginator mesh__D004924 NLM
% 208.88/209.05  |- skos__historyNote mesh__D004924 Behavior, Animal %28%1966-1967%29%
% 208.88/209.05  |- skos__hiddenLabel mesh__D004924 Escape Reactions
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004924 2006
% 208.88/209.05  |- mesh__dateCreated mesh__D004924 1999-01-01
% 208.88/209.05  |- mesh__recordAuthorizer mesh__D004924 sjn
% 208.88/209.05  |- skos__hiddenLabel mesh__D004924 Reaction, Flight
% 208.88/209.05  |- mesh__dateEstablished mesh__D004924 1968-01-01
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004924 2003
% 208.88/209.05  |- skos__hiddenLabel mesh__D004924 Reaction, Escape
% 208.88/209.05  |- rdf__type mesh__D004924sskos__Concept
% 208.88/209.05  |- skos__historyNote mesh__D004924 Fear %28%1966-1967%29%
% 208.88/209.05  |- mesh__onlineNote mesh__D004924
% 208.88/209.05       use ESCAPE REACTION to search FLIGHT REACTION 1968-78   
% 208.88/209.05  |- mesh__recordMaintainer mesh__D004924 TAP
% 208.88/209.05  |- skos__altLabel mesh__D004924 Flight Reaction
% 208.88/209.05  |- skos__scopeNote mesh__D004924
% 208.88/209.05       Innate response elicited by sensory stimuli associated with a threatening situation, or actual confrontation with an enemy.%A%    
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004924 2004
% 208.88/209.05  |- skos__prefLabel mesh__D004924 Escape Reaction
% 208.88/209.05  |- skos__broader mesh__D004924smesh__D001522
% 208.88/209.05  |- mesh__historyNote mesh__D004924
% 208.88/209.05       68; FLIGHT REACTION was see under ESCAPE REACTION 1968-78%A%  
% 208.88/209.05  |- skos__hiddenLabel mesh__D004924 Reactions, Flight
% 208.88/209.05  |- skos__hiddenLabel mesh__D004924 Reactions, Escape
% 208.88/209.05  |- mesh__publicMeSHNote mesh__D004924 68   
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004126 2006
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004126 1998
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004126 1993
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004126 2003
% 208.88/209.05  |- mesh__historyNote mesh__D004126 66%28%63%29%   
% 208.88/209.05  |- skos__prefLabel mesh__D004126 Dimethylformamide
% 208.88/209.05  |- skos__annotation mesh__D004126 D25-26 qualif   
% 208.88/209.05  |- mesh__dateCreated mesh__D004126 1999-01-01
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004126 1999
% 208.88/209.05  |- mesh__dateRevised mesh__D004126 1991-06-26
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004126 1996
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004126 2004
% 208.88/209.05  |- mesh__publicMeSHNote mesh__D004126 66   
% 208.88/209.05  |- mesh__recordOriginator mesh__D004126 NLM
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004126 1997
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004126 2000
% 208.88/209.05  |- mesh__recordMaintainer mesh__D004126 TAP
% 208.88/209.05  |- mesh__dateEstablished mesh__D004126 1966-01-01
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004126 1994
% 208.88/209.05  |- skos__broader mesh__D004126smesh__D005559
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004126 2001
% 208.88/209.05  |- rdf__type mesh__D004126sskos__Concept
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004126 1995
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004126 2005
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004126 1992
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D004126 2002
% 208.88/209.05  |- mesh__recordAuthorizer mesh__D004126 PLS
% 208.88/209.05  |- mesh__dateCreated mesh__D020591 1999-11-03
% 208.88/209.05  |- mesh__historyNote mesh__D020591 2000   
% 208.88/209.05  |- mesh__recordAuthorizer mesh__D020591 sjn
% 208.88/209.05  |- skos__historyNote mesh__D020591
% 208.88/209.05       Gram-Negative Aerobic Bacteria %28%1977-1999%29%
% 208.88/209.05  |- skos__scopeNote mesh__D020591
% 208.88/209.05       A genus of gram-negative, straight or curved rods which are motile by means of a single, polar flagellum. Members of this genus are found in coastal waters and the open ocean. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 208.88/209.05  |- skos__prefLabel mesh__D020591 Alteromonas
% 208.88/209.05  |- mesh__publicMeSHNote mesh__D020591 2000   
% 208.88/209.05  |- mesh__dateEstablished mesh__D020591 2000-01-01
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D020591 2006
% 208.88/209.05  |- mesh__recordMaintainer mesh__D020591 SYSTEM
% 208.88/209.05  |- mesh__dateRevised mesh__D020591 2005-06-30
% 208.88/209.05  |- rdf__type mesh__D020591sskos__Concept
% 208.88/209.05  |- skos__broader mesh__D020591smesh__D034241
% 208.88/209.05  |- skos__broader mesh__D020591smesh__D016946
% 208.88/209.05  |- mesh__recordOriginator mesh__D020591 ndw
% 208.88/209.05  |- skos__annotation mesh__D014554
% 208.88/209.05       urine volume: index under URINE probably NIM   
% 208.88/209.05  |- skos__hiddenLabel mesh__D014554 Urinations
% 208.88/209.05  |- rdf__type mesh__D014554sskos__Concept
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D014554 2006
% 208.88/209.05  |- mesh__recordAuthorizer mesh__D014554 sjn
% 208.88/209.05  |- skos__broader mesh__D014554smesh__D014553
% 208.88/209.05  |- skos__prefLabel mesh__D014554 Urination
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D014554 2005
% 208.88/209.05  |- mesh__dateRevised mesh__D014554 2004-07-07
% 208.88/209.05  |- mesh__recordOriginator mesh__D014554 NLM
% 208.88/209.05  |- mesh__recordMaintainer mesh__D014554 lkt
% 208.88/209.05  |- mesh__dateCreated mesh__D014554 1999-01-01
% 208.88/209.05  |- skos__altLabel mesh__D008517 Herbal Therapy
% 208.88/209.05  |- skos__prefLabel mesh__D008517 Phytotherapy
% 208.88/209.05  |- mesh__recordAuthorizer mesh__D008517 sjn
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D008517 2006
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D008517 2003
% 208.88/209.05  |- mesh__recordOriginator mesh__D008517 NLM
% 208.88/209.05  |- skos__altLabel mesh__D008517 Herb Therapy
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D008517 2004
% 208.88/209.05  |- mesh__dateRevised mesh__D008517 2001-07-25
% 208.88/209.05  |- mesh__historyNote mesh__D008517 2002%28%1963%29%   
% 208.88/209.05  |- rdf__type mesh__D008517sskos__Concept
% 208.88/209.05  |- skos__scopeNote mesh__D008517
% 208.88/209.05       Use of plants or herbs to treat diseases or to alleviate pain.%A%    
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D008517 2002
% 208.88/209.05  |- mesh__recordMaintainer mesh__D008517 ssb
% 208.88/209.05  |- skos__related mesh__D008517smesh__D010946
% 208.88/209.05  |- skos__annotation mesh__D008517
% 208.88/209.05       coord IM disease /drug ther %28%IM%29% + specific plant %28%IM%29% + PLANT PREPARATIONS or its indentations/ ther use %28%IM or NIM%29% + specific chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.88/209.05  |- mesh__publicMeSHNote mesh__D008517
% 208.88/209.05       2002; see MEDICINE, HERBAL 1981-2001, see HERBALISM 1963-1980%A%  
% 208.88/209.05  |- skos__related mesh__D008517smesh__D010936
% 208.88/209.05  |- skos__related mesh__D008517smesh__D004365
% 208.88/209.05  |- skos__broader mesh__D008517smesh__D000529
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D008517 2005
% 208.88/209.05  |- mesh__dateCreated mesh__D008517 1999-01-01
% 208.88/209.05  |- skos__related mesh__D008517smesh__D010944
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D000534 1998
% 208.88/209.05  |- skos__broader mesh__D000534smesh__D017607
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D000534 1995
% 208.88/209.05  |- skos__annotation mesh__D000534
% 208.88/209.05       astringents; also many indust uses; used also in vet med; D25-26 qualif; DF: ALUM CPDS%A%  
% 208.88/209.05  |- skos__prefLabel mesh__D000534 Alum Compounds
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D000534 2006
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D000534 2001
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D000534 1999
% 208.88/209.05  |- mesh__recordMaintainer mesh__D000534 TPW
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D000534 2003
% 208.88/209.05  |- skos__hiddenLabel mesh__D000534 Compounds, Alum
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D000534 1996
% 208.88/209.05  |- mesh__dateEstablished mesh__D000534 1991-01-01
% 208.88/209.05  |- mesh__dateRevised mesh__D000534 1993-06-04
% 208.88/209.05  |- mesh__onlineNote mesh__D000534
% 208.88/209.05       use ALUM COMPOUNDS to search ALUMINUM AMMONIUM SULFATE %26% ALUMINUM POTASSIUM SULFATE 1975-93%A%  
% 208.88/209.05  |- skos__historyNote mesh__D000534 Sulfates %28%1973-1974%29%
% 208.88/209.05  |- mesh__dateCreated mesh__D000534 1974-11-19
% 208.88/209.05  |- skos__historyNote mesh__D000534 Aluminum %28%1973-1974%29%
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D000534 2004
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D000534 1997
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D000534 2002
% 208.88/209.05  |- mesh__recordOriginator mesh__D000534 NLM
% 208.88/209.05  |- skos__scopeNote mesh__D000534
% 208.88/209.05       Aluminum metal sulfate compounds used medically as astringents and for many industrial purposes. They are used in veterinary medicine for the treatment of ulcerative stomatitis, leukorrhea, conjunctivitis, pharyngitis, metritis, and minor wounds.%A%    
% 208.88/209.05  |- mesh__publicMeSHNote mesh__D000534
% 208.88/209.05       91; was see under ALUMINUM 1975-90; ALUMINUM AMMONIUM SULFATE %26% ALUMINUM POTASSIUM SULFATE were see ALUM COMPOUNDS 1975-93%A%  
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D000534 1994
% 208.88/209.05  |- mesh__recordAuthorizer mesh__D000534 PLS
% 208.88/209.05  |- skos__broader mesh__D000534smesh__D013431
% 208.88/209.05  |- rdf__type mesh__D000534sskos__Concept
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D000534 2005
% 208.88/209.05  |- mesh__historyNote mesh__D000534
% 208.88/209.05       91%28%75%29%; was see under ALUMINUM 1975-90; ALUMINUM AMMONIUM SULFATE %26% ALUMINUM POTASSIUM SULFATE were see ALUM COMPOUNDS 1975-93%A%  
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D000534 2000
% 208.88/209.05  |- skos__altLabel mesh__D024982 Myophosphorylase a and b
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D024982 2004
% 208.88/209.05  |- skos__altLabel mesh__D024982 Myophosphorylase
% 208.88/209.05  |- skos__historyNote mesh__D024982 Phosphorylases %28%1979-2001%29%
% 208.88/209.05  |- skos__scopeNote mesh__D024982
% 208.88/209.05       An isoenzyme of GLYCOGEN PHOSPHORYLASE that catalyzes the degradation of GLYCOGEN in muscle. Mutation of the gene coding this enzyme is the cause of McArdle disease %28%GLYCOGEN STORAGE DISEASE TYPE V%29%.%A%    
% 208.88/209.05  |- mesh__publicMeSHNote mesh__D024982 2002   
% 208.88/209.05  |- skos__related mesh__D024982smesh__D006012
% 208.88/209.05  |- mesh__historyNote mesh__D024982 2002   
% 208.88/209.05  |- mesh__dateRevised mesh__D024982 2003-07-09
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D024982 2006
% 208.88/209.05  |- skos__broader mesh__D024982smesh__D024981
% 208.88/209.05  |- skos__historyNote mesh__D024982 Glucosyltransferases %28%1967-1978%29%
% 208.88/209.05  |- mesh__dateEstablished mesh__D024982 2002-01-01
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D024982 2005
% 208.88/209.05  |- rdf__type mesh__D024982sskos__Concept
% 208.88/209.05  |- mesh__dateCreated mesh__D024982 2001-07-25
% 208.88/209.05  |- skos__prefLabel mesh__D024982 Glycogen Phosphorylase, Muscle Form
% 208.88/209.05  |- mesh__publicMeSHNote mesh__D018945 96   
% 208.88/209.05  |- skos__annotation mesh__D018945
% 208.88/209.05       chemokines; MONOCYTE CHEMOATTRACTANT PROTEIN-1 is also available%A%  
% 208.88/209.05  |- skos__scopeNote mesh__D018945
% 208.88/209.05       Chemokines that are chemoattractants for monocytes. These CC chemokines %28%cysteines adjacent%29% number at least three including MONOCYTE CHEMOATTRACTANT PROTEIN-1.%A%    
% 208.88/209.05  |- mesh__recordAuthorizer mesh__D018945 sjn
% 208.88/209.05  |- mesh__dateEstablished mesh__D018945 1996-01-01
% 208.88/209.05  |- skos__prefLabel mesh__D018945 Monocyte Chemoattractant Proteins
% 208.88/209.05  |- skos__historyNote mesh__D018945 Chemotactic Factors %28%1991-1995%29%
% 208.88/209.05  |- mesh__recordOriginator mesh__D018945 AGS
% 208.88/209.05  |- mesh__dateCreated mesh__D018945 1995-02-21
% 208.88/209.05  |- rdf__type mesh__D018945sskos__Concept
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D018945 2006
% 208.88/209.05  |- skos__hiddenLabel mesh__D018945 Chemotactic Proteins, Monocyte
% 208.88/209.05  |- mesh__historyNote mesh__D018945 96   
% 208.88/209.05  |- skos__broader mesh__D018945smesh__D018925
% 208.88/209.05  |- skos__hiddenLabel mesh__D018945 Chemoattractant Proteins, Monocyte
% 208.88/209.05  |- skos__altLabel mesh__D018945 Monocyte Chemotactic Proteins
% 208.88/209.05  |- mesh__dateRevised mesh__D018945 2005-06-30
% 208.88/209.05  |- mesh__recordMaintainer mesh__D018945 ssb
% 208.88/209.05  |- rdf__type mesh__D010962sskos__Concept
% 208.88/209.05  |- skos__scopeNote mesh__D010962
% 208.88/209.05       A protozoan parasite of rodents transmitted by the mosquito Anopheles dureni.%A%    
% 208.88/209.05  |- mesh__historyNote mesh__D010962 73   
% 208.88/209.05  |- skos__historyNote mesh__D010962 Plasmodium %28%1966-1972%29%
% 208.88/209.05  |- mesh__recordAuthorizer mesh__D010962 sjn
% 208.88/209.05  |- skos__annotation mesh__D010962
% 208.88/209.05       in rodents; infection: coord IM with MALARIA %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D010962 2005
% 208.88/209.05  |- mesh__dateEstablished mesh__D010962 1973-01-01
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D010962 2006
% 208.88/209.05  |- skos__broader mesh__D010962smesh__D010961
% 208.88/209.05  |- mesh__publicMeSHNote mesh__D010962 73   
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D010962 2004
% 208.88/209.05  |- mesh__dateCreated mesh__D010962 1999-01-01
% 208.88/209.05  |- mesh__recordMaintainer mesh__D010962 ags
% 208.88/209.05  |- skos__prefLabel mesh__D010962 Plasmodium berghei
% 208.88/209.05  |- mesh__recordOriginator mesh__D010962 NLM
% 208.88/209.05  |- mesh__dateRevised mesh__D010962 2003-07-09
% 208.88/209.05  |- mesh__dateCreated mesh__D018147 1993-06-04
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D018147 2000
% 208.88/209.05  |- mesh__publicMeSHNote mesh__D018147 94   
% 208.88/209.05  |- mesh__historyNote mesh__D018147 94   
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D018147 1996
% 208.88/209.05  |- mesh__activeMeSHYear mesh__D018147 1995
% 208.88/209.06  |- skos__scopeNote mesh__D018147
% 208.88/209.06       A subfamily of the family POXVIRIDAE, containing eight genera comprising all the vertebrate poxviruses.%A%    
% 208.88/209.06  |- skos__prefLabel mesh__D018147 Chordopoxvirinae
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D018147 1994
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D018147 2006
% 208.88/209.06  |- skos__annotation mesh__D018147
% 208.88/209.06       a subfamily of the family Poxviridae comprising all vertebrate %28%Chordo-%29%poxviruses; infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29%%A%  
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D018147 1999
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D018147 2005
% 208.88/209.06  |- skos__broader mesh__D018147smesh__D011212
% 208.88/209.06  |- rdf__type mesh__D018147sskos__Concept
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D018147 2002
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D018147 1998
% 208.88/209.06  |- mesh__dateEstablished mesh__D018147 1994-01-01
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D018147 2004
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D018147 2001
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D018147 1997
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D018147 2003
% 208.88/209.06  |- mesh__dateRevised mesh__D010164 1994-04-11
% 208.88/209.06  |- mesh__recordOriginator mesh__D010164 NLM
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D010164 2004
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D010164 1997
% 208.88/209.06  |- skos__annotation mesh__D010164
% 208.88/209.06       IM; SPEC: SPEC qualif; as NIM coord, no qualif; check tags HISTORICAL ARTICLE %26% ANCIENT or MEDIEVAL; for prehist, ANCIENT tag is all right; paleopathol is for pre-Columbian, nothing later; consider also MUMMIES /pathol %26% do not coord with PALEOPATHOLOGY; DF: PALEOPATHOL%A%  
% 208.88/209.06  |- skos__prefLabel mesh__D010164 Paleopathology
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D010164 2001
% 208.88/209.06  |- skos__broader mesh__D010164smesh__D010163
% 208.88/209.06  |- mesh__dateCreated mesh__D010164 1999-01-01
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D010164 2003
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D010164 1996
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D010164 2000
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D010164 2006
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D010164 1999
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D010164 1995
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D010164 2005
% 208.88/209.06  |- mesh__recordMaintainer mesh__D010164 TGC
% 208.88/209.06  |- mesh__recordAuthorizer mesh__D010164 PLS
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D010164 1998
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D010164 2002
% 208.88/209.06  |- rdf__type mesh__D010164sskos__Concept
% 208.88/209.06  |- skos__scopeNote mesh__D010164
% 208.88/209.06       The study of disease in prehistoric times as revealed in bones, mummies, and archaeologic artifacts.%A%    
% 208.88/209.06  |- skos__scopeNote mesh__D004925
% 208.88/209.06       A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms occur in the lower part of the intestine of warm-blooded animals. The species are either nonpathogenic or opportunistic pathogens.%A%    
% 208.88/209.06  |- mesh__dateCreated mesh__D004925 1999-01-01
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D004925 2006
% 208.88/209.06  |- mesh__dateRevised mesh__D004925 2005-06-30
% 208.88/209.06  |- mesh__recordMaintainer mesh__D004925 SYSTEM
% 208.88/209.06  |- skos__broader mesh__D004925smesh__D004755
% 208.88/209.06  |- rdf__type mesh__D004925sskos__Concept
% 208.88/209.06  |- mesh__recordOriginator mesh__D004925 NLM
% 208.88/209.06  |- skos__prefLabel mesh__D004925 Escherichia
% 208.88/209.06  |- mesh__recordAuthorizer mesh__D004925 sjn
% 208.88/209.06  |- skos__annotation mesh__D004925
% 208.88/209.06       infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 208.88/209.06  |- rdf__type mesh__D004127sskos__Concept
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D004127 2000
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D004127 2004
% 208.88/209.06  |- mesh__onlineNote mesh__D004127
% 208.88/209.06       use DIMETHYLHYDRAZINES to search 1,2 DIMETHYLHYDRAZINE 1975-77%A%  
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D004127 2006
% 208.88/209.06  |- mesh__historyNote mesh__D004127
% 208.88/209.06       91%28%78%29%; was see under METHYLHYDRAZINES 1978-90; was 1,2 DIMETHYLHYDRAZINE see under HYDRAZINES 1975-77%A%  
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D004127 2003
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D004127 1997
% 208.88/209.06  |- mesh__dateEstablished mesh__D004127 1991-01-01
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D004127 2005
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D004127 1999
% 208.88/209.06  |- skos__broader mesh__D004127smesh__D008763
% 208.88/209.06  |- mesh__recordMaintainer mesh__D004127 JRT
% 208.88/209.06  |- mesh__publicMeSHNote mesh__D004127
% 208.88/209.06       91; was see under METHYLHYDRAZINES 1978-90; was 1,2 DIMETHYLHYDRAZINE see under HYDRAZINES 1975-77%A%  
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D004127 2002
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D004127 1996
% 208.88/209.06  |- mesh__recordOriginator mesh__D004127 NLM
% 208.88/209.06  |- mesh__dateCreated mesh__D004127 1974-11-11
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D004127 1998
% 208.88/209.06  |- skos__prefLabel mesh__D004127 Dimethylhydrazines
% 208.88/209.06  |- skos__annotation mesh__D004127 carcinogens; D25-26 qualif   
% 208.88/209.06  |- skos__scopeNote mesh__D004127
% 208.88/209.06       Hydrazines substituted with two methyl groups in any position.%A%    
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D004127 2001
% 208.88/209.06  |- skos__historyNote mesh__D004127 Hydrazines %28%1968-1974%29%
% 208.88/209.06  |- mesh__dateRevised mesh__D004127 1995-06-08
% 208.88/209.06  |- mesh__recordAuthorizer mesh__D004127 PLS
% 208.88/209.06  |- skos__historyNote mesh__D009610 Hydrazones %28%1972-1974%29%
% 208.88/209.06  |- mesh__publicMeSHNote mesh__D009610
% 208.88/209.06       91; was see under NITROFURANS 1975-90   
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D009610 2002
% 208.88/209.06  |- mesh__recordMaintainer mesh__D009610 jmp
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D009610 2005
% 208.88/209.06  |- mesh__historyNote mesh__D009610
% 208.88/209.06       91%28%75%29%; was see under NITROFURANS 1975-90   
% 208.88/209.06  |- skos__scopeNote mesh__D009610
% 208.88/209.06       An antibacterial growth promoter used in animal feeds.     
% 208.88/209.06  |- skos__historyNote mesh__D009610 Nitrofurans %28%1971-1974%29%
% 208.88/209.06  |- mesh__recordAuthorizer mesh__D009610 sjn
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D009610 2006
% 208.88/209.06  |- skos__broader mesh__D009610smesh__D009581
% 208.88/209.06  |- mesh__dateCreated mesh__D009610 1974-11-19
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D009610 2003
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D009610 2001
% 208.88/209.06  |- skos__historyNote mesh__D009610 Amidines %28%1971-1974%29%
% 208.88/209.06  |- rdf__type mesh__D009610sskos__Concept
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D009610 2004
% 208.88/209.06  |- mesh__dateEstablished mesh__D009610 1991-01-01
% 208.88/209.06  |- mesh__dateRevised mesh__D009610 2000-06-22
% 208.88/209.06  |- skos__prefLabel mesh__D009610 Nitrovin
% 208.88/209.06  |- mesh__recordOriginator mesh__D009610 NLM
% 208.88/209.06  |- skos__scopeNote mesh__D020592
% 208.88/209.06       A genus of gram-negative, facultatively anaerobic rods. It is a saprophytic, marine organism which is often isolated from spoiling fish.%A%    
% 208.88/209.06  |- skos__historyNote mesh__D020592
% 208.88/209.06       Gram-Negative Facultatively Anaerobic Rods %28%1995-1999%29%
% 208.88/209.06  |- skos__annotation mesh__D020592
% 208.88/209.06       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 208.88/209.06  |- skos__broader mesh__D020592smesh__D006092
% 208.88/209.06  |- mesh__dateCreated mesh__D020592 1999-11-03
% 208.88/209.06  |- mesh__recordAuthorizer mesh__D020592 sjn
% 208.88/209.06  |- mesh__dateEstablished mesh__D020592 2000-01-01
% 208.88/209.06  |- skos__prefLabel mesh__D020592 Shewanella
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D020592 2006
% 208.88/209.06  |- mesh__recordMaintainer mesh__D020592 SYSTEM
% 208.88/209.06  |- rdf__type mesh__D020592sskos__Concept
% 208.88/209.06  |- skos__broader mesh__D020592smesh__D034241
% 208.88/209.06  |- mesh__recordOriginator mesh__D020592 ndw
% 208.88/209.06  |- mesh__publicMeSHNote mesh__D020592 2000   
% 208.88/209.06  |- mesh__historyNote mesh__D020592 2000   
% 208.88/209.06  |- mesh__dateRevised mesh__D020592 2005-06-30
% 208.88/209.06  |- skos__prefLabel mesh__D014555 Urination Disorders
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D014555 2004
% 208.88/209.06  |- mesh__recordMaintainer mesh__D014555 KEV
% 208.88/209.06  |- mesh__recordOriginator mesh__D014555 NLM
% 208.88/209.06  |- skos__hiddenLabel mesh__D014555 Disorders, Urination
% 208.88/209.06  |- mesh__dateRevised mesh__D014555 1999-11-03
% 208.88/209.06  |- skos__broader mesh__D014555smesh__D014570
% 208.88/209.06  |- rdf__type mesh__D014555sskos__Concept
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D014555 2003
% 208.88/209.06  |- skos__altLabel mesh__D014555 Nocturia
% 208.88/209.06  |- skos__scopeNote mesh__D014555
% 208.88/209.06       Disorders in the frequency of urination, the volume of urine produced or eliminated, or the ability to retain or void urine in normal fashion.%A%    
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D014555 2001
% 208.88/209.06  |- skos__hiddenLabel mesh__D014555 Disorder, Urination
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D014555 2006
% 208.88/209.06  |- skos__related mesh__D014555smesh__D020924
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D014555 2000
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D014555 2005
% 208.88/209.06  |- skos__hiddenLabel mesh__D014555 Urination Disorder
% 208.88/209.06  |- mesh__dateCreated mesh__D014555 1999-01-01
% 208.88/209.06  |- mesh__recordAuthorizer mesh__D014555 sjn
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D014555 2002
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D008518 2005
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D008518 2003
% 208.88/209.06  |- skos__hiddenLabel mesh__D008518 Traditional Oriental Medicine
% 208.88/209.06  |- mesh__publicMeSHNote mesh__D008518 84; was MEDICINE, ORIENTAL 1966-83   
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D008518 2006
% 208.88/209.06  |- rdf__type mesh__D008518sskos__Concept
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D008518 2004
% 208.88/209.06  |- skos__related mesh__D008518smesh__D015670
% 208.88/209.06  |- skos__hiddenLabel mesh__D008518 Traditional Oriental Medicines
% 208.88/209.06  |- skos__prefLabel mesh__D008518 Medicine, Oriental Traditional
% 208.88/209.06  |- mesh__dateRevised mesh__D008518 2001-07-25
% 208.88/209.06  |- skos__altLabel mesh__D008518 Oriental Medicine, Traditional
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D008518 2002
% 208.88/209.06  |- mesh__recordMaintainer mesh__D008518 ssb
% 208.88/209.06  |- skos__scopeNote mesh__D008518
% 208.88/209.06       A system of traditional medicine which is based on the customs, beliefs and practices of the Oriental people.%A%    
% 208.88/209.06  |- skos__broader mesh__D008518smesh__D008519
% 208.88/209.06  |- skos__annotation mesh__D008518
% 208.88/209.06       do not use for %22%medicine in the Orient%22% %28% = MEDICINE %28%IM%29% + country%29%; specify Oriental country; Manual 32.13; Oriental taking of pulses = PULSE + appropriate acupuncture or Oriental medicine terms;  DF: MED ORIENTAL TRADITIONAL%A%  
% 208.88/209.06  |- skos__hiddenLabel mesh__D008518 Medicine, Traditional Oriental
% 208.88/209.06  |- skos__altLabel mesh__D008518 Traditional Medicine, Oriental
% 208.88/209.06  |- mesh__historyNote mesh__D008518 84; was MEDICINE, ORIENTAL 1966-83   
% 208.88/209.06  |- mesh__onlineNote mesh__D008518
% 208.88/209.06       use MEDICINE, ORIENTAL TRADITIONAL to search MEDICINE, ORIENTAL 1966-83%A%  
% 208.88/209.06  |- skos__altLabel mesh__D008518 Medicine, Oriental
% 208.88/209.06  |- mesh__dateCreated mesh__D008518 1999-01-01
% 208.88/209.06  |- skos__hiddenLabel mesh__D008518 Oriental Traditional Medicine
% 208.88/209.06  |- mesh__recordAuthorizer mesh__D008518 sjn
% 208.88/209.06  |- mesh__recordOriginator mesh__D008518 NLM
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D000535 2003
% 208.88/209.06  |- skos__scopeNote mesh__D000535
% 208.88/209.06       A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98.%A%    
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D000535 2004
% 208.88/209.06  |- mesh__recordAuthorizer mesh__D000535 sjn
% 208.88/209.06  |- skos__broader mesh__D000535smesh__D019565
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D000535 2001
% 208.88/209.06  |- mesh__dateCreated mesh__D000535 1999-01-01
% 208.88/209.06  |- skos__prefLabel mesh__D000535 Aluminum
% 208.88/209.06  |- rdf__type mesh__D000535sskos__Concept
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D000535 2005
% 208.88/209.06  |- skos__annotation mesh__D000535
% 208.88/209.06       Al-27; Al-23-26, 28-30 = ALUMINUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 208.88/209.06  |- mesh__recordMaintainer mesh__D000535 adp
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D000535 2002
% 208.88/209.06  |- mesh__recordOriginator mesh__D000535 NLM
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D000535 2006
% 208.88/209.06  |- mesh__dateRevised mesh__D000535 2000-06-21
% 208.88/209.06  |- skos__annotation mesh__D019240 coord with specific bacterium /virol   
% 208.88/209.06  |- skos__altLabel mesh__D019240 Bacteriophage PM2
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D019240 2004
% 208.88/209.06  |- mesh__recordOriginator mesh__D019240 AGS
% 208.88/209.06  |- skos__altLabel mesh__D019240 PM2 Bacteriophage
% 208.88/209.06  |- skos__hiddenLabel mesh__D019240 PM2 Bacteriophages
% 208.88/209.06  |- skos__scopeNote mesh__D019240
% 208.88/209.06       A family of icosahedral, lipid-containing, non-enveloped bacteriophages containing one genus %28%Corticovirus%29%.%A%    
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D019240 2003
% 208.88/209.06  |- mesh__historyNote mesh__D019240 97   
% 208.88/209.06  |- skos__prefLabel mesh__D019240 Corticoviridae
% 208.88/209.06  |- skos__hiddenLabel mesh__D019240 Bacteriophage, PM2
% 208.88/209.06  |- skos__broader mesh__D019240smesh__D001435
% 208.88/209.06  |- mesh__publicMeSHNote mesh__D019240 97   
% 208.88/209.06  |- rdf__type mesh__D019240sskos__Concept
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D019240 2006
% 208.88/209.06  |- mesh__recordMaintainer mesh__D019240 ags
% 208.88/209.06  |- mesh__dateEstablished mesh__D019240 1997-01-01
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D019240 2005
% 208.88/209.06  |- mesh__dateRevised mesh__D019240 2002-07-02
% 208.88/209.06  |- mesh__dateCreated mesh__D019240 1996-06-10
% 208.88/209.06  |- skos__hiddenLabel mesh__D019240 Bacteriophages, PM2
% 208.88/209.06  |- mesh__recordAuthorizer mesh__D019240 sjn
% 208.88/209.06  |- skos__scopeNote mesh__D005220 Male parents, human or animal.     
% 208.88/209.06  |- skos__historyNote mesh__D005220 Father-Child Relations %28%1968-1977%29%
% 208.88/209.06  |- skos__broader mesh__D005220smesh__D010290
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D005220 2005
% 208.88/209.06  |- rdf__type mesh__D005220sskos__Concept
% 208.88/209.06  |- skos__annotation mesh__D005220
% 208.88/209.06       human %26% animal; /psychol: consider also FATHER-CHILD RELATIONS%A%  
% 208.88/209.06  |- mesh__historyNote mesh__D005220 78   
% 208.88/209.06  |- skos__hiddenLabel mesh__D005220 Father
% 208.88/209.06  |- mesh__recordOriginator mesh__D005220 EC
% 208.88/209.06  |- mesh__recordAuthorizer mesh__D005220 sjn
% 208.88/209.06  |- mesh__dateCreated mesh__D005220 1977-04-22
% 208.88/209.06  |- skos__historyNote mesh__D005220 Paternal Behavior %28%1969-1977%29%
% 208.88/209.06  |- mesh__dateRevised mesh__D005220 2004-07-13
% 208.88/209.06  |- mesh__recordMaintainer mesh__D005220 sjn
% 208.88/209.06  |- mesh__dateEstablished mesh__D005220 1978-01-01
% 208.88/209.06  |- skos__prefLabel mesh__D005220 Fathers
% 208.88/209.06  |- skos__historyNote mesh__D005220 Male %28%1966-1977%29%
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D005220 2006
% 208.88/209.06  |- mesh__publicMeSHNote mesh__D005220 78   
% 208.88/209.06  |- mesh__recordAuthorizer mesh__D018946 sjn
% 208.88/209.06  |- mesh__publicMeSHNote mesh__D018946
% 208.88/209.06       96; RANTES PROTEIN, T-CELL was indexed under LYMPHOKINES 1988-95; RANTES PROTEIN, MURINE was indexed under LYMPHOKINES 1992-95%A%  
% 208.88/209.06  |- mesh__dateEstablished mesh__D018946 1996-01-01
% 208.88/209.06  |- skos__historyNote mesh__D018946 Lymphokines %28%1988-1995%29%
% 208.88/209.06  |- skos__hiddenLabel mesh__D018946 T-Cell RANTES Protein
% 208.88/209.06  |- mesh__recordOriginator mesh__D018946 AGS
% 208.88/209.06  |- rdf__type mesh__D018946sskos__Concept
% 208.88/209.06  |- skos__broader mesh__D018946smesh__D018925
% 208.88/209.06  |- skos__annotation mesh__D018946
% 208.88/209.06       a chemokine; RANTES stands for Regulated on Activation, Normal T Expressed and Secreted, often preceded by rh %28% = recombinant human%29%%A%  
% 208.88/209.06  |- skos__hiddenLabel mesh__D018946 Murine RANTES Protein
% 208.88/209.06  |- mesh__dateCreated mesh__D018946 1995-02-21
% 208.88/209.06  |- skos__hiddenLabel mesh__D018946 RANTES Protein, T Cell
% 208.88/209.06  |- mesh__onlineNote mesh__D018946
% 208.88/209.06       use RANTES %28%NM%29% to search RANTES PROTEIN, MURINE 1992-95 %26% RANTES PROTEIN, T-CELL 1988-95%A%  
% 208.88/209.06  |- mesh__historyNote mesh__D018946
% 208.88/209.06       96; was RANTES PROTEIN, T-CELL %28%NM%29% 1988-95; RANTES PROTEIN, MURINE was NM 1992-95%A%  
% 208.88/209.06  |- skos__altLabel mesh__D018946 RANTES Protein, T-Cell
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D018946 2006
% 208.88/209.06  |- skos__prefLabel mesh__D018946 RANTES
% 208.88/209.06  |- mesh__recordMaintainer mesh__D018946 ssb
% 208.88/209.06  |- skos__scopeNote mesh__D018946
% 208.88/209.06       A chemokine that is a chemoattractant for eosinophils, monocytes, and lymphocytes. It is a potent and selective eosinophil chemotaxin that is stored in and released from platelets and activated T-cells.%A%    
% 208.88/209.06  |- mesh__dateRevised mesh__D018946 2005-06-30
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D010963 2005
% 208.88/209.06  |- skos__annotation mesh__D010963
% 208.88/209.06       infection = MALARIA, FALCIPARUM; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 208.88/209.06  |- mesh__recordOriginator mesh__D010963 NLM
% 208.88/209.06  |- rdf__type mesh__D010963sskos__Concept
% 208.88/209.06  |- mesh__dateRevised mesh__D010963 2003-07-09
% 208.88/209.06  |- mesh__recordMaintainer mesh__D010963 ags
% 208.88/209.06  |- skos__scopeNote mesh__D010963
% 208.88/209.06       A species of protozoa that is the causal agent of falciparum malaria %28%MALARIA, FALCIPARUM%29%. It is most prevalent in the tropics and subtropics.%A%    
% 208.88/209.06  |- mesh__dateCreated mesh__D010963 1999-01-01
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D010963 2004
% 208.88/209.06  |- mesh__recordAuthorizer mesh__D010963 sjn
% 208.88/209.06  |- skos__prefLabel mesh__D010963 Plasmodium falciparum
% 208.88/209.06  |- skos__broader mesh__D010963smesh__D010961
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D010963 2006
% 208.88/209.06  |- mesh__recordAuthorizer mesh__D018148 sjn
% 208.88/209.06  |- mesh__recordOriginator mesh__D018148 AGS
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D018148 2002
% 208.88/209.06  |- skos__hiddenLabel mesh__D018148 Swine Pox Viruses
% 208.88/209.06  |- mesh__recordMaintainer mesh__D018148 ags
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D018148 2005
% 208.88/209.06  |- skos__altLabel mesh__D018148 Swine Pox Virus
% 208.88/209.06  |- rdf__type mesh__D018148sskos__Concept
% 208.88/209.06  |- skos__hiddenLabel mesh__D018148 Suipoxviruses
% 208.88/209.06  |- mesh__publicMeSHNote mesh__D018148
% 208.88/209.06       94; SWINEPOX VIRUS was see POXVIRIDAE 1986-93; see under POXVIRIDAE 1981-85; see under POXVIRUSES 1975-80%A%  
% 208.88/209.06  |- skos__prefLabel mesh__D018148 Suipoxvirus
% 208.88/209.06  |- mesh__onlineNote mesh__D018148
% 208.88/209.06       use POXVIRIDAE to search SWINEPOX VIRUS 1975-93   
% 208.88/209.06  |- skos__hiddenLabel mesh__D018148 Swinepox viruses
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D018148 2004
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D018148 2003
% 208.88/209.06  |- mesh__dateRevised mesh__D018148 2001-07-25
% 208.88/209.06  |- mesh__historyNote mesh__D018148
% 208.88/209.06       94; SWINEPOX VIRUS was see POXVIRIDAE 1986-93; see under POXVIRIDAE 1981-85; see under POXVIRUSES 1975-80%A%  
% 208.88/209.06  |- skos__scopeNote mesh__D018148
% 208.88/209.06       A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, containing one species, swinepox virus.%A%    
% 208.88/209.06  |- skos__broader mesh__D018148smesh__D018147
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D018148 2006
% 208.88/209.06  |- skos__annotation mesh__D018148
% 208.88/209.06       infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29%   
% 208.88/209.06  |- mesh__dateCreated mesh__D018148 1993-06-30
% 208.88/209.06  |- mesh__dateEstablished mesh__D018148 1994-01-01
% 208.88/209.06  |- mesh__dateCreated mesh__D010165 1999-01-01
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D010165 2003
% 208.88/209.06  |- skos__annotation mesh__D010165
% 208.88/209.06       Pd-106; Pd-102, 104, 105, 108, 110 = PALLADIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Pd-98-101, 103, 107, 109, 111-115 = PALLADIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D010165 2006
% 208.88/209.06  |- mesh__recordOriginator mesh__D010165 NLM
% 208.88/209.06  |- mesh__dateRevised mesh__D010165 2001-07-25
% 208.88/209.06  |- skos__prefLabel mesh__D010165 Palladium
% 208.88/209.06  |- skos__broader mesh__D010165smesh__D019216
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D010165 2005
% 208.88/209.06  |- skos__broader mesh__D010165smesh__D028561
% 208.88/209.06  |- skos__scopeNote mesh__D010165
% 208.88/209.06       A chemical element having an atomic weight of 106.4, atomic number of 46, and the symbol Pd. It is a white, ductile metal resembling platinum, and following it in abundance and importance of applications. It is used in dentistry in the form of gold, silver, and copper alloys.%A%    
% 208.88/209.06  |- rdf__type mesh__D010165sskos__Concept
% 208.88/209.06  |- mesh__recordMaintainer mesh__D010165 jmp
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D010165 2004
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D010165 2002
% 208.88/209.06  |- mesh__recordAuthorizer mesh__D010165 sjn
% 208.88/209.06  |- mesh__onlineNote mesh__D004926
% 208.88/209.06       use SHIGELLA to search ALKALESCENS-DISPAR GROUP 1974; use ENTEROBACTERIACEAE 1966-73%A%  
% 208.88/209.06  |- skos__related mesh__D004926smesh__D029968
% 208.88/209.06  |- mesh__recordMaintainer mesh__D004926 ags
% 208.88/209.06  |- skos__annotation mesh__D004926
% 208.88/209.06       not for %22%coliform bacillus%22% %28% = COLIFORM BACILLI see ENTEROBACTERIACEAE%29%; infection = ESCHERICHIA COLI INFECTIONS%A%  
% 208.88/209.06  |- mesh__publicMeSHNote mesh__D004926
% 208.88/209.06       ALKALESCENS-DISPAR GROUP was heading 1975-96 %28%see under ESCHERICHIA 1975-90%29%; was see under SHIGELLA 1974; was see under ENTEROBACTERIACEAE 1968-73%A%  
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D004926 2006A
% 208.88/209.06  |- mesh__dateRevised mesh__D004926 2005-07-15
% 208.88/209.06  |- skos__scopeNote mesh__D004926
% 208.88/209.06       A species of gram-negative, facultatively anaerobic, rod-shaped bacteria %28%GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS%29% commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections.%A%    
% 208.88/209.06  |- skos__prefLabel mesh__D004926 Escherichia coli
% 208.88/209.06  |- mesh__dateCreated mesh__D004926 1999-01-01
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D004926 2006
% 208.88/209.06  |- skos__altLabel mesh__D004926 E coli
% 208.88/209.06  |- skos__broader mesh__D004926smesh__D004925
% 208.88/209.06  |- mesh__recordOriginator mesh__D004926 NLM
% 208.88/209.06  |- mesh__recordAuthorizer mesh__D004926 ags
% 208.88/209.06  |- mesh__historyNote mesh__D004926
% 208.88/209.06       ALKALESCENS-DISPAR GROUP was heading 1975-96 %28%see under ESCHERICHIA 1975-90%29%; was see under SHIGELLA 1974; was see under ENTEROBACTERIACEAE 1963-73 %28%Prov 1963-67%29%%A%  
% 208.88/209.06  |- rdf__type mesh__D004926sskos__Concept
% 208.88/209.06  |- skos__historyNote mesh__D037302 Invertebrates %28%1970-2002%29%
% 208.88/209.06  |- mesh__recordMaintainer mesh__D037302 ags
% 208.88/209.06  |- mesh__dateRevised mesh__D037302 2005-07-08
% 208.88/209.06  |- mesh__dateCreated mesh__D037302 2002-07-02
% 208.88/209.06  |- rdf__type mesh__D037302sskos__Concept
% 208.88/209.06  |- mesh__dateEstablished mesh__D037302 2003-01-01
% 208.88/209.06  |- skos__altLabel mesh__D037302 Sea Walnuts
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D037302 2006A
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D037302 2004
% 208.88/209.06  |- skos__broader mesh__D037302smesh__D007448
% 208.88/209.06  |- skos__historyNote mesh__D037302 Cnidaria %28%1969-1997%29%
% 208.88/209.06  |- skos__prefLabel mesh__D037302 Ctenophora
% 208.88/209.06  |- mesh__recordOriginator mesh__D037302 ags
% 208.88/209.06  |- mesh__recordAuthorizer mesh__D037302 ags
% 208.88/209.06  |- skos__altLabel mesh__D037302 Ctenophores
% 208.88/209.06  |- mesh__historyNote mesh__D037302 2003   
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D037302 2006
% 208.88/209.06  |- mesh__publicMeSHNote mesh__D037302 2003   
% 208.88/209.06  |- skos__altLabel mesh__D037302 Comb Jellies
% 208.88/209.06  |- skos__scopeNote mesh__D037302
% 208.88/209.06       Phylum of marine colenterates characterized by eight comb rows of fused cilia on the body surface. In contrast to CNIDARIA they lack stinging cells, but they are voracious predators and possess sticky cells %28%colloblasts%29% for capturing prey. Most species are transparent and many exhibit bioluminescence.%A%    
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D037302 2005
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D004128 2004
% 208.88/209.06  |- skos__scopeNote mesh__D004128
% 208.88/209.06       A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties. It causes serious liver damage and is a hepatocarcinogen in rodents.%A%    
% 208.88/209.06  |- skos__historyNote mesh__D004128 Dimethylamines %28%1974%29%
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D004128 2001
% 208.88/209.06  |- skos__historyNote mesh__D004128 Nitrosamines %28%1966-1974%29%
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D004128 2006
% 208.88/209.06  |- mesh__recordAuthorizer mesh__D004128 sjn
% 208.88/209.06  |- skos__prefLabel mesh__D004128 Dimethylnitrosamine
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D004128 2003
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D004128 2005
% 208.88/209.06  |- mesh__historyNote mesh__D004128
% 208.88/209.06       80%28%75%29%; was see under NITROSAMINES 1975-79   
% 208.88/209.06  |- skos__altLabel mesh__D004128 Nitrosodimethylamine
% 208.88/209.06  |- mesh__dateCreated mesh__D004128 1974-11-11
% 208.88/209.06  |- mesh__recordMaintainer mesh__D004128 CCR
% 208.88/209.06  |- mesh__dateRevised mesh__D004128 2000-06-22
% 208.88/209.06  |- skos__historyNote mesh__D004128 Amines %28%1966-1971%29%
% 208.88/209.06  |- mesh__dateEstablished mesh__D004128 1980-01-01
% 208.88/209.06  |- mesh__publicMeSHNote mesh__D004128
% 208.88/209.06       80; was see under NITROSAMINES 1975-79   
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D004128 2002
% 208.88/209.06  |- rdf__type mesh__D004128sskos__Concept
% 208.88/209.06  |- mesh__recordOriginator mesh__D004128 NLM
% 208.88/209.06  |- skos__historyNote mesh__D004128 Methylamines %28%1971-1974%29%
% 208.88/209.06  |- skos__broader mesh__D004128smesh__D009602
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D009611 2005
% 208.88/209.06  |- skos__broader mesh__D009611smesh__D009596
% 208.88/209.06  |- skos__prefLabel mesh__D009611 Nitroxinil
% 208.88/209.06  |- skos__altLabel mesh__D009611 Nitroxynil
% 208.88/209.06  |- skos__historyNote mesh__D009611 Nitriles %28%1972-1974%29%
% 208.88/209.06  |- mesh__recordOriginator mesh__D009611 NLM
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D009611 2006
% 208.88/209.06  |- mesh__recordMaintainer mesh__D009611 CCR
% 208.88/209.06  |- mesh__historyNote mesh__D009611
% 208.88/209.06       91%28%75%29%; was see under NITROPHENOLS 1975-90   
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D009611 2002
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D009611 2003
% 208.88/209.06  |- mesh__publicMeSHNote mesh__D009611
% 208.88/209.06       91; was see under NITROPHENOLS 1975-90   
% 208.88/209.06  |- mesh__recordAuthorizer mesh__D009611 sjn
% 208.88/209.06  |- rdf__type mesh__D009611sskos__Concept
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D009611 2004
% 208.88/209.06  |- mesh__dateRevised mesh__D009611 2000-06-22
% 208.88/209.06  |- mesh__dateEstablished mesh__D009611 1991-01-01
% 208.88/209.06  |- mesh__dateCreated mesh__D009611 1974-11-19
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D009611 2001
% 208.88/209.06  |- skos__scopeNote mesh__D009611
% 208.88/209.06       Proposed anthelmintic for fasciola and liver fluke infestations.%A%    
% 208.88/209.06  |- skos__historyNote mesh__D009611 Nitrophenols %28%1972-1974%29%
% 208.88/209.06  |- mesh__dateRevised mesh__D020593 2005-06-30
% 208.88/209.06  |- skos__scopeNote mesh__D020593
% 208.88/209.06       A genus of gram-negative, facultatively anaerobic rod-shaped cells which are motile by peritrichous flagella. Late in the growth cycle, spheroplasts or coccoid bodies occur, resulting from disintegration of the cell wall. The natural habitat is the intestinal lumen of certain nematodes. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 208.88/209.06  |- skos__prefLabel mesh__D020593 Xenorhabdus
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D020593 2006
% 208.88/209.06  |- mesh__historyNote mesh__D020593 2000   
% 208.88/209.06  |- skos__broader mesh__D020593smesh__D004755
% 208.88/209.06  |- rdf__type mesh__D020593sskos__Concept
% 208.88/209.06  |- mesh__recordOriginator mesh__D020593 ndw
% 208.88/209.06  |- skos__annotation mesh__D020593
% 208.88/209.06       XENORHABDUS LUMINESCENS see PHOTORHABDUS is also available%A%  
% 208.88/209.06  |- mesh__recordAuthorizer mesh__D020593 sjn
% 208.88/209.06  |- skos__altLabel mesh__D020593 Xenorhabdus nematophilus
% 208.88/209.06  |- skos__historyNote mesh__D020593 Enterobacteriaceae %28%1983-1999%29%
% 208.88/209.06  |- mesh__publicMeSHNote mesh__D020593 2000   
% 208.88/209.06  |- mesh__dateEstablished mesh__D020593 2000-01-01
% 208.88/209.06  |- mesh__dateCreated mesh__D020593 1999-11-03
% 208.88/209.06  |- mesh__recordMaintainer mesh__D020593 SYSTEM
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D014556 2000
% 208.88/209.06  |- skos__related mesh__D014556smesh__D006456
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D014556 2006
% 208.88/209.06  |- skos__related mesh__D014556smesh__D000474
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D014556 1996
% 208.88/209.06  |- mesh__dateRevised mesh__D014556 1996-09-23
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D014556 2005
% 208.88/209.06  |- skos__broader mesh__D014556smesh__D001826
% 208.88/209.06  |- skos__related mesh__D014556smesh__D011141
% 208.88/209.06  |- mesh__activeMeSHYear mesh__D014556 1999
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D014556 2002
% 208.88/209.07  |- mesh__recordAuthorizer mesh__D014556 PLS
% 208.88/209.07  |- skos__related mesh__D014556smesh__D011776
% 208.88/209.07  |- mesh__dateCreated mesh__D014556 1999-01-01
% 208.88/209.07  |- skos__related mesh__D014556smesh__D006029
% 208.88/209.07  |- skos__related mesh__D014556smesh__D003555
% 208.88/209.07  |- skos__related mesh__D014556smesh__D011507
% 208.88/209.07  |- skos__related mesh__D014556smesh__D001002
% 208.88/209.07  |- skos__related mesh__D014556smesh__D008375
% 208.88/209.07  |- skos__related mesh__D014556smesh__D000419
% 208.88/209.07  |- skos__prefLabel mesh__D014556 Urine
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D014556 1998
% 208.88/209.07  |- mesh__recordOriginator mesh__D014556 NLM
% 208.88/209.07  |- skos__related mesh__D014556smesh__D000608
% 208.88/209.07  |- skos__annotation mesh__D014556
% 208.88/209.07       GEN only: prefer /urine with higher animals, substances %26% diseases: Manual 19.7+, 19.8.79; for microbiol, see TN 190; urine volume: index under URINE probably NIM%A%  
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D014556 2004
% 208.88/209.07  |- skos__related mesh__D014556smesh__D006417
% 208.88/209.07  |- mesh__recordMaintainer mesh__D014556 SJN
% 208.88/209.07  |- skos__related mesh__D014556smesh__D010661
% 208.88/209.07  |- skos__related mesh__D014556smesh__D001437
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D014556 2001
% 208.88/209.07  |- rdf__type mesh__D014556sskos__Concept
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D014556 2003
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D014556 1997
% 208.88/209.07  |- rdf__type mesh__D008519sskos__Concept
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D008519 2006
% 208.88/209.07  |- skos__altLabel mesh__D008519 Primitive Medicine
% 208.88/209.07  |- mesh__recordAuthorizer mesh__D008519 sjn
% 208.88/209.07  |- skos__altLabel mesh__D008519 Traditional Medicine
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D008519 2004
% 208.88/209.07  |- skos__annotation mesh__D008519
% 208.88/209.07       IM; includes medicine among aborigines %26% other primitive cultures %26% folk medicine among non-primitive cultures; specify geog; DF: MED TRADITIONAL%A%  
% 208.88/209.07  |- mesh__recordOriginator mesh__D008519 NLM
% 208.88/209.07  |- skos__related mesh__D008519smesh__D008419
% 208.88/209.07  |- skos__hiddenLabel mesh__D008519 Remedy, Folk
% 208.88/209.07  |- mesh__onlineNote mesh__D008519
% 208.88/209.07       use MEDICINE, TRADITIONAL to search MEDICINE, PRIMITIVE  1966-80, FOLK MEDICINE 1966-77, %26% FOLKLORE 1968-77%A%  
% 208.88/209.07  |- skos__hiddenLabel mesh__D008519 Folk Remedy
% 208.88/209.07  |- skos__hiddenLabel mesh__D008519 Remedy, Home
% 208.88/209.07  |- skos__altLabel mesh__D008519 Indigenous Medicine
% 208.88/209.07  |- skos__hiddenLabel mesh__D008519 Remedies, Folk
% 208.88/209.07  |- skos__hiddenLabel mesh__D008519 Remedies, Home
% 208.88/209.07  |- skos__hiddenLabel mesh__D008519 Home Remedy
% 208.88/209.07  |- skos__altLabel mesh__D008519 Folk Medicine
% 208.88/209.07  |- mesh__dateCreated mesh__D008519 1999-01-01
% 208.88/209.07  |- mesh__dateRevised mesh__D008519 2001-07-25
% 208.88/209.07  |- skos__broader mesh__D008519smesh__D003469
% 208.88/209.07  |- skos__scopeNote mesh__D008519
% 208.88/209.07       Systems of medicine based on cultural beliefs and practices handed down from generation to generation. The concept includes mystical and magical rituals, herbal therapy, and other treatments which may not be explained by modern medicine.%A%    
% 208.88/209.07  |- skos__broader mesh__D008519smesh__D000529
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D008519 2002
% 208.88/209.07  |- mesh__recordMaintainer mesh__D008519 ssb
% 208.88/209.07  |- mesh__historyNote mesh__D008519
% 208.88/209.07       81; was MEDICINE, PRIMITIVE 1963-80; FOLK MEDICINE was see under FOLKLORE 1968-77%A%  
% 208.88/209.07  |- skos__related mesh__D008519smesh__D006303
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D008519 2005
% 208.88/209.07  |- skos__prefLabel mesh__D008519 Medicine, Traditional
% 208.88/209.07  |- skos__related mesh__D008519smesh__D019423
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D008519 2003
% 208.88/209.07  |- mesh__publicMeSHNote mesh__D008519
% 208.88/209.07       81; was MEDICINE, PRIMITIVE 1963-80; FOLK MEDICINE was see under FOLKLORE 1968-77%A%  
% 208.88/209.07  |- skos__hiddenLabel mesh__D000536 Algeldrate Philopharm Brand
% 208.88/209.07  |- skos__altLabel mesh__D000536 Aldrox
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D000536 2006
% 208.88/209.07  |- skos__altLabel mesh__D000536 Hydrated Alumina
% 208.88/209.07  |- skos__historyNote mesh__D000536 Hydroxides %28%1966-1977%29%
% 208.88/209.07  |- skos__historyNote mesh__D000536 Aluminum %28%1966-1977%29%
% 208.88/209.07  |- skos__altLabel mesh__D000536
% 208.88/209.07       Rh%C3%%B4%ne-Poulenc Rorer Brand of Algeldrate
% 208.88/209.07  |- rdf__type mesh__D000536sskos__Concept
% 208.88/209.07  |- skos__hiddenLabel mesh__D000536 Gel, Aluminum Hydroxide
% 208.88/209.07  |- mesh__dateCreated mesh__D000536 1977-05-16
% 208.88/209.07  |- mesh__publicMeSHNote mesh__D000536
% 208.88/209.07       78; ALUMINUM HYDROXIDE GEL was heading 1973-77; ALUMINUM GELS was see under ANTACIDS 1963-72%A%  
% 208.88/209.07  |- skos__altLabel mesh__D000536 Pharmacia Brand of Algeldrate
% 208.88/209.07  |- skos__altLabel mesh__D000536 Algeldrate
% 208.88/209.07  |- skos__altLabel mesh__D000536 Roques Brand of Algeldrate
% 208.88/209.07  |- skos__hiddenLabel mesh__D000536 Algeldrate Axcan Brand
% 208.88/209.07  |- skos__altLabel mesh__D000536 Whitehall Brand of Algeldrate
% 208.88/209.07  |- skos__hiddenLabel mesh__D000536
% 208.88/209.07       Rh%C3%%B4%ne Poulenc Rorer Brand of Algeldrate
% 208.88/209.07  |- mesh__dateRevised mesh__D000536 2005-06-30
% 208.88/209.07  |- skos__altLabel mesh__D000536 SmithKline Beecham Brand of Algeldrate
% 208.88/209.07  |- skos__altLabel mesh__D000536 Philopharm Brand of Algeldrate
% 208.88/209.07  |- skos__altLabel mesh__D000536 Basalgel
% 208.88/209.07  |- mesh__recordMaintainer mesh__D000536 lkw
% 208.88/209.07  |- skos__altLabel mesh__D000536 Axcan Brand of Algeldrate
% 208.88/209.07  |- mesh__dateEstablished mesh__D000536 1978-01-01
% 208.88/209.07  |- mesh__recordAuthorizer mesh__D000536 sjn
% 208.88/209.07  |- skos__hiddenLabel mesh__D000536 Hydroxide, Aluminum
% 208.88/209.07  |- mesh__onlineNote mesh__D000536
% 208.88/209.07       use ALUMINUM HYDROXIDE to search ALUMINUM HYDROXIDE GEL 1972-77 %28%as Prov 1972%29%; use ANTACIDS 1966-71%A%  
% 208.88/209.07  |- skos__altLabel mesh__D000536 Sanofi Winthrop Brand of Algeldrate
% 208.88/209.07  |- skos__hiddenLabel mesh__D000536 Algeldrate Whitehall Brand
% 208.88/209.07  |- skos__altLabel mesh__D000536 Wyeth Brand of Algeldrate
% 208.88/209.07  |- skos__hiddenLabel mesh__D000536 Algeldrate Roques Brand
% 208.88/209.07  |- skos__hiddenLabel mesh__D000536 Algeldrate Wyeth Brand
% 208.88/209.07  |- skos__hiddenLabel mesh__D000536 Algeldrate Stiefel Brand
% 208.88/209.07  |- mesh__recordOriginator mesh__D000536 RLS
% 208.88/209.07  |- skos__hiddenLabel mesh__D000536 Alumina, Hydrated
% 208.88/209.07  |- skos__broader mesh__D000536smesh__D017607
% 208.88/209.07  |- skos__scopeNote mesh__D000536
% 208.88/209.07       A compound with many biomedical applications: as a gastric antacid, an antiperspirant, in dentifrices, as an emulsifier, as an adjuvant in bacterins and vaccines, in water purification, etc.%A%    
% 208.88/209.07  |- skos__broader mesh__D000536smesh__D006878
% 208.88/209.07  |- mesh__historyNote mesh__D000536
% 208.88/209.07       78; ALUMINUM HYDROXIDE GEL was heading 1972-77 %28%Prov 1972%29%; ALUMINUM GELS was see under ANTACIDS 1963-72%A%  
% 208.88/209.07  |- skos__altLabel mesh__D000536 Stiefel Brand of Algeldrate
% 208.88/209.07  |- skos__prefLabel mesh__D000536 Aluminum Hydroxide
% 208.88/209.07  |- skos__hiddenLabel mesh__D000536 Algeldrate Pharmacia Brand
% 208.88/209.07  |- skos__historyNote mesh__D000536 Antacids %28%1966-1971%29%
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D019241 2003
% 208.88/209.07  |- mesh__historyNote mesh__D019241 97   
% 208.88/209.07  |- rdf__type mesh__D019241sskos__Concept
% 208.88/209.07  |- mesh__dateRevised mesh__D019241 2001-07-25
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D019241 2006
% 208.88/209.07  |- mesh__dateCreated mesh__D019241 1996-06-10
% 208.88/209.07  |- mesh__recordAuthorizer mesh__D019241 sjn
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D019241 2005
% 208.88/209.07  |- mesh__recordMaintainer mesh__D019241 ags
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D019241 2002
% 208.88/209.07  |- mesh__recordOriginator mesh__D019241 AGS
% 208.88/209.07  |- skos__annotation mesh__D019241 coord with specific Archaea /virol   
% 208.88/209.07  |- skos__altLabel mesh__D019241 SSV1
% 208.88/209.07  |- skos__broader mesh__D019241smesh__D004267
% 208.88/209.07  |- skos__broader mesh__D019241smesh__D023641
% 208.88/209.07  |- skos__scopeNote mesh__D019241
% 208.88/209.07       A family of lemon-shaped DNA viruses infecting ARCHAEA and containing one genus: Fusellovirus.%A%    
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D019241 2004
% 208.88/209.07  |- skos__prefLabel mesh__D019241 Fuselloviridae
% 208.88/209.07  |- mesh__dateEstablished mesh__D019241 1997-01-01
% 208.88/209.07  |- mesh__publicMeSHNote mesh__D019241 97   
% 208.88/209.07  |- skos__scopeNote mesh__D005221
% 208.88/209.07       The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.%A%    
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D005221 2003
% 208.88/209.07  |- skos__related mesh__D005221smesh__D001247
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D005221 2001
% 208.88/209.07  |- rdf__type mesh__D005221sskos__Concept
% 208.88/209.07  |- skos__annotation mesh__D005221
% 208.88/209.07       do not use for fatigue of isolated muscle fibers in physiol exper %28% = MUSCLE FATIGUE%29%%A%  
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D005221 2000
% 208.88/209.07  |- mesh__recordMaintainer mesh__D005221 KEV
% 208.88/209.07  |- skos__broader mesh__D005221smesh__D012816
% 208.88/209.07  |- mesh__dateRevised mesh__D005221 1999-11-03
% 208.88/209.07  |- mesh__dateCreated mesh__D005221 1999-01-01
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D005221 2006
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D005221 2002
% 208.88/209.07  |- mesh__recordAuthorizer mesh__D005221 sjn
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D005221 2005
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D005221 2004
% 208.88/209.07  |- mesh__recordOriginator mesh__D005221 NLM
% 208.88/209.07  |- skos__prefLabel mesh__D005221 Fatigue
% 208.88/209.07  |- skos__scopeNote mesh__D018947
% 208.88/209.07       A group of islands in the southwest central Pacific, divided into AMERICAN SAMOA and the INDEPENDENT STATE OF SAMOA %28%Western Samoa%29%. First European contact was made in 1722 by Jacob Roggeveen, a Dutchman. In 1768 they were named Navigators Islands by Louis de Bougainville. The present name may derive from that of a local chieftain or from a local word meaning place of the moa, a now-extinct island bird. %28%From Webster%27%s New Geographical Dictionary, 1988, p1061 %26% Room, Brewer%27%s Dictionary of Names, 1992, p481%29%%A%    
% 208.88/209.07  |- mesh__dateEstablished mesh__D018947 1996-01-01
% 208.88/209.07  |- skos__altLabel mesh__D018947 Samoa Islands
% 208.88/209.07  |- mesh__onlineNote mesh__D018947
% 208.88/209.07       use WESTERN SAMOA to search SAMOA 1994-95   
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D018947 2005
% 208.88/209.07  |- skos__prefLabel mesh__D018947 Samoa
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D018947 1999
% 208.88/209.07  |- skos__altLabel mesh__D018947 Samoan Islands
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D018947 2001
% 208.88/209.07  |- mesh__dateCreated mesh__D018947 1995-06-08
% 208.88/209.07  |- skos__altLabel mesh__D018947 Navigator Island
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D018947 2000
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D018947 2004
% 208.88/209.07  |- skos__altLabel mesh__D018947 Navigator Islands
% 208.88/209.07  |- skos__broader mesh__D018947smesh__D011114
% 208.88/209.07  |- mesh__recordOriginator mesh__D018947 TGC
% 208.88/209.07  |- mesh__historyNote mesh__D018947 96; was see WESTERN SAMOA 1994-95   
% 208.88/209.07  |- skos__historyNote mesh__D018947 Western Samoa %28%1968-1995%29%
% 208.88/209.07  |- mesh__recordAuthorizer mesh__D018947 SJN
% 208.88/209.07  |- rdf__type mesh__D018947sskos__Concept
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D018947 2003
% 208.88/209.07  |- skos__annotation mesh__D018947
% 208.88/209.07       an island group in Polynesia; AMERICAN SAMOA %26% INDEPENDENT STATE OF SAMOA are also available%A%  
% 208.88/209.07  |- mesh__dateRevised mesh__D018947 1998-06-11
% 208.88/209.07  |- skos__historyNote mesh__D018947 Pacific Islands %28%1967-1970%29%
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D018947 2002
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D018947 2006
% 208.88/209.07  |- mesh__recordMaintainer mesh__D018947 JLS
% 208.88/209.07  |- skos__broader mesh__D010964smesh__D010961
% 208.88/209.07  |- rdf__type mesh__D010964sskos__Concept
% 208.88/209.07  |- skos__prefLabel mesh__D010964 Plasmodium gallinaceum
% 208.88/209.07  |- mesh__dateRevised mesh__D010964 2003-07-09
% 208.88/209.07  |- mesh__recordMaintainer mesh__D010964 ags
% 208.88/209.07  |- skos__annotation mesh__D010964
% 208.88/209.07       in chickens; infection = MALARIA, AVIAN %28%see note there%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D010964 2004
% 208.88/209.07  |- skos__historyNote mesh__D010964 Plasmodium %28%1966-1985%29%
% 208.88/209.07  |- mesh__dateCreated mesh__D010964 1985-03-11
% 208.88/209.07  |- mesh__dateEstablished mesh__D010964 1991-01-01
% 208.88/209.07  |- mesh__recordOriginator mesh__D010964 EC
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D010964 2006
% 208.88/209.07  |- mesh__historyNote mesh__D010964
% 208.88/209.07       91%28%86%29%; was see under PLASMODIUM 1986-90   
% 208.88/209.07  |- mesh__publicMeSHNote mesh__D010964
% 208.88/209.07       91; was see under PLASMODIUM 1986-90   
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D010964 2005
% 208.88/209.07  |- skos__scopeNote mesh__D010964
% 208.88/209.07       A protozoan parasite that causes avian malaria %28%MALARIA, AVIAN%29%, primarily in chickens, and is transmitted by the Aedes mosquito.%A%    
% 208.88/209.07  |- mesh__recordAuthorizer mesh__D010964 sjn
% 208.88/209.07  |- rdf__type mesh__D018149sskos__Concept
% 208.88/209.07  |- mesh__dateEstablished mesh__D018149 1994-01-01
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D018149 2004
% 208.88/209.07  |- mesh__recordAuthorizer mesh__D018149 sjn
% 208.88/209.07  |- skos__hiddenLabel mesh__D018149 Glucose Intolerances
% 208.88/209.07  |- mesh__dateCreated mesh__D018149 1993-06-03
% 208.88/209.07  |- skos__broader mesh__D018149smesh__D006943
% 208.88/209.07  |- mesh__historyNote mesh__D018149 94   
% 208.88/209.07  |- mesh__recordMaintainer mesh__D018149 lkt
% 208.88/209.07  |- skos__related mesh__D018149smesh__D003920
% 208.88/209.07  |- mesh__dateRevised mesh__D018149 2003-07-09
% 208.88/209.07  |- mesh__publicMeSHNote mesh__D018149 94   
% 208.88/209.07  |- skos__related mesh__D018149smesh__D005951
% 208.88/209.07  |- skos__hiddenLabel mesh__D018149 Intolerance, Glucose
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D018149 2006
% 208.88/209.07  |- skos__prefLabel mesh__D018149 Glucose Intolerance
% 208.88/209.07  |- skos__scopeNote mesh__D018149
% 208.88/209.07       A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.%A%    
% 208.88/209.07  |- skos__hiddenLabel mesh__D018149 Intolerances, Glucose
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D018149 2005
% 208.88/209.07  |- skos__historyNote mesh__D018149 Blood Glucose %28%1966-1993%29%
% 208.88/209.07  |- mesh__recordOriginator mesh__D018149 PXP
% 208.88/209.07  |- mesh__recordAuthorizer mesh__D010166 SJN
% 208.88/209.07  |- mesh__publicMeSHNote mesh__D010166
% 208.88/209.07       96; was PALLIATIVE TREATMENT 1966-95   
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D010166 2005
% 208.88/209.07  |- skos__scopeNote mesh__D010166
% 208.88/209.07       Care alleviating symptoms without curing the underlying disease. %28%Stedman, 25th ed%29%%A%    
% 208.88/209.07  |- skos__altLabel mesh__D010166 Palliative Treatment
% 208.88/209.07  |- mesh__recordMaintainer mesh__D010166 JLS
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D010166 2006
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D010166 1999
% 208.88/209.07  |- skos__altLabel mesh__D010166 Surgery, Palliative
% 208.88/209.07  |- skos__hiddenLabel mesh__D010166 Palliative Treatments
% 208.88/209.07  |- skos__hiddenLabel mesh__D010166 Care, Palliative
% 208.88/209.07  |- skos__altLabel mesh__D010166 Medicine, Palliative
% 208.88/209.07  |- skos__broader mesh__D010166smesh__D005791
% 208.88/209.07  |- skos__hiddenLabel mesh__D010166 Treatments, Palliative
% 208.88/209.07  |- rdf__type mesh__D010166sskos__Concept
% 208.88/209.07  |- skos__prefLabel mesh__D010166 Palliative Care
% 208.88/209.07  |- skos__altLabel mesh__D010166 Palliative Therapy
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D010166 2000
% 208.88/209.07  |- mesh__recordOriginator mesh__D010166 NLM
% 208.88/209.07  |- skos__annotation mesh__D010166
% 208.88/209.07       = relief without cure; coord IM with disease /ther or /surg or /drug ther or other specific qualif %28%IM%29%; consider also PAIN /ther%A%  
% 208.88/209.07  |- mesh__dateCreated mesh__D010166 1999-01-01
% 208.88/209.07  |- skos__altLabel mesh__D010166 Therapy, Palliative
% 208.88/209.07  |- skos__hiddenLabel mesh__D010166 Treatment, Palliative
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D010166 2003
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D010166 2001
% 208.88/209.07  |- mesh__dateRevised mesh__D010166 1998-06-10
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D010166 2004
% 208.88/209.07  |- mesh__dateEstablished mesh__D010166 1966-01-01
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D010166 2002
% 208.88/209.07  |- mesh__historyNote mesh__D010166
% 208.88/209.07       96; was PALLIATIVE TREATMENT 1964-95 %28%Prov 1964-65%29%   
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D004927 1997
% 208.88/209.07  |- skos__hiddenLabel mesh__D004927 E coli Infection
% 208.88/209.07  |- skos__broader mesh__D004927smesh__D004756
% 208.88/209.07  |- skos__altLabel mesh__D004927 E coli Infections
% 208.88/209.07  |- skos__altLabel mesh__D004927 Infections, Escherichia coli
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D004927 2005
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D004927 2002
% 208.88/209.07  |- mesh__recordMaintainer mesh__D004927 TAP
% 208.88/209.07  |- skos__hiddenLabel mesh__D004927 Infection, Escherichia coli
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D004927 1994
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D004927 2006
% 208.88/209.07  |- mesh__dateCreated mesh__D004927 1999-01-01
% 208.88/209.07  |- mesh__recordAuthorizer mesh__D004927 PLS
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D004927 1998
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D004927 1995
% 208.88/209.07  |- rdf__type mesh__D004927sskos__Concept
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D004927 2003
% 208.88/209.07  |- skos__annotation mesh__D004927
% 208.88/209.07       gram-neg bact infect; DF: E COLI INFECTIONS or E COLI INFECT%A%  
% 208.88/209.07  |- skos__altLabel mesh__D004927 Infections, E coli
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D004927 2000
% 208.88/209.07  |- skos__prefLabel mesh__D004927 Escherichia coli Infections
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D004927 1999
% 208.88/209.07  |- mesh__dateRevised mesh__D004927 1993-06-02
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D004927 2004
% 208.88/209.07  |- skos__hiddenLabel mesh__D004927 Infection, E coli
% 208.88/209.07  |- skos__hiddenLabel mesh__D004927 Escherichia coli Infection
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D004927 1996
% 208.88/209.07  |- skos__scopeNote mesh__D004927
% 208.88/209.07       Infections with bacteria of the species ESCHERICHIA COLI.%A%    
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D004927 2001
% 208.88/209.07  |- mesh__recordOriginator mesh__D004927 NLM
% 208.88/209.07  |- skos__historyNote mesh__D004129 Silicone Elastomers %28%1972-1974%29%
% 208.88/209.07  |- mesh__recordAuthorizer mesh__D004129 sjn
% 208.88/209.07  |- mesh__dateCreated mesh__D004129 1974-11-19
% 208.88/209.07  |- mesh__dateEstablished mesh__D004129 1991-01-01
% 208.88/209.07  |- skos__scopeNote mesh__D004129
% 208.88/209.07       Silicone polymers which consist of silicon atoms substituted with methyl groups and linked by oxygen atoms. They comprise a series of biocompatible materials used as liquids, gels or solids; as film for artificial membranes, gels for implants, and liquids for drug vehicles; and as antifoaming agents.%A%    
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D004129 2006
% 208.88/209.07  |- skos__annotation mesh__D004129 organosiloxane polymers; D25-26 qualif   
% 208.88/209.07  |- skos__altLabel mesh__D004129 Polydimethylsiloxanes
% 208.88/209.07  |- skos__historyNote mesh__D004129 Silicones %28%1972-1974%29%
% 208.88/209.07  |- mesh__publicMeSHNote mesh__D004129
% 208.88/209.07       91; was see under SILICONES 1975-90   
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D004129 2005
% 208.88/209.07  |- skos__broader mesh__D004129smesh__D012828
% 208.88/209.07  |- skos__prefLabel mesh__D004129 Dimethylpolysiloxanes
% 208.88/209.07  |- mesh__historyNote mesh__D004129
% 208.88/209.07       91%28%75%29%; was see under SILICONES 1975-90   
% 208.88/209.07  |- rdf__type mesh__D004129sskos__Concept
% 208.88/209.07  |- mesh__recordOriginator mesh__D004129 RLS
% 208.88/209.07  |- mesh__recordMaintainer mesh__D004129 jmp
% 208.88/209.07  |- mesh__dateRevised mesh__D004129 2004-07-07
% 208.88/209.07  |- mesh__recordAuthorizer mesh__D009612 sjn
% 208.88/209.07  |- skos__altLabel mesh__D009612 NAD Pyrophosphorylase
% 208.88/209.07  |- mesh__dateEstablished mesh__D009612 1991-01-01
% 208.88/209.07  |- skos__hiddenLabel mesh__D009612 Adenylyltransferase, ATP-NMN
% 208.88/209.07  |- skos__prefLabel mesh__D009612
% 208.88/209.07       Nicotinamide-Nucleotide Adenylyltransferase
% 208.88/209.07  |- skos__hiddenLabel mesh__D009612 ATP NMN Adenylyltransferase
% 208.88/209.07  |- skos__altLabel mesh__D009612
% 208.88/209.07       Nicotinamide Mononucleotide Adenylyltransferase
% 208.88/209.07  |- mesh__dateCreated mesh__D009612 1978-03-13
% 208.88/209.07  |- skos__hiddenLabel mesh__D009612 Adenylyltransferase, NMN
% 208.88/209.07  |- skos__historyNote mesh__D009612 Transferases %28%1966-1967%29%
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D009612 2006
% 208.88/209.07  |- skos__historyNote mesh__D009612
% 208.88/209.07       Nucleotidyltransferases %28%1966-1978%29%
% 208.88/209.07  |- skos__hiddenLabel mesh__D009612
% 208.88/209.07       Nicotinamide Nucleotide Adenylyltransferase
% 208.88/209.07  |- skos__hiddenLabel mesh__D009612 Pyrophosphorylase, NAD
% 208.88/209.07  |- mesh__dateRevised mesh__D009612 2003-07-09
% 208.88/209.07  |- skos__altLabel mesh__D009612 ATP-NMN Adenylyltransferase
% 208.88/209.07  |- skos__historyNote mesh__D009612
% 208.88/209.07       Nicotinamide Mononucleotide %28%1973-1978%29%
% 208.88/209.07  |- skos__historyNote mesh__D009612 Adenosine Triphosphate %28%1966-1978%29%
% 208.88/209.07  |- skos__hiddenLabel mesh__D009612
% 208.88/209.07       Mononucleotide Adenylyltransferase, Nicotinamide
% 208.88/209.07  |- mesh__historyNote mesh__D009612 98%28%79%29%   
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D009612 2005
% 208.88/209.07  |- skos__altLabel mesh__D009612 NMN Adenylyltransferase
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D009612 2004
% 208.88/209.07  |- mesh__recordMaintainer mesh__D009612 ssb
% 208.88/209.07  |- skos__annotation mesh__D009612 DF: note short X ref   
% 208.88/209.07  |- rdf__type mesh__D009612sskos__Concept
% 208.88/209.07  |- skos__broader mesh__D009612smesh__D009713
% 208.88/209.07  |- mesh__recordOriginator mesh__D009612 CAB
% 208.88/209.07  |- skos__scopeNote mesh__D009612
% 208.88/209.07       An enzyme that catalyzes reversibly the transfer of the adenylyl moiety of ATP to the phosphoryl group of NMN to form NAD+ and pyrophosphate. The enzyme is found predominantly in the nuclei and catalyzes the final reaction in the major pathway for the biosynthesis of NAD in mammals. EC 2.7.7.1.%A%    
% 208.88/209.07  |- skos__hiddenLabel mesh__D009612
% 208.88/209.07       Adenylyltransferase, Nicotinamide-Nucleotide
% 208.88/209.07  |- skos__hiddenLabel mesh__D009612
% 208.88/209.07       Adenylyltransferase, Nicotinamide Mononucleotide
% 208.88/209.07  |- mesh__publicMeSHNote mesh__D009612
% 208.88/209.07       98; see NMN ADENYLYLTRANSFERASE 1991-97; see NUCLEOTIDYLTRANSFERASES 1979-90%A%  
% 208.88/209.07  |- skos__historyNote mesh__D020594 Enterobacteriaceae %28%1969-1999%29%
% 208.88/209.07  |- mesh__publicMeSHNote mesh__D020594 2000   
% 208.88/209.07  |- mesh__dateCreated mesh__D020594 1999-11-03
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D020594 2006
% 208.88/209.07  |- mesh__historyNote mesh__D020594 2000   
% 208.88/209.07  |- rdf__type mesh__D020594sskos__Concept
% 208.88/209.07  |- mesh__recordOriginator mesh__D020594 ndw
% 208.88/209.07  |- skos__broader mesh__D020594smesh__D004755
% 208.88/209.07  |- skos__annotation mesh__D020594
% 208.88/209.07       infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 208.88/209.07  |- mesh__dateRevised mesh__D020594 2005-06-30
% 208.88/209.07  |- skos__prefLabel mesh__D020594 Edwardsiella
% 208.88/209.07  |- skos__scopeNote mesh__D020594
% 208.88/209.07       A genus of small, straight gram-negative rods which are facultatively anaerobic, chemoorganotrophic, and usually motile by peritrichous flagella. Members of this genus are usually found in the intestines of cold-blooded animals and in fresh water. They are pathogenic for eels, CATFISHES, and other animals and are rare opportunistic pathogens for humans. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 208.88/209.07  |- mesh__dateEstablished mesh__D020594 2000-01-01
% 208.88/209.07  |- mesh__recordMaintainer mesh__D020594 SYSTEM
% 208.88/209.07  |- mesh__recordAuthorizer mesh__D020594 sjn
% 208.88/209.07  |- mesh__recordAuthorizer mesh__D014557 sjn
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D014557 2006
% 208.88/209.07  |- mesh__dateCreated mesh__D014557 1999-01-01
% 208.88/209.07  |- skos__prefLabel mesh__D014557 Urobilin
% 208.88/209.07  |- mesh__recordOriginator mesh__D014557 NLM
% 208.88/209.07  |- skos__broader mesh__D014557smesh__D001654
% 208.88/209.07  |- mesh__recordMaintainer mesh__D014557 ssb
% 208.88/209.07  |- skos__annotation mesh__D014557
% 208.88/209.07       a bile pigment; /biosyn /physiol permitted   
% 208.88/209.07  |- rdf__type mesh__D014557sskos__Concept
% 208.88/209.07  |- mesh__dateRevised mesh__D014557 2005-06-30
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D000537 2004
% 208.88/209.07  |- skos__altLabel mesh__D000537 Alumina
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D000537 2005
% 208.88/209.07  |- mesh__dateCreated mesh__D000537 1977-04-15
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D000537 2003
% 208.88/209.07  |- skos__scopeNote mesh__D000537
% 208.88/209.07       An oxide of aluminum, occurring in nature as various minerals such as bauxite, corundum, etc. It is used as an adsorbent, desiccating agent, and catalyst, and in the manufacture of dental cements and refractories.%A%    
% 208.88/209.07  |- mesh__dateEstablished mesh__D000537 1991-01-01
% 208.88/209.07  |- skos__hiddenLabel mesh__D000537 Ceramic, Alumina
% 208.88/209.07  |- mesh__publicMeSHNote mesh__D000537 91; was see under ALUMINUM 1978-90   
% 208.88/209.07  |- skos__prefLabel mesh__D000537 Aluminum Oxide
% 208.88/209.07  |- mesh__dateRevised mesh__D000537 2001-07-25
% 208.88/209.07  |- skos__broader mesh__D000537smesh__D017607
% 208.88/209.07  |- skos__historyNote mesh__D000537 Aluminum %28%1966-1977%29%
% 208.88/209.07  |- mesh__recordOriginator mesh__D000537 RLS
% 208.88/209.07  |- mesh__historyNote mesh__D000537
% 208.88/209.07       91%28%78%29%; was see under ALUMINUM 1978-90   
% 208.88/209.07  |- mesh__recordMaintainer mesh__D000537 ssb
% 208.88/209.07  |- rdf__type mesh__D000537sskos__Concept
% 208.88/209.07  |- skos__historyNote mesh__D000537 Oxides %28%1966-1977%29%
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D000537 2002
% 208.88/209.07  |- skos__hiddenLabel mesh__D000537 Oxide, Aluminum
% 208.88/209.07  |- skos__broader mesh__D000537smesh__D010087
% 208.88/209.07  |- mesh__recordAuthorizer mesh__D000537 sjn
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D000537 2006
% 208.88/209.07  |- rdf__type mesh__D019242sskos__Concept
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D019242 2006
% 208.88/209.07  |- mesh__dateEstablished mesh__D019242 1997-01-01
% 208.88/209.07  |- skos__broader mesh__D019242smesh__D003813
% 208.88/209.07  |- mesh__recordAuthorizer mesh__D019242 SJN
% 208.88/209.07  |- skos__historyNote mesh__D019242 Dentistry %28%1966-1996%29%
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D019242 2001
% 208.88/209.07  |- mesh__recordMaintainer mesh__D019242 TGC
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D019242 2005
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D019242 1999
% 208.88/209.07  |- skos__altLabel mesh__D019242 Stomatology
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D019242 2000
% 208.88/209.07  |- skos__prefLabel mesh__D019242 Oral Medicine
% 208.88/209.07  |- skos__annotation mesh__D019242
% 208.88/209.07       %22%a branch of dentistry dealing with dis of the oral %26% paraoral struct %26% the oral management of system dis%22%; SPEC: SPEC qualif; X ref STOMATOLOGY: seen most often in foreign lit: translate as %22%oral medicine%22%; %22%stomatol dis%22% = MOUTH DISEASES%A%  
% 208.88/209.07  |- skos__altLabel mesh__D019242 Medicine, Oral
% 208.88/209.07  |- mesh__historyNote mesh__D019242
% 208.88/209.07       97; was see DENTISTRY 1980-96; STOMATOLOGY was see DENTISTRY 1989-96%A%  
% 208.88/209.07  |- mesh__dateCreated mesh__D019242 1996-06-10
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D019242 1998
% 208.88/209.07  |- mesh__publicMeSHNote mesh__D019242
% 208.88/209.07       97; was see DENTISTRY 1980-96; STOMATOLOGY was see DENTISTRY 1989-96%A%  
% 208.88/209.07  |- mesh__onlineNote mesh__D019242
% 208.88/209.07       use DENTISTRY to search ORAL MEDICINE 1980-96 %26% STOMATOLOGY 1989-96%A%  
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D019242 2004
% 208.88/209.07  |- skos__scopeNote mesh__D019242
% 208.88/209.07       A branch of dentistry dealing with diseases of the oral and paraoral structures and the oral management of systemic diseases. %28%Hall, What is Oral Medicine, Anyway? Clinical Update: National Naval Dental Center, March 1991, p7-8%29%%A%    
% 208.88/209.07  |- mesh__dateRevised mesh__D019242 1997-06-20
% 208.88/209.07  |- skos__related mesh__D019242smesh__D009912
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D019242 2002
% 208.88/209.07  |- mesh__activeMeSHYear mesh__D019242 2003
% 208.88/209.07  |- skos__related mesh__D019242smesh__D009059
% 208.88/209.07  |- skos__related mesh__D019242smesh__D003813
% 208.88/209.07  |- mesh__recordOriginator mesh__D019242 TGC
% 208.88/209.07  |- skos__altLabel mesh__D005222 Fatigue, Mental
% 208.88/209.07  |- skos__broader mesh__D005222smesh__D008606
% 208.88/209.07  |- mesh__publicMeSHNote mesh__D005222 95; was FATIGUE, MENTAL 1963-94   
% 208.88/209.07  |- mesh__recordAuthorizer mesh__D005222 sjn
% 208.88/209.07  |- mesh__dateCreated mesh__D005222 1999-01-01
% 208.88/209.07  |- mesh__recordMaintainer mesh__D005222 JLS
% 208.88/209.07  |- mesh__recordOriginator mesh__D005222 NLM
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D005222 2006
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D005222 2005
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D005222 2004
% 208.88/209.08  |- mesh__historyNote mesh__D005222 95; was FATIGUE, MENTAL 1963-94   
% 208.88/209.08  |- skos__broader mesh__D005222smesh__D001526
% 208.88/209.08  |- skos__prefLabel mesh__D005222 Mental Fatigue
% 208.88/209.08  |- mesh__dateRevised mesh__D005222 2002-07-03
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D005222 2003
% 208.88/209.08  |- mesh__onlineNote mesh__D005222
% 208.88/209.08       use MENTAL FATIGUE to search FATIGUE, MENTAL 1966-94   
% 208.88/209.08  |- rdf__type mesh__D005222sskos__Concept
% 208.88/209.08  |- skos__scopeNote mesh__D005222
% 208.88/209.08       Fatigue arising in consequence of mental effort.     
% 208.88/209.08  |- skos__altLabel mesh__D018948 Eastern Samoa
% 208.88/209.08  |- mesh__onlineNote mesh__D018948
% 208.88/209.08       use WESTERN SAMOA to search AMERICAN SAMOA 1976-95   
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D018948 2002
% 208.88/209.08  |- mesh__historyNote mesh__D018948 96; was see WESTERN SAMOA 1976-95   
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D018948 1998
% 208.88/209.08  |- mesh__dateCreated mesh__D018948 1995-06-08
% 208.88/209.08  |- skos__annotation mesh__D018948
% 208.88/209.08       an island group in Samoa; admin by US Dept of Interior   
% 208.88/209.08  |- mesh__dateEstablished mesh__D018948 1996-01-01
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D018948 2004
% 208.88/209.08  |- skos__prefLabel mesh__D018948 American Samoa
% 208.88/209.08  |- skos__historyNote mesh__D018948 Western Samoa %28%1968-1995%29%
% 208.88/209.08  |- rdf__type mesh__D018948sskos__Concept
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D018948 2001
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D018948 2003
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D018948 1997
% 208.88/209.08  |- skos__broader mesh__D018948smesh__D018947
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D018948 2000
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D018948 1996
% 208.88/209.08  |- skos__historyNote mesh__D018948 Polynesia %28%1970-1974%29%
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D018948 2006
% 208.88/209.08  |- skos__scopeNote mesh__D018948
% 208.88/209.08       A group of islands of SAMOA, in the southwest central Pacific. Its capital is Pago Pago. The islands were ruled by native chiefs until about 1869. An object of American interest beginning in 1839, Pago Pago and trading and extraterritorial rights were granted to the United States in 1878. The United States, Germany, and England administered the islands jointly 1889-99, but in 1899 they were granted to the United States by treaty. The Department of the Interior has administered American Samoa since 1951. %28%From Webster%27%s New Geographical Dictionary, 1988, p44%29%%A%    
% 208.88/209.08  |- skos__historyNote mesh__D018948 Pacific Islands %28%1966-1968%29%
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D018948 2005
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D018948 1999
% 208.88/209.08  |- mesh__dateCreated mesh__D010965 1999-01-01
% 208.88/209.08  |- mesh__recordMaintainer mesh__D010965 ags
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D010965 2004
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D010965 2006
% 208.88/209.08  |- mesh__recordAuthorizer mesh__D010965 sjn
% 208.88/209.08  |- skos__broader mesh__D010965smesh__D010961
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D010965 2005
% 208.88/209.08  |- skos__annotation mesh__D010965
% 208.88/209.08       infection: coord IM with MALARIA %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 208.88/209.08  |- skos__prefLabel mesh__D010965 Plasmodium malariae
% 208.88/209.08  |- rdf__type mesh__D010965sskos__Concept
% 208.88/209.08  |- mesh__dateRevised mesh__D010965 2003-07-09
% 208.88/209.08  |- mesh__recordOriginator mesh__D010965 NLM
% 208.88/209.08  |- skos__scopeNote mesh__D010965
% 208.88/209.08       A protozoan parasite that occurs primarily in subtropical and temperate areas. It is the causal agent of quartan malaria. As the parasite grows it exhibits little ameboid activity.%A%    
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D010167 2001
% 208.88/209.08  |- skos__broader mesh__D010167smesh__D012877
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D010167 2006
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D010167 2002
% 208.88/209.08  |- skos__prefLabel mesh__D010167 Pallor
% 208.88/209.08  |- rdf__type mesh__D010167sskos__Concept
% 208.88/209.08  |- skos__hiddenLabel mesh__D010167 Pallors
% 208.88/209.08  |- mesh__dateCreated mesh__D010167 1999-01-01
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D010167 2003
% 208.88/209.08  |- mesh__dateRevised mesh__D010167 1999-11-03
% 208.88/209.08  |- mesh__recordAuthorizer mesh__D010167 sjn
% 208.88/209.08  |- mesh__recordMaintainer mesh__D010167 KEV
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D010167 2004
% 208.88/209.08  |- skos__scopeNote mesh__D010167
% 208.88/209.08       A clinical manifestation consisting of an unnatural paleness of the skin.%A%    
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D010167 2000
% 208.88/209.08  |- mesh__recordOriginator mesh__D010167 NLM
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D010167 2005
% 208.88/209.08  |- skos__prefLabel mesh__D004928 Escin
% 208.88/209.08  |- mesh__dateRevised mesh__D004928 2005-06-30
% 208.88/209.08  |- mesh__dateCreated mesh__D004928 1974-11-19
% 208.88/209.08  |- skos__broader mesh__D004928smesh__D012503
% 208.88/209.08  |- skos__altLabel mesh__D004928 beta-Aescin
% 208.88/209.08  |- mesh__publicMeSHNote mesh__D004928 91; was see under SAPONINS 1975-90   
% 208.88/209.08  |- skos__historyNote mesh__D004928 Saponins %28%1971-1975%29%
% 208.88/209.08  |- skos__hiddenLabel mesh__D004928 beta Escin
% 208.88/209.08  |- skos__hiddenLabel mesh__D004928 beta Aescin
% 208.88/209.08  |- skos__altLabel mesh__D004928 Fepalitan
% 208.88/209.08  |- skos__altLabel mesh__D004928 opino-biomo
% 208.88/209.08  |- skos__altLabel mesh__D004928 Eskuzan
% 208.88/209.08  |- mesh__dateEstablished mesh__D004928 1991-01-01
% 208.88/209.08  |- mesh__recordOriginator mesh__D004928 NLM
% 208.88/209.08  |- skos__altLabel mesh__D004928 Sankyo Brand of Escin
% 208.88/209.08  |- skos__altLabel mesh__D004928 Feparil
% 208.88/209.08  |- mesh__recordAuthorizer mesh__D004928 sjn
% 208.88/209.08  |- skos__altLabel mesh__D004928 biomo Brand of Escin
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D004928 2006
% 208.88/209.08  |- mesh__historyNote mesh__D004928
% 208.88/209.08       91%28%75%29%; was see under SAPONINS 1975-90   
% 208.88/209.08  |- skos__historyNote mesh__D004928 Glycosides %28%1971-1974%29%
% 208.88/209.08  |- mesh__recordMaintainer mesh__D004928 exl
% 208.88/209.08  |- skos__altLabel mesh__D004928 Escina
% 208.88/209.08  |- rdf__type mesh__D004928sskos__Concept
% 208.88/209.08  |- skos__altLabel mesh__D004928 Madaus Brand of Escin
% 208.88/209.08  |- skos__altLabel mesh__D004928 Aescin
% 208.88/209.08  |- skos__scopeNote mesh__D004928
% 208.88/209.08       Saponin occurring in the seed of the horse chestnut tree. Inhibits edema formation and decreases vascular fragility.%A%    
% 208.88/209.08  |- skos__historyNote mesh__D015650
% 208.88/209.08       Dihydroxycholecalciferols %28%1973-1989%29%
% 208.88/209.08  |- mesh__recordMaintainer mesh__D015650 ssb
% 208.88/209.08  |- mesh__historyNote mesh__D015650 90   
% 208.88/209.08  |- skos__altLabel mesh__D015650 24R,25-Dihydroxycholecalciferol
% 208.88/209.08  |- skos__hiddenLabel mesh__D015650 Dihydroxyvitamin D3, 24,25
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D015650 2006
% 208.88/209.08  |- mesh__recordAuthorizer mesh__D015650 sjn
% 208.88/209.08  |- mesh__recordOriginator mesh__D015650 RLS
% 208.88/209.08  |- skos__hiddenLabel mesh__D015650 24,25 Dihydroxycholecalciferol
% 208.88/209.08  |- skos__altLabel mesh__D015650 24,25 Dihydroxyvitamin D3
% 208.88/209.08  |- mesh__dateRevised mesh__D015650 2005-06-30
% 208.88/209.08  |- skos__altLabel mesh__D015650 24,25-Dihydroxyvitamin D3
% 208.88/209.08  |- skos__scopeNote mesh__D015650
% 208.88/209.08       A physiologically active metabolite of VITAMIN D. The compound is involved in the regulation of calcium metabolism, alkaline phosphatase activity, and enhances the calcemic effect of CALCITRIOL.%A%    
% 208.88/209.08  |- skos__altLabel mesh__D015650 24,25-Dihydroxycholecalciferol
% 208.88/209.08  |- mesh__dateEstablished mesh__D015650 1990-01-01
% 208.88/209.08  |- skos__annotation mesh__D015650
% 208.88/209.08       deficiency: coordinate 24,25-DIHYDROXYVITAMIN D 3 /defic %28%IM%29% with RICKETS %28%IM%29% or with VITAMIN D DEFICIENCY %28%IM%29%%A%  
% 208.88/209.08  |- skos__altLabel mesh__D015650 %28%24R%29%-24,25-Dihydroxyvitamin D3
% 208.88/209.08  |- skos__prefLabel mesh__D015650 24,25-Dihydroxyvitamin D 3
% 208.88/209.08  |- mesh__publicMeSHNote mesh__D015650 90   
% 208.88/209.08  |- mesh__dateCreated mesh__D015650 1989-07-21
% 208.88/209.08  |- skos__hiddenLabel mesh__D015650 24,25 Dihydroxyvitamin D 3
% 208.88/209.08  |- skos__broader mesh__D015650smesh__D004100
% 208.88/209.08  |- rdf__type mesh__D015650sskos__Concept
% 208.88/209.08  |- skos__annotation mesh__D009613
% 208.88/209.08       award for medicine: coordinate with specific field or specialty but not with MEDICINE%A%  
% 208.88/209.08  |- mesh__recordAuthorizer mesh__D009613 sjn
% 208.88/209.08  |- mesh__dateCreated mesh__D009613 1999-01-01
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D009613 2006
% 208.88/209.08  |- skos__hiddenLabel mesh__D009613 Prize, Nobel
% 208.88/209.08  |- mesh__dateRevised mesh__D009613 2005-06-30
% 208.88/209.08  |- rdf__type mesh__D009613sskos__Concept
% 208.88/209.08  |- mesh__recordOriginator mesh__D009613 NLM
% 208.88/209.08  |- skos__broader mesh__D009613smesh__D001363
% 208.88/209.08  |- skos__prefLabel mesh__D009613 Nobel Prize
% 208.88/209.08  |- mesh__recordMaintainer mesh__D009613 ags
% 208.88/209.08  |- skos__hiddenLabel mesh__D001630 Hair Ball
% 208.88/209.08  |- mesh__dateCreated mesh__D001630 1999-01-01
% 208.88/209.08  |- skos__prefLabel mesh__D001630 Bezoars
% 208.88/209.08  |- rdf__type mesh__D001630sskos__Concept
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D001630 2004
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D001630 1998
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D001630 2000
% 208.88/209.08  |- skos__scopeNote mesh__D001630
% 208.88/209.08       Concretions of swallowed hair, fruit or vegetable fibers, or similar substances found in the alimentary canal.%A%    
% 208.88/209.08  |- mesh__recordAuthorizer mesh__D001630 SJN
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D001630 2003
% 208.88/209.08  |- skos__broader mesh__D001630smesh__D005547
% 208.88/209.08  |- skos__hiddenLabel mesh__D001630 Balls, Hair
% 208.88/209.08  |- skos__hiddenLabel mesh__D001630 Bezoar
% 208.88/209.08  |- skos__hiddenLabel mesh__D001630 Trichobezoar
% 208.88/209.08  |- mesh__dateRevised mesh__D001630 1997-06-20
% 208.88/209.08  |- skos__altLabel mesh__D001630 Trichobezoars
% 208.88/209.08  |- skos__hiddenLabel mesh__D001630 Ball, Hair
% 208.88/209.08  |- mesh__recordOriginator mesh__D001630 NLM
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D001630 2006
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D001630 2002
% 208.88/209.08  |- mesh__recordMaintainer mesh__D001630 TPW
% 208.88/209.08  |- skos__annotation mesh__D001630
% 208.88/209.08       concretions from ingested foreign matter; coord IM with organ %28%IM%29%, not organ/dis: Manual 21.39%A%  
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D001630 2005
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D001630 1999
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D001630 2001
% 208.88/209.08  |- skos__scopeNote mesh__D020595
% 208.88/209.08       A genus of straight, gram-negative bacterial rods which are facultatively anaerobic and motile by peritrichous flagella. This genus is found in human and animal feces, soil, water, and dairy products. It is an opportunistic pathogen in humans. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 208.88/209.08  |- mesh__recordOriginator mesh__D020595 ndw
% 208.88/209.08  |- skos__prefLabel mesh__D020595 Hafnia
% 208.88/209.08  |- mesh__dateCreated mesh__D020595 1999-11-03
% 208.88/209.08  |- mesh__recordAuthorizer mesh__D020595 sjn
% 208.88/209.08  |- mesh__publicMeSHNote mesh__D020595 2000   
% 208.88/209.08  |- mesh__dateEstablished mesh__D020595 2000-01-01
% 208.88/209.08  |- mesh__recordMaintainer mesh__D020595 SYSTEM
% 208.88/209.08  |- skos__annotation mesh__D020595
% 208.88/209.08       infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D020595 2006
% 208.88/209.08  |- mesh__historyNote mesh__D020595 2000   
% 208.88/209.08  |- skos__historyNote mesh__D020595 Enterobacteriaceae %28%1966-1999%29%
% 208.88/209.08  |- mesh__dateRevised mesh__D020595 2005-06-30
% 208.88/209.08  |- rdf__type mesh__D020595sskos__Concept
% 208.88/209.08  |- skos__broader mesh__D020595smesh__D004755
% 208.88/209.08  |- mesh__dateCreated mesh__D014558 1999-01-01
% 208.88/209.08  |- mesh__dateRevised mesh__D014558 2005-06-30
% 208.88/209.08  |- mesh__recordAuthorizer mesh__D014558 sjn
% 208.88/209.08  |- skos__annotation mesh__D014558
% 208.88/209.08       a bile pigment; /biosyn /physiol permitted   
% 208.88/209.08  |- skos__prefLabel mesh__D014558 Urobilinogen
% 208.88/209.08  |- rdf__type mesh__D014558sskos__Concept
% 208.88/209.08  |- mesh__recordOriginator mesh__D014558 NLM
% 208.88/209.08  |- skos__broader mesh__D014558smesh__D001654
% 208.88/209.08  |- mesh__recordMaintainer mesh__D014558 ssb
% 208.88/209.08  |- skos__scopeNote mesh__D014558
% 208.88/209.08       A colorless compound formed in the intestines by the reduction of bilirubin. Some is excreted in the feces where it is oxidized to urobilin. Some is reabsorbed and re-excreted in the bile as bilirubin. At times, it is re-excreted in the urine, where it may be later oxidized to urobilin.%A%    
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D014558 2006
% 208.88/209.08  |- mesh__dateCreated mesh__D000538 1999-01-01
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D000538 2002
% 208.88/209.08  |- skos__annotation mesh__D000538 %22%numerous types of clay%22%   
% 208.88/209.08  |- mesh__dateRevised mesh__D000538 1993-06-04
% 208.88/209.08  |- skos__broader mesh__D000538smesh__D017640
% 208.88/209.08  |- rdf__type mesh__D000538sskos__Concept
% 208.88/209.08  |- skos__prefLabel mesh__D000538 Aluminum Silicates
% 208.88/209.08  |- skos__scopeNote mesh__D000538
% 208.88/209.08       Any of the numerous types of clay which contain varying proportions of Al2O3 and SiO2. They are made synthetically by heating aluminum fluoride at 1000-2000 degrees C with silica and water vapor. %28%From Hawley%27%s Condensed Chemical Dictionary, 11th ed%29%%A%    
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D000538 1995
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D000538 2006
% 208.88/209.08  |- skos__hiddenLabel mesh__D000538 Silicates, Aluminum
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D000538 2001
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D000538 1999
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D000538 2004
% 208.88/209.08  |- mesh__recordAuthorizer mesh__D000538 PLS
% 208.88/209.08  |- mesh__recordMaintainer mesh__D000538 TPW
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D000538 1994
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D000538 1997
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D000538 2000
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D000538 2005
% 208.88/209.08  |- skos__broader mesh__D000538smesh__D000537
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D000538 1998
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D000538 2003
% 208.88/209.08  |- mesh__recordOriginator mesh__D000538 NLM
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D000538 1996
% 208.88/209.08  |- rdf__type mesh__D019243sskos__Concept
% 208.88/209.08  |- skos__altLabel mesh__D019243 Dental Microabrasions
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D019243 2006
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D019243 1998
% 208.88/209.08  |- skos__scopeNote mesh__D019243
% 208.88/209.08       Mechanical removal of a small amount of tooth structure %28%not more than a few tenths of a millimeter in depth%29% to eliminate superficial enamel discoloration defects not successfully removed by bleaching techniques. A common abrasive is a mixture of pumice and hydrochloric acid.%A%    
% 208.88/209.08  |- skos__altLabel mesh__D019243 Dental Microabrasion
% 208.88/209.08  |- skos__prefLabel mesh__D019243 Enamel Microabrasion
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D019243 1999
% 208.88/209.08  |- skos__altLabel mesh__D019243 Microabrasions, Enamel
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D019243 2000
% 208.88/209.08  |- skos__altLabel mesh__D019243 Microabrasion, Enamel
% 208.88/209.08  |- skos__broader mesh__D019243smesh__D004955
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D019243 2003
% 208.88/209.08  |- skos__annotation mesh__D019243 to remove surface discoloration   
% 208.88/209.08  |- mesh__publicMeSHNote mesh__D019243 97   
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D019243 2004
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D019243 2001
% 208.88/209.08  |- skos__altLabel mesh__D019243 Microabrasion, Dental
% 208.88/209.08  |- mesh__dateEstablished mesh__D019243 1997-01-01
% 208.88/209.08  |- skos__altLabel mesh__D019243 Enamel Microabrasions
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D019243 2002
% 208.88/209.08  |- mesh__historyNote mesh__D019243 97   
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D019243 1997
% 208.88/209.08  |- mesh__dateCreated mesh__D019243 1996-06-10
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D019243 2005
% 208.88/209.08  |- skos__altLabel mesh__D019243 Microabrasions, Dental
% 208.88/209.08  |- skos__historyNote mesh__D019243
% 208.88/209.08       Tooth Discoloration/therapy %28%1989-1996%29%
% 208.88/209.08  |- mesh__dateCreated mesh__D005223 1999-01-01
% 208.88/209.08  |- skos__scopeNote mesh__D005223
% 208.88/209.08       The glyceryl esters of a fatty acid, or of a mixture of fatty acids. They are generally odorless, colorless, and tasteless if pure, but they may be flavored according to origin. Fats are insoluble in water, soluble in most organic solvents. They occur in animal and vegetable tissue and are generally obtained by boiling or by extraction under pressure. They are important in the diet %28%DIETARY FATS%29% as a source of energy. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D005223 2006
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D005223 2005
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D005223 2004
% 208.88/209.08  |- mesh__recordAuthorizer mesh__D005223 sjn
% 208.88/209.08  |- mesh__recordMaintainer mesh__D005223 ssb
% 208.88/209.08  |- mesh__recordOriginator mesh__D005223 NLM
% 208.88/209.08  |- mesh__dateRevised mesh__D005223 2003-07-09
% 208.88/209.08  |- skos__annotation mesh__D005223
% 208.88/209.08       table fats only or fats %22%outside the body%22%; differentiate from LIPIDS %28%%22%inside the body%22% but not body fat which = ADIPOSE TISSUE%29%; do not confuse with DIETARY FATS%A%  
% 208.88/209.08  |- skos__broader mesh__D005223smesh__D008055
% 208.88/209.08  |- mesh__publicMeSHNote mesh__D005223
% 208.88/209.08       /metabolism was FAT METABOLISM see under LIPID METABOLISM 1963-65%A%  
% 208.88/209.08  |- mesh__historyNote mesh__D005223
% 208.88/209.08       /metabolism was FAT METABOLISM see under LIPID METABOLISM 1963-65%A%  
% 208.88/209.08  |- rdf__type mesh__D005223sskos__Concept
% 208.88/209.08  |- skos__prefLabel mesh__D005223 Fats
% 208.88/209.08  |- skos__broader mesh__D018949smesh__D000945
% 208.88/209.08  |- skos__historyNote mesh__D018949 T-Lymphocytes %28%1988%29%
% 208.88/209.08  |- mesh__recordAuthorizer mesh__D018949 sjn
% 208.88/209.08  |- mesh__dateCreated mesh__D018949 1995-05-26
% 208.88/209.08  |- rdf__type mesh__D018949sskos__Concept
% 208.88/209.08  |- skos__annotation mesh__D018949
% 208.88/209.08       T-lymphocyte differentiation antigens; but read MeSH definition%A%  
% 208.88/209.08  |- mesh__historyNote mesh__D018949
% 208.88/209.08       96; was CD1 ANTIGENS %28%NM%29% 1988-95   
% 208.88/209.08  |- skos__historyNote mesh__D018949
% 208.88/209.08       Antigens, Differentiation %28%1988-1991%29%
% 208.88/209.08  |- skos__altLabel mesh__D018949 CD1 Antigens
% 208.88/209.08  |- skos__prefLabel mesh__D018949 Antigens, CD1
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D018949 2006
% 208.88/209.08  |- mesh__recordMaintainer mesh__D018949 ssb
% 208.88/209.08  |- mesh__dateEstablished mesh__D018949 1996-01-01
% 208.88/209.08  |- skos__scopeNote mesh__D018949
% 208.88/209.08       Glycoproteins expressed on cortical thymocytes and on some dendritic cells and B-cells. Their structure is similar to that of MHC Class I and their function has been postulated as similar also. CD1 antigens are highly specific markers for human LANGERHANS CELLS.%A%    
% 208.88/209.08  |- skos__hiddenLabel mesh__D018949 Antigen, CD1
% 208.88/209.08  |- mesh__publicMeSHNote mesh__D018949
% 208.88/209.08       96; CD1 ANTIGENS was indexed under ANTIGENS, CD 1990-95; ANTIGENS, DIFFERENTIATION 1988-91; %26% T-LYMPHYCYTES 1988%A%  
% 208.88/209.08  |- mesh__recordOriginator mesh__D018949 AGS
% 208.88/209.08  |- mesh__onlineNote mesh__D018949
% 208.88/209.08       use ANTIGENS, CD1 %28%NM%29% to search CD1 ANTIGENS 1988-95   
% 208.88/209.08  |- skos__broader mesh__D018949smesh__D015703
% 208.88/209.08  |- skos__historyNote mesh__D018949 Antigens, CD %28%1990-1995%29%
% 208.88/209.08  |- skos__altLabel mesh__D018949 CD1 Antigen
% 208.88/209.08  |- mesh__dateRevised mesh__D018949 2005-06-30
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D010966 2006
% 208.88/209.08  |- mesh__recordOriginator mesh__D010966 NLM
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D010966 2005
% 208.88/209.08  |- skos__annotation mesh__D010966
% 208.88/209.08       infection = MALARIA, VIVAX; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 208.88/209.08  |- rdf__type mesh__D010966sskos__Concept
% 208.88/209.08  |- mesh__recordAuthorizer mesh__D010966 sjn
% 208.88/209.08  |- skos__prefLabel mesh__D010966 Plasmodium vivax
% 208.88/209.08  |- skos__broader mesh__D010966smesh__D010961
% 208.88/209.08  |- mesh__dateRevised mesh__D010966 2003-07-09
% 208.88/209.08  |- skos__scopeNote mesh__D010966
% 208.88/209.08       A protozoan parasite that causes vivax malaria %28%MALARIA, VIVAX%29%. This species is found almost everywhere malaria is endemic and is the only one that has a range extending into the temperate regions.%A%    
% 208.88/209.08  |- mesh__recordMaintainer mesh__D010966 ags
% 208.88/209.08  |- mesh__dateCreated mesh__D010966 1999-01-01
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D010966 2004
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D010168 2005
% 208.88/209.08  |- mesh__dateEstablished mesh__D010168 1991-01-01
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D010168 2006
% 208.88/209.08  |- skos__scopeNote mesh__D010168
% 208.88/209.08       Salts and esters of the 16-carbon saturated monocarboxylic acid--palmitic acid.%A%    
% 208.88/209.08  |- mesh__recordMaintainer mesh__D010168 ssb
% 208.88/209.08  |- mesh__dateRevised mesh__D010168 2003-07-09
% 208.88/209.08  |- mesh__historyNote mesh__D010168
% 208.88/209.08       91%28%75%29%; was see under PALMITIC ACIDS 1975-90   
% 208.88/209.08  |- rdf__type mesh__D010168sskos__Concept
% 208.88/209.08  |- mesh__recordAuthorizer mesh__D010168 sjn
% 208.88/209.08  |- skos__historyNote mesh__D010168 Fatty Acids %28%1966-1974%29%
% 208.88/209.08  |- mesh__dateCreated mesh__D010168 1974-11-11
% 208.88/209.08  |- mesh__publicMeSHNote mesh__D010168
% 208.88/209.08       91; was see under PALMITIC ACIDS 1975-90   
% 208.88/209.08  |- mesh__recordOriginator mesh__D010168 NLM
% 208.88/209.08  |- skos__altLabel mesh__D010168 Hexadecanoates
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D010168 2004
% 208.88/209.08  |- skos__prefLabel mesh__D010168 Palmitates
% 208.88/209.08  |- skos__broader mesh__D010168smesh__D010169
% 208.88/209.08  |- skos__prefLabel mesh__D004929 Esculin
% 208.88/209.08  |- mesh__onlineNote mesh__D004929 search BIOFLAVONOIDS 1966-74   
% 208.88/209.08  |- mesh__publicMeSHNote mesh__D004929
% 208.88/209.08       91; was see under COUMARINS 1989-90; was see under BIOFLAVONOIDS 1966-88%A%  
% 208.88/209.08  |- mesh__dateEstablished mesh__D004929 1991-01-01
% 208.88/209.08  |- mesh__recordMaintainer mesh__D004929 ssb
% 208.88/209.08  |- skos__altLabel mesh__D004929 Esculoside
% 208.88/209.08  |- mesh__dateRevised mesh__D004929 2005-06-30
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D004929 2006
% 208.88/209.08  |- skos__broader mesh__D004929smesh__D005960
% 208.88/209.08  |- mesh__recordOriginator mesh__D004929 NLM
% 208.88/209.08  |- mesh__historyNote mesh__D004929
% 208.88/209.08       91%28%75%29%; was see under COUMARINS 1989-90; was see under BIOFLAVONOIDS 1966-88%A%  
% 208.88/209.08  |- mesh__dateCreated mesh__D004929 1999-01-01
% 208.88/209.08  |- skos__broader mesh__D004929smesh__D003374
% 208.88/209.08  |- skos__altLabel mesh__D004929 Aesculin
% 208.88/209.08  |- mesh__recordAuthorizer mesh__D004929 sjn
% 208.88/209.08  |- skos__altLabel mesh__D004929 Venoplant
% 208.88/209.08  |- rdf__type mesh__D004929sskos__Concept
% 208.88/209.08  |- skos__hiddenLabel mesh__D015651 Fungus Poisonings
% 208.88/209.08  |- mesh__recordAuthorizer mesh__D015651 PLS
% 208.88/209.08  |- skos__historyNote mesh__D015651 Mushroom Poisoning %28%1985-1989%29%
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D015651 2004
% 208.88/209.08  |- skos__scopeNote mesh__D015651
% 208.88/209.08       Poisoning caused by the ingestion of mycotoxins %28%toxins of fungal origin%29%.%A%    
% 208.88/209.08  |- skos__annotation mesh__D015651
% 208.88/209.08       %22%caused by ingestion of mycotoxins %28%toxins of fungal origin%29%%22%%A%  
% 208.88/209.08  |- skos__altLabel mesh__D015651 Poisoning, Fungus
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D015651 2002
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D015651 2006
% 208.88/209.08  |- skos__historyNote mesh__D015651 Toxins %28%1966%29%
% 208.88/209.08  |- mesh__dateEstablished mesh__D015651 1990-01-01
% 208.88/209.08  |- mesh__historyNote mesh__D015651
% 208.88/209.08       90; was see MUSHROOM POISONING 1985-89   
% 208.88/209.08  |- skos__hiddenLabel mesh__D015651 Poisonings, Fungus
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D015651 1996
% 208.88/209.08  |- skos__prefLabel mesh__D015651 Mycotoxicosis
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D015651 1998
% 208.88/209.08  |- skos__altLabel mesh__D015651 Fungus Poisoning
% 208.88/209.08  |- skos__broader mesh__D015651smesh__D011041
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D015651 1997
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D015651 1994
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D015651 2000
% 208.88/209.08  |- mesh__dateRevised mesh__D015651 1992-05-15
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D015651 1999
% 208.88/209.08  |- skos__hiddenLabel mesh__D015651 Mycotoxicoses
% 208.88/209.08  |- mesh__onlineNote mesh__D015651
% 208.88/209.08       use MUSHROOM POISONING to search MYCOTOXICOSIS 1985-89   
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D015651 1993
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D015651 2001
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D015651 1995
% 208.88/209.08  |- mesh__recordOriginator mesh__D015651 PXP
% 208.88/209.08  |- rdf__type mesh__D015651sskos__Concept
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D015651 2003
% 208.88/209.08  |- mesh__dateCreated mesh__D015651 1989-05-15
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D015651 2005
% 208.88/209.08  |- mesh__publicMeSHNote mesh__D015651
% 208.88/209.08       90; was see MUSHROOM POISONING 1985-89   
% 208.88/209.08  |- skos__historyNote mesh__D015651 Mycotoxins %28%1967-1989%29%
% 208.88/209.08  |- mesh__recordMaintainer mesh__D015651 TGC
% 208.88/209.08  |- mesh__recordOriginator mesh__D009614 NLM
% 208.88/209.08  |- skos__annotation mesh__D009614 man-made radioactive element; IM   
% 208.88/209.08  |- rdf__type mesh__D009614sskos__Concept
% 208.88/209.08  |- skos__scopeNote mesh__D009614
% 208.88/209.08       Nobelium. A man-made radioactive element of the actinide metal series. It has the atomic symbol No, atomic number 102, and atomic weight 259.%A%    
% 208.88/209.08  |- skos__broader mesh__D009614smesh__D008671
% 208.88/209.08  |- mesh__recordAuthorizer mesh__D009614 sjn
% 208.88/209.08  |- mesh__recordMaintainer mesh__D009614 jmp
% 208.88/209.08  |- skos__prefLabel mesh__D009614 Nobelium
% 208.88/209.08  |- mesh__dateCreated mesh__D009614 1999-01-01
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D009614 2006
% 208.88/209.08  |- skos__broader mesh__D009614smesh__D019216
% 208.88/209.08  |- mesh__dateRevised mesh__D009614 2005-06-30
% 208.88/209.08  |- skos__broader mesh__D001631smesh__D001211
% 208.88/209.08  |- skos__scopeNote mesh__D001631
% 208.88/209.08       A kingdom in the eastern Himalayas on the northeast border of India, bounded on the north by Tibet, on the east by Assam, on the south by Assam and West Bengal, and on the west by Sikkim and Tibet. From 1720 to 1970 it was under Chinese or Indian domination. In 1971 it became a member of the United Nations. The name comes from the Sanskrit bhota, the name for Tibet, + anta, end, with reference to its location at the southern extremity of Tibet. %28%From Webster%27%s New Geographical Dictionary, 1988, p144 %26% Room, Brewer%27%s Dictionary of Names, 1992, p64%29%%A%    
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D001631 2003
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D001631 1997
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D001631 2001
% 208.88/209.08  |- skos__prefLabel mesh__D001631 Bhutan
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D001631 1996
% 208.88/209.08  |- mesh__dateRevised mesh__D001631 1995-02-17
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D001631 2000
% 208.88/209.08  |- skos__annotation mesh__D001631 a kingdom in the eastern Himalayas   
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D001631 2006
% 208.88/209.08  |- mesh__recordMaintainer mesh__D001631 TGC
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D001631 2005
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D001631 1999
% 208.88/209.08  |- mesh__dateCreated mesh__D001631 1999-01-01
% 208.88/209.08  |- mesh__recordOriginator mesh__D001631 NLM
% 208.88/209.08  |- rdf__type mesh__D001631sskos__Concept
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D001631 2004
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D001631 1998
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D001631 2002
% 208.88/209.08  |- mesh__recordAuthorizer mesh__D001631 PLS
% 208.88/209.08  |- mesh__activeMeSHYear mesh__D020596 2006
% 208.88/209.08  |- skos__broader mesh__D020596smesh__D004755
% 208.88/209.08  |- mesh__recordAuthorizer mesh__D020596 sjn
% 208.88/209.08  |- skos__historyNote mesh__D020596 Enterobacteriaceae %28%1974-1999%29%
% 208.88/209.08  |- mesh__dateCreated mesh__D020596 1999-11-03
% 208.88/209.08  |- mesh__recordOriginator mesh__D020596 ndw
% 208.88/209.08  |- mesh__publicMeSHNote mesh__D020596 2000   
% 208.88/209.08  |- mesh__dateEstablished mesh__D020596 2000-01-01
% 208.88/209.08  |- skos__scopeNote mesh__D020596
% 208.88/209.08       A genus of gram-negative, facultatively anaerobic, straight rods which are motile by peritrichous flagella. These organisms are chemoorganotrophic and have both a respiratory and fermentative type of metabolism. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 208.88/209.08  |- skos__prefLabel mesh__D020596 Morganella
% 208.88/209.08  |- mesh__recordMaintainer mesh__D020596 SYSTEM
% 208.88/209.08  |- mesh__historyNote mesh__D020596 2000   
% 208.88/209.09  |- rdf__type mesh__D020596sskos__Concept
% 208.88/209.09  |- mesh__dateRevised mesh__D020596 2005-06-30
% 208.88/209.09  |- skos__annotation mesh__D020596
% 208.88/209.09       infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 208.88/209.09  |- skos__broader mesh__D014559smesh__D006836
% 208.88/209.09  |- skos__hiddenLabel mesh__D014559 Hydratase, Urocanate
% 208.88/209.09  |- skos__scopeNote mesh__D014559
% 208.88/209.09       An enzyme that catalyzes the conversion of 4,5-dihydro-4-oxo-5-imidazolepropanoate to urocanate and water. EC 4.2.1.49.%A%    
% 208.88/209.09  |- skos__prefLabel mesh__D014559 Urocanate Hydratase
% 208.88/209.09  |- mesh__dateRevised mesh__D014559 2003-07-09
% 208.88/209.09  |- mesh__onlineNote mesh__D014559
% 208.88/209.09       use UROCANATE HYDRATASE to search UROCANASE 1972-94   
% 208.88/209.09  |- skos__altLabel mesh__D014559 Urocanase
% 208.88/209.09  |- skos__altLabel mesh__D014559 Urocaninase
% 208.88/209.09  |- rdf__type mesh__D014559sskos__Concept
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D014559 2004
% 208.88/209.09  |- skos__historyNote mesh__D014559 Hydro-Lyases %28%1966-1971%29%
% 208.88/209.09  |- mesh__dateCreated mesh__D014559 1999-01-01
% 208.88/209.09  |- mesh__recordAuthorizer mesh__D014559 sjn
% 208.88/209.09  |- mesh__recordMaintainer mesh__D014559 ssb
% 208.88/209.09  |- mesh__historyNote mesh__D014559
% 208.88/209.09       95; was UROCANASE 1972-94, see under HYDRO-LYASES 1972-90%A%  
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D014559 2005
% 208.88/209.09  |- mesh__dateEstablished mesh__D014559 1991-01-01
% 208.88/209.09  |- mesh__publicMeSHNote mesh__D014559
% 208.88/209.09       95; was UROCANASE 1972-94, see under HYDRO-LYASES 1972-90%A%  
% 208.88/209.09  |- mesh__recordOriginator mesh__D014559 NLM
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D014559 2006
% 208.88/209.09  |- rdf__type mesh__D025281sskos__Concept
% 208.88/209.09  |- mesh__recordMaintainer mesh__D025281 SYSTEM
% 208.88/209.09  |- skos__historyNote mesh__D025281 Fungi/ultrastructure %28%1966-2001%29%
% 208.88/209.09  |- mesh__recordAuthorizer mesh__D025281 sjn
% 208.88/209.09  |- mesh__dateRevised mesh__D025281 2005-06-30
% 208.88/209.09  |- skos__broader mesh__D025281smesh__D005658
% 208.88/209.09  |- mesh__historyNote mesh__D025281 2002   
% 208.88/209.09  |- mesh__publicMeSHNote mesh__D025281 2002   
% 208.88/209.09  |- mesh__dateCreated mesh__D025281 2001-07-25
% 208.88/209.09  |- mesh__recordOriginator mesh__D025281 ags
% 208.88/209.09  |- mesh__dateEstablished mesh__D025281 2002-01-01
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D025281 2006
% 208.88/209.09  |- skos__scopeNote mesh__D025281
% 208.88/209.09       The anatomical components of a fungus.     
% 208.88/209.09  |- skos__prefLabel mesh__D025281 Fungal Components
% 208.88/209.09  |- skos__historyNote mesh__D025281
% 208.88/209.09       specific fungus/ultrastructure %28%1964-2001%29%
% 208.88/209.09  |- skos__annotation mesh__D025281 GEN or unspecified; prefer specifics   
% 208.88/209.09  |- skos__annotation mesh__D019244
% 208.88/209.09       RNA molecules acting as molecular parasites of various RNA plant viruses; coord IM with specific plant virus /genet %28%IM or NIM%29% but note that CUCUMBER MOSAIC VIRUS SATELLITE is available%A%  
% 208.88/209.09  |- skos__broader mesh__D019244smesh__D012313
% 208.88/209.09  |- skos__historyNote mesh__D019244 RNA %28%1981-1996%29%
% 208.88/209.09  |- mesh__dateCreated mesh__D019244 1996-06-10
% 208.88/209.09  |- mesh__recordOriginator mesh__D019244 AGS
% 208.88/209.09  |- skos__prefLabel mesh__D019244 RNA, Satellite
% 208.88/209.09  |- mesh__recordAuthorizer mesh__D019244 sjn
% 208.88/209.09  |- skos__hiddenLabel mesh__D019244 RNAs, Satellite
% 208.88/209.09  |- skos__scopeNote mesh__D019244
% 208.88/209.09       Small, linear single-stranded RNA molecules functionally acting as molecular parasites of certain RNA plant viruses. Satellite RNAs exhibit four characteristic traits: %28%1%29% they require helper viruses to replicate; %28%2%29% they are unnecessary for the replication of helper viruses; %28%3%29% they are encapsidated in the coat protein of the helper virus; %28%4%29% they have no extensive sequence homology to the helper virus. Thus they differ from SATELLITE VIRUSES which encode their own coat protein, and from the genomic RNA; %28%=RNA, VIRAL%29%; of satellite viruses. %28%From Maramorosch, Viroids and Satellites, 1991, p143%29%%A%    
% 208.88/209.09  |- skos__altLabel mesh__D019244 Satellite RNAs
% 208.88/209.09  |- skos__related mesh__D019244smesh__D006378
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D019244 2003
% 208.88/209.09  |- mesh__onlineNote mesh__D019244
% 208.88/209.09       use RNA, SATELLITE %28%NM%29% to search SATELLITE RNA 1981-96   
% 208.88/209.09  |- skos__altLabel mesh__D019244 Satellite RNA
% 208.88/209.09  |- mesh__publicMeSHNote mesh__D019244
% 208.88/209.09       97; SATELLITE RNA was indexed under RNA 1981-96   
% 208.88/209.09  |- mesh__recordMaintainer mesh__D019244 mdb
% 208.88/209.09  |- mesh__historyNote mesh__D019244
% 208.88/209.09       97; was SATELLLITE RNA %28%NM%29% 1981-96   
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D019244 2004
% 208.88/209.09  |- skos__related mesh__D019244smesh__D012526
% 208.88/209.09  |- skos__historyNote mesh__D019244 RNA, Viral %28%1974-1996%29%
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D019244 2005
% 208.88/209.09  |- mesh__dateRevised mesh__D019244 2001-07-25
% 208.88/209.09  |- rdf__type mesh__D019244sskos__Concept
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D019244 2006
% 208.88/209.09  |- mesh__dateEstablished mesh__D019244 1997-01-01
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D019244 2002
% 208.88/209.09  |- rdf__type mesh__D000539sskos__Concept
% 208.88/209.09  |- skos__related mesh__D000539smesh__D003724
% 208.88/209.09  |- mesh__recordOriginator mesh__D000539 NLM
% 208.88/209.09  |- skos__related mesh__D000539smesh__D000541
% 208.88/209.09  |- skos__related mesh__D000539smesh__D000543
% 208.88/209.09  |- skos__broader mesh__D000539smesh__D007568
% 208.88/209.09  |- skos__scopeNote mesh__D000539
% 208.88/209.09       The thickest and spongiest part of the maxilla and mandible hollowed out into deep cavities for the teeth.%A%    
% 208.88/209.09  |- mesh__dateEstablished mesh__D000539 1965-01-01
% 208.88/209.09  |- skos__annotation mesh__D000539
% 208.88/209.09       dis: coord with JAW DISEASES or specific precoord jaw dis %28%IM%29%; for /surg, prefer ALVEOLECTOMY or ALVEOLOPLASTY%A%  
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D000539 2006
% 208.88/209.09  |- skos__hiddenLabel mesh__D000539 Process, Alveolar
% 208.88/209.09  |- skos__hiddenLabel mesh__D000539 Alveolar Processes
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D000539 2004
% 208.88/209.09  |- mesh__recordAuthorizer mesh__D000539 sjn
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D000539 2005
% 208.88/209.09  |- mesh__recordMaintainer mesh__D000539 lkt
% 208.88/209.09  |- skos__broader mesh__D000539smesh__D010519
% 208.88/209.09  |- skos__prefLabel mesh__D000539 Alveolar Process
% 208.88/209.09  |- mesh__publicMeSHNote mesh__D000539 65   
% 208.88/209.09  |- skos__hiddenLabel mesh__D000539 Processes, Alveolar
% 208.88/209.09  |- skos__hiddenLabel mesh__D000539 Ridge, Alveolar
% 208.88/209.09  |- mesh__historyNote mesh__D000539 65   
% 208.88/209.09  |- mesh__dateCreated mesh__D000539 1999-01-01
% 208.88/209.09  |- mesh__dateRevised mesh__D000539 2003-07-09
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D011261 2006
% 208.88/209.09  |- mesh__recordMaintainer mesh__D011261 jls
% 208.88/209.09  |- skos__hiddenLabel mesh__D011261 First Trimester Pregnancies
% 208.88/209.09  |- skos__altLabel mesh__D011261 Trimester, First
% 208.88/209.09  |- skos__hiddenLabel mesh__D011261 Placental Phases, Early
% 208.88/209.09  |- mesh__dateCreated mesh__D011261 1975-07-25
% 208.88/209.09  |- skos__hiddenLabel mesh__D011261 First Trimester
% 208.88/209.09  |- skos__hiddenLabel mesh__D011261 Early Placental Phases
% 208.88/209.09  |- mesh__historyNote mesh__D011261
% 208.88/209.09       76; was PREGNANCY, FIRST TRIMESTER 1975   
% 208.88/209.09  |- skos__altLabel mesh__D011261 Pregnancy, First Trimester
% 208.88/209.09  |- mesh__dateRevised mesh__D011261 2004-07-30
% 208.88/209.09  |- skos__hiddenLabel mesh__D011261 Pregnancy Trimesters, First
% 208.88/209.09  |- skos__prefLabel mesh__D011261 Pregnancy Trimester, First
% 208.88/209.09  |- skos__hiddenLabel mesh__D011261 First Pregnancy Trimesters
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D011261 2005A
% 208.88/209.09  |- skos__scopeNote mesh__D011261
% 208.88/209.09       The beginning third of a human PREGNANCY, from the first day of the last normal menstrual period %28%MENSTRUATION%29% through the completion of 14 weeks %28%98 days%29% of gestation.%A%    
% 208.88/209.09  |- skos__hiddenLabel mesh__D011261 Phases, Early Placental
% 208.88/209.09  |- skos__hiddenLabel mesh__D011261 First Pregnancy Trimester
% 208.88/209.09  |- skos__altLabel mesh__D011261 Early Placental Phase
% 208.88/209.09  |- mesh__recordAuthorizer mesh__D011261 jls
% 208.88/209.09  |- rdf__type mesh__D011261sskos__Concept
% 208.88/209.09  |- skos__hiddenLabel mesh__D011261 First Trimesters
% 208.88/209.09  |- mesh__onlineNote mesh__D011261
% 208.88/209.09       use PREGNANCY TRIMESTER, FIRST to search PREGNANCY, FIRST TRIMESTER 1975%A%  
% 208.88/209.09  |- skos__hiddenLabel mesh__D011261 Trimesters, First
% 208.88/209.09  |- skos__hiddenLabel mesh__D011261 Pregnancies, First Trimester
% 208.88/209.09  |- skos__historyNote mesh__D011261 Time Factors %28%1967-1974%29%
% 208.88/209.09  |- skos__historyNote mesh__D011261 Pregnancy %28%1966-1974%29%
% 208.88/209.09  |- skos__hiddenLabel mesh__D011261 Phase, Early Placental
% 208.88/209.09  |- skos__hiddenLabel mesh__D011261 First Trimester Pregnancy
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D011261 2005
% 208.88/209.09  |- mesh__dateEstablished mesh__D011261 1975-01-01
% 208.88/209.09  |- skos__broader mesh__D011261smesh__D011264
% 208.88/209.09  |- skos__historyNote mesh__D011261 Gestational Age %28%1968-1974%29%
% 208.88/209.09  |- skos__hiddenLabel mesh__D011261 Placental Phase, Early
% 208.88/209.09  |- mesh__recordOriginator mesh__D011261 SMH
% 208.88/209.09  |- skos__annotation mesh__D011261
% 208.88/209.09        human only; check tags HUMANS %26% FEMALE %26% PREGNANCY; DF: PREGN TRIMESTER FIRST%A%  
% 208.88/209.09  |- mesh__publicMeSHNote mesh__D011261
% 208.88/209.09       76; was PREGNANCY, FIRST TRIMESTER 1975   
% 208.88/209.09  |- skos__broader mesh__D005224smesh__D005223
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D005224 2006
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D005224 2004
% 208.88/209.09  |- mesh__recordMaintainer mesh__D005224 ssb
% 208.88/209.09  |- mesh__dateRevised mesh__D005224 2003-07-09
% 208.88/209.09  |- skos__scopeNote mesh__D005224
% 208.88/209.09       Fats containing one or more double bonds, as from oleic acid, an unsaturated fatty acid.%A%    
% 208.88/209.09  |- mesh__dateCreated mesh__D005224 1999-01-01
% 208.88/209.09  |- rdf__type mesh__D005224sskos__Concept
% 208.88/209.09  |- skos__prefLabel mesh__D005224 Fats, Unsaturated
% 208.88/209.09  |- mesh__recordAuthorizer mesh__D005224 sjn
% 208.88/209.09  |- mesh__recordOriginator mesh__D005224 NLM
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D005224 2005
% 208.88/209.09  |- skos__altLabel mesh__D005224 Unsaturated Oils
% 208.88/209.09  |- skos__altLabel mesh__D005224 Unsaturated Fats
% 208.88/209.09  |- skos__broader mesh__D010967smesh__D010961
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D010967 2006
% 208.88/209.09  |- mesh__recordOriginator mesh__D010967 EC
% 208.88/209.09  |- skos__scopeNote mesh__D010967
% 208.88/209.09       A species of PLASMODIUM causing malaria in rodents.     
% 208.88/209.09  |- rdf__type mesh__D010967sskos__Concept
% 208.88/209.09  |- skos__historyNote mesh__D010967 Plasmodium %28%1966-1987%29%
% 208.88/209.09  |- mesh__dateCreated mesh__D010967 1987-03-10
% 208.88/209.09  |- mesh__dateEstablished mesh__D010967 1988-01-01
% 208.88/209.09  |- mesh__dateRevised mesh__D010967 2003-07-09
% 208.88/209.09  |- mesh__publicMeSHNote mesh__D010967 88   
% 208.88/209.09  |- mesh__recordMaintainer mesh__D010967 ags
% 208.88/209.09  |- skos__prefLabel mesh__D010967 Plasmodium yoelii
% 208.88/209.09  |- skos__annotation mesh__D010967
% 208.88/209.09       in rodents; infection: coord IM with MALARIA %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord wtih ANTIBODIES, PROTOZOAN%A%  
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D010967 2004
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D010967 2005
% 208.88/209.09  |- mesh__recordAuthorizer mesh__D010967 sjn
% 208.88/209.09  |- mesh__historyNote mesh__D010967 88   
% 208.88/209.09  |- skos__altLabel mesh__D043343 Eifelfango Brand of Testosterone Propionate
% 208.88/209.09  |- mesh__publicMeSHNote mesh__D043343 2004; see TESTOSTERONE 1977-2003   
% 208.88/209.09  |- skos__historyNote mesh__D043343 Testosterone %28%1965-2003%29%
% 208.88/209.09  |- mesh__dateEstablished mesh__D043343 2004-01-01
% 208.88/209.09  |- skos__scopeNote mesh__D043343
% 208.88/209.09       An ester of TESTOSTERONE with a propionate substitution at the 17-beta position.%A%    
% 208.88/209.09  |- mesh__dateCreated mesh__D043343 2003-07-09
% 208.88/209.09  |- mesh__dateRevised mesh__D043343 2005-06-30
% 208.88/209.09  |- skos__broader mesh__D043343smesh__D013739
% 208.88/209.09  |- skos__prefLabel mesh__D043343 Testosterone Propionate
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D043343 2006
% 208.88/209.09  |- mesh__recordOriginator mesh__D043343 lkt
% 208.88/209.09  |- mesh__recordMaintainer mesh__D043343 CCR
% 208.88/209.09  |- mesh__recordAuthorizer mesh__D043343 sjn
% 208.88/209.09  |- skos__altLabel mesh__D043343 Ferring Brand of Testosterone Propionate
% 208.88/209.09  |- rdf__type mesh__D043343sskos__Concept
% 208.88/209.09  |- mesh__historyNote mesh__D043343 2004; use TESTOSTERONE 1977-2003   
% 208.88/209.09  |- skos__hiddenLabel mesh__D043343 propionat Eifelfango, Testosteron
% 208.88/209.09  |- mesh__recordOriginator mesh__D010169 NLM
% 208.88/209.09  |- skos__hiddenLabel mesh__D010169 Acids, Palmitic
% 208.88/209.09  |- skos__annotation mesh__D010169
% 208.88/209.09       a group of fatty acids; do not confuse with PALMITIC ACID%A%  
% 208.88/209.09  |- mesh__onlineNote mesh__D010169
% 208.88/209.09       use PALMITIC ACIDS to search PALMITIC ACID 1966-74   
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D010169 2004
% 208.88/209.09  |- skos__prefLabel mesh__D010169 Palmitic Acids
% 208.88/209.09  |- skos__scopeNote mesh__D010169
% 208.88/209.09       A group of 16-carbon fatty acids that contain no double bonds.%A%    
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D010169 2005
% 208.88/209.09  |- mesh__publicMeSHNote mesh__D010169 75; was PALMITIC ACID 1963-74   
% 208.88/209.09  |- mesh__recordMaintainer mesh__D010169 ssb
% 208.88/209.09  |- skos__broader mesh__D010169smesh__D005227
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D010169 2006
% 208.88/209.09  |- mesh__historyNote mesh__D010169 75; was PALMITIC ACID 1963-74   
% 208.88/209.09  |- mesh__recordAuthorizer mesh__D010169 sjn
% 208.88/209.09  |- mesh__dateRevised mesh__D010169 2003-07-09
% 208.88/209.09  |- rdf__type mesh__D010169sskos__Concept
% 208.88/209.09  |- mesh__dateCreated mesh__D010169 1999-01-01
% 208.88/209.09  |- mesh__recordOriginator mesh__D015652 RLS
% 208.88/209.09  |- skos__altLabel mesh__D015652 25-Hydroxycalciferol
% 208.88/209.09  |- skos__prefLabel mesh__D015652 25-Hydroxyvitamin D 2
% 208.88/209.09  |- mesh__dateEstablished mesh__D015652 1990-01-01
% 208.88/209.09  |- mesh__dateCreated mesh__D015652 1989-09-06
% 208.88/209.09  |- mesh__publicMeSHNote mesh__D015652 90   
% 208.88/209.09  |- mesh__recordMaintainer mesh__D015652 ssb
% 208.88/209.09  |- skos__historyNote mesh__D015652 Ergocalciferols %28%1966-1989%29%
% 208.88/209.09  |- skos__hiddenLabel mesh__D015652 25 Hydroxyvitamin D 2
% 208.88/209.09  |- skos__altLabel mesh__D015652
% 208.88/209.09       9,10-Secoergosta-5,7,10%28%19%29%,22-tetraene-3 beta,25-diol
% 208.88/209.09  |- skos__scopeNote mesh__D015652
% 208.88/209.09       9,10-Secoergosta-5,7,10%28%19%29%,22-tetraene-3,25-diol. Biologically active metabolite of vitamin D2 which is more active in curing rickets than its parent. The compound is believed to attach to the same receptor as vitamin D2 and 25-hydroxyvitamin D3.%A%    
% 208.88/209.09  |- skos__hiddenLabel mesh__D015652 25 Hydroxyergocalciferol
% 208.88/209.09  |- skos__altLabel mesh__D015652 Ercalcidiol
% 208.88/209.09  |- rdf__type mesh__D015652sskos__Concept
% 208.88/209.09  |- skos__annotation mesh__D015652
% 208.88/209.09       deficiency: coordinate 25-HYDROXYVITAMIN D 2 /defic %28%IM%29% with RICKETS %28%IM%29% or with VITAMIN D DEFICIENCY %28%IM%29%%A%  
% 208.88/209.09  |- skos__altLabel mesh__D015652 25-Hydroxyergocalciferol
% 208.88/209.09  |- skos__hiddenLabel mesh__D015652 25 Hydroxycalciferol
% 208.88/209.09  |- mesh__recordAuthorizer mesh__D015652 sjn
% 208.88/209.09  |- mesh__historyNote mesh__D015652 90   
% 208.88/209.09  |- skos__broader mesh__D015652smesh__D004872
% 208.88/209.09  |- skos__altLabel mesh__D015652 25-Hydroxyvitamin D2
% 208.88/209.09  |- mesh__dateRevised mesh__D015652 2005-06-30
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D015652 2006
% 208.88/209.09  |- skos__hiddenLabel mesh__D015652 25 Hydroxyvitamin D2
% 208.88/209.09  |- rdf__type mesh__D009615sskos__Concept
% 208.88/209.09  |- mesh__dateRevised mesh__D009615 2005-06-30
% 208.88/209.09  |- mesh__recordOriginator mesh__D009615 NLM
% 208.88/209.09  |- mesh__recordMaintainer mesh__D009615 SYSTEM
% 208.88/209.09  |- mesh__dateCreated mesh__D009615 1999-01-01
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D009615 2006
% 208.88/209.09  |- skos__broader mesh__D009615smesh__D009618
% 208.88/209.09  |- skos__scopeNote mesh__D009615
% 208.88/209.09       A genus of gram-positive, aerobic bacteria whose species are widely distributed and are abundant in soil. Some strains are pathogenic opportunists for man and animals.%A%    
% 208.88/209.09  |- skos__annotation mesh__D009615 infection = NOCARDIA INFECTIONS   
% 208.88/209.09  |- mesh__recordAuthorizer mesh__D009615 sjn
% 208.88/209.09  |- skos__prefLabel mesh__D009615 Nocardia
% 208.88/209.09  |- mesh__recordMaintainer mesh__D001632 ssb
% 208.88/209.09  |- mesh__historyNote mesh__D001632 68   
% 208.88/209.09  |- skos__broader mesh__D001632smesh__D013267
% 208.88/209.09  |- skos__scopeNote mesh__D001632
% 208.88/209.09       Compounds with 1,2-diphenylethane. They are structurally like reduced STILBENES.%A%    
% 208.88/209.09  |- mesh__dateEstablished mesh__D001632 1968-01-01
% 208.88/209.09  |- skos__prefLabel mesh__D001632 Bibenzyls
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D001632 2006
% 208.88/209.09  |- mesh__publicMeSHNote mesh__D001632 68   
% 208.88/209.09  |- mesh__recordOriginator mesh__D001632 NLM
% 208.88/209.09  |- mesh__dateCreated mesh__D001632 1999-01-01
% 208.88/209.09  |- mesh__dateRevised mesh__D001632 2004-07-07
% 208.88/209.09  |- rdf__type mesh__D001632sskos__Concept
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D001632 2005
% 208.88/209.09  |- skos__broader mesh__D001632smesh__D001593
% 208.88/209.09  |- mesh__recordAuthorizer mesh__D001632 sjn
% 208.88/209.09  |- skos__historyNote mesh__D020597 Myxococcales %28%1978-1999%29%
% 208.88/209.09  |- skos__scopeNote mesh__D020597
% 208.88/209.09       A genus of the MYXOCOCCALES having vegetative cells which are straight rods with tapered ends and myxospores which are short and somewhat crooked. Fruiting bodies consist of spherical, ovoid, or club-shaped sporangioles on stalks. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 208.88/209.09  |- mesh__recordOriginator mesh__D020597 ndw
% 208.88/209.09  |- mesh__dateRevised mesh__D020597 2005-06-30
% 208.88/209.09  |- mesh__dateEstablished mesh__D020597 2000-01-01
% 208.88/209.09  |- mesh__recordAuthorizer mesh__D020597 sjn
% 208.88/209.09  |- skos__historyNote mesh__D020597 Bacteria %28%1969-1977%29%
% 208.88/209.09  |- mesh__dateCreated mesh__D020597 1999-11-03
% 208.88/209.09  |- mesh__recordMaintainer mesh__D020597 SYSTEM
% 208.88/209.09  |- mesh__publicMeSHNote mesh__D020597 2000   
% 208.88/209.09  |- mesh__historyNote mesh__D020597 2000   
% 208.88/209.09  |- rdf__type mesh__D020597sskos__Concept
% 208.88/209.09  |- skos__broader mesh__D020597smesh__D009231
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D020597 2006
% 208.88/209.09  |- skos__prefLabel mesh__D020597 Stigmatella
% 208.88/209.09  |- mesh__recordOriginator mesh__D025282 ags
% 208.88/209.09  |- mesh__dateEstablished mesh__D025282 2002-01-01
% 208.88/209.09  |- skos__annotation mesh__D025282 coord with specific fungus   
% 208.88/209.09  |- rdf__type mesh__D025282sskos__Concept
% 208.88/209.09  |- mesh__dateCreated mesh__D025282 2001-07-25
% 208.88/209.09  |- mesh__recordMaintainer mesh__D025282 SYSTEM
% 208.88/209.09  |- skos__broader mesh__D025282smesh__D025281
% 208.88/209.09  |- mesh__recordAuthorizer mesh__D025282 sjn
% 208.88/209.09  |- mesh__dateRevised mesh__D025282 2005-06-30
% 208.88/209.09  |- mesh__publicMeSHNote mesh__D025282 2002   
% 208.88/209.09  |- mesh__historyNote mesh__D025282 2002   
% 208.88/209.09  |- skos__prefLabel mesh__D025282 Mycelium
% 208.88/209.09  |- skos__scopeNote mesh__D025282
% 208.88/209.09       The body of a fungus which is made up of HYPHAE.     
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D025282 2006
% 208.88/209.09  |- skos__hiddenLabel mesh__D019245 Strength, Compressive
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D019245 2004
% 208.88/209.09  |- mesh__dateEstablished mesh__D019245 1997-01-01
% 208.88/209.09  |- mesh__publicMeSHNote mesh__D019245 97   
% 208.88/209.09  |- mesh__historyNote mesh__D019245 97   
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D019245 2005
% 208.88/209.09  |- skos__prefLabel mesh__D019245 Compressive Strength
% 208.88/209.09  |- mesh__dateRevised mesh__D019245 2003-07-09
% 208.88/209.09  |- skos__broader mesh__D019245smesh__D001696
% 208.88/209.09  |- rdf__type mesh__D019245sskos__Concept
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D019245 2006
% 208.88/209.09  |- skos__scopeNote mesh__D019245
% 208.88/209.09       The maximum compression a material can withstand without failure. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed, p427%29%%A%    
% 208.88/209.09  |- skos__hiddenLabel mesh__D019245 Strengths, Compressive
% 208.88/209.09  |- skos__annotation mesh__D019245
% 208.88/209.09       NIM; do not confuse with TENSILE STRENGTH   
% 208.88/209.09  |- mesh__dateCreated mesh__D019245 1996-06-20
% 208.88/209.09  |- skos__hiddenLabel mesh__D019245 Compressive Strengths
% 208.88/209.09  |- skos__broader mesh__D019245smesh__D019563
% 208.88/209.09  |- skos__hiddenLabel mesh__D011262 Second Trimester Pregnancy
% 208.88/209.09  |- mesh__dateEstablished mesh__D011262 1975-01-01
% 208.88/209.09  |- skos__hiddenLabel mesh__D011262 Pregnancies, Second Trimester
% 208.88/209.09  |- mesh__dateCreated mesh__D011262 1975-07-25
% 208.88/209.09  |- mesh__historyNote mesh__D011262
% 208.88/209.09       76; was PREGNANCY, SECOND TRIMESTER 1975   
% 208.88/209.09  |- mesh__recordOriginator mesh__D011262 SMH
% 208.88/209.09  |- skos__hiddenLabel mesh__D011262 Second Pregnancy Trimester
% 208.88/209.09  |- mesh__dateRevised mesh__D011262 2004-07-13
% 208.88/209.09  |- skos__hiddenLabel mesh__D011262 Second Pregnancy Trimesters
% 208.88/209.09  |- skos__altLabel mesh__D011262 Pregnancy, Second Trimester
% 208.88/209.09  |- mesh__recordMaintainer mesh__D011262 sjn
% 208.88/209.09  |- skos__annotation mesh__D011262
% 208.88/209.09        human only; check tags HUMANS %26% FEMALE %26% PREGNANCY; DF: PREGN TRIMESTER SECOND%A%  
% 208.88/209.09  |- rdf__type mesh__D011262sskos__Concept
% 208.88/209.09  |- skos__hiddenLabel mesh__D011262 Trimesters, Second
% 208.88/209.09  |- skos__altLabel mesh__D011262 Trimester, Second
% 208.88/209.09  |- skos__historyNote mesh__D011262 Time Factors %28%1967-1974%29%
% 208.88/209.09  |- skos__hiddenLabel mesh__D011262 Second Trimester Pregnancies
% 208.88/209.09  |- mesh__recordAuthorizer mesh__D011262 sjn
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D011262 2005
% 208.88/209.09  |- skos__broader mesh__D011262smesh__D011264
% 208.88/209.09  |- skos__historyNote mesh__D011262 Gestational Age %28%1968-1974%29%
% 208.88/209.09  |- skos__hiddenLabel mesh__D011262 Second Trimesters
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D011262 2006
% 208.88/209.09  |- skos__hiddenLabel mesh__D011262 Pregnancy Trimesters, Second
% 208.88/209.09  |- skos__prefLabel mesh__D011262 Pregnancy Trimester, Second
% 208.88/209.09  |- skos__hiddenLabel mesh__D011262 Midtrimesters
% 208.88/209.09  |- skos__altLabel mesh__D011262 Midtrimester
% 208.88/209.09  |- skos__scopeNote mesh__D011262
% 208.88/209.09       The middle third of a human PREGNANCY, from the beginning of the 15th through the 28th completed week %28%99 to 196 days%29% of gestation.%A%    
% 208.88/209.09  |- mesh__onlineNote mesh__D011262
% 208.88/209.09       use PREGNANCY TRIMESTER, SECOND to search PREGNANCY, SECOND TRIMESTER 1975%A%  
% 208.88/209.09  |- skos__historyNote mesh__D011262 Pregnancy %28%1966-1974%29%
% 208.88/209.09  |- skos__hiddenLabel mesh__D011262 Second Trimester
% 208.88/209.09  |- mesh__publicMeSHNote mesh__D011262
% 208.88/209.09       76; was PREGNANCY, SECOND TRIMESTER 1975   
% 208.88/209.09  |- mesh__recordOriginator mesh__D010968 SH
% 208.88/209.09  |- mesh__recordAuthorizer mesh__D010968 sjn
% 208.88/209.09  |- skos__historyNote mesh__D010968 Phthalic Acids %28%1970-1976%29%
% 208.88/209.09  |- mesh__dateCreated mesh__D010968 1976-04-13
% 208.88/209.09  |- mesh__dateEstablished mesh__D010968 1977-01-01
% 208.88/209.09  |- rdf__type mesh__D010968sskos__Concept
% 208.88/209.09  |- skos__broader mesh__D010968smesh__D020313
% 208.88/209.09  |- mesh__dateRevised mesh__D010968 2005-06-30
% 208.88/209.09  |- mesh__historyNote mesh__D010968 77   
% 208.88/209.09  |- mesh__recordMaintainer mesh__D010968 ssb
% 208.88/209.09  |- mesh__publicMeSHNote mesh__D010968 77   
% 208.88/209.09  |- skos__prefLabel mesh__D010968 Plasticizers
% 208.88/209.09  |- skos__scopeNote mesh__D010968
% 208.88/209.09       Materials incorporated mechanically in plastics %28%usually PVC%29% to increase flexibility, workability or distensibility; due to the non-chemical inclusion, plasticizers leach out from the plastic and are found in body fluids and the general environment.%A%    
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D010968 2006
% 208.88/209.09  |- mesh__publicMeSHNote mesh__D043344
% 208.88/209.09       2004, 1966-1999; see CHORDATA, NON-VERTEBRATE 2000-2003   
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D043344 2004
% 208.88/209.09  |- skos__prefLabel mesh__D043344 Chordata
% 208.88/209.09  |- mesh__dateEstablished mesh__D043344 2004-01-01
% 208.88/209.09  |- mesh__dateCreated mesh__D043344 2003-07-09
% 208.88/209.09  |- skos__broader mesh__D043344smesh__D000818
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D043344 2005
% 208.88/209.09  |- skos__historyNote mesh__D043344
% 208.88/209.09       Chordata, Nonvertebrate %28%2000-2003%29%
% 208.88/209.09  |- skos__hiddenLabel mesh__D043344 Chordate
% 208.88/209.09  |- skos__altLabel mesh__D043344 Chordates
% 208.88/209.09  |- rdf__type mesh__D043344sskos__Concept
% 208.88/209.09  |- skos__historyNote mesh__D043344 Animals %28%1963-1999%29%
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D043344 2006
% 208.88/209.09  |- mesh__historyNote mesh__D043344
% 208.88/209.09       2004, 1966-1999; use CHORDATA, NON-VERTEBRATE 2000-2003   
% 208.88/209.09  |- skos__scopeNote mesh__D043344
% 208.88/209.09       Phylum in the domain Eukarya, comprised of animals either with fully developed backbones %28%VERTEBRATES%29%, or those with notochords only during some developmental stage %28%CHORDATA, NONVERTEBRATE%29%.%A%    
% 208.88/209.09  |- mesh__historyNote mesh__D015653 90   
% 208.88/209.09  |- skos__related mesh__D015653smesh__D014547
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D015653 2000
% 208.88/209.09  |- mesh__dateCreated mesh__D015653 1989-06-19
% 208.88/209.09  |- mesh__recordOriginator mesh__D015653 AGS
% 208.88/209.09  |- rdf__type mesh__D015653sskos__Concept
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D015653 2003
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D015653 2001
% 208.88/209.09  |- skos__hiddenLabel mesh__D015653 Cystectomies
% 208.88/209.09  |- skos__annotation mesh__D015653
% 208.88/209.09       %22%cyst-%22% refers to the bladder, not to %22%cyst%22%; do not use /util except by MeSH definition%A%  
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D015653 2005
% 208.88/209.09  |- skos__broader mesh__D015653smesh__D013520
% 208.88/209.09  |- skos__scopeNote mesh__D015653
% 208.88/209.09       Used for excision of the urinary bladder.     
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D015653 2004
% 208.88/209.09  |- skos__historyNote mesh__D015653 Bladder %28%1966-1989%29%
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D015653 2006
% 208.88/209.09  |- mesh__recordMaintainer mesh__D015653 PXP
% 208.88/209.09  |- skos__historyNote mesh__D015653 Bladder Neoplasms %28%1966-1989%29%
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D015653 2002
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D015653 1998
% 208.88/209.09  |- mesh__dateRevised mesh__D015653 1997-06-20
% 208.88/209.09  |- mesh__dateEstablished mesh__D015653 1990-01-01
% 208.88/209.09  |- mesh__recordAuthorizer mesh__D015653 SJN
% 208.88/209.09  |- mesh__publicMeSHNote mesh__D015653 90   
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D015653 1999
% 208.88/209.09  |- skos__prefLabel mesh__D015653 Cystectomy
% 208.88/209.09  |- rdf__type mesh__D009616sskos__Concept
% 208.88/209.09  |- mesh__historyNote mesh__D009616
% 208.88/209.09       74%28%72%29%; ACTINOMYCES ASTEROIDES was see NOCARDIA ASTEROIDES 1974-91%A%  
% 208.88/209.09  |- mesh__recordAuthorizer mesh__D009616 sjn
% 208.88/209.09  |- skos__historyNote mesh__D009616 Nocardia %28%1966-1971%29%
% 208.88/209.09  |- mesh__dateCreated mesh__D009616 1999-01-01
% 208.88/209.09  |- skos__broader mesh__D009616smesh__D009615
% 208.88/209.09  |- mesh__publicMeSHNote mesh__D009616
% 208.88/209.09       74; ACTINOMYCES ASTEROIDES was see NOCARDIA ASTEROIDES 1974-91%A%  
% 208.88/209.09  |- mesh__dateRevised mesh__D009616 2005-06-30
% 208.88/209.09  |- mesh__dateEstablished mesh__D009616 1974-01-01
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D009616 2006
% 208.88/209.09  |- mesh__recordOriginator mesh__D009616 NLM
% 208.88/209.09  |- mesh__onlineNote mesh__D009616
% 208.88/209.09       use NOCARDIA ASTEROIDES to search ACTINOMYCES ASTEROIDES 1974-91%A%  
% 208.88/209.09  |- skos__annotation mesh__D009616
% 208.88/209.09       infection: coord IM with NOCARDIA INFECTIONS %28%IM%29%   
% 208.88/209.09  |- mesh__recordMaintainer mesh__D009616 SYSTEM
% 208.88/209.09  |- skos__prefLabel mesh__D009616 Nocardia asteroides
% 208.88/209.09  |- skos__scopeNote mesh__D009616
% 208.88/209.09       A species of bacterium of the family NOCARDIACEAE, producing pulmonary infections in man.%A%    
% 208.88/209.09  |- skos__prefLabel mesh__D001633 Bible
% 208.88/209.09  |- mesh__recordOriginator mesh__D001633 NLM
% 208.88/209.09  |- skos__annotation mesh__D001633
% 208.88/209.09       no qualif; Old and New Testament only: does not include Koran %28%index under ISLAM + specific aspect discussed in article%29%; includes Talmud      CATALOG: use NAF entry%A%  
% 208.88/209.09  |- mesh__activeMeSHYear mesh__D001633 2000
% 208.88/209.09  |- mesh__dateCreated mesh__D001633 1999-01-01
% 208.88/209.09  |- skos__broader mesh__D001633smesh__D008091
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D001633 2005
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D001633 1998
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D001633 2001
% 208.88/209.10  |- mesh__recordMaintainer mesh__D001633 TGC
% 208.88/209.10  |- skos__scopeNote mesh__D001633
% 208.88/209.10       The book composed of writings generally accepted by Christians as inspired by God and of divine authority. %28%Webster, 3d ed%29%%A%    
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D001633 2006
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D001633 1999
% 208.88/209.10  |- mesh__dateRevised mesh__D001633 1996-06-10
% 208.88/209.10  |- skos__hiddenLabel mesh__D001633 Interpretation, Scriptural
% 208.88/209.10  |- skos__hiddenLabel mesh__D001633 Interpretations, Scriptural
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D001633 2003
% 208.88/209.10  |- rdf__type mesh__D001633sskos__Concept
% 208.88/209.10  |- skos__hiddenLabel mesh__D001633 Bibles
% 208.88/209.10  |- mesh__recordAuthorizer mesh__D001633 PLS
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D001633 2002
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D001633 2004
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D001633 1997
% 208.88/209.10  |- skos__hiddenLabel mesh__D001633 Scriptural Interpretations
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D020598 2006
% 208.88/209.10  |- mesh__dateCreated mesh__D020598 1999-11-03
% 208.88/209.10  |- skos__hiddenLabel mesh__D020598 c myb Protein
% 208.88/209.10  |- skos__altLabel mesh__D020598 c-myb Proteins
% 208.88/209.10  |- mesh__recordMaintainer mesh__D020598 DRC
% 208.88/209.10  |- skos__scopeNote mesh__D020598
% 208.88/209.10       Cellular DNA-binding proteins encoded by the myb gene %28%GENES, MYB%29%. They are expressed in a wide variety of cells including thymocytes and lymphocytes, and regulate cell differentiation. Overexpression of myb is associated with autoimmune diseases and malignancies.%A%    
% 208.88/209.10  |- skos__historyNote mesh__D020598
% 208.88/209.10       Proto-Oncogene Proteins %28%1986-1999%29%
% 208.88/209.10  |- mesh__historyNote mesh__D020598
% 208.88/209.10       2000; use PROTO-ONCOGENE PROTEINS C-MYB %28%NM%29% 1986-1999   
% 208.88/209.10  |- skos__hiddenLabel mesh__D020598 Proto Oncogene Proteins c myb
% 208.88/209.10  |- skos__hiddenLabel mesh__D020598 Proto Oncogene Proteins myb
% 208.88/209.10  |- skos__hiddenLabel mesh__D020598 c myb Proteins
% 208.88/209.10  |- skos__broader mesh__D020598smesh__D014157
% 208.88/209.10  |- skos__hiddenLabel mesh__D020598 myb Proto Oncogene Proteins
% 208.88/209.10  |- skos__prefLabel mesh__D020598 Proto-Oncogene Proteins c-myb
% 208.88/209.10  |- skos__hiddenLabel mesh__D020598 Proto Oncogene Products c myb
% 208.88/209.10  |- skos__historyNote mesh__D020598 Trans-Activators %28%1990-1999%29%
% 208.88/209.10  |- mesh__dateEstablished mesh__D020598 2000-01-01
% 208.88/209.10  |- skos__hiddenLabel mesh__D020598 myb, Proto-Oncogene Protein
% 208.88/209.10  |- skos__hiddenLabel mesh__D020598 c-myb, Proto-Oncogene Proteins
% 208.88/209.10  |- skos__altLabel mesh__D020598 Proto-Oncogene Products c-myb
% 208.88/209.10  |- skos__broader mesh__D020598smesh__D004268
% 208.88/209.10  |- skos__altLabel mesh__D020598 Proto-Oncogene Proteins myb
% 208.88/209.10  |- mesh__dateRevised mesh__D020598 2005-06-30
% 208.88/209.10  |- mesh__recordOriginator mesh__D020598 ags
% 208.88/209.10  |- skos__altLabel mesh__D020598 c-myb Protein
% 208.88/209.10  |- skos__broader mesh__D020598smesh__D011518
% 208.88/209.10  |- mesh__publicMeSHNote mesh__D020598
% 208.88/209.10       2000; PROTO-ONCOGENE PROTEIN MYB was indexed under PROTO-ONCOGENE PROTEINS 1986-1990 %26% TRANS-ACTIVATORS 1990-1999%A%  
% 208.88/209.10  |- skos__hiddenLabel mesh__D020598 Proto Oncogene Protein myb
% 208.88/209.10  |- mesh__recordAuthorizer mesh__D020598 sjn
% 208.88/209.10  |- skos__hiddenLabel mesh__D020598 Proto-Oncogene Proteins, myb
% 208.88/209.10  |- skos__altLabel mesh__D020598 myb Proto-Oncogene Proteins
% 208.88/209.10  |- skos__hiddenLabel mesh__D020598 myb, Proto-Oncogene Proteins
% 208.88/209.10  |- skos__hiddenLabel mesh__D020598 c-myb, Proto-Oncogene Products
% 208.88/209.10  |- skos__altLabel mesh__D020598 Proto-Oncogene Protein myb
% 208.88/209.10  |- rdf__type mesh__D020598sskos__Concept
% 208.88/209.10  |- skos__related mesh__D020598smesh__D020570
% 208.88/209.10  |- skos__broader mesh__D004093Q000172smesh__D004093
% 208.88/209.10  |- mesh__preferredCombination mesh__D004093Q000172smesh__D010661
% 208.88/209.10  |- rdf__type mesh__D004093Q000172smesh__CompoundConcept
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D019246 2005
% 208.88/209.10  |- mesh__historyNote mesh__D019246 97   
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D019246 1997
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D019246 2006
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D019246 1998
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D019246 2000
% 208.88/209.10  |- mesh__dateEstablished mesh__D019246 1997-01-01
% 208.88/209.10  |- rdf__type mesh__D019246sskos__Concept
% 208.88/209.10  |- skos__hiddenLabel mesh__D019246 Preparation, Tooth
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D019246 2001
% 208.88/209.10  |- skos__broader mesh__D019246smesh__D003813
% 208.88/209.10  |- mesh__publicMeSHNote mesh__D019246 97   
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D019246 1999
% 208.88/209.10  |- skos__hiddenLabel mesh__D019246 Tooth Preparations
% 208.88/209.10  |- skos__annotation mesh__D019246
% 208.88/209.10       GEN or unspecified; prefer specifics; coord IM with specific dental procedure %28%IM%29%%A%  
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D019246 2002
% 208.88/209.10  |- mesh__dateCreated mesh__D019246 1996-06-10
% 208.88/209.10  |- skos__scopeNote mesh__D019246
% 208.88/209.10       Procedures carried out with regard to the teeth or tooth structures preparatory to specified dental therapeutic and surgical measures.%A%    
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D019246 2003
% 208.88/209.10  |- skos__prefLabel mesh__D019246 Tooth Preparation
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D019246 2004
% 208.88/209.10  |- skos__hiddenLabel mesh__D019246 Preparations, Tooth
% 208.88/209.10  |- skos__hiddenLabel mesh__D011263 Trimesters, Last
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D011263 2006
% 208.88/209.10  |- skos__hiddenLabel mesh__D011263 Third Pregnancy Trimesters
% 208.88/209.10  |- skos__hiddenLabel mesh__D011263 Last Trimesters
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D011263 2005
% 208.88/209.10  |- skos__historyNote mesh__D011263 Gestational Age %28%1968-1974%29%
% 208.88/209.10  |- skos__altLabel mesh__D011263 Pregnancy, Third Trimester
% 208.88/209.10  |- skos__hiddenLabel mesh__D011263 Trimester, Last
% 208.88/209.10  |- mesh__dateCreated mesh__D011263 1975-07-25
% 208.88/209.10  |- skos__hiddenLabel mesh__D011263 Third Trimester Pregnancy
% 208.88/209.10  |- mesh__publicMeSHNote mesh__D011263
% 208.88/209.10       76; was PREGNANCY, THIRD TRIMESTER 1975   
% 208.88/209.10  |- skos__scopeNote mesh__D011263
% 208.88/209.10       The last third of a human PREGNANCY, from the beginning of the 29th through the 42nd completed week %28%197 to 294 days%29% of gestation.%A%    
% 208.88/209.10  |- skos__hiddenLabel mesh__D011263 Pregnancy Trimesters, Third
% 208.88/209.10  |- skos__hiddenLabel mesh__D011263 Pregnancies, Third Trimester
% 208.88/209.10  |- mesh__recordOriginator mesh__D011263 SMH
% 208.88/209.10  |- mesh__recordMaintainer mesh__D011263 ags
% 208.88/209.10  |- rdf__type mesh__D011263sskos__Concept
% 208.88/209.10  |- mesh__dateRevised mesh__D011263 2005-07-18
% 208.88/209.10  |- skos__hiddenLabel mesh__D011263 Third Trimester Pregnancies
% 208.88/209.10  |- skos__hiddenLabel mesh__D011263 Third Pregnancy Trimester
% 208.88/209.10  |- mesh__dateEstablished mesh__D011263 1975-01-01
% 208.88/209.10  |- mesh__historyNote mesh__D011263
% 208.88/209.10       76; was PREGNANCY, THIRD TRIMESTER 1975   
% 208.88/209.10  |- skos__prefLabel mesh__D011263 Pregnancy Trimester, Third
% 208.88/209.10  |- mesh__recordAuthorizer mesh__D011263 ags
% 208.88/209.10  |- mesh__onlineNote mesh__D011263
% 208.88/209.10       use PREGNANCY TRIMESTER, THIRD to search PREGNANCY, THIRD TRIMESTER 1975%A%  
% 208.88/209.10  |- skos__hiddenLabel mesh__D011263 Trimesters, Third
% 208.88/209.10  |- skos__hiddenLabel mesh__D011263 Third Trimester
% 208.88/209.10  |- skos__historyNote mesh__D011263 Pregnancy %28%1966-1974%29%
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D011263 2006A
% 208.88/209.10  |- skos__hiddenLabel mesh__D011263 Third Trimesters
% 208.88/209.10  |- skos__altLabel mesh__D011263 Last Trimester
% 208.88/209.10  |- skos__annotation mesh__D011263
% 208.88/209.10       human only; check tags HUMANS %26% FEMALE %26% PREGNANCY; %22%at term%22%: consider better LABOR, OBSTETRIC; DF: PREGN TRIMESTER THIRD%A%  
% 208.88/209.10  |- skos__altLabel mesh__D011263 Trimester, Third
% 208.88/209.10  |- skos__historyNote mesh__D011263 Time Factors %28%1967-1974%29%
% 208.88/209.10  |- skos__broader mesh__D011263smesh__D011264
% 208.88/209.10  |- skos__altLabel mesh__D005226 Fatty Acid Synthase
% 208.88/209.10  |- rdf__type mesh__D005226sskos__Concept
% 208.88/209.10  |- skos__hiddenLabel mesh__D005226 Synthase, Fatty Acid
% 208.88/209.10  |- mesh__dateEstablished mesh__D005226 1972-01-01
% 208.88/209.10  |- mesh__publicMeSHNote mesh__D005226 72   
% 208.88/209.10  |- mesh__dateRevised mesh__D005226 2004-07-07
% 208.88/209.10  |- mesh__historyNote mesh__D005226 72%28%71%29%   
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D005226 2005
% 208.88/209.10  |- mesh__recordAuthorizer mesh__D005226 sjn
% 208.88/209.10  |- skos__historyNote mesh__D005226 Ligases %28%1966-1970%29%
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D005226 2006
% 208.88/209.10  |- mesh__recordOriginator mesh__D005226 NLM
% 208.88/209.10  |- skos__prefLabel mesh__D005226 Fatty Acid Synthetase Complex
% 208.88/209.10  |- skos__historyNote mesh__D005226 Fatty Acids/BI %28%1966-1970%29%
% 208.88/209.10  |- skos__broader mesh__D005226smesh__D009097
% 208.88/209.10  |- skos__hiddenLabel mesh__D005226 Acid Synthase, Fatty
% 208.88/209.10  |- mesh__recordMaintainer mesh__D005226 jmp
% 208.88/209.10  |- mesh__dateCreated mesh__D005226 1999-01-01
% 208.88/209.10  |- skos__broader mesh__D014867Q000097smesh__D014867
% 208.88/209.10  |- mesh__preferredCombination mesh__D014867Q000097smesh__D001769
% 208.88/209.10  |- rdf__type mesh__D014867Q000097smesh__CompoundConcept
% 208.88/209.10  |- skos__broader mesh__D010969smesh__D011108
% 208.88/209.10  |- mesh__recordOriginator mesh__D010969 NLM
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D010969 2005
% 208.88/209.10  |- skos__annotation mesh__D010969 D25-26 qualif   
% 208.88/209.10  |- skos__prefLabel mesh__D010969 Plastics
% 208.88/209.10  |- mesh__dateRevised mesh__D010969 2004-07-07
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D010969 2006
% 208.88/209.10  |- mesh__recordMaintainer mesh__D010969 jmp
% 208.88/209.10  |- mesh__recordAuthorizer mesh__D010969 sjn
% 208.88/209.10  |- mesh__historyNote mesh__D010969
% 208.88/209.10       was in Cat D %26% J 1967-82, was in Cat J only 1963-66   
% 208.88/209.10  |- skos__scopeNote mesh__D010969
% 208.88/209.10       Polymeric materials %28%usually organic%29% of large molecular weight which can be shaped by flow. Plastic usually refers to the final product with fillers, plasticizers, pigments, and stabilizers included %28%versus the resin, the homogeneous polymeric starting material%29%. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 208.88/209.10  |- mesh__dateCreated mesh__D010969 1999-01-01
% 208.88/209.10  |- rdf__type mesh__D010969sskos__Concept
% 208.88/209.10  |- skos__altLabel mesh__D015654 Human herpesvirus 6
% 208.88/209.10  |- skos__hiddenLabel mesh__D015654 Human B-Lymphotropic Viruses
% 208.88/209.10  |- skos__hiddenLabel mesh__D015654 Human B Lymphotropic Virus
% 208.88/209.10  |- mesh__publicMeSHNote mesh__D015654
% 208.88/209.10       94; was HERPESVIRUS-6, HUMAN 1990-93; HUMAN HERPESVIRUS-6 was see HERPESVIRUS-6, HUMAN 1990-93%A%  
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D015654 2003
% 208.88/209.10  |- mesh__dateRevised mesh__D015654 2001-07-25
% 208.88/209.10  |- skos__hiddenLabel mesh__D015654 B-Lymphotropic Virus, Human
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D015654 2005
% 208.88/209.10  |- skos__scopeNote mesh__D015654
% 208.88/209.10       The type species of ROSEOLOVIRUS isolated from patients with AIDS and other LYMPHOPROLIFERATIVE DISORDERS. It infects and replicates in fresh and established lines of hematopoietic cells and cells of neural origin. It also appears to alter NK cell activity. HHV-6; %28%HBLV%29% antibodies are elevated in patients with AIDS, Sjogren%27%s syndrome, sarcoidosis, chronic fatigue syndrome, and certain malignancies. HHV-6 is the cause of EXANTHEMA SUBITUM and has been implicated in encephalitis.%A%    
% 208.88/209.10  |- mesh__onlineNote mesh__D015654
% 208.88/209.10       use HERPESVIRUS 6, HUMAN to search HERPESVIRUS-6, HUMAN %26% HUMAN HERPESVIRUS-6 1990-93%A%  
% 208.88/209.10  |- skos__hiddenLabel mesh__D015654 Human Herpesvirus 6A
% 208.88/209.10  |- skos__altLabel mesh__D015654 HBLV
% 208.88/209.10  |- skos__hiddenLabel mesh__D015654 Human Herpesvirus 6B
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D015654 2004
% 208.88/209.10  |- skos__annotation mesh__D015654
% 208.88/209.10       infection: coord IM with ROSEOLOVIRUS INFECTIONS %28%IM%29% but consider also EXANTHEMA SUBITUM%A%  
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D015654 2006
% 208.88/209.10  |- mesh__recordOriginator mesh__D015654 AGS
% 208.88/209.10  |- mesh__recordAuthorizer mesh__D015654 sjn
% 208.88/209.10  |- mesh__dateCreated mesh__D015654 1989-05-25
% 208.88/209.10  |- skos__hiddenLabel mesh__D015654 B-Lymphotropic Viruses, Human
% 208.88/209.10  |- mesh__historyNote mesh__D015654
% 208.88/209.10       94; was HERPESVIRUS-6, HUMAN 1990-93; HUMAN HERPESVIRUS-6 was see HERPESVIRUS-6, HUMAN 1990-93%A%  
% 208.88/209.10  |- skos__altLabel mesh__D015654 Human B-Lymphotropic Virus
% 208.88/209.10  |- skos__historyNote mesh__D015654 Herpesviridae %28%1986-1989%29%
% 208.88/209.10  |- mesh__dateEstablished mesh__D015654 1990-01-01
% 208.88/209.10  |- skos__prefLabel mesh__D015654 Herpesvirus 6, Human
% 208.88/209.10  |- mesh__recordMaintainer mesh__D015654 ags
% 208.88/209.10  |- skos__altLabel mesh__D015654 HHV-6A
% 208.88/209.10  |- skos__broader mesh__D015654smesh__D019211
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D015654 2002
% 208.88/209.10  |- skos__altLabel mesh__D015654 HHV-6
% 208.88/209.10  |- skos__related mesh__D015654smesh__D005077
% 208.88/209.10  |- skos__altLabel mesh__D015654 HHV-6B
% 208.88/209.10  |- rdf__type mesh__D015654sskos__Concept
% 208.88/209.10  |- mesh__recordAuthorizer mesh__D048030 sjn
% 208.88/209.10  |- skos__altLabel mesh__D048030 Algal RNA
% 208.88/209.10  |- skos__broader mesh__D048030smesh__D012313
% 208.88/209.10  |- skos__prefLabel mesh__D048030 RNA, Algal
% 208.88/209.10  |- mesh__recordMaintainer mesh__D048030 ags
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D048030 2006
% 208.88/209.10  |- rdf__type mesh__D048030sskos__Concept
% 208.88/209.10  |- mesh__dateEstablished mesh__D048030 2005-01-01
% 208.88/209.10  |- mesh__historyNote mesh__D048030 2005   
% 208.88/209.10  |- skos__historyNote mesh__D048030 RNA, Ribosomal %28%1974-2004%29%
% 208.88/209.10  |- mesh__recordOriginator mesh__D048030 ags
% 208.88/209.10  |- mesh__dateCreated mesh__D048030 2004-07-07
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D048030 2005
% 208.88/209.10  |- mesh__publicMeSHNote mesh__D048030 2005   
% 208.88/209.10  |- skos__scopeNote mesh__D048030
% 208.88/209.10       Ribonucleic acid in ALGAE having regulatory and catalytic roles as well as involvement in protein synthesis.%A%    
% 208.88/209.10  |- mesh__dateCreated mesh__D009617 1999-01-01
% 208.88/209.10  |- skos__hiddenLabel mesh__D009617 Nocardia Infection
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D009617 2002
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D009617 1997
% 208.88/209.10  |- skos__annotation mesh__D009617 gram-pos bact infect   
% 208.88/209.10  |- mesh__dateRevised mesh__D009617 1993-06-02
% 208.88/209.10  |- skos__prefLabel mesh__D009617 Nocardia Infections
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D009617 2005
% 208.88/209.10  |- skos__scopeNote mesh__D009617
% 208.88/209.10       Infections with bacteria of the genus NOCARDIA.     
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D009617 1994
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D009617 2006
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D009617 2003
% 208.88/209.10  |- skos__altLabel mesh__D009617 Infections, Nocardia
% 208.88/209.10  |- skos__broader mesh__D009617smesh__D000193
% 208.88/209.10  |- mesh__recordMaintainer mesh__D009617 TAP
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D009617 1995
% 208.88/209.10  |- mesh__recordAuthorizer mesh__D009617 PLS
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D009617 2004
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D009617 2000
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D009617 1998
% 208.88/209.10  |- rdf__type mesh__D009617sskos__Concept
% 208.88/209.10  |- skos__hiddenLabel mesh__D009617 Infection, Nocardia
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D009617 2001
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D009617 1999
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D009617 1996
% 208.88/209.10  |- mesh__recordOriginator mesh__D009617 NLM
% 208.88/209.10  |- skos__prefLabel mesh__D001634 Bibliography
% 208.88/209.10  |- mesh__dateRevised mesh__D001634 1999-11-03
% 208.88/209.10  |- mesh__recordMaintainer mesh__D001634 kle
% 208.88/209.10  |- mesh__dateCreated mesh__D001634 1999-01-01
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D001634 2002
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D001634 2005
% 208.88/209.10  |- skos__broader mesh__D001634smesh__D007255
% 208.88/209.10  |- skos__broader mesh__D001634smesh__D011642
% 208.88/209.10  |- mesh__recordOriginator mesh__D001634 NLM
% 208.88/209.10  |- skos__scopeNote mesh__D001634
% 208.88/209.10       A list of works, documents or other publications, usually with some relationship between them, e.g., by a given author, on a given subject, or published in a given place, and differing from a catalog in that its contents are restricted to holdings of a single collection, library, or group of libraries. %28%The ALA Glossary of Library and Information Science, 1983%29%%A%    
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D001634 2006
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D001634 2000
% 208.88/209.10  |- skos__annotation mesh__D001634
% 208.88/209.10       IM for bibliog as a subject: do not confuse with Publication Type BIBLIOGRAPHY; for bibliog on specific subject, index under subject %28%IM%29% + BIBLIOGRAPHY %28%PT%29%; no qualif; policy: Manual 17.4.+, 33.4-33.9, 36.22; TN 121: differentiate from LITERATURE; med bibliog: see note on BIBLIOGRAPHY OF MEDICINE; lists of books: consider also BOOK SELECTION; DF: BIBLIOGR%A%  
% 208.88/209.10  |- mesh__recordAuthorizer mesh__D001634 sjn
% 208.88/209.10  |- skos__related mesh__D001634smesh__D004282
% 208.88/209.10  |- mesh__historyNote mesh__D001634
% 208.88/209.10       for articles that were or contained bibliographies 1963-90%A%  
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D001634 2003
% 208.88/209.10  |- rdf__type mesh__D001634sskos__Concept
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D001634 2001
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D001634 2004
% 208.88/209.10  |- skos__hiddenLabel mesh__D001634 Bibliographies
% 208.88/209.10  |- skos__broader mesh__D020599smesh__D020583
% 208.88/209.10  |- mesh__dateEstablished mesh__D020599 2000-01-01
% 208.88/209.10  |- mesh__dateCreated mesh__D020599 1999-11-03
% 208.88/209.10  |- skos__historyNote mesh__D020599 Rhizobiaceae/genetics %28%1988-1999%29%
% 208.88/209.10  |- rdf__type mesh__D020599sskos__Concept
% 208.88/209.10  |- mesh__historyNote mesh__D020599 2000   
% 208.88/209.10  |- mesh__recordOriginator mesh__D020599 ndw
% 208.88/209.10  |- mesh__recordMaintainer mesh__D020599 SYSTEM
% 208.88/209.10  |- mesh__publicMeSHNote mesh__D020599 2000   
% 208.88/209.10  |- mesh__dateRevised mesh__D020599 2005-06-30
% 208.88/209.10  |- skos__scopeNote mesh__D020599
% 208.88/209.10       A species of AZORHIZOBIUM which forms nodules on the roots of the tropical legume Sesbania rostrata. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 208.88/209.10  |- skos__prefLabel mesh__D020599 Azorhizobium caulinodans
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D020599 2006
% 208.88/209.10  |- mesh__recordAuthorizer mesh__D020599 sjn
% 208.88/209.10  |- skos__altLabel mesh__D019247 AIDS Wasting Syndrome
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D019247 2003
% 208.88/209.10  |- mesh__dateEstablished mesh__D019247 1997-01-01
% 208.88/209.10  |- mesh__recordMaintainer mesh__D019247 ags
% 208.88/209.10  |- mesh__recordAuthorizer mesh__D019247 sjn
% 208.88/209.10  |- skos__altLabel mesh__D019247 Wasting Disease, HIV
% 208.88/209.10  |- skos__altLabel mesh__D019247 HIV Wasting Disease
% 208.88/209.10  |- mesh__dateCreated mesh__D019247 1996-06-10
% 208.88/209.10  |- skos__altLabel mesh__D019247 Wasting Syndrome, HIV
% 208.88/209.10  |- skos__hiddenLabel mesh__D019247 Wasting Syndrome, AIDS
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D019247 2002
% 208.88/209.10  |- mesh__recordOriginator mesh__D019247 AGS
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D019247 2006
% 208.88/209.10  |- skos__prefLabel mesh__D019247 HIV Wasting Syndrome
% 208.88/209.10  |- skos__historyNote mesh__D019247 HIV Infections %28%1991-1996%29%
% 208.88/209.10  |- rdf__type mesh__D019247sskos__Concept
% 208.88/209.10  |- skos__altLabel mesh__D019247 Slim Disease
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D019247 2005
% 208.88/209.10  |- skos__broader mesh__D019247smesh__D015658
% 208.88/209.10  |- mesh__dateRevised mesh__D019247 2001-07-25
% 208.88/209.10  |- mesh__publicMeSHNote mesh__D019247 97   
% 208.88/209.10  |- mesh__historyNote mesh__D019247 97   
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D019247 2004
% 208.88/209.10  |- skos__scopeNote mesh__D019247
% 208.88/209.10       Involuntary weight loss of greater than 10 percent associated with intermittent or constant fever and chronic diarrhea or fatigue for more than 30 days in the absence of a defined cause other than HIV infection. A constant feature is major muscle wasting with scattered myofiber degeneration. A variety of etiologies, which vary among patients, contributes to this syndrome. %28%From Harrison%27%s Principles of Internal Medicine, 13th ed, p1611%29%.%A%    
% 208.88/209.10  |- skos__broader mesh__D019247smesh__D019282
% 208.88/209.10  |- skos__historyNote mesh__D011264 Gestational Age %28%1968-1974%29%
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D011264 2005
% 208.88/209.10  |- mesh__historyNote mesh__D011264 98; use explode 1975-97   
% 208.88/209.10  |- mesh__recordAuthorizer mesh__D011264 sjn
% 208.88/209.10  |- mesh__dateEstablished mesh__D011264 1998-01-01
% 208.88/209.10  |- skos__hiddenLabel mesh__D011264 Trimester, Pregnancy
% 208.88/209.10  |- mesh__publicMeSHNote mesh__D011264 98   
% 208.88/209.10  |- rdf__type mesh__D011264sskos__Concept
% 208.88/209.10  |- mesh__dateCreated mesh__D011264 1999-01-01
% 208.88/209.10  |- skos__annotation mesh__D011264
% 208.88/209.10       human only; GEN or unspecified; prefer specifics; trimesters are indexed only when the point of the article or substantively discussed: they are not sought out routinely nor indexed when merely mentioned; DF: PREGN TRIMESTERS%A%  
% 208.88/209.10  |- skos__historyNote mesh__D011264 specific trimester %28%1975-1997%29%
% 208.88/209.10  |- skos__broader mesh__D011264smesh__D011247
% 208.88/209.10  |- mesh__recordMaintainer mesh__D011264 sjn
% 208.88/209.10  |- skos__hiddenLabel mesh__D011264 Pregnancy Trimester
% 208.88/209.10  |- skos__prefLabel mesh__D011264 Pregnancy Trimesters
% 208.88/209.10  |- skos__historyNote mesh__D011264 Time Factors %28%1967-1974%29%
% 208.88/209.10  |- mesh__dateRevised mesh__D011264 2004-07-13
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D011264 2006
% 208.88/209.10  |- skos__altLabel mesh__D011264 Trimesters, Pregnancy
% 208.88/209.10  |- mesh__recordOriginator mesh__D011264 NLM
% 208.88/209.10  |- skos__historyNote mesh__D011264 Pregnancy %28%1966-1974%29%
% 208.88/209.10  |- skos__scopeNote mesh__D011264
% 208.88/209.10       The three approximately equal periods of a normal human PREGNANCY. Each trimester is about three months or 13 to 14 weeks in duration depending on the designation of the first day of gestation.%A%    
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D005227 2005
% 208.88/209.10  |- mesh__recordMaintainer mesh__D005227 ssb
% 208.88/209.10  |- mesh__historyNote mesh__D005227
% 208.88/209.10       /metabolism was FATTY ACID METABOLISM 1965   
% 208.88/209.10  |- skos__hiddenLabel mesh__D005227 Saturated Fatty Acids
% 208.88/209.10  |- skos__hiddenLabel mesh__D005227 Acids, Saturated Fatty
% 208.88/209.10  |- mesh__publicMeSHNote mesh__D005227
% 208.88/209.10       /metabolism was FATTY ACID METABOLISM 1965; SODIUM MORRHUATE was see under SCLEROSING SOLUTIONS 1963-74%A%  
% 208.88/209.10  |- skos__hiddenLabel mesh__D005227 Acids, Esterified Fatty
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D005227 2006
% 208.88/209.10  |- skos__broader mesh__D005227smesh__D008055
% 208.88/209.10  |- skos__scopeNote mesh__D005227
% 208.88/209.10       Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated %28%FATTY ACIDS, UNSATURATED%29%. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D005227 2004
% 208.88/209.10  |- skos__prefLabel mesh__D005227 Fatty Acids
% 208.88/209.10  |- mesh__recordAuthorizer mesh__D005227 sjn
% 208.88/209.10  |- skos__hiddenLabel mesh__D005227 Esterified Fatty Acids
% 208.88/209.10  |- mesh__dateRevised mesh__D005227 2003-07-09
% 208.88/209.10  |- mesh__recordOriginator mesh__D005227 NLM
% 208.88/209.10  |- skos__hiddenLabel mesh__D005227 Acids, Fatty
% 208.88/209.10  |- mesh__dateCreated mesh__D005227 1999-01-01
% 208.88/209.10  |- skos__hiddenLabel mesh__D005227 Acids, Aliphatic
% 208.88/209.10  |- rdf__type mesh__D005227sskos__Concept
% 208.88/209.10  |- mesh__historyNote mesh__D015655 90   
% 208.88/209.10  |- skos__hiddenLabel mesh__D015655 1 Methyl 4 phenylpyridinium Ion
% 208.88/209.10  |- skos__hiddenLabel mesh__D015655 1 Methyl 4 phenylpyridinium
% 208.88/209.10  |- skos__prefLabel mesh__D015655 1-Methyl-4-phenylpyridinium
% 208.88/209.10  |- mesh__dateRevised mesh__D015655 2001-07-25
% 208.88/209.10  |- rdf__type mesh__D015655sskos__Concept
% 208.88/209.10  |- skos__altLabel mesh__D015655 N-Methyl-4-phenylpyridinium
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D015655 2004
% 208.88/209.10  |- mesh__recordOriginator mesh__D015655 RLS
% 208.88/209.10  |- skos__scopeNote mesh__D015655
% 208.88/209.10       An active neurotoxic metabolite of 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE. The compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. These and other toxic effects lead to cessation of oxidative phosphorylation, ATP depletion, and cell death. The compound, which is related to PARAQUAT, has also been used as an herbicide.%A%    
% 208.88/209.10  |- skos__altLabel mesh__D015655 1-Methyl-4-phenylpyridinium Ion
% 208.88/209.10  |- skos__hiddenLabel mesh__D015655 1 Methyl 4 phenylpyridinium Chloride
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D015655 2003
% 208.88/209.10  |- skos__hiddenLabel mesh__D015655 1 Methyl 4 phenylpyridine
% 208.88/209.10  |- skos__altLabel mesh__D015655 N-Methyl-4-phenylpyridine
% 208.88/209.10  |- skos__altLabel mesh__D015655 1-Methyl-4-phenylpyridine
% 208.88/209.10  |- mesh__publicMeSHNote mesh__D015655 90   
% 208.88/209.10  |- mesh__dateCreated mesh__D015655 1989-05-16
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D015655 2006
% 208.88/209.10  |- skos__altLabel mesh__D015655 Cyperquat
% 208.88/209.10  |- skos__broader mesh__D015655smesh__D011726
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D015655 2002
% 208.88/209.10  |- mesh__dateEstablished mesh__D015655 1990-01-01
% 208.88/209.10  |- skos__related mesh__D015655smesh__D020267
% 208.88/209.10  |- skos__historyNote mesh__D015655 Pyridinium Compounds %28%1968-1989%29%
% 208.88/209.10  |- skos__hiddenLabel mesh__D015655 N Methyl 4 phenylpyridine
% 208.88/209.10  |- mesh__recordAuthorizer mesh__D015655 sjn
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D015655 2005
% 208.88/209.10  |- mesh__recordMaintainer mesh__D015655 ssb
% 208.88/209.10  |- mesh__recordMaintainer mesh__D048031 jls
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D048031 2005A
% 208.88/209.10  |- skos__altLabel mesh__D048031 c-jun Amino-Terminal Kinase
% 208.88/209.10  |- skos__hiddenLabel mesh__D048031 c jun N Terminal Kinase
% 208.88/209.10  |- skos__scopeNote mesh__D048031
% 208.88/209.10       A subgroup of mitogen-activated protein kinases that activate TRANSCRIPTION FACTOR AP-1 via the phosphorylation of C-JUN PROTEINS. They are components of intracellular signaling pathways that regulate CELL PROLIFERATION; APOPTOSIS; and CELL DIFFERENTIATION.%A%    
% 208.88/209.10  |- skos__hiddenLabel mesh__D048031 jun NH2 Terminal Kinases
% 208.88/209.10  |- skos__historyNote mesh__D048031
% 208.88/209.10       Ca%28%2+%29%-Calmodulin Dependent Protein Kinase %28%1995-1999%29%
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D048031 2006
% 208.88/209.10  |- rdf__type mesh__D048031sskos__Concept
% 208.88/209.10  |- skos__altLabel mesh__D048031 jun-NH2-Terminal Kinase
% 208.88/209.10  |- skos__annotation mesh__D048031 note specifics   
% 208.88/209.10  |- mesh__dateCreated mesh__D048031 2004-07-07
% 208.88/209.10  |- skos__hiddenLabel mesh__D048031 JNK Mitogen Activated Protein Kinases
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D048031 2005
% 208.88/209.10  |- skos__broader mesh__D048031smesh__D020928
% 208.88/209.10  |- mesh__publicMeSHNote mesh__D048031
% 208.88/209.10       2005; JNK MITOGEN-ACTIVATED PROTEIN KINASES was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004, CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1995-1999 %26% under PROTEIN-SERINE-THREONINE KINASES 1993-1994%A%  
% 208.88/209.10  |- mesh__recordOriginator mesh__D048031 jmp
% 208.88/209.10  |- skos__historyNote mesh__D048031
% 208.88/209.10       Mitogen-Activated Protein Kinases %28%2000-2004%29%
% 208.88/209.10  |- skos__prefLabel mesh__D048031 JNK Mitogen-Activated Protein Kinases
% 208.88/209.10  |- skos__hiddenLabel mesh__D048031 jun NH2 Terminal Kinase
% 208.88/209.10  |- skos__hiddenLabel mesh__D048031 c jun Amino Terminal Kinase
% 208.88/209.10  |- skos__hiddenLabel mesh__D048031 Amino-Terminal Kinase, c-jun
% 208.88/209.10  |- skos__altLabel mesh__D048031 c-jun N-Terminal Kinase
% 208.88/209.10  |- mesh__recordAuthorizer mesh__D048031 jls
% 208.88/209.10  |- mesh__dateEstablished mesh__D048031 2005-01-01
% 208.88/209.10  |- skos__hiddenLabel mesh__D048031 N-Terminal Kinase, c-jun
% 208.88/209.10  |- skos__altLabel mesh__D048031 jun-NH2-Terminal Kinases
% 208.88/209.10  |- mesh__historyNote mesh__D048031 2005   
% 208.88/209.10  |- mesh__dateRevised mesh__D048031 2004-07-28
% 208.88/209.10  |- skos__historyNote mesh__D048031
% 208.88/209.10       Protein-Serine-Threonine Kinases %28%1993-1994%29%
% 208.88/209.10  |- mesh__recordOriginator mesh__D009618 JW
% 208.88/209.10  |- mesh__publicMeSHNote mesh__D009618 76   
% 208.88/209.10  |- skos__historyNote mesh__D009618 Actinomycetaceae %28%1975%29%
% 208.88/209.10  |- mesh__recordAuthorizer mesh__D009618 sjn
% 208.88/209.10  |- skos__historyNote mesh__D009618 Actinomycetales %28%1966-1974%29%
% 208.88/209.10  |- skos__prefLabel mesh__D009618 Nocardiaceae
% 208.88/209.10  |- skos__annotation mesh__D009618 in soil, animals %26% man   
% 208.88/209.10  |- skos__scopeNote mesh__D009618
% 208.88/209.10       A family of gram-positive, aerobic actinomycetes found in soil and animal tissue. Some species are the cause of infection in man and animals.%A%    
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D009618 2006
% 208.88/209.10  |- skos__broader mesh__D009618smesh__D000192
% 208.88/209.10  |- rdf__type mesh__D009618sskos__Concept
% 208.88/209.10  |- mesh__dateCreated mesh__D009618 1975-07-18
% 208.88/209.10  |- mesh__dateRevised mesh__D009618 2005-06-30
% 208.88/209.10  |- mesh__recordMaintainer mesh__D009618 SYSTEM
% 208.88/209.10  |- mesh__dateEstablished mesh__D009618 1976-01-01
% 208.88/209.10  |- mesh__historyNote mesh__D009618 76   
% 208.88/209.10  |- skos__annotation mesh__D001635
% 208.88/209.10       IM for bibliog of med as a subject; do not use for specific medical subjects: use BIBLIOGRAPHY instead but see note there; no qualif; Manual 33.9; DF: BIBLIOG MED or BIBLIOGR MED%A%  
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D001635 2006
% 208.88/209.10  |- mesh__activeMeSHYear mesh__D001635 2001
% 208.88/209.11  |- skos__altLabel mesh__D001635 Medicine, Bibliography
% 208.88/209.11  |- rdf__type mesh__D001635sskos__Concept
% 208.88/209.11  |- skos__altLabel mesh__D001635 Bibliographies, Medical
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D001635 2003
% 208.88/209.11  |- skos__prefLabel mesh__D001635 Bibliography of Medicine
% 208.88/209.11  |- mesh__dateRevised mesh__D001635 1999-11-03
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D001635 2004
% 208.88/209.11  |- mesh__recordMaintainer mesh__D001635 kle
% 208.88/209.11  |- skos__hiddenLabel mesh__D001635 Medicine Bibliography
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D001635 2002
% 208.88/209.11  |- skos__hiddenLabel mesh__D001635 Medicine Bibliographies
% 208.88/209.11  |- skos__altLabel mesh__D001635 Medical Bibliographies
% 208.88/209.11  |- mesh__recordOriginator mesh__D001635 NLM
% 208.88/209.11  |- mesh__dateCreated mesh__D001635 1999-01-01
% 208.88/209.11  |- skos__broader mesh__D001635smesh__D001634
% 208.88/209.11  |- skos__altLabel mesh__D001635 Bibliography, Medical
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D001635 2005
% 208.88/209.11  |- skos__altLabel mesh__D001635 Medical Bibliography
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D001635 2000
% 208.88/209.11  |- mesh__recordAuthorizer mesh__D001635 sjn
% 208.88/209.11  |- skos__altLabel mesh__D001635 Medicine, Bibliographies
% 208.88/209.11  |- skos__scopeNote mesh__D001635
% 208.88/209.11       A list of works, documents, and other publications on medical subjects and topics of interest to the field of medicine.%A%    
% 208.88/209.11  |- mesh__recordOriginator mesh__D006320 NLM
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006320 2006
% 208.88/209.11  |- skos__hiddenLabel mesh__D006320 Test, Hearing
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006320 2002
% 208.88/209.11  |- mesh__recordAuthorizer mesh__D006320 SJN
% 208.88/209.11  |- skos__broader mesh__D006320smesh__D003939
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006320 2003
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006320 2004
% 208.88/209.11  |- skos__prefLabel mesh__D006320 Hearing Tests
% 208.88/209.11  |- mesh__dateCreated mesh__D006320 1999-01-01
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006320 2000
% 208.88/209.11  |- skos__annotation mesh__D006320 NIM   
% 208.88/209.11  |- mesh__dateRevised mesh__D006320 1997-06-20
% 208.88/209.11  |- rdf__type mesh__D006320sskos__Concept
% 208.88/209.11  |- skos__hiddenLabel mesh__D006320 Hearing Test
% 208.88/209.11  |- mesh__recordMaintainer mesh__D006320 PXP
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006320 1998
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006320 2001
% 208.88/209.11  |- skos__hiddenLabel mesh__D006320 Tests, Hearing
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006320 1999
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006320 2005
% 208.88/209.11  |- skos__broader mesh__D006281Q000364smesh__D006281
% 208.88/209.11  |- mesh__preferredCombination mesh__D006281Q000364smesh__D006280
% 208.88/209.11  |- rdf__type mesh__D006281Q000364smesh__CompoundConcept
% 208.88/209.11  |- mesh__publicMeSHNote mesh__D019248 97   
% 208.88/209.11  |- skos__hiddenLabel mesh__D019248 Technic, Jaw Fixation
% 208.88/209.11  |- skos__hiddenLabel mesh__D019248 Technique, Jaw Fixation
% 208.88/209.11  |- skos__scopeNote mesh__D019248
% 208.88/209.11       The stable placement of surgically induced fractures of the mandible or maxilla through the use of elastics, wire ligatures, arch bars, or other splints. It is used often in the cosmetic surgery of retrognathism and prognathism. %28%From Dorland, 28th ed, p636%29%%A%    
% 208.88/209.11  |- skos__hiddenLabel mesh__D019248 Fixation Technics, Jaw
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D019248 2006
% 208.88/209.11  |- mesh__recordAuthorizer mesh__D019248 SJN
% 208.88/209.11  |- mesh__dateEstablished mesh__D019248 1997-01-01
% 208.88/209.11  |- rdf__type mesh__D019248sskos__Concept
% 208.88/209.11  |- skos__hiddenLabel mesh__D019248 Fixation Techniques, Jaw
% 208.88/209.11  |- skos__hiddenLabel mesh__D019248 Jaw Fixation Technique
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D019248 2005
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D019248 1999
% 208.88/209.11  |- mesh__dateCreated mesh__D019248 1996-06-10
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D019248 2002
% 208.88/209.11  |- skos__hiddenLabel mesh__D019248 Maxillomandibular Fixations
% 208.88/209.11  |- skos__altLabel mesh__D019248 Jaw Fixation Technics
% 208.88/209.11  |- skos__hiddenLabel mesh__D019248 Jaw Fixation Technic
% 208.88/209.11  |- mesh__recordOriginator mesh__D019248 TGC
% 208.88/209.11  |- mesh__historyNote mesh__D019248 97   
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D019248 1998
% 208.88/209.11  |- skos__hiddenLabel mesh__D019248 Technics, Jaw Fixation
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D019248 2004
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D019248 2001
% 208.88/209.11  |- skos__hiddenLabel mesh__D019248 Fixation Technic, Jaw
% 208.88/209.11  |- mesh__dateRevised mesh__D019248 1997-06-20
% 208.88/209.11  |- skos__broader mesh__D019248smesh__D019647
% 208.88/209.11  |- skos__hiddenLabel mesh__D019248 Fixation Technique, Jaw
% 208.88/209.11  |- mesh__recordMaintainer mesh__D019248 PXP
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D019248 2003
% 208.88/209.11  |- skos__hiddenLabel mesh__D019248 Fixation, Maxillomandibular
% 208.88/209.11  |- skos__annotation mesh__D019248
% 208.88/209.11       coord IM with MANDIBLE /surg or MAXILLA /surg %28%IM%29%; MANDIBULAR ADVANCEMENT is also available%A%  
% 208.88/209.11  |- skos__prefLabel mesh__D019248 Jaw Fixation Techniques
% 208.88/209.11  |- skos__hiddenLabel mesh__D019248 Techniques, Jaw Fixation
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D019248 2000
% 208.88/209.11  |- skos__hiddenLabel mesh__D019248 Fixations, Maxillomandibular
% 208.88/209.11  |- mesh__recordOriginator mesh__D005228 NLM
% 208.88/209.11  |- skos__annotation mesh__D005228
% 208.88/209.11       GEN or unspecified; prefer specific groups or specific acid%A%  
% 208.88/209.11  |- rdf__type mesh__D005228sskos__Concept
% 208.88/209.11  |- mesh__dateRevised mesh__D005228 2003-07-09
% 208.88/209.11  |- skos__hiddenLabel mesh__D005228 Essential Fatty Acids
% 208.88/209.11  |- skos__broader mesh__D005228smesh__D005231
% 208.88/209.11  |- skos__hiddenLabel mesh__D005228 Acids, Essential Fatty
% 208.88/209.11  |- mesh__recordMaintainer mesh__D005228 ssb
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D005228 2004
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D005228 2006
% 208.88/209.11  |- skos__prefLabel mesh__D005228 Fatty Acids, Essential
% 208.88/209.11  |- mesh__dateCreated mesh__D005228 1999-01-01
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D005228 2005
% 208.88/209.11  |- mesh__recordAuthorizer mesh__D005228 sjn
% 208.88/209.11  |- skos__scopeNote mesh__D005228
% 208.88/209.11       Long chain organic acid molecules that must be obtained from the diet. Examples are LINOLEIC ACIDS and LINOLENIC ACIDS.%A%    
% 208.88/209.11  |- rdf__type mesh__D015656sskos__Concept
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D015656 2004
% 208.88/209.11  |- skos__related mesh__D015656smesh__D008170
% 208.88/209.11  |- mesh__recordMaintainer mesh__D015656 jls
% 208.88/209.11  |- skos__related mesh__D015656smesh__D000403
% 208.88/209.11  |- skos__hiddenLabel mesh__D015656 Breathing Mechanic
% 208.88/209.11  |- skos__hiddenLabel mesh__D015656 Mechanic, Respiratory
% 208.88/209.11  |- mesh__dateRevised mesh__D015656 2004-08-02
% 208.88/209.11  |- mesh__historyNote mesh__D015656 90   
% 208.88/209.11  |- skos__hiddenLabel mesh__D015656 Respiratory Mechanic
% 208.88/209.11  |- skos__broader mesh__D015656smesh__D012119
% 208.88/209.11  |- skos__prefLabel mesh__D015656 Respiratory Mechanics
% 208.88/209.11  |- mesh__publicMeSHNote mesh__D015656 90   
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D015656 2006
% 208.88/209.11  |- skos__historyNote mesh__D015656 Respiration %28%1966-1989%29%
% 208.88/209.11  |- mesh__dateEstablished mesh__D015656 1990-01-01
% 208.88/209.11  |- mesh__recordAuthorizer mesh__D015656 jls
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D015656 2005
% 208.88/209.11  |- skos__scopeNote mesh__D015656
% 208.88/209.11       The physical or mechanical action of the LUNGS; DIAPHRAGM; RIBS; and CHEST WALL during respiration. It includes airflow, lung volume, neural and reflex controls, mechanoreceptors, breathing patterns, etc.%A%    
% 208.88/209.11  |- skos__hiddenLabel mesh__D015656 Mechanics, Breathing
% 208.88/209.11  |- mesh__dateCreated mesh__D015656 1989-05-16
% 208.88/209.11  |- skos__hiddenLabel mesh__D015656 Mechanic, Breathing
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D015656 2005A
% 208.88/209.11  |- skos__hiddenLabel mesh__D015656 Mechanics, Respiratory
% 208.88/209.11  |- skos__altLabel mesh__D015656 Breathing Mechanics
% 208.88/209.11  |- mesh__recordOriginator mesh__D015656 TGC
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D009619 2000
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D009619 2003
% 208.88/209.11  |- skos__annotation mesh__D009619
% 208.88/209.11       sensory receptors for pain; DF: NOCICEPT   
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D009619 1994
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D009619 2006
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D009619 2001
% 208.88/209.11  |- skos__scopeNote mesh__D009619
% 208.88/209.11       Peripheral receptors for pain. Nociceptors include receptors which are sensitive to painful mechanical stimuli, extreme heat or cold, and chemical stimuli. All nociceptors are free nerve endings.%A%    
% 208.88/209.11  |- skos__historyNote mesh__D009619 Pain %28%1966-1977%29%
% 208.88/209.11  |- skos__historyNote mesh__D009619 Neurons, Afferent %28%1969-1977%29%
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D009619 1998
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D009619 2004
% 208.88/209.11  |- mesh__recordOriginator mesh__D009619 RC
% 208.88/209.11  |- rdf__type mesh__D009619sskos__Concept
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D009619 1995
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D009619 1996
% 208.88/209.11  |- skos__hiddenLabel mesh__D009619 Pain Receptor
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D009619 2002
% 208.88/209.11  |- skos__broader mesh__D009619smesh__D011984
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D009619 1999
% 208.88/209.11  |- skos__altLabel mesh__D009619 Receptors, Pain
% 208.88/209.11  |- skos__prefLabel mesh__D009619 Nociceptors
% 208.88/209.11  |- skos__altLabel mesh__D009619 Pain Receptors
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D009619 1997
% 208.88/209.11  |- mesh__dateCreated mesh__D009619 1977-04-11
% 208.88/209.11  |- mesh__dateRevised mesh__D009619 1993-06-18
% 208.88/209.11  |- mesh__recordMaintainer mesh__D009619 RAZ
% 208.88/209.11  |- mesh__historyNote mesh__D009619 78   
% 208.88/209.11  |- mesh__dateEstablished mesh__D009619 1978-01-01
% 208.88/209.11  |- mesh__recordAuthorizer mesh__D009619 PLS
% 208.88/209.11  |- skos__hiddenLabel mesh__D009619 Receptor, Pain
% 208.88/209.11  |- mesh__publicMeSHNote mesh__D009619 78   
% 208.88/209.11  |- skos__hiddenLabel mesh__D009619 Nociceptor
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D009619 2005
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D001636 2000
% 208.88/209.11  |- skos__altLabel mesh__D001636 Descriptive Bibliographies
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D001636 2004
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D001636 1997
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D001636 2001
% 208.88/209.11  |- mesh__dateCreated mesh__D001636 1999-01-01
% 208.88/209.11  |- mesh__recordAuthorizer mesh__D001636 PLS
% 208.88/209.11  |- skos__altLabel mesh__D001636 Bibliographies, Descriptive
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D001636 2005
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D001636 1998
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D001636 2002
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D001636 1995
% 208.88/209.11  |- mesh__historyNote mesh__D001636 INSCRIPTIONS was heading 1963-65   
% 208.88/209.11  |- mesh__publicMeSHNote mesh__D001636 INSCRIPTIONS was heading 1963-65   
% 208.88/209.11  |- skos__scopeNote mesh__D001636
% 208.88/209.11       The area of bibliography which makes known precisely the material conditions of books, i.e., the full name of the author, the exact title of the work, the date and place of publication, the publisher%27%s and printer%27%s names, the format, the pagination, typographical particulars, illustrations, and the price, and for old books, other characteristics such as the kind of paper, binding, etc. It is also called analytical bibliography and physical bibliography. %28%Harrod%27%s Librarians%27% Glossary, 7th ed%29%%A%    
% 208.88/209.11  |- skos__prefLabel mesh__D001636 Bibliography, Descriptive
% 208.88/209.11  |- mesh__dateRevised mesh__D001636 1994-05-31
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D001636 2006
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D001636 1999
% 208.88/209.11  |- skos__altLabel mesh__D001636 Descriptive Bibliography
% 208.88/209.11  |- mesh__recordOriginator mesh__D001636 NLM
% 208.88/209.11  |- mesh__recordMaintainer mesh__D001636 TGC
% 208.88/209.11  |- skos__broader mesh__D001636smesh__D001634
% 208.88/209.11  |- rdf__type mesh__D001636sskos__Concept
% 208.88/209.11  |- skos__annotation mesh__D001636
% 208.88/209.11       cataloging term; no qualif; DF: BIBLIOG DESCRIPTIVE or BIBLIOGR DESCRIPTIVE%A%  
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D001636 2003
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D001636 1996
% 208.88/209.11  |- rdf__type mesh__D006321sskos__Concept
% 208.88/209.11  |- skos__related mesh__D006321smesh__D000790
% 208.88/209.11  |- skos__related mesh__D006321smesh__D000889
% 208.88/209.11  |- mesh__dateRevised mesh__D006321 2000-06-22
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006321 2006
% 208.88/209.11  |- skos__scopeNote mesh__D006321
% 208.88/209.11       The hollow, muscular organ that maintains the circulation of the blood.%A%    
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006321 2001
% 208.88/209.11  |- mesh__considerAlso mesh__D006321
% 208.88/209.11       consider also terms at CARDI- and MYOCARDI-   
% 208.88/209.11  |- skos__related mesh__D006321smesh__D002316
% 208.88/209.11  |- mesh__recordOriginator mesh__D006321 NLM
% 208.88/209.11  |- skos__related mesh__D006321smesh__D004562
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006321 2005
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006321 2004
% 208.88/209.11  |- skos__prefLabel mesh__D006321 Heart
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006321 2003
% 208.88/209.11  |- skos__related mesh__D006321smesh__D001450
% 208.88/209.11  |- mesh__recordAuthorizer mesh__D006321 sjn
% 208.88/209.11  |- mesh__recordMaintainer mesh__D006321 nns
% 208.88/209.11  |- skos__broader mesh__D006321smesh__D002319
% 208.88/209.11  |- skos__annotation mesh__D006321
% 208.88/209.11       heart as pump, not tissue %28%MYOCARDIUM%29%; qualif permitted: /anat /drug eff /embryol %28%FETAL HEART also exists%29% /growth /innerv %28%HEART CONDUCTION SYSTEM also exists%29% /microbiol /parasitol /physiol %28%see also ATRIAL FUNCTION %26% VENTRICULAR FUNCTION %26% their specifics; see also MYOCARDIAL CONTRACTION %26% its specifics%29% /physiopathol /rad eff /radiogr %28%do not confuse with ANGIOCARDIOGRAPHY%29% /radionuclide /virol; /blood supply = CORONARY VESSELS but consider also CORONARY CIRCULATION; /drug eff: consider also MYOCARDIAL DEPRESSANTS see ANTI-ARRHYTHMIA AGENTS %26% CARDIOTONIC AGENTS; /transpl = HEART TRANSPLANTATION: do not coord with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; /ultrasonogr = ECHOCARDIOGRAPHY or ECHOCARDIOGRAPHY, DOPPLER; inotropism: INOTROPISM, CARDIAC see MYOCARDIAL CONTRACTION %26% INOTROPIC AGENTS, POSITIVE CARDIAC are available but see MYOCARDIAL CONTRACTION note; chronotropism: see HEART RATE note; DIASTOLE %26% SYSTOLE are also available; heart-lung prep: index HEART /physiol %28%probably NIM%29%; Manual 21.48+; carditis = MYOCARDITIS; mural thrombosis: index HEART DIS %28%IM%29% + THROMBOSIS %28%IM%29%%A%  
% 208.88/209.11  |- skos__related mesh__D006321smesh__D009206
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006321 2002
% 208.88/209.11  |- mesh__dateCreated mesh__D006321 1999-01-01
% 208.88/209.11  |- skos__altLabel mesh__D006321 Hearts
% 208.88/209.11  |- skos__altLabel mesh__D011266
% 208.88/209.11       Insulin-Like Growth Factor-Dependent IGF Binding Protein-4 Protease
% 208.88/209.11  |- skos__historyNote mesh__D011266 Glycoproteins %28%1966-1979%29%
% 208.88/209.11  |- skos__hiddenLabel mesh__D011266
% 208.88/209.11       Insulin Like Growth Factor Dependent IGF Binding Protein 4 Protease
% 208.88/209.11  |- skos__historyNote mesh__D011266 Alpha Macroglobulins %28%1976-1979%29%
% 208.88/209.11  |- skos__broader mesh__D011266smesh__D008666
% 208.88/209.11  |- skos__altLabel mesh__D011266
% 208.88/209.11       Insulin-Like-Growth Factor Binding Protein-4 Protease
% 208.88/209.11  |- mesh__publicMeSHNote mesh__D011266
% 208.88/209.11       2004; for PREGNANCY-ASSOCIATED ALPHA-PLASMA PROTEIN see PREGNANCY-ASSOCIATED ALPHA-PLASMA PROTEIN 1991-2003, see PREGNANCY PROTEINS 1980-1990%A%  
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D011266 2006
% 208.88/209.11  |- skos__scopeNote mesh__D011266
% 208.88/209.11       A product of the PLACENTA, and DECIDUA, secreted into the maternal circulation during PREGNANCY. It has been identified as an IGF binding protein %28%IGFBP%29%-4 protease that proteolyzes IGFBP-4 and thus increases IGF bioavailability. It is found also in human FIBROBLASTS, ovarian FOLLICULAR FLUID, and GRANULOSA CELLS. The enzyme is a heterotetramer of about 500-kDa.%A%    
% 208.88/209.11  |- skos__altLabel mesh__D011266 PAPP-alpha
% 208.88/209.11  |- mesh__historyNote mesh__D011266 2004 %28%1996%29%   
% 208.88/209.11  |- skos__hiddenLabel mesh__D011266
% 208.88/209.11       Insulin Like Growth Factor Binding Protein 4 Protease
% 208.88/209.11  |- skos__broader mesh__D011266smesh__D011257
% 208.88/209.11  |- skos__prefLabel mesh__D011266 Pregnancy-Associated Plasma Protein-A
% 208.88/209.11  |- mesh__dateEstablished mesh__D011266 1991-01-01
% 208.88/209.11  |- skos__altLabel mesh__D011266 PAPP-A
% 208.88/209.11  |- mesh__dateRevised mesh__D011266 2004-07-13
% 208.88/209.11  |- skos__historyNote mesh__D011266 Pregnancy %28%1966-1979%29%
% 208.88/209.11  |- mesh__dateCreated mesh__D011266 1979-02-22
% 208.88/209.11  |- skos__historyNote mesh__D011266 Blood Proteins %28%1966-1979%29%
% 208.88/209.11  |- skos__altLabel mesh__D011266 Pregnancy-Associated alpha-Plasma Protein
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D011266 2005
% 208.88/209.11  |- mesh__recordOriginator mesh__D011266 RLS
% 208.88/209.11  |- skos__altLabel mesh__D011266 IGFBP-4-Specific Proteinase
% 208.88/209.11  |- skos__hiddenLabel mesh__D011266 Metalloproteinase, IGFBP-4
% 208.88/209.11  |- mesh__recordAuthorizer mesh__D011266 sjn
% 208.88/209.11  |- rdf__type mesh__D011266sskos__Concept
% 208.88/209.11  |- skos__altLabel mesh__D011266 IGFBP-4 Metalloproteinase
% 208.88/209.11  |- skos__hiddenLabel mesh__D011266 PAPP alpha
% 208.88/209.11  |- skos__hiddenLabel mesh__D011266 IGFBP 4 Protease
% 208.88/209.11  |- skos__hiddenLabel mesh__D011266 Protease, IGFBP-4
% 208.88/209.11  |- skos__hiddenLabel mesh__D011266 IGFBP 4 Metalloproteinase
% 208.88/209.11  |- skos__altLabel mesh__D011266 IGFBP-4 Protease
% 208.88/209.11  |- mesh__recordMaintainer mesh__D011266 sjn
% 208.88/209.11  |- skos__hiddenLabel mesh__D011266 Pregnancy Associated Plasma Protein A
% 208.88/209.11  |- skos__historyNote mesh__D011266 Alpha Globulins %28%1966-1979%29%
% 208.88/209.11  |- skos__altLabel mesh__D011266 Pregnancy Associated alpha Plasma Protein
% 208.88/209.11  |- rdf__type mesh__D005229sskos__Concept
% 208.88/209.11  |- skos__historyNote mesh__D005229 Fatty Acids %28%1966-1972%29%
% 208.88/209.11  |- mesh__historyNote mesh__D005229
% 208.88/209.11       88; MONOUNSATURATED FATTY ACIDS was see FATTY ACIDS, MONOUNSATURATED 1988-93%A%  
% 208.88/209.11  |- mesh__dateCreated mesh__D005229 1987-03-31
% 208.88/209.11  |- mesh__recordMaintainer mesh__D005229 ssb
% 208.88/209.11  |- skos__hiddenLabel mesh__D005229 Acids, Monounsaturated Fatty
% 208.88/209.11  |- skos__hiddenLabel mesh__D005229 Monounsaturated Fatty Acids
% 208.88/209.11  |- skos__broader mesh__D005229smesh__D005231
% 208.88/209.11  |- mesh__dateRevised mesh__D005229 2003-07-09
% 208.88/209.11  |- mesh__publicMeSHNote mesh__D005229
% 208.88/209.11       88; MONOUNSATURATED FATTY ACIDS was see FATTY ACIDS, MONOUNSATURATED 1988-93%A%  
% 208.88/209.11  |- skos__scopeNote mesh__D005229
% 208.88/209.11       Fatty acids which are unsaturated in only one position.%A%    
% 208.88/209.11  |- skos__prefLabel mesh__D005229 Fatty Acids, Monounsaturated
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D005229 2004
% 208.88/209.11  |- mesh__onlineNote mesh__D005229
% 208.88/209.11       use FATTY ACIDS, MONOUNSATURATED to search MONOUNSATURATED FATTY ACIDS 1988-93%A%  
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D005229 2006
% 208.88/209.11  |- mesh__recordOriginator mesh__D005229 RLS
% 208.88/209.11  |- mesh__recordAuthorizer mesh__D005229 sjn
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D005229 2005
% 208.88/209.11  |- mesh__dateEstablished mesh__D005229 1988-01-01
% 208.88/209.11  |- skos__historyNote mesh__D005229
% 208.88/209.11       Fatty Acids, Unsaturated %28%1973-1987%29%
% 208.88/209.11  |- mesh__historyNote mesh__D015657 90   
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D015657 2004
% 208.88/209.11  |- mesh__publicMeSHNote mesh__D015657 90   
% 208.88/209.11  |- skos__hiddenLabel mesh__D015657 Transport, Respiratory
% 208.88/209.11  |- skos__prefLabel mesh__D015657 Respiratory Transport
% 208.88/209.11  |- skos__broader mesh__D015657smesh__D001692
% 208.88/209.11  |- skos__historyNote mesh__D015657 Respiration %28%1966-1989%29%
% 208.88/209.11  |- mesh__dateEstablished mesh__D015657 1990-01-01
% 208.88/209.11  |- skos__hiddenLabel mesh__D015657 Respiratory Transports
% 208.88/209.11  |- skos__hiddenLabel mesh__D015657 Transports, Respiratory
% 208.88/209.11  |- skos__broader mesh__D015657smesh__D012119
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D015657 2006
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D015657 2005
% 208.88/209.11  |- mesh__recordMaintainer mesh__D015657 nns
% 208.88/209.11  |- mesh__recordAuthorizer mesh__D015657 sjn
% 208.88/209.11  |- mesh__recordOriginator mesh__D015657 TGC
% 208.88/209.11  |- skos__scopeNote mesh__D015657
% 208.88/209.11       The processes of diffusion across the BLOOD-AIR BARRIER, and the chemical reactions coupled with diffusion that effect the rate of PULMONARY GAS EXCHANGE, generally at the alveolar level.%A%    
% 208.88/209.11  |- mesh__dateCreated mesh__D015657 1989-05-16
% 208.88/209.11  |- rdf__type mesh__D015657sskos__Concept
% 208.88/209.11  |- mesh__dateRevised mesh__D015657 2003-07-09
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D001637 2006
% 208.88/209.11  |- mesh__dateRevised mesh__D001637 2004-07-19
% 208.88/209.11  |- rdf__type mesh__D001637sskos__Concept
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D001637 2005
% 208.88/209.11  |- mesh__recordMaintainer mesh__D001637 jls
% 208.88/209.11  |- mesh__recordOriginator mesh__D001637 NLM
% 208.88/209.11  |- skos__altLabel mesh__D001637 National Bibliographies
% 208.88/209.11  |- mesh__recordAuthorizer mesh__D001637 sjn
% 208.88/209.11  |- skos__scopeNote mesh__D001637
% 208.88/209.11       A bibliography which lists all the books and other publications published, or distributed in significant quantity, in a particular country. Sometimes the term is used with respect to the new publications published within a specific period, and sometimes with respect to all those published within a lengthy period of many years. It is also used to indicate a bibliography of publications about a country %28%whether written by its nationals or not%29% and those written in the language of the country as well as those published in it. %28%Harrod%27%s Librarians%27% Glossary, 7th ed%29%%A%    
% 208.88/209.11  |- skos__annotation mesh__D001637
% 208.88/209.11       cataloging term: no qualif; DF: BIBLIOG NATIONAL or BIBLIOGR NATIONAL%A%  
% 208.88/209.11  |- skos__prefLabel mesh__D001637 Bibliography, National
% 208.88/209.11  |- skos__altLabel mesh__D001637 National Bibliography
% 208.88/209.11  |- skos__altLabel mesh__D001637 Bibliographies, National
% 208.88/209.11  |- skos__broader mesh__D001637smesh__D001634
% 208.88/209.11  |- mesh__dateCreated mesh__D001637 1999-01-01
% 208.88/209.11  |- skos__hiddenLabel mesh__D006322 Heart Aneurysms
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006322 1998
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006322 2006
% 208.88/209.11  |- skos__hiddenLabel mesh__D006322 Cardiac Aneurysms
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006322 2002
% 208.88/209.11  |- mesh__recordMaintainer mesh__D006322 TGC
% 208.88/209.11  |- skos__hiddenLabel mesh__D006322 Aneurysm, Cardiac
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006322 2005
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006322 2004
% 208.88/209.11  |- skos__altLabel mesh__D006322 Cardiac Aneurysm
% 208.88/209.11  |- skos__broader mesh__D006322smesh__D006331
% 208.88/209.11  |- skos__scopeNote mesh__D006322
% 208.88/209.11       An aneurysmal dilatation of a portion of the wall of the ventricle, usually the left, or, rarely, a saccular protrusion through it %28%false aneurysm of the heart%29%. It is usually consequent to myocardial infarction but other causes such as bacterial endocarditis or trauma have been described. %28%Dorland, 28th ed%29%%A%    
% 208.88/209.11  |- skos__hiddenLabel mesh__D006322 Aneurysm, Heart
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006322 2003
% 208.88/209.11  |- skos__annotation mesh__D006322
% 208.88/209.11       of myocardium only: not for CORONARY ANEURYSM   
% 208.88/209.11  |- skos__related mesh__D006322smesh__D003323
% 208.88/209.11  |- mesh__recordAuthorizer mesh__D006322 SJN
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006322 2001
% 208.88/209.11  |- mesh__recordOriginator mesh__D006322 NLM
% 208.88/209.11  |- mesh__dateCreated mesh__D006322 1999-01-01
% 208.88/209.11  |- skos__prefLabel mesh__D006322 Heart Aneurysm
% 208.88/209.11  |- rdf__type mesh__D006322sskos__Concept
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006322 2000
% 208.88/209.11  |- skos__broader mesh__D006322smesh__D000783
% 208.88/209.11  |- skos__hiddenLabel mesh__D006322 Aneurysms, Heart
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D006322 1999
% 208.88/209.11  |- mesh__dateRevised mesh__D006322 1997-06-20
% 208.88/209.11  |- skos__hiddenLabel mesh__D006322 Aneurysms, Cardiac
% 208.88/209.11  |- mesh__dateCreated mesh__D016750 1991-04-29
% 208.88/209.11  |- mesh__dateRevised mesh__D016750 2002-07-03
% 208.88/209.11  |- skos__altLabel mesh__D016750 Stiffman Syndrome
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D016750 2004
% 208.88/209.11  |- mesh__recordOriginator mesh__D016750 AGS
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D016750 2006
% 208.88/209.11  |- skos__hiddenLabel mesh__D016750 Stiff Man Syndrome
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D016750 2003
% 208.88/209.11  |- mesh__recordMaintainer mesh__D016750 mdb
% 208.88/209.11  |- skos__prefLabel mesh__D016750 Stiff-Person Syndrome
% 208.88/209.11  |- skos__historyNote mesh__D016750 Autoimmune Diseases %28%1988-1991%29%
% 208.88/209.11  |- skos__broader mesh__D016750smesh__D020274
% 208.88/209.11  |- mesh__historyNote mesh__D016750 2000%28%1992%29%   
% 208.88/209.11  |- mesh__activeMeSHYear mesh__D016750 2005
% 208.97/209.11  |- skos__hiddenLabel mesh__D016750 Syndrome, Moersch-Woltmann
% 208.97/209.11  |- skos__altLabel mesh__D016750 Moersch-Woltmann Syndrome
% 208.97/209.11  |- skos__hiddenLabel mesh__D016750 Moersch Woltmann Syndrome
% 208.97/209.11  |- skos__historyNote mesh__D016750 Neuromuscular Diseases %28%1972-1991%29%
% 208.97/209.11  |- skos__hiddenLabel mesh__D016750 Syndrome, Stiff-Person
% 208.97/209.11  |- skos__broader mesh__D016750smesh__D013118
% 208.97/209.11  |- mesh__publicMeSHNote mesh__D016750
% 208.97/209.11       2000; see STIFF-MAN SYNDROME 1992-1999   
% 208.97/209.11  |- skos__historyNote mesh__D016750 Fibromyalgia %28%1966-1976%29%
% 208.97/209.11  |- rdf__type mesh__D016750sskos__Concept
% 208.97/209.11  |- skos__historyNote mesh__D016750 Muscular Diseases %28%1966-1982%29%
% 208.97/209.11  |- skos__hiddenLabel mesh__D016750 Syndrome, Stiffman
% 208.97/209.11  |- mesh__dateEstablished mesh__D016750 1992-01-01
% 208.97/209.11  |- mesh__recordAuthorizer mesh__D016750 sjn
% 208.97/209.11  |- skos__broader mesh__D016750smesh__D009468
% 208.97/209.11  |- skos__altLabel mesh__D016750 Stiff-Man Syndrome
% 208.97/209.11  |- skos__historyNote mesh__D016750
% 208.97/209.11       Central Nervous System Diseases %28%1986-1991%29%
% 208.97/209.11  |- skos__hiddenLabel mesh__D016750 Stiff Person Syndrome
% 208.97/209.11  |- skos__scopeNote mesh__D016750
% 208.97/209.11       A condition characterized by persistent spasms %28%SPASM%29% involving multiple muscles, primarily in the lower limbs and trunk. The illness tends to occur in the fourth to sixth decade of life, presenting with intermittent spasms that become continuous. Minor sensory stimuli, such as noise and light touch, precipitate severe spasms. Spasms do not occur during sleep and only rarely involve cranial muscles. Respiration may become impaired in advanced cases. %28%Adams et al., Principles of Neurology, 6th ed, p1492; Neurology 1998 Jul;51%28%1%29%:85-93%29%%A%    
% 208.97/209.11  |- skos__hiddenLabel mesh__D016750 Syndrome, Stiff-Man
% 208.97/209.11  |- mesh__dateCreated mesh__D030421 2001-07-25
% 208.97/209.11  |- mesh__activeMeSHYear mesh__D030421 2005
% 208.97/209.11  |- skos__historyNote mesh__D030421 Nitrates %28%1990-2001%29%
% 208.97/209.11  |- mesh__dateEstablished mesh__D030421 2002-01-01
% 208.97/209.11  |- skos__altLabel mesh__D030421 Peroxonitrite
% 208.97/209.11  |- rdf__type mesh__D030421sskos__Concept
% 208.97/209.11  |- mesh__publicMeSHNote mesh__D030421
% 208.97/209.11       2002; PEROXYNITRITE was indexed under NITRATES 1990-2001   
% 208.97/209.11  |- skos__hiddenLabel mesh__D030421 Peroxonitrites
% 208.97/209.11  |- mesh__activeMeSHYear mesh__D030421 2002
% 208.97/209.11  |- skos__hiddenLabel mesh__D030421 Acids, Peroxynitrous
% 208.97/209.11  |- mesh__historyNote mesh__D030421
% 208.97/209.11       2002; for PEROXYNITRITE use PEROXYNITROUS ACID %28%NM%29% 1990-2001%A%  
% 208.97/209.11  |- skos__prefLabel mesh__D030421 Peroxynitrous Acid
% 208.97/209.11  |- skos__scopeNote mesh__D030421
% 208.97/209.11       A potent oxidant synthesized by the cell during its normal metabolism.  Peroxynitrite is formed from the reaction of two free radicals, NITRIC OXIDE and the superoxide anion %28%SUPEROXIDES%29%.%A%    
% 208.97/209.11  |- mesh__activeMeSHYear mesh__D030421 2004
% 208.97/209.11  |- skos__hiddenLabel mesh__D030421 Acid, Peroxynitrous
% 208.97/209.11  |- skos__broader mesh__D030421smesh__D026361
% 208.97/209.11  |- skos__hiddenLabel mesh__D030421 Peroxynitrites
% 208.97/209.11  |- skos__broader mesh__D030421smesh__D009608
% 208.97/209.11  |- skos__hiddenLabel mesh__D030421 Peroxynitrous Acids
% 208.97/209.11  |- mesh__activeMeSHYear mesh__D030421 2003
% 208.97/209.11  |- mesh__activeMeSHYear mesh__D030421 2006
% 208.97/209.11  |- skos__scopeNote mesh__D002730
% 208.97/209.11       Mercuriphenols substituted with one or more chlorine atoms and one or more nitro groups. Some of these are sulfhydryl reagents which act as chromophoric probes in enzymes and other proteins.%A%    
% 208.97/209.11  |- mesh__activeMeSHYear mesh__D002730 2003
% 208.97/209.11  |- mesh__recordAuthorizer mesh__D002730 sjn
% 208.97/209.11  |- mesh__recordMaintainer mesh__D002730 CCR
% 208.97/209.11  |- skos__historyNote mesh__D002730 Mercury %28%1968-1976%29%
% 208.97/209.11  |- mesh__dateEstablished mesh__D002730 1991-01-01
% 208.97/209.11  |- mesh__recordOriginator mesh__D002730 RLS
% 208.97/209.11  |- skos__broader mesh__D002730smesh__D010663
% 208.97/209.11  |- mesh__publicMeSHNote mesh__D002730
% 208.97/209.11       91; was see under PHENYLMERCURY COMPOUNDS 1980-90; was see under PHENYL MERCURY COMPOUNDS 1977-79%A%  
% 208.97/209.12  |- mesh__historyNote mesh__D002730
% 208.97/209.12       91%28%77%29%; was see under PHENYLMERCURY COMPOUNDS 1980-90; was see under PHENYL MERCURY COMPOUNDS 1977-79%A%  
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D002730 2006
% 208.97/209.12  |- mesh__dateRevised mesh__D002730 2000-06-22
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D002730 2005
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D002730 2002
% 208.97/209.12  |- skos__historyNote mesh__D002730 Nitrophenols %28%1968-1976%29%
% 208.97/209.12  |- mesh__dateCreated mesh__D002730 1976-04-19
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D002730 2004
% 208.97/209.12  |- skos__prefLabel mesh__D002730 Chloromercurinitrophenols
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D002730 2001
% 208.97/209.12  |- skos__historyNote mesh__D002730
% 208.97/209.12       Organometallic Compounds %28%1968-1976%29%
% 208.97/209.12  |- rdf__type mesh__D002730sskos__Concept
% 208.97/209.12  |- mesh__dateCreated mesh__D015658 1989-05-25
% 208.97/209.12  |- mesh__publicMeSHNote mesh__D015658
% 208.97/209.12       90; T-LYMPHOTROPIC VIRUS TYPE III INFECTION, HUMAN was HUMAN T-LYMPHOTROPIC VIRUS TYPE III INFECTION see ACQUIRED IMMUNODEFICIENCY SYNDROME 1989; HIV INFECTION was see ACQUIRED IMMUNODEFICIENCY SYNDROME 1988-89; HTLV-III INFECTION %26% HTLV-III-LAV INFECTION were see ACQUIRED IMMUNODEFICIENCY SYNDROME 1987-89%A%  
% 208.97/209.12  |- skos__hiddenLabel mesh__D015658 HIV Infection
% 208.97/209.12  |- mesh__dateEstablished mesh__D015658 1990-01-01
% 208.97/209.12  |- mesh__onlineNote mesh__D015658
% 208.97/209.12       use ACQUIRED IMMUNODEFICIENCY SYNDROME to search HUMAN T-LYMPHOTROPIC VIRUS TYPE III INFECTION 1989; HIV INFECTION 1988-89; HTLV-III INFECTION %26% HTLV-III LAV INFECTION 1987-89%A%  
% 208.97/209.12  |- skos__hiddenLabel mesh__D015658
% 208.97/209.12       T Lymphotropic Virus Type III Infections, Human
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D015658 2006
% 208.97/209.12  |- skos__prefLabel mesh__D015658 HIV Infections
% 208.97/209.12  |- mesh__recordAuthorizer mesh__D015658 sjn
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D015658 2005
% 208.97/209.12  |- skos__hiddenLabel mesh__D015658 Infections, HTLV-III
% 208.97/209.12  |- skos__hiddenLabel mesh__D015658 Infection, HTLV-III
% 208.97/209.12  |- skos__hiddenLabel mesh__D015658 HTLV-III Infection
% 208.97/209.12  |- skos__hiddenLabel mesh__D015658 Infections, HTLV-III-LAV
% 208.97/209.12  |- skos__altLabel mesh__D015658
% 208.97/209.12       T-Lymphotropic Virus Type III Infections, Human
% 208.97/209.12  |- skos__historyNote mesh__D015658
% 208.97/209.12       Acquired Immunodeficiency Syndrome %28%1983-1989%29%
% 208.97/209.12  |- skos__annotation mesh__D015658
% 208.97/209.12       caused by a lentivirus; GEN or unspecified; coord IM with HIV-1 %28%IM%29% or HIV-2 %28%IM%29%; note specific indentions under HIV INFECTIONS; DF: HIV INFECT%A%  
% 208.97/209.12  |- skos__hiddenLabel mesh__D015658 HTLV III LAV Infections
% 208.97/209.12  |- skos__broader mesh__D015658smesh__D016180
% 208.97/209.12  |- rdf__type mesh__D015658sskos__Concept
% 208.97/209.12  |- skos__hiddenLabel mesh__D015658 HTLV-III-LAV Infection
% 208.97/209.12  |- skos__broader mesh__D015658smesh__D007153
% 208.97/209.12  |- mesh__historyNote mesh__D015658
% 208.97/209.12       90; T-LYMPHOTROPIC VIRUS TYPE III INFECTION, HUMAN was HUMAN T-LYMPHOTROPIC VIRUS TYPE III INFECTION see ACQUIRED IMMUNODEFICIENCY SYNDROME 1989; HIV INFECTION was see ACQUIRED IMMUNODEFICIENCY SYNDROME 1988-89; HTLV-III INFECTION %26% HTLV-III-LAV INFECTION were see ACQUIRED IMMUNODEFICIENCY SYNDROME 1987-89%A%  
% 208.97/209.12  |- skos__historyNote mesh__D015658 HIV Seropositivity %28%1988-1989%29%
% 208.97/209.12  |- skos__hiddenLabel mesh__D015658 Infections, HIV
% 208.97/209.12  |- mesh__recordOriginator mesh__D015658 AGS
% 208.97/209.12  |- skos__related mesh__D015658smesh__D016483
% 208.97/209.12  |- skos__hiddenLabel mesh__D015658 HTLV III Infections
% 208.97/209.12  |- skos__altLabel mesh__D015658 HTLV-III-LAV Infections
% 208.97/209.12  |- skos__altLabel mesh__D015658 HTLV-III Infections
% 208.97/209.12  |- skos__broader mesh__D015658smesh__D015229
% 208.97/209.12  |- skos__hiddenLabel mesh__D015658 Infection, HIV
% 208.97/209.12  |- mesh__dateRevised mesh__D015658 2004-07-13
% 208.97/209.12  |- skos__hiddenLabel mesh__D015658 Infection, HTLV-III-LAV
% 208.97/209.12  |- skos__scopeNote mesh__D015658
% 208.97/209.12       Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex %28%ARC%29%, to acquired immunodeficiency syndrome %28%AIDS%29%.%A%    
% 208.97/209.12  |- mesh__recordMaintainer mesh__D015658 sjn
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D001638 2005
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D001638 1998
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D001638 2001
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D001638 2003
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D001638 1996
% 208.97/209.12  |- skos__annotation mesh__D001638 a psychother technique; DF: BIBLIOTHER   
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D001638 2000
% 208.97/209.12  |- skos__broader mesh__D001638smesh__D012046
% 208.97/209.12  |- mesh__dateRevised mesh__D001638 1995-05-31
% 208.97/209.12  |- skos__scopeNote mesh__D001638
% 208.97/209.12       A form of supportive psychotherapy in which the patient is given carefully selected material to read.%A%    
% 208.97/209.12  |- mesh__recordOriginator mesh__D001638 NLM
% 208.97/209.12  |- mesh__recordMaintainer mesh__D001638 TGC
% 208.97/209.12  |- skos__hiddenLabel mesh__D001638 Bibliotherapies
% 208.97/209.12  |- skos__broader mesh__D001638smesh__D011613
% 208.97/209.12  |- mesh__dateCreated mesh__D001638 1999-01-01
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D001638 2002
% 208.97/209.12  |- mesh__recordAuthorizer mesh__D001638 PLS
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D001638 2006
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D001638 1999
% 208.97/209.12  |- skos__prefLabel mesh__D001638 Bibliotherapy
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D001638 2004
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D001638 1997
% 208.97/209.12  |- rdf__type mesh__D001638sskos__Concept
% 208.97/209.12  |- mesh__publicMeSHNote mesh__D012360
% 208.97/209.12       91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.97/209.12  |- skos__altLabel mesh__D012360 Phenylalanine-Specific tRNA
% 208.97/209.12  |- skos__historyNote mesh__D012360 Amino Acyl T RNA %28%1978-1987%29%
% 208.97/209.12  |- skos__scopeNote mesh__D012360
% 208.97/209.12       A transfer RNA which is specific for carrying phenylalanine to sites on the ribosomes in preparation for protein synthesis.%A%    
% 208.97/209.12  |- skos__broader mesh__D012360smesh__D012345
% 208.97/209.12  |- skos__historyNote mesh__D012360 RNA, Transfer %28%1966-1987%29%
% 208.97/209.12  |- rdf__type mesh__D012360sskos__Concept
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D012360 2000
% 208.97/209.12  |- mesh__recordOriginator mesh__D012360 RLS
% 208.97/209.12  |- skos__hiddenLabel mesh__D012360 Phenylalanine Specific tRNA
% 208.97/209.12  |- mesh__dateEstablished mesh__D012360 1991-01-01
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D012360 2001
% 208.97/209.12  |- skos__altLabel mesh__D012360 Transfer RNA, Phe
% 208.97/209.12  |- skos__annotation mesh__D012360
% 208.97/209.12       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 208.97/209.12  |- skos__prefLabel mesh__D012360 RNA, Transfer, Phe
% 208.97/209.12  |- skos__hiddenLabel mesh__D012360 RNA, Phe Transfer
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D012360 1998
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D012360 2003
% 208.97/209.12  |- skos__altLabel mesh__D012360 tRNAPhe
% 208.97/209.12  |- mesh__historyNote mesh__D012360
% 208.97/209.12       91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.97/209.12  |- mesh__dateCreated mesh__D012360 1987-05-14
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D012360 2005
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D012360 1997
% 208.97/209.12  |- skos__hiddenLabel mesh__D012360 Phe Transfer RNA
% 208.97/209.12  |- mesh__recordMaintainer mesh__D012360 TGC
% 208.97/209.12  |- mesh__recordAuthorizer mesh__D012360 PLS
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D012360 1999
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D012360 2004
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D012360 2002
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D012360 2006
% 208.97/209.12  |- mesh__dateRevised mesh__D012360 1996-06-10
% 208.97/209.12  |- skos__hiddenLabel mesh__D012360 tRNA, Phenylalanine-Specific
% 208.97/209.12  |- skos__altLabel mesh__D012360 tRNA%28%Phe%29%
% 208.97/209.12  |- skos__hiddenLabel mesh__D006323 Arrest, Heart
% 208.97/209.12  |- skos__related mesh__D006323smesh__D016757
% 208.97/209.12  |- mesh__recordOriginator mesh__D006323 NLM
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D006323 2003
% 208.97/209.12  |- skos__hiddenLabel mesh__D006323 Arrest, Cardiac
% 208.97/209.12  |- mesh__recordMaintainer mesh__D006323 nns
% 208.97/209.12  |- skos__prefLabel mesh__D006323 Heart Arrest
% 208.97/209.12  |- skos__related mesh__D006323smesh__D006324
% 208.97/209.12  |- mesh__publicMeSHNote mesh__D006323
% 208.97/209.12       ASYSTOLE was see under ARRHYTHMIA 1969-90   
% 208.97/209.12  |- mesh__dateCreated mesh__D006323 1999-01-01
% 208.97/209.12  |- rdf__type mesh__D006323sskos__Concept
% 208.97/209.12  |- skos__altLabel mesh__D006323 Cardiac Arrest
% 208.97/209.12  |- skos__altLabel mesh__D006323 Asystole
% 208.97/209.12  |- mesh__recordAuthorizer mesh__D006323 sjn
% 208.97/209.12  |- mesh__dateRevised mesh__D006323 2001-07-25
% 208.97/209.12  |- skos__broader mesh__D006323smesh__D006331
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D006323 2002
% 208.97/209.12  |- mesh__historyNote mesh__D006323
% 208.97/209.12       ASYSTOLE was see under ARRHYTHMIA 1969-90   
% 208.97/209.12  |- skos__scopeNote mesh__D006323 Cessation of the heart beat.     
% 208.97/209.12  |- mesh__onlineNote mesh__D006323
% 208.97/209.12       use HEART ARREST to search ASYSTOLE 1969-74   
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D006323 2006
% 208.97/209.12  |- skos__hiddenLabel mesh__D006323 Arrest, Cardiopulmonary
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D006323 2005
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D006323 2004
% 208.97/209.12  |- skos__hiddenLabel mesh__D006323 Asystoles
% 208.97/209.12  |- skos__related mesh__D006323smesh__D016887
% 208.97/209.12  |- skos__hiddenLabel mesh__D011268 1, Schwangerschaftsprotein
% 208.97/209.12  |- mesh__dateCreated mesh__D011268 1979-02-22
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D011268 2006
% 208.97/209.12  |- skos__prefLabel mesh__D011268 Pregnancy-Specific beta 1-Glycoproteins
% 208.97/209.12  |- skos__hiddenLabel mesh__D011268 1-Glycoproteins, Pregnancy-Specific beta
% 208.97/209.12  |- skos__hiddenLabel mesh__D011268 beta-Globulin, Trophoblastic
% 208.97/209.12  |- skos__historyNote mesh__D011268 Blood Proteins %28%1966-1979%29%
% 208.97/209.12  |- skos__altLabel mesh__D011268 Pregnancy-Specific beta 1-Glycoprotein
% 208.97/209.12  |- skos__altLabel mesh__D011268 Pregnancy Specific beta 1 Glycoprotein
% 208.97/209.12  |- skos__altLabel mesh__D011268 beta 1-Glycoprotein, Pregnancy-Specific
% 208.97/209.12  |- mesh__recordOriginator mesh__D011268 RLS
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D011268 2005
% 208.97/209.12  |- skos__altLabel mesh__D011268 beta-1 Glycoprotein, Trophoblast-Specific
% 208.97/209.12  |- skos__hiddenLabel mesh__D011268 Pregnancy Associated Plasma Protein B
% 208.97/209.12  |- rdf__type mesh__D011268sskos__Concept
% 208.97/209.12  |- skos__altLabel mesh__D011268 Schwangerschaftsprotein 1
% 208.97/209.12  |- skos__hiddenLabel mesh__D011268 Trophoblast Specific beta 1 Glycoprotein
% 208.97/209.12  |- skos__scopeNote mesh__D011268
% 208.97/209.12       Glycoproteins with the electrophoretic mobility of BETA-GLOBULINS, secreted by the placental TROPHOBLASTS into the maternal bloodstream during PREGNANCY. They can be detected 18 days after OVULATION and reach 200 mg/ml at the end of pregnancy. They are associated with fetal well-being.%A%    
% 208.97/209.12  |- skos__hiddenLabel mesh__D011268 beta-1 Globulin, Pregnancy-Specific
% 208.97/209.12  |- skos__altLabel mesh__D011268 beta 1-Globulin, Trophoblast-Specific
% 208.97/209.12  |- mesh__dateRevised mesh__D011268 2004-07-07
% 208.97/209.12  |- skos__altLabel mesh__D011268 Pregnancy-Associated beta-Plasma Protein
% 208.97/209.12  |- skos__altLabel mesh__D011268 PAPP-C
% 208.97/209.12  |- skos__altLabel mesh__D011268 Pregnancy Specific beta1-Glycoprotein.
% 208.97/209.12  |- mesh__dateEstablished mesh__D011268 1991-01-01
% 208.97/209.12  |- skos__hiddenLabel mesh__D011268 Protein, SP1 Pregnancy
% 208.97/209.12  |- skos__altLabel mesh__D011268 Pregnancy Specific beta-1 Glycoprotein
% 208.97/209.12  |- skos__hiddenLabel mesh__D011268 Pregnancy Specific beta 1 Glycoproteins
% 208.97/209.12  |- skos__hiddenLabel mesh__D011268 Pregnancy Associated Plasma Protein C
% 208.97/209.12  |- skos__hiddenLabel mesh__D011268 Pregnancy Protein, SP1
% 208.97/209.12  |- mesh__recordAuthorizer mesh__D011268 sjn
% 208.97/209.12  |- skos__hiddenLabel mesh__D011268 Trophoblast-Specific beta-1 Glycoprotein
% 208.97/209.12  |- mesh__historyNote mesh__D011268 2005%28%1980%29%   
% 208.97/209.12  |- skos__hiddenLabel mesh__D011268 beta 1-Glycoproteins, Pregnancy-Specific
% 208.97/209.12  |- skos__altLabel mesh__D011268 Trophoblastic beta%28%1%29%-Globulin
% 208.97/209.12  |- skos__hiddenLabel mesh__D011268 Trophoblast-Specific beta 1-Globulin
% 208.97/209.12  |- skos__hiddenLabel mesh__D011268 PSBG 1
% 208.97/209.12  |- skos__altLabel mesh__D011268 PAPP-B
% 208.97/209.12  |- skos__historyNote mesh__D011268 Glycoproteins %28%1966-1979%29%
% 208.97/209.12  |- skos__hiddenLabel mesh__D011268 beta 1 Globulin, Trophoblast Specific
% 208.97/209.12  |- skos__historyNote mesh__D011268 Beta Globulins %28%1966-1979%29%
% 208.97/209.12  |- skos__altLabel mesh__D011268 SP1 Pregnancy Protein
% 208.97/209.12  |- skos__altLabel mesh__D011268 Trophoblastic beta-Globulin
% 208.97/209.12  |- skos__altLabel mesh__D011268 Trophoblast-Specific beta 1-Glycoprotein
% 208.97/209.12  |- skos__hiddenLabel mesh__D011268 Pregnancy Specific beta 1 Globulin
% 208.97/209.12  |- skos__altLabel mesh__D011268 Pregnancy-Specific beta-1 Globulin
% 208.97/209.12  |- skos__hiddenLabel mesh__D011268 PAPP B
% 208.97/209.12  |- skos__altLabel mesh__D011268 Trophoblastic beta 1-Glycoprotein
% 208.97/209.12  |- skos__historyNote mesh__D011268 Pregnancy %28%1966-1979%29%
% 208.97/209.12  |- mesh__publicMeSHNote mesh__D011268
% 208.97/209.12       2005; see PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 1990-2004; see PREGNANCY PROTEINS 1980-1990; for PREGNANCY-ASSOCIATED BETA-PLASMA PROTEIN see PREGNANCY-ASSOCIATED BETA-PLASMA PROTEIN 1996-2003, see PREGNANCY-ASSOCIATED BETA PLASMA PROTEIN 1991-1995, see PREGNANCY PROTEINS 1980-1990%A%  
% 208.97/209.12  |- skos__hiddenLabel mesh__D011268 Trophoblastic beta Globulin
% 208.97/209.12  |- mesh__recordMaintainer mesh__D011268 jmp
% 208.97/209.12  |- skos__broader mesh__D011268smesh__D011257
% 208.97/209.12  |- skos__altLabel mesh__D011268 PSBG-1
% 208.97/209.12  |- skos__historyNote mesh__D011268 Serum Globulins %28%1966-1979%29%
% 208.97/209.12  |- skos__altLabel mesh__D016751 ET-NANBH
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D016751 2006
% 208.97/209.12  |- skos__broader mesh__D016751smesh__D006525
% 208.97/209.12  |- skos__historyNote mesh__D016751
% 208.97/209.12       Hepatitis, Viral, Human %28%1990-1991%29%
% 208.97/209.12  |- skos__altLabel mesh__D016751 Hepatitis, Water-Borne
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D016751 2005
% 208.97/209.12  |- skos__hiddenLabel mesh__D016751 Water-Borne Hepatitides
% 208.97/209.12  |- skos__prefLabel mesh__D016751 Hepatitis E
% 208.97/209.12  |- mesh__historyNote mesh__D016751 92   
% 208.97/209.12  |- mesh__recordOriginator mesh__D016751 AGS
% 208.97/209.12  |- mesh__publicMeSHNote mesh__D016751 92   
% 208.97/209.12  |- skos__altLabel mesh__D016751
% 208.97/209.12       Hepatitis, Viral, Non-A, Non-B, Enterically-Transmitted
% 208.97/209.12  |- rdf__type mesh__D016751sskos__Concept
% 208.97/209.12  |- skos__altLabel mesh__D016751 Epidemic Non-A, Non-B Hepatitis
% 208.97/209.12  |- skos__broader mesh__D016751smesh__D012327
% 208.97/209.12  |- skos__hiddenLabel mesh__D016751 Water-Borne Hepatitis
% 208.97/209.12  |- mesh__dateRevised mesh__D016751 2004-07-07
% 208.97/209.12  |- skos__scopeNote mesh__D016751
% 208.97/209.12       Acute INFLAMMATION of the LIVER in humans; caused by HEPATITIS E VIRUS, a non-enveloped single-stranded RNA virus. Similar to HEPATITIS A, its incubation period is 15-60 days and is enterically transmitted, usually by fecal-oral transmission.%A%    
% 208.97/209.12  |- skos__hiddenLabel mesh__D016751 Epidemic Non A, Non B Hepatitis
% 208.97/209.12  |- skos__hiddenLabel mesh__D016751 Hepatitis, Water Borne
% 208.97/209.12  |- skos__hiddenLabel mesh__D016751
% 208.97/209.12       Enterically Transmitted Non A, Non B Hepatitis
% 208.97/209.12  |- mesh__dateCreated mesh__D016751 1991-04-29
% 208.97/209.12  |- skos__hiddenLabel mesh__D016751 Hepatitides, Water-Borne
% 208.97/209.12  |- skos__altLabel mesh__D016751
% 208.97/209.12       Enterically-Transmitted Non-A, Non-B Hepatitis
% 208.97/209.12  |- mesh__recordMaintainer mesh__D016751 lkt
% 208.97/209.12  |- mesh__dateEstablished mesh__D016751 1992-01-01
% 208.97/209.12  |- mesh__recordAuthorizer mesh__D016751 sjn
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D002731 2002
% 208.97/209.12  |- mesh__dateRevised mesh__D002731 2000-06-21
% 208.97/209.12  |- mesh__historyNote mesh__D002731
% 208.97/209.12       94; was CHLOROMERCURIPHENYLSULFONATE %28%see under PHENYLMERCURY COMPOUNDS 1977-90, see under ORGANOMETALLIC COMPOUNDS 1975-76%29%; CHLOROMERCURIBENZENESULFONATE was see CHLOROMERCURIPHENYLSULFONATE 1975-93%A%  
% 208.97/209.12  |- skos__hiddenLabel mesh__D002731 4 Chloromercuribenzenesulfonate
% 208.97/209.12  |- skos__altLabel mesh__D002731 Chloromercuribenzenesulfonate
% 208.97/209.12  |- skos__altLabel mesh__D002731 PCMBS
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D002731 2005
% 208.97/209.12  |- skos__historyNote mesh__D002731 Benzenesulfonates %28%1974%29%
% 208.97/209.12  |- mesh__recordMaintainer mesh__D002731 CCR
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D002731 2001
% 208.97/209.12  |- skos__hiddenLabel mesh__D002731 Acid, Chloromercuribenzene-p-sulphonic
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D002731 2004
% 208.97/209.12  |- mesh__recordAuthorizer mesh__D002731 sjn
% 208.97/209.12  |- skos__historyNote mesh__D002731 Sulfonic Acids %28%1966-1973%29%
% 208.97/209.12  |- skos__annotation mesh__D002731 DF: note short X ref   
% 208.97/209.12  |- mesh__recordOriginator mesh__D002731 NLM
% 208.97/209.12  |- skos__broader mesh__D002731smesh__D001557
% 208.97/209.12  |- rdf__type mesh__D002731sskos__Concept
% 208.97/209.12  |- mesh__onlineNote mesh__D002731
% 208.97/209.12       use 4-CHLOROMERCURIBENZENESULFONATE to search CHLOROMERCURIPHENYLSULFONATE %26% CHLOROMERCURIBENZENESULFONATE 1975-93%A%  
% 208.97/209.12  |- skos__historyNote mesh__D002731 Benzene %28%1966-1967%29%
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D002731 2003
% 208.97/209.12  |- skos__hiddenLabel mesh__D002731 p Chloromercuriphenylsulphonate
% 208.97/209.12  |- skos__broader mesh__D002731smesh__D010663
% 208.97/209.12  |- skos__historyNote mesh__D002731
% 208.97/209.12       Organometallic Compounds %28%1968-1974%29%
% 208.97/209.12  |- skos__scopeNote mesh__D002731
% 208.97/209.12       A cytotoxic sulfhydryl reagent that inhibits several subcellular metabolic systems and is used as a tool in cellular physiology.%A%    
% 208.97/209.12  |- skos__historyNote mesh__D002731 Mercury %28%1966-1974%29%
% 208.97/209.12  |- skos__hiddenLabel mesh__D002731 Chloromercuribenzene p sulphonic Acid
% 208.97/209.12  |- skos__altLabel mesh__D002731 PCMPS
% 208.97/209.12  |- skos__altLabel mesh__D002731 Chloromercuriphenylsulfonate
% 208.97/209.12  |- mesh__dateCreated mesh__D002731 1974-11-19
% 208.97/209.12  |- skos__altLabel mesh__D002731 p-Chloromercuriphenylsulphonate
% 208.97/209.12  |- skos__prefLabel mesh__D002731 4-Chloromercuribenzenesulfonate
% 208.97/209.12  |- mesh__publicMeSHNote mesh__D002731
% 208.97/209.12       94; was CHLOROMERCURIPHENYLSULFONATE %28%see under PHENYLMERCURY COMPOUNDS 1977-90, see under ORGANOMETALLIC COMPOUNDS 1975-76%29%; CHLOROMERCURIBENZENESULFONATE was see CHLOROMERCURIPHENYLSULFONATE 1975-93%A%  
% 208.97/209.12  |- mesh__dateEstablished mesh__D002731 1991-01-01
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D002731 2006
% 208.97/209.12  |- skos__broader mesh__D009206Q000382smesh__D009206
% 208.97/209.12  |- mesh__preferredCombination mesh__D009206Q000382smesh__D006321Q000382
% 208.97/209.12  |- rdf__type mesh__D009206Q000382smesh__CompoundConcept
% 208.97/209.12  |- mesh__historyNote mesh__D001639
% 208.97/209.12       BICARBONATE ION was %28%NM%29% 1981-93   
% 208.97/209.12  |- skos__altLabel mesh__D001639 Hydrogen Carbonates
% 208.97/209.12  |- mesh__recordAuthorizer mesh__D001639 sjn
% 208.97/209.12  |- skos__hiddenLabel mesh__D001639 Ions, Carbonic Acid
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D001639 2002
% 208.97/209.12  |- skos__broader mesh__D001639smesh__D002254
% 208.97/209.12  |- mesh__dateRevised mesh__D001639 2001-07-25
% 208.97/209.12  |- mesh__onlineNote mesh__D001639
% 208.97/209.12       use BICARBONATES %28%NM%29% to search BICARBONATE ION 1981-93   
% 208.97/209.12  |- mesh__dateCreated mesh__D001639 1999-01-01
% 208.97/209.12  |- skos__hiddenLabel mesh__D001639 Carbonates, Hydrogen
% 208.97/209.12  |- skos__scopeNote mesh__D001639
% 208.97/209.12       Inorganic salts that contain the -HCO3 radical. They are an important factor in determining the pH of the blood and the concentration of bicarbonate ions is regulated by the kidney. Levels in the blood are an index of the alkali reserve or buffering capacity.%A%    
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D001639 2006
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D001639 2004
% 208.97/209.12  |- rdf__type mesh__D001639sskos__Concept
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D001639 2005
% 208.97/209.12  |- mesh__recordMaintainer mesh__D001639 jmp
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D001639 2003
% 208.97/209.12  |- skos__altLabel mesh__D001639 Bicarbonate Ion
% 208.97/209.12  |- mesh__publicMeSHNote mesh__D001639
% 208.97/209.12       BICARBONATE ION was indexed under BICARBONATES 1981-93   
% 208.97/209.12  |- skos__hiddenLabel mesh__D001639 Carbonate, Hydrogen
% 208.97/209.12  |- mesh__recordOriginator mesh__D001639 NLM
% 208.97/209.12  |- skos__prefLabel mesh__D001639 Bicarbonates
% 208.97/209.12  |- skos__hiddenLabel mesh__D001639 Ions, Bicarbonate
% 208.97/209.12  |- mesh__dateRevised mesh__D012361 1996-06-10
% 208.97/209.12  |- mesh__dateEstablished mesh__D012361 1991-01-01
% 208.97/209.12  |- skos__hiddenLabel mesh__D012361 Pro Transfer RNA
% 208.97/209.12  |- skos__annotation mesh__D012361
% 208.97/209.12       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 208.97/209.12  |- skos__hiddenLabel mesh__D012361 tRNA, Proline-Specific
% 208.97/209.12  |- skos__historyNote mesh__D012361 Amino Acyl T RNA %28%1978-1987%29%
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D012361 1998
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D012361 2003
% 208.97/209.12  |- skos__altLabel mesh__D012361 Transfer RNA, Pro
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D012361 2005
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D012361 1997
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D012361 2000
% 208.97/209.12  |- mesh__recordOriginator mesh__D012361 RLS
% 208.97/209.12  |- mesh__recordMaintainer mesh__D012361 TGC
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D012361 1999
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D012361 2004
% 208.97/209.12  |- skos__prefLabel mesh__D012361 RNA, Transfer, Pro
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D012361 2001
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D012361 2006
% 208.97/209.12  |- mesh__dateCreated mesh__D012361 1987-05-07
% 208.97/209.12  |- skos__altLabel mesh__D012361 Proline-Specific tRNA
% 208.97/209.12  |- skos__hiddenLabel mesh__D012361 RNA, Pro Transfer
% 208.97/209.12  |- skos__hiddenLabel mesh__D012361 Proline Specific tRNA
% 208.97/209.12  |- skos__altLabel mesh__D012361 tRNA%28%Pro%29%
% 208.97/209.12  |- skos__scopeNote mesh__D012361
% 208.97/209.12       A transfer RNA which is specific for carrying proline to sites on the ribosomes in preparation for protein synthesis.%A%    
% 208.97/209.12  |- skos__altLabel mesh__D012361 tRNAPro
% 208.97/209.12  |- mesh__historyNote mesh__D012361
% 208.97/209.12       91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.97/209.12  |- mesh__publicMeSHNote mesh__D012361
% 208.97/209.12       91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.97/209.12  |- mesh__recordAuthorizer mesh__D012361 PLS
% 208.97/209.12  |- skos__broader mesh__D012361smesh__D012345
% 208.97/209.12  |- skos__historyNote mesh__D012361 RNA, Transfer %28%1966-1987%29%
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D012361 2002
% 208.97/209.12  |- rdf__type mesh__D012361sskos__Concept
% 208.97/209.12  |- skos__scopeNote mesh__D006324
% 208.97/209.12       A procedure to stop the contraction of MYOCARDIUM during HEART SURGERY. It is usually achieved with the use of chemicals %28%CARDIOPLEGIC SOLUTIONS%29% or cold temperature %28%such as chilled perfusate%29%.%A%    
% 208.97/209.12  |- skos__annotation mesh__D006324
% 208.97/209.12       note category: a technique, not a disease; do not coordinate with HYPOTHERMIA, INDUCED unless this is particularly discussed%A%  
% 208.97/209.12  |- mesh__dateCreated mesh__D006324 1999-01-01
% 208.97/209.12  |- rdf__type mesh__D006324sskos__Concept
% 208.97/209.12  |- skos__altLabel mesh__D006324 Induced Heart Arrest
% 208.97/209.12  |- mesh__recordMaintainer mesh__D006324 lkt
% 208.97/209.12  |- mesh__recordOriginator mesh__D006324 NLM
% 208.97/209.12  |- skos__broader mesh__D006324smesh__D006348
% 208.97/209.12  |- skos__hiddenLabel mesh__D006324 Cardioplegias
% 208.97/209.12  |- skos__prefLabel mesh__D006324 Heart Arrest, Induced
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D006324 2006
% 208.97/209.12  |- skos__related mesh__D006324smesh__D002314
% 208.97/209.12  |- mesh__recordAuthorizer mesh__D006324 sjn
% 208.97/209.12  |- skos__altLabel mesh__D006324 Cardiac Arrest, Induced
% 208.97/209.12  |- skos__altLabel mesh__D006324 Induced Cardiac Arrest
% 208.97/209.12  |- skos__altLabel mesh__D006324 Cardioplegia
% 208.97/209.12  |- mesh__dateRevised mesh__D006324 2005-06-30
% 208.97/209.12  |- skos__hiddenLabel mesh__D050480 Sodium Neurotransmitter Symporters
% 208.97/209.12  |- skos__prefLabel mesh__D050480
% 208.97/209.12       Plasma Membrane Neurotransmitter Transport Proteins
% 208.97/209.12  |- skos__hiddenLabel mesh__D050480 Symporters, Sodium-Neurotransmitter
% 208.97/209.12  |- skos__broader mesh__D050480smesh__D050479
% 208.97/209.12  |- rdf__type mesh__D050480sskos__Concept
% 208.97/209.12  |- skos__altLabel mesh__D050480
% 208.97/209.12       Neurotransmitter Transport Proteins, Plasma Membrane
% 208.97/209.12  |- skos__altLabel mesh__D050480
% 208.97/209.12       Neurotransmitter Transporters, Plasma Membrane
% 208.97/209.12  |- mesh__publicMeSHNote mesh__D050480 2006   
% 208.97/209.12  |- mesh__historyNote mesh__D050480 2006   
% 208.97/209.12  |- mesh__recordOriginator mesh__D050480 DRC
% 208.97/209.12  |- skos__altLabel mesh__D050480
% 208.97/209.12       Plasma Membrane Neurotransmitter Transporter Proteins
% 208.97/209.12  |- skos__scopeNote mesh__D050480
% 208.97/209.12       A family of neurotransmitter transporter proteins that facilitate NEUROTRANSMITTER reuptake into PRESYNAPTIC TERMINALS. They may play a role in regulating the intensity and duration of neurotransmission.%A%    
% 208.97/209.12  |- skos__altLabel mesh__D050480
% 208.97/209.12       Plasma Membrane Neurotransmitter Transporters
% 208.97/209.12  |- skos__annotation mesh__D050480
% 208.97/209.12       don%27%t confuse sodium chloride-dependent neurotransmitter symporters with SODIUM-POTASSIUM-CHLORIDE SYMPORTERS%A%  
% 208.97/209.12  |- skos__hiddenLabel mesh__D050480
% 208.97/209.12       Sodium Chloride Dependent Neurotransmitter Symporters
% 208.97/209.12  |- skos__altLabel mesh__D050480 Sodium-Neurotransmitter Symporters
% 208.97/209.12  |- mesh__dateCreated mesh__D050480 2005-06-30
% 208.97/209.12  |- mesh__recordMaintainer mesh__D050480 DRC
% 208.97/209.12  |- mesh__recordAuthorizer mesh__D050480 sjn
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D050480 2006
% 208.97/209.12  |- mesh__dateEstablished mesh__D050480 2006-01-01
% 208.97/209.12  |- mesh__dateEstablished mesh__D044443 2004-01-01
% 208.97/209.12  |- skos__historyNote mesh__D044443 Algae %28%1965-1995%29%
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D044443 2006
% 208.97/209.12  |- skos__scopeNote mesh__D044443
% 208.97/209.12       A genus of ALGAE in the family CHARACEAE. They are found in shallow to deep waters of soft water or acid lakes and bogs.%A%    
% 208.97/209.12  |- mesh__recordMaintainer mesh__D044443 SYSTEM
% 208.97/209.12  |- mesh__publicMeSHNote mesh__D044443 2004; see ALGAE, GREEN 1998-2003   
% 208.97/209.12  |- skos__historyNote mesh__D044443 Algae, Green %28%1967-2003%29%
% 208.97/209.12  |- skos__prefLabel mesh__D044443 Nitella
% 208.97/209.12  |- mesh__historyNote mesh__D044443 2004; use ALGAE, GREEN 1998-2003   
% 208.97/209.12  |- skos__broader mesh__D044443smesh__D044522
% 208.97/209.12  |- rdf__type mesh__D044443sskos__Concept
% 208.97/209.12  |- mesh__dateRevised mesh__D044443 2005-06-30
% 208.97/209.12  |- mesh__recordOriginator mesh__D044443 ags
% 208.97/209.12  |- mesh__recordAuthorizer mesh__D044443 sjn
% 208.97/209.12  |- mesh__dateCreated mesh__D044443 2003-07-09
% 208.97/209.12  |- mesh__dateCreated mesh__D011269 1999-01-01
% 208.97/209.12  |- skos__broader mesh__D011269smesh__D011271
% 208.97/209.12  |- skos__scopeNote mesh__D011269
% 208.97/209.12       A type of ectopic pregnancy in which the EMBRYO implants in the ABDOMINAL CAVITY instead of in the ENDOMETRIUM of the UTERUS.%A%    
% 208.97/209.12  |- mesh__activeMeSHYear mesh__D011269 2006
% 208.97/209.12  |- mesh__recordAuthorizer mesh__D011269 sjn
% 208.97/209.12  |- skos__hiddenLabel mesh__D011269 Abdominal Pregnancies
% 208.97/209.12  |- skos__altLabel mesh__D011269 Abdominal Pregnancy
% 208.97/209.12  |- skos__prefLabel mesh__D011269 Pregnancy, Abdominal
% 208.97/209.12  |- rdf__type mesh__D011269sskos__Concept
% 208.97/209.12  |- skos__hiddenLabel mesh__D011269 Pregnancies, Abdominal
% 208.97/209.12  |- mesh__dateRevised mesh__D011269 2005-06-30
% 208.97/209.12  |- mesh__recordMaintainer mesh__D011269 lkt
% 208.97/209.12  |- skos__annotation mesh__D011269
% 208.97/209.12       check the tags FEMALE %26% PREGNANCY; heterotopic or combined uterine %26% abdominal pregnancy: see note at PREGNANCY, ECTOPIC; DF: PREGN ABDOMINAL%A%  
% 208.97/209.12  |- mesh__recordOriginator mesh__D011269 NLM
% 208.97/209.12  |- mesh__recordMaintainer mesh__D016752 ags
% 208.97/209.13  |- skos__annotation mesh__D016752 infection = HEPATITIS E   
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D016752 2002
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D016752 2006
% 208.97/209.13  |- skos__prefLabel mesh__D016752 Hepatitis E virus
% 208.97/209.13  |- mesh__dateEstablished mesh__D016752 1992-01-01
% 208.97/209.13  |- skos__historyNote mesh__D016752 Hepatitis Viruses %28%1990-1991%29%
% 208.97/209.13  |- mesh__historyNote mesh__D016752 92   
% 208.97/209.13  |- mesh__recordAuthorizer mesh__D016752 sjn
% 208.97/209.13  |- mesh__recordOriginator mesh__D016752 AGS
% 208.97/209.13  |- rdf__type mesh__D016752sskos__Concept
% 208.97/209.13  |- skos__scopeNote mesh__D016752
% 208.97/209.13       A positive-stranded RNA virus species in an unassigned genus, Hepatitis E-like Viruses, causing enterically-transmitted non-A, non-B hepatitis %28%HEPATITIS E%29%.%A%    
% 208.97/209.13  |- skos__broader mesh__D016752smesh__D012328
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D016752 2003
% 208.97/209.13  |- skos__broader mesh__D016752smesh__D006518
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D016752 2005
% 208.97/209.13  |- mesh__publicMeSHNote mesh__D016752 92   
% 208.97/209.13  |- mesh__dateRevised mesh__D016752 2001-07-25
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D016752 2004
% 208.97/209.13  |- mesh__dateCreated mesh__D016752 1991-06-21
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012362 1999
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012362 2004
% 208.97/209.13  |- mesh__historyNote mesh__D012362
% 208.97/209.13       91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012362 2006
% 208.97/209.13  |- mesh__recordMaintainer mesh__D012362 TGC
% 208.97/209.13  |- skos__hiddenLabel mesh__D012362 tRNA, Serine-Specific
% 208.97/209.13  |- mesh__recordAuthorizer mesh__D012362 PLS
% 208.97/209.13  |- skos__altLabel mesh__D012362 tRNASer
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012362 2002
% 208.97/209.13  |- mesh__dateRevised mesh__D012362 1996-06-10
% 208.97/209.13  |- skos__prefLabel mesh__D012362 RNA, Transfer, Ser
% 208.97/209.13  |- mesh__publicMeSHNote mesh__D012362
% 208.97/209.13       91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.97/209.13  |- skos__broader mesh__D012362smesh__D012345
% 208.97/209.13  |- rdf__type mesh__D012362sskos__Concept
% 208.97/209.13  |- skos__historyNote mesh__D012362 RNA, Transfer %28%1966-1987%29%
% 208.97/209.13  |- skos__altLabel mesh__D012362 tRNA%28%Ser%29%
% 208.97/209.13  |- skos__altLabel mesh__D012362 Serine-Specific tRNA
% 208.97/209.13  |- skos__hiddenLabel mesh__D012362 Serine Specific tRNA
% 208.97/209.13  |- mesh__recordOriginator mesh__D012362 RLS
% 208.97/209.13  |- mesh__dateCreated mesh__D012362 1987-05-08
% 208.97/209.13  |- skos__historyNote mesh__D012362 Amino Acyl T RNA %28%1978-1987%29%
% 208.97/209.13  |- skos__scopeNote mesh__D012362
% 208.97/209.13       A transfer RNA which is specific for carrying serine to sites on the ribosomes in preparation for protein synthesis.%A%    
% 208.97/209.13  |- skos__annotation mesh__D012362
% 208.97/209.13       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012362 2000
% 208.97/209.13  |- skos__hiddenLabel mesh__D012362 Ser Transfer RNA
% 208.97/209.13  |- skos__altLabel mesh__D012362 Transfer RNA, Ser
% 208.97/209.13  |- mesh__dateEstablished mesh__D012362 1991-01-01
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012362 1998
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012362 2003
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012362 2001
% 208.97/209.13  |- skos__hiddenLabel mesh__D012362 RNA, Ser Transfer
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012362 2005
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012362 1997
% 208.97/209.13  |- mesh__recordAuthorizer mesh__D006325 sjn
% 208.97/209.13  |- skos__hiddenLabel mesh__D006325 Atrium, Heart
% 208.97/209.13  |- skos__broader mesh__D006325smesh__D006321
% 208.97/209.13  |- rdf__type mesh__D006325sskos__Concept
% 208.97/209.13  |- skos__annotation mesh__D006325 NIM: Manual 21.51   
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D006325 2005
% 208.97/209.13  |- skos__hiddenLabel mesh__D006325 Atrium, Right
% 208.97/209.13  |- skos__hiddenLabel mesh__D006325 Atrium, Left
% 208.97/209.13  |- mesh__historyNote mesh__D006325 2004%28%1966%29%   
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D006325 2006
% 208.97/209.13  |- skos__altLabel mesh__D006325 Heart Atrium
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D006325 2004
% 208.97/209.13  |- mesh__recordOriginator mesh__D006325 NLM
% 208.97/209.13  |- mesh__recordMaintainer mesh__D006325 nns
% 208.97/209.13  |- mesh__dateCreated mesh__D006325 1999-01-01
% 208.97/209.13  |- mesh__dateEstablished mesh__D006325 1968-01-01
% 208.97/209.13  |- skos__hiddenLabel mesh__D006325 Atria, Heart
% 208.97/209.13  |- skos__scopeNote mesh__D006325
% 208.97/209.13       The chambers of the heart, to which the BLOOD returns from the circulation.%A%    
% 208.97/209.13  |- skos__related mesh__D006325smesh__D016275
% 208.97/209.13  |- mesh__publicMeSHNote mesh__D006325 2004; see HEART ATRIUM 1966-2003   
% 208.97/209.13  |- mesh__dateRevised mesh__D006325 2003-07-09
% 208.97/209.13  |- skos__prefLabel mesh__D006325 Heart Atria
% 208.97/209.13  |- skos__scopeNote mesh__D050481
% 208.97/209.13       A family of neurotransmitter transporter proteins that are INTEGRAL MEMBRANE PROTEINS of the LIPID BILAYER of SECRETORY VESICLES. They are ANTIPORTERS that exchange vesicular PROTONS for cytoplasmic NEUROTRANSMITTER and play an essential role in regulating neurotransmission.%A%    
% 208.97/209.13  |- skos__prefLabel mesh__D050481
% 208.97/209.13       Vesicular Neurotransmitter Transport Proteins
% 208.97/209.13  |- mesh__recordMaintainer mesh__D050481 DRC
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D050481 2006
% 208.97/209.13  |- mesh__publicMeSHNote mesh__D050481 2006   
% 208.97/209.13  |- skos__hiddenLabel mesh__D050481 Vesicular Neurotransmitter Transporters
% 208.97/209.13  |- mesh__recordAuthorizer mesh__D050481 sjn
% 208.97/209.13  |- skos__broader mesh__D050481smesh__D050479
% 208.97/209.13  |- skos__altLabel mesh__D050481
% 208.97/209.13       Vesicle Neurotransmitter Transporter Proteins
% 208.97/209.13  |- mesh__recordOriginator mesh__D050481 DRC
% 208.97/209.13  |- rdf__type mesh__D050481sskos__Concept
% 208.97/209.13  |- mesh__dateEstablished mesh__D050481 2006-01-01
% 208.97/209.13  |- skos__altLabel mesh__D050481
% 208.97/209.13       Neurotransmitter Transport Proteins, Vesicular
% 208.97/209.13  |- skos__annotation mesh__D050481
% 208.97/209.13       do not confuse with VESICULAR TRANSPORT PROTEINS   
% 208.97/209.13  |- mesh__dateCreated mesh__D050481 2005-06-30
% 208.97/209.13  |- skos__altLabel mesh__D050481
% 208.97/209.13       Vesicular Neurotransmitter Transporter Proteins
% 208.97/209.13  |- skos__hiddenLabel mesh__D050481 Transporters, Vesicular Neurotransmitter
% 208.97/209.13  |- mesh__historyNote mesh__D050481 2006   
% 208.97/209.13  |- skos__broader mesh__D050481smesh__D017920
% 208.97/209.13  |- skos__altLabel mesh__D050481 Neurotransmitter Transporters, Vesicular
% 208.97/209.13  |- mesh__dateCreated mesh__D044444 2003-07-09
% 208.97/209.13  |- skos__historyNote mesh__D044444 Algae, Green %28%1969-2003%29%
% 208.97/209.13  |- skos__historyNote mesh__D044444 Algae %28%1964-2003%29%
% 208.97/209.13  |- skos__broader mesh__D044444smesh__D000460
% 208.97/209.13  |- mesh__historyNote mesh__D044444 2004; use ALGAE, GREEN 1998-2003   
% 208.97/209.13  |- mesh__dateEstablished mesh__D044444 2004-01-01
% 208.97/209.13  |- mesh__publicMeSHNote mesh__D044444 2004; see ALGAE, GREEN 1998-2003   
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D044444 2006
% 208.97/209.13  |- mesh__recordMaintainer mesh__D044444 SYSTEM
% 208.97/209.13  |- rdf__type mesh__D044444sskos__Concept
% 208.97/209.13  |- mesh__recordAuthorizer mesh__D044444 sjn
% 208.97/209.13  |- skos__scopeNote mesh__D044444
% 208.97/209.13       A genus of GREEN ALGAE in the family Scenedesmaceae. It forms colonies of usually four or eight cylindrical cells that are widely distributed in freshwater and SOIL.%A%    
% 208.97/209.13  |- mesh__recordOriginator mesh__D044444 ags
% 208.97/209.13  |- skos__prefLabel mesh__D044444 Scenedesmus
% 208.97/209.13  |- mesh__dateRevised mesh__D044444 2005-06-30
% 208.97/209.13  |- skos__altLabel mesh__D016753 IL-10
% 208.97/209.13  |- skos__scopeNote mesh__D016753
% 208.97/209.13       Factor that is a coregulator of mast cell growth. It is produced by T-cells and B-cells and shows extensive homology with the Epstein-Barr virus BCRFI gene.%A%    
% 208.97/209.13  |- mesh__recordMaintainer mesh__D016753 ssb
% 208.97/209.13  |- mesh__dateCreated mesh__D016753 1991-06-27
% 208.97/209.13  |- skos__altLabel mesh__D016753 Cytokine Synthesis Inhibitory Factor
% 208.97/209.13  |- skos__historyNote mesh__D016753 Interleukins %28%1990-1991%29%
% 208.97/209.13  |- rdf__type mesh__D016753sskos__Concept
% 208.97/209.13  |- mesh__dateEstablished mesh__D016753 1992-01-01
% 208.97/209.13  |- skos__annotation mesh__D016753 DF: IL 10 or IL10   
% 208.97/209.13  |- mesh__recordAuthorizer mesh__D016753 sjn
% 208.97/209.13  |- skos__altLabel mesh__D016753 CSIF-10
% 208.97/209.13  |- mesh__dateRevised mesh__D016753 2005-06-30
% 208.97/209.13  |- mesh__publicMeSHNote mesh__D016753
% 208.97/209.13       92; INTERLEUKIN-10 %28%NM%29% was indexed under INTERLEUKINS 1990-91%A%  
% 208.97/209.13  |- mesh__historyNote mesh__D016753
% 208.97/209.13       92; was INTERLEUKIN-10 %28%NM%29% 1990-91   
% 208.97/209.13  |- mesh__recordOriginator mesh__D016753 AGS
% 208.97/209.13  |- skos__hiddenLabel mesh__D016753 Interleukin 10
% 208.97/209.13  |- mesh__onlineNote mesh__D016753
% 208.97/209.13       use INTERLEUKIN-10 %28%NM%29% to search INTERLEUKIN-10 1990-91   
% 208.97/209.13  |- skos__altLabel mesh__D016753 IL10
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D016753 2006
% 208.97/209.13  |- skos__broader mesh__D016753smesh__D007378
% 208.97/209.13  |- skos__prefLabel mesh__D016753 Interleukin-10
% 208.97/209.13  |- mesh__dateCreated mesh__D002733 1976-05-19
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D002733 1997
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D002733 2005
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D002733 2002
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D002733 1996
% 208.97/209.13  |- mesh__historyNote mesh__D002733 77   
% 208.97/209.13  |- rdf__type mesh__D002733sskos__Concept
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D002733 2004
% 208.97/209.13  |- skos__broader mesh__D002733smesh__D010636
% 208.97/209.13  |- skos__prefLabel mesh__D002733 Chlorophenols
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D002733 2001
% 208.97/209.13  |- mesh__recordMaintainer mesh__D002733 PLS
% 208.97/209.13  |- skos__scopeNote mesh__D002733
% 208.97/209.13       Phenols substituted with one or more chlorine atoms in any position.%A%    
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D002733 2003
% 208.97/209.13  |- skos__altLabel mesh__D002733 Hydroxychlorobenzenes
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D002733 2000
% 208.97/209.13  |- skos__historyNote mesh__D002733 Phenols %28%1966-1976%29%
% 208.97/209.13  |- skos__historyNote mesh__D002733 Chlorobenzenes %28%1974-1976%29%
% 208.97/209.13  |- mesh__publicMeSHNote mesh__D002733
% 208.97/209.13       77; PENTACHLOROPHENOL was see under PHENOLS 1971-76   
% 208.97/209.13  |- mesh__recordAuthorizer mesh__D002733 PLS
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D002733 1995
% 208.97/209.13  |- mesh__dateEstablished mesh__D002733 1977-01-01
% 208.97/209.13  |- mesh__recordOriginator mesh__D002733 RLS
% 208.97/209.13  |- skos__broader mesh__D002733smesh__D002722
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D002733 1999
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D002733 1994
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D002733 1998
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D002733 2006
% 208.97/209.13  |- mesh__dateRevised mesh__D002733 1993-06-02
% 208.97/209.13  |- skos__hiddenLabel mesh__D012363 tRNA, Threonine-Specific
% 208.97/209.13  |- skos__altLabel mesh__D012363 Threonine-Specific tRNA
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012363 2001
% 208.97/209.13  |- skos__altLabel mesh__D012363 Transfer RNA, Thr
% 208.97/209.13  |- skos__altLabel mesh__D012363 tRNAThr
% 208.97/209.13  |- mesh__publicMeSHNote mesh__D012363
% 208.97/209.13       91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.97/209.13  |- skos__broader mesh__D012363smesh__D012345
% 208.97/209.13  |- skos__historyNote mesh__D012363 RNA, Transfer %28%1966-1987%29%
% 208.97/209.13  |- rdf__type mesh__D012363sskos__Concept
% 208.97/209.13  |- mesh__historyNote mesh__D012363
% 208.97/209.13       91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.97/209.13  |- skos__hiddenLabel mesh__D012363 Threonine Specific tRNA
% 208.97/209.13  |- mesh__recordAuthorizer mesh__D012363 PLS
% 208.97/209.13  |- skos__hiddenLabel mesh__D012363 RNA, Thr Transfer
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012363 2002
% 208.97/209.13  |- skos__annotation mesh__D012363
% 208.97/209.13       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 208.97/209.13  |- skos__hiddenLabel mesh__D012363 Thr Transfer RNA
% 208.97/209.13  |- mesh__dateRevised mesh__D012363 1996-06-10
% 208.97/209.13  |- skos__altLabel mesh__D012363 tRNA%28%Thr%29%
% 208.97/209.13  |- mesh__dateEstablished mesh__D012363 1991-01-01
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012363 1998
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012363 2003
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012363 2005
% 208.97/209.13  |- mesh__recordOriginator mesh__D012363 RLS
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012363 1997
% 208.97/209.13  |- skos__scopeNote mesh__D012363
% 208.97/209.13       A transfer RNA which is specific for carrying threonine to sites on the ribosomes in preparation for protein synthesis.%A%    
% 208.97/209.13  |- mesh__dateCreated mesh__D012363 1987-05-08
% 208.97/209.13  |- skos__prefLabel mesh__D012363 RNA, Transfer, Thr
% 208.97/209.13  |- skos__historyNote mesh__D012363 Amino Acyl T RNA %28%1978-1987%29%
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012363 1999
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012363 2004
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012363 2006
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012363 2000
% 208.97/209.13  |- mesh__recordMaintainer mesh__D012363 TGC
% 208.97/209.13  |- skos__hiddenLabel mesh__D006326 Auscultation, Heart
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D006326 1999
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D006326 2005
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D006326 2006
% 208.97/209.13  |- skos__hiddenLabel mesh__D006326 Auscultations, Cardiac
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D006326 2003
% 208.97/209.13  |- mesh__recordAuthorizer mesh__D006326 SJN
% 208.97/209.13  |- skos__broader mesh__D006326smesh__D006334
% 208.97/209.13  |- skos__broader mesh__D006326smesh__D001314
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D006326 2004
% 208.97/209.13  |- mesh__dateCreated mesh__D006326 1999-01-01
% 208.97/209.13  |- skos__hiddenLabel mesh__D006326 Cardiac Auscultations
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D006326 2000
% 208.97/209.13  |- skos__hiddenLabel mesh__D006326 Auscultation, Cardiac
% 208.97/209.13  |- skos__scopeNote mesh__D006326
% 208.97/209.13       Act of listening for sounds within the heart.     
% 208.97/209.13  |- skos__hiddenLabel mesh__D006326 Heart Auscultations
% 208.97/209.13  |- mesh__dateRevised mesh__D006326 1997-06-20
% 208.97/209.13  |- mesh__recordMaintainer mesh__D006326 PXP
% 208.97/209.13  |- skos__hiddenLabel mesh__D006326 Auscultations, Heart
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D006326 2001
% 208.97/209.13  |- skos__prefLabel mesh__D006326 Heart Auscultation
% 208.97/209.13  |- mesh__recordOriginator mesh__D006326 NLM
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D006326 2002
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D006326 1998
% 208.97/209.13  |- rdf__type mesh__D006326sskos__Concept
% 208.97/209.13  |- skos__annotation mesh__D006326
% 208.97/209.13       /drug eff /rad eff permitted; do not use /util except by MeSH definition; /instrum: STETHOSCOPES is also available%A%  
% 208.97/209.13  |- skos__altLabel mesh__D006326 Cardiac Auscultation
% 208.97/209.13  |- skos__related mesh__D006326smesh__D010701
% 208.97/209.13  |- skos__scopeNote mesh__D050482
% 208.97/209.13       A group of membrane transport proteins that transport biogenic amine derivatives of catechol across the PLASMA MEMBRANE. Catecholamine plasma membrane transporter proteins regulate neural transmission as well as catecholamine metabolism and recycling.%A%    
% 208.97/209.13  |- mesh__recordOriginator mesh__D050482 DRC
% 208.97/209.13  |- mesh__recordMaintainer mesh__D050482 DRC
% 208.97/209.13  |- skos__hiddenLabel mesh__D050482
% 208.97/209.13       Neurotransmitter Transport Proteins, Catecholamine Specific
% 208.97/209.13  |- rdf__type mesh__D050482sskos__Concept
% 208.97/209.13  |- skos__prefLabel mesh__D050482
% 208.97/209.13       Catecholamine Plasma Membrane Transport Proteins
% 208.97/209.13  |- skos__hiddenLabel mesh__D050482
% 208.97/209.13       Neurotransmitter Transporters, Catecholamine Specific
% 208.97/209.13  |- skos__altLabel mesh__D050482
% 208.97/209.13       Neurotransmitter Transporters, Catecholamine-Specific
% 208.97/209.13  |- mesh__publicMeSHNote mesh__D050482
% 208.97/209.13       2006; CATACHOLAMINE TRANSPORT PROTEIN was indexed under MEMBRANE TRANSPORT PROTEINS 2004 %26% CARRIER PROTEINS 1980-2004%A%  
% 208.97/209.13  |- skos__altLabel mesh__D050482 Catecholamine Carrier
% 208.97/209.13  |- mesh__recordAuthorizer mesh__D050482 sjn
% 208.97/209.13  |- skos__altLabel mesh__D050482 Catecholamine Transport Protein
% 208.97/209.13  |- skos__hiddenLabel mesh__D050482
% 208.97/209.13       Catecholamine-Specific Neurotransmitter Transporters
% 208.97/209.13  |- skos__broader mesh__D050482smesh__D050480
% 208.97/209.13  |- skos__hiddenLabel mesh__D050482 Transport Protein, Catecholamine
% 208.97/209.13  |- mesh__dateEstablished mesh__D050482 2006-01-01
% 208.97/209.13  |- skos__historyNote mesh__D050482
% 208.97/209.13       Membrane Transport Proteins %28%1980-2005%29%
% 208.97/209.13  |- skos__altLabel mesh__D050482 Catecholamine Plasma Membrane Transporters
% 208.97/209.13  |- skos__altLabel mesh__D050482
% 208.97/209.13       Catecholamine Plasma Membrane Transporter Proteins
% 208.97/209.13  |- mesh__historyNote mesh__D050482 2006%28%1980%29%   
% 208.97/209.13  |- skos__altLabel mesh__D050482
% 208.97/209.13       Neurotransmitter Transport Proteins, Catecholamine-Specific
% 208.97/209.13  |- mesh__dateCreated mesh__D050482 2005-06-30
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D050482 2006
% 208.97/209.13  |- skos__hiddenLabel mesh__D050482
% 208.97/209.13       Transporters, Catecholamine-Specific Neurotransmitter
% 208.97/209.13  |- mesh__recordAuthorizer mesh__D044445 sjn
% 208.97/209.13  |- mesh__recordOriginator mesh__D044445 ags
% 208.97/209.13  |- mesh__recordMaintainer mesh__D044445 SYSTEM
% 208.97/209.13  |- mesh__publicMeSHNote mesh__D044445 2004; see ALGAE, GREEN 2000-2003   
% 208.97/209.13  |- mesh__dateRevised mesh__D044445 2005-06-30
% 208.97/209.13  |- skos__prefLabel mesh__D044445 Ulva
% 208.97/209.13  |- mesh__historyNote mesh__D044445 2004; use ALGAE, GREEN 2000-2003   
% 208.97/209.13  |- mesh__dateEstablished mesh__D044445 2004-01-01
% 208.97/209.13  |- skos__altLabel mesh__D044445 Sea Lettuces
% 208.97/209.13  |- skos__scopeNote mesh__D044445
% 208.97/209.13       A genus of GREEN ALGAE in the family Ulvaceae. Commonly know as sea lettuces, they grow attached to rocks and KELP in marine and estuarine waters.%A%    
% 208.97/209.13  |- mesh__dateCreated mesh__D044445 2003-07-09
% 208.97/209.13  |- skos__altLabel mesh__D044445 Ulva arasakii
% 208.97/209.13  |- skos__broader mesh__D044445smesh__D000460
% 208.97/209.13  |- skos__historyNote mesh__D044445 Algae, Green %28%1969-2003%29%
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D044445 2006
% 208.97/209.13  |- rdf__type mesh__D044445sskos__Concept
% 208.97/209.13  |- skos__historyNote mesh__D016754 Boron %28%1966-1992%29%
% 208.97/209.13  |- skos__scopeNote mesh__D016754
% 208.97/209.13       A technique for the treatment of neoplasms, especially gliomas and melanomas in which boron-10, an isotope, is introduced into the target cells followed by irradiation with thermal neutrons.%A%    
% 208.97/209.13  |- skos__altLabel mesh__D016754 Therapy, Boron Neutron Capture
% 208.97/209.13  |- skos__altLabel mesh__D016754 Boron-Neutron Capture Therapy
% 208.97/209.13  |- mesh__publicMeSHNote mesh__D016754 93   
% 208.97/209.13  |- mesh__recordOriginator mesh__D016754 JLS
% 208.97/209.13  |- skos__annotation mesh__D016754
% 208.97/209.13       do not use /util except by MeSH definition; coord IM with disease /radiother %28%IM%29%; DF: BNCT%A%  
% 208.97/209.13  |- skos__historyNote mesh__D016754
% 208.97/209.13       Radiotherapy, High-Energy %28%1966-1992%29%
% 208.97/209.13  |- mesh__dateCreated mesh__D016754 1992-05-07
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D016754 2006
% 208.97/209.13  |- skos__prefLabel mesh__D016754 Boron Neutron Capture Therapy
% 208.97/209.13  |- skos__altLabel mesh__D016754 Neutron Capture Therapy, Boron
% 208.97/209.13  |- mesh__dateEstablished mesh__D016754 1993-01-01
% 208.97/209.13  |- skos__broader mesh__D016754smesh__D017247
% 208.97/209.13  |- mesh__historyNote mesh__D016754 93   
% 208.97/209.13  |- skos__hiddenLabel mesh__D016754 Therapy, Boron-Neutron Capture
% 208.97/209.13  |- skos__historyNote mesh__D016754 Neutrons %28%1966-1992%29%
% 208.97/209.13  |- rdf__type mesh__D016754sskos__Concept
% 208.97/209.13  |- mesh__recordAuthorizer mesh__D016754 sjn
% 208.97/209.13  |- mesh__recordMaintainer mesh__D016754 lkt
% 208.97/209.13  |- mesh__dateRevised mesh__D016754 2005-06-30
% 208.97/209.13  |- skos__prefLabel mesh__D002734 Chlorophyll
% 208.97/209.13  |- skos__broader mesh__D002734smesh__D008665
% 208.97/209.13  |- mesh__dateRevised mesh__D002734 2005-06-30
% 208.97/209.13  |- rdf__type mesh__D002734sskos__Concept
% 208.97/209.13  |- skos__scopeNote mesh__D002734
% 208.97/209.13       Porphyrin derivatives containing magnesium that act to convert light energy in photosynthetic organisms.%A%    
% 208.97/209.13  |- skos__broader mesh__D002734smesh__D011166
% 208.97/209.13  |- skos__broader mesh__D002734smesh__D045725
% 208.97/209.13  |- skos__related mesh__D002734smesh__D010788
% 208.97/209.13  |- skos__hiddenLabel mesh__D002734 740, Chlorophyll
% 208.97/209.13  |- mesh__dateCreated mesh__D002734 1999-01-01
% 208.97/209.13  |- mesh__recordMaintainer mesh__D002734 ssb
% 208.97/209.13  |- mesh__recordAuthorizer mesh__D002734 sjn
% 208.97/209.13  |- mesh__recordOriginator mesh__D002734 NLM
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D002734 2006
% 208.97/209.13  |- mesh__dateEstablished mesh__D012364 1991-01-01
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012364 2003
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012364 1999
% 208.97/209.13  |- skos__hiddenLabel mesh__D012364 tRNA, Tryptophan-Specific
% 208.97/209.13  |- skos__prefLabel mesh__D012364 RNA, Transfer, Trp
% 208.97/209.13  |- mesh__historyNote mesh__D012364
% 208.97/209.13       91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.97/209.13  |- skos__altLabel mesh__D012364 TRNATrp
% 208.97/209.13  |- skos__hiddenLabel mesh__D012364 Tryptophan Specific tRNA
% 208.97/209.13  |- skos__hiddenLabel mesh__D012364 Trp Transfer RNA
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012364 2006
% 208.97/209.13  |- skos__hiddenLabel mesh__D012364 RNA, Trp Transfer
% 208.97/209.13  |- skos__altLabel mesh__D012364 tRNA%28%Trp%29%
% 208.97/209.13  |- mesh__dateRevised mesh__D012364 1996-06-10
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012364 1998
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012364 2002
% 208.97/209.13  |- skos__altLabel mesh__D012364 Tryptophan-Specific tRNA
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012364 2005
% 208.97/209.13  |- mesh__recordAuthorizer mesh__D012364 PLS
% 208.97/209.13  |- skos__historyNote mesh__D012364 Amino Acyl T RNA %28%1978-1987%29%
% 208.97/209.13  |- rdf__type mesh__D012364sskos__Concept
% 208.97/209.13  |- mesh__dateCreated mesh__D012364 1987-05-08
% 208.97/209.13  |- skos__scopeNote mesh__D012364
% 208.97/209.13       A transfer RNA which is specific for carrying tryptophan to sites on the ribosomes in preparation for protein synthesis.%A%    
% 208.97/209.13  |- mesh__publicMeSHNote mesh__D012364
% 208.97/209.13       91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.97/209.13  |- mesh__recordOriginator mesh__D012364 RLS
% 208.97/209.13  |- skos__broader mesh__D012364smesh__D012345
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012364 1997
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012364 2001
% 208.97/209.13  |- mesh__recordMaintainer mesh__D012364 TGC
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012364 2004
% 208.97/209.13  |- skos__historyNote mesh__D012364 RNA, Transfer %28%1966-1987%29%
% 208.97/209.13  |- skos__altLabel mesh__D012364 Transfer RNA, Trp
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D012364 2000
% 208.97/209.13  |- skos__annotation mesh__D012364
% 208.97/209.13       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D006327 2000
% 208.97/209.13  |- skos__hiddenLabel mesh__D006327 Dissociations, Auriculo-Ventricular
% 208.97/209.13  |- skos__hiddenLabel mesh__D006327 Block, Atrioventricular
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D006327 2004
% 208.97/209.13  |- skos__hiddenLabel mesh__D006327 Dissociation, Auriculo-Ventricular
% 208.97/209.13  |- mesh__dateCreated mesh__D006327 1999-01-01
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D006327 2001
% 208.97/209.13  |- skos__broader mesh__D006327smesh__D001145
% 208.97/209.13  |- skos__hiddenLabel mesh__D006327 Heart Blocks
% 208.97/209.13  |- mesh__recordOriginator mesh__D006327 NLM
% 208.97/209.13  |- skos__annotation mesh__D006327 a type of arrhythmia   
% 208.97/209.13  |- skos__hiddenLabel mesh__D006327 Block, Heart
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D006327 2002
% 208.97/209.13  |- mesh__dateRevised mesh__D006327 1999-11-03
% 208.97/209.13  |- skos__hiddenLabel mesh__D006327 Auriculo-Ventricular Dissociations
% 208.97/209.13  |- skos__hiddenLabel mesh__D006327 Blocks, Atrioventricular
% 208.97/209.13  |- rdf__type mesh__D006327sskos__Concept
% 208.97/209.13  |- mesh__recordAuthorizer mesh__D006327 sjn
% 208.97/209.13  |- skos__hiddenLabel mesh__D006327 Atrioventricular Blocks
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D006327 2005
% 208.97/209.13  |- skos__scopeNote mesh__D006327
% 208.97/209.13       Impairment of conduction in heart excitation. It is often applied specifically to atrioventricular heart block. %28%Dorland, 27th ed%29%%A%    
% 208.97/209.13  |- skos__prefLabel mesh__D006327 Heart Block
% 208.97/209.13  |- mesh__recordMaintainer mesh__D006327 TAP
% 208.97/209.13  |- skos__hiddenLabel mesh__D006327 Auriculo Ventricular Dissociation
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D006327 2006
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D006327 2003
% 208.97/209.13  |- skos__hiddenLabel mesh__D006327 Blocks, Heart
% 208.97/209.13  |- skos__scopeNote mesh__D050483
% 208.97/209.13       Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of dopaminergic neurons. They remove DOPAMINE from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS and are the target of DOPAMINE UPTAKE INHIBITORS.%A%    
% 208.97/209.13  |- skos__altLabel mesh__D050483 DAT Dopamine Transporter
% 208.97/209.13  |- skos__hiddenLabel mesh__D050483 Transporter Proteins, Dopamine
% 208.97/209.13  |- mesh__dateCreated mesh__D050483 2005-06-30
% 208.97/209.13  |- skos__prefLabel mesh__D050483
% 208.97/209.13       Dopamine Plasma Membrane Transport Proteins
% 208.97/209.13  |- skos__altLabel mesh__D050483
% 208.97/209.13       Neurotransmitter Transport Proteins, Dopamine-Specific
% 208.97/209.13  |- mesh__activeMeSHYear mesh__D050483 2006
% 208.97/209.13  |- skos__hiddenLabel mesh__D050483
% 208.97/209.13       Transporters, Dopamine-Specific Neurotransmitter
% 208.97/209.13  |- skos__altLabel mesh__D050483 Dopamine Carriers
% 208.97/209.13  |- mesh__recordOriginator mesh__D050483 DRC
% 208.97/209.13  |- rdf__type mesh__D050483sskos__Concept
% 208.97/209.13  |- skos__hiddenLabel mesh__D050483 Dopamine Transporter, DAT
% 208.97/209.13  |- skos__altLabel mesh__D050483 Dopamine Transporter Proteins
% 208.97/209.13  |- mesh__recordMaintainer mesh__D050483 DRC
% 208.97/209.13  |- mesh__recordAuthorizer mesh__D050483 sjn
% 208.97/209.13  |- skos__altLabel mesh__D050483 DAT Dopamine Transporter Proteins
% 208.97/209.13  |- mesh__publicMeSHNote mesh__D050483
% 208.97/209.13       2006; DOPAMINE TRANSPORTER PROTEINS was indexed under MEMBRANE TRANSPORT PROTEINS 2005, CARRIER PROTEINS 1993-2004, NERVE TISSUE PROTEINS; MEMBRANE GLYOPROTEINS %26% MEMBRANE PROTEINS 1987-2004; DOPAMINE UPTAKE COMPLEX was indexed under MEMBRANE PROTEINS %26% NERVE TISSUE PROTEINS 1993-2004, DOPAMINE/metab 1991-1992%A%  
% 208.97/209.13  |- skos__broader mesh__D050483smesh__D050482
% 208.97/209.13  |- skos__altLabel mesh__D050483 Dopamine Transporter
% 208.97/209.13  |- skos__altLabel mesh__D050483
% 208.97/209.13       Dopamine Plasma Membrane Transporter Proteins
% 208.97/209.13  |- skos__hiddenLabel mesh__D050483
% 208.97/209.13       Neurotransmitter Transporters, Dopamine Specific
% 208.97/209.13  |- skos__hiddenLabel mesh__D050483
% 208.97/209.13       Dopamine-Specific Neurotransmitter Transporters
% 208.97/209.13  |- skos__altLabel mesh__D050483
% 208.97/209.13       Neurotransmitter Transporters, Dopamine-Specific
% 208.97/209.13  |- skos__hiddenLabel mesh__D050483 Transporter, Dopamine
% 208.97/209.13  |- mesh__historyNote mesh__D050483 2006%28%1987%29%   
% 208.97/209.13  |- skos__historyNote mesh__D050483
% 208.97/209.13       Membrane Transport Proteins %28%1987-2005%29%
% 208.97/209.13  |- mesh__dateEstablished mesh__D050483 2006-01-01
% 208.97/209.13  |- skos__hiddenLabel mesh__D050483 Transporter, DAT Dopamine
% 208.97/209.13  |- skos__broader mesh__D050483smesh__D027981
% 208.97/209.13  |- skos__hiddenLabel mesh__D050483 Carriers, Dopamine
% 208.97/209.13  |- skos__hiddenLabel mesh__D050483
% 208.97/209.13       Neurotransmitter Transport Proteins, Dopamine Specific
% 208.97/209.13  |- skos__historyNote mesh__D044446 Algae, Green %28%1970-2003%29%
% 208.97/209.13  |- skos__scopeNote mesh__D044446
% 208.97/209.13       A genus of GREEN ALGAE in the family Volvocaceae. They form spherical colonies of hundreds or thousands of bi-flagellated cells in a semi-transparent gelatinous ball.%A%    
% 208.97/209.13  |- mesh__recordAuthorizer mesh__D044446 sjn
% 208.97/209.13  |- skos__prefLabel mesh__D044446 Volvox
% 208.97/209.13  |- mesh__recordOriginator mesh__D044446 ags
% 208.97/209.13  |- mesh__dateCreated mesh__D044446 2003-07-09
% 208.97/209.13  |- mesh__dateRevised mesh__D044446 2005-06-30
% 208.97/209.13  |- skos__broader mesh__D044446smesh__D000460
% 208.97/209.13  |- mesh__historyNote mesh__D044446 2004; use ALGAE, GREEN 1998-2003   
% 208.97/209.13  |- mesh__dateEstablished mesh__D044446 2004-01-01
% 208.97/209.14  |- mesh__publicMeSHNote mesh__D044446 2004; see ALGAE, GREEN 1998-2003   
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D044446 2006
% 208.97/209.14  |- rdf__type mesh__D044446sskos__Concept
% 208.97/209.14  |- mesh__recordMaintainer mesh__D044446 SYSTEM
% 208.97/209.14  |- skos__altLabel mesh__D016755 Proto-Oncogene Products c-jun
% 208.97/209.14  |- skos__hiddenLabel mesh__D016755 jun Proto Oncogene Proteins
% 208.97/209.14  |- skos__broader mesh__D016755smesh__D009687
% 208.97/209.14  |- skos__altLabel mesh__D016755 c-fos-Associated Protein p39
% 208.97/209.14  |- skos__altLabel mesh__D016755 fos-Associated Protein p39
% 208.97/209.14  |- skos__broader mesh__D016755smesh__D050976
% 208.97/209.14  |- skos__historyNote mesh__D016755
% 208.97/209.14       Proto-Oncogene Proteins %28%1987-1991%29%
% 208.97/209.14  |- mesh__recordAuthorizer mesh__D016755 sjn
% 208.97/209.14  |- skos__hiddenLabel mesh__D016755 Proto Oncogene Proteins c jun
% 208.97/209.14  |- skos__altLabel mesh__D016755 jun Proto-Oncogene Proteins
% 208.97/209.14  |- mesh__dateRevised mesh__D016755 2005-06-30
% 208.97/209.14  |- mesh__recordOriginator mesh__D016755 AGS
% 208.97/209.14  |- skos__altLabel mesh__D016755 c-jun Proteins
% 208.97/209.14  |- skos__hiddenLabel mesh__D016755 p39 c jun
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D016755 2006
% 208.97/209.14  |- mesh__onlineNote mesh__D016755
% 208.97/209.14       use PROTO-ONCOGENE PROTEINS C-JUN %28%NM%29% to search PROTO-ONCOGENE PROTEIN JUN %28%NM%29% 1988-91%A%  
% 208.97/209.14  |- mesh__historyNote mesh__D016755
% 208.97/209.14       92; was PROTO-ONCOGENE PROTEIN JUN %28%NM%29% 1988-91   
% 208.97/209.14  |- skos__altLabel mesh__D016755 p39%28%c-jun%29%
% 208.97/209.14  |- skos__altLabel mesh__D016755 jun Proto-Oncogene Product p39
% 208.97/209.14  |- mesh__publicMeSHNote mesh__D016755
% 208.97/209.14       92; PROTO-ONCOGENE PROTEIN JUN %28%NM%29% was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1988-91%A%  
% 208.97/209.14  |- skos__historyNote mesh__D016755 Transcription Factors %28%1987-1991%29%
% 208.97/209.14  |- skos__related mesh__D016755smesh__D018808
% 208.97/209.14  |- skos__altLabel mesh__D016755 Proto-Oncogene Proteins jun
% 208.97/209.14  |- skos__hiddenLabel mesh__D016755 c fos Associated Protein p39
% 208.97/209.14  |- skos__broader mesh__D016755smesh__D011518
% 208.97/209.14  |- skos__annotation mesh__D016755
% 208.97/209.14       /drug eff /ultrastruct permitted; DF: note short X refs   
% 208.97/209.14  |- rdf__type mesh__D016755sskos__Concept
% 208.97/209.14  |- skos__altLabel mesh__D016755 p39 c-jun
% 208.97/209.14  |- skos__hiddenLabel mesh__D016755 c jun Proteins
% 208.97/209.14  |- skos__scopeNote mesh__D016755
% 208.97/209.14       Cellular DNA-binding proteins encoded by the c-jun genes %28%GENES, JUN%29%. They are involved in growth-related transcriptional control. There appear to be three distinct functions: dimerization %28%with c-fos%29%, DNA-binding, and transcriptional activation. Oncogenic transformation can take place by constitutive expression of c-jun.%A%    
% 208.97/209.14  |- mesh__dateEstablished mesh__D016755 1992-01-01
% 208.97/209.14  |- skos__hiddenLabel mesh__D016755 fos Associated Protein p39
% 208.97/209.14  |- mesh__recordMaintainer mesh__D016755 DRC
% 208.97/209.14  |- mesh__dateCreated mesh__D016755 1991-07-12
% 208.97/209.14  |- skos__prefLabel mesh__D016755 Proto-Oncogene Proteins c-jun
% 208.97/209.14  |- skos__historyNote mesh__D016755 DNA-Binding Proteins %28%1987-1991%29%
% 208.97/209.14  |- skos__hiddenLabel mesh__D016755 Proto Oncogene Products c jun
% 208.97/209.14  |- skos__hiddenLabel mesh__D016755 Proto Oncogene Proteins jun
% 208.97/209.14  |- skos__hiddenLabel mesh__D016755 jun Proto Oncogene Product p39
% 208.97/209.14  |- rdf__type mesh__D002735sskos__Concept
% 208.97/209.14  |- mesh__recordAuthorizer mesh__D002735 sjn
% 208.97/209.14  |- mesh__recordOriginator mesh__D002735 NLM
% 208.97/209.14  |- skos__broader mesh__D002735smesh__D002734
% 208.97/209.14  |- skos__prefLabel mesh__D002735 Chlorophyllides
% 208.97/209.14  |- mesh__publicMeSHNote mesh__D002735
% 208.97/209.14       91; was see under CHLOROPHYLL 1975-90   
% 208.97/209.14  |- mesh__dateCreated mesh__D002735 1974-11-19
% 208.97/209.14  |- mesh__dateRevised mesh__D002735 2005-06-30
% 208.97/209.14  |- mesh__historyNote mesh__D002735
% 208.97/209.14       91%28%75%29%; was see under CHLOROPHYLL 1975-90   
% 208.97/209.14  |- skos__annotation mesh__D002735 products of chlorophil hydrolysis   
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D002735 2006
% 208.97/209.14  |- mesh__dateEstablished mesh__D002735 1991-01-01
% 208.97/209.14  |- skos__historyNote mesh__D002735 Chlorophyll %28%1972-1974%29%
% 208.97/209.14  |- skos__scopeNote mesh__D002735
% 208.97/209.14       Products of the hydrolysis of chlorophylls in which the phytic acid side chain has been removed and the carboxylic acids saponified.%A%    
% 208.97/209.14  |- mesh__recordMaintainer mesh__D002735 ssb
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D007420 2005
% 208.97/209.14  |- skos__scopeNote mesh__D007420
% 208.97/209.14       A segment of the LOWER GASTROINTESTINAL TRACT that includes the CECUM; the COLON; and the RECTUM.%A%    
% 208.97/209.14  |- skos__altLabel mesh__D007420 Large Intestine
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D007420 2006
% 208.97/209.14  |- mesh__recordOriginator mesh__D007420 NLM
% 208.97/209.14  |- skos__prefLabel mesh__D007420 Intestine, Large
% 208.97/209.14  |- mesh__onlineNote mesh__D007420
% 208.97/209.14       search INTESTINAL MICROORGANISMS under INTESTINES 1966-67%A%  
% 208.97/209.14  |- mesh__recordAuthorizer mesh__D007420 sjn
% 208.97/209.14  |- mesh__dateCreated mesh__D007420 1999-01-01
% 208.97/209.14  |- skos__annotation mesh__D007420
% 208.97/209.14       GEN: prefer specifics; inflammation: coord IM with GASTROENTERITIS %28%IM%29%%A%  
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D007420 2004
% 208.97/209.14  |- mesh__recordMaintainer mesh__D007420 lkt
% 208.97/209.14  |- mesh__historyNote mesh__D007420
% 208.97/209.14       INTESTINAL MICROORGANISMS was heading 1963-67   
% 208.97/209.14  |- rdf__type mesh__D007420sskos__Concept
% 208.97/209.14  |- skos__broader mesh__D007420smesh__D007422
% 208.97/209.14  |- mesh__dateRevised mesh__D007420 2003-07-09
% 208.97/209.14  |- mesh__publicMeSHNote mesh__D007420
% 208.97/209.14       INTESTINAL MICROORGANISMS was heading 1963-67   
% 208.97/209.14  |- skos__broader mesh__D007420smesh__D041741
% 208.97/209.14  |- skos__hiddenLabel mesh__D012365 RNA, Tyr Transfer
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D012365 1998
% 208.97/209.14  |- skos__hiddenLabel mesh__D012365 Tyr Transfer RNA
% 208.97/209.14  |- skos__altLabel mesh__D012365 Transfer RNA, Tyr
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D012365 2000
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D012365 2005
% 208.97/209.14  |- mesh__historyNote mesh__D012365
% 208.97/209.14       91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.97/209.14  |- skos__prefLabel mesh__D012365 RNA, Transfer, Tyr
% 208.97/209.14  |- skos__hiddenLabel mesh__D012365 Tyrosine Specific tRNA
% 208.97/209.14  |- skos__altLabel mesh__D012365 Tyrosine-Specific tRNA
% 208.97/209.14  |- rdf__type mesh__D012365sskos__Concept
% 208.97/209.14  |- mesh__dateRevised mesh__D012365 1996-06-10
% 208.97/209.14  |- mesh__publicMeSHNote mesh__D012365
% 208.97/209.14       91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D012365 2002
% 208.97/209.14  |- skos__broader mesh__D012365smesh__D012345
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D012365 1997
% 208.97/209.14  |- mesh__recordMaintainer mesh__D012365 TGC
% 208.97/209.14  |- mesh__recordAuthorizer mesh__D012365 PLS
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D012365 2004
% 208.97/209.14  |- skos__altLabel mesh__D012365 tRNATyr
% 208.97/209.14  |- skos__historyNote mesh__D012365 Amino Acyl T RNA %28%1978-1987%29%
% 208.97/209.14  |- skos__historyNote mesh__D012365 RNA, Transfer %28%1966-1987%29%
% 208.97/209.14  |- skos__altLabel mesh__D012365 tRNA%28%Tyr%29%
% 208.97/209.14  |- skos__annotation mesh__D012365
% 208.97/209.14       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 208.97/209.14  |- skos__scopeNote mesh__D012365
% 208.97/209.14       A transfer RNA which is specific for carrying tyrosine to sites on the ribosomes in preparation for protein synthesis.%A%    
% 208.97/209.14  |- mesh__dateCreated mesh__D012365 1987-05-08
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D012365 2003
% 208.97/209.14  |- mesh__dateEstablished mesh__D012365 1991-01-01
% 208.97/209.14  |- mesh__recordOriginator mesh__D012365 RLS
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D012365 1999
% 208.97/209.14  |- skos__hiddenLabel mesh__D012365 tRNA, Tyrosine-Specific
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D012365 2001
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D012365 2006
% 208.97/209.14  |- mesh__publicMeSHNote mesh__D039502
% 208.97/209.14       2003; CBP80 PROTEIN was indexed under RNA-BINDING PROTEINS 1994-2002; CAF20 PROTEIN was indexed under RNA-BINDING PROTEINS 1997-2002; CBP20 PROTEIN was indexed under RNA-BINDING PROTEINS 1996-2002%A%  
% 208.97/209.14  |- skos__hiddenLabel mesh__D039502 Cap Binding Complex 80 kDa protein
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D039502 2006
% 208.97/209.14  |- mesh__recordOriginator mesh__D039502 jmp
% 208.97/209.14  |- skos__altLabel mesh__D039502 CBP80 Protein
% 208.97/209.14  |- skos__altLabel mesh__D039502 NCBP2 Protein
% 208.97/209.14  |- skos__prefLabel mesh__D039502 Nuclear Cap-Binding Protein Complex
% 208.97/209.14  |- skos__hiddenLabel mesh__D039502 Cap Binding Protein Complex, Nuclear
% 208.97/209.14  |- mesh__historyNote mesh__D039502
% 208.97/209.14       2003; for CBP80 PROTEIN use RNA CAP-BINDING PROTEINS 1994-2002; for CAF20 PROTEIN use RNA CAP-BINDING PROTEINS 1997-2002;  for CBP20 PROTEIN use RNA CAP-BINDING PROTEINS 1996-2002%A%  
% 208.97/209.14  |- skos__hiddenLabel mesh__D039502
% 208.97/209.14       Nuclear Cap Binding Protein Subunit 1, 80 kDa
% 208.97/209.14  |- mesh__recordAuthorizer mesh__D039502 ags
% 208.97/209.14  |- mesh__dateCreated mesh__D039502 2002-07-03
% 208.97/209.14  |- mesh__dateRevised mesh__D039502 2005-07-21
% 208.97/209.14  |- skos__hiddenLabel mesh__D039502
% 208.97/209.14       Nuclear Cap Binding Protein Subunit 2, 20 kDa
% 208.97/209.14  |- skos__altLabel mesh__D039502 Nuclear Cap Binding Protein, 80-kDa
% 208.97/209.14  |- skos__broader mesh__D039502smesh__D039381
% 208.97/209.14  |- skos__altLabel mesh__D039502 NCBP1 Protein
% 208.97/209.14  |- skos__historyNote mesh__D039502 RNA-Binding Proteins %28%1981-2002%29%
% 208.97/209.14  |- skos__altLabel mesh__D039502 CAF20 Gene Product
% 208.97/209.14  |- skos__hiddenLabel mesh__D039502 Nuclear Cap Binding Protein Complex
% 208.97/209.14  |- skos__hiddenLabel mesh__D039502 Nuclear Cap Binding Protein, 80 kDa
% 208.97/209.14  |- mesh__dateEstablished mesh__D039502 2003-01-01
% 208.97/209.14  |- skos__altLabel mesh__D039502 Cap-Binding Protein Complex, Nuclear
% 208.97/209.14  |- skos__scopeNote mesh__D039502
% 208.97/209.14       A heterodimeric protein complex of RNA cap-binding proteins, which binds with high affinity to the 5%27% MRNA CAP STRUCTURE in the CELL NUCLEUS. The complex contains two subunits, one of 80-kDa molecular weight and another of 20-kDa molecular weight.%A%    
% 208.97/209.14  |- rdf__type mesh__D039502sskos__Concept
% 208.97/209.14  |- skos__altLabel mesh__D039502 Cap-Binding Complex 80-kDa protein
% 208.97/209.14  |- mesh__recordMaintainer mesh__D039502 ags
% 208.97/209.14  |- skos__altLabel mesh__D039502 CBP20 Protein
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D039502 2006A
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D039502 2005
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D006328 2000
% 208.97/209.14  |- skos__prefLabel mesh__D006328 Heart Catheterization
% 208.97/209.14  |- mesh__recordMaintainer mesh__D006328 PXP
% 208.97/209.14  |- mesh__dateRevised mesh__D006328 1997-06-20
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D006328 1998
% 208.97/209.14  |- rdf__type mesh__D006328sskos__Concept
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D006328 2001
% 208.97/209.14  |- skos__altLabel mesh__D006328 Catheterization, Cardiac
% 208.97/209.14  |- skos__scopeNote mesh__D006328
% 208.97/209.14       Procedure which includes placement of catheter, recording of intracardiac and intravascular pressure, obtaining blood samples for chemical analysis, and cardiac output measurement, etc. Specific angiographic injection techniques are also involved.%A%    
% 208.97/209.14  |- mesh__recordOriginator mesh__D006328 NLM
% 208.97/209.14  |- skos__altLabel mesh__D006328 Cardiac Catheterization
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D006328 1999
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D006328 2005
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D006328 2002
% 208.97/209.14  |- skos__hiddenLabel mesh__D006328 Catheterizations, Cardiac
% 208.97/209.14  |- skos__hiddenLabel mesh__D006328 Heart Catheterizations
% 208.97/209.14  |- skos__hiddenLabel mesh__D006328 Cardiac Catheterizations
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D006328 2006
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D006328 2003
% 208.97/209.14  |- skos__broader mesh__D006328smesh__D006334
% 208.97/209.14  |- skos__hiddenLabel mesh__D006328 Catheterizations, Heart
% 208.97/209.14  |- skos__annotation mesh__D006328
% 208.97/209.14       /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: HEART CATH%A%  
% 208.97/209.14  |- skos__broader mesh__D006328smesh__D002404
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D006328 2004
% 208.97/209.14  |- mesh__recordAuthorizer mesh__D006328 SJN
% 208.97/209.14  |- skos__related mesh__D006328smesh__D011669
% 208.97/209.14  |- skos__altLabel mesh__D006328 Catheterization, Heart
% 208.97/209.14  |- mesh__dateCreated mesh__D006328 1999-01-01
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D017050 2001
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D017050 2006
% 208.97/209.14  |- skos__annotation mesh__D017050
% 208.97/209.14       may be one instance of care, a series of episodes or a sequence of care: read MeSH definition; no qualif%A%  
% 208.97/209.14  |- skos__altLabel mesh__D017050 Patient Care Episodes
% 208.97/209.14  |- skos__hiddenLabel mesh__D017050 Care Episodes
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D017050 2000
% 208.97/209.14  |- skos__hiddenLabel mesh__D017050 Care Episode
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D017050 2005
% 208.97/209.14  |- mesh__dateEstablished mesh__D017050 1992-01-01
% 208.97/209.14  |- skos__scopeNote mesh__D017050
% 208.97/209.14       An interval of care by a health care facility or provider for a specific medical problem or condition. It may be continuous or it may consist of a series of intervals marked by one or more brief separations from care, and can also identify the sequence of care %28%e.g., emergency, inpatient, outpatient%29%, thus serving as one measure of health care provided.%A%    
% 208.97/209.14  |- skos__hiddenLabel mesh__D017050 Episode, Patient Care
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D017050 1999
% 208.97/209.14  |- mesh__recordAuthorizer mesh__D017050 SJN
% 208.97/209.14  |- skos__prefLabel mesh__D017050 Episode of Care
% 208.97/209.14  |- rdf__type mesh__D017050sskos__Concept
% 208.97/209.14  |- skos__hiddenLabel mesh__D017050 Patient Care Episode
% 208.97/209.14  |- mesh__publicMeSHNote mesh__D017050 92   
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D017050 1998
% 208.97/209.14  |- skos__altLabel mesh__D017050 Episodes of Care
% 208.97/209.14  |- mesh__dateRevised mesh__D017050 1997-06-20
% 208.97/209.14  |- mesh__historyNote mesh__D017050 92   
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D017050 2002
% 208.97/209.14  |- skos__hiddenLabel mesh__D017050 Episodes, Patient Care
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D017050 2004
% 208.97/209.14  |- mesh__recordOriginator mesh__D017050 PLS
% 208.97/209.14  |- mesh__dateCreated mesh__D017050 1991-06-20
% 208.97/209.14  |- mesh__recordMaintainer mesh__D017050 PXP
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D017050 2003
% 208.97/209.14  |- skos__broader mesh__D017050smesh__D005791
% 208.97/209.14  |- skos__altLabel mesh__D050484 NET Protein, Neuronal
% 208.97/209.14  |- skos__broader mesh__D050484smesh__D050482
% 208.97/209.14  |- skos__hiddenLabel mesh__D050484 Transporter Protein, Norepinephrine
% 208.97/209.14  |- skos__altLabel mesh__D050484
% 208.97/209.14       Noradrenaline Plasma Membrane Transport Proteins
% 208.97/209.14  |- skos__hiddenLabel mesh__D050484
% 208.97/209.14       Transporters, Noradrenaline-Specific Neurotransmitter
% 208.97/209.14  |- skos__hiddenLabel mesh__D050484
% 208.97/209.14       Noradrenaline-Specific Neurotransmitter Transporters
% 208.97/209.14  |- skos__historyNote mesh__D050484 Symporters %28%2005%29%
% 208.97/209.14  |- skos__prefLabel mesh__D050484
% 208.97/209.14       Norepinephrine Plasma Membrane Transport Proteins
% 208.97/209.14  |- mesh__publicMeSHNote mesh__D050484
% 208.97/209.14       2006; NOREPINEPHRINE TRANSPORTER PROTEIN was indexed under SYMPORTERS 2005 %26% under CARRIER PROTEINS 1991-2004%A%  
% 208.97/209.14  |- skos__hiddenLabel mesh__D050484
% 208.97/209.14       Sodium Dependent Noradrenaline Transporter
% 208.97/209.14  |- skos__altLabel mesh__D050484 Norepinephrine Transporter
% 208.97/209.14  |- mesh__dateCreated mesh__D050484 2005-06-30
% 208.97/209.14  |- skos__broader mesh__D050484smesh__D027981
% 208.97/209.14  |- skos__historyNote mesh__D050484 Carrier Proteins %28%1991-2004%29%
% 208.97/209.14  |- skos__altLabel mesh__D050484 Noradrenaline Transporter
% 208.97/209.14  |- mesh__recordMaintainer mesh__D050484 DRC
% 208.97/209.14  |- skos__altLabel mesh__D050484
% 208.97/209.14       Neurotransmitter Transporters, Noradrenaline-Specific
% 208.97/209.14  |- skos__altLabel mesh__D050484 Norepinephrine Transporter Protein
% 208.97/209.14  |- skos__hiddenLabel mesh__D050484 Transporter, Norepinephrine
% 208.97/209.14  |- skos__altLabel mesh__D050484 Sodium-Dependent Noradrenaline Transporter
% 208.97/209.14  |- skos__altLabel mesh__D050484 Norepinephrine Plasma Membrane Transporters
% 208.97/209.14  |- skos__altLabel mesh__D050484
% 208.97/209.14       Norepinephrine Plasma Membrane Transporter Proteins
% 208.97/209.14  |- mesh__historyNote mesh__D050484 2006%28%1991%29%   
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D050484 2006
% 208.97/209.14  |- mesh__recordAuthorizer mesh__D050484 sjn
% 208.97/209.14  |- skos__hiddenLabel mesh__D050484 Transporter, Noradrenaline
% 208.97/209.14  |- mesh__recordOriginator mesh__D050484 DRC
% 208.97/209.14  |- rdf__type mesh__D050484sskos__Concept
% 208.97/209.14  |- skos__hiddenLabel mesh__D050484 Neuronal NET Protein
% 208.97/209.14  |- skos__hiddenLabel mesh__D050484
% 208.97/209.14       Noradrenaline Transporter, Sodium-Dependent
% 208.97/209.14  |- skos__hiddenLabel mesh__D050484
% 208.97/209.14       Neurotransmitter Transporters, Noradrenaline Specific
% 208.97/209.14  |- mesh__dateEstablished mesh__D050484 2006-01-01
% 208.97/209.14  |- skos__scopeNote mesh__D050484
% 208.97/209.14       Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of noradrenergic neurons. They remove NOREPINEPHRINE from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS. It regulates signal amplitude and duration at noradrenergic synapses and is the target of ADRENERGIC UPTAKE INHIBITORS.%A%    
% 208.97/209.14  |- mesh__recordAuthorizer mesh__D003030 sjn
% 208.97/209.14  |- mesh__onlineNote mesh__D003030
% 208.97/209.14       use HYDROLASES to search STAPHYLOCOAGULASE 1966-67   
% 208.97/209.14  |- mesh__historyNote mesh__D003030
% 208.97/209.14       66%28%64%29%; was see under HYDROLASES 1963-65; STAPHYLOCOAGULASE was see under HYDROLASES 1963-67%A%  
% 208.97/209.14  |- mesh__publicMeSHNote mesh__D003030
% 208.97/209.14       66; was see under HYDROLASES 1963-65; STAPHYLOCOAGULASE was see under HYDROLASES 1963-67%A%  
% 208.97/209.14  |- skos__broader mesh__D003030smesh__D001426
% 208.97/209.14  |- skos__hiddenLabel mesh__D003030 Clumping Factor, Staphylococcal
% 208.97/209.14  |- skos__hiddenLabel mesh__D003030 Factor, Staphylococcal Clumping
% 208.97/209.14  |- skos__scopeNote mesh__D003030
% 208.97/209.14       Enzymes that cause coagulation in plasma by forming a complex with human PROTHROMBIN. Coagulases are produced by certain STAPHYLOCOCCUS and YERSINIA PESTIS. Staphylococci produce two types of coagulase: Staphylocoagulase, a free coagulase that produces true clotting of plasma, and Staphylococcal clumping factor, a bound coagulase in the cell wall that induces clumping of cells in the presence of fibrinogen.%A%    
% 208.97/209.14  |- mesh__dateRevised mesh__D003030 2005-06-30
% 208.97/209.14  |- skos__annotation mesh__D003030
% 208.97/209.14       do not routinely add when indexing coagulase negative organisms; index only when discussed%A%  
% 208.97/209.14  |- skos__hiddenLabel mesh__D003030
% 208.97/209.14       Staphylococcus aureus strain 8325 4 of Coagulase
% 208.97/209.14  |- mesh__dateEstablished mesh__D003030 1966-01-01
% 208.97/209.14  |- mesh__dateCreated mesh__D003030 1999-01-01
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D003030 2006
% 208.97/209.14  |- skos__broader mesh__D003030smesh__D010450
% 208.97/209.14  |- mesh__recordMaintainer mesh__D003030 ssb
% 208.97/209.14  |- mesh__recordOriginator mesh__D003030 NLM
% 208.97/209.14  |- rdf__type mesh__D003030sskos__Concept
% 208.97/209.14  |- skos__altLabel mesh__D003030 Clumping Factor %28%Staphylococcal%29%
% 208.97/209.14  |- skos__prefLabel mesh__D003030 Coagulase
% 208.97/209.14  |- skos__scopeNote mesh__D049930
% 208.97/209.14       A plant genus of the family POACEAE. The RHIZOME contains SESQUITERPENES and is the source of vetiver oil used in PERFUME.%A%    
% 208.97/209.14  |- mesh__dateCreated mesh__D049930 2005-06-30
% 208.97/209.14  |- mesh__recordOriginator mesh__D049930 ssb
% 208.97/209.14  |- mesh__dateEstablished mesh__D049930 2006-01-01
% 208.97/209.14  |- skos__broader mesh__D049930smesh__D006109
% 208.97/209.14  |- skos__prefLabel mesh__D049930 Vetiveria
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D049930 2006
% 208.97/209.14  |- mesh__recordAuthorizer mesh__D049930 sjn
% 208.97/209.14  |- mesh__historyNote mesh__D049930 2006   
% 208.97/209.14  |- skos__annotation mesh__D049930
% 208.97/209.14       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.97/209.14  |- skos__altLabel mesh__D049930 Andropogon zizanioides
% 208.97/209.14  |- skos__altLabel mesh__D049930 Vetiver Grass
% 208.97/209.14  |- rdf__type mesh__D049930sskos__Concept
% 208.97/209.14  |- mesh__publicMeSHNote mesh__D049930 2006   
% 208.97/209.14  |- mesh__recordMaintainer mesh__D049930 ssb
% 208.97/209.14  |- skos__historyNote mesh__D016756 IgG %28%1970-1991%29%
% 208.97/209.14  |- mesh__recordMaintainer mesh__D016756 jmp
% 208.97/209.14  |- mesh__dateCreated mesh__D016756 1991-04-29
% 208.97/209.14  |- skos__altLabel mesh__D016756 Antibodies, Intravenous
% 208.97/209.14  |- skos__hiddenLabel mesh__D016756 Intravenous Immune Globulin
% 208.97/209.14  |- skos__hiddenLabel mesh__D016756 Globulin N
% 208.97/209.14  |- skos__hiddenLabel mesh__D016756 GlobulinN
% 208.97/209.14  |- skos__altLabel mesh__D016756 Intravenous Antibodies
% 208.97/209.14  |- skos__scopeNote mesh__D016756
% 208.97/209.14       Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA.%A%    
% 208.97/209.14  |- mesh__historyNote mesh__D016756
% 208.97/209.14       92; GLOBULIN-N was NM 1986-91; VENOGLOBULIN was NM 1983-91; GAMMONATIV %26% INTRAGLOBIN were NM 1982-91; SANDOGLOBULIN %26% MODIFIED IMMUNE GLOBULIN %28%ANTI-ECHOVIRUS ANTIBODY%29% were NM 1981-91%A%  
% 208.97/209.14  |- mesh__onlineNote mesh__D016756
% 208.97/209.14       use IMMUNOGLOBULINS, INTRAVENOUS %28%NM%29% to search GLOBULIN-N %28%NM%29% 1986-91, VENOGLOBULIN %28%NM%29% 1983-91, GAMMONATIV %28%NM%29% %26% INTRAGLOBIN %28%NM%29% 1982-91, and SANDOGLOBULIN %28%NM%29% %26% MODIFIED IMMUNE GLOBULIN %28%ANTI-ECHOVIRUS ANTIBODY%29% %28%NM%29% 1981-91.%A%  
% 208.97/209.14  |- skos__altLabel mesh__D016756 Intravenous IG
% 208.97/209.14  |- skos__altLabel mesh__D016756 Gamimmune
% 208.97/209.14  |- skos__hiddenLabel mesh__D016756 Immunoglobulins, IV
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D016756 2006
% 208.97/209.14  |- skos__hiddenLabel mesh__D016756 VenoglobulinI
% 208.97/209.14  |- skos__broader mesh__D016756smesh__D007074
% 208.97/209.14  |- mesh__recordAuthorizer mesh__D016756 sjn
% 208.97/209.14  |- skos__altLabel mesh__D016756 Intravenous Immunoglobulins
% 208.97/209.14  |- skos__altLabel mesh__D016756 IV Immunoglobulins
% 208.97/209.14  |- mesh__dateRevised mesh__D016756 2005-06-30
% 208.97/209.14  |- skos__altLabel mesh__D016756 Gamimmune N
% 208.97/209.14  |- skos__altLabel mesh__D016756 Immune Globulin, Intravenous
% 208.97/209.14  |- skos__altLabel mesh__D016756 IVIG
% 208.97/209.14  |- skos__broader mesh__D016756smesh__D000906
% 208.97/209.14  |- mesh__dateEstablished mesh__D016756 1992-01-01
% 208.97/209.14  |- skos__prefLabel mesh__D016756 Immunoglobulins, Intravenous
% 208.97/209.14  |- skos__historyNote mesh__D016756 Immunoglobulins %28%1970-1991%29%
% 208.97/209.14  |- skos__hiddenLabel mesh__D016756 Venoglobulin I
% 208.97/209.14  |- rdf__type mesh__D016756sskos__Concept
% 208.97/209.14  |- mesh__publicMeSHNote mesh__D016756
% 208.97/209.14       92; GLOBULIN-N was indexed under IGG, IGA, %26% DRUG COMBINATIONS 1986-91; VENOGLOBULIN was indexed under GAMMA GLOBULINS, FIBRINOLYSIN, %26% DRUG COMBINATIONS 1983-91; INTRAGLOBIN was indexed under IGG/analogs 1982-91; GAMMONATIV was indexed under IGG 1982-90; MODIFIED IMMUNE GLOBULIN %28%ANTI-ECHOVIRUS ANTIBODY%29% was indexed under IMMUNOGLOBULINS %26% ANTIBODIES, VIRAL 1981-90; SANDOGLOBULIN was indexed under IGG 1981-91%A%  
% 208.97/209.14  |- mesh__recordOriginator mesh__D016756 AGS
% 208.97/209.14  |- mesh__recordAuthorizer mesh__D002736 ags
% 208.97/209.14  |- skos__prefLabel mesh__D002736 Chloroplasts
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D002736 2005
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D002736 2006
% 208.97/209.14  |- mesh__recordMaintainer mesh__D002736 ags
% 208.97/209.14  |- mesh__historyNote mesh__D002736 66%28%64%29%   
% 208.97/209.14  |- mesh__publicMeSHNote mesh__D002736 66   
% 208.97/209.14  |- skos__broader mesh__D002736smesh__D018087
% 208.97/209.14  |- mesh__recordOriginator mesh__D002736 NLM
% 208.97/209.14  |- rdf__type mesh__D002736sskos__Concept
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D002736 2004
% 208.97/209.14  |- mesh__dateRevised mesh__D002736 2005-07-27
% 208.97/209.14  |- skos__scopeNote mesh__D002736
% 208.97/209.14       Plant cell inclusion bodies that contain the photosynthetic pigment chlorophyll, which is associated with the membrane of THYLAKOIDS. Chloroplasts occur in cells of leaves and young stems of higher plants.%A%    
% 208.97/209.14  |- mesh__dateEstablished mesh__D002736 1966-01-01
% 208.97/209.14  |- skos__altLabel mesh__D002736 Chloroplast
% 208.97/209.14  |- mesh__dateCreated mesh__D002736 1999-01-01
% 208.97/209.14  |- skos__annotation mesh__D002736
% 208.97/209.14       coord IM with PLANTS; ALGAE; or specific plant or alga usually NIM%A%  
% 208.97/209.14  |- skos__related mesh__D002736smesh__D010788
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D002736 2006A
% 208.97/209.14  |- mesh__publicMeSHNote mesh__D007421
% 208.97/209.14       INTESTINAL MICROORGANISMS was heading 1963-67   
% 208.97/209.14  |- skos__altLabel mesh__D007421 Small Intestine
% 208.97/209.14  |- skos__annotation mesh__D007421
% 208.97/209.14       GEN; inflammation = ENTERITIS but ENTEROCOLITIS; DUODENITIS %26% ILEITIS are available%A%  
% 208.97/209.14  |- mesh__onlineNote mesh__D007421
% 208.97/209.14       search INTESTINAL MICROORGANISMS under INTESTINES 1966-67%A%  
% 208.97/209.14  |- mesh__dateCreated mesh__D007421 1999-01-01
% 208.97/209.14  |- skos__prefLabel mesh__D007421 Intestine, Small
% 208.97/209.14  |- skos__broader mesh__D007421smesh__D007422
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D007421 2004
% 208.97/209.14  |- mesh__dateRevised mesh__D007421 2003-07-09
% 208.97/209.14  |- mesh__historyNote mesh__D007421
% 208.97/209.14       INTESTINAL MICROORGANISMS was heading 1963-67   
% 208.97/209.14  |- rdf__type mesh__D007421sskos__Concept
% 208.97/209.14  |- mesh__recordOriginator mesh__D007421 NLM
% 208.97/209.14  |- skos__hiddenLabel mesh__D007421 Intestines, Small
% 208.97/209.14  |- mesh__recordAuthorizer mesh__D007421 sjn
% 208.97/209.14  |- skos__hiddenLabel mesh__D007421 Small Intestines
% 208.97/209.14  |- skos__scopeNote mesh__D007421
% 208.97/209.14       The portion of the GASTROINTESTINAL TRACT between the PYLORUS of the STOMACH and the ILEOCECAL VALVE of the LARGE INTESTINE. It is divisible into three portions: the DUODENUM, the JEJUNUM, and the ILEUM.%A%    
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D007421 2005
% 208.97/209.14  |- mesh__recordMaintainer mesh__D007421 lkt
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D007421 2006
% 208.97/209.14  |- skos__hiddenLabel mesh__D012366 RNA, Val Transfer
% 208.97/209.14  |- mesh__recordOriginator mesh__D012366 RLS
% 208.97/209.14  |- mesh__dateCreated mesh__D012366 1987-05-08
% 208.97/209.14  |- mesh__recordAuthorizer mesh__D012366 PLS
% 208.97/209.14  |- mesh__publicMeSHNote mesh__D012366
% 208.97/209.14       91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.97/209.14  |- skos__historyNote mesh__D012366 Amino Acyl T RNA %28%1978-1987%29%
% 208.97/209.14  |- skos__broader mesh__D012366smesh__D012345
% 208.97/209.14  |- skos__hiddenLabel mesh__D012366 Val Transfer RNA
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D012366 1997
% 208.97/209.14  |- skos__altLabel mesh__D012366 tRNAVal
% 208.97/209.14  |- skos__scopeNote mesh__D012366
% 208.97/209.14       A transfer RNA which is specific for carrying valine to sites on the ribosomes in preparation for protein synthesis.%A%    
% 208.97/209.14  |- skos__hiddenLabel mesh__D012366 Valine Specific tRNA
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D012366 2004
% 208.97/209.14  |- skos__historyNote mesh__D012366 RNA, Transfer %28%1966-1987%29%
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D012366 2001
% 208.97/209.14  |- mesh__recordMaintainer mesh__D012366 TGC
% 208.97/209.14  |- skos__annotation mesh__D012366
% 208.97/209.14       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 208.97/209.14  |- skos__altLabel mesh__D012366 Transfer RNA, Val
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D012366 2003
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D012366 1999
% 208.97/209.14  |- skos__hiddenLabel mesh__D012366 tRNA, Valine-Specific
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D012366 2000
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D012366 2006
% 208.97/209.14  |- mesh__dateEstablished mesh__D012366 1991-01-01
% 208.97/209.14  |- skos__altLabel mesh__D012366 tRNA%28%Val%29%
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D012366 1998
% 208.97/209.14  |- mesh__historyNote mesh__D012366
% 208.97/209.14       91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A%  
% 208.97/209.14  |- skos__altLabel mesh__D012366 Valine-Specific tRNA
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D012366 2005
% 208.97/209.14  |- mesh__dateRevised mesh__D012366 1996-06-10
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D012366 2002
% 208.97/209.14  |- rdf__type mesh__D012366sskos__Concept
% 208.97/209.14  |- skos__prefLabel mesh__D012366 RNA, Transfer, Val
% 208.97/209.14  |- skos__broader mesh__D004044Q000172smesh__D004044
% 208.97/209.14  |- mesh__preferredCombination mesh__D004044Q000172smesh__D011488
% 208.97/209.14  |- rdf__type mesh__D004044Q000172smesh__CompoundConcept
% 208.97/209.14  |- mesh__historyNote mesh__D039503
% 208.97/209.14       2003; use INTEGRIN ALPHA6 %28%NM%29% 1994-2002   
% 208.97/209.14  |- skos__hiddenLabel mesh__D039503 alpha6, Integrin
% 208.97/209.14  |- skos__related mesh__D039503smesh__D039161
% 208.97/209.14  |- skos__altLabel mesh__D039503 CD49f Antigen
% 208.97/209.14  |- mesh__recordMaintainer mesh__D039503 ssb
% 208.97/209.14  |- skos__hiddenLabel mesh__D039503 Integrin, alpha6
% 208.97/209.14  |- skos__scopeNote mesh__D039503
% 208.97/209.14       An integrin alpha subunit that primarily associates with INTEGRIN BETA1 or INTEGRIN BETA4 to form laminin-binding heterodimers. Integrin alpha6 has two alternatively spliced isoforms: integrin alpha6A and integrin alpha6B, which differ in their cytoplasmic domains and are regulated in a tissue-specific and developmental stage-specific manner.%A%    
% 208.97/209.14  |- skos__altLabel mesh__D039503 CD49f Antigens
% 208.97/209.14  |- skos__altLabel mesh__D039503 alpha6 Integrin
% 208.97/209.14  |- skos__altLabel mesh__D039503 Antigens, CD49f
% 208.97/209.14  |- skos__altLabel mesh__D039503 alpha%28%6%29% Integrin
% 208.97/209.14  |- skos__hiddenLabel mesh__D039503 alpha6B, Integrin
% 208.97/209.14  |- mesh__recordAuthorizer mesh__D039503 sjn
% 208.97/209.14  |- skos__prefLabel mesh__D039503 Integrin alpha6
% 208.97/209.14  |- skos__broader mesh__D039503smesh__D015703
% 208.97/209.14  |- rdf__type mesh__D039503sskos__Concept
% 208.97/209.14  |- mesh__dateRevised mesh__D039503 2005-06-30
% 208.97/209.14  |- skos__hiddenLabel mesh__D039503 Antigen, CD49f
% 208.97/209.14  |- mesh__recordOriginator mesh__D039503 MDJ
% 208.97/209.14  |- skos__historyNote mesh__D039503 Antigens, CD %28%1994-2002%29%
% 208.97/209.14  |- mesh__dateCreated mesh__D039503 2002-07-02
% 208.97/209.14  |- mesh__publicMeSHNote mesh__D039503
% 208.97/209.14       2003; INTEGRIN ALPHA6 was indexed under ANTIGENS, CD 1994-2002%A%  
% 208.97/209.14  |- skos__related mesh__D039503smesh__D039121
% 208.97/209.14  |- skos__hiddenLabel mesh__D039503 alpha6A, Integrin
% 208.97/209.14  |- mesh__dateEstablished mesh__D039503 2003-01-01
% 208.97/209.14  |- skos__broader mesh__D039503smesh__D039001
% 208.97/209.14  |- mesh__activeMeSHYear mesh__D039503 2006
% 208.97/209.14  |- skos__related mesh__D006329smesh__D001145
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D006329 2000
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D006329 1994
% 208.97/209.15  |- skos__hiddenLabel mesh__D006329 Kent Bundle
% 208.97/209.15  |- rdf__type mesh__D006329sskos__Concept
% 208.97/209.15  |- skos__hiddenLabel mesh__D006329 System, Heart Conduction
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D006329 2001
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D006329 1998
% 208.97/209.15  |- skos__annotation mesh__D006329
% 208.97/209.15       disord = ARRHYTHMIA or HEART BLOCK %26% their specifics   
% 208.97/209.15  |- mesh__recordOriginator mesh__D006329 NLM
% 208.97/209.15  |- skos__broader mesh__D006329smesh__D006321
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D006329 1995
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D006329 1996
% 208.97/209.15  |- skos__scopeNote mesh__D006329
% 208.97/209.15       An impulse-conducting system composed of modified cardiac muscle and having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart.%A%    
% 208.97/209.15  |- mesh__dateRevised mesh__D006329 1992-05-15
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D006329 1993
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D006329 1999
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D006329 2002
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D006329 1997
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D006329 2005
% 208.97/209.15  |- skos__hiddenLabel mesh__D006329 Heart Conduction Systems
% 208.97/209.15  |- skos__hiddenLabel mesh__D006329 Conduction Systems, Heart
% 208.97/209.15  |- skos__prefLabel mesh__D006329 Heart Conduction System
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D006329 2003
% 208.97/209.15  |- skos__hiddenLabel mesh__D006329 Conduction System, Heart
% 208.97/209.15  |- mesh__dateCreated mesh__D006329 1999-01-01
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D006329 2006
% 208.97/209.15  |- skos__hiddenLabel mesh__D006329 Systems, Heart Conduction
% 208.97/209.15  |- mesh__recordAuthorizer mesh__D006329 PLS
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D006329 2004
% 208.97/209.15  |- mesh__recordMaintainer mesh__D006329 TAP
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017051 2002
% 208.97/209.15  |- skos__annotation mesh__D017051 for the dying; /psychol permitted   
% 208.97/209.15  |- rdf__type mesh__D017051sskos__Concept
% 208.97/209.15  |- mesh__recordAuthorizer mesh__D017051 sjn
% 208.97/209.15  |- skos__scopeNote mesh__D017051
% 208.97/209.15       Specialized health care, supportive in nature, provided to a dying person. A holistic approach is often taken, providing patients and their families with legal, financial, emotional, or spiritual counseling in addition to meeting patients%27% immediate physical needs. Care may be provided in the home, in the hospital, in specialized facilities %28%HOSPICES%29%, or in specially designated areas of long-term care facilities. The concept also includes bereavement care for the family. %28%From Dictionary of Health Services Management, 2d ed%29%%A%    
% 208.97/209.15  |- mesh__historyNote mesh__D017051 92   
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017051 2004
% 208.97/209.15  |- skos__hiddenLabel mesh__D017051 Program, Hospice
% 208.97/209.15  |- mesh__recordOriginator mesh__D017051 PLS
% 208.97/209.15  |- skos__broader mesh__D017051smesh__D013727
% 208.97/209.15  |- mesh__dateRevised mesh__D017051 1999-11-03
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017051 2001
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017051 2003
% 208.97/209.15  |- skos__historyNote mesh__D017051 Hospices %28%1977-1991%29%
% 208.97/209.15  |- skos__hiddenLabel mesh__D017051 Care, Bereavement
% 208.97/209.15  |- skos__hiddenLabel mesh__D017051 Hospice Program
% 208.97/209.15  |- mesh__dateEstablished mesh__D017051 1992-01-01
% 208.97/209.15  |- skos__related mesh__D017051smesh__D012144
% 208.97/209.15  |- mesh__dateCreated mesh__D017051 1991-06-20
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017051 2000
% 208.97/209.15  |- mesh__recordMaintainer mesh__D017051 jls
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017051 2006
% 208.97/209.15  |- skos__prefLabel mesh__D017051 Hospice Care
% 208.97/209.15  |- skos__hiddenLabel mesh__D017051 Care, Hospice
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017051 2005
% 208.97/209.15  |- skos__hiddenLabel mesh__D017051 Programs, Hospice
% 208.97/209.15  |- mesh__publicMeSHNote mesh__D017051 92   
% 208.97/209.15  |- skos__altLabel mesh__D050485 GAT-3 Transporter
% 208.97/209.15  |- skos__altLabel mesh__D050485 GAT1 Transporter
% 208.97/209.15  |- skos__altLabel mesh__D050485 GAT-1 Transporter
% 208.97/209.15  |- skos__related mesh__D050485smesh__D018757
% 208.97/209.15  |- skos__hiddenLabel mesh__D050485 Transporter, GAT-4
% 208.97/209.15  |- rdf__type mesh__D050485sskos__Concept
% 208.97/209.15  |- skos__hiddenLabel mesh__D050485 Transporters, GABA
% 208.97/209.15  |- mesh__dateRevised mesh__D050485 2005-07-14
% 208.97/209.15  |- skos__scopeNote mesh__D050485
% 208.97/209.15       A family of plasma membrane neurotransmitter transporter proteins that regulates that extracellular levels of the inhibitory neurotransmitter GAMMA-AMINOBUTYRIC ACID. They differ from GABA RECEPTORS, which signal cellular responses to GAMMA-AMINOBUTYRIC ACID.  They control GABA reuptake into PRESYNAPTIC TERMINALS in the CENTRAL NERVOUS SYSTEM through high-affinity sodium-dependent transport.%A%    
% 208.97/209.15  |- skos__hiddenLabel mesh__D050485 GAT 1 Transporter
% 208.97/209.15  |- skos__hiddenLabel mesh__D050485 Transporter, GAT2
% 208.97/209.15  |- mesh__historyNote mesh__D050485 2006%28%1979%29%   
% 208.97/209.15  |- skos__altLabel mesh__D050485 GABA Plasma Membrane Transporter Proteins
% 208.97/209.15  |- skos__historyNote mesh__D050485
% 208.97/209.15       Membrane Transport Proteins %28%1980-2005%29%
% 208.97/209.15  |- skos__broader mesh__D050485smesh__D050480
% 208.97/209.15  |- mesh__recordMaintainer mesh__D050485 ags
% 208.97/209.15  |- skos__hiddenLabel mesh__D050485 GAT 2 Transporter
% 208.97/209.15  |- mesh__publicMeSHNote mesh__D050485
% 208.97/209.15       2006; GABA TRANSPORTERS was indexed under MEMBRANE TRANSPORT PROTEINS 2002-2005, CARRIER PROTEINS %26% under MEMBRANE PROTEINS 1979-2001%A%  
% 208.97/209.15  |- skos__altLabel mesh__D050485
% 208.97/209.15       Neurotransmitter Transport Proteins, GABA-Specific
% 208.97/209.15  |- skos__hiddenLabel mesh__D050485 Transporter, GAT-2
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D050485 2006
% 208.97/209.15  |- mesh__dateEstablished mesh__D050485 2006-01-01
% 208.97/209.15  |- skos__hiddenLabel mesh__D050485 GAT 3 Transporter
% 208.97/209.15  |- skos__hiddenLabel mesh__D050485
% 208.97/209.15       Gamma Aminobutyric Acid Plasma Membrane Transport Proteins
% 208.97/209.15  |- skos__hiddenLabel mesh__D050485 Transporter 2, GABA
% 208.97/209.15  |- skos__altLabel mesh__D050485 GAT-2 Transporter
% 208.97/209.15  |- skos__hiddenLabel mesh__D050485
% 208.97/209.15       Neurotransmitter Transport Proteins, GABA Specific
% 208.97/209.15  |- mesh__recordAuthorizer mesh__D050485 ags
% 208.97/209.15  |- skos__hiddenLabel mesh__D050485
% 208.97/209.15       GABA-Specific Neurotransmitter Transporters
% 208.97/209.15  |- skos__altLabel mesh__D050485
% 208.97/209.15       Gamma-Aminobutyric Acid Plasma Membrane Transport Proteins
% 208.97/209.15  |- skos__altLabel mesh__D050485 GAT3 Transporter
% 208.97/209.15  |- mesh__dateCreated mesh__D050485 2005-06-30
% 208.97/209.15  |- mesh__recordOriginator mesh__D050485 DRC
% 208.97/209.15  |- skos__related mesh__D050485smesh__D018079
% 208.97/209.15  |- skos__prefLabel mesh__D050485 GABA Plasma Membrane Transport Proteins
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D050485 2006A
% 208.97/209.15  |- skos__hiddenLabel mesh__D050485
% 208.97/209.15       Neurotransmitter Transporters, GABA Specific
% 208.97/209.15  |- skos__altLabel mesh__D050485 GABA Transporters
% 208.97/209.15  |- skos__altLabel mesh__D050485
% 208.97/209.15       Neurotransmitter Transporters, GABA-Specific
% 208.97/209.15  |- skos__altLabel mesh__D050485 GAT-4 Transporter
% 208.97/209.15  |- skos__hiddenLabel mesh__D050485
% 208.97/209.15       Transporters, GABA-Specific Neurotransmitter
% 208.97/209.15  |- skos__hiddenLabel mesh__D050485 GAT 4 Transporter
% 208.97/209.15  |- skos__altLabel mesh__D050485 GAT2 Transporter
% 208.97/209.15  |- skos__broader mesh__D050485smesh__D027981
% 208.97/209.15  |- mesh__recordAuthorizer mesh__D003031 SJN
% 208.97/209.15  |- mesh__publicMeSHNote mesh__D003031 68   
% 208.97/209.15  |- mesh__historyNote mesh__D003031
% 208.97/209.15       68%28%64%29%; was in Cat J only 1964-81   
% 208.97/209.15  |- mesh__recordMaintainer mesh__D003031 JLS
% 208.97/209.15  |- mesh__dateCreated mesh__D003031 1999-01-01
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D003031 2006
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D003031 2002
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D003031 1999
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D003031 2004
% 208.97/209.15  |- skos__annotation mesh__D003031
% 208.97/209.15       /adv eff permitted but do not use for COAL MINING + PNEUMOCONIOSIS or ANTHRACOSILICOSIS unless particularly discussed as coal%A%  
% 208.97/209.15  |- skos__hiddenLabel mesh__D003031 Coals
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D003031 2005
% 208.97/209.15  |- mesh__dateEstablished mesh__D003031 1968-01-01
% 208.97/209.15  |- rdf__type mesh__D003031sskos__Concept
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D003031 1998
% 208.97/209.15  |- skos__scopeNote mesh__D003031
% 208.97/209.15       A natural fuel formed by partial decomposition of vegetable matter under certain environmental conditions.%A%    
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D003031 2003
% 208.97/209.15  |- mesh__dateRevised mesh__D003031 1997-06-20
% 208.97/209.15  |- skos__prefLabel mesh__D003031 Coal
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D003031 2001
% 208.97/209.15  |- skos__broader mesh__D003031smesh__D005579
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D003031 2000
% 208.97/209.15  |- mesh__recordOriginator mesh__D003031 NLM
% 208.97/209.15  |- rdf__type mesh__D049931sskos__Concept
% 208.97/209.15  |- skos__annotation mesh__D049931
% 208.97/209.15       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.97/209.15  |- skos__historyNote mesh__D049931 Fabaceae %28%1982-2005%29%
% 208.97/209.15  |- skos__scopeNote mesh__D049931
% 208.97/209.15       A plant genus of the family FABACEAE. Members contain piperidine alkaloids %28%PIPERIDINES%29%.%A%    
% 208.97/209.15  |- skos__prefLabel mesh__D049931 Sesbania
% 208.97/209.15  |- mesh__publicMeSHNote mesh__D049931 2006   
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D049931 2006
% 208.97/209.15  |- mesh__recordOriginator mesh__D049931 ssb
% 208.97/209.15  |- skos__broader mesh__D049931smesh__D007887
% 208.97/209.15  |- mesh__dateEstablished mesh__D049931 2006-01-01
% 208.97/209.15  |- mesh__recordMaintainer mesh__D049931 ssb
% 208.97/209.15  |- mesh__recordAuthorizer mesh__D049931 sjn
% 208.97/209.15  |- mesh__historyNote mesh__D049931 2006   
% 208.97/209.15  |- mesh__dateCreated mesh__D049931 2005-06-30
% 208.97/209.15  |- mesh__dateCreated mesh__D016757 1991-04-29
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D016757 2004
% 208.97/209.15  |- mesh__publicMeSHNote mesh__D016757 92   
% 208.97/209.15  |- mesh__recordOriginator mesh__D016757 MXR
% 208.97/209.15  |- skos__hiddenLabel mesh__D016757 Cardiac Death, Sudden
% 208.97/209.15  |- skos__altLabel mesh__D016757 Sudden Cardiac Death
% 208.97/209.15  |- skos__broader mesh__D016757smesh__D003645
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D016757 2003
% 208.97/209.15  |- skos__hiddenLabel mesh__D016757 Sudden Death, Cardiac
% 208.97/209.15  |- mesh__recordAuthorizer mesh__D016757 sjn
% 208.97/209.15  |- skos__scopeNote mesh__D016757
% 208.97/209.15       Sudden death %28%DEATH, SUDDEN%29% that is due to HEART ARREST.%A%    
% 208.97/209.15  |- skos__altLabel mesh__D016757 Cardiac Sudden Death
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D016757 2002
% 208.97/209.15  |- mesh__recordMaintainer mesh__D016757 nns
% 208.97/209.15  |- skos__hiddenLabel mesh__D016757 Death, Sudden Cardiac
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D016757 2006
% 208.97/209.15  |- skos__broader mesh__D016757smesh__D006323
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D016757 2005
% 208.97/209.15  |- skos__prefLabel mesh__D016757 Death, Sudden, Cardiac
% 208.97/209.15  |- rdf__type mesh__D016757sskos__Concept
% 208.97/209.15  |- skos__related mesh__D016757smesh__D006323
% 208.97/209.15  |- skos__hiddenLabel mesh__D016757 Death, Cardiac Sudden
% 208.97/209.15  |- mesh__dateEstablished mesh__D016757 1992-01-01
% 208.97/209.15  |- mesh__dateRevised mesh__D016757 2001-07-25
% 208.97/209.15  |- mesh__historyNote mesh__D016757 92   
% 208.97/209.15  |- skos__historyNote mesh__D016757 Death, Sudden %28%1966-1991%29%
% 208.97/209.15  |- skos__prefLabel mesh__D002737 Chloroprene
% 208.97/209.15  |- mesh__dateCreated mesh__D002737 1978-05-01
% 208.97/209.15  |- skos__broader mesh__D002737smesh__D000466
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D002737 2006
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D002737 2003
% 208.97/209.15  |- skos__historyNote mesh__D002737 Butadienes %28%1966-1978%29%
% 208.97/209.15  |- mesh__dateEstablished mesh__D002737 1991-01-01
% 208.97/209.15  |- mesh__publicMeSHNote mesh__D002737
% 208.97/209.15       91; was see under BUTADIENES 1979-90   
% 208.97/209.15  |- rdf__type mesh__D002737sskos__Concept
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D002737 2004
% 208.97/209.15  |- mesh__recordMaintainer mesh__D002737 CCR
% 208.97/209.15  |- mesh__recordOriginator mesh__D002737 SH
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D002737 2001
% 208.97/209.15  |- mesh__recordAuthorizer mesh__D002737 sjn
% 208.97/209.15  |- skos__historyNote mesh__D002737 Neoprene %28%1975-1978%29%
% 208.97/209.15  |- mesh__dateRevised mesh__D002737 2000-06-22
% 208.97/209.15  |- mesh__historyNote mesh__D002737
% 208.97/209.15       91%28%79%29%; was see under BUTADIENES 1979-90   
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D002737 2005
% 208.97/209.15  |- skos__scopeNote mesh__D002737
% 208.97/209.15       Toxic, possibly carcinogenic, monomer of neoprene, a synthetic rubber; causes damage to skin, lungs, CNS, kidneys, liver, blood cells and fetuses. Synonym: 2-chlorobutadiene.%A%    
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D002737 2002
% 208.97/209.15  |- skos__prefLabel mesh__D007422 Intestines
% 208.97/209.15  |- mesh__recordAuthorizer mesh__D007422 sjn
% 208.97/209.15  |- skos__annotation mesh__D007422
% 208.97/209.15       GEN; /secret = INTESTINAL MUCOSA /secret or INTESTINAL SECRETIONS; invagination = INTUSSUSCEPTION; /surg: consider also ENTEROSTOMY %26% GASTROENTEROSTOMY; inflammation or inflamm dis: see note on INTESTINAL DISEASES; gas cysts = PNEUMATOSIS CYSTOIDES INTESTINALIS%A%  
% 208.97/209.15  |- skos__related mesh__D007422smesh__D005763
% 208.97/209.15  |- skos__related mesh__D007422smesh__D004766
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D007422 2006
% 208.97/209.15  |- skos__hiddenLabel mesh__D007422 Intestine
% 208.97/209.15  |- mesh__recordMaintainer mesh__D007422 sjn
% 208.97/209.15  |- mesh__publicMeSHNote mesh__D007422
% 208.97/209.15       /microbiology was INTESTINAL MICROORGANISMS 1963-67   
% 208.97/209.15  |- mesh__considerAlso mesh__D007422 consider also terms at ENTER-   
% 208.97/209.15  |- mesh__onlineNote mesh__D007422
% 208.97/209.15       use INTESTINES to search INTESTINAL MICROORGANISMS 1966-67%A%  
% 208.97/209.15  |- skos__broader mesh__D007422smesh__D041981
% 208.97/209.15  |- mesh__dateCreated mesh__D007422 1999-01-01
% 208.97/209.15  |- mesh__historyNote mesh__D007422
% 208.97/209.15       /microbiology was INTESTINAL MICROORGANISMS 1963-67   
% 208.97/209.15  |- mesh__dateRevised mesh__D007422 2005-07-01
% 208.97/209.15  |- rdf__type mesh__D007422sskos__Concept
% 208.97/209.15  |- skos__scopeNote mesh__D007422
% 208.97/209.15       The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE.%A%    
% 208.97/209.15  |- mesh__recordOriginator mesh__D007422 NLM
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D012367 2004
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D012367 2002
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D012367 1996
% 208.97/209.15  |- mesh__recordAuthorizer mesh__D012367 PLS
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D012367 2003
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D012367 1999
% 208.97/209.15  |- skos__annotation mesh__D012367
% 208.97/209.15       IM; /drug eff /ultrastruct permitted; coord with specific virus %28%IM%29%%A%  
% 208.97/209.15  |- mesh__recordMaintainer mesh__D012367 KEV
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D012367 2006
% 208.97/209.15  |- skos__scopeNote mesh__D012367
% 208.97/209.15       Ribonucleic acid that makes up the genetic material of viruses.%A%    
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D012367 1998
% 208.97/209.15  |- skos__broader mesh__D012367smesh__D012313
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D012367 2001
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D012367 2005
% 208.97/209.15  |- mesh__dateRevised mesh__D012367 1995-06-08
% 208.97/209.15  |- mesh__dateCreated mesh__D012367 1999-01-01
% 208.97/209.15  |- rdf__type mesh__D012367sskos__Concept
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D012367 2000
% 208.97/209.15  |- skos__altLabel mesh__D012367 Viral RNA
% 208.97/209.15  |- mesh__recordOriginator mesh__D012367 NLM
% 208.97/209.15  |- skos__prefLabel mesh__D012367 RNA, Viral
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D012367 1997
% 208.97/209.15  |- skos__broader mesh__D017850smesh__D004467
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017850 2002
% 208.97/209.15  |- skos__related mesh__D017850smesh__D011306
% 208.97/209.15  |- mesh__recordOriginator mesh__D017850 TGC
% 208.97/209.15  |- skos__related mesh__D017850smesh__D016527
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017850 2004
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017850 2001
% 208.97/209.15  |- rdf__type mesh__D017850sskos__Concept
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017850 2006
% 208.97/209.15  |- mesh__dateEstablished mesh__D017850 1994-01-01
% 208.97/209.15  |- mesh__dateRevised mesh__D017850 1999-11-03
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017850 2003
% 208.97/209.15  |- skos__related mesh__D017850smesh__D005252
% 208.97/209.15  |- mesh__recordAuthorizer mesh__D017850 sjn
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017850 2005
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017850 2000
% 208.97/209.15  |- skos__altLabel mesh__D017850 Pharmaceutical Economics
% 208.97/209.15  |- mesh__dateCreated mesh__D017850 1993-05-27
% 208.97/209.15  |- skos__historyNote mesh__D017850 Economics %28%1966-1979%29%
% 208.97/209.15  |- mesh__publicMeSHNote mesh__D017850 94   
% 208.97/209.15  |- mesh__historyNote mesh__D017850 94   
% 208.97/209.15  |- skos__historyNote mesh__D017850 Pharmacy %28%1966-1979%29%
% 208.97/209.15  |- skos__scopeNote mesh__D017850
% 208.97/209.15       Economic aspects of the fields of pharmacy and pharmacology as they apply to the development and study of medical economics in rational drug therapy and the impact of pharmaceuticals on the cost of medical care. Pharmaceutical economics also includes the economic considerations of the pharmaceutical care delivery system and in drug prescribing, particularly of cost-benefit values. %28%From J Res Pharm Econ 1989;1%28%1%29%; PharmacoEcon 1992;1%28%1%29%%29%%A%    
% 208.97/209.15  |- skos__prefLabel mesh__D017850 Economics, Pharmaceutical
% 208.97/209.15  |- skos__annotation mesh__D017850
% 208.97/209.15       GEN or unspecified only: pref /econ with specific drugs or specific pharmaceutical subject; Manual 19.8.27; DF: ECON PHARM%A%  
% 208.97/209.15  |- skos__historyNote mesh__D017850 Pharmacy/economics %28%1980-1993%29%
% 208.97/209.15  |- skos__altLabel mesh__D017850 Pharmacoeconomics
% 208.97/209.15  |- mesh__recordMaintainer mesh__D017850 kle
% 208.97/209.15  |- mesh__publicMeSHNote mesh__D031521 2003   
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D031521 2004
% 208.97/209.15  |- mesh__dateCreated mesh__D031521 2002-07-03
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D031521 2003
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D031521 2006
% 208.97/209.15  |- skos__annotation mesh__D031521
% 208.97/209.15       DOSE FRACTIONATION; CELL FRACTIONATION and FRACTIONATION, FIELD FLOW are also available%A%  
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D031521 2005
% 208.97/209.15  |- mesh__historyNote mesh__D031521 2003   
% 208.97/209.15  |- rdf__type mesh__D031521sskos__Concept
% 208.97/209.15  |- mesh__dateEstablished mesh__D031521 2003-01-01
% 208.97/209.15  |- skos__broader mesh__D031521smesh__D005591
% 208.97/209.15  |- skos__historyNote mesh__D031521 Fractionation %28%1980-2002%29%
% 208.97/209.15  |- skos__scopeNote mesh__D031521
% 208.97/209.15       Separation of molecules and particles by a simultaneous action of carrier liquid flow and focusing field forces %28%electrical, sedimentation, or thermal%29%, without a stationary phase.%A%    
% 208.97/209.15  |- skos__altLabel mesh__D031521 SdFFF
% 208.97/209.15  |- skos__prefLabel mesh__D031521 Fractionation, Field Flow
% 208.97/209.15  |- skos__altLabel mesh__D031521 Field Flow Fractionation
% 208.97/209.15  |- skos__historyNote mesh__D031521 Chromatography %28%1980-2002%29%
% 208.97/209.15  |- skos__hiddenLabel mesh__D017052 Mortalities, Hospital
% 208.97/209.15  |- skos__hiddenLabel mesh__D017052 Hospital Mortality, In
% 208.97/209.15  |- skos__altLabel mesh__D017052 Mortality, In-Hospital
% 208.97/209.15  |- skos__altLabel mesh__D017052 In Hospital Mortality
% 208.97/209.15  |- skos__hiddenLabel mesh__D017052 Mortalities, In house
% 208.97/209.15  |- skos__hiddenLabel mesh__D017052 In-house Mortalities
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017052 2004
% 208.97/209.15  |- mesh__historyNote mesh__D017052 92   
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017052 1998
% 208.97/209.15  |- skos__scopeNote mesh__D017052
% 208.97/209.15       A vital statistic measuring or recording the rate of death from any cause in hospitalized populations.%A%    
% 208.97/209.15  |- mesh__publicMeSHNote mesh__D017052 92   
% 208.97/209.15  |- skos__hiddenLabel mesh__D017052 Mortality, In Hospital
% 208.97/209.15  |- skos__hiddenLabel mesh__D017052 Mortalities, In-Hospital
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017052 2000
% 208.97/209.15  |- mesh__recordMaintainer mesh__D017052 WDJ
% 208.97/209.15  |- mesh__recordOriginator mesh__D017052 PLS
% 208.97/209.15  |- skos__altLabel mesh__D017052 Hospital Mortalities
% 208.97/209.15  |- mesh__dateEstablished mesh__D017052 1992-01-01
% 208.97/209.15  |- skos__altLabel mesh__D017052 Inhospital Mortalities
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017052 1999
% 208.97/209.15  |- skos__annotation mesh__D017052
% 208.97/209.15       death statist from any cause in hosp patients; DF: HOSP MORTAL%A%  
% 208.97/209.15  |- skos__hiddenLabel mesh__D017052 Hospital Mortalities, In
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017052 2005
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017052 2001
% 208.97/209.15  |- skos__hiddenLabel mesh__D017052 Mortality, In-house
% 208.97/209.15  |- skos__altLabel mesh__D017052 Mortalities, Inhospital
% 208.97/209.15  |- skos__hiddenLabel mesh__D017052 In-Hospital Mortalities
% 208.97/209.15  |- skos__broader mesh__D017052smesh__D009026
% 208.97/209.15  |- skos__prefLabel mesh__D017052 Hospital Mortality
% 208.97/209.15  |- skos__historyNote mesh__D017052 Mortality %28%1966-1991%29%
% 208.97/209.15  |- skos__hiddenLabel mesh__D017052 In-house Mortality
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017052 2006
% 208.97/209.15  |- rdf__type mesh__D017052sskos__Concept
% 208.97/209.15  |- skos__altLabel mesh__D017052 Mortality, Inhospital
% 208.97/209.15  |- skos__altLabel mesh__D017052 In Hospital Mortalities
% 208.97/209.15  |- skos__altLabel mesh__D017052 In-Hospital Mortality
% 208.97/209.15  |- skos__altLabel mesh__D017052 Mortality, Hospital
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017052 2002
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D017052 2003
% 208.97/209.15  |- mesh__dateRevised mesh__D017052 1997-07-10
% 208.97/209.15  |- skos__altLabel mesh__D017052 Mortalities, In-house
% 208.97/209.15  |- skos__altLabel mesh__D017052 Inhospital Mortality
% 208.97/209.15  |- mesh__dateCreated mesh__D017052 1991-06-20
% 208.97/209.15  |- mesh__recordAuthorizer mesh__D017052 SJN
% 208.97/209.15  |- skos__hiddenLabel mesh__D017052 Mortalities, In Hospital
% 208.97/209.15  |- mesh__recordMaintainer mesh__D003830 TGC
% 208.97/209.15  |- skos__hiddenLabel mesh__D003830 Fixed Partial Dentures
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D003830 2000
% 208.97/209.15  |- skos__altLabel mesh__D003830 Fixed Bridge
% 208.97/209.15  |- mesh__dateRevised mesh__D003830 1997-06-20
% 208.97/209.15  |- mesh__recordOriginator mesh__D003830 NLM
% 208.97/209.15  |- mesh__publicMeSHNote mesh__D003830
% 208.97/209.15       65; CROWN AND BRIDGEWORK was heading 1963-64   
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D003830 2004
% 208.97/209.15  |- rdf__type mesh__D003830sskos__Concept
% 208.97/209.15  |- mesh__historyNote mesh__D003830
% 208.97/209.15       65; CROWN AND BRIDGEWORK was heading 1963-64   
% 208.97/209.15  |- skos__hiddenLabel mesh__D003830 Partial Dentures, Fixed
% 208.97/209.15  |- skos__hiddenLabel mesh__D003830 Partial Denture, Fixed
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D003830 2003
% 208.97/209.15  |- skos__hiddenLabel mesh__D003830 Pontics
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D003830 1999
% 208.97/209.15  |- mesh__recordAuthorizer mesh__D003830 SJN
% 208.97/209.15  |- mesh__dateEstablished mesh__D003830 1965-01-01
% 208.97/209.15  |- skos__broader mesh__D003830smesh__D003829
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D003830 2002
% 208.97/209.15  |- skos__scopeNote mesh__D003830
% 208.97/209.15       A partial denture attached to prepared natural teeth, roots, or implants by cementation.%A%    
% 208.97/209.15  |- skos__hiddenLabel mesh__D003830 Dentures, Fixed Partial
% 208.97/209.15  |- skos__hiddenLabel mesh__D003830 Denture, Fixed Partial
% 208.97/209.15  |- mesh__dateCreated mesh__D003830 1999-01-01
% 208.97/209.15  |- skos__hiddenLabel mesh__D003830 Bridges, Fixed
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D003830 2006
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D003830 1998
% 208.97/209.15  |- skos__prefLabel mesh__D003830 Denture, Partial, Fixed
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D003830 2001
% 208.97/209.15  |- skos__hiddenLabel mesh__D003830 Bridge, Fixed
% 208.97/209.15  |- skos__hiddenLabel mesh__D003830 Fixed Bridges
% 208.97/209.15  |- skos__altLabel mesh__D003830 Fixed Partial Denture
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D003830 2005
% 208.97/209.15  |- mesh__dateEstablished mesh__D050486 2006-01-01
% 208.97/209.15  |- skos__altLabel mesh__D050486
% 208.97/209.15       5-Hydroxytryptamine Plasma Membrane Transport Protein
% 208.97/209.15  |- skos__altLabel mesh__D050486 Platelet Serotonin Transporter
% 208.97/209.15  |- skos__historyNote mesh__D050486 Nerve Tissue Proteins %28%1992-2005%29%
% 208.97/209.15  |- skos__historyNote mesh__D050486 Membrane Glycoproteins %28%1992-2005%29%
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D050486 2006
% 208.97/209.15  |- skos__altLabel mesh__D050486
% 208.97/209.15       Neurotransmitter Transporters, Serotonin-Specific
% 208.97/209.15  |- skos__hiddenLabel mesh__D050486
% 208.97/209.15       5 Hydroxytryptamine Plasma Membrane Transport Protein
% 208.97/209.15  |- skos__hiddenLabel mesh__D050486 Transporter, Sodium-Dependent Serotonin
% 208.97/209.15  |- skos__hiddenLabel mesh__D050486 Transporter, Serotonin
% 208.97/209.15  |- mesh__recordMaintainer mesh__D050486 DRC
% 208.97/209.15  |- skos__altLabel mesh__D050486 Sodium-Dependent Serotonin Transporter
% 208.97/209.15  |- skos__hiddenLabel mesh__D050486 Transporter, Platelets Serotonin
% 208.97/209.15  |- skos__altLabel mesh__D050486 Serotonin Transporter, Platelets
% 208.97/209.15  |- mesh__recordAuthorizer mesh__D050486 sjn
% 208.97/209.15  |- skos__hiddenLabel mesh__D050486
% 208.97/209.15       Serotonin-Specific Neurotransmitter Transporters
% 208.97/209.15  |- skos__altLabel mesh__D050486 SERT Proteins
% 208.97/209.15  |- skos__scopeNote mesh__D050486
% 208.97/209.15       Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of serotonergic neurons. They are different than SEROTONIN RECEPTORS, which signal cellular responses to SEROTONIN. They remove SEROTONIN from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS. Regulates signal amplitude and duration at serotonergic synapses and is the site of action of the SEROTONIN UPTAKE INHIBITORS.%A%    
% 208.97/209.15  |- mesh__historyNote mesh__D050486 2006%28%1992%29%   
% 208.97/209.15  |- mesh__dateCreated mesh__D050486 2005-06-30
% 208.97/209.15  |- skos__altLabel mesh__D050486
% 208.97/209.15       Neurotransmitter Transport Proteins, Serotonin-Specific
% 208.97/209.15  |- skos__related mesh__D050486smesh__D011985
% 208.97/209.15  |- skos__broader mesh__D050486smesh__D050480
% 208.97/209.15  |- skos__hiddenLabel mesh__D050486 Sodium Dependent Serotonin Transporter
% 208.97/209.15  |- skos__hiddenLabel mesh__D050486 Transporter, Platelet Serotonin
% 208.97/209.15  |- mesh__publicMeSHNote mesh__D050486
% 208.97/209.15       2006; SEROTONIN TRANSPORTER was indexed under MEMBRANE TRANSPORT PROTEINS 2005, MEMBRANE GLYCOPROTEINS, NERVE TISSUE PROTEINS %26% MEMBRANE TRANSPORT PROTEINS 1992-2005, CARRIER PROTEINS 1992-2004; SEROTONECTIN was indexed under CARRIER PROTEINS 1983-2005%A%  
% 208.97/209.15  |- skos__hiddenLabel mesh__D050486
% 208.97/209.15       Neurotransmitter Transporters, Serotonin Specific
% 208.97/209.15  |- skos__prefLabel mesh__D050486
% 208.97/209.15       Serotonin Plasma Membrane Transport Proteins
% 208.97/209.15  |- skos__altLabel mesh__D050486 Serotonin Transporter
% 208.97/209.15  |- skos__hiddenLabel mesh__D050486 Platelets Serotonin Transporter
% 208.97/209.15  |- skos__hiddenLabel mesh__D050486 Serotonin Transporter, Platelet
% 208.97/209.15  |- skos__broader mesh__D050486smesh__D027981
% 208.97/209.15  |- skos__hiddenLabel mesh__D050486
% 208.97/209.15       Transporters, Serotonin-Specific Neurotransmitter
% 208.97/209.15  |- skos__altLabel mesh__D050486
% 208.97/209.15       Serotonin Plasma Membrane Transporter Proteins
% 208.97/209.15  |- skos__hiddenLabel mesh__D050486
% 208.97/209.15       Neurotransmitter Transport Proteins, Serotonin Specific
% 208.97/209.15  |- skos__hiddenLabel mesh__D050486 Serotonin Transporter, Sodium-Dependent
% 208.97/209.15  |- rdf__type mesh__D050486sskos__Concept
% 208.97/209.15  |- mesh__recordOriginator mesh__D050486 DRC
% 208.97/209.15  |- skos__altLabel mesh__D050486 5HT Transporter
% 208.97/209.15  |- skos__historyNote mesh__D050486 Carrier Proteins %28%1992-2004%29%
% 208.97/209.15  |- skos__historyNote mesh__D050486 Membrane Transport Proteins %28%2005%29%
% 208.97/209.15  |- mesh__activeMeSHYear mesh__D003032 1999
% 208.97/209.15  |- skos__broader mesh__D003032smesh__D008906
% 208.97/209.16  |- skos__related mesh__D003032smesh__D012829
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D003032 2005
% 208.97/209.16  |- skos__hiddenLabel mesh__D003032 Coal Minings
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D003032 2004
% 208.97/209.16  |- skos__related mesh__D003032smesh__D011009
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D003032 1998
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D003032 2001
% 208.97/209.16  |- mesh__dateRevised mesh__D003032 1997-06-20
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D003032 2003
% 208.97/209.16  |- rdf__type mesh__D003032sskos__Concept
% 208.97/209.16  |- mesh__recordOriginator mesh__D003032 NLM
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D003032 2000
% 208.97/209.16  |- skos__hiddenLabel mesh__D003032 Minings, Coal
% 208.97/209.16  |- skos__related mesh__D003032smesh__D000874
% 208.97/209.16  |- mesh__recordAuthorizer mesh__D003032 SJN
% 208.97/209.16  |- mesh__recordMaintainer mesh__D003032 JLS
% 208.97/209.16  |- skos__annotation mesh__D003032
% 208.97/209.16       SPEC: SPEC qualif; consider also PNEUMOCONIOSIS but particularly SILICOSIS %26% ANTHRACOSILICOSIS%A%  
% 208.97/209.16  |- skos__prefLabel mesh__D003032 Coal Mining
% 208.97/209.16  |- skos__hiddenLabel mesh__D003032 Mining, Coal
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D003032 2002
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D003032 2006
% 208.97/209.16  |- mesh__dateCreated mesh__D003032 1999-01-01
% 208.97/209.16  |- mesh__dateEstablished mesh__D049932 2006-01-01
% 208.97/209.16  |- mesh__recordOriginator mesh__D049932 nns
% 208.97/209.16  |- mesh__recordAuthorizer mesh__D049932 sjn
% 208.97/209.16  |- mesh__historyNote mesh__D049932 2006   
% 208.97/209.16  |- mesh__dateCreated mesh__D049932 2005-06-30
% 208.97/209.16  |- skos__prefLabel mesh__D049932 Nijmegen Breakage Syndrome
% 208.97/209.16  |- skos__broader mesh__D049932smesh__D049914
% 208.97/209.16  |- mesh__recordMaintainer mesh__D049932 nns
% 208.97/209.16  |- skos__hiddenLabel mesh__D049932 Breakage Syndrome, Nijmegen
% 208.97/209.16  |- mesh__publicMeSHNote mesh__D049932 2006   
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D049932 2006
% 208.97/209.16  |- skos__scopeNote mesh__D049932
% 208.97/209.16       A chromosome instability syndrome resulting from a defective response to DNA double-strand breaks. In addition to characteristic FACIES and MICROCEPHALY, patients have a range of findings including RADIOSENSITIVITY, immunodeficiency, increased cancer risk, and growth retardation. Causative mutations occur in the NBS1 gene, located on human chromosome 8q21. NBS1 codes for nibrin, the key regulator protein of the R/M/N %28%RAD50/MRE11/NBS1%29% protein complex which senses and mediates cellular response to DNA DAMAGE caused by IONIZING RADIATION.%A%    
% 208.97/209.16  |- skos__hiddenLabel mesh__D049932 Syndrome, Nijmegen Breakage
% 208.97/209.16  |- rdf__type mesh__D049932sskos__Concept
% 208.97/209.16  |- skos__hiddenLabel mesh__D016758 c-jun Gene
% 208.97/209.16  |- skos__hiddenLabel mesh__D016758 v-jun Gene
% 208.97/209.16  |- skos__hiddenLabel mesh__D016758 v-jun Oncogene
% 208.97/209.16  |- mesh__dateEstablished mesh__D016758 1992-01-01
% 208.97/209.16  |- skos__altLabel mesh__D016758 jun Genes
% 208.97/209.16  |- mesh__recordOriginator mesh__D016758 AGS
% 208.97/209.16  |- skos__hiddenLabel mesh__D016758 jun Proto Oncogene
% 208.97/209.16  |- skos__broader mesh__D016758smesh__D011519
% 208.97/209.16  |- skos__hiddenLabel mesh__D016758 c jun Proto Oncogenes
% 208.97/209.16  |- skos__prefLabel mesh__D016758 Genes, jun
% 208.97/209.16  |- skos__historyNote mesh__D016758 Proto-Oncogenes %28%1987-1991%29%
% 208.97/209.16  |- mesh__publicMeSHNote mesh__D016758 92   
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D016758 2006
% 208.97/209.16  |- skos__related mesh__D016758smesh__D016759
% 208.97/209.16  |- skos__hiddenLabel mesh__D016758 jun Gene
% 208.97/209.16  |- skos__annotation mesh__D016758
% 208.97/209.16       jun stands for %22%JU-Nana%22%, Japanese for 17 %28%avian sarcoma virus 17%29%%A%  
% 208.97/209.16  |- skos__hiddenLabel mesh__D016758 Oncogenes, jun
% 208.97/209.16  |- rdf__type mesh__D016758sskos__Concept
% 208.97/209.16  |- skos__related mesh__D016758smesh__D016755
% 208.97/209.16  |- mesh__recordAuthorizer mesh__D016758 sjn
% 208.97/209.16  |- skos__hiddenLabel mesh__D016758 c jun Genes
% 208.97/209.16  |- skos__hiddenLabel mesh__D016758 Proto-Oncogenes, jun
% 208.97/209.16  |- skos__hiddenLabel mesh__D016758 v jun Oncogenes
% 208.97/209.16  |- skos__hiddenLabel mesh__D016758 c-jun Proto-Oncogene
% 208.97/209.16  |- skos__historyNote mesh__D016758 Genes, Viral %28%1987-1991%29%
% 208.97/209.16  |- skos__hiddenLabel mesh__D016758 Proto-Oncogene, jun
% 208.97/209.16  |- skos__scopeNote mesh__D016758
% 208.97/209.16       Retrovirus-associated DNA sequences %28%jun%29% originally isolated from the avian sarcoma virus 17 %28%ASV 17%29%. The proto-oncogene jun %28%c-jun%29% codes for a nuclear protein which is involved in growth-related transcriptional control. Insertion of c-jun into ASV-17 or the constitutive expression of the c-jun protein produces tumorgenicity. The human c-jun gene is located at 1p31-32 on the short arm of chromosome 1.%A%    
% 208.97/209.16  |- mesh__historyNote mesh__D016758 92   
% 208.97/209.16  |- skos__hiddenLabel mesh__D016758 jun Oncogenes
% 208.97/209.16  |- skos__hiddenLabel mesh__D016758 v jun Genes
% 208.97/209.16  |- mesh__recordMaintainer mesh__D016758 nns
% 208.97/209.16  |- mesh__dateRevised mesh__D016758 2005-06-30
% 208.97/209.16  |- skos__hiddenLabel mesh__D016758 Oncogene, jun
% 208.97/209.16  |- skos__hiddenLabel mesh__D016758 jun Proto-Oncogenes
% 208.97/209.16  |- skos__historyNote mesh__D016758 Oncogenes %28%1987-1991%29%
% 208.97/209.16  |- mesh__dateCreated mesh__D016758 1991-07-12
% 208.97/209.16  |- mesh__recordAuthorizer mesh__D002738 sjn
% 208.97/209.16  |- mesh__dateCreated mesh__D002738 1999-01-01
% 208.97/209.16  |- skos__altLabel mesh__D002738 Arechine
% 208.97/209.16  |- mesh__recordOriginator mesh__D002738 NLM
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D002738 2001
% 208.97/209.16  |- skos__broader mesh__D002738smesh__D000634
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D002738 2006
% 208.97/209.16  |- skos__prefLabel mesh__D002738 Chloroquine
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D002738 2004
% 208.97/209.16  |- skos__scopeNote mesh__D002738
% 208.97/209.16       The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.%A%    
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D002738 2005
% 208.97/209.16  |- skos__altLabel mesh__D002738 Chloroquine Sulphate
% 208.97/209.16  |- rdf__type mesh__D002738sskos__Concept
% 208.97/209.16  |- skos__altLabel mesh__D002738 Khingamin
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D002738 2003
% 208.97/209.16  |- skos__altLabel mesh__D002738 Chingamin
% 208.97/209.16  |- skos__altLabel mesh__D002738 Chlorochin
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D002738 2002
% 208.97/209.16  |- mesh__dateRevised mesh__D002738 2000-06-21
% 208.97/209.16  |- skos__hiddenLabel mesh__D002738 Sulfate, Chloroquine
% 208.97/209.16  |- skos__hiddenLabel mesh__D002738 Sulphate, Chloroquine
% 208.97/209.16  |- mesh__recordMaintainer mesh__D002738 TWD
% 208.97/209.16  |- mesh__recordAuthorizer mesh__D013460 sjn
% 208.97/209.16  |- skos__annotation mesh__D013460 S-33,34,36; NIM   
% 208.97/209.16  |- skos__scopeNote mesh__D013460
% 208.97/209.16       Stable sulfur atoms that have the same atomic number as the element sulfur, but differ in atomic weight. S-33, 34, and 36 are stable sulfur isotopes.%A%    
% 208.97/209.16  |- rdf__type mesh__D013460sskos__Concept
% 208.97/209.16  |- skos__hiddenLabel mesh__D013460 Isotopes, Sulfur
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D013460 2004
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D013460 2002
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D013460 2006
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D013460 2003
% 208.97/209.16  |- mesh__dateCreated mesh__D013460 1999-01-01
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D013460 2001
% 208.97/209.16  |- mesh__recordOriginator mesh__D013460 NLM
% 208.97/209.16  |- mesh__recordMaintainer mesh__D013460 nns
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D013460 2005
% 208.97/209.16  |- skos__prefLabel mesh__D013460 Sulfur Isotopes
% 208.97/209.16  |- skos__broader mesh__D013460smesh__D007554
% 208.97/209.16  |- mesh__dateRevised mesh__D013460 2000-06-22
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D007423 2006
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D007423 2002
% 208.97/209.16  |- mesh__dateCreated mesh__D007423 1976-04-13
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D007423 2005
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D007423 2004
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D007423 1999
% 208.97/209.16  |- skos__scopeNote mesh__D007423
% 208.97/209.16       Counterpulsation in which a pumping unit synchronized with the patient%27%s electrocardiogram rapidly fills a balloon in the aorta with helium or carbon dioxide in early diastole and evacuates the balloon at the onset of systole. As the balloon inflates, it raises aortic diastolic pressure, and as it deflates, it lowers aortic systolic pressure. The result is a decrease in left ventricular work and increased myocardial and peripheral perfusion.%A%    
% 208.97/209.16  |- skos__broader mesh__D007423smesh__D015908
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D007423 2003
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D007423 1998
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D007423 1997
% 208.97/209.16  |- skos__hiddenLabel mesh__D007423 Pumping, Intra Aortic Balloon
% 208.97/209.16  |- skos__altLabel mesh__D007423 Pumping, Intra-Aortic Balloon
% 208.97/209.16  |- mesh__recordMaintainer mesh__D007423 AGS
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D007423 2001
% 208.97/209.16  |- rdf__type mesh__D007423sskos__Concept
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D007423 1996
% 208.97/209.16  |- skos__historyNote mesh__D007423 Assisted Circulation %28%1967-1976%29%
% 208.97/209.16  |- mesh__recordOriginator mesh__D007423 SMH
% 208.97/209.16  |- skos__altLabel mesh__D007423 Intraaortic Balloon Pumping
% 208.97/209.16  |- skos__hiddenLabel mesh__D007423 Intra Aortic Balloon Pumping
% 208.97/209.16  |- skos__hiddenLabel mesh__D007423 Balloon Pumping, Intra-Aortic
% 208.97/209.16  |- skos__hiddenLabel mesh__D007423 Pumping, Intraaortic Balloon
% 208.97/209.16  |- skos__prefLabel mesh__D007423 Intra-Aortic Balloon Pumping
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D007423 2000
% 208.97/209.16  |- mesh__publicMeSHNote mesh__D007423
% 208.97/209.16       86; was see under ASSISTED CIRCULATION 1977-85   
% 208.97/209.16  |- mesh__dateEstablished mesh__D007423 1986-01-01
% 208.97/209.16  |- mesh__recordAuthorizer mesh__D007423 PLS
% 208.97/209.16  |- skos__hiddenLabel mesh__D007423 Balloon Pumping, Intraaortic
% 208.97/209.16  |- mesh__dateRevised mesh__D007423 1994-01-25
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D007423 1995
% 208.97/209.16  |- mesh__historyNote mesh__D007423
% 208.97/209.16       86%28%77%29%; was see under ASSISTED CIRCULATION 1977-85   
% 208.97/209.16  |- skos__annotation mesh__D007423 DF: IABP   
% 208.97/209.16  |- skos__altLabel mesh__D045542
% 208.97/209.16       2,7,9-Tricarboxy-1H-Pyrrolo-%28%2,3-f%29%Quinoline-4,5-Dione
% 208.97/209.16  |- mesh__historyNote mesh__D045542
% 208.97/209.16       2004; use PQQ COFACTOR %28%NM%29% 1981-2003   
% 208.97/209.16  |- skos__hiddenLabel mesh__D045542 PQQ, Coenzyme
% 208.97/209.16  |- skos__hiddenLabel mesh__D045542 Cofactor, PQQ
% 208.97/209.16  |- skos__broader mesh__D045542smesh__D015363
% 208.97/209.16  |- mesh__dateCreated mesh__D045542 2003-07-09
% 208.97/209.16  |- skos__altLabel mesh__D045542 Coenzyme PQQ
% 208.97/209.16  |- skos__scopeNote mesh__D045542
% 208.97/209.16       A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.%A%    
% 208.97/209.16  |- skos__altLabel mesh__D045542 2,7,9-Tricarboxypyrroloquinoline Quinone
% 208.97/209.16  |- skos__hiddenLabel mesh__D045542 Pyrrolo Quinoline Quinone
% 208.97/209.16  |- skos__hiddenLabel mesh__D045542 Coenzyme, PQQ
% 208.97/209.16  |- skos__hiddenLabel mesh__D045542 Quinone, Pyrrolo-Quinoline
% 208.97/209.16  |- skos__altLabel mesh__D045542 Methoxatin
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D045542 2006
% 208.97/209.16  |- skos__broader mesh__D045542smesh__D003067
% 208.97/209.16  |- rdf__type mesh__D045542sskos__Concept
% 208.97/209.16  |- skos__altLabel mesh__D045542
% 208.97/209.16       4,5-Dihydro-4,5-Dioxo-1-H-Pyrrolo%28%2,3-f%29%Quinoline-2,7,9-Tricarboxylic Acid
% 208.97/209.16  |- skos__altLabel mesh__D045542 Pyrroloquinoline Quinone
% 208.97/209.16  |- skos__altLabel mesh__D045542 Pyrrolo-Quinoline Quinone
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D045542 2005
% 208.97/209.16  |- skos__altLabel mesh__D045542 PQQ Coenzyme
% 208.97/209.16  |- skos__prefLabel mesh__D045542 PQQ Cofactor
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D045542 2004
% 208.97/209.16  |- mesh__dateEstablished mesh__D045542 2004-01-01
% 208.97/209.16  |- skos__hiddenLabel mesh__D045542 Quinone, Pyrroloquinoline
% 208.97/209.16  |- mesh__publicMeSHNote mesh__D045542
% 208.97/209.16       2004; METHOXATIN %28%now PQQ COFACTOR%29% was indexed under QUINOLONES 1981-2003%A%  
% 208.97/209.16  |- skos__altLabel mesh__D012368 Ro 20-1724
% 208.97/209.16  |- mesh__historyNote mesh__D012368 2005%28%1975%29%   
% 208.97/209.16  |- mesh__recordMaintainer mesh__D012368 ssb
% 208.97/209.16  |- mesh__dateEstablished mesh__D012368 1991-01-01
% 208.97/209.16  |- skos__historyNote mesh__D012368 Imidazoles %28%1972-1974%29%
% 208.97/209.16  |- skos__scopeNote mesh__D012368 Inhibitor of phosphodiesterases.     
% 208.97/209.16  |- skos__historyNote mesh__D012368 Benzyl Compounds %28%1972-1974%29%
% 208.97/209.16  |- skos__altLabel mesh__D012368 Ro 20 1724
% 208.97/209.16  |- mesh__recordAuthorizer mesh__D012368 sjn
% 208.97/209.16  |- mesh__dateCreated mesh__D012368 1974-11-19
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D012368 2006
% 208.97/209.16  |- mesh__recordOriginator mesh__D012368 NLM
% 208.97/209.16  |- rdf__type mesh__D012368sskos__Concept
% 208.97/209.16  |- mesh__dateRevised mesh__D012368 2005-06-30
% 208.97/209.16  |- skos__altLabel mesh__D012368 Ro 201724
% 208.97/209.16  |- mesh__publicMeSHNote mesh__D012368
% 208.97/209.16       2005; see RO 21 1724 1991-2004;see IMIDAZOLES 1975-1990   
% 208.97/209.16  |- skos__altLabel mesh__D012368 Ro 1724
% 208.97/209.16  |- skos__prefLabel mesh__D012368
% 208.97/209.16       4-%28%3-Butoxy-4-methoxybenzyl%29%-2-imidazolidinone
% 208.97/209.16  |- skos__broader mesh__D012368smesh__D007093
% 208.97/209.16  |- skos__historyNote mesh__D012368 Ethers %28%1974%29%
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D017851 2005
% 208.97/209.16  |- mesh__publicMeSHNote mesh__D017851 94   
% 208.97/209.16  |- skos__scopeNote mesh__D017851
% 208.97/209.16       A class of enzymes that transfers phosphate groups and has a carboxyl group as an acceptor. EC 2.7.2.%A%    
% 208.97/209.16  |- skos__broader mesh__D017851smesh__D010770
% 208.97/209.16  |- mesh__dateCreated mesh__D017851 1993-06-18
% 208.97/209.16  |- mesh__historyNote mesh__D017851 94   
% 208.97/209.16  |- skos__historyNote mesh__D017851 Phosphotransferases %28%1966-1993%29%
% 208.97/209.16  |- mesh__dateEstablished mesh__D017851 1994-01-01
% 208.97/209.16  |- skos__prefLabel mesh__D017851
% 208.97/209.16       Phosphotransferases %28%Carboxyl Group Acceptor%29%
% 208.97/209.16  |- skos__annotation mesh__D017851 DF: PHOSPHOTRANSFERASES CARBOXYL   
% 208.97/209.16  |- mesh__dateRevised mesh__D017851 2003-07-09
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D017851 2004
% 208.97/209.16  |- rdf__type mesh__D017851sskos__Concept
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D017851 2006
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D017053 2001
% 208.97/209.16  |- skos__altLabel mesh__D017053 Control, Infection
% 208.97/209.16  |- skos__historyNote mesh__D017053
% 208.97/209.16       Communicable Disease Control %28%1966-1991%29%
% 208.97/209.16  |- mesh__recordOriginator mesh__D017053 PLS
% 208.97/209.16  |- mesh__dateRevised mesh__D017053 1999-11-03
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D017053 2002
% 208.97/209.16  |- skos__broader mesh__D017053smesh__D003140
% 208.97/209.16  |- skos__historyNote mesh__D017053
% 208.97/209.16       Cross Infection/prevention %26% control %28%1966-1991%29%
% 208.97/209.16  |- mesh__onlineNote mesh__D017053
% 208.97/209.16       use INFECTION CONTROL to search INFECTION/prevention %26% control 1966-91%A%  
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D017053 2005
% 208.97/209.16  |- skos__prefLabel mesh__D017053 Infection Control
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D017053 2006
% 208.97/209.16  |- mesh__recordMaintainer mesh__D017053 kle
% 208.97/209.16  |- mesh__publicMeSHNote mesh__D017053
% 208.97/209.16       92; was INFECTION/prevention %26% control 1966-91   
% 208.97/209.16  |- mesh__historyNote mesh__D017053
% 208.97/209.16       92; was INFECTION/prevention %26% control 1966-91   
% 208.97/209.16  |- mesh__recordAuthorizer mesh__D017053 sjn
% 208.97/209.16  |- skos__scopeNote mesh__D017053
% 208.97/209.16       Programs of disease surveillance, generally within health care facilities, designed to investigate, prevent, and control the spread of infections and their causative microorganisms.%A%    
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D017053 2000
% 208.97/209.16  |- skos__historyNote mesh__D017053
% 208.97/209.16       Infection/prevention %26% control %28%1966-1991%29%
% 208.97/209.16  |- rdf__type mesh__D017053sskos__Concept
% 208.97/209.16  |- skos__annotation mesh__D017053
% 208.97/209.16       differentiate from COMMUNICABLE DISEASE CONTROL which tends to be on a large geog, demog or social level %28%e.g., city, underprivileged, elementary school, prison%29% while INFECTION CONTROL tends to be restricted within hosp or other health care facilities; if in doubt, use term of author; DF: INFECT CONTROL%A%  
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D017053 2003
% 208.97/209.16  |- mesh__dateCreated mesh__D017053 1991-07-19
% 208.97/209.16  |- mesh__dateEstablished mesh__D017053 1992-01-01
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D017053 2004
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D003831 2001
% 208.97/209.16  |- rdf__type mesh__D003831sskos__Concept
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D003831 2003
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D003831 2000
% 208.97/209.16  |- mesh__dateRevised mesh__D003831 1997-06-20
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D003831 1999
% 208.97/209.16  |- mesh__recordOriginator mesh__D003831 NLM
% 208.97/209.16  |- mesh__dateCreated mesh__D003831 1999-01-01
% 208.97/209.16  |- skos__broader mesh__D003831smesh__D003829
% 208.97/209.16  |- mesh__historyNote mesh__D003831
% 208.97/209.16       65; CROWN AND BRIDGEWORK was heading 1963-64   
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D003831 2006
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D003831 1998
% 208.97/209.16  |- mesh__recordMaintainer mesh__D003831 PXP
% 208.97/209.16  |- mesh__recordAuthorizer mesh__D003831 SJN
% 208.97/209.16  |- mesh__dateEstablished mesh__D003831 1965-01-01
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D003831 2005
% 208.97/209.16  |- skos__scopeNote mesh__D003831
% 208.97/209.16       A partial denture constructed before the teeth it replaces are removed. It is then inserted immediately after the removal of the natural teeth for functional and cosmetic reasons during the healing process. It is to be replaced later by the fitted partial denture.%A%    
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D003831 2002
% 208.97/209.16  |- skos__prefLabel mesh__D003831 Denture, Partial, Immediate
% 208.97/209.16  |- mesh__publicMeSHNote mesh__D003831
% 208.97/209.16       65; CROWN AND BRIDGEWORK was heading 1963-64   
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D003831 2004
% 208.97/209.16  |- mesh__recordOriginator mesh__D050487 DRC
% 208.97/209.16  |- skos__broader mesh__D050487smesh__D027981
% 208.97/209.16  |- skos__related mesh__D050487smesh__D018684
% 208.97/209.16  |- mesh__recordMaintainer mesh__D050487 DRC
% 208.97/209.16  |- skos__hiddenLabel mesh__D050487
% 208.97/209.16       Neurotransmitter Transport Proteins, Glycine Specific
% 208.97/209.16  |- mesh__dateCreated mesh__D050487 2005-06-30
% 208.97/209.16  |- skos__altLabel mesh__D050487
% 208.97/209.16       Neurotransmitter Transport Proteins, Glycine-Specific
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D050487 2006
% 208.97/209.16  |- skos__altLabel mesh__D050487
% 208.97/209.16       Neurotransmitter Transporters, Glycine-Specific
% 208.97/209.16  |- rdf__type mesh__D050487sskos__Concept
% 208.97/209.16  |- skos__historyNote mesh__D050487
% 208.97/209.16       Amino Acid Transport Systems, Neutral %28%1987-2005%29%
% 208.97/209.16  |- mesh__historyNote mesh__D050487 2006%28%1987%29%   
% 208.97/209.16  |- skos__broader mesh__D050487smesh__D026921
% 208.97/209.16  |- mesh__recordAuthorizer mesh__D050487 sjn
% 208.97/209.16  |- skos__altLabel mesh__D050487
% 208.97/209.16       Glycine Plasma Membrane Transporter Proteins
% 208.97/209.16  |- skos__broader mesh__D050487smesh__D050480
% 208.97/209.16  |- skos__prefLabel mesh__D050487 Glycine Plasma Membrane Transport Proteins
% 208.97/209.16  |- skos__hiddenLabel mesh__D050487
% 208.97/209.16       Glycine-Specific Neurotransmitter Transporters
% 208.97/209.16  |- skos__altLabel mesh__D050487 GLYT Proteins
% 208.97/209.16  |- mesh__publicMeSHNote mesh__D050487
% 208.97/209.16       2006; GLYCINE TRANSPORTER was indexed under AMINO ACID TRANSPORT SYSTEMS, NEUTRAL 2002-2005 %26% under CARRIER PROTEINS 1987-2001%A%  
% 208.97/209.16  |- skos__scopeNote mesh__D050487
% 208.97/209.16       A family of sodium chloride-dependent neurotransmitter symporters that transport the amino acid GLYCINE. They differ from GLYCINE RECEPTORS, which signal cellular responses to GLYCINE. They are located primarily on the PLASMA MEMBRANE of NEURONS; GLIAL CELLS; EPITHELIAL CELLS; and RED BLOOD CELLS where they remove inhibitory neurotransmitter glycine from the EXTRACELLULAR SPACE. Glycine plasma membrane transport proteins are different than%A%    
% 208.97/209.16  |- skos__altLabel mesh__D050487 Glycine Transporter
% 208.97/209.16  |- skos__related mesh__D050487smesh__D018009
% 208.97/209.16  |- skos__hiddenLabel mesh__D050487
% 208.97/209.16       Transporters, Glycine-Specific Neurotransmitter
% 208.97/209.16  |- skos__hiddenLabel mesh__D050487
% 208.97/209.16       Neurotransmitter Transporters, Glycine Specific
% 208.97/209.16  |- mesh__dateEstablished mesh__D050487 2006-01-01
% 208.97/209.16  |- skos__hiddenLabel mesh__D003033 Tar, Coal
% 208.97/209.16  |- rdf__type mesh__D003033sskos__Concept
% 208.97/209.16  |- skos__annotation mesh__D003033 D25-26 qualif   
% 208.97/209.16  |- skos__broader mesh__D003033smesh__D013638
% 208.97/209.16  |- skos__prefLabel mesh__D003033 Coal Tar
% 208.97/209.16  |- mesh__dateRevised mesh__D003033 2003-07-09
% 208.97/209.16  |- skos__scopeNote mesh__D003033
% 208.97/209.16       A by-product of the destructive distillation of coal used as a topical antieczematic. It is an antipruritic and keratoplastic agent used also in the treatment of psoriasis and other skin conditions. Occupational exposure to soots, tars, and certain mineral oils is known to be carcinogenic according to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29% %28%Merck Index, 11th ed%29%.%A%    
% 208.97/209.16  |- mesh__recordMaintainer mesh__D003033 ssb
% 208.97/209.16  |- mesh__recordOriginator mesh__D003033 NLM
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D003033 2006
% 208.97/209.16  |- mesh__dateCreated mesh__D003033 1999-01-01
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D003033 2005
% 208.97/209.16  |- mesh__recordAuthorizer mesh__D003033 sjn
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D003033 2004
% 208.97/209.16  |- mesh__recordAuthorizer mesh__D049933 sjn
% 208.97/209.16  |- mesh__dateEstablished mesh__D049933 2006-01-01
% 208.97/209.16  |- mesh__historyNote mesh__D049933 2006   
% 208.97/209.16  |- skos__scopeNote mesh__D049933
% 208.97/209.16       COUMARINS with an amino group, exemplified by NOVOBIOCIN.%A%    
% 208.97/209.16  |- skos__prefLabel mesh__D049933 Aminocoumarins
% 208.97/209.16  |- mesh__publicMeSHNote mesh__D049933 2006   
% 208.97/209.16  |- mesh__dateCreated mesh__D049933 2005-06-30
% 208.97/209.16  |- skos__historyNote mesh__D049933 Coumarins %28%1999-2005%29%
% 208.97/209.16  |- skos__altLabel mesh__D049933 Amino-Coumarins
% 208.97/209.16  |- rdf__type mesh__D049933sskos__Concept
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D049933 2006
% 208.97/209.16  |- mesh__recordOriginator mesh__D049933 ssb
% 208.97/209.16  |- skos__hiddenLabel mesh__D049933 Amino Coumarins
% 208.97/209.16  |- mesh__recordMaintainer mesh__D049933 ssb
% 208.97/209.16  |- skos__broader mesh__D049933smesh__D003374
% 208.97/209.16  |- skos__hiddenLabel mesh__D016759 Oncogene Protein v jun
% 208.97/209.16  |- skos__hiddenLabel mesh__D016759 gag-jun, p65
% 208.97/209.16  |- mesh__onlineNote mesh__D016759
% 208.97/209.16       use ONCOGENE PROTEIN P65%28%GAG-JUN%29% %28%NM%29% to search ONCOGENE PROTEIN JUN %28%NM%29% 1987-91%A%  
% 208.97/209.16  |- skos__hiddenLabel mesh__D016759 Oncogene Product v jun
% 208.97/209.16  |- skos__annotation mesh__D016759
% 208.97/209.16       IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted; DF: note short X refs%A%  
% 208.97/209.16  |- skos__hiddenLabel mesh__D016759 Oncogene Protein, jun
% 208.97/209.16  |- mesh__recordOriginator mesh__D016759 AGS
% 208.97/209.16  |- skos__scopeNote mesh__D016759
% 208.97/209.16       Transforming protein coded by jun oncogenes %28%GENES, JUN%29%. This is a gag-onc fusion protein of about 65 kDa derived from avian sarcoma virus. v-jun lacks a negative regulatory domain that regulates transcription in c-jun.%A%    
% 208.97/209.16  |- skos__hiddenLabel mesh__D016759 v jun Protein
% 208.97/209.16  |- mesh__dateEstablished mesh__D016759 1992-01-01
% 208.97/209.16  |- skos__hiddenLabel mesh__D016759 p65 gag jun
% 208.97/209.16  |- skos__hiddenLabel mesh__D016759 gag-jun Fusion Proteins
% 208.97/209.16  |- skos__hiddenLabel mesh__D016759 Product v-jun, Oncogene
% 208.97/209.16  |- skos__altLabel mesh__D016759 p65%28%gag-jun%29%
% 208.97/209.16  |- skos__altLabel mesh__D016759 Oncogene Protein v-jun
% 208.97/209.16  |- mesh__dateCreated mesh__D016759 1991-07-12
% 208.97/209.16  |- mesh__recordAuthorizer mesh__D016759 sjn
% 208.97/209.16  |- skos__hiddenLabel mesh__D016759 Protein v-jun, Oncogene
% 208.97/209.16  |- skos__hiddenLabel mesh__D016759 jun, Oncogene Protein
% 208.97/209.16  |- skos__altLabel mesh__D016759 Oncogene Protein jun
% 208.97/209.16  |- skos__altLabel mesh__D016759 Oncogene Product v-jun
% 208.97/209.16  |- skos__hiddenLabel mesh__D016759 Fusion Proteins, gag jun
% 208.97/209.16  |- mesh__recordMaintainer mesh__D016759 nns
% 208.97/209.16  |- mesh__dateRevised mesh__D016759 2005-06-30
% 208.97/209.16  |- skos__altLabel mesh__D016759 v-jun Protein
% 208.97/209.16  |- skos__broader mesh__D016759smesh__D015681
% 208.97/209.16  |- skos__prefLabel mesh__D016759 Oncogene Protein p65%28%gag-jun%29%
% 208.97/209.16  |- skos__hiddenLabel mesh__D016759 v-jun, Oncogene Protein
% 208.97/209.16  |- skos__altLabel mesh__D016759 jun Oncogene Protein
% 208.97/209.16  |- skos__altLabel mesh__D016759 Fusion Proteins, gag-jun
% 208.97/209.16  |- skos__hiddenLabel mesh__D016759 Protein jun, Oncogene
% 208.97/209.16  |- skos__hiddenLabel mesh__D016759 Protein, jun Oncogene
% 208.97/209.16  |- skos__historyNote mesh__D016759 Retroviridae Proteins %28%1987-1989%29%
% 208.97/209.16  |- mesh__historyNote mesh__D016759
% 208.97/209.16       92; was ONCOGENE PROTEIN JUN %28%NM%29% 1987-91   
% 208.97/209.16  |- skos__hiddenLabel mesh__D016759 Protein, v-jun
% 208.97/209.16  |- skos__altLabel mesh__D016759 p65 gag-jun
% 208.97/209.16  |- rdf__type mesh__D016759sskos__Concept
% 208.97/209.16  |- skos__historyNote mesh__D016759
% 208.97/209.16       Retroviridae Proteins, Oncogenic %28%1990-1991%29%
% 208.97/209.16  |- skos__hiddenLabel mesh__D016759 v-jun, Oncogene Product
% 208.97/209.16  |- mesh__publicMeSHNote mesh__D016759
% 208.97/209.16       92; ONCOGENE PROTEIN JUN %28%NM%29% was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-91 %26% under RETROVIRIDAE PROTEINS 1987-89%A%  
% 208.97/209.16  |- skos__hiddenLabel mesh__D016759 Proteins, gag-jun Fusion
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D016759 2006
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D027481 2006
% 208.97/209.16  |- mesh__historyNote mesh__D027481 2002   
% 208.97/209.16  |- mesh__dateRevised mesh__D027481 2003-07-09
% 208.97/209.16  |- skos__annotation mesh__D027481
% 208.97/209.16       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.97/209.16  |- mesh__recordAuthorizer mesh__D027481 sjn
% 208.97/209.16  |- mesh__dateEstablished mesh__D027481 2002-01-01
% 208.97/209.16  |- rdf__type mesh__D027481sskos__Concept
% 208.97/209.16  |- mesh__publicMeSHNote mesh__D027481 2002   
% 208.97/209.16  |- skos__altLabel mesh__D027481 Umbrella Tree
% 208.97/209.16  |- mesh__dateCreated mesh__D027481 2001-07-25
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D027481 2004
% 208.97/209.16  |- skos__scopeNote mesh__D027481
% 208.97/209.16       The ginseng plant family of the order Apiales, subclass Rosidae, class Magnoliopsida. Leaves are generally alternate, large, and compound.  Flowers are five-parted and arranged in compound flat-topped umbels.  The fruit is a berry or %28%rarely%29% a drupe %28%a one-seeded fruit%29%. It is well known for plant preparations used as adaptogens %28%immune support and anti-fatigue%29%.%A%    
% 208.97/209.16  |- mesh__recordOriginator mesh__D027481 ssb
% 208.97/209.16  |- mesh__recordMaintainer mesh__D027481 ssb
% 208.97/209.16  |- skos__prefLabel mesh__D027481 Araliaceae
% 208.97/209.16  |- skos__broader mesh__D027481smesh__D019684
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D027481 2005
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D002739 2006
% 208.97/209.16  |- mesh__recordMaintainer mesh__D002739 TWD
% 208.97/209.16  |- mesh__onlineNote mesh__D002739
% 208.97/209.16       use HYDROXYQUINOLINES to search CHLOROQUINOLINOLS 1966-74 %28%as Prov%29%%A%  
% 208.97/209.16  |- mesh__historyNote mesh__D002739
% 208.97/209.16       91%28%65%29%; was see under HYDROXYQUINOLINES 1965-90 %28%Prov 1965-74%29%%A%  
% 208.97/209.16  |- skos__prefLabel mesh__D002739 Chloroquinolinols
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D002739 2004
% 208.97/209.16  |- mesh__recordAuthorizer mesh__D002739 sjn
% 208.97/209.16  |- mesh__recordOriginator mesh__D002739 NLM
% 208.97/209.16  |- skos__scopeNote mesh__D002739
% 208.97/209.16       8-Hydroxyquinolinols chlorinated on the number 5 and/or 7 carbon atom%28%s%29%. They are antibacterial, antiprotozoal, and antidiarrheal, especially in amebiasis, and have also been used as antiseborrheics. The compounds are mostly used topically, but have been used also as animal feed additives. They may cause optic and other neuropathies and are most frequently administered in combination with other agents.%A%    
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D002739 2005
% 208.97/209.16  |- rdf__type mesh__D002739sskos__Concept
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D002739 2001
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D002739 2003
% 208.97/209.16  |- mesh__dateEstablished mesh__D002739 1991-01-01
% 208.97/209.16  |- skos__broader mesh__D002739smesh__D015125
% 208.97/209.16  |- mesh__dateRevised mesh__D002739 2000-06-22
% 208.97/209.16  |- mesh__dateCreated mesh__D002739 1999-01-01
% 208.97/209.16  |- mesh__publicMeSHNote mesh__D002739
% 208.97/209.16       91; was see under HYDROXYQUINOLINES 1975-90   
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D002739 2002
% 208.97/209.16  |- mesh__historyNote mesh__D013461 75   
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D013461 2001
% 208.97/209.16  |- mesh__recordOriginator mesh__D013461 NLM
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D013461 1999
% 208.97/209.16  |- mesh__recordAuthorizer mesh__D013461 PLS
% 208.97/209.16  |- skos__broader mesh__D013461smesh__D013457
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D013461 2003
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D013461 1995
% 208.97/209.16  |- mesh__dateCreated mesh__D013461 1999-01-01
% 208.97/209.16  |- rdf__type mesh__D013461sskos__Concept
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D013461 2005
% 208.97/209.16  |- skos__broader mesh__D013461smesh__D010087
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D013461 2004
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D013461 2002
% 208.97/209.16  |- mesh__activeMeSHYear mesh__D013461 2006
% 208.97/209.16  |- mesh__dateRevised mesh__D013461 1993-06-03
% 208.97/209.17  |- mesh__publicMeSHNote mesh__D013461 75   
% 208.97/209.17  |- mesh__dateEstablished mesh__D013461 1975-09-01
% 208.97/209.17  |- skos__prefLabel mesh__D013461 Sulfur Oxides
% 208.97/209.17  |- mesh__recordMaintainer mesh__D013461 TPW
% 208.97/209.17  |- skos__hiddenLabel mesh__D013461 Oxides, Sulfur
% 208.97/209.17  |- skos__historyNote mesh__D013461 Oxides %28%1966-1974%29%
% 208.97/209.17  |- skos__historyNote mesh__D013461 Sulfur %28%1966-1974%29%
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013461 1996
% 208.97/209.17  |- skos__scopeNote mesh__D013461 Inorganic oxides of sulfur.     
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013461 1998
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013461 2000
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013461 1997
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013461 1994
% 208.97/209.17  |- skos__annotation mesh__D013461 inorganic; SULFUR DIOXIDE is available   
% 208.97/209.17  |- mesh__dateCreated mesh__D007424 1999-01-01
% 208.97/209.17  |- skos__hiddenLabel mesh__D007424 Fluids, Intracellular
% 208.97/209.17  |- rdf__type mesh__D007424sskos__Concept
% 208.97/209.17  |- mesh__recordMaintainer mesh__D007424 nns
% 208.97/209.17  |- skos__scopeNote mesh__D007424 The fluid inside CELLS.     
% 208.97/209.17  |- skos__broader mesh__D007424smesh__D042541
% 208.97/209.17  |- mesh__publicMeSHNote mesh__D007424
% 208.97/209.17       91; was see under BODY FLUIDS 1975-90   
% 208.97/209.17  |- skos__hiddenLabel mesh__D007424 Intracellular Fluids
% 208.97/209.17  |- skos__hiddenLabel mesh__D007424 Fluid, Intracellular
% 208.97/209.17  |- skos__annotation mesh__D007424
% 208.97/209.17       do not confuse with INTERSTITIAL FLUID see EXTRACELLULAR FLUID%A%  
% 208.97/209.17  |- mesh__recordOriginator mesh__D007424 NLM
% 208.97/209.17  |- mesh__onlineNote mesh__D007424 search BODY FLUIDS 1966-74   
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D007424 2006
% 208.97/209.17  |- skos__prefLabel mesh__D007424 Intracellular Fluid
% 208.97/209.17  |- mesh__recordAuthorizer mesh__D007424 sjn
% 208.97/209.17  |- skos__broader mesh__D007424smesh__D013347
% 208.97/209.17  |- mesh__historyNote mesh__D007424
% 208.97/209.17       91%28%75%29%; was see under BODY FLUIDS 1975-90   
% 208.97/209.17  |- mesh__dateEstablished mesh__D007424 1991-01-01
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D007424 2005
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D007424 2004
% 208.97/209.17  |- mesh__dateRevised mesh__D007424 2003-07-09
% 208.97/209.17  |- skos__broader mesh__D007424smesh__D001826
% 208.97/209.17  |- rdf__type mesh__D051580sskos__Concept
% 208.97/209.17  |- skos__hiddenLabel mesh__D051580 Neuronal Calcium Sensor Proteins
% 208.97/209.17  |- mesh__dateCreated mesh__D051580 2005-06-30
% 208.97/209.17  |- mesh__recordAuthorizer mesh__D051580 sjn
% 208.97/209.17  |- skos__broader mesh__D051580smesh__D052139
% 208.97/209.17  |- skos__scopeNote mesh__D051580
% 208.97/209.17       A family of intracellular calcium-sensing proteins found predominately in NEURONS and PHOTORECEPTORS. They contain EF HAND MOTIFS and undergo conformational changes upon calcium-binding. Neuronal calcium-sensor proteins interact with other regulatory proteins to mediate physiological responses to a change in intracellular calcium concentration.%A%    
% 208.97/209.17  |- mesh__recordMaintainer mesh__D051580 DRC
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D051580 2006
% 208.97/209.17  |- skos__hiddenLabel mesh__D051580 Calcium-Sensor Proteins, Neuronal
% 208.97/209.17  |- mesh__publicMeSHNote mesh__D051580 2006   
% 208.97/209.17  |- skos__prefLabel mesh__D051580 Neuronal Calcium-Sensor Proteins
% 208.97/209.17  |- mesh__historyNote mesh__D051580 2006   
% 208.97/209.17  |- skos__broader mesh__D051580smesh__D009419
% 208.97/209.17  |- mesh__recordOriginator mesh__D051580 DRC
% 208.97/209.17  |- mesh__dateEstablished mesh__D051580 2006-01-01
% 208.97/209.17  |- mesh__recordOriginator mesh__D012369 NLM
% 208.97/209.17  |- mesh__dateRevised mesh__D012369 2004-07-07
% 208.97/209.17  |- mesh__publicMeSHNote mesh__D012369
% 208.97/209.17       2005; see RO 4-1284 1991-2004; see QUINOLIZINES 1988-1990; see QUINOLIZINES 1975-1987%A%  
% 208.97/209.17  |- mesh__historyNote mesh__D012369 2005%28%1988%29%   
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D012369 2005
% 208.97/209.17  |- skos__historyNote mesh__D012369 Quinolizines %28%1970%29%
% 208.97/209.17  |- skos__scopeNote mesh__D012369 Proposed catecholamine depletor.     
% 208.97/209.17  |- skos__prefLabel mesh__D012369
% 208.97/209.17       2H-Benzo%28%a%29%quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D012369 2006
% 208.97/209.17  |- mesh__recordMaintainer mesh__D012369 jmp
% 208.97/209.17  |- rdf__type mesh__D012369sskos__Concept
% 208.97/209.17  |- mesh__dateCreated mesh__D012369 1974-11-19
% 208.97/209.17  |- mesh__dateEstablished mesh__D012369 1991-01-01
% 208.97/209.17  |- skos__altLabel mesh__D012369 Ro4-1284
% 208.97/209.17  |- mesh__recordAuthorizer mesh__D012369 sjn
% 208.97/209.17  |- skos__broader mesh__D012369smesh__D011807
% 208.97/209.17  |- skos__altLabel mesh__D012369 Ro 41284
% 208.97/209.17  |- skos__broader mesh__D017852smesh__D010770
% 208.97/209.17  |- mesh__dateCreated mesh__D017852 1993-06-18
% 208.97/209.17  |- mesh__historyNote mesh__D017852 94   
% 208.97/209.17  |- skos__historyNote mesh__D017852 Phosphotransferases %28%1966-1993%29%
% 208.97/209.17  |- mesh__publicMeSHNote mesh__D017852 94   
% 208.97/209.17  |- skos__scopeNote mesh__D017852
% 208.97/209.17       A group of enzymes that catalyzes the transfer of a phosphate group onto a nitrogenous group acceptor. EC 2.7.3.%A%    
% 208.97/209.17  |- skos__annotation mesh__D017852 DF: PHOSPHOTRANSFERASES NITROGENOUS   
% 208.97/209.17  |- mesh__dateRevised mesh__D017852 2003-07-09
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017852 2004
% 208.97/209.17  |- rdf__type mesh__D017852sskos__Concept
% 208.97/209.17  |- skos__prefLabel mesh__D017852
% 208.97/209.17       Phosphotransferases %28%Nitrogenous Group Acceptor%29%
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017852 2006
% 208.97/209.17  |- mesh__dateEstablished mesh__D017852 1994-01-01
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017852 2005
% 208.97/209.17  |- skos__broader mesh__D017054smesh__D007348
% 208.97/209.17  |- skos__altLabel mesh__D017054 Medigap Policy
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017054 2005
% 208.97/209.17  |- mesh__dateEstablished mesh__D017054 1992-01-01
% 208.97/209.17  |- skos__hiddenLabel mesh__D017054 Policy, Medigap
% 208.97/209.17  |- skos__altLabel mesh__D017054 Medigap Insurance
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017054 2001
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017054 2006
% 208.97/209.17  |- skos__annotation mesh__D017054
% 208.97/209.17       insures the gap between payments by private insurers %26% Medicare; specify geog%A%  
% 208.97/209.17  |- skos__historyNote mesh__D017054 Medicare %28%1977-1991%29%
% 208.97/209.17  |- mesh__dateRevised mesh__D017054 1999-11-03
% 208.97/209.17  |- skos__hiddenLabel mesh__D017054 Policies, Medigap
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017054 2002
% 208.97/209.17  |- skos__historyNote mesh__D017054 Insurance, Health %28%1977-1991%29%
% 208.97/209.17  |- skos__prefLabel mesh__D017054 Insurance, Medigap
% 208.97/209.17  |- mesh__dateCreated mesh__D017054 1991-06-20
% 208.97/209.17  |- rdf__type mesh__D017054sskos__Concept
% 208.97/209.17  |- skos__hiddenLabel mesh__D017054 Medigap Policies
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017054 2003
% 208.97/209.17  |- mesh__recordMaintainer mesh__D017054 kle
% 208.97/209.17  |- mesh__publicMeSHNote mesh__D017054 92   
% 208.97/209.17  |- mesh__historyNote mesh__D017054 92   
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017054 2004
% 208.97/209.17  |- skos__scopeNote mesh__D017054
% 208.97/209.17       A supplemental health insurance policy sold by private insurance companies and designed to pay for health care costs and services that are not paid for either by Medicare alone or by a combination of Medicare and existing private health insurance benefits. %28%From Facts on File Dictionary of Health Care Management, 1988%29%%A%    
% 208.97/209.17  |- mesh__recordAuthorizer mesh__D017054 sjn
% 208.97/209.17  |- mesh__recordOriginator mesh__D017054 PLS
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017054 2000
% 208.97/209.17  |- rdf__type mesh__D003832sskos__Concept
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003832 2004
% 208.97/209.17  |- mesh__publicMeSHNote mesh__D003832
% 208.97/209.17       65; CROWN AND BRIDGEWORK was heading 1963-64   
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003832 2000
% 208.97/209.17  |- mesh__dateRevised mesh__D003832 1997-06-20
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003832 2003
% 208.97/209.17  |- mesh__recordOriginator mesh__D003832 NLM
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003832 1999
% 208.97/209.17  |- mesh__dateCreated mesh__D003832 1999-01-01
% 208.97/209.17  |- skos__broader mesh__D003832smesh__D003829
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003832 1998
% 208.97/209.17  |- mesh__dateEstablished mesh__D003832 1965-01-01
% 208.97/209.17  |- mesh__recordAuthorizer mesh__D003832 SJN
% 208.97/209.17  |- mesh__historyNote mesh__D003832
% 208.97/209.17       65; CROWN AND BRIDGEWORK was heading 1963-64   
% 208.97/209.17  |- skos__prefLabel mesh__D003832 Denture, Partial, Removable
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003832 2006
% 208.97/209.17  |- skos__scopeNote mesh__D003832
% 208.97/209.17       A partial denture designed and constructed to be removed readily from the mouth.%A%    
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003832 2002
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003832 2005
% 208.97/209.17  |- mesh__recordMaintainer mesh__D003832 PXP
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003832 2001
% 208.97/209.17  |- skos__scopeNote mesh__D050488
% 208.97/209.17       Displacement of the great toe %28%HALLUX%29% towards the midline or away from the other TOES. It can be congenital or acquired.%A%    
% 208.97/209.17  |- skos__broader mesh__D050488smesh__D005530
% 208.97/209.17  |- mesh__dateEstablished mesh__D050488 2006-01-01
% 208.97/209.17  |- skos__hiddenLabel mesh__D050488 Varus, Hallux
% 208.97/209.17  |- skos__prefLabel mesh__D050488 Hallux Varus
% 208.97/209.17  |- mesh__recordMaintainer mesh__D050488 ags
% 208.97/209.17  |- mesh__historyNote mesh__D050488 2006   
% 208.97/209.17  |- mesh__dateCreated mesh__D050488 2005-06-30
% 208.97/209.17  |- mesh__publicMeSHNote mesh__D050488 2006   
% 208.97/209.17  |- mesh__recordAuthorizer mesh__D050488 sjn
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D050488 2006
% 208.97/209.17  |- mesh__recordOriginator mesh__D050488 ags
% 208.97/209.17  |- rdf__type mesh__D050488sskos__Concept
% 208.97/209.17  |- skos__hiddenLabel mesh__D003034 Coated Pit, Cell-Membrane
% 208.97/209.17  |- skos__prefLabel mesh__D003034 Coated Pits, Cell-Membrane
% 208.97/209.17  |- mesh__dateCreated mesh__D003034 1982-04-22
% 208.97/209.17  |- rdf__type mesh__D003034sskos__Concept
% 208.97/209.17  |- skos__annotation mesh__D003034
% 208.97/209.17       A 11 qualif except /cytol; /genet permitted; DF: COATED PITS%A%  
% 208.97/209.17  |- mesh__recordOriginator mesh__D003034 AEP
% 208.97/209.17  |- skos__hiddenLabel mesh__D003034 Pits, Cell-Membrane Coated
% 208.97/209.17  |- mesh__dateEstablished mesh__D003034 1991-01-01
% 208.97/209.17  |- skos__scopeNote mesh__D003034
% 208.97/209.17       Specialized regions of the cell membrane composed of pits coated with a bristle covering made of the protein CLATHRIN. These pits are the entry route for macromolecules bound by cell surface receptors. The pits are then internalized into the cytoplasm to form the COATED VESICLES.%A%    
% 208.97/209.17  |- skos__altLabel mesh__D003034 Cell-Membrane Coated Pits
% 208.97/209.17  |- skos__hiddenLabel mesh__D003034 Bristle-Coated Pit
% 208.97/209.17  |- mesh__recordAuthorizer mesh__D003034 sjn
% 208.97/209.17  |- skos__hiddenLabel mesh__D003034 Cell Membrane Coated Pits
% 208.97/209.17  |- skos__historyNote mesh__D003034 Endocytosis %28%1973-1982%29%
% 208.97/209.17  |- skos__hiddenLabel mesh__D003034 Bristle Coated Pits
% 208.97/209.17  |- skos__altLabel mesh__D003034 Bristle-Coated Pits
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003034 2005
% 208.97/209.17  |- mesh__dateRevised mesh__D003034 2000-06-22
% 208.97/209.17  |- skos__hiddenLabel mesh__D003034 Pit, Bristle-Coated
% 208.97/209.17  |- skos__historyNote mesh__D003034 Cell Membrane %28%1966-1982%29%
% 208.97/209.17  |- skos__hiddenLabel mesh__D003034 Pits, Bristle-Coated
% 208.97/209.17  |- mesh__publicMeSHNote mesh__D003034
% 208.97/209.17       91; was see under RECEPTOSOMES 1983-90   
% 208.97/209.17  |- skos__hiddenLabel mesh__D003034 Cell-Membrane Coated Pit
% 208.97/209.17  |- skos__hiddenLabel mesh__D003034 Coated Pits, Cell Membrane
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003034 2003
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003034 2006
% 208.97/209.17  |- mesh__recordMaintainer mesh__D003034 PXP
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003034 2001
% 208.97/209.17  |- skos__related mesh__D003034smesh__D002966
% 208.97/209.17  |- skos__broader mesh__D003034smesh__D021961
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003034 2004
% 208.97/209.17  |- mesh__historyNote mesh__D003034
% 208.97/209.17       91%28%83%29%; was see under RECEPTOSOMES 1983-90   
% 208.97/209.17  |- skos__hiddenLabel mesh__D003034 Pit, Cell-Membrane Coated
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003034 2002
% 208.97/209.17  |- skos__altLabel mesh__D049934 1H-2-Benzopyran-1-ones
% 208.97/209.17  |- skos__historyNote mesh__D049934 Coumarins %28%1971-2005%29%
% 208.97/209.17  |- mesh__dateEstablished mesh__D049934 2006-01-01
% 208.97/209.17  |- rdf__type mesh__D049934sskos__Concept
% 208.97/209.17  |- skos__altLabel mesh__D049934 1-Isochromen-1-ones
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D049934 2006
% 208.97/209.17  |- mesh__recordMaintainer mesh__D049934 ssb
% 208.97/209.17  |- skos__scopeNote mesh__D049934
% 208.97/209.17       Compounds that differ from COUMARINS in having the positions of the ring and ketone oxygens reversed so the keto oxygen is at the 1-position of the molecule.%A%    
% 208.97/209.17  |- mesh__recordAuthorizer mesh__D049934 sjn
% 208.97/209.17  |- mesh__historyNote mesh__D049934 2006   
% 208.97/209.17  |- mesh__recordOriginator mesh__D049934 ssb
% 208.97/209.17  |- skos__broader mesh__D049934smesh__D003374
% 208.97/209.17  |- mesh__dateCreated mesh__D049934 2005-06-30
% 208.97/209.17  |- skos__prefLabel mesh__D049934 Isocoumarins
% 208.97/209.17  |- mesh__publicMeSHNote mesh__D049934 2006   
% 208.97/209.17  |- skos__broader mesh__D007703Q000037smesh__D007703
% 208.97/209.17  |- mesh__preferredCombination mesh__D007703Q000037smesh__D000806
% 208.97/209.17  |- rdf__type mesh__D007703Q000037smesh__CompoundConcept
% 208.97/209.17  |- mesh__publicMeSHNote mesh__D013462 74   
% 208.97/209.17  |- mesh__dateCreated mesh__D013462 1999-01-01
% 208.97/209.17  |- rdf__type mesh__D013462sskos__Concept
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013462 2005
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013462 2000
% 208.97/209.17  |- skos__broader mesh__D013462smesh__D013460
% 208.97/209.17  |- skos__broader mesh__D013462smesh__D011868
% 208.97/209.17  |- skos__annotation mesh__D013462
% 208.97/209.17       S-29-31, 35, 37, 38; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 208.97/209.17  |- mesh__recordOriginator mesh__D013462 NLM
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013462 2004
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013462 2001
% 208.97/209.17  |- skos__hiddenLabel mesh__D013462 Radioisotopes, Sulfur
% 208.97/209.17  |- skos__prefLabel mesh__D013462 Sulfur Radioisotopes
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013462 2006
% 208.97/209.17  |- mesh__recordAuthorizer mesh__D013462 PLS
% 208.97/209.17  |- mesh__recordMaintainer mesh__D013462 TPW
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013462 1996
% 208.97/209.17  |- mesh__dateRevised mesh__D013462 1993-06-04
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013462 1998
% 208.97/209.17  |- mesh__historyNote mesh__D013462 74   
% 208.97/209.17  |- skos__scopeNote mesh__D013462
% 208.97/209.17       Unstable isotopes of sulfur that decay or disintegrate spontaneously emitting radiation. S 29-31, 35, 37, and 38 are radioactive sulfur isotopes.%A%    
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013462 2002
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013462 1997
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013462 1994
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013462 1999
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013462 2003
% 208.97/209.17  |- mesh__onlineNote mesh__D013462 search SULFUR ISOTOPES 1966-73   
% 208.97/209.17  |- mesh__dateEstablished mesh__D013462 1974-01-01
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013462 1995
% 208.97/209.17  |- skos__scopeNote mesh__D007425
% 208.97/209.17       Thin structures that encapsulate subcellular structures or ORGANELLES in EUKARYOTIC CELLS. They include a variety of membranes associated with the CELL NUCLEUS; the MITOCHONDRIA; the GOLGI APPARATUS; the ENDOPLASMIC RETICULUM; LYSOSOMES; PLASTIDS; and VACUOLES.%A%    
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D007425 2006B
% 208.97/209.17  |- mesh__recordOriginator mesh__D007425 VDK
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D007425 2006
% 208.97/209.17  |- mesh__dateRevised mesh__D007425 2005-07-21
% 208.97/209.17  |- skos__hiddenLabel mesh__D007425 Membrane, Intracellular
% 208.97/209.17  |- skos__prefLabel mesh__D007425 Intracellular Membranes
% 208.97/209.17  |- skos__broader mesh__D007425smesh__D002462
% 208.97/209.17  |- mesh__dateEstablished mesh__D007425 1979-01-01
% 208.97/209.17  |- mesh__publicMeSHNote mesh__D007425 79   
% 208.97/209.17  |- mesh__recordAuthorizer mesh__D007425 ags
% 208.97/209.17  |- mesh__dateCreated mesh__D007425 1978-05-19
% 208.97/209.17  |- mesh__recordMaintainer mesh__D007425 ags
% 208.97/209.17  |- skos__historyNote mesh__D007425 Membranes %28%1966-1978%29%
% 208.97/209.17  |- mesh__historyNote mesh__D007425 79   
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D007425 2006A
% 208.97/209.17  |- skos__broader mesh__D007425smesh__D013347
% 208.97/209.17  |- rdf__type mesh__D007425sskos__Concept
% 208.97/209.17  |- skos__related mesh__D007425smesh__D033921
% 208.97/209.17  |- skos__hiddenLabel mesh__D007425 Intracellular Membrane
% 208.97/209.17  |- skos__altLabel mesh__D007425 Membranes, Intracellular
% 208.97/209.17  |- skos__broader mesh__D017853smesh__D010770
% 208.97/209.17  |- mesh__dateCreated mesh__D017853 1993-06-18
% 208.97/209.17  |- mesh__historyNote mesh__D017853 94   
% 208.97/209.17  |- skos__historyNote mesh__D017853 Phosphotransferases %28%1966-1993%29%
% 208.97/209.17  |- mesh__recordMaintainer mesh__D017853 ssb
% 208.97/209.17  |- skos__scopeNote mesh__D017853
% 208.97/209.17       A group of enzymes that transfers a phosphate group onto an alcohol group acceptor. EC 2.7.1.%A%    
% 208.97/209.17  |- mesh__recordAuthorizer mesh__D017853 sjn
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017853 2005
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017853 2004
% 208.97/209.17  |- mesh__dateRevised mesh__D017853 2003-07-09
% 208.97/209.17  |- rdf__type mesh__D017853sskos__Concept
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017853 2006
% 208.97/209.17  |- mesh__publicMeSHNote mesh__D017853 94   
% 208.97/209.17  |- skos__prefLabel mesh__D017853
% 208.97/209.17       Phosphotransferases %28%Alcohol Group Acceptor%29%
% 208.97/209.17  |- skos__annotation mesh__D017853 DF: PHOSPHOTRANSFERASES ALCOHOL   
% 208.97/209.17  |- mesh__recordOriginator mesh__D017853 TPW
% 208.97/209.17  |- mesh__dateEstablished mesh__D017853 1994-01-01
% 208.97/209.17  |- mesh__publicMeSHNote mesh__D017055 92; was see CRITICAL CARE 1980-91   
% 208.97/209.17  |- mesh__onlineNote mesh__D017055
% 208.97/209.17       use CRITICAL CARE to search INTENSIVE CARE 1980-91   
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017055 1999
% 208.97/209.17  |- skos__prefLabel mesh__D017055 Intensive Care
% 208.97/209.17  |- mesh__historyNote mesh__D017055 92; was see CRITICAL CARE 1980-91   
% 208.97/209.17  |- rdf__type mesh__D017055sskos__Concept
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017055 2003
% 208.97/209.17  |- mesh__dateCreated mesh__D017055 1991-06-20
% 208.97/209.17  |- mesh__dateEstablished mesh__D017055 1992-01-01
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017055 2000
% 208.97/209.17  |- skos__scopeNote mesh__D017055
% 208.97/209.17       Advanced and highly specialized care provided to medical or surgical patients whose conditions are life-threatening and require comprehensive care and constant monitoring. It is usually administered in specially equipped units of a health care facility.%A%    
% 208.97/209.17  |- skos__related mesh__D017055smesh__D003422
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017055 2004
% 208.97/209.17  |- mesh__recordOriginator mesh__D017055 PLS
% 208.97/209.17  |- mesh__recordAuthorizer mesh__D017055 SJN
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017055 2001
% 208.97/209.17  |- skos__broader mesh__D017055smesh__D003422
% 208.97/209.17  |- skos__altLabel mesh__D017055 Intensive Care, Surgical
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017055 2005
% 208.97/209.17  |- mesh__dateRevised mesh__D017055 1997-06-20
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017055 2002
% 208.97/209.17  |- skos__hiddenLabel mesh__D017055 Care, Surgical Intensive
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017055 2006
% 208.97/209.17  |- mesh__recordMaintainer mesh__D017055 PXP
% 208.97/209.17  |- skos__hiddenLabel mesh__D017055 Care, Intensive
% 208.97/209.17  |- skos__annotation mesh__D017055
% 208.97/209.17       coord IM with disease /ther or /surg %28%IM%29%   
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D017055 1998
% 208.97/209.17  |- mesh__recordAuthorizer mesh__D003833 SJN
% 208.97/209.17  |- skos__hiddenLabel mesh__D003833 Prosthesis Dental, Interim
% 208.97/209.17  |- mesh__historyNote mesh__D003833
% 208.97/209.17       65; CROWN AND BRIDGEWORK was heading 1963-64   
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003833 1998
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003833 2002
% 208.97/209.17  |- skos__altLabel mesh__D003833 Interim Prosthesis Dental
% 208.97/209.17  |- skos__hiddenLabel mesh__D003833 Dental Prostheses, Interim
% 208.97/209.17  |- skos__hiddenLabel mesh__D003833 Prosthesis Dentals, Interim
% 208.97/209.17  |- skos__broader mesh__D003833smesh__D003829
% 208.97/209.17  |- mesh__recordMaintainer mesh__D003833 PXP
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003833 2006
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003833 2001
% 208.97/209.17  |- skos__hiddenLabel mesh__D003833 Dentals, Interim Prosthesis
% 208.97/209.17  |- skos__prefLabel mesh__D003833 Denture, Partial, Temporary
% 208.97/209.17  |- skos__hiddenLabel mesh__D003833 Prostheses, Interim Dental
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003833 2005
% 208.97/209.17  |- skos__scopeNote mesh__D003833
% 208.97/209.17       A partial denture intended for short-term use in a temporary or emergency situation.%A%    
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003833 2000
% 208.97/209.17  |- skos__hiddenLabel mesh__D003833 Prosthesis, Interim Dental
% 208.97/209.17  |- mesh__dateRevised mesh__D003833 1997-06-20
% 208.97/209.17  |- mesh__recordOriginator mesh__D003833 NLM
% 208.97/209.17  |- rdf__type mesh__D003833sskos__Concept
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003833 2004
% 208.97/209.17  |- mesh__publicMeSHNote mesh__D003833
% 208.97/209.17       65; CROWN AND BRIDGEWORK was heading 1963-64   
% 208.97/209.17  |- skos__hiddenLabel mesh__D003833 Interim Dental Prostheses
% 208.97/209.17  |- mesh__dateEstablished mesh__D003833 1965-01-01
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003833 2003
% 208.97/209.17  |- skos__hiddenLabel mesh__D003833 Interim Prosthesis Dentals
% 208.97/209.17  |- skos__altLabel mesh__D003833 Dental Prosthesis, Interim
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003833 1999
% 208.97/209.17  |- mesh__dateCreated mesh__D003833 1999-01-01
% 208.97/209.17  |- skos__hiddenLabel mesh__D003833 Dental, Interim Prosthesis
% 208.97/209.17  |- mesh__recordAuthorizer mesh__D050489 sjn
% 208.97/209.17  |- mesh__recordOriginator mesh__D050489 ags
% 208.97/209.17  |- skos__related mesh__D050489smesh__D006215
% 208.97/209.17  |- mesh__recordMaintainer mesh__D050489 ags
% 208.97/209.17  |- mesh__dateEstablished mesh__D050489 2006-01-01
% 208.97/209.17  |- skos__hiddenLabel mesh__D050489 Bunionettes
% 208.97/209.17  |- mesh__publicMeSHNote mesh__D050489 2006   
% 208.97/209.17  |- skos__hiddenLabel mesh__D050489 Bunion, Tailors
% 208.97/209.17  |- skos__altLabel mesh__D050489 Tailor%27%s Bunion
% 208.97/209.17  |- skos__prefLabel mesh__D050489 Bunion, Tailor%27%s
% 208.97/209.17  |- skos__hiddenLabel mesh__D050489 Tailors Bunion
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D050489 2006
% 208.97/209.17  |- rdf__type mesh__D050489sskos__Concept
% 208.97/209.17  |- skos__historyNote mesh__D050489 Hallux Valgus %28%1972-2005%29%
% 208.97/209.17  |- skos__scopeNote mesh__D050489
% 208.97/209.17       Abnormal swelling of the outer aspect of the fifth metatarsal head affecting the fifth METATARSOPHALANGEAL JOINT.%A%    
% 208.97/209.17  |- mesh__historyNote mesh__D050489 2006   
% 208.97/209.17  |- skos__altLabel mesh__D050489 Bunionette
% 208.97/209.17  |- skos__hiddenLabel mesh__D050489 Bunions, Tailor%27%s
% 208.97/209.17  |- mesh__dateCreated mesh__D050489 2005-06-30
% 208.97/209.17  |- skos__broader mesh__D050489smesh__D005531
% 208.97/209.17  |- skos__hiddenLabel mesh__D050489 Tailor%27%s Bunions
% 208.97/209.17  |- skos__related mesh__D003035smesh__D003037
% 208.97/209.17  |- skos__broader mesh__D003035smesh__D028561
% 208.97/209.17  |- skos__scopeNote mesh__D003035
% 208.97/209.17       A trace element that is a component of vitamin B12. It has the atomic symbol Co, atomic number 27, and atomic weight 58.93. It is used in nuclear weapons, alloys, and pigments. Deficiency in animals leads to anemia; its excess in humans can lead to erythrocytosis.%A%    
% 208.97/209.17  |- mesh__dateCreated mesh__D003035 1999-01-01
% 208.97/209.17  |- mesh__recordOriginator mesh__D003035 NLM
% 208.97/209.17  |- skos__annotation mesh__D003035 Co-59   
% 208.97/209.17  |- skos__prefLabel mesh__D003035 Cobalt
% 208.97/209.17  |- skos__related mesh__D003035smesh__D003036
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D003035 2006
% 208.97/209.17  |- mesh__recordAuthorizer mesh__D003035 sjn
% 208.97/209.17  |- mesh__recordMaintainer mesh__D003035 ssb
% 208.97/209.17  |- skos__broader mesh__D003035smesh__D019216
% 208.97/209.17  |- mesh__dateRevised mesh__D003035 2005-06-30
% 208.97/209.17  |- rdf__type mesh__D003035sskos__Concept
% 208.97/209.17  |- rdf__type mesh__D049935sskos__Concept
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D049935 2006
% 208.97/209.17  |- skos__annotation mesh__D049935
% 208.97/209.17       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.97/209.17  |- skos__scopeNote mesh__D049935
% 208.97/209.17       A plant family of the order Laurales, subclass Magnoliidae, class Magnoliopsida. Members contain cytotoxic furofuran LIGNANS and isoquinoline ALKALOIDS.%A%    
% 208.97/209.17  |- mesh__recordOriginator mesh__D049935 ssb
% 208.97/209.17  |- skos__broader mesh__D049935smesh__D019684
% 208.97/209.17  |- mesh__dateEstablished mesh__D049935 2006-01-01
% 208.97/209.17  |- mesh__recordMaintainer mesh__D049935 ssb
% 208.97/209.17  |- mesh__recordAuthorizer mesh__D049935 sjn
% 208.97/209.17  |- mesh__historyNote mesh__D049935 2006   
% 208.97/209.17  |- mesh__publicMeSHNote mesh__D049935 2006   
% 208.97/209.17  |- skos__prefLabel mesh__D049935 Hernandiaceae
% 208.97/209.17  |- mesh__dateCreated mesh__D049935 2005-06-30
% 208.97/209.17  |- mesh__recordMaintainer mesh__D013463 TPW
% 208.97/209.17  |- mesh__historyNote mesh__D013463
% 208.97/209.17       91%28%75%29%; was see under SULFURIC ACIDS 1975-90; SULFATES, ORGANIC was see SULFURIC ACIDS 1977-93; THIOSULFURIC ACID ESTERS was heading 1975-93 %28%see under SULFURIC ACIDS 1975-90%29%%A%  
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013463 2002
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013463 1996
% 208.97/209.17  |- skos__scopeNote mesh__D013463 Organic esters of sulfuric acid.     
% 208.97/209.17  |- skos__altLabel mesh__D013463 Sulfates, Organic
% 208.97/209.17  |- mesh__onlineNote mesh__D013463
% 208.97/209.17       search SULFURIC ACIDS 1968-74; use SULFURIC ACIDS to search SULFATES, ORGANIC 1977-93; use SULFURIC ACID ESTERS to search THIOSULFURIC ACID ESTERS 1975-93%A%  
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013463 1998
% 208.97/209.17  |- skos__hiddenLabel mesh__D013463 Esters, Sulfuric Acid
% 208.97/209.17  |- mesh__publicMeSHNote mesh__D013463
% 208.97/209.17       91; was see under SULFURIC ACIDS 1975-90; SULFATES, ORGANIC was see SULFURIC ACIDS 1977-93; THIOSULFURIC ACID ESTERS was heading 1975-93 %28%see under SULFURIC ACIDS 1975-90%29%%A%  
% 208.97/209.17  |- skos__hiddenLabel mesh__D013463 Esters, Thiosulfuric Acid
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013463 1997
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013463 1994
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013463 1999
% 208.97/209.17  |- skos__altLabel mesh__D013463 Organic Sulfates
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013463 2000
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013463 2003
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013463 1995
% 208.97/209.17  |- mesh__recordOriginator mesh__D013463 NLM
% 208.97/209.17  |- mesh__dateCreated mesh__D013463 1999-01-01
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013463 2001
% 208.97/209.17  |- rdf__type mesh__D013463sskos__Concept
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013463 2005
% 208.97/209.17  |- mesh__recordAuthorizer mesh__D013463 PLS
% 208.97/209.17  |- skos__prefLabel mesh__D013463 Sulfuric Acid Esters
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013463 2004
% 208.97/209.17  |- mesh__activeMeSHYear mesh__D013463 2006
% 208.97/209.17  |- skos__broader mesh__D013463smesh__D013464
% 208.97/209.17  |- mesh__dateRevised mesh__D013463 1993-06-25
% 208.97/209.17  |- mesh__dateEstablished mesh__D013463 1991-01-01
% 208.97/209.18  |- skos__hiddenLabel mesh__D007426 Gene, Intracisternal A-Particle
% 208.97/209.18  |- skos__hiddenLabel mesh__D007426 A-Particle Gene, Intracisternal
% 208.97/209.18  |- mesh__dateCreated mesh__D007426 1985-03-11
% 208.97/209.18  |- mesh__publicMeSHNote mesh__D007426
% 208.97/209.18       92; was INTRACISTERNAL A-PARTICLE GENES 1986-91 %28%see under PROTO-ONCOGENES 1986-90%29%%A%  
% 208.97/209.18  |- skos__altLabel mesh__D007426 Intracisternal A-Particle Genes
% 208.97/209.18  |- mesh__recordAuthorizer mesh__D007426 sjn
% 208.97/209.18  |- skos__broader mesh__D007426smesh__D005814
% 208.97/209.18  |- mesh__recordOriginator mesh__D007426 AEP
% 208.97/209.18  |- skos__hiddenLabel mesh__D007426 Intracisternal A Particle Genes
% 208.97/209.18  |- skos__hiddenLabel mesh__D007426 IAP Element
% 208.97/209.18  |- skos__broader mesh__D007426smesh__D018626
% 208.97/209.18  |- skos__hiddenLabel mesh__D007426 Element, Intracisternal A-Particle
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D007426 2006
% 208.97/209.18  |- mesh__historyNote mesh__D007426
% 208.97/209.18       92; was INTRACISTERNAL A-PARTICLE GENES 1986-91 %28%see under PROTO-ONCOGENES 1986-90%29%%A%  
% 208.97/209.18  |- skos__historyNote mesh__D007426
% 208.97/209.18       Repetitive Sequences, Nucleic Acid %28%1981-1985%29%
% 208.97/209.18  |- skos__historyNote mesh__D007426 Base Sequence %28%1980-1985%29%
% 208.97/209.18  |- skos__scopeNote mesh__D007426
% 208.97/209.18       Genes of IAP elements %28%a family of retrovirus-like genetic elements%29% which code for virus-like particles %28%IAPs%29% found regularly in rodent early embryos. %28%%22%Intracisternal%22% refers to the cisternae of the endoplasmic reticulum.%29% Under certain circumstances, such as DNA hypomethylation they are transcribed. Their transcripts are found in a variety of neoplasms, including plasmacytomas, neuroblastoma, rhabdomyosarcomas, teratocarcinomas, and colon carcinomas.%A%    
% 208.97/209.18  |- mesh__onlineNote mesh__D007426
% 208.97/209.18       use GENES, INTRACISTERNAL A-PARTICLE to search INTRACISTERNAL A-PARTICLE GENES 1986-91%A%  
% 208.97/209.18  |- mesh__recordMaintainer mesh__D007426 nns
% 208.97/209.18  |- skos__historyNote mesh__D007426 Genes, Viral %28%1980-1985%29%
% 208.97/209.18  |- skos__hiddenLabel mesh__D007426 Intracisternal A Particle Elements
% 208.97/209.18  |- skos__hiddenLabel mesh__D007426 Intracisternal A-Particle Gene
% 208.97/209.18  |- skos__altLabel mesh__D007426 Gene, Intracisternal A Particle
% 208.97/209.18  |- skos__historyNote mesh__D007426 Oncogenes %28%1983-1985%29%
% 208.97/209.18  |- skos__hiddenLabel mesh__D007426 Genes, Intracisternal A Particle
% 208.97/209.18  |- skos__hiddenLabel mesh__D007426 A-Particle Elements, Intracisternal
% 208.97/209.18  |- skos__prefLabel mesh__D007426 Genes, Intracisternal A-Particle
% 208.97/209.18  |- skos__hiddenLabel mesh__D007426 Intracisternal A-Particle Element
% 208.97/209.18  |- skos__historyNote mesh__D007426 Retroviridae %28%1980-1985%29%
% 208.97/209.18  |- skos__hiddenLabel mesh__D007426 Element, IAP
% 208.97/209.18  |- mesh__dateRevised mesh__D007426 2005-06-30
% 208.97/209.18  |- skos__hiddenLabel mesh__D007426 A-Particle Genes, Intracisternal
% 208.97/209.18  |- skos__altLabel mesh__D007426 IAP Elements
% 208.97/209.18  |- rdf__type mesh__D007426sskos__Concept
% 208.97/209.18  |- skos__hiddenLabel mesh__D007426 Elements, IAP
% 208.97/209.18  |- skos__hiddenLabel mesh__D007426 A-Particle Element, Intracisternal
% 208.97/209.18  |- mesh__dateEstablished mesh__D007426 1991-01-01
% 208.97/209.18  |- skos__hiddenLabel mesh__D007426 Elements, Intracisternal A-Particle
% 208.97/209.18  |- mesh__dateEstablished mesh__D017854 1994-01-01
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017854 2005
% 208.97/209.18  |- skos__altLabel mesh__D017854 Pyrophosphokinases
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017854 2004
% 208.97/209.18  |- mesh__dateRevised mesh__D017854 2003-07-09
% 208.97/209.18  |- rdf__type mesh__D017854sskos__Concept
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017854 2006
% 208.97/209.18  |- skos__altLabel mesh__D017854 Pyrophosphotransferases
% 208.97/209.18  |- skos__scopeNote mesh__D017854
% 208.97/209.18       A class of phosphotransferases that catalyzes the transfer of diphosphate-containing groups. EC 2.7.6.%A%    
% 208.97/209.18  |- skos__broader mesh__D017854smesh__D010770
% 208.97/209.18  |- mesh__dateCreated mesh__D017854 1993-06-18
% 208.97/209.18  |- skos__prefLabel mesh__D017854 Diphosphotransferases
% 208.97/209.18  |- mesh__publicMeSHNote mesh__D017854 94   
% 208.97/209.18  |- mesh__historyNote mesh__D017854 94   
% 208.97/209.18  |- skos__historyNote mesh__D017854 Phosphotransferases %28%1966-1993%29%
% 208.97/209.18  |- rdf__type mesh__D017056sskos__Concept
% 208.97/209.18  |- skos__hiddenLabel mesh__D017056 Scientist, Laboratory
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017056 2003
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017056 1995
% 208.97/209.18  |- mesh__dateRevised mesh__D017056 1992-03-25
% 208.97/209.18  |- mesh__recordMaintainer mesh__D017056 TAP
% 208.97/209.18  |- mesh__dateCreated mesh__D017056 1991-06-20
% 208.97/209.18  |- skos__hiddenLabel mesh__D017056 Assistant, Laboratory
% 208.97/209.18  |- mesh__historyNote mesh__D017056 92   
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017056 2004
% 208.97/209.18  |- skos__scopeNote mesh__D017056
% 208.97/209.18       Those health care professionals, technicians, and assistants staffing a research or health care facility where specimens are grown, tested, or evaluated and the results of such measures are recorded.%A%    
% 208.97/209.18  |- skos__hiddenLabel mesh__D017056 Laboratory Assistant
% 208.97/209.18  |- mesh__publicMeSHNote mesh__D017056 92   
% 208.97/209.18  |- mesh__recordOriginator mesh__D017056 PLS
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017056 1996
% 208.97/209.18  |- skos__hiddenLabel mesh__D017056 Laboratory Technician
% 208.97/209.18  |- skos__annotation mesh__D017056
% 208.97/209.18       coord IM with type of lab or occup %28%IM%29%, as hosp lab personnel = LABORATORY PERSONNEL %28%IM%29% + LABORATORIES, HOSPITAL %28%IM%29% or hematol lab personnel = LABORATORY PERSONNEL %28%IM%29% + HEMATOLOGY %28%IM%29%%A%  
% 208.97/209.18  |- skos__hiddenLabel mesh__D017056 Laboratory Scientist
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017056 2005
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017056 1997
% 208.97/209.18  |- skos__hiddenLabel mesh__D017056 Personnel, Laboratory
% 208.97/209.18  |- mesh__dateEstablished mesh__D017056 1992-01-01
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017056 2000
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017056 2006
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017056 1993
% 208.97/209.18  |- skos__broader mesh__D017056smesh__D006282
% 208.97/209.18  |- skos__hiddenLabel mesh__D017056 Technicians, Laboratory
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017056 1998
% 208.97/209.18  |- mesh__recordAuthorizer mesh__D017056 PLS
% 208.97/209.18  |- skos__hiddenLabel mesh__D017056 Scientists, Laboratory
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017056 2001
% 208.97/209.18  |- skos__hiddenLabel mesh__D017056 Technician, Laboratory
% 208.97/209.18  |- skos__prefLabel mesh__D017056 Laboratory Personnel
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017056 1994
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017056 1999
% 208.97/209.18  |- skos__hiddenLabel mesh__D017056 Assistants, Laboratory
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017056 2002
% 208.97/209.18  |- mesh__dateCreated mesh__D003834 1999-01-01
% 208.97/209.18  |- skos__hiddenLabel mesh__D003834 Attachments, Intracoronal
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003834 2006
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003834 2001
% 208.97/209.18  |- skos__hiddenLabel mesh__D003834 Attachment, Intracoronal
% 208.97/209.18  |- mesh__dateRevised mesh__D003834 1999-11-03
% 208.97/209.18  |- skos__hiddenLabel mesh__D003834 Attachments, Denture Precision
% 208.97/209.18  |- rdf__type mesh__D003834sskos__Concept
% 208.97/209.18  |- skos__hiddenLabel mesh__D003834 Intracoronal Attachments
% 208.97/209.18  |- skos__altLabel mesh__D003834 Slotted Attachments, Dental
% 208.97/209.18  |- skos__prefLabel mesh__D003834 Denture Precision Attachment
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003834 2002
% 208.97/209.18  |- skos__hiddenLabel mesh__D003834 Precision Attachment Denture
% 208.97/209.18  |- skos__hiddenLabel mesh__D003834 Attachment, Denture Precision
% 208.97/209.18  |- mesh__recordAuthorizer mesh__D003834 sjn
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003834 2003
% 208.97/209.18  |- skos__altLabel mesh__D003834 Slotted Attachment, Dental
% 208.97/209.18  |- skos__hiddenLabel mesh__D003834 Denture Precision Attachments
% 208.97/209.18  |- skos__hiddenLabel mesh__D003834 Attachment Denture, Precision
% 208.97/209.18  |- skos__altLabel mesh__D003834 Denture, Precision Attachment
% 208.97/209.18  |- skos__annotation mesh__D003834 restrict to partial dentures   
% 208.97/209.18  |- skos__hiddenLabel mesh__D003834 Precision Attachment Dentures
% 208.97/209.18  |- skos__altLabel mesh__D003834 Dental Slotted Attachments
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003834 2004
% 208.97/209.18  |- skos__historyNote mesh__D003834 Denture, Partial %28%1966-1969%29%
% 208.97/209.18  |- skos__hiddenLabel mesh__D003834 Precision Attachments, Denture
% 208.97/209.18  |- skos__altLabel mesh__D003834 Attachments, Dental Slotted
% 208.97/209.18  |- mesh__recordOriginator mesh__D003834 NLM
% 208.97/209.18  |- skos__historyNote mesh__D003834
% 208.97/209.18       Denture, Partial, Removable %28%1966-1969%29%
% 208.97/209.18  |- mesh__publicMeSHNote mesh__D003834 70   
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003834 2005
% 208.97/209.18  |- skos__altLabel mesh__D003834 Dental Slotted Attachment
% 208.97/209.18  |- skos__scopeNote mesh__D003834
% 208.97/209.18       A precision device used for attaching a fixed or removable partial denture to the crown of an abutment tooth or a restoration. One type is the intracoronal attachment and the other type is the extracoronal attachment. It consists of a female portion within the coronal portion of the crown of an abutment and a fitted male portion attached to the denture proper. %28%Jablonski, Dictionary of Dentistry, 1992, p85; from Boucher%27%s Clinical Dental Terminology, 4th ed, p264%29%%A%    
% 208.97/209.18  |- skos__hiddenLabel mesh__D003834 Dentures, Precision Attachment
% 208.97/209.18  |- skos__altLabel mesh__D003834 Attachment, Dental Slotted
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003834 2000
% 208.97/209.18  |- skos__broader mesh__D003834smesh__D003829
% 208.97/209.18  |- mesh__dateEstablished mesh__D003834 1970-01-01
% 208.97/209.18  |- mesh__recordMaintainer mesh__D003834 KEV
% 208.97/209.18  |- mesh__historyNote mesh__D003834 70   
% 208.97/209.18  |- skos__hiddenLabel mesh__D003834 Attachment Dentures, Precision
% 208.97/209.18  |- skos__altLabel mesh__D003834 Precision Attachment, Denture
% 208.97/209.18  |- mesh__dateRevised mesh__D003036 2000-06-22
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003036 2006
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003036 2003
% 208.97/209.18  |- skos__broader mesh__D003036smesh__D007554
% 208.97/209.18  |- skos__annotation mesh__D003036 Co-59; NIM   
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003036 2004
% 208.97/209.18  |- skos__hiddenLabel mesh__D003036 Isotopes, Cobalt
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003036 2001
% 208.97/209.18  |- mesh__recordMaintainer mesh__D003036 nns
% 208.97/209.18  |- rdf__type mesh__D003036sskos__Concept
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003036 2002
% 208.97/209.18  |- skos__prefLabel mesh__D003036 Cobalt Isotopes
% 208.97/209.18  |- mesh__recordOriginator mesh__D003036 NLM
% 208.97/209.18  |- skos__scopeNote mesh__D003036
% 208.97/209.18       Stable cobalt atoms that have the same atomic number as the element cobalt, but differ in atomic weight. Co-59 is a stable cobalt isotope.%A%    
% 208.97/209.18  |- mesh__dateCreated mesh__D003036 1999-01-01
% 208.97/209.18  |- mesh__recordAuthorizer mesh__D003036 sjn
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003036 2005
% 208.97/209.18  |- mesh__recordAuthorizer mesh__D049936 sjn
% 208.97/209.18  |- rdf__type mesh__D049936sskos__Concept
% 208.97/209.18  |- mesh__dateEstablished mesh__D049936 2006-01-01
% 208.97/209.18  |- mesh__historyNote mesh__D049936 2006   
% 208.97/209.18  |- skos__altLabel mesh__D049936 Hornworts
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D049936 2006
% 208.97/209.18  |- skos__annotation mesh__D049936
% 208.97/209.18       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 208.97/209.18  |- mesh__dateCreated mesh__D049936 2005-06-30
% 208.97/209.18  |- mesh__recordMaintainer mesh__D049936 ssb
% 208.97/209.18  |- skos__prefLabel mesh__D049936 Anthocerotophyta
% 208.97/209.18  |- mesh__publicMeSHNote mesh__D049936 2006   
% 208.97/209.18  |- skos__broader mesh__D049936smesh__D019669
% 208.97/209.18  |- mesh__recordOriginator mesh__D049936 ssb
% 208.97/209.18  |- skos__scopeNote mesh__D049936
% 208.97/209.18       A plant division that includes hornworts, named for the horn-like appearance of the spore-producing plant %28%sporophyte%29%.%A%    
% 208.97/209.18  |- skos__scopeNote mesh__D013464
% 208.97/209.18       Inorganic and organic derivatives of sulfuric acid %28%H2SO4%29%. The salts and esters of sulfuric acid are known as SULFATES and SULFURIC ACID ESTERS respectively.%A%    
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D013464 1998
% 208.97/209.18  |- skos__broader mesh__D013464smesh__D013456
% 208.97/209.18  |- mesh__dateEstablished mesh__D013464 1968-01-01
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D013464 1997
% 208.97/209.18  |- mesh__dateRevised mesh__D013464 1993-06-04
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D013464 1994
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D013464 1999
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D013464 2002
% 208.97/209.18  |- skos__prefLabel mesh__D013464 Sulfuric Acids
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D013464 1995
% 208.97/209.18  |- mesh__dateCreated mesh__D013464 1999-01-01
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D013464 2003
% 208.97/209.18  |- rdf__type mesh__D013464sskos__Concept
% 208.97/209.18  |- mesh__historyNote mesh__D013464 68; was SULFURIC ACID 1963-67   
% 208.97/209.18  |- skos__annotation mesh__D013464 do not confuse with SULFUR ACIDS   
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D013464 2005
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D013464 2004
% 208.97/209.18  |- mesh__onlineNote mesh__D013464
% 208.97/209.18       use SULFURIC ACIDS to search SULFURIC ACID 1966-68   
% 208.97/209.18  |- mesh__publicMeSHNote mesh__D013464 68; was SULFURIC ACID 1963-67   
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D013464 2006
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D013464 2000
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D013464 2001
% 208.97/209.18  |- mesh__recordOriginator mesh__D013464 NLM
% 208.97/209.18  |- mesh__recordMaintainer mesh__D013464 TPW
% 208.97/209.18  |- skos__hiddenLabel mesh__D013464 Acids, Sulfuric
% 208.97/209.18  |- mesh__recordAuthorizer mesh__D013464 PLS
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D013464 1996
% 208.97/209.18  |- skos__altLabel mesh__D007427 Subarachnoid Pressure
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D007427 2005
% 208.97/209.18  |- skos__hiddenLabel mesh__D007427 Pressures, Intracerebral
% 208.97/209.18  |- mesh__recordAuthorizer mesh__D007427 SJN
% 208.97/209.18  |- skos__scopeNote mesh__D007427
% 208.97/209.18       Pressure within the cranial cavity. It is influenced by brain mass, the circulatory system, CSF dynamics, and skull rigidity.%A%    
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D007427 2006
% 208.97/209.18  |- mesh__recordMaintainer mesh__D007427 TGC
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D007427 2003
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D007427 1998
% 208.97/209.18  |- mesh__dateCreated mesh__D007427 1999-01-01
% 208.97/209.18  |- skos__hiddenLabel mesh__D007427 Subarachnoid Pressures
% 208.97/209.18  |- mesh__recordOriginator mesh__D007427 NLM
% 208.97/209.18  |- skos__hiddenLabel mesh__D007427 Intracerebral Pressures
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D007427 2004
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D007427 1999
% 208.97/209.18  |- skos__broader mesh__D007427smesh__D015170
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D007427 2000
% 208.97/209.18  |- skos__hiddenLabel mesh__D007427 Intracranial Pressures
% 208.97/209.18  |- skos__hiddenLabel mesh__D007427 Pressure, Intracranial
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D007427 2001
% 208.97/209.18  |- rdf__type mesh__D007427sskos__Concept
% 208.97/209.18  |- mesh__dateRevised mesh__D007427 1997-06-20
% 208.97/209.18  |- skos__hiddenLabel mesh__D007427 Pressure, Subarachnoid
% 208.97/209.18  |- skos__hiddenLabel mesh__D007427 Pressure, Intracerebral
% 208.97/209.18  |- skos__hiddenLabel mesh__D007427 Pressures, Subarachnoid
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D007427 2002
% 208.97/209.18  |- skos__prefLabel mesh__D007427 Intracranial Pressure
% 208.97/209.18  |- skos__hiddenLabel mesh__D007427 Pressures, Intracranial
% 208.97/209.18  |- skos__annotation mesh__D007427
% 208.97/209.18       INTRACRANIAL HYPOTENSION %26% INTRACRANIAL HYPERTENSION are also available%A%  
% 208.97/209.18  |- skos__broader mesh__D020003Q000031smesh__D020003
% 208.97/209.18  |- mesh__preferredCombination mesh__D020003Q000031smesh__D000442
% 208.97/209.18  |- rdf__type mesh__D020003Q000031smesh__CompoundConcept
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017855 2006
% 208.97/209.18  |- skos__altLabel mesh__D017855
% 208.97/209.18       Phosphotransferases %28%Other Substituted Phosphate Groups%29%
% 208.97/209.18  |- mesh__dateCreated mesh__D017855 1993-06-04
% 208.97/209.18  |- mesh__recordOriginator mesh__D017855 TPW
% 208.97/209.18  |- mesh__publicMeSHNote mesh__D017855 94   
% 208.97/209.18  |- mesh__dateEstablished mesh__D017855 1994-01-01
% 208.97/209.18  |- skos__prefLabel mesh__D017855
% 208.97/209.18       Transferases %28%Other Substituted Phosphate Groups%29%
% 208.97/209.18  |- skos__broader mesh__D017855smesh__D010770
% 208.97/209.18  |- mesh__historyNote mesh__D017855 94   
% 208.97/209.18  |- skos__historyNote mesh__D017855 Phosphotransferases %28%1966-1993%29%
% 208.97/209.18  |- skos__scopeNote mesh__D017855
% 208.97/209.18       A class of enzymes that transfers substituted phosphate groups. EC 2.7.8.%A%    
% 208.97/209.18  |- mesh__recordMaintainer mesh__D017855 ssb
% 208.97/209.18  |- skos__annotation mesh__D017855 DF: TRANSFERASES OSPG   
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017855 2005
% 208.97/209.18  |- rdf__type mesh__D017855sskos__Concept
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017855 2004
% 208.97/209.18  |- mesh__recordAuthorizer mesh__D017855 sjn
% 208.97/209.18  |- mesh__dateRevised mesh__D017855 2003-07-09
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017057 2005
% 208.97/209.18  |- mesh__publicMeSHNote mesh__D017057 92   
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017057 1999
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017057 2000
% 208.97/209.18  |- skos__related mesh__D017057smesh__D017664
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017057 2004
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017057 1998
% 208.97/209.18  |- rdf__type mesh__D017057sskos__Concept
% 208.97/209.18  |- mesh__historyNote mesh__D017057 92   
% 208.97/209.18  |- skos__annotation mesh__D017057
% 208.97/209.18       uninsured or underinsured; DF: MED UNINSURED   
% 208.97/209.18  |- mesh__dateEstablished mesh__D017057 1992-01-01
% 208.97/209.18  |- skos__scopeNote mesh__D017057
% 208.97/209.18       Individuals or groups with no or inadequate health insurance coverage. Those falling into this category usually comprise three primary groups: the medically indigent %28%MEDICAL INDIGENCY%29%; those whose clinical condition makes them medically uninsurable; and the working uninsured.%A%    
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017057 2003
% 208.97/209.18  |- mesh__recordMaintainer mesh__D017057 PLS
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017057 1997
% 208.97/209.18  |- skos__prefLabel mesh__D017057 Medically Uninsured
% 208.97/209.18  |- skos__broader mesh__D017057smesh__D009272
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017057 2002
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017057 1996
% 208.97/209.18  |- mesh__dateRevised mesh__D017057 1994-06-16
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017057 1995
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017057 2006
% 208.97/209.18  |- mesh__recordAuthorizer mesh__D017057 PLS
% 208.97/209.18  |- mesh__recordOriginator mesh__D017057 PLS
% 208.97/209.18  |- mesh__dateCreated mesh__D017057 1991-06-20
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D017057 2001
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003835 1997
% 208.97/209.18  |- mesh__recordAuthorizer mesh__D003835 PLS
% 208.97/209.18  |- skos__historyNote mesh__D003835 Dental Auxiliaries %28%1979%29%
% 208.97/209.18  |- skos__hiddenLabel mesh__D003835 Denturist
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003835 2006
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003835 2003
% 208.97/209.18  |- skos__prefLabel mesh__D003835 Denturists
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003835 1994
% 208.97/209.18  |- rdf__type mesh__D003835sskos__Concept
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003835 2002
% 208.97/209.18  |- skos__broader mesh__D003835smesh__D003800
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003835 2004
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003835 1998
% 208.97/209.18  |- mesh__dateEstablished mesh__D003835 1991-01-01
% 208.97/209.18  |- mesh__historyNote mesh__D003835
% 208.97/209.18       91%28%80%29%; was see under DENTAL AUXILIARIES 1980-90; was see DENTAL AUXILIARIES 1979%A%  
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003835 1995
% 208.97/209.18  |- mesh__dateRevised mesh__D003835 1992-05-14
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003835 1999
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003835 2000
% 208.97/209.18  |- skos__annotation mesh__D003835
% 208.97/209.18       dent technicians working with patients requiring dentures %28%prep, repair, fitting%29%%A%  
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003835 1996
% 208.97/209.18  |- mesh__publicMeSHNote mesh__D003835
% 208.97/209.18       91; was see under DENTAL AUXILIARIES 1980-90; was see DENTAL AUXILIARIES 1979%A%  
% 208.97/209.18  |- skos__historyNote mesh__D003835 Dental Technicians %28%1966-1978%29%
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003835 1993
% 208.97/209.18  |- mesh__dateCreated mesh__D003835 1979-03-09
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003835 2005
% 208.97/209.18  |- mesh__recordMaintainer mesh__D003835 TAP
% 208.97/209.18  |- mesh__recordOriginator mesh__D003835 SMH
% 208.97/209.18  |- skos__scopeNote mesh__D003835
% 208.97/209.18       Dental technicians who provide dentures for patients without benefit of a dentist%27%s professional services. Their duties include taking impressions and bite registrations for preparing and repairing dentures and fitting dentures. They are rarely found in the United States, where their practice is illegal in many states, but are becoming increasingly common in Canada.%A%    
% 208.97/209.18  |- mesh__onlineNote mesh__D003835 search DENTAL AUXILIARIES 1979   
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003835 2001
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003037 2004
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003037 1997
% 208.97/209.18  |- mesh__dateEstablished mesh__D003037 1974-01-01
% 208.97/209.18  |- skos__broader mesh__D003037smesh__D011868
% 208.97/209.18  |- skos__hiddenLabel mesh__D003037 Radioisotopes, Cobalt
% 208.97/209.18  |- skos__prefLabel mesh__D003037 Cobalt Radioisotopes
% 208.97/209.18  |- skos__broader mesh__D003037smesh__D003036
% 208.97/209.18  |- rdf__type mesh__D003037sskos__Concept
% 208.97/209.18  |- mesh__recordMaintainer mesh__D003037 TPW
% 208.97/209.18  |- mesh__onlineNote mesh__D003037 search COBALT ISOTOPES 1966-73   
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003037 2000
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003037 1994
% 208.97/209.18  |- mesh__dateCreated mesh__D003037 1999-01-01
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003037 2001
% 208.97/209.18  |- mesh__publicMeSHNote mesh__D003037 74   
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003037 1995
% 208.97/209.18  |- mesh__recordAuthorizer mesh__D003037 PLS
% 208.97/209.18  |- skos__scopeNote mesh__D003037
% 208.97/209.18       Unstable isotopes of cobalt that decay or disintegrate emitting radiation. Co atoms with atomic weights of 54-64, except 59, are radioactive cobalt isotopes.%A%    
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003037 2005
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003037 2002
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003037 1998
% 208.97/209.18  |- skos__annotation mesh__D003037
% 208.97/209.18       Co-54-64 except Co-59; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%; often discussed with RADIOISOTOPE TELETHERAPY %28%IM%29%%A%  
% 208.97/209.18  |- mesh__recordOriginator mesh__D003037 NLM
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003037 2006
% 208.97/209.18  |- mesh__historyNote mesh__D003037 74   
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003037 2003
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003037 1999
% 208.97/209.18  |- mesh__dateRevised mesh__D003037 1993-06-01
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D003037 1996
% 208.97/209.18  |- mesh__dateRevised mesh__D008520 2005-06-30
% 208.97/209.18  |- skos__broader mesh__D008520smesh__D004077
% 208.97/209.18  |- skos__altLabel mesh__D008520 beta-Methyldigoxin
% 208.97/209.18  |- skos__altLabel mesh__D008520 Metildigoxin
% 208.97/209.18  |- skos__hiddenLabel mesh__D008520 beta Methyldigoxin
% 208.97/209.18  |- mesh__recordOriginator mesh__D008520 SH
% 208.97/209.18  |- skos__altLabel mesh__D008520 4%27%%27%%27%-O-Methyldigoxin
% 208.97/209.18  |- mesh__dateEstablished mesh__D008520 1991-01-01
% 208.97/209.18  |- mesh__historyNote mesh__D008520
% 208.97/209.18       91%28%79%29%; was see under DIGOXIN 1979-90   
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D008520 2006
% 208.97/209.18  |- skos__altLabel mesh__D008520 Kern Brand of Medigoxin
% 208.97/209.18  |- skos__prefLabel mesh__D008520 Medigoxin
% 208.97/209.18  |- mesh__dateCreated mesh__D008520 1978-03-20
% 208.97/209.18  |- rdf__type mesh__D008520sskos__Concept
% 208.97/209.18  |- mesh__recordAuthorizer mesh__D008520 sjn
% 208.97/209.18  |- skos__historyNote mesh__D008520 Digoxin %28%1966-1978%29%
% 208.97/209.18  |- skos__hiddenLabel mesh__D008520 4%27%%27%%27% O Methyldigoxin
% 208.97/209.18  |- skos__altLabel mesh__D008520 Roche Brand of Medigoxin
% 208.97/209.18  |- mesh__recordMaintainer mesh__D008520 CCR
% 208.97/209.18  |- skos__scopeNote mesh__D008520
% 208.97/209.18       A semisynthetic digitalis glycoside with the general properties of DIGOXIN but more rapid onset of action. Its cardiotonic action is prolonged by its demethylation to DIGOXIN in the liver. It has been used in the treatment of congestive heart failure %28%HEART FAILURE, CONGESTIVE%29%.%A%    
% 208.97/209.18  |- mesh__publicMeSHNote mesh__D008520 91; was see under DIGOXIN 1979-90   
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D007428 2001
% 208.97/209.18  |- skos__hiddenLabel mesh__D007428 Test, Passive Transfer
% 208.97/209.18  |- mesh__dateRevised mesh__D007428 1997-06-20
% 208.97/209.18  |- skos__hiddenLabel mesh__D007428 Test, Intradermal
% 208.97/209.18  |- skos__hiddenLabel mesh__D007428 Intradermal Test
% 208.97/209.18  |- skos__hiddenLabel mesh__D007428 Tests, Intradermal
% 208.97/209.18  |- skos__altLabel mesh__D007428 Prausnitz-Kustner Test
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D007428 2002
% 208.97/209.18  |- skos__broader mesh__D007428smesh__D012882
% 208.97/209.18  |- rdf__type mesh__D007428sskos__Concept
% 208.97/209.18  |- mesh__historyNote mesh__D007428
% 208.97/209.18       91%28%75%29%; was see under SKIN TESTS 1975-90   
% 208.97/209.18  |- skos__hiddenLabel mesh__D007428 Passive Transfer Tests
% 208.97/209.18  |- mesh__recordMaintainer mesh__D007428 PXP
% 208.97/209.18  |- mesh__recordAuthorizer mesh__D007428 SJN
% 208.97/209.18  |- skos__scopeNote mesh__D007428
% 208.97/209.18       Skin tests in which the sensitizer is injected.     
% 208.97/209.18  |- mesh__dateEstablished mesh__D007428 1991-01-01
% 208.97/209.18  |- skos__hiddenLabel mesh__D007428 Tests, Passive Transfer
% 208.97/209.18  |- skos__hiddenLabel mesh__D007428 Prausnitz Kustner Test
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D007428 2005
% 208.97/209.18  |- mesh__publicMeSHNote mesh__D007428
% 208.97/209.18       91; was see under SKIN TESTS 1975-90   
% 208.97/209.18  |- mesh__recordOriginator mesh__D007428 NLM
% 208.97/209.18  |- skos__hiddenLabel mesh__D007428 Test, Prausnitz-Kustner
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D007428 2006
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D007428 2003
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D007428 1998
% 208.97/209.18  |- mesh__onlineNote mesh__D007428 search SKIN TESTS 1966-74   
% 208.97/209.18  |- mesh__dateCreated mesh__D007428 1999-01-01
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D007428 2000
% 208.97/209.18  |- skos__annotation mesh__D007428 NIM   
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D007428 2004
% 208.97/209.18  |- skos__prefLabel mesh__D007428 Intradermal Tests
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D007428 1999
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D018150 2004
% 208.97/209.18  |- skos__hiddenLabel mesh__D018150 Viruses, Bird Pox
% 208.97/209.18  |- skos__broader mesh__D018150smesh__D018147
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D018150 2003
% 208.97/209.18  |- mesh__onlineNote mesh__D018150
% 208.97/209.18       use FOWLPOX VIRUS to search BIRD POX VIRUS %26% POXVIRUS AVIUM 1975-93%A%  
% 208.97/209.18  |- mesh__publicMeSHNote mesh__D018150
% 208.97/209.18       94; BIRD POX VIRUS %26% POXVIRUS AVIUM were see FOWL POX VIRUS 1975-93%A%  
% 208.97/209.18  |- skos__hiddenLabel mesh__D018150 Bird Pox Viruses
% 208.97/209.18  |- skos__scopeNote mesh__D018150
% 208.97/209.18       A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, comprising bird poxviruses. The type species is FOWLPOX VIRUS. Transmission is mechanical by arthropods.%A%    
% 208.97/209.18  |- skos__hiddenLabel mesh__D018150 Avipoxviruses
% 208.97/209.18  |- mesh__dateRevised mesh__D018150 2001-07-25
% 208.97/209.18  |- skos__hiddenLabel mesh__D018150 Pox Virus, Bird
% 208.97/209.18  |- mesh__recordAuthorizer mesh__D018150 sjn
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D018150 2006
% 208.97/209.18  |- skos__hiddenLabel mesh__D018150 Pox Viruses, Bird
% 208.97/209.18  |- mesh__activeMeSHYear mesh__D018150 2002
% 208.97/209.18  |- mesh__dateCreated mesh__D018150 1993-06-04
% 208.97/209.19  |- mesh__activeMeSHYear mesh__D018150 2005
% 208.97/209.19  |- mesh__recordOriginator mesh__D018150 AGS
% 208.97/209.19  |- rdf__type mesh__D018150sskos__Concept
% 208.97/209.19  |- skos__annotation mesh__D018150
% 208.97/209.19       infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29%   
% 208.97/209.19  |- skos__hiddenLabel mesh__D018150 Virus, Bird Pox
% 208.97/209.19  |- skos__altLabel mesh__D018150 Bird Pox Virus
% 208.97/209.19  |- mesh__historyNote mesh__D018150
% 208.97/209.19       94; BIRD POX VIRUS %26% POXVIRUS AVIUM were see FOWL POX VIRUS 1975-93%A%  
% 208.97/209.19  |- skos__altLabel mesh__D018150 Poxvirus avium
% 208.97/209.19  |- mesh__recordMaintainer mesh__D018150 ags
% 208.97/209.19  |- skos__prefLabel mesh__D018150 Avipoxvirus
% 208.97/209.19  |- mesh__dateEstablished mesh__D018150 1994-01-01
% 208.97/209.19  |- mesh__activeMeSHYear mesh__D004130 2006
% 208.97/209.19  |- skos__altLabel mesh__D004130 Dimethyltryptamine
% 208.97/209.19  |- mesh__publicMeSHNote mesh__D004130
% 208.97/209.19       91; was see under TRYPTAMINES 1989-90; was DIMETHYLTRYPTAMINE 1975-88%A%  
% 208.97/209.19  |- mesh__activeMeSHYear mesh__D004130 2002
% 208.97/209.19  |- skos__prefLabel mesh__D004130 N,N-Dimethyltryptamine
% 208.97/209.19  |- mesh__activeMeSHYear mesh__D004130 2003
% 208.97/209.19  |- skos__scopeNote mesh__D004130
% 208.97/209.19       An N-methylated indoleamine derivative, a serotonergic hallucinogen found in several plants, especially Prestonia amazonica %28%Apocynaceae%29% and in mammalian brain, blood, and urine. It apparently acts as an agonist at some types of serotonin receptors and an antagonist at others.%A%    
% 208.97/209.19  |- mesh__dateCreated mesh__D004130 1999-01-01
% 208.97/209.19  |- mesh__activeMeSHYear mesh__D004130 2004
% 208.97/209.19  |- mesh__recordOriginator mesh__D004130 NLM
% 208.97/209.19  |- mesh__onlineNote mesh__D004130
% 208.97/209.19       use N,N-DIMETHYLTRYPTAMINE to search DIMETHYLTRYPTAMINE 1973-88 %28%as Prov 1973-74%29%%A%  
% 208.97/209.19  |- skos__broader mesh__D004130smesh__D014363
% 208.97/209.19  |- mesh__recordMaintainer mesh__D004130 TWD
% 208.97/209.19  |- mesh__recordAuthorizer mesh__D004130 sjn
% 208.97/209.19  |- rdf__type mesh__D004130sskos__Concept
% 208.97/209.19  |- mesh__activeMeSHYear mesh__D004130 2001
% 208.97/209.19  |- skos__hiddenLabel mesh__D004130 N,N Dimethyltryptamine
% 208.97/209.19  |- mesh__activeMeSHYear mesh__D004130 2005
% 208.97/209.19  |- mesh__dateRevised mesh__D004130 2000-06-22
% 208.97/209.19  |- mesh__dateEstablished mesh__D004130 1991-01-01
% 208.97/209.19  |- mesh__historyNote mesh__D004130
% 208.97/209.19       91%28%89%29%; was see under TRYPTAMINES 1989-90; was DIMETHYLTRYPTAMINE 1973-88 %28%Prov 1973-74%29%%A%  
% 208.97/209.19  |- skos__broader mesh__D017856smesh__D010770
% 208.97/209.19  |- mesh__dateCreated mesh__D017856 1993-06-18
% 209.04/209.19  |- mesh__historyNote mesh__D017856 94   
% 209.04/209.19  |- skos__historyNote mesh__D017856 Phosphotransferases %28%1966-1993%29%
% 209.04/209.19  |- mesh__publicMeSHNote mesh__D017856 94   
% 209.04/209.19  |- mesh__dateEstablished mesh__D017856 1994-01-01
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D017856 2005
% 209.04/209.19  |- skos__scopeNote mesh__D017856
% 209.04/209.19       A group of enzymes that catalyzes the transfer of a phosphate group onto a phosphate group acceptor. EC 2.7.4.%A%    
% 209.04/209.19  |- rdf__type mesh__D017856sskos__Concept
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D017856 2004
% 209.04/209.19  |- skos__prefLabel mesh__D017856
% 209.04/209.19       Phosphotransferases %28%Phosphate Group Acceptor%29%
% 209.04/209.19  |- mesh__dateRevised mesh__D017856 2003-07-09
% 209.04/209.19  |- skos__annotation mesh__D017856 DF: PHOSPHOSTRANSFERASES PHOSPHATE   
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D017856 2006
% 209.04/209.19  |- skos__scopeNote mesh__D017058
% 209.04/209.19       Persons living in the United States of Mexican descent.%A%    
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D017058 2004
% 209.04/209.19  |- rdf__type mesh__D017058sskos__Concept
% 209.04/209.19  |- skos__annotation mesh__D017058 specify geog if relevant   
% 209.04/209.19  |- skos__broader mesh__D017058smesh__D006630
% 209.04/209.19  |- skos__prefLabel mesh__D017058 Mexican Americans
% 209.04/209.19  |- skos__hiddenLabel mesh__D017058 Americans, Mexican
% 209.04/209.19  |- mesh__dateRevised mesh__D017058 2003-10-30
% 209.04/209.19  |- skos__hiddenLabel mesh__D017058 American, Mexican
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D017058 2004B
% 209.04/209.19  |- skos__altLabel mesh__D017058 Chicanos
% 209.04/209.19  |- skos__hiddenLabel mesh__D017058 Mexican American
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D017058 2006
% 209.04/209.19  |- mesh__dateEstablished mesh__D017058 1992-01-01
% 209.04/209.19  |- mesh__recordOriginator mesh__D017058 PLS
% 209.04/209.19  |- mesh__dateCreated mesh__D017058 1991-06-20
% 209.04/209.19  |- skos__historyNote mesh__D017058 Mexico/ethnology %28%1978-1991%29%
% 209.04/209.19  |- mesh__recordMaintainer mesh__D017058 jls
% 209.04/209.19  |- mesh__recordAuthorizer mesh__D017058 jls
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D017058 2004A
% 209.04/209.19  |- mesh__historyNote mesh__D017058
% 209.04/209.19       92; was see HISPANIC AMERICANS 1978-91; CHICANOS was see HISPANIC AMERICANS 1990-91%A%  
% 209.04/209.19  |- mesh__publicMeSHNote mesh__D017058
% 209.04/209.19       92; was see HISPANIC AMERICANS 1978-91; CHICANOS was see HISPANIC AMERICANS 1990-91%A%  
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D017058 2005
% 209.04/209.19  |- skos__historyNote mesh__D017058 Hispanic Americans %28%1977-1991%29%
% 209.04/209.19  |- mesh__onlineNote mesh__D017058
% 209.04/209.19       use HISPANIC AMERICANS to search MEXICAN AMERICANS 1978-91 %26% CHICANOS 1990-91%A%  
% 209.04/209.19  |- skos__hiddenLabel mesh__D017058 Chicano
% 209.04/209.19  |- skos__altLabel mesh__D017058 Chicanas
% 209.04/209.19  |- skos__hiddenLabel mesh__D017058 Chicana
% 209.04/209.19  |- mesh__dateRevised mesh__D003836 2005-06-30
% 209.04/209.19  |- mesh__dateCreated mesh__D003836 1999-01-01
% 209.04/209.19  |- rdf__type mesh__D003836sskos__Concept
% 209.04/209.19  |- skos__prefLabel mesh__D003836 Deodorants
% 209.04/209.19  |- mesh__recordMaintainer mesh__D003836 lkt
% 209.04/209.19  |- mesh__recordOriginator mesh__D003836 NLM
% 209.04/209.19  |- mesh__recordAuthorizer mesh__D003836 sjn
% 209.04/209.19  |- skos__broader mesh__D003836smesh__D003358
% 209.04/209.19  |- skos__scopeNote mesh__D003836
% 209.04/209.19       Agents that remove, correct, repress, or mask undesirable ODORS. In personal hygiene, deodorants often contain astringent preparations that reduce SWEATING, referred to as ANTIPERSPIRANTS. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D003836 2006
% 209.04/209.19  |- skos__broader mesh__D003038smesh__D014805
% 209.04/209.19  |- skos__broader mesh__D003038smesh__D003067
% 209.04/209.19  |- skos__altLabel mesh__D003038 Deoxyadenosinecobalamins
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D003038 2006
% 209.04/209.19  |- mesh__publicMeSHNote mesh__D003038 74   
% 209.04/209.19  |- skos__annotation mesh__D003038
% 209.04/209.19       deficiency: coordinate COBAMIDES /defic %28%IM%29% with VITAMIN B 12 DEFICIENCY %28%IM%29%%A%  
% 209.04/209.19  |- skos__prefLabel mesh__D003038 Cobamides
% 209.04/209.19  |- mesh__recordOriginator mesh__D003038 NLM
% 209.04/209.19  |- mesh__recordMaintainer mesh__D003038 ssb
% 209.04/209.19  |- rdf__type mesh__D003038sskos__Concept
% 209.04/209.19  |- mesh__recordAuthorizer mesh__D003038 sjn
% 209.04/209.19  |- skos__historyNote mesh__D003038 Vitamin B 12 %28%1966-1971%29%
% 209.04/209.19  |- skos__hiddenLabel mesh__D003038 B12 Coenzymes, Vitamin
% 209.04/209.19  |- mesh__dateCreated mesh__D003038 1999-01-01
% 209.04/209.19  |- mesh__dateRevised mesh__D003038 2005-06-30
% 209.04/209.19  |- skos__hiddenLabel mesh__D003038 Coenzymes, Vitamin B12
% 209.04/209.19  |- skos__altLabel mesh__D003038 Vitamin B 12 Coenzymes
% 209.04/209.19  |- skos__altLabel mesh__D003038 Vitamin B12 Coenzymes
% 209.04/209.19  |- mesh__dateEstablished mesh__D003038 1974-01-01
% 209.04/209.19  |- mesh__historyNote mesh__D003038 74%28%72%29%   
% 209.04/209.19  |- skos__historyNote mesh__D003038 Coenzymes %28%1966-1971%29%
% 209.04/209.19  |- mesh__dateCreated mesh__D008521 1999-01-01
% 209.04/209.19  |- skos__broader mesh__D008521smesh__D019083
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008521 2000
% 209.04/209.19  |- skos__scopeNote mesh__D008521
% 209.04/209.19       Scattered islands in the Mediterranean Sea. The chief islands are the Balearic Islands %28%belong to Spain; Majorca and Minorca are among these%29%, Corsica %28%belongs to France%29%, Crete %28%belongs to Greece%29%, CYPRUS %28%a republic%29%, the Cyclades, Dodecanese and Ionian Islands %28%belong to Greece%29%, MALTA %28%a republic%29%, Sardinia and SICILY %28%belong to Italy%29%. %28%From Webster%27%s New Geographical Dictionary, 1988, p747%29%%A%    
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008521 2003
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008521 2001
% 209.04/209.19  |- mesh__dateRevised mesh__D008521 2005-07-12
% 209.04/209.19  |- skos__prefLabel mesh__D008521 Mediterranean Islands
% 209.04/209.19  |- mesh__recordOriginator mesh__D008521 NLM
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008521 1998
% 209.04/209.19  |- rdf__type mesh__D008521sskos__Concept
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008521 2004
% 209.04/209.19  |- skos__annotation mesh__D008521
% 209.04/209.19       CYPRUS; MALTA; %26% SICILY are available; for Corsica, coord with FRANCE; for Crete, coord with GREECE%A%  
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008521 1999
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008521 2002
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008521 1996
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008521 2006A
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008521 2005
% 209.04/209.19  |- mesh__recordMaintainer mesh__D008521 ags
% 209.04/209.19  |- mesh__recordAuthorizer mesh__D008521 ags
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008521 1997
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008521 2006
% 209.04/209.19  |- mesh__publicMeSHNote mesh__D013466 72   
% 209.04/209.19  |- mesh__recordMaintainer mesh__D013466 ssb
% 209.04/209.19  |- skos__annotation mesh__D013466 do not confuse with SULFOTRANSFERASES   
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D013466 2004
% 209.04/209.19  |- mesh__recordOriginator mesh__D013466 NLM
% 209.04/209.19  |- rdf__type mesh__D013466sskos__Concept
% 209.04/209.19  |- mesh__dateCreated mesh__D013466 1999-01-01
% 209.04/209.19  |- mesh__historyNote mesh__D013466 72   
% 209.04/209.19  |- skos__scopeNote mesh__D013466
% 209.04/209.19       Enzymes which transfer sulfur atoms to various acceptor molecules. EC 2.8.1.%A%    
% 209.04/209.19  |- skos__historyNote mesh__D013466 Transferases %28%1966-1971%29%
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D013466 2006
% 209.04/209.19  |- mesh__dateEstablished mesh__D013466 1972-01-01
% 209.04/209.19  |- skos__prefLabel mesh__D013466 Sulfurtransferases
% 209.04/209.19  |- mesh__recordAuthorizer mesh__D013466 sjn
% 209.04/209.19  |- mesh__dateRevised mesh__D013466 2003-07-09
% 209.04/209.19  |- skos__broader mesh__D013466smesh__D019885
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D013466 2005
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D007429 2004
% 209.04/209.19  |- skos__annotation mesh__D007429
% 209.04/209.19       OCULAR HYPERTENSION %26% OCULAR HYPOTENSION are also available%A%  
% 209.04/209.19  |- skos__hiddenLabel mesh__D007429 Tensions, Ocular
% 209.04/209.19  |- skos__hiddenLabel mesh__D007429 Pressures, Intraocular
% 209.04/209.19  |- skos__related mesh__D007429smesh__D015814
% 209.04/209.19  |- mesh__dateRevised mesh__D007429 2003-07-09
% 209.04/209.19  |- rdf__type mesh__D007429sskos__Concept
% 209.04/209.19  |- skos__altLabel mesh__D007429 Ocular Tension
% 209.04/209.19  |- skos__hiddenLabel mesh__D007429 Ocular Tensions
% 209.04/209.19  |- skos__related mesh__D007429smesh__D009798
% 209.04/209.19  |- skos__hiddenLabel mesh__D007429 Pressure, Intraocular
% 209.04/209.19  |- skos__related mesh__D007429smesh__D005901
% 209.04/209.19  |- skos__hiddenLabel mesh__D007429 Tension, Ocular
% 209.04/209.19  |- skos__hiddenLabel mesh__D007429 Intraocular Pressures
% 209.04/209.19  |- mesh__recordOriginator mesh__D007429 NLM
% 209.04/209.19  |- skos__prefLabel mesh__D007429 Intraocular Pressure
% 209.04/209.19  |- skos__related mesh__D007429smesh__D014065
% 209.04/209.19  |- mesh__recordAuthorizer mesh__D007429 sjn
% 209.04/209.19  |- mesh__dateCreated mesh__D007429 1999-01-01
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D007429 2005
% 209.04/209.19  |- skos__broader mesh__D007429smesh__D043722
% 209.04/209.19  |- mesh__recordMaintainer mesh__D007429 nns
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D007429 2006
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D018151 2003
% 209.04/209.19  |- skos__hiddenLabel mesh__D018151 Pox Viruses, Goat
% 209.04/209.19  |- skos__altLabel mesh__D018151 Sheep Pox Virus
% 209.04/209.19  |- mesh__dateEstablished mesh__D018151 1994-01-01
% 209.04/209.19  |- skos__prefLabel mesh__D018151 Capripoxvirus
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D018151 2006
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D018151 2005
% 209.04/209.19  |- rdf__type mesh__D018151sskos__Concept
% 209.04/209.19  |- skos__historyNote mesh__D018151 Poxviridae %28%1985-1993%29%
% 209.04/209.19  |- skos__hiddenLabel mesh__D018151 Goat Pox Viruses
% 209.04/209.19  |- skos__hiddenLabel mesh__D018151 Sheeppox viruses
% 209.04/209.19  |- skos__hiddenLabel mesh__D018151 Sheep Pox Viruses
% 209.04/209.19  |- mesh__dateRevised mesh__D018151 2001-07-25
% 209.04/209.19  |- mesh__recordMaintainer mesh__D018151 ags
% 209.04/209.19  |- mesh__publicMeSHNote mesh__D018151 94   
% 209.04/209.19  |- mesh__recordAuthorizer mesh__D018151 sjn
% 209.04/209.19  |- skos__hiddenLabel mesh__D018151 Goatpox viruses
% 209.04/209.19  |- skos__altLabel mesh__D018151 Goat Pox Virus
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D018151 2002
% 209.04/209.19  |- mesh__dateCreated mesh__D018151 1993-06-04
% 209.04/209.19  |- skos__hiddenLabel mesh__D018151 Pox Viruses, Sheep
% 209.04/209.19  |- skos__hiddenLabel mesh__D018151 Pox Virus, Sheep
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D018151 2004
% 209.04/209.19  |- mesh__recordOriginator mesh__D018151 AGS
% 209.04/209.19  |- skos__annotation mesh__D018151
% 209.04/209.19       infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29%   
% 209.04/209.19  |- skos__hiddenLabel mesh__D018151 Capripoxviruses
% 209.04/209.19  |- skos__broader mesh__D018151smesh__D018147
% 209.04/209.19  |- skos__scopeNote mesh__D018151
% 209.04/209.19       A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, comprising poxviruses infecting sheep, goats, and cattle. Transmission is usually mechanical by arthropods, but also includes contact, airborne routes, and non-living reservoirs %28%fomites%29%.%A%    
% 209.04/209.19  |- mesh__historyNote mesh__D018151 94   
% 209.04/209.19  |- mesh__recordAuthorizer mesh__D004131 sjn
% 209.04/209.19  |- skos__broader mesh__D004131smesh__D009593
% 209.04/209.19  |- mesh__recordMaintainer mesh__D004131 ssb
% 209.04/209.19  |- mesh__historyNote mesh__D004131
% 209.04/209.19       91%28%75%29%; was see under NITROIMIDAZOLES 1975-90   
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D004131 2006
% 209.04/209.19  |- mesh__dateEstablished mesh__D004131 1991-01-01
% 209.04/209.19  |- mesh__dateRevised mesh__D004131 2005-06-30
% 209.04/209.19  |- mesh__publicMeSHNote mesh__D004131
% 209.04/209.19       91; was see under NITROIMIDAZOLES 1975-90   
% 209.04/209.19  |- mesh__dateCreated mesh__D004131 1974-11-19
% 209.04/209.19  |- skos__historyNote mesh__D004131 Nitroimidazoles %28%1974%29%
% 209.04/209.19  |- skos__prefLabel mesh__D004131 Dimetridazole
% 209.04/209.19  |- mesh__recordOriginator mesh__D004131 RLS
% 209.04/209.19  |- rdf__type mesh__D004131sskos__Concept
% 209.04/209.19  |- skos__scopeNote mesh__D004131
% 209.04/209.19       A compound used to treat histomoniasis in poultry.     
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D017857 2006
% 209.04/209.19  |- skos__altLabel mesh__D017857 Sea Snakes
% 209.04/209.19  |- mesh__recordAuthorizer mesh__D017857 sjn
% 209.04/209.19  |- skos__hiddenLabel mesh__D017857 Snake, Sea
% 209.04/209.19  |- skos__historyNote mesh__D017857 Snakes %28%1966-1993%29%
% 209.04/209.19  |- mesh__historyNote mesh__D017857 94   
% 209.04/209.19  |- skos__scopeNote mesh__D017857
% 209.04/209.19       A family of sea snakes comprising about 50 species with flattened oar-like tails used as sculls. They are found mostly in the coastal waters of south Asia and Australia. The largest reach a length of almost 9 feet but most species are only about a third as long. They are all venomous. %28%Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, pp331-3; Moore: Poisonous Snakes of the World, 1980, p159%29%%A%    
% 209.04/209.19  |- mesh__publicMeSHNote mesh__D017857 94   
% 209.04/209.19  |- mesh__dateEstablished mesh__D017857 1994-01-01
% 209.04/209.19  |- skos__annotation mesh__D017857 a family of poisonous sea snakes   
% 209.04/209.19  |- mesh__dateCreated mesh__D017857 1993-02-16
% 209.04/209.19  |- rdf__type mesh__D017857sskos__Concept
% 209.04/209.19  |- mesh__recordOriginator mesh__D017857 TGC
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D017857 2005
% 209.04/209.19  |- mesh__recordMaintainer mesh__D017857 ags
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D017857 2004
% 209.04/209.19  |- skos__related mesh__D017857smesh__D006870
% 209.04/209.19  |- skos__prefLabel mesh__D017857 Hydrophidae
% 209.04/209.19  |- mesh__dateRevised mesh__D017857 2003-07-09
% 209.04/209.19  |- skos__hiddenLabel mesh__D017857 Snakes, Sea
% 209.04/209.19  |- skos__hiddenLabel mesh__D017857 Sea Snake
% 209.04/209.19  |- skos__broader mesh__D017857smesh__D012911
% 209.04/209.19  |- skos__hiddenLabel mesh__D017059 Model, Econometric
% 209.04/209.19  |- skos__prefLabel mesh__D017059 Models, Econometric
% 209.04/209.19  |- mesh__recordOriginator mesh__D017059 PLS
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D017059 2006
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D017059 2002
% 209.04/209.19  |- skos__scopeNote mesh__D017059
% 209.04/209.19       The application of mathematical formulas and statistical techniques to the testing and quantifying of economic theories and the solution of economic problems.%A%    
% 209.04/209.19  |- skos__annotation mesh__D017059
% 209.04/209.19       models of econ theory %26% for solution of econ problems: a type of MODELS, ECONOMIC; no qualif; apply TN 128 for relation to MODELS, THEORETICAL%A%  
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D017059 2005
% 209.04/209.19  |- mesh__dateCreated mesh__D017059 1991-06-20
% 209.04/209.19  |- mesh__recordAuthorizer mesh__D017059 PLS
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D017059 2001
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D017059 1999
% 209.04/209.19  |- mesh__dateRevised mesh__D017059 1996-06-10
% 209.04/209.19  |- skos__hiddenLabel mesh__D017059 Econometric Model
% 209.04/209.19  |- mesh__recordMaintainer mesh__D017059 TGC
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D017059 2004
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D017059 1998
% 209.04/209.19  |- mesh__publicMeSHNote mesh__D017059 92   
% 209.04/209.19  |- rdf__type mesh__D017059sskos__Concept
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D017059 2000
% 209.04/209.19  |- mesh__historyNote mesh__D017059 92   
% 209.04/209.19  |- mesh__dateEstablished mesh__D017059 1992-01-01
% 209.04/209.19  |- skos__broader mesh__D017059smesh__D018803
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D017059 2003
% 209.04/209.19  |- skos__altLabel mesh__D017059 Econometric Models
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D017059 1997
% 209.04/209.19  |- mesh__publicMeSHNote mesh__D003837
% 209.04/209.19       74; DEOXYGLUCOSE was see under GLUCOSE 1973-74, was see under HEXOSES 1967-72%A%  
% 209.04/209.19  |- mesh__historyNote mesh__D003837 74   
% 209.04/209.19  |- skos__broader mesh__D003837smesh__D002241
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D003837 2005
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D003837 2006
% 209.04/209.19  |- mesh__dateRevised mesh__D003837 2004-07-07
% 209.04/209.19  |- skos__prefLabel mesh__D003837 Deoxy Sugars
% 209.04/209.19  |- mesh__dateEstablished mesh__D003837 1974-01-01
% 209.04/209.19  |- mesh__recordMaintainer mesh__D003837 ssb
% 209.04/209.19  |- mesh__dateCreated mesh__D003837 1999-01-01
% 209.04/209.19  |- rdf__type mesh__D003837sskos__Concept
% 209.04/209.19  |- mesh__recordOriginator mesh__D003837 NLM
% 209.04/209.19  |- skos__hiddenLabel mesh__D003837 Sugars, Deoxy
% 209.04/209.19  |- mesh__recordAuthorizer mesh__D003837 sjn
% 209.04/209.19  |- mesh__dateCreated mesh__D003039 1977-04-27
% 209.04/209.19  |- skos__historyNote mesh__D003039 Venoms %28%1966-1974%29%
% 209.04/209.19  |- skos__hiddenLabel mesh__D003039 Neurotoxins, Cobra
% 209.04/209.19  |- rdf__type mesh__D003039sskos__Concept
% 209.04/209.19  |- skos__annotation mesh__D003039
% 209.04/209.19       /antag permitted but consider also ANTITOXINS   
% 209.04/209.19  |- skos__historyNote mesh__D003039 Snakes %28%1966-1974%29%
% 209.04/209.19  |- skos__historyNote mesh__D003039 Peptides %28%1966-1975%29%
% 209.04/209.19  |- mesh__recordOriginator mesh__D003039 SH
% 209.04/209.19  |- mesh__historyNote mesh__D003039
% 209.04/209.19       91%28%78%29%; was see under COBRA VENOMS 1978-90   
% 209.04/209.19  |- mesh__publicMeSHNote mesh__D003039
% 209.04/209.19       91; was see under COBRA VENOMS 1978-90   
% 209.04/209.19  |- mesh__recordMaintainer mesh__D003039 ssb
% 209.04/209.19  |- skos__prefLabel mesh__D003039 Cobra Neurotoxins
% 209.04/209.19  |- mesh__recordAuthorizer mesh__D003039 sjn
% 209.04/209.19  |- skos__broader mesh__D003039smesh__D003040
% 209.04/209.19  |- mesh__dateEstablished mesh__D003039 1991-01-01
% 209.04/209.19  |- skos__scopeNote mesh__D003039
% 209.04/209.19       Toxins, contained in cobra %28%Naja%29% venom that block cholinergic receptors; two specific proteins have been described, the small %28%short, Type I%29% and the large %28%long, Type II%29% which also exist in other Elapid venoms.%A%    
% 209.04/209.19  |- mesh__dateRevised mesh__D003039 2005-06-30
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D003039 2006
% 209.04/209.19  |- skos__historyNote mesh__D003039 Snake Venoms %28%1975-1977%29%
% 209.04/209.19  |- skos__prefLabel mesh__D008522 Mediterranean Sea
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008522 1998
% 209.04/209.19  |- rdf__type mesh__D008522sskos__Concept
% 209.04/209.19  |- mesh__dateEstablished mesh__D008522 1987-01-01
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008522 2004
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008522 2000
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008522 1999
% 209.04/209.19  |- mesh__recordOriginator mesh__D008522 RC
% 209.04/209.19  |- skos__broader mesh__D008522smesh__D009792
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008522 2001
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008522 1993
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008522 2005
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008522 1996
% 209.04/209.19  |- mesh__dateCreated mesh__D008522 1986-04-02
% 209.04/209.19  |- mesh__recordAuthorizer mesh__D008522 PLS
% 209.04/209.19  |- mesh__recordMaintainer mesh__D008522 TGC
% 209.04/209.19  |- mesh__historyNote mesh__D008522 87   
% 209.04/209.19  |- mesh__dateRevised mesh__D008522 1992-05-14
% 209.04/209.19  |- skos__annotation mesh__D008522 no qualif   
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008522 1997
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008522 1994
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008522 2006
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008522 2002
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008522 1995
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D008522 2003
% 209.04/209.19  |- skos__historyNote mesh__D013467 Benzene Derivatives %28%1968-1974%29%
% 209.04/209.19  |- skos__altLabel mesh__D013467 Chemia Brand of Sulindac
% 209.04/209.19  |- skos__historyNote mesh__D013467 Indenes %28%1966-1978%29%
% 209.04/209.19  |- mesh__dateCreated mesh__D013467 1978-02-08
% 209.04/209.19  |- rdf__type mesh__D013467sskos__Concept
% 209.04/209.19  |- skos__broader mesh__D013467smesh__D007192
% 209.04/209.19  |- skos__altLabel mesh__D013467 Klinoril
% 209.04/209.19  |- mesh__dateEstablished mesh__D013467 1990-01-01
% 209.04/209.19  |- mesh__recordAuthorizer mesh__D013467 sjn
% 209.04/209.19  |- skos__hiddenLabel mesh__D013467 Novo Sundac
% 209.04/209.19  |- skos__altLabel mesh__D013467 Alphapharm Brand of Sulindac
% 209.04/209.19  |- skos__altLabel mesh__D013467 Apotex Brand of Sulindac
% 209.04/209.19  |- mesh__recordMaintainer mesh__D013467 CCR
% 209.04/209.19  |- skos__hiddenLabel mesh__D013467 Apo Sulin
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D013467 2006
% 209.04/209.19  |- skos__altLabel mesh__D013467 Nu-Pharm Brand of Sulindac
% 209.04/209.19  |- skos__hiddenLabel mesh__D013467 Nu Sulindac
% 209.04/209.19  |- skos__altLabel mesh__D013467 Novopharm Brand of Sulindac
% 209.04/209.19  |- skos__altLabel mesh__D013467 Cahill May Roberts Brand of Sulindac
% 209.04/209.19  |- skos__altLabel mesh__D013467 Arthrocine
% 209.04/209.19  |- mesh__dateRevised mesh__D013467 2005-06-30
% 209.04/209.19  |- skos__hiddenLabel mesh__D013467 MK231
% 209.04/209.19  |- mesh__recordOriginator mesh__D013467 SH
% 209.04/209.19  |- skos__prefLabel mesh__D013467 Sulindac
% 209.04/209.19  |- skos__hiddenLabel mesh__D013467 MK 231
% 209.04/209.19  |- skos__altLabel mesh__D013467 Merck Brand of Sulindac
% 209.04/209.19  |- skos__altLabel mesh__D013467 Chibret
% 209.04/209.19  |- mesh__historyNote mesh__D013467
% 209.04/209.19       90%28%79%29%; was see under INDENES 1979-89   
% 209.04/209.19  |- skos__hiddenLabel mesh__D013467 Nu Pharm Brand of Sulindac
% 209.04/209.19  |- skos__historyNote mesh__D013467 Benzene %28%1966-1967%29%
% 209.04/209.19  |- mesh__publicMeSHNote mesh__D013467 90; was see under INDENES 1979-89   
% 209.04/209.19  |- skos__altLabel mesh__D013467 Kendrick Brand of Sulindac
% 209.04/209.19  |- skos__scopeNote mesh__D013467
% 209.04/209.19       A sulfinylindene derivative prodrug whose sulfinyl moiety is converted in vivo to an active NSAID analgesic. Specifically, the prodrug is converted by liver enzymes to a sulfide which is excreted in the bile and then reabsorbed from the intestine. This helps to maintain constant blood levels with reduced gastrointestinal side effects.%A%    
% 209.04/209.19  |- skos__altLabel mesh__D013467 Merck Sharp %26% Dohme Brand of Sulindac
% 209.04/209.19  |- skos__historyNote mesh__D013467 Benzylidene Compounds %28%1975-1978%29%
% 209.04/209.19  |- skos__altLabel mesh__D018950 Receptors, Lipopolysaccharide
% 209.04/209.19  |- skos__altLabel mesh__D018950 CD14 Antigen
% 209.04/209.19  |- skos__altLabel mesh__D018950 CD14 Antigens
% 209.04/209.19  |- skos__broader mesh__D018950smesh__D011971
% 209.04/209.19  |- skos__prefLabel mesh__D018950 Antigens, CD14
% 209.04/209.19  |- skos__historyNote mesh__D018950 Receptors, Immunologic %28%1983-1995%29%
% 209.04/209.19  |- skos__altLabel mesh__D018950 Lipopolysaccharide Receptors
% 209.04/209.19  |- mesh__dateEstablished mesh__D018950 1996-01-01
% 209.04/209.19  |- skos__historyNote mesh__D018950 Antigens, CD %28%1990-1995%29%
% 209.04/209.19  |- mesh__recordOriginator mesh__D018950 AGS
% 209.04/209.19  |- skos__broader mesh__D018950smesh__D015703
% 209.04/209.19  |- skos__altLabel mesh__D018950 LPS Receptor
% 209.04/209.19  |- skos__altLabel mesh__D018950 Receptor, Lipoglycan
% 209.04/209.19  |- skos__annotation mesh__D018950 myelomonocytic differentiation antigen   
% 209.04/209.19  |- mesh__dateRevised mesh__D018950 2005-06-30
% 209.04/209.19  |- mesh__historyNote mesh__D018950
% 209.04/209.19       96; was CD14 MONOCYTE DIFFERENTIATION ANTIGEN %28%NM%29% 1988-95 %26% LIPOGLYCAN RECEPTOR %28%NM%29% 1983-95%A%  
% 209.04/209.19  |- mesh__dateCreated mesh__D018950 1995-06-08
% 209.04/209.19  |- mesh__publicMeSHNote mesh__D018950
% 209.04/209.19       96; CD14 MONOCYTE DIFFERENTIATION ANTIGEN was indexed under ANTIGENS, CD 1990-95; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-95; %26% ANTIGENS, DIFFERENTIATION 1988; LIPOGLYCAN RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1983-95%A%  
% 209.04/209.19  |- skos__scopeNote mesh__D018950
% 209.04/209.19       Glycolipid-anchored membrane glycoproteins expressed on cells of the myelomonocyte lineage including monocytes, macrophages, and some granulocytes. They function as receptors for the complex of lipopolysaccharide %28%LPS%29% and LPS-binding protein.%A%    
% 209.04/209.19  |- mesh__activeMeSHYear mesh__D018950 2006
% 209.04/209.19  |- mesh__recordAuthorizer mesh__D018950 sjn
% 209.04/209.19  |- rdf__type mesh__D018950sskos__Concept
% 209.04/209.19  |- skos__historyNote mesh__D018950
% 209.04/209.19       Antigens, Differentiation, Myelomonocytic %28%1989-1995%29%
% 209.04/209.19  |- skos__historyNote mesh__D018950 Antigens, Differentiation %28%1988%29%
% 209.04/209.19  |- mesh__recordMaintainer mesh__D018950 ssb
% 209.04/209.19  |- skos__altLabel mesh__D018950 Lipoglycan Receptor
% 209.04/209.19  |- skos__broader mesh__D018950smesh__D015214
% 209.04/209.19  |- skos__altLabel mesh__D018950 CD14 Monocyte Differentiation Antigen
% 209.04/209.19  |- mesh__onlineNote mesh__D018950
% 209.04/209.19       use ANTIGENS, CD14 %28%NM%29% to search CD14 MONOCYTE DIFFERENTIATION ANTIGEN 1988-95 %26% LIPOGLYCAN RECEPTOR 1983-95%A%  
% 209.04/209.19  |- skos__altLabel mesh__D018950 Receptor, LPS
% 209.04/209.19  |- skos__hiddenLabel mesh__D032621 Breeding, Molecular
% 209.04/209.20  |- skos__hiddenLabel mesh__D032621 Shuffling, DNA
% 209.04/209.20  |- mesh__publicMeSHNote mesh__D032621 2003   
% 209.04/209.20  |- skos__hiddenLabel mesh__D032621 Shufflings, DNA
% 209.04/209.20  |- skos__altLabel mesh__D032621 Molecular Breeding
% 209.04/209.20  |- skos__hiddenLabel mesh__D032621 Molecular Breedings
% 209.04/209.20  |- mesh__dateCreated mesh__D032621 2002-07-02
% 209.04/209.20  |- skos__prefLabel mesh__D032621 DNA Shuffling
% 209.04/209.20  |- skos__hiddenLabel mesh__D032621 Breedings, Molecular
% 209.04/209.20  |- skos__altLabel mesh__D032621 In Vitro Exon Shuffling
% 209.04/209.20  |- skos__hiddenLabel mesh__D032621 DNA Shufflings
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D032621 2005
% 209.04/209.20  |- skos__broader mesh__D032621smesh__D005818
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D032621 2003
% 209.04/209.20  |- mesh__dateEstablished mesh__D032621 2003-01-01
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D032621 2006
% 209.04/209.20  |- skos__related mesh__D032621smesh__D015202
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D032621 2004
% 209.04/209.20  |- skos__scopeNote mesh__D032621
% 209.04/209.20       The use of DNA recombination %28%RECOMBINATION, GENETIC%29% to prepare a large gene library of novel, chimeric genes from a population of randomly fragmented DNA from related gene sequences.%A%    
% 209.04/209.20  |- rdf__type mesh__D032621sskos__Concept
% 209.04/209.20  |- mesh__historyNote mesh__D032621 2003   
% 209.04/209.20  |- mesh__publicMeSHNote mesh__D018152 94   
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018152 2005
% 209.04/209.20  |- rdf__type mesh__D018152sskos__Concept
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018152 1999
% 209.04/209.20  |- skos__scopeNote mesh__D018152
% 209.04/209.20       A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, consisting of ether-sensitive viruses of leporids and squirrels. They commonly cause tumors and are usually transmitted mechanically by arthropods. MYXOMA VIRUS is the type species.%A%    
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018152 2002
% 209.04/209.20  |- skos__prefLabel mesh__D018152 Leporipoxvirus
% 209.04/209.20  |- mesh__dateCreated mesh__D018152 1993-06-04
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018152 1995
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018152 1998
% 209.04/209.20  |- mesh__dateEstablished mesh__D018152 1994-01-01
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018152 1994
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018152 2004
% 209.04/209.20  |- skos__broader mesh__D018152smesh__D018147
% 209.04/209.20  |- mesh__historyNote mesh__D018152 94   
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018152 2001
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018152 2003
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018152 1997
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018152 2000
% 209.04/209.20  |- skos__broader mesh__D018152smesh__D004263
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018152 1996
% 209.04/209.20  |- skos__annotation mesh__D018152
% 209.04/209.20       a genus of the subfamily Chordopoxvirinae; from Latin lepori-, rabbit; infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%%A%  
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018152 2006
% 209.04/209.20  |- skos__hiddenLabel mesh__D018152 Leporipoxviruses
% 209.04/209.20  |- skos__historyNote mesh__D018152 Poxviridae %28%1989-1993%29%
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D004930 2005
% 209.04/209.20  |- mesh__recordAuthorizer mesh__D004930 ags
% 209.04/209.20  |- skos__scopeNote mesh__D004930
% 209.04/209.20       Inuktitut-speakers generally associated with the northern polar region.%A%    
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D004930 2006
% 209.04/209.20  |- mesh__dateCreated mesh__D004930 1999-01-01
% 209.04/209.20  |- mesh__recordOriginator mesh__D004930 NLM
% 209.04/209.20  |- skos__hiddenLabel mesh__D004930 Inuit
% 209.04/209.20  |- skos__hiddenLabel mesh__D004930 Eskimo
% 209.04/209.20  |- mesh__recordMaintainer mesh__D004930 ags
% 209.04/209.20  |- skos__broader mesh__D004930smesh__D005006
% 209.04/209.20  |- skos__prefLabel mesh__D004930 Inuits
% 209.04/209.20  |- mesh__dateRevised mesh__D004930 2005-07-15
% 209.04/209.20  |- skos__hiddenLabel mesh__D004930 Aleut
% 209.04/209.20  |- skos__annotation mesh__D004930 specify geog if pertinent   
% 209.04/209.20  |- skos__hiddenLabel mesh__D004930 Inupiat
% 209.04/209.20  |- rdf__type mesh__D004930sskos__Concept
% 209.04/209.20  |- skos__broader mesh__D004930smesh__D044467
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D004930 2006A
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D004930 2004
% 209.04/209.20  |- skos__hiddenLabel mesh__D004930 Kalaallit
% 209.04/209.20  |- skos__broader mesh__D008055Q000172smesh__D008055
% 209.04/209.20  |- rdf__type mesh__D008055Q000172smesh__CompoundConcept
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D004132 2006
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D004132 2002
% 209.04/209.20  |- mesh__onlineNote mesh__D004132
% 209.04/209.20       use DIFLUBENZURON to search DIMILIN 1977-90   
% 209.04/209.20  |- skos__altLabel mesh__D004132 Dioflubenzuron
% 209.04/209.20  |- mesh__recordOriginator mesh__D004132 RLS
% 209.04/209.20  |- skos__hiddenLabel mesh__D004132 TH 6040
% 209.04/209.20  |- skos__historyNote mesh__D004132 Insect Control %28%1974-1976%29%
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D004132 2005
% 209.04/209.20  |- mesh__dateEstablished mesh__D004132 1991-01-01
% 209.04/209.20  |- mesh__publicMeSHNote mesh__D004132
% 209.04/209.20       91; was DIMILIN see under JUVENILE HORMONES 1977-90   
% 209.04/209.20  |- skos__broader mesh__D004132smesh__D010671
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D004132 2004
% 209.04/209.20  |- skos__broader mesh__D004132smesh__D007605
% 209.04/209.20  |- mesh__recordMaintainer mesh__D004132 CCR
% 209.04/209.20  |- mesh__dateCreated mesh__D004132 1976-04-27
% 209.04/209.20  |- mesh__recordAuthorizer mesh__D004132 sjn
% 209.04/209.20  |- skos__historyNote mesh__D004132 Juvenile Hormones %28%1975-1976%29%
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D004132 2003
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D004132 2001
% 209.04/209.20  |- skos__scopeNote mesh__D004132
% 209.04/209.20       An insect growth regulator which interferes with the formation of the insect cuticle. It is effective in the control of mosquitoes and flies.%A%    
% 209.04/209.20  |- mesh__historyNote mesh__D004132
% 209.04/209.20       91%28%77%29%; was DIMILIN see under JUVENILE HORMONES 1977-90   
% 209.04/209.20  |- skos__hiddenLabel mesh__D004132 TH6040
% 209.04/209.20  |- mesh__dateRevised mesh__D004132 2000-06-22
% 209.04/209.20  |- rdf__type mesh__D004132sskos__Concept
% 209.04/209.20  |- skos__historyNote mesh__D004132 Mosquito Control %28%1974-1976%29%
% 209.04/209.20  |- skos__prefLabel mesh__D004132 Diflubenzuron
% 209.04/209.20  |- skos__historyNote mesh__D004132 Phenylurea Compounds %28%1974-1976%29%
% 209.04/209.20  |- skos__scopeNote mesh__D017858
% 209.04/209.20       An order of fish comprising salmons, trouts, whitefish, graylings, and other families. They are both marine and freshwater fish, found in all oceans and are quite numerous in the Northern Hemisphere. %28%From Nelson: Fishes of the World%29%%A%    
% 209.04/209.20  |- skos__hiddenLabel mesh__D017858 Salmoniforme
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D017858 2006
% 209.04/209.20  |- skos__annotation mesh__D017858
% 209.04/209.20       GEN or unspecified: prefer specific families or specific genera%A%  
% 209.04/209.20  |- mesh__recordOriginator mesh__D017858 TGC
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D017858 2005
% 209.04/209.20  |- mesh__recordAuthorizer mesh__D017858 sjn
% 209.04/209.20  |- mesh__historyNote mesh__D017858 94   
% 209.04/209.20  |- mesh__dateEstablished mesh__D017858 1994-01-01
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D017858 2004
% 209.04/209.20  |- mesh__dateCreated mesh__D017858 1992-12-28
% 209.04/209.20  |- skos__broader mesh__D017858smesh__D005399
% 209.04/209.20  |- mesh__recordMaintainer mesh__D017858 ags
% 209.04/209.20  |- skos__prefLabel mesh__D017858 Salmoniformes
% 209.04/209.20  |- mesh__dateRevised mesh__D017858 2003-07-09
% 209.04/209.20  |- rdf__type mesh__D017858sskos__Concept
% 209.04/209.20  |- mesh__publicMeSHNote mesh__D017858 94   
% 209.04/209.20  |- mesh__dateRevised mesh__D003838 1993-06-02
% 209.04/209.20  |- mesh__dateCreated mesh__D003838 1977-04-22
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D003838 1996
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D003838 2005
% 209.04/209.20  |- skos__broader mesh__D003838smesh__D003854
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D003838 2002
% 209.04/209.20  |- skos__hiddenLabel mesh__D003838 Phosphates, Deoxyadenosine
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D003838 1997
% 209.04/209.20  |- skos__historyNote mesh__D003838 Adenine Nucleotides %28%1966-1977%29%
% 209.04/209.20  |- skos__hiddenLabel mesh__D003838 Nucleotides, Deoxyadenine
% 209.04/209.20  |- skos__prefLabel mesh__D003838 Deoxyadenine Nucleotides
% 209.04/209.20  |- skos__altLabel mesh__D003838 Deoxyadenosine Phosphates
% 209.04/209.20  |- skos__annotation mesh__D003838 /biosyn /physiol permitted   
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D003838 2006
% 209.04/209.20  |- skos__historyNote mesh__D003838 Deoxyribonucleotides %28%1973-1977%29%
% 209.04/209.20  |- mesh__publicMeSHNote mesh__D003838 78   
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D003838 2003
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D003838 2000
% 209.04/209.20  |- rdf__type mesh__D003838sskos__Concept
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D003838 1994
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D003838 2004
% 209.04/209.20  |- mesh__recordOriginator mesh__D003838 RLS
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D003838 1998
% 209.04/209.20  |- mesh__recordMaintainer mesh__D003838 TAP
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D003838 1995
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D003838 2001
% 209.04/209.20  |- mesh__historyNote mesh__D003838 78   
% 209.04/209.20  |- mesh__recordAuthorizer mesh__D003838 PLS
% 209.04/209.20  |- mesh__dateEstablished mesh__D003838 1978-01-01
% 209.04/209.20  |- skos__broader mesh__D003838smesh__D000227
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D003838 1999
% 209.04/209.20  |- skos__scopeNote mesh__D003838
% 209.04/209.20       Adenine nucleotides which contain deoxyribose as the sugar moiety.%A%    
% 209.04/209.20  |- skos__hiddenLabel mesh__D014560 Acid, Urocanic
% 209.04/209.20  |- mesh__recordAuthorizer mesh__D014560 sjn
% 209.04/209.20  |- skos__historyNote mesh__D014560 Imidazoles %28%1969-1974%29%
% 209.04/209.20  |- skos__scopeNote mesh__D014560 4-Imidazoleacrylic acid.     
% 209.04/209.20  |- mesh__recordMaintainer mesh__D014560 ssb
% 209.04/209.20  |- skos__hiddenLabel mesh__D014560 Acid, Glyoxalinylacrylic
% 209.04/209.20  |- skos__prefLabel mesh__D014560 Urocanic Acid
% 209.04/209.20  |- skos__broader mesh__D014560smesh__D007093
% 209.04/209.20  |- rdf__type mesh__D014560sskos__Concept
% 209.04/209.20  |- skos__historyNote mesh__D014560 Acrylates %28%1969-1974%29%
% 209.04/209.20  |- mesh__dateEstablished mesh__D014560 1991-01-01
% 209.04/209.20  |- mesh__historyNote mesh__D014560
% 209.04/209.20       91%28%75%29%; was see under IMIDAZOLES 1975-90   
% 209.04/209.20  |- mesh__recordOriginator mesh__D014560 NLM
% 209.04/209.20  |- skos__altLabel mesh__D014560 Glyoxalinylacrylic Acid
% 209.04/209.20  |- mesh__publicMeSHNote mesh__D014560
% 209.04/209.20       91; was see under IMIDAZOLES 1975-90   
% 209.04/209.20  |- mesh__dateRevised mesh__D014560 2005-06-30
% 209.04/209.20  |- mesh__dateCreated mesh__D014560 1974-11-19
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D014560 2006
% 209.04/209.20  |- skos__broader mesh__D014560smesh__D000179
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D008523 2006
% 209.04/209.20  |- skos__historyNote mesh__D008523 Information Systems %28%1966-1977%29%
% 209.04/209.20  |- skos__prefLabel mesh__D008523 MEDLARS
% 209.04/209.20  |- skos__annotation mesh__D008523 IM      CATALOG: use NAF entry   
% 209.04/209.20  |- skos__scopeNote mesh__D008523
% 209.04/209.20       A computerized biomedical bibliographic storage and retrieval system operated by the NATIONAL LIBRARY OF MEDICINE. MEDLARS stands for Medical Literature Analysis and Retrieval System, which was first introduced in 1964 and evolved into an online system in 1971 called MEDLINE %28%MEDLARS Online%29%. As other online databases were developed,  MEDLARS became the name of the entire NLM information system while MEDLINE became the name of the premier database. MEDLARS was used to produce the former printed Cumulated Index Medicus, and the printed monthly Index Medicus, until that publication ceased in December 2004.%A%    
% 209.04/209.20  |- skos__hiddenLabel mesh__D008523 MEDLARS MEDLINE Information System
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D008523 2005
% 209.04/209.20  |- skos__broader mesh__D008523smesh__D016247
% 209.04/209.20  |- mesh__dateRevised mesh__D008523 2004-07-07
% 209.04/209.20  |- skos__altLabel mesh__D008523 MEDLARS-MEDLINE Information System
% 209.04/209.20  |- rdf__type mesh__D008523sskos__Concept
% 209.04/209.20  |- mesh__publicMeSHNote mesh__D008523
% 209.04/209.20       1991; see MEDLARS-MEDLINE INFORMATION SYSTEM 1978-1990   
% 209.04/209.20  |- skos__historyNote mesh__D008523
% 209.04/209.20       National Library of Medicine %28%U.S.%29% %28%1966-1977%29%
% 209.04/209.20  |- skos__broader mesh__D008523smesh__D007256
% 209.04/209.20  |- mesh__dateCreated mesh__D008523 1977-05-11
% 209.04/209.20  |- mesh__recordMaintainer mesh__D008523 ags
% 209.04/209.20  |- skos__hiddenLabel mesh__D008523 Information System, MEDLARS-MEDLINE
% 209.04/209.20  |- skos__altLabel mesh__D008523
% 209.04/209.20       Medical Literature Analysis and Retrieval System
% 209.04/209.20  |- mesh__recordOriginator mesh__D008523 EC
% 209.04/209.20  |- mesh__recordAuthorizer mesh__D008523 sjn
% 209.04/209.20  |- mesh__historyNote mesh__D008523 1991 %28%1978%29%   
% 209.04/209.20  |- skos__hiddenLabel mesh__D008523 System, MEDLARS-MEDLINE Information
% 209.04/209.20  |- mesh__dateEstablished mesh__D008523 1978-01-01
% 209.04/209.20  |- mesh__publicMeSHNote mesh__D000540
% 209.04/209.20       91; was see under SURGERY, ORAL, PREPROSTHETIC 1980-90   
% 209.04/209.20  |- skos__hiddenLabel mesh__D000540 Ridge Augmentations, Alveolar
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D000540 2005
% 209.04/209.20  |- skos__hiddenLabel mesh__D000540 Maxillary Ridge Augmentations
% 209.04/209.20  |- mesh__recordAuthorizer mesh__D000540 SJN
% 209.04/209.20  |- skos__hiddenLabel mesh__D000540 Augmentation, Mandibular Ridge
% 209.04/209.20  |- skos__hiddenLabel mesh__D000540 Ridge Augmentation, Maxillary
% 209.04/209.20  |- skos__historyNote mesh__D000540 Mandible/surgery %28%1966-1979%29%
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D000540 1999
% 209.04/209.20  |- skos__hiddenLabel mesh__D000540 Ridge Augmentation, Mandibular
% 209.04/209.20  |- mesh__recordOriginator mesh__D000540 SMH
% 209.04/209.20  |- skos__hiddenLabel mesh__D000540 Augmentations, Mandibular Ridge
% 209.04/209.20  |- skos__hiddenLabel mesh__D000540 Mandibular Ridge Augmentations
% 209.04/209.20  |- skos__hiddenLabel mesh__D000540 Augmentation, Maxillary Ridge
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D000540 2006
% 209.04/209.20  |- skos__historyNote mesh__D000540 Alveoloplasty %28%1966-1979%29%
% 209.04/209.20  |- mesh__dateRevised mesh__D000540 1997-06-20
% 209.04/209.20  |- skos__hiddenLabel mesh__D000540 Augmentation, Alveolar Ridge
% 209.04/209.20  |- mesh__dateEstablished mesh__D000540 1991-01-01
% 209.04/209.20  |- skos__scopeNote mesh__D000540
% 209.04/209.20       Preprosthetic surgery involving rib, cartilage, or iliac crest bone grafts, usually autologous, or synthetic implants for rebuilding the alveolar ridge.%A%    
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D000540 2000
% 209.04/209.20  |- skos__hiddenLabel mesh__D000540 Ridge Augmentation, Alveolar
% 209.04/209.20  |- skos__hiddenLabel mesh__D000540 Augmentations, Alveolar Ridge
% 209.04/209.20  |- skos__hiddenLabel mesh__D000540 Augmentations, Maxillary Ridge
% 209.04/209.20  |- skos__annotation mesh__D000540
% 209.04/209.20       do not use /util except by MeSH definition   
% 209.04/209.20  |- rdf__type mesh__D000540sskos__Concept
% 209.04/209.20  |- skos__hiddenLabel mesh__D000540 Ridge Augmentations, Mandibular
% 209.04/209.20  |- mesh__historyNote mesh__D000540
% 209.04/209.20       91%28%80%29%; was see under SURGERY, ORAL, PREPROSTHETIC 1980-90%A%  
% 209.04/209.20  |- mesh__recordMaintainer mesh__D000540 PXP
% 209.04/209.20  |- skos__hiddenLabel mesh__D000540 Alveolar Ridge Augmentations
% 209.04/209.20  |- skos__prefLabel mesh__D000540 Alveolar Ridge Augmentation
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D000540 2001
% 209.04/209.20  |- mesh__dateCreated mesh__D000540 1979-04-27
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D000540 2003
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D000540 2002
% 209.04/209.20  |- skos__hiddenLabel mesh__D000540 Ridge Augmentations, Maxillary
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D000540 2004
% 209.04/209.20  |- skos__historyNote mesh__D000540
% 209.04/209.20       Mandibular Diseases/surgery %28%1966-1979%29%
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D000540 1998
% 209.04/209.20  |- skos__broader mesh__D000540smesh__D013516
% 209.04/209.20  |- skos__historyNote mesh__D013468 Propanolamines %28%1974-1979%29%
% 209.04/209.20  |- mesh__recordAuthorizer mesh__D013468 sjn
% 209.04/209.20  |- skos__broader mesh__D013468smesh__D011412
% 209.04/209.20  |- skos__broader mesh__D013468smesh__D010627
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D013468 2006
% 209.04/209.20  |- mesh__recordOriginator mesh__D013468 SH
% 209.04/209.20  |- mesh__dateRevised mesh__D013468 2005-06-30
% 209.04/209.20  |- mesh__recordMaintainer mesh__D013468 ssb
% 209.04/209.20  |- mesh__dateEstablished mesh__D013468 1991-01-01
% 209.04/209.20  |- skos__scopeNote mesh__D013468
% 209.04/209.20       A peripheral vasodilator that was formerly used in the management of peripheral and cerebral vascular disorders. It is hepatotoxic and fatalities have occurred. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1312%29%%A%    
% 209.04/209.20  |- skos__prefLabel mesh__D013468 Suloctidil
% 209.04/209.20  |- mesh__dateCreated mesh__D013468 1979-05-30
% 209.04/209.20  |- skos__historyNote mesh__D013468 Amino Alcohols %28%1966-1973%29%
% 209.04/209.20  |- rdf__type mesh__D013468sskos__Concept
% 209.04/209.20  |- mesh__historyNote mesh__D013468
% 209.04/209.20       91%28%80%29%; was see under PROPANOLAMINES 1980-90   
% 209.04/209.20  |- mesh__publicMeSHNote mesh__D013468
% 209.04/209.20       91; was see under PROPANOLAMINES 1980-90   
% 209.04/209.20  |- skos__prefLabel mesh__D018951 Antigens, CD20
% 209.04/209.20  |- skos__scopeNote mesh__D018951
% 209.04/209.20       Unglycosylated phosphoproteins expressed only on B-cells. They are regulators of transmembrane Ca2+ conductance and thought to play a role in B-cell activation and proliferation.%A%    
% 209.04/209.20  |- mesh__recordMaintainer mesh__D018951 ssb
% 209.04/209.20  |- skos__altLabel mesh__D018951 CD20 Antigen
% 209.04/209.20  |- skos__historyNote mesh__D018951 Antigens, CD %28%1990-1995%29%
% 209.04/209.20  |- skos__hiddenLabel mesh__D018951 Antigen, CD20
% 209.04/209.20  |- mesh__dateCreated mesh__D018951 1995-05-26
% 209.04/209.20  |- mesh__historyNote mesh__D018951
% 209.04/209.20       96; was CD20 ANTIGEN %28%NM%29% 1988-95   
% 209.04/209.20  |- skos__broader mesh__D018951smesh__D000944
% 209.04/209.20  |- mesh__dateEstablished mesh__D018951 1996-01-01
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018951 2006
% 209.04/209.20  |- skos__broader mesh__D018951smesh__D015703
% 209.04/209.20  |- mesh__recordOriginator mesh__D018951 AGS
% 209.04/209.20  |- rdf__type mesh__D018951sskos__Concept
% 209.04/209.20  |- mesh__dateRevised mesh__D018951 2005-06-30
% 209.04/209.20  |- skos__altLabel mesh__D018951 CD20 Antigens
% 209.04/209.20  |- mesh__publicMeSHNote mesh__D018951
% 209.04/209.20       96; CD20 ANTIGEN was indexed under ANTIGENS, CD 1990-95 %26% ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1988-95%A%  
% 209.04/209.20  |- mesh__recordAuthorizer mesh__D018951 sjn
% 209.04/209.20  |- skos__historyNote mesh__D018951
% 209.04/209.20       Antigens, Differentiation, B-Lymphocyte %28%1988-1995%29%
% 209.04/209.20  |- mesh__onlineNote mesh__D018951
% 209.04/209.20       use ANTIGENS, CD20 %28%NM%29% to search CD20 ANTIGEN 1988-95   
% 209.04/209.20  |- skos__annotation mesh__D018951 B-lymphocyte differentiation antigens   
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018153 1998
% 209.04/209.20  |- mesh__dateRevised mesh__D018153 1995-06-08
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018153 2004
% 209.04/209.20  |- skos__prefLabel mesh__D018153 Czech Republic
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018153 2002
% 209.04/209.20  |- mesh__dateCreated mesh__D018153 1993-05-26
% 209.04/209.20  |- mesh__recordOriginator mesh__D018153 TGC
% 209.04/209.20  |- mesh__historyNote mesh__D018153 94   
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018153 2003
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018153 1997
% 209.04/209.20  |- mesh__onlineNote mesh__D018153
% 209.04/209.20       use CZECHOSLOVAKIA to search CZECH REPUBLIC 1966-93   
% 209.04/209.20  |- mesh__dateEstablished mesh__D018153 1994-01-01
% 209.04/209.20  |- skos__broader mesh__D018153smesh__D003604
% 209.04/209.20  |- skos__scopeNote mesh__D018153
% 209.04/209.20       Created 1 January 1993 as a result of the division of Czechoslovakia into the Czech Republic and Slovakia.%A%    
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018153 2006
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018153 1996
% 209.04/209.20  |- mesh__recordMaintainer mesh__D018153 PLS
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018153 2001
% 209.04/209.20  |- mesh__recordAuthorizer mesh__D018153 PLS
% 209.04/209.20  |- rdf__type mesh__D018153sskos__Concept
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018153 2005
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018153 1999
% 209.04/209.20  |- skos__broader mesh__D018153smesh__D005061
% 209.04/209.20  |- skos__historyNote mesh__D018153 Czechoslovakia %28%1966-1993%29%
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D018153 2000
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D010170 2005
% 209.04/209.20  |- skos__altLabel mesh__D010170 Stearoyl CoA Hydrolase
% 209.04/209.20  |- skos__hiddenLabel mesh__D010170 Hydrolase, Palmitoyl-CoA
% 209.04/209.20  |- mesh__recordMaintainer mesh__D010170 ssb
% 209.04/209.20  |- mesh__recordOriginator mesh__D010170 RLS
% 209.04/209.20  |- skos__hiddenLabel mesh__D010170 CoA Hydrolase, Acyl
% 209.04/209.20  |- skos__hiddenLabel mesh__D010170 Long Chain Fatty Acyl CoA Hydrolase
% 209.04/209.20  |- skos__hiddenLabel mesh__D010170 Hydrolase, Stearoyl CoA
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D010170 2006
% 209.04/209.20  |- skos__altLabel mesh__D010170 Oleoyl-CoA Acylhydrolase
% 209.04/209.20  |- mesh__historyNote mesh__D010170
% 209.04/209.20       91%28%78%29%; was see under THIOLESTER HYDROLASES 1978-90   
% 209.04/209.20  |- skos__hiddenLabel mesh__D010170 Oleoyl CoA Acylhydrolase
% 209.04/209.20  |- mesh__dateEstablished mesh__D010170 1991-01-01
% 209.04/209.20  |- skos__historyNote mesh__D010170 Thiolester Hydrolases %28%1973-1977%29%
% 209.04/209.20  |- skos__hiddenLabel mesh__D010170 CoA Deacylase, Palmitoyl
% 209.04/209.20  |- skos__hiddenLabel mesh__D010170 Deacylase, Palmitoyl CoA
% 209.04/209.20  |- skos__hiddenLabel mesh__D010170 Acylhydrolase, Oleoyl-CoA
% 209.04/209.20  |- skos__altLabel mesh__D010170 Fatty Acyl Thioesterase
% 209.04/209.20  |- mesh__recordAuthorizer mesh__D010170 sjn
% 209.04/209.20  |- rdf__type mesh__D010170sskos__Concept
% 209.04/209.20  |- mesh__dateRevised mesh__D010170 2003-07-09
% 209.04/209.20  |- skos__broader mesh__D010170smesh__D013869
% 209.04/209.20  |- skos__hiddenLabel mesh__D010170 CoA Hydrolase, Stearoyl
% 209.04/209.20  |- skos__scopeNote mesh__D010170
% 209.04/209.20       Enzyme catalyzing reversibly the hydrolysis of palmitoyl-CoA or other long-chain acyl coenzyme A compounds to yield CoA and palmitate or other acyl esters. The enzyme is involved in the esterification of fatty acids to form triglycerides. EC 3.1.2.2.%A%    
% 209.04/209.20  |- skos__altLabel mesh__D010170 Long-Chain Fatty-Acyl-CoA Hydrolase
% 209.04/209.20  |- skos__altLabel mesh__D010170 Palmitoyl CoA Deacylase
% 209.04/209.20  |- skos__hiddenLabel mesh__D010170 Hydrolase, Long-Chain Fatty-Acyl-CoA
% 209.04/209.20  |- skos__hiddenLabel mesh__D010170 Fatty-Acyl-CoA Hydrolase, Long-Chain
% 209.04/209.20  |- skos__hiddenLabel mesh__D010170 Thioesterase, Palmitoyl
% 209.04/209.20  |- skos__hiddenLabel mesh__D010170 Hydrolase, Acyl CoA
% 209.04/209.20  |- mesh__dateCreated mesh__D010170 1977-05-17
% 209.04/209.20  |- skos__altLabel mesh__D010170 Palmitoyl Coenzyme A Hydrolase
% 209.04/209.20  |- skos__prefLabel mesh__D010170 Palmitoyl-CoA Hydrolase
% 209.04/209.20  |- skos__hiddenLabel mesh__D010170 Thioesterase, Fatty Acyl
% 209.04/209.20  |- skos__hiddenLabel mesh__D010170 Palmitoyl CoA Hydrolase
% 209.04/209.20  |- mesh__publicMeSHNote mesh__D010170
% 209.04/209.20       91; was see under THIOLESTER HYDROLASES 1978-90   
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D010170 2004
% 209.04/209.20  |- skos__altLabel mesh__D010170 Palmitoyl Thioesterase
% 209.04/209.20  |- skos__prefLabel mesh__D004931 Esophageal Achalasia
% 209.04/209.20  |- mesh__onlineNote mesh__D004931
% 209.04/209.20       use ESOPHAGEAL ACHALASIA to search CARDIOSPASM 1966-84   
% 209.04/209.20  |- mesh__dateCreated mesh__D004931 1999-01-01
% 209.04/209.20  |- mesh__publicMeSHNote mesh__D004931
% 209.04/209.20       85; was ACHALASIA OF ESOPHAGUS see CARDIOSPASM 1974-84; was ACHALASIA see under CARDIOSPASM 1963-73; CARDIOSPASM was heading 1963-84%A%  
% 209.04/209.20  |- mesh__dateRevised mesh__D004931 2005-06-30
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D004931 2006
% 209.04/209.20  |- skos__hiddenLabel mesh__D004931 Cardiospasms
% 209.04/209.20  |- mesh__recordMaintainer mesh__D004931 lkt
% 209.04/209.20  |- mesh__historyNote mesh__D004931
% 209.04/209.20       85; was ACHALASIA OF ESOPHAGUS see CARDIOSPASM 1974-84; was ACHALASIA see under CARDIOSPASM 1963-73; CARDIOSPASM was heading 1963-84%A%  
% 209.04/209.20  |- skos__altLabel mesh__D004931 Achalasia, Esophageal
% 209.04/209.20  |- mesh__recordOriginator mesh__D004931 NLM
% 209.04/209.20  |- skos__hiddenLabel mesh__D004931 Esophageal Achalasias
% 209.04/209.20  |- skos__altLabel mesh__D004931 Cardiospasm
% 209.04/209.20  |- skos__hiddenLabel mesh__D004931 Achalasias, Esophageal
% 209.04/209.20  |- mesh__recordAuthorizer mesh__D004931 sjn
% 209.04/209.20  |- skos__scopeNote mesh__D004931
% 209.04/209.20       A motility disorder of the ESOPHAGUS in which the LOWER ESOPHAGEAL SPHINCTER %28%near the CARDIA%29% fails to relax resulting in functional obstruction of the esophagus, and DYSPHAGIA. Achalasia is characterized by a grossly contorted and dilated esophagus %28%megaesophagus%29%.%A%    
% 209.04/209.20  |- skos__annotation mesh__D004931
% 209.04/209.20       CARDIOSPASM refers to spasm of the CARDIA, not the heart; not for esophageal spasm %28% = ESOPHAGEAL SPASM, DIFFUSE%29%%A%  
% 209.04/209.20  |- skos__broader mesh__D004931smesh__D015154
% 209.04/209.20  |- rdf__type mesh__D004931sskos__Concept
% 209.04/209.20  |- mesh__dateCreated mesh__D004133 1974-11-19
% 209.04/209.20  |- skos__historyNote mesh__D004133 Triazenes %28%1974%29%
% 209.04/209.20  |- skos__hiddenLabel mesh__D004133 4,4%27% Diazoaminobenzamidine
% 209.04/209.20  |- mesh__recordOriginator mesh__D004133 RLS
% 209.04/209.20  |- rdf__type mesh__D004133sskos__Concept
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D004133 2002
% 209.04/209.20  |- skos__historyNote mesh__D004133 Amidines %28%1969-1974%29%
% 209.04/209.20  |- mesh__recordMaintainer mesh__D004133 CCR
% 209.04/209.20  |- skos__broader mesh__D004133smesh__D014226
% 209.04/209.20  |- skos__prefLabel mesh__D004133 Diminazene
% 209.04/209.20  |- mesh__publicMeSHNote mesh__D004133 91; was see under AMIDINES 1975-90   
% 209.04/209.20  |- skos__scopeNote mesh__D004133 An effective trypanocidal agent.     
% 209.04/209.20  |- mesh__dateRevised mesh__D004133 2000-06-22
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D004133 2006
% 209.04/209.20  |- skos__altLabel mesh__D004133 4,4%27%-Diazoaminobenzamidine
% 209.04/209.20  |- mesh__recordAuthorizer mesh__D004133 sjn
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D004133 2005
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D004133 2004
% 209.04/209.20  |- skos__broader mesh__D004133smesh__D001550
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D004133 2001
% 209.04/209.20  |- mesh__historyNote mesh__D004133
% 209.04/209.20       91%28%75%29%; was see under AMIDINES 1975-90   
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D004133 2003
% 209.04/209.20  |- mesh__dateEstablished mesh__D004133 1991-01-01
% 209.04/209.20  |- mesh__onlineNote mesh__D017859 use SALMONIDAE to search ESOX 1987-93   
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D017859 2006
% 209.04/209.20  |- skos__hiddenLabel mesh__D017859 Muskellunges
% 209.04/209.20  |- skos__broader mesh__D017859smesh__D023661
% 209.04/209.20  |- skos__altLabel mesh__D017859 Pike
% 209.04/209.20  |- skos__altLabel mesh__D017859 Chain Pickerel
% 209.04/209.20  |- mesh__publicMeSHNote mesh__D017859
% 209.04/209.20       94; ESOX was see SALMONIDAE 1987-93   
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D017859 2005
% 209.04/209.20  |- skos__hiddenLabel mesh__D017859 Pike, Northern
% 209.04/209.20  |- skos__altLabel mesh__D017859 Amur Pike
% 209.04/209.20  |- skos__prefLabel mesh__D017859 Esocidae
% 209.04/209.20  |- skos__hiddenLabel mesh__D017859 Pickerel, Grass
% 209.04/209.20  |- skos__scopeNote mesh__D017859
% 209.04/209.20       A family of freshwater fish of the order ESOCIFORMES, comprising the pikes, inhabiting the waters of the Northern Hemisphere. There is one genus, Esox, with five species: northern pike, grass pickerel, chain pickerel, muskellunge, and Amur pike.%A%    
% 209.04/209.20  |- skos__hiddenLabel mesh__D017859 Pike, Amur
% 209.04/209.20  |- skos__hiddenLabel mesh__D017859 Pickerel, Chain
% 209.04/209.20  |- skos__altLabel mesh__D017859 Muskellunge
% 209.04/209.20  |- mesh__recordOriginator mesh__D017859 TGC
% 209.04/209.20  |- mesh__activeMeSHYear mesh__D017859 2004
% 209.04/209.20  |- mesh__recordMaintainer mesh__D017859 ags
% 209.04/209.20  |- mesh__dateCreated mesh__D017859 1992-12-28
% 209.04/209.20  |- mesh__recordAuthorizer mesh__D017859 sjn
% 209.04/209.20  |- skos__altLabel mesh__D017859 Grass Pickerel
% 209.04/209.20  |- rdf__type mesh__D017859sskos__Concept
% 209.04/209.20  |- mesh__dateRevised mesh__D017859 2003-07-09
% 209.04/209.20  |- skos__altLabel mesh__D017859 Northern Pike
% 209.04/209.20  |- mesh__dateEstablished mesh__D017859 1994-01-01
% 209.04/209.20  |- mesh__historyNote mesh__D017859 94; ESOX was see SALMONIDAE 1987-93   
% 209.04/209.20  |- skos__altLabel mesh__D028581 Lanthanides
% 209.04/209.20  |- skos__altLabel mesh__D028581 Lanthanoids
% 209.04/209.20  |- skos__hiddenLabel mesh__D028581 Elements, Lanthanoid Series
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D028581 2005
% 209.04/209.21  |- mesh__dateCreated mesh__D028581 2001-07-25
% 209.04/209.21  |- skos__prefLabel mesh__D028581 Lanthanoid Series Elements
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D028581 2006
% 209.04/209.21  |- mesh__publicMeSHNote mesh__D028581
% 209.04/209.21       2002; for LANTHANIDES see METALS, RARE EARTH 1976-2001   
% 209.04/209.21  |- rdf__type mesh__D028581sskos__Concept
% 209.04/209.21  |- skos__broader mesh__D028581smesh__D008674
% 209.04/209.21  |- skos__scopeNote mesh__D028581
% 209.04/209.21       Elements of the lanthanoid series including atomic number 57 %28%LATHANUM%29% through atomic number 71 %28%LUTETIUM%29%.%A%    
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D028581 2003
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D028581 2004
% 209.04/209.21  |- mesh__dateEstablished mesh__D028581 2002-01-01
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D028581 2002
% 209.04/209.21  |- mesh__historyNote mesh__D028581
% 209.04/209.21       2002; for LANTHANIDES use METALS, RARE EARTH 1976-2001   
% 209.04/209.21  |- skos__broader mesh__D028581smesh__D004602
% 209.04/209.21  |- skos__scopeNote mesh__D003839
% 209.04/209.21       Adenosine molecules which can be substituted in any position, but are lacking one hydroxyl group in the ribose part of the molecule.%A%    
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D003839 1993
% 209.04/209.21  |- skos__broader mesh__D003839smesh__D003853
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D003839 1999
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D003839 1994
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D003839 1997
% 209.04/209.21  |- mesh__historyNote mesh__D003839
% 209.04/209.21       90; was DEOXYADENOSINE 1971-89 %28%Prov 1971-72%29%   
% 209.04/209.21  |- mesh__dateRevised mesh__D003839 1992-05-13
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D003839 1998
% 209.04/209.21  |- skos__prefLabel mesh__D003839 Deoxyadenosines
% 209.04/209.21  |- skos__annotation mesh__D003839 /biosyn /physiol permitted   
% 209.04/209.21  |- mesh__publicMeSHNote mesh__D003839 90; was DEOXYADENOSINE 1973-89   
% 209.04/209.21  |- skos__altLabel mesh__D003839 Adenine Deoxyribonucleosides
% 209.04/209.21  |- skos__altLabel mesh__D003839 Adenylyldeoxyribonucleosides
% 209.04/209.21  |- skos__hiddenLabel mesh__D003839 Deoxyribonucleosides, Adenine
% 209.04/209.21  |- mesh__recordOriginator mesh__D003839 NLM
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D003839 2001
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D003839 1996
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D003839 2006
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D003839 2000
% 209.04/209.21  |- mesh__recordMaintainer mesh__D003839 TGC
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D003839 2004
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D003839 2005
% 209.04/209.21  |- mesh__onlineNote mesh__D003839
% 209.04/209.21       use DEOXYADENOSINES to search DEOXYADENOSINE 1971-89%28%Prov 1971-72%29%%A%  
% 209.04/209.21  |- rdf__type mesh__D003839sskos__Concept
% 209.04/209.21  |- skos__broader mesh__D003839smesh__D000241
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D003839 2003
% 209.04/209.21  |- mesh__recordAuthorizer mesh__D003839 PLS
% 209.04/209.21  |- skos__historyNote mesh__D003839 Adenosine %28%1966-1970%29%
% 209.04/209.21  |- mesh__dateCreated mesh__D003839 1999-01-01
% 209.04/209.21  |- mesh__dateEstablished mesh__D003839 1973-01-01
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D003839 2002
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D003839 1995
% 209.04/209.21  |- skos__broader mesh__D014561smesh__D002816
% 209.04/209.21  |- skos__altLabel mesh__D014561 Urochordates
% 209.04/209.21  |- mesh__historyNote mesh__D014561 73   
% 209.04/209.21  |- mesh__dateRevised mesh__D014561 2003-07-09
% 209.04/209.21  |- rdf__type mesh__D014561sskos__Concept
% 209.04/209.21  |- mesh__dateCreated mesh__D014561 1999-01-01
% 209.04/209.21  |- mesh__recordAuthorizer mesh__D014561 sjn
% 209.04/209.21  |- skos__historyNote mesh__D014561 Chordata %28%1966-1972%29%
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D014561 2004
% 209.04/209.21  |- mesh__dateEstablished mesh__D014561 1973-01-01
% 209.04/209.21  |- skos__prefLabel mesh__D014561 Urochordata
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D014561 2006
% 209.04/209.21  |- skos__altLabel mesh__D014561 Tunicata
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D014561 2005
% 209.04/209.21  |- skos__scopeNote mesh__D014561
% 209.04/209.21       A subphylum of chordates intermediate between the invertebrates and the true vertebrates. It includes the Ascidians.%A%    
% 209.04/209.21  |- mesh__publicMeSHNote mesh__D014561 73   
% 209.04/209.21  |- mesh__recordOriginator mesh__D014561 NLM
% 209.04/209.21  |- mesh__recordMaintainer mesh__D014561 ags
% 209.04/209.21  |- skos__altLabel mesh__D014561 Tunicates
% 209.04/209.21  |- mesh__dateCreated mesh__D008524 1999-01-01
% 209.04/209.21  |- mesh__publicMeSHNote mesh__D008524
% 209.04/209.21       91; was see under PREGNADIENES 1972-90   
% 209.04/209.21  |- mesh__recordOriginator mesh__D008524 NLM
% 209.04/209.21  |- mesh__recordMaintainer mesh__D008524 CCR
% 209.04/209.21  |- rdf__type mesh__D008524sskos__Concept
% 209.04/209.21  |- skos__hiddenLabel mesh__D008524 Medrogestone Wyeth Brand
% 209.04/209.21  |- mesh__dateEstablished mesh__D008524 1991-01-01
% 209.04/209.21  |- skos__scopeNote mesh__D008524
% 209.04/209.21       6,17-Dimethylpregna-4,6-diene-3,20-dione. A synthetic progestational hormone with actions similar to those of progesterone. It is used in the treatment of menstrual irregularities and has also been employed in the treatment of prostatic hypertrophy and endometrial carcinoma.%A%    
% 209.04/209.21  |- skos__prefLabel mesh__D008524 Medrogestone
% 209.04/209.21  |- skos__historyNote mesh__D008524 Pregnadienes %28%1966-1971%29%
% 209.04/209.21  |- mesh__dateRevised mesh__D008524 2005-06-30
% 209.04/209.21  |- skos__altLabel mesh__D008524 Biodim Brand of Medrogestone
% 209.04/209.21  |- skos__broader mesh__D008524smesh__D011245
% 209.04/209.21  |- skos__altLabel mesh__D008524 Solvay Brand of Medrogestone
% 209.04/209.21  |- skos__hiddenLabel mesh__D008524 Medrogestone Biodim Brand
% 209.04/209.21  |- mesh__historyNote mesh__D008524
% 209.04/209.21       91%28%72%29%; was see under PREGNADIENES 1972-90   
% 209.04/209.21  |- skos__altLabel mesh__D008524 Wyeth Brand of Medrogestone
% 209.04/209.21  |- skos__hiddenLabel mesh__D008524 Medrogestone Solvay Brand
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D008524 2006
% 209.04/209.21  |- skos__annotation mesh__D008524 a synthetic progestational hormone   
% 209.04/209.21  |- skos__historyNote mesh__D008524
% 209.04/209.21       Progestational Hormones %28%1966-1971%29%
% 209.04/209.21  |- mesh__recordAuthorizer mesh__D008524 sjn
% 209.04/209.21  |- skos__scopeNote mesh__D000541
% 209.04/209.21       Subtotal or complete excision of the alveolar process of the maxilla or mandible. %28%Dorland, 28th ed%29%%A%    
% 209.04/209.21  |- mesh__recordMaintainer mesh__D000541 PXP
% 209.04/209.21  |- rdf__type mesh__D000541sskos__Concept
% 209.04/209.21  |- mesh__recordOriginator mesh__D000541 NLM
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000541 2006
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000541 2002
% 209.04/209.21  |- mesh__historyNote mesh__D000541 65   
% 209.04/209.21  |- mesh__dateEstablished mesh__D000541 1965-01-01
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000541 2005
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000541 2001
% 209.04/209.21  |- mesh__dateCreated mesh__D000541 1999-01-01
% 209.04/209.21  |- skos__broader mesh__D000541smesh__D013516
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000541 1999
% 209.04/209.21  |- skos__annotation mesh__D000541
% 209.04/209.21       excision of part of the ALVEOLAR PROCESS %28%see note there%29%; do not confuse with ALVEOLOPLASTY; do not use /util except by MeSH definition%A%  
% 209.04/209.21  |- mesh__publicMeSHNote mesh__D000541 65   
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000541 2004
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000541 2000
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000541 1998
% 209.04/209.21  |- skos__hiddenLabel mesh__D000541 Alveolectomies
% 209.04/209.21  |- skos__prefLabel mesh__D000541 Alveolectomy
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000541 2003
% 209.04/209.21  |- mesh__recordAuthorizer mesh__D000541 SJN
% 209.04/209.21  |- mesh__dateRevised mesh__D000541 1997-06-20
% 209.04/209.21  |- skos__altLabel mesh__D013469 Almirall Brand of Sulpiride
% 209.04/209.21  |- skos__altLabel mesh__D013469 Spyfarma Brand of Sulpiride
% 209.04/209.21  |- mesh__historyNote mesh__D013469 74   
% 209.04/209.21  |- mesh__recordOriginator mesh__D013469 NLM
% 209.04/209.21  |- skos__hiddenLabel mesh__D013469 Sanofi Synthelabo Brand of Sulpiride
% 209.04/209.21  |- skos__hiddenLabel mesh__D013469 Vertigo Meresa
% 209.04/209.21  |- skos__altLabel mesh__D013469 Hoechst Brand of Sulpiride
% 209.04/209.21  |- skos__altLabel mesh__D013469 Fumouzer Brand of Sulpiride
% 209.04/209.21  |- mesh__dateCreated mesh__D013469 1999-01-01
% 209.04/209.21  |- skos__altLabel mesh__D013469 Areu Brand of Sulpiride
% 209.04/209.21  |- skos__altLabel mesh__D013469 Desitin Brand of Sulpiride
% 209.04/209.21  |- skos__altLabel mesh__D013469 Sulperide
% 209.04/209.21  |- mesh__dateRevised mesh__D013469 2005-06-30
% 209.04/209.21  |- skos__altLabel mesh__D013469 Hormosan Brand of Sulpiride
% 209.04/209.21  |- mesh__recordMaintainer mesh__D013469 CCR
% 209.04/209.21  |- skos__altLabel mesh__D013469 Allphar Brand of Sulpiride
% 209.04/209.21  |- skos__altLabel mesh__D013469 Vertigo-Meresa
% 209.04/209.21  |- skos__altLabel mesh__D013469 Erempharma Brand of Sulpiride
% 209.04/209.21  |- skos__altLabel mesh__D013469 Uriach Brand of Sulpiride
% 209.04/209.21  |- skos__altLabel mesh__D013469 Hennig Brand of Sulpiride
% 209.04/209.21  |- mesh__publicMeSHNote mesh__D013469 74   
% 209.04/209.21  |- skos__altLabel mesh__D013469 Rosemont Brand of Sulpiride
% 209.04/209.21  |- skos__broader mesh__D013469smesh__D001549
% 209.04/209.21  |- skos__scopeNote mesh__D013469
% 209.04/209.21       A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. %28%From Merck Index, 11th ed%29%%A%    
% 209.04/209.21  |- rdf__type mesh__D013469sskos__Concept
% 209.04/209.21  |- skos__altLabel mesh__D013469 Hexal Brand of Sulpiride
% 209.04/209.21  |- skos__altLabel mesh__D013469 Meresa
% 209.04/209.21  |- skos__altLabel mesh__D013469 Dolmatil
% 209.04/209.21  |- skos__altLabel mesh__D013469 Psicofarma Brand of Sulpiride
% 209.04/209.21  |- skos__altLabel mesh__D013469 Pharmacia Brand of Sulpiride
% 209.04/209.21  |- skos__prefLabel mesh__D013469 Sulpiride
% 209.04/209.21  |- skos__altLabel mesh__D013469 Centrum Brand of Sulpiride
% 209.04/209.21  |- skos__altLabel mesh__D013469 Sanofi-Synthelabo Brand of Sulpiride
% 209.04/209.21  |- skos__altLabel mesh__D013469 Dolorgiet Brand of Sulpiride
% 209.04/209.21  |- skos__hiddenLabel mesh__D013469 vertigo neogama
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D013469 2006
% 209.04/209.21  |- mesh__recordAuthorizer mesh__D013469 sjn
% 209.04/209.21  |- mesh__dateEstablished mesh__D013469 1974-01-01
% 209.04/209.21  |- skos__altLabel mesh__D013469 Krewel Brand of Sulpiride
% 209.04/209.21  |- skos__altLabel mesh__D013469 vertigo-neogama
% 209.04/209.21  |- skos__altLabel mesh__D018952 CD34 Antigens
% 209.04/209.21  |- mesh__dateRevised mesh__D018952 2005-06-30
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D018952 2006
% 209.04/209.21  |- rdf__type mesh__D018952sskos__Concept
% 209.04/209.21  |- mesh__historyNote mesh__D018952
% 209.04/209.21       96; was CD34 ANTIGEN %28%NM%29% 1988-95   
% 209.04/209.21  |- mesh__recordAuthorizer mesh__D018952 sjn
% 209.04/209.21  |- mesh__publicMeSHNote mesh__D018952
% 209.04/209.21       96; CD34 ANTIGEN was indexed under ANTIGENS, CD 1990-95 %26% ANTIGENS, DIFFERENTIATION 1988-91%A%  
% 209.04/209.21  |- skos__historyNote mesh__D018952
% 209.04/209.21       Antigens, Differentiation %28%1988-1991%29%
% 209.04/209.21  |- mesh__recordMaintainer mesh__D018952 ssb
% 209.04/209.21  |- mesh__dateEstablished mesh__D018952 1996-01-01
% 209.04/209.21  |- skos__hiddenLabel mesh__D018952 Antigen, CD34
% 209.04/209.21  |- skos__scopeNote mesh__D018952
% 209.04/209.21       Glycoproteins found on immature hematopoietic cells and endothelial cells. They are the only molecules to date whose expression within the blood system is restricted to a small number of progenitor cells in the bone marrow.%A%    
% 209.04/209.21  |- skos__annotation mesh__D018952 differentiation antigens   
% 209.04/209.21  |- skos__altLabel mesh__D018952 CD34 Antigen
% 209.04/209.21  |- skos__broader mesh__D018952smesh__D015703
% 209.04/209.21  |- mesh__recordOriginator mesh__D018952 AGS
% 209.04/209.21  |- mesh__dateCreated mesh__D018952 1995-05-26
% 209.04/209.21  |- skos__historyNote mesh__D018952 Antigens, CD %28%1990-1995%29%
% 209.04/209.21  |- skos__prefLabel mesh__D018952 Antigens, CD34
% 209.04/209.21  |- mesh__onlineNote mesh__D018952
% 209.04/209.21       use ANTIGENS, CD34 %28%NM%29% to search CD34 ANTIGEN 1988-95   
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D018154 2003
% 209.04/209.21  |- skos__scopeNote mesh__D018154
% 209.04/209.21       Created 1 January 1993 as a result of the division of Czechoslovakia into the Czech Republic and Slovakia.%A%    
% 209.04/209.21  |- skos__broader mesh__D018154smesh__D005061
% 209.04/209.21  |- mesh__dateRevised mesh__D018154 1996-06-10
% 209.04/209.21  |- skos__altLabel mesh__D018154 Slovak Republic
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D018154 2004
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D018154 2001
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D018154 2002
% 209.04/209.21  |- mesh__historyNote mesh__D018154 94   
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D018154 1997
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D018154 2005
% 209.04/209.21  |- skos__historyNote mesh__D018154 Czechoslovakia %28%1966-1993%29%
% 209.04/209.21  |- skos__prefLabel mesh__D018154 Slovakia
% 209.04/209.21  |- mesh__dateCreated mesh__D018154 1993-06-03
% 209.04/209.21  |- skos__broader mesh__D018154smesh__D003604
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D018154 2006
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D018154 1998
% 209.04/209.21  |- mesh__dateEstablished mesh__D018154 1994-01-01
% 209.04/209.21  |- mesh__recordMaintainer mesh__D018154 TGC
% 209.04/209.21  |- mesh__recordOriginator mesh__D018154 TGC
% 209.04/209.21  |- rdf__type mesh__D018154sskos__Concept
% 209.04/209.21  |- mesh__onlineNote mesh__D018154
% 209.04/209.21       use CZECHOSLOVAKIA to search SLOVAKIA 1966-93   
% 209.04/209.21  |- mesh__recordAuthorizer mesh__D018154 PLS
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D018154 1999
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D018154 2000
% 209.04/209.21  |- skos__hiddenLabel mesh__D010171 CoA, Hexadecanoyl
% 209.04/209.21  |- mesh__dateCreated mesh__D010171 1977-05-20
% 209.04/209.21  |- skos__prefLabel mesh__D010171 Palmitoyl Coenzyme A
% 209.04/209.21  |- skos__hiddenLabel mesh__D010171 CoA, Palmityl
% 209.04/209.21  |- mesh__dateEstablished mesh__D010171 1991-01-01
% 209.04/209.21  |- mesh__recordOriginator mesh__D010171 RLS
% 209.04/209.21  |- mesh__dateRevised mesh__D010171 2003-07-09
% 209.04/209.21  |- skos__altLabel mesh__D010171 Palmitoyl CoA
% 209.04/209.21  |- mesh__recordMaintainer mesh__D010171 ssb
% 209.04/209.21  |- skos__historyNote mesh__D010171 Palmitic Acids %28%1966-1977%29%
% 209.04/209.21  |- skos__hiddenLabel mesh__D010171 A, Palmitoyl Coenzyme
% 209.04/209.21  |- rdf__type mesh__D010171sskos__Concept
% 209.04/209.21  |- skos__broader mesh__D010171smesh__D000214
% 209.04/209.21  |- skos__hiddenLabel mesh__D010171 CoA, Palmitoyl
% 209.04/209.21  |- skos__historyNote mesh__D010171 Palmitates %28%1975-1977%29%
% 209.04/209.21  |- skos__hiddenLabel mesh__D010171 Coenzyme A, Palmitoyl
% 209.04/209.21  |- mesh__publicMeSHNote mesh__D010171
% 209.04/209.21       91; was see under ACYL COENZYME A 1978-90   
% 209.04/209.21  |- skos__historyNote mesh__D010171 Coenzyme A %28%1966-1977%29%
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D010171 2005
% 209.04/209.21  |- mesh__recordAuthorizer mesh__D010171 sjn
% 209.04/209.21  |- skos__altLabel mesh__D010171 Palmityl CoA
% 209.04/209.21  |- skos__altLabel mesh__D010171 Hexadecanoyl CoA
% 209.04/209.21  |- mesh__historyNote mesh__D010171
% 209.04/209.21       91%28%78%29%; was see under ACYL COENZYME A 1978-90   
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D010171 2004
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D010171 2006
% 209.04/209.21  |- skos__scopeNote mesh__D010171
% 209.04/209.21       A fatty acid coenzyme derivative which plays a key role in fatty acid oxidation and biosynthesis.%A%    
% 209.04/209.21  |- skos__broader mesh__D004932smesh__D006975
% 209.04/209.21  |- skos__scopeNote mesh__D004932
% 209.04/209.21       Dilated blood vessels in the ESOPHAGUS or GASTRIC FUNDUS that shunt blood from the portal circulation %28%PORTAL SYSTEM%29% to the systemic venous circulation. Often they are observed in individuals with portal hypertension %28%HYPERTENSION, PORTAL%29%.%A%    
% 209.04/209.21  |- skos__hiddenLabel mesh__D004932 Varix, Esophageal
% 209.04/209.21  |- skos__altLabel mesh__D004932 Esophageal Varix
% 209.04/209.21  |- skos__hiddenLabel mesh__D004932 Varix, Gastric
% 209.04/209.21  |- skos__altLabel mesh__D004932 Gastric Varices
% 209.04/209.21  |- skos__broader mesh__D004932smesh__D004935
% 209.04/209.21  |- mesh__historyNote mesh__D004932 85; was ESOPHAGEAL VARICES 1963-84   
% 209.04/209.21  |- skos__hiddenLabel mesh__D004932 Varices, Gastric
% 209.04/209.21  |- mesh__dateRevised mesh__D004932 2004-07-07
% 209.04/209.21  |- mesh__recordOriginator mesh__D004932 NLM
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D004932 2006
% 209.04/209.21  |- mesh__recordAuthorizer mesh__D004932 sjn
% 209.04/209.21  |- mesh__recordMaintainer mesh__D004932 lkt
% 209.04/209.21  |- skos__hiddenLabel mesh__D004932 Varices, Esophageal
% 209.04/209.21  |- mesh__onlineNote mesh__D004932
% 209.04/209.21       use ESOPHAGEAL AND GASTRIC VARICES to search ESOPHAGEAL VARICES 1966-84%A%  
% 209.04/209.21  |- mesh__publicMeSHNote mesh__D004932 85; was ESOPHAGEAL VARICES 1963-84   
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D004932 2005
% 209.04/209.21  |- rdf__type mesh__D004932sskos__Concept
% 209.04/209.21  |- skos__annotation mesh__D004932
% 209.04/209.21       do not specify esophageal or gastric aspect unless particularly discussed; hemorrhaging esophageal or gastric varices: coord IM with HEMORRHAGE, GASTROINTESTINAL %28%IM%29%%A%  
% 209.04/209.21  |- mesh__dateCreated mesh__D004932 1999-01-01
% 209.04/209.21  |- skos__prefLabel mesh__D004932 Esophageal and Gastric Varices
% 209.04/209.21  |- mesh__recordMaintainer mesh__D004134 ssb
% 209.04/209.21  |- mesh__dateRevised mesh__D004134 2003-07-09
% 209.04/209.21  |- mesh__dateCreated mesh__D004134 1983-03-17
% 209.04/209.21  |- skos__altLabel mesh__D004134 1,2-Ditetradecyl-glycero-3-phosphocholine
% 209.04/209.21  |- skos__hiddenLabel mesh__D004134
% 209.04/209.21       1,2 Ditetradecyl glycero 3 phosphocholine
% 209.04/209.21  |- rdf__type mesh__D004134sskos__Concept
% 209.04/209.21  |- skos__altLabel mesh__D004134
% 209.04/209.21       1,2-Ditetradecanoyl-glycero-3-phosphocholine
% 209.04/209.21  |- skos__broader mesh__D004134smesh__D010713
% 209.04/209.21  |- skos__historyNote mesh__D004134 Myristates %28%1977-1980%29%
% 209.04/209.21  |- skos__hiddenLabel mesh__D004134
% 209.04/209.21       1,2 Dimyristoyl glycero 3 phosphorylcholine
% 209.04/209.21  |- skos__altLabel mesh__D004134 DMCP
% 209.04/209.21  |- skos__annotation mesh__D004134
% 209.04/209.21       used in study of biol membranes; DF: DMPC   
% 209.04/209.21  |- skos__hiddenLabel mesh__D004134
% 209.04/209.21       1,2 Ditetradecanoyl glycero 3 phosphocholine
% 209.04/209.21  |- skos__altLabel mesh__D004134 DMPC
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D004134 2006
% 209.04/209.21  |- mesh__recordOriginator mesh__D004134 RLS
% 209.04/209.21  |- mesh__historyNote mesh__D004134 84   
% 209.04/209.21  |- mesh__dateEstablished mesh__D004134 1984-01-01
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D004134 2005
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D004134 2004
% 209.04/209.21  |- skos__altLabel mesh__D004134 1,2-Dimyristoyl-glycero-3-phosphorylcholine
% 209.04/209.21  |- skos__prefLabel mesh__D004134 Dimyristoylphosphatidylcholine
% 209.04/209.21  |- skos__altLabel mesh__D004134 Dimyristoyllecithin
% 209.04/209.21  |- skos__historyNote mesh__D004134 Phosphatidylcholines %28%1980-1983%29%
% 209.04/209.21  |- skos__scopeNote mesh__D004134
% 209.04/209.21       A synthetic phospholipid used in liposomes and lipid bilayers for the study of biological membranes.%A%    
% 209.04/209.21  |- mesh__recordAuthorizer mesh__D004134 sjn
% 209.04/209.21  |- mesh__publicMeSHNote mesh__D004134 84   
% 209.04/209.21  |- skos__hiddenLabel mesh__D014562 Congo Eels
% 209.04/209.21  |- skos__altLabel mesh__D014562 Caudata
% 209.04/209.21  |- mesh__dateCreated mesh__D014562 1999-01-01
% 209.04/209.21  |- skos__scopeNote mesh__D014562
% 209.04/209.21       An order of the Amphibia class which includes salamanders and newts. They are characterized by usually having slim bodies and tails, four limbs of about equal size %28%except in Sirenidae%29%, and a reduction in skull bones.%A%    
% 209.04/209.21  |- mesh__recordOriginator mesh__D014562 NLM
% 209.04/209.21  |- mesh__historyNote mesh__D014562 81; was SALAMANDERS 1963-80   
% 209.04/209.21  |- mesh__dateRevised mesh__D014562 2003-07-09
% 209.04/209.21  |- rdf__type mesh__D014562sskos__Concept
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D014562 2005
% 209.04/209.21  |- skos__broader mesh__D014562smesh__D000663
% 209.04/209.21  |- mesh__publicMeSHNote mesh__D014562 81; was SALAMANDERS 1963-80   
% 209.04/209.21  |- skos__annotation mesh__D014562
% 209.04/209.21       includes SALAMANDERS %28%note X ref below%29%, mudpuppies %28% = NECTURUS %26% specific%29% %26% NEWTS %28% = SALAMANDRIDAE %26% specifics%29%; NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D014562 2004
% 209.04/209.21  |- skos__hiddenLabel mesh__D014562 Eels, Congo
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D014562 2006
% 209.04/209.21  |- mesh__recordMaintainer mesh__D014562 ags
% 209.04/209.21  |- mesh__onlineNote mesh__D014562
% 209.04/209.21       use URODELA to search SALAMANDERS 1966-80   
% 209.04/209.21  |- skos__hiddenLabel mesh__D014562 Salamander
% 209.04/209.21  |- skos__prefLabel mesh__D014562 Urodela
% 209.04/209.21  |- skos__hiddenLabel mesh__D014562 Congo Eel
% 209.04/209.21  |- skos__altLabel mesh__D014562 Amphiuma
% 209.04/209.21  |- mesh__recordAuthorizer mesh__D014562 sjn
% 209.04/209.21  |- skos__annotation mesh__D008525 a synthetic progestational hormone   
% 209.04/209.21  |- skos__scopeNote mesh__D008525
% 209.04/209.21       %28%6 alpha%29%-17-Hydroxy-6-methylpregn-4-ene-3,20-dione. A synthetic progestational hormone used in veterinary practice as an estrus regulator.%A%    
% 209.04/209.21  |- mesh__recordMaintainer mesh__D008525 CCR
% 209.04/209.21  |- mesh__recordAuthorizer mesh__D008525 sjn
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D008525 2006
% 209.04/209.21  |- mesh__recordOriginator mesh__D008525 NLM
% 209.04/209.21  |- skos__prefLabel mesh__D008525 Medroxyprogesterone
% 209.04/209.21  |- mesh__dateCreated mesh__D008525 1999-01-01
% 209.04/209.21  |- skos__hiddenLabel mesh__D008525 Medroxyprogesterone Strakan Brand
% 209.04/209.21  |- mesh__dateRevised mesh__D008525 2005-06-30
% 209.04/209.21  |- skos__altLabel mesh__D008525 Strakan Brand of Medroxyprogesterone
% 209.04/209.21  |- mesh__onlineNote mesh__D008525
% 209.04/209.21       use MEDROXYPROGESTERONE to search METHYPREGNONE 1977-93   
% 209.04/209.21  |- mesh__historyNote mesh__D008525
% 209.04/209.21       METHYPREGNONE was see MEDROXYPROGESTERONE 1977-93   
% 209.04/209.21  |- rdf__type mesh__D008525sskos__Concept
% 209.04/209.21  |- skos__altLabel mesh__D008525 Methylhydroxyprogesterone
% 209.04/209.21  |- skos__broader mesh__D008525smesh__D011374
% 209.04/209.21  |- skos__hiddenLabel mesh__D008525
% 209.04/209.21       17 alpha Hydroxy 6 alpha Methylprogesterone
% 209.04/209.21  |- skos__altLabel mesh__D008525 17 alpha-Hydroxy-6 alpha-Methylprogesterone
% 209.04/209.21  |- mesh__publicMeSHNote mesh__D008525
% 209.04/209.21       METHYPREGNONE was see MEDROXYPROGESTERONE 1977-93   
% 209.04/209.21  |- skos__hiddenLabel mesh__D000542 Allergic Alveolitides, Extrinsic
% 209.04/209.21  |- mesh__recordAuthorizer mesh__D000542 PLS
% 209.04/209.21  |- mesh__dateCreated mesh__D000542 1976-04-27
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000542 2006
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000542 1996
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000542 1995
% 209.04/209.21  |- mesh__dateRevised mesh__D000542 1993-03-03
% 209.04/209.21  |- mesh__recordMaintainer mesh__D000542 TGC
% 209.04/209.21  |- skos__broader mesh__D000542smesh__D017563
% 209.04/209.21  |- skos__hiddenLabel mesh__D000542 Hypersensitivity Pneumonitides
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000542 2005
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000542 1994
% 209.04/209.21  |- mesh__dateEstablished mesh__D000542 1977-01-01
% 209.04/209.21  |- skos__historyNote mesh__D000542
% 209.04/209.21       Respiratory Hypersensitivity %28%1966-1976%29%
% 209.04/209.21  |- skos__altLabel mesh__D000542 Pneumonitis, Hypersensitivity
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000542 1999
% 209.04/209.21  |- mesh__publicMeSHNote mesh__D000542 77   
% 209.04/209.21  |- skos__broader mesh__D000542smesh__D012130
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000542 2004
% 209.04/209.21  |- skos__scopeNote mesh__D000542
% 209.04/209.21       Conditions in which inhalation of organic dusts results in hypersensitivity reactions at the alveolar level, associated with the production of precipitins.%A%    
% 209.04/209.21  |- skos__hiddenLabel mesh__D000542 Alveolitides, Extrinsic Allergic
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000542 2002
% 209.04/209.21  |- skos__hiddenLabel mesh__D000542 Pneumonitides, Hypersensitivity
% 209.04/209.21  |- skos__annotation mesh__D000542 a type of resp hypersensitivity   
% 209.04/209.21  |- skos__hiddenLabel mesh__D000542 Extrinsic Allergic Alveolitis
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000542 1998
% 209.04/209.21  |- mesh__recordOriginator mesh__D000542 VDK
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000542 2003
% 209.04/209.21  |- skos__hiddenLabel mesh__D000542 Extrinsic Allergic Alveolitides
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000542 2001
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000542 1997
% 209.04/209.21  |- mesh__historyNote mesh__D000542 77   
% 209.04/209.21  |- skos__altLabel mesh__D000542 Allergic Alveolitis, Extrinsic
% 209.04/209.21  |- skos__altLabel mesh__D000542 Hypersensitivity Pneumonitis
% 209.04/209.21  |- skos__prefLabel mesh__D000542 Alveolitis, Extrinsic Allergic
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D000542 2000
% 209.04/209.21  |- rdf__type mesh__D000542sskos__Concept
% 209.04/209.21  |- skos__annotation mesh__D018953
% 209.04/209.21       a type of alternative med; do not confuse with KINESIS; KINETICS or KINESTHESIS; DF: KINESIOL APPLIED%A%  
% 209.04/209.21  |- skos__broader mesh__D018953smesh__D026201
% 209.04/209.21  |- mesh__dateCreated mesh__D018953 1995-02-21
% 209.04/209.21  |- mesh__dateRevised mesh__D018953 2005-06-30
% 209.04/209.21  |- mesh__publicMeSHNote mesh__D018953 96   
% 209.04/209.21  |- skos__prefLabel mesh__D018953 Kinesiology, Applied
% 209.04/209.21  |- mesh__recordOriginator mesh__D018953 TGC
% 209.04/209.21  |- skos__altLabel mesh__D018953 Applied Kinesiology
% 209.04/209.21  |- mesh__recordAuthorizer mesh__D018953 sjn
% 209.04/209.21  |- skos__scopeNote mesh__D018953
% 209.04/209.21       The study of muscles and the movement of the human body. In holistic medicine it is the balance of movement and the interaction of a person%27%s energy systems. Applied kinesiology is the name given by its inventor, Dr. George Goodheart, to the system of applying muscle testing diagnostically and therapeutically to different aspects of health care. %28%Thorsons Introductory Guide to Kinesiology, 1992, p13%29%%A%    
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D018953 2006
% 209.04/209.21  |- mesh__dateEstablished mesh__D018953 1996-01-01
% 209.04/209.21  |- mesh__historyNote mesh__D018953 96   
% 209.04/209.21  |- rdf__type mesh__D018953sskos__Concept
% 209.04/209.21  |- mesh__recordMaintainer mesh__D018953 lkt
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D010970 1994
% 209.04/209.21  |- mesh__publicMeSHNote mesh__D010970
% 209.04/209.21       91; was see under PLANT PROTEINS 1975-90   
% 209.04/209.21  |- mesh__dateCreated mesh__D010970 1974-11-19
% 209.04/209.21  |- mesh__recordAuthorizer mesh__D010970 PLS
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D010970 1995
% 209.04/209.21  |- skos__hiddenLabel mesh__D010970 Plastocyanin, Silver
% 209.04/209.21  |- skos__altLabel mesh__D010970 Plastocyanine
% 209.04/209.21  |- skos__scopeNote mesh__D010970
% 209.04/209.21       A copper-containing plant protein that is a fundamental link in the electron transport chain of green plants during the photosynthetic conversion of light energy by photophosphorylation into the potential energy of chemical bonds.%A%    
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D010970 1998
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D010970 1993
% 209.04/209.21  |- skos__broader mesh__D010970smesh__D008667
% 209.04/209.21  |- mesh__dateRevised mesh__D010970 1992-05-19
% 209.04/209.21  |- rdf__type mesh__D010970sskos__Concept
% 209.04/209.21  |- mesh__recordMaintainer mesh__D010970 TAP
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D010970 1999
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D010970 1996
% 209.04/209.21  |- skos__historyNote mesh__D010970 Plant Proteins %28%1970-1974%29%
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D010970 2005
% 209.04/209.21  |- skos__prefLabel mesh__D010970 Plastocyanin
% 209.04/209.21  |- mesh__dateEstablished mesh__D010970 1991-01-01
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D010970 2000
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D010970 1997
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D010970 2006
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D010970 2003
% 209.04/209.21  |- skos__annotation mesh__D010970 a plant protein   
% 209.04/209.21  |- mesh__recordOriginator mesh__D010970 NLM
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D010970 2001
% 209.04/209.21  |- skos__historyNote mesh__D010970 Copper %28%1970-1974%29%
% 209.04/209.21  |- skos__broader mesh__D010970smesh__D010940
% 209.04/209.21  |- mesh__activeMeSHYear mesh__D010970 2004
% 209.04/209.22  |- mesh__historyNote mesh__D010970
% 209.04/209.22       91%28%75%29%; was see under PLANT PROTEINS 1975-90   
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D010970 2002
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018155 2004
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018155 1996
% 209.04/209.22  |- skos__prefLabel mesh__D018155 Orthopoxvirus
% 209.04/209.22  |- skos__hiddenLabel mesh__D018155 Orthopoxviruses
% 209.04/209.22  |- skos__scopeNote mesh__D018155
% 209.04/209.22       A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, comprising many species infecting mammals. Viruses of this genus cause generalized infections and a rash in some hosts. The type species is VACCINIA VIRUS.%A%    
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018155 2000
% 209.04/209.22  |- mesh__dateRevised mesh__D018155 2005-07-12
% 209.04/209.22  |- mesh__historyNote mesh__D018155 94   
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018155 1997
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018155 2005
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018155 2001
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018155 2006
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018155 1998
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018155 2002
% 209.04/209.22  |- mesh__dateCreated mesh__D018155 1993-06-04
% 209.04/209.22  |- rdf__type mesh__D018155sskos__Concept
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018155 1994
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018155 1999
% 209.04/209.22  |- mesh__recordOriginator mesh__D018155 AGS
% 209.04/209.22  |- mesh__recordAuthorizer mesh__D018155 ags
% 209.04/209.22  |- skos__broader mesh__D018155smesh__D018147
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018155 1995
% 209.04/209.22  |- mesh__recordMaintainer mesh__D018155 ags
% 209.04/209.22  |- skos__historyNote mesh__D018155 Poxviridae %28%1977-1993%29%
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018155 2003
% 209.04/209.22  |- mesh__publicMeSHNote mesh__D018155 94   
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018155 2006A
% 209.04/209.22  |- mesh__dateEstablished mesh__D018155 1994-01-01
% 209.04/209.22  |- skos__annotation mesh__D018155
% 209.04/209.22       a genus of the subfamily Chordopoxvirinae; infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29%%A%  
% 209.04/209.22  |- rdf__type mesh__D010172sskos__Concept
% 209.04/209.22  |- mesh__dateCreated mesh__D010172 1977-05-17
% 209.04/209.22  |- skos__scopeNote mesh__D010172
% 209.04/209.22       A long-chain fatty acid ester of carnitine which facilitates the transfer of long-chain fatty acids from cytoplasm into mitochondria during the oxidation of fatty acids.%A%    
% 209.04/209.22  |- mesh__recordAuthorizer mesh__D010172 sjn
% 209.04/209.22  |- skos__prefLabel mesh__D010172 Palmitoylcarnitine
% 209.04/209.22  |- mesh__publicMeSHNote mesh__D010172
% 209.04/209.22       91; was see under CARNITINE 1978-90   
% 209.04/209.22  |- skos__altLabel mesh__D010172 Hexadecanoylcarnitine
% 209.04/209.22  |- mesh__dateRevised mesh__D010172 2005-06-30
% 209.04/209.22  |- skos__historyNote mesh__D010172 Carnitine %28%1966-1977%29%
% 209.04/209.22  |- mesh__recordOriginator mesh__D010172 RLS
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D010172 2006
% 209.04/209.22  |- skos__altLabel mesh__D010172 Palmitylcarnitine
% 209.04/209.22  |- mesh__recordMaintainer mesh__D010172 ssb
% 209.04/209.22  |- mesh__historyNote mesh__D010172
% 209.04/209.22       91%28%78%29%; was see under CARNITINE 1978-90   
% 209.04/209.22  |- skos__historyNote mesh__D010172 Palmitic Acids %28%1966-1977%29%
% 209.04/209.22  |- skos__annotation mesh__D010172
% 209.04/209.22       deficiency: coordinate PALMITOYLCARNITINE /defic %28%IM%29% with VITAMIN B DEFICIENCY %28%IM%29%%A%  
% 209.04/209.22  |- skos__broader mesh__D010172smesh__D002331
% 209.04/209.22  |- mesh__dateEstablished mesh__D010172 1991-01-01
% 209.04/209.22  |- mesh__dateRevised mesh__D004933 2003-07-09
% 209.04/209.22  |- mesh__historyNote mesh__D004933 70%28%66%29%   
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D004933 2006
% 209.04/209.22  |- skos__scopeNote mesh__D004933
% 209.04/209.22       Congenital abnormality characterized by the lack of full development of the ESOPHAGUS that commonly occurs with TRACHEOESOPHAGEAL FISTULA. Symptoms include excessive SALIVATION; GAGGING; CYANOSIS; and DYSPNEA.%A%    
% 209.04/209.22  |- skos__altLabel mesh__D004933 Atresia, Esophageal
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D004933 2005
% 209.04/209.22  |- skos__broader mesh__D004933smesh__D004935
% 209.04/209.22  |- rdf__type mesh__D004933sskos__Concept
% 209.04/209.22  |- mesh__recordOriginator mesh__D004933 NLM
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D004933 2004
% 209.04/209.22  |- mesh__dateCreated mesh__D004933 1999-01-01
% 209.04/209.22  |- mesh__recordAuthorizer mesh__D004933 sjn
% 209.04/209.22  |- mesh__recordMaintainer mesh__D004933 lkt
% 209.04/209.22  |- skos__hiddenLabel mesh__D004933 Atresias, Esophageal
% 209.04/209.22  |- skos__hiddenLabel mesh__D004933 Esophageal Atresias
% 209.04/209.22  |- mesh__publicMeSHNote mesh__D004933 70   
% 209.04/209.22  |- skos__prefLabel mesh__D004933 Esophageal Atresia
% 209.04/209.22  |- mesh__dateEstablished mesh__D004933 1970-01-01
% 209.04/209.22  |- skos__broader mesh__D004933smesh__D004065
% 209.04/209.22  |- mesh__recordOriginator mesh__D004135 NLM
% 209.04/209.22  |- rdf__type mesh__D004135sskos__Concept
% 209.04/209.22  |- mesh__dateEstablished mesh__D004135 1991-01-01
% 209.04/209.22  |- skos__scopeNote mesh__D004135 A coccidiostat for poultry.     
% 209.04/209.22  |- skos__altLabel mesh__D004135 Dinitrotoluamide
% 209.04/209.22  |- mesh__recordAuthorizer mesh__D004135 sjn
% 209.04/209.22  |- skos__historyNote mesh__D004135 Benzamides %28%1974%29%
% 209.04/209.22  |- mesh__publicMeSHNote mesh__D004135
% 209.04/209.22       91; was see under BENZAMIDES 1975-90   
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D004135 2006
% 209.04/209.22  |- mesh__dateCreated mesh__D004135 1974-11-19
% 209.04/209.22  |- mesh__recordMaintainer mesh__D004135 exl
% 209.04/209.22  |- skos__altLabel mesh__D004135 Methyldinitrobenzamide
% 209.04/209.22  |- mesh__dateRevised mesh__D004135 2005-06-30
% 209.04/209.22  |- skos__historyNote mesh__D004135 Nitrobenzenes %28%1974%29%
% 209.04/209.22  |- skos__broader mesh__D004135smesh__D001549
% 209.04/209.22  |- mesh__historyNote mesh__D004135
% 209.04/209.22       91%28%75%29%; was see under BENZAMIDES 1975-90   
% 209.04/209.22  |- skos__prefLabel mesh__D004135 Dinitolmide
% 209.04/209.22  |- mesh__recordAuthorizer mesh__D014563 sjn
% 209.04/209.22  |- skos__broader mesh__D014563smesh__D014553
% 209.04/209.22  |- skos__historyNote mesh__D014563 specific urologic disease
% 209.04/209.22  |- skos__historyNote mesh__D014563 Urination %28%1966-1977%29%
% 209.04/209.22  |- rdf__type mesh__D014563sskos__Concept
% 209.04/209.22  |- skos__historyNote mesh__D014563 specific urinary tract heading
% 209.04/209.22  |- skos__historyNote mesh__D014563 Urologic Diseases %28%1966-1977%29%
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D014563 2005
% 209.04/209.22  |- mesh__historyNote mesh__D014563 78   
% 209.04/209.22  |- mesh__dateEstablished mesh__D014563 1978-01-01
% 209.04/209.22  |- skos__annotation mesh__D014563
% 209.04/209.22       same relation to URINARY TRACT that HEMODYNAMIC PROCESSES is to CARDIOVASCULAR SYSTEM; urine volume: index under URINE probably NIM%A%  
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D014563 2006
% 209.04/209.22  |- mesh__dateRevised mesh__D014563 2004-07-07
% 209.04/209.22  |- mesh__recordMaintainer mesh__D014563 lkt
% 209.04/209.22  |- skos__historyNote mesh__D014563 Urinary Tract %28%1972-1977%29%
% 209.04/209.22  |- skos__hiddenLabel mesh__D014563 Urodynamic
% 209.04/209.22  |- skos__scopeNote mesh__D014563
% 209.04/209.22       The mechanical laws of fluid dynamics as they apply to urine transport.%A%    
% 209.04/209.22  |- skos__prefLabel mesh__D014563 Urodynamics
% 209.04/209.22  |- mesh__dateCreated mesh__D014563 1977-04-22
% 209.04/209.22  |- mesh__recordOriginator mesh__D014563 SMH
% 209.04/209.22  |- mesh__publicMeSHNote mesh__D014563 78   
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D008526 2000
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D008526 1996
% 209.04/209.22  |- skos__hiddenLabel mesh__D008526 Oblongata, Medulla
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D008526 2006
% 209.04/209.22  |- mesh__recordMaintainer mesh__D008526 TAP
% 209.04/209.22  |- skos__broader mesh__D008526smesh__D012249
% 209.04/209.22  |- skos__hiddenLabel mesh__D008526 Oblongatas, Medulla
% 209.04/209.22  |- skos__hiddenLabel mesh__D008526 Myelencephalons
% 209.04/209.22  |- mesh__dateRevised mesh__D008526 1992-05-15
% 209.04/209.22  |- mesh__recordAuthorizer mesh__D008526 PLS
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D008526 2005
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D008526 2004
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D008526 1995
% 209.04/209.22  |- mesh__dateCreated mesh__D008526 1999-01-01
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D008526 2002
% 209.04/209.22  |- skos__altLabel mesh__D008526 Myelencephalon
% 209.04/209.22  |- rdf__type mesh__D008526sskos__Concept
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D008526 1993
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D008526 2003
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D008526 1994
% 209.04/209.22  |- mesh__recordOriginator mesh__D008526 NLM
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D008526 1999
% 209.04/209.22  |- skos__prefLabel mesh__D008526 Medulla Oblongata
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D008526 2001
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D008526 1997
% 209.04/209.22  |- skos__hiddenLabel mesh__D008526 Medulla Oblongatas
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D008526 1998
% 209.04/209.22  |- mesh__recordAuthorizer mesh__D000543 SJN
% 209.04/209.22  |- mesh__dateRevised mesh__D000543 1997-06-20
% 209.04/209.22  |- skos__related mesh__D000543smesh__D003825
% 209.04/209.22  |- mesh__dateCreated mesh__D000543 1999-01-01
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D000543 2006
% 209.04/209.22  |- mesh__recordOriginator mesh__D000543 NLM
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D000543 1999
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D000543 2005
% 209.04/209.22  |- mesh__dateEstablished mesh__D000543 1965-01-01
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D000543 2002
% 209.04/209.22  |- mesh__recordMaintainer mesh__D000543 PXP
% 209.04/209.22  |- skos__scopeNote mesh__D000543
% 209.04/209.22       Conservative contouring of the alveolar process, in preparation for immediate or future denture construction. %28%Dorland, 28th ed%29%%A%    
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D000543 1998
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D000543 2004
% 209.04/209.22  |- skos__prefLabel mesh__D000543 Alveoloplasty
% 209.04/209.22  |- skos__hiddenLabel mesh__D000543 Alveoloplasties
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D000543 2001
% 209.04/209.22  |- mesh__publicMeSHNote mesh__D000543 65   
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D000543 2003
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D000543 2000
% 209.04/209.22  |- rdf__type mesh__D000543sskos__Concept
% 209.04/209.22  |- skos__annotation mesh__D000543
% 209.04/209.22       refers to ALVEOLAR PROCESS %28%see note there%29%; do not confuse with ALVEOLECTOMY; do not use /util except by MeSH definition%A%  
% 209.04/209.22  |- mesh__historyNote mesh__D000543 65   
% 209.04/209.22  |- skos__broader mesh__D000543smesh__D013516
% 209.04/209.22  |- mesh__dateRevised mesh__D018954 2003-07-09
% 209.04/209.22  |- mesh__dateEstablished mesh__D018954 1996-01-01
% 209.04/209.22  |- skos__annotation mesh__D018954
% 209.04/209.22       %22%essential to meet the health needs of a population%22%; IM GEN; for specific drug as essential, coord IM with drug %28%IM%29%%A%  
% 209.04/209.22  |- skos__hiddenLabel mesh__D018954 Essential Drugs
% 209.04/209.22  |- mesh__dateCreated mesh__D018954 1995-02-17
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018954 2005
% 209.04/209.22  |- mesh__recordMaintainer mesh__D018954 ssb
% 209.04/209.22  |- skos__historyNote mesh__D018954 Drugs %28%1978-1995%29%
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018954 2004
% 209.04/209.22  |- mesh__publicMeSHNote mesh__D018954 96   
% 209.04/209.22  |- skos__scopeNote mesh__D018954
% 209.04/209.22       Drugs considered essential to meet the health needs of a population as well as to control drug costs. %28%World Health Organization Action Programme on Essential Drugs, 1994, p3%29%%A%    
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018954 2006
% 209.04/209.22  |- mesh__recordOriginator mesh__D018954 TGC
% 209.04/209.22  |- mesh__recordAuthorizer mesh__D018954 sjn
% 209.04/209.22  |- mesh__historyNote mesh__D018954 96   
% 209.04/209.22  |- rdf__type mesh__D018954sskos__Concept
% 209.04/209.22  |- skos__prefLabel mesh__D018954 Drugs, Essential
% 209.04/209.22  |- skos__broader mesh__D018954smesh__D004364
% 209.04/209.22  |- skos__historyNote mesh__D010971 Quinones %28%1972-1974%29%
% 209.04/209.22  |- mesh__recordMaintainer mesh__D010971 CCR
% 209.04/209.22  |- mesh__recordAuthorizer mesh__D010971 sjn
% 209.04/209.22  |- mesh__dateCreated mesh__D010971 1974-11-19
% 209.04/209.22  |- mesh__historyNote mesh__D010971
% 209.04/209.22       91%28%75%29%; was see under QUINONES 1975-90   
% 209.04/209.22  |- mesh__dateRevised mesh__D010971 2000-06-21
% 209.04/209.22  |- mesh__publicMeSHNote mesh__D010971 91; was see under QUINONES 1975-90   
% 209.04/209.22  |- skos__scopeNote mesh__D010971
% 209.04/209.22       Polyunsaturated side-chain quinone derivative which is an important link in the electron transport chain of green plants during the photosynthetic conversion of light energy by photophosphorylation into the potential energy of chemical bonds.%A%    
% 209.04/209.22  |- skos__historyNote mesh__D010971 Plant Proteins %28%1972-1974%29%
% 209.04/209.22  |- rdf__type mesh__D010971sskos__Concept
% 209.04/209.22  |- skos__broader mesh__D010971smesh__D016227
% 209.04/209.22  |- mesh__dateEstablished mesh__D010971 1991-01-01
% 209.04/209.22  |- skos__hiddenLabel mesh__D010971 Plastoquinone 9
% 209.04/209.22  |- skos__altLabel mesh__D010971 Plastoquinone-9
% 209.04/209.22  |- mesh__recordOriginator mesh__D010971 NLM
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D010971 2005
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D010971 2001
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D010971 2003
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D010971 2006
% 209.04/209.22  |- skos__prefLabel mesh__D010971 Plastoquinone
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D010971 2002
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D010971 2004
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018156 2006
% 209.04/209.22  |- mesh__recordMaintainer mesh__D018156 JLS
% 209.04/209.22  |- skos__historyNote mesh__D018156 Publishing %28%1966-1993%29%
% 209.04/209.22  |- mesh__dateEstablished mesh__D018156 1994-01-01
% 209.04/209.22  |- mesh__publicMeSHNote mesh__D018156 98; see JOURNALISM 1994-97   
% 209.04/209.22  |- mesh__dateCreated mesh__D018156 1993-06-02
% 209.04/209.22  |- mesh__recordAuthorizer mesh__D018156 SJN
% 209.04/209.22  |- rdf__type mesh__D018156sskos__Concept
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018156 1999
% 209.04/209.22  |- mesh__recordOriginator mesh__D018156 TGC
% 209.04/209.22  |- skos__broader mesh__D018156smesh__D020452
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018156 2003
% 209.04/209.22  |- mesh__historyNote mesh__D018156 98   
% 209.04/209.22  |- skos__scopeNote mesh__D018156
% 209.04/209.22       The collection, writing, and editing of current interest material on topics related to biomedicine for presentation through the mass media, including newspapers, magazines, radio, or television, usually for a public audience such as health care consumers.%A%    
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018156 2000
% 209.04/209.22  |- skos__prefLabel mesh__D018156 Journalism, Medical
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018156 2004
% 209.04/209.22  |- skos__historyNote mesh__D018156 Periodicals %28%1966-1993%29%
% 209.04/209.22  |- mesh__dateRevised mesh__D018156 1998-06-10
% 209.04/209.22  |- skos__annotation mesh__D018156
% 209.04/209.22       IM; JOURNALISM, DENTAL is also available   
% 209.04/209.22  |- skos__altLabel mesh__D018156 Medical Journalism
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018156 2001
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018156 2005
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D018156 2002
% 209.04/209.22  |- mesh__dateRevised mesh__D010173 2001-07-25
% 209.04/209.22  |- mesh__recordMaintainer mesh__D010173 mdb
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D010173 2003
% 209.04/209.22  |- mesh__dateCreated mesh__D010173 1999-01-01
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D010173 2005
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D010173 2004
% 209.04/209.22  |- mesh__recordAuthorizer mesh__D010173 sjn
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D010173 2006
% 209.04/209.22  |- mesh__recordOriginator mesh__D010173 NLM
% 209.04/209.22  |- skos__hiddenLabel mesh__D010173 Palpations
% 209.04/209.22  |- skos__scopeNote mesh__D010173
% 209.04/209.22       Application of fingers with light pressure to the surface of the body to determine consistence of parts beneath in physical diagnosis; includes palpation for determining the outlines of organs.%A%    
% 209.04/209.22  |- rdf__type mesh__D010173sskos__Concept
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D010173 2002
% 209.04/209.22  |- skos__prefLabel mesh__D010173 Palpation
% 209.04/209.22  |- skos__broader mesh__D010173smesh__D010808
% 209.04/209.22  |- skos__annotation mesh__D010173
% 209.04/209.22       do not confuse with %22%palpitation%22% %28% = HEART RATE; ARRHYTHMIA or specific arrhythmia%29%%A%  
% 209.04/209.22  |- mesh__recordMaintainer mesh__D004934 lkt
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D004934 2006
% 209.04/209.22  |- mesh__recordOriginator mesh__D004934 NLM
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D004934 2005
% 209.04/209.22  |- mesh__recordAuthorizer mesh__D004934 sjn
% 209.04/209.22  |- rdf__type mesh__D004934sskos__Concept
% 209.04/209.22  |- skos__scopeNote mesh__D004934
% 209.04/209.22       Any fluid-filled closed cavity or sac %28%CYSTS%29% that is lined by an EPITHELIUM and found in the ESOPHAGUS region.%A%    
% 209.04/209.22  |- skos__broader mesh__D004934smesh__D003560
% 209.04/209.22  |- skos__annotation mesh__D004934 non-neoplastic   
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D004934 2004
% 209.04/209.22  |- mesh__dateCreated mesh__D004934 1999-01-01
% 209.04/209.22  |- skos__prefLabel mesh__D004934 Esophageal Cyst
% 209.04/209.22  |- skos__hiddenLabel mesh__D004934 Esophageal Cysts
% 209.04/209.22  |- mesh__dateRevised mesh__D004934 2003-07-09
% 209.04/209.22  |- skos__hiddenLabel mesh__D004934 Cysts, Esophageal
% 209.04/209.22  |- skos__hiddenLabel mesh__D004934 Cyst, Esophageal
% 209.04/209.22  |- skos__broader mesh__D004934smesh__D004935
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D004136 2005
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D004136 1995
% 209.04/209.22  |- mesh__dateCreated mesh__D004136 1976-04-13
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D004136 2006
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D004136 2003
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D004136 1993
% 209.04/209.22  |- mesh__recordMaintainer mesh__D004136 TGC
% 209.04/209.22  |- skos__prefLabel mesh__D004136 Dinitrobenzenes
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D004136 1998
% 209.04/209.22  |- mesh__recordOriginator mesh__D004136 RLS
% 209.04/209.22  |- skos__annotation mesh__D004136
% 209.04/209.22       includes ortho-, meta- %26% para-dinitrobenzenes   
% 209.04/209.22  |- mesh__historyNote mesh__D004136
% 209.04/209.22       91%28%77%29%; was see under NITROBENZENES 1977-90   
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D004136 2004
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D004136 1999
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D004136 1996
% 209.04/209.22  |- skos__broader mesh__D004136smesh__D009578
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D004136 2000
% 209.04/209.22  |- skos__scopeNote mesh__D004136
% 209.04/209.22       Benzene derivatives which are substituted with two nitro groups in the ortho, meta or para positions.%A%    
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D004136 1997
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D004136 2001
% 209.04/209.22  |- mesh__dateRevised mesh__D004136 1992-05-13
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D004136 2002
% 209.04/209.22  |- mesh__publicMeSHNote mesh__D004136
% 209.04/209.22       91; was see under NITROBENZENES 1977-90   
% 209.04/209.22  |- mesh__recordAuthorizer mesh__D004136 PLS
% 209.04/209.22  |- skos__hiddenLabel mesh__D004136 Compounds, Dinitrophenyl
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D004136 1994
% 209.04/209.22  |- skos__historyNote mesh__D004136 Nitrobenzenes %28%1966-1976%29%
% 209.04/209.22  |- skos__historyNote mesh__D004136 Dinitrophenols %28%1966-1976%29%
% 209.04/209.22  |- mesh__dateEstablished mesh__D004136 1991-01-01
% 209.04/209.22  |- rdf__type mesh__D004136sskos__Concept
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D014564 2006
% 209.04/209.22  |- skos__broader mesh__D014564smesh__D016146
% 209.04/209.22  |- mesh__historyNote mesh__D014564 98; use explode 1972-97   
% 209.04/209.22  |- skos__annotation mesh__D014564
% 209.04/209.22       general or unspecified; prefer specifics or specific parts of urogenital system /abnorm; DF: UROGENITAL ABNORM%A%  
% 209.04/209.22  |- mesh__dateEstablished mesh__D014564 1998-01-01
% 209.04/209.22  |- skos__scopeNote mesh__D014564
% 209.04/209.22       Congenital structural abnormalities of the UROGENITAL SYSTEM in either the male or the female.%A%    
% 209.04/209.22  |- skos__hiddenLabel mesh__D014564 Urogenital Abnormality
% 209.04/209.22  |- skos__hiddenLabel mesh__D014564 Abnormality, Urogenital
% 209.04/209.22  |- mesh__dateCreated mesh__D014564 1999-01-01
% 209.04/209.22  |- skos__hiddenLabel mesh__D014564 Genitourinary Abnormality
% 209.04/209.22  |- skos__hiddenLabel mesh__D014564 Abnormality, Genitourinary
% 209.04/209.22  |- skos__altLabel mesh__D014564 Abnormalities, Urogenital
% 209.04/209.22  |- mesh__recordAuthorizer mesh__D014564 sjn
% 209.04/209.22  |- skos__broader mesh__D014564smesh__D000013
% 209.04/209.22  |- skos__historyNote mesh__D014564
% 209.04/209.22       Urogenital System/abnormalities %28%1966-1997%29%
% 209.04/209.22  |- skos__prefLabel mesh__D014564 Urogenital Abnormalities
% 209.04/209.22  |- rdf__type mesh__D014564sskos__Concept
% 209.04/209.22  |- skos__hiddenLabel mesh__D014564 Abnormalities, Genitourinary
% 209.04/209.22  |- skos__altLabel mesh__D014564 Genitourinary Abnormalities
% 209.04/209.22  |- mesh__recordMaintainer mesh__D014564 lkt
% 209.04/209.22  |- mesh__publicMeSHNote mesh__D014564 98   
% 209.04/209.22  |- mesh__recordOriginator mesh__D014564 NLM
% 209.04/209.22  |- mesh__dateRevised mesh__D014564 2005-06-30
% 209.04/209.22  |- mesh__dateCreated mesh__D008527 1999-01-01
% 209.04/209.22  |- skos__hiddenLabel mesh__D008527 Childhood Medulloblastomas
% 209.04/209.22  |- skos__altLabel mesh__D008527
% 209.04/209.22       Sarcoma, Cerebellar, Circumscribed Arachnoidal
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D008527 2000
% 209.04/209.22  |- mesh__recordOriginator mesh__D008527 NLM
% 209.04/209.22  |- skos__annotation mesh__D008527
% 209.04/209.22       coord IM with CEREBELLAR NEOPLASMS %28%IM%29%   
% 209.04/209.22  |- skos__hiddenLabel mesh__D008527 Medullomyoblastomas
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D008527 2006
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D008527 2003
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D008527 2001
% 209.04/209.22  |- skos__altLabel mesh__D008527 Medulloblastoma, Desmoplastic
% 209.04/209.22  |- skos__scopeNote mesh__D008527
% 209.04/209.22       A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood %28%see NEUROECTODERMAL TUMOR, PRIMITIVE%29%. The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. %28%From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1%29%%A%    
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D008527 2004
% 209.04/209.22  |- skos__prefLabel mesh__D008527 Medulloblastoma
% 209.04/209.22  |- skos__hiddenLabel mesh__D008527 Adult Medulloblastoma
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D008527 2002
% 209.04/209.22  |- skos__hiddenLabel mesh__D008527 Medulloblastomas, Childhood
% 209.04/209.22  |- skos__broader mesh__D008527smesh__D005910
% 209.04/209.22  |- skos__hiddenLabel mesh__D008527 Desmoplastic Medulloblastomas
% 209.04/209.22  |- skos__hiddenLabel mesh__D008527 Medulloblastomas
% 209.04/209.22  |- skos__hiddenLabel mesh__D008527 Desmoplastic Medulloblastoma
% 209.04/209.22  |- rdf__type mesh__D008527sskos__Concept
% 209.04/209.22  |- skos__hiddenLabel mesh__D008527 Medulloblastoma, Melanocytic
% 209.04/209.22  |- skos__hiddenLabel mesh__D008527 Medulloblastomas, Melanocytic
% 209.04/209.22  |- skos__broader mesh__D008527smesh__D018242
% 209.04/209.22  |- mesh__recordMaintainer mesh__D008527 KEV
% 209.04/209.22  |- skos__hiddenLabel mesh__D008527 Childhood Medulloblastoma
% 209.04/209.22  |- skos__hiddenLabel mesh__D008527 Melanocytic Medulloblastomas
% 209.04/209.22  |- skos__hiddenLabel mesh__D008527 Medulloblastomas, Adult
% 209.04/209.22  |- skos__hiddenLabel mesh__D008527 Medulloblastomas, Desmoplastic
% 209.04/209.22  |- skos__hiddenLabel mesh__D008527 Adult Medulloblastomas
% 209.04/209.22  |- mesh__dateRevised mesh__D008527 1999-11-03
% 209.04/209.22  |- mesh__recordAuthorizer mesh__D008527 sjn
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D008527 2005
% 209.04/209.22  |- skos__altLabel mesh__D000544 Senile Dementia, Alzheimer Type
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D000544 2006A
% 209.04/209.22  |- skos__hiddenLabel mesh__D000544 Dementias, Presenile
% 209.04/209.22  |- skos__altLabel mesh__D000544 Dementia, Alzheimer Type
% 209.04/209.22  |- mesh__dateRevised mesh__D000544 2005-07-29
% 209.04/209.22  |- skos__related mesh__D000544smesh__D016900
% 209.04/209.22  |- mesh__recordAuthorizer mesh__D000544 jls
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D000544 2006
% 209.04/209.22  |- skos__altLabel mesh__D000544 Presenile Alzheimer Dementia
% 209.04/209.22  |- skos__related mesh__D000544smesh__D016229
% 209.04/209.22  |- skos__hiddenLabel mesh__D000544 Disease, Alzheimer%27%s
% 209.04/209.22  |- skos__broader mesh__D000544smesh__D024801
% 209.04/209.22  |- skos__related mesh__D000544smesh__D016875
% 209.04/209.22  |- mesh__recordMaintainer mesh__D000544 jls
% 209.04/209.22  |- rdf__type mesh__D000544sskos__Concept
% 209.04/209.22  |- skos__altLabel mesh__D000544 Late Onset Alzheimer Disease
% 209.04/209.22  |- skos__related mesh__D000544smesh__D018888
% 209.04/209.22  |- skos__altLabel mesh__D000544 Focal Onset Alzheimer%27%s Disease
% 209.04/209.22  |- skos__prefLabel mesh__D000544 Alzheimer Disease
% 209.04/209.22  |- skos__altLabel mesh__D000544 Early Onset Alzheimer Disease
% 209.04/209.22  |- mesh__dateCreated mesh__D000544 1999-01-01
% 209.04/209.22  |- mesh__activeMeSHYear mesh__D000544 2005
% 209.04/209.22  |- skos__altLabel mesh__D000544 Dementia, Primary Senile Degenerative
% 209.04/209.22  |- mesh__historyNote mesh__D000544
% 209.04/209.22       1998%28%1963%29%; for DEMENTIA, PRESENILE and DEMENTIA, PRIMARY DEGENERATIVE SENILE use DEMENTIA 1981-1999; for DEMENTIA SENILE use DEMENTIA 1966-1999%A%  
% 209.04/209.22  |- skos__hiddenLabel mesh__D000544 Alzheimer Dementia, Presenile
% 209.04/209.22  |- skos__related mesh__D000544smesh__D016657
% 209.04/209.22  |- skos__hiddenLabel mesh__D000544 Dementia, Presenile Alzheimer
% 209.04/209.22  |- mesh__publicMeSHNote mesh__D000544
% 209.04/209.22       1998; see ALZHEIMER%27%S DISEASE 1984-1997, see DEMENTIA, PRESENILE 1967-1983, see PSYCHOSES, PRESENILE 1963-1966; for DEMENTIA PRESENILE and DEMENTIA, PRIMARY DEGENERATIVE, SENILE see DEMENTIA 1981-1999; for DEMENTIA, SENILE see DEMENTIA 1966-1999%A%  
% 209.04/209.22  |- skos__hiddenLabel mesh__D000544 Senile Dementias
% 209.04/209.22  |- skos__scopeNote mesh__D000544
% 209.04/209.22       A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. %28%From Adams et al., Principles of Neurology, 6th ed, pp1049-57%29%%A%    
% 209.04/209.22  |- skos__related mesh__D000544smesh__D016564
% 209.04/209.22  |- skos__altLabel mesh__D000544 Dementia, Senile
% 209.04/209.22  |- skos__broader mesh__D000544smesh__D003704
% 209.04/209.22  |- skos__related mesh__D000544smesh__D020232
% 209.04/209.22  |- skos__hiddenLabel mesh__D000544 Senile Dementia
% 209.04/209.22  |- skos__hiddenLabel mesh__D000544 Presenile Dementia
% 209.04/209.22  |- skos__hiddenLabel mesh__D000544 Dementias, Senile
% 209.04/209.22  |- skos__hiddenLabel mesh__D000544 Presenile Dementias
% 209.04/209.22  |- skos__altLabel mesh__D000544 Alzheimer%27%s Disease
% 209.04/209.22  |- skos__hiddenLabel mesh__D000544 Disease, Alzheimer
% 209.04/209.22  |- skos__altLabel mesh__D000544 Senile Dementia, Acute Confusional
% 209.04/209.22  |- skos__altLabel mesh__D000544 Primary Senile Degenerative Dementia
% 209.04/209.22  |- skos__hiddenLabel mesh__D000544 Alzheimer Type Dementia
% 209.04/209.22  |- skos__altLabel mesh__D000544 Alzheimer Type Senile Dementia
% 209.04/209.22  |- mesh__dateEstablished mesh__D000544 1984-01-01
% 209.04/209.22  |- mesh__recordOriginator mesh__D000544 NLM
% 209.04/209.22  |- skos__altLabel mesh__D018955 OKM5 Antigen
% 209.04/209.22  |- skos__altLabel mesh__D018955 Platelet Glycoprotein IIIb
% 209.04/209.22  |- skos__altLabel mesh__D018955 SR-BI Receptor
% 209.04/209.22  |- mesh__recordAuthorizer mesh__D018955 sjn
% 209.04/209.22  |- skos__hiddenLabel mesh__D018955 Antigen, OKM5
% 209.04/209.22  |- skos__altLabel mesh__D018955
% 209.04/209.22       FAT %28%Fatty Acid Translocase%29% - CD36 Antigen
% 209.04/209.22  |- skos__hiddenLabel mesh__D018955 Glycoprotein IIIb, Platelet
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D018955 2006
% 209.04/209.23  |- skos__broader mesh__D018955smesh__D015703
% 209.04/209.23  |- skos__altLabel mesh__D018955 Scavenger Receptors, Class B, Type I
% 209.04/209.23  |- skos__altLabel mesh__D018955 CD36 Antigens
% 209.04/209.23  |- skos__prefLabel mesh__D018955 Antigens, CD36
% 209.04/209.23  |- skos__hiddenLabel mesh__D018955 Platelet Glycoprotein, GPIV
% 209.04/209.23  |- skos__altLabel mesh__D018955 CD36 Antigen
% 209.04/209.23  |- skos__hiddenLabel mesh__D018955 Receptor, Thrombospondin
% 209.04/209.23  |- skos__altLabel mesh__D018955 Thrombospondin Receptors
% 209.04/209.23  |- mesh__recordOriginator mesh__D018955 AGS
% 209.04/209.23  |- skos__altLabel mesh__D018955 SR-BI Protein
% 209.04/209.23  |- mesh__dateRevised mesh__D018955 2005-06-30
% 209.04/209.23  |- skos__altLabel mesh__D018955 GPIIIb Platelet Glycoprotein
% 209.04/209.23  |- skos__hiddenLabel mesh__D018955 Platelet Glycoprotein, GPIIIb
% 209.04/209.23  |- rdf__type mesh__D018955sskos__Concept
% 209.04/209.23  |- skos__altLabel mesh__D018955 CD36 Protein
% 209.04/209.23  |- mesh__recordMaintainer mesh__D018955 jmp
% 209.04/209.23  |- skos__altLabel mesh__D018955 Platelet Membrane Glycoprotein IIIb
% 209.04/209.23  |- skos__hiddenLabel mesh__D018955 Glycoprotein IV, Platelet
% 209.04/209.23  |- skos__altLabel mesh__D018955 Platelet Membrane Glycoprotein IV
% 209.04/209.23  |- skos__scopeNote mesh__D018955
% 209.04/209.23       Leukocyte differentiation antigens and major platelet membrane glycoproteins present on MONOCYTES; ENDOTHELIAL CELLS; PLATELETS; and mammary EPITHELIAL CELLS. They play major roles in CELL ADHESION; SIGNAL TRANSDUCTION; and regulation of angiogenesis. CD36 is a receptor for THROMBOSPONDINS and can act as a scavenger receptor that recognizes and transports oxidized LIPOPROTEINS and FATTY ACIDS.%A%    
% 209.04/209.23  |- mesh__dateCreated mesh__D018955 1995-05-26
% 209.04/209.23  |- mesh__historyNote mesh__D018955 1996   
% 209.04/209.23  |- skos__broader mesh__D018955smesh__D050612
% 209.04/209.23  |- skos__altLabel mesh__D018955 Thrombospondin Receptor
% 209.04/209.23  |- skos__altLabel mesh__D018955 Adipocyte Membrane Protein p88
% 209.04/209.23  |- skos__altLabel mesh__D018955 GPIV Platelet Glycoprotein
% 209.04/209.23  |- mesh__dateEstablished mesh__D018955 1996-01-01
% 209.04/209.23  |- skos__altLabel mesh__D018955 Platelet Glycoprotein IV
% 209.04/209.23  |- skos__broader mesh__D018955smesh__D011956
% 209.04/209.23  |- skos__hiddenLabel mesh__D018955 Antigen, CD36
% 209.04/209.23  |- skos__altLabel mesh__D018955
% 209.04/209.23       CD36 Antigen %28%Collagen Type I Receptor, Thrombospondin Receptor%29%
% 209.04/209.23  |- skos__altLabel mesh__D018955 Receptors, Thrombospondin
% 209.04/209.23  |- skos__broader mesh__D018955smesh__D051122
% 209.04/209.23  |- skos__altLabel mesh__D018955 CD36 Fatty Acid Transporter
% 209.04/209.23  |- mesh__publicMeSHNote mesh__D018955
% 209.04/209.23       1996; CD36 ANTIGEN was indexed under ANTIGENS, CD 1990-1995 %26% ANTIGENS, DIFFERENTIATION 1989-1991; CD36 ANTIGEN %28%COLLAGEN TYPE I RECEPTOR, THROMBSPONDIN RECEPTOR%29% was indexed under ANTIGENS, CD36 2004; ORGANIC ANION TRANSPORTERS 1996-2004 %26% under MEMBRANE GLYCOPROTEINS 1996-2004; SCAVENGER RECEPTORS, CLASS B, TYPE I was indexed under RECEPTORS, IMMUNOLOGIC 2005%A%  
% 209.04/209.23  |- skos__broader mesh__D018955smesh__D010980
% 209.04/209.23  |- skos__broader mesh__D010972smesh__D001779
% 209.04/209.23  |- skos__scopeNote mesh__D010972
% 209.04/209.23       A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION.%A%    
% 209.04/209.23  |- rdf__type mesh__D010972sskos__Concept
% 209.04/209.23  |- skos__hiddenLabel mesh__D010972 Factor, Platelet Activating
% 209.04/209.23  |- skos__altLabel mesh__D010972 1-Alkyl-2-acetyl-sn-glycerophosphocholine
% 209.04/209.23  |- mesh__recordAuthorizer mesh__D010972 sjn
% 209.04/209.23  |- mesh__historyNote mesh__D010972 1983%28%1979%29%   
% 209.04/209.23  |- skos__prefLabel mesh__D010972 Platelet Activating Factor
% 209.04/209.23  |- skos__altLabel mesh__D010972 Platelet-Activating Substance
% 209.04/209.23  |- skos__altLabel mesh__D010972 Thrombocyte Aggregating Activity
% 209.04/209.23  |- skos__broader mesh__D010972smesh__D002794
% 209.04/209.23  |- skos__hiddenLabel mesh__D010972
% 209.04/209.23       1 Alkyl 2 acetyl sn glycerophosphocholine
% 209.04/209.23  |- mesh__recordOriginator mesh__D010972 RLS
% 209.04/209.23  |- skos__altLabel mesh__D010972 Platelet Aggregating Factor
% 209.04/209.23  |- mesh__dateCreated mesh__D010972 1982-05-11
% 209.04/209.23  |- skos__hiddenLabel mesh__D010972 PAF Acether
% 209.04/209.23  |- mesh__recordMaintainer mesh__D010972 jmp
% 209.04/209.23  |- mesh__dateRevised mesh__D010972 2005-06-30
% 209.04/209.23  |- skos__hiddenLabel mesh__D010972 Aggregating Factor, Platelet
% 209.04/209.23  |- skos__altLabel mesh__D010972 Phosphorylcholine, Acetyl Glyceryl Ether
% 209.04/209.23  |- skos__altLabel mesh__D010972 PAF-Acether
% 209.04/209.23  |- skos__broader mesh__D010972smesh__D010742
% 209.04/209.23  |- mesh__publicMeSHNote mesh__D010972
% 209.04/209.23       1983; PLATELET AGGREGATING FACTOR was indexed under PLATLET ACTIVATING FACTOR 2002-2005 %26% BLOOD COAGULATION FACTORS 1979-2001%A%  
% 209.04/209.23  |- skos__altLabel mesh__D010972 Acetyl Glyceryl Ether Phosphorylcholine
% 209.04/209.23  |- skos__altLabel mesh__D010972 AGEPC
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D010972 2006
% 209.04/209.23  |- skos__broader mesh__D010972smesh__D012898
% 209.04/209.23  |- skos__altLabel mesh__D010972 Platelet Aggregation Enhancing Factor
% 209.04/209.23  |- mesh__dateEstablished mesh__D010972 1983-01-01
% 209.04/209.23  |- skos__hiddenLabel mesh__D010972 Platelet Activating Substance
% 209.04/209.23  |- skos__historyNote mesh__D010972
% 209.04/209.23       Lysophosphatidylcholines %28%1966-1980%29%
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D018157 1999
% 209.04/209.23  |- skos__hiddenLabel mesh__D018157 Parapoxviruses
% 209.04/209.23  |- skos__broader mesh__D018157smesh__D018147
% 209.04/209.23  |- rdf__type mesh__D018157sskos__Concept
% 209.04/209.23  |- mesh__dateCreated mesh__D018157 1993-06-30
% 209.04/209.23  |- skos__scopeNote mesh__D018157
% 209.04/209.23       A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, which infect ungulates and may infect humans. ORF VIRUS is the type species.%A%    
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D018157 2002
% 209.04/209.23  |- skos__annotation mesh__D018157
% 209.04/209.23       a genus of the family Poxviridae; infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29%%A%  
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D018157 1995
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D018157 2003
% 209.04/209.23  |- skos__prefLabel mesh__D018157 Parapoxvirus
% 209.04/209.23  |- mesh__dateEstablished mesh__D018157 1994-01-01
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D018157 2004
% 209.04/209.23  |- mesh__publicMeSHNote mesh__D018157 94   
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D018157 1996
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D018157 2005
% 209.04/209.23  |- mesh__historyNote mesh__D018157 94   
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D018157 1997
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D018157 2006
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D018157 2000
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D018157 1998
% 209.04/209.23  |- skos__historyNote mesh__D018157 Poxviridae %28%1978-1993%29%
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D018157 2001
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D018157 1994
% 209.04/209.23  |- skos__altLabel mesh__D010174 Booklets
% 209.04/209.23  |- rdf__type mesh__D010174sskos__Concept
% 209.04/209.23  |- mesh__dateRevised mesh__D010174 1993-06-03
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D010174 2001
% 209.04/209.23  |- skos__scopeNote mesh__D010174
% 209.04/209.23       Printed publications usually having a format with no binding and no cover and having fewer than some set number of pages. They are often devoted to a single subject.%A%    
% 209.04/209.23  |- skos__hiddenLabel mesh__D010174 Booklet
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D010174 2004
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D010174 1997
% 209.04/209.23  |- skos__prefLabel mesh__D010174 Pamphlets
% 209.04/209.23  |- skos__hiddenLabel mesh__D010174 Brochure
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D010174 2000
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D010174 2003
% 209.04/209.23  |- mesh__dateCreated mesh__D010174 1999-01-01
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D010174 1996
% 209.04/209.23  |- skos__hiddenLabel mesh__D010174 Pamphlet
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D010174 2006
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D010174 1999
% 209.04/209.23  |- mesh__recordMaintainer mesh__D010174 PLS
% 209.04/209.23  |- mesh__recordAuthorizer mesh__D010174 PLS
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D010174 2002
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D010174 1995
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D010174 2005
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D010174 1998
% 209.04/209.23  |- skos__broader mesh__D010174smesh__D011642
% 209.04/209.23  |- skos__altLabel mesh__D010174 Brochures
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D010174 1994
% 209.04/209.23  |- mesh__recordOriginator mesh__D010174 NLM
% 209.04/209.23  |- rdf__type mesh__D004935sskos__Concept
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D004935 2004
% 209.04/209.23  |- mesh__dateCreated mesh__D004935 1999-01-01
% 209.04/209.23  |- mesh__recordMaintainer mesh__D004935 lkt
% 209.04/209.23  |- skos__related mesh__D004935smesh__D004933
% 209.04/209.23  |- skos__scopeNote mesh__D004935
% 209.04/209.23       Pathological processes in the ESOPHAGUS.     
% 209.04/209.23  |- skos__prefLabel mesh__D004935 Esophageal Diseases
% 209.04/209.23  |- mesh__recordOriginator mesh__D004935 NLM
% 209.04/209.23  |- skos__annotation mesh__D004935
% 209.04/209.23       inflamm dis = ESOPHAGITIS; hemorrhage: coord IM with HEMORRHAGE, GASTROINTESTINAL %28%IM%29%; motility disord = ESOPHAGEAL MOTILITY DISORDERS or specific; esophageal varix or varices = ESOPHAGEAL AND GASTRIC VARICES %26% see note there%A%  
% 209.04/209.23  |- skos__broader mesh__D004935smesh__D005767
% 209.04/209.23  |- skos__hiddenLabel mesh__D004935 Diseases, Esophageal
% 209.04/209.23  |- skos__hiddenLabel mesh__D004935 Disease, Esophageal
% 209.04/209.23  |- mesh__recordAuthorizer mesh__D004935 sjn
% 209.04/209.23  |- mesh__dateRevised mesh__D004935 2003-07-09
% 209.04/209.23  |- skos__hiddenLabel mesh__D004935 Esophageal Disease
% 209.04/209.23  |- mesh__dateEstablished mesh__D004935 1966-01-01
% 209.04/209.23  |- mesh__publicMeSHNote mesh__D004935 66   
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D004935 2006
% 209.04/209.23  |- mesh__historyNote mesh__D004935 66   
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D004935 2005
% 209.04/209.23  |- skos__altLabel mesh__D004137 Chlorodinitrobenzene
% 209.04/209.23  |- skos__broader mesh__D004137smesh__D009578
% 209.04/209.23  |- skos__broader mesh__D004137smesh__D004136
% 209.04/209.23  |- mesh__dateRevised mesh__D004137 2005-06-30
% 209.04/209.23  |- skos__broader mesh__D004137smesh__D002722
% 209.04/209.23  |- skos__prefLabel mesh__D004137 Dinitrochlorobenzene
% 209.04/209.23  |- skos__annotation mesh__D004137 D25-26 qualif; DF: note short X ref   
% 209.04/209.23  |- mesh__dateEstablished mesh__D004137 1987-01-01
% 209.04/209.23  |- skos__historyNote mesh__D004137 Chlorine %28%1971-1974%29%
% 209.04/209.23  |- mesh__historyNote mesh__D004137
% 209.04/209.23       87%28%75%29%; was see under NITROBENZENES 1975-86   
% 209.04/209.23  |- mesh__dateCreated mesh__D004137 1974-11-11
% 209.04/209.23  |- rdf__type mesh__D004137sskos__Concept
% 209.04/209.23  |- skos__altLabel mesh__D004137 DNCB
% 209.04/209.23  |- mesh__publicMeSHNote mesh__D004137
% 209.04/209.23       87; was see under NITROBENZENES 1975-86   
% 209.04/209.23  |- mesh__recordOriginator mesh__D004137 NLM
% 209.04/209.23  |- mesh__recordMaintainer mesh__D004137 ssb
% 209.04/209.23  |- skos__broader mesh__D004137smesh__D006241
% 209.04/209.23  |- skos__hiddenLabel mesh__D004137 1 Chloro 2,4 Dinitrobenzene
% 209.04/209.23  |- skos__altLabel mesh__D004137 1-Chloro-2,4-Dinitrobenzene
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D004137 2006
% 209.04/209.23  |- skos__historyNote mesh__D004137 Nitrobenzenes %28%1971-1974%29%
% 209.04/209.23  |- skos__scopeNote mesh__D004137
% 209.04/209.23       A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds.%A%    
% 209.04/209.23  |- mesh__recordAuthorizer mesh__D004137 sjn
% 209.04/209.23  |- mesh__recordMaintainer mesh__D009620 TGC
% 209.04/209.23  |- skos__scopeNote mesh__D009620
% 209.04/209.23       The inferior %28%caudal%29% ganglion of the vagus %28%10th cranial%29% nerve. The unipolar nodose ganglion cells are sensory cells with central projections to the medulla and peripheral processes traveling in various branches of the vagus nerve.%A%    
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D009620 2002
% 209.04/209.23  |- skos__hiddenLabel mesh__D009620 Ganglion, Nodose
% 209.04/209.23  |- skos__altLabel mesh__D009620 Nodose Ganglia
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D009620 1999
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D009620 1996
% 209.04/209.23  |- skos__annotation mesh__D009620
% 209.04/209.23       a ganglion of the vagus %28%10th cranial%29% nerve; neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 209.04/209.23  |- mesh__recordAuthorizer mesh__D009620 PLS
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D009620 2000
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D009620 2005
% 209.04/209.23  |- skos__broader mesh__D009620smesh__D017950
% 209.04/209.23  |- skos__prefLabel mesh__D009620 Nodose Ganglion
% 209.04/209.23  |- mesh__dateCreated mesh__D009620 1999-01-01
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D009620 1997
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D009620 2006
% 209.04/209.23  |- skos__hiddenLabel mesh__D009620 Ganglia, Nodose
% 209.04/209.23  |- mesh__historyNote mesh__D009620
% 209.04/209.23       91%28%75%29%; was see under VAGUS NERVE 1975-90   
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D009620 2001
% 209.04/209.23  |- mesh__dateRevised mesh__D009620 1994-06-03
% 209.04/209.23  |- mesh__onlineNote mesh__D009620 search VAGUS NERVE 1966-74   
% 209.04/209.23  |- skos__broader mesh__D009620smesh__D014630
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D009620 2003
% 209.04/209.23  |- rdf__type mesh__D009620sskos__Concept
% 209.04/209.23  |- mesh__dateEstablished mesh__D009620 1991-01-01
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D009620 1995
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D009620 2004
% 209.04/209.23  |- mesh__publicMeSHNote mesh__D009620
% 209.04/209.23       91; was see under VAGUS NERVE 1975-90   
% 209.04/209.23  |- mesh__recordOriginator mesh__D009620 NLM
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D009620 1998
% 209.04/209.23  |- mesh__recordMaintainer mesh__D014565 lkt
% 209.04/209.23  |- skos__hiddenLabel mesh__D014565 Cancer, Genito-urinary
% 209.04/209.23  |- skos__hiddenLabel mesh__D014565 Neoplasm, Genito-urinary
% 209.04/209.23  |- skos__hiddenLabel mesh__D014565 Cancers, Urogenital
% 209.04/209.23  |- mesh__recordOriginator mesh__D014565 NLM
% 209.04/209.23  |- skos__hiddenLabel mesh__D014565 Genitourinary Neoplasm
% 209.04/209.23  |- mesh__dateRevised mesh__D014565 2005-06-30
% 209.04/209.23  |- skos__hiddenLabel mesh__D014565 Neoplasm, Genitourinary
% 209.04/209.23  |- mesh__dateCreated mesh__D014565 1999-01-01
% 209.04/209.23  |- skos__altLabel mesh__D014565 Genitourinary Neoplasms
% 209.04/209.23  |- skos__hiddenLabel mesh__D014565 Cancers, Genitourinary
% 209.04/209.23  |- skos__annotation mesh__D014565
% 209.04/209.23       general or unspecified; prefer specifics; coordinate IM with histological type of neoplasm %28%IM%29%%A%  
% 209.04/209.23  |- skos__scopeNote mesh__D014565
% 209.04/209.23       Tumors or cancer of the UROGENITAL SYSTEM in either the male or the female.%A%    
% 209.04/209.23  |- skos__altLabel mesh__D014565 Genito-urinary Cancer
% 209.04/209.23  |- skos__hiddenLabel mesh__D014565 Neoplasm, Urogenital
% 209.04/209.23  |- skos__altLabel mesh__D014565 Urogenital Cancer
% 209.04/209.23  |- skos__altLabel mesh__D014565 Neoplasms, Urogenital
% 209.04/209.23  |- skos__altLabel mesh__D014565 Neoplasms, Genitourinary
% 209.04/209.23  |- skos__altLabel mesh__D014565 Genito-urinary Neoplasm
% 209.04/209.23  |- skos__hiddenLabel mesh__D014565 Genito urinary Cancer
% 209.04/209.23  |- skos__broader mesh__D014565smesh__D009371
% 209.04/209.23  |- rdf__type mesh__D014565sskos__Concept
% 209.04/209.23  |- skos__hiddenLabel mesh__D014565 Cancer, Urogenital
% 209.04/209.23  |- skos__hiddenLabel mesh__D014565 Cancers, Genito-urinary
% 209.04/209.23  |- skos__hiddenLabel mesh__D014565 Cancer, Genitourinary
% 209.04/209.23  |- skos__hiddenLabel mesh__D014565 Neoplasms, Genito-urinary
% 209.04/209.23  |- skos__hiddenLabel mesh__D014565 Urogenital Cancers
% 209.04/209.23  |- skos__hiddenLabel mesh__D014565 Genito-urinary Neoplasms
% 209.04/209.23  |- mesh__recordAuthorizer mesh__D014565 sjn
% 209.04/209.23  |- skos__hiddenLabel mesh__D014565 Genitourinary Cancers
% 209.04/209.23  |- skos__hiddenLabel mesh__D014565 Urogenital Neoplasm
% 209.04/209.23  |- skos__hiddenLabel mesh__D014565 Genito-urinary Cancers
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D014565 2006
% 209.04/209.23  |- skos__broader mesh__D014565smesh__D016146
% 209.04/209.23  |- skos__prefLabel mesh__D014565 Urogenital Neoplasms
% 209.04/209.23  |- skos__hiddenLabel mesh__D008528 NuMefenamic
% 209.04/209.23  |- skos__hiddenLabel mesh__D008528 Nu Mefenamic
% 209.04/209.23  |- skos__hiddenLabel mesh__D008528 Acid, Mefenaminic
% 209.04/209.23  |- skos__altLabel mesh__D008528 Parke Davis Brand of Mefenamic Acid
% 209.04/209.23  |- skos__hiddenLabel mesh__D008528 PMS Mefenamic Acid
% 209.04/209.23  |- mesh__historyNote mesh__D008528 72%28%65%29%   
% 209.04/209.23  |- skos__altLabel mesh__D008528 Pharmascience Brand of Mefenamic Acid
% 209.04/209.23  |- skos__prefLabel mesh__D008528 Mefenamic Acid
% 209.04/209.23  |- skos__altLabel mesh__D008528 Mefic
% 209.04/209.23  |- skos__altLabel mesh__D008528 APS Brand of Mefenamic Acid
% 209.04/209.23  |- skos__altLabel mesh__D008528 Apotex Brand of Mefenamic Acid
% 209.04/209.23  |- mesh__recordAuthorizer mesh__D008528 sjn
% 209.04/209.23  |- skos__altLabel mesh__D008528 Ponstan Forte
% 209.04/209.23  |- skos__altLabel mesh__D008528 First Horizon Brand of Mefenamic Acid
% 209.04/209.23  |- skos__altLabel mesh__D008528 Ashbourne Brand of Mefenamic Acid
% 209.04/209.23  |- skos__altLabel mesh__D008528 G%C3%%B6%decke Brand of Mefenamic Acid
% 209.04/209.23  |- skos__altLabel mesh__D008528 Nu-Pharm Brand of Mefenamic Acid
% 209.04/209.23  |- skos__altLabel mesh__D008528 Chemidex Brand of Mefenamic Acid
% 209.04/209.23  |- skos__hiddenLabel mesh__D008528 ApoMefenamic
% 209.04/209.23  |- skos__altLabel mesh__D008528 Elan Brand of Mefenamic Acid
% 209.04/209.23  |- mesh__dateCreated mesh__D008528 1999-01-01
% 209.04/209.23  |- skos__hiddenLabel mesh__D008528 Nu Pharm Brand of Mefenamic Acid
% 209.04/209.23  |- skos__hiddenLabel mesh__D008528 Forte, Ponstan
% 209.04/209.23  |- skos__altLabel mesh__D008528 Pinewood Brand of Mefenamic Acid
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D008528 2006
% 209.04/209.23  |- rdf__type mesh__D008528sskos__Concept
% 209.04/209.23  |- skos__scopeNote mesh__D008528
% 209.04/209.23       A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.%A%    
% 209.04/209.23  |- mesh__dateRevised mesh__D008528 2005-06-30
% 209.04/209.23  |- mesh__recordMaintainer mesh__D008528 CCR
% 209.04/209.23  |- skos__hiddenLabel mesh__D008528 Acid, Mefenamic
% 209.04/209.23  |- skos__altLabel mesh__D008528 Parkemed
% 209.04/209.23  |- mesh__recordOriginator mesh__D008528 NLM
% 209.04/209.23  |- mesh__dateEstablished mesh__D008528 1972-01-01
% 209.04/209.23  |- skos__altLabel mesh__D008528 Farmasierra Brand of Mefenamic Acid
% 209.04/209.23  |- skos__altLabel mesh__D008528 Ponsyl
% 209.04/209.23  |- skos__altLabel mesh__D008528 Pfizer Brand of Mefenamic Acid
% 209.04/209.23  |- skos__hiddenLabel mesh__D008528 Warner Lambert Brand of Mefenamic Acid
% 209.04/209.23  |- skos__altLabel mesh__D008528 Warner-Lambert Brand of Mefenamic Acid
% 209.04/209.23  |- skos__hiddenLabel mesh__D008528 Apo Mefenamic
% 209.04/209.23  |- skos__altLabel mesh__D008528 Antigen Brand of Mefenamic Acid
% 209.04/209.23  |- skos__altLabel mesh__D008528 Clonmel Brand of Mefenamic Acid
% 209.04/209.23  |- mesh__publicMeSHNote mesh__D008528 72   
% 209.04/209.23  |- skos__altLabel mesh__D008528 Rowa Brand of Mefenamic Acid
% 209.04/209.23  |- skos__broader mesh__D008528smesh__D000879
% 209.04/209.23  |- skos__altLabel mesh__D008528 Mefenaminic Acid
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D000545 2006
% 209.04/209.23  |- skos__prefLabel mesh__D000545 Amanita
% 209.04/209.23  |- mesh__historyNote mesh__D000545
% 209.04/209.23       91%28%75%29%; was see under AGARICALES 1986-90; was see under AGARICACEAE 1975-85%A%  
% 209.04/209.23  |- mesh__dateEstablished mesh__D000545 1991-01-01
% 209.04/209.23  |- mesh__recordMaintainer mesh__D000545 SYSTEM
% 209.04/209.23  |- mesh__recordAuthorizer mesh__D000545 sjn
% 209.04/209.23  |- mesh__publicMeSHNote mesh__D000545
% 209.04/209.23       91; was see under AGARICALES 1986-90; was see under AGARICACEAE 1975-85%A%  
% 209.04/209.23  |- skos__broader mesh__D000545smesh__D000363
% 209.04/209.23  |- skos__annotation mesh__D000545
% 209.04/209.23       a poisonous basidiomycete; coord NIM for MUSHROOM POISONING %28%IM%29% by Amanita%A%  
% 209.04/209.23  |- mesh__dateRevised mesh__D000545 2005-06-30
% 209.04/209.23  |- skos__scopeNote mesh__D000545
% 209.04/209.23       A genus of fungi of the family Agaricaceae, order Agaricales; most species are poisonous.%A%    
% 209.04/209.23  |- rdf__type mesh__D000545sskos__Concept
% 209.04/209.23  |- mesh__dateCreated mesh__D000545 1974-12-12
% 209.04/209.23  |- mesh__recordOriginator mesh__D000545 NLM
% 209.04/209.23  |- mesh__recordMaintainer mesh__D019250 PXP
% 209.04/209.23  |- skos__altLabel mesh__D019250 Implants, Single-Tooth Dental
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D019250 2000
% 209.04/209.23  |- mesh__recordOriginator mesh__D019250 TGC
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D019250 2006
% 209.04/209.23  |- rdf__type mesh__D019250sskos__Concept
% 209.04/209.23  |- skos__altLabel mesh__D019250 Dental Implant, Single-Tooth
% 209.04/209.23  |- mesh__dateEstablished mesh__D019250 1997-01-01
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D019250 2001
% 209.04/209.23  |- skos__hiddenLabel mesh__D019250 Single Tooth Dental Implants
% 209.04/209.23  |- skos__hiddenLabel mesh__D019250 Dental Implants, Single Tooth
% 209.04/209.23  |- skos__scopeNote mesh__D019250
% 209.04/209.23       Devices, usually alloplastic, surgically inserted into or onto the jawbone, which support a single prosthetic tooth and serve either as abutments or as cosmetic replacements for missing teeth.%A%    
% 209.04/209.23  |- skos__hiddenLabel mesh__D019250 Implants, Single-Tooth
% 209.04/209.23  |- skos__prefLabel mesh__D019250 Dental Implants, Single-Tooth
% 209.04/209.23  |- skos__broader mesh__D019250smesh__D015921
% 209.04/209.23  |- skos__altLabel mesh__D019250 Implant, Single-Tooth Dental
% 209.04/209.23  |- skos__hiddenLabel mesh__D019250 Dental Implant, Single Tooth
% 209.04/209.23  |- mesh__publicMeSHNote mesh__D019250 97   
% 209.04/209.23  |- skos__altLabel mesh__D019250 Single-Tooth Dental Implant
% 209.04/209.23  |- mesh__dateCreated mesh__D019250 1996-06-10
% 209.04/209.23  |- skos__hiddenLabel mesh__D019250 Implant, Single-Tooth
% 209.04/209.23  |- skos__hiddenLabel mesh__D019250 Implants, Single Tooth Dental
% 209.04/209.23  |- skos__altLabel mesh__D019250 Single-Tooth Implants
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D019250 2002
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D019250 2003
% 209.04/209.23  |- skos__annotation mesh__D019250 DF: DENT IMPLANTS SINGLE TOOTH   
% 209.04/209.23  |- mesh__recordAuthorizer mesh__D019250 sjn
% 209.04/209.23  |- skos__altLabel mesh__D019250 Single-Tooth Dental Implants
% 209.04/209.23  |- skos__hiddenLabel mesh__D019250 Single Tooth Dental Implant
% 209.04/209.23  |- mesh__historyNote mesh__D019250 97   
% 209.04/209.23  |- mesh__dateRevised mesh__D019250 1999-11-03
% 209.04/209.23  |- skos__hiddenLabel mesh__D019250 Single-Tooth Implant
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D019250 2005
% 209.04/209.23  |- skos__historyNote mesh__D019250 Dental Implants %28%1990-1996%29%
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D019250 2004
% 209.04/209.23  |- skos__hiddenLabel mesh__D019250 Single Tooth Implants
% 209.04/209.23  |- skos__hiddenLabel mesh__D019250 Implant, Single Tooth Dental
% 209.04/209.23  |- skos__annotation mesh__D005230 DF: note short X ref   
% 209.04/209.23  |- mesh__dateRevised mesh__D005230 2003-07-09
% 209.04/209.23  |- mesh__dateCreated mesh__D005230 1999-01-01
% 209.04/209.23  |- skos__hiddenLabel mesh__D005230 Acids, Free Fatty
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D005230 2005
% 209.04/209.23  |- skos__scopeNote mesh__D005230
% 209.04/209.23       FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form.%A%    
% 209.04/209.23  |- skos__hiddenLabel mesh__D005230 Acids, Nonesterified Fatty
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D005230 2006
% 209.04/209.23  |- mesh__recordAuthorizer mesh__D005230 sjn
% 209.04/209.23  |- skos__prefLabel mesh__D005230 Fatty Acids, Nonesterified
% 209.04/209.23  |- mesh__publicMeSHNote mesh__D005230 68   
% 209.04/209.23  |- mesh__dateEstablished mesh__D005230 1968-01-01
% 209.04/209.23  |- mesh__recordOriginator mesh__D005230 NLM
% 209.04/209.23  |- skos__altLabel mesh__D005230 Free Fatty Acids
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D005230 2004
% 209.04/209.23  |- skos__altLabel mesh__D005230 NEFA
% 209.04/209.23  |- skos__altLabel mesh__D005230 Fatty Acids, Free
% 209.04/209.23  |- mesh__historyNote mesh__D005230 68%28%66%29%   
% 209.04/209.23  |- mesh__recordMaintainer mesh__D005230 ssb
% 209.04/209.23  |- skos__broader mesh__D005230smesh__D005227
% 209.04/209.23  |- rdf__type mesh__D005230sskos__Concept
% 209.04/209.23  |- skos__hiddenLabel mesh__D005230 Nonesterified Fatty Acids
% 209.04/209.23  |- skos__annotation mesh__D018956
% 209.04/209.23       T-lymphocyte differentiation antigens; but read MeSH definition%A%  
% 209.04/209.23  |- skos__broader mesh__D018956smesh__D000944
% 209.04/209.23  |- skos__broader mesh__D018956smesh__D015703
% 209.04/209.23  |- skos__prefLabel mesh__D018956 Antigens, CD5
% 209.04/209.23  |- mesh__dateCreated mesh__D018956 1995-05-26
% 209.04/209.23  |- mesh__onlineNote mesh__D018956
% 209.04/209.23       use ANTIGENS, CD5 %28%NM%29% to search CD5 ANTIGEN 1988-95   
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D018956 2006
% 209.04/209.23  |- mesh__historyNote mesh__D018956
% 209.04/209.23       96; was CD5 ANTIGEN %28%NM%29% 1988-95   
% 209.04/209.23  |- mesh__dateRevised mesh__D018956 2005-06-30
% 209.04/209.23  |- mesh__recordMaintainer mesh__D018956 ssb
% 209.04/209.23  |- skos__hiddenLabel mesh__D018956 Leu 1 Antigen
% 209.04/209.23  |- rdf__type mesh__D018956sskos__Concept
% 209.04/209.23  |- skos__historyNote mesh__D018956
% 209.04/209.23       Antigens, Differentiation %28%1990-1991%29%
% 209.04/209.23  |- mesh__publicMeSHNote mesh__D018956
% 209.04/209.23       96; CD5 ANTIGEN was indexed under ANTIGENS, CD 1990-95 %26% ANTIGENS, DIFFERENTIATION 1990-91%A%  
% 209.04/209.23  |- skos__hiddenLabel mesh__D018956 Antigen, CD5
% 209.04/209.23  |- mesh__recordAuthorizer mesh__D018956 sjn
% 209.04/209.23  |- mesh__dateEstablished mesh__D018956 1996-01-01
% 209.04/209.23  |- skos__altLabel mesh__D018956 CD5 Antigen
% 209.04/209.23  |- skos__scopeNote mesh__D018956
% 209.04/209.23       Glycoproteins expressed on all mature T-cells, thymocytes, and a subset of mature B-cells. Antibodies specific for CD5 can enhance T-cell receptor-mediated T-cell activation. The B-cell-specific molecule CD72 is a natural ligand for CD5. %28%From Abbas et al., Cellular and Molecular Immunology, 2d ed, p156%29%%A%    
% 209.04/209.23  |- skos__historyNote mesh__D018956 Antigens, CD %28%1990-1995%29%
% 209.04/209.23  |- mesh__recordOriginator mesh__D018956 AGS
% 209.04/209.23  |- skos__altLabel mesh__D018956 Leu-1 Antigen
% 209.04/209.23  |- skos__broader mesh__D018956smesh__D000945
% 209.04/209.23  |- skos__altLabel mesh__D018956 T1 Antigen
% 209.04/209.23  |- skos__altLabel mesh__D018956 CD5 Antigens
% 209.04/209.23  |- skos__broader mesh__D010973smesh__D045122
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D010973 2005
% 209.04/209.23  |- skos__prefLabel mesh__D010973 Platelet Adhesiveness
% 209.04/209.23  |- mesh__dateEstablished mesh__D010973 1972-01-01
% 209.04/209.23  |- skos__scopeNote mesh__D010973
% 209.04/209.23       The process whereby PLATELETS adhere to something other than platelets, e.g., COLLAGEN; BASEMENT MEMBRANE; MICROFIBRILS; or other %22%foreign%22% surfaces.%A%    
% 209.04/209.23  |- mesh__recordOriginator mesh__D010973 NLM
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D010973 2006
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D010973 2004
% 209.04/209.23  |- mesh__historyNote mesh__D010973 72%28%69%29%   
% 209.04/209.23  |- skos__hiddenLabel mesh__D010973 Adhesivenesses, Platelet
% 209.04/209.23  |- skos__hiddenLabel mesh__D010973 Adhesiveness, Platelet
% 209.04/209.23  |- mesh__dateCreated mesh__D010973 1999-01-01
% 209.04/209.23  |- skos__related mesh__D010973smesh__D010980
% 209.04/209.23  |- mesh__dateRevised mesh__D010973 2003-07-09
% 209.04/209.23  |- skos__broader mesh__D010973smesh__D015539
% 209.04/209.23  |- mesh__recordAuthorizer mesh__D010973 sjn
% 209.04/209.23  |- mesh__recordMaintainer mesh__D010973 nns
% 209.04/209.23  |- rdf__type mesh__D010973sskos__Concept
% 209.04/209.23  |- skos__historyNote mesh__D010973 Blood Platelets %28%1966-1968%29%
% 209.04/209.23  |- mesh__publicMeSHNote mesh__D010973 72   
% 209.04/209.23  |- skos__hiddenLabel mesh__D010973 Platelet Adhesivenesses
% 209.04/209.23  |- skos__scopeNote mesh__D018158
% 209.04/209.23       A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, causing tumors in primates. The type species is YABA MONKEY TUMOR VIRUS.%A%    
% 209.04/209.23  |- mesh__recordMaintainer mesh__D018158 ags
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D018158 2006
% 209.04/209.23  |- mesh__dateEstablished mesh__D018158 1994-01-01
% 209.04/209.23  |- mesh__activeMeSHYear mesh__D018158 2005
% 209.04/209.23  |- mesh__dateCreated mesh__D018158 1993-06-04
% 209.04/209.23  |- rdf__type mesh__D018158sskos__Concept
% 209.04/209.24  |- mesh__publicMeSHNote mesh__D018158 94   
% 209.04/209.24  |- skos__hiddenLabel mesh__D018158 Yatapoxviruses
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D018158 2004
% 209.04/209.24  |- mesh__dateRevised mesh__D018158 2001-07-25
% 209.04/209.24  |- skos__prefLabel mesh__D018158 Yatapoxvirus
% 209.04/209.24  |- skos__broader mesh__D018158smesh__D004263
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D018158 2003
% 209.04/209.24  |- skos__annotation mesh__D018158
% 209.04/209.24       infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%%A%  
% 209.04/209.24  |- skos__hiddenLabel mesh__D018158 Tanapox viruses
% 209.04/209.24  |- mesh__historyNote mesh__D018158 94   
% 209.04/209.24  |- mesh__recordAuthorizer mesh__D018158 sjn
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D018158 2002
% 209.04/209.24  |- skos__broader mesh__D018158smesh__D018147
% 209.04/209.24  |- mesh__recordOriginator mesh__D018158 AGS
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010175 1997
% 209.04/209.24  |- mesh__dateCreated mesh__D010175 1999-01-01
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010175 2003
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010175 1996
% 209.04/209.24  |- mesh__recordOriginator mesh__D010175 NLM
% 209.04/209.24  |- skos__annotation mesh__D010175 IM      CATALOG: use NAF entry   
% 209.04/209.24  |- mesh__dateRevised mesh__D010175 1993-06-03
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010175 2001
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010175 2006
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010175 1999
% 209.04/209.24  |- skos__altLabel mesh__D010175 PAHO
% 209.04/209.24  |- skos__historyNote mesh__D010175
% 209.04/209.24       World Health Organization %28%1966-1972%29%
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010175 1995
% 209.04/209.24  |- mesh__dateEstablished mesh__D010175 1973-01-01
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010175 2005
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010175 2000
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010175 1998
% 209.04/209.24  |- skos__prefLabel mesh__D010175 Pan American Health Organization
% 209.04/209.24  |- mesh__publicMeSHNote mesh__D010175 73   
% 209.04/209.24  |- skos__historyNote mesh__D010175 International Agencies %28%1966-1972%29%
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010175 1994
% 209.04/209.24  |- skos__scopeNote mesh__D010175
% 209.04/209.24       WHO regional office for the Americas acting as a coordinating agency for the improvement of health conditions in the hemisphere. The four main functions are: control or eradication of communicable diseases, strengthening of national and local health services, education and training, and research.%A%    
% 209.04/209.24  |- mesh__recordAuthorizer mesh__D010175 PLS
% 209.04/209.24  |- skos__broader mesh__D010175smesh__D014944
% 209.04/209.24  |- rdf__type mesh__D010175sskos__Concept
% 209.04/209.24  |- mesh__recordMaintainer mesh__D010175 PLS
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010175 2002
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010175 2004
% 209.04/209.24  |- mesh__historyNote mesh__D010175 73   
% 209.04/209.24  |- rdf__type mesh__D004936sskos__Concept
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004936 2004
% 209.04/209.24  |- skos__altLabel mesh__D004936 Diverticula, Esophageal
% 209.04/209.24  |- skos__scopeNote mesh__D004936
% 209.04/209.24       Saccular protrusion beyond the wall of the ESOPHAGUS.     
% 209.04/209.24  |- skos__related mesh__D004936smesh__D045723
% 209.04/209.24  |- mesh__publicMeSHNote mesh__D004936
% 209.04/209.24       92; was ESOPHAGEAL DIVERTICULA 1963-91   
% 209.04/209.24  |- mesh__dateRevised mesh__D004936 2003-07-09
% 209.04/209.24  |- mesh__onlineNote mesh__D004936
% 209.04/209.24       use ESOPHAGEAL DIVERTICULUM to search ESOPHAGEAL DIVERTICULA 1966-91%A%  
% 209.04/209.24  |- skos__annotation mesh__D004936
% 209.04/209.24       inflamm divertic or diverticulitis: coord IM with DIVERTICULITIS %28%IM%29%%A%  
% 209.04/209.24  |- skos__broader mesh__D004936smesh__D004240
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004936 2005
% 209.04/209.24  |- mesh__historyNote mesh__D004936
% 209.04/209.24       92; was ESOPHAGEAL DIVERTICULA 1963-91   
% 209.04/209.24  |- skos__altLabel mesh__D004936 Esophageal Diverticula
% 209.04/209.24  |- mesh__recordOriginator mesh__D004936 NLM
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004936 2006
% 209.04/209.24  |- mesh__dateCreated mesh__D004936 1999-01-01
% 209.04/209.24  |- mesh__recordAuthorizer mesh__D004936 sjn
% 209.04/209.24  |- skos__altLabel mesh__D004936 Esophageal Diverticulum
% 209.04/209.24  |- mesh__recordMaintainer mesh__D004936 lkt
% 209.04/209.24  |- skos__prefLabel mesh__D004936 Diverticulum, Esophageal
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004138 1997
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004138 2000
% 209.04/209.24  |- mesh__historyNote mesh__D004138
% 209.04/209.24       91%28%72%29%; was see under CRESOLS 1972-90   
% 209.04/209.24  |- skos__broader mesh__D004138smesh__D009574
% 209.04/209.24  |- skos__historyNote mesh__D004138 Cresols %28%1966-1971%29%
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004138 2001
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004138 1994
% 209.04/209.24  |- mesh__dateRevised mesh__D004138 1992-05-13
% 209.04/209.24  |- skos__broader mesh__D004138smesh__D003408
% 209.04/209.24  |- rdf__type mesh__D004138sskos__Concept
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004138 2005
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004138 2002
% 209.04/209.24  |- mesh__recordAuthorizer mesh__D004138 PLS
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004138 1995
% 209.04/209.24  |- mesh__dateEstablished mesh__D004138 1991-01-01
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004138 2006
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004138 2003
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004138 1993
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004138 1998
% 209.04/209.24  |- mesh__publicMeSHNote mesh__D004138 91; was see under CRESOLS 1972-90   
% 209.04/209.24  |- mesh__dateCreated mesh__D004138 1999-01-01
% 209.04/209.24  |- skos__prefLabel mesh__D004138 Dinitrocresols
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004138 2004
% 209.04/209.24  |- mesh__recordMaintainer mesh__D004138 TGC
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004138 1999
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004138 1996
% 209.04/209.24  |- mesh__recordOriginator mesh__D004138 NLM
% 209.04/209.24  |- skos__historyNote mesh__D009621 Glycosides %28%1966-1975%29%
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D009621 2005
% 209.04/209.24  |- skos__historyNote mesh__D009621 Antibiotics %28%1966%29%
% 209.04/209.24  |- skos__hiddenLabel mesh__D009621 U15167
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D009621 2006
% 209.04/209.24  |- skos__historyNote mesh__D009621 Naphthacenes %28%1966-1975%29%
% 209.04/209.24  |- skos__scopeNote mesh__D009621
% 209.04/209.24       An anthrocycline from a Streptomyces nogalater variant. It is a cytolytic antineoplastic that inhibits DNA-dependent RNA synthesis by binding to DNA.%A%    
% 209.04/209.24  |- mesh__dateCreated mesh__D009621 1975-07-23
% 209.04/209.24  |- mesh__recordAuthorizer mesh__D009621 sjn
% 209.04/209.24  |- mesh__recordMaintainer mesh__D009621 ssb
% 209.04/209.24  |- rdf__type mesh__D009621sskos__Concept
% 209.04/209.24  |- mesh__historyNote mesh__D009621
% 209.04/209.24       91%28%76%29%; was see under DAUNORUBICIN 1981-90; was see under NAPHTHACENES 1976-80%A%  
% 209.04/209.24  |- skos__historyNote mesh__D009621
% 209.04/209.24       Antibiotics, Antineoplastic %28%1967-1975%29%
% 209.04/209.24  |- mesh__dateEstablished mesh__D009621 1991-01-01
% 209.04/209.24  |- mesh__publicMeSHNote mesh__D009621
% 209.04/209.24       91; was see under DAUNORUBICIN 1981-90; was see under NAPHTHACENES 1976-80%A%  
% 209.04/209.24  |- skos__prefLabel mesh__D009621 Nogalamycin
% 209.04/209.24  |- skos__hiddenLabel mesh__D009621 U 15167
% 209.04/209.24  |- skos__broader mesh__D009621smesh__D003630
% 209.04/209.24  |- mesh__dateRevised mesh__D009621 2004-07-07
% 209.04/209.24  |- mesh__recordOriginator mesh__D009621 SH
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D014566 2006
% 209.04/209.24  |- mesh__recordAuthorizer mesh__D014566 ags
% 209.04/209.24  |- skos__hiddenLabel mesh__D014566 System, Urogenital
% 209.04/209.24  |- mesh__recordMaintainer mesh__D014566 ags
% 209.04/209.24  |- skos__hiddenLabel mesh__D014566 Genitourinary Systems
% 209.04/209.24  |- skos__scopeNote mesh__D014566
% 209.04/209.24       All the organs involved in reproduction and the formation and release of URINE. It includes the kidneys, ureters, BLADDER; URETHRA, and the organs of reproduction - ovaries, UTERUS; FALLOPIAN TUBES; VAGINA; and CLITORIS in women and the testes; SEMINAL VESICLES; PROSTATE; seminal ducts; and PENIS in men.%A%    
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D014566 2005
% 209.04/209.24  |- skos__hiddenLabel mesh__D014566 Urogenital Systems
% 209.04/209.24  |- mesh__dateRevised mesh__D014566 2005-07-08
% 209.04/209.24  |- skos__altLabel mesh__D014566 Genitourinary System
% 209.04/209.24  |- skos__hiddenLabel mesh__D014566 Systems, Genitourinary
% 209.04/209.24  |- mesh__runningHead mesh__D014566 A5 - ANATOMY-UROGENITAL SYSTEM   
% 209.04/209.24  |- skos__related mesh__D014566smesh__D014567
% 209.04/209.24  |- mesh__recordOriginator mesh__D014566 NLM
% 209.04/209.24  |- skos__hiddenLabel mesh__D014566 System, Genitourinary
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D014566 2006A
% 209.04/209.24  |- skos__hiddenLabel mesh__D014566 Systems, Urogenital
% 209.04/209.24  |- skos__prefLabel mesh__D014566 Urogenital System
% 209.04/209.24  |- mesh__dateCreated mesh__D014566 1999-01-01
% 209.04/209.24  |- rdf__type mesh__D014566sskos__Concept
% 209.04/209.24  |- skos__annotation mesh__D014566
% 209.04/209.24       must be both uro + genital; GEN or unspecified; prefer specifics; UROGENITAL ABNORMALITIES is available but consider also specific urogenital organs with /abnorm; UROGRAPHY is available but consider also specific organs with  /radiogr; /surg: consider also UROGENITAL SURGICAL PROCEDURES%A%  
% 209.04/209.24  |- skos__historyNote mesh__D008529 Furans %28%1972-1975%29%
% 209.04/209.24  |- mesh__historyNote mesh__D008529
% 209.04/209.24       91%28%76%29%; was see under DIURETICS, SULFAMYL 1976-90   
% 209.04/209.24  |- mesh__dateCreated mesh__D008529 1975-07-23
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D008529 2006
% 209.04/209.24  |- rdf__type mesh__D008529sskos__Concept
% 209.04/209.24  |- skos__prefLabel mesh__D008529 Mefruside
% 209.04/209.24  |- skos__scopeNote mesh__D008529
% 209.04/209.24       A benzene-sulfonamide-furan. It is used as a diuretic that affects the concentrating ability of the KIDNEY, increases SODIUM CHLORIDE excretion, but may not spare POTASSIUM. It inhibits CARBONIC ANHYDRASES and may increase the blood URIC ACID level.%A%    
% 209.04/209.24  |- mesh__dateRevised mesh__D008529 2005-06-30
% 209.04/209.24  |- skos__historyNote mesh__D008529 Diuretics, Sulfamyl %28%1974-1975%29%
% 209.04/209.24  |- mesh__recordMaintainer mesh__D008529 ssb
% 209.04/209.24  |- mesh__recordOriginator mesh__D008529 SH
% 209.04/209.24  |- mesh__dateEstablished mesh__D008529 1991-01-01
% 209.04/209.24  |- skos__broader mesh__D008529smesh__D013449
% 209.04/209.24  |- mesh__publicMeSHNote mesh__D008529
% 209.04/209.24       91; was see under DIURETICS, SULFAMYL 1976-90   
% 209.04/209.24  |- mesh__recordAuthorizer mesh__D008529 sjn
% 209.04/209.24  |- skos__broader mesh__D000546smesh__D009842
% 209.04/209.24  |- skos__broader mesh__D000546smesh__D010456
% 209.04/209.24  |- mesh__historyNote mesh__D000546 75   
% 209.04/209.24  |- skos__historyNote mesh__D000546 Oligopeptides %28%1974%29%
% 209.04/209.24  |- skos__hiddenLabel mesh__D000546 Alpha Amanitin
% 209.04/209.24  |- skos__broader mesh__D000546smesh__D009183
% 209.04/209.24  |- skos__scopeNote mesh__D000546
% 209.04/209.24       Cyclic peptides extracted from carpophores of various mushroom species. They are potent inhibitors of RNA polymerases in most eukaryotic species, blocking the production of mRNA and protein synthesis. These peptides are important in the study of transcription. Alpha-amanitin is the main toxin from the species Amanitia phalloides, poisonous if ingested by humans or animals.%A%    
% 209.04/209.24  |- rdf__type mesh__D000546sskos__Concept
% 209.04/209.24  |- mesh__recordOriginator mesh__D000546 NLM
% 209.04/209.24  |- skos__prefLabel mesh__D000546 Amanitins
% 209.04/209.24  |- skos__historyNote mesh__D000546 Mycotoxins %28%1974%29%
% 209.04/209.24  |- skos__annotation mesh__D000546
% 209.04/209.24       /antag permitted but consider also ANTITOXINS   
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D000546 2006
% 209.04/209.24  |- mesh__dateCreated mesh__D000546 1974-11-11
% 209.04/209.24  |- mesh__recordAuthorizer mesh__D000546 jls
% 209.04/209.24  |- mesh__dateEstablished mesh__D000546 1975-09-01
% 209.04/209.24  |- mesh__recordMaintainer mesh__D000546 jls
% 209.04/209.24  |- mesh__dateRevised mesh__D000546 2005-07-29
% 209.04/209.24  |- mesh__publicMeSHNote mesh__D000546 75   
% 209.04/209.24  |- skos__hiddenLabel mesh__D000546 Alpha Amanitine
% 209.04/209.24  |- skos__historyNote mesh__D000546 Peptides, Cyclic %28%1974%29%
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D000546 2006A
% 209.04/209.24  |- skos__broader mesh__D019251smesh__D014771
% 209.04/209.24  |- mesh__dateEstablished mesh__D019251 1997-01-01
% 209.04/209.24  |- mesh__publicMeSHNote mesh__D019251
% 209.04/209.24       97; VIRAL N PROTEIN was indexed under VIRAL CORE PROTEINS 1986-96, CAPSID 1983-96, and VIRAL PROTEINS 1983-85%A%  
% 209.04/209.24  |- mesh__onlineNote mesh__D019251
% 209.04/209.24       use NUCLEOCAPSID %28%NM%29% to search VIRAL N PROTEIN 1983-96   
% 209.04/209.24  |- mesh__historyNote mesh__D019251
% 209.04/209.24       97; was VIRAL N PROTEIN %28%NM%29% 1983-96   
% 209.04/209.24  |- mesh__dateCreated mesh__D019251 1996-06-10
% 209.04/209.24  |- mesh__recordAuthorizer mesh__D019251 sjn
% 209.04/209.24  |- skos__related mesh__D019251smesh__D019590
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D019251 2006
% 209.04/209.24  |- rdf__type mesh__D019251sskos__Concept
% 209.04/209.24  |- skos__prefLabel mesh__D019251 Nucleocapsid
% 209.04/209.24  |- skos__historyNote mesh__D019251 Capsid %28%1977-1996%29%
% 209.04/209.24  |- skos__scopeNote mesh__D019251
% 209.04/209.24       A protein-nucleic acid complex which forms part or all of a virion. It consists of a CAPSID plus enclosed nucleic acid. Depending on the virus, the nucleocapsid may correspond to a naked core or be surrounded by a membranous envelope.%A%    
% 209.04/209.24  |- mesh__dateRevised mesh__D019251 2005-06-30
% 209.04/209.24  |- mesh__recordOriginator mesh__D019251 AGS
% 209.04/209.24  |- mesh__recordMaintainer mesh__D019251 SYSTEM
% 209.04/209.24  |- skos__hiddenLabel mesh__D019251 Nucleocapsids
% 209.04/209.24  |- skos__historyNote mesh__D019251 Viral Core Proteins %28%1986-1996%29%
% 209.04/209.24  |- skos__annotation mesh__D019251
% 209.04/209.24       a protein-nucleic acid complex of a virion   
% 209.04/209.24  |- skos__historyNote mesh__D019251 Viral Proteins %28%1966-1985%29%
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D005231 2005
% 209.04/209.24  |- mesh__recordMaintainer mesh__D005231 ssb
% 209.04/209.24  |- skos__hiddenLabel mesh__D005231 Unsaturated Fatty Acids
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D005231 2006
% 209.04/209.24  |- mesh__publicMeSHNote mesh__D005231 73   
% 209.04/209.24  |- skos__scopeNote mesh__D005231
% 209.04/209.24       FATTY ACIDS in which the carbon chain contains one or more double or triple carbon-carbon bonds.%A%    
% 209.04/209.24  |- skos__altLabel mesh__D005231 Fatty Acids, Polyunsaturated
% 209.04/209.24  |- skos__prefLabel mesh__D005231 Fatty Acids, Unsaturated
% 209.04/209.24  |- mesh__dateEstablished mesh__D005231 1973-01-01
% 209.04/209.24  |- skos__historyNote mesh__D005231 Fatty Acids, Essential %28%1966-1972%29%
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D005231 2004
% 209.04/209.24  |- mesh__recordAuthorizer mesh__D005231 sjn
% 209.04/209.24  |- skos__hiddenLabel mesh__D005231 Acids, Unsaturated Fatty
% 209.04/209.24  |- skos__broader mesh__D005231smesh__D005227
% 209.04/209.24  |- mesh__historyNote mesh__D005231 73   
% 209.04/209.24  |- rdf__type mesh__D005231sskos__Concept
% 209.04/209.24  |- mesh__recordOriginator mesh__D005231 NLM
% 209.04/209.24  |- mesh__dateRevised mesh__D005231 2003-07-09
% 209.04/209.24  |- mesh__dateCreated mesh__D005231 1999-01-01
% 209.04/209.24  |- skos__annotation mesh__D005231
% 209.04/209.24       GEN or unspecified; prefer specific groups or specific acid%A%  
% 209.04/209.24  |- skos__hiddenLabel mesh__D005231 Acids, Polyunsaturated Fatty
% 209.04/209.24  |- mesh__dateEstablished mesh__D046648 2005-01-01
% 209.04/209.24  |- mesh__publicMeSHNote mesh__D046648
% 209.04/209.24       2005; see HEMATOMA, SUBDURAL 2000-2004   
% 209.04/209.24  |- skos__broader mesh__D046648smesh__D006408
% 209.04/209.24  |- skos__hiddenLabel mesh__D046648 Intracranial Subdural Hematomas
% 209.04/209.24  |- skos__hiddenLabel mesh__D046648 Subdural Hematomas, Intracranial
% 209.04/209.24  |- mesh__historyNote mesh__D046648
% 209.04/209.24       2005; use HEMATOMA, SUBDURAL 2000-2004   
% 209.04/209.24  |- skos__altLabel mesh__D046648 Traumatic Intracranial Subdural Hematoma
% 209.04/209.24  |- mesh__dateCreated mesh__D046648 2004-07-07
% 209.04/209.24  |- skos__prefLabel mesh__D046648 Hematoma, Subdural, Intracranial
% 209.04/209.24  |- rdf__type mesh__D046648sskos__Concept
% 209.04/209.24  |- skos__scopeNote mesh__D046648
% 209.04/209.24       Subdural hematoma occurring over the surface of the cerebral hemisphere.%A%    
% 209.04/209.24  |- mesh__recordMaintainer mesh__D046648 ags
% 209.04/209.24  |- skos__altLabel mesh__D046648 Hematoma, Subdural, Cranial
% 209.04/209.24  |- mesh__recordOriginator mesh__D046648 ags
% 209.04/209.24  |- mesh__recordAuthorizer mesh__D046648 sjn
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D046648 2005
% 209.04/209.24  |- skos__hiddenLabel mesh__D046648 Subdural Hematoma, Intracranial
% 209.04/209.24  |- skos__hiddenLabel mesh__D046648 Hematomas, Intracranial Subdural
% 209.04/209.24  |- skos__hiddenLabel mesh__D046648 Hematoma, Intracranial Subdural
% 209.04/209.24  |- skos__altLabel mesh__D046648 Subdural Hematoma, Traumatic Intracranial
% 209.04/209.24  |- skos__altLabel mesh__D046648 Intracranial Subdural Hematoma
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D046648 2006
% 209.04/209.24  |- skos__historyNote mesh__D046648 Hematoma, Subdural %28%1965-2004%29%
% 209.04/209.24  |- skos__altLabel mesh__D018957 HRF20
% 209.04/209.24  |- skos__scopeNote mesh__D018957
% 209.04/209.24       Small glycoproteins found on both hematopoietic and non-hematopoietic cells. CD59 restricts the cytolytic activity of homologous complement by binding to C8 and C9 and blocking the assembly of the membrane attack complex. %28%From Barclay et al., The Leukocyte Antigen FactsBook, 1993, p234%29%%A%    
% 209.04/209.24  |- mesh__recordMaintainer mesh__D018957 ssb
% 209.04/209.24  |- mesh__dateCreated mesh__D018957 1995-05-26
% 209.04/209.24  |- skos__prefLabel mesh__D018957 Antigens, CD59
% 209.04/209.24  |- rdf__type mesh__D018957sskos__Concept
% 209.04/209.24  |- mesh__dateRevised mesh__D018957 2005-06-30
% 209.04/209.24  |- skos__broader mesh__D018957smesh__D008562
% 209.04/209.24  |- mesh__recordAuthorizer mesh__D018957 sjn
% 209.04/209.24  |- mesh__dateEstablished mesh__D018957 1996-01-01
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D018957 2006
% 209.04/209.24  |- skos__altLabel mesh__D018957 Membrane Attack Complex Inhibition Factor
% 209.04/209.24  |- mesh__publicMeSHNote mesh__D018957
% 209.04/209.24       1996; CD59 ANTIGEN was indexed under ANTIGENS, CD 1990-1995; MEMBRANE GLYCOPROTEINS 1989-1995; %26% ANTIGENS, DIFFERENTIATION 1989-1991; MEMBRANE ATTACK COMPLEX INHIBITION FACTOR %28%now ANTIGENS, CD59%29% was indexed under PROTEINS 1992-1997 %26% BLOOD PROTEINS 1990-1991; PROTECTIN was indexed under ION CHANNELS 1996-1999%A%  
% 209.04/209.24  |- skos__altLabel mesh__D018957 CD59 Antigens
% 209.04/209.24  |- skos__altLabel mesh__D018957 Protectin
% 209.04/209.24  |- mesh__recordOriginator mesh__D018957 AGS
% 209.04/209.24  |- skos__historyNote mesh__D018957
% 209.04/209.24       Antigens, Differentiation %28%1989-1991%29%
% 209.04/209.24  |- skos__historyNote mesh__D018957 Membrane Glycoproteins %28%1989-1995%29%
% 209.04/209.24  |- skos__altLabel mesh__D018957 Homologous Restriction Factor 20
% 209.04/209.24  |- skos__altLabel mesh__D018957 MACIF
% 209.04/209.24  |- skos__altLabel mesh__D018957 Membrane Inhibitor of Reactive Lysis
% 209.04/209.24  |- skos__historyNote mesh__D018957 Antigens, CD %28%1990-1995%29%
% 209.04/209.24  |- mesh__historyNote mesh__D018957
% 209.04/209.24       1996; use CD59 ANTIGEN %28%NM%29% 1989-1995, for PROTECTIN use CATIONIC PROTEIN, URATE-CALCIUM OXALATE STONE %28%NM%29% 1996-1999%A%  
% 209.04/209.24  |- skos__broader mesh__D018957smesh__D015703
% 209.04/209.24  |- skos__altLabel mesh__D018957 CD59 Antigen
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010974 2006
% 209.04/209.24  |- skos__prefLabel mesh__D010974 Platelet Aggregation
% 209.04/209.24  |- mesh__dateEstablished mesh__D010974 1976-01-01
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010974 2004
% 209.04/209.24  |- mesh__dateCreated mesh__D010974 1999-01-01
% 209.04/209.24  |- mesh__onlineNote mesh__D010974 search PLATELET ADHESIVENESS 1974   
% 209.04/209.24  |- skos__related mesh__D010974smesh__D010980
% 209.04/209.24  |- skos__historyNote mesh__D010974 Platelet Adhesiveness %28%1969-1974%29%
% 209.04/209.24  |- mesh__dateRevised mesh__D010974 2003-07-09
% 209.04/209.24  |- skos__hiddenLabel mesh__D010974 Aggregation, Platelet
% 209.04/209.24  |- mesh__recordOriginator mesh__D010974 NLM
% 209.04/209.24  |- mesh__publicMeSHNote mesh__D010974
% 209.04/209.24       76; was see under PLATELET ADHESIVENESS 1974-75   
% 209.04/209.24  |- skos__historyNote mesh__D010974 Blood Platelets %28%1966-1974%29%
% 209.04/209.24  |- skos__scopeNote mesh__D010974
% 209.04/209.24       The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents %28%e.g., THROMBIN; COLLAGEN%29% and is part of the mechanism leading to the formation of a THROMBUS.%A%    
% 209.04/209.24  |- rdf__type mesh__D010974sskos__Concept
% 209.04/209.24  |- skos__broader mesh__D010974smesh__D015539
% 209.04/209.24  |- mesh__recordAuthorizer mesh__D010974 sjn
% 209.04/209.24  |- mesh__recordMaintainer mesh__D010974 nns
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010974 2005
% 209.04/209.24  |- mesh__historyNote mesh__D010974
% 209.04/209.24       76%28%75%29%; was see under PLATELET ADHESIVENESS 1974-75   
% 209.04/209.24  |- skos__broader mesh__D009729Q000331smesh__D009729
% 209.04/209.24  |- mesh__preferredCombination mesh__D009729Q000331smesh__D007884
% 209.04/209.24  |- rdf__type mesh__D009729Q000331smesh__CompoundConcept
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D018159 2005
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D018159 1999
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D018159 2002
% 209.04/209.24  |- rdf__type mesh__D018159sskos__Concept
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D018159 1998
% 209.04/209.24  |- skos__scopeNote mesh__D018159
% 209.04/209.24       An accumulation of endolymph in the inner ear resulting in deafness and tinnitus, and sometimes vertigo %28%MENIERE%27%S DISEASE%29%. Induced experimentally, it often serves as an animal model for Meniere%27%s disease. %28%From Dorland, 27th ed.%29%%A%    
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D018159 2004
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D018159 2001
% 209.04/209.24  |- skos__prefLabel mesh__D018159 Endolymphatic Hydrops
% 209.04/209.24  |- mesh__dateEstablished mesh__D018159 1994-01-01
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D018159 2003
% 209.04/209.24  |- skos__annotation mesh__D018159
% 209.04/209.24       endolymphatic refers to the endolymph of the inner ear; note see related%A%  
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D018159 1997
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D018159 2000
% 209.04/209.24  |- mesh__publicMeSHNote mesh__D018159 94   
% 209.04/209.24  |- skos__broader mesh__D018159smesh__D007759
% 209.04/209.24  |- skos__historyNote mesh__D018159 Meniere%27%s Disease %28%1966-1993%29%
% 209.04/209.24  |- skos__historyNote mesh__D018159 Labyrinthine Fluids %28%1966-1991%29%
% 209.04/209.24  |- skos__hiddenLabel mesh__D018159 Hydrops, Endolymphatic
% 209.04/209.24  |- mesh__historyNote mesh__D018159 94   
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D018159 1996
% 209.04/209.24  |- skos__related mesh__D018159smesh__D008575
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D018159 1995
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D018159 2006
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D018159 1994
% 209.04/209.24  |- mesh__dateCreated mesh__D018159 1993-05-27
% 209.04/209.24  |- mesh__recordMaintainer mesh__D010176 PLS
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010176 1995
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010176 2005
% 209.04/209.24  |- mesh__recordAuthorizer mesh__D010176 PLS
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010176 1998
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010176 2002
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010176 1994
% 209.04/209.24  |- rdf__type mesh__D010176sskos__Concept
% 209.04/209.24  |- skos__prefLabel mesh__D010176 Panama
% 209.04/209.24  |- skos__annotation mesh__D010176 do not confuse with PANAMA CANAL ZONE   
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010176 2004
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010176 1997
% 209.04/209.24  |- mesh__recordOriginator mesh__D010176 NLM
% 209.04/209.24  |- mesh__dateRevised mesh__D010176 1993-06-03
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010176 2001
% 209.04/209.24  |- skos__broader mesh__D010176smesh__D002489
% 209.04/209.24  |- mesh__dateCreated mesh__D010176 1999-01-01
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010176 2003
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010176 1996
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010176 2000
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010176 2006
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D010176 1999
% 209.04/209.24  |- mesh__recordMaintainer mesh__D004937 ags
% 209.04/209.24  |- skos__broader mesh__D004937smesh__D016154
% 209.04/209.24  |- skos__annotation mesh__D004937
% 209.04/209.24       fistula policy: Manual 23.19+; ESOPHAGOTRACHEAL FISTULA see TRACHEOESOPHAGEAL FISTULA is also available%A%  
% 209.04/209.24  |- skos__hiddenLabel mesh__D004937 Fistula, Esophageal
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004937 2005
% 209.04/209.24  |- skos__prefLabel mesh__D004937 Esophageal Fistula
% 209.04/209.24  |- skos__broader mesh__D004937smesh__D004935
% 209.04/209.24  |- mesh__dateCreated mesh__D004937 1999-01-01
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004937 2006
% 209.04/209.24  |- skos__hiddenLabel mesh__D004937 Esophageal Fistulas
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004937 2006A
% 209.04/209.24  |- mesh__dateRevised mesh__D004937 2005-08-02
% 209.04/209.24  |- mesh__recordAuthorizer mesh__D004937 ags
% 209.04/209.24  |- rdf__type mesh__D004937sskos__Concept
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004937 2004
% 209.04/209.24  |- mesh__recordOriginator mesh__D004937 NLM
% 209.04/209.24  |- skos__hiddenLabel mesh__D004937 Fistulas, Esophageal
% 209.04/209.24  |- skos__scopeNote mesh__D004937
% 209.04/209.24       Abnormal passage communicating with the ESOPHAGUS. The most common type is TRACHEOESOPHAGEAL FISTULA between the esophagus and the TRACHEA.%A%    
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004139 2005
% 209.04/209.24  |- skos__prefLabel mesh__D004139 Dinitrofluorobenzene
% 209.04/209.24  |- skos__historyNote mesh__D004139 Nitrobenzenes %28%1969-1974%29%
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004139 2002
% 209.04/209.24  |- skos__altLabel mesh__D004139 DNFB
% 209.04/209.24  |- mesh__recordOriginator mesh__D004139 NLM
% 209.04/209.24  |- skos__broader mesh__D004139smesh__D004136
% 209.04/209.24  |- mesh__historyNote mesh__D004139
% 209.04/209.24       91%28%75%29%; was see under NITROBENZENES 1975-90   
% 209.04/209.24  |- skos__scopeNote mesh__D004139
% 209.04/209.24       Irritants and reagents for labeling terminal amino acid groups.%A%    
% 209.04/209.24  |- mesh__dateRevised mesh__D004139 2000-06-22
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004139 2001
% 209.04/209.24  |- mesh__recordAuthorizer mesh__D004139 sjn
% 209.04/209.24  |- mesh__publicMeSHNote mesh__D004139
% 209.04/209.24       91; was see under NITROBENZENES 1975-90   
% 209.04/209.24  |- mesh__dateCreated mesh__D004139 1974-11-19
% 209.04/209.24  |- skos__historyNote mesh__D004139 Fluorine %28%1969-1974%29%
% 209.04/209.24  |- skos__altLabel mesh__D004139 Fluorodinitrobenzene
% 209.04/209.24  |- rdf__type mesh__D004139sskos__Concept
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004139 2004
% 209.04/209.24  |- skos__hiddenLabel mesh__D004139 1 Fluoro 2,4 dinitrobenzene
% 209.04/209.24  |- skos__altLabel mesh__D004139 1-Fluoro-2,4-dinitrobenzene
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004139 2006
% 209.04/209.24  |- mesh__recordMaintainer mesh__D004139 CCR
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D004139 2003
% 209.04/209.24  |- skos__broader mesh__D004139smesh__D009578
% 209.04/209.24  |- mesh__dateEstablished mesh__D004139 1991-01-01
% 209.04/209.24  |- mesh__recordAuthorizer mesh__D009622 PLS
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D009622 2000
% 209.04/209.24  |- mesh__recordMaintainer mesh__D009622 TAP
% 209.04/209.24  |- skos__related mesh__D009622smesh__D000161
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D009622 2003
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D009622 2001
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D009622 1995
% 209.04/209.24  |- rdf__type mesh__D009622sskos__Concept
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D009622 1998
% 209.04/209.24  |- mesh__dateRevised mesh__D009622 1992-05-15
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D009622 2004
% 209.04/209.24  |- skos__broader mesh__D009622smesh__D004787
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D009622 1999
% 209.04/209.24  |- skos__prefLabel mesh__D009622 Noise
% 209.04/209.24  |- skos__broader mesh__D009622smesh__D013016
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D009622 1993
% 209.04/209.24  |- skos__hiddenLabel mesh__D009622 Noises
% 209.04/209.24  |- mesh__recordOriginator mesh__D009622 NLM
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D009622 2002
% 209.04/209.24  |- skos__broader mesh__D009622smesh__D004777
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D009622 2005
% 209.04/209.24  |- mesh__activeMeSHYear mesh__D009622 1996
% 209.04/209.24  |- skos__related mesh__D009622smesh__D006317
% 209.04/209.24  |- skos__annotation mesh__D009622
% 209.04/209.24       restrict to noise as a type of sound: do not use for %22%noise%22% as artifacts or interference with data in various techniques or electrical interference %28% = ELECTRICITY%29%; /adv eff: consider also HEARING LOSS, NOISE-INDUCED/%A%  
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D009622 2006
% 209.04/209.25  |- mesh__dateCreated mesh__D009622 1999-01-01
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D009622 1997
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D009622 1994
% 209.04/209.25  |- skos__scopeNote mesh__D014567
% 209.04/209.25       Radiography of any part of the urinary tract.     
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D014567 2000
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D014567 2005
% 209.04/209.25  |- mesh__recordMaintainer mesh__D014567 PXP
% 209.04/209.25  |- skos__prefLabel mesh__D014567 Urography
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D014567 1999
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D014567 2002
% 209.04/209.25  |- mesh__dateCreated mesh__D014567 1999-01-01
% 209.04/209.25  |- skos__annotation mesh__D014567
% 209.04/209.25       GEN only: prefer specific organ with /radiogr; NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: UROGR%A%  
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D014567 1998
% 209.04/209.25  |- skos__broader mesh__D014567smesh__D003950
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D014567 2004
% 209.04/209.25  |- rdf__type mesh__D014567sskos__Concept
% 209.04/209.25  |- skos__broader mesh__D014567smesh__D011859
% 209.04/209.25  |- mesh__dateRevised mesh__D014567 1997-06-20
% 209.04/209.25  |- mesh__recordOriginator mesh__D014567 NLM
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D014567 2003
% 209.04/209.25  |- mesh__recordAuthorizer mesh__D014567 SJN
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D014567 2001
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D014567 2006
% 209.04/209.25  |- mesh__publicMeSHNote mesh__D033721
% 209.04/209.25       2003; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1 was indexed under MEMBRANE TRANSPORT PROTEINS 2001, MEMBRANE PROTEINS %26% CARRIER PROTEINS 1997-2002%A%  
% 209.04/209.25  |- mesh__recordMaintainer mesh__D033721 SYSTEM
% 209.04/209.25  |- skos__altLabel mesh__D033721
% 209.04/209.25       Equilibrative NBMPR-Sensitive Nucleoside Transporter
% 209.04/209.25  |- skos__prefLabel mesh__D033721 Equilibrative Nucleoside Transporter 1
% 209.04/209.25  |- mesh__historyNote mesh__D033721
% 209.04/209.25       2003; use EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1 %28%NM%29% 1997-2002%A%  
% 209.04/209.25  |- mesh__dateEstablished mesh__D033721 2003-01-01
% 209.04/209.25  |- skos__hiddenLabel mesh__D033721
% 209.04/209.25       Equilibrative Nitrobenzylmercaptopurine Riboside Sensitive Nucleoside Transporter
% 209.04/209.25  |- mesh__recordAuthorizer mesh__D033721 sjn
% 209.04/209.25  |- skos__hiddenLabel mesh__D033721
% 209.04/209.25       Equilibrative NBMPR Sensitive Nucleoside Transporter
% 209.04/209.25  |- skos__altLabel mesh__D033721
% 209.04/209.25       Solute Carrier Family 29 %28%Nucleoside Transporters%29%, Member 1
% 209.04/209.25  |- mesh__dateCreated mesh__D033721 2002-07-03
% 209.04/209.25  |- skos__altLabel mesh__D033721 SLC29A1 Transporter
% 209.04/209.25  |- mesh__dateRevised mesh__D033721 2005-06-30
% 209.04/209.25  |- skos__broader mesh__D033721smesh__D033705
% 209.04/209.25  |- skos__scopeNote mesh__D033721
% 209.04/209.25       A subtype of equilibrative nucleoside transporter proteins that is sensitive to inhibition by 4-nitrobenzylthioinosine.%A%    
% 209.04/209.25  |- skos__historyNote mesh__D033721 Membrane Proteins %28%1997-2001%29%
% 209.04/209.25  |- skos__historyNote mesh__D033721 Carrier Proteins %28%1997-2001%29%
% 209.04/209.25  |- mesh__recordOriginator mesh__D033721 jmp
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D033721 2006
% 209.04/209.25  |- skos__altLabel mesh__D033721
% 209.04/209.25       Equilibrative Nitrobenzylmercaptopurine Riboside-Sensitive Nucleoside Transporter
% 209.04/209.25  |- rdf__type mesh__D033721sskos__Concept
% 209.04/209.25  |- skos__historyNote mesh__D033721
% 209.04/209.25       Membrane Transport Proteins %28%2001-2002%29%
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 Amantadinratiopharm
% 209.04/209.25  |- mesh__historyNote mesh__D000547 68%28%65%29%   
% 209.04/209.25  |- skos__altLabel mesh__D000547 Azupharma Brand of Amantadine Hydrochloride
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 AmantaHCIAZU
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 AZU, Amantadin
% 209.04/209.25  |- skos__altLabel mesh__D000547 neuraxpharm Brand of Amantadine Sulfate
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 Amantadin ratiopharm
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D000547 2006
% 209.04/209.25  |- skos__altLabel mesh__D000547 Hexal Brand of Amantadine Sulfate
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 PMS Amantadine
% 209.04/209.25  |- skos__altLabel mesh__D000547 Krewel Brand of Amantadine Hydrochloride
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 Sulfate, Amantadine
% 209.04/209.25  |- skos__altLabel mesh__D000547 Amantadin AZU
% 209.04/209.25  |- rdf__type mesh__D000547sskos__Concept
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 Amanta Sulfate AZU
% 209.04/209.25  |- skos__altLabel mesh__D000547 Novartis Brand of Amantadine Hydrochloride
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 AL, Amantadin
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 Amantadin neuraxpharm
% 209.04/209.25  |- mesh__publicMeSHNote mesh__D000547 68   
% 209.04/209.25  |- mesh__dateCreated mesh__D000547 1999-01-01
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547
% 209.04/209.25       Ciba Geigy Brand of Amantadine Hydrochloride
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 Amantadinneuraxpharm
% 209.04/209.25  |- skos__altLabel mesh__D000547 Mantadix
% 209.04/209.25  |- skos__altLabel mesh__D000547 Merz Brand of Amantadine Sulfate
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 InfectoFlu
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D000547 2005
% 209.04/209.25  |- mesh__dateRevised mesh__D000547 2004-07-07
% 209.04/209.25  |- skos__altLabel mesh__D000547 Stada Brand of Amantadine Hydrochloride
% 209.04/209.25  |- skos__altLabel mesh__D000547 Alliance Brand of Amantadine Hydrochloride
% 209.04/209.25  |- skos__altLabel mesh__D000547
% 209.04/209.25       Ciba-Geigy Brand of Amantadine Hydrochloride
% 209.04/209.25  |- skos__altLabel mesh__D000547 Thiemann Brand of Amantadine Hydrochloride
% 209.04/209.25  |- skos__altLabel mesh__D000547 Genpharm Brand of Amantadine Hydrochloride
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 Juventus, Amantadina
% 209.04/209.25  |- skos__altLabel mesh__D000547 Solvay Brand of Amantadine Hydrochloride
% 209.04/209.25  |- mesh__recordAuthorizer mesh__D000547 sjn
% 209.04/209.25  |- skos__altLabel mesh__D000547 Du Pont Brand of Amantadine Hydrochloride
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 AmantaSulfateAZU
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 Llorente, Amantadina
% 209.04/209.25  |- skos__altLabel mesh__D000547 Azupharma Brand of Amantadine Sulfate
% 209.04/209.25  |- skos__broader mesh__D000547smesh__D000218
% 209.04/209.25  |- skos__altLabel mesh__D000547 Stada Brand of Amantadine Sulfate
% 209.04/209.25  |- skos__altLabel mesh__D000547 Endo Brand of Amantadine Hydrochloride
% 209.04/209.25  |- skos__altLabel mesh__D000547
% 209.04/209.25       ratiopharm Brand of Amantadine Hydrochloride
% 209.04/209.25  |- skos__altLabel mesh__D000547 Adamantylamine
% 209.04/209.25  |- skos__altLabel mesh__D000547
% 209.04/209.25       Pharmascience Brand of Amantadine Hydrochloride
% 209.04/209.25  |- mesh__recordMaintainer mesh__D000547 mdb
% 209.04/209.25  |- skos__altLabel mesh__D000547 Aliud Brand of Amantadine Sulfate
% 209.04/209.25  |- skos__altLabel mesh__D000547 Orion Brand of Amantadine Hydrochloride
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 GenAmantadine
% 209.04/209.25  |- skos__altLabel mesh__D000547 Desitin Brand of Amantadine Hydrochloride
% 209.04/209.25  |- skos__prefLabel mesh__D000547 Amantadine
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 Stada, Amantadin
% 209.04/209.25  |- skos__altLabel mesh__D000547 1-Aminoadamantane
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 Hydrochloride, Amantadine
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 1 Aminoadamantane
% 209.04/209.25  |- skos__altLabel mesh__D000547 Neuro Hexal Brand of Amantadine Sulfate
% 209.04/209.25  |- skos__altLabel mesh__D000547 Llorente Brand of Amantadine Hydrochloride
% 209.04/209.25  |- skos__altLabel mesh__D000547 Endantadine
% 209.04/209.25  |- skos__altLabel mesh__D000547
% 209.04/209.25       Infectopharm Brand of Amantadine Hydrochloride
% 209.04/209.25  |- skos__altLabel mesh__D000547 AbZ Brand of Amantadine Hydrochloride
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 Amanta HCI AZU
% 209.04/209.25  |- skos__scopeNote mesh__D000547
% 209.04/209.25       An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake.%A%    
% 209.04/209.25  |- skos__altLabel mesh__D000547 Juventus Brand of Amantadine Hydrochloride
% 209.04/209.25  |- skos__altLabel mesh__D000547 Hormosan Brand of Amantadine Sulfate
% 209.04/209.25  |- mesh__recordOriginator mesh__D000547 NLM
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 PMSAmantadine
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 Infecto Flu
% 209.04/209.25  |- skos__hiddenLabel mesh__D000547 Gen Amantadine
% 209.04/209.25  |- mesh__dateEstablished mesh__D000547 1968-01-01
% 209.04/209.25  |- skos__hiddenLabel mesh__D019252 Digoras
% 209.04/209.25  |- skos__prefLabel mesh__D019252 Radiography, Dental, Digital
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D019252 2001
% 209.04/209.25  |- mesh__publicMeSHNote mesh__D019252
% 209.04/209.25       98; see RADIOVISIOGRAPHY, DENTAL 1997   
% 209.04/209.25  |- mesh__recordAuthorizer mesh__D019252 SJN
% 209.04/209.25  |- skos__broader mesh__D019252smesh__D011856
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D019252 2006
% 209.04/209.25  |- mesh__recordMaintainer mesh__D019252 AGS
% 209.04/209.25  |- rdf__type mesh__D019252sskos__Concept
% 209.04/209.25  |- skos__altLabel mesh__D019252 Digital Radiography, Dental
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D019252 2000
% 209.04/209.25  |- mesh__dateEstablished mesh__D019252 1997-01-01
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D019252 2005
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D019252 1999
% 209.04/209.25  |- skos__hiddenLabel mesh__D019252 SensARay
% 209.04/209.25  |- mesh__dateCreated mesh__D019252 1996-06-10
% 209.04/209.25  |- mesh__historyNote mesh__D019252 98%28%97%29%   
% 209.04/209.25  |- skos__hiddenLabel mesh__D019252 Radiography, Dental Digital
% 209.04/209.25  |- skos__hiddenLabel mesh__D019252 Visualices
% 209.04/209.25  |- skos__broader mesh__D019252smesh__D011861
% 209.04/209.25  |- skos__scopeNote mesh__D019252
% 209.04/209.25       A rapid, low-dose, digital imaging system using a small intraoral sensor instead of radiographic film, an intensifying screen, and a charge-coupled device. It presents the possibility of reduced patient exposure and minimal distortion, although resolution and latitude are inferior to standard dental radiography. A receiver is placed in the mouth, routing signals to a computer which images the signals on a screen or in print. It includes digitizing from x-ray film or any other detector. %28%From MEDLINE abstracts; personal communication from Dr. Charles Berthold, NIDR%29%%A%    
% 209.04/209.25  |- skos__annotation mesh__D019252
% 209.04/209.25       a type of intraoral radiogr; do not use /util except by MeSH definition; DF: RADIOGR DENT DIGITAL%A%  
% 209.04/209.25  |- skos__altLabel mesh__D019252 Dental Digital Radiography
% 209.04/209.25  |- skos__altLabel mesh__D019252 Radiovisiography, Dental
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D019252 2002
% 209.04/209.25  |- skos__hiddenLabel mesh__D019252 Sens A Ray
% 209.04/209.25  |- skos__hiddenLabel mesh__D019252 Scanoras
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D019252 2004
% 209.04/209.25  |- skos__historyNote mesh__D019252 Radiography, Dental %28%1989-1996%29%
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D019252 2003
% 209.04/209.25  |- mesh__recordOriginator mesh__D019252 TGC
% 209.04/209.25  |- mesh__dateRevised mesh__D019252 1998-06-11
% 209.04/209.25  |- rdf__type mesh__D005232sskos__Concept
% 209.04/209.25  |- mesh__recordAuthorizer mesh__D005232 sjn
% 209.04/209.25  |- skos__scopeNote mesh__D005232
% 209.04/209.25       Short-chain fatty acids of up to six carbon atoms in length. They are the major end products of microbial fermentation in the ruminant digestive tract and have also been implicated in the causation of neurological diseases in humans.%A%    
% 209.04/209.25  |- mesh__recordMaintainer mesh__D005232 ssb
% 209.04/209.25  |- skos__historyNote mesh__D005232 Fatty Acids %28%1966-1972%29%
% 209.04/209.25  |- mesh__recordOriginator mesh__D005232 NLM
% 209.04/209.25  |- skos__annotation mesh__D005232
% 209.04/209.25       GEN or unspecified; prefer specific groups or specific acid%A%  
% 209.04/209.25  |- skos__hiddenLabel mesh__D005232 Volatile Fatty Acids
% 209.04/209.25  |- mesh__dateEstablished mesh__D005232 1973-01-01
% 209.04/209.25  |- mesh__dateCreated mesh__D005232 1999-01-01
% 209.04/209.25  |- skos__broader mesh__D005232smesh__D005227
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D005232 2006
% 209.04/209.25  |- skos__altLabel mesh__D005232 Fatty Acids, Short-Chain
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D005232 2005
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D005232 2004
% 209.04/209.25  |- skos__prefLabel mesh__D005232 Fatty Acids, Volatile
% 209.04/209.25  |- mesh__historyNote mesh__D005232 73   
% 209.04/209.25  |- skos__hiddenLabel mesh__D005232 Short-Chain Fatty Acids
% 209.04/209.25  |- skos__hiddenLabel mesh__D005232 Fatty Acids, Short Chain
% 209.04/209.25  |- mesh__dateRevised mesh__D005232 2003-07-09
% 209.04/209.25  |- mesh__publicMeSHNote mesh__D005232 73   
% 209.04/209.25  |- skos__hiddenLabel mesh__D046649 Subdural Hematoma, Spinal
% 209.04/209.25  |- mesh__recordOriginator mesh__D046649 ags
% 209.04/209.25  |- mesh__recordAuthorizer mesh__D046649 sjn
% 209.04/209.25  |- skos__broader mesh__D046649smesh__D006408
% 209.04/209.25  |- skos__prefLabel mesh__D046649 Hematoma, Subdural, Spinal
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D046649 2006
% 209.04/209.25  |- skos__hiddenLabel mesh__D046649 Subdural Hematomas, Spinal
% 209.04/209.25  |- mesh__publicMeSHNote mesh__D046649
% 209.04/209.25       2005; see HEMATOMA, SUBDURAL %28%2000-2004%29%   
% 209.04/209.25  |- skos__hiddenLabel mesh__D046649 Hematomas, Spinal Subdural
% 209.04/209.25  |- mesh__dateEstablished mesh__D046649 2005-01-01
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D046649 2005
% 209.04/209.25  |- skos__hiddenLabel mesh__D046649 Hematoma, Spinal Subdural
% 209.04/209.25  |- skos__altLabel mesh__D046649 Subdural Hematoma, Spinal, Traumatic
% 209.04/209.25  |- skos__altLabel mesh__D046649 Spinal Subdural Hematoma
% 209.04/209.25  |- skos__scopeNote mesh__D046649
% 209.04/209.25       Subdural hematoma of the SPINAL CANAL.     
% 209.04/209.25  |- skos__altLabel mesh__D046649 Spinal Subdural Hematoma, Traumatic
% 209.04/209.25  |- mesh__recordMaintainer mesh__D046649 ags
% 209.04/209.25  |- mesh__historyNote mesh__D046649
% 209.04/209.25       2005; use HEMATOMA, SUBDURAL %28%2000-2004%29%   
% 209.04/209.25  |- mesh__dateCreated mesh__D046649 2004-07-07
% 209.04/209.25  |- skos__historyNote mesh__D046649 Hematoma, Subdural %28%1969-2004%29%
% 209.04/209.25  |- rdf__type mesh__D046649sskos__Concept
% 209.04/209.25  |- skos__hiddenLabel mesh__D046649 Spinal Subdural Hematomas
% 209.04/209.25  |- skos__historyNote mesh__D018958 Membrane Proteins %28%1985-1992%29%
% 209.04/209.25  |- skos__annotation mesh__D018958 differentiation antigens   
% 209.04/209.25  |- skos__prefLabel mesh__D018958 Antigens, CD55
% 209.04/209.25  |- skos__broader mesh__D018958smesh__D015703
% 209.04/209.25  |- skos__altLabel mesh__D018958 Decay-Accelerating Factor
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D018958 2006
% 209.04/209.25  |- mesh__onlineNote mesh__D018958
% 209.04/209.25       use ANTIGENS, CD55 %28%NM%29% to search DECAY-ACCELERATING FACTOR 1985-95%A%  
% 209.04/209.25  |- mesh__publicMeSHNote mesh__D018958
% 209.04/209.25       96; DECAY-ACCELERATING FACTOR was indexed under ANTIGENS, CD 1990-95; MEMBRANE GLYCOPROTEINS 1988-95; MEMBRANE PROTEINS 1985-92; %26% BLOOD PROTEINS 1985-86%A%  
% 209.04/209.25  |- mesh__recordMaintainer mesh__D018958 ssb
% 209.04/209.25  |- mesh__historyNote mesh__D018958
% 209.04/209.25       96; was DECAY-ACCELERATING FACTOR %28%NM%29% 1985-95   
% 209.04/209.25  |- mesh__dateRevised mesh__D018958 2005-06-30
% 209.04/209.25  |- skos__broader mesh__D018958smesh__D008562
% 209.04/209.25  |- mesh__recordAuthorizer mesh__D018958 sjn
% 209.04/209.25  |- skos__hiddenLabel mesh__D018958 Decay Accelerating Factor
% 209.04/209.25  |- mesh__dateEstablished mesh__D018958 1996-01-01
% 209.04/209.25  |- skos__historyNote mesh__D018958 Antigens, CD %28%1990-1995%29%
% 209.04/209.25  |- skos__altLabel mesh__D018958 CD55 Antigens
% 209.04/209.25  |- skos__historyNote mesh__D018958 Blood Proteins %28%1985-1986%29%
% 209.04/209.25  |- mesh__recordOriginator mesh__D018958 AGS
% 209.04/209.25  |- mesh__dateCreated mesh__D018958 1995-05-26
% 209.04/209.25  |- skos__altLabel mesh__D018958 CD55 Antigen
% 209.04/209.25  |- skos__historyNote mesh__D018958 Membrane Glycoproteins %28%1988-1995%29%
% 209.04/209.25  |- rdf__type mesh__D018958sskos__Concept
% 209.04/209.25  |- skos__scopeNote mesh__D018958
% 209.04/209.25       Glycoproteins broadly distributed among hematopoietic and non-hematopoietic cells. CD55 prevents the assembly of C3 convertase or accelerates the disassembly of preformed convertase, thus blocking the formation of the membrane attack complex.%A%    
% 209.04/209.25  |- skos__hiddenLabel mesh__D010975 Drugs, Antiplatelet
% 209.04/209.25  |- skos__hiddenLabel mesh__D010975 Antagonists, Blood Platelet
% 209.04/209.25  |- skos__altLabel mesh__D010975 Blood Platelet Aggregation Inhibitors
% 209.04/209.25  |- skos__annotation mesh__D010975 DF: PLATELET INHIB   
% 209.04/209.25  |- mesh__recordAuthorizer mesh__D010975 sjn
% 209.04/209.25  |- mesh__historyNote mesh__D010975 88   
% 209.04/209.25  |- mesh__dateEstablished mesh__D010975 1988-01-01
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D010975 2006
% 209.04/209.25  |- mesh__recordOriginator mesh__D010975 SCD
% 209.04/209.25  |- skos__altLabel mesh__D010975 Platelet Antiaggregants
% 209.04/209.25  |- skos__hiddenLabel mesh__D010975 Inhibitors, Platelet Aggregation
% 209.04/209.25  |- mesh__dateRevised mesh__D010975 2005-06-30
% 209.04/209.25  |- skos__hiddenLabel mesh__D010975 Antagonists, Platelet
% 209.04/209.25  |- skos__altLabel mesh__D010975 Blood Platelet Antagonists
% 209.04/209.25  |- skos__hiddenLabel mesh__D010975 Inhibitors, Platelet
% 209.04/209.25  |- skos__scopeNote mesh__D010975
% 209.04/209.25       Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.%A%    
% 209.04/209.25  |- skos__altLabel mesh__D010975 Blood Platelet Antiaggregants
% 209.04/209.25  |- skos__historyNote mesh__D010975 Blood Platelets %28%1966-1987%29%
% 209.04/209.25  |- skos__hiddenLabel mesh__D010975 Aggregation Inhibitors, Platelet
% 209.04/209.25  |- mesh__dateCreated mesh__D010975 1987-03-13
% 209.04/209.25  |- skos__historyNote mesh__D010975 Platelet Adhesiveness %28%1972-1987%29%
% 209.04/209.25  |- skos__hiddenLabel mesh__D010975 Antiaggregants, Blood Platelet
% 209.04/209.25  |- skos__hiddenLabel mesh__D010975 Agents, Antiplatelet
% 209.04/209.25  |- rdf__type mesh__D010975sskos__Concept
% 209.04/209.25  |- skos__historyNote mesh__D010975 Platelet Aggregation %28%1976-1987%29%
% 209.04/209.25  |- mesh__recordMaintainer mesh__D010975 ssb
% 209.04/209.25  |- skos__prefLabel mesh__D010975 Platelet Aggregation Inhibitors
% 209.04/209.25  |- skos__altLabel mesh__D010975 Antiplatelet Drugs
% 209.04/209.25  |- skos__broader mesh__D010975smesh__D006401
% 209.04/209.25  |- mesh__publicMeSHNote mesh__D010975 88   
% 209.04/209.25  |- skos__altLabel mesh__D010975 Antiaggregants, Platelet
% 209.04/209.25  |- mesh__dateRevised mesh__D010177 1999-12-01
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D010177 1990
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D010177 1994
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D010177 2000
% 209.04/209.25  |- rdf__type mesh__D010177sskos__Concept
% 209.04/209.25  |- mesh__recordAuthorizer mesh__D010177 ags
% 209.04/209.25  |- mesh__recordMaintainer mesh__D010177 ags
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D010177 1989
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D010177 2004
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D010177 1997
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D010177 2002
% 209.04/209.25  |- mesh__dateCreated mesh__D010177 1999-01-01
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D010177 1993
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D010177 2003
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D010177 1996
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D010177 1991
% 209.04/209.25  |- skos__prefLabel mesh__D010177 Panama Canal Zone
% 209.04/209.25  |- skos__broader mesh__D010177smesh__D010176
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D010177 2006
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D010177 1999
% 209.04/209.25  |- skos__annotation mesh__D010177 do not confuse with PANAMA   
% 209.04/209.25  |- mesh__recordOriginator mesh__D010177 NLM
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D010177 1992
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D010177 2000A
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D010177 1995
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D010177 2001
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D010177 2005
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D010177 1998
% 209.04/209.25  |- skos__hiddenLabel mesh__D004938 Esophagus Cancers
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D004938 2005
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D004938 2006
% 209.04/209.25  |- mesh__dateCreated mesh__D004938 1999-01-01
% 209.04/209.25  |- mesh__recordMaintainer mesh__D004938 lkt
% 209.04/209.25  |- skos__hiddenLabel mesh__D004938 Neoplasm, Esophagus
% 209.04/209.25  |- mesh__recordOriginator mesh__D004938 NLM
% 209.04/209.25  |- skos__scopeNote mesh__D004938 Tumors or cancer of the ESOPHAGUS.     
% 209.04/209.25  |- skos__hiddenLabel mesh__D004938 Esophageal Cancers
% 209.04/209.25  |- mesh__recordAuthorizer mesh__D004938 sjn
% 209.04/209.25  |- rdf__type mesh__D004938sskos__Concept
% 209.04/209.25  |- skos__broader mesh__D004938smesh__D005770
% 209.04/209.25  |- skos__altLabel mesh__D004938 Esophagus Cancer
% 209.04/209.25  |- skos__annotation mesh__D004938
% 209.04/209.25       coord IM with histol type of neopl %28%IM%29%   
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D004938 2004
% 209.04/209.25  |- skos__hiddenLabel mesh__D004938 Neoplasm, Esophageal
% 209.04/209.25  |- skos__altLabel mesh__D004938 Esophageal Cancer
% 209.04/209.25  |- skos__hiddenLabel mesh__D004938 Cancer, Esophageal
% 209.04/209.25  |- skos__hiddenLabel mesh__D004938 Neoplasms, Esophagus
% 209.04/209.25  |- skos__prefLabel mesh__D004938 Esophageal Neoplasms
% 209.04/209.25  |- skos__hiddenLabel mesh__D004938 Cancers, Esophageal
% 209.04/209.25  |- skos__altLabel mesh__D004938 Cancer of the Esophagus
% 209.04/209.25  |- skos__hiddenLabel mesh__D004938 Cancers, Esophagus
% 209.04/209.25  |- skos__broader mesh__D004938smesh__D006258
% 209.04/209.25  |- skos__hiddenLabel mesh__D004938 Esophagus Neoplasms
% 209.04/209.25  |- skos__altLabel mesh__D004938 Esophagus Neoplasm
% 209.04/209.25  |- skos__broader mesh__D004938smesh__D004935
% 209.04/209.25  |- skos__hiddenLabel mesh__D004938 Esophageal Neoplasm
% 209.04/209.25  |- skos__hiddenLabel mesh__D004938 Cancer, Esophagus
% 209.04/209.25  |- mesh__dateRevised mesh__D004938 2003-07-09
% 209.04/209.25  |- skos__altLabel mesh__D004938 Neoplasms, Esophageal
% 209.04/209.25  |- skos__hiddenLabel mesh__D015660 Deethylase, Ethoxycoumarin
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D015660 2006
% 209.04/209.25  |- skos__altLabel mesh__D015660 7-Ethoxycoumarin O-Deethylase
% 209.04/209.25  |- skos__altLabel mesh__D015660 7-Ethoxycoumarin O-Dealkylase
% 209.04/209.25  |- skos__altLabel mesh__D015660 Cytochrome P-450-Dependent O-Dealkylase
% 209.04/209.25  |- skos__hiddenLabel mesh__D015660 7 Ethoxycoumarin Monooxygenase
% 209.04/209.25  |- skos__broader mesh__D015660smesh__D001189
% 209.04/209.25  |- mesh__dateRevised mesh__D015660 2004-07-07
% 209.04/209.25  |- skos__hiddenLabel mesh__D015660 Dealkylase, 7-Ethoxycoumarin
% 209.04/209.25  |- skos__hiddenLabel mesh__D015660 7 Ethoxycoumarin O Dealkylase
% 209.04/209.25  |- skos__hiddenLabel mesh__D015660 7 Ethoxycoumarin Dealkylase
% 209.04/209.25  |- rdf__type mesh__D015660sskos__Concept
% 209.04/209.25  |- skos__hiddenLabel mesh__D015660 O-Depropylase, 7-Propoxycoumarin
% 209.04/209.25  |- skos__hiddenLabel mesh__D015660 7 Ethoxycoumarin Hydroxylase
% 209.04/209.25  |- mesh__recordMaintainer mesh__D015660 ssb
% 209.04/209.25  |- skos__hiddenLabel mesh__D015660 Monooxygenase, 7-Ethoxycoumarin
% 209.04/209.25  |- skos__altLabel mesh__D015660 7-Propoxycoumarin O-Depropylase
% 209.04/209.25  |- skos__altLabel mesh__D015660 7-Ethoxycoumarin Hydroxylase
% 209.04/209.25  |- mesh__historyNote mesh__D015660 90   
% 209.04/209.25  |- skos__altLabel mesh__D015660 Ethoxycoumarin Deethylase
% 209.04/209.25  |- skos__hiddenLabel mesh__D015660 Hydroxylase, 7-Ethoxycoumarin
% 209.04/209.25  |- skos__hiddenLabel mesh__D015660 P-450-Dependent O-Dealkylase, Cytochrome
% 209.04/209.25  |- skos__hiddenLabel mesh__D015660 Ethoxycoumarin O Deethylase
% 209.04/209.25  |- mesh__recordOriginator mesh__D015660 RLS
% 209.04/209.25  |- mesh__publicMeSHNote mesh__D015660 90   
% 209.04/209.25  |- skos__altLabel mesh__D015660 7-Ethoxycoumarin Monooxygenase
% 209.04/209.25  |- skos__hiddenLabel mesh__D015660 7 Alkoxycoumarin O Dealkylase
% 209.04/209.25  |- skos__altLabel mesh__D015660 7-Ethoxycoumarin Dealkylase
% 209.04/209.25  |- skos__historyNote mesh__D015660 Oxygenases %28%1966-1989%29%
% 209.04/209.25  |- skos__altLabel mesh__D015660 7-Ethoxycoumarin O-De-Ethylase
% 209.04/209.25  |- skos__hiddenLabel mesh__D015660 7 Ethoxycoumarin O Deethylase
% 209.04/209.25  |- skos__altLabel mesh__D015660 Ethoxycoumarin O-Deethylase
% 209.04/209.25  |- skos__hiddenLabel mesh__D015660 7 Propoxycoumarin O Depropylase
% 209.04/209.25  |- skos__scopeNote mesh__D015660
% 209.04/209.25       A drug-metabolizing enzyme found in the hepatic, placental and intestinal microsomes that metabolizes 7-alkoxycoumarin to 7-hydroxycoumarin. The enzyme is cytochrome P-450- dependent.%A%    
% 209.04/209.25  |- skos__hiddenLabel mesh__D015660 O-Deethylase, 7-Ethoxycoumarin
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D015660 2005
% 209.04/209.25  |- mesh__recordAuthorizer mesh__D015660 sjn
% 209.04/209.25  |- skos__prefLabel mesh__D015660 7-Alkoxycoumarin O-Dealkylase
% 209.04/209.25  |- skos__hiddenLabel mesh__D015660 Cytochrome P 450 Dependent O Dealkylase
% 209.04/209.25  |- mesh__dateEstablished mesh__D015660 1990-01-01
% 209.04/209.25  |- skos__hiddenLabel mesh__D015660 7 Ethoxycoumarin O De Ethylase
% 209.04/209.25  |- mesh__dateCreated mesh__D015660 1989-05-25
% 209.04/209.25  |- rdf__type mesh__D009623sskos__Concept
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D009623 1998
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D009623 2004
% 209.04/209.25  |- mesh__recordAuthorizer mesh__D009623 PLS
% 209.04/209.25  |- mesh__dateEstablished mesh__D009623 1991-01-01
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D009623 2000
% 209.04/209.25  |- skos__hiddenLabel mesh__D009623 Noises, Occupational
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D009623 1999
% 209.04/209.25  |- skos__scopeNote mesh__D009623
% 209.04/209.25       Noise present in occupational, industrial, and factory situations.%A%    
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D009623 2001
% 209.04/209.25  |- mesh__publicMeSHNote mesh__D009623 91; was see under NOISE 1979-90   
% 209.04/209.25  |- mesh__dateCreated mesh__D009623 1978-05-22
% 209.04/209.25  |- skos__broader mesh__D009623smesh__D009622
% 209.04/209.25  |- skos__annotation mesh__D009623
% 209.04/209.25       coord IM with specific occupation %28%IM%29% if pertinent; consider also HEARING LOSS, NOISE-INDUCED; DF: NOISE OCCUP%A%  
% 209.04/209.25  |- skos__altLabel mesh__D009623 Occupational Noise
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D009623 2005
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D009623 1996
% 209.04/209.25  |- skos__historyNote mesh__D009623 Occupational Medicine %28%1966-1978%29%
% 209.04/209.25  |- skos__hiddenLabel mesh__D009623 Occupational Noises
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D009623 2006
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D009623 1997
% 209.04/209.25  |- skos__historyNote mesh__D009623 Noise %28%1966-1978%29%
% 209.04/209.25  |- mesh__historyNote mesh__D009623
% 209.04/209.25       91%28%79%29%; was see under NOISE 1979-90   
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D009623 2002
% 209.04/209.25  |- mesh__dateRevised mesh__D009623 1995-05-18
% 209.04/209.25  |- skos__prefLabel mesh__D009623 Noise, Occupational
% 209.04/209.25  |- mesh__recordOriginator mesh__D009623 RC
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D009623 2003
% 209.04/209.25  |- mesh__recordMaintainer mesh__D009623 KEV
% 209.04/209.25  |- mesh__recordMaintainer mesh__D001640 ssb
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D001640 2004
% 209.04/209.25  |- rdf__type mesh__D001640sskos__Concept
% 209.04/209.25  |- skos__historyNote mesh__D001640 Dioxoles %28%1972-1974%29%
% 209.04/209.25  |- mesh__dateRevised mesh__D001640 2003-07-09
% 209.04/209.25  |- skos__historyNote mesh__D001640 Isoquinolines %28%1971-1974%29%
% 209.04/209.25  |- skos__historyNote mesh__D001640 Alkaloids %28%1972-1974%29%
% 209.04/209.25  |- mesh__dateCreated mesh__D001640 1974-11-11
% 209.04/209.25  |- mesh__dateEstablished mesh__D001640 1980-01-01
% 209.04/209.25  |- skos__altLabel mesh__D001640
% 209.04/209.25       6-%28%5,6,7,8-Tetrahydro-6-methyl-1,3-dioxolo%28%4,5-g%29%isoquinolin-5-yl%29%furo%28%3,4-e%29%1,3-benzodioxol-8%28%6H%29%one
% 209.04/209.25  |- skos__broader mesh__D001640smesh__D044182
% 209.04/209.25  |- mesh__recordOriginator mesh__D001640 NLM
% 209.04/209.25  |- mesh__historyNote mesh__D001640
% 209.04/209.25       80%28%75%29%; was see under ISOQUINOLINES 1975-79   
% 209.04/209.25  |- mesh__recordAuthorizer mesh__D001640 sjn
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D001640 2006
% 209.04/209.25  |- skos__prefLabel mesh__D001640 Bicuculline
% 209.04/209.25  |- mesh__publicMeSHNote mesh__D001640
% 209.04/209.25       80; was see under ISOQUINOLINES 1975-79   
% 209.04/209.25  |- skos__broader mesh__D001640smesh__D000470
% 209.04/209.25  |- skos__scopeNote mesh__D001640
% 209.04/209.25       Isoquinoline alkaloid from Dicentra cucullaria and other plants that is a competitive antagonist at GABA-A receptors and thus causes convulsions.%A%    
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D001640 2005
% 209.04/209.25  |- skos__hiddenLabel mesh__D014568 Urokinase Type Plasminogen Activator
% 209.04/209.25  |- skos__historyNote mesh__D014568 Fibrinolytic Agents %28%1966-1974%29%
% 209.04/209.25  |- mesh__activeMeSHYear mesh__D014568 2006
% 209.04/209.25  |- skos__altLabel mesh__D014568 Plasminogen Activator, Urokinase-Type
% 209.04/209.25  |- mesh__recordAuthorizer mesh__D014568 sjn
% 209.04/209.26  |- skos__hiddenLabel mesh__D014568 Activator, Urinary Plasminogen
% 209.04/209.26  |- mesh__dateCreated mesh__D014568 1999-01-01
% 209.04/209.26  |- skos__hiddenLabel mesh__D014568
% 209.04/209.26       Single Chain Urokinase Type Plasminogen Activator
% 209.04/209.26  |- skos__broader mesh__D014568smesh__D010960
% 209.04/209.26  |- skos__annotation mesh__D014568 DF: U-PA   
% 209.04/209.26  |- skos__hiddenLabel mesh__D014568 Activator, U-Plasminogen
% 209.04/209.26  |- skos__hiddenLabel mesh__D014568 U Plasminogen Activator
% 209.04/209.26  |- rdf__type mesh__D014568sskos__Concept
% 209.04/209.26  |- mesh__recordMaintainer mesh__D014568 ssb
% 209.04/209.26  |- mesh__recordOriginator mesh__D014568 NLM
% 209.04/209.26  |- skos__altLabel mesh__D014568 Urokinase
% 209.04/209.26  |- skos__altLabel mesh__D014568 U-Plasminogen Activator
% 209.04/209.26  |- skos__prefLabel mesh__D014568 Urinary Plasminogen Activator
% 209.04/209.26  |- mesh__publicMeSHNote mesh__D014568
% 209.04/209.26       2000; see UROKINASE 1984-1999, see PEPTIDE PEPTIDOHYDROLASES 1975-1983, see FIBRINOLYTIC AGENTS 1966-1974, see STREPTODORNASE AND STREPTOKINASE 1963-1965, UROKINASE-TYPE PLASMINOGEN ACTIVATOR was indexed under PLASMINOGEN ACTIVATORS %26% UROKINASE 1984-1999%A%  
% 209.04/209.26  |- skos__altLabel mesh__D014568 Urokinase-Type Plasminogen Activator
% 209.04/209.26  |- mesh__historyNote mesh__D014568
% 209.04/209.26       2000%28%1963%29%; for UROKINASE-TYPE PLASMINOGEN ACTIVATOR use URINARY PLASMINOGEN ACTIVATOR %28%NM%29% 1984-1999%A%  
% 209.04/209.26  |- mesh__dateEstablished mesh__D014568 1984-01-01
% 209.04/209.26  |- skos__hiddenLabel mesh__D014568 Plasminogen Activator, Urinary
% 209.04/209.26  |- mesh__dateRevised mesh__D014568 2005-06-30
% 209.04/209.26  |- skos__altLabel mesh__D014568 U-PA
% 209.04/209.26  |- skos__broader mesh__D014568smesh__D012697
% 209.04/209.26  |- skos__scopeNote mesh__D014568
% 209.04/209.26       A proteolytic enzyme that converts plasminogen to plasmin where the preferential cleavage is between arginine and valine. It was isolated originally from human urine, but is found in most tissues of most vertebrates. EC 3.4.21.73.%A%    
% 209.04/209.26  |- skos__altLabel mesh__D033722
% 209.04/209.26       Nitrobenzylmercaptopurine Riboside %28%NBMPR%29%-Insensitive, Equilibrative Nucleoside Transporter
% 209.04/209.26  |- mesh__publicMeSHNote mesh__D033722
% 209.04/209.26       2003; EQUILIBRATIVE-NUCLEOSIDE TRANSPORTER 2 was indexed under MEMBRANE TRANSPORT PROTEINS 2002, CARRIER PROTEINS 1998-2001 %26% MEMBRANE PROTEINS 1998-2001%A%  
% 209.04/209.26  |- mesh__historyNote mesh__D033722
% 209.04/209.26       2003; use EQUILIBRATIVE-NUCLEOSIDE TRANSPORTER 2 %28%NM%29% 1998-2002%A%  
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D033722 2005
% 209.04/209.26  |- skos__historyNote mesh__D033722 Membrane Transport Proteins %28%2002%29%
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D033722 2003
% 209.04/209.26  |- mesh__dateEstablished mesh__D033722 2003-01-01
% 209.04/209.26  |- skos__altLabel mesh__D033722
% 209.04/209.26       Equilibrative, Nitrobenzylmercaptopurine Riboside %28%NBMPR%29%-Insensitive Nucleoside Transporter
% 209.04/209.26  |- skos__broader mesh__D033722smesh__D033705
% 209.04/209.26  |- skos__historyNote mesh__D033722 Carrier Proteins %28%1998-2001%29%
% 209.04/209.26  |- skos__altLabel mesh__D033722
% 209.04/209.26       Solute Carrier-Family 29 %28%Nucleoside Transporters%29%, Member 2
% 209.04/209.26  |- mesh__recordAuthorizer mesh__D033722 sjn
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D033722 2006
% 209.04/209.26  |- skos__historyNote mesh__D033722 Membrane Proteins %28%1998-2001%29%
% 209.04/209.26  |- mesh__dateCreated mesh__D033722 2002-07-03
% 209.04/209.26  |- skos__scopeNote mesh__D033722
% 209.04/209.26       A subtype of equilibrative nucleoside transporter proteins that is insensitive to inhibition by 4-nitrobenzylthioinosine.%A%    
% 209.04/209.26  |- skos__altLabel mesh__D033722 SLC29A2 Protein
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D033722 2004
% 209.04/209.26  |- rdf__type mesh__D033722sskos__Concept
% 209.04/209.26  |- mesh__recordMaintainer mesh__D033722 jmp
% 209.04/209.26  |- mesh__recordOriginator mesh__D033722 jmp
% 209.04/209.26  |- skos__prefLabel mesh__D033722 Equilibrative-Nucleoside Transporter 2
% 209.04/209.26  |- skos__broader mesh__D019253smesh__D011518
% 209.04/209.26  |- skos__hiddenLabel mesh__D019253 Proto Oncogene Proteins c bcl 2
% 209.04/209.26  |- mesh__dateRevised mesh__D019253 2005-06-30
% 209.04/209.26  |- skos__broader mesh__D019253smesh__D051017
% 209.04/209.26  |- mesh__publicMeSHNote mesh__D019253
% 209.04/209.26       97; PROTO-ONCOGENE PROTEIN BCL-2 was indexed under PROTO-ONCOGENE PROTEINS 1989-96%A%  
% 209.04/209.26  |- skos__hiddenLabel mesh__D019253 Proto-Oncogene Proteins, bcl-2
% 209.04/209.26  |- skos__historyNote mesh__D019253
% 209.04/209.26       Proto-Oncogene Proteins %28%1989-1996%29%
% 209.04/209.26  |- mesh__recordOriginator mesh__D019253 AGS
% 209.04/209.26  |- skos__hiddenLabel mesh__D019253 bcl 2 Proto Oncogene Proteins
% 209.04/209.26  |- mesh__recordMaintainer mesh__D019253 DRC
% 209.04/209.26  |- skos__scopeNote mesh__D019253
% 209.04/209.26       Membrane proteins encoded by the BCL-2 GENES and serving as potent inhibitors of cell death by APOPTOSIS. The proteins are found on mitochondrial, microsomal, and NUCLEAR MEMBRANE sites within many cell types. Overexpression of bcl-2 proteins, due to a translocation of the gene, is associated with follicular lymphoma.%A%    
% 209.04/209.26  |- skos__prefLabel mesh__D019253 Proto-Oncogene Proteins c-bcl-2
% 209.04/209.26  |- skos__altLabel mesh__D019253 c-bcl-2 Proteins
% 209.04/209.26  |- mesh__dateEstablished mesh__D019253 1997-01-01
% 209.04/209.26  |- skos__altLabel mesh__D019253 bcl-2 Proto-Oncogene Proteins
% 209.04/209.26  |- mesh__onlineNote mesh__D019253
% 209.04/209.26       use PROTO-ONCOGENE PROTEINS C-BCL-2 %28%NM%29% to search PROTO-ONCOGENE PROTEIN BCL-2 1989-96%A%  
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D019253 2006
% 209.04/209.26  |- rdf__type mesh__D019253sskos__Concept
% 209.04/209.26  |- skos__hiddenLabel mesh__D019253 c-bcl-2, Proto-Oncogene Proteins
% 209.04/209.26  |- mesh__dateCreated mesh__D019253 1996-06-10
% 209.04/209.26  |- mesh__recordAuthorizer mesh__D019253 sjn
% 209.04/209.26  |- skos__hiddenLabel mesh__D019253 c bcl 2 Proteins
% 209.04/209.26  |- skos__hiddenLabel mesh__D019253 B Cell Leukemia 2 Family Proteins
% 209.04/209.26  |- mesh__historyNote mesh__D019253
% 209.04/209.26       97; was PROTO-ONCOGENE PROTEIN BCL-2 %28%NM%29% 1989-96   
% 209.04/209.26  |- mesh__recordAuthorizer mesh__D000548 ags
% 209.04/209.26  |- skos__prefLabel mesh__D000548 Amaranth Dye
% 209.04/209.26  |- mesh__dateRevised mesh__D000548 2005-07-07
% 209.04/209.26  |- mesh__dateEstablished mesh__D000548 1991-01-01
% 209.04/209.26  |- mesh__dateCreated mesh__D000548 1974-11-19
% 209.04/209.26  |- rdf__type mesh__D000548sskos__Concept
% 209.04/209.26  |- mesh__publicMeSHNote mesh__D000548
% 209.04/209.26       2002; see AMARANTH 1991-2001, see AZO COMPOUNDS 1975-1990; for C.I. ACID RED 27, C.I. 16185, %26% FD%26%C RED NO. 2 see AMARANTH 1975-1993%A%  
% 209.04/209.26  |- skos__annotation mesh__D000548
% 209.04/209.26       AMARANTH PLANT see AMARANTHUS is also available; D25-26 qualif%A%  
% 209.04/209.26  |- skos__scopeNote mesh__D000548
% 209.04/209.26       A sulfonic acid-based naphthylazo dye used as a coloring agent for foodstuffs and medicines and as a dye and chemical indicator. It was banned by the FDA in 1976 for use in foods, drugs, and cosmetics. %28%From Merck Index, 11th ed%29%%A%    
% 209.04/209.26  |- skos__broader mesh__D000548smesh__D009282
% 209.04/209.26  |- mesh__historyNote mesh__D000548 1991%28%1975%29%   
% 209.04/209.26  |- skos__historyNote mesh__D000548 Naphthalenesulfonates %28%1974%29%
% 209.04/209.26  |- skos__historyNote mesh__D000548 Azo Compounds %28%1969-1975%29%
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D000548 2006
% 209.04/209.26  |- skos__hiddenLabel mesh__D000548 Dye, Amaranth
% 209.04/209.26  |- mesh__recordMaintainer mesh__D000548 ags
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D000548 2006A
% 209.04/209.26  |- skos__altLabel mesh__D000548 Red Dye No. 2
% 209.04/209.26  |- skos__broader mesh__D000548smesh__D001391
% 209.04/209.26  |- mesh__recordOriginator mesh__D000548 NLM
% 209.04/209.26  |- skos__scopeNote mesh__D011270
% 209.04/209.26       The process of bearing developing young %28%EMBRYOS or FETUSES%29% in utero in non-human mammals, beginning from FERTILIZATION to BIRTH.%A%    
% 209.04/209.26  |- mesh__dateCreated mesh__D011270 1999-01-01
% 209.04/209.26  |- mesh__recordMaintainer mesh__D011270 lkt
% 209.04/209.26  |- skos__broader mesh__D011270smesh__D011247
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D011270 2006
% 209.04/209.26  |- skos__hiddenLabel mesh__D011270 Animal Pregnancy
% 209.04/209.26  |- skos__hiddenLabel mesh__D011270 Animal Pregnancies
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D011270 2005
% 209.04/209.26  |- mesh__dateRevised mesh__D011270 2004-07-07
% 209.04/209.26  |- rdf__type mesh__D011270sskos__Concept
% 209.04/209.26  |- skos__prefLabel mesh__D011270 Pregnancy, Animal
% 209.04/209.26  |- skos__related mesh__D011270smesh__D000831
% 209.04/209.26  |- skos__hiddenLabel mesh__D011270 Pregnancies, Animal
% 209.04/209.26  |- mesh__recordOriginator mesh__D011270 NLM
% 209.04/209.26  |- mesh__recordAuthorizer mesh__D011270 sjn
% 209.04/209.26  |- skos__annotation mesh__D011270
% 209.04/209.26       IM for articles on normal animal pregn but check also tag PREGNANCY; for NIM animal pregnancy do not index PREGNANCY, ANIMAL: merely check tag PREGNANCY; check tags ANIMALS %26% FEMALE also; Manual 18.4.6; DF: PREGN ANIMAL%A%  
% 209.04/209.26  |- skos__broader mesh__D005233smesh__D000438
% 209.04/209.26  |- mesh__dateCreated mesh__D005233 1999-01-01
% 209.04/209.26  |- skos__historyNote mesh__D005233 Alcohols %28%1966-1971%29%
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D005233 2006
% 209.04/209.26  |- skos__prefLabel mesh__D005233 Fatty Alcohols
% 209.04/209.26  |- mesh__recordAuthorizer mesh__D005233 sjn
% 209.04/209.26  |- mesh__recordMaintainer mesh__D005233 ssb
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D005233 2005
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D005233 2004
% 209.04/209.26  |- mesh__publicMeSHNote mesh__D005233
% 209.04/209.26       72; SODIUM TETRADECYL SULFATE was SODIUM TETRADECYL SULFATES see under SCLEROSING SOLUTIONS 1963-74%A%  
% 209.04/209.26  |- mesh__recordOriginator mesh__D005233 NLM
% 209.04/209.26  |- skos__scopeNote mesh__D005233
% 209.04/209.26       Usually high-molecular-weight, straight-chain primary alcohols, but can also range from as few as 4 carbons, derived from natural fats and oils, including lauryl, stearyl, oleyl, and linoleyl alcohols. They are used in pharmaceuticals, cosmetics, detergents, plastics, and lube oils and in textile manufacture. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%    
% 209.04/209.26  |- mesh__dateRevised mesh__D005233 2003-07-09
% 209.04/209.26  |- mesh__dateEstablished mesh__D005233 1972-01-01
% 209.04/209.26  |- mesh__historyNote mesh__D005233 72   
% 209.04/209.26  |- skos__broader mesh__D005233smesh__D008055
% 209.04/209.26  |- skos__hiddenLabel mesh__D005233 Alcohols, Fatty
% 209.04/209.26  |- rdf__type mesh__D005233sskos__Concept
% 209.04/209.26  |- skos__altLabel mesh__D018959 CD57 Antigens
% 209.04/209.26  |- skos__historyNote mesh__D018959
% 209.04/209.26       Antigens, Differentiation, T-Lymphocyte %28%1989-1993%29%
% 209.04/209.26  |- skos__altLabel mesh__D018959 CD57 Antigen
% 209.04/209.26  |- skos__altLabel mesh__D018959 Leu-7 Antigen
% 209.04/209.26  |- skos__scopeNote mesh__D018959
% 209.04/209.26       Oligosaccharide antigenic determinants found principally on NK cells and T-cells. Their role in the immune response is poorly understood.%A%    
% 209.04/209.26  |- skos__historyNote mesh__D018959
% 209.04/209.26       Antigens, Differentiation %28%1989-1993%29%
% 209.04/209.26  |- mesh__dateCreated mesh__D018959 1995-05-26
% 209.04/209.26  |- rdf__type mesh__D018959sskos__Concept
% 209.04/209.26  |- skos__hiddenLabel mesh__D018959 Antigen, HNK-1
% 209.04/209.26  |- skos__hiddenLabel mesh__D018959 Leu 7 Antigen
% 209.04/209.26  |- mesh__recordMaintainer mesh__D018959 ssb
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D018959 2006
% 209.04/209.26  |- skos__annotation mesh__D018959 T-lymphocyte differentiation antigens   
% 209.04/209.26  |- mesh__dateEstablished mesh__D018959 1996-01-01
% 209.04/209.26  |- skos__hiddenLabel mesh__D018959 HNK 1 Antigen
% 209.04/209.26  |- skos__hiddenLabel mesh__D018959 Antigen, CD57
% 209.04/209.26  |- mesh__historyNote mesh__D018959
% 209.04/209.26       96; was HNK-1 ANTIGEN %28%NM%29% 1989-95   
% 209.04/209.26  |- mesh__recordOriginator mesh__D018959 AGS
% 209.04/209.26  |- mesh__onlineNote mesh__D018959
% 209.04/209.26       use ANTIGENS, CD57 %28%NM%29% to search HNK-1 ANTIGEN 1989-95   
% 209.04/209.26  |- skos__broader mesh__D018959smesh__D015703
% 209.04/209.26  |- skos__altLabel mesh__D018959 HNK-1 Antigen
% 209.04/209.26  |- skos__prefLabel mesh__D018959 Antigens, CD57
% 209.04/209.26  |- skos__historyNote mesh__D018959 Antigens, CD %28%1990-1995%29%
% 209.04/209.26  |- mesh__dateRevised mesh__D018959 2005-06-30
% 209.04/209.26  |- skos__broader mesh__D018959smesh__D000945
% 209.04/209.26  |- mesh__recordAuthorizer mesh__D018959 sjn
% 209.04/209.26  |- skos__hiddenLabel mesh__D018959 Antigen, Leu-7
% 209.04/209.26  |- mesh__publicMeSHNote mesh__D018959
% 209.04/209.26       96; HNK-1 ANTIGEN was indexed under ANTIGENS, CD 1990-95; ANTIGENS DIFFERENTIATION, T-LYMPHOCYTE 1989-95; %26% ANTIGENS, DIFFERENTIATION 1989-93%A%  
% 209.04/209.26  |- skos__hiddenLabel mesh__D010976 Count, Platelet
% 209.04/209.26  |- skos__hiddenLabel mesh__D010976 Counts, Platelet
% 209.04/209.26  |- skos__hiddenLabel mesh__D010976 Blood Platelet Counts
% 209.04/209.26  |- skos__scopeNote mesh__D010976
% 209.04/209.26       The number of PLATELETS per unit volume in a sample of venous BLOOD.%A%    
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D010976 2006
% 209.04/209.26  |- skos__hiddenLabel mesh__D010976 Numbers, Platelet
% 209.04/209.26  |- mesh__dateEstablished mesh__D010976 1980-01-01
% 209.04/209.26  |- skos__prefLabel mesh__D010976 Platelet Count
% 209.04/209.26  |- skos__hiddenLabel mesh__D010976 Platelet Counts
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D010976 2005
% 209.04/209.26  |- skos__hiddenLabel mesh__D010976 Numbers, Blood Platelet
% 209.04/209.26  |- mesh__publicMeSHNote mesh__D010976 80   
% 209.04/209.26  |- mesh__recordAuthorizer mesh__D010976 sjn
% 209.04/209.26  |- mesh__recordOriginator mesh__D010976 SMH
% 209.04/209.26  |- skos__altLabel mesh__D010976 Blood Platelet Number
% 209.04/209.26  |- skos__broader mesh__D010976smesh__D010979
% 209.04/209.26  |- skos__altLabel mesh__D010976 Platelet Number
% 209.04/209.26  |- skos__historyNote mesh__D010976 Blood Cell Count %28%1966-1979%29%
% 209.04/209.26  |- skos__hiddenLabel mesh__D010976 Number, Blood Platelet
% 209.04/209.26  |- skos__hiddenLabel mesh__D010976 Platelet Numbers, Blood
% 209.04/209.26  |- skos__hiddenLabel mesh__D010976 Platelet Numbers
% 209.04/209.26  |- mesh__historyNote mesh__D010976 80   
% 209.04/209.26  |- rdf__type mesh__D010976sskos__Concept
% 209.04/209.26  |- skos__hiddenLabel mesh__D010976 Platelet Count, Blood
% 209.04/209.26  |- skos__hiddenLabel mesh__D010976 Number, Platelet
% 209.04/209.26  |- mesh__dateRevised mesh__D010976 2003-07-09
% 209.04/209.26  |- skos__annotation mesh__D010976
% 209.04/209.26       usually NIM; coord with disease /blood, not /physiopathol%A%  
% 209.04/209.26  |- mesh__recordMaintainer mesh__D010976 nns
% 209.04/209.26  |- skos__hiddenLabel mesh__D010976 Count, Blood Platelet
% 209.04/209.26  |- skos__historyNote mesh__D010976 Blood Platelets %28%1966-1979%29%
% 209.04/209.26  |- skos__hiddenLabel mesh__D010976 Counts, Blood Platelet
% 209.04/209.26  |- mesh__dateCreated mesh__D010976 1979-03-12
% 209.04/209.26  |- skos__hiddenLabel mesh__D010976 Platelet Number, Blood
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D010976 2004
% 209.04/209.26  |- skos__broader mesh__D010976smesh__D001772
% 209.04/209.26  |- skos__hiddenLabel mesh__D010976 Blood Platelet Numbers
% 209.04/209.26  |- skos__altLabel mesh__D010976 Blood Platelet Count
% 209.04/209.26  |- skos__hiddenLabel mesh__D010976 Platelet Counts, Blood
% 209.04/209.26  |- mesh__recordAuthorizer mesh__D029681 sjn
% 209.04/209.26  |- mesh__recordOriginator mesh__D029681 jmp
% 209.04/209.26  |- skos__hiddenLabel mesh__D029681 Proteins, Arabidopsis thaliana
% 209.04/209.26  |- mesh__dateCreated mesh__D029681 2001-07-25
% 209.04/209.26  |- skos__hiddenLabel mesh__D029681 thaliana Proteins, Arabidopsis
% 209.04/209.26  |- mesh__publicMeSHNote mesh__D029681 2002   
% 209.04/209.26  |- mesh__dateEstablished mesh__D029681 2002-01-01
% 209.04/209.26  |- mesh__historyNote mesh__D029681 2002   
% 209.04/209.26  |- skos__scopeNote mesh__D029681
% 209.04/209.26       Proteins that originate from plants species belonging to the genus ARABIDOPSIS. The most intensely studied species of Arabidopsis, Arabidopsis thaliana, is commonly used in laboratory experiments.%A%    
% 209.04/209.26  |- skos__historyNote mesh__D029681 Plant Proteins %28%1994-2001%29%
% 209.04/209.26  |- rdf__type mesh__D029681sskos__Concept
% 209.04/209.26  |- mesh__recordMaintainer mesh__D029681 SYSTEM
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D029681 2006
% 209.04/209.26  |- mesh__dateRevised mesh__D029681 2005-06-30
% 209.04/209.26  |- skos__related mesh__D029681smesh__D017360
% 209.04/209.26  |- skos__prefLabel mesh__D029681 Arabidopsis Proteins
% 209.04/209.26  |- skos__altLabel mesh__D029681 Thale Cress Proteins
% 209.04/209.26  |- skos__broader mesh__D029681smesh__D010940
% 209.04/209.26  |- skos__prefLabel mesh__D010178 Pancoast%27%s Syndrome
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D010178 2000
% 209.04/209.26  |- skos__scopeNote mesh__D010178
% 209.04/209.26       Destructive lesions of the thoracic inlet with involvement of the brachial and sympathetic plexus or carcinoma of the lung apex. It is characterized by pain in the shoulder region radiating toward the axilla and scapula, sensory and motor disorders and wasting of the muscles of the hand, the Bernard-Horner syndrome, and compression of the blood vessels with edema. %28%Jablonski%27%s Dictionary of Syndromes and Eponymic Diseases, 2d ed%29%%A%    
% 209.04/209.26  |- mesh__recordOriginator mesh__D010178 NLM
% 209.04/209.26  |- mesh__dateCreated mesh__D010178 1999-01-01
% 209.04/209.26  |- rdf__type mesh__D010178sskos__Concept
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D010178 2003
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D010178 1996
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D010178 2001
% 209.04/209.26  |- skos__broader mesh__D010178smesh__D008175
% 209.04/209.26  |- mesh__recordMaintainer mesh__D010178 KEV
% 209.04/209.26  |- mesh__recordAuthorizer mesh__D010178 PLS
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D010178 2004
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D010178 1997
% 209.04/209.26  |- skos__annotation mesh__D010178 an apicocostovertebral syndrome   
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D010178 2002
% 209.04/209.26  |- skos__hiddenLabel mesh__D010178 Syndrome, Pancoast%27%s
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D010178 2005
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D010178 1998
% 209.04/209.26  |- mesh__dateRevised mesh__D010178 1995-06-08
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D010178 2006
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D010178 1999
% 209.04/209.26  |- skos__hiddenLabel mesh__D010178 Pancoast Syndrome
% 209.04/209.26  |- skos__hiddenLabel mesh__D010178 Pancoasts Syndrome
% 209.04/209.26  |- skos__hiddenLabel mesh__D004939 Esophageal Perforations
% 209.04/209.26  |- skos__broader mesh__D004939smesh__D004935
% 209.04/209.26  |- skos__annotation mesh__D004939
% 209.04/209.26       esophageal rupture does not go here: index ESOPHAGUS /inj %28%IM%29% + RUPTURE %28%NIM%29% or ESOPHAGEAL DISEASES %28%IM%29% + RUPTURE, SPONTANEOUS %28%NIM%29%%A%  
% 209.04/209.26  |- rdf__type mesh__D004939sskos__Concept
% 209.04/209.26  |- mesh__recordMaintainer mesh__D004939 lkt
% 209.04/209.26  |- skos__hiddenLabel mesh__D004939 Perforation, Esophageal
% 209.04/209.26  |- mesh__dateRevised mesh__D004939 2004-07-07
% 209.04/209.26  |- mesh__recordOriginator mesh__D004939 NLM
% 209.04/209.26  |- skos__prefLabel mesh__D004939 Esophageal Perforation
% 209.04/209.26  |- skos__scopeNote mesh__D004939
% 209.04/209.26       An opening or hole in the ESOPHAGUS that is caused by TRAUMA, injury, or pathological process.%A%    
% 209.04/209.26  |- mesh__recordAuthorizer mesh__D004939 sjn
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D004939 2005
% 209.04/209.26  |- skos__broader mesh__D004939smesh__D014947
% 209.04/209.26  |- skos__hiddenLabel mesh__D004939 Perforations, Esophageal
% 209.04/209.26  |- mesh__dateCreated mesh__D004939 1999-01-01
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D004939 2006
% 209.04/209.26  |- skos__broader mesh__D015661smesh__D020563
% 209.04/209.26  |- skos__broader mesh__D015661smesh__D006092
% 209.04/209.26  |- mesh__recordMaintainer mesh__D015661 SYSTEM
% 209.04/209.26  |- mesh__dateEstablished mesh__D015661 1990-01-01
% 209.04/209.26  |- mesh__publicMeSHNote mesh__D015661 90   
% 209.04/209.26  |- mesh__recordOriginator mesh__D015661 EGC
% 209.04/209.26  |- mesh__historyNote mesh__D015661 90   
% 209.04/209.26  |- mesh__dateCreated mesh__D015661 1989-07-03
% 209.04/209.26  |- skos__scopeNote mesh__D015661
% 209.04/209.26       A family of coccoid to rod-shaped nonsporeforming, gram-negative, nonmotile, facultatively anaerobic bacteria that includes the genera ACTINOBACILLUS; HAEMOPHILUS; MANNHEIMIA; and PASTEURELLA.%A%    
% 209.04/209.26  |- skos__historyNote mesh__D015661 Pasteurella %28%1974-1989%29%
% 209.04/209.26  |- mesh__recordAuthorizer mesh__D015661 sjn
% 209.04/209.26  |- skos__prefLabel mesh__D015661 Pasteurellaceae
% 209.04/209.26  |- rdf__type mesh__D015661sskos__Concept
% 209.04/209.26  |- mesh__dateRevised mesh__D015661 2005-06-30
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D015661 2006
% 209.04/209.26  |- skos__annotation mesh__D015661 infection = PASTEURELLACEAE INFECTIONS   
% 209.04/209.26  |- mesh__dateCreated mesh__D009624 1978-05-22
% 209.04/209.26  |- skos__hiddenLabel mesh__D009624 Transportation Noises
% 209.04/209.26  |- mesh__dateRevised mesh__D009624 2001-07-25
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D009624 2005
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D009624 2004
% 209.04/209.26  |- mesh__recordMaintainer mesh__D009624 mdb
% 209.04/209.26  |- skos__historyNote mesh__D009624 Noise %28%1966-1978%29%
% 209.04/209.26  |- mesh__publicMeSHNote mesh__D009624 91; was see under NOISE 1979-90   
% 209.04/209.26  |- skos__hiddenLabel mesh__D009624 Noises, Transportation
% 209.04/209.26  |- rdf__type mesh__D009624sskos__Concept
% 209.04/209.26  |- skos__prefLabel mesh__D009624 Noise, Transportation
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D009624 2003
% 209.04/209.26  |- skos__annotation mesh__D009624
% 209.04/209.26       coord IM with specific mode of transport %28%AIRCRAFT; AUTOMOBILES; RAILROADS; etc.%29% %28%IM%29%; consider also HEARING LOSS, NOISE-INDUCED%A%  
% 209.04/209.26  |- mesh__recordAuthorizer mesh__D009624 sjn
% 209.04/209.26  |- mesh__recordOriginator mesh__D009624 RC
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D009624 2002
% 209.04/209.26  |- mesh__historyNote mesh__D009624
% 209.04/209.26       91%28%79%29%; was see under NOISE 1979-90   
% 209.04/209.26  |- mesh__dateEstablished mesh__D009624 1991-01-01
% 209.04/209.26  |- skos__broader mesh__D009624smesh__D009622
% 209.04/209.26  |- skos__hiddenLabel mesh__D009624 Transportation Noise
% 209.04/209.26  |- skos__historyNote mesh__D009624 Aircraft %28%1966-1978%29%
% 209.04/209.26  |- skos__scopeNote mesh__D009624
% 209.04/209.26       Noise associated with transportation, particularly aircraft and automobiles.%A%    
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D009624 2006
% 209.04/209.26  |- rdf__type mesh__D001641sskos__Concept
% 209.04/209.26  |- skos__prefLabel mesh__D001641 Bicuspid
% 209.04/209.26  |- skos__scopeNote mesh__D001641
% 209.04/209.26       One of the eight permanent teeth, two on either side in each jaw, between the canines %28%CUSPID%29% and the molars %28%MOLAR%29%, serving for grinding and crushing food. The upper have two cusps %28%bicuspid%29% but the lower have one to three. %28%Jablonski, Dictionary of Dentistry, 1992, p822%29%%A%    
% 209.04/209.26  |- mesh__dateRevised mesh__D001641 2003-07-09
% 209.04/209.26  |- skos__hiddenLabel mesh__D001641 Premolars
% 209.04/209.26  |- skos__altLabel mesh__D001641 Premolar
% 209.04/209.26  |- mesh__recordMaintainer mesh__D001641 lkt
% 209.04/209.26  |- skos__broader mesh__D001641smesh__D014070
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D001641 2006
% 209.04/209.26  |- mesh__dateEstablished mesh__D001641 1965-01-01
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D001641 2005
% 209.04/209.26  |- skos__annotation mesh__D001641
% 209.04/209.26       between the canine %26% molar teeth; NIM when merely locational%A%  
% 209.04/209.26  |- mesh__recordOriginator mesh__D001641 NLM
% 209.04/209.26  |- mesh__historyNote mesh__D001641 65   
% 209.04/209.26  |- mesh__recordAuthorizer mesh__D001641 sjn
% 209.04/209.26  |- mesh__dateCreated mesh__D001641 1999-01-01
% 209.04/209.26  |- skos__hiddenLabel mesh__D001641 Bicuspids
% 209.04/209.26  |- mesh__publicMeSHNote mesh__D001641 65   
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D001641 2004
% 209.04/209.26  |- mesh__recordAuthorizer mesh__D014569 SJN
% 209.04/209.26  |- rdf__type mesh__D014569sskos__Concept
% 209.04/209.26  |- mesh__recordMaintainer mesh__D014569 MSR
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D014569 2001
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D014569 2004
% 209.04/209.26  |- skos__annotation mesh__D014569
% 209.04/209.26       not used for indexing; DF:UROL MALE GENITAL DIS      CATALOG: do not use%A%  
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D014569 2000
% 209.04/209.26  |- skos__scopeNote mesh__D014569
% 209.04/209.26       A collective term for urinary tract diseases in male and female and diseases of the male genitalia.%A%    
% 209.04/209.26  |- mesh__recordOriginator mesh__D014569 SMH
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D014569 2003
% 209.04/209.26  |- skos__altLabel mesh__D014569 Urological and Male Genital Diseases
% 209.04/209.26  |- mesh__dateRevised mesh__D014569 1998-06-11
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D014569 2006
% 209.04/209.26  |- mesh__runningHead mesh__D014569
% 209.04/209.26       C12 - DISEASES-UROLOGIC AND MALE GENITAL   
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D014569 2002
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D014569 1999
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D014569 2005
% 209.04/209.26  |- mesh__publicMeSHNote mesh__D014569 98   
% 209.04/209.26  |- mesh__dateEstablished mesh__D014569 1998-01-01
% 209.04/209.26  |- skos__prefLabel mesh__D014569 Urologic and Male Genital Diseases
% 209.04/209.26  |- mesh__historyNote mesh__D014569 98; use explode 1978-97   
% 209.04/209.26  |- mesh__dateCreated mesh__D014569 1977-03-29
% 209.04/209.26  |- skos__related mesh__D019254smesh__D019253
% 209.04/209.26  |- skos__altLabel mesh__D019254 bcl-2 Genes
% 209.04/209.26  |- mesh__recordMaintainer mesh__D019254 nns
% 209.04/209.26  |- skos__hiddenLabel mesh__D019254 Gene, bcl-2
% 209.04/209.26  |- skos__historyNote mesh__D019254 Oncogenes %28%1984-1996%29%
% 209.04/209.26  |- skos__broader mesh__D019254smesh__D011519
% 209.04/209.26  |- mesh__dateRevised mesh__D019254 2005-06-30
% 209.04/209.26  |- skos__hiddenLabel mesh__D019254 Proto-Oncogenes, c-bcl-2
% 209.04/209.26  |- skos__scopeNote mesh__D019254
% 209.04/209.26       The B-cell leukemia/lymphoma-2 genes, responsible for blocking apoptosis in normal cells, and associated with follicular lymphoma when overexpressed. Overexpression results from the t%28%14;18%29% translocation. The human c-bcl-2 gene is located at 18q24 on the long arm of chromosome 18.%A%    
% 209.04/209.26  |- mesh__historyNote mesh__D019254 97   
% 209.04/209.26  |- skos__hiddenLabel mesh__D019254 bcl 2 Genes
% 209.04/209.26  |- skos__prefLabel mesh__D019254 Genes, bcl-2
% 209.04/209.26  |- skos__hiddenLabel mesh__D019254 c bcl 2 Proto Oncogenes
% 209.04/209.26  |- skos__hiddenLabel mesh__D019254 Gene, c-bcl-2
% 209.04/209.26  |- mesh__recordOriginator mesh__D019254 AGS
% 209.04/209.26  |- skos__hiddenLabel mesh__D019254 c-bcl-2 Proto-Oncogene
% 209.04/209.26  |- mesh__dateCreated mesh__D019254 1996-06-13
% 209.04/209.26  |- skos__altLabel mesh__D019254 c-bcl-2 Proto-Oncogenes
% 209.04/209.26  |- skos__hiddenLabel mesh__D019254 c-bcl-2 Gene
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D019254 2006
% 209.04/209.26  |- skos__hiddenLabel mesh__D019254 Genes, c-bcl-2
% 209.04/209.26  |- rdf__type mesh__D019254sskos__Concept
% 209.04/209.26  |- mesh__publicMeSHNote mesh__D019254 97   
% 209.04/209.26  |- mesh__dateEstablished mesh__D019254 1997-01-01
% 209.04/209.26  |- skos__hiddenLabel mesh__D019254 c bcl 2 Genes
% 209.04/209.26  |- skos__historyNote mesh__D019254 Proto-Oncogenes %28%1988-1996%29%
% 209.04/209.26  |- skos__hiddenLabel mesh__D019254 bcl-2 Gene
% 209.04/209.26  |- skos__hiddenLabel mesh__D019254 Proto-Oncogene, c-bcl-2
% 209.04/209.26  |- skos__hiddenLabel mesh__D019254 Genes, bcl 2
% 209.04/209.26  |- skos__annotation mesh__D019254 bcl stands for %22%B-Cell Leukemia%22%   
% 209.04/209.26  |- mesh__recordAuthorizer mesh__D019254 sjn
% 209.04/209.26  |- rdf__type mesh__D000549sskos__Concept
% 209.04/209.26  |- mesh__recordOriginator mesh__D000549 NLM
% 209.04/209.26  |- skos__broader mesh__D000549smesh__D000644
% 209.04/209.26  |- mesh__recordMaintainer mesh__D000549 ssb
% 209.04/209.26  |- mesh__dateCreated mesh__D000549 1999-01-01
% 209.04/209.26  |- skos__hiddenLabel mesh__D000549 Chloride, Ambenonium
% 209.04/209.26  |- skos__altLabel mesh__D000549
% 209.04/209.26       Sanofi Winthrop Brand of Ambenonium Chloride
% 209.04/209.26  |- mesh__recordAuthorizer mesh__D000549 sjn
% 209.04/209.26  |- mesh__historyNote mesh__D000549
% 209.04/209.26       65; AMBESTIGMINUM was see AMBENONIUM CHLORIDE 1977-94   
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D000549 2006
% 209.04/209.26  |- skos__broader mesh__D000549smesh__D050339
% 209.04/209.26  |- mesh__dateEstablished mesh__D000549 1965-01-01
% 209.04/209.26  |- mesh__dateRevised mesh__D000549 2005-06-30
% 209.04/209.26  |- skos__scopeNote mesh__D000549
% 209.04/209.26       A quaternary ammonium compound that is an inhibitor of cholinesterase activity with actions similar to those of NEOSTIGMINE, but of longer duration. Ambenonium is given by mouth in the treatment of myasthenia gravis. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1112%29%%A%    
% 209.04/209.26  |- mesh__publicMeSHNote mesh__D000549
% 209.04/209.26       65; AMBESTIGMINUM was see AMBENONIUM CHLORIDE 1977-94   
% 209.04/209.26  |- skos__prefLabel mesh__D000549 Ambenonium Chloride
% 209.04/209.26  |- mesh__onlineNote mesh__D000549
% 209.04/209.26       use AMBENONIUM CHLORIDE to search AMBESTIGMINUM 1977-94   
% 209.04/209.26  |- mesh__activeMeSHYear mesh__D011271 2006
% 209.04/209.26  |- mesh__recordOriginator mesh__D011271 NLM
% 209.04/209.26  |- skos__annotation mesh__D011271
% 209.04/209.26       check the tags FEMALE %26% PREGNANCY; heterotopic = PREGNANCY %28%IM%29% + PREGNANCY, ECTOPIC or its specifics %28%IM%29% + site %28%NIM%29%; DF: PREGN ECTOPIC%A%  
% 209.04/209.26  |- skos__hiddenLabel mesh__D011271 Ectopic Pregnancies
% 209.04/209.26  |- skos__broader mesh__D011271smesh__D011248
% 209.04/209.26  |- mesh__recordAuthorizer mesh__D011271 sjn
% 209.04/209.26  |- skos__hiddenLabel mesh__D011271 Pregnancies, Ectopic
% 209.04/209.26  |- skos__altLabel mesh__D011271 Ovarian Pregnancy
% 209.04/209.26  |- mesh__dateRevised mesh__D011271 2005-06-30
% 209.04/209.26  |- skos__scopeNote mesh__D011271
% 209.04/209.26       A potentially life-threatening condition in which the EMBRYO implants outside the cavity of the UTERUS. Most ectopic pregnancies %28%%3E%96%25%%29% occur in the FALLOPIAN TUBES, known as TUBAL PREGNANCY. They can be in other locations, such as UTERINE CERVIX; OVARY; and abdominal cavity %28%PREGNANCY, ABDOMINAL%29%.%A%    
% 209.04/209.26  |- skos__prefLabel mesh__D011271 Pregnancy, Ectopic
% 209.04/209.26  |- rdf__type mesh__D011271sskos__Concept
% 209.04/209.26  |- skos__hiddenLabel mesh__D011271 Ovarian Pregnancies
% 209.04/209.26  |- mesh__recordMaintainer mesh__D011271 lkt
% 209.04/209.27  |- mesh__dateCreated mesh__D011271 1999-01-01
% 209.04/209.27  |- skos__hiddenLabel mesh__D011271 Pregnancies, Ovarian
% 209.04/209.27  |- skos__altLabel mesh__D011271 Ectopic Pregnancy
% 209.04/209.27  |- skos__altLabel mesh__D005234 Liver Steatosis
% 209.04/209.27  |- skos__broader mesh__D005234smesh__D008107
% 209.04/209.27  |- rdf__type mesh__D005234sskos__Concept
% 209.04/209.27  |- skos__scopeNote mesh__D005234
% 209.04/209.27       Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.%A%    
% 209.04/209.27  |- mesh__recordMaintainer mesh__D005234 lkt
% 209.04/209.27  |- mesh__recordAuthorizer mesh__D005234 sjn
% 209.04/209.27  |- mesh__dateCreated mesh__D005234 1999-01-01
% 209.04/209.27  |- mesh__recordOriginator mesh__D005234 NLM
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D005234 2006
% 209.04/209.27  |- mesh__dateRevised mesh__D005234 2004-07-07
% 209.04/209.27  |- skos__hiddenLabel mesh__D005234 Steatosis, Liver
% 209.04/209.27  |- skos__prefLabel mesh__D005234 Fatty Liver
% 209.04/209.27  |- skos__hiddenLabel mesh__D005234 Liver, Fatty
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D005234 2005
% 209.04/209.27  |- skos__hiddenLabel mesh__D010977 Factor 3, Platelet
% 209.04/209.27  |- skos__scopeNote mesh__D010977
% 209.04/209.27       A lipoprotein with pronounced electronegative surface charge found in association with platelet membrane and platelet granules. In the sequence of blood coagulation reactions, it is required for activation of factor VIII and for the conversion of prothrombin to thrombin.%A%    
% 209.04/209.27  |- mesh__dateRevised mesh__D010977 2005-06-30
% 209.04/209.27  |- skos__altLabel mesh__D010977 PF3
% 209.04/209.27  |- rdf__type mesh__D010977sskos__Concept
% 209.04/209.27  |- mesh__publicMeSHNote mesh__D010977
% 209.04/209.27       91; was see under BLOOD COAGULATION FACTORS 1975-90   
% 209.04/209.27  |- skos__historyNote mesh__D010977 Blood Platelets %28%1974%29%
% 209.04/209.27  |- mesh__recordOriginator mesh__D010977 NLM
% 209.04/209.27  |- mesh__historyNote mesh__D010977
% 209.04/209.27       91%28%75%29%; was see under BLOOD COAGULATION FACTORS 1975-90   
% 209.04/209.27  |- skos__prefLabel mesh__D010977 Platelet Factor 3
% 209.04/209.27  |- mesh__recordMaintainer mesh__D010977 ssb
% 209.04/209.27  |- skos__historyNote mesh__D010977 Lipoproteins %28%1974%29%
% 209.04/209.27  |- skos__altLabel mesh__D010977 PF 3
% 209.04/209.27  |- mesh__dateCreated mesh__D010977 1974-11-19
% 209.04/209.27  |- skos__broader mesh__D010977smesh__D008074
% 209.04/209.27  |- skos__historyNote mesh__D010977 Blood Coagulation Factors %28%1974%29%
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D010977 2006
% 209.04/209.27  |- mesh__recordAuthorizer mesh__D010977 sjn
% 209.04/209.27  |- mesh__dateEstablished mesh__D010977 1991-01-01
% 209.04/209.27  |- skos__annotation mesh__D010977 a coagulant   
% 209.04/209.27  |- skos__broader mesh__D010977smesh__D001779
% 209.04/209.27  |- skos__prefLabel mesh__D029682 Amsinckia
% 209.04/209.27  |- mesh__dateCreated mesh__D029682 2001-07-25
% 209.04/209.27  |- mesh__publicMeSHNote mesh__D029682 2002   
% 209.04/209.27  |- skos__broader mesh__D029682smesh__D028082
% 209.04/209.27  |- mesh__dateRevised mesh__D029682 2002-07-02
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D029682 2005
% 209.04/209.27  |- mesh__recordAuthorizer mesh__D029682 sjn
% 209.04/209.27  |- rdf__type mesh__D029682sskos__Concept
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D029682 2006
% 209.04/209.27  |- mesh__recordMaintainer mesh__D029682 ssb
% 209.04/209.27  |- skos__scopeNote mesh__D029682
% 209.04/209.27       A plant genus of the family BORAGINACEAE. Members contain PYRROLIZIDINE ALKALOIDS.  The common name of burweed is also used for Triumfetta %28%TILIACEAE%29%.%A%    
% 209.04/209.27  |- skos__annotation mesh__D029682
% 209.04/209.27       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.04/209.27  |- mesh__historyNote mesh__D029682 2002   
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D029682 2003
% 209.04/209.27  |- mesh__dateEstablished mesh__D029682 2002-01-01
% 209.04/209.27  |- mesh__recordOriginator mesh__D029682 ssb
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D029682 2004
% 209.04/209.27  |- mesh__recordOriginator mesh__D010179 NLM
% 209.04/209.27  |- mesh__dateCreated mesh__D010179 1999-01-01
% 209.04/209.27  |- mesh__recordMaintainer mesh__D010179 sjn
% 209.04/209.27  |- rdf__type mesh__D010179sskos__Concept
% 209.04/209.27  |- skos__annotation mesh__D010179
% 209.04/209.27       /enzymol: consider also PANCREATIN for %22%pancreatic enzymes%22% particularly in ther; /surg: consider also PANCREATECTOMY; note that ISLETS OF LANGERHANS TRANSPLANTATION is also available; inflammation = PANCREATITIS; pancreatic A, B, C cells: index under ISLETS OF LANGERHANS; D cells = SOMATOSTATIN-SECRETING CELLS%A%  
% 209.04/209.27  |- mesh__dateRevised mesh__D010179 2005-07-01
% 209.04/209.27  |- skos__prefLabel mesh__D010179 Pancreas
% 209.04/209.27  |- skos__scopeNote mesh__D010179
% 209.04/209.27       A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion %28%EXOCRINE PANCREAS%29% is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.%A%    
% 209.04/209.27  |- skos__related mesh__D010179smesh__D010180
% 209.04/209.27  |- skos__broader mesh__D010179smesh__D004064
% 209.04/209.27  |- mesh__recordAuthorizer mesh__D010179 sjn
% 209.04/209.27  |- skos__related mesh__D010179smesh__D010193
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D010179 2006
% 209.04/209.27  |- mesh__publicMeSHNote mesh__D015662 90   
% 209.04/209.27  |- skos__prefLabel mesh__D015662 Trimethoprim-Sulfamethoxazole Combination
% 209.04/209.27  |- skos__hiddenLabel mesh__D015662
% 209.04/209.27       Trimethoprim Sulfamethoxazole Combination
% 209.04/209.27  |- skos__altLabel mesh__D015662 Eslectin
% 209.04/209.27  |- skos__hiddenLabel mesh__D015662 Biseptol480
% 209.04/209.27  |- skos__historyNote mesh__D015662 Sulfamethoxazole %28%1966-1989%29%
% 209.04/209.27  |- skos__altLabel mesh__D015662 TMP-SMX
% 209.04/209.27  |- skos__altLabel mesh__D015662 Centrin
% 209.04/209.27  |- skos__annotation mesh__D015662 DF: TMP SMX   
% 209.04/209.27  |- skos__altLabel mesh__D015662 Cotrimoxazole
% 209.04/209.27  |- mesh__dateRevised mesh__D015662 2004-07-07
% 209.04/209.27  |- rdf__type mesh__D015662sskos__Concept
% 209.04/209.27  |- skos__altLabel mesh__D015662 TMP SMX
% 209.04/209.27  |- mesh__dateCreated mesh__D015662 1989-09-01
% 209.04/209.27  |- skos__hiddenLabel mesh__D015662
% 209.04/209.27       Sulfamethoxazole Trimethoprim Combination
% 209.04/209.27  |- skos__broader mesh__D015662smesh__D013420
% 209.04/209.27  |- skos__hiddenLabel mesh__D015662 Trimethoprim Sulfamethoxazole
% 209.04/209.27  |- skos__altLabel mesh__D015662 Sulfamethoxazole-Trimethoprim Combination
% 209.04/209.27  |- mesh__historyNote mesh__D015662 90   
% 209.04/209.27  |- mesh__recordMaintainer mesh__D015662 ssb
% 209.04/209.27  |- skos__scopeNote mesh__D015662
% 209.04/209.27       This drug combination has proved to be an effective therapeutic agent with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.%A%    
% 209.04/209.27  |- skos__hiddenLabel mesh__D015662 Biseptol 480
% 209.04/209.27  |- skos__altLabel mesh__D015662 Insozalin
% 209.04/209.27  |- skos__historyNote mesh__D015662 Drug Combinations %28%1971-1989%29%
% 209.04/209.27  |- skos__altLabel mesh__D015662 Trimedin
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D015662 2006
% 209.04/209.27  |- skos__altLabel mesh__D015662 Centran
% 209.04/209.27  |- mesh__recordAuthorizer mesh__D015662 sjn
% 209.04/209.27  |- skos__altLabel mesh__D015662 Trimethoprim-Sulfamethoxazole
% 209.04/209.27  |- mesh__recordOriginator mesh__D015662 RLS
% 209.04/209.27  |- skos__broader mesh__D015662smesh__D014295
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D015662 2005
% 209.04/209.27  |- skos__historyNote mesh__D015662 Trimethoprim %28%1972-1989%29%
% 209.04/209.27  |- mesh__dateEstablished mesh__D015662 1990-01-01
% 209.04/209.27  |- skos__altLabel mesh__D015662 Co-Trimoxazole
% 209.04/209.27  |- skos__altLabel mesh__D015662 Trimezole
% 209.04/209.27  |- rdf__type mesh__D009625sskos__Concept
% 209.04/209.27  |- mesh__dateRevised mesh__D009625 1996-06-10
% 209.04/209.27  |- skos__broader mesh__D009625smesh__D009059
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D009625 2003
% 209.04/209.27  |- skos__hiddenLabel mesh__D009625 Gangrenous Stomatitis
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D009625 2001
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D009625 1999
% 209.04/209.27  |- skos__hiddenLabel mesh__D009625 Gangrenous Stomatitides
% 209.04/209.27  |- skos__prefLabel mesh__D009625 Noma
% 209.04/209.27  |- mesh__recordOriginator mesh__D009625 NLM
% 209.04/209.27  |- mesh__recordAuthorizer mesh__D009625 PLS
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D009625 2000
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D009625 1997
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D009625 1998
% 209.04/209.27  |- skos__scopeNote mesh__D009625
% 209.04/209.27       A severe gangrenous process occurring predominantly in debilitated and malnourished children, especially in underdeveloped countries. It typically begins as a small vesicle or ulcer on the gingiva that rapidly becomes necrotic and spreads to produce extensive destruction of the buccal and labial mucosa and tissues of the face, which may result in severe disfigurement and even death. Various bacteria have been implicated in the etiology. %28%Dorland, 27th ed%29%%A%    
% 209.04/209.27  |- skos__hiddenLabel mesh__D009625 Nomas
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D009625 2006
% 209.04/209.27  |- skos__hiddenLabel mesh__D009625 Stomatitides, Gangrenous
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D009625 2002
% 209.04/209.27  |- skos__altLabel mesh__D009625 Stomatitis, Gangrenous
% 209.04/209.27  |- mesh__dateCreated mesh__D009625 1999-01-01
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D009625 2004
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D009625 2005
% 209.04/209.27  |- skos__altLabel mesh__D009625 Cancrum Oris
% 209.04/209.27  |- mesh__recordMaintainer mesh__D009625 TGC
% 209.04/209.27  |- skos__annotation mesh__D009625
% 209.04/209.27       severe gangrene of gingiva often spreading to face   
% 209.04/209.27  |- mesh__dateRevised mesh__D001642 1997-06-20
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D001642 2006
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D001642 2002
% 209.04/209.27  |- mesh__dateEstablished mesh__D001642 1990-01-01
% 209.04/209.27  |- mesh__recordMaintainer mesh__D001642 TPW
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D001642 2005
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D001642 1999
% 209.04/209.27  |- skos__historyNote mesh__D001642 Exercise Test %28%1966-1982%29%
% 209.04/209.27  |- skos__historyNote mesh__D001642 Exertion %28%1966-1982%29%
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D001642 2001
% 209.04/209.27  |- skos__scopeNote mesh__D001642
% 209.04/209.27       The use of a bicycle for transportation or recreation. It does not include the use of a bicycle in studying the body%27%s response to physical exertion %28%BICYCLE ERGOMETRY TEST see EXERCISE TEST%29%.%A%    
% 209.04/209.27  |- skos__annotation mesh__D001642
% 209.04/209.27       for transport or recreation: not for test of phys exertion %28% = probably BICYCLE ERGOMETRY TEST see EXERCISE TEST%29%; /inj: coord IM with specific inj %28%IM%29%; /physiol permitted; Manual 30.15.1%A%  
% 209.04/209.27  |- mesh__dateCreated mesh__D001642 1982-04-28
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D001642 2004
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D001642 1998
% 209.04/209.27  |- rdf__type mesh__D001642sskos__Concept
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D001642 2000
% 209.04/209.27  |- skos__prefLabel mesh__D001642 Bicycling
% 209.04/209.27  |- mesh__recordAuthorizer mesh__D001642 SJN
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D001642 2003
% 209.04/209.27  |- mesh__historyNote mesh__D001642
% 209.04/209.27       90%28%83%29%; was see under SPORTS 1983-89   
% 209.04/209.27  |- skos__broader mesh__D001642smesh__D013177
% 209.04/209.27  |- mesh__recordOriginator mesh__D001642 EC
% 209.04/209.27  |- mesh__publicMeSHNote mesh__D001642 90; was see under SPORTS 1983-89   
% 209.04/209.27  |- mesh__recordMaintainer mesh__D019255 AKE
% 209.04/209.27  |- skos__scopeNote mesh__D019255
% 209.04/209.27       A flavoprotein enzyme that catalyzes the univalent reduction of OXYGEN using NADPH as an electron donor to create SUPEROXIDE ANION. The enzyme is dependent on a variety of CYTOCHROMES. Defects in the production of superoxide ions by enzymes such as NADPH oxidase result in GRANULOMATOUS DISEASE, CHRONIC.%A%    
% 209.04/209.27  |- skos__broader mesh__D019255smesh__D009247
% 209.04/209.27  |- mesh__dateEstablished mesh__D019255 1997-01-01
% 209.04/209.27  |- skos__altLabel mesh__D019255 NAD%28%P%29%H oxidase
% 209.04/209.27  |- mesh__recordAuthorizer mesh__D019255 sjn
% 209.04/209.27  |- mesh__dateCreated mesh__D019255 1996-06-10
% 209.04/209.27  |- skos__hiddenLabel mesh__D019255 Oxidase, NADPH
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D019255 2006
% 209.04/209.27  |- rdf__type mesh__D019255sskos__Concept
% 209.04/209.27  |- skos__broader mesh__D019255smesh__D005420
% 209.04/209.27  |- skos__historyNote mesh__D019255 Oxidoreductases %28%1972-1978%29%
% 209.04/209.27  |- skos__historyNote mesh__D019255 NADP %28%1972-1980%29%
% 209.04/209.27  |- mesh__dateRevised mesh__D019255 2005-06-30
% 209.04/209.27  |- skos__historyNote mesh__D019255
% 209.04/209.27       NADH, NADPH Oxidoreductases %28%1979-1996%29%
% 209.04/209.27  |- skos__prefLabel mesh__D019255 NADPH Oxidase
% 209.04/209.27  |- mesh__historyNote mesh__D019255 1997   
% 209.04/209.27  |- mesh__recordOriginator mesh__D019255 TPW
% 209.04/209.27  |- skos__related mesh__D019255smesh__D006105
% 209.04/209.27  |- mesh__publicMeSHNote mesh__D019255
% 209.04/209.27       1997;  NAD%28%P%29%H OXIDASE was indexed under NADH, NADPH OXIDOREDUCTASES 2000-2005; NADPH OXIDASE was indexed under NADH, NADPH OXIDOREDUCTASES 1979-1996, NADP 1972-1980 %26% OXIDOREDUCTASES 1972-1978;%A%  
% 209.04/209.27  |- skos__prefLabel mesh__D011272 Pregnancy, Multiple
% 209.04/209.27  |- skos__broader mesh__D011272smesh__D011247
% 209.04/209.27  |- skos__annotation mesh__D011272
% 209.04/209.27       human %26% animal; this is the mother: TWINS; TRIPLETS; etc. is the offspring; specify TWINS, etc. NIM if pertinent; in ref to animals, do not use PREGNANCY, MULTIPLE for animals naturally having litters; consider LITTER SIZE; not for %22%heterotopic pregnancy%22%: see note at PREGNANCY, ECTOPIC; check tags FEMALE %26% PREGNANCY; Manual 28.16.4, 34.14; DF: PREGN MULTIPLE%A%  
% 209.04/209.27  |- mesh__recordOriginator mesh__D011272 NLM
% 209.04/209.27  |- rdf__type mesh__D011272sskos__Concept
% 209.04/209.27  |- mesh__recordAuthorizer mesh__D011272 sjn
% 209.04/209.27  |- skos__related mesh__D011272smesh__D018607
% 209.04/209.27  |- mesh__dateCreated mesh__D011272 1999-01-01
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D011272 2005
% 209.04/209.27  |- skos__scopeNote mesh__D011272
% 209.04/209.27       The condition of bearing two or more FETUSES simultaneously. %28%Stedman, 25th ed%29%%A%    
% 209.04/209.27  |- skos__hiddenLabel mesh__D011272 Pregnancies, Multiple
% 209.04/209.27  |- skos__hiddenLabel mesh__D011272 Multiple Pregnancies
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D011272 2006
% 209.04/209.27  |- mesh__dateRevised mesh__D011272 2004-07-07
% 209.04/209.27  |- skos__altLabel mesh__D011272 Multiple Pregnancy
% 209.04/209.27  |- mesh__recordMaintainer mesh__D011272 lkt
% 209.04/209.27  |- skos__broader mesh__D005235smesh__D008108
% 209.04/209.27  |- rdf__type mesh__D005235sskos__Concept
% 209.04/209.27  |- skos__prefLabel mesh__D005235 Fatty Liver, Alcoholic
% 209.04/209.27  |- mesh__dateCreated mesh__D005235 1977-04-22
% 209.04/209.27  |- mesh__dateEstablished mesh__D005235 1978-01-01
% 209.04/209.27  |- mesh__recordOriginator mesh__D005235 SMH
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D005235 2006
% 209.04/209.27  |- skos__broader mesh__D005235smesh__D005234
% 209.04/209.27  |- mesh__publicMeSHNote mesh__D005235 78   
% 209.04/209.27  |- mesh__historyNote mesh__D005235 78   
% 209.04/209.27  |- mesh__dateRevised mesh__D005235 2004-07-07
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D005235 2005
% 209.04/209.27  |- skos__historyNote mesh__D005235 Fatty Liver %28%1966-1977%29%
% 209.04/209.27  |- skos__historyNote mesh__D005235 Alcoholism %28%1966-1977%29%
% 209.04/209.27  |- mesh__recordAuthorizer mesh__D005235 sjn
% 209.04/209.27  |- mesh__recordMaintainer mesh__D005235 lkt
% 209.04/209.27  |- skos__altLabel mesh__D005235 Alcoholic Fatty Liver
% 209.04/209.27  |- skos__scopeNote mesh__D005235
% 209.04/209.27       Lipid infiltration of the hepatic parenchymal cells that is due to ALCOHOL ABUSE. The fatty changes in the alcoholic fatty liver may be reversible, depending on the amounts of TRIGLYCERIDES accumulated.%A%    
% 209.04/209.27  |- skos__broader mesh__D005459Q000506smesh__D005459
% 209.04/209.27  |- mesh__preferredCombination mesh__D005459Q000506smesh__D005458
% 209.04/209.27  |- rdf__type mesh__D005459Q000506smesh__CompoundConcept
% 209.04/209.27  |- skos__historyNote mesh__D010978 Glycoproteins %28%1974-1975%29%
% 209.04/209.27  |- skos__hiddenLabel mesh__D010978 gamma Thromboglobulin
% 209.04/209.27  |- skos__altLabel mesh__D010978 gamma-Thromboglobulin
% 209.04/209.27  |- skos__hiddenLabel mesh__D010978 Factor 4, Platelet
% 209.04/209.27  |- skos__altLabel mesh__D010978 PF 4
% 209.04/209.27  |- skos__broader mesh__D010978smesh__D001779
% 209.04/209.27  |- skos__historyNote mesh__D010978
% 209.04/209.27       Blood Coagulation Factors %28%1973-1975%29%
% 209.04/209.27  |- mesh__dateRevised mesh__D010978 2005-06-30
% 209.04/209.27  |- skos__prefLabel mesh__D010978 Platelet Factor 4
% 209.04/209.27  |- skos__historyNote mesh__D010978 Blood Platelets %28%1974-1975%29%
% 209.04/209.27  |- skos__altLabel mesh__D010978 PF4
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D010978 2006
% 209.04/209.27  |- mesh__publicMeSHNote mesh__D010978
% 209.04/209.27       84; was see under BLOOD COAGULATION FACTORS 1976-83   
% 209.04/209.27  |- skos__altLabel mesh__D010978 Antiheparin Factor
% 209.04/209.27  |- mesh__dateCreated mesh__D010978 1975-07-25
% 209.04/209.27  |- skos__broader mesh__D010978smesh__D018925
% 209.04/209.27  |- mesh__recordMaintainer mesh__D010978 ssb
% 209.04/209.27  |- skos__broader mesh__D010978smesh__D011509
% 209.04/209.27  |- mesh__dateEstablished mesh__D010978 1984-01-01
% 209.04/209.27  |- skos__hiddenLabel mesh__D010978 Protein, Heparin Neutralizing
% 209.04/209.27  |- mesh__recordOriginator mesh__D010978 RLS
% 209.04/209.27  |- skos__scopeNote mesh__D010978
% 209.04/209.27       A high-molecular-weight proteoglycan-platelet factor complex which is released from blood platelets by thrombin. It acts as a mediator in the heparin-neutralizing capacity of the blood and plays a role in platelet aggregation. At high ionic strength %28%I=0.75%29%, the complex dissociates into the active component %28%molecular weight 29,000%29% and the proteoglycan carrier %28%chondroitin 4-sulfate, molecular weight 350,000%29%. The molecule exists in the form of a dimer consisting of 8 moles of platelet factor 4 and 2 moles of proteoglycan.%A%    
% 209.04/209.27  |- skos__altLabel mesh__D010978 Heparin Neutralizing Protein
% 209.04/209.27  |- mesh__historyNote mesh__D010978
% 209.04/209.27       84%28%76%29%; was see under BLOOD COAGULATION FACTORS 1976-83   
% 209.04/209.27  |- mesh__recordAuthorizer mesh__D010978 sjn
% 209.04/209.27  |- rdf__type mesh__D010978sskos__Concept
% 209.04/209.27  |- mesh__publicMeSHNote mesh__D029683 2002   
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D029683 2005
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D029683 2002
% 209.04/209.27  |- rdf__type mesh__D029683sskos__Concept
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D029683 2006
% 209.04/209.27  |- skos__prefLabel mesh__D029683 Borago
% 209.04/209.27  |- mesh__dateCreated mesh__D029683 2001-07-25
% 209.04/209.27  |- skos__broader mesh__D029683smesh__D028082
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D029683 2003
% 209.04/209.27  |- mesh__dateEstablished mesh__D029683 2002-01-01
% 209.04/209.27  |- skos__altLabel mesh__D029683 Borage
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D029683 2004
% 209.04/209.27  |- skos__annotation mesh__D029683
% 209.04/209.27       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.04/209.27  |- skos__scopeNote mesh__D029683
% 209.04/209.27       A plant genus of the family BORAGINACEAE.     
% 209.04/209.27  |- mesh__historyNote mesh__D029683 2002   
% 209.04/209.27  |- mesh__recordAuthorizer mesh__D015663 sjn
% 209.04/209.27  |- skos__hiddenLabel mesh__D015663 Osteoporosis, Post Menopausal
% 209.04/209.27  |- skos__altLabel mesh__D015663 Postmenopausal Bone Loss
% 209.04/209.27  |- mesh__historyNote mesh__D015663
% 209.04/209.27       90; BONE LOSS, PERIMENOPAUSAL; BONE LOSS, POSTMENOPAUSAL; PERIMENOPAUSAL BONE LOSS; %26% POSTMENOPAUSAL BONE LOSS were see OSTEOPOROSIS 1987-89%A%  
% 209.04/209.27  |- mesh__publicMeSHNote mesh__D015663
% 209.04/209.27       90; BONE LOSS, PERIMENOPAUSAL; BONE LOSS, POSTMENOPAUSAL; PERIMENOPAUSAL BONE LOSS; %26% POSTMENOPAUSAL BONE LOSS were see OSTEOPOROSIS 1987-89%A%  
% 209.04/209.27  |- skos__historyNote mesh__D015663 Osteoporosis %28%1966-1989%29%
% 209.04/209.27  |- skos__hiddenLabel mesh__D015663 Osteoporoses, Post-Menopausal
% 209.04/209.27  |- skos__altLabel mesh__D015663 Postmenopausal Osteoporosis
% 209.04/209.27  |- skos__broader mesh__D015663smesh__D010024
% 209.04/209.27  |- skos__hiddenLabel mesh__D015663 Perimenopausal Bone Losses
% 209.04/209.27  |- mesh__recordMaintainer mesh__D015663 sjn
% 209.04/209.27  |- rdf__type mesh__D015663sskos__Concept
% 209.04/209.27  |- skos__hiddenLabel mesh__D015663 Bone Losses, Postmenopausal
% 209.04/209.27  |- skos__altLabel mesh__D015663 Osteoporosis, Post-Menopausal
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D015663 2005
% 209.04/209.27  |- skos__scopeNote mesh__D015663
% 209.04/209.27       Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.%A%    
% 209.04/209.27  |- skos__altLabel mesh__D015663 Bone Loss, Perimenopausal
% 209.04/209.27  |- skos__hiddenLabel mesh__D015663 Postmenopausal Bone Losses
% 209.04/209.27  |- skos__hiddenLabel mesh__D015663 Post-Menopausal Osteoporoses
% 209.04/209.27  |- skos__annotation mesh__D015663
% 209.04/209.27        in females; don%27%t forget also check tags  HUMANS + FEMALE; corresponding age-related osteoporosis in men goes under OSTEOPOROSIS%A%  
% 209.04/209.27  |- mesh__onlineNote mesh__D015663
% 209.04/209.27       use OSTEOPOROSIS to search BONE LOSS, PERIMENOPAUSAL; BONE LOSS, POSTMENOPAUSAL; PERIMENOPAUSAL BONE LOSS; %26% POSTMENOPAUSAL BONE LOSS 1987-89%A%  
% 209.04/209.27  |- skos__hiddenLabel mesh__D015663 Bone Losses, Perimenopausal
% 209.04/209.27  |- skos__altLabel mesh__D015663 Bone Loss, Postmenopausal
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D015663 2006
% 209.04/209.27  |- skos__hiddenLabel mesh__D015663 Postmenopausal Osteoporoses
% 209.04/209.27  |- mesh__dateRevised mesh__D015663 2004-07-13
% 209.04/209.27  |- mesh__dateCreated mesh__D015663 1989-05-25
% 209.04/209.27  |- mesh__dateEstablished mesh__D015663 1990-01-01
% 209.04/209.27  |- skos__hiddenLabel mesh__D015663 Post-Menopausal Osteoporosis
% 209.04/209.27  |- skos__altLabel mesh__D015663 Perimenopausal Bone Loss
% 209.04/209.27  |- skos__historyNote mesh__D015663 Menopause %28%1966-1989%29%
% 209.04/209.27  |- skos__hiddenLabel mesh__D015663 Osteoporoses, Postmenopausal
% 209.04/209.27  |- skos__prefLabel mesh__D015663 Osteoporosis, Postmenopausal
% 209.04/209.27  |- mesh__recordOriginator mesh__D015663 AGS
% 209.04/209.27  |- mesh__recordAuthorizer mesh__D009626 sjn
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D009626 2002
% 209.04/209.27  |- mesh__recordMaintainer mesh__D009626 kle
% 209.04/209.27  |- mesh__publicMeSHNote mesh__D009626
% 209.04/209.27       99; was TERMINOLOGY see NOMENCLATURE 1966-98   
% 209.04/209.27  |- skos__hiddenLabel mesh__D009626 Terminologies
% 209.04/209.27  |- skos__broader mesh__D009626smesh__D008037
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D009626 2006
% 209.04/209.27  |- mesh__historyNote mesh__D009626 99%28%66%29%   
% 209.04/209.27  |- skos__annotation mesh__D009626
% 209.04/209.27       IM; no qualif; Manual 33.15; %22%medical nomenclature%22%: do not coord with MEDICINE%A%  
% 209.04/209.27  |- mesh__dateCreated mesh__D009626 1999-01-01
% 209.04/209.27  |- skos__hiddenLabel mesh__D009626 Etymologies
% 209.04/209.27  |- mesh__dateRevised mesh__D009626 1999-11-03
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D009626 2004
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D009626 2005
% 209.04/209.27  |- skos__scopeNote mesh__D009626
% 209.04/209.27       The terms, expressions, designations, or symbols used in a particular science, discipline, or specialized subject area.%A%    
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D009626 2001
% 209.04/209.27  |- rdf__type mesh__D009626sskos__Concept
% 209.04/209.27  |- skos__prefLabel mesh__D009626 Terminology
% 209.04/209.27  |- skos__hiddenLabel mesh__D009626 Nomenclatures
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D009626 2003
% 209.04/209.27  |- mesh__recordOriginator mesh__D009626 NLM
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D009626 2000
% 209.04/209.27  |- mesh__recordOriginator mesh__D001643 NLM
% 209.04/209.27  |- mesh__onlineNote mesh__D001643 search BRIDGED COMPOUNDS 1966-74   
% 209.04/209.27  |- mesh__recordAuthorizer mesh__D001643 PLS
% 209.04/209.27  |- mesh__recordMaintainer mesh__D001643 JRT
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D001643 2002
% 209.04/209.27  |- mesh__dateEstablished mesh__D001643 1991-01-01
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D001643 2006
% 209.04/209.27  |- mesh__publicMeSHNote mesh__D001643
% 209.04/209.27       91; was see under BRIDGED COMPOUNDS 1975-90   
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D001643 1999
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D001643 2001
% 209.04/209.27  |- skos__broader mesh__D001643smesh__D001952
% 209.04/209.27  |- mesh__dateCreated mesh__D001643 1999-01-01
% 209.04/209.27  |- skos__prefLabel mesh__D001643 Bicyclo Compounds
% 209.04/209.27  |- rdf__type mesh__D001643sskos__Concept
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D001643 2005
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D001643 1998
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D001643 2000
% 209.04/209.27  |- mesh__dateRevised mesh__D001643 1995-06-08
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D001643 2004
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D001643 1997
% 209.04/209.27  |- skos__hiddenLabel mesh__D001643 Compounds, Bicyclo
% 209.04/209.27  |- skos__annotation mesh__D001643 DF: BICYCLO CPDS   
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D001643 2003
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D001643 1996
% 209.04/209.27  |- mesh__historyNote mesh__D001643
% 209.04/209.27       91%28%75%29%; was see under BRIDGED COMPOUNDS 1975-90   
% 209.04/209.27  |- skos__altLabel mesh__D019256 Cadmium Dichloride
% 209.04/209.27  |- skos__historyNote mesh__D019256 Cadmium %28%1980-1996%29%
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D019256 2000
% 209.04/209.27  |- skos__scopeNote mesh__D019256
% 209.04/209.27       A cadmium halide in the form of colorless crystals, soluble in water, methanol, and ethanol. It is used in photography, in dyeing, and calico printing, and as a solution to precipitate sulfides. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%    
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D019256 2005
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D019256 2001
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D019256 2006
% 209.04/209.27  |- rdf__type mesh__D019256sskos__Concept
% 209.04/209.27  |- mesh__dateEstablished mesh__D019256 1997-01-01
% 209.04/209.27  |- mesh__publicMeSHNote mesh__D019256
% 209.04/209.27       97; CADMIUM CHLORIDE was indexed under CADMIUM %26% CHLORIDES 1980-96%A%  
% 209.04/209.27  |- skos__broader mesh__D019256smesh__D019187
% 209.04/209.27  |- mesh__recordMaintainer mesh__D019256 adp
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D019256 2002
% 209.04/209.27  |- skos__altLabel mesh__D019256 CdCl2
% 209.04/209.27  |- skos__broader mesh__D019256smesh__D002712
% 209.04/209.27  |- skos__historyNote mesh__D019256 Chlorides %28%1980-1996%29%
% 209.04/209.27  |- mesh__recordAuthorizer mesh__D019256 sjn
% 209.04/209.27  |- mesh__dateCreated mesh__D019256 1996-06-10
% 209.04/209.27  |- mesh__historyNote mesh__D019256
% 209.04/209.27       97; was CADMIUM CHLORIDE %28%NM%29% 1980-96   
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D019256 2003
% 209.04/209.27  |- skos__prefLabel mesh__D019256 Cadmium Chloride
% 209.04/209.27  |- skos__hiddenLabel mesh__D019256 Chloride, Cadmium
% 209.04/209.27  |- skos__hiddenLabel mesh__D019256 Dichloride, Cadmium
% 209.04/209.27  |- mesh__dateRevised mesh__D019256 1999-11-03
% 209.04/209.27  |- mesh__activeMeSHYear mesh__D019256 2004
% 209.04/209.27  |- mesh__recordOriginator mesh__D019256 TPW
% 209.04/209.27  |- mesh__onlineNote mesh__D019256
% 209.04/209.27       use CADMIUM CHLORIDE %28%NM%29% to search CADMIUM CHLORIDE 1980-96%A%  
% 209.04/209.27  |- skos__annotation mesh__D011273
% 209.04/209.27       check tags FEMALE %26% PREGNANCY; DF: PREGN PROLONGED   
% 209.04/209.28  |- skos__hiddenLabel mesh__D011273 Pregnancies, Prolonged
% 209.04/209.28  |- skos__hiddenLabel mesh__D011273 Prolonged Pregnancies
% 209.04/209.28  |- mesh__recordMaintainer mesh__D011273 lkt
% 209.04/209.28  |- skos__altLabel mesh__D011273 Prolonged Pregnancy
% 209.04/209.28  |- mesh__dateCreated mesh__D011273 1999-01-01
% 209.04/209.28  |- skos__scopeNote mesh__D011273
% 209.04/209.28       A term used to describe pregnancies that exceed the upper limit of a normal gestational period. In humans, a prolonged pregnancy is defined as one that extends beyond 42 weeks %28%294 days%29% after the first day of the last menstrual period %28%MENSTRUATION%29%, or birth with gestational age of 41 weeks or more.%A%    
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D011273 2006
% 209.04/209.28  |- mesh__recordOriginator mesh__D011273 NLM
% 209.04/209.28  |- skos__broader mesh__D011273smesh__D011248
% 209.04/209.28  |- mesh__recordAuthorizer mesh__D011273 sjn
% 209.04/209.28  |- rdf__type mesh__D011273sskos__Concept
% 209.04/209.28  |- mesh__dateRevised mesh__D011273 2005-06-30
% 209.04/209.28  |- skos__prefLabel mesh__D011273 Pregnancy, Prolonged
% 209.04/209.28  |- skos__broader mesh__D005236smesh__D005517
% 209.04/209.28  |- mesh__dateCreated mesh__D005236 1999-01-01
% 209.04/209.28  |- skos__broader mesh__D005236smesh__D010939
% 209.04/209.28  |- rdf__type mesh__D005236sskos__Concept
% 209.04/209.28  |- skos__annotation mesh__D005236
% 209.04/209.28       a hemolytic anemia caused by fava bean or its pollen   
% 209.04/209.28  |- mesh__recordAuthorizer mesh__D005236 sjn
% 209.04/209.28  |- skos__hiddenLabel mesh__D005236 Favisms
% 209.04/209.28  |- mesh__recordMaintainer mesh__D005236 nns
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D005236 2005
% 209.04/209.28  |- mesh__recordOriginator mesh__D005236 NLM
% 209.04/209.28  |- skos__broader mesh__D005236smesh__D005955
% 209.04/209.28  |- mesh__dateRevised mesh__D005236 2001-07-25
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D005236 2006
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D005236 2003
% 209.04/209.28  |- skos__scopeNote mesh__D005236
% 209.04/209.28       Hemolytic anemia due to the ingestion of fava beans or after inhalation of pollen from the Vicia fava plant by persons with glucose-6-phosphate dehydrogenase deficient erythrocytes.%A%    
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D005236 2004
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D005236 2002
% 209.04/209.28  |- skos__prefLabel mesh__D005236 Favism
% 209.04/209.28  |- skos__broader mesh__D005236smesh__D000743
% 209.04/209.28  |- skos__hiddenLabel mesh__D010979 Function Test, Platelet
% 209.04/209.28  |- rdf__type mesh__D010979sskos__Concept
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D010979 1999
% 209.04/209.28  |- skos__hiddenLabel mesh__D010979 Platelet Function Test
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D010979 2003
% 209.04/209.28  |- mesh__recordAuthorizer mesh__D010979 SJN
% 209.04/209.28  |- skos__hiddenLabel mesh__D010979 Tests, Platelet Function
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D010979 2002
% 209.04/209.28  |- skos__prefLabel mesh__D010979 Platelet Function Tests
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D010979 2005
% 209.04/209.28  |- mesh__recordOriginator mesh__D010979 SMH
% 209.04/209.28  |- skos__hiddenLabel mesh__D010979 Function Tests, Platelet
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D010979 2004
% 209.04/209.28  |- skos__annotation mesh__D010979 NIM   
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D010979 2006
% 209.04/209.28  |- mesh__historyNote mesh__D010979 80   
% 209.04/209.28  |- skos__broader mesh__D010979smesh__D006403
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D010979 2000
% 209.04/209.28  |- mesh__dateEstablished mesh__D010979 1980-01-01
% 209.04/209.28  |- skos__historyNote mesh__D010979 Platelet Aggregation %28%1975-1979%29%
% 209.04/209.28  |- skos__historyNote mesh__D010979 Platelet Adhesiveness %28%1969-1979%29%
% 209.04/209.28  |- skos__historyNote mesh__D010979 Blood Platelets %28%1966-1979%29%
% 209.04/209.28  |- skos__hiddenLabel mesh__D010979 Test, Platelet Function
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D010979 2001
% 209.04/209.28  |- mesh__dateRevised mesh__D010979 1997-06-20
% 209.04/209.28  |- mesh__dateCreated mesh__D010979 1979-03-07
% 209.04/209.28  |- mesh__recordMaintainer mesh__D010979 PXP
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D010979 1998
% 209.04/209.28  |- mesh__publicMeSHNote mesh__D010979 80   
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D029684 2006
% 209.04/209.28  |- skos__scopeNote mesh__D029684
% 209.04/209.28       A plant genus of the family BORAGINACEAE. Members contain lithospermans and lithospermic acid.%A%    
% 209.04/209.28  |- skos__annotation mesh__D029684
% 209.04/209.28       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.04/209.28  |- mesh__recordAuthorizer mesh__D029684 sjn
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D029684 2003
% 209.04/209.28  |- mesh__recordMaintainer mesh__D029684 ssb
% 209.04/209.28  |- skos__altLabel mesh__D029684 Gromwell
% 209.04/209.28  |- skos__altLabel mesh__D029684 Lithospermi
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D029684 2004
% 209.04/209.28  |- mesh__historyNote mesh__D029684 2002   
% 209.04/209.28  |- mesh__dateEstablished mesh__D029684 2002-01-01
% 209.04/209.28  |- mesh__recordOriginator mesh__D029684 ssb
% 209.04/209.28  |- skos__prefLabel mesh__D029684 Lithospermum
% 209.04/209.28  |- skos__broader mesh__D029684smesh__D028082
% 209.04/209.28  |- mesh__dateRevised mesh__D029684 2002-07-03
% 209.04/209.28  |- mesh__publicMeSHNote mesh__D029684 2002   
% 209.04/209.28  |- mesh__dateCreated mesh__D029684 2001-07-25
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D029684 2005
% 209.04/209.28  |- skos__altLabel mesh__D029684 Puccoon
% 209.04/209.28  |- rdf__type mesh__D029684sskos__Concept
% 209.04/209.28  |- skos__altLabel mesh__D009627 Linamiphen
% 209.04/209.28  |- skos__altLabel mesh__D009627 Nomifensine Maleate %28%1:1%29%
% 209.04/209.28  |- skos__scopeNote mesh__D009627
% 209.04/209.28       An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p266%29%%A%    
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D009627 2006
% 209.04/209.28  |- skos__hiddenLabel mesh__D009627 Hoe 984
% 209.04/209.28  |- mesh__recordAuthorizer mesh__D009627 sjn
% 209.04/209.28  |- skos__historyNote mesh__D009627 Isoquinolines %28%1969-1977%29%
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D009627 2004
% 209.04/209.28  |- mesh__publicMeSHNote mesh__D009627
% 209.04/209.28       86; was see under ISOQUINOLINES 1978-85   
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D009627 2005
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D009627 2002
% 209.04/209.28  |- rdf__type mesh__D009627sskos__Concept
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D009627 2003
% 209.04/209.28  |- skos__hiddenLabel mesh__D009627 Maleate, Nomifensine
% 209.04/209.28  |- mesh__dateCreated mesh__D009627 1977-04-22
% 209.04/209.28  |- skos__historyNote mesh__D009627 Quinolines %28%1966-1968%29%
% 209.04/209.28  |- skos__altLabel mesh__D009627 Nomifensin
% 209.04/209.28  |- skos__hiddenLabel mesh__D009627 Hoe984
% 209.04/209.28  |- mesh__recordOriginator mesh__D009627 SH
% 209.04/209.28  |- mesh__historyNote mesh__D009627
% 209.04/209.28       86%28%78%29%; was see under ISOQUINOLINES 1978-85   
% 209.04/209.28  |- skos__prefLabel mesh__D009627 Nomifensine
% 209.04/209.28  |- mesh__recordMaintainer mesh__D009627 ssb
% 209.04/209.28  |- mesh__dateRevised mesh__D009627 2001-07-25
% 209.04/209.28  |- skos__broader mesh__D009627smesh__D007546
% 209.04/209.28  |- mesh__dateEstablished mesh__D009627 1986-01-01
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D001644 2006
% 209.04/209.28  |- mesh__historyNote mesh__D001644 84   
% 209.04/209.28  |- rdf__type mesh__D001644sskos__Concept
% 209.04/209.28  |- mesh__dateEstablished mesh__D001644 1984-01-01
% 209.04/209.28  |- mesh__recordAuthorizer mesh__D001644 sjn
% 209.04/209.28  |- skos__historyNote mesh__D001644 Actinomycetaceae %28%1975-1983%29%
% 209.04/209.28  |- skos__scopeNote mesh__D001644
% 209.04/209.28       A rod-shaped, gram-positive, non-acid-fast, non-spore-forming, non-motile bacterium that is a genus of the family Bifidobacteriaceae, order Bifidobacteriales, class ACTINOBACTERIA. It inhabits the intestines and feces of humans as well as the human vagina.%A%    
% 209.04/209.28  |- mesh__recordOriginator mesh__D001644 RC
% 209.04/209.28  |- skos__annotation mesh__D001644
% 209.04/209.28       infection: coord IM with BIFIDOBACTERIALES INFECTIONS %28%IM%29%; DF: BIFIDOBACT%A%  
% 209.04/209.28  |- mesh__publicMeSHNote mesh__D001644 84   
% 209.04/209.28  |- skos__broader mesh__D001644smesh__D039903
% 209.04/209.28  |- mesh__recordMaintainer mesh__D001644 SYSTEM
% 209.04/209.28  |- skos__prefLabel mesh__D001644 Bifidobacterium
% 209.04/209.28  |- mesh__dateRevised mesh__D001644 2005-06-30
% 209.04/209.28  |- skos__historyNote mesh__D001644 Actinomycetales %28%1967-1974%29%
% 209.04/209.28  |- mesh__dateCreated mesh__D001644 1983-03-10
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D020000 1999
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D020000 2005
% 209.04/209.28  |- skos__altLabel mesh__D020000 Clinical Decision Support Systems
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D020000 2000
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D020000 2006
% 209.04/209.28  |- rdf__type mesh__D020000sskos__Concept
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D020000 2001
% 209.04/209.28  |- mesh__dateEstablished mesh__D020000 1998-01-01
% 209.04/209.28  |- skos__prefLabel mesh__D020000 Decision Support Systems, Clinical
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D020000 2003
% 209.04/209.28  |- mesh__historyNote mesh__D020000 98   
% 209.04/209.28  |- mesh__dateCreated mesh__D020000 1997-06-20
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D020000 2004
% 209.04/209.28  |- skos__broader mesh__D020000smesh__D007256
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D020000 2002
% 209.04/209.28  |- skos__scopeNote mesh__D020000
% 209.04/209.28       Computer-based information systems used to integrate clinical and patient information and provide support for decision-making in patient care.%A%    
% 209.04/209.28  |- mesh__publicMeSHNote mesh__D020000 98   
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D020000 1998
% 209.04/209.28  |- rdf__type mesh__D019257sskos__Concept
% 209.04/209.28  |- mesh__recordAuthorizer mesh__D019257 sjn
% 209.04/209.28  |- mesh__recordMaintainer mesh__D019257 jmp
% 209.04/209.28  |- skos__historyNote mesh__D019257 Ergolines %28%1981-1996%29%
% 209.04/209.28  |- mesh__recordOriginator mesh__D019257 TPW
% 209.04/209.28  |- mesh__publicMeSHNote mesh__D019257
% 209.04/209.28       97; QUINPIROLE was indexed under ERGOLINES 1981-96   
% 209.04/209.28  |- skos__altLabel mesh__D019257 Quinpirole Monohydrochloride
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D019257 2003
% 209.04/209.28  |- skos__scopeNote mesh__D019257 A dopamine D2/D3 receptor agonist.     
% 209.04/209.28  |- mesh__historyNote mesh__D019257 97; was QUINPIROLE %28%NM%29% 1981-96   
% 209.04/209.28  |- mesh__dateRevised mesh__D019257 2001-07-25
% 209.04/209.28  |- skos__broader mesh__D019257smesh__D011804
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D019257 2004
% 209.04/209.28  |- mesh__dateEstablished mesh__D019257 1997-01-01
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D019257 2005
% 209.04/209.28  |- skos__broader mesh__D019257smesh__D006575
% 209.04/209.28  |- skos__prefLabel mesh__D019257 Quinpirole
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D019257 2002
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D019257 2006
% 209.04/209.28  |- mesh__onlineNote mesh__D019257
% 209.04/209.28       use QUINPIROLE %28%NM%29% to search QUINPIROLE 1981-96   
% 209.04/209.28  |- mesh__dateCreated mesh__D019257 1996-06-10
% 209.04/209.28  |- skos__hiddenLabel mesh__D011274 Tubal Pregnancies
% 209.04/209.28  |- mesh__recordAuthorizer mesh__D011274 sjn
% 209.04/209.28  |- mesh__dateRevised mesh__D011274 2005-06-30
% 209.04/209.28  |- skos__prefLabel mesh__D011274 Pregnancy, Tubal
% 209.04/209.28  |- mesh__recordMaintainer mesh__D011274 lkt
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D011274 2006
% 209.04/209.28  |- skos__altLabel mesh__D011274 Tubal Pregnancy
% 209.04/209.28  |- skos__broader mesh__D011274smesh__D011271
% 209.04/209.28  |- skos__scopeNote mesh__D011274
% 209.04/209.28       The most common %28%%3E%96%25%%29% type of ectopic pregnancy in which the extrauterine EMBRYO IMPLANTATION occurs in the FALLOPIAN TUBE, usually in the ampullary region where FERTILIZATION takes place.%A%    
% 209.04/209.28  |- rdf__type mesh__D011274sskos__Concept
% 209.04/209.28  |- skos__annotation mesh__D011274
% 209.04/209.28       check the tags FEMALE %26% PREGNANCY; heterotopic or combined uterine %26% tubal pregnancy: see note on PREGNANCY, ECTOPIC; DF: PREGN TUBAL%A%  
% 209.04/209.28  |- mesh__recordOriginator mesh__D011274 NLM
% 209.04/209.28  |- mesh__dateCreated mesh__D011274 1999-01-01
% 209.04/209.28  |- skos__hiddenLabel mesh__D011274 Pregnancies, Tubal
% 209.04/209.28  |- skos__broader mesh__D014955Q000293smesh__D014955
% 209.04/209.28  |- mesh__preferredCombination mesh__D014955Q000293smesh__D014954
% 209.04/209.28  |- rdf__type mesh__D014955Q000293smesh__CompoundConcept
% 209.04/209.28  |- mesh__dateCreated mesh__D029685 2001-07-25
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D029685 2004
% 209.04/209.28  |- skos__annotation mesh__D029685
% 209.04/209.28       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.04/209.28  |- mesh__dateEstablished mesh__D029685 2002-01-01
% 209.04/209.28  |- mesh__publicMeSHNote mesh__D029685 2002   
% 209.04/209.28  |- mesh__historyNote mesh__D029685 2002   
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D029685 2005
% 209.04/209.28  |- skos__scopeNote mesh__D029685
% 209.04/209.28       A plant genus of the family BORAGINACEAE.     
% 209.04/209.28  |- skos__prefLabel mesh__D029685 Pulmonaria
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D029685 2006
% 209.04/209.28  |- rdf__type mesh__D029685sskos__Concept
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D029685 2002
% 209.04/209.28  |- skos__altLabel mesh__D029685 Lungwort
% 209.04/209.28  |- skos__broader mesh__D029685smesh__D028082
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D029685 2003
% 209.04/209.28  |- mesh__historyNote mesh__D009628
% 209.04/209.28       91%28%79%29%; was see under PHENOTHIAZINES 1979-90   
% 209.04/209.28  |- skos__historyNote mesh__D009628 Phenothiazines %28%1966-1978%29%
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D009628 2006
% 209.04/209.28  |- mesh__dateCreated mesh__D009628 1978-02-08
% 209.04/209.28  |- skos__altLabel mesh__D009628 Azaclorzine
% 209.04/209.28  |- skos__altLabel mesh__D009628 Nonachlazin
% 209.04/209.28  |- skos__altLabel mesh__D009628 Nonakhlazin
% 209.04/209.28  |- rdf__type mesh__D009628sskos__Concept
% 209.04/209.28  |- mesh__dateEstablished mesh__D009628 1991-01-01
% 209.04/209.28  |- mesh__recordAuthorizer mesh__D009628 sjn
% 209.04/209.28  |- skos__prefLabel mesh__D009628 Nonachlazine
% 209.04/209.28  |- skos__broader mesh__D009628smesh__D010640
% 209.04/209.28  |- mesh__publicMeSHNote mesh__D009628
% 209.04/209.28       91; was see under PHENOTHIAZINES 1979-90   
% 209.04/209.28  |- mesh__recordOriginator mesh__D009628 SH
% 209.04/209.28  |- skos__scopeNote mesh__D009628
% 209.04/209.28       Coronary vasodilator with a novel mechanism of action; proposed as antianginal agent.%A%    
% 209.04/209.28  |- mesh__dateRevised mesh__D009628 2005-06-30
% 209.04/209.28  |- mesh__recordMaintainer mesh__D009628 ssb
% 209.04/209.28  |- skos__historyNote mesh__D009628 Piperazines %28%1966-1978%29%
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D001645 2006
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D001645 1999
% 209.04/209.28  |- mesh__dateRevised mesh__D001645 1992-05-08
% 209.04/209.28  |- mesh__historyNote mesh__D001645 66%28%65%29%   
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D001645 2003
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D001645 1996
% 209.04/209.28  |- rdf__type mesh__D001645sskos__Concept
% 209.04/209.28  |- mesh__recordAuthorizer mesh__D001645 PLS
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D001645 1993
% 209.04/209.28  |- skos__prefLabel mesh__D001645 Biguanides
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D001645 2002
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D001645 2004
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D001645 1997
% 209.04/209.28  |- skos__broader mesh__D001645smesh__D006146
% 209.04/209.28  |- mesh__recordOriginator mesh__D001645 NLM
% 209.04/209.28  |- mesh__publicMeSHNote mesh__D001645 66   
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D001645 2000
% 209.04/209.28  |- mesh__recordMaintainer mesh__D001645 TAP
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D001645 1994
% 209.04/209.28  |- mesh__dateCreated mesh__D001645 1999-01-01
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D001645 2005
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D001645 1998
% 209.04/209.28  |- mesh__dateEstablished mesh__D001645 1966-01-01
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D001645 2001
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D001645 1995
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D034021 2004
% 209.04/209.28  |- mesh__historyNote mesh__D034021
% 209.04/209.28       2003; for AUXILIN use ADAPTOR PROTEINS %28%NM%29% 1993-2002   
% 209.04/209.28  |- mesh__publicMeSHNote mesh__D034021
% 209.04/209.28       2003; AUXILIN was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1993-2002%A%  
% 209.04/209.28  |- skos__altLabel mesh__D034021 Auxilin
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D034021 2006
% 209.04/209.28  |- skos__broader mesh__D034021smesh__D033921
% 209.04/209.28  |- mesh__dateEstablished mesh__D034021 2003-01-01
% 209.04/209.28  |- skos__scopeNote mesh__D034021
% 209.04/209.28       A family of proteins that play a role as cofactors in the process of CLATHRIN recycling in cells.%A%    
% 209.04/209.28  |- skos__historyNote mesh__D034021 Membrane Proteins %28%1993-2002%29%
% 209.04/209.28  |- skos__prefLabel mesh__D034021 Auxilins
% 209.04/209.28  |- skos__historyNote mesh__D034021 Carrier Proteins %28%1993-2002%29%
% 209.04/209.28  |- rdf__type mesh__D034021sskos__Concept
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D034021 2003
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D034021 2005
% 209.04/209.28  |- mesh__dateCreated mesh__D034021 2002-07-02
% 209.04/209.28  |- mesh__recordOriginator mesh__D006330 NLM
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D006330 2005
% 209.04/209.28  |- skos__altLabel mesh__D006330 Heart Defect, Congenital
% 209.04/209.28  |- mesh__recordMaintainer mesh__D006330 mdb
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D006330 2006
% 209.04/209.28  |- skos__prefLabel mesh__D006330 Heart Defects, Congenital
% 209.04/209.28  |- mesh__recordAuthorizer mesh__D006330 sjn
% 209.04/209.28  |- skos__broader mesh__D006330smesh__D006331
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D006330 2003
% 209.04/209.28  |- skos__scopeNote mesh__D006330
% 209.04/209.28       Imperfections or malformations of the heart, existing at birth.%A%    
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D006330 2004
% 209.04/209.28  |- skos__annotation mesh__D006330
% 209.04/209.28       GEN only; do not use as coord for specific term /abnorm; cyanotic defects probably go here but do not also index under CYANOSIS unless especially discussed%A%  
% 209.04/209.28  |- skos__broader mesh__D006330smesh__D018376
% 209.04/209.28  |- rdf__type mesh__D006330sskos__Concept
% 209.04/209.28  |- skos__hiddenLabel mesh__D006330 Heart Abnormality
% 209.04/209.28  |- skos__hiddenLabel mesh__D006330 Defect, Congenital Heart
% 209.04/209.28  |- skos__hiddenLabel mesh__D006330 Cordis, Ectopia
% 209.04/209.28  |- skos__hiddenLabel mesh__D006330 Abnormalities, Heart
% 209.04/209.28  |- skos__altLabel mesh__D006330 Defects, Congenital Heart
% 209.04/209.28  |- skos__altLabel mesh__D006330 Heart Abnormalities
% 209.04/209.28  |- skos__altLabel mesh__D006330 Congenital Heart Defects
% 209.04/209.28  |- skos__altLabel mesh__D006330 Congenital Heart Defect
% 209.04/209.28  |- skos__altLabel mesh__D006330 Abnormality, Heart
% 209.04/209.28  |- mesh__dateCreated mesh__D006330 1999-01-01
% 209.04/209.28  |- mesh__dateRevised mesh__D006330 2002-07-02
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D020001 2006
% 209.04/209.28  |- rdf__type mesh__D020001sskos__Concept
% 209.04/209.28  |- skos__altLabel mesh__D020001 n-Butanol
% 209.04/209.28  |- skos__altLabel mesh__D020001 n-Butyl Alcohol
% 209.04/209.28  |- skos__hiddenLabel mesh__D020001 n Butyl Alcohol
% 209.04/209.28  |- skos__hiddenLabel mesh__D020001 Alcohol, n-Butyl
% 209.04/209.28  |- mesh__dateRevised mesh__D020001 2003-07-09
% 209.04/209.28  |- skos__broader mesh__D020001smesh__D000440
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D020001 2004
% 209.04/209.28  |- skos__hiddenLabel mesh__D020001 1 Butanol
% 209.04/209.28  |- mesh__dateEstablished mesh__D020001 1998-01-01
% 209.04/209.28  |- skos__annotation mesh__D020001 BUTANOLS is also available   
% 209.04/209.28  |- skos__prefLabel mesh__D020001 1-Butanol
% 209.04/209.28  |- skos__hiddenLabel mesh__D020001 n Butanol
% 209.04/209.28  |- mesh__dateCreated mesh__D020001 1997-06-20
% 209.04/209.28  |- mesh__publicMeSHNote mesh__D020001
% 209.04/209.28       98; N-BUTYL ALCOHOL %28%now 1-BUTANOL%29% was indexed under ALCOHOLS, BUTYL 1980-97%A%  
% 209.04/209.28  |- mesh__historyNote mesh__D020001 98; use 1-BUTANOL %28%NM%29% 1980-97   
% 209.04/209.28  |- skos__historyNote mesh__D020001 Butanols %28%1980-1997%29%
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D020001 2005
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D019258 2002
% 209.04/209.28  |- mesh__recordOriginator mesh__D019258 AGS
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D019258 2003
% 209.04/209.28  |- mesh__dateCreated mesh__D019258 1996-06-10
% 209.04/209.28  |- mesh__dateRevised mesh__D019258 2000-06-22
% 209.04/209.28  |- mesh__recordAuthorizer mesh__D019258 sjn
% 209.04/209.28  |- mesh__publicMeSHNote mesh__D019258
% 209.04/209.28       97; SAQUINAVIR was indexed under ISOQUINOLINES %26% QUINOLINES 1993-96 and HIV PROTEASE/antagonists %26% inhibitors 1990-92%A%  
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D019258 2004
% 209.04/209.28  |- skos__broader mesh__D019258smesh__D011804
% 209.04/209.28  |- skos__hiddenLabel mesh__D019258 Monomethanesulfonate, Saquinavir
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D019258 2005
% 209.04/209.28  |- skos__hiddenLabel mesh__D019258 Ro 318959
% 209.04/209.28  |- mesh__historyNote mesh__D019258 97; was SAQUINAVIR %28%NM%29% 1990-96   
% 209.04/209.28  |- skos__altLabel mesh__D019258 Saquinivir
% 209.04/209.28  |- skos__prefLabel mesh__D019258 Saquinavir
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D019258 2006
% 209.04/209.28  |- skos__historyNote mesh__D019258 Quinolines %28%1993-1996%29%
% 209.04/209.28  |- skos__altLabel mesh__D019258 Saquinavir Mesylate
% 209.04/209.28  |- mesh__dateEstablished mesh__D019258 1997-01-01
% 209.04/209.28  |- mesh__recordMaintainer mesh__D019258 TWD
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D019258 2001
% 209.04/209.28  |- rdf__type mesh__D019258sskos__Concept
% 209.04/209.28  |- skos__historyNote mesh__D019258
% 209.04/209.28       HIV Protease/antagonists %26% inhibitors %28%1990-1992%29%
% 209.04/209.28  |- skos__broader mesh__D019258smesh__D007546
% 209.04/209.28  |- skos__hiddenLabel mesh__D019258 Ro 31 8959
% 209.04/209.28  |- mesh__onlineNote mesh__D019258
% 209.04/209.28       use SAQUINAVIR %28%NM%29% to search SAQUINAVIR 1990-96   
% 209.04/209.28  |- skos__historyNote mesh__D019258 Isoquinolines %28%1993-1996%29%
% 209.04/209.28  |- skos__scopeNote mesh__D019258
% 209.04/209.28       An HIV protease inhibitor which acts as an analog of an HIV protease cleavage site. It is a highly specific inhibitor of HIV-1 and HIV-2 proteases.%A%    
% 209.04/209.28  |- skos__historyNote mesh__D011275 Pregnancy %28%1966-1972%29%
% 209.04/209.28  |- mesh__dateRevised mesh__D011275 2004-07-13
% 209.04/209.28  |- mesh__dateCreated mesh__D011275 1999-01-01
% 209.04/209.28  |- mesh__recordOriginator mesh__D011275 NLM
% 209.04/209.28  |- mesh__publicMeSHNote mesh__D011275
% 209.04/209.28       91; was see under PREGNANCY 1973-90   
% 209.04/209.28  |- mesh__recordAuthorizer mesh__D011275 sjn
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D011275 2006
% 209.04/209.28  |- mesh__dateEstablished mesh__D011275 1991-01-01
% 209.04/209.28  |- skos__related mesh__D011275smesh__D049168
% 209.04/209.28  |- skos__scopeNote mesh__D011275
% 209.04/209.28       Pregnancy, usually accidental, that is not desired by the parent or parents.%A%    
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D011275 2005
% 209.04/209.28  |- mesh__historyNote mesh__D011275
% 209.04/209.28       91%28%73%29%; was see under PREGNANCY 1973-90   
% 209.04/209.28  |- mesh__recordMaintainer mesh__D011275 sjn
% 209.04/209.28  |- skos__hiddenLabel mesh__D011275 Pregnancies, Unwanted
% 209.04/209.28  |- skos__hiddenLabel mesh__D011275 Unwanted Pregnancy
% 209.04/209.28  |- skos__broader mesh__D011275smesh__D011247
% 209.04/209.28  |- rdf__type mesh__D011275sskos__Concept
% 209.04/209.28  |- skos__annotation mesh__D011275
% 209.04/209.28        PREGNANCY, UNPLANNED is also available; check tags  HUMANS %26% FEMALE %26% PREGNANCY; DF: PREGN UNWANTED%A%  
% 209.04/209.28  |- skos__altLabel mesh__D011275 Unwanted Pregnancies
% 209.04/209.28  |- skos__prefLabel mesh__D011275 Pregnancy, Unwanted
% 209.04/209.28  |- skos__broader mesh__D020820Q000139smesh__D020820
% 209.04/209.28  |- mesh__preferredCombination mesh__D020820Q000139smesh__D004409
% 209.04/209.28  |- rdf__type mesh__D020820Q000139smesh__CompoundConcept
% 209.04/209.28  |- mesh__recordMaintainer mesh__D029686 sjn
% 209.04/209.28  |- rdf__type mesh__D029686sskos__Concept
% 209.04/209.28  |- mesh__dateCreated mesh__D029686 2001-07-25
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D029686 2005
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D029686 2004
% 209.04/209.28  |- mesh__dateRevised mesh__D029686 2002-07-03
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D029686 2003
% 209.04/209.28  |- skos__broader mesh__D029686smesh__D019607
% 209.04/209.28  |- skos__annotation mesh__D029686
% 209.04/209.28       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.04/209.28  |- mesh__recordOriginator mesh__D029686 ssb
% 209.04/209.28  |- skos__prefLabel mesh__D029686 Lepidium
% 209.04/209.28  |- mesh__dateEstablished mesh__D029686 2002-01-01
% 209.04/209.28  |- mesh__publicMeSHNote mesh__D029686 2002   
% 209.04/209.28  |- mesh__recordAuthorizer mesh__D029686 sjn
% 209.04/209.28  |- skos__altLabel mesh__D029686 Maca
% 209.04/209.28  |- mesh__historyNote mesh__D029686 2002   
% 209.04/209.28  |- skos__scopeNote mesh__D029686
% 209.04/209.28       A plant genus of the family BRASSICACEAE growing in Peru mountains.  It is the source of maca root.%A%    
% 209.04/209.28  |- mesh__activeMeSHYear mesh__D029686 2006
% 209.04/209.28  |- mesh__publicMeSHNote mesh__D009629 69   
% 209.04/209.28  |- skos__hiddenLabel mesh__D009629 Therapy, Client Centered
% 209.04/209.29  |- mesh__historyNote mesh__D009629 69%28%65%29%   
% 209.04/209.29  |- mesh__activeMeSHYear mesh__D009629 2005
% 209.04/209.29  |- mesh__dateRevised mesh__D009629 1995-05-31
% 209.04/209.29  |- mesh__activeMeSHYear mesh__D009629 2001
% 209.04/209.29  |- mesh__activeMeSHYear mesh__D009629 2003
% 209.04/209.29  |- skos__altLabel mesh__D009629 Therapy, Nondirective
% 209.04/209.29  |- skos__altLabel mesh__D009629 Client-Centered Therapy
% 209.04/209.29  |- mesh__recordOriginator mesh__D009629 NLM
% 209.04/209.29  |- skos__altLabel mesh__D009629 Therapy, Rogerian
% 209.04/209.29  |- mesh__activeMeSHYear mesh__D009629 2006
% 209.04/209.29  |- rdf__type mesh__D009629sskos__Concept
% 209.04/209.29  |- mesh__activeMeSHYear mesh__D009629 2002
% 209.04/209.29  |- skos__prefLabel mesh__D009629 Nondirective Therapy
% 209.04/209.29  |- mesh__activeMeSHYear mesh__D009629 2004
% 209.04/209.29  |- skos__annotation mesh__D009629
% 209.04/209.29       a psychother technique; DF: NONDIRECTIVE THER   
% 209.04/209.29  |- skos__scopeNote mesh__D009629
% 209.04/209.29       A procedure in which the therapist refrains from directing the client, but instead reflects back to the client what the latter has said, sometimes restating the client%27%s remark.%A%    
% 209.04/209.29  |- mesh__activeMeSHYear mesh__D009629 1998
% 209.04/209.29  |- skos__hiddenLabel mesh__D009629 Client-Centered Therapies
% 209.04/209.29  |- skos__hiddenLabel mesh__D009629 Therapies, Nondirective
% 209.04/209.29  |- skos__hiddenLabel mesh__D009629 Nondirective Therapies
% 209.04/209.29  |- skos__altLabel mesh__D009629 Rogerian Therapy
% 209.04/209.29  |- skos__hiddenLabel mesh__D009629 Client Centered Therapy
% 209.04/209.29  |- mesh__activeMeSHYear mesh__D009629 1996
% 209.04/209.29  |- mesh__recordMaintainer mesh__D009629 TGC
% 209.04/209.29  |- mesh__activeMeSHYear mesh__D009629 1999
% 209.04/209.29  |- skos__broader mesh__D009629smesh__D011613
% 209.04/209.29  |- skos__altLabel mesh__D009629 Therapy, Client-Centered
% 209.04/209.29  |- mesh__activeMeSHYear mesh__D009629 1997
% 209.04/209.29  |- mesh__dateCreated mesh__D009629 1999-01-01
% 209.04/209.29  |- mesh__dateEstablished mesh__D009629 1969-01-01
% 209.04/209.29  |- mesh__recordAuthorizer mesh__D009629 PLS
% 209.04/209.29  |- mesh__activeMeSHYear mesh__D009629 2000
% 209.04/209.29  |- skos__hiddenLabel mesh__D009629 Therapies, Client-Centered
% 209.04/209.29  |- mesh__activeMeSHYear mesh__D001646 2003
% 209.04/209.29  |- skos__broader mesh__D001646smesh__D012634
% 209.04/209.29  |- rdf__type mesh__D001646sskos__Concept
% 209.04/209.29  |- skos__scopeNote mesh__D001646
% 209.04/209.29       An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL;  and ELECTROLYTES. It aids DIGESTION of fats in the duodenum.%A%    
% 209.04/209.29  |- mesh__activeMeSHYear mesh__D001646 2004
% 209.04/209.29  |- skos__altLabel mesh__D001646 Sludge, Biliary
% 209.04/209.29  |- mesh__dateCreated mesh__D001646 1999-01-01
% 209.04/209.29  |- mesh__activeMeSHYear mesh__D001646 2002
% 209.04/209.29  |- skos__prefLabel mesh__D001646 Bile
% 209.04/209.29  |- mesh__activeMeSHYear mesh__D001646 2005
% 209.04/209.29  |- mesh__recordMaintainer mesh__D001646 sjn
% 209.04/209.29  |- mesh__dateRevised mesh__D001646 2001-08-08
% 209.04/209.29  |- mesh__recordOriginator mesh__D001646 NLM
% 209.04/209.29  |- mesh__activeMeSHYear mesh__D001646 2006
% 209.14/209.29  |- skos__annotation mesh__D001646
% 209.14/209.29       stasis = CHOLESTASIS; drugs stimulating or increasing flow of bile = CHOLAGOGUES AND CHOLERETICS%A%  
% 209.14/209.29  |- mesh__recordAuthorizer mesh__D001646 sjn
% 209.14/209.29  |- skos__altLabel mesh__D020800 p75 Neurotrophin Receptor
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D020800 2006
% 209.14/209.29  |- skos__scopeNote mesh__D020800
% 209.14/209.29       A low affinity receptor that binds NERVE GROWTH FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN 3; and neurotrophin 4.%A%    
% 209.14/209.29  |- mesh__historyNote mesh__D020800 2000%28%1994%29%   
% 209.14/209.29  |- skos__altLabel mesh__D020800 Nerve Growth Factor Receptor p75
% 209.14/209.29  |- skos__hiddenLabel mesh__D020800 Receptor, NGF
% 209.14/209.29  |- skos__hiddenLabel mesh__D020800 GP80 LNGFR
% 209.14/209.29  |- mesh__recordOriginator mesh__D020800 jmp
% 209.14/209.29  |- skos__altLabel mesh__D020800 Nerve Growth Factor Receptor, Low-Affinity
% 209.14/209.29  |- skos__hiddenLabel mesh__D020800 NGFR, gp75
% 209.14/209.29  |- mesh__dateCreated mesh__D020800 1999-11-05
% 209.14/209.29  |- skos__annotation mesh__D020800
% 209.14/209.29       do not confuse with RECEPTORS, NERVE GROWTH FACTOR   
% 209.14/209.29  |- skos__prefLabel mesh__D020800 Receptor, Nerve Growth Factor
% 209.14/209.29  |- skos__altLabel mesh__D020800 GP80-LNGFR
% 209.14/209.29  |- mesh__publicMeSHNote mesh__D020800
% 209.14/209.29       2000; NERVE GROWTH FACTOR RECEPTOR P75 %28%now RECEPTOR, NERVE GROWTH FACTOR%29% was indexed under RECEPTORS, NERVE GROWTH FACTOR 1994-1999; P75 NEUROTROPHIN RECEPTOR was indexed under RECEPTORS, NERVE GROWTH FACTOR 2000-2005%A%  
% 209.14/209.29  |- skos__hiddenLabel mesh__D020800 Receptor, p75 Neurotrophin
% 209.14/209.29  |- skos__hiddenLabel mesh__D020800 Neurotrophin Receptor, p75
% 209.14/209.29  |- mesh__recordMaintainer mesh__D020800 jmp
% 209.14/209.29  |- mesh__dateRevised mesh__D020800 2005-06-30
% 209.14/209.29  |- mesh__dateEstablished mesh__D020800 2000-01-01
% 209.14/209.29  |- skos__hiddenLabel mesh__D020800 p75, Neurotropin Receptor
% 209.14/209.29  |- skos__altLabel mesh__D020800 Neurotrophin Receptor p75
% 209.14/209.29  |- skos__altLabel mesh__D020800 NGFR Protein
% 209.14/209.29  |- skos__hiddenLabel mesh__D020800 Receptor p75, Neurotrophin
% 209.14/209.29  |- skos__altLabel mesh__D020800 gp75 NGFR
% 209.14/209.29  |- skos__altLabel mesh__D020800 NGF Receptor
% 209.14/209.29  |- mesh__recordAuthorizer mesh__D020800 sjn
% 209.14/209.29  |- rdf__type mesh__D020800sskos__Concept
% 209.14/209.29  |- skos__hiddenLabel mesh__D020800
% 209.14/209.29       Nerve Growth Factor Receptor, Low Affinity
% 209.14/209.29  |- skos__hiddenLabel mesh__D020800 Receptor p75, Neurotropin
% 209.14/209.29  |- skos__broader mesh__D020800smesh__D017475
% 209.14/209.29  |- skos__altLabel mesh__D020800 Neurotropin Receptor p75
% 209.14/209.29  |- skos__hiddenLabel mesh__D020800 p75, Neurotrophin Receptor
% 209.14/209.29  |- skos__annotation mesh__D006331
% 209.14/209.29        usually dis of function: differentiate from  CARDIOMYOPATHIES, dis of myocardial tissue %28%see note there%29%; cyanotic heart dis is probably HEART DEFECTS, CONGENITAL %26% not CYANOSIS unless especially discussed; parasitic dis of the heart: coord PARASITIC DISEASES or specific parasitic dis %28%IM%29% with CARDIOMYOPATHIES %28%IM%29%, not HEART DISEASES; heart dis, unspecified or specific, with rheumatic fever is probably RHEUMATIC HEART DISEASE: see note there%A%  
% 209.14/209.29  |- skos__hiddenLabel mesh__D006331 Disease, Heart
% 209.14/209.29  |- rdf__type mesh__D006331sskos__Concept
% 209.14/209.29  |- mesh__onlineNote mesh__D006331
% 209.14/209.29       pre-explosion = HEART DISEASES %28%PX%29%   
% 209.14/209.29  |- mesh__recordMaintainer mesh__D006331 sjn
% 209.14/209.29  |- mesh__dateCreated mesh__D006331 1999-01-01
% 209.14/209.29  |- mesh__dateRevised mesh__D006331 2004-07-13
% 209.14/209.29  |- mesh__recordOriginator mesh__D006331 NLM
% 209.14/209.29  |- skos__hiddenLabel mesh__D006331 Diseases, Cardiac
% 209.14/209.29  |- skos__prefLabel mesh__D006331 Heart Diseases
% 209.14/209.29  |- skos__hiddenLabel mesh__D006331 Heart Disease
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D006331 2005
% 209.14/209.29  |- mesh__recordAuthorizer mesh__D006331 sjn
% 209.14/209.29  |- skos__related mesh__D006331smesh__D009449
% 209.14/209.29  |- skos__broader mesh__D006331smesh__D002318
% 209.14/209.29  |- skos__hiddenLabel mesh__D006331 Cardiac Disease
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D006331 2006
% 209.14/209.29  |- skos__altLabel mesh__D006331 Cardiac Diseases
% 209.14/209.29  |- skos__hiddenLabel mesh__D006331 Diseases, Heart
% 209.14/209.29  |- skos__hiddenLabel mesh__D006331 Disease, Cardiac
% 209.14/209.29  |- mesh__historyNote mesh__D020002
% 209.14/209.29       98; use TERT-BUTYL ALCOHOL %28%NM%29% 1981-97   
% 209.14/209.29  |- rdf__type mesh__D020002sskos__Concept
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D020002 2005
% 209.14/209.29  |- skos__hiddenLabel mesh__D020002 tert Butanol
% 209.14/209.29  |- skos__historyNote mesh__D020002 Butanols %28%1981-1997%29%
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D020002 2006
% 209.14/209.29  |- mesh__publicMeSHNote mesh__D020002
% 209.14/209.29       98; TERT-BUTYL ALCOHOL was indexed under ALCOHOLS, BUTYL 1981-97%A%  
% 209.14/209.29  |- skos__hiddenLabel mesh__D020002 Alcohol, tert-Butyl
% 209.14/209.29  |- skos__altLabel mesh__D020002 t-Butanol
% 209.14/209.29  |- skos__hiddenLabel mesh__D020002 tertiary Butyl Alcohol
% 209.14/209.29  |- mesh__dateEstablished mesh__D020002 1998-01-01
% 209.14/209.29  |- mesh__dateRevised mesh__D020002 2003-07-09
% 209.14/209.29  |- mesh__recordAuthorizer mesh__D020002 sjn
% 209.14/209.29  |- skos__hiddenLabel mesh__D020002 Alcohol, tertiary-Butyl
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D020002 2004
% 209.14/209.29  |- skos__broader mesh__D020002smesh__D000440
% 209.14/209.29  |- skos__altLabel mesh__D020002 tert-Butanol
% 209.14/209.29  |- skos__hiddenLabel mesh__D020002 t Butanol
% 209.14/209.29  |- mesh__recordMaintainer mesh__D020002 ssb
% 209.14/209.29  |- mesh__dateCreated mesh__D020002 1997-06-20
% 209.14/209.29  |- mesh__recordOriginator mesh__D020002 ADP
% 209.14/209.29  |- skos__hiddenLabel mesh__D020002 tert Butyl Alcohol
% 209.14/209.29  |- skos__prefLabel mesh__D020002 tert-Butyl Alcohol
% 209.14/209.29  |- skos__altLabel mesh__D020002 tertiary-Butyl Alcohol
% 209.14/209.29  |- mesh__historyNote mesh__D047748
% 209.14/209.29       2005; for INAPPROPRIATE ACTH SECRETION SYNDROME use HYPERPITUITARISM 2000-2004%A%  
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D047748 2005
% 209.14/209.29  |- skos__hiddenLabel mesh__D047748 Hypersecretion, Pituitary ACTH
% 209.14/209.29  |- skos__historyNote mesh__D047748 Cushing Syndrome %28%1973-2004%29%
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D047748 2006
% 209.14/209.29  |- skos__hiddenLabel mesh__D047748 ACTH Hypersecretion, Pituitary
% 209.14/209.29  |- rdf__type mesh__D047748sskos__Concept
% 209.14/209.29  |- skos__prefLabel mesh__D047748 Pituitary ACTH Hypersecretion
% 209.14/209.29  |- skos__related mesh__D047748smesh__D003480
% 209.14/209.29  |- skos__altLabel mesh__D047748 Cushing Disease
% 209.14/209.29  |- mesh__recordMaintainer mesh__D047748 lkt
% 209.14/209.29  |- mesh__dateEstablished mesh__D047748 2005-01-01
% 209.14/209.29  |- skos__broader mesh__D047748smesh__D006964
% 209.14/209.29  |- mesh__recordOriginator mesh__D047748 lkt
% 209.14/209.29  |- skos__altLabel mesh__D047748
% 209.14/209.29       Adrenocorticotropic Hormone, Inappropriate Secretion
% 209.14/209.29  |- skos__annotation mesh__D047748
% 209.14/209.29       do not confuse X ref CUSHING DISEASE with CUSHING SYNDROME%A%  
% 209.14/209.29  |- skos__altLabel mesh__D047748
% 209.14/209.29       Inappropriate Adrenocorticotropic Hormone Secretion
% 209.14/209.29  |- mesh__recordAuthorizer mesh__D047748 sjn
% 209.14/209.29  |- skos__hiddenLabel mesh__D047748 Disease, Cushing
% 209.14/209.29  |- mesh__dateCreated mesh__D047748 2004-07-07
% 209.14/209.29  |- skos__scopeNote mesh__D047748
% 209.14/209.29       A disease of the PITUITARY GLAND characterized by the excess amount of ADRENOCORTICOTROPIC HORMONE secreted. This leads to hypersecretion of cortisol %28%HYDROCORTISONE%29% by the ADRENAL GLANDS resulting in CUSHING SYNDROME.%A%    
% 209.14/209.29  |- mesh__publicMeSHNote mesh__D047748
% 209.14/209.29       2005; for INAPPROPRIATE ACTH SECRETION SYNDROME see HYPERPITUITARISM 2000-2004%A%  
% 209.14/209.29  |- skos__historyNote mesh__D047748 Pituitary Neoplasms %28%1973-2004%29%
% 209.14/209.29  |- rdf__type mesh__D019259sskos__Concept
% 209.14/209.29  |- skos__broader mesh__D019259smesh__D016047
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D019259 2005
% 209.14/209.29  |- mesh__historyNote mesh__D019259 97; was LAMIVUDINE %28%NM%29% 1991-96   
% 209.14/209.29  |- skos__altLabel mesh__D019259 GR109714X
% 209.14/209.29  |- mesh__dateRevised mesh__D019259 2001-07-25
% 209.14/209.29  |- skos__hiddenLabel mesh__D019259 BCH189
% 209.14/209.29  |- skos__historyNote mesh__D019259
% 209.14/209.29       Zalcitabine/analogs %26% derivatives %28%1993-1996%29%
% 209.14/209.29  |- mesh__recordMaintainer mesh__D019259 ssb
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D019259 2004
% 209.14/209.29  |- mesh__publicMeSHNote mesh__D019259
% 209.14/209.29       97; LAMIVUDINE was indexed under ZALCITABINE/analogs %26% derivatives 1993-96 and CYTOSINE/analogs %26% derivatives 1991-92%A%  
% 209.14/209.29  |- skos__historyNote mesh__D019259
% 209.14/209.29       Cytosine/analogs %26% derivatives %28%1991-1992%29%
% 209.14/209.29  |- skos__altLabel mesh__D019259 3TC
% 209.14/209.29  |- skos__altLabel mesh__D019259 2%27%,3%27%-Dideoxy-3%27%-thiacytidine
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D019259 2003
% 209.14/209.29  |- skos__prefLabel mesh__D019259 Lamivudine
% 209.14/209.29  |- mesh__dateEstablished mesh__D019259 1997-01-01
% 209.14/209.29  |- mesh__recordAuthorizer mesh__D019259 sjn
% 209.14/209.29  |- skos__hiddenLabel mesh__D019259 BCH 189
% 209.14/209.29  |- mesh__dateCreated mesh__D019259 1996-06-10
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D019259 2002
% 209.14/209.29  |- skos__scopeNote mesh__D019259
% 209.14/209.29       A reverse transcriptase inhibitor and ZALCITABINE analog in which a sulfur atom replaces the 3%27% carbon of the pentose ring. It is used to treat HIV disease.%A%    
% 209.14/209.29  |- skos__hiddenLabel mesh__D019259 2%27%,3%27% Dideoxy 3%27% thiacytidine
% 209.14/209.29  |- mesh__recordOriginator mesh__D019259 AGS
% 209.14/209.29  |- mesh__onlineNote mesh__D019259
% 209.14/209.29       use LAMIVUDINE %28%NM%29% to search LAMIVUDINE 1991-96   
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D019259 2006
% 209.14/209.29  |- mesh__dateRevised mesh__D011276 2003-07-09
% 209.14/209.29  |- mesh__dateCreated mesh__D011276 1999-01-01
% 209.14/209.29  |- mesh__recordMaintainer mesh__D011276 lkt
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D011276 2006
% 209.14/209.29  |- skos__broader mesh__D011276smesh__D011374
% 209.14/209.29  |- skos__broader mesh__D011276smesh__D011278
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D011276 2005
% 209.14/209.29  |- mesh__recordOriginator mesh__D011276 NLM
% 209.14/209.29  |- mesh__recordAuthorizer mesh__D011276 sjn
% 209.14/209.29  |- rdf__type mesh__D011276sskos__Concept
% 209.14/209.29  |- skos__scopeNote mesh__D011276
% 209.14/209.29       An inactive metabolite of PROGESTERONE by reduction at C5, C3, and C20 position. Pregnanediol has two hydroxyl groups, at 3-alpha and 20-alpha. It is detectable in URINE after OVULATION and is found in great quantities in the pregnancy urine.%A%    
% 209.14/209.29  |- skos__prefLabel mesh__D011276 Pregnanediol
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D011276 2004
% 209.14/209.29  |- skos__hiddenLabel mesh__D005239 Fears
% 209.14/209.29  |- mesh__recordOriginator mesh__D005239 NLM
% 209.14/209.29  |- skos__scopeNote mesh__D005239
% 209.14/209.29       The affective response to an actual current external danger which subsides with the elimination of the threatening condition.%A%    
% 209.14/209.29  |- mesh__dateCreated mesh__D005239 1999-01-01
% 209.14/209.29  |- mesh__dateRevised mesh__D005239 1998-06-10
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D005239 2000
% 209.14/209.29  |- rdf__type mesh__D005239sskos__Concept
% 209.14/209.29  |- mesh__recordAuthorizer mesh__D005239 SJN
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D005239 2001
% 209.14/209.29  |- skos__related mesh__D005239smesh__D010698
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D005239 1999
% 209.14/209.29  |- skos__broader mesh__D005239smesh__D004644
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D005239 2005
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D005239 2002
% 209.14/209.29  |- skos__prefLabel mesh__D005239 Fear
% 209.14/209.29  |- mesh__recordMaintainer mesh__D005239 ADP
% 209.14/209.29  |- skos__annotation mesh__D005239 human %26% animal   
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D005239 2006
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D005239 2003
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D005239 2004
% 209.14/209.29  |- mesh__historyNote mesh__D029687 2002   
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D029687 2003
% 209.14/209.29  |- skos__scopeNote mesh__D029687
% 209.14/209.29       A plant genus of the family CRUCIFERAE.     
% 209.14/209.29  |- skos__annotation mesh__D029687
% 209.14/209.29       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.14/209.29  |- mesh__dateCreated mesh__D029687 2001-07-25
% 209.14/209.29  |- mesh__dateEstablished mesh__D029687 2002-01-01
% 209.14/209.29  |- skos__prefLabel mesh__D029687 Capsella
% 209.14/209.29  |- mesh__dateRevised mesh__D029687 2002-07-03
% 209.14/209.29  |- mesh__publicMeSHNote mesh__D029687 2002   
% 209.14/209.29  |- skos__broader mesh__D029687smesh__D019607
% 209.14/209.29  |- skos__altLabel mesh__D029687 Shepherd%27%s Purse
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D029687 2006
% 209.14/209.29  |- rdf__type mesh__D029687sskos__Concept
% 209.14/209.29  |- skos__altLabel mesh__D029687 Shepherds Purse
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D029687 2005
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D029687 2004
% 209.14/209.29  |- mesh__recordOriginator mesh__D015667 EGC
% 209.14/209.29  |- mesh__historyNote mesh__D015667
% 209.14/209.29       1990; for ACUPUNCTURE ANESTHESIA use ACUPUNCTURE ANESTHESIA 1991-2001; use ACUPUNCTURE 1990%A%  
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D015667 2006
% 209.14/209.29  |- skos__historyNote mesh__D015667 Analgesia %28%1972-1989%29%
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D015667 2002
% 209.14/209.29  |- mesh__dateEstablished mesh__D015667 1990-01-01
% 209.14/209.29  |- skos__scopeNote mesh__D015667
% 209.14/209.29       Analgesia produced by the insertion of ACUPUNCTURE needles at certain ACUPUNCTURE POINTS on the body. This activates small myelinated nerve fibers in the muscle which transmit impulses to the spinal cord and then activate three centers - the spinal cord, midbrain and pituitary/hypothalamus - to produce analgesia.%A%    
% 209.14/209.29  |- mesh__recordAuthorizer mesh__D015667 sjn
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D015667 2005
% 209.14/209.29  |- skos__prefLabel mesh__D015667 Acupuncture Analgesia
% 209.14/209.29  |- mesh__recordMaintainer mesh__D015667 ssb
% 209.14/209.29  |- skos__altLabel mesh__D015667 Anesthesia, Acupuncture
% 209.14/209.29  |- skos__historyNote mesh__D015667 Acupuncture %28%1972-1989%29%
% 209.14/209.29  |- mesh__dateRevised mesh__D015667 2001-07-25
% 209.14/209.29  |- mesh__dateCreated mesh__D015667 1989-04-07
% 209.14/209.29  |- skos__broader mesh__D015667smesh__D000698
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D015667 2004
% 209.14/209.29  |- rdf__type mesh__D015667sskos__Concept
% 209.14/209.29  |- mesh__publicMeSHNote mesh__D015667
% 209.14/209.29       1990; for ACUPUNCTURE ANESTHESIA see ACUPUNCTURE ANESTHESIA 1990-2001; see ACUPUNCTURE 1990%A%  
% 209.14/209.29  |- skos__altLabel mesh__D015667 Analgesia, Acupuncture
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D015667 2003
% 209.14/209.29  |- skos__broader mesh__D015667smesh__D015670
% 209.14/209.29  |- skos__broader mesh__D034821smesh__D019684
% 209.14/209.29  |- mesh__historyNote mesh__D034821 2003   
% 209.14/209.29  |- skos__scopeNote mesh__D034821
% 209.14/209.29       A plant family of the order Commelinales, subclass Commelinidae, class Liliopsida %28%monocotyledons%29% that are often somewhat succulent. The leaves are alternate, simple, parallel-veined, and usually with a closed sheathing base. The flowers are often in cymes and have 3 petals and 3 sepals.%A%    
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D034821 2005
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D034821 2003
% 209.14/209.29  |- mesh__dateCreated mesh__D034821 2002-07-03
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D034821 2006
% 209.14/209.29  |- mesh__publicMeSHNote mesh__D034821 2003   
% 209.14/209.29  |- rdf__type mesh__D034821sskos__Concept
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D034821 2004
% 209.14/209.29  |- mesh__dateEstablished mesh__D034821 2003-01-01
% 209.14/209.29  |- skos__annotation mesh__D034821
% 209.14/209.29       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.14/209.29  |- skos__prefLabel mesh__D034821 Commelinaceae
% 209.14/209.29  |- mesh__dateCreated mesh__D001647 1999-01-01
% 209.14/209.29  |- mesh__recordOriginator mesh__D001647 NLM
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D001647 2000
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D001647 2005
% 209.14/209.29  |- mesh__recordAuthorizer mesh__D001647 sjn
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D001647 2006
% 209.14/209.29  |- skos__hiddenLabel mesh__D001647 Acids, Bile
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D001647 2001
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D001647 2003
% 209.14/209.29  |- rdf__type mesh__D001647sskos__Concept
% 209.14/209.29  |- skos__scopeNote mesh__D001647
% 209.14/209.29       Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones.%A%    
% 209.14/209.29  |- skos__hiddenLabel mesh__D001647 Salts, Bile
% 209.14/209.29  |- skos__prefLabel mesh__D001647 Bile Acids and Salts
% 209.14/209.29  |- mesh__recordMaintainer mesh__D001647 adp
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D001647 2004
% 209.14/209.29  |- skos__annotation mesh__D001647
% 209.14/209.29       /biosyn /physiol permitted; DF: BILE ACIDS   
% 209.14/209.29  |- mesh__dateRevised mesh__D001647 1999-11-03
% 209.14/209.29  |- skos__broader mesh__D001647smesh__D013256
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D001647 2002
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D020801 2006
% 209.14/209.29  |- skos__historyNote mesh__D020801
% 209.14/209.29       Receptors, Cell Surface %28%1991-1999%29%
% 209.14/209.29  |- skos__altLabel mesh__D020801 CNTF Receptor
% 209.14/209.29  |- mesh__dateCreated mesh__D020801 1999-11-03
% 209.14/209.29  |- mesh__recordAuthorizer mesh__D020801 sjn
% 209.14/209.29  |- mesh__publicMeSHNote mesh__D020801
% 209.14/209.29       2000; CILIARY NEUROTROPHIC FACTOR RECEPTOR %28%now RECEPTOR, CILIARY NEUROTROPHIC FACTOR%29% was indexed under RECEPTORS, NERVE GROWTH FACTOR 1995-1999, RECEPTOR PROTEIN-TYROSINE KINASE 1997-1999, RECEPTORS, GROWTH FACTOR 1993-1994, %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1991-1999%A%  
% 209.14/209.29  |- skos__prefLabel mesh__D020801 Receptor, Ciliary Neurotrophic Factor
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D020801 2003
% 209.14/209.29  |- skos__historyNote mesh__D020801
% 209.14/209.29       Receptors, Nerve Growth Factor %28%1995-1999%29%
% 209.14/209.29  |- skos__scopeNote mesh__D020801
% 209.14/209.29       The ciliary neurotrophic factor receptor is comprised of three components: the ciliary neutrophilic factor receptor alpha subunit, the leukemia inhibitory factor receptor and the gp130 signal transducer. The specificity of the receptor for ciliary neurotrophic factor is determined by the alpha subunit, while signal transduction is mediated through the GP130 subunit. Although the receptor regulates neuronal development, it is structurally similar to the cytokine receptor for INTERLEUKIN-6; %28%RECEPTORS, INTERLEUKIN-6%29%.%A%    
% 209.14/209.29  |- mesh__recordMaintainer mesh__D020801 mdb
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D020801 2002
% 209.14/209.29  |- mesh__dateRevised mesh__D020801 2001-07-25
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D020801 2004
% 209.14/209.29  |- mesh__recordOriginator mesh__D020801 jmp
% 209.14/209.29  |- skos__altLabel mesh__D020801
% 209.14/209.29       Ciliary Neurotrophic Factor Receptor alpha Subunit
% 209.14/209.29  |- mesh__historyNote mesh__D020801
% 209.14/209.29       2000; use RECEPTOR, CILIARY NEUROTROPHIC FACTOR %28%NM%29% 1991-1999%A%  
% 209.14/209.29  |- rdf__type mesh__D020801sskos__Concept
% 209.14/209.29  |- skos__hiddenLabel mesh__D020801 Receptor, CNTF
% 209.14/209.29  |- skos__annotation mesh__D020801 DF: CNTF RECEPT   
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D020801 2005
% 209.14/209.29  |- skos__broader mesh__D020801smesh__D017475
% 209.14/209.29  |- skos__historyNote mesh__D020801
% 209.14/209.29       Receptor Protein-Tyrosine Kinases %28%1997-1999%29%
% 209.14/209.29  |- skos__altLabel mesh__D020801 Ciliary Neurotrophic Factor Receptor
% 209.14/209.29  |- mesh__dateEstablished mesh__D020801 2000-01-01
% 209.14/209.29  |- skos__historyNote mesh__D020801
% 209.14/209.29       Receptors, Growth Factor %28%1993-1994%29%
% 209.14/209.29  |- skos__altLabel mesh__D006332 Heart Hypertrophy
% 209.14/209.29  |- rdf__type mesh__D006332sskos__Concept
% 209.14/209.29  |- mesh__dateCreated mesh__D006332 1999-01-01
% 209.14/209.29  |- mesh__publicMeSHNote mesh__D006332
% 209.14/209.29       2000; see HEART HYPERTROPHY 1993-1999; see HEART ENLARGEMENT 1963-1992%A%  
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D006332 2005
% 209.14/209.29  |- skos__scopeNote mesh__D006332
% 209.14/209.29       Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure %28%HEART FAILURE, CONGESTIVE%29% or several forms of CARDIOMYOPATHIES.%A%    
% 209.14/209.29  |- skos__hiddenLabel mesh__D006332 Heart, Enlarged
% 209.14/209.29  |- skos__altLabel mesh__D006332 Enlarged Heart
% 209.14/209.29  |- skos__broader mesh__D006332smesh__D006984
% 209.14/209.29  |- mesh__historyNote mesh__D006332 2000%28%1963%29%   
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D006332 2006
% 209.14/209.29  |- mesh__recordOriginator mesh__D006332 NLM
% 209.14/209.29  |- mesh__recordMaintainer mesh__D006332 lkt
% 209.14/209.29  |- skos__hiddenLabel mesh__D006332 Enlargement, Heart
% 209.14/209.29  |- mesh__dateRevised mesh__D006332 2004-07-07
% 209.14/209.29  |- skos__broader mesh__D006332smesh__D006331
% 209.14/209.29  |- skos__annotation mesh__D006332
% 209.14/209.29       GEN or unspecified; prefer HYPERTROPHY, LEFT VENTRICULAR or HYPERTROPHY, RIGHT VENTRICULAR; note X ref CARDIAC HYPERTROPHY: do not confuse with CARDIOMYOPATHY, HYPERTROPHIC%A%  
% 209.14/209.29  |- skos__prefLabel mesh__D006332 Cardiomegaly
% 209.14/209.29  |- skos__altLabel mesh__D006332 Heart Enlargement
% 209.14/209.29  |- mesh__recordAuthorizer mesh__D006332 sjn
% 209.14/209.29  |- mesh__dateRevised mesh__D020003 2003-07-09
% 209.14/209.29  |- skos__hiddenLabel mesh__D020003 n Octyl Alcohol
% 209.14/209.29  |- skos__altLabel mesh__D020003 n-Octanol
% 209.14/209.29  |- mesh__recordMaintainer mesh__D020003 ssb
% 209.14/209.29  |- mesh__dateCreated mesh__D020003 1997-06-20
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D020003 2004
% 209.14/209.29  |- mesh__recordOriginator mesh__D020003 ADP
% 209.14/209.29  |- skos__annotation mesh__D020003 OCTANOLS is also available   
% 209.14/209.29  |- skos__altLabel mesh__D020003 n-Octyl Alcohol
% 209.14/209.29  |- skos__hiddenLabel mesh__D020003 n Octanol
% 209.14/209.29  |- skos__broader mesh__D020003smesh__D000442
% 209.14/209.29  |- skos__historyNote mesh__D020003 Octanols %28%1981-1997%29%
% 209.14/209.29  |- skos__hiddenLabel mesh__D020003 Alcohol, n-Octyl
% 209.14/209.29  |- rdf__type mesh__D020003sskos__Concept
% 209.14/209.29  |- mesh__dateEstablished mesh__D020003 1998-01-01
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D020003 2005
% 209.14/209.29  |- skos__scopeNote mesh__D020003
% 209.14/209.29       A colorless, slightly viscous liquid used as a defoaming or wetting agent. It is also used as a solvent for protective coatings, waxes, and oils, and as a raw material for plasticizers. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%    
% 209.14/209.29  |- mesh__publicMeSHNote mesh__D020003
% 209.14/209.29       98; 1-OCTANOL was indexed under ALCOHOLS, OCTYL 1981-97   
% 209.14/209.29  |- skos__hiddenLabel mesh__D020003 1 Octanol
% 209.14/209.29  |- skos__prefLabel mesh__D020003 1-Octanol
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D020003 2006
% 209.14/209.29  |- mesh__recordAuthorizer mesh__D020003 sjn
% 209.14/209.29  |- mesh__historyNote mesh__D020003 98; use 1-OCTANOL %28%NM%29% 1981-97   
% 209.14/209.29  |- mesh__dateEstablished mesh__D011277 1974-01-01
% 209.14/209.29  |- mesh__publicMeSHNote mesh__D011277 74   
% 209.14/209.29  |- skos__altLabel mesh__D011277 Dioxopregnanes
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D011277 1995
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D011277 2005
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D011277 1998
% 209.14/209.29  |- mesh__dateRevised mesh__D011277 1993-06-03
% 209.14/209.29  |- skos__prefLabel mesh__D011277 Pregnanediones
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D011277 2002
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D011277 1994
% 209.14/209.29  |- rdf__type mesh__D011277sskos__Concept
% 209.14/209.29  |- mesh__historyNote mesh__D011277 74   
% 209.14/209.29  |- mesh__recordMaintainer mesh__D011277 PLS
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D011277 2004
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D011277 1997
% 209.14/209.29  |- mesh__dateCreated mesh__D011277 1999-01-01
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D011277 2001
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D011277 2003
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D011277 1996
% 209.14/209.29  |- mesh__recordAuthorizer mesh__D011277 PLS
% 209.14/209.29  |- skos__altLabel mesh__D011277 Diketopregnanes
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D011277 2000
% 209.14/209.29  |- mesh__recordOriginator mesh__D011277 NLM
% 209.14/209.29  |- mesh__activeMeSHYear mesh__D011277 2006
% 209.14/209.29  |- skos__scopeNote mesh__D011277
% 209.14/209.29       Pregnane derivatives in which two side-chain methyl groups or two methylene groups in the ring skeleton %28%or a combination thereof%29% have been oxidized to keto groups.%A%    
% 209.14/209.30  |- mesh__activeMeSHYear mesh__D011277 1999
% 209.14/209.30  |- skos__broader mesh__D011277smesh__D011278
% 209.14/209.30  |- skos__historyNote mesh__D016760
% 209.14/209.30       Proto-Oncogene Proteins %28%1985-1991%29%
% 209.14/209.30  |- skos__broader mesh__D016760smesh__D011518
% 209.14/209.30  |- skos__altLabel mesh__D016760 Proto-Oncogene Proteins fos
% 209.14/209.30  |- skos__altLabel mesh__D016760 p55 c-fos
% 209.14/209.30  |- skos__related mesh__D016760smesh__D018808
% 209.14/209.30  |- mesh__recordOriginator mesh__D016760 AGS
% 209.14/209.30  |- skos__altLabel mesh__D016760 c-fos Proteins
% 209.14/209.30  |- skos__hiddenLabel mesh__D016760 Proto Oncogene Products c fos
% 209.14/209.30  |- skos__hiddenLabel mesh__D016760 Fos Related Antigens
% 209.14/209.30  |- mesh__activeMeSHYear mesh__D016760 2006
% 209.14/209.30  |- mesh__recordMaintainer mesh__D016760 ags
% 209.14/209.30  |- skos__altLabel mesh__D016760 p55%28%c-fos%29%
% 209.14/209.30  |- skos__broader mesh__D016760smesh__D050976
% 209.14/209.30  |- skos__altLabel mesh__D016760 fos Proto-Oncogene Proteins
% 209.14/209.30  |- skos__hiddenLabel mesh__D016760 Proto Oncogene Proteins c fos
% 209.14/209.30  |- mesh__activeMeSHYear mesh__D016760 2006A
% 209.14/209.30  |- skos__hiddenLabel mesh__D016760 p55 c fos
% 209.14/209.30  |- mesh__dateRevised mesh__D016760 2005-07-08
% 209.14/209.30  |- mesh__publicMeSHNote mesh__D016760
% 209.14/209.30       92; PROTO-ONCOGENE PROTEIN FOS %28%NM%29% was indexed under PROTO-ONCOGENE PROTEINS 1985-91; FOS B PROTEIN %28%NM%29% was indexed under NUCLEAR PROTEINS 1990-91%A%  
% 209.14/209.30  |- skos__broader mesh__D016760smesh__D009687
% 209.14/209.30  |- skos__altLabel mesh__D016760 Proto-Oncogene Products c-fos
% 209.14/209.30  |- skos__hiddenLabel mesh__D016760 Proto Oncogene Proteins fos
% 209.14/209.30  |- skos__hiddenLabel mesh__D016760 c fos Proteins
% 209.14/209.30  |- mesh__dateEstablished mesh__D016760 1992-01-01
% 209.14/209.30  |- mesh__dateCreated mesh__D016760 1991-07-12
% 209.14/209.30  |- skos__annotation mesh__D016760
% 209.14/209.30       /drug eff /ultrastruct permitted; not for c-fos 39 %28% = C-FOS-ASSOCIATED PROTEIN P39 see PROTO-ONCOGENE PROTEINS C-JUN%29%; DF: note short X refs%A%  
% 209.14/209.30  |- rdf__type mesh__D016760sskos__Concept
% 209.14/209.30  |- mesh__onlineNote mesh__D016760
% 209.14/209.30       use PROTO-ONCOGENE PROTEINS C-FOS %28%NM%29% to search PROTO-ONCOGENE PROTEIN FOS %28%NM%29% 1985-91 %26% FOS B PROTEIN %28%NM%29% 1990-91%A%  
% 209.14/209.30  |- mesh__historyNote mesh__D016760
% 209.14/209.30       92; was PROTO-ONCOGENE PROTEIN FOS %28%NM%29% 1985-91; FOS B PROTEIN was FOS B PROTEIN %28%NM%29% 1990-91%A%  
% 209.14/209.30  |- skos__altLabel mesh__D016760 FRAs
% 209.14/209.30  |- skos__prefLabel mesh__D016760 Proto-Oncogene Proteins c-fos
% 209.14/209.30  |- mesh__recordAuthorizer mesh__D016760 ags
% 209.14/209.30  |- skos__scopeNote mesh__D016760
% 209.14/209.30       Cellular DNA-binding proteins encoded by the c-fos genes %28%GENES, FOS%29%. They are involved in growth-related transcriptional control. c-fos combines with c-jun %28%PROTO-ONCOGENE PROTEINS C-JUN%29% to form a c-fos/c-jun heterodimer %28%TRANSCRIPTION FACTOR AP-1%29% that binds to the TRE %28%TPA-responsive element%29% in promoters of certain genes.%A%    
% 209.14/209.30  |- skos__hiddenLabel mesh__D016760 fos Proto Oncogene Proteins
% 209.14/209.30  |- skos__altLabel mesh__D016760 Fos-Related Antigens
% 209.14/209.30  |- mesh__dateRevised mesh__D002740 2005-06-30
% 209.16/209.30  |- skos__prefLabel mesh__D002740 Chlorothiazide
% 209.16/209.30  |- mesh__dateCreated mesh__D002740 1999-01-01
% 209.16/209.30  |- rdf__type mesh__D002740sskos__Concept
% 209.16/209.30  |- mesh__recordMaintainer mesh__D002740 ssb
% 209.16/209.30  |- mesh__historyNote mesh__D002740
% 209.16/209.30       CHLORTHIZIDE was see CHLOROTHIAZIDE 1977-95; /adv eff-pois-tox was CHLOROTHIAZIDE TOXICOLOGY 1963-65%A%  
% 209.16/209.30  |- skos__broader mesh__D002740smesh__D001581
% 209.16/209.30  |- mesh__publicMeSHNote mesh__D002740
% 209.16/209.30       CHLORTHIZIDE was see CHLOROTHIAZIDE 1977-95; /adverse effects /poisoning /toxicity were CHLOROTHIAZIDE TOXICOLOGY 1963-65%A%  
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D002740 2006
% 209.16/209.30  |- mesh__recordAuthorizer mesh__D002740 sjn
% 209.16/209.30  |- mesh__recordOriginator mesh__D002740 NLM
% 209.16/209.30  |- skos__scopeNote mesh__D002740
% 209.16/209.30       A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p812%29%%A%    
% 209.16/209.30  |- mesh__recordOriginator mesh__D029688 ssb
% 209.16/209.30  |- mesh__publicMeSHNote mesh__D029688
% 209.16/209.30       2002; for TURNIP %26% RUTABAGA see BRASSICA 1998-2001   
% 209.16/209.30  |- mesh__historyNote mesh__D029688
% 209.16/209.30       2002; for TURNIP %26% RUTABAGA use BRASSICA 1998-2001   
% 209.16/209.30  |- skos__broader mesh__D029688smesh__D001937
% 209.16/209.30  |- mesh__dateEstablished mesh__D029688 2002-01-01
% 209.16/209.30  |- mesh__recordAuthorizer mesh__D029688 sjn
% 209.16/209.30  |- mesh__recordMaintainer mesh__D029688 sjn
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D029688 2006
% 209.16/209.30  |- rdf__type mesh__D029688sskos__Concept
% 209.16/209.30  |- skos__prefLabel mesh__D029688 Brassica napus
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D029688 2005
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D029688 2004
% 209.16/209.30  |- skos__historyNote mesh__D029688 Brassica %28%1998-2001%29%
% 209.16/209.30  |- mesh__dateCreated mesh__D029688 2001-07-25
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D029688 2003
% 209.16/209.30  |- skos__annotation mesh__D029688
% 209.16/209.30       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.16/209.30  |- mesh__dateRevised mesh__D029688 2002-07-03
% 209.16/209.30  |- skos__scopeNote mesh__D029688
% 209.16/209.30       A plant species of the family BRASSICACEAE best known for the edible roots.%A%    
% 209.16/209.30  |- skos__altLabel mesh__D040061 Peptide Initiation Factor EIF-5
% 209.16/209.30  |- skos__hiddenLabel mesh__D040061 Initiation Factor-5, Eukaryotic
% 209.16/209.30  |- skos__hiddenLabel mesh__D040061 Eukaryotic Peptide Initiation Factor 5
% 209.16/209.30  |- skos__prefLabel mesh__D040061 Eukaryotic Initiation Factor-5
% 209.16/209.30  |- mesh__historyNote mesh__D040061
% 209.16/209.30       2003; use EUKARYOTIC INITIATION FACTOR-5 %28%NM%29% 1982-2002   
% 209.16/209.30  |- skos__hiddenLabel mesh__D040061 Eukaryotic Initiation Factor 5
% 209.16/209.30  |- mesh__publicMeSHNote mesh__D040061
% 209.16/209.30       2003; EIF-5 %28%now EUKARYOTIC INITIATION FACTOR-5%29% was indexed under PEPTIDE INITIATION FACTORS 1982-2002%A%  
% 209.16/209.30  |- mesh__recordAuthorizer mesh__D040061 jls
% 209.16/209.30  |- rdf__type mesh__D040061sskos__Concept
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D040061 2006
% 209.16/209.30  |- skos__altLabel mesh__D040061 Eukaryotic Peptide Initiation Factor-5
% 209.16/209.30  |- mesh__dateEstablished mesh__D040061 2003-01-01
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D040061 2005
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D040061 2005A
% 209.16/209.30  |- skos__broader mesh__D040061smesh__D039642
% 209.16/209.30  |- mesh__dateRevised mesh__D040061 2004-07-27
% 209.16/209.30  |- skos__historyNote mesh__D040061
% 209.16/209.30       Peptide Initiation Factors %28%1982-2002%29%
% 209.16/209.30  |- skos__hiddenLabel mesh__D040061 Peptide Initiation Factor EIF 5
% 209.16/209.30  |- mesh__recordOriginator mesh__D040061 jmp
% 209.16/209.30  |- skos__broader mesh__D040061smesh__D020690
% 209.16/209.30  |- skos__scopeNote mesh__D040061
% 209.16/209.30       A eukaryotic initiation factor that interacts with the 40S initiation complex and promotes the hydrolysis of the bound GTP. The hydrolysis of GTP causes the release of EUKARYOTIC INITIATION FACTOR-2 and EUKARYOTIC INITIATION FACTOR-3 from the 40S subunit and the subsequent joining of the 60S ribosomal subunit to the 40S complex to form the functional 80S initiation complex%A%    
% 209.16/209.30  |- mesh__recordMaintainer mesh__D040061 jls
% 209.16/209.30  |- skos__altLabel mesh__D040061 EIF-5
% 209.16/209.30  |- mesh__dateCreated mesh__D040061 2002-07-03
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D034822 2006
% 209.16/209.30  |- skos__prefLabel mesh__D034822 Commelina
% 209.16/209.30  |- mesh__publicMeSHNote mesh__D034822 2003   
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D034822 2004
% 209.16/209.30  |- rdf__type mesh__D034822sskos__Concept
% 209.16/209.30  |- skos__broader mesh__D034822smesh__D034821
% 209.16/209.30  |- skos__scopeNote mesh__D034822
% 209.16/209.30       A plant genus of the family COMMELINACEAE of perennial herbs with blue flowers.%A%    
% 209.16/209.30  |- skos__altLabel mesh__D034822 Dayflower
% 209.16/209.30  |- skos__annotation mesh__D034822
% 209.16/209.30       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.16/209.30  |- mesh__historyNote mesh__D034822 2003   
% 209.16/209.30  |- mesh__dateCreated mesh__D034822 2002-07-03
% 209.16/209.30  |- mesh__dateEstablished mesh__D034822 2003-01-01
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D034822 2005
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D034822 2003
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D001648 1991
% 209.16/209.30  |- mesh__recordAuthorizer mesh__D001648 PLS
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D001648 2005
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D001648 1998
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D001648 1995
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D001648 2002
% 209.16/209.30  |- skos__broader mesh__D001648smesh__D001653
% 209.16/209.30  |- mesh__publicMeSHNote mesh__D001648
% 209.16/209.30       91; was see under BILE DUCTS, INTRAHEPATIC 1981-90; was see BILE DUCTS, INTRAHEPATIC 1980%A%  
% 209.16/209.30  |- skos__hiddenLabel mesh__D001648 Bile Canaliculus
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D001648 2006
% 209.16/209.30  |- mesh__recordOriginator mesh__D001648 RC
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D001648 1999
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D001648 1992
% 209.16/209.30  |- mesh__dateRevised mesh__D001648 1990-04-13
% 209.16/209.30  |- rdf__type mesh__D001648sskos__Concept
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D001648 2003
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D001648 1996
% 209.16/209.30  |- skos__historyNote mesh__D001648
% 209.16/209.30       Bile Ducts, Intrahepatic %28%1966-1980%29%
% 209.16/209.30  |- skos__scopeNote mesh__D001648
% 209.16/209.30       Minute intercellular channels that occur between liver cells and carry bile towards interlobar bile ducts. Also called bile capillaries.%A%    
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D001648 1993
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D001648 2000
% 209.16/209.30  |- skos__annotation mesh__D001648 also called %22%bile capillaries%22%   
% 209.16/209.30  |- mesh__dateCreated mesh__D001648 1980-04-09
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D001648 2004
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D001648 1997
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D001648 2001
% 209.16/209.30  |- mesh__recordMaintainer mesh__D001648 NLM
% 209.16/209.30  |- mesh__dateEstablished mesh__D001648 1991-01-01
% 209.16/209.30  |- mesh__onlineNote mesh__D001648 search BILE DUCTS, INTRAHEPATIC 1980   
% 209.16/209.30  |- mesh__historyNote mesh__D001648
% 209.16/209.30       91%28%81%29%; was see under BILE DUCTS, INTRAHEPATIC 1981-90; was see BILE DUCTS, INTRAHEPATIC 1980%A%  
% 209.16/209.30  |- skos__hiddenLabel mesh__D001648 Canaliculus, Bile
% 209.16/209.30  |- skos__hiddenLabel mesh__D001648 Canaliculi, Bile
% 209.16/209.30  |- skos__prefLabel mesh__D001648 Bile Canaliculi
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D001648 1994
% 209.16/209.30  |- mesh__recordMaintainer mesh__D012370 CCR
% 209.16/209.30  |- skos__hiddenLabel mesh__D012370 Hydrochloride, Robenidine
% 209.16/209.30  |- mesh__publicMeSHNote mesh__D012370
% 209.16/209.30       91; was see under GUANIDINES 1975-90   
% 209.16/209.30  |- skos__altLabel mesh__D012370 Robenzidene
% 209.16/209.30  |- skos__scopeNote mesh__D012370
% 209.16/209.30       An anticoccidial agent mainly for poultry.     
% 209.16/209.30  |- skos__prefLabel mesh__D012370 Robenidine
% 209.16/209.30  |- skos__altLabel mesh__D012370 Alpharma Brand of Robenidine Hydrochloride
% 209.16/209.30  |- skos__broader mesh__D012370smesh__D006146
% 209.16/209.30  |- mesh__dateEstablished mesh__D012370 1991-01-01
% 209.16/209.30  |- mesh__recordAuthorizer mesh__D012370 sjn
% 209.16/209.30  |- mesh__dateRevised mesh__D012370 2005-06-30
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D012370 2006
% 209.16/209.30  |- mesh__dateCreated mesh__D012370 1974-11-19
% 209.16/209.30  |- mesh__recordOriginator mesh__D012370 NLM
% 209.16/209.30  |- skos__historyNote mesh__D012370 Guanidines %28%1971-1974%29%
% 209.16/209.30  |- mesh__historyNote mesh__D012370
% 209.16/209.30       91%28%75%29%; was see under GUANIDINES 1975-90   
% 209.16/209.30  |- rdf__type mesh__D012370sskos__Concept
% 209.16/209.30  |- skos__historyNote mesh__D012370 Chlorobenzenes %28%1974%29%
% 209.16/209.30  |- skos__historyNote mesh__D020802 Spinal Cord Diseases %28%1967-1999%29%
% 209.16/209.30  |- mesh__dateEstablished mesh__D020802 2000-01-01
% 209.16/209.30  |- skos__historyNote mesh__D020802 Abscess/complications %28%1966-1999%29%
% 209.16/209.30  |- skos__broader mesh__D020802smesh__D000038
% 209.16/209.30  |- skos__hiddenLabel mesh__D020802 Intracranial Epidural Abscess
% 209.16/209.30  |- skos__broader mesh__D020802smesh__D020819
% 209.16/209.30  |- skos__broader mesh__D020802smesh__D013118
% 209.16/209.30  |- skos__hiddenLabel mesh__D020802 Extradural Abscess, Intracranial
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D020802 2003
% 209.16/209.30  |- skos__hiddenLabel mesh__D020802 Extradural Abscess, Spinal
% 209.16/209.30  |- skos__altLabel mesh__D020802 Abscess, Extradural
% 209.16/209.30  |- skos__hiddenLabel mesh__D020802 Abscess, Spinal Epidural
% 209.16/209.30  |- skos__hiddenLabel mesh__D020802 Abscess, Intracranial Epidural
% 209.16/209.30  |- skos__hiddenLabel mesh__D020802 Extradural Abscesses, Intracranial
% 209.16/209.30  |- skos__hiddenLabel mesh__D020802 Abscesses, Intracranial Extradural
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D020802 2002
% 209.16/209.30  |- skos__hiddenLabel mesh__D020802 Abscess, Cranial Extradural
% 209.16/209.30  |- skos__historyNote mesh__D020802
% 209.16/209.30       Spinal Cord Compression/etiology %28%1966-1999%29%
% 209.16/209.30  |- skos__annotation mesh__D020802
% 209.16/209.30       coord %28%IM%29% with site %28%IM%29% + precoord organism infect %28%IM%29% + specific CNS infect term %28%IM%29%%A%  
% 209.16/209.30  |- mesh__historyNote mesh__D020802 2000   
% 209.16/209.30  |- mesh__dateCreated mesh__D020802 1999-11-03
% 209.16/209.30  |- skos__hiddenLabel mesh__D020802 Abscess, Spinal Extradural
% 209.16/209.30  |- skos__hiddenLabel mesh__D020802 Intracranial Extradural Abscesses
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D020802 2001
% 209.16/209.30  |- mesh__publicMeSHNote mesh__D020802 2000   
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D020802 2006
% 209.16/209.30  |- skos__broader mesh__D020802smesh__D002494
% 209.16/209.30  |- skos__broader mesh__D020802smesh__D020806
% 209.16/209.30  |- skos__hiddenLabel mesh__D020802 Abscess, Intracranial Extradural
% 209.16/209.30  |- rdf__type mesh__D020802sskos__Concept
% 209.16/209.30  |- skos__altLabel mesh__D020802 Cranial Extradural Abscess
% 209.16/209.30  |- skos__prefLabel mesh__D020802 Epidural Abscess
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D020802 2000
% 209.16/209.30  |- skos__altLabel mesh__D020802 Intracranial Extradural Abscess
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D020802 2005
% 209.16/209.30  |- skos__altLabel mesh__D020802 Spinal Extradural Abscess
% 209.16/209.30  |- skos__hiddenLabel mesh__D020802 Spinal Epidural Abscess
% 209.16/209.30  |- skos__altLabel mesh__D020802 Abscess, Epidural
% 209.16/209.30  |- skos__hiddenLabel mesh__D020802 Abscess, Cranial Epidural
% 209.16/209.30  |- skos__hiddenLabel mesh__D020802 Epidural Abscess, Cranial
% 209.16/209.30  |- skos__altLabel mesh__D020802 Epidural Abscess, Intracranial
% 209.16/209.30  |- skos__scopeNote mesh__D020802
% 209.16/209.30       Circumscribed collections of suppurative material occurring in the spinal or intracranial EPIDURAL SPACE. The majority of epidural abscesses occur in the spinal canal and are associated with OSTEOMYELITIS of a vertebral body; ANALGESIA, EPIDURAL; and other conditions. Clinical manifestations include local and radicular pain, weakness, sensory loss, URINARY INCONTINENCE, and FECAL INCONTINENCE. Cranial epidural abscesses are usually associated with OSTEOMYELITIS of a cranial bone, SINUSITIS, or OTITIS MEDIA. %28%From Adams et al., Principles of Neurology, 6th ed, p710 and pp1240-1; J Neurol Neurosurg Psychiatry 1998 Aug;65%28%2%29%:209-12%29%%A%    
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D020802 2004
% 209.16/209.30  |- skos__hiddenLabel mesh__D020802 Extradural Abscess
% 209.16/209.30  |- mesh__recordOriginator mesh__D006333 NLM
% 209.16/209.30  |- skos__hiddenLabel mesh__D006333 Congestive Heart Failure
% 209.16/209.30  |- skos__altLabel mesh__D006333 Heart Decompensation
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D006333 2003
% 209.16/209.30  |- skos__prefLabel mesh__D006333 Heart Failure, Congestive
% 209.16/209.30  |- mesh__recordAuthorizer mesh__D006333 sjn
% 209.16/209.30  |- mesh__recordMaintainer mesh__D006333 nns
% 209.16/209.30  |- rdf__type mesh__D006333sskos__Concept
% 209.16/209.30  |- mesh__dateRevised mesh__D006333 2001-07-25
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D006333 2002
% 209.16/209.30  |- skos__annotation mesh__D006333
% 209.16/209.30       %22%scompenso di cuore%22% is %22%heart decompensation%22% in Italian; do not confuse with CARDIOMYOPATHY, CONGESTIVE; heart failure that is not congestive is CARDIAC OUTPUT, LOW%A%  
% 209.16/209.30  |- skos__hiddenLabel mesh__D006333 Failure, Congestive Heart
% 209.16/209.30  |- mesh__dateCreated mesh__D006333 1999-01-01
% 209.16/209.30  |- skos__broader mesh__D006333smesh__D006331
% 209.16/209.30  |- skos__scopeNote mesh__D006333
% 209.16/209.30       A complication of HEART DISEASES. Defective cardiac filling and/or impaired contraction and emptying, resulting in the heart%27%s inability to pump a sufficient amount of blood to meet the needs of the body tissues or to be able to do so only with an elevated filling pressure. %28%from Braunwald, Heart Disease, 5th ed%29%%A%    
% 209.16/209.30  |- skos__hiddenLabel mesh__D006333 Decompensation, Heart
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D006333 2006
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D006333 2005
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D006333 2004
% 209.16/209.30  |- mesh__recordAuthorizer mesh__D011278 PLS
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D011278 2000
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D011278 1994
% 209.16/209.30  |- mesh__recordOriginator mesh__D011278 NLM
% 209.16/209.30  |- rdf__type mesh__D011278sskos__Concept
% 209.16/209.30  |- skos__prefLabel mesh__D011278 Pregnanes
% 209.16/209.30  |- skos__annotation mesh__D011278 do not confuse with PREGNENES   
% 209.16/209.30  |- skos__scopeNote mesh__D011278
% 209.16/209.30       Saturated derivatives of the steroid pregnane. The 5-beta series includes PROGESTERONE and related hormones; the 5-alpha series includes forms generally excreted in the urine.%A%    
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D011278 2004
% 209.16/209.30  |- mesh__dateEstablished mesh__D011278 1968-01-01
% 209.16/209.30  |- mesh__dateRevised mesh__D011278 1993-06-03
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D011278 1997
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D011278 2002
% 209.16/209.30  |- mesh__dateCreated mesh__D011278 1999-01-01
% 209.16/209.30  |- mesh__historyNote mesh__D011278 68   
% 209.16/209.30  |- skos__broader mesh__D011278smesh__D013256
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D011278 2003
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D011278 1996
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D011278 2006
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D011278 1999
% 209.16/209.30  |- mesh__publicMeSHNote mesh__D011278 68   
% 209.16/209.30  |- mesh__recordMaintainer mesh__D011278 PLS
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D011278 2001
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D011278 1995
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D011278 2005
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D011278 1998
% 209.16/209.30  |- mesh__dateEstablished mesh__D016761 1992-01-01
% 209.16/209.30  |- mesh__dateCreated mesh__D016761 1991-07-12
% 209.16/209.30  |- skos__hiddenLabel mesh__D016761 p75 gag fos fox
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D016761 2006
% 209.16/209.30  |- skos__hiddenLabel mesh__D016761 Oncogene Products v fos
% 209.16/209.30  |- skos__altLabel mesh__D016761 Oncogene Proteins fos
% 209.16/209.30  |- mesh__historyNote mesh__D016761
% 209.16/209.30       92; was ONCOGENE PROTEIN FOS %28%NM%29% 1990-91   
% 209.16/209.30  |- skos__altLabel mesh__D016761 Oncogene Products v-fos
% 209.16/209.30  |- mesh__recordOriginator mesh__D016761 AGS
% 209.16/209.30  |- mesh__publicMeSHNote mesh__D016761
% 209.16/209.30       92; ONCOGENE PROTEIN FOS %28%NM%29% was indexed under ONCOGENE PROTEINS, VIRAL 1990-91%A%  
% 209.16/209.30  |- skos__scopeNote mesh__D016761
% 209.16/209.30       Transforming proteins coded by fos oncogenes. These proteins have been found in the Finkel-Biskis-Jinkins %28%FBJ-MSV%29% and Finkel-Biskis-Reilly %28%FBR-MSV%29% murine sarcoma viruses which induce osteogenic sarcomas in mice. The FBJ-MSV v-fos gene encodes a p55-kDa protein and the FBR-MSV v-fos gene encodes a p75-kDa fusion protein.%A%    
% 209.16/209.30  |- skos__altLabel mesh__D016761 p75%28%gag-fos%29%
% 209.16/209.30  |- skos__altLabel mesh__D016761 fos Oncogene Proteins
% 209.16/209.30  |- skos__altLabel mesh__D016761 Oncogene Protein p75%28%gag-fos-fox%29%
% 209.16/209.30  |- skos__hiddenLabel mesh__D016761 p75 gag fos
% 209.16/209.30  |- skos__hiddenLabel mesh__D016761 Oncogene Proteins v fos
% 209.16/209.30  |- skos__historyNote mesh__D016761
% 209.16/209.30       Oncogene Proteins, Viral %28%1989-1991%29%
% 209.16/209.30  |- skos__altLabel mesh__D016761 p75 gag-fos-fox
% 209.16/209.30  |- rdf__type mesh__D016761sskos__Concept
% 209.16/209.30  |- skos__historyNote mesh__D016761 Retroviridae Proteins %28%1987-1988%29%
% 209.16/209.30  |- skos__altLabel mesh__D016761 Oncogene Protein p55%28%v-fos%29%
% 209.16/209.30  |- skos__hiddenLabel mesh__D016761 gag-fos-fox Fusion Proteins
% 209.16/209.30  |- skos__hiddenLabel mesh__D016761 v fos Proteins
% 209.16/209.30  |- mesh__recordMaintainer mesh__D016761 SYSTEM
% 209.16/209.30  |- skos__annotation mesh__D016761
% 209.16/209.30       IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 209.16/209.30  |- mesh__recordAuthorizer mesh__D016761 sjn
% 209.16/209.30  |- skos__broader mesh__D016761smesh__D015682
% 209.16/209.30  |- mesh__onlineNote mesh__D016761
% 209.16/209.30       use ONCOGENE PROTEINS V-FOS %28%NM%29% to search ONCOGENE PROTEIN FOS %28%NM%29% 1990-91%A%  
% 209.16/209.30  |- mesh__dateRevised mesh__D016761 2005-06-30
% 209.16/209.30  |- skos__prefLabel mesh__D016761 Oncogene Proteins v-fos
% 209.16/209.30  |- skos__altLabel mesh__D016761 v-fos Proteins
% 209.16/209.30  |- mesh__publicMeSHNote mesh__D002741
% 209.16/209.30       65; TRIANISOESTROL was see CHLOROTRIANISENE 1978-93   
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D002741 2006
% 209.16/209.30  |- skos__broader mesh__D002741smesh__D013267
% 209.16/209.30  |- mesh__dateCreated mesh__D002741 1999-01-01
% 209.16/209.30  |- mesh__recordAuthorizer mesh__D002741 sjn
% 209.16/209.30  |- mesh__recordOriginator mesh__D002741 NLM
% 209.16/209.30  |- mesh__historyNote mesh__D002741
% 209.16/209.30       65%28%64%29%; TRIANISOESTROL was see CHLOROTRIANISENE 1978-93   
% 209.16/209.30  |- mesh__dateRevised mesh__D002741 2005-06-30
% 209.16/209.30  |- mesh__onlineNote mesh__D002741
% 209.16/209.30       use CHLOROTRIANISENE to search TRIANISOESTROL 1978-93   
% 209.16/209.30  |- skos__prefLabel mesh__D002741 Chlorotrianisene
% 209.16/209.30  |- mesh__recordMaintainer mesh__D002741 lkw
% 209.16/209.30  |- rdf__type mesh__D002741sskos__Concept
% 209.16/209.30  |- skos__scopeNote mesh__D002741
% 209.16/209.30       A powerful synthetic, non-steroidal estrogen.     
% 209.16/209.30  |- mesh__dateEstablished mesh__D002741 1965-01-01
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D015669 2006
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D015669 2005
% 209.16/209.30  |- skos__broader mesh__D015669smesh__D016740
% 209.16/209.30  |- mesh__recordAuthorizer mesh__D015669 sjn
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D015669 2002
% 209.16/209.30  |- skos__hiddenLabel mesh__D015669 Points, Acupuncture
% 209.16/209.30  |- mesh__recordMaintainer mesh__D015669 ssb
% 209.16/209.30  |- rdf__type mesh__D015669sskos__Concept
% 209.16/209.30  |- skos__scopeNote mesh__D015669
% 209.16/209.30       Designated locations along nerves or organ meridians for inserting acupuncture needles.%A%    
% 209.16/209.30  |- skos__hiddenLabel mesh__D015669 Acupoint
% 209.16/209.30  |- mesh__historyNote mesh__D015669 90   
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D015669 2004
% 209.16/209.30  |- skos__altLabel mesh__D015669 Acupoints
% 209.16/209.30  |- skos__prefLabel mesh__D015669 Acupuncture Points
% 209.16/209.30  |- mesh__publicMeSHNote mesh__D015669 90   
% 209.16/209.30  |- skos__hiddenLabel mesh__D015669 Point, Acupuncture
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D015669 2003
% 209.16/209.30  |- skos__hiddenLabel mesh__D015669 Acupuncture Point
% 209.16/209.30  |- mesh__dateEstablished mesh__D015669 1990-01-01
% 209.16/209.30  |- mesh__dateCreated mesh__D015669 1989-04-07
% 209.16/209.30  |- mesh__recordOriginator mesh__D015669 EGC
% 209.16/209.30  |- mesh__dateRevised mesh__D015669 2001-07-25
% 209.16/209.30  |- skos__historyNote mesh__D015669 Acupuncture %28%1966-1989%29%
% 209.16/209.30  |- rdf__type mesh__D034823sskos__Concept
% 209.16/209.30  |- mesh__dateEstablished mesh__D034823 2003-01-01
% 209.16/209.30  |- skos__scopeNote mesh__D034823
% 209.16/209.30       A plant genus of the family COMMELINACEAE that is used in genotoxic bioassays.%A%    
% 209.16/209.30  |- skos__altLabel mesh__D034823 Spiderwort
% 209.16/209.30  |- skos__annotation mesh__D034823
% 209.16/209.30       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.16/209.30  |- skos__broader mesh__D034823smesh__D034821
% 209.16/209.30  |- skos__prefLabel mesh__D034823 Tradescantia
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D034823 2005
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D034823 2003
% 209.16/209.30  |- mesh__historyNote mesh__D034823 2003   
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D034823 2006
% 209.16/209.30  |- mesh__dateCreated mesh__D034823 2002-07-03
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D034823 2004
% 209.16/209.30  |- mesh__publicMeSHNote mesh__D034823 2003   
% 209.16/209.30  |- mesh__dateEstablished mesh__D001649 1980-01-01
% 209.16/209.30  |- skos__historyNote mesh__D001649 specific bile duct
% 209.16/209.30  |- skos__hiddenLabel mesh__D001649 Duct Diseases, Bile
% 209.16/209.30  |- skos__hiddenLabel mesh__D001649 Duct Disease, Bile
% 209.16/209.30  |- skos__scopeNote mesh__D001649
% 209.16/209.30       Diseases in any part of the ductal system of the BILIARY TRACT from the smallest BILE CANALICULI to the largest COMMON BILE DUCT.%A%    
% 209.16/209.30  |- mesh__recordOriginator mesh__D001649 SMH
% 209.16/209.30  |- mesh__publicMeSHNote mesh__D001649 80   
% 209.16/209.30  |- skos__hiddenLabel mesh__D001649 Diseases, Bile Duct
% 209.16/209.30  |- skos__historyNote mesh__D001649 Bile Ducts %28%1966-1979%29%
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D001649 2006
% 209.16/209.30  |- skos__hiddenLabel mesh__D001649 Disease, Bile Duct
% 209.16/209.30  |- skos__historyNote mesh__D001649 Biliary Tract Diseases %28%1966-1979%29%
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D001649 2004
% 209.16/209.30  |- skos__broader mesh__D001649smesh__D001660
% 209.16/209.30  |- mesh__recordMaintainer mesh__D001649 lkt
% 209.16/209.30  |- rdf__type mesh__D001649sskos__Concept
% 209.16/209.30  |- skos__prefLabel mesh__D001649 Bile Duct Diseases
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D001649 2005
% 209.16/209.30  |- skos__historyNote mesh__D001649 Cholestasis %28%1966-1979%29%
% 209.16/209.30  |- mesh__dateCreated mesh__D001649 1979-05-29
% 209.16/209.30  |- mesh__historyNote mesh__D001649 80   
% 209.16/209.30  |- skos__annotation mesh__D001649
% 209.16/209.30       inflamm dis = CHOLANGITIS; calculi = BILIARY CALCULI see GALLSTONES but consider also CHOLELITHIASIS + BILE DUCT DISEASES%A%  
% 209.16/209.30  |- mesh__recordAuthorizer mesh__D001649 sjn
% 209.16/209.30  |- mesh__dateRevised mesh__D001649 2003-07-09
% 209.16/209.30  |- skos__hiddenLabel mesh__D001649 Bile Duct Disease
% 209.16/209.30  |- skos__prefLabel mesh__D012371 Robotics
% 209.16/209.30  |- skos__historyNote mesh__D012371 Automation %28%1966-1986%29%
% 209.16/209.30  |- skos__hiddenLabel mesh__D012371 Operations, Remote %28%Robotics%29%
% 209.16/209.30  |- mesh__recordMaintainer mesh__D012371 sjn
% 209.16/209.30  |- skos__broader mesh__D012371smesh__D001331
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D012371 2006
% 209.16/209.30  |- mesh__dateEstablished mesh__D012371 1987-01-01
% 209.16/209.30  |- mesh__recordOriginator mesh__D012371 SH
% 209.16/209.30  |- mesh__activeMeSHYear mesh__D012371 2005
% 209.16/209.30  |- mesh__dateCreated mesh__D012371 1986-04-08
% 209.16/209.30  |- skos__historyNote mesh__D012371 Bionics %28%1966-1986%29%
% 209.16/209.30  |- skos__hiddenLabel mesh__D012371 Operation, Remote %28%Robotics%29%
% 209.16/209.30  |- skos__broader mesh__D012371smesh__D001185
% 209.16/209.30  |- skos__broader mesh__D012371smesh__D004581
% 209.16/209.30  |- mesh__dateRevised mesh__D012371 2004-07-13
% 209.16/209.30  |- rdf__type mesh__D012371sskos__Concept
% 209.16/209.30  |- mesh__historyNote mesh__D012371 87; was see AUTOMATION 1963-86   
% 209.16/209.30  |- mesh__onlineNote mesh__D012371 search AUTOMATION 1966-86   
% 209.16/209.30  |- mesh__recordAuthorizer mesh__D012371 sjn
% 209.16/209.30  |- skos__hiddenLabel mesh__D012371 Remote Operation %28%Robotics%29%
% 209.16/209.31  |- mesh__publicMeSHNote mesh__D012371 87; was see AUTOMATION 1963-86   
% 209.16/209.31  |- skos__scopeNote mesh__D012371
% 209.16/209.31       The application of electronic, computerized control systems to mechanical devices designed to perform human functions. Formerly restricted to industry, but nowadays applied to artificial organs controlled by bionic %28%bioelectronic%29% devices, like automated insulin pumps and other prostheses.%A%    
% 209.16/209.31  |- skos__altLabel mesh__D020803 Herpes Encephalitis
% 209.16/209.31  |- skos__hiddenLabel mesh__D020803 Herpetic Meningoencephalitides
% 209.16/209.31  |- skos__hiddenLabel mesh__D020803 Meningoencephalitis, Herpes Simplex
% 209.16/209.31  |- skos__hiddenLabel mesh__D020803 Herpetic Encephalitides
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020803 2005
% 209.16/209.31  |- skos__hiddenLabel mesh__D020803 Encephalitis, Herpes
% 209.16/209.31  |- mesh__publicMeSHNote mesh__D020803 2000   
% 209.16/209.31  |- rdf__type mesh__D020803sskos__Concept
% 209.16/209.31  |- skos__hiddenLabel mesh__D020803 Meningoencephalitis, Herpetic
% 209.16/209.31  |- skos__scopeNote mesh__D020803
% 209.16/209.31       An acute %28%or rarely chronic%29% inflammatory process of the brain caused by SIMPLEXVIRUS infections which may be fatal. The majority of infections are caused by human herpesvirus 1 %28%HERPESVIRUS 1, HUMAN%29% and less often by human herpesvirus 2 %28%HERPESVIRUS 2, HUMAN%29%. Clinical manifestations include FEVER; HEADACHE; SEIZURES; HALLUCINATIONS; behavioral alterations; APHASIA; hemiparesis; and COMA. Pathologically, the condition is marked by a hemorrhagic necrosis involving the medial and inferior TEMPORAL LOBE and orbital regions of the FRONTAL LOBE. %28%From Adams et al., Principles of Neurology, 6th ed, pp751-4%29%%A%    
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020803 2006
% 209.16/209.31  |- skos__hiddenLabel mesh__D020803 Encephalitides, Herpes Simplex
% 209.16/209.31  |- skos__altLabel mesh__D020803 Herpetic Meningoencephalitis
% 209.16/209.31  |- mesh__recordMaintainer mesh__D020803 sjn
% 209.16/209.31  |- skos__altLabel mesh__D020803 Herpetic Encephalitis
% 209.16/209.31  |- mesh__dateCreated mesh__D020803 1999-11-08
% 209.16/209.31  |- skos__altLabel mesh__D020803 Acute Necrotizing Encephalitis, Herpetic
% 209.16/209.31  |- skos__altLabel mesh__D020803 Herpes Simplex Encephalitis
% 209.16/209.31  |- mesh__dateEstablished mesh__D020803 2000-01-01
% 209.16/209.31  |- skos__hiddenLabel mesh__D020803 Encephalitis, Herpetic
% 209.16/209.31  |- skos__prefLabel mesh__D020803 Encephalitis, Herpes Simplex
% 209.16/209.31  |- mesh__recordOriginator mesh__D020803 KEV
% 209.16/209.31  |- skos__hiddenLabel mesh__D020803 Herpes Simplex Meningoencephalitides
% 209.16/209.31  |- skos__altLabel mesh__D020803 Herpes Simplex Meningoencephalitis
% 209.16/209.31  |- skos__broader mesh__D020803smesh__D006566
% 209.16/209.31  |- mesh__recordAuthorizer mesh__D020803 sjn
% 209.16/209.31  |- skos__hiddenLabel mesh__D020803 Meningoencephalitides, Herpetic
% 209.16/209.31  |- skos__broader mesh__D020803smesh__D018792
% 209.16/209.31  |- skos__hiddenLabel mesh__D020803 Herpes Simplex Encephalitides
% 209.16/209.31  |- skos__hiddenLabel mesh__D020803 Meningoencephalitides, Herpes Simplex
% 209.16/209.31  |- skos__hiddenLabel mesh__D020803 Encephalitides, Herpetic
% 209.16/209.31  |- skos__annotation mesh__D020803
% 209.16/209.31       coord IM with specific SIMPLEXVIRUS if given; DF: ENCEPH HERPES SIMPLEX%A%  
% 209.16/209.31  |- mesh__dateRevised mesh__D020803 2004-07-13
% 209.16/209.31  |- mesh__historyNote mesh__D020803 2000   
% 209.16/209.31  |- skos__hiddenLabel mesh__D006334 Function Tests, Cardiac
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006334 2001
% 209.16/209.31  |- skos__hiddenLabel mesh__D006334 Test, Cardiac Function
% 209.16/209.31  |- rdf__type mesh__D006334sskos__Concept
% 209.16/209.31  |- skos__hiddenLabel mesh__D006334 Function Tests, Heart
% 209.16/209.31  |- mesh__recordOriginator mesh__D006334 NLM
% 209.16/209.31  |- skos__hiddenLabel mesh__D006334 Tests, Cardiac Function
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006334 2000
% 209.16/209.31  |- mesh__recordMaintainer mesh__D006334 PXP
% 209.16/209.31  |- skos__prefLabel mesh__D006334 Heart Function Tests
% 209.16/209.31  |- skos__hiddenLabel mesh__D006334 Heart Function Test
% 209.16/209.31  |- mesh__dateCreated mesh__D006334 1999-01-01
% 209.16/209.31  |- skos__broader mesh__D006334smesh__D003935
% 209.16/209.31  |- skos__hiddenLabel mesh__D006334 Function Test, Heart
% 209.16/209.31  |- mesh__dateRevised mesh__D006334 1997-06-20
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006334 1999
% 209.16/209.31  |- skos__hiddenLabel mesh__D006334 Function Test, Cardiac
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006334 2006
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006334 2002
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006334 1998
% 209.16/209.31  |- skos__hiddenLabel mesh__D006334 Cardiac Function Test
% 209.16/209.31  |- skos__hiddenLabel mesh__D006334 Tests, Heart Function
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006334 2005
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006334 2004
% 209.16/209.31  |- skos__annotation mesh__D006334 /drug eff /rad eff permitted   
% 209.16/209.31  |- skos__altLabel mesh__D006334 Cardiac Function Tests
% 209.16/209.31  |- mesh__recordAuthorizer mesh__D006334 SJN
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006334 2003
% 209.16/209.31  |- skos__hiddenLabel mesh__D006334 Test, Heart Function
% 209.16/209.31  |- mesh__dateEstablished mesh__D020005 1998-01-01
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020005 2005
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020005 2003
% 209.16/209.31  |- skos__broader mesh__D020005smesh__D000438
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020005 2002
% 209.16/209.31  |- mesh__dateCreated mesh__D020005 1997-06-20
% 209.16/209.31  |- skos__prefLabel mesh__D020005 Propanols
% 209.16/209.31  |- skos__scopeNote mesh__D020005
% 209.16/209.31       Isomeric forms and derivatives of PROPANOL %28%C3H7OH%29%.     
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020005 1999
% 209.16/209.31  |- rdf__type mesh__D020005sskos__Concept
% 209.16/209.31  |- skos__hiddenLabel mesh__D020005 Propyl Alcohols
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020005 1998
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020005 2001
% 209.16/209.31  |- skos__altLabel mesh__D020005 Alcohols, Propyl
% 209.16/209.31  |- mesh__historyNote mesh__D020005 98   
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020005 2006
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020005 2000
% 209.16/209.31  |- mesh__publicMeSHNote mesh__D020005 98   
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020005 2004
% 209.16/209.31  |- mesh__dateEstablished mesh__D050490 2006-01-01
% 209.16/209.31  |- mesh__recordAuthorizer mesh__D050490 ags
% 209.16/209.31  |- skos__hiddenLabel mesh__D050490 tpr-met Fusion Proteins
% 209.16/209.31  |- skos__hiddenLabel mesh__D050490 Protein tpr-met, Oncogene
% 209.16/209.31  |- skos__hiddenLabel mesh__D050490 tpr-met, Oncogene Protein
% 209.16/209.31  |- rdf__type mesh__D050490sskos__Concept
% 209.16/209.31  |- skos__scopeNote mesh__D050490
% 209.16/209.31       The GENETIC TRANSLATION product from a GENE FUSION between a sequence from the tpr protein gene on the human CHROMOSOME 1 and the gene for PROTO-ONCOGENE PROTEINS C-MET.%A%    
% 209.16/209.31  |- skos__hiddenLabel mesh__D050490 Oncogene Protein tpr met
% 209.16/209.31  |- skos__broader mesh__D050490smesh__D015514
% 209.16/209.31  |- mesh__publicMeSHNote mesh__D050490
% 209.16/209.31       2006; see ONCOGENE PROTEINS, FUSION 1990-2005   
% 209.16/209.31  |- mesh__dateCreated mesh__D050490 2005-06-30
% 209.16/209.31  |- mesh__recordOriginator mesh__D050490 nns
% 209.16/209.31  |- skos__altLabel mesh__D050490 Fusion Proteins, tpr-met
% 209.16/209.31  |- mesh__historyNote mesh__D050490
% 209.16/209.31       2006; use ONCOGENE PROTEINS, FUSION 1990-2005   
% 209.16/209.31  |- skos__prefLabel mesh__D050490 Oncogene Protein tpr-met
% 209.16/209.31  |- skos__hiddenLabel mesh__D050490 Fusion Proteins, tpr met
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D050490 2006A
% 209.16/209.31  |- mesh__recordMaintainer mesh__D050490 ags
% 209.16/209.31  |- mesh__dateRevised mesh__D050490 2005-07-27
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D050490 2006
% 209.16/209.31  |- rdf__type mesh__D011279sskos__Concept
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D011279 2005
% 209.16/209.31  |- mesh__recordAuthorizer mesh__D011279 sjn
% 209.16/209.31  |- skos__altLabel mesh__D011279 5beta-Pregnane-3alpha,17alpha,20alpha-triol
% 209.16/209.31  |- mesh__dateCreated mesh__D011279 1999-01-01
% 209.16/209.31  |- skos__broader mesh__D011279smesh__D019326
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D011279 2004
% 209.16/209.31  |- skos__altLabel mesh__D011279 5-beta-Pregnane-3,17,20-triol
% 209.16/209.31  |- mesh__dateEstablished mesh__D011279 1966-01-01
% 209.16/209.31  |- mesh__publicMeSHNote mesh__D011279 66   
% 209.16/209.31  |- skos__prefLabel mesh__D011279 Pregnanetriol
% 209.16/209.31  |- mesh__recordMaintainer mesh__D011279 lkt
% 209.16/209.31  |- mesh__dateRevised mesh__D011279 2003-07-09
% 209.16/209.31  |- mesh__historyNote mesh__D011279 66%28%64%29%   
% 209.16/209.31  |- skos__broader mesh__D011279smesh__D011278
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D011279 2006
% 209.16/209.31  |- mesh__recordOriginator mesh__D011279 NLM
% 209.16/209.31  |- skos__scopeNote mesh__D011279
% 209.16/209.31       A metabolite of 17-ALPHA-HYDROXYPROTESTERONE, normally produced in small quantities by the GONADS and the ADRENAL GLANDS, found in URINE. An elevated urinary pregnanetriol is associated with CONGENITAL ADRENAL HYPERPLASIA with a deficiency of  STEROID 21-HYDROXYLASE.%A%    
% 209.16/209.31  |- mesh__historyNote mesh__D016762 92   
% 209.16/209.31  |- skos__hiddenLabel mesh__D016762 c-fos Gene
% 209.16/209.31  |- skos__historyNote mesh__D016762 Oncogenes %28%1983-1991%29%
% 209.16/209.31  |- skos__altLabel mesh__D016762 v-fos Oncogenes
% 209.16/209.31  |- skos__related mesh__D016762smesh__D016760
% 209.16/209.31  |- skos__broader mesh__D016762smesh__D011519
% 209.16/209.31  |- mesh__dateEstablished mesh__D016762 1992-01-01
% 209.16/209.31  |- rdf__type mesh__D016762sskos__Concept
% 209.16/209.31  |- skos__altLabel mesh__D016762 c-fos Proto-Oncogenes
% 209.16/209.31  |- skos__hiddenLabel mesh__D016762 v-fos Gene
% 209.16/209.31  |- mesh__recordAuthorizer mesh__D016762 sjn
% 209.16/209.31  |- skos__hiddenLabel mesh__D016762 v fos Genes
% 209.16/209.31  |- skos__altLabel mesh__D016762 fos Genes
% 209.16/209.31  |- skos__related mesh__D016762smesh__D016761
% 209.16/209.31  |- mesh__dateRevised mesh__D016762 2005-06-30
% 209.16/209.31  |- skos__scopeNote mesh__D016762
% 209.16/209.31       Retrovirus-associated DNA sequences %28%fos%29% originally isolated from the Finkel-Biskis-Jinkins %28%FBJ-MSV%29% and Finkel-Biskis-Reilly %28%FBR-MSV%29% murine sarcoma viruses. The proto-oncogene protein c-fos codes for a nuclear protein which is involved in growth-related transcriptional control. The insertion of c-fos into FBJ-MSV or FBR-MSV induces osteogenic sarcomas in mice. The human c-fos gene is located at 14q21-31 on the long arm of chromosome 14.%A%    
% 209.16/209.31  |- skos__historyNote mesh__D016762 Proto-Oncogenes %28%1985-1991%29%
% 209.16/209.31  |- skos__prefLabel mesh__D016762 Genes, fos
% 209.16/209.31  |- mesh__dateCreated mesh__D016762 1991-07-12
% 209.16/209.31  |- skos__hiddenLabel mesh__D016762 fos Gene
% 209.16/209.31  |- skos__hiddenLabel mesh__D016762 c fos Genes
% 209.16/209.31  |- skos__hiddenLabel mesh__D016762 v-fos Oncogene
% 209.16/209.31  |- skos__hiddenLabel mesh__D016762 v fos Oncogenes
% 209.16/209.31  |- skos__annotation mesh__D016762
% 209.16/209.31       fos stands for %22%Finkel%22% %26% %22%Osteogenic Sarcoma%22%   
% 209.16/209.31  |- mesh__recordOriginator mesh__D016762 AGS
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D016762 2006
% 209.16/209.31  |- mesh__publicMeSHNote mesh__D016762 92   
% 209.16/209.31  |- skos__hiddenLabel mesh__D016762 c fos Proto Oncogenes
% 209.16/209.31  |- mesh__recordMaintainer mesh__D016762 nns
% 209.16/209.31  |- skos__hiddenLabel mesh__D016762 c-fos Proto-Oncogene
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D002742 2005
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D002742 2002
% 209.16/209.31  |- skos__broader mesh__D002742smesh__D000578
% 209.16/209.31  |- skos__altLabel mesh__D002742 Chlordimeform
% 209.16/209.31  |- skos__scopeNote mesh__D002742
% 209.16/209.31       An acaricide used against many organophosphate and carbamate resistant pests. It acts as an uncoupling agent and monoamine oxidase inhibitor.%A%    
% 209.16/209.31  |- skos__historyNote mesh__D002742 Toluene %28%1972-1974%29%
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D002742 2004
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D002742 2001
% 209.16/209.31  |- mesh__publicMeSHNote mesh__D002742 91; was see under AMIDINES 1975-90   
% 209.16/209.31  |- mesh__dateCreated mesh__D002742 1974-11-11
% 209.16/209.31  |- rdf__type mesh__D002742sskos__Concept
% 209.16/209.31  |- mesh__historyNote mesh__D002742
% 209.16/209.31       91%28%75%29%; was see under AMIDINES 1975-90   
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D002742 2003
% 209.16/209.31  |- mesh__recordMaintainer mesh__D002742 CCR
% 209.16/209.31  |- skos__annotation mesh__D002742 TN 111 for eff on insects, etc.   
% 209.16/209.31  |- mesh__recordAuthorizer mesh__D002742 sjn
% 209.16/209.31  |- mesh__recordOriginator mesh__D002742 NLM
% 209.16/209.31  |- mesh__dateEstablished mesh__D002742 1991-01-01
% 209.16/209.31  |- skos__prefLabel mesh__D002742 Chlorphenamidine
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D002742 2006
% 209.16/209.31  |- skos__historyNote mesh__D002742 Amidines %28%1971-1974%29%
% 209.16/209.31  |- mesh__dateRevised mesh__D002742 2000-06-22
% 209.16/209.31  |- skos__altLabel mesh__D040861 Business Ethics
% 209.16/209.31  |- mesh__recordOriginator mesh__D040861 hjn
% 209.16/209.31  |- mesh__recordAuthorizer mesh__D040861 sjn
% 209.16/209.31  |- mesh__dateEstablished mesh__D040861 2003-01-01
% 209.16/209.31  |- skos__scopeNote mesh__D040861
% 209.16/209.31       The moral obligations governing the conduct of commercial or industrial enterprises.%A%    
% 209.16/209.31  |- mesh__dateRevised mesh__D040861 2003-07-25
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D040861 2004
% 209.16/209.31  |- skos__related mesh__D040861smesh__D004991
% 209.16/209.31  |- skos__altLabel mesh__D040861 Corporate Ethics
% 209.16/209.31  |- mesh__recordMaintainer mesh__D040861 sjn
% 209.16/209.31  |- skos__related mesh__D040861smesh__D003132
% 209.16/209.31  |- skos__prefLabel mesh__D040861 Ethics, Business
% 209.16/209.31  |- skos__broader mesh__D040861smesh__D004989
% 209.16/209.31  |- skos__related mesh__D040861smesh__D007221
% 209.16/209.31  |- rdf__type mesh__D040861sskos__Concept
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D040861 2006
% 209.16/209.31  |- mesh__dateCreated mesh__D040861 2002-07-02
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D040861 2005
% 209.16/209.31  |- mesh__publicMeSHNote mesh__D040861 2003   
% 209.16/209.31  |- mesh__historyNote mesh__D040861 2003   
% 209.16/209.31  |- mesh__recordOriginator mesh__D012372 EC
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D012372 2005
% 209.16/209.31  |- mesh__historyNote mesh__D012372 88   
% 209.16/209.31  |- skos__broader mesh__D012372smesh__D013223
% 209.16/209.31  |- skos__broader mesh__D012372smesh__D012680
% 209.16/209.31  |- skos__hiddenLabel mesh__D012372 Curve, ROC
% 209.16/209.31  |- mesh__recordAuthorizer mesh__D012372 sjn
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D012372 2004
% 209.16/209.31  |- skos__prefLabel mesh__D012372 ROC Curve
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D012372 2002
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D012372 2006
% 209.16/209.31  |- skos__annotation mesh__D012372 ROC: note 1st X ref; no qualif   
% 209.16/209.31  |- skos__hiddenLabel mesh__D012372 Analyses, ROC
% 209.16/209.31  |- skos__hiddenLabel mesh__D012372 ROC Curves
% 209.16/209.31  |- skos__hiddenLabel mesh__D012372 ROC Analyses
% 209.16/209.31  |- skos__hiddenLabel mesh__D012372 Characteristics, Receiver Operating
% 209.16/209.31  |- skos__hiddenLabel mesh__D012372 Curves, ROC
% 209.16/209.31  |- skos__altLabel mesh__D012372 Analysis, ROC
% 209.16/209.31  |- rdf__type mesh__D012372sskos__Concept
% 209.16/209.31  |- mesh__recordMaintainer mesh__D012372 ags
% 209.16/209.31  |- mesh__dateEstablished mesh__D012372 1988-01-01
% 209.16/209.31  |- mesh__dateCreated mesh__D012372 1987-04-06
% 209.16/209.31  |- skos__hiddenLabel mesh__D012372 Receiver Operating Characteristics
% 209.16/209.31  |- skos__hiddenLabel mesh__D012372 Characteristic, Receiver Operating
% 209.16/209.31  |- skos__altLabel mesh__D012372 ROC Analysis
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D012372 2003
% 209.16/209.31  |- mesh__publicMeSHNote mesh__D012372 88   
% 209.16/209.31  |- mesh__dateRevised mesh__D012372 2001-07-25
% 209.16/209.31  |- skos__scopeNote mesh__D012372
% 209.16/209.31       A graphic means for assessing the ability of a screening test to discriminate between healthy and diseased persons; may also be used in other studies, e.g., distinguishing stimuli responses as to a faint stimuli or nonstimuli.%A%    
% 209.16/209.31  |- skos__broader mesh__D020804smesh__D018792
% 209.16/209.31  |- rdf__type mesh__D020804sskos__Concept
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020804 2001
% 209.16/209.31  |- skos__altLabel mesh__D020804 Varicella Encephalitis
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020804 2006
% 209.16/209.31  |- skos__altLabel mesh__D020804 Encephalitis, Herpes Zoster
% 209.16/209.31  |- skos__scopeNote mesh__D020804
% 209.16/209.31       Inflammation of brain tissue caused by infection with the varicella-zoster virus %28%HERPESVIRUS 3, HUMAN%29%. This condition is associated with immunocompromised states, including the ACQUIRED IMMUNODEFICIENCY SYNDROME. Pathologically, the virus tends to induce a vasculopathy and infect oligodendrocytes and ependymal cells, leading to CEREBRAL INFARCTION, multifocal regions of demyelination, and periventricular necrosis. Manifestations of varicella encephalitis usually occur 5-7 days after onset of HERPES ZOSTER and include HEADACHE; VOMITING; lethargy; focal neurologic deficits; FEVER; and COMA. %28%From Joynt, Clinical Neurology, 1996, Ch 26, pp29-32; Hum Pathol 1996 Sep;27%28%9%29%:927-38%29%%A%    
% 209.16/209.31  |- skos__altLabel mesh__D020804 Herpes Zoster Encephalitis
% 209.16/209.31  |- skos__altLabel mesh__D020804 Encephalitis, Varicella
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020804 2002
% 209.16/209.31  |- skos__hiddenLabel mesh__D020804 Varicella Encephalitides
% 209.16/209.31  |- mesh__dateEstablished mesh__D020804 2000-01-01
% 209.16/209.31  |- skos__prefLabel mesh__D020804 Encephalitis, Varicella Zoster
% 209.16/209.31  |- skos__hiddenLabel mesh__D020804 Virus Encephalitis, VZ
% 209.16/209.31  |- skos__altLabel mesh__D020804 Encephalitis, VZ Virus
% 209.16/209.31  |- mesh__publicMeSHNote mesh__D020804 2000   
% 209.16/209.31  |- skos__historyNote mesh__D020804 Encephalitis %28%1966-1999%29%
% 209.16/209.31  |- skos__historyNote mesh__D020804 Herpes Zoster %28%1966-1999%29%
% 209.16/209.31  |- skos__altLabel mesh__D020804 Herpes Zoster Meningoencephalitis
% 209.16/209.31  |- skos__broader mesh__D020804smesh__D006566
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020804 2003
% 209.16/209.31  |- mesh__dateCreated mesh__D020804 1999-11-08
% 209.16/209.31  |- mesh__historyNote mesh__D020804 2000   
% 209.16/209.31  |- skos__altLabel mesh__D020804 Encephalitis, Human Herpesvirus 3
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020804 2004
% 209.16/209.31  |- skos__hiddenLabel mesh__D020804 Zoster Encephalitis, Varicella
% 209.16/209.31  |- skos__hiddenLabel mesh__D020804 Zoster Encephalitis, Herpes
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020804 2005
% 209.16/209.31  |- skos__annotation mesh__D020804 DF: ENCEPH VARICELLA ZOSTER   
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020804 2000
% 209.16/209.31  |- skos__altLabel mesh__D020804 Varicella Zoster Encephalitis
% 209.16/209.31  |- mesh__dateCreated mesh__D006335 1999-01-01
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006335 2002
% 209.16/209.31  |- skos__altLabel mesh__D006335 Cardiac Rupture, Traumatic
% 209.16/209.31  |- mesh__dateRevised mesh__D006335 1994-02-08
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006335 1999
% 209.16/209.31  |- skos__hiddenLabel mesh__D006335 Ruptures, Traumatic Heart
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006335 2006
% 209.16/209.31  |- skos__hiddenLabel mesh__D006335 Injury, Heart
% 209.16/209.31  |- skos__scopeNote mesh__D006335
% 209.16/209.31       General or unspecified injuries to the heart.     
% 209.16/209.31  |- skos__hiddenLabel mesh__D006335 Traumatic Heart Ruptures
% 209.16/209.31  |- skos__hiddenLabel mesh__D006335 Traumatic Heart Rupture
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006335 1998
% 209.16/209.31  |- skos__hiddenLabel mesh__D006335 Rupture, Traumatic Heart
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006335 1997
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006335 2005
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006335 2004
% 209.16/209.31  |- mesh__recordMaintainer mesh__D006335 TGC
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006335 2001
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006335 1996
% 209.16/209.31  |- skos__prefLabel mesh__D006335 Heart Injuries
% 209.16/209.31  |- skos__annotation mesh__D006335
% 209.16/209.31       coord IM with specific part of heart /inj %28%NIM%29%   
% 209.16/209.31  |- skos__hiddenLabel mesh__D006335 Cardiac Ruptures, Traumatic
% 209.16/209.31  |- skos__hiddenLabel mesh__D006335 Traumatic Cardiac Rupture
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006335 2003
% 209.16/209.31  |- skos__broader mesh__D006335smesh__D013898
% 209.16/209.31  |- mesh__recordOriginator mesh__D006335 NLM
% 209.16/209.31  |- skos__hiddenLabel mesh__D006335 Ruptures, Traumatic Cardiac
% 209.16/209.31  |- mesh__recordAuthorizer mesh__D006335 PLS
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006335 2000
% 209.16/209.31  |- skos__hiddenLabel mesh__D006335 Heart Ruptures, Traumatic
% 209.16/209.31  |- skos__hiddenLabel mesh__D006335 Rupture, Traumatic Cardiac
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006335 1995
% 209.16/209.31  |- rdf__type mesh__D006335sskos__Concept
% 209.16/209.31  |- skos__altLabel mesh__D006335 Injuries, Heart
% 209.16/209.31  |- skos__hiddenLabel mesh__D006335 Heart Injury
% 209.16/209.31  |- skos__hiddenLabel mesh__D006335 Traumatic Cardiac Ruptures
% 209.16/209.31  |- mesh__publicMeSHNote mesh__D050491
% 209.16/209.31       2006; SODIUM-GLUTAMATE COTRANSPORTER was indexed under AMINO ACID TRANSPORT SYSTEM X-AG %26% SYMPORTERS 2003-2005, CARRIER PROTEINS 1984-2002%A%  
% 209.16/209.31  |- mesh__dateCreated mesh__D050491 2005-06-30
% 209.16/209.31  |- skos__hiddenLabel mesh__D050491
% 209.16/209.31       Neurotransmitter Transport Proteins, Glutamate Specific
% 209.16/209.31  |- mesh__recordMaintainer mesh__D050491 DRC
% 209.16/209.31  |- mesh__recordAuthorizer mesh__D050491 sjn
% 209.16/209.31  |- skos__scopeNote mesh__D050491
% 209.16/209.31       A family of plasma membrane neurotransmitter transporter proteins that couple the uptake of GLUTAMATE with the import of SODIUM ions and PROTONS and the export of POTASSIUM ions. In the CENTRAL NERVOUS SYSTEM they regulate neurotransmission through synaptic reuptake of the excitatory neurotransmitter glutamate. Outside the central nervous system they function as signal mediators and regulators of glutamate metabolism.%A%    
% 209.16/209.31  |- skos__altLabel mesh__D050491 Excitatory Amino Acid Transport Proteins
% 209.16/209.31  |- mesh__dateEstablished mesh__D050491 2006-01-01
% 209.16/209.31  |- mesh__recordOriginator mesh__D050491 DRC
% 209.16/209.31  |- skos__broader mesh__D050491smesh__D050480
% 209.16/209.31  |- skos__hiddenLabel mesh__D050491
% 209.16/209.31       Neurotransmitter Transporters, Glutamate Specific
% 209.16/209.31  |- skos__prefLabel mesh__D050491
% 209.16/209.31       Glutamate Plasma Membrane Transport Proteins
% 209.16/209.31  |- skos__altLabel mesh__D050491
% 209.16/209.31       Neurotransmitter Transporters, Glutamate-Specific
% 209.16/209.31  |- skos__altLabel mesh__D050491
% 209.16/209.31       Neurotransmitter Transport Proteins, Glutamate-Specific
% 209.16/209.31  |- skos__historyNote mesh__D050491 Symporters %28%1984-2005%29%
% 209.16/209.31  |- mesh__historyNote mesh__D050491 2006%28%1984%29%   
% 209.16/209.31  |- skos__historyNote mesh__D050491
% 209.16/209.31       Amino Acid Transport System X-AG %28%1984-2005%29%
% 209.16/209.31  |- skos__hiddenLabel mesh__D050491 Cotransporter, Sodium-Glutamate
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D050491 2006
% 209.16/209.31  |- skos__broader mesh__D050491smesh__D027322
% 209.16/209.31  |- skos__altLabel mesh__D050491 Sodium-Glutamate Transporter
% 209.16/209.31  |- skos__hiddenLabel mesh__D050491 Sodium Glutamate Transporter
% 209.16/209.31  |- skos__altLabel mesh__D050491 EAAT Proteins
% 209.16/209.31  |- skos__hiddenLabel mesh__D050491 Sodium Glutamate Cotransporter
% 209.16/209.31  |- skos__broader mesh__D050491smesh__D027981
% 209.16/209.31  |- skos__hiddenLabel mesh__D050491
% 209.16/209.31       Transporters, Glutamate-Specific Neurotransmitter
% 209.16/209.31  |- skos__altLabel mesh__D050491
% 209.16/209.31       Glutamate Plasma Membrane Transporter Proteins
% 209.16/209.31  |- rdf__type mesh__D050491sskos__Concept
% 209.16/209.31  |- skos__hiddenLabel mesh__D050491
% 209.16/209.31       Glutamate-Specific Neurotransmitter Transporters
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D002743 2006
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D002743 2002
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D002743 2005
% 209.16/209.31  |- mesh__publicMeSHNote mesh__D002743 74   
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D002743 2001
% 209.16/209.31  |- skos__prefLabel mesh__D002743 Chlorphenesin
% 209.16/209.31  |- skos__broader mesh__D002743smesh__D011409
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D002743 2004
% 209.16/209.31  |- mesh__recordOriginator mesh__D002743 NLM
% 209.16/209.31  |- mesh__recordAuthorizer mesh__D002743 sjn
% 209.16/209.31  |- rdf__type mesh__D002743sskos__Concept
% 209.16/209.31  |- mesh__recordMaintainer mesh__D002743 CCR
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D002743 2003
% 209.16/209.31  |- mesh__historyNote mesh__D002743 74%28%64%29%   
% 209.16/209.31  |- skos__scopeNote mesh__D002743
% 209.16/209.31       A centrally acting muscle relaxant. Its mode of action is unknown. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1203%29%%A%    
% 209.16/209.31  |- mesh__dateEstablished mesh__D002743 1974-01-01
% 209.16/209.31  |- mesh__dateRevised mesh__D002743 2000-06-22
% 209.16/209.31  |- mesh__dateCreated mesh__D002743 1999-01-01
% 209.16/209.31  |- skos__altLabel mesh__D012373 Typhus, Sao Paulo
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D012373 2006
% 209.16/209.31  |- mesh__dateCreated mesh__D012373 1999-01-01
% 209.16/209.31  |- mesh__recordAuthorizer mesh__D012373 sjn
% 209.16/209.31  |- rdf__type mesh__D012373sskos__Concept
% 209.16/209.31  |- mesh__recordOriginator mesh__D012373 NLM
% 209.16/209.31  |- mesh__recordMaintainer mesh__D012373 ags
% 209.16/209.31  |- skos__scopeNote mesh__D012373
% 209.16/209.31       An acute febrile illness caused by RICKETTSIA RICKETTSII. It is transmitted to humans by bites of infected ticks and occurs only in North and South America. Characteristics include a sudden onset with headache and chills and fever lasting about two to three weeks. A cutaneous rash commonly appears on the extremities and trunk about the fourth day of illness.%A%    
% 209.16/209.31  |- skos__prefLabel mesh__D012373 Rocky Mountain Spotted Fever
% 209.16/209.31  |- mesh__dateRevised mesh__D012373 2003-07-09
% 209.16/209.31  |- mesh__historyNote mesh__D012373
% 209.16/209.31       SAO PAULO TYPHUS was see under ROCKY MOUNTAIN SPOTTED FEVER 1963-76%A%  
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D012373 2005
% 209.16/209.31  |- skos__broader mesh__D012373smesh__D017282
% 209.16/209.31  |- skos__broader mesh__D012373smesh__D012282
% 209.16/209.31  |- skos__altLabel mesh__D012373 Sao Paulo Typhus
% 209.16/209.31  |- skos__annotation mesh__D012373
% 209.16/209.31       caused by Rickettsia rickettsii; for X ref, in titles %26% translations use diacrit: S%C3%%A3%o Paulo%A%  
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D012373 2004
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020805 2003
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020805 2002
% 209.16/209.31  |- skos__altLabel mesh__D020805 Infections, CNS, Viral
% 209.16/209.31  |- skos__altLabel mesh__D020805 Viral Diseases, Central Nervous System
% 209.16/209.31  |- mesh__historyNote mesh__D020805 2000   
% 209.16/209.31  |- skos__altLabel mesh__D020805 Viral Infections, Central Nervous System
% 209.16/209.31  |- skos__broader mesh__D020805smesh__D002494
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020805 2001
% 209.16/209.31  |- rdf__type mesh__D020805sskos__Concept
% 209.16/209.31  |- skos__hiddenLabel mesh__D020805 Viral CNS Infection
% 209.16/209.31  |- skos__scopeNote mesh__D020805
% 209.16/209.31       Viral infections of the brain, spinal cord, meninges, or perimeningeal spaces.%A%    
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020805 2006
% 209.16/209.31  |- skos__hiddenLabel mesh__D020805 Infection, Viral CNS
% 209.16/209.31  |- skos__hiddenLabel mesh__D020805 Viral CNS Infections
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020805 2000
% 209.16/209.31  |- mesh__dateEstablished mesh__D020805 2000-01-01
% 209.16/209.31  |- skos__annotation mesh__D020805
% 209.16/209.31       coord IM with specific virus disease %28%IM%29% and specific site/dis term if pertinent; DF: CNS VIRAL DIS%A%  
% 209.16/209.31  |- skos__hiddenLabel mesh__D020805 CNS Infection, Viral
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020805 2005
% 209.16/209.31  |- skos__prefLabel mesh__D020805 Central Nervous System Viral Diseases
% 209.16/209.31  |- skos__historyNote mesh__D020805
% 209.16/209.31       Central Nervous System Diseases %28%1966-1999%29%
% 209.16/209.31  |- skos__historyNote mesh__D020805 Meningitis, Viral %28%1967-1999%29%
% 209.16/209.31  |- skos__broader mesh__D020805smesh__D014777
% 209.16/209.31  |- skos__altLabel mesh__D020805 Infections, Viral CNS
% 209.16/209.31  |- mesh__dateCreated mesh__D020805 1999-11-03
% 209.16/209.31  |- skos__hiddenLabel mesh__D020805 CNS Infections, Viral
% 209.16/209.31  |- skos__historyNote mesh__D020805 Virus Diseases %28%1966-1999%29%
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D020805 2004
% 209.16/209.31  |- skos__altLabel mesh__D020805 Central Nervous System Viral Infections
% 209.16/209.31  |- skos__historyNote mesh__D020805 Encephalitis %28%1967-1999%29%
% 209.16/209.31  |- mesh__publicMeSHNote mesh__D020805 2000   
% 209.16/209.31  |- skos__broader mesh__D006336smesh__D006348
% 209.16/209.31  |- mesh__dateRevised mesh__D006336 1997-06-20
% 209.16/209.31  |- skos__hiddenLabel mesh__D006336 Cardiac Massages
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006336 1998
% 209.16/209.31  |- skos__annotation mesh__D006336
% 209.16/209.31       do not use /util except by MeSH definition   
% 209.16/209.31  |- skos__hiddenLabel mesh__D006336 Heart Massages
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006336 2004
% 209.16/209.31  |- mesh__activeMeSHYear mesh__D006336 2005
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D006336 2002
% 209.16/209.32  |- skos__hiddenLabel mesh__D006336 Massages, Cardiac
% 209.16/209.32  |- skos__hiddenLabel mesh__D006336 Massage, Cardiac
% 209.16/209.32  |- skos__altLabel mesh__D006336 Cardiac Massage
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D006336 2003
% 209.16/209.32  |- mesh__recordAuthorizer mesh__D006336 SJN
% 209.16/209.32  |- rdf__type mesh__D006336sskos__Concept
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D006336 2001
% 209.16/209.32  |- mesh__dateCreated mesh__D006336 1999-01-01
% 209.16/209.32  |- skos__scopeNote mesh__D006336
% 209.16/209.32       Rhythmic compression of the heart by pressure applied manually over the sternum %28%closed heart massage%29% or directly to the heart through an opening in the chest wall %28%open heart massage%29%. It is done to reinstate and maintain circulation. %28%Dorland, 28th ed%29%%A%    
% 209.16/209.32  |- skos__broader mesh__D006336smesh__D012151
% 209.16/209.32  |- skos__hiddenLabel mesh__D006336 Massage, Heart
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D006336 2000
% 209.16/209.32  |- mesh__recordOriginator mesh__D006336 NLM
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D006336 1999
% 209.16/209.32  |- skos__hiddenLabel mesh__D006336 Massages, Heart
% 209.16/209.32  |- mesh__recordMaintainer mesh__D006336 PXP
% 209.16/209.32  |- skos__prefLabel mesh__D006336 Heart Massage
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D006336 2006
% 209.16/209.32  |- skos__hiddenLabel mesh__D020007 Implant, Experimental
% 209.16/209.32  |- skos__prefLabel mesh__D020007 Implants, Experimental
% 209.16/209.32  |- rdf__type mesh__D020007sskos__Concept
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D020007 1998
% 209.16/209.32  |- skos__hiddenLabel mesh__D020007 Experimental Implant
% 209.16/209.32  |- mesh__historyNote mesh__D020007 98   
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D020007 2006
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D020007 2001
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D020007 2004
% 209.16/209.32  |- skos__hiddenLabel mesh__D020007 Experimental Implants
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D020007 2000
% 209.16/209.32  |- mesh__dateEstablished mesh__D020007 1998-01-01
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D020007 2005
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D020007 2003
% 209.16/209.32  |- mesh__publicMeSHNote mesh__D020007 98   
% 209.16/209.32  |- skos__historyNote mesh__D020007
% 209.16/209.32       Prostheses and Implants %28%1966-1997%29%
% 209.16/209.32  |- skos__broader mesh__D020007smesh__D019736
% 209.16/209.32  |- skos__scopeNote mesh__D020007
% 209.16/209.32       Artificial substitutes for body parts and materials inserted into organisms during experimental studies.%A%    
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D020007 2002
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D020007 1999
% 209.16/209.32  |- mesh__dateCreated mesh__D020007 1997-06-20
% 209.16/209.32  |- skos__altLabel mesh__D050492 Vesicular Amine Transporter Proteins
% 209.16/209.32  |- mesh__recordOriginator mesh__D050492 DRC
% 209.16/209.32  |- skos__prefLabel mesh__D050492
% 209.16/209.32       Vesicular Biogenic Amine Transport Proteins
% 209.16/209.32  |- skos__altLabel mesh__D050492 Vesicular Amine Transport Proteins
% 209.16/209.32  |- mesh__dateCreated mesh__D050492 2005-06-30
% 209.16/209.32  |- mesh__historyNote mesh__D050492 2006%28%1992%29%   
% 209.16/209.32  |- mesh__recordMaintainer mesh__D050492 DRC
% 209.16/209.32  |- mesh__recordAuthorizer mesh__D050492 sjn
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D050492 2006
% 209.16/209.32  |- skos__broader mesh__D050492smesh__D050481
% 209.16/209.32  |- mesh__dateEstablished mesh__D050492 2006-01-01
% 209.16/209.32  |- rdf__type mesh__D050492sskos__Concept
% 209.16/209.32  |- skos__hiddenLabel mesh__D050492 Amine Transporter, Vesicular
% 209.16/209.32  |- skos__altLabel mesh__D050492 Vesicular Amine Transporter
% 209.16/209.32  |- skos__altLabel mesh__D050492 Biogenic Amine Transporters, Vesicular
% 209.16/209.32  |- skos__scopeNote mesh__D050492
% 209.16/209.32       Integral membrane proteins of the LIPID BILAYER of SECRETORY VESICLES that catalyze transport and storage of biogenic amine NEUROTRANSMITTERS such as ACETYLCHOLINE; SEROTONIN; MELATONIN; HISTAMINE; and CATECHOLAMINES. The transporters exchange vesicular protons for cytoplasmic neurotransmitters.%A%    
% 209.16/209.32  |- mesh__publicMeSHNote mesh__D050492
% 209.16/209.32       2006; VESICULAR AMINE TRANSPORTER was indexed under MEMBRANE GLYCOPROTEINS 1997-2005, under NEUROPEPTIDES 1997-2005, %26% under GLYCOPROTEINS 1992-1996%A%  
% 209.16/209.32  |- skos__altLabel mesh__D050492 Vesicular Biogenic Amine Transporters
% 209.16/209.32  |- rdf__type mesh__D016764sskos__Concept
% 209.16/209.32  |- skos__hiddenLabel mesh__D016764 Cell Polarities
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D016764 1997
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D016764 2001
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D016764 1994
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D016764 1999
% 209.16/209.32  |- mesh__dateCreated mesh__D016764 1991-05-02
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D016764 1993
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D016764 2003
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D016764 1995
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D016764 2005
% 209.16/209.32  |- mesh__recordMaintainer mesh__D016764 TAP
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D016764 2004
% 209.16/209.32  |- mesh__publicMeSHNote mesh__D016764 92   
% 209.16/209.32  |- skos__prefLabel mesh__D016764 Cell Polarity
% 209.16/209.32  |- skos__scopeNote mesh__D016764
% 209.16/209.32       Orientation of intracellular structures especially with respect to the apical and basolateral domains of the plasma membrane. Polarized cells must direct proteins from the Golgi apparatus to the appropriate domain since tight junctions prevent proteins from diffusing between the two domains.%A%    
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D016764 2002
% 209.16/209.32  |- skos__broader mesh__D016764smesh__D002468
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D016764 2006
% 209.16/209.32  |- mesh__dateRevised mesh__D016764 1992-05-07
% 209.16/209.32  |- mesh__dateEstablished mesh__D016764 1992-01-01
% 209.16/209.32  |- skos__hiddenLabel mesh__D016764 Polarities, Cell
% 209.16/209.32  |- mesh__recordAuthorizer mesh__D016764 PLS
% 209.16/209.32  |- mesh__historyNote mesh__D016764 92   
% 209.16/209.32  |- skos__hiddenLabel mesh__D016764 Polarity, Cell
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D016764 1996
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D016764 2000
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D016764 1998
% 209.16/209.32  |- mesh__recordOriginator mesh__D016764 AGS
% 209.16/209.32  |- skos__annotation mesh__D016764
% 209.16/209.32       orientation of intracell struct to plasma membrane   
% 209.16/209.32  |- skos__altLabel mesh__D002744
% 209.16/209.32       Schering-Plough Brand of Chlorpheniramine Maleate
% 209.16/209.32  |- skos__altLabel mesh__D002744 Vortech Brand 2 of Chlorpheniramine Maleate
% 209.16/209.32  |- skos__prefLabel mesh__D002744 Chlorpheniramine
% 209.16/209.32  |- mesh__dateRevised mesh__D002744 2005-06-30
% 209.16/209.32  |- skos__altLabel mesh__D002744 Llorens Brand of Chlorpheniramine Maleate
% 209.16/209.32  |- mesh__recordMaintainer mesh__D002744 lkw
% 209.16/209.32  |- skos__hiddenLabel mesh__D002744 Tannate, Chlorpheniramine
% 209.16/209.32  |- mesh__historyNote mesh__D002744 65%28%63%29%   
% 209.16/209.32  |- skos__altLabel mesh__D002744 Schering Brand of Chlorpheniramine Maleate
% 209.16/209.32  |- skos__altLabel mesh__D002744 Vortech Brand 3 of Chlorpheniramine Maleate
% 209.16/209.32  |- skos__altLabel mesh__D002744
% 209.16/209.32       Halsey Drug Brand of Chlorpheniramine Maleate
% 209.16/209.32  |- skos__altLabel mesh__D002744 Bayer Brand of Chlorpheniramine Maleate
% 209.16/209.32  |- skos__altLabel mesh__D002744 Rugby Brand of Chlorpheniramine Maleate
% 209.16/209.32  |- skos__altLabel mesh__D002744 Chlorphenamine
% 209.16/209.32  |- skos__hiddenLabel mesh__D002744 Maleate, Chlorpheniramine
% 209.16/209.32  |- mesh__publicMeSHNote mesh__D002744 65   
% 209.16/209.32  |- skos__annotation mesh__D002744 a histamine H1 antag %26% antipruritic   
% 209.16/209.32  |- mesh__dateCreated mesh__D002744 1999-01-01
% 209.16/209.32  |- skos__altLabel mesh__D002744 Chlorprophenpyridamine
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D002744 2006
% 209.16/209.32  |- skos__altLabel mesh__D002744 Vortech Brand 1 of Chlorpheniramine Maleate
% 209.16/209.32  |- skos__altLabel mesh__D002744 Cloro-Trimeton
% 209.16/209.32  |- skos__altLabel mesh__D002744
% 209.16/209.32       Stafford-Miller Brand of Chlorpheniramine Maleate
% 209.16/209.32  |- skos__altLabel mesh__D002744 Schein Brand of Chlorpheniramine Maleate
% 209.16/209.32  |- skos__altLabel mesh__D002744 Intra Brand of Chlorpheniramine Maleate
% 209.16/209.32  |- mesh__recordAuthorizer mesh__D002744 sjn
% 209.16/209.32  |- mesh__recordOriginator mesh__D002744 NLM
% 209.16/209.32  |- skos__altLabel mesh__D002744 Hogil Brand 1 of Chlorpheniramine Maleate
% 209.16/209.32  |- skos__broader mesh__D002744smesh__D010632
% 209.16/209.32  |- skos__altLabel mesh__D002744 Hogil Brand 2 of Chlorpheniramine Maleate
% 209.16/209.32  |- mesh__dateEstablished mesh__D002744 1965-01-01
% 209.16/209.32  |- skos__scopeNote mesh__D002744
% 209.16/209.32       A histamine H1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, and asthma. It has also been used in veterinary applications. One of the most widely used of the classical antihistaminics, it generally causes less drowsiness and sedation than PROMETHAZINE.%A%    
% 209.16/209.32  |- rdf__type mesh__D002744sskos__Concept
% 209.16/209.32  |- skos__historyNote mesh__D048048 Information Systems %28%1980-2004%29%
% 209.16/209.32  |- skos__prefLabel mesh__D048048 Dental Informatics
% 209.16/209.32  |- mesh__dateEstablished mesh__D048048 2005-01-01
% 209.16/209.32  |- mesh__recordAuthorizer mesh__D048048 sjn
% 209.16/209.32  |- mesh__dateCreated mesh__D048048 2004-07-07
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D048048 2005
% 209.16/209.32  |- skos__broader mesh__D048048smesh__D048088
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D048048 2006
% 209.16/209.32  |- mesh__recordMaintainer mesh__D048048 jls
% 209.16/209.32  |- skos__hiddenLabel mesh__D048048 Informatics, Dental
% 209.16/209.32  |- mesh__recordOriginator mesh__D048048 jls
% 209.16/209.32  |- rdf__type mesh__D048048sskos__Concept
% 209.16/209.32  |- skos__scopeNote mesh__D048048
% 209.16/209.32       The application of computer and information sciences to improve dental practice, research, education and management.%A%    
% 209.16/209.32  |- mesh__historyNote mesh__D048048 2005   
% 209.16/209.32  |- mesh__publicMeSHNote mesh__D048048 2005   
% 209.16/209.32  |- skos__broader mesh__D034841Q000293smesh__D034841
% 209.16/209.32  |- mesh__preferredCombination mesh__D034841Q000293smesh__D000007
% 209.16/209.32  |- rdf__type mesh__D034841Q000293smesh__CompoundConcept
% 209.16/209.32  |- mesh__dateCreated mesh__D012374 1980-04-09
% 209.16/209.32  |- rdf__type mesh__D012374sskos__Concept
% 209.16/209.32  |- skos__historyNote mesh__D012374 Rods and Cones %28%1966-1980%29%
% 209.16/209.32  |- skos__hiddenLabel mesh__D012374 Outer Segment, Rod
% 209.16/209.32  |- mesh__recordOriginator mesh__D012374 RC
% 209.16/209.32  |- skos__hiddenLabel mesh__D012374 Segment, Rod Outer
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D012374 2000
% 209.16/209.32  |- mesh__recordAuthorizer mesh__D012374 SJN
% 209.16/209.32  |- skos__broader mesh__D012374smesh__D017948
% 209.16/209.32  |- skos__scopeNote mesh__D012374
% 209.16/209.32       The portion of the retinal rod cell between the inner segment and the pigment epithelium layer of the retina.%A%    
% 209.16/209.32  |- mesh__dateEstablished mesh__D012374 1991-01-01
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D012374 2003
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D012374 2001
% 209.16/209.32  |- mesh__recordMaintainer mesh__D012374 NDW
% 209.16/209.32  |- skos__hiddenLabel mesh__D012374 Rod Outer Segment
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D012374 2005
% 209.16/209.32  |- mesh__dateRevised mesh__D012374 1998-06-11
% 209.16/209.32  |- skos__hiddenLabel mesh__D012374 Outer Segments, Rod
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D012374 1999
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D012374 2004
% 209.16/209.32  |- skos__prefLabel mesh__D012374 Rod Outer Segments
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D012374 2006
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D012374 2002
% 209.16/209.32  |- mesh__publicMeSHNote mesh__D012374
% 209.16/209.32       91; was see under RODS AND CONES 1981-90   
% 209.16/209.32  |- skos__hiddenLabel mesh__D012374 Segments, Rod Outer
% 209.16/209.32  |- mesh__historyNote mesh__D012374
% 209.16/209.32       91%28%81%29%; was see under RODS AND CONES 1981-90   
% 209.16/209.32  |- skos__broader mesh__D020806smesh__D001424
% 209.16/209.32  |- skos__prefLabel mesh__D020806
% 209.16/209.32       Central Nervous System Bacterial Infections
% 209.16/209.32  |- rdf__type mesh__D020806sskos__Concept
% 209.16/209.32  |- skos__broader mesh__D020806smesh__D002494
% 209.16/209.32  |- skos__annotation mesh__D020806
% 209.16/209.32       coord IM  with precoord bacterial infection %28%IM%29% and specific site/dis term %28%IM%29% if pertinent; DF: CNS BACT INFECT%A%  
% 209.16/209.32  |- skos__historyNote mesh__D020806 Meningitis %28%1967-1999%29%
% 209.16/209.32  |- mesh__publicMeSHNote mesh__D020806 2000   
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D020806 2006
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D020806 2002
% 209.16/209.32  |- skos__altLabel mesh__D020806
% 209.16/209.32       Infections, Bacterial, Central Nervous System
% 209.16/209.32  |- mesh__dateEstablished mesh__D020806 2000-01-01
% 209.16/209.32  |- skos__scopeNote mesh__D020806
% 209.16/209.32       Bacterial infections of the brain, spinal cord, and meninges, including infections involving the perimeningeal spaces.%A%    
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D020806 2005
% 209.16/209.32  |- skos__historyNote mesh__D020806 Brain Diseases %28%1966-1999%29%
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D020806 2001
% 209.16/209.32  |- skos__historyNote mesh__D020806 Brain Abscess %28%1965-1999%29%
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D020806 2004
% 209.16/209.32  |- skos__altLabel mesh__D020806
% 209.16/209.32       Bacterial Infections, Central Nervous System
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D020806 2000
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D020806 2003
% 209.16/209.32  |- mesh__historyNote mesh__D020806 2000   
% 209.16/209.32  |- mesh__dateCreated mesh__D020806 1999-11-03
% 209.16/209.32  |- skos__broader mesh__D004064Q000002smesh__D004064
% 209.16/209.32  |- mesh__preferredCombination mesh__D004064Q000002smesh__D004065
% 209.16/209.32  |- rdf__type mesh__D004064Q000002smesh__CompoundConcept
% 209.16/209.32  |- skos__hiddenLabel mesh__D006337 Murmurs, Cardiac
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D006337 2004
% 209.16/209.32  |- skos__related mesh__D006337smesh__D010701
% 209.16/209.32  |- mesh__recordMaintainer mesh__D006337 nns
% 209.16/209.32  |- skos__hiddenLabel mesh__D006337 Cardiac Murmur
% 209.16/209.32  |- mesh__recordOriginator mesh__D006337 NLM
% 209.16/209.32  |- mesh__dateCreated mesh__D006337 1999-01-01
% 209.16/209.32  |- skos__broader mesh__D006337smesh__D012816
% 209.16/209.32  |- mesh__historyNote mesh__D006337
% 209.16/209.32       91%28%75%29%; was see under HEART AUSCULTATION in Cat E 1972-90%A%  
% 209.16/209.32  |- skos__hiddenLabel mesh__D006337 Murmur, Heart
% 209.16/209.32  |- mesh__publicMeSHNote mesh__D006337
% 209.16/209.32       91; was see under HEART AUSCULTATION in Cat E 1972-90   
% 209.16/209.32  |- skos__related mesh__D006337smesh__D006326
% 209.16/209.32  |- skos__altLabel mesh__D006337 Cardiac Murmurs
% 209.16/209.32  |- skos__hiddenLabel mesh__D006337 Murmurs, Heart
% 209.16/209.32  |- skos__hiddenLabel mesh__D006337 Murmur, Cardiac
% 209.16/209.32  |- mesh__recordAuthorizer mesh__D006337 sjn
% 209.16/209.32  |- mesh__dateRevised mesh__D006337 2003-07-09
% 209.16/209.32  |- mesh__onlineNote mesh__D006337 search HEART AUSCULTATION 1972-74   
% 209.16/209.32  |- skos__prefLabel mesh__D006337 Heart Murmurs
% 209.16/209.32  |- rdf__type mesh__D006337sskos__Concept
% 209.16/209.32  |- mesh__dateEstablished mesh__D006337 1991-01-01
% 209.16/209.32  |- skos__broader mesh__D006337smesh__D006347
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D006337 2005
% 209.16/209.32  |- skos__scopeNote mesh__D006337
% 209.16/209.32       Heart sounds caused by vibrations resulting from the flow of BLOOD through the HEART.  They are classified by time of occurrence during the cardiac cycle and duration, and graded by the intensity of sound on a scale of I to VI. They may be normal or abnormal.%A%    
% 209.16/209.32  |- skos__annotation mesh__D006337
% 209.16/209.32       do not confuse with HEART SOUNDS, a physiol concept; /etiol: coord with specific heart valve disease %28%IM%29%%A%  
% 209.16/209.32  |- skos__hiddenLabel mesh__D006337 Heart Murmur
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D006337 2006
% 209.16/209.32  |- skos__broader mesh__D006337smesh__D006349
% 209.16/209.32  |- skos__related mesh__D006337smesh__D006347
% 209.16/209.32  |- skos__broader mesh__D020008smesh__D010879
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D020008 2006
% 209.16/209.32  |- skos__altLabel mesh__D020008 Pharmacia Brand of Delavirdine Mesylate
% 209.16/209.32  |- skos__hiddenLabel mesh__D020008 U90152
% 209.16/209.32  |- mesh__dateCreated mesh__D020008 1997-06-20
% 209.16/209.32  |- mesh__recordAuthorizer mesh__D020008 sjn
% 209.16/209.32  |- mesh__publicMeSHNote mesh__D020008
% 209.16/209.32       98; DELAVIRDINE was indexed under PIPERAZINES %26% INDOLES 1993-97%A%  
% 209.16/209.32  |- mesh__recordOriginator mesh__D020008 AGS
% 209.16/209.32  |- skos__hiddenLabel mesh__D020008 U 90152S
% 209.16/209.32  |- skos__historyNote mesh__D020008 Indoles %28%1993-1997%29%
% 209.16/209.32  |- skos__altLabel mesh__D020008 U-90152S
% 209.16/209.32  |- skos__broader mesh__D020008smesh__D007211
% 209.16/209.32  |- mesh__recordMaintainer mesh__D020008 exl
% 209.16/209.32  |- skos__scopeNote mesh__D020008
% 209.16/209.32       A potent, non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1.%A%    
% 209.16/209.32  |- skos__hiddenLabel mesh__D020008 U 90152
% 209.16/209.32  |- mesh__dateRevised mesh__D020008 2005-06-30
% 209.16/209.32  |- mesh__dateEstablished mesh__D020008 1998-01-01
% 209.16/209.32  |- skos__hiddenLabel mesh__D020008 Mesylate, Delavirdine
% 209.16/209.32  |- skos__historyNote mesh__D020008 Piperazines %28%1993-1997%29%
% 209.16/209.32  |- rdf__type mesh__D020008sskos__Concept
% 209.16/209.32  |- skos__hiddenLabel mesh__D020008 U90152S
% 209.16/209.32  |- skos__altLabel mesh__D020008 Parke Davis Brand of Delavirdine Mesylate
% 209.16/209.32  |- skos__altLabel mesh__D020008 Agouron Brand of Delavirdine Mesylate
% 209.16/209.32  |- skos__prefLabel mesh__D020008 Delavirdine
% 209.16/209.32  |- mesh__historyNote mesh__D020008
% 209.16/209.32       98; use DELAVIRDINE %28%NM%29% 1993-97   
% 209.16/209.32  |- rdf__type mesh__D050493sskos__Concept
% 209.16/209.32  |- skos__historyNote mesh__D050493 Glycoproteins %28%1992-1996%29%
% 209.16/209.32  |- mesh__historyNote mesh__D050493 2006%28%1992%29%   
% 209.16/209.32  |- skos__altLabel mesh__D050493 Vesicular Monoamine Transporter Proteins
% 209.16/209.32  |- skos__hiddenLabel mesh__D050493 Monoamine Transporter, Vesicular
% 209.16/209.32  |- skos__altLabel mesh__D050493 Monoamine Vesicular Transporter
% 209.16/209.32  |- skos__prefLabel mesh__D050493 Vesicular Monoamine Transport Proteins
% 209.16/209.32  |- skos__broader mesh__D050493smesh__D050492
% 209.16/209.32  |- skos__scopeNote mesh__D050493
% 209.16/209.32       A family of vesicular amine transporter proteins that catalyze the transport and storage of CATECHOLAMINES and indolamines into SECRETORY VESICLES.%A%    
% 209.16/209.32  |- mesh__dateCreated mesh__D050493 2005-06-30
% 209.16/209.32  |- mesh__publicMeSHNote mesh__D050493
% 209.16/209.32       2006; VESICULAR AMINE TRANSPORTER was indexed under MEMBRANE TRANSPORT PROTEINS 2005; MEMBRANE GLYCORPOTEINS %26% NEUROPEPTIDES 1997-2005, %26%  under GLYCOPROTEINS 1992-1996%A%  
% 209.16/209.32  |- skos__altLabel mesh__D050493 Chromaffin Granule Amine Transporter
% 209.16/209.32  |- skos__hiddenLabel mesh__D050493 Vesicular Monoamine Transporters
% 209.16/209.32  |- mesh__recordMaintainer mesh__D050493 DRC
% 209.16/209.32  |- skos__hiddenLabel mesh__D050493 VMAT 1 Vesicular Monoamine Transporter
% 209.16/209.32  |- skos__altLabel mesh__D050493 Vesicular Monoamine Transporter
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D050493 2006
% 209.16/209.32  |- skos__hiddenLabel mesh__D050493 Vesicular Transporter, Monoamine
% 209.16/209.32  |- skos__altLabel mesh__D050493 Monoamine Vesicular Transport Proteins
% 209.16/209.32  |- mesh__recordAuthorizer mesh__D050493 sjn
% 209.16/209.32  |- skos__annotation mesh__D050493 see SCR for organism-specific terms   
% 209.16/209.32  |- skos__altLabel mesh__D050493 VMAT2 Vesicular Monoamine Transporter
% 209.16/209.32  |- skos__historyNote mesh__D050493 Neuropeptides %28%1992-2004%29%
% 209.16/209.32  |- skos__historyNote mesh__D050493 Membrane Glycoproteins %28%1996-2004%29%
% 209.16/209.32  |- skos__altLabel mesh__D050493 VMAT-1 Vesicular Monoamine Transporter
% 209.16/209.32  |- skos__altLabel mesh__D050493 Monoamine Transporters, Vesicular
% 209.16/209.32  |- mesh__recordOriginator mesh__D050493 DRC
% 209.16/209.32  |- mesh__dateEstablished mesh__D050493 2006-01-01
% 209.16/209.32  |- skos__historyNote mesh__D050493 Membrane Transport Proteins %28%2005%29%
% 209.16/209.32  |- mesh__recordAuthorizer mesh__D016765 sjn
% 209.16/209.32  |- skos__hiddenLabel mesh__D016765 Feline Enteric Coronaviruses
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D016765 2003
% 209.16/209.32  |- skos__hiddenLabel mesh__D016765 Enteric Coronavirus, Feline
% 209.16/209.32  |- skos__hiddenLabel mesh__D016765 Enteric Coronaviruses, Feline
% 209.16/209.32  |- skos__altLabel mesh__D016765 Coronavirus, Feline Enteric
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D016765 2005
% 209.16/209.32  |- skos__hiddenLabel mesh__D016765 Feline Coronavirus
% 209.16/209.32  |- mesh__recordOriginator mesh__D016765 AGS
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D016765 2004
% 209.16/209.32  |- skos__hiddenLabel mesh__D016765 Feline Coronaviruses
% 209.16/209.32  |- skos__altLabel mesh__D016765 Peritonitis Virus, Infectious Feline
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D016765 2006
% 209.16/209.32  |- mesh__recordMaintainer mesh__D016765 ags
% 209.16/209.32  |- mesh__dateCreated mesh__D016765 1991-05-02
% 209.16/209.32  |- skos__annotation mesh__D016765
% 209.16/209.32       infection: coord IM with CORONAVIRUS INFECTIONS %28%IM%29%; infection by FIPV = FELINE INFECTIOUS PERITONITIS%A%  
% 209.16/209.32  |- skos__hiddenLabel mesh__D016765 Coronaviruses, Feline
% 209.16/209.32  |- skos__altLabel mesh__D016765 Infectious Peritonitis Virus, Feline
% 209.16/209.32  |- skos__prefLabel mesh__D016765 Coronavirus, Feline
% 209.16/209.32  |- mesh__historyNote mesh__D016765 2002 %28%1992%29%   
% 209.16/209.32  |- skos__broader mesh__D016765smesh__D017934
% 209.16/209.32  |- skos__scopeNote mesh__D016765
% 209.16/209.32       A species of CORONAVIRUS infecting cats of all ages and commonly found in catteries and zoos. Cats are often found carrying the virus but only a small proportion develop disease. Feline coronavirus and Feline infectious peritonitis virus %28%FIPV%29% are virtually the same virus in genetic and antigenetic terms, and are morphologically indistinguishable. Since they only differ in their disease potential %28%with FIPV causing a more serious illness%29%, they are considered biotypes of each other. %28%From Hoskins, JD. Update on Feline Coronavirus Disease. http://maxshouse.com.FIP%25%20Update.htm %28%April 3, 2001%29%%29%%A%    
% 209.16/209.32  |- mesh__dateRevised mesh__D016765 2001-07-25
% 209.16/209.32  |- mesh__publicMeSHNote mesh__D016765
% 209.16/209.32       2002; see INFECTIOUS PERITONITIS VIRUS, FELINE 1994-2001, see FELINE INFECTIOUS PERITONITIS VIRUS 1992-1993; for INFECTIOUS PERITONITIS VIRUS, FELINE see FELINE INFECTIOUS PERITONITIS VIRUS 1992-93%A%  
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D016765 2002
% 209.16/209.32  |- skos__altLabel mesh__D016765 Feline Enteric Coronavirus
% 209.16/209.32  |- skos__altLabel mesh__D016765 FIPV
% 209.16/209.32  |- rdf__type mesh__D016765sskos__Concept
% 209.16/209.32  |- mesh__dateEstablished mesh__D016765 1992-01-01
% 209.16/209.32  |- skos__hiddenLabel mesh__D016765 Coronaviruses, Feline Enteric
% 209.16/209.32  |- skos__altLabel mesh__D016765 FECV
% 209.16/209.32  |- skos__historyNote mesh__D016765 Coronaviridae %28%1977-1991%29%
% 209.16/209.32  |- mesh__dateEstablished mesh__D002745 1991-01-01
% 209.16/209.32  |- mesh__historyNote mesh__D002745 91%28%66%29%   
% 209.16/209.32  |- skos__broader mesh__D002745smesh__D010645
% 209.16/209.32  |- mesh__dateRevised mesh__D002745 2005-06-30
% 209.16/209.32  |- mesh__recordMaintainer mesh__D002745 lkw
% 209.16/209.32  |- mesh__dateCreated mesh__D002745 1999-01-01
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D002745 2006
% 209.16/209.32  |- skos__prefLabel mesh__D002745 Chlorphentermine
% 209.16/209.32  |- skos__scopeNote mesh__D002745
% 209.16/209.32       A sympathomimetic agent that was formerly used as an anorectic. It has properties similar to those of DEXTROAMPHETAMINE. It has been implicated in lipid storage disorders and pulmonary hypertension. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1223%29%%A%    
% 209.16/209.32  |- rdf__type mesh__D002745sskos__Concept
% 209.16/209.32  |- mesh__publicMeSHNote mesh__D002745 91; see PHENTERMINE 1966-90   
% 209.16/209.32  |- skos__hiddenLabel mesh__D002745 Hydrochloride, Chlorphentermine
% 209.16/209.32  |- mesh__recordOriginator mesh__D002745 NLM
% 209.16/209.32  |- skos__altLabel mesh__D002745
% 209.16/209.32       Warner Chilcott Brand of Chlorphentermine Hydrochloride
% 209.16/209.32  |- mesh__recordAuthorizer mesh__D002745 sjn
% 209.16/209.32  |- skos__altLabel mesh__D007430 Care, Intraoperative
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D007430 2000
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D007430 2005
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D007430 2006
% 209.16/209.32  |- skos__annotation mesh__D007430
% 209.16/209.32       during surg; use qualif discreetly; DF: INTRAOP CARE   
% 209.16/209.32  |- mesh__dateEstablished mesh__D007430 1980-01-01
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D007430 1998
% 209.16/209.32  |- mesh__dateRevised mesh__D007430 1997-06-20
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D007430 2001
% 209.16/209.32  |- mesh__historyNote mesh__D007430 80   
% 209.16/209.32  |- skos__altLabel mesh__D007430 Peroperative Care
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D007430 2003
% 209.16/209.32  |- mesh__dateCreated mesh__D007430 1979-03-12
% 209.16/209.32  |- skos__prefLabel mesh__D007430 Intraoperative Care
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D007430 1999
% 209.16/209.32  |- skos__scopeNote mesh__D007430
% 209.16/209.32       Patient care procedures performed during the operation that are ancillary to the actual surgery. It includes monitoring, fluid therapy, medication, transfusion, anesthesia, radiography, and laboratory tests.%A%    
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D007430 2004
% 209.16/209.32  |- skos__broader mesh__D007430smesh__D013514
% 209.16/209.32  |- mesh__recordOriginator mesh__D007430 SMH
% 209.16/209.32  |- rdf__type mesh__D007430sskos__Concept
% 209.16/209.32  |- mesh__publicMeSHNote mesh__D007430 80   
% 209.16/209.32  |- mesh__recordAuthorizer mesh__D007430 SJN
% 209.16/209.32  |- mesh__recordMaintainer mesh__D007430 PXP
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D007430 2002
% 209.16/209.32  |- skos__broader mesh__D007430smesh__D019990
% 209.16/209.32  |- skos__altLabel mesh__D007430 Care, Peroperative
% 209.16/209.32  |- mesh__dateEstablished mesh__D021101 2001-01-01
% 209.16/209.32  |- mesh__activeMeSHYear mesh__D021101 2001
% 209.16/209.32  |- skos__broader mesh__D021101smesh__D020161
% 209.18/209.32  |- skos__scopeNote mesh__D021101
% 209.18/209.32       A method for ordering genetic loci along CHROMOSOMES. The method involves fusing irradiated donor cells with host cells from another species. Following cell fusion, fragments of DNA from the irradiated cells become integrated into the chromosomes of the host cells.  Molecular probing of DNA obtained from the fused cells is used to determine if two or more genetic loci are located within the same fragment of donor cell DNA.%A%    
% 209.18/209.32  |- mesh__dateCreated mesh__D021101 2000-06-22
% 209.18/209.32  |- mesh__activeMeSHYear mesh__D021101 2003
% 209.18/209.32  |- mesh__publicMeSHNote mesh__D021101 2001   
% 209.18/209.32  |- skos__historyNote mesh__D021101 Chromosome Mapping %28%1968-1998%29%
% 209.18/209.32  |- skos__historyNote mesh__D021101
% 209.18/209.32       Physical Chromosome Mapping %28%1999-2000%29%
% 209.18/209.32  |- rdf__type mesh__D021101sskos__Concept
% 209.18/209.32  |- mesh__activeMeSHYear mesh__D021101 2004
% 209.18/209.32  |- mesh__historyNote mesh__D021101 2001   
% 209.18/209.32  |- mesh__activeMeSHYear mesh__D021101 2002
% 209.18/209.32  |- skos__hiddenLabel mesh__D021101 Mapping, Radiation Hybrid
% 209.18/209.32  |- skos__hiddenLabel mesh__D021101 Radiation Hybrid
% 209.18/209.32  |- skos__prefLabel mesh__D021101 Radiation Hybrid Mapping
% 209.18/209.32  |- skos__hiddenLabel mesh__D021101 Hybrid Maps, Radiation
% 209.18/209.32  |- skos__hiddenLabel mesh__D021101 Hybrids, Radiation
% 209.18/209.32  |- skos__hiddenLabel mesh__D021101 Radiation Hybrid Map
% 209.18/209.32  |- skos__hiddenLabel mesh__D021101 Map, Radiation Hybrid
% 209.18/209.32  |- mesh__activeMeSHYear mesh__D021101 2005
% 209.18/209.32  |- skos__hiddenLabel mesh__D021101 Hybrid, Radiation
% 209.18/209.32  |- mesh__activeMeSHYear mesh__D021101 2006
% 209.18/209.32  |- skos__altLabel mesh__D048049 ERK MAP Kinases
% 209.18/209.32  |- skos__annotation mesh__D048049 note specifics   
% 209.18/209.32  |- mesh__historyNote mesh__D048049
% 209.18/209.32       2005; for EXTRACELLULAR SIGNAL-REGULATED KINASES use MITOGEN-ACTIVATED PROTEIN KINASES 1994-2004%A%  
% 209.18/209.32  |- skos__hiddenLabel mesh__D048049
% 209.18/209.32       MAP Kinases, Extracellular Signal Regulated
% 209.18/209.32  |- skos__hiddenLabel mesh__D048049 Kinases, Extracellular Signal-Regulated
% 209.18/209.32  |- skos__hiddenLabel mesh__D048049
% 209.18/209.32       Extracellular Signal Regulated MAP Kinases
% 209.18/209.32  |- mesh__recordAuthorizer mesh__D048049 ags
% 209.18/209.32  |- mesh__dateCreated mesh__D048049 2004-07-07
% 209.18/209.32  |- mesh__activeMeSHYear mesh__D048049 2005
% 209.18/209.32  |- mesh__activeMeSHYear mesh__D048049 2006A
% 209.18/209.32  |- skos__hiddenLabel mesh__D048049 Extracellular Signal Regulated Kinases
% 209.18/209.32  |- skos__altLabel mesh__D048049 MAP Kinases, Extracellular Signal-Regulated
% 209.18/209.32  |- mesh__activeMeSHYear mesh__D048049 2006
% 209.18/209.32  |- skos__prefLabel mesh__D048049 Extracellular Signal-Regulated MAP Kinases
% 209.18/209.32  |- mesh__dateEstablished mesh__D048049 2005-01-01
% 209.18/209.32  |- skos__historyNote mesh__D048049
% 209.18/209.32       Mitogen-Activated Protein Kinases %28%1992-2004%29%
% 209.18/209.32  |- rdf__type mesh__D048049sskos__Concept
% 209.18/209.32  |- mesh__dateRevised mesh__D048049 2005-07-19
% 209.18/209.32  |- mesh__recordMaintainer mesh__D048049 ags
% 209.18/209.32  |- skos__scopeNote mesh__D048049
% 209.18/209.32       A mitogen-activated protein kinase subfamily that is widely expressed and plays a role in regulation of MEIOSIS; MITOSIS; and post mitotic functions in differentiated cells. The extracellular signal regulated MAP kinases are regulated by a broad variety of CELL SURFACE RECEPTORS and can be activated by certain CARCINOGENS.%A%    
% 209.18/209.32  |- skos__broader mesh__D048049smesh__D020928
% 209.18/209.33  |- mesh__publicMeSHNote mesh__D048049
% 209.18/209.33       2005; see MITOGEN-ACTIVATED PROTEIN KINASES 1994-2004   
% 209.18/209.33  |- mesh__recordOriginator mesh__D048049 jmp
% 209.18/209.33  |- skos__altLabel mesh__D048049 Extracellular Signal-Regulated Kinases
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D012375 2002
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D012375 1996
% 209.18/209.33  |- skos__broader mesh__D012375smesh__D010571
% 209.18/209.33  |- mesh__recordOriginator mesh__D012375 NLM
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D012375 1998
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D012375 2003
% 209.18/209.33  |- mesh__dateRevised mesh__D012375 1992-05-18
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D012375 1997
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D012375 2005
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D012375 1994
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D012375 1999
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D012375 2004
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D012375 1993
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D012375 2006
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D012375 2000
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D012375 1995
% 209.18/209.33  |- skos__prefLabel mesh__D012375 Rodent Control
% 209.18/209.33  |- mesh__dateCreated mesh__D012375 1999-01-01
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D012375 2001
% 209.18/209.33  |- skos__annotation mesh__D012375
% 209.18/209.33       coord IM with specific rodent %28%IM%29%   
% 209.18/209.33  |- skos__hiddenLabel mesh__D012375 Control, Rodent
% 209.18/209.33  |- rdf__type mesh__D012375sskos__Concept
% 209.18/209.33  |- skos__related mesh__D012375smesh__D012378
% 209.18/209.33  |- skos__scopeNote mesh__D012375
% 209.18/209.33       The reduction or regulation of the population of noxious, destructive, or dangerous rodents through chemical, biological, or other means.%A%    
% 209.18/209.33  |- mesh__recordAuthorizer mesh__D012375 PLS
% 209.18/209.33  |- mesh__recordMaintainer mesh__D012375 TAP
% 209.18/209.33  |- skos__broader mesh__D020807smesh__D010272
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D020807 2000
% 209.18/209.33  |- mesh__dateEstablished mesh__D020807 2000-01-01
% 209.18/209.33  |- skos__altLabel mesh__D020807
% 209.18/209.33       Infections, Central Nervous System, Parasitic
% 209.18/209.33  |- mesh__dateCreated mesh__D020807 1999-11-03
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D020807 2004
% 209.18/209.33  |- skos__historyNote mesh__D020807 Parasitic Diseases %28%1966-1999%29%
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D020807 2003
% 209.18/209.33  |- skos__annotation mesh__D020807
% 209.18/209.33       coord IM with precoord parasitic infection %28%IM%29% and site/dis term %28%IM%29% if pertinent; DF: CNS PARASITIC INFECT%A%  
% 209.18/209.33  |- skos__historyNote mesh__D020807 Helminthiasis %28%1966-1999%29%
% 209.18/209.33  |- mesh__historyNote mesh__D020807 2000   
% 209.18/209.33  |- mesh__publicMeSHNote mesh__D020807 2000   
% 209.18/209.33  |- skos__scopeNote mesh__D020807
% 209.18/209.33       Infections of the brain, spinal cord, and meninges caused by parasites, primarily PROTOZOA and HELMINTHS.%A%    
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D020807 2002
% 209.18/209.33  |- skos__broader mesh__D020807smesh__D002494
% 209.18/209.33  |- rdf__type mesh__D020807sskos__Concept
% 209.18/209.33  |- skos__prefLabel mesh__D020807
% 209.18/209.33       Central Nervous System Parasitic Infections
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D020807 2006
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D020807 2001
% 209.18/209.33  |- skos__altLabel mesh__D020807
% 209.18/209.33       Parasitic Infections, Central Nervous System
% 209.18/209.33  |- skos__altLabel mesh__D020807
% 209.18/209.33       Infections, Parasitic, Central Nervous System
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D020807 2005
% 209.18/209.33  |- skos__annotation mesh__D006338
% 209.18/209.33       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with specific site in heart %28%NIM%29% + histol type of neopl %28%IM%29%%A%  
% 209.18/209.33  |- mesh__recordAuthorizer mesh__D006338 PLS
% 209.18/209.33  |- skos__altLabel mesh__D006338 Neoplasms, Cardiac
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D006338 2000
% 209.18/209.33  |- skos__hiddenLabel mesh__D006338 Cardiac Neoplasm
% 209.18/209.33  |- mesh__dateCreated mesh__D006338 1999-01-01
% 209.18/209.33  |- mesh__dateRevised mesh__D006338 1995-06-08
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D006338 2001
% 209.18/209.33  |- skos__broader mesh__D006338smesh__D013899
% 209.18/209.33  |- rdf__type mesh__D006338sskos__Concept
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D006338 2002
% 209.18/209.33  |- skos__prefLabel mesh__D006338 Heart Neoplasms
% 209.18/209.33  |- skos__hiddenLabel mesh__D006338 Neoplasm, Cardiac
% 209.18/209.33  |- mesh__recordOriginator mesh__D006338 NLM
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D006338 1998
% 209.18/209.33  |- mesh__recordMaintainer mesh__D006338 KEV
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D006338 2005
% 209.18/209.33  |- skos__hiddenLabel mesh__D006338 Heart Neoplasm
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D006338 1999
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D006338 1996
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D006338 2006
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D006338 2003
% 209.18/209.33  |- skos__altLabel mesh__D006338 Neoplasms, Heart
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D006338 1997
% 209.18/209.33  |- skos__altLabel mesh__D006338 Cardiac Neoplasms
% 209.18/209.33  |- skos__hiddenLabel mesh__D006338 Neoplasm, Heart
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D006338 2004
% 209.18/209.33  |- skos__broader mesh__D006338smesh__D006331
% 209.18/209.33  |- skos__related mesh__D017060smesh__D010342
% 209.18/209.33  |- mesh__onlineNote mesh__D017060
% 209.18/209.33       use CONSUMER SATISFACTION to search PATIENT SATISFACTION 1982-91%A%  
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D017060 2002
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D017060 2003
% 209.18/209.33  |- mesh__historyNote mesh__D017060
% 209.18/209.33       92; was see CONSUMER SATISFACTION 1982-91   
% 209.18/209.33  |- skos__broader mesh__D017060smesh__D003258
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D017060 2005
% 209.18/209.33  |- mesh__recordOriginator mesh__D017060 PLS
% 209.18/209.33  |- mesh__dateCreated mesh__D017060 1991-06-20
% 209.18/209.33  |- skos__broader mesh__D017060smesh__D017531
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D017060 2004
% 209.18/209.33  |- skos__hiddenLabel mesh__D017060 Patient Preferences
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D017060 2000
% 209.18/209.33  |- skos__hiddenLabel mesh__D017060 Satisfaction, Patient
% 209.18/209.33  |- mesh__recordMaintainer mesh__D017060 jls
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D017060 2006
% 209.18/209.33  |- skos__hiddenLabel mesh__D017060 Preferences, Patient
% 209.18/209.33  |- skos__prefLabel mesh__D017060 Patient Satisfaction
% 209.18/209.33  |- mesh__recordAuthorizer mesh__D017060 sjn
% 209.18/209.33  |- skos__scopeNote mesh__D017060
% 209.18/209.33       The degree to which the individual regards the health care service or product or the manner in which it is delivered by the provider as useful, effective, or beneficial.%A%    
% 209.18/209.33  |- mesh__publicMeSHNote mesh__D017060
% 209.18/209.33       92; was see CONSUMER SATISFACTION 1982-91   
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D017060 2001
% 209.18/209.33  |- skos__historyNote mesh__D017060 Consumer Satisfaction %28%1966-1991%29%
% 209.18/209.33  |- mesh__dateEstablished mesh__D017060 1992-01-01
% 209.18/209.33  |- rdf__type mesh__D017060sskos__Concept
% 209.18/209.33  |- mesh__dateRevised mesh__D017060 1999-11-03
% 209.18/209.33  |- skos__hiddenLabel mesh__D017060 Preference, Patient
% 209.18/209.33  |- skos__broader mesh__D017060smesh__D010342
% 209.18/209.33  |- mesh__historyNote mesh__D050494 2006%28%1992%29%   
% 209.18/209.33  |- mesh__dateEstablished mesh__D050494 2006-01-01
% 209.18/209.33  |- skos__historyNote mesh__D050494 Membrane Transport Proteins %28%2005%29%
% 209.18/209.33  |- skos__hiddenLabel mesh__D050494 Transporter, Vesicular Acetylcholine
% 209.18/209.33  |- skos__prefLabel mesh__D050494 Vesicular Acetylcholine Transport Proteins
% 209.18/209.33  |- skos__broader mesh__D050494smesh__D050492
% 209.18/209.33  |- mesh__dateCreated mesh__D050494 2005-06-30
% 209.18/209.33  |- skos__hiddenLabel mesh__D050494 Acetylcholine Transporter, Vesicular
% 209.18/209.33  |- skos__altLabel mesh__D050494 Vesicular Acetylcholine Transporter
% 209.18/209.33  |- mesh__recordMaintainer mesh__D050494 DRC
% 209.18/209.33  |- mesh__recordAuthorizer mesh__D050494 sjn
% 209.18/209.33  |- skos__hiddenLabel mesh__D050494 Vesicular Acetylcholine Transporters
% 209.18/209.33  |- mesh__publicMeSHNote mesh__D050494
% 209.18/209.33       2006; VESICULAR ACETYLCHOLINE TRANSPORTER was indexed under MEMBRANE TRANSPORT PROTEINS 1992-2005%A%  
% 209.18/209.33  |- skos__scopeNote mesh__D050494
% 209.18/209.33       Vesicular amine transporter proteins that transport the neurotransmitter ACETYLCHOLINE into small SECRETORY VESICLES. Proteins of this family contain 12 transmembrane domains and exchange vesicular PROTONS for cytoplasmic acetylcholine.%A%    
% 209.18/209.33  |- skos__hiddenLabel mesh__D050494 Transporters, Vesicular Acetylcholine
% 209.18/209.33  |- skos__historyNote mesh__D050494 Carrier Proteins %28%1992-2004%29%
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D050494 2006
% 209.18/209.33  |- skos__altLabel mesh__D050494 Acetylcholine Transporters, Vesicular
% 209.18/209.33  |- skos__annotation mesh__D050494 see SCR for organism-specific terms   
% 209.18/209.33  |- mesh__recordOriginator mesh__D050494 DRC
% 209.18/209.33  |- rdf__type mesh__D050494sskos__Concept
% 209.18/209.33  |- skos__altLabel mesh__D050494
% 209.18/209.33       Vesicular Acetylcholine Transporter Proteins
% 209.18/209.33  |- skos__altLabel mesh__D050494 VAChT Proteins
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D003040 2006
% 209.18/209.33  |- mesh__dateCreated mesh__D003040 1977-04-22
% 209.18/209.33  |- skos__historyNote mesh__D003040 Venoms %28%1966-1974%29%
% 209.18/209.33  |- skos__altLabel mesh__D003040 Cobra Venom
% 209.18/209.33  |- skos__annotation mesh__D003040
% 209.18/209.33       /antag permitted but consider also ANTIVENINS; /enzymol permitted%A%  
% 209.18/209.33  |- skos__historyNote mesh__D003040 Snakes %28%1966-1974%29%
% 209.18/209.33  |- mesh__dateRevised mesh__D003040 2005-06-30
% 209.18/209.33  |- mesh__publicMeSHNote mesh__D003040 78   
% 209.18/209.33  |- rdf__type mesh__D003040sskos__Concept
% 209.18/209.33  |- skos__altLabel mesh__D003040 Naja Venom
% 209.18/209.33  |- skos__historyNote mesh__D003040 Toxins %28%1966-1977%29%
% 209.18/209.33  |- skos__hiddenLabel mesh__D003040 Venom, Cobra
% 209.18/209.33  |- mesh__recordOriginator mesh__D003040 SH
% 209.18/209.33  |- skos__scopeNote mesh__D003040
% 209.18/209.33       Venoms from snakes of the genus Naja %28%family Elapidae%29%. They contain many specific proteins that have cytotoxic, hemolytic, neurotoxic, and other properties. Like other elapid venoms, they are rich in enzymes. They include cobramines and cobralysins.%A%    
% 209.18/209.33  |- skos__prefLabel mesh__D003040 Cobra Venoms
% 209.18/209.33  |- mesh__historyNote mesh__D003040 78   
% 209.18/209.33  |- skos__hiddenLabel mesh__D003040 Venom, Naja
% 209.18/209.33  |- skos__hiddenLabel mesh__D003040 Venoms, Cobra
% 209.18/209.33  |- skos__historyNote mesh__D003040 Snake Venoms %28%1975-1977%29%
% 209.18/209.33  |- skos__broader mesh__D003040smesh__D004546
% 209.18/209.33  |- mesh__recordMaintainer mesh__D003040 ssb
% 209.18/209.33  |- mesh__recordAuthorizer mesh__D003040 sjn
% 209.18/209.33  |- skos__altLabel mesh__D003040 Naja Venoms
% 209.18/209.33  |- mesh__dateEstablished mesh__D003040 1978-01-01
% 209.18/209.33  |- skos__hiddenLabel mesh__D003040 Venoms, Naja
% 209.18/209.33  |- skos__scopeNote mesh__D016766
% 209.18/209.33       Common coronavirus infection of cats caused by the feline infectious peritonitis virus %28%CORONAVIRUS, FELINE%29%. The disease is characterized by a long incubation period, fever, depression, loss of appetite, wasting, and progressive abdominal enlargement. Infection of cells of the monocyte-macrophage lineage appears to be essential in FIP pathogenesis.%A%    
% 209.18/209.33  |- mesh__publicMeSHNote mesh__D016766 92   
% 209.18/209.33  |- skos__altLabel mesh__D016766 Infectious Peritonitis, Feline
% 209.18/209.33  |- mesh__dateEstablished mesh__D016766 1992-01-01
% 209.18/209.33  |- mesh__dateRevised mesh__D016766 2001-07-25
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D016766 2002
% 209.18/209.33  |- mesh__recordMaintainer mesh__D016766 ags
% 209.18/209.33  |- skos__historyNote mesh__D016766 Cat Diseases %28%1966-1991%29%
% 209.18/209.33  |- mesh__historyNote mesh__D016766 92   
% 209.18/209.33  |- skos__altLabel mesh__D016766 Peritonitis, Infectious, Feline
% 209.18/209.33  |- rdf__type mesh__D016766sskos__Concept
% 209.18/209.33  |- mesh__recordAuthorizer mesh__D016766 sjn
% 209.18/209.33  |- skos__annotation mesh__D016766 DF: FELINE INFECT PERITONITIS   
% 209.18/209.33  |- skos__hiddenLabel mesh__D016766 Infectious Peritonitides, Feline
% 209.18/209.33  |- mesh__recordOriginator mesh__D016766 AGS
% 209.18/209.33  |- skos__prefLabel mesh__D016766 Feline Infectious Peritonitis
% 209.18/209.33  |- skos__broader mesh__D016766smesh__D018352
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D016766 2003
% 209.18/209.33  |- skos__hiddenLabel mesh__D016766 Peritonitis, Feline Infectious
% 209.18/209.33  |- skos__historyNote mesh__D016766 Coronavirus Infections %28%1978-1991%29%
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D016766 2005
% 209.18/209.33  |- mesh__dateCreated mesh__D016766 1991-05-02
% 209.18/209.33  |- skos__broader mesh__D016766smesh__D002371
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D016766 2004
% 209.18/209.33  |- skos__hiddenLabel mesh__D016766 Feline Infectious Peritonitides
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D016766 2006
% 209.18/209.33  |- skos__hiddenLabel mesh__D002746 Hydrochloride, Chlorpromazine
% 209.18/209.33  |- skos__scopeNote mesh__D002746
% 209.18/209.33       The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine%27%s antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.%A%    
% 209.18/209.33  |- mesh__recordMaintainer mesh__D002746 ssb
% 209.18/209.33  |- skos__broader mesh__D002746smesh__D010640
% 209.18/209.33  |- mesh__recordOriginator mesh__D002746 NLM
% 209.18/209.33  |- mesh__recordAuthorizer mesh__D002746 sjn
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D002746 2006
% 209.18/209.33  |- skos__prefLabel mesh__D002746 Chlorpromazine
% 209.18/209.33  |- mesh__historyNote mesh__D002746
% 209.18/209.33       /adv eff-pois-tox was CHLORPROMAZINE TOXICOLOGY 1963-65   
% 209.18/209.33  |- mesh__dateRevised mesh__D002746 2005-06-30
% 209.18/209.33  |- rdf__type mesh__D002746sskos__Concept
% 209.18/209.33  |- mesh__publicMeSHNote mesh__D002746
% 209.18/209.33       /adverse effects /poisoning /toxicity were CHLORPROMAZINE TOXICOLOGY 1963-65%A%  
% 209.18/209.33  |- mesh__dateCreated mesh__D002746 1999-01-01
% 209.18/209.33  |- skos__altLabel mesh__D007431 Surgical Injuries
% 209.18/209.33  |- skos__hiddenLabel mesh__D007431 Complications, Intraoperative
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D007431 2006
% 209.18/209.33  |- mesh__dateEstablished mesh__D007431 1980-01-01
% 209.18/209.33  |- skos__hiddenLabel mesh__D007431 Intraoperative Complication
% 209.18/209.33  |- mesh__historyNote mesh__D007431 80   
% 209.18/209.33  |- skos__hiddenLabel mesh__D007431 Complications, Peroperative
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D007431 2003
% 209.18/209.33  |- mesh__dateCreated mesh__D007431 1979-03-12
% 209.18/209.33  |- mesh__recordMaintainer mesh__D007431 KEV
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D007431 2000
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D007431 2004
% 209.18/209.33  |- mesh__recordAuthorizer mesh__D007431 sjn
% 209.18/209.33  |- skos__hiddenLabel mesh__D007431 Surgical Injury
% 209.18/209.33  |- skos__hiddenLabel mesh__D007431 Peroperative Complication
% 209.18/209.33  |- rdf__type mesh__D007431sskos__Concept
% 209.18/209.33  |- skos__altLabel mesh__D007431 Complication, Peroperative
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D007431 2001
% 209.18/209.33  |- skos__scopeNote mesh__D007431
% 209.18/209.33       Complications that affect patients during surgery. They may or may not be associated with the disease for which the surgery is done, or within the same surgical procedure.%A%    
% 209.18/209.33  |- mesh__dateRevised mesh__D007431 1999-11-08
% 209.18/209.33  |- skos__broader mesh__D007431smesh__D010335
% 209.18/209.33  |- skos__annotation mesh__D007431
% 209.18/209.33       few qualif apply; IM; coord with Cat E4 term %28%IM%29% if pertinent with or without /adv eff depending on its relation to the intraop compl: for policy apply principles of POSTOPERATIVE COMPLICATIONS, Manual 23.18+; for iatrogenic compl %28%as X ref SURGICAL INJURIES%29% or other: TN 179; DF: INTRAOP COMPL%A%  
% 209.18/209.33  |- skos__hiddenLabel mesh__D007431 Injury, Surgical
% 209.18/209.33  |- skos__prefLabel mesh__D007431 Intraoperative Complications
% 209.18/209.33  |- skos__altLabel mesh__D007431 Complication, Intraoperative
% 209.18/209.33  |- skos__altLabel mesh__D007431 Peroperative Complications
% 209.18/209.33  |- mesh__recordOriginator mesh__D007431 SMH
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D007431 2005
% 209.18/209.33  |- mesh__publicMeSHNote mesh__D007431 80   
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D007431 2002
% 209.18/209.33  |- skos__hiddenLabel mesh__D048848 Protein Kinase, ASK1
% 209.18/209.33  |- skos__altLabel mesh__D048848 ASK1 Protein Kinase
% 209.18/209.33  |- skos__altLabel mesh__D048848
% 209.18/209.33       Mitogen-Activated Kinase Kinase Kinase Kinase 5
% 209.18/209.33  |- rdf__type mesh__D048848sskos__Concept
% 209.18/209.33  |- skos__scopeNote mesh__D048848
% 209.18/209.33       A 150-kDa MAP kinase kinase kinase that may play a role in the induction of APOPTOSIS. It has specificity for MAP KINASE KINASE 3; MAP KINASE KINASE 4; and MAP KINASE KINASE 6.%A%    
% 209.18/209.33  |- mesh__dateCreated mesh__D048848 2004-07-07
% 209.18/209.33  |- skos__hiddenLabel mesh__D048848
% 209.18/209.33       Mitogen Activated Kinase Kinase Kinase Kinase 5
% 209.18/209.33  |- skos__historyNote mesh__D048848
% 209.18/209.33       Mitogen-Activated Protein Kinase Kinase Kinases %28%2000-2004%29%
% 209.18/209.33  |- skos__altLabel mesh__D048848 MAPK Kinase Kinase 5
% 209.18/209.33  |- skos__broader mesh__D048848smesh__D020930
% 209.18/209.33  |- skos__hiddenLabel mesh__D048848 Protein Kinase, MAP3K5
% 209.18/209.33  |- skos__prefLabel mesh__D048848 MAP Kinase Kinase Kinase 5
% 209.18/209.33  |- mesh__recordOriginator mesh__D048848 jmp
% 209.18/209.33  |- skos__altLabel mesh__D048848 MAPKKK5
% 209.18/209.33  |- skos__historyNote mesh__D048848
% 209.18/209.33       Protein-Serine-Threonine Kinases %28%1995-1999%29%
% 209.18/209.33  |- skos__altLabel mesh__D048848 MAP3K5 Protein Kinase
% 209.18/209.33  |- skos__altLabel mesh__D048848 Apoptosis Signal-Regulating Kinase 1
% 209.18/209.33  |- skos__hiddenLabel mesh__D048848 Apoptosis Signal Regulating Kinase 1
% 209.18/209.33  |- mesh__publicMeSHNote mesh__D048848
% 209.18/209.33       2005: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 4 was indexed under MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASES 2000-2004, %26% under PROTEIN-SERINE-THREONINE KINASES 1996-1999%A%  
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D048848 2005
% 209.18/209.33  |- mesh__recordMaintainer mesh__D048848 jmp
% 209.18/209.33  |- mesh__dateEstablished mesh__D048848 2005-01-01
% 209.18/209.33  |- mesh__historyNote mesh__D048848 2005%28%1996%29%   
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D048848 2006
% 209.18/209.33  |- mesh__recordAuthorizer mesh__D048848 sjn
% 209.18/209.33  |- rdf__type mesh__D012376sskos__Concept
% 209.18/209.33  |- skos__hiddenLabel mesh__D012376 Disease, Rodent
% 209.18/209.33  |- mesh__recordMaintainer mesh__D012376 ags
% 209.18/209.33  |- mesh__recordAuthorizer mesh__D012376 sjn
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D012376 2004
% 209.18/209.33  |- skos__hiddenLabel mesh__D012376 Diseases, Rodent
% 209.18/209.33  |- skos__hiddenLabel mesh__D012376 Rodent Disease
% 209.18/209.33  |- mesh__recordOriginator mesh__D012376 NLM
% 209.18/209.33  |- skos__scopeNote mesh__D012376
% 209.18/209.33       Diseases of rodents of the order RODENTIA. This term includes diseases of Sciuridae %28%squirrels%29%, Geomyidae %28%gophers%29%, Heteromyidae %28%pouched mice%29%, Castoridae %28%beavers%29%, Cricetidae %28%rats and mice%29%, Muridae %28%Old World rats and mice%29%, Erethizontidae %28%porcupines%29%, and Caviidae %28%guinea pigs%29%.%A%    
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D012376 2006
% 209.18/209.33  |- skos__broader mesh__D012376smesh__D000820
% 209.18/209.33  |- mesh__dateRevised mesh__D012376 2003-07-30
% 209.18/209.33  |- skos__prefLabel mesh__D012376 Rodent Diseases
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D012376 2005
% 209.18/209.33  |- skos__annotation mesh__D012376
% 209.18/209.33       IM GEN or unspecified; coord IM with specific dis /vet %28%IM%29% or specific rodent dis %28%IM%29%; coord IM with specific rodent %28%IM%29%; don%27%t forget also RODENTIA %28%NIM%29% %26% check tag ANIMALS; DF: RODENT DIS%A%  
% 209.18/209.33  |- mesh__dateCreated mesh__D012376 1999-01-01
% 209.18/209.33  |- skos__scopeNote mesh__D020808
% 209.18/209.33       Infections of the brain, spinal cord, or meninges by single celled organisms of the subkingdom PROTOZOA. The central nervous system may be the primary or secondary site of protozoal infection. Examples of primary infections include cerebral amebiasis, granulomatous amebic encephalitis, primary amebic meningoencephalitis, and TRYPANOSOMIASIS, AFRICAN. Cerebral malaria, cerebral babesiosis, and chagasic meningoencephalitis are examples of secondary infections. These diseases may occur as OPPORTUNISTIC INFECTIONS or arise in immunocompetent hosts. %28%From Joynt, Clinical Neurology, 1998, Ch27, pp37-47%29%%A%    
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D020808 2004
% 209.18/209.33  |- skos__altLabel mesh__D020808
% 209.18/209.33       Infection, Central Nervous System, Protozoal
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D020808 2001
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D020808 2003
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D020808 2000
% 209.18/209.33  |- mesh__historyNote mesh__D020808 2000   
% 209.18/209.33  |- mesh__dateCreated mesh__D020808 1999-11-05
% 209.18/209.33  |- skos__hiddenLabel mesh__D020808 Cerebral Protozoal Infection
% 209.18/209.33  |- skos__broader mesh__D020808smesh__D011528
% 209.18/209.33  |- skos__annotation mesh__D020808
% 209.18/209.33       coord IM with specific protozoan infection %28%IM%29% and specific site/dis term %28%IM%29% if pertinent; DF: CNS PROTOZOAL INFECT%A%  
% 209.18/209.33  |- rdf__type mesh__D020808sskos__Concept
% 209.18/209.33  |- skos__hiddenLabel mesh__D020808 Infection, Cerebral Protozoal
% 209.18/209.33  |- skos__hiddenLabel mesh__D020808 Protozoal Meningoencephalitides
% 209.18/209.33  |- skos__historyNote mesh__D020808 Amebiasis %28%1966-1999%29%
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D020808 2006
% 209.18/209.33  |- skos__broader mesh__D020808smesh__D020807
% 209.18/209.33  |- skos__hiddenLabel mesh__D020808 Infections, Cerebral Protozoal
% 209.18/209.33  |- skos__hiddenLabel mesh__D020808 Protozoal Infection, Cerebral
% 209.18/209.33  |- skos__altLabel mesh__D020808 Protozoal Infections, Cerebral
% 209.18/209.33  |- mesh__publicMeSHNote mesh__D020808 2000   
% 209.18/209.33  |- skos__altLabel mesh__D020808
% 209.18/209.33       Protozoal Infections, Central Nervous System
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D020808 2005
% 209.18/209.33  |- skos__prefLabel mesh__D020808
% 209.18/209.33       Central Nervous System Protozoal Infections
% 209.18/209.33  |- skos__hiddenLabel mesh__D020808 Meningoencephalitides, Protozoal
% 209.18/209.33  |- skos__altLabel mesh__D020808 Protozoal Meningoencephalitis
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D020808 2002
% 209.18/209.33  |- mesh__dateEstablished mesh__D020808 2000-01-01
% 209.18/209.33  |- skos__altLabel mesh__D020808
% 209.18/209.33       Infections, Protozoal, Central Nervous System
% 209.18/209.33  |- skos__hiddenLabel mesh__D006339 Rate, Heart
% 209.18/209.33  |- mesh__historyNote mesh__D006339 66%28%64%29%   
% 209.18/209.33  |- skos__altLabel mesh__D006339 Chronotropism, Cardiac
% 209.18/209.33  |- mesh__recordAuthorizer mesh__D006339 sjn
% 209.18/209.33  |- mesh__dateEstablished mesh__D006339 1966-01-01
% 209.18/209.33  |- mesh__publicMeSHNote mesh__D006339 66   
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D006339 2005
% 209.18/209.33  |- skos__scopeNote mesh__D006339
% 209.18/209.33       The number of times the HEART VENTRICLES contract per unit of time, usually per minute.%A%    
% 209.18/209.33  |- skos__hiddenLabel mesh__D006339 Rates, Heart
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D006339 2006
% 209.18/209.33  |- skos__hiddenLabel mesh__D006339 Chronotropisms, Cardiac
% 209.18/209.33  |- skos__hiddenLabel mesh__D006339 Rates, Pulse
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D006339 2004
% 209.18/209.33  |- mesh__recordMaintainer mesh__D006339 nns
% 209.18/209.33  |- skos__broader mesh__D006339smesh__D045472
% 209.18/209.33  |- skos__annotation mesh__D006339
% 209.18/209.33       policy: Manual 23.27+; chronotropic action of drugs = HEART RATE /drug eff %28%IM%29% + drug with /pharmacol %28%IM%29% + STIMULATION, CHEMICAL %28%NIM%29% for positive chronotropic action %26% DEPRESSION, CHEMICAL %28%NIM%29% for negative; for inotropic action see note on MYOCARDIAL CONTRACTION%A%  
% 209.18/209.33  |- skos__hiddenLabel mesh__D006339 Rate, Pulse
% 209.18/209.33  |- mesh__dateCreated mesh__D006339 1999-01-01
% 209.18/209.33  |- skos__hiddenLabel mesh__D006339 Cardiac Chronotropism
% 209.18/209.33  |- skos__prefLabel mesh__D006339 Heart Rate
% 209.18/209.33  |- mesh__recordOriginator mesh__D006339 NLM
% 209.18/209.33  |- skos__hiddenLabel mesh__D006339 Cardiac Chronotropisms
% 209.18/209.33  |- skos__hiddenLabel mesh__D006339 Heart Rates
% 209.18/209.33  |- mesh__dateRevised mesh__D006339 2003-07-09
% 209.18/209.33  |- rdf__type mesh__D006339sskos__Concept
% 209.18/209.33  |- skos__hiddenLabel mesh__D006339 Pulse Rates
% 209.18/209.33  |- skos__related mesh__D006339smesh__D011674
% 209.18/209.33  |- rdf__type mesh__D017061sskos__Concept
% 209.18/209.33  |- mesh__dateRevised mesh__D017061 1993-09-16
% 209.18/209.33  |- skos__broader mesh__D017061smesh__D007348
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D017061 1999
% 209.18/209.33  |- mesh__recordAuthorizer mesh__D017061 NLM
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D017061 1995
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D017061 2001
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D017061 1998
% 209.18/209.33  |- mesh__recordOriginator mesh__D017061 PLS
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D017061 2004
% 209.18/209.33  |- skos__prefLabel mesh__D017061 Prepaid Health Plans
% 209.18/209.33  |- mesh__historyNote mesh__D017061 92   
% 209.18/209.33  |- skos__related mesh__D017061smesh__D006125
% 209.18/209.33  |- skos__hiddenLabel mesh__D017061 Prepaid Health Plan
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D017061 2000
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D017061 2003
% 209.18/209.33  |- skos__altLabel mesh__D017061 Health Plans, Prepaid
% 209.18/209.33  |- mesh__dateCreated mesh__D017061 1991-06-20
% 209.18/209.33  |- mesh__recordMaintainer mesh__D017061 PLS
% 209.18/209.33  |- skos__historyNote mesh__D017061 Insurance, Health %28%1966-1991%29%
% 209.18/209.33  |- skos__hiddenLabel mesh__D017061 Plan, Prepaid Health
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D017061 1997
% 209.18/209.33  |- mesh__publicMeSHNote mesh__D017061 92   
% 209.18/209.33  |- mesh__dateEstablished mesh__D017061 1992-01-01
% 209.18/209.33  |- skos__hiddenLabel mesh__D017061 Plans, Prepaid Health
% 209.18/209.33  |- skos__historyNote mesh__D017061
% 209.18/209.33       Health Maintenance Organizations %28%1972-1991%29%
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D017061 2006
% 209.18/209.33  |- skos__scopeNote mesh__D017061
% 209.18/209.33       Contracts between an insurer and a subscriber or a group of subscribers whereby a specified set of health benefits is provided in return for a periodic premium.%A%    
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D017061 1996
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D017061 2002
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D017061 2005
% 209.18/209.33  |- skos__hiddenLabel mesh__D017061 Health Plan, Prepaid
% 209.18/209.33  |- skos__hiddenLabel mesh__D050495
% 209.18/209.33       Vesicular GABA Glycine Transport Proteins
% 209.18/209.33  |- skos__prefLabel mesh__D050495
% 209.18/209.33       Vesicular Inhibitory Amino Acid Transport Proteins
% 209.18/209.33  |- skos__hiddenLabel mesh__D050495
% 209.18/209.33       Vesicular GABA Glycine Transporter Proteins
% 209.18/209.33  |- skos__hiddenLabel mesh__D050495 Transporter Proteins, VGAT
% 209.18/209.33  |- skos__altLabel mesh__D050495 VGAT Transporter Proteins
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D050495 2006A
% 209.18/209.33  |- skos__altLabel mesh__D050495
% 209.18/209.33       Vesicular Inhibitory Amino Acid Transporter Proteins
% 209.18/209.33  |- skos__altLabel mesh__D050495 VIAAT Transporter Proteins
% 209.18/209.33  |- mesh__dateEstablished mesh__D050495 2006-01-01
% 209.18/209.33  |- mesh__recordAuthorizer mesh__D050495 ags
% 209.18/209.33  |- mesh__publicMeSHNote mesh__D050495 2006   
% 209.18/209.33  |- skos__altLabel mesh__D050495 Vesicular GABA-Glycine Transport Proteins
% 209.18/209.33  |- mesh__historyNote mesh__D050495 2006   
% 209.18/209.33  |- mesh__dateRevised mesh__D050495 2005-07-15
% 209.18/209.33  |- skos__scopeNote mesh__D050495
% 209.18/209.33       A family of vesicular neurotransmitter transporter proteins that sequester the inhibitory neurotransmitters GLYCINE; GAMMA-AMINOBUTYRIC ACID; and possibly GAMMA-HYDROXYBUTYRATE into SECRETORY VESICLES.%A%    
% 209.18/209.33  |- mesh__dateCreated mesh__D050495 2005-06-30
% 209.18/209.33  |- mesh__activeMeSHYear mesh__D050495 2006
% 209.18/209.33  |- skos__altLabel mesh__D050495 Vesicular GABA-Glycine Transporter Proteins
% 209.18/209.33  |- mesh__recordOriginator mesh__D050495 DRC
% 209.18/209.33  |- rdf__type mesh__D050495sskos__Concept
% 209.18/209.33  |- skos__hiddenLabel mesh__D050495 Transporter Proteins, VIAAT
% 209.18/209.33  |- skos__broader mesh__D050495smesh__D050481
% 209.18/209.33  |- mesh__recordMaintainer mesh__D050495 ags
% 209.18/209.33  |- rdf__type mesh__D003041sskos__Concept
% 209.18/209.33  |- skos__prefLabel mesh__D003041 Coca
% 209.18/209.33  |- mesh__recordMaintainer mesh__D003041 ssb
% 209.18/209.33  |- skos__broader mesh__D003041smesh__D030921
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D003041 2004
% 209.18/209.34  |- mesh__recordAuthorizer mesh__D003041 sjn
% 209.18/209.34  |- skos__altLabel mesh__D003041 Erythroxylon
% 209.18/209.34  |- mesh__dateRevised mesh__D003041 2001-07-25
% 209.18/209.34  |- skos__annotation mesh__D003041 do not confuse with cocoa see CACAO   
% 209.18/209.34  |- skos__scopeNote mesh__D003041
% 209.18/209.34       Any of several South American shrubs of the Erythroxylon genus %28%and family%29% that yield COCAINE; the leaves are chewed with alum for CNS stimulation.%A%    
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D003041 2005
% 209.18/209.34  |- mesh__dateCreated mesh__D003041 1999-01-01
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D003041 2006
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D003041 2002
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D003041 2003
% 209.18/209.34  |- mesh__recordOriginator mesh__D003041 NLM
% 209.18/209.34  |- skos__historyNote mesh__D016767
% 209.18/209.34       Bile Ducts, Intrahepatic/abnormalities %28%1985-1992%29%
% 209.18/209.34  |- skos__historyNote mesh__D016767
% 209.18/209.34       Bile Duct Diseases/congenital %28%1966-1992%29%
% 209.18/209.34  |- mesh__dateEstablished mesh__D016767 1993-01-01
% 209.18/209.34  |- rdf__type mesh__D016767sskos__Concept
% 209.18/209.34  |- skos__hiddenLabel mesh__D016767 Carolis Disease
% 209.18/209.34  |- skos__hiddenLabel mesh__D016767 Syndrome, Caroli%27%s
% 209.18/209.34  |- skos__hiddenLabel mesh__D016767 Disease, Caroli%27%s
% 209.18/209.34  |- skos__scopeNote mesh__D016767
% 209.18/209.34       Congenital cystic dilatation of the intrahepatic bile ducts %28%BILE DUCTS, INTRAHEPATIC%29%. It consists of 2 types: simple Caroli disease is characterized by bile duct dilatation %28%ectasia%29% alone; and complex Caroli disease is characterized by bile duct dilatation with extensive hepatic fibrosis and portal hypertension %28%HYPERTENSION, PORTAL%29%. Benign renal tubular ectasia is associated with both types of Caroli disease.%A%    
% 209.18/209.34  |- skos__broader mesh__D016767smesh__D015529
% 209.18/209.34  |- mesh__recordOriginator mesh__D016767 JLS
% 209.18/209.34  |- skos__prefLabel mesh__D016767 Caroli Disease
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D016767 2005
% 209.18/209.34  |- skos__altLabel mesh__D016767 Caroli%27%s Syndrome
% 209.18/209.34  |- mesh__recordMaintainer mesh__D016767 lkt
% 209.18/209.34  |- mesh__dateCreated mesh__D016767 1992-05-07
% 209.18/209.34  |- mesh__dateRevised mesh__D016767 2003-07-09
% 209.18/209.34  |- mesh__recordAuthorizer mesh__D016767 sjn
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D016767 2004
% 209.18/209.34  |- skos__altLabel mesh__D016767 Caroli%27%s Disease
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D016767 2006
% 209.18/209.34  |- skos__hiddenLabel mesh__D016767 Disease, Caroli
% 209.18/209.34  |- skos__historyNote mesh__D016767 Biliary Dyskinesia %28%1966-1984%29%
% 209.18/209.34  |- skos__hiddenLabel mesh__D016767 Carolis Syndrome
% 209.18/209.34  |- mesh__publicMeSHNote mesh__D016767
% 209.18/209.34       2004; see CAROLI%27%S DISEASE 1993-2003   
% 209.18/209.34  |- skos__annotation mesh__D016767
% 209.18/209.34       do not coord with INFANT, NEWBORN, DISEASES; DF: CAROLI DIS%A%  
% 209.18/209.34  |- mesh__historyNote mesh__D016767 2004 %28%1993%29%   
% 209.18/209.34  |- skos__hiddenLabel mesh__D016767 Caroli Syndrome
% 209.18/209.34  |- mesh__recordOriginator mesh__D035921 jmp
% 209.18/209.34  |- mesh__dateRevised mesh__D035921 2005-06-30
% 209.18/209.34  |- skos__related mesh__D035921smesh__D006508
% 209.18/209.34  |- rdf__type mesh__D035921sskos__Concept
% 209.18/209.34  |- mesh__recordAuthorizer mesh__D035921 sjn
% 209.18/209.34  |- mesh__recordMaintainer mesh__D035921 ssb
% 209.18/209.34  |- mesh__dateEstablished mesh__D035921 2003-01-01
% 209.18/209.34  |- skos__hiddenLabel mesh__D035921 Antigens, Hepatitis A
% 209.18/209.34  |- skos__scopeNote mesh__D035921
% 209.18/209.34       Antigens produced by various strains of HEPATITIS A VIRUS such as the human hepatitis A virus %28%HEPATITIS A VIRUS, HUMAN%29%.%A%    
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D035921 2006
% 209.18/209.34  |- mesh__publicMeSHNote mesh__D035921
% 209.18/209.34       2003; HEPATITIS A ANTIGENS was indexed under ANTIGENS, VIRAL 1985-2002%A%  
% 209.18/209.34  |- mesh__historyNote mesh__D035921
% 209.18/209.34       2003; use HEPATITIS A ANTIGENS %28%NM%29% 1985-2002   
% 209.18/209.34  |- skos__prefLabel mesh__D035921 Hepatitis A Antigens
% 209.18/209.34  |- skos__broader mesh__D035921smesh__D018963
% 209.18/209.34  |- skos__altLabel mesh__D035921 Hepatitis A Virus Antigens
% 209.18/209.34  |- skos__historyNote mesh__D035921 Antigens, Viral %28%1985-2002%29%
% 209.18/209.34  |- mesh__dateCreated mesh__D035921 2002-07-02
% 209.18/209.34  |- skos__annotation mesh__D035921
% 209.18/209.34       for antigens to human virus, coord IM with HEPATITIS A VIRUS, HUMAN /immunol %28%IM%29%%A%  
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D002747 2006
% 209.18/209.34  |- skos__altLabel mesh__D002747 Farmasierra Brand of Chlorpropamide
% 209.18/209.34  |- skos__scopeNote mesh__D002747
% 209.18/209.34       A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p277%29%%A%    
% 209.18/209.34  |- mesh__recordAuthorizer mesh__D002747 sjn
% 209.18/209.34  |- rdf__type mesh__D002747sskos__Concept
% 209.18/209.34  |- mesh__recordOriginator mesh__D002747 NLM
% 209.18/209.34  |- mesh__dateCreated mesh__D002747 1999-01-01
% 209.18/209.34  |- mesh__recordMaintainer mesh__D002747 lkw
% 209.18/209.34  |- skos__altLabel mesh__D002747 Byk Gulden Brand of Chlorpropamide
% 209.18/209.34  |- skos__altLabel mesh__D002747 Pfizer Brand of Chlorpropamide
% 209.18/209.34  |- mesh__dateRevised mesh__D002747 2005-06-30
% 209.18/209.34  |- skos__altLabel mesh__D002747 Apotex Brand of Chlorpropamide
% 209.18/209.34  |- skos__prefLabel mesh__D002747 Chlorpropamide
% 209.18/209.34  |- skos__altLabel mesh__D002747 Clorpropamid
% 209.18/209.34  |- skos__broader mesh__D002747smesh__D013453
% 209.18/209.34  |- skos__hiddenLabel mesh__D021901 Regions, Intergenic
% 209.18/209.34  |- skos__hiddenLabel mesh__D021901 Intercistronic Regions
% 209.18/209.34  |- skos__hiddenLabel mesh__D021901 Sequences, Intergenic
% 209.18/209.34  |- skos__altLabel mesh__D021901 DNA, Spacer
% 209.18/209.34  |- skos__hiddenLabel mesh__D021901 DNAs, Spacer
% 209.18/209.34  |- skos__hiddenLabel mesh__D021901 DNAs, Intergenic
% 209.18/209.34  |- skos__scopeNote mesh__D021901
% 209.18/209.34       Any of the DNA in between gene-coding DNA, including untranslated regions, 5%27% and 3%27% flanking regions, INTRONS, non-functional pseudogenes, and non-functional repetitive sequences. This DNA may or may not encode regulatory functions.%A%    
% 209.18/209.34  |- mesh__dateCreated mesh__D021901 2000-06-22
% 209.18/209.34  |- skos__altLabel mesh__D021901 Intercistronic Sequence
% 209.18/209.34  |- skos__hiddenLabel mesh__D021901 Region, Intergenic
% 209.18/209.34  |- mesh__recordAuthorizer mesh__D021901 sjn
% 209.18/209.34  |- skos__hiddenLabel mesh__D021901 Regions, Intercistronic
% 209.18/209.34  |- skos__altLabel mesh__D021901 Intercistronic Region
% 209.18/209.34  |- mesh__dateRevised mesh__D021901 2005-06-30
% 209.18/209.34  |- skos__altLabel mesh__D021901 Sequence, Intergenic
% 209.18/209.34  |- mesh__recordMaintainer mesh__D021901 nns
% 209.18/209.34  |- skos__hiddenLabel mesh__D021901 Intercistronic Sequences
% 209.18/209.34  |- skos__hiddenLabel mesh__D021901 Intergenic Sequences
% 209.18/209.34  |- skos__hiddenLabel mesh__D021901 DNAs, Junk
% 209.18/209.34  |- skos__altLabel mesh__D021901 Intergenic DNA
% 209.18/209.34  |- skos__hiddenLabel mesh__D021901 Sequences, Intercistronic
% 209.18/209.34  |- mesh__recordOriginator mesh__D021901 nns
% 209.18/209.34  |- mesh__historyNote mesh__D021901 2001   
% 209.18/209.34  |- skos__broader mesh__D021901smesh__D040481
% 209.18/209.34  |- skos__historyNote mesh__D021901 Base Sequence %28%1983-2000%29%
% 209.18/209.34  |- skos__hiddenLabel mesh__D021901 Sequence, Intercistronic
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D021901 2006
% 209.18/209.34  |- skos__broader mesh__D021901smesh__D004247
% 209.18/209.34  |- rdf__type mesh__D021901sskos__Concept
% 209.18/209.34  |- skos__altLabel mesh__D021901 Junk DNA
% 209.18/209.34  |- mesh__dateEstablished mesh__D021901 2001-01-01
% 209.18/209.34  |- skos__hiddenLabel mesh__D021901 Junk DNAs
% 209.18/209.34  |- skos__hiddenLabel mesh__D021901 Intergenic Regions
% 209.18/209.34  |- mesh__publicMeSHNote mesh__D021901 2001   
% 209.18/209.34  |- skos__hiddenLabel mesh__D021901 Spacer DNAs
% 209.18/209.34  |- skos__prefLabel mesh__D021901 DNA, Intergenic
% 209.18/209.34  |- skos__historyNote mesh__D021901 DNA or specifics %28%1984-2000%29%
% 209.18/209.34  |- skos__annotation mesh__D021901
% 209.18/209.34       note that DNA, RIBOSOMAL SPACER is available   
% 209.18/209.34  |- skos__hiddenLabel mesh__D021901 Intergenic DNAs
% 209.18/209.34  |- skos__hiddenLabel mesh__D021901 Region, Intercistronic
% 209.18/209.34  |- skos__hiddenLabel mesh__D007432 Periods, Intraoperative
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D007432 1996
% 209.18/209.34  |- mesh__recordMaintainer mesh__D007432 NLM
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D007432 2004
% 209.18/209.34  |- skos__hiddenLabel mesh__D007432 Periods, Peroperative
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D007432 1991
% 209.18/209.34  |- mesh__publicMeSHNote mesh__D007432
% 209.18/209.34       91; was see under SURGERY, OPERATIVE 1980-90   
% 209.18/209.34  |- rdf__type mesh__D007432sskos__Concept
% 209.18/209.34  |- mesh__recordOriginator mesh__D007432 SMH
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D007432 1997
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D007432 1994
% 209.18/209.34  |- skos__broader mesh__D007432smesh__D013514
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D007432 2002
% 209.18/209.34  |- skos__hiddenLabel mesh__D007432 Peroperative Periods
% 209.18/209.34  |- skos__scopeNote mesh__D007432
% 209.18/209.34       The period during a surgical operation.     
% 209.18/209.34  |- mesh__dateEstablished mesh__D007432 1991-01-01
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D007432 2005
% 209.18/209.34  |- skos__hiddenLabel mesh__D007432 Period, Peroperative
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D007432 1995
% 209.18/209.34  |- mesh__dateRevised mesh__D007432 1990-04-13
% 209.18/209.34  |- skos__hiddenLabel mesh__D007432 Period, Intraoperative
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D007432 1998
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D007432 2006
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D007432 1992
% 209.18/209.34  |- skos__hiddenLabel mesh__D007432 Intraoperative Periods
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D007432 2000
% 209.18/209.34  |- skos__annotation mesh__D007432
% 209.18/209.34       almost never IM; use qualif discreetly; DF: INTRAOP PERIOD%A%  
% 209.18/209.34  |- mesh__recordAuthorizer mesh__D007432 PLS
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D007432 1999
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D007432 2003
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D007432 2001
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D007432 1993
% 209.18/209.34  |- mesh__dateCreated mesh__D007432 1979-03-12
% 209.18/209.34  |- skos__prefLabel mesh__D007432 Intraoperative Period
% 209.18/209.34  |- mesh__historyNote mesh__D007432
% 209.18/209.34       91%28%80%29%; was see under SURGERY, OPERATIVE 1980-90   
% 209.18/209.34  |- skos__hiddenLabel mesh__D012377 Beaver
% 209.18/209.34  |- skos__hiddenLabel mesh__D012377 Rodent
% 209.18/209.34  |- skos__altLabel mesh__D012377 Rodents
% 209.18/209.34  |- skos__altLabel mesh__D012377 Dipodidae
% 209.18/209.34  |- skos__hiddenLabel mesh__D012377 Capybara
% 209.18/209.34  |- skos__hiddenLabel mesh__D012377 Rodentias
% 209.18/209.34  |- skos__altLabel mesh__D012377 Hydrochaeris
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D012377 2006
% 209.18/209.34  |- skos__annotation mesh__D012377 GEN or unspecified; prefer specifics   
% 209.18/209.34  |- mesh__recordAuthorizer mesh__D012377 sjn
% 209.18/209.34  |- mesh__dateRevised mesh__D012377 2004-07-07
% 209.18/209.34  |- skos__scopeNote mesh__D012377
% 209.18/209.34       A mammalian order which consists of 29 families and many genera.%A%    
% 209.18/209.34  |- skos__hiddenLabel mesh__D012377 Hydrochaeri
% 209.18/209.34  |- skos__prefLabel mesh__D012377 Rodentia
% 209.18/209.34  |- skos__altLabel mesh__D012377 Beavers
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D012377 2005
% 209.18/209.34  |- mesh__publicMeSHNote mesh__D012377 1982; see RODENTS 1963-1981   
% 209.18/209.34  |- mesh__recordOriginator mesh__D012377 NLM
% 209.18/209.34  |- mesh__dateCreated mesh__D012377 1999-01-01
% 209.18/209.34  |- skos__hiddenLabel mesh__D012377 Jerboa
% 209.18/209.34  |- rdf__type mesh__D012377sskos__Concept
% 209.18/209.34  |- mesh__historyNote mesh__D012377 1982; use RODENTS 1963-1981   
% 209.18/209.34  |- skos__broader mesh__D012377smesh__D008322
% 209.18/209.34  |- mesh__recordMaintainer mesh__D012377 ags
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D020809 2004
% 209.18/209.34  |- skos__prefLabel mesh__D020809 Central Nervous System Helminthiasis
% 209.18/209.34  |- skos__historyNote mesh__D020809 Helminthiasis %28%1968-1999%29%
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D020809 2000
% 209.18/209.34  |- mesh__dateEstablished mesh__D020809 2000-01-01
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D020809 2005
% 209.18/209.34  |- skos__broader mesh__D020809smesh__D020807
% 209.18/209.34  |- rdf__type mesh__D020809sskos__Concept
% 209.18/209.34  |- skos__scopeNote mesh__D020809
% 209.18/209.34       Infections of the BRAIN; SPINAL CORD; or MENINGES caused by HELMINTHS %28%parasitic worms%29%.%A%    
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D020809 2001
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D020809 2006
% 209.18/209.34  |- skos__altLabel mesh__D020809 Helminthiasis, Central Nervous System
% 209.18/209.34  |- mesh__publicMeSHNote mesh__D020809 2000   
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D020809 2003
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D020809 2002
% 209.18/209.34  |- mesh__dateCreated mesh__D020809 1999-11-03
% 209.18/209.34  |- skos__hiddenLabel mesh__D020809 Helminthiasis, Cerebral
% 209.18/209.34  |- mesh__historyNote mesh__D020809 2000   
% 209.18/209.34  |- mesh__dateCreated mesh__D017860 1993-06-29
% 209.18/209.34  |- mesh__recordMaintainer mesh__D017860 ags
% 209.18/209.34  |- mesh__recordAuthorizer mesh__D017860 sjn
% 209.18/209.34  |- mesh__dateRevised mesh__D017860 2001-07-25
% 209.18/209.34  |- skos__annotation mesh__D017860 coord IM with specific plant /virol   
% 209.18/209.34  |- mesh__publicMeSHNote mesh__D017860
% 209.18/209.34       94; TOBACCO RINGSPOT VIRUSES was see NEPOVIRUS 1994-96   
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D017860 2005
% 209.18/209.34  |- skos__broader mesh__D017860smesh__D019180
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D017860 2002
% 209.18/209.34  |- mesh__recordOriginator mesh__D017860 AGS
% 209.18/209.34  |- skos__hiddenLabel mesh__D017860 Nepoviruses
% 209.18/209.34  |- rdf__type mesh__D017860sskos__Concept
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D017860 2003
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D017860 2006
% 209.18/209.34  |- mesh__onlineNote mesh__D017860
% 209.18/209.34       use NEPOVIRUS to search TOBACCO RINGSPOT VIRUSES 1994-96   
% 209.18/209.34  |- skos__hiddenLabel mesh__D017860 Tobacco ringspot viruses
% 209.18/209.34  |- skos__prefLabel mesh__D017860 Nepovirus
% 209.18/209.34  |- skos__historyNote mesh__D017860 Plant Viruses %28%1985-1993%29%
% 209.18/209.34  |- skos__scopeNote mesh__D017860
% 209.18/209.34       A genus of polyhedral plant viruses of the family COMOVIRIDAE causing ringspots and spotting on leaves or sometimes symptomless infection. Transmission occurs by seeds, soil nematodes, or experimentally by mechanical inoculation. Tobacco ringspot virus is the type species.%A%    
% 209.18/209.34  |- mesh__dateEstablished mesh__D017860 1994-01-01
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D017860 2004
% 209.18/209.34  |- mesh__historyNote mesh__D017860
% 209.18/209.34       94; TOBACCO RINGSPOT VIRUSES was see NEPOVIRUS 1994-96   
% 209.18/209.34  |- skos__hiddenLabel mesh__D017062 Studies, Small-Area
% 209.18/209.34  |- skos__hiddenLabel mesh__D017062 Analysis, Small-Area Variation
% 209.18/209.34  |- skos__annotation mesh__D017062
% 209.18/209.34       restrict to small geog or demog areas; no qualif; DF: SMALL AREA ANAL%A%  
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D017062 2005
% 209.18/209.34  |- mesh__dateCreated mesh__D017062 1991-06-20
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D017062 2000
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D017062 1998
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D017062 1995
% 209.18/209.34  |- skos__hiddenLabel mesh__D017062 Analyses, Small-Area
% 209.18/209.34  |- skos__scopeNote mesh__D017062
% 209.18/209.34       A method of analyzing the variation in utilization of health care in small geographic or demographic areas. It often studies, for example, the usage rates for a given service or procedure in several small areas, documenting the variation among the areas. By comparing high- and low-use areas, the analysis attempts to determine whether there is a pattern to such use and to identify variables that are associated with and contribute to the variation.%A%    
% 209.18/209.34  |- skos__hiddenLabel mesh__D017062 Small Area Variation
% 209.18/209.34  |- skos__hiddenLabel mesh__D017062 Study, Small-Area
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D017062 2006
% 209.18/209.34  |- rdf__type mesh__D017062sskos__Concept
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D017062 2001
% 209.18/209.34  |- skos__hiddenLabel mesh__D017062 Analysis, Small Area
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D017062 1999
% 209.18/209.34  |- skos__hiddenLabel mesh__D017062 Analyses, Small-Area Variation
% 209.18/209.34  |- skos__hiddenLabel mesh__D017062 Small Area Studies
% 209.18/209.34  |- skos__hiddenLabel mesh__D017062 Variation Analyses, Small-Area
% 209.18/209.34  |- skos__prefLabel mesh__D017062 Small-Area Analysis
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D017062 2003
% 209.18/209.34  |- skos__hiddenLabel mesh__D017062 Variation Analysis, Small Area
% 209.18/209.34  |- mesh__recordMaintainer mesh__D017062 PLS
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D017062 1996
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D017062 1993
% 209.18/209.34  |- mesh__dateRevised mesh__D017062 1992-05-22
% 209.18/209.34  |- skos__hiddenLabel mesh__D017062 Small-Area Variation Analyses
% 209.18/209.34  |- skos__hiddenLabel mesh__D017062 Small-Area Analyses
% 209.18/209.34  |- mesh__recordAuthorizer mesh__D017062 PLS
% 209.18/209.34  |- skos__hiddenLabel mesh__D017062 Variations, Small-Area
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D017062 2002
% 209.18/209.34  |- skos__altLabel mesh__D017062 Variation Analysis, Small-Area
% 209.18/209.34  |- mesh__historyNote mesh__D017062 92   
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D017062 2004
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D017062 1997
% 209.18/209.34  |- skos__hiddenLabel mesh__D017062 Small-Area Variations
% 209.18/209.34  |- skos__altLabel mesh__D017062 Small-Area Variation Analysis
% 209.18/209.34  |- skos__broader mesh__D017062smesh__D016000
% 209.18/209.34  |- skos__hiddenLabel mesh__D017062 Variation, Small-Area
% 209.18/209.34  |- skos__altLabel mesh__D017062 Analysis, Small-Area
% 209.18/209.34  |- skos__hiddenLabel mesh__D017062 Small-Area Study
% 209.18/209.34  |- skos__hiddenLabel mesh__D017062 Small Area Analysis
% 209.18/209.34  |- mesh__recordOriginator mesh__D017062 PLS
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D017062 1994
% 209.18/209.34  |- mesh__dateEstablished mesh__D017062 1992-01-01
% 209.18/209.34  |- skos__hiddenLabel mesh__D017062 Small Area Variation Analysis
% 209.18/209.34  |- mesh__publicMeSHNote mesh__D017062 92   
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D003840 2005
% 209.18/209.34  |- skos__hiddenLabel mesh__D003840 Deoxycholic Acid, 12beta Isomer
% 209.18/209.34  |- skos__hiddenLabel mesh__D003840 Acid, Choleic
% 209.18/209.34  |- skos__historyNote mesh__D003840 Bile Acids and Salts %28%1966-1972%29%
% 209.18/209.34  |- mesh__recordOriginator mesh__D003840 NLM
% 209.18/209.34  |- mesh__dateEstablished mesh__D003840 1974-01-01
% 209.18/209.34  |- skos__hiddenLabel mesh__D003840 Deoxycholate, Sodium
% 209.18/209.34  |- mesh__recordAuthorizer mesh__D003840 sjn
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D003840 2006
% 209.18/209.34  |- skos__annotation mesh__D003840 /biosyn /physiol permitted   
% 209.18/209.34  |- skos__hiddenLabel mesh__D003840 Deoxycholic Acid, 3beta Isomer
% 209.18/209.34  |- skos__hiddenLabel mesh__D003840 3beta-Isomer Deoxycholic Acid
% 209.18/209.34  |- skos__altLabel mesh__D003840 Sodium Deoxycholate
% 209.18/209.34  |- skos__altLabel mesh__D003840 Desoxycholic Acid
% 209.18/209.34  |- skos__hiddenLabel mesh__D003840 5alpha-Isomer Deoxycholic Acid
% 209.18/209.34  |- mesh__publicMeSHNote mesh__D003840 74   
% 209.18/209.34  |- mesh__dateCreated mesh__D003840 1999-01-01
% 209.18/209.34  |- mesh__historyNote mesh__D003840 74%28%73%29%   
% 209.18/209.34  |- skos__hiddenLabel mesh__D003840 Acid, Deoxycholic
% 209.18/209.34  |- skos__hiddenLabel mesh__D003840 12beta-Isomer Deoxycholic Acid
% 209.18/209.34  |- skos__scopeNote mesh__D003840
% 209.18/209.34       A bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent.%A%    
% 209.18/209.34  |- skos__hiddenLabel mesh__D003840 Deoxycholic Acid, 5alpha Isomer
% 209.18/209.34  |- skos__broader mesh__D003840smesh__D002793
% 209.18/209.34  |- skos__hiddenLabel mesh__D003840 Acid, Dihydroxycholanoic
% 209.18/209.34  |- skos__hiddenLabel mesh__D003840 Acid, Desoxycholic
% 209.18/209.34  |- mesh__recordMaintainer mesh__D003840 ssb
% 209.18/209.34  |- mesh__dateRevised mesh__D003840 2003-07-09
% 209.18/209.34  |- skos__hiddenLabel mesh__D003840 Acid, 5alpha-Isomer Deoxycholic
% 209.18/209.34  |- rdf__type mesh__D003840sskos__Concept
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D003840 2004
% 209.18/209.34  |- skos__hiddenLabel mesh__D003840 Acid, Lagodeoxycholic
% 209.18/209.34  |- skos__prefLabel mesh__D003840 Deoxycholic Acid
% 209.18/209.34  |- skos__altLabel mesh__D003840 Dihydroxycholanoic Acid
% 209.18/209.34  |- skos__altLabel mesh__D050496 Glutamate Transporters, Vesicular
% 209.18/209.34  |- mesh__publicMeSHNote mesh__D050496 2006   
% 209.18/209.34  |- skos__altLabel mesh__D050496 VGLUT Transport Proteins
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D050496 2006
% 209.18/209.34  |- mesh__recordAuthorizer mesh__D050496 sjn
% 209.18/209.34  |- mesh__recordOriginator mesh__D050496 DRC
% 209.18/209.34  |- rdf__type mesh__D050496sskos__Concept
% 209.18/209.34  |- skos__scopeNote mesh__D050496
% 209.18/209.34       A family of vesicular neurotransmitter transporter proteins that were originally characterized as sodium dependent inorganic phosphate cotransporters. Vesicular glutamate transport proteins sequester the excitatory neurotransmitter GLUTAMATE from the CYTOPLASM into SECRETORY VESICLES in exchange for lumenal PROTONS.%A%    
% 209.18/209.34  |- skos__broader mesh__D050496smesh__D050481
% 209.18/209.34  |- mesh__dateEstablished mesh__D050496 2006-01-01
% 209.18/209.34  |- skos__altLabel mesh__D050496 Vesicular Glutamate Transporter Proteins
% 209.18/209.34  |- skos__hiddenLabel mesh__D050496 Transporters, Vesicular Glutamate
% 209.18/209.34  |- skos__hiddenLabel mesh__D050496 Transport Proteins, VGLUT
% 209.18/209.34  |- skos__hiddenLabel mesh__D050496 Vesicular Glutamate Transporters
% 209.18/209.34  |- skos__prefLabel mesh__D050496 Vesicular Glutamate Transport Proteins
% 209.18/209.34  |- mesh__historyNote mesh__D050496 2006   
% 209.18/209.34  |- mesh__dateCreated mesh__D050496 2005-06-30
% 209.18/209.34  |- mesh__recordMaintainer mesh__D050496 DRC
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D003042 2006
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D003042 2004
% 209.18/209.34  |- skos__altLabel mesh__D003042 Cocaine HCl
% 209.18/209.34  |- mesh__dateCreated mesh__D003042 1999-01-01
% 209.18/209.34  |- skos__prefLabel mesh__D003042 Cocaine
% 209.18/209.34  |- skos__annotation mesh__D003042
% 209.18/209.34       cocaine derivatives = COCAINE /analogs;CRACK COCAINE is available; cocaine addiction = COCAINE-RELATED DISORDERS%A%  
% 209.18/209.34  |- rdf__type mesh__D003042sskos__Concept
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D003042 2005
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D003042 2003
% 209.18/209.34  |- mesh__recordMaintainer mesh__D003042 tpw
% 209.18/209.34  |- mesh__recordOriginator mesh__D003042 NLM
% 209.18/209.34  |- mesh__publicMeSHNote mesh__D003042
% 209.18/209.34       COCAINE DERIVATIVES was see under COCAINE 1975-77; was see under TROPANES 1969-74%A%  
% 209.18/209.34  |- mesh__recordAuthorizer mesh__D003042 sjn
% 209.18/209.34  |- skos__scopeNote mesh__D003042
% 209.18/209.34       An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake.%A%    
% 209.18/209.34  |- skos__hiddenLabel mesh__D003042 Hydrochloride, Cocaine
% 209.18/209.34  |- mesh__onlineNote mesh__D003042
% 209.18/209.34       use COCAINE/analogs %26% derivatives to search COCAINE DERIVATIVES 1975-77; use TROPANES 1969-74%A%  
% 209.18/209.34  |- skos__hiddenLabel mesh__D003042 HCl, Cocaine
% 209.18/209.34  |- skos__broader mesh__D003042smesh__D014326
% 209.18/209.34  |- mesh__historyNote mesh__D003042
% 209.18/209.34       COCAINE DERIVATIVES was see under COCAINE 1975-77; was see under TROPANES 1969-74%A%  
% 209.18/209.34  |- mesh__dateRevised mesh__D003042 2002-07-03
% 209.18/209.34  |- skos__broader mesh__D014070Q000293smesh__D014070
% 209.18/209.34  |- mesh__preferredCombination mesh__D014070Q000293smesh__D018677
% 209.18/209.34  |- rdf__type mesh__D014070Q000293smesh__CompoundConcept
% 209.18/209.34  |- mesh__dateEstablished mesh__D041161 2003-01-01
% 209.18/209.34  |- skos__broader mesh__D041161smesh__D012281
% 209.18/209.34  |- mesh__historyNote mesh__D041161 2003   
% 209.18/209.34  |- skos__prefLabel mesh__D041161 Rickettsia felis
% 209.18/209.34  |- mesh__recordOriginator mesh__D041161 ags
% 209.18/209.34  |- skos__annotation mesh__D041161
% 209.18/209.34       infection: coord IM with RICKETTSIA INFECTIONS %28%IM%29%   
% 209.18/209.34  |- mesh__dateCreated mesh__D041161 2002-07-03
% 209.18/209.34  |- skos__scopeNote mesh__D041161
% 209.18/209.34       A species of gram-negative bacteria transmitted by the flea Ctenocephalides felis, and known to infect CATS, oppossums, and humans.%A%    
% 209.18/209.34  |- mesh__dateRevised mesh__D041161 2005-06-30
% 209.18/209.34  |- rdf__type mesh__D041161sskos__Concept
% 209.18/209.34  |- skos__historyNote mesh__D041161 Rickettsia %28%1990-2002%29%
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D041161 2006
% 209.18/209.34  |- mesh__recordAuthorizer mesh__D041161 sjn
% 209.18/209.34  |- mesh__publicMeSHNote mesh__D041161 2003   
% 209.18/209.34  |- mesh__recordMaintainer mesh__D041161 SYSTEM
% 209.18/209.34  |- mesh__publicMeSHNote mesh__D035922
% 209.18/209.34       2003; HEPATITIS A ANTIBODIES was indexed under HEPATITIS ANTIBODIES 1985-2002, ANTIBODIES, VIRAL 1981-1984%A%  
% 209.18/209.34  |- skos__scopeNote mesh__D035922
% 209.18/209.34       Antibodies to the HEPATITIS A ANTIGENS including antibodies to envelope, core, and non-structural proteins.%A%    
% 209.18/209.34  |- mesh__dateCreated mesh__D035922 2002-07-02
% 209.18/209.34  |- skos__broader mesh__D035922smesh__D006508
% 209.18/209.34  |- skos__altLabel mesh__D035922 Anti-HAV
% 209.18/209.34  |- skos__historyNote mesh__D035922 Hepatitis Antibodies %28%1985-2002%29%
% 209.18/209.34  |- mesh__dateRevised mesh__D035922 2005-06-30
% 209.18/209.34  |- mesh__recordOriginator mesh__D035922 jmp
% 209.18/209.34  |- skos__hiddenLabel mesh__D035922 Anti HAV
% 209.18/209.34  |- mesh__recordAuthorizer mesh__D035922 sjn
% 209.18/209.34  |- mesh__recordMaintainer mesh__D035922 ssb
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D035922 2006
% 209.18/209.34  |- mesh__dateEstablished mesh__D035922 2003-01-01
% 209.18/209.34  |- mesh__historyNote mesh__D035922
% 209.18/209.34       2003; use HEPATITIS A ANTIBODIES %28%NM%29% 1981-2002   
% 209.18/209.34  |- skos__related mesh__D035922smesh__D035921
% 209.18/209.34  |- skos__hiddenLabel mesh__D035922 Antibodies, Hepatitis A
% 209.18/209.34  |- skos__prefLabel mesh__D035922 Hepatitis A Antibodies
% 209.18/209.34  |- skos__altLabel mesh__D035922 Hepatitis A Virus Antibodies
% 209.18/209.34  |- skos__annotation mesh__D035922
% 209.18/209.34       for antibodies to human virus, coordinate IM with HEPATITIS A VIRUS, HUMAN /immunol %28%IM%29%%A%  
% 209.18/209.34  |- rdf__type mesh__D035922sskos__Concept
% 209.18/209.34  |- skos__historyNote mesh__D035922 Antibodies, Viral %28%1981-1984%29%
% 209.18/209.34  |- skos__scopeNote mesh__D002748
% 209.18/209.34       A carbamate that is used as an herbicide and as a plant growth regulator.%A%    
% 209.18/209.34  |- skos__altLabel mesh__D002748 Isopropyl N-%28%3-Chlorophenol%29%carbamate
% 209.18/209.34  |- mesh__dateEstablished mesh__D002748 1991-01-01
% 209.18/209.34  |- rdf__type mesh__D002748sskos__Concept
% 209.18/209.34  |- skos__altLabel mesh__D002748 CIPC
% 209.18/209.34  |- mesh__dateCreated mesh__D002748 1999-01-01
% 209.18/209.34  |- mesh__historyNote mesh__D002748
% 209.18/209.34       91%28%72%29%; was see under HERBICIDES, CARBAMATE 1972-90   
% 209.18/209.34  |- skos__historyNote mesh__D002748 Carbamates %28%1966-1971%29%
% 209.18/209.34  |- skos__prefLabel mesh__D002748 Chlorpropham
% 209.18/209.34  |- mesh__dateRevised mesh__D002748 2004-07-07
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D002748 2005
% 209.18/209.34  |- mesh__publicMeSHNote mesh__D002748
% 209.18/209.34       91; was see under HERBICIDES, CARBAMATE 1972-90   
% 209.18/209.34  |- mesh__recordMaintainer mesh__D002748 ssb
% 209.18/209.34  |- mesh__activeMeSHYear mesh__D002748 2006
% 209.18/209.34  |- skos__broader mesh__D002748smesh__D048448
% 209.18/209.34  |- skos__historyNote mesh__D002748 Herbicides %28%1966-1971%29%
% 209.18/209.34  |- mesh__recordAuthorizer mesh__D002748 sjn
% 209.18/209.34  |- mesh__recordOriginator mesh__D002748 NLM
% 209.18/209.34  |- skos__scopeNote mesh__D021902
% 209.18/209.34       Gram-negative, capsulated, gas-producing rods found widely in nature. Both motile and non-motile strains exist. The species is closely related to KLEBSIELLA PNEUMONIAE and is frequently associated with nosocomial infections%A%    
% 209.18/209.34  |- skos__altLabel mesh__D021902 Klebsiella aerogenes
% 209.18/209.34  |- mesh__recordOriginator mesh__D021902 jmp
% 209.18/209.34  |- skos__broader mesh__D021902smesh__D004754
% 209.18/209.34  |- skos__historyNote mesh__D021902 Klebsiella pneumoniae %28%1992-2000%29%
% 209.18/209.34  |- skos__annotation mesh__D021902
% 209.18/209.34       infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 209.18/209.34  |- skos__historyNote mesh__D021902 Enterobacter %28%1966-1991%29%
% 209.18/209.34  |- mesh__dateCreated mesh__D021902 2000-06-27
% 209.18/209.34  |- skos__altLabel mesh__D021902 Aerobacter aerogenes
% 209.18/209.34  |- mesh__dateEstablished mesh__D021902 2001-01-01
% 209.18/209.35  |- skos__altLabel mesh__D021902 Klebsiella mobilus
% 209.18/209.35  |- mesh__recordMaintainer mesh__D021902 SYSTEM
% 209.18/209.35  |- skos__prefLabel mesh__D021902 Enterobacter aerogenes
% 209.18/209.35  |- skos__related mesh__D021902smesh__D007711
% 209.18/209.35  |- mesh__publicMeSHNote mesh__D021902
% 209.18/209.35       2001; for AEROBACTER AEROGENES see KLEBSIELLA PNEUMONIAE 1992-2000, ENTEROBACTER 1976-1991, %26% AEROBACTER AEROGENES 1963-1975%A%  
% 209.18/209.35  |- mesh__historyNote mesh__D021902
% 209.18/209.35       2001; for AEROBACTER AEROGENES use KLEBSIELLA PNEUMONIAE 1992-2000 %26% ENTEROBACTER 1963-1991%A%  
% 209.18/209.35  |- mesh__dateRevised mesh__D021902 2005-06-30
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D021902 2006
% 209.18/209.35  |- rdf__type mesh__D021902sskos__Concept
% 209.18/209.35  |- mesh__recordAuthorizer mesh__D021902 sjn
% 209.18/209.35  |- skos__broader mesh__D007433smesh__D007434
% 209.18/209.35  |- rdf__type mesh__D007433sskos__Concept
% 209.18/209.35  |- mesh__recordOriginator mesh__D007433 NLM
% 209.18/209.35  |- skos__prefLabel mesh__D007433 Intrauterine Device Expulsion
% 209.18/209.35  |- skos__historyNote mesh__D007433 Intrauterine Devices %28%1967-1974%29%
% 209.18/209.35  |- mesh__recordAuthorizer mesh__D007433 sjn
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D007433 2005
% 209.18/209.35  |- mesh__recordMaintainer mesh__D007433 lkt
% 209.18/209.35  |- skos__altLabel mesh__D007433 IUD Expulsion
% 209.18/209.35  |- skos__scopeNote mesh__D007433
% 209.18/209.35       Spontaneous loss of INTRAUTERINE DEVICES from the UTERUS.%A%    
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D007433 2006
% 209.18/209.35  |- skos__annotation mesh__D007433 DF: IUD EXPULSION   
% 209.18/209.35  |- skos__hiddenLabel mesh__D007433 Intrauterine Device Expulsions
% 209.18/209.35  |- skos__broader mesh__D007433smesh__D004868
% 209.18/209.35  |- mesh__dateCreated mesh__D007433 1974-11-19
% 209.18/209.35  |- mesh__historyNote mesh__D007433
% 209.18/209.35       78%28%75%29%; was see under INTRAUTERINE DEVICES 1975-77   
% 209.18/209.35  |- mesh__publicMeSHNote mesh__D007433
% 209.18/209.35       78; was see under INTRAUTERINE DEVICES 1975-77   
% 209.18/209.35  |- mesh__dateEstablished mesh__D007433 1978-01-01
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D007433 2004
% 209.18/209.35  |- mesh__dateRevised mesh__D007433 2003-07-09
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D012378 2006
% 209.18/209.35  |- mesh__recordOriginator mesh__D012378 NLM
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D012378 2005
% 209.18/209.35  |- mesh__dateCreated mesh__D012378 1999-01-01
% 209.18/209.35  |- skos__scopeNote mesh__D012378
% 209.18/209.35       Substances used to destroy or inhibit the action of rats, mice, or other rodents.%A%    
% 209.18/209.35  |- skos__broader mesh__D012378smesh__D010575
% 209.18/209.35  |- rdf__type mesh__D012378sskos__Concept
% 209.18/209.35  |- mesh__dateRevised mesh__D012378 2003-07-09
% 209.18/209.35  |- mesh__recordMaintainer mesh__D012378 ssb
% 209.18/209.35  |- skos__prefLabel mesh__D012378 Rodenticides
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D012378 2004
% 209.18/209.35  |- mesh__recordAuthorizer mesh__D012378 sjn
% 209.18/209.35  |- skos__annotation mesh__D012378
% 209.18/209.35       specify rodent if pertinent but not with /drug eff   
% 209.18/209.35  |- mesh__dateRevised mesh__D017861 2005-06-30
% 209.18/209.35  |- mesh__recordOriginator mesh__D017861 PXP
% 209.18/209.35  |- skos__prefLabel mesh__D017861 Porphyromonas
% 209.18/209.35  |- mesh__historyNote mesh__D017861 94   
% 209.18/209.35  |- mesh__recordMaintainer mesh__D017861 SYSTEM
% 209.18/209.35  |- skos__broader mesh__D017861smesh__D001438
% 209.18/209.35  |- mesh__dateEstablished mesh__D017861 1994-01-01
% 209.18/209.35  |- mesh__recordAuthorizer mesh__D017861 sjn
% 209.18/209.35  |- skos__scopeNote mesh__D017861
% 209.18/209.35       A genus of gram-negative, anaerobic, nonsporeforming, nonmotile rods or coccobacilli. Organisms in this genus had originally been classified as members of the BACTEROIDES genus but overwhelming biochemical and chemical findings indicated the need to separate them from other Bacteroides species, and hence, this new genus was created.%A%    
% 209.18/209.35  |- mesh__dateCreated mesh__D017861 1993-02-16
% 209.18/209.35  |- skos__annotation mesh__D017861
% 209.18/209.35       infection: coord IM with BACTEROIDACEAE INFECTIONS %28%IM%29%   
% 209.18/209.35  |- skos__historyNote mesh__D017861 Bacteroides %28%1988-1993%29%
% 209.18/209.35  |- rdf__type mesh__D017861sskos__Concept
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017861 2006
% 209.18/209.35  |- mesh__publicMeSHNote mesh__D017861 94   
% 209.18/209.35  |- mesh__recordOriginator mesh__D017063 PLS
% 209.18/209.35  |- skos__hiddenLabel mesh__D017063 Assessment, Outcome %28%Health Care%29%
% 209.18/209.35  |- skos__altLabel mesh__D017063 Assessment, Outcomes
% 209.18/209.35  |- mesh__recordAuthorizer mesh__D017063 ags
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017063 2001
% 209.18/209.35  |- skos__hiddenLabel mesh__D017063 Research, Outcomes
% 209.18/209.35  |- skos__hiddenLabel mesh__D017063 Assessments, Patient Outcome
% 209.18/209.35  |- skos__broader mesh__D017063smesh__D010043
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017063 2005
% 209.18/209.35  |- skos__altLabel mesh__D017063 Assessment, Patient Outcomes
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017063 1998
% 209.18/209.35  |- skos__hiddenLabel mesh__D017063 Study, Outcome
% 209.18/209.35  |- mesh__dateRevised mesh__D017063 1999-12-16
% 209.18/209.35  |- skos__hiddenLabel mesh__D017063 Assessments, Outcome %28%Health Care%29%
% 209.18/209.35  |- skos__hiddenLabel mesh__D017063 Measures, Outcome
% 209.18/209.35  |- skos__hiddenLabel mesh__D017063 Assessments, Patient Outcomes
% 209.18/209.35  |- skos__historyNote mesh__D017063
% 209.18/209.35       Outcome and Process Assessment %28%Health Care%29% %28%1979-1991%29%
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017063 2000A
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017063 2006
% 209.18/209.35  |- rdf__type mesh__D017063sskos__Concept
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017063 1999
% 209.18/209.35  |- skos__hiddenLabel mesh__D017063 Studies, Outcome
% 209.18/209.35  |- skos__altLabel mesh__D017063 Assessment, Patient Outcome
% 209.18/209.35  |- skos__scopeNote mesh__D017063
% 209.18/209.35       Research aimed at assessing the quality and effectiveness of health care as measured by the attainment of a specified end result or outcome. Measures include parameters such as improved health, lowered morbidity or mortality, and improvement of abnormal states %28%such as elevated blood pressure%29%.%A%    
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017063 2002
% 209.18/209.35  |- skos__annotation mesh__D017063
% 209.18/209.35       note category: for admin aspects of patient assessment; outcome only: for outcome assessment with process assessment, OUTCOME AND PROCESS ASSESSMENT %28%HEALTH CARE%29% and TREATMENT OUTCOME are available; DF: OUTCOME ASSESS%A%  
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017063 2003
% 209.18/209.35  |- skos__hiddenLabel mesh__D017063 Patient Outcomes Assessments
% 209.18/209.35  |- skos__hiddenLabel mesh__D017063 Outcomes Assessment, Patient
% 209.18/209.35  |- skos__hiddenLabel mesh__D017063 Assessments, Outcomes
% 209.18/209.35  |- mesh__historyNote mesh__D017063
% 209.18/209.35       92; PATIENT OUTCOME ASSESSMENT was see OUTCOME AND PROCESS ASSESSMENT %28%HEALTH CARE%29% 1979-91%A%  
% 209.18/209.35  |- skos__altLabel mesh__D017063 Outcomes Assessment
% 209.18/209.35  |- skos__hiddenLabel mesh__D017063 Outcomes Assessments
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017063 2004
% 209.18/209.35  |- skos__hiddenLabel mesh__D017063 Outcome Assessments, Patient
% 209.18/209.35  |- skos__hiddenLabel mesh__D017063 Patient Outcome Assessments
% 209.18/209.35  |- skos__altLabel mesh__D017063 Outcome Assessment, Patient
% 209.18/209.35  |- skos__hiddenLabel mesh__D017063 Measure, Outcome
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017063 2000
% 209.18/209.35  |- mesh__recordMaintainer mesh__D017063 ags
% 209.18/209.35  |- skos__hiddenLabel mesh__D017063 Outcome Study
% 209.18/209.35  |- skos__hiddenLabel mesh__D017063 Outcome Assessments %28%Health Care%29%
% 209.18/209.35  |- skos__hiddenLabel mesh__D017063 Patient Outcomes Assessment
% 209.18/209.35  |- skos__prefLabel mesh__D017063 Outcome Assessment %28%Health Care%29%
% 209.18/209.35  |- skos__altLabel mesh__D017063 Outcomes Assessments, Patient
% 209.18/209.35  |- mesh__dateEstablished mesh__D017063 1992-01-01
% 209.18/209.35  |- mesh__publicMeSHNote mesh__D017063
% 209.18/209.35       92; PATIENT OUTCOME ASSESSMENT was see OUTCOME AND PROCESS ASSESSMENT %28%HEALTH CARE%29% 1979-91%A%  
% 209.18/209.35  |- mesh__onlineNote mesh__D017063
% 209.18/209.35       use OUTCOME AND PROCESS ASSESSMENT %28%HEALTH CARE%29% to search PATIENT OUTCOME ASSESSMENT 1979-91%A%  
% 209.18/209.35  |- skos__hiddenLabel mesh__D017063 Outcome Measure
% 209.18/209.35  |- mesh__dateCreated mesh__D017063 1991-06-20
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D003841 2006
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D003841 2000
% 209.18/209.35  |- skos__hiddenLabel mesh__D003841 Deoxyribonucleoside, Cytosine
% 209.18/209.35  |- skos__altLabel mesh__D003841 CDR
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D003841 2001
% 209.18/209.35  |- skos__altLabel mesh__D003841 Cytosine Deoxyriboside
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D003841 1996
% 209.18/209.35  |- mesh__recordOriginator mesh__D003841 NLM
% 209.18/209.35  |- mesh__dateCreated mesh__D003841 1999-01-01
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D003841 2002
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D003841 1997
% 209.18/209.35  |- skos__altLabel mesh__D003841 Cytosine Deoxyribonucleoside
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D003841 2003
% 209.18/209.35  |- rdf__type mesh__D003841sskos__Concept
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D003841 1998
% 209.18/209.35  |- skos__historyNote mesh__D003841 Nucleosides %28%1966-1972%29%
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D003841 1993
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D003841 2004
% 209.18/209.35  |- mesh__recordMaintainer mesh__D003841 TGC
% 209.18/209.35  |- skos__prefLabel mesh__D003841 Deoxycytidine
% 209.18/209.35  |- skos__broader mesh__D003841smesh__D003853
% 209.18/209.35  |- mesh__dateRevised mesh__D003841 1992-05-13
% 209.18/209.35  |- mesh__historyNote mesh__D003841 75%28%73%29%   
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D003841 1994
% 209.18/209.35  |- skos__hiddenLabel mesh__D003841 Deoxyriboside, Cytosine
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D003841 1999
% 209.18/209.35  |- mesh__recordAuthorizer mesh__D003841 PLS
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D003841 2005
% 209.18/209.35  |- mesh__publicMeSHNote mesh__D003841 75   
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D003841 1995
% 209.18/209.35  |- skos__broader mesh__D003841smesh__D003562
% 209.18/209.35  |- skos__prefLabel mesh__D050497 Stillbirth
% 209.18/209.35  |- skos__scopeNote mesh__D050497
% 209.18/209.35       The event that a FETUS is born dead or stillborn.     
% 209.18/209.35  |- mesh__historyNote mesh__D050497
% 209.18/209.35       2006; use PREGNANCY OUTCOME 2004-2005, use FETAL DEATH 1963-2003%A%  
% 209.18/209.35  |- rdf__type mesh__D050497sskos__Concept
% 209.18/209.35  |- mesh__dateCreated mesh__D050497 2005-06-30
% 209.18/209.35  |- mesh__recordMaintainer mesh__D050497 lkt
% 209.18/209.35  |- skos__hiddenLabel mesh__D050497 Stillbirths
% 209.18/209.35  |- skos__historyNote mesh__D050497 Fetal Death %28%1965-2003%29%
% 209.18/209.35  |- mesh__recordOriginator mesh__D050497 lkt
% 209.18/209.35  |- skos__historyNote mesh__D050497 Pregnancy Outcome %28%2004-2005%29%
% 209.18/209.35  |- mesh__recordAuthorizer mesh__D050497 sjn
% 209.18/209.35  |- mesh__dateEstablished mesh__D050497 2006-01-01
% 209.18/209.35  |- skos__historyNote mesh__D050497 Pregnancy %28%1965-2003%29%
% 209.18/209.35  |- skos__broader mesh__D050497smesh__D011256
% 209.18/209.35  |- skos__related mesh__D050497smesh__D005313
% 209.18/209.35  |- mesh__publicMeSHNote mesh__D050497
% 209.18/209.35       2006; see PREGNANCY OUTCOME 2004-2005, see FETAL DEATH 1963-2003%A%  
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D050497 2006
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D003043 2004
% 209.18/209.35  |- mesh__dateRevised mesh__D003043 2005-07-21
% 209.18/209.35  |- rdf__type mesh__D003043sskos__Concept
% 209.18/209.35  |- mesh__historyNote mesh__D003043 77   
% 209.18/209.35  |- mesh__dateCreated mesh__D003043 1976-05-19
% 209.18/209.35  |- skos__annotation mesh__D003043
% 209.18/209.35       do not confuse with NEOPLASMS, MULTIPLE PRIMARY; Manual 24.4.1.14%A%  
% 209.18/209.35  |- mesh__recordOriginator mesh__D003043 VDK
% 209.18/209.35  |- skos__broader mesh__D003043smesh__D009385
% 209.18/209.35  |- skos__scopeNote mesh__D003043
% 209.18/209.35       The combination of two or more different factors in the production of cancer.%A%    
% 209.18/209.35  |- mesh__publicMeSHNote mesh__D003043 77   
% 209.18/209.35  |- skos__hiddenLabel mesh__D003043 Cocarcinogeneses
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D003043 2006A
% 209.18/209.35  |- skos__historyNote mesh__D003043 Neoplasms %28%1966-1976%29%
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D003043 2006
% 209.18/209.35  |- mesh__dateEstablished mesh__D003043 1977-01-01
% 209.18/209.35  |- skos__prefLabel mesh__D003043 Cocarcinogenesis
% 209.18/209.35  |- mesh__recordMaintainer mesh__D003043 ags
% 209.18/209.35  |- mesh__recordAuthorizer mesh__D003043 ags
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D003043 2005
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D016769 2002
% 209.18/209.35  |- skos__annotation mesh__D016769
% 209.18/209.35       not used for indexing      CATALOG: do not use   
% 209.18/209.35  |- skos__prefLabel mesh__D016769 Embolism and Thrombosis
% 209.18/209.35  |- mesh__dateCreated mesh__D016769 1991-08-23
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D016769 2006
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D016769 2005
% 209.18/209.35  |- rdf__type mesh__D016769sskos__Concept
% 209.18/209.35  |- mesh__historyNote mesh__D016769 98; use explode 1992-97   
% 209.18/209.35  |- mesh__dateEstablished mesh__D016769 1998-01-01
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D016769 2001
% 209.18/209.35  |- mesh__recordOriginator mesh__D016769 AGS
% 209.18/209.35  |- mesh__recordMaintainer mesh__D016769 MSR
% 209.18/209.35  |- mesh__recordAuthorizer mesh__D016769 SJN
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D016769 1999
% 209.18/209.35  |- skos__scopeNote mesh__D016769
% 209.18/209.35       A collective term for diseases characterized by the formation, development, or presence of a thrombus %28%THROMBOSIS%29% and the blocking of a vessel by the thrombus brought to its site by the blood current %28%EMBOLISM%29%. %28%From Dorland, 28th ed%29%%A%    
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D016769 2000
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D016769 2004
% 209.18/209.35  |- mesh__publicMeSHNote mesh__D016769 98   
% 209.18/209.35  |- skos__hiddenLabel mesh__D016769 Thrombosis and Embolism
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D016769 2003
% 209.18/209.35  |- skos__broader mesh__D016769smesh__D014652
% 209.18/209.35  |- mesh__dateRevised mesh__D016769 1998-06-10
% 209.18/209.35  |- mesh__dateEstablished mesh__D041162 2003-01-01
% 209.18/209.35  |- rdf__type mesh__D041162sskos__Concept
% 209.18/209.35  |- skos__historyNote mesh__D041162 Staphylococcus %28%1981-2002%29%
% 209.18/209.35  |- mesh__historyNote mesh__D041162 2003   
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D041162 2006
% 209.18/209.35  |- mesh__recordOriginator mesh__D041162 ags
% 209.18/209.35  |- mesh__dateCreated mesh__D041162 2002-07-03
% 209.18/209.35  |- mesh__publicMeSHNote mesh__D041162 2003   
% 209.18/209.35  |- mesh__recordMaintainer mesh__D041162 SYSTEM
% 209.18/209.35  |- mesh__dateRevised mesh__D041162 2005-06-30
% 209.18/209.35  |- skos__scopeNote mesh__D041162
% 209.18/209.35       A species of STAPHYLOCOCCUS found on the skin of humans %28%and non-human primates%29%, often causing hospital-acquired infections %28%CROSS INFECTION%29%.%A%    
% 209.18/209.35  |- skos__broader mesh__D041162smesh__D013210
% 209.18/209.35  |- skos__annotation mesh__D041162
% 209.18/209.35       infection: coord IM with STAPHYLOCOCCAL INFECTIONS %28%IM%29%; DF: STAPH HAEMOLYTICUS%A%  
% 209.18/209.35  |- mesh__recordAuthorizer mesh__D041162 sjn
% 209.18/209.35  |- skos__prefLabel mesh__D041162 Staphylococcus haemolyticus
% 209.18/209.35  |- skos__altLabel mesh__D035923 Hepatitis D Antigen
% 209.18/209.35  |- skos__historyNote mesh__D035923 Antigens, Viral %28%1988-1995%29%
% 209.18/209.35  |- mesh__publicMeSHNote mesh__D035923
% 209.18/209.35       2003; HEPATITIS D ANTIGENS %28%now HEPATITUS DELTA ANTIGENS%29% was indexed under HEPATITIS ANTIGENS 1996-2002, ANTIGENS, VIRAL 1988-1996 %26% HEPATITIS B ANTIGENS 1981-1987%A%  
% 209.18/209.35  |- skos__altLabel mesh__D035923 delta Antigen
% 209.18/209.35  |- skos__broader mesh__D035923smesh__D018963
% 209.18/209.35  |- skos__hiddenLabel mesh__D035923 Antigen, Hepatitis D
% 209.18/209.35  |- skos__altLabel mesh__D035923 Hepatitis D Antigens
% 209.18/209.35  |- skos__altLabel mesh__D035923 HDAg
% 209.18/209.35  |- skos__scopeNote mesh__D035923
% 209.18/209.35       Antigens produced by various strains of HEPATITIS D VIRUS.%A%    
% 209.18/209.35  |- mesh__dateCreated mesh__D035923 2002-07-02
% 209.18/209.35  |- mesh__historyNote mesh__D035923
% 209.18/209.35       2003; use HEPATITIS DELTA ANTIGENS %28%NM%29% 1981-2002   
% 209.18/209.35  |- rdf__type mesh__D035923sskos__Concept
% 209.18/209.35  |- skos__historyNote mesh__D035923 Hepatitis Antigens %28%1996-2002%29%
% 209.18/209.35  |- skos__hiddenLabel mesh__D035923 Antigens, Hepatitis D
% 209.18/209.35  |- mesh__dateRevised mesh__D035923 2005-06-30
% 209.18/209.35  |- skos__hiddenLabel mesh__D035923 Antigens, Hepatitis delta
% 209.18/209.35  |- skos__hiddenLabel mesh__D035923 Antigen, delta
% 209.18/209.35  |- mesh__recordOriginator mesh__D035923 jmp
% 209.18/209.35  |- skos__prefLabel mesh__D035923 Hepatitis delta Antigens
% 209.18/209.35  |- skos__historyNote mesh__D035923 Hepatitis B Antigens %28%1981-1987%29%
% 209.18/209.35  |- mesh__dateEstablished mesh__D035923 2003-01-01
% 209.18/209.35  |- mesh__recordAuthorizer mesh__D035923 sjn
% 209.18/209.35  |- mesh__recordMaintainer mesh__D035923 ssb
% 209.18/209.35  |- skos__hiddenLabel mesh__D035923 delta Antigens, Hepatitis
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D035923 2006
% 209.18/209.35  |- skos__prefLabel mesh__D002749 Chlorprothixene
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D002749 2001
% 209.18/209.35  |- mesh__recordAuthorizer mesh__D002749 sjn
% 209.18/209.35  |- mesh__recordOriginator mesh__D002749 NLM
% 209.18/209.35  |- mesh__dateCreated mesh__D002749 1999-01-01
% 209.18/209.35  |- mesh__dateRevised mesh__D002749 2000-06-22
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D002749 2005
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D002749 2002
% 209.18/209.35  |- skos__altLabel mesh__D002749 Chlorprotixen
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D002749 2006
% 209.18/209.35  |- mesh__recordMaintainer mesh__D002749 TWD
% 209.18/209.35  |- skos__broader mesh__D002749smesh__D013892
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D002749 2003
% 209.18/209.35  |- skos__scopeNote mesh__D002749
% 209.18/209.35       A thioxanthine with effects similar to the phenothiazine antipsychotics.%A%    
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D002749 2004
% 209.18/209.35  |- rdf__type mesh__D002749sskos__Concept
% 209.18/209.35  |- rdf__type mesh__D013471sskos__Concept
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D013471 2004
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D013471 1994
% 209.18/209.35  |- skos__prefLabel mesh__D013471 Sunburn
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D013471 2000
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D013471 2006
% 209.18/209.35  |- skos__hiddenLabel mesh__D013471 Sunburns
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D013471 2003
% 209.18/209.35  |- mesh__dateCreated mesh__D013471 1999-01-01
% 209.18/209.35  |- mesh__recordMaintainer mesh__D013471 PLS
% 209.18/209.35  |- skos__broader mesh__D013471smesh__D010787
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D013471 2005
% 209.18/209.35  |- skos__annotation mesh__D013471
% 209.18/209.35       /prev: consider also SUNSCREENING AGENTS   
% 209.18/209.35  |- mesh__dateRevised mesh__D013471 1992-05-22
% 209.18/209.35  |- mesh__recordAuthorizer mesh__D013471 PLS
% 209.18/209.35  |- skos__broader mesh__D013471smesh__D002056
% 209.18/209.35  |- skos__scopeNote mesh__D013471
% 209.18/209.35       An injury to the skin causing erythema, tenderness, and sometimes blistering and resulting from excessive exposure to the sun. The reaction is produced by the ultraviolet radiation in sunlight.%A%    
% 209.18/209.35  |- skos__related mesh__D013471smesh__D013473
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D013471 1997
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D013471 2002
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D013471 1999
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D013471 1993
% 209.18/209.35  |- mesh__recordOriginator mesh__D013471 NLM
% 209.18/209.35  |- skos__related mesh__D013471smesh__D013474
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D013471 1996
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D013471 2001
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D013471 1995
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D013471 1998
% 209.18/209.35  |- skos__broader mesh__D021903smesh__D021901
% 209.18/209.35  |- skos__prefLabel mesh__D021903 DNA, Ribosomal Spacer
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D021903 2003
% 209.18/209.35  |- skos__scopeNote mesh__D021903
% 209.18/209.35       The intergenic DNA segments that are between the ribosomal RNA genes %28%internal transcribed spacers%29% and between the tandemly repeated units of rDNA %28%external transcribed spacers and nontranscribed spacers%29%.%A%    
% 209.18/209.35  |- mesh__dateCreated mesh__D021903 2000-06-22
% 209.18/209.35  |- mesh__dateEstablished mesh__D021903 2001-01-01
% 209.18/209.35  |- mesh__historyNote mesh__D021903 2001   
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D021903 2004
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D021903 2001
% 209.18/209.35  |- skos__historyNote mesh__D021903 RNA, Ribosomal %28%1984-2000%29%
% 209.18/209.35  |- skos__annotation mesh__D021903
% 209.18/209.35       DNA, RIBOSOMAL and DNA, SPACER see DNA, INTERGENIC are also available%A%  
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D021903 2005
% 209.18/209.35  |- skos__altLabel mesh__D021903 Ribosomal Spacer DNA
% 209.18/209.35  |- skos__broader mesh__D021903smesh__D004275
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D021903 2002
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D021903 2006
% 209.18/209.35  |- rdf__type mesh__D021903sskos__Concept
% 209.18/209.35  |- skos__historyNote mesh__D021903 DNA, Ribosomal %28%1984-2000%29%
% 209.18/209.35  |- skos__hiddenLabel mesh__D021903 Spacer DNA, Ribosomal
% 209.18/209.35  |- mesh__publicMeSHNote mesh__D021903 2001   
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Intrauterine Contraceptive Device
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D007434 2001
% 209.18/209.35  |- mesh__dateRevised mesh__D007434 1999-11-08
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Migration, IUD
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Intrauterine Contraceptive Devices
% 209.18/209.35  |- rdf__type mesh__D007434sskos__Concept
% 209.18/209.35  |- mesh__dateEstablished mesh__D007434 1967-01-01
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Intrauterine Pessaries
% 209.18/209.35  |- skos__altLabel mesh__D007434 IUD Migration
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Intrauterine Device
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Migrations, Intrauterine Device
% 209.18/209.35  |- mesh__recordMaintainer mesh__D007434 adp
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 IUD Migrations
% 209.18/209.35  |- skos__altLabel mesh__D007434 IUDs
% 209.18/209.35  |- mesh__recordOriginator mesh__D007434 NLM
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D007434 2003
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Pessary, Intrauterine
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Intracervical Pessary
% 209.18/209.35  |- mesh__dateCreated mesh__D007434 1999-01-01
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Device, Intrauterine
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D007434 2002
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Intracervical Pessaries
% 209.18/209.35  |- skos__annotation mesh__D007434
% 209.18/209.35       coord IM with material of which device is made %28%NIM%29%; pregnancy despite use of IUD = IUD with no qualif, not IUD /adv eff; DF: IUD%A%  
% 209.18/209.35  |- skos__broader mesh__D007434smesh__D003274
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Migrations, IUD
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D007434 2004
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D007434 2005
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Devices, Intrauterine Contraceptive
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Migration, Intrauterine Device
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Device Migrations, Intrauterine
% 209.18/209.35  |- skos__altLabel mesh__D007434 IUD, Unmedicated
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Contraceptive Device, Intrauterine
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Pessary, Intracervical
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D007434 2006
% 209.18/209.35  |- mesh__historyNote mesh__D007434 67   
% 209.18/209.35  |- skos__prefLabel mesh__D007434 Intrauterine Devices
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Devices, Intrauterine
% 209.18/209.35  |- skos__scopeNote mesh__D007434
% 209.18/209.35       Contraceptive devices placed high in the uterine fundus with a string extending from the device through the cervical as into the vagina. %28%UMDNS, 1999%29%%A%    
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Intrauterine Pessary
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D007434 2000
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Device Migration, Intrauterine
% 209.18/209.35  |- mesh__recordAuthorizer mesh__D007434 sjn
% 209.18/209.35  |- skos__altLabel mesh__D007434 Contraceptive Devices, Intrauterine
% 209.18/209.35  |- skos__historyNote mesh__D007434 Contraceptive Devices %28%1966%29%
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Unmedicated IUD
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Intrauterine Device Migrations
% 209.18/209.35  |- mesh__publicMeSHNote mesh__D007434 67   
% 209.18/209.35  |- skos__hiddenLabel mesh__D007434 Device, Intrauterine Contraceptive
% 209.18/209.35  |- skos__altLabel mesh__D007434 IUD
% 209.18/209.35  |- skos__broader mesh__D017862smesh__D004267
% 209.18/209.35  |- mesh__publicMeSHNote mesh__D017862 94   
% 209.18/209.35  |- mesh__historyNote mesh__D017862 94   
% 209.18/209.35  |- skos__altLabel mesh__D017862 Algal Viruses
% 209.18/209.35  |- skos__hiddenLabel mesh__D017862 Algal Virus
% 209.18/209.35  |- skos__annotation mesh__D017862
% 209.18/209.35       a family of plant viruses infecting algae; from PHYCOs %28%Greek for alga%29% DNA viruses%A%  
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017862 1997
% 209.18/209.35  |- skos__broader mesh__D017862smesh__D010942
% 209.18/209.35  |- skos__hiddenLabel mesh__D017862 Virus, Algal
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017862 1999
% 209.18/209.35  |- mesh__recordOriginator mesh__D017862 AGS
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017862 2002
% 209.18/209.35  |- skos__hiddenLabel mesh__D017862 Viruses, Algal
% 209.18/209.35  |- mesh__dateCreated mesh__D017862 1993-06-04
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017862 1998
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017862 2004
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017862 2001
% 209.18/209.35  |- mesh__recordAuthorizer mesh__D017862 PLS
% 209.18/209.35  |- mesh__dateRevised mesh__D017862 1996-06-10
% 209.18/209.35  |- skos__prefLabel mesh__D017862 Phycodnaviridae
% 209.18/209.35  |- rdf__type mesh__D017862sskos__Concept
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017862 2006
% 209.18/209.35  |- mesh__dateEstablished mesh__D017862 1994-01-01
% 209.18/209.35  |- skos__scopeNote mesh__D017862
% 209.18/209.35       A family of DNA plant viruses that infect eukaryotic algae.%A%    
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017862 2003
% 209.18/209.35  |- mesh__recordMaintainer mesh__D017862 AGS
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017862 2005
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017862 2000
% 209.18/209.35  |- mesh__historyNote mesh__D017064
% 209.18/209.35       92; was see OUTCOME AND PROCESS ASSESSMENT %28%HEALTH CARE%29% 1979-91%A%  
% 209.18/209.35  |- mesh__onlineNote mesh__D017064
% 209.18/209.35       use OUTCOME AND PROCESS ASSESSMENT %28%HEALTH CARE%29% to search PROCESS ASSESSMENT 1979-91%A%  
% 209.18/209.35  |- mesh__dateRevised mesh__D017064 2004-07-13
% 209.18/209.35  |- skos__prefLabel mesh__D017064 Process Assessment %28%Health Care%29%
% 209.18/209.35  |- mesh__activeMeSHYear mesh__D017064 2005
% 209.18/209.35  |- skos__hiddenLabel mesh__D017064 Assessments, Process
% 209.18/209.35  |- rdf__type mesh__D017064sskos__Concept
% 209.18/209.35  |- skos__broader mesh__D017064smesh__D010043
% 209.18/209.35  |- mesh__dateEstablished mesh__D017064 1992-01-01
% 209.18/209.35  |- skos__hiddenLabel mesh__D017064 Process Measure
% 209.18/209.35  |- skos__hiddenLabel mesh__D017064 Assessment, Process %28%Health Care%29%
% 209.18/209.35  |- skos__hiddenLabel mesh__D017064 Measure, Process
% 209.18/209.35  |- mesh__recordOriginator mesh__D017064 PLS
% 209.18/209.35  |- skos__hiddenLabel mesh__D017064 Assessments, Process %28%Health Care%29%
% 209.18/209.35  |- skos__hiddenLabel mesh__D017064 Process Assessments
% 209.18/209.35  |- skos__hiddenLabel mesh__D017064 Measures, Process
% 209.18/209.35  |- skos__annotation mesh__D017064
% 209.18/209.35       note category; process only: for outcome assessment with process assessment, OUTCOME AND PROCESS ASSESSMENT %28%HEALTH CARE%29% is available; DF: PROCESS ASSESS%A%  
% 209.18/209.35  |- mesh__publicMeSHNote mesh__D017064
% 209.18/209.35       92; was see OUTCOME AND PROCESS ASSESSMENT %28%HEALTH CARE%29% 1979-91%A%  
% 209.18/209.35  |- skos__hiddenLabel mesh__D017064 Process Assessments %28%Health Care%29%
% 209.18/209.35  |- mesh__recordMaintainer mesh__D017064 sjn
% 209.18/209.35  |- mesh__recordAuthorizer mesh__D017064 sjn
% 209.18/209.35  |- skos__scopeNote mesh__D017064
% 209.18/209.35       An evaluation procedure that focuses on how care is delivered, based on the premise that there are standards of performance for activities undertaken in delivering patient care, in which the specific actions taken, events occurring, and human interactions are compared with accepted standards.%A%    
% 209.18/209.36  |- skos__altLabel mesh__D017064 Assessment, Process
% 209.18/209.36  |- mesh__dateCreated mesh__D017064 1991-06-20
% 209.18/209.36  |- skos__hiddenLabel mesh__D017064 Process Assessment
% 209.18/209.36  |- skos__historyNote mesh__D017064
% 209.18/209.36       Outcome and Process Assessment %28%Health Care%29% %28%1979-1991%29%
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D017064 2006
% 209.18/209.36  |- skos__broader mesh__D003842smesh__D017853
% 209.18/209.36  |- mesh__dateRevised mesh__D003842 2003-07-09
% 209.18/209.36  |- skos__hiddenLabel mesh__D003842 Kinase, Deoxycytidine
% 209.18/209.36  |- skos__prefLabel mesh__D003842 Deoxycytidine Kinase
% 209.18/209.36  |- skos__historyNote mesh__D003842 Deoxycytidine %28%1973-1978%29%
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D003842 2006
% 209.18/209.36  |- mesh__recordOriginator mesh__D003842 RLS
% 209.18/209.36  |- mesh__historyNote mesh__D003842
% 209.18/209.36       91%28%79%29%; was see under PHOSPHOTRANSFERASES, ATP 1979-90   
% 209.18/209.36  |- mesh__dateEstablished mesh__D003842 1991-01-01
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D003842 2005
% 209.18/209.36  |- mesh__dateCreated mesh__D003842 1977-12-09
% 209.18/209.36  |- skos__scopeNote mesh__D003842
% 209.18/209.36       An enzyme that catalyzes reversibly the phosphorylation of deoxycytidine with the formation of a nucleoside diphosphate and deoxycytidine monophosphate. Cytosine arabinoside can also act as an acceptor. All natural nucleoside triphosphates, except deoxycytidine triphosphate, can act as donors. The enzyme is induced by some viruses, particularly the herpes simplex virus %28%HERPESVIRUS HOMINIS%29%. EC 2.7.1.74.%A%    
% 209.18/209.36  |- mesh__publicMeSHNote mesh__D003842
% 209.18/209.36       91; was see under PHOSPHOTRANSFERASES, ATP 1979-90   
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D003842 2004
% 209.18/209.36  |- mesh__recordAuthorizer mesh__D003842 sjn
% 209.18/209.36  |- rdf__type mesh__D003842sskos__Concept
% 209.18/209.36  |- skos__historyNote mesh__D003842 Phosphotransferases %28%1966-1978%29%
% 209.18/209.36  |- mesh__recordMaintainer mesh__D003842 ssb
% 209.18/209.36  |- skos__hiddenLabel mesh__D050498 Live Births
% 209.18/209.36  |- rdf__type mesh__D050498sskos__Concept
% 209.18/209.36  |- mesh__dateEstablished mesh__D050498 2006-01-01
% 209.18/209.36  |- mesh__recordOriginator mesh__D050498 lkt
% 209.18/209.36  |- mesh__publicMeSHNote mesh__D050498
% 209.18/209.36       2006; see PREGNANCY OUTCOME 2004-2005   
% 209.18/209.36  |- skos__broader mesh__D050498smesh__D011256
% 209.18/209.36  |- mesh__dateCreated mesh__D050498 2005-06-30
% 209.18/209.36  |- skos__scopeNote mesh__D050498
% 209.18/209.36       The event that a FETUS is born alive with heartbeats or RESPIRATION regardless of GESTATIONAL AGE. Such a newborn is called a liveborn INFANT.%A%    
% 209.18/209.36  |- skos__historyNote mesh__D050498 Pregnancy Outcome %28%2004-2005%29%
% 209.18/209.36  |- mesh__historyNote mesh__D050498 2006; use PREGNANCY OUTCOME 2004-2005   
% 209.18/209.36  |- mesh__recordAuthorizer mesh__D050498 sjn
% 209.18/209.36  |- mesh__recordMaintainer mesh__D050498 lkt
% 209.18/209.36  |- skos__prefLabel mesh__D050498 Live Birth
% 209.18/209.36  |- skos__historyNote mesh__D050498 Pregnancy %28%1967-2003%29%
% 209.18/209.36  |- skos__annotation mesh__D050498
% 209.18/209.36       use only in relation to the outcome of the pregnancy; use BIRTH for the physiologic process of giving birth%A%  
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D050498 2006
% 209.18/209.36  |- skos__historyNote mesh__D050498 Infant, Newborn %28%1967-2003%29%
% 209.18/209.36  |- mesh__publicMeSHNote mesh__D003044 79; was see under SPOROZOA 1963-78   
% 209.18/209.36  |- mesh__recordOriginator mesh__D003044 NLM
% 209.18/209.36  |- skos__annotation mesh__D003044
% 209.18/209.36       infection = COCCIDIOSIS; /drug eff: consider also COCCIDIOSTATS; %22%coccidial%22% refers to COCCIDIA: do not confuse with %22%coccidioidal%22% %28%refers to COCCIDIOIDES, a fungus%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 209.18/209.36  |- skos__broader mesh__D003044smesh__D016782
% 209.18/209.36  |- mesh__dateEstablished mesh__D003044 1979-01-01
% 209.18/209.36  |- mesh__dateRevised mesh__D003044 2003-07-09
% 209.18/209.36  |- mesh__historyNote mesh__D003044
% 209.18/209.36       79%28%75%29%; was see under SPOROZOA 1963-78   
% 209.18/209.36  |- mesh__recordAuthorizer mesh__D003044 sjn
% 209.18/209.36  |- skos__prefLabel mesh__D003044 Coccidia
% 209.18/209.36  |- mesh__onlineNote mesh__D003044 search SPOROZOA 1966-74   
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D003044 2006
% 209.18/209.36  |- skos__related mesh__D003044smesh__D003049
% 209.18/209.36  |- skos__scopeNote mesh__D003044
% 209.18/209.36       A subclass of protozoans commonly parasitic in the epithelial cells of the intestinal tract but also found in the liver and other organs. Its organisms are found in both vertebrates and higher invertebrates and comprise two orders: EIMERIIDA and EUCOCCIDIIDA.%A%    
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D003044 2005
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D003044 2004
% 209.18/209.36  |- mesh__dateCreated mesh__D003044 1999-01-01
% 209.18/209.36  |- rdf__type mesh__D003044sskos__Concept
% 209.18/209.36  |- mesh__recordMaintainer mesh__D003044 ags
% 209.18/209.36  |- skos__historyNote mesh__D003044 Sporozoa %28%1966-1974%29%
% 209.18/209.36  |- skos__hiddenLabel mesh__D041961 Hydrogen Deuterium Exchange Measurement
% 209.18/209.36  |- skos__hiddenLabel mesh__D041961 Deuterium Exchange Measurements
% 209.18/209.36  |- skos__hiddenLabel mesh__D041961 Exchange Measurement, Hydrogen-Deuterium
% 209.18/209.36  |- skos__hiddenLabel mesh__D041961 Exchange Measurements, Deuterium
% 209.18/209.36  |- skos__hiddenLabel mesh__D041961
% 209.18/209.36       Measurements, Hydrogen-Deuterium Exchange
% 209.18/209.36  |- skos__hiddenLabel mesh__D041961 Hydrogen-Deuterium Exchange Measurements
% 209.18/209.36  |- rdf__type mesh__D041961sskos__Concept
% 209.18/209.36  |- mesh__publicMeSHNote mesh__D041961 2004   
% 209.18/209.36  |- skos__altLabel mesh__D041961 Hydrogen-Deuterium Exchange Measurement
% 209.18/209.36  |- skos__hiddenLabel mesh__D041961 Measurements, Deuterium Exchange
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D041961 2006
% 209.18/209.36  |- skos__hiddenLabel mesh__D041961 Measurement, Hydrogen-Deuterium Exchange
% 209.18/209.36  |- mesh__dateEstablished mesh__D041961 2004-01-01
% 209.18/209.36  |- skos__hiddenLabel mesh__D041961 Measurement, Deuterium Exchange
% 209.18/209.36  |- mesh__historyNote mesh__D041961 2004   
% 209.18/209.36  |- skos__historyNote mesh__D041961 Spectrophotometry %28%1966-2003%29%
% 209.18/209.36  |- skos__scopeNote mesh__D041961
% 209.18/209.36       A research technique to measure solvent exposed regions of molecules that is used to provide insight about PROTEIN CONFORMATION.%A%    
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D041961 2005
% 209.18/209.36  |- skos__historyNote mesh__D041961 Deuterium %28%1965-2003%29%
% 209.18/209.36  |- skos__hiddenLabel mesh__D041961 Exchange Measurement, Deuterium
% 209.18/209.36  |- skos__historyNote mesh__D041961 Hydrogen %28%1965-2003%29%
% 209.18/209.36  |- skos__hiddenLabel mesh__D041961
% 209.18/209.36       Exchange Measurements, Hydrogen-Deuterium
% 209.18/209.36  |- mesh__dateCreated mesh__D041961 2003-07-09
% 209.18/209.36  |- skos__prefLabel mesh__D041961 Deuterium Exchange Measurement
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D041961 2004
% 209.18/209.36  |- skos__broader mesh__D041961smesh__D002623
% 209.18/209.36  |- skos__historyNote mesh__D035924 Oxepins %28%1980-2002%29%
% 209.18/209.36  |- mesh__publicMeSHNote mesh__D035924
% 209.18/209.36       2003; ZOAPATLE was indexed under OXEPINS 1980-2002   
% 209.18/209.36  |- skos__annotation mesh__D035924
% 209.18/209.36       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.18/209.36  |- mesh__dateCreated mesh__D035924 2002-07-03
% 209.18/209.36  |- skos__broader mesh__D035924smesh__D019659
% 209.18/209.36  |- skos__scopeNote mesh__D035924
% 209.18/209.36       A plant genus of the family ASTERACEAE. Steroidal activity has been observed in animals. Members of this genus contain sesquiterpene lactones such as tomentosin, OXEPINS such as zoapatanol, and kaurene type DITERPENES.%A%    
% 209.18/209.36  |- rdf__type mesh__D035924sskos__Concept
% 209.18/209.36  |- mesh__historyNote mesh__D035924
% 209.18/209.36       2003; for ZOAPATLE use MONTANOA %28%NM%29% 1980-2002   
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D035924 2005
% 209.18/209.36  |- skos__prefLabel mesh__D035924 Montanoa
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D035924 2003
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D035924 2006
% 209.18/209.36  |- skos__altLabel mesh__D035924 Zoapatle
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D035924 2004
% 209.18/209.36  |- mesh__dateEstablished mesh__D035924 2003-01-01
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D013472 2006
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D013472 2003
% 209.18/209.36  |- mesh__dateCreated mesh__D013472 1999-01-01
% 209.18/209.36  |- mesh__recordOriginator mesh__D013472 NLM
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D013472 2001
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D013472 2005
% 209.18/209.36  |- skos__related mesh__D013472smesh__D006370
% 209.18/209.36  |- skos__prefLabel mesh__D013472 Sunlight
% 209.18/209.36  |- skos__annotation mesh__D013472
% 209.18/209.36       /adv eff permitted but consider also SUNBURN %26% SUNSTROKE; using sunlight therapeutically = HELIOTHERAPY%A%  
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D013472 2000
% 209.18/209.36  |- mesh__recordMaintainer mesh__D013472 TGC
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D013472 1997
% 209.18/209.36  |- mesh__recordAuthorizer mesh__D013472 PLS
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D013472 1999
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D013472 1996
% 209.18/209.36  |- skos__broader mesh__D013472smesh__D014887
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D013472 1998
% 209.18/209.36  |- mesh__dateRevised mesh__D013472 1995-02-23
% 209.18/209.36  |- rdf__type mesh__D013472sskos__Concept
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D013472 2004
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D013472 2002
% 209.18/209.36  |- mesh__publicMeSHNote mesh__D007435 78   
% 209.18/209.36  |- rdf__type mesh__D007435sskos__Concept
% 209.18/209.36  |- skos__prefLabel mesh__D007435 Intrauterine Devices, Copper
% 209.18/209.36  |- mesh__recordOriginator mesh__D007435 SMH
% 209.18/209.36  |- skos__hiddenLabel mesh__D007435 Copper-Releasing IUD
% 209.18/209.36  |- mesh__historyNote mesh__D007435 78   
% 209.18/209.36  |- skos__broader mesh__D007435smesh__D007436
% 209.18/209.36  |- skos__historyNote mesh__D007435
% 209.18/209.36       Intrauterine Devices, Medicated %28%1975-1977%29%
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D007435 2000
% 209.18/209.36  |- skos__hiddenLabel mesh__D007435 IUDs, Copper-Releasing
% 209.18/209.36  |- skos__hiddenLabel mesh__D007435 Copper Releasing IUD
% 209.18/209.36  |- skos__hiddenLabel mesh__D007435 Copper Intrauterine Device
% 209.18/209.36  |- skos__hiddenLabel mesh__D007435 Device, Copper Intrauterine
% 209.18/209.36  |- skos__hiddenLabel mesh__D007435 Devices, Copper Intrauterine
% 209.18/209.36  |- skos__altLabel mesh__D007435 Copper Intrauterine Devices
% 209.18/209.36  |- mesh__dateEstablished mesh__D007435 1978-01-01
% 209.18/209.36  |- mesh__dateCreated mesh__D007435 1977-04-22
% 209.18/209.36  |- skos__hiddenLabel mesh__D007435 Intrauterine Device, Copper
% 209.18/209.36  |- mesh__dateRevised mesh__D007435 1997-06-20
% 209.18/209.36  |- skos__hiddenLabel mesh__D007435 IUD, Copper-Releasing
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D007435 2006
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D007435 2002
% 209.18/209.36  |- skos__historyNote mesh__D007435 Intrauterine Devices %28%1967-1977%29%
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D007435 2005
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D007435 2004
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D007435 1999
% 209.18/209.36  |- mesh__recordMaintainer mesh__D007435 PXP
% 209.18/209.36  |- skos__altLabel mesh__D007435 Copper-Releasing IUDs
% 209.18/209.36  |- mesh__recordAuthorizer mesh__D007435 SJN
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D007435 2003
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D007435 1998
% 209.18/209.36  |- skos__altLabel mesh__D007435 IUD, Copper Releasing
% 209.18/209.36  |- skos__scopeNote mesh__D007435
% 209.18/209.36       Intrauterine contraceptive devices that depend on the release of metallic copper.%A%    
% 209.18/209.36  |- skos__annotation mesh__D007435
% 209.18/209.36       pregn despite use: see note under INTRAUTERINE DEVICES; DF: IUD COPPER%A%  
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D007435 2001
% 209.18/209.36  |- mesh__dateEstablished mesh__D017863 1994-01-01
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D017863 2001
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D017863 1999
% 209.18/209.36  |- mesh__recordAuthorizer mesh__D017863 PLS
% 209.18/209.36  |- mesh__dateRevised mesh__D017863 1996-06-10
% 209.18/209.36  |- skos__annotation mesh__D017863
% 209.18/209.36       a genus of plant viruses; from POTato X virus; coord IM with specific plant /virol %28%IM or NIM%29%%A%  
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D017863 1998
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D017863 2004
% 209.18/209.36  |- rdf__type mesh__D017863sskos__Concept
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D017863 2000
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D017863 2006
% 209.18/209.36  |- skos__historyNote mesh__D017863 Plant Viruses %28%1988-1993%29%
% 209.18/209.36  |- skos__hiddenLabel mesh__D017863 Potexviruses
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D017863 2003
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D017863 2005
% 209.18/209.36  |- skos__hiddenLabel mesh__D017863 Virus X, Potato
% 209.18/209.36  |- mesh__publicMeSHNote mesh__D017863 94   
% 209.18/209.36  |- skos__scopeNote mesh__D017863
% 209.18/209.36       A genus of plant viruses that cause mosaic and ringspot symptoms. Transmission occurs mechanically.%A%    
% 209.18/209.36  |- mesh__recordMaintainer mesh__D017863 AGS
% 209.18/209.36  |- skos__prefLabel mesh__D017863 Potexvirus
% 209.18/209.36  |- mesh__dateCreated mesh__D017863 1993-06-15
% 209.18/209.36  |- skos__broader mesh__D017863smesh__D012328
% 209.18/209.36  |- skos__broader mesh__D017863smesh__D010942
% 209.18/209.36  |- mesh__historyNote mesh__D017863 94   
% 209.18/209.36  |- mesh__recordOriginator mesh__D017863 AGS
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D017863 2002
% 209.18/209.36  |- skos__historyNote mesh__D017863 Mosaic Viruses %28%1983-1993%29%
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D017863 1997
% 209.18/209.36  |- mesh__historyNote mesh__D017065 1992   
% 209.18/209.36  |- skos__prefLabel mesh__D017065
% 209.18/209.36       Practice Guideline %5B%Publication Type%5D%
% 209.18/209.36  |- mesh__recordAuthorizer mesh__D017065 sjn
% 209.18/209.36  |- rdf__type mesh__D017065sskos__Concept
% 209.18/209.36  |- skos__altLabel mesh__D017065 Practice Guideline %28%PT%29%
% 209.18/209.36  |- skos__annotation mesh__D017065
% 209.18/209.36       publication type only; restrict to health care; for guidelines in other fields consider publication type GUIDELINE; practice guidelines as a subject are indexed with the main heading PRACTICE GUIDELINES%A%  
% 209.18/209.36  |- skos__scopeNote mesh__D017065
% 209.18/209.36       Work consisting of a set of directions or principles to assist the health care practitioner with patient care decisions about appropriate diagnostic, therapeutic, or other clinical procedures for specific clinical circumstances. Practice guidelines may be developed by government agencies at any level, institutions, organizations such as professional societies or governing boards, or by the convening of expert panels. They can provide a foundation for assessing and evaluating the quality and effectiveness of health care in terms of measuring improved health, reduction of variation in services or procedures performed, and reduction of variation in outcomes of health care delivered.%A%    
% 209.18/209.36  |- skos__altLabel mesh__D017065 Practice Guideline
% 209.18/209.36  |- mesh__recordOriginator mesh__D017065 PLS
% 209.18/209.36  |- mesh__dateRevised mesh__D017065 2005-06-30
% 209.18/209.36  |- mesh__dateCreated mesh__D017065 1995-06-23
% 209.18/209.36  |- mesh__recordMaintainer mesh__D017065 jls
% 209.18/209.36  |- skos__altLabel mesh__D017065 Clinical Practice Guideline %28%PT%29%
% 209.18/209.36  |- mesh__dateEstablished mesh__D017065 1996-01-01
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D017065 2006
% 209.18/209.36  |- skos__broader mesh__D017065smesh__D016431
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D003843 1999
% 209.18/209.36  |- mesh__dateCreated mesh__D003843 1999-01-01
% 209.18/209.36  |- mesh__onlineNote mesh__D003843
% 209.18/209.36       to search DEOXYCYTIDYLIC ACIDS use DEOXYCYTIDINE MONOPHOSPHATE 1975-77 %26% CYTOSINE NUCLEOTIDES 1966-74%A%  
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D003843 2002
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D003843 1998
% 209.18/209.36  |- skos__historyNote mesh__D003843 Cytosine Nucleotides %28%1966-1974%29%
% 209.18/209.36  |- skos__prefLabel mesh__D003843 Deoxycytidine Monophosphate
% 209.18/209.36  |- mesh__dateEstablished mesh__D003843 1991-01-01
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D003843 2001
% 209.18/209.36  |- skos__annotation mesh__D003843 /biosyn /physiol permitted   
% 209.18/209.36  |- mesh__recordMaintainer mesh__D003843 TAP
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D003843 1997
% 209.18/209.36  |- skos__scopeNote mesh__D003843
% 209.18/209.36       Deoxycytidine %28%dihydrogen phosphate%29%. A deoxycytosine nucleotide containing one phosphate group esterified to the deoxyribose moiety in the 2%27%-,3%27%- or 5- positions.%A%    
% 209.18/209.36  |- skos__hiddenLabel mesh__D003843 Acids, Deoxycytidylic
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D003843 2006
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D003843 2000
% 209.18/209.36  |- mesh__historyNote mesh__D003843
% 209.18/209.36       91%28%78%29%; was see under DEOXYCYTOSINE NUCLEOTIDES 1978-90; was DEOXYCYTIDYLIC ACIDS see under CYTOSINE NUCLEOTIDES 1963-77%A%  
% 209.18/209.36  |- skos__hiddenLabel mesh__D003843 Acid, Deoxycytidylic
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D003843 1996
% 209.18/209.36  |- mesh__recordOriginator mesh__D003843 NLM
% 209.18/209.36  |- skos__altLabel mesh__D003843 Deoxycytidylic Acid
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D003843 2005
% 209.18/209.36  |- mesh__dateRevised mesh__D003843 1995-05-18
% 209.18/209.36  |- mesh__recordAuthorizer mesh__D003843 PLS
% 209.18/209.36  |- rdf__type mesh__D003843sskos__Concept
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D003843 2004
% 209.18/209.36  |- skos__broader mesh__D003843smesh__D003845
% 209.18/209.36  |- skos__altLabel mesh__D003843 DCMP
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D003843 2003
% 209.18/209.36  |- mesh__publicMeSHNote mesh__D003843
% 209.18/209.36       91; was see under DEOXYCYTOSINE NUCLEOTIDES 1978-90; was DEOXYCYTIDYLIC ACIDS see under CYTOSINE NUCLEOTIDES 1963-77%A%  
% 209.18/209.36  |- skos__hiddenLabel mesh__D003843 Monophosphate, Deoxycytidine
% 209.18/209.36  |- skos__scopeNote mesh__D050499
% 209.18/209.36       A stage of development at which the ADRENAL GLANDS undergo maturation leading to the capability of producing increasing amounts of adrenal androgens, DEHYDROEPIANDROSTERONE and ANDROSTENEDIONE. Adrenarche usually begins at about 7 or 8 years of age before the signs of PUBERTY and continues throughout puberty.%A%    
% 209.18/209.36  |- mesh__recordOriginator mesh__D050499 lkt
% 209.18/209.36  |- skos__historyNote mesh__D050499 Adrenal Glands %28%1973-2005%29%
% 209.18/209.36  |- mesh__dateEstablished mesh__D050499 2006-01-01
% 209.18/209.36  |- skos__prefLabel mesh__D050499 Adrenarche
% 209.18/209.36  |- mesh__publicMeSHNote mesh__D050499 2006   
% 209.18/209.36  |- skos__broader mesh__D050499smesh__D011627
% 209.18/209.36  |- mesh__historyNote mesh__D050499 2006   
% 209.18/209.36  |- skos__historyNote mesh__D050499 Puberty, Precocious %28%1966-2005%29%
% 209.18/209.36  |- mesh__dateCreated mesh__D050499 2005-06-30
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D050499 2006
% 209.18/209.36  |- rdf__type mesh__D050499sskos__Concept
% 209.18/209.36  |- mesh__recordAuthorizer mesh__D050499 sjn
% 209.18/209.36  |- mesh__recordMaintainer mesh__D050499 lkt
% 209.18/209.36  |- mesh__recordOriginator mesh__D003045 NLM
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D003045 2006
% 209.18/209.36  |- skos__scopeNote mesh__D003045
% 209.18/209.36       A mitosporic fungal genus which causes COCCIDIOIDOMYCOSIS.%A%    
% 209.18/209.36  |- mesh__recordMaintainer mesh__D003045 SYSTEM
% 209.18/209.36  |- skos__prefLabel mesh__D003045 Coccidioides
% 209.18/209.36  |- skos__annotation mesh__D003045
% 209.18/209.36       do not confuse with the sporozoon COCCIDIA; %22%coccidioidal%22% refers to COCCIDIOIDES: do not confuse with %22%coccidial%22% %28%refers to COCCIDIA%29%; infection = COCCIDIOIDOMYCOSIS%A%  
% 209.18/209.36  |- mesh__recordAuthorizer mesh__D003045 sjn
% 209.18/209.36  |- mesh__dateCreated mesh__D003045 1999-01-01
% 209.18/209.36  |- rdf__type mesh__D003045sskos__Concept
% 209.18/209.36  |- skos__broader mesh__D003045smesh__D003904
% 209.18/209.36  |- mesh__dateRevised mesh__D003045 2005-06-30
% 209.18/209.36  |- mesh__recordOriginator mesh__D041962 ags
% 209.18/209.36  |- skos__broader mesh__D041962smesh__D006088
% 209.18/209.36  |- mesh__publicMeSHNote mesh__D041962
% 209.18/209.36       2004; for BEGGIATOACEAE see BEGGIATOACEAE 1976-2003   
% 209.18/209.36  |- mesh__dateCreated mesh__D041962 2003-07-09
% 209.18/209.36  |- mesh__dateEstablished mesh__D041962 2004-01-01
% 209.18/209.36  |- mesh__recordAuthorizer mesh__D041962 sjn
% 209.18/209.36  |- skos__broader mesh__D041962smesh__D020563
% 209.18/209.36  |- mesh__dateRevised mesh__D041962 2005-06-30
% 209.18/209.36  |- mesh__recordMaintainer mesh__D041962 SYSTEM
% 209.18/209.36  |- skos__prefLabel mesh__D041962 Thiotrichaceae
% 209.18/209.36  |- mesh__historyNote mesh__D041962 2004   
% 209.18/209.36  |- rdf__type mesh__D041962sskos__Concept
% 209.18/209.36  |- skos__scopeNote mesh__D041962
% 209.18/209.36       A family of colorless sulfur bacteria in the order Thiotrichales, class GAMMAPROTEOBACTERIA.%A%    
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D041962 2006
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D035925 2006
% 209.18/209.36  |- mesh__recordAuthorizer mesh__D035925 jls
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D035925 2003
% 209.18/209.36  |- skos__hiddenLabel mesh__D035925 Iron Regulatory Proteins
% 209.18/209.36  |- skos__altLabel mesh__D035925 Iron-Responsive Elements-Binding Protein
% 209.18/209.36  |- mesh__dateCreated mesh__D035925 2002-07-03
% 209.18/209.36  |- skos__altLabel mesh__D035925 IRE-BP
% 209.18/209.36  |- skos__hiddenLabel mesh__D035925 Iron Responsive Elements Binding Protein
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D035925 2005
% 209.18/209.36  |- skos__historyNote mesh__D035925 Iron-Sulfur Proteins %28%1991-2002%29%
% 209.18/209.36  |- skos__scopeNote mesh__D035925
% 209.18/209.36       Proteins that regulate cellular and organismal iron homeostasis. They play an important biological role by maintaining iron levels that are adequate for metabolic need, but below the toxicity threshold.%A%    
% 209.18/209.36  |- mesh__publicMeSHNote mesh__D035925
% 209.18/209.36       2003; IRON REGULATORY FACTOR now IRON-REGULATORY PROTEINS was indexed under RNA-BINDING PROTEINS %26% IRON-SULFUR PROTEINS 1991-2002, CARRIER PROTEINS 1990%A%  
% 209.18/209.36  |- skos__hiddenLabel mesh__D035925 Regulatory Factor, Iron
% 209.18/209.36  |- skos__hiddenLabel mesh__D035925 Iron Regulatory Protein
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D035925 2005A
% 209.18/209.36  |- skos__prefLabel mesh__D035925 Iron-Regulatory Proteins
% 209.18/209.36  |- skos__historyNote mesh__D035925 Carrier Proteins %28%1990%29%
% 209.18/209.36  |- mesh__dateRevised mesh__D035925 2004-07-28
% 209.18/209.36  |- mesh__dateEstablished mesh__D035925 2003-01-01
% 209.18/209.36  |- skos__altLabel mesh__D035925 Iron Regulatory Factor
% 209.18/209.36  |- skos__altLabel mesh__D035925 Iron-Regulatory Protein
% 209.18/209.36  |- skos__altLabel mesh__D035925 IRE-Binding Protein
% 209.18/209.36  |- rdf__type mesh__D035925sskos__Concept
% 209.18/209.36  |- skos__historyNote mesh__D035925 Ribonucleoproteins %28%1992-2002%29%
% 209.18/209.36  |- skos__hiddenLabel mesh__D035925 Iron Response Proteins
% 209.18/209.36  |- skos__altLabel mesh__D035925 Iron-Response Proteins
% 209.18/209.36  |- mesh__recordOriginator mesh__D035925 jmp
% 209.18/209.36  |- mesh__historyNote mesh__D035925
% 209.18/209.36       2003; use IRON-REGULATORY PROTEINS %28%NM%29% 1990-2002   
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D035925 2004
% 209.18/209.36  |- skos__broader mesh__D035925smesh__D011506
% 209.18/209.36  |- skos__hiddenLabel mesh__D035925 Iron Responsive Element Binding Proteins
% 209.18/209.36  |- skos__hiddenLabel mesh__D035925 IRE Binding Protein
% 209.18/209.36  |- mesh__recordMaintainer mesh__D035925 jls
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D013473 2006
% 209.18/209.36  |- skos__prefLabel mesh__D013473 Sunscreening Agents
% 209.18/209.36  |- skos__hiddenLabel mesh__D013473 Agents, Sunscreening
% 209.18/209.36  |- mesh__dateRevised mesh__D013473 2005-06-30
% 209.18/209.36  |- skos__broader mesh__D013473smesh__D011837
% 209.18/209.36  |- skos__broader mesh__D013473smesh__D003358
% 209.18/209.36  |- skos__annotation mesh__D013473 D25-26 qualif   
% 209.18/209.36  |- mesh__recordOriginator mesh__D013473 NLM
% 209.18/209.36  |- mesh__dateEstablished mesh__D013473 1972-01-01
% 209.18/209.36  |- skos__scopeNote mesh__D013473
% 209.18/209.36       Chemical or physical agents that protect the skin from sunburn and erythema by absorbing or blocking ultraviolet radiation.%A%    
% 209.18/209.36  |- skos__broader mesh__D013473smesh__D003879
% 209.18/209.36  |- mesh__dateCreated mesh__D013473 1999-01-01
% 209.18/209.36  |- mesh__recordMaintainer mesh__D013473 ssb
% 209.18/209.36  |- rdf__type mesh__D013473sskos__Concept
% 209.18/209.36  |- mesh__historyNote mesh__D013473 72%28%66%29%   
% 209.18/209.36  |- mesh__publicMeSHNote mesh__D013473 72   
% 209.18/209.36  |- skos__altLabel mesh__D013473 Sunscreens
% 209.18/209.36  |- mesh__recordAuthorizer mesh__D013473 sjn
% 209.18/209.36  |- skos__hiddenLabel mesh__D007436 Devices, Hormone-Releasing Intrauterine
% 209.18/209.36  |- skos__historyNote mesh__D007436 Intrauterine Devices %28%1967-1974%29%
% 209.18/209.36  |- skos__hiddenLabel mesh__D007436 Hormone-Releasing Intrauterine Device
% 209.18/209.36  |- skos__hiddenLabel mesh__D007436 Hormone Releasing IUD
% 209.18/209.36  |- skos__scopeNote mesh__D007436
% 209.18/209.36       Intrauterine devices that release contraceptive agents.%A%    
% 209.18/209.36  |- skos__hiddenLabel mesh__D007436 Hormone-Releasing Intrauterine Devices
% 209.18/209.36  |- rdf__type mesh__D007436sskos__Concept
% 209.18/209.36  |- skos__hiddenLabel mesh__D007436 Device, Hormone-Releasing Intrauterine
% 209.18/209.36  |- mesh__recordOriginator mesh__D007436 NLM
% 209.18/209.36  |- skos__hiddenLabel mesh__D007436 IUDs, Hormone-Releasing
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D007436 2002
% 209.18/209.36  |- mesh__recordAuthorizer mesh__D007436 PLS
% 209.18/209.36  |- skos__altLabel mesh__D007436 IUD, Hormone Releasing
% 209.18/209.36  |- skos__broader mesh__D007436smesh__D007434
% 209.18/209.36  |- skos__annotation mesh__D007436
% 209.18/209.36       %22%IUDs that release contraceptive agents%22%; coord IM with specific contraceptive agent %28%IM%29%; pregn despite use: see note on INTRAUTERINE DEVICES; DF: IUD MEDICATED%A%  
% 209.18/209.36  |- mesh__recordMaintainer mesh__D007436 TGC
% 209.18/209.36  |- skos__hiddenLabel mesh__D007436 IUD, Hormone-Releasing
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D007436 2003
% 209.18/209.36  |- skos__hiddenLabel mesh__D007436 Intrauterine Device, Hormone-Releasing
% 209.18/209.36  |- skos__hiddenLabel mesh__D007436 Intrauterine Devices, Hormone Releasing
% 209.18/209.36  |- skos__altLabel mesh__D007436 Hormone-Releasing IUDs
% 209.18/209.36  |- skos__hiddenLabel mesh__D007436
% 209.18/209.36       Device, Progesterone-Releasing Intrauterine
% 209.18/209.36  |- skos__hiddenLabel mesh__D007436 Device, Medicated Intrauterine
% 209.18/209.36  |- skos__hiddenLabel mesh__D007436 Hormone-Releasing IUD
% 209.18/209.36  |- mesh__publicMeSHNote mesh__D007436
% 209.18/209.36       79; was see under INTRAUTERINE DEVICES 1975-78   
% 209.18/209.36  |- skos__hiddenLabel mesh__D007436
% 209.18/209.36       Intrauterine Devices, Progesterone Releasing
% 209.18/209.36  |- skos__hiddenLabel mesh__D007436
% 209.18/209.36       Progesterone-Releasing Intrauterine Device
% 209.18/209.36  |- skos__hiddenLabel mesh__D007436 Medicated Intrauterine Device
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D007436 2004
% 209.18/209.36  |- skos__hiddenLabel mesh__D007436
% 209.18/209.36       Devices, Progesterone-Releasing Intrauterine
% 209.18/209.36  |- mesh__dateCreated mesh__D007436 1974-11-19
% 209.18/209.36  |- skos__hiddenLabel mesh__D007436
% 209.18/209.36       Progesterone-Releasing Intrauterine Devices
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D007436 2005
% 209.18/209.36  |- mesh__dateEstablished mesh__D007436 1979-01-01
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D007436 2000
% 209.18/209.36  |- skos__altLabel mesh__D007436 Medicated Intrauterine Devices
% 209.18/209.36  |- skos__hiddenLabel mesh__D007436 Intrauterine Device, Medicated
% 209.18/209.36  |- mesh__dateRevised mesh__D007436 1996-06-10
% 209.18/209.36  |- skos__prefLabel mesh__D007436 Intrauterine Devices, Medicated
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D007436 1997
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D007436 1998
% 209.18/209.36  |- mesh__historyNote mesh__D007436
% 209.18/209.36       79%28%75%29%; was see under INTRAUTERINE DEVICES 1975-78   
% 209.18/209.36  |- skos__altLabel mesh__D007436 Intrauterine Devices, Hormone-Releasing
% 209.18/209.36  |- skos__hiddenLabel mesh__D007436
% 209.18/209.36       Intrauterine Device, Progesterone-Releasing
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D007436 2006
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D007436 2001
% 209.18/209.36  |- skos__hiddenLabel mesh__D007436 Devices, Medicated Intrauterine
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D007436 1999
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D017864 2004
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D017864 2002
% 209.18/209.36  |- rdf__type mesh__D017864sskos__Concept
% 209.18/209.36  |- mesh__recordMaintainer mesh__D017864 ags
% 209.18/209.36  |- skos__annotation mesh__D017864 coord IM with specific plant /virol   
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D017864 2006
% 209.18/209.36  |- mesh__recordOriginator mesh__D017864 AGS
% 209.18/209.36  |- mesh__dateEstablished mesh__D017864 1994-01-01
% 209.18/209.36  |- skos__scopeNote mesh__D017864
% 209.18/209.36       A genus of plant viruses that infects ANGIOSPERMS. Transmission occurs mechanically and through soil, with one species transmitted via a fungal vector. The type species is Tomato bushy stunt virus.%A%    
% 209.18/209.36  |- mesh__historyNote mesh__D017864
% 209.18/209.36       94; TOMATO BUSHY STUNT VIRUSES was see TOMBUSVIRUS 1994-96%A%  
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D017864 2003
% 209.18/209.36  |- skos__broader mesh__D017864smesh__D019183
% 209.18/209.36  |- mesh__activeMeSHYear mesh__D017864 2005
% 209.18/209.36  |- skos__historyNote mesh__D017864 Plant Viruses %28%1975-1993%29%
% 209.18/209.36  |- skos__prefLabel mesh__D017864 Tombusvirus
% 209.18/209.36  |- mesh__recordAuthorizer mesh__D017864 sjn
% 209.18/209.36  |- mesh__dateRevised mesh__D017864 2001-07-25
% 209.18/209.36  |- mesh__publicMeSHNote mesh__D017864
% 209.18/209.36       94; TOMATO BUSHY STUNT VIRUSES was see TOMBUSVIRUS 1994-96%A%  
% 209.18/209.36  |- mesh__onlineNote mesh__D017864
% 209.18/209.36       use TOMBUSVIRUS to search TOMATO BUSHY STUNT VIRUSES 1994-96%A%  
% 209.18/209.36  |- mesh__dateCreated mesh__D017864 1993-06-03
% 209.18/209.36  |- skos__prefLabel mesh__D003844 DCMP Deaminase
% 209.18/209.36  |- mesh__recordMaintainer mesh__D003844 ssb
% 209.18/209.36  |- skos__altLabel mesh__D003844 Deoxycytidylate Deaminase
% 209.18/209.36  |- skos__historyNote mesh__D003844 Deoxycytidine Monophosphate %28%1975%29%
% 209.18/209.36  |- mesh__publicMeSHNote mesh__D003844
% 209.18/209.36       97; was DEOXYCYTIDYLATE DEAMINASE 1976-96 %28%see under NUCLEOTIDE DEAMINASES 1976-90%29%; DCMP DEAMINASE was see DEOXYCYTIDYLATE DEAMINASE 1976-96%A%  
% 209.18/209.37  |- mesh__dateCreated mesh__D003844 1975-07-25
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003844 2006
% 209.18/209.37  |- skos__altLabel mesh__D003844 Deoxycytidine Monophosphate Deaminase
% 209.18/209.37  |- skos__broader mesh__D003844smesh__D009709
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003844 2005
% 209.18/209.37  |- skos__scopeNote mesh__D003844
% 209.18/209.37       An enzyme that catalyzes the hydrolytic deamination of deoxycytidylic acid to deoxyuridylic acid and ammonia. It plays an important role in the regulation of the pool of deoxynucleotides in higher organisms. The enzyme also acts on some 5-substituted deoxycytidylic acids. EC 3.5.4.12.%A%    
% 209.18/209.37  |- skos__hiddenLabel mesh__D003844 Aminohydrolase, Deoxycytidylate
% 209.18/209.37  |- skos__hiddenLabel mesh__D003844 Deaminase, Deoxycytidylate
% 209.18/209.37  |- rdf__type mesh__D003844sskos__Concept
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003844 2004
% 209.18/209.37  |- mesh__recordOriginator mesh__D003844 RLS
% 209.18/209.37  |- skos__historyNote mesh__D003844 Aminohydrolases %28%1970-1974%29%
% 209.18/209.37  |- skos__historyNote mesh__D003844 Cytosine Nucleotides %28%1970-1974%29%
% 209.18/209.37  |- mesh__historyNote mesh__D003844
% 209.18/209.37       97; was DEOXYCYTIDYLATE DEAMINASE 1976-96 %28%see under NUCLEOTIDE DEAMINASES 1976-90%29%; DCMP DEAMINASE was see DEOXYCYTIDYLATE DEAMINASE 1976-96%A%  
% 209.18/209.37  |- skos__hiddenLabel mesh__D003844 Monophosphate Deaminase, Deoxycytidine
% 209.18/209.37  |- skos__hiddenLabel mesh__D003844 Deaminase, Deoxycytidine Monophosphate
% 209.18/209.37  |- skos__hiddenLabel mesh__D003844 Deaminase, DCMP
% 209.18/209.37  |- mesh__recordAuthorizer mesh__D003844 sjn
% 209.18/209.37  |- mesh__dateRevised mesh__D003844 2003-07-09
% 209.18/209.37  |- skos__historyNote mesh__D003844 Nucleotide Deaminases %28%1975%29%
% 209.18/209.37  |- skos__historyNote mesh__D003844 Deoxyribonucleotides %28%1973-1974%29%
% 209.18/209.37  |- skos__altLabel mesh__D003844 Deoxycytidylate Aminohydrolase
% 209.18/209.37  |- mesh__dateEstablished mesh__D003844 1991-01-01
% 209.18/209.37  |- mesh__recordMaintainer mesh__D003046 ssb
% 209.18/209.37  |- mesh__dateRevised mesh__D003046 2005-06-30
% 209.18/209.37  |- mesh__dateCreated mesh__D003046 1974-11-19
% 209.18/209.37  |- skos__historyNote mesh__D003046 Antigens, Fungal %28%1973-1974%29%
% 209.18/209.37  |- skos__historyNote mesh__D003046 Coccidioides/IM %28%1973-1974%29%
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003046 2006
% 209.18/209.37  |- skos__broader mesh__D003046smesh__D000946
% 209.18/209.37  |- mesh__historyNote mesh__D003046
% 209.18/209.37       91%28%75%29%; was see under ANTIGENS, FUNGAL 1975-90   
% 209.18/209.37  |- skos__scopeNote mesh__D003046
% 209.18/209.37       A sterile solution containing the by-products of growth products of Coccidioides immitis, injected intracutaneously as a test for coccidioidomycosis.%A%    
% 209.18/209.37  |- rdf__type mesh__D003046sskos__Concept
% 209.18/209.37  |- mesh__recordOriginator mesh__D003046 NLM
% 209.18/209.37  |- mesh__dateEstablished mesh__D003046 1991-01-01
% 209.18/209.37  |- skos__prefLabel mesh__D003046 Coccidioidin
% 209.18/209.37  |- mesh__recordAuthorizer mesh__D003046 sjn
% 209.18/209.37  |- mesh__publicMeSHNote mesh__D003046
% 209.18/209.37       91; was see under ANTIGENS, FUNGAL 1975-90   
% 209.18/209.37  |- mesh__dateCreated mesh__D041963 2003-07-09
% 209.18/209.37  |- mesh__publicMeSHNote mesh__D041963
% 209.18/209.37       2004; for CYTOPHAGALES use CYTOPHAGALES 1976-2003   
% 209.18/209.37  |- skos__broader mesh__D041963smesh__D001419
% 209.18/209.37  |- mesh__recordOriginator mesh__D041963 ags
% 209.18/209.37  |- mesh__recordMaintainer mesh__D041963 SYSTEM
% 209.18/209.37  |- skos__prefLabel mesh__D041963 Bacteroidetes
% 209.18/209.37  |- rdf__type mesh__D041963sskos__Concept
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D041963 2006
% 209.18/209.37  |- mesh__dateEstablished mesh__D041963 2004-01-01
% 209.18/209.37  |- mesh__recordAuthorizer mesh__D041963 sjn
% 209.18/209.37  |- mesh__dateRevised mesh__D041963 2005-06-30
% 209.18/209.37  |- skos__scopeNote mesh__D041963
% 209.18/209.37       A phylum of bacteria comprised of three classes: Bacteroides, Flavobacteria, and Sphingobacteria.%A%    
% 209.18/209.37  |- mesh__historyNote mesh__D041963 2004   
% 209.18/209.37  |- skos__hiddenLabel mesh__D049148 Acids Activations, Amino
% 209.18/209.37  |- skos__hiddenLabel mesh__D049148 Amino Acylations
% 209.18/209.37  |- skos__hiddenLabel mesh__D049148 Amino Acids Activation
% 209.18/209.37  |- skos__hiddenLabel mesh__D049148 Acylations, Amino
% 209.18/209.37  |- skos__altLabel mesh__D049148 Amino Acylation
% 209.18/209.37  |- skos__hiddenLabel mesh__D049148 Acids Activation, Amino
% 209.18/209.37  |- rdf__type mesh__D049148sskos__Concept
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D049148 2006
% 209.18/209.37  |- skos__broader mesh__D049148smesh__D010452
% 209.18/209.37  |- skos__hiddenLabel mesh__D049148 Aminoacylations
% 209.18/209.37  |- skos__broader mesh__D049148smesh__D000215
% 209.18/209.37  |- skos__scopeNote mesh__D049148
% 209.18/209.37       A reaction that introduces an aminoacyl group to a molecule. TRANSFER RNA AMINOACYLATION is the first step in GENETIC TRANSLATION.%A%    
% 209.18/209.37  |- skos__hiddenLabel mesh__D049148 Amino Acids Activations
% 209.18/209.37  |- mesh__recordOriginator mesh__D049148 nns
% 209.18/209.37  |- mesh__recordMaintainer mesh__D049148 nns
% 209.18/209.37  |- mesh__recordAuthorizer mesh__D049148 sjn
% 209.18/209.37  |- mesh__dateEstablished mesh__D049148 2005-01-01
% 209.18/209.37  |- mesh__historyNote mesh__D049148 2005   
% 209.18/209.37  |- mesh__publicMeSHNote mesh__D049148 2005   
% 209.18/209.37  |- skos__prefLabel mesh__D049148 Aminoacylation
% 209.18/209.37  |- mesh__dateCreated mesh__D049148 2004-07-07
% 209.18/209.37  |- skos__hiddenLabel mesh__D049148 Acylation, Amino
% 209.18/209.37  |- skos__annotation mesh__D049148
% 209.18/209.37       not for activation of enzymes, receptors, cells, etc. by amino acids: index ENZYME ACTIVATION or specific term with /metab%A%  
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D049148 2005
% 209.18/209.37  |- skos__prefLabel mesh__D035926 Hepatophyta
% 209.18/209.37  |- mesh__publicMeSHNote mesh__D035926 2003   
% 209.18/209.37  |- mesh__recordMaintainer mesh__D035926 ssb
% 209.18/209.37  |- skos__broader mesh__D035926smesh__D019669
% 209.18/209.37  |- rdf__type mesh__D035926sskos__Concept
% 209.18/209.37  |- mesh__dateCreated mesh__D035926 2002-07-03
% 209.18/209.37  |- mesh__dateRevised mesh__D035926 2005-06-30
% 209.18/209.37  |- skos__annotation mesh__D035926
% 209.18/209.37       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.18/209.37  |- mesh__recordAuthorizer mesh__D035926 sjn
% 209.18/209.37  |- skos__altLabel mesh__D035926 Liverworts
% 209.18/209.37  |- mesh__dateEstablished mesh__D035926 2003-01-01
% 209.18/209.37  |- skos__scopeNote mesh__D035926
% 209.18/209.37       A plant division. They are simple plants that lack vascular tissue and possess rudimentary rootlike organs %28%rhizoids%29%. Like MOSSES, liverworts have alternation of generations between haploid gamete-bearing forms %28%gametophytes%29% and diploid spore-bearing forms %28%sporophytes%29%.%A%    
% 209.18/209.37  |- mesh__recordOriginator mesh__D035926 ssb
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D035926 2006
% 209.18/209.37  |- mesh__historyNote mesh__D035926 2003   
% 209.18/209.37  |- skos__broader mesh__D013474smesh__D006359
% 209.18/209.37  |- skos__scopeNote mesh__D013474
% 209.18/209.37       A condition produced by exposure to the sun, and marked by convulsions, coma, and a high temperature of the skin. It is distinguished from HEAT STROKE which is caused by excessive heat, natural or artificial, and is marked by dry skin, vertigo, headache, thirst, nausea and muscular cramps. %28%From Dorland, 27th ed%29%%A%    
% 209.18/209.37  |- mesh__recordMaintainer mesh__D013474 TGC
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013474 1996
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013474 2002
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013474 1998
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013474 1997
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013474 1999
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013474 2003
% 209.18/209.37  |- mesh__dateCreated mesh__D013474 1999-01-01
% 209.18/209.37  |- mesh__dateRevised mesh__D013474 1994-12-27
% 209.18/209.37  |- rdf__type mesh__D013474sskos__Concept
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013474 2005
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013474 2000
% 209.18/209.37  |- mesh__recordOriginator mesh__D013474 NLM
% 209.18/209.37  |- skos__hiddenLabel mesh__D013474 Sunstrokes
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013474 2004
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013474 2001
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013474 2006
% 209.18/209.37  |- mesh__recordAuthorizer mesh__D013474 PLS
% 209.18/209.37  |- skos__annotation mesh__D013474 a form of heat exhaustion   
% 209.18/209.37  |- skos__prefLabel mesh__D013474 Sunstroke
% 209.18/209.37  |- skos__prefLabel mesh__D007437 Intrinsic Factor
% 209.18/209.37  |- mesh__recordOriginator mesh__D007437 NLM
% 209.18/209.37  |- mesh__recordAuthorizer mesh__D007437 sjn
% 209.18/209.37  |- mesh__dateCreated mesh__D007437 1999-01-01
% 209.18/209.37  |- rdf__type mesh__D007437sskos__Concept
% 209.18/209.37  |- mesh__recordMaintainer mesh__D007437 SYSTEM
% 209.18/209.37  |- skos__scopeNote mesh__D007437
% 209.18/209.37       A glycoprotein secreted by the cells of the gastric glands that is required for the absorption of VITAMIN B 12. Deficiency of intrinsic factor results in ANEMIA, PERNICIOUS.%A%    
% 209.18/209.37  |- skos__broader mesh__D007437smesh__D009088
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D007437 2006
% 209.18/209.37  |- skos__hiddenLabel mesh__D007437 Factor, Intrinsic
% 209.18/209.37  |- mesh__dateRevised mesh__D007437 2005-06-30
% 209.18/209.37  |- skos__broader mesh__D017865smesh__D010942
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D017865 2004
% 209.18/209.37  |- skos__historyNote mesh__D017865 Plant Viruses %28%1966-1993%29%
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D017865 2002
% 209.18/209.37  |- rdf__type mesh__D017865sskos__Concept
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D017865 2006
% 209.18/209.37  |- mesh__dateCreated mesh__D017865 1993-06-04
% 209.18/209.37  |- mesh__recordOriginator mesh__D017865 AGS
% 209.18/209.37  |- mesh__publicMeSHNote mesh__D017865 94   
% 209.18/209.37  |- skos__broader mesh__D017865smesh__D002043
% 209.18/209.37  |- skos__hiddenLabel mesh__D017865 Tospoviruses
% 209.18/209.37  |- mesh__dateEstablished mesh__D017865 1994-01-01
% 209.18/209.37  |- skos__annotation mesh__D017865 coord IM with specific plant /virol   
% 209.18/209.37  |- mesh__historyNote mesh__D017865 94   
% 209.18/209.37  |- skos__scopeNote mesh__D017865
% 209.18/209.37       A genus of plant viruses in the family BUNYAVIRIDAE. Tomato spotted wilt virus is the type species. Transmission occurs by at least nine species of thrips.%A%    
% 209.18/209.37  |- mesh__dateRevised mesh__D017865 2001-07-25
% 209.18/209.37  |- mesh__recordAuthorizer mesh__D017865 sjn
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D017865 2003
% 209.18/209.37  |- mesh__recordMaintainer mesh__D017865 ags
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D017865 2005
% 209.18/209.37  |- skos__prefLabel mesh__D017865 Tospovirus
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003845 2000
% 209.18/209.37  |- mesh__dateRevised mesh__D003845 1992-05-13
% 209.18/209.37  |- mesh__publicMeSHNote mesh__D003845
% 209.18/209.37       78; DEOXYCYTIDINE MONOPHOSPHATE was DEOXYCYTIDYLIC ACIDS see under CYTOSINE NUCLEOTIDES 1963-77%A%  
% 209.18/209.37  |- skos__hiddenLabel mesh__D003845 Phosphates, Deoxycytidine
% 209.18/209.37  |- rdf__type mesh__D003845sskos__Concept
% 209.18/209.37  |- skos__hiddenLabel mesh__D003845 Nucleotides, Deoxycytosine
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003845 2004
% 209.18/209.37  |- skos__historyNote mesh__D003845 Deoxyribonucleotides %28%1973-1977%29%
% 209.18/209.37  |- skos__historyNote mesh__D003845 Cytosine Nucleotides %28%1966-1977%29%
% 209.18/209.37  |- skos__prefLabel mesh__D003845 Deoxycytosine Nucleotides
% 209.18/209.37  |- mesh__recordMaintainer mesh__D003845 TGC
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003845 1995
% 209.18/209.37  |- mesh__historyNote mesh__D003845 78   
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003845 2003
% 209.18/209.37  |- mesh__recordAuthorizer mesh__D003845 PLS
% 209.18/209.37  |- skos__altLabel mesh__D003845 Deoxycytidine Phosphates
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003845 1999
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003845 1994
% 209.18/209.37  |- mesh__dateCreated mesh__D003845 1977-04-22
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003845 1998
% 209.18/209.37  |- skos__scopeNote mesh__D003845
% 209.18/209.37       Cytosine nucleotides which contain deoxyribose as the sugar moiety.%A%    
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003845 1993
% 209.18/209.37  |- skos__broader mesh__D003845smesh__D003854
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003845 2002
% 209.18/209.37  |- mesh__dateEstablished mesh__D003845 1978-01-01
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003845 1997
% 209.18/209.37  |- skos__broader mesh__D003845smesh__D003597
% 209.18/209.37  |- mesh__recordOriginator mesh__D003845 RLS
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003845 2006
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003845 2001
% 209.18/209.37  |- skos__annotation mesh__D003845 /biosyn /physiol permitted   
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003845 1996
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003845 2005
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003047 2003
% 209.18/209.37  |- skos__broader mesh__D003047smesh__D009181
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003047 1999
% 209.18/209.37  |- skos__annotation mesh__D003047
% 209.18/209.37       fungus dis caused by COCCIDIOIDES, not COCCIDIA   
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003047 1996
% 209.18/209.37  |- skos__scopeNote mesh__D003047
% 209.18/209.37       Infection with a fungus of the genus COCCIDIOIDES, species C. immitis. The primary form is an acute, benign, self-limited respiratory infection due to inhalation of spores and varying in severity. The secondary form is a virulent, severe, chronic, progressive granulomatous disease with systemic involvement. %28%From Dorland, 27th ed%29%%A%    
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003047 2004
% 209.18/209.37  |- rdf__type mesh__D003047sskos__Concept
% 209.18/209.37  |- skos__prefLabel mesh__D003047 Coccidioidomycosis
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003047 2000
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003047 1997
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003047 2001
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003047 1994
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003047 2002
% 209.18/209.37  |- mesh__dateRevised mesh__D003047 1993-06-02
% 209.18/209.37  |- mesh__recordAuthorizer mesh__D003047 PLS
% 209.18/209.37  |- skos__hiddenLabel mesh__D003047 Coccidioidomycoses
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003047 1995
% 209.18/209.37  |- mesh__dateCreated mesh__D003047 1999-01-01
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003047 2005
% 209.18/209.37  |- mesh__recordOriginator mesh__D003047 NLM
% 209.18/209.37  |- mesh__recordMaintainer mesh__D003047 TAP
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003047 1998
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003047 2006
% 209.18/209.37  |- mesh__dateRevised mesh__D008530 2003-07-09
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D008530 2006
% 209.18/209.37  |- mesh__onlineNote mesh__D008530
% 209.18/209.37       use MEGACINS to search MEGACIN 1975-78; use BACTERIOCINS 1968-74; use ANTIBIOTICS 1966-67%A%  
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D008530 2005
% 209.18/209.37  |- rdf__type mesh__D008530sskos__Concept
% 209.18/209.37  |- skos__historyNote mesh__D008530 Megacin %28%1975-1978%29%
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D008530 2004
% 209.18/209.37  |- mesh__dateCreated mesh__D008530 1999-01-01
% 209.18/209.37  |- mesh__historyNote mesh__D008530
% 209.18/209.37       91%28%79%29%; was see under BACTERIOCINS 1979-90; was MEGACIN see under BACTERIOCINS 1968-78, see under ANTIBIOTICS 1966-67%A%  
% 209.18/209.37  |- mesh__recordAuthorizer mesh__D008530 sjn
% 209.18/209.37  |- mesh__dateEstablished mesh__D008530 1991-01-01
% 209.18/209.37  |- skos__historyNote mesh__D008530 Antibiotics %28%1966-1967%29%
% 209.18/209.37  |- skos__prefLabel mesh__D008530 Megacins
% 209.18/209.37  |- mesh__recordOriginator mesh__D008530 NLM
% 209.18/209.37  |- mesh__recordMaintainer mesh__D008530 jmp
% 209.18/209.37  |- skos__historyNote mesh__D008530 Bacteriocins %28%1968-1974%29%
% 209.18/209.37  |- mesh__publicMeSHNote mesh__D008530
% 209.18/209.37       91; was see under BACTERIOCINS 1979-80; was MEGACIN see under BACTERIOCINS 1968-78, see under ANTIBIOTICS 1966-67%A%  
% 209.18/209.37  |- skos__scopeNote mesh__D008530
% 209.18/209.37       Bacteriocins elaborated by mutant strains of Bacillus megaterium. They are protein or protein-lipopolysaccharide complexes lethal to other strains of the same species.%A%    
% 209.18/209.37  |- skos__broader mesh__D008530smesh__D001430
% 209.18/209.37  |- rdf__type mesh__D022201sskos__Concept
% 209.18/209.37  |- skos__broader mesh__D022201smesh__D002875
% 209.18/209.37  |- mesh__recordOriginator mesh__D022201 nns
% 209.18/209.37  |- mesh__dateCreated mesh__D022201 2000-06-21
% 209.18/209.37  |- skos__broader mesh__D022201smesh__D005822
% 209.18/209.37  |- skos__prefLabel mesh__D022201 Chromosomes, Artificial
% 209.18/209.37  |- mesh__publicMeSHNote mesh__D022201 2001   
% 209.18/209.37  |- skos__historyNote mesh__D022201 Chromosomes %28%1992-2000%29%
% 209.18/209.37  |- mesh__recordMaintainer mesh__D022201 jls
% 209.18/209.37  |- skos__scopeNote mesh__D022201
% 209.18/209.37       DNA constructs that are composed of, at least, elements such as a REPLICATION ORIGIN; TELOMERE; and CENTROMERE, that are required for successful replication, propagation to and maintenance in progeny cells. In addition, they are constructed to carry other sequences for analysis or gene transfer.%A%    
% 209.18/209.37  |- mesh__historyNote mesh__D022201 2001   
% 209.18/209.37  |- skos__annotation mesh__D022201
% 209.18/209.37       coord with specific organism /genet  only if particularly discussed; for insertion of the artificial chromosome, coord with GENE TRANSFER TECHNIQUES%A%  
% 209.18/209.37  |- skos__hiddenLabel mesh__D022201 Chromosome, Artificial
% 209.18/209.37  |- mesh__dateRevised mesh__D022201 2004-07-19
% 209.18/209.37  |- skos__hiddenLabel mesh__D022201 Artificial Chromosome
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D022201 2006
% 209.18/209.37  |- mesh__dateEstablished mesh__D022201 2001-01-01
% 209.18/209.37  |- skos__altLabel mesh__D022201 Artificial Chromosomes
% 209.18/209.37  |- mesh__recordAuthorizer mesh__D022201 sjn
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D022201 2005
% 209.18/209.37  |- skos__prefLabel mesh__D041964 Flexibacteraceae
% 209.18/209.37  |- mesh__dateCreated mesh__D041964 2003-07-09
% 209.18/209.37  |- mesh__publicMeSHNote mesh__D041964
% 209.18/209.37       2004; for CYTOPHAGACEAE see CYTOPHAGACEAE 1975-2003   
% 209.18/209.37  |- mesh__recordAuthorizer mesh__D041964 sjn
% 209.18/209.37  |- mesh__dateRevised mesh__D041964 2005-06-30
% 209.18/209.37  |- mesh__dateEstablished mesh__D041964 2004-01-01
% 209.18/209.37  |- mesh__historyNote mesh__D041964 2004   
% 209.18/209.37  |- mesh__recordOriginator mesh__D041964 ags
% 209.18/209.37  |- rdf__type mesh__D041964sskos__Concept
% 209.18/209.37  |- skos__broader mesh__D041964smesh__D016946
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D041964 2006
% 209.18/209.37  |- skos__broader mesh__D041964smesh__D041963
% 209.18/209.37  |- skos__scopeNote mesh__D041964
% 209.18/209.37       A family of bacteria in the order Sphingobacteriales, class Sphingobacteria.%A%    
% 209.18/209.37  |- skos__annotation mesh__D041964
% 209.18/209.37       infection = FLEXIBACTERACEAE INFECTIONS   
% 209.18/209.37  |- mesh__recordMaintainer mesh__D041964 SYSTEM
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013475 1993
% 209.18/209.37  |- mesh__dateCreated mesh__D013475 1999-01-01
% 209.18/209.37  |- mesh__recordOriginator mesh__D013475 NLM
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013475 2003
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013475 2001
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013475 1995
% 209.18/209.37  |- rdf__type mesh__D013475sskos__Concept
% 209.18/209.37  |- mesh__recordAuthorizer mesh__D013475 PLS
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013475 2005
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013475 2004
% 209.18/209.37  |- skos__annotation mesh__D013475 no qualif   
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013475 1991
% 209.18/209.37  |- mesh__historyNote mesh__D013475 68   
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013475 2006
% 209.18/209.37  |- skos__broader mesh__D013475smesh__D010553
% 209.18/209.37  |- skos__prefLabel mesh__D013475 Superego
% 209.18/209.37  |- mesh__dateRevised mesh__D013475 1989-05-16
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013475 2002
% 209.18/209.37  |- mesh__publicMeSHNote mesh__D013475 68   
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013475 1996
% 209.18/209.37  |- mesh__dateEstablished mesh__D013475 1968-01-01
% 209.18/209.37  |- skos__broader mesh__D013475smesh__D011574
% 209.18/209.37  |- skos__hiddenLabel mesh__D013475 Superegos
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013475 1998
% 209.18/209.37  |- skos__scopeNote mesh__D013475
% 209.18/209.37       The component of the personality associated with ethics, standards, and self-criticism - the %22%conscience%22%. It is derived mainly from identification with parents and parent substitutes.%A%    
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013475 1992
% 209.18/209.37  |- mesh__recordMaintainer mesh__D013475 TGC
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013475 1990
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013475 1997
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013475 2000
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013475 1994
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D013475 1999
% 209.18/209.37  |- mesh__recordMaintainer mesh__D007438 nns
% 209.18/209.37  |- mesh__onlineNote mesh__D007438
% 209.18/209.37       use BASE SEQUENCE to search INTRONS %26% INTERVENING SEQUENCES 1981-86%A%  
% 209.18/209.37  |- skos__prefLabel mesh__D007438 Introns
% 209.18/209.37  |- skos__scopeNote mesh__D007438
% 209.18/209.37       Sequences of DNA in the genes that are located between the EXONS. They are transcribed along with the exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some introns code for separate genes.%A%    
% 209.18/209.37  |- mesh__recordOriginator mesh__D007438 SCD
% 209.18/209.37  |- mesh__dateRevised mesh__D007438 2005-06-30
% 209.18/209.37  |- rdf__type mesh__D007438sskos__Concept
% 209.18/209.37  |- mesh__dateCreated mesh__D007438 1986-06-18
% 209.18/209.37  |- skos__hiddenLabel mesh__D007438 Intervening Sequence
% 209.18/209.37  |- skos__broader mesh__D007438smesh__D021901
% 209.18/209.37  |- mesh__recordAuthorizer mesh__D007438 sjn
% 209.18/209.37  |- skos__historyNote mesh__D007438 Genes %28%1977-1980%29%
% 209.18/209.37  |- skos__altLabel mesh__D007438 Sequences, Intervening
% 209.18/209.37  |- skos__hiddenLabel mesh__D007438 Intron
% 209.18/209.37  |- mesh__historyNote mesh__D007438
% 209.18/209.37       87; INTERVENING SEQUENCES %26% INTRONS were see BASE SEQUENCE 1981-86%A%  
% 209.18/209.37  |- skos__hiddenLabel mesh__D007438 Sequence, Intervening
% 209.18/209.37  |- skos__altLabel mesh__D007438 Intervening Sequences
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D007438 2006
% 209.18/209.37  |- skos__historyNote mesh__D007438 Base Sequence %28%1977-1986%29%
% 209.18/209.37  |- skos__broader mesh__D007438smesh__D040461
% 209.18/209.37  |- mesh__dateEstablished mesh__D007438 1987-01-01
% 209.18/209.37  |- mesh__publicMeSHNote mesh__D007438
% 209.18/209.37       87; INTERVENING SEQUENCES %26% INTRONS were see BASE SEQUENCE 1981-86%A%  
% 209.18/209.37  |- skos__historyNote mesh__D007438 Genes, Structural %28%1977-1986%29%
% 209.18/209.37  |- mesh__dateEstablished mesh__D018160 1994-01-01
% 209.18/209.37  |- skos__altLabel mesh__D018160 Nuclear and Cytoplasmic Receptors
% 209.18/209.37  |- skos__altLabel mesh__D018160 Nuclear Hormone Receptors
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D018160 2002
% 209.18/209.37  |- mesh__dateCreated mesh__D018160 1993-06-30
% 209.18/209.37  |- rdf__type mesh__D018160sskos__Concept
% 209.18/209.37  |- mesh__publicMeSHNote mesh__D018160 94   
% 209.18/209.37  |- mesh__recordAuthorizer mesh__D018160 sjn
% 209.18/209.37  |- skos__related mesh__D018160smesh__D014157
% 209.18/209.37  |- skos__historyNote mesh__D018160
% 209.18/209.37       Receptors, Cell Surface %28%1983-1993%29%
% 209.18/209.37  |- skos__altLabel mesh__D018160 Nuclear Receptors
% 209.18/209.37  |- skos__hiddenLabel mesh__D018160 Receptors, Nuclear Hormone
% 209.18/209.37  |- skos__prefLabel mesh__D018160 Receptors, Cytoplasmic and Nuclear
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D018160 2003
% 209.18/209.37  |- skos__hiddenLabel mesh__D018160 Receptors, Cytoplasmic Hormone
% 209.18/209.37  |- skos__broader mesh__D018160smesh__D011506
% 209.18/209.37  |- skos__annotation mesh__D018160
% 209.18/209.37       GEN; prefer specifics; for hormone receptors, see note on RECEPTORS, CELL SURFACE; DF: RECEPT CYTOPLASMIC%A%  
% 209.18/209.37  |- skos__altLabel mesh__D018160 Receptors, Cytosolic and Nuclear
% 209.18/209.37  |- mesh__historyNote mesh__D018160 94   
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D018160 2001
% 209.18/209.37  |- skos__altLabel mesh__D018160 Cytoplasmic and Nuclear Receptors
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D018160 2005
% 209.18/209.37  |- mesh__dateRevised mesh__D018160 2000-06-22
% 209.18/209.37  |- mesh__recordOriginator mesh__D018160 RAZ
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D018160 2004
% 209.18/209.37  |- skos__scopeNote mesh__D018160
% 209.18/209.37       Proteins in the cytoplasm or nucleus that specifically bind signaling molecules and trigger changes which influence the behavior of cells. The major groups are the steroid hormone receptors %28%RECEPTORS, STEROID%29%, which usually are found in the cytoplasm, and the thyroid hormone receptors %28%RECEPTORS, THYROID HORMONE%29%, which usually are found in the nucleus. Receptors, unlike enzymes, generally do not catalyze chemical changes in their ligands.%A%    
% 209.18/209.37  |- skos__altLabel mesh__D018160 Receptors, Nuclear and Cytoplasmic
% 209.18/209.37  |- skos__altLabel mesh__D018160 Cytosol and Nuclear Receptors
% 209.18/209.37  |- skos__altLabel mesh__D018160 Cytoplasmic Receptors
% 209.18/209.37  |- skos__altLabel mesh__D018160 Cytosolic and Nuclear Receptors
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D018160 2006
% 209.18/209.37  |- mesh__recordMaintainer mesh__D018160 jmp
% 209.18/209.37  |- skos__altLabel mesh__D018160 Cytoplasmic Hormone Receptors
% 209.18/209.37  |- skos__altLabel mesh__D018160 Receptors, Cytosol and Nuclear
% 209.18/209.37  |- mesh__recordMaintainer mesh__D004140 JRT
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D004140 2006
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D004140 1998
% 209.18/209.37  |- mesh__dateRevised mesh__D004140 1995-06-08
% 209.18/209.37  |- mesh__publicMeSHNote mesh__D004140 64   
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D004140 2003
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D004140 2000
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D004140 1999
% 209.18/209.37  |- mesh__recordOriginator mesh__D004140 NLM
% 209.18/209.37  |- mesh__dateEstablished mesh__D004140 1964-01-01
% 209.18/209.37  |- mesh__dateCreated mesh__D004140 1999-01-01
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D004140 2004
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D004140 1996
% 209.18/209.37  |- skos__scopeNote mesh__D004140
% 209.18/209.37       Organic compounds that contain two nitro groups attached to a phenol.%A%    
% 209.18/209.37  |- skos__broader mesh__D004140smesh__D009596
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D004140 2001
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D004140 1997
% 209.18/209.37  |- mesh__recordAuthorizer mesh__D004140 PLS
% 209.18/209.37  |- rdf__type mesh__D004140sskos__Concept
% 209.18/209.37  |- skos__annotation mesh__D004140
% 209.18/209.37       uncoupling agents %26% indust fungicides   
% 209.18/209.37  |- skos__prefLabel mesh__D004140 Dinitrophenols
% 209.18/209.37  |- mesh__historyNote mesh__D004140 64%28%63%29%   
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D004140 2005
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D004140 2002
% 209.18/209.37  |- mesh__recordAuthorizer mesh__D017866 sjn
% 209.18/209.37  |- skos__broader mesh__D017866smesh__D010770
% 209.18/209.37  |- mesh__publicMeSHNote mesh__D017866 94   
% 209.18/209.37  |- mesh__dateCreated mesh__D017866 1993-06-18
% 209.18/209.37  |- mesh__historyNote mesh__D017866 94   
% 209.18/209.37  |- skos__historyNote mesh__D017866 Phosphotransferases %28%1966-1993%29%
% 209.18/209.37  |- mesh__recordOriginator mesh__D017866 TPW
% 209.18/209.37  |- skos__scopeNote mesh__D017866
% 209.18/209.37       A group of enzymes that transfers two phosphate groups from a donor such as ATP to two different acceptors. %28%From Enzyme Nomenclature, 1992%29% EC 2.7.9.%A%    
% 209.18/209.37  |- mesh__dateEstablished mesh__D017866 1994-01-01
% 209.18/209.37  |- skos__prefLabel mesh__D017866
% 209.18/209.37       Phosphotransferases %28%Paired Acceptors%29%
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D017866 2005
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D017866 2004
% 209.18/209.37  |- mesh__dateRevised mesh__D017866 2003-07-09
% 209.18/209.37  |- skos__annotation mesh__D017866 DF: PHOSPHOTRANSFERASES PAIRED   
% 209.18/209.37  |- rdf__type mesh__D017866sskos__Concept
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D017866 2006
% 209.18/209.37  |- mesh__recordMaintainer mesh__D017866 ssb
% 209.18/209.37  |- mesh__publicMeSHNote mesh__D003846 91; was see under DOPAMINE 1975-90   
% 209.18/209.37  |- skos__altLabel mesh__D003846 Methyldopamine
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003846 2001
% 209.18/209.37  |- skos__altLabel mesh__D003846 Deoxyadrenaline
% 209.18/209.37  |- mesh__activeMeSHYear mesh__D003846 2003
% 209.18/209.37  |- mesh__historyNote mesh__D003846
% 209.18/209.37       91%28%75%29%; was see under DOPAMINE 1975-90   
% 209.18/209.37  |- skos__altLabel mesh__D003846 Desoxyadrenaline
% 209.18/209.37  |- mesh__recordOriginator mesh__D003846 NLM
% 209.18/209.37  |- skos__historyNote mesh__D003846 Dopamine %28%1971-1974%29%
% 209.18/209.37  |- mesh__recordMaintainer mesh__D003846 CCR
% 209.18/209.37  |- mesh__dateCreated mesh__D003846 1974-11-27
% 209.18/209.38  |- mesh__recordAuthorizer mesh__D003846 sjn
% 209.18/209.38  |- mesh__dateEstablished mesh__D003846 1991-01-01
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D003846 2006
% 209.18/209.38  |- skos__broader mesh__D003846smesh__D004837
% 209.18/209.38  |- skos__altLabel mesh__D003846 Desoxyepinephrine
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D003846 2005
% 209.18/209.38  |- mesh__dateRevised mesh__D003846 2000-06-22
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D003846 2002
% 209.18/209.38  |- skos__prefLabel mesh__D003846 Deoxyepinephrine
% 209.18/209.38  |- skos__broader mesh__D003846smesh__D004298
% 209.18/209.38  |- rdf__type mesh__D003846sskos__Concept
% 209.18/209.38  |- skos__historyNote mesh__D003846 Methane %28%1973-1974%29%
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D003846 2004
% 209.18/209.38  |- skos__scopeNote mesh__D003846
% 209.18/209.38       Sympathomimetic, vasoconstrictor agent.     
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D003048 2002
% 209.18/209.38  |- skos__annotation mesh__D003048
% 209.18/209.38       protozoan infect caused by COCCIDIA, not COCCIDIOIDES; /drug ther: consider also COCCIDIOSTATS%A%  
% 209.18/209.38  |- skos__hiddenLabel mesh__D003048 Coccidioses
% 209.18/209.38  |- mesh__recordOriginator mesh__D003048 NLM
% 209.18/209.38  |- skos__broader mesh__D003048smesh__D011528
% 209.18/209.38  |- skos__related mesh__D003048smesh__D003049
% 209.18/209.38  |- mesh__historyNote mesh__D003048
% 209.18/209.38       BESNOITIASIS was see PROTOZOAN INFECTIONS 1985-94, was heading 1968-84; EIMERIA INFECTIONS %26% ISOSPORA INFECTIONS were see COCCIDIOSIS 1975-91, were see under COCCIDIOSIS 1967-74%A%  
% 209.18/209.38  |- mesh__recordAuthorizer mesh__D003048 sjn
% 209.18/209.38  |- mesh__dateCreated mesh__D003048 1999-01-01
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D003048 2005
% 209.18/209.38  |- skos__prefLabel mesh__D003048 Coccidiosis
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D003048 2006
% 209.18/209.38  |- mesh__dateRevised mesh__D003048 2000-06-22
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D003048 2003
% 209.18/209.38  |- skos__scopeNote mesh__D003048
% 209.18/209.38       Protozoan infection found in animals and man. It is caused by several different genera of COCCIDIA.%A%    
% 209.18/209.38  |- mesh__publicMeSHNote mesh__D003048
% 209.18/209.38       BESNOITIASIS was see PROTOZOAN INFECTIONS 1985-94, was heading 1968-84; EIMERIA INFECTIONS %26% ISOSPORA INFECTIONS were see COCCIDIOSIS 1975-91, were see under COCCIDIOSIS 1967-74%A%  
% 209.18/209.38  |- mesh__recordMaintainer mesh__D003048 PXP
% 209.18/209.38  |- skos__hiddenLabel mesh__D003048 Besnoitiases
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D003048 2004
% 209.18/209.38  |- mesh__onlineNote mesh__D003048
% 209.18/209.38       use PROTOZOAN INFECTIONS to search BESNOITIASIS 1968-94; use COCCIDIOSIS to search EIMERIA INFECTIONS %26% ISOSPORA INFECTIONS 1967-91%A%  
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D003048 2001
% 209.18/209.38  |- rdf__type mesh__D003048sskos__Concept
% 209.18/209.38  |- skos__hiddenLabel mesh__D003048 Besnoitioses
% 209.18/209.38  |- skos__altLabel mesh__D003048 Besnoitiosis
% 209.18/209.38  |- mesh__dateCreated mesh__D008531 1999-01-01
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D008531 2006
% 209.18/209.38  |- mesh__recordOriginator mesh__D008531 NLM
% 209.18/209.38  |- skos__prefLabel mesh__D008531 Megacolon
% 209.18/209.38  |- skos__broader mesh__D008531smesh__D003108
% 209.18/209.38  |- rdf__type mesh__D008531sskos__Concept
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D008531 2004
% 209.18/209.38  |- skos__scopeNote mesh__D008531
% 209.18/209.38       Dilatation of the COLON, often to alarming dimensions. There are various types of megacolon including congenital megacolon in HIRSCHSPRUNG DISEASE, idiopathic megacolon in CONSTIPATION, and TOXIC MEGACOLON.%A%    
% 209.18/209.38  |- mesh__recordMaintainer mesh__D008531 lkt
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D008531 2005
% 209.18/209.38  |- skos__hiddenLabel mesh__D008531 Megacolons
% 209.18/209.38  |- mesh__recordAuthorizer mesh__D008531 sjn
% 209.18/209.38  |- mesh__dateRevised mesh__D008531 2003-07-09
% 209.18/209.38  |- skos__hiddenLabel mesh__D022202 Bacterial Artificial Chromosome
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D022202 2005
% 209.18/209.38  |- mesh__recordOriginator mesh__D022202 nns
% 209.18/209.38  |- skos__broader mesh__D022202smesh__D022201
% 209.18/209.38  |- skos__broader mesh__D022202smesh__D002876
% 209.18/209.38  |- skos__altLabel mesh__D022202 Bacterial Artificial Chromosomes
% 209.18/209.38  |- skos__altLabel mesh__D022202 BACs %28%Chromosomes%29%
% 209.18/209.38  |- skos__annotation mesh__D022202
% 209.18/209.38       coord with specific bacterium /genet  only if particularly discussed%A%  
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D022202 2004
% 209.18/209.38  |- mesh__dateRevised mesh__D022202 2003-07-09
% 209.18/209.38  |- skos__prefLabel mesh__D022202 Chromosomes, Artificial, Bacterial
% 209.18/209.38  |- mesh__recordMaintainer mesh__D022202 nns
% 209.18/209.38  |- skos__scopeNote mesh__D022202
% 209.18/209.38       DNA constructs that are composed of, at least,  a REPLICATION ORIGIN,  for successful replication, propagation to and maintainance as an extra chromosome in bacteria. In addition, they can carry large amounts %28%about 200 kilobases%29% of other sequence for a variety of bioengineering purposes.%A%    
% 209.18/209.38  |- mesh__publicMeSHNote mesh__D022202
% 209.18/209.38       2002; see CHROMOSOMES, BACTERIAL ARTIFICIAL 2001   
% 209.18/209.38  |- mesh__dateEstablished mesh__D022202 2001-01-01
% 209.18/209.38  |- skos__hiddenLabel mesh__D022202 Artificial Chromosome, Bacterial
% 209.18/209.38  |- mesh__historyNote mesh__D022202 2002%28%2001%29%   
% 209.18/209.38  |- skos__altLabel mesh__D022202 Chromosomes, Bacterial Artificial
% 209.18/209.38  |- skos__hiddenLabel mesh__D022202 Chromosome, Bacterial Artificial
% 209.18/209.38  |- mesh__recordAuthorizer mesh__D022202 sjn
% 209.18/209.38  |- skos__historyNote mesh__D022202 Chromosomes, Bacterial %28%1994-2000%29%
% 209.18/209.38  |- rdf__type mesh__D022202sskos__Concept
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D022202 2006
% 209.18/209.38  |- mesh__dateCreated mesh__D022202 2000-06-21
% 209.18/209.38  |- skos__altLabel mesh__D022202 BAC %28%Chromosome%29%
% 209.18/209.38  |- skos__altLabel mesh__D022202 Artificial Chromosomes, Bacterial
% 209.18/209.38  |- skos__prefLabel mesh__D041965 Flavobacteriaceae
% 209.18/209.38  |- rdf__type mesh__D041965sskos__Concept
% 209.18/209.38  |- mesh__recordAuthorizer mesh__D041965 sjn
% 209.18/209.38  |- mesh__publicMeSHNote mesh__D041965 2004   
% 209.18/209.38  |- skos__annotation mesh__D041965
% 209.18/209.38       infection = FLAVOBACTERIACEAE INFECTIONS   
% 209.18/209.38  |- mesh__dateRevised mesh__D041965 2005-06-30
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D041965 2006
% 209.18/209.38  |- mesh__dateEstablished mesh__D041965 2004-01-01
% 209.18/209.38  |- mesh__historyNote mesh__D041965 2004   
% 209.18/209.38  |- skos__scopeNote mesh__D041965
% 209.18/209.38       A family of bacteria in the order Sphingobacteriales, class Sphingobacteria. They are gram-negative rods, mostly saprophytic in terrestrial and aquatic habitats.%A%    
% 209.18/209.38  |- mesh__recordMaintainer mesh__D041965 SYSTEM
% 209.18/209.38  |- mesh__recordOriginator mesh__D041965 ags
% 209.18/209.38  |- skos__broader mesh__D041965smesh__D016946
% 209.18/209.38  |- mesh__dateCreated mesh__D041965 2003-07-09
% 209.18/209.38  |- skos__broader mesh__D041965smesh__D041963
% 209.18/209.38  |- mesh__dateCreated mesh__D046650 2004-07-07
% 209.18/209.38  |- mesh__historyNote mesh__D046650 2005   
% 209.18/209.38  |- mesh__recordMaintainer mesh__D046650 jls
% 209.18/209.38  |- mesh__publicMeSHNote mesh__D046650 2005   
% 209.18/209.38  |- skos__historyNote mesh__D046650 Subject Headings %28%1969-2004%29%
% 209.18/209.38  |- skos__scopeNote mesh__D046650
% 209.18/209.38       Controlled vocabulary thesaurus produced by the NATIONAL LIBRARY OF MEDICINE. It consists of sets of terms naming descriptors in a hierarchical structure that permits searching at various levels of specificity.%A%    
% 209.18/209.38  |- skos__hiddenLabel mesh__D046650 Medical Subject Heading
% 209.18/209.38  |- mesh__recordAuthorizer mesh__D046650 jls
% 209.18/209.38  |- mesh__recordOriginator mesh__D046650 ags
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D046650 2005
% 209.18/209.38  |- mesh__dateEstablished mesh__D046650 2005-01-01
% 209.18/209.38  |- skos__broader mesh__D046650smesh__D013358
% 209.18/209.38  |- skos__hiddenLabel mesh__D046650 Subject Headings, Medical
% 209.18/209.38  |- skos__prefLabel mesh__D046650 Medical Subject Headings
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D046650 2005A
% 209.18/209.38  |- skos__hiddenLabel mesh__D046650 Subject Heading, Medical
% 209.18/209.38  |- skos__related mesh__D046650smesh__D016239
% 209.18/209.38  |- mesh__dateRevised mesh__D046650 2004-11-15
% 209.18/209.38  |- rdf__type mesh__D046650sskos__Concept
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D046650 2006
% 209.18/209.38  |- skos__altLabel mesh__D046650 MeSH Headings
% 209.18/209.38  |- skos__annotation mesh__D046650 CATALOG: use NAF entry   
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D013476 2005
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D013476 2006
% 209.18/209.38  |- mesh__recordMaintainer mesh__D013476 lkt
% 209.18/209.38  |- mesh__recordOriginator mesh__D013476 NLM
% 209.18/209.38  |- skos__scopeNote mesh__D013476
% 209.18/209.38       The FERTILIZATION of an OVUM that takes place when a FETUS is already present in the UTERUS. Superfetation results in an unusual PREGNANCY with fetuses of different ages and sizes developing in utero simultaneously.%A%    
% 209.18/209.38  |- skos__broader mesh__D013476smesh__D011272
% 209.18/209.38  |- skos__prefLabel mesh__D013476 Superfetation
% 209.18/209.38  |- skos__hiddenLabel mesh__D013476 Superfetations
% 209.18/209.38  |- mesh__recordAuthorizer mesh__D013476 sjn
% 209.18/209.38  |- mesh__dateCreated mesh__D013476 1999-01-01
% 209.18/209.38  |- mesh__dateRevised mesh__D013476 2004-07-07
% 209.18/209.38  |- rdf__type mesh__D013476sskos__Concept
% 209.18/209.38  |- skos__hiddenLabel mesh__D007439 Introversions %28%Psychology%29%
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D007439 1997
% 209.18/209.38  |- mesh__recordAuthorizer mesh__D007439 PLS
% 209.18/209.38  |- skos__broader mesh__D007439smesh__D010553
% 209.18/209.38  |- mesh__recordMaintainer mesh__D007439 JLS
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D007439 2001
% 209.18/209.38  |- rdf__type mesh__D007439sskos__Concept
% 209.18/209.38  |- skos__historyNote mesh__D007439 Personality %28%1966-1967%29%
% 209.18/209.38  |- mesh__publicMeSHNote mesh__D007439 68   
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D007439 2002
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D007439 1994
% 209.18/209.38  |- skos__annotation mesh__D007439 no qualif; DF: INTROVERSION   
% 209.18/209.38  |- mesh__dateRevised mesh__D007439 1993-06-04
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D007439 2005
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D007439 1995
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D007439 2006
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D007439 2003
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D007439 1998
% 209.18/209.38  |- mesh__dateCreated mesh__D007439 1999-01-01
% 209.18/209.38  |- skos__altLabel mesh__D007439 Introversion
% 209.18/209.38  |- mesh__dateEstablished mesh__D007439 1968-01-01
% 209.18/209.38  |- mesh__recordOriginator mesh__D007439 NLM
% 209.18/209.38  |- mesh__historyNote mesh__D007439 68   
% 209.18/209.38  |- skos__prefLabel mesh__D007439 Introversion %28%Psychology%29%
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D007439 2004
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D007439 1999
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D007439 1996
% 209.18/209.38  |- skos__broader mesh__D007439smesh__D011574
% 209.18/209.38  |- skos__scopeNote mesh__D007439
% 209.18/209.38       A state in which attention is largely directed inward upon one%27%s self.%A%    
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D007439 2000
% 209.18/209.38  |- mesh__onlineNote mesh__D018161
% 209.18/209.38       use RECEPTORS, MINERALOCORTICOID %28%NM%29% to search MINERALOCORTICOID RECEPTORS 1980-93%A%  
% 209.18/209.38  |- skos__altLabel mesh__D018161 Mineralocorticoid Receptor
% 209.18/209.38  |- mesh__historyNote mesh__D018161
% 209.18/209.38       94; was MINERALOCORTICOID RECEPTOR %28%NM%29% 1980-93   
% 209.18/209.38  |- skos__altLabel mesh__D018161 Corticoid I Receptor
% 209.18/209.38  |- mesh__dateEstablished mesh__D018161 1994-01-01
% 209.18/209.38  |- skos__historyNote mesh__D018161 Receptors, Steroid %28%1980-1993%29%
% 209.18/209.38  |- mesh__publicMeSHNote mesh__D018161
% 209.18/209.38       94; MINERALOCORTICOID RECEPTOR was indexed under RECEPTORS, STEROID 1980-93%A%  
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D018161 2002
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D018161 2003
% 209.18/209.38  |- skos__prefLabel mesh__D018161 Receptors, Mineralocorticoid
% 209.18/209.38  |- skos__broader mesh__D018161smesh__D011987
% 209.18/209.38  |- skos__hiddenLabel mesh__D018161 Mineralocorticoids Receptors
% 209.18/209.38  |- mesh__recordMaintainer mesh__D018161 KEV
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D018161 2005
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D018161 2004
% 209.18/209.38  |- mesh__recordAuthorizer mesh__D018161 PLS
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D018161 1996
% 209.18/209.38  |- mesh__dateRevised mesh__D018161 1995-06-08
% 209.18/209.38  |- skos__hiddenLabel mesh__D018161 Receptor, Mineralocorticoid
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D018161 2000
% 209.18/209.38  |- skos__scopeNote mesh__D018161
% 209.18/209.38       Cytoplasmic proteins that specifically bind mineralocorticoids and mediate their cellular effects. The receptor with its bound ligand acts in the nucleus to induce transcription of specific segments of DNA. Mineralocorticoids were named for their actions on extracellular electrolyte concentrations. The most important example is aldosterone.%A%    
% 209.18/209.38  |- skos__hiddenLabel mesh__D018161 Receptor, Corticoid I
% 209.18/209.38  |- skos__altLabel mesh__D018161 Corticoid Type I Receptors
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D018161 2006
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D018161 1998
% 209.18/209.38  |- mesh__dateCreated mesh__D018161 1993-06-21
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D018161 1997
% 209.18/209.38  |- skos__annotation mesh__D018161
% 209.18/209.38       coord IM with specific mineralocorticoid %28%IM%29%; DF: RECEPT MINERALOCORTICOID%A%  
% 209.18/209.38  |- skos__hiddenLabel mesh__D018161 Corticoid I Receptors
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D018161 2001
% 209.18/209.38  |- skos__altLabel mesh__D018161 Mineralocorticoid Receptors
% 209.18/209.38  |- skos__altLabel mesh__D018161 Receptors, Mineralocorticoids
% 209.18/209.38  |- skos__altLabel mesh__D018161 Receptors, Corticoid I
% 209.18/209.38  |- mesh__recordOriginator mesh__D018161 RAZ
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D018161 1999
% 209.18/209.38  |- rdf__type mesh__D018161sskos__Concept
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D004141 2004
% 209.18/209.38  |- mesh__recordMaintainer mesh__D004141 ags
% 209.18/209.38  |- mesh__onlineNote mesh__D004141
% 209.18/209.38       use DINOFLAGELLIDA to search DINOFLAGELLATES 1975-85 %26% use MASTIGOPHORA 1969-74; use DINOFLAGELLIDA to search RED TIDE 1975 %26% use MASTIGOPHORA 1974; use DINOFLAGELLIDA to search GONYAULAX, GYMNODINIUM %26% PERIDINIUM 1979-85%A%  
% 209.18/209.38  |- mesh__historyNote mesh__D004141
% 209.18/209.38       86; was DINOFLAGELLATES 1979-85, was DINOFLAGELLATES see under MASTIGOPHORA 1969-78; RED TIDE was heading 1979-85, was see under MASTIGOPHORA 1974-78; GONYAULAX, GYMNODINIUM %26% PERIDINIUM were see RED TIDE 1979-85%A%  
% 209.18/209.38  |- skos__altLabel mesh__D004141 Dinoflagellates
% 209.18/209.38  |- skos__prefLabel mesh__D004141 Dinoflagellida
% 209.18/209.38  |- skos__related mesh__D004141smesh__D012530
% 209.18/209.38  |- rdf__type mesh__D004141sskos__Concept
% 209.18/209.38  |- skos__scopeNote mesh__D004141
% 209.18/209.38       Protozoans of the class PHYTOMASTIGOPHOREA, found mainly in the oceans. They are characterized by the presence of transverse and longitudinal flagella which propel the organisms in a rotating manner through the water.%A%    
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D004141 2005
% 209.18/209.38  |- mesh__publicMeSHNote mesh__D004141
% 209.18/209.38       86; was DINOFLAGELLATES 1979-85, was DINOFLAGELLATES see under MASTIGOPHORA 1969-78; RED TIDE was heading 1979-85, was see under MASTIGOPHORA 1974-78; GONYAULAX, GYMNODINIUM %26% PERIDINIUM were see RED TIDE 1979-85%A%  
% 209.18/209.38  |- skos__historyNote mesh__D004141 Mastigophora %28%1966-1974%29%
% 209.18/209.38  |- mesh__dateRevised mesh__D004141 2003-07-09
% 209.18/209.38  |- skos__related mesh__D004141smesh__D010839
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D004141 2006
% 209.18/209.38  |- mesh__recordOriginator mesh__D004141 NLM
% 209.18/209.38  |- skos__broader mesh__D004141smesh__D016821
% 209.18/209.38  |- mesh__recordAuthorizer mesh__D004141 sjn
% 209.18/209.38  |- mesh__dateCreated mesh__D004141 1999-01-01
% 209.18/209.38  |- mesh__dateEstablished mesh__D004141 1979-01-01
% 209.18/209.38  |- skos__hiddenLabel mesh__D017867
% 209.18/209.38       Cyclic Nucleotide Regulated Protein Kinases
% 209.18/209.38  |- mesh__dateCreated mesh__D017867 1993-08-26
% 209.18/209.38  |- mesh__dateEstablished mesh__D017867 1998-01-01
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D017867 2005
% 209.18/209.38  |- mesh__recordMaintainer mesh__D017867 jmp
% 209.18/209.38  |- mesh__publicMeSHNote mesh__D017867 98   
% 209.18/209.38  |- mesh__dateRevised mesh__D017867 2004-07-07
% 209.18/209.38  |- skos__annotation mesh__D017867
% 209.18/209.38       GEN; prefer specifics; used for mapping supplementary chemicals; DF: CYCL NUC REG KINASES%A%  
% 209.18/209.38  |- mesh__recordAuthorizer mesh__D017867 sjn
% 209.18/209.38  |- skos__broader mesh__D017867smesh__D017346
% 209.18/209.38  |- rdf__type mesh__D017867sskos__Concept
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D017867 2006
% 209.18/209.38  |- mesh__historyNote mesh__D017867 98; use explode 1994-97   
% 209.18/209.38  |- skos__broader mesh__D017867smesh__D047908
% 209.18/209.38  |- skos__historyNote mesh__D017867 Protein Kinases %28%1973-1993%29%
% 209.18/209.38  |- mesh__recordOriginator mesh__D017867 TPW
% 209.18/209.38  |- skos__prefLabel mesh__D017867
% 209.18/209.38       Cyclic Nucleotide-Regulated Protein Kinases
% 209.18/209.38  |- skos__scopeNote mesh__D017867
% 209.18/209.38       A group of enzymes that catalyzes the phosphorylation of serine or threonine residues of proteins and is dependent on cyclic nucleotides.%A%    
% 209.18/209.38  |- skos__altLabel mesh__D003847 2-Deoxyglucose
% 209.18/209.38  |- skos__scopeNote mesh__D003847
% 209.18/209.38       2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity.%A%    
% 209.18/209.38  |- skos__hiddenLabel mesh__D003847 2 Deoxy D glucose
% 209.18/209.38  |- skos__hiddenLabel mesh__D003847 2 Desoxy D glucose
% 209.18/209.38  |- mesh__historyNote mesh__D003847
% 209.18/209.38       91%28%75%29%; was see under DEOXY SUGARS 1975-90; was see under GLUCOSE 1973-74; was see under HEXOSES 1967-72%A%  
% 209.18/209.38  |- mesh__onlineNote mesh__D003847
% 209.18/209.38       use GLUCOSE to search DEOXYGLUCOSE 1973-74 %26% use HEXOSES 1967-72%A%  
% 209.18/209.38  |- skos__prefLabel mesh__D003847 Deoxyglucose
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D003847 2005
% 209.18/209.38  |- skos__altLabel mesh__D003847 2-Deoxy-D-glucose
% 209.18/209.38  |- mesh__publicMeSHNote mesh__D003847
% 209.18/209.38       91; was see under DEOXY SUGARS 1975-90; was see under GLUCOSE 1973-74; was see under HEXOSES 1967-72%A%  
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D003847 2006
% 209.18/209.38  |- skos__hiddenLabel mesh__D003847 2 Deoxyglucose
% 209.18/209.38  |- mesh__recordMaintainer mesh__D003847 ssb
% 209.18/209.38  |- mesh__dateRevised mesh__D003847 2004-07-07
% 209.18/209.38  |- skos__annotation mesh__D003847
% 209.18/209.38       /blood = DEOXYGLUCOSE /blood %28%NIM%29% + BLOOD GLUCOSE %28%IM%29%; do not use /defic /physiol%A%  
% 209.18/209.38  |- skos__altLabel mesh__D003847 2-Desoxy-D-glucose
% 209.18/209.38  |- mesh__recordOriginator mesh__D003847 NLM
% 209.18/209.38  |- mesh__dateCreated mesh__D003847 1999-01-01
% 209.18/209.38  |- mesh__recordAuthorizer mesh__D003847 sjn
% 209.18/209.38  |- rdf__type mesh__D003847sskos__Concept
% 209.18/209.38  |- skos__broader mesh__D003847smesh__D003837
% 209.18/209.38  |- mesh__dateEstablished mesh__D003847 1991-01-01
% 209.18/209.38  |- skos__hiddenLabel mesh__D036223 Kinase HEK2, Receptor-Tyrosine
% 209.18/209.38  |- skos__hiddenLabel mesh__D036223 HEK2, Receptor-Tyrosine Kinase
% 209.18/209.38  |- mesh__recordMaintainer mesh__D036223 jmp
% 209.18/209.38  |- mesh__recordAuthorizer mesh__D036223 sjn
% 209.18/209.38  |- rdf__type mesh__D036223sskos__Concept
% 209.18/209.38  |- mesh__dateRevised mesh__D036223 2005-06-30
% 209.18/209.38  |- mesh__dateCreated mesh__D036223 2002-07-03
% 209.18/209.38  |- skos__scopeNote mesh__D036223
% 209.18/209.38       An eph family receptor found in a number of tissues including BRAIN; LUNG; KIDNEY; PANCREAS; INTESTINE; and HEART. During embryogenesis EphB3 receptor is expressed at high levels in the brain.%A%    
% 209.18/209.38  |- mesh__publicMeSHNote mesh__D036223
% 209.18/209.38       2003; CEK10 PROTEIN %28%now RECEPTOR, EPHB3%29% was indexed under PROTEIN-TYROSINE KINASE 1993-2002, EPHB3  RECEPTOR was indexed under RECEPTOR PROTEIN TYROSINE KINASES 2001-2002%A%  
% 209.18/209.38  |- skos__altLabel mesh__D036223 HEK2 Protein
% 209.18/209.38  |- skos__historyNote mesh__D036223
% 209.18/209.38       Receptor Protein-Tyrosine Kinases %28%2001-2002%29%
% 209.18/209.38  |- skos__altLabel mesh__D036223 Cek10 Protein
% 209.18/209.38  |- skos__hiddenLabel mesh__D036223 Receptor Tyrosine Kinase HEK2
% 209.18/209.38  |- skos__broader mesh__D036223smesh__D036081
% 209.18/209.38  |- mesh__recordOriginator mesh__D036223 jmp
% 209.18/209.38  |- skos__altLabel mesh__D036223 Receptor-Tyrosine Kinase HEK2
% 209.18/209.38  |- mesh__dateEstablished mesh__D036223 2003-01-01
% 209.18/209.38  |- skos__prefLabel mesh__D036223 Receptor, EphB3
% 209.18/209.38  |- skos__altLabel mesh__D036223 EphB3 Receptor
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D036223 2006
% 209.18/209.38  |- mesh__historyNote mesh__D036223
% 209.18/209.38       2003; use RECEPTOR, EPHB3 %28%NM%29% 1993-2002; for EPHB3 RECEPTOR use RECEPTORS, EPH FAMILY %28%NM%29% 2001-2002%A%  
% 209.18/209.38  |- skos__historyNote mesh__D036223
% 209.18/209.38       Protein-Tyrosine Kinase %28%1993-2002%29%
% 209.18/209.38  |- mesh__publicMeSHNote mesh__D003049 75   
% 209.18/209.38  |- mesh__dateRevised mesh__D003049 2003-07-09
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D003049 2005
% 209.18/209.38  |- skos__broader mesh__D003049smesh__D000981
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D003049 2006
% 209.18/209.38  |- mesh__recordOriginator mesh__D003049 NLM
% 209.18/209.38  |- mesh__dateEstablished mesh__D003049 1975-09-01
% 209.18/209.38  |- skos__scopeNote mesh__D003049
% 209.18/209.38       Agents useful in the treatment or prevention of COCCIDIOSIS in man or animals.%A%    
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D003049 2004
% 209.18/209.38  |- mesh__recordAuthorizer mesh__D003049 sjn
% 209.18/209.38  |- mesh__historyNote mesh__D003049 75   
% 209.18/209.38  |- skos__hiddenLabel mesh__D003049 Agents, Anticoccidial
% 209.18/209.38  |- rdf__type mesh__D003049sskos__Concept
% 209.18/209.38  |- skos__annotation mesh__D003049
% 209.18/209.38       consider also COCCIDIA /drug eff %26% COCCIDIOSIS /drug ther %28%%26% not COCCIDIOIDES %26% COCCIDIOIDOMYCOSIS%29%%A%  
% 209.18/209.38  |- mesh__recordMaintainer mesh__D003049 ssb
% 209.18/209.38  |- mesh__dateCreated mesh__D003049 1974-11-19
% 209.18/209.38  |- skos__historyNote mesh__D003049 Antiprotozoal Agents %28%1969-1974%29%
% 209.18/209.38  |- skos__prefLabel mesh__D003049 Coccidiostats
% 209.18/209.38  |- mesh__recordMaintainer mesh__D008532 lkt
% 209.18/209.38  |- rdf__type mesh__D008532sskos__Concept
% 209.18/209.38  |- mesh__recordAuthorizer mesh__D008532 sjn
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D008532 2004
% 209.18/209.38  |- skos__scopeNote mesh__D008532
% 209.18/209.38       An acute form of MEGACOLON, severe pathological dilatation of the COLON. It is associated with clinical conditions such as ULCERATIVE COLITIS; CROHN DISEASE; AMEBIC DYSENTERY; or CLOSTRIDIUM ENTEROCOLITIS.%A%    
% 209.18/209.38  |- mesh__recordOriginator mesh__D008532 NLM
% 209.18/209.38  |- mesh__historyNote mesh__D008532
% 209.18/209.38       91%28%75%29%%28%64-66%29%; was see under COLITIS, ULCERATIVE 1964-90 %28%Prov 1964-66%29%%A%  
% 209.18/209.38  |- skos__broader mesh__D008532smesh__D008531
% 209.18/209.38  |- mesh__publicMeSHNote mesh__D008532
% 209.18/209.38       91; was see under COLITIS, ULCERATIVE 1967-90   
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D008532 2005
% 209.18/209.38  |- mesh__onlineNote mesh__D008532
% 209.18/209.38       use COLITIS, ULCERATIVE to search MEGACOLON, TOXIC 1966-74%A%  
% 209.18/209.38  |- mesh__dateRevised mesh__D008532 2003-07-09
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D008532 2006
% 209.18/209.38  |- mesh__dateEstablished mesh__D008532 1991-01-01
% 209.18/209.38  |- skos__altLabel mesh__D008532 Toxic Megacolon
% 209.18/209.38  |- mesh__dateCreated mesh__D008532 1999-01-01
% 209.18/209.38  |- skos__prefLabel mesh__D008532 Megacolon, Toxic
% 209.18/209.38  |- skos__altLabel mesh__D013477 Optic Tectum
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D013477 1999
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D013477 2004
% 209.18/209.38  |- mesh__historyNote mesh__D013477 71   
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D013477 1995
% 209.18/209.38  |- rdf__type mesh__D013477sskos__Concept
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D013477 2000
% 209.18/209.38  |- skos__altLabel mesh__D013477 Tectum, Optic
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D013477 1998
% 209.18/209.38  |- mesh__dateCreated mesh__D013477 1999-01-01
% 209.18/209.38  |- skos__historyNote mesh__D013477 Corpora Quadrigemina %28%1966-1970%29%
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D013477 2003
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D013477 1994
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D013477 2006
% 209.18/209.38  |- mesh__dateEstablished mesh__D013477 1971-01-01
% 209.18/209.38  |- mesh__recordAuthorizer mesh__D013477 PLS
% 209.18/209.38  |- mesh__recordMaintainer mesh__D013477 TAP
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D013477 2002
% 209.18/209.38  |- mesh__publicMeSHNote mesh__D013477 71   
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D013477 2005
% 209.18/209.38  |- mesh__dateRevised mesh__D013477 1992-05-18
% 209.18/209.38  |- mesh__recordOriginator mesh__D013477 NLM
% 209.18/209.38  |- skos__prefLabel mesh__D013477 Superior Colliculus
% 209.18/209.38  |- skos__hiddenLabel mesh__D013477 Optic Tectums
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D013477 1997
% 209.18/209.38  |- skos__altLabel mesh__D013477 Colliculus, Superior
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D013477 1993
% 209.18/209.38  |- skos__hiddenLabel mesh__D013477 Tectums, Optic
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D013477 1996
% 209.18/209.38  |- skos__broader mesh__D013477smesh__D003336
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D013477 2001
% 209.18/209.38  |- skos__hiddenLabel mesh__D018960 Receptor, Hyaluronan
% 209.18/209.38  |- mesh__dateEstablished mesh__D018960 1996-01-01
% 209.18/209.38  |- skos__altLabel mesh__D018960 CD44 Antigen
% 209.18/209.38  |- mesh__historyNote mesh__D018960
% 209.18/209.38       96; was HYALURONIC ACID BINDING PROTEIN %28%NM%29% 1980-95; CD44 ANTIGENS was see RECEPTORS, LYMPHOCYTE HOMING 1992-93; CD44 ANTIGEN was see RECEPTORS, LYMPHOCYTE HOMING 1991-92%A%  
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D018960 2006
% 209.18/209.38  |- mesh__recordMaintainer mesh__D018960 ssb
% 209.18/209.38  |- rdf__type mesh__D018960sskos__Concept
% 209.18/209.38  |- mesh__publicMeSHNote mesh__D018960
% 209.18/209.38       96; HYALURONIC ACID BINDING PROTEIN was indexed under CARRIER PROTEINS 1980-95; RECEPTORS, LYPHOCYTE HOMING 1991-95%A%  
% 209.18/209.38  |- skos__prefLabel mesh__D018960 Antigens, CD44
% 209.18/209.38  |- skos__annotation mesh__D018960 lymphocyte homing receptors   
% 209.18/209.38  |- skos__altLabel mesh__D018960 Hyaluronan-Binding Protein
% 209.18/209.38  |- mesh__onlineNote mesh__D018960
% 209.18/209.38       use ANTIGENS, CD44 %28%NM%29% to search HYALURONIC ACID BINDING PROTEIN 1980-95; use RECEPTORS, LYMPHOCYTE HOMING to search CD44 ANTIGENS 1992-93 %26% CD44 ANTIGEN 1991-92%A%  
% 209.18/209.38  |- skos__altLabel mesh__D018960 Hyaluronic Acid Binding Protein
% 209.18/209.38  |- mesh__dateRevised mesh__D018960 2005-06-30
% 209.18/209.38  |- skos__broader mesh__D018960smesh__D016201
% 209.18/209.38  |- skos__historyNote mesh__D018960 Carrier Proteins %28%1980-1995%29%
% 209.18/209.38  |- skos__hiddenLabel mesh__D018960 Hyaluronan Binding Protein
% 209.18/209.38  |- skos__altLabel mesh__D018960 CD44 Antigens
% 209.18/209.38  |- skos__historyNote mesh__D018960
% 209.18/209.38       Receptors, Cell Surface %28%1984-1995%29%
% 209.18/209.38  |- mesh__recordAuthorizer mesh__D018960 sjn
% 209.18/209.38  |- skos__altLabel mesh__D018960 Hyaluronan Receptor
% 209.18/209.38  |- skos__hiddenLabel mesh__D018960 Antigen, CD44
% 209.18/209.38  |- skos__altLabel mesh__D018960 Receptors, Hyaluronan
% 209.18/209.38  |- skos__scopeNote mesh__D018960
% 209.18/209.38       Acidic sulfated integral membrane glycoproteins expressed in several alternatively spliced and variable glycosylated forms on a wide variety of cell types including mature T-cells, B-cells, medullary thymocytes, granulocytes, macrophages, erythrocytes, and fibroblasts. CD44 antigens are the principle cell surface receptors for hyaluronate and this interaction mediates binding of lymphocytes to high endothelial venules. %28%From Abbas et al., Cellular and Molecular Immunology, 2d ed, p156%29%%A%    
% 209.18/209.38  |- skos__altLabel mesh__D018960 Hyaluronan Receptors
% 209.18/209.38  |- skos__historyNote mesh__D018960
% 209.18/209.38       Receptors, Lymphocyte Homing %28%1991-1995%29%
% 209.18/209.38  |- mesh__recordOriginator mesh__D018960 AGS
% 209.18/209.38  |- mesh__dateCreated mesh__D018960 1995-05-26
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D018162 2002
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D018162 2005
% 209.18/209.38  |- mesh__dateCreated mesh__D018162 1993-06-04
% 209.18/209.38  |- mesh__recordOriginator mesh__D018162 AGS
% 209.18/209.38  |- rdf__type mesh__D018162sskos__Concept
% 209.18/209.38  |- mesh__recordMaintainer mesh__D018162 ags
% 209.18/209.38  |- mesh__dateEstablished mesh__D018162 1994-01-01
% 209.18/209.38  |- skos__prefLabel mesh__D018162 Coltivirus
% 209.18/209.38  |- skos__annotation mesh__D018162
% 209.18/209.38       infection: coord IM with REOVIRIDAE INFECTIONS %28%IM%29%   
% 209.18/209.38  |- skos__broader mesh__D018162smesh__D012087
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D018162 2004
% 209.18/209.38  |- skos__hiddenLabel mesh__D018162 Coltiviruses
% 209.18/209.38  |- skos__scopeNote mesh__D018162
% 209.18/209.38       A genus of REOVIRIDAE infecting Ixodidae ticks and transmitted by them to humans, deer, and small animals. The type species is COLORADO TICK FEVER VIRUS.%A%    
% 209.18/209.38  |- mesh__historyNote mesh__D018162 94   
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D018162 2003
% 209.18/209.38  |- mesh__dateRevised mesh__D018162 2001-07-25
% 209.18/209.38  |- mesh__publicMeSHNote mesh__D018162 94   
% 209.18/209.38  |- mesh__recordAuthorizer mesh__D018162 sjn
% 209.18/209.38  |- mesh__activeMeSHYear mesh__D018162 2006
% 209.18/209.38  |- mesh__recordAuthorizer mesh__D004940 sjn
% 209.18/209.38  |- mesh__recordMaintainer mesh__D004940 lkt
% 209.18/209.38  |- mesh__dateCreated mesh__D004940 1999-01-01
% 209.18/209.38  |- skos__altLabel mesh__D004940 Stenosis, Esophageal
% 209.18/209.39  |- skos__hiddenLabel mesh__D004940 Esophageal Stenoses
% 209.18/209.39  |- rdf__type mesh__D004940sskos__Concept
% 209.18/209.39  |- skos__annotation mesh__D004940
% 209.18/209.39       caustic stenosis is indexed ESOPHAGEAL STENOSIS /chem ind + BURNS, CHEMICAL%A%  
% 209.18/209.39  |- mesh__dateRevised mesh__D004940 2004-07-07
% 209.18/209.39  |- skos__hiddenLabel mesh__D004940 Stenoses, Esophageal
% 209.18/209.39  |- skos__broader mesh__D004940smesh__D004935
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D004940 2005
% 209.18/209.39  |- skos__scopeNote mesh__D004940
% 209.18/209.39       A stricture of the ESOPHAGUS. Most are acquired but can be congenital.%A%    
% 209.18/209.39  |- skos__hiddenLabel mesh__D004940 Stricture, Esophageal
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D004940 2006
% 209.18/209.39  |- skos__altLabel mesh__D004940 Esophageal Stricture
% 209.18/209.39  |- mesh__recordOriginator mesh__D004940 NLM
% 209.18/209.39  |- skos__prefLabel mesh__D004940 Esophageal Stenosis
% 209.18/209.39  |- skos__altLabel mesh__D051596 Hippocalcin-Like Protein 3
% 209.18/209.39  |- skos__hiddenLabel mesh__D051596 Hippocalcin Like Protein 3
% 209.18/209.39  |- mesh__dateCreated mesh__D051596 2005-06-30
% 209.18/209.39  |- skos__hiddenLabel mesh__D051596 Visinin Like 1 Protein
% 209.18/209.39  |- mesh__recordAuthorizer mesh__D051596 sjn
% 209.18/209.39  |- rdf__type mesh__D051596sskos__Concept
% 209.18/209.39  |- skos__broader mesh__D051596smesh__D051580
% 209.18/209.39  |- mesh__publicMeSHNote mesh__D051596
% 209.18/209.39       2006; NEUROCALCIN was indexed under RECEPTORS, CALCIUM-SENSING 2004-2005, under NERVE TISSUE PROTEINS 1992-2005, %26% under CALCIUM-BINDING PROTEINS 1992-2003%A%  
% 209.18/209.39  |- skos__altLabel mesh__D051596 Visinin-Like Protein
% 209.18/209.39  |- mesh__recordMaintainer mesh__D051596 DRC
% 209.18/209.39  |- skos__prefLabel mesh__D051596 Neurocalcin
% 209.18/209.39  |- mesh__recordOriginator mesh__D051596 DRC
% 209.18/209.39  |- skos__altLabel mesh__D051596 Visinin-Like 1 Protein
% 209.18/209.39  |- mesh__dateEstablished mesh__D051596 2006-01-01
% 209.18/209.39  |- skos__scopeNote mesh__D051596
% 209.18/209.39       A neuronal calcium sensor protein that is expressed as several isoforms and can interact with ACTIN; TUBULIN; and CLATHRIN.%A%    
% 209.18/209.39  |- skos__hiddenLabel mesh__D051596 Visinin Like Protein
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D051596 2006
% 209.18/209.39  |- mesh__historyNote mesh__D051596 2006%28%1992%29%   
% 209.18/209.39  |- skos__hiddenLabel mesh__D017868 Kinases, cAMP-Dependent Protein
% 209.18/209.39  |- skos__hiddenLabel mesh__D017868
% 209.18/209.39       Protein Kinase Type II, Cyclic AMP Dependent
% 209.18/209.39  |- skos__altLabel mesh__D017868 Protein Kinase A
% 209.18/209.39  |- skos__prefLabel mesh__D017868 Cyclic AMP-Dependent Protein Kinases
% 209.18/209.39  |- skos__annotation mesh__D017868 DF: CAMP PROTEIN KINASES   
% 209.18/209.39  |- skos__altLabel mesh__D017868 cAMP-Dependent Protein Kinases
% 209.18/209.39  |- mesh__recordAuthorizer mesh__D017868 sjn
% 209.18/209.39  |- skos__hiddenLabel mesh__D017868 Protein Kinase, cAMP-Dependent
% 209.18/209.39  |- skos__hiddenLabel mesh__D017868 Cyclic AMP Dependent Protein Kinase
% 209.18/209.39  |- rdf__type mesh__D017868sskos__Concept
% 209.18/209.39  |- mesh__recordMaintainer mesh__D017868 jmp
% 209.18/209.39  |- skos__hiddenLabel mesh__D017868
% 209.18/209.39       Adenosine Cyclic Monophosphate Dependent Protein Kinases
% 209.18/209.39  |- mesh__dateRevised mesh__D017868 2004-07-07
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D017868 2005
% 209.18/209.39  |- skos__hiddenLabel mesh__D017868 Protein Kinases, cAMP-Dependent
% 209.18/209.39  |- skos__hiddenLabel mesh__D017868 cAMP Dependent Protein Kinase
% 209.18/209.39  |- skos__scopeNote mesh__D017868
% 209.18/209.39       A group of enzymes that are dependent on cyclic AMP and catalyze the phosphorylation of serine or threonine residues on proteins.%A%    
% 209.18/209.39  |- skos__hiddenLabel mesh__D017868 Kinase, cAMP-Dependent Protein
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D017868 2006
% 209.18/209.39  |- mesh__dateCreated mesh__D017868 1993-06-21
% 209.18/209.39  |- skos__altLabel mesh__D017868
% 209.18/209.39       Adenosine Cyclic Monophosphate-Dependent Protein Kinases
% 209.18/209.39  |- mesh__publicMeSHNote mesh__D017868
% 209.18/209.39       94; was CYCLIC AMP-DEPENDENT PROTEIN KINASE see PROTEIN KINASES 1984-93%A%  
% 209.18/209.39  |- skos__hiddenLabel mesh__D017868 cAMP Dependent Protein Kinases
% 209.18/209.39  |- mesh__recordOriginator mesh__D017868 TPW
% 209.18/209.39  |- skos__broader mesh__D017868smesh__D017867
% 209.18/209.39  |- mesh__onlineNote mesh__D017868
% 209.18/209.39       use PROTEIN KINASES to search CYCLIC AMP-DEPENDENT PROTEIN KINASE 1984-93%A%  
% 209.18/209.39  |- mesh__historyNote mesh__D017868
% 209.18/209.39       94; was CYCLIC AMP-DEPENDENT PROTEIN KINASE see PROTEIN KINASES 1984-93%A%  
% 209.18/209.39  |- skos__altLabel mesh__D017868 Cyclic AMP-Dependent Protein Kinase
% 209.18/209.39  |- mesh__dateEstablished mesh__D017868 1994-01-01
% 209.18/209.39  |- skos__hiddenLabel mesh__D017868 Cyclic AMP Dependent Protein Kinases
% 209.18/209.39  |- skos__hiddenLabel mesh__D017868
% 209.18/209.39       Catalytic Subunit Cyclic AMP Dependent Protein Kinase
% 209.18/209.39  |- skos__historyNote mesh__D017868 Protein Kinases %28%1973-1993%29%
% 209.18/209.39  |- skos__altLabel mesh__D017868 cAMP-Dependent Protein Kinase
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D042261 2005
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D042261 2004
% 209.18/209.39  |- rdf__type mesh__D042261sskos__Concept
% 209.18/209.39  |- skos__scopeNote mesh__D042261
% 209.18/209.39       Instruments for RETINOSCOPY that determines the refractive state of the EYE, such as the degree of NEARSIGHTEDNESS; FARSIGHTEDNESS; or ASTIGMATISM. In principle, a retinoscope provides a light source to illuminate the RETINA, and then locates the aerial image of the retina in space to obtain an index of the refractive quality of the patient%27%s lens system.%A%    
% 209.18/209.39  |- skos__prefLabel mesh__D042261 Retinoscopes
% 209.18/209.39  |- mesh__historyNote mesh__D042261 2004   
% 209.18/209.39  |- skos__broader mesh__D042261smesh__D019721
% 209.18/209.39  |- mesh__dateCreated mesh__D042261 2003-07-09
% 209.18/209.39  |- mesh__publicMeSHNote mesh__D042261 2004   
% 209.18/209.39  |- skos__altLabel mesh__D042261 Retinoscope
% 209.18/209.39  |- mesh__dateEstablished mesh__D042261 2004-01-01
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D042261 2006
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D003848 2002
% 209.18/209.39  |- skos__hiddenLabel mesh__D003848 Phosphates, Deoxyguanosine
% 209.18/209.39  |- skos__broader mesh__D003848smesh__D003854
% 209.18/209.39  |- mesh__dateCreated mesh__D003848 1977-04-22
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D003848 1996
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D003848 1993
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D003848 2005
% 209.18/209.39  |- skos__prefLabel mesh__D003848 Deoxyguanine Nucleotides
% 209.18/209.39  |- skos__annotation mesh__D003848 /biosyn /physiol permitted   
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D003848 1997
% 209.18/209.39  |- skos__historyNote mesh__D003848 Deoxyribonucleotides %28%1973-1977%29%
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D003848 2006
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D003848 2000
% 209.18/209.39  |- mesh__dateRevised mesh__D003848 1992-05-13
% 209.18/209.39  |- skos__broader mesh__D003848smesh__D006150
% 209.18/209.39  |- skos__altLabel mesh__D003848 Deoxyguanosine Phosphates
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D003848 2003
% 209.18/209.39  |- mesh__publicMeSHNote mesh__D003848 78   
% 209.18/209.39  |- mesh__recordMaintainer mesh__D003848 TGC
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D003848 2001
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D003848 1994
% 209.18/209.39  |- rdf__type mesh__D003848sskos__Concept
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D003848 2004
% 209.18/209.39  |- mesh__recordAuthorizer mesh__D003848 PLS
% 209.18/209.39  |- mesh__historyNote mesh__D003848 78   
% 209.18/209.39  |- skos__scopeNote mesh__D003848
% 209.18/209.39       Guanine nucleotides which contain deoxyribose as the sugar moiety.%A%    
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D003848 1998
% 209.18/209.39  |- mesh__recordOriginator mesh__D003848 RLS
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D003848 1995
% 209.18/209.39  |- skos__hiddenLabel mesh__D003848 Nucleotides, Deoxyguanine
% 209.18/209.39  |- mesh__dateEstablished mesh__D003848 1978-01-01
% 209.18/209.39  |- skos__historyNote mesh__D003848 Guanine Nucleotides %28%1966-1977%29%
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D003848 1999
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D014570 2006
% 209.18/209.39  |- skos__hiddenLabel mesh__D014570 Urinary Tract Disease
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D014570 2003
% 209.18/209.39  |- skos__scopeNote mesh__D014570
% 209.18/209.39       Diseases of the urinary tract in both male and female. It does not include the male genitalia for which UROGENITAL DISEASES is used for general discussions of diseases of both the urinary tract and the genitalia.%A%    
% 209.18/209.39  |- mesh__recordAuthorizer mesh__D014570 sjn
% 209.18/209.39  |- skos__hiddenLabel mesh__D014570 Disease, Urinary Tract
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D014570 2005
% 209.18/209.39  |- skos__hiddenLabel mesh__D014570 Disease, Urological
% 209.18/209.39  |- skos__hiddenLabel mesh__D014570 Disease, Urologic
% 209.18/209.39  |- skos__altLabel mesh__D014570 Urinary Tract Diseases
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D014570 2002
% 209.18/209.39  |- skos__prefLabel mesh__D014570 Urologic Diseases
% 209.18/209.39  |- skos__annotation mesh__D014570
% 209.18/209.39       urinary tract dis only: do not confuse with UROGENITAL DISEASES which is uro + genital; GEN or unspecified: prefer specifics; /diag: consider also DIAGNOSTIC TECHNIQUES, UROLOGICAL; DF: UROL DIS%A%  
% 209.18/209.39  |- skos__hiddenLabel mesh__D014570 Urologic Disease
% 209.18/209.39  |- skos__hiddenLabel mesh__D014570 Diseases, Urologic
% 209.18/209.39  |- skos__hiddenLabel mesh__D014570 Diseases, Urological
% 209.18/209.39  |- skos__hiddenLabel mesh__D014570 Diseases, Urinary Tract
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D014570 2001
% 209.18/209.39  |- mesh__recordOriginator mesh__D014570 NLM
% 209.18/209.39  |- mesh__dateRevised mesh__D014570 1999-11-03
% 209.18/209.39  |- mesh__historyNote mesh__D014570 65   
% 209.18/209.39  |- mesh__dateEstablished mesh__D014570 1965-01-01
% 209.18/209.39  |- skos__hiddenLabel mesh__D014570 Urological Disease
% 209.18/209.39  |- rdf__type mesh__D014570sskos__Concept
% 209.18/209.39  |- mesh__dateCreated mesh__D014570 1999-01-01
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D014570 2000
% 209.18/209.39  |- skos__altLabel mesh__D014570 Urological Diseases
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D014570 2004
% 209.18/209.39  |- mesh__publicMeSHNote mesh__D014570 65   
% 209.18/209.39  |- skos__broader mesh__D014570smesh__D014569
% 209.18/209.39  |- mesh__recordMaintainer mesh__D014570 kle
% 209.18/209.39  |- rdf__type mesh__D036224sskos__Concept
% 209.18/209.39  |- skos__prefLabel mesh__D036224 Receptor, EphB4
% 209.18/209.39  |- skos__altLabel mesh__D036224 EPHB4 Protein
% 209.18/209.39  |- skos__scopeNote mesh__D036224
% 209.18/209.39       An eph family receptor found a variety of adult and embryonic tissues. Unlike the majority of proteins in this class there is little or no expression of EphB4 receptor in the BRAIN. It has been found at high levels in developing mammary glands and in invasive mammary tumors.%A%    
% 209.18/209.39  |- mesh__publicMeSHNote mesh__D036224
% 209.18/209.39       2003; HEPATOMA TRANSMEMBRANE KINASE %28%now RECEPTOR, EPHB4%29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1994-2002; EPHB4 RECEPTOR was indexed under RECEPTOR PROTEIN TYROSINE-KINASE 2000-2002%A%  
% 209.18/209.39  |- skos__hiddenLabel mesh__D036224 Kinase, Hepatoma Transmembrane
% 209.18/209.39  |- skos__historyNote mesh__D036224
% 209.18/209.39       Receptor Protein-Tyrosine Kinases %28%1994-2002%29%
% 209.18/209.39  |- mesh__historyNote mesh__D036224
% 209.18/209.39       2003; use RECEPTOR, EPHB4 %28%NM%29% 1994-2002; for EPHB4 RECPTOR use RECEPTORS, EPH FAMILY 2000-2002%A%  
% 209.18/209.39  |- mesh__recordAuthorizer mesh__D036224 sjn
% 209.18/209.39  |- skos__hiddenLabel mesh__D036224 Transmembrane Kinase, Hepatoma
% 209.18/209.39  |- mesh__dateRevised mesh__D036224 2005-06-30
% 209.18/209.39  |- mesh__dateCreated mesh__D036224 2002-07-03
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D036224 2006
% 209.18/209.39  |- skos__altLabel mesh__D036224 Hepatoma Transmembrane Kinase
% 209.18/209.39  |- skos__broader mesh__D036224smesh__D036081
% 209.18/209.39  |- mesh__recordOriginator mesh__D036224 jmp
% 209.18/209.39  |- mesh__dateEstablished mesh__D036224 2003-01-01
% 209.18/209.39  |- skos__altLabel mesh__D036224 EphB4 Receptor
% 209.18/209.39  |- mesh__recordMaintainer mesh__D036224 jmp
% 209.18/209.39  |- skos__prefLabel mesh__D008533 Megakaryocytes
% 209.18/209.39  |- skos__hiddenLabel mesh__D008533 Megakaryocyte
% 209.18/209.39  |- skos__scopeNote mesh__D008533
% 209.18/209.39       Very large BONE MARROW CELLS which release mature BLOOD PLATELETS.%A%    
% 209.18/209.39  |- mesh__recordMaintainer mesh__D008533 nns
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D008533 2005
% 209.18/209.39  |- mesh__dateRevised mesh__D008533 2003-07-09
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D008533 2006
% 209.18/209.39  |- mesh__dateCreated mesh__D008533 1999-01-01
% 209.18/209.39  |- mesh__recordAuthorizer mesh__D008533 sjn
% 209.18/209.39  |- mesh__recordOriginator mesh__D008533 NLM
% 209.18/209.39  |- rdf__type mesh__D008533sskos__Concept
% 209.18/209.39  |- skos__broader mesh__D008533smesh__D015672
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D008533 2004
% 209.18/209.39  |- mesh__recordAuthorizer mesh__D000550 sjn
% 209.18/209.39  |- skos__hiddenLabel mesh__D000550 Suppression Amblyopias
% 209.18/209.39  |- skos__hiddenLabel mesh__D000550 Amblyopias
% 209.18/209.39  |- rdf__type mesh__D000550sskos__Concept
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D000550 2006
% 209.18/209.39  |- skos__hiddenLabel mesh__D000550 Suppression Amblyopia
% 209.18/209.39  |- skos__hiddenLabel mesh__D000550 Lazy Eyes
% 209.18/209.39  |- skos__prefLabel mesh__D000550 Amblyopia
% 209.18/209.39  |- skos__hiddenLabel mesh__D000550 Developmental Amblyopia
% 209.18/209.39  |- skos__scopeNote mesh__D000550
% 209.18/209.39       A nonspecific term referring to impaired vision. Major subcategories include stimulus deprivation-induced amblyopia and toxic amblyopia. Stimulus deprivation-induced amblyopia is a developmental disorder of the visual cortex. A discrepancy between visual information received by the visual cortex from each eye results in abnormal cortical development. STRABISMUS and REFRACTIVE ERRORS may cause this condition. Toxic amblyopia is a disorder of the OPTIC NERVE which is associated with ALCOHOLISM, tobacco SMOKING, and other toxins and as an adverse effect of the use of some medications.%A%    
% 209.18/209.39  |- skos__hiddenLabel mesh__D000550 Amblyopia, Anisometropic
% 209.18/209.39  |- skos__altLabel mesh__D000550 Amblyopia, Stimulus Deprivation-Induced
% 209.18/209.39  |- mesh__dateRevised mesh__D000550 2004-07-19
% 209.18/209.39  |- skos__broader mesh__D000550smesh__D014786
% 209.18/209.39  |- skos__hiddenLabel mesh__D000550 Developmental Amblyopias
% 209.18/209.39  |- mesh__recordMaintainer mesh__D000550 jls
% 209.18/209.39  |- skos__hiddenLabel mesh__D000550 Deprivation-Induced Amblyopias, Stimulus
% 209.18/209.39  |- skos__hiddenLabel mesh__D000550 Anisometropic Amblyopias
% 209.18/209.39  |- skos__hiddenLabel mesh__D000550 Amblyopias, Suppression
% 209.18/209.39  |- skos__broader mesh__D000550smesh__D001927
% 209.18/209.39  |- skos__hiddenLabel mesh__D000550 Stimulus Deprivation Induced Amblyopia
% 209.18/209.39  |- skos__hiddenLabel mesh__D000550 Amblyopias, Stimulus Deprivation-Induced
% 209.18/209.39  |- skos__hiddenLabel mesh__D000550 Stimulus Deprivation-Induced Amblyopias
% 209.18/209.39  |- skos__hiddenLabel mesh__D000550 Amblyopias, Developmental
% 209.18/209.39  |- mesh__dateCreated mesh__D000550 1999-01-01
% 209.18/209.39  |- skos__hiddenLabel mesh__D000550 Amblyopias, Anisometropic
% 209.18/209.39  |- skos__hiddenLabel mesh__D000550 Amblyopia, Stimulus Deprivation Induced
% 209.18/209.39  |- mesh__recordOriginator mesh__D000550 NLM
% 209.18/209.39  |- skos__hiddenLabel mesh__D000550 Eye, Lazy
% 209.18/209.39  |- skos__altLabel mesh__D000550 Stimulus Deprivation-Induced Amblyopia
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D000550 2005
% 209.18/209.39  |- skos__hiddenLabel mesh__D000550 Eyes, Lazy
% 209.18/209.39  |- skos__hiddenLabel mesh__D000550 Deprivation-Induced Amblyopia, Stimulus
% 209.18/209.39  |- mesh__recordMaintainer mesh__D013478 lkt
% 209.18/209.39  |- skos__scopeNote mesh__D013478
% 209.18/209.39       DUODENAL OBSTRUCTION by the superior mesenteric artery %28%MESENTERIC ARTERY, SUPERIOR%29% which travels in the root of the MESENTERY and crosses over the DUODENUM. The syndrome is characterized by the dilated proximal duodenum and STOMACH, bloating, ABDOMINAL CRAMPS, and VOMITING. Often it is observed in patient with body casts after spinal surgery.%A%    
% 209.18/209.39  |- skos__altLabel mesh__D013478 Duodenal Compression Syndrome, Mesenteric
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D013478 2006
% 209.18/209.39  |- skos__historyNote mesh__D013478 Duodenal Obstruction %28%1966-1979%29%
% 209.18/209.39  |- mesh__recordAuthorizer mesh__D013478 sjn
% 209.18/209.39  |- mesh__publicMeSHNote mesh__D013478
% 209.18/209.39       91; was see under DUODENAL OBSTRUCTION 1980-90   
% 209.18/209.39  |- mesh__dateRevised mesh__D013478 2003-07-09
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D013478 2005
% 209.18/209.39  |- skos__altLabel mesh__D013478 Mesenteric Duodenal Compression Syndrome
% 209.18/209.39  |- skos__hiddenLabel mesh__D013478 Syndrome, Cast
% 209.18/209.39  |- mesh__dateEstablished mesh__D013478 1991-01-01
% 209.18/209.39  |- mesh__historyNote mesh__D013478
% 209.18/209.39       91%28%80%29%; was see under DUODENAL OBSTRUCTION 1980-90   
% 209.18/209.39  |- skos__historyNote mesh__D013478 Mesenteric Arteries %28%1966-1979%29%
% 209.18/209.39  |- mesh__dateCreated mesh__D013478 1979-05-30
% 209.18/209.39  |- skos__prefLabel mesh__D013478 Superior Mesenteric Artery Syndrome
% 209.18/209.39  |- skos__broader mesh__D013478smesh__D004380
% 209.18/209.39  |- mesh__recordOriginator mesh__D013478 SMH
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D013478 2004
% 209.18/209.39  |- skos__altLabel mesh__D013478 Cast Syndrome
% 209.18/209.39  |- rdf__type mesh__D013478sskos__Concept
% 209.18/209.39  |- skos__hiddenLabel mesh__D018961 Instructional Technologies
% 209.18/209.39  |- mesh__recordOriginator mesh__D018961 TGC
% 209.18/209.39  |- skos__scopeNote mesh__D018961
% 209.18/209.39       Systematic identification, development, organization, or utilization of educational resources and the management of these processes. It is occasionally used also in a more limited sense to describe the use of equipment-oriented techniques or audiovisual aids in educational settings. %28%Thesaurus of ERIC Descriptors, December 1993, p132%29%%A%    
% 209.18/209.39  |- mesh__publicMeSHNote mesh__D018961 96   
% 209.18/209.39  |- skos__related mesh__D018961smesh__D013664
% 209.18/209.39  |- mesh__dateEstablished mesh__D018961 1996-01-01
% 209.18/209.39  |- skos__hiddenLabel mesh__D018961 Educational Technologies
% 209.18/209.39  |- mesh__recordMaintainer mesh__D018961 ags
% 209.18/209.39  |- skos__altLabel mesh__D018961 Technology, Educational
% 209.18/209.39  |- mesh__dateRevised mesh__D018961 2004-07-07
% 209.18/209.39  |- skos__broader mesh__D018961smesh__D013672
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D018961 2005
% 209.18/209.39  |- skos__hiddenLabel mesh__D018961 Technologies, Instructional
% 209.18/209.39  |- mesh__dateCreated mesh__D018961 1995-03-17
% 209.18/209.39  |- skos__annotation mesh__D018961
% 209.18/209.39       IM; coord with field or medium of educ %28%IM%29%; DF: EDUC TECHNOL%A%  
% 209.18/209.39  |- mesh__recordAuthorizer mesh__D018961 sjn
% 209.18/209.39  |- skos__hiddenLabel mesh__D018961 Technologies, Educational
% 209.18/209.39  |- skos__altLabel mesh__D018961 Technology, Instructional
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D018961 2006
% 209.18/209.39  |- skos__prefLabel mesh__D018961 Educational Technology
% 209.18/209.39  |- mesh__historyNote mesh__D018961 96   
% 209.18/209.39  |- rdf__type mesh__D018961sskos__Concept
% 209.18/209.39  |- mesh__dateRevised mesh__D018163 2001-07-25
% 209.18/209.39  |- skos__historyNote mesh__D018163 RNA Viruses %28%1975-1977%29%
% 209.18/209.39  |- mesh__recordMaintainer mesh__D018163 ags
% 209.18/209.39  |- mesh__recordAuthorizer mesh__D018163 sjn
% 209.18/209.39  |- skos__broader mesh__D018163smesh__D012087
% 209.18/209.39  |- mesh__historyNote mesh__D018163
% 209.18/209.39       1994; for CHANGUINOLA VIRUS use REOVIRIDAE 1976-1993; for CHENUDA VIRUS see REOVIRIDAE 1976-1993; for KEMEROVO VIRUS, REOVIRIDAE 1981-1990%A%  
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D018163 2002
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D018163 2004
% 209.18/209.39  |- mesh__dateCreated mesh__D018163 1993-06-04
% 209.18/209.39  |- mesh__recordOriginator mesh__D018163 AGS
% 209.18/209.39  |- skos__hiddenLabel mesh__D018163 Orbiviruses
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D018163 2003
% 209.18/209.39  |- skos__prefLabel mesh__D018163 Orbivirus
% 209.18/209.39  |- mesh__dateEstablished mesh__D018163 1994-01-01
% 209.18/209.39  |- skos__annotation mesh__D018163
% 209.18/209.39       infection: coord IM with REOVIRIDAE INFECTIONS %28%IM%29%   
% 209.18/209.39  |- skos__scopeNote mesh__D018163
% 209.18/209.39       A genus of REOVIRIDAE infecting a wide range of arthropods and vertebrates including humans. It comprises at least twelve serological subgroups. Transmission is by vectors such as midges, mosquitoes, sandflies, and ticks.%A%    
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D018163 2006
% 209.18/209.39  |- skos__historyNote mesh__D018163 Reoviridae %28%1976-1993%29%
% 209.18/209.39  |- mesh__publicMeSHNote mesh__D018163
% 209.18/209.39       1994; for CHANGUINOLA VIRUS see REOVIRIDAE 1976-1993; for CHENUDA VIRUS see KEMEROVO VIRUS 1994-2001, see REOVIRIDAE 1976-1993; for KEMEROVO VIRUS see KEMEROVO VIRUS 1994-2001, see KEMEROVO GROUP VIRUSES 1979-1993, REOVIRIDAE 1981-1990, see REOVIRUSES 1975-1980%A%  
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D018163 2005
% 209.18/209.39  |- rdf__type mesh__D018163sskos__Concept
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D010180 2005
% 209.18/209.39  |- mesh__dateEstablished mesh__D010180 1967-01-01
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D010180 1998
% 209.18/209.39  |- skos__related mesh__D010180smesh__D010193
% 209.18/209.39  |- mesh__recordAuthorizer mesh__D010180 SJN
% 209.18/209.39  |- rdf__type mesh__D010180sskos__Concept
% 209.18/209.39  |- skos__prefLabel mesh__D010180 Pancreatectomy
% 209.18/209.39  |- skos__broader mesh__D010180smesh__D013505
% 209.18/209.39  |- mesh__recordMaintainer mesh__D010180 PXP
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D010180 2002
% 209.18/209.39  |- mesh__dateRevised mesh__D010180 1997-06-20
% 209.18/209.39  |- mesh__historyNote mesh__D010180 67%28%65%29%   
% 209.18/209.39  |- mesh__recordOriginator mesh__D010180 NLM
% 209.18/209.39  |- mesh__publicMeSHNote mesh__D010180 67   
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D010180 2001
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D010180 2004
% 209.18/209.39  |- skos__scopeNote mesh__D010180
% 209.18/209.39       Surgical removal of the pancreas. %28%Dorland, 28th ed%29%     
% 209.18/209.39  |- skos__hiddenLabel mesh__D010180 Pancreatectomies
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D010180 2000
% 209.18/209.39  |- skos__annotation mesh__D010180
% 209.18/209.39       do not use /util except by MeSH definition   
% 209.18/209.39  |- mesh__dateCreated mesh__D010180 1999-01-01
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D010180 2006
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D010180 2003
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D010180 1999
% 209.18/209.39  |- skos__broader mesh__D004941smesh__D004935
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D004941 2004
% 209.18/209.39  |- skos__annotation mesh__D004941 ESOPHAGITIS, PEPTIC is also available   
% 209.18/209.39  |- mesh__recordOriginator mesh__D004941 NLM
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D004941 2005
% 209.18/209.39  |- mesh__recordMaintainer mesh__D004941 lkt
% 209.18/209.39  |- mesh__recordAuthorizer mesh__D004941 sjn
% 209.18/209.39  |- skos__broader mesh__D004941smesh__D005759
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D004941 2006
% 209.18/209.39  |- skos__scopeNote mesh__D004941
% 209.18/209.39       INFLAMMATION, acute or chronic, of the ESOPHAGUS caused by BACTERIA, chemicals, or TRAUMA.%A%    
% 209.18/209.39  |- mesh__dateRevised mesh__D004941 2003-07-09
% 209.18/209.39  |- skos__prefLabel mesh__D004941 Esophagitis
% 209.18/209.39  |- mesh__dateCreated mesh__D004941 1999-01-01
% 209.18/209.39  |- skos__hiddenLabel mesh__D004941 Esophagitides
% 209.18/209.39  |- rdf__type mesh__D004941sskos__Concept
% 209.18/209.39  |- skos__prefLabel mesh__D051597 Hippocalcin
% 209.18/209.39  |- mesh__publicMeSHNote mesh__D051597
% 209.18/209.39       2006; HIPPOCALCIN was indexed under CALCIUM-BINDING PROTEINS %26% NERVE TISSUE PROTEINS 1992-2005%A%  
% 209.18/209.39  |- mesh__recordOriginator mesh__D051597 DRC
% 209.18/209.39  |- skos__altLabel mesh__D051597 Recoverin-Like Calcium-Binding Protein P23k
% 209.18/209.39  |- mesh__historyNote mesh__D051597 2006%28%1992%29%   
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D051597 2006
% 209.18/209.39  |- skos__scopeNote mesh__D051597
% 209.18/209.39       A neuronal calcium-sensor protein that was initially found in the NEURONS of the HIPPOCAMPUS. It interacts with NEURONAL APOPTOSIS-INHIBITORY PROTEIN.%A%    
% 209.18/209.39  |- mesh__dateCreated mesh__D051597 2005-06-30
% 209.18/209.39  |- skos__hiddenLabel mesh__D051597 P23k Recoverin Like Protein
% 209.18/209.39  |- skos__hiddenLabel mesh__D051597 Recoverin-Like Protein, P23k
% 209.18/209.39  |- mesh__recordAuthorizer mesh__D051597 ags
% 209.18/209.39  |- mesh__dateEstablished mesh__D051597 2006-01-01
% 209.18/209.39  |- mesh__dateRevised mesh__D051597 2005-07-21
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D051597 2006A
% 209.18/209.39  |- skos__hiddenLabel mesh__D051597
% 209.18/209.39       Recoverin Like Calcium Binding Protein P23k
% 209.18/209.39  |- skos__altLabel mesh__D051597 P23k Recoverin-Like Protein
% 209.18/209.39  |- rdf__type mesh__D051597sskos__Concept
% 209.18/209.39  |- mesh__recordMaintainer mesh__D051597 ags
% 209.18/209.39  |- skos__broader mesh__D051597smesh__D051580
% 209.18/209.39  |- skos__historyNote mesh__D004143 Succinates %28%1966-1977%29%
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D004143 2003
% 209.18/209.39  |- skos__hiddenLabel mesh__D004143 Sulfosuccinate, Dioctyl
% 209.18/209.39  |- skos__altLabel mesh__D004143 Docusate
% 209.18/209.39  |- skos__altLabel mesh__D004143 Sodium Dioctyl Sulfosuccinate
% 209.18/209.39  |- skos__altLabel mesh__D004143 DOSS
% 209.18/209.39  |- skos__scopeNote mesh__D004143
% 209.18/209.39       All-purpose surfactant, wetting agent, and solubilizer used in the drug, cosmetics, and food industries. It has also been used in laxatives and as cerumenolytics. It is usually administered as either the calcium, potassium, or sodium salt.%A%    
% 209.18/209.39  |- skos__altLabel mesh__D004143 Docusate Sodium
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D004143 2002
% 209.18/209.39  |- skos__hiddenLabel mesh__D004143 Sodium, Docusate
% 209.18/209.39  |- skos__altLabel mesh__D004143
% 209.18/209.39       Sodium Bis%28%2-ethylhexyl%29%sulfosuccinate
% 209.18/209.39  |- skos__historyNote mesh__D004143 Surface-Active Agents %28%1966-1977%29%
% 209.18/209.39  |- mesh__recordOriginator mesh__D004143 SH
% 209.18/209.39  |- skos__altLabel mesh__D004143 Sodium Dioctylsulphosuccinate
% 209.18/209.39  |- rdf__type mesh__D004143sskos__Concept
% 209.18/209.39  |- mesh__dateCreated mesh__D004143 1977-04-22
% 209.18/209.39  |- skos__hiddenLabel mesh__D004143 Sulfosuccinates, Dioctyl
% 209.18/209.39  |- mesh__recordAuthorizer mesh__D004143 sjn
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D004143 2006
% 209.18/209.39  |- skos__hiddenLabel mesh__D004143 Potassium, Docusate
% 209.18/209.39  |- skos__altLabel mesh__D004143 Docusate Potassium
% 209.18/209.39  |- skos__hiddenLabel mesh__D004143 Dioctylsulphosuccinate, Sodium
% 209.18/209.39  |- skos__altLabel mesh__D004143 Dioctyl Sulfosuccinate
% 209.18/209.39  |- skos__altLabel mesh__D004143 Dioctylsulfosuccinate
% 209.18/209.39  |- mesh__dateRevised mesh__D004143 2001-07-25
% 209.18/209.39  |- mesh__recordMaintainer mesh__D004143 ssb
% 209.18/209.39  |- skos__broader mesh__D004143smesh__D019822
% 209.18/209.39  |- mesh__publicMeSHNote mesh__D004143
% 209.18/209.39       96; was DIOCTYL SULFOSUCCINATES 1978-95 %28%see under SUCCINATES 1978-90%29%; DIOCTYL SULFOSUCCINIC ACID was indexed under DIOCTYL SULFOSUCCINATES 1978-95; ALCOHOLS, OCTYL 1973-78; ALKYL SULFONATES 1974-76; %26% SUCCINATES 1968-78%A%  
% 209.18/209.39  |- skos__altLabel mesh__D004143 Docusate Calcium
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D004143 2005
% 209.18/209.39  |- mesh__dateEstablished mesh__D004143 1991-01-01
% 209.18/209.39  |- skos__hiddenLabel mesh__D004143 Calcium, Docusate
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D004143 2004
% 209.18/209.39  |- skos__hiddenLabel mesh__D004143 Dioctyl Sulfosuccinate, Sodium
% 209.18/209.39  |- mesh__historyNote mesh__D004143
% 209.18/209.39       96; was DIOCTYL SULFOSUCCINATES 1978-95 %28%see under SUCCINATES 1978-90%29%; DIOCTYL SULFOSUCCINIC ACID was NM 1968-95%A%  
% 209.18/209.39  |- skos__prefLabel mesh__D004143 Dioctyl Sulfosuccinic Acid
% 209.18/209.39  |- skos__hiddenLabel mesh__D017869 Cyclic GMP Dependent Protein Kinases
% 209.18/209.39  |- mesh__dateEstablished mesh__D017869 1994-01-01
% 209.18/209.39  |- mesh__historyNote mesh__D017869
% 209.18/209.39       1994; for PROTEIN KINASE G use CYCLIC GMP-DEPENDENT PROTEIN KINASES %28%NM%29% 1999-2000%A%  
% 209.18/209.39  |- skos__hiddenLabel mesh__D017869 Kinases, cGMP-Dependent Protein
% 209.18/209.39  |- rdf__type mesh__D017869sskos__Concept
% 209.18/209.39  |- mesh__recordMaintainer mesh__D017869 jmp
% 209.18/209.39  |- mesh__dateRevised mesh__D017869 2004-07-07
% 209.18/209.39  |- skos__altLabel mesh__D017869
% 209.18/209.39       Guanosine Cyclic 3%27%,5%27%-Phosphate-Dependent Protein Kinase
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D017869 2005
% 209.18/209.39  |- skos__hiddenLabel mesh__D017869 Cyclic GMP Dependent Protein Kinase
% 209.18/209.39  |- skos__hiddenLabel mesh__D017869
% 209.18/209.39       Guanosine Cyclic 3%27%,5%27% Phosphate Dependent Protein Kinase
% 209.18/209.39  |- mesh__activeMeSHYear mesh__D017869 2006
% 209.18/209.39  |- mesh__recordAuthorizer mesh__D017869 sjn
% 209.18/209.39  |- skos__broader mesh__D017869smesh__D017867
% 209.18/209.39  |- skos__altLabel mesh__D017869 Protein Kinase G
% 209.18/209.39  |- skos__prefLabel mesh__D017869 Cyclic GMP-Dependent Protein Kinases
% 209.18/209.39  |- skos__altLabel mesh__D017869
% 209.18/209.39       Guanosine Cyclic Monophosphate-Dependent Protein Kinases
% 209.18/209.39  |- skos__altLabel mesh__D017869 cGMP-Dependent Protein Kinases
% 209.18/209.39  |- mesh__dateCreated mesh__D017869 1993-06-04
% 209.18/209.39  |- skos__historyNote mesh__D017869 Protein Kinases %28%1982-1993%29%
% 209.18/209.39  |- skos__hiddenLabel mesh__D017869
% 209.18/209.39       Guanosine Cyclic Monophosphate Dependent Protein Kinases
% 209.18/209.39  |- skos__hiddenLabel mesh__D017869 Protein Kinases, cGMP-Dependent
% 209.18/209.39  |- mesh__publicMeSHNote mesh__D017869
% 209.18/209.39       1994; PROTEIN KINASE G was indexed under PROTEIN KINASES 1999-2000%A%  
% 209.18/209.39  |- skos__scopeNote mesh__D017869
% 209.18/209.39       A group of enzymes that are dependent on cyclic GMP and catalyzes the phosphorylation of serine or threonine residues of proteins.%A%    
% 209.18/209.39  |- skos__altLabel mesh__D017869 Cyclic GMP-Dependent Protein Kinase
% 209.18/209.39  |- skos__hiddenLabel mesh__D017869 cGMP Dependent Protein Kinases
% 209.18/209.39  |- mesh__recordOriginator mesh__D017869 TPW
% 209.18/209.39  |- skos__hiddenLabel mesh__D042262 Shadow Tests
% 209.18/209.39  |- skos__broader mesh__D042262smesh__D009887
% 209.18/209.39  |- mesh__publicMeSHNote mesh__D042262 2004   
% 209.18/209.39  |- skos__hiddenLabel mesh__D042262 Skiametries
% 209.18/209.40  |- mesh__dateCreated mesh__D042262 2003-07-09
% 209.18/209.40  |- skos__prefLabel mesh__D042262 Retinoscopy
% 209.18/209.40  |- skos__altLabel mesh__D042262 Skiametry
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D042262 2006
% 209.18/209.40  |- skos__altLabel mesh__D042262 Shadow Test
% 209.18/209.40  |- skos__hiddenLabel mesh__D042262 Retinoscopies
% 209.18/209.40  |- skos__scopeNote mesh__D042262
% 209.18/209.40       An objective determination of the refractive state of the eye %28%NEARSIGHTEDNESS; FARSIGHTEDNESS; ASTIGMATISM%29%. By using a RETINOSCOPE, the amount of correction and the power of lens needed can be determined.%A%    
% 209.18/209.40  |- skos__related mesh__D042262smesh__D012029
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D042262 2005
% 209.18/209.40  |- skos__historyNote mesh__D042262 Refraction, Ocular %28%1966-2003%29%
% 209.18/209.40  |- mesh__historyNote mesh__D042262 2004   
% 209.18/209.40  |- skos__altLabel mesh__D042262 Skiascopy
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D042262 2004
% 209.18/209.40  |- skos__hiddenLabel mesh__D042262 Skiascopies
% 209.18/209.40  |- rdf__type mesh__D042262sskos__Concept
% 209.18/209.40  |- mesh__dateEstablished mesh__D042262 2004-01-01
% 209.18/209.40  |- skos__annotation mesh__D003849 /biosyn /physiol permitted   
% 209.18/209.40  |- skos__historyNote mesh__D003849 Deoxyribonucleosides %28%1973-1977%29%
% 209.18/209.40  |- mesh__dateRevised mesh__D003849 1990-05-30
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D003849 2001
% 209.18/209.40  |- mesh__historyNote mesh__D003849 78   
% 209.18/209.40  |- skos__broader mesh__D003849smesh__D003853
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D003849 2003
% 209.18/209.40  |- mesh__publicMeSHNote mesh__D003849 78   
% 209.18/209.40  |- skos__scopeNote mesh__D003849
% 209.18/209.40       A nucleoside consisting of the base guanine and the sugar deoxyribose.%A%    
% 209.18/209.40  |- skos__broader mesh__D003849smesh__D006151
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D003849 1994
% 209.18/209.40  |- rdf__type mesh__D003849sskos__Concept
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D003849 2004
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D003849 1998
% 209.18/209.40  |- skos__prefLabel mesh__D003849 Deoxyguanosine
% 209.18/209.40  |- mesh__recordMaintainer mesh__D003849 PLS
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D003849 1995
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D003849 2002
% 209.18/209.40  |- mesh__dateEstablished mesh__D003849 1978-01-01
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D003849 1999
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D003849 1992
% 209.18/209.40  |- mesh__recordAuthorizer mesh__D003849 NLM
% 209.18/209.40  |- skos__historyNote mesh__D003849 Guanosine %28%1972-1977%29%
% 209.18/209.40  |- mesh__dateCreated mesh__D003849 1977-04-22
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D003849 1996
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D003849 1993
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D003849 2000
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D003849 2005
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D003849 1997
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D003849 1991
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D003849 2006
% 209.18/209.40  |- mesh__recordOriginator mesh__D003849 RLS
% 209.18/209.40  |- skos__altLabel mesh__D014571 Urologic Cancer
% 209.18/209.40  |- skos__altLabel mesh__D014571 Urological Cancer
% 209.18/209.40  |- mesh__recordAuthorizer mesh__D014571 sjn
% 209.18/209.40  |- mesh__recordMaintainer mesh__D014571 lkt
% 209.18/209.40  |- skos__hiddenLabel mesh__D014571 Neoplasms, Urinary Tract
% 209.18/209.40  |- skos__hiddenLabel mesh__D014571 Cancers, Urological
% 209.18/209.40  |- skos__hiddenLabel mesh__D014571 Cancers, Urinary Tract
% 209.18/209.40  |- skos__hiddenLabel mesh__D014571 Neoplasms, Urological
% 209.18/209.40  |- skos__hiddenLabel mesh__D014571 Neoplasm, Urological
% 209.18/209.40  |- skos__altLabel mesh__D014571 Cancer of the Urinary Tract
% 209.18/209.40  |- skos__hiddenLabel mesh__D014571 Urologic Cancers
% 209.18/209.40  |- skos__hiddenLabel mesh__D014571 Cancer, Urologic
% 209.18/209.40  |- skos__hiddenLabel mesh__D014571 Cancer, Urological
% 209.18/209.40  |- skos__hiddenLabel mesh__D014571 Urinary Tract Cancers
% 209.18/209.40  |- skos__hiddenLabel mesh__D014571 Urological Neoplasm
% 209.18/209.40  |- skos__hiddenLabel mesh__D014571 Tract Neoplasms, Urinary
% 209.18/209.40  |- skos__hiddenLabel mesh__D014571 Urinary Tract Neoplasm
% 209.18/209.40  |- skos__altLabel mesh__D014571 Urinary Tract Cancer
% 209.18/209.40  |- skos__hiddenLabel mesh__D014571 Urological Cancers
% 209.18/209.40  |- skos__scopeNote mesh__D014571
% 209.18/209.40       Tumors or cancer of the URINARY TRACT in either the male or the female.%A%    
% 209.18/209.40  |- skos__hiddenLabel mesh__D014571 Cancers, Urologic
% 209.18/209.40  |- skos__historyNote mesh__D014571 Urogenital Neoplasms %28%1966-1977%29%
% 209.18/209.40  |- skos__hiddenLabel mesh__D014571 Neoplasm, Urinary Tract
% 209.18/209.40  |- skos__hiddenLabel mesh__D014571 Cancer, Urinary Tract
% 209.18/209.40  |- skos__altLabel mesh__D014571 Urinary Tract Neoplasms
% 209.18/209.40  |- mesh__dateCreated mesh__D014571 1977-03-29
% 209.18/209.40  |- mesh__recordOriginator mesh__D014571 SMH
% 209.18/209.40  |- skos__hiddenLabel mesh__D014571 Urologic Neoplasm
% 209.18/209.40  |- mesh__dateRevised mesh__D014571 2005-06-30
% 209.18/209.40  |- skos__hiddenLabel mesh__D014571 Neoplasm, Urologic
% 209.18/209.40  |- skos__broader mesh__D014571smesh__D014565
% 209.18/209.40  |- skos__annotation mesh__D014571
% 209.18/209.40       general or unspecified: prefer specifics; coordinate IM with histological type of neoplasm %28%IM%29%;  DF: UROL NEOPL%A%  
% 209.18/209.40  |- skos__prefLabel mesh__D014571 Urologic Neoplasms
% 209.18/209.40  |- skos__altLabel mesh__D014571 Urological Neoplasms
% 209.18/209.40  |- skos__altLabel mesh__D014571 Neoplasms, Urologic
% 209.18/209.40  |- rdf__type mesh__D014571sskos__Concept
% 209.18/209.40  |- mesh__dateEstablished mesh__D014571 1978-01-01
% 209.18/209.40  |- mesh__publicMeSHNote mesh__D014571 78   
% 209.18/209.40  |- skos__hiddenLabel mesh__D014571 Tract Neoplasm, Urinary
% 209.18/209.40  |- mesh__historyNote mesh__D014571 78   
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D014571 2006
% 209.18/209.40  |- mesh__recordMaintainer mesh__D036225 ags
% 209.18/209.40  |- mesh__recordOriginator mesh__D036225 jmp
% 209.18/209.40  |- rdf__type mesh__D036225sskos__Concept
% 209.18/209.40  |- skos__altLabel mesh__D036225 EPHT2 Protein
% 209.18/209.40  |- mesh__historyNote mesh__D036225
% 209.18/209.40       2003; for RECEPTOR, EPHB1, ELK PROTEIN EPHT2 PROTEIN %26% NEURONALLY EXPRESSED EPH-TYROSINE KINASE use RECEPTORS, EPH FAMILY 1999-2002%A%  
% 209.18/209.40  |- skos__altLabel mesh__D036225 EphB1 Receptor
% 209.18/209.40  |- skos__altLabel mesh__D036225
% 209.18/209.40       Neuronally Expressed EPH-Related Tyrosine Kinase
% 209.18/209.40  |- skos__scopeNote mesh__D036225
% 209.18/209.40       An eph family receptor found primarily in the nervous system. In the embryonic BRAIN EphB1 receptor expression occurs in the mantle layer and increases with the progression of embryogenesis. In adult brain it is found in the several regions including the CEREBELLUM; CEREBRAL CORTEX; and CAUDATE NUCLEUS; and PUTAMEN.%A%    
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D036225 2006A
% 209.18/209.40  |- skos__broader mesh__D036225smesh__D036081
% 209.18/209.40  |- skos__hiddenLabel mesh__D036225
% 209.18/209.40       Neuronally Expressed EPH Related Tyrosine Kinase
% 209.18/209.40  |- skos__prefLabel mesh__D036225 Receptor, EphB1
% 209.18/209.40  |- mesh__dateEstablished mesh__D036225 2003-01-01
% 209.18/209.40  |- mesh__recordAuthorizer mesh__D036225 ags
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D036225 2006
% 209.18/209.40  |- skos__historyNote mesh__D036225
% 209.18/209.40       Receptor Protein-Tyrosine Kinases %28%1997-2002%29%
% 209.18/209.40  |- mesh__dateRevised mesh__D036225 2005-07-12
% 209.18/209.40  |- mesh__publicMeSHNote mesh__D036225
% 209.18/209.40       2003; EPHB1 RECEPTOR, ELK PROTEIN EPHT2 PROTEIN %26% NEURONALLY EXPRESSED EPH-TYROSINE KINASE were indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1999-2002%A%  
% 209.18/209.40  |- mesh__dateCreated mesh__D036225 2002-07-03
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D008534 2005
% 209.18/209.40  |- mesh__dateRevised mesh__D008534 2003-07-09
% 209.18/209.40  |- mesh__historyNote mesh__D008534
% 209.18/209.40       91%28%75%29%; was see under ERYTHROCYTES, ABNORMAL 1975-90; was see under ERYTHROCYTES 1963-74%A%  
% 209.18/209.40  |- skos__scopeNote mesh__D008534
% 209.18/209.40       Red blood cell precursors, corresponding to ERYTHROBLASTS, that are larger than normal, usually resulting from a FOLIC ACID DEFICIENCY or VITAMIN B 12 DEFICIENCY.%A%    
% 209.18/209.40  |- skos__related mesh__D008534smesh__D000749
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D008534 2006
% 209.18/209.40  |- mesh__dateCreated mesh__D008534 1999-01-01
% 209.18/209.40  |- mesh__publicMeSHNote mesh__D008534
% 209.18/209.40       91; was see under ERYTHROCYTES, ABNORMAL 1975-90; was see under ERYTHROCYTES 1963-74%A%  
% 209.18/209.40  |- mesh__recordMaintainer mesh__D008534 nns
% 209.18/209.40  |- mesh__dateEstablished mesh__D008534 1991-01-01
% 209.18/209.40  |- skos__broader mesh__D008534smesh__D004913
% 209.18/209.40  |- rdf__type mesh__D008534sskos__Concept
% 209.18/209.40  |- mesh__onlineNote mesh__D008534 search ERYTHROCYTES 1966-74   
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D008534 2004
% 209.18/209.40  |- skos__hiddenLabel mesh__D008534 Megaloblast
% 209.18/209.40  |- skos__broader mesh__D008534smesh__D004900
% 209.18/209.40  |- mesh__recordAuthorizer mesh__D008534 sjn
% 209.18/209.40  |- skos__prefLabel mesh__D008534 Megaloblasts
% 209.18/209.40  |- mesh__recordOriginator mesh__D008534 NLM
% 209.18/209.40  |- skos__altLabel mesh__D000551 Europharma Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__hiddenLabel mesh__D000551 NA 872
% 209.18/209.40  |- skos__altLabel mesh__D000551 Mack Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__altLabel mesh__D000551 Sankyo Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__altLabel mesh__D000551
% 209.18/209.40       Lichtenstein Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__altLabel mesh__D000551 Farmasan Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__altLabel mesh__D000551 Degort%27%s Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__altLabel mesh__D000551 Duramucal
% 209.18/209.40  |- skos__altLabel mesh__D000551 Fustery Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__altLabel mesh__D000551 Isis Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- mesh__dateEstablished mesh__D000551 1991-01-01
% 209.18/209.40  |- skos__altLabel mesh__D000551
% 209.18/209.40       SmithKline Beecham Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- mesh__dateCreated mesh__D000551 1976-04-16
% 209.18/209.40  |- skos__altLabel mesh__D000551 Surbronc
% 209.18/209.40  |- skos__altLabel mesh__D000551 Pulmopharm Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__hiddenLabel mesh__D000551 Contac Husten Trunk
% 209.18/209.40  |- skos__hiddenLabel mesh__D000551 NA872
% 209.18/209.40  |- skos__altLabel mesh__D000551 Promeco Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__altLabel mesh__D000551 Chiesi Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__scopeNote mesh__D000551
% 209.18/209.40       A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.%A%    
% 209.18/209.40  |- skos__hiddenLabel mesh__D000551
% 209.18/209.40       Berlin Chemie Brand of Abmbroxol Hydrochloride
% 209.18/209.40  |- skos__altLabel mesh__D000551 Sekretovit
% 209.18/209.40  |- skos__hiddenLabel mesh__D000551 Contac HustenTrunk
% 209.18/209.40  |- skos__altLabel mesh__D000551
% 209.18/209.40       Boehringer Ingelheim Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- mesh__historyNote mesh__D000551
% 209.18/209.40       91%28%77%29%; was see under BROMHEXINE 1977-90   
% 209.18/209.40  |- skos__hiddenLabel mesh__D000551 AmbroPuren
% 209.18/209.40  |- skos__altLabel mesh__D000551 Esparma Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__altLabel mesh__D000551 Stada Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__altLabel mesh__D000551 Rentschler Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__altLabel mesh__D000551 Betapharm Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__altLabel mesh__D000551
% 209.18/209.40       Glaxo Wellcome Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- mesh__recordOriginator mesh__D000551 SH
% 209.18/209.40  |- skos__altLabel mesh__D000551 Bromhexine Metabolite VIII
% 209.18/209.40  |- skos__hiddenLabel mesh__D000551 Larylin Husten L%C3%%B6%ser
% 209.18/209.40  |- mesh__recordMaintainer mesh__D000551 jls
% 209.18/209.40  |- skos__hiddenLabel mesh__D000551 Ambroxol Marjan Brand
% 209.18/209.40  |- skos__hiddenLabel mesh__D000551 Ambro Puren
% 209.18/209.40  |- skos__prefLabel mesh__D000551 Ambroxol
% 209.18/209.40  |- skos__hiddenLabel mesh__D000551 stas Hustenl%C3%%B6%ser
% 209.18/209.40  |- skos__altLabel mesh__D000551 Nattermann Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__altLabel mesh__D000551 Ambrol%C3%%B6%s
% 209.18/209.40  |- skos__altLabel mesh__D000551 P%C3%%A4%dia Brand of Ambroxol
% 209.18/209.40  |- skos__altLabel mesh__D000551 Marjan Brand of Ambroxol
% 209.18/209.40  |- skos__altLabel mesh__D000551 Hexal Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- mesh__recordAuthorizer mesh__D000551 jls
% 209.18/209.40  |- skos__hiddenLabel mesh__D000551 stasHustenl%C3%%B6%ser
% 209.18/209.40  |- skos__altLabel mesh__D000551 Diba Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__altLabel mesh__D000551 Orion Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__hiddenLabel mesh__D000551 Metabolite VIII, Bromhexine
% 209.18/209.40  |- skos__historyNote mesh__D000551 Cyclohexylamines %28%1974%29%
% 209.18/209.40  |- skos__altLabel mesh__D000551
% 209.18/209.40       Schaper %26% Br%C3%%BC%mmer Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__altLabel mesh__D000551 Teva Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__historyNote mesh__D000551 Aniline Compounds %28%1974%29%
% 209.18/209.40  |- skos__altLabel mesh__D000551 Wernigerode Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__altLabel mesh__D000551 Ringelheimer Pulmonal
% 209.18/209.40  |- skos__altLabel mesh__D000551 Mucosolvan
% 209.18/209.40  |- skos__hiddenLabel mesh__D000551 AM, Bisolvon
% 209.18/209.40  |- skos__hiddenLabel mesh__D000551 Hustenl%C3%%B6%ser, Therapin
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D000551 2005
% 209.18/209.40  |- skos__altLabel mesh__D000551 Muco-Fips
% 209.18/209.40  |- skos__altLabel mesh__D000551 Merck Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__altLabel mesh__D000551 Thomae Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__altLabel mesh__D000551 Cascan Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- rdf__type mesh__D000551sskos__Concept
% 209.18/209.40  |- skos__hiddenLabel mesh__D000551 Muco Fips
% 209.18/209.40  |- skos__hiddenLabel mesh__D000551 Larylin HustenL%C3%%B6%ser
% 209.18/209.40  |- skos__historyNote mesh__D000551
% 209.18/209.40       Bromhexine/analogs %26% derivatives %28%1975-1976%29%
% 209.18/209.40  |- skos__altLabel mesh__D000551 Ambroxocompren
% 209.18/209.40  |- skos__altLabel mesh__D000551 Hefa Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- mesh__publicMeSHNote mesh__D000551
% 209.18/209.40       91; was see under BROMHEXINE 1977-90   
% 209.18/209.40  |- skos__hiddenLabel mesh__D000551 Ambroxol P%C3%%A4%dia Brand
% 209.18/209.40  |- skos__altLabel mesh__D000551 Ambrohexal
% 209.18/209.40  |- mesh__dateRevised mesh__D000551 2005-07-29
% 209.18/209.40  |- skos__altLabel mesh__D000551
% 209.18/209.40       Berlin-Chemie Brand of Abmbroxol Hydrochloride
% 209.18/209.40  |- skos__hiddenLabel mesh__D000551 Hustenl%C3%%B6%ser, Pect
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D000551 2006
% 209.18/209.40  |- skos__altLabel mesh__D000551 Carnot Brand of Ambroxol Hydrochloride
% 209.18/209.40  |- skos__broader mesh__D000551smesh__D001964
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D000551 2006A
% 209.18/209.40  |- skos__altLabel mesh__D000551
% 209.18/209.40       4-%28%%28%%28%2-Amino-3,5-dibromophenyl%29%methyl%29%amino%29%cyclohexanol
% 209.18/209.40  |- skos__hiddenLabel mesh__D000551 Pulmonal, Ringelheimer
% 209.18/209.40  |- skos__hiddenLabel mesh__D000551 MucoFips
% 209.18/209.40  |- skos__broader mesh__D013284Q000002smesh__D013284
% 209.18/209.40  |- mesh__preferredCombination mesh__D013284Q000002smesh__D018640
% 209.18/209.40  |- rdf__type mesh__D013284Q000002smesh__CompoundConcept
% 209.18/209.40  |- skos__scopeNote mesh__D013479
% 209.18/209.40       Obstruction of the superior vena cava caused by neoplasm, thrombosis, aneurysm, or external compression and causing suffusion and/or cyanosis of the face, neck, and upper arms.%A%    
% 209.18/209.40  |- mesh__dateRevised mesh__D013479 1996-06-10
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D013479 2001
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D013479 2003
% 209.18/209.40  |- mesh__historyNote mesh__D013479 86   
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D013479 2000
% 209.18/209.40  |- mesh__dateEstablished mesh__D013479 1986-01-01
% 209.18/209.40  |- mesh__recordMaintainer mesh__D013479 TPW
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D013479 1997
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D013479 2006
% 209.18/209.40  |- skos__prefLabel mesh__D013479 Superior Vena Cava Syndrome
% 209.18/209.40  |- skos__historyNote mesh__D013479 Vascular Diseases %28%1966-1985%29%
% 209.18/209.40  |- skos__historyNote mesh__D013479 Thrombosis %28%1966-1985%29%
% 209.18/209.40  |- mesh__recordAuthorizer mesh__D013479 PLS
% 209.18/209.40  |- skos__broader mesh__D013479smesh__D014652
% 209.18/209.40  |- mesh__publicMeSHNote mesh__D013479 86   
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D013479 2005
% 209.18/209.40  |- skos__annotation mesh__D013479 caval obstruction   
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D013479 2002
% 209.18/209.40  |- mesh__recordOriginator mesh__D013479 VDK
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D013479 1999
% 209.18/209.40  |- rdf__type mesh__D013479sskos__Concept
% 209.18/209.40  |- skos__historyNote mesh__D013479 Vena Cava, Superior %28%1966-1985%29%
% 209.18/209.40  |- mesh__dateCreated mesh__D013479 1985-03-20
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D013479 2004
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D013479 1998
% 209.18/209.40  |- skos__altLabel mesh__D013479 Superior Vena Cava Obstruction
% 209.18/209.40  |- skos__altLabel mesh__D018962 Venesection
% 209.18/209.40  |- skos__hiddenLabel mesh__D018962 Phlebotomies
% 209.18/209.40  |- skos__related mesh__D018962smesh__D001815
% 209.18/209.40  |- mesh__recordAuthorizer mesh__D018962 sjn
% 209.18/209.40  |- skos__broader mesh__D018962smesh__D011677
% 209.18/209.40  |- skos__related mesh__D018962smesh__D024763
% 209.18/209.40  |- mesh__recordMaintainer mesh__D018962 sjn
% 209.18/209.40  |- skos__scopeNote mesh__D018962
% 209.18/209.40       The techniques used to draw blood from a vein for diagnostic purposes or for treatment of certain blood disorders such as erythrocytosis, hemochromatosis, polycythemia vera, and porphyria cutanea tarda.%A%    
% 209.18/209.40  |- skos__related mesh__D018962smesh__D007262
% 209.18/209.40  |- mesh__publicMeSHNote mesh__D018962
% 209.18/209.40       1996; see BLOODLETTING 1987-1995; VENESECTION see BLOODLETTING 1987-1995; VENIPUNCTURE see BLOODLETTING 1989-1995%A%  
% 209.18/209.40  |- mesh__recordOriginator mesh__D018962 TGC
% 209.18/209.40  |- mesh__dateCreated mesh__D018962 1995-05-26
% 209.18/209.40  |- mesh__dateEstablished mesh__D018962 1996-01-01
% 209.18/209.40  |- skos__prefLabel mesh__D018962 Phlebotomy
% 209.18/209.40  |- skos__annotation mesh__D018962
% 209.18/209.40       for hist articles %26% hist contexts use BLOODLETTING   
% 209.18/209.40  |- mesh__historyNote mesh__D018962
% 209.18/209.40       1996; use BLOODLETTING 1987-1995; VENESECTION use BLOODLETTING 1987-1995; VENIPUNCTURE use BLOODLETTING 1989-1995%A%  
% 209.18/209.40  |- skos__hiddenLabel mesh__D018962 Venipunctures
% 209.18/209.40  |- rdf__type mesh__D018962sskos__Concept
% 209.18/209.40  |- skos__related mesh__D018962smesh__D007275
% 209.18/209.40  |- skos__hiddenLabel mesh__D018962 Venesections
% 209.18/209.40  |- mesh__dateRevised mesh__D018962 2004-07-13
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D018962 2006
% 209.18/209.40  |- skos__historyNote mesh__D018962 Bloodletting %28%1966-1995%29%
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D018962 2005
% 209.18/209.40  |- skos__broader mesh__D018962smesh__D001800
% 209.18/209.40  |- mesh__historyNote mesh__D018164 94   
% 209.18/209.40  |- skos__annotation mesh__D018164
% 209.18/209.40       infection: coord IM with REOVIRIDAE INFECTIONS %28%IM%29%   
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D018164 2003
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D018164 2006
% 209.18/209.40  |- skos__scopeNote mesh__D018164
% 209.18/209.40       A species of ORBIVIRUS causing a fatal disease in deer. It is transmitted by flies of the genus Culicoides.%A%    
% 209.18/209.40  |- skos__prefLabel mesh__D018164 Hemorrhagic Disease Virus, Epizootic
% 209.18/209.40  |- mesh__dateRevised mesh__D018164 2001-07-25
% 209.18/209.40  |- mesh__recordAuthorizer mesh__D018164 sjn
% 209.18/209.40  |- skos__broader mesh__D018164smesh__D018163
% 209.18/209.40  |- mesh__publicMeSHNote mesh__D018164 94   
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D018164 2005
% 209.18/209.40  |- skos__altLabel mesh__D018164 Epizootic hemorrhagic disease virus
% 209.18/209.40  |- rdf__type mesh__D018164sskos__Concept
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D018164 2002
% 209.18/209.40  |- mesh__dateCreated mesh__D018164 1993-06-04
% 209.18/209.40  |- mesh__recordOriginator mesh__D018164 AGS
% 209.18/209.40  |- skos__historyNote mesh__D018164 Reoviridae %28%1970-1993%29%
% 209.18/209.40  |- mesh__dateEstablished mesh__D018164 1994-01-01
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D018164 2004
% 209.18/209.40  |- mesh__recordMaintainer mesh__D018164 ags
% 209.18/209.40  |- skos__broader mesh__D010181smesh__D010182
% 209.18/209.40  |- skos__hiddenLabel mesh__D010181 Cysts, Pancreatic
% 209.18/209.40  |- rdf__type mesh__D010181sskos__Concept
% 209.18/209.40  |- mesh__recordMaintainer mesh__D010181 lkt
% 209.18/209.40  |- skos__annotation mesh__D010181
% 209.18/209.40       non-neoplastic; pancreatic pseudocyst = PANCREATIC PSEUDOCYST%A%  
% 209.18/209.40  |- mesh__dateRevised mesh__D010181 2004-07-07
% 209.18/209.40  |- skos__hiddenLabel mesh__D010181 Cyst, Pancreatic
% 209.18/209.40  |- mesh__recordAuthorizer mesh__D010181 sjn
% 209.18/209.40  |- skos__broader mesh__D010181smesh__D003560
% 209.18/209.40  |- skos__hiddenLabel mesh__D010181 Pancreatic Cysts
% 209.18/209.40  |- mesh__dateCreated mesh__D010181 1999-01-01
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D010181 2006
% 209.18/209.40  |- skos__prefLabel mesh__D010181 Pancreatic Cyst
% 209.18/209.40  |- mesh__recordOriginator mesh__D010181 NLM
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D010181 2005
% 209.18/209.40  |- skos__scopeNote mesh__D010181
% 209.18/209.40       A true cyst of the PANCREAS, distinguished from the much more common PANCREATIC PSEUDOCYST by possessing a lining of mucous EPITHELIUM. Pancreatic cysts are categorized as congenital, retention, neoplastic, parasitic, enterogenous, or dermoid. Congenital cysts occur more frequently as solitary cysts but may be multiple. Retention cysts are gross enlargements of PANCREATIC DUCTS secondary to ductal obstruction. %28%From Bockus Gastroenterology, 4th ed, p4145%29%%A%    
% 209.18/209.40  |- skos__hiddenLabel mesh__D004942 Reflux Esophagitis
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D004942 2005
% 209.18/209.40  |- skos__altLabel mesh__D004942 Esophagitis, Reflux
% 209.18/209.40  |- skos__broader mesh__D004942smesh__D010437
% 209.18/209.40  |- skos__hiddenLabel mesh__D004942 Peptic Esophagitides
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D004942 2006
% 209.18/209.40  |- skos__hiddenLabel mesh__D004942 Esophagitides, Peptic
% 209.18/209.40  |- skos__prefLabel mesh__D004942 Esophagitis, Peptic
% 209.18/209.40  |- mesh__dateRevised mesh__D004942 2003-07-09
% 209.18/209.40  |- mesh__recordOriginator mesh__D004942 NLM
% 209.18/209.40  |- mesh__recordMaintainer mesh__D004942 lkt
% 209.18/209.40  |- skos__scopeNote mesh__D004942
% 209.18/209.40       INFLAMMATION of the ESOPHAGUS that is caused by the reflux of GASTRIC JUICE with contents of the STOMACH and DUODENUM.%A%    
% 209.18/209.40  |- mesh__dateCreated mesh__D004942 1999-01-01
% 209.18/209.40  |- mesh__recordAuthorizer mesh__D004942 sjn
% 209.18/209.40  |- rdf__type mesh__D004942sskos__Concept
% 209.18/209.40  |- skos__hiddenLabel mesh__D004942 Reflux Esophagitides
% 209.18/209.40  |- skos__broader mesh__D004942smesh__D004941
% 209.18/209.40  |- skos__hiddenLabel mesh__D004942 Peptic Esophagitis
% 209.18/209.40  |- skos__hiddenLabel mesh__D004942 Esophagitides, Reflux
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D004942 2004
% 209.18/209.40  |- skos__hiddenLabel mesh__D051598 Imagings, Whole Body
% 209.18/209.40  |- skos__broader mesh__D051598smesh__D003952
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D051598 2006
% 209.18/209.40  |- skos__hiddenLabel mesh__D051598 Scans, Whole Body
% 209.18/209.40  |- skos__altLabel mesh__D051598 Whole Body Scan
% 209.18/209.40  |- skos__broader mesh__D051598smesh__D008919
% 209.18/209.40  |- mesh__historyNote mesh__D051598 2006   
% 209.18/209.40  |- skos__hiddenLabel mesh__D051598 Imaging, Whole Body
% 209.18/209.40  |- skos__hiddenLabel mesh__D051598 Screening, Whole Body
% 209.18/209.40  |- skos__hiddenLabel mesh__D051598 Whole Body Imagings
% 209.18/209.40  |- skos__altLabel mesh__D051598 Whole Body Scanning
% 209.18/209.40  |- skos__scopeNote mesh__D051598
% 209.18/209.40       The creation of a visual display of the inside of the entire body of a human or animal for the purposes of diagnostic evaluation. This is most commonly achieved by using MAGNETIC RESONANCE IMAGING; or POSITRON EMISSION TOMOGRAPHY.%A%    
% 209.18/209.40  |- skos__hiddenLabel mesh__D051598 Whole Body Screenings
% 209.18/209.40  |- mesh__recordOriginator mesh__D051598 ags
% 209.18/209.40  |- mesh__publicMeSHNote mesh__D051598 2006   
% 209.18/209.40  |- mesh__dateCreated mesh__D051598 2005-06-30
% 209.18/209.40  |- rdf__type mesh__D051598sskos__Concept
% 209.18/209.40  |- skos__hiddenLabel mesh__D051598 Screenings, Whole Body
% 209.18/209.40  |- mesh__recordMaintainer mesh__D051598 ags
% 209.18/209.40  |- mesh__recordAuthorizer mesh__D051598 sjn
% 209.18/209.40  |- mesh__dateEstablished mesh__D051598 2006-01-01
% 209.18/209.40  |- skos__hiddenLabel mesh__D051598 Scan, Whole Body
% 209.18/209.40  |- skos__prefLabel mesh__D051598 Whole Body Imaging
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D004144 1996
% 209.18/209.40  |- skos__historyNote mesh__D004144 Saponins %28%1966-1975%29%
% 209.18/209.40  |- skos__historyNote mesh__D004144 Hydroxysteroids %28%1972-1975%29%
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D004144 2000
% 209.18/209.40  |- skos__historyNote mesh__D004144 Spirostans %28%1968-1978%29%
% 209.18/209.40  |- skos__broader mesh__D004144smesh__D012502
% 209.18/209.40  |- rdf__type mesh__D004144sskos__Concept
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D004144 1995
% 209.18/209.40  |- mesh__historyNote mesh__D004144
% 209.18/209.40       91%28%79%29%; was see under SAPOGENINS 1979-90   
% 209.18/209.40  |- mesh__dateRevised mesh__D004144 1992-05-13
% 209.18/209.40  |- skos__annotation mesh__D004144 a sapogenin   
% 209.18/209.40  |- skos__scopeNote mesh__D004144
% 209.18/209.40       %28%25R%29%-Spirost-5-en-3-beta-ol. A steroid sapogenin which is isolated from various plants. Can be converted to ecdysone, pregnenolone, and progesterone. Synonym: nitogenin.%A%    
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D004144 2006
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D004144 2002
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D004144 1994
% 209.18/209.40  |- mesh__recordMaintainer mesh__D004144 TGC
% 209.18/209.40  |- mesh__recordAuthorizer mesh__D004144 PLS
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D004144 1993
% 209.18/209.40  |- mesh__recordOriginator mesh__D004144 RLS
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D004144 2005
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D004144 2004
% 209.18/209.40  |- mesh__dateEstablished mesh__D004144 1991-01-01
% 209.18/209.40  |- mesh__publicMeSHNote mesh__D004144
% 209.18/209.40       91; was see under SAPOGENINS 1979-90   
% 209.18/209.40  |- skos__altLabel mesh__D004144 Yamogenin
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D004144 1999
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D004144 2003
% 209.18/209.40  |- skos__prefLabel mesh__D004144 Diosgenin
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D004144 1998
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D004144 1997
% 209.18/209.40  |- mesh__dateCreated mesh__D004144 1977-12-16
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D004144 2001
% 209.18/209.40  |- skos__related mesh__D014572smesh__D033441
% 209.18/209.40  |- skos__related mesh__D014572smesh__D014570
% 209.18/209.40  |- mesh__recordMaintainer mesh__D014572 lkt
% 209.18/209.40  |- mesh__dateCreated mesh__D014572 1999-01-01
% 209.18/209.40  |- rdf__type mesh__D014572sskos__Concept
% 209.18/209.40  |- skos__broader mesh__D014572smesh__D013043
% 209.18/209.40  |- mesh__recordOriginator mesh__D014572 NLM
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D014572 2004
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D014572 2006
% 209.18/209.40  |- skos__annotation mesh__D014572 SPEC; DF: UROL   
% 209.18/209.40  |- skos__prefLabel mesh__D014572 Urology
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D014572 2003
% 209.18/209.40  |- skos__scopeNote mesh__D014572
% 209.18/209.40       A surgical specialty concerned with the study, diagnosis, and treatment of diseases of the urinary tract in both sexes, and the genital tract in the male. Common urological problems include urinary obstruction, URINARY INCONTINENCE, infections, and UROGENITAL NEOPLASMS.%A%    
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D014572 2005
% 209.18/209.40  |- mesh__recordAuthorizer mesh__D014572 sjn
% 209.18/209.40  |- skos__related mesh__D014572smesh__D013520
% 209.18/209.40  |- mesh__dateRevised mesh__D014572 2002-07-03
% 209.18/209.40  |- rdf__type mesh__D036226sskos__Concept
% 209.18/209.40  |- mesh__dateCreated mesh__D036226 2002-07-03
% 209.18/209.40  |- mesh__publicMeSHNote mesh__D036226 2003; see PLANTS 1995-2002   
% 209.18/209.40  |- mesh__activeMeSHYear mesh__D036226 2004
% 209.18/209.41  |- skos__related mesh__D036226smesh__D018525
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D036226 2003
% 209.18/209.41  |- mesh__historyNote mesh__D036226 2003%28%1995%29%   
% 209.18/209.41  |- skos__annotation mesh__D036226 coord with specific plant   
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D036226 2006
% 209.18/209.41  |- skos__broader mesh__D036226smesh__D010944
% 209.18/209.41  |- skos__historyNote mesh__D036226 Plants %28%1995-2002%29%
% 209.18/209.41  |- skos__altLabel mesh__D036226 Seedlings
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D036226 2005
% 209.18/209.41  |- skos__prefLabel mesh__D036226 Seedling
% 209.18/209.41  |- skos__scopeNote mesh__D036226
% 209.18/209.41       Very young plant after GERMINATION of SEEDS.     
% 209.18/209.41  |- mesh__dateEstablished mesh__D036226 2003-01-01
% 209.18/209.41  |- mesh__dateRevised mesh__D008535 2003-07-09
% 209.18/209.41  |- skos__broader mesh__D008535smesh__D011245
% 209.18/209.41  |- skos__scopeNote mesh__D008535
% 209.18/209.41       17-Hydroxy-6-methylpregna-3,6-diene-3,20-dione. A progestational hormone used most commonly as the acetate ester. As the acetate, it is more potent than progesterone both as a progestagen and as an ovulation inhibitor. It has also been used in the palliative treatment of breast cancer.%A%    
% 209.18/209.41  |- skos__annotation mesh__D008535 a synthetic progestational hormone   
% 209.18/209.41  |- mesh__recordAuthorizer mesh__D008535 sjn
% 209.18/209.41  |- mesh__dateEstablished mesh__D008535 1972-01-01
% 209.18/209.41  |- mesh__recordOriginator mesh__D008535 NLM
% 209.18/209.41  |- mesh__historyNote mesh__D008535 72%28%63%29%   
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D008535 2006
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D008535 2005
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D008535 2004
% 209.18/209.41  |- mesh__dateCreated mesh__D008535 1999-01-01
% 209.18/209.41  |- mesh__publicMeSHNote mesh__D008535 72   
% 209.18/209.41  |- rdf__type mesh__D008535sskos__Concept
% 209.18/209.41  |- skos__prefLabel mesh__D008535 Megestrol
% 209.18/209.41  |- mesh__recordMaintainer mesh__D008535 lkt
% 209.18/209.41  |- skos__broader mesh__D000552smesh__D018986
% 209.18/209.41  |- skos__hiddenLabel mesh__D000552 Unit, Emergency Mobile
% 209.18/209.41  |- mesh__recordAuthorizer mesh__D000552 SJN
% 209.18/209.41  |- rdf__type mesh__D000552sskos__Concept
% 209.18/209.41  |- skos__hiddenLabel mesh__D000552 Mobile Emergency Unit
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D000552 2006
% 209.18/209.41  |- skos__hiddenLabel mesh__D000552 Emergency Mobile Unit
% 209.18/209.41  |- mesh__dateRevised mesh__D000552 1998-06-10
% 209.18/209.41  |- skos__prefLabel mesh__D000552 Ambulances
% 209.18/209.41  |- skos__hiddenLabel mesh__D000552 Units, Emergency Mobile
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D000552 2005
% 209.18/209.41  |- mesh__recordOriginator mesh__D000552 NLM
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D000552 2002
% 209.18/209.41  |- mesh__recordMaintainer mesh__D000552 JLS
% 209.18/209.41  |- mesh__dateCreated mesh__D000552 1999-01-01
% 209.18/209.41  |- skos__altLabel mesh__D000552 Mobile Emergency Units
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D000552 1999
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D000552 2004
% 209.18/209.41  |- skos__hiddenLabel mesh__D000552 Emergency Units, Mobile
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D000552 2001
% 209.18/209.41  |- skos__hiddenLabel mesh__D000552 Mobile Units, Emergency
% 209.18/209.41  |- skos__hiddenLabel mesh__D000552 Ambulance
% 209.18/209.41  |- skos__hiddenLabel mesh__D000552 Units, Mobile Emergency
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D000552 2003
% 209.18/209.41  |- skos__hiddenLabel mesh__D000552 Mobile Unit, Emergency
% 209.18/209.41  |- skos__scopeNote mesh__D000552
% 209.18/209.41       A vehicle equipped for transporting patients in need of emergency care.%A%    
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D000552 2000
% 209.18/209.41  |- skos__broader mesh__D000552smesh__D014187
% 209.18/209.41  |- skos__hiddenLabel mesh__D000552 Emergency Unit, Mobile
% 209.18/209.41  |- skos__hiddenLabel mesh__D000552 Unit, Mobile Emergency
% 209.18/209.41  |- mesh__recordMaintainer mesh__D018963 ssb
% 209.18/209.41  |- skos__scopeNote mesh__D018963
% 209.18/209.41       Antigens from any of the hepatitis viruses including surface, core, and other associated antigens.%A%    
% 209.18/209.41  |- mesh__recordOriginator mesh__D018963 AGS
% 209.18/209.41  |- mesh__dateCreated mesh__D018963 1995-02-22
% 209.18/209.41  |- mesh__recordAuthorizer mesh__D018963 sjn
% 209.18/209.41  |- rdf__type mesh__D018963sskos__Concept
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D018963 2006
% 209.18/209.41  |- skos__prefLabel mesh__D018963 Hepatitis Antigens
% 209.18/209.41  |- skos__broader mesh__D018963smesh__D000956
% 209.18/209.41  |- mesh__dateEstablished mesh__D018963 1996-01-01
% 209.18/209.41  |- mesh__historyNote mesh__D018963 96   
% 209.18/209.41  |- mesh__dateRevised mesh__D018963 2005-06-30
% 209.18/209.41  |- skos__altLabel mesh__D018963 Antigens, Hepatitis
% 209.18/209.41  |- mesh__publicMeSHNote mesh__D018963 96   
% 209.18/209.41  |- skos__annotation mesh__D018963 GEN or unspecified; prefer specifics   
% 209.18/209.41  |- mesh__recordAuthorizer mesh__D010980 sjn
% 209.18/209.41  |- mesh__dateCreated mesh__D010980 1986-06-16
% 209.18/209.41  |- skos__broader mesh__D010980smesh__D008562
% 209.18/209.41  |- skos__altLabel mesh__D010980 PM-GPs
% 209.18/209.41  |- skos__hiddenLabel mesh__D010980 Glycoproteins, Platelet
% 209.18/209.41  |- rdf__type mesh__D010980sskos__Concept
% 209.18/209.41  |- skos__hiddenLabel mesh__D010980 Membrane Glycoproteins, Platelet
% 209.18/209.41  |- mesh__publicMeSHNote mesh__D010980 87   
% 209.18/209.41  |- skos__broader mesh__D010980smesh__D011971
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D010980 2006
% 209.18/209.41  |- skos__prefLabel mesh__D010980 Platelet Membrane Glycoproteins
% 209.18/209.41  |- mesh__dateEstablished mesh__D010980 1987-01-01
% 209.18/209.41  |- mesh__recordMaintainer mesh__D010980 jmp
% 209.18/209.41  |- skos__hiddenLabel mesh__D010980 Glycoproteins, Platelet Membrane
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D010980 2004
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D010980 2005
% 209.18/209.41  |- skos__annotation mesh__D010980
% 209.18/209.41       /biosyn /drug eff /physiol /ultrastruct permitted   
% 209.18/209.41  |- skos__scopeNote mesh__D010980
% 209.18/209.41       Surface glycoproteins on platelets which have a key role in hemostasis and thrombosis such as platelet adhesion and aggregation. Many of these are receptors.%A%    
% 209.18/209.41  |- mesh__recordOriginator mesh__D010980 RLS
% 209.18/209.41  |- mesh__historyNote mesh__D010980 87   
% 209.18/209.41  |- mesh__dateRevised mesh__D010980 2003-07-09
% 209.18/209.41  |- skos__historyNote mesh__D010980 Glycoproteins %28%1966-1986%29%
% 209.18/209.41  |- skos__historyNote mesh__D010980 Membrane Proteins %28%1966-1986%29%
% 209.18/209.41  |- mesh__dateEstablished mesh__D018165 1994-01-01
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D018165 2006
% 209.18/209.41  |- skos__hiddenLabel mesh__D018165 Orthoreoviruses
% 209.18/209.41  |- mesh__historyNote mesh__D018165 1994   
% 209.18/209.41  |- skos__scopeNote mesh__D018165
% 209.18/209.41       A genus of the family REOVIRIDAE infecting vertebrates only. Transmission is horizontal and infected species include humans, birds, cattle, monkeys, sheep, swine, baboons, and bats. MAMMALIAN ORTHOREOVIRUS is the type species.%A%    
% 209.18/209.41  |- skos__annotation mesh__D018165
% 209.18/209.41       infection: coord IM with REOVIRIDAE INFECTIONS %28%IM%29%   
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D018165 2005
% 209.18/209.41  |- rdf__type mesh__D018165sskos__Concept
% 209.18/209.41  |- skos__altLabel mesh__D018165 Nelson Bay orthoreovirus
% 209.18/209.41  |- skos__prefLabel mesh__D018165 Orthoreovirus
% 209.18/209.41  |- skos__broader mesh__D018165smesh__D012087
% 209.18/209.41  |- mesh__dateRevised mesh__D018165 2001-07-25
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D018165 2004
% 209.18/209.41  |- mesh__recordAuthorizer mesh__D018165 sjn
% 209.18/209.41  |- mesh__recordMaintainer mesh__D018165 ags
% 209.18/209.41  |- mesh__publicMeSHNote mesh__D018165 1994   
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D018165 2002
% 209.18/209.41  |- skos__altLabel mesh__D018165 Baboon orthoreovirus
% 209.18/209.41  |- mesh__dateCreated mesh__D018165 1993-06-04
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D018165 2003
% 209.18/209.41  |- mesh__recordOriginator mesh__D018165 AGS
% 209.18/209.41  |- mesh__dateRevised mesh__D010182 2004-07-07
% 209.18/209.41  |- skos__hiddenLabel mesh__D010182 Diseases, Pancreatic
% 209.18/209.41  |- rdf__type mesh__D010182sskos__Concept
% 209.18/209.41  |- skos__related mesh__D010182smesh__D006946
% 209.18/209.41  |- skos__hiddenLabel mesh__D010182 Pancreatic Disease
% 209.18/209.41  |- mesh__recordOriginator mesh__D010182 NLM
% 209.18/209.41  |- mesh__dateCreated mesh__D010182 1999-01-01
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D010182 2005
% 209.18/209.41  |- mesh__publicMeSHNote mesh__D010182 66   
% 209.18/209.41  |- skos__broader mesh__D010182smesh__D004066
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D010182 2006
% 209.18/209.41  |- mesh__dateEstablished mesh__D010182 1966-01-01
% 209.18/209.41  |- skos__annotation mesh__D010182 inflamm dis = PANCREATITIS   
% 209.18/209.41  |- mesh__historyNote mesh__D010182 66   
% 209.18/209.41  |- mesh__recordMaintainer mesh__D010182 lkt
% 209.18/209.41  |- skos__scopeNote mesh__D010182
% 209.18/209.41       Pathological processes of the PANCREAS.     
% 209.18/209.41  |- skos__hiddenLabel mesh__D010182 Disease, Pancreatic
% 209.18/209.41  |- skos__prefLabel mesh__D010182 Pancreatic Diseases
% 209.18/209.41  |- mesh__recordAuthorizer mesh__D010182 sjn
% 209.18/209.41  |- mesh__publicMeSHNote mesh__D004943 66   
% 209.18/209.41  |- mesh__historyNote mesh__D004943 66%28%64%29%   
% 209.18/209.41  |- skos__prefLabel mesh__D004943 Esophagogastric Junction
% 209.18/209.41  |- skos__hiddenLabel mesh__D004943 Junctions, Gastroesophageal
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D004943 2005
% 209.18/209.41  |- skos__broader mesh__D004943smesh__D013270
% 209.18/209.41  |- mesh__recordOriginator mesh__D004943 NLM
% 209.18/209.41  |- skos__hiddenLabel mesh__D004943 Junction, Gastroesophageal
% 209.18/209.41  |- skos__hiddenLabel mesh__D004943 Junction, Esophagogastric
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D004943 2006
% 209.18/209.41  |- mesh__dateCreated mesh__D004943 1999-01-01
% 209.18/209.41  |- mesh__recordAuthorizer mesh__D004943 sjn
% 209.18/209.41  |- skos__scopeNote mesh__D004943
% 209.18/209.41       The area covering the terminal portion of ESOPHAGUS and the beginning of STOMACH at the cardiac orifice.%A%    
% 209.18/209.41  |- mesh__recordMaintainer mesh__D004943 lkt
% 209.18/209.41  |- rdf__type mesh__D004943sskos__Concept
% 209.18/209.41  |- mesh__dateEstablished mesh__D004943 1966-01-01
% 209.18/209.41  |- skos__broader mesh__D004943smesh__D004947
% 209.18/209.41  |- skos__annotation mesh__D004943
% 209.18/209.41       diseases: coordinate IM with ESOPHAGEAL DISEASES %28%IM%29% or specific esophageal disease %28%IM%29%; neoplasms: coordinate IM with STOMACH NEOPLASMS %28%IM%29% or ESOPHAGEAL NEOPLASMS %28%IM%29% depending on text%A%  
% 209.18/209.41  |- skos__altLabel mesh__D004943 Gastroesophageal Junction
% 209.18/209.41  |- skos__hiddenLabel mesh__D004943 Gastroesophageal Junctions
% 209.18/209.41  |- mesh__dateRevised mesh__D004943 2004-07-07
% 209.18/209.41  |- skos__hiddenLabel mesh__D051599 Synthetase, ADP-Glucose
% 209.18/209.41  |- skos__altLabel mesh__D051599 ADP-Glucose Pyrophosphorylase
% 209.18/209.41  |- skos__hiddenLabel mesh__D051599 ADP Glucose Synthase
% 209.18/209.41  |- mesh__dateCreated mesh__D051599 2005-06-30
% 209.18/209.41  |- skos__altLabel mesh__D051599 ADPGlucose Pyrophosphorylase
% 209.18/209.41  |- skos__hiddenLabel mesh__D051599 Synthase, ADP-Glucose
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D051599 2006
% 209.18/209.41  |- mesh__publicMeSHNote mesh__D051599
% 209.18/209.41       2006; GLUCOSE-1-PHOSPHATE ADENYLYLTRANSFERASE was indexed under NUCLEOTIDYLTRANSFERASES 1976-2005, under GLUCOSEPHOSPHATES 1972-1975, under ADENINE NUCLEOTIDES 1970-1972, %26% under ATP 1972-1975%A%  
% 209.18/209.41  |- mesh__recordOriginator mesh__D051599 AKE
% 209.18/209.41  |- mesh__recordAuthorizer mesh__D051599 sjn
% 209.18/209.41  |- skos__altLabel mesh__D051599 ADP-Glucose Synthase
% 209.18/209.41  |- skos__altLabel mesh__D051599
% 209.18/209.41       Adenosine Diphosphate Glucose Pyrophosphorylase
% 209.18/209.41  |- mesh__recordMaintainer mesh__D051599 AKE
% 209.18/209.41  |- skos__hiddenLabel mesh__D051599 ADP Glucose Pyrophosphorylase
% 209.18/209.41  |- mesh__dateEstablished mesh__D051599 2006-01-01
% 209.18/209.41  |- skos__altLabel mesh__D051599 ADP-Glucose Synthetase
% 209.18/209.41  |- skos__scopeNote mesh__D051599
% 209.18/209.41       An ATP-dependent enzyme that catalyzes the addition of ADP to alpha-D-glucose 1-phosphate to form ADP-glucose and diphosphate. The reaction is the rate-limiting reaction in prokaryotic GLYCOGEN and plant STARCH biosynthesis.%A%    
% 209.18/209.41  |- skos__hiddenLabel mesh__D051599 Synthetase, ADPG
% 209.18/209.41  |- rdf__type mesh__D051599sskos__Concept
% 209.18/209.41  |- skos__hiddenLabel mesh__D051599
% 209.18/209.41       Pyrophosphorylase, Adenosine Diphosphoglucose
% 209.18/209.41  |- skos__hiddenLabel mesh__D051599 Pyrophosphorylase, ADPGlucose
% 209.18/209.41  |- skos__hiddenLabel mesh__D051599 ADP Glucose Synthetase
% 209.18/209.41  |- skos__hiddenLabel mesh__D051599 Adenylyltransferase, Glucose-1-Phosphate
% 209.18/209.41  |- mesh__historyNote mesh__D051599
% 209.18/209.41       2006%28%1980%29%; use  NUCLEOTIDYLTRANSFERASES 1976-1979, GLUCOSEPHOSPHATES 1972-1975, ADENINE NUCLEOTIDES 1970-1972, %26%  ATP 1972-1975%A%  
% 209.18/209.41  |- skos__altLabel mesh__D051599 ADPG Synthetase
% 209.18/209.41  |- skos__hiddenLabel mesh__D051599 Pyrophosphorylase, ADP-Glucose
% 209.18/209.41  |- skos__hiddenLabel mesh__D051599 Glucose 1 Phosphate Adenylyltransferase
% 209.18/209.41  |- skos__prefLabel mesh__D051599 Glucose-1-Phosphate Adenylyltransferase
% 209.18/209.41  |- skos__broader mesh__D051599smesh__D009713
% 209.18/209.41  |- skos__hiddenLabel mesh__D051599
% 209.18/209.41       Diphosphoglucose Pyrophosphorylase, Adenosine
% 209.18/209.41  |- skos__altLabel mesh__D051599
% 209.18/209.41       Adenosine Diphosphoglucose Pyrophosphorylase
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D004145 2006
% 209.18/209.41  |- skos__hiddenLabel mesh__D004145 Resin, Buchu
% 209.18/209.41  |- skos__historyNote mesh__D004145 Bioflavonoids %28%1973-1974%29%
% 209.18/209.41  |- mesh__recordAuthorizer mesh__D004145 sjn
% 209.18/209.41  |- skos__scopeNote mesh__D004145
% 209.18/209.41       A bioflavonoid that strengthens vascular walls.     
% 209.18/209.41  |- skos__prefLabel mesh__D004145 Diosmin
% 209.18/209.41  |- mesh__historyNote mesh__D004145
% 209.18/209.41       91%28%75%29%; was see under BIOFLAVONOIDS 1975-90   
% 209.18/209.41  |- mesh__recordMaintainer mesh__D004145 ssb
% 209.18/209.41  |- skos__broader mesh__D004145smesh__D047309
% 209.18/209.41  |- skos__altLabel mesh__D004145 Barosmin
% 209.18/209.41  |- mesh__dateEstablished mesh__D004145 1991-01-01
% 209.18/209.41  |- skos__altLabel mesh__D004145 Buchu Resin
% 209.18/209.41  |- mesh__dateCreated mesh__D004145 1974-11-19
% 209.18/209.41  |- mesh__dateRevised mesh__D004145 2005-06-30
% 209.18/209.41  |- mesh__publicMeSHNote mesh__D004145
% 209.18/209.41       91; was see under BIOFLAVONOIDS 1975-90   
% 209.18/209.41  |- rdf__type mesh__D004145sskos__Concept
% 209.18/209.41  |- mesh__recordOriginator mesh__D004145 NLM
% 209.18/209.41  |- skos__broader mesh__D050486Q000037smesh__D050486
% 209.18/209.41  |- mesh__preferredCombination mesh__D050486Q000037smesh__D017367
% 209.18/209.41  |- rdf__type mesh__D050486Q000037smesh__CompoundConcept
% 209.18/209.41  |- mesh__recordAuthorizer mesh__D014573 PLS
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D014573 2004
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D014573 2002
% 209.18/209.41  |- mesh__dateRevised mesh__D014573 1992-05-18
% 209.18/209.41  |- mesh__recordOriginator mesh__D014573 EC
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D014573 2006
% 209.18/209.41  |- skos__altLabel mesh__D014573 Department, Hospital Urology
% 209.18/209.41  |- mesh__historyNote mesh__D014573
% 209.18/209.41       91%28%Aug 77%29%; was see under HOSPITAL DEPARTMENTS 1977-90   
% 209.18/209.41  |- mesh__recordMaintainer mesh__D014573 TGC
% 209.18/209.41  |- mesh__publicMeSHNote mesh__D014573
% 209.18/209.41       91; was see under HOSPITAL DEPARTMENTS Aug 1977-90   
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D014573 2003
% 209.18/209.41  |- skos__historyNote mesh__D014573 Urology %28%1966-Jul 1977%29%
% 209.18/209.41  |- skos__hiddenLabel mesh__D014573 Departments, Hospital Urology
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D014573 2001
% 209.18/209.41  |- skos__altLabel mesh__D014573 Urology Departments, Hospital
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D014573 2005
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D014573 1997
% 209.18/209.41  |- mesh__dateCreated mesh__D014573 1977-05-19
% 209.18/209.41  |- skos__hiddenLabel mesh__D014573 Hospital Urology Departments
% 209.18/209.41  |- skos__altLabel mesh__D014573 Hospital Urology Department
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D014573 1999
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D014573 2000
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D014573 1996
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D014573 1993
% 209.18/209.41  |- skos__historyNote mesh__D014573
% 209.18/209.41       Hospital Departments %28%1968-Jul 1977%29%
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D014573 1995
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D014573 1998
% 209.18/209.41  |- skos__scopeNote mesh__D014573
% 209.18/209.41       Hospital department responsible for the administration and provision of diagnostic and therapeutic services for the urologic patient.%A%    
% 209.18/209.41  |- skos__prefLabel mesh__D014573 Urology Department, Hospital
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D014573 1994
% 209.18/209.41  |- rdf__type mesh__D014573sskos__Concept
% 209.18/209.41  |- skos__broader mesh__D014573smesh__D006748
% 209.18/209.41  |- skos__annotation mesh__D014573 DF: UROL DEP   
% 209.18/209.41  |- mesh__dateEstablished mesh__D014573 1991-01-01
% 209.18/209.41  |- skos__scopeNote mesh__D008536
% 209.18/209.41       1-Deoxy-1-%28%methylamino%29%-D-glucitol. A derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. Often used in conjunction with iodinated organic compounds as contrast medium.%A%    
% 209.18/209.41  |- mesh__dateCreated mesh__D008536 1976-04-16
% 209.18/209.41  |- skos__broader mesh__D008536smesh__D013012
% 209.18/209.41  |- skos__altLabel mesh__D008536 Methylglucamine
% 209.18/209.41  |- skos__historyNote mesh__D008536 Amino Sugars %28%1971-1976%29%
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D008536 2006
% 209.18/209.41  |- skos__historyNote mesh__D008536 Sorbitol %28%1969-1976%29%
% 209.18/209.41  |- mesh__recordOriginator mesh__D008536 RLS
% 209.18/209.41  |- mesh__recordMaintainer mesh__D008536 ssb
% 209.18/209.41  |- mesh__recordAuthorizer mesh__D008536 sjn
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D008536 2005
% 209.18/209.41  |- mesh__dateRevised mesh__D008536 2004-07-07
% 209.18/209.41  |- mesh__publicMeSHNote mesh__D008536 91; was see under SORBITOL 1977-90   
% 209.18/209.41  |- rdf__type mesh__D008536sskos__Concept
% 209.18/209.41  |- mesh__dateEstablished mesh__D008536 1991-01-01
% 209.18/209.41  |- skos__broader mesh__D008536smesh__D006595
% 209.18/209.41  |- skos__prefLabel mesh__D008536 Meglumine
% 209.18/209.41  |- mesh__historyNote mesh__D008536
% 209.18/209.41       91%28%77%29%; was see under SORBITOL 1977-90   
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D000553 2001
% 209.18/209.41  |- mesh__dateCreated mesh__D000553 1999-01-01
% 209.18/209.41  |- skos__hiddenLabel mesh__D000553 Outpatient Health Service
% 209.18/209.41  |- skos__hiddenLabel mesh__D000553 Care, Ambulatory
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D000553 1999
% 209.18/209.41  |- skos__altLabel mesh__D000553 Outpatient Care
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D000553 2004
% 209.18/209.41  |- skos__broader mesh__D000553smesh__D005791
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D000553 2000
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D000553 1998
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D000553 2003
% 209.18/209.41  |- skos__hiddenLabel mesh__D000553 Clinic Visit
% 209.18/209.41  |- mesh__historyNote mesh__D000553 68%28%66%29%   
% 209.18/209.41  |- mesh__dateEstablished mesh__D000553 1968-01-01
% 209.18/209.41  |- skos__hiddenLabel mesh__D000553 Visit, Clinic
% 209.18/209.41  |- skos__hiddenLabel mesh__D000553 Health Service, Outpatient
% 209.18/209.41  |- mesh__recordAuthorizer mesh__D000553 SJN
% 209.18/209.41  |- mesh__dateRevised mesh__D000553 1997-06-20
% 209.18/209.41  |- skos__hiddenLabel mesh__D000553 Care, Outpatient
% 209.18/209.41  |- mesh__recordMaintainer mesh__D000553 PXP
% 209.18/209.41  |- skos__altLabel mesh__D000553 Outpatient Health Services
% 209.18/209.41  |- skos__prefLabel mesh__D000553 Ambulatory Care
% 209.18/209.41  |- rdf__type mesh__D000553sskos__Concept
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D000553 2006
% 209.18/209.41  |- mesh__recordOriginator mesh__D000553 NLM
% 209.18/209.41  |- skos__scopeNote mesh__D000553
% 209.18/209.41       Health care services provided to patients on an ambulatory basis, rather than by admission to a hospital or other health care facility. The services may be a part of a hospital, augmenting its inpatient services, or may be provided at a free-standing facility.%A%    
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D000553 2002
% 209.18/209.41  |- skos__hiddenLabel mesh__D000553 Visits, Clinic
% 209.18/209.41  |- skos__altLabel mesh__D000553 Services, Outpatient Health
% 209.18/209.41  |- mesh__publicMeSHNote mesh__D000553 68   
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D000553 2005
% 209.18/209.41  |- skos__hiddenLabel mesh__D000553 Service, Outpatient Health
% 209.18/209.41  |- rdf__type mesh__D010981sskos__Concept
% 209.18/209.41  |- skos__altLabel mesh__D010981 Deficiency, Platelet Storage Pool
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D010981 1999
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D010981 2000
% 209.18/209.41  |- mesh__recordAuthorizer mesh__D010981 SJN
% 209.18/209.41  |- skos__broader mesh__D010981smesh__D001778
% 209.18/209.41  |- skos__hiddenLabel mesh__D010981 Deficiencies, Storage Pool
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D010981 2006
% 209.18/209.41  |- skos__broader mesh__D010981smesh__D001791
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D010981 2004
% 209.18/209.41  |- mesh__historyNote mesh__D010981
% 209.18/209.41       91%28%86%29%; was see under BLOOD PLATELET DISORDERS 1986-90   
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D010981 2005
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D010981 2002
% 209.18/209.41  |- skos__broader mesh__D010981smesh__D006474
% 209.18/209.41  |- skos__altLabel mesh__D010981 Storage Pool Deficiency, Platelet
% 209.18/209.41  |- skos__altLabel mesh__D010981 Storage Pool Deficiency
% 209.18/209.41  |- mesh__dateRevised mesh__D010981 1998-06-10
% 209.18/209.41  |- mesh__recordMaintainer mesh__D010981 NNS
% 209.18/209.41  |- mesh__publicMeSHNote mesh__D010981
% 209.18/209.41       91; was see under BLOOD PLATELET DISORDERS 1986-90   
% 209.18/209.41  |- mesh__dateCreated mesh__D010981 1985-03-11
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D010981 2003
% 209.18/209.41  |- skos__prefLabel mesh__D010981 Platelet Storage Pool Deficiency
% 209.18/209.41  |- skos__scopeNote mesh__D010981
% 209.18/209.41       Disorder characterized by a decrease or lack of platelet dense bodies in which the releasable pool of adenine nucleotides and 5HT are normally stored.%A%    
% 209.18/209.41  |- skos__hiddenLabel mesh__D010981 Storage Pool Deficiencies
% 209.18/209.41  |- mesh__dateEstablished mesh__D010981 1991-01-01
% 209.18/209.41  |- skos__altLabel mesh__D010981 Deficiency, Storage Pool
% 209.18/209.41  |- skos__historyNote mesh__D010981
% 209.18/209.41       Blood Platelet Disorders %28%1967-1985%29%
% 209.18/209.41  |- mesh__recordOriginator mesh__D010981 VDK
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D010981 2001
% 209.18/209.41  |- skos__historyNote mesh__D018166 Health Planning %28%1968-1992%29%
% 209.18/209.41  |- mesh__recordAuthorizer mesh__D018166 sjn
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D018166 2006
% 209.18/209.41  |- mesh__publicMeSHNote mesh__D018166 94   
% 209.18/209.41  |- skos__broader mesh__D018166smesh__D006291
% 209.18/209.41  |- skos__historyNote mesh__D018166
% 209.18/209.41       Delivery of Health Care %28%1970-1993%29%
% 209.18/209.41  |- skos__prefLabel mesh__D018166 Health Care Reform
% 209.18/209.41  |- mesh__dateEstablished mesh__D018166 1994-01-01
% 209.18/209.41  |- mesh__recordOriginator mesh__D018166 TGC
% 209.18/209.41  |- rdf__type mesh__D018166sskos__Concept
% 209.18/209.41  |- skos__hiddenLabel mesh__D018166 Reforms, Healthcare
% 209.18/209.41  |- skos__broader mesh__D018166smesh__D003695
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D018166 2000
% 209.18/209.41  |- skos__hiddenLabel mesh__D018166 Healthcare Reforms
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D018166 2003
% 209.18/209.41  |- skos__hiddenLabel mesh__D018166 Reforms, Health Care
% 209.18/209.41  |- skos__scopeNote mesh__D018166
% 209.18/209.41       Innovation and improvement of the health care system by reappraisal, amendment of services, and removal of faults and abuses in providing and distributing health services to patients. It includes a re-alignment of health services and health insurance to maximum demographic elements %28%the unemployed, indigent, uninsured, elderly, inner cities, rural areas%29% with reference to coverage, hospitalization, pricing and cost containment, insurers%27% and employers%27% costs, pre-existing medical conditions, prescribed drugs, equipment, and services.%A%    
% 209.18/209.41  |- mesh__dateRevised mesh__D018166 1999-11-03
% 209.18/209.41  |- skos__related mesh__D018166smesh__D018855
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D018166 2004
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D018166 2001
% 209.18/209.41  |- skos__historyNote mesh__D018166 Health Services %28%1977-1993%29%
% 209.18/209.41  |- mesh__dateCreated mesh__D018166 1993-05-28
% 209.18/209.41  |- skos__historyNote mesh__D018166 Health Policy %28%1981-1993%29%
% 209.18/209.41  |- skos__hiddenLabel mesh__D018166 Reform, Healthcare
% 209.18/209.41  |- skos__hiddenLabel mesh__D018166 Reform, Health Care
% 209.18/209.41  |- skos__hiddenLabel mesh__D018166 Health Care Reforms
% 209.18/209.41  |- mesh__recordMaintainer mesh__D018166 kle
% 209.18/209.41  |- skos__altLabel mesh__D018166 Healthcare Reform
% 209.18/209.41  |- skos__annotation mesh__D018166
% 209.18/209.41       not restricted to US; specify state or country   
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D018166 2002
% 209.18/209.41  |- mesh__historyNote mesh__D018166 94   
% 209.18/209.41  |- skos__broader mesh__D018166smesh__D006285
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D018166 2005
% 209.18/209.41  |- skos__hiddenLabel mesh__D010183 Ducts, Accessory Pancreatic
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D010183 2006
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D010183 2001
% 209.18/209.41  |- skos__altLabel mesh__D010183 Wirsung%27%s Duct
% 209.18/209.41  |- skos__hiddenLabel mesh__D010183 Wirsung Duct
% 209.18/209.41  |- skos__altLabel mesh__D010183 Duct of Santorini
% 209.18/209.41  |- skos__hiddenLabel mesh__D010183 Pancreatic Duct, Main
% 209.18/209.41  |- skos__hiddenLabel mesh__D010183 Minor Duodenal Papilla
% 209.18/209.41  |- skos__hiddenLabel mesh__D010183 Santorinis Duct
% 209.18/209.41  |- skos__hiddenLabel mesh__D010183 Ducts, Main Pancreatic
% 209.18/209.41  |- skos__altLabel mesh__D010183 Santorini%27%s Duct
% 209.18/209.41  |- mesh__recordMaintainer mesh__D010183 jls
% 209.18/209.41  |- skos__hiddenLabel mesh__D010183 Duct, Pancreatic
% 209.18/209.41  |- skos__hiddenLabel mesh__D010183 Accessory Pancreatic Ducts
% 209.18/209.41  |- skos__hiddenLabel mesh__D010183 Duct, Accessory Pancreatic
% 209.18/209.41  |- skos__hiddenLabel mesh__D010183 Ducts, Pancreatic
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D010183 2005
% 209.18/209.41  |- skos__hiddenLabel mesh__D010183 Duct, Main Pancreatic
% 209.18/209.41  |- skos__hiddenLabel mesh__D010183 Duodenal Papillas, Minor
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D010183 2004
% 209.18/209.41  |- skos__hiddenLabel mesh__D010183 Pancreatic Duct, Accessory
% 209.18/209.41  |- skos__hiddenLabel mesh__D010183 Pancreatic Duct
% 209.18/209.41  |- skos__hiddenLabel mesh__D010183 Papillas, Minor Duodenal
% 209.18/209.41  |- skos__hiddenLabel mesh__D010183 Main Pancreatic Ducts
% 209.18/209.41  |- skos__hiddenLabel mesh__D010183 Pancreatic Ducts, Main
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D010183 2003
% 209.18/209.41  |- skos__broader mesh__D010183smesh__D010179
% 209.18/209.41  |- skos__hiddenLabel mesh__D010183 Duct, Wirsung%27%s
% 209.18/209.41  |- skos__scopeNote mesh__D010183
% 209.18/209.41       Ducts that collect PANCREATIC JUICE from the PANCREAS and supply it to the DUODENUM.%A%    
% 209.18/209.41  |- mesh__recordOriginator mesh__D010183 NLM
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D010183 2005B
% 209.18/209.41  |- skos__annotation mesh__D010183
% 209.18/209.41       note X ref DUODENAL PAPILLA, MINOR: do not confuse with DUODENAL PAPILLA, MAJOR see VATER%27%S AMPULLA; %22%duodenal papilla%22% unspecified is probably DUODENAL PAPILLA, MAJOR%A%  
% 209.18/209.41  |- skos__hiddenLabel mesh__D010183 Wirsungs Duct
% 209.18/209.41  |- skos__altLabel mesh__D010183 Duct of Wirsung
% 209.18/209.41  |- skos__hiddenLabel mesh__D010183 Papilla, Minor Duodenal
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D010183 2005A
% 209.18/209.41  |- mesh__recordAuthorizer mesh__D010183 jls
% 209.18/209.41  |- mesh__dateCreated mesh__D010183 1999-01-01
% 209.18/209.41  |- mesh__activeMeSHYear mesh__D010183 2002
% 209.18/209.42  |- rdf__type mesh__D010183sskos__Concept
% 209.18/209.42  |- skos__hiddenLabel mesh__D010183 Minor Duodenal Papillas
% 209.18/209.42  |- skos__hiddenLabel mesh__D010183 Pancreatic Ducts, Accessory
% 209.18/209.42  |- skos__hiddenLabel mesh__D010183 Duct, Santorini%27%s
% 209.18/209.42  |- skos__hiddenLabel mesh__D010183 Santorini Duct
% 209.18/209.42  |- mesh__dateRevised mesh__D010183 2004-07-30
% 209.18/209.42  |- skos__prefLabel mesh__D010183 Pancreatic Ducts
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004944 2004
% 209.18/209.42  |- skos__annotation mesh__D004944
% 209.18/209.42       do not use /util except by MeSH definition   
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004944 2003
% 209.18/209.42  |- mesh__dateCreated mesh__D004944 1999-01-01
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004944 2002
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004944 1999
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004944 2001
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004944 1998
% 209.18/209.42  |- skos__prefLabel mesh__D004944 Esophagoplasty
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004944 2006
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004944 2000
% 209.18/209.42  |- mesh__recordOriginator mesh__D004944 NLM
% 209.18/209.42  |- skos__broader mesh__D004944smesh__D013505
% 209.18/209.42  |- rdf__type mesh__D004944sskos__Concept
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004944 2005
% 209.18/209.42  |- mesh__recordMaintainer mesh__D004944 PXP
% 209.18/209.42  |- mesh__recordAuthorizer mesh__D004944 SJN
% 209.18/209.42  |- skos__scopeNote mesh__D004944
% 209.18/209.42       A plastic operation on the esophagus. %28%Dorland, 28th ed%29%%A%    
% 209.18/209.42  |- mesh__dateRevised mesh__D004944 1997-06-20
% 209.18/209.42  |- skos__hiddenLabel mesh__D004944 Esophagoplasties
% 209.18/209.42  |- mesh__dateRevised mesh__D004146 1992-05-13
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004146 2005
% 209.18/209.42  |- mesh__onlineNote mesh__D004146 use DIOXINS to search DIOXANES 1966-74   
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004146 2004
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004146 2002
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004146 1999
% 209.18/209.42  |- mesh__recordOriginator mesh__D004146 NLM
% 209.18/209.42  |- mesh__recordAuthorizer mesh__D004146 PLS
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004146 2003
% 209.18/209.42  |- mesh__dateEstablished mesh__D004146 1991-01-01
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004146 1998
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004146 1997
% 209.18/209.42  |- skos__scopeNote mesh__D004146
% 209.18/209.42       1,4-Diethylene dioxides. Industrial solvents. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%, dioxane itself may %22%reasonably be anticipated to be a carcinogen.%22% %28%Merck Index, 11th ed%29%%A%    
% 209.18/209.42  |- mesh__dateCreated mesh__D004146 1999-01-01
% 209.18/209.42  |- mesh__publicMeSHNote mesh__D004146
% 209.18/209.42       91,63-67; was see under DIOXINS 1968-90; was heading 1963-67%A%  
% 209.18/209.42  |- mesh__recordMaintainer mesh__D004146 TAP
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004146 1996
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004146 2001
% 209.18/209.42  |- skos__broader mesh__D004146smesh__D004147
% 209.18/209.42  |- skos__annotation mesh__D004146 indust solvents   
% 209.18/209.42  |- rdf__type mesh__D004146sskos__Concept
% 209.18/209.42  |- skos__prefLabel mesh__D004146 Dioxanes
% 209.18/209.42  |- mesh__historyNote mesh__D004146
% 209.18/209.42       91%28%75%29%63-67; was see under DIOXINS 1968-90; was heading 1963-67%A%  
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004146 1995
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004146 2000
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004146 2006
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004146 1994
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004146 1993
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D014574 2006
% 209.18/209.42  |- mesh__recordMaintainer mesh__D014574 ssb
% 209.18/209.42  |- skos__prefLabel mesh__D014574 Uronic Acids
% 209.18/209.42  |- mesh__dateRevised mesh__D014574 2004-07-07
% 209.18/209.42  |- skos__broader mesh__D014574smesh__D013400
% 209.18/209.42  |- skos__broader mesh__D014574smesh__D000145
% 209.18/209.42  |- mesh__recordAuthorizer mesh__D014574 sjn
% 209.18/209.42  |- skos__hiddenLabel mesh__D014574 Acids, Uronic
% 209.18/209.42  |- mesh__dateCreated mesh__D014574 1999-01-01
% 209.18/209.42  |- mesh__recordOriginator mesh__D014574 NLM
% 209.18/209.42  |- rdf__type mesh__D014574sskos__Concept
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D014574 2005
% 209.18/209.42  |- skos__scopeNote mesh__D014574
% 209.18/209.42       Acids derived from monosaccharides by the oxidation of the terminal %28%-CH2OH%29% group farthest removed from the carbonyl group to a %28%-COOH%29% group. %28%From Stedmans, 26th ed%29%%A%    
% 209.18/209.42  |- skos__hiddenLabel mesh__D008537 Tarsal Gland
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D008537 2004
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D008537 2005
% 209.18/209.42  |- mesh__dateCreated mesh__D008537 1999-01-01
% 209.18/209.42  |- mesh__historyNote mesh__D008537
% 209.18/209.42       91%28%75%29%; was see under EYELIDS 1975-90   
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D008537 2001
% 209.18/209.42  |- skos__broader mesh__D008537smesh__D005143
% 209.18/209.42  |- skos__hiddenLabel mesh__D008537 Gland, Meibomian
% 209.18/209.42  |- rdf__type mesh__D008537sskos__Concept
% 209.18/209.42  |- skos__related mesh__D008537smesh__D017043
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D008537 2003
% 209.18/209.42  |- skos__prefLabel mesh__D008537 Meibomian Glands
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D008537 2000
% 209.18/209.42  |- skos__scopeNote mesh__D008537
% 209.18/209.42       The sebaceous glands situated on the inner surface of the eyelids between the tarsal plates and CONJUNCTIVA.%A%    
% 209.18/209.42  |- skos__hiddenLabel mesh__D008537 Gland, Tarsal
% 209.18/209.42  |- mesh__dateEstablished mesh__D008537 1991-01-01
% 209.18/209.42  |- mesh__recordMaintainer mesh__D008537 KEV
% 209.18/209.42  |- mesh__publicMeSHNote mesh__D008537 91; was see under EYELIDS 1975-90   
% 209.18/209.42  |- skos__annotation mesh__D008537
% 209.18/209.42       dis: coord IM with EYELID DISEASES %28%IM%29%; neopl: coord IM with EYELID NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 209.18/209.42  |- mesh__dateRevised mesh__D008537 1999-11-03
% 209.18/209.42  |- skos__hiddenLabel mesh__D008537 Meibomian Gland
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D008537 2002
% 209.18/209.42  |- skos__hiddenLabel mesh__D008537 Glands, Tarsal
% 209.18/209.42  |- skos__broader mesh__D008537smesh__D012627
% 209.18/209.42  |- mesh__recordAuthorizer mesh__D008537 sjn
% 209.18/209.42  |- skos__altLabel mesh__D008537 Tarsal Glands
% 209.18/209.42  |- mesh__onlineNote mesh__D008537 search EYELIDS 1966-74   
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D008537 2006
% 209.18/209.42  |- skos__hiddenLabel mesh__D008537 Glands, Meibomian
% 209.18/209.42  |- mesh__recordOriginator mesh__D008537 NLM
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Facilities, Ambulatory Care
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Facility, Ambulatory Care
% 209.18/209.42  |- mesh__onlineNote mesh__D000554
% 209.18/209.42       use AMBULATORY CARE FACILITIES to search AMBULATORY CARE FACILITIES, NON-HOSPITAL 1980-82 %26% HEALTH CENTERS 1979%A%  
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D000554 2001
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D000554 2006
% 209.18/209.42  |- skos__altLabel mesh__D000554 Ambulatory Care Facilities, Non-Hospital
% 209.18/209.42  |- mesh__dateRevised mesh__D000554 1999-11-03
% 209.18/209.42  |- skos__prefLabel mesh__D000554 Ambulatory Care Facilities
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Centers, Ambulatory Health
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Activities, Clinic
% 209.18/209.42  |- skos__broader mesh__D000554smesh__D006268
% 209.18/209.42  |- mesh__publicMeSHNote mesh__D000554
% 209.18/209.42       83; was AMBULATORY CARE FACILITIES, NON-HOSPITAL 1980-82; was HEALTH CENTERS 1979%A%  
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D000554 2002
% 209.18/209.42  |- skos__historyNote mesh__D000554 Health Facilities %28%1968-1978%29%
% 209.18/209.42  |- mesh__recordAuthorizer mesh__D000554 sjn
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Free-Standing Clinic
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Clinic, Outpatient
% 209.18/209.42  |- skos__altLabel mesh__D000554 Outpatient Clinic
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Ambulatory Health Center
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Center, Ambulatory Health
% 209.18/209.42  |- mesh__historyNote mesh__D000554
% 209.18/209.42       83; was AMBULATORY CARE FACILITIES, NON-HOSPITAL 1980-82; was HEALTH CENTERS 1979%A%  
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D000554 2003
% 209.18/209.42  |- skos__annotation mesh__D000554 IM   
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Free-Standing Clinics
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Center, Family Planning
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Clinics, Free Standing
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Clinic, Free-Standing
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Center, Abortion
% 209.18/209.42  |- skos__scopeNote mesh__D000554
% 209.18/209.42       Those facilities which administer health services to individuals who do not require hospitalization or institutionalization.%A%    
% 209.18/209.42  |- mesh__dateCreated mesh__D000554 1978-04-26
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Family Planning Center
% 209.18/209.42  |- mesh__recordOriginator mesh__D000554 EC
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Centers, Family Planning
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D000554 2004
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Clinics, Outpatient
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Ambulatory Health Centers
% 209.18/209.42  |- skos__altLabel mesh__D000554 Outpatient Clinics
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Ambulatory Care Facility
% 209.18/209.42  |- mesh__dateEstablished mesh__D000554 1979-01-01
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Activity, Clinic
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Centers, Abortion
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D000554 2000
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D000554 2005
% 209.18/209.42  |- rdf__type mesh__D000554sskos__Concept
% 209.18/209.42  |- skos__altLabel mesh__D000554 Ambulatory Care Facilities, Nonhospital
% 209.18/209.42  |- mesh__recordMaintainer mesh__D000554 kle
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Clinic Activity
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Abortion Center
% 209.18/209.42  |- skos__hiddenLabel mesh__D000554 Health Center, Ambulatory
% 209.18/209.42  |- skos__altLabel mesh__D000554 Ambulatory Care Facilities, Non Hospital
% 209.18/209.42  |- skos__related mesh__D018965smesh__D016368
% 209.18/209.42  |- mesh__publicMeSHNote mesh__D018965
% 209.18/209.42       96; was RIBOSOMAL FRAMESHIFT see FRAMESHIFT MUTATION 1991-95%A%  
% 209.18/209.42  |- skos__historyNote mesh__D018965 Translation, Genetic %28%1979-1995%29%
% 209.18/209.42  |- mesh__dateEstablished mesh__D018965 1996-01-01
% 209.18/209.42  |- skos__hiddenLabel mesh__D018965 Frame Shift, Ribosomal
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D018965 2005
% 209.18/209.42  |- skos__scopeNote mesh__D018965
% 209.18/209.42       A directed change in translational READING FRAMES that allows the production of a single protein from two or more OVERLAPPING GENES. The process is programmed by the nucleotide sequence of the MRNA and is sometimes also affected by the secondary or tertiary mRNA structure. It has been described mainly in VIRUSES %28%especially RETROVIRUSES%29%; RETROTRANSPOSONS; and bacterial insertion elements but also in some cellular genes.%A%    
% 209.18/209.42  |- skos__hiddenLabel mesh__D018965 Translational Frameshifting
% 209.18/209.42  |- skos__historyNote mesh__D018965 Frameshift Mutation %28%1991-1995%29%
% 209.18/209.42  |- skos__annotation mesh__D018965
% 209.18/209.42       do not confuse with FRAMESHIFT MUTATION, non-physiol insertion or deletion of coding sequence nucleotides%A%  
% 209.18/209.42  |- skos__prefLabel mesh__D018965 Frameshifting, Ribosomal
% 209.18/209.42  |- skos__hiddenLabel mesh__D018965 Frameshift, Ribosomal
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D018965 2006A
% 209.18/209.42  |- skos__hiddenLabel mesh__D018965 Frame Shifts, Ribosomal
% 209.18/209.42  |- skos__altLabel mesh__D018965 Ribosomal Frame Shift
% 209.18/209.42  |- skos__hiddenLabel mesh__D018965 Ribosomal Frameshifts
% 209.18/209.42  |- mesh__dateRevised mesh__D018965 2005-07-28
% 209.18/209.42  |- skos__altLabel mesh__D018965 Ribosomal Frameshift
% 209.18/209.42  |- mesh__onlineNote mesh__D018965
% 209.18/209.42       use FRAMESHIFT MUTATION to search RIBOSOMAL FRAMESHIFT 1991-95%A%  
% 209.18/209.42  |- skos__hiddenLabel mesh__D018965 Ribosomal Frame Shifts
% 209.18/209.42  |- mesh__recordMaintainer mesh__D018965 ags
% 209.18/209.42  |- mesh__historyNote mesh__D018965
% 209.18/209.42       96; was RIBOSOMAL FRAMESHIFT see FRAMESHIFT MUTATION 1991-95%A%  
% 209.18/209.42  |- skos__altLabel mesh__D018965 Ribosomal Frameshifting
% 209.18/209.42  |- mesh__recordAuthorizer mesh__D018965 ags
% 209.18/209.42  |- skos__historyNote mesh__D018965 Ribosomes %28%1979-1995%29%
% 209.18/209.42  |- skos__altLabel mesh__D018965 Frameshifting, Translational
% 209.18/209.42  |- mesh__dateCreated mesh__D018965 1995-02-22
% 209.18/209.42  |- skos__broader mesh__D018965smesh__D005786
% 209.18/209.42  |- skos__altLabel mesh__D018965 Ribosomal Frame Shifting
% 209.18/209.42  |- rdf__type mesh__D018965sskos__Concept
% 209.18/209.42  |- skos__hiddenLabel mesh__D018965 Frameshifts, Ribosomal
% 209.18/209.42  |- skos__hiddenLabel mesh__D018965 Frame Shifting, Ribosomal
% 209.18/209.42  |- skos__broader mesh__D018965smesh__D014176
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D018965 2006
% 209.18/209.42  |- mesh__recordOriginator mesh__D018965 AGS
% 209.18/209.42  |- skos__hiddenLabel mesh__D010982 Factor, Platelet-Derived Growth
% 209.18/209.42  |- mesh__dateEstablished mesh__D010982 1984-01-01
% 209.18/209.42  |- skos__broader mesh__D010982smesh__D006133
% 209.18/209.42  |- mesh__publicMeSHNote mesh__D010982 84   
% 209.18/209.42  |- skos__historyNote mesh__D010982 Peptides %28%1977-1983%29%
% 209.18/209.42  |- mesh__recordAuthorizer mesh__D010982 sjn
% 209.18/209.42  |- mesh__recordOriginator mesh__D010982 RLS
% 209.18/209.42  |- mesh__dateCreated mesh__D010982 1983-05-31
% 209.18/209.42  |- skos__historyNote mesh__D010982 Growth Substances %28%1977-1983%29%
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D010982 2006
% 209.18/209.42  |- mesh__dateRevised mesh__D010982 2005-06-30
% 209.18/209.42  |- skos__broader mesh__D010982smesh__D036341
% 209.18/209.42  |- mesh__recordMaintainer mesh__D010982 ssb
% 209.18/209.42  |- skos__annotation mesh__D010982 /biosyn /physiol permitted; DF: PDGF   
% 209.18/209.42  |- skos__scopeNote mesh__D010982
% 209.18/209.42       Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication.%A%    
% 209.18/209.42  |- skos__historyNote mesh__D010982 Blood Proteins %28%1977-1983%29%
% 209.18/209.42  |- skos__hiddenLabel mesh__D010982 Growth Factor, Platelet-Derived
% 209.18/209.42  |- skos__broader mesh__D010982smesh__D001798
% 209.18/209.42  |- skos__prefLabel mesh__D010982 Platelet-Derived Growth Factor
% 209.18/209.42  |- skos__related mesh__D010982smesh__D017479
% 209.18/209.42  |- skos__altLabel mesh__D010982 Platelet Derived Growth Factor
% 209.18/209.42  |- mesh__historyNote mesh__D010982 84   
% 209.18/209.42  |- rdf__type mesh__D010982sskos__Concept
% 209.18/209.42  |- skos__altLabel mesh__D018167 1,25-Dihydroxyvitamin D 3 Receptor
% 209.18/209.42  |- skos__hiddenLabel mesh__D018167 Receptors, 1,25-Dihydroxyvitamin D3
% 209.18/209.42  |- skos__altLabel mesh__D018167 Calcitriol Receptor
% 209.18/209.42  |- mesh__recordOriginator mesh__D018167 RAZ
% 209.18/209.42  |- skos__hiddenLabel mesh__D018167 Receptor, Vitamin D3
% 209.18/209.42  |- skos__historyNote mesh__D018167 Receptors, Steroid %28%1980-1993%29%
% 209.18/209.42  |- skos__altLabel mesh__D018167 Receptors, Vitamin D3
% 209.18/209.42  |- skos__altLabel mesh__D018167 Vitamin D3 Receptor
% 209.18/209.42  |- skos__hiddenLabel mesh__D018167 1,25 Dihydroxyvitamin D3 Receptors
% 209.18/209.42  |- skos__hiddenLabel mesh__D018167 D Receptors, Vitamin
% 209.18/209.42  |- skos__hiddenLabel mesh__D018167 Receptor, 1,25-Dihydroxycholecalciferol
% 209.18/209.42  |- skos__hiddenLabel mesh__D018167 D3 Receptor, 1,25-Dihydroxyvitamin
% 209.18/209.42  |- skos__altLabel mesh__D018167 Receptors, Vitamin D 3
% 209.18/209.42  |- skos__altLabel mesh__D018167 1,25-Dihydroxyvitamin D3 Receptors
% 209.18/209.42  |- mesh__historyNote mesh__D018167
% 209.18/209.42       94; was 1,25-DIHYDROXYCHOLECALCIFEROL RECEPTOR %28%NM%29% 1980-93; VITAMIN D3 RECEPTOR was %28%NM%29% 1988-93%A%  
% 209.18/209.42  |- skos__altLabel mesh__D018167 Receptors, 1,25-Dihydroxyvitamin D 3
% 209.18/209.42  |- skos__broader mesh__D018167smesh__D018160
% 209.18/209.42  |- skos__altLabel mesh__D018167 1,25-Dihydroxyvitamin D3 Receptor
% 209.18/209.42  |- skos__hiddenLabel mesh__D018167 1,25 Dihydroxycholecalciferol Receptors
% 209.18/209.42  |- skos__altLabel mesh__D018167 Receptors, Cholecalciferol
% 209.18/209.42  |- skos__hiddenLabel mesh__D018167 Receptor, Vitamin D
% 209.18/209.42  |- skos__altLabel mesh__D018167 Receptors, Vitamin D
% 209.18/209.42  |- skos__hiddenLabel mesh__D018167 D3 Receptors, 1,25-Dihydroxyvitamin
% 209.18/209.42  |- skos__altLabel mesh__D018167 Vitamin D Receptors
% 209.18/209.42  |- mesh__dateRevised mesh__D018167 2005-06-30
% 209.18/209.42  |- mesh__dateCreated mesh__D018167 1993-06-21
% 209.18/209.42  |- skos__altLabel mesh__D018167 Vitamin D Receptor
% 209.18/209.42  |- skos__altLabel mesh__D018167 1,25-Dihydroxycholecalciferol Receptor
% 209.18/209.42  |- skos__hiddenLabel mesh__D018167 D3 Receptor, Vitamin
% 209.18/209.42  |- mesh__recordMaintainer mesh__D018167 ssb
% 209.18/209.42  |- skos__hiddenLabel mesh__D018167 D3 Receptors, Vitamin
% 209.18/209.42  |- skos__hiddenLabel mesh__D018167 1,25 Dihydroxyvitamin D 3 Receptor
% 209.18/209.42  |- skos__altLabel mesh__D018167 Vitamin D 3 Receptors
% 209.18/209.42  |- skos__prefLabel mesh__D018167 Receptors, Calcitriol
% 209.18/209.42  |- skos__hiddenLabel mesh__D018167 D Receptor, Vitamin
% 209.18/209.42  |- skos__hiddenLabel mesh__D018167 1,25 Dihydroxycholecalciferol Receptor
% 209.18/209.42  |- skos__broader mesh__D018167smesh__D014157
% 209.18/209.42  |- skos__annotation mesh__D018167 DF: RECEPT CALCITRIOL   
% 209.18/209.42  |- skos__altLabel mesh__D018167 Vitamin D 3 Receptor
% 209.18/209.42  |- skos__altLabel mesh__D018167 Cholecalciferol Receptors
% 209.18/209.42  |- skos__hiddenLabel mesh__D018167 1,25 Dihydroxyvitamin D3 Receptor
% 209.18/209.42  |- skos__altLabel mesh__D018167 1,25-Dihydroxycholecalciferol Receptors
% 209.18/209.42  |- skos__hiddenLabel mesh__D018167 Receptors, 1,25-Dihydroxycholecalciferol
% 209.18/209.42  |- mesh__recordAuthorizer mesh__D018167 sjn
% 209.18/209.42  |- skos__altLabel mesh__D018167 Vitamin D3 Receptors
% 209.18/209.42  |- skos__hiddenLabel mesh__D018167 Receptor, 1,25-Dihydroxyvitamin D3
% 209.18/209.42  |- mesh__onlineNote mesh__D018167
% 209.18/209.42       use RECEPTORS, CALCITRIOL %28%NM%29% to search 1,25-DIHYDROXYCHOLECALCIFEROL RECEPTOR 1980-93 %26% VITAMIN D3 RECEPTOR 1988-93%A%  
% 209.18/209.42  |- mesh__publicMeSHNote mesh__D018167
% 209.18/209.42       94; 1,25-DIHYDROXYCHOLECALCIFEROL RECEPTOR was indexed under RECEPTORS, STEROID 1980-93; VITAMIN D3 RECEPTOR was indexed under RECEPTORS, STEROID 1988-93%A%  
% 209.18/209.42  |- skos__scopeNote mesh__D018167
% 209.18/209.42       Proteins, usually found in the cytoplasm, that specifically bind calcitriol, migrate to the nucleus, and regulate transcription of specific segments of DNA with the participation of D receptor interacting proteins %28%called DRIP%29%. Vitamin D is converted in the liver and kidney to calcitriol and ultimately acts through these receptors.%A%    
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D018167 2006
% 209.18/209.42  |- mesh__dateEstablished mesh__D018167 1994-01-01
% 209.18/209.42  |- rdf__type mesh__D018167sskos__Concept
% 209.18/209.42  |- skos__altLabel mesh__D018167 Calcitriol Receptors
% 209.18/209.42  |- skos__hiddenLabel mesh__D018167 Receptor, Calcitriol
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D010184 2006
% 209.18/209.42  |- mesh__recordMaintainer mesh__D010184 ssb
% 209.18/209.42  |- skos__broader mesh__D010184smesh__D014020
% 209.18/209.42  |- skos__prefLabel mesh__D010184 Pancreatic Extracts
% 209.18/209.42  |- skos__hiddenLabel mesh__D010184 Extracts, Pancreatic
% 209.18/209.42  |- rdf__type mesh__D010184sskos__Concept
% 209.18/209.42  |- skos__annotation mesh__D010184
% 209.18/209.42       extracts of pancreas or pancreatic fractions containing uncharacterized factors; do not confuse with chemical substances %22%extracted%22% from the pancreas, as %22%peptides extracted from the mouse pancreas%22% %28% = PEPTIDES /anal + PANCREAS /anal%29%; PANCREATIN, a pancreatic extract, is also available%A%  
% 209.18/209.42  |- mesh__recordAuthorizer mesh__D010184 sjn
% 209.18/209.42  |- mesh__dateCreated mesh__D010184 1999-01-01
% 209.18/209.42  |- skos__scopeNote mesh__D010184
% 209.18/209.42       Extracts prepared from pancreatic tissue that may contain the pancreatic enzymes or other specific uncharacterized factors or proteins with specific activities. PANCREATIN is a specific extract containing digestive enzymes and used to treat pancreatic insufficiency.%A%    
% 209.18/209.42  |- mesh__dateRevised mesh__D010184 2005-06-30
% 209.18/209.42  |- mesh__recordOriginator mesh__D010184 NLM
% 209.18/209.42  |- mesh__dateRevised mesh__D004945 1999-11-04
% 209.18/209.42  |- mesh__recordAuthorizer mesh__D004945 sjn
% 209.18/209.42  |- skos__hiddenLabel mesh__D004945 Esophagoscopies
% 209.18/209.42  |- mesh__dateCreated mesh__D004945 1999-01-01
% 209.18/209.42  |- skos__hiddenLabel mesh__D004945 Procedures, Esophagoscopic Surgical
% 209.18/209.42  |- skos__scopeNote mesh__D004945
% 209.18/209.42       Endoscopic examination, therapy or surgery of the esophagus.%A%    
% 209.18/209.42  |- skos__hiddenLabel mesh__D004945 Procedure, Esophagoscopic Surgical
% 209.18/209.42  |- skos__prefLabel mesh__D004945 Esophagoscopy
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004945 2006
% 209.18/209.42  |- skos__altLabel mesh__D004945 Esophagoscopic Surgery
% 209.18/209.42  |- skos__broader mesh__D004945smesh__D016145
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004945 2002
% 209.18/209.42  |- rdf__type mesh__D004945sskos__Concept
% 209.18/209.42  |- skos__hiddenLabel mesh__D004945 Esophagoscopic Surgeries
% 209.18/209.42  |- mesh__recordMaintainer mesh__D004945 nns
% 209.18/209.42  |- skos__hiddenLabel mesh__D004945 Surgeries, Esophagoscopic
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004945 2005
% 209.18/209.42  |- skos__hiddenLabel mesh__D004945 Esophagoscopic Surgical Procedure
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004945 2001
% 209.18/209.42  |- skos__altLabel mesh__D004945 Surgical Procedures, Esophagoscopic
% 209.18/209.42  |- skos__altLabel mesh__D004945 Surgery, Esophagoscopic
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004945 2004
% 209.18/209.42  |- skos__hiddenLabel mesh__D004945 Surgical Procedure, Esophagoscopic
% 209.18/209.42  |- mesh__recordOriginator mesh__D004945 NLM
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004945 2000
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004945 2003
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004147 2004
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004147 2002
% 209.18/209.42  |- mesh__dateEstablished mesh__D004147 1968-01-01
% 209.18/209.42  |- mesh__dateRevised mesh__D004147 2000-06-22
% 209.18/209.42  |- skos__scopeNote mesh__D004147
% 209.18/209.42       Chlorinated hydrocarbons containing heteroatoms that are present as contaminants of herbicides. Dioxins are carcinogenic, teratogenic, and mutagenic. They have been banned from use by the FDA.%A%    
% 209.18/209.42  |- mesh__recordOriginator mesh__D004147 NLM
% 209.18/209.42  |- mesh__historyNote mesh__D004147 68   
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004147 2005
% 209.18/209.42  |- rdf__type mesh__D004147sskos__Concept
% 209.18/209.42  |- mesh__recordMaintainer mesh__D004147 adp
% 209.18/209.42  |- skos__prefLabel mesh__D004147 Dioxins
% 209.18/209.42  |- mesh__recordAuthorizer mesh__D004147 sjn
% 209.18/209.42  |- mesh__publicMeSHNote mesh__D004147 68; DIOXANES was heading 1963-67   
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004147 2006
% 209.18/209.42  |- skos__broader mesh__D004147smesh__D006573
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004147 2003
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D004147 2001
% 209.18/209.42  |- mesh__dateCreated mesh__D004147 1999-01-01
% 209.18/209.42  |- mesh__publicMeSHNote mesh__D009630 82   
% 209.18/209.42  |- mesh__recordAuthorizer mesh__D009630 sjn
% 209.18/209.42  |- mesh__dateEstablished mesh__D009630 1982-01-01
% 209.18/209.42  |- skos__hiddenLabel mesh__D009630 Non-Disjunctions, Genetic
% 209.18/209.42  |- mesh__dateRevised mesh__D009630 2004-07-07
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D009630 2006
% 209.18/209.42  |- skos__historyNote mesh__D009630 Cell Division %28%1966-1967%29%
% 209.18/209.42  |- skos__broader mesh__D009630smesh__D020090
% 209.18/209.42  |- skos__broader mesh__D009630smesh__D002869
% 209.18/209.42  |- skos__historyNote mesh__D009630 Meiosis %28%1968-1981%29%
% 209.18/209.42  |- skos__hiddenLabel mesh__D009630 Non Disjunction, Genetic
% 209.18/209.42  |- skos__altLabel mesh__D009630 Non-Disjunction, Genetic
% 209.18/209.42  |- mesh__recordOriginator mesh__D009630 AEP
% 209.18/209.42  |- rdf__type mesh__D009630sskos__Concept
% 209.18/209.42  |- mesh__activeMeSHYear mesh__D009630 2005
% 209.18/209.42  |- skos__hiddenLabel mesh__D009630 Genetic Non-Disjunctions
% 209.18/209.42  |- skos__historyNote mesh__D009630 Chromosomes %28%1966-1967%29%
% 209.18/209.42  |- mesh__historyNote mesh__D009630 82   
% 209.18/209.42  |- skos__scopeNote mesh__D009630
% 209.18/209.42       The failure of homologous CHROMOSOMES or CHROMATIDS to segregate during MITOSIS or MEIOSIS with the result that one daughter cell has both of a pair of parental chromosomes or chromatids and the other has none.%A%    
% 209.28/209.42  |- skos__historyNote mesh__D009630 Chromosome Aberrations %28%1968-1981%29%
% 209.28/209.42  |- mesh__recordMaintainer mesh__D009630 nns
% 209.28/209.42  |- skos__broader mesh__D009630smesh__D016296
% 209.28/209.42  |- skos__prefLabel mesh__D009630 Nondisjunction, Genetic
% 209.28/209.42  |- skos__hiddenLabel mesh__D009630 Genetic Non Disjunction
% 209.28/209.42  |- skos__altLabel mesh__D009630 Genetic Nondisjunction
% 209.28/209.42  |- skos__altLabel mesh__D009630 Genetic Non-Disjunction
% 209.28/209.42  |- skos__hiddenLabel mesh__D009630 Nondisjunctions, Genetic
% 209.28/209.42  |- skos__hiddenLabel mesh__D009630 Genetic Nondisjunctions
% 209.28/209.42  |- mesh__dateCreated mesh__D009630 1981-02-23
% 209.28/209.42  |- skos__historyNote mesh__D014575 Porphyrinogens %28%1975%29%
% 209.28/209.42  |- skos__altLabel mesh__D014575 Uroporphyrinogen Carboxy-Lyase
% 209.28/209.42  |- skos__hiddenLabel mesh__D014575 Uroporphyrinogen Carboxy Lyase
% 209.28/209.42  |- mesh__publicMeSHNote mesh__D014575
% 209.28/209.42       91; was see under CARBOXY-LYASES 1976-90   
% 209.28/209.42  |- mesh__recordMaintainer mesh__D014575 ags
% 209.28/209.42  |- skos__hiddenLabel mesh__D014575 Decarboxylase, Uroporphyrinogen
% 209.28/209.42  |- mesh__recordOriginator mesh__D014575 RLS
% 209.28/209.42  |- mesh__dateEstablished mesh__D014575 1991-01-01
% 209.28/209.42  |- skos__historyNote mesh__D014575 Porphyrins %28%1974%29%
% 209.28/209.42  |- skos__hiddenLabel mesh__D014575 Decarboxylase, Uroporphyrinogen III
% 209.28/209.42  |- skos__historyNote mesh__D014575 Carboxy-Lyases %28%1974-1975%29%
% 209.28/209.42  |- mesh__historyNote mesh__D014575
% 209.28/209.42       91%28%76%29%; was see under CARBOXY-LYASES 1976-90   
% 209.28/209.42  |- skos__altLabel mesh__D014575 Uroporphyrinogen III Decarboxylase
% 209.28/209.42  |- skos__annotation mesh__D014575
% 209.28/209.42       /defic permitted but consider also PORPHYRIA CUTANEA TARDA and HEPATOERYTHROPOIETIC PORPHYRIA%A%  
% 209.28/209.42  |- mesh__recordAuthorizer mesh__D014575 ags
% 209.28/209.42  |- skos__broader mesh__D014575smesh__D002262
% 209.28/209.42  |- rdf__type mesh__D014575sskos__Concept
% 209.28/209.42  |- mesh__dateCreated mesh__D014575 1975-07-25
% 209.28/209.42  |- mesh__dateRevised mesh__D014575 2005-07-12
% 209.28/209.42  |- mesh__activeMeSHYear mesh__D014575 2005
% 209.28/209.42  |- mesh__activeMeSHYear mesh__D014575 2006A
% 209.28/209.42  |- skos__hiddenLabel mesh__D014575 Carboxy-Lyase, Uroporphyrinogen
% 209.28/209.42  |- skos__scopeNote mesh__D014575
% 209.28/209.42       An enzyme that catalyzes the decarboxylation of UROPORPHYRINOGEN III to coproporphyrinogen III by the conversion of four acetate groups to four methyl groups. It is the fifth enzyme in the 8-enzyme biosynthetic pathway of HEME. Several forms of cutaneous  PORPHYRIAS are results of this enzyme deficiency as in PORPHYRIA CUTANEA TARDA; and HEPATOERYTHROPOIETIC PORPHYRIA.%A%    
% 209.28/209.42  |- mesh__activeMeSHYear mesh__D014575 2006
% 209.28/209.42  |- skos__prefLabel mesh__D014575 Uroporphyrinogen Decarboxylase
% 209.28/209.42  |- skos__altLabel mesh__D008538
% 209.28/209.42       Idiopathic Blepharospasm-Oromandibular Dystonia Syndrome
% 209.28/209.42  |- skos__hiddenLabel mesh__D008538 Blepharospasm Oromandibular Dystonia
% 209.28/209.42  |- skos__hiddenLabel mesh__D008538
% 209.28/209.42       Idiopathic Blepharospasm Oromandibular Dystonia Syndrome
% 209.28/209.42  |- skos__hiddenLabel mesh__D008538 Orofacial Dyskinesias, Idiopathic
% 209.28/209.42  |- rdf__type mesh__D008538sskos__Concept
% 209.28/209.42  |- mesh__dateEstablished mesh__D008538 1991-01-01
% 209.28/209.42  |- skos__scopeNote mesh__D008538
% 209.28/209.42       A syndrome characterized by orofacial DYSTONIA; including BLEPHAROSPASM; forceful jaw opening; lip retraction; platysma muscle spasm; and tongue protrusion. It primarily affects older adults, with an incidence peak in the seventh decade of life. %28%From Adams et al., Principles of Neurology, 6th ed, p108%29%%A%    
% 209.28/209.42  |- skos__prefLabel mesh__D008538 Meige Syndrome
% 209.28/209.42  |- mesh__publicMeSHNote mesh__D008538
% 209.28/209.42       1991; see BASAL GANGLIA DISEASES 1985-1990   
% 209.28/209.42  |- skos__hiddenLabel mesh__D008538 Blepharospasm-Oromandibular Dyskinesias
% 209.28/209.42  |- skos__hiddenLabel mesh__D008538 Dyskinesias, Idiopathic Orofacial
% 209.28/209.42  |- skos__hiddenLabel mesh__D008538 Dystonias, Blepharospasm-Oromandibular
% 209.28/209.42  |- mesh__activeMeSHYear mesh__D008538 2006
% 209.28/209.42  |- mesh__historyNote mesh__D008538 1991%28%1985%29%   
% 209.28/209.42  |- skos__altLabel mesh__D008538 Idiopathic Orofacial Dyskinesia
% 209.28/209.42  |- mesh__recordOriginator mesh__D008538 RC
% 209.28/209.42  |- skos__historyNote mesh__D008538 Facial Muscles %28%1966-1984%29%
% 209.28/209.42  |- mesh__dateCreated mesh__D008538 1984-06-05
% 209.28/209.42  |- skos__hiddenLabel mesh__D008538 Dyskinesia, Idiopathic Orofacial
% 209.28/209.42  |- mesh__recordMaintainer mesh__D008538 sjn
% 209.28/209.43  |- skos__hiddenLabel mesh__D008538 Blepharospasm-Oromandibular Dystonias
% 209.28/209.43  |- skos__historyNote mesh__D008538 Dystonia %28%1982-1984%29%
% 209.28/209.43  |- skos__altLabel mesh__D008538 Brueghel Syndrome
% 209.28/209.43  |- skos__hiddenLabel mesh__D008538
% 209.28/209.43       Blepharospasm Oromandibular Dystonia Syndrome
% 209.28/209.43  |- skos__annotation mesh__D008538
% 209.28/209.43       note X refs: do not confuse with Meige Syndrome of familial lymphedema %28% = MILROY%27%S DISEASE see LYMPHEDEMA%29% nor with MEIGS SYNDROME%A%  
% 209.28/209.43  |- skos__hiddenLabel mesh__D008538 Blepharospasm Oromandibular Dyskinesia
% 209.28/209.43  |- skos__hiddenLabel mesh__D008538 Dystonia, Blepharospasm-Oromandibular
% 209.28/209.43  |- skos__broader mesh__D008538smesh__D020821
% 209.28/209.43  |- skos__hiddenLabel mesh__D008538 Dyskinesia, Blepharospasm-Oromandibular
% 209.28/209.43  |- mesh__dateRevised mesh__D008538 2005-07-01
% 209.28/209.43  |- skos__altLabel mesh__D008538
% 209.28/209.43       Blepharospasm-Oromandibular Dystonia Syndrome
% 209.28/209.43  |- skos__hiddenLabel mesh__D008538
% 209.28/209.43       Blepharospasm Oromandibular Dystonia Syndrome, Idiopathic
% 209.28/209.43  |- skos__hiddenLabel mesh__D008538
% 209.28/209.43       Dystonia Syndromes, Blepharospasm-Oromandibular
% 209.28/209.43  |- skos__hiddenLabel mesh__D008538 Orofacial Dyskinesia, Idiopathic
% 209.28/209.43  |- skos__hiddenLabel mesh__D008538
% 209.28/209.43       Dystonia Syndrome, Blepharospasm-Oromandibular
% 209.28/209.43  |- skos__altLabel mesh__D008538 Blepharospasm-Oromandibular Dystonia
% 209.28/209.43  |- skos__hiddenLabel mesh__D008538
% 209.28/209.43       Blepharospasm-Oromandibular Dystonia Syndromes
% 209.28/209.43  |- skos__hiddenLabel mesh__D008538 Idiopathic Orofacial Dyskinesias
% 209.28/209.43  |- skos__altLabel mesh__D008538
% 209.28/209.43       Syndrome, Blepharospasm-Oromandibular Dystonia
% 209.28/209.43  |- skos__historyNote mesh__D008538 Blepharospasm %28%1975-1984%29%
% 209.28/209.43  |- skos__altLabel mesh__D008538
% 209.28/209.43       Blepharospasm-Oromandibular Dystonia Syndrome, Idiopathic
% 209.28/209.43  |- skos__altLabel mesh__D008538 Blepharospasm-Oromandibular Dyskinesia
% 209.28/209.43  |- mesh__recordAuthorizer mesh__D008538 sjn
% 209.28/209.43  |- skos__broader mesh__D008538smesh__D001480
% 209.28/209.43  |- skos__hiddenLabel mesh__D008538 Dyskinesias, Blepharospasm-Oromandibular
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D000555 1998
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D000555 2004
% 209.28/209.43  |- skos__annotation mesh__D000555 IM   
% 209.28/209.43  |- skos__prefLabel mesh__D000555 Ambulatory Care Information Systems
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D000555 2001
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D000555 1997
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D000555 2003
% 209.28/209.43  |- skos__broader mesh__D000555smesh__D006751
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D000555 2000
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D000555 1996
% 209.28/209.43  |- mesh__recordAuthorizer mesh__D000555 PLS
% 209.28/209.43  |- mesh__dateEstablished mesh__D000555 1991-01-01
% 209.28/209.43  |- rdf__type mesh__D000555sskos__Concept
% 209.28/209.43  |- mesh__recordOriginator mesh__D000555 EC
% 209.28/209.43  |- mesh__dateRevised mesh__D000555 1994-05-05
% 209.28/209.43  |- skos__scopeNote mesh__D000555
% 209.28/209.43       Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative activities associated with the provision and utilization of ambulatory care services and facilities.%A%    
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D000555 2006
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D000555 1995
% 209.28/209.43  |- mesh__publicMeSHNote mesh__D000555
% 209.28/209.43       91; was see under INFORMATION SYSTEMS 1987-90   
% 209.28/209.43  |- skos__broader mesh__D000555smesh__D008331
% 209.28/209.43  |- mesh__dateCreated mesh__D000555 1986-06-17
% 209.28/209.43  |- mesh__recordMaintainer mesh__D000555 TGC
% 209.28/209.43  |- mesh__historyNote mesh__D000555
% 209.28/209.43       91%28%87%29%; was see under INFORMATION SYSTEMS 1987-90   
% 209.28/209.43  |- skos__altLabel mesh__D000555 Information Systems, Ambulatory Care
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D000555 1999
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D000555 2005
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D000555 2002
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D019260 2004
% 209.28/209.43  |- skos__hiddenLabel mesh__D019260 Emotion, Expressed
% 209.28/209.43  |- skos__hiddenLabel mesh__D019260 Expressed Emotions
% 209.28/209.43  |- skos__scopeNote mesh__D019260
% 209.28/209.43       Frequency and quality of negative emotions, e.g., anger or hostility, expressed by family members or significant others, that often lead to a high relapse rate, especially in schizophrenic patients. %28%APA, Thesaurus of Psychological Index Terms, 7th ed%29%%A%    
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D019260 2001
% 209.28/209.43  |- skos__broader mesh__D019260smesh__D004644
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D019260 2006
% 209.28/209.43  |- mesh__dateEstablished mesh__D019260 1997-01-01
% 209.28/209.43  |- rdf__type mesh__D019260sskos__Concept
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D019260 1998
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D019260 1997
% 209.28/209.43  |- mesh__publicMeSHNote mesh__D019260 97   
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D019260 1999
% 209.28/209.43  |- mesh__dateCreated mesh__D019260 1996-06-10
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D019260 2002
% 209.28/209.43  |- skos__hiddenLabel mesh__D019260 Emotions, Expressed
% 209.28/209.43  |- skos__historyNote mesh__D019260 Emotions %28%1966-1996%29%
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D019260 2003
% 209.28/209.43  |- skos__annotation mesh__D019260
% 209.28/209.43       negative emotions like anger %26% hostility: coord IM with specific emotion %28%IM%29% if relevant%A%  
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D019260 2000
% 209.28/209.43  |- mesh__historyNote mesh__D019260 97   
% 209.28/209.43  |- skos__prefLabel mesh__D019260 Expressed Emotion
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D019260 2005
% 209.28/209.43  |- rdf__type mesh__D005240sskos__Concept
% 209.28/209.43  |- skos__broader mesh__D005240smesh__D016020
% 209.28/209.43  |- skos__scopeNote mesh__D005240
% 209.28/209.43       Studies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project.%A%    
% 209.28/209.43  |- skos__prefLabel mesh__D005240 Feasibility Studies
% 209.28/209.43  |- skos__annotation mesh__D005240
% 209.28/209.43       IM GEN only; coord NIM with specific subject %28%IM%29%; no qualif%A%  
% 209.28/209.43  |- mesh__dateCreated mesh__D005240 1979-05-31
% 209.28/209.43  |- mesh__recordAuthorizer mesh__D005240 sjn
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D005240 2005
% 209.28/209.43  |- skos__broader mesh__D005240smesh__D012106
% 209.28/209.43  |- mesh__dateRevised mesh__D005240 2001-07-25
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D005240 2006
% 209.28/209.43  |- skos__hiddenLabel mesh__D005240 Study, Feasibility
% 209.28/209.43  |- skos__hiddenLabel mesh__D005240 Studies, Feasibility
% 209.28/209.43  |- skos__hiddenLabel mesh__D005240 Feasibility Study
% 209.28/209.43  |- mesh__historyNote mesh__D005240 80   
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D005240 2003
% 209.28/209.43  |- mesh__publicMeSHNote mesh__D005240 80   
% 209.28/209.43  |- mesh__dateEstablished mesh__D005240 1980-01-01
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D005240 2004
% 209.28/209.43  |- mesh__recordOriginator mesh__D005240 EC
% 209.28/209.43  |- mesh__recordMaintainer mesh__D005240 ags
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D005240 2002
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D018966 1997
% 209.28/209.43  |- skos__annotation mesh__D018966
% 209.28/209.43       print %26% non-print materials in libraries: not restricted to books%A%  
% 209.28/209.43  |- skos__broader mesh__D018966smesh__D003146
% 209.28/209.43  |- mesh__historyNote mesh__D018966 96   
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D018966 1999
% 209.28/209.43  |- skos__prefLabel mesh__D018966 Library Materials
% 209.28/209.43  |- mesh__dateEstablished mesh__D018966 1996-01-01
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D018966 2000
% 209.28/209.43  |- skos__scopeNote mesh__D018966
% 209.28/209.43       Print and non-print materials collected, processed, and stored by libraries. They comprise books, periodicals, pamphlets, reports, microforms, maps, manuscripts, motion pictures, and all other forms of audiovisual records. %28%Harrod, The Librarians%27% Glossary, 4th ed, p497%29%%A%    
% 209.28/209.43  |- skos__hiddenLabel mesh__D018966 Materials, Library
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D018966 2001
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D018966 2003
% 209.28/209.43  |- skos__hiddenLabel mesh__D018966 Material, Library
% 209.28/209.43  |- skos__hiddenLabel mesh__D018966 Library Material
% 209.28/209.43  |- mesh__dateCreated mesh__D018966 1995-02-22
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D018966 2005
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D018966 2004
% 209.28/209.43  |- rdf__type mesh__D018966sskos__Concept
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D018966 1996
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D018966 2002
% 209.28/209.43  |- mesh__publicMeSHNote mesh__D018966 96   
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D018966 2006
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D018966 1998
% 209.28/209.43  |- skos__altLabel mesh__D010983 Blood Plateletpheresis
% 209.28/209.43  |- mesh__dateEstablished mesh__D010983 1991-01-01
% 209.28/209.43  |- skos__historyNote mesh__D010983 Plasmapheresis %28%1978%29%
% 209.28/209.43  |- skos__historyNote mesh__D010983 Blood Transfusion %28%1966-1978%29%
% 209.28/209.43  |- skos__altLabel mesh__D010983 Thrombocytapheresis
% 209.28/209.43  |- skos__hiddenLabel mesh__D010983 Thrombocytophereses
% 209.28/209.43  |- mesh__historyNote mesh__D010983
% 209.28/209.43       91%28%79%29%; was see under BLOOD COMPONENT REMOVAL 1986-90; was see under CELL SEPARATION 1981-85; was see under BLOOD TRANSFUSION 1979-80; was see PLASMAPHERESIS 1978%A%  
% 209.28/209.43  |- skos__hiddenLabel mesh__D010983 Plateletphereses, Blood
% 209.28/209.43  |- mesh__publicMeSHNote mesh__D010983
% 209.28/209.43       91; was see under BLOOD COMPONENT REMOVAL 1986-90; was see under CELL SEPARATION 1981-85; was see under BLOOD TRANSFUSION 1979-80; was see PLASMAPHERESIS 1978%A%  
% 209.28/209.43  |- mesh__dateCreated mesh__D010983 1978-01-26
% 209.28/209.43  |- skos__hiddenLabel mesh__D010983 Plateletpheresis, Blood
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D010983 2006
% 209.28/209.43  |- skos__hiddenLabel mesh__D010983 Blood Plateletphereses
% 209.28/209.43  |- skos__historyNote mesh__D010983 Blood Platelets %28%1966-1978%29%
% 209.28/209.43  |- skos__hiddenLabel mesh__D010983 Thrombocytaphereses
% 209.28/209.43  |- mesh__recordAuthorizer mesh__D010983 sjn
% 209.28/209.43  |- mesh__recordOriginator mesh__D010983 SMH
% 209.28/209.43  |- skos__broader mesh__D010983smesh__D016238
% 209.28/209.43  |- skos__historyNote mesh__D010983 Cell Separation %28%1972-1978%29%
% 209.28/209.43  |- skos__scopeNote mesh__D010983
% 209.28/209.43       The preparation of platelet concentrates with the return of red cells and platelet-poor plasma to the donor.%A%    
% 209.28/209.43  |- mesh__onlineNote mesh__D010983 search PLASMAPHERESIS 1978   
% 209.28/209.43  |- skos__hiddenLabel mesh__D010983 Plateletphereses
% 209.28/209.43  |- skos__prefLabel mesh__D010983 Plateletpheresis
% 209.28/209.43  |- mesh__dateRevised mesh__D010983 2005-06-30
% 209.28/209.43  |- rdf__type mesh__D010983sskos__Concept
% 209.28/209.43  |- skos__annotation mesh__D010983
% 209.28/209.43       do not use /util except by MeSH definition; removal of platelets %26% return of plateletless blood to donor: do not confuse with PLATELET TRANSFUSION%A%  
% 209.28/209.43  |- mesh__recordMaintainer mesh__D010983 lkt
% 209.28/209.43  |- skos__altLabel mesh__D010983 Thrombocytopheresis
% 209.28/209.43  |- skos__prefLabel mesh__D018168 Receptors, Retinoic Acid
% 209.28/209.43  |- skos__hiddenLabel mesh__D018168 Proteins, Retinoic Acid-Binding
% 209.28/209.43  |- mesh__historyNote mesh__D018168
% 209.28/209.43       94; was RETINOIC ACID-BINDING PROTEINS %28%NM%29% 1976-93   
% 209.28/209.43  |- skos__annotation mesh__D018168 DF: RECEPT RETINOIC ACID   
% 209.28/209.43  |- skos__broader mesh__D018168smesh__D014157
% 209.28/209.43  |- mesh__publicMeSHNote mesh__D018168
% 209.28/209.43       94; RETINOIC ACID-BINDING PROTEINS was indexed under CARRIER PROTEINS 1979-93 and under PROTEINS %26% PROTEIN BINDING 1976-78%A%  
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D018168 2005
% 209.28/209.43  |- mesh__dateRevised mesh__D018168 2004-07-07
% 209.28/209.43  |- skos__historyNote mesh__D018168 Proteins %28%1976-1978%29%
% 209.28/209.43  |- mesh__recordOriginator mesh__D018168 RAZ
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D018168 2006
% 209.28/209.43  |- skos__related mesh__D018168smesh__D012177
% 209.28/209.43  |- mesh__recordMaintainer mesh__D018168 ssb
% 209.28/209.43  |- mesh__onlineNote mesh__D018168
% 209.28/209.43       use RECEPTORS, RETINOIC ACID %28%NM%29% to search RETINOIC ACID-BINDING PROTEINS 1980-93%A%  
% 209.28/209.43  |- mesh__dateEstablished mesh__D018168 1994-01-01
% 209.28/209.43  |- skos__scopeNote mesh__D018168
% 209.28/209.43       Proteins in the nucleus or cytoplasm that specifically bind RETINOIC ACID or RETINOL and trigger changes in the behavior of cells. Retinoic acid receptors, like steroid receptors, are ligand-activated transcription regulators. Several types have been recognized.%A%    
% 209.28/209.43  |- mesh__recordAuthorizer mesh__D018168 sjn
% 209.28/209.43  |- rdf__type mesh__D018168sskos__Concept
% 209.28/209.43  |- skos__historyNote mesh__D018168 Carrier Proteins %28%1979-1993%29%
% 209.28/209.43  |- skos__historyNote mesh__D018168 Protein Binding %28%1976-1978%29%
% 209.28/209.43  |- skos__hiddenLabel mesh__D018168 Retinoic Acid Binding Proteins
% 209.28/209.43  |- skos__hiddenLabel mesh__D018168 Receptor, Retinoic Acid
% 209.28/209.43  |- skos__broader mesh__D018168smesh__D018160
% 209.28/209.43  |- skos__altLabel mesh__D018168 Retinoic Acid Receptors
% 209.28/209.43  |- skos__altLabel mesh__D018168 Retinoic Acid Receptor
% 209.28/209.43  |- mesh__dateCreated mesh__D018168 1993-06-21
% 209.28/209.43  |- mesh__recordOriginator mesh__D010185 NLM
% 209.28/209.43  |- skos__hiddenLabel mesh__D010185 Pancreatic Fistulas
% 209.28/209.43  |- skos__prefLabel mesh__D010185 Pancreatic Fistula
% 209.28/209.43  |- skos__hiddenLabel mesh__D010185 Fistula, Pancreatic
% 209.28/209.43  |- skos__broader mesh__D010185smesh__D010182
% 209.28/209.43  |- mesh__dateRevised mesh__D010185 2004-07-07
% 209.28/209.43  |- mesh__recordMaintainer mesh__D010185 lkt
% 209.28/209.43  |- rdf__type mesh__D010185sskos__Concept
% 209.28/209.43  |- mesh__dateCreated mesh__D010185 1999-01-01
% 209.28/209.43  |- skos__hiddenLabel mesh__D010185 Fistulas, Pancreatic
% 209.28/209.43  |- skos__scopeNote mesh__D010185
% 209.28/209.43       Abnormal passage communicating with the PANCREAS.     
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D010185 2005
% 209.28/209.43  |- skos__broader mesh__D010185smesh__D016154
% 209.28/209.43  |- mesh__recordAuthorizer mesh__D010185 sjn
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D010185 2006
% 209.28/209.43  |- skos__annotation mesh__D010185 fistula policy: Manual 23.19+   
% 209.28/209.43  |- skos__hiddenLabel mesh__D004946 Esophagostomy, Cervical
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004946 1998
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004946 2006
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004946 2001
% 209.28/209.43  |- rdf__type mesh__D004946sskos__Concept
% 209.28/209.43  |- skos__broader mesh__D004946smesh__D013505
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004946 2005
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004946 2000
% 209.28/209.43  |- mesh__dateEstablished mesh__D004946 1988-01-01
% 209.28/209.43  |- skos__hiddenLabel mesh__D004946 Esophagostomies
% 209.28/209.43  |- skos__hiddenLabel mesh__D004946 Esophagostomies, Cervical
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004946 2004
% 209.28/209.43  |- mesh__recordMaintainer mesh__D004946 PXP
% 209.28/209.43  |- skos__scopeNote mesh__D004946
% 209.28/209.43       Surgical formation of an external opening %28%stoma%29% into the esophagus.%A%    
% 209.28/209.43  |- mesh__recordAuthorizer mesh__D004946 SJN
% 209.28/209.43  |- skos__annotation mesh__D004946
% 209.28/209.43       do not use /util except by MeSH definition   
% 209.28/209.43  |- mesh__dateRevised mesh__D004946 1997-06-20
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004946 2003
% 209.28/209.43  |- skos__broader mesh__D004946smesh__D010030
% 209.28/209.43  |- mesh__dateCreated mesh__D004946 1987-03-19
% 209.28/209.43  |- skos__hiddenLabel mesh__D004946 Cervical Esophagostomies
% 209.28/209.43  |- skos__historyNote mesh__D004946 Esophagus/surgery %28%1966-1987%29%
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004946 1999
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004946 2002
% 209.28/209.43  |- mesh__historyNote mesh__D004946 88   
% 209.28/209.43  |- mesh__recordOriginator mesh__D004946 SCD
% 209.28/209.43  |- skos__prefLabel mesh__D004946 Esophagostomy
% 209.28/209.43  |- mesh__publicMeSHNote mesh__D004946 88   
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D037322 2003
% 209.28/209.43  |- skos__altLabel mesh__D037322 Thyrotropin, beta Chain
% 209.28/209.43  |- mesh__dateCreated mesh__D037322 2002-07-03
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D037322 2005
% 209.28/209.43  |- skos__scopeNote mesh__D037322
% 209.28/209.43       The beta subunit of thyroid stimulating hormone, thyrotropin. It is a 112-amino acid glycopolypeptide of about 16 kD. Full biological activity of TSH  requires the non-covalently bound heterodimers of an alpha and a beta subunit.%A%    
% 209.28/209.43  |- skos__historyNote mesh__D037322 Thyrotropin %28%1975-2002%29%
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D037322 2004
% 209.28/209.43  |- skos__altLabel mesh__D037322 Thyroid Stimulating Hormone, beta Subunit
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D037322 2006
% 209.28/209.43  |- skos__hiddenLabel mesh__D037322 TSH beta
% 209.28/209.43  |- skos__altLabel mesh__D037322 TSH, beta Subunit
% 209.28/209.43  |- mesh__historyNote mesh__D037322
% 209.28/209.43       2003; use THYROTROPIN, BETA SUBUNIT %28%NM%29% 1983-2002   
% 209.28/209.43  |- skos__altLabel mesh__D037322 TSHB Gene Product
% 209.28/209.43  |- skos__broader mesh__D037322smesh__D013972
% 209.28/209.43  |- skos__altLabel mesh__D037322 TSH, beta Chain
% 209.28/209.43  |- mesh__dateEstablished mesh__D037322 2003-01-01
% 209.28/209.43  |- mesh__publicMeSHNote mesh__D037322
% 209.28/209.43       2003; THYROTROPIN, BETA SUBUNIT was indexed under THYROTROPIN 1983-2002%A%  
% 209.28/209.43  |- rdf__type mesh__D037322sskos__Concept
% 209.28/209.43  |- skos__altLabel mesh__D037322 Thyrotropin, beta Polypeptide Chain
% 209.28/209.43  |- skos__altLabel mesh__D037322 Thyrotropin-beta
% 209.28/209.43  |- skos__hiddenLabel mesh__D037322 Thyrotropin beta
% 209.28/209.43  |- skos__prefLabel mesh__D037322 Thyrotropin, beta Subunit
% 209.28/209.43  |- skos__altLabel mesh__D037322 TSH-beta
% 209.28/209.43  |- mesh__onlineNote mesh__D004148 search DIOXOLES 1968-74   
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004148 1997
% 209.28/209.43  |- mesh__recordMaintainer mesh__D004148 TAP
% 209.28/209.43  |- skos__prefLabel mesh__D004148 Dioxolanes
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004148 2001
% 209.28/209.43  |- mesh__dateRevised mesh__D004148 1992-05-13
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004148 2002
% 209.28/209.43  |- mesh__recordAuthorizer mesh__D004148 PLS
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004148 1994
% 209.28/209.43  |- mesh__historyNote mesh__D004148
% 209.28/209.43       91%28%75%29%; was see under DIOXOLES 1975-90   
% 209.28/209.43  |- mesh__dateEstablished mesh__D004148 1991-01-01
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004148 2005
% 209.28/209.43  |- rdf__type mesh__D004148sskos__Concept
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004148 1995
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004148 2006
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004148 2003
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004148 1998
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004148 1993
% 209.28/209.43  |- mesh__dateCreated mesh__D004148 1999-01-01
% 209.28/209.43  |- mesh__recordOriginator mesh__D004148 NLM
% 209.28/209.43  |- mesh__publicMeSHNote mesh__D004148 91; was see under DIOXOLES 1975-90   
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004148 2004
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004148 1999
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004148 1996
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D004148 2000
% 209.28/209.43  |- skos__broader mesh__D004148smesh__D004149
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D009631 2006
% 209.28/209.43  |- mesh__recordOriginator mesh__D009631 NLM
% 209.28/209.43  |- skos__hiddenLabel mesh__D009631 Cyst, Nonodontogenic
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D009631 1996
% 209.28/209.43  |- rdf__type mesh__D009631sskos__Concept
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D009631 2005
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D009631 1995
% 209.28/209.43  |- mesh__publicMeSHNote mesh__D009631 65   
% 209.28/209.43  |- skos__hiddenLabel mesh__D009631 Nonodontogenic Cyst
% 209.28/209.43  |- skos__prefLabel mesh__D009631 Nonodontogenic Cysts
% 209.28/209.43  |- mesh__dateCreated mesh__D009631 1999-01-01
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D009631 2004
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D009631 1994
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D009631 2002
% 209.28/209.43  |- mesh__dateRevised mesh__D009631 1993-06-02
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D009631 2003
% 209.28/209.43  |- skos__annotation mesh__D009631
% 209.28/209.43       non-neoplastic; of jaw; /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/dis term %28%IM%29%%A%  
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D009631 1999
% 209.28/209.43  |- skos__scopeNote mesh__D009631
% 209.28/209.43       Cysts formed from epithelial inclusions in the lines of fusion of the embryonic processes which form the jaws. They include nasopalatine or incisive canal cyst, incisive papilla cyst, globulomaxillary cyst, median palatal cyst, median alveolar cyst, median mandibular cyst, and nasoalveolar cyst.%A%    
% 209.28/209.43  |- mesh__recordMaintainer mesh__D009631 TGC
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D009631 2001
% 209.28/209.43  |- skos__hiddenLabel mesh__D009631 Cysts, Nonodontogenic
% 209.28/209.43  |- mesh__dateEstablished mesh__D009631 1965-01-01
% 209.28/209.43  |- skos__broader mesh__D009631smesh__D007570
% 209.28/209.43  |- mesh__recordAuthorizer mesh__D009631 PLS
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D009631 1998
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D009631 2000
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D009631 1997
% 209.28/209.43  |- mesh__historyNote mesh__D009631 65   
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D023302 2006
% 209.28/209.43  |- mesh__dateCreated mesh__D023302 2000-07-06
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D023302 2005
% 209.28/209.43  |- skos__prefLabel mesh__D023302 Protein Footprinting
% 209.28/209.43  |- mesh__recordMaintainer mesh__D023302 lkt
% 209.28/209.43  |- mesh__historyNote mesh__D023302 2001   
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D023302 2004
% 209.28/209.43  |- mesh__dateRevised mesh__D023302 2002-07-03
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D023302 2003
% 209.28/209.43  |- mesh__dateEstablished mesh__D023302 2001-01-01
% 209.28/209.43  |- skos__hiddenLabel mesh__D023302 Footprint, Protein
% 209.28/209.43  |- skos__scopeNote mesh__D023302
% 209.28/209.43       A method for determining points of contact between interacting proteins or binding sites of proteins to nucleic acids. Protein footprinting utilizes a protein cutting reagent or protease. Protein cleavage is inhibited where the proteins, or nucleic acids and protein, contact each other. After completion of the cutting reaction, the remaining peptide fragments are analyzed by electrophoresis.%A%    
% 209.28/209.43  |- mesh__publicMeSHNote mesh__D023302 2001   
% 209.28/209.43  |- skos__broader mesh__D023302smesh__D010449
% 209.28/209.43  |- mesh__recordAuthorizer mesh__D023302 sjn
% 209.28/209.43  |- rdf__type mesh__D023302sskos__Concept
% 209.28/209.43  |- skos__hiddenLabel mesh__D023302 Footprinting, Protein
% 209.28/209.43  |- skos__hiddenLabel mesh__D023302 Protein Footprint
% 209.28/209.43  |- mesh__recordOriginator mesh__D023302 nns
% 209.28/209.43  |- skos__altLabel mesh__D023302 Footprints, Protein
% 209.28/209.43  |- skos__altLabel mesh__D014576 Uroporphyrinogen Isomerase
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D014576 2005A
% 209.28/209.43  |- skos__historyNote mesh__D014576 Isomerases %28%1971-1974%29%
% 209.28/209.43  |- skos__altLabel mesh__D014576 Cosynthase
% 209.28/209.43  |- mesh__historyNote mesh__D014576 2005 %28%1975%29%   
% 209.28/209.43  |- skos__broader mesh__D014576smesh__D006836
% 209.28/209.43  |- mesh__dateCreated mesh__D014576 1974-11-19
% 209.28/209.43  |- skos__hiddenLabel mesh__D014576 Isomerase, Uroporphyrinogen
% 209.28/209.43  |- mesh__dateRevised mesh__D014576 2004-10-20
% 209.28/209.43  |- skos__altLabel mesh__D014576 Uroporphyrinogen III Cosynthetase
% 209.28/209.43  |- skos__hiddenLabel mesh__D014576 Synthase, Uroporphyrinogen-III
% 209.28/209.43  |- skos__hiddenLabel mesh__D014576 Cosynthetase, Uroporphyrinogen III
% 209.28/209.43  |- rdf__type mesh__D014576sskos__Concept
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D014576 2005
% 209.28/209.43  |- mesh__recordOriginator mesh__D014576 NLM
% 209.28/209.43  |- skos__altLabel mesh__D014576 Uroporphyrinogen-III Synthase
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D014576 2006
% 209.28/209.43  |- mesh__publicMeSHNote mesh__D014576
% 209.28/209.43       2005; see UROPORPHYRINOGEN-III SYNTHASE 1998-2004, see UROPORPHYRINOGEN III SYNTHASE 1991-1997, see HYDRO-LYASES 1985-1990, see ISOMERASES 1975-1984%A%  
% 209.28/209.43  |- skos__hiddenLabel mesh__D014576 Uroporphyrinogen III Synthase
% 209.28/209.43  |- skos__historyNote mesh__D014576 Porphobilinogen %28%1973-1974%29%
% 209.28/209.43  |- skos__prefLabel mesh__D014576 Uroporphyrinogen III Synthetase
% 209.28/209.43  |- skos__scopeNote mesh__D014576
% 209.28/209.43       An enzyme that catalyzes the cyclization of hydroxymethylbilane to yield UROPORPHYRINOGEN III and water. It is the fourth enzyme in the 8-enzyme biosynthetic pathway of HEME, and is encoded by UROS gene. Mutations of UROS gene result in CONGENITAL ERYTHROPOIETIC PORPHYRIA.%A%    
% 209.28/209.43  |- skos__hiddenLabel mesh__D014576 Synthetase, Uroporphyrinogen III
% 209.28/209.43  |- mesh__recordAuthorizer mesh__D014576 sjn
% 209.28/209.43  |- mesh__dateEstablished mesh__D014576 1991-01-01
% 209.28/209.43  |- mesh__recordMaintainer mesh__D014576 sjn
% 209.28/209.43  |- rdf__type mesh__D008539sskos__Concept
% 209.28/209.43  |- mesh__recordMaintainer mesh__D008539 lkt
% 209.28/209.43  |- skos__annotation mesh__D008539 do not confuse with MEIGE SYNDROME   
% 209.28/209.43  |- mesh__recordAuthorizer mesh__D008539 sjn
% 209.28/209.43  |- mesh__dateEstablished mesh__D008539 1965-01-01
% 209.28/209.43  |- mesh__dateCreated mesh__D008539 1999-01-01
% 209.28/209.43  |- skos__broader mesh__D008539smesh__D010051
% 209.28/209.43  |- skos__prefLabel mesh__D008539 Meigs Syndrome
% 209.28/209.43  |- mesh__recordOriginator mesh__D008539 NLM
% 209.28/209.43  |- skos__hiddenLabel mesh__D008539 Meig Syndrome
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D008539 2006
% 209.28/209.43  |- skos__hiddenLabel mesh__D008539 Meig%27%s Syndrome
% 209.28/209.43  |- mesh__dateRevised mesh__D008539 2005-06-30
% 209.28/209.43  |- skos__altLabel mesh__D008539 Meigs%27% Syndrome
% 209.28/209.43  |- mesh__historyNote mesh__D008539 2006 %28%1964%29%   
% 209.28/209.43  |- mesh__publicMeSHNote mesh__D008539
% 209.28/209.43       2006; see MEIGS%27% SYNDROME 1964-2005   
% 209.28/209.43  |- skos__scopeNote mesh__D008539
% 209.28/209.43       The triad of benign FIBROMA or other ovarian tumors with ASCITES, and HYDROTHORAX due to large PLEURAL EFFUSIONS.%A%    
% 209.28/209.43  |- skos__altLabel mesh__D000556 Ambulatory Surgical Procedure
% 209.28/209.43  |- skos__prefLabel mesh__D000556 Ambulatory Surgical Procedures
% 209.28/209.43  |- mesh__historyNote mesh__D000556 98%28%80%29%   
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D000556 2000
% 209.28/209.43  |- skos__altLabel mesh__D000556 Office Surgery
% 209.28/209.43  |- skos__historyNote mesh__D000556 Ambulatory Care %28%1966-1979%29%
% 209.28/209.43  |- skos__historyNote mesh__D000556
% 209.28/209.43       Outpatient Clinics, Hospital %28%1966-1979%29%
% 209.28/209.43  |- skos__altLabel mesh__D000556 Surgical Procedure, Ambulatory
% 209.28/209.43  |- skos__hiddenLabel mesh__D000556 Ambulatory Surgeries
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D000556 2004
% 209.28/209.43  |- mesh__dateCreated mesh__D000556 1979-04-25
% 209.28/209.43  |- mesh__recordMaintainer mesh__D000556 PXP
% 209.28/209.43  |- skos__annotation mesh__D000556
% 209.28/209.43       outpatient surg performed in MD%27%s office, surgicenter or hosp%A%  
% 209.28/209.43  |- skos__altLabel mesh__D000556 Procedure, Ambulatory Surgical
% 209.28/209.43  |- skos__altLabel mesh__D000556 Surgery, Ambulatory
% 209.28/209.43  |- mesh__recordAuthorizer mesh__D000556 SJN
% 209.28/209.43  |- mesh__recordOriginator mesh__D000556 SMH
% 209.28/209.43  |- skos__altLabel mesh__D000556 Surgical Procedures, Ambulatory
% 209.28/209.43  |- mesh__activeMeSHYear mesh__D000556 2003
% 209.28/209.44  |- rdf__type mesh__D000556sskos__Concept
% 209.28/209.44  |- skos__altLabel mesh__D000556 Procedures, Ambulatory Surgical
% 209.28/209.44  |- skos__hiddenLabel mesh__D000556 Outpatient Surgeries
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D000556 2002
% 209.28/209.44  |- skos__altLabel mesh__D000556 Surgery, Outpatient
% 209.28/209.44  |- skos__altLabel mesh__D000556 Ambulatory Surgery
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D000556 1999
% 209.28/209.44  |- skos__hiddenLabel mesh__D000556 Surgeries, Outpatient
% 209.28/209.44  |- skos__related mesh__D000556smesh__D013531
% 209.28/209.44  |- mesh__dateEstablished mesh__D000556 1980-01-01
% 209.28/209.44  |- mesh__dateRevised mesh__D000556 1997-06-20
% 209.28/209.44  |- skos__hiddenLabel mesh__D000556 Surgeries, Office
% 209.28/209.44  |- skos__hiddenLabel mesh__D000556 Surgeries, Ambulatory
% 209.28/209.44  |- skos__hiddenLabel mesh__D000556 Surgeries, Day
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D000556 2006
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D000556 1998
% 209.28/209.44  |- skos__scopeNote mesh__D000556
% 209.28/209.44       Surgery performed on an outpatient basis. It may be hospital-based or performed in an office or surgicenter.%A%    
% 209.28/209.44  |- skos__broader mesh__D000556smesh__D013514
% 209.28/209.44  |- skos__hiddenLabel mesh__D000556 Office Surgeries
% 209.28/209.44  |- mesh__publicMeSHNote mesh__D000556 98; see AMBULATORY SURGERY 1980-97   
% 209.28/209.44  |- skos__hiddenLabel mesh__D000556 Day Surgeries
% 209.28/209.44  |- skos__altLabel mesh__D000556 Outpatient Surgery
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D000556 2001
% 209.28/209.44  |- skos__altLabel mesh__D000556 Day Surgery
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D000556 2005
% 209.28/209.44  |- skos__broader mesh__D019261smesh__D008032
% 209.28/209.44  |- mesh__recordMaintainer mesh__D019261 ags
% 209.28/209.44  |- mesh__recordAuthorizer mesh__D019261 sjn
% 209.28/209.44  |- mesh__dateRevised mesh__D019261 1999-11-03
% 209.28/209.44  |- mesh__recordOriginator mesh__D019261 RAZ
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D019261 2000
% 209.28/209.44  |- skos__scopeNote mesh__D019261
% 209.28/209.44       The dorsal posterior subdivision of the diencephalon. The epithalamus is generally considered to include the habenular nuclei %28%HABENULA%29% and associated fiber bundles, the PINEAL BODY, and the epithelial roof of the third ventricle. The anterior and posterior paraventricular nuclei of the thalamus are included with the THALAMIC NUCLEI although they develop from the same pronuclear mass as the epithalamic nuclei and are sometimes considered part of the epithalamus.%A%    
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D019261 2003
% 209.28/209.44  |- mesh__dateEstablished mesh__D019261 1997-01-01
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D019261 2001
% 209.28/209.44  |- mesh__historyNote mesh__D019261 97   
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D019261 2005
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D019261 2004
% 209.28/209.44  |- skos__prefLabel mesh__D019261 Epithalamus
% 209.28/209.44  |- skos__broader mesh__D019261smesh__D004027
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D019261 2006
% 209.28/209.44  |- mesh__publicMeSHNote mesh__D019261 97   
% 209.28/209.44  |- rdf__type mesh__D019261sskos__Concept
% 209.28/209.44  |- mesh__dateCreated mesh__D019261 1996-06-10
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D019261 2002
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005241 1993
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005241 2005
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005241 1999
% 209.28/209.44  |- mesh__historyNote mesh__D005241 66%28%63%29%   
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005241 2002
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005241 1990
% 209.28/209.44  |- skos__prefLabel mesh__D005241 Feathers
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005241 2006
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005241 1996
% 209.28/209.44  |- mesh__publicMeSHNote mesh__D005241 66   
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005241 2003
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005241 1997
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005241 2000
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005241 2004
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005241 1994
% 209.28/209.44  |- mesh__recordOriginator mesh__D005241 NLM
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005241 1991
% 209.28/209.44  |- mesh__dateEstablished mesh__D005241 1966-01-01
% 209.28/209.44  |- skos__broader mesh__D005241smesh__D000825
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005241 2001
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005241 1995
% 209.28/209.44  |- mesh__recordAuthorizer mesh__D005241 NLM
% 209.28/209.44  |- rdf__type mesh__D005241sskos__Concept
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005241 1992
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005241 1989
% 209.28/209.44  |- mesh__dateCreated mesh__D005241 1999-01-01
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005241 1998
% 209.28/209.44  |- mesh__recordMaintainer mesh__D005241 GJB
% 209.28/209.44  |- mesh__dateRevised mesh__D005241 1978-11-07
% 209.28/209.44  |- skos__hiddenLabel mesh__D005241 Feather
% 209.28/209.44  |- skos__altLabel mesh__D018967 R-64766
% 209.28/209.44  |- mesh__dateRevised mesh__D018967 2004-07-07
% 209.28/209.44  |- mesh__publicMeSHNote mesh__D018967
% 209.28/209.44       96; RISPERIDONE was indexed under ISOXAZOLES %26% PIPERIDINES 1988-95%A%  
% 209.28/209.44  |- skos__hiddenLabel mesh__D018967 R64766
% 209.28/209.44  |- mesh__onlineNote mesh__D018967
% 209.28/209.44       use RISPERIDONE %28%NM%29% to search RISPERIDONE 1988-95   
% 209.28/209.44  |- skos__hiddenLabel mesh__D018967 Consta, Risperdal
% 209.28/209.44  |- skos__prefLabel mesh__D018967 Risperidone
% 209.28/209.44  |- skos__historyNote mesh__D018967 Piperidines %28%1988-1995%29%
% 209.28/209.44  |- mesh__dateCreated mesh__D018967 1995-06-05
% 209.28/209.44  |- skos__hiddenLabel mesh__D018967 R 64766
% 209.28/209.44  |- mesh__dateEstablished mesh__D018967 1996-01-01
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D018967 2005
% 209.28/209.44  |- mesh__recordAuthorizer mesh__D018967 sjn
% 209.28/209.44  |- rdf__type mesh__D018967sskos__Concept
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D018967 2006
% 209.28/209.44  |- skos__hiddenLabel mesh__D018967 R64,766
% 209.28/209.44  |- mesh__historyNote mesh__D018967
% 209.28/209.44       96; was RISPERIDONE %28%NM%29% 1988-95   
% 209.28/209.44  |- skos__scopeNote mesh__D018967
% 209.28/209.44       A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.%A%    
% 209.28/209.44  |- skos__hiddenLabel mesh__D018967 R 64,766
% 209.28/209.44  |- skos__historyNote mesh__D018967 Isoxazoles %28%1988-1995%29%
% 209.28/209.44  |- mesh__recordMaintainer mesh__D018967 ssb
% 209.28/209.44  |- mesh__recordOriginator mesh__D018967 TPW
% 209.28/209.44  |- skos__broader mesh__D018967smesh__D011744
% 209.28/209.44  |- skos__related mesh__D010984smesh__D009944
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D010984 2003
% 209.28/209.44  |- skos__altLabel mesh__D010984 Platinum Black
% 209.28/209.44  |- skos__broader mesh__D010984smesh__D028561
% 209.28/209.44  |- skos__annotation mesh__D010984
% 209.28/209.44       Pt-195; Pt-194, 196, 198 = PLATINUM %28%IM%29% + ISOTOPES %28%NIM%29%; Pt-173-193, 197, 199, 200 = PLATINUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D010984 2006
% 209.28/209.44  |- mesh__recordOriginator mesh__D010984 NLM
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D010984 2004
% 209.28/209.44  |- mesh__dateCreated mesh__D010984 1999-01-01
% 209.28/209.44  |- skos__broader mesh__D010984smesh__D019216
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D010984 2002
% 209.28/209.44  |- rdf__type mesh__D010984sskos__Concept
% 209.28/209.44  |- mesh__recordAuthorizer mesh__D010984 sjn
% 209.28/209.44  |- skos__scopeNote mesh__D010984
% 209.28/209.44       Platinum. A heavy, soft, whitish metal, resembling tin, atomic number 78, atomic weight 195.09, symbol Pt. %28%From Dorland, 28th ed%29% It is used in manufacturing equipment for laboratory and industrial use. It occurs as a black powder %28%platinum black%29% and as a spongy substance %28%spongy platinum%29% and may have been known in Pliny%27%s time as %22%alutiae%22%.%A%    
% 209.28/209.44  |- mesh__dateRevised mesh__D010984 2001-07-25
% 209.28/209.44  |- mesh__recordMaintainer mesh__D010984 jmp
% 209.28/209.44  |- skos__prefLabel mesh__D010984 Platinum
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D010984 2005
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D018169 2005
% 209.28/209.44  |- mesh__historyNote mesh__D018169 94   
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D018169 1997
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D018169 2006
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D018169 2000
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D018169 1998
% 209.28/209.44  |- mesh__dateRevised mesh__D018169 2005-07-12
% 209.28/209.44  |- skos__annotation mesh__D018169
% 209.28/209.44       a genus of the subfamily Chordopoxvirinae; mollusci- refers to agent of the disease molluscum contagiosum, not to mollusks; infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29%%A%  
% 209.28/209.44  |- skos__prefLabel mesh__D018169 Molluscipoxvirus
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D018169 2001
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D018169 1994
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D018169 1999
% 209.28/209.44  |- skos__scopeNote mesh__D018169
% 209.28/209.44       A genus of POXVIRIDAE, subfamily CHORDOPOXVIRINAE, infecting humans. Transmission is by direct contact among children, by sexual contact among young adults, or by fomites. MOLLUSCUM CONTAGIOSUM VIRUS is the type species.%A%    
% 209.28/209.44  |- mesh__recordAuthorizer mesh__D018169 ags
% 209.28/209.44  |- skos__broader mesh__D018169smesh__D018147
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D018169 2002
% 209.28/209.44  |- rdf__type mesh__D018169sskos__Concept
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D018169 1995
% 209.28/209.44  |- mesh__recordOriginator mesh__D018169 AGS
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D018169 2003
% 209.28/209.44  |- mesh__dateCreated mesh__D018169 1993-06-04
% 209.28/209.44  |- mesh__dateEstablished mesh__D018169 1994-01-01
% 209.28/209.44  |- skos__hiddenLabel mesh__D018169 Molluscipoxviruses
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D018169 2004
% 209.28/209.44  |- mesh__publicMeSHNote mesh__D018169 94   
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D018169 1996
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D018169 2006A
% 209.28/209.44  |- mesh__recordMaintainer mesh__D018169 ags
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D010186 2006
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D010186 1999
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D010186 2002
% 209.28/209.44  |- skos__historyNote mesh__D010186 Pancreas %28%1966-1979%29%
% 209.28/209.44  |- mesh__dateEstablished mesh__D010186 1980-01-01
% 209.28/209.44  |- skos__hiddenLabel mesh__D010186 Function Tests, Pancreatic
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D010186 2005
% 209.28/209.44  |- mesh__recordAuthorizer mesh__D010186 SJN
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D010186 1998
% 209.28/209.44  |- skos__hiddenLabel mesh__D010186 Test, Pancreatic Function
% 209.28/209.44  |- skos__prefLabel mesh__D010186 Pancreatic Function Tests
% 209.28/209.44  |- mesh__recordMaintainer mesh__D010186 PXP
% 209.28/209.44  |- skos__broader mesh__D010186smesh__D003938
% 209.28/209.44  |- skos__historyNote mesh__D010186 Pancreatic Diseases %28%1966-1979%29%
% 209.28/209.44  |- rdf__type mesh__D010186sskos__Concept
% 209.28/209.44  |- mesh__dateRevised mesh__D010186 1997-06-20
% 209.28/209.44  |- mesh__dateCreated mesh__D010186 1979-03-12
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D010186 2001
% 209.28/209.44  |- skos__scopeNote mesh__D010186
% 209.28/209.44       Tests based on the biochemistry and physiology of the exocrine pancreas and involving analysis of blood, duodenal contents, feces, or urine for products of pancreatic secretion.%A%    
% 209.28/209.44  |- mesh__recordOriginator mesh__D010186 SMH
% 209.28/209.44  |- skos__hiddenLabel mesh__D010186 Pancreatic Function Test
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D010186 2004
% 209.28/209.44  |- skos__hiddenLabel mesh__D010186 Tests, Pancreatic Function
% 209.28/209.44  |- skos__historyNote mesh__D010186 specific pancreatic disease
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D010186 2000
% 209.28/209.44  |- mesh__publicMeSHNote mesh__D010186 80   
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D010186 2003
% 209.28/209.44  |- mesh__historyNote mesh__D010186 80   
% 209.28/209.44  |- skos__hiddenLabel mesh__D010186 Function Test, Pancreatic
% 209.28/209.44  |- rdf__type mesh__D004947sskos__Concept
% 209.28/209.44  |- skos__prefLabel mesh__D004947 Esophagus
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D004947 2005
% 209.28/209.44  |- mesh__recordMaintainer mesh__D004947 ags
% 209.28/209.44  |- skos__related mesh__D004947smesh__D004945
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D004947 2004
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D004947 2006A
% 209.28/209.44  |- skos__annotation mesh__D004947
% 209.28/209.44       /blood supply: ESOPHAGEAL AND GASTRIC VARICES is available: see note there; /surg: consider also ESOPHAGECTOMY; ESOPHAGOPLASTY; or ESOPHAGOSTOMY; inflammation = ESOPHAGITIS; hemorrhage = ESOPHAGEAL DISEASES %28%IM%29% + GASTROINTESTINAL HEMORRHAGE %28%NIM%29%; rupture: index under ESOPHAGUS /inj %28%IM%29% + RUPTURE %28%NIM%29% or ESOPHAGEAL DISEASES %28%IM%29% + RUPTURE, SPONTANEOUS %28%NIM%29%; peristalsis of the esophagus = ESOPHAGUS /physiol %28%IM%29% + PERISTALSIS %28%NIM%29%; esophageal intubation = ESOPHAGUS %28%IM%29% + INTUBATION %28%IM%29%; esophageal obturator airway = ESOPHAGUS %28%IM%29% + INTUBATION /instrum %28%IM%29%%A%  
% 209.28/209.44  |- skos__related mesh__D004947smesh__D004946
% 209.28/209.44  |- skos__scopeNote mesh__D004947
% 209.28/209.44       The muscular membranous segment between the PHARYNX and the STOMACH in the UPPER GASTROINTESTINAL TRACT.%A%    
% 209.28/209.44  |- mesh__dateCreated mesh__D004947 1999-01-01
% 209.28/209.44  |- mesh__dateRevised mesh__D004947 2005-07-13
% 209.28/209.44  |- mesh__recordOriginator mesh__D004947 NLM
% 209.28/209.44  |- mesh__recordAuthorizer mesh__D004947 ags
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D004947 2006
% 209.28/209.44  |- skos__broader mesh__D004947smesh__D041742
% 209.28/209.44  |- skos__related mesh__D004947smesh__D004944
% 209.28/209.44  |- skos__related mesh__D004947smesh__D016629
% 209.28/209.44  |- skos__historyNote mesh__D004149 Heterocyclic Compounds %28%1966-1967%29%
% 209.28/209.44  |- rdf__type mesh__D004149sskos__Concept
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D004149 2005
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D004149 1995
% 209.28/209.44  |- mesh__recordOriginator mesh__D004149 NLM
% 209.28/209.44  |- mesh__historyNote mesh__D004149 68   
% 209.28/209.44  |- skos__broader mesh__D004149smesh__D006573
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D004149 2006
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D004149 2003
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D004149 1998
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D004149 1993
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D004149 2000
% 209.28/209.44  |- mesh__dateCreated mesh__D004149 1999-01-01
% 209.28/209.44  |- mesh__recordMaintainer mesh__D004149 TAP
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D004149 2004
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D004149 1999
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D004149 1996
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D004149 2001
% 209.28/209.44  |- mesh__publicMeSHNote mesh__D004149 68   
% 209.28/209.44  |- mesh__dateRevised mesh__D004149 1992-05-13
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D004149 1997
% 209.28/209.44  |- skos__prefLabel mesh__D004149 Dioxoles
% 209.28/209.44  |- mesh__dateEstablished mesh__D004149 1968-01-01
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D004149 2002
% 209.28/209.44  |- mesh__recordAuthorizer mesh__D004149 PLS
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D004149 1994
% 209.28/209.44  |- skos__scopeNote mesh__D009632
% 209.28/209.44       A blood protein %28%NSILA%29% which mimics the biological activity of insulin in serum, but is not suppressed by insulin antibodies. During acid-ethanol extraction of Cohn fraction III, 10%25% of the activity is found in the supernatant %28%NSILA-S%29% and the remaining activity in the precipitate %28%NSILA-P%29%. The latter is a large molecular compound, much less stable than the soluble fraction. NSILA-S is a more potent growth factor than insulin and exhibits sulfation activity.%A%    
% 209.28/209.44  |- mesh__dateRevised mesh__D009632 2005-06-30
% 209.28/209.44  |- mesh__dateEstablished mesh__D009632 1977-01-01
% 209.28/209.44  |- skos__historyNote mesh__D009632 Insulin %28%1966-1976%29%
% 209.28/209.44  |- rdf__type mesh__D009632sskos__Concept
% 209.28/209.44  |- skos__hiddenLabel mesh__D009632 Insulin-Like Activity, Nonsuppressible
% 209.28/209.44  |- skos__hiddenLabel mesh__D009632 Activity, Nonsuppressible Insulin-Like
% 209.28/209.44  |- mesh__recordOriginator mesh__D009632 RLS
% 209.28/209.44  |- skos__historyNote mesh__D009632 Blood Proteins %28%1966-1976%29%
% 209.28/209.44  |- skos__broader mesh__D009632smesh__D013002
% 209.28/209.44  |- skos__altLabel mesh__D009632 NSILA
% 209.28/209.44  |- mesh__dateCreated mesh__D009632 1976-05-19
% 209.28/209.44  |- skos__altLabel mesh__D009632 Nonsuppressible Insulinlike Activity
% 209.28/209.44  |- skos__hiddenLabel mesh__D009632 Activity, Nonsuppressible Insulinlike
% 209.28/209.44  |- skos__prefLabel mesh__D009632 Nonsuppressible Insulin-Like Activity
% 209.28/209.44  |- mesh__recordAuthorizer mesh__D009632 sjn
% 209.28/209.44  |- skos__hiddenLabel mesh__D009632 Insulinlike Activity, Nonsuppressible
% 209.28/209.44  |- skos__hiddenLabel mesh__D009632 Nonsuppressible Insulin Like Activity
% 209.28/209.44  |- mesh__recordMaintainer mesh__D009632 ssb
% 209.28/209.44  |- mesh__historyNote mesh__D009632 77   
% 209.28/209.44  |- mesh__publicMeSHNote mesh__D009632 77   
% 209.28/209.44  |- skos__annotation mesh__D009632
% 209.28/209.44       note category; a blood protein mimicking blood insulin   
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D009632 2006
% 209.28/209.44  |- skos__hiddenLabel mesh__D023303 1,3 Oxazolidine 2 one
% 209.28/209.44  |- mesh__publicMeSHNote mesh__D023303
% 209.28/209.44       2001; 1,3-OXAZOLIDINE-2-ONE %28%now OXAZOLIDIONES%29% was indexed under OXAZOLES 1995-2000%A%  
% 209.28/209.44  |- mesh__historyNote mesh__D023303
% 209.28/209.44       2001; use OXAZOLIDINONES %28%NM%29% 1995-2000   
% 209.28/209.44  |- mesh__dateRevised mesh__D023303 2005-06-30
% 209.28/209.44  |- skos__historyNote mesh__D023303 Oxazoles %28%1995-2000%29%
% 209.28/209.44  |- skos__altLabel mesh__D023303 1,3-Oxazolidin-2-one
% 209.28/209.44  |- skos__altLabel mesh__D023303 2-oxazolidinone
% 209.28/209.44  |- mesh__dateEstablished mesh__D023303 2001-01-01
% 209.28/209.44  |- skos__hiddenLabel mesh__D023303 2 oxazolidinone
% 209.28/209.44  |- skos__hiddenLabel mesh__D023303 2 Oxazolidone
% 209.28/209.44  |- skos__prefLabel mesh__D023303 Oxazolidinones
% 209.28/209.44  |- skos__hiddenLabel mesh__D023303 1,3 Oxazolidin 2 one
% 209.28/209.44  |- skos__broader mesh__D023303smesh__D010080
% 209.28/209.44  |- skos__altLabel mesh__D023303 2-Oxazolidone
% 209.28/209.44  |- skos__altLabel mesh__D023303 1,3-Oxazolidine-2-one
% 209.28/209.44  |- rdf__type mesh__D023303sskos__Concept
% 209.28/209.44  |- skos__scopeNote mesh__D023303
% 209.28/209.44       Derivatives of oxazolidin-2-one. They represent an important class of synthetic antibiotic agents.%A%    
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D023303 2006
% 209.28/209.44  |- skos__hiddenLabel mesh__D023303 Oxazolidin 2 one
% 209.28/209.44  |- mesh__recordOriginator mesh__D023303 jmp
% 209.28/209.44  |- mesh__dateCreated mesh__D023303 2000-06-23
% 209.28/209.44  |- mesh__recordAuthorizer mesh__D023303 sjn
% 209.28/209.44  |- mesh__recordMaintainer mesh__D023303 ssb
% 209.28/209.44  |- rdf__type mesh__D014577sskos__Concept
% 209.28/209.44  |- mesh__dateCreated mesh__D014577 1975-07-25
% 209.28/209.44  |- mesh__recordAuthorizer mesh__D014577 sjn
% 209.28/209.44  |- skos__broader mesh__D014577smesh__D011165
% 209.28/209.44  |- mesh__historyNote mesh__D014577
% 209.28/209.44       91%28%76%29%; was see under PORPHYRINOGENS 1976-90   
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D014577 2006
% 209.28/209.44  |- skos__prefLabel mesh__D014577 Uroporphyrinogens
% 209.28/209.44  |- mesh__recordOriginator mesh__D014577 RLS
% 209.28/209.44  |- skos__historyNote mesh__D014577 Porphyrinogens %28%1975%29%
% 209.28/209.44  |- mesh__publicMeSHNote mesh__D014577
% 209.28/209.44       91; was see under PORPHYRINOGENS 1976-90   
% 209.28/209.44  |- mesh__dateRevised mesh__D014577 2005-06-30
% 209.28/209.44  |- skos__historyNote mesh__D014577 Porphyrins %28%1971-1974%29%
% 209.28/209.44  |- mesh__dateEstablished mesh__D014577 1991-01-01
% 209.28/209.44  |- skos__annotation mesh__D014577 porphyrins   
% 209.28/209.44  |- mesh__recordMaintainer mesh__D014577 ssb
% 209.28/209.44  |- skos__scopeNote mesh__D014577
% 209.28/209.44       Porphyrinogens which are intermediates in heme biosynthesis. They have four acetic acid and four propionic acid side chains attached to the pyrrole rings. Uroporphyrinogen I and III are formed from polypyrryl methane in the presence of uroporphyrinogen III cosynthetase and uroporphyrin I synthetase, respectively. They can yield uroporphyrins by autooxidation or coproporphyrinogens by decarboxylation.%A%    
% 209.28/209.44  |- skos__hiddenLabel mesh__D000557 Amblystomas
% 209.28/209.44  |- skos__altLabel mesh__D000557 Axolotl
% 209.28/209.44  |- mesh__dateCreated mesh__D000557 1999-01-01
% 209.28/209.44  |- skos__scopeNote mesh__D000557
% 209.28/209.44       A genus of the Ambystomatidae family. The best known species of this genus are the axolotl forms AMBYSTOMA MEXICANUM and Ambystoma tigrinum. They may retain gills and remain aquatic without developing all of the adult characteristics. However, under proper changes in the environment they metamorphose.%A%    
% 209.28/209.44  |- skos__altLabel mesh__D000557 Amblystoma
% 209.28/209.44  |- rdf__type mesh__D000557sskos__Concept
% 209.28/209.44  |- mesh__historyNote mesh__D000557 72   
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D000557 2005
% 209.28/209.44  |- skos__annotation mesh__D000557
% 209.28/209.44       salamander; NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 209.28/209.44  |- skos__prefLabel mesh__D000557 Ambystoma
% 209.28/209.44  |- mesh__recordOriginator mesh__D000557 NLM
% 209.28/209.44  |- mesh__dateRevised mesh__D000557 2003-07-09
% 209.28/209.44  |- mesh__dateEstablished mesh__D000557 1972-01-01
% 209.28/209.44  |- mesh__publicMeSHNote mesh__D000557 72   
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D000557 2006
% 209.28/209.44  |- mesh__recordMaintainer mesh__D000557 ags
% 209.28/209.44  |- mesh__recordAuthorizer mesh__D000557 sjn
% 209.28/209.44  |- skos__broader mesh__D000557smesh__D000559
% 209.28/209.44  |- skos__historyNote mesh__D000557 Urodela %28%1966-1971%29%
% 209.28/209.44  |- skos__hiddenLabel mesh__D000557 Axolotls
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D000557 2004
% 209.28/209.44  |- skos__hiddenLabel mesh__D000557 Ambystomas
% 209.28/209.44  |- skos__historyNote mesh__D019262 Thalamic Nuclei %28%1971-1996%29%
% 209.28/209.44  |- mesh__publicMeSHNote mesh__D019262 97   
% 209.28/209.44  |- skos__hiddenLabel mesh__D019262 Nuclei, Habenular
% 209.28/209.44  |- mesh__dateCreated mesh__D019262 1996-06-10
% 209.28/209.44  |- skos__scopeNote mesh__D019262
% 209.28/209.44       A small protuberance at the dorsal, posterior corner of the wall of the third ventricle, adjacent to the dorsal thalamus and pineal body. It contains the habenular nuclei and is a major part of the epithalamus. %28%From Lockard, Desk Reference for Neuroscience, 2nd ed, p121%29%%A%    
% 209.28/209.44  |- skos__prefLabel mesh__D019262 Habenula
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D019262 2002
% 209.28/209.44  |- skos__historyNote mesh__D019262 Diencephalon %28%1967-1996%29%
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D019262 2003
% 209.28/209.44  |- mesh__recordAuthorizer mesh__D019262 sjn
% 209.28/209.44  |- mesh__dateRevised mesh__D019262 1999-11-03
% 209.28/209.44  |- mesh__historyNote mesh__D019262 97   
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D019262 2005
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D019262 2004
% 209.28/209.44  |- mesh__recordOriginator mesh__D019262 RAZ
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D019262 2000
% 209.28/209.44  |- skos__hiddenLabel mesh__D019262 Nucleus, Habenular
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D019262 2006
% 209.28/209.44  |- rdf__type mesh__D019262sskos__Concept
% 209.28/209.44  |- mesh__dateEstablished mesh__D019262 1997-01-01
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D019262 2001
% 209.28/209.44  |- skos__broader mesh__D019262smesh__D019261
% 209.28/209.44  |- skos__historyNote mesh__D019262 Thalamus %28%1966-1996%29%
% 209.28/209.44  |- skos__altLabel mesh__D019262 Habenular Nucleus
% 209.28/209.44  |- mesh__recordMaintainer mesh__D019262 ags
% 209.28/209.44  |- skos__hiddenLabel mesh__D019262 Habenulas
% 209.28/209.44  |- skos__broader mesh__D019039Q000172smesh__D019039
% 209.28/209.44  |- mesh__preferredCombination mesh__D019039Q000172smesh__D013915
% 209.28/209.44  |- rdf__type mesh__D019039Q000172smesh__CompoundConcept
% 209.28/209.44  |- mesh__recordOriginator mesh__D005242 NLM
% 209.28/209.44  |- mesh__dateRevised mesh__D005242 1997-06-20
% 209.28/209.44  |- mesh__recordAuthorizer mesh__D005242 SJN
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005242 2003
% 209.28/209.44  |- mesh__publicMeSHNote mesh__D005242 70   
% 209.28/209.44  |- mesh__historyNote mesh__D005242 70%28%66%29%   
% 209.28/209.44  |- skos__hiddenLabel mesh__D005242 Incontinence, Fecal
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005242 2001
% 209.28/209.44  |- skos__hiddenLabel mesh__D005242 Fecal Incontinences
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005242 2004
% 209.28/209.44  |- skos__annotation mesh__D005242
% 209.28/209.44       of organic origin: differentiate from ENCOPRESIS, of psychol origin%A%  
% 209.28/209.44  |- skos__related mesh__D005242smesh__D004688
% 209.28/209.44  |- rdf__type mesh__D005242sskos__Concept
% 209.28/209.44  |- mesh__dateEstablished mesh__D005242 1970-01-01
% 209.28/209.44  |- mesh__dateCreated mesh__D005242 1999-01-01
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005242 2002
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005242 1998
% 209.28/209.44  |- skos__prefLabel mesh__D005242 Fecal Incontinence
% 209.28/209.44  |- skos__scopeNote mesh__D005242
% 209.28/209.44       Failure of voluntary control of the anal sphincters, with involuntary passage of feces and flatus.%A%    
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005242 2005
% 209.28/209.44  |- skos__related mesh__D005242smesh__D019841
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005242 1999
% 209.28/209.44  |- skos__hiddenLabel mesh__D005242 Incontinences, Fecal
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005242 2006
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D005242 2000
% 209.28/209.44  |- skos__broader mesh__D005242smesh__D012002
% 209.28/209.44  |- mesh__recordMaintainer mesh__D005242 TGC
% 209.28/209.44  |- skos__annotation mesh__D018968 differentiation antigens   
% 209.28/209.44  |- mesh__recordOriginator mesh__D018968 AGS
% 209.28/209.44  |- skos__altLabel mesh__D018968 LFA-3
% 209.28/209.44  |- skos__scopeNote mesh__D018968
% 209.28/209.44       Glycoproteins with a wide distribution on hematopoietic and non-hematopoietic cells and strongly expressed on macrophages. CD58 mediates cell adhesion by binding to CD2; %28%ANTIGENS, CD2%29%; and this enhances antigen-specific T-cell activation.%A%    
% 209.28/209.44  |- skos__altLabel mesh__D018968 CD58 Antigen
% 209.28/209.44  |- skos__prefLabel mesh__D018968 Antigens, CD58
% 209.28/209.44  |- mesh__onlineNote mesh__D018968
% 209.28/209.44       use ANTIGENS, CD58 %28%NM%29% to search LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN-3 1988-95%A%  
% 209.28/209.44  |- skos__hiddenLabel mesh__D018968 Lymphocyte Function Associated Antigen 3
% 209.28/209.44  |- skos__historyNote mesh__D018968 Membrane Glycoproteins %28%1988-1995%29%
% 209.28/209.44  |- mesh__recordAuthorizer mesh__D018968 sjn
% 209.28/209.44  |- mesh__dateEstablished mesh__D018968 1996-01-01
% 209.28/209.44  |- skos__historyNote mesh__D018968 Antigens, Surface %28%1988-1992%29%
% 209.28/209.44  |- rdf__type mesh__D018968sskos__Concept
% 209.28/209.44  |- skos__broader mesh__D018968smesh__D015703
% 209.28/209.44  |- skos__broader mesh__D018968smesh__D008562
% 209.28/209.44  |- mesh__historyNote mesh__D018968
% 209.28/209.44       96; was LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN-3 %28%NM%29% 1988-95%A%  
% 209.28/209.44  |- mesh__recordMaintainer mesh__D018968 ssb
% 209.28/209.44  |- skos__historyNote mesh__D018968 Antigens, CD %28%1990-1995%29%
% 209.28/209.44  |- mesh__dateCreated mesh__D018968 1995-06-08
% 209.28/209.44  |- mesh__publicMeSHNote mesh__D018968
% 209.28/209.44       96; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN-3 was indexed under ANTIGENS, CD 1990-95; ANTIGENS DIFFERENTIATION 1990-91; MEMBRANE GLYCOPROTEINS 1988-95; %26% ANTIGENS, SURFACE 1988-92%A%  
% 209.28/209.44  |- skos__altLabel mesh__D018968 Lymphocyte Function Associated Antigen-3
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D018968 2006
% 209.28/209.44  |- skos__hiddenLabel mesh__D018968 Antigen, CD58
% 209.28/209.44  |- skos__historyNote mesh__D018968
% 209.28/209.44       Antigens, Differentiation %28%1990-1991%29%
% 209.28/209.44  |- mesh__dateRevised mesh__D018968 2005-06-30
% 209.28/209.44  |- skos__altLabel mesh__D018968 CD58 Antigens
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D010985 2002
% 209.28/209.44  |- skos__broader mesh__D010985smesh__D019465
% 209.28/209.44  |- mesh__recordAuthorizer mesh__D010985 sjn
% 209.28/209.44  |- skos__hiddenLabel mesh__D010985 Impression, Basilar
% 209.28/209.44  |- mesh__dateRevised mesh__D010985 1999-11-03
% 209.28/209.44  |- mesh__publicMeSHNote mesh__D010985 67   
% 209.28/209.44  |- skos__prefLabel mesh__D010985 Platybasia
% 209.28/209.44  |- skos__broader mesh__D010985smesh__D013122
% 209.28/209.44  |- mesh__dateEstablished mesh__D010985 1967-01-01
% 209.28/209.44  |- skos__historyNote mesh__D010985
% 209.28/209.44       Occipital Bone/abnormalities %28%1966%29%
% 209.28/209.44  |- rdf__type mesh__D010985sskos__Concept
% 209.28/209.44  |- skos__hiddenLabel mesh__D010985 Impressions, Basilar
% 209.28/209.44  |- skos__hiddenLabel mesh__D010985 Basilar Impressions
% 209.28/209.44  |- mesh__historyNote mesh__D010985 67   
% 209.28/209.44  |- skos__broader mesh__D010985smesh__D001848
% 209.28/209.44  |- skos__scopeNote mesh__D010985
% 209.28/209.44       A developmental deformity of the occipital bone and upper end of the cervical spine, in which the latter appears to have pushed the floor of the occipital bone upward. %28%Dorland, 27th ed%29%%A%    
% 209.28/209.44  |- skos__related mesh__D010985smesh__D001139
% 209.28/209.44  |- mesh__activeMeSHYear mesh__D010985 2005
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010985 2000
% 209.28/209.45  |- mesh__recordMaintainer mesh__D010985 KEV
% 209.28/209.45  |- mesh__recordOriginator mesh__D010985 NLM
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010985 2003
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010985 2006
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010985 2001
% 209.28/209.45  |- skos__hiddenLabel mesh__D010985 Platybasias
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010985 2004
% 209.28/209.45  |- skos__altLabel mesh__D010985 Basilar Impression
% 209.28/209.45  |- mesh__dateCreated mesh__D010985 1999-01-01
% 209.28/209.45  |- skos__annotation mesh__D010985
% 209.28/209.45       occipital bone abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010187 2000
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010187 2005
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010187 1995
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010187 1998
% 209.28/209.45  |- skos__hiddenLabel mesh__D010187 Hormones, Pancreatic
% 209.28/209.45  |- mesh__recordAuthorizer mesh__D010187 PLS
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010187 1994
% 209.28/209.45  |- rdf__type mesh__D010187sskos__Concept
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010187 2002
% 209.28/209.45  |- skos__related mesh__D010187smesh__D018026
% 209.28/209.45  |- mesh__dateRevised mesh__D010187 1993-06-21
% 209.28/209.45  |- mesh__historyNote mesh__D010187 74   
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010187 2004
% 209.28/209.45  |- skos__prefLabel mesh__D010187 Pancreatic Hormones
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010187 1997
% 209.28/209.45  |- mesh__recordMaintainer mesh__D010187 RAZ
% 209.28/209.45  |- skos__scopeNote mesh__D010187
% 209.28/209.45       Peptide hormones secreted into the blood by cells in the ISLETS OF LANGERHANS of the pancreas. The alpha cells secrete glucagon; the beta cells secrete insulin; the delta cells secrete somatostatin; and the PP cells secrete pancreatic polypeptide.%A%    
% 209.28/209.45  |- mesh__dateCreated mesh__D010187 1999-01-01
% 209.28/209.45  |- mesh__recordOriginator mesh__D010187 NLM
% 209.28/209.45  |- skos__broader mesh__D010187smesh__D006728
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010187 2003
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010187 2001
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010187 1996
% 209.28/209.45  |- mesh__dateEstablished mesh__D010187 1974-01-01
% 209.28/209.45  |- skos__annotation mesh__D010187 /biosyn /physiol permitted   
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010187 2006
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010187 1999
% 209.28/209.45  |- mesh__publicMeSHNote mesh__D010187 74   
% 209.28/209.45  |- mesh__historyNote mesh__D004948
% 209.28/209.45       90%28%80%29%; was see under STRABISMUS 1980-89; was see STRABISMUS 1975-79%A%  
% 209.28/209.45  |- mesh__recordAuthorizer mesh__D004948 sjn
% 209.28/209.45  |- skos__hiddenLabel mesh__D004948 Esotropias
% 209.28/209.45  |- skos__hiddenLabel mesh__D004948 Esodeviations
% 209.28/209.45  |- mesh__onlineNote mesh__D004948
% 209.28/209.45       use STRABISMUS to search ESOTROPIA 1975-89   
% 209.28/209.45  |- skos__altLabel mesh__D004948 Internal Strabismus
% 209.28/209.45  |- mesh__recordMaintainer mesh__D004948 ags
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D004948 2005
% 209.28/209.45  |- skos__hiddenLabel mesh__D004948 Esotropias, Monocular
% 209.28/209.45  |- skos__hiddenLabel mesh__D004948 Secondary Esotropias
% 209.28/209.45  |- rdf__type mesh__D004948sskos__Concept
% 209.28/209.45  |- skos__hiddenLabel mesh__D004948 Cross Eye
% 209.28/209.45  |- skos__altLabel mesh__D004948 Convergent Strabismus
% 209.28/209.45  |- skos__hiddenLabel mesh__D004948 Monocular Esotropias
% 209.28/209.45  |- skos__hiddenLabel mesh__D004948 Esotropias, Primary
% 209.28/209.45  |- skos__altLabel mesh__D004948 Cross-Eye
% 209.28/209.45  |- mesh__recordOriginator mesh__D004948 RC
% 209.28/209.45  |- skos__hiddenLabel mesh__D004948 Esotropia, Monocular
% 209.28/209.45  |- skos__altLabel mesh__D004948 Esodeviation
% 209.28/209.45  |- skos__prefLabel mesh__D004948 Esotropia
% 209.28/209.45  |- mesh__dateCreated mesh__D004948 1979-05-22
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D004948 2004
% 209.28/209.45  |- skos__altLabel mesh__D004948 Strabismus, Convergent
% 209.28/209.45  |- skos__hiddenLabel mesh__D004948 Esotropias, Secondary
% 209.28/209.45  |- mesh__dateRevised mesh__D004948 2001-07-25
% 209.28/209.45  |- mesh__dateEstablished mesh__D004948 1990-01-01
% 209.28/209.45  |- skos__broader mesh__D004948smesh__D013285
% 209.28/209.45  |- skos__hiddenLabel mesh__D004948 Esotropia, Secondary
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D004948 2003
% 209.28/209.45  |- skos__hiddenLabel mesh__D004948 Esotropia, Intermittent
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D004948 2002
% 209.28/209.45  |- skos__hiddenLabel mesh__D004948 Cross-Eyes
% 209.28/209.45  |- skos__hiddenLabel mesh__D004948 Esotropias, Intermittent
% 209.28/209.45  |- skos__hiddenLabel mesh__D004948 Esophorias
% 209.28/209.45  |- skos__altLabel mesh__D004948 Strabismus, Internal
% 209.28/209.45  |- skos__hiddenLabel mesh__D004948 Intermittent Esotropias
% 209.28/209.45  |- skos__hiddenLabel mesh__D004948 Esotropia, Primary
% 209.28/209.45  |- skos__annotation mesh__D004948
% 209.28/209.45       do not confuse with EXOTROPIA, eye turning outward   
% 209.28/209.45  |- skos__scopeNote mesh__D004948
% 209.28/209.45       A form of ocular misalignment characterized by an excessive convergence of the visual axes, resulting in a %22%cross-eye%22% appearance. An example of this condition occurs when paralysis of the lateral rectus muscle causes an abnormal inward deviation of one eye on attempted gaze.%A%    
% 209.28/209.45  |- skos__historyNote mesh__D004948 Strabismus %28%1966-1979%29%
% 209.28/209.45  |- mesh__publicMeSHNote mesh__D004948
% 209.28/209.45       90; was see under STRABISMUS 1980-89; was see STRABISMUS 1975-79%A%  
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D004948 2006
% 209.28/209.45  |- skos__hiddenLabel mesh__D004948 Primary Esotropias
% 209.28/209.45  |- mesh__dateRevised mesh__D015670 2004-08-03
% 209.28/209.45  |- skos__annotation mesh__D015670
% 209.28/209.45       do not confuse with ACUPUNCTURE, the specialty; ACUPUNCTURE, EAR is also available; Oriental taking of pulses = PULSE + appropriate acupuncture or Oriental medicine terms%A%  
% 209.28/209.45  |- mesh__historyNote mesh__D015670 1990   
% 209.28/209.45  |- skos__related mesh__D015670smesh__D008516
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D015670 2005A
% 209.28/209.45  |- rdf__type mesh__D015670sskos__Concept
% 209.28/209.45  |- skos__historyNote mesh__D015670 Acupuncture %28%1966-1989%29%
% 209.28/209.45  |- mesh__recordOriginator mesh__D015670 EGC
% 209.28/209.45  |- skos__broader mesh__D015670smesh__D000529
% 209.28/209.45  |- mesh__recordMaintainer mesh__D015670 jls
% 209.28/209.45  |- skos__scopeNote mesh__D015670
% 209.28/209.45       Treatment of disease by inserting needles along specific pathways or meridians. The placement varies with the disease being treated. It is sometimes used in conjunction with heat, moxibustion, acupressure, or electric stimulation.%A%    
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D015670 2005
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D015670 2002
% 209.28/209.45  |- mesh__publicMeSHNote mesh__D015670 1990   
% 209.28/209.45  |- mesh__recordAuthorizer mesh__D015670 jls
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D015670 2003
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D015670 2006
% 209.28/209.45  |- skos__prefLabel mesh__D015670 Acupuncture Therapy
% 209.28/209.45  |- mesh__dateCreated mesh__D015670 1989-04-07
% 209.28/209.45  |- skos__related mesh__D015670smesh__D026881
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D015670 2004
% 209.28/209.45  |- skos__altLabel mesh__D015670 Therapy, Acupuncture
% 209.28/209.45  |- mesh__dateEstablished mesh__D015670 1990-01-01
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D009633 2003
% 209.28/209.45  |- skos__historyNote mesh__D009633 Communication %28%1966-1969%29%
% 209.28/209.45  |- skos__broader mesh__D009633smesh__D003142
% 209.28/209.45  |- rdf__type mesh__D009633sskos__Concept
% 209.28/209.45  |- mesh__historyNote mesh__D009633 71%28%70%29%   
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D009633 2004
% 209.28/209.45  |- skos__historyNote mesh__D009633 Verbal Behavior %28%1966-1969%29%
% 209.28/209.45  |- mesh__dateEstablished mesh__D009633 1971-01-01
% 209.28/209.45  |- skos__hiddenLabel mesh__D009633 Nonverbal Communications
% 209.28/209.45  |- skos__annotation mesh__D009633
% 209.28/209.45       human only; for animals use ANIMAL COMMUNICATION or VOCALIZATION, ANIMAL; consider also MANUAL COMMUNICATION %26% SIGN LANGUAGE%A%  
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D009633 2005
% 209.28/209.45  |- skos__hiddenLabel mesh__D009633 Communication, Nonverbal
% 209.28/209.45  |- mesh__recordOriginator mesh__D009633 NLM
% 209.28/209.45  |- mesh__dateCreated mesh__D009633 1999-01-01
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D009633 2006
% 209.28/209.45  |- skos__hiddenLabel mesh__D009633 Communications, Nonverbal
% 209.28/209.45  |- mesh__recordMaintainer mesh__D009633 PLS
% 209.28/209.45  |- mesh__dateRevised mesh__D009633 2002-07-03
% 209.28/209.45  |- mesh__publicMeSHNote mesh__D009633 71   
% 209.28/209.45  |- skos__scopeNote mesh__D009633
% 209.28/209.45       Transmission of emotions, ideas, and attitudes between individuals in ways other than the spoken language.%A%    
% 209.28/209.45  |- mesh__recordAuthorizer mesh__D009633 sjn
% 209.28/209.45  |- skos__prefLabel mesh__D009633 Nonverbal Communication
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D001650 2005
% 209.28/209.45  |- skos__hiddenLabel mesh__D001650 Neoplasm, Bile Duct
% 209.28/209.45  |- skos__altLabel mesh__D001650 Cancer of Bile Duct
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D001650 2006
% 209.28/209.45  |- skos__prefLabel mesh__D001650 Bile Duct Neoplasms
% 209.28/209.45  |- skos__annotation mesh__D001650
% 209.28/209.45       coord IM with specific bile duct %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 209.28/209.45  |- skos__altLabel mesh__D001650 Cancer of the Bile Duct
% 209.28/209.45  |- skos__altLabel mesh__D001650 Neoplasms, Bile Duct
% 209.28/209.45  |- skos__hiddenLabel mesh__D001650 Cancer, Bile Duct
% 209.28/209.45  |- skos__hiddenLabel mesh__D001650 Bile Duct Neoplasm
% 209.28/209.45  |- skos__hiddenLabel mesh__D001650 Bile Duct Cancers
% 209.28/209.45  |- rdf__type mesh__D001650sskos__Concept
% 209.28/209.45  |- mesh__recordAuthorizer mesh__D001650 sjn
% 209.28/209.45  |- mesh__recordOriginator mesh__D001650 NLM
% 209.28/209.45  |- skos__scopeNote mesh__D001650 Tumors or cancer of the BILE DUCTS.     
% 209.28/209.45  |- mesh__dateRevised mesh__D001650 2003-07-09
% 209.28/209.45  |- skos__broader mesh__D001650smesh__D001649
% 209.28/209.45  |- mesh__dateCreated mesh__D001650 1999-01-01
% 209.28/209.45  |- mesh__recordMaintainer mesh__D001650 lkt
% 209.28/209.45  |- skos__broader mesh__D001650smesh__D001661
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D001650 2004
% 209.28/209.45  |- skos__hiddenLabel mesh__D001650 Cancers, Bile Duct
% 209.28/209.45  |- skos__prefLabel mesh__D014578 Uroporphyrins
% 209.28/209.45  |- mesh__recordOriginator mesh__D014578 NLM
% 209.28/209.45  |- mesh__dateRevised mesh__D014578 2005-06-30
% 209.28/209.45  |- mesh__publicMeSHNote mesh__D014578
% 209.28/209.45       91; was see under PORPHYRINS 1975-90   
% 209.28/209.45  |- mesh__dateEstablished mesh__D014578 1991-01-01
% 209.28/209.45  |- skos__annotation mesh__D014578 porphyrins   
% 209.28/209.45  |- skos__broader mesh__D014578smesh__D011166
% 209.28/209.45  |- rdf__type mesh__D014578sskos__Concept
% 209.28/209.45  |- mesh__dateCreated mesh__D014578 1974-11-19
% 209.28/209.45  |- mesh__historyNote mesh__D014578
% 209.28/209.45       91%28%75%29%; was see under PORPHYRINS 1975-90   
% 209.28/209.45  |- mesh__recordAuthorizer mesh__D014578 sjn
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D014578 2006
% 209.28/209.45  |- skos__scopeNote mesh__D014578
% 209.28/209.45       Porphyrins with four acetic acid and four propionic acid side chains attached to the pyrrole rings.%A%    
% 209.28/209.45  |- skos__historyNote mesh__D014578 Porphyrins %28%1968-1974%29%
% 209.28/209.45  |- mesh__recordMaintainer mesh__D014578 ssb
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D019263 2005
% 209.28/209.45  |- mesh__publicMeSHNote mesh__D019263
% 209.28/209.45       97; was see DEPRESSIVE DISORDER 1981-96   
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D019263 1999
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D019263 1998
% 209.28/209.45  |- skos__hiddenLabel mesh__D019263 Dysthymic Disorders
% 209.28/209.45  |- mesh__dateCreated mesh__D019263 1996-06-18
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D019263 2001
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D019263 2004
% 209.28/209.45  |- mesh__recordAuthorizer mesh__D019263 SJN
% 209.28/209.45  |- mesh__historyNote mesh__D019263
% 209.28/209.45       97; was see DEPRESSIVE DISORDER 1981-96   
% 209.28/209.45  |- mesh__dateEstablished mesh__D019263 1997-01-01
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D019263 2000
% 209.28/209.45  |- skos__historyNote mesh__D019263 Depressive Disorder %28%1981-1996%29%
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D019263 2003
% 209.28/209.45  |- mesh__recordOriginator mesh__D019263 JLS
% 209.28/209.45  |- mesh__recordMaintainer mesh__D019263 JLS
% 209.28/209.45  |- skos__prefLabel mesh__D019263 Dysthymic Disorder
% 209.28/209.45  |- skos__broader mesh__D019263smesh__D003866
% 209.28/209.45  |- skos__scopeNote mesh__D019263
% 209.28/209.45       Chronically depressed mood that occurs for most of the day more days than not for at least 2 years. The required minimum duration in children to make this diagnosis is 1 year. During periods of depressed mood, at least 2 of the following additional symptoms are present: poor appetite or overeating, insomnia or hypersomnia, low energy or fatigue, low self esteem, poor concentration or difficulty making decisions, and feelings of hopelessness. %28%DSM-IV%29%%A%    
% 209.28/209.45  |- mesh__onlineNote mesh__D019263
% 209.28/209.45       use DEPRESSIVE DISORDER to search DYSTHYMIC DISORDER 1981-96%A%  
% 209.28/209.45  |- skos__hiddenLabel mesh__D019263 Disorder, Dysthymic
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D019263 2006
% 209.28/209.45  |- rdf__type mesh__D019263sskos__Concept
% 209.28/209.45  |- mesh__dateRevised mesh__D019263 1997-06-20
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D019263 2002
% 209.28/209.45  |- skos__hiddenLabel mesh__D000558 mexicanums, Ambystoma
% 209.28/209.45  |- mesh__dateRevised mesh__D000558 2003-07-09
% 209.28/209.45  |- mesh__recordAuthorizer mesh__D000558 sjn
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D000558 2006
% 209.28/209.45  |- skos__prefLabel mesh__D000558 Ambystoma mexicanum
% 209.28/209.45  |- skos__hiddenLabel mesh__D000558 mexicanum, Ambystoma
% 209.28/209.45  |- skos__hiddenLabel mesh__D000558 Mexican Axolotl
% 209.28/209.45  |- skos__hiddenLabel mesh__D000558 Mexican Axolotls
% 209.28/209.45  |- mesh__dateEstablished mesh__D000558 1991-01-01
% 209.28/209.45  |- mesh__dateCreated mesh__D000558 1980-04-02
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D000558 2004
% 209.28/209.45  |- mesh__recordMaintainer mesh__D000558 ags
% 209.28/209.45  |- skos__hiddenLabel mesh__D000558 Ambystoma mexicanums
% 209.28/209.45  |- skos__broader mesh__D000558smesh__D000557
% 209.28/209.45  |- mesh__historyNote mesh__D000558
% 209.28/209.45       91%28%81%29%; was see under AMBYSTOMA 1981-90   
% 209.28/209.45  |- skos__scopeNote mesh__D000558
% 209.28/209.45       An axolotl found in Mexican mountain lakes and accounting for about 30 percent of the urodeles used in research.%A%    
% 209.28/209.45  |- skos__hiddenLabel mesh__D000558 Axolotls, Mexican
% 209.28/209.45  |- rdf__type mesh__D000558sskos__Concept
% 209.28/209.45  |- skos__altLabel mesh__D000558 Axolotl, Mexican
% 209.28/209.45  |- mesh__publicMeSHNote mesh__D000558
% 209.28/209.45       91; was see under AMBYSTOMA 1981-90   
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D000558 2005
% 209.28/209.45  |- skos__historyNote mesh__D000558 Ambystoma %28%1972-1980%29%
% 209.28/209.45  |- skos__annotation mesh__D000558
% 209.28/209.45       salamander; NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 209.28/209.45  |- mesh__recordOriginator mesh__D000558 EC
% 209.28/209.45  |- skos__hiddenLabel mesh__D011280 3beta Hydroxy 5alpha pregnan 20 one
% 209.28/209.45  |- mesh__recordOriginator mesh__D011280 NLM
% 209.28/209.45  |- skos__hiddenLabel mesh__D011280 alpha-pregnan-20-one, 3 alpha-Hydroxy-5
% 209.28/209.45  |- rdf__type mesh__D011280sskos__Concept
% 209.28/209.45  |- skos__hiddenLabel mesh__D011280 beta-pregnan-20-one, 3 alpha-Hydroxy-5
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D011280 2006
% 209.28/209.45  |- mesh__publicMeSHNote mesh__D011280
% 209.28/209.45       91; was see under PREGNANES 1975-90   
% 209.28/209.45  |- skos__altLabel mesh__D011280 Eltanolone
% 209.28/209.45  |- skos__altLabel mesh__D011280 Allopregnanolone
% 209.28/209.45  |- skos__altLabel mesh__D011280 3-Hydroxypregnan-20-one
% 209.28/209.45  |- skos__historyNote mesh__D011280 Ketosteroids %28%1972-1974%29%
% 209.28/209.45  |- skos__scopeNote mesh__D011280
% 209.28/209.45       A pregnane found in the urine of pregnant women and sows. It has anesthetic, hypnotic, and sedative properties.%A%    
% 209.28/209.45  |- skos__altLabel mesh__D011280 Epipregnanolone
% 209.28/209.45  |- skos__hiddenLabel mesh__D011280 alpha-Hydroxy-5 beta-pregnan-20-one, 3
% 209.28/209.45  |- skos__hiddenLabel mesh__D011280 3 alpha Hydroxy 5 alpha pregnan 20 one
% 209.28/209.45  |- skos__hiddenLabel mesh__D011280 Pregnan 3alpha ol 20 one
% 209.28/209.45  |- skos__altLabel mesh__D011280 3 alpha, 5 beta-Tetrahydroprogesterone
% 209.28/209.45  |- skos__altLabel mesh__D011280 3 alpha-Hydroxy-5 alpha-pregnan-20-one
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D011280 2004
% 209.28/209.45  |- skos__historyNote mesh__D011280 Hydroxysteroids %28%1972-1974%29%
% 209.28/209.45  |- skos__hiddenLabel mesh__D011280 3 Hydroxypregnan 20 one
% 209.28/209.45  |- skos__altLabel mesh__D011280 Pregnan-3alpha-ol-20-one
% 209.28/209.45  |- mesh__dateEstablished mesh__D011280 1991-01-01
% 209.28/209.45  |- skos__hiddenLabel mesh__D011280 alpha-Hydroxy-5 alpha-pregnan-20-one, 3
% 209.28/209.45  |- skos__hiddenLabel mesh__D011280 beta-ol-20-one, Allopregnan-3
% 209.28/209.45  |- skos__hiddenLabel mesh__D011280 3 alpha, 5 beta Tetrahydroprogesterone
% 209.28/209.45  |- mesh__dateRevised mesh__D011280 2003-07-09
% 209.28/209.45  |- skos__prefLabel mesh__D011280 Pregnanolone
% 209.28/209.45  |- mesh__recordAuthorizer mesh__D011280 sjn
% 209.28/209.45  |- skos__hiddenLabel mesh__D011280 Allopregnan 3 beta ol 20 one
% 209.28/209.45  |- skos__altLabel mesh__D011280 Pregnanolone, %28%3alpha,5beta%29%-isomer
% 209.28/209.45  |- mesh__recordMaintainer mesh__D011280 lkt
% 209.28/209.45  |- skos__historyNote mesh__D011280 Pregnanes %28%1969-1974%29%
% 209.28/209.45  |- skos__hiddenLabel mesh__D011280 3 alpha Hydroxy 5 beta pregnan 20 one
% 209.28/209.45  |- mesh__historyNote mesh__D011280
% 209.28/209.45       91%28%75%29%; was see under PREGNANES 1975-90   
% 209.28/209.45  |- skos__broader mesh__D011280smesh__D011278
% 209.28/209.45  |- skos__annotation mesh__D011280 do not confuse with PREGNENOLONE   
% 209.28/209.45  |- skos__altLabel mesh__D011280 Allopregnan-3 beta-ol-20-one
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D011280 2005
% 209.28/209.45  |- skos__altLabel mesh__D011280 3beta-Hydroxy-5alpha-pregnan-20-one
% 209.28/209.45  |- mesh__dateCreated mesh__D011280 1974-11-19
% 209.28/209.45  |- skos__altLabel mesh__D011280 3 alpha-Hydroxy-5 beta-pregnan-20-one
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D005243 2004
% 209.28/209.45  |- mesh__recordAuthorizer mesh__D005243 sjn
% 209.28/209.45  |- mesh__recordOriginator mesh__D005243 NLM
% 209.28/209.45  |- rdf__type mesh__D005243sskos__Concept
% 209.28/209.45  |- mesh__dateCreated mesh__D005243 1999-01-01
% 209.28/209.45  |- skos__related mesh__D005243smesh__D008551
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D005243 2005
% 209.28/209.45  |- mesh__dateRevised mesh__D005243 2003-07-25
% 209.28/209.45  |- skos__annotation mesh__D005243
% 209.28/209.45       /parasitol: often coord with PARASITE EGG COUNT; consider also DEFECATION; CONSTIPATION; DIARRHEA; FECAL IMPACTION %26% FECAL INCONTINENCE; fecalith: index FECAL IMPACTION; fecal blood: index under OCCULT BLOOD %26% not also here%A%  
% 209.28/209.45  |- skos__related mesh__D005243smesh__D008372
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D005243 2006
% 209.28/209.45  |- skos__prefLabel mesh__D005243 Feces
% 209.28/209.45  |- mesh__recordMaintainer mesh__D005243 sjn
% 209.28/209.45  |- skos__broader mesh__D005243smesh__D005441
% 209.28/209.45  |- skos__scopeNote mesh__D005243
% 209.28/209.45       Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.%A%    
% 209.28/209.45  |- mesh__publicMeSHNote mesh__D018969
% 209.28/209.45       2005; see INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS 1996-2004; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-1995%A%  
% 209.28/209.45  |- rdf__type mesh__D018969sskos__Concept
% 209.28/209.45  |- mesh__recordOriginator mesh__D018969 TPW
% 209.28/209.45  |- skos__altLabel mesh__D018969 IGF-Binding Proteins
% 209.28/209.45  |- mesh__dateRevised mesh__D018969 2005-06-30
% 209.28/209.45  |- mesh__recordMaintainer mesh__D018969 SYSTEM
% 209.28/209.45  |- skos__scopeNote mesh__D018969
% 209.28/209.45       A family of soluble proteins that bind insulin-like growth factors and modulate their biological actions at the cellular level. %28%Int J Gynaecol Obstet 1992;39%28%1%29%:3-9%29%%A%    
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D018969 2006
% 209.28/209.45  |- skos__annotation mesh__D018969
% 209.28/209.45       GEN or unspecified; prefer specifics; /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X refs%A%  
% 209.28/209.45  |- skos__altLabel mesh__D018969 IGFBP
% 209.28/209.45  |- mesh__historyNote mesh__D018969 2005%28%1996%29%   
% 209.28/209.45  |- mesh__dateEstablished mesh__D018969 1996-01-01
% 209.28/209.45  |- skos__hiddenLabel mesh__D018969 IGF Binding Proteins
% 209.28/209.45  |- skos__prefLabel mesh__D018969
% 209.28/209.45       Insulin-Like Growth Factor Binding Proteins
% 209.28/209.45  |- skos__altLabel mesh__D018969 Somatomedin-Binding Proteins
% 209.28/209.45  |- mesh__recordAuthorizer mesh__D018969 sjn
% 209.28/209.45  |- skos__broader mesh__D018969smesh__D002352
% 209.28/209.45  |- skos__hiddenLabel mesh__D018969 Somatomedin Binding Proteins
% 209.28/209.45  |- skos__historyNote mesh__D018969 Carrier Proteins %28%1980-1995%29%
% 209.28/209.45  |- mesh__dateCreated mesh__D018969 1995-06-16
% 209.28/209.45  |- rdf__type mesh__D010986sskos__Concept
% 209.28/209.45  |- mesh__dateEstablished mesh__D010986 1965-01-01
% 209.28/209.45  |- mesh__recordAuthorizer mesh__D010986 sjn
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010986 2005
% 209.28/209.45  |- skos__prefLabel mesh__D010986 Platyhelminths
% 209.28/209.45  |- skos__broader mesh__D010986smesh__D006376
% 209.28/209.45  |- skos__scopeNote mesh__D010986
% 209.28/209.45       A phylum of acoelomate, bilaterally symmetrical flatworms, without a definite anus. It includes three classes: Cestoda, Turbellaria, and Trematoda.%A%    
% 209.28/209.45  |- mesh__historyNote mesh__D010986 65   
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010986 2006
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010986 2004
% 209.28/209.45  |- mesh__dateCreated mesh__D010986 1999-01-01
% 209.28/209.45  |- skos__annotation mesh__D010986
% 209.28/209.45       infection = CESTODE INFECTIONS or TREMATODE INFECTIONS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 209.28/209.45  |- mesh__recordOriginator mesh__D010986 NLM
% 209.28/209.45  |- mesh__recordMaintainer mesh__D010986 ags
% 209.28/209.45  |- skos__altLabel mesh__D010986 Flatworms
% 209.28/209.45  |- mesh__publicMeSHNote mesh__D010986 65   
% 209.28/209.45  |- mesh__dateRevised mesh__D010986 2003-07-09
% 209.28/209.45  |- rdf__type mesh__D043362sskos__Concept
% 209.28/209.45  |- mesh__recordAuthorizer mesh__D043362 sjn
% 209.28/209.45  |- skos__prefLabel mesh__D043362 Rhodocyclaceae
% 209.28/209.45  |- mesh__recordOriginator mesh__D043362 ags
% 209.28/209.45  |- mesh__historyNote mesh__D043362 2004   
% 209.28/209.45  |- mesh__recordMaintainer mesh__D043362 SYSTEM
% 209.28/209.45  |- mesh__dateCreated mesh__D043362 2003-07-09
% 209.28/209.45  |- mesh__publicMeSHNote mesh__D043362 2004   
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D043362 2006
% 209.28/209.45  |- mesh__dateRevised mesh__D043362 2005-06-30
% 209.28/209.45  |- mesh__dateEstablished mesh__D043362 2004-01-01
% 209.28/209.45  |- skos__scopeNote mesh__D043362
% 209.28/209.45       A family of gram-negative bacteria in the order Rhodocyclales, class BETAPROTEOBACTERIA. It includes many genera previously assigned to the family PSEUDOMONADACEAE.%A%    
% 209.28/209.45  |- skos__broader mesh__D043362smesh__D020562
% 209.28/209.45  |- skos__scopeNote mesh__D010188
% 209.28/209.45       A malabsorption condition resulting from greater than 10%25% reduction in the secretion of pancreatic digestive enzymes %28%LIPASE; PROTEASES; and AMYLASE%29% by the EXOCRINE PANCREAS into the DUODENUM. This condition is often associated with CYSTIC FIBROSIS and with chronic PANCREATITIS.%A%    
% 209.28/209.45  |- skos__hiddenLabel mesh__D010188 Exocrine Pancreatic Insufficiencies
% 209.28/209.45  |- mesh__recordOriginator mesh__D010188 RC
% 209.28/209.45  |- mesh__historyNote mesh__D010188 2005 %28%1981%29%   
% 209.28/209.45  |- skos__hiddenLabel mesh__D010188 Insufficiencies, Exocrine Pancreatic
% 209.28/209.45  |- skos__altLabel mesh__D010188 Pancreatic Insufficiency
% 209.28/209.45  |- mesh__recordMaintainer mesh__D010188 lkt
% 209.28/209.45  |- skos__hiddenLabel mesh__D010188 Pancreatic Insufficiencies
% 209.28/209.45  |- skos__hiddenLabel mesh__D010188 Insufficiencies, Pancreatic
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010188 2006
% 209.28/209.45  |- skos__hiddenLabel mesh__D010188 Pancreatic Insufficiencies, Exocrine
% 209.28/209.45  |- mesh__dateCreated mesh__D010188 1980-04-09
% 209.28/209.45  |- skos__broader mesh__D010188smesh__D010182
% 209.28/209.45  |- skos__historyNote mesh__D010188 Pancreatitis %28%1966-1980%29%
% 209.28/209.45  |- mesh__publicMeSHNote mesh__D010188
% 209.28/209.45       2005; see PANCREATIC INSUFFICIENCY 1981-2004   
% 209.28/209.45  |- skos__hiddenLabel mesh__D010188 Pancreatic Insufficiency, Exocrine
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D010188 2005
% 209.28/209.45  |- mesh__dateEstablished mesh__D010188 1981-01-01
% 209.28/209.45  |- mesh__recordAuthorizer mesh__D010188 sjn
% 209.28/209.45  |- skos__hiddenLabel mesh__D010188 Insufficiency, Pancreatic
% 209.28/209.45  |- skos__prefLabel mesh__D010188 Exocrine Pancreatic Insufficiency
% 209.28/209.45  |- rdf__type mesh__D010188sskos__Concept
% 209.28/209.45  |- skos__historyNote mesh__D010188 Pancreatic Diseases %28%1966-1980%29%
% 209.28/209.45  |- skos__hiddenLabel mesh__D010188 Insufficiency, Exocrine Pancreatic
% 209.28/209.45  |- mesh__dateRevised mesh__D010188 2004-07-07
% 209.28/209.45  |- mesh__recordMaintainer mesh__D004949 exl
% 209.28/209.45  |- skos__altLabel mesh__D004949 Abbott Brand of Estazolam
% 209.28/209.45  |- mesh__recordOriginator mesh__D004949 NLM
% 209.28/209.45  |- skos__prefLabel mesh__D004949 Estazolam
% 209.28/209.45  |- mesh__recordAuthorizer mesh__D004949 sjn
% 209.28/209.45  |- skos__historyNote mesh__D004949 Benzazepines %28%1972-1974%29%
% 209.28/209.45  |- mesh__historyNote mesh__D004949
% 209.28/209.45       91%28%80%29%; was see under BENZODIAZEPINE TRANQUILIZERS 1980-90; was D 40TA see under BENZODIAZEPINE TRANQUILIZERS 1975-79%A%  
% 209.28/209.45  |- skos__altLabel mesh__D004949 Hormona Brand of Estazolam
% 209.28/209.45  |- mesh__dateEstablished mesh__D004949 1991-01-01
% 209.28/209.45  |- skos__altLabel mesh__D004949 Takeda Brand of Estazolam
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D004949 2006
% 209.28/209.45  |- skos__broader mesh__D004949smesh__D001569
% 209.28/209.45  |- mesh__dateCreated mesh__D004949 1974-11-27
% 209.28/209.45  |- mesh__dateRevised mesh__D004949 2005-06-30
% 209.28/209.45  |- mesh__publicMeSHNote mesh__D004949
% 209.28/209.45       91; was see under BENZODIAZEPINE TRANQUILIZERS 1980-90; was D 40TA see under BENZODIAZEPINE TRANQUILIZERS 1975-79%A%  
% 209.28/209.45  |- skos__scopeNote mesh__D004949
% 209.28/209.45       A benzodiazepine with anticonvulsant, hypnotic, and muscle relaxant properties. It has been shown in some cases to be more potent than DIAZEPAM or NITRAZEPAM.%A%    
% 209.28/209.45  |- skos__altLabel mesh__D004949 D40TA
% 209.28/209.45  |- rdf__type mesh__D004949sskos__Concept
% 209.28/209.45  |- mesh__onlineNote mesh__D004949 use ESTAZOLAM to search D 40TA 1975-79   
% 209.28/209.45  |- skos__historyNote mesh__D004949 Triazoles %28%1972-1974%29%
% 209.28/209.45  |- skos__scopeNote mesh__D015671
% 209.28/209.45       A form of acupuncture with electrical impulses passing through the needles to stimulate NERVE TISSUE. It can be used for ANALGESIA; ANESTHESIA; PHYSICAL REHABILITATION; and treatment for diseases.%A%    
% 209.28/209.45  |- skos__broader mesh__D015671smesh__D004599
% 209.28/209.45  |- mesh__historyNote mesh__D015671 90   
% 209.28/209.45  |- mesh__publicMeSHNote mesh__D015671 90   
% 209.28/209.45  |- skos__broader mesh__D015671smesh__D004561
% 209.28/209.45  |- skos__historyNote mesh__D015671 Acupuncture %28%1966-1989%29%
% 209.28/209.45  |- mesh__recordAuthorizer mesh__D015671 sjn
% 209.28/209.45  |- skos__broader mesh__D015671smesh__D003131
% 209.28/209.45  |- rdf__type mesh__D015671sskos__Concept
% 209.28/209.45  |- mesh__dateCreated mesh__D015671 1989-04-07
% 209.28/209.45  |- skos__broader mesh__D015671smesh__D015670
% 209.28/209.45  |- mesh__dateRevised mesh__D015671 2005-06-30
% 209.28/209.45  |- mesh__recordMaintainer mesh__D015671 lkt
% 209.28/209.45  |- mesh__recordOriginator mesh__D015671 EGC
% 209.28/209.45  |- skos__broader mesh__D015671smesh__D000758
% 209.28/209.45  |- mesh__dateEstablished mesh__D015671 1990-01-01
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D015671 2006
% 209.28/209.45  |- skos__prefLabel mesh__D015671 Electroacupuncture
% 209.28/209.45  |- skos__hiddenLabel mesh__D009634 Female Pseudo-Turner Syndromes
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D009634 2006A
% 209.28/209.45  |- skos__related mesh__D009634smesh__D044542
% 209.28/209.45  |- skos__related mesh__D009634smesh__D009456
% 209.28/209.45  |- skos__hiddenLabel mesh__D009634 Male Turner Syndrome
% 209.28/209.45  |- skos__prefLabel mesh__D009634 Noonan Syndrome
% 209.28/209.45  |- mesh__historyNote mesh__D009634 79   
% 209.28/209.45  |- skos__altLabel mesh__D009634 Turner%27%s Syndrome, Male
% 209.28/209.45  |- mesh__activeMeSHYear mesh__D009634 2005
% 209.28/209.45  |- mesh__recordMaintainer mesh__D009634 ags
% 209.28/209.46  |- skos__hiddenLabel mesh__D009634 Male Turner%27%s Syndrome
% 209.28/209.46  |- mesh__dateRevised mesh__D009634 2005-07-21
% 209.28/209.46  |- mesh__recordAuthorizer mesh__D009634 ags
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D009634 2006
% 209.28/209.46  |- skos__hiddenLabel mesh__D009634 Pseudo-Turner Syndromes, Female
% 209.28/209.46  |- skos__related mesh__D009634smesh__D014424
% 209.28/209.46  |- mesh__dateCreated mesh__D009634 1977-12-05
% 209.28/209.46  |- mesh__dateEstablished mesh__D009634 1979-01-01
% 209.28/209.46  |- skos__hiddenLabel mesh__D009634 Turners Syndrome, Male
% 209.28/209.46  |- skos__historyNote mesh__D009634 Turner%27%s Syndrome %28%1966-1978%29%
% 209.28/209.46  |- mesh__recordOriginator mesh__D009634 AEP
% 209.28/209.46  |- skos__hiddenLabel mesh__D009634 Syndrome, Female Pseudo-Turner
% 209.28/209.46  |- skos__broader mesh__D009634smesh__D003240
% 209.28/209.46  |- skos__hiddenLabel mesh__D009634 Syndromes, Female Pseudo-Turner
% 209.28/209.46  |- rdf__type mesh__D009634sskos__Concept
% 209.28/209.46  |- skos__broader mesh__D009634smesh__D019465
% 209.28/209.46  |- skos__hiddenLabel mesh__D009634 Pseudo-Turner Syndrome, Female
% 209.28/209.46  |- skos__hiddenLabel mesh__D009634 Female Pseudo Turner Syndrome
% 209.28/209.46  |- mesh__publicMeSHNote mesh__D009634 79   
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D009634 2005A
% 209.28/209.46  |- skos__scopeNote mesh__D009634
% 209.28/209.46       A multifaceted disorder characterized by short stature, webbed neck, ptosis, skeletal malformations, hypertelorism, hormonal imbalance, CRYPTORCHIDISM, multiple cardiac abnormalities %28%most commonly including PULMONARY VALVE STENOSIS%29%, and some degree of MENTAL RETARDATION. The phenotype bears similarities to that of TURNER SYNDROME that occurs only in females and has its basis in a 45, X karyotype abnormality. However, Noonan syndrome occurs in both males and females with a normal sex chromosome constitution %28%46,XX and 46,XY%29%.  NS1 is due to mutations at chromosome location 12q24.1, in PTPN11, a gene encoding the non-receptor type 11 PROTEIN TYROSINE PHOSPHATASE. LEOPARD SYNDROME, a disorder that has clinical features overlapping those of Noonan Syndrome, is also due to mutations in PTPN11. In addition, there is a syndrome called neurofibromatosis-Noonan syndrome. Both the PTPN11 and NF1 gene products are involved in the SIGNAL TRANSDUCTION pathway of Ras %28%RAS PROTEINS%29%.%A%    
% 209.28/209.46  |- mesh__recordMaintainer mesh__D001651 lkt
% 209.28/209.46  |- skos__broader mesh__D001651smesh__D002779
% 209.28/209.46  |- mesh__dateCreated mesh__D001651 1979-05-29
% 209.28/209.46  |- mesh__recordOriginator mesh__D001651 SMH
% 209.28/209.46  |- rdf__type mesh__D001651sskos__Concept
% 209.28/209.46  |- skos__historyNote mesh__D001651
% 209.28/209.46       specific extrahepatic bile duct %28%1966-1979%29%
% 209.28/209.46  |- mesh__publicMeSHNote mesh__D001651 80   
% 209.28/209.46  |- skos__altLabel mesh__D001651 Bile Duct Obstruction, Extrahepatic
% 209.28/209.46  |- mesh__dateRevised mesh__D001651 2003-07-09
% 209.28/209.46  |- skos__related mesh__D001651smesh__D041781
% 209.28/209.46  |- skos__historyNote mesh__D001651 Bile Ducts %28%1966-1979%29%
% 209.28/209.46  |- mesh__historyNote mesh__D001651 80   
% 209.28/209.46  |- skos__scopeNote mesh__D001651
% 209.28/209.46       Impairment of bile flow in the large BILE DUCTS by mechanical obstruction or stricture due to benign or malignant processes.%A%    
% 209.28/209.46  |- skos__altLabel mesh__D001651 Extrahepatic Cholestasis
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D001651 2004
% 209.28/209.46  |- skos__hiddenLabel mesh__D001651 Extrahepatic Biliary Stasis
% 209.28/209.46  |- skos__prefLabel mesh__D001651 Cholestasis, Extrahepatic
% 209.28/209.46  |- mesh__recordAuthorizer mesh__D001651 sjn
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D001651 2005
% 209.28/209.46  |- skos__historyNote mesh__D001651 Biliary Tract Diseases %28%1966-1979%29%
% 209.28/209.46  |- skos__annotation mesh__D001651
% 209.28/209.46       coord IM with specific bile duct %28%IM%29% or specific precoord bile duct dis %28%IM%29%%A%  
% 209.28/209.46  |- skos__altLabel mesh__D001651 Biliary Stasis, Extrahepatic
% 209.28/209.46  |- mesh__dateEstablished mesh__D001651 1980-01-01
% 209.28/209.46  |- skos__historyNote mesh__D001651 Cholestasis %28%1966-1979%29%
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D001651 2006
% 209.28/209.46  |- mesh__dateEstablished mesh__D014579 1991-01-01
% 209.28/209.46  |- mesh__dateRevised mesh__D014579 2005-06-30
% 209.28/209.46  |- rdf__type mesh__D014579sskos__Concept
% 209.28/209.46  |- skos__annotation mesh__D014579
% 209.28/209.46       antihypertensives; from urophyses of fish; /biosyn /physiol permitted%A%  
% 209.28/209.46  |- skos__scopeNote mesh__D014579
% 209.28/209.46       Teleost hormones. A family of small peptides isolated from urophyses of bony fishes. They have many different physiological effects, including long-lasting hypotensive activity and have been proposed as antihypertensives. There are at least four different compounds: urotensin I, urotensin II, urotensin III, and urotensin IV.%A%    
% 209.28/209.46  |- skos__historyNote mesh__D014579 Fishes %28%1966-1978%29%
% 209.28/209.46  |- skos__broader mesh__D014579smesh__D036361
% 209.28/209.46  |- mesh__recordOriginator mesh__D014579 SH
% 209.28/209.46  |- mesh__historyNote mesh__D014579
% 209.28/209.46       91%28%79%29%; was see under PEPTIDES 1979-90   
% 209.28/209.46  |- skos__prefLabel mesh__D014579 Urotensins
% 209.28/209.46  |- mesh__recordAuthorizer mesh__D014579 sjn
% 209.28/209.46  |- skos__broader mesh__D014579smesh__D007705
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D014579 2006
% 209.28/209.46  |- mesh__publicMeSHNote mesh__D014579 91; was see under PEPTIDES 1979-90   
% 209.28/209.46  |- mesh__dateCreated mesh__D014579 1977-12-09
% 209.28/209.46  |- mesh__recordMaintainer mesh__D014579 ssb
% 209.28/209.46  |- skos__historyNote mesh__D014579 Peptides %28%1966-1978%29%
% 209.28/209.46  |- mesh__publicMeSHNote mesh__D019264
% 209.28/209.46       97; was ADOPTIVE CELL TRANSFER see IMMUNOTHERAPY, ADOPTIVE 1991-96, was see IMMUNIZATION, PASSIVE 1983-90%A%  
% 209.28/209.46  |- skos__prefLabel mesh__D019264 Adoptive Transfer
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D019264 1998
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D019264 2002
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D019264 2004
% 209.28/209.46  |- skos__scopeNote mesh__D019264
% 209.28/209.46       Form of passive immunization where previously sensitized immunologic agents %28%cells or serum%29% are transferred to non-immune recipients. When transfer of cells is used as a therapy for the treatment of neoplasms, it is called adoptive immunotherapy %28%IMMUNOTHERAPY, ADOPTIVE%29%.%A%    
% 209.28/209.46  |- skos__hiddenLabel mesh__D019264 Adoptive Cell Transfers
% 209.28/209.46  |- skos__historyNote mesh__D019264 Immunization, Passive %28%1983-1990%29%
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D019264 2003
% 209.28/209.46  |- mesh__onlineNote mesh__D019264
% 209.28/209.46       use IMMUNOTHERAPY, ADOPTIVE to search ADOPTIVE CELL TRANSFER 1991-96; use IMMUNIZATION, PASSIVE 1983-90%A%  
% 209.28/209.46  |- skos__hiddenLabel mesh__D019264 Cell Transfer, Adoptive
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D019264 1997
% 209.28/209.46  |- mesh__historyNote mesh__D019264
% 209.28/209.46       97; was ADOPTIVE CELL TRANSFER see IMMUNOTHERAPY, ADOPTIVE 1991-96, was see IMMUNIZATION, PASSIVE 1983-90%A%  
% 209.28/209.46  |- skos__hiddenLabel mesh__D019264 Cell Transfers, Adoptive
% 209.28/209.46  |- skos__hiddenLabel mesh__D019264 Adoptive Transfers
% 209.28/209.46  |- skos__broader mesh__D019264smesh__D007116
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D019264 2001
% 209.28/209.46  |- skos__annotation mesh__D019264
% 209.28/209.46       a form of passive immuniz by transpl of lymphocytes; do not use /util except by MeSH definition%A%  
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D019264 2006
% 209.28/209.46  |- mesh__dateEstablished mesh__D019264 1997-01-01
% 209.28/209.46  |- skos__historyNote mesh__D019264
% 209.28/209.46       Immunotherapy, Adoptive %28%1991-1996%29%
% 209.28/209.46  |- rdf__type mesh__D019264sskos__Concept
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D019264 2000
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D019264 2005
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D019264 1999
% 209.28/209.46  |- mesh__dateCreated mesh__D019264 1996-06-10
% 209.28/209.46  |- skos__broader mesh__D000559smesh__D014562
% 209.28/209.46  |- mesh__recordOriginator mesh__D000559 EC
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D000559 2004
% 209.28/209.46  |- mesh__recordAuthorizer mesh__D000559 sjn
% 209.28/209.46  |- mesh__recordMaintainer mesh__D000559 ags
% 209.28/209.46  |- skos__hiddenLabel mesh__D000559 Mole Salamander
% 209.28/209.46  |- skos__prefLabel mesh__D000559 Ambystomatidae
% 209.28/209.46  |- skos__scopeNote mesh__D000559
% 209.28/209.46       A family of the class Urodela which includes 4 living genera, about 33 species, and occurs only in North America. Adults are usually terrestrial, but the larval forms are aquatic.%A%    
% 209.28/209.46  |- rdf__type mesh__D000559sskos__Concept
% 209.28/209.46  |- mesh__dateCreated mesh__D000559 1980-04-02
% 209.28/209.46  |- skos__hiddenLabel mesh__D000559 Mole Salamanders
% 209.28/209.46  |- mesh__publicMeSHNote mesh__D000559 81   
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D000559 2005
% 209.28/209.46  |- skos__hiddenLabel mesh__D000559 Salamanders, Mole
% 209.28/209.46  |- skos__annotation mesh__D000559
% 209.28/209.46       a family of salamanders; NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 209.28/209.46  |- mesh__dateRevised mesh__D000559 2003-07-09
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D000559 2006
% 209.28/209.46  |- mesh__historyNote mesh__D000559 81   
% 209.28/209.46  |- mesh__dateEstablished mesh__D000559 1981-01-01
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011281 2005
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011281 1998
% 209.28/209.46  |- mesh__dateRevised mesh__D011281 1993-06-03
% 209.28/209.46  |- rdf__type mesh__D011281sskos__Concept
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011281 1994
% 209.28/209.46  |- skos__historyNote mesh__D011281 Pregnanes %28%1966-1972%29%
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011281 2002
% 209.28/209.46  |- mesh__recordMaintainer mesh__D011281 PLS
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011281 2001
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011281 2004
% 209.28/209.46  |- mesh__recordAuthorizer mesh__D011281 PLS
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011281 1997
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011281 2000
% 209.28/209.46  |- mesh__dateCreated mesh__D011281 1999-01-01
% 209.28/209.46  |- skos__scopeNote mesh__D011281
% 209.28/209.46       Pregnane derivatives containing three double bonds in the ring structures.%A%    
% 209.28/209.46  |- mesh__historyNote mesh__D011281 73   
% 209.28/209.46  |- mesh__dateEstablished mesh__D011281 1973-01-01
% 209.28/209.46  |- skos__broader mesh__D011281smesh__D011278
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011281 2006
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011281 2003
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011281 1999
% 209.28/209.46  |- skos__prefLabel mesh__D011281 Pregnatrienes
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011281 1996
% 209.28/209.46  |- mesh__publicMeSHNote mesh__D011281 73   
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011281 1995
% 209.28/209.46  |- mesh__recordOriginator mesh__D011281 NLM
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D005244 2005
% 209.28/209.46  |- mesh__dateEstablished mesh__D005244 1964-01-01
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D005244 2004
% 209.28/209.46  |- mesh__dateRevised mesh__D005244 2003-07-09
% 209.28/209.46  |- mesh__historyNote mesh__D005244 2004 %28%1964%29%   
% 209.28/209.46  |- skos__scopeNote mesh__D005244
% 209.28/209.46       Formation of a firm impassable mass of stool in the RECTUM or distal COLON.%A%    
% 209.28/209.46  |- rdf__type mesh__D005244sskos__Concept
% 209.28/209.46  |- mesh__publicMeSHNote mesh__D005244
% 209.28/209.46       2004; see FECES, IMPACTED 1964-2003   
% 209.28/209.46  |- mesh__recordAuthorizer mesh__D005244 sjn
% 209.28/209.46  |- skos__broader mesh__D005244smesh__D007415
% 209.28/209.46  |- mesh__recordOriginator mesh__D005244 NLM
% 209.28/209.46  |- skos__prefLabel mesh__D005244 Fecal Impaction
% 209.28/209.46  |- skos__altLabel mesh__D005244 Fecalith
% 209.28/209.46  |- mesh__dateCreated mesh__D005244 1999-01-01
% 209.28/209.46  |- mesh__recordMaintainer mesh__D005244 lkt
% 209.28/209.46  |- skos__hiddenLabel mesh__D005244 Impaction, Fecal
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D005244 2006
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D010987 2005
% 209.28/209.46  |- skos__hiddenLabel mesh__D010987 Platypus, Duckbilled
% 209.28/209.46  |- skos__scopeNote mesh__D010987
% 209.28/209.46       A small aquatic oviparous mammal of the order Monotremata found in Australia and Tasmania.%A%    
% 209.28/209.46  |- mesh__historyNote mesh__D010987
% 209.28/209.46       91%28%75%29%; was see under MONOTREMATA 1975-90; DUCKMOLE was see PLATYPUS 9175-95%A%  
% 209.28/209.46  |- skos__prefLabel mesh__D010987 Platypus
% 209.28/209.46  |- mesh__recordOriginator mesh__D010987 NLM
% 209.28/209.46  |- rdf__type mesh__D010987sskos__Concept
% 209.28/209.46  |- mesh__dateRevised mesh__D010987 2003-07-09
% 209.28/209.46  |- mesh__recordMaintainer mesh__D010987 ags
% 209.28/209.46  |- mesh__publicMeSHNote mesh__D010987
% 209.28/209.46       91; was see under MONOTREMATA 1975-95; DUCKMOLE was see PLATYPUS 1975-95%A%  
% 209.28/209.46  |- skos__altLabel mesh__D010987 Duckbilled Platypus
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D010987 2004
% 209.28/209.46  |- mesh__recordAuthorizer mesh__D010987 sjn
% 209.28/209.46  |- mesh__dateCreated mesh__D010987 1974-11-19
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D010987 2006
% 209.28/209.46  |- mesh__dateEstablished mesh__D010987 1991-01-01
% 209.28/209.46  |- skos__annotation mesh__D010987 IM; qualif permitted   
% 209.28/209.46  |- skos__broader mesh__D010987smesh__D009007
% 209.28/209.46  |- mesh__onlineNote mesh__D010987
% 209.28/209.46       use PLATYPUS to search DUCKMOLE 1975-95   
% 209.28/209.46  |- mesh__dateEstablished mesh__D043363 2004-01-01
% 209.28/209.46  |- mesh__dateCreated mesh__D043363 2003-07-09
% 209.28/209.46  |- mesh__dateRevised mesh__D043363 2005-06-30
% 209.28/209.46  |- mesh__publicMeSHNote mesh__D043363 2004   
% 209.28/209.46  |- mesh__recordMaintainer mesh__D043363 SYSTEM
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D043363 2006
% 209.28/209.46  |- skos__scopeNote mesh__D043363
% 209.28/209.46       A family of gram-negative bacteria in the order Hydrogenophilales, class BETAPROTEOBACTERIA.%A%    
% 209.28/209.46  |- mesh__recordAuthorizer mesh__D043363 sjn
% 209.28/209.46  |- skos__broader mesh__D043363smesh__D020562
% 209.28/209.46  |- mesh__recordOriginator mesh__D043363 ags
% 209.28/209.46  |- skos__prefLabel mesh__D043363 Hydrogenophilaceae
% 209.28/209.46  |- rdf__type mesh__D043363sskos__Concept
% 209.28/209.46  |- mesh__historyNote mesh__D043363 2004   
% 209.28/209.46  |- mesh__dateCreated mesh__D010189 1999-01-01
% 209.28/209.46  |- skos__hiddenLabel mesh__D010189 Juices, Pancreatic
% 209.28/209.46  |- skos__annotation mesh__D010189
% 209.28/209.46       /secret permitted but consider PANCREAS /secret if pertinent%A%  
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D010189 2003
% 209.28/209.46  |- skos__related mesh__D010189smesh__D002919
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D010189 2006
% 209.28/209.46  |- mesh__recordOriginator mesh__D010189 NLM
% 209.28/209.46  |- skos__broader mesh__D010189smesh__D012634
% 209.28/209.46  |- skos__hiddenLabel mesh__D010189 Pancreatic Juices
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D010189 2001
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D010189 2005
% 209.28/209.46  |- skos__scopeNote mesh__D010189
% 209.28/209.46       The fluid containing digestive enzymes secreted by the pancreas in response to food in the duodenum.%A%    
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D010189 2000
% 209.28/209.46  |- rdf__type mesh__D010189sskos__Concept
% 209.28/209.46  |- skos__related mesh__D010189smesh__D014362
% 209.28/209.46  |- mesh__dateRevised mesh__D010189 1999-11-03
% 209.28/209.46  |- skos__hiddenLabel mesh__D010189 Juice, Pancreatic
% 209.28/209.46  |- skos__prefLabel mesh__D010189 Pancreatic Juice
% 209.28/209.46  |- skos__related mesh__D010189smesh__D014357
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D010189 2004
% 209.28/209.46  |- mesh__recordMaintainer mesh__D010189 KEV
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D010189 2002
% 209.28/209.46  |- skos__related mesh__D010189smesh__D002918
% 209.28/209.46  |- mesh__recordAuthorizer mesh__D010189 sjn
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Cells, Erythropoietic Stem
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Erythropoietic Stem Cell
% 209.28/209.46  |- skos__altLabel mesh__D015672 Stem Cells, Erythroid
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Cells, Erythroid Progenitor
% 209.28/209.46  |- skos__altLabel mesh__D015672 Erythropoietic Progenitor Cells
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Erythroid Burst-Forming Units
% 209.28/209.46  |- skos__altLabel mesh__D015672 Progenitor Cells, Erythropoietic
% 209.28/209.46  |- skos__scopeNote mesh__D015672
% 209.28/209.46       Committed, erythroid stem cells derived from MYELOID PROGENITOR CELLS. The progenitor cells develop in two phases: erythroid burst-forming units %28%BFU-E%29% followed by erythroid colony-forming units %28%CFU-E%29%; BFU-E differentiate into CFU-E on stimulation by ERYTHROPOIETIN, and then further differentiate into ERYTHROBLASTS when stimulated by other factors.%A%    
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Stem Cell, Erythroid
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Progenitor Cell, Erythroid
% 209.28/209.46  |- mesh__dateRevised mesh__D015672 2003-07-09
% 209.28/209.46  |- skos__historyNote mesh__D015672 Erythrocytes %28%1972-1989%29%
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Progenitor Cell, Erythropoietic
% 209.28/209.46  |- mesh__publicMeSHNote mesh__D015672 90   
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Stem Cells, Erythropoietic
% 209.28/209.46  |- skos__broader mesh__D015672smesh__D023461
% 209.28/209.46  |- skos__prefLabel mesh__D015672 Erythroid Progenitor Cells
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Erythroid Stem Cells
% 209.28/209.46  |- skos__altLabel mesh__D015672 CFU-E
% 209.28/209.46  |- skos__historyNote mesh__D015672
% 209.28/209.46       Hematopoietic Stem Cells %28%1977-1989%29%
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Progenitor Cells, Erythroid
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Cell, Erythropoietic Progenitor
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Cell, Erythropoietic Stem
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Burst Forming Units, Erythroid
% 209.28/209.46  |- skos__broader mesh__D015672smesh__D041905
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Precursor Cell, Erythroid
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Units, Erythroid Burst-Forming
% 209.28/209.46  |- mesh__dateCreated mesh__D015672 1989-05-15
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Cells, Erythroid Precursor
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Burst-Forming Unit, Erythroid
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Cell, Erythroid Progenitor
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Cells, Erythropoietic Progenitor
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D015672 2005
% 209.28/209.46  |- skos__altLabel mesh__D015672 Erythroid Precursor Cells
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 BFU-Es
% 209.28/209.46  |- mesh__historyNote mesh__D015672 90   
% 209.28/209.46  |- mesh__recordAuthorizer mesh__D015672 sjn
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 BFU E
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Stem Cell, Erythropoietic
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Unit, Erythroid Burst-Forming
% 209.28/209.46  |- mesh__dateEstablished mesh__D015672 1990-01-01
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Erythroid Progenitor Cell
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Cell, Erythroid Precursor
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Erythroid Precursor Cell
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D015672 2006
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Erythroid Burst-Forming Unit
% 209.28/209.46  |- skos__altLabel mesh__D015672 Erythropoietic Stem Cells
% 209.28/209.46  |- mesh__recordOriginator mesh__D015672 AGS
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Cell, Erythroid Stem
% 209.28/209.46  |- skos__historyNote mesh__D015672 Erythroblasts %28%1977-1989%29%
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Erythropoietic Progenitor Cell
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Precursor Cells, Erythroid
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Erythroid Stem Cell
% 209.28/209.46  |- skos__hiddenLabel mesh__D015672 Cells, Erythroid Stem
% 209.28/209.46  |- mesh__recordMaintainer mesh__D015672 nns
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D015672 2004
% 209.28/209.46  |- rdf__type mesh__D015672sskos__Concept
% 209.28/209.46  |- skos__altLabel mesh__D015672 BFU-E
% 209.28/209.46  |- mesh__dateCreated mesh__D009635 1974-11-11
% 209.28/209.46  |- mesh__dateEstablished mesh__D009635 1975-09-01
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D009635 2006
% 209.28/209.46  |- skos__historyNote mesh__D009635 Norsteroids %28%1968-1974%29%
% 209.28/209.46  |- mesh__recordAuthorizer mesh__D009635 SJN
% 209.28/209.46  |- mesh__recordOriginator mesh__D009635 NLM
% 209.28/209.46  |- mesh__historyNote mesh__D009635 75   
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D009635 2002
% 209.28/209.46  |- skos__scopeNote mesh__D009635
% 209.28/209.46       Androstanes in which ring contractions have occurred or which are lacking carbon-18. Compounds with any degree of unsaturation are included. Androstanes which are lacking carbon-19 are ESTRANES.%A%    
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D009635 2003
% 209.28/209.46  |- skos__broader mesh__D009635smesh__D009654
% 209.28/209.46  |- skos__prefLabel mesh__D009635 Norandrostanes
% 209.28/209.46  |- rdf__type mesh__D009635sskos__Concept
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D009635 1998
% 209.28/209.46  |- mesh__dateRevised mesh__D009635 1997-06-20
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D009635 2004
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D009635 2000
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D009635 1999
% 209.28/209.46  |- mesh__publicMeSHNote mesh__D009635 75   
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D009635 2001
% 209.28/209.46  |- mesh__recordMaintainer mesh__D009635 TGC
% 209.28/209.46  |- skos__historyNote mesh__D009635 Androstanes %28%1968-1974%29%
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D009635 2005
% 209.28/209.46  |- skos__hiddenLabel mesh__D001652 Bile Duct
% 209.28/209.46  |- skos__related mesh__D001652smesh__D002758
% 209.28/209.46  |- mesh__recordOriginator mesh__D001652 NLM
% 209.28/209.46  |- mesh__recordAuthorizer mesh__D001652 sjn
% 209.28/209.46  |- skos__hiddenLabel mesh__D001652 Ducts, Bile
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D001652 2006
% 209.28/209.46  |- skos__hiddenLabel mesh__D001652 Duct, Bile
% 209.28/209.46  |- skos__related mesh__D001652smesh__D002760
% 209.28/209.46  |- mesh__dateCreated mesh__D001652 1999-01-01
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D001652 2005
% 209.28/209.46  |- skos__related mesh__D001652smesh__D011171
% 209.28/209.46  |- mesh__recordMaintainer mesh__D001652 lkt
% 209.28/209.46  |- rdf__type mesh__D001652sskos__Concept
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D001652 2004
% 209.28/209.46  |- skos__annotation mesh__D001652
% 209.28/209.46       /abnorm: BILIARY ATRESIA is also available; inflammation = CHOLANGITIS; calculi = BILIARY CALCULI see GALLSTONES but consider also CHOLELITHIASIS %28%IM%29% + BILE DUCT DISEASES %28%IM%29%%A%  
% 209.28/209.46  |- skos__scopeNote mesh__D001652
% 209.28/209.46       The channels that collect and transport the bile secretion from the BILE CANALICULI, the smallest branch of the BILIARY TRACT in the LIVER, through the bile ductules, the bile ducts out the liver, and to the GALLBLADDER for storage.%A%    
% 209.28/209.46  |- skos__prefLabel mesh__D001652 Bile Ducts
% 209.28/209.46  |- mesh__dateRevised mesh__D001652 2003-07-09
% 209.28/209.46  |- skos__broader mesh__D001652smesh__D001659
% 209.28/209.46  |- skos__annotation mesh__D019265
% 209.28/209.46       a type of spectrum anal; DF: note short X ref   
% 209.28/209.46  |- mesh__recordOriginator mesh__D019265 JLS
% 209.28/209.46  |- skos__broader mesh__D019265smesh__D003952
% 209.28/209.46  |- skos__hiddenLabel mesh__D019265 Near-Infrared Spectroscopy
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D019265 2005A
% 209.28/209.46  |- mesh__recordMaintainer mesh__D019265 jls
% 209.28/209.46  |- skos__hiddenLabel mesh__D019265 Spectrometries, Near-Infrared
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D019265 2006
% 209.28/209.46  |- mesh__recordAuthorizer mesh__D019265 jls
% 209.28/209.46  |- rdf__type mesh__D019265sskos__Concept
% 209.28/209.46  |- skos__hiddenLabel mesh__D019265 Near-Infrared Spectrometry
% 209.28/209.46  |- skos__hiddenLabel mesh__D019265 Spectroscopy, Near Infrared
% 209.28/209.46  |- mesh__dateCreated mesh__D019265 1996-06-10
% 209.28/209.46  |- skos__hiddenLabel mesh__D019265 Spectroscopy, NIR
% 209.28/209.46  |- skos__historyNote mesh__D019265
% 209.28/209.46       Spectrophotometry, Infrared %28%1991-1996%29%
% 209.28/209.46  |- skos__broader mesh__D019265smesh__D013057
% 209.28/209.46  |- skos__hiddenLabel mesh__D019265 Spectroscopies, NIR
% 209.28/209.46  |- skos__hiddenLabel mesh__D019265 Spectrometry, Near Infrared
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D019265 2005
% 209.28/209.46  |- skos__hiddenLabel mesh__D019265 Near-Infrared Spectroscopies
% 209.28/209.46  |- skos__prefLabel mesh__D019265 Spectroscopy, Near-Infrared
% 209.28/209.46  |- mesh__dateRevised mesh__D019265 2004-08-02
% 209.28/209.46  |- skos__hiddenLabel mesh__D019265 Near-Infrared Spectrometries
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D019265 2004
% 209.28/209.46  |- skos__altLabel mesh__D019265 Spectrometry, Near-Infrared
% 209.28/209.46  |- skos__scopeNote mesh__D019265
% 209.28/209.46       A noninvasive technique that uses the differential absorption properties of hemoglobin and myoglobin to evaluate tissue oxygenation and indirectly can measure regional hemodynamics and blood flow. Near-infrared light %28%NIR%29% can propagate through tissues and at particular wavelengths is differentially absorbed by oxygenated vs. deoxygenated forms of hemoglobin and myoglobin. Illumination of intact tissue with NIR allows qualitative assessment of changes in the tissue concentration of these molecules. The analysis is also used to determine body composition.%A%    
% 209.28/209.46  |- mesh__dateEstablished mesh__D019265 1997-01-01
% 209.28/209.46  |- skos__hiddenLabel mesh__D019265 Spectroscopies, Near-Infrared
% 209.28/209.46  |- skos__hiddenLabel mesh__D019265 NIR Spectroscopies
% 209.28/209.46  |- mesh__historyNote mesh__D019265 97   
% 209.28/209.46  |- skos__altLabel mesh__D019265 NIR Spectroscopy
% 209.28/209.46  |- mesh__publicMeSHNote mesh__D019265 97   
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D019265 2003
% 209.28/209.46  |- rdf__type mesh__D011282sskos__Concept
% 209.28/209.46  |- mesh__dateEstablished mesh__D011282 1974-01-01
% 209.28/209.46  |- mesh__publicMeSHNote mesh__D011282 74   
% 209.28/209.46  |- skos__prefLabel mesh__D011282 Pregnenediones
% 209.28/209.46  |- mesh__recordOriginator mesh__D011282 NLM
% 209.28/209.46  |- mesh__dateRevised mesh__D011282 1993-06-03
% 209.28/209.46  |- skos__scopeNote mesh__D011282
% 209.28/209.46       Unsaturated pregnane derivatives containing two keto groups on side chains or ring structures.%A%    
% 209.28/209.46  |- mesh__historyNote mesh__D011282 74   
% 209.28/209.46  |- skos__altLabel mesh__D011282 Diketopregnenes
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011282 2004
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011282 1997
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011282 2002
% 209.28/209.46  |- skos__altLabel mesh__D011282 Dioxopregnenes
% 209.28/209.46  |- mesh__dateCreated mesh__D011282 1999-01-01
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011282 2006
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011282 1999
% 209.28/209.46  |- mesh__recordMaintainer mesh__D011282 PLS
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011282 2003
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011282 1996
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011282 2001
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011282 2005
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011282 1995
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011282 1998
% 209.28/209.46  |- mesh__recordAuthorizer mesh__D011282 PLS
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011282 1994
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D011282 2000
% 209.28/209.46  |- skos__broader mesh__D011282smesh__D011283
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D005245 2003
% 209.28/209.46  |- mesh__recordAuthorizer mesh__D005245 PLS
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D005245 2001
% 209.28/209.46  |- mesh__dateEstablished mesh__D005245 1968-01-01
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D005245 1995
% 209.28/209.46  |- mesh__dateRevised mesh__D005245 1994-05-05
% 209.28/209.46  |- skos__hiddenLabel mesh__D005245 Schedules, Fee
% 209.28/209.46  |- rdf__type mesh__D005245sskos__Concept
% 209.28/209.46  |- mesh__recordMaintainer mesh__D005245 TGC
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D005245 2000
% 209.28/209.46  |- skos__historyNote mesh__D005245 Economics %28%1966-1967%29%
% 209.28/209.46  |- mesh__historyNote mesh__D005245 68   
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D005245 1999
% 209.28/209.46  |- skos__prefLabel mesh__D005245 Fee Schedules
% 209.28/209.46  |- mesh__dateCreated mesh__D005245 1999-01-01
% 209.28/209.46  |- skos__hiddenLabel mesh__D005245 Schedule, Fee
% 209.28/209.46  |- skos__hiddenLabel mesh__D005245 Fee Schedule
% 209.28/209.46  |- skos__related mesh__D005245smesh__D005249
% 209.28/209.46  |- skos__broader mesh__D005245smesh__D009934
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D005245 2006
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D005245 1998
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D005245 2002
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D005245 1997
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D005245 2005
% 209.28/209.46  |- mesh__recordOriginator mesh__D005245 NLM
% 209.28/209.46  |- skos__scopeNote mesh__D005245
% 209.28/209.46       A listing of established professional service charges, for specified dental and medical procedures.%A%    
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D005245 2004
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D005245 1996
% 209.28/209.46  |- mesh__publicMeSHNote mesh__D005245 68   
% 209.28/209.46  |- rdf__type mesh__D010988sskos__Concept
% 209.28/209.46  |- mesh__activeMeSHYear mesh__D010988 2002
% 209.28/209.47  |- mesh__dateRevised mesh__D010988 1999-11-03
% 209.28/209.47  |- skos__prefLabel mesh__D010988 Play and Playthings
% 209.28/209.47  |- skos__hiddenLabel mesh__D010988 Toy
% 209.28/209.47  |- mesh__publicMeSHNote mesh__D010988 78; was PLAY 1963-77   
% 209.28/209.47  |- mesh__onlineNote mesh__D010988
% 209.28/209.47       use PLAY AND PLAYTHINGS to search PLAY 1966-77   
% 209.28/209.47  |- skos__broader mesh__D010988smesh__D011998
% 209.28/209.47  |- skos__hiddenLabel mesh__D010988 Playthings and Play
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D010988 2001
% 209.28/209.47  |- mesh__dateCreated mesh__D010988 1999-01-01
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D010988 2004
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D010988 2000
% 209.28/209.47  |- mesh__recordOriginator mesh__D010988 NLM
% 209.28/209.47  |- skos__scopeNote mesh__D010988
% 209.28/209.47       Spontaneous or voluntary recreational activities pursued for enjoyment and accessories or equipment used in the activities; includes games, toys, etc.%A%    
% 209.28/209.47  |- mesh__historyNote mesh__D010988 78; was PLAY 1963-77   
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D010988 2006
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D010988 2003
% 209.28/209.47  |- skos__hiddenLabel mesh__D010988 Plaything
% 209.28/209.47  |- skos__annotation mesh__D010988
% 209.28/209.47       /psychol permitted but do not confuse with PLAY THERAPY; includes games; DF: PLAY%A%  
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D010988 2005
% 209.28/209.47  |- mesh__recordMaintainer mesh__D010988 kle
% 209.28/209.47  |- mesh__recordAuthorizer mesh__D010988 sjn
% 209.28/209.47  |- skos__hiddenLabel mesh__D010988 Plays
% 209.28/209.47  |- skos__hiddenLabel mesh__D010988 Puppet
% 209.28/209.47  |- skos__hiddenLabel mesh__D043364 1,4 beta D Xylanohydrolase
% 209.28/209.47  |- skos__hiddenLabel mesh__D043364 Endo 1,4 Xylanase II
% 209.28/209.47  |- skos__broader mesh__D043364smesh__D014995
% 209.28/209.47  |- mesh__historyNote mesh__D043364
% 209.28/209.47       2004; use ENDO-1,4-BETA XYLANASES %28%NM%29% 1980-2003; for XYLANASE B use ENDO-1,4-BETA XYLANASES %28%NM%29% 1990-2003; for XYLANASE C use ENDO-1,4-BETA XYLANASES %28%NM%29% 1992-2003; for XYLANASE D use ENDO-1,4-BETA XYLANASES %28%NM%29% 1993-2003%A%  
% 209.28/209.47  |- skos__altLabel mesh__D043364 Endo-1,4-beta-Xylanase
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D043364 2006
% 209.28/209.47  |- mesh__recordOriginator mesh__D043364 AKE
% 209.28/209.47  |- mesh__dateEstablished mesh__D043364 2004-01-01
% 209.28/209.47  |- skos__historyNote mesh__D043364 Xylans %28%1977-1980%29%
% 209.28/209.47  |- skos__hiddenLabel mesh__D043364 Endo 1,4 beta Xylanase II
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D043364 2005
% 209.28/209.47  |- skos__altLabel mesh__D043364 beta Xylanase
% 209.28/209.47  |- skos__altLabel mesh__D043364 Endoxylanase
% 209.28/209.47  |- rdf__type mesh__D043364sskos__Concept
% 209.28/209.47  |- skos__hiddenLabel mesh__D043364 Xylanases, Endo-1,4-beta
% 209.28/209.47  |- mesh__publicMeSHNote mesh__D043364
% 209.28/209.47       2004; ENDO-1,4 BETA XYLANASES was indexed under XYLOSIDASES 1995-2003, under GLYCOSIDE HYDROLASES 1980-1994 %26% under XYLANS 1977-1980, XYLANASE B was indexed under XYLOSIDASES 1995-2003 %26% under GLYCOSIDE HYDROLASES 1990-1994, XYLANASE C was indexed under XYLOSIDASES 1995-2003 %26% under GLYCOSIDE HYDROLASES 1992-1994, XYLANASE D was indexed under XYLOSIDASES %26% BETA-GLUCOSIDASE 1995-2003, under GLYCOSIDE HYDROLASES 1993-1994%A%  
% 209.28/209.47  |- skos__hiddenLabel mesh__D043364 Beta 1 4 Endoxylanase
% 209.28/209.47  |- skos__altLabel mesh__D043364 Beta-1-4-Endoxylanase
% 209.28/209.47  |- mesh__recordMaintainer mesh__D043364 AKE
% 209.28/209.47  |- skos__altLabel mesh__D043364 1,4-beta-D-Xylanohydrolase
% 209.28/209.47  |- skos__hiddenLabel mesh__D043364 Xylanase, beta
% 209.28/209.47  |- skos__hiddenLabel mesh__D043364 Endo 1,4 beta Xylanase
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D043364 2004
% 209.28/209.47  |- skos__altLabel mesh__D043364 Endo-1,4-Xylanase II
% 209.28/209.47  |- skos__hiddenLabel mesh__D043364 Endo 1,4 beta Xylanases
% 209.28/209.47  |- mesh__recordAuthorizer mesh__D043364 sjn
% 209.28/209.47  |- skos__scopeNote mesh__D043364
% 209.28/209.47       Enzymes which catalyze the endohydrolysis of 1,4-beta-D-xylosidic linkages in XYLANS.%A%    
% 209.28/209.47  |- skos__historyNote mesh__D043364 Glycoside Hydrolases %28%1980-1994%29%
% 209.28/209.47  |- skos__prefLabel mesh__D043364 Endo-1,4-beta Xylanases
% 209.28/209.47  |- skos__historyNote mesh__D043364 Xylosidases %28%1995-2003%29%
% 209.28/209.47  |- mesh__dateCreated mesh__D043364 2003-07-09
% 209.28/209.47  |- skos__broader mesh__D015673smesh__D009468
% 209.28/209.47  |- skos__broader mesh__D015673smesh__D014777
% 209.28/209.47  |- skos__hiddenLabel mesh__D015673
% 209.28/209.47       Infectious Mononucleosis Like Syndrome, Chronic
% 209.28/209.47  |- skos__related mesh__D015673smesh__D005356
% 209.28/209.47  |- mesh__recordMaintainer mesh__D015673 ags
% 209.28/209.47  |- skos__historyNote mesh__D015673 Muscular Diseases %28%1966-1989%29%
% 209.28/209.47  |- skos__altLabel mesh__D015673 Chronic Fatigue Syndrome
% 209.28/209.47  |- skos__hiddenLabel mesh__D015673 Syndrome, Chronic Fatigue-Fibromyalgia
% 209.28/209.47  |- skos__hiddenLabel mesh__D015673 Fatigue Syndromes, Postviral
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D015673 2004
% 209.28/209.47  |- rdf__type mesh__D015673sskos__Concept
% 209.28/209.47  |- mesh__publicMeSHNote mesh__D015673 90   
% 209.28/209.47  |- skos__altLabel mesh__D015673 Myalgic Encephalomyelitis
% 209.28/209.47  |- skos__hiddenLabel mesh__D015673 Fatigue-Fibromyalgia Syndrome, Chronic
% 209.28/209.47  |- skos__historyNote mesh__D015673 Virus Diseases %28%1986-1989%29%
% 209.28/209.47  |- skos__hiddenLabel mesh__D015673 Disorders, Chronic Fatigue
% 209.28/209.47  |- skos__altLabel mesh__D015673 Fatigue Syndrome, Postviral
% 209.28/209.47  |- skos__altLabel mesh__D015673 Chronic Fatigue-Fibromyalgia Syndrome
% 209.28/209.47  |- skos__hiddenLabel mesh__D015673 Chronic Fatigue Syndromes
% 209.28/209.47  |- mesh__recordAuthorizer mesh__D015673 sjn
% 209.28/209.47  |- skos__altLabel mesh__D015673 Postviral Fatigue Syndrome
% 209.28/209.47  |- skos__altLabel mesh__D015673 Royal Free Disease
% 209.28/209.47  |- skos__hiddenLabel mesh__D015673 Fatigue Syndromes, Chronic
% 209.28/209.47  |- skos__broader mesh__D015673smesh__D009135
% 209.28/209.47  |- skos__altLabel mesh__D015673 Chronic Fatigue Disorder
% 209.28/209.47  |- skos__hiddenLabel mesh__D015673 Fatigue-Fibromyalgia Syndromes, Chronic
% 209.28/209.47  |- mesh__dateCreated mesh__D015673 1989-05-25
% 209.28/209.47  |- skos__hiddenLabel mesh__D015673 Chronic Fatigue Disorders
% 209.28/209.47  |- skos__annotation mesh__D015673
% 209.28/209.47       a clinical entity: do not confuse with %22%chronic fatigue%22% %28% = FATIGUE %28%IM%29% + CHRONIC DISEASE %28%NIM%29%%29%; DF: CFIDS%A%  
% 209.28/209.47  |- skos__hiddenLabel mesh__D015673 Fatigue Disorders, Chronic
% 209.28/209.47  |- skos__hiddenLabel mesh__D015673 Chronic Fatigue-Fibromyalgia Syndromes
% 209.28/209.47  |- mesh__dateEstablished mesh__D015673 1990-01-01
% 209.28/209.47  |- mesh__historyNote mesh__D015673 90   
% 209.28/209.47  |- skos__hiddenLabel mesh__D015673 Postviral Fatigue Syndromes
% 209.28/209.47  |- mesh__recordOriginator mesh__D015673 AGS
% 209.28/209.47  |- skos__hiddenLabel mesh__D015673 Fatigue Disorder, Chronic
% 209.28/209.47  |- skos__altLabel mesh__D015673
% 209.28/209.47       Infectious Mononucleosis-Like Syndrome, Chronic
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D015673 2005
% 209.28/209.47  |- skos__broader mesh__D015673smesh__D004679
% 209.28/209.47  |- skos__altLabel mesh__D015673
% 209.28/209.47       Chronic Fatigue and Immune Dysfunction Syndrome
% 209.28/209.47  |- skos__hiddenLabel mesh__D015673 Syndromes, Postviral Fatigue
% 209.28/209.47  |- skos__altLabel mesh__D015673 Encephalomyelitis, Myalgic
% 209.28/209.47  |- skos__prefLabel mesh__D015673 Fatigue Syndrome, Chronic
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D015673 2002
% 209.28/209.47  |- skos__historyNote mesh__D015673 Encephalomyelitis %28%1966-1989%29%
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D015673 2006
% 209.28/209.47  |- mesh__dateRevised mesh__D015673 2001-07-25
% 209.28/209.47  |- skos__historyNote mesh__D015673 Fatigue %28%1977-1989%29%
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D015673 2003
% 209.28/209.47  |- skos__scopeNote mesh__D015673
% 209.28/209.47       A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. %28%From Semin Neurol 1998;18%28%2%29%:237-42; Ann Intern Med 1994 Dec 15;121%28%12%29%: 953-9%29%%A%    
% 209.28/209.47  |- skos__hiddenLabel mesh__D015673 Syndromes, Chronic Fatigue-Fibromyalgia
% 209.28/209.47  |- skos__hiddenLabel mesh__D015673 Chronic Fatigue Fibromyalgia Syndrome
% 209.28/209.47  |- skos__historyNote mesh__D009636 Heterocyclic Compounds %28%1966-1970%29%
% 209.28/209.47  |- skos__historyNote mesh__D009636 Bridged Compounds %28%1966-1970%29%
% 209.28/209.47  |- skos__historyNote mesh__D009636 Camphor %28%1966-1970%29%
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D009636 2006
% 209.28/209.47  |- skos__historyNote mesh__D009636 Polycyclic Compounds %28%1966-1970%29%
% 209.28/209.47  |- mesh__dateCreated mesh__D009636 1999-01-01
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D009636 2004
% 209.28/209.47  |- mesh__dateRevised mesh__D009636 2003-07-09
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D009636 2005
% 209.28/209.47  |- mesh__recordMaintainer mesh__D009636 ssb
% 209.28/209.47  |- skos__prefLabel mesh__D009636 Norbornanes
% 209.28/209.47  |- mesh__recordOriginator mesh__D009636 NLM
% 209.28/209.47  |- rdf__type mesh__D009636sskos__Concept
% 209.28/209.47  |- mesh__dateEstablished mesh__D009636 1974-01-01
% 209.28/209.47  |- mesh__publicMeSHNote mesh__D009636 74   
% 209.28/209.47  |- skos__historyNote mesh__D009636 Terpenes %28%1970-1971%29%
% 209.28/209.47  |- skos__altLabel mesh__D009636 Norcamphanes
% 209.28/209.47  |- mesh__recordAuthorizer mesh__D009636 sjn
% 209.28/209.47  |- skos__broader mesh__D009636smesh__D039821
% 209.28/209.47  |- mesh__historyNote mesh__D009636 74%28%72%29%   
% 209.28/209.47  |- skos__annotation mesh__D009636 includes norbornenes   
% 209.28/209.47  |- skos__hiddenLabel mesh__D001653 Bile Duct, Intrahepatic
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D001653 1999
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D001653 2006
% 209.28/209.47  |- mesh__recordAuthorizer mesh__D001653 SJN
% 209.28/209.47  |- skos__scopeNote mesh__D001653
% 209.28/209.47       Passages within the liver for the conveyance of bile. Includes right and left hepatic ducts even though these may join outside the liver to form the common hepatic duct.%A%    
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D001653 2005
% 209.28/209.47  |- mesh__dateCreated mesh__D001653 1999-01-01
% 209.28/209.47  |- skos__broader mesh__D001653smesh__D008099
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D001653 2002
% 209.28/209.47  |- skos__prefLabel mesh__D001653 Bile Ducts, Intrahepatic
% 209.28/209.47  |- rdf__type mesh__D001653sskos__Concept
% 209.28/209.47  |- mesh__dateRevised mesh__D001653 1998-06-10
% 209.28/209.47  |- mesh__recordOriginator mesh__D001653 NLM
% 209.28/209.47  |- skos__annotation mesh__D001653
% 209.28/209.47       do not confuse with BILE DUCTS, EXTRAHEPATIC; do not confuse with HEPATIC DUCT, COMMON, the external junction of right %26% left hepatic ducts; diseases: coord IM with BILE DUCT DISEASES %28%IM%29%; neopl: coord IM with BILE DUCT NEOPLASMS %28%IM%29%; inflammation: coord IM with CHOLANGITIS %28%IM%29%; BILE DUCT OBSTRUCTION, INTRAHEPATIC see CHOLESTASIS, INTRAHEPATIC is also available%A%  
% 209.28/209.47  |- skos__broader mesh__D001653smesh__D001652
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D001653 2004
% 209.28/209.47  |- skos__hiddenLabel mesh__D001653 Intrahepatic Bile Ducts
% 209.28/209.47  |- skos__hiddenLabel mesh__D001653 Intrahepatic Bile Duct
% 209.28/209.47  |- skos__hiddenLabel mesh__D001653 Duct, Intrahepatic Bile
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D001653 2001
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D001653 2003
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D001653 2000
% 209.28/209.47  |- skos__hiddenLabel mesh__D001653 Ducts, Intrahepatic Bile
% 209.28/209.47  |- mesh__recordMaintainer mesh__D001653 MSR
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D019266 2006
% 209.28/209.47  |- rdf__type mesh__D019266sskos__Concept
% 209.28/209.47  |- mesh__dateEstablished mesh__D019266 1997-01-01
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D019266 2001
% 209.28/209.47  |- mesh__dateCreated mesh__D019266 1996-06-19
% 209.28/209.47  |- mesh__publicMeSHNote mesh__D019266 97   
% 209.28/209.47  |- skos__broader mesh__D019266smesh__D017614
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D019266 2005
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D019266 2000
% 209.28/209.47  |- skos__altLabel mesh__D019266 Dietary Iron
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D019266 1999
% 209.28/209.47  |- skos__annotation mesh__D019266
% 209.28/209.47       /adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with disease /diet ther%A%  
% 209.28/209.47  |- skos__historyNote mesh__D019266 Iron %28%1966-1996%29%
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D019266 1998
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D019266 2004
% 209.28/209.47  |- skos__scopeNote mesh__D019266
% 209.28/209.47       Iron or iron compounds used in foods or as food. Dietary iron is important in oxygen transport and the synthesis of the iron-porphyrin proteins hemoglobin, myoglobin, cytochromes, and cytochrome oxidase. Insufficient amounts of dietary iron can lead to iron-deficiency anemia.%A%    
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D019266 2002
% 209.28/209.47  |- skos__prefLabel mesh__D019266 Iron, Dietary
% 209.28/209.47  |- mesh__historyNote mesh__D019266 97   
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D019266 2003
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D019266 1997
% 209.28/209.47  |- skos__annotation mesh__D011283 do not confuse with PREGNANES   
% 209.28/209.47  |- rdf__type mesh__D011283sskos__Concept
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D011283 2001
% 209.28/209.47  |- mesh__dateCreated mesh__D011283 1999-01-01
% 209.28/209.47  |- mesh__recordMaintainer mesh__D011283 PLS
% 209.28/209.47  |- skos__scopeNote mesh__D011283 Unsaturated derivatives of PREGNANES.     
% 209.28/209.47  |- skos__broader mesh__D011283smesh__D011278
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D011283 2003
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D011283 1996
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D011283 2005
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D011283 1998
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D011283 2004
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D011283 1997
% 209.28/209.47  |- mesh__historyNote mesh__D011283 73   
% 209.28/209.47  |- mesh__publicMeSHNote mesh__D011283 73   
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D011283 1994
% 209.28/209.47  |- skos__historyNote mesh__D011283 Pregnanes %28%1966-1972%29%
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D011283 2002
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D011283 2006
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D011283 1999
% 209.28/209.47  |- skos__prefLabel mesh__D011283 Pregnenes
% 209.28/209.47  |- mesh__dateEstablished mesh__D011283 1973-01-01
% 209.28/209.47  |- mesh__recordOriginator mesh__D011283 NLM
% 209.28/209.47  |- mesh__dateRevised mesh__D011283 1993-06-03
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D011283 1995
% 209.28/209.47  |- mesh__recordAuthorizer mesh__D011283 PLS
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D011283 2000
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D005246 2002
% 209.28/209.47  |- mesh__recordMaintainer mesh__D005246 lkt
% 209.28/209.47  |- mesh__recordAuthorizer mesh__D005246 sjn
% 209.28/209.47  |- skos__annotation mesh__D005246
% 209.28/209.47       note category; FEEDBACK, BIOCHEMICAL and FEEDBACK, PSYCHOLOGICAL are also available%A%  
% 209.28/209.47  |- mesh__dateCreated mesh__D005246 1999-01-01
% 209.28/209.47  |- mesh__recordOriginator mesh__D005246 NLM
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D005246 2006
% 209.28/209.47  |- mesh__publicMeSHNote mesh__D005246 1965   
% 209.28/209.47  |- skos__related mesh__D005246smesh__D001676
% 209.28/209.47  |- skos__broader mesh__D005246smesh__D003491
% 209.28/209.47  |- skos__scopeNote mesh__D005246
% 209.28/209.47       A mechanism of communication within a system in that the input signal generates an output response which returns to influence the continued activity or productivity of that system.%A%    
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D005246 2005
% 209.28/209.47  |- skos__prefLabel mesh__D005246 Feedback
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D005246 2004
% 209.28/209.47  |- skos__related mesh__D005246smesh__D025461
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D005246 2003
% 209.28/209.47  |- skos__related mesh__D005246smesh__D007721
% 209.28/209.47  |- mesh__dateRevised mesh__D005246 2001-07-25
% 209.28/209.47  |- mesh__historyNote mesh__D005246 1965   
% 209.28/209.47  |- mesh__dateEstablished mesh__D005246 1965-01-01
% 209.28/209.47  |- rdf__type mesh__D005246sskos__Concept
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D010989 2004
% 209.28/209.47  |- skos__prefLabel mesh__D010989 Play Therapy
% 209.28/209.47  |- skos__historyNote mesh__D010989 Psychotherapy, Group %28%1966-1968%29%
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D010989 2006
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D010989 2003
% 209.28/209.47  |- mesh__dateEstablished mesh__D010989 1969-01-01
% 209.28/209.47  |- mesh__recordAuthorizer mesh__D010989 sjn
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D010989 2005
% 209.28/209.47  |- skos__broader mesh__D010989smesh__D011613
% 209.28/209.47  |- skos__historyNote mesh__D010989 Projective Techniques %28%1966-1967%29%
% 209.28/209.47  |- skos__altLabel mesh__D010989 Therapy, Play
% 209.28/209.47  |- skos__hiddenLabel mesh__D010989 Therapies, Play
% 209.28/209.47  |- mesh__publicMeSHNote mesh__D010989
% 209.28/209.47       69; was see under ACTING OUT 1968, was see under PROJECTIVE TECHNIQUES 1963-67%A%  
% 209.28/209.47  |- mesh__dateRevised mesh__D010989 2001-07-25
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D010989 2002
% 209.28/209.47  |- skos__historyNote mesh__D010989 Play %28%1966-1968%29%
% 209.28/209.47  |- skos__annotation mesh__D010989 a psychother technique; DF: PLAY THER   
% 209.28/209.47  |- skos__broader mesh__D010989smesh__D026421
% 209.28/209.47  |- mesh__onlineNote mesh__D010989
% 209.28/209.47       search ACTING OUT 1968 %26% PROJECTIVE TECHNIQUES 1966-67   
% 209.28/209.47  |- rdf__type mesh__D010989sskos__Concept
% 209.28/209.47  |- skos__scopeNote mesh__D010989
% 209.28/209.47       A treatment technique utilizing play as a medium for expression and communication between patient and therapist.%A%    
% 209.28/209.47  |- mesh__historyNote mesh__D010989
% 209.28/209.47       69; was see under ACTING OUT 1968, was see under PROJECTIVE TECHNIQUES 1963-67%A%  
% 209.28/209.47  |- skos__historyNote mesh__D010989 Acting Out %28%1968%29%
% 209.28/209.47  |- mesh__recordOriginator mesh__D010989 NLM
% 209.28/209.47  |- mesh__recordMaintainer mesh__D010989 ssb
% 209.28/209.47  |- skos__hiddenLabel mesh__D010989 Play Therapies
% 209.28/209.47  |- mesh__dateCreated mesh__D010989 1999-01-01
% 209.28/209.47  |- mesh__publicMeSHNote mesh__D043365 2004   
% 209.28/209.47  |- mesh__recordAuthorizer mesh__D043365 sjn
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D043365 2006
% 209.28/209.47  |- mesh__recordOriginator mesh__D043365 ags
% 209.28/209.47  |- skos__scopeNote mesh__D043365
% 209.28/209.47       A family of gram-negative bacteria in the order Burkholderiales, class BETAPROTEOBACTERIA. It is comprised of a single genus RALSTONIA.%A%    
% 209.28/209.47  |- skos__prefLabel mesh__D043365 Ralstoniaceae
% 209.28/209.47  |- skos__broader mesh__D043365smesh__D016946
% 209.28/209.47  |- rdf__type mesh__D043365sskos__Concept
% 209.28/209.47  |- mesh__historyNote mesh__D043365 2004   
% 209.28/209.47  |- mesh__recordMaintainer mesh__D043365 SYSTEM
% 209.28/209.47  |- mesh__dateRevised mesh__D043365 2005-06-30
% 209.28/209.47  |- mesh__dateEstablished mesh__D043365 2004-01-01
% 209.28/209.47  |- skos__broader mesh__D043365smesh__D020562
% 209.28/209.47  |- mesh__dateCreated mesh__D043365 2003-07-09
% 209.28/209.47  |- skos__broader mesh__D003813Q000295smesh__D003813
% 209.28/209.47  |- mesh__preferredCombination mesh__D003813Q000295smesh__D003762
% 209.28/209.47  |- rdf__type mesh__D003813Q000295smesh__CompoundConcept
% 209.28/209.47  |- skos__hiddenLabel mesh__D015674 Mammary Neoplasm
% 209.28/209.47  |- skos__hiddenLabel mesh__D015674 Carcinoma, Animal Mammary
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D015674 2004
% 209.28/209.47  |- mesh__recordOriginator mesh__D015674 PXP
% 209.28/209.47  |- skos__hiddenLabel mesh__D015674 Neoplasm, Animal Mammary
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D015674 2006
% 209.28/209.47  |- skos__broader mesh__D015674smesh__D009371
% 209.28/209.47  |- mesh__recordAuthorizer mesh__D015674 sjn
% 209.28/209.47  |- mesh__dateCreated mesh__D015674 1989-05-15
% 209.28/209.47  |- skos__hiddenLabel mesh__D015674 Carcinomas, Animal Mammary
% 209.28/209.47  |- mesh__historyNote mesh__D015674 2004 %28%1990%29%   
% 209.28/209.47  |- skos__hiddenLabel mesh__D015674 Mammary Carcinomas, Animal
% 209.28/209.47  |- skos__annotation mesh__D015674
% 209.28/209.47       animal only but MAMMARY NEOPLASMS, EXPERIMENTAL is also available; coord IM with histol type of neopl %28%IM%29% + precoord animal/dis term %28%IM%29% + specific animal %28%NIM%29%; do not coord with NEOPLASMS, EXPERIMENTAL; check tag ANIMALS%A%  
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D015674 2005
% 209.28/209.47  |- mesh__dateEstablished mesh__D015674 1990-01-01
% 209.28/209.47  |- mesh__recordMaintainer mesh__D015674 lkt
% 209.28/209.47  |- skos__historyNote mesh__D015674 Mammae %28%1968-1989%29%
% 209.28/209.47  |- mesh__publicMeSHNote mesh__D015674
% 209.28/209.47       2004; see MAMMARY NEOPLASMS 1990-2003   
% 209.28/209.47  |- mesh__dateRevised mesh__D015674 2003-07-30
% 209.28/209.47  |- skos__historyNote mesh__D015674 Neoplasms/veterinary %28%1967-1989%29%
% 209.28/209.47  |- skos__hiddenLabel mesh__D015674 Neoplasm, Mammary
% 209.28/209.47  |- skos__prefLabel mesh__D015674 Mammary Neoplasms, Animal
% 209.28/209.47  |- skos__altLabel mesh__D015674 Animal Mammary Carcinoma
% 209.28/209.47  |- skos__altLabel mesh__D015674 Neoplasms, Mammary
% 209.28/209.47  |- skos__scopeNote mesh__D015674
% 209.28/209.47       Tumors or cancer of the MAMMARY GLAND in animals %28%MAMMARY GLANDS, ANIMAL%29%.%A%    
% 209.28/209.47  |- skos__hiddenLabel mesh__D015674 Animal Mammary Carcinomas
% 209.28/209.47  |- skos__altLabel mesh__D015674 Mammary Neoplasms
% 209.28/209.47  |- rdf__type mesh__D015674sskos__Concept
% 209.28/209.47  |- skos__broader mesh__D015674smesh__D000820
% 209.28/209.47  |- skos__hiddenLabel mesh__D015674 Neoplasms, Animal Mammary
% 209.28/209.47  |- skos__hiddenLabel mesh__D015674 Animal Mammary Neoplasm
% 209.28/209.47  |- skos__hiddenLabel mesh__D015674 Animal Mammary Neoplasms
% 209.28/209.47  |- skos__hiddenLabel mesh__D015674 Mammary Neoplasm, Animal
% 209.28/209.47  |- mesh__recordOriginator mesh__D009637 RLS
% 209.28/209.47  |- skos__altLabel mesh__D009637 Dihydronorguaiaretic Acid
% 209.28/209.47  |- mesh__recordAuthorizer mesh__D009637 sjn
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D009637 2006
% 209.28/209.47  |- mesh__historyNote mesh__D009637
% 209.28/209.47       91%28%87%29%; was see under CATECHOLS 1987-90   
% 209.28/209.47  |- mesh__publicMeSHNote mesh__D009637
% 209.28/209.47       91; was see under CATECHOLS 1987-90   
% 209.28/209.47  |- mesh__dateRevised mesh__D009637 2005-06-30
% 209.28/209.47  |- skos__annotation mesh__D009637 DF: NDGA   
% 209.28/209.47  |- skos__altLabel mesh__D009637
% 209.28/209.47       4,4%27%-%28%2,3 Dimethyl-1,4-butanediyl%29%bis%28%1,2-benzenediol%29%
% 209.28/209.47  |- skos__altLabel mesh__D009637 meso-Nordihydroguaiaretic Acid
% 209.28/209.47  |- rdf__type mesh__D009637sskos__Concept
% 209.28/209.47  |- skos__broader mesh__D009637smesh__D017705
% 209.28/209.47  |- skos__altLabel mesh__D009637
% 209.28/209.47       Nordihydroguaiaretic Acid, %28%R*,S*%29%-Isomer
% 209.28/209.47  |- skos__prefLabel mesh__D009637 Nordihydroguaiaretic Acid
% 209.28/209.47  |- skos__scopeNote mesh__D009637
% 209.28/209.47       A potent lipoxygenase inhibitor that interferes with arachidonic acid metabolism. The compound also inhibits formyltetrahydrofolate synthetase, carboxylesterase, and cyclooxygenase to a lesser extent. It also serves as an antioxidant in fats and oils.%A%    
% 209.28/209.47  |- mesh__dateCreated mesh__D009637 1986-04-09
% 209.28/209.47  |- mesh__recordMaintainer mesh__D009637 ssb
% 209.28/209.47  |- skos__historyNote mesh__D009637 Catechols %28%1966-1986%29%
% 209.28/209.47  |- mesh__dateEstablished mesh__D009637 1991-01-01
% 209.28/209.47  |- skos__broader mesh__D009637smesh__D002396
% 209.28/209.47  |- mesh__dateRevised mesh__D001654 2005-06-30
% 209.28/209.47  |- skos__broader mesh__D001654smesh__D045725
% 209.28/209.47  |- mesh__dateCreated mesh__D001654 1999-01-01
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D001654 2006
% 209.28/209.47  |- mesh__recordOriginator mesh__D001654 NLM
% 209.28/209.47  |- mesh__recordAuthorizer mesh__D001654 sjn
% 209.28/209.47  |- rdf__type mesh__D001654sskos__Concept
% 209.28/209.47  |- skos__altLabel mesh__D001654 Bile Pigment
% 209.28/209.47  |- skos__broader mesh__D001654smesh__D010860
% 209.28/209.47  |- skos__scopeNote mesh__D001654
% 209.28/209.47       Linear TETRAPYRROLES that give a characteristic color to BILE including: BILIRUBIN; BILIVERDIN; and bilicyanin.%A%    
% 209.28/209.47  |- mesh__recordMaintainer mesh__D001654 ssb
% 209.28/209.47  |- skos__prefLabel mesh__D001654 Bile Pigments
% 209.28/209.47  |- skos__hiddenLabel mesh__D001654 Pigments, Bile
% 209.28/209.47  |- skos__hiddenLabel mesh__D001654 Pigment, Bile
% 209.28/209.47  |- mesh__dateRevised mesh__D020010 2004-07-07
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D020010 2005
% 209.28/209.47  |- mesh__recordAuthorizer mesh__D020010 sjn
% 209.28/209.47  |- skos__broader mesh__D020010smesh__D019529
% 209.28/209.47  |- skos__scopeNote mesh__D020010
% 209.28/209.47       The sexual attraction or relationship between members of the opposite SEX.%A%    
% 209.28/209.47  |- mesh__historyNote mesh__D020010
% 209.28/209.47       98; use SEXUALITY 1997; use SEX BEHAVIOR 1990-96   
% 209.28/209.47  |- mesh__recordOriginator mesh__D020010 JLS
% 209.28/209.47  |- mesh__dateEstablished mesh__D020010 1998-01-01
% 209.28/209.47  |- skos__prefLabel mesh__D020010 Heterosexuality
% 209.28/209.47  |- mesh__recordMaintainer mesh__D020010 lkt
% 209.28/209.47  |- mesh__dateCreated mesh__D020010 1997-06-20
% 209.28/209.47  |- mesh__publicMeSHNote mesh__D020010
% 209.28/209.47       98; see SEXUALITY 1997; see SEX BEHAVIOR 1990-96   
% 209.28/209.47  |- skos__hiddenLabel mesh__D020010 Heterosexual
% 209.28/209.47  |- rdf__type mesh__D020010sskos__Concept
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D020010 2006
% 209.28/209.47  |- skos__scopeNote mesh__D019267
% 209.28/209.47       Membrane glycoproteins from influenza viruses which are involved in hemagglutination, virus attachment, and envelope fusion. Fourteen distinct subtypes of HA glycoproteins and nine of NA glycoproteins have been identified from INFLUENZA A VIRUS; no subtypes have been identified for Influenza B or Influenza C viruses.%A%    
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D019267 2006
% 209.28/209.47  |- rdf__type mesh__D019267sskos__Concept
% 209.28/209.47  |- mesh__dateRevised mesh__D019267 2005-06-30
% 209.28/209.47  |- mesh__onlineNote mesh__D019267
% 209.28/209.47       use HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS %28%NM%29% to search HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS 1980-96%A%  
% 209.28/209.47  |- skos__historyNote mesh__D019267 Hemagglutinins, Viral %28%1983-1996%29%
% 209.28/209.47  |- skos__historyNote mesh__D019267 Glycoproteins %28%1980-1982%29%
% 209.28/209.47  |- skos__broader mesh__D019267smesh__D006389
% 209.28/209.47  |- skos__annotation mesh__D019267 DF: HGIV   
% 209.28/209.47  |- mesh__dateEstablished mesh__D019267 1997-01-01
% 209.28/209.47  |- mesh__publicMeSHNote mesh__D019267
% 209.28/209.47       97; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS was indexed under HEMAGGLUTININS, VIRAL 1983-96 %26% GLYCOPROTEINS 1980-82%A%  
% 209.28/209.47  |- mesh__recordMaintainer mesh__D019267 ssb
% 209.28/209.47  |- mesh__recordAuthorizer mesh__D019267 sjn
% 209.28/209.47  |- mesh__historyNote mesh__D019267
% 209.28/209.47       97; was HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS %28%NM%29% 1980-96%A%  
% 209.28/209.47  |- mesh__dateCreated mesh__D019267 1996-06-10
% 209.28/209.47  |- mesh__recordOriginator mesh__D019267 AGS
% 209.28/209.47  |- skos__prefLabel mesh__D019267
% 209.28/209.47       Hemagglutinin Glycoproteins, Influenza Virus
% 209.28/209.47  |- skos__hiddenLabel mesh__D011284 5 Pregnen 3 beta ol 20 one
% 209.28/209.47  |- skos__altLabel mesh__D011284 5-Pregnen-3-beta-ol-20-one
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D011284 2005
% 209.28/209.47  |- mesh__dateRevised mesh__D011284 2003-07-09
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D011284 2004
% 209.28/209.47  |- skos__annotation mesh__D011284 do not confuse with PREGNANOLONE   
% 209.28/209.47  |- mesh__recordMaintainer mesh__D011284 lkt
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D011284 2006
% 209.28/209.47  |- skos__broader mesh__D011284smesh__D006889
% 209.28/209.47  |- skos__broader mesh__D011284smesh__D045167
% 209.28/209.47  |- skos__broader mesh__D011284smesh__D011283
% 209.28/209.47  |- mesh__recordOriginator mesh__D011284 NLM
% 209.28/209.47  |- rdf__type mesh__D011284sskos__Concept
% 209.28/209.47  |- mesh__recordAuthorizer mesh__D011284 sjn
% 209.28/209.47  |- skos__scopeNote mesh__D011284
% 209.28/209.47       A 21-carbon steroid, derived from CHOLESTEROL and found in steroid hormone-producing tissues. Pregnenolone is the precursor to GONADAL STEROID HORMONES and the adrenal CORTICOSTEROIDS.%A%    
% 209.28/209.47  |- skos__prefLabel mesh__D011284 Pregnenolone
% 209.28/209.47  |- mesh__dateCreated mesh__D011284 1999-01-01
% 209.28/209.47  |- skos__hiddenLabel mesh__D038421 Hemispherectomy, Total
% 209.28/209.47  |- mesh__historyNote mesh__D038421 2003   
% 209.28/209.47  |- mesh__dateEstablished mesh__D038421 2003-01-01
% 209.28/209.47  |- rdf__type mesh__D038421sskos__Concept
% 209.28/209.47  |- skos__hiddenLabel mesh__D038421 Hemispherectomy, Functional
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D038421 2004
% 209.28/209.47  |- skos__scopeNote mesh__D038421
% 209.28/209.47       A neurosurgical procedure that removes or disconnects the epileptogenic CEREBRAL CORTEX of a hemisphere. Hemispherectomy is usually performed for patients with intractable unilateral EPILEPSY due to malformations of cortical development or brain lesions. Depending on the epileptogenic area in the hemisphere, cortical removal can be total or partial.%A%    
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D038421 2006
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D038421 2003
% 209.28/209.47  |- mesh__activeMeSHYear mesh__D038421 2005
% 209.28/209.47  |- skos__altLabel mesh__D038421 Functional Hemispherectomy
% 209.28/209.47  |- mesh__publicMeSHNote mesh__D038421 2003   
% 209.28/209.47  |- skos__historyNote mesh__D038421 Hemiplegia %28%1965-2002%29%
% 209.28/209.47  |- skos__prefLabel mesh__D038421 Hemispherectomy
% 209.28/209.47  |- skos__hiddenLabel mesh__D038421 Hemispherectomy, Partial
% 209.28/209.47  |- mesh__dateCreated mesh__D038421 2002-07-03
% 209.28/209.47  |- skos__broader mesh__D038421smesh__D002541
% 209.28/209.47  |- skos__historyNote mesh__D038421 Epilepsy %28%1965-2002%29%
% 209.28/209.48  |- skos__scopeNote mesh__D005247
% 209.28/209.48       Behavioral responses or sequences associated with eating including modes of feeding, rhythmic patterns of eating, and time intervals.%A%    
% 209.28/209.48  |- skos__broader mesh__D005247smesh__D001522
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D005247 2006
% 209.28/209.48  |- skos__hiddenLabel mesh__D005247 Behavior, Feeding
% 209.28/209.48  |- skos__historyNote mesh__D005247 Nutrition %28%1966-1968%29%
% 209.28/209.48  |- skos__broader mesh__D005247smesh__D001519
% 209.28/209.48  |- skos__historyNote mesh__D005247 Behavior %28%1966-1968%29%
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D005247 2004
% 209.28/209.48  |- skos__hiddenLabel mesh__D005247 Feeding Pattern
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D005247 2005
% 209.28/209.48  |- mesh__recordAuthorizer mesh__D005247 sjn
% 209.28/209.48  |- mesh__historyNote mesh__D005247
% 209.28/209.48       69; FEEDING PATTERNS was see under FEEDING BEHAVIOR 1969-78%A%  
% 209.28/209.48  |- skos__hiddenLabel mesh__D005247 Behavior, Eating
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D005247 2003
% 209.28/209.48  |- mesh__recordMaintainer mesh__D005247 JLS
% 209.28/209.48  |- mesh__recordOriginator mesh__D005247 NLM
% 209.28/209.48  |- mesh__onlineNote mesh__D005247
% 209.28/209.48       use FEEDING BEHAVIOR to search FEEDING PATTERNS 1969-78   
% 209.28/209.48  |- skos__hiddenLabel mesh__D005247 Behaviors, Eating
% 209.28/209.48  |- skos__hiddenLabel mesh__D005247 Patterns, Feeding
% 209.28/209.48  |- mesh__dateRevised mesh__D005247 2002-07-02
% 209.28/209.48  |- skos__hiddenLabel mesh__D005247 Feeding Behaviors
% 209.28/209.48  |- skos__prefLabel mesh__D005247 Feeding Behavior
% 209.28/209.48  |- skos__altLabel mesh__D005247 Eating Behavior
% 209.28/209.48  |- rdf__type mesh__D005247sskos__Concept
% 209.28/209.48  |- skos__hiddenLabel mesh__D005247 Pattern, Feeding
% 209.28/209.48  |- mesh__dateEstablished mesh__D005247 1969-01-01
% 209.28/209.48  |- mesh__dateCreated mesh__D005247 1999-01-01
% 209.28/209.48  |- skos__hiddenLabel mesh__D005247 Eating Behaviors
% 209.28/209.48  |- mesh__publicMeSHNote mesh__D005247 69   
% 209.28/209.48  |- skos__annotation mesh__D005247
% 209.28/209.48       human %26% animal; = manner of eating or feeding %28%TN 63%29%: differentiate from EATING, the act of eating or feeding; permitted for feeding behavior of insects, as mosquitoes on skin, ticks sucking blood, maggots on flesh, etc., but NIM with feeding organism IM%A%  
% 209.28/209.48  |- skos__hiddenLabel mesh__D005247 Behaviors, Feeding
% 209.28/209.48  |- mesh__publicMeSHNote mesh__D024401
% 209.28/209.48       2002; see CARBONIC DEHYDATASE 1992-2001 %26% CARBONIC ANHYDRASE 1983-1991; for CA I HIROSHIMA-1, CARBONIC ANHYDRASE B see CARBONIC DEHYDRATASE 1992-2001 %26% CARBONIC ANHYDRASE 1983-2001; for CARBONIC ANHYDRASE ISOENZYME B see CARBONIC DEHYDRATASE 1992-2001 %26% CARBONIC ANHYDRASE 1984-2001%A%  
% 209.28/209.48  |- skos__prefLabel mesh__D024401 Carbonic Anhydrase I
% 209.28/209.48  |- skos__altLabel mesh__D024401 Carbonic Anhydrase Isoenzyme B
% 209.28/209.48  |- mesh__dateCreated mesh__D024401 2001-07-25
% 209.28/209.48  |- mesh__recordOriginator mesh__D024401 jmp
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D024401 2004
% 209.28/209.48  |- skos__hiddenLabel mesh__D024401 Carbonic Anhydrase I Hiroshima 1
% 209.28/209.48  |- skos__altLabel mesh__D024401 Carbonic Anhydrase I Hiroshima-1
% 209.28/209.48  |- skos__altLabel mesh__D024401 Carbonic Anhydrase B
% 209.28/209.48  |- mesh__recordMaintainer mesh__D024401 ssb
% 209.28/209.48  |- skos__broader mesh__D024401smesh__D002256
% 209.28/209.48  |- skos__annotation mesh__D024401
% 209.28/209.48       /antag: coord with CARBONIC ANHYDRASE INHIBITORS   
% 209.28/209.48  |- mesh__dateEstablished mesh__D024401 2002-01-01
% 209.28/209.48  |- mesh__recordAuthorizer mesh__D024401 sjn
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D024401 2006
% 209.28/209.48  |- skos__hiddenLabel mesh__D024401 CA I Hiroshima 1
% 209.28/209.48  |- skos__hiddenLabel mesh__D024401 Anhydrase B, Carbonic
% 209.28/209.48  |- mesh__dateRevised mesh__D024401 2003-07-09
% 209.28/209.48  |- skos__historyNote mesh__D024401 Carbonic Anhydrases %28%1965-2001%29%
% 209.28/209.48  |- rdf__type mesh__D024401sskos__Concept
% 209.28/209.48  |- mesh__historyNote mesh__D024401
% 209.28/209.48       2002; use CARBONIC ANHYDRASES 1983-2001; for CA I HIROSHIMA-1 %26% CARBONIC ANHYDRASE B use CARBONIC ANHYDRASES 1983-2001; for CARBONIC ANHYDRASE ISOENZYME B use CARBONIC ANHYDRASES 1984-2001%A%  
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D024401 2005
% 209.28/209.48  |- skos__scopeNote mesh__D024401
% 209.28/209.48       A cytosolic carbonic anhydrase isoenzyme primarily expressed in ERYTHROCYTES, vascular endothelial cells, and the gastrointestinal mucosa. EC 4.2.1.-%A%    
% 209.28/209.48  |- skos__broader mesh__D043366smesh__D044602
% 209.28/209.48  |- skos__scopeNote mesh__D043366
% 209.28/209.48       An exocellulase with specificity for the hydrolysis of 1,4-beta-D-glucosidic linkages in CELLULOSE and cellotetraose. It catalyzes the hydrolysis of terminal non-reducing ends of beta-D-glucosides with release of CELLOBIOSE.%A%    
% 209.28/209.48  |- mesh__historyNote mesh__D043366
% 209.28/209.48       2004; use CELLULOSE 1,4-BETA-CELLOBIOSIDASE %28%NM%29% 1974-2003; for EXOGLUCANASE II use GLUCAN 1,3-BETA-GLUCOSIDASE %28%NM%29% 1992-2003%A%  
% 209.28/209.48  |- skos__altLabel mesh__D043366 CEL1 Protein
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D043366 2005
% 209.28/209.48  |- skos__prefLabel mesh__D043366 Cellulose 1,4-beta-Cellobiosidase
% 209.28/209.48  |- skos__hiddenLabel mesh__D043366 Exo Cellobiohydrolase
% 209.28/209.48  |- skos__altLabel mesh__D043366 Exoglucanase II
% 209.28/209.48  |- skos__hiddenLabel mesh__D043366 1,4-beta-Cellobiosidase, Cellulose
% 209.28/209.48  |- mesh__recordMaintainer mesh__D043366 jmp
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D043366 2006
% 209.28/209.48  |- rdf__type mesh__D043366sskos__Concept
% 209.28/209.48  |- skos__altLabel mesh__D043366 1,4-beta-D-Glucan Cellobiohydrolase
% 209.28/209.48  |- skos__historyNote mesh__D043366 Cellulase %28%1974-2003%29%
% 209.28/209.48  |- skos__hiddenLabel mesh__D043366 Beta Glucancellobiohydrolase
% 209.28/209.48  |- skos__hiddenLabel mesh__D043366 1,4 beta D Glucan Cellobiohydrolase
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D043366 2004
% 209.28/209.48  |- skos__altLabel mesh__D043366 Cellobiohydrolase
% 209.28/209.48  |- mesh__recordOriginator mesh__D043366 AKE
% 209.28/209.48  |- skos__hiddenLabel mesh__D043366 Cellulose 1,4 beta Cellobiosidase
% 209.28/209.48  |- skos__hiddenLabel mesh__D043366 Cellobiohydrolase, 1,4-beta-D-Glucan
% 209.28/209.48  |- skos__altLabel mesh__D043366 Exo-Cellobiohydrolase
% 209.28/209.48  |- skos__altLabel mesh__D043366 CbhI Protein
% 209.28/209.48  |- mesh__publicMeSHNote mesh__D043366
% 209.28/209.48       2004; EXO-CELLOBIOHYDROLASE %28%now CELLULOSE 1,4-BETA-CELLOBIOSIDASE%29% was indexed under CELLULASE 1974-2003; EXOGLUCANASE II was indexed under BETA-GLUCOSIDASE 1992-2003%A%  
% 209.28/209.48  |- skos__altLabel mesh__D043366 Beta-Glucancellobiohydrolase
% 209.28/209.48  |- mesh__recordAuthorizer mesh__D043366 sjn
% 209.28/209.48  |- mesh__dateEstablished mesh__D043366 2004-01-01
% 209.28/209.48  |- mesh__dateCreated mesh__D043366 2003-07-09
% 209.28/209.48  |- skos__hiddenLabel mesh__D015675 Vitamin K Dependent Bone Protein
% 209.28/209.48  |- skos__hiddenLabel mesh__D015675 Bone 4-Carboxyglutamic Protein
% 209.28/209.48  |- skos__altLabel mesh__D015675 Vitamin K-Dependent Bone Protein
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D015675 2006
% 209.28/209.48  |- skos__prefLabel mesh__D015675 Osteocalcin
% 209.28/209.48  |- skos__historyNote mesh__D015675
% 209.28/209.48       Calcium-Binding Proteins %28%1980-1989%29%
% 209.28/209.48  |- mesh__dateEstablished mesh__D015675 1990-01-01
% 209.28/209.48  |- skos__hiddenLabel mesh__D015675 Bone gamma Carboxyglutamic Acid Protein
% 209.28/209.48  |- mesh__historyNote mesh__D015675
% 209.28/209.48       90; GLA-PROTEIN was see OSTEOCACLIN 1990-96   
% 209.28/209.48  |- skos__historyNote mesh__D015675 Proteins %28%1980-1981%29%
% 209.28/209.48  |- mesh__recordOriginator mesh__D015675 AGS
% 209.28/209.48  |- skos__hiddenLabel mesh__D015675 Protein, Bone Gla
% 209.28/209.48  |- mesh__publicMeSHNote mesh__D015675
% 209.28/209.48       90; GLA-PROTEIN was see OSTEOCALCIN 1990-96   
% 209.28/209.48  |- skos__historyNote mesh__D015675 1-Carboxyglutamic Acid %28%1978-1981%29%
% 209.28/209.48  |- skos__historyNote mesh__D015675 Binding Proteins %28%1978-1980%29%
% 209.28/209.48  |- skos__hiddenLabel mesh__D015675 4 Carboxyglutamic Protein, Bone
% 209.28/209.48  |- mesh__recordAuthorizer mesh__D015675 sjn
% 209.28/209.48  |- mesh__dateRevised mesh__D015675 2004-07-07
% 209.28/209.48  |- skos__altLabel mesh__D015675 Gla Protein, Bone
% 209.28/209.48  |- skos__altLabel mesh__D015675 4-Carboxyglutamic Protein, Bone
% 209.28/209.48  |- rdf__type mesh__D015675sskos__Concept
% 209.28/209.48  |- skos__scopeNote mesh__D015675
% 209.28/209.48       Vitamin K-dependent calcium-binding protein synthesized by OSTEOBLASTS and found primarily in BONES. Serum osteocalcin measurements provide a noninvasive specific marker of bone metabolism. The protein contains three residues of the amino acid gamma-carboxyglutamic acid %28%Gla%29%, which, in the presence of CALCIUM, promotes binding to HYDROXYAPATITE and subsequent accumulation in BONE MATRIX.%A%    
% 209.28/209.48  |- skos__historyNote mesh__D015675 Calcium %28%1978-1980%29%
% 209.28/209.48  |- skos__altLabel mesh__D015675 Bone Gla Protein
% 209.28/209.48  |- skos__altLabel mesh__D015675
% 209.28/209.48       Calcium-Binding Protein, Vitamin K-Dependent
% 209.28/209.48  |- skos__altLabel mesh__D015675 Bone gamma-Carboxyglutamic Acid Protein
% 209.28/209.48  |- mesh__onlineNote mesh__D015675
% 209.28/209.48       use OSTEOCALCIN to search GLA-PROTEIN 1990-96   
% 209.28/209.48  |- skos__hiddenLabel mesh__D015675 Protein, Bone 4-Carboxyglutamic
% 209.28/209.48  |- skos__broader mesh__D015675smesh__D002135
% 209.28/209.48  |- skos__hiddenLabel mesh__D015675
% 209.28/209.48       Calcium Binding Protein, Vitamin K Dependent
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D015675 2005
% 209.28/209.48  |- mesh__dateCreated mesh__D015675 1989-09-06
% 209.28/209.48  |- mesh__recordMaintainer mesh__D015675 ssb
% 209.28/209.48  |- mesh__historyNote mesh__D048051 2005%28%1994%29%   
% 209.28/209.48  |- skos__altLabel mesh__D048051 p38 Protein Kinase
% 209.28/209.48  |- skos__hiddenLabel mesh__D048051 MAPK, p38
% 209.28/209.48  |- skos__altLabel mesh__D048051 p38 MAP Kinase
% 209.28/209.48  |- skos__altLabel mesh__D048051 p38 MAPK
% 209.28/209.48  |- skos__broader mesh__D048051smesh__D020928
% 209.28/209.48  |- skos__historyNote mesh__D048051
% 209.28/209.48       Mitogen-Activated Protein Kinases %28%2000-2004%29%
% 209.28/209.48  |- mesh__dateRevised mesh__D048051 2005-07-12
% 209.28/209.48  |- skos__altLabel mesh__D048051 Mitogen-Activated Protein Kinase p38
% 209.28/209.48  |- mesh__dateCreated mesh__D048051 2004-07-08
% 209.28/209.48  |- skos__hiddenLabel mesh__D048051 Protein Kinase, p38
% 209.28/209.48  |- mesh__recordOriginator mesh__D048051 jmp
% 209.28/209.48  |- skos__prefLabel mesh__D048051 p38 Mitogen-Activated Protein Kinases
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D048051 2006A
% 209.28/209.48  |- skos__hiddenLabel mesh__D048051 MAP Kinase, p38
% 209.28/209.48  |- skos__historyNote mesh__D048051
% 209.28/209.48       Ca%28%2+%29%-Calmodulin Dependent Protein Kinase %28%1994-2000%29%
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D048051 2005
% 209.28/209.48  |- mesh__recordAuthorizer mesh__D048051 ags
% 209.28/209.48  |- skos__hiddenLabel mesh__D048051 p38 Mitogen Activated Protein Kinases
% 209.28/209.48  |- skos__hiddenLabel mesh__D048051 Mitogen Activated Protein Kinase p38
% 209.28/209.48  |- mesh__publicMeSHNote mesh__D048051
% 209.28/209.48       2005; P38 MITOGEN-ACTIVATED PROTEIN KINASES was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2001-2004 %26% under CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1994-2000%A%  
% 209.28/209.48  |- skos__scopeNote mesh__D048051
% 209.28/209.48       A mitogen-activated protein kinase subfamily that regulates a variety of cellular processes including CELL GROWTH PROCESSES; CELL DIFFERENTIATION; APOPTOSIS; and cellular responses to INFLAMMATION. The P38 MAP kinases are regulated by CYTOKINE RECEPTORS and can be activated in response to bacterial pathogens.%A%    
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D048051 2006
% 209.28/209.48  |- mesh__recordMaintainer mesh__D048051 ags
% 209.28/209.48  |- skos__altLabel mesh__D048051 p38 SAPK
% 209.28/209.48  |- mesh__dateEstablished mesh__D048051 2005-01-01
% 209.28/209.48  |- rdf__type mesh__D048051sskos__Concept
% 209.28/209.48  |- skos__altLabel mesh__D009638 Abbott Brand of Levophed Bitartrate
% 209.28/209.48  |- skos__altLabel mesh__D009638 Norepinephrine l-Tartrate %28%1:1%29%
% 209.28/209.48  |- mesh__historyNote mesh__D009638
% 209.28/209.48       ARTERENOL was see NOREPINEPHRINE 1974-93; LEVONOREPINEPHRINE was heading 1963-65%A%  
% 209.28/209.48  |- skos__hiddenLabel mesh__D009638 tartrate renaudin, Noradr%C3%%A9%naline
% 209.28/209.48  |- mesh__publicMeSHNote mesh__D009638
% 209.28/209.48       ARTERENOL was see NOREPINEPHRINE 1974-93; LEVONOREPINEPHRINE was heading 1963-65%A%  
% 209.28/209.48  |- rdf__type mesh__D009638sskos__Concept
% 209.28/209.48  |- skos__hiddenLabel mesh__D009638 Hydrochloride, Norepinephrine
% 209.28/209.48  |- skos__prefLabel mesh__D009638 Norepinephrine
% 209.28/209.48  |- skos__hiddenLabel mesh__D009638 Bitartrate, Noradrenaline
% 209.28/209.48  |- skos__hiddenLabel mesh__D009638 Bitartrate, Norepinephrine
% 209.28/209.48  |- mesh__recordMaintainer mesh__D009638 ssb
% 209.28/209.48  |- skos__altLabel mesh__D009638 Levonorepinephrine
% 209.28/209.48  |- skos__altLabel mesh__D009638 Noradrenaline Bitartrate
% 209.28/209.48  |- skos__broader mesh__D009638smesh__D002395
% 209.28/209.48  |- mesh__recordOriginator mesh__D009638 NLM
% 209.28/209.48  |- skos__altLabel mesh__D009638
% 209.28/209.48       Aventis Brand of Norepinephrine Hydrochloride
% 209.28/209.48  |- skos__related mesh__D009638smesh__D011941
% 209.28/209.48  |- skos__scopeNote mesh__D009638
% 209.28/209.48       Precursor of epinephrine that is secreted by the adrenal medulla and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers and of the diffuse projection system in the brain arising from the locus ceruleus. It is also found in plants and is used pharmacologically as a sympathomimetic.%A%    
% 209.28/209.48  |- skos__broader mesh__D009638smesh__D004983
% 209.28/209.48  |- skos__hiddenLabel mesh__D009638 renaudin, Noradr%C3%%A9%naline tartrate
% 209.28/209.48  |- mesh__recordAuthorizer mesh__D009638 sjn
% 209.28/209.48  |- skos__broader mesh__D009638smesh__D000605
% 209.28/209.48  |- skos__altLabel mesh__D009638 Levarterenol
% 209.28/209.48  |- skos__hiddenLabel mesh__D009638 Bitartrate, Levophed
% 209.28/209.48  |- skos__altLabel mesh__D009638 Renaudin Brand of Norepinephrine Bitartrate
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D009638 2006
% 209.28/209.48  |- mesh__dateRevised mesh__D009638 2005-06-30
% 209.28/209.48  |- mesh__onlineNote mesh__D009638
% 209.28/209.48       use NOREPINEPHRINE to search ARTERENOL 1974-93   
% 209.28/209.48  |- skos__broader mesh__D009638smesh__D004837
% 209.28/209.48  |- skos__altLabel mesh__D009638 Noradrenaline
% 209.28/209.48  |- mesh__dateCreated mesh__D009638 1999-01-01
% 209.28/209.48  |- skos__altLabel mesh__D009638 Levophed Bitartrate
% 209.28/209.48  |- skos__prefLabel mesh__D001655 Bile Reflux
% 209.28/209.48  |- mesh__recordMaintainer mesh__D001655 lkt
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D001655 2004
% 209.28/209.48  |- skos__broader mesh__D001655smesh__D004383
% 209.28/209.48  |- skos__broader mesh__D001655smesh__D001660
% 209.28/209.48  |- skos__scopeNote mesh__D001655
% 209.28/209.48       Retrograde bile flow. Reflux of bile can be from the duodenum to the stomach %28%DUODENOGASTRIC REFLUX%29%; to the esophagus %28%GASTROESOPHAGEAL REFLUX%29%; or to the PANCREAS.%A%    
% 209.28/209.48  |- mesh__recordOriginator mesh__D001655 RC
% 209.28/209.48  |- mesh__publicMeSHNote mesh__D001655
% 209.28/209.48       91; was see under BILIARY TRACT DISEASES 1981-90   
% 209.28/209.48  |- skos__hiddenLabel mesh__D001655 Reflux, Bile
% 209.28/209.48  |- mesh__dateRevised mesh__D001655 2003-07-09
% 209.28/209.48  |- skos__historyNote mesh__D001655 Gastritis %28%1966-1980%29%
% 209.28/209.48  |- mesh__dateEstablished mesh__D001655 1991-01-01
% 209.28/209.48  |- mesh__historyNote mesh__D001655
% 209.28/209.48       91%28%81%29%; was see under BILIARY TRACT DISEASES 1981-90   
% 209.28/209.48  |- mesh__recordAuthorizer mesh__D001655 sjn
% 209.28/209.48  |- mesh__dateCreated mesh__D001655 1980-04-04
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D001655 2006
% 209.28/209.48  |- skos__historyNote mesh__D001655 Bile %28%1966-1980%29%
% 209.28/209.48  |- rdf__type mesh__D001655sskos__Concept
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D001655 2005
% 209.28/209.48  |- skos__annotation mesh__D006340 mammals only   
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D006340 2005
% 209.28/209.48  |- mesh__recordAuthorizer mesh__D006340 sjn
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D006340 2004
% 209.28/209.48  |- skos__historyNote mesh__D006340 Heart Rate %28%1966-1986%29%
% 209.28/209.48  |- mesh__recordOriginator mesh__D006340 VDK
% 209.28/209.48  |- skos__broader mesh__D006340smesh__D006339
% 209.28/209.48  |- skos__hiddenLabel mesh__D006340 Rate, Fetal Heart
% 209.28/209.48  |- rdf__type mesh__D006340sskos__Concept
% 209.28/209.48  |- mesh__publicMeSHNote mesh__D006340 87   
% 209.28/209.48  |- mesh__dateEstablished mesh__D006340 1987-01-01
% 209.28/209.48  |- skos__scopeNote mesh__D006340
% 209.28/209.48       The heart rate of the FETUS. The normal range at term is between 120 and 160 beats per minute.%A%    
% 209.28/209.48  |- skos__hiddenLabel mesh__D006340 Rates, Fetal Heart
% 209.28/209.48  |- skos__altLabel mesh__D006340 Fetal Heart Rate
% 209.28/209.48  |- mesh__dateRevised mesh__D006340 2003-07-09
% 209.28/209.48  |- skos__historyNote mesh__D006340 Fetal Heart %28%1966-1986%29%
% 209.28/209.48  |- mesh__dateCreated mesh__D006340 1986-04-18
% 209.28/209.48  |- skos__hiddenLabel mesh__D006340 Heart Rates, Fetal
% 209.28/209.48  |- skos__prefLabel mesh__D006340 Heart Rate, Fetal
% 209.28/209.48  |- mesh__historyNote mesh__D006340 87   
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D006340 2006
% 209.28/209.48  |- mesh__recordMaintainer mesh__D006340 nns
% 209.28/209.48  |- skos__hiddenLabel mesh__D006340 Fetal Heart Rates
% 209.28/209.48  |- skos__scopeNote mesh__D020011
% 209.28/209.48       Synthetic or natural substances which are given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent.%A%    
% 209.28/209.48  |- mesh__historyNote mesh__D020011 98   
% 209.28/209.48  |- mesh__recordMaintainer mesh__D020011 ssb
% 209.28/209.48  |- mesh__dateRevised mesh__D020011 2003-07-09
% 209.28/209.48  |- mesh__publicMeSHNote mesh__D020011 98   
% 209.28/209.48  |- skos__prefLabel mesh__D020011 Protective Agents
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D020011 2004
% 209.28/209.48  |- skos__hiddenLabel mesh__D020011 Agents, Protective
% 209.28/209.48  |- mesh__recordAuthorizer mesh__D020011 sjn
% 209.28/209.48  |- skos__altLabel mesh__D020011 Protective Drugs
% 209.28/209.48  |- mesh__recordOriginator mesh__D020011 ADP
% 209.28/209.48  |- mesh__dateEstablished mesh__D020011 1998-01-01
% 209.28/209.48  |- rdf__type mesh__D020011sskos__Concept
% 209.28/209.48  |- skos__broader mesh__D020011smesh__D020313
% 209.28/209.48  |- skos__annotation mesh__D020011
% 209.28/209.48       GEN: prefer specific groups of protective agents; D25-26 qualif%A%  
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D020011 2006
% 209.28/209.48  |- skos__hiddenLabel mesh__D020011 Drugs, Protective
% 209.28/209.48  |- skos__broader mesh__D020011smesh__D045505
% 209.28/209.48  |- mesh__dateCreated mesh__D020011 1997-06-20
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D020011 2005
% 209.28/209.48  |- skos__altLabel mesh__D019268 Anti-Neutrophil Cytoplasmic Antibodies
% 209.28/209.48  |- mesh__recordOriginator mesh__D019268 AGS
% 209.28/209.48  |- mesh__dateCreated mesh__D019268 1996-06-10
% 209.28/209.48  |- skos__broader mesh__D019268smesh__D001323
% 209.28/209.48  |- skos__hiddenLabel mesh__D019268 Cytoplasmic Antibodies, Antineutrophil
% 209.28/209.48  |- mesh__recordMaintainer mesh__D019268 ssb
% 209.28/209.48  |- mesh__recordAuthorizer mesh__D019268 sjn
% 209.28/209.48  |- skos__hiddenLabel mesh__D019268 Antibody, Antineutrophil Cytoplasmic
% 209.28/209.48  |- skos__historyNote mesh__D019268 Autoantibodies %28%1991-1996%29%
% 209.28/209.48  |- skos__altLabel mesh__D019268 Antineutrophil Cytoplasmic Antibody
% 209.28/209.48  |- skos__altLabel mesh__D019268 Antineutrophil Cytoplasmic Antibodies
% 209.28/209.48  |- skos__broader mesh__D019268smesh__D015415
% 209.28/209.48  |- skos__hiddenLabel mesh__D019268 Cytoplasmic Antibody, Antineutrophil
% 209.28/209.48  |- skos__hiddenLabel mesh__D019268 Anti Neutrophil Cytoplasmic Antibody
% 209.28/209.48  |- skos__hiddenLabel mesh__D019268 p ANCA
% 209.28/209.48  |- skos__hiddenLabel mesh__D019268 Cytoplasmic Antibodies, Anti-Neutrophil
% 209.28/209.48  |- skos__hiddenLabel mesh__D019268 Antibody, Anti-Neutrophil Cytoplasmic
% 209.28/209.48  |- mesh__dateRevised mesh__D019268 2005-06-30
% 209.28/209.48  |- skos__hiddenLabel mesh__D019268 c ANCA
% 209.28/209.48  |- skos__hiddenLabel mesh__D019268 Anti Neutrophil Cytoplasmic Antibodies
% 209.28/209.48  |- skos__scopeNote mesh__D019268
% 209.28/209.48       Autoantibodies directed against cytoplasmic constituents of POLYMORPHONUCLEAR LEUKOCYTES and/or MONOCYTES. They are used as specific markers for WEGENER%27%S GRANULOMATOSIS and other diseases, though their pathophysiological role is not clear. ANCA are routinely detected by indirect immunofluorescence with three different patterns: c-ANCA %28%cytoplasmic%29%, p-ANCA %28%perinuclear%29%, and atypical ANCA.%A%    
% 209.28/209.48  |- mesh__onlineNote mesh__D019268
% 209.28/209.48       use ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC %28%NM%29% to search C-ANCA 1991-96%A%  
% 209.28/209.48  |- skos__annotation mesh__D019268
% 209.28/209.48       do not coordinate with ANTIBODY FORMATION for /biosyn;   
% 209.28/209.48  |- skos__altLabel mesh__D019268 ANCA
% 209.28/209.48  |- mesh__publicMeSHNote mesh__D019268
% 209.28/209.48       97; C-ANCA was indexed under AUTOANTIBODIES 1991-96   
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D019268 2006
% 209.28/209.48  |- skos__hiddenLabel mesh__D019268 Antibodies, Anti-Neutrophil Cytoplasmic
% 209.28/209.48  |- skos__prefLabel mesh__D019268 Antibodies, Antineutrophil Cytoplasmic
% 209.28/209.48  |- mesh__dateEstablished mesh__D019268 1997-01-01
% 209.28/209.48  |- skos__altLabel mesh__D019268 Anti-Neutrophil Cytoplasmic Antibody
% 209.28/209.48  |- mesh__historyNote mesh__D019268 97; was C-ANCA %28%NM%29% 1991-96   
% 209.28/209.48  |- rdf__type mesh__D019268sskos__Concept
% 209.28/209.48  |- skos__hiddenLabel mesh__D019268 Cytoplasmic Antibody, Anti-Neutrophil
% 209.28/209.48  |- skos__hiddenLabel mesh__D011285 Pregnenolone 16 alpha Carbonitrile
% 209.28/209.48  |- mesh__publicMeSHNote mesh__D011285 74   
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D011285 2002
% 209.28/209.48  |- mesh__recordOriginator mesh__D011285 NLM
% 209.28/209.48  |- skos__broader mesh__D011285smesh__D011284
% 209.28/209.48  |- skos__altLabel mesh__D011285 Pregnenolone 16 alpha-Carbonitrile
% 209.28/209.48  |- skos__hiddenLabel mesh__D011285 Carbonitrile, Pregnenolone
% 209.28/209.48  |- mesh__recordAuthorizer mesh__D011285 sjn
% 209.28/209.48  |- mesh__dateRevised mesh__D011285 2000-06-22
% 209.28/209.48  |- rdf__type mesh__D011285sskos__Concept
% 209.28/209.48  |- skos__annotation mesh__D011285 DF: PCN   
% 209.28/209.48  |- skos__prefLabel mesh__D011285 Pregnenolone Carbonitrile
% 209.28/209.48  |- mesh__dateCreated mesh__D011285 1999-01-01
% 209.28/209.48  |- skos__altLabel mesh__D011285 PCN
% 209.28/209.48  |- skos__hiddenLabel mesh__D011285 16 alpha-Carbonitrile, Pregnenolone
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D011285 2003
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D011285 2001
% 209.28/209.48  |- mesh__historyNote mesh__D011285 74   
% 209.28/209.48  |- mesh__dateEstablished mesh__D011285 1974-01-01
% 209.28/209.48  |- mesh__recordMaintainer mesh__D011285 CCR
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D011285 2005
% 209.28/209.48  |- skos__broader mesh__D011285smesh__D009570
% 209.28/209.48  |- skos__scopeNote mesh__D011285
% 209.28/209.48       A catatoxic steroid and microsomal enzyme inducer having significant effects on the induction of cytochrome P450. It has also demonstrated the potential for protective capability against acetaminophen-induced liver damage.%A%    
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D011285 2004
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D011285 2006
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D005248 2006
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D005248 2003
% 209.28/209.48  |- mesh__dateRevised mesh__D005248 1997-06-20
% 209.28/209.48  |- mesh__publicMeSHNote mesh__D005248 98   
% 209.28/209.48  |- mesh__recordAuthorizer mesh__D005248 SJN
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D005248 2001
% 209.28/209.48  |- mesh__historyNote mesh__D005248 98; use explode 1970-97   
% 209.28/209.48  |- skos__prefLabel mesh__D005248 Feeding Methods
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D005248 2004
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D005248 2002
% 209.28/209.48  |- skos__hiddenLabel mesh__D005248 Methods, Feeding
% 209.28/209.48  |- mesh__dateCreated mesh__D005248 1999-01-01
% 209.28/209.48  |- skos__hiddenLabel mesh__D005248 Method, Feeding
% 209.28/209.48  |- skos__broader mesh__D005248smesh__D013812
% 209.28/209.48  |- rdf__type mesh__D005248sskos__Concept
% 209.28/209.48  |- skos__scopeNote mesh__D005248
% 209.28/209.48       Methods of giving food to humans or animals.     
% 209.28/209.48  |- mesh__dateEstablished mesh__D005248 1998-01-01
% 209.28/209.48  |- mesh__recordMaintainer mesh__D005248 TGC
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D005248 1998
% 209.28/209.48  |- skos__annotation mesh__D005248
% 209.28/209.48       human %26% animal; GEN or unspecified; prefer specifics   
% 209.28/209.48  |- skos__hiddenLabel mesh__D005248 Feeding Method
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D005248 2005
% 209.28/209.48  |- mesh__recordOriginator mesh__D005248 NLM
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D005248 1999
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D005248 2000
% 209.28/209.48  |- mesh__dateRevised mesh__D024402 2003-07-09
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D024402 2005
% 209.28/209.48  |- mesh__dateCreated mesh__D024402 2001-07-25
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D024402 2004
% 209.28/209.48  |- mesh__historyNote mesh__D024402
% 209.28/209.48       2002; use CARBONIC ANHYDRASES 1983-2001; for CARBONIC ANHYDRASE C use CARBONIC ANHYDRASES 1984-2001; for CARBONIC ANHYDRASE ISOENZYME C use CARBONIC ANHDYRASES 1983-2001%A%  
% 209.28/209.48  |- mesh__recordMaintainer mesh__D024402 ssb
% 209.28/209.48  |- skos__historyNote mesh__D024402 Carbonic Anhydrases %28%1967-2001%29%
% 209.28/209.48  |- skos__scopeNote mesh__D024402
% 209.28/209.48       A cytosolic carbonic anhydrase isoenzyme found widely distributed in cells of almost all tissues. Deficiencies of carbonic anhydrase II produce a syndrome characterized by OSTEOPETROSIS, renal tubular acidosis %28%ACIDOSIS, RENAL TUBULAR%29% and cerebral calcification.  EC 4.2.1.-%A%    
% 209.28/209.48  |- skos__annotation mesh__D024402
% 209.28/209.48       /antag: coord with CARBONIC ANHYDRASE INHIBITORS   
% 209.28/209.48  |- mesh__dateEstablished mesh__D024402 2002-01-01
% 209.28/209.48  |- mesh__recordAuthorizer mesh__D024402 sjn
% 209.28/209.48  |- skos__broader mesh__D024402smesh__D002256
% 209.28/209.48  |- skos__altLabel mesh__D024402 Carbonic Anhydrase Isoenzyme C
% 209.28/209.48  |- rdf__type mesh__D024402sskos__Concept
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D024402 2006
% 209.28/209.48  |- skos__prefLabel mesh__D024402 Carbonic Anhydrase II
% 209.28/209.48  |- mesh__publicMeSHNote mesh__D024402
% 209.28/209.48       2002; see CARBONIC DEHYDATASE 1992-2001 %26% CARBONIC ANHYDRASE 1983-1991; for CARBONIC ANHYDRASE C see CARBONIC DEHYDATASE 1992-2001 %26% CARBONIC ANHYDRASE 1984-1991; for CARBONIC ANHYDRASE ISOENZYME C see CARBONIC DEHYDATASE 1992-2001 %26% CARBONIC ANHYDRASE 1983-1991%A%  
% 209.28/209.48  |- skos__altLabel mesh__D024402 Carbonic Anhydrase C
% 209.28/209.48  |- mesh__recordOriginator mesh__D024402 jmp
% 209.28/209.48  |- skos__broader mesh__D010944Q000502smesh__D010944
% 209.28/209.48  |- mesh__preferredCombination mesh__D010944Q000502smesh__D018521
% 209.28/209.48  |- rdf__type mesh__D010944Q000502smesh__CompoundConcept
% 209.28/209.48  |- mesh__dateRevised mesh__D043367 2005-06-30
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D043367 2006
% 209.28/209.48  |- rdf__type mesh__D043367sskos__Concept
% 209.28/209.48  |- mesh__recordAuthorizer mesh__D043367 sjn
% 209.28/209.48  |- mesh__dateEstablished mesh__D043367 2004-01-01
% 209.28/209.48  |- mesh__recordOriginator mesh__D043367 ags
% 209.28/209.48  |- skos__broader mesh__D043367smesh__D043365
% 209.28/209.48  |- skos__historyNote mesh__D043367 Betaproteobacteria %28%2000-2003%29%
% 209.28/209.48  |- skos__scopeNote mesh__D043367
% 209.28/209.48       The sole genus in the family RALSTONIACEAE, comprised of many species. They are associated with a variety of infections including MENINGITIS; PERITONITIS; and URINARY TRACT INFECTIONS.%A%    
% 209.28/209.48  |- skos__prefLabel mesh__D043367 Ralstonia
% 209.28/209.48  |- mesh__historyNote mesh__D043367 2004   
% 209.28/209.48  |- skos__annotation mesh__D043367
% 209.28/209.48       infection: coordinate IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 209.28/209.48  |- mesh__recordMaintainer mesh__D043367 ags
% 209.28/209.48  |- mesh__dateCreated mesh__D043367 2003-07-09
% 209.28/209.48  |- mesh__publicMeSHNote mesh__D043367 2004   
% 209.28/209.48  |- skos__altLabel mesh__D015676 SPARC Glycoprotein
% 209.28/209.48  |- skos__historyNote mesh__D015676
% 209.28/209.48       Calcium-Binding Proteins %28%1986-1989%29%
% 209.28/209.48  |- mesh__recordMaintainer mesh__D015676 jmp
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D015676 2002
% 209.28/209.48  |- skos__altLabel mesh__D015676 BM 40 Protein
% 209.28/209.48  |- mesh__publicMeSHNote mesh__D015676 90   
% 209.28/209.48  |- skos__historyNote mesh__D015676 Carrier Proteins %28%1980-1989%29%
% 209.28/209.48  |- skos__broader mesh__D015676smesh__D006023
% 209.28/209.48  |- mesh__recordOriginator mesh__D015676 AGS
% 209.28/209.48  |- rdf__type mesh__D015676sskos__Concept
% 209.28/209.48  |- mesh__dateCreated mesh__D015676 1989-05-15
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D015676 2003
% 209.28/209.48  |- mesh__historyNote mesh__D015676 90   
% 209.28/209.48  |- skos__broader mesh__D015676smesh__D002135
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D015676 2005
% 209.28/209.48  |- skos__prefLabel mesh__D015676 Osteonectin
% 209.28/209.48  |- mesh__recordAuthorizer mesh__D015676 sjn
% 209.28/209.48  |- mesh__dateRevised mesh__D015676 2000-06-22
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D015676 2004
% 209.28/209.48  |- skos__scopeNote mesh__D015676
% 209.28/209.48       Non-collagenous, calcium-binding glycoprotein of developing bone. It links collagen to mineral in the bone matrix. In the synonym SPARC glycoprotein, the acronym stands for Secreted Protein, Acidic and Rich in Cysteine.%A%    
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D015676 2001
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D015676 2006
% 209.28/209.48  |- skos__altLabel mesh__D015676 Basement Membrane Tumor Protein
% 209.28/209.48  |- mesh__dateEstablished mesh__D015676 1990-01-01
% 209.28/209.48  |- skos__altLabel mesh__D015676 BM-40
% 209.28/209.48  |- skos__altLabel mesh__D048052
% 209.28/209.48       Meiosis-Activated Myelin Basic Protein Kinase p44%28%mpk%29%
% 209.28/209.48  |- skos__hiddenLabel mesh__D048052 Kinase, ERK1
% 209.28/209.48  |- skos__hiddenLabel mesh__D048052 Extracellular Signal Regulated Kinase 1
% 209.28/209.48  |- skos__altLabel mesh__D048052 Extracellular Signal-Regulated Kinase 1
% 209.28/209.48  |- skos__hiddenLabel mesh__D048052 p44mpk, PSTkinase
% 209.28/209.48  |- mesh__dateEstablished mesh__D048052 2005-01-01
% 209.28/209.48  |- skos__altLabel mesh__D048052
% 209.28/209.48       Protein-Serine-Threonine Kinase p44%28%mpk%29%
% 209.28/209.48  |- mesh__dateRevised mesh__D048052 2005-07-20
% 209.28/209.48  |- skos__altLabel mesh__D048052 MAPK3 Mitogen-Activated Protein Kinase
% 209.28/209.48  |- mesh__recordAuthorizer mesh__D048052 ags
% 209.28/209.48  |- mesh__activeMeSHYear mesh__D048052 2005
% 209.28/209.48  |- skos__scopeNote mesh__D048052
% 209.28/209.48       A 44-kDa extracellular signal-regulated MAP kinase that may play a role the initiation and regulation of MEIOSIS; MITOSIS; and postmitotic functions in differentiated cells. It phosphorylates a number of TRANSCRIPTION FACTORS; and MICROTUBULE-ASSOCIATED PROTEINS.%A%    
% 209.28/209.48  |- skos__hiddenLabel mesh__D048052 Microtubule Associated Protein 2 Kinase
% 209.28/209.48  |- skos__altLabel mesh__D048052 Microtubule-Associated Protein-2 Kinase
% 209.28/209.48  |- skos__altLabel mesh__D048052 ERK1 Kinase
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D048052 2006
% 209.28/209.49  |- skos__hiddenLabel mesh__D048052 MAPK3 Mitogen Activated Protein Kinase
% 209.28/209.49  |- mesh__dateCreated mesh__D048052 2004-07-07
% 209.28/209.49  |- rdf__type mesh__D048052sskos__Concept
% 209.28/209.49  |- skos__altLabel mesh__D048052 PSTkinase p44mpk
% 209.28/209.49  |- mesh__recordMaintainer mesh__D048052 ags
% 209.28/209.49  |- skos__hiddenLabel mesh__D048052 Mitogen Activated Protein Kinase 3
% 209.28/209.49  |- skos__altLabel mesh__D048052 p44 MAPK
% 209.28/209.49  |- mesh__historyNote mesh__D048052 2005%28%2000%29%   
% 209.28/209.49  |- mesh__recordOriginator mesh__D048052 jmp
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D048052 2006A
% 209.28/209.49  |- skos__broader mesh__D048052smesh__D048049
% 209.28/209.49  |- skos__historyNote mesh__D048052
% 209.28/209.49       Mitogen-Activated Protein Kinases %28%1990-2004%29%
% 209.28/209.49  |- skos__prefLabel mesh__D048052 Mitogen-Activated Protein Kinase 3
% 209.28/209.49  |- skos__hiddenLabel mesh__D048052 Kinase, Microtubule-Associated Protein-2
% 209.28/209.49  |- mesh__publicMeSHNote mesh__D048052
% 209.28/209.49       2005; MITOGEN-ACTIVATED PROTEIN KINASE 3 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004 %26% under CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1994-1999%A%  
% 209.28/209.49  |- skos__scopeNote mesh__D009639
% 209.28/209.49       A synthetic hormone with anabolic and androgenic properties and moderate progestational activity.%A%    
% 209.28/209.49  |- skos__altLabel mesh__D009639 Laphal Brand of Norethandrolone
% 209.28/209.49  |- mesh__recordMaintainer mesh__D009639 lkw
% 209.28/209.49  |- skos__prefLabel mesh__D009639 Norethandrolone
% 209.28/209.49  |- skos__broader mesh__D009639smesh__D009652
% 209.28/209.49  |- skos__altLabel mesh__D009639 Ethylnortestosterone
% 209.28/209.49  |- mesh__dateRevised mesh__D009639 2004-07-07
% 209.28/209.49  |- skos__altLabel mesh__D009639 Ethylestrenolone
% 209.28/209.49  |- mesh__recordOriginator mesh__D009639 NLM
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D009639 2006
% 209.28/209.49  |- mesh__recordAuthorizer mesh__D009639 sjn
% 209.28/209.49  |- mesh__dateCreated mesh__D009639 1999-01-01
% 209.28/209.49  |- skos__hiddenLabel mesh__D009639 Norethandrolone Laphal Brand
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D009639 2005
% 209.28/209.49  |- rdf__type mesh__D009639sskos__Concept
% 209.28/209.49  |- mesh__recordOriginator mesh__D001656 RC
% 209.28/209.49  |- skos__broader mesh__D001656smesh__D004065
% 209.28/209.49  |- mesh__dateCreated mesh__D001656 1986-04-03
% 209.28/209.49  |- skos__scopeNote mesh__D001656
% 209.28/209.49       Progressive destruction or the absence of all or part of the extrahepatic BILE DUCTS, resulting in the complete obstruction of BILE flow. Usually, biliary atresia is found in infants and accounts for one third of the neonatal cholestatic JAUNDICE.%A%    
% 209.28/209.49  |- mesh__recordMaintainer mesh__D001656 lkt
% 209.28/209.49  |- mesh__dateRevised mesh__D001656 2003-07-09
% 209.28/209.49  |- skos__annotation mesh__D001656
% 209.28/209.49       do not coord with INFANT, NEWBORN, DISEASES   
% 209.28/209.49  |- skos__prefLabel mesh__D001656 Biliary Atresia
% 209.28/209.49  |- skos__altLabel mesh__D001656 Atresia, Biliary
% 209.28/209.49  |- mesh__dateEstablished mesh__D001656 1987-01-01
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D001656 2006
% 209.28/209.49  |- rdf__type mesh__D001656sskos__Concept
% 209.28/209.49  |- skos__historyNote mesh__D001656
% 209.28/209.49       Bile Ducts/abnormalities %28%1966-1986%29%
% 209.28/209.49  |- skos__broader mesh__D001656smesh__D001649
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D001656 2005
% 209.28/209.49  |- mesh__recordAuthorizer mesh__D001656 sjn
% 209.28/209.49  |- mesh__historyNote mesh__D001656 87   
% 209.28/209.49  |- mesh__publicMeSHNote mesh__D001656 87   
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D001656 2004
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006341 2003
% 209.28/209.49  |- skos__hiddenLabel mesh__D006341 Rupture, Heart
% 209.28/209.49  |- mesh__recordMaintainer mesh__D006341 TGC
% 209.28/209.49  |- skos__historyNote mesh__D006341 Myocardial Infarction %28%1966-1977%29%
% 209.28/209.49  |- skos__historyNote mesh__D006341 Heart Diseases %28%1966-1977%29%
% 209.28/209.49  |- mesh__publicMeSHNote mesh__D006341 78   
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006341 2004
% 209.28/209.49  |- skos__hiddenLabel mesh__D006341 Ruptures, Heart
% 209.28/209.49  |- mesh__recordAuthorizer mesh__D006341 SJN
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006341 2002
% 209.28/209.49  |- rdf__type mesh__D006341sskos__Concept
% 209.28/209.49  |- mesh__dateEstablished mesh__D006341 1978-01-01
% 209.28/209.49  |- skos__prefLabel mesh__D006341 Heart Rupture
% 209.28/209.49  |- skos__historyNote mesh__D006341 Rupture, Spontaneous %28%1966-1977%29%
% 209.28/209.49  |- skos__hiddenLabel mesh__D006341 Cardiac Ruptures
% 209.28/209.49  |- skos__annotation mesh__D006341
% 209.28/209.49       rupt of any part of heart as result of heart pathol: do not confuse with HEART RUPTURE, TRAUMATIC see HEART INJURIES; coord IM with specific part %28%IM%29% if pertinent but VENTRICULAR SEPTAL RUPTURE is available; usually caused by myocard infarct %28% = HEART RUPTURE, POST-INFARCTION%29%%A%  
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006341 1998
% 209.28/209.49  |- mesh__dateCreated mesh__D006341 1977-04-27
% 209.28/209.49  |- skos__broader mesh__D006341smesh__D006331
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006341 2000
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006341 2005
% 209.28/209.49  |- skos__altLabel mesh__D006341 Cardiac Rupture
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006341 1999
% 209.28/209.49  |- skos__hiddenLabel mesh__D006341 Ruptures, Cardiac
% 209.28/209.49  |- skos__hiddenLabel mesh__D006341 Rupture, Cardiac
% 209.28/209.49  |- skos__hiddenLabel mesh__D006341 Heart Ruptures
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006341 2006
% 209.28/209.49  |- mesh__dateRevised mesh__D006341 1997-06-20
% 209.28/209.49  |- mesh__recordOriginator mesh__D006341 VDK
% 209.28/209.49  |- mesh__historyNote mesh__D006341 78   
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006341 2001
% 209.28/209.49  |- skos__scopeNote mesh__D006341
% 209.28/209.49       Laceration or tearing of the walls of the heart, of the interatrial or interventricular septum, of the papillary muscles or chordae tendineae, or of any of the valves of the heart. Rupture may be due to a variety of pathological entities, however, the majority are secondary to myocardial infarction %28%HEART RUPTURE, POST-INFARCTION%29%.%A%    
% 209.28/209.49  |- skos__altLabel mesh__D019269 PtdInsP2
% 209.28/209.49  |- mesh__dateEstablished mesh__D019269 1997-01-01
% 209.28/209.49  |- skos__prefLabel mesh__D019269 Phosphatidylinositol 4,5-Diphosphate
% 209.28/209.49  |- mesh__dateRevised mesh__D019269 2004-07-07
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D019269 2005
% 209.28/209.49  |- skos__hiddenLabel mesh__D019269 Phosphatidylinositol 4,5 Bisphosphate
% 209.28/209.49  |- skos__altLabel mesh__D019269 Phosphatidylinositol 4,5-Biphosphate
% 209.28/209.49  |- skos__altLabel mesh__D019269 PIP2
% 209.28/209.49  |- skos__historyNote mesh__D019269
% 209.28/209.49       Phosphatidylinositol Phosphates %28%1994-1996%29%
% 209.28/209.49  |- skos__hiddenLabel mesh__D019269 Phosphatidylinositol 4,5 Biphosphate
% 209.28/209.49  |- skos__altLabel mesh__D019269 Phosphatidylinositol-4,5-Bisphosphate
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D019269 2006
% 209.28/209.49  |- mesh__onlineNote mesh__D019269
% 209.28/209.49       use PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE %28%NM%29% to search PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE 1981-96%A%  
% 209.28/209.49  |- skos__scopeNote mesh__D019269
% 209.28/209.49       A phosphoinositide present in all eukaryotic cells, particularly in the plasma membrane. It is the major substrate for receptor-stimulated phosphoinositidase C, with the consequent formation of inositol 1,4,5-triphosphate and diacylglycerol, and probably also for receptor-stimulated inositol phospholipid 3-kinase. %28%Kendrew, The Encyclopedia of Molecular Biology, 1994%29%%A%    
% 209.28/209.49  |- skos__historyNote mesh__D019269 Phosphatidylinositols %28%1981-1993%29%
% 209.28/209.49  |- mesh__dateCreated mesh__D019269 1996-06-10
% 209.28/209.49  |- skos__broader mesh__D019269smesh__D018129
% 209.28/209.49  |- mesh__recordMaintainer mesh__D019269 jmp
% 209.28/209.49  |- mesh__recordAuthorizer mesh__D019269 sjn
% 209.28/209.49  |- rdf__type mesh__D019269sskos__Concept
% 209.28/209.49  |- mesh__historyNote mesh__D019269
% 209.28/209.49       97; see PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE %28%NM%29% 1981-96%A%  
% 209.28/209.49  |- skos__hiddenLabel mesh__D019269 Phosphatidylinositol 4,5 Diphosphate
% 209.28/209.49  |- mesh__publicMeSHNote mesh__D019269
% 209.28/209.49       97; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE was indexed under PHOSPHATIDYLINOSITOL PHOSPHATES 1994-96 %26% PHOSPHOINOSITIDES 1981-93%A%  
% 209.28/209.49  |- mesh__recordOriginator mesh__D019269 TPW
% 209.28/209.49  |- skos__annotation mesh__D019269 DF: note short X refs   
% 209.28/209.49  |- skos__hiddenLabel mesh__D019269 4,5-Biphosphate, Phosphatidylinositol
% 209.28/209.49  |- skos__hiddenLabel mesh__D019269 4,5-Diphosphate, Phosphatidylinositol
% 209.28/209.49  |- skos__altLabel mesh__D019269 PtIns 4,5-P2
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D005249 2004
% 209.28/209.49  |- mesh__recordOriginator mesh__D005249 NLM
% 209.28/209.49  |- mesh__publicMeSHNote mesh__D005249 68   
% 209.28/209.49  |- mesh__dateRevised mesh__D005249 2002-07-18
% 209.28/209.49  |- skos__related mesh__D005249smesh__D011907
% 209.28/209.49  |- skos__hiddenLabel mesh__D005249 Remunerations
% 209.28/209.49  |- skos__hiddenLabel mesh__D005249 Charge
% 209.28/209.49  |- skos__historyNote mesh__D005249 Economics %28%1966-1967%29%
% 209.28/209.49  |- skos__annotation mesh__D005249 DF: FEES   
% 209.28/209.49  |- skos__altLabel mesh__D005249 Charges and Fees
% 209.28/209.49  |- mesh__dateCreated mesh__D005249 1999-01-01
% 209.28/209.49  |- rdf__type mesh__D005249sskos__Concept
% 209.28/209.49  |- skos__broader mesh__D005249smesh__D004467
% 209.28/209.49  |- skos__hiddenLabel mesh__D005249 Fee
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D005249 2005
% 209.28/209.49  |- mesh__historyNote mesh__D005249 68   
% 209.28/209.49  |- skos__prefLabel mesh__D005249 Fees and Charges
% 209.28/209.49  |- mesh__recordMaintainer mesh__D005249 sjn
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D005249 2006
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D005249 2003
% 209.28/209.49  |- skos__scopeNote mesh__D005249
% 209.28/209.49       Amounts charged to the patient as payer for health care services.%A%    
% 209.28/209.49  |- mesh__recordAuthorizer mesh__D005249 sjn
% 209.28/209.49  |- mesh__dateEstablished mesh__D005249 1968-01-01
% 209.28/209.49  |- skos__hiddenLabel mesh__D024403 Carbonic Anhydrase, Muscle Specific
% 209.28/209.49  |- skos__prefLabel mesh__D024403 Carbonic Anhydrase III
% 209.28/209.49  |- skos__broader mesh__D024403smesh__D002256
% 209.28/209.49  |- mesh__dateEstablished mesh__D024403 2002-01-01
% 209.28/209.49  |- mesh__historyNote mesh__D024403
% 209.28/209.49       2002; use CARBONIC ANHYDRASES 1983-2001   
% 209.28/209.49  |- mesh__recordOriginator mesh__D024403 jmp
% 209.28/209.49  |- rdf__type mesh__D024403sskos__Concept
% 209.28/209.49  |- mesh__dateCreated mesh__D024403 2001-07-25
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D024403 2006
% 209.28/209.49  |- mesh__dateRevised mesh__D024403 2003-07-09
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D024403 2005
% 209.28/209.49  |- skos__altLabel mesh__D024403 Carbonic Anhydrase, Muscle-Specific
% 209.28/209.49  |- skos__annotation mesh__D024403
% 209.28/209.49       /antag: coord with CARBONIC ANHYDRASE INHIBITORS   
% 209.28/209.49  |- mesh__publicMeSHNote mesh__D024403
% 209.28/209.49       2002; see CARBONIC DEHYDATASE 1992-2001 %26% CARBONIC ANHYDRASE 1983-1991%A%  
% 209.28/209.49  |- mesh__recordMaintainer mesh__D024403 ssb
% 209.28/209.49  |- skos__scopeNote mesh__D024403
% 209.28/209.49       A cytosolic carbonic anhydrase isoenzyme primarily expressed in skeletal muscle %28%MUSCLES, SKELETAL%29%. EC 4.2.1.-%A%    
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D024403 2004
% 209.28/209.49  |- skos__historyNote mesh__D024403 Carbonic Anhydrases %28%1972-2001%29%
% 209.28/209.49  |- skos__hiddenLabel mesh__D024403 Muscle-Specific Carbonic Anhydrase
% 209.28/209.49  |- mesh__recordAuthorizer mesh__D024403 sjn
% 209.28/209.49  |- skos__hiddenLabel mesh__D024403 Anhydrase, Muscle-Specific Carbonic
% 209.28/209.49  |- skos__broader mesh__D043368smesh__D043367
% 209.28/209.49  |- mesh__historyNote mesh__D043368 2004   
% 209.28/209.49  |- skos__altLabel mesh__D043368 Pseudomonas solanacearum
% 209.28/209.49  |- skos__scopeNote mesh__D043368
% 209.28/209.49       A species of Ralstonia previously classed in the genera PSEUDOMONAS and BURKHOLDERIA. It is an important plant pathogen.%A%    
% 209.28/209.49  |- skos__historyNote mesh__D043368
% 209.28/209.49       Gram-Negative Aerobic Rods and Cocci %28%1995-2003%29%
% 209.28/209.49  |- mesh__recordMaintainer mesh__D043368 SYSTEM
% 209.28/209.49  |- mesh__dateEstablished mesh__D043368 2004-01-01
% 209.28/209.49  |- mesh__dateCreated mesh__D043368 2003-07-09
% 209.28/209.49  |- mesh__dateRevised mesh__D043368 2005-06-30
% 209.28/209.49  |- skos__altLabel mesh__D043368 Burkholderia solanacearum
% 209.28/209.49  |- mesh__publicMeSHNote mesh__D043368 2004   
% 209.28/209.49  |- skos__historyNote mesh__D043368 Betaproteobacteria %28%1995-2003%29%
% 209.28/209.49  |- mesh__recordAuthorizer mesh__D043368 sjn
% 209.28/209.49  |- mesh__recordOriginator mesh__D043368 ags
% 209.28/209.49  |- rdf__type mesh__D043368sskos__Concept
% 209.28/209.49  |- skos__prefLabel mesh__D043368 Ralstonia solanacearum
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D043368 2006
% 209.28/209.49  |- mesh__recordOriginator mesh__D048053 jmp
% 209.28/209.49  |- skos__scopeNote mesh__D048053
% 209.28/209.49       A 97-kDa extracellular signal-regulated MAP kinase. Mitogen-activated protein kinase 6 levels increase during cellular differentiation, while in proliferating cells the enzyme is degraded rapidly via the PROTEASOME ENDOPEPTIDASE COMPLEX.%A%    
% 209.28/209.49  |- mesh__publicMeSHNote mesh__D048053
% 209.28/209.49       2005; MITOGEN-ACTIVATED PROTEIN KINASE 6 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004, under CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1994-2000 %26% under PROTEIN KINASES 1991-1993%A%  
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D048053 2005
% 209.28/209.49  |- skos__altLabel mesh__D048053 p97%28%MAPK%29% Protein
% 209.28/209.49  |- mesh__recordMaintainer mesh__D048053 jmp
% 209.28/209.49  |- skos__hiddenLabel mesh__D048053 Extracellular Signal Regulated Kinase 3
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D048053 2006
% 209.28/209.49  |- skos__hiddenLabel mesh__D048053 Kinase, ERK3
% 209.28/209.49  |- mesh__dateEstablished mesh__D048053 2005-01-01
% 209.28/209.49  |- rdf__type mesh__D048053sskos__Concept
% 209.28/209.49  |- mesh__dateCreated mesh__D048053 2004-07-07
% 209.28/209.49  |- skos__altLabel mesh__D048053 p97MAPK Protein
% 209.28/209.49  |- skos__prefLabel mesh__D048053 Mitogen-Activated Protein Kinase 6
% 209.28/209.49  |- skos__hiddenLabel mesh__D048053 MAPK6 Mitogen Activated Protein Kinase
% 209.28/209.49  |- mesh__recordAuthorizer mesh__D048053 sjn
% 209.28/209.49  |- mesh__historyNote mesh__D048053 2005%28%1991%29%   
% 209.28/209.49  |- skos__broader mesh__D048053smesh__D048049
% 209.28/209.49  |- skos__altLabel mesh__D048053 Extracellular Signal-Regulated Kinase 3
% 209.28/209.49  |- skos__altLabel mesh__D048053 ERK3 Kinase
% 209.28/209.49  |- skos__hiddenLabel mesh__D048053 Mitogen Activated Protein Kinase 6
% 209.28/209.49  |- skos__altLabel mesh__D048053 MAPK6 Mitogen-Activated Protein Kinase
% 209.28/209.49  |- skos__historyNote mesh__D048053
% 209.28/209.49       Mitogen-Activated Protein Kinases %28%1991-2004%29%
% 209.28/209.49  |- mesh__recordMaintainer mesh__D001657 ags
% 209.28/209.49  |- skos__hiddenLabel mesh__D001657 Dyskinesia, Gallbladder
% 209.28/209.49  |- skos__hiddenLabel mesh__D001657 Gallbladder Dyskinesias
% 209.28/209.49  |- mesh__dateCreated mesh__D001657 1999-01-01
% 209.28/209.49  |- mesh__recordOriginator mesh__D001657 NLM
% 209.28/209.49  |- mesh__dateRevised mesh__D001657 2005-08-01
% 209.28/209.49  |- skos__hiddenLabel mesh__D001657 Dyskinesias, Gallbladder
% 209.28/209.49  |- skos__broader mesh__D001657smesh__D003137
% 209.28/209.49  |- mesh__recordAuthorizer mesh__D001657 ags
% 209.28/209.49  |- skos__hiddenLabel mesh__D001657 Dyskinesias, Biliary
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D001657 2005
% 209.28/209.49  |- skos__hiddenLabel mesh__D001657 Dyskinesia, Biliary
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D001657 2006
% 209.28/209.49  |- skos__prefLabel mesh__D001657 Biliary Dyskinesia
% 209.28/209.49  |- rdf__type mesh__D001657sskos__Concept
% 209.28/209.49  |- skos__scopeNote mesh__D001657
% 209.28/209.49       A motility disorder characterized by biliary COLIC, absence of GALLSTONES, and an abnormal GALLBLADDER ejection fraction. It is caused by gallbladder dyskinesia and/or SPHINCTER OF ODDI DYSFUNCTION.%A%    
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D001657 2006A
% 209.28/209.49  |- skos__hiddenLabel mesh__D001657 Biliary Dyskinesias
% 209.28/209.49  |- skos__altLabel mesh__D020811 Health Care Technology
% 209.28/209.49  |- mesh__recordAuthorizer mesh__D020811 sjn
% 209.28/209.49  |- mesh__dateCreated mesh__D020811 1999-11-08
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D020811 2004
% 209.28/209.49  |- mesh__dateEstablished mesh__D020811 2000-01-01
% 209.28/209.49  |- skos__scopeNote mesh__D020811
% 209.28/209.49       The application of technology to the solution of medical problems.%A%    
% 209.28/209.49  |- mesh__publicMeSHNote mesh__D020811
% 209.28/209.49       2000; BIOMEDICAL TECHNOLOGY use TECHNOLOGY, MEDICAL %28%1991-1999%29%; HEALTH CARE TECHNOLOGY %26% HEALTH TECHNOLOGY use TECHNOLOGY, MEDICAL %28%1998-1999%29%%A%  
% 209.28/209.49  |- mesh__historyNote mesh__D020811
% 209.28/209.49       2000; BIOMEDICAL TECHNOLOGY was see TECHNOLOGY, MEDICAL %28%1991-1999%29%; HEALTH CARE TECHNOLOGY %26% HEALTH TECHNOLOGY see TECHNOLOGY, MEDICAL %28%1998-1999%29%%A%  
% 209.28/209.49  |- skos__altLabel mesh__D020811 Technology, Biomedical
% 209.28/209.49  |- rdf__type mesh__D020811sskos__Concept
% 209.28/209.49  |- skos__related mesh__D020811smesh__D001698
% 209.28/209.49  |- skos__historyNote mesh__D020811 Technology, Medical %28%1991-1999%29%
% 209.28/209.49  |- skos__altLabel mesh__D020811 Technology, Health
% 209.28/209.49  |- skos__prefLabel mesh__D020811 Biomedical Technology
% 209.28/209.49  |- skos__altLabel mesh__D020811 Health Technology
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D020811 2006
% 209.28/209.49  |- mesh__recordOriginator mesh__D020811 jls
% 209.28/209.49  |- mesh__recordMaintainer mesh__D020811 jls
% 209.28/209.49  |- skos__broader mesh__D020811smesh__D013672
% 209.28/209.49  |- skos__annotation mesh__D020811
% 209.28/209.49       very general - application of technology to medical problems%A%  
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D020811 2005
% 209.28/209.49  |- skos__altLabel mesh__D020811 Biomedical Technologies
% 209.28/209.49  |- mesh__dateRevised mesh__D020811 2003-07-22
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006342 2005
% 209.28/209.49  |- skos__historyNote mesh__D006342 Myocardial Infarction %28%1979-1986%29%
% 209.28/209.49  |- mesh__dateEstablished mesh__D006342 1991-01-01
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006342 2001
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006342 1997
% 209.28/209.49  |- skos__broader mesh__D006342smesh__D006341
% 209.28/209.49  |- mesh__dateCreated mesh__D006342 1986-06-24
% 209.28/209.49  |- skos__hiddenLabel mesh__D006342 Post-Infarction Heart Ruptures
% 209.28/209.49  |- mesh__recordMaintainer mesh__D006342 AGS
% 209.28/209.49  |- skos__annotation mesh__D006342
% 209.28/209.49       do not coord with MYOCARDIAL INFARCTION unless specifically discussed%A%  
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006342 1993
% 209.28/209.49  |- skos__hiddenLabel mesh__D006342 Ruptures, Post-Infarction Heart
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006342 2000
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006342 2004
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006342 1996
% 209.28/209.49  |- mesh__historyNote mesh__D006342
% 209.28/209.49       91%28%87%29%; was see under HEART RUPTURE 1987-90   
% 209.28/209.49  |- skos__altLabel mesh__D006342 Cardiac Rupture, Post-Infarction
% 209.28/209.49  |- skos__altLabel mesh__D006342 Post-Infarction Heart Rupture
% 209.28/209.49  |- skos__hiddenLabel mesh__D006342 Post Infarction Heart Rupture
% 209.28/209.49  |- skos__hiddenLabel mesh__D006342 Rupture, Post-Infarction Cardiac
% 209.28/209.49  |- skos__hiddenLabel mesh__D006342 Post-Infarction Cardiac Rupture
% 209.28/209.49  |- mesh__recordOriginator mesh__D006342 VDK
% 209.28/209.49  |- skos__hiddenLabel mesh__D006342 Rupture, Post-Infarction Heart
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006342 2003
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006342 1999
% 209.28/209.49  |- skos__historyNote mesh__D006342 Heart Rupture %28%1978-1986%29%
% 209.28/209.49  |- skos__hiddenLabel mesh__D006342 Heart Rupture, Post Infarction
% 209.28/209.49  |- rdf__type mesh__D006342sskos__Concept
% 209.28/209.49  |- skos__hiddenLabel mesh__D006342 Ruptures, Post-Infarction Cardiac
% 209.28/209.49  |- skos__prefLabel mesh__D006342 Heart Rupture, Post-Infarction
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006342 1995
% 209.28/209.49  |- mesh__publicMeSHNote mesh__D006342
% 209.28/209.49       91; was see under HEART RUPTURE 1987-90   
% 209.28/209.49  |- skos__hiddenLabel mesh__D006342 Cardiac Ruptures, Post-Infarction
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006342 2002
% 209.28/209.49  |- skos__hiddenLabel mesh__D006342 Post-Infarction Cardiac Ruptures
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006342 2006
% 209.28/209.49  |- skos__hiddenLabel mesh__D006342 Heart Ruptures, Post-Infarction
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006342 1998
% 209.28/209.49  |- mesh__dateRevised mesh__D006342 1992-05-20
% 209.28/209.49  |- skos__scopeNote mesh__D006342
% 209.28/209.49       Rupture of the heart after myocardial infarction.     
% 209.28/209.49  |- skos__hiddenLabel mesh__D006342 Cardiac Rupture, Post Infarction
% 209.28/209.49  |- mesh__recordAuthorizer mesh__D006342 PLS
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D006342 1994
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D020013 2000
% 209.28/209.49  |- skos__hiddenLabel mesh__D020013 Calcium Wave
% 209.28/209.49  |- skos__related mesh__D020013smesh__D015220
% 209.28/209.49  |- skos__scopeNote mesh__D020013
% 209.28/209.49       Signal transduction mechanisms whereby calcium mobilization %28%from outside the cell or from intracellular storage pools%29% to the cytoplasm is triggered by external stimuli. Calcium signals are often seen to propagate as waves, oscillations, spikes or puffs. The calcium acts as an intracellular messenger by activating calcium-responsive proteins.%A%    
% 209.28/209.49  |- skos__hiddenLabel mesh__D020013 Spike, Calcium
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D020013 2004
% 209.28/209.49  |- skos__historyNote mesh__D020013 Signal Transduction %28%1989-1998%29%
% 209.28/209.49  |- skos__historyNote mesh__D020013 Calcium/physiology %28%1981-1988%29%
% 209.28/209.49  |- skos__related mesh__D020013smesh__D002147
% 209.28/209.49  |- skos__hiddenLabel mesh__D020013 Oscillations, Calcium
% 209.28/209.49  |- skos__hiddenLabel mesh__D020013 Spikes, Calcium
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D020013 1999
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D020013 2003
% 209.28/209.49  |- skos__broader mesh__D020013smesh__D015290
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D020013 2002
% 209.28/209.49  |- skos__annotation mesh__D020013
% 209.28/209.49       calcium mobilization in context of signal transduction goes here, in other cases index CALCIUM/metab%A%  
% 209.28/209.49  |- mesh__dateEstablished mesh__D020013 1999-01-01
% 209.28/209.49  |- skos__hiddenLabel mesh__D020013 Puff, Calcium
% 209.28/209.49  |- skos__hiddenLabel mesh__D020013 Calcium Oscillation
% 209.28/209.49  |- skos__hiddenLabel mesh__D020013 Wave, Calcium
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D020013 2006
% 209.28/209.49  |- skos__hiddenLabel mesh__D020013 Calcium Spike
% 209.28/209.49  |- mesh__historyNote mesh__D020013 99   
% 209.28/209.49  |- skos__hiddenLabel mesh__D020013 Puffs, Calcium
% 209.28/209.49  |- skos__hiddenLabel mesh__D020013 Waves, Calcium
% 209.28/209.49  |- skos__prefLabel mesh__D020013 Calcium Signaling
% 209.28/209.49  |- skos__related mesh__D020013smesh__D015544
% 209.28/209.49  |- rdf__type mesh__D020013sskos__Concept
% 209.28/209.49  |- skos__hiddenLabel mesh__D020013 Calcium Signalings
% 209.28/209.49  |- skos__hiddenLabel mesh__D020013 Signaling, Calcium
% 209.28/209.49  |- mesh__dateCreated mesh__D020013 1998-06-10
% 209.28/209.49  |- skos__altLabel mesh__D020013 Calcium Oscillations
% 209.28/209.49  |- mesh__publicMeSHNote mesh__D020013 99   
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D020013 2001
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D020013 2005
% 209.28/209.49  |- skos__hiddenLabel mesh__D020013 Calcium Puff
% 209.28/209.49  |- skos__hiddenLabel mesh__D020013 Signalings, Calcium
% 209.28/209.49  |- skos__historyNote mesh__D020013 Calcium/metabolism %28%1981-1988%29%
% 209.28/209.49  |- skos__broader mesh__D020013smesh__D017136
% 209.28/209.49  |- skos__hiddenLabel mesh__D020013 Oscillation, Calcium
% 209.28/209.49  |- skos__annotation mesh__D011287
% 209.28/209.49       no qualif; coord IM with object of prejudice %28%IM%29%   
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D011287 2002
% 209.28/209.49  |- skos__hiddenLabel mesh__D011287 Bias, Sex
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D011287 2005
% 209.28/209.49  |- skos__broader mesh__D011287smesh__D011593
% 209.28/209.49  |- mesh__dateRevised mesh__D011287 2001-07-25
% 209.28/209.49  |- skos__scopeNote mesh__D011287
% 209.28/209.49       A preconceived judgment made without adequate evidence and not easily alterable by presentation of contrary evidence.%A%    
% 209.28/209.49  |- skos__hiddenLabel mesh__D011287 Bias, Gender
% 209.28/209.49  |- rdf__type mesh__D011287sskos__Concept
% 209.28/209.49  |- skos__hiddenLabel mesh__D011287 Discrimination, Social
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D011287 2004
% 209.28/209.49  |- skos__hiddenLabel mesh__D011287 Discrimination, Sex
% 209.28/209.49  |- skos__altLabel mesh__D011287 Sex Bias
% 209.28/209.49  |- mesh__dateCreated mesh__D011287 1999-01-01
% 209.28/209.49  |- mesh__recordMaintainer mesh__D011287 nns
% 209.28/209.49  |- mesh__recordOriginator mesh__D011287 NLM
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D011287 2003
% 209.28/209.49  |- mesh__recordAuthorizer mesh__D011287 sjn
% 209.28/209.49  |- skos__hiddenLabel mesh__D011287 Prejudices
% 209.28/209.49  |- skos__altLabel mesh__D011287 Gender Bias
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D011287 2006
% 209.28/209.49  |- skos__prefLabel mesh__D011287 Prejudice
% 209.28/209.49  |- mesh__dateRevised mesh__D016770 1993-06-04
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D016770 2001
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D016770 1995
% 209.28/209.49  |- mesh__historyNote mesh__D016770 92   
% 209.28/209.49  |- mesh__recordOriginator mesh__D016770 PXP
% 209.28/209.49  |- mesh__recordAuthorizer mesh__D016770 PLS
% 209.28/209.49  |- mesh__dateCreated mesh__D016770 1991-05-02
% 209.28/209.49  |- rdf__type mesh__D016770sskos__Concept
% 209.28/209.49  |- mesh__dateEstablished mesh__D016770 1992-01-01
% 209.28/209.49  |- skos__altLabel mesh__D016770 Infections, Ciliophora
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D016770 2002
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D016770 1998
% 209.28/209.49  |- skos__annotation mesh__D016770
% 209.28/209.49       protozoan infect; GEN or unspecified; most common infect is BALANTIDIASIS%A%  
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D016770 1996
% 209.28/209.49  |- skos__hiddenLabel mesh__D016770 Ciliophora Infection
% 209.28/209.49  |- skos__hiddenLabel mesh__D016770 Infection, Ciliophora
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D016770 1999
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D016770 1997
% 209.28/209.49  |- mesh__recordMaintainer mesh__D016770 JLS
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D016770 2005
% 209.28/209.49  |- mesh__publicMeSHNote mesh__D016770 92   
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D016770 2003
% 209.28/209.49  |- skos__broader mesh__D016770smesh__D011528
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D016770 2006
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D016770 2000
% 209.28/209.49  |- skos__prefLabel mesh__D016770 Ciliophora Infections
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D016770 2004
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D016770 1994
% 209.28/209.49  |- skos__scopeNote mesh__D016770
% 209.28/209.49       Infections with protozoa of the phylum CILIOPHORA.     
% 209.28/209.49  |- mesh__dateCreated mesh__D030441 2001-07-25
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D030441 2005
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D030441 2003
% 209.28/209.49  |- skos__annotation mesh__D030441
% 209.28/209.49       do not confuse X ref SAUSSUREA COSTUS with COSTUS; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.28/209.49  |- skos__scopeNote mesh__D030441
% 209.28/209.49       A plant genus of the family ASTERACEAE, order Asterales, subclass Asteridae. It is a source of costus root oil and should not be confused with the genus COSTUS.%A%    
% 209.28/209.49  |- mesh__publicMeSHNote mesh__D030441 2002   
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D030441 2006
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D030441 2004
% 209.28/209.49  |- mesh__historyNote mesh__D030441 2002   
% 209.28/209.49  |- skos__prefLabel mesh__D030441 Saussurea
% 209.28/209.49  |- skos__broader mesh__D030441smesh__D019659
% 209.28/209.49  |- mesh__dateEstablished mesh__D030441 2002-01-01
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D030441 2002
% 209.28/209.49  |- rdf__type mesh__D030441sskos__Concept
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D002750 2002
% 209.28/209.49  |- skos__scopeNote mesh__D002750
% 209.28/209.49       Local anti-infective agent used for skin, gastrointestinal, and vaginal infections with fungi, protozoa, and certain bacteria. In animals, it causes central nervous system damage and is not administered parenterally. It is also used as antiseptic, fungistat, or deodorant.%A%    
% 209.28/209.49  |- mesh__dateRevised mesh__D002750 2000-06-21
% 209.28/209.49  |- mesh__publicMeSHNote mesh__D002750
% 209.28/209.49       91,63-82; was see under HYDROXYQUINOLINES 1983-90; was heading 1963-82%A%  
% 209.28/209.49  |- skos__altLabel mesh__D002750 Chloroquinaldol
% 209.28/209.49  |- skos__altLabel mesh__D002750 5,7-Dichloro-2-methyl-8-quinolinol
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D002750 2003
% 209.28/209.49  |- mesh__recordMaintainer mesh__D002750 TWD
% 209.28/209.49  |- skos__altLabel mesh__D002750 Chlorchinaldine
% 209.28/209.49  |- mesh__dateEstablished mesh__D002750 1963-01-01
% 209.28/209.49  |- mesh__dateCreated mesh__D002750 1999-01-01
% 209.28/209.49  |- skos__hiddenLabel mesh__D002750 5,7 Dichloro 2 methyl 8 quinolinol
% 209.28/209.49  |- mesh__activeMeSHYear mesh__D002750 2004
% 209.28/209.49  |- rdf__type mesh__D002750sskos__Concept
% 209.28/209.49  |- skos__altLabel mesh__D002750 Chlorchinaldol
% 209.28/209.50  |- mesh__activeMeSHYear mesh__D002750 2005
% 209.28/209.50  |- mesh__recordAuthorizer mesh__D002750 sjn
% 209.28/209.50  |- mesh__recordOriginator mesh__D002750 NLM
% 209.28/209.50  |- mesh__activeMeSHYear mesh__D002750 2001
% 209.28/209.50  |- skos__broader mesh__D002750smesh__D002739
% 209.28/209.50  |- mesh__activeMeSHYear mesh__D002750 2006
% 209.28/209.50  |- skos__prefLabel mesh__D002750 Chlorquinaldol
% 209.28/209.50  |- mesh__historyNote mesh__D002750
% 209.28/209.50       91%28%83%29%63; was see under HYDROXYQUINOLINES 1983-90; was heading 1963-82%A%  
% 209.28/209.50  |- skos__broader mesh__D024404smesh__D002256
% 209.35/209.50  |- skos__historyNote mesh__D024404 Carbonic Anhydrases %28%1992-2001%29%
% 209.35/209.50  |- mesh__dateEstablished mesh__D024404 2002-01-01
% 209.35/209.50  |- mesh__historyNote mesh__D024404
% 209.35/209.50       2002; use CARBONIC ANHYDRASES 1992-2001   
% 209.35/209.50  |- rdf__type mesh__D024404sskos__Concept
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D024404 2006
% 209.35/209.50  |- skos__altLabel mesh__D024404 Carbonic Anhydrase Isozyme V
% 209.35/209.50  |- mesh__dateRevised mesh__D024404 2003-07-09
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D024404 2005
% 209.35/209.50  |- skos__prefLabel mesh__D024404 Carbonic Anhydrase V
% 209.35/209.50  |- skos__scopeNote mesh__D024404
% 209.35/209.50       A carbonic anhydrase isoenzyme found in MITOCHONDRIA where it provides bicarbonate ions that are components in the urea cycle and in GLUCONEOGENESIS.%A%    
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D024404 2004
% 209.35/209.50  |- mesh__dateCreated mesh__D024404 2001-07-25
% 209.35/209.50  |- mesh__publicMeSHNote mesh__D024404
% 209.35/209.50       2002; see CARBONIC DEHYDATASE 1992-2001   
% 209.35/209.50  |- skos__annotation mesh__D024404
% 209.35/209.50       /antag: coord with CARBONIC ANHYDRASE INHIBITORS   
% 209.35/209.50  |- skos__broader mesh__D043369smesh__D016946
% 209.35/209.50  |- mesh__recordMaintainer mesh__D043369 SYSTEM
% 209.35/209.50  |- skos__broader mesh__D043369smesh__D020562
% 209.35/209.50  |- mesh__dateCreated mesh__D043369 2003-07-09
% 209.35/209.50  |- skos__prefLabel mesh__D043369 Nitrosomonadaceae
% 209.35/209.50  |- mesh__historyNote mesh__D043369 2004   
% 209.35/209.50  |- mesh__publicMeSHNote mesh__D043369 2004   
% 209.35/209.50  |- skos__scopeNote mesh__D043369
% 209.35/209.50       A family of gram-negative nitrifying bacteria, in the order Nitrosomonadales, class BETAPROTEOBACTERIA.%A%    
% 209.35/209.50  |- rdf__type mesh__D043369sskos__Concept
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D043369 2006
% 209.35/209.50  |- mesh__dateEstablished mesh__D043369 2004-01-01
% 209.35/209.50  |- mesh__dateRevised mesh__D043369 2005-06-30
% 209.35/209.50  |- mesh__recordAuthorizer mesh__D043369 sjn
% 209.35/209.50  |- mesh__recordOriginator mesh__D043369 ags
% 209.35/209.50  |- mesh__recordOriginator mesh__D015678 AGS
% 209.35/209.50  |- mesh__historyNote mesh__D015678 90   
% 209.35/209.50  |- skos__annotation mesh__D015678
% 209.35/209.50       coordinate IM with specific protein %28%IM%29% + specific virus %28%IM%29%%A%  
% 209.35/209.50  |- skos__hiddenLabel mesh__D015678 VP1, Structural Polypeptide
% 209.35/209.50  |- skos__prefLabel mesh__D015678 Viral Structural Proteins
% 209.35/209.50  |- skos__hiddenLabel mesh__D015678 Structural Polypeptide VP1
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D015678 2006
% 209.35/209.50  |- mesh__recordAuthorizer mesh__D015678 sjn
% 209.35/209.50  |- skos__broader mesh__D015678smesh__D014764
% 209.35/209.50  |- mesh__dateCreated mesh__D015678 1989-05-25
% 209.35/209.50  |- mesh__dateEstablished mesh__D015678 1990-01-01
% 209.35/209.50  |- skos__scopeNote mesh__D015678
% 209.35/209.50       Viral proteins that are components of the mature assembled VIRUS PARTICLES. They may include nucleocapsid core proteins %28%gag proteins%29%, enzymes packaged within the virus particle %28%pol proteins%29%, and membrane components %28%env proteins%29%. These do not include the proteins encoded in the VIRAL GENOME that are produced in infected cells but which are not packaged in the mature virus particle,i.e. the so called non-structural proteins %28%VIRAL NONSTRUCTURAL PROTEINS.%29%%A%    
% 209.35/209.50  |- mesh__recordMaintainer mesh__D015678 nns
% 209.35/209.50  |- mesh__dateRevised mesh__D015678 2005-06-30
% 209.35/209.50  |- skos__historyNote mesh__D015678 Viral Proteins %28%1973-1989%29%
% 209.35/209.50  |- skos__hiddenLabel mesh__D015678 Proteins, Viral Structural
% 209.35/209.50  |- rdf__type mesh__D015678sskos__Concept
% 209.35/209.50  |- mesh__publicMeSHNote mesh__D015678 90   
% 209.35/209.50  |- skos__hiddenLabel mesh__D015678 Structural Proteins, Viral
% 209.35/209.50  |- skos__hiddenLabel mesh__D048054 Mitogen Activated Protein Kinase 7
% 209.35/209.50  |- mesh__publicMeSHNote mesh__D048054
% 209.35/209.50       2005; MITOGEN-ACTIVATED PROTEIN KINASE 7 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 1999-2004%A%  
% 209.35/209.50  |- skos__altLabel mesh__D048054 MAPK7 Mitogen-Activated Protein Kinase
% 209.35/209.50  |- mesh__historyNote mesh__D048054 2005%28%1999%29%   
% 209.35/209.50  |- skos__historyNote mesh__D048054
% 209.35/209.50       Mitogen-Activated Protein Kinases %28%1999-2004%29%
% 209.35/209.50  |- mesh__recordMaintainer mesh__D048054 jmp
% 209.35/209.50  |- skos__broader mesh__D048054smesh__D048049
% 209.35/209.50  |- skos__hiddenLabel mesh__D048054
% 209.35/209.50       Mitogen Activated Protein Kinase 7 Isoform 2
% 209.35/209.50  |- skos__scopeNote mesh__D048054
% 209.35/209.50       A 110-kDa extracellular signal-regulated MAP kinase that is activated in response to cellular stress and by GROWTH FACTOR RECEPTOR-mediated pathways.%A%    
% 209.35/209.50  |- skos__altLabel mesh__D048054 BMK1 Kinase
% 209.35/209.50  |- mesh__recordOriginator mesh__D048054 jmp
% 209.35/209.50  |- skos__hiddenLabel mesh__D048054 Kinase, ERK5
% 209.35/209.50  |- skos__altLabel mesh__D048054 Extracellular Signal-Regulated Kinase 5
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D048054 2006
% 209.35/209.50  |- mesh__dateEstablished mesh__D048054 2005-01-01
% 209.35/209.50  |- skos__altLabel mesh__D048054 Big MAP Kinase 1
% 209.35/209.50  |- rdf__type mesh__D048054sskos__Concept
% 209.35/209.50  |- skos__prefLabel mesh__D048054 Mitogen-Activated Protein Kinase 7
% 209.35/209.50  |- skos__hiddenLabel mesh__D048054 MAPK7 Mitogen Activated Protein Kinase
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D048054 2005
% 209.35/209.50  |- skos__altLabel mesh__D048054 ERK5 Kinase
% 209.35/209.50  |- mesh__dateCreated mesh__D048054 2004-07-07
% 209.35/209.50  |- skos__hiddenLabel mesh__D048054
% 209.35/209.50       Mitogen Activated Protein Kinase 7 Isoform 1
% 209.35/209.50  |- skos__hiddenLabel mesh__D048054 Extracellular Signal Regulated Kinase 5
% 209.35/209.50  |- skos__hiddenLabel mesh__D048054 Kinase, BMK1
% 209.35/209.50  |- mesh__recordAuthorizer mesh__D048054 sjn
% 209.35/209.50  |- mesh__recordMaintainer mesh__D001658 lkt
% 209.35/209.50  |- skos__scopeNote mesh__D001658
% 209.35/209.50       Abnormal passage in any organ of the biliary tract or between biliary organs and other organs.%A%    
% 209.35/209.50  |- mesh__dateRevised mesh__D001658 2003-07-09
% 209.35/209.50  |- skos__prefLabel mesh__D001658 Biliary Fistula
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D001658 2005
% 209.35/209.50  |- skos__hiddenLabel mesh__D001658 Biliary Fistulas
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D001658 2006
% 209.35/209.50  |- mesh__recordAuthorizer mesh__D001658 sjn
% 209.35/209.50  |- rdf__type mesh__D001658sskos__Concept
% 209.35/209.50  |- mesh__recordOriginator mesh__D001658 NLM
% 209.35/209.50  |- skos__annotation mesh__D001658
% 209.35/209.50       coord IM with specific precoord biliary tract/dis heading %28%IM%29%; fistula policy: Manual 23.19+%A%  
% 209.35/209.50  |- skos__hiddenLabel mesh__D001658 Fistula, Biliary
% 209.35/209.50  |- skos__hiddenLabel mesh__D001658 Fistulas, Biliary
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D001658 2004
% 209.35/209.50  |- skos__broader mesh__D001658smesh__D016154
% 209.35/209.50  |- mesh__dateCreated mesh__D001658 1999-01-01
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D012380 2004
% 209.35/209.50  |- mesh__recordMaintainer mesh__D012380 hjn
% 209.35/209.50  |- mesh__historyNote mesh__D012380
% 209.35/209.50       69; ROLE CONCEPT was see under ROLE 1969-78, was see under PSYCHOLOGY, SOCIAL 1966-68%A%  
% 209.35/209.50  |- mesh__publicMeSHNote mesh__D012380
% 209.35/209.50       69; ROLE CONCEPT was see under PSYCHOLOGY, SOCIAL 1966-68%A%  
% 209.35/209.50  |- skos__hiddenLabel mesh__D012380 Role Concepts
% 209.35/209.50  |- mesh__recordAuthorizer mesh__D012380 sjn
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D012380 2006
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D012380 2003
% 209.35/209.50  |- skos__hiddenLabel mesh__D012380 Roles
% 209.35/209.50  |- mesh__recordOriginator mesh__D012380 NLM
% 209.35/209.50  |- rdf__type mesh__D012380sskos__Concept
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D012380 2005
% 209.35/209.50  |- mesh__onlineNote mesh__D012380
% 209.35/209.50       use ROLE to search ROLE CONCEPT 1969-78; use PSYCHOLOGY, SOCIAL 1966-68%A%  
% 209.35/209.50  |- skos__broader mesh__D012380smesh__D006126
% 209.35/209.50  |- skos__hiddenLabel mesh__D012380 Concepts, Role
% 209.35/209.50  |- skos__scopeNote mesh__D012380
% 209.35/209.50       The expected and characteristic pattern of behavior exhibited by an individual as a member of a particular social group.%A%    
% 209.35/209.50  |- mesh__dateCreated mesh__D012380 1999-01-01
% 209.35/209.50  |- skos__historyNote mesh__D012380 Psychology, Social %28%1966-1968%29%
% 209.35/209.50  |- mesh__dateRevised mesh__D012380 2002-07-03
% 209.35/209.50  |- skos__hiddenLabel mesh__D012380 Concept, Role
% 209.35/209.50  |- skos__annotation mesh__D012380 GEN; prefer specifics   
% 209.35/209.50  |- mesh__dateEstablished mesh__D012380 1969-01-01
% 209.35/209.50  |- skos__prefLabel mesh__D012380 Role
% 209.35/209.50  |- skos__historyNote mesh__D020812 Membrane Glycoproteins %28%1991-1993%29%
% 209.35/209.50  |- skos__hiddenLabel mesh__D020812 Receptor, Neurotrophin 3
% 209.35/209.50  |- mesh__recordMaintainer mesh__D020812 jmp
% 209.35/209.50  |- mesh__dateRevised mesh__D020812 2005-06-30
% 209.35/209.50  |- mesh__dateEstablished mesh__D020812 2000-01-01
% 209.35/209.50  |- mesh__dateCreated mesh__D020812 1999-11-04
% 209.35/209.50  |- skos__altLabel mesh__D020812 NTRK3 Receptor
% 209.35/209.50  |- mesh__recordAuthorizer mesh__D020812 sjn
% 209.35/209.50  |- skos__scopeNote mesh__D020812
% 209.35/209.50       A protein-tyrosine kinase receptor that is specific for NEUROTROPHIN 3. It is widely expressed in nervous tissue and may play a role in mediating the effects of NEUROTROPHIN 3 on the proliferation and differentiation of NEURONS.%A%    
% 209.35/209.50  |- skos__altLabel mesh__D020812 Neurotrophin 3 Receptor
% 209.35/209.50  |- skos__historyNote mesh__D020812
% 209.35/209.50       Receptors, Growth Factor %28%1993-1999%29%
% 209.35/209.50  |- rdf__type mesh__D020812sskos__Concept
% 209.35/209.50  |- skos__broader mesh__D020812smesh__D020794
% 209.35/209.50  |- skos__altLabel mesh__D020812
% 209.35/209.50       Neurotrophic Tyrosine-Kinase-Receptor Type 3
% 209.35/209.50  |- skos__broader mesh__D020812smesh__D017475
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D020812 2006
% 209.35/209.50  |- skos__altLabel mesh__D020812
% 209.35/209.50       Receptor, Neurotrophic-Tyrosine-Kinase Type 3
% 209.35/209.50  |- mesh__publicMeSHNote mesh__D020812
% 209.35/209.50       2000; TRKC PROTEIN %28%now RECEPTOR, TYPE 3 NEUROTROPHIC TYROSINE KINASE%29% was indexed under RECEPTORS, NERVE GROWTH FACTOR 1995-1999, RECEPTOR PROTEIN-TYROSINE KINASE 1994-1999, RECEPTORS, GROWTH FACTOR 1993-1994, MEMBRANE GLYCOPROTEINS 1991-1993 %26% PROTEIN-TYROSINE KINASE 1991-1993%A%  
% 209.35/209.50  |- skos__altLabel mesh__D020812 Protein-Tyrosine Kinase TRKC
% 209.35/209.50  |- skos__hiddenLabel mesh__D020812 Kinase TRKC, Protein-Tyrosine
% 209.35/209.50  |- skos__altLabel mesh__D020812 NTRK3 Protein
% 209.35/209.50  |- skos__altLabel mesh__D020812 trkC Protein
% 209.35/209.50  |- mesh__recordOriginator mesh__D020812 jmp
% 209.35/209.50  |- skos__prefLabel mesh__D020812 Receptor, trkC
% 209.35/209.50  |- skos__historyNote mesh__D020812
% 209.35/209.50       Receptors, Nerve Growth Factor %28%1995-1999%29%
% 209.35/209.50  |- skos__annotation mesh__D020812 DF: RECEPT TRKC   
% 209.35/209.50  |- skos__historyNote mesh__D020812
% 209.35/209.50       Receptor Protein-Tyrosine Kinases %28%1994-1999%29%
% 209.35/209.50  |- mesh__historyNote mesh__D020812
% 209.35/209.50       2000; use RECEPTOR, TYPE 3 NEUROTROPHIC TYROSINE KINASE %28%NM%29% 1991-1999%A%  
% 209.35/209.50  |- skos__hiddenLabel mesh__D020812 Protein Tyrosine Kinase TRKC
% 209.35/209.50  |- skos__hiddenLabel mesh__D020812 TRKC, Protein-Tyrosine Kinase
% 209.35/209.50  |- skos__hiddenLabel mesh__D020812 Receptor, NTRK3
% 209.35/209.50  |- skos__historyNote mesh__D020812
% 209.35/209.50       Protein-Tyrosine Kinase %28%1991-1993%29%
% 209.35/209.50  |- skos__altLabel mesh__D020812 trkC Receptor
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D006343 2005
% 209.35/209.50  |- skos__hiddenLabel mesh__D006343 Defects, Heart Septal
% 209.35/209.50  |- mesh__recordAuthorizer mesh__D006343 sjn
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D006343 2006
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D006343 2000
% 209.35/209.50  |- skos__scopeNote mesh__D006343
% 209.35/209.50       Defects in the cardiac septa, resulting in abnormal communications between the opposite chambers of the heart.%A%    
% 209.35/209.50  |- mesh__recordMaintainer mesh__D006343 kle
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D006343 2003
% 209.35/209.50  |- mesh__dateEstablished mesh__D006343 1964-01-01
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D006343 2001
% 209.35/209.50  |- skos__annotation mesh__D006343
% 209.35/209.50       GEN or unspecified; prefer specifics; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 209.35/209.50  |- skos__broader mesh__D006343smesh__D006330
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D006343 2004
% 209.35/209.50  |- mesh__publicMeSHNote mesh__D006343 64   
% 209.35/209.50  |- skos__hiddenLabel mesh__D006343 Heart Septal Defect
% 209.35/209.50  |- rdf__type mesh__D006343sskos__Concept
% 209.35/209.50  |- skos__hiddenLabel mesh__D006343 Septal Defects, Heart
% 209.35/209.50  |- skos__hiddenLabel mesh__D006343 Septal Defect, Heart
% 209.35/209.50  |- skos__prefLabel mesh__D006343 Heart Septal Defects
% 209.35/209.50  |- mesh__dateCreated mesh__D006343 1999-01-01
% 209.35/209.50  |- skos__hiddenLabel mesh__D006343 Defect, Heart Septal
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D006343 2002
% 209.35/209.50  |- mesh__historyNote mesh__D006343 64   
% 209.35/209.50  |- mesh__dateRevised mesh__D006343 1999-11-03
% 209.35/209.50  |- mesh__recordOriginator mesh__D006343 NLM
% 209.35/209.50  |- mesh__dateRevised mesh__D020014 2003-07-09
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D020014 2004
% 209.35/209.50  |- mesh__dateEstablished mesh__D020014 1999-01-01
% 209.35/209.50  |- skos__broader mesh__D020014smesh__D045744
% 209.35/209.50  |- mesh__publicMeSHNote mesh__D020014 99   
% 209.35/209.50  |- skos__historyNote mesh__D020014 Cell Line %28%1976-1998%29%
% 209.35/209.50  |- rdf__type mesh__D020014sskos__Concept
% 209.35/209.50  |- skos__annotation mesh__D020014
% 209.35/209.50       almost always NIM with no subheadings; check HUMAN; do not routinely add ERYTHROLEUKEMIA%A%  
% 209.35/209.50  |- skos__hiddenLabel mesh__D020014 Cells, K562
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D020014 2005
% 209.35/209.50  |- mesh__historyNote mesh__D020014 99   
% 209.35/209.50  |- skos__historyNote mesh__D020014 Tumor Cells, Cultured %28%1988-1998%29%
% 209.35/209.50  |- skos__broader mesh__D020014smesh__D015672
% 209.35/209.50  |- skos__scopeNote mesh__D020014
% 209.35/209.50       An ERYTHROLEUKEMIA cell line derived from a CHRONIC MYELOID LEUKEMIA patient in BLAST CRISIS.%A%    
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D020014 2006
% 209.35/209.50  |- skos__prefLabel mesh__D020014 K562 Cells
% 209.35/209.50  |- mesh__dateCreated mesh__D020014 1998-06-10
% 209.35/209.50  |- skos__hiddenLabel mesh__D044462 Protease Activated Receptors
% 209.35/209.50  |- skos__hiddenLabel mesh__D044462 Receptors, Endopeptidase-Activated
% 209.35/209.50  |- skos__hiddenLabel mesh__D044462 Proteinase Activated Receptors
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D044462 2006
% 209.35/209.50  |- mesh__publicMeSHNote mesh__D044462 2004   
% 209.35/209.50  |- skos__altLabel mesh__D044462 Proteinase-Activated Receptors
% 209.35/209.50  |- skos__hiddenLabel mesh__D044462 Receptors, Protease-Activated
% 209.35/209.50  |- skos__hiddenLabel mesh__D044462 Endopeptidase Activated Receptors
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D044462 2005
% 209.35/209.50  |- skos__historyNote mesh__D044462 Receptors, Thrombin %28%1994-2003%29%
% 209.35/209.50  |- rdf__type mesh__D044462sskos__Concept
% 209.35/209.50  |- skos__hiddenLabel mesh__D044462 Receptors, Proteinase Activated
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D044462 2004
% 209.35/209.50  |- skos__altLabel mesh__D044462 Endopeptidase-Activated Receptors
% 209.35/209.50  |- mesh__dateEstablished mesh__D044462 2004-01-01
% 209.35/209.50  |- mesh__dateCreated mesh__D044462 2003-07-09
% 209.35/209.50  |- skos__altLabel mesh__D044462 Protease-Activated Receptors
% 209.35/209.50  |- skos__scopeNote mesh__D044462
% 209.35/209.50       A class of receptors that are activated by the action of PROTEINASES. The most notable examples are the THROMBIN RECEPTORS. The receptors contain cryptic ligands that are exposed upon the selective proteolysis of specific N-terminal cleavage sites.%A%    
% 209.35/209.50  |- mesh__historyNote mesh__D044462 2004   
% 209.35/209.50  |- skos__prefLabel mesh__D044462 Receptors, Proteinase-Activated
% 209.35/209.50  |- skos__broader mesh__D044462smesh__D011956
% 209.35/209.50  |- skos__prefLabel mesh__D011288 Prekallikrein
% 209.35/209.50  |- skos__historyNote mesh__D011288 Enzyme Precursors %28%1973-1975%29%
% 209.35/209.50  |- mesh__dateCreated mesh__D011288 1975-07-25
% 209.35/209.50  |- skos__broader mesh__D011288smesh__D007610
% 209.35/209.50  |- mesh__recordAuthorizer mesh__D011288 sjn
% 209.35/209.50  |- mesh__publicMeSHNote mesh__D011288
% 209.35/209.50       89; was see under KALLIKREIN 1976-88   
% 209.35/209.50  |- skos__hiddenLabel mesh__D011288 Prokallikrein A, Plasma
% 209.35/209.50  |- skos__scopeNote mesh__D011288
% 209.35/209.50       A plasma protein which is the precursor of kallikrein. Plasma that is deficient in prekallikrein has been found to be abnormal in thromboplastin formation, kinin generation, evolution of a permeability globulin, and plasmin formation. The absence of prekallikrein in plasma leads to Fletcher factor deficiency, a congenital disease.%A%    
% 209.35/209.50  |- mesh__dateRevised mesh__D011288 2005-06-30
% 209.35/209.50  |- rdf__type mesh__D011288sskos__Concept
% 209.35/209.50  |- skos__altLabel mesh__D011288 Fletcher Factor
% 209.35/209.50  |- mesh__historyNote mesh__D011288
% 209.35/209.50       89%28%76%29%; was see under KALLIKREINS 1976-88   
% 209.35/209.50  |- skos__hiddenLabel mesh__D011288 Factor, Fletcher
% 209.35/209.50  |- skos__historyNote mesh__D011288
% 209.35/209.50       Blood Coagulation Factors %28%1973-1975%29%
% 209.35/209.50  |- skos__hiddenLabel mesh__D011288 Prokallikrein, Plasma
% 209.35/209.50  |- skos__historyNote mesh__D011288 Kallikrein %28%1973-1975%29%
% 209.35/209.50  |- skos__altLabel mesh__D011288 Plasma Prokallikrein
% 209.35/209.50  |- skos__related mesh__D011288smesh__D003029
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D011288 2006
% 209.35/209.50  |- mesh__dateEstablished mesh__D011288 1989-01-01
% 209.35/209.50  |- mesh__recordOriginator mesh__D011288 RLS
% 209.35/209.50  |- mesh__recordMaintainer mesh__D011288 ssb
% 209.35/209.50  |- skos__altLabel mesh__D011288 Kallikreinogen
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D016771 1998
% 209.35/209.50  |- skos__broader mesh__D016771smesh__D011528
% 209.35/209.50  |- mesh__recordOriginator mesh__D016771 PXP
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D016771 2000
% 209.35/209.50  |- rdf__type mesh__D016771sskos__Concept
% 209.35/209.50  |- skos__hiddenLabel mesh__D016771 Sarcomastigophora Infection
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D016771 1996
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D016771 2001
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D016771 1999
% 209.35/209.50  |- skos__annotation mesh__D016771
% 209.35/209.50       protozoan infect; GEN: prefer specifics   
% 209.35/209.50  |- skos__altLabel mesh__D016771 Infections, Sarcomastigophora
% 209.35/209.50  |- mesh__dateCreated mesh__D016771 1991-05-02
% 209.35/209.50  |- mesh__dateRevised mesh__D016771 1993-06-03
% 209.35/209.50  |- mesh__dateEstablished mesh__D016771 1992-01-01
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D016771 2005
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D016771 1997
% 209.35/209.50  |- mesh__recordAuthorizer mesh__D016771 PLS
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D016771 2002
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D016771 2003
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D016771 2006
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D016771 1994
% 209.35/209.50  |- skos__scopeNote mesh__D016771
% 209.35/209.50       Infections with protozoa of the phylum SARCOMASTIGOPHORA.%A%    
% 209.35/209.50  |- skos__hiddenLabel mesh__D016771 Infection, Sarcomastigophora
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D016771 2004
% 209.35/209.50  |- mesh__publicMeSHNote mesh__D016771 92   
% 209.35/209.50  |- mesh__recordMaintainer mesh__D016771 TGC
% 209.35/209.50  |- mesh__historyNote mesh__D016771 92   
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D016771 1995
% 209.35/209.50  |- skos__prefLabel mesh__D016771 Sarcomastigophora Infections
% 209.35/209.50  |- mesh__dateCreated mesh__D002751 1999-01-01
% 209.35/209.50  |- skos__altLabel mesh__D002751 Chlorotetracycline
% 209.35/209.50  |- mesh__recordAuthorizer mesh__D002751 sjn
% 209.35/209.50  |- rdf__type mesh__D002751sskos__Concept
% 209.35/209.50  |- mesh__recordOriginator mesh__D002751 NLM
% 209.35/209.50  |- skos__hiddenLabel mesh__D002751 Chlortetracycline, 4 Epimer
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D002751 2005
% 209.35/209.50  |- skos__hiddenLabel mesh__D002751 Hydrochloride, Chlortetracycline
% 209.35/209.50  |- skos__altLabel mesh__D002751 Aureomycine
% 209.35/209.50  |- skos__scopeNote mesh__D002751
% 209.35/209.50       A TETRACYCLINE with a 7-chloro substitution.     
% 209.35/209.50  |- skos__hiddenLabel mesh__D002751 4-Epimer Chlortetracycline
% 209.35/209.50  |- skos__hiddenLabel mesh__D002751 Monohydrochloride, Chlortetracycline
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D002751 2006
% 209.35/209.50  |- skos__prefLabel mesh__D002751 Chlortetracycline
% 209.35/209.50  |- skos__broader mesh__D002751smesh__D013754
% 209.35/209.50  |- mesh__dateRevised mesh__D002751 2004-07-07
% 209.35/209.50  |- skos__hiddenLabel mesh__D002751 Bisulfate, Chlortetracycline
% 209.35/209.50  |- skos__hiddenLabel mesh__D002751 Calcium Salt Chlortetracycline
% 209.35/209.50  |- skos__hiddenLabel mesh__D002751 Salt Chlortetracycline, Calcium
% 209.35/209.50  |- mesh__recordMaintainer mesh__D002751 ssb
% 209.35/209.50  |- skos__hiddenLabel mesh__D024405 Gastroepiploic Arteries
% 209.35/209.50  |- skos__hiddenLabel mesh__D024405 Arteries, Gastroepiploic
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D024405 2005
% 209.35/209.50  |- skos__prefLabel mesh__D024405 Gastroepiploic Artery
% 209.35/209.50  |- rdf__type mesh__D024405sskos__Concept
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D024405 2006
% 209.35/209.50  |- mesh__publicMeSHNote mesh__D024405 2002   
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D024405 2003
% 209.35/209.50  |- skos__historyNote mesh__D024405
% 209.35/209.50       Arteries/transplantation %28%1990-2001%29%
% 209.35/209.50  |- mesh__dateEstablished mesh__D024405 2002-01-01
% 209.35/209.50  |- skos__scopeNote mesh__D024405
% 209.35/209.50       Abdominal artery that follows the curvature of the stomach. The right gasteroepiploic artery is frequently used in coronary artery bypass grafting, myocardial revascularization, and other vascular reconstruction.%A%    
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D024405 2002
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D024405 2004
% 209.35/209.50  |- mesh__dateCreated mesh__D024405 2001-07-25
% 209.35/209.50  |- skos__hiddenLabel mesh__D024405 Artery, Gastroepiploic
% 209.35/209.50  |- skos__broader mesh__D024405smesh__D001158
% 209.35/209.50  |- mesh__historyNote mesh__D024405 2002   
% 209.35/209.50  |- skos__historyNote mesh__D024405 Stomach/blood supply %28%1967-2001%29%
% 209.35/209.50  |- skos__broader mesh__D048055smesh__D048031
% 209.35/209.50  |- skos__altLabel mesh__D048055 c-jun Kinase-1
% 209.35/209.50  |- skos__altLabel mesh__D048055 c-jun N-Terminal Kinase 1
% 209.35/209.50  |- mesh__recordMaintainer mesh__D048055 jmp
% 209.35/209.50  |- skos__prefLabel mesh__D048055 Mitogen-Activated Protein Kinase 8
% 209.35/209.50  |- skos__hiddenLabel mesh__D048055 Mitogen Activated Protein Kinase 8
% 209.35/209.50  |- skos__scopeNote mesh__D048055
% 209.35/209.50       A c-jun amino-terminal kinase that is activated by environmental stress and pro-inflammatory cytokines. Several isoforms of the protein with molecular sizes of 43 and 48 KD exist due to multiple ALTERNATIVE SPLICING.%A%    
% 209.35/209.50  |- skos__hiddenLabel mesh__D048055 c jun Kinase 1
% 209.35/209.50  |- mesh__publicMeSHNote mesh__D048055
% 209.35/209.50       2005; MITOGEN-ACTIVATED PROTEIN KINASE 8 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004%A%  
% 209.35/209.50  |- mesh__recordAuthorizer mesh__D048055 sjn
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D048055 2006
% 209.35/209.50  |- skos__hiddenLabel mesh__D048055 SAPK1 Mitogen Activated Protein Kinase
% 209.35/209.50  |- skos__hiddenLabel mesh__D048055 Stress Activated Protein Kinase 1
% 209.35/209.50  |- skos__altLabel mesh__D048055 Stress-Activated Protein Kinase JNK1
% 209.35/209.50  |- skos__hiddenLabel mesh__D048055 SAP Kinase 1
% 209.35/209.50  |- skos__altLabel mesh__D048055 JNK1 Kinase
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D048055 2005
% 209.35/209.50  |- rdf__type mesh__D048055sskos__Concept
% 209.35/209.50  |- skos__hiddenLabel mesh__D048055 Stress Activated Protein Kinase gamma
% 209.35/209.50  |- mesh__dateCreated mesh__D048055 2004-07-07
% 209.35/209.50  |- skos__hiddenLabel mesh__D048055 Stress Activated Protein Kinase JNK1
% 209.35/209.50  |- mesh__recordOriginator mesh__D048055 jmp
% 209.35/209.50  |- skos__hiddenLabel mesh__D048055 MAPK8 Mitogen Activated Protein Kinase
% 209.35/209.50  |- skos__altLabel mesh__D048055 Stress-Activated Protein Kinase 1
% 209.35/209.50  |- skos__altLabel mesh__D048055 SAPK1 Mitogen-Activated Protein Kinase
% 209.35/209.50  |- skos__hiddenLabel mesh__D048055 c jun N Terminal Kinase 1
% 209.35/209.50  |- skos__altLabel mesh__D048055 SAP Kinase-1
% 209.35/209.50  |- mesh__dateEstablished mesh__D048055 2005-01-01
% 209.35/209.50  |- skos__historyNote mesh__D048055
% 209.35/209.50       Mitogen-Activated Protein Kinases %28%2000-2004%29%
% 209.35/209.50  |- skos__altLabel mesh__D048055 MAPK8 Mitogen-Activated Protein Kinase
% 209.35/209.50  |- skos__altLabel mesh__D048055 Stress-Activated Protein Kinase gamma
% 209.35/209.50  |- mesh__historyNote mesh__D048055 2005%28%2000%29%   
% 209.35/209.50  |- skos__hiddenLabel mesh__D001659 Tract, Biliary
% 209.35/209.50  |- rdf__type mesh__D001659sskos__Concept
% 209.35/209.50  |- skos__annotation mesh__D001659
% 209.35/209.50       /abnorm: BILIARY ATRESIA is also available; /radiogr permitted but CHOLECYSTOGRAPHY for gallbladder x-ray %26% CHOLANGIOGRAPHY for bile duct x-ray are available; calculi = BILIARY CALCULI see GALLSTONES but consider also CHOLELITHIASIS; empyema = EMPYEMA, GALLBLADDER see CHOLECYSTITIS or EMPYEMA %28%IM%29% + BILIARY TRACT DISEASES %28%IM%29% if not of gallbladder; inflammation = CHOLECYSTITIS or CHOLANGITIS%A%  
% 209.35/209.50  |- mesh__recordMaintainer mesh__D001659 lkt
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D001659 2004
% 209.35/209.50  |- skos__altLabel mesh__D001659 Biliary System
% 209.35/209.50  |- skos__hiddenLabel mesh__D001659 Tree, Biliary
% 209.35/209.50  |- mesh__dateCreated mesh__D001659 1999-01-01
% 209.35/209.50  |- skos__related mesh__D001659smesh__D002756
% 209.35/209.50  |- skos__altLabel mesh__D001659 Biliary Tree
% 209.35/209.50  |- skos__scopeNote mesh__D001659 The BILE DUCTS and the GALLBLADDER.     
% 209.35/209.50  |- skos__hiddenLabel mesh__D001659 System, Biliary
% 209.35/209.50  |- mesh__dateRevised mesh__D001659 2003-07-09
% 209.35/209.50  |- skos__related mesh__D001659smesh__D002758
% 209.35/209.50  |- mesh__recordAuthorizer mesh__D001659 sjn
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D001659 2005
% 209.35/209.50  |- mesh__recordOriginator mesh__D001659 NLM
% 209.35/209.50  |- skos__prefLabel mesh__D001659 Biliary Tract
% 209.35/209.50  |- skos__broader mesh__D001659smesh__D004064
% 209.35/209.50  |- skos__related mesh__D001659smesh__D002765
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D001659 2006
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D012381 2003
% 209.35/209.50  |- mesh__onlineNote mesh__D012381 search PSYCHODRAMA 1968-74   
% 209.35/209.50  |- skos__scopeNote mesh__D012381
% 209.35/209.50       The adopting or performing the role of another significant individual in order to gain insight into the behavior of that person.%A%    
% 209.35/209.50  |- rdf__type mesh__D012381sskos__Concept
% 209.35/209.50  |- skos__prefLabel mesh__D012381 Role Playing
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D012381 2005
% 209.35/209.50  |- mesh__dateEstablished mesh__D012381 1991-01-01
% 209.35/209.50  |- mesh__recordAuthorizer mesh__D012381 sjn
% 209.35/209.50  |- mesh__dateRevised mesh__D012381 2001-07-25
% 209.35/209.50  |- skos__hiddenLabel mesh__D012381 Role Playings
% 209.35/209.50  |- mesh__recordOriginator mesh__D012381 NLM
% 209.35/209.50  |- mesh__historyNote mesh__D012381
% 209.35/209.50       91%28%75%29%; was see under PSYCHODRAMA 1975-90   
% 209.35/209.50  |- skos__annotation mesh__D012381 no qualif   
% 209.35/209.50  |- mesh__dateCreated mesh__D012381 1999-01-01
% 209.35/209.50  |- skos__broader mesh__D012381smesh__D011577
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D012381 2002
% 209.35/209.50  |- mesh__activeMeSHYear mesh__D012381 2004
% 209.35/209.51  |- skos__hiddenLabel mesh__D012381 Playings, Role
% 209.35/209.51  |- mesh__recordMaintainer mesh__D012381 ssb
% 209.35/209.51  |- skos__hiddenLabel mesh__D012381 Playing, Role
% 209.35/209.51  |- mesh__publicMeSHNote mesh__D012381
% 209.35/209.51       91; was see under PSYCHODRAMA 1975-90   
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D012381 2006
% 209.35/209.51  |- mesh__recordOriginator mesh__D020813 jmp
% 209.35/209.51  |- skos__prefLabel mesh__D020813 Receptor, trkB
% 209.35/209.51  |- skos__annotation mesh__D020813 DF: RECEPT TRKB   
% 209.35/209.51  |- skos__historyNote mesh__D020813
% 209.35/209.51       Protein-Tyrosine Kinase %28%1990-1993%29%
% 209.35/209.51  |- skos__hiddenLabel mesh__D020813
% 209.35/209.51       Brain Derived Neurotrophic Factor Receptor
% 209.35/209.51  |- skos__historyNote mesh__D020813
% 209.35/209.51       Receptors, Growth Factor %28%1990-1993%29%
% 209.35/209.51  |- mesh__publicMeSHNote mesh__D020813
% 209.35/209.51       2000; TRKB%28%GP145%29% PROTEIN was indexed under RECEPTORS, NERVE GROWTH FACTOR %26% RECEPTOR PROTEIN-TYROSINE KINASE 1994-1999, and under MEMBRANE GLYCOPROTEINS, PROTEIN-TYROSINE KINASE %26% RECEPTORS, GROWTH FACTOR 1990-1999; BDNF RECEPTOR was indexed under RECEPTORS, NERVE GROWTH FACTOR %26% RECEPTOR PROTEIN-TYROSINE KINASE 1995-1999%A%  
% 209.35/209.51  |- skos__hiddenLabel mesh__D020813 Receptor, NTRK2
% 209.35/209.51  |- skos__altLabel mesh__D020813 Brain-Derived Neurotrophic Factor Receptor
% 209.35/209.51  |- skos__historyNote mesh__D020813 Membrane Glycoproteins %28%1990-1993%29%
% 209.35/209.51  |- rdf__type mesh__D020813sskos__Concept
% 209.35/209.51  |- skos__broader mesh__D020813smesh__D017475
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D020813 2006
% 209.35/209.51  |- mesh__dateEstablished mesh__D020813 2000-01-01
% 209.35/209.51  |- skos__hiddenLabel mesh__D020813 Receptor, BDNF
% 209.35/209.51  |- mesh__dateRevised mesh__D020813 2005-06-30
% 209.35/209.51  |- skos__altLabel mesh__D020813 NTRK2 Receptor
% 209.35/209.51  |- mesh__dateCreated mesh__D020813 1999-11-03
% 209.35/209.51  |- skos__altLabel mesh__D020813 trkB Receptor
% 209.35/209.51  |- skos__broader mesh__D020813smesh__D020794
% 209.35/209.51  |- skos__scopeNote mesh__D020813
% 209.35/209.51       A protein-tyrosine kinase receptor that is specific for BRAIN-DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN 3; neurotrophin 4 and neurotrophin 5. It is widely expressed in nervous tissue and plays a role in mediating the effects of neurotrophins on growth and differentiation of neuronal cells.%A%    
% 209.35/209.51  |- skos__altLabel mesh__D020813 trkB%28%gp145%29% Protein
% 209.35/209.51  |- mesh__recordAuthorizer mesh__D020813 sjn
% 209.35/209.51  |- mesh__historyNote mesh__D020813
% 209.35/209.51       2000; for TRKB%28%GP145%29% PROTEIN use RECEPTOR, TYPE 2 NEUROTROPHIC TYROSINE KINASE %28%NM%29% 1990-1999; for BDNF RECEPTOR use RECEPTOR, TYPE 2 NEUROTROPHIC TYROSINE KINASE %28%NM%29% 1995-1999%A%  
% 209.35/209.51  |- skos__altLabel mesh__D020813
% 209.35/209.51       Neurotrophic Factor, Brain-Derived, Receptor
% 209.35/209.51  |- mesh__recordMaintainer mesh__D020813 jmp
% 209.35/209.51  |- skos__altLabel mesh__D020813
% 209.35/209.51       Neurotrophic Tyrosine-Kinase Receptor Type 2
% 209.35/209.51  |- skos__historyNote mesh__D020813
% 209.35/209.51       Receptors, Nerve Growth Factor %28%1994-1999%29%
% 209.35/209.51  |- skos__historyNote mesh__D020813
% 209.35/209.51       Receptor Protein-Tyrosine Kinase %28%1994-1999%29%
% 209.35/209.51  |- skos__altLabel mesh__D020813
% 209.35/209.51       Receptor, Neurotrophic Tyrosine-Kinase Type 2
% 209.35/209.51  |- skos__altLabel mesh__D020813 BDNF Receptor
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D006344 2006
% 209.35/209.51  |- skos__scopeNote mesh__D006344
% 209.35/209.51       Defects in the septum between the atria of the heart, due to failure of fusion between either the septum secundum or the septum primum and the endocardial cushions.%A%    
% 209.35/209.51  |- skos__annotation mesh__D006344
% 209.35/209.51       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 209.35/209.51  |- skos__hiddenLabel mesh__D006344 Foramen Ovales, Patent
% 209.35/209.51  |- skos__hiddenLabel mesh__D006344 Atrial Septal Defect
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D006344 2002
% 209.35/209.51  |- skos__prefLabel mesh__D006344 Heart Septal Defects, Atrial
% 209.35/209.51  |- skos__altLabel mesh__D006344 Atrial Septal Defects
% 209.35/209.51  |- mesh__dateRevised mesh__D006344 1999-11-03
% 209.35/209.51  |- mesh__recordOriginator mesh__D006344 NLM
% 209.35/209.51  |- skos__hiddenLabel mesh__D006344 Septal Defect, Atrial
% 209.35/209.51  |- skos__hiddenLabel mesh__D006344 Septal Defects, Atrial
% 209.35/209.51  |- skos__broader mesh__D006344smesh__D006343
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D006344 2003
% 209.35/209.51  |- skos__hiddenLabel mesh__D006344 Patent Foramen Ovales
% 209.35/209.51  |- mesh__recordAuthorizer mesh__D006344 sjn
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D006344 2004
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D006344 2000
% 209.35/209.51  |- mesh__recordMaintainer mesh__D006344 kle
% 209.35/209.51  |- rdf__type mesh__D006344sskos__Concept
% 209.35/209.51  |- skos__hiddenLabel mesh__D006344 Defects, Atrial Septal
% 209.35/209.51  |- skos__hiddenLabel mesh__D006344 Defect, Atrial Septal
% 209.35/209.51  |- mesh__dateEstablished mesh__D006344 1964-01-01
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D006344 2001
% 209.35/209.51  |- mesh__dateCreated mesh__D006344 1999-01-01
% 209.35/209.51  |- mesh__historyNote mesh__D006344 64   
% 209.35/209.51  |- skos__hiddenLabel mesh__D006344 Ovales, Patent Foramen
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D006344 2005
% 209.35/209.51  |- skos__hiddenLabel mesh__D006344 Ovale, Patent Foramen
% 209.35/209.51  |- skos__hiddenLabel mesh__D006344 Patent Foramen Ovale
% 209.35/209.51  |- mesh__publicMeSHNote mesh__D006344 64   
% 209.35/209.51  |- skos__altLabel mesh__D044463 Protease-Activated Receptor 1
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D044463 2005
% 209.35/209.51  |- skos__hiddenLabel mesh__D044463 Protease Activated Receptor 1
% 209.35/209.51  |- skos__hiddenLabel mesh__D044463 PAR 1 Receptor
% 209.35/209.51  |- skos__hiddenLabel mesh__D044463 Proteinase Activated Receptor 1
% 209.35/209.51  |- rdf__type mesh__D044463sskos__Concept
% 209.35/209.51  |- skos__historyNote mesh__D044463 Receptors, Thrombin %28%1997-2003%29%
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D044463 2004
% 209.35/209.51  |- skos__altLabel mesh__D044463 PAR-1 Receptor
% 209.35/209.51  |- skos__hiddenLabel mesh__D044463 Receptor, PAR 1
% 209.35/209.51  |- skos__hiddenLabel mesh__D044463 Receptor, PAR1
% 209.35/209.51  |- skos__altLabel mesh__D044463 Proteinase-Activated Receptor 1
% 209.35/209.51  |- mesh__dateCreated mesh__D044463 2003-07-09
% 209.35/209.51  |- skos__broader mesh__D044463smesh__D018179
% 209.35/209.51  |- skos__altLabel mesh__D044463 PAR1 Receptor
% 209.35/209.51  |- skos__prefLabel mesh__D044463 Receptor, PAR-1
% 209.35/209.51  |- mesh__historyNote mesh__D044463
% 209.35/209.51       2004; use RECEPTOR, PROTEINASE-ACTIVATED 1 %28%NM%29% 1997-2003%A%  
% 209.35/209.51  |- mesh__publicMeSHNote mesh__D044463
% 209.35/209.51       2004; PROTEASE-ACTIVATED RECEPTOR-1 %28%now RECEPTOR, PROTIENASE-ACTIVATED%29% was indexed under RECEPTORS, THROMBIN 1997-2003%A%  
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D044463 2006
% 209.35/209.51  |- mesh__dateEstablished mesh__D044463 2004-01-01
% 209.35/209.51  |- skos__scopeNote mesh__D044463
% 209.35/209.51       A thrombin receptor subtype that couples to HETEROTRIMERIC GTP-BINDING PROTEINS resulting in the activation of a variety of signaling mechanisms including decreased intracellular CYCLIC AMP, increased PHOSPHOLIPASE C and increased PHOSPHOLIPASE A2.%A%    
% 209.35/209.51  |- mesh__historyNote mesh__D011289 77   
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D011289 2004
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D011289 1997
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D011289 2001
% 209.35/209.51  |- skos__annotation mesh__D011289
% 209.35/209.51       do not use /compl for develop into leukemia   
% 209.35/209.51  |- skos__broader mesh__D011289smesh__D011230
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D011289 2003
% 209.35/209.51  |- mesh__publicMeSHNote mesh__D011289 77   
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D011289 1996
% 209.35/209.51  |- mesh__recordAuthorizer mesh__D011289 PLS
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D011289 2000
% 209.35/209.51  |- mesh__recordOriginator mesh__D011289 VDK
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D011289 2006
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D011289 1999
% 209.35/209.51  |- mesh__recordMaintainer mesh__D011289 KEV
% 209.35/209.51  |- skos__hiddenLabel mesh__D011289 Preleukemias
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D011289 2005
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D011289 1998
% 209.35/209.51  |- mesh__dateCreated mesh__D011289 1976-04-27
% 209.35/209.51  |- skos__scopeNote mesh__D011289
% 209.35/209.51       Conditions in which the abnormalities in the peripheral blood or bone marrow represent the early manifestations of acute leukemia, but in which the changes are not of sufficient magnitude or specificity to permit a diagnosis of acute leukemia by the usual clinical criteria.%A%    
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D011289 2002
% 209.35/209.51  |- mesh__dateRevised mesh__D011289 1995-06-08
% 209.35/209.51  |- skos__broader mesh__D011289smesh__D006402
% 209.35/209.51  |- mesh__dateEstablished mesh__D011289 1977-01-01
% 209.35/209.51  |- rdf__type mesh__D011289sskos__Concept
% 209.35/209.51  |- skos__prefLabel mesh__D011289 Preleukemia
% 209.35/209.51  |- skos__altLabel mesh__D016772 Infections, Mastigophora
% 209.35/209.51  |- mesh__historyNote mesh__D016772 92   
% 209.35/209.51  |- skos__annotation mesh__D016772
% 209.35/209.51       protozoan infect; GEN: prefer specifics   
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016772 2002
% 209.35/209.51  |- mesh__recordOriginator mesh__D016772 PXP
% 209.35/209.51  |- mesh__dateEstablished mesh__D016772 1992-01-01
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016772 2001
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016772 1997
% 209.35/209.51  |- rdf__type mesh__D016772sskos__Concept
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016772 1999
% 209.35/209.51  |- mesh__recordAuthorizer mesh__D016772 PLS
% 209.35/209.51  |- skos__prefLabel mesh__D016772 Mastigophora Infections
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016772 1996
% 209.35/209.51  |- skos__hiddenLabel mesh__D016772 Infection, Mastigophora
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016772 2000
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016772 1995
% 209.35/209.51  |- mesh__recordMaintainer mesh__D016772 TGC
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016772 1998
% 209.35/209.51  |- mesh__dateRevised mesh__D016772 1993-06-02
% 209.35/209.51  |- skos__broader mesh__D016772smesh__D016771
% 209.35/209.51  |- mesh__publicMeSHNote mesh__D016772 92   
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016772 2004
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016772 1994
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016772 2006
% 209.35/209.51  |- mesh__dateCreated mesh__D016772 1991-05-02
% 209.35/209.51  |- skos__hiddenLabel mesh__D016772 Mastigophora Infection
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016772 2003
% 209.35/209.51  |- skos__scopeNote mesh__D016772
% 209.35/209.51       Infections with protozoa of the subphylum MASTIGOPHORA.%A%    
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016772 2005
% 209.35/209.51  |- rdf__type mesh__D002752sskos__Concept
% 209.35/209.51  |- mesh__recordMaintainer mesh__D002752 ssb
% 209.35/209.51  |- skos__scopeNote mesh__D002752
% 209.35/209.51       A benzenesulfonamide-phthalimidine that tautomerizes to a BENZOPHENONES form. It is considered a thiazide-like diuretic.%A%    
% 209.35/209.51  |- skos__broader mesh__D002752smesh__D013449
% 209.35/209.51  |- skos__altLabel mesh__D002752 Chlorphthalidolone
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D002752 2006
% 209.35/209.51  |- skos__altLabel mesh__D002752 Oxodoline
% 209.35/209.51  |- mesh__recordAuthorizer mesh__D002752 sjn
% 209.35/209.51  |- skos__altLabel mesh__D002752 Chlortalidone
% 209.35/209.51  |- mesh__recordOriginator mesh__D002752 NLM
% 209.35/209.51  |- skos__prefLabel mesh__D002752 Chlorthalidone
% 209.35/209.51  |- mesh__dateRevised mesh__D002752 2005-06-30
% 209.35/209.51  |- skos__broader mesh__D002752smesh__D001577
% 209.35/209.51  |- skos__altLabel mesh__D002752 Phthalamudine
% 209.35/209.51  |- mesh__dateCreated mesh__D002752 1999-01-01
% 209.35/209.51  |- skos__broader mesh__D002752smesh__D010797
% 209.35/209.51  |- skos__altLabel mesh__D048056 MAPK9 Mitogen-Activated Protein Kinase
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D048056 2005
% 209.35/209.51  |- rdf__type mesh__D048056sskos__Concept
% 209.35/209.51  |- mesh__recordAuthorizer mesh__D048056 ags
% 209.35/209.51  |- mesh__dateCreated mesh__D048056 2004-07-07
% 209.35/209.51  |- mesh__recordMaintainer mesh__D048056 ags
% 209.35/209.51  |- skos__historyNote mesh__D048056
% 209.35/209.51       Mitogen-Activated Protein Kinases %28%2001-2004%29%
% 209.35/209.51  |- skos__prefLabel mesh__D048056 Mitogen-Activated Protein Kinase 9
% 209.35/209.51  |- skos__hiddenLabel mesh__D048056 Mitogen Activated Protein Kinase 9
% 209.35/209.51  |- skos__broader mesh__D048056smesh__D048031
% 209.35/209.51  |- skos__altLabel mesh__D048056 c-jun N-terminal Kinase 2
% 209.35/209.51  |- skos__hiddenLabel mesh__D048056 Stress Activated Protein Kinase JNK2
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D048056 2006A
% 209.35/209.51  |- mesh__dateRevised mesh__D048056 2005-07-07
% 209.35/209.51  |- skos__historyNote mesh__D048056 Protein Kinases %28%1994-2000%29%
% 209.35/209.51  |- skos__scopeNote mesh__D048056
% 209.35/209.51       A c-jun amino-terminal kinase that is activated by environmental stress and pro-inflammatory cytokines. Several isoforms of the protein with molecular sizes of 48 and 54 KD exist due to multiple ALTERNATIVE SPLICING.%A%    
% 209.35/209.51  |- skos__altLabel mesh__D048056 Stress-Activated Protein Kinase JNK2
% 209.35/209.51  |- mesh__publicMeSHNote mesh__D048056
% 209.35/209.51       2005; MITOGEN-ACTIVATED PROTEIN KINASE 9 was indexed under MITOGEN-ACITVATED PROTEIN KINASES 2001-2004; under PROTEIN KINASES 1994-2000%A%  
% 209.35/209.51  |- skos__hiddenLabel mesh__D048056 Kinase-2, c-jun
% 209.35/209.51  |- skos__hiddenLabel mesh__D048056 JNK2 Stress Activated Protein Kinase
% 209.35/209.51  |- skos__altLabel mesh__D048056 c-jun Kinase-2
% 209.35/209.51  |- skos__altLabel mesh__D048056 JNK2 Kinase
% 209.35/209.51  |- skos__hiddenLabel mesh__D048056 MAPK9 Mitogen Activated Protein Kinase
% 209.35/209.51  |- skos__hiddenLabel mesh__D048056 c jun N terminal Kinase 2
% 209.35/209.51  |- mesh__historyNote mesh__D048056 2005%28%1994%29%   
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D048056 2006
% 209.35/209.51  |- skos__hiddenLabel mesh__D048056 c jun Kinase 2
% 209.35/209.51  |- mesh__recordOriginator mesh__D048056 jmp
% 209.35/209.51  |- skos__altLabel mesh__D048056 JNK2 Stress-Activated Protein Kinase
% 209.35/209.51  |- mesh__dateEstablished mesh__D048056 2005-01-01
% 209.35/209.51  |- skos__hiddenLabel mesh__D012382 Monohydrochloride, Rolitetracycline
% 209.35/209.51  |- skos__altLabel mesh__D012382 Pyrrolidinomethyltetracycline
% 209.35/209.51  |- skos__broader mesh__D012382smesh__D013754
% 209.35/209.51  |- mesh__dateCreated mesh__D012382 1999-01-01
% 209.35/209.51  |- skos__hiddenLabel mesh__D012382 Hydrochloride, Rolitetracycline
% 209.35/209.51  |- mesh__recordMaintainer mesh__D012382 ssb
% 209.35/209.51  |- skos__hiddenLabel mesh__D012382 Nitrate, Rolitetracycline
% 209.35/209.51  |- skos__altLabel mesh__D012382 Revrin
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D012382 2006
% 209.35/209.51  |- mesh__dateRevised mesh__D012382 2004-07-07
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D012382 2005
% 209.35/209.51  |- mesh__recordAuthorizer mesh__D012382 sjn
% 209.35/209.51  |- skos__prefLabel mesh__D012382 Rolitetracycline
% 209.35/209.51  |- skos__hiddenLabel mesh__D012382
% 209.35/209.51       Sesquihydrate Rolitetracycline Mononitrate
% 209.35/209.51  |- skos__hiddenLabel mesh__D012382
% 209.35/209.51       Mononitrate, Sesquihydrate Rolitetracycline
% 209.35/209.51  |- rdf__type mesh__D012382sskos__Concept
% 209.35/209.51  |- skos__hiddenLabel mesh__D012382 Mononitrate, Rolitetracycline
% 209.35/209.51  |- mesh__recordOriginator mesh__D012382 NLM
% 209.35/209.51  |- skos__scopeNote mesh__D012382 A pyrrolidinylmethyl TETRACYCLINE.     
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D020814 2005
% 209.35/209.51  |- skos__broader mesh__D020814smesh__D004927
% 209.35/209.51  |- rdf__type mesh__D020814sskos__Concept
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D020814 2002
% 209.35/209.51  |- skos__annotation mesh__D020814 DF: MENINGITIS E COLI   
% 209.35/209.51  |- skos__hiddenLabel mesh__D020814 Meningitides, Escherichia coli
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D020814 2006
% 209.35/209.51  |- skos__altLabel mesh__D020814 Escherichia coli Meningitis
% 209.35/209.51  |- mesh__dateEstablished mesh__D020814 2000-01-01
% 209.35/209.51  |- mesh__publicMeSHNote mesh__D020814 2000   
% 209.35/209.51  |- skos__broader mesh__D020814smesh__D016920
% 209.35/209.51  |- mesh__dateCreated mesh__D020814 1999-11-04
% 209.35/209.51  |- skos__scopeNote mesh__D020814
% 209.35/209.51       A form of gram-negative meningitis that tends to occur in neonates, in association with anatomical abnormalities %28%which feature communication between the meninges and cutaneous structures%29% or as OPPORTUNISTIC INFECTIONS in association with IMMUNOLOGIC DEFICIENCY SYNDROMES. In premature neonates the clinical presentation may be limited to ANOREXIA; VOMITING; lethargy; or respiratory distress. Full-term infants may have as additional features FEVER; SEIZURES; and bulging of the anterior fontanelle. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp398-400%29%%A%    
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D020814 2003
% 209.35/209.51  |- skos__historyNote mesh__D020814 Meningitis, Bacterial %28%1966-1999%29%
% 209.35/209.51  |- skos__hiddenLabel mesh__D020814 Escherichia coli Meningitides
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D020814 2000
% 209.35/209.51  |- mesh__historyNote mesh__D020814 2000   
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D020814 2004
% 209.35/209.51  |- skos__prefLabel mesh__D020814 Meningitis, Escherichia coli
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D020814 2001
% 209.35/209.51  |- skos__hiddenLabel mesh__D006345 Septal Defect, Ventricular
% 209.35/209.51  |- mesh__dateCreated mesh__D006345 1999-01-01
% 209.35/209.51  |- mesh__historyNote mesh__D006345 64   
% 209.35/209.51  |- skos__annotation mesh__D006345
% 209.35/209.51       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D006345 2006
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D006345 2001
% 209.35/209.51  |- skos__prefLabel mesh__D006345 Heart Septal Defects, Ventricular
% 209.35/209.51  |- skos__hiddenLabel mesh__D006345 Defect, Ventricular Septal
% 209.35/209.51  |- skos__broader mesh__D006345smesh__D006343
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D006345 2005
% 209.35/209.51  |- skos__scopeNote mesh__D006345
% 209.35/209.51       Congenital defects in the septum between the cardiac ventricles, most often due to failure of the bulbar septum to completely close the interventricular foramen.%A%    
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D006345 2004
% 209.35/209.51  |- mesh__recordOriginator mesh__D006345 NLM
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D006345 2000
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D006345 2003
% 209.35/209.51  |- mesh__dateRevised mesh__D006345 1999-11-03
% 209.35/209.51  |- skos__hiddenLabel mesh__D006345 Defects, Ventricular Septal
% 209.35/209.51  |- mesh__recordAuthorizer mesh__D006345 sjn
% 209.35/209.51  |- skos__hiddenLabel mesh__D006345 Ventricular Septal Defect
% 209.35/209.51  |- skos__hiddenLabel mesh__D006345 Septal Defects, Ventricular
% 209.35/209.51  |- mesh__dateEstablished mesh__D006345 1964-01-01
% 209.35/209.51  |- rdf__type mesh__D006345sskos__Concept
% 209.35/209.51  |- skos__altLabel mesh__D006345 Ventricular Septal Defects
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D006345 2002
% 209.35/209.51  |- mesh__recordMaintainer mesh__D006345 kle
% 209.35/209.51  |- mesh__publicMeSHNote mesh__D006345 64   
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D020016 2002
% 209.35/209.51  |- mesh__recordOriginator mesh__D020016 NNS
% 209.35/209.51  |- skos__scopeNote mesh__D020016
% 209.35/209.51       A hemostatic disorder characterized by a poor anticoagulant response to activated protein C %28%APC%29%. The activated form of Factor V %28%Factor Va%29% is more slowly degraded by activated protein C. Factor V Leiden mutation %28%R506Q%29% is the most common cause of APC resistance.%A%    
% 209.35/209.51  |- mesh__dateRevised mesh__D020016 2001-07-25
% 209.35/209.51  |- skos__broader mesh__D020016smesh__D020147
% 209.35/209.51  |- skos__broader mesh__D020016smesh__D019851
% 209.35/209.51  |- mesh__historyNote mesh__D020016 99   
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D020016 2006
% 209.35/209.51  |- skos__broader mesh__D020016smesh__D025861
% 209.35/209.51  |- mesh__recordMaintainer mesh__D020016 nns
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D020016 2003
% 209.35/209.51  |- mesh__dateCreated mesh__D020016 1998-06-10
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D020016 2004
% 209.35/209.51  |- skos__hiddenLabel mesh__D020016 Resistance, APC
% 209.35/209.51  |- mesh__recordAuthorizer mesh__D020016 sjn
% 209.35/209.51  |- skos__altLabel mesh__D020016 APC Resistance
% 209.35/209.51  |- mesh__dateEstablished mesh__D020016 1999-01-01
% 209.35/209.51  |- mesh__publicMeSHNote mesh__D020016 99   
% 209.35/209.51  |- skos__related mesh__D020016smesh__D020151
% 209.35/209.51  |- skos__prefLabel mesh__D020016 Activated Protein C Resistance
% 209.35/209.51  |- rdf__type mesh__D020016sskos__Concept
% 209.35/209.51  |- skos__historyNote mesh__D020016 Factor V/genetics %28%1994-1998%29%
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D020016 2005
% 209.35/209.51  |- skos__historyNote mesh__D020016 Protein C %28%1993-1998%29%
% 209.35/209.51  |- mesh__recordAuthorizer mesh__D044464 sjn
% 209.35/209.51  |- skos__altLabel mesh__D044464 Trypsin Receptor
% 209.35/209.51  |- skos__hiddenLabel mesh__D044464 Receptors, Trypsin
% 209.35/209.51  |- mesh__dateEstablished mesh__D044464 2004-01-01
% 209.35/209.51  |- skos__altLabel mesh__D044464 Protease-Activated Receptor 2
% 209.35/209.51  |- mesh__historyNote mesh__D044464
% 209.35/209.51       2004; use RECEPTOR, PAR-2 %28%NM%29% 1994-2003; for TRYPSIN RECEPTOR use RECEPTOR, PAR-2 %28%NM%29% 1986-2003%A%  
% 209.35/209.51  |- mesh__recordMaintainer mesh__D044464 jmp
% 209.35/209.51  |- mesh__dateCreated mesh__D044464 2003-07-09
% 209.35/209.51  |- skos__hiddenLabel mesh__D044464 PAR 2 Receptor
% 209.35/209.51  |- skos__broader mesh__D044464smesh__D044462
% 209.35/209.51  |- skos__prefLabel mesh__D044464 Receptor, PAR-2
% 209.35/209.51  |- skos__hiddenLabel mesh__D044464 Receptor, PAR2
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D044464 2006
% 209.35/209.51  |- skos__altLabel mesh__D044464 Trypsin Receptors
% 209.35/209.51  |- skos__hiddenLabel mesh__D044464 Protease Activated Receptor 2
% 209.35/209.51  |- skos__altLabel mesh__D044464 PAR-2 Receptor
% 209.35/209.51  |- skos__broader mesh__D044464smesh__D043562
% 209.35/209.51  |- skos__scopeNote mesh__D044464
% 209.35/209.51       A G-protein-coupled, proteinase-activated receptor that is expressed in a variety of tissues including ENDOTHELIUM; LEUKOCYTES; and the GASTROINTESTINAL TRACT. The receptor is activated by TRYPSIN, which cleaves off the N-terminal peptide from the receptor. The new N-terminal peptide is a cryptic ligand for the receptor. The uncleaved receptor can also be activated by the N-terminal peptide present on the activated THROMBIN RECEPTOR and by small synthetic peptides that contain the unmasked N-terminal sequence.%A%    
% 209.35/209.51  |- skos__altLabel mesh__D044464 Proteinase Activated Receptor 2
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D044464 2005
% 209.35/209.51  |- skos__hiddenLabel mesh__D044464 Receptor, PAR 2
% 209.35/209.51  |- rdf__type mesh__D044464sskos__Concept
% 209.35/209.51  |- skos__altLabel mesh__D044464 Receptor, Trypsin
% 209.35/209.51  |- skos__hiddenLabel mesh__D044464 Receptor 2, Protease-Activated
% 209.35/209.51  |- mesh__publicMeSHNote mesh__D044464
% 209.35/209.51       2004; PROTEINASE ACTIVATED RECEPTOR 2 %28%now RECEPTOR, PAR-2%29% was indexed under RECEPTORS, THROMBIN 1994-2003; TRYPSIN RECEPTOR %28%now RECEPTOR, PAR-2%29% was indexed under RECEPTORS, CELL SURFACE 1986-2003%A%  
% 209.35/209.51  |- mesh__recordOriginator mesh__D044464 jmp
% 209.35/209.51  |- skos__altLabel mesh__D044464 PAR2 Receptor
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D044464 2004
% 209.35/209.51  |- skos__historyNote mesh__D044464 Receptors, Thrombin %28%1994-2003%29%
% 209.35/209.51  |- mesh__dateCreated mesh__D016773 1991-05-02
% 209.35/209.51  |- mesh__historyNote mesh__D016773
% 209.35/209.51       92; was see LEISHMANIASIS 1979-91; ORIENTAL SORE was see LEISHMANIASIS 1979-91, was see under LEISHMANIASIS 1963-78%A%  
% 209.35/209.51  |- skos__prefLabel mesh__D016773 Leishmaniasis, Cutaneous
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016773 1997
% 209.35/209.51  |- rdf__type mesh__D016773sskos__Concept
% 209.35/209.51  |- skos__altLabel mesh__D016773 Leishmaniasis, Old World
% 209.35/209.51  |- mesh__publicMeSHNote mesh__D016773
% 209.35/209.51       92; was see LEISHMANIASIS 1979-91; ORIENTAL SORE was see LEISHMANIASIS 1979-91%A%  
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016773 1999
% 209.35/209.51  |- skos__hiddenLabel mesh__D016773 Leishmaniases, Cutaneous
% 209.35/209.51  |- skos__annotation mesh__D016773
% 209.35/209.51       caused by L. aethiopica, L. braziliensis, L. major, L. mexicana or L. tropica; LEISHMANIASIS, DIFFUSE CUTANEOUS %26% LEISHMANIASIS, MUCOCUTANEOUS are also available%A%  
% 209.35/209.51  |- skos__hiddenLabel mesh__D016773 Cutaneous Leishmaniasis
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016773 1996
% 209.35/209.51  |- skos__hiddenLabel mesh__D016773 Sore, Oriental
% 209.35/209.51  |- skos__altLabel mesh__D016773 Leishmaniasis, American
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016773 2002
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016773 1995
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016773 1998
% 209.35/209.51  |- skos__broader mesh__D016773smesh__D007896
% 209.35/209.51  |- mesh__onlineNote mesh__D016773
% 209.35/209.51       use LEISHMANIASIS to search LEISHMANIASIS, CUTANEOUS 1979-91 %26% ORIENTAL SORE 1966-91%A%  
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016773 2004
% 209.35/209.51  |- mesh__dateEstablished mesh__D016773 1992-01-01
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016773 2001
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016773 1994
% 209.35/209.51  |- skos__hiddenLabel mesh__D016773 Old World Leishmaniasis
% 209.35/209.51  |- skos__hiddenLabel mesh__D016773 Cutaneous Leishmaniases
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016773 2006
% 209.35/209.51  |- mesh__recordAuthorizer mesh__D016773 PLS
% 209.35/209.51  |- skos__scopeNote mesh__D016773
% 209.35/209.51       An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.%A%    
% 209.35/209.51  |- mesh__dateRevised mesh__D016773 1993-06-03
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016773 2003
% 209.35/209.51  |- mesh__recordMaintainer mesh__D016773 PXP
% 209.35/209.51  |- skos__hiddenLabel mesh__D016773 New World Leishmaniasis
% 209.35/209.51  |- skos__hiddenLabel mesh__D016773 American Leishmaniasis
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016773 2005
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D016773 2000
% 209.35/209.51  |- skos__historyNote mesh__D016773 Leishmaniasis %28%1966-1991%29%
% 209.35/209.51  |- mesh__recordOriginator mesh__D016773 PXP
% 209.35/209.51  |- mesh__publicMeSHNote mesh__D002753
% 209.35/209.51       91; was see under BENZOXAZOLES 1966-90   
% 209.35/209.51  |- mesh__dateRevised mesh__D002753 2005-06-30
% 209.35/209.51  |- skos__altLabel mesh__D002753 Ortho Brand of Chlorzoxazone
% 209.35/209.51  |- mesh__recordMaintainer mesh__D002753 lkw
% 209.35/209.51  |- rdf__type mesh__D002753sskos__Concept
% 209.35/209.51  |- mesh__dateEstablished mesh__D002753 1991-01-01
% 209.35/209.51  |- skos__broader mesh__D002753smesh__D001583
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D002753 2006
% 209.35/209.51  |- mesh__dateCreated mesh__D002753 1999-01-01
% 209.35/209.51  |- mesh__recordAuthorizer mesh__D002753 sjn
% 209.35/209.51  |- skos__scopeNote mesh__D002753
% 209.35/209.51       A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. %28%From Martindale, The Extra Pharmacopoea, 30th ed, p1202%29%%A%    
% 209.35/209.51  |- skos__prefLabel mesh__D002753 Chlorzoxazone
% 209.35/209.51  |- mesh__historyNote mesh__D002753
% 209.35/209.51       91%28%66%29%; was see under BENZOXAZOLES 1966-90   
% 209.35/209.51  |- mesh__recordOriginator mesh__D002753 NLM
% 209.35/209.51  |- skos__altLabel mesh__D002753 McNeil Brand of Chlorzoxazone
% 209.35/209.51  |- skos__prefLabel mesh__D048057 Mitogen-Activated Protein Kinase 10
% 209.35/209.51  |- skos__hiddenLabel mesh__D048057 3F12 Kinase, p49
% 209.35/209.51  |- skos__altLabel mesh__D048057 c-jun N-Terminal Kinase 3
% 209.35/209.51  |- skos__altLabel mesh__D048057 p49%28%3F12%29% SAP Kinase
% 209.35/209.51  |- skos__historyNote mesh__D048057
% 209.35/209.51       Protein-Serine-Threonine Kinases %28%1995-1999%29%
% 209.35/209.51  |- skos__altLabel mesh__D048057
% 209.35/209.51       Mitogen Activated Protein Kinase p49%28%3F12%29%
% 209.35/209.51  |- mesh__recordOriginator mesh__D048057 jmp
% 209.35/209.51  |- skos__hiddenLabel mesh__D048057 c jun Kinase 3
% 209.35/209.51  |- mesh__dateEstablished mesh__D048057 2005-01-01
% 209.35/209.51  |- skos__historyNote mesh__D048057
% 209.35/209.51       Mitogen-Activated Protein Kinases %28%2000-2004%29%
% 209.35/209.51  |- skos__altLabel mesh__D048057 MAP Kinase p49%28%3F12%29%
% 209.35/209.51  |- skos__altLabel mesh__D048057 p54-SAPK%28%beta%29%
% 209.35/209.51  |- skos__altLabel mesh__D048057 c-jun Kinase 3
% 209.35/209.51  |- skos__hiddenLabel mesh__D048057 Stress Activated Protein Kinase JNK3
% 209.35/209.51  |- skos__hiddenLabel mesh__D048057 Kinase 3, c-jun
% 209.35/209.51  |- skos__broader mesh__D048057smesh__D048031
% 209.35/209.51  |- mesh__publicMeSHNote mesh__D048057
% 209.35/209.51       2005; MITOGEN-ACTIVATED PROTEIN KINASE 10 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004, under PROTEIN-SERINE-THREONINE KINASES 1995-1999%A%  
% 209.35/209.51  |- skos__altLabel mesh__D048057 MAPK10 Mitogen-Activated Protein Kinase
% 209.35/209.51  |- skos__hiddenLabel mesh__D048057 MAPK10 Mitogen Activated Protein Kinase
% 209.35/209.51  |- skos__altLabel mesh__D048057 Stress-Activated Protein Kinase JNK3
% 209.35/209.51  |- mesh__historyNote mesh__D048057 2005%28%1995%29%   
% 209.35/209.51  |- skos__altLabel mesh__D048057 p49 3F12 Kinase
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D048057 2006
% 209.35/209.51  |- mesh__recordMaintainer mesh__D048057 jmp
% 209.35/209.51  |- skos__altLabel mesh__D048057 JNK3 Mitogen Activated Protein Kinase
% 209.35/209.51  |- mesh__recordAuthorizer mesh__D048057 sjn
% 209.35/209.51  |- mesh__activeMeSHYear mesh__D048057 2005
% 209.35/209.51  |- rdf__type mesh__D048057sskos__Concept
% 209.35/209.51  |- skos__hiddenLabel mesh__D048057 c jun N Terminal Kinase 3
% 209.35/209.51  |- skos__hiddenLabel mesh__D048057 Mitogen Activated Protein Kinase 10
% 209.35/209.51  |- mesh__dateCreated mesh__D048057 2004-07-07
% 209.35/209.51  |- skos__scopeNote mesh__D048057
% 209.35/209.51       A c-jun amino-terminal kinase that is found predominantly within NEURONS of the BRAIN, suggesting a role in stress-induced neuronal APOPTOSIS. Several isoforms of the protein with molecular sizes of 47 kDa and 52 kDa exist due to multiple ALTERNATIVE SPLICING.%A%    
% 209.35/209.51  |- skos__altLabel mesh__D012383 Roumania
% 209.35/209.52  |- mesh__dateCreated mesh__D012383 1999-01-01
% 209.35/209.52  |- mesh__recordOriginator mesh__D012383 NLM
% 209.35/209.52  |- mesh__dateRevised mesh__D012383 1995-05-23
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012383 2004
% 209.35/209.52  |- skos__altLabel mesh__D012383 Rumania
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012383 2002
% 209.35/209.52  |- mesh__recordMaintainer mesh__D012383 KEV
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012383 2006
% 209.35/209.52  |- skos__annotation mesh__D012383
% 209.35/209.52       do not spell Roumania; despite current spelling, %28%RUM%29% continues to be the language symbol%A%  
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012383 2003
% 209.35/209.52  |- skos__broader mesh__D012383smesh__D005061
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012383 2001
% 209.35/209.52  |- mesh__onlineNote mesh__D012383 use ROMANIA to search RUMANIA 1966-78   
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012383 2005
% 209.35/209.52  |- rdf__type mesh__D012383sskos__Concept
% 209.35/209.52  |- mesh__historyNote mesh__D012383 79; was RUMANIA 1963-78   
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012383 1997
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012383 2000
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012383 1999
% 209.35/209.52  |- mesh__recordAuthorizer mesh__D012383 PLS
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012383 1996
% 209.35/209.52  |- skos__prefLabel mesh__D012383 Romania
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012383 1998
% 209.35/209.52  |- skos__prefLabel mesh__D020815 Polyproteins
% 209.35/209.52  |- mesh__dateEstablished mesh__D020815 2000-01-01
% 209.35/209.52  |- mesh__dateRevised mesh__D020815 2005-06-30
% 209.35/209.52  |- mesh__recordAuthorizer mesh__D020815 sjn
% 209.35/209.52  |- mesh__recordOriginator mesh__D020815 nns
% 209.35/209.52  |- skos__broader mesh__D020815smesh__D011506
% 209.35/209.52  |- rdf__type mesh__D020815sskos__Concept
% 209.35/209.52  |- mesh__publicMeSHNote mesh__D020815 2000; see PROTEINS 1988-1999   
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D020815 2006
% 209.35/209.52  |- skos__scopeNote mesh__D020815
% 209.35/209.52       Proteins which are synthesized as a single polymer and then cleaved into several distinct proteins.%A%    
% 209.35/209.52  |- mesh__recordMaintainer mesh__D020815 SYSTEM
% 209.35/209.52  |- mesh__historyNote mesh__D020815 2000; use PROTEINS 1988-1999   
% 209.35/209.52  |- mesh__dateCreated mesh__D020815 1999-11-03
% 209.35/209.52  |- mesh__recordAuthorizer mesh__D006346 sjn
% 209.35/209.52  |- skos__annotation mesh__D006346
% 209.35/209.52        /abnorm = HEART SEPTAL DEFECTS or its specifics; heart septal dis: coord IM with  CARDIOMYOPATHIES %28%IM%29%%A%  
% 209.35/209.52  |- mesh__recordMaintainer mesh__D006346 sjn
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D006346 2006
% 209.35/209.52  |- skos__prefLabel mesh__D006346 Heart Septum
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D006346 2005
% 209.35/209.52  |- mesh__historyNote mesh__D006346
% 209.35/209.52       HEART SEPTUM, ATRIAL %26% HEART SEPTUM, VENTRICULAR were headings 1963%A%  
% 209.35/209.52  |- skos__hiddenLabel mesh__D006346 Septum, Heart
% 209.35/209.52  |- skos__altLabel mesh__D006346 Heart Septa
% 209.35/209.52  |- skos__altLabel mesh__D006346 Oval Foramen
% 209.35/209.52  |- skos__hiddenLabel mesh__D006346 Foramen, Oval
% 209.35/209.52  |- mesh__publicMeSHNote mesh__D006346
% 209.35/209.52       HEART SEPTUM, ATRIAL %26% HEART SEPTUM, VENTRICULAR were headings 1963%A%  
% 209.35/209.52  |- rdf__type mesh__D006346sskos__Concept
% 209.35/209.52  |- mesh__dateRevised mesh__D006346 2004-07-13
% 209.35/209.52  |- mesh__recordOriginator mesh__D006346 NLM
% 209.35/209.52  |- skos__hiddenLabel mesh__D006346 Septa, Heart
% 209.35/209.52  |- mesh__dateCreated mesh__D006346 1999-01-01
% 209.35/209.52  |- skos__broader mesh__D006346smesh__D006321
% 209.35/209.52  |- skos__scopeNote mesh__D006346
% 209.35/209.52       The thin membranous structure between the two heart atria or the thick muscular structure between the two heart ventricles.%A%    
% 209.35/209.52  |- mesh__recordOriginator mesh__D044465 jls
% 209.35/209.52  |- mesh__recordAuthorizer mesh__D044465 sjn
% 209.35/209.52  |- skos__hiddenLabel mesh__D044465 Races, Caucasoid
% 209.35/209.52  |- skos__broader mesh__D044465smesh__D044469
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D044465 2006
% 209.35/209.52  |- mesh__dateEstablished mesh__D044465 2004-01-01
% 209.35/209.52  |- skos__hiddenLabel mesh__D044465 Caucasian Races
% 209.35/209.52  |- skos__hiddenLabel mesh__D044465 Races, Caucasian
% 209.35/209.52  |- mesh__historyNote mesh__D044465 2004%28%1966%29%   
% 209.35/209.52  |- skos__hiddenLabel mesh__D044465 Caucasoid Races
% 209.35/209.52  |- skos__altLabel mesh__D044465 Caucasian Race
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D044465 2005
% 209.35/209.52  |- rdf__type mesh__D044465sskos__Concept
% 209.35/209.52  |- mesh__dateCreated mesh__D044465 2003-07-14
% 209.35/209.52  |- skos__hiddenLabel mesh__D044465 Race, Caucasian
% 209.35/209.52  |- skos__annotation mesh__D044465 specify geog if relevant   
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D044465 2004
% 209.35/209.52  |- mesh__recordMaintainer mesh__D044465 jls
% 209.35/209.52  |- skos__hiddenLabel mesh__D044465 White
% 209.35/209.52  |- skos__hiddenLabel mesh__D044465 Race, Caucasoid
% 209.35/209.52  |- mesh__publicMeSHNote mesh__D044465
% 209.35/209.52       2004; see WHITES 1978-2003; see CAUCASOID RACE 1978-2003; see CAUCASIA RACE 1963-1977%A%  
% 209.35/209.52  |- skos__scopeNote mesh__D044465
% 209.35/209.52       Individuals whose ancestral origins are in the continent of Europe.%A%    
% 209.35/209.52  |- skos__prefLabel mesh__D044465 European Continental Ancestry Group
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016774 1995
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016774 1998
% 209.35/209.52  |- mesh__recordAuthorizer mesh__D016774 PLS
% 209.35/209.52  |- mesh__dateRevised mesh__D016774 1993-06-03
% 209.35/209.52  |- skos__hiddenLabel mesh__D016774 Cutaneous Leishmaniasis, Diffuse
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016774 2004
% 209.35/209.52  |- mesh__recordMaintainer mesh__D016774 PXP
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016774 1994
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016774 2000
% 209.35/209.52  |- skos__hiddenLabel mesh__D016774 Diffuse Cutaneous Leishmaniases
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016774 2006
% 209.35/209.52  |- skos__scopeNote mesh__D016774
% 209.35/209.52       A form of LEISHMANIASIS, CUTANEOUS caused by Leishmania aethiopica in Ethiopia and Kenya, L. pifanoi in Venezuela, L. braziliensis in South America, and L. mexicana in Central America. This disease is characterized by massive dissemination of skin lesions without visceral involvement.%A%    
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016774 2003
% 209.35/209.52  |- mesh__publicMeSHNote mesh__D016774 92   
% 209.35/209.52  |- skos__hiddenLabel mesh__D016774 Diffuse Cutaneous Leishmaniasis
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016774 2005
% 209.35/209.52  |- mesh__dateCreated mesh__D016774 1991-05-02
% 209.35/209.52  |- skos__annotation mesh__D016774
% 209.35/209.52       caused by L. aethiopica, L. braziliensis, L. mexicana or L. pifanoi; see MeSH definition for locales%A%  
% 209.35/209.52  |- skos__hiddenLabel mesh__D016774 Cutaneous Leishmaniases, Diffuse
% 209.35/209.52  |- mesh__historyNote mesh__D016774 92   
% 209.35/209.52  |- skos__prefLabel mesh__D016774 Leishmaniasis, Diffuse Cutaneous
% 209.35/209.52  |- skos__historyNote mesh__D016774 Leishmaniasis %28%1966-1991%29%
% 209.35/209.52  |- mesh__dateEstablished mesh__D016774 1992-01-01
% 209.35/209.52  |- rdf__type mesh__D016774sskos__Concept
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016774 2002
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016774 1997
% 209.35/209.52  |- mesh__recordOriginator mesh__D016774 PXP
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016774 1999
% 209.35/209.52  |- skos__broader mesh__D016774smesh__D016773
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016774 1996
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016774 2001
% 209.35/209.52  |- skos__hiddenLabel mesh__D016774 Leishmaniases, Diffuse Cutaneous
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D002754 2004
% 209.35/209.52  |- rdf__type mesh__D002754sskos__Concept
% 209.35/209.52  |- mesh__recordOriginator mesh__D002754 VDK
% 209.35/209.52  |- mesh__recordMaintainer mesh__D002754 kle
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D002754 2003
% 209.35/209.52  |- skos__scopeNote mesh__D002754
% 209.35/209.52       Congenital bony or membranous occlusion of one or both choanae, due to failure of the embryonic bucconasal membrane to rupture.%A%    
% 209.35/209.52  |- mesh__publicMeSHNote mesh__D002754 86   
% 209.35/209.52  |- skos__broader mesh__D002754smesh__D009668
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D002754 2002
% 209.35/209.52  |- skos__broader mesh__D002754smesh__D015619
% 209.35/209.52  |- mesh__historyNote mesh__D002754 86   
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D002754 2001
% 209.35/209.52  |- skos__altLabel mesh__D002754 Atresia, Choanal
% 209.35/209.52  |- mesh__recordAuthorizer mesh__D002754 sjn
% 209.35/209.52  |- skos__prefLabel mesh__D002754 Choanal Atresia
% 209.35/209.52  |- mesh__dateRevised mesh__D002754 1999-11-03
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D002754 2006
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D002754 2000
% 209.35/209.52  |- mesh__dateEstablished mesh__D002754 1986-01-01
% 209.35/209.52  |- skos__historyNote mesh__D002754 Nose/abnormalities %28%1966-1974%29%
% 209.35/209.52  |- skos__annotation mesh__D002754
% 209.35/209.52       nose abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 209.35/209.52  |- skos__hiddenLabel mesh__D002754 Atresias, Choanal
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D002754 2005
% 209.35/209.52  |- mesh__dateCreated mesh__D002754 1985-06-06
% 209.35/209.52  |- skos__historyNote mesh__D002754
% 209.35/209.52       Nasal Cavity/abnormalities %28%1975-1985%29%
% 209.35/209.52  |- skos__hiddenLabel mesh__D002754 Choanal Atresias
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012384 2003
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012384 2005
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012384 2004
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012384 2002
% 209.35/209.52  |- skos__annotation mesh__D012384
% 209.35/209.52       the city ancient or modern Rome: do not confuse with ROMAN WORLD %28%see MeSH definition%29%; Manual 36.14%A%  
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012384 2006
% 209.35/209.52  |- mesh__recordOriginator mesh__D012384 NLM
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012384 1996
% 209.35/209.52  |- skos__broader mesh__D012384smesh__D007558
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012384 1998
% 209.35/209.52  |- mesh__dateRevised mesh__D012384 1994-05-12
% 209.35/209.52  |- skos__prefLabel mesh__D012384 Rome
% 209.35/209.52  |- rdf__type mesh__D012384sskos__Concept
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012384 1997
% 209.35/209.52  |- mesh__dateCreated mesh__D012384 1999-01-01
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012384 2000
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012384 1999
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012384 2001
% 209.35/209.52  |- mesh__recordMaintainer mesh__D012384 TGC
% 209.35/209.52  |- skos__broader mesh__D012384smesh__D002947
% 209.35/209.52  |- mesh__recordAuthorizer mesh__D012384 PLS
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D012384 1995
% 209.35/209.52  |- skos__hiddenLabel mesh__D020816 Supersecondary Protein Structures
% 209.35/209.52  |- skos__scopeNote mesh__D020816
% 209.35/209.52       Commonly observed structural components of proteins formed by simple combinations of adjacent secondary structures. A commonly observed structure may be composed of a CONSERVED SEQUENCE which can be represented by a CONSENSUS SEQUENCE.%A%    
% 209.35/209.52  |- skos__related mesh__D020816smesh__D016384
% 209.35/209.52  |- mesh__dateCreated mesh__D020816 1999-11-08
% 209.35/209.52  |- skos__altLabel mesh__D020816 Protein Motifs
% 209.35/209.52  |- mesh__recordOriginator mesh__D020816 nns
% 209.35/209.52  |- mesh__historyNote mesh__D020816 2000   
% 209.35/209.52  |- skos__annotation mesh__D020816
% 209.35/209.52       IM general; coord NIM with specific protein %28%IM%29%; PROTEIN DOMAINS see PROTEIN STRUCTURE, TERTIARY is available; if the amino acid motif is a representative of conserved sequence then also index CONSENSUS SEQUENCE; DF: AA MOTIFS%A%  
% 209.35/209.52  |- skos__hiddenLabel mesh__D020816 Motif, Amino Acid
% 209.35/209.52  |- skos__broader mesh__D020816smesh__D017433
% 209.35/209.52  |- skos__hiddenLabel mesh__D020816 Motifs, Protein
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D020816 2005
% 209.35/209.52  |- skos__hiddenLabel mesh__D020816 Protein Motif
% 209.35/209.52  |- skos__altLabel mesh__D020816 Supersecondary Protein Structure
% 209.35/209.52  |- mesh__dateRevised mesh__D020816 2004-07-07
% 209.35/209.52  |- mesh__recordAuthorizer mesh__D020816 sjn
% 209.35/209.52  |- skos__hiddenLabel mesh__D020816 Motif, Protein
% 209.35/209.52  |- rdf__type mesh__D020816sskos__Concept
% 209.35/209.52  |- skos__related mesh__D020816smesh__D017124
% 209.35/209.52  |- skos__prefLabel mesh__D020816 Amino Acid Motifs
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D020816 2006
% 209.35/209.52  |- skos__hiddenLabel mesh__D020816 Amino Acid Motif
% 209.35/209.52  |- skos__hiddenLabel mesh__D020816 Protein Structures, Supersecondary
% 209.35/209.52  |- skos__altLabel mesh__D020816 Motifs, Amino Acid
% 209.35/209.52  |- mesh__recordMaintainer mesh__D020816 nns
% 209.35/209.52  |- mesh__dateEstablished mesh__D020816 2000-01-01
% 209.35/209.52  |- mesh__publicMeSHNote mesh__D020816 2000   
% 209.35/209.52  |- skos__broader mesh__D020816smesh__D000595
% 209.35/209.52  |- skos__broader mesh__D039521smesh__D018845
% 209.35/209.52  |- rdf__type mesh__D039521sskos__Concept
% 209.35/209.52  |- skos__hiddenLabel mesh__D039521 Leu M5 Antigens
% 209.35/209.52  |- mesh__historyNote mesh__D039521
% 209.35/209.52       2003; for CD11C ANTIGEN %26% ANTIGENS, CD11C use INTEGRIN ALPHAXBETA2 1995-2002%A%  
% 209.35/209.52  |- mesh__recordOriginator mesh__D039521 MDJ
% 209.35/209.52  |- skos__scopeNote mesh__D039521
% 209.35/209.52       An integrin alpha subunit of approximately 150-kDa molecular weight. It is expressed at high levels on monocytes and combines with CD18 ANTIGEN to form the cell surface receptor INTEGRIN ALPHAXBETA2. The subunit contains a conserved I domain which is characteristic of several of alpha integrins.%A%    
% 209.35/209.52  |- skos__hiddenLabel mesh__D039521 alphaX, Integrin
% 209.35/209.52  |- skos__broader mesh__D039521smesh__D039001
% 209.35/209.52  |- skos__hiddenLabel mesh__D039521 Antigens, Leu-M5
% 209.35/209.52  |- mesh__dateCreated mesh__D039521 2002-07-02
% 209.35/209.52  |- skos__altLabel mesh__D039521 Leu-M5 Antigens
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D039521 2006
% 209.35/209.52  |- mesh__publicMeSHNote mesh__D039521
% 209.35/209.52       2003; for CD11C ANTIGEN %26% ANTIGENS, CD11C see COMPLEMENT 4-BINDING PROTEIN 1995-2002%A%  
% 209.35/209.52  |- skos__altLabel mesh__D039521 Integrin alphaX
% 209.35/209.52  |- skos__historyNote mesh__D039521 Integrin alphaXbeta2 %28%1995-2002%29%
% 209.35/209.52  |- skos__prefLabel mesh__D039521 Antigens, CD11c
% 209.35/209.52  |- skos__altLabel mesh__D039521 CD11c Antigen
% 209.35/209.52  |- skos__hiddenLabel mesh__D039521 Antigen, CD11c
% 209.35/209.52  |- mesh__recordAuthorizer mesh__D039521 sjn
% 209.35/209.52  |- mesh__recordMaintainer mesh__D039521 ssb
% 209.35/209.52  |- mesh__dateEstablished mesh__D039521 2003-01-01
% 209.35/209.52  |- skos__altLabel mesh__D039521 CD11c Antigens
% 209.35/209.52  |- mesh__dateRevised mesh__D039521 2005-06-30
% 209.35/209.52  |- skos__hiddenLabel mesh__D006347 Sounds, Cardiac
% 209.35/209.52  |- skos__related mesh__D006347smesh__D010701
% 209.35/209.52  |- mesh__recordOriginator mesh__D006347 NLM
% 209.35/209.52  |- mesh__dateRevised mesh__D006347 2003-07-09
% 209.35/209.52  |- skos__altLabel mesh__D006347 Cardiac Sounds
% 209.35/209.52  |- skos__annotation mesh__D006347
% 209.35/209.52       note category: do not confuse with HEART MURMURS, a disease concept%A%  
% 209.35/209.52  |- mesh__publicMeSHNote mesh__D006347
% 209.35/209.52       91; was see under HEART AUSCULTATION 1963-90; was in Cat E 1963-90%A%  
% 209.35/209.52  |- skos__hiddenLabel mesh__D006347 Cardiac Sound
% 209.35/209.52  |- mesh__recordMaintainer mesh__D006347 nns
% 209.35/209.52  |- rdf__type mesh__D006347sskos__Concept
% 209.35/209.52  |- mesh__onlineNote mesh__D006347 search HEART AUSCULTATION 1966-74   
% 209.35/209.52  |- mesh__recordAuthorizer mesh__D006347 sjn
% 209.35/209.52  |- skos__hiddenLabel mesh__D006347 Sounds, Heart
% 209.35/209.52  |- mesh__dateCreated mesh__D006347 1999-01-01
% 209.35/209.52  |- skos__hiddenLabel mesh__D006347 Heart Sound
% 209.35/209.52  |- skos__related mesh__D006347smesh__D006326
% 209.35/209.52  |- mesh__historyNote mesh__D006347
% 209.35/209.52       91%28%75%29%; was see under HEART AUSCULTATION 1963-90; was in Cat E 1963-90%A%  
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D006347 2006
% 209.35/209.52  |- skos__scopeNote mesh__D006347
% 209.35/209.52       The sounds heard over the cardiac region produced by the functioning of the heart. There are four distinct sounds: the first occurs at the beginning of SYSTOLE and is heard as a %22%lubb%22% sound; the second is produced by the closing of the AORTIC VALVE and PULMONARY VALVE and is heard as a %22%dupp%22% sound; the third is produced by vibrations of the ventricular walls when suddenly distended by the rush of blood from the HEART ATRIA; and the fourth is produced by atrial contraction and ventricular filling.%A%    
% 209.35/209.52  |- skos__hiddenLabel mesh__D006347 Sound, Cardiac
% 209.35/209.52  |- skos__hiddenLabel mesh__D006347 Sound, Heart
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D006347 2004
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D006347 2005
% 209.35/209.52  |- skos__broader mesh__D006347smesh__D045472
% 209.35/209.52  |- mesh__dateEstablished mesh__D006347 1991-01-01
% 209.35/209.52  |- skos__prefLabel mesh__D006347 Heart Sounds
% 209.35/209.52  |- skos__related mesh__D006347smesh__D006337
% 209.35/209.52  |- skos__hiddenLabel mesh__D020018 Dysfunctions, Psychosexual
% 209.35/209.52  |- skos__hiddenLabel mesh__D020018 Disorder, Psychosexual
% 209.35/209.52  |- skos__altLabel mesh__D020018 Psychosexual Disorders
% 209.35/209.52  |- skos__hiddenLabel mesh__D020018 Psychosexual Dysfunction
% 209.35/209.52  |- mesh__recordAuthorizer mesh__D020018 sjn
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D020018 2006
% 209.35/209.52  |- mesh__dateCreated mesh__D020018 1997-07-14
% 209.35/209.52  |- skos__hiddenLabel mesh__D020018 Dysfunctions, Psychological Sexual
% 209.35/209.52  |- skos__broader mesh__D020018smesh__D019968
% 209.35/209.52  |- skos__hiddenLabel mesh__D020018 Disorders, Sexual Aversion
% 209.35/209.52  |- skos__prefLabel mesh__D020018 Sexual Dysfunctions, Psychological
% 209.35/209.52  |- skos__hiddenLabel mesh__D020018 Disorders, Psychosexual
% 209.35/209.52  |- skos__hiddenLabel mesh__D020018 Psychosexual Disorder
% 209.35/209.52  |- mesh__dateRevised mesh__D020018 2005-06-30
% 209.35/209.52  |- skos__hiddenLabel mesh__D020018 Psychological Sexual Dysfunction
% 209.35/209.52  |- skos__hiddenLabel mesh__D020018 Dysfunction, Psychosexual
% 209.35/209.52  |- skos__scopeNote mesh__D020018
% 209.35/209.52       Disturbances in sexual desire and the psychophysiologic changes that characterize the sexual response cycle and cause marked distress and interpersonal difficulty. %28%APA, DSM-IV, 1994%29%%A%    
% 209.35/209.52  |- skos__hiddenLabel mesh__D020018 Sexual Arousal Disorders
% 209.35/209.52  |- mesh__historyNote mesh__D020018 99%28%81%29%   
% 209.35/209.52  |- skos__hiddenLabel mesh__D020018 Sexual Aversion Disorders
% 209.35/209.52  |- mesh__recordOriginator mesh__D020018 JLS
% 209.35/209.52  |- skos__hiddenLabel mesh__D020018 Arousal Disorders, Sexual
% 209.35/209.52  |- skos__altLabel mesh__D020018 Psychosexual Dysfunctions
% 209.35/209.52  |- skos__hiddenLabel mesh__D020018 Disorders, Sexual Arousal
% 209.35/209.52  |- skos__hiddenLabel mesh__D020018 Disorders, Orgasmic
% 209.35/209.52  |- mesh__dateEstablished mesh__D020018 1998-01-01
% 209.35/209.52  |- skos__hiddenLabel mesh__D020018 Orgasmic Disorders
% 209.35/209.52  |- skos__hiddenLabel mesh__D020018 Dysfunction, Psychological Sexual
% 209.35/209.52  |- rdf__type mesh__D020018sskos__Concept
% 209.35/209.52  |- skos__hiddenLabel mesh__D020018 Sexual Dysfunction, Psychological
% 209.35/209.52  |- skos__hiddenLabel mesh__D020018 Psychological Sexual Dysfunctions
% 209.35/209.52  |- mesh__recordMaintainer mesh__D020018 lkt
% 209.35/209.52  |- mesh__publicMeSHNote mesh__D020018
% 209.35/209.52       99; see SEXUAL DYSFUNCTIONS 1998; see PSYCHOSEXUAL DISORDERS was heading 1981-98; for FRIGIDITY see FRIGIDITY 1966-97; for PSYCHOSEXUAL DISORDERS see PSYCHOSEXUAL DISORDERS 1981-97%A%  
% 209.35/209.52  |- skos__hiddenLabel mesh__D020018 Aversion Disorders, Sexual
% 209.35/209.52  |- skos__historyNote mesh__D025501 6-Phosphofructokinase %28%1977-2001%29%
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D025501 2006
% 209.35/209.52  |- rdf__type mesh__D025501sskos__Concept
% 209.35/209.52  |- skos__prefLabel mesh__D025501 Phosphofructokinase-1, Liver Type
% 209.35/209.52  |- skos__hiddenLabel mesh__D025501 Phosphofructokinase 1, Liver Type
% 209.35/209.52  |- skos__altLabel mesh__D025501 Phosphofructo-1-kinase Isozyme B
% 209.35/209.52  |- mesh__historyNote mesh__D025501 2002   
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D025501 2005
% 209.35/209.52  |- mesh__publicMeSHNote mesh__D025501 2002   
% 209.35/209.52  |- skos__altLabel mesh__D025501 6-Phosphofructokinase, Liver Type
% 209.35/209.52  |- mesh__dateCreated mesh__D025501 2001-07-25
% 209.35/209.52  |- skos__scopeNote mesh__D025501
% 209.35/209.52       An allosteric enzyme that regulates glycolysis by catalyzing the transfer of a phosphate group from ATP to fructose-6-phosphate to yield fructose-1,6-bisphosphate. In human liver, the 6-phosphofructose-1-kinase exists as the homotetramer of L subunits.%A%    
% 209.35/209.52  |- mesh__recordAuthorizer mesh__D025501 sjn
% 209.35/209.52  |- mesh__dateEstablished mesh__D025501 2002-01-01
% 209.35/209.52  |- mesh__dateRevised mesh__D025501 2004-07-13
% 209.35/209.52  |- mesh__recordMaintainer mesh__D025501 sjn
% 209.35/209.52  |- skos__broader mesh__D025501smesh__D010732
% 209.35/209.52  |- mesh__recordOriginator mesh__D025501 lkt
% 209.35/209.52  |- skos__hiddenLabel mesh__D044466 Asiatic Races
% 209.35/209.52  |- skos__prefLabel mesh__D044466 Asian Continental Ancestry Group
% 209.35/209.52  |- mesh__recordAuthorizer mesh__D044466 sjn
% 209.35/209.52  |- skos__broader mesh__D044466smesh__D044469
% 209.35/209.52  |- mesh__dateCreated mesh__D044466 2003-07-09
% 209.35/209.52  |- skos__hiddenLabel mesh__D044466 Race, Mongoloid
% 209.35/209.52  |- skos__hiddenLabel mesh__D044466 Races, Mongoloid
% 209.35/209.52  |- mesh__recordOriginator mesh__D044466 jls
% 209.35/209.52  |- skos__altLabel mesh__D044466 Asiatic Race
% 209.35/209.52  |- rdf__type mesh__D044466sskos__Concept
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D044466 2006
% 209.35/209.52  |- mesh__historyNote mesh__D044466 2004%28%1966%29%   
% 209.35/209.52  |- skos__scopeNote mesh__D044466
% 209.35/209.52       Individuals whose ancestral origins are in the continent of Asia.%A%    
% 209.35/209.52  |- mesh__dateEstablished mesh__D044466 2004-01-01
% 209.35/209.52  |- skos__hiddenLabel mesh__D044466 Mongoloid Races
% 209.35/209.52  |- mesh__recordMaintainer mesh__D044466 jls
% 209.35/209.52  |- skos__hiddenLabel mesh__D044466 Races, Asiatic
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D044466 2005
% 209.35/209.52  |- skos__hiddenLabel mesh__D044466 Race, Asiatic
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D044466 2004
% 209.35/209.52  |- skos__hiddenLabel mesh__D044466 Asian
% 209.35/209.52  |- mesh__publicMeSHNote mesh__D044466 2004; see Mongoloid Race 1966-2003   
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016775 2006
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016775 2003
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016775 2001
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016775 2005
% 209.35/209.52  |- mesh__recordAuthorizer mesh__D016775 PLS
% 209.35/209.52  |- mesh__dateRevised mesh__D016775 1993-06-03
% 209.35/209.52  |- mesh__historyNote mesh__D016775 92   
% 209.35/209.52  |- skos__prefLabel mesh__D016775 Sarcodina Infections
% 209.35/209.52  |- skos__hiddenLabel mesh__D016775 Sarcodina Infection
% 209.35/209.52  |- skos__hiddenLabel mesh__D016775 Infection, Sarcodina
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016775 2000
% 209.35/209.52  |- skos__annotation mesh__D016775
% 209.35/209.52       protozoan infect; GEN or unspecified; most common infect is AMEBIASIS or its specifics%A%  
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016775 1997
% 209.35/209.52  |- mesh__publicMeSHNote mesh__D016775 92   
% 209.35/209.52  |- rdf__type mesh__D016775sskos__Concept
% 209.35/209.52  |- mesh__recordOriginator mesh__D016775 PXP
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016775 1999
% 209.35/209.52  |- mesh__dateCreated mesh__D016775 1991-05-02
% 209.35/209.52  |- skos__scopeNote mesh__D016775
% 209.35/209.52       Infections with protozoa of the subphylum SARCODINA.     
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016775 1996
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016775 1995
% 209.35/209.52  |- skos__altLabel mesh__D016775 Infections, Sarcodina
% 209.35/209.52  |- skos__broader mesh__D016775smesh__D016771
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016775 1998
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016775 2004
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016775 2002
% 209.35/209.52  |- mesh__recordMaintainer mesh__D016775 TGC
% 209.35/209.52  |- mesh__dateEstablished mesh__D016775 1992-01-01
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D016775 1994
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D002755 2003
% 209.35/209.52  |- skos__historyNote mesh__D002755 Decision Making %28%1974%29%
% 209.35/209.52  |- skos__broader mesh__D002755smesh__D003657
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D002755 1995
% 209.35/209.52  |- mesh__onlineNote mesh__D002755 search DECISION MAKING 1974   
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D002755 1999
% 209.35/209.52  |- skos__scopeNote mesh__D002755
% 209.35/209.52       The act of making a selection among two or more alternatives, usually after a period of deliberation.%A%    
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D002755 1994
% 209.35/209.52  |- mesh__dateCreated mesh__D002755 1999-01-01
% 209.35/209.52  |- skos__hiddenLabel mesh__D002755 Choice Behaviors
% 209.35/209.52  |- skos__hiddenLabel mesh__D002755 Behaviors, Choice
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D002755 2006
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D002755 1998
% 209.35/209.52  |- mesh__publicMeSHNote mesh__D002755
% 209.35/209.52       79; was see under DECISION MAKING 1974-78; CAREER CHOICE was see under DECISION MAKING 1975-80%A%  
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D002755 1993
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D002755 2002
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D002755 2005
% 209.35/209.52  |- mesh__historyNote mesh__D002755
% 209.35/209.52       79%28%75%29%; was see under DECISION MAKING 1974-78   
% 209.35/209.52  |- mesh__dateRevised mesh__D002755 1992-05-07
% 209.35/209.52  |- mesh__recordMaintainer mesh__D002755 TAP
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D002755 1997
% 209.35/209.52  |- mesh__dateEstablished mesh__D002755 1979-01-01
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D002755 2001
% 209.35/209.52  |- skos__hiddenLabel mesh__D002755 Behavior, Choice
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D002755 2004
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D002755 1996
% 209.35/209.52  |- mesh__recordOriginator mesh__D002755 NLM
% 209.35/209.52  |- rdf__type mesh__D002755sskos__Concept
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D002755 2000
% 209.35/209.52  |- skos__prefLabel mesh__D002755 Choice Behavior
% 209.35/209.52  |- mesh__recordAuthorizer mesh__D002755 PLS
% 209.35/209.52  |- skos__scopeNote mesh__D007440
% 209.35/209.52       Introduction of a tube into a hollow organ to restore or maintain patency if obstructed. It is differentiated from CATHETERIZATION in that the insertion of a catheter is usually performed for the introducing or withdrawing of fluids from the body.%A%    
% 209.35/209.52  |- mesh__dateRevised mesh__D007440 1997-06-20
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D007440 2003
% 209.35/209.52  |- skos__broader mesh__D007440smesh__D008919
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D007440 1999
% 209.35/209.52  |- mesh__dateCreated mesh__D007440 1999-01-01
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D007440 1998
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D007440 2006
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D007440 2002
% 209.35/209.52  |- mesh__publicMeSHNote mesh__D007440 66   
% 209.35/209.52  |- skos__hiddenLabel mesh__D007440 Intubations
% 209.35/209.52  |- mesh__recordMaintainer mesh__D007440 TGC
% 209.35/209.52  |- skos__annotation mesh__D007440
% 209.35/209.52       do not use /util except by MeSH definition; for intub proced in dis, coord with dis /ther, not /surg; esophageal intub = ESOPHAGUS %28%IM%29% + INTUBATION %28%IM%29%, not INTUBATION, GASTROINTESTINAL; esophageal obturator airway = ESOPHAGUS %28%IM%29% + INTUBATION /instrum %28%IM%29%%A%  
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D007440 2005
% 209.35/209.52  |- mesh__recordOriginator mesh__D007440 NLM
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D007440 2001
% 209.35/209.52  |- skos__related mesh__D007440smesh__D015505
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D007440 2004
% 209.35/209.52  |- rdf__type mesh__D007440sskos__Concept
% 209.35/209.52  |- skos__prefLabel mesh__D007440 Intubation
% 209.35/209.52  |- mesh__activeMeSHYear mesh__D007440 2000
% 209.35/209.52  |- mesh__historyNote mesh__D007440 66   
% 209.35/209.52  |- mesh__recordAuthorizer mesh__D007440 SJN
% 209.35/209.52  |- mesh__dateEstablished mesh__D007440 1966-01-01
% 209.35/209.52  |- skos__altLabel mesh__D012385 Ronidazol
% 209.35/209.52  |- mesh__dateCreated mesh__D012385 1974-11-19
% 209.35/209.53  |- mesh__publicMeSHNote mesh__D012385
% 209.35/209.53       91; was see under NITROIMIDAZOLES 1975-90   
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D012385 2006
% 209.35/209.53  |- mesh__dateEstablished mesh__D012385 1991-01-01
% 209.35/209.53  |- skos__prefLabel mesh__D012385 Ronidazole
% 209.35/209.53  |- skos__broader mesh__D012385smesh__D009593
% 209.35/209.53  |- mesh__dateRevised mesh__D012385 2005-06-30
% 209.35/209.53  |- rdf__type mesh__D012385sskos__Concept
% 209.35/209.53  |- skos__historyNote mesh__D012385 Nitroimidazoles %28%1974%29%
% 209.35/209.53  |- skos__historyNote mesh__D012385 Carbamates %28%1974%29%
% 209.35/209.53  |- mesh__recordAuthorizer mesh__D012385 sjn
% 209.35/209.53  |- mesh__historyNote mesh__D012385
% 209.35/209.53       91%28%75%29%; was see under NITROIMIDAZOLES 1975-90   
% 209.35/209.53  |- mesh__recordOriginator mesh__D012385 NLM
% 209.35/209.53  |- mesh__recordMaintainer mesh__D012385 ssb
% 209.35/209.53  |- skos__scopeNote mesh__D012385
% 209.35/209.53       Antiprotozoal and antimicrobial agent used mainly in veterinary practice.%A%    
% 209.35/209.53  |- skos__altLabel mesh__D012385 Hesse Brand of Ronidazole
% 209.35/209.53  |- mesh__dateEstablished mesh__D020817 2000-01-01
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D020817 2005
% 209.35/209.53  |- mesh__dateCreated mesh__D020817 1999-11-08
% 209.35/209.53  |- skos__prefLabel mesh__D020817 Asperger Syndrome
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D020817 2004
% 209.35/209.53  |- skos__scopeNote mesh__D020817
% 209.35/209.53       A childhood disorder predominately affecting boys and similar to autism %28%AUTISTIC DISORDER%29%. It is characterized by severe, sustained, clinically significant impairment of social interaction, and restricted repetitive and stereotyped patterns of behavior. In contrast to autism, there are no clinically significant delays in language or cognitive development. %28%From DSM-IV%29%%A%    
% 209.35/209.53  |- skos__altLabel mesh__D020817 Asperger%27%s Syndrome
% 209.35/209.53  |- mesh__publicMeSHNote mesh__D020817 2000   
% 209.35/209.53  |- skos__broader mesh__D020817smesh__D002659
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D020817 2003
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D020817 2002
% 209.35/209.53  |- skos__altLabel mesh__D020817 Asperger%27%s Disorder
% 209.35/209.53  |- skos__hiddenLabel mesh__D020817 Asperger Disorder
% 209.35/209.53  |- mesh__historyNote mesh__D020817 2000   
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D020817 2001
% 209.35/209.53  |- skos__hiddenLabel mesh__D020817 Aspergers Syndrome
% 209.35/209.53  |- rdf__type mesh__D020817sskos__Concept
% 209.35/209.53  |- skos__historyNote mesh__D020817 Autistic Disorder %28%1981-1999%29%
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D020817 2006
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D020817 2000
% 209.35/209.53  |- skos__hiddenLabel mesh__D020817 Aspergers Disorder
% 209.35/209.53  |- skos__altLabel mesh__D006348 Procedure, Cardiac Surgical
% 209.35/209.53  |- skos__related mesh__D006348smesh__D013903
% 209.35/209.53  |- rdf__type mesh__D006348sskos__Concept
% 209.35/209.53  |- mesh__dateCreated mesh__D006348 1999-01-01
% 209.35/209.53  |- skos__altLabel mesh__D006348 Surgical Procedures, Heart
% 209.35/209.53  |- skos__altLabel mesh__D006348 Heart Surgical Procedure
% 209.35/209.53  |- mesh__publicMeSHNote mesh__D006348 98; was HEART SURGERY 1963-97   
% 209.35/209.53  |- skos__altLabel mesh__D006348 Heart Surgical Procedures
% 209.35/209.53  |- mesh__recordOriginator mesh__D006348 NLM
% 209.35/209.53  |- skos__prefLabel mesh__D006348 Cardiac Surgical Procedures
% 209.35/209.53  |- skos__annotation mesh__D006348
% 209.35/209.53       GEN only: do not use for surg of specific part of heart %28% = specific heart term /surg%29% or specific heart dis %28% = disease /surg%29%; HEART TRANSPLANTATION %26% HEART-LUNG TRANSPLANTATION are also available%A%  
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D006348 2006
% 209.35/209.53  |- skos__altLabel mesh__D006348 Procedure, Heart Surgical
% 209.35/209.53  |- mesh__historyNote mesh__D006348 98; was HEART SURGERY 1963-97   
% 209.35/209.53  |- skos__broader mesh__D006348smesh__D019616
% 209.35/209.53  |- skos__altLabel mesh__D006348 Procedures, Cardiac Surgical
% 209.35/209.53  |- mesh__recordAuthorizer mesh__D006348 sjn
% 209.35/209.53  |- skos__scopeNote mesh__D006348 Surgery performed on the heart.     
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D006348 2004
% 209.35/209.53  |- skos__altLabel mesh__D006348 Surgical Procedures, Cardiac
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D006348 2005
% 209.35/209.53  |- mesh__recordMaintainer mesh__D006348 jls
% 209.35/209.53  |- skos__altLabel mesh__D006348 Procedures, Heart Surgical
% 209.35/209.53  |- skos__broader mesh__D006348smesh__D013504
% 209.35/209.53  |- mesh__dateRevised mesh__D006348 2002-07-03
% 209.35/209.53  |- skos__altLabel mesh__D006348 Cardiac Surgical Procedure
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D006348 2003
% 209.35/209.53  |- skos__altLabel mesh__D006348 Surgical Procedure, Heart
% 209.35/209.53  |- skos__altLabel mesh__D006348 Surgical Procedure, Cardiac
% 209.35/209.53  |- skos__related mesh__D020019smesh__D013621
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D020019 2003
% 209.35/209.53  |- mesh__recordMaintainer mesh__D020019 ags
% 209.35/209.53  |- mesh__historyNote mesh__D020019 1999   
% 209.35/209.53  |- skos__scopeNote mesh__D020019
% 209.35/209.53       Infection of the brain, spinal cord, or perimeningeal structures with the larval forms of the genus TAENIA %28%primarily T. solium in humans%29%. Lesions formed by the organism are referred to as cysticerci. The infection may be subacute or chronic, and the severity of symptoms depends on the severity of the host immune response and the location and number of lesions. SEIZURES represent the most common clinical manifestation although focal neurologic deficits may occur. %28%From Joynt, Clinical Neurology, 1998, Ch27, pp46-50%29%%A%    
% 209.35/209.53  |- skos__altLabel mesh__D020019 Cysticercosis, Brain
% 209.35/209.53  |- skos__altLabel mesh__D020019 Central Nervous System Cysticercosis
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D020019 2000A
% 209.35/209.53  |- skos__historyNote mesh__D020019 Brain Diseases %28%1966-1998%29%
% 209.35/209.53  |- rdf__type mesh__D020019sskos__Concept
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D020019 2002
% 209.35/209.53  |- mesh__dateCreated mesh__D020019 1998-06-10
% 209.35/209.53  |- skos__annotation mesh__D020019
% 209.35/209.53       coord IM with specific site/dis term %28%IM%29% if pertinent   
% 209.35/209.53  |- skos__prefLabel mesh__D020019 Neurocysticercosis
% 209.35/209.53  |- skos__broader mesh__D020019smesh__D003551
% 209.35/209.53  |- skos__historyNote mesh__D020019 Cysticercosis %28%1966-1998%29%
% 209.35/209.53  |- mesh__dateRevised mesh__D020019 1999-12-13
% 209.35/209.53  |- mesh__dateEstablished mesh__D020019 1999-01-01
% 209.35/209.53  |- skos__broader mesh__D020019smesh__D020809
% 209.35/209.53  |- mesh__recordOriginator mesh__D020019 AGS
% 209.35/209.53  |- mesh__publicMeSHNote mesh__D020019 1999   
% 209.35/209.53  |- skos__hiddenLabel mesh__D020019 Brain Cysticercosis
% 209.35/209.53  |- mesh__recordAuthorizer mesh__D020019 ags
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D020019 2006
% 209.35/209.53  |- skos__altLabel mesh__D020019 Cysticercosis, Central Nervous System
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D020019 2001
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D020019 2004
% 209.35/209.53  |- skos__hiddenLabel mesh__D020019 Neurocysticercoses
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D020019 2000
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D020019 2005
% 209.35/209.53  |- rdf__type mesh__D025502sskos__Concept
% 209.35/209.53  |- mesh__dateRevised mesh__D025502 2003-07-09
% 209.35/209.53  |- skos__altLabel mesh__D025502 6-Phosphofructokinase, Platelet Type
% 209.35/209.53  |- skos__altLabel mesh__D025502 Phosphofructo-1-kinase Isozyme C
% 209.35/209.53  |- skos__historyNote mesh__D025502 6-Phosphofructokinase %28%1977-2001%29%
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D025502 2006
% 209.35/209.53  |- mesh__dateEstablished mesh__D025502 2002-01-01
% 209.35/209.53  |- mesh__dateCreated mesh__D025502 2001-07-25
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D025502 2005
% 209.35/209.53  |- mesh__historyNote mesh__D025502 2002   
% 209.35/209.53  |- mesh__publicMeSHNote mesh__D025502 2002   
% 209.35/209.53  |- skos__prefLabel mesh__D025502 Phosphofructokinase-1, Type C
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D025502 2004
% 209.35/209.53  |- skos__broader mesh__D025502smesh__D010732
% 209.35/209.53  |- skos__scopeNote mesh__D025502
% 209.35/209.53       An allosteric enzyme that regulates glycolysis by catalyzing the transfer of a phosphate group from ATP to fructose-6-phosphate to yield fructose-1,6-bisphosphate. In the humans, 6-phosphofructose-1-kinase isozyme C is found in platelets, brain, heart, kidney, colon and testis. This isozyme C can exist as the homotetramer of C subunits %28%P subunits%29%, or heterotetramer of C type and L type subunits.%A%    
% 209.35/209.53  |- skos__hiddenLabel mesh__D025502 Phosphofructokinase 1, Type C
% 209.35/209.53  |- skos__annotation mesh__D003050
% 209.35/209.53       a bone of the spine; do not confuse with COCCYGEAL REGION, merely locational; coord IM with specific disease %28%IM%29%%A%  
% 209.35/209.53  |- mesh__recordMaintainer mesh__D003050 sjn
% 209.35/209.53  |- mesh__dateCreated mesh__D003050 1999-01-01
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003050 1992
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003050 1998
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003050 2006
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003050 2001
% 209.35/209.53  |- skos__broader mesh__D003050smesh__D013131
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003050 1993
% 209.35/209.53  |- mesh__dateRevised mesh__D003050 2002-10-23
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003050 1999
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003050 2003
% 209.35/209.53  |- rdf__type mesh__D003050sskos__Concept
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003050 1991
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003050 1996
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003050 2004
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003050 2003A
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003050 1997
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003050 2002
% 209.35/209.53  |- mesh__recordOriginator mesh__D003050 NLM
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003050 1994
% 209.35/209.53  |- skos__prefLabel mesh__D003050 Coccyx
% 209.35/209.53  |- mesh__recordAuthorizer mesh__D003050 sjn
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003050 1995
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003050 2000
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003050 2005
% 209.35/209.53  |- skos__prefLabel mesh__D044467 American Native Continental Ancestry Group
% 209.35/209.53  |- mesh__dateCreated mesh__D044467 2003-07-09
% 209.35/209.53  |- mesh__dateEstablished mesh__D044467 2004-01-01
% 209.35/209.53  |- mesh__historyNote mesh__D044467 2004   
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D044467 2005
% 209.35/209.53  |- mesh__publicMeSHNote mesh__D044467 2004   
% 209.35/209.53  |- mesh__recordAuthorizer mesh__D044467 sjn
% 209.35/209.53  |- rdf__type mesh__D044467sskos__Concept
% 209.35/209.53  |- skos__broader mesh__D044467smesh__D044469
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D044467 2006
% 209.35/209.53  |- skos__scopeNote mesh__D044467
% 209.35/209.53       Individuals whose ancestral origins are in the continents of the Americas.%A%    
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D044467 2004
% 209.35/209.53  |- mesh__recordMaintainer mesh__D044467 jls
% 209.35/209.53  |- mesh__recordOriginator mesh__D044467 jls
% 209.35/209.53  |- mesh__dateEstablished mesh__D049950 2006-01-01
% 209.35/209.53  |- skos__altLabel mesh__D049950 Primary Hyperparathyroidism
% 209.35/209.53  |- mesh__recordOriginator mesh__D049950 lkt
% 209.35/209.53  |- skos__hiddenLabel mesh__D049950 Primary Hyperparathyroidisms
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D049950 2006
% 209.35/209.53  |- skos__prefLabel mesh__D049950 Hyperparathyroidism, Primary
% 209.35/209.53  |- mesh__recordAuthorizer mesh__D049950 sjn
% 209.35/209.53  |- mesh__historyNote mesh__D049950 2006   
% 209.35/209.53  |- skos__scopeNote mesh__D049950
% 209.35/209.53       A condition of abnormally elevated output of PARATHYROID HORMONE due to parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. It is characterized by the combination of HYPERCALCEMIA, phosphaturia, elevated renal 1,25-DIHYDROXYVITAMIN D3 synthesis, and increased BONE RESORPTION.%A%    
% 209.35/209.53  |- skos__broader mesh__D049950smesh__D006961
% 209.35/209.53  |- skos__historyNote mesh__D049950 Hyperparathyroidism %28%1964-2005%29%
% 209.35/209.53  |- rdf__type mesh__D049950sskos__Concept
% 209.35/209.53  |- mesh__publicMeSHNote mesh__D049950 2006   
% 209.35/209.53  |- mesh__recordMaintainer mesh__D049950 lkt
% 209.35/209.53  |- skos__hiddenLabel mesh__D049950 Hyperparathyroidisms, Primary
% 209.35/209.53  |- mesh__dateCreated mesh__D049950 2005-06-30
% 209.35/209.53  |- skos__historyNote mesh__D016776
% 209.35/209.53       Intestinal Diseases, Parasitic %28%1983-1991%29%
% 209.35/209.53  |- skos__broader mesh__D016776smesh__D007411
% 209.35/209.53  |- mesh__dateEstablished mesh__D016776 1992-01-01
% 209.35/209.53  |- skos__broader mesh__D016776smesh__D000562
% 209.35/209.53  |- mesh__recordAuthorizer mesh__D016776 sjn
% 209.35/209.53  |- mesh__historyNote mesh__D016776 92   
% 209.35/209.53  |- skos__altLabel mesh__D016776 Infections, Blastocystis
% 209.35/209.53  |- skos__hiddenLabel mesh__D016776 Blastocystis Infection
% 209.35/209.53  |- skos__historyNote mesh__D016776 Protozoan Infections %28%1983-1991%29%
% 209.35/209.53  |- rdf__type mesh__D016776sskos__Concept
% 209.35/209.53  |- mesh__dateCreated mesh__D016776 1991-05-02
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D016776 2005
% 209.35/209.53  |- skos__prefLabel mesh__D016776 Blastocystis Infections
% 209.35/209.53  |- mesh__recordMaintainer mesh__D016776 sjn
% 209.35/209.53  |- skos__scopeNote mesh__D016776
% 209.35/209.53       Infections with PROTOZOA of the genus BLASTOCYSTIS. The species B. hominis is responsible for most infections. Parasitologic surveys have generally found small numbers of this species in human stools, but higher positivity rates and organism numbers in AIDS patients and other immunosuppressed patients %28%IMMUNOCOMPROMISED HOST%29%. Symptoms include ABDOMINAL PAIN; DIARRHEA; CONSTIPATION; VOMITING; and FATIGUE.%A%    
% 209.35/209.53  |- skos__hiddenLabel mesh__D016776 Infection, Blastocystis
% 209.35/209.53  |- mesh__publicMeSHNote mesh__D016776 92   
% 209.35/209.53  |- mesh__dateRevised mesh__D016776 2004-07-13
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D016776 2006
% 209.35/209.53  |- mesh__recordOriginator mesh__D016776 PXP
% 209.35/209.53  |- skos__altLabel mesh__D002756 Cholagogues, Choleretics
% 209.35/209.53  |- mesh__dateCreated mesh__D002756 1999-01-01
% 209.35/209.53  |- skos__altLabel mesh__D002756 Choleretics and Cholagogues
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D002756 2006
% 209.35/209.53  |- skos__annotation mesh__D002756 DF: CHOLAGOGUES   
% 209.35/209.53  |- skos__scopeNote mesh__D002756
% 209.35/209.53       Gastrointestinal agents that stimulate the flow of bile into the duodenum %28%cholagogues%29% or stimulate the production of bile by the liver %28%choleretic%29%.%A%    
% 209.35/209.53  |- skos__prefLabel mesh__D002756 Cholagogues and Choleretics
% 209.35/209.53  |- mesh__recordAuthorizer mesh__D002756 sjn
% 209.35/209.53  |- mesh__recordOriginator mesh__D002756 NLM
% 209.35/209.53  |- skos__broader mesh__D002756smesh__D005765
% 209.35/209.53  |- rdf__type mesh__D002756sskos__Concept
% 209.35/209.53  |- mesh__recordMaintainer mesh__D002756 ssb
% 209.35/209.53  |- mesh__dateRevised mesh__D002756 2005-06-30
% 209.35/209.53  |- mesh__recordOriginator mesh__D007441 NLM
% 209.35/209.53  |- skos__prefLabel mesh__D007441 Intubation, Gastrointestinal
% 209.35/209.53  |- skos__broader mesh__D007441smesh__D007440
% 209.35/209.53  |- mesh__recordAuthorizer mesh__D007441 sjn
% 209.35/209.53  |- mesh__publicMeSHNote mesh__D007441
% 209.35/209.53       66; DUODENAL INTUBATION was heading 1963-65   
% 209.35/209.53  |- mesh__dateEstablished mesh__D007441 1966-01-01
% 209.35/209.53  |- mesh__dateCreated mesh__D007441 1999-01-01
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D007441 2006
% 209.35/209.53  |- skos__hiddenLabel mesh__D007441 Intubations, Nasogastric
% 209.35/209.53  |- mesh__dateRevised mesh__D007441 2001-07-25
% 209.35/209.53  |- skos__annotation mesh__D007441
% 209.35/209.53       do not use /util except by MeSH definition; for intub in dis, coord with dis /ther, not /surg; esophageal intub %26% esophageal obturator airway do not go here: see note on INTUBATION%A%  
% 209.35/209.53  |- skos__hiddenLabel mesh__D007441 Nasogastric Intubation
% 209.35/209.53  |- skos__hiddenLabel mesh__D007441 Gastrointestinal Intubation
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D007441 2005
% 209.35/209.53  |- mesh__recordMaintainer mesh__D007441 lkt
% 209.35/209.53  |- mesh__historyNote mesh__D007441
% 209.35/209.53       66; DUODENAL INTUBATION was heading 1963-65   
% 209.35/209.53  |- rdf__type mesh__D007441sskos__Concept
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D007441 2004
% 209.35/209.53  |- skos__hiddenLabel mesh__D007441 Intubations, Gastrointestinal
% 209.35/209.53  |- skos__scopeNote mesh__D007441
% 209.35/209.53       The insertion of a tube into the stomach, intestines, or other portion of the gastrointestinal tract to allow for the passage of food products, etc.%A%    
% 209.35/209.53  |- skos__hiddenLabel mesh__D007441 Gastrointestinal Intubations
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D007441 2002
% 209.35/209.53  |- skos__hiddenLabel mesh__D007441 Nasogastric Intubations
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D007441 2003
% 209.35/209.53  |- mesh__recordOriginator mesh__D012386 EC
% 209.35/209.53  |- rdf__type mesh__D012386sskos__Concept
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D012386 1997
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D012386 1994
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D012386 1999
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D012386 1993
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D012386 2000
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D012386 1995
% 209.35/209.53  |- skos__prefLabel mesh__D012386 Rooming-in Care
% 209.35/209.53  |- skos__hiddenLabel mesh__D012386 Rooming-in Cares
% 209.35/209.53  |- skos__hiddenLabel mesh__D012386 Care, Rooming-in
% 209.35/209.53  |- mesh__publicMeSHNote mesh__D012386
% 209.35/209.53       91; was see under INFANT CARE 1979-90   
% 209.35/209.53  |- mesh__recordAuthorizer mesh__D012386 PLS
% 209.35/209.53  |- mesh__recordMaintainer mesh__D012386 TGC
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D012386 2003
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D012386 2001
% 209.35/209.53  |- skos__scopeNote mesh__D012386
% 209.35/209.53       Care of the newborn infant in a crib near the mother%27%s bed, instead of in a nursery, during the hospital stay.%A%    
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D012386 2005
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D012386 2004
% 209.35/209.53  |- skos__hiddenLabel mesh__D012386 Rooming in Care
% 209.35/209.53  |- mesh__historyNote mesh__D012386
% 209.35/209.53       91%28%79%29%; was see under INFANT CARE 1979-90   
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D012386 2006
% 209.35/209.53  |- mesh__dateCreated mesh__D012386 1978-05-10
% 209.35/209.53  |- skos__annotation mesh__D012386
% 209.35/209.53       care of a neonate in a crib near the mother%27%s bed in a hosp; check the tag INFANT, NEWBORN%A%  
% 209.35/209.53  |- skos__hiddenLabel mesh__D012386 Cares, Rooming-in
% 209.35/209.53  |- mesh__dateRevised mesh__D012386 1992-05-18
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D012386 2002
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D012386 1996
% 209.35/209.53  |- skos__broader mesh__D012386smesh__D007224
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D012386 1998
% 209.35/209.53  |- mesh__dateEstablished mesh__D012386 1991-01-01
% 209.35/209.53  |- mesh__recordAuthorizer mesh__D020818 sjn
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D020818 2004
% 209.35/209.53  |- skos__annotation mesh__D020818
% 209.35/209.53       coord IM with precoord organism/infection %28%IM%29% and specific site/dis term %28%IM%29% if pertinent%A%  
% 209.35/209.53  |- skos__hiddenLabel mesh__D020818 Myeloradiculopathies, Schistosomal
% 209.35/209.53  |- skos__scopeNote mesh__D020818
% 209.35/209.53       SCHISTOSOMIASIS of the brain, spinal cord, or meninges caused by infections with trematodes of the genus SCHISTOSOMA %28%primarily SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; and SCHISTOSOMA HAEMATOBIUM in humans%29%. S. japonicum infections of the nervous system may cause an acute meningoencephalitis or a chronic encephalopathy. S. mansoni and S. haematobium nervous system infections are associated with acute transverse myelitis involving the lower portions of the spinal cord. %28%From Joynt, Clinical Neurology, 1998, Ch27, pp61-2%29%%A%    
% 209.35/209.53  |- skos__altLabel mesh__D020818 Central Nervous System Schistosomiasis
% 209.35/209.53  |- skos__prefLabel mesh__D020818 Neuroschistosomiasis
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D020818 2003
% 209.35/209.53  |- mesh__historyNote mesh__D020818 2000   
% 209.35/209.53  |- skos__historyNote mesh__D020818 Schistosomiasis %28%1965-1999%29%
% 209.35/209.53  |- mesh__recordOriginator mesh__D020818 KEV
% 209.35/209.53  |- mesh__dateCreated mesh__D020818 1999-11-03
% 209.35/209.53  |- mesh__dateRevised mesh__D020818 2001-07-25
% 209.35/209.53  |- skos__hiddenLabel mesh__D020818 Myelitis, Schistosomal
% 209.35/209.53  |- rdf__type mesh__D020818sskos__Concept
% 209.35/209.53  |- skos__hiddenLabel mesh__D020818 Schistosomal Myelopathies
% 209.35/209.53  |- skos__hiddenLabel mesh__D020818 Neuroschistosomiases
% 209.35/209.53  |- mesh__publicMeSHNote mesh__D020818 2000   
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D020818 2006
% 209.35/209.53  |- skos__hiddenLabel mesh__D020818 Myeloradiculopathy, Schistosomal
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D020818 2002
% 209.35/209.53  |- skos__hiddenLabel mesh__D020818 Schistosomal Myeloradiculopathies
% 209.35/209.53  |- skos__broader mesh__D020818smesh__D012552
% 209.35/209.53  |- skos__hiddenLabel mesh__D020818 Myelopathies, Schistosomal
% 209.35/209.53  |- mesh__dateEstablished mesh__D020818 2000-01-01
% 209.35/209.53  |- mesh__recordMaintainer mesh__D020818 nns
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D020818 2005
% 209.35/209.53  |- skos__broader mesh__D020818smesh__D020809
% 209.35/209.53  |- skos__hiddenLabel mesh__D020818 Myelopathy, Schistosomal
% 209.35/209.53  |- skos__altLabel mesh__D020818 Schistosomiasis, Central Nervous System
% 209.35/209.53  |- rdf__type mesh__D006349sskos__Concept
% 209.35/209.53  |- mesh__dateEstablished mesh__D006349 1967-01-01
% 209.35/209.53  |- skos__historyNote mesh__D006349 specific heart valve disease
% 209.35/209.53  |- skos__broader mesh__D006349smesh__D006331
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D006349 2005
% 209.35/209.53  |- skos__prefLabel mesh__D006349 Heart Valve Diseases
% 209.35/209.53  |- skos__hiddenLabel mesh__D006349 Heart Valve Disease
% 209.35/209.53  |- skos__annotation mesh__D006349
% 209.35/209.53       coord IM with specific valve %28%IM%29%   
% 209.35/209.53  |- mesh__publicMeSHNote mesh__D006349
% 209.35/209.53       67; AORTIC VALVE DISEASES was heading 1963-66   
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D006349 2006
% 209.35/209.53  |- skos__hiddenLabel mesh__D006349 Valvular Heart Disease
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D006349 2003
% 209.35/209.53  |- skos__scopeNote mesh__D006349
% 209.35/209.53       Diseases caused by or resulting in abnormal functioning of heart valves.%A%    
% 209.35/209.53  |- skos__hiddenLabel mesh__D006349 Heart Diseases, Valvular
% 209.35/209.53  |- skos__hiddenLabel mesh__D006349 Disease, Heart Valve
% 209.35/209.53  |- skos__hiddenLabel mesh__D006349 Disease, Valvular Heart
% 209.35/209.53  |- skos__hiddenLabel mesh__D006349 Valve Diseases, Heart
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D006349 2004
% 209.35/209.53  |- mesh__onlineNote mesh__D006349
% 209.35/209.53       use HEART VALVE DISEASES to search AORTIC VALVE DISEASES 1966%A%  
% 209.35/209.53  |- mesh__recordMaintainer mesh__D006349 nns
% 209.35/209.53  |- skos__hiddenLabel mesh__D006349 Valve Disease, Heart
% 209.35/209.53  |- skos__hiddenLabel mesh__D006349 Diseases, Heart Valve
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D006349 2002
% 209.35/209.53  |- mesh__dateRevised mesh__D006349 2001-07-25
% 209.35/209.53  |- skos__altLabel mesh__D006349 Valvular Heart Diseases
% 209.35/209.53  |- skos__hiddenLabel mesh__D006349 Heart Disease, Valvular
% 209.35/209.53  |- mesh__recordOriginator mesh__D006349 NLM
% 209.35/209.53  |- skos__hiddenLabel mesh__D006349 Diseases, Valvular Heart
% 209.35/209.53  |- mesh__dateCreated mesh__D006349 1999-01-01
% 209.35/209.53  |- skos__historyNote mesh__D006349 Heart Diseases %28%1966%29%
% 209.35/209.53  |- mesh__historyNote mesh__D006349
% 209.35/209.53       67; AORTIC VALVE DISEASES was heading 1963-66   
% 209.35/209.53  |- mesh__recordAuthorizer mesh__D006349 sjn
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003051 1993
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003051 1999
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003051 2003
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003051 2000
% 209.35/209.53  |- rdf__type mesh__D003051sskos__Concept
% 209.35/209.53  |- mesh__publicMeSHNote mesh__D003051
% 209.35/209.53       COCHLEAR DUCT was DUCTUS COCHLEARIS see under LABYRINTH 1963-78; BASILAR MEMBRANE was see under LABYRINTH 1960-89%A%  
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003051 1996
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003051 2004
% 209.35/209.53  |- skos__hiddenLabel mesh__D003051 Cochleas
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003051 1997
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003051 2001
% 209.35/209.53  |- mesh__recordAuthorizer mesh__D003051 PLS
% 209.35/209.53  |- skos__related mesh__D003051smesh__D017084
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003051 1994
% 209.35/209.53  |- mesh__dateRevised mesh__D003051 1992-05-07
% 209.35/209.53  |- mesh__recordMaintainer mesh__D003051 MXR
% 209.35/209.53  |- skos__broader mesh__D003051smesh__D007758
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003051 1995
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003051 2005
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003051 2002
% 209.35/209.53  |- mesh__dateCreated mesh__D003051 1999-01-01
% 209.35/209.53  |- skos__annotation mesh__D003051 dis = COCHLEAR DISEASES   
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003051 1998
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D003051 2006
% 209.35/209.53  |- skos__scopeNote mesh__D003051
% 209.35/209.53       The part of the internal ear that is concerned with hearing. It forms the anterior part of the labyrinth, is conical, and is placed almost horizontally anterior to the vestibule.%A%    
% 209.35/209.53  |- skos__prefLabel mesh__D003051 Cochlea
% 209.35/209.53  |- mesh__recordOriginator mesh__D003051 NLM
% 209.35/209.53  |- mesh__recordMaintainer mesh__D044468 jls
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D044468 2005
% 209.35/209.53  |- skos__hiddenLabel mesh__D044468 Pacific Island American
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D044468 2006A
% 209.35/209.53  |- rdf__type mesh__D044468sskos__Concept
% 209.35/209.53  |- skos__hiddenLabel mesh__D044468 Ancestry Groups, Oceanic
% 209.35/209.53  |- skos__hiddenLabel mesh__D044468 Oceanic Ancestry Groups
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D044468 2006
% 209.35/209.53  |- mesh__dateEstablished mesh__D044468 2004-01-01
% 209.35/209.53  |- skos__hiddenLabel mesh__D044468 Group, Oceanic Ancestry
% 209.35/209.53  |- skos__altLabel mesh__D044468 Pacific Island Americans
% 209.35/209.53  |- skos__hiddenLabel mesh__D044468 Races, Australian
% 209.35/209.53  |- mesh__historyNote mesh__D044468 2004   
% 209.35/209.53  |- skos__hiddenLabel mesh__D044468 Australoid Races
% 209.35/209.53  |- skos__hiddenLabel mesh__D044468 Race, Australian
% 209.35/209.53  |- skos__hiddenLabel mesh__D044468 Groups, Oceanic Ancestry
% 209.35/209.53  |- skos__scopeNote mesh__D044468
% 209.35/209.53       Individuals whose ancestral origins are in the islands of the central and South Pacific, including Micronesia, Melanesia, Polynesia, and traditionally Australasia.%A%    
% 209.35/209.53  |- mesh__recordAuthorizer mesh__D044468 jls
% 209.35/209.53  |- skos__hiddenLabel mesh__D044468 Australian Aborigines
% 209.35/209.53  |- mesh__dateRevised mesh__D044468 2005-09-28
% 209.35/209.53  |- skos__hiddenLabel mesh__D044468 Ancestry Group, Oceanic
% 209.35/209.53  |- skos__hiddenLabel mesh__D044468 Aborigine, Australian
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D044468 2004
% 209.35/209.53  |- skos__hiddenLabel mesh__D044468 Australian Aborigine
% 209.35/209.53  |- mesh__recordOriginator mesh__D044468 jls
% 209.35/209.53  |- skos__broader mesh__D044468smesh__D044469
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D044468 2006B
% 209.35/209.53  |- mesh__publicMeSHNote mesh__D044468
% 209.35/209.53       2004; for ABORIGINES, AUSTRALIAN see OCEANIC ANCESTRY GROUP 2006-; see ABORIGINES 1991-2003; for AUSTRALOID RACE see AUSTRALOID RACE 1978-2003, see AUSTRALIAN RACE 1963-1977%A%  
% 209.35/209.53  |- skos__prefLabel mesh__D044468 Oceanic Ancestry Group
% 209.35/209.53  |- skos__hiddenLabel mesh__D044468 Pacific Islander American
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D044468 2006C
% 209.35/209.53  |- mesh__dateCreated mesh__D044468 2003-07-09
% 209.35/209.53  |- skos__hiddenLabel mesh__D044468 Races, Australoid
% 209.35/209.53  |- skos__altLabel mesh__D044468 Australian Race
% 209.35/209.53  |- skos__hiddenLabel mesh__D049951 Inactivation, X Chromosome
% 209.35/209.53  |- skos__historyNote mesh__D049951 X Chromosome %28%1983-2005%29%
% 209.35/209.53  |- skos__prefLabel mesh__D049951 X Chromosome Inactivation
% 209.35/209.53  |- skos__altLabel mesh__D049951 X-Inactivation
% 209.35/209.53  |- mesh__activeMeSHYear mesh__D049951 2006
% 209.35/209.53  |- skos__historyNote mesh__D049951
% 209.35/209.53       Dosage Compensation, Genetic %28%1982-2005%29%
% 209.35/209.53  |- skos__hiddenLabel mesh__D049951 X Inactivations
% 209.35/209.53  |- mesh__dateCreated mesh__D049951 2005-06-30
% 209.35/209.53  |- skos__hiddenLabel mesh__D049951 Inactivation, X
% 209.35/209.53  |- skos__altLabel mesh__D049951 X Inactivation
% 209.35/209.53  |- skos__broader mesh__D049951smesh__D004303
% 209.35/209.53  |- skos__hiddenLabel mesh__D049951 Chromosome Inactivation, X
% 209.35/209.53  |- skos__scopeNote mesh__D049951
% 209.35/209.53       A dosage compensation process occurring at an early embryonic stage in mammalian development whereby, at random, one X CHROMOSOME of the pair is repressed in the somatic cells of females.%A%    
% 209.35/209.53  |- skos__hiddenLabel mesh__D049951 Hypothesis, Lyon
% 209.35/209.54  |- mesh__dateEstablished mesh__D049951 2006-01-01
% 209.35/209.54  |- rdf__type mesh__D049951sskos__Concept
% 209.35/209.54  |- mesh__recordOriginator mesh__D049951 nns
% 209.35/209.54  |- mesh__recordAuthorizer mesh__D049951 sjn
% 209.35/209.54  |- skos__altLabel mesh__D049951 Lyonization
% 209.35/209.54  |- mesh__recordMaintainer mesh__D049951 nns
% 209.35/209.54  |- mesh__historyNote mesh__D049951
% 209.35/209.54       2006; use DOSAGE COMPENSATION, GENETIC 1982-2005   
% 209.35/209.54  |- mesh__publicMeSHNote mesh__D049951
% 209.35/209.54       2006; see DOSAGE COMPENSATION %28%GENETICS%29% 1982-2005   
% 209.35/209.54  |- skos__prefLabel mesh__D002757 Cholanes
% 209.35/209.54  |- skos__annotation mesh__D002757 do not confuse with CHOLENES   
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002757 2005
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002757 1997
% 209.35/209.54  |- mesh__publicMeSHNote mesh__D002757 68   
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002757 2002
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002757 2004
% 209.35/209.54  |- rdf__type mesh__D002757sskos__Concept
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002757 1996
% 209.35/209.54  |- mesh__historyNote mesh__D002757 68   
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002757 2001
% 209.35/209.54  |- skos__broader mesh__D002757smesh__D013256
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002757 2003
% 209.35/209.54  |- mesh__recordOriginator mesh__D002757 NLM
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002757 2000
% 209.35/209.54  |- mesh__dateRevised mesh__D002757 1992-05-11
% 209.35/209.54  |- mesh__dateEstablished mesh__D002757 1968-01-01
% 209.35/209.54  |- mesh__recordAuthorizer mesh__D002757 PLS
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002757 1995
% 209.35/209.54  |- mesh__recordMaintainer mesh__D002757 TGC
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002757 1999
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002757 1994
% 209.35/209.54  |- mesh__dateCreated mesh__D002757 1999-01-01
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002757 2006
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002757 1998
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002757 1993
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D007442 1993
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D007442 1999
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D007442 2000
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D007442 2005
% 209.35/209.54  |- skos__hiddenLabel mesh__D007442 Intratracheal Intubations
% 209.35/209.54  |- mesh__dateRevised mesh__D007442 1991-05-15
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D007442 1996
% 209.35/209.54  |- mesh__recordMaintainer mesh__D007442 TGC
% 209.35/209.54  |- skos__altLabel mesh__D007442 Intubation, Endotracheal
% 209.35/209.54  |- skos__annotation mesh__D007442
% 209.35/209.54       do not use /util except by MeSH definition; for intub in dis, coord with dis /ther, not /surg%A%  
% 209.35/209.54  |- skos__hiddenLabel mesh__D007442 Intubations, Endotracheal
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D007442 2006
% 209.35/209.54  |- mesh__recordOriginator mesh__D007442 NLM
% 209.35/209.54  |- skos__hiddenLabel mesh__D007442 Intubations, Intratracheal
% 209.35/209.54  |- skos__hiddenLabel mesh__D007442 Endotracheal Intubation
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D007442 2001
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D007442 1997
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D007442 2003
% 209.35/209.54  |- skos__broader mesh__D007442smesh__D007440
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D007442 1994
% 209.35/209.54  |- rdf__type mesh__D007442sskos__Concept
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D007442 2004
% 209.35/209.54  |- skos__hiddenLabel mesh__D007442 Endotracheal Intubations
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D007442 1995
% 209.35/209.54  |- skos__prefLabel mesh__D007442 Intubation, Intratracheal
% 209.35/209.54  |- mesh__dateCreated mesh__D007442 1999-01-01
% 209.35/209.54  |- skos__hiddenLabel mesh__D007442 Intratracheal Intubation
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D007442 2002
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D007442 1992
% 209.35/209.54  |- mesh__recordAuthorizer mesh__D007442 PLS
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D007442 1998
% 209.35/209.54  |- skos__scopeNote mesh__D012387
% 209.35/209.54       Materials placed inside a root canal for the purpose of obturating or sealing it. The materials may be gutta-percha, silver cones, paste mixtures, or other substances. %28%Dorland, 28th ed, p631 %26% Boucher%27%s Clinical Dental Terminology, 4th ed, p187%29%%A%    
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D012387 2002
% 209.35/209.54  |- mesh__dateRevised mesh__D012387 1996-06-10
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D012387 2003
% 209.35/209.54  |- mesh__recordMaintainer mesh__D012387 JLS
% 209.35/209.54  |- mesh__recordOriginator mesh__D012387 NLM
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D012387 2005
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D012387 2004
% 209.35/209.54  |- skos__altLabel mesh__D012387 Sealants, Root Canal
% 209.35/209.54  |- skos__broader mesh__D012387smesh__D003764
% 209.35/209.54  |- skos__annotation mesh__D012387
% 209.35/209.54       IM; coord with specific material if pertinent %28%IM%29%; D25-26 qualif%A%  
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D012387 2006
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D012387 2000
% 209.35/209.54  |- skos__hiddenLabel mesh__D012387 Canal Sealants, Root
% 209.35/209.54  |- mesh__historyNote mesh__D012387 72%28%70%29%   
% 209.35/209.54  |- mesh__recordAuthorizer mesh__D012387 PLS
% 209.35/209.54  |- mesh__dateEstablished mesh__D012387 1972-01-01
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D012387 2001
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D012387 1998
% 209.35/209.54  |- rdf__type mesh__D012387sskos__Concept
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D012387 1997
% 209.35/209.54  |- mesh__publicMeSHNote mesh__D012387 72   
% 209.35/209.54  |- mesh__dateCreated mesh__D012387 1999-01-01
% 209.35/209.54  |- skos__prefLabel mesh__D012387 Root Canal Filling Materials
% 209.35/209.54  |- skos__historyNote mesh__D012387 Dental Materials %28%1966-1969%29%
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D012387 1999
% 209.35/209.54  |- mesh__historyNote mesh__D020819 2000   
% 209.35/209.54  |- mesh__publicMeSHNote mesh__D020819 2000   
% 209.35/209.54  |- skos__altLabel mesh__D020819 Parameningeal Infections
% 209.35/209.54  |- skos__altLabel mesh__D020819 Infections, Perimeningeal
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D020819 2002
% 209.35/209.54  |- rdf__type mesh__D020819sskos__Concept
% 209.35/209.54  |- skos__annotation mesh__D020819
% 209.35/209.54       coord IM with specific infection term %28%IM%29%   
% 209.35/209.54  |- skos__broader mesh__D020819smesh__D002494
% 209.35/209.54  |- skos__prefLabel mesh__D020819 Perimeningeal Infections
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D020819 2006
% 209.35/209.54  |- skos__hiddenLabel mesh__D020819 Infection, Parameningeal
% 209.35/209.54  |- skos__hiddenLabel mesh__D020819 Parameningeal Infection
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D020819 2001
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D020819 2005
% 209.35/209.54  |- skos__hiddenLabel mesh__D020819 Perimeningeal Infection
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D020819 2000
% 209.35/209.54  |- mesh__dateEstablished mesh__D020819 2000-01-01
% 209.35/209.54  |- skos__hiddenLabel mesh__D020819 Infection, Perimeningeal
% 209.35/209.54  |- mesh__dateCreated mesh__D020819 1999-11-03
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D020819 2004
% 209.35/209.54  |- skos__altLabel mesh__D020819 Infections, Parameningeal
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D020819 2003
% 209.35/209.54  |- skos__scopeNote mesh__D020819
% 209.35/209.54       Infectious processes, including abscesses, effusions, and empyemas which occur in the epidural or subdural spaces surrounding the brain and spinal cord.%A%    
% 209.35/209.54  |- rdf__type mesh__D031541sskos__Concept
% 209.35/209.54  |- mesh__dateRevised mesh__D031541 2004-07-07
% 209.35/209.54  |- mesh__dateCreated mesh__D031541 2002-07-03
% 209.35/209.54  |- skos__historyNote mesh__D031541
% 209.35/209.54       Spectrometry, Fluorescence %28%1971-2002%29%
% 209.35/209.54  |- skos__prefLabel mesh__D031541 Fluorescence Resonance Energy Transfer
% 209.35/209.54  |- mesh__dateEstablished mesh__D031541 2003-01-01
% 209.35/209.54  |- mesh__recordAuthorizer mesh__D031541 sjn
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D031541 2005
% 209.35/209.54  |- mesh__publicMeSHNote mesh__D031541 2003   
% 209.35/209.54  |- mesh__historyNote mesh__D031541 2003   
% 209.35/209.54  |- skos__annotation mesh__D031541
% 209.35/209.54       coord as appropriate with MICROSCOPY and its indentations%A%  
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D031541 2006
% 209.35/209.54  |- skos__broader mesh__D031541smesh__D013050
% 209.35/209.54  |- skos__scopeNote mesh__D031541
% 209.35/209.54       A type of FLUORESCENCE SPECTROSCOPY using two FLUORESCENT DYES with overlapping emission and absorption spectra, which is used to indicate proximity of labeled molecules.  This technique is useful for studying interactions of molecules and PROTEIN FOLDING.%A%    
% 209.35/209.54  |- mesh__recordMaintainer mesh__D031541 ssb
% 209.35/209.54  |- mesh__recordOriginator mesh__D031541 ssb
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D017072 2006
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D017072 2001
% 209.35/209.54  |- skos__annotation mesh__D017072
% 209.35/209.54       the newer part of the corpus striatum, hence neo-; also called %22%striatum%22%%A%  
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D017072 1998
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D017072 1997
% 209.35/209.54  |- mesh__dateCreated mesh__D017072 1992-05-22
% 209.35/209.54  |- mesh__publicMeSHNote mesh__D017072 93   
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D017072 1994
% 209.35/209.54  |- rdf__type mesh__D017072sskos__Concept
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D017072 1993
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D017072 1999
% 209.35/209.54  |- mesh__dateEstablished mesh__D017072 1993-01-01
% 209.35/209.54  |- skos__broader mesh__D017072smesh__D003342
% 209.35/209.54  |- skos__historyNote mesh__D017072 Corpus Striatum %28%1974-1992%29%
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D017072 1995
% 209.35/209.54  |- mesh__historyNote mesh__D017072 93   
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D017072 2002
% 209.35/209.54  |- skos__historyNote mesh__D017072 Basal Ganglia %28%1966-1973%29%
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D017072 2003
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D017072 2005
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D017072 2004
% 209.35/209.54  |- skos__scopeNote mesh__D017072
% 209.35/209.54       The phylogenetically newer part of the CORPUS STRIATUM consisting of the CAUDATE NUCLEUS and PUTAMEN. It is often called simply the striatum.%A%    
% 209.35/209.54  |- skos__prefLabel mesh__D017072 Neostriatum
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D017072 2000
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D017072 1996
% 209.35/209.54  |- skos__historyNote mesh__D003850 Deoxyribonucleases %28%1966-1982%29%
% 209.35/209.54  |- skos__altLabel mesh__D003850 DNA Nicking Enzyme
% 209.35/209.54  |- skos__altLabel mesh__D003850 DNA Endonuclease
% 209.35/209.54  |- mesh__recordAuthorizer mesh__D003850 sjn
% 209.35/209.54  |- mesh__dateEstablished mesh__D003850 1985-01-01
% 209.35/209.54  |- skos__hiddenLabel mesh__D003850 T7 Endonuclease I
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D003850 2005
% 209.35/209.54  |- skos__hiddenLabel mesh__D003850 Endonuclease, DNA
% 209.35/209.54  |- mesh__onlineNote mesh__D003850
% 209.35/209.54       use DEOXYRIBONUCLEASES to search STREPTODORNASE 1966-93   
% 209.35/209.54  |- skos__hiddenLabel mesh__D003850 T4 Endonuclease II
% 209.35/209.54  |- skos__historyNote mesh__D003850 Endonucleases %28%1973-1982%29%
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D003850 2006
% 209.35/209.54  |- mesh__dateCreated mesh__D003850 1984-05-24
% 209.35/209.54  |- skos__altLabel mesh__D003850 Thymonuclease
% 209.35/209.54  |- mesh__publicMeSHNote mesh__D003850
% 209.35/209.54       85; STREPTORDORNASE was see DEOXYRIBONUCLEASES 1966-93   
% 209.35/209.54  |- skos__prefLabel mesh__D003850 Deoxyribonuclease I
% 209.35/209.54  |- skos__altLabel mesh__D003850 Endonuclease I
% 209.35/209.54  |- skos__altLabel mesh__D003850 DNase I
% 209.35/209.54  |- skos__annotation mesh__D003850
% 209.35/209.54       do not confuse X ref STREPTODORNASE with STREPTODORNASE AND STREPTOKINASE: see note there; DF: note short X ref%A%  
% 209.35/209.54  |- skos__scopeNote mesh__D003850
% 209.35/209.54       An enzyme capable of hydrolyzing highly polymerized DNA by splitting phosphodiester linkages, preferentially adjacent to a pyrimidine nucleotide. This catalyzes endonucleolytic cleavage of DNA yielding 5%27%-phosphodi- and oligonucleotide end-products. The enzyme has a preference for double-stranded DNA.%A%    
% 209.35/209.54  |- skos__historyNote mesh__D003850 Endodeoxyribonucleases %28%1983-1984%29%
% 209.35/209.54  |- skos__altLabel mesh__D003850 Pancreatic DNase
% 209.35/209.54  |- skos__altLabel mesh__D003850 DNAase I
% 209.35/209.54  |- mesh__recordMaintainer mesh__D003850 ssb
% 209.35/209.54  |- mesh__recordOriginator mesh__D003850 RLS
% 209.35/209.54  |- mesh__historyNote mesh__D003850
% 209.35/209.54       85; STREPTODORNASE was see DEOXYRIBONUCLEASES 1966-93   
% 209.35/209.54  |- skos__broader mesh__D003850smesh__D004706
% 209.35/209.54  |- mesh__dateRevised mesh__D003850 2003-07-09
% 209.35/209.54  |- skos__hiddenLabel mesh__D003850 DNase, Pancreatic
% 209.35/209.54  |- rdf__type mesh__D003850sskos__Concept
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D003850 2004
% 209.35/209.54  |- skos__hiddenLabel mesh__D003052 Perilymphatic Ducts
% 209.35/209.54  |- mesh__dateEstablished mesh__D003052 1991-01-01
% 209.35/209.54  |- mesh__dateCreated mesh__D003052 1978-05-19
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D003052 1994
% 209.35/209.54  |- mesh__dateRevised mesh__D003052 1990-04-13
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D003052 2002
% 209.35/209.54  |- mesh__recordMaintainer mesh__D003052 NLM
% 209.35/209.54  |- mesh__publicMeSHNote mesh__D003052 91; was see under COCHLEA 1979-90   
% 209.35/209.54  |- skos__hiddenLabel mesh__D003052 Cochlear Aqueducts
% 209.35/209.54  |- skos__prefLabel mesh__D003052 Cochlear Aqueduct
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D003052 1995
% 209.35/209.54  |- skos__hiddenLabel mesh__D003052 Duct, Perilymphatic
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D003052 2005
% 209.35/209.54  |- skos__historyNote mesh__D003052 Cochlea %28%1966-1978%29%
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D003052 1992
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D003052 1998
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D003052 2006
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D003052 2000
% 209.35/209.54  |- skos__hiddenLabel mesh__D003052 Aqueduct, Cochlear
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D003052 1999
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D003052 1993
% 209.35/209.54  |- mesh__recordOriginator mesh__D003052 RC
% 209.35/209.54  |- mesh__historyNote mesh__D003052
% 209.35/209.54       91%28%79%29%; was see under COCHLEA 1979-90   
% 209.35/209.54  |- skos__annotation mesh__D003052 do not confuse with COCHLEAR DUCT   
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D003052 2003
% 209.35/209.54  |- skos__scopeNote mesh__D003052
% 209.35/209.54       A channel containing perilymph passing through the temporal bone, connecting the scala tympani of the cochlea to the subarachnoid space.%A%    
% 209.35/209.54  |- rdf__type mesh__D003052sskos__Concept
% 209.35/209.54  |- skos__altLabel mesh__D003052 Perilymphatic Duct
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D003052 2001
% 209.35/209.54  |- skos__hiddenLabel mesh__D003052 Aqueducts, Cochlear
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D003052 1996
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D003052 2004
% 209.35/209.54  |- skos__hiddenLabel mesh__D003052 Ducts, Perilymphatic
% 209.35/209.54  |- mesh__recordAuthorizer mesh__D003052 PLS
% 209.35/209.54  |- skos__broader mesh__D003052smesh__D003051
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D003052 1997
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D003052 1991
% 209.35/209.54  |- skos__hiddenLabel mesh__D044469 Stocks, Racial
% 209.35/209.54  |- skos__annotation mesh__D044469 GEN or unspecified; prefer specifics   
% 209.35/209.54  |- skos__broader mesh__D044469smesh__D044382
% 209.35/209.54  |- skos__hiddenLabel mesh__D044469 Population Groups, Continental
% 209.35/209.54  |- skos__hiddenLabel mesh__D044469 Racial Stock
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D044469 2004B
% 209.35/209.54  |- mesh__publicMeSHNote mesh__D044469
% 209.35/209.54       2004%28%1968%29%; see RACIAL STOCKS 1968-2003   
% 209.35/209.54  |- mesh__recordMaintainer mesh__D044469 jls
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D044469 2004
% 209.35/209.54  |- mesh__recordOriginator mesh__D044469 jls
% 209.35/209.54  |- skos__hiddenLabel mesh__D044469 Population Group, Continental
% 209.35/209.54  |- skos__scopeNote mesh__D044469
% 209.35/209.54       Groups of individuals whose putative ancestry is from native continental populations based on similarities in physical appearance.%A%    
% 209.35/209.54  |- mesh__historyNote mesh__D044469
% 209.35/209.54       2004%28%1968%29%; use RACIAL STOCKS 1968-2003   
% 209.35/209.54  |- skos__hiddenLabel mesh__D044469 Group, Continental Population
% 209.35/209.54  |- mesh__dateEstablished mesh__D044469 2004-01-01
% 209.35/209.54  |- mesh__dateCreated mesh__D044469 2003-07-14
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D044469 2005
% 209.35/209.54  |- skos__prefLabel mesh__D044469 Continental Population Groups
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D044469 2004A
% 209.35/209.54  |- mesh__dateRevised mesh__D044469 2003-10-30
% 209.35/209.54  |- skos__hiddenLabel mesh__D044469 Groups, Continental Population
% 209.35/209.54  |- skos__altLabel mesh__D044469 Race
% 209.35/209.54  |- rdf__type mesh__D044469sskos__Concept
% 209.35/209.54  |- skos__hiddenLabel mesh__D044469 Stock, Racial
% 209.35/209.54  |- skos__hiddenLabel mesh__D044469 Continental Population Group
% 209.35/209.54  |- skos__hiddenLabel mesh__D044469 Races
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D044469 2006
% 209.35/209.54  |- mesh__recordAuthorizer mesh__D044469 jls
% 209.35/209.54  |- mesh__historyNote mesh__D016778 1992   
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D016778 2003
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D016778 2001
% 209.35/209.54  |- skos__altLabel mesh__D016778 Plasmodium falciparum Malaria
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D016778 2005
% 209.35/209.54  |- skos__broader mesh__D016778smesh__D008288
% 209.35/209.54  |- mesh__dateCreated mesh__D016778 1991-05-02
% 209.35/209.54  |- skos__scopeNote mesh__D016778
% 209.35/209.54       Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations.%A%    
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D016778 2004
% 209.35/209.54  |- mesh__recordMaintainer mesh__D016778 TGC
% 209.35/209.54  |- skos__historyNote mesh__D016778 Malaria %28%1966-1991%29%
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D016778 2006
% 209.35/209.54  |- skos__hiddenLabel mesh__D016778 Malaria, Plasmodium falciparum
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D016778 2002
% 209.35/209.54  |- mesh__recordOriginator mesh__D016778 PXP
% 209.35/209.54  |- mesh__publicMeSHNote mesh__D016778 1992   
% 209.35/209.54  |- mesh__dateEstablished mesh__D016778 1992-01-01
% 209.35/209.54  |- skos__hiddenLabel mesh__D016778 Falciparum Malaria
% 209.35/209.54  |- mesh__dateRevised mesh__D016778 2000-06-22
% 209.35/209.54  |- mesh__recordAuthorizer mesh__D016778 sjn
% 209.35/209.54  |- rdf__type mesh__D016778sskos__Concept
% 209.35/209.54  |- skos__prefLabel mesh__D016778 Malaria, Falciparum
% 209.35/209.54  |- skos__broader mesh__D001980Q000530smesh__D001980
% 209.35/209.54  |- mesh__preferredCombination mesh__D001980Q000530smesh__D001995
% 209.35/209.54  |- rdf__type mesh__D001980Q000530smesh__CompoundConcept
% 209.35/209.54  |- skos__hiddenLabel mesh__D002758 Cholangiographies
% 209.35/209.54  |- skos__broader mesh__D002758smesh__D011860
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002758 2003
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002758 2002
% 209.35/209.54  |- skos__annotation mesh__D002758
% 209.35/209.54       do not use /util except by MeSH definition; DF: CHOLANGIOGR%A%  
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002758 2004
% 209.35/209.54  |- skos__prefLabel mesh__D002758 Cholangiography
% 209.35/209.54  |- rdf__type mesh__D002758sskos__Concept
% 209.35/209.54  |- mesh__recordMaintainer mesh__D002758 PXP
% 209.35/209.54  |- mesh__dateCreated mesh__D002758 1999-01-01
% 209.35/209.54  |- skos__scopeNote mesh__D002758
% 209.35/209.54       Radiographic examination of the bile ducts.     
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002758 2000
% 209.35/209.54  |- skos__broader mesh__D002758smesh__D003938
% 209.35/209.54  |- mesh__recordAuthorizer mesh__D002758 SJN
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002758 1998
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002758 2005
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002758 1999
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002758 2001
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D002758 2006
% 209.35/209.54  |- mesh__dateRevised mesh__D002758 1997-06-20
% 209.35/209.54  |- mesh__recordOriginator mesh__D002758 NLM
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D013480 2003
% 209.35/209.54  |- mesh__publicMeSHNote mesh__D013480
% 209.35/209.54       91; was see under OVULATION 1975-90   
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D013480 2006
% 209.35/209.54  |- mesh__dateEstablished mesh__D013480 1991-01-01
% 209.35/209.54  |- skos__broader mesh__D013480smesh__D010060
% 209.35/209.54  |- mesh__historyNote mesh__D013480
% 209.35/209.54       91%28%75%29%; was see under OVULATION 1975-90   
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D013480 2004
% 209.35/209.54  |- skos__broader mesh__D013480smesh__D010062
% 209.35/209.54  |- skos__scopeNote mesh__D013480
% 209.35/209.54       Occurrence or induction of release of more ova than are normally released at the same time in a given species. The term applies to both animals and humans.%A%    
% 209.35/209.54  |- skos__hiddenLabel mesh__D013480 Superovulations
% 209.35/209.54  |- mesh__recordMaintainer mesh__D013480 lkt
% 209.35/209.54  |- mesh__recordOriginator mesh__D013480 NLM
% 209.35/209.54  |- skos__prefLabel mesh__D013480 Superovulation
% 209.35/209.54  |- mesh__dateCreated mesh__D013480 1974-11-11
% 209.35/209.54  |- mesh__dateRevised mesh__D013480 2001-07-25
% 209.35/209.54  |- rdf__type mesh__D013480sskos__Concept
% 209.35/209.54  |- mesh__recordAuthorizer mesh__D013480 sjn
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D013480 2005
% 209.35/209.54  |- skos__annotation mesh__D013480
% 209.35/209.54       note categories; qualif permitted as for PREGNANCY   
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D013480 2002
% 209.35/209.54  |- skos__annotation mesh__D007443
% 209.35/209.54       coord IM with specific precoord intestinal dis term; ileocolic intussusception = ILEAL DISEASES %28%IM%29% + INTUSSUSCEPTION %28%IM%29% but not also COLONIC DISEASES; ileocecal intussusception = ILEOCECAL VALVE %28%IM%29% + INTUSSUSCEPTION %28%IM%29% + ILEAL DISEASES %28%NIM%29% but not also CECAL DISEASES; cecocolic intussusception = CECAL DISEASES %28%IM%29% + INTUSSUSCEPTION %28%IM%29% but not also COLONIC DISEASES%A%  
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D007443 2006
% 209.35/209.54  |- skos__altLabel mesh__D007443 Invagination, Intestinal
% 209.35/209.54  |- skos__hiddenLabel mesh__D007443 Intestinal Invaginations
% 209.35/209.54  |- skos__hiddenLabel mesh__D007443 Intussusceptions
% 209.35/209.54  |- skos__prefLabel mesh__D007443 Intussusception
% 209.35/209.54  |- mesh__dateRevised mesh__D007443 2003-07-09
% 209.35/209.54  |- mesh__recordMaintainer mesh__D007443 lkt
% 209.35/209.54  |- skos__altLabel mesh__D007443 Intususception
% 209.35/209.54  |- skos__hiddenLabel mesh__D007443 Invaginations, Intestinal
% 209.35/209.54  |- skos__hiddenLabel mesh__D007443 Intestinal Invagination
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D007443 2004
% 209.35/209.54  |- skos__broader mesh__D007443smesh__D007415
% 209.35/209.54  |- rdf__type mesh__D007443sskos__Concept
% 209.35/209.54  |- mesh__recordOriginator mesh__D007443 NLM
% 209.35/209.54  |- mesh__dateCreated mesh__D007443 1999-01-01
% 209.35/209.54  |- mesh__recordAuthorizer mesh__D007443 sjn
% 209.35/209.54  |- skos__hiddenLabel mesh__D007443 Intususceptions
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D007443 2005
% 209.35/209.54  |- skos__scopeNote mesh__D007443
% 209.35/209.54       A form of intestinal obstruction caused by the PROLAPSE of a part of the intestine into the adjoining intestinal lumen. There are four types: colic, involving segments of the LARGE INTESTINE; enteric, involving only the SMALL INTESTINE; ileocecal, in which the ILEOCECAL VALVE prolapses into the CECUM, drawing the ILEUM along with it; and ileocolic, in which the ileum prolapses through the ileocecal valve into the COLON.%A%    
% 209.35/209.54  |- skos__annotation mesh__D012388 D25-D26 qualif   
% 209.35/209.54  |- rdf__type mesh__D012388sskos__Concept
% 209.35/209.54  |- mesh__recordOriginator mesh__D012388 RC
% 209.35/209.54  |- mesh__publicMeSHNote mesh__D012388 84   
% 209.35/209.54  |- skos__hiddenLabel mesh__D012388 Medicaments, Root Canal
% 209.35/209.54  |- mesh__dateEstablished mesh__D012388 1984-01-01
% 209.35/209.54  |- skos__prefLabel mesh__D012388 Root Canal Irrigants
% 209.35/209.54  |- skos__broader mesh__D012388smesh__D001697
% 209.35/209.54  |- mesh__recordMaintainer mesh__D012388 jmp
% 209.35/209.54  |- skos__scopeNote mesh__D012388
% 209.35/209.54       Chemicals used mainly to disinfect root canals after pulpectomy and before obturation. The major ones are camphorated monochlorophenol, EDTA, formocresol, hydrogen peroxide, metacresylacetate, and sodium hypochlorite. Root canal irrigants include also rinsing solutions of distilled water, sodium chloride, etc.%A%    
% 209.35/209.54  |- skos__altLabel mesh__D012388 Root Canal Medicaments
% 209.35/209.54  |- mesh__dateRevised mesh__D012388 1999-11-03
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D012388 2001
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D012388 2004
% 209.35/209.54  |- skos__historyNote mesh__D012388 Root Canal Therapy %28%1966-1983%29%
% 209.35/209.54  |- skos__hiddenLabel mesh__D012388 Canal Medicaments, Root
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D012388 2000
% 209.35/209.54  |- skos__hiddenLabel mesh__D012388 Canal Irrigants, Root
% 209.35/209.54  |- mesh__recordAuthorizer mesh__D012388 sjn
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D012388 2003
% 209.35/209.54  |- mesh__dateCreated mesh__D012388 1983-04-22
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D012388 2006
% 209.35/209.54  |- skos__historyNote mesh__D012388 Irrigation %28%1966-1983%29%
% 209.35/209.54  |- mesh__historyNote mesh__D012388 84   
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D012388 2002
% 209.35/209.54  |- skos__hiddenLabel mesh__D012388 Irrigants, Root Canal
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D012388 2005
% 209.35/209.54  |- mesh__historyNote mesh__D017871
% 209.35/209.54       1998%28%1994%29%; use CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE %28%NM%29% 1990-1993%A%  
% 209.35/209.54  |- skos__historyNote mesh__D017871 Protein Kinases %28%1990-1993%29%
% 209.35/209.54  |- skos__scopeNote mesh__D017871
% 209.35/209.54       A calmodulin-dependent enzyme that catalyzes the phosphorylation of proteins. This enzyme is also sometimes dependent on calcium. A wide range of proteins can act as acceptor, including vimentin, synapsin, glycogen synthase, myosin light chains, and the microtubule-associated proteins. %28%From Enzyme Nomenclature, 1992, p277%29%%A%    
% 209.35/209.54  |- mesh__dateEstablished mesh__D017871 1994-01-01
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D017871 2005
% 209.35/209.54  |- mesh__recordMaintainer mesh__D017871 jmp
% 209.35/209.54  |- skos__hiddenLabel mesh__D017871 Protein Kinases, Calmodulin-Dependent
% 209.35/209.54  |- skos__broader mesh__D017871smesh__D017346
% 209.35/209.54  |- mesh__recordOriginator mesh__D017871 TPW
% 209.35/209.54  |- rdf__type mesh__D017871sskos__Concept
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D017871 2006
% 209.35/209.54  |- skos__hiddenLabel mesh__D017871 Calmodulin Kinase
% 209.35/209.54  |- mesh__dateRevised mesh__D017871 2004-07-07
% 209.35/209.54  |- skos__prefLabel mesh__D017871
% 209.35/209.54       Ca%28%2+%29%-Calmodulin Dependent Protein Kinase
% 209.35/209.54  |- mesh__recordAuthorizer mesh__D017871 sjn
% 209.35/209.54  |- skos__altLabel mesh__D017871 Calmodulin-Kinase
% 209.35/209.54  |- skos__altLabel mesh__D017871 Calmodulin-Dependent Protein Kinases
% 209.35/209.54  |- skos__hiddenLabel mesh__D017871 Kinases, Calmodulin-Dependent Protein
% 209.35/209.54  |- skos__altLabel mesh__D017871
% 209.35/209.54       Calcium-Calmodulin Dependent Protein Kinases
% 209.35/209.54  |- mesh__dateCreated mesh__D017871 1993-06-15
% 209.35/209.54  |- mesh__publicMeSHNote mesh__D017871
% 209.35/209.54       1998; see CALMODULIN-DEPENDENT PROTEIN KINASES 1994-1997 %26%  PROTEIN KINASES 1990-1993%A%  
% 209.35/209.54  |- skos__broader mesh__D017871smesh__D047908
% 209.35/209.54  |- skos__hiddenLabel mesh__D017871 Calmodulin Dependent Protein Kinases
% 209.35/209.54  |- skos__annotation mesh__D017871 DF: CALMODULIN KINASE   
% 209.35/209.54  |- mesh__activeMeSHYear mesh__D017073 1999
% 209.35/209.54  |- skos__historyNote mesh__D017073
% 209.35/209.54       Angioplasty, Transluminal, Percutaneous Coronary %28%1989-1992%29%
% 209.35/209.54  |- mesh__recordAuthorizer mesh__D017073 SJN
% 209.35/209.54  |- skos__hiddenLabel mesh__D017073 Atherectomies, Percutaneous Transluminal
% 209.35/209.54  |- skos__hiddenLabel mesh__D017073 Transluminal Atherectomy, Percutaneous
% 209.35/209.54  |- skos__hiddenLabel mesh__D017073 Percutaneous Transluminal Atherectomies
% 209.35/209.54  |- mesh__dateRevised mesh__D017073 1997-06-20
% 209.35/209.55  |- skos__historyNote mesh__D017073 Atherosclerosis %28%1987-1992%29%
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D017073 2003
% 209.35/209.55  |- mesh__recordMaintainer mesh__D017073 PXP
% 209.35/209.55  |- mesh__dateEstablished mesh__D017073 1993-01-01
% 209.35/209.55  |- skos__hiddenLabel mesh__D017073 Transluminal Atherectomies
% 209.35/209.55  |- skos__altLabel mesh__D017073 Transluminal Atherectomy
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D017073 2002
% 209.35/209.55  |- skos__prefLabel mesh__D017073 Atherectomy
% 209.35/209.55  |- skos__related mesh__D017073smesh__D004691
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D017073 2004
% 209.35/209.55  |- mesh__recordOriginator mesh__D017073 AGS
% 209.35/209.55  |- skos__altLabel mesh__D017073 Percutaneous Atherectomy
% 209.35/209.55  |- skos__hiddenLabel mesh__D017073 Atherectomies
% 209.35/209.55  |- skos__annotation mesh__D017073
% 209.35/209.55       do not use /util except by MeSH definition   
% 209.35/209.55  |- skos__hiddenLabel mesh__D017073 Atherectomy, Percutaneous Transluminal
% 209.35/209.55  |- skos__hiddenLabel mesh__D017073 Atherectomies, Percutaneous
% 209.35/209.55  |- rdf__type mesh__D017073sskos__Concept
% 209.35/209.55  |- skos__historyNote mesh__D017073 Angioplasty, Balloon %28%1986-1992%29%
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D017073 2000
% 209.35/209.55  |- skos__altLabel mesh__D017073 Percutaneous Transluminal Atherectomy
% 209.35/209.55  |- skos__broader mesh__D017073smesh__D017130
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D017073 2005
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D017073 1998
% 209.35/209.55  |- mesh__historyNote mesh__D017073 93   
% 209.35/209.55  |- skos__scopeNote mesh__D017073
% 209.35/209.55       Endovascular procedure in which atheromatous plaque is excised by a cutting or rotating catheter. It differs from balloon and laser angioplasty procedures which enlarge vessels by dilation but frequently do not remove much plaque. If the plaque is removed by surgical excision under general anesthesia rather than by an endovascular procedure through a catheter, it is called ENDARTERECTOMY.%A%    
% 209.35/209.55  |- skos__hiddenLabel mesh__D017073 Atherectomies, Transluminal
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D017073 2001
% 209.35/209.55  |- skos__hiddenLabel mesh__D017073 Transluminal Atherectomies, Percutaneous
% 209.35/209.55  |- skos__hiddenLabel mesh__D017073 Atherectomy, Transluminal
% 209.35/209.55  |- skos__hiddenLabel mesh__D017073 Atherectomy, Percutaneous
% 209.35/209.55  |- mesh__publicMeSHNote mesh__D017073 93   
% 209.35/209.55  |- mesh__dateCreated mesh__D017073 1992-05-07
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D017073 2006
% 209.35/209.55  |- skos__hiddenLabel mesh__D017073 Percutaneous Atherectomies
% 209.35/209.55  |- skos__hiddenLabel mesh__D003851 DNA Nucleases
% 209.35/209.55  |- skos__altLabel mesh__D003851 DNAase
% 209.35/209.55  |- skos__prefLabel mesh__D003851 Deoxyribonucleases
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D003851 2006
% 209.35/209.55  |- skos__scopeNote mesh__D003851
% 209.35/209.55       Enzymes which catalyze the hydrolases of ester bonds within DNA. EC 3.1.-.%A%    
% 209.35/209.55  |- mesh__recordOriginator mesh__D003851 NLM
% 209.35/209.55  |- skos__altLabel mesh__D003851 Desoxyribonucleases
% 209.35/209.55  |- skos__hiddenLabel mesh__D003851 DNase, Acid
% 209.35/209.55  |- skos__annotation mesh__D003851
% 209.35/209.55       differentiate STREPTODORNASE referred to here and STREPTODORNASE AND STREPTOKINASE %28%see note there%29%%A%  
% 209.35/209.55  |- skos__broader mesh__D003851smesh__D004950
% 209.35/209.55  |- mesh__recordAuthorizer mesh__D003851 sjn
% 209.35/209.55  |- mesh__publicMeSHNote mesh__D003851
% 209.35/209.55       83; was DEOXYRIBONUCLEASE 1966-82, was DESOXYRIBONUCLEASE 1963-65%A%  
% 209.35/209.55  |- mesh__dateEstablished mesh__D003851 1966-01-01
% 209.35/209.55  |- mesh__dateCreated mesh__D003851 1999-01-01
% 209.35/209.55  |- skos__altLabel mesh__D003851 DNase
% 209.35/209.55  |- mesh__historyNote mesh__D003851
% 209.35/209.55       83; was DEOXYRIBONUCLEASE 1966-82, was DESOXYRIBONUCLEASE 1963-65%A%  
% 209.35/209.55  |- skos__hiddenLabel mesh__D003851 DNase, Alkaline
% 209.35/209.55  |- mesh__dateRevised mesh__D003851 2003-07-09
% 209.35/209.55  |- rdf__type mesh__D003851sskos__Concept
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D003851 2004
% 209.35/209.55  |- mesh__recordMaintainer mesh__D003851 ssb
% 209.35/209.55  |- skos__altLabel mesh__D003851 Nucleases, DNA
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D003851 2005
% 209.35/209.55  |- mesh__onlineNote mesh__D003851
% 209.35/209.55       use DEOXYRIBONUCLEASES to search DEOXYRIBONUCLEASE 1966-83%A%  
% 209.35/209.55  |- skos__scopeNote mesh__D003053
% 209.35/209.55       Spiral tube in the bony canal of the cochlea, lying on its outer wall between the scala vestibuli and SCALA TYMPANI.%A%    
% 209.35/209.55  |- skos__hiddenLabel mesh__D003053 Media, Scala
% 209.35/209.55  |- skos__hiddenLabel mesh__D003053 Cochlear Ducts
% 209.35/209.55  |- skos__altLabel mesh__D003053 Ductus Cochlearis
% 209.35/209.55  |- skos__altLabel mesh__D003053 Scala Media
% 209.35/209.55  |- skos__broader mesh__D003053smesh__D003051
% 209.35/209.55  |- mesh__dateCreated mesh__D003053 1999-01-01
% 209.35/209.55  |- mesh__historyNote mesh__D003053
% 209.35/209.55       91%28%79%29%; was see under COCHLEA 1979-90; was DUCTUS COCHLEARIS see under LABYRINTH 1963-78%A%  
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D003053 2006
% 209.35/209.55  |- skos__annotation mesh__D003053 do not confuse with COCHLEAR AQUEDUCT   
% 209.35/209.55  |- skos__hiddenLabel mesh__D003053 Scala Medias
% 209.35/209.55  |- mesh__recordOriginator mesh__D003053 NLM
% 209.35/209.55  |- rdf__type mesh__D003053sskos__Concept
% 209.35/209.55  |- mesh__onlineNote mesh__D003053
% 209.35/209.55       use COCHLEAR DUCT to search DUCTUS COCHLEARIS 1975-78; use LABYRINTH 1966-74%A%  
% 209.35/209.55  |- mesh__recordMaintainer mesh__D003053 ags
% 209.35/209.55  |- skos__hiddenLabel mesh__D003053 Cochlearis, Ductus
% 209.35/209.55  |- mesh__recordAuthorizer mesh__D003053 sjn
% 209.35/209.55  |- skos__hiddenLabel mesh__D003053 Medias, Scala
% 209.35/209.55  |- skos__prefLabel mesh__D003053 Cochlear Duct
% 209.35/209.55  |- skos__hiddenLabel mesh__D003053 Ducts, Cochlear
% 209.35/209.55  |- mesh__dateEstablished mesh__D003053 1991-01-01
% 209.35/209.55  |- skos__hiddenLabel mesh__D003053 Duct, Cochlear
% 209.35/209.55  |- mesh__dateRevised mesh__D003053 2005-06-30
% 209.35/209.55  |- skos__historyNote mesh__D003053 Labyrinth %28%1966-1978%29%
% 209.35/209.55  |- mesh__publicMeSHNote mesh__D003053
% 209.35/209.55       91; was see under COCHLEA 1979-90; was DUCTUS COCHLEARIS see under LABYRINTH 1963-78%A%  
% 209.35/209.55  |- skos__historyNote mesh__D016779 Brain Diseases %28%1966-1991%29%
% 209.35/209.55  |- skos__annotation mesh__D016779
% 209.35/209.55       coord IM with Plasmodium species %28%IM%29% but do not coord with PLASMODIUM FALCIPARUM unless particularly discussed%A%  
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D016779 2001
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D016779 2003
% 209.35/209.55  |- mesh__historyNote mesh__D016779 1992   
% 209.35/209.55  |- skos__broader mesh__D016779smesh__D020808
% 209.35/209.55  |- skos__altLabel mesh__D016779 Cerebral Malaria
% 209.35/209.55  |- skos__broader mesh__D016779smesh__D008288
% 209.35/209.55  |- skos__scopeNote mesh__D016779
% 209.35/209.55       A condition characterized by somnolence or coma in the presence of an acute infection with PLASMODIUM FALCIPARUM %28%and rarely other Plasmodium species%29%. Initial clinical manifestations include HEADACHES; SEIZURES; and alterations of mentation followed by a rapid progression to COMA. Pathologic features include cerebral capillaries filled with parasitized erythrocytes and multiple small foci of cortical and subcortical necrosis. %28%From Adams et al., Principles of Neurology, 6th ed, p136%29%%A%    
% 209.35/209.55  |- skos__historyNote mesh__D016779 Malaria %28%1966-1991%29%
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D016779 2005
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D016779 2004
% 209.35/209.55  |- mesh__recordOriginator mesh__D016779 PXP
% 209.35/209.55  |- skos__hiddenLabel mesh__D016779 Meningitis, Malaria
% 209.35/209.55  |- skos__broader mesh__D016779smesh__D016778
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D016779 2006A
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D016779 2002
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D016779 2006
% 209.35/209.55  |- mesh__recordAuthorizer mesh__D016779 ags
% 209.35/209.55  |- mesh__publicMeSHNote mesh__D016779 1992   
% 209.35/209.55  |- mesh__dateEstablished mesh__D016779 1992-01-01
% 209.35/209.55  |- mesh__recordMaintainer mesh__D016779 ags
% 209.35/209.55  |- skos__prefLabel mesh__D016779 Malaria, Cerebral
% 209.35/209.55  |- rdf__type mesh__D016779sskos__Concept
% 209.35/209.55  |- mesh__dateCreated mesh__D016779 1999-11-03
% 209.35/209.55  |- mesh__dateRevised mesh__D016779 2005-07-15
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D002759 2004
% 209.35/209.55  |- mesh__historyNote mesh__D002759 94; was CHOLANGIOMA 1963-93   
% 209.35/209.55  |- skos__broader mesh__D002759smesh__D000236
% 209.35/209.55  |- rdf__type mesh__D002759sskos__Concept
% 209.35/209.55  |- skos__hiddenLabel mesh__D002759 Bile Duct Adenoma
% 209.35/209.55  |- mesh__publicMeSHNote mesh__D002759 94; was CHOLANGIOMA 1963-93   
% 209.35/209.55  |- mesh__recordOriginator mesh__D002759 NLM
% 209.35/209.55  |- skos__hiddenLabel mesh__D002759 Bile Duct Adenomas
% 209.35/209.55  |- mesh__dateCreated mesh__D002759 1999-01-01
% 209.35/209.55  |- skos__scopeNote mesh__D002759
% 209.35/209.55       A benign tumor of the intrahepatic bile ducts.     
% 209.35/209.55  |- mesh__onlineNote mesh__D002759
% 209.35/209.55       use ADENOMA, BILE DUCT to search CHOLANGIOMA 1966-93   
% 209.35/209.55  |- skos__altLabel mesh__D002759 Cholangioma
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D002759 2002
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D002759 1998
% 209.35/209.55  |- mesh__recordMaintainer mesh__D002759 KEV
% 209.35/209.55  |- mesh__dateRevised mesh__D002759 1995-06-08
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D002759 2005
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D002759 1999
% 209.35/209.55  |- skos__hiddenLabel mesh__D002759 Adenomas, Bile Duct
% 209.35/209.55  |- skos__annotation mesh__D002759
% 209.35/209.55       /blood supply /chem /secret /ultrastruct permitted; coord IM with BILE DUCTS, INTRAHEPATIC %28%IM%29% + BILE DUCT NEOPLASMS %28%IM%29%%A%  
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D002759 2006
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D002759 2000
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D002759 1996
% 209.35/209.55  |- skos__prefLabel mesh__D002759 Adenoma, Bile Duct
% 209.35/209.55  |- mesh__recordAuthorizer mesh__D002759 PLS
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D002759 2003
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D002759 1997
% 209.35/209.55  |- skos__hiddenLabel mesh__D002759 Cholangiomas
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D002759 2001
% 209.35/209.55  |- rdf__type mesh__D013481sskos__Concept
% 209.35/209.55  |- mesh__dateEstablished mesh__D013481 1984-01-01
% 209.35/209.55  |- mesh__recordAuthorizer mesh__D013481 sjn
% 209.35/209.55  |- mesh__historyNote mesh__D013481
% 209.35/209.55       1994; was SUPEROXIDE 1975-1993 %28%see under OXYGEN 1975-1983%29%%A%  
% 209.35/209.55  |- skos__scopeNote mesh__D013481
% 209.35/209.55       Highly reactive compounds produced when oxygen is reduced by a single electron. In biological systems, they may be generated during the normal catalytic function of a number of enzymes and during the oxidation of hemoglobin to METHEMOGLOBIN. In living organisms, SUPEROXIDE DISMUTASE protects the cell from the deleterious effects of superoxides.%A%    
% 209.35/209.55  |- mesh__publicMeSHNote mesh__D013481
% 209.35/209.55       1994; was SUPEROXIDE 1975-1993 %28%see under OXYGEN 1975-1983%29%%A%  
% 209.35/209.55  |- skos__prefLabel mesh__D013481 Superoxides
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D013481 2006
% 209.35/209.55  |- mesh__recordMaintainer mesh__D013481 ssb
% 209.35/209.55  |- skos__broader mesh__D013481smesh__D017382
% 209.35/209.55  |- mesh__onlineNote mesh__D013481
% 209.35/209.55       use SUPEROXIDES to search SUPEROXIDE 1975-1993   
% 209.35/209.55  |- skos__historyNote mesh__D013481 Oxygen %28%1974%29%
% 209.35/209.55  |- skos__broader mesh__D013481smesh__D010545
% 209.35/209.55  |- skos__related mesh__D013481smesh__D017382
% 209.35/209.55  |- skos__related mesh__D013481smesh__D016897
% 209.35/209.55  |- skos__altLabel mesh__D013481 Superoxide Radical
% 209.35/209.55  |- skos__altLabel mesh__D013481 Superoxide
% 209.35/209.55  |- mesh__dateRevised mesh__D013481 2005-06-30
% 209.35/209.55  |- mesh__dateCreated mesh__D013481 1974-11-11
% 209.35/209.55  |- skos__altLabel mesh__D013481 Superoxide Anion
% 209.35/209.55  |- mesh__recordOriginator mesh__D013481 NLM
% 209.35/209.55  |- skos__related mesh__D013481smesh__D013482
% 209.35/209.55  |- skos__historyNote mesh__D013481 Anions %28%1974%29%
% 209.35/209.55  |- mesh__recordOriginator mesh__D007444 NLM
% 209.35/209.55  |- skos__broader mesh__D007444smesh__D013213
% 209.35/209.55  |- rdf__type mesh__D007444sskos__Concept
% 209.35/209.55  |- mesh__recordAuthorizer mesh__D007444 sjn
% 209.35/209.55  |- skos__prefLabel mesh__D007444 Inulin
% 209.35/209.55  |- skos__scopeNote mesh__D007444
% 209.35/209.55       A starch found in the tubers and roots of many plants. Since it is hydrolyzable to FRUCTOSE, it is classified as a fructosan. It has been used in physiologic investigation for determination of the rate of glomerular function.%A%    
% 209.35/209.55  |- skos__broader mesh__D007444smesh__D005630
% 209.35/209.55  |- mesh__dateCreated mesh__D007444 1999-01-01
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D007444 2005
% 209.35/209.55  |- skos__annotation mesh__D007444
% 209.35/209.55       usually /diag use in KIDNEY FUNCTION TESTS; do not confuse with INSULIN%A%  
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D007444 2006
% 209.35/209.55  |- mesh__recordMaintainer mesh__D007444 jmp
% 209.35/209.55  |- mesh__dateRevised mesh__D007444 2004-07-07
% 209.35/209.55  |- skos__altLabel mesh__D045563 Indoloquinones
% 209.35/209.55  |- mesh__publicMeSHNote mesh__D045563 2004   
% 209.35/209.55  |- skos__annotation mesh__D045563
% 209.35/209.55       coord with appropriate specific chemical terms if pertinent%A%  
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D045563 2006
% 209.35/209.55  |- rdf__type mesh__D045563sskos__Concept
% 209.35/209.55  |- mesh__dateEstablished mesh__D045563 2004-01-01
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D045563 2005
% 209.35/209.55  |- skos__hiddenLabel mesh__D045563 Indole Quinones
% 209.35/209.55  |- skos__broader mesh__D045563smesh__D011809
% 209.35/209.55  |- skos__prefLabel mesh__D045563 Indolequinones
% 209.35/209.55  |- skos__scopeNote mesh__D045563
% 209.35/209.55       INDOLES which have two keto groups forming QUINONES like structures of the indole aromatic ring.%A%    
% 209.35/209.55  |- mesh__historyNote mesh__D045563 2004   
% 209.35/209.55  |- skos__broader mesh__D045563smesh__D007211
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D045563 2004
% 209.35/209.55  |- skos__altLabel mesh__D045563 Indole-Quinones
% 209.35/209.55  |- mesh__dateCreated mesh__D045563 2003-07-09
% 209.35/209.55  |- skos__historyNote mesh__D045563 Indoles %28%1990-2003%29%
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D012389 1999
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D012389 1992
% 209.35/209.55  |- mesh__dateRevised mesh__D012389 1978-11-01
% 209.35/209.55  |- skos__prefLabel mesh__D012389 Root Canal Obturation
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D012389 2002
% 209.35/209.55  |- mesh__dateCreated mesh__D012389 1999-01-01
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D012389 1990
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D012389 1995
% 209.35/209.55  |- mesh__historyNote mesh__D012389 66; was DENTAL PULP OBTURATION 1965   
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D012389 1998
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D012389 2004
% 209.35/209.55  |- mesh__recordAuthorizer mesh__D012389 NLM
% 209.35/209.55  |- skos__hiddenLabel mesh__D012389 Root Canal Obturations
% 209.35/209.55  |- skos__hiddenLabel mesh__D012389 Obturation, Root Canal
% 209.35/209.55  |- mesh__dateEstablished mesh__D012389 1966-01-01
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D012389 1994
% 209.35/209.55  |- skos__hiddenLabel mesh__D012389 Canal Obturation, Root
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D012389 2003
% 209.35/209.55  |- mesh__publicMeSHNote mesh__D012389
% 209.35/209.55       66; was DENTAL PULP OBTURATION 1965   
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D012389 2001
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D012389 2006
% 209.35/209.55  |- skos__broader mesh__D012389smesh__D012390
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D012389 1989
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D012389 1991
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D012389 1997
% 209.35/209.55  |- skos__annotation mesh__D012389
% 209.35/209.55       do not use /util except by MeSH definition   
% 209.35/209.55  |- mesh__recordMaintainer mesh__D012389 SMH
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D012389 2000
% 209.35/209.55  |- skos__hiddenLabel mesh__D012389 Canal Obturations, Root
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D012389 2005
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D012389 1993
% 209.35/209.55  |- rdf__type mesh__D012389sskos__Concept
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D012389 1996
% 209.35/209.55  |- mesh__recordOriginator mesh__D012389 NLM
% 209.35/209.55  |- skos__hiddenLabel mesh__D012389 Obturations, Root Canal
% 209.35/209.55  |- skos__scopeNote mesh__D017074
% 209.35/209.55       Heterogeneous group of immunodeficiency syndromes characterized by hypogammaglobulinemia of most isotypes, variable B-cell defects, and the presence of recurrent bacterial infections.%A%    
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D017074 2006
% 209.35/209.55  |- mesh__dateCreated mesh__D017074 1992-05-07
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D017074 2000
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D017074 1996
% 209.35/209.55  |- skos__hiddenLabel mesh__D017074 Common Variable Immunodeficiencies
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D017074 2005
% 209.35/209.55  |- skos__annotation mesh__D017074
% 209.35/209.55       an immunodefic syndrome with hypogammaglobulinemia   
% 209.35/209.55  |- mesh__recordMaintainer mesh__D017074 AGS
% 209.35/209.55  |- rdf__type mesh__D017074sskos__Concept
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D017074 1999
% 209.35/209.55  |- mesh__dateEstablished mesh__D017074 1993-01-01
% 209.35/209.55  |- skos__altLabel mesh__D017074 Immunodeficiency, Common Variable
% 209.35/209.55  |- skos__hiddenLabel mesh__D017074 Immunodeficiencies, Common Variable
% 209.35/209.55  |- mesh__recordAuthorizer mesh__D017074 PLS
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D017074 2002
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D017074 1995
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D017074 1998
% 209.35/209.55  |- mesh__historyNote mesh__D017074 93   
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D017074 2004
% 209.35/209.55  |- mesh__dateRevised mesh__D017074 1994-07-06
% 209.35/209.55  |- skos__prefLabel mesh__D017074 Common Variable Immunodeficiency
% 209.35/209.55  |- skos__broader mesh__D017074smesh__D007153
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D017074 2003
% 209.35/209.55  |- mesh__recordOriginator mesh__D017074 AGS
% 209.35/209.55  |- skos__historyNote mesh__D017074
% 209.35/209.55       Immunologic Deficiency Syndromes %28%1975-1992%29%
% 209.35/209.55  |- mesh__publicMeSHNote mesh__D017074 93   
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D017074 2001
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D017074 1997
% 209.35/209.55  |- skos__broader mesh__D003852smesh__D009698
% 209.35/209.55  |- mesh__dateRevised mesh__D003852 2005-06-30
% 209.35/209.55  |- mesh__dateEstablished mesh__D003852 1984-01-01
% 209.35/209.55  |- mesh__historyNote mesh__D003852
% 209.35/209.55       84%28%76%29%; was see under NUCLEOPROTEINS 1976-83   
% 209.35/209.55  |- mesh__recordOriginator mesh__D003852 RLS
% 209.35/209.55  |- rdf__type mesh__D003852sskos__Concept
% 209.35/209.55  |- skos__scopeNote mesh__D003852
% 209.35/209.55       Proteins conjugated with deoxyribonucleic acids %28%DNA%29% or specific DNA.%A%    
% 209.35/209.55  |- skos__historyNote mesh__D003852 specific DNA %28%1966-1975%29%
% 209.35/209.55  |- mesh__publicMeSHNote mesh__D003852
% 209.35/209.55       84; was see under NUCLEOPROTEINS 1976-83   
% 209.35/209.55  |- skos__prefLabel mesh__D003852 Deoxyribonucleoproteins
% 209.35/209.55  |- mesh__dateCreated mesh__D003852 1975-07-25
% 209.35/209.55  |- skos__historyNote mesh__D003852 DNA %28%1966-1975%29%
% 209.35/209.55  |- mesh__recordAuthorizer mesh__D003852 sjn
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D003852 2006
% 209.35/209.55  |- skos__historyNote mesh__D003852 Nucleoproteins %28%1966-1975%29%
% 209.35/209.55  |- mesh__recordMaintainer mesh__D003852 SYSTEM
% 209.35/209.55  |- skos__hiddenLabel mesh__D003054 Prosthesis, Cochlear
% 209.35/209.55  |- mesh__recordMaintainer mesh__D003054 lkt
% 209.35/209.55  |- mesh__recordAuthorizer mesh__D003054 sjn
% 209.35/209.55  |- skos__historyNote mesh__D003054 Electric Stimulation %28%1966-1979%29%
% 209.35/209.55  |- skos__related mesh__D003054smesh__D019929
% 209.35/209.55  |- skos__hiddenLabel mesh__D003054 Prostheses, Cochlear
% 209.35/209.55  |- skos__prefLabel mesh__D003054 Cochlear Implants
% 209.35/209.55  |- mesh__dateRevised mesh__D003054 2002-07-02
% 209.35/209.55  |- mesh__dateCreated mesh__D003054 1978-12-21
% 209.35/209.55  |- skos__broader mesh__D003054smesh__D019736
% 209.35/209.55  |- skos__broader mesh__D003054smesh__D004567
% 209.35/209.55  |- skos__hiddenLabel mesh__D003054 Auditory Prostheses
% 209.35/209.55  |- mesh__historyNote mesh__D003054 98%28%80%29%   
% 209.35/209.55  |- skos__scopeNote mesh__D003054
% 209.35/209.55       Electronic hearing devices typically used for patients with normal outer and middle ear function, but defective inner ear function. In the COCHLEA, the hair cells %28%HAIR CELLS, VESTIBULAR%29% may be absent or damaged but there are residual nerve fibers. The device electrically stimulates the COCHLEAR NERVE to create sound sensation.%A%    
% 209.35/209.55  |- skos__historyNote mesh__D003054 Prosthesis %28%1966-1979%29%
% 209.35/209.55  |- skos__altLabel mesh__D003054 Auditory Prosthesis
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D003054 2006
% 209.35/209.55  |- mesh__publicMeSHNote mesh__D003054
% 209.35/209.55       98; see COCHLEAR IMPLANT 1987-97, see AUDITORY PROSTHESIS 1980-86%A%  
% 209.35/209.55  |- skos__historyNote mesh__D003054 Deafness %28%1966-1979%29%
% 209.35/209.55  |- skos__hiddenLabel mesh__D003054 Cochlear Prostheses
% 209.35/209.55  |- skos__historyNote mesh__D003054 Hearing Aids %28%1966-1979%29%
% 209.35/209.55  |- skos__hiddenLabel mesh__D003054 Prostheses, Auditory
% 209.35/209.55  |- skos__altLabel mesh__D003054 Implants, Cochlear
% 209.35/209.55  |- skos__hiddenLabel mesh__D003054 Implant, Cochlear
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D003054 2005
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D003054 2004
% 209.35/209.55  |- skos__historyNote mesh__D003054 Cochlea %28%1966-1979%29%
% 209.35/209.55  |- skos__hiddenLabel mesh__D003054 Prosthesis, Auditory
% 209.35/209.55  |- skos__altLabel mesh__D003054 Cochlear Prosthesis
% 209.35/209.55  |- skos__broader mesh__D003054smesh__D006310
% 209.35/209.55  |- skos__hiddenLabel mesh__D003054 Cochlear Implant
% 209.35/209.55  |- mesh__dateEstablished mesh__D003054 1980-01-01
% 209.35/209.55  |- rdf__type mesh__D003054sskos__Concept
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D003054 2003
% 209.35/209.55  |- skos__annotation mesh__D003054
% 209.35/209.55       subcutaneous electronic implants: do not confuse with French %22%prothese auditive%22% translated as %22%hearing aid%22% %26% indexed under HEARING AIDS%A%  
% 209.35/209.55  |- mesh__recordOriginator mesh__D003054 RC
% 209.35/209.55  |- mesh__dateRevised mesh__D013482 2003-07-09
% 209.35/209.55  |- mesh__dateCreated mesh__D013482 1999-01-01
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Dismutase, Fe-Zn Superoxide
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Dismutase, Mn-Superoxide
% 209.35/209.55  |- skos__altLabel mesh__D013482 Manganese Superoxide Dismutase
% 209.35/209.55  |- skos__altLabel mesh__D013482 Fe-Superoxide Dismutase
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Superoxide Dismutase, Fe-Zn
% 209.35/209.55  |- skos__prefLabel mesh__D013482 Superoxide Dismutase
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Dismutase, Superoxide
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Superoxide Dismutase, Iron
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Superoxide Dismutase, Cu-Zn
% 209.35/209.55  |- mesh__historyNote mesh__D013482 74%28%73%29%   
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Cu Zn Superoxide Dismutase
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Superoxide Dismutase, Cobalt
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D013482 2005
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Dismutase, Cu-Superoxide
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Ag Zn Superoxide Dismutase
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Dismutase, Fe-Superoxide
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Dismutase, Cu-Zn Superoxide
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Dismutase, Manganese Superoxide
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Superoxide Dismutase, Cuprozinc
% 209.35/209.55  |- skos__historyNote mesh__D013482 Oxidoreductases %28%1966-1972%29%
% 209.35/209.55  |- skos__altLabel mesh__D013482 Hemocuprein
% 209.35/209.55  |- skos__altLabel mesh__D013482 Erythrocuprein
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Fe Superoxide Dismutase
% 209.35/209.55  |- skos__scopeNote mesh__D013482
% 209.35/209.55       An oxidoreductase that catalyzes the reaction between superoxide anions and hydrogen to yield molecular oxygen and hydrogen peroxide. The enzyme protects the cell against dangerous levels of superoxide. EC 1.15.1.1.%A%    
% 209.35/209.55  |- mesh__publicMeSHNote mesh__D013482 74   
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Dismutase, Cuprozinc Superoxide
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D013482 2006
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Superoxide Dismutase, Manganese
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Dismutase, Cobalt Superoxide
% 209.35/209.55  |- skos__altLabel mesh__D013482 Cuprozinc Superoxide Dismutase
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Dismutase, Ag-Zn Superoxide
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Mn Superoxide Dismutase
% 209.35/209.55  |- mesh__dateEstablished mesh__D013482 1974-01-01
% 209.35/209.55  |- skos__altLabel mesh__D013482 Mn-SOD
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Cu Superoxide Dismutase
% 209.35/209.55  |- mesh__recordMaintainer mesh__D013482 ssb
% 209.35/209.55  |- mesh__recordAuthorizer mesh__D013482 sjn
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Dismutase, Iron Superoxide
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Fe Zn Superoxide Dismutase
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Mn SOD
% 209.35/209.55  |- rdf__type mesh__D013482sskos__Concept
% 209.35/209.55  |- skos__hiddenLabel mesh__D013482 Superoxide Dismutase, Ag-Zn
% 209.35/209.55  |- skos__broader mesh__D013482smesh__D010088
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D013482 2004
% 209.35/209.55  |- mesh__recordOriginator mesh__D013482 NLM
% 209.35/209.55  |- skos__scopeNote mesh__D007445
% 209.35/209.55       Materials and equipment in stock; includes drugs in pharmacies, blood in blood banks, etc.%A%    
% 209.35/209.55  |- mesh__historyNote mesh__D007445
% 209.35/209.55       91%28%78%29%; was see under MATERIALS MANAGEMENT, HOSPITAL 1978-90%A%  
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D007445 2000
% 209.35/209.55  |- mesh__dateCreated mesh__D007445 1977-05-11
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D007445 2001
% 209.35/209.55  |- skos__prefLabel mesh__D007445 Inventories, Hospital
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D007445 2005
% 209.35/209.55  |- mesh__recordAuthorizer mesh__D007445 sjn
% 209.35/209.55  |- skos__altLabel mesh__D007445 Inventory, Hospital
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D007445 2006
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D007445 2002
% 209.35/209.55  |- mesh__recordMaintainer mesh__D007445 JLS
% 209.35/209.55  |- skos__broader mesh__D007445smesh__D008421
% 209.35/209.55  |- skos__altLabel mesh__D007445 Hospital Inventories
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D007445 2003
% 209.35/209.55  |- mesh__recordOriginator mesh__D007445 EC
% 209.35/209.55  |- skos__altLabel mesh__D007445 Hospital Inventory
% 209.35/209.55  |- mesh__dateRevised mesh__D007445 1999-11-05
% 209.35/209.55  |- mesh__dateEstablished mesh__D007445 1991-01-01
% 209.35/209.55  |- mesh__publicMeSHNote mesh__D007445
% 209.35/209.55       91; was see under MATERIALS MANAGEMENT, HOSPITAL 1978-90   
% 209.35/209.55  |- rdf__type mesh__D007445sskos__Concept
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D007445 2004
% 209.35/209.55  |- skos__scopeNote mesh__D045564
% 209.35/209.55       Recombinases that involved in the propagation of DNA TRANSPOSONS. They bind to transposon sequences found at two different sites along the same stretch of DNA and bring them into close proximity. The enzymes then catalyze the double strand cleavage, exchange of double strands and rejoining of DNA helices so that the DNA transposon is formed into a circular PLASMID.%A%    
% 209.35/209.55  |- skos__prefLabel mesh__D045564 Transposon Resolvases
% 209.35/209.55  |- rdf__type mesh__D045564sskos__Concept
% 209.35/209.55  |- skos__historyNote mesh__D045564
% 209.35/209.55       DNA Nucleotidyltransferases %28%1992-1997%29%
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D045564 2005
% 209.35/209.55  |- mesh__recordMaintainer mesh__D045564 jmp
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D045564 2004
% 209.35/209.55  |- mesh__recordAuthorizer mesh__D045564 sjn
% 209.35/209.55  |- skos__historyNote mesh__D045564
% 209.35/209.55       Nucleotidyltransferases %28%1981-1995%29%
% 209.35/209.55  |- mesh__dateEstablished mesh__D045564 2004-01-01
% 209.35/209.55  |- mesh__dateCreated mesh__D045564 2003-07-09
% 209.35/209.55  |- skos__historyNote mesh__D045564 Transposase %28%1998-2003%29%
% 209.35/209.55  |- skos__annotation mesh__D045564
% 209.35/209.55       Don%27%t confuse with HOLLIDAY JUNCTION RESOLVASES   
% 209.35/209.55  |- mesh__historyNote mesh__D045564 2004   
% 209.35/209.55  |- skos__broader mesh__D045564smesh__D045522
% 209.35/209.55  |- skos__altLabel mesh__D045564 Resolvases, Transposon
% 209.35/209.55  |- mesh__publicMeSHNote mesh__D045564 2004   
% 209.35/209.55  |- mesh__recordOriginator mesh__D045564 jmp
% 209.35/209.55  |- skos__broader mesh__D045564smesh__D009713
% 209.35/209.55  |- mesh__activeMeSHYear mesh__D045564 2006
% 209.35/209.55  |- skos__altLabel mesh__D045564 TnpR Protein
% 209.35/209.55  |- skos__broader mesh__D017075smesh__D007833
% 209.35/209.55  |- skos__altLabel mesh__D017075 Laser Thermocoagulation
% 209.35/209.56  |- mesh__publicMeSHNote mesh__D017075
% 209.35/209.56       93; was see LIGHT COAGULATION 1992; was heading 1968-85   
% 209.35/209.56  |- skos__hiddenLabel mesh__D017075 Laser Coagulations
% 209.35/209.56  |- skos__scopeNote mesh__D017075
% 209.35/209.56       The coagulation of tissues using lasers. These lasers produce light in the visible green wavelength that is selectively absorbed by hemoglobin, and thus it is possible to seal bleeding blood vessels.%A%    
% 209.35/209.56  |- mesh__recordOriginator mesh__D017075 MXR
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017075 2004
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017075 1998
% 209.35/209.56  |- skos__hiddenLabel mesh__D017075 Thermocoagulations, Laser
% 209.35/209.56  |- skos__prefLabel mesh__D017075 Laser Coagulation
% 209.35/209.56  |- mesh__recordMaintainer mesh__D017075 TGC
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017075 2001
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017075 2003
% 209.35/209.56  |- mesh__onlineNote mesh__D017075
% 209.35/209.56       use LIGHT COAGULATION to search LASER COAGULATION 1992 %26% use LASERS/TU 1968-85%A%  
% 209.35/209.56  |- skos__broader mesh__D017075smesh__D008028
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017075 2000
% 209.35/209.56  |- mesh__dateCreated mesh__D017075 1992-05-20
% 209.35/209.56  |- skos__annotation mesh__D017075
% 209.35/209.56       do not confuse with LIGHT COAGULATION or with LASER SURGERY; do not use /util except by MeSH definition; coord IM with Cat A or C term with /surg; DF: LASER COAG%A%  
% 209.35/209.56  |- skos__historyNote mesh__D017075 Light Coagulation %28%1966-1992%29%
% 209.35/209.56  |- mesh__recordAuthorizer mesh__D017075 SJN
% 209.35/209.56  |- mesh__dateEstablished mesh__D017075 1993-01-01
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017075 2006
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017075 2005
% 209.35/209.56  |- skos__hiddenLabel mesh__D017075 Coagulations, Laser
% 209.35/209.56  |- skos__altLabel mesh__D017075 Thermocoagulation, Laser
% 209.35/209.56  |- mesh__historyNote mesh__D017075
% 209.35/209.56       93; was see LIGHT COAGULATION 1992; was heading 1968-85   
% 209.35/209.56  |- rdf__type mesh__D017075sskos__Concept
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017075 2002
% 209.35/209.56  |- skos__hiddenLabel mesh__D017075 Laser Thermocoagulations
% 209.35/209.56  |- skos__altLabel mesh__D017075 Coagulation, Laser
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017075 1999
% 209.35/209.56  |- mesh__dateRevised mesh__D017075 1997-06-20
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003853 2003
% 209.35/209.56  |- skos__annotation mesh__D003853 GEN or unspecified; prefer specific   
% 209.35/209.56  |- skos__historyNote mesh__D003853 Nucleosides %28%1966-1972%29%
% 209.35/209.56  |- mesh__onlineNote mesh__D003853
% 209.35/209.56       use DEOXYRIBONUCLEOSIDES to search RIBONUCLEOSIDES, DEOXY 1971-72 %28%as Prov%29%%A%  
% 209.35/209.56  |- rdf__type mesh__D003853sskos__Concept
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003853 2004
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003853 2005
% 209.35/209.56  |- skos__prefLabel mesh__D003853 Deoxyribonucleosides
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003853 2006
% 209.35/209.56  |- skos__broader mesh__D003853smesh__D009705
% 209.35/209.56  |- skos__historyNote mesh__D003853 specific nucleoside %28%1966-1972%29%
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003853 2001
% 209.35/209.56  |- mesh__recordMaintainer mesh__D003853 adp
% 209.35/209.56  |- mesh__recordOriginator mesh__D003853 NLM
% 209.35/209.56  |- mesh__dateRevised mesh__D003853 2000-06-22
% 209.35/209.56  |- mesh__dateCreated mesh__D003853 1999-01-01
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003853 2002
% 209.35/209.56  |- mesh__historyNote mesh__D003853
% 209.35/209.56       73; was RIBONUCLEOSIDES, DEOXY 1971-72 %28%Prov%29%   
% 209.35/209.56  |- mesh__recordAuthorizer mesh__D003853 sjn
% 209.35/209.56  |- skos__scopeNote mesh__D003853
% 209.35/209.56       A purine or pyrimidine base bonded to DEOXYRIBOSE.     
% 209.35/209.56  |- mesh__publicMeSHNote mesh__D003853 73   
% 209.35/209.56  |- mesh__dateEstablished mesh__D003853 1973-01-01
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003055 2000
% 209.35/209.56  |- skos__hiddenLabel mesh__D003055 Potential, Cochlear Microphonic
% 209.35/209.56  |- mesh__recordMaintainer mesh__D003055 AGS
% 209.35/209.56  |- mesh__dateCreated mesh__D003055 1978-12-14
% 209.35/209.56  |- mesh__dateEstablished mesh__D003055 1991-01-01
% 209.35/209.56  |- skos__hiddenLabel mesh__D003055 Microphonic Potential, Cochlear
% 209.35/209.56  |- skos__historyNote mesh__D003055 Electrophysiology %28%1966%29%
% 209.35/209.56  |- skos__hiddenLabel mesh__D003055 Potentials, Cochlear Microphonic
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003055 2006
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003055 2002
% 209.35/209.56  |- mesh__recordAuthorizer mesh__D003055 PLS
% 209.35/209.56  |- skos__prefLabel mesh__D003055 Cochlear Microphonic Potentials
% 209.35/209.56  |- skos__historyNote mesh__D003055 Evoked Potentials %28%1967-1979%29%
% 209.35/209.56  |- skos__historyNote mesh__D003055 Action Potentials %28%1967-1979%29%
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003055 1999
% 209.35/209.56  |- mesh__dateRevised mesh__D003055 1995-02-23
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003055 2005
% 209.35/209.56  |- skos__hiddenLabel mesh__D003055 Cochlear Microphonic Potential
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003055 2004
% 209.35/209.56  |- skos__historyNote mesh__D003055 Cochlea %28%1966-1979%29%
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003055 1998
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003055 1997
% 209.35/209.56  |- rdf__type mesh__D003055sskos__Concept
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003055 2003
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003055 2001
% 209.35/209.56  |- skos__broader mesh__D003055smesh__D005072
% 209.35/209.56  |- mesh__recordOriginator mesh__D003055 RC
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003055 1996
% 209.35/209.56  |- mesh__publicMeSHNote mesh__D003055
% 209.35/209.56       91; was see under EVOKED POTENTIALS, AUDITORY 1980-90   
% 209.35/209.56  |- skos__scopeNote mesh__D003055
% 209.35/209.56       The electric response of the cochlear hair cells to acoustic stimulation.%A%    
% 209.35/209.56  |- skos__hiddenLabel mesh__D003055 Microphonic Potentials, Cochlear
% 209.35/209.56  |- mesh__historyNote mesh__D003055
% 209.35/209.56       91%28%80%29%; was see under EVOKED POTENTIALS, AUDITORY 1980-90%A%  
% 209.35/209.56  |- mesh__recordMaintainer mesh__D013483 TGC
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D013483 2002
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D013483 1999
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D013483 2001
% 209.35/209.56  |- mesh__recordOriginator mesh__D013483 NLM
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D013483 1998
% 209.35/209.56  |- skos__prefLabel mesh__D013483 Superstitions
% 209.35/209.56  |- rdf__type mesh__D013483sskos__Concept
% 209.35/209.56  |- mesh__dateRevised mesh__D013483 1997-06-20
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D013483 2004
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D013483 2000
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D013483 2006
% 209.35/209.56  |- skos__scopeNote mesh__D013483
% 209.35/209.56       A belief or practice which lacks adequate basis for proof; an embodiment of fear of the unknown, magic, and ignorance.%A%    
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D013483 2003
% 209.35/209.56  |- mesh__dateCreated mesh__D013483 1999-01-01
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D013483 2005
% 209.35/209.56  |- skos__hiddenLabel mesh__D013483 Superstition
% 209.35/209.56  |- skos__broader mesh__D013483smesh__D003469
% 209.35/209.56  |- mesh__recordAuthorizer mesh__D013483 SJN
% 209.35/209.56  |- skos__broader mesh__D009206Q000601smesh__D009206
% 209.35/209.56  |- mesh__preferredCombination mesh__D009206Q000601smesh__D006348
% 209.35/209.56  |- rdf__type mesh__D009206Q000601smesh__CompoundConcept
% 209.35/209.56  |- skos__prefLabel mesh__D007446 Inversion, Chromosome
% 209.35/209.56  |- skos__altLabel mesh__D007446 Inversion, Chromosomal
% 209.35/209.56  |- mesh__dateRevised mesh__D007446 2005-07-18
% 209.35/209.56  |- skos__hiddenLabel mesh__D007446 Sequence Inversion
% 209.35/209.56  |- rdf__type mesh__D007446sskos__Concept
% 209.35/209.56  |- mesh__publicMeSHNote mesh__D007446
% 209.35/209.56       2005; see INVERSION %28%GENETICS%29% 1978-2004, see CHROMOSOME ABERRATIONS 1969-1977%A%  
% 209.35/209.56  |- mesh__recordAuthorizer mesh__D007446 ags
% 209.35/209.56  |- skos__hiddenLabel mesh__D007446 Chromosomal Inversions
% 209.35/209.56  |- skos__historyNote mesh__D007446 Chromosome Aberrations %28%1968-1974%29%
% 209.35/209.56  |- mesh__recordMaintainer mesh__D007446 ags
% 209.35/209.56  |- mesh__historyNote mesh__D007446 2005%28%1969%29%   
% 209.35/209.56  |- skos__hiddenLabel mesh__D007446 Inversions, Chromosomal
% 209.35/209.56  |- mesh__dateCreated mesh__D007446 1999-01-01
% 209.35/209.56  |- skos__hiddenLabel mesh__D007446 Inversions, Sequence
% 209.35/209.56  |- skos__scopeNote mesh__D007446
% 209.35/209.56       An aberration in which a chromosomal segment is deleted and reinserted in the same place but turned 180 degrees from its original orientation, so that the gene sequence for the segment is reversed with respect to that of the rest of the chromosome.%A%    
% 209.35/209.56  |- skos__broader mesh__D007446smesh__D016296
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D007446 2006A
% 209.35/209.56  |- mesh__recordOriginator mesh__D007446 NLM
% 209.35/209.56  |- skos__altLabel mesh__D007446 Chromosome Inversion
% 209.35/209.56  |- skos__hiddenLabel mesh__D007446 Chromosome Inversions
% 209.35/209.56  |- skos__hiddenLabel mesh__D007446 Inversions, Chromosome
% 209.35/209.56  |- skos__hiddenLabel mesh__D007446 Sequence Inversions
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D007446 2006
% 209.35/209.56  |- mesh__dateEstablished mesh__D007446 1978-01-01
% 209.35/209.56  |- skos__historyNote mesh__D007446
% 209.35/209.56       Chromosome Abnormalities %28%1966-1967%29%
% 209.35/209.56  |- skos__altLabel mesh__D007446 Inversion, Sequence
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D007446 2005
% 209.35/209.56  |- skos__broader mesh__D007446smesh__D002869
% 209.35/209.56  |- skos__hiddenLabel mesh__D007446 Chromosomal Inversion
% 209.35/209.56  |- skos__hiddenLabel mesh__D045565 Endonuclease, Cruciform Cutting
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D045565 2004
% 209.35/209.56  |- skos__hiddenLabel mesh__D045565 Resolvase, Holliday Junction
% 209.35/209.56  |- skos__altLabel mesh__D045565 Resolvases, Holliday Junction
% 209.35/209.56  |- mesh__recordMaintainer mesh__D045565 jmp
% 209.35/209.56  |- skos__historyNote mesh__D045565 Endonucleases %28%1989-2003%29%
% 209.35/209.56  |- skos__broader mesh__D045565smesh__D045522
% 209.35/209.56  |- skos__broader mesh__D045565smesh__D004706
% 209.35/209.56  |- mesh__dateCreated mesh__D045565 2003-07-09
% 209.35/209.56  |- mesh__recordOriginator mesh__D045565 jmp
% 209.35/209.56  |- mesh__publicMeSHNote mesh__D045565
% 209.35/209.56       2004; HOLLIDAY JUNCTION RESOLVASES was indexed under ENDONUCLEASES 1989-2003%A%  
% 209.35/209.56  |- skos__scopeNote mesh__D045565
% 209.35/209.56       Enzymes that recognize CRUCIFORM DNA structures and introduce paired incisions that help to resolve the structure into two DNA helices.%A%    
% 209.35/209.56  |- skos__altLabel mesh__D045565 Cruciform DNA Resolving Endonuclease
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D045565 2006
% 209.35/209.56  |- skos__annotation mesh__D045565
% 209.35/209.56       do not confuse with TRANSPOSON RESOLVASES   
% 209.35/209.56  |- rdf__type mesh__D045565sskos__Concept
% 209.35/209.56  |- skos__altLabel mesh__D045565 Holliday Junction Resolvase
% 209.35/209.56  |- mesh__dateEstablished mesh__D045565 2004-01-01
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D045565 2005
% 209.35/209.56  |- skos__prefLabel mesh__D045565 Holliday Junction Resolvases
% 209.35/209.56  |- mesh__recordAuthorizer mesh__D045565 sjn
% 209.35/209.56  |- skos__altLabel mesh__D045565 Cruciform Cutting Endonuclease
% 209.35/209.56  |- mesh__historyNote mesh__D045565
% 209.35/209.56       2004; use HOLLIDAY JUNCTION RESOLVASES %28%NM%29% 1989-2003   
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017874 2002
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017874 1999
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017874 1996
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017874 2004
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017874 2001
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017874 1995
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017874 1998
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017874 2006
% 209.35/209.56  |- rdf__type mesh__D017874sskos__Concept
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017874 2003
% 209.35/209.56  |- mesh__dateEstablished mesh__D017874 1994-01-01
% 209.35/209.56  |- mesh__dateCreated mesh__D017874 1992-12-28
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017874 1994
% 209.35/209.56  |- skos__hiddenLabel mesh__D017874 Proteins, Immediate Early
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017874 2005
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017874 2000
% 209.35/209.56  |- skos__scopeNote mesh__D017874
% 209.35/209.56       Proteins that are coded by immediate-early genes, in the absence of de novo protein synthesis. The term was originally used exclusively for viral regulatory proteins that were synthesized just after viral integration into the host cell. It is also used to describe cellular proteins which are synthesized immediately after the resting cell is stimulated by extracellular signals.%A%    
% 209.35/209.56  |- skos__broader mesh__D017874smesh__D015520
% 209.35/209.56  |- skos__historyNote mesh__D017874 Viral Proteins %28%1974-1993%29%
% 209.35/209.56  |- mesh__publicMeSHNote mesh__D017874 94   
% 209.35/209.56  |- skos__hiddenLabel mesh__D017874 Immediate Early Proteins
% 209.35/209.56  |- mesh__historyNote mesh__D017874 94   
% 209.35/209.56  |- skos__broader mesh__D017874smesh__D011506
% 209.35/209.56  |- skos__altLabel mesh__D017874 Proteins, Immediate-Early
% 209.35/209.56  |- skos__prefLabel mesh__D017874 Immediate-Early Proteins
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017874 1997
% 209.35/209.56  |- skos__annotation mesh__D017874
% 209.35/209.56       proteins coded by immed-early genes: read MeSH definition for history of %22%immediate-early%22%%A%  
% 209.35/209.56  |- skos__hiddenLabel mesh__D017076 Computer-Assisted Designs
% 209.35/209.56  |- skos__prefLabel mesh__D017076 Computer-Aided Design
% 209.35/209.56  |- skos__hiddenLabel mesh__D017076 Computer Aided Design
% 209.35/209.56  |- skos__hiddenLabel mesh__D017076 Computer Aided Manufacturing
% 209.35/209.56  |- skos__hiddenLabel mesh__D017076 Manufacturing, Computer-Assisted
% 209.35/209.56  |- skos__hiddenLabel mesh__D017076 Design, Computer-Assisted
% 209.35/209.56  |- mesh__recordAuthorizer mesh__D017076 sjn
% 209.35/209.56  |- skos__historyNote mesh__D017076 Computers %28%1968-1992%29%
% 209.35/209.56  |- skos__hiddenLabel mesh__D017076 Manufacturing, Computer-Aided
% 209.35/209.56  |- skos__hiddenLabel mesh__D017076 Computer-Aided Designs
% 209.35/209.56  |- mesh__publicMeSHNote mesh__D017076 93   
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017076 2006
% 209.35/209.56  |- mesh__dateCreated mesh__D017076 1992-05-07
% 209.35/209.56  |- skos__scopeNote mesh__D017076
% 209.35/209.56       The use of computers for designing and/or manufacturing of anything, including drugs, surgical procedures, orthotics, and prosthetics.%A%    
% 209.35/209.56  |- skos__hiddenLabel mesh__D017076 Designs, Computer-Aided
% 209.35/209.56  |- mesh__dateRevised mesh__D017076 2004-07-07
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017076 2005
% 209.35/209.56  |- skos__altLabel mesh__D017076 Computer-Assisted Design
% 209.35/209.56  |- skos__broader mesh__D017076smesh__D003196
% 209.35/209.56  |- skos__hiddenLabel mesh__D017076 Computer Assisted Design
% 209.35/209.56  |- rdf__type mesh__D017076sskos__Concept
% 209.35/209.56  |- mesh__dateEstablished mesh__D017076 1993-01-01
% 209.35/209.56  |- skos__annotation mesh__D017076 in design of equipment or drugs   
% 209.35/209.56  |- mesh__recordMaintainer mesh__D017076 jls
% 209.35/209.56  |- skos__altLabel mesh__D017076 Computer-Assisted Manufacturing
% 209.35/209.56  |- mesh__recordOriginator mesh__D017076 MXR
% 209.35/209.56  |- mesh__historyNote mesh__D017076 93   
% 209.35/209.56  |- skos__hiddenLabel mesh__D017076 Designs, Computer-Assisted
% 209.35/209.56  |- skos__hiddenLabel mesh__D017076 Computer Assisted Manufacturing
% 209.35/209.56  |- skos__hiddenLabel mesh__D017076 Design, Computer-Aided
% 209.35/209.56  |- mesh__historyNote mesh__D003854
% 209.35/209.56       73; was RIBONUCLEOTIDES, DEOXY 1971-72 %28%Prov%29%   
% 209.35/209.56  |- skos__annotation mesh__D003854 GEN or unspecified; prefer specific   
% 209.35/209.56  |- rdf__type mesh__D003854sskos__Concept
% 209.35/209.56  |- mesh__dateEstablished mesh__D003854 1973-01-01
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003854 2004
% 209.35/209.56  |- skos__prefLabel mesh__D003854 Deoxyribonucleotides
% 209.35/209.56  |- skos__historyNote mesh__D003854 Nucleotides %28%1966-1972%29%
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003854 2005
% 209.35/209.56  |- mesh__onlineNote mesh__D003854
% 209.35/209.56       use DEOXYRIBONUCLEOTIDES to search RIBONUCLEOTIDES, DEOXY 1971-72 %28%as Prov%29%%A%  
% 209.35/209.56  |- skos__broader mesh__D003854smesh__D009711
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003854 2001
% 209.35/209.56  |- mesh__recordOriginator mesh__D003854 NLM
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003854 2006
% 209.35/209.56  |- mesh__dateCreated mesh__D003854 1999-01-01
% 209.35/209.56  |- mesh__dateRevised mesh__D003854 2000-06-22
% 209.35/209.56  |- mesh__recordAuthorizer mesh__D003854 sjn
% 209.35/209.56  |- mesh__recordMaintainer mesh__D003854 adp
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003854 2002
% 209.35/209.56  |- mesh__publicMeSHNote mesh__D003854 73   
% 209.35/209.56  |- skos__scopeNote mesh__D003854
% 209.35/209.56       A purine or pyrimidine base bonded to a DEOXYRIBOSE containing a bond to a phosphate group.%A%    
% 209.35/209.56  |- skos__historyNote mesh__D003854 specific nucleotide %28%1966-1972%29%
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003854 2003
% 209.35/209.56  |- skos__hiddenLabel mesh__D003056 Nerve, Auditory
% 209.35/209.56  |- skos__hiddenLabel mesh__D003056 Auditory Nerves
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003056 2005
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003056 2004
% 209.35/209.56  |- mesh__dateCreated mesh__D003056 1999-01-01
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003056 2001
% 209.35/209.56  |- rdf__type mesh__D003056sskos__Concept
% 209.35/209.56  |- skos__scopeNote mesh__D003056
% 209.35/209.56       The cochlear part of the 8th cranial nerve %28%VESTIBULOCOCHLEAR NERVE%29%. The cochlear nerve fibers originate from neurons of the SPIRAL GANGLION and project peripherally to cochlear hair cells and centrally to the cochlear nuclei %28%COCHLEAR NUCLEUS%29% of the BRAIN STEM. They mediate the sense of hearing.%A%    
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003056 2003
% 209.35/209.56  |- skos__altLabel mesh__D003056 Auditory Nerve
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003056 2000
% 209.35/209.56  |- mesh__recordOriginator mesh__D003056 NLM
% 209.35/209.56  |- skos__broader mesh__D003056smesh__D000159
% 209.35/209.56  |- skos__hiddenLabel mesh__D003056 Nerve, Cochlear
% 209.35/209.56  |- skos__hiddenLabel mesh__D003056 Nerves, Auditory
% 209.35/209.56  |- mesh__recordAuthorizer mesh__D003056 sjn
% 209.35/209.56  |- mesh__dateRevised mesh__D003056 1999-11-08
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003056 2002
% 209.35/209.56  |- mesh__publicMeSHNote mesh__D003056
% 209.35/209.56       1963; for AUDITORY NERVE see ACOUSTIC NERVE 1979-1999; for ACOUSTIC NERVE see VESTIBULOCOCHLEAR NERVE 1963-1999%A%  
% 209.35/209.56  |- skos__annotation mesh__D003056
% 209.35/209.56       dis: coord IM with VESTIBULOCOCHLEAR NERVE DISEASES %28%IM%29%; neopl: coord IM with VESTIBULOCOCHLEAR NERVE DISEASES %28%IM%29% + CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 209.35/209.56  |- mesh__historyNote mesh__D003056
% 209.35/209.56       1963; for AUDITORY NERVE use VESTIBULOCOCHLEAR NERVE 1979-1999; for ACOUSTIC NERVE use VESTIBULOCOCHLEAR NERVE 1963-1999%A%  
% 209.35/209.56  |- skos__hiddenLabel mesh__D003056 Nerves, Cochlear
% 209.35/209.56  |- skos__hiddenLabel mesh__D003056 Nerves, Acoustic
% 209.35/209.56  |- skos__hiddenLabel mesh__D003056 Acoustic Nerves
% 209.35/209.56  |- skos__prefLabel mesh__D003056 Cochlear Nerve
% 209.35/209.56  |- skos__altLabel mesh__D003056 Acoustic Nerve
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D003056 2006
% 209.35/209.56  |- skos__hiddenLabel mesh__D003056 Cochlear Nerves
% 209.35/209.56  |- skos__hiddenLabel mesh__D003056 Nerve, Acoustic
% 209.35/209.56  |- mesh__recordMaintainer mesh__D003056 adp
% 209.35/209.56  |- mesh__recordAuthorizer mesh__D013484 sjn
% 209.35/209.56  |- mesh__historyNote mesh__D013484 88   
% 209.35/209.56  |- rdf__type mesh__D013484sskos__Concept
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D013484 2004
% 209.35/209.56  |- mesh__recordOriginator mesh__D013484 EC
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D013484 2006
% 209.35/209.56  |- mesh__dateEstablished mesh__D013484 1988-01-01
% 209.35/209.56  |- skos__scopeNote mesh__D013484
% 209.35/209.56       Applies to the movements of the forearm in turning the palm forward or upward and when applied to the foot, a combination of adduction and inversion of the foot.%A%    
% 209.35/209.56  |- skos__historyNote mesh__D013484 Movement %28%1966-1987%29%
% 209.35/209.56  |- mesh__recordMaintainer mesh__D013484 nns
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D013484 2005
% 209.35/209.56  |- skos__annotation mesh__D013484
% 209.35/209.56       refers to foot or forearm; do not confuse with SUPINE POSITION%A%  
% 209.35/209.56  |- skos__prefLabel mesh__D013484 Supination
% 209.35/209.56  |- mesh__dateCreated mesh__D013484 1987-04-06
% 209.35/209.56  |- skos__hiddenLabel mesh__D013484 Supinations
% 209.35/209.56  |- mesh__dateRevised mesh__D013484 2003-07-09
% 209.35/209.56  |- mesh__publicMeSHNote mesh__D013484 88   
% 209.35/209.56  |- skos__historyNote mesh__D013484 Posture %28%1966-1987%29%
% 209.35/209.56  |- skos__broader mesh__D013484smesh__D009068
% 209.35/209.56  |- rdf__type mesh__D007447sskos__Concept
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D007447 2001
% 209.35/209.56  |- skos__prefLabel mesh__D007447 Invertebrate Hormones
% 209.35/209.56  |- skos__historyNote mesh__D007447 Hormones %28%1966%29%
% 209.35/209.56  |- skos__annotation mesh__D007447
% 209.35/209.56       coord IM with specific invertebrate %28%IM%29%   
% 209.35/209.56  |- mesh__dateCreated mesh__D007447 1999-01-01
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D007447 2000
% 209.35/209.56  |- mesh__recordMaintainer mesh__D007447 TGC
% 209.35/209.56  |- skos__historyNote mesh__D007447 Insects %28%1966%29%
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D007447 1999
% 209.35/209.56  |- mesh__historyNote mesh__D007447 67   
% 209.35/209.56  |- mesh__dateRevised mesh__D007447 1995-03-17
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D007447 1997
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D007447 1998
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D007447 2006
% 209.35/209.56  |- skos__broader mesh__D007447smesh__D006728
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D007447 2002
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D007447 1996
% 209.35/209.56  |- mesh__publicMeSHNote mesh__D007447 67   
% 209.35/209.56  |- mesh__dateEstablished mesh__D007447 1967-01-01
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D007447 2004
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D007447 2005
% 209.35/209.56  |- skos__altLabel mesh__D007447 Hormones, Invertebrate
% 209.35/209.56  |- skos__scopeNote mesh__D007447
% 209.35/209.56       Hormones produced by invertebrates, usually insects, mollusks, annelids, and helminths.%A%    
% 209.35/209.56  |- mesh__recordOriginator mesh__D007447 NLM
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D007447 2003
% 209.35/209.56  |- mesh__recordAuthorizer mesh__D007447 PLS
% 209.35/209.56  |- skos__scopeNote mesh__D026601
% 209.35/209.56       A PROTEIN O-METHYLTRANSFERASE that recognizes and catalyzes the  methyl esterification of ISOASPARTIC ACID and D-ASPARTIC ACID residues in peptides and proteins. It initiates the repair of proteins damaged by the spontaneous decomposition of normal L-aspartic acid and L-asparagine residues.%A%    
% 209.35/209.56  |- skos__historyNote mesh__D026601
% 209.35/209.56       Protein Methyltransferases %28%1984-2001%29%
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601
% 209.35/209.56       L Isoaspartyl Protein Carboxymethyltransferase
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601 Gene Product, PCMT1
% 209.35/209.56  |- skos__altLabel mesh__D026601 Protein-L-Isoaspartate Methyltransferase
% 209.35/209.56  |- mesh__publicMeSHNote mesh__D026601
% 209.35/209.56       2002; PROTEIN-D-ASPARTATE METHYLTRANSFERASE %28%now PROTEIN D-ASPARTATE-L-ISOASPARTATE METHYLTRANSFERASE%29% was indexed under PROTEIN METHYLTRANSFERASES 1984-2001%A%  
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601
% 209.35/209.56       Protein D Aspartate L Isoaspartate Methyltransferase
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601
% 209.35/209.56       Methyltransferase, Isoaspartyl-Aspartyl Protein
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601 PIMT, Methyltransferase
% 209.35/209.56  |- skos__altLabel mesh__D026601 Protein-beta-Aspartate Methyltransferase
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601
% 209.35/209.56       Methyltransferase, D-Aspartyl-L-Isoaspartyl
% 209.35/209.56  |- mesh__dateEstablished mesh__D026601 2002-01-01
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601
% 209.35/209.56       Methyltransferase, Protein-L-Isoaspartate
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601 Protein beta Aspartate Methyltransferase
% 209.35/209.56  |- skos__altLabel mesh__D026601 D-Aspartyl-L-Isoaspartyl Methyltransferase
% 209.35/209.56  |- skos__altLabel mesh__D026601 Protein L-Isoaspartate O-Methyltransferase
% 209.35/209.56  |- mesh__dateCreated mesh__D026601 2001-07-25
% 209.35/209.56  |- skos__altLabel mesh__D026601
% 209.35/209.56       Isoaspartyl-Aspartyl Protein Methyltransferase
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601
% 209.35/209.56       Methyltransferase, Protein-beta-Aspartate
% 209.35/209.56  |- skos__altLabel mesh__D026601 pcm Gene Product
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D026601 2006
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601 Protein D Aspartate Methyltransferase
% 209.35/209.56  |- skos__altLabel mesh__D026601 Protein-D-Aspartate Methyltransferase
% 209.35/209.56  |- skos__altLabel mesh__D026601 PCMT1 Gene Product
% 209.35/209.56  |- mesh__historyNote mesh__D026601
% 209.35/209.56       2002; use PROTEIN D-ASPARTATE-L-ISOASPARTATE METHYLTRANSFERASE %28%NM%29% 1984-2001%A%  
% 209.35/209.56  |- skos__prefLabel mesh__D026601
% 209.35/209.56       Protein D-Aspartate-L-Isoaspartate Methyltransferase
% 209.35/209.56  |- skos__altLabel mesh__D026601 Methyltransferase PIMT
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601
% 209.35/209.56       Protein L Isoaspartate D Aspartate O Methyltransferase
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601
% 209.35/209.56       L-Isoaspartate O-Methyltransferase, Protein
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601 Methyltransferase, Protein-D-Aspartate
% 209.35/209.56  |- skos__altLabel mesh__D026601 Protein L-Isoaspartyl Methyltransferase
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D026601 2005
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601
% 209.35/209.56       Methyltransferase, Protein D-Aspartate-L-Isoaspartate
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601
% 209.35/209.56       Protein L Isoaspartate O Methyltransferase
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601
% 209.35/209.56       D Aspartyl L Isoaspartyl Methyltransferase
% 209.35/209.56  |- mesh__dateRevised mesh__D026601 2003-07-09
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601 Methyltransferase, Protein L-Isoaspartyl
% 209.35/209.56  |- skos__altLabel mesh__D026601
% 209.35/209.56       Protein-L-Isoaspartate-D-Aspartate-O-Methyltransferase
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601 Methyltransferase, Protein-D-Asp
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601 Protein L Isoaspartyl Methyltransferase
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D026601 2004
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601
% 209.35/209.56       Protein Carboxymethyltransferase, L-Isoaspartyl
% 209.35/209.56  |- skos__broader mesh__D026601smesh__D011497
% 209.35/209.56  |- skos__altLabel mesh__D026601 Protein-D-Asp Methyltransferase
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601
% 209.35/209.56       Protein Methyltransferase, Isoaspartyl-Aspartyl
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601 Protein D Asp Methyltransferase
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601
% 209.35/209.56       O-Methyltransferase, Protein L-Isoaspartate
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601
% 209.35/209.56       Carboxymethyltransferase, L-Isoaspartyl Protein
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601 Protein L Isoaspartate Methyltransferase
% 209.35/209.56  |- skos__altLabel mesh__D026601
% 209.35/209.56       L-Isoaspartyl Protein Carboxymethyltransferase
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601 L-Isoaspartyl Methyltransferase, Protein
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601
% 209.35/209.56       Isoaspartyl Aspartyl Protein Methyltransferase
% 209.35/209.56  |- skos__hiddenLabel mesh__D026601 Gene Product, pcm
% 209.35/209.56  |- rdf__type mesh__D026601sskos__Concept
% 209.35/209.56  |- mesh__historyNote mesh__D045566 2004;   
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D045566 2004
% 209.35/209.56  |- skos__prefLabel mesh__D045566 DNA, Cruciform
% 209.35/209.56  |- mesh__publicMeSHNote mesh__D045566 2004;   
% 209.35/209.56  |- skos__altLabel mesh__D045566 Cruciform DNA
% 209.35/209.56  |- skos__broader mesh__D045566smesh__D004247
% 209.35/209.56  |- mesh__dateCreated mesh__D045566 2003-07-09
% 209.35/209.56  |- rdf__type mesh__D045566sskos__Concept
% 209.35/209.56  |- skos__hiddenLabel mesh__D045566 DNA, Holliday Junction
% 209.35/209.56  |- skos__altLabel mesh__D045566 Holliday Junction DNA
% 209.35/209.56  |- skos__related mesh__D045566smesh__D045565
% 209.35/209.56  |- skos__scopeNote mesh__D045566
% 209.35/209.56       A cross-shaped DNA structure that can be observed under the electron microscope. It is formed by the incomplete exchange of strands between two double-stranded helices.%A%    
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D045566 2006
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D045566 2005
% 209.35/209.56  |- skos__altLabel mesh__D045566 Holliday Junctions
% 209.35/209.56  |- mesh__dateEstablished mesh__D045566 2004-01-01
% 209.35/209.56  |- skos__altLabel mesh__D045566 DNA Cruciforms
% 209.35/209.56  |- mesh__activeMeSHYear mesh__D017875 2005
% 209.35/209.56  |- mesh__recordOriginator mesh__D017875 TPW
% 209.35/209.56  |- mesh__publicMeSHNote mesh__D017875 94   
% 209.35/209.56  |- skos__historyNote mesh__D017875 Isomerases %28%1984-1993%29%
% 209.35/209.56  |- mesh__dateCreated mesh__D017875 1993-06-18
% 209.35/209.56  |- skos__historyNote mesh__D017875 Phosphotransferases %28%1966-1993%29%
% 209.35/209.56  |- mesh__historyNote mesh__D017875 94   
% 209.35/209.56  |- skos__broader mesh__D017875smesh__D019751
% 209.35/209.57  |- skos__altLabel mesh__D017875 Phosphomutases
% 209.35/209.57  |- mesh__dateEstablished mesh__D017875 1994-01-01
% 209.35/209.57  |- skos__scopeNote mesh__D017875
% 209.35/209.57       A group of enzymes that catalyze an intramolecular transfer of a phosphate group. It has been shown in some cases that the enzyme has a functional phosphate group, which can act as the donor. These were previously listed under PHOSPHOTRANSFERASES %28%EC 2.7.-%29%. %28%From Enzyme Nomenclature, 1992%29% EC 5.4.2.%A%    
% 209.35/209.57  |- mesh__activeMeSHYear mesh__D017875 2004
% 209.35/209.57  |- skos__annotation mesh__D017875 DF: note short X ref   
% 209.35/209.57  |- mesh__recordAuthorizer mesh__D017875 sjn
% 209.35/209.57  |- mesh__activeMeSHYear mesh__D017875 2006
% 209.35/209.57  |- mesh__dateRevised mesh__D017875 2003-07-09
% 209.35/209.57  |- rdf__type mesh__D017875sskos__Concept
% 209.35/209.57  |- skos__prefLabel mesh__D017875 Phosphotransferases %28%Phosphomutases%29%
% 209.35/209.57  |- mesh__recordMaintainer mesh__D017875 ssb
% 209.35/209.57  |- mesh__recordMaintainer mesh__D050700 ags
% 209.35/209.57  |- mesh__publicMeSHNote mesh__D050700
% 209.35/209.57       2006; E2F5 TRANSCRIPTION FACTOR, E2F Transcription Factor 5 Protein, %26% TRANSCRIPTION FACTOR E2F-5 were indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTIONS FACTORS 2004-2005%A%  
% 209.35/209.57  |- mesh__dateRevised mesh__D050700 2005-07-13
% 209.35/209.57  |- rdf__type mesh__D050700sskos__Concept
% 209.35/209.57  |- skos__altLabel mesh__D050700 E2F Transcription Factor 5 Protein
% 209.35/209.57  |- skos__hiddenLabel mesh__D050700 E2F-5, Transcription Factor
% 209.35/209.57  |- mesh__historyNote mesh__D050700 2006%28%2004%29%   
% 209.35/209.57  |- mesh__recordAuthorizer mesh__D050700 ags
% 209.35/209.57  |- skos__hiddenLabel mesh__D050700 Transcription Factor E2F 5
% 209.35/209.57  |- skos__scopeNote mesh__D050700
% 209.35/209.57       An E2F transcription factor that represses GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis. E2F5 recruits chromatin remodeling factors indirectly to target gene promoters through RETINOBLASTOMA LIKE PROTEIN P130.%A%    
% 209.35/209.57  |- skos__altLabel mesh__D050700 Transcription Factor E2F-5
% 209.35/209.57  |- skos__annotation mesh__D050700 see SCR for organism-specific terms   
% 209.35/209.57  |- skos__historyNote mesh__D050700 Transcription Factors %28%1991-2005%29%
% 209.35/209.57  |- mesh__recordOriginator mesh__D050700 DRC
% 209.35/209.57  |- skos__historyNote mesh__D050700 Cell Cycle Proteins %28%1991-2005%29%
% 209.35/209.57  |- mesh__dateEstablished mesh__D050700 2006-01-01
% 209.35/209.57  |- mesh__activeMeSHYear mesh__D050700 2006A
% 209.35/209.57  |- skos__prefLabel mesh__D050700 E2F5 Transcription Factor
% 209.35/209.57  |- skos__hiddenLabel mesh__D050700 Transcription Factor, E2F5
% 209.35/209.57  |- skos__broader mesh__D050700smesh__D050684
% 209.35/209.57  |- mesh__activeMeSHYear mesh__D050700 2006
% 209.35/209.57  |- skos__historyNote mesh__D050700 DNA-Binding Proteins %28%1991-2005%29%
% 209.35/209.57  |- mesh__dateCreated mesh__D050700 2005-06-30
% 209.35/209.57  |- skos__historyNote mesh__D017077 Culture Media %28%1967-1992%29%
% 209.35/209.57  |- skos__broader mesh__D017077smesh__D003470
% 209.35/209.57  |- skos__altLabel mesh__D017077 Conditioned Culture Medium
% 209.35/209.57  |- skos__prefLabel mesh__D017077 Culture Media, Conditioned
% 209.35/209.57  |- mesh__activeMeSHYear mesh__D017077 2005
% 209.35/209.57  |- mesh__dateEstablished mesh__D017077 1993-01-01
% 209.35/209.57  |- mesh__activeMeSHYear mesh__D017077 2006
% 209.35/209.57  |- mesh__dateRevised mesh__D017077 2003-07-09
% 209.35/209.57  |- skos__altLabel mesh__D017077 Conditioned Media
% 209.35/209.57  |- skos__altLabel mesh__D017077 Conditioned Medium
% 209.35/209.57  |- mesh__dateCreated mesh__D017077 1992-05-07
% 209.35/209.57  |- skos__scopeNote mesh__D017077
% 209.35/209.57       Culture media containing biologically active components obtained from previously cultured cells or tissues that have released into the media substances affecting certain cell functions %28%e.g., growth, lysis%29%.%A%    
% 209.35/209.57  |- mesh__recordMaintainer mesh__D017077 ssb
% 209.35/209.57  |- skos__altLabel mesh__D017077 Conditioned Culture Media
% 209.35/209.57  |- mesh__recordAuthorizer mesh__D017077 sjn
% 209.35/209.57  |- rdf__type mesh__D017077sskos__Concept
% 209.35/209.57  |- mesh__recordOriginator mesh__D017077 MXR
% 209.35/209.57  |- skos__annotation mesh__D017077
% 209.35/209.57       culture media containing biol active components from previously cultured matter; NIM; D25-26 qualif%A%  
% 209.35/209.57  |- skos__hiddenLabel mesh__D017077 Media, Conditioned
% 209.35/209.57  |- mesh__publicMeSHNote mesh__D017077 93   
% 209.35/209.57  |- skos__altLabel mesh__D017077 Culture Medium, Conditioned
% 209.35/209.57  |- mesh__historyNote mesh__D017077 93   
% 209.35/209.57  |- skos__hiddenLabel mesh__D017077 Medium, Conditioned
% 209.35/209.57  |- mesh__activeMeSHYear mesh__D017077 2004
% 209.35/209.57  |- mesh__activeMeSHYear mesh__D003855 2005
% 209.35/209.57  |- skos__broader mesh__D003855smesh__D003837
% 209.35/209.57  |- mesh__recordAuthorizer mesh__D003855 sjn
% 209.35/209.57  |- rdf__type mesh__D003855sskos__Concept
% 209.35/209.57  |- mesh__recordMaintainer mesh__D003855 ssb
% 209.35/209.57  |- mesh__dateRevised mesh__D003855 2004-07-07
% 209.35/209.57  |- mesh__dateEstablished mesh__D003855 1974-01-01
% 209.35/209.57  |- mesh__historyNote mesh__D003855 74   
% 209.35/209.57  |- mesh__dateCreated mesh__D003855 1999-01-01
% 209.35/209.57  |- skos__altLabel mesh__D003855 2-Deoxyribose
% 209.35/209.57  |- mesh__publicMeSHNote mesh__D003855 74   
% 209.35/209.57  |- mesh__activeMeSHYear mesh__D003855 2006
% 209.35/209.57  |- skos__prefLabel mesh__D003855 Deoxyribose
% 209.35/209.57  |- skos__hiddenLabel mesh__D003855 2 Deoxyribose
% 209.35/209.57  |- mesh__recordOriginator mesh__D003855 NLM
% 209.35/209.57  |- rdf__type mesh__D003057sskos__Concept
% 209.35/209.57  |- skos__hiddenLabel mesh__D003057 Progeria Like Syndrome
% 209.35/209.57  |- skos__altLabel mesh__D003057 Type C Cockayne Syndrome
% 209.35/209.57  |- skos__altLabel mesh__D003057 Type III Cockayne Syndrome
% 209.35/209.57  |- skos__hiddenLabel mesh__D003057 Syndrome, Progeria-Like
% 209.35/209.57  |- skos__altLabel mesh__D003057 Type A Cockayne Syndrome
% 209.35/209.57  |- skos__altLabel mesh__D003057 Group B Cockayne Syndrome
% 209.35/209.57  |- skos__prefLabel mesh__D003057 Cockayne Syndrome
% 209.35/209.57  |- skos__altLabel mesh__D003057 Cockayne Syndrome, Type B
% 209.35/209.57  |- skos__altLabel mesh__D003057 Cockayne Syndrome, Group C
% 209.35/209.57  |- mesh__dateRevised mesh__D003057 2005-06-30
% 209.35/209.57  |- mesh__recordOriginator mesh__D003057 VDK
% 209.35/209.57  |- skos__broader mesh__D003057smesh__D049914
% 209.35/209.57  |- skos__historyNote mesh__D003057 Dwarfism %28%1966-1980%29%
% 209.35/209.57  |- skos__altLabel mesh__D003057 Cockayne Syndrome, Type A
% 209.35/209.57  |- skos__altLabel mesh__D003057 Cockayne Syndrome, Group B
% 209.35/209.57  |- skos__broader mesh__D003057smesh__D004392
% 209.35/209.57  |- skos__related mesh__D003057smesh__D008607
% 209.35/209.57  |- skos__altLabel mesh__D003057 Group A Cockayne Syndrome
% 209.35/209.57  |- mesh__historyNote mesh__D003057
% 209.35/209.57       91%28%81%29%; was see under DWARFISM 1981-90   
% 209.35/209.57  |- skos__altLabel mesh__D003057 Type B Cockayne Syndrome
% 209.43/209.57  |- skos__altLabel mesh__D003057 Cockayne Syndrome, Group A
% 209.43/209.57  |- mesh__recordMaintainer mesh__D003057 lkt
% 209.43/209.57  |- mesh__dateCreated mesh__D003057 1980-05-09
% 209.43/209.57  |- mesh__publicMeSHNote mesh__D003057 91; was see under DWARFISM 1981-90   
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D003057 2006
% 209.43/209.57  |- skos__broader mesh__D003057smesh__D020271
% 209.43/209.57  |- skos__altLabel mesh__D003057 Type II Cockayne Syndrome
% 209.43/209.57  |- skos__altLabel mesh__D003057 Progeria-Like Syndrome
% 209.43/209.57  |- mesh__dateEstablished mesh__D003057 1991-01-01
% 209.43/209.57  |- skos__historyNote mesh__D003057
% 209.43/209.57       Photosensitivity Disorders %28%1966-1980%29%
% 209.43/209.57  |- skos__altLabel mesh__D003057 Type I Cockayne Syndrome
% 209.43/209.57  |- skos__altLabel mesh__D003057 Group C Cockayne Syndrome
% 209.43/209.57  |- mesh__recordAuthorizer mesh__D003057 sjn
% 209.43/209.57  |- skos__altLabel mesh__D003057 Cockayne Syndrome, Type C
% 209.43/209.57  |- skos__scopeNote mesh__D003057
% 209.43/209.57       A syndrome characterized by multiple system abnormalities including DWARFISM; PHOTOSENSITIVITY DISORDERS; PREMATURE AGING; and HEARING LOSS. It is caused by mutations of a number of autosomal recessive genes encoding proteins that involve transcriptional-coupled DNA REPAIR processes. Cockayne syndrome is classified by the severity and age of onset. Type I %28%classical; CSA%29% is early childhood onset in the second year of life; type II %28%congenital; CSB%29% is early onset at birth with severe symptoms; type III %28%xeroderma pigmentosum; XP%29% is late childhood onset with mild symptoms.%A%    
% 209.43/209.57  |- skos__hiddenLabel mesh__D003057 Syndrome, Cockayne
% 209.43/209.57  |- skos__broader mesh__D003057smesh__D000015
% 209.43/209.57  |- skos__prefLabel mesh__D008540 Meiosis
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D008540 2006
% 209.43/209.57  |- skos__hiddenLabel mesh__D008540 Meioses
% 209.43/209.57  |- skos__scopeNote mesh__D008540
% 209.43/209.57       A type of CELL NUCLEUS division, occurring during maturation of the GERM CELLS. Two successive cell nucleus divisions following a single chromosome duplication %28%S PHASE%29% result in daughter cells with half the number of CHROMOSOMES as the parent cells.%A%    
% 209.43/209.57  |- mesh__dateEstablished mesh__D008540 1968-01-01
% 209.43/209.57  |- mesh__recordAuthorizer mesh__D008540 sjn
% 209.43/209.57  |- rdf__type mesh__D008540sskos__Concept
% 209.43/209.57  |- mesh__historyNote mesh__D008540 68   
% 209.43/209.57  |- mesh__dateCreated mesh__D008540 1999-01-01
% 209.43/209.57  |- skos__historyNote mesh__D008540 Cell Division %28%1966-1967%29%
% 209.43/209.57  |- mesh__publicMeSHNote mesh__D008540 68   
% 209.43/209.57  |- skos__related mesh__D008540smesh__D016200
% 209.43/209.57  |- mesh__recordOriginator mesh__D008540 NLM
% 209.43/209.57  |- mesh__recordMaintainer mesh__D008540 nns
% 209.43/209.57  |- skos__broader mesh__D008540smesh__D048750
% 209.43/209.57  |- mesh__dateRevised mesh__D008540 2005-06-30
% 209.43/209.57  |- skos__altLabel mesh__D008540 Meiotic M Phase
% 209.43/209.57  |- mesh__dateCreated mesh__D013485 1980-03-07
% 209.43/209.57  |- skos__broader mesh__D013485smesh__D052288
% 209.43/209.57  |- skos__altLabel mesh__D013485 Support, Non-U.S. Gov%27%t
% 209.43/209.57  |- mesh__historyNote mesh__D013485 2005 %28%1981%29%   
% 209.43/209.57  |- rdf__type mesh__D013485sskos__Concept
% 209.43/209.57  |- mesh__dateEstablished mesh__D013485 1981-01-01
% 209.43/209.57  |- mesh__recordAuthorizer mesh__D013485 sjn
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D013485 2006
% 209.43/209.57  |- skos__altLabel mesh__D013485 Support, Non U.S. Govt
% 209.43/209.57  |- mesh__recordMaintainer mesh__D013485 jls
% 209.43/209.57  |- mesh__dateRevised mesh__D013485 2005-06-30
% 209.43/209.57  |- mesh__recordOriginator mesh__D013485 SMH
% 209.43/209.57  |- skos__altLabel mesh__D013485 Support, Non U.S. Gov%27%t
% 209.43/209.57  |- skos__prefLabel mesh__D013485 Research Support, Non-U.S. Gov%27%t
% 209.43/209.57  |- skos__annotation mesh__D013485
% 209.43/209.57       for all articles noted as supported by American sources %28%societies, institutes, state governments, universities, private organizations, etc.%29% or by foreign sources %28%national, departmental, provincial, academic %26% private organizations%29%, etc; CATALOG: do not use%A%  
% 209.43/209.57  |- skos__altLabel mesh__D013485 Support, Non-U.S. Govt
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D007448 2006
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D007448 2006A
% 209.43/209.57  |- mesh__recordOriginator mesh__D007448 NLM
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D007448 2004
% 209.43/209.57  |- mesh__recordAuthorizer mesh__D007448 sjn
% 209.43/209.57  |- skos__prefLabel mesh__D007448 Invertebrates
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D007448 2005
% 209.43/209.57  |- skos__broader mesh__D007448smesh__D000818
% 209.43/209.57  |- mesh__publicMeSHNote mesh__D007448
% 209.43/209.57       BRACHIOPODA was heading 1963-85; MESOZOA was heading 1977-85%A%  
% 209.43/209.57  |- mesh__historyNote mesh__D007448
% 209.43/209.57       BRACHIOPODA was heading 1963-85; MESOZOA was heading 1977-85%A%  
% 209.43/209.57  |- skos__annotation mesh__D007448
% 209.43/209.57       avoid: too general; prefer specific classes, orders, families %26% genera; IM; qualif permitted but use /embryol %26% /parasitol with caution%A%  
% 209.43/209.57  |- skos__scopeNote mesh__D007448 Animals that have no spinal column.     
% 209.43/209.57  |- rdf__type mesh__D007448sskos__Concept
% 209.43/209.57  |- mesh__recordMaintainer mesh__D007448 sjn
% 209.43/209.57  |- mesh__onlineNote mesh__D007448
% 209.43/209.57       pre-explosion - INVERTEBRATES %28%PX%29%   
% 209.43/209.57  |- mesh__dateCreated mesh__D007448 1999-01-01
% 209.43/209.57  |- mesh__dateRevised mesh__D007448 2005-08-15
% 209.43/209.57  |- skos__broader mesh__D018170smesh__D013449
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D018170 2006
% 209.43/209.57  |- rdf__type mesh__D018170sskos__Concept
% 209.43/209.57  |- skos__hiddenLabel mesh__D018170 Succinate, Sumatriptan
% 209.43/209.57  |- mesh__recordAuthorizer mesh__D018170 sjn
% 209.43/209.57  |- mesh__publicMeSHNote mesh__D018170
% 209.43/209.57       94; SUMATRIPTAN was indexed under INDOLES %26% SULFONAMIDES 1988-93%A%  
% 209.43/209.57  |- skos__prefLabel mesh__D018170 Sumatriptan
% 209.43/209.57  |- mesh__dateEstablished mesh__D018170 1994-01-01
% 209.43/209.57  |- skos__altLabel mesh__D018170
% 209.43/209.57       3-%28%2-%28%Dimethylamino%29%ethyl%29%-N-methyl-1H-indole-5-methanesulfonamide
% 209.43/209.57  |- mesh__onlineNote mesh__D018170
% 209.43/209.57       use SUMATRIPTAN %28%NM%29% to search SUMATRIPTAN 1988-93   
% 209.43/209.57  |- skos__scopeNote mesh__D018170
% 209.43/209.57       A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.%A%    
% 209.43/209.57  |- skos__historyNote mesh__D018170 Indoles %28%1988-1993%29%
% 209.43/209.57  |- skos__hiddenLabel mesh__D018170 GR43175
% 209.43/209.57  |- mesh__historyNote mesh__D018170
% 209.43/209.57       94; was SUMATRIPTAN %28%NM%29% 1988-93   
% 209.43/209.57  |- skos__hiddenLabel mesh__D018170 GR 43175
% 209.43/209.57  |- mesh__recordMaintainer mesh__D018170 ssb
% 209.43/209.57  |- mesh__dateRevised mesh__D018170 2005-06-30
% 209.43/209.57  |- mesh__dateCreated mesh__D018170 1993-06-04
% 209.43/209.57  |- skos__historyNote mesh__D018170 Sulfonamides %28%1988-1993%29%
% 209.43/209.57  |- mesh__recordOriginator mesh__D018170 TPW
% 209.43/209.57  |- skos__broader mesh__D018170smesh__D014363
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D026602 2003
% 209.43/209.57  |- skos__scopeNote mesh__D026602
% 209.43/209.57       Nerve cells where transmission is mediated by NITRIC OXIDE.%A%    
% 209.43/209.57  |- skos__altLabel mesh__D026602 Nitroxidergic Neurons
% 209.43/209.57  |- skos__broader mesh__D026602smesh__D009474
% 209.43/209.57  |- mesh__dateCreated mesh__D026602 2001-07-25
% 209.43/209.57  |- skos__altLabel mesh__D026602 Neurons, Nitrergic
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D026602 2004
% 209.43/209.57  |- skos__altLabel mesh__D026602 Neurons, Nitroxidergic
% 209.43/209.57  |- mesh__publicMeSHNote mesh__D026602 2002   
% 209.43/209.57  |- skos__prefLabel mesh__D026602 Nitrergic Neurons
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D026602 2005
% 209.43/209.57  |- mesh__historyNote mesh__D026602 2002   
% 209.43/209.57  |- skos__hiddenLabel mesh__D026602 Nitrergic Neuron
% 209.43/209.57  |- skos__hiddenLabel mesh__D026602 Neuron, Nitroxidergic
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D026602 2006
% 209.43/209.57  |- skos__altLabel mesh__D026602 Nitroxidergic Nerves
% 209.43/209.57  |- skos__hiddenLabel mesh__D026602 Neuron, Nitrergic
% 209.43/209.57  |- rdf__type mesh__D026602sskos__Concept
% 209.43/209.57  |- mesh__dateEstablished mesh__D026602 2002-01-01
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D026602 2002
% 209.43/209.57  |- skos__hiddenLabel mesh__D026602 Nitroxidergic Neuron
% 209.43/209.57  |- skos__historyNote mesh__D026602 Neurons %28%1992-2001%29%
% 209.43/209.57  |- skos__prefLabel mesh__D004150 Dipeptidases
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D004150 2004
% 209.43/209.57  |- mesh__dateCreated mesh__D004150 1999-01-01
% 209.43/209.57  |- mesh__recordMaintainer mesh__D004150 ssb
% 209.43/209.57  |- mesh__recordOriginator mesh__D004150 NLM
% 209.43/209.57  |- rdf__type mesh__D004150sskos__Concept
% 209.43/209.57  |- mesh__recordAuthorizer mesh__D004150 sjn
% 209.43/209.57  |- skos__scopeNote mesh__D004150
% 209.43/209.57       EXOPEPTIDASES that specifically act on dipeptides. EC 3.4.13.%A%    
% 209.43/209.57  |- mesh__dateRevised mesh__D004150 2003-07-09
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D004150 2006
% 209.43/209.57  |- skos__broader mesh__D004150smesh__D020689
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D004150 2005
% 209.43/209.57  |- skos__related mesh__D045567smesh__D015321
% 209.43/209.57  |- skos__hiddenLabel mesh__D045567 V D J Recombinase
% 209.43/209.57  |- mesh__dateCreated mesh__D045567 2003-07-09
% 209.43/209.57  |- skos__hiddenLabel mesh__D045567 Recombinases, VDJ
% 209.43/209.57  |- mesh__dateEstablished mesh__D045567 2004-01-01
% 209.43/209.57  |- skos__altLabel mesh__D045567 V-%28%D%29%-J Recombinase
% 209.43/209.57  |- mesh__publicMeSHNote mesh__D045567
% 209.43/209.57       2004; VDJ RECOMBINASE was indexed under DNA NUCLEOTIDYLTRANSFERASES 1986-2003%A%  
% 209.43/209.57  |- skos__altLabel mesh__D045567 V-D-J Recombinase
% 209.43/209.57  |- skos__prefLabel mesh__D045567 VDJ Recombinases
% 209.43/209.57  |- skos__hiddenLabel mesh__D045567 Recombinases, Immunoglobulin
% 209.43/209.57  |- skos__hiddenLabel mesh__D045567 Recombinase, VDJ
% 209.43/209.57  |- skos__altLabel mesh__D045567 VDJ Recombinase
% 209.43/209.57  |- rdf__type mesh__D045567sskos__Concept
% 209.43/209.57  |- skos__broader mesh__D045567smesh__D045522
% 209.43/209.57  |- skos__hiddenLabel mesh__D045567 Recombinase, Immunoglobulin
% 209.43/209.57  |- mesh__historyNote mesh__D045567
% 209.43/209.57       2004; use VDJ RECOMBINASES %28%NM%29% 1986-2003   
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D045567 2006
% 209.43/209.57  |- skos__broader mesh__D045567smesh__D009713
% 209.43/209.57  |- skos__historyNote mesh__D045567
% 209.43/209.57       DNA Nucleotidyltransferases %28%1986-2003%29%
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D045567 2005
% 209.43/209.57  |- skos__altLabel mesh__D045567 V%28%D%29%J Recombinase
% 209.43/209.57  |- skos__altLabel mesh__D045567 Immunoglobulin Recombinase
% 209.43/209.57  |- skos__hiddenLabel mesh__D045567 Recombinase, V-D-J
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D045567 2004
% 209.43/209.57  |- skos__scopeNote mesh__D045567
% 209.43/209.57       Recombinases involved in the rearrangement of immunity-related GENES such as IMMUNOGLOBULIN GENES and T-CELL RECEPTOR GENES.%A%    
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D050701 2006B
% 209.43/209.57  |- skos__hiddenLabel mesh__D050701 Transcription Factor E2F 6
% 209.43/209.57  |- mesh__recordMaintainer mesh__D050701 ags
% 209.43/209.57  |- skos__altLabel mesh__D050701 E2F Transcription Factor 6 Protein
% 209.43/209.57  |- skos__historyNote mesh__D050701 Transcription Factors %28%1991-2005%29%
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D050701 2006
% 209.43/209.57  |- skos__scopeNote mesh__D050701
% 209.43/209.57       An E2F transcription factor that represses GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis. E2F6 recruits chromatin remodeling factors directly to target gene promoters and lacks the transactivation domain responsible for binding to the retinoblastoma family of tumor suppressors.%A%    
% 209.43/209.57  |- rdf__type mesh__D050701sskos__Concept
% 209.43/209.57  |- skos__broader mesh__D050701smesh__D050684
% 209.43/209.57  |- mesh__dateEstablished mesh__D050701 2006-01-01
% 209.43/209.57  |- mesh__dateCreated mesh__D050701 2005-06-30
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D050701 2006A
% 209.43/209.57  |- skos__altLabel mesh__D050701 Transcription Factor E2F-6
% 209.43/209.57  |- mesh__historyNote mesh__D050701 2006%28%2004%29%   
% 209.43/209.57  |- mesh__publicMeSHNote mesh__D050701
% 209.43/209.57       2006; E2F6 TRANSCRIPTION FACTOR, E2F TRANSCRIPTION FACTOR 6 PROTEIN, %26% TRANSCRIPTION FACTOR E2F-6 were indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTIONS FACTORS 2004-2005%A%  
% 209.43/209.57  |- skos__prefLabel mesh__D050701 E2F6 Transcription Factor
% 209.43/209.57  |- mesh__recordAuthorizer mesh__D050701 ags
% 209.43/209.57  |- skos__historyNote mesh__D050701 DNA-Binding Proteins %28%1991-2005%29%
% 209.43/209.57  |- skos__historyNote mesh__D050701 Cell Cycle Proteins %28%1991-2005%29%
% 209.43/209.57  |- skos__hiddenLabel mesh__D050701 Transcription Factor, E2F6
% 209.43/209.57  |- mesh__recordOriginator mesh__D050701 DRC
% 209.43/209.57  |- skos__annotation mesh__D050701 see SCR for organism-specific terms   
% 209.43/209.57  |- skos__hiddenLabel mesh__D050701 E2F-6, Transcription Factor
% 209.43/209.57  |- mesh__dateRevised mesh__D050701 2005-08-02
% 209.43/209.57  |- mesh__publicMeSHNote mesh__D017078 93   
% 209.43/209.57  |- skos__broader mesh__D017078smesh__D003935
% 209.43/209.57  |- mesh__recordAuthorizer mesh__D017078 SJN
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D017078 2005
% 209.43/209.57  |- skos__prefLabel mesh__D017078 Laser-Doppler Flowmetry
% 209.43/209.57  |- skos__annotation mesh__D017078
% 209.43/209.57       measurement of Doppler eff of laser light in microcirc studies %26% diag; index laser velocimeters %26% Doppler velocimeters here with /instrum %26% do not coord with LASERS or DOPPLER EFFECT%A%  
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D017078 2001
% 209.43/209.57  |- skos__hiddenLabel mesh__D017078 Laser Doppler Velocimetry
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D017078 2006
% 209.43/209.57  |- skos__altLabel mesh__D017078 Doppler-Laser Flowmetry
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D017078 2002
% 209.43/209.57  |- mesh__dateCreated mesh__D017078 1992-05-20
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D017078 1998
% 209.43/209.57  |- mesh__dateRevised mesh__D017078 1997-06-20
% 209.43/209.57  |- skos__hiddenLabel mesh__D017078 Velocimetry, Laser Doppler
% 209.43/209.57  |- mesh__recordMaintainer mesh__D017078 PXP
% 209.43/209.57  |- skos__hiddenLabel mesh__D017078 Laser Doppler Flowmetry
% 209.43/209.57  |- skos__altLabel mesh__D017078 Laser-Doppler Velocimetry
% 209.43/209.57  |- rdf__type mesh__D017078sskos__Concept
% 209.43/209.57  |- skos__scopeNote mesh__D017078
% 209.43/209.57       A method of non-invasive, continuous measurement of microcirculation. The technique is based on the values of the Doppler effect of low-power laser light scattered randomly by static structures and moving tissue particulates.%A%    
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D017078 1999
% 209.43/209.57  |- skos__hiddenLabel mesh__D017078 Flowmetry, Laser Doppler
% 209.43/209.57  |- mesh__dateEstablished mesh__D017078 1993-01-01
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D017078 2003
% 209.43/209.57  |- skos__historyNote mesh__D017078 Doppler Effect %28%1975-1992%29%
% 209.43/209.57  |- skos__hiddenLabel mesh__D017078 Flowmetry, Doppler-Laser
% 209.43/209.57  |- mesh__historyNote mesh__D017078 93   
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D017078 2004
% 209.43/209.57  |- skos__altLabel mesh__D017078 Flowmetry, Laser-Doppler
% 209.43/209.57  |- mesh__recordOriginator mesh__D017078 TGC
% 209.43/209.57  |- skos__broader mesh__D017078smesh__D012212
% 209.43/209.57  |- skos__historyNote mesh__D017078 Lasers %28%1966-1992%29%
% 209.43/209.57  |- skos__hiddenLabel mesh__D017078 Doppler Laser Flowmetry
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D017078 2000
% 209.43/209.57  |- mesh__publicMeSHNote mesh__D003856
% 209.43/209.57       78; FLUORODEOXYURIDYLATE was see under URACIL NUCLEOTIDES 1975-77%A%  
% 209.43/209.57  |- mesh__recordMaintainer mesh__D003856 TGC
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D003856 2004
% 209.43/209.57  |- skos__historyNote mesh__D003856 Deoxyribonucleotides %28%1973-1977%29%
% 209.43/209.57  |- skos__scopeNote mesh__D003856
% 209.43/209.57       Uracil nucleotides which contain deoxyribose as the sugar moiety.%A%    
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D003856 2000
% 209.43/209.57  |- mesh__recordOriginator mesh__D003856 RLS
% 209.43/209.57  |- mesh__dateRevised mesh__D003856 1992-05-13
% 209.43/209.57  |- mesh__dateCreated mesh__D003856 1977-05-17
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D003856 2003
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D003856 1995
% 209.43/209.57  |- skos__historyNote mesh__D003856 Uracil Nucleotides %28%1966-1977%29%
% 209.43/209.57  |- mesh__historyNote mesh__D003856 78   
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D003856 1999
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D003856 1994
% 209.43/209.57  |- mesh__recordAuthorizer mesh__D003856 PLS
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D003856 1993
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D003856 1998
% 209.43/209.57  |- skos__annotation mesh__D003856 /biosyn /physiol permitted   
% 209.43/209.57  |- mesh__dateEstablished mesh__D003856 1978-01-01
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D003856 2006
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D003856 1997
% 209.43/209.57  |- skos__prefLabel mesh__D003856 Deoxyuracil Nucleotides
% 209.43/209.57  |- skos__altLabel mesh__D003856 Deoxyuridine Phosphates
% 209.43/209.57  |- skos__hiddenLabel mesh__D003856 Phosphates, Deoxyuridine
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D003856 2002
% 209.43/209.57  |- skos__broader mesh__D003856smesh__D003854
% 209.43/209.57  |- skos__hiddenLabel mesh__D003856 Nucleotides, Deoxyuracil
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D003856 2005
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D003856 1996
% 209.43/209.57  |- skos__broader mesh__D003856smesh__D014500
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D003856 2001
% 209.43/209.57  |- rdf__type mesh__D003856sskos__Concept
% 209.43/209.57  |- rdf__type mesh__D003058sskos__Concept
% 209.43/209.57  |- mesh__recordOriginator mesh__D003058 NLM
% 209.43/209.57  |- mesh__recordAuthorizer mesh__D003058 sjn
% 209.43/209.57  |- mesh__publicMeSHNote mesh__D003058
% 209.43/209.57       72; for DICTYOPTERA see ORTHOPTERA 1986-98, see DICTYOPTERA 1975-85%A%  
% 209.43/209.57  |- skos__prefLabel mesh__D003058 Cockroaches
% 209.43/209.57  |- skos__altLabel mesh__D003058 Cockroach
% 209.43/209.57  |- skos__broader mesh__D003058smesh__D007313
% 209.43/209.57  |- mesh__dateRevised mesh__D003058 2003-07-09
% 209.43/209.57  |- skos__historyNote mesh__D003058 Insects %28%1966-1971%29%
% 209.43/209.57  |- mesh__dateCreated mesh__D003058 1999-01-01
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D003058 2005
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D003058 2006
% 209.43/209.57  |- mesh__dateEstablished mesh__D003058 1972-01-01
% 209.43/209.57  |- skos__scopeNote mesh__D003058
% 209.43/209.57       Insects of the order Dictyoptera comprising several families including Blaberidae, BLATTELLIDAE, Blattidae %28%containing the American cockroach PERIPLANETA americana%29%, Cryptocercidae, and Polyphagidae.%A%    
% 209.43/209.57  |- skos__annotation mesh__D003058
% 209.43/209.57       do not use /drug eff for insecticides: TN 111   
% 209.43/209.57  |- skos__altLabel mesh__D003058 Dictyoptera
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D003058 2004
% 209.43/209.57  |- mesh__recordMaintainer mesh__D003058 ags
% 209.43/209.57  |- mesh__historyNote mesh__D003058
% 209.43/209.57       72; for DICTYOPTERA use ORTHOPTERA 1975-98   
% 209.43/209.57  |- skos__broader mesh__D004194Q000662smesh__D004194
% 209.43/209.57  |- mesh__preferredCombination mesh__D004194Q000662smesh__D000820
% 209.43/209.57  |- rdf__type mesh__D004194Q000662smesh__CompoundConcept
% 209.43/209.57  |- mesh__recordOriginator mesh__D008541 NLM
% 209.43/209.57  |- skos__prefLabel mesh__D008541 Mekong Valley
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D008541 2001
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D008541 1995
% 209.43/209.57  |- rdf__type mesh__D008541sskos__Concept
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D008541 2004
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D008541 1991
% 209.43/209.57  |- mesh__dateCreated mesh__D008541 1999-01-01
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D008541 2000
% 209.43/209.57  |- mesh__historyNote mesh__D008541 75   
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D008541 1994
% 209.43/209.57  |- skos__scopeNote mesh__D008541
% 209.43/209.57       The geographic area of the Mekong Valley in general or when the specific country or countries are not indicated. Usually includes Cambodia, Indochina, and Laos.%A%    
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D008541 2003
% 209.43/209.57  |- mesh__recordMaintainer mesh__D008541 HMM
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D008541 1990
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D008541 1993
% 209.43/209.57  |- mesh__dateRevised mesh__D008541 1978-03-30
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D008541 1999
% 209.43/209.57  |- skos__broader mesh__D008541smesh__D001210
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D008541 1992
% 209.43/209.57  |- mesh__recordAuthorizer mesh__D008541 NLM
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D008541 1998
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D008541 1997
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D008541 1989
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D008541 2006
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D008541 2002
% 209.43/209.57  |- mesh__dateEstablished mesh__D008541 1975-01-01
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D008541 1996
% 209.43/209.57  |- mesh__activeMeSHYear mesh__D008541 2005
% 209.43/209.58  |- mesh__historyNote mesh__D013486
% 209.43/209.58       2005; was SUPPORT, U.S. Gov%27%t, Non-P.H.S. 1981-2004; was UNITED STATES GOV%27%T SUPPORTED %28%used for U.S. gov%27%t agencies other than P.H.S.%29% 1979-1980; UNITED STATES GOV%27%T SUPPORTED, N.I.H. %26% UNITED STATES GOV%27%T SUPPORTED, NON-N.I.H. were headings 1978, were headings having slightly different forms 1975-77 %28%UNITED STATES was U.S. 1977; GOV%27%T WAS GOVERNMENT 1975-1976%29%%A%  
% 209.43/209.58  |- mesh__recordAuthorizer mesh__D013486 ags
% 209.43/209.58  |- rdf__type mesh__D013486sskos__Concept
% 209.43/209.58  |- mesh__recordOriginator mesh__D013486 NLM
% 209.43/209.58  |- skos__annotation mesh__D013486
% 209.43/209.58       for all articles noted as supported by US Government agencies other than PHS %26% NIH %28%which is RESEARCH SUPPORT, U.S. GOV%27%T, P.H.S.;%29%; National Science Foundation support is checked here, National Academy of Sciences %26% National  Research Council support are checked RESEARCH SUPPORT, NON-U.S. GOVT; CATALOG: do not use%A%  
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D013486 2006
% 209.43/209.58  |- skos__prefLabel mesh__D013486
% 209.43/209.58       Research Support, U.S. Gov%27%t, Non-P.H.S.
% 209.43/209.58  |- skos__altLabel mesh__D013486 Support, U.S. Gov%27%t, Non P.H.S.
% 209.43/209.58  |- skos__broader mesh__D013486smesh__D052288
% 209.43/209.58  |- mesh__dateCreated mesh__D013486 1975-02-04
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D013486 2006A
% 209.43/209.58  |- mesh__recordMaintainer mesh__D013486 ags
% 209.43/209.58  |- mesh__dateEstablished mesh__D013486 1979-01-01
% 209.43/209.58  |- skos__altLabel mesh__D013486 Support, U.S. Govt, Non-P.H.S.
% 209.43/209.58  |- skos__altLabel mesh__D013486 Support, U.S. Govt, Non P.H.S.
% 209.43/209.58  |- mesh__dateRevised mesh__D013486 2005-07-28
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D013486 2006B
% 209.43/209.58  |- skos__altLabel mesh__D013486
% 209.43/209.58       United States Gov%27%t Supported, Non-P.H.S.
% 209.43/209.58  |- mesh__historyNote mesh__D007449 68%28%64%29%   
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D007449 1996
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D007449 2004
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D007449 2005
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D007449 2002
% 209.43/209.58  |- skos__hiddenLabel mesh__D007449 Investment
% 209.43/209.58  |- mesh__recordAuthorizer mesh__D007449 NLM
% 209.43/209.58  |- mesh__dateEstablished mesh__D007449 1968-01-01
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D007449 2003
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D007449 1995
% 209.43/209.58  |- rdf__type mesh__D007449sskos__Concept
% 209.43/209.58  |- mesh__recordOriginator mesh__D007449 NLM
% 209.43/209.58  |- skos__prefLabel mesh__D007449 Investments
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D007449 2001
% 209.43/209.58  |- mesh__recordMaintainer mesh__D007449 PLS
% 209.43/209.58  |- mesh__dateCreated mesh__D007449 1999-01-01
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D007449 1999
% 209.43/209.58  |- skos__scopeNote mesh__D007449
% 209.43/209.58       Use for articles on the investing of funds for income or profit.%A%    
% 209.43/209.58  |- mesh__publicMeSHNote mesh__D007449 68   
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D007449 2000
% 209.43/209.58  |- mesh__dateRevised mesh__D007449 1993-09-16
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D007449 1997
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D007449 1998
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D007449 2006
% 209.43/209.58  |- skos__broader mesh__D007449smesh__D004467
% 209.43/209.58  |- mesh__publicMeSHNote mesh__D018171
% 209.43/209.58       94; AGRIN was indexed under NERVE TISSUE PROTEINS 1988-93%A%  
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D018171 2002
% 209.43/209.58  |- mesh__historyNote mesh__D018171 94; was AGRIN %28%NM%29% 1988-93   
% 209.43/209.58  |- skos__broader mesh__D018171smesh__D009419
% 209.43/209.58  |- mesh__onlineNote mesh__D018171
% 209.43/209.58       use AGRIN %28%NM%29% to search AGRIN 1988-93   
% 209.43/209.58  |- mesh__dateEstablished mesh__D018171 1994-01-01
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D018171 1996
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D018171 2003
% 209.43/209.58  |- skos__annotation mesh__D018171 a nerve tissue protein   
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D018171 2000
% 209.43/209.58  |- skos__scopeNote mesh__D018171
% 209.43/209.58       A protein component of the synaptic basal lamina. It has been shown to induce clustering of acetylcholine receptors on the surface of muscle fibers and other synaptic molecules in both synapse regeneration and development.%A%    
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D018171 1998
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D018171 2005
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D018171 1997
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D018171 2004
% 209.43/209.58  |- mesh__dateCreated mesh__D018171 1993-06-16
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D018171 1994
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D018171 2001
% 209.43/209.58  |- skos__prefLabel mesh__D018171 Agrin
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D018171 1999
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D018171 2006
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D018171 1995
% 209.43/209.58  |- rdf__type mesh__D018171sskos__Concept
% 209.43/209.58  |- skos__historyNote mesh__D018171 Nerve Tissue Proteins %28%1988-1993%29%
% 209.43/209.58  |- skos__hiddenLabel mesh__D026603 D Aspartate
% 209.43/209.58  |- skos__scopeNote mesh__D026603 The D-isomer of ASPARTIC ACID.     
% 209.43/209.58  |- rdf__type mesh__D026603sskos__Concept
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D026603 2005
% 209.43/209.58  |- skos__broader mesh__D026603smesh__D001224
% 209.43/209.58  |- mesh__publicMeSHNote mesh__D026603 2002   
% 209.43/209.58  |- skos__altLabel mesh__D026603
% 209.43/209.58       3-hydroxy-N-%28%2-methyl-1-oxo-2-propenyl%29%-
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D026603 2004
% 209.43/209.58  |- mesh__dateCreated mesh__D026603 2001-07-25
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D026603 2003
% 209.43/209.58  |- skos__prefLabel mesh__D026603 D-Aspartic Acid
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D026603 2002
% 209.43/209.58  |- skos__hiddenLabel mesh__D026603 D Aspartic Acid
% 209.43/209.58  |- mesh__dateEstablished mesh__D026603 2002-01-01
% 209.43/209.58  |- skos__historyNote mesh__D026603 Aspartic Acid %28%1966-2001%29%
% 209.43/209.58  |- mesh__historyNote mesh__D026603 2002   
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D026603 2006
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D004151 2004
% 209.43/209.58  |- skos__prefLabel mesh__D004151 Dipeptides
% 209.43/209.58  |- mesh__dateRevised mesh__D004151 2000-06-22
% 209.43/209.58  |- skos__broader mesh__D004151smesh__D009842
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D004151 2002
% 209.43/209.58  |- skos__scopeNote mesh__D004151
% 209.43/209.58       Peptides composed of two amino acid units.     
% 209.43/209.58  |- rdf__type mesh__D004151sskos__Concept
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D004151 2005
% 209.43/209.58  |- mesh__recordOriginator mesh__D004151 NLM
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D004151 2006
% 209.43/209.58  |- mesh__recordMaintainer mesh__D004151 adp
% 209.43/209.58  |- mesh__recordAuthorizer mesh__D004151 sjn
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D004151 2001
% 209.43/209.58  |- mesh__dateCreated mesh__D004151 1999-01-01
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D004151 2003
% 209.43/209.58  |- mesh__dateCreated mesh__D045568 2003-07-09
% 209.43/209.58  |- skos__hiddenLabel mesh__D045568 Tetra Oxanes
% 209.43/209.58  |- skos__altLabel mesh__D045568 Tetra-Oxanes
% 209.43/209.58  |- mesh__recordMaintainer mesh__D045568 ssb
% 209.43/209.58  |- mesh__publicMeSHNote mesh__D045568 2004   
% 209.43/209.58  |- rdf__type mesh__D045568sskos__Concept
% 209.43/209.58  |- mesh__recordOriginator mesh__D045568 ssb
% 209.43/209.58  |- mesh__recordAuthorizer mesh__D045568 sjn
% 209.43/209.58  |- skos__altLabel mesh__D045568 Tetroxanes
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D045568 2006
% 209.43/209.58  |- skos__annotation mesh__D045568
% 209.43/209.58       coord with appropriate specific chemical terms if pertinent%A%  
% 209.43/209.58  |- mesh__dateRevised mesh__D045568 2005-06-30
% 209.43/209.58  |- mesh__dateEstablished mesh__D045568 2004-01-01
% 209.43/209.58  |- skos__scopeNote mesh__D045568
% 209.43/209.58       Compounds with two peroxide groups, that is, two pairs of adjacent OXYGEN atoms. They may have activity against PLASMODIUM similar to the ARTEMISININS.%A%    
% 209.43/209.58  |- mesh__historyNote mesh__D045568 2004   
% 209.43/209.58  |- skos__prefLabel mesh__D045568 Tetraoxanes
% 209.43/209.58  |- skos__broader mesh__D045568smesh__D010545
% 209.43/209.58  |- skos__scopeNote mesh__D017877
% 209.43/209.58       A family of ESOCIFORMES comprising the mudminnows. There are three genera: Dallia, Novumbra, and Umbra, with much disagreement about their taxonomic interrelations. The Umbridae are freshwater fish inhabiting parts of the Northern Hemisphere.%A%    
% 209.43/209.58  |- mesh__recordOriginator mesh__D017877 TGC
% 209.43/209.58  |- mesh__historyNote mesh__D017877 1994   
% 209.43/209.58  |- mesh__publicMeSHNote mesh__D017877 1994   
% 209.43/209.58  |- skos__broader mesh__D017877smesh__D023661
% 209.43/209.58  |- mesh__recordAuthorizer mesh__D017877 sjn
% 209.43/209.58  |- skos__hiddenLabel mesh__D017877 Mudminnow
% 209.43/209.58  |- mesh__recordMaintainer mesh__D017877 ags
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D017877 2005
% 209.43/209.58  |- skos__prefLabel mesh__D017877 Umbridae
% 209.43/209.58  |- skos__annotation mesh__D017877
% 209.43/209.58       note X ref; MINNOWS see CYPRINIDAE is also available   
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D017877 2004
% 209.43/209.58  |- rdf__type mesh__D017877sskos__Concept
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D017877 2006
% 209.43/209.58  |- mesh__dateRevised mesh__D017877 2003-07-09
% 209.43/209.58  |- mesh__dateCreated mesh__D017877 1992-12-28
% 209.43/209.58  |- skos__altLabel mesh__D017877 Mudminnows
% 209.43/209.58  |- mesh__dateEstablished mesh__D017877 1994-01-01
% 209.43/209.58  |- skos__hiddenLabel mesh__D050702 Transcription Factor E2F 7
% 209.43/209.58  |- rdf__type mesh__D050702sskos__Concept
% 209.43/209.58  |- skos__altLabel mesh__D050702 Transcription Factor E2F-7
% 209.43/209.58  |- skos__historyNote mesh__D050702 DNA-Binding Proteins %28%1991-2005%29%
% 209.43/209.58  |- skos__annotation mesh__D050702 see SCR for organism-specific terms   
% 209.43/209.58  |- mesh__publicMeSHNote mesh__D050702
% 209.43/209.58       2006; E2F7 TRANSCRIPTION FACTOR; E2F TRANSCRIPTION FACTOR 7 PROTEIN; %26% TRANSCRIPTION FACTOR E2F-7 were indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTIONS FACTORS 1991-2005%A%  
% 209.43/209.58  |- skos__hiddenLabel mesh__D050702 Transcription Factor, E2F7
% 209.43/209.58  |- mesh__dateRevised mesh__D050702 2005-07-13
% 209.43/209.58  |- skos__historyNote mesh__D050702 Transcription Factors %28%1991-2005%29%
% 209.43/209.58  |- skos__scopeNote mesh__D050702
% 209.43/209.58       An E2F transcription factor that represses GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis. E2F7 has two separate DNA-binding domains and binds to DNA independently of a dimerization partner.%A%    
% 209.43/209.58  |- skos__broader mesh__D050702smesh__D050684
% 209.43/209.58  |- skos__altLabel mesh__D050702 E2F Transcription Factor 7 Protein
% 209.43/209.58  |- mesh__dateEstablished mesh__D050702 2006-01-01
% 209.43/209.58  |- mesh__dateCreated mesh__D050702 2005-06-30
% 209.43/209.58  |- mesh__historyNote mesh__D050702 2006%28%1991%29%   
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D050702 2006A
% 209.43/209.58  |- mesh__recordAuthorizer mesh__D050702 ags
% 209.43/209.58  |- mesh__recordOriginator mesh__D050702 DRC
% 209.43/209.58  |- skos__historyNote mesh__D050702 Cell Cycle Proteins %28%1991-2005%29%
% 209.43/209.58  |- skos__prefLabel mesh__D050702 E2F7 Transcription Factor
% 209.43/209.58  |- mesh__recordMaintainer mesh__D050702 ags
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D050702 2006
% 209.43/209.58  |- mesh__dateCreated mesh__D017079 1992-05-26
% 209.43/209.58  |- rdf__type mesh__D017079sskos__Concept
% 209.43/209.58  |- mesh__historyNote mesh__D017079 93   
% 209.43/209.58  |- skos__broader mesh__D017079smesh__D010807
% 209.43/209.58  |- skos__scopeNote mesh__D017079
% 209.43/209.58       The exercise capacity of an individual as measured by endurance %28%maximal exercise duration and/or maximal attained work load%29% during an EXERCISE TEST.%A%    
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D017079 2004
% 209.43/209.58  |- mesh__publicMeSHNote mesh__D017079 93   
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D017079 2005
% 209.43/209.58  |- skos__hiddenLabel mesh__D017079 Tolerance, Exercise
% 209.43/209.58  |- skos__prefLabel mesh__D017079 Exercise Tolerance
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D017079 2006
% 209.43/209.58  |- mesh__dateRevised mesh__D017079 2003-07-09
% 209.43/209.58  |- mesh__dateEstablished mesh__D017079 1993-01-01
% 209.43/209.58  |- skos__historyNote mesh__D017079 Exercise Test %28%1966-1992%29%
% 209.43/209.58  |- mesh__dateRevised mesh__D003857 1995-06-08
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D003857 1998
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D003857 2002
% 209.43/209.58  |- mesh__publicMeSHNote mesh__D003857 66   
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D003857 2006
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D003857 1997
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D003857 2001
% 209.43/209.58  |- mesh__dateEstablished mesh__D003857 1966-01-01
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D003857 2005
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D003857 1996
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D003857 2000
% 209.43/209.58  |- mesh__recordOriginator mesh__D003857 NLM
% 209.43/209.58  |- mesh__historyNote mesh__D003857 66%28%64%29%   
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D003857 2004
% 209.43/209.58  |- rdf__type mesh__D003857sskos__Concept
% 209.43/209.58  |- mesh__recordMaintainer mesh__D003857 JRT
% 209.43/209.58  |- skos__annotation mesh__D003857 an antimetabolite   
% 209.43/209.58  |- skos__prefLabel mesh__D003857 Deoxyuridine
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D003857 2003
% 209.43/209.58  |- mesh__recordAuthorizer mesh__D003857 PLS
% 209.43/209.58  |- skos__altLabel mesh__D003857
% 209.43/209.58       %28%beta 1-%28%2-Deoxyribopyranosyl%29%%29%thymidine
% 209.43/209.58  |- skos__broader mesh__D003857smesh__D003853
% 209.43/209.58  |- mesh__dateCreated mesh__D003857 1999-01-01
% 209.43/209.58  |- skos__broader mesh__D003857smesh__D014529
% 209.43/209.58  |- skos__scopeNote mesh__D003857
% 209.43/209.58       2%27%-Deoxyuridine. An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemias due to vitamin B12 and folate deficiencies.%A%    
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D003857 1999
% 209.43/209.58  |- mesh__publicMeSHNote mesh__D003059
% 209.43/209.58       91,63-85; was see under NUTS 1986-90; was heading 1963-85%A%  
% 209.43/209.58  |- mesh__dateCreated mesh__D003059 1999-01-01
% 209.43/209.58  |- skos__annotation mesh__D003059
% 209.43/209.58       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D003059 2005
% 209.43/209.58  |- skos__scopeNote mesh__D003059
% 209.43/209.58       A plant genus of the family ARECACEAE. It is a tropical palm tree that yields a  large, edible hard-shelled fruit from which oil and fiber are also obtained.%A%    
% 209.43/209.58  |- mesh__recordOriginator mesh__D003059 NLM
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D003059 2006
% 209.43/209.58  |- mesh__recordAuthorizer mesh__D003059 sjn
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D003059 2003
% 209.43/209.58  |- skos__prefLabel mesh__D003059 Cocos
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D003059 2004
% 209.43/209.58  |- mesh__historyNote mesh__D003059
% 209.43/209.58       91%28%86%29%63; was see under NUTS 1986-90; was heading 1963-85; was in Cat J only 1963-80%A%  
% 209.43/209.58  |- mesh__recordMaintainer mesh__D003059 ssb
% 209.43/209.58  |- rdf__type mesh__D003059sskos__Concept
% 209.43/209.58  |- mesh__dateRevised mesh__D003059 2002-07-03
% 209.43/209.58  |- skos__altLabel mesh__D003059 Cocoanut
% 209.43/209.58  |- skos__broader mesh__D003059smesh__D028023
% 209.43/209.58  |- mesh__dateEstablished mesh__D003059 1991-01-01
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D008542 2002
% 209.43/209.58  |- mesh__recordAuthorizer mesh__D008542 sjn
% 209.43/209.58  |- mesh__historyNote mesh__D008542 68   
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D008542 2003
% 209.43/209.58  |- mesh__recordOriginator mesh__D008542 NLM
% 209.43/209.58  |- skos__scopeNote mesh__D008542
% 209.43/209.58       The collective name for the islands of the Pacific Ocean northeast of Australia, including NEW CALEDONIA; VANUATU; New Hebrides, Solomon Islands, Admiralty Islands, Bismarck Archipelago, FIJI, etc. Melanesia %28%from the Greek melas, black + nesos, island%29% is so called from the black color of the natives who are generally considered to be descended originally from the Negroid Papuans and the Polynesians or Malays. %28%From Webster%27%s New Geographical Dictionary, 1988, p748 %26% Room, Brewer%27%s Dictionary of Names, 1992, p344%29%%A%    
% 209.43/209.58  |- mesh__recordMaintainer mesh__D008542 mdb
% 209.43/209.58  |- skos__annotation mesh__D008542
% 209.43/209.58       a group of islands northeast of Australia; includes, in addition to indentions %26% X refs, Norfolk Island; Melanesians are of Negroid race unless otherwise specified%A%  
% 209.43/209.58  |- skos__broader mesh__D008542smesh__D010139
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D008542 2006
% 209.43/209.58  |- mesh__dateRevised mesh__D008542 2001-07-25
% 209.43/209.58  |- skos__prefLabel mesh__D008542 Melanesia
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D008542 2005
% 209.43/209.58  |- rdf__type mesh__D008542sskos__Concept
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D008542 2004
% 209.43/209.58  |- mesh__dateCreated mesh__D008542 1999-01-01
% 209.43/209.58  |- skos__annotation mesh__D013487
% 209.43/209.58       for all articles noted as supported by PHS %26% its bureaus %26% services; includes  support by any institute of NIH; support by BRSG %28%Biomedical Research  Support Grants%29% goes here;  CATALOG: do not use%A%  
% 209.43/209.58  |- skos__altLabel mesh__D013487 Support, U.S. Govt, P.H.S.
% 209.43/209.58  |- mesh__historyNote mesh__D013487
% 209.43/209.58       2005; was SUPPORT, U.S. Gov%27%t P.H.S 1981-2004; was UNITED STATES GOV%27%T SUPPORTED, P.H.S. 1979-1980; UNITED STATES GOV%27%T SUPPORTED, N.I.H. %26% UNITED STATES GOV%27%T SUPPORTED, NON-N.I.H. were headings 1978, were headings having slightly different forms 1975-1977 %28%UNITED STATES was U.S. 1977; GOV%27%T was GOVERNMENT 1975-1976%29%%A%  
% 209.43/209.58  |- mesh__recordMaintainer mesh__D013487 jls
% 209.43/209.58  |- mesh__dateEstablished mesh__D013487 1979-01-01
% 209.43/209.58  |- mesh__dateRevised mesh__D013487 2005-06-30
% 209.43/209.58  |- skos__altLabel mesh__D013487 Support, U.S. Gov%27%t, N.I.H.
% 209.43/209.58  |- skos__altLabel mesh__D013487 United States Gov%27%t Supported, P.H.S.
% 209.43/209.58  |- skos__prefLabel mesh__D013487 Research Support, U.S. Gov%27%t, P.H.S.
% 209.43/209.58  |- mesh__recordOriginator mesh__D013487 NLM
% 209.43/209.58  |- rdf__type mesh__D013487sskos__Concept
% 209.43/209.58  |- skos__broader mesh__D013487smesh__D052288
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D013487 2006
% 209.43/209.58  |- mesh__recordAuthorizer mesh__D013487 sjn
% 209.43/209.58  |- mesh__dateCreated mesh__D013487 1975-02-04
% 209.43/209.58  |- mesh__recordMaintainer mesh__D018970 jmp
% 209.43/209.58  |- skos__altLabel mesh__D018970 IGFBP-1
% 209.43/209.58  |- skos__historyNote mesh__D018970 Carrier Proteins %28%1992-1995%29%
% 209.43/209.58  |- skos__prefLabel mesh__D018970
% 209.43/209.58       Insulin-Like Growth Factor Binding Protein 1
% 209.43/209.58  |- mesh__dateRevised mesh__D018970 2004-07-07
% 209.43/209.58  |- mesh__recordOriginator mesh__D018970 TPW
% 209.43/209.58  |- skos__altLabel mesh__D018970 IGF-Binding Protein 1
% 209.43/209.58  |- skos__broader mesh__D018970smesh__D018969
% 209.43/209.58  |- mesh__recordAuthorizer mesh__D018970 sjn
% 209.43/209.58  |- mesh__historyNote mesh__D018970 2005%28%1992%29%   
% 209.43/209.58  |- skos__scopeNote mesh__D018970
% 209.43/209.58       One of the six homologous proteins that specifically bind insulin-like growth factors %28%SOMATOMEDINS%29% and modulate their mitogenic and metabolic actions. The function of this protein is not completely defined. However, several studies demonstrate that it inhibits IGF binding to cell surface receptors and thereby inhibits IGF-mediated mitogenic and cell metabolic actions. %28%Proc Soc Exp Biol Med 1993;204%28%1%29%:4-29%29%%A%    
% 209.43/209.58  |- mesh__publicMeSHNote mesh__D018970
% 209.43/209.58       2005; see  INSULIN-LIKE-GROWTH-FACTOR-BINDING PROTEIN-1 1996-2005; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1 was indexed under CARRIER PROTEINS 1992-95%A%  
% 209.43/209.58  |- rdf__type mesh__D018970sskos__Concept
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D018970 2005
% 209.43/209.58  |- mesh__dateCreated mesh__D018970 1995-06-08
% 209.43/209.58  |- skos__annotation mesh__D018970
% 209.43/209.58       /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X refs%A%  
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D018970 2006
% 209.43/209.58  |- skos__hiddenLabel mesh__D018970
% 209.43/209.58       Insulin Like Growth Factor Binding Protein 1
% 209.43/209.58  |- skos__hiddenLabel mesh__D018970 IGF Binding Protein 1
% 209.43/209.58  |- mesh__dateEstablished mesh__D018970 1996-01-01
% 209.43/209.58  |- mesh__dateRevised mesh__D032641 2005-06-30
% 209.43/209.58  |- skos__prefLabel mesh__D032641 Eurotiales
% 209.43/209.58  |- skos__scopeNote mesh__D032641
% 209.43/209.58       An order of fungi in the phylum ASCOMYCOTA characterized by the presence of well defined peridia and cleistothecial asci. Notable anamorphs %28%mitosporic forms%29% of Eurotiales include PENICILLIUM and ASPERGILLUS.%A%    
% 209.43/209.58  |- mesh__recordOriginator mesh__D032641 ags
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D032641 2006
% 209.43/209.58  |- mesh__dateCreated mesh__D032641 2002-07-03
% 209.43/209.58  |- mesh__recordAuthorizer mesh__D032641 sjn
% 209.43/209.58  |- mesh__recordMaintainer mesh__D032641 SYSTEM
% 209.43/209.58  |- rdf__type mesh__D032641sskos__Concept
% 209.43/209.58  |- mesh__historyNote mesh__D032641 2003   
% 209.43/209.58  |- mesh__publicMeSHNote mesh__D032641 2003   
% 209.43/209.58  |- mesh__dateEstablished mesh__D032641 2003-01-01
% 209.43/209.58  |- skos__broader mesh__D032641smesh__D001203
% 209.43/209.58  |- mesh__onlineNote mesh__D018172
% 209.43/209.58       use UNITED STATES OFFICE OF RESEARCH INTEGRITY to search NIH OFFICE OF SCIENTIFIC INTEGRITY, NATIONAL INSTITUTES OF HEALTH OFFICE OF SCIENTIFIC INTEGRITY %26% OFFICE OF SCIENTIFIC INTEGRITY %28%U.S.%29% 1991-93%A%  
% 209.43/209.58  |- skos__altLabel mesh__D018172
% 209.43/209.58       U.S. Office of the Assistant Secretary for Health Office of Research Integrity
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D018172 2005
% 209.43/209.58  |- mesh__recordMaintainer mesh__D018172 ags
% 209.43/209.58  |- skos__altLabel mesh__D018172
% 209.43/209.58       United States Office of the Assistant Secretary for Health Office of Research Integrity
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D018172 2006
% 209.43/209.58  |- skos__altLabel mesh__D018172 Office of Research Integrity %28%U.S.%29%
% 209.43/209.58  |- mesh__recordOriginator mesh__D018172 TGC
% 209.43/209.58  |- skos__broader mesh__D018172smesh__D014492
% 209.43/209.58  |- mesh__dateEstablished mesh__D018172 1994-01-01
% 209.43/209.58  |- rdf__type mesh__D018172sskos__Concept
% 209.43/209.58  |- skos__prefLabel mesh__D018172 United States Office of Research Integrity
% 209.43/209.58  |- mesh__dateCreated mesh__D018172 1993-06-03
% 209.43/209.58  |- skos__annotation mesh__D018172
% 209.43/209.58       add UNITED STATES %28%NIM%29%; DF: ORI      CATALOG: use NAF entry%A%  
% 209.43/209.58  |- skos__scopeNote mesh__D018172
% 209.43/209.58       An office of the UNITED STATES PUBLIC HEALTH SERVICE organized in June 1992 to promote research integrity and investigate misconduct in research supported by the Public Health Service. It consolidates the Office of Scientific Integrity of the National Institutes of Health and the Office of Scientific Integrity Review in the Office of the Assistant Secretary for Health.%A%    
% 209.43/209.58  |- mesh__publicMeSHNote mesh__D018172
% 209.43/209.58       94; NIH OFFICE OF SCIENTIFIC INTEGRITY was heading 1991-93; NATIONAL INSTITUTES OF HEALTH OFFICE OF SCIENTIFIC INTEGRITY %26% OFFICE OF SCIENTIFIC INTEGRITY %28%U.S.%29% were see NIH OFFICE OF SCIENTIFIC INTEGRITY 1991-93%A%  
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D018172 2006A
% 209.43/209.58  |- mesh__dateRevised mesh__D018172 2005-07-13
% 209.43/209.58  |- mesh__historyNote mesh__D018172
% 209.43/209.58       1994; NIH OFFICE OF SCIENTIFIC INTEGRITY was heading 1991-1993; NATIONAL INSTITUTES OF HEALTH OFFICE OF SCIENTIFIC INTEGRITY %26% OFFICE OF SCIENTIFIC INTEGRITY %28%U.S.%29% were see NIH OFFICE OF SCIENTIFIC INTEGRITY 1991-1993%A%  
% 209.43/209.58  |- mesh__recordAuthorizer mesh__D018172 ags
% 209.43/209.58  |- skos__altLabel mesh__D018172 Office of Research Integrity
% 209.43/209.58  |- rdf__type mesh__D004950sskos__Concept
% 209.43/209.58  |- skos__broader mesh__D004950smesh__D006867
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D004950 2004
% 209.43/209.58  |- mesh__dateCreated mesh__D004950 1999-01-01
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D004950 2006
% 209.43/209.58  |- mesh__dateRevised mesh__D004950 2003-07-09
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D004950 2005
% 209.43/209.58  |- mesh__recordOriginator mesh__D004950 NLM
% 209.43/209.58  |- skos__prefLabel mesh__D004950 Esterases
% 209.43/209.58  |- mesh__recordAuthorizer mesh__D004950 sjn
% 209.43/209.58  |- mesh__recordMaintainer mesh__D004950 ssb
% 209.43/209.58  |- skos__scopeNote mesh__D004152
% 209.43/209.58       Enzymes which cleave dipeptides from the amino terminal of a polypeptide. Dipeptidyl peptidase I, II, III, IV are known. They hydrolyze the beta-naphthylamides of glycine-arginine, lysine-alanine, arginine-arginine and glycine-proline, respectively. DIPEPTIDYL PEPTIDASE I is cathepsin C. EC 3.4.14.-.%A%    
% 209.43/209.58  |- mesh__recordAuthorizer mesh__D004152 sjn
% 209.43/209.58  |- rdf__type mesh__D004152sskos__Concept
% 209.43/209.58  |- mesh__historyNote mesh__D004152
% 209.43/209.58       86%28%80%29%; was see under ENDOPEPTIDASES 1980-85   
% 209.43/209.58  |- mesh__publicMeSHNote mesh__D004152
% 209.43/209.58       86; was see under PEPTIDE PEPTIDOHYDROLASES 1980-85   
% 209.43/209.58  |- skos__historyNote mesh__D004152
% 209.43/209.58       Peptide Peptidohydrolases %28%1966-1979%29%
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D004152 2005
% 209.43/209.58  |- skos__altLabel mesh__D004152 Dipeptidylpeptide Hydrolases
% 209.43/209.58  |- mesh__dateCreated mesh__D004152 1979-05-23
% 209.43/209.58  |- skos__broader mesh__D004152smesh__D020689
% 209.43/209.58  |- skos__altLabel mesh__D004152 Dipeptidyl Aminopeptidases
% 209.43/209.58  |- mesh__recordMaintainer mesh__D004152 ssb
% 209.43/209.58  |- skos__historyNote mesh__D004152 Dipeptidases %28%1966-1979%29%
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D004152 2006
% 209.43/209.58  |- mesh__dateRevised mesh__D004152 2003-07-09
% 209.43/209.58  |- mesh__dateEstablished mesh__D004152 1986-01-01
% 209.43/209.58  |- skos__prefLabel mesh__D004152 Dipeptidyl Peptidases
% 209.43/209.58  |- mesh__recordOriginator mesh__D004152 RLS
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D004152 2004
% 209.43/209.58  |- skos__historyNote mesh__D004152 Cathepsins %28%1966-1979%29%
% 209.43/209.58  |- skos__broader mesh__D019840Q000031smesh__D019840
% 209.43/209.58  |- mesh__preferredCombination mesh__D019840Q000031smesh__D020005
% 209.43/209.58  |- rdf__type mesh__D019840Q000031smesh__CompoundConcept
% 209.43/209.58  |- mesh__recordMaintainer mesh__D017878 jmp
% 209.43/209.58  |- mesh__recordOriginator mesh__D017878 TPW
% 209.43/209.58  |- mesh__publicMeSHNote mesh__D017878
% 209.43/209.58       2001; see DIDS 1981-2000;  4,4%27%-DISOTHIOCYANOSTILBEN-2,2%27%-DISULFONIC ACID was indexed under SITS/analogs %26% derivatives 1981-1993 %26% STILBENES 1977-1980%A%  
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D017878 2003
% 209.43/209.58  |- mesh__dateEstablished mesh__D017878 1994-01-01
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D017878 2005
% 209.43/209.58  |- mesh__dateCreated mesh__D017878 1993-02-16
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D017878 2004
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D017878 2001
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D017878 2006
% 209.43/209.58  |- rdf__type mesh__D017878sskos__Concept
% 209.43/209.58  |- skos__prefLabel mesh__D017878
% 209.43/209.58       4,4%27%-Diisothiocyanostilbene-2,2%27%-Disulfonic Acid
% 209.43/209.58  |- skos__scopeNote mesh__D017878
% 209.43/209.58       An inhibitor of anion conductance including band 3-mediated anion transport.%A%    
% 209.43/209.58  |- mesh__historyNote mesh__D017878
% 209.43/209.58       2001%28%1994%29%; use DIDS %28%NM%29% 1977-93   
% 209.43/209.58  |- skos__broader mesh__D017878smesh__D017879
% 209.43/209.58  |- mesh__recordAuthorizer mesh__D017878 sjn
% 209.43/209.58  |- skos__historyNote mesh__D017878
% 209.43/209.58       SITS/analogs %26% derivatives %28%1981-1993%29%
% 209.43/209.58  |- mesh__dateRevised mesh__D017878 2000-06-22
% 209.43/209.58  |- skos__broader mesh__D017878smesh__D013267
% 209.43/209.58  |- skos__altLabel mesh__D017878 DIDS
% 209.43/209.58  |- skos__annotation mesh__D017878 DF: DIDS   
% 209.43/209.58  |- skos__historyNote mesh__D017878 Stilbenes %28%1977-1980%29%
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D017878 2002
% 209.43/209.58  |- skos__altLabel mesh__D017878
% 209.43/209.58       4,4%27%-Diisothiocyano-2,2%27%-Stilbene Disulfonic Acid
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D050703 2006A
% 209.43/209.58  |- mesh__publicMeSHNote mesh__D050703
% 209.43/209.58       2006; E2F TRANSCRIPTION FACTORS was indexed under CELL CYCLE PROTEINS, DNA-BINDING PROTEINS, %26% TRANSCRIPTION FACTORS 1993-2005%A%  
% 209.43/209.58  |- skos__altLabel mesh__D050703 E2F-2 Protein
% 209.43/209.58  |- mesh__recordAuthorizer mesh__D050703 ags
% 209.43/209.58  |- mesh__historyNote mesh__D050703 2006%28%1993%29%   
% 209.43/209.58  |- skos__historyNote mesh__D050703 Transcription Factors %28%1993-2005%29%
% 209.43/209.58  |- mesh__recordOriginator mesh__D050703 DRC
% 209.43/209.58  |- skos__annotation mesh__D050703 see SCR for organism-specific terms   
% 209.43/209.58  |- skos__hiddenLabel mesh__D050703 Transcription Factor E2F 2
% 209.43/209.58  |- skos__altLabel mesh__D050703 Transcription Factor E2F-2
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D050703 2006
% 209.43/209.58  |- skos__hiddenLabel mesh__D050703 E2F-2, Transcription Factor
% 209.43/209.58  |- mesh__recordMaintainer mesh__D050703 ags
% 209.43/209.58  |- skos__altLabel mesh__D050703 E2F2 Protein
% 209.43/209.58  |- skos__altLabel mesh__D050703 E2F Transcription Factor 2 Protein
% 209.43/209.58  |- mesh__dateRevised mesh__D050703 2005-07-13
% 209.43/209.58  |- rdf__type mesh__D050703sskos__Concept
% 209.43/209.58  |- skos__hiddenLabel mesh__D050703 Transcription Factor, E2F2
% 209.43/209.58  |- mesh__dateEstablished mesh__D050703 2006-01-01
% 209.43/209.58  |- skos__scopeNote mesh__D050703
% 209.43/209.58       An E2F transcription factor that interacts directly with RETINOBLASTOMA PROTEIN and CYCLIN A. E2F2 activates GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis.%A%    
% 209.43/209.58  |- skos__prefLabel mesh__D050703 E2F2 Transcription Factor
% 209.43/209.58  |- skos__broader mesh__D050703smesh__D050684
% 209.43/209.58  |- mesh__dateCreated mesh__D050703 2005-06-30
% 209.43/209.58  |- mesh__dateCreated mesh__D003858 1974-11-11
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D003858 2006
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D003858 1997
% 209.43/209.58  |- mesh__dateEstablished mesh__D003858 1991-01-01
% 209.43/209.58  |- skos__hiddenLabel mesh__D003858 Burden, Dependency
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D003858 2005
% 209.43/209.58  |- mesh__activeMeSHYear mesh__D003858 1996
% 209.43/209.58  |- skos__altLabel mesh__D003858 Dependency
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D003858 2002
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D003858 2004
% 209.43/209.59  |- mesh__historyNote mesh__D003858
% 209.43/209.59       91%28%75%29%; was see under PERSONALITY 1975-90   
% 209.43/209.59  |- rdf__type mesh__D003858sskos__Concept
% 209.43/209.59  |- skos__annotation mesh__D003858 no qualif; DF: DEPENDENCY   
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D003858 2001
% 209.43/209.59  |- skos__scopeNote mesh__D003858
% 209.43/209.59       The tendency of an individual or individuals to rely on others for advice, guidance, or support.%A%    
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D003858 1995
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D003858 2003
% 209.43/209.59  |- skos__broader mesh__D003858smesh__D010551
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D003858 2000
% 209.43/209.59  |- skos__prefLabel mesh__D003858 Dependency %28%Psychology%29%
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D003858 1999
% 209.43/209.59  |- skos__hiddenLabel mesh__D003858 Dependencies %28%Psychology%29%
% 209.43/209.59  |- mesh__recordOriginator mesh__D003858 NLM
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D003858 1994
% 209.43/209.59  |- mesh__recordMaintainer mesh__D003858 JLS
% 209.43/209.59  |- mesh__dateRevised mesh__D003858 1993-06-04
% 209.43/209.59  |- mesh__publicMeSHNote mesh__D003858
% 209.43/209.59       91; was see under PERSONALITY 1975-90   
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D003858 1998
% 209.43/209.59  |- mesh__recordAuthorizer mesh__D003858 PLS
% 209.43/209.59  |- skos__historyNote mesh__D014580 Chenodeoxycholic Acid %28%1973-1979%29%
% 209.43/209.59  |- skos__broader mesh__D014580smesh__D003840
% 209.43/209.59  |- skos__altLabel mesh__D014580 Galen Brand of Ursodeoxycholic Acid
% 209.43/209.59  |- skos__altLabel mesh__D014580 Norgine Brand of Ursodeoxycholic Acid
% 209.43/209.59  |- skos__altLabel mesh__D014580 Zambon Brand of Ursodeoxycholic Acid
% 209.43/209.59  |- skos__altLabel mesh__D014580 Aventis Brand of Ursodeoxycholic Acid
% 209.43/209.59  |- mesh__dateRevised mesh__D014580 2005-06-30
% 209.43/209.59  |- skos__historyNote mesh__D014580 Bile Acids and Salts %28%1966-1972%29%
% 209.43/209.59  |- skos__altLabel mesh__D014580 Ursodiol
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D014580 2006
% 209.43/209.59  |- skos__hiddenLabel mesh__D014580 Ursodeoxycholate, Sodium
% 209.43/209.59  |- skos__altLabel mesh__D014580 CP Brand of Ursodeoxycholic Acid
% 209.43/209.59  |- skos__altLabel mesh__D014580 Ursacholic Acid
% 209.43/209.59  |- skos__altLabel mesh__D014580
% 209.43/209.59       Sanofi Synthelabo Brand of Ursodeoxycholic Acid
% 209.43/209.59  |- mesh__historyNote mesh__D014580
% 209.43/209.59       91%28%80%29%; was see under DEOXYCHOLIC ACID 1980-90   
% 209.43/209.59  |- skos__altLabel mesh__D014580 Provalis Brand of Ursodeoxycholic Acid
% 209.43/209.59  |- skos__altLabel mesh__D014580 Antigen Brand of Ursodeoxycholic Acid
% 209.43/209.59  |- skos__altLabel mesh__D014580 Estedi Brand of Ursodeoxycholic Acid
% 209.43/209.59  |- mesh__dateEstablished mesh__D014580 1991-01-01
% 209.43/209.59  |- skos__annotation mesh__D014580
% 209.43/209.59        /biosyn /defic /physiol permitted; urso- refers to its first isol from  URSIDAE %28%Latin ursus%29%%A%  
% 209.43/209.59  |- skos__hiddenLabel mesh__D014580 Acid, Deoxyursocholic
% 209.43/209.59  |- skos__hiddenLabel mesh__D014580 Acid, Ursodeoxycholic
% 209.43/209.59  |- mesh__recordAuthorizer mesh__D014580 sjn
% 209.43/209.59  |- skos__altLabel mesh__D014580 Falk Brand of Ursodeoxycholic Acid
% 209.43/209.59  |- skos__altLabel mesh__D014580
% 209.43/209.59       3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid
% 209.43/209.59  |- skos__scopeNote mesh__D014580
% 209.43/209.59       An epimer of chenodeoxycholic acid. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic.%A%    
% 209.43/209.59  |- mesh__dateCreated mesh__D014580 1979-05-30
% 209.43/209.59  |- skos__altLabel mesh__D014580 Orphan Brand of Ursodeoxycholic Acid
% 209.43/209.59  |- mesh__recordOriginator mesh__D014580 SH
% 209.43/209.59  |- skos__altLabel mesh__D014580 Niddapharm Brand of Ursodeoxycholic Acid
% 209.43/209.59  |- skos__hiddenLabel mesh__D014580
% 209.43/209.59       3 alpha,7 beta Dihydroxy 5 beta cholan 24 oic Acid
% 209.43/209.59  |- mesh__recordMaintainer mesh__D014580 lkw
% 209.43/209.59  |- skos__prefLabel mesh__D014580 Ursodeoxycholic Acid
% 209.43/209.59  |- skos__altLabel mesh__D014580 Axcan Brand of Ursodeoxycholic Acid
% 209.43/209.59  |- skos__altLabel mesh__D014580 Farmasa Brand of Ursodeoxycholic Acid
% 209.43/209.59  |- skos__altLabel mesh__D014580 Vita Brand of Ursodeoxycholic Acid
% 209.43/209.59  |- mesh__publicMeSHNote mesh__D014580
% 209.43/209.59       91; was see under DEOXYCHOLIC ACID 1980-90   
% 209.43/209.59  |- skos__hiddenLabel mesh__D014580 Acid, Ursacholic
% 209.43/209.59  |- skos__altLabel mesh__D014580 Heumann Brand of Ursodeoxycholic Acid
% 209.43/209.59  |- skos__historyNote mesh__D014580
% 209.43/209.59       Deoxycholic Acid %28%1973-1974%29% /analogs %26% derivatives %28%1975-1979%29%
% 209.43/209.59  |- skos__altLabel mesh__D014580 Deoxyursocholic Acid
% 209.43/209.59  |- skos__altLabel mesh__D014580 Tramedico Brand of Ursodeoxycholic Acid
% 209.43/209.59  |- rdf__type mesh__D014580sskos__Concept
% 209.43/209.59  |- mesh__historyNote mesh__D008543 78; was MELANIN 1963-77   
% 209.43/209.59  |- skos__scopeNote mesh__D008543
% 209.43/209.59       Insoluble polymers of TYROSINE derivatives found in and causing darkness in skin %28%SKIN PIGMENTATION%29%, hair, and feathers providing protection against SUNBURN induced by SUNLIGHT. CAROTENES contribute yellow and red coloration.%A%    
% 209.43/209.59  |- mesh__onlineNote mesh__D008543 use MELANINS to search MELANIN 1966-77   
% 209.43/209.59  |- skos__altLabel mesh__D008543 Melanin
% 209.43/209.59  |- skos__prefLabel mesh__D008543 Melanins
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D008543 2006
% 209.43/209.59  |- mesh__recordAuthorizer mesh__D008543 sjn
% 209.43/209.59  |- mesh__dateCreated mesh__D008543 1999-01-01
% 209.43/209.59  |- mesh__recordOriginator mesh__D008543 NLM
% 209.43/209.59  |- mesh__publicMeSHNote mesh__D008543 78; was MELANIN 1963-77   
% 209.43/209.59  |- skos__broader mesh__D008543smesh__D014443
% 209.43/209.59  |- mesh__dateRevised mesh__D008543 2005-06-30
% 209.43/209.59  |- skos__broader mesh__D008543smesh__D010860
% 209.43/209.59  |- mesh__recordMaintainer mesh__D008543 ssb
% 209.43/209.59  |- rdf__type mesh__D008543sskos__Concept
% 209.43/209.59  |- mesh__dateCreated mesh__D000560 1977-04-22
% 209.43/209.59  |- skos__altLabel mesh__D000560 Penicillin Hx
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D000560 2006
% 209.43/209.59  |- rdf__type mesh__D000560sskos__Concept
% 209.43/209.59  |- mesh__dateEstablished mesh__D000560 1985-01-01
% 209.43/209.59  |- skos__historyNote mesh__D000560 Antibiotics %28%1966-1972%29%
% 209.43/209.59  |- skos__hiddenLabel mesh__D000560 FL1060
% 209.43/209.59  |- skos__historyNote mesh__D000560 Thiazoles %28%1966-1972%29%
% 209.43/209.59  |- skos__broader mesh__D000560smesh__D010406
% 209.43/209.59  |- skos__prefLabel mesh__D000560 Amdinocillin
% 209.43/209.59  |- skos__historyNote mesh__D000560 Penicillanic Acids %28%1973-1977%29%
% 209.43/209.59  |- mesh__dateRevised mesh__D000560 2004-07-07
% 209.43/209.59  |- skos__hiddenLabel mesh__D000560 FL 1060
% 209.43/209.59  |- mesh__historyNote mesh__D000560
% 209.43/209.59       85; was MECILLINAM see under PENICILLANIC ACIDS 1978-84   
% 209.43/209.59  |- mesh__recordMaintainer mesh__D000560 ssb
% 209.43/209.59  |- skos__scopeNote mesh__D000560
% 209.43/209.59       Amidinopenicillanic acid derivative with broad spectrum antibacterial action. It is poorly absorbed if given orally and is used in urinary infections and typhus.%A%    
% 209.43/209.59  |- mesh__publicMeSHNote mesh__D000560
% 209.43/209.59       85; was MECILLINAM see under PENICILLANIC ACIDS 1978-84; AMDINOCILLIN PIVOXIL was PIVMECILLINAM see under PENICILLANIC ACIDS 1978-84%A%  
% 209.43/209.59  |- mesh__onlineNote mesh__D000560
% 209.43/209.59       use AMDINOCILLIN to search MECILLINAM 1978-84   
% 209.43/209.59  |- mesh__recordAuthorizer mesh__D000560 sjn
% 209.43/209.59  |- mesh__recordOriginator mesh__D000560 SH
% 209.43/209.59  |- skos__altLabel mesh__D000560 Mecillinam
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D000560 2005
% 209.43/209.59  |- skos__hiddenLabel mesh__D013488 Suppositories, Vaginal
% 209.43/209.59  |- mesh__recordMaintainer mesh__D013488 ssb
% 209.43/209.59  |- skos__prefLabel mesh__D013488 Suppositories
% 209.43/209.59  |- mesh__dateRevised mesh__D013488 2003-07-09
% 209.43/209.59  |- mesh__recordAuthorizer mesh__D013488 sjn
% 209.43/209.59  |- skos__scopeNote mesh__D013488
% 209.43/209.59       Medicated dosage forms that are designed to be inserted into the rectal, vaginal, or urethral orifice of the body for absorption. Generally, the active ingredients are packaged in dosage forms containing fatty bases such as cocoa butter, hydrogenated oil, or glycerogelatin that are solid at room temperature but melt or dissolve at body temperature.%A%    
% 209.43/209.59  |- skos__annotation mesh__D013488
% 209.43/209.59       IM GEN only; coord NIM %28%no qualif%29% with specific drug IM   
% 209.43/209.59  |- mesh__dateCreated mesh__D013488 1999-01-01
% 209.43/209.59  |- rdf__type mesh__D013488sskos__Concept
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D013488 2005
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D013488 2004
% 209.43/209.59  |- skos__broader mesh__D013488smesh__D004304
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D013488 2006
% 209.43/209.59  |- mesh__recordOriginator mesh__D013488 NLM
% 209.43/209.59  |- skos__hiddenLabel mesh__D013488 Suppositories, Rectal
% 209.43/209.59  |- skos__hiddenLabel mesh__D013488 Suppository, Vaginal
% 209.43/209.59  |- skos__altLabel mesh__D013488 Vaginal Suppository
% 209.43/209.59  |- skos__hiddenLabel mesh__D018971 IGF Binding Protein 2
% 209.43/209.59  |- mesh__dateEstablished mesh__D018971 1996-01-01
% 209.43/209.59  |- mesh__dateRevised mesh__D018971 2004-07-07
% 209.43/209.59  |- skos__historyNote mesh__D018971 Carrier Proteins %28%1991-1995%29%
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D018971 2005
% 209.43/209.59  |- skos__altLabel mesh__D018971 IGFBP-2
% 209.43/209.59  |- skos__hiddenLabel mesh__D018971
% 209.43/209.59       Insulin Like Growth Factor Binding Protein 2
% 209.43/209.59  |- mesh__onlineNote mesh__D018971
% 209.43/209.59       use INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 2 %28%NM%29% to search INSULIN LIKE GROWTH FACTOR-BINDING PROTEIN-2 1991-95%A%  
% 209.43/209.59  |- mesh__dateCreated mesh__D018971 1995-06-08
% 209.43/209.59  |- skos__annotation mesh__D018971
% 209.43/209.59       /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X refs%A%  
% 209.43/209.59  |- rdf__type mesh__D018971sskos__Concept
% 209.43/209.59  |- skos__broader mesh__D018971smesh__D018969
% 209.43/209.59  |- mesh__recordOriginator mesh__D018971 TPW
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D018971 2006
% 209.43/209.59  |- skos__hiddenLabel mesh__D018971 IGFBP 2
% 209.43/209.59  |- mesh__publicMeSHNote mesh__D018971
% 209.43/209.59       96; INSULIN LIKE GROWTH FACTOR-BINDING PROTEIN-2 was indexed under CARRIER PROTEINS 1991-95%A%  
% 209.43/209.59  |- mesh__recordAuthorizer mesh__D018971 sjn
% 209.43/209.59  |- skos__scopeNote mesh__D018971
% 209.43/209.59       One of the six homologous soluble proteins that bind insulin-like growth factors %28%SOMATOMEDINS%29% and modulate their mitogenic and metabolic actions at the cellular level.%A%    
% 209.43/209.59  |- mesh__historyNote mesh__D018971
% 209.43/209.59       96; was INSULIN LIKE GROWTH FACTOR-BINDING PROTEIN-2 %28%NM%29% 1991-95%A%  
% 209.43/209.59  |- skos__altLabel mesh__D018971 IGF-Binding Protein 2
% 209.43/209.59  |- mesh__recordMaintainer mesh__D018971 jmp
% 209.43/209.59  |- skos__prefLabel mesh__D018971
% 209.43/209.59       Insulin-Like Growth Factor Binding Protein 2
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D018173 1997
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D018173 2004
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D018173 2000
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D018173 1994
% 209.43/209.59  |- skos__hiddenLabel mesh__D018173 Circovirus Infection
% 209.43/209.59  |- skos__hiddenLabel mesh__D018173 Infection, Circovirus
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D018173 1999
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D018173 2006
% 209.43/209.59  |- rdf__type mesh__D018173sskos__Concept
% 209.43/209.59  |- mesh__publicMeSHNote mesh__D018173 94   
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D018173 2001
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D018173 1995
% 209.43/209.59  |- skos__altLabel mesh__D018173 Infections, Circoviridae
% 209.43/209.59  |- skos__broader mesh__D018173smesh__D004266
% 209.43/209.59  |- skos__scopeNote mesh__D018173
% 209.43/209.59       Virus diseases caused by the CIRCOVIRIDAE.     
% 209.43/209.59  |- skos__hiddenLabel mesh__D018173 Circoviridae Infection
% 209.43/209.59  |- skos__hiddenLabel mesh__D018173 Infection, Circoviridae
% 209.43/209.59  |- mesh__historyNote mesh__D018173 94   
% 209.43/209.59  |- skos__prefLabel mesh__D018173 Circoviridae Infections
% 209.43/209.59  |- mesh__dateCreated mesh__D018173 1993-06-04
% 209.43/209.59  |- skos__annotation mesh__D018173 GEN or unspecified   
% 209.43/209.59  |- mesh__dateEstablished mesh__D018173 1994-01-01
% 209.43/209.59  |- skos__altLabel mesh__D018173 Infections, Circovirus
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D018173 2002
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D018173 1996
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D018173 2003
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D018173 1998
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D018173 2005
% 209.43/209.59  |- skos__hiddenLabel mesh__D010190 Cancer, Pancreatic
% 209.43/209.59  |- skos__hiddenLabel mesh__D010190 Cancer, Pancreas
% 209.43/209.59  |- skos__annotation mesh__D010190
% 209.43/209.59       coord IM with histol type of neopl %28%IM%29%; available are ALPHA-CELL TUMOR see GLUCAGONOMA; BETA-CELL TUMOR see INSULINOMA; and pancreatic delta-cell tumor see SOMATOSTATINOMA%A%  
% 209.43/209.59  |- skos__broader mesh__D010190smesh__D004067
% 209.43/209.59  |- skos__hiddenLabel mesh__D010190 Pancreatic Cancers
% 209.43/209.59  |- skos__hiddenLabel mesh__D010190 Neoplasm, Pancreas
% 209.43/209.59  |- skos__altLabel mesh__D010190 Pancreas Cancer
% 209.43/209.59  |- skos__hiddenLabel mesh__D010190 Neoplasm, Pancreatic
% 209.43/209.59  |- skos__broader mesh__D010190smesh__D010182
% 209.43/209.59  |- mesh__recordMaintainer mesh__D010190 ags
% 209.43/209.59  |- rdf__type mesh__D010190sskos__Concept
% 209.43/209.59  |- mesh__recordAuthorizer mesh__D010190 ags
% 209.43/209.59  |- skos__hiddenLabel mesh__D010190 Pancreas Cancers
% 209.43/209.59  |- skos__prefLabel mesh__D010190 Pancreatic Neoplasms
% 209.43/209.59  |- skos__altLabel mesh__D010190 Neoplasms, Pancreatic
% 209.43/209.59  |- skos__hiddenLabel mesh__D010190 Cancers, Pancreatic
% 209.43/209.59  |- skos__hiddenLabel mesh__D010190 Cancers, Pancreas
% 209.43/209.59  |- mesh__recordOriginator mesh__D010190 NLM
% 209.43/209.59  |- mesh__dateRevised mesh__D010190 2005-07-15
% 209.43/209.59  |- skos__hiddenLabel mesh__D010190 Neoplasms, Pancreas
% 209.43/209.59  |- skos__broader mesh__D010190smesh__D004701
% 209.43/209.59  |- skos__altLabel mesh__D010190 Pancreatic Cancer
% 209.43/209.59  |- skos__altLabel mesh__D010190 Pancreas Neoplasms
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D010190 2006A
% 209.43/209.59  |- skos__hiddenLabel mesh__D010190 Pancreas Neoplasm
% 209.43/209.59  |- skos__scopeNote mesh__D010190
% 209.43/209.59       Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors %28%INSULINOMA%29%.%A%    
% 209.43/209.59  |- mesh__dateCreated mesh__D010190 1999-01-01
% 209.43/209.59  |- skos__hiddenLabel mesh__D010190 Pancreatic Neoplasm
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D010190 2006
% 209.43/209.59  |- skos__altLabel mesh__D010190 Cancer of the Pancreas
% 209.43/209.59  |- skos__prefLabel mesh__D004951 Esterification
% 209.43/209.59  |- skos__annotation mesh__D004951 almost never IM   
% 209.43/209.59  |- rdf__type mesh__D004951sskos__Concept
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D004951 2003
% 209.43/209.59  |- skos__historyNote mesh__D004951 Esters %28%1968-1975%29%
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D004951 2001
% 209.43/209.59  |- skos__scopeNote mesh__D004951
% 209.43/209.59       The process of converting an acid into an alkyl or aryl derivative. Most frequently the process consists of the reaction of an acid with an alcohol in the presence of a trace of mineral acid as catalyst or the reaction of an acyl chloride with an alcohol. Esterification can also be accomplished by enzymatic processes.%A%    
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D004951 2004
% 209.43/209.59  |- skos__broader mesh__D004951smesh__D008660
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D004951 2002
% 209.43/209.59  |- mesh__dateCreated mesh__D004951 1975-07-25
% 209.43/209.59  |- skos__hiddenLabel mesh__D004951 Esterifications
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D004951 2005
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D004951 1998
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D004951 2006
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D004951 1999
% 209.43/209.59  |- skos__broader mesh__D004951smesh__D002625
% 209.43/209.59  |- mesh__recordOriginator mesh__D004951 RLS
% 209.43/209.59  |- mesh__historyNote mesh__D004951
% 209.43/209.59       91%28%76%29%; was see under CHEMISTRY, ORGANIC 1976-90   
% 209.43/209.59  |- mesh__publicMeSHNote mesh__D004951
% 209.43/209.59       91; was see under CHEMISTRY, ORGANIC 1976-90   
% 209.43/209.59  |- mesh__dateEstablished mesh__D004951 1991-01-01
% 209.43/209.59  |- mesh__recordAuthorizer mesh__D004951 SJN
% 209.43/209.59  |- mesh__dateRevised mesh__D004951 1997-06-20
% 209.43/209.59  |- mesh__recordMaintainer mesh__D004951 PXP
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D004951 2000
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D004153 2005
% 209.43/209.59  |- skos__broader mesh__D004153smesh__D005370
% 209.43/209.59  |- skos__annotation mesh__D004153
% 209.43/209.59       infection = DIPETALONEMA INFECTIONS; coord with specific helminth term %28%ANTIGENS, HELMINTH, etc%29% if pertinent; /drug eff: consider FILARICIDES%A%  
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D004153 2006
% 209.43/209.59  |- mesh__dateRevised mesh__D004153 2003-07-09
% 209.43/209.59  |- skos__scopeNote mesh__D004153
% 209.43/209.59       A filarial nematode parasite of mammalian blood with the vector being a tick or small fly.%A%    
% 209.43/209.59  |- mesh__dateCreated mesh__D004153 1999-01-01
% 209.43/209.59  |- mesh__recordOriginator mesh__D004153 NLM
% 209.43/209.59  |- skos__prefLabel mesh__D004153 Dipetalonema
% 209.43/209.59  |- mesh__recordAuthorizer mesh__D004153 sjn
% 209.43/209.59  |- mesh__onlineNote mesh__D004153
% 209.43/209.59       use DIPETALONEMA to search ACANTHOCHEILONEMA 1966-85   
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D004153 2004
% 209.43/209.59  |- mesh__publicMeSHNote mesh__D004153 86; was ACANTHOCHEILONEMA 1963-85   
% 209.43/209.59  |- mesh__recordMaintainer mesh__D004153 ags
% 209.43/209.59  |- rdf__type mesh__D004153sskos__Concept
% 209.43/209.59  |- mesh__historyNote mesh__D004153 86; was ACANTHOCHEILONEMA 1963-85   
% 209.43/209.59  |- skos__altLabel mesh__D004153 Acanthocheilonema
% 209.43/209.59  |- skos__historyNote mesh__D017879 Thiocyanates %28%1966-1993%29%
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D017879 2000
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D017879 2003
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D017879 1999
% 209.43/209.59  |- mesh__dateEstablished mesh__D017879 1994-01-01
% 209.43/209.59  |- mesh__dateCreated mesh__D017879 1993-02-16
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D017879 1994
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D017879 2001
% 209.43/209.59  |- rdf__type mesh__D017879sskos__Concept
% 209.43/209.59  |- skos__broader mesh__D017879smesh__D013457
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D017879 2005
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D017879 2004
% 209.43/209.59  |- skos__broader mesh__D017879smesh__D017953
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D017879 1995
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D017879 2006
% 209.43/209.59  |- skos__prefLabel mesh__D017879 Isothiocyanates
% 209.43/209.59  |- skos__scopeNote mesh__D017879
% 209.43/209.59       Organic compounds with the general formula R-NCS.     
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D017879 2002
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D017879 1996
% 209.43/209.59  |- mesh__publicMeSHNote mesh__D017879 94   
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D017879 1998
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D017879 1997
% 209.43/209.59  |- mesh__historyNote mesh__D017879 94   
% 209.43/209.59  |- skos__hiddenLabel mesh__D050704 Transcription Factor, E2F-4
% 209.43/209.59  |- mesh__recordAuthorizer mesh__D050704 ags
% 209.43/209.59  |- skos__broader mesh__D050704smesh__D050684
% 209.43/209.59  |- skos__hiddenLabel mesh__D050704 Transcription Factor, E2F4
% 209.43/209.59  |- skos__altLabel mesh__D050704 Transcription Factor E2F-4
% 209.43/209.59  |- mesh__dateCreated mesh__D050704 2005-06-30
% 209.43/209.59  |- mesh__recordOriginator mesh__D050704 DRC
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D050704 2006A
% 209.43/209.59  |- skos__historyNote mesh__D050704 DNA-Binding Proteins %28%1994-2005%29%
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D050704 2006
% 209.43/209.59  |- skos__hiddenLabel mesh__D050704 E2F-4, Transcription Factor
% 209.43/209.59  |- skos__altLabel mesh__D050704 E2F Transcription Factor 4 Protein
% 209.43/209.59  |- mesh__recordMaintainer mesh__D050704 ags
% 209.43/209.59  |- rdf__type mesh__D050704sskos__Concept
% 209.43/209.59  |- skos__annotation mesh__D050704 see SCR for organism-specific terms   
% 209.43/209.59  |- skos__scopeNote mesh__D050704
% 209.43/209.59       An E2F transcription factor that represses GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis. E2F4 recruits chromatin remodeling factors indirectly to target gene PROMOTER REGIONS through RETINOBLASTOMA LIKE PROTEIN P130 and RETINOBLASTOMA LIKE PROTEIN P107.%A%    
% 209.43/209.59  |- skos__altLabel mesh__D050704 E2F-4 Transcription Factor
% 209.43/209.59  |- skos__hiddenLabel mesh__D050704 Transcription Factor E2F 4
% 209.43/209.59  |- skos__historyNote mesh__D050704 Transcription Factors %28%1994-2005%29%
% 209.43/209.59  |- skos__altLabel mesh__D050704 E2F-4 Protein
% 209.43/209.59  |- mesh__historyNote mesh__D050704 2006%28%1994%29%   
% 209.43/209.59  |- mesh__dateRevised mesh__D050704 2005-07-13
% 209.43/209.59  |- skos__hiddenLabel mesh__D050704 E2F 4 Transcription Factor
% 209.43/209.59  |- skos__prefLabel mesh__D050704 E2F4 Transcription Factor
% 209.43/209.59  |- skos__hiddenLabel mesh__D050704 E2F 4 Protein
% 209.43/209.59  |- mesh__dateEstablished mesh__D050704 2006-01-01
% 209.43/209.59  |- mesh__publicMeSHNote mesh__D050704
% 209.43/209.59       2006; E2F4 TRANSCRIPTION FACTOR  was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1994-2005%A%  
% 209.43/209.59  |- skos__altLabel mesh__D003859 Personality Disorder, Dependent
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D003859 2006
% 209.43/209.59  |- skos__altLabel mesh__D003859 Passive-Dependent Personality
% 209.43/209.59  |- skos__hiddenLabel mesh__D003859 Dependent Personality Disorders
% 209.43/209.59  |- mesh__recordOriginator mesh__D003859 NLM
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D003859 2003
% 209.43/209.59  |- mesh__dateRevised mesh__D003859 1999-11-03
% 209.43/209.59  |- skos__prefLabel mesh__D003859 Dependent Personality Disorder
% 209.43/209.59  |- skos__hiddenLabel mesh__D003859 Passive Dependent Personality
% 209.43/209.59  |- mesh__recordAuthorizer mesh__D003859 sjn
% 209.43/209.59  |- mesh__onlineNote mesh__D003859
% 209.43/209.59       use DEPENDENT PERSONALITY DISORDER to search PASSIVE-DEPENDENT PERSONALITY 1975-80%A%  
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D003859 2002
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D003859 2004
% 209.43/209.59  |- mesh__publicMeSHNote mesh__D003859
% 209.43/209.59       91; was see under PERSONALITY DISORDERS 1981-90; was PASSIVE-DEPENDENT PERSONALITY see under PERSONALITY DISORDERS 1975-80%A%  
% 209.43/209.59  |- rdf__type mesh__D003859sskos__Concept
% 209.43/209.59  |- mesh__dateEstablished mesh__D003859 1991-01-01
% 209.43/209.59  |- mesh__dateCreated mesh__D003859 1974-11-11
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D003859 2000
% 209.43/209.59  |- mesh__historyNote mesh__D003859
% 209.43/209.59       91%28%81%29%; was see under PERSONALITY DISORDERS 1981-90; was PASSIVE-DEPENDENT PERSONALITY see under PERSONALITY DISORDERS 1975-80%A%  
% 209.43/209.59  |- skos__hiddenLabel mesh__D003859 Disorder, Dependent Personality
% 209.43/209.59  |- skos__broader mesh__D003859smesh__D010554
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D003859 2005
% 209.43/209.59  |- skos__scopeNote mesh__D003859
% 209.43/209.59       A personality disorder characterized by a pervasive and excessive need to be taken care of that leads to submissive and clinging behavior and fears of separation, beginning by early adulthood and present in a variety of contexts. %28%From DSM-IV, 1994%29%%A%    
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D003859 2001
% 209.43/209.59  |- mesh__recordMaintainer mesh__D003859 jls
% 209.43/209.59  |- skos__hiddenLabel mesh__D003859 Personality, Passive-Dependent
% 209.43/209.59  |- skos__broader mesh__D014581smesh__D017445
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D014581 2005
% 209.43/209.59  |- mesh__recordMaintainer mesh__D014581 PLS
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D014581 2002
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D014581 2003
% 209.43/209.59  |- skos__hiddenLabel mesh__D014581 Urticarias
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D014581 2006
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D014581 1995
% 209.43/209.59  |- mesh__dateCreated mesh__D014581 1999-01-01
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D014581 2004
% 209.43/209.59  |- skos__broader mesh__D014581smesh__D006969
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D014581 1998
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D014581 1996
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D014581 1999
% 209.43/209.59  |- mesh__recordAuthorizer mesh__D014581 PLS
% 209.43/209.59  |- skos__annotation mesh__D014581
% 209.43/209.59       a form of immediate hypersensitivity; note X ref   
% 209.43/209.59  |- skos__prefLabel mesh__D014581 Urticaria
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D014581 2000
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D014581 1997
% 209.43/209.59  |- skos__altLabel mesh__D014581 Hives
% 209.43/209.59  |- mesh__dateRevised mesh__D014581 1994-05-27
% 209.43/209.59  |- mesh__recordOriginator mesh__D014581 NLM
% 209.43/209.59  |- rdf__type mesh__D014581sskos__Concept
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D014581 2001
% 209.43/209.59  |- skos__scopeNote mesh__D014581
% 209.43/209.59       A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress.%A%    
% 209.43/209.59  |- mesh__publicMeSHNote mesh__D008544 72   
% 209.43/209.59  |- skos__annotation mesh__D008544 do not confuse with MELANOPHORES   
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D008544 2005
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D008544 2002
% 209.43/209.59  |- skos__broader mesh__D008544smesh__D004847
% 209.43/209.59  |- skos__hiddenLabel mesh__D008544 Melanocyte
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D008544 2006
% 209.43/209.59  |- mesh__historyNote mesh__D008544 72%28%69%29%   
% 209.43/209.59  |- mesh__dateCreated mesh__D008544 1999-01-01
% 209.43/209.59  |- mesh__dateEstablished mesh__D008544 1972-01-01
% 209.43/209.59  |- mesh__recordMaintainer mesh__D008544 mdb
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D008544 2003
% 209.43/209.59  |- mesh__dateRevised mesh__D008544 2001-07-25
% 209.43/209.59  |- rdf__type mesh__D008544sskos__Concept
% 209.43/209.59  |- mesh__recordAuthorizer mesh__D008544 sjn
% 209.43/209.59  |- skos__scopeNote mesh__D008544
% 209.43/209.59       Epidermal dendritic pigment cells which control long-term morphological color changes by alteration in their number or in the amount of pigment they produce and store in the pigment containing organelles called MELANOSOMES; MELANOPHORES are larger cells which do not exist in mammals.%A%    
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D008544 2004
% 209.43/209.59  |- skos__prefLabel mesh__D008544 Melanocytes
% 209.43/209.59  |- mesh__recordOriginator mesh__D008544 NLM
% 209.43/209.59  |- skos__historyNote mesh__D008544 Chromatophores %28%1966-1968%29%
% 209.43/209.59  |- skos__broader mesh__D000561smesh__D000560
% 209.43/209.59  |- skos__altLabel mesh__D000561 Pivamdinocillin
% 209.43/209.59  |- mesh__publicMeSHNote mesh__D000561
% 209.43/209.59       91; was see under AMDINOCILLIN 1985-90; was PIVMECILLINAM see under PENICILLANIC ACIDS 1978-84%A%  
% 209.43/209.59  |- mesh__historyNote mesh__D000561
% 209.43/209.59       91%28%85%29%; was see under AMDINOCILLIN 1985-90; was PIVMECILLINAM see under PENICILLANIC ACIDS 1978-84%A%  
% 209.43/209.59  |- mesh__recordAuthorizer mesh__D000561 sjn
% 209.43/209.59  |- skos__altLabel mesh__D000561 Pivmecillinam
% 209.43/209.59  |- skos__hiddenLabel mesh__D000561 Hydrochloride, Pivmecillinam
% 209.43/209.59  |- skos__hiddenLabel mesh__D000561 FL 1039
% 209.43/209.59  |- skos__altLabel mesh__D000561 Leo Brand of Pivmecillinam Hydrochloride
% 209.43/209.59  |- mesh__dateRevised mesh__D000561 2005-06-30
% 209.43/209.59  |- mesh__dateEstablished mesh__D000561 1991-01-01
% 209.43/209.59  |- skos__scopeNote mesh__D000561
% 209.43/209.59       Pivaloyloxymethyl ester of amdinocillin that is well absorbed orally, but broken down to amdinocillin in the intestinal mucosa. It is active against gram-negative organisms and used as for amdinocillin.%A%    
% 209.43/209.59  |- skos__prefLabel mesh__D000561 Amdinocillin Pivoxil
% 209.43/209.59  |- skos__hiddenLabel mesh__D000561 Pivoxil, Amdinocillin
% 209.43/209.59  |- skos__hiddenLabel mesh__D000561 Pivaloyl Ester, Mecillinam
% 209.43/209.59  |- mesh__recordOriginator mesh__D000561 SH
% 209.43/209.59  |- skos__hiddenLabel mesh__D000561 FL1039
% 209.43/209.59  |- skos__historyNote mesh__D000561 Antibiotics %28%1966-1972%29%
% 209.43/209.59  |- mesh__dateCreated mesh__D000561 1977-04-22
% 209.43/209.59  |- skos__historyNote mesh__D000561 Thiazoles %28%1966-1977%29%
% 209.43/209.59  |- skos__altLabel mesh__D000561 Mecillinam Pivaloyl Ester
% 209.43/209.59  |- mesh__recordMaintainer mesh__D000561 lkw
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D000561 2006
% 209.43/209.59  |- mesh__onlineNote mesh__D000561
% 209.43/209.59       use AMDINOCILLIN PIVOXIL to search PIVMECILLINAM 1978-84   
% 209.43/209.59  |- rdf__type mesh__D000561sskos__Concept
% 209.43/209.59  |- skos__historyNote mesh__D000561 Penicillanic Acids %28%1973-1977%29%
% 209.43/209.59  |- skos__historyNote mesh__D013489 Genes %28%1966-1967%29%
% 209.43/209.59  |- mesh__recordMaintainer mesh__D013489 TPW
% 209.43/209.59  |- skos__broader mesh__D013489smesh__D009154
% 209.43/209.59  |- mesh__activeMeSHYear mesh__D013489 2005
% 209.43/209.59  |- skos__altLabel mesh__D013489 Genetic Suppression
% 209.43/209.59  |- mesh__recordOriginator mesh__D013489 NLM
% 209.43/209.59  |- skos__prefLabel mesh__D013489 Suppression, Genetic
% 209.43/209.59  |- mesh__dateRevised mesh__D013489 2002-07-03
% 209.43/209.59  |- skos__hiddenLabel mesh__D013489 Suppressor Mutations
% 209.43/209.59  |- skos__hiddenLabel mesh__D013489 Genetic Suppressions
% 209.43/209.59  |- mesh__dateEstablished mesh__D013489 1970-01-01
% 209.43/209.59  |- mesh__publicMeSHNote mesh__D013489 80; was GENES, SUPPRESSOR 1970-79   
% 209.43/209.60  |- skos__scopeNote mesh__D013489
% 209.43/209.60       Mutation process that restores the wild-type PHENOTYPE in an organism possessing a mutationally altered GENOTYPE. The second %22%suppressor%22% mutation may be on a different gene, on the same gene but located at a distance from the site of the primary mutation, or in extrachromosomal genes %28%EXTRACHROMOSOMAL INHERITANCE%29%.%A%    
% 209.43/209.60  |- mesh__activeMeSHYear mesh__D013489 2004
% 209.43/209.60  |- mesh__recordAuthorizer mesh__D013489 sjn
% 209.43/209.60  |- skos__hiddenLabel mesh__D013489 Mutations, Suppressor
% 209.43/209.60  |- skos__hiddenLabel mesh__D013489 Suppressions, Genetic
% 209.43/209.60  |- rdf__type mesh__D013489sskos__Concept
% 209.43/209.60  |- mesh__dateCreated mesh__D013489 1999-01-01
% 209.43/209.60  |- mesh__activeMeSHYear mesh__D013489 2003
% 209.43/209.60  |- mesh__historyNote mesh__D013489
% 209.43/209.60       80; was GENES, SUPPRESSOR 1968-79 %28%Prov 1968-69%29%   
% 209.43/209.60  |- skos__broader mesh__D013489smesh__D016296
% 209.43/209.60  |- skos__hiddenLabel mesh__D013489 Mutation, Suppressor
% 209.43/209.60  |- mesh__activeMeSHYear mesh__D013489 2006
% 209.43/209.60  |- skos__historyNote mesh__D013489 Genes, Suppressor %28%1968-1979%29%
% 209.43/209.60  |- skos__hiddenLabel mesh__D018972 3, IGF-Binding Protein
% 209.43/209.60  |- skos__hiddenLabel mesh__D018972 IGF Binding Protein 3
% 209.43/209.60  |- skos__hiddenLabel mesh__D018972 Protein 3, IGF-Binding
% 209.43/209.60  |- mesh__dateCreated mesh__D018972 1995-06-08
% 209.43/209.60  |- mesh__recordAuthorizer mesh__D018972 sjn
% 209.43/209.60  |- skos__annotation mesh__D018972
% 209.43/209.60       /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X refs%A%  
% 209.43/209.60  |- rdf__type mesh__D018972sskos__Concept
% 209.43/209.60  |- mesh__activeMeSHYear mesh__D018972 2006
% 209.43/209.60  |- skos__altLabel mesh__D018972 IGFBP-3
% 209.43/209.60  |- mesh__onlineNote mesh__D018972
% 209.43/209.60       use INSULIN-LIKE GROWTH-FACTOR-BINDING PROTEINS %28%NM%29% to search INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3 1980-95%A%  
% 209.43/209.60  |- mesh__dateEstablished mesh__D018972 1996-01-01
% 209.43/209.60  |- skos__altLabel mesh__D018972 IGF-Binding Protein 3
% 209.43/209.60  |- skos__prefLabel mesh__D018972
% 209.43/209.60       Insulin-Like Growth Factor Binding Protein 3
% 209.43/209.60  |- mesh__publicMeSHNote mesh__D018972
% 209.43/209.60       96; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-95%A%  
% 209.43/209.60  |- mesh__historyNote mesh__D018972
% 209.43/209.60       96; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3 was SY to INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS 1980-95%A%  
% 209.45/209.60  |- skos__scopeNote mesh__D018972
% 209.45/209.60       One of the six homologous soluble proteins that bind insulin-like growth factors %28%SOMATOMEDINS%29% and modulate their mitogenic and metabolic actions at the cellular level.%A%    
% 209.45/209.60  |- skos__historyNote mesh__D018972 Carrier Proteins %28%1980-1995%29%
% 209.45/209.60  |- mesh__recordMaintainer mesh__D018972 jmp
% 209.45/209.60  |- mesh__recordOriginator mesh__D018972 TPW
% 209.45/209.60  |- mesh__dateRevised mesh__D018972 2004-07-07
% 209.45/209.60  |- skos__broader mesh__D018972smesh__D018969
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018972 2005
% 209.45/209.60  |- mesh__recordMaintainer mesh__D018174 ags
% 209.45/209.60  |- skos__prefLabel mesh__D018174 Arterivirus Infections
% 209.45/209.60  |- skos__hiddenLabel mesh__D018174 Infection, Arterivirus
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018174 2003
% 209.45/209.60  |- skos__altLabel mesh__D018174 Infections, Arterivirus
% 209.45/209.60  |- skos__hiddenLabel mesh__D018174 Arterivirus Infection
% 209.45/209.60  |- skos__broader mesh__D018174smesh__D030341
% 209.45/209.60  |- mesh__recordOriginator mesh__D018174 AGS
% 209.45/209.60  |- mesh__recordAuthorizer mesh__D018174 sjn
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018174 2006
% 209.45/209.60  |- rdf__type mesh__D018174sskos__Concept
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018174 2002
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018174 2005
% 209.45/209.60  |- mesh__dateRevised mesh__D018174 2001-07-25
% 209.45/209.60  |- skos__scopeNote mesh__D018174
% 209.45/209.60       Infections caused by viruses of the genus ARTERIVIRUS.     
% 209.45/209.60  |- mesh__publicMeSHNote mesh__D018174 94   
% 209.45/209.60  |- mesh__dateCreated mesh__D018174 1993-06-04
% 209.45/209.60  |- skos__annotation mesh__D018174 caused by an RNA virus   
% 209.45/209.60  |- mesh__historyNote mesh__D018174 94   
% 209.45/209.60  |- mesh__dateEstablished mesh__D018174 1994-01-01
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018174 2004
% 209.45/209.60  |- mesh__historyNote mesh__D010191 79   
% 209.45/209.60  |- skos__scopeNote mesh__D010191
% 209.45/209.60       A 36-amino acid polypeptide secreted by the PANCREAS that has physiological regulatory functions. Plasma pancreatic polypeptide increases after ingestion of food, with age, and in disease states. A lack of pancreatic polypeptide in the ISLETS OF LANGERHANS has been associated with the OBESITY in rats and mice.%A%    
% 209.45/209.60  |- mesh__recordOriginator mesh__D010191 RLS
% 209.45/209.60  |- skos__broader mesh__D010191smesh__D009479
% 209.45/209.60  |- rdf__type mesh__D010191sskos__Concept
% 209.45/209.60  |- skos__historyNote mesh__D010191 Peptides %28%1966-1978%29%
% 209.45/209.60  |- mesh__publicMeSHNote mesh__D010191 79   
% 209.45/209.60  |- mesh__recordMaintainer mesh__D010191 ssb
% 209.45/209.60  |- skos__prefLabel mesh__D010191 Pancreatic Polypeptide
% 209.45/209.60  |- mesh__recordAuthorizer mesh__D010191 sjn
% 209.45/209.60  |- skos__broader mesh__D010191smesh__D010187
% 209.45/209.60  |- mesh__dateEstablished mesh__D010191 1979-01-01
% 209.45/209.60  |- mesh__dateRevised mesh__D010191 2005-06-30
% 209.45/209.60  |- skos__historyNote mesh__D010191 Hormones %28%1966-1973%29%
% 209.45/209.60  |- skos__broader mesh__D010191smesh__D036361
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D010191 2006
% 209.45/209.60  |- skos__historyNote mesh__D010191 Pancreatic Hormones %28%1974-1978%29%
% 209.45/209.60  |- skos__hiddenLabel mesh__D010191 Polypeptide, Pancreatic
% 209.45/209.60  |- mesh__dateCreated mesh__D010191 1978-05-18
% 209.45/209.60  |- mesh__publicMeSHNote mesh__D004952
% 209.45/209.60       91; was see under CARBOXYLIC ACIDS 1968-90   
% 209.45/209.60  |- mesh__recordMaintainer mesh__D004952 TAP
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004952 2004
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004952 1997
% 209.45/209.60  |- skos__prefLabel mesh__D004952 Esters
% 209.45/209.60  |- skos__broader mesh__D004952smesh__D002264
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004952 2005
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004952 2000
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004952 1998
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004952 1993
% 209.45/209.60  |- mesh__recordAuthorizer mesh__D004952 PLS
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004952 2001
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004952 1994
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004952 2006
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004952 1999
% 209.45/209.60  |- mesh__recordOriginator mesh__D004952 NLM
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004952 2002
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004952 1995
% 209.45/209.60  |- skos__annotation mesh__D004952 NIM; avoid qualif   
% 209.45/209.60  |- mesh__dateEstablished mesh__D004952 1991-01-01
% 209.45/209.60  |- skos__historyNote mesh__D004952 specific alcohol %28%1968-1990%29%
% 209.45/209.60  |- mesh__dateCreated mesh__D004952 1999-01-01
% 209.45/209.60  |- rdf__type mesh__D004952sskos__Concept
% 209.45/209.60  |- mesh__historyNote mesh__D004952
% 209.45/209.60       91%28%68%29%; was see under CARBOXYLIC ACIDS 1968-90   
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004952 2003
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004952 1996
% 209.45/209.60  |- skos__historyNote mesh__D004952 specific acid %28%1968-1990%29%
% 209.45/209.60  |- mesh__dateRevised mesh__D004952 1992-06-25
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004154 2002
% 209.45/209.60  |- skos__annotation mesh__D004154 /drug ther: consider FILARICIDES   
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004154 2003
% 209.45/209.60  |- mesh__dateCreated mesh__D004154 1999-01-01
% 209.45/209.60  |- skos__prefLabel mesh__D004154 Dipetalonema Infections
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004154 2004
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004154 2000
% 209.45/209.60  |- mesh__historyNote mesh__D004154
% 209.45/209.60       91%28%86%29%; was see under FILARIASIS 1986-90; was ACANTHOCHEILONEMIASIS see under FILARIASIS 1975-85 %26% see under NEMATODE INFECTIONS 1967-74%A%  
% 209.45/209.60  |- mesh__recordOriginator mesh__D004154 NLM
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004154 2001
% 209.45/209.60  |- rdf__type mesh__D004154sskos__Concept
% 209.45/209.60  |- skos__altLabel mesh__D004154 Infections, Dipetalonema
% 209.45/209.60  |- mesh__onlineNote mesh__D004154
% 209.45/209.60       use DIPETALONEMA INFECTIONS to search ACANTHOCHEILONEMIASIS 1975-85 %26% NEMATODE INFECTIONS 1967-74%A%  
% 209.45/209.60  |- mesh__dateEstablished mesh__D004154 1991-01-01
% 209.45/209.60  |- skos__scopeNote mesh__D004154
% 209.45/209.60       Infections with nematodes of the genus DIPETALONEMA.     
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004154 2005
% 209.45/209.60  |- skos__hiddenLabel mesh__D004154 Infection, Dipetalonema
% 209.45/209.60  |- mesh__dateRevised mesh__D004154 1998-06-10
% 209.45/209.60  |- mesh__publicMeSHNote mesh__D004154
% 209.45/209.60       91; was see under FILARIASIS 1986-90; was ACANTHOCHEILONEMIASIS see under FILARIASIS 1975-85 %26% see under NEMATODE INFECTIONS 1967-74%A%  
% 209.45/209.60  |- skos__broader mesh__D004154smesh__D005368
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004154 2006
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004154 1999
% 209.45/209.60  |- skos__hiddenLabel mesh__D004154 Dipetalonema Infection
% 209.45/209.60  |- skos__hiddenLabel mesh__D004154 Acanthocheilonemiases
% 209.45/209.60  |- mesh__recordAuthorizer mesh__D004154 SJN
% 209.45/209.60  |- mesh__recordMaintainer mesh__D004154 MSR
% 209.45/209.60  |- mesh__publicMeSHNote mesh__D050705 2006   
% 209.45/209.60  |- skos__hiddenLabel mesh__D050705 Receptors, Guanylate Cyclase Coupled
% 209.45/209.60  |- mesh__historyNote mesh__D050705 2006   
% 209.45/209.60  |- skos__altLabel mesh__D050705 Guanylyl Cyclase-Linked Receptors
% 209.45/209.60  |- skos__hiddenLabel mesh__D050705 Receptors, Guanylyl Cyclase
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D050705 2006
% 209.45/209.60  |- mesh__recordOriginator mesh__D050705 jmp
% 209.45/209.60  |- rdf__type mesh__D050705sskos__Concept
% 209.45/209.60  |- mesh__recordAuthorizer mesh__D050705 sjn
% 209.45/209.60  |- mesh__recordMaintainer mesh__D050705 jmp
% 209.45/209.60  |- mesh__dateEstablished mesh__D050705 2006-01-01
% 209.45/209.60  |- mesh__dateCreated mesh__D050705 2005-06-30
% 209.45/209.60  |- skos__scopeNote mesh__D050705
% 209.45/209.60       A class of cellular membrane receptors that either have an intrinsic guanylate cyclase activity or are closely coupled to specific guanylate cyclases within the cell.%A%    
% 209.45/209.60  |- skos__broader mesh__D050705smesh__D011956
% 209.45/209.60  |- skos__hiddenLabel mesh__D050705 Cyclase-Linked Receptors, Guanylyl
% 209.45/209.60  |- skos__altLabel mesh__D050705 Guanylate Cyclase-Coupled Receptors
% 209.45/209.60  |- skos__broader mesh__D050705smesh__D006162
% 209.45/209.60  |- skos__hiddenLabel mesh__D050705 Receptors, Guanylyl Cyclase-Linked
% 209.45/209.60  |- skos__hiddenLabel mesh__D050705 Cyclase Receptors, Guanylyl
% 209.45/209.60  |- skos__historyNote mesh__D050705
% 209.45/209.60       Receptors, Cell Surface %28%1971-2005%29%
% 209.45/209.60  |- skos__historyNote mesh__D050705 Guanylate Cyclase %28%1971-2005%29%
% 209.45/209.60  |- skos__hiddenLabel mesh__D050705 Guanylyl Cyclase Linked Receptors
% 209.45/209.60  |- skos__hiddenLabel mesh__D050705 Guanylate Cyclase Coupled Receptors
% 209.45/209.60  |- skos__hiddenLabel mesh__D050705 Cyclase-Coupled Receptors, Guanylate
% 209.45/209.60  |- skos__altLabel mesh__D050705 Guanylyl Cyclase Receptors
% 209.45/209.60  |- skos__prefLabel mesh__D050705 Receptors, Guanylate Cyclase-Coupled
% 209.45/209.60  |- skos__scopeNote mesh__D014582
% 209.45/209.60       The most common form of cutaneous mastocytosis %28%MASTOCYTOSIS, CUTANEOUS%29% that occurs primarily in children. It is characterized by the multiple small reddish-brown pigmented pruritic macules and papules.%A%    
% 209.45/209.60  |- mesh__recordOriginator mesh__D014582 NLM
% 209.45/209.60  |- mesh__dateEstablished mesh__D014582 1965-01-01
% 209.45/209.60  |- skos__prefLabel mesh__D014582 Urticaria Pigmentosa
% 209.45/209.60  |- mesh__recordMaintainer mesh__D014582 lkt
% 209.45/209.60  |- mesh__dateCreated mesh__D014582 1999-01-01
% 209.45/209.60  |- skos__broader mesh__D014582smesh__D034701
% 209.45/209.60  |- rdf__type mesh__D014582sskos__Concept
% 209.45/209.60  |- skos__broader mesh__D014582smesh__D010859
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D014582 2004
% 209.45/209.60  |- skos__hiddenLabel mesh__D014582 Cutaneous Mastocytoses, Maculopapular
% 209.45/209.60  |- mesh__publicMeSHNote mesh__D014582 65   
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D014582 2006
% 209.45/209.60  |- skos__altLabel mesh__D014582 Maculopapular Cutaneous Mastocytosis
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D014582 2003
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D014582 2005
% 209.45/209.60  |- mesh__recordAuthorizer mesh__D014582 sjn
% 209.45/209.60  |- mesh__historyNote mesh__D014582 65%28%63%29%   
% 209.45/209.60  |- skos__annotation mesh__D014582
% 209.45/209.60       X ref MACULOPAPULAR CUTANEOUS MASTOCYTOSIS: MASTOCYTOSIS, CUTANEOUS is also available%A%  
% 209.45/209.60  |- mesh__dateRevised mesh__D014582 2002-07-03
% 209.45/209.60  |- skos__hiddenLabel mesh__D014582 Cutaneous Mastocytosis, Maculopapular
% 209.45/209.60  |- skos__hiddenLabel mesh__D014582 Maculopapular Cutaneous Mastocytoses
% 209.45/209.60  |- skos__prefLabel mesh__D008545 Melanoma
% 209.45/209.60  |- mesh__dateCreated mesh__D008545 1999-01-01
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D008545 2000
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D008545 2003
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D008545 2001
% 209.45/209.60  |- mesh__recordOriginator mesh__D008545 NLM
% 209.45/209.60  |- mesh__dateRevised mesh__D008545 1996-06-10
% 209.45/209.60  |- skos__hiddenLabel mesh__D008545 Malignant Melanomas
% 209.45/209.60  |- mesh__recordAuthorizer mesh__D008545 PLS
% 209.45/209.60  |- rdf__type mesh__D008545sskos__Concept
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D008545 1998
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D008545 2004
% 209.45/209.60  |- skos__annotation mesh__D008545
% 209.45/209.60       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; MELANOMA, EXPERIMENTAL is also available%A%  
% 209.45/209.60  |- skos__altLabel mesh__D008545 Malignant Melanoma
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D008545 1999
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D008545 2002
% 209.45/209.60  |- skos__hiddenLabel mesh__D008545 Melanoma, Malignant
% 209.45/209.60  |- skos__scopeNote mesh__D008545
% 209.45/209.60       A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. %28%Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445%29%%A%    
% 209.45/209.60  |- skos__broader mesh__D008545smesh__D018326
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D008545 2005
% 209.45/209.60  |- mesh__recordMaintainer mesh__D008545 TGC
% 209.45/209.60  |- skos__hiddenLabel mesh__D008545 Melanomas, Malignant
% 209.45/209.60  |- skos__broader mesh__D008545smesh__D018358
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D008545 2006
% 209.45/209.60  |- skos__hiddenLabel mesh__D008545 Melanomas
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D008545 1997
% 209.45/209.60  |- mesh__recordMaintainer mesh__D000562 TGC
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D000562 2003
% 209.45/209.60  |- skos__related mesh__D000562smesh__D000563
% 209.45/209.60  |- skos__hiddenLabel mesh__D000562 Abscesses, Amebic
% 209.45/209.60  |- mesh__recordOriginator mesh__D000562 NLM
% 209.45/209.60  |- mesh__dateCreated mesh__D000562 1999-01-01
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D000562 2004
% 209.45/209.60  |- skos__altLabel mesh__D000562 Amoebiasis
% 209.45/209.60  |- skos__annotation mesh__D000562
% 209.45/209.60       caused by %22%any of various amebae%22%; /drug ther: consider also AMEBICIDES; note X ref ABSCESS, AMEBIC: LIVER ABSCESS, AMEBIC is also available%A%  
% 209.45/209.60  |- skos__hiddenLabel mesh__D000562 Amebic Abscess
% 209.45/209.60  |- mesh__dateRevised mesh__D000562 1997-06-20
% 209.45/209.60  |- mesh__recordAuthorizer mesh__D000562 SJN
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D000562 2005
% 209.45/209.60  |- skos__hiddenLabel mesh__D000562 Amebiases
% 209.45/209.60  |- skos__scopeNote mesh__D000562
% 209.45/209.60       Infection with any of various amebae. It is an asymptomatic carrier state in most individuals, but diseases ranging from chronic, mild diarrhea to fulminant dysentery may occur.%A%    
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D000562 2006
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D000562 2000
% 209.45/209.60  |- skos__hiddenLabel mesh__D000562 Amebic Abscesses
% 209.45/209.60  |- rdf__type mesh__D000562sskos__Concept
% 209.45/209.60  |- skos__hiddenLabel mesh__D000562 Amebomas
% 209.45/209.60  |- skos__prefLabel mesh__D000562 Amebiasis
% 209.45/209.60  |- skos__broader mesh__D000562smesh__D016775
% 209.45/209.60  |- skos__hiddenLabel mesh__D000562 Iodamoebiases
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D000562 2001
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D000562 1998
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D000562 2002
% 209.45/209.60  |- skos__hiddenLabel mesh__D000562 Amoebiases
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D000562 1999
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018973 2006
% 209.45/209.60  |- skos__scopeNote mesh__D018973
% 209.45/209.60       Property, such as patents, trademarks, and copyright, that results from creative effort. The Patent and Copyright Clause %28%Art. 1, Sec. 8, cl. 8%29% of the United States Constitution provides for promoting the progress of science and useful arts by securing for limited times to authors and inventors, the exclusive right to their respective writings and discoveries. %28%From Black%27%s Law Dictionary, 5th ed, p1014%29%%A%    
% 209.45/209.60  |- mesh__historyNote mesh__D018973 96   
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018973 1996
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018973 2004
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018973 1999
% 209.45/209.60  |- skos__hiddenLabel mesh__D018973 Properties, Intellectual
% 209.45/209.60  |- skos__broader mesh__D018973smesh__D007603
% 209.45/209.60  |- mesh__publicMeSHNote mesh__D018973 96   
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018973 1997
% 209.45/209.60  |- skos__hiddenLabel mesh__D018973 Property, Intellectual
% 209.45/209.60  |- mesh__dateEstablished mesh__D018973 1996-01-01
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018973 2000
% 209.45/209.60  |- skos__historyNote mesh__D018973 Copyright %28%1993-1995%29%
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018973 2001
% 209.45/209.60  |- skos__prefLabel mesh__D018973 Intellectual Property
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018973 2005
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018973 2002
% 209.45/209.60  |- skos__hiddenLabel mesh__D018973 Intellectual Properties
% 209.45/209.60  |- skos__historyNote mesh__D018973 Patents %28%1992-1995%29%
% 209.45/209.60  |- mesh__dateCreated mesh__D018973 1995-06-05
% 209.45/209.60  |- rdf__type mesh__D018973sskos__Concept
% 209.45/209.60  |- skos__annotation mesh__D018973
% 209.45/209.60       refers to PATENTS, trademarks, COPYRIGHT, espec under US Constitution; no qualif; specify geog%A%  
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018973 2003
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018973 1998
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D010990 1995
% 209.45/209.60  |- skos__hiddenLabel mesh__D010990 Principles, Pleasure-Pain
% 209.45/209.60  |- mesh__dateEstablished mesh__D010990 1973-01-01
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D010990 2002
% 209.45/209.60  |- skos__hiddenLabel mesh__D010990 Pleasure-Pain Principles
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D010990 1993
% 209.45/209.60  |- mesh__historyNote mesh__D010990 73%28%64%29%   
% 209.45/209.60  |- mesh__publicMeSHNote mesh__D010990 73   
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D010990 1994
% 209.45/209.60  |- skos__hiddenLabel mesh__D010990 Principle, Pleasure-Pain
% 209.45/209.60  |- mesh__recordAuthorizer mesh__D010990 PLS
% 209.45/209.60  |- mesh__recordMaintainer mesh__D010990 TGC
% 209.45/209.60  |- mesh__dateCreated mesh__D010990 1999-01-01
% 209.45/209.60  |- rdf__type mesh__D010990sskos__Concept
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D010990 1999
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D010990 1992
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D010990 2006
% 209.45/209.60  |- skos__broader mesh__D010990smesh__D011574
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D010990 1997
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D010990 2001
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D010990 1998
% 209.45/209.60  |- mesh__recordOriginator mesh__D010990 NLM
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D010990 2004
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D010990 2005
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D010990 1996
% 209.45/209.60  |- skos__hiddenLabel mesh__D010990 Pleasure Pain Principle
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D010990 2000
% 209.45/209.60  |- skos__scopeNote mesh__D010990
% 209.45/209.60       The psychoanalytic concept that man instinctively seeks to avoid pain and discomfort and strives for gratification and pleasure.%A%    
% 209.45/209.60  |- mesh__dateRevised mesh__D010990 1991-06-11
% 209.45/209.60  |- skos__prefLabel mesh__D010990 Pleasure-Pain Principle
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D010990 2003
% 209.45/209.60  |- skos__annotation mesh__D010990 no qualif   
% 209.45/209.60  |- mesh__recordAuthorizer mesh__D018175 PLS
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018175 2001
% 209.45/209.60  |- mesh__dateEstablished mesh__D018175 1994-01-01
% 209.45/209.60  |- mesh__dateRevised mesh__D018175 1996-06-10
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018175 1999
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018175 2006
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018175 2000
% 209.45/209.60  |- skos__hiddenLabel mesh__D018175 Birnaviridae Infection
% 209.45/209.60  |- skos__annotation mesh__D018175 GEN or unspecified; prefer specifics   
% 209.45/209.60  |- rdf__type mesh__D018175sskos__Concept
% 209.45/209.60  |- skos__broader mesh__D018175smesh__D012327
% 209.45/209.60  |- mesh__publicMeSHNote mesh__D018175
% 209.45/209.60       94; BIRNAVIRUS INFECTIONS was see BIRNAVIRIDAE INFECTIONS 1994-96%A%  
% 209.45/209.60  |- mesh__onlineNote mesh__D018175
% 209.45/209.60       use BIRNAVIRIDAE INFECTIONS to search BIRNAVIRUS INFECTIONS 1994-96%A%  
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018175 1998
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018175 2005
% 209.45/209.60  |- skos__scopeNote mesh__D018175
% 209.45/209.60       Virus diseases caused by the BIRNAVIRIDAE.     
% 209.45/209.60  |- mesh__recordMaintainer mesh__D018175 AGS
% 209.45/209.60  |- mesh__historyNote mesh__D018175
% 209.45/209.60       94; BIRNAVIRUS INFECTIONS was see BIRNAVIRIDAE INFECTIONS 1994-96%A%  
% 209.45/209.60  |- skos__hiddenLabel mesh__D018175 Infection, Birnaviridae
% 209.45/209.60  |- skos__prefLabel mesh__D018175 Birnaviridae Infections
% 209.45/209.60  |- mesh__recordOriginator mesh__D018175 AGS
% 209.45/209.60  |- skos__altLabel mesh__D018175 Infections, Birnaviridae
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018175 2002
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018175 1997
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018175 2004
% 209.45/209.60  |- mesh__dateCreated mesh__D018175 1993-06-04
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D018175 2003
% 209.45/209.60  |- skos__hiddenLabel mesh__D010192 Pancreatic Pseudocysts
% 209.45/209.60  |- mesh__recordOriginator mesh__D010192 RC
% 209.45/209.60  |- mesh__dateRevised mesh__D010192 2004-07-07
% 209.45/209.60  |- mesh__dateEstablished mesh__D010192 1991-01-01
% 209.45/209.60  |- skos__hiddenLabel mesh__D010192 Pseudocyst, Pancreatic
% 209.45/209.60  |- skos__historyNote mesh__D010192 Pancreatic Cyst %28%1966-1980%29%
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D010192 2006
% 209.45/209.60  |- mesh__recordMaintainer mesh__D010192 lkt
% 209.45/209.60  |- mesh__publicMeSHNote mesh__D010192
% 209.45/209.60       91; was see under PANCREATIC CYST 1981-90   
% 209.45/209.60  |- skos__hiddenLabel mesh__D010192 Pseudocysts, Pancreatic
% 209.45/209.60  |- mesh__dateCreated mesh__D010192 1980-04-09
% 209.45/209.60  |- mesh__historyNote mesh__D010192
% 209.45/209.60       91%28%81%29%; was see under PANCREATIC CYST 1981-90   
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D010192 2005
% 209.45/209.60  |- skos__scopeNote mesh__D010192
% 209.45/209.60       Cyst-like space not lined by EPITHELIUM and contained within the PANCREAS. Pancreatic pseudocysts account for most of the cystic collections in the pancreas and are often associated with chronic PANCREATITIS.%A%    
% 209.45/209.60  |- skos__broader mesh__D010192smesh__D010181
% 209.45/209.60  |- skos__prefLabel mesh__D010192 Pancreatic Pseudocyst
% 209.45/209.60  |- rdf__type mesh__D010192sskos__Concept
% 209.45/209.60  |- mesh__recordAuthorizer mesh__D010192 sjn
% 209.45/209.60  |- skos__prefLabel mesh__D004953 Estetrol
% 209.45/209.60  |- skos__hiddenLabel mesh__D004953 15 alpha Hydroxy Estriol
% 209.45/209.60  |- mesh__dateRevised mesh__D004953 2003-07-09
% 209.45/209.60  |- mesh__dateCreated mesh__D004953 1974-11-19
% 209.45/209.60  |- skos__altLabel mesh__D004953 15-alpha-Hydroxy-Estriol
% 209.45/209.60  |- mesh__historyNote mesh__D004953
% 209.45/209.60       91%28%75%29%; was see under ESTRIOL 1975-90   
% 209.45/209.60  |- mesh__dateEstablished mesh__D004953 1991-01-01
% 209.45/209.60  |- skos__altLabel mesh__D004953 15 alpha-Hydroxyestriol
% 209.45/209.60  |- rdf__type mesh__D004953sskos__Concept
% 209.45/209.60  |- mesh__publicMeSHNote mesh__D004953 91; was see under ESTRIOL 1975-90   
% 209.45/209.60  |- skos__historyNote mesh__D004953 Estriol %28%1973-1974%29%
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004953 2004
% 209.45/209.60  |- skos__hiddenLabel mesh__D004953 15 alpha Hydroxyestriol
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004953 2005
% 209.45/209.60  |- mesh__recordOriginator mesh__D004953 NLM
% 209.45/209.60  |- mesh__recordMaintainer mesh__D004953 lkt
% 209.45/209.60  |- skos__broader mesh__D004953smesh__D004964
% 209.45/209.60  |- mesh__recordAuthorizer mesh__D004953 sjn
% 209.45/209.60  |- skos__scopeNote mesh__D004953
% 209.45/209.60       A metabolite of ESTRIOL with a 15-alpha-hydroxyl group.  Estetrol can be converted from estriol sulfate or DEHYDROEPIANDROSTERONE SULFATE by the fetal-placental unit.%A%    
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004953 2006
% 209.45/209.60  |- skos__altLabel mesh__D004155 Diphenylhydramin
% 209.45/209.60  |- skos__altLabel mesh__D004155 Benhydramin
% 209.45/209.60  |- mesh__recordAuthorizer mesh__D004155 sjn
% 209.45/209.60  |- mesh__activeMeSHYear mesh__D004155 2006
% 209.45/209.60  |- skos__hiddenLabel mesh__D004155 Citrate, Diphenhydramine
% 209.45/209.60  |- skos__altLabel mesh__D004155 Diphenhydramine Citrate %28%1:1%29%
% 209.45/209.60  |- skos__broader mesh__D004155smesh__D005021
% 209.45/209.60  |- skos__altLabel mesh__D004155 Diphenylhydramine
% 209.45/209.60  |- mesh__dateCreated mesh__D004155 1999-01-01
% 209.45/209.60  |- skos__hiddenLabel mesh__D004155 Hydrochloride, Diphenhydramine
% 209.45/209.60  |- skos__altLabel mesh__D004155 2-Diphenylmethoxy-N,N-dimethylethylamine
% 209.45/209.60  |- mesh__dateRevised mesh__D004155 2005-06-30
% 209.45/209.60  |- skos__altLabel mesh__D004155 Benzhydramine
% 209.45/209.60  |- skos__broader mesh__D004155smesh__D001559
% 209.45/209.60  |- skos__prefLabel mesh__D004155 Diphenhydramine
% 209.45/209.60  |- skos__scopeNote mesh__D004155
% 209.45/209.60       A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects.%A%    
% 209.45/209.60  |- mesh__recordMaintainer mesh__D004155 lkw
% 209.45/209.60  |- rdf__type mesh__D004155sskos__Concept
% 209.45/209.60  |- mesh__recordOriginator mesh__D004155 NLM
% 209.45/209.61  |- mesh__recordMaintainer mesh__D050706 ags
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D050706 2006
% 209.45/209.61  |- skos__hiddenLabel mesh__D050706 Dolphin, Spinner
% 209.45/209.61  |- skos__hiddenLabel mesh__D050706 Dolphins, Striped
% 209.45/209.61  |- skos__hiddenLabel mesh__D050706 Dolphin, Striped
% 209.45/209.61  |- skos__altLabel mesh__D050706 Stenella longirostris
% 209.45/209.61  |- rdf__type mesh__D050706sskos__Concept
% 209.45/209.61  |- skos__hiddenLabel mesh__D050706 Spinner Dolphin
% 209.45/209.61  |- skos__scopeNote mesh__D050706
% 209.45/209.61       A genus comprised of spinner, spotted, and striped DOLPHINS, in the family Delphinidae. Schools of Stenella, that may number in the thousands, often associate with schools of TUNA, and are thus vulnerable to accidental harvesting.%A%    
% 209.45/209.61  |- skos__hiddenLabel mesh__D050706 Dolphins, Spotted
% 209.45/209.61  |- skos__hiddenLabel mesh__D050706 Striped Dolphins
% 209.45/209.61  |- mesh__recordOriginator mesh__D050706 ags
% 209.45/209.61  |- skos__hiddenLabel mesh__D050706 Spotted Dolphin
% 209.45/209.61  |- skos__hiddenLabel mesh__D050706 Dolphin, Spotted
% 209.45/209.61  |- skos__altLabel mesh__D050706 Stenella frontalis
% 209.45/209.61  |- skos__hiddenLabel mesh__D050706 Dolphins, Spinner
% 209.45/209.61  |- skos__historyNote mesh__D050706 Dolphins %28%1966-2005%29%
% 209.45/209.61  |- mesh__recordAuthorizer mesh__D050706 sjn
% 209.45/209.61  |- skos__broader mesh__D050706smesh__D004289
% 209.45/209.61  |- mesh__dateEstablished mesh__D050706 2006-01-01
% 209.45/209.61  |- mesh__dateCreated mesh__D050706 2005-06-30
% 209.45/209.61  |- skos__prefLabel mesh__D050706 Stenella
% 209.45/209.61  |- mesh__historyNote mesh__D050706 2006; use DOLPHINS 1998-2005   
% 209.45/209.61  |- mesh__publicMeSHNote mesh__D050706 2006; see DOLPHINS 1998-2005   
% 209.45/209.61  |- skos__altLabel mesh__D050706 Stenella coeruleoalba
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D014583 2002
% 209.45/209.61  |- mesh__dateCreated mesh__D014583 1999-01-01
% 209.45/209.61  |- rdf__type mesh__D014583sskos__Concept
% 209.45/209.61  |- skos__broader mesh__D014583smesh__D013020
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D014583 2004
% 209.45/209.61  |- mesh__dateRevised mesh__D014583 1995-05-23
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D014583 2001
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D014583 2006
% 209.45/209.61  |- mesh__recordOriginator mesh__D014583 NLM
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D014583 2003
% 209.45/209.61  |- mesh__recordMaintainer mesh__D014583 KEV
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D014583 2005
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D014583 2000
% 209.45/209.61  |- skos__prefLabel mesh__D014583 Uruguay
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D014583 1997
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D014583 1999
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D014583 1996
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D014583 1998
% 209.45/209.61  |- mesh__recordAuthorizer mesh__D014583 PLS
% 209.45/209.61  |- skos__altLabel mesh__D008546 Experimental Melanoma
% 209.45/209.61  |- mesh__dateEstablished mesh__D008546 1987-01-01
% 209.45/209.61  |- rdf__type mesh__D008546sskos__Concept
% 209.45/209.61  |- mesh__recordOriginator mesh__D008546 VDK
% 209.45/209.61  |- skos__hiddenLabel mesh__D008546 Cloudman S91 Melanoma
% 209.45/209.61  |- skos__hiddenLabel mesh__D008546 Melanoma, Harding Passey
% 209.45/209.61  |- skos__hiddenLabel mesh__D008546 S91 Melanoma, Cloudman
% 209.45/209.61  |- mesh__recordAuthorizer mesh__D008546 sjn
% 209.45/209.61  |- skos__altLabel mesh__D008546 Harding Passey Melanoma
% 209.45/209.61  |- skos__altLabel mesh__D008546 Experimental Melanomas
% 209.45/209.61  |- mesh__publicMeSHNote mesh__D008546 87   
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D008546 2005
% 209.45/209.61  |- skos__altLabel mesh__D008546 Melanomas, Experimental
% 209.45/209.61  |- skos__hiddenLabel mesh__D008546 Harding-Passey Melanoma
% 209.45/209.61  |- mesh__historyNote mesh__D008546 87   
% 209.45/209.61  |- mesh__dateRevised mesh__D008546 2004-07-13
% 209.45/209.61  |- skos__hiddenLabel mesh__D008546 Melanomas, B16
% 209.45/209.61  |- skos__prefLabel mesh__D008546 Melanoma, Experimental
% 209.45/209.61  |- skos__hiddenLabel mesh__D008546 B16 Melanomas
% 209.45/209.61  |- skos__scopeNote mesh__D008546
% 209.45/209.61       Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA.%A%    
% 209.45/209.61  |- skos__historyNote mesh__D008546 Melanoma %28%1966-1986%29%
% 209.45/209.61  |- mesh__recordMaintainer mesh__D008546 sjn
% 209.45/209.61  |- skos__broader mesh__D008546smesh__D008545
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D008546 2006
% 209.45/209.61  |- skos__altLabel mesh__D008546 B16 Melanoma
% 209.45/209.61  |- skos__annotation mesh__D008546
% 209.45/209.61       coordinate IM with pre-coordinated organ/neoplasm term %28%IM%29%; DF: MELANOMA EXPER%A%  
% 209.45/209.61  |- mesh__dateCreated mesh__D008546 1986-06-24
% 209.45/209.61  |- skos__broader mesh__D008546smesh__D009374
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D000563 2005
% 209.45/209.61  |- mesh__dateCreated mesh__D000563 1999-01-01
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D000563 2004
% 209.45/209.61  |- skos__prefLabel mesh__D000563 Amebicides
% 209.45/209.61  |- mesh__recordMaintainer mesh__D000563 ssb
% 209.45/209.61  |- skos__annotation mesh__D000563
% 209.45/209.61       GEN or unspecified; prefer specific amebicide; consider also AMOEBA /drug eff %26% AMEBIASIS /drug ther%A%  
% 209.45/209.61  |- skos__broader mesh__D000563smesh__D000981
% 209.45/209.61  |- skos__scopeNote mesh__D000563
% 209.45/209.61       Agents which are destructive to amebae, especially the parasitic species causing AMEBIASIS in man and animal.%A%    
% 209.45/209.61  |- mesh__recordOriginator mesh__D000563 NLM
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D000563 2006
% 209.45/209.61  |- skos__altLabel mesh__D000563 Amoebicides
% 209.45/209.61  |- rdf__type mesh__D000563sskos__Concept
% 209.45/209.61  |- mesh__dateRevised mesh__D000563 2003-07-09
% 209.45/209.61  |- mesh__recordAuthorizer mesh__D000563 sjn
% 209.45/209.61  |- skos__annotation mesh__D018974
% 209.45/209.61       /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X refs%A%  
% 209.45/209.61  |- mesh__recordOriginator mesh__D018974 TPW
% 209.45/209.61  |- skos__scopeNote mesh__D018974
% 209.45/209.61       One of the six homologous soluble proteins that bind insulin-like growth factors %28%SOMATOMEDINS%29% and modulate their mitogenic and metabolic actions at the cellular level.%A%    
% 209.45/209.61  |- skos__altLabel mesh__D018974 IGF-Binding Protein 4
% 209.45/209.61  |- mesh__dateRevised mesh__D018974 2004-09-20
% 209.45/209.61  |- skos__hiddenLabel mesh__D018974
% 209.45/209.61       Insulin Like Growth Factor Binding Protein 4
% 209.45/209.61  |- rdf__type mesh__D018974sskos__Concept
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018974 2006
% 209.45/209.61  |- skos__broader mesh__D018974smesh__D018969
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018974 2005
% 209.45/209.61  |- mesh__dateCreated mesh__D018974 1995-06-08
% 209.45/209.61  |- skos__altLabel mesh__D018974 IGFBP-4
% 209.45/209.61  |- mesh__historyNote mesh__D018974 2005%28%1991%29%   
% 209.45/209.61  |- skos__historyNote mesh__D018974 Carrier Proteins %28%1991-1995%29%
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018974 2005A
% 209.45/209.61  |- skos__prefLabel mesh__D018974
% 209.45/209.61       Insulin-Like Growth Factor Binding Protein 4
% 209.45/209.61  |- mesh__recordAuthorizer mesh__D018974 sjn
% 209.45/209.61  |- skos__hiddenLabel mesh__D018974 IGF Binding Protein 4
% 209.45/209.61  |- mesh__recordMaintainer mesh__D018974 sjn
% 209.45/209.61  |- mesh__publicMeSHNote mesh__D018974
% 209.45/209.61       2005; see INSULIN-LIKE GROWTH-FACTOR-BINDING PROTEIN 4 1996-2005; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4 was indexed under CARRIER PROTEINS 1991-95%A%  
% 209.45/209.61  |- mesh__dateEstablished mesh__D018974 1996-01-01
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010991 2000
% 209.45/209.61  |- mesh__recordAuthorizer mesh__D010991 SJN
% 209.45/209.61  |- rdf__type mesh__D010991sskos__Concept
% 209.45/209.61  |- mesh__dateCreated mesh__D010991 1999-01-01
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010991 1999
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010991 2006
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010991 2002
% 209.45/209.61  |- skos__broader mesh__D010991smesh__D003935
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010991 1998
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010991 2004
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010991 2005
% 209.45/209.61  |- skos__broader mesh__D010991smesh__D019937
% 209.45/209.61  |- skos__scopeNote mesh__D010991
% 209.45/209.61       Recording of change in the size of a part as modified by the circulation in it.%A%    
% 209.45/209.61  |- mesh__dateRevised mesh__D010991 1997-06-20
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010991 2003
% 209.45/209.61  |- mesh__recordOriginator mesh__D010991 NLM
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010991 2001
% 209.45/209.61  |- skos__hiddenLabel mesh__D010991 Plethysmographies
% 209.45/209.61  |- skos__prefLabel mesh__D010991 Plethysmography
% 209.45/209.61  |- skos__annotation mesh__D010991
% 209.45/209.61       NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; %22%venous occlusion plethysmography%22% %26% %22%strain gauge plethysmography%22% go here; DF: PLETHYSMOGR%A%  
% 209.45/209.61  |- mesh__recordMaintainer mesh__D010991 PXP
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018176 2005
% 209.45/209.61  |- mesh__recordOriginator mesh__D018176 AGS
% 209.45/209.61  |- skos__prefLabel mesh__D018176 Torovirus Infections
% 209.45/209.61  |- skos__scopeNote mesh__D018176
% 209.45/209.61       Infections with viruses of the genus TOROVIRUS, family CORONAVIRIDAE.%A%    
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018176 2002
% 209.45/209.61  |- mesh__dateRevised mesh__D018176 2001-07-25
% 209.45/209.61  |- mesh__dateCreated mesh__D018176 1993-06-04
% 209.45/209.61  |- mesh__publicMeSHNote mesh__D018176 94   
% 209.45/209.61  |- mesh__historyNote mesh__D018176 94   
% 209.45/209.61  |- skos__broader mesh__D018176smesh__D003333
% 209.45/209.61  |- mesh__dateEstablished mesh__D018176 1994-01-01
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018176 2004
% 209.45/209.61  |- skos__hiddenLabel mesh__D018176 Torovirus Infection
% 209.45/209.61  |- skos__annotation mesh__D018176
% 209.45/209.61       caused by a member of the family Coronaviridae   
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018176 2003
% 209.45/209.61  |- mesh__recordMaintainer mesh__D018176 ags
% 209.45/209.61  |- skos__hiddenLabel mesh__D018176 Infection, Torovirus
% 209.45/209.61  |- skos__altLabel mesh__D018176 Infections, Torovirus
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018176 2006
% 209.45/209.61  |- rdf__type mesh__D018176sskos__Concept
% 209.45/209.61  |- mesh__recordAuthorizer mesh__D018176 sjn
% 209.45/209.61  |- mesh__recordAuthorizer mesh__D010193 SJN
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010193 2004
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010193 2002
% 209.45/209.61  |- skos__annotation mesh__D010193
% 209.45/209.61       do not use /util except by MeSH definition   
% 209.45/209.61  |- mesh__recordMaintainer mesh__D010193 PXP
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010193 2006
% 209.45/209.61  |- skos__historyNote mesh__D010193 Pancreas/surgery %28%1966-1987%29%
% 209.45/209.61  |- skos__hiddenLabel mesh__D010193 Pancreatojejunostomies
% 209.45/209.61  |- mesh__publicMeSHNote mesh__D010193 88   
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010193 2003
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010193 1999
% 209.45/209.61  |- skos__hiddenLabel mesh__D010193 Pancreaticojejunostomies
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010193 2001
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010193 2005
% 209.45/209.61  |- mesh__dateRevised mesh__D010193 1997-06-20
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010193 1998
% 209.45/209.61  |- skos__historyNote mesh__D010193 Pancreatitis/surgery %28%1966-1987%29%
% 209.45/209.61  |- skos__altLabel mesh__D010193 Pancreatojejunostomy
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010193 2000
% 209.45/209.61  |- skos__prefLabel mesh__D010193 Pancreaticojejunostomy
% 209.45/209.61  |- skos__historyNote mesh__D010193 Jejunum/surgery %28%1966-1987%29%
% 209.45/209.61  |- mesh__dateCreated mesh__D010193 1987-03-19
% 209.45/209.61  |- mesh__historyNote mesh__D010193 88   
% 209.45/209.61  |- skos__scopeNote mesh__D010193
% 209.45/209.61       Surgical anastomosis of the pancreatic duct, or the divided end of the transected pancreas, with the jejunum. %28%Dorland, 28th ed%29%%A%    
% 209.45/209.61  |- rdf__type mesh__D010193sskos__Concept
% 209.45/209.61  |- mesh__recordOriginator mesh__D010193 SCD
% 209.45/209.61  |- mesh__dateEstablished mesh__D010193 1988-01-01
% 209.45/209.61  |- skos__historyNote mesh__D010193
% 209.45/209.61       Pancreatic ducts/surgery %28%1966-1987%29%
% 209.45/209.61  |- skos__broader mesh__D010193smesh__D013505
% 209.45/209.61  |- skos__broader mesh__D010193smesh__D000714
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D004954 2006
% 209.45/209.61  |- mesh__dateCreated mesh__D004954 1999-01-01
% 209.45/209.61  |- mesh__publicMeSHNote mesh__D004954 67; was BEAUTY 1963-66   
% 209.45/209.61  |- skos__prefLabel mesh__D004954 Esthetics
% 209.45/209.61  |- skos__broader mesh__D004954smesh__D013850
% 209.45/209.61  |- mesh__dateRevised mesh__D004954 1999-11-03
% 209.45/209.61  |- rdf__type mesh__D004954sskos__Concept
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D004954 2000
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D004954 2003
% 209.45/209.61  |- mesh__historyNote mesh__D004954 67; was BEAUTY 1963-66   
% 209.45/209.61  |- mesh__recordMaintainer mesh__D004954 jls
% 209.45/209.61  |- mesh__recordOriginator mesh__D004954 NLM
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D004954 2001
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D004954 2004
% 209.45/209.61  |- mesh__recordAuthorizer mesh__D004954 sjn
% 209.45/209.61  |- skos__scopeNote mesh__D004954
% 209.45/209.61       The branch of philosophy dealing with the nature of the beautiful. It includes beauty, esthetic experience, esthetic judgment, esthetic aspects of medicine, etc.%A%    
% 209.45/209.61  |- mesh__dateEstablished mesh__D004954 1967-01-01
% 209.45/209.61  |- skos__altLabel mesh__D004954 Aesthetics
% 209.45/209.61  |- skos__broader mesh__D004954smesh__D010684
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D004954 2002
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D004954 2005
% 209.45/209.61  |- mesh__onlineNote mesh__D004954 use ESTHETICS to search BEAUTY 1966   
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D004156 2005
% 209.45/209.61  |- mesh__recordOriginator mesh__D004156 NLM
% 209.45/209.61  |- skos__altLabel mesh__D004156 Polyphenoloxidase
% 209.45/209.61  |- mesh__historyNote mesh__D004156 92; was DIPHENOL OXIDASES 1968-91   
% 209.45/209.61  |- mesh__dateRevised mesh__D004156 2004-07-07
% 209.45/209.61  |- skos__hiddenLabel mesh__D004156 Oxidases, Diphenol
% 209.45/209.61  |- mesh__recordAuthorizer mesh__D004156 sjn
% 209.45/209.61  |- mesh__dateCreated mesh__D004156 1999-01-01
% 209.45/209.61  |- mesh__recordMaintainer mesh__D004156 ssb
% 209.45/209.61  |- skos__broader mesh__D004156smesh__D006899
% 209.45/209.61  |- skos__prefLabel mesh__D004156 Catechol Oxidase
% 209.45/209.61  |- skos__hiddenLabel mesh__D004156 Oxidase, Polyphenol
% 209.45/209.61  |- skos__altLabel mesh__D004156 Diphenol Oxidase
% 209.45/209.61  |- skos__historyNote mesh__D004156 Oxidoreductases %28%1966-1967%29%
% 209.45/209.61  |- skos__hiddenLabel mesh__D004156 Oxidase, Diphenol
% 209.45/209.61  |- skos__altLabel mesh__D004156 Diphenol Oxidases
% 209.45/209.61  |- mesh__dateEstablished mesh__D004156 1968-01-01
% 209.45/209.61  |- rdf__type mesh__D004156sskos__Concept
% 209.45/209.61  |- mesh__publicMeSHNote mesh__D004156 92; was DIPHENOL OXIDASES 1968-91   
% 209.45/209.61  |- skos__scopeNote mesh__D004156
% 209.45/209.61       An enzyme of the oxidoreductase class that catalyzes the reaction between catechol and oxygen to yield benzoquinone and water. It is a complex of copper-containing proteins that acts also on a variety of substituted catechols. EC 1.10.3.1.%A%    
% 209.45/209.61  |- skos__hiddenLabel mesh__D004156 Oxidase, Catechol
% 209.45/209.61  |- skos__altLabel mesh__D004156 Polyphenol Oxidase
% 209.45/209.61  |- mesh__onlineNote mesh__D004156
% 209.45/209.61       use CATECHOL OXIDASE to search DIPHENOL OXIDASES 1968-91   
% 209.45/209.61  |- skos__historyNote mesh__D004156 Tyrosine Decarboxylase %28%1966-1967%29%
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D004156 2006
% 209.45/209.61  |- skos__hiddenLabel mesh__D014584 Virtual System
% 209.45/209.61  |- mesh__recordMaintainer mesh__D014584 jls
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D014584 2005
% 209.45/209.61  |- skos__annotation mesh__D014584 IM; no qualif   
% 209.45/209.61  |- skos__related mesh__D014584smesh__D049250
% 209.45/209.61  |- skos__scopeNote mesh__D014584
% 209.45/209.61       The portion of an interactive computer program that issues messages to and receives commands from a user.%A%    
% 209.45/209.61  |- skos__prefLabel mesh__D014584 User-Computer Interface
% 209.45/209.61  |- skos__hiddenLabel mesh__D014584 System, Virtual
% 209.45/209.61  |- skos__hiddenLabel mesh__D014584 User-Computer Interfaces
% 209.45/209.61  |- mesh__recordAuthorizer mesh__D014584 sjn
% 209.45/209.61  |- skos__hiddenLabel mesh__D014584 Systems, Virtual
% 209.45/209.61  |- mesh__recordOriginator mesh__D014584 EC
% 209.45/209.61  |- mesh__dateRevised mesh__D014584 2004-07-07
% 209.45/209.61  |- skos__hiddenLabel mesh__D014584 Interfaces, User Computer
% 209.45/209.61  |- mesh__publicMeSHNote mesh__D014584 91; was see under SOFTWARE 1987-90   
% 209.45/209.61  |- mesh__dateCreated mesh__D014584 1986-06-18
% 209.45/209.61  |- skos__broader mesh__D014584smesh__D012984
% 209.45/209.61  |- rdf__type mesh__D014584sskos__Concept
% 209.45/209.61  |- skos__hiddenLabel mesh__D014584 User Computer Interfaces
% 209.45/209.61  |- skos__hiddenLabel mesh__D014584 Interfaces, User-Computer
% 209.45/209.61  |- skos__altLabel mesh__D014584 Interface, User Computer
% 209.45/209.61  |- mesh__dateEstablished mesh__D014584 1991-01-01
% 209.45/209.61  |- mesh__historyNote mesh__D014584
% 209.45/209.61       91%28%87%29%; was see under SOFTWARE 1987-90   
% 209.45/209.61  |- skos__hiddenLabel mesh__D014584 Interface, User-Computer
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D014584 2006
% 209.45/209.61  |- skos__altLabel mesh__D014584 User Computer Interface
% 209.45/209.61  |- skos__broader mesh__D007461Q000031smesh__D007461
% 209.45/209.61  |- mesh__preferredCombination mesh__D007461Q000031smesh__D000085
% 209.45/209.61  |- rdf__type mesh__D007461Q000031smesh__CompoundConcept
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D008547 2001
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D008547 2004
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D008547 2005
% 209.45/209.61  |- mesh__dateCreated mesh__D008547 1999-01-01
% 209.45/209.61  |- skos__prefLabel mesh__D008547 Melanophores
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D008547 2000
% 209.45/209.61  |- mesh__historyNote mesh__D008547
% 209.45/209.61       78%28%75%29%; was see under CHROMATOPHORES 1963-77   
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D008547 2003
% 209.45/209.61  |- rdf__type mesh__D008547sskos__Concept
% 209.45/209.61  |- skos__historyNote mesh__D008547 Chromatophores %28%1966-1974%29%
% 209.45/209.61  |- mesh__onlineNote mesh__D008547 search CHROMATOPHORES 1966-74   
% 209.45/209.61  |- mesh__dateRevised mesh__D008547 1998-06-10
% 209.45/209.61  |- skos__broader mesh__D008547smesh__D002856
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D008547 1999
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D008547 2002
% 209.45/209.61  |- skos__hiddenLabel mesh__D008547 Melanophore
% 209.45/209.61  |- mesh__publicMeSHNote mesh__D008547
% 209.45/209.61       78; was see under CHROMATOPHORES 1963-77   
% 209.45/209.61  |- mesh__recordMaintainer mesh__D008547 NNS
% 209.45/209.61  |- mesh__recordOriginator mesh__D008547 NLM
% 209.45/209.61  |- mesh__recordAuthorizer mesh__D008547 SJN
% 209.45/209.61  |- skos__annotation mesh__D008547 do not confuse with MELANOCYTES   
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D008547 2006
% 209.45/209.61  |- mesh__dateEstablished mesh__D008547 1978-01-01
% 209.45/209.61  |- skos__scopeNote mesh__D008547
% 209.45/209.61       Chromatophores %28%large pigment cells of fish, amphibia, reptiles and many invertebrates%29% which contain melanin. Short term color changes are brought about by an active redistribution of the melanophores pigment containing organelles %28%MELANOSOMES%29%. Mammals do not have melanophores; however they have retained smaller pigment cells known as MELANOCYTES.%A%    
% 209.45/209.61  |- mesh__recordAuthorizer mesh__D000564 sjn
% 209.45/209.61  |- skos__scopeNote mesh__D000564
% 209.45/209.61       An immature epithelial tumor of the JAW originating from the epithelial rests of Malassez or from other epithelial remnants of the ENAMEL from the developmental period. It is a slowly growing tumor, usually benign, but displays a marked propensity for invasive growth.%A%    
% 209.45/209.61  |- mesh__dateEstablished mesh__D000564 1965-01-01
% 209.45/209.61  |- mesh__dateRevised mesh__D000564 2005-06-30
% 209.45/209.61  |- skos__related mesh__D000564smesh__D000565
% 209.45/209.61  |- skos__annotation mesh__D000564
% 209.45/209.61       benign or malignant; coordinate IM with probably JAW NEOPLASMS %28%IM%29% or precoordinated jaw/neoplasm term %28%IM%29%%A%  
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D000564 2006
% 209.45/209.61  |- rdf__type mesh__D000564sskos__Concept
% 209.45/209.61  |- mesh__publicMeSHNote mesh__D000564 1965; see ADAMANTINOMA 1963-1964   
% 209.45/209.61  |- mesh__recordOriginator mesh__D000564 NLM
% 209.45/209.61  |- skos__prefLabel mesh__D000564 Ameloblastoma
% 209.45/209.61  |- skos__broader mesh__D000564smesh__D009808
% 209.45/209.61  |- mesh__historyNote mesh__D000564 1965 %28%1963%29%   
% 209.45/209.61  |- skos__hiddenLabel mesh__D000564 Ameloblastomas
% 209.45/209.61  |- mesh__dateCreated mesh__D000564 1999-01-01
% 209.45/209.61  |- mesh__recordMaintainer mesh__D000564 ags
% 209.45/209.61  |- skos__scopeNote mesh__D027701
% 209.45/209.61       A family of proteins involved in the transport of organic cations. They play an important role in the elimination of a variety of endogenous substances, xenobiotics, and their metabolites from the body.%A%    
% 209.45/209.61  |- mesh__dateRevised mesh__D027701 2005-06-30
% 209.45/209.61  |- mesh__dateEstablished mesh__D027701 2002-01-01
% 209.45/209.61  |- mesh__historyNote mesh__D027701 2002   
% 209.45/209.61  |- mesh__recordOriginator mesh__D027701 jmp
% 209.45/209.61  |- skos__broader mesh__D027701smesh__D027682
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D027701 2006
% 209.45/209.61  |- mesh__recordAuthorizer mesh__D027701 sjn
% 209.45/209.61  |- mesh__dateCreated mesh__D027701 2001-07-25
% 209.45/209.61  |- mesh__recordMaintainer mesh__D027701 SYSTEM
% 209.45/209.61  |- skos__prefLabel mesh__D027701 Organic Cation Transport Proteins
% 209.45/209.61  |- mesh__publicMeSHNote mesh__D027701 2002   
% 209.45/209.61  |- rdf__type mesh__D027701sskos__Concept
% 209.45/209.61  |- skos__altLabel mesh__D027701 Membrane Transport-Proteins, Organic Cation
% 209.45/209.61  |- skos__historyNote mesh__D027701 Ion Pumps %28%1992-2001%29%
% 209.45/209.61  |- skos__broader mesh__D012701Q000819smesh__D012701
% 209.45/209.61  |- mesh__preferredCombination mesh__D012701Q000819smesh__D017366
% 209.45/209.61  |- rdf__type mesh__D012701Q000819smesh__CompoundConcept
% 209.45/209.61  |- skos__altLabel mesh__D018975 IGF-Binding Protein 5
% 209.45/209.61  |- skos__altLabel mesh__D018975 IGFBP-5
% 209.45/209.61  |- mesh__publicMeSHNote mesh__D018975
% 209.45/209.61       2005; see INSULIN-LIKE GROWTH-FACTOR-BINDING-PROTEIN-5 1996-2004; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-5 was indexed under CARRIER PROTEINS 1991-1995%A%  
% 209.45/209.61  |- mesh__dateEstablished mesh__D018975 1996-01-01
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018975 2005
% 209.45/209.61  |- mesh__recordOriginator mesh__D018975 TPW
% 209.45/209.61  |- mesh__recordMaintainer mesh__D018975 jmp
% 209.45/209.61  |- skos__hiddenLabel mesh__D018975
% 209.45/209.61       Insulin Like Growth Factor Binding Protein 5
% 209.45/209.61  |- skos__broader mesh__D018975smesh__D018969
% 209.45/209.61  |- mesh__dateCreated mesh__D018975 1995-06-16
% 209.45/209.61  |- skos__prefLabel mesh__D018975
% 209.45/209.61       Insulin-Like Growth Factor Binding Protein 5
% 209.45/209.61  |- mesh__dateRevised mesh__D018975 2004-07-07
% 209.45/209.61  |- skos__hiddenLabel mesh__D018975 IGF Binding Protein 5
% 209.45/209.61  |- mesh__historyNote mesh__D018975 2005%28%1991%29%   
% 209.45/209.61  |- skos__annotation mesh__D018975
% 209.45/209.61       /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X refs%A%  
% 209.45/209.61  |- mesh__recordAuthorizer mesh__D018975 sjn
% 209.45/209.61  |- skos__historyNote mesh__D018975 Carrier Proteins %28%1991-1995%29%
% 209.45/209.61  |- skos__scopeNote mesh__D018975
% 209.45/209.61       One of the six homologous soluble proteins that bind insulin-like growth factors %28%SOMATOMEDINS%29% and modulate their mitogenic and metabolic actions at the cellular level.%A%    
% 209.45/209.61  |- rdf__type mesh__D018975sskos__Concept
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018975 2006
% 209.45/209.61  |- skos__prefLabel mesh__D010992 Plethysmography, Impedance
% 209.45/209.61  |- skos__annotation mesh__D010992
% 209.45/209.61       NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; do not confuse X ref RHEOGRAPHY with %22%rheography%22% as a synonym for the study of flow dynamics of body %26% other fluids %28% = RHEOLOGY%29%; DF: PLETHYSMOGR IMPEDANCE%A%  
% 209.45/209.61  |- mesh__dateRevised mesh__D010992 1997-06-20
% 209.45/209.61  |- mesh__publicMeSHNote mesh__D010992 66   
% 209.45/209.61  |- skos__hiddenLabel mesh__D010992 Plethysmographies, Impedance
% 209.45/209.61  |- skos__altLabel mesh__D010992 Rheography
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010992 2004
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010992 2005
% 209.45/209.61  |- mesh__recordOriginator mesh__D010992 NLM
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010992 2001
% 209.45/209.61  |- skos__hiddenLabel mesh__D010992 Rheographies
% 209.45/209.61  |- skos__broader mesh__D010992smesh__D010991
% 209.45/209.61  |- mesh__dateEstablished mesh__D010992 1966-01-01
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010992 2003
% 209.45/209.61  |- mesh__historyNote mesh__D010992 66   
% 209.45/209.61  |- mesh__recordMaintainer mesh__D010992 PXP
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010992 2000
% 209.45/209.61  |- mesh__recordAuthorizer mesh__D010992 SJN
% 209.45/209.61  |- skos__scopeNote mesh__D010992
% 209.45/209.61       Recording changes in electrical impedance between electrodes placed on opposite sides of a part of the body, as a measure of volume changes in the path of the current. %28%Stedman, 25th ed%29%%A%    
% 209.45/209.61  |- skos__hiddenLabel mesh__D010992 Impedance Plethysmographies
% 209.45/209.61  |- rdf__type mesh__D010992sskos__Concept
% 209.45/209.61  |- skos__altLabel mesh__D010992 Impedance Plethysmography
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010992 2002
% 209.45/209.61  |- mesh__dateCreated mesh__D010992 1999-01-01
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010992 1999
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010992 2006
% 209.45/209.61  |- skos__broader mesh__D010992smesh__D004568
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010992 1998
% 209.45/209.61  |- skos__hiddenLabel mesh__D018177 Flavivirus Infection
% 209.45/209.61  |- mesh__historyNote mesh__D018177 94   
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018177 1997
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018177 2004
% 209.45/209.61  |- skos__annotation mesh__D018177
% 209.45/209.61       caused by members of the Flavivirus genus: do not confuse with FLAVIVIRIDAE INFECTIONS caused by members of the Flaviviridae family; GEN or unspecified; prefer specifics%A%  
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018177 2002
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018177 1996
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018177 2003
% 209.45/209.61  |- mesh__dateCreated mesh__D018177 1993-06-04
% 209.45/209.61  |- mesh__publicMeSHNote mesh__D018177 94   
% 209.45/209.61  |- mesh__dateEstablished mesh__D018177 1994-01-01
% 209.45/209.61  |- skos__prefLabel mesh__D018177 Flavivirus Infections
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018177 1999
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018177 2006
% 209.45/209.61  |- skos__scopeNote mesh__D018177
% 209.45/209.61       Infections with viruses of the genus FLAVIVIRUS, family FLAVIVIRIDAE.%A%    
% 209.45/209.61  |- rdf__type mesh__D018177sskos__Concept
% 209.45/209.61  |- skos__altLabel mesh__D018177 Infections, Flavivirus
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018177 1995
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018177 2001
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018177 1998
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018177 2005
% 209.45/209.61  |- skos__broader mesh__D018177smesh__D018178
% 209.45/209.61  |- skos__hiddenLabel mesh__D018177 Infection, Flavivirus
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018177 2000
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D018177 1994
% 209.45/209.61  |- mesh__publicMeSHNote mesh__D010194
% 209.45/209.61       67; was see PANCREATIC EXTRACTS 1963-66   
% 209.45/209.61  |- mesh__recordMaintainer mesh__D010194 ssb
% 209.45/209.61  |- mesh__activeMeSHYear mesh__D010194 2006
% 209.45/209.61  |- mesh__historyNote mesh__D010194
% 209.45/209.61       67%28%64%29%; was see PANCREATIC EXTRACTS 1963-66   
% 209.45/209.61  |- mesh__dateEstablished mesh__D010194 1967-01-01
% 209.45/209.61  |- mesh__recordAuthorizer mesh__D010194 sjn
% 209.45/209.61  |- rdf__type mesh__D010194sskos__Concept
% 209.45/209.61  |- mesh__dateRevised mesh__D010194 2005-06-30
% 209.45/209.61  |- skos__broader mesh__D010194smesh__D006867
% 209.45/209.62  |- mesh__recordOriginator mesh__D010194 NLM
% 209.45/209.62  |- mesh__dateCreated mesh__D010194 1999-01-01
% 209.45/209.62  |- skos__prefLabel mesh__D010194 Pancreatin
% 209.45/209.62  |- skos__scopeNote mesh__D010194
% 209.45/209.62       A mammalian pancreatic extract composed of enzymes with protease, amylase and lipase activities. It is used as a digestant in pancreatic malfunction.%A%    
% 209.45/209.62  |- skos__broader mesh__D010194smesh__D010184
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004955 2002
% 209.45/209.62  |- skos__broader mesh__D004955smesh__D003813
% 209.45/209.62  |- mesh__publicMeSHNote mesh__D004955 65   
% 209.45/209.62  |- mesh__historyNote mesh__D004955 65   
% 209.45/209.62  |- rdf__type mesh__D004955sskos__Concept
% 209.45/209.62  |- skos__hiddenLabel mesh__D004955 Cosmetic Dentistries
% 209.45/209.62  |- skos__hiddenLabel mesh__D004955 Dentistry, Cosmetic
% 209.45/209.62  |- mesh__dateEstablished mesh__D004955 1965-01-01
% 209.45/209.62  |- skos__scopeNote mesh__D004955
% 209.45/209.62       Skills, techniques, standards, and principles used to improve the art and symmetry of the teeth and face to improve the appearance as well as the function of the teeth, mouth, and face. %28%From Boucher%27%s Clinical Dental Terminology, 4th ed, p108%29%%A%    
% 209.45/209.62  |- skos__altLabel mesh__D004955 Cosmetic Dentistry
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004955 2003
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004955 2004
% 209.45/209.62  |- mesh__dateRevised mesh__D004955 1999-11-03
% 209.45/209.62  |- skos__altLabel mesh__D004955 Dental Esthetics
% 209.45/209.62  |- skos__annotation mesh__D004955
% 209.45/209.62       includes teeth, mouth or face; DF: ESTHETICS DENT   
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004955 2000
% 209.45/209.62  |- skos__altLabel mesh__D004955 Aesthetics, Dental
% 209.45/209.62  |- skos__prefLabel mesh__D004955 Esthetics, Dental
% 209.45/209.62  |- skos__hiddenLabel mesh__D004955 Dentistries, Cosmetic
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004955 2005
% 209.45/209.62  |- mesh__recordMaintainer mesh__D004955 jls
% 209.45/209.62  |- mesh__recordOriginator mesh__D004955 NLM
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004955 2001
% 209.45/209.62  |- skos__altLabel mesh__D004955 Dental Esthetic
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004955 2006
% 209.45/209.62  |- mesh__dateCreated mesh__D004955 1999-01-01
% 209.45/209.62  |- mesh__recordAuthorizer mesh__D004955 sjn
% 209.45/209.62  |- skos__altLabel mesh__D004955 Esthetic, Dental
% 209.45/209.62  |- mesh__publicMeSHNote mesh__D004157
% 209.45/209.62       91; was see under ISONIPECOTIC ACIDS 1975-90   
% 209.45/209.62  |- skos__hiddenLabel mesh__D004157 Monohydrochloride, Diphenoxylate
% 209.45/209.62  |- skos__historyNote mesh__D004157 Isonipecotic Acids %28%1970-1974%29%
% 209.45/209.62  |- skos__prefLabel mesh__D004157 Diphenoxylate
% 209.45/209.62  |- mesh__dateRevised mesh__D004157 2005-06-30
% 209.45/209.62  |- skos__broader mesh__D004157smesh__D007540
% 209.45/209.62  |- rdf__type mesh__D004157sskos__Concept
% 209.45/209.62  |- skos__historyNote mesh__D004157 Nitriles %28%1974%29%
% 209.45/209.62  |- skos__scopeNote mesh__D004157
% 209.45/209.62       A MEPERIDINE congener used as an antidiarrheal, usually in combination with atropine. At high doses, it acts like morphine. Its unesterified metabolite difenoxin has similar properties and is used similarly. It has little or no analgesic activity.%A%    
% 209.45/209.62  |- mesh__dateCreated mesh__D004157 1974-11-11
% 209.45/209.62  |- mesh__recordOriginator mesh__D004157 NLM
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004157 2006
% 209.45/209.62  |- skos__hiddenLabel mesh__D004157 Hydrochloride, Diphenoxylate
% 209.45/209.62  |- mesh__recordAuthorizer mesh__D004157 sjn
% 209.45/209.62  |- mesh__historyNote mesh__D004157
% 209.45/209.62       91%28%75%29%; was see under ISONIPECOTIC ACIDS 1975-90   
% 209.45/209.62  |- mesh__dateEstablished mesh__D004157 1991-01-01
% 209.45/209.62  |- mesh__recordMaintainer mesh__D004157 exl
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D009640 2006
% 209.45/209.62  |- skos__hiddenLabel mesh__D009640 Nor QD
% 209.45/209.62  |- skos__altLabel mesh__D009640 Norethisterone
% 209.45/209.62  |- mesh__recordMaintainer mesh__D009640 lkt
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D009640 2005
% 209.45/209.62  |- skos__hiddenLabel mesh__D009640 NorQD
% 209.45/209.62  |- mesh__dateCreated mesh__D009640 1999-01-01
% 209.45/209.62  |- rdf__type mesh__D009640sskos__Concept
% 209.45/209.62  |- skos__scopeNote mesh__D009640
% 209.45/209.62       A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for contraception.%A%    
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D009640 2004
% 209.45/209.62  |- mesh__recordOriginator mesh__D009640 NLM
% 209.45/209.62  |- mesh__dateRevised mesh__D009640 2003-07-09
% 209.45/209.62  |- skos__broader mesh__D009640smesh__D009652
% 209.45/209.62  |- skos__altLabel mesh__D009640 Norpregneninolone
% 209.45/209.62  |- skos__prefLabel mesh__D009640 Norethindrone
% 209.45/209.62  |- mesh__recordAuthorizer mesh__D009640 sjn
% 209.45/209.62  |- skos__altLabel mesh__D009640 Ethinylnortestosterone
% 209.45/209.62  |- mesh__recordOriginator mesh__D008548 NLM
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D008548 2003
% 209.45/209.62  |- rdf__type mesh__D008548sskos__Concept
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D008548 2001
% 209.45/209.62  |- skos__broader mesh__D008548smesh__D017495
% 209.45/209.62  |- skos__annotation mesh__D008548
% 209.45/209.62       for neurocutaneous melanosis, coord with NEUROCUTANEOUS SYNDROMES%A%  
% 209.45/209.62  |- mesh__recordMaintainer mesh__D008548 KEV
% 209.45/209.62  |- skos__hiddenLabel mesh__D008548 Chloasmas
% 209.45/209.62  |- skos__hiddenLabel mesh__D008548 Freckle
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D008548 2000
% 209.45/209.62  |- skos__scopeNote mesh__D008548
% 209.45/209.62       Disorders of increased melanin pigmentation that develop without preceding inflammatory disease.%A%    
% 209.45/209.62  |- mesh__publicMeSHNote mesh__D008548 FRECKLES was see LENTIGO 1963-79   
% 209.45/209.62  |- mesh__historyNote mesh__D008548 FRECKLES was see LENTIGO 1963-79   
% 209.45/209.62  |- skos__hiddenLabel mesh__D008548 Melanoses
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D008548 2006
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D008548 2002
% 209.45/209.62  |- skos__altLabel mesh__D008548 Melanism
% 209.45/209.62  |- mesh__dateRevised mesh__D008548 1999-11-03
% 209.45/209.62  |- skos__prefLabel mesh__D008548 Melanosis
% 209.45/209.62  |- mesh__recordAuthorizer mesh__D008548 sjn
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D008548 2004
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D008548 2005
% 209.45/209.62  |- mesh__dateCreated mesh__D008548 1999-01-01
% 209.45/209.62  |- mesh__onlineNote mesh__D008548 use LENTIGO to search FRECKLES 1966-79   
% 209.45/209.62  |- skos__hiddenLabel mesh__D008548 Melasmas
% 209.45/209.62  |- skos__altLabel mesh__D008548 Melasma
% 209.45/209.62  |- mesh__dateEstablished mesh__D000565 1965-01-01
% 209.45/209.62  |- mesh__publicMeSHNote mesh__D000565 65   
% 209.45/209.62  |- mesh__dateRevised mesh__D000565 2005-06-30
% 209.45/209.62  |- skos__scopeNote mesh__D000565
% 209.45/209.62       Cylindrical epithelial cells in the innermost layer of the ENAMEL ORGAN. Their functions include contribution to the development of the dentinoenamel junction by the deposition of a layer of the matrix, thus producing the foundation for the prisms %28%the structural units of the DENTAL ENAMEL%29%, and production of the matrix for the enamel prisms and interprismatic substance. %28%From Jablonski%27%s Dictionary of Dentistry, 1992%29%%A%    
% 209.45/209.62  |- skos__broader mesh__D000565smesh__D004847
% 209.45/209.62  |- rdf__type mesh__D000565sskos__Concept
% 209.45/209.62  |- mesh__historyNote mesh__D000565 65   
% 209.45/209.62  |- skos__hiddenLabel mesh__D000565 Ameloblast
% 209.45/209.62  |- skos__related mesh__D000565smesh__D000564
% 209.45/209.62  |- mesh__recordOriginator mesh__D000565 NLM
% 209.45/209.62  |- mesh__dateCreated mesh__D000565 1999-01-01
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D000565 2006
% 209.45/209.62  |- mesh__recordAuthorizer mesh__D000565 sjn
% 209.45/209.62  |- skos__prefLabel mesh__D000565 Ameloblasts
% 209.45/209.62  |- mesh__recordMaintainer mesh__D000565 ags
% 209.45/209.62  |- mesh__dateRevised mesh__D019270 2004-07-27
% 209.45/209.62  |- skos__altLabel mesh__D019270 D-Isoglucosamine
% 209.45/209.62  |- skos__scopeNote mesh__D019270
% 209.45/209.62       An amino sugar formed when glucose non-enzymatically reacts with the N-terminal amino group of proteins. The fructose moiety is derived from glucose by the %22%classical%22% Amadori rearrangement.%A%    
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D019270 2005
% 209.45/209.62  |- mesh__onlineNote mesh__D019270
% 209.45/209.62       use FRUCTOSAMINE %28%NM%29% to search FRUCTOSAMINE 1983-96   
% 209.45/209.62  |- mesh__recordMaintainer mesh__D019270 jls
% 209.45/209.62  |- mesh__dateCreated mesh__D019270 1996-06-10
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D019270 2005A
% 209.45/209.62  |- mesh__recordAuthorizer mesh__D019270 jls
% 209.45/209.62  |- mesh__publicMeSHNote mesh__D019270
% 209.45/209.62       97; FRUCTOSAMINE was indexed under HEXOSAMINES 1983-96   
% 209.45/209.62  |- skos__historyNote mesh__D019270 Hexosamines %28%1983-1996%29%
% 209.45/209.62  |- skos__hiddenLabel mesh__D019270 D Isoglucosamine
% 209.45/209.62  |- mesh__historyNote mesh__D019270
% 209.45/209.62       97; was FRUCTOSAMINE %28%NM%29% 1983-96   
% 209.45/209.62  |- mesh__dateEstablished mesh__D019270 1997-01-01
% 209.45/209.62  |- skos__broader mesh__D019270smesh__D006595
% 209.45/209.62  |- mesh__recordOriginator mesh__D019270 TPW
% 209.45/209.62  |- rdf__type mesh__D019270sskos__Concept
% 209.45/209.62  |- skos__prefLabel mesh__D019270 Fructosamine
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D019270 2006
% 209.45/209.62  |- skos__broader mesh__D027702smesh__D027701
% 209.45/209.62  |- mesh__historyNote mesh__D027702
% 209.45/209.62       2002; use ORGANIC CATION TRANSPORTER 1 %28%NM%29% 1995-2001   
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D027702 2003
% 209.45/209.62  |- skos__hiddenLabel mesh__D027702 Protein, OCT1 Transport
% 209.45/209.62  |- skos__altLabel mesh__D027702 OCT1 Protein
% 209.45/209.62  |- mesh__dateEstablished mesh__D027702 2002-01-01
% 209.45/209.62  |- skos__altLabel mesh__D027702
% 209.45/209.62       Solute Carrier Family 22 %28%Organic Cation Transporter%29%, Member 1
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D027702 2004
% 209.45/209.62  |- skos__hiddenLabel mesh__D027702 Transport Protein, OCT1
% 209.45/209.62  |- skos__historyNote mesh__D027702 Membrane Proteins %28%1995-2001%29%
% 209.45/209.62  |- mesh__publicMeSHNote mesh__D027702
% 209.45/209.62       2002; OCT1 PROTEIN now ORGANIC CATION TRANSPORTER 1 was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1995-2001%A%  
% 209.45/209.62  |- mesh__recordOriginator mesh__D027702 jmp
% 209.45/209.62  |- skos__hiddenLabel mesh__D027702 Transporter, SLC22A1
% 209.45/209.62  |- mesh__recordAuthorizer mesh__D027702 sjn
% 209.45/209.62  |- mesh__recordMaintainer mesh__D027702 jmp
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D027702 2002
% 209.45/209.62  |- skos__altLabel mesh__D027702 OCT1 Transport Protein
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D027702 2005
% 209.45/209.62  |- skos__prefLabel mesh__D027702 Organic Cation Transporter 1
% 209.45/209.62  |- skos__scopeNote mesh__D027702
% 209.45/209.62       An organic cation transporter found in kidney. It is localized to the basal lateral membrane and is likely to be involved in the renal secretion of organic cations.%A%    
% 209.45/209.62  |- mesh__dateCreated mesh__D027702 2001-07-25
% 209.45/209.62  |- skos__altLabel mesh__D027702 SLC22A1 Transporter
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D027702 2006
% 209.45/209.62  |- rdf__type mesh__D027702sskos__Concept
% 209.45/209.62  |- skos__historyNote mesh__D027702 Carrier Proteins %28%1995-2001%29%
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D005250 2006
% 209.45/209.62  |- mesh__recordMaintainer mesh__D005250 kle
% 209.45/209.62  |- mesh__recordAuthorizer mesh__D005250 sjn
% 209.45/209.62  |- skos__altLabel mesh__D005250 Dental Fees
% 209.45/209.62  |- mesh__dateCreated mesh__D005250 1999-01-01
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D005250 2002
% 209.45/209.62  |- mesh__publicMeSHNote mesh__D005250 68   
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D005250 2005
% 209.45/209.62  |- mesh__recordOriginator mesh__D005250 NLM
% 209.45/209.62  |- skos__annotation mesh__D005250 DF: FEES DENT   
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D005250 2001
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D005250 2004
% 209.45/209.62  |- skos__broader mesh__D005250smesh__D005249
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D005250 2000
% 209.45/209.62  |- skos__broader mesh__D005250smesh__D004468
% 209.45/209.62  |- skos__historyNote mesh__D005250 Economics, Dental %28%1966-1967%29%
% 209.45/209.62  |- mesh__dateEstablished mesh__D005250 1968-01-01
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D005250 2003
% 209.45/209.62  |- rdf__type mesh__D005250sskos__Concept
% 209.45/209.62  |- skos__altLabel mesh__D005250 Dental Fee
% 209.45/209.62  |- skos__scopeNote mesh__D005250
% 209.45/209.62       Amounts charged to the patient as payer for dental services.%A%    
% 209.45/209.62  |- skos__altLabel mesh__D005250 Fee, Dental
% 209.45/209.62  |- mesh__historyNote mesh__D005250 68   
% 209.45/209.62  |- mesh__dateRevised mesh__D005250 1999-11-03
% 209.45/209.62  |- skos__prefLabel mesh__D005250 Fees, Dental
% 209.45/209.62  |- skos__hiddenLabel mesh__D018976
% 209.45/209.62       Insulin Like Growth Factor Binding Protein 6
% 209.45/209.62  |- skos__hiddenLabel mesh__D018976 IGF Binding Protein 6
% 209.45/209.62  |- skos__altLabel mesh__D018976 IGF-Binding Protein 6
% 209.45/209.62  |- mesh__recordMaintainer mesh__D018976 jmp
% 209.45/209.62  |- mesh__recordAuthorizer mesh__D018976 sjn
% 209.45/209.62  |- skos__altLabel mesh__D018976 IGFBP-6
% 209.45/209.62  |- mesh__dateCreated mesh__D018976 1995-06-16
% 209.45/209.62  |- mesh__dateRevised mesh__D018976 2004-07-07
% 209.45/209.62  |- mesh__dateEstablished mesh__D018976 1996-01-01
% 209.45/209.62  |- skos__annotation mesh__D018976
% 209.45/209.62       /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X refs%A%  
% 209.45/209.62  |- mesh__recordOriginator mesh__D018976 TPW
% 209.45/209.62  |- mesh__historyNote mesh__D018976 2005%28%1992%29%   
% 209.45/209.62  |- rdf__type mesh__D018976sskos__Concept
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D018976 2006
% 209.45/209.62  |- skos__historyNote mesh__D018976 Carrier Proteins %28%1992-1995%29%
% 209.45/209.62  |- skos__scopeNote mesh__D018976
% 209.45/209.62       One of the six homologous soluble proteins that bind insulin-like growth factors %28%SOMATOMEDINS%29% and modulate their mitogenic and metabolic actions at the cellular level.%A%    
% 209.45/209.62  |- skos__prefLabel mesh__D018976
% 209.45/209.62       Insulin-Like Growth Factor Binding Protein 6
% 209.45/209.62  |- mesh__publicMeSHNote mesh__D018976
% 209.45/209.62       2005; see INSULIN-LIKE-GROWTH-FACTOR-BINDING PROTEIN 6 1996-2004; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6 was indexed under CARRIER PROTEINS 1992-1995%A%  
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D018976 2005
% 209.45/209.62  |- skos__broader mesh__D018976smesh__D018969
% 209.45/209.62  |- mesh__recordOriginator mesh__D010993 NLM
% 209.45/209.62  |- skos__annotation mesh__D010993
% 209.45/209.62       used in resp funct tests; do not use /util except by MeSH definition; DF: PLETHYSMOGR WHOLE BODY%A%  
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D010993 2006
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D010993 2001
% 209.45/209.62  |- skos__hiddenLabel mesh__D010993 Plethysmographies, Whole Body
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D010993 2004
% 209.45/209.62  |- skos__scopeNote mesh__D010993
% 209.45/209.62       Measurement of the volume of gas in the lungs, including that which is trapped in poorly communicating air spaces. It is of particular use in chronic obstructive pulmonary disease and emphysema. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D010993 2005
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D010993 2000
% 209.45/209.62  |- skos__hiddenLabel mesh__D010993 Whole Body Plethysmographies
% 209.45/209.62  |- skos__prefLabel mesh__D010993 Plethysmography, Whole Body
% 209.45/209.62  |- mesh__recordAuthorizer mesh__D010993 SJN
% 209.45/209.62  |- skos__broader mesh__D010993smesh__D010991
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D010993 2003
% 209.45/209.62  |- skos__hiddenLabel mesh__D010993 Body Plethysmography, Whole
% 209.45/209.62  |- skos__hiddenLabel mesh__D010993 Body Plethysmographies, Whole
% 209.45/209.62  |- mesh__historyNote mesh__D010993 73%28%71%29%   
% 209.45/209.62  |- skos__historyNote mesh__D010993 Plethysmography %28%1966-1970%29%
% 209.45/209.62  |- mesh__recordMaintainer mesh__D010993 PXP
% 209.45/209.62  |- mesh__dateEstablished mesh__D010993 1973-01-01
% 209.45/209.62  |- skos__historyNote mesh__D010993
% 209.45/209.62       Respiratory Function Tests %28%1966-1970%29%
% 209.45/209.62  |- mesh__dateCreated mesh__D010993 1999-01-01
% 209.45/209.62  |- rdf__type mesh__D010993sskos__Concept
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D010993 2002
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D010993 1999
% 209.45/209.62  |- mesh__publicMeSHNote mesh__D010993 73   
% 209.45/209.62  |- skos__altLabel mesh__D010993 Whole Body Plethysmography
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D010993 1998
% 209.45/209.62  |- mesh__dateRevised mesh__D010993 1997-06-20
% 209.45/209.62  |- skos__broader mesh__D010993smesh__D012129
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D018178 2003
% 209.45/209.62  |- skos__hiddenLabel mesh__D018178 Flaviviridae Infection
% 209.45/209.62  |- mesh__historyNote mesh__D018178 94   
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D018178 2004
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D018178 1997
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D018178 2001
% 209.45/209.62  |- skos__annotation mesh__D018178
% 209.45/209.62       caused by members of the Flaviviridae family: do not confuse with FLAVIVIRUS INFECTIONS caused by members of the Flavivirus genus; GEN or unspecified; prefer specifics%A%  
% 209.45/209.62  |- skos__prefLabel mesh__D018178 Flaviviridae Infections
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D018178 2002
% 209.45/209.62  |- skos__broader mesh__D018178smesh__D012327
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D018178 1998
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D018178 2005
% 209.45/209.62  |- mesh__dateCreated mesh__D018178 1993-06-04
% 209.45/209.62  |- skos__hiddenLabel mesh__D018178 Infection, Flaviviridae
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D018178 1994
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D018178 1999
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D018178 2006
% 209.45/209.62  |- rdf__type mesh__D018178sskos__Concept
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D018178 1995
% 209.45/209.62  |- mesh__dateEstablished mesh__D018178 1994-01-01
% 209.45/209.62  |- skos__scopeNote mesh__D018178
% 209.45/209.62       Infections with viruses of the family FLAVIVIRIDAE.     
% 209.45/209.62  |- skos__altLabel mesh__D018178 Infections, Flaviviridae
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D018178 2000
% 209.45/209.62  |- mesh__publicMeSHNote mesh__D018178 94   
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D018178 1996
% 209.45/209.62  |- skos__prefLabel mesh__D010195 Pancreatitis
% 209.45/209.62  |- skos__broader mesh__D010195smesh__D010182
% 209.45/209.62  |- skos__hiddenLabel mesh__D010195 Pancreatitides
% 209.45/209.62  |- mesh__recordMaintainer mesh__D010195 lkt
% 209.45/209.62  |- rdf__type mesh__D010195sskos__Concept
% 209.45/209.62  |- skos__scopeNote mesh__D010195
% 209.45/209.62       INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS %28%International Symposium on Acute Pancreatitis, Atlanta, 1992%29%. The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis.%A%    
% 209.45/209.62  |- mesh__dateCreated mesh__D010195 1999-01-01
% 209.45/209.62  |- mesh__recordAuthorizer mesh__D010195 sjn
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D010195 2006
% 209.45/209.62  |- mesh__dateRevised mesh__D010195 2005-06-30
% 209.45/209.62  |- mesh__recordOriginator mesh__D010195 NLM
% 209.45/209.62  |- skos__annotation mesh__D004956
% 209.45/209.62       animal only; a natural physiol process; summer dormancy corresponding to HIBERNATION, winter dormancy%A%  
% 209.45/209.62  |- mesh__publicMeSHNote mesh__D004956
% 209.45/209.62       91; was see under ADAPTATION, PHYSIOLOGICAL 1966-90   
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004956 2006
% 209.45/209.62  |- mesh__recordOriginator mesh__D004956 NLM
% 209.45/209.62  |- skos__broader mesh__D004956smesh__D000222
% 209.45/209.62  |- rdf__type mesh__D004956sskos__Concept
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004956 2005
% 209.45/209.62  |- mesh__recordAuthorizer mesh__D004956 sjn
% 209.45/209.62  |- mesh__dateEstablished mesh__D004956 1991-01-01
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004956 2004
% 209.45/209.62  |- mesh__dateRevised mesh__D004956 2003-07-09
% 209.45/209.62  |- mesh__recordMaintainer mesh__D004956 lkt
% 209.45/209.62  |- mesh__historyNote mesh__D004956
% 209.45/209.62       91%28%66%29%; was see under ADAPTATION, PHYSIOLOGICAL 1966-90   
% 209.45/209.62  |- mesh__dateCreated mesh__D004956 1999-01-01
% 209.45/209.62  |- skos__scopeNote mesh__D004956
% 209.45/209.62       In certain living species, a period of dormancy during the summer months marked by decreased metabolism.%A%    
% 209.45/209.62  |- skos__prefLabel mesh__D004956 Estivation
% 209.45/209.62  |- skos__hiddenLabel mesh__D004158 Acids, Diphenylacetic
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004158 2001
% 209.45/209.62  |- rdf__type mesh__D004158sskos__Concept
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004158 1993
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004158 1994
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004158 2000
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004158 2006
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004158 1999
% 209.45/209.62  |- mesh__recordAuthorizer mesh__D004158 PLS
% 209.45/209.62  |- mesh__dateRevised mesh__D004158 1992-05-13
% 209.45/209.62  |- mesh__recordMaintainer mesh__D004158 TGC
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004158 2004
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004158 1997
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004158 2005
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004158 1998
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004158 2002
% 209.45/209.62  |- mesh__historyNote mesh__D004158 68   
% 209.45/209.62  |- skos__prefLabel mesh__D004158 Diphenylacetic Acids
% 209.45/209.62  |- mesh__dateCreated mesh__D004158 1999-01-01
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004158 2003
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004158 1996
% 209.45/209.62  |- mesh__recordOriginator mesh__D004158 NLM
% 209.45/209.62  |- skos__broader mesh__D004158smesh__D010648
% 209.45/209.62  |- mesh__publicMeSHNote mesh__D004158 68   
% 209.45/209.62  |- mesh__dateEstablished mesh__D004158 1968-01-01
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D004158 1995
% 209.45/209.62  |- skos__broader mesh__D009641smesh__D009652
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D009641 2006
% 209.45/209.62  |- mesh__recordAuthorizer mesh__D009641 sjn
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D009641 2005
% 209.45/209.62  |- rdf__type mesh__D009641sskos__Concept
% 209.45/209.62  |- skos__scopeNote mesh__D009641
% 209.45/209.62       A synthetic progestational hormone with actions and uses similar to those of PROGESTERONE. It has been used in the treatment of functional uterine bleeding and endometriosis. As a contraceptive, it has usually been administered in combination with MESTRANOL.%A%    
% 209.45/209.62  |- mesh__dateCreated mesh__D009641 1999-01-01
% 209.45/209.62  |- skos__prefLabel mesh__D009641 Norethynodrel
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D009641 2004
% 209.45/209.62  |- mesh__dateRevised mesh__D009641 2003-07-09
% 209.45/209.62  |- mesh__recordMaintainer mesh__D009641 lkt
% 209.45/209.62  |- mesh__recordOriginator mesh__D009641 NLM
% 209.45/209.62  |- mesh__dateCreated mesh__D014586 1999-01-01
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D014586 1994
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D014586 2000
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D014586 1999
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D014586 1993
% 209.45/209.62  |- mesh__recordMaintainer mesh__D014586 PLS
% 209.45/209.62  |- skos__altLabel mesh__D014586 Union of Soviet Socialist Republics
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D014586 1995
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D014586 2001
% 209.45/209.62  |- mesh__dateRevised mesh__D014586 1992-05-22
% 209.45/209.62  |- mesh__recordOriginator mesh__D014586 NLM
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D014586 2003
% 209.45/209.62  |- rdf__type mesh__D014586sskos__Concept
% 209.45/209.62  |- skos__broader mesh__D014586smesh__D017516
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D014586 2005
% 209.45/209.62  |- mesh__recordAuthorizer mesh__D014586 PLS
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D014586 2004
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D014586 2002
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D014586 2006
% 209.45/209.62  |- skos__annotation mesh__D014586
% 209.45/209.62       GEN; each former Soviet republic is available as a heading; MOSCOW is also available; note spelling: no periods%A%  
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D014586 1996
% 209.45/209.62  |- skos__altLabel mesh__D014586 Soviet Union
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D014586 1998
% 209.45/209.62  |- mesh__activeMeSHYear mesh__D014586 1997
% 209.45/209.62  |- skos__prefLabel mesh__D014586 USSR
% 209.48/209.62  |- mesh__publicMeSHNote mesh__D008549
% 209.48/209.62       91; was see under ARSENICALS 1975-90   
% 209.48/209.62  |- skos__historyNote mesh__D008549 Arsenicals %28%1968-1974%29%
% 209.48/209.62  |- mesh__recordMaintainer mesh__D008549 jmp
% 209.48/209.62  |- mesh__activeMeSHYear mesh__D008549 2002
% 209.48/209.62  |- skos__hiddenLabel mesh__D008549 B, Mel
% 209.48/209.62  |- skos__hiddenLabel mesh__D008549 MelarsenoxidBAL
% 209.48/209.62  |- mesh__recordAuthorizer mesh__D008549 sjn
% 209.48/209.62  |- mesh__dateCreated mesh__D008549 1974-11-19
% 209.48/209.62  |- mesh__activeMeSHYear mesh__D008549 2006
% 209.48/209.62  |- skos__broader mesh__D008549smesh__D001152
% 209.48/209.62  |- skos__historyNote mesh__D008549 Triazines %28%1968-1974%29%
% 209.48/209.62  |- mesh__recordOriginator mesh__D008549 NLM
% 209.48/209.62  |- skos__prefLabel mesh__D008549 Melarsoprol
% 209.48/209.62  |- mesh__dateRevised mesh__D008549 2000-06-21
% 209.48/209.62  |- mesh__activeMeSHYear mesh__D008549 2004
% 209.48/209.62  |- mesh__activeMeSHYear mesh__D008549 2005
% 209.48/209.62  |- mesh__activeMeSHYear mesh__D008549 2001
% 209.48/209.62  |- rdf__type mesh__D008549sskos__Concept
% 209.48/209.62  |- mesh__activeMeSHYear mesh__D008549 2003
% 209.48/209.62  |- skos__scopeNote mesh__D008549
% 209.48/209.62       Arsenical used in trypanosomiases. It may cause fatal encephalopathy and other undesirable side effects.%A%    
% 209.48/209.62  |- mesh__historyNote mesh__D008549
% 209.48/209.62       91%28%75%29%; was see under ARSENICALS 1975-90   
% 209.48/209.62  |- skos__hiddenLabel mesh__D008549 Melarsenoxid BAL
% 209.48/209.62  |- mesh__dateEstablished mesh__D008549 1991-01-01
% 209.48/209.62  |- skos__hiddenLabel mesh__D000566 Amelogeneses
% 209.48/209.62  |- mesh__recordOriginator mesh__D000566 NLM
% 209.48/209.62  |- rdf__type mesh__D000566sskos__Concept
% 209.48/209.62  |- mesh__historyNote mesh__D000566 65   
% 209.48/209.62  |- mesh__dateEstablished mesh__D000566 1965-01-01
% 209.48/209.62  |- mesh__recordAuthorizer mesh__D000566 sjn
% 209.48/209.62  |- mesh__dateCreated mesh__D000566 1999-01-01
% 209.48/209.62  |- mesh__activeMeSHYear mesh__D000566 2006
% 209.48/209.62  |- skos__prefLabel mesh__D000566 Amelogenesis
% 209.48/209.62  |- mesh__publicMeSHNote mesh__D000566 65   
% 209.48/209.62  |- mesh__activeMeSHYear mesh__D000566 2005
% 209.48/209.62  |- mesh__recordMaintainer mesh__D000566 lkt
% 209.48/209.62  |- skos__broader mesh__D000566smesh__D009805
% 209.48/209.62  |- mesh__dateRevised mesh__D000566 2004-07-07
% 209.48/209.62  |- skos__annotation mesh__D000566
% 209.48/209.62       formation of dent enamel; DENTINOGENESIS, formation of dentin, is also available%A%  
% 209.48/209.62  |- skos__scopeNote mesh__D000566
% 209.48/209.62       The elaboration of dental enamel by ameloblasts, beginning with its participation in the formation of the dentino-enamel junction to the production of the matrix for the enamel prisms and interprismatic substance. %28%Jablonski, Dictionary of Dentistry, 1992%29%%A%    
% 209.48/209.62  |- rdf__type mesh__D019271sskos__Concept
% 209.48/209.62  |- mesh__onlineNote mesh__D019271
% 209.48/209.62       use HYPOXANTHINE %28%NM%29% to search HYPOXANTHINE 1981-96   
% 209.48/209.62  |- skos__annotation mesh__D019271 do not confuse with HYPOXANTHINES   
% 209.48/209.62  |- skos__prefLabel mesh__D019271 Hypoxanthine
% 209.48/209.62  |- mesh__historyNote mesh__D019271
% 209.48/209.62       97; was HYPOXANTHINE %28%NM%29% 1981-96   
% 209.48/209.62  |- skos__broader mesh__D019271smesh__D007042
% 209.48/209.63  |- mesh__recordOriginator mesh__D019271 TPW
% 209.48/209.63  |- mesh__publicMeSHNote mesh__D019271
% 209.48/209.63       97; HYPOXANTHINE was indexed under HYPOXANTHINES 1981-96   
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D019271 2001
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D019271 2003
% 209.48/209.63  |- mesh__dateRevised mesh__D019271 2000-06-22
% 209.48/209.63  |- mesh__dateEstablished mesh__D019271 1997-01-01
% 209.48/209.63  |- mesh__recordMaintainer mesh__D019271 TWD
% 209.48/209.63  |- skos__historyNote mesh__D019271 Hypoxanthines %28%1981-1996%29%
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D019271 2005
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D019271 2004
% 209.48/209.63  |- mesh__dateCreated mesh__D019271 1996-06-10
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D019271 2002
% 209.48/209.63  |- skos__scopeNote mesh__D019271
% 209.48/209.63       A purine and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway.%A%    
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D019271 2006
% 209.48/209.63  |- mesh__recordAuthorizer mesh__D019271 sjn
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D027703 2004
% 209.48/209.63  |- skos__scopeNote mesh__D027703
% 209.48/209.63       A family of flowering plants in the order Caryophyllales, with about 60 genera and more than 800 species of plants, with a few shrubs, trees, and vines. The leaves usually have nonindented edges.%A%    
% 209.48/209.63  |- skos__prefLabel mesh__D027703 Amaranthaceae
% 209.48/209.63  |- mesh__recordMaintainer mesh__D027703 ssb
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D027703 2005
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D027703 2006
% 209.48/209.63  |- rdf__type mesh__D027703sskos__Concept
% 209.48/209.63  |- skos__annotation mesh__D027703
% 209.48/209.63       GEN or unspecified; prefer specifics;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.48/209.63  |- mesh__recordAuthorizer mesh__D027703 sjn
% 209.48/209.63  |- mesh__dateRevised mesh__D027703 2003-07-09
% 209.48/209.63  |- mesh__historyNote mesh__D027703 2002   
% 209.48/209.63  |- skos__broader mesh__D027703smesh__D019684
% 209.48/209.63  |- mesh__publicMeSHNote mesh__D027703 2002   
% 209.48/209.63  |- mesh__dateCreated mesh__D027703 2001-07-25
% 209.48/209.63  |- mesh__dateEstablished mesh__D027703 2002-01-01
% 209.48/209.63  |- mesh__recordOriginator mesh__D027703 ssb
% 209.48/209.63  |- skos__prefLabel mesh__D005251 Fees, Medical
% 209.48/209.63  |- mesh__publicMeSHNote mesh__D005251 68   
% 209.48/209.63  |- mesh__historyNote mesh__D005251 68   
% 209.48/209.63  |- mesh__dateRevised mesh__D005251 1999-11-03
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D005251 2005
% 209.48/209.63  |- skos__altLabel mesh__D005251 Medical Fee
% 209.48/209.63  |- skos__altLabel mesh__D005251 Medical Fees
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D005251 2004
% 209.48/209.63  |- skos__broader mesh__D005251smesh__D005249
% 209.48/209.63  |- mesh__recordMaintainer mesh__D005251 kle
% 209.48/209.63  |- mesh__recordAuthorizer mesh__D005251 sjn
% 209.48/209.63  |- skos__related mesh__D005251smesh__D015895
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D005251 2002
% 209.48/209.63  |- skos__altLabel mesh__D005251 Fee, Medical
% 209.48/209.63  |- mesh__dateEstablished mesh__D005251 1968-01-01
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D005251 2003
% 209.48/209.63  |- rdf__type mesh__D005251sskos__Concept
% 209.48/209.63  |- skos__scopeNote mesh__D005251
% 209.48/209.63       Amounts charged to the patient as payer for medical services.%A%    
% 209.48/209.63  |- mesh__recordOriginator mesh__D005251 NLM
% 209.48/209.63  |- skos__historyNote mesh__D005251 Economics, Medical %28%1966-1967%29%
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D005251 2001
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D005251 2000
% 209.48/209.63  |- skos__broader mesh__D005251smesh__D004470
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D005251 2006
% 209.48/209.63  |- mesh__dateCreated mesh__D005251 1999-01-01
% 209.48/209.63  |- skos__annotation mesh__D005251 DF: FEES MED   
% 209.48/209.63  |- mesh__onlineNote mesh__D018977
% 209.48/209.63       use TRACE ELEMENTS to search MICRONUTRIENTS 1994-95   
% 209.48/209.63  |- skos__historyNote mesh__D018977 Trace Elements %28%1966-1995%29%
% 209.48/209.63  |- mesh__recordMaintainer mesh__D018977 ssb
% 209.48/209.63  |- mesh__historyNote mesh__D018977 96; was see TRACE ELEMENTS 1994-95   
% 209.48/209.63  |- rdf__type mesh__D018977sskos__Concept
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D018977 2006
% 209.48/209.63  |- skos__hiddenLabel mesh__D018977 Micronutrient
% 209.48/209.63  |- mesh__recordAuthorizer mesh__D018977 sjn
% 209.48/209.63  |- skos__prefLabel mesh__D018977 Micronutrients
% 209.48/209.63  |- skos__annotation mesh__D018977
% 209.48/209.63       coord IM with specific micronutrient %28%IM%29%   
% 209.48/209.63  |- mesh__dateCreated mesh__D018977 1995-05-24
% 209.48/209.63  |- mesh__dateEstablished mesh__D018977 1996-01-01
% 209.48/209.63  |- skos__broader mesh__D018977smesh__D006133
% 209.48/209.63  |- skos__scopeNote mesh__D018977
% 209.48/209.63       Essential dietary elements or organic compounds that are required in only small quantities for normal physiologic processes to occur.%A%    
% 209.48/209.63  |- skos__related mesh__D018977smesh__D014131
% 209.48/209.63  |- mesh__recordOriginator mesh__D018977 TGC
% 209.48/209.63  |- mesh__dateRevised mesh__D018977 2005-06-30
% 209.48/209.63  |- mesh__publicMeSHNote mesh__D018977 96; was see TRACE ELEMENTS 1994-95   
% 209.48/209.63  |- skos__annotation mesh__D010994
% 209.48/209.63       /surg: consider also PNEUMONOLYSIS; inflammation = PLEURISY; PLEURAL CAVITY is also available%A%  
% 209.48/209.63  |- mesh__recordOriginator mesh__D010994 NLM
% 209.48/209.63  |- skos__broader mesh__D010994smesh__D012704
% 209.48/209.63  |- skos__broader mesh__D010994smesh__D012137
% 209.48/209.63  |- skos__hiddenLabel mesh__D010994 Pleura, Parietal
% 209.48/209.63  |- mesh__dateCreated mesh__D010994 1999-01-01
% 209.48/209.63  |- rdf__type mesh__D010994sskos__Concept
% 209.48/209.63  |- mesh__recordAuthorizer mesh__D010994 sjn
% 209.48/209.63  |- skos__prefLabel mesh__D010994 Pleura
% 209.48/209.63  |- skos__related mesh__D010994smesh__D011025
% 209.48/209.63  |- skos__scopeNote mesh__D010994
% 209.48/209.63       The thin serous membrane enveloping the lungs %28%LUNG%29% and lining the THORACIC CAVITY. Pleura consist of two layers, the inner visceral pleura lying next to the pulmonary parenchyma and the outer parietal pleura. Between the two layers is the PLEURAL CAVITY which contains a thin film of liquid.%A%    
% 209.48/209.63  |- mesh__recordMaintainer mesh__D010994 lkt
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D010994 2006
% 209.48/209.63  |- skos__hiddenLabel mesh__D010994 Pleura, Visceral
% 209.48/209.63  |- skos__related mesh__D010994smesh__D010998
% 209.48/209.63  |- mesh__dateRevised mesh__D010994 2005-06-30
% 209.48/209.63  |- skos__historyNote mesh__D043370 Nitrosomonas %28%1965-2003%29%
% 209.48/209.63  |- skos__prefLabel mesh__D043370 Nitrosomonas europaea
% 209.48/209.63  |- mesh__dateRevised mesh__D043370 2005-06-30
% 209.48/209.63  |- rdf__type mesh__D043370sskos__Concept
% 209.48/209.63  |- mesh__publicMeSHNote mesh__D043370 2004   
% 209.48/209.63  |- skos__broader mesh__D043370smesh__D009606
% 209.48/209.63  |- mesh__recordAuthorizer mesh__D043370 sjn
% 209.48/209.63  |- mesh__recordOriginator mesh__D043370 ags
% 209.48/209.63  |- mesh__recordMaintainer mesh__D043370 SYSTEM
% 209.48/209.63  |- mesh__historyNote mesh__D043370 2004   
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D043370 2006
% 209.48/209.63  |- mesh__dateCreated mesh__D043370 2003-07-09
% 209.48/209.63  |- mesh__dateEstablished mesh__D043370 2004-01-01
% 209.48/209.63  |- skos__scopeNote mesh__D043370
% 209.48/209.63       The type species of the genus NITROSOMONAS, a gram-negative chemolithotroph that oxidizes ammonia to nitrite. It is found in soil, sewage, freshwater, and on building walls, and especially in polluted areas where air contains high levels of nitrogen compounds.%A%    
% 209.48/209.63  |- skos__broader mesh__D018179smesh__D043562
% 209.48/209.63  |- skos__historyNote mesh__D018179 Proteins %28%2000-2003%29%
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D018179 2004
% 209.48/209.63  |- skos__historyNote mesh__D018179
% 209.48/209.63       Receptors, Cell Surface %28%1981-1993%29%
% 209.48/209.63  |- mesh__historyNote mesh__D018179
% 209.48/209.63       1994; use THROMBIN RECEPTOR %28%NM%29% 1981-1993; for TRAP PEPTIDE use RECEPTORS, THROMBIN %28%NM%29% 2000-2003%A%  
% 209.48/209.63  |- mesh__recordMaintainer mesh__D018179 jmp
% 209.48/209.63  |- mesh__dateRevised mesh__D018179 2003-07-09
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D018179 2005
% 209.48/209.63  |- skos__scopeNote mesh__D018179
% 209.48/209.63       A family of proteinase-activated receptors that are specific for THROMBIN. They are found primarily on PLATELETS and on ENDOTHELIAL CELLS.  Activation of thrombin receptors occurs through the proteolytic action of THROMBIN, which cleaves the N-terminal peptide from the receptor to reveal a new N-terminal peptide that is a cryptic ligand for the receptor. The receptors signal through HETEROTRIMERIC GTP-BINDING PROTEINS. Small synthetic peptides that contain the unmasked N-terminal peptide sequence can also activate the receptor in the absence of proteolytic activity.%A%    
% 209.48/209.63  |- skos__hiddenLabel mesh__D018179 Receptor, Thrombin
% 209.48/209.63  |- skos__broader mesh__D018179smesh__D010980
% 209.48/209.63  |- skos__hiddenLabel mesh__D018179 Peptide, TRAP
% 209.48/209.63  |- mesh__recordOriginator mesh__D018179 RAZ
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D018179 2006
% 209.48/209.63  |- mesh__dateCreated mesh__D018179 1993-06-30
% 209.48/209.63  |- skos__altLabel mesh__D018179 Thrombin Receptors
% 209.48/209.63  |- rdf__type mesh__D018179sskos__Concept
% 209.48/209.63  |- mesh__publicMeSHNote mesh__D018179
% 209.48/209.63       1994; THROMBIN RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-1993; TRAP PEPTIDE was indexed under PROTEINS 2000-2003%A%  
% 209.48/209.63  |- skos__altLabel mesh__D018179 Thrombin Receptor Activator Peptide
% 209.48/209.63  |- skos__prefLabel mesh__D018179 Receptors, Thrombin
% 209.48/209.63  |- skos__altLabel mesh__D018179 Thrombin Receptor Activating Peptide Ligand
% 209.48/209.63  |- skos__broader mesh__D018179smesh__D018000
% 209.48/209.63  |- mesh__recordAuthorizer mesh__D018179 sjn
% 209.48/209.63  |- skos__altLabel mesh__D018179 Thrombin Receptor
% 209.48/209.63  |- skos__altLabel mesh__D018179 TRAP Peptide
% 209.48/209.63  |- skos__broader mesh__D018179smesh__D044462
% 209.48/209.63  |- skos__annotation mesh__D018179 DF: RECEPT THROMBIN   
% 209.48/209.63  |- mesh__dateEstablished mesh__D018179 1994-01-01
% 209.48/209.63  |- rdf__type mesh__D010196sskos__Concept
% 209.48/209.63  |- mesh__publicMeSHNote mesh__D010196
% 209.48/209.63       2000; see PANCREATOPEPTIDASE 1965-1999; for PANCREATIC ELASTASE see PANCREATOPEPTIDASE 1991-1999%A%  
% 209.48/209.63  |- mesh__dateEstablished mesh__D010196 1965-01-01
% 209.48/209.63  |- mesh__recordAuthorizer mesh__D010196 sjn
% 209.48/209.63  |- mesh__dateCreated mesh__D010196 1999-01-01
% 209.48/209.63  |- skos__altLabel mesh__D010196 Pancreatopeptidase
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D010196 2005
% 209.48/209.63  |- skos__altLabel mesh__D010196 Pancreatic Elastase I
% 209.48/209.63  |- mesh__recordOriginator mesh__D010196 NLM
% 209.48/209.63  |- skos__altLabel mesh__D010196 Elastase
% 209.48/209.63  |- skos__prefLabel mesh__D010196 Pancreatic Elastase
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D010196 2004
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D010196 2006
% 209.48/209.63  |- skos__scopeNote mesh__D010196
% 209.48/209.63       A protease of broad specificity, obtained from dried pancreas. Molecular weight is approximately 25,000. The enzyme breaks down elastin, the specific protein of elastic fibers, and digests other proteins such as fibrin, hemoglobin, and albumin. EC 3.4.21.36.%A%    
% 209.48/209.63  |- mesh__recordMaintainer mesh__D010196 ssb
% 209.48/209.63  |- skos__hiddenLabel mesh__D010196 Elastase, Pancreatic
% 209.48/209.63  |- skos__broader mesh__D010196smesh__D012697
% 209.48/209.63  |- mesh__historyNote mesh__D010196 2000%28%1965%29%   
% 209.48/209.63  |- skos__hiddenLabel mesh__D010196 Elastase I, Pancreatic
% 209.48/209.63  |- mesh__dateRevised mesh__D010196 2003-07-09
% 209.48/209.63  |- skos__annotation mesh__D010196 LEUKOCYTE ELASTASE is also available   
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D004957 2002
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D004957 1997
% 209.48/209.63  |- rdf__type mesh__D004957sskos__Concept
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D004957 2005
% 209.48/209.63  |- skos__prefLabel mesh__D004957 Estonia
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D004957 2001
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D004957 1996
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D004957 2004
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D004957 2000
% 209.48/209.63  |- mesh__recordMaintainer mesh__D004957 PLS
% 209.48/209.63  |- mesh__recordOriginator mesh__D004957 NLM
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D004957 2003
% 209.48/209.63  |- mesh__dateCreated mesh__D004957 1999-01-01
% 209.48/209.63  |- skos__broader mesh__D004957smesh__D001454
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D004957 1995
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D004957 1999
% 209.48/209.63  |- mesh__dateRevised mesh__D004957 1994-03-17
% 209.48/209.63  |- mesh__recordAuthorizer mesh__D004957 PLS
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D004957 1998
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D004957 2006
% 209.48/209.63  |- skos__prefLabel mesh__D004159 Diphenylamine
% 209.48/209.63  |- rdf__type mesh__D004159sskos__Concept
% 209.48/209.63  |- skos__scopeNote mesh__D004159
% 209.48/209.63       In humans it may be irritating to mucous membranes. Methemoglobinemia has been produced experimentally. In veterinary use, it is one of active ingredients in topical agents for prevention and treatment of screwworm infestation. An indicator in tests for nitrate poisoning.%A%    
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D004159 2005
% 209.48/209.63  |- mesh__recordOriginator mesh__D004159 NLM
% 209.48/209.63  |- mesh__dateCreated mesh__D004159 1974-11-19
% 209.48/209.63  |- mesh__recordAuthorizer mesh__D004159 sjn
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D004159 2006
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D004159 2003
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D004159 2001
% 209.48/209.63  |- mesh__historyNote mesh__D004159
% 209.48/209.63       91%28%75%29%; was see under ANILINE COMPOUNDS 1975-90   
% 209.48/209.63  |- mesh__recordMaintainer mesh__D004159 CCR
% 209.48/209.63  |- mesh__dateRevised mesh__D004159 2000-06-22
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D004159 2004
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D004159 2002
% 209.48/209.63  |- skos__historyNote mesh__D004159 Aniline Compounds %28%1969-1974%29%
% 209.48/209.63  |- skos__broader mesh__D004159smesh__D000814
% 209.48/209.63  |- mesh__dateEstablished mesh__D004159 1991-01-01
% 209.48/209.63  |- mesh__publicMeSHNote mesh__D004159
% 209.48/209.63       91; was see under ANILINE COMPOUNDS 1975-90   
% 209.48/209.63  |- skos__broader mesh__D006412Q000637smesh__D006412
% 209.48/209.63  |- mesh__preferredCombination mesh__D006412Q000637smesh__D018380
% 209.48/209.63  |- rdf__type mesh__D006412Q000637smesh__CompoundConcept
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D009642 2001
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D009642 2004
% 209.48/209.63  |- skos__historyNote mesh__D009642 Hydrocarbons, Fluorinated %28%1974%29%
% 209.48/209.63  |- mesh__publicMeSHNote mesh__D009642
% 209.48/209.63       91; was see under FENFLURAMINE 1975-90   
% 209.48/209.63  |- skos__prefLabel mesh__D009642 Norfenfluramine
% 209.48/209.63  |- mesh__recordMaintainer mesh__D009642 CCR
% 209.48/209.63  |- skos__broader mesh__D009642smesh__D005277
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D009642 2003
% 209.48/209.63  |- mesh__recordOriginator mesh__D009642 NLM
% 209.48/209.63  |- skos__historyNote mesh__D009642 Phenethylamines %28%1973-1974%29%
% 209.48/209.63  |- mesh__dateCreated mesh__D009642 1974-11-19
% 209.48/209.63  |- mesh__recordAuthorizer mesh__D009642 sjn
% 209.48/209.63  |- mesh__dateEstablished mesh__D009642 1991-01-01
% 209.48/209.63  |- skos__scopeNote mesh__D009642
% 209.48/209.63       A FENFLURAMINE analog that inhibits serotonin uptake and may provoke release of serotonin. It is used as an appetite depressant and an experimental tool in animal studies.%A%    
% 209.48/209.63  |- mesh__dateRevised mesh__D009642 2000-06-22
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D009642 2006
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D009642 2002
% 209.48/209.63  |- mesh__historyNote mesh__D009642
% 209.48/209.63       91%28%75%29%; was see under FENFLURAMINE 1975-90   
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D009642 2005
% 209.48/209.63  |- rdf__type mesh__D009642sskos__Concept
% 209.48/209.63  |- mesh__historyNote mesh__D014587
% 209.48/209.63       91%28%75%29%; was see under BASIDIOMYCETES 1975-90   
% 209.48/209.63  |- mesh__recordAuthorizer mesh__D014587 sjn
% 209.48/209.63  |- rdf__type mesh__D014587sskos__Concept
% 209.48/209.63  |- skos__annotation mesh__D014587
% 209.48/209.63       an order of basidiomycetes; parasitic on POACEAE %26% corn   
% 209.48/209.63  |- mesh__onlineNote mesh__D014587 search BASIDIOMYCETES 1966-74   
% 209.48/209.63  |- skos__prefLabel mesh__D014587 Ustilaginales
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D014587 2006
% 209.48/209.63  |- mesh__recordMaintainer mesh__D014587 SYSTEM
% 209.48/209.63  |- mesh__recordOriginator mesh__D014587 NLM
% 209.48/209.63  |- skos__broader mesh__D014587smesh__D001487
% 209.48/209.63  |- mesh__publicMeSHNote mesh__D014587
% 209.48/209.63       91; was see under BASIDIOMYCETES 1975-90   
% 209.48/209.63  |- mesh__dateRevised mesh__D014587 2005-06-30
% 209.48/209.63  |- mesh__dateEstablished mesh__D014587 1991-01-01
% 209.48/209.63  |- mesh__dateCreated mesh__D014587 1999-01-01
% 209.48/209.63  |- skos__scopeNote mesh__D014587
% 209.48/209.63       An order of basidiomycetous fungi; some species are parasitic on grasses %28%POACEAE%29% and maize.%A%    
% 209.48/209.63  |- skos__hiddenLabel mesh__D033741 Transport Protein, ANT-1
% 209.48/209.63  |- skos__historyNote mesh__D033741
% 209.48/209.63       Adenine Nucleotide Translocase %28%1999-2002%29%
% 209.48/209.63  |- skos__prefLabel mesh__D033741 Adenine Nucleotide Translocator 1
% 209.48/209.63  |- mesh__publicMeSHNote mesh__D033741
% 209.48/209.63       2003; see ADENINE NUCLEOTIDE TRANSLOCASE 1999-2002   
% 209.48/209.63  |- skos__altLabel mesh__D033741
% 209.48/209.63       Solute Carrier Family 25%28%Mitochondrial Carrier; Adenine Nucleotide Translocator%29%, Member 4
% 209.48/209.63  |- skos__broader mesh__D033741smesh__D000226
% 209.48/209.63  |- skos__hiddenLabel mesh__D033741 ANT 1 Transport Protein
% 209.48/209.63  |- skos__altLabel mesh__D033741
% 209.48/209.63       Adenine Nucleotide Translocator, Muscle Isoform
% 209.48/209.63  |- mesh__dateEstablished mesh__D033741 2003-01-01
% 209.48/209.63  |- skos__altLabel mesh__D033741 ANT1 Transport Protein
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D033741 2006
% 209.48/209.63  |- skos__scopeNote mesh__D033741
% 209.48/209.63       A subtype of mitochondrial ADP, ATP translocase found primarily in heart muscle %28%MYOCARDIUM%29% and skeletal muscle %28%MUSCLE, SKELETAL%29%.%A%    
% 209.48/209.63  |- skos__altLabel mesh__D033741 SLC25A4 Protein
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D033741 2004
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D033741 2005
% 209.48/209.63  |- rdf__type mesh__D033741sskos__Concept
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D033741 2003
% 209.48/209.63  |- skos__altLabel mesh__D033741 Adenine Nucleotide Carrier Protein
% 209.48/209.63  |- mesh__historyNote mesh__D033741
% 209.48/209.63       2003; use MITOCHONDRIAL ADP, ATP TRANSLOCASES 1999-2002   
% 209.48/209.63  |- skos__altLabel mesh__D033741 ANT-1 Transport Protein
% 209.48/209.63  |- mesh__dateCreated mesh__D033741 2002-07-02
% 209.48/209.63  |- mesh__dateCreated mesh__D000567 1999-01-01
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D000567 2006
% 209.48/209.63  |- mesh__recordOriginator mesh__D000567 NLM
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D000567 2005
% 209.48/209.63  |- mesh__dateEstablished mesh__D000567 1965-01-01
% 209.48/209.63  |- skos__broader mesh__D000567smesh__D014071
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D000567 2002
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D000567 2004
% 209.48/209.63  |- mesh__recordAuthorizer mesh__D000567 sjn
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D000567 2001
% 209.48/209.63  |- mesh__dateRevised mesh__D000567 1999-11-03
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D000567 2003
% 209.48/209.63  |- mesh__publicMeSHNote mesh__D000567 65   
% 209.48/209.63  |- skos__annotation mesh__D000567
% 209.48/209.63       a tooth abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D000567 2000
% 209.48/209.63  |- skos__prefLabel mesh__D000567 Amelogenesis Imperfecta
% 209.48/209.63  |- skos__scopeNote mesh__D000567
% 209.48/209.63       An autosomal dominant or X-linked disorder in which there is faulty development of the dental enamel owing to agenesis, hypoplasia, or hypocalcification of the enamel. It is marked by enamel that is very thin and friable and frequently stained in various shades of brown. %28%Dorland, 27th ed%29%%A%    
% 209.48/209.63  |- rdf__type mesh__D000567sskos__Concept
% 209.48/209.63  |- mesh__historyNote mesh__D000567 65   
% 209.48/209.63  |- mesh__recordMaintainer mesh__D000567 kle
% 209.48/209.63  |- skos__hiddenLabel mesh__D019272 Elastase, Leukocyte
% 209.48/209.63  |- mesh__dateCreated mesh__D019272 1996-06-10
% 209.48/209.63  |- mesh__onlineNote mesh__D019272
% 209.48/209.63       use LEUKOCYTE ELASTASE %28%NM%29% to search LEUKOCYTE ELASTASE 1988-96%A%  
% 209.48/209.63  |- skos__altLabel mesh__D019272 Lysosomal Elastase
% 209.48/209.63  |- skos__altLabel mesh__D019272 Polymorphonuclear Leukocyte Elastase
% 209.48/209.63  |- mesh__recordAuthorizer mesh__D019272 sjn
% 209.48/209.63  |- skos__broader mesh__D019272smesh__D010196
% 209.48/209.63  |- skos__hiddenLabel mesh__D019272 Elastase, Neutrophil
% 209.48/209.63  |- skos__historyNote mesh__D019272 Pancreatopeptidase %28%1988-1996%29%
% 209.48/209.63  |- skos__hiddenLabel mesh__D019272 Elastase, Granulocyte
% 209.48/209.63  |- skos__altLabel mesh__D019272 Neutrophil Elastase
% 209.48/209.63  |- skos__hiddenLabel mesh__D019272 Elastase, Lysosomal
% 209.48/209.63  |- mesh__historyNote mesh__D019272
% 209.48/209.63       97; was LEUKOCYTE ELASTASE %28%NM%29% 1988-96   
% 209.48/209.63  |- skos__hiddenLabel mesh__D019272 Elastase, Polymorphonuclear Leukocyte
% 209.48/209.63  |- skos__scopeNote mesh__D019272
% 209.48/209.63       An enzyme that catalyzes the hydrolysis of proteins, including elastin. It cleaves preferentially bonds at the carboxyl side of Ala and Val, with greater specificity for Ala. EC 3.4.21.37.%A%    
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D019272 2005
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D019272 2004
% 209.48/209.63  |- mesh__recordOriginator mesh__D019272 TPW
% 209.48/209.63  |- skos__prefLabel mesh__D019272 Leukocyte Elastase
% 209.48/209.63  |- skos__altLabel mesh__D019272 Granulocyte Elastase
% 209.48/209.63  |- skos__hiddenLabel mesh__D019272 Elastase, PMN
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D019272 2006
% 209.48/209.63  |- mesh__publicMeSHNote mesh__D019272
% 209.48/209.63       97; LEUKOCYTE ELASTASE was indexed under PANCREATOPEPTIDASE 1988-96%A%  
% 209.48/209.63  |- mesh__dateEstablished mesh__D019272 1997-01-01
% 209.48/209.63  |- rdf__type mesh__D019272sskos__Concept
% 209.48/209.63  |- mesh__dateRevised mesh__D019272 2003-07-09
% 209.48/209.63  |- skos__altLabel mesh__D019272 PMN Elastase
% 209.48/209.63  |- skos__hiddenLabel mesh__D019272 Leukocyte Elastase, Polymorphonuclear
% 209.48/209.63  |- mesh__recordMaintainer mesh__D019272 ssb
% 209.48/209.63  |- skos__hiddenLabel mesh__D005252 Pharmaceutic Fee
% 209.48/209.63  |- skos__altLabel mesh__D005252 Fee, Pharmacy
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D005252 2001
% 209.48/209.63  |- skos__annotation mesh__D005252
% 209.48/209.63       costs to the patient or third-party payer: do not confuse with DRUG COSTS which are costs to a health facility or organiz; DF: FEES PHARM%A%  
% 209.48/209.63  |- mesh__publicMeSHNote mesh__D005252 68   
% 209.48/209.63  |- skos__hiddenLabel mesh__D005252 Fee, Pharmaceutic
% 209.48/209.63  |- mesh__dateEstablished mesh__D005252 1968-01-01
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D005252 2003
% 209.48/209.63  |- skos__hiddenLabel mesh__D005252 Pharmaceutic Fees
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D005252 2004
% 209.48/209.63  |- skos__prefLabel mesh__D005252 Fees, Pharmaceutical
% 209.48/209.63  |- skos__scopeNote mesh__D005252
% 209.48/209.63       Amounts charged to the patient or third-party payer for medication. It includes the pharmacist%27%s professional fee and cost of ingredients, containers, etc.%A%    
% 209.48/209.63  |- skos__altLabel mesh__D005252 Pharmacy Fee
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D005252 2002
% 209.48/209.63  |- rdf__type mesh__D005252sskos__Concept
% 209.48/209.63  |- mesh__historyNote mesh__D005252 68   
% 209.48/209.63  |- skos__hiddenLabel mesh__D005252 Pharmaceutical Fee
% 209.48/209.63  |- skos__hiddenLabel mesh__D005252 Fees, Pharmacy
% 209.48/209.63  |- skos__altLabel mesh__D005252 Fees, Pharmaceutic
% 209.48/209.63  |- skos__hiddenLabel mesh__D005252 Pharmacy Fees
% 209.48/209.63  |- mesh__dateCreated mesh__D005252 1999-01-01
% 209.48/209.63  |- skos__historyNote mesh__D005252 Prescriptions %28%1966-1967%29%
% 209.48/209.63  |- skos__historyNote mesh__D005252 Pharmacy %28%1966-1967%29%
% 209.48/209.63  |- mesh__dateRevised mesh__D005252 1999-11-03
% 209.48/209.63  |- mesh__recordMaintainer mesh__D005252 kle
% 209.48/209.63  |- skos__hiddenLabel mesh__D005252 Fee, Pharmaceutical
% 209.48/209.63  |- mesh__recordAuthorizer mesh__D005252 sjn
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D005252 2000
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D005252 2005
% 209.48/209.63  |- skos__broader mesh__D005252smesh__D005249
% 209.48/209.63  |- mesh__recordOriginator mesh__D005252 NLM
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D005252 2006
% 209.48/209.63  |- skos__altLabel mesh__D005252 Pharmaceutical Fees
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D018978 2005
% 209.48/209.63  |- mesh__recordMaintainer mesh__D018978 lkt
% 209.48/209.63  |- skos__altLabel mesh__D018978 Moulting
% 209.48/209.63  |- rdf__type mesh__D018978sskos__Concept
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D018978 2006
% 209.48/209.63  |- mesh__publicMeSHNote mesh__D018978 96   
% 209.48/209.63  |- skos__hiddenLabel mesh__D018978 Ecdyses
% 209.48/209.63  |- mesh__dateCreated mesh__D018978 1995-05-24
% 209.48/209.63  |- skos__prefLabel mesh__D018978 Molting
% 209.48/209.63  |- skos__altLabel mesh__D018978 Ecdysis
% 209.48/209.63  |- mesh__historyNote mesh__D018978 96   
% 209.48/209.63  |- mesh__recordOriginator mesh__D018978 PXP
% 209.48/209.63  |- mesh__dateRevised mesh__D018978 2004-07-07
% 209.48/209.63  |- skos__hiddenLabel mesh__D018978 Moltings
% 209.48/209.63  |- skos__broader mesh__D018978smesh__D008675
% 209.48/209.63  |- skos__related mesh__D018978smesh__D004441
% 209.48/209.63  |- mesh__dateEstablished mesh__D018978 1996-01-01
% 209.48/209.63  |- skos__hiddenLabel mesh__D018978 Moultings
% 209.48/209.63  |- mesh__recordAuthorizer mesh__D018978 sjn
% 209.48/209.63  |- skos__scopeNote mesh__D018978
% 209.48/209.63       Periodic casting off FEATHERS; HAIR; or cuticle. Molting is a process of sloughing or desquamation, especially the shedding of an outer covering and the development of a new one. This phenomenon permits growth in ARTHROPODS, skin renewal in AMPHIBIANS and REPTILES, and the shedding of winter coats in BIRDS and MAMMALS.%A%    
% 209.48/209.63  |- skos__related mesh__D018978smesh__D004440
% 209.48/209.63  |- mesh__dateCreated mesh__D010995 1999-01-01
% 209.48/209.63  |- mesh__publicMeSHNote mesh__D010995 66   
% 209.48/209.63  |- mesh__historyNote mesh__D010995 66   
% 209.48/209.63  |- mesh__dateRevised mesh__D010995 1997-06-20
% 209.48/209.63  |- skos__broader mesh__D010995smesh__D012140
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D010995 1998
% 209.48/209.63  |- rdf__type mesh__D010995sskos__Concept
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D010995 2000
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D010995 1999
% 209.48/209.63  |- mesh__recordAuthorizer mesh__D010995 SJN
% 209.48/209.63  |- mesh__recordOriginator mesh__D010995 NLM
% 209.48/209.63  |- mesh__dateEstablished mesh__D010995 1966-01-01
% 209.48/209.63  |- skos__hiddenLabel mesh__D010995 Pleural Disease
% 209.48/209.63  |- mesh__activeMeSHYear mesh__D010995 2005
% 209.48/209.64  |- mesh__recordMaintainer mesh__D010995 TGC
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010995 2001
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010995 2003
% 209.48/209.64  |- skos__prefLabel mesh__D010995 Pleural Diseases
% 209.48/209.64  |- skos__hiddenLabel mesh__D010995 Disease, Pleural
% 209.48/209.64  |- skos__hiddenLabel mesh__D010995 Diseases, Pleural
% 209.48/209.64  |- skos__annotation mesh__D010995 inflamm dis = PLEURISY   
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010995 2006
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010995 2002
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010995 2004
% 209.48/209.64  |- skos__altLabel mesh__D043371 Fatty Acids, Omega 6
% 209.48/209.64  |- skos__hiddenLabel mesh__D043371 N 6 Fatty Acids
% 209.48/209.64  |- mesh__dateEstablished mesh__D043371 2004-01-01
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D043371 2004
% 209.48/209.64  |- skos__altLabel mesh__D043371 N-6 Fatty Acids
% 209.48/209.64  |- skos__altLabel mesh__D043371 Omega-6 Fatty Acids
% 209.48/209.64  |- mesh__historyNote mesh__D043371 2004   
% 209.48/209.64  |- skos__hiddenLabel mesh__D043371 Fatty Acids, N-6
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D043371 2005
% 209.48/209.64  |- skos__scopeNote mesh__D043371
% 209.48/209.64       FATTY ACIDS which have the first unsaturated bond in the sixth position from the omega carbon. A typical American diet tends to contain substantially more omega-6 than OMEGA-3 FATTY ACIDS.%A%    
% 209.48/209.64  |- skos__historyNote mesh__D043371
% 209.48/209.64       Fatty Acids, Unsaturated %28%1980-2003%29%
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D043371 2006
% 209.48/209.64  |- mesh__dateCreated mesh__D043371 2003-07-09
% 209.48/209.64  |- skos__hiddenLabel mesh__D043371 Acids, Omega-6 Fatty
% 209.48/209.64  |- skos__hiddenLabel mesh__D043371 Omega 6 Fatty Acids
% 209.48/209.64  |- skos__hiddenLabel mesh__D043371 Acids, N-6 Fatty
% 209.48/209.64  |- rdf__type mesh__D043371sskos__Concept
% 209.48/209.64  |- skos__broader mesh__D043371smesh__D005231
% 209.48/209.64  |- mesh__publicMeSHNote mesh__D043371 2004   
% 209.48/209.64  |- skos__prefLabel mesh__D043371 Fatty Acids, Omega-6
% 209.48/209.64  |- skos__broader mesh__D010197smesh__D000732
% 209.48/209.64  |- skos__historyNote mesh__D010197 Curare-Like Agents %28%1970-1971%29%
% 209.48/209.64  |- mesh__recordMaintainer mesh__D010197 CCR
% 209.48/209.64  |- skos__altLabel mesh__D010197 Pancuronium Organon
% 209.48/209.64  |- skos__scopeNote mesh__D010197
% 209.48/209.64       A bis-quaternary steroid that is a competitive nicotinic antagonist. As a neuromuscular blocking agent it is more potent than CURARE but has less effect on the circulatory system and on histamine release.%A%    
% 209.48/209.64  |- mesh__recordAuthorizer mesh__D010197 sjn
% 209.48/209.64  |- skos__historyNote mesh__D010197 Androstanes %28%1968-1971%29%
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010197 2006
% 209.48/209.64  |- skos__prefLabel mesh__D010197 Pancuronium
% 209.48/209.64  |- mesh__dateRevised mesh__D010197 2005-06-30
% 209.48/209.64  |- skos__altLabel mesh__D010197
% 209.48/209.64       Organon Teknika Brand of Pancuronium Bromide
% 209.48/209.64  |- mesh__recordOriginator mesh__D010197 NLM
% 209.48/209.64  |- mesh__publicMeSHNote mesh__D010197 74   
% 209.48/209.64  |- skos__altLabel mesh__D010197 Organon Brand of Pancuronium Bromide
% 209.48/209.64  |- mesh__historyNote mesh__D010197 74%28%72%29%   
% 209.48/209.64  |- rdf__type mesh__D010197sskos__Concept
% 209.48/209.64  |- mesh__dateEstablished mesh__D010197 1974-01-01
% 209.48/209.64  |- skos__hiddenLabel mesh__D010197 Bromide, Pancuronium
% 209.48/209.64  |- skos__altLabel mesh__D010197 Schwabe Brand of Pancuronium Bromide
% 209.48/209.64  |- mesh__dateCreated mesh__D010197 1999-01-01
% 209.48/209.64  |- skos__prefLabel mesh__D004958 Estradiol
% 209.48/209.64  |- skos__altLabel mesh__D004958 Estradiol-17 beta
% 209.48/209.64  |- mesh__recordMaintainer mesh__D004958 lkt
% 209.48/209.64  |- mesh__dateCreated mesh__D004958 1999-01-01
% 209.48/209.64  |- skos__altLabel mesh__D004958 Estradiol-17beta
% 209.48/209.64  |- skos__broader mesh__D004958smesh__D004963
% 209.48/209.64  |- skos__altLabel mesh__D004958 Oestradiol
% 209.48/209.64  |- mesh__historyNote mesh__D004958
% 209.48/209.64       63; for OVOCYCLIN use ESTRADIOL DIPROPIONATE %28%NM%29% 1980-98; /therapeutic use was ESTRADIOL, THERAPEUTIC 1965%A%  
% 209.48/209.64  |- mesh__publicMeSHNote mesh__D004958
% 209.48/209.64       63; OVOCYCLIN was indexed under ESTRADIOL/analogs %26% derivatives 1980-98; /therapeutic use was ESTRADIOL, THERAPEUTIC 1965%A%  
% 209.48/209.64  |- skos__altLabel mesh__D004958 17 beta-Estradiol
% 209.48/209.64  |- skos__scopeNote mesh__D004958
% 209.48/209.64       Generally refers to the 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. In humans, it is produced primarily by the cyclic ovaries and the PLACENTA. It is also produced by the adipose tissue of men and postmenopausal women. The 17-alpha-isomer of estradiol binds weakly to estrogen receptors %28%RECEPTORS, ESTROGEN%29% and exhibits little estrogenic activity in estrogen-responsive tissues. Various isomers can be synthesized.%A%    
% 209.48/209.64  |- skos__hiddenLabel mesh__D004958 Estradiol 17 beta
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D004958 2006
% 209.48/209.64  |- skos__related mesh__D004958smesh__D011959
% 209.48/209.64  |- skos__broader mesh__D004958smesh__D045166
% 209.48/209.64  |- skos__hiddenLabel mesh__D004958 Estradiol 17 alpha
% 209.48/209.64  |- rdf__type mesh__D004958sskos__Concept
% 209.48/209.64  |- skos__hiddenLabel mesh__D004958 17 beta Estradiol
% 209.48/209.64  |- skos__altLabel mesh__D004958 17 beta-Oestradiol
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D004958 2005
% 209.48/209.64  |- skos__altLabel mesh__D004958 Estradiol, %28%17-alpha%29%-Isomer
% 209.48/209.64  |- skos__hiddenLabel mesh__D004958 Estradiol 17beta
% 209.48/209.64  |- mesh__recordOriginator mesh__D004958 NLM
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D004958 2004
% 209.48/209.64  |- mesh__recordAuthorizer mesh__D004958 sjn
% 209.48/209.64  |- skos__hiddenLabel mesh__D004958 17 beta Oestradiol
% 209.48/209.64  |- mesh__dateRevised mesh__D004958 2003-07-09
% 209.48/209.64  |- skos__hiddenLabel mesh__D009643 AM 715
% 209.48/209.64  |- skos__historyNote mesh__D009643 Anti-Infective Agents %28%1966-1985%29%
% 209.48/209.64  |- mesh__publicMeSHNote mesh__D009643 86   
% 209.48/209.64  |- skos__prefLabel mesh__D009643 Norfloxacin
% 209.48/209.64  |- mesh__recordOriginator mesh__D009643 SH
% 209.48/209.64  |- mesh__recordMaintainer mesh__D009643 ssb
% 209.48/209.64  |- skos__scopeNote mesh__D009643
% 209.48/209.64       A synthetic fluoroquinolone %28%FLUOROQUINOLONES%29% with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.%A%    
% 209.48/209.64  |- skos__altLabel mesh__D009643 MK0366
% 209.48/209.64  |- skos__historyNote mesh__D009643
% 209.48/209.64       Anti-Infective Agents, Urinary %28%1966-1985%29%
% 209.48/209.64  |- skos__hiddenLabel mesh__D009643 MK 366
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D009643 2006
% 209.48/209.64  |- skos__broader mesh__D009643smesh__D024841
% 209.48/209.64  |- skos__altLabel mesh__D009643 MK-366
% 209.48/209.64  |- mesh__dateEstablished mesh__D009643 1986-01-01
% 209.48/209.64  |- skos__historyNote mesh__D009643 Nalidixic Acid %28%1966-1985%29%
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D009643 2005
% 209.48/209.64  |- skos__altLabel mesh__D009643 MK366
% 209.48/209.64  |- skos__hiddenLabel mesh__D009643 AM0715
% 209.48/209.64  |- skos__hiddenLabel mesh__D009643 MK 0366
% 209.48/209.64  |- skos__hiddenLabel mesh__D009643 AM 0715
% 209.48/209.64  |- skos__altLabel mesh__D009643 AM-715
% 209.48/209.64  |- mesh__dateCreated mesh__D009643 1985-06-06
% 209.48/209.64  |- mesh__historyNote mesh__D009643 86   
% 209.48/209.64  |- mesh__recordAuthorizer mesh__D009643 sjn
% 209.48/209.64  |- rdf__type mesh__D009643sskos__Concept
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D009643 2004
% 209.48/209.64  |- mesh__dateRevised mesh__D009643 2003-07-09
% 209.48/209.64  |- skos__hiddenLabel mesh__D001660 Tract Diseases, Biliary
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D001660 2005
% 209.48/209.64  |- mesh__dateEstablished mesh__D001660 1966-01-01
% 209.48/209.64  |- skos__broader mesh__D001660smesh__D004066
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D001660 2006
% 209.48/209.64  |- skos__hiddenLabel mesh__D001660 Biliary Tract Disease
% 209.48/209.64  |- mesh__publicMeSHNote mesh__D001660 66   
% 209.48/209.64  |- skos__scopeNote mesh__D001660
% 209.48/209.64       Diseases in any part of the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.%A%    
% 209.48/209.64  |- skos__related mesh__D001660smesh__D002758
% 209.48/209.64  |- skos__hiddenLabel mesh__D001660 Tract Disease, Biliary
% 209.48/209.64  |- mesh__recordOriginator mesh__D001660 NLM
% 209.48/209.64  |- mesh__recordAuthorizer mesh__D001660 sjn
% 209.48/209.64  |- rdf__type mesh__D001660sskos__Concept
% 209.48/209.64  |- skos__prefLabel mesh__D001660 Biliary Tract Diseases
% 209.48/209.64  |- mesh__dateRevised mesh__D001660 2003-07-09
% 209.48/209.64  |- skos__annotation mesh__D001660
% 209.48/209.64       GEN: prefer specifics; biliary empyema = EMPYEMA %28%IM%29% + BILIARY TRACT DISEASES %28%IM%29% or if of gallbladder, EMPYEMA, GALLBLADDER see CHOLECYSTITIS;  inflamm dis = CHOLECYSTITIS or CHOLANGITIS; calculi = BILIARY CALCULI see GALLSTONES but consider also CHOLELITHIASIS%A%  
% 209.48/209.64  |- skos__hiddenLabel mesh__D001660 Disease, Biliary Tract
% 209.48/209.64  |- mesh__recordMaintainer mesh__D001660 lkt
% 209.48/209.64  |- mesh__historyNote mesh__D001660 66   
% 209.48/209.64  |- mesh__dateCreated mesh__D001660 1999-01-01
% 209.48/209.64  |- skos__hiddenLabel mesh__D001660 Diseases, Biliary Tract
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D001660 2004
% 209.48/209.64  |- skos__scopeNote mesh__D014588
% 209.48/209.64       A genus of basidiomycetous smut fungi comprising the loose smuts.%A%    
% 209.48/209.64  |- mesh__dateRevised mesh__D014588 2005-06-30
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D014588 2006
% 209.48/209.64  |- skos__broader mesh__D014588smesh__D014587
% 209.48/209.64  |- mesh__publicMeSHNote mesh__D014588
% 209.48/209.64       91; was see under BASIDIOMYCETES 1975-90   
% 209.48/209.64  |- mesh__recordMaintainer mesh__D014588 SYSTEM
% 209.48/209.64  |- mesh__dateCreated mesh__D014588 1974-12-12
% 209.48/209.64  |- skos__prefLabel mesh__D014588 Ustilago
% 209.48/209.64  |- mesh__recordAuthorizer mesh__D014588 sjn
% 209.48/209.64  |- mesh__dateEstablished mesh__D014588 1991-01-01
% 209.48/209.64  |- skos__annotation mesh__D014588 a basidiomycete representing the smuts   
% 209.48/209.64  |- rdf__type mesh__D014588sskos__Concept
% 209.48/209.64  |- mesh__historyNote mesh__D014588
% 209.48/209.64       91%28%75%29%; was see under BASIDIOMYCETES 1975-90   
% 209.48/209.64  |- mesh__recordOriginator mesh__D014588 NLM
% 209.48/209.64  |- mesh__dateCreated mesh__D033742 2002-07-02
% 209.48/209.64  |- skos__altLabel mesh__D033742
% 209.48/209.64       Solute Carrier-Family 25%28%Mitochondrial Carrier; Adenine Nucleotide Translocator%29%, Member 5
% 209.48/209.64  |- skos__historyNote mesh__D033742
% 209.48/209.64       Adenine Nucleotide Translocase %28%1999-2002%29%
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D033742 2006
% 209.48/209.64  |- mesh__publicMeSHNote mesh__D033742
% 209.48/209.64       2003; see ADENINE NUCLEOTIDE TRANSLOCASE 1999-2002   
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D033742 2004
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D033742 2005
% 209.48/209.64  |- skos__broader mesh__D033742smesh__D000226
% 209.48/209.64  |- skos__hiddenLabel mesh__D033742 ANT 2 Transport Protein
% 209.48/209.64  |- rdf__type mesh__D033742sskos__Concept
% 209.48/209.64  |- skos__altLabel mesh__D033742
% 209.48/209.64       Adenine Nucleotide Translocator, Fibroblast Isoform
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D033742 2003
% 209.48/209.64  |- mesh__historyNote mesh__D033742
% 209.48/209.64       2003; use MITOCHONDRIAL ADP, ATP TRANSLOCASES 1999-2002   
% 209.48/209.64  |- mesh__dateEstablished mesh__D033742 2003-01-01
% 209.48/209.64  |- skos__scopeNote mesh__D033742
% 209.48/209.64       A subtype of mitochondrial ADP, ATP translocase found primarily in FIBROBLASTS.%A%    
% 209.48/209.64  |- skos__altLabel mesh__D033742 ANT-2 Transport Protein
% 209.48/209.64  |- skos__hiddenLabel mesh__D033742 Transport Protein, ANT-2
% 209.48/209.64  |- skos__altLabel mesh__D033742 SLC25A5 Protein
% 209.48/209.64  |- skos__prefLabel mesh__D033742 Adenine Nucleotide Translocator 2
% 209.48/209.64  |- skos__altLabel mesh__D033742 ANT2 Transport Protein
% 209.48/209.64  |- skos__hiddenLabel mesh__D033742 Transport Protein, ANT2
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D000568 2001
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D000568 2006
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D000568 2003
% 209.48/209.64  |- mesh__recordMaintainer mesh__D000568 jls
% 209.48/209.64  |- skos__prefLabel mesh__D000568 Amenorrhea
% 209.48/209.64  |- skos__hiddenLabel mesh__D000568 Postpartum Amenorrheas
% 209.48/209.64  |- skos__broader mesh__D000568smesh__D008599
% 209.48/209.64  |- skos__hiddenLabel mesh__D000568 Amenorrhea, Postpartum
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D000568 2002
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D000568 2004
% 209.48/209.64  |- skos__annotation mesh__D000568
% 209.48/209.64       %22%postpartum amenorrhea%22% is indexed under AMENORRHEA %28%IM%29% + PUERPERIUM %28%IM%29% %26% not LACTATION unless lactation is particularly discussed%A%  
% 209.48/209.64  |- mesh__recordOriginator mesh__D000568 NLM
% 209.48/209.64  |- mesh__dateCreated mesh__D000568 1999-01-01
% 209.48/209.64  |- mesh__dateRevised mesh__D000568 1999-11-09
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D000568 2000
% 209.48/209.64  |- skos__related mesh__D000568smesh__D009839
% 209.48/209.64  |- skos__scopeNote mesh__D000568 Absence of menstruation.     
% 209.48/209.64  |- rdf__type mesh__D000568sskos__Concept
% 209.48/209.64  |- mesh__recordAuthorizer mesh__D000568 sjn
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D000568 2005
% 209.48/209.64  |- skos__historyNote mesh__D005253 Cats %28%1969-1974%29%
% 209.48/209.64  |- skos__altLabel mesh__D005253 Feline Sarcoma Viruses
% 209.48/209.64  |- skos__prefLabel mesh__D005253 Sarcoma Viruses, Feline
% 209.48/209.64  |- skos__altLabel mesh__D005253 Gardner-Arnstein feline sarcoma virus
% 209.48/209.64  |- skos__hiddenLabel mesh__D005253 Feline Sarcoma Virus, Snyder Theilen
% 209.48/209.64  |- mesh__dateEstablished mesh__D005253 1991-01-01
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D005253 2004
% 209.48/209.64  |- skos__altLabel mesh__D005253 Feline Sarcoma Virus, Hardy-Zuckerman
% 209.48/209.64  |- mesh__dateRevised mesh__D005253 2001-07-25
% 209.48/209.64  |- skos__historyNote mesh__D005253 Retroviridae %28%1970-1974%29%
% 209.48/209.64  |- skos__altLabel mesh__D005253 Feline Sarcoma Virus, Snyder-Theilen
% 209.48/209.64  |- mesh__recordOriginator mesh__D005253 NLM
% 209.48/209.64  |- mesh__publicMeSHNote mesh__D005253
% 209.48/209.64       2002; see SARCOMA VIRUS, FELINE 1994-2001, see FELINE FIBROSARCOMA VIRUS 1991-1993, see RETROVIRIDAE 1981-1990, see LEUKOVIRUSES 1978-1980, see LEUKEMOGENIC VIRUSES 1975-1977%A%  
% 209.48/209.64  |- skos__historyNote mesh__D005253 Oncogenic Viruses %28%1970-1974%29%
% 209.48/209.64  |- mesh__recordMaintainer mesh__D005253 ags
% 209.48/209.64  |- mesh__historyNote mesh__D005253 2002 %28%1975%29%   
% 209.48/209.64  |- rdf__type mesh__D005253sskos__Concept
% 209.48/209.64  |- skos__altLabel mesh__D005253 Feline Sarcoma Virus, Gardner-Arnstein
% 209.48/209.64  |- skos__altLabel mesh__D005253 Hardy-Zuckerman feline sarcoma virus
% 209.48/209.64  |- mesh__dateCreated mesh__D005253 1974-12-12
% 209.48/209.64  |- skos__broader mesh__D005253smesh__D017988
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D005253 2005
% 209.48/209.64  |- skos__scopeNote mesh__D005253
% 209.48/209.64       Species of GAMMARETROVIRUS isolated from fibrosarcoma in cats. The viruses are actually recombinant feline leukemia viruses %28%FeLV%29% where part of the genome has been replaced by cellular oncogenes. It is unique to individuals and not transmitted naturally to other cats. FeSVs are replication defective and require FeLV to reproduce.%A%    
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D005253 2002
% 209.48/209.64  |- skos__hiddenLabel mesh__D005253 Gardner Arnstein feline sarcoma virus
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D005253 2006
% 209.48/209.64  |- skos__annotation mesh__D005253
% 209.48/209.64       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%; DF: FESV%A%  
% 209.48/209.64  |- skos__hiddenLabel mesh__D005253 Feline Sarcoma Virus, Hardy Zuckerman
% 209.48/209.64  |- skos__historyNote mesh__D005253 Fibrosarcoma %28%1969-1974%29%
% 209.48/209.64  |- skos__altLabel mesh__D005253 Snyder-Theilen feline sarcoma virus
% 209.48/209.64  |- skos__hiddenLabel mesh__D005253 Feline Sarcoma Virus, Gardner Arnstein
% 209.48/209.64  |- skos__hiddenLabel mesh__D005253 Hardy Zuckerman feline sarcoma virus
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D005253 2003
% 209.48/209.64  |- skos__hiddenLabel mesh__D005253 Snyder Theilen feline sarcoma virus
% 209.48/209.64  |- mesh__recordAuthorizer mesh__D005253 sjn
% 209.48/209.64  |- skos__historyNote mesh__D005253
% 209.48/209.64       Vertebrate Viruses, Unclassified %28%1970-1974%29%
% 209.48/209.64  |- skos__altLabel mesh__D018979 Inclusion Body Myositis
% 209.48/209.64  |- mesh__recordOriginator mesh__D018979 TGC
% 209.48/209.64  |- skos__altLabel mesh__D018979 Sporadic Inclusion Body Myositis
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D018979 2003
% 209.48/209.64  |- rdf__type mesh__D018979sskos__Concept
% 209.48/209.64  |- skos__scopeNote mesh__D018979
% 209.48/209.64       Progressive myopathies characterized by the presence of inclusion bodies on muscle biopsy. Sporadic and hereditary forms have been described. The sporadic form is an acquired, adult-onset inflammatory vacuolar myopathy affecting proximal and distal muscles. Familial forms usually begin in childhood and lack inflammatory changes. Both forms feature intracytoplasmic and intranuclear inclusions in muscle tissue. %28%Adams et al., Principles of Neurology, 6th ed, pp1409-10%29%%A%    
% 209.48/209.64  |- skos__annotation mesh__D018979
% 209.48/209.64       do not coord with INCLUSION BODIES but coord with INCLUSION BODIES, VIRAL if relevant %28%IM or NIM%29%%A%  
% 209.48/209.64  |- mesh__dateRevised mesh__D018979 1999-11-04
% 209.48/209.64  |- skos__altLabel mesh__D018979 Inclusion Body Myositis, Sporadic
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D018979 2002
% 209.48/209.64  |- mesh__publicMeSHNote mesh__D018979 96   
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D018979 2005
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D018979 2004
% 209.48/209.64  |- skos__altLabel mesh__D018979 Myopathy, Inclusion Body, Sporadic
% 209.48/209.64  |- mesh__historyNote mesh__D018979 96   
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D018979 2006
% 209.48/209.64  |- skos__historyNote mesh__D018979 Myositis %28%1968-1995%29%
% 209.48/209.64  |- mesh__dateCreated mesh__D018979 1995-05-24
% 209.48/209.64  |- skos__broader mesh__D018979smesh__D009220
% 209.48/209.64  |- skos__hiddenLabel mesh__D018979 Myositides, Inclusion Body
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D018979 2000
% 209.48/209.64  |- skos__prefLabel mesh__D018979 Myositis, Inclusion Body
% 209.48/209.64  |- mesh__recordAuthorizer mesh__D018979 sjn
% 209.48/209.64  |- mesh__dateEstablished mesh__D018979 1996-01-01
% 209.48/209.64  |- skos__hiddenLabel mesh__D018979 Inclusion Body Myositides
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D018979 2001
% 209.48/209.64  |- mesh__recordMaintainer mesh__D018979 KEV
% 209.48/209.64  |- skos__altLabel mesh__D018979 Myositis, Inclusion Body, Sporadic
% 209.48/209.64  |- skos__hiddenLabel mesh__D010996 Pleural Effusions
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010996 1998
% 209.48/209.64  |- mesh__dateEstablished mesh__D010996 1968-01-01
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010996 2002
% 209.48/209.64  |- skos__scopeNote mesh__D010996
% 209.48/209.64       Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself.%A%    
% 209.48/209.64  |- rdf__type mesh__D010996sskos__Concept
% 209.48/209.64  |- mesh__recordAuthorizer mesh__D010996 PLS
% 209.48/209.64  |- skos__hiddenLabel mesh__D010996 Effusions, Pleural
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010996 1999
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010996 1997
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010996 2005
% 209.48/209.64  |- mesh__recordMaintainer mesh__D010996 TGC
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010996 2003
% 209.48/209.64  |- skos__hiddenLabel mesh__D010996 Effusion, Pleural
% 209.48/209.64  |- mesh__dateRevised mesh__D010996 1996-06-10
% 209.48/209.64  |- mesh__onlineNote mesh__D010996
% 209.48/209.64       use PLEURAL EFFUSION to search PLEURAL EFFUSIONS 1966-67   
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010996 2006
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010996 2000
% 209.48/209.64  |- mesh__publicMeSHNote mesh__D010996 68; was PLEURAL EFFUSIONS 1963-67   
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010996 2004
% 209.48/209.64  |- mesh__recordOriginator mesh__D010996 NLM
% 209.48/209.64  |- mesh__dateCreated mesh__D010996 1999-01-01
% 209.48/209.64  |- skos__prefLabel mesh__D010996 Pleural Effusion
% 209.48/209.64  |- mesh__historyNote mesh__D010996
% 209.48/209.64       68; was in Cat A %26% C 1968-83, was PLEURAL EFFUSIONS in Cat A %26% C 1963-67%A%  
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010996 2001
% 209.48/209.64  |- skos__broader mesh__D010996smesh__D010995
% 209.48/209.64  |- skos__annotation mesh__D010996
% 209.48/209.64       note category; presence of fluid in the pleural space; PLEURAL EFFUSION, MALIGNANT is also available%A%  
% 209.48/209.64  |- mesh__recordAuthorizer mesh__D043372 sjn
% 209.48/209.64  |- mesh__recordOriginator mesh__D043372 ags
% 209.48/209.64  |- mesh__recordMaintainer mesh__D043372 SYSTEM
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D043372 2006
% 209.48/209.64  |- mesh__dateCreated mesh__D043372 2003-07-09
% 209.48/209.64  |- mesh__dateEstablished mesh__D043372 2004-01-01
% 209.48/209.64  |- mesh__historyNote mesh__D043372 2004   
% 209.48/209.64  |- skos__broader mesh__D043372smesh__D006088
% 209.48/209.64  |- rdf__type mesh__D043372sskos__Concept
% 209.48/209.64  |- mesh__publicMeSHNote mesh__D043372 2004   
% 209.48/209.64  |- skos__scopeNote mesh__D043372
% 209.48/209.64       A family of gram-negative bacteria in the order Nitrosomonadales, class BETAPROTEOBACTERIA. It contains a single genus Gallionella.%A%    
% 209.48/209.64  |- skos__broader mesh__D043372smesh__D020562
% 209.48/209.64  |- mesh__dateRevised mesh__D043372 2005-06-30
% 209.48/209.64  |- skos__prefLabel mesh__D043372 Gallionellaceae
% 209.48/209.64  |- rdf__type mesh__D010198sskos__Concept
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010198 2001
% 209.48/209.64  |- skos__hiddenLabel mesh__D010198 Pancytopenias
% 209.48/209.64  |- mesh__recordOriginator mesh__D010198 VDK
% 209.48/209.64  |- mesh__dateRevised mesh__D010198 1990-05-29
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010198 2004
% 209.48/209.64  |- skos__broader mesh__D010198smesh__D006402
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010198 1997
% 209.48/209.64  |- mesh__recordAuthorizer mesh__D010198 NLM
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010198 2000
% 209.48/209.64  |- skos__annotation mesh__D010198
% 209.48/209.64       combined defic of erythrocytes, leukocytes %26% platelets   
% 209.48/209.64  |- skos__prefLabel mesh__D010198 Pancytopenia
% 209.48/209.64  |- mesh__dateEstablished mesh__D010198 1977-01-01
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010198 2003
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010198 1993
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010198 1996
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010198 2006
% 209.48/209.64  |- mesh__publicMeSHNote mesh__D010198 77   
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010198 1999
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010198 2002
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010198 1992
% 209.48/209.64  |- skos__scopeNote mesh__D010198
% 209.48/209.64       Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.%A%    
% 209.48/209.64  |- mesh__recordMaintainer mesh__D010198 PLS
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010198 2005
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010198 1995
% 209.48/209.64  |- mesh__dateCreated mesh__D010198 1976-05-19
% 209.48/209.64  |- mesh__historyNote mesh__D010198 77   
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010198 1998
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010198 1991
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D010198 1994
% 209.48/209.64  |- skos__historyNote mesh__D004959 Estradiol %28%1966-1977%29%
% 209.48/209.64  |- mesh__dateCreated mesh__D004959 1999-11-08
% 209.48/209.64  |- skos__hiddenLabel mesh__D004959 Antagonists, Estradiol
% 209.48/209.64  |- mesh__recordAuthorizer mesh__D004959 sjn
% 209.48/209.64  |- skos__annotation mesh__D004959 DF: ESTRADIOL ANTAG   
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D004959 2006
% 209.48/209.64  |- mesh__publicMeSHNote mesh__D004959 78   
% 209.48/209.64  |- mesh__recordOriginator mesh__D004959 RLS
% 209.48/209.64  |- mesh__dateEstablished mesh__D004959 1978-01-01
% 209.48/209.64  |- mesh__recordMaintainer mesh__D004959 ssb
% 209.48/209.64  |- rdf__type mesh__D004959sskos__Concept
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D004959 2005
% 209.48/209.64  |- skos__prefLabel mesh__D004959 Estradiol Antagonists
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D004959 2004
% 209.48/209.64  |- mesh__dateRevised mesh__D004959 2003-07-09
% 209.48/209.64  |- mesh__historyNote mesh__D004959 78   
% 209.48/209.64  |- skos__scopeNote mesh__D004959
% 209.48/209.64       Compounds which inhibit or antagonize the biosynthesis or action of estradiol.%A%    
% 209.48/209.64  |- skos__broader mesh__D004959smesh__D004965
% 209.48/209.64  |- mesh__historyNote mesh__D015681 91; was GAG-ONC FUSION PROTEINS 1990   
% 209.48/209.64  |- mesh__recordOriginator mesh__D015681 AGS
% 209.48/209.64  |- skos__hiddenLabel mesh__D015681 gag myc Fused Protein p110
% 209.48/209.64  |- mesh__onlineNote mesh__D015681
% 209.48/209.64       use FUSION PROTEINS, GAG-ONC to search GAG-ONC FUSION PROTEINS 1990%A%  
% 209.48/209.64  |- skos__hiddenLabel mesh__D015681 Protein v-fes, Oncogene
% 209.48/209.64  |- mesh__recordAuthorizer mesh__D015681 sjn
% 209.48/209.64  |- mesh__dateCreated mesh__D015681 1989-05-25
% 209.48/209.64  |- skos__annotation mesh__D015681
% 209.48/209.64       IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 209.48/209.64  |- skos__hiddenLabel mesh__D015681 p140 gag fps
% 209.48/209.64  |- skos__historyNote mesh__D015681 Viral Proteins %28%1980-1985%29%
% 209.48/209.64  |- skos__historyNote mesh__D015681 Retroviridae Proteins %28%1986-1989%29%
% 209.48/209.64  |- skos__hiddenLabel mesh__D015681 pp85 gag fes
% 209.48/209.64  |- mesh__activeMeSHYear mesh__D015681 2006
% 209.48/209.64  |- skos__broader mesh__D015681smesh__D015682
% 209.48/209.64  |- skos__hiddenLabel mesh__D015681 v-fes, Oncogene Protein
% 209.48/209.64  |- skos__altLabel mesh__D015681 gag-onc Fusion Proteins
% 209.48/209.64  |- skos__hiddenLabel mesh__D015681 gag-fes, p140
% 209.48/209.64  |- skos__hiddenLabel mesh__D015681 gag-fps, p140
% 209.48/209.64  |- mesh__dateEstablished mesh__D015681 1990-01-01
% 209.48/209.64  |- mesh__dateRevised mesh__D015681 2005-06-30
% 209.48/209.64  |- skos__hiddenLabel mesh__D015681 Fujinami Sarcoma Virus P140 gag fps
% 209.48/209.64  |- skos__broader mesh__D015681smesh__D015683
% 209.48/209.64  |- skos__hiddenLabel mesh__D015681 gag-ros Fusion Proteins
% 209.48/209.64  |- skos__hiddenLabel mesh__D015681 gag-pol-myc, p200
% 209.48/209.64  |- skos__hiddenLabel mesh__D015681 gag onc Fusion Proteins
% 209.48/209.64  |- skos__hiddenLabel mesh__D015681 Proteins, gag-onc Fusion
% 209.48/209.64  |- skos__hiddenLabel mesh__D015681 Oncogene Protein v fes
% 209.48/209.64  |- mesh__publicMeSHNote mesh__D015681
% 209.48/209.64       91; was GAG-ONC FUSION PROTEINS 1990   
% 209.48/209.64  |- skos__broader mesh__D015681smesh__D015514
% 209.48/209.64  |- skos__prefLabel mesh__D015681 Fusion Proteins, gag-onc
% 209.48/209.64  |- skos__hiddenLabel mesh__D015681 Fusion Proteins, gag ros
% 209.48/209.64  |- skos__scopeNote mesh__D015681
% 209.48/209.64       General name for the translation products of a fusion mRNA consisting of a gag gene and a viral oncogene %28%v-onc%29%. These products are thought to have the ability to transform cells.%A%    
% 209.48/209.64  |- skos__hiddenLabel mesh__D015681 Proteins, gag-ros Fusion
% 209.48/209.64  |- mesh__recordMaintainer mesh__D015681 nns
% 209.48/209.64  |- rdf__type mesh__D015681sskos__Concept
% 209.48/209.64  |- skos__hiddenLabel mesh__D015681 p140 gag fes
% 209.48/209.64  |- skos__hiddenLabel mesh__D015681 gag-fes, pp85
% 209.48/209.64  |- skos__hiddenLabel mesh__D015681 Fusion Proteins, gag onc
% 209.48/209.64  |- skos__hiddenLabel mesh__D015681 p200 gag pol myc
% 209.48/209.64  |- skos__hiddenLabel mesh__D009644 Wy 3707
% 209.48/209.64  |- skos__broader mesh__D009644smesh__D009652
% 209.48/209.64  |- skos__historyNote mesh__D009644 Contraceptives, Oral %28%1966-1971%29%
% 209.48/209.64  |- skos__hiddenLabel mesh__D009644 Norgestrel Wyeth Brand
% 209.48/209.64  |- skos__hiddenLabel mesh__D009644 DL Norgestrel
% 209.48/209.64  |- mesh__recordMaintainer mesh__D009644 jls
% 209.48/209.64  |- skos__scopeNote mesh__D009644
% 209.48/209.64       A synthetic progestational agent with actions similar to those of PROGESTERONE. This racemic or %28%+-%29%-form has about half the potency of the levo form %28%LEVONORGESTREL%29%. Norgestrel is used as a contraceptive, ovulation inhibitor, and for the control of menstrual disorders and endometriosis.%A%    
% 209.48/209.65  |- mesh__dateEstablished mesh__D009644 1972-01-01
% 209.48/209.65  |- skos__hiddenLabel mesh__D009644 Norgestrel Schering Brand
% 209.48/209.65  |- skos__historyNote mesh__D009644
% 209.48/209.65       Progestational Hormones %28%1966-1971%29%
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D009644 2005
% 209.48/209.65  |- skos__altLabel mesh__D009644 Wyeth Brand of Norgestrel
% 209.48/209.65  |- skos__altLabel mesh__D009644 Schering Brand of Norgestrel
% 209.48/209.65  |- skos__prefLabel mesh__D009644 Norgestrel
% 209.48/209.65  |- skos__altLabel mesh__D009644 DL-Norgestrel
% 209.48/209.65  |- mesh__dateCreated mesh__D009644 1999-01-01
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D009644 2006
% 209.48/209.65  |- skos__historyNote mesh__D009644 Ketones %28%1966-1971%29%
% 209.48/209.65  |- mesh__publicMeSHNote mesh__D009644 72   
% 209.48/209.65  |- skos__historyNote mesh__D009644 Pregnanes %28%1968-1971%29%
% 209.48/209.65  |- mesh__historyNote mesh__D009644 72   
% 209.48/209.65  |- mesh__recordAuthorizer mesh__D009644 jls
% 209.48/209.65  |- mesh__dateRevised mesh__D009644 2004-07-29
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D009644 2005A
% 209.48/209.65  |- rdf__type mesh__D009644sskos__Concept
% 209.48/209.65  |- skos__hiddenLabel mesh__D009644 Wy3707
% 209.48/209.65  |- mesh__recordOriginator mesh__D009644 NLM
% 209.48/209.65  |- skos__broader mesh__D001661smesh__D001660
% 209.48/209.65  |- skos__historyNote mesh__D001661 Bile Duct Neoplasms %28%1966-1979%29%
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D001661 2006
% 209.48/209.65  |- mesh__recordMaintainer mesh__D001661 lkt
% 209.48/209.65  |- mesh__dateCreated mesh__D001661 1979-05-29
% 209.48/209.65  |- skos__historyNote mesh__D001661 Gallbladder Neoplasms %28%1966-1979%29%
% 209.48/209.65  |- skos__altLabel mesh__D001661 Cancer of the Biliary Tract
% 209.48/209.65  |- skos__annotation mesh__D001661
% 209.48/209.65       GEN: prefer specifics; coord IM with histol type of neopl %28%IM%29%%A%  
% 209.48/209.65  |- skos__scopeNote mesh__D001661
% 209.48/209.65       Tumors or cancer in the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.%A%    
% 209.48/209.65  |- mesh__publicMeSHNote mesh__D001661 80   
% 209.48/209.65  |- rdf__type mesh__D001661sskos__Concept
% 209.48/209.65  |- skos__hiddenLabel mesh__D001661 Cancer, Biliary Tract
% 209.48/209.65  |- skos__hiddenLabel mesh__D001661 Biliary Tract Cancers
% 209.48/209.65  |- mesh__dateRevised mesh__D001661 2003-07-09
% 209.48/209.65  |- mesh__recordAuthorizer mesh__D001661 sjn
% 209.48/209.65  |- mesh__historyNote mesh__D001661 80   
% 209.48/209.65  |- skos__hiddenLabel mesh__D001661 Biliary Tract Neoplasm
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D001661 2004
% 209.48/209.65  |- mesh__dateEstablished mesh__D001661 1980-01-01
% 209.48/209.65  |- skos__hiddenLabel mesh__D001661 Neoplasm, Biliary Tract
% 209.48/209.65  |- skos__broader mesh__D001661smesh__D004067
% 209.48/209.65  |- skos__altLabel mesh__D001661 Neoplasms, Biliary Tract
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D001661 2005
% 209.48/209.65  |- skos__hiddenLabel mesh__D001661 Cancers, Biliary Tract
% 209.48/209.65  |- skos__altLabel mesh__D001661 Cancer of Biliary Tract
% 209.48/209.65  |- skos__prefLabel mesh__D001661 Biliary Tract Neoplasms
% 209.48/209.65  |- mesh__recordOriginator mesh__D001661 SMH
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D014589 2001
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D014589 1998
% 209.48/209.65  |- mesh__recordOriginator mesh__D014589 NLM
% 209.48/209.65  |- mesh__dateCreated mesh__D014589 1999-01-01
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D014589 1999
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D014589 2002
% 209.48/209.65  |- skos__prefLabel mesh__D014589 Utah
% 209.48/209.65  |- mesh__dateRevised mesh__D014589 1997-06-20
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D014589 2003
% 209.48/209.65  |- skos__broader mesh__D014589smesh__D015206
% 209.48/209.65  |- rdf__type mesh__D014589sskos__Concept
% 209.48/209.65  |- mesh__recordAuthorizer mesh__D014589 SJN
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D014589 2005
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D014589 2004
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D014589 2006
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D014589 2000
% 209.48/209.65  |- mesh__recordMaintainer mesh__D014589 PXP
% 209.48/209.65  |- skos__historyNote mesh__D019274 Botulinum Toxins %28%1982-1996%29%
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D019274 2006
% 209.48/209.65  |- mesh__dateRevised mesh__D019274 2005-06-30
% 209.48/209.65  |- skos__altLabel mesh__D019274 Botulinum Neurotoxin A
% 209.48/209.65  |- rdf__type mesh__D019274sskos__Concept
% 209.48/209.65  |- mesh__dateEstablished mesh__D019274 1997-01-01
% 209.48/209.65  |- skos__altLabel mesh__D019274 Allergan Brand of Botulinum A Toxin
% 209.48/209.65  |- skos__altLabel mesh__D019274 Speywood Brand of Botulinum A Toxin
% 209.48/209.65  |- skos__hiddenLabel mesh__D019274 Toxin, Botulinum A
% 209.48/209.65  |- skos__altLabel mesh__D019274 Botulinum A Toxin
% 209.48/209.65  |- skos__scopeNote mesh__D019274
% 209.48/209.65       A 150 kDa neurotoxic protein produced by CLOSTRIDIUM BOTULINUM. When consumed in contaminated food it can cause paralysis and death. In its purified form, it has been used in the treatment of BLEPHAROSPASM and STRABISMUS.%A%    
% 209.48/209.65  |- skos__prefLabel mesh__D019274 Botulinum Toxin Type A
% 209.48/209.65  |- mesh__publicMeSHNote mesh__D019274 97   
% 209.48/209.65  |- skos__annotation mesh__D019274
% 209.48/209.65       /antag permitted but consider also BOTULINUM ANTITOXIN   
% 209.48/209.65  |- mesh__recordMaintainer mesh__D019274 ssb
% 209.48/209.65  |- mesh__dateCreated mesh__D019274 1996-06-10
% 209.48/209.65  |- skos__altLabel mesh__D019274 Clostridium botulinum A Toxin
% 209.48/209.65  |- skos__altLabel mesh__D019274 Lasa Brand of Botulinum A Toxin
% 209.48/209.65  |- skos__altLabel mesh__D019274 Ispen Brand of Botulinum A Toxin
% 209.48/209.65  |- mesh__recordAuthorizer mesh__D019274 sjn
% 209.48/209.65  |- skos__hiddenLabel mesh__D019274 Neurotoxin A, Botulinum
% 209.48/209.65  |- mesh__historyNote mesh__D019274 97   
% 209.48/209.65  |- skos__broader mesh__D019274smesh__D001905
% 209.48/209.65  |- skos__altLabel mesh__D019274 Clostridium Botulinum Toxin Type A
% 209.48/209.65  |- skos__altLabel mesh__D019274 Merz Brand of Botulinum A Toxin
% 209.48/209.65  |- mesh__recordOriginator mesh__D019274 TPW
% 209.48/209.65  |- mesh__historyNote mesh__D000569 96; was AMERICA 1975-95   
% 209.48/209.65  |- mesh__recordMaintainer mesh__D000569 mdb
% 209.48/209.65  |- skos__broader mesh__D000569smesh__D005842
% 209.48/209.65  |- skos__scopeNote mesh__D000569
% 209.48/209.65       The general name for NORTH AMERICA; CENTRAL AMERICA; and SOUTH AMERICA unspecified or combined.%A%    
% 209.48/209.65  |- mesh__dateRevised mesh__D000569 2001-07-25
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D000569 2003
% 209.48/209.65  |- mesh__recordAuthorizer mesh__D000569 sjn
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D000569 2004
% 209.48/209.65  |- skos__altLabel mesh__D000569 America
% 209.48/209.65  |- mesh__dateCreated mesh__D000569 1999-01-01
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D000569 2002
% 209.48/209.65  |- rdf__type mesh__D000569sskos__Concept
% 209.48/209.65  |- skos__prefLabel mesh__D000569 Americas
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D000569 2005
% 209.48/209.65  |- mesh__recordOriginator mesh__D000569 NLM
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D000569 2006
% 209.48/209.65  |- skos__annotation mesh__D000569
% 209.48/209.65       too general; avoid; prefer specific continents or countries; titles saying %22%American%22% are likely to be indexed to UNITED STATES, not here%A%  
% 209.48/209.65  |- mesh__recordAuthorizer mesh__D011291 SJN
% 209.48/209.65  |- skos__hiddenLabel mesh__D011291 Examination, Premarital
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D011291 2005
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D011291 1998
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D011291 2002
% 209.48/209.65  |- skos__broader mesh__D011291smesh__D019937
% 209.48/209.65  |- rdf__type mesh__D011291sskos__Concept
% 209.48/209.65  |- skos__altLabel mesh__D011291 Examinations, Premarital
% 209.48/209.65  |- mesh__dateRevised mesh__D011291 1997-06-20
% 209.48/209.65  |- skos__prefLabel mesh__D011291 Premarital Examinations
% 209.48/209.65  |- mesh__recordMaintainer mesh__D011291 PXP
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D011291 2001
% 209.48/209.65  |- skos__hiddenLabel mesh__D011291 Premarital Examination
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D011291 2000
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D011291 2004
% 209.48/209.65  |- mesh__dateCreated mesh__D011291 1999-01-01
% 209.48/209.65  |- mesh__recordOriginator mesh__D011291 NLM
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D011291 2006
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D011291 2003
% 209.48/209.65  |- skos__annotation mesh__D011291 IM; DF: PREMARITAL EXAM   
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D011291 1999
% 209.48/209.65  |- skos__hiddenLabel mesh__D005254 Panleukopenias, Feline
% 209.48/209.65  |- skos__hiddenLabel mesh__D005254 Plagues, Cat
% 209.48/209.65  |- skos__hiddenLabel mesh__D005254 Feline Infectious Enteritides
% 209.48/209.65  |- skos__scopeNote mesh__D005254
% 209.48/209.65       A highly contagious DNA virus infection of the cat family and of mink, characterized by fever, enteritis and bone marrow changes. It is also called feline ataxia, feline agranulocytosis, feline infectious enteritis, cat fever, cat plague, show fever.%A%    
% 209.48/209.65  |- skos__hiddenLabel mesh__D005254 Feline Distempers
% 209.48/209.65  |- skos__hiddenLabel mesh__D005254 Feline Panleukopenias
% 209.48/209.65  |- skos__hiddenLabel mesh__D005254 Infectious Enteritides, Feline
% 209.48/209.65  |- skos__hiddenLabel mesh__D005254 Enteritis, Feline Infectious
% 209.48/209.65  |- skos__altLabel mesh__D005254 Distemper, Feline
% 209.48/209.65  |- skos__hiddenLabel mesh__D005254 Infectious Enteritis, Feline
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D005254 2004
% 209.48/209.65  |- skos__prefLabel mesh__D005254 Feline Panleukopenia
% 209.48/209.65  |- mesh__recordOriginator mesh__D005254 NLM
% 209.48/209.65  |- skos__hiddenLabel mesh__D005254 Cat Plagues
% 209.48/209.65  |- mesh__recordAuthorizer mesh__D005254 sjn
% 209.48/209.65  |- skos__annotation mesh__D005254
% 209.48/209.65       caused by a parvovirus; don%27%t forget also CATS %28%NIM%29% %26% check tag ANIMALS; in minks, coord with MINK %28%IM%29%%A%  
% 209.48/209.65  |- skos__altLabel mesh__D005254 Feline Ataxia
% 209.48/209.65  |- skos__altLabel mesh__D005254 Agranulocytosis, Feline
% 209.48/209.65  |- skos__hiddenLabel mesh__D005254 Plague, Cat
% 209.48/209.65  |- mesh__dateEstablished mesh__D005254 1970-01-01
% 209.48/209.65  |- skos__historyNote mesh__D005254 Cat Diseases %28%1966-1969%29%
% 209.48/209.65  |- skos__hiddenLabel mesh__D005254 Ataxias, Feline
% 209.48/209.65  |- skos__altLabel mesh__D005254 Show Fever
% 209.48/209.65  |- skos__hiddenLabel mesh__D005254 Distempers, Feline
% 209.48/209.65  |- skos__hiddenLabel mesh__D005254 Feline Distemper
% 209.48/209.65  |- skos__hiddenLabel mesh__D005254 Feline Ataxias
% 209.48/209.65  |- skos__broader mesh__D005254smesh__D010322
% 209.48/209.65  |- skos__hiddenLabel mesh__D005254 Agranulocytoses, Feline
% 209.48/209.65  |- mesh__dateRevised mesh__D005254 2003-07-30
% 209.48/209.65  |- skos__broader mesh__D005254smesh__D002371
% 209.48/209.65  |- mesh__publicMeSHNote mesh__D005254
% 209.48/209.65       97; was FELINE INFECTIOUS ENTERITIS 1970-96   
% 209.48/209.65  |- mesh__historyNote mesh__D005254
% 209.48/209.65       97; was FELINE INFECTIOUS ENTERITIS 1970-96   
% 209.48/209.65  |- skos__altLabel mesh__D005254 Panleukopenia, Feline
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D005254 2006
% 209.48/209.65  |- skos__hiddenLabel mesh__D005254 Show Fevers
% 209.48/209.65  |- skos__altLabel mesh__D005254 Enteritis, Infectious, of Mink
% 209.48/209.65  |- mesh__dateCreated mesh__D005254 1999-01-01
% 209.48/209.65  |- skos__altLabel mesh__D005254 Cat Plague
% 209.48/209.65  |- skos__historyNote mesh__D005254 Virus Diseases %28%1966-1969%29%
% 209.48/209.65  |- skos__hiddenLabel mesh__D005254 Fevers, Show
% 209.48/209.65  |- skos__altLabel mesh__D005254 Ataxia, Feline
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D005254 2005
% 209.48/209.65  |- skos__hiddenLabel mesh__D005254 Fever, Show
% 209.48/209.65  |- rdf__type mesh__D005254sskos__Concept
% 209.48/209.65  |- mesh__recordMaintainer mesh__D005254 ags
% 209.48/209.65  |- skos__hiddenLabel mesh__D005254 Feline Agranulocytosis
% 209.48/209.65  |- skos__altLabel mesh__D005254 Feline Infectious Enteritis
% 209.48/209.65  |- skos__hiddenLabel mesh__D005254 Feline Agranulocytoses
% 209.48/209.65  |- skos__hiddenLabel mesh__D005254 Enteritides, Feline Infectious
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D010997 2000
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D010997 2005
% 209.48/209.65  |- mesh__recordMaintainer mesh__D010997 KEV
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D010997 2003
% 209.48/209.65  |- mesh__recordOriginator mesh__D010997 NLM
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D010997 2006
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D010997 2001
% 209.48/209.65  |- mesh__dateRevised mesh__D010997 1995-06-08
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D010997 2004
% 209.48/209.65  |- skos__broader mesh__D010997smesh__D010995
% 209.48/209.65  |- mesh__dateCreated mesh__D010997 1999-01-01
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D010997 2002
% 209.48/209.65  |- mesh__recordAuthorizer mesh__D010997 PLS
% 209.48/209.65  |- skos__annotation mesh__D010997
% 209.48/209.65       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%  
% 209.48/209.65  |- skos__scopeNote mesh__D010997
% 209.48/209.65       Neoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms.%A%    
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D010997 1998
% 209.48/209.65  |- skos__hiddenLabel mesh__D010997 Neoplasm, Pleural
% 209.48/209.65  |- rdf__type mesh__D010997sskos__Concept
% 209.48/209.65  |- skos__broader mesh__D010997smesh__D012142
% 209.48/209.65  |- skos__altLabel mesh__D010997 Neoplasms, Pleural
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D010997 1996
% 209.48/209.65  |- skos__prefLabel mesh__D010997 Pleural Neoplasms
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D010997 1999
% 209.48/209.65  |- skos__hiddenLabel mesh__D010997 Pleural Neoplasm
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D010997 1997
% 209.48/209.65  |- skos__altLabel mesh__D043373 Human FSH
% 209.48/209.65  |- skos__altLabel mesh__D043373 FSH, Human
% 209.48/209.65  |- mesh__dateEstablished mesh__D043373 2004-01-01
% 209.48/209.65  |- mesh__dateRevised mesh__D043373 2004-07-13
% 209.48/209.65  |- skos__altLabel mesh__D043373 hFSH
% 209.48/209.65  |- mesh__dateCreated mesh__D043373 2003-07-09
% 209.48/209.65  |- skos__altLabel mesh__D043373 Org-32489
% 209.48/209.65  |- mesh__historyNote mesh__D043373
% 209.48/209.65       2004; use FOLLICLE STIMULATING HORMONE 1987-2003; for ANTHROGON use FOLLICLE STIMULATING HORMONE 1985-2003%A%  
% 209.48/209.65  |- mesh__recordAuthorizer mesh__D043373 sjn
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D043373 2006
% 209.48/209.65  |- skos__altLabel mesh__D043373
% 209.48/209.65       FSH, human %28%follicle stimulating hormone%29%
% 209.48/209.65  |- skos__broader mesh__D043373smesh__D005640
% 209.48/209.65  |- mesh__recordOriginator mesh__D043373 lkt
% 209.48/209.65  |- skos__scopeNote mesh__D043373
% 209.48/209.65       A major gonadotropin secreted by the human adenohypophysis %28%PITUITARY GLAND, ANTERIOR%29%. Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and the LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. The alpha subunit is common in the three human pituitary glycoprotein hormones %28%TSH, LH, and FSH%29%, but the beta subunit is unique and confers its biological specificity.%A%    
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D043373 2005
% 209.48/209.65  |- skos__historyNote mesh__D043373
% 209.48/209.65       Follicle Stimulating Hormone %28%1966-2003%29%
% 209.48/209.65  |- mesh__recordMaintainer mesh__D043373 sjn
% 209.48/209.65  |- skos__annotation mesh__D043373
% 209.48/209.65       for alpha subunit, coord with GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; for beta subunit, coord with FOLLICLE STIMULATING HORMONE, BETA SUBUNIT%A%  
% 209.48/209.65  |- skos__altLabel mesh__D043373 Gonal-F
% 209.48/209.65  |- rdf__type mesh__D043373sskos__Concept
% 209.48/209.65  |- skos__altLabel mesh__D043373 Human Follicle Stimulating Hormone
% 209.48/209.65  |- skos__prefLabel mesh__D043373 Follicle Stimulating Hormone, Human
% 209.48/209.65  |- mesh__publicMeSHNote mesh__D043373
% 209.48/209.65       2004; see FOLLICLE STIMULATING HORMONE 1987-2003; for ANTHROGON see FOLLICLE STIMULATING HORMONE 1985-2003%A%  
% 209.48/209.65  |- mesh__dateCreated mesh__D015682 1989-05-25
% 209.48/209.65  |- skos__annotation mesh__D015682
% 209.48/209.65       IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 209.48/209.65  |- mesh__recordOriginator mesh__D015682 AGS
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D015682 2006
% 209.48/209.65  |- skos__hiddenLabel mesh__D015682 Proteins, Oncogenic Retroviridae
% 209.48/209.65  |- mesh__dateEstablished mesh__D015682 1990-01-01
% 209.48/209.65  |- skos__broader mesh__D015682smesh__D009856
% 209.48/209.65  |- mesh__recordAuthorizer mesh__D015682 sjn
% 209.48/209.65  |- skos__historyNote mesh__D015682 Viral Proteins %28%1980-1985%29%
% 209.48/209.65  |- mesh__publicMeSHNote mesh__D015682 90   
% 209.48/209.65  |- skos__scopeNote mesh__D015682
% 209.48/209.65       Retroviral proteins that have the ability to transform cells. They can induce sarcomas, leukemias, lymphomas, and mammary carcinomas. Not all retroviral proteins are oncogenic.%A%    
% 209.48/209.65  |- skos__historyNote mesh__D015682 Retroviridae Proteins %28%1986-1989%29%
% 209.48/209.65  |- mesh__recordMaintainer mesh__D015682 SYSTEM
% 209.48/209.65  |- skos__broader mesh__D015682smesh__D012191
% 209.48/209.65  |- skos__prefLabel mesh__D015682 Retroviridae Proteins, Oncogenic
% 209.48/209.65  |- rdf__type mesh__D015682sskos__Concept
% 209.48/209.65  |- skos__hiddenLabel mesh__D015682 Oncogenic Retroviridae Proteins
% 209.48/209.65  |- mesh__dateRevised mesh__D015682 2005-06-30
% 209.48/209.65  |- mesh__historyNote mesh__D015682 90   
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D009645 2005
% 209.48/209.65  |- skos__historyNote mesh__D009645 Norpregnanes %28%1974%29%
% 209.48/209.65  |- mesh__recordOriginator mesh__D009645 NLM
% 209.48/209.65  |- skos__scopeNote mesh__D009645
% 209.48/209.65       A synthetic steroid with progestational and contraceptive activities.%A%    
% 209.48/209.65  |- mesh__historyNote mesh__D009645
% 209.48/209.65       91%28%75%29%; was see under NORPREGNATRIENES 1975-90   
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D009645 2006
% 209.48/209.65  |- mesh__publicMeSHNote mesh__D009645
% 209.48/209.65       91; was see under NORPREGNATRIENES 1975-90   
% 209.48/209.65  |- mesh__dateCreated mesh__D009645 1974-11-14
% 209.48/209.65  |- mesh__recordAuthorizer mesh__D009645 sjn
% 209.48/209.65  |- skos__hiddenLabel mesh__D009645 A 301
% 209.48/209.65  |- rdf__type mesh__D009645sskos__Concept
% 209.48/209.65  |- mesh__dateEstablished mesh__D009645 1991-01-01
% 209.48/209.65  |- skos__broader mesh__D009645smesh__D009651
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D009645 2004
% 209.48/209.65  |- skos__prefLabel mesh__D009645 Norgestrienone
% 209.48/209.65  |- mesh__dateRevised mesh__D009645 2003-07-09
% 209.48/209.65  |- skos__historyNote mesh__D009645 Ketosteroids %28%1973-1974%29%
% 209.48/209.65  |- skos__historyNote mesh__D009645 Hydroxysteroids %28%1973-1974%29%
% 209.48/209.65  |- skos__historyNote mesh__D009645 Pregnatrienes %28%1973-1974%29%
% 209.48/209.65  |- mesh__recordMaintainer mesh__D009645 lkt
% 209.48/209.65  |- skos__hiddenLabel mesh__D009645 A301
% 209.48/209.65  |- mesh__recordOriginator mesh__D001662 SCD
% 209.48/209.65  |- mesh__historyNote mesh__D001662 98%28%88%29%   
% 209.48/209.65  |- rdf__type mesh__D001662sskos__Concept
% 209.48/209.65  |- skos__prefLabel mesh__D001662 Biliary Tract Surgical Procedures
% 209.48/209.65  |- mesh__recordAuthorizer mesh__D001662 SJN
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D001662 2003
% 209.48/209.65  |- skos__altLabel mesh__D001662 Biliary Surgical Procedures
% 209.48/209.65  |- mesh__dateRevised mesh__D001662 1997-06-20
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D001662 2000
% 209.48/209.65  |- skos__altLabel mesh__D001662 Surgical Procedure, Biliary
% 209.48/209.65  |- skos__altLabel mesh__D001662 Surgical Procedures, Biliary Tract
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D001662 2004
% 209.48/209.65  |- skos__altLabel mesh__D001662 Biliary Surgical Procedure
% 209.48/209.65  |- skos__scopeNote mesh__D001662
% 209.48/209.65       Any surgical procedure performed on the biliary tract.     
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D001662 2001
% 209.48/209.65  |- mesh__dateEstablished mesh__D001662 1988-01-01
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D001662 1998
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D001662 2005
% 209.48/209.65  |- skos__broader mesh__D001662smesh__D013505
% 209.48/209.65  |- skos__altLabel mesh__D001662 Surgical Procedures, Biliary
% 209.48/209.65  |- skos__altLabel mesh__D001662 Biliary Tract Surgical Procedure
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D001662 2002
% 209.48/209.65  |- skos__altLabel mesh__D001662 Surgical Procedure, Biliary Tract
% 209.48/209.65  |- mesh__publicMeSHNote mesh__D001662
% 209.48/209.65       98; see BILIARY TRACT SURGERY 1988-97   
% 209.48/209.65  |- mesh__recordMaintainer mesh__D001662 PXP
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D001662 1999
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D001662 2006
% 209.48/209.65  |- skos__historyNote mesh__D001662 Biliary Tract/surgery %28%1966-1987%29%
% 209.48/209.65  |- skos__annotation mesh__D001662
% 209.48/209.65       GEN only: prefer specific organ with /surg or specific biliary surg technique; do not use /util except by MeSH definition.%A%  
% 209.48/209.65  |- mesh__dateCreated mesh__D001662 1987-03-23
% 209.48/209.65  |- skos__historyNote mesh__D001662
% 209.48/209.65       Biliary Tract Diseases/surgery %28%1966-1987%29%
% 209.48/209.65  |- mesh__historyNote mesh__D028001
% 209.48/209.65       2002; use ELEUTHEROCOCC %28%NM%29% 1987-2001   
% 209.48/209.65  |- mesh__recordMaintainer mesh__D028001 sjn
% 209.48/209.65  |- mesh__dateRevised mesh__D028001 2003-07-25
% 209.48/209.65  |- skos__broader mesh__D028001smesh__D027481
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D028001 2005
% 209.48/209.65  |- mesh__recordAuthorizer mesh__D028001 sjn
% 209.48/209.65  |- rdf__type mesh__D028001sskos__Concept
% 209.48/209.65  |- skos__annotation mesh__D028001
% 209.48/209.65       do not confuse X ref SIBERIAN GINSENG with GINSENG see PANAX; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.48/209.65  |- skos__altLabel mesh__D028001 Ginseng, Siberian
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D028001 2006
% 209.48/209.65  |- skos__prefLabel mesh__D028001 Eleutherococcus
% 209.48/209.65  |- skos__altLabel mesh__D028001 Eleuthero
% 209.48/209.65  |- mesh__recordOriginator mesh__D028001 ssb
% 209.48/209.65  |- mesh__dateEstablished mesh__D028001 2002-01-01
% 209.48/209.65  |- mesh__publicMeSHNote mesh__D028001
% 209.48/209.65       2002; ELEUTHEROCOCC %28%now ELEUTHEROCOCCUS%29% was indexed under PLANT EXTRACTS 1987-2001%A%  
% 209.48/209.65  |- skos__historyNote mesh__D028001 Plant Extracts %28%1987-2001%29%
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D028001 2004
% 209.48/209.65  |- skos__scopeNote mesh__D028001
% 209.48/209.65       A plant genus in the family ARALIACEAE, order Apiales, subclass Rosidae.  It is best known as an adaptogen and a substitute for ginseng.%A%    
% 209.48/209.65  |- mesh__dateCreated mesh__D028001 2001-07-25
% 209.48/209.65  |- skos__altLabel mesh__D028001 Siberian Ginseng
% 209.48/209.65  |- skos__broader mesh__D014599Q000530smesh__D014599
% 209.48/209.65  |- mesh__preferredCombination mesh__D014599Q000530smesh__D007047
% 209.48/209.65  |- rdf__type mesh__D014599Q000530smesh__CompoundConcept
% 209.48/209.65  |- mesh__historyNote mesh__D019275 97   
% 209.48/209.65  |- skos__historyNote mesh__D019275 specific chemical %28%1966-1996%29%
% 209.48/209.65  |- mesh__recordAuthorizer mesh__D019275 sjn
% 209.48/209.65  |- skos__broader mesh__D019275smesh__D007202
% 209.48/209.65  |- skos__prefLabel mesh__D019275 Radiopharmaceuticals
% 209.48/209.65  |- mesh__dateCreated mesh__D019275 1996-06-10
% 209.48/209.65  |- mesh__dateRevised mesh__D019275 2003-07-09
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D019275 2006
% 209.48/209.65  |- skos__scopeNote mesh__D019275
% 209.48/209.65       Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. %28%Martindale, The Extra Pharmacopoeia, 30th ed, p1161%29%%A%    
% 209.48/209.65  |- rdf__type mesh__D019275sskos__Concept
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D019275 2005
% 209.48/209.65  |- skos__annotation mesh__D019275
% 209.48/209.65       pharmaceuticals as source of radiation in radiother %26% radioisotope scanning; D25-26 qualif%A%  
% 209.48/209.65  |- mesh__recordOriginator mesh__D019275 TPW
% 209.48/209.65  |- mesh__recordMaintainer mesh__D019275 ssb
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D019275 2004
% 209.48/209.65  |- mesh__publicMeSHNote mesh__D019275 97   
% 209.48/209.65  |- mesh__dateEstablished mesh__D019275 1997-01-01
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D011292 1998
% 209.48/209.65  |- mesh__recordOriginator mesh__D011292 NLM
% 209.48/209.65  |- rdf__type mesh__D011292sskos__Concept
% 209.48/209.65  |- mesh__dateEstablished mesh__D011292 1973-01-01
% 209.48/209.65  |- skos__related mesh__D011292smesh__D019072
% 209.48/209.65  |- mesh__historyNote mesh__D011292 73%28%69%29%   
% 209.48/209.65  |- skos__scopeNote mesh__D011292
% 209.48/209.65       Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics %28%ANTIBIOTIC PROPHYLAXIS%29% and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION.%A%    
% 209.48/209.65  |- skos__annotation mesh__D011292
% 209.48/209.65       coord IM with specific drug /ther use %28%IM%29%; includes anti-anxiety medication; does not include antibiotic premedication %28% = ANTIBIOTIC PROPHYLAXIS%29%%A%  
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D011292 2002
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D011292 2004
% 209.48/209.65  |- skos__broader mesh__D011292smesh__D004358
% 209.48/209.65  |- mesh__dateCreated mesh__D011292 1999-01-01
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D011292 1997
% 209.48/209.65  |- skos__hiddenLabel mesh__D011292 Premedications
% 209.48/209.65  |- skos__historyNote mesh__D011292
% 209.48/209.65       specific drug/therapeutic use %28%1966-1968%29%
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D011292 2001
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D011292 2006
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D011292 2003
% 209.48/209.65  |- mesh__recordAuthorizer mesh__D011292 PLS
% 209.48/209.65  |- skos__prefLabel mesh__D011292 Premedication
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D011292 2000
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D011292 1999
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D011292 1996
% 209.48/209.65  |- mesh__dateRevised mesh__D011292 1995-05-31
% 209.48/209.65  |- mesh__recordMaintainer mesh__D011292 TGC
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D011292 2005
% 209.48/209.65  |- skos__related mesh__D011292smesh__D011229
% 209.48/209.65  |- mesh__publicMeSHNote mesh__D011292 73   
% 209.48/209.65  |- skos__hiddenLabel mesh__D005255 Feline Parvoviruses
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D005255 2006
% 209.48/209.65  |- mesh__publicMeSHNote mesh__D005255
% 209.48/209.65       1994; see FELINE INFECTIOUS ENTERITIS VIRUS 1991-1993, see  PARVOVIRIDAE 1981-1990, see PARVOVIRUSES 1975-1980%A%  
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D005255 2002
% 209.48/209.65  |- skos__scopeNote mesh__D005255
% 209.48/209.65       A species of PARVOVIRUS chiefly affecting young cats in endemic areas, but all felines are susceptible.%A%    
% 209.48/209.65  |- skos__altLabel mesh__D005255 Feline parvovirus
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D005255 2003
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D005255 2004
% 209.48/209.65  |- skos__broader mesh__D005255smesh__D017992
% 209.48/209.65  |- skos__hiddenLabel mesh__D005255 Parvoviruses, Feline
% 209.48/209.65  |- mesh__dateRevised mesh__D005255 2001-07-25
% 209.48/209.65  |- mesh__recordAuthorizer mesh__D005255 sjn
% 209.48/209.65  |- mesh__dateEstablished mesh__D005255 1991-01-01
% 209.48/209.65  |- mesh__historyNote mesh__D005255 1994 %28%1975%29%   
% 209.48/209.65  |- mesh__recordOriginator mesh__D005255 NLM
% 209.48/209.65  |- mesh__dateCreated mesh__D005255 1974-12-12
% 209.48/209.65  |- rdf__type mesh__D005255sskos__Concept
% 209.48/209.65  |- skos__annotation mesh__D005255
% 209.48/209.65       infection: coord IM with PARVOVIRIDAE INFECTIONS %28%IM%29%   
% 209.48/209.65  |- mesh__recordMaintainer mesh__D005255 ags
% 209.48/209.65  |- mesh__activeMeSHYear mesh__D005255 2005
% 209.48/209.65  |- skos__prefLabel mesh__D005255 Parvovirus, Feline
% 209.48/209.65  |- mesh__recordMaintainer mesh__D010998 lkt
% 209.48/209.65  |- skos__related mesh__D010998smesh__D010994
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D010998 2006
% 209.48/209.66  |- skos__hiddenLabel mesh__D010998 Pleuritides
% 209.48/209.66  |- mesh__dateRevised mesh__D010998 2005-06-30
% 209.48/209.66  |- skos__altLabel mesh__D010998 Pleuritis
% 209.48/209.66  |- mesh__dateCreated mesh__D010998 1999-01-01
% 209.48/209.66  |- skos__broader mesh__D010998smesh__D012141
% 209.48/209.66  |- mesh__recordOriginator mesh__D010998 NLM
% 209.48/209.66  |- skos__broader mesh__D010998smesh__D010995
% 209.48/209.66  |- skos__prefLabel mesh__D010998 Pleurisy
% 209.48/209.66  |- rdf__type mesh__D010998sskos__Concept
% 209.48/209.66  |- mesh__recordAuthorizer mesh__D010998 sjn
% 209.48/209.66  |- skos__scopeNote mesh__D010998
% 209.48/209.66       INFLAMMATION of PLEURA, the lining of the LUNG. When PARIETAL PLEURA is involved, there is pleuritic CHEST PAIN.%A%    
% 209.48/209.66  |- skos__hiddenLabel mesh__D010998 Pleurisies
% 209.48/209.66  |- skos__annotation mesh__D015683 coord with specific virus %28%IM%29%   
% 209.48/209.66  |- rdf__type mesh__D015683sskos__Concept
% 209.48/209.66  |- skos__hiddenLabel mesh__D015683 Viral Proteins, gag
% 209.48/209.66  |- skos__broader mesh__D015683smesh__D012191
% 209.48/209.66  |- skos__altLabel mesh__D015683 gag Gene Products
% 209.48/209.66  |- mesh__dateRevised mesh__D015683 2005-06-30
% 209.48/209.66  |- skos__historyNote mesh__D015683 Retroviridae Proteins %28%1986-1989%29%
% 209.48/209.66  |- skos__hiddenLabel mesh__D015683 Protein, gag
% 209.48/209.66  |- skos__hiddenLabel mesh__D015683 Antigens, gag
% 209.48/209.66  |- skos__broader mesh__D015683smesh__D014758
% 209.48/209.66  |- skos__altLabel mesh__D015683 gag Polyprotein
% 209.48/209.66  |- skos__historyNote mesh__D015683 Antigens, Viral %28%1983-1989%29%
% 209.48/209.66  |- skos__hiddenLabel mesh__D015683 gag Proteins, Viral
% 209.48/209.66  |- skos__hiddenLabel mesh__D015683 Proteins, gag Viral
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D015683 2006
% 209.48/209.66  |- skos__hiddenLabel mesh__D015683 Polyprotein, gag
% 209.48/209.66  |- skos__altLabel mesh__D015683 Viral gag Proteins
% 209.48/209.66  |- mesh__dateEstablished mesh__D015683 1990-01-01
% 209.48/209.66  |- skos__prefLabel mesh__D015683 Gene Products, gag
% 209.48/209.66  |- skos__historyNote mesh__D015683 Viral Core Proteins %28%1986-1989%29%
% 209.48/209.66  |- skos__altLabel mesh__D015683 gag Viral Proteins
% 209.48/209.66  |- skos__hiddenLabel mesh__D015683 gag Gene Product
% 209.48/209.66  |- mesh__recordMaintainer mesh__D015683 SYSTEM
% 209.48/209.66  |- skos__scopeNote mesh__D015683
% 209.48/209.66       Proteins coded by the retroviral gag gene. The products are usually synthesized as protein precursors or POLYPROTEINS, which are then cleaved by viral proteases to yield the final products. Many of the final products are associated with the nucleoprotein core of the virion. gag is short for group-specific antigen.%A%    
% 209.48/209.66  |- skos__altLabel mesh__D015683 Gene Product, gag
% 209.48/209.66  |- mesh__historyNote mesh__D015683 90   
% 209.48/209.66  |- skos__altLabel mesh__D015683 gag Protein
% 209.48/209.66  |- skos__hiddenLabel mesh__D015683 Proteins, Viral gag
% 209.48/209.66  |- skos__altLabel mesh__D015683 gag Polyproteins
% 209.48/209.66  |- mesh__publicMeSHNote mesh__D015683 90   
% 209.48/209.66  |- skos__altLabel mesh__D015683 Retroviral Antigen gag Protein
% 209.48/209.66  |- mesh__recordAuthorizer mesh__D015683 sjn
% 209.48/209.66  |- skos__altLabel mesh__D015683 gag Antigens
% 209.48/209.66  |- skos__broader mesh__D015683smesh__D020815
% 209.48/209.66  |- mesh__recordOriginator mesh__D015683 AGS
% 209.48/209.66  |- mesh__dateCreated mesh__D015683 1989-07-06
% 209.48/209.66  |- skos__hiddenLabel mesh__D015683 Polyproteins, gag
% 209.48/209.66  |- skos__historyNote mesh__D015683 Viral Proteins %28%1972-1989%29%
% 209.48/209.66  |- skos__historyNote mesh__D009646 Aminocaproic Acids %28%1966-1971%29%
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D009646 2003
% 209.48/209.66  |- skos__scopeNote mesh__D009646
% 209.48/209.66       An unnatural amino acid that is used experimentally to study protein structure and function. It is structurally similar to METHIONINE, however it does not contain SULFUR.%A%    
% 209.48/209.66  |- skos__prefLabel mesh__D009646 Norleucine
% 209.48/209.66  |- rdf__type mesh__D009646sskos__Concept
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D009646 2004
% 209.48/209.66  |- mesh__dateEstablished mesh__D009646 1991-01-01
% 209.48/209.66  |- mesh__historyNote mesh__D009646
% 209.48/209.66       91%28%72%29%; was see under AMINOCAPROIC ACIDS 1972-90   
% 209.48/209.66  |- mesh__recordOriginator mesh__D009646 NLM
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D009646 2002
% 209.48/209.66  |- skos__hiddenLabel mesh__D009646 Norleucine, L Isomer
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D009646 2005
% 209.48/209.66  |- mesh__recordMaintainer mesh__D009646 jmp
% 209.48/209.66  |- skos__hiddenLabel mesh__D009646 L-Isomer Norleucine
% 209.48/209.66  |- mesh__publicMeSHNote mesh__D009646
% 209.48/209.66       91; was see under AMINOCAPROIC ACIDS 1972-90   
% 209.48/209.66  |- mesh__dateRevised mesh__D009646 2001-07-25
% 209.48/209.66  |- mesh__recordAuthorizer mesh__D009646 sjn
% 209.48/209.66  |- mesh__dateCreated mesh__D009646 1999-01-01
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D009646 2006
% 209.48/209.66  |- skos__broader mesh__D009646smesh__D000614
% 209.48/209.66  |- mesh__dateCreated mesh__D001663 1999-01-01
% 209.48/209.66  |- skos__hiddenLabel mesh__D001663 Calcium Salt Bilirubin
% 209.48/209.66  |- mesh__recordAuthorizer mesh__D001663 sjn
% 209.48/209.66  |- skos__annotation mesh__D001663
% 209.48/209.66       BILIRUBIN ENCEPHALOPATHY see KERNICTERUS is available   
% 209.48/209.66  |- mesh__recordOriginator mesh__D001663 NLM
% 209.48/209.66  |- skos__broader mesh__D001663smesh__D001654
% 209.48/209.66  |- skos__altLabel mesh__D001663 Calcium Bilirubinate
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D001663 2006
% 209.48/209.66  |- skos__altLabel mesh__D001663 Bilirubin IX alpha
% 209.48/209.66  |- skos__hiddenLabel mesh__D001663 delta Bilirubin
% 209.48/209.66  |- skos__hiddenLabel mesh__D001663 Monosodium Salt Bilirubin
% 209.48/209.66  |- skos__hiddenLabel mesh__D001663 Bilirubinate, Calcium
% 209.48/209.66  |- skos__prefLabel mesh__D001663 Bilirubin
% 209.48/209.66  |- skos__hiddenLabel mesh__D001663 Salt Bilirubin, Calcium
% 209.48/209.66  |- skos__hiddenLabel mesh__D001663 Disodium Salt Bilirubin
% 209.48/209.66  |- skos__scopeNote mesh__D001663
% 209.48/209.66       A bile pigment that is a degradation product of HEME.     
% 209.48/209.66  |- mesh__dateRevised mesh__D001663 2005-06-30
% 209.48/209.66  |- rdf__type mesh__D001663sskos__Concept
% 209.48/209.66  |- skos__related mesh__D001663smesh__D006932
% 209.48/209.66  |- mesh__recordMaintainer mesh__D001663 ssb
% 209.48/209.66  |- skos__altLabel mesh__D028002 Ginseng, Alaskan
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D028002 2006
% 209.48/209.66  |- mesh__publicMeSHNote mesh__D028002
% 209.48/209.66       2002; for ECHINOPANAX see GINSENG 1984-2001   
% 209.48/209.66  |- skos__altLabel mesh__D028002 Echinopanax
% 209.48/209.66  |- rdf__type mesh__D028002sskos__Concept
% 209.48/209.66  |- skos__historyNote mesh__D028002 Plants, Medicinal %28%1983-2001%29%
% 209.48/209.66  |- skos__annotation mesh__D028002
% 209.48/209.66       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D028002 2003
% 209.48/209.66  |- mesh__dateCreated mesh__D028002 2001-07-25
% 209.48/209.66  |- skos__scopeNote mesh__D028002
% 209.48/209.66       A plant genus in the family ARALIACEAE, order Apiales, subclass Rosidae. It is the source of cirensenosides %28%triterpenoid saponins%29%.%A%    
% 209.48/209.66  |- mesh__recordOriginator mesh__D028002 ssb
% 209.48/209.66  |- mesh__recordMaintainer mesh__D028002 ssb
% 209.48/209.66  |- skos__altLabel mesh__D028002 Echinopanax horridus
% 209.48/209.66  |- skos__broader mesh__D028002smesh__D027481
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D028002 2004
% 209.48/209.66  |- mesh__dateEstablished mesh__D028002 2002-01-01
% 209.48/209.66  |- skos__altLabel mesh__D028002 Devil%27%s Club
% 209.48/209.66  |- skos__prefLabel mesh__D028002 Oplopanax
% 209.48/209.66  |- mesh__historyNote mesh__D028002
% 209.48/209.66       2002; for ECHINOPANAX use GINSENG 1984-2001   
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D028002 2002
% 209.48/209.66  |- mesh__recordAuthorizer mesh__D028002 sjn
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D028002 2005
% 209.48/209.66  |- skos__altLabel mesh__D019276 Glycocalix
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D019276 2001
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D019276 2006
% 209.48/209.66  |- skos__historyNote mesh__D019276 Polysaccharides %28%1976-1996%29%
% 209.48/209.66  |- skos__hiddenLabel mesh__D019276 Coat, Cell
% 209.48/209.66  |- mesh__dateEstablished mesh__D019276 1997-01-01
% 209.48/209.66  |- rdf__type mesh__D019276sskos__Concept
% 209.48/209.66  |- skos__prefLabel mesh__D019276 Glycocalyx
% 209.48/209.66  |- skos__scopeNote mesh__D019276
% 209.48/209.66       The carbohydrate-rich zone on the cell surface. This zone can be visualized by a variety of stains as well as by its affinity for lectins. Although most of the carbohydrate is attached to intrinsic plasma membrane molecules, the glycocalyx usually also contains both glycoproteins and proteoglycans that have been secreted into the extracellular space and then adsorbed onto the cell surface. %28%Alberts et al., Molecular Biology of the Cell, 3d ed, p502%29%%A%    
% 209.48/209.66  |- skos__hiddenLabel mesh__D019276 Cell Coats
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D019276 2005
% 209.48/209.66  |- skos__hiddenLabel mesh__D019276 Coats, Cell
% 209.48/209.66  |- mesh__recordAuthorizer mesh__D019276 sjn
% 209.48/209.66  |- skos__historyNote mesh__D019276 Glycoproteins %28%1976-1996%29%
% 209.48/209.66  |- skos__altLabel mesh__D019276 Cell Coat
% 209.48/209.66  |- mesh__dateCreated mesh__D019276 1996-06-10
% 209.48/209.66  |- mesh__publicMeSHNote mesh__D019276
% 209.48/209.66       97; GLYCOCALYX was indexed under GLYCOPROTEINS %26% POLYSACCHARIDES 1976-96%A%  
% 209.48/209.66  |- skos__broader mesh__D019276smesh__D021961
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D019276 2002
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D019276 2004
% 209.48/209.66  |- skos__annotation mesh__D019276
% 209.48/209.66       a carbohydrate-rich zone on cell surface   
% 209.48/209.66  |- mesh__recordMaintainer mesh__D019276 MSR
% 209.48/209.66  |- mesh__recordOriginator mesh__D019276 TPW
% 209.48/209.66  |- mesh__dateRevised mesh__D019276 2000-06-22
% 209.48/209.66  |- mesh__historyNote mesh__D019276 97; was GLYCOCALYX %28%NM%29% 1976-96   
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D019276 2003
% 209.48/209.66  |- skos__hiddenLabel mesh__D011293 Tensions, Premenstrual
% 209.48/209.66  |- skos__prefLabel mesh__D011293 Premenstrual Syndrome
% 209.48/209.66  |- skos__broader mesh__D011293smesh__D008599
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D011293 2004
% 209.48/209.66  |- mesh__publicMeSHNote mesh__D011293
% 209.48/209.66       86; was PREMENSTRUAL TENSION 1963-85   
% 209.48/209.66  |- mesh__dateCreated mesh__D011293 1999-01-01
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D011293 2006
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D011293 2003
% 209.48/209.66  |- mesh__historyNote mesh__D011293 86; was PREMENSTRUAL TENSION 1963-85   
% 209.48/209.66  |- skos__scopeNote mesh__D011293
% 209.48/209.66       A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse %28%such as pain, water-retention, anxiety, cravings, and depression%29% and they diminish markedly 2 or 3 days after the initiation of menses.%A%    
% 209.48/209.66  |- mesh__onlineNote mesh__D011293
% 209.48/209.66       use PREMENSTRUAL SYNDROME to search PREMENSTRUAL TENSION 1966-85%A%  
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D011293 2005
% 209.48/209.66  |- skos__hiddenLabel mesh__D011293 Premenstrual Syndromes
% 209.48/209.66  |- mesh__recordOriginator mesh__D011293 NLM
% 209.48/209.66  |- skos__hiddenLabel mesh__D011293 Tension, Premenstrual
% 209.48/209.66  |- mesh__recordMaintainer mesh__D011293 jls
% 209.48/209.66  |- mesh__recordAuthorizer mesh__D011293 jls
% 209.48/209.66  |- skos__hiddenLabel mesh__D011293 Syndrome, Premenstrual
% 209.48/209.66  |- rdf__type mesh__D011293sskos__Concept
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D011293 2005A
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D011293 2002
% 209.48/209.66  |- skos__hiddenLabel mesh__D011293 Premenstrual Tensions
% 209.48/209.66  |- mesh__dateRevised mesh__D011293 2004-07-30
% 209.48/209.66  |- skos__hiddenLabel mesh__D011293 Syndromes, Premenstrual
% 209.48/209.66  |- skos__scopeNote mesh__D005256
% 209.48/209.66       A species of GAMMARETROVIRUS causing leukemia, lymphosarcoma, immune deficiency, or other degenerative diseases in cats. Several cellular oncogenes confer on FeLV the ability to induce sarcomas %28%see also SARCOMA VIRUSES, FELINE%29%.%A%    
% 209.48/209.66  |- mesh__recordAuthorizer mesh__D005256 sjn
% 209.48/209.66  |- rdf__type mesh__D005256sskos__Concept
% 209.48/209.66  |- skos__hiddenLabel mesh__D005256 Leukemia Viruses, Cat
% 209.48/209.66  |- mesh__recordOriginator mesh__D005256 NLM
% 209.48/209.66  |- skos__hiddenLabel mesh__D005256 Lymphoma Viruses, Feline
% 209.48/209.66  |- skos__broader mesh__D005256smesh__D017988
% 209.48/209.66  |- mesh__dateCreated mesh__D005256 1999-01-01
% 209.48/209.66  |- skos__prefLabel mesh__D005256 Leukemia Virus, Feline
% 209.48/209.66  |- mesh__recordMaintainer mesh__D005256 sjn
% 209.48/209.66  |- mesh__historyNote mesh__D005256 94; was FELINE LEUKEMIA VIRUS 1973-93   
% 209.48/209.66  |- mesh__dateEstablished mesh__D005256 1973-01-01
% 209.48/209.66  |- skos__altLabel mesh__D005256 Feline Lymphoma Virus
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D005256 2006
% 209.48/209.66  |- skos__hiddenLabel mesh__D005256 Cat Leukemia Viruses
% 209.48/209.66  |- skos__altLabel mesh__D005256 Cat Leukemia Virus
% 209.48/209.66  |- skos__historyNote mesh__D005256 Retroviridae %28%1966-1972%29%
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D005256 2005
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D005256 2004
% 209.48/209.66  |- skos__related mesh__D005256smesh__D005253
% 209.48/209.66  |- skos__hiddenLabel mesh__D005256 Leukemia Viruses, Feline
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D005256 2003
% 209.48/209.66  |- skos__annotation mesh__D005256
% 209.48/209.66       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% or if so specified by author index instead under LEUKEMIA, FELINE %28%IM but see note there%29% or FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME %28%IM but see note there%29%; DF: FELV%A%  
% 209.48/209.66  |- skos__hiddenLabel mesh__D005256 Leukemia Virus, Cat
% 209.48/209.66  |- skos__hiddenLabel mesh__D005256 Feline Lymphoma Viruses
% 209.48/209.66  |- mesh__publicMeSHNote mesh__D005256
% 209.48/209.66       94; was FELINE LEUKEMIA VIRUS 1973-93   
% 209.48/209.66  |- skos__altLabel mesh__D005256 Feline leukemia virus
% 209.48/209.66  |- skos__altLabel mesh__D005256 FeLV
% 209.48/209.66  |- skos__hiddenLabel mesh__D005256 Lymphoma Virus, Feline
% 209.48/209.66  |- skos__hiddenLabel mesh__D005256 Feline Leukemia Viruses
% 209.48/209.66  |- mesh__dateRevised mesh__D005256 2001-08-07
% 209.48/209.66  |- mesh__onlineNote mesh__D005256
% 209.48/209.66       use LEUKEMIA VIRUS, FELINE to search FELINE LEUKEMIA VIRUS 1973-93%A%  
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D005256 2002
% 209.48/209.66  |- mesh__dateRevised mesh__D010999 2003-07-09
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D010999 2004
% 209.48/209.66  |- skos__historyNote mesh__D010999 Salamandridae %28%1975-1980%29%
% 209.48/209.66  |- skos__historyNote mesh__D010999 Urodela %28%1966-1974%29%
% 209.48/209.66  |- mesh__recordAuthorizer mesh__D010999 sjn
% 209.48/209.66  |- skos__hiddenLabel mesh__D010999 Pleurodele
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D010999 2006
% 209.48/209.66  |- mesh__publicMeSHNote mesh__D010999
% 209.48/209.66       91; was see under SALAMANDRIDAE 1981-90   
% 209.48/209.66  |- mesh__historyNote mesh__D010999
% 209.48/209.66       91%28%81%29%; was see under SALAMANDRIDAE 1981-90   
% 209.48/209.66  |- mesh__dateEstablished mesh__D010999 1991-01-01
% 209.48/209.66  |- skos__broader mesh__D010999smesh__D012455
% 209.48/209.66  |- skos__scopeNote mesh__D010999
% 209.48/209.66       A genus of aquatic newts belonging to the family Salamandridae and sometimes referred to as %22%spiny%22% tritons. There are two species P. waltlii and P. poireti. P. waltlii is commonly used in the laboratory. Since this genus adapts to aquarium living, it is easy to maintain in laboratories.%A%    
% 209.48/209.66  |- mesh__dateCreated mesh__D010999 1980-05-12
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D010999 2005
% 209.48/209.66  |- skos__historyNote mesh__D010999 Amphibia %28%1966-1980%29%
% 209.48/209.66  |- skos__prefLabel mesh__D010999 Pleurodeles
% 209.48/209.66  |- rdf__type mesh__D010999sskos__Concept
% 209.48/209.66  |- mesh__recordMaintainer mesh__D010999 ags
% 209.48/209.66  |- skos__annotation mesh__D010999
% 209.48/209.66       aquatic newt; NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 209.48/209.66  |- mesh__recordOriginator mesh__D010999 EC
% 209.48/209.66  |- skos__historyNote mesh__D015684 Reverse Transcriptase %28%1977-1989%29%
% 209.48/209.66  |- skos__related mesh__D015684smesh__D012194
% 209.48/209.66  |- mesh__recordAuthorizer mesh__D015684 sjn
% 209.48/209.66  |- mesh__recordOriginator mesh__D015684 AGS
% 209.48/209.66  |- skos__hiddenLabel mesh__D015684 Protein, pol
% 209.48/209.66  |- skos__historyNote mesh__D015684 Viral Proteins %28%1977-1989%29%
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D015684 2006
% 209.48/209.66  |- mesh__dateEstablished mesh__D015684 1990-01-01
% 209.48/209.66  |- skos__broader mesh__D015684smesh__D012191
% 209.48/209.66  |- mesh__recordMaintainer mesh__D015684 SYSTEM
% 209.48/209.66  |- skos__altLabel mesh__D015684 pol Polyprotein
% 209.48/209.66  |- skos__altLabel mesh__D015684 Gene Product, pol
% 209.48/209.66  |- skos__altLabel mesh__D015684 pol Protein
% 209.48/209.66  |- mesh__dateRevised mesh__D015684 2005-06-30
% 209.48/209.66  |- skos__hiddenLabel mesh__D015684 pol Gene Product
% 209.48/209.66  |- skos__altLabel mesh__D015684 pol Polyproteins
% 209.48/209.66  |- skos__broader mesh__D015684smesh__D014758
% 209.48/209.66  |- skos__scopeNote mesh__D015684
% 209.48/209.66       Retroviral proteins coded by the pol gene. They are usually synthesized as a protein precursor %28%POLYPROTEINS%29% and later cleaved into final products that include reverse transcriptase, endonuclease/integrase, and viral protease. Sometimes they are synthesized as a gag-pol fusion protein %28%FUSION PROTEINS, GAG-POL%29%. pol is short for polymerase, the enzyme class of reverse transcriptase.%A%    
% 209.48/209.66  |- skos__related mesh__D015684smesh__D010447
% 209.48/209.66  |- skos__hiddenLabel mesh__D015684 Polyprotein, pol
% 209.48/209.66  |- mesh__publicMeSHNote mesh__D015684 90   
% 209.48/209.66  |- skos__broader mesh__D015684smesh__D020815
% 209.48/209.66  |- skos__hiddenLabel mesh__D015684 Polyproteins, pol
% 209.48/209.66  |- mesh__dateCreated mesh__D015684 1989-10-12
% 209.48/209.66  |- skos__historyNote mesh__D015684 Retroviridae Proteins %28%1983-1989%29%
% 209.48/209.66  |- skos__annotation mesh__D015684 coord with specific virus %28%IM%29%   
% 209.48/209.66  |- rdf__type mesh__D015684sskos__Concept
% 209.48/209.66  |- skos__prefLabel mesh__D015684 Gene Products, pol
% 209.48/209.66  |- mesh__historyNote mesh__D015684 90   
% 209.48/209.66  |- skos__related mesh__D015684smesh__D004720
% 209.48/209.66  |- skos__altLabel mesh__D015684 pol Gene Products
% 209.48/209.66  |- mesh__recordAuthorizer mesh__D009647 sjn
% 209.48/209.66  |- rdf__type mesh__D009647sskos__Concept
% 209.48/209.66  |- mesh__recordMaintainer mesh__D009647 ssb
% 209.48/209.66  |- skos__broader mesh__D009647smesh__D004837
% 209.48/209.66  |- mesh__historyNote mesh__D009647 66%28%63%29%   
% 209.48/209.66  |- skos__broader mesh__D009647smesh__D009638
% 209.48/209.66  |- skos__prefLabel mesh__D009647 Normetanephrine
% 209.48/209.66  |- mesh__publicMeSHNote mesh__D009647 66   
% 209.48/209.66  |- skos__scopeNote mesh__D009647
% 209.48/209.66       A methylated metabolite of norepinephrine that is excreted in the urine and found in certain tissues. It is a marker for tumors.%A%    
% 209.48/209.66  |- mesh__dateEstablished mesh__D009647 1966-01-01
% 209.48/209.66  |- mesh__dateRevised mesh__D009647 2005-06-30
% 209.48/209.66  |- skos__hiddenLabel mesh__D009647 3 Methoxynoradrenaline
% 209.48/209.66  |- skos__altLabel mesh__D009647 Normetadrenaline
% 209.48/209.66  |- mesh__dateCreated mesh__D009647 1999-01-01
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D009647 2006
% 209.48/209.66  |- skos__altLabel mesh__D009647 3-Methoxynoradrenaline
% 209.48/209.66  |- skos__broader mesh__D009647smesh__D014408
% 209.48/209.66  |- mesh__recordOriginator mesh__D009647 NLM
% 209.48/209.66  |- mesh__publicMeSHNote mesh__D001664
% 209.48/209.66       91; was see under BILIRUBIN 1976-90   
% 209.48/209.66  |- rdf__type mesh__D001664sskos__Concept
% 209.48/209.66  |- mesh__recordOriginator mesh__D001664 RLS
% 209.48/209.66  |- skos__hiddenLabel mesh__D001664 IX alpha, Biliverdin
% 209.48/209.66  |- skos__historyNote mesh__D001664 Bilirubin %28%1969-1975%29%
% 209.48/209.66  |- mesh__dateRevised mesh__D001664 2005-07-30
% 209.48/209.66  |- skos__hiddenLabel mesh__D001664 IX, Biliverdin
% 209.48/209.66  |- skos__hiddenLabel mesh__D001664 alpha, Biliverdin IX
% 209.48/209.66  |- mesh__recordMaintainer mesh__D001664 jls
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D001664 2006A
% 209.48/209.66  |- skos__altLabel mesh__D001664 Biliverdin
% 209.48/209.66  |- mesh__dateEstablished mesh__D001664 1991-01-01
% 209.48/209.66  |- skos__prefLabel mesh__D001664 Biliverdine
% 209.48/209.66  |- skos__scopeNote mesh__D001664
% 209.48/209.66       1,3,6,7-Tetramethyl-4,5-dicarboxyethyl-2,8-divinylbilenone. Biosynthesized from hemoglobin as a precursor of bilirubin. Occurs in the bile of amphibia and of birds, but not in normal human bile or serum.%A%    
% 209.48/209.66  |- skos__annotation mesh__D001664
% 209.48/209.66       a bile pigment in amphibia %26% birds but not in normal human bile; /biosyn /physiol permitted%A%  
% 209.48/209.66  |- skos__altLabel mesh__D001664 Uteroverdine
% 209.48/209.66  |- skos__altLabel mesh__D001664 Ooecyan
% 209.48/209.66  |- skos__altLabel mesh__D001664 Dehydrobilirubin
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D001664 2006
% 209.48/209.66  |- mesh__dateCreated mesh__D001664 1975-07-18
% 209.48/209.66  |- mesh__recordAuthorizer mesh__D001664 jls
% 209.48/209.66  |- skos__broader mesh__D001664smesh__D001663
% 209.48/209.66  |- mesh__historyNote mesh__D001664
% 209.48/209.66       91%28%76%29%; was see under BILIRUBIN 1976-90   
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D019277 1999
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D019277 2002
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D019277 1998
% 209.48/209.66  |- skos__broader mesh__D019277smesh__D013816
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D019277 2004
% 209.48/209.66  |- skos__prefLabel mesh__D019277 Entropy
% 209.48/209.66  |- mesh__dateEstablished mesh__D019277 1997-01-01
% 209.48/209.66  |- mesh__historyNote mesh__D019277 97   
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D019277 2001
% 209.48/209.66  |- mesh__publicMeSHNote mesh__D019277 97   
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D019277 2003
% 209.48/209.66  |- skos__hiddenLabel mesh__D019277 Entropies
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D019277 1997
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D019277 2000
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D019277 2006
% 209.48/209.66  |- skos__scopeNote mesh__D019277
% 209.48/209.66       The measure of that part of the heat or energy of a system which is not available to perform work. Entropy increases in all natural %28%spontaneous and irreversible%29% processes. %28%From Dorland, 28th ed%29%%A%    
% 209.48/209.66  |- rdf__type mesh__D019277sskos__Concept
% 209.48/209.66  |- mesh__dateCreated mesh__D019277 1996-06-10
% 209.48/209.66  |- skos__annotation mesh__D019277
% 209.48/209.66       a principle of thermodynamics wherein %22%heat or energy of a system is not available to perform work%22%; no qualif%A%  
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D019277 2005
% 209.48/209.66  |- skos__historyNote mesh__D019277 Thermodynamics %28%1966-1996%29%
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D011294 2006
% 209.48/209.66  |- skos__historyNote mesh__D011294 Propylamines %28%1966-1974%29%
% 209.48/209.66  |- skos__hiddenLabel mesh__D011294 A Ba C 50,005
% 209.48/209.66  |- mesh__dateEstablished mesh__D011294 1987-01-01
% 209.48/209.66  |- mesh__recordOriginator mesh__D011294 RLS
% 209.48/209.66  |- mesh__publicMeSHNote mesh__D011294 87   
% 209.48/209.66  |- skos__hiddenLabel mesh__D011294 H8062
% 209.48/209.66  |- mesh__dateCreated mesh__D011294 1986-06-12
% 209.48/209.66  |- skos__hiddenLabel mesh__D011294 Hydrochloride, Prenalterol
% 209.48/209.66  |- mesh__recordMaintainer mesh__D011294 ssb
% 209.48/209.66  |- rdf__type mesh__D011294sskos__Concept
% 209.48/209.66  |- skos__prefLabel mesh__D011294 Prenalterol
% 209.48/209.66  |- skos__broader mesh__D011294smesh__D050198
% 209.48/209.66  |- skos__historyNote mesh__D011294
% 209.48/209.66       Practolol/analogs and derivatives %28%1975-1986%29%
% 209.48/209.66  |- skos__hiddenLabel mesh__D011294 ABaC50,005
% 209.48/209.66  |- skos__broader mesh__D011294smesh__D011412
% 209.48/209.66  |- mesh__recordAuthorizer mesh__D011294 sjn
% 209.48/209.66  |- skos__hiddenLabel mesh__D011294 KWD2033
% 209.48/209.66  |- skos__hiddenLabel mesh__D011294 H13322
% 209.48/209.66  |- skos__scopeNote mesh__D011294
% 209.48/209.66       A partial adrenergic agonist with functional beta 1-receptor specificity and inotropic effect. It is effective in the treatment of acute cardiac failure, postmyocardial infarction low-output syndrome, shock, and reducing orthostatic hypotension in the Shy-Drager syndrome.%A%    
% 209.48/209.66  |- mesh__historyNote mesh__D011294 87   
% 209.48/209.66  |- mesh__dateRevised mesh__D011294 2005-06-30
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D005257 1999
% 209.48/209.66  |- mesh__dateCreated mesh__D005257 1999-01-01
% 209.48/209.66  |- skos__prefLabel mesh__D005257 Fellowships and Scholarships
% 209.48/209.66  |- skos__scopeNote mesh__D005257
% 209.48/209.66       Stipends or grants-in-aid granted by foundations or institutions to individuals for study.%A%    
% 209.48/209.66  |- skos__hiddenLabel mesh__D005257 Scholarships and Fellowships
% 209.48/209.66  |- mesh__dateEstablished mesh__D005257 1979-01-01
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D005257 2006
% 209.48/209.66  |- skos__hiddenLabel mesh__D005257 Fellowship
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D005257 1998
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D005257 2002
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D005257 1997
% 209.48/209.66  |- mesh__onlineNote mesh__D005257
% 209.48/209.66       to search SCHOLARSHIPS %26% FELLOWSHIPS use FELLOWSHIPS AND SCHOLARSHIPS 1975-78 %26% TRAINING SUPPORT 1966-74%A%  
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D005257 2005
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D005257 2004
% 209.48/209.66  |- mesh__recordOriginator mesh__D005257 NLM
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D005257 1996
% 209.48/209.66  |- skos__historyNote mesh__D005257 Training Support %28%1966-1974%29%
% 209.48/209.66  |- skos__annotation mesh__D005257
% 209.48/209.66       SPEC qualif; specify agency or govt %26% geog if possible; DF: FELLOWSHIPS%A%  
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D005257 2003
% 209.48/209.66  |- mesh__dateRevised mesh__D005257 1995-05-18
% 209.48/209.66  |- mesh__recordMaintainer mesh__D005257 TAP
% 209.48/209.66  |- mesh__recordAuthorizer mesh__D005257 PLS
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D005257 2001
% 209.48/209.66  |- skos__hiddenLabel mesh__D005257 Scholarship
% 209.48/209.66  |- rdf__type mesh__D005257sskos__Concept
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D005257 2000
% 209.48/209.66  |- skos__broader mesh__D005257smesh__D014146
% 209.48/209.66  |- mesh__historyNote mesh__D005257
% 209.48/209.66       79; was SCHOLARSHIPS AND FELLOWSHIPS 1963-65; FELLOWSHIPS %26% SCHOLARSHIPS were see under TRAINING SUPPORT 1966-78%A%  
% 209.48/209.66  |- mesh__publicMeSHNote mesh__D005257
% 209.48/209.66       79; was SCHOLARSHIPS AND FELLOWSHIPS 1963-65; FELLOWSHIPS %26% SCHOLARSHIPS were see under TRAINING SUPPORT 1966-78%A%  
% 209.48/209.66  |- skos__hiddenLabel mesh__D015685 Fused Protein, gag-pol
% 209.48/209.66  |- skos__hiddenLabel mesh__D015685 Fusion Proteins, gag pol
% 209.48/209.66  |- skos__altLabel mesh__D015685 gag-pol Fusion Proteins
% 209.48/209.66  |- mesh__dateCreated mesh__D015685 1989-07-07
% 209.48/209.66  |- mesh__recordMaintainer mesh__D015685 SYSTEM
% 209.48/209.66  |- mesh__dateEstablished mesh__D015685 1991-01-01
% 209.48/209.66  |- skos__broader mesh__D015685smesh__D015683
% 209.48/209.66  |- skos__scopeNote mesh__D015685
% 209.48/209.66       Polyprotein products of a fused portion of retroviral mRNA containing the gag and pol genes. The polyprotein is synthesized only five percent of the time since pol is out of frame with gag, and is generated by ribosomal frameshifting.%A%    
% 209.48/209.66  |- skos__prefLabel mesh__D015685 Fusion Proteins, gag-pol
% 209.48/209.66  |- skos__annotation mesh__D015685 coord with specific virus %28%IM%29%   
% 209.48/209.66  |- rdf__type mesh__D015685sskos__Concept
% 209.48/209.66  |- mesh__onlineNote mesh__D015685
% 209.48/209.66       use GENE PRODUCTS, GAG to search GAG-POL FUSION PROTEINS 1990%A%  
% 209.48/209.66  |- mesh__recordAuthorizer mesh__D015685 sjn
% 209.48/209.66  |- skos__hiddenLabel mesh__D015685 gag pol Protein
% 209.48/209.66  |- skos__hiddenLabel mesh__D015685 Proteins, gag-pol Fusion
% 209.48/209.66  |- mesh__recordOriginator mesh__D015685 AGS
% 209.48/209.66  |- skos__historyNote mesh__D015685 Viral Proteins %28%1980-1985%29%
% 209.48/209.66  |- skos__hiddenLabel mesh__D015685 gag pol Fused Protein
% 209.48/209.66  |- skos__broader mesh__D015685smesh__D015684
% 209.48/209.66  |- skos__hiddenLabel mesh__D015685 Protein, gag-pol Fused
% 209.48/209.66  |- mesh__historyNote mesh__D015685
% 209.48/209.66       91%28%90%29%; was GAG-POL FUSION PROTEINS see under GENE PRODUCTS, GAG 1990%A%  
% 209.48/209.66  |- skos__altLabel mesh__D015685 gag-pol Fused Protein
% 209.48/209.66  |- skos__altLabel mesh__D015685 gag-pol Protein
% 209.48/209.66  |- mesh__publicMeSHNote mesh__D015685
% 209.48/209.66       91; was GAG-POL FUSION PROTEINS see under GENE PRODUCTS, GAG 1990%A%  
% 209.48/209.66  |- skos__hiddenLabel mesh__D015685 gag pol Fusion Proteins
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D015685 2006
% 209.48/209.66  |- mesh__dateRevised mesh__D015685 2005-06-30
% 209.48/209.66  |- skos__historyNote mesh__D015685 Retroviridae Proteins %28%1986-1989%29%
% 209.48/209.66  |- skos__hiddenLabel mesh__D015685 Protein, gag-pol
% 209.48/209.66  |- mesh__activeMeSHYear mesh__D001665 2003
% 209.48/209.66  |- skos__altLabel mesh__D001665 Reactive Site
% 209.48/209.67  |- skos__hiddenLabel mesh__D001665 Binding Site
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D001665 2002
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D001665 1997
% 209.48/209.67  |- skos__altLabel mesh__D001665 Combining Site
% 209.48/209.67  |- skos__related mesh__D001665smesh__D011485
% 209.48/209.67  |- skos__prefLabel mesh__D001665 Binding Sites
% 209.48/209.67  |- skos__hiddenLabel mesh__D001665 Sites, Combining
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D001665 2004
% 209.48/209.67  |- rdf__type mesh__D001665sskos__Concept
% 209.48/209.67  |- mesh__historyNote mesh__D001665 68   
% 209.48/209.67  |- mesh__dateRevised mesh__D001665 2005-07-28
% 209.48/209.67  |- skos__hiddenLabel mesh__D001665 Site, Reactive
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D001665 1998
% 209.48/209.67  |- skos__hiddenLabel mesh__D001665 Reactive Sites
% 209.48/209.67  |- mesh__dateEstablished mesh__D001665 1968-01-01
% 209.48/209.67  |- skos__hiddenLabel mesh__D001665 Site, Combining
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D001665 2005
% 209.48/209.67  |- skos__annotation mesh__D001665
% 209.48/209.67       NIM; note category; restrict to site of binding: do not use as substitute for chem or metab mechanism of binding; do not coord with receptors terms unless the site of binding is particularly discussed%A%  
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D001665 1999
% 209.48/209.67  |- skos__scopeNote mesh__D001665
% 209.48/209.67       The reactive parts of a macromolecule that directly participate in its specific combination with another molecule.%A%    
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D001665 2006A
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D001665 2000
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D001665 2006
% 209.48/209.67  |- skos__hiddenLabel mesh__D001665 Sites, Active
% 209.48/209.67  |- skos__hiddenLabel mesh__D001665 Site, Binding
% 209.48/209.67  |- skos__hiddenLabel mesh__D001665 Site, Active
% 209.48/209.67  |- skos__hiddenLabel mesh__D001665 Combining Sites
% 209.48/209.67  |- mesh__dateCreated mesh__D001665 1999-01-01
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D001665 2001
% 209.48/209.67  |- mesh__recordMaintainer mesh__D001665 ags
% 209.48/209.67  |- mesh__publicMeSHNote mesh__D001665 68   
% 209.48/209.67  |- mesh__recordOriginator mesh__D001665 NLM
% 209.48/209.67  |- skos__historyNote mesh__D001665 Enzymes %28%1966-1967%29%
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D001665 1996
% 209.48/209.67  |- skos__historyNote mesh__D001665
% 209.48/209.67       Antigen-Antibody Reactions %28%1966-1967%29%
% 209.48/209.67  |- skos__related mesh__D001665smesh__D011956
% 209.48/209.67  |- skos__broader mesh__D001665smesh__D001669
% 209.48/209.67  |- skos__hiddenLabel mesh__D001665 Sites, Binding
% 209.48/209.67  |- skos__hiddenLabel mesh__D001665 Active Sites
% 209.48/209.67  |- mesh__recordAuthorizer mesh__D001665 ags
% 209.48/209.67  |- skos__hiddenLabel mesh__D001665 Sites, Reactive
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D034041 2005
% 209.48/209.67  |- mesh__dateEstablished mesh__D034041 2003-01-01
% 209.48/209.67  |- rdf__type mesh__D034041sskos__Concept
% 209.48/209.67  |- mesh__historyNote mesh__D034041 2003   
% 209.48/209.67  |- skos__prefLabel mesh__D034041 Monomeric Clathrin Assembly Proteins
% 209.48/209.67  |- mesh__dateCreated mesh__D034041 2002-07-03
% 209.48/209.67  |- skos__broader mesh__D034041smesh__D033942
% 209.48/209.67  |- skos__scopeNote mesh__D034041
% 209.48/209.67       A subclass of clathrin assembly proteins that occur as monomers.%A%    
% 209.48/209.67  |- mesh__publicMeSHNote mesh__D034041 2003   
% 209.48/209.67  |- skos__altLabel mesh__D034041 Monomeric Clathrin Adaptor Proteins
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D034041 2004
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D034041 2006
% 209.48/209.67  |- skos__altLabel mesh__D034041 Clathrin Assembly Proteins, Monomeric
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D034041 2003
% 209.48/209.67  |- mesh__publicMeSHNote mesh__D006350 65   
% 209.48/209.67  |- mesh__dateEstablished mesh__D006350 1965-01-01
% 209.48/209.67  |- mesh__recordMaintainer mesh__D006350 jls
% 209.48/209.67  |- skos__hiddenLabel mesh__D006350 Heart Valve Prostheses
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D006350 2005
% 209.48/209.67  |- mesh__recordAuthorizer mesh__D006350 jls
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D006350 2002
% 209.48/209.67  |- skos__hiddenLabel mesh__D006350 Valve Prosthesis, Heart
% 209.48/209.67  |- skos__prefLabel mesh__D006350 Heart Valve Prosthesis
% 209.48/209.67  |- skos__annotation mesh__D006350
% 209.48/209.67       coord IM with specific valve %28%IM%29%; for bioprostheses coord IM with BIOPROSTHESIS %28%IM%29% %26% do not specify source of biol material unless especially discussed%A%  
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D006350 2004
% 209.48/209.67  |- mesh__historyNote mesh__D006350 65   
% 209.48/209.67  |- skos__hiddenLabel mesh__D006350 Prostheses, Heart Valve
% 209.48/209.67  |- skos__altLabel mesh__D006350 Prosthesis, Heart Valve
% 209.48/209.67  |- skos__broader mesh__D006350smesh__D019736
% 209.48/209.67  |- rdf__type mesh__D006350sskos__Concept
% 209.48/209.67  |- skos__hiddenLabel mesh__D006350 Valve Prostheses, Cardiac
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D006350 2003
% 209.48/209.67  |- skos__hiddenLabel mesh__D006350 Valve Prosthesis, Cardiac
% 209.48/209.67  |- mesh__dateRevised mesh__D006350 2005-07-30
% 209.48/209.67  |- skos__hiddenLabel mesh__D006350 Prosthesis, Cardiac Valve
% 209.48/209.67  |- skos__hiddenLabel mesh__D006350 Prostheses, Cardiac Valve
% 209.48/209.67  |- skos__hiddenLabel mesh__D006350 Valve Prostheses, Heart
% 209.48/209.67  |- skos__related mesh__D006350smesh__D019918
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D006350 2006A
% 209.48/209.67  |- mesh__recordOriginator mesh__D006350 NLM
% 209.48/209.67  |- skos__altLabel mesh__D006350 Cardiac Valve Prosthesis
% 209.48/209.67  |- skos__hiddenLabel mesh__D006350 Cardiac Valve Prostheses
% 209.48/209.67  |- mesh__dateCreated mesh__D006350 1999-01-01
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D006350 2006
% 209.48/209.67  |- skos__scopeNote mesh__D006350
% 209.48/209.67       A device that substitutes for a heart valve. It may be composed of biological material %28%BIOPROSTHESIS%29% and/or synthetic material.%A%    
% 209.48/209.67  |- mesh__dateCreated mesh__D019278 1996-06-10
% 209.48/209.67  |- skos__altLabel mesh__D019278 Stromelysin
% 209.48/209.67  |- mesh__publicMeSHNote mesh__D019278
% 209.48/209.67       97; STROMELYSIN 1 was indexed under METALLOPROTEINASES 1988-96 %26% PEPTIDE PEPTIDOHYDROLASES 1985-87%A%  
% 209.48/209.67  |- mesh__recordOriginator mesh__D019278 TPW
% 209.48/209.67  |- skos__altLabel mesh__D019278 Transin
% 209.48/209.67  |- skos__hiddenLabel mesh__D019278 Metalloproteinase 3, Matrix
% 209.48/209.67  |- mesh__recordMaintainer mesh__D019278 sjn
% 209.48/209.67  |- skos__altLabel mesh__D019278 Matrix Metalloproteinase 3
% 209.48/209.67  |- skos__scopeNote mesh__D019278
% 209.48/209.67       An extracellular endopeptidase of vertebrate tissues similar to INTERSTITIAL COLLAGENASE. It digests proteoglycan, fibronectin, collagen types III, IV, V, and IX, and activates procollagenase. %28%Enzyme Nomenclature, 1992%29% EC 3.4.24.17.%A%    
% 209.48/209.67  |- skos__historyNote mesh__D019278 Metalloendopeptidases %28%1988-1996%29%
% 209.48/209.67  |- mesh__historyNote mesh__D019278
% 209.48/209.67       97; was STROMELYSIN 1 %28%NM%29% 1985-96   
% 209.48/209.67  |- mesh__dateRevised mesh__D019278 2004-07-13
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D019278 2006
% 209.48/209.67  |- rdf__type mesh__D019278sskos__Concept
% 209.48/209.67  |- skos__annotation mesh__D019278
% 209.48/209.67        /antag is permitted but  TISSUE INHIBITOR OF METALLOPROTEINASE-3 is available%A%  
% 209.48/209.67  |- mesh__dateEstablished mesh__D019278 1997-01-01
% 209.48/209.67  |- mesh__onlineNote mesh__D019278
% 209.48/209.67       use STROMELYSIN 1 %28%NM%29% to search STROMELYSIN 1 1985-96   
% 209.48/209.67  |- skos__prefLabel mesh__D019278 Stromelysin 1
% 209.48/209.67  |- skos__broader mesh__D019278smesh__D020782
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D019278 2005
% 209.48/209.67  |- skos__historyNote mesh__D019278
% 209.48/209.67       Peptide Peptidohydrolases %28%1985-1987%29%
% 209.48/209.67  |- skos__altLabel mesh__D019278 MMP-3
% 209.48/209.67  |- mesh__recordAuthorizer mesh__D019278 sjn
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D011295 2002
% 209.48/209.67  |- skos__hiddenLabel mesh__D011295 Care, Prenatal
% 209.48/209.67  |- mesh__recordOriginator mesh__D011295 NLM
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D011295 2006
% 209.48/209.67  |- skos__scopeNote mesh__D011295
% 209.48/209.67       Care provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality.%A%    
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D011295 1999
% 209.48/209.67  |- skos__prefLabel mesh__D011295 Prenatal Care
% 209.48/209.67  |- mesh__recordMaintainer mesh__D011295 PXP
% 209.48/209.67  |- mesh__dateRevised mesh__D011295 1997-06-20
% 209.48/209.67  |- skos__broader mesh__D011295smesh__D008427
% 209.48/209.67  |- skos__annotation mesh__D011295 check tags FEMALE %26% PREGNANCY   
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D011295 2000
% 209.48/209.67  |- rdf__type mesh__D011295sskos__Concept
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D011295 2001
% 209.48/209.67  |- mesh__dateCreated mesh__D011295 1999-01-01
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D011295 2003
% 209.48/209.67  |- skos__broader mesh__D011295smesh__D005791
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D011295 2005
% 209.48/209.67  |- mesh__recordAuthorizer mesh__D011295 SJN
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D011295 1998
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D011295 2004
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D005258 2001
% 209.48/209.67  |- skos__hiddenLabel mesh__D005258 Felty Syndrome
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D005258 2003
% 209.48/209.67  |- skos__hiddenLabel mesh__D005258 Feltys Syndrome
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D005258 2000
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D005258 1995
% 209.48/209.67  |- skos__annotation mesh__D005258 a type of rheum arthritis   
% 209.48/209.67  |- rdf__type mesh__D005258sskos__Concept
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D005258 1993
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D005258 1994
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D005258 2002
% 209.48/209.67  |- mesh__dateRevised mesh__D005258 1992-05-20
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D005258 1999
% 209.48/209.67  |- skos__scopeNote mesh__D005258
% 209.48/209.67       A combination of rheumatoid arthritis, splenomegaly, leukopenia, pigmented spots on lower extremities, and other evidence of hypersplenism %28%anemia and thrombocytopenia%29%. %28%From Dorland, 27th ed%29%%A%    
% 209.48/209.67  |- mesh__dateCreated mesh__D005258 1999-01-01
% 209.48/209.67  |- mesh__recordMaintainer mesh__D005258 PLS
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D005258 2006
% 209.48/209.67  |- skos__broader mesh__D005258smesh__D001172
% 209.48/209.67  |- skos__hiddenLabel mesh__D005258 Syndrome, Felty%27%s
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D005258 1997
% 209.48/209.67  |- mesh__recordOriginator mesh__D005258 NLM
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D005258 1998
% 209.48/209.67  |- skos__prefLabel mesh__D005258 Felty%27%s Syndrome
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D005258 2004
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D005258 2005
% 209.48/209.67  |- mesh__recordAuthorizer mesh__D005258 PLS
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D005258 1996
% 209.48/209.67  |- mesh__dateRevised mesh__D015686 2005-06-30
% 209.48/209.67  |- skos__historyNote mesh__D015686 Retroviridae Proteins %28%1986-1989%29%
% 209.48/209.67  |- skos__hiddenLabel mesh__D015686 Products, env Gene
% 209.48/209.67  |- skos__altLabel mesh__D015686 env Antigens
% 209.48/209.67  |- skos__scopeNote mesh__D015686
% 209.48/209.67       Retroviral proteins, often glycosylated, coded by the envelope %28%env%29% gene. They are usually synthesized as protein precursors %28%POLYPROTEINS%29% and later cleaved into the final viral envelope glycoproteins by a viral protease.%A%    
% 209.48/209.67  |- mesh__dateCreated mesh__D015686 1989-05-25
% 209.48/209.67  |- skos__broader mesh__D015686smesh__D014759
% 209.48/209.67  |- rdf__type mesh__D015686sskos__Concept
% 209.48/209.67  |- mesh__publicMeSHNote mesh__D015686 90   
% 209.48/209.67  |- skos__broader mesh__D015686smesh__D020815
% 209.48/209.67  |- mesh__historyNote mesh__D015686 90   
% 209.48/209.67  |- skos__historyNote mesh__D015686 Viral Proteins %28%1977-1985%29%
% 209.48/209.67  |- skos__annotation mesh__D015686
% 209.48/209.67       Env stands for %22%envelope%22%; IM; coord with specific virus %28%IM%29%%A%  
% 209.48/209.67  |- skos__historyNote mesh__D015686
% 209.48/209.67       Viral Envelope Proteins %28%1984-1989%29%
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D015686 2006
% 209.48/209.67  |- mesh__recordAuthorizer mesh__D015686 sjn
% 209.48/209.67  |- skos__altLabel mesh__D015686 env Polyprotein
% 209.48/209.67  |- skos__altLabel mesh__D015686 env Gene Products
% 209.48/209.67  |- skos__historyNote mesh__D015686 Antigens, Viral %28%1977-1989%29%
% 209.48/209.67  |- skos__hiddenLabel mesh__D015686 Polyprotein, env
% 209.48/209.67  |- skos__altLabel mesh__D015686 env Protein
% 209.48/209.67  |- skos__broader mesh__D015686smesh__D012191
% 209.48/209.67  |- mesh__recordOriginator mesh__D015686 AGS
% 209.48/209.67  |- skos__altLabel mesh__D015686 env Polyproteins
% 209.48/209.67  |- mesh__dateEstablished mesh__D015686 1990-01-01
% 209.48/209.67  |- skos__historyNote mesh__D015686 Antigens, Surface %28%1979-1989%29%
% 209.48/209.67  |- skos__hiddenLabel mesh__D015686 Protein, env
% 209.48/209.67  |- skos__hiddenLabel mesh__D015686 Glycoproteins, env
% 209.48/209.67  |- skos__hiddenLabel mesh__D015686 Polyproteins, env
% 209.48/209.67  |- skos__hiddenLabel mesh__D015686 Antigens, env
% 209.48/209.67  |- skos__prefLabel mesh__D015686 Gene Products, env
% 209.48/209.67  |- mesh__recordMaintainer mesh__D015686 SYSTEM
% 209.48/209.67  |- rdf__type mesh__D009649sskos__Concept
% 209.48/209.67  |- mesh__historyNote mesh__D009649 75; was see under NORPREGNANES 1974   
% 209.48/209.67  |- mesh__publicMeSHNote mesh__D009649
% 209.48/209.67       75; was see under NORPREGNANES 1974   
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D009649 2003
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D009649 2001
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D009649 1994
% 209.48/209.67  |- skos__scopeNote mesh__D009649
% 209.48/209.67       Pregnadienes which have undergone ring contractions or are lacking carbon-18 or carbon-19.%A%    
% 209.48/209.67  |- skos__broader mesh__D009649smesh__D009650
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D009649 1999
% 209.48/209.67  |- mesh__recordOriginator mesh__D009649 NLM
% 209.48/209.67  |- mesh__recordAuthorizer mesh__D009649 PLS
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D009649 2000
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D009649 1997
% 209.48/209.67  |- mesh__dateRevised mesh__D009649 1993-06-03
% 209.48/209.67  |- mesh__onlineNote mesh__D009649 search NORPREGNANES 1974   
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D009649 1998
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D009649 2006
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D009649 2002
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D009649 1996
% 209.48/209.67  |- skos__prefLabel mesh__D009649 Norpregnadienes
% 209.48/209.67  |- mesh__dateCreated mesh__D009649 1999-01-01
% 209.48/209.67  |- mesh__recordMaintainer mesh__D009649 PLS
% 209.48/209.67  |- mesh__dateEstablished mesh__D009649 1975-09-01
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D009649 2004
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D009649 2005
% 209.48/209.67  |- skos__historyNote mesh__D009649 Norpregnanes %28%1974%29%
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D009649 1995
% 209.48/209.67  |- skos__related mesh__D001666smesh__D000915
% 209.48/209.67  |- mesh__recordMaintainer mesh__D001666 ssb
% 209.48/209.67  |- skos__altLabel mesh__D001666 Paratopes
% 209.48/209.67  |- skos__hiddenLabel mesh__D001666 Binding Site, Antibody
% 209.48/209.67  |- skos__historyNote mesh__D001666 Antigens %28%1966-1972%29%
% 209.48/209.67  |- skos__broader mesh__D001666smesh__D000906
% 209.48/209.67  |- skos__prefLabel mesh__D001666 Binding Sites, Antibody
% 209.48/209.67  |- mesh__dateRevised mesh__D001666 2005-06-30
% 209.48/209.67  |- skos__broader mesh__D001666smesh__D001665
% 209.48/209.67  |- mesh__dateCreated mesh__D001666 1999-01-01
% 209.48/209.67  |- mesh__publicMeSHNote mesh__D001666 73   
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D001666 2006
% 209.48/209.67  |- skos__historyNote mesh__D001666 Antibodies %28%1966-1972%29%
% 209.48/209.67  |- skos__hiddenLabel mesh__D001666 Antibody Binding Site
% 209.48/209.67  |- mesh__recordAuthorizer mesh__D001666 sjn
% 209.48/209.67  |- mesh__dateEstablished mesh__D001666 1973-01-01
% 209.48/209.67  |- mesh__recordOriginator mesh__D001666 NLM
% 209.48/209.67  |- skos__altLabel mesh__D001666 Antibody Binding Sites
% 209.48/209.67  |- rdf__type mesh__D001666sskos__Concept
% 209.48/209.67  |- skos__scopeNote mesh__D001666
% 209.48/209.67       Local surface sites on antibodies which react with antigen determinant sites on antigens. They are formed from parts of the variable regions of FAB FRAGMENTS.%A%    
% 209.48/209.67  |- skos__historyNote mesh__D001666 Binding Sites %28%1968-1972%29%
% 209.48/209.67  |- skos__broader mesh__D001666smesh__D000937
% 209.48/209.67  |- mesh__historyNote mesh__D001666 73; was in Cat D only 1973-76   
% 209.48/209.67  |- skos__hiddenLabel mesh__D001666 Paratope
% 209.48/209.67  |- skos__annotation mesh__D020820
% 209.48/209.67       DYSKINESIA SYNDROMES see MOVEMENT DISORDERS is also available%A%  
% 209.48/209.67  |- skos__hiddenLabel mesh__D020820 Abnormal Movement
% 209.48/209.67  |- mesh__recordMaintainer mesh__D020820 ags
% 209.48/209.67  |- skos__broader mesh__D020820smesh__D009461
% 209.48/209.67  |- skos__hiddenLabel mesh__D020820 Dyskinesia
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D020820 2003
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D020820 2000
% 209.48/209.67  |- skos__prefLabel mesh__D020820 Dyskinesias
% 209.48/209.67  |- mesh__recordOriginator mesh__D020820 KEV
% 209.48/209.67  |- skos__hiddenLabel mesh__D020820 Movement, Abnormal
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D020820 2004
% 209.48/209.67  |- mesh__dateRevised mesh__D020820 1999-11-19
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D020820 2005
% 209.48/209.67  |- mesh__historyNote mesh__D020820 2000   
% 209.48/209.67  |- skos__altLabel mesh__D020820 Abnormal Movements
% 209.48/209.67  |- rdf__type mesh__D020820sskos__Concept
% 209.48/209.67  |- skos__related mesh__D020820smesh__D009069
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D020820 2001
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D020820 2006
% 209.48/209.67  |- skos__hiddenLabel mesh__D020820 Movement, Involuntary
% 209.48/209.67  |- skos__historyNote mesh__D020820 Movement Disorders %28%1966-1999%29%
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D020820 2000A
% 209.48/209.67  |- skos__scopeNote mesh__D020820
% 209.48/209.67       Abnormal involuntary movements which primarily affect the extremities, trunk, or jaw that occur as a manifestation of an underlying disease process. Conditions which feature recurrent or persistent episodes of dyskinesia as a primary manifestation of disease may be referred to as dyskinesia syndromes %28%see MOVEMENT DISORDERS%29%. Dyskinesias are also a relatively common manifestation of BASAL GANGLIA DISEASES.%A%    
% 209.48/209.67  |- skos__altLabel mesh__D020820 Hemiballism
% 209.48/209.67  |- skos__hiddenLabel mesh__D020820 Movements, Abnormal
% 209.48/209.67  |- mesh__publicMeSHNote mesh__D020820 2000   
% 209.48/209.67  |- skos__hiddenLabel mesh__D020820 Involuntary Movement
% 209.48/209.67  |- mesh__dateCreated mesh__D020820 1999-11-05
% 209.48/209.67  |- mesh__recordAuthorizer mesh__D020820 ags
% 209.48/209.67  |- skos__hiddenLabel mesh__D020820 Movements, Involuntary
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D020820 2002
% 209.48/209.67  |- mesh__dateEstablished mesh__D020820 2000-01-01
% 209.48/209.67  |- skos__hiddenLabel mesh__D006351 Cardiac Valve
% 209.48/209.67  |- skos__hiddenLabel mesh__D006351 Valve, Cardiac
% 209.48/209.67  |- rdf__type mesh__D006351sskos__Concept
% 209.48/209.67  |- mesh__recordMaintainer mesh__D006351 nns
% 209.48/209.67  |- mesh__recordOriginator mesh__D006351 NLM
% 209.48/209.67  |- skos__hiddenLabel mesh__D006351 Valve, Heart
% 209.48/209.67  |- skos__annotation mesh__D006351 GEN or unspecified: prefer specifics   
% 209.48/209.67  |- skos__prefLabel mesh__D006351 Heart Valves
% 209.48/209.67  |- mesh__dateRevised mesh__D006351 2003-07-09
% 209.48/209.67  |- mesh__recordAuthorizer mesh__D006351 sjn
% 209.48/209.67  |- skos__hiddenLabel mesh__D006351 Valves, Cardiac
% 209.48/209.67  |- mesh__dateCreated mesh__D006351 1999-01-01
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D006351 2006
% 209.48/209.67  |- skos__broader mesh__D006351smesh__D006321
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D006351 2005
% 209.48/209.67  |- skos__scopeNote mesh__D006351
% 209.48/209.67       Flaps of tissue that prevent regurgitation of BLOOD from the HEART VENTRICLES to the HEART ATRIA or from the PULMONARY ARTERIES or AORTA to the ventricles.%A%    
% 209.48/209.67  |- skos__hiddenLabel mesh__D006351 Valves, Heart
% 209.48/209.67  |- skos__hiddenLabel mesh__D006351 Heart Valve
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D006351 2004
% 209.48/209.67  |- skos__altLabel mesh__D006351 Cardiac Valves
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D020022 2003
% 209.48/209.67  |- mesh__recordMaintainer mesh__D020022 KEV
% 209.48/209.67  |- skos__historyNote mesh__D020022
% 209.48/209.67       specific disease/genetics %28%1966-1998%29%
% 209.48/209.67  |- skos__altLabel mesh__D020022 Predisposition, Genetic
% 209.48/209.67  |- skos__hiddenLabel mesh__D020022 Genetic Predispositions
% 209.48/209.67  |- skos__related mesh__D020022smesh__D005820
% 209.48/209.67  |- mesh__publicMeSHNote mesh__D020022 99   
% 209.48/209.67  |- mesh__historyNote mesh__D020022 99   
% 209.48/209.67  |- rdf__type mesh__D020022sskos__Concept
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D020022 2006
% 209.48/209.67  |- skos__prefLabel mesh__D020022 Genetic Predisposition to Disease
% 209.48/209.67  |- skos__hiddenLabel mesh__D020022 Genetic Susceptibilities
% 209.48/209.67  |- skos__altLabel mesh__D020022 Genetic Susceptibility
% 209.48/209.67  |- mesh__dateCreated mesh__D020022 1998-06-10
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D020022 2005
% 209.48/209.67  |- skos__broader mesh__D020022smesh__D004198
% 209.48/209.67  |- skos__broader mesh__D020022smesh__D005838
% 209.48/209.67  |- skos__scopeNote mesh__D020022
% 209.48/209.67       A latent susceptibility to disease at the genetic level, which may be activated under certain conditions.%A%    
% 209.48/209.67  |- mesh__recordAuthorizer mesh__D020022 sjn
% 209.48/209.67  |- mesh__recordOriginator mesh__D020022 AGS
% 209.48/209.67  |- mesh__dateRevised mesh__D020022 2002-07-03
% 209.48/209.67  |- mesh__dateEstablished mesh__D020022 1999-01-01
% 209.48/209.67  |- skos__hiddenLabel mesh__D020022 Predispositions, Genetic
% 209.48/209.67  |- skos__altLabel mesh__D020022 Genetic Predisposition
% 209.48/209.67  |- skos__annotation mesh__D020022
% 209.48/209.67       latent susceptibility to dis only: coord with specific dis/genet; for positive genetic predisposition %28%like longevity%29% use specific trait/genet%A%  
% 209.48/209.67  |- skos__hiddenLabel mesh__D020022 Susceptibilities, Genetic
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D020022 2004
% 209.48/209.67  |- skos__altLabel mesh__D020022 Susceptibility, Genetic
% 209.48/209.67  |- skos__altLabel mesh__D047768
% 209.48/209.67       Inositol 1,2-Cyclic Phosphate 2-Phosphohydrolase
% 209.48/209.67  |- skos__historyNote mesh__D047768 Annexin A3 %28%1980-2004%29%
% 209.48/209.67  |- skos__hiddenLabel mesh__D047768
% 209.48/209.67       1,2 Cyclic Inositol Phosphate Phosphodiesterase
% 209.48/209.67  |- mesh__recordOriginator mesh__D047768 jmp
% 209.48/209.67  |- skos__hiddenLabel mesh__D047768
% 209.48/209.67       Phosphodiesterase, 1,2-Cyclic-Inositol-Phosphate
% 209.48/209.67  |- skos__hiddenLabel mesh__D047768
% 209.48/209.67       Inositolphosphodiesterase, Glycerophosphoinositol
% 209.48/209.67  |- skos__altLabel mesh__D047768
% 209.48/209.67       1,2-Cyclic Inositolphosphate Phosphodiesterase
% 209.48/209.67  |- mesh__dateCreated mesh__D047768 2004-07-07
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D047768 2006
% 209.48/209.67  |- skos__scopeNote mesh__D047768
% 209.48/209.67       A phosphoric diester hydrolase with specificity for the cleavage of GLYCEROL from 1-%28%sn-glycero-3-phospho%29%-1D-myo-inositol. It also has specificity for hydrolysis of the cyclic phosphate bond in inositol 1,2-cyclic phosphate%A%    
% 209.48/209.67  |- skos__hiddenLabel mesh__D047768
% 209.48/209.67       Inositolphosphate Phosphodiesterase, 1,2-Cyclic
% 209.48/209.67  |- rdf__type mesh__D047768sskos__Concept
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D047768 2005
% 209.48/209.67  |- mesh__publicMeSHNote mesh__D047768
% 209.48/209.67       2005; for 1,2-CYCLIC INOSITOLPHOSPHATE PHOSPHODIESTERASE; 1,2-CYCLIC-INOSITOL-PHOSPHATE PHOSPHODIESTERASE; %26% INOSITOL 1,2-CYCLIC PHOSPHATE 2-PHOSPHOHYDROLASE see ANNEXIN A3 1980-2004; 1,2-CYCLIC-INOSITOL-PHOSPHATE PHOSPHODIESTERASE was indexed under PHOSPHODIESTERASES 1973-1992%A%  
% 209.48/209.67  |- mesh__historyNote mesh__D047768
% 209.48/209.67       2005%28%1993%29%; for 1,2-CYCLIC INOSITOLPHOSPHATE PHOSPHODIESTERASE; 1,2-CYCLIC-INOSITOL-PHOSPHATE PHOSPHODIESTERASE; %26% INOSITOL 1,2-CYCLIC PHOSPHATE 2-PHOSPHOHYDROLASE use ANNEXIN A3 1980-2004%A%  
% 209.48/209.67  |- skos__hiddenLabel mesh__D047768
% 209.48/209.67       1,2 Cyclic Inositolphosphate Phosphodiesterase
% 209.48/209.67  |- mesh__recordMaintainer mesh__D047768 jmp
% 209.48/209.67  |- mesh__recordAuthorizer mesh__D047768 sjn
% 209.48/209.67  |- skos__broader mesh__D047768smesh__D010727
% 209.48/209.67  |- skos__hiddenLabel mesh__D047768
% 209.48/209.67       Inositol 1,2 Cyclic Phosphate 2 Phosphohydrolase
% 209.48/209.67  |- skos__prefLabel mesh__D047768
% 209.48/209.67       Glycerophosphoinositol Inositolphosphodiesterase
% 209.48/209.67  |- mesh__dateEstablished mesh__D047768 2005-01-01
% 209.48/209.67  |- skos__hiddenLabel mesh__D047768
% 209.48/209.67       Phosphodiesterase, 1,2-Cyclic Inositolphosphate
% 209.48/209.67  |- skos__altLabel mesh__D047768
% 209.48/209.67       1,2-Cyclic-Inositol-Phosphate Phosphodiesterase
% 209.48/209.67  |- skos__annotation mesh__D019279 dent cements; D25-26 qualif   
% 209.48/209.67  |- mesh__publicMeSHNote mesh__D019279 97   
% 209.48/209.67  |- mesh__dateEstablished mesh__D019279 1997-01-01
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D019279 2005
% 209.48/209.67  |- mesh__dateRevised mesh__D019279 2004-07-07
% 209.48/209.67  |- mesh__historyNote mesh__D019279 97   
% 209.48/209.67  |- skos__historyNote mesh__D019279 Dental Cements %28%1974-1996%29%
% 209.48/209.67  |- mesh__dateCreated mesh__D019279 1996-06-10
% 209.48/209.67  |- mesh__recordAuthorizer mesh__D019279 sjn
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D019279 2006
% 209.48/209.67  |- mesh__recordMaintainer mesh__D019279 jmp
% 209.48/209.67  |- skos__altLabel mesh__D019279 Resin Cement
% 209.48/209.67  |- skos__broader mesh__D019279smesh__D012117
% 209.48/209.67  |- rdf__type mesh__D019279sskos__Concept
% 209.48/209.67  |- skos__prefLabel mesh__D019279 Resin Cements
% 209.48/209.67  |- skos__scopeNote mesh__D019279
% 209.48/209.67       Dental cements composed either of polymethyl methacrylate or dimethacrylate, produced by mixing an acrylic monomer liquid with acrylic polymers and mineral fillers. The cement is insoluble in water and is thus resistant to fluids in the mouth, but is also irritating to the dental pulp. It is used chiefly as a luting agent for fabricated and temporary restorations. %28%Jablonski%27%s Dictionary of Dentistry, 1992, p159%29%%A%    
% 209.48/209.67  |- mesh__recordOriginator mesh__D019279 TPW
% 209.48/209.67  |- skos__broader mesh__D019279smesh__D003738
% 209.48/209.67  |- skos__hiddenLabel mesh__D019279 Cements, Resin
% 209.48/209.67  |- skos__hiddenLabel mesh__D019279 Cement, Resin
% 209.48/209.67  |- skos__historyNote mesh__D011296 Amniocentesis %28%1971-1972%29%
% 209.48/209.67  |- skos__altLabel mesh__D011296 Diagnosis, Prenatal
% 209.48/209.67  |- skos__related mesh__D011296smesh__D005817
% 209.48/209.67  |- skos__altLabel mesh__D011296 Diagnosis, Antenatal
% 209.48/209.67  |- skos__hiddenLabel mesh__D011296 Diagnoses, Prenatal
% 209.48/209.67  |- mesh__publicMeSHNote mesh__D011296 73   
% 209.48/209.67  |- mesh__recordMaintainer mesh__D011296 jrf
% 209.48/209.67  |- skos__hiddenLabel mesh__D011296 Diagnoses, Antenatal
% 209.48/209.67  |- mesh__recordOriginator mesh__D011296 NLM
% 209.48/209.67  |- skos__related mesh__D011296smesh__D033142
% 209.48/209.67  |- skos__hiddenLabel mesh__D011296 Prenatal Diagnoses
% 209.48/209.67  |- rdf__type mesh__D011296sskos__Concept
% 209.48/209.67  |- mesh__dateEstablished mesh__D011296 1973-01-01
% 209.48/209.67  |- mesh__recordAuthorizer mesh__D011296 sjn
% 209.48/209.67  |- mesh__dateRevised mesh__D011296 2002-07-02
% 209.48/209.67  |- skos__related mesh__D011296smesh__D019836
% 209.48/209.67  |- mesh__dateCreated mesh__D011296 1999-01-01
% 209.48/209.67  |- skos__historyNote mesh__D011296
% 209.48/209.67       specific disease or abnormality/diagnosis %28%1966-1972%29%
% 209.48/209.67  |- skos__hiddenLabel mesh__D011296 Intrauterine Diagnoses
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D011296 2003
% 209.48/209.67  |- skos__altLabel mesh__D011296 Antenatal Diagnosis
% 209.48/209.67  |- skos__altLabel mesh__D011296 Intrauterine Diagnosis
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D011296 2005
% 209.48/209.67  |- skos__hiddenLabel mesh__D011296 Diagnoses, Intrauterine
% 209.48/209.67  |- skos__annotation mesh__D011296
% 209.48/209.67       check tags FEMALE %26% PREGNANCY; if a fetal dis is discussed, coord IM with FETAL DISEASES %28%IM%29% or FETAL DISEASES %28%IM%29% + specific dis in the fetus %28%IM%29%%A%  
% 209.48/209.67  |- mesh__activeMeSHYear mesh__D011296 2004
% 209.48/209.67  |- skos__hiddenLabel mesh__D011296 Antenatal Diagnoses
% 209.48/209.67  |- skos__prefLabel mesh__D011296 Prenatal Diagnosis
% 209.48/209.67  |- mesh__historyNote mesh__D011296 73   
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D011296 2006
% 209.48/209.68  |- skos__scopeNote mesh__D011296
% 209.48/209.68       Determination of the nature of a pathological condition or disease in the postimplantation embryo, fetus, or pregnant female before birth.%A%    
% 209.48/209.68  |- skos__broader mesh__D011296smesh__D003944
% 209.48/209.68  |- skos__altLabel mesh__D011296 Diagnosis, Intrauterine
% 209.48/209.68  |- mesh__historyNote mesh__D005259
% 209.48/209.68       91%28%79%29%; was see under LYPRESSIN 1979-90; was PHELYPRESSIN see under VASOPRESSIN 1965-78 %28%Prov 1965-74%29%%A%  
% 209.48/209.68  |- skos__broader mesh__D005259smesh__D008236
% 209.48/209.68  |- skos__hiddenLabel mesh__D005259 Vasopressin, Phenylalanyl Lysyl
% 209.48/209.68  |- skos__altLabel mesh__D005259 Octapressin
% 209.48/209.68  |- rdf__type mesh__D005259sskos__Concept
% 209.48/209.68  |- mesh__dateRevised mesh__D005259 2005-06-30
% 209.48/209.68  |- skos__altLabel mesh__D005259 PLV-2
% 209.48/209.68  |- skos__altLabel mesh__D005259 Octopressin
% 209.48/209.68  |- mesh__dateCreated mesh__D005259 1999-01-01
% 209.48/209.68  |- mesh__publicMeSHNote mesh__D005259
% 209.48/209.68       91; was see under LYPRESSIN 1979-90; was PHELYPRESSIN see under VASOPRESSIN 1975-78%A%  
% 209.48/209.68  |- mesh__dateEstablished mesh__D005259 1991-01-01
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D005259 2006
% 209.48/209.68  |- skos__annotation mesh__D005259 a vasoconstrictor   
% 209.48/209.68  |- skos__prefLabel mesh__D005259 Felypressin
% 209.48/209.68  |- skos__altLabel mesh__D005259 Phelypressin
% 209.48/209.68  |- skos__broader mesh__D005259smesh__D014667
% 209.48/209.68  |- mesh__recordAuthorizer mesh__D005259 sjn
% 209.48/209.68  |- skos__hiddenLabel mesh__D005259 Phenylalanyl-Lysyl Vasopressin
% 209.48/209.68  |- skos__hiddenLabel mesh__D005259 Lysine Vasopressin, Phenylalanine
% 209.48/209.68  |- mesh__recordMaintainer mesh__D005259 ssb
% 209.48/209.68  |- skos__altLabel mesh__D005259 Vasopressin, Phenylalanyl-Lysyl
% 209.48/209.68  |- skos__scopeNote mesh__D005259
% 209.48/209.68       Synthetic analog of LYPRESSIN with more vasoconstrictor than antidiuretic action. It is used as a hemostatic.%A%    
% 209.48/209.68  |- skos__hiddenLabel mesh__D005259 Vasopressin, Phenylalanine Lysine
% 209.48/209.68  |- mesh__onlineNote mesh__D005259
% 209.48/209.68       use FELYPRESSIN to search PHELYPRESSIN 1966-78   
% 209.48/209.68  |- skos__altLabel mesh__D005259 Phenylalanine Lysine Vasopressin
% 209.48/209.68  |- mesh__recordOriginator mesh__D005259 NLM
% 209.48/209.68  |- mesh__dateCreated mesh__D015687 1989-05-15
% 209.48/209.68  |- skos__hiddenLabel mesh__D015687 Hypoxias, Cell
% 209.48/209.68  |- skos__prefLabel mesh__D015687 Cell Hypoxia
% 209.48/209.68  |- mesh__recordMaintainer mesh__D015687 JLS
% 209.48/209.68  |- skos__altLabel mesh__D015687 Cell Anoxia
% 209.48/209.68  |- mesh__recordOriginator mesh__D015687 PXP
% 209.48/209.68  |- skos__hiddenLabel mesh__D015687 Cell Anoxias
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D015687 2001
% 209.48/209.68  |- rdf__type mesh__D015687sskos__Concept
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D015687 2006
% 209.48/209.68  |- skos__annotation mesh__D015687 NIM; not for micro-organisms   
% 209.48/209.68  |- skos__hiddenLabel mesh__D015687 Anoxia, Cell
% 209.48/209.68  |- skos__scopeNote mesh__D015687
% 209.48/209.68       A condition of decreased oxygen content at the cellular level.%A%    
% 209.48/209.68  |- skos__hiddenLabel mesh__D015687 Anoxias, Cell
% 209.48/209.68  |- skos__broader mesh__D015687smesh__D019069
% 209.48/209.68  |- skos__altLabel mesh__D015687 Hypoxia, Cellular
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D015687 2000
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D015687 2005
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D015687 1999
% 209.48/209.68  |- skos__historyNote mesh__D015687 Oxygen %28%1985-1989%29%
% 209.48/209.68  |- skos__altLabel mesh__D015687 Anoxia, Cellular
% 209.48/209.68  |- skos__hiddenLabel mesh__D015687 Hypoxia, Cell
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D015687 2004
% 209.48/209.68  |- skos__hiddenLabel mesh__D015687 Cellular Anoxia
% 209.48/209.68  |- skos__hiddenLabel mesh__D015687 Cellular Anoxias
% 209.48/209.68  |- skos__hiddenLabel mesh__D015687 Cellular Hypoxias
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D015687 1998
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D015687 1997
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D015687 2003
% 209.48/209.68  |- mesh__dateRevised mesh__D015687 1995-06-05
% 209.48/209.68  |- skos__historyNote mesh__D015687 Anoxia %28%1968-1989%29%
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D015687 2002
% 209.48/209.68  |- skos__hiddenLabel mesh__D015687 Hypoxias, Cellular
% 209.48/209.68  |- mesh__publicMeSHNote mesh__D015687 90   
% 209.48/209.68  |- mesh__recordAuthorizer mesh__D015687 PLS
% 209.48/209.68  |- mesh__dateEstablished mesh__D015687 1990-01-01
% 209.48/209.68  |- skos__hiddenLabel mesh__D015687 Cellular Hypoxia
% 209.48/209.68  |- skos__hiddenLabel mesh__D015687 Cell Hypoxias
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D015687 1996
% 209.48/209.68  |- mesh__historyNote mesh__D015687 90   
% 209.48/209.68  |- skos__hiddenLabel mesh__D015687 Anoxias, Cellular
% 209.48/209.68  |- skos__hiddenLabel mesh__D034841 Cavities, Abdominal
% 209.48/209.68  |- skos__broader mesh__D034841smesh__D000005
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D034841 2006
% 209.48/209.68  |- rdf__type mesh__D034841sskos__Concept
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D034841 2004
% 209.48/209.68  |- skos__annotation mesh__D034841
% 209.48/209.68       prefer specifics; ABDOMEN is also available, use author%27%s language%A%  
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D034841 2005
% 209.48/209.68  |- skos__scopeNote mesh__D034841
% 209.48/209.68       The region in the abdomen extending from the thoracic DIAPHRAGM to the plane of the superior pelvic aperture %28%pelvic inlet%29%. The abdominal cavity contains the PERITONEUM and abdominal VISCERA, as well as the extraperitoneal space which includes the RETROPERITONEAL SPACE.%A%    
% 209.48/209.68  |- mesh__publicMeSHNote mesh__D034841 2003   
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D034841 2003
% 209.48/209.68  |- skos__hiddenLabel mesh__D034841 Cavity, Abdominal
% 209.48/209.68  |- skos__hiddenLabel mesh__D034841 Abdominal Cavities
% 209.48/209.68  |- mesh__dateEstablished mesh__D034841 2003-01-01
% 209.48/209.68  |- skos__prefLabel mesh__D034841 Abdominal Cavity
% 209.48/209.68  |- mesh__historyNote mesh__D034841 2003   
% 209.48/209.68  |- skos__altLabel mesh__D034841 Cavitas abdominis
% 209.48/209.68  |- mesh__dateCreated mesh__D034841 2002-07-02
% 209.48/209.68  |- skos__historyNote mesh__D034841 Abdomen %28%1964-2002%29%
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D001667 1999
% 209.48/209.68  |- mesh__publicMeSHNote mesh__D001667 73   
% 209.48/209.68  |- mesh__recordOriginator mesh__D001667 NLM
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D001667 2002
% 209.48/209.68  |- mesh__dateCreated mesh__D001667 1999-01-01
% 209.48/209.68  |- mesh__dateRevised mesh__D001667 1998-06-10
% 209.48/209.68  |- mesh__recordMaintainer mesh__D001667 MSR
% 209.48/209.68  |- skos__hiddenLabel mesh__D001667 Bindings, Competitive
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D001667 2006
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D001667 2001
% 209.48/209.68  |- rdf__type mesh__D001667sskos__Concept
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D001667 2005
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D001667 2000
% 209.48/209.68  |- skos__altLabel mesh__D001667 Competitive Binding
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D001667 2004
% 209.48/209.68  |- skos__historyNote mesh__D001667 Binding Sites %28%1968-1972%29%
% 209.48/209.68  |- skos__hiddenLabel mesh__D001667 Competitive Bindings
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D001667 2003
% 209.48/209.68  |- mesh__recordAuthorizer mesh__D001667 SJN
% 209.48/209.68  |- mesh__historyNote mesh__D001667 73   
% 209.48/209.68  |- skos__prefLabel mesh__D001667 Binding, Competitive
% 209.48/209.68  |- skos__broader mesh__D001667smesh__D001665
% 209.48/209.68  |- mesh__dateEstablished mesh__D001667 1973-01-01
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Familial Dystonias, Idiopathic
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D020821 2001
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Adult-Onset Dystonia
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Dystonias, Primary
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Familial Dystonias
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Psychogenic Dystonias
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Dystonias, Hereditary
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Childhood Onset Dystonia
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D020821 2006
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Dystonia, Childhood Onset
% 209.48/209.68  |- skos__altLabel mesh__D020821 Dystonia Disorders
% 209.48/209.68  |- mesh__dateEstablished mesh__D020821 2000-01-01
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Primary Dystonia
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Hereditary Dystonia
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Dystonias, Focal
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Sporadic Dystonia
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Dystonia, Idiopathic Familial
% 209.48/209.68  |- skos__altLabel mesh__D020821 Familial Dystonia, Autosomal Recessive
% 209.48/209.68  |- skos__altLabel mesh__D020821 Dystonia, Hereditary
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D020821 2003
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Primary Dystonias
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D020821 2002
% 209.48/209.68  |- skos__altLabel mesh__D020821 Dystonia, Psychogenic
% 209.48/209.68  |- skos__related mesh__D020821smesh__D004421
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Dystonias, Secondary
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Psychogenic Dystonia
% 209.48/209.68  |- rdf__type mesh__D020821sskos__Concept
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Hereditary Dystonias
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Dystonias, Idiopathic Familial
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D020821 2004
% 209.48/209.68  |- mesh__dateCreated mesh__D020821 1999-11-08
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Secondary Dystonias
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Adult Onset Idiopathic Torsion Dystonias
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Dystonias, Adult-Onset
% 209.48/209.68  |- mesh__publicMeSHNote mesh__D020821 2000   
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Pseudodystonias
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Dystonia, Sporadic
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Adult Onset Dystonias
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Dystonia, Adult-Onset
% 209.48/209.68  |- skos__altLabel mesh__D020821 Secondary Dystonia
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Idiopathic Familial Dystonia
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Dystonia, Familial
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Idiopathic Familial Dystonias
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Dystonias, Familial
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Dystonia Disorder
% 209.48/209.68  |- skos__prefLabel mesh__D020821 Dystonic Disorders
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Writer Cramp
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Dystonic Disorder
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D020821 2000
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Sporadic Dystonias
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Writers Cramp
% 209.48/209.68  |- skos__annotation mesh__D020821 DYSTONIA is also available   
% 209.48/209.68  |- skos__broader mesh__D020821smesh__D009069
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Dystonias, Childhood Onset
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Focal Dystonias
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Dystonia, Focal
% 209.48/209.68  |- skos__historyNote mesh__D020821 Dystonia %28%1966-1999%29%
% 209.48/209.68  |- mesh__historyNote mesh__D020821 2000   
% 209.48/209.68  |- skos__altLabel mesh__D020821 Familial Dystonia, Autosomal Dominant
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Adult Onset Idiopathic Focal Dystonias
% 209.48/209.68  |- skos__hiddenLabel mesh__D020821 Dystonias, Psychogenic
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D020821 2005
% 209.48/209.68  |- skos__scopeNote mesh__D020821
% 209.48/209.68       Acquired and inherited conditions that feature DYSTONIA as a primary manifestation of disease. These disorders are generally divided into generalized dystonias %28%e.g., dystonia musculorum deformans%29% and focal dystonias %28%e.g., writer%27%s cramp%29%. They are also classified by patterns of inheritance and by age of onset.%A%    
% 209.48/209.68  |- skos__hiddenLabel mesh__D006352 Right Ventricles
% 209.48/209.68  |- skos__altLabel mesh__D006352 Heart Ventricle
% 209.48/209.68  |- skos__altLabel mesh__D006352 Cardiac Ventricles
% 209.48/209.68  |- skos__hiddenLabel mesh__D006352 Ventricle, Right
% 209.48/209.68  |- mesh__dateEstablished mesh__D006352 1968-01-01
% 209.48/209.68  |- skos__related mesh__D006352smesh__D016276
% 209.48/209.68  |- skos__hiddenLabel mesh__D006352 Ventricle, Heart
% 209.48/209.68  |- skos__hiddenLabel mesh__D006352 Ventricles, Heart
% 209.48/209.68  |- mesh__dateCreated mesh__D006352 1999-01-01
% 209.48/209.68  |- skos__related mesh__D006352smesh__D017725
% 209.48/209.68  |- skos__hiddenLabel mesh__D006352 Ventricles, Left
% 209.48/209.68  |- skos__hiddenLabel mesh__D006352 Ventricle, Left
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D006352 2006
% 209.48/209.68  |- mesh__recordMaintainer mesh__D006352 nns
% 209.48/209.68  |- mesh__recordOriginator mesh__D006352 NLM
% 209.48/209.68  |- skos__hiddenLabel mesh__D006352 Left Ventricles
% 209.48/209.68  |- skos__broader mesh__D006352smesh__D006321
% 209.48/209.68  |- mesh__dateRevised mesh__D006352 2003-07-25
% 209.48/209.68  |- skos__altLabel mesh__D006352 Cardiac Ventricle
% 209.48/209.68  |- skos__hiddenLabel mesh__D006352 Ventricles, Right
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D006352 2005
% 209.48/209.68  |- mesh__historyNote mesh__D006352 2004%28%1966%29%   
% 209.48/209.68  |- mesh__recordAuthorizer mesh__D006352 sjn
% 209.48/209.68  |- skos__scopeNote mesh__D006352
% 209.48/209.68       The lower right and left chambers of the heart. The right ventricle pumps venous BLOOD into the LUNGS and the left ventricle pumps oxygenated blood into the systemic arterial circulation.%A%    
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D006352 2004
% 209.48/209.68  |- skos__hiddenLabel mesh__D006352 Ventricles, Cardiac
% 209.48/209.68  |- mesh__publicMeSHNote mesh__D006352
% 209.48/209.68       2004; see HEART VENTRICLE 1966-2003   
% 209.48/209.68  |- skos__prefLabel mesh__D006352 Heart Ventricles
% 209.48/209.68  |- skos__hiddenLabel mesh__D006352 Ventricle, Cardiac
% 209.48/209.68  |- rdf__type mesh__D006352sskos__Concept
% 209.48/209.68  |- skos__annotation mesh__D006352
% 209.48/209.68       NIM: Manual 21.51; /physiol: consider also VENTRICULAR FUNCTION %26% specifics; /radionuclide permitted but consider also RADIONUCLIDE VENTRICULOGRAPHY; ventric hypertrophy = HYPERTROPHY, LEFT VENTRICULAR or HYPERTROPHY, RIGHT VENTRICULAR; false ventric tendons: index under PURKINJE FIBERS but see note there; PAPILLARY MUSCLES %26% CHORDAE TENDINEAE are available but read MeSH definitions%A%  
% 209.48/209.68  |- skos__broader mesh__D015632Q000633smesh__D015632
% 209.48/209.68  |- mesh__preferredCombination mesh__D015632Q000633smesh__D020267
% 209.48/209.68  |- rdf__type mesh__D015632Q000633smesh__CompoundConcept
% 209.48/209.68  |- mesh__recordMaintainer mesh__D011297 lkt
% 209.48/209.68  |- mesh__publicMeSHNote mesh__D011297
% 209.48/209.68       82; PRENATAL INFLUENCES was heading 1963-72   
% 209.48/209.68  |- skos__altLabel mesh__D011297 Delayed Effects, Prenatal Exposure
% 209.48/209.68  |- mesh__recordOriginator mesh__D011297 SMH
% 209.48/209.68  |- skos__altLabel mesh__D011297 Late Effects, Prenatal Exposure
% 209.48/209.68  |- skos__scopeNote mesh__D011297
% 209.48/209.68       The consequences of exposing the FETUS in utero to certain factors, such as NUTRITION; STRESS; DRUGS; RADIATION; and other physical or chemical factors. These consequences are observed later in the offspring after BIRTH.%A%    
% 209.48/209.68  |- skos__prefLabel mesh__D011297 Prenatal Exposure Delayed Effects
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D011297 2006
% 209.48/209.68  |- skos__broader mesh__D011297smesh__D049188
% 209.48/209.68  |- skos__annotation mesh__D011297
% 209.48/209.68       for mammals only; note PRECONCEPTION INJURIES; MATERNAL EXPOSURE %26% PATERNAL EXPOSURE are available for environmental exposure of mother or father; check tags FEMALE %26% PREGNANCY%A%  
% 209.48/209.68  |- mesh__historyNote mesh__D011297
% 209.48/209.68       82; PRENATAL INFLUENCES was heading 1963-72   
% 209.48/209.68  |- skos__related mesh__D011297smesh__D018812
% 209.48/209.68  |- mesh__recordAuthorizer mesh__D011297 sjn
% 209.48/209.68  |- mesh__dateCreated mesh__D011297 1981-05-19
% 209.48/209.68  |- mesh__dateEstablished mesh__D011297 1982-01-01
% 209.48/209.68  |- skos__related mesh__D011297smesh__D018811
% 209.48/209.68  |- mesh__dateRevised mesh__D011297 2005-06-30
% 209.48/209.68  |- rdf__type mesh__D011297sskos__Concept
% 209.48/209.68  |- mesh__onlineNote mesh__D011297
% 209.48/209.68       search PRENATAL INFLUENCES under PREGNANCY 1966-72   
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D016780 2001
% 209.48/209.68  |- mesh__recordOriginator mesh__D016780 PXP
% 209.48/209.68  |- mesh__dateCreated mesh__D016780 1991-05-02
% 209.48/209.68  |- skos__prefLabel mesh__D016780 Malaria, Vivax
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D016780 2002
% 209.48/209.68  |- skos__altLabel mesh__D016780 Plasmodium vivax Malaria
% 209.48/209.68  |- rdf__type mesh__D016780sskos__Concept
% 209.48/209.68  |- skos__hiddenLabel mesh__D016780 Vivax Malaria
% 209.48/209.68  |- mesh__dateEstablished mesh__D016780 1992-01-01
% 209.48/209.68  |- mesh__recordAuthorizer mesh__D016780 sjn
% 209.48/209.68  |- skos__historyNote mesh__D016780 Malaria %28%1966-1991%29%
% 209.48/209.68  |- skos__broader mesh__D016780smesh__D008288
% 209.48/209.68  |- skos__scopeNote mesh__D016780
% 209.48/209.68       Malaria caused by PLASMODIUM VIVAX. This form of malaria is less severe than MALARIA, FALCIPARUM, but there is a higher probability for relapses to occur. Febrile paroxysms often occur every other day.%A%    
% 209.48/209.68  |- mesh__dateRevised mesh__D016780 2000-06-22
% 209.48/209.68  |- mesh__publicMeSHNote mesh__D016780 1992   
% 209.48/209.68  |- skos__hiddenLabel mesh__D016780 Malaria, Plasmodium vivax
% 209.48/209.68  |- mesh__historyNote mesh__D016780 1992   
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D016780 2005
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D016780 2003
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D016780 2006
% 209.48/209.68  |- mesh__recordMaintainer mesh__D016780 TGC
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D016780 2004
% 209.48/209.68  |- skos__altLabel mesh__D002760
% 209.48/209.68       Retrograde Cholangiopancreatography, Endoscopic
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D002760 2000
% 209.48/209.68  |- skos__related mesh__D002760smesh__D016717
% 209.48/209.68  |- skos__broader mesh__D002760smesh__D016145
% 209.48/209.68  |- skos__hiddenLabel mesh__D002760
% 209.48/209.68       Retrograde Cholangiopancreatographies, Endoscopic
% 209.48/209.68  |- skos__hiddenLabel mesh__D002760
% 209.48/209.68       Endoscopic Retrograde Cholangiopancreatographies
% 209.48/209.68  |- rdf__type mesh__D002760sskos__Concept
% 209.48/209.68  |- mesh__dateRevised mesh__D002760 1999-11-08
% 209.48/209.68  |- skos__historyNote mesh__D002760 Endoscopy %28%1966-1980%29%
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D002760 2004
% 209.48/209.68  |- skos__scopeNote mesh__D002760
% 209.48/209.68       Fiberoptic endoscopy designed for duodenal observation and cannulation of VATER%27%S AMPULLA, in order to visualize the pancreatic and biliary duct system by retrograde injection of contrast media. Endoscopic %28%Vater%29% papillotomy %28%SPHINCTEROTOMY, ENDOSCOPIC%29% may be performed during this procedure.%A%    
% 209.48/209.68  |- skos__altLabel mesh__D002760
% 209.48/209.68       Endoscopic Retrograde Cholangiopancreatography
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D002760 2002
% 209.48/209.68  |- mesh__recordMaintainer mesh__D002760 KEV
% 209.48/209.68  |- mesh__publicMeSHNote mesh__D002760 81   
% 209.48/209.68  |- mesh__dateEstablished mesh__D002760 1981-01-01
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D002760 2003
% 209.48/209.68  |- mesh__dateCreated mesh__D002760 1980-04-04
% 209.48/209.68  |- skos__historyNote mesh__D002760 Pancreas %28%1966-1980%29%
% 209.48/209.68  |- skos__altLabel mesh__D002760 ERCP
% 209.48/209.68  |- skos__broader mesh__D002760smesh__D002758
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D002760 2006
% 209.48/209.68  |- mesh__recordOriginator mesh__D002760 RC
% 209.48/209.68  |- skos__historyNote mesh__D002760 Cholangiography %28%1966-1980%29%
% 209.48/209.68  |- mesh__recordAuthorizer mesh__D002760 sjn
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D002760 2001
% 209.48/209.68  |- mesh__historyNote mesh__D002760 81   
% 209.48/209.68  |- skos__prefLabel mesh__D002760
% 209.48/209.68       Cholangiopancreatography, Endoscopic Retrograde
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D002760 2005
% 209.48/209.68  |- skos__hiddenLabel mesh__D002760
% 209.48/209.68       Cholangiopancreatographies, Endoscopic Retrograde
% 209.48/209.68  |- skos__annotation mesh__D002760 /instrum is probably DUODENOSCOPES   
% 209.48/209.68  |- skos__hiddenLabel mesh__D015688 Protein src, Oncogene
% 209.48/209.68  |- skos__altLabel mesh__D015688 Oncogene Protein src
% 209.48/209.68  |- skos__altLabel mesh__D015688 src Oncogene Product pp60
% 209.48/209.68  |- skos__altLabel mesh__D015688 Oncogene Protein pp60%28%src%29%
% 209.48/209.68  |- skos__altLabel mesh__D015688 v-src Protein pp60
% 209.48/209.68  |- skos__hiddenLabel mesh__D015688 v src Protein
% 209.48/209.68  |- skos__hiddenLabel mesh__D015688 v src Protein pp60
% 209.48/209.68  |- mesh__recordMaintainer mesh__D015688 SYSTEM
% 209.48/209.68  |- mesh__recordAuthorizer mesh__D015688 sjn
% 209.48/209.68  |- skos__scopeNote mesh__D015688
% 209.48/209.68       A tyrosine-specific protein kinase encoded by the v-src oncogene of Rous sarcoma virus. The transforming activity of pp60%28%v-src%29% depends on both the lack of a critical carboxy-terminal tyrosine phosphorylation site at position 527, and the attachment of pp60%28%v-src%29% to the plasma membrane which is accomplished by myristylation of its N-terminal glycine.%A%    
% 209.48/209.68  |- skos__altLabel mesh__D015688 Phosphoprotein pp60%28%v-src%29%
% 209.48/209.68  |- skos__altLabel mesh__D015688
% 209.48/209.68       Rous Sarcoma Virus-Transforming Protein pp60%28%v-src%29%
% 209.48/209.68  |- skos__historyNote mesh__D015688 Viral Proteins %28%1981-1985%29%
% 209.48/209.68  |- skos__hiddenLabel mesh__D015688 pp60 v src
% 209.48/209.68  |- skos__hiddenLabel mesh__D015688 v-src, pp60
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D015688 2006
% 209.48/209.68  |- skos__hiddenLabel mesh__D015688 Avian Sarcoma Virus Transforming Protein
% 209.48/209.68  |- mesh__dateEstablished mesh__D015688 1990-01-01
% 209.48/209.68  |- mesh__dateCreated mesh__D015688 1989-05-25
% 209.48/209.68  |- mesh__dateRevised mesh__D015688 2005-06-30
% 209.48/209.68  |- mesh__historyNote mesh__D015688
% 209.48/209.68       91; was ONCOGENE PROTEIN PP60%28%SRC%29% 1990; PP60%28%SRC%29% was see ONCOGENE PROTEIN PP60%28%SRC%29% 1990%A%  
% 209.48/209.68  |- skos__historyNote mesh__D015688 Retroviridae Proteins %28%1986-1989%29%
% 209.48/209.68  |- skos__hiddenLabel mesh__D015688 src, Oncogene Protein
% 209.48/209.68  |- mesh__publicMeSHNote mesh__D015688
% 209.48/209.68       91; was ONCOGENE PROTEIN PP60%28%SRC%29% 1990; PP60%28%SRC%29% was see ONCOGENE PROTEIN PP60%28%SRC%29% 1990%A%  
% 209.48/209.68  |- skos__prefLabel mesh__D015688 Oncogene Protein pp60%28%v-src%29%
% 209.48/209.68  |- skos__altLabel mesh__D015688 pp60%28%v-src%29%
% 209.48/209.68  |- skos__altLabel mesh__D015688 src Oncogene Protein pp60
% 209.48/209.68  |- mesh__onlineNote mesh__D015688
% 209.48/209.68       use ONCOGENE PROTEIN PP60%28%V-SRC%29% to search ONCOGENE PROTEIN PP60%28%SRC%29% %26% PP60%28%SRC%29% 1990%A%  
% 209.48/209.68  |- skos__altLabel mesh__D015688 Avian Sarcoma Virus-Transforming Protein
% 209.48/209.68  |- skos__broader mesh__D015688smesh__D015682
% 209.48/209.68  |- skos__hiddenLabel mesh__D015688 Protein pp60, v-src
% 209.48/209.68  |- skos__altLabel mesh__D015688 v-src Protein
% 209.48/209.68  |- skos__broader mesh__D015688smesh__D019061
% 209.48/209.68  |- mesh__recordOriginator mesh__D015688 AGS
% 209.48/209.68  |- rdf__type mesh__D015688sskos__Concept
% 209.48/209.68  |- skos__altLabel mesh__D015688 pp60 v-src
% 209.48/209.68  |- skos__altLabel mesh__D015688 p60%28%v-src%29%
% 209.48/209.68  |- skos__hiddenLabel mesh__D015688 pp60, v-src Protein
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 ProteinChips
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Analyses, Protein Array
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Microchip, Protein
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Array, Protein
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Microarray, Protein Profiling
% 209.48/209.68  |- mesh__recordOriginator mesh__D040081 nns
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Microchips, Protein
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Assays, Protein Microarray
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Assay, Protein Microarray
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Biochip, Protein
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Array Analysis, Protein
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Analysis, Protein Microarray
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Protein Microarray
% 209.48/209.68  |- skos__altLabel mesh__D040081 Protein Biochips
% 209.48/209.68  |- mesh__historyNote mesh__D040081 2003   
% 209.48/209.68  |- mesh__publicMeSHNote mesh__D040081 2003   
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D040081 2006
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Chips, Protein Profiling
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Protein Array
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Profiling Microarray, Protein
% 209.48/209.68  |- mesh__recordAuthorizer mesh__D040081 sjn
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Protein Microarray Assays
% 209.48/209.68  |- mesh__dateRevised mesh__D040081 2005-06-30
% 209.48/209.68  |- skos__broader mesh__D040081smesh__D046228
% 209.48/209.68  |- rdf__type mesh__D040081sskos__Concept
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Biochips, Protein
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Assay, Protein Array
% 209.48/209.68  |- skos__related mesh__D040081smesh__D025941
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Microarray, Protein
% 209.48/209.68  |- mesh__recordMaintainer mesh__D040081 ssb
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Chip, Protein Profiling
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Analyses, Protein Microarray
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Assays, Protein Array
% 209.48/209.68  |- skos__broader mesh__D040081smesh__D015336
% 209.48/209.68  |- skos__altLabel mesh__D040081 Protein Chips
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Profiling Microarrays, Protein
% 209.48/209.68  |- skos__altLabel mesh__D040081 Protein Profiling Microarrays
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Protein Profiling Chip
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Protein Biochip
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Protein Array Analyses
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Protein Chip
% 209.48/209.68  |- mesh__dateCreated mesh__D040081 2002-07-02
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Protein Array Assays
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Profiling Chip, Protein
% 209.48/209.68  |- skos__altLabel mesh__D040081 Protein Microchips
% 209.48/209.68  |- skos__altLabel mesh__D040081 Protein Microarray Assay
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Microarrays, Protein Profiling
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Microarray Analyses, Protein
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Protein Profiling Microarray
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Microarray Assays, Protein
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Arrays, Protein
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Chip, Protein
% 209.48/209.68  |- skos__scopeNote mesh__D040081
% 209.48/209.68       Ligand-binding assays that measure protein-protein, protein-small molecule, or protein-nucleic acid interactions using a very large set of capturing molecules, i.e., those attached separately on a solid support, to measure the presence or interaction of target molecules in the sample.%A%    
% 209.48/209.68  |- skos__altLabel mesh__D040081 Protein Array Assay
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Protein Microchip
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Protein Microarray Analyses
% 209.48/209.68  |- mesh__dateEstablished mesh__D040081 2003-01-01
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Array Assays, Protein
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Profiling Chips, Protein
% 209.48/209.68  |- skos__prefLabel mesh__D040081 Protein Array Analysis
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Array Assay, Protein
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Microarray Assay, Protein
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Analysis, Protein Array
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Array Analyses, Protein
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Microarrays, Protein
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Chips, Protein
% 209.48/209.68  |- skos__hiddenLabel mesh__D040081 Microarray Analysis, Protein
% 209.48/209.68  |- mesh__dateCreated mesh__D001668 1999-01-01
% 209.48/209.68  |- skos__annotation mesh__D001668
% 209.48/209.68       IM for biobibliog as a subject; for biobibliog of a biographee coord NIM + BIOBIBLIOGRAPHY %28%PT%29%; no qualif; DF: BIOBIBLIOG or BIOBIBLIOGR%A%  
% 209.48/209.68  |- mesh__activeMeSHYear mesh__D001668 2006
% 209.48/209.68  |- skos__altLabel mesh__D001668 Biobibliographies
% 209.48/209.68  |- skos__scopeNote mesh__D001668
% 209.48/209.68       A biography which includes a list of the writings of the subject person.%A%    
% 209.48/209.69  |- mesh__dateRevised mesh__D001668 2002-07-31
% 209.48/209.69  |- rdf__type mesh__D001668sskos__Concept
% 209.48/209.69  |- mesh__recordMaintainer mesh__D001668 sjn
% 209.48/209.69  |- skos__prefLabel mesh__D001668 Biobibliography
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D001668 2005
% 209.48/209.69  |- mesh__recordOriginator mesh__D001668 NLM
% 209.48/209.69  |- mesh__recordAuthorizer mesh__D001668 sjn
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D001668 2004
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D001668 2003
% 209.48/209.69  |- skos__broader mesh__D001668smesh__D001634
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012390 1996
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012390 2002
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012390 1999
% 209.48/209.69  |- skos__hiddenLabel mesh__D012390 Root Canal Therapies
% 209.48/209.69  |- skos__prefLabel mesh__D012390 Root Canal Therapy
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012390 1997
% 209.48/209.69  |- skos__annotation mesh__D012390
% 209.48/209.69       do not use /util except by MeSH definition; the corresponding specialty is ENDODONTICS; reamers %26% broaches: index under ROOT CANAL PREPARATION /instrum; DF: ROOT CANAL THER%A%  
% 209.48/209.69  |- mesh__recordOriginator mesh__D012390 NLM
% 209.48/209.69  |- mesh__recordAuthorizer mesh__D012390 PLS
% 209.48/209.69  |- skos__hiddenLabel mesh__D012390 Therapies, Root Canal
% 209.48/209.69  |- mesh__dateRevised mesh__D012390 1995-06-08
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012390 2005
% 209.48/209.69  |- skos__altLabel mesh__D012390 Therapy, Root Canal
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012390 2003
% 209.48/209.69  |- skos__scopeNote mesh__D012390
% 209.48/209.69       A treatment modality in endodontics concerned with the therapy of diseases of the dental pulp. For preparatory procedures, ROOT CANAL PREPARATION is available.%A%    
% 209.48/209.69  |- mesh__publicMeSHNote mesh__D012390
% 209.48/209.69       65; was see under ENDODONTICS 1963-64   
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012390 2006
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012390 2000
% 209.48/209.69  |- mesh__recordMaintainer mesh__D012390 TGC
% 209.48/209.69  |- mesh__dateCreated mesh__D012390 1999-01-01
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012390 2004
% 209.48/209.69  |- skos__broader mesh__D012390smesh__D004708
% 209.48/209.69  |- mesh__historyNote mesh__D012390 65; was see under ENDODONTICS 1963-64   
% 209.48/209.69  |- rdf__type mesh__D012390sskos__Concept
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012390 2001
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012390 1998
% 209.48/209.69  |- skos__hiddenLabel mesh__D012390 Canal Therapies, Root
% 209.48/209.69  |- skos__hiddenLabel mesh__D012390 Canal Therapy, Root
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Choreas, Chronic Progressive
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Senile Choreas
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Dyskinesia, Paroxysmal
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D020822 2006
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Chorea Syndrome
% 209.48/209.69  |- mesh__recordMaintainer mesh__D020822 ags
% 209.48/209.69  |- mesh__dateEstablished mesh__D020822 2000-01-01
% 209.48/209.69  |- skos__historyNote mesh__D020822 Chorea %28%1966-1999%29%
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Choreatic Disorder
% 209.48/209.69  |- mesh__dateCreated mesh__D020822 1999-11-05
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Sydenham Choreas
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D020822 2003
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Hereditary Choreas, Benign
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Choreas, Rheumatic
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Progressive Choreas, Chronic
% 209.48/209.69  |- skos__annotation mesh__D020822 CHOREA is also available   
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D020822 2002
% 209.48/209.69  |- skos__prefLabel mesh__D020822 Choreatic Disorders
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Benign Hereditary Chorea
% 209.48/209.69  |- rdf__type mesh__D020822sskos__Concept
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D020822 2004
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Chorea Acanthocytosis Syndromes
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Hereditary Choreas
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Paroxysmal Dyskinesia
% 209.48/209.69  |- mesh__recordOriginator mesh__D020822 KEV
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Benign Hereditary Choreas
% 209.48/209.69  |- skos__scopeNote mesh__D020822
% 209.48/209.69       Acquired and hereditary conditions which feature CHOREA as a primary manifestation of the disease process.%A%    
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Rheumatic Choreas
% 209.48/209.69  |- mesh__recordAuthorizer mesh__D020822 sjn
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Choreas, Benign Hereditary
% 209.48/209.69  |- mesh__publicMeSHNote mesh__D020822 2000   
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Chronic Progressive Chorea
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Choreatic Syndrome
% 209.48/209.69  |- skos__altLabel mesh__D020822 Sydenham Chorea
% 209.48/209.69  |- mesh__dateRevised mesh__D020822 2001-07-25
% 209.48/209.69  |- skos__altLabel mesh__D020822 Choreatic Syndromes
% 209.48/209.69  |- skos__altLabel mesh__D020822 Rheumatic Chorea
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Chorea, Hereditary
% 209.48/209.69  |- skos__altLabel mesh__D020822 Neuroacanthocytosis
% 209.48/209.69  |- skos__altLabel mesh__D020822 St. Vitus%27%s Dance
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Choreas, Senile
% 209.48/209.69  |- skos__altLabel mesh__D020822 Chorea Syndromes
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Progressive Chorea, Chronic
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Hereditary Chorea, Benign
% 209.48/209.69  |- skos__altLabel mesh__D020822 Chorea, Sydenham
% 209.48/209.69  |- skos__altLabel mesh__D020822 Paroxysmal Dyskinesias
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Chorea Disorder
% 209.48/209.69  |- mesh__historyNote mesh__D020822 2000   
% 209.48/209.69  |- skos__altLabel mesh__D020822 Chorea Disorders
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Choreas, Hereditary
% 209.48/209.69  |- skos__broader mesh__D020822smesh__D009069
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D020822 2005
% 209.48/209.69  |- skos__altLabel mesh__D020822 Senile Chorea
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Chronic Progressive Choreas
% 209.48/209.69  |- skos__hiddenLabel mesh__D020822 Choreas, Sydenham
% 209.48/209.69  |- skos__scopeNote mesh__D006353
% 209.48/209.69       Small pumps, often implantable, designed for temporarily assisting the heart, usually the left ventricle, to pump blood; they consist of a pumping chamber and a power source, which may be partially or totally external to the body and activated by electromagnetic motors; the devices are used after myocardial infarction or to wean the repaired heart from the heart-lung machine after open-heart surgery.%A%    
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Artificial Ventricles
% 209.48/209.69  |- mesh__dateEstablished mesh__D006353 1990-01-01
% 209.48/209.69  |- skos__historyNote mesh__D006353 Assisted Circulation %28%1967-1985%29%
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Ventricles, Artificial Heart
% 209.48/209.69  |- rdf__type mesh__D006353sskos__Concept
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D006353 2004
% 209.48/209.69  |- skos__historyNote mesh__D006353 Heart, Artificial %28%1967-1985%29%
% 209.48/209.69  |- mesh__dateRevised mesh__D006353 1997-06-20
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Ventricle, Artificial Heart
% 209.48/209.69  |- skos__altLabel mesh__D006353 Heart Ventricle, Artificial
% 209.48/209.69  |- skos__prefLabel mesh__D006353 Heart-Assist Devices
% 209.48/209.69  |- mesh__recordMaintainer mesh__D006353 PXP
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Device, Heart-Assist
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D006353 2003
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Artificial Heart Ventricles
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Ventricles, Artificial
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Ventricle, Artificial
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D006353 2002
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Heart Assist Devices
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Heart-Assist Device
% 209.48/209.69  |- skos__broader mesh__D006353smesh__D006354
% 209.48/209.69  |- skos__historyNote mesh__D006353 Pacemaker, Artificial %28%1966-1985%29%
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Device, Vascular-Assist
% 209.48/209.69  |- skos__altLabel mesh__D006353 Pumps, Heart-Assist
% 209.48/209.69  |- skos__broader mesh__D006353smesh__D001243
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Devices, Ventricle-Assist
% 209.48/209.69  |- mesh__publicMeSHNote mesh__D006353
% 209.48/209.69       90; was see under ASSISTED CIRCULATION 1986-89   
% 209.48/209.69  |- skos__altLabel mesh__D006353 Ventricle-Assist Device
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D006353 2006
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Heart Ventricles, Artificial
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Heart-Assist Pumps
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Ventricle-Assist Devices
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D006353 1999
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Artificial Heart Ventricle
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D006353 2005
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Device, Ventricle-Assist
% 209.48/209.69  |- mesh__historyNote mesh__D006353
% 209.48/209.69       90%28%86%29%; was see under ASSISTED CIRCULATION 1986-89   
% 209.48/209.69  |- mesh__recordOriginator mesh__D006353 SH
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Heart-Assist Pump
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D006353 2001
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Vascular-Assist Device
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Devices, Heart-Assist
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Pumps, Heart Assist
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Pump, Heart-Assist
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Devices, Vascular-Assist
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D006353 1998
% 209.48/209.69  |- mesh__dateCreated mesh__D006353 1985-06-07
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Vascular Assist Devices
% 209.48/209.69  |- skos__hiddenLabel mesh__D006353 Ventricle Assist Device
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D006353 2000
% 209.48/209.69  |- skos__altLabel mesh__D006353 Vascular-Assist Devices
% 209.48/209.69  |- mesh__recordAuthorizer mesh__D006353 SJN
% 209.48/209.69  |- rdf__type mesh__D020024sskos__Concept
% 209.48/209.69  |- mesh__publicMeSHNote mesh__D020024 99   
% 209.48/209.69  |- skos__altLabel mesh__D020024 Antagonists, Leukotriene
% 209.48/209.69  |- skos__broader mesh__D020024smesh__D006727
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D020024 2006
% 209.48/209.69  |- skos__prefLabel mesh__D020024 Leukotriene Antagonists
% 209.48/209.69  |- skos__hiddenLabel mesh__D020024 Antagonists, Leukotriene Receptor
% 209.48/209.69  |- skos__altLabel mesh__D020024 Leukotriene Receptor Antagonists
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D020024 2005
% 209.48/209.69  |- mesh__dateRevised mesh__D020024 2003-07-09
% 209.48/209.69  |- mesh__dateCreated mesh__D020024 1998-06-10
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D020024 2004
% 209.48/209.69  |- mesh__historyNote mesh__D020024 99   
% 209.48/209.69  |- mesh__dateEstablished mesh__D020024 1999-01-01
% 209.48/209.69  |- skos__altLabel mesh__D020024 Receptor Antagonists, Leukotriene
% 209.48/209.69  |- skos__scopeNote mesh__D020024
% 209.48/209.69       A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level.%A%    
% 209.48/209.69  |- skos__altLabel mesh__D011298 Feprazone
% 209.48/209.69  |- skos__hiddenLabel mesh__D011298 DA 2370
% 209.48/209.69  |- mesh__dateEstablished mesh__D011298 1991-01-01
% 209.48/209.69  |- mesh__dateRevised mesh__D011298 2005-06-30
% 209.48/209.69  |- skos__scopeNote mesh__D011298
% 209.48/209.69       A pyrazole that has analgesic, anti-inflammatory, and antipyretic properties. It has been used in mild to moderate pain, fever, and inflammation associated with musculoskeletal and joint disorders. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p15%29%%A%    
% 209.48/209.69  |- skos__historyNote mesh__D011298 Terpenes %28%1972-1974%29%
% 209.48/209.69  |- mesh__recordMaintainer mesh__D011298 ssb
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D011298 2006
% 209.48/209.69  |- skos__historyNote mesh__D011298 Pyrazoles %28%1972-1974%29%
% 209.48/209.69  |- skos__broader mesh__D011298smesh__D010653
% 209.48/209.69  |- mesh__dateCreated mesh__D011298 1974-11-19
% 209.48/209.69  |- skos__historyNote mesh__D011298 Alkenes %28%1974%29%
% 209.48/209.69  |- skos__altLabel mesh__D011298 Fenilprenazone
% 209.48/209.69  |- skos__altLabel mesh__D011298 Escaned Brand of Prenazone
% 209.48/209.69  |- skos__prefLabel mesh__D011298 Prenazone
% 209.48/209.69  |- rdf__type mesh__D011298sskos__Concept
% 209.48/209.69  |- skos__altLabel mesh__D011298 Phenylprenazone
% 209.48/209.69  |- skos__hiddenLabel mesh__D011298 DA2370
% 209.48/209.69  |- mesh__recordOriginator mesh__D011298 NLM
% 209.48/209.69  |- mesh__publicMeSHNote mesh__D011298
% 209.48/209.69       91; was see under PHENYLBUTAZONE 1975-90   
% 209.48/209.69  |- mesh__historyNote mesh__D011298
% 209.48/209.69       91%28%75%29%; was see under PHENYLBUTAZONE 1975-90   
% 209.48/209.69  |- mesh__recordAuthorizer mesh__D011298 sjn
% 209.48/209.69  |- skos__broader mesh__D016781smesh__D001922
% 209.48/209.69  |- skos__historyNote mesh__D016781 Toxoplasmosis %28%1966-1991%29%
% 209.48/209.69  |- skos__annotation mesh__D016781
% 209.48/209.69       coord IM with specific brain disease %28%IM%29% or specific site %28%IM%29% if pertinent; congenital: coord IM with TOXOPLASMOSIS, CONGENITAL %28%IM%29%%A%  
% 209.48/209.69  |- rdf__type mesh__D016781sskos__Concept
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D016781 2001
% 209.48/209.69  |- mesh__dateRevised mesh__D016781 2000-06-22
% 209.48/209.69  |- skos__broader mesh__D016781smesh__D020808
% 209.48/209.69  |- skos__broader mesh__D016781smesh__D014123
% 209.48/209.69  |- skos__scopeNote mesh__D016781
% 209.48/209.69       Infections of the BRAIN caused by the protozoan TOXOPLASMA gondii that primarily arise in individuals with IMMUNOLOGIC DEFICIENCY SYNDROMES %28%see also AIDS-RELATED OPPORTUNISTIC INFECTIONS%29%. The infection may involve the brain diffusely or form discrete abscesses. Clinical manifestations include SEIZURES, altered mentation, headache, focal neurologic deficits, and INTRACRANIAL HYPERTENSION. %28%From Joynt, Clinical Neurology, 1998, Ch27, pp41-3%29%%A%    
% 209.48/209.69  |- mesh__dateCreated mesh__D016781 1991-05-02
% 209.48/209.69  |- skos__historyNote mesh__D016781 Brain Diseases %28%1966-1991%29%
% 209.48/209.69  |- skos__altLabel mesh__D016781 Cerebral Toxoplasmosis
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D016781 2002
% 209.48/209.69  |- mesh__publicMeSHNote mesh__D016781 1992   
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D016781 2005
% 209.48/209.69  |- mesh__dateEstablished mesh__D016781 1992-01-01
% 209.48/209.69  |- skos__altLabel mesh__D016781 Central Nervous System Toxoplasmosis
% 209.48/209.69  |- mesh__recordAuthorizer mesh__D016781 sjn
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D016781 2003
% 209.48/209.69  |- mesh__recordMaintainer mesh__D016781 KEV
% 209.48/209.69  |- skos__prefLabel mesh__D016781 Toxoplasmosis, Cerebral
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D016781 2006
% 209.48/209.69  |- skos__hiddenLabel mesh__D016781 Toxoplasmoses, Cerebral
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D016781 2004
% 209.48/209.69  |- mesh__recordOriginator mesh__D016781 PXP
% 209.48/209.69  |- mesh__historyNote mesh__D016781 1992   
% 209.48/209.69  |- skos__hiddenLabel mesh__D016781 Toxoplasmosis, Intracranial
% 209.48/209.69  |- mesh__recordMaintainer mesh__D002761 lkt
% 209.48/209.69  |- mesh__recordAuthorizer mesh__D002761 sjn
% 209.48/209.69  |- rdf__type mesh__D002761sskos__Concept
% 209.48/209.69  |- skos__broader mesh__D002761smesh__D001649
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D002761 2004
% 209.48/209.69  |- mesh__recordOriginator mesh__D002761 NLM
% 209.48/209.69  |- mesh__dateCreated mesh__D002761 1999-01-01
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D002761 2005
% 209.48/209.69  |- skos__prefLabel mesh__D002761 Cholangitis
% 209.48/209.69  |- skos__hiddenLabel mesh__D002761 Cholangitides
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D002761 2006
% 209.48/209.69  |- mesh__dateRevised mesh__D002761 2003-07-09
% 209.48/209.69  |- skos__related mesh__D002761smesh__D002764
% 209.48/209.69  |- skos__scopeNote mesh__D002761
% 209.48/209.69       Inflammation of the biliary ductal system %28%BILE DUCTS%29%; intrahepatic, extrahepatic, or both.%A%    
% 209.48/209.69  |- mesh__dateRevised mesh__D015689 2005-06-30
% 209.48/209.69  |- skos__hiddenLabel mesh__D015689 p21 v ras
% 209.48/209.69  |- mesh__dateCreated mesh__D015689 1989-07-19
% 209.48/209.69  |- skos__hiddenLabel mesh__D015689 p21 v H ras
% 209.48/209.69  |- skos__altLabel mesh__D015689 p21%28%v-Ki-ras%29%
% 209.48/209.69  |- skos__altLabel mesh__D015689 ras Oncogene p21 Product
% 209.48/209.69  |- skos__altLabel mesh__D015689 p21 v-Ki-ras
% 209.48/209.69  |- skos__annotation mesh__D015689 coord with specific virus   
% 209.48/209.69  |- skos__altLabel mesh__D015689 p21%28%v-K-ras%29%
% 209.48/209.69  |- skos__prefLabel mesh__D015689 Oncogene Protein p21%28%ras%29%
% 209.48/209.69  |- mesh__dateEstablished mesh__D015689 1990-01-01
% 209.48/209.69  |- skos__altLabel mesh__D015689 p21 v-Ha-ras
% 209.48/209.69  |- skos__altLabel mesh__D015689 p21 Transforming Viral Protein
% 209.48/209.69  |- mesh__recordOriginator mesh__D015689 AGS
% 209.48/209.69  |- skos__altLabel mesh__D015689 ras Oncogene Product p21
% 209.48/209.69  |- skos__hiddenLabel mesh__D015689 p21 v Ha ras
% 209.48/209.69  |- mesh__historyNote mesh__D015689 1990   
% 209.48/209.69  |- skos__altLabel mesh__D015689 p21%28%v-H-ras%29%
% 209.48/209.69  |- skos__altLabel mesh__D015689 p21%28%v-Ha-ras%29%
% 209.48/209.69  |- skos__broader mesh__D015689smesh__D015682
% 209.48/209.69  |- skos__broader mesh__D015689smesh__D018631
% 209.48/209.69  |- rdf__type mesh__D015689sskos__Concept
% 209.48/209.69  |- skos__historyNote mesh__D015689 Neoplasm Proteins %28%1980-1986%29%
% 209.48/209.69  |- skos__hiddenLabel mesh__D015689 v-Ki-ras, p21
% 209.48/209.69  |- mesh__recordAuthorizer mesh__D015689 sjn
% 209.48/209.69  |- skos__historyNote mesh__D015689
% 209.48/209.69       Oncogene Proteins, Viral %28%1986-1989%29%
% 209.48/209.69  |- skos__hiddenLabel mesh__D015689 v-H-ras, p21
% 209.48/209.69  |- skos__altLabel mesh__D015689 p21 v-H-ras
% 209.48/209.69  |- skos__altLabel mesh__D015689 p21 v-ras
% 209.48/209.69  |- skos__altLabel mesh__D015689 ras Oncogene Protein p21
% 209.48/209.69  |- skos__hiddenLabel mesh__D015689 v-ras, p21
% 209.48/209.69  |- skos__hiddenLabel mesh__D015689 p21 v Ki ras
% 209.48/209.69  |- mesh__recordMaintainer mesh__D015689 DRC
% 209.48/209.69  |- mesh__publicMeSHNote mesh__D015689 1990   
% 209.48/209.69  |- skos__scopeNote mesh__D015689
% 209.48/209.69       Transforming protein encoded by ras oncogenes. Point mutations in the cellular ras gene %28%c-ras%29% can also result in a mutant p21 protein that can transform mammalian cells. Oncogene protein p21%28%ras%29% has been directly implicated in human neoplasms, perhaps accounting for as much as 15-20%25% of all human tumors. This enzyme was formerly listed as EC 3.6.1.47.%A%    
% 209.48/209.69  |- skos__hiddenLabel mesh__D015689 v-Ha-ras, p21
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D015689 2006
% 209.48/209.69  |- skos__broader mesh__D001669smesh__D001670
% 209.48/209.69  |- mesh__recordAuthorizer mesh__D001669 SJN
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D001669 2006
% 209.48/209.69  |- skos__scopeNote mesh__D001669
% 209.48/209.69       Biochemical functions, activities, and processes at organic and molecular levels in humans, animals, microorganisms, and plants.%A%    
% 209.48/209.69  |- mesh__dateRevised mesh__D001669 1997-06-20
% 209.48/209.69  |- rdf__type mesh__D001669sskos__Concept
% 209.48/209.69  |- mesh__publicMeSHNote mesh__D001669 98   
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D001669 2003
% 209.48/209.69  |- skos__annotation mesh__D001669
% 209.48/209.69       GEN or unspecified; prefer specifics; BIOLOGICAL PHENOMENA is also available; DF: BIOCHEM PHENOMENA%A%  
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D001669 2002
% 209.48/209.69  |- skos__altLabel mesh__D001669 Phenomena, Biochemical
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D001669 2004
% 209.48/209.69  |- mesh__dateEstablished mesh__D001669 1998-01-01
% 209.48/209.69  |- skos__prefLabel mesh__D001669 Biochemical Phenomena
% 209.48/209.69  |- mesh__dateCreated mesh__D001669 1999-01-01
% 209.48/209.69  |- skos__historyNote mesh__D001669 Biochemistry %28%1966-1997%29%
% 209.48/209.69  |- mesh__historyNote mesh__D001669 98; use explode 1970-97   
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D001669 2000
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D001669 1998
% 209.48/209.69  |- mesh__recordOriginator mesh__D001669 NLM
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D001669 1999
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D001669 2005
% 209.48/209.69  |- mesh__recordMaintainer mesh__D001669 TGC
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D001669 2001
% 209.48/209.69  |- skos__hiddenLabel mesh__D012391 Root Resorptions
% 209.48/209.69  |- skos__hiddenLabel mesh__D012391 Resorptions, Root
% 209.48/209.69  |- mesh__historyNote mesh__D012391 72%28%63%29%   
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012391 2001
% 209.48/209.69  |- skos__hiddenLabel mesh__D012391 Resorption, Root
% 209.48/209.69  |- skos__scopeNote mesh__D012391
% 209.48/209.69       Resorption in which cementum or dentin is lost from the root of a tooth owing to cementoclastic or osteoclastic activity in conditions such as trauma of occlusion or neoplasms. %28%Dorland, 27th ed%29%%A%    
% 209.48/209.69  |- skos__broader mesh__D012391smesh__D014091
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012391 2005
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012391 2002
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012391 2003
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012391 1994
% 209.48/209.69  |- mesh__recordOriginator mesh__D012391 NLM
% 209.48/209.69  |- mesh__recordMaintainer mesh__D012391 TGC
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012391 2006
% 209.48/209.69  |- mesh__recordAuthorizer mesh__D012391 PLS
% 209.48/209.69  |- mesh__dateCreated mesh__D012391 1999-01-01
% 209.48/209.69  |- skos__annotation mesh__D012391
% 209.48/209.69       loss of cementum or dentin from root of tooth; only Cat C qualif%A%  
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012391 2004
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012391 1995
% 209.48/209.69  |- rdf__type mesh__D012391sskos__Concept
% 209.48/209.69  |- mesh__publicMeSHNote mesh__D012391 72   
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012391 1998
% 209.48/209.69  |- mesh__dateEstablished mesh__D012391 1972-01-01
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012391 1996
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012391 2000
% 209.48/209.69  |- mesh__dateRevised mesh__D012391 1993-06-02
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012391 1999
% 209.48/209.69  |- skos__prefLabel mesh__D012391 Root Resorption
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D012391 1997
% 209.48/209.69  |- skos__historyNote mesh__D020823 G-Proteins %28%1993-1999%29%
% 209.48/209.69  |- rdf__type mesh__D020823sskos__Concept
% 209.48/209.69  |- skos__hiddenLabel mesh__D020823 ADP Ribosylation Factor 1
% 209.48/209.69  |- skos__prefLabel mesh__D020823 ADP-Ribosylation Factor 1
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D020823 2006
% 209.48/209.69  |- skos__broader mesh__D020823smesh__D020755
% 209.48/209.69  |- mesh__dateCreated mesh__D020823 1999-11-03
% 209.48/209.69  |- skos__scopeNote mesh__D020823
% 209.48/209.69       ADP-RIBOSYLATION FACTOR 1 is involved in regulating intracellular transport by modulating the interaction of coat proteins with organelle membranes in the early secretory pathway. It is a component of COAT PROTEIN COMPLEX I. This enzyme was formerly listed as EC 3.6.1.47.%A%    
% 209.48/209.69  |- mesh__dateRevised mesh__D020823 2005-06-30
% 209.48/209.69  |- mesh__historyNote mesh__D020823
% 209.48/209.69       2000; use ADP-RIBOSYLATION FACTOR 1 %28%NM%29% 1993-1999   
% 209.48/209.69  |- skos__altLabel mesh__D020823 ARF1p
% 209.48/209.69  |- skos__broader mesh__D020823smesh__D020727
% 209.48/209.69  |- mesh__recordAuthorizer mesh__D020823 sjn
% 209.48/209.69  |- mesh__recordMaintainer mesh__D020823 jmp
% 209.48/209.69  |- mesh__publicMeSHNote mesh__D020823
% 209.48/209.69       2000; ADP RIBOSYLATION FACTOR 1 %28%now ADP-RIBOSYLATION FACTOR 1%29% was indexed under G-PROTEINS 1993-1999%A%  
% 209.48/209.69  |- mesh__dateEstablished mesh__D020823 2000-01-01
% 209.48/209.69  |- skos__hiddenLabel mesh__D020823 Protein, ARF1
% 209.48/209.69  |- skos__altLabel mesh__D020823 ARF1 Protein
% 209.48/209.69  |- mesh__recordOriginator mesh__D020823 jmp
% 209.48/209.69  |- skos__altLabel mesh__D020823 ARF 1 Protein
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D006354 2002
% 209.48/209.69  |- mesh__recordOriginator mesh__D006354 NLM
% 209.48/209.69  |- skos__altLabel mesh__D006354 Artificial Heart
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D006354 2006
% 209.48/209.69  |- mesh__dateRevised mesh__D006354 1999-11-03
% 209.48/209.69  |- skos__hiddenLabel mesh__D006354 Artificial Hearts
% 209.48/209.69  |- mesh__recordAuthorizer mesh__D006354 sjn
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D006354 2003
% 209.48/209.69  |- mesh__recordMaintainer mesh__D006354 ndw
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D006354 2000
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D006354 2004
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D006354 2001
% 209.48/209.69  |- skos__scopeNote mesh__D006354
% 209.48/209.69       A pumping mechanism that duplicates the output, rate, and blood pressure of the natural heart. It may replace the function of the entire heart or a portion of it, and may be an intracorporeal, extracorporeal, or paracorporeal heart. %28%Dorland, 28th ed%29%%A%    
% 209.48/209.69  |- skos__broader mesh__D006354smesh__D001187
% 209.48/209.69  |- mesh__historyNote mesh__D006354 67   
% 209.48/209.69  |- skos__prefLabel mesh__D006354 Heart, Artificial
% 209.48/209.69  |- skos__broader mesh__D006354smesh__D019736
% 209.48/209.69  |- rdf__type mesh__D006354sskos__Concept
% 209.48/209.69  |- mesh__dateCreated mesh__D006354 1999-01-01
% 209.48/209.69  |- skos__hiddenLabel mesh__D006354 Hearts, Artificial
% 209.48/209.69  |- mesh__dateEstablished mesh__D006354 1967-01-01
% 209.48/209.69  |- skos__annotation mesh__D006354
% 209.48/209.69       pump replacing whole or part of heart: do not confuse with HEART-LUNG MACHINE %28%external to heart%29%; /psychol permitted%A%  
% 209.48/209.69  |- mesh__publicMeSHNote mesh__D006354 67   
% 209.48/209.69  |- skos__historyNote mesh__D006354 Artificial Organs %28%1966%29%
% 209.48/209.69  |- skos__historyNote mesh__D006354 Heart-Lung Machine %28%1966%29%
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D006354 2005
% 209.48/209.69  |- skos__historyNote mesh__D020025
% 209.48/209.69       Liver Neoplasms, Experimental %28%1986-1998%29%
% 209.48/209.69  |- mesh__dateRevised mesh__D020025 2004-07-07
% 209.48/209.69  |- mesh__dateCreated mesh__D020025 1998-06-10
% 209.48/209.69  |- rdf__type mesh__D020025sskos__Concept
% 209.48/209.69  |- skos__hiddenLabel mesh__D020025 Proliferators, Peroxisome
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D020025 2005
% 209.48/209.69  |- mesh__recordAuthorizer mesh__D020025 sjn
% 209.48/209.69  |- skos__related mesh__D020025smesh__D047492
% 209.48/209.69  |- skos__historyNote mesh__D020025 Antilipemic Agents %28%1976-1998%29%
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D020025 2006
% 209.48/209.69  |- skos__scopeNote mesh__D020025
% 209.48/209.69       A class of nongenotoxic CARCINOGENS that induce the production of hepatic PEROXISOMES and induce hepatic neoplasms after long-term administration.%A%    
% 209.48/209.69  |- mesh__dateEstablished mesh__D020025 1999-01-01
% 209.48/209.69  |- mesh__recordMaintainer mesh__D020025 ssb
% 209.48/209.69  |- mesh__recordOriginator mesh__D020025 ADP
% 209.48/209.69  |- skos__broader mesh__D020025smesh__D002273
% 209.48/209.69  |- skos__related mesh__D020025smesh__D008830
% 209.48/209.69  |- mesh__historyNote mesh__D020025 99   
% 209.48/209.69  |- mesh__publicMeSHNote mesh__D020025 99   
% 209.48/209.69  |- skos__prefLabel mesh__D020025 Peroxisome Proliferators
% 209.48/209.69  |- skos__broader mesh__D011299smesh__D010627
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D011299 2001
% 209.48/209.69  |- mesh__dateEstablished mesh__D011299 1966-01-01
% 209.48/209.69  |- skos__prefLabel mesh__D011299 Prenylamine
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D011299 2004
% 209.48/209.69  |- mesh__dateCreated mesh__D011299 1999-01-01
% 209.48/209.69  |- mesh__recordOriginator mesh__D011299 NLM
% 209.48/209.69  |- mesh__activeMeSHYear mesh__D011299 2003
% 209.48/209.69  |- mesh__recordAuthorizer mesh__D011299 sjn
% 209.48/209.69  |- mesh__publicMeSHNote mesh__D011299 66; was SEGONTIN 1963-65   
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D011299 2006
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D011299 2002
% 209.48/209.70  |- skos__scopeNote mesh__D011299
% 209.48/209.70       A drug formerly used in the treatment of angina pectoris but superseded by less hazardous drugs. Prenylamine depletes myocardial catecholamine stores and has some calcium channel blocking activity. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1406%29%%A%    
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D011299 2005
% 209.48/209.70  |- mesh__historyNote mesh__D011299 66; was SEGONTIN 1963-65   
% 209.48/209.70  |- mesh__dateRevised mesh__D011299 2000-06-22
% 209.48/209.70  |- mesh__recordMaintainer mesh__D011299 CCR
% 209.48/209.70  |- rdf__type mesh__D011299sskos__Concept
% 209.48/209.70  |- skos__scopeNote mesh__D016782
% 209.48/209.70       A phylum of protozoa characterized by the presence of complex apical organelles generally consisting of a conoid that aids in penetrating host cells, rhoptries that possibly secrete a proteolytic enzyme, and subpellicular microtubules that may be related to motility.%A%    
% 209.48/209.70  |- mesh__recordMaintainer mesh__D016782 ags
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D016782 2005
% 209.48/209.70  |- mesh__recordAuthorizer mesh__D016782 sjn
% 209.48/209.70  |- skos__annotation mesh__D016782
% 209.48/209.70       GEN: prefer specifics; infection: coord IM with PROTOZOAN INFECTIONS %28%IM%29%; coord with specific protozoan terms %28%ANTIGENS, PROTOZOAN, etc%29% if pertinent%A%  
% 209.48/209.70  |- mesh__historyNote mesh__D016782 1992   
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D016782 2006
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D016782 2004
% 209.48/209.70  |- skos__broader mesh__D016782smesh__D011527
% 209.48/209.70  |- mesh__dateCreated mesh__D016782 1991-05-02
% 209.48/209.70  |- mesh__dateEstablished mesh__D016782 1992-01-01
% 209.48/209.70  |- skos__prefLabel mesh__D016782 Apicomplexa
% 209.48/209.70  |- mesh__recordOriginator mesh__D016782 PXP
% 209.48/209.70  |- rdf__type mesh__D016782sskos__Concept
% 209.48/209.70  |- mesh__dateRevised mesh__D016782 2003-07-09
% 209.48/209.70  |- mesh__publicMeSHNote mesh__D016782 1992   
% 209.48/209.70  |- skos__altLabel mesh__D016782 Sporozoa
% 209.48/209.70  |- skos__broader mesh__D002762smesh__D002782
% 209.48/209.70  |- mesh__dateCreated mesh__D002762 1999-01-01
% 209.48/209.70  |- skos__altLabel mesh__D002762 Vitamin D 3
% 209.48/209.70  |- skos__broader mesh__D002762smesh__D014807
% 209.48/209.70  |- mesh__recordAuthorizer mesh__D002762 sjn
% 209.48/209.70  |- skos__altLabel mesh__D002762 Calciol
% 209.48/209.70  |- skos__prefLabel mesh__D002762 Cholecalciferol
% 209.48/209.70  |- skos__broader mesh__D002762smesh__D013261
% 209.48/209.70  |- mesh__dateRevised mesh__D002762 2005-06-30
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D002762 2006
% 209.48/209.70  |- mesh__publicMeSHNote mesh__D002762
% 209.48/209.70       94, 67-74; was CHOLECALCIFEROLS 1975-93, was CHOLECALCIFEROL 1967-74, was VITAMIN D 3 1963-66%A%  
% 209.48/209.70  |- mesh__recordOriginator mesh__D002762 NLM
% 209.48/209.70  |- mesh__historyNote mesh__D002762
% 209.48/209.70       94, 67-74; was CHOLECALCIFEROLS 1975-93, was CHOLECALCIFEROL 1967-74, was VITAMIN D 3 1963-66%A%  
% 209.48/209.70  |- skos__altLabel mesh__D002762
% 209.48/209.70       %28%3 beta,5Z,7E%29%-9,10-Secocholesta-5,7,10%28%19%29%-trien-3-ol
% 209.48/209.70  |- skos__annotation mesh__D002762
% 209.48/209.70       deficiency: coordinate CHOLECALCIFEROL /defic %28%IM%29% with VITAMIN D DEFICIENCY %28%IM%29%%A%  
% 209.48/209.70  |- mesh__onlineNote mesh__D002762
% 209.48/209.70       use CHOLECALCIFEROL to search CHOLECALCIFEROLS 1975-93 %26%  VITAMIN D 3 1966-74%A%  
% 209.48/209.70  |- skos__scopeNote mesh__D002762
% 209.48/209.70       Derivative of 7-dehydroxycholesterol formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. It differs from ERGOCALCIFEROL in having a single bond between C22 and C23 and lacking a methyl group at C24.%A%    
% 209.48/209.70  |- skos__altLabel mesh__D002762 Vitamin D3
% 209.48/209.70  |- skos__related mesh__D002762smesh__D018167
% 209.48/209.70  |- mesh__dateEstablished mesh__D002762 1967-01-01
% 209.48/209.70  |- mesh__recordMaintainer mesh__D002762 ssb
% 209.48/209.70  |- rdf__type mesh__D002762sskos__Concept
% 209.48/209.70  |- skos__altLabel mesh__D029101 Bovine parainfluenza virus 3
% 209.48/209.70  |- mesh__dateRevised mesh__D029101 2004-07-30
% 209.48/209.70  |- mesh__recordMaintainer mesh__D029101 jls
% 209.48/209.70  |- mesh__recordAuthorizer mesh__D029101 jls
% 209.48/209.70  |- mesh__dateEstablished mesh__D029101 2002-01-01
% 209.48/209.70  |- mesh__recordOriginator mesh__D029101 ags
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D029101 2005A
% 209.48/209.70  |- skos__prefLabel mesh__D029101 Parainfluenza Virus 3, Bovine
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D029101 2005
% 209.48/209.70  |- skos__scopeNote mesh__D029101
% 209.48/209.70       A species of RESPIROVIRUS, subfamily PARAMYXOVIRINAE, most often seen in conjunction with a secondary infection of MANNHEIMIA HAEMOLYTICA resulting in pneumonic pasteurellosis %28%PASTEURELLOSIS, PNEUMONIC%29%.%A%    
% 209.48/209.70  |- skos__annotation mesh__D029101
% 209.48/209.70       infection: coord IM with RESPIROVIRUS INFECTIONS %28%IM%29% but consider also PASTEURELLOSIS, PNEUMONIC%A%  
% 209.48/209.70  |- mesh__historyNote mesh__D029101
% 209.48/209.70       2002; use RESPIROVIRUS 1997-2001, use PARAINFLUENZA VIRUS TYPE 3 1976-1996%A%  
% 209.48/209.70  |- mesh__dateCreated mesh__D029101 2001-07-25
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D029101 2006
% 209.48/209.70  |- skos__broader mesh__D029101smesh__D018108
% 209.48/209.70  |- skos__historyNote mesh__D029101 Respirovirus %28%1965-2001%29%
% 209.48/209.70  |- skos__altLabel mesh__D029101 Shipping Fever Virus
% 209.48/209.70  |- skos__hiddenLabel mesh__D029101 Shipping Fever Viruses
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D029101 2003
% 209.48/209.70  |- mesh__publicMeSHNote mesh__D029101
% 209.48/209.70       2002; see PARAMYXOVIRUS 1997-2001, see PARAINFLUENZA VIRUS TYPE 3 1976-1996%A%  
% 209.48/209.70  |- rdf__type mesh__D029101sskos__Concept
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D029101 2004
% 209.48/209.70  |- skos__broader mesh__D040881smesh__D039001
% 209.48/209.70  |- skos__broader mesh__D040881smesh__D018845
% 209.48/209.70  |- mesh__publicMeSHNote mesh__D040881
% 209.48/209.70       2003; for ANTIGENS, CD11A see LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 195-2002%A%  
% 209.48/209.70  |- skos__hiddenLabel mesh__D040881 Antigen, CD11a
% 209.48/209.70  |- rdf__type mesh__D040881sskos__Concept
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D040881 2006
% 209.48/209.70  |- mesh__historyNote mesh__D040881
% 209.48/209.70       2003; for ANTIGENS, CD11A use LYPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 1995-2002%A%  
% 209.48/209.70  |- skos__historyNote mesh__D040881
% 209.48/209.70       Lymphocyte Function-Associated Antigen-1 %28%1995-2002%29%
% 209.48/209.70  |- skos__altLabel mesh__D040881 CD11a Antigen
% 209.48/209.70  |- mesh__recordOriginator mesh__D040881 jmp
% 209.48/209.70  |- skos__scopeNote mesh__D040881
% 209.48/209.70       An alpha-integrin subunit found on lymphocytes, granulocytes, macrophages and monocytes. It combines with the integrin beta2 subunit %28%CD18 ANTIGEN%29% to form LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1.%A%    
% 209.48/209.70  |- skos__hiddenLabel mesh__D040881 alphaL, Integrin
% 209.48/209.70  |- skos__altLabel mesh__D040881 Integrin alphaL
% 209.48/209.70  |- mesh__dateRevised mesh__D040881 2005-06-30
% 209.48/209.70  |- mesh__dateEstablished mesh__D040881 2003-01-01
% 209.48/209.70  |- mesh__recordMaintainer mesh__D040881 ssb
% 209.48/209.70  |- mesh__recordAuthorizer mesh__D040881 sjn
% 209.48/209.70  |- mesh__dateCreated mesh__D040881 2002-07-02
% 209.48/209.70  |- skos__prefLabel mesh__D040881 Antigens, CD11a
% 209.48/209.70  |- mesh__recordMaintainer mesh__D012392 TAP
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D012392 2002
% 209.48/209.70  |- skos__hiddenLabel mesh__D012392 Test, Rorschach
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D012392 1993
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D012392 1999
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D012392 1996
% 209.48/209.70  |- skos__broader mesh__D012392smesh__D007282
% 209.48/209.70  |- mesh__dateRevised mesh__D012392 1992-05-18
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D012392 2001
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D012392 1995
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D012392 1998
% 209.48/209.70  |- skos__prefLabel mesh__D012392 Rorschach Test
% 209.48/209.70  |- mesh__dateCreated mesh__D012392 1999-01-01
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D012392 2000
% 209.48/209.70  |- skos__scopeNote mesh__D012392
% 209.48/209.70       A projective test used to evaluate a broad range of personality variables including pathology of thought and perception. The subject%27%s responses to inkblot prints are scored along with subjective interpretation by the test administrator.%A%    
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D012392 1994
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D012392 2004
% 209.48/209.70  |- mesh__recordAuthorizer mesh__D012392 PLS
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D012392 2006
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D012392 2003
% 209.48/209.70  |- mesh__recordOriginator mesh__D012392 NLM
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D012392 2005
% 209.48/209.70  |- rdf__type mesh__D012392sskos__Concept
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D012392 1997
% 209.48/209.70  |- mesh__historyNote mesh__D020824 2000   
% 209.48/209.70  |- mesh__dateRevised mesh__D020824 2004-07-13
% 209.48/209.70  |- skos__historyNote mesh__D020824 Neural Pathways %28%1967-1999%29%
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D020824 2005
% 209.48/209.70  |- skos__broader mesh__D020824smesh__D000344
% 209.48/209.70  |- skos__prefLabel mesh__D020824 Spinocerebellar Tracts
% 209.48/209.70  |- mesh__dateCreated mesh__D020824 1999-11-03
% 209.48/209.70  |- mesh__dateEstablished mesh__D020824 2000-01-01
% 209.48/209.70  |- skos__hiddenLabel mesh__D020824 Spinocerebellar Tract
% 209.48/209.70  |- mesh__publicMeSHNote mesh__D020824 2000   
% 209.48/209.70  |- skos__hiddenLabel mesh__D020824 Tracts, Spinocerebellar
% 209.48/209.70  |- mesh__recordOriginator mesh__D020824 ags
% 209.48/209.70  |- mesh__recordAuthorizer mesh__D020824 sjn
% 209.48/209.70  |- mesh__recordMaintainer mesh__D020824 sjn
% 209.48/209.70  |- skos__scopeNote mesh__D020824
% 209.48/209.70       Fibers that arise from cell groups within the spinal cord and pass directly to the cerebellum. They include the anterior, posterior, and rostral spinocerebellar tracts, and the cuneocerebellar tract. %28%From Parent, Carpenter%27%s Human Neuroanatomy, 9th ed, p607%29%%A%    
% 209.48/209.70  |- rdf__type mesh__D020824sskos__Concept
% 209.48/209.70  |- skos__hiddenLabel mesh__D020824 Tract, Spinocerebellar
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D020824 2006
% 209.48/209.70  |- skos__annotation mesh__D006355
% 209.48/209.70       external: do not confuse with HEART, ARTIFICIAL %28%pump replacing whole or part of heart%29%%A%  
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D006355 2004
% 209.48/209.70  |- skos__scopeNote mesh__D006355
% 209.48/209.70       Apparatus that provides mechanical circulatory support during open-heart surgery, by passing the heart to facilitate surgery on the organ. The basic function of the machine is to oxygenate the body%27%s venous supply of blood and then pump it back into the arterial system. The machine also provides intracardiac suction, filtration, and temperature control. Some of the more important components of these machines include pumps, oxygenators, temperature regulators, and filters. %28%UMDNS, 1999%29%%A%    
% 209.48/209.70  |- mesh__recordMaintainer mesh__D006355 adp
% 209.48/209.70  |- skos__broader mesh__D006355smesh__D001187
% 209.48/209.70  |- rdf__type mesh__D006355sskos__Concept
% 209.48/209.70  |- skos__hiddenLabel mesh__D006355 Machine, Heart-Lung
% 209.48/209.70  |- mesh__dateCreated mesh__D006355 1999-01-01
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D006355 2002
% 209.48/209.70  |- mesh__recordOriginator mesh__D006355 NLM
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D006355 2005
% 209.48/209.70  |- skos__prefLabel mesh__D006355 Heart-Lung Machine
% 209.48/209.70  |- skos__hiddenLabel mesh__D006355 Heart Lung Machine
% 209.48/209.70  |- mesh__publicMeSHNote mesh__D006355
% 209.48/209.70       98; see HEART, MECHANICAL 1963-97, for HEART-LUNG MACHINE see HEART, MECHANICAL 1967-97%A%  
% 209.48/209.70  |- mesh__dateRevised mesh__D006355 1999-11-08
% 209.48/209.70  |- skos__hiddenLabel mesh__D006355 Heart-Lung Machines
% 209.48/209.70  |- mesh__historyNote mesh__D006355 98%28%63%29%   
% 209.48/209.70  |- mesh__recordAuthorizer mesh__D006355 sjn
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D006355 2006
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D006355 2000
% 209.48/209.70  |- skos__hiddenLabel mesh__D006355 Machines, Heart-Lung
% 209.48/209.70  |- skos__related mesh__D006355smesh__D010106
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D006355 2003
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D006355 2001
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D016783 2006
% 209.48/209.70  |- skos__scopeNote mesh__D016783
% 209.48/209.70       An order of parasitic PROTOZOA  found in blood cells and epithelial cells of vertebrates and invertebrates. Life cycles involve both sexual and asexual phases.%A%    
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D016783 2004
% 209.48/209.70  |- mesh__recordAuthorizer mesh__D016783 sjn
% 209.48/209.70  |- mesh__historyNote mesh__D016783 1992   
% 209.48/209.70  |- skos__broader mesh__D016783smesh__D003044
% 209.48/209.70  |- mesh__recordOriginator mesh__D016783 PXP
% 209.48/209.70  |- skos__annotation mesh__D016783
% 209.48/209.70       infection: coord IM with COCCIDIOSIS %28%IM%29%; /drug eff: consider also COCCIDIOSTATS; coord with specific protozoan terms %28%ANTIGENS, PROTOZOAN, etc%29% if pertinent%A%  
% 209.48/209.70  |- rdf__type mesh__D016783sskos__Concept
% 209.48/209.70  |- mesh__dateRevised mesh__D016783 2003-07-09
% 209.48/209.70  |- mesh__publicMeSHNote mesh__D016783 1992   
% 209.48/209.70  |- mesh__dateCreated mesh__D016783 1991-05-02
% 209.48/209.70  |- mesh__recordMaintainer mesh__D016783 ags
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D016783 2005
% 209.48/209.70  |- mesh__dateEstablished mesh__D016783 1992-01-01
% 209.48/209.70  |- skos__prefLabel mesh__D016783 Eucoccidiida
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D002763 2006
% 209.48/209.70  |- skos__prefLabel mesh__D002763 Cholecystectomy
% 209.48/209.70  |- mesh__dateRevised mesh__D002763 2003-07-09
% 209.48/209.70  |- mesh__recordMaintainer mesh__D002763 lkt
% 209.48/209.70  |- skos__scopeNote mesh__D002763 Surgical removal of the GALLBLADDER.     
% 209.48/209.70  |- skos__broader mesh__D002763smesh__D001662
% 209.48/209.70  |- skos__hiddenLabel mesh__D002763 Cholecystectomies
% 209.48/209.70  |- rdf__type mesh__D002763sskos__Concept
% 209.48/209.70  |- mesh__recordAuthorizer mesh__D002763 sjn
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D002763 2004
% 209.48/209.70  |- mesh__dateCreated mesh__D002763 1999-01-01
% 209.48/209.70  |- skos__related mesh__D002763smesh__D017562
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D002763 2005
% 209.48/209.70  |- mesh__recordOriginator mesh__D002763 NLM
% 209.48/209.70  |- skos__broader mesh__D012393smesh__D012871
% 209.48/209.70  |- skos__hiddenLabel mesh__D012393 Rosacea, Granulomatous
% 209.48/209.70  |- mesh__recordOriginator mesh__D012393 NLM
% 209.48/209.70  |- skos__prefLabel mesh__D012393 Rosacea
% 209.48/209.70  |- mesh__publicMeSHNote mesh__D012393
% 209.48/209.70       2005, 1963-1992; see ACNE ROSACEA 1993-2004   
% 209.48/209.70  |- mesh__dateCreated mesh__D012393 1999-01-01
% 209.48/209.70  |- skos__scopeNote mesh__D012393
% 209.48/209.70       A cutaneous disorder primarily of convexities of the central part of the FACE, such as FOREHEAD; CHEEK; NOSE; and CHIN. It is characterized by FLUSHING; ERYTHEMA; EDEMA; RHINOPHYMA; papules; and ocular symptoms. It may occur at any age but typically after age 30. There are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular %28%National Rosacea Society%27%s Expert Committee on the Classification and Staging of Rosacea, J Am Acad Dermatol 2002; 46:584-7%29%.%A%    
% 209.48/209.70  |- skos__hiddenLabel mesh__D012393 Rosacea, Papulopustular
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D012393 2006
% 209.48/209.70  |- skos__hiddenLabel mesh__D012393 Rosacea, Erythematotelangiectatic
% 209.48/209.70  |- skos__altLabel mesh__D012393 Acne Rosacea
% 209.48/209.70  |- mesh__historyNote mesh__D012393 2005, 1963-1992   
% 209.48/209.70  |- mesh__dateRevised mesh__D012393 2004-07-07
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D012393 2005
% 209.48/209.70  |- skos__hiddenLabel mesh__D012393 Rosacea, Ocular
% 209.48/209.70  |- mesh__recordMaintainer mesh__D012393 lkt
% 209.48/209.70  |- rdf__type mesh__D012393sskos__Concept
% 209.48/209.70  |- skos__hiddenLabel mesh__D012393 Rosacea, Phymatous
% 209.48/209.70  |- mesh__recordAuthorizer mesh__D012393 sjn
% 209.48/209.70  |- mesh__dateCreated mesh__D020825 1999-11-03
% 209.48/209.70  |- mesh__dateRevised mesh__D020825 2005-06-30
% 209.48/209.70  |- skos__scopeNote mesh__D020825
% 209.48/209.70       Proteins containing a region of conserved sequence, about 200 amino acids long, which encodes a particular sequence specific DNA binding domain %28%the T-box domain%29%. These proteins are transcription factors that control developmental pathways. The prototype of this family is the mouse Brachyury %28%or T%29% gene product.%A%    
% 209.48/209.70  |- skos__hiddenLabel mesh__D020825 T Box Domain Proteins
% 209.48/209.70  |- mesh__recordAuthorizer mesh__D020825 sjn
% 209.48/209.70  |- skos__historyNote mesh__D020825 DNA-Binding Proteins %28%1996-1999%29%
% 209.48/209.70  |- skos__broader mesh__D020825smesh__D014157
% 209.48/209.70  |- skos__broader mesh__D020825smesh__D004268
% 209.48/209.70  |- mesh__recordMaintainer mesh__D020825 ags
% 209.48/209.70  |- skos__historyNote mesh__D020825 Transcription Factors %28%1996-1999%29%
% 209.48/209.70  |- mesh__recordOriginator mesh__D020825 nns
% 209.48/209.70  |- mesh__publicMeSHNote mesh__D020825 2000   
% 209.48/209.70  |- mesh__historyNote mesh__D020825 2000   
% 209.48/209.70  |- skos__prefLabel mesh__D020825 T-Box Domain Proteins
% 209.48/209.70  |- rdf__type mesh__D020825sskos__Concept
% 209.48/209.70  |- skos__hiddenLabel mesh__D020825 Proteins, T-Box Domain
% 209.48/209.70  |- mesh__dateEstablished mesh__D020825 2000-01-01
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D020825 2006
% 209.48/209.70  |- skos__broader mesh__D006356smesh__D012817
% 209.48/209.70  |- skos__scopeNote mesh__D006356
% 209.48/209.70       Substernal pain or burning sensation, usually associated with regurgitation of gastric juice into the esophagus.%A%    
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D006356 2000
% 209.48/209.70  |- rdf__type mesh__D006356sskos__Concept
% 209.48/209.70  |- skos__hiddenLabel mesh__D006356 Pyroses
% 209.48/209.70  |- mesh__dateEstablished mesh__D006356 1964-01-01
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D006356 2001
% 209.48/209.70  |- skos__related mesh__D006356smesh__D005764
% 209.48/209.70  |- mesh__dateCreated mesh__D006356 1999-01-01
% 209.48/209.70  |- mesh__historyNote mesh__D006356 64   
% 209.48/209.70  |- skos__altLabel mesh__D006356 Pyrosis
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D006356 2005
% 209.48/209.70  |- mesh__publicMeSHNote mesh__D006356 64   
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D006356 2006
% 209.48/209.70  |- mesh__recordOriginator mesh__D006356 NLM
% 209.48/209.70  |- mesh__recordMaintainer mesh__D006356 KEV
% 209.48/209.70  |- mesh__dateRevised mesh__D006356 1999-11-03
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D006356 2002
% 209.48/209.70  |- skos__prefLabel mesh__D006356 Heartburn
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D006356 2003
% 209.48/209.70  |- mesh__recordAuthorizer mesh__D006356 sjn
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D006356 2004
% 209.48/209.70  |- skos__annotation mesh__D020027 a species of archaea   
% 209.48/209.70  |- skos__scopeNote mesh__D020027
% 209.48/209.70       A species of strictly anaerobic, hyperthermophilic archaea which lives in geothermally-heated marine sediments. It exhibits heterotropic growth by fermentation or sulfur respiration.%A%    
% 209.48/209.70  |- mesh__dateRevised mesh__D020027 2005-06-30
% 209.48/209.70  |- mesh__publicMeSHNote mesh__D020027 99   
% 209.48/209.70  |- skos__historyNote mesh__D020027 Archaea %28%1989-1998%29%
% 209.48/209.70  |- mesh__historyNote mesh__D020027 99   
% 209.48/209.70  |- rdf__type mesh__D020027sskos__Concept
% 209.48/209.70  |- mesh__recordOriginator mesh__D020027 AGS
% 209.48/209.70  |- skos__broader mesh__D020027smesh__D019711
% 209.48/209.70  |- mesh__dateCreated mesh__D020027 1998-06-10
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D020027 2006
% 209.48/209.70  |- mesh__recordAuthorizer mesh__D020027 sjn
% 209.48/209.70  |- mesh__recordMaintainer mesh__D020027 SYSTEM
% 209.48/209.70  |- mesh__dateEstablished mesh__D020027 1999-01-01
% 209.48/209.70  |- skos__prefLabel mesh__D020027 Pyrococcus furiosus
% 209.48/209.70  |- mesh__recordOriginator mesh__D002764 NLM
% 209.48/209.70  |- skos__broader mesh__D002764smesh__D005705
% 209.48/209.70  |- skos__altLabel mesh__D002764 Gallbladder Inflammation
% 209.48/209.70  |- mesh__dateRevised mesh__D002764 2003-07-09
% 209.48/209.70  |- skos__altLabel mesh__D002764 Empyema, Gall Bladder
% 209.48/209.70  |- skos__hiddenLabel mesh__D002764 Inflammation, Gallbladder
% 209.48/209.70  |- rdf__type mesh__D002764sskos__Concept
% 209.48/209.70  |- skos__hiddenLabel mesh__D002764 Gall Bladder Empyema
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D002764 2004
% 209.48/209.70  |- skos__scopeNote mesh__D002764
% 209.48/209.70       Inflammation of the GALLBLADDER; generally caused by impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, or other diseases.%A%    
% 209.48/209.70  |- mesh__dateCreated mesh__D002764 1999-01-01
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D002764 2005
% 209.48/209.70  |- mesh__recordMaintainer mesh__D002764 lkt
% 209.48/209.70  |- skos__annotation mesh__D002764
% 209.48/209.70       note specifics; X ref EMPYEMA, GALLBLADDER: restrict to gallbladder; %22%biliary empyema%22%: unless of gallbladder, index under EMPYEMA %28%IM%29% + BILIARY TRACT DISEASES %28%IM%29% or specific biliary precoord%A%  
% 209.48/209.70  |- skos__hiddenLabel mesh__D002764 Gallbladder Empyema
% 209.48/209.70  |- skos__related mesh__D002764smesh__D002761
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D002764 2006
% 209.48/209.70  |- skos__prefLabel mesh__D002764 Cholecystitis
% 209.48/209.70  |- mesh__recordAuthorizer mesh__D002764 sjn
% 209.48/209.70  |- mesh__dateEstablished mesh__D029901 2002-01-01
% 209.48/209.70  |- skos__annotation mesh__D029901
% 209.48/209.70       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D029901 2004
% 209.48/209.70  |- mesh__dateCreated mesh__D029901 2001-07-25
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D029901 2002
% 209.48/209.70  |- mesh__publicMeSHNote mesh__D029901 2002   
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D029901 2005
% 209.48/209.70  |- skos__broader mesh__D029901smesh__D007887
% 209.48/209.70  |- skos__prefLabel mesh__D029901 Maackia
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D029901 2006
% 209.48/209.70  |- skos__scopeNote mesh__D029901
% 209.48/209.70       A plant genus of the family FABACEAE.  It contains a hemagglutinin.%A%    
% 209.48/209.70  |- skos__altLabel mesh__D029901 Macckia
% 209.48/209.70  |- rdf__type mesh__D029901sskos__Concept
% 209.48/209.70  |- mesh__historyNote mesh__D029901 2002   
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D029901 2003
% 209.48/209.70  |- mesh__recordAuthorizer mesh__D048068 sjn
% 209.48/209.70  |- mesh__recordMaintainer mesh__D048068 ssb
% 209.48/209.70  |- skos__hiddenLabel mesh__D048068 PPAR beta
% 209.48/209.70  |- skos__altLabel mesh__D048068 PPARbeta
% 209.48/209.70  |- skos__historyNote mesh__D048068 Transcription Factors %28%1993-2004%29%
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D048068 2006
% 209.48/209.70  |- rdf__type mesh__D048068sskos__Concept
% 209.48/209.70  |- skos__scopeNote mesh__D048068
% 209.48/209.70       One of the PPAR nuclear transcription factors.     
% 209.48/209.70  |- mesh__publicMeSHNote mesh__D048068
% 209.48/209.70       2005; PPAR BETA was indexed under TRANSCRIPTION FACTORS %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1994-2004, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993%A%  
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D048068 2005
% 209.48/209.70  |- mesh__dateEstablished mesh__D048068 2005-01-01
% 209.48/209.70  |- mesh__dateCreated mesh__D048068 2004-07-07
% 209.48/209.70  |- mesh__recordOriginator mesh__D048068 ssb
% 209.48/209.70  |- mesh__historyNote mesh__D048068 2005%28%1992%29%   
% 209.48/209.70  |- skos__prefLabel mesh__D048068 PPAR-beta
% 209.48/209.70  |- skos__broader mesh__D048068smesh__D047492
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D012394 2006
% 209.48/209.70  |- mesh__recordMaintainer mesh__D012394 sjn
% 209.48/209.70  |- mesh__dateRevised mesh__D012394 2005-07-01
% 209.48/209.70  |- skos__hiddenLabel mesh__D012394 Compounds, Triphenylmethane Aniline
% 209.48/209.70  |- skos__altLabel mesh__D012394 Magentas
% 209.48/209.70  |- skos__altLabel mesh__D012394 Fuchsin
% 209.48/209.70  |- mesh__recordAuthorizer mesh__D012394 sjn
% 209.48/209.70  |- mesh__historyNote mesh__D012394
% 209.48/209.70       FUCHSINS was FUCHSIN see under ROSANILINE DYES 1963-80   
% 209.48/209.70  |- skos__broader mesh__D012394smesh__D000814
% 209.48/209.70  |- rdf__type mesh__D012394sskos__Concept
% 209.48/209.70  |- skos__hiddenLabel mesh__D012394 Aniline Compounds, Triphenylmethane
% 209.48/209.70  |- mesh__recordOriginator mesh__D012394 NLM
% 209.48/209.70  |- skos__scopeNote mesh__D012394
% 209.48/209.70       Compounds that contain the triphenylmethane aniline structure found in rosaniline.  Many of them have a characteristic magenta color and are used as COLORING AGENTS.%A%    
% 209.48/209.70  |- mesh__onlineNote mesh__D012394
% 209.48/209.70       use ROSANILINE DYES to search FUCHSIN 1966-80   
% 209.48/209.70  |- skos__altLabel mesh__D012394 Triphenylmethane Aniline Compounds
% 209.48/209.70  |- skos__altLabel mesh__D012394 Fuchsins
% 209.48/209.70  |- skos__hiddenLabel mesh__D012394 Dyes, Rosaniline
% 209.48/209.70  |- mesh__dateCreated mesh__D012394 1999-01-01
% 209.48/209.70  |- skos__prefLabel mesh__D012394 Rosaniline Dyes
% 209.48/209.70  |- skos__broader mesh__D004041Q000737smesh__D004041
% 209.48/209.70  |- mesh__preferredCombination mesh__D004041Q000737smesh__D005223Q000737
% 209.48/209.70  |- rdf__type mesh__D004041Q000737smesh__CompoundConcept
% 209.48/209.70  |- skos__broader mesh__D020826smesh__D020692
% 209.48/209.70  |- skos__altLabel mesh__D020826 rab3A Protein
% 209.48/209.70  |- mesh__recordMaintainer mesh__D020826 jmp
% 209.48/209.70  |- mesh__publicMeSHNote mesh__D020826
% 209.48/209.70       2000; RAB3A PROTEIN was indexed under G-PROTEINS 1992-1999%A%  
% 209.48/209.70  |- skos__hiddenLabel mesh__D020826 GTP-Binding Protein, rab3A
% 209.48/209.70  |- mesh__dateCreated mesh__D020826 1999-11-03
% 209.48/209.70  |- mesh__dateRevised mesh__D020826 2005-06-30
% 209.48/209.70  |- skos__prefLabel mesh__D020826 rab3A GTP-Binding Protein
% 209.48/209.70  |- mesh__recordAuthorizer mesh__D020826 sjn
% 209.48/209.70  |- skos__hiddenLabel mesh__D020826 rab3A GTP Binding Protein
% 209.48/209.70  |- skos__altLabel mesh__D020826 smg25a GTP Binding Protein
% 209.48/209.70  |- skos__historyNote mesh__D020826 G-Proteins %28%1992-1999%29%
% 209.48/209.70  |- skos__scopeNote mesh__D020826
% 209.48/209.70       The most abundant member of the RAB3 GTP-BINDING PROTEINS. It is involved in calcium-dependent EXOCYTOSIS and is localized to neurons and neuroendocrine cells. This enzyme was formerly listed as EC 3.6.1.47.%A%    
% 209.48/209.70  |- mesh__recordOriginator mesh__D020826 jmp
% 209.48/209.70  |- rdf__type mesh__D020826sskos__Concept
% 209.48/209.70  |- mesh__dateEstablished mesh__D020826 2000-01-01
% 209.48/209.70  |- mesh__historyNote mesh__D020826
% 209.48/209.70       2000; for RAB3A PROTEIN see RAB3 GTP-BINDING PROTEINS %28%NM%29% 1992-1999;%A%  
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D020826 2006
% 209.48/209.70  |- skos__altLabel mesh__D020826 smg p25A Protein
% 209.48/209.70  |- skos__annotation mesh__D020826 DF: RAB3A PROTEIN   
% 209.48/209.70  |- skos__hiddenLabel mesh__D020826 p25A Protein, smg
% 209.48/209.70  |- skos__broader mesh__D006357smesh__D000820
% 209.48/209.70  |- skos__historyNote mesh__D006357 Rickettsial Infections %28%1966-1969%29%
% 209.48/209.70  |- skos__broader mesh__D006357smesh__D017282
% 209.48/209.70  |- mesh__recordMaintainer mesh__D006357 ags
% 209.48/209.70  |- mesh__recordAuthorizer mesh__D006357 sjn
% 209.48/209.70  |- mesh__dateRevised mesh__D006357 2003-07-09
% 209.48/209.70  |- skos__prefLabel mesh__D006357 Heartwater Disease
% 209.48/209.70  |- skos__hiddenLabel mesh__D006357 Disease, Heartwater
% 209.48/209.70  |- rdf__type mesh__D006357sskos__Concept
% 209.48/209.70  |- skos__historyNote mesh__D006357 Cattle Diseases %28%1966-1969%29%
% 209.48/209.70  |- mesh__dateCreated mesh__D006357 1999-01-01
% 209.48/209.70  |- skos__broader mesh__D006357smesh__D016873
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D006357 2006
% 209.48/209.70  |- mesh__historyNote mesh__D006357 70   
% 209.48/209.70  |- mesh__dateEstablished mesh__D006357 1970-01-01
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D006357 2005
% 209.48/209.70  |- mesh__publicMeSHNote mesh__D006357 70   
% 209.48/209.70  |- skos__scopeNote mesh__D006357
% 209.48/209.70       A tick-borne septicemic disease of domestic and wild ruminants caused by EHRLICHIA RUMINANTIUM.%A%    
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D006357 2004
% 209.48/209.70  |- mesh__recordOriginator mesh__D006357 NLM
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D016785 2004
% 209.48/209.70  |- mesh__recordMaintainer mesh__D016785 ags
% 209.48/209.70  |- mesh__dateRevised mesh__D016785 2003-07-09
% 209.48/209.70  |- skos__scopeNote mesh__D016785
% 209.48/209.70       A species of parasitic protozoa that infects humans and most domestic mammals. Its oocysts measure five microns in diameter. These organisms exhibit alternating cycles of sexual and asexual reproduction.%A%    
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D016785 2006
% 209.48/209.70  |- mesh__dateEstablished mesh__D016785 1992-01-01
% 209.48/209.70  |- skos__broader mesh__D016785smesh__D003458
% 209.48/209.70  |- skos__historyNote mesh__D016785 Cryptosporidium %28%1985-1991%29%
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D016785 2005
% 209.48/209.70  |- mesh__publicMeSHNote mesh__D016785 92   
% 209.48/209.70  |- mesh__recordOriginator mesh__D016785 PXP
% 209.48/209.70  |- mesh__historyNote mesh__D016785 92   
% 209.48/209.70  |- rdf__type mesh__D016785sskos__Concept
% 209.48/209.70  |- mesh__dateCreated mesh__D016785 1991-05-02
% 209.48/209.70  |- mesh__recordAuthorizer mesh__D016785 sjn
% 209.48/209.70  |- skos__prefLabel mesh__D016785 Cryptosporidium parvum
% 209.48/209.70  |- skos__annotation mesh__D016785
% 209.48/209.70       infection: coord IM with CRYPTOSPORIDIOSIS %28%IM%29%; /drug eff: consider also COCCIDIOSTATS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D002765 2002
% 209.48/209.70  |- skos__scopeNote mesh__D002765
% 209.48/209.70       Radiography of the gallbladder after ingestion of a contrast medium.%A%    
% 209.48/209.70  |- mesh__recordAuthorizer mesh__D002765 SJN
% 209.48/209.70  |- rdf__type mesh__D002765sskos__Concept
% 209.48/209.70  |- skos__annotation mesh__D002765
% 209.48/209.70       do not use /util except by MeSH definition; DF: CHOLECYSTOGR%A%  
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D002765 2003
% 209.48/209.70  |- skos__broader mesh__D002765smesh__D003938
% 209.48/209.70  |- mesh__dateCreated mesh__D002765 1999-01-01
% 209.48/209.70  |- mesh__recordMaintainer mesh__D002765 PXP
% 209.48/209.70  |- skos__hiddenLabel mesh__D002765 Cholecystographies
% 209.48/209.70  |- mesh__activeMeSHYear mesh__D002765 2004
% 209.48/209.71  |- mesh__dateRevised mesh__D002765 1997-06-20
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D002765 2000
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D002765 1998
% 209.48/209.71  |- skos__broader mesh__D002765smesh__D011860
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D002765 2005
% 209.48/209.71  |- skos__prefLabel mesh__D002765 Cholecystography
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D002765 2001
% 209.48/209.71  |- mesh__recordOriginator mesh__D002765 NLM
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D002765 1999
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D002765 2006
% 209.48/209.71  |- skos__scopeNote mesh__D035141
% 209.48/209.71       Programs in which participation is not required.     
% 209.48/209.71  |- mesh__historyNote mesh__D035141 2003   
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D035141 2006
% 209.48/209.71  |- skos__hiddenLabel mesh__D035141 Voluntary Program
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D035141 2003
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D035141 2005
% 209.48/209.71  |- skos__broader mesh__D035141smesh__D009934
% 209.48/209.71  |- skos__related mesh__D035141smesh__D037141
% 209.48/209.71  |- skos__hiddenLabel mesh__D035141 Programs, Voluntary
% 209.48/209.71  |- rdf__type mesh__D035141sskos__Concept
% 209.48/209.71  |- skos__hiddenLabel mesh__D035141 Program, Voluntary
% 209.48/209.71  |- mesh__publicMeSHNote mesh__D035141 2003   
% 209.48/209.71  |- skos__prefLabel mesh__D035141 Voluntary Programs
% 209.48/209.71  |- mesh__dateCreated mesh__D035141 2002-07-03
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D035141 2004
% 209.48/209.71  |- mesh__dateEstablished mesh__D035141 2003-01-01
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D029902 2002
% 209.48/209.71  |- mesh__dateCreated mesh__D029902 2001-07-25
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D029902 2004
% 209.48/209.71  |- skos__scopeNote mesh__D029902
% 209.48/209.71       A plant genus of the family FABACEAE.  It is distinct from Sweet Clover %28%MELILOTUS%29%, from Bush Clover %28%LESPEDEZA%29%, and from Red Clover %28%TRIFOLIUM%29%.%A%    
% 209.48/209.71  |- skos__annotation mesh__D029902
% 209.48/209.71       note X ref CLOVER: BUSH CLOVER see LESPEDEZA; SWEET CLOVER see MELILOTUS; and RED CLOVER see TRIFOLIUM are also available;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D029902 2005
% 209.48/209.71  |- mesh__dateRevised mesh__D029902 2005-07-18
% 209.48/209.71  |- mesh__publicMeSHNote mesh__D029902 2002   
% 209.48/209.71  |- mesh__recordAuthorizer mesh__D029902 ags
% 209.48/209.71  |- rdf__type mesh__D029902sskos__Concept
% 209.48/209.71  |- skos__broader mesh__D029902smesh__D007887
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D029902 2006
% 209.48/209.71  |- mesh__recordOriginator mesh__D029902 ssb
% 209.48/209.71  |- mesh__historyNote mesh__D029902 2002   
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D029902 2006A
% 209.48/209.71  |- mesh__dateEstablished mesh__D029902 2002-01-01
% 209.48/209.71  |- skos__prefLabel mesh__D029902 Medicago
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D029902 2003
% 209.48/209.71  |- mesh__recordMaintainer mesh__D029902 ags
% 209.48/209.71  |- skos__broader mesh__D021121smesh__D015336
% 209.48/209.71  |- skos__hiddenLabel mesh__D021121 bDNA Assays
% 209.48/209.71  |- skos__altLabel mesh__D021121 bDNA Assay
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D021121 2002
% 209.48/209.71  |- skos__hiddenLabel mesh__D021121 Assays, bDNA
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D021121 2006
% 209.48/209.71  |- skos__broader mesh__D021121smesh__D009693
% 209.48/209.71  |- skos__hiddenLabel mesh__D021121 Assays, Branched DNA
% 209.48/209.71  |- mesh__dateEstablished mesh__D021121 2001-01-01
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D021121 2001
% 209.48/209.71  |- mesh__dateCreated mesh__D021121 2000-06-21
% 209.48/209.71  |- skos__hiddenLabel mesh__D021121 Branched DNA Assays
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D021121 2005
% 209.48/209.71  |- skos__prefLabel mesh__D021121 Branched DNA Signal Amplification Assay
% 209.48/209.71  |- skos__hiddenLabel mesh__D021121 Assay, Branched DNA
% 209.48/209.71  |- skos__altLabel mesh__D021121 Branched DNA Assay
% 209.48/209.71  |- skos__historyNote mesh__D021121
% 209.48/209.71       Molecular Probe Techniques %28%1991-2000%29%
% 209.48/209.71  |- skos__hiddenLabel mesh__D021121 Assay, bDNA
% 209.48/209.71  |- rdf__type mesh__D021121sskos__Concept
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D021121 2004
% 209.48/209.71  |- mesh__historyNote mesh__D021121 2001   
% 209.48/209.71  |- skos__scopeNote mesh__D021121
% 209.48/209.71       A molecular probe technique that utilizes branched DNA %28%bDNA%29% as a means to amplify the hybridization signal. One end of the bDNA molecule is designed to bind a specific target, while the other end of the bDNA molecule contains many branches of DNA that are designed to bind a probe used for signal detection.%A%    
% 209.48/209.71  |- skos__annotation mesh__D021121 DF: BDNA ASSAY   
% 209.48/209.71  |- mesh__publicMeSHNote mesh__D021121 2001   
% 209.48/209.71  |- skos__altLabel mesh__D021121 bDNA Signal Amplification Assay
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D021121 2003
% 209.48/209.71  |- mesh__historyNote mesh__D048069 2005   
% 209.48/209.71  |- skos__scopeNote mesh__D048069
% 209.48/209.71       A family of proteins that were originally identified by their ability to cause NECROSIS of NEOPLASMS. Their necrotic effect on cells is mediated through TUMOR NECROSIS FACTOR RECEPTORS which induce APOPTOSIS.%A%    
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D048069 2006
% 209.48/209.71  |- skos__broader mesh__D048069smesh__D036341
% 209.48/209.71  |- rdf__type mesh__D048069sskos__Concept
% 209.48/209.71  |- mesh__recordAuthorizer mesh__D048069 sjn
% 209.48/209.71  |- mesh__recordMaintainer mesh__D048069 ssb
% 209.48/209.71  |- mesh__publicMeSHNote mesh__D048069 2005   
% 209.48/209.71  |- mesh__dateCreated mesh__D048069 2004-07-07
% 209.48/209.71  |- skos__hiddenLabel mesh__D048069 Receptor Ligands, TNF
% 209.48/209.71  |- skos__broader mesh__D048069smesh__D016207
% 209.48/209.71  |- mesh__recordOriginator mesh__D048069 jmp
% 209.48/209.71  |- skos__altLabel mesh__D048069 TNF Receptor Ligands
% 209.48/209.71  |- mesh__dateRevised mesh__D048069 2005-06-30
% 209.48/209.71  |- mesh__dateEstablished mesh__D048069 2005-01-01
% 209.48/209.71  |- skos__prefLabel mesh__D048069 Tumor Necrosis Factors
% 209.48/209.71  |- skos__hiddenLabel mesh__D048069 Necrosis Factors, Tumor
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D012395 2005
% 209.48/209.71  |- skos__scopeNote mesh__D012395
% 209.48/209.71       A bright bluish pink compound that has been used as a dye, biological stain, and diagnostic aid.%A%    
% 209.48/209.71  |- mesh__recordMaintainer mesh__D012395 ssb
% 209.48/209.71  |- skos__hiddenLabel mesh__D012395 Bengal, Rose
% 209.48/209.71  |- rdf__type mesh__D012395sskos__Concept
% 209.48/209.71  |- skos__prefLabel mesh__D012395 Rose Bengal
% 209.48/209.71  |- skos__annotation mesh__D012395 D25-26n qualif   
% 209.48/209.71  |- mesh__dateRevised mesh__D012395 2001-07-25
% 209.48/209.71  |- mesh__recordAuthorizer mesh__D012395 sjn
% 209.48/209.71  |- mesh__dateCreated mesh__D012395 1999-01-01
% 209.48/209.71  |- mesh__recordOriginator mesh__D012395 NLM
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D012395 2004
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D012395 2002
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D012395 2006
% 209.48/209.71  |- skos__broader mesh__D012395smesh__D005452
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D012395 2003
% 209.48/209.71  |- skos__hiddenLabel mesh__D020827 SMG p21A GTP Binding Protein
% 209.48/209.71  |- mesh__recordOriginator mesh__D020827 jmp
% 209.48/209.71  |- skos__hiddenLabel mesh__D020827 rap1A GTP Binding Protein
% 209.48/209.71  |- skos__altLabel mesh__D020827 smg p21A Protein
% 209.48/209.71  |- skos__hiddenLabel mesh__D020827 p21A Protein, smg
% 209.48/209.71  |- skos__hiddenLabel mesh__D020827 Krev 1 Protein
% 209.48/209.71  |- skos__hiddenLabel mesh__D020827 GTP-Binding Protein, rap1A
% 209.48/209.71  |- skos__altLabel mesh__D020827 rap1A Protein
% 209.48/209.71  |- mesh__publicMeSHNote mesh__D020827
% 209.48/209.71       2000; RAP1A PROTEIN, K-REV-1 PROTEIN %26% SMG P21A were indexed under G-PROTEINS 1991-1999%A%  
% 209.48/209.71  |- skos__hiddenLabel mesh__D020827 GTP-Binding Protein, Krev-1
% 209.48/209.71  |- rdf__type mesh__D020827sskos__Concept
% 209.48/209.71  |- skos__hiddenLabel mesh__D020827 GTP-Binding Protein, rap1
% 209.48/209.71  |- skos__scopeNote mesh__D020827
% 209.48/209.71       A genetically related subfamily of RAP GTP-BINDING PROTEINS that share homology with RAS PROTEINS. They bind to Ras effectors but do not activate them, therefore they may antagonize the effects of RAS PROTEINS. This enzyme was formerly listed as EC 3.6.1.47.%A%    
% 209.48/209.71  |- skos__hiddenLabel mesh__D020827 rap1 GTP Binding Proteins
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D020827 2006
% 209.48/209.71  |- skos__altLabel mesh__D020827 smg p21 GTP-Binding Protein
% 209.48/209.71  |- skos__prefLabel mesh__D020827 rap1 GTP-Binding Proteins
% 209.48/209.71  |- skos__altLabel mesh__D020827 rap1A GTP-Binding Protein
% 209.48/209.71  |- mesh__dateCreated mesh__D020827 1999-11-03
% 209.48/209.71  |- skos__hiddenLabel mesh__D020827 Krev 1 GTP Binding Protein
% 209.48/209.71  |- skos__hiddenLabel mesh__D020827 GTP-Binding Proteins, rap1
% 209.48/209.71  |- skos__altLabel mesh__D020827 SMG p21A GTP-Binding Protein
% 209.48/209.71  |- mesh__dateEstablished mesh__D020827 2000-01-01
% 209.48/209.71  |- skos__historyNote mesh__D020827 G-Proteins %28%1991-1999%29%
% 209.48/209.71  |- mesh__dateRevised mesh__D020827 2005-06-30
% 209.48/209.71  |- mesh__historyNote mesh__D020827
% 209.48/209.71       2000; for RAP1A PROTEIN, K-REV-1 PROTEIN %26% SMG P21A use RAP GTP-BINDING PROTEINS %28%NM%29% 1991-1999%A%  
% 209.48/209.71  |- mesh__recordAuthorizer mesh__D020827 sjn
% 209.48/209.71  |- mesh__recordMaintainer mesh__D020827 jmp
% 209.48/209.71  |- skos__altLabel mesh__D020827 Krev-1 GTP-Binding Protein
% 209.48/209.71  |- skos__broader mesh__D020827smesh__D020668
% 209.48/209.71  |- skos__altLabel mesh__D020827 Krev-1 Protein
% 209.48/209.71  |- skos__hiddenLabel mesh__D020827 smg p21 GTP Binding Protein
% 209.48/209.71  |- skos__hiddenLabel mesh__D020827 rap1 GTP Binding Protein
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D006358 2001
% 209.48/209.71  |- skos__prefLabel mesh__D006358 Heat
% 209.48/209.71  |- mesh__considerAlso mesh__D006358 consider also terms at THERM-   
% 209.48/209.71  |- rdf__type mesh__D006358sskos__Concept
% 209.48/209.71  |- mesh__recordOriginator mesh__D006358 NLM
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D006358 2000
% 209.48/209.71  |- mesh__dateCreated mesh__D006358 1999-01-01
% 209.48/209.71  |- skos__related mesh__D006358smesh__D017694
% 209.48/209.71  |- skos__broader mesh__D006358smesh__D013816
% 209.48/209.71  |- mesh__dateRevised mesh__D006358 1997-06-20
% 209.48/209.71  |- skos__related mesh__D006358smesh__D002151
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D006358 1999
% 209.48/209.71  |- skos__related mesh__D006358smesh__D006979
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D006358 2006
% 209.48/209.71  |- skos__broader mesh__D006358smesh__D013696
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D006358 2002
% 209.48/209.71  |- mesh__recordMaintainer mesh__D006358 TGC
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D006358 2004
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D006358 1998
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D006358 2005
% 209.48/209.71  |- skos__related mesh__D006358smesh__D014329
% 209.48/209.71  |- skos__related mesh__D006358smesh__D003889
% 209.48/209.71  |- mesh__recordAuthorizer mesh__D006358 SJN
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D006358 2003
% 209.48/209.71  |- skos__annotation mesh__D006358
% 209.48/209.71       differentiate from HEATING %28%the environment%29%; /ther use: consider also HYPERTHERMIA, INDUCED; HEAT /adv eff: consider also HEAT STRESS DISORDERS %26% its specifics%A%  
% 209.48/209.71  |- skos__scopeNote mesh__D006358
% 209.48/209.71       The form of energy and the sensation of an increase in temperature. Its interest in medicine is largely with reference to its physiological effects, its therapeutic use, and its use in procedures in physics and physical chemistry.%A%    
% 209.48/209.71  |- skos__related mesh__D020029smesh__D001482
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D020029 2005
% 209.48/209.71  |- mesh__dateCreated mesh__D020029 1998-06-10
% 209.48/209.71  |- skos__broader mesh__D020029smesh__D009690
% 209.48/209.71  |- mesh__publicMeSHNote mesh__D020029 99; see BASE COMPOSITION 1980-98   
% 209.48/209.71  |- mesh__recordAuthorizer mesh__D020029 sjn
% 209.48/209.71  |- skos__altLabel mesh__D020029 Base Pair
% 209.48/209.71  |- skos__scopeNote mesh__D020029
% 209.48/209.71       Pairing of purine and pyrimidine bases by hydrogen bonding in double-stranded DNA or RNA.%A%    
% 209.48/209.71  |- rdf__type mesh__D020029sskos__Concept
% 209.48/209.71  |- skos__prefLabel mesh__D020029 Base Pairing
% 209.48/209.71  |- skos__related mesh__D020029smesh__D020137
% 209.48/209.71  |- mesh__historyNote mesh__D020029 99; use BASE COMPOSITION 1980-98   
% 209.48/209.71  |- skos__historyNote mesh__D020029
% 209.48/209.71       Nucleic Acid Conformation %28%1972-1998%29%
% 209.48/209.71  |- mesh__dateEstablished mesh__D020029 1999-01-01
% 209.48/209.71  |- mesh__dateRevised mesh__D020029 2004-07-07
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D020029 2006
% 209.48/209.71  |- mesh__recordOriginator mesh__D020029 NNS
% 209.48/209.71  |- skos__historyNote mesh__D020029 Base Composition %28%1980-1998%29%
% 209.48/209.71  |- mesh__recordMaintainer mesh__D020029 nns
% 209.48/209.71  |- skos__annotation mesh__D020029 coord with DNA or RNA or specific   
% 209.48/209.71  |- skos__altLabel mesh__D020029 Base Pairs
% 209.48/209.71  |- skos__hiddenLabel mesh__D020029 Base Pairings
% 209.48/209.71  |- skos__broader mesh__D003060smesh__D005395
% 209.48/209.71  |- mesh__publicMeSHNote mesh__D003060
% 209.48/209.71       91; was see under FISH OILS 1983-90; was see under FISH LIVER OILS 1963-82%A%  
% 209.48/209.71  |- rdf__type mesh__D003060sskos__Concept
% 209.48/209.71  |- mesh__recordMaintainer mesh__D003060 ssb
% 209.48/209.71  |- mesh__dateCreated mesh__D003060 1999-01-01
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D003060 2004
% 209.48/209.71  |- skos__broader mesh__D003060smesh__D005224
% 209.48/209.71  |- skos__scopeNote mesh__D003060
% 209.48/209.71       Oil obtained from fresh livers of the cod family, Gadidae. It is a source of vitamins A and D.%A%    
% 209.48/209.71  |- mesh__onlineNote mesh__D003060 search FISH OILS 1966-74   
% 209.48/209.71  |- skos__prefLabel mesh__D003060 Cod Liver Oil
% 209.48/209.71  |- mesh__recordOriginator mesh__D003060 NLM
% 209.48/209.71  |- skos__broader mesh__D003060smesh__D004042
% 209.48/209.71  |- mesh__recordAuthorizer mesh__D003060 sjn
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D003060 2006
% 209.48/209.71  |- mesh__dateRevised mesh__D003060 2003-07-09
% 209.48/209.71  |- mesh__dateEstablished mesh__D003060 1991-01-01
% 209.48/209.71  |- mesh__historyNote mesh__D003060
% 209.48/209.71       91%28%75%29%; was see under FISH OILS 1983-90; was see under FISH LIVER OILS 1963-82%A%  
% 209.48/209.71  |- skos__hiddenLabel mesh__D003060 Oil, Cod Liver
% 209.48/209.71  |- skos__hiddenLabel mesh__D003060 Liver Oil, Cod
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D003060 2005
% 209.48/209.71  |- skos__broader mesh__D012965Q000737smesh__D012965
% 209.48/209.71  |- rdf__type mesh__D012965Q000737smesh__CompoundConcept
% 209.48/209.71  |- mesh__historyNote mesh__D016786 92   
% 209.48/209.71  |- rdf__type mesh__D016786sskos__Concept
% 209.48/209.71  |- skos__broader mesh__D016786smesh__D004539
% 209.48/209.71  |- mesh__recordAuthorizer mesh__D016786 sjn
% 209.48/209.71  |- mesh__recordOriginator mesh__D016786 PXP
% 209.48/209.71  |- mesh__dateEstablished mesh__D016786 1992-01-01
% 209.48/209.71  |- skos__scopeNote mesh__D016786
% 209.48/209.71       A species of coccidian protozoa that mainly infects domestic poultry.%A%    
% 209.48/209.71  |- skos__annotation mesh__D016786
% 209.48/209.71       infection: coord IM with COCCIDIOSIS %28%IM%29%; drug eff: consider also COCCIDIOSTATS;  for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 209.48/209.71  |- skos__prefLabel mesh__D016786 Eimeria tenella
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D016786 2004
% 209.48/209.71  |- skos__historyNote mesh__D016786 Eimeria %28%1966-1991%29%
% 209.48/209.71  |- mesh__dateRevised mesh__D016786 2003-07-09
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D016786 2006
% 209.48/209.71  |- mesh__publicMeSHNote mesh__D016786 92   
% 209.48/209.71  |- mesh__recordMaintainer mesh__D016786 ags
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D016786 2005
% 209.48/209.71  |- mesh__dateCreated mesh__D016786 1991-05-02
% 209.48/209.71  |- skos__related mesh__D002766smesh__D011949
% 209.48/209.71  |- mesh__recordAuthorizer mesh__D002766 sjn
% 209.48/209.71  |- mesh__historyNote mesh__D002766
% 209.48/209.71       PANCREOZYMIN was heading 1963-76 %28%Prov 1963-66%29%, was see under GASTROINTESTINAL HORMONES 1963-66%A%  
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D002766 2006
% 209.48/209.71  |- skos__prefLabel mesh__D002766 Cholecystokinin
% 209.48/209.71  |- mesh__dateCreated mesh__D002766 1999-01-01
% 209.48/209.71  |- mesh__recordOriginator mesh__D002766 NLM
% 209.48/209.71  |- skos__scopeNote mesh__D002766
% 209.48/209.71       A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine %28%or digestive%29% enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety.%A%    
% 209.48/209.71  |- mesh__recordMaintainer mesh__D002766 ssb
% 209.48/209.71  |- mesh__publicMeSHNote mesh__D002766 PANCREOZYMIN was heading 1967-76   
% 209.48/209.71  |- skos__broader mesh__D002766smesh__D010455
% 209.48/209.71  |- skos__altLabel mesh__D002766 Uropancreozymin
% 209.48/209.71  |- mesh__dateRevised mesh__D002766 2005-06-30
% 209.48/209.71  |- rdf__type mesh__D002766sskos__Concept
% 209.48/209.71  |- skos__altLabel mesh__D002766 Pancreozymin
% 209.48/209.71  |- skos__altLabel mesh__D002766 Cholecystokinin 33
% 209.48/209.71  |- mesh__onlineNote mesh__D002766
% 209.48/209.71       use CHOLECYSTOKININ to search PANCREOZYMIN 1966-76 %28%as Prov 1966%29%%A%  
% 209.48/209.71  |- skos__related mesh__D002766smesh__D005765
% 209.48/209.71  |- skos__broader mesh__D002766smesh__D009479
% 209.48/209.71  |- skos__broader mesh__D002766smesh__D005768
% 209.48/209.71  |- skos__scopeNote mesh__D029903 A plant genus of the family FABACEAE.     
% 209.48/209.71  |- mesh__historyNote mesh__D029903 2002   
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D029903 2006A
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D029903 2005
% 209.48/209.71  |- skos__prefLabel mesh__D029903 Melilotus
% 209.48/209.71  |- mesh__publicMeSHNote mesh__D029903 2002   
% 209.48/209.71  |- mesh__recordAuthorizer mesh__D029903 ags
% 209.48/209.71  |- rdf__type mesh__D029903sskos__Concept
% 209.48/209.71  |- skos__broader mesh__D029903smesh__D007887
% 209.48/209.71  |- mesh__dateCreated mesh__D029903 2001-07-25
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D029903 2006
% 209.48/209.71  |- mesh__recordOriginator mesh__D029903 ssb
% 209.48/209.71  |- mesh__dateEstablished mesh__D029903 2002-01-01
% 209.48/209.71  |- skos__altLabel mesh__D029903 Clover, Sweet
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D029903 2003
% 209.48/209.71  |- mesh__recordMaintainer mesh__D029903 ags
% 209.48/209.71  |- mesh__dateRevised mesh__D029903 2005-07-19
% 209.48/209.71  |- skos__annotation mesh__D029903
% 209.48/209.71       note X ref SWEET CLOVER: CLOVER see MEDICAGO; BUSH CLOVER see LESPEDEZA; and RED CLOVER see TRIFOLIUM are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D029903 2004
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D007451 2003
% 209.48/209.71  |- mesh__recordAuthorizer mesh__D007451 sjn
% 209.48/209.71  |- skos__broader mesh__D007451smesh__D014283
% 209.48/209.71  |- skos__prefLabel mesh__D007451 Iodamide
% 209.48/209.71  |- mesh__recordMaintainer mesh__D007451 CCR
% 209.48/209.71  |- mesh__dateCreated mesh__D007451 1974-11-19
% 209.48/209.71  |- skos__historyNote mesh__D007451 Iodobenzoates %28%1974%29%
% 209.48/209.71  |- skos__scopeNote mesh__D007451
% 209.48/209.71       An ionic monomeric contrast medium. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p706%29%%A%    
% 209.48/209.71  |- skos__annotation mesh__D007451 D25-26 qualif   
% 209.48/209.71  |- mesh__publicMeSHNote mesh__D007451
% 209.48/209.71       91; was see under IODOBENZOATES 1975-90   
% 209.48/209.71  |- skos__historyNote mesh__D007451 Acetamides %28%1974%29%
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D007451 2006
% 209.48/209.71  |- mesh__historyNote mesh__D007451
% 209.48/209.71       91%28%75%29%; was see under IODOBENZOATES 1975-90   
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D007451 2005
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D007451 2002
% 209.48/209.71  |- mesh__dateRevised mesh__D007451 2000-06-22
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D007451 2004
% 209.48/209.71  |- rdf__type mesh__D007451sskos__Concept
% 209.48/209.71  |- mesh__dateEstablished mesh__D007451 1991-01-01
% 209.48/209.71  |- mesh__recordOriginator mesh__D007451 NLM
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D007451 2001
% 209.48/209.71  |- mesh__publicMeSHNote mesh__D021122 2001   
% 209.48/209.71  |- skos__altLabel mesh__D021122 Protomer
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D021122 2006
% 209.48/209.71  |- mesh__dateRevised mesh__D021122 2003-07-25
% 209.48/209.71  |- skos__altLabel mesh__D021122 Protein Subunit
% 209.48/209.71  |- mesh__dateEstablished mesh__D021122 2001-01-01
% 209.48/209.71  |- skos__prefLabel mesh__D021122 Protein Subunits
% 209.48/209.71  |- skos__broader mesh__D021122smesh__D011506
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D021122 2005
% 209.48/209.71  |- mesh__recordOriginator mesh__D021122 nns
% 209.48/209.71  |- skos__hiddenLabel mesh__D021122 Subunits, Protein
% 209.48/209.71  |- mesh__dateCreated mesh__D021122 2000-06-22
% 209.48/209.71  |- mesh__recordMaintainer mesh__D021122 sjn
% 209.48/209.71  |- rdf__type mesh__D021122sskos__Concept
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D021122 2004
% 209.48/209.71  |- skos__hiddenLabel mesh__D021122 Subunit, Protein
% 209.48/209.71  |- mesh__historyNote mesh__D021122 2001   
% 209.48/209.71  |- skos__historyNote mesh__D021122 Protein Conformation %28%1972-2000%29%
% 209.48/209.71  |- skos__scopeNote mesh__D021122
% 209.48/209.71       Single chains of amino acids that are the units of multimeric PROTEINS. Multimeric proteins can be composed of identical or non-identical subunits. One or more monomeric subunits may compose a protomer which itself is a subunit structure of a larger assembly.%A%    
% 209.48/209.71  |- mesh__recordAuthorizer mesh__D021122 sjn
% 209.48/209.71  |- mesh__dateEstablished mesh__D048868 2005-01-01
% 209.48/209.71  |- skos__scopeNote mesh__D048868
% 209.48/209.71       A broad category of carrier proteins that play a role in SIGNAL TRANSDUCTION. They generally contain several modular domains, each of which having its own binding activity, and act by forming complexes with other intracellular-signaling molecules. Signal-transducing adaptor proteins lack enzyme activity, however their activity can be modulated by other signal-transducing enzymes%A%    
% 209.48/209.71  |- mesh__historyNote mesh__D048868 2005   
% 209.48/209.71  |- mesh__recordOriginator mesh__D048868 jmp
% 209.48/209.71  |- mesh__publicMeSHNote mesh__D048868 2005   
% 209.48/209.71  |- skos__broader mesh__D048868smesh__D002352
% 209.48/209.71  |- mesh__dateCreated mesh__D048868 2004-07-07
% 209.48/209.71  |- skos__altLabel mesh__D048868 Signal Transducing Adaptor Proteins
% 209.48/209.71  |- skos__historyNote mesh__D048868 Carrier Proteins %28%1991-2004%29%
% 209.48/209.71  |- skos__broader mesh__D048868smesh__D047908
% 209.48/209.71  |- mesh__recordMaintainer mesh__D048868 jmp
% 209.48/209.71  |- skos__prefLabel mesh__D048868 Adaptor Proteins, Signal Transducing
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D048868 2006
% 209.48/209.71  |- mesh__recordAuthorizer mesh__D048868 sjn
% 209.48/209.71  |- rdf__type mesh__D048868sskos__Concept
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D048868 2005
% 209.48/209.71  |- skos__altLabel mesh__D020828 Paralysis, Pseudobulbar
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Palsy, Spastic Bulbar
% 209.48/209.71  |- skos__altLabel mesh__D020828 Pseudobulbar Syndrome
% 209.48/209.71  |- skos__prefLabel mesh__D020828 Pseudobulbar Palsy
% 209.48/209.71  |- mesh__historyNote mesh__D020828
% 209.48/209.71       2000; for PSEUDOBULBAR PARALYSIS and PARALYSIS, PSEUDOBULBAR use PARALYSIS 1985-1999%A%  
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Mutism, Pseudobulbar
% 209.48/209.71  |- mesh__dateCreated mesh__D020828 1999-11-05
% 209.48/209.71  |- skos__broader mesh__D020828smesh__D010243
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Pseudobulbar Pareses
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D020828 2005
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Paralyses, Pseudobulbar
% 209.48/209.71  |- skos__altLabel mesh__D020828 Pseudobulbar Paresis
% 209.48/209.71  |- skos__historyNote mesh__D020828
% 209.48/209.71       Bulbar Palsy, Progressive %28%1966-1982%29%
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Spastic Bulbar Palsies
% 209.48/209.71  |- mesh__dateEstablished mesh__D020828 2000-01-01
% 209.48/209.71  |- skos__altLabel mesh__D020828 Spastic Bulbar Palsy
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Palsies, Spastic Bulbar
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Syndromes, Pseudobulbar
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Dysarthrias, Pseudobulbar
% 209.48/209.71  |- rdf__type mesh__D020828sskos__Concept
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D020828 2004
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Pseudobulbar Dysarthria
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Pseudobulbar Paralyses
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Pseudobulbar Mutisms
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D020828 2002
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Pareses, Pseudobulbar
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Bulbar Palsy, Spastic
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D020828 2003
% 209.48/209.71  |- mesh__publicMeSHNote mesh__D020828
% 209.48/209.71       2000; for PSEUDOBULBAR PARALYSIS and PARALYSIS, PSEUDOBULBAR see PARALYSIS 1985-1999%A%  
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Palsies, Pseudobulbar
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Mutisms, Pseudobulbar
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D020828 2001
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Pseudobulbar Palsies
% 209.48/209.71  |- skos__scopeNote mesh__D020828
% 209.48/209.71       A syndrome characterized by DYSARTHRIA, dysphagia, dysphonia, impairment of voluntary movements of tongue and facial muscles, and emotional lability. This condition is caused by diseases that affect the motor fibers that travel from the cerebral cortex to the lower BRAIN STEM %28%i.e., corticobulbar tracts%29%; including MULTIPLE SCLEROSIS; MOTOR NEURON DISEASE; and CEREBROVASCULAR DISORDERS. %28%From Adams et al., Principles of Neurology, 6th ed, p489%29%%A%    
% 209.48/209.71  |- skos__historyNote mesh__D020828 Paralysis %28%1982-1999%29%
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Paresis, Pseudobulbar
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Pseudobulbar Dysarthrias
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Palsy, Pseudobulbar
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Syndrome, Pseudobulbar
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Pseudobulbar Syndromes
% 209.48/209.71  |- skos__altLabel mesh__D020828 Pseudobulbar Paralysis
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D020828 2000
% 209.48/209.71  |- skos__hiddenLabel mesh__D020828 Bulbar Palsies, Spastic
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D020828 2006
% 209.48/209.71  |- skos__hiddenLabel mesh__D006359 Exhaustion, Heat
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D006359 1999
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D006359 2006
% 209.48/209.71  |- skos__hiddenLabel mesh__D006359 Collapse, Heat
% 209.48/209.71  |- mesh__recordAuthorizer mesh__D006359 SJN
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D006359 2004
% 209.48/209.71  |- skos__prefLabel mesh__D006359 Heat Exhaustion
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D006359 2005
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D006359 2001
% 209.48/209.71  |- skos__annotation mesh__D006359
% 209.48/209.71       subnormal body temp: do not confuse with HEAT STROKE where body temp is dangerously high; SUNSTROKE is also available%A%  
% 209.48/209.71  |- skos__scopeNote mesh__D006359
% 209.48/209.71       An effect of excessive exposure to heat occurring commonly among workers in furnace rooms, foundries, etc., although it may occur from exposure to the sun%27%s heat %28%SUNSTROKE%29%. It is marked by subnormal temperature, with dizziness, headache, nausea, and sometimes delirium and/or collapse. It is distinguished from HEAT STROKE, in which the body temperature may be dangerously elevated. %28%Dorland, 27th ed%29%%A%    
% 209.48/209.71  |- mesh__recordMaintainer mesh__D006359 SJN
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D006359 2003
% 209.48/209.71  |- skos__hiddenLabel mesh__D006359 Prostration, Heat
% 209.48/209.71  |- mesh__recordOriginator mesh__D006359 NLM
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D006359 2000
% 209.48/209.71  |- skos__altLabel mesh__D006359 Heat Prostration
% 209.48/209.71  |- mesh__dateRevised mesh__D006359 1998-06-10
% 209.48/209.71  |- skos__broader mesh__D006359smesh__D018882
% 209.48/209.71  |- rdf__type mesh__D006359sskos__Concept
% 209.48/209.71  |- mesh__dateCreated mesh__D006359 1999-01-01
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D006359 2002
% 209.48/209.71  |- skos__altLabel mesh__D017081 Cholecystectomy, Celioscopic
% 209.48/209.71  |- mesh__historyNote mesh__D017081 93   
% 209.48/209.71  |- skos__prefLabel mesh__D017081 Cholecystectomy, Laparoscopic
% 209.48/209.71  |- mesh__publicMeSHNote mesh__D017081 93   
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D017081 2003
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D017081 2002
% 209.48/209.71  |- mesh__recordMaintainer mesh__D017081 KEV
% 209.48/209.71  |- mesh__dateCreated mesh__D017081 1992-05-26
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D017081 2005
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D017081 2004
% 209.48/209.71  |- mesh__dateEstablished mesh__D017081 1993-01-01
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D017081 2006
% 209.48/209.71  |- skos__hiddenLabel mesh__D017081 Laparoscopic Cholecystectomies
% 209.48/209.71  |- skos__hiddenLabel mesh__D017081 Cholecystectomies, Celioscopic
% 209.48/209.71  |- skos__broader mesh__D017081smesh__D002763
% 209.48/209.71  |- mesh__activeMeSHYear mesh__D017081 2000
% 209.48/209.72  |- skos__hiddenLabel mesh__D017081 Cholecystectomies, Laparoscopic
% 209.48/209.72  |- rdf__type mesh__D017081sskos__Concept
% 209.48/209.72  |- mesh__recordOriginator mesh__D017081 MXR
% 209.48/209.72  |- skos__broader mesh__D017081smesh__D010535
% 209.48/209.72  |- skos__hiddenLabel mesh__D017081 Celioscopic Cholecystectomies
% 209.48/209.72  |- mesh__dateRevised mesh__D017081 1999-11-08
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D017081 2001
% 209.48/209.72  |- mesh__recordAuthorizer mesh__D017081 sjn
% 209.48/209.72  |- skos__scopeNote mesh__D017081
% 209.48/209.72       Excision of the gallbladder through an abdominal incision using a laparoscope.%A%    
% 209.48/209.72  |- skos__hiddenLabel mesh__D017081 Celioscopic Cholecystectomy
% 209.48/209.72  |- skos__historyNote mesh__D017081 Laparoscopy %28%1989-1992%29%
% 209.48/209.72  |- skos__altLabel mesh__D017081 Laparoscopic Cholecystectomy
% 209.48/209.72  |- mesh__publicMeSHNote mesh__D003061
% 209.48/209.72       CODEINE DERIVATIVES was see under CODEINE 1975-77, was see under MORPHINANS 1969-74%A%  
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D003061 2002
% 209.48/209.72  |- skos__annotation mesh__D003061 codeine derivatives = CODEINE /analogs   
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D003061 2003
% 209.48/209.72  |- mesh__dateRevised mesh__D003061 2000-06-21
% 209.48/209.72  |- mesh__onlineNote mesh__D003061
% 209.48/209.72       use CODEINE/analogs %26% derivatives to search CODEINE DERIVATIVES 1975-77; use MORPHINANS 1969-74%A%  
% 209.48/209.72  |- skos__scopeNote mesh__D003061
% 209.48/209.72       An opioid analgesic related to MORPHINE but with less potent analgesic properties and mild sedative effects. It also acts centrally to suppress cough.%A%    
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D003061 2001
% 209.48/209.72  |- skos__hiddenLabel mesh__D003061 N Methylmorphine
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D003061 2006
% 209.48/209.72  |- mesh__recordMaintainer mesh__D003061 TWD
% 209.48/209.72  |- skos__altLabel mesh__D003061 N-Methylmorphine
% 209.48/209.72  |- mesh__recordOriginator mesh__D003061 NLM
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D003061 2005
% 209.48/209.72  |- skos__prefLabel mesh__D003061 Codeine
% 209.48/209.72  |- rdf__type mesh__D003061sskos__Concept
% 209.48/209.72  |- mesh__historyNote mesh__D003061
% 209.48/209.72       CODEINE DERIVATIVES was see under CODEINE 1975-77, was see under MORPHINANS 1969-74%A%  
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D003061 2004
% 209.48/209.72  |- mesh__dateCreated mesh__D003061 1999-01-01
% 209.48/209.72  |- mesh__recordAuthorizer mesh__D003061 sjn
% 209.48/209.72  |- skos__broader mesh__D003061smesh__D009022
% 209.48/209.72  |- mesh__recordOriginator mesh__D016787 PXP
% 209.48/209.72  |- skos__scopeNote mesh__D016787
% 209.48/209.72       An order of heteroxenous protozoa in which the macrogamete and microgamont develop independently. A conoid is usually absent.%A%    
% 209.48/209.72  |- skos__broader mesh__D016787smesh__D016782
% 209.48/209.72  |- mesh__dateCreated mesh__D016787 1991-05-02
% 209.48/209.72  |- mesh__publicMeSHNote mesh__D016787 2001; see HAEMOSPORINA 1992-2000   
% 209.48/209.72  |- skos__altLabel mesh__D016787 Haemosporina
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D016787 2004
% 209.48/209.72  |- mesh__historyNote mesh__D016787 2001%28%1992%29%   
% 209.48/209.72  |- skos__prefLabel mesh__D016787 Haemosporida
% 209.48/209.72  |- mesh__recordAuthorizer mesh__D016787 sjn
% 209.48/209.72  |- mesh__dateRevised mesh__D016787 2003-07-09
% 209.48/209.72  |- skos__annotation mesh__D016787
% 209.48/209.72       an order of protozoa to which Plasmodium belongs   
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D016787 2006
% 209.48/209.72  |- mesh__dateEstablished mesh__D016787 1992-01-01
% 209.48/209.72  |- mesh__recordMaintainer mesh__D016787 ags
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D016787 2005
% 209.48/209.72  |- rdf__type mesh__D016787sskos__Concept
% 209.48/209.72  |- mesh__dateCreated mesh__D035941 2002-07-02
% 209.48/209.72  |- skos__hiddenLabel mesh__D035941 Soluble Aconitase 1
% 209.48/209.72  |- skos__hiddenLabel mesh__D035941 Repressor Protein, Ferritin
% 209.48/209.72  |- skos__broader mesh__D035941smesh__D035925
% 209.48/209.72  |- skos__broader mesh__D035941smesh__D016601
% 209.48/209.72  |- skos__broader mesh__D035941smesh__D007506
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D035941 2006
% 209.48/209.72  |- skos__hiddenLabel mesh__D035941 IRE BP1
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D035941 2004
% 209.48/209.72  |- mesh__publicMeSHNote mesh__D035941
% 209.48/209.72       2003; FERRITIN REPRESSOR PROTEIN was indexed under IRON-SULFUR PROTEINS %26% RNA-BINDING PROTEINS 1991-2002, IRE-BP1, IRON REGULATORY PROTEIN 1, IRP-1 PROTEIN %26% IRP1 PROTEIN were indexed under IRON-SULFUR PROTEINS %26% RNA-BINDING PROTEINS 1995-2002%A%  
% 209.48/209.72  |- skos__altLabel mesh__D035941 Ferritin Repressor Protein
% 209.48/209.72  |- skos__altLabel mesh__D035941 ACO1 Protein
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D035941 2005
% 209.48/209.72  |- skos__broader mesh__D035941smesh__D000154
% 209.48/209.72  |- skos__altLabel mesh__D035941 IRP-1 Protein
% 209.48/209.72  |- skos__historyNote mesh__D035941 Iron-Sulfur Proteins %28%1995-2002%29%
% 209.48/209.72  |- skos__prefLabel mesh__D035941 Iron Regulatory Protein 1
% 209.48/209.72  |- skos__scopeNote mesh__D035941
% 209.48/209.72       A multifunctional iron-sulfur protein that is both an iron regulatory protein and cytoplasmic form of aconitate hydratase. It binds to iron regulatory elements found on mRNAs involved in iron metabolism and regulates their translation. Its RNA binding ability and its aconitate hydrolase activity are dependent upon availability of IRON.%A%    
% 209.48/209.72  |- mesh__historyNote mesh__D035941
% 209.48/209.72       2003; for FERRITIN REPRESSOR PROTEIN use IRON-REGULATORY PROTEINS %28%NM%29% 1991-2002, for IRE-BP1, IRON REGULATORY PROTEIN 1, IRP-1 PROTEIN %26% IRP1 PROTEIN use IRON-REGULATORY PROTEINS %28%NM%29% 1995-2002%A%  
% 209.48/209.72  |- mesh__dateEstablished mesh__D035941 2003-01-01
% 209.48/209.72  |- skos__altLabel mesh__D035941 IRE-BP1
% 209.48/209.72  |- rdf__type mesh__D035941sskos__Concept
% 209.48/209.72  |- skos__altLabel mesh__D035941 IRP1 Protein
% 209.48/209.72  |- mesh__dateRevised mesh__D035941 2003-07-09
% 209.48/209.72  |- skos__altLabel mesh__D035941 Aconitase 1, Soluble
% 209.48/209.72  |- skos__historyNote mesh__D035941 Ribonucleoproteins %28%1995-2002%29%
% 209.48/209.72  |- skos__hiddenLabel mesh__D035941 IRP 1 Protein
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D002767 2006
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D002767 2002
% 209.48/209.72  |- skos__scopeNote mesh__D002767
% 209.48/209.72       Establishment of an opening into the gallbladder either for drainage or surgical communication with another part of the digestive tract, usually the duodenum or jejunum.%A%    
% 209.48/209.72  |- mesh__recordOriginator mesh__D002767 SCD
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D002767 1998
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D002767 2005
% 209.48/209.72  |- mesh__recordMaintainer mesh__D002767 PXP
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D002767 2001
% 209.48/209.72  |- rdf__type mesh__D002767sskos__Concept
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D002767 2004
% 209.48/209.72  |- mesh__recordAuthorizer mesh__D002767 SJN
% 209.48/209.72  |- skos__broader mesh__D002767smesh__D000714
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D002767 2000
% 209.48/209.72  |- mesh__publicMeSHNote mesh__D002767 88   
% 209.48/209.72  |- mesh__dateCreated mesh__D002767 1987-03-20
% 209.48/209.72  |- mesh__dateEstablished mesh__D002767 1988-01-01
% 209.48/209.72  |- skos__hiddenLabel mesh__D002767 Cholecystostomies
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D002767 2003
% 209.48/209.72  |- skos__annotation mesh__D002767
% 209.48/209.72       do not use /util except by MeSH definition   
% 209.48/209.72  |- mesh__historyNote mesh__D002767 88   
% 209.48/209.72  |- skos__historyNote mesh__D002767 Drainage %28%1966-1987%29%
% 209.48/209.72  |- mesh__dateRevised mesh__D002767 1997-06-20
% 209.48/209.72  |- skos__prefLabel mesh__D002767 Cholecystostomy
% 209.48/209.72  |- skos__historyNote mesh__D002767 Gallbladder/surgery %28%1966-1987%29%
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D002767 1999
% 209.48/209.72  |- skos__broader mesh__D002767smesh__D001662
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D029904 2006
% 209.48/209.72  |- skos__scopeNote mesh__D029904
% 209.48/209.72       A plant genus of the family FABACEAE that is a source of aromatic resinous balsams %28%Balsam of Tolu and Balsam of Peru%29% used in perfumery and as a constituent in cough syrups and lozenge.%A%    
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D029904 2003
% 209.48/209.72  |- skos__annotation mesh__D029904
% 209.48/209.72       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.48/209.72  |- mesh__historyNote mesh__D029904 2002   
% 209.48/209.72  |- mesh__dateEstablished mesh__D029904 2002-01-01
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D029904 2004
% 209.48/209.72  |- skos__prefLabel mesh__D029904 Myroxylon
% 209.48/209.72  |- mesh__dateCreated mesh__D029904 2001-07-25
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D029904 2005
% 209.48/209.72  |- mesh__dateRevised mesh__D029904 2002-07-03
% 209.48/209.72  |- mesh__publicMeSHNote mesh__D029904 2002   
% 209.48/209.72  |- rdf__type mesh__D029904sskos__Concept
% 209.48/209.72  |- skos__broader mesh__D029904smesh__D007887
% 209.48/209.72  |- skos__hiddenLabel mesh__D021921 Stenosis, Supravalvular Aortic
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D021921 2003
% 209.48/209.72  |- skos__hiddenLabel mesh__D021921 Aortic Supravalvular Stenoses
% 209.48/209.72  |- mesh__dateEstablished mesh__D021921 2001-01-01
% 209.48/209.72  |- skos__altLabel mesh__D021921 Supravalvular Aortic Stenosis
% 209.48/209.72  |- skos__historyNote mesh__D021921 Aortic Valve Stenosis %28%1965-2000%29%
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D021921 2004
% 209.48/209.72  |- rdf__type mesh__D021921sskos__Concept
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D021921 2005
% 209.48/209.72  |- skos__hiddenLabel mesh__D021921 Supravalvular Stenoses, Aortic
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D021921 2001
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D021921 2006
% 209.48/209.72  |- skos__hiddenLabel mesh__D021921 Stenosis, Aortic Supravalvular
% 209.48/209.72  |- mesh__publicMeSHNote mesh__D021921
% 209.48/209.72       2001; see AORTIC VALVE STENOSIS 1980-2000   
% 209.48/209.72  |- skos__altLabel mesh__D021921 Aortic Supravalvular Stenosis
% 209.48/209.72  |- skos__broader mesh__D021921smesh__D001024
% 209.48/209.72  |- skos__scopeNote mesh__D021921
% 209.48/209.72       A narrowing of the aorta in the region above the aortic valve.%A%    
% 209.48/209.72  |- skos__prefLabel mesh__D021921 Aortic Stenosis, Supravalvular
% 209.48/209.72  |- skos__hiddenLabel mesh__D021921 Supravalvular Stenosis, Aortic
% 209.48/209.72  |- skos__hiddenLabel mesh__D021921 Stenoses, Aortic Supravalvular
% 209.48/209.72  |- mesh__dateCreated mesh__D021921 2000-06-21
% 209.48/209.72  |- mesh__historyNote mesh__D021921
% 209.48/209.72       2001; use AORTIC VALVE STENOSIS 1980-2000   
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D021921 2002
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D007452 1998
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D007452 2006
% 209.48/209.72  |- mesh__dateRevised mesh__D007452 1993-06-02
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D007452 2002
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D007452 1997
% 209.48/209.72  |- mesh__recordAuthorizer mesh__D007452 PLS
% 209.48/209.72  |- mesh__publicMeSHNote mesh__D007452 91; was see under IODINE 1971-90   
% 209.48/209.72  |- mesh__recordMaintainer mesh__D007452 TPW
% 209.48/209.72  |- skos__scopeNote mesh__D007452
% 209.48/209.72       Inorganic salts of iodic acid %28%HIO3%29%.     
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D007452 2005
% 209.48/209.72  |- mesh__recordOriginator mesh__D007452 NLM
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D007452 2001
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D007452 1996
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D007452 2004
% 209.48/209.72  |- rdf__type mesh__D007452sskos__Concept
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D007452 2000
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D007452 1995
% 209.48/209.72  |- skos__annotation mesh__D007452 salts of iodic acid   
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D007452 2003
% 209.48/209.72  |- skos__broader mesh__D007452smesh__D000838
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D007452 1994
% 209.48/209.72  |- mesh__dateEstablished mesh__D007452 1991-01-01
% 209.48/209.72  |- skos__prefLabel mesh__D007452 Iodates
% 209.48/209.72  |- skos__historyNote mesh__D007452 Iodine %28%1966-1970%29%
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D007452 1999
% 209.48/209.72  |- skos__broader mesh__D007452smesh__D017613
% 209.48/209.72  |- mesh__dateCreated mesh__D007452 1999-01-01
% 209.48/209.72  |- mesh__historyNote mesh__D007452
% 209.48/209.72       91%28%71%29%; was see under IODINE 1971-90   
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D012397 1994
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D012397 1999
% 209.48/209.72  |- skos__annotation mesh__D012397 an immunol technique   
% 209.48/209.72  |- skos__prefLabel mesh__D012397 Rosette Formation
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D012397 1993
% 209.48/209.72  |- mesh__dateEstablished mesh__D012397 1978-01-01
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D012397 1995
% 209.48/209.72  |- mesh__recordOriginator mesh__D012397 SMH
% 209.48/209.72  |- skos__hiddenLabel mesh__D012397 Formations, Rosette
% 209.48/209.72  |- skos__altLabel mesh__D012397 Immunocytoadherence
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D012397 2003
% 209.48/209.72  |- mesh__recordMaintainer mesh__D012397 TAP
% 209.48/209.72  |- mesh__historyNote mesh__D012397 78   
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D012397 2000
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D012397 2005
% 209.48/209.72  |- skos__scopeNote mesh__D012397
% 209.48/209.72       The in vitro formation of clusters consisting of a cell %28%usually a lymphocyte%29% surrounded by antigenic cells or antigen-bearing particles %28%usually erythrocytes, which may or may not be coated with antibody or antibody and complement%29%. The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells.%A%    
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D012397 2004
% 209.48/209.72  |- mesh__publicMeSHNote mesh__D012397 78   
% 209.48/209.72  |- skos__hiddenLabel mesh__D012397 Rosette Formations
% 209.48/209.72  |- mesh__recordAuthorizer mesh__D012397 PLS
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D012397 2001
% 209.48/209.72  |- skos__broader mesh__D012397smesh__D007158
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D012397 2006
% 209.48/209.72  |- skos__hiddenLabel mesh__D012397 Formation, Rosette
% 209.48/209.72  |- skos__hiddenLabel mesh__D012397 Immunocytoadherences
% 209.48/209.72  |- mesh__dateRevised mesh__D012397 1992-05-18
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D012397 1996
% 209.48/209.72  |- skos__historyNote mesh__D012397
% 209.48/209.72       Immune Adherence Reaction %28%1971-1977%29%
% 209.48/209.72  |- mesh__dateCreated mesh__D012397 1977-03-01
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D012397 1998
% 209.48/209.72  |- rdf__type mesh__D012397sskos__Concept
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D012397 1997
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D012397 2002
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D020829 2002
% 209.48/209.72  |- mesh__historyNote mesh__D020829 2000   
% 209.48/209.72  |- skos__broader mesh__D020829smesh__D019669
% 209.48/209.72  |- mesh__recordOriginator mesh__D020829 ags
% 209.48/209.72  |- rdf__type mesh__D020829sskos__Concept
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D020829 2006
% 209.48/209.72  |- mesh__recordAuthorizer mesh__D020829 sjn
% 209.48/209.72  |- mesh__dateEstablished mesh__D020829 2000-01-01
% 209.48/209.72  |- skos__historyNote mesh__D020829 Plants, Medicinal %28%1976-1999%29%
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D020829 2005
% 209.48/209.72  |- skos__historyNote mesh__D020829 Plants %28%1971-1999%29%
% 209.48/209.72  |- skos__annotation mesh__D020829
% 209.48/209.72       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.48/209.72  |- skos__scopeNote mesh__D020829
% 209.48/209.72       The only living genus of the order Equisetales, class Equisetopsida %28%Sphenopsida%29%, division Equisetophyta %28%Sphenophyta%29%; distantly related to ferns. It grows in moist places. The hollow, jointed, ridged stems contain SILICATES.%A%    
% 209.48/209.72  |- mesh__dateCreated mesh__D020829 1999-11-03
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D020829 2004
% 209.48/209.72  |- mesh__dateRevised mesh__D020829 2001-07-25
% 209.48/209.72  |- mesh__recordMaintainer mesh__D020829 ssb
% 209.48/209.72  |- skos__altLabel mesh__D020829 Horsetail
% 209.48/209.72  |- mesh__publicMeSHNote mesh__D020829 2000   
% 209.48/209.72  |- skos__prefLabel mesh__D020829 Equisetum
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D020829 2003
% 209.48/209.72  |- skos__prefLabel mesh__D017880 Limb Deformities, Congenital
% 209.48/209.72  |- skos__historyNote mesh__D017880
% 209.48/209.72       Extremities/abnormalities %28%1968-1997%29%
% 209.48/209.72  |- mesh__recordAuthorizer mesh__D017880 sjn
% 209.48/209.72  |- mesh__recordOriginator mesh__D017880 TGC
% 209.48/209.72  |- mesh__dateCreated mesh__D017880 1993-08-26
% 209.48/209.72  |- skos__hiddenLabel mesh__D017880 Congenital Limb Deformity
% 209.48/209.72  |- skos__broader mesh__D017880smesh__D009139
% 209.48/209.72  |- skos__hiddenLabel mesh__D017880 Deformities, Congenital Limb
% 209.48/209.72  |- rdf__type mesh__D017880sskos__Concept
% 209.48/209.72  |- mesh__publicMeSHNote mesh__D017880 98   
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D017880 2006
% 209.48/209.72  |- mesh__dateRevised mesh__D017880 2005-06-30
% 209.48/209.72  |- mesh__historyNote mesh__D017880 98; use explode 1994-97   
% 209.48/209.72  |- skos__hiddenLabel mesh__D017880 Deformity, Congenital Limb
% 209.48/209.72  |- skos__annotation mesh__D017880
% 209.48/209.72       general or unspecified; LOWER EXTREMITY DEFORMITIES, CONGENITAL and UPPER EXTREMITY DEFORMITIES, CONGENITAL are available as well as /abnorm with specifics treed under UPPER EXTREMITIES and LOWER EXTREMITIES;  DF: LIMB DEFORMITIES CONGEN%A%  
% 209.48/209.72  |- skos__hiddenLabel mesh__D017880 Limb Deformity, Congenital
% 209.48/209.72  |- skos__altLabel mesh__D017880 Congenital Limb Deformities
% 209.48/209.72  |- mesh__recordMaintainer mesh__D017880 ags
% 209.48/209.72  |- skos__scopeNote mesh__D017880
% 209.48/209.72       Congenital structural deformities of the upper and lower extremities collectively or unspecified.%A%    
% 209.48/209.72  |- mesh__dateEstablished mesh__D017880 1998-01-01
% 209.48/209.72  |- skos__broader mesh__D017082smesh__D014690
% 209.48/209.72  |- skos__scopeNote mesh__D017082
% 209.48/209.72       The venous pressure measured in the PORTAL VEIN.     
% 209.48/209.72  |- mesh__dateCreated mesh__D017082 1992-05-22
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D017082 2006
% 209.48/209.72  |- mesh__publicMeSHNote mesh__D017082 93   
% 209.48/209.72  |- skos__hiddenLabel mesh__D017082 Pressure, Portal
% 209.48/209.72  |- mesh__dateRevised mesh__D017082 2003-07-09
% 209.48/209.72  |- rdf__type mesh__D017082sskos__Concept
% 209.48/209.72  |- mesh__dateEstablished mesh__D017082 1993-01-01
% 209.48/209.72  |- mesh__historyNote mesh__D017082 93   
% 209.48/209.72  |- skos__prefLabel mesh__D017082 Portal Pressure
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D017082 2005
% 209.48/209.72  |- skos__historyNote mesh__D017082 Blood Pressure %28%1966-1992%29%
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D017082 2004
% 209.48/209.72  |- skos__hiddenLabel mesh__D003062 Sense Codons
% 209.48/209.72  |- skos__prefLabel mesh__D003062 Codon
% 209.48/209.72  |- mesh__dateEstablished mesh__D003062 1991-01-01
% 209.48/209.72  |- skos__annotation mesh__D003062 GEN or unspecified; prefer specifics   
% 209.48/209.72  |- skos__altLabel mesh__D003062 Codon, Sense
% 209.48/209.72  |- mesh__recordOriginator mesh__D003062 NLM
% 209.48/209.72  |- skos__broader mesh__D003062smesh__D040461
% 209.48/209.72  |- skos__broader mesh__D003062smesh__D005815
% 209.48/209.72  |- mesh__recordAuthorizer mesh__D003062 sjn
% 209.48/209.72  |- mesh__historyNote mesh__D003062
% 209.48/209.72       91%28%75%29%; was see under RNA, MESSENGER 1975-90   
% 209.48/209.72  |- skos__scopeNote mesh__D003062
% 209.48/209.72       A set of three nucleotides in a protein coding sequence that specifies individual  amino acids or a termination signal %28%CODON, TERMINATOR%29%.  Most codons are universal, but some organisms do not produce the transfer RNAs %28%RNA, TRANSFER%29% complementary to all codons. These codons are referred to as unassigned codons %28%CODONS, NONSENSE%29%.%A%    
% 209.48/209.72  |- mesh__dateCreated mesh__D003062 1999-01-01
% 209.48/209.72  |- skos__hiddenLabel mesh__D003062 Codons
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D003062 2006
% 209.48/209.72  |- skos__related mesh__D003062smesh__D016364
% 209.48/209.72  |- mesh__dateRevised mesh__D003062 2005-06-30
% 209.48/209.72  |- mesh__publicMeSHNote mesh__D003062
% 209.48/209.72       91; was see under RNA, MESSENGER 1975-90   
% 209.48/209.72  |- skos__related mesh__D003062smesh__D005815
% 209.48/209.72  |- skos__broader mesh__D003062smesh__D012333
% 209.48/209.72  |- mesh__recordMaintainer mesh__D003062 nns
% 209.48/209.72  |- rdf__type mesh__D003062sskos__Concept
% 209.48/209.72  |- skos__hiddenLabel mesh__D003062 Codons, Sense
% 209.48/209.72  |- mesh__onlineNote mesh__D003062 search RNA, MESSENGER 1974   
% 209.48/209.72  |- skos__broader mesh__D019357Q000031smesh__D019357
% 209.48/209.72  |- mesh__preferredCombination mesh__D019357Q000031smesh__D002951
% 209.48/209.72  |- rdf__type mesh__D019357Q000031smesh__CompoundConcept
% 209.48/209.72  |- mesh__dateCreated mesh__D016788 1991-05-02
% 209.48/209.72  |- skos__scopeNote mesh__D016788
% 209.48/209.72       A protozoan parasite of rodents transmitted by the mosquito Anopheles stephensi.%A%    
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D016788 2005
% 209.48/209.72  |- mesh__publicMeSHNote mesh__D016788 92   
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D016788 2004
% 209.48/209.72  |- mesh__recordMaintainer mesh__D016788 ags
% 209.48/209.72  |- mesh__dateRevised mesh__D016788 2003-07-09
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D016788 2006
% 209.48/209.72  |- mesh__recordOriginator mesh__D016788 PXP
% 209.48/209.72  |- skos__prefLabel mesh__D016788 Plasmodium chabaudi
% 209.48/209.72  |- mesh__dateEstablished mesh__D016788 1992-01-01
% 209.48/209.72  |- mesh__recordAuthorizer mesh__D016788 sjn
% 209.48/209.72  |- skos__broader mesh__D016788smesh__D010961
% 209.48/209.72  |- rdf__type mesh__D016788sskos__Concept
% 209.48/209.72  |- skos__annotation mesh__D016788
% 209.48/209.72       in rodents; infection: coord IM with MALARIA %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 209.48/209.72  |- mesh__historyNote mesh__D016788 92   
% 209.48/209.72  |- skos__historyNote mesh__D016788 Plasmodium %28%1966-1991%29%
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D041181 2006
% 209.48/209.72  |- mesh__recordOriginator mesh__D041181 ags
% 209.48/209.72  |- rdf__type mesh__D041181sskos__Concept
% 209.48/209.72  |- mesh__publicMeSHNote mesh__D041181 2003   
% 209.48/209.72  |- mesh__dateRevised mesh__D041181 2005-06-30
% 209.48/209.72  |- mesh__recordAuthorizer mesh__D041181 sjn
% 209.48/209.72  |- mesh__recordMaintainer mesh__D041181 SYSTEM
% 209.48/209.72  |- mesh__historyNote mesh__D041181 2003   
% 209.48/209.72  |- mesh__dateCreated mesh__D041181 2002-07-03
% 209.48/209.72  |- skos__historyNote mesh__D041181 Staphylococcus %28%1984-2002%29%
% 209.48/209.72  |- skos__broader mesh__D041181smesh__D013210
% 209.48/209.72  |- skos__scopeNote mesh__D041181
% 209.48/209.72       A species of STAPHYLOCOCCUS similar to STAPHYLOCOCCUS  HAEMOLYTICUS, but containing different esterases. The subspecies Staphylococcus hominis novobiosepticus is highly virulent and novobiocin resistant.%A%    
% 209.48/209.72  |- skos__prefLabel mesh__D041181 Staphylococcus hominis
% 209.48/209.72  |- mesh__dateEstablished mesh__D041181 2003-01-01
% 209.48/209.72  |- skos__annotation mesh__D041181
% 209.48/209.72       infection: coord IM with STAPHYLOCOCCAL INFECTIONS %28%IM%29%; DF: STAPH HAEMOLYTICUS%A%  
% 209.48/209.72  |- skos__broader mesh__D035942smesh__D016601
% 209.48/209.72  |- skos__hiddenLabel mesh__D035942 IRP 2 RNA binding protein
% 209.48/209.72  |- skos__historyNote mesh__D035942 Ribonucleoproteins %28%1995-2002%29%
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D035942 2006
% 209.48/209.72  |- skos__altLabel mesh__D035942 IRP2 Protein
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D035942 2004
% 209.48/209.72  |- skos__broader mesh__D035942smesh__D035925
% 209.48/209.72  |- skos__hiddenLabel mesh__D035942 RNA-binding protein, IRP-2
% 209.48/209.72  |- skos__altLabel mesh__D035942 IREB2 Protein
% 209.48/209.72  |- mesh__activeMeSHYear mesh__D035942 2005
% 209.48/209.72  |- skos__prefLabel mesh__D035942 Iron Regulatory Protein 2
% 209.48/209.72  |- skos__broader mesh__D035942smesh__D000154
% 209.48/209.72  |- skos__historyNote mesh__D035942 Iron-Sulfur Proteins %28%1995-2002%29%
% 209.48/209.72  |- mesh__dateCreated mesh__D035942 2002-07-03
% 209.48/209.72  |- skos__altLabel mesh__D035942 IRP-2 RNA-binding protein
% 209.48/209.72  |- skos__broader mesh__D035942smesh__D007506
% 209.48/209.72  |- rdf__type mesh__D035942sskos__Concept
% 209.48/209.72  |- mesh__dateRevised mesh__D035942 2003-07-09
% 209.48/209.72  |- skos__scopeNote mesh__D035942
% 209.48/209.72       A multifunctional iron-sulfur protein that is both an iron regulatory protein and cytoplasmic form of aconitate hydratase. It binds to iron regulatory elements found on mRNAs involved in iron metabolism and regulates their translation. Its rate of degradation is increased in the presence of IRON.%A%    
% 209.48/209.72  |- skos__altLabel mesh__D035942 Iron-Responsive-Element Binding Protein 2
% 209.48/209.72  |- skos__altLabel mesh__D035942 IRE-BP2
% 209.48/209.72  |- mesh__historyNote mesh__D035942
% 209.48/209.72       2003; for IRON REGULATORY PROTEIN 2, IRE-BP2 %26% IRP-2 RNA-BINDING PROTEIN use IRON-REGULATORY PROTEINS %28%NM%29% 1995-2002%A%  
% 209.58/209.72  |- mesh__dateEstablished mesh__D035942 2003-01-01
% 209.58/209.72  |- mesh__publicMeSHNote mesh__D035942
% 209.58/209.72       2003; IRON REGULATORY PROTEIN 2, IRE-BP2 %26% IRP-2 RNA-BINDING PROTEIN were indexed under RNA-BINDING PROTEINS %26% IRON-SULFUR PROTEINS 1995-2002%A%  
% 209.58/209.72  |- mesh__publicMeSHNote mesh__D002768 88   
% 209.58/209.72  |- skos__scopeNote mesh__D002768
% 209.58/209.72       Surgical formation of an opening %28%stoma%29% into the COMMON BILE DUCT for drainage or for direct communication with a site in the small intestine, primarily the DUODENUM or JEJUNUM.%A%    
% 209.58/209.72  |- mesh__historyNote mesh__D002768 88   
% 209.58/209.72  |- skos__hiddenLabel mesh__D002768 Choledochojejunostomies
% 209.58/209.72  |- mesh__dateRevised mesh__D002768 2003-07-09
% 209.58/209.72  |- skos__hiddenLabel mesh__D002768 Choledochoduodenostomies
% 209.58/209.72  |- skos__altLabel mesh__D002768 Choledojejunostomies
% 209.58/209.72  |- skos__historyNote mesh__D002768 Duodenum/surgery %28%1966-1987%29%
% 209.58/209.72  |- skos__historyNote mesh__D002768 Drainage %28%1966-1987%29%
% 209.58/209.72  |- skos__prefLabel mesh__D002768 Choledochostomy
% 209.58/209.72  |- skos__related mesh__D002768smesh__D017562
% 209.58/209.72  |- skos__historyNote mesh__D002768 Jejunum/surgery %28%1966-1987%29%
% 209.58/209.72  |- skos__historyNote mesh__D002768
% 209.58/209.72       Common Bile Duct Calculi/surgery %28%1966-1987%29%
% 209.58/209.72  |- skos__hiddenLabel mesh__D002768 Choledojejunostomy
% 209.58/209.72  |- skos__hiddenLabel mesh__D002768 Choledochostomies
% 209.58/209.72  |- skos__historyNote mesh__D002768
% 209.58/209.72       Common Bile Duct/surgery %28%1966-1987%29%
% 209.58/209.72  |- skos__broader mesh__D002768smesh__D001662
% 209.58/209.72  |- mesh__activeMeSHYear mesh__D002768 2006
% 209.58/209.72  |- mesh__dateEstablished mesh__D002768 1988-01-01
% 209.58/209.72  |- mesh__recordMaintainer mesh__D002768 lkt
% 209.58/209.72  |- mesh__dateCreated mesh__D002768 1987-03-19
% 209.58/209.72  |- mesh__recordOriginator mesh__D002768 SCD
% 209.58/209.72  |- mesh__recordAuthorizer mesh__D002768 sjn
% 209.58/209.72  |- mesh__activeMeSHYear mesh__D002768 2005
% 209.58/209.72  |- skos__broader mesh__D002768smesh__D000714
% 209.58/209.72  |- rdf__type mesh__D002768sskos__Concept
% 209.58/209.72  |- mesh__activeMeSHYear mesh__D002768 2004
% 209.58/209.72  |- mesh__activeMeSHYear mesh__D029905 2003
% 209.58/209.72  |- skos__annotation mesh__D029905
% 209.58/209.72       PACHYRHIZUS THUNBERGIANUS see PUERARIA; YAM see DIOSCOREA; YAM BEAN, AFRICAN see SPHENOSTYLIS; PSEUDO-YAM see IPOMOEA BATATAS; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.58/209.72  |- mesh__dateEstablished mesh__D029905 2002-01-01
% 209.58/209.72  |- mesh__activeMeSHYear mesh__D029905 2004
% 209.58/209.72  |- skos__prefLabel mesh__D029905 Pachyrhizus
% 209.58/209.72  |- mesh__dateRevised mesh__D029905 2002-07-02
% 209.58/209.72  |- skos__altLabel mesh__D029905 Bean, Yam
% 209.58/209.72  |- mesh__activeMeSHYear mesh__D029905 2005
% 209.58/209.72  |- mesh__historyNote mesh__D029905 2002   
% 209.58/209.72  |- mesh__publicMeSHNote mesh__D029905 2002   
% 209.58/209.72  |- rdf__type mesh__D029905sskos__Concept
% 209.58/209.72  |- skos__broader mesh__D029905smesh__D007887
% 209.58/209.72  |- skos__scopeNote mesh__D029905
% 209.58/209.72       A plant genus of the family FABACEAE. Some Pachyrhizus have been reclassified to PUERARIA. Do not confuse with yam %28%IPOMOEA; or DIOSCOREA%29% or African yam bean %28%SPHENOSTYLIS%29%.%A%    
% 209.58/209.72  |- skos__altLabel mesh__D029905 Jicama
% 209.58/209.72  |- mesh__activeMeSHYear mesh__D029905 2006
% 209.58/209.72  |- mesh__dateCreated mesh__D029905 2001-07-25
% 209.58/209.72  |- skos__historyNote mesh__D021922 Aortic Valve Stenosis %28%1972-2000%29%
% 209.58/209.72  |- mesh__activeMeSHYear mesh__D021922 2001
% 209.58/209.72  |- mesh__dateCreated mesh__D021922 2000-07-06
% 209.58/209.72  |- mesh__dateEstablished mesh__D021922 2001-01-01
% 209.58/209.72  |- skos__altLabel mesh__D021922 Subaortic Stenosis, Discrete
% 209.58/209.72  |- skos__hiddenLabel mesh__D021922 Subaortic Stenoses, Discrete
% 209.58/209.73  |- skos__hiddenLabel mesh__D021922 Discrete Subaortic Stenoses
% 209.58/209.73  |- skos__scopeNote mesh__D021922
% 209.58/209.73       An anatomic alteration in the mitral valve apparatus and interventricular septum leading to obstruction of left ventricular outflow. %28%from Eur J Cardiothorac Surg 1998;14%28%3%29%:296-303%29%%A%    
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D021922 2004
% 209.58/209.73  |- mesh__historyNote mesh__D021922
% 209.58/209.73       2001; use AORTIC VALVE STENOSIS 1986-2000   
% 209.58/209.73  |- skos__hiddenLabel mesh__D021922 Stenoses, Discrete Subaortic
% 209.58/209.73  |- mesh__recordOriginator mesh__D021922 nns
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D021922 2003
% 209.58/209.73  |- mesh__publicMeSHNote mesh__D021922
% 209.58/209.73       2001; see AORTIC VALVE STENOSIS 1986-2000   
% 209.58/209.73  |- rdf__type mesh__D021922sskos__Concept
% 209.58/209.73  |- skos__historyNote mesh__D021922
% 209.58/209.73       Aortic Stenosis, Subvalvular %28%1986-2000%29%
% 209.58/209.73  |- skos__broader mesh__D021922smesh__D001020
% 209.58/209.73  |- skos__hiddenLabel mesh__D021922 Stenosis, Discrete Subaortic
% 209.58/209.73  |- mesh__recordMaintainer mesh__D021922 nns
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D021922 2002
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D021922 2006
% 209.58/209.73  |- skos__prefLabel mesh__D021922 Discrete Subaortic Stenosis
% 209.58/209.73  |- mesh__recordAuthorizer mesh__D021922 ags
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D021922 2005
% 209.58/209.73  |- skos__hiddenLabel mesh__D007453
% 209.58/209.73       Triiodothyronine 5%27%-Deiodinase, Reverse
% 209.58/209.73  |- mesh__recordMaintainer mesh__D007453 sjn
% 209.58/209.73  |- skos__scopeNote mesh__D007453
% 209.58/209.73       A hemeprotein that catalyzes the oxidation of the iodide radical to iodine with the subsequent iodination of many organic compounds, particularly proteins. EC 1.11.1.8.%A%    
% 209.58/209.73  |- mesh__recordOriginator mesh__D007453 RLS
% 209.58/209.73  |- skos__historyNote mesh__D007453 Peroxidases %28%1973-1975%29%
% 209.58/209.73  |- skos__historyNote mesh__D007453 Iodotyrosine %28%1973-1975%29%
% 209.58/209.73  |- skos__historyNote mesh__D007453 Iodides %28%1973-1975%29%
% 209.58/209.73  |- mesh__historyNote mesh__D007453
% 209.58/209.73       86%28%76%29%; was see under PEROXIDASES 1976-85   
% 209.58/209.73  |- skos__hiddenLabel mesh__D007453 5%27%-Deiodinase, Iodothyronine
% 209.58/209.73  |- skos__hiddenLabel mesh__D007453 Deiodinase, Triiodothyronine
% 209.58/209.73  |- skos__hiddenLabel mesh__D007453 Peroxidase, Thyroid
% 209.58/209.73  |- skos__hiddenLabel mesh__D007453
% 209.58/209.73       Reverse Triiodothyronine 5%27% Deiodinase
% 209.58/209.73  |- mesh__publicMeSHNote mesh__D007453
% 209.58/209.73       86; was see under PEROXIDASES 1976-85   
% 209.58/209.73  |- mesh__recordAuthorizer mesh__D007453 sjn
% 209.58/209.73  |- skos__hiddenLabel mesh__D007453 Deiodase, Iodotyrosine
% 209.58/209.73  |- mesh__dateEstablished mesh__D007453 1986-01-01
% 209.58/209.73  |- rdf__type mesh__D007453sskos__Concept
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D007453 2006
% 209.58/209.73  |- skos__annotation mesh__D007453
% 209.58/209.73       /defic: consider also MONOIODOTYROSINE /metab %28%IM%29% + AMINO ACID METABOLISM, INBORN ERRORS %28%IM%29% + CONGENITAL HYPOTHYROIDISM%A%  
% 209.58/209.73  |- skos__prefLabel mesh__D007453 Iodide Peroxidase
% 209.58/209.73  |- skos__altLabel mesh__D007453 5%27%-Deiodinase
% 209.58/209.73  |- skos__hiddenLabel mesh__D007453 Deiodinase, Iodotyrosine
% 209.58/209.73  |- skos__altLabel mesh__D007453 Thyroid Peroxidase
% 209.58/209.73  |- skos__hiddenLabel mesh__D007453 5%27%-Deiodinase, Thyroxine
% 209.58/209.73  |- skos__hiddenLabel mesh__D007453
% 209.58/209.73       5%27%-Deiodinase, Reverse Triiodothyronine
% 209.58/209.73  |- skos__altLabel mesh__D007453 Deiodinase
% 209.58/209.73  |- skos__hiddenLabel mesh__D007453 T4 5%27% Deiodinase
% 209.58/209.73  |- skos__broader mesh__D007453smesh__D010544
% 209.58/209.73  |- skos__hiddenLabel mesh__D007453 Peroxidase, Iodide
% 209.58/209.73  |- skos__hiddenLabel mesh__D007453 Iodothyronine 5%27% Deiodinase
% 209.58/209.73  |- mesh__dateCreated mesh__D007453 1975-07-18
% 209.58/209.73  |- skos__hiddenLabel mesh__D007453 T4 Monodeiodinase
% 209.58/209.73  |- skos__hiddenLabel mesh__D007453 Tetraiodothyronine 5%27% Deiodinase
% 209.58/209.73  |- skos__hiddenLabel mesh__D007453 Thyroxine 5%27% Monodeiodinase
% 209.58/209.73  |- skos__hiddenLabel mesh__D007453 Thyroxine 5%27% Deiodinase
% 209.58/209.73  |- skos__hiddenLabel mesh__D007453 Deiodinase, Iodothyronine
% 209.58/209.73  |- skos__altLabel mesh__D007453 Iodotyrosine Deiodinase
% 209.58/209.73  |- skos__hiddenLabel mesh__D007453 5%27% Deiodinase
% 209.58/209.73  |- skos__altLabel mesh__D007453 Iodotyrosine Deiodase
% 209.58/209.73  |- mesh__dateRevised mesh__D007453 2005-07-01
% 209.58/209.73  |- skos__altLabel mesh__D007453 T4-5%27%-Deiodinase
% 209.58/209.73  |- skos__hiddenLabel mesh__D007453 Enzyme, Thyroxine Converting
% 209.58/209.73  |- skos__hiddenLabel mesh__D007453 5%27%-Monodeiodinase, Thyroxine
% 209.58/209.73  |- skos__altLabel mesh__D007453 Monodeiodinase
% 209.58/209.73  |- skos__altLabel mesh__D007453 Iodinase
% 209.58/209.73  |- skos__hiddenLabel mesh__D007453 5%27%-Deiodinase, Tetraiodothyronine
% 209.58/209.73  |- mesh__publicMeSHNote mesh__D012398
% 209.58/209.73       91; was see under ALPHAVIRUSES 1981-90; was see under ARBOVIRUSES 1975-80%A%  
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D012398 2006
% 209.58/209.73  |- mesh__dateRevised mesh__D012398 2005-06-30
% 209.58/209.73  |- skos__hiddenLabel mesh__D012398 virus, Ross River
% 209.58/209.73  |- mesh__dateEstablished mesh__D012398 1991-01-01
% 209.58/209.73  |- mesh__recordAuthorizer mesh__D012398 sjn
% 209.58/209.73  |- skos__prefLabel mesh__D012398 Ross River virus
% 209.58/209.73  |- mesh__recordMaintainer mesh__D012398 ags
% 209.58/209.73  |- rdf__type mesh__D012398sskos__Concept
% 209.58/209.73  |- mesh__historyNote mesh__D012398
% 209.58/209.73       91%28%75%29%; was see under ALPHAVIRUSES 1981-90; was see under ARBOVIRUSES 1975-80%A%  
% 209.58/209.73  |- mesh__recordOriginator mesh__D012398 NLM
% 209.58/209.73  |- mesh__dateCreated mesh__D012398 1974-12-12
% 209.58/209.73  |- skos__hiddenLabel mesh__D012398 virus, Sagiyama
% 209.58/209.73  |- skos__scopeNote mesh__D012398
% 209.58/209.73       A species of ALPHAVIRUS associated with epidemic EXANTHEMA and polyarthritis in Australia.%A%    
% 209.58/209.73  |- skos__broader mesh__D012398smesh__D000524
% 209.58/209.73  |- skos__annotation mesh__D012398
% 209.58/209.73       infection: coord IM with ALPHAVIRUS INFECTIONS %28%IM%29%   
% 209.58/209.73  |- skos__scopeNote mesh__D017881
% 209.58/209.73       A genus of gram-negative, aerobic, rod-shaped bacteria whose organisms are part of the normal flora of the mucous membranes of the upper respiratory tract. Some species are pathogenic for man.%A%    
% 209.58/209.73  |- skos__historyNote mesh__D017881 Moraxella %28%1969-1988%29%
% 209.58/209.73  |- mesh__recordMaintainer mesh__D017881 SYSTEM
% 209.58/209.73  |- mesh__publicMeSHNote mesh__D017881 94   
% 209.58/209.73  |- mesh__dateEstablished mesh__D017881 1994-01-01
% 209.58/209.73  |- rdf__type mesh__D017881sskos__Concept
% 209.58/209.73  |- skos__historyNote mesh__D017881 Neisseriaceae %28%1983-1993%29%
% 209.58/209.73  |- mesh__recordAuthorizer mesh__D017881 sjn
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D017881 2006
% 209.58/209.73  |- skos__prefLabel mesh__D017881 Kingella
% 209.58/209.73  |- mesh__recordOriginator mesh__D017881 PXP
% 209.58/209.73  |- skos__annotation mesh__D017881
% 209.58/209.73       bacterium of upper resp mucous membranes; infection: coord IM with NEISSERIACEAE INFECTIONS %28%IM%29%%A%  
% 209.58/209.73  |- mesh__dateCreated mesh__D017881 1993-06-03
% 209.58/209.73  |- skos__broader mesh__D017881smesh__D009346
% 209.58/209.73  |- mesh__dateRevised mesh__D017881 2005-06-30
% 209.58/209.73  |- mesh__historyNote mesh__D017881 94   
% 209.58/209.73  |- skos__broader mesh__D017083smesh__D008163
% 209.58/209.73  |- skos__hiddenLabel mesh__D017083 Chemoluminescence Measurement
% 209.58/209.73  |- skos__altLabel mesh__D017083 Chemiluminescence Measurements
% 209.58/209.73  |- rdf__type mesh__D017083sskos__Concept
% 209.58/209.73  |- skos__hiddenLabel mesh__D017083 Measurement, Chemiluminescence
% 209.58/209.73  |- mesh__recordOriginator mesh__D017083 TGC
% 209.58/209.73  |- skos__prefLabel mesh__D017083 Chemiluminescent Measurements
% 209.58/209.73  |- skos__hiddenLabel mesh__D017083 Measurements, Chemiluminescence
% 209.58/209.73  |- skos__hiddenLabel mesh__D017083 Assays, Chemiluminescent
% 209.58/209.73  |- mesh__historyNote mesh__D017083 2005%28%1993%29%   
% 209.58/209.73  |- skos__altLabel mesh__D017083 Chemiluminescent Assays
% 209.58/209.73  |- skos__historyNote mesh__D017083 Luminescence %28%1966-1992%29%
% 209.58/209.73  |- mesh__recordAuthorizer mesh__D017083 sjn
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D017083 2005
% 209.58/209.73  |- skos__hiddenLabel mesh__D017083 Chemiluminescence Measurement
% 209.58/209.73  |- skos__hiddenLabel mesh__D017083 Measurements, Chemoluminescence
% 209.58/209.73  |- skos__hiddenLabel mesh__D017083 Measurements, Chemiluminescent
% 209.58/209.73  |- mesh__publicMeSHNote mesh__D017083
% 209.58/209.73       2005; see CHEMILUMINESCENCE 1993-2004   
% 209.58/209.73  |- skos__scopeNote mesh__D017083
% 209.58/209.73       Measurement of light resulting from PHYSICAL CHEMILUMINESCENCE such as from LUMINESCENT PROTEINS and LUMINESCENT AGENTS.%A%    
% 209.58/209.73  |- skos__hiddenLabel mesh__D017083 Measurement, Chemoluminescence
% 209.58/209.73  |- skos__hiddenLabel mesh__D017083 Measurement, Chemiluminescent
% 209.58/209.73  |- mesh__dateCreated mesh__D017083 1992-05-07
% 209.58/209.73  |- mesh__dateEstablished mesh__D017083 1993-01-01
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D017083 2006
% 209.58/209.73  |- mesh__dateRevised mesh__D017083 2004-07-13
% 209.58/209.73  |- skos__hiddenLabel mesh__D017083 Assay, Chemiluminescent
% 209.58/209.73  |- skos__hiddenLabel mesh__D017083 Chemiluminescent Assay
% 209.58/209.73  |- mesh__recordMaintainer mesh__D017083 sjn
% 209.58/209.73  |- skos__altLabel mesh__D017083 Chemoluminescence Measurements
% 209.58/209.73  |- skos__hiddenLabel mesh__D017083 Chemiluminescent Measurement
% 209.58/209.73  |- skos__hiddenLabel mesh__D003861 Disorders, Depersonalization
% 209.58/209.73  |- skos__hiddenLabel mesh__D003861 Disorder, Depersonalization
% 209.58/209.73  |- mesh__dateRevised mesh__D003861 2002-07-03
% 209.58/209.73  |- skos__prefLabel mesh__D003861 Depersonalization
% 209.58/209.73  |- mesh__recordOriginator mesh__D003861 NLM
% 209.58/209.73  |- mesh__publicMeSHNote mesh__D003861
% 209.58/209.73       98; see DEPERSONALIZATION DISORDER 1963-80; see DEPERSONALIZATION 1963-80%A%  
% 209.58/209.73  |- mesh__recordAuthorizer mesh__D003861 sjn
% 209.58/209.73  |- skos__hiddenLabel mesh__D003861 Derealizations
% 209.58/209.73  |- mesh__recordMaintainer mesh__D003861 jls
% 209.58/209.73  |- skos__hiddenLabel mesh__D003861 Depersonalizations
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D003861 2004
% 209.58/209.73  |- mesh__dateCreated mesh__D003861 1999-01-01
% 209.58/209.73  |- rdf__type mesh__D003861sskos__Concept
% 209.58/209.73  |- mesh__historyNote mesh__D003861 98%28%63%29%   
% 209.58/209.73  |- skos__hiddenLabel mesh__D003861 Depersonalization Disorders
% 209.58/209.73  |- skos__scopeNote mesh__D003861
% 209.58/209.73       State in which an individual perceives or experiences a sensation of unreality concerning the self or the environment; it is seen in disorders such as schizophrenia, affection disorders, organic mental disorders, and personality disorders. %28%APA, Thesaurus of Psychological Index Terms, 8th ed.%29%%A%    
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D003861 2003
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D003861 2006
% 209.58/209.73  |- skos__broader mesh__D003861smesh__D001526
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D003861 2005
% 209.58/209.73  |- skos__broader mesh__D003063smesh__D007448
% 209.58/209.73  |- skos__related mesh__D003063smesh__D003064
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D003063 2005
% 209.58/209.73  |- skos__prefLabel mesh__D003063 Cnidaria
% 209.58/209.73  |- mesh__dateCreated mesh__D003063 1999-01-01
% 209.58/209.73  |- mesh__recordOriginator mesh__D003063 NLM
% 209.58/209.73  |- skos__altLabel mesh__D003063 Cnidarians
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D003063 2006
% 209.58/209.73  |- mesh__dateRevised mesh__D003063 2003-07-09
% 209.58/209.73  |- mesh__recordMaintainer mesh__D003063 ags
% 209.58/209.73  |- mesh__recordAuthorizer mesh__D003063 sjn
% 209.58/209.73  |- mesh__publicMeSHNote mesh__D003063 1995; see COELENTERATA 1963-1994   
% 209.58/209.73  |- rdf__type mesh__D003063sskos__Concept
% 209.58/209.73  |- skos__scopeNote mesh__D003063
% 209.58/209.73       A phylum of radially symmetrical invertebrates characterized by possession of stinging cells called nematocysts. It includes the classes ANTHOZOA; CUBOZOA; HYDROZOA, and SCYPHOZOA. Members carry CNIDARIAN VENOMS.%A%    
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D003063 2004
% 209.58/209.73  |- mesh__historyNote mesh__D003063 1995 %28%1963%29%   
% 209.58/209.73  |- skos__annotation mesh__D003063
% 209.58/209.73       poisoning: coord with CNIDARIAN VENOMS if pertinent   
% 209.58/209.73  |- mesh__recordAuthorizer mesh__D016789 sjn
% 209.58/209.73  |- skos__prefLabel mesh__D016789 Plasmodium cynomolgi
% 209.58/209.73  |- skos__broader mesh__D016789smesh__D010961
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D016789 2005
% 209.58/209.73  |- skos__annotation mesh__D016789
% 209.58/209.73       in macaques; infection: coord IM with MALARIA %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D016789 2006
% 209.58/209.73  |- mesh__recordOriginator mesh__D016789 PXP
% 209.58/209.73  |- mesh__dateCreated mesh__D016789 1991-05-02
% 209.58/209.73  |- mesh__recordMaintainer mesh__D016789 sjn
% 209.58/209.73  |- mesh__publicMeSHNote mesh__D016789 92   
% 209.58/209.73  |- rdf__type mesh__D016789sskos__Concept
% 209.58/209.73  |- skos__scopeNote mesh__D016789
% 209.58/209.73       A protozoan parasite that occurs naturally in the macaque. It is similar to PLASMODIUM VIVAX and produces a type of malaria similar to vivax malaria %28%MALARIA, VIVAX%29%. This species has been found to give rise to both natural and experimental human infections.%A%    
% 209.58/209.73  |- mesh__dateRevised mesh__D016789 2004-07-13
% 209.58/209.73  |- mesh__historyNote mesh__D016789 92   
% 209.58/209.73  |- skos__historyNote mesh__D016789 Plasmodium %28%1966-1991%29%
% 209.58/209.73  |- mesh__dateEstablished mesh__D016789 1992-01-01
% 209.58/209.73  |- mesh__onlineNote mesh__D002769
% 209.58/209.73       to search for chem composition of biliary calculi, use CHOLELITHIASIS/anal 1987-90 %26% CHOLELITHIASIS/metab 1966-86%A%  
% 209.58/209.73  |- mesh__recordOriginator mesh__D002769 NLM
% 209.58/209.73  |- skos__annotation mesh__D002769
% 209.58/209.73       CHOLECYSTOLITHIASIS and CHOLEDOCHOLITHIASIS are also available%A%  
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D002769 2006
% 209.58/209.73  |- mesh__dateCreated mesh__D002769 1999-01-01
% 209.58/209.73  |- skos__scopeNote mesh__D002769
% 209.58/209.73       Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder %28%CHOLECYSTOLITHIASIS%29% or the common bile duct %28%CHOLEDOCHOLITHIASIS%29%.%A%    
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D002769 2005
% 209.58/209.73  |- rdf__type mesh__D002769sskos__Concept
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D002769 2004
% 209.58/209.73  |- skos__hiddenLabel mesh__D002769 Cholelithiases
% 209.58/209.73  |- skos__broader mesh__D002769smesh__D001660
% 209.58/209.73  |- mesh__recordMaintainer mesh__D002769 lkt
% 209.58/209.73  |- mesh__recordAuthorizer mesh__D002769 sjn
% 209.58/209.73  |- mesh__dateRevised mesh__D002769 2003-07-09
% 209.58/209.73  |- skos__prefLabel mesh__D002769 Cholelithiasis
% 209.58/209.73  |- skos__hiddenLabel mesh__D013491 T-Cell Factors, Suppressor
% 209.58/209.73  |- mesh__publicMeSHNote mesh__D013491 86   
% 209.58/209.73  |- mesh__recordAuthorizer mesh__D013491 sjn
% 209.58/209.73  |- mesh__dateEstablished mesh__D013491 1986-01-01
% 209.58/209.73  |- skos__hiddenLabel mesh__D013491 Suppressive Factors, T-Cell
% 209.58/209.73  |- skos__altLabel mesh__D013491 T-Suppressor Factors
% 209.58/209.73  |- mesh__recordOriginator mesh__D013491 SH
% 209.58/209.73  |- skos__broader mesh__D013491smesh__D008222
% 209.58/209.73  |- skos__historyNote mesh__D013491 Lymphokines %28%1966-1985%29%
% 209.58/209.73  |- skos__hiddenLabel mesh__D013491 Factors, T-Cell Suppressive
% 209.58/209.73  |- skos__altLabel mesh__D013491 Factors, T Suppressor
% 209.58/209.73  |- skos__altLabel mesh__D013491 T Cell Suppressor Factors
% 209.58/209.73  |- mesh__dateCreated mesh__D013491 1985-06-14
% 209.58/209.73  |- skos__prefLabel mesh__D013491 Suppressor Factors, Immunologic
% 209.58/209.73  |- mesh__dateRevised mesh__D013491 2005-06-30
% 209.58/209.73  |- skos__historyNote mesh__D013491 Suppressor Cells %28%1979-1985%29%
% 209.58/209.73  |- skos__hiddenLabel mesh__D013491 Suppressor T Cell Factors
% 209.58/209.73  |- rdf__type mesh__D013491sskos__Concept
% 209.58/209.73  |- skos__hiddenLabel mesh__D013491 Factors, Suppressor T-Cell
% 209.58/209.73  |- skos__hiddenLabel mesh__D013491 T Suppressor Factors
% 209.58/209.73  |- skos__altLabel mesh__D013491 Immunologic Suppressor Factors
% 209.58/209.73  |- skos__hiddenLabel mesh__D013491 Factors, T-Suppressor
% 209.58/209.73  |- skos__altLabel mesh__D013491 T-Cell Suppressive Factors
% 209.58/209.73  |- mesh__recordMaintainer mesh__D013491 ssb
% 209.58/209.73  |- skos__scopeNote mesh__D013491
% 209.58/209.73       Proteins, protein complexes, or glycoproteins secreted by suppressor T-cells that inhibit either subsequent T-cells, B-cells, or other immunologic phenomena. Some of these factors have both histocompatibility %28%I-J%29% and antigen-specific domains which may be linked by disulfide bridges. They can be elicited by haptens or other antigens and may be mass-produced by hybridomas or monoclones in the laboratory.%A%    
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D013491 2006
% 209.58/209.73  |- skos__annotation mesh__D013491
% 209.58/209.73       lymphokines; /biosyn /drug eff /physiol /ultrastruct permitted; DF: SUPPRESSOR FACTORS IMMUNOL%A%  
% 209.58/209.73  |- skos__hiddenLabel mesh__D013491 Suppressor Factors, T
% 209.58/209.73  |- skos__hiddenLabel mesh__D013491 T Cell Suppressive Factors
% 209.58/209.73  |- skos__altLabel mesh__D013491 Factors, Immunologic Suppressor
% 209.58/209.73  |- mesh__historyNote mesh__D013491 86   
% 209.58/209.73  |- skos__altLabel mesh__D013491 Suppressor T-Cell Factors
% 209.58/209.73  |- mesh__historyNote mesh__D029906 2002   
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D029906 2006
% 209.58/209.73  |- skos__broader mesh__D029906smesh__D007887
% 209.58/209.73  |- skos__annotation mesh__D029906
% 209.58/209.73       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.58/209.73  |- mesh__dateEstablished mesh__D029906 2002-01-01
% 209.58/209.73  |- skos__altLabel mesh__D029906 Calabar Bean
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D029906 2005
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D029906 2004
% 209.58/209.73  |- mesh__publicMeSHNote mesh__D029906 2002   
% 209.58/209.73  |- skos__scopeNote mesh__D029906
% 209.58/209.73       A plant genus of the family FABACEAE that is a source of PHYSOSTIGMINE.%A%    
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D029906 2003
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D029906 2002
% 209.58/209.73  |- skos__prefLabel mesh__D029906 Physostigma
% 209.58/209.73  |- rdf__type mesh__D029906sskos__Concept
% 209.58/209.73  |- mesh__dateCreated mesh__D029906 2001-07-25
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D007454 1997
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D007454 1994
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D007454 2003
% 209.58/209.73  |- skos__scopeNote mesh__D007454
% 209.58/209.73       Inorganic binary compounds of iodine or the I- ion.     
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D007454 1995
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D007454 2004
% 209.58/209.73  |- rdf__type mesh__D007454sskos__Concept
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D007454 2002
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D007454 1998
% 209.58/209.73  |- mesh__dateCreated mesh__D007454 1999-01-01
% 209.58/209.73  |- mesh__dateRevised mesh__D007454 1993-06-02
% 209.58/209.73  |- skos__prefLabel mesh__D007454 Iodides
% 209.58/209.73  |- mesh__recordAuthorizer mesh__D007454 PLS
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D007454 1999
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D007454 2005
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D007454 2000
% 209.58/209.73  |- skos__broader mesh__D007454smesh__D017613
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D007454 1996
% 209.58/209.73  |- skos__annotation mesh__D007454 inorganic cpds or iodide ion only   
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D007454 2006
% 209.58/209.73  |- skos__broader mesh__D007454smesh__D000838
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D007454 2001
% 209.58/209.73  |- mesh__recordOriginator mesh__D007454 NLM
% 209.58/209.73  |- mesh__recordMaintainer mesh__D007454 TPW
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D012399 2006
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D012399 2000
% 209.58/209.73  |- mesh__historyNote mesh__D012399 68   
% 209.58/209.73  |- mesh__dateEstablished mesh__D012399 1968-01-01
% 209.58/209.73  |- skos__historyNote mesh__D012399 Aerospace Medicine %28%1966-1967%29%
% 209.58/209.73  |- skos__scopeNote mesh__D012399
% 209.58/209.73       Motion of a rigid body in which either one point is fixed, or all the points on a straight line are fixed. It is also the motion of a particle about a fixed point. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D012399 2001
% 209.58/209.73  |- skos__hiddenLabel mesh__D012399 Rotations
% 209.58/209.73  |- rdf__type mesh__D012399sskos__Concept
% 209.58/209.73  |- mesh__dateRevised mesh__D012399 1998-06-11
% 209.58/209.73  |- mesh__dateCreated mesh__D012399 1999-01-01
% 209.58/209.73  |- skos__historyNote mesh__D012399 Acceleration %28%1966-1967%29%
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D012399 1999
% 209.58/209.73  |- skos__prefLabel mesh__D012399 Rotation
% 209.58/209.73  |- mesh__recordAuthorizer mesh__D012399 SJN
% 209.58/209.73  |- skos__related mesh__D012399smesh__D002498
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D012399 2002
% 209.58/209.73  |- skos__broader mesh__D012399smesh__D009038
% 209.58/209.73  |- skos__related mesh__D012399smesh__D018470
% 209.58/209.73  |- skos__hiddenLabel mesh__D012399 Clinorotations
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D012399 2003
% 209.58/209.73  |- mesh__recordMaintainer mesh__D012399 JLS
% 209.58/209.73  |- mesh__recordOriginator mesh__D012399 NLM
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D012399 2005
% 209.58/209.73  |- skos__annotation mesh__D012399
% 209.58/209.73       /adv eff permitted; rotation of a body part on its axis is TORSION%A%  
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D012399 2004
% 209.58/209.73  |- mesh__publicMeSHNote mesh__D012399 68   
% 209.58/209.73  |- skos__altLabel mesh__D017882 Kingella kingii
% 209.58/209.73  |- skos__annotation mesh__D017882
% 209.58/209.73       formerly called Moraxella kingae; infection: coord IM with NEISSERIACEAE INFECTIONS %28%IM%29%%A%  
% 209.58/209.73  |- mesh__dateRevised mesh__D017882 2005-06-30
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D017882 2006
% 209.58/209.73  |- rdf__type mesh__D017882sskos__Concept
% 209.58/209.73  |- mesh__dateCreated mesh__D017882 1993-06-30
% 209.58/209.73  |- mesh__publicMeSHNote mesh__D017882 94   
% 209.58/209.73  |- mesh__recordOriginator mesh__D017882 PXP
% 209.58/209.73  |- mesh__dateEstablished mesh__D017882 1994-01-01
% 209.58/209.73  |- skos__historyNote mesh__D017882 Neisseriaceae %28%1983-1993%29%
% 209.58/209.73  |- skos__altLabel mesh__D017882 Moraxella kingii
% 209.58/209.73  |- mesh__recordAuthorizer mesh__D017882 sjn
% 209.58/209.73  |- skos__altLabel mesh__D017882 Moraxella kingae
% 209.58/209.73  |- mesh__historyNote mesh__D017882 94   
% 209.58/209.73  |- skos__broader mesh__D017882smesh__D017881
% 209.58/209.73  |- skos__scopeNote mesh__D017882
% 209.58/209.73       A species of gram-negative, aerobic, rod-shaped bacteria which is distinguished from other members of the genus KINGELLA by its beta hemolysis. It occurs normally in human mucous membranes of the upper respiratory tract, but can cause septic arthritis and endocarditis. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 209.58/209.73  |- skos__historyNote mesh__D017882 Moraxella %28%1969-1988%29%
% 209.58/209.73  |- skos__prefLabel mesh__D017882 Kingella kingae
% 209.58/209.73  |- mesh__recordMaintainer mesh__D017882 SYSTEM
% 209.58/209.73  |- skos__hiddenLabel mesh__D017084 Spontaneous Otoacoustic Emissions
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D017084 2002
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D017084 1995
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D017084 2003
% 209.58/209.73  |- mesh__historyNote mesh__D017084 93   
% 209.58/209.73  |- skos__historyNote mesh__D017084 Acoustics %28%1984-1992%29%
% 209.58/209.73  |- skos__historyNote mesh__D017084 Cochlea %28%1983-1992%29%
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D017084 2005
% 209.58/209.73  |- skos__hiddenLabel mesh__D017084 Spontaneous Otoacoustic Emission
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D017084 2004
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D017084 2000
% 209.58/209.73  |- skos__historyNote mesh__D017084 Acoustic Stimulation %28%1984-1992%29%
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D017084 2006
% 209.58/209.73  |- skos__scopeNote mesh__D017084
% 209.58/209.73       Sinusoidal tones originating in the cochlea. These faint sounds, with levels between 10-30 decibels, are usually not recognized by the persons having them. However, the emissions can be recorded using sensitive microphones placed in the ear canals. The clinical significance of having or not having spontaneous otoacoustic emissions is unclear; however, some association between tinnitus and the spontaneous emissions has been reported.%A%    
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D017084 1996
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D017084 2001
% 209.58/209.73  |- skos__hiddenLabel mesh__D017084 Otoacoustic Emission, Spontaneous
% 209.58/209.73  |- mesh__dateCreated mesh__D017084 1992-05-22
% 209.58/209.73  |- skos__annotation mesh__D017084
% 209.58/209.73       note category; faint microphone-recordable sounds emitted by the cochlea%A%  
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D017084 1998
% 209.58/209.73  |- mesh__publicMeSHNote mesh__D017084 93   
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D017084 1997
% 209.58/209.73  |- skos__broader mesh__D017084smesh__D006309
% 209.58/209.73  |- skos__hiddenLabel mesh__D017084 Emissions, Spontaneous Otoacoustic
% 209.58/209.73  |- skos__prefLabel mesh__D017084 Otoacoustic Emissions, Spontaneous
% 209.58/209.73  |- rdf__type mesh__D017084sskos__Concept
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D017084 1994
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D017084 1993
% 209.58/209.73  |- mesh__dateEstablished mesh__D017084 1993-01-01
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D017084 1999
% 209.58/209.73  |- skos__hiddenLabel mesh__D017084 Emission, Spontaneous Otoacoustic
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D003862 1996
% 209.58/209.73  |- skos__scopeNote mesh__D003862
% 209.58/209.73       Decline in value of capital assets of a permanent or fixed nature over time with use.%A%    
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D003862 2000
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D003862 2003
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D003862 2001
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D003862 1997
% 209.58/209.73  |- skos__prefLabel mesh__D003862 Depreciation
% 209.58/209.73  |- mesh__recordOriginator mesh__D003862 EC
% 209.58/209.73  |- mesh__recordMaintainer mesh__D003862 TGC
% 209.58/209.73  |- rdf__type mesh__D003862sskos__Concept
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D003862 2004
% 209.58/209.73  |- skos__hiddenLabel mesh__D003862 Depreciations
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D003862 1998
% 209.58/209.73  |- mesh__dateRevised mesh__D003862 1992-05-14
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D003862 1993
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D003862 2002
% 209.58/209.73  |- mesh__dateEstablished mesh__D003862 1991-01-01
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D003862 2005
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D003862 1994
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D003862 1999
% 209.58/209.73  |- skos__broader mesh__D003862smesh__D000066
% 209.58/209.73  |- mesh__publicMeSHNote mesh__D003862
% 209.58/209.73       91; was see under ACCOUNTING 1978-90   
% 209.58/209.73  |- skos__annotation mesh__D003862 NIM   
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D003862 2006
% 209.58/209.73  |- mesh__activeMeSHYear mesh__D003862 1995
% 209.58/209.73  |- mesh__historyNote mesh__D003862
% 209.58/209.73       91%28%78%29%; was see under ACCOUNTING 1978-90   
% 209.58/209.73  |- mesh__dateCreated mesh__D003862 1977-05-05
% 209.58/209.73  |- mesh__recordAuthorizer mesh__D003862 PLS
% 209.58/209.73  |- mesh__dateEstablished mesh__D003064 1978-01-01
% 209.58/209.73  |- mesh__dateCreated mesh__D003064 1977-04-22
% 209.58/209.73  |- skos__annotation mesh__D003064
% 209.58/209.73       /antag permitted but consider also ANTIVENINS; coordinate with specific Cnidaria source%A%  
% 209.58/209.73  |- skos__hiddenLabel mesh__D003064 Venoms, Sea Anemone
% 209.58/209.73  |- skos__historyNote mesh__D003064 Coelenterata %28%1966-1977%29%
% 209.58/209.73  |- skos__hiddenLabel mesh__D003064 Venoms, Cnidarian
% 209.58/209.73  |- skos__hiddenLabel mesh__D003064 Venom, Cnidarian
% 209.58/209.73  |- mesh__dateRevised mesh__D003064 2005-06-30
% 209.58/209.73  |- rdf__type mesh__D003064sskos__Concept
% 209.58/209.73  |- skos__hiddenLabel mesh__D003064 Portuguese Man of War Venom
% 209.58/209.73  |- skos__prefLabel mesh__D003064 Cnidarian Venoms
% 209.58/209.73  |- mesh__publicMeSHNote mesh__D003064
% 209.58/209.73       95; was COELENTERATE VENOMS 1978-94   
% 209.58/209.73  |- mesh__onlineNote mesh__D003064
% 209.58/209.73       use CNIDARIAN VENOMS to search COELENTERATE VENOMS 1978-94%A%  
% 209.58/209.73  |- skos__hiddenLabel mesh__D003064 Venoms, Jellyfish
% 209.58/209.74  |- skos__altLabel mesh__D003064 Jellyfish Venom
% 209.58/209.74  |- skos__hiddenLabel mesh__D003064 Venom, Chironex
% 209.58/209.74  |- skos__altLabel mesh__D003064 Sea Anemone Venoms
% 209.58/209.74  |- skos__scopeNote mesh__D003064
% 209.58/209.74       Venoms from jellyfish; CORALS; SEA ANEMONES; etc. They contain hemo-, cardio-, dermo- , and neuro-toxic substances and probably ENZYMES. They include palytoxin, sarcophine, and anthopleurine.%A%    
% 209.58/209.74  |- mesh__recordOriginator mesh__D003064 SH
% 209.58/209.74  |- skos__hiddenLabel mesh__D003064 Venom, Jellyfish
% 209.58/209.74  |- skos__historyNote mesh__D003064 Venoms %28%1966-1977%29%
% 209.58/209.74  |- skos__hiddenLabel mesh__D003064 Venom, Portuguese Man-of-War
% 209.58/209.74  |- skos__hiddenLabel mesh__D003064 Venoms, Chironex
% 209.58/209.74  |- skos__broader mesh__D003064smesh__D008387
% 209.58/209.74  |- skos__related mesh__D003064smesh__D003063
% 209.58/209.74  |- skos__altLabel mesh__D003064 Cnidarian Venom
% 209.58/209.74  |- skos__historyNote mesh__D003064 Toxins %28%1966-1973%29%
% 209.58/209.74  |- mesh__historyNote mesh__D003064 95; was COELENTERATE VENOMS 1978-94   
% 209.58/209.74  |- skos__hiddenLabel mesh__D003064 Venom, Sea Anemone
% 209.58/209.74  |- mesh__recordMaintainer mesh__D003064 ssb
% 209.58/209.74  |- mesh__recordAuthorizer mesh__D003064 sjn
% 209.58/209.74  |- skos__broader mesh__D003064smesh__D014688
% 209.58/209.74  |- skos__historyNote mesh__D003064 Marine Toxins %28%1974-1977%29%
% 209.58/209.74  |- skos__altLabel mesh__D003064 Chironex Venom
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003064 2006
% 209.58/209.74  |- skos__historyNote mesh__D041981
% 209.58/209.74       Gastrointestinal System %28%1965-2003%29%
% 209.58/209.74  |- skos__hiddenLabel mesh__D041981 Digestive Tracts
% 209.58/209.74  |- mesh__historyNote mesh__D041981 2004   
% 209.58/209.74  |- skos__scopeNote mesh__D041981
% 209.58/209.74       Generally refers to the digestive structures stretching from the MOUTH to ANUS, but does not include the accessory glandular organs %28%LIVER; BILIARY TRACT; PANCREAS%29%.%A%    
% 209.58/209.74  |- skos__altLabel mesh__D041981 Digestive Tract
% 209.58/209.74  |- skos__altLabel mesh__D041981 GI Tract
% 209.58/209.74  |- skos__prefLabel mesh__D041981 Gastrointestinal Tract
% 209.58/209.74  |- mesh__dateCreated mesh__D041981 2003-07-09
% 209.58/209.74  |- skos__broader mesh__D041981smesh__D004064
% 209.58/209.74  |- skos__hiddenLabel mesh__D041981 GI Tracts
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D041981 2005
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D041981 2004
% 209.58/209.74  |- skos__hiddenLabel mesh__D041981 Gastrointestinal Tracts
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D041981 2006
% 209.58/209.74  |- mesh__publicMeSHNote mesh__D041981 2004   
% 209.58/209.74  |- rdf__type mesh__D041981sskos__Concept
% 209.58/209.74  |- mesh__dateEstablished mesh__D041981 2004-01-01
% 209.58/209.74  |- skos__scopeNote mesh__D013492
% 209.58/209.74       A pathologic process consisting in the formation of pus.%A%    
% 209.58/209.74  |- skos__broader mesh__D013492smesh__D007249
% 209.58/209.74  |- mesh__recordMaintainer mesh__D013492 adp
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013492 2001
% 209.58/209.74  |- mesh__recordAuthorizer mesh__D013492 sjn
% 209.58/209.74  |- rdf__type mesh__D013492sskos__Concept
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013492 2005
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013492 2002
% 209.58/209.74  |- skos__annotation mesh__D013492
% 209.58/209.74       NIM; TN 178: for suppurative dis %26% coord   
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013492 2003
% 209.58/209.74  |- skos__broader mesh__D013492smesh__D007239
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013492 2006
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013492 2004
% 209.58/209.74  |- mesh__dateRevised mesh__D013492 1999-11-08
% 209.58/209.74  |- skos__prefLabel mesh__D013492 Suppuration
% 209.58/209.74  |- mesh__recordOriginator mesh__D013492 NLM
% 209.58/209.74  |- mesh__dateCreated mesh__D013492 1999-01-01
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013492 2000
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D029907 2005
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D029907 2004
% 209.58/209.74  |- mesh__publicMeSHNote mesh__D029907 2002   
% 209.58/209.74  |- mesh__dateCreated mesh__D029907 2001-07-25
% 209.58/209.74  |- mesh__historyNote mesh__D029907 2002   
% 209.58/209.74  |- skos__annotation mesh__D029907
% 209.58/209.74       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D029907 2003
% 209.58/209.74  |- skos__scopeNote mesh__D029907
% 209.58/209.74       A plant genus of the family FABACEAE that is a source of psoralen %28%FICUSIN%29%.%A%    
% 209.58/209.74  |- skos__prefLabel mesh__D029907 Psoralea
% 209.58/209.74  |- rdf__type mesh__D029907sskos__Concept
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D029907 2006
% 209.58/209.74  |- skos__broader mesh__D029907smesh__D007887
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D029907 2002
% 209.58/209.74  |- mesh__dateEstablished mesh__D029907 2002-01-01
% 209.58/209.74  |- rdf__type mesh__D007455sskos__Concept
% 209.58/209.74  |- mesh__recordOriginator mesh__D007455 NLM
% 209.58/209.74  |- mesh__dateCreated mesh__D007455 1999-01-01
% 209.58/209.74  |- skos__related mesh__D007455smesh__D007456
% 209.58/209.74  |- mesh__recordAuthorizer mesh__D007455 sjn
% 209.58/209.74  |- skos__annotation mesh__D007455 I-127   
% 209.58/209.74  |- skos__scopeNote mesh__D007455
% 209.58/209.74       A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.%A%    
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D007455 2006
% 209.58/209.74  |- mesh__recordMaintainer mesh__D007455 ssb
% 209.58/209.74  |- mesh__dateRevised mesh__D007455 2005-06-30
% 209.58/209.74  |- skos__prefLabel mesh__D007455 Iodine
% 209.58/209.74  |- skos__broader mesh__D007455smesh__D006219
% 209.58/209.74  |- skos__related mesh__D007455smesh__D007457
% 209.58/209.74  |- skos__broader mesh__D017883smesh__D020565
% 209.58/209.74  |- mesh__recordAuthorizer mesh__D017883 sjn
% 209.58/209.74  |- mesh__dateCreated mesh__D017883 1993-06-03
% 209.58/209.74  |- mesh__recordOriginator mesh__D017883 PXP
% 209.58/209.74  |- skos__broader mesh__D017883smesh__D006090
% 209.58/209.74  |- skos__scopeNote mesh__D017883
% 209.58/209.74       A genus of gram-negative, spiral-shaped bacteria that is pathogenic and has been isolated from the GASTRIC MUCOSA of MAMMALS, including humans.%A%    
% 209.58/209.74  |- mesh__historyNote mesh__D017883 94   
% 209.58/209.74  |- skos__annotation mesh__D017883
% 209.58/209.74       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%; GASTROSPIRILLUM HOMINIS and GASTROSPIRILLUM SUIS see HELICOBACTER HEILMANNII are available%A%  
% 209.58/209.74  |- mesh__dateRevised mesh__D017883 2005-06-30
% 209.58/209.74  |- skos__historyNote mesh__D017883 Gram-Negative Bacteria %28%1989-1993%29%
% 209.58/209.74  |- mesh__dateEstablished mesh__D017883 1994-01-01
% 209.58/209.74  |- mesh__recordMaintainer mesh__D017883 SYSTEM
% 209.58/209.74  |- skos__prefLabel mesh__D017883 Gastrospirillum
% 209.58/209.74  |- mesh__publicMeSHNote mesh__D017883 94   
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D017883 2006
% 209.58/209.74  |- rdf__type mesh__D017883sskos__Concept
% 209.58/209.74  |- skos__historyNote mesh__D017085 Thalassemia %28%1966-1992%29%
% 209.58/209.74  |- rdf__type mesh__D017085sskos__Concept
% 209.58/209.74  |- mesh__recordOriginator mesh__D017085 PXP
% 209.58/209.74  |- skos__broader mesh__D017085smesh__D013789
% 209.58/209.74  |- mesh__publicMeSHNote mesh__D017085
% 209.58/209.74       93; was see THALASSEMIA 1988-92; HEMOGLOBIN H DISEASE was see THALASSEMIA 1982-92%A%  
% 209.58/209.74  |- skos__hiddenLabel mesh__D017085 alpha Thalassemia
% 209.58/209.74  |- skos__hiddenLabel mesh__D017085 Disease, Hemoglobin H
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D017085 2004
% 209.58/209.74  |- skos__related mesh__D017085smesh__D006447
% 209.58/209.74  |- skos__altLabel mesh__D017085 Hemoglobin H Disease
% 209.58/209.74  |- skos__hiddenLabel mesh__D017085 Thalassemia-alphas
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D017085 2003
% 209.58/209.74  |- skos__scopeNote mesh__D017085
% 209.58/209.74       A disorder characterized by reduced synthesis of the alpha chains of hemoglobin. The severity of this condition can vary from mild anemia to death, depending on the number of genes deleted.%A%    
% 209.58/209.74  |- skos__hiddenLabel mesh__D017085 Diseases, Hemoglobin H
% 209.58/209.74  |- skos__hiddenLabel mesh__D017085 Hemoglobin H Diseases
% 209.58/209.74  |- skos__prefLabel mesh__D017085 alpha-Thalassemia
% 209.58/209.74  |- skos__altLabel mesh__D017085 Thalassemia-alpha
% 209.58/209.74  |- skos__annotation mesh__D017085
% 209.58/209.74       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 209.58/209.74  |- skos__hiddenLabel mesh__D017085 alpha-Thalassemias
% 209.58/209.74  |- mesh__recordMaintainer mesh__D017085 nns
% 209.58/209.74  |- mesh__onlineNote mesh__D017085
% 209.58/209.74       use THALASSEMIA to search ALPHA-THALASSEMIA 1988-92 %26% HEMOGLOBIN H DISEASE 1982-92%A%  
% 209.58/209.74  |- mesh__dateEstablished mesh__D017085 1993-01-01
% 209.58/209.74  |- mesh__dateCreated mesh__D017085 1992-05-07
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D017085 2006
% 209.58/209.74  |- skos__hiddenLabel mesh__D017085 Thalassemia alpha
% 209.58/209.74  |- mesh__dateRevised mesh__D017085 2001-07-25
% 209.58/209.74  |- mesh__historyNote mesh__D017085
% 209.58/209.74       93; was see THALASSEMIA 1988-92; HEMOGLOBIN H DISEASE was see THALASSEMIA 1982-92%A%  
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D017085 2002
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D017085 2005
% 209.58/209.74  |- mesh__recordAuthorizer mesh__D017085 sjn
% 209.58/209.74  |- skos__prefLabel mesh__D003863 Depression
% 209.58/209.74  |- skos__hiddenLabel mesh__D003863 Depression, Emotional
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003863 2003
% 209.58/209.74  |- skos__related mesh__D003863smesh__D000928
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003863 2004
% 209.58/209.74  |- rdf__type mesh__D003863sskos__Concept
% 209.58/209.74  |- skos__hiddenLabel mesh__D003863 Depressions, Emotional
% 209.58/209.74  |- skos__broader mesh__D003863smesh__D001526
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003863 2005
% 209.58/209.74  |- skos__hiddenLabel mesh__D003863 Depressive Symptom
% 209.58/209.74  |- skos__annotation mesh__D003863
% 209.58/209.74       human %26% animal; /drug ther: consider also ANTIDEPRESSIVE AGENTS; do not confuse this or X ref %28%depression of %22%moderate intensity%22%%29% with DEPRESSIVE DISORDER %28%%22%prominent %26% relatively persistent%22% depression%29%: psychiatrists differentiate on basis of degree%A%  
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003863 2006
% 209.58/209.74  |- mesh__dateRevised mesh__D003863 2002-07-03
% 209.58/209.74  |- skos__hiddenLabel mesh__D003863 Symptom, Depressive
% 209.58/209.74  |- mesh__recordOriginator mesh__D003863 NLM
% 209.58/209.74  |- skos__hiddenLabel mesh__D003863 Depressions
% 209.58/209.74  |- mesh__recordAuthorizer mesh__D003863 sjn
% 209.58/209.74  |- skos__hiddenLabel mesh__D003863 Symptoms, Depressive
% 209.58/209.74  |- skos__altLabel mesh__D003863 Emotional Depression
% 209.58/209.74  |- skos__scopeNote mesh__D003863
% 209.58/209.74       Depressive states usually of moderate intensity in contrast with major depression present in neurotic and psychotic disorders.%A%    
% 209.58/209.74  |- mesh__dateCreated mesh__D003863 1999-01-01
% 209.58/209.74  |- mesh__recordMaintainer mesh__D003863 JLS
% 209.58/209.74  |- skos__hiddenLabel mesh__D003863 Emotional Depressions
% 209.58/209.74  |- rdf__type mesh__D003065sskos__Concept
% 209.58/209.74  |- mesh__recordMaintainer mesh__D003065 ssb
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003065 2004
% 209.58/209.74  |- mesh__recordAuthorizer mesh__D003065 sjn
% 209.58/209.74  |- skos__prefLabel mesh__D003065 Coenzyme A
% 209.58/209.74  |- skos__hiddenLabel mesh__D003065 A, Coenzyme
% 209.58/209.74  |- skos__broader mesh__D003065smesh__D003067
% 209.58/209.74  |- skos__altLabel mesh__D003065 CoA
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003065 2005
% 209.58/209.74  |- skos__annotation mesh__D003065 /biosyn /physiol permitted   
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003065 2006
% 209.58/209.74  |- mesh__dateRevised mesh__D003065 2003-07-09
% 209.58/209.74  |- mesh__dateCreated mesh__D003065 1999-01-01
% 209.58/209.74  |- skos__broader mesh__D003065smesh__D000227
% 209.58/209.74  |- mesh__recordOriginator mesh__D003065 NLM
% 209.58/209.74  |- mesh__recordMaintainer mesh__D013493 TAP
% 209.58/209.74  |- skos__annotation mesh__D013493 in the HYPOTHALAMUS, ANTERIOR   
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013493 2002
% 209.58/209.74  |- skos__prefLabel mesh__D013493 Suprachiasmatic Nucleus
% 209.58/209.74  |- skos__scopeNote mesh__D013493
% 209.58/209.74       An ovoid densely packed collection of small cells of the anterior hypothalamus lying close to the midline in a shallow impression of the optic chiasm.%A%    
% 209.58/209.74  |- mesh__dateRevised mesh__D013493 1992-05-18
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013493 2001
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013493 1997
% 209.58/209.74  |- skos__hiddenLabel mesh__D013493 Nucleus, Suprachiasmatic
% 209.58/209.74  |- mesh__publicMeSHNote mesh__D013493 83   
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013493 1999
% 209.58/209.74  |- mesh__dateCreated mesh__D013493 1982-04-28
% 209.58/209.74  |- rdf__type mesh__D013493sskos__Concept
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013493 1993
% 209.58/209.74  |- mesh__dateEstablished mesh__D013493 1983-01-01
% 209.58/209.74  |- skos__historyNote mesh__D013493 Hypothalamus %28%1966-1982%29%
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013493 1996
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013493 2000
% 209.58/209.74  |- skos__broader mesh__D013493smesh__D007032
% 209.58/209.74  |- mesh__historyNote mesh__D013493 83   
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013493 1995
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013493 1998
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013493 2004
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013493 2006
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013493 1994
% 209.58/209.74  |- mesh__recordOriginator mesh__D013493 RC
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013493 2003
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013493 2005
% 209.58/209.74  |- mesh__recordAuthorizer mesh__D013493 PLS
% 209.58/209.74  |- skos__scopeNote mesh__D029908
% 209.58/209.74       A plant genus of the family FABACEAE a common weed of the southeast US. There has been folk use for alcoholism and liver protection. It contains puerarin,  kakkalide, daidzein %28%isoflavonoids%29%, and kudzusaponins %28%oleanene-type triterpene glycosides%29%.%A%    
% 209.58/209.74  |- mesh__recordAuthorizer mesh__D029908 sjn
% 209.58/209.74  |- skos__annotation mesh__D029908
% 209.58/209.74       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.58/209.74  |- skos__altLabel mesh__D029908 Puerariae
% 209.58/209.74  |- mesh__recordMaintainer mesh__D029908 ssb
% 209.58/209.74  |- rdf__type mesh__D029908sskos__Concept
% 209.58/209.74  |- mesh__recordOriginator mesh__D029908 ssb
% 209.58/209.74  |- skos__prefLabel mesh__D029908 Pueraria
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D029908 2006
% 209.58/209.74  |- skos__broader mesh__D029908smesh__D007887
% 209.58/209.74  |- mesh__dateCreated mesh__D029908 2001-07-25
% 209.58/209.74  |- mesh__historyNote mesh__D029908 2002   
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D029908 2005
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D029908 2004
% 209.58/209.74  |- mesh__publicMeSHNote mesh__D029908 2002   
% 209.58/209.74  |- mesh__dateEstablished mesh__D029908 2002-01-01
% 209.58/209.74  |- skos__altLabel mesh__D029908 Pachyrhizus thunbergianus
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D029908 2003
% 209.58/209.74  |- mesh__dateRevised mesh__D029908 2002-07-03
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D007456 2005
% 209.58/209.74  |- mesh__recordMaintainer mesh__D007456 nns
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D007456 2006
% 209.58/209.74  |- mesh__publicMeSHNote mesh__D007456
% 209.58/209.74       /diagnostic use was IODINE ISOTOPES, DIAGNOSTIC 1963-76; /therapeutic use was IODINE ISOTOPES, THERAPEUTIC 1963-65%A%  
% 209.58/209.74  |- skos__scopeNote mesh__D007456
% 209.58/209.74       Stable iodine atoms that have the same atomic number as the element iodine, but differ in atomic weight. I-127 is the only naturally occurring stable iodine isotope.%A%    
% 209.58/209.74  |- mesh__dateRevised mesh__D007456 2000-06-22
% 209.58/209.74  |- skos__hiddenLabel mesh__D007456 Isotopes, Iodine
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D007456 2003
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D007456 2001
% 209.58/209.74  |- mesh__recordOriginator mesh__D007456 NLM
% 209.58/209.74  |- skos__broader mesh__D007456smesh__D007554
% 209.58/209.74  |- skos__prefLabel mesh__D007456 Iodine Isotopes
% 209.58/209.74  |- mesh__onlineNote mesh__D007456
% 209.58/209.74       search IODINE ISOTOPES, DIAGNOSTIC under IODINE RADIOISOTOPES /DU 1966-76%A%  
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D007456 2004
% 209.58/209.74  |- mesh__recordAuthorizer mesh__D007456 sjn
% 209.58/209.74  |- rdf__type mesh__D007456sskos__Concept
% 209.58/209.74  |- skos__annotation mesh__D007456 I-127; NIM   
% 209.58/209.74  |- mesh__dateCreated mesh__D007456 1999-01-01
% 209.58/209.74  |- mesh__historyNote mesh__D007456
% 209.58/209.74       /diagnostic use was IODINE ISOTOPES, DIAGNOSTIC 1963-76; /therapeutic use was IODINE ISOTOPES, THERAPEUTIC 1963-65%A%  
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D007456 2002
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D017086 2002
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D017086 2004
% 209.58/209.74  |- skos__prefLabel mesh__D017086 beta-Thalassemia
% 209.58/209.74  |- mesh__recordAuthorizer mesh__D017086 sjn
% 209.58/209.74  |- skos__hiddenLabel mesh__D017086 Mediterranean Anemia
% 209.58/209.74  |- skos__altLabel mesh__D017086 Anemia, Cooley%27%s
% 209.58/209.74  |- skos__hiddenLabel mesh__D017086 Cooley%27%s Anemia
% 209.58/209.74  |- skos__hiddenLabel mesh__D017086 beta Thalassemia
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D017086 2003
% 209.58/209.74  |- mesh__publicMeSHNote mesh__D017086
% 209.58/209.74       93; was see THALASSEMIA 1988-92; ANEMIA, ERYTHROBLASTIC was see THALASSEMIA 1965-92, was heading 1963-64; ANEMIA, COOLEY%27%S was see THALASSEMIA 1963-92; ANEMIA, MEDITERRANEAN was see THALASSEMIA 1965-92; HEMOGLOBIN F DISEASE %26% THALASSEMIA MAJOR were see THALASSEMIA 1988-92%A%  
% 209.58/209.74  |- skos__hiddenLabel mesh__D017086 Anemia, Cooleys
% 209.58/209.74  |- skos__broader mesh__D017086smesh__D013789
% 209.58/209.74  |- skos__scopeNote mesh__D017086
% 209.58/209.74       A disorder characterized by reduced synthesis of the beta chains of hemoglobin. There is retardation of hemoglobin A synthesis in the heterozygous form %28%thalassemia minor%29%, which is asymptomatic, while in the homozygous form %28%thalassemia major, Cooley%27%s anemia, Mediterranean anemia, erythroblastic anemia%29%, which can result in severe complications and even death, hemoglobin A synthesis is absent.%A%    
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D017086 2006
% 209.58/209.74  |- skos__hiddenLabel mesh__D017086 Erythroblastic Anemia
% 209.58/209.74  |- mesh__dateCreated mesh__D017086 1992-05-07
% 209.58/209.74  |- skos__hiddenLabel mesh__D017086 Anemia, Cooley
% 209.58/209.74  |- mesh__historyNote mesh__D017086
% 209.58/209.74       93; was see THALASSEMIA 1988-92; ANEMIA, ERYTHROBLASTIC was see THALASSEMIA 1965-92, was heading 1963-64; ANEMIA, COOLEY%27%S was see THALASSEMIA 1963-92; ANEMIA, MEDITERRANEAN was see THALASSEMIA 1965-92; HEMOGLOBIN F DISEASE %26% THALASSEMIA MAJOR were see THALASSEMIA 1988-92%A%  
% 209.58/209.74  |- skos__hiddenLabel mesh__D017086 Anemias, Erythroblastic
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D017086 2005
% 209.58/209.74  |- skos__historyNote mesh__D017086 Thalassemia %28%1966-1992%29%
% 209.58/209.74  |- skos__altLabel mesh__D017086 Anemia, Erythroblastic
% 209.58/209.74  |- rdf__type mesh__D017086sskos__Concept
% 209.58/209.74  |- mesh__onlineNote mesh__D017086
% 209.58/209.74       use THALASSEMIA to search ANEMIA, ERYTHROBLASTIC %26% ANEMIA, COOLEY%27%S %26% ANEMIA, MEDITERRANEAN 1966-92 and HEMOGLOBIN F DISEASE %26% THALASSEMIA MAJOR 1988-92%A%  
% 209.58/209.74  |- skos__altLabel mesh__D017086 Anemia, Mediterranean
% 209.58/209.74  |- skos__hiddenLabel mesh__D017086 Disease, Hemoglobin F
% 209.58/209.74  |- mesh__dateEstablished mesh__D017086 1993-01-01
% 209.58/209.74  |- skos__annotation mesh__D017086
% 209.58/209.74       one of the congen hemolytic anemias; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 209.58/209.74  |- mesh__recordMaintainer mesh__D017086 nns
% 209.58/209.74  |- mesh__recordOriginator mesh__D017086 PXP
% 209.58/209.74  |- mesh__dateRevised mesh__D017086 2001-07-25
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003864 2005
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003864 1999
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003864 1994
% 209.58/209.74  |- mesh__publicMeSHNote mesh__D003864 68   
% 209.58/209.74  |- mesh__dateRevised mesh__D003864 1991-05-28
% 209.58/209.74  |- mesh__recordOriginator mesh__D003864 NLM
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003864 2002
% 209.58/209.74  |- mesh__historyNote mesh__D003864 68   
% 209.58/209.74  |- skos__broader mesh__D003864smesh__D002620
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003864 2006
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003864 1995
% 209.58/209.74  |- skos__hiddenLabel mesh__D003864 Chemical Depressions
% 209.58/209.74  |- skos__altLabel mesh__D003864 Chemical Depression
% 209.58/209.74  |- mesh__dateCreated mesh__D003864 1999-01-01
% 209.58/209.74  |- mesh__dateEstablished mesh__D003864 1968-01-01
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003864 1996
% 209.58/209.74  |- skos__annotation mesh__D003864
% 209.58/209.74       never IM; TN 49: definition %26% use as NIM   
% 209.58/209.74  |- mesh__recordAuthorizer mesh__D003864 PLS
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003864 2003
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003864 1997
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003864 1992
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003864 2000
% 209.58/209.74  |- skos__hiddenLabel mesh__D003864 Depressions, Chemical
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003864 2004
% 209.58/209.74  |- rdf__type mesh__D003864sskos__Concept
% 209.58/209.74  |- skos__prefLabel mesh__D003864 Depression, Chemical
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003864 1998
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003864 1993
% 209.58/209.74  |- mesh__recordMaintainer mesh__D003864 TGC
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003864 2001
% 209.58/209.74  |- skos__hiddenLabel mesh__D003066 Ligases, Acid-Thiol
% 209.58/209.74  |- skos__hiddenLabel mesh__D003066 Acid Thiol Ligases
% 209.58/209.74  |- skos__hiddenLabel mesh__D003066 Ligases, Coenzyme A
% 209.58/209.74  |- skos__altLabel mesh__D003066 Co A Ligases
% 209.58/209.74  |- skos__altLabel mesh__D003066 Acyl Coenzyme A Synthetases
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003066 2005
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003066 2004
% 209.58/209.74  |- mesh__dateCreated mesh__D003066 1999-01-01
% 209.58/209.74  |- skos__historyNote mesh__D003066 Ligases %28%1966-1972%29%
% 209.58/209.74  |- mesh__recordMaintainer mesh__D003066 ssb
% 209.58/209.74  |- mesh__historyNote mesh__D003066 98%28%73%29%   
% 209.58/209.74  |- skos__altLabel mesh__D003066 Acid-Thiol Ligases
% 209.58/209.74  |- mesh__dateEstablished mesh__D003066 1973-01-01
% 209.58/209.74  |- rdf__type mesh__D003066sskos__Concept
% 209.58/209.74  |- mesh__recordOriginator mesh__D003066 NLM
% 209.58/209.74  |- skos__hiddenLabel mesh__D003066 A Ligases, Coenzyme
% 209.58/209.74  |- skos__hiddenLabel mesh__D003066 Ligases, Co A
% 209.58/209.74  |- skos__hiddenLabel mesh__D003066 A Synthetases, Coenzyme
% 209.58/209.74  |- mesh__recordAuthorizer mesh__D003066 sjn
% 209.58/209.74  |- skos__altLabel mesh__D003066 Acyl CoA Synthetases
% 209.58/209.74  |- mesh__publicMeSHNote mesh__D003066
% 209.58/209.74       98; see COENZYME A SYNTHETASES 1973-97   
% 209.58/209.74  |- skos__altLabel mesh__D003066 Coenzyme A Synthetases
% 209.58/209.74  |- skos__hiddenLabel mesh__D003066 A Ligases, Co
% 209.58/209.74  |- skos__scopeNote mesh__D003066
% 209.58/209.74       Enzymes that catalyze the formation of acyl-CoA derivatives. EC 6.2.1.%A%    
% 209.58/209.74  |- mesh__dateRevised mesh__D003066 2003-07-09
% 209.58/209.74  |- skos__hiddenLabel mesh__D003066 Synthetases, Acyl CoA
% 209.58/209.74  |- skos__broader mesh__D003066smesh__D019730
% 209.58/209.74  |- skos__prefLabel mesh__D003066 Coenzyme A Ligases
% 209.58/209.74  |- skos__hiddenLabel mesh__D003066 CoA Synthetases, Acyl
% 209.58/209.74  |- skos__hiddenLabel mesh__D003066 Synthetases, Coenzyme A
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D003066 2006
% 209.58/209.74  |- rdf__type mesh__D049168sskos__Concept
% 209.58/209.74  |- skos__hiddenLabel mesh__D049168 Pregnancies, Unplanned
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D049168 2005
% 209.58/209.74  |- mesh__dateCreated mesh__D049168 2004-07-07
% 209.58/209.74  |- skos__hiddenLabel mesh__D049168 Unplanned Pregnancies
% 209.58/209.74  |- mesh__recordOriginator mesh__D049168 lkt
% 209.58/209.74  |- mesh__recordAuthorizer mesh__D049168 sjn
% 209.58/209.74  |- skos__historyNote mesh__D049168 Pregnancy %28%1966-2004%29%
% 209.58/209.74  |- skos__scopeNote mesh__D049168
% 209.58/209.74       Unintended accidental pregnancy, including pregnancy resulting from failed contraceptive measures.%A%    
% 209.58/209.74  |- mesh__dateEstablished mesh__D049168 2005-01-01
% 209.58/209.74  |- mesh__historyNote mesh__D049168 2005; use PREGNANCY 1980-2004   
% 209.58/209.74  |- skos__annotation mesh__D049168 PREGNANCY, UNWANTED is also available   
% 209.58/209.74  |- mesh__recordMaintainer mesh__D049168 lkt
% 209.58/209.74  |- skos__broader mesh__D049168smesh__D011247
% 209.58/209.74  |- mesh__publicMeSHNote mesh__D049168 2005; see PREGNANCY 1980-2004   
% 209.58/209.74  |- skos__prefLabel mesh__D049168 Pregnancy, Unplanned
% 209.58/209.74  |- skos__related mesh__D049168smesh__D011275
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D049168 2006
% 209.58/209.74  |- skos__altLabel mesh__D049168 Unplanned Pregnancy
% 209.58/209.74  |- skos__hiddenLabel mesh__D013494 Progressive Supranuclear Palsy
% 209.58/209.74  |- skos__historyNote mesh__D013494 Paralysis %28%1966-1986%29%
% 209.58/209.74  |- skos__historyNote mesh__D013494 Paralysis, Bulbar %28%1966-1986%29%
% 209.58/209.74  |- skos__prefLabel mesh__D013494 Supranuclear Palsy, Progressive
% 209.58/209.74  |- skos__hiddenLabel mesh__D013494 Supranuclear Palsies, Progressive
% 209.58/209.74  |- skos__hiddenLabel mesh__D013494 Progressive Supranuclear Palsies
% 209.58/209.74  |- skos__broader mesh__D013494smesh__D009069
% 209.58/209.74  |- skos__hiddenLabel mesh__D013494 Steele Richardson Olszewski Syndrome
% 209.58/209.74  |- rdf__type mesh__D013494sskos__Concept
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013494 2002
% 209.58/209.74  |- skos__scopeNote mesh__D013494
% 209.58/209.74       A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS %28%supranuclear ophthalmoplegia%29%; DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. %28%From Adams et al., Principles of Neurology, 6th ed, pp1076-7%29%%A%    
% 209.58/209.74  |- skos__hiddenLabel mesh__D013494
% 209.58/209.74       Supranuclear Ophthalmoplegia, Progressive
% 209.58/209.74  |- skos__altLabel mesh__D013494 Steele-Richardson-Olszewski Disease
% 209.58/209.74  |- skos__altLabel mesh__D013494 Ophthalmoplegia, Progressive Supranuclear
% 209.58/209.74  |- skos__hiddenLabel mesh__D013494
% 209.58/209.74       Supranuclear Ophthalmoplegias, Progressive
% 209.58/209.74  |- mesh__dateEstablished mesh__D013494 1987-01-01
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013494 2004
% 209.58/209.74  |- skos__hiddenLabel mesh__D013494 Syndrome, Steele-Richardson-Olszewski
% 209.58/209.74  |- skos__hiddenLabel mesh__D013494
% 209.58/209.74       Progressive Supranuclear Ophthalmoplegias
% 209.58/209.74  |- skos__broader mesh__D013494smesh__D009886
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013494 2006
% 209.58/209.74  |- mesh__recordOriginator mesh__D013494 RC
% 209.58/209.74  |- skos__broader mesh__D013494smesh__D024801
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013494 2003
% 209.58/209.74  |- mesh__dateCreated mesh__D013494 1986-04-01
% 209.58/209.74  |- mesh__historyNote mesh__D013494 1987   
% 209.58/209.74  |- skos__hiddenLabel mesh__D013494 Steele Richardson Olszewski Disease
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D013494 2005
% 209.58/209.74  |- skos__altLabel mesh__D013494 Steele-Richardson-Olszewski Syndrome
% 209.58/209.74  |- mesh__recordMaintainer mesh__D013494 lkt
% 209.58/209.74  |- skos__altLabel mesh__D013494 Progressive Supranuclear Ophthalmoplegia
% 209.58/209.74  |- mesh__dateRevised mesh__D013494 2001-07-25
% 209.58/209.74  |- mesh__publicMeSHNote mesh__D013494 1987   
% 209.58/209.74  |- mesh__recordAuthorizer mesh__D013494 sjn
% 209.58/209.74  |- skos__historyNote mesh__D013494 Ophthalmoplegia %28%1979-1986%29%
% 209.58/209.74  |- skos__hiddenLabel mesh__D013494
% 209.58/209.74       Ophthalmoplegias, Progressive Supranuclear
% 209.58/209.74  |- skos__altLabel mesh__D013494 Palsy, Progressive Supranuclear
% 209.58/209.74  |- skos__broader mesh__D013494smesh__D001480
% 209.58/209.74  |- rdf__type mesh__D029909sskos__Concept
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D029909 2006
% 209.58/209.74  |- skos__broader mesh__D029909smesh__D007887
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D029909 2005
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D029909 2002
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D029909 2004
% 209.58/209.74  |- mesh__publicMeSHNote mesh__D029909 2002   
% 209.58/209.74  |- mesh__dateEstablished mesh__D029909 2002-01-01
% 209.58/209.74  |- skos__scopeNote mesh__D029909 A plant genus of the family FABACEAE.     
% 209.58/209.74  |- skos__prefLabel mesh__D029909 Sophora
% 209.58/209.74  |- mesh__activeMeSHYear mesh__D029909 2003
% 209.58/209.74  |- mesh__dateCreated mesh__D029909 2001-07-25
% 209.58/209.74  |- mesh__historyNote mesh__D029909 2002   
% 209.58/209.74  |- skos__annotation mesh__D029909
% 209.58/209.74       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D007457 1996
% 209.58/209.75  |- mesh__publicMeSHNote mesh__D007457
% 209.58/209.75       74; /diagnostic use was IODINE ISOTOPES, DIAGNOSTIC 1963-76; /therapeutic use was IODINE ISOTOPES, THERAPEUTIC 1963-65%A%  
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D007457 2006
% 209.58/209.75  |- skos__annotation mesh__D007457
% 209.58/209.75       I-117 through I-139 except I-127; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 209.58/209.75  |- skos__prefLabel mesh__D007457 Iodine Radioisotopes
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D007457 2002
% 209.58/209.75  |- mesh__recordMaintainer mesh__D007457 TPW
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D007457 1997
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D007457 1994
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D007457 2003
% 209.58/209.75  |- mesh__recordAuthorizer mesh__D007457 PLS
% 209.58/209.75  |- skos__broader mesh__D007457smesh__D007456
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D007457 1995
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D007457 2004
% 209.58/209.75  |- rdf__type mesh__D007457sskos__Concept
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D007457 2000
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D007457 1998
% 209.58/209.75  |- mesh__dateCreated mesh__D007457 1999-01-01
% 209.58/209.75  |- mesh__dateRevised mesh__D007457 1993-06-18
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D007457 2001
% 209.58/209.75  |- mesh__recordOriginator mesh__D007457 NLM
% 209.58/209.75  |- skos__scopeNote mesh__D007457
% 209.58/209.75       Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes.%A%    
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D007457 1999
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D007457 2005
% 209.58/209.75  |- skos__broader mesh__D007457smesh__D011868
% 209.58/209.75  |- mesh__dateEstablished mesh__D007457 1974-01-01
% 209.58/209.75  |- skos__hiddenLabel mesh__D007457 Radioisotopes, Iodine
% 209.58/209.75  |- mesh__onlineNote mesh__D007457
% 209.58/209.75       search IODINE ISOTOPES 1966-73; search IODINE ISOTOPES, DIAGNOSTIC under IODINE RADIOISOTOPES /DU 1966-76%A%  
% 209.58/209.75  |- mesh__historyNote mesh__D007457
% 209.58/209.75       74; /diagnostic use was IODINE ISOTOPES, DIAGNOSTIC 1963-76; /therapeutic use was IODINE ISOTOPES, THERAPEUTIC 1963-65%A%  
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017885 2003
% 209.58/209.75  |- skos__hiddenLabel mesh__D017885 Ligament, Collateral
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017885 2005
% 209.58/209.75  |- skos__hiddenLabel mesh__D017885 Ligament, Lateral
% 209.58/209.75  |- skos__altLabel mesh__D017885 Ligaments, Lateral
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017885 2002
% 209.58/209.75  |- skos__altLabel mesh__D017885 Ligaments, Collateral
% 209.58/209.75  |- skos__scopeNote mesh__D017885
% 209.58/209.75       A number of ligaments on either side of, and serving as a radius of movement of, a joint having a hingelike movement. They occur at the elbow, knee, wrist, metacarpo- and metatarsophalangeal, proximal interphalangeal, and distal interphalangeal joints of the hands and feet. %28%Stedman, 25th ed%29%%A%    
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017885 2001
% 209.58/209.75  |- mesh__historyNote mesh__D017885 94   
% 209.58/209.75  |- mesh__recordAuthorizer mesh__D017885 PLS
% 209.58/209.75  |- mesh__recordOriginator mesh__D017885 TGC
% 209.58/209.75  |- skos__hiddenLabel mesh__D017885 Collateral Ligament
% 209.58/209.75  |- skos__historyNote mesh__D017885 Ligaments %28%1966-1993%29%
% 209.58/209.75  |- skos__hiddenLabel mesh__D017885 Lateral Ligament
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017885 1997
% 209.58/209.75  |- mesh__recordMaintainer mesh__D017885 RAZ
% 209.58/209.75  |- mesh__dateEstablished mesh__D017885 1994-01-01
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017885 2000
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017885 1999
% 209.58/209.75  |- skos__historyNote mesh__D017885 Ligaments, Articular %28%1968-1993%29%
% 209.58/209.75  |- skos__annotation mesh__D017885
% 209.58/209.75       artic ligaments of extremities; coord IM with specific joint or bone %28%IM%29%%A%  
% 209.58/209.75  |- mesh__dateCreated mesh__D017885 1993-02-16
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017885 1996
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017885 2004
% 209.58/209.75  |- skos__prefLabel mesh__D017885 Collateral Ligaments
% 209.58/209.75  |- skos__broader mesh__D017885smesh__D008023
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017885 1998
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017885 2006
% 209.58/209.75  |- mesh__publicMeSHNote mesh__D017885 94   
% 209.58/209.75  |- rdf__type mesh__D017885sskos__Concept
% 209.58/209.75  |- mesh__dateRevised mesh__D017885 1995-06-08
% 209.58/209.75  |- skos__annotation mesh__D017087
% 209.58/209.75       refers to domestic, laboratory or wild animals; ANIMAL WELFARE is also available%A%  
% 209.58/209.75  |- mesh__dateEstablished mesh__D017087 1993-01-01
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017087 2006
% 209.58/209.75  |- mesh__recordMaintainer mesh__D017087 jls
% 209.58/209.75  |- mesh__dateCreated mesh__D017087 1992-05-07
% 209.58/209.75  |- mesh__dateRevised mesh__D017087 2003-07-09
% 209.58/209.75  |- mesh__onlineNote mesh__D017087
% 209.58/209.75       use ANIMAL WELFARE to search ANIMAL RIGHTS 1986-92 and SPECIESISM 1987-92%A%  
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017087 2005
% 209.58/209.75  |- skos__hiddenLabel mesh__D017087 Rights, Animal
% 209.58/209.75  |- rdf__type mesh__D017087sskos__Concept
% 209.58/209.75  |- mesh__recordAuthorizer mesh__D017087 sjn
% 209.58/209.75  |- skos__scopeNote mesh__D017087
% 209.58/209.75       The moral and ethical bases of the protection of animals from cruelty and abuse. The rights are extended to domestic animals, laboratory animals, and wild animals.%A%    
% 209.58/209.75  |- mesh__recordOriginator mesh__D017087 TGC
% 209.58/209.75  |- mesh__publicMeSHNote mesh__D017087
% 209.58/209.75       93; was see ANIMAL WELFARE 1986-92; SPECIESISM was see ANIMAL WELFARE 1987-92%A%  
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017087 2004
% 209.58/209.75  |- mesh__historyNote mesh__D017087
% 209.58/209.75       93; was see ANIMAL WELFARE 1986-92; SPECIESISM was see ANIMAL WELFARE 1987-92%A%  
% 209.58/209.75  |- skos__broader mesh__D017087smesh__D000827
% 209.58/209.75  |- skos__prefLabel mesh__D017087 Animal Rights
% 209.58/209.75  |- skos__historyNote mesh__D017087 Animal Welfare %28%1986-1992%29%
% 209.58/209.75  |- skos__altLabel mesh__D003865 Melancholia, Involutional
% 209.58/209.75  |- mesh__recordAuthorizer mesh__D003865 sjn
% 209.58/209.75  |- mesh__publicMeSHNote mesh__D003865
% 209.58/209.75       81; was PSYCHOSES, INVOLUTIONAL 1963-80   
% 209.58/209.75  |- skos__hiddenLabel mesh__D003865 Paraphrenias, Involutional
% 209.58/209.75  |- skos__scopeNote mesh__D003865
% 209.58/209.75       Marked depression appearing in the involution period and characterized by hallucinations, delusions, paranoia, and agitation.%A%    
% 209.58/209.75  |- skos__hiddenLabel mesh__D003865 Involutional Psychoses
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D003865 2005
% 209.58/209.75  |- skos__hiddenLabel mesh__D003865 Major Depressive Disorders
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D003865 2006
% 209.58/209.75  |- mesh__dateCreated mesh__D003865 1999-01-01
% 209.58/209.75  |- skos__altLabel mesh__D003865 Psychosis, Involutional
% 209.58/209.75  |- skos__hiddenLabel mesh__D003865 Involutional Psychosis
% 209.58/209.75  |- skos__broader mesh__D003865smesh__D003866
% 209.58/209.75  |- skos__prefLabel mesh__D003865 Depressive Disorder, Major
% 209.58/209.75  |- skos__hiddenLabel mesh__D003865 Involutional Melancholia
% 209.58/209.75  |- skos__hiddenLabel mesh__D003865 Disorder, Major Depressive
% 209.58/209.75  |- skos__altLabel mesh__D003865 Major Depressive Disorder
% 209.58/209.75  |- skos__altLabel mesh__D003865 Depression, Involutional
% 209.58/209.75  |- mesh__recordMaintainer mesh__D003865 jls
% 209.58/209.75  |- skos__altLabel mesh__D003865 Paraphrenia, Involutional
% 209.58/209.75  |- mesh__dateRevised mesh__D003865 2004-07-07
% 209.58/209.75  |- rdf__type mesh__D003865sskos__Concept
% 209.58/209.75  |- skos__hiddenLabel mesh__D003865 Psychoses, Involutional
% 209.58/209.75  |- skos__hiddenLabel mesh__D003865 Disorders, Major Depressive
% 209.58/209.75  |- mesh__onlineNote mesh__D003865
% 209.58/209.75       use DEPRESSION, INVOLUTIONAL to search PSYCHOSES, INVOLUTIONAL %26% MELANCHOLIA, INVOLUTIONAL 1966-80%A%  
% 209.58/209.75  |- skos__hiddenLabel mesh__D003865 Depressive Disorders, Major
% 209.58/209.75  |- skos__hiddenLabel mesh__D003865 Involutional Paraphrenia
% 209.58/209.75  |- mesh__historyNote mesh__D003865
% 209.58/209.75       81; was PSYCHOSES, INVOLUTIONAL 1963-80; MELANCHOLIA, INVOLUTIONAL was see under PSYCHOSES, INVOLUTIONAL 1963-78%A%  
% 209.58/209.75  |- skos__hiddenLabel mesh__D003865 Involutional Depression
% 209.58/209.75  |- mesh__recordOriginator mesh__D003865 NLM
% 209.58/209.75  |- skos__altLabel mesh__D003067 Enzyme Cofactors
% 209.58/209.75  |- skos__broader mesh__D003067smesh__D045762
% 209.58/209.75  |- rdf__type mesh__D003067sskos__Concept
% 209.58/209.75  |- skos__scopeNote mesh__D003067
% 209.58/209.75       Small molecules that are required for the catalytic function of ENZYMES. Many VITAMINS are coenzymes.%A%    
% 209.58/209.75  |- mesh__recordMaintainer mesh__D003067 ssb
% 209.58/209.75  |- skos__prefLabel mesh__D003067 Coenzymes
% 209.58/209.75  |- mesh__dateRevised mesh__D003067 2003-07-09
% 209.58/209.75  |- mesh__recordOriginator mesh__D003067 NLM
% 209.58/209.75  |- mesh__recordAuthorizer mesh__D003067 sjn
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D003067 2006
% 209.58/209.75  |- skos__altLabel mesh__D003067 Cofactors, Enzyme
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D003067 2005
% 209.58/209.75  |- mesh__dateCreated mesh__D003067 1999-01-01
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D003067 2004
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D008550 2003
% 209.58/209.75  |- skos__broader mesh__D008550smesh__D014363
% 209.58/209.75  |- mesh__historyNote mesh__D008550 68%28%65%29%   
% 209.58/209.75  |- mesh__recordMaintainer mesh__D008550 lkt
% 209.58/209.75  |- skos__scopeNote mesh__D008550
% 209.58/209.75       A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.%A%    
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D008550 2004
% 209.58/209.75  |- skos__prefLabel mesh__D008550 Melatonin
% 209.58/209.75  |- mesh__recordAuthorizer mesh__D008550 sjn
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D008550 2005
% 209.58/209.75  |- skos__broader mesh__D008550smesh__D006728
% 209.58/209.75  |- mesh__dateCreated mesh__D008550 1999-01-01
% 209.58/209.75  |- mesh__dateEstablished mesh__D008550 1968-01-01
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D008550 2006
% 209.58/209.75  |- mesh__recordOriginator mesh__D008550 NLM
% 209.58/209.75  |- mesh__publicMeSHNote mesh__D008550 68   
% 209.58/209.75  |- mesh__dateRevised mesh__D008550 2002-07-02
% 209.58/209.75  |- rdf__type mesh__D008550sskos__Concept
% 209.58/209.75  |- skos__hiddenLabel mesh__D022221 Mammalian Artificial Chromosome
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D022221 2005
% 209.58/209.75  |- mesh__historyNote mesh__D022221 2002%28%2001%29%   
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D022221 2006
% 209.58/209.75  |- skos__altLabel mesh__D022221 Mammalian Artificial Chromosomes
% 209.58/209.75  |- skos__broader mesh__D022221smesh__D022201
% 209.58/209.75  |- skos__hiddenLabel mesh__D022221 Chromosome, Mammalian Artificial
% 209.58/209.75  |- skos__altLabel mesh__D022221 MACs %28%Chromosomes%29%
% 209.58/209.75  |- mesh__dateRevised mesh__D022221 2003-07-09
% 209.58/209.75  |- mesh__dateCreated mesh__D022221 2000-06-21
% 209.58/209.75  |- skos__scopeNote mesh__D022221
% 209.58/209.75       DNA constructs that are composed of, at least, all elements, such as a REPLICATION ORIGIN; TELOMERE; and CENTROMERE, that are required for successful replication, propagation to and maintainance in progeny mammalian cells. In addition, they are constructed to carry other sequences for analysis or gene transfer.%A%    
% 209.58/209.75  |- mesh__recordOriginator mesh__D022221 nns
% 209.58/209.75  |- skos__broader mesh__D022221smesh__D033481
% 209.58/209.75  |- rdf__type mesh__D022221sskos__Concept
% 209.58/209.75  |- skos__altLabel mesh__D022221 Chromosomes, Mammalian Artificial
% 209.58/209.75  |- skos__altLabel mesh__D022221 Artificial Chromosomes, Mammalian
% 209.58/209.75  |- skos__annotation mesh__D022221
% 209.58/209.75       coord with specific animal /genet  only if particularly discussed%A%  
% 209.58/209.75  |- skos__historyNote mesh__D022221 Chromosomes %28%1994-2000%29%
% 209.58/209.75  |- mesh__recordAuthorizer mesh__D022221 sjn
% 209.58/209.75  |- skos__prefLabel mesh__D022221 Chromosomes, Artificial, Mammalian
% 209.58/209.75  |- skos__hiddenLabel mesh__D022221 Artificial Chromosome, Mammalian
% 209.58/209.75  |- skos__altLabel mesh__D022221 MAC %28%Chromosome%29%
% 209.58/209.75  |- mesh__publicMeSHNote mesh__D022221
% 209.58/209.75       2002; see CHROMOSOMES, MAMMALIAN ARTIFICIAL 2001   
% 209.58/209.75  |- mesh__dateEstablished mesh__D022221 2001-01-01
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D022221 2004
% 209.58/209.75  |- mesh__recordMaintainer mesh__D022221 nns
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D013495 1995
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D013495 1998
% 209.58/209.75  |- mesh__historyNote mesh__D013495
% 209.58/209.75       83%28%75%29%; was see under HYPOTHALAMUS 1975-82   
% 209.58/209.75  |- skos__hiddenLabel mesh__D013495 Nucleus, Supraoptic
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D013495 2004
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D013495 2000
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D013495 2006
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D013495 2003
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D013495 2005
% 209.58/209.75  |- mesh__dateCreated mesh__D013495 1974-11-11
% 209.58/209.75  |- skos__annotation mesh__D013495 in the anterior hypothalamus   
% 209.58/209.75  |- mesh__publicMeSHNote mesh__D013495
% 209.58/209.75       83; was see under HYPOTHALAMUS 1975-82   
% 209.58/209.75  |- mesh__recordAuthorizer mesh__D013495 PLS
% 209.58/209.75  |- mesh__recordMaintainer mesh__D013495 TGC
% 209.58/209.75  |- skos__prefLabel mesh__D013495 Supraoptic Nucleus
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D013495 2002
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D013495 1997
% 209.58/209.75  |- mesh__dateRevised mesh__D013495 1994-05-12
% 209.58/209.75  |- rdf__type mesh__D013495sskos__Concept
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D013495 1999
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D013495 2001
% 209.58/209.75  |- mesh__dateEstablished mesh__D013495 1983-01-01
% 209.58/209.75  |- skos__broader mesh__D013495smesh__D007032
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D013495 1996
% 209.58/209.75  |- skos__scopeNote mesh__D013495
% 209.58/209.75       Hypothalamic nucleus overlying the beginning of the optic tract.%A%    
% 209.58/209.75  |- mesh__recordOriginator mesh__D013495 NLM
% 209.58/209.75  |- mesh__dateRevised mesh__D007458 2000-06-21
% 209.58/209.75  |- mesh__recordOriginator mesh__D007458 NLM
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D007458 2006
% 209.58/209.75  |- skos__prefLabel mesh__D007458 Iodipamide
% 209.58/209.75  |- mesh__recordAuthorizer mesh__D007458 sjn
% 209.58/209.75  |- skos__broader mesh__D007458smesh__D014283
% 209.58/209.75  |- mesh__recordMaintainer mesh__D007458 CCR
% 209.58/209.75  |- skos__scopeNote mesh__D007458
% 209.58/209.75       A water-soluble radiographic contrast media for cholecystography and intravenous cholangiography.%A%    
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D007458 2001
% 209.58/209.75  |- skos__annotation mesh__D007458 D25-26 qualif   
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D007458 2004
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D007458 2005
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D007458 2003
% 209.58/209.75  |- rdf__type mesh__D007458sskos__Concept
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D007458 2002
% 209.58/209.75  |- skos__altLabel mesh__D007458 Adipiodon
% 209.58/209.75  |- mesh__dateCreated mesh__D007458 1999-01-01
% 209.58/209.75  |- mesh__recordAuthorizer mesh__D018180 sjn
% 209.58/209.75  |- skos__broader mesh__D018180smesh__D018179
% 209.58/209.75  |- mesh__onlineNote mesh__D018180
% 209.58/209.75       use RECEPTORS, THROMBIN %28%NM%29% to search THROMBOMODULIN 1981-93%A%  
% 209.58/209.75  |- skos__annotation mesh__D018180 a thrombin receptor   
% 209.58/209.75  |- mesh__historyNote mesh__D018180
% 209.58/209.75       94; THROMBOMODULIN was SY to THROMBIN RECEPTOR %28%NM%29% 1981-93%A%  
% 209.58/209.75  |- skos__prefLabel mesh__D018180 Thrombomodulin
% 209.58/209.75  |- mesh__dateCreated mesh__D018180 1993-06-30
% 209.58/209.75  |- skos__scopeNote mesh__D018180
% 209.58/209.75       A cell surface glycoprotein of endothelial cells that binds thrombin and serves as a cofactor in the activation of protein C and its regulation of blood coagulation.%A%    
% 209.58/209.75  |- mesh__dateEstablished mesh__D018180 1994-01-01
% 209.58/209.75  |- mesh__recordOriginator mesh__D018180 RAZ
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D018180 2004
% 209.58/209.75  |- mesh__publicMeSHNote mesh__D018180
% 209.58/209.75       94; RECEPTORS, THROMBIN was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-93%A%  
% 209.58/209.75  |- skos__historyNote mesh__D018180
% 209.58/209.75       Receptors, Cell Surface %28%1981-1993%29%
% 209.58/209.75  |- mesh__recordMaintainer mesh__D018180 jmp
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D018180 2006
% 209.58/209.75  |- rdf__type mesh__D018180sskos__Concept
% 209.58/209.75  |- mesh__dateRevised mesh__D018180 2003-07-09
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D018180 2005
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D004160 2005
% 209.58/209.75  |- skos__scopeNote mesh__D004160
% 209.58/209.75       Used as an indicator in titrating iron and for the colorimetric determination of chromium and the detection of cadmium, mercury, magnesium, aldehydes, and emetine.%A%    
% 209.58/209.75  |- skos__historyNote mesh__D004160 Semicarbazides %28%1972-1974%29%
% 209.58/209.75  |- skos__altLabel mesh__D004160 S-Diphenylcarbazide
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D004160 2002
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D004160 2004
% 209.58/209.75  |- mesh__recordOriginator mesh__D004160 NLM
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D004160 2001
% 209.58/209.75  |- mesh__publicMeSHNote mesh__D004160
% 209.58/209.75       91; was see under SEMICARBAZIDES 1975-90   
% 209.58/209.75  |- skos__hiddenLabel mesh__D004160 S Diphenylcarbazide
% 209.58/209.75  |- mesh__recordAuthorizer mesh__D004160 sjn
% 209.58/209.75  |- skos__altLabel mesh__D004160 1,5-Diphenylcarbazide
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D004160 2003
% 209.58/209.75  |- skos__annotation mesh__D004160 D25-26 qualif   
% 209.58/209.75  |- rdf__type mesh__D004160sskos__Concept
% 209.58/209.75  |- skos__historyNote mesh__D004160 Benzene Derivatives %28%1972-1974%29%
% 209.58/209.75  |- mesh__recordMaintainer mesh__D004160 CCR
% 209.58/209.75  |- skos__prefLabel mesh__D004160 Diphenylcarbazide
% 209.58/209.75  |- mesh__dateRevised mesh__D004160 2000-06-22
% 209.58/209.75  |- mesh__dateEstablished mesh__D004160 1991-01-01
% 209.58/209.75  |- mesh__dateCreated mesh__D004160 1974-11-19
% 209.58/209.75  |- mesh__historyNote mesh__D004160
% 209.58/209.75       91%28%75%29%; was see under SEMICARBAZIDES 1975-90   
% 209.58/209.75  |- skos__broader mesh__D004160smesh__D012663
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D004160 2006
% 209.58/209.75  |- skos__hiddenLabel mesh__D004160 1,5 Diphenylcarbazide
% 209.58/209.75  |- skos__broader mesh__D006280Q000193smesh__D006280
% 209.58/209.75  |- mesh__preferredCombination mesh__D006280Q000193smesh__D006281Q000193
% 209.58/209.75  |- rdf__type mesh__D006280Q000193smesh__CompoundConcept
% 209.58/209.75  |- skos__altLabel mesh__D017886 Calcium Hydroxyapatite
% 209.58/209.75  |- skos__prefLabel mesh__D017886 Durapatite
% 209.58/209.75  |- skos__broader mesh__D017886smesh__D006882
% 209.58/209.75  |- skos__hiddenLabel mesh__D017886 Interpore 200
% 209.58/209.75  |- mesh__publicMeSHNote mesh__D017886
% 209.58/209.75       94; HYDROXYAPATITE was indexed under HYDROXYAPATITES 1981-93%A%  
% 209.58/209.75  |- skos__altLabel mesh__D017886 Hydroxylapatite
% 209.58/209.75  |- mesh__onlineNote mesh__D017886
% 209.58/209.75       use DURAPATITE %28%NM%29% to search HYDROXYAPATITE 1981-93   
% 209.58/209.75  |- mesh__recordOriginator mesh__D017886 TPW
% 209.58/209.75  |- skos__historyNote mesh__D017886 Hydroxyapatites %28%1981-1993%29%
% 209.58/209.75  |- mesh__historyNote mesh__D017886
% 209.58/209.75       94; was HYDROXYAPATITE %28%NM%29% 1981-93   
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017886 2002
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017886 1999
% 209.58/209.75  |- skos__hiddenLabel mesh__D017886 Interpore500
% 209.58/209.75  |- skos__altLabel mesh__D017886 Hydroxyapatite
% 209.58/209.75  |- skos__scopeNote mesh__D017886
% 209.58/209.75       The mineral component of bones and teeth; it has been used therapeutically as a prosthetic aid and in the prevention and treatment of osteoporosis.%A%    
% 209.58/209.75  |- skos__hiddenLabel mesh__D017886 Ossein Hydroxyapatite Compound
% 209.58/209.75  |- mesh__recordMaintainer mesh__D017886 KEV
% 209.58/209.75  |- skos__hiddenLabel mesh__D017886 Interpore200
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017886 2004
% 209.58/209.75  |- mesh__recordAuthorizer mesh__D017886 SJN
% 209.58/209.75  |- mesh__dateCreated mesh__D017886 1993-02-16
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017886 2001
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017886 2006
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017886 1998
% 209.58/209.75  |- skos__hiddenLabel mesh__D017886 Hydroxyapatite, Calcium
% 209.58/209.75  |- skos__hiddenLabel mesh__D017886 Interpore 500
% 209.58/209.75  |- rdf__type mesh__D017886sskos__Concept
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017886 2003
% 209.58/209.75  |- mesh__dateRevised mesh__D017886 1997-06-20
% 209.58/209.75  |- mesh__dateEstablished mesh__D017886 1994-01-01
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017886 2000
% 209.58/209.75  |- skos__annotation mesh__D017886
% 209.58/209.75       mineral component of bones %26% teeth; used as a biocompatible material%A%  
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017886 2005
% 209.58/209.75  |- skos__hiddenLabel mesh__D017088 Opportunistic Infection, AIDS-Related
% 209.58/209.75  |- skos__hiddenLabel mesh__D017088 Opportunistic Infections, AIDS Related
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017088 2005
% 209.58/209.75  |- skos__scopeNote mesh__D017088
% 209.58/209.75       Opportunistic infections found in patients who test positive for human immunodeficiency virus %28%HIV%29%. The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi%27%s sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.%A%    
% 209.58/209.75  |- mesh__dateRevised mesh__D017088 2004-07-13
% 209.58/209.75  |- skos__broader mesh__D017088smesh__D015658
% 209.58/209.75  |- rdf__type mesh__D017088sskos__Concept
% 209.58/209.75  |- skos__altLabel mesh__D017088 HIV-Related Opportunistic Infections
% 209.58/209.75  |- mesh__dateEstablished mesh__D017088 1993-01-01
% 209.58/209.75  |- skos__hiddenLabel mesh__D017088 AIDS-Related Opportunistic Infection
% 209.58/209.75  |- skos__related mesh__D017088smesh__D016919
% 209.58/209.75  |- skos__historyNote mesh__D017088 specific HIV infection %28%1983-1992%29%
% 209.58/209.75  |- skos__hiddenLabel mesh__D017088 Opportunistic Infection, HIV-Related
% 209.58/209.75  |- skos__annotation mesh__D017088
% 209.58/209.75       coord IM with HIV-1 or HIV-2 %28%IM or NIM if pertinent%29%; coord IM with specific opportunistic infect %28%IM%29%; DF: AIDS RELAT OPPORTUNISTIC INFECT%A%  
% 209.58/209.75  |- skos__hiddenLabel mesh__D017088 Opportunistic Infections, HIV Related
% 209.58/209.75  |- skos__altLabel mesh__D017088 Opportunistic Infections, HIV-Related
% 209.58/209.75  |- mesh__historyNote mesh__D017088 93   
% 209.58/209.75  |- skos__broader mesh__D017088smesh__D009894
% 209.58/209.75  |- skos__related mesh__D017088smesh__D016781
% 209.58/209.75  |- skos__historyNote mesh__D017088
% 209.58/209.75       specific opportunistic infection %28%1983-1992%29%
% 209.58/209.75  |- skos__altLabel mesh__D017088 Opportunistic Infections, AIDS-Related
% 209.58/209.75  |- skos__hiddenLabel mesh__D017088 HIV Related Opportunistic Infections
% 209.58/209.75  |- mesh__recordMaintainer mesh__D017088 sjn
% 209.58/209.75  |- skos__hiddenLabel mesh__D017088 Infections, HIV-Related Opportunistic
% 209.58/209.75  |- mesh__recordAuthorizer mesh__D017088 sjn
% 209.58/209.75  |- skos__hiddenLabel mesh__D017088 HIV-Related Opportunistic Infection
% 209.58/209.75  |- skos__hiddenLabel mesh__D017088 AIDS Related Opportunistic Infections
% 209.58/209.75  |- mesh__dateCreated mesh__D017088 1992-05-13
% 209.58/209.75  |- mesh__publicMeSHNote mesh__D017088 93   
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D017088 2006
% 209.58/209.75  |- skos__historyNote mesh__D017088
% 209.58/209.75       Opportunistic Infections %28%1983-1992%29%
% 209.58/209.75  |- mesh__recordOriginator mesh__D017088 AGS
% 209.58/209.75  |- skos__hiddenLabel mesh__D017088 Infection, HIV-Related Opportunistic
% 209.58/209.75  |- skos__prefLabel mesh__D017088 AIDS-Related Opportunistic Infections
% 209.58/209.75  |- mesh__recordMaintainer mesh__D003866 JLS
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D003866 2003
% 209.58/209.75  |- skos__scopeNote mesh__D003866
% 209.58/209.75       An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.%A%    
% 209.58/209.75  |- mesh__dateRevised mesh__D003866 1997-06-20
% 209.58/209.75  |- skos__hiddenLabel mesh__D003866 Depressions, Neurotic
% 209.58/209.75  |- skos__altLabel mesh__D003866 Depression, Unipolar
% 209.58/209.75  |- skos__hiddenLabel mesh__D003866 Depressions, Endogenous
% 209.58/209.75  |- skos__hiddenLabel mesh__D003866 Neurotic Depressions
% 209.58/209.75  |- skos__broader mesh__D003866smesh__D019964
% 209.58/209.75  |- skos__hiddenLabel mesh__D003866 Endogenous Depression
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D003866 1998
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D003866 2001
% 209.58/209.75  |- mesh__publicMeSHNote mesh__D003866
% 209.58/209.75       81; DEPRESSION, NEUROTIC was DEPRESSIVE NEUROSES see DEPRESSION, REACTIVE 1979-80, see under DEPRESSION, REACTIVE 1969-78%A%  
% 209.58/209.75  |- mesh__historyNote mesh__D003866
% 209.58/209.75       81; DEPRESSION, NEUROTIC was DEPRESSIVE NEUROSES see DEPRESSION, REACTIVE 1979-80, see under DEPRESSION, REACTIVE 1969-78%A%  
% 209.58/209.75  |- skos__historyNote mesh__D003866 Adjustment Disorders %28%1966-1980%29%
% 209.58/209.75  |- skos__hiddenLabel mesh__D003866 Disorders, Depressive
% 209.58/209.75  |- skos__hiddenLabel mesh__D003866 Endogenous Depressions
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D003866 2000
% 209.58/209.75  |- skos__hiddenLabel mesh__D003866 Disorder, Depressive
% 209.58/209.75  |- mesh__recordOriginator mesh__D003866 EC
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D003866 2006
% 209.58/209.75  |- mesh__dateCreated mesh__D003866 1980-05-21
% 209.58/209.75  |- skos__annotation mesh__D003866
% 209.58/209.75       do not confuse with DEPRESSION: see note there; depression lasting over 2 years = DYSTHYMIC DISORDER%A%  
% 209.58/209.75  |- skos__hiddenLabel mesh__D003866 Unipolar Depressions
% 209.58/209.75  |- skos__hiddenLabel mesh__D003866 Depressions, Unipolar
% 209.58/209.75  |- skos__hiddenLabel mesh__D003866 Depressive Syndromes
% 209.58/209.75  |- skos__prefLabel mesh__D003866 Depressive Disorder
% 209.58/209.75  |- skos__altLabel mesh__D003866 Neurosis, Depressive
% 209.58/209.75  |- mesh__dateEstablished mesh__D003866 1981-01-01
% 209.58/209.75  |- rdf__type mesh__D003866sskos__Concept
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D003866 2005
% 209.58/209.75  |- skos__hiddenLabel mesh__D003866 Neuroses, Depressive
% 209.58/209.75  |- skos__hiddenLabel mesh__D003866 Melancholias
% 209.58/209.75  |- skos__hiddenLabel mesh__D003866 Depressive Neuroses
% 209.58/209.75  |- skos__hiddenLabel mesh__D003866 Depressive Neurosis
% 209.58/209.75  |- skos__hiddenLabel mesh__D003866 Neurotic Depression
% 209.58/209.75  |- skos__hiddenLabel mesh__D003866 Depressive Disorders
% 209.58/209.75  |- mesh__recordAuthorizer mesh__D003866 SJN
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D003866 2004
% 209.58/209.75  |- skos__historyNote mesh__D003866 Depression %28%1966-1980%29%
% 209.58/209.75  |- skos__hiddenLabel mesh__D003866 Syndromes, Depressive
% 209.58/209.75  |- mesh__onlineNote mesh__D003866
% 209.58/209.75       use ADJUSTMENT DISORDERS to search DEPRESSIVE NEUROSES 1969-80%A%  
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D003866 1999
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D003866 2002
% 209.58/209.75  |- skos__hiddenLabel mesh__D003866 Syndrome, Depressive
% 209.58/209.75  |- skos__broader mesh__D001853Q000166smesh__D001853
% 209.58/209.75  |- mesh__preferredCombination mesh__D001853Q000166smesh__D001854
% 209.58/209.75  |- rdf__type mesh__D001853Q000166smesh__CompoundConcept
% 209.58/209.75  |- skos__prefLabel mesh__D003068 Coercion
% 209.58/209.75  |- skos__hiddenLabel mesh__D003068 Fertility Control, Involuntary
% 209.58/209.75  |- mesh__recordAuthorizer mesh__D003068 sjn
% 209.58/209.75  |- mesh__historyNote mesh__D003068 78   
% 209.58/209.75  |- mesh__recordOriginator mesh__D003068 EC
% 209.58/209.75  |- mesh__dateCreated mesh__D003068 1977-04-22
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D003068 2006
% 209.58/209.75  |- mesh__dateRevised mesh__D003068 2002-07-03
% 209.58/209.75  |- mesh__recordMaintainer mesh__D003068 hjn
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D003068 2005
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D003068 2004
% 209.58/209.75  |- skos__related mesh__D003068smesh__D037141
% 209.58/209.75  |- rdf__type mesh__D003068sskos__Concept
% 209.58/209.75  |- mesh__activeMeSHYear mesh__D003068 2003
% 209.58/209.75  |- mesh__dateEstablished mesh__D003068 1978-01-01
% 209.58/209.75  |- mesh__publicMeSHNote mesh__D003068 78   
% 209.58/209.75  |- skos__broader mesh__D003068smesh__D012927
% 209.58/209.75  |- skos__scopeNote mesh__D003068
% 209.58/209.75       The use of force or intimidation to obtain compliance.     
% 209.58/209.75  |- skos__broader mesh__D003068smesh__D012926
% 209.58/209.75  |- mesh__recordOriginator mesh__D008551 NLM
% 209.58/209.75  |- rdf__type mesh__D008551sskos__Concept
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D008551 2005
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D008551 2004
% 209.58/209.76  |- skos__broader mesh__D008551smesh__D005243
% 209.58/209.76  |- mesh__dateCreated mesh__D008551 1999-01-01
% 209.58/209.76  |- skos__scopeNote mesh__D008551
% 209.58/209.76       The black, tarry, foul-smelling FECES that contain degraded blood.%A%    
% 209.58/209.76  |- skos__prefLabel mesh__D008551 Melena
% 209.58/209.76  |- mesh__recordMaintainer mesh__D008551 lkt
% 209.58/209.76  |- skos__hiddenLabel mesh__D008551 Melenas
% 209.58/209.76  |- mesh__recordAuthorizer mesh__D008551 sjn
% 209.58/209.76  |- mesh__dateRevised mesh__D008551 2003-07-09
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D008551 2006
% 209.58/209.76  |- skos__broader mesh__D008551smesh__D006471
% 209.58/209.76  |- skos__altLabel mesh__D022222 Human Artificial Chromosomes
% 209.58/209.76  |- mesh__recordMaintainer mesh__D022222 sjn
% 209.58/209.76  |- skos__altLabel mesh__D022222 Chromosomes, Human Artificial
% 209.58/209.76  |- mesh__recordAuthorizer mesh__D022222 sjn
% 209.58/209.76  |- mesh__publicMeSHNote mesh__D022222
% 209.58/209.76       2002; see CHROMOSOMES, HUMAN ARTIFICIAL 2001   
% 209.58/209.76  |- skos__hiddenLabel mesh__D022222 Artificial Chromosome, Human
% 209.58/209.76  |- skos__annotation mesh__D022222
% 209.58/209.76       coord with specific human chromosome /genet  only if particularly discussed%A%  
% 209.58/209.76  |- skos__altLabel mesh__D022222 Artificial Chromosomes, Human
% 209.58/209.76  |- skos__broader mesh__D022222smesh__D022221
% 209.58/209.76  |- skos__hiddenLabel mesh__D022222 Chromosome, Human Artificial
% 209.58/209.76  |- mesh__dateEstablished mesh__D022222 2001-01-01
% 209.58/209.76  |- mesh__dateRevised mesh__D022222 2004-07-13
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D022222 2006
% 209.58/209.76  |- skos__scopeNote mesh__D022222
% 209.58/209.76       DNA constructs that are composed of, at least, all elements, such as a REPLICATION ORIGIN; TELOMERE; and CENTROMERE, required for successful replication, propagation to and maintainance in progeny human cells. In addition, they are constructed to carry other sequences for analysis or gene transfer.%A%    
% 209.58/209.76  |- skos__broader mesh__D022222smesh__D002877
% 209.58/209.76  |- skos__prefLabel mesh__D022222 Chromosomes, Artificial, Human
% 209.58/209.76  |- skos__altLabel mesh__D022222 HACs %28%Chromosomes%29%
% 209.58/209.76  |- skos__historyNote mesh__D022222 Chromosomes %28%1992-2000%29%
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D022222 2005
% 209.58/209.76  |- skos__hiddenLabel mesh__D022222 Human Artificial Chromosome
% 209.58/209.76  |- mesh__dateCreated mesh__D022222 2000-06-21
% 209.58/209.76  |- mesh__historyNote mesh__D022222 2002%28%2001%29%   
% 209.58/209.76  |- rdf__type mesh__D022222sskos__Concept
% 209.58/209.76  |- skos__altLabel mesh__D022222 HAC %28%Chromosome%29%
% 209.58/209.76  |- mesh__recordOriginator mesh__D022222 nns
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D013496 2003
% 209.58/209.76  |- skos__hiddenLabel mesh__D013496 TN762
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D013496 2001
% 209.58/209.76  |- skos__broader mesh__D013496smesh__D010666
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D013496 2005
% 209.58/209.76  |- skos__hiddenLabel mesh__D013496 R 25061
% 209.58/209.76  |- mesh__historyNote mesh__D013496
% 209.58/209.76       90%28%78%29%; was see under PHENYLPROPIONATES 1978-89   
% 209.58/209.76  |- mesh__dateRevised mesh__D013496 2000-06-22
% 209.58/209.76  |- mesh__recordOriginator mesh__D013496 SH
% 209.58/209.76  |- mesh__recordAuthorizer mesh__D013496 sjn
% 209.58/209.76  |- mesh__recordMaintainer mesh__D013496 CCR
% 209.58/209.76  |- skos__scopeNote mesh__D013496
% 209.58/209.76       An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It inhibits prostaglandin synthesis and has been proposed as an anti-arthritic.%A%    
% 209.58/209.76  |- skos__hiddenLabel mesh__D013496 R25061
% 209.58/209.76  |- rdf__type mesh__D013496sskos__Concept
% 209.58/209.76  |- mesh__publicMeSHNote mesh__D013496
% 209.58/209.76       90; was see under PHENYLPROPIONATES 1978-89   
% 209.58/209.76  |- skos__historyNote mesh__D013496 Benzene Derivatives %28%1968-1973%29%
% 209.58/209.76  |- mesh__dateEstablished mesh__D013496 1990-01-01
% 209.58/209.76  |- skos__hiddenLabel mesh__D013496 TN 762
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D013496 2004
% 209.58/209.76  |- skos__prefLabel mesh__D013496 Suprofen
% 209.58/209.76  |- mesh__dateCreated mesh__D013496 1977-04-22
% 209.58/209.76  |- skos__historyNote mesh__D013496 Thiophenes %28%1966-1977%29%
% 209.58/209.76  |- skos__historyNote mesh__D013496 Phenylpropionates %28%1974-1977%29%
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D013496 2002
% 209.58/209.76  |- skos__historyNote mesh__D013496 Propionates %28%1966-1973%29%
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D013496 2006
% 209.58/209.76  |- skos__broader mesh__D001419Q000502smesh__D001419
% 209.58/209.76  |- mesh__preferredCombination mesh__D001419Q000502smesh__D018407
% 209.58/209.76  |- rdf__type mesh__D001419Q000502smesh__CompoundConcept
% 209.58/209.76  |- skos__prefLabel mesh__D007459 Iodized Oil
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D007459 2006
% 209.58/209.76  |- mesh__publicMeSHNote mesh__D007459
% 209.58/209.76       94; was IODIZED OILS 1963-93; OIL, IODIZED was OILS, IODIZED 1963-93; LIPIODOL was heading 1975-93 %28%see under IODIZED OILS 1975-90%29%; IODOLIPOL was indexed under IODIZED OILS 1967-93%A%  
% 209.58/209.76  |- mesh__historyNote mesh__D007459
% 209.58/209.76       94; was IODIZED OILS 1963-93; OIL, IODIZED was OILS, IODIZED 1963-93; LIPIODOL was heading 1975-93 %28%see under IODIZED OILS 1975-90%29%; IODOLIPOL was %28%NM%29% 1967-93%A%  
% 209.58/209.76  |- skos__hiddenLabel mesh__D007459 Oils, Iodized
% 209.58/209.76  |- mesh__recordOriginator mesh__D007459 NLM
% 209.58/209.76  |- mesh__recordAuthorizer mesh__D007459 sjn
% 209.58/209.76  |- rdf__type mesh__D007459sskos__Concept
% 209.58/209.76  |- mesh__recordMaintainer mesh__D007459 ssb
% 209.58/209.76  |- skos__annotation mesh__D007459 D25-26 qualif   
% 209.58/209.76  |- skos__scopeNote mesh__D007459
% 209.58/209.76       The mixture contains 38-42%25% organically combined iodine that is used as a diagnostic aid %28%radiopaque medium%29%. %28%From Merck Index, 11th ed%29%%A%    
% 209.58/209.76  |- mesh__dateCreated mesh__D007459 1999-01-01
% 209.58/209.76  |- skos__broader mesh__D007459smesh__D010938
% 209.58/209.76  |- mesh__onlineNote mesh__D007459
% 209.58/209.76       use IODIZED OIL to search IODIZED OILS 1966-93 %26% LIPIODOL 1975-93; use IODIZED OIL %28%NM%29% to search IODOLIPOL 1980-93%A%  
% 209.58/209.76  |- skos__altLabel mesh__D007459 Iodolipol
% 209.58/209.76  |- skos__altLabel mesh__D007459 Oil, Iodized
% 209.58/209.76  |- skos__altLabel mesh__D007459 Iodized Oils
% 209.58/209.76  |- mesh__dateRevised mesh__D007459 2005-06-30
% 209.58/209.76  |- skos__altLabel mesh__D018181 Mouse, Inbred CFTR
% 209.58/209.76  |- mesh__historyNote mesh__D018181 94   
% 209.58/209.76  |- skos__hiddenLabel mesh__D018181 CFTR Mouse
% 209.58/209.76  |- mesh__dateCreated mesh__D018181 1993-06-03
% 209.58/209.76  |- mesh__recordAuthorizer mesh__D018181 sjn
% 209.58/209.76  |- skos__annotation mesh__D018181
% 209.58/209.76       NIM when exper animal: no qualif; when IM, qualif permitted; used a model for cystic fibrosis; do not forget also to check tag MICE%A%  
% 209.58/209.76  |- skos__historyNote mesh__D018181 Mice %28%1992-1993%29%
% 209.58/209.76  |- skos__hiddenLabel mesh__D018181 CFTR Mouse, Inbred
% 209.58/209.76  |- skos__hiddenLabel mesh__D018181 Inbred CFTR Mice
% 209.58/209.76  |- mesh__recordMaintainer mesh__D018181 ags
% 209.58/209.76  |- skos__altLabel mesh__D018181 Mice, CFTR
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D018181 2006
% 209.58/209.76  |- rdf__type mesh__D018181sskos__Concept
% 209.58/209.76  |- mesh__dateEstablished mesh__D018181 1994-01-01
% 209.58/209.76  |- skos__prefLabel mesh__D018181 Mice, Inbred CFTR
% 209.58/209.76  |- skos__altLabel mesh__D018181 Mouse, CFTR
% 209.58/209.76  |- mesh__publicMeSHNote mesh__D018181 94   
% 209.58/209.76  |- skos__hiddenLabel mesh__D018181 Inbred CFTR Mouse
% 209.58/209.76  |- skos__hiddenLabel mesh__D018181 CFTR Mice
% 209.58/209.76  |- skos__broader mesh__D018181smesh__D008815
% 209.58/209.76  |- skos__hiddenLabel mesh__D018181 CFTR Mice, Inbred
% 209.58/209.76  |- mesh__recordOriginator mesh__D018181 PXP
% 209.58/209.76  |- mesh__dateRevised mesh__D018181 2005-06-30
% 209.58/209.76  |- skos__scopeNote mesh__D018181
% 209.58/209.76       A strain of mice widely studied as a model for cystic fibrosis. These mice are generated from embryonic stem cells in which the CFTR %28%cystic fibrosis transmembrane conductance regulator%29% gene is inactivated by gene targeting. As a result, all mice have one copy of this altered gene in all their tissues. Mice homozygous for the disrupted gene exhibit many features common to young cystic fibrosis patients, including failure to thrive, meconium ileus, and alteration of mucous and serous glands.%A%    
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D004161 2003
% 209.58/209.76  |- mesh__recordOriginator mesh__D004161 SH
% 209.58/209.76  |- rdf__type mesh__D004161sskos__Concept
% 209.58/209.76  |- skos__altLabel mesh__D004161 1,6-Diphenyl-1,3,5-hexatriene
% 209.58/209.76  |- skos__hiddenLabel mesh__D004161 1,6 Diphenylhexatriene
% 209.58/209.76  |- skos__prefLabel mesh__D004161 Diphenylhexatriene
% 209.58/209.76  |- skos__altLabel mesh__D004161 1,6-Diphenylhexatriene
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D004161 2006
% 209.58/209.76  |- mesh__dateRevised mesh__D004161 2000-06-22
% 209.58/209.76  |- mesh__dateEstablished mesh__D004161 1991-01-01
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D004161 2002
% 209.58/209.76  |- skos__broader mesh__D004161smesh__D011090
% 209.58/209.76  |- skos__historyNote mesh__D004161
% 209.58/209.76       Spectrometry, Fluorescence %28%1974-1979%29%
% 209.58/209.76  |- mesh__publicMeSHNote mesh__D004161 91; was see under POLYENES 1980-90   
% 209.58/209.76  |- mesh__historyNote mesh__D004161
% 209.58/209.76       91%28%80%29%; was see under POLYENES 1980-90   
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D004161 2005
% 209.58/209.76  |- mesh__recordAuthorizer mesh__D004161 sjn
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D004161 2001
% 209.58/209.76  |- skos__scopeNote mesh__D004161
% 209.58/209.76       A fluorescent compound that emits light only in specific configurations in certain lipid media. It is used as a tool in the study of membrane lipids.%A%    
% 209.58/209.76  |- mesh__dateCreated mesh__D004161 1979-05-30
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D004161 2004
% 209.58/209.76  |- mesh__recordMaintainer mesh__D004161 CCR
% 209.58/209.76  |- skos__historyNote mesh__D004161 Polyenes %28%1966-1979%29%
% 209.58/209.76  |- skos__altLabel mesh__D017887
% 209.58/209.76       Posterior Longitudinal Ligament Calcification
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D017887 2001
% 209.58/209.76  |- mesh__dateRevised mesh__D017887 1999-11-03
% 209.58/209.76  |- mesh__dateEstablished mesh__D017887 1994-01-01
% 209.58/209.76  |- mesh__recordOriginator mesh__D017887 TGC
% 209.58/209.76  |- skos__historyNote mesh__D017887
% 209.58/209.76       Ossification, Heterotopic %28%1967-1993%29%
% 209.58/209.76  |- skos__historyNote mesh__D017887 Calcinosis %28%1969-1993%29%
% 209.58/209.76  |- skos__broader mesh__D017887smesh__D013122
% 209.58/209.76  |- mesh__recordMaintainer mesh__D017887 KEV
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D017887 2004
% 209.58/209.76  |- mesh__dateCreated mesh__D017887 1993-02-16
% 209.58/209.76  |- mesh__recordAuthorizer mesh__D017887 sjn
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D017887 2000
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D017887 2006
% 209.58/209.76  |- skos__broader mesh__D017887smesh__D009999
% 209.58/209.76  |- rdf__type mesh__D017887sskos__Concept
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D017887 2003
% 209.58/209.76  |- skos__altLabel mesh__D017887
% 209.58/209.76       Posterior Longitudinal Ligament Ossification
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D017887 2005
% 209.58/209.76  |- skos__annotation mesh__D017887 DF: OPLL   
% 209.58/209.76  |- mesh__publicMeSHNote mesh__D017887 94   
% 209.58/209.76  |- skos__altLabel mesh__D017887
% 209.58/209.76       Calcification of Posterior Longitudinal Ligament
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D017887 2002
% 209.58/209.76  |- mesh__historyNote mesh__D017887 94   
% 209.58/209.76  |- skos__scopeNote mesh__D017887
% 209.58/209.76       A calcification of the posterior longitudinal ligament of the spinal column, usually at the level of the cervical spine. It is often associated with anterior ankylosing hyperostosis.%A%    
% 209.58/209.76  |- skos__prefLabel mesh__D017887
% 209.58/209.76       Ossification of Posterior Longitudinal Ligament
% 209.58/209.76  |- skos__altLabel mesh__D017089 ANK Repeat
% 209.58/209.76  |- skos__historyNote mesh__D017089 Membrane Proteins %28%1990-1992%29%
% 209.58/209.76  |- skos__hiddenLabel mesh__D017089 Repeat, Ankyrin-Like
% 209.58/209.76  |- skos__altLabel mesh__D017089 Ankyrin Repeats
% 209.58/209.76  |- skos__historyNote mesh__D017089 Amino Acid Sequence %28%1990-1992%29%
% 209.58/209.76  |- mesh__dateRevised mesh__D017089 2005-07-07
% 209.58/209.76  |- skos__broader mesh__D017089smesh__D020449
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D017089 2006A
% 209.58/209.76  |- skos__broader mesh__D017089smesh__D020816
% 209.58/209.76  |- skos__hiddenLabel mesh__D017089 Repeats, Ankyrin-Like
% 209.58/209.76  |- rdf__type mesh__D017089sskos__Concept
% 209.58/209.76  |- mesh__recordMaintainer mesh__D017089 ags
% 209.58/209.76  |- mesh__publicMeSHNote mesh__D017089 93   
% 209.58/209.76  |- skos__hiddenLabel mesh__D017089 Ankyrin-Like Repeat
% 209.58/209.76  |- mesh__recordAuthorizer mesh__D017089 ags
% 209.58/209.76  |- mesh__historyNote mesh__D017089 93   
% 209.58/209.76  |- skos__scopeNote mesh__D017089
% 209.58/209.76       Protein motif that contains a 33-amino acid long sequence that often occurs in tandem arrays. This repeating sequence of 33-amino acids was discovered in ANKYRIN where it is involved in interaction with the anion exchanger %28%ANION EXCHANGE PROTEIN 1, ERYTHROCYTE%29%. Ankyrin repeats cooperatively fold into structures that mediate molecular recognition via protein-protein interactions.%A%    
% 209.58/209.76  |- skos__hiddenLabel mesh__D017089 Repeat, ANK
% 209.58/209.76  |- skos__hiddenLabel mesh__D017089 Repeats, Ankyrin
% 209.58/209.76  |- skos__prefLabel mesh__D017089 Ankyrin Repeat
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D017089 2005
% 209.58/209.76  |- skos__hiddenLabel mesh__D017089 Ankyrin Like Repeats
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D017089 2006
% 209.58/209.76  |- mesh__dateEstablished mesh__D017089 1993-01-01
% 209.58/209.76  |- mesh__dateCreated mesh__D017089 1992-05-13
% 209.58/209.76  |- skos__hiddenLabel mesh__D017089 Repeat, Ankyrin
% 209.58/209.76  |- skos__hiddenLabel mesh__D017089 Repeats, ANK
% 209.58/209.76  |- mesh__recordOriginator mesh__D017089 PXP
% 209.58/209.76  |- skos__hiddenLabel mesh__D017089 ANK Repeats
% 209.58/209.76  |- mesh__dateCreated mesh__D003867 1999-01-01
% 209.58/209.76  |- mesh__recordMaintainer mesh__D003867 nns
% 209.58/209.76  |- skos__hiddenLabel mesh__D003867 Stereoscopic Visions
% 209.58/209.76  |- mesh__dateRevised mesh__D003867 2003-07-09
% 209.58/209.76  |- skos__altLabel mesh__D003867 Stereopsis
% 209.58/209.76  |- skos__hiddenLabel mesh__D003867 Perceptions, Depth
% 209.58/209.76  |- skos__scopeNote mesh__D003867 Perception of three-dimensionality.     
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D003867 2006
% 209.58/209.76  |- skos__broader mesh__D003867smesh__D010465
% 209.58/209.76  |- mesh__recordOriginator mesh__D003867 NLM
% 209.58/209.76  |- skos__hiddenLabel mesh__D003867 Perception, Depth
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D003867 2005
% 209.58/209.76  |- skos__hiddenLabel mesh__D003867 Stereopses
% 209.58/209.76  |- skos__prefLabel mesh__D003867 Depth Perception
% 209.58/209.76  |- mesh__recordAuthorizer mesh__D003867 sjn
% 209.58/209.76  |- skos__broader mesh__D003867smesh__D014796
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D003867 2004
% 209.58/209.76  |- skos__hiddenLabel mesh__D003867 Vision, Stereoscopic
% 209.58/209.76  |- skos__altLabel mesh__D003867 Stereoscopic Vision
% 209.58/209.76  |- skos__broader mesh__D003867smesh__D013028
% 209.58/209.76  |- rdf__type mesh__D003867sskos__Concept
% 209.58/209.76  |- skos__annotation mesh__D003867
% 209.58/209.76       disord of depth perception: coord IM with PERCEPTUAL DISORDERS %28%IM%29%%A%  
% 209.58/209.76  |- skos__hiddenLabel mesh__D003867 Visions, Stereoscopic
% 209.58/209.76  |- skos__hiddenLabel mesh__D003867 Depth Perceptions
% 209.58/209.76  |- skos__related mesh__D003069smesh__D040503
% 209.58/209.76  |- skos__related mesh__D003069smesh__D018651
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D003069 2006
% 209.58/209.76  |- mesh__recordOriginator mesh__D003069 NLM
% 209.58/209.76  |- mesh__dateRevised mesh__D003069 2004-07-19
% 209.58/209.76  |- mesh__recordAuthorizer mesh__D003069 sjn
% 209.58/209.76  |- mesh__dateCreated mesh__D003069 1999-01-01
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D003069 2005
% 209.58/209.76  |- mesh__recordMaintainer mesh__D003069 jls
% 209.58/209.76  |- rdf__type mesh__D003069sskos__Concept
% 209.58/209.76  |- skos__related mesh__D003069smesh__D002110
% 209.58/209.76  |- skos__scopeNote mesh__D003069
% 209.58/209.76       A beverage made from ground COFFEA beans %28%SEEDS%29% infused in hot water. It generally contains CAFFEINE and THEOPHYLLINE unless it is decaffeinated.%A%    
% 209.58/209.76  |- skos__annotation mesh__D003069 for the plant use COFFEA   
% 209.58/209.76  |- skos__prefLabel mesh__D003069 Coffee
% 209.58/209.76  |- skos__broader mesh__D003069smesh__D001628
% 209.58/209.76  |- mesh__dateEstablished mesh__D008552 1991-01-01
% 209.58/209.76  |- skos__scopeNote mesh__D008552
% 209.58/209.76       A 6-methyl PROGESTERONE acetate with reported glucocorticoid activity and effect on ESTRUS.%A%    
% 209.58/209.76  |- mesh__historyNote mesh__D008552
% 209.58/209.76       97; was MELENGESTROL 1973-96 %28%see under PREGNADIENES 1973-90%29%%A%  
% 209.58/209.76  |- mesh__dateCreated mesh__D008552 1999-01-01
% 209.58/209.76  |- mesh__recordOriginator mesh__D008552 NLM
% 209.58/209.76  |- skos__historyNote mesh__D008552 Pregnadienes %28%1966-1972%29%
% 209.58/209.76  |- skos__historyNote mesh__D008552
% 209.58/209.76       Progestational Hormones %28%1966-1972%29%
% 209.58/209.76  |- skos__broader mesh__D008552smesh__D011245
% 209.58/209.76  |- mesh__publicMeSHNote mesh__D008552
% 209.58/209.76       97; was MELENGESTROL 1973-96 %28%see under PREGNADIENES 1973-90%29%%A%  
% 209.58/209.76  |- mesh__dateRevised mesh__D008552 2003-07-09
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D008552 2006
% 209.58/209.76  |- skos__hiddenLabel mesh__D008552 Acetate, Melengestrol
% 209.58/209.76  |- rdf__type mesh__D008552sskos__Concept
% 209.58/209.76  |- skos__prefLabel mesh__D008552 Melengestrol Acetate
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D008552 2005
% 209.58/209.76  |- mesh__recordMaintainer mesh__D008552 lkt
% 209.58/209.76  |- mesh__recordAuthorizer mesh__D008552 sjn
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D008552 2004
% 209.58/209.76  |- skos__historyNote mesh__D022223 Vaccines, Synthetic %28%1978-2000%29%
% 209.58/209.76  |- mesh__historyNote mesh__D022223 2001   
% 209.58/209.76  |- mesh__recordOriginator mesh__D022223 ags
% 209.58/209.76  |- mesh__dateEstablished mesh__D022223 2001-01-01
% 209.58/209.76  |- skos__hiddenLabel mesh__D022223 Subunit Vaccines
% 209.58/209.76  |- mesh__recordAuthorizer mesh__D022223 sjn
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D022223 2006
% 209.58/209.76  |- rdf__type mesh__D022223sskos__Concept
% 209.58/209.76  |- skos__annotation mesh__D022223
% 209.58/209.76       IM general only; coord NIM with specific vaccine %28%IM%29%   
% 209.58/209.76  |- mesh__publicMeSHNote mesh__D022223 2001   
% 209.58/209.76  |- mesh__dateCreated mesh__D022223 2000-06-22
% 209.58/209.76  |- skos__prefLabel mesh__D022223 Vaccines, Subunit
% 209.58/209.76  |- skos__scopeNote mesh__D022223
% 209.58/209.76       Vaccines consisting of one or more antigens that stimulate a strong immune response. They are purified from microorganisms or produced by recombinant DNA techniques, or they can be chemically synthesized peptides.%A%    
% 209.58/209.76  |- skos__altLabel mesh__D022223 Peptide Vaccines
% 209.58/209.76  |- skos__broader mesh__D022223smesh__D014612
% 209.58/209.76  |- mesh__recordMaintainer mesh__D022223 ssb
% 209.58/209.76  |- mesh__dateRevised mesh__D022223 2005-06-30
% 209.58/209.76  |- skos__annotation mesh__D013497
% 209.58/209.76       dis: coord IM with PERIPHERAL NERVOUS SYSTEM DISEASES %28%IM%29%; neopl: coord IM with PERIPHERAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 209.58/209.76  |- skos__broader mesh__D013497smesh__D013979
% 209.58/209.76  |- mesh__publicMeSHNote mesh__D013497
% 209.58/209.76       91; was see under SPINAL NERVES 1971-90   
% 209.58/209.76  |- skos__hiddenLabel mesh__D013497 Sural Nerves
% 209.58/209.76  |- mesh__historyNote mesh__D013497
% 209.58/209.76       91%28%71%29%; was see under SPINAL NERVES 1971-90   
% 209.58/209.76  |- mesh__dateRevised mesh__D013497 1999-11-03
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D013497 2000
% 209.58/209.76  |- mesh__recordMaintainer mesh__D013497 kle
% 209.58/209.76  |- skos__hiddenLabel mesh__D013497 Nerve, Sural
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D013497 2001
% 209.58/209.76  |- skos__hiddenLabel mesh__D013497 Nerves, Sural
% 209.58/209.76  |- skos__historyNote mesh__D013497 Leg/innervation %28%1966-1970%29%
% 209.58/209.76  |- mesh__recordOriginator mesh__D013497 NLM
% 209.58/209.76  |- skos__historyNote mesh__D013497 Spinal Nerves %28%1966-1970%29%
% 209.58/209.76  |- rdf__type mesh__D013497sskos__Concept
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D013497 2003
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D013497 2005
% 209.58/209.76  |- mesh__dateCreated mesh__D013497 1999-01-01
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D013497 2004
% 209.58/209.76  |- mesh__recordAuthorizer mesh__D013497 sjn
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D013497 2002
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D013497 2006
% 209.58/209.76  |- skos__prefLabel mesh__D013497 Sural Nerve
% 209.58/209.76  |- mesh__dateEstablished mesh__D013497 1991-01-01
% 209.58/209.76  |- skos__scopeNote mesh__D013497
% 209.58/209.76       A branch of the tibial nerve which supplies sensory innervation to parts of the lower leg and foot.%A%    
% 209.58/209.76  |- skos__related mesh__D018980smesh__D004549
% 209.58/209.76  |- mesh__dateEstablished mesh__D018980 1996-01-01
% 209.58/209.76  |- skos__scopeNote mesh__D018980
% 209.58/209.76       A contiguous gene syndrome associated with a heterozygous microdeletion in the chromosomal region 7q11.23, encompassing the ELASTIN gene. Clinical manifestations include supravalvular aortic stenosis %28%AORTIC STENOSIS, SUPRAVALVULAR%29%, MENTAL RETARDATION, elfin facies, impaired visuospatial constructive abilities, and transient hypercalcemia in infancy. The condition affects both sexes, with onset at birth or in early infancy.%A%    
% 209.58/209.76  |- skos__hiddenLabel mesh__D018980 Williams Beuren Syndrome
% 209.58/209.76  |- skos__historyNote mesh__D018980 Aortic Valve Stenosis %28%1969-1995%29%
% 209.58/209.76  |- skos__altLabel mesh__D018980 Williams-Beuren Syndrome
% 209.58/209.76  |- skos__prefLabel mesh__D018980 Williams Syndrome
% 209.58/209.76  |- mesh__recordAuthorizer mesh__D018980 sjn
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D018980 2002
% 209.58/209.76  |- skos__broader mesh__D018980smesh__D025063
% 209.58/209.76  |- rdf__type mesh__D018980sskos__Concept
% 209.58/209.76  |- skos__hiddenLabel mesh__D018980 Syndrome, Elfin Facies
% 209.58/209.76  |- skos__altLabel mesh__D018980 Elfin Facies Syndrome
% 209.58/209.76  |- skos__hiddenLabel mesh__D018980 Syndrome, Williams
% 209.58/209.76  |- mesh__publicMeSHNote mesh__D018980 96   
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D018980 2006
% 209.58/209.76  |- skos__altLabel mesh__D018980 Contiguous Gene Syndrome, Williams
% 209.58/209.76  |- mesh__dateRevised mesh__D018980 2001-07-25
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D018980 2004
% 209.58/209.76  |- skos__related mesh__D018980smesh__D008607
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D018980 2005
% 209.58/209.76  |- mesh__historyNote mesh__D018980 96   
% 209.58/209.76  |- skos__hiddenLabel mesh__D018980 Syndrome, Williams-Beuren
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D018980 2003
% 209.58/209.76  |- skos__broader mesh__D018980smesh__D021921
% 209.58/209.76  |- skos__annotation mesh__D018980
% 209.58/209.76       do not confuse with Williams-Campbell syndrome, congen bronchomalacia causing bronchiectasis%A%  
% 209.58/209.76  |- skos__altLabel mesh__D018980 Williams Contiguous Gene Syndrome
% 209.58/209.76  |- mesh__recordOriginator mesh__D018980 TGC
% 209.58/209.76  |- skos__hiddenLabel mesh__D018980 Elfin Facies Syndromes
% 209.58/209.76  |- mesh__dateCreated mesh__D018980 1995-05-24
% 209.58/209.76  |- skos__broader mesh__D018980smesh__D008607
% 209.58/209.76  |- mesh__recordMaintainer mesh__D018980 nns
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D018182 1996
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D018182 2003
% 209.58/209.76  |- skos__scopeNote mesh__D018182
% 209.58/209.76       Infections with viruses of the genus PESTIVIRUS, family FLAVIVIRIDAE.%A%    
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D018182 1998
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D018182 2005
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D018182 1997
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D018182 2004
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D018182 1994
% 209.58/209.76  |- mesh__dateCreated mesh__D018182 1993-06-04
% 209.58/209.76  |- skos__hiddenLabel mesh__D018182 Infection, Pestivirus
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D018182 2002
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D018182 1999
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D018182 2006
% 209.58/209.76  |- skos__broader mesh__D018182smesh__D018178
% 209.58/209.76  |- skos__prefLabel mesh__D018182 Pestivirus Infections
% 209.58/209.76  |- skos__altLabel mesh__D018182 Infections, Pestivirus
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D018182 1995
% 209.58/209.76  |- skos__annotation mesh__D018182
% 209.58/209.76       caused by a flavivirus; GEN or unspecified; prefer specifics%A%  
% 209.58/209.76  |- mesh__dateEstablished mesh__D018182 1994-01-01
% 209.58/209.76  |- rdf__type mesh__D018182sskos__Concept
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D018182 2000
% 209.58/209.76  |- skos__hiddenLabel mesh__D018182 Pestivirus Infection
% 209.58/209.76  |- mesh__historyNote mesh__D018182 94   
% 209.58/209.76  |- mesh__publicMeSHNote mesh__D018182 94   
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D018182 2001
% 209.58/209.76  |- skos__altLabel mesh__D004960 Estradiol Dehydrogenase
% 209.58/209.76  |- skos__hiddenLabel mesh__D004960 17 beta Estradiol Dehydrogenase
% 209.58/209.76  |- rdf__type mesh__D004960sskos__Concept
% 209.58/209.76  |- mesh__historyNote mesh__D004960
% 209.58/209.76       91%28%78%29%; was see under 17-HYDROXYSTEROID DEHYDROGENASES 1978-90; was ESTRADIOL DEHYDROGENASE see under HYDROXYSTEROID DEHYDROGENASES 1975-77%A%  
% 209.58/209.76  |- skos__hiddenLabel mesh__D004960 17 beta-Dehydrogenase, Estradiol
% 209.58/209.76  |- skos__hiddenLabel mesh__D004960 Dehydrogenase, 17 beta-Estradiol
% 209.58/209.76  |- skos__hiddenLabel mesh__D004960 Estradiol 17 alpha Dehydrogenase
% 209.58/209.76  |- skos__scopeNote mesh__D004960
% 209.58/209.76       Enzymes that catalyze the oxidation of estradiol at the 17-hydroxyl group in the presence of NAD+ or NADP+ to yield estrone and NADH or NADPH. The 17-hydroxyl group can be in the alpha- or beta-configuration. EC 1.1.1.62%A%    
% 209.58/209.76  |- mesh__dateEstablished mesh__D004960 1991-01-01
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D004960 2004
% 209.58/209.76  |- skos__hiddenLabel mesh__D004960 17 alpha-Dehydrogenase, Estradiol
% 209.58/209.76  |- mesh__onlineNote mesh__D004960
% 209.58/209.76       use ESTRADIOL DEHYDROGENASES to search ESTRADIOL DEHYDROGENASE 1975-77%A%  
% 209.58/209.76  |- skos__hiddenLabel mesh__D004960 Dehydrogenases, Estradiol
% 209.58/209.76  |- skos__hiddenLabel mesh__D004960 Estradiol 17 beta Dehydrogenase
% 209.58/209.76  |- mesh__publicMeSHNote mesh__D004960
% 209.58/209.76       91; was see under 17-HYDROXYSTEROID DEHYDROGENASES 1978-90; was ESTRADIOL DEHYDROGENASE see under HYDROXYSTEROID DEHYDROGENASES 1975-77%A%  
% 209.58/209.76  |- mesh__recordOriginator mesh__D004960 NLM
% 209.58/209.76  |- skos__broader mesh__D004960smesh__D015067
% 209.58/209.76  |- mesh__dateCreated mesh__D004960 1974-11-19
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D004960 2006
% 209.58/209.76  |- skos__altLabel mesh__D004960 17 beta-Estradiol Dehydrogenase
% 209.58/209.76  |- skos__hiddenLabel mesh__D004960 Dehydrogenase, Estradiol
% 209.58/209.76  |- mesh__recordAuthorizer mesh__D004960 sjn
% 209.58/209.76  |- mesh__recordMaintainer mesh__D004960 ssb
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D004960 2005
% 209.58/209.76  |- mesh__dateRevised mesh__D004960 2003-07-09
% 209.58/209.76  |- skos__historyNote mesh__D004960 Estradiol %28%1973-1974%29%
% 209.58/209.76  |- skos__historyNote mesh__D004960
% 209.58/209.76       Hydroxysteroid Dehydrogenases %28%1973-1974%29%
% 209.58/209.76  |- skos__prefLabel mesh__D004960 Estradiol Dehydrogenases
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D017888 2004
% 209.58/209.76  |- mesh__dateCreated mesh__D017888 1993-02-16
% 209.58/209.76  |- skos__hiddenLabel mesh__D017888 Knee Medial Ligaments
% 209.58/209.76  |- skos__altLabel mesh__D017888 Knee Medial Collateral Ligament
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D017888 2002
% 209.58/209.76  |- skos__hiddenLabel mesh__D017888 Collaterale Tibiales, Ligamentum
% 209.58/209.76  |- skos__hiddenLabel mesh__D017888 Collateral Ligament, Tibial
% 209.58/209.76  |- skos__historyNote mesh__D017888 Ligaments, Articular %28%1968-1993%29%
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D017888 2006
% 209.58/209.76  |- skos__hiddenLabel mesh__D017888 Tibiales, Ligamentum Collaterale
% 209.58/209.76  |- rdf__type mesh__D017888sskos__Concept
% 209.58/209.76  |- skos__annotation mesh__D017888
% 209.58/209.76       an artic ligament between tibia %26% femur: do not confuse with PATELLAR LIGAMENT, between patella %26% tibia%A%  
% 209.58/209.76  |- skos__historyNote mesh__D017888 Ligaments %28%1966-1993%29%
% 209.58/209.76  |- skos__hiddenLabel mesh__D017888 Tibiale, Ligamentum Collaterale
% 209.58/209.76  |- skos__hiddenLabel mesh__D017888 Tibial Collateral Ligaments
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D017888 2003
% 209.58/209.76  |- mesh__recordOriginator mesh__D017888 TGC
% 209.58/209.76  |- mesh__dateRevised mesh__D017888 1999-11-03
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D017888 2001
% 209.58/209.76  |- mesh__dateEstablished mesh__D017888 1994-01-01
% 209.58/209.76  |- mesh__activeMeSHYear mesh__D017888 2005
% 209.58/209.76  |- skos__hiddenLabel mesh__D017888 Ligamentum Collaterale Tibiales
% 209.58/209.76  |- skos__hiddenLabel mesh__D017888 Ligaments, Tibial Collateral
% 209.58/209.76  |- mesh__recordAuthorizer mesh__D017888 sjn
% 209.58/209.76  |- skos__altLabel mesh__D017888 Medial Ligament of Knee
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D017888 2000
% 209.58/209.77  |- skos__hiddenLabel mesh__D017888 Ligament, Tibial Collateral
% 209.58/209.77  |- skos__hiddenLabel mesh__D017888 Knee Medial Ligament
% 209.58/209.77  |- mesh__historyNote mesh__D017888 94   
% 209.58/209.77  |- skos__altLabel mesh__D017888 Tibial Collateral Ligament
% 209.58/209.77  |- skos__broader mesh__D017888smesh__D017885
% 209.58/209.77  |- skos__hiddenLabel mesh__D017888 Collaterale Tibiale, Ligamentum
% 209.58/209.77  |- mesh__publicMeSHNote mesh__D017888 94   
% 209.58/209.77  |- skos__altLabel mesh__D017888 Ligamentum Collaterale Tibiale
% 209.58/209.77  |- skos__altLabel mesh__D017888 Collateral Ligament, Medial, Knee
% 209.58/209.77  |- skos__hiddenLabel mesh__D017888 Collateral Ligaments, Tibial
% 209.58/209.77  |- mesh__recordMaintainer mesh__D017888 KEV
% 209.58/209.77  |- skos__prefLabel mesh__D017888 Medial Collateral Ligament, Knee
% 209.58/209.77  |- skos__scopeNote mesh__D017888
% 209.58/209.77       The ligament that travels from the medial epicondyle of the FEMUR to the medial margin and medial surface of the TIBIA. The medial meniscus is attached to its deep surface.%A%    
% 209.58/209.77  |- skos__broader mesh__D042281smesh__D020561
% 209.58/209.77  |- mesh__recordOriginator mesh__D042281 ags
% 209.58/209.77  |- mesh__historyNote mesh__D042281 2004   
% 209.58/209.77  |- mesh__dateCreated mesh__D042281 2003-07-09
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D042281 2006
% 209.58/209.77  |- mesh__dateEstablished mesh__D042281 2004-01-01
% 209.58/209.77  |- mesh__publicMeSHNote mesh__D042281 2004   
% 209.58/209.77  |- mesh__recordMaintainer mesh__D042281 SYSTEM
% 209.58/209.77  |- skos__prefLabel mesh__D042281 Holosporaceae
% 209.58/209.77  |- mesh__recordAuthorizer mesh__D042281 sjn
% 209.58/209.77  |- rdf__type mesh__D042281sskos__Concept
% 209.58/209.77  |- mesh__dateRevised mesh__D042281 2005-06-30
% 209.58/209.77  |- skos__scopeNote mesh__D042281
% 209.58/209.77       A family of bacteria comprised of endosymbionts of PROTOZOA.%A%    
% 209.58/209.77  |- skos__broader mesh__D003868smesh__D011806
% 209.58/209.77  |- mesh__dateEstablished mesh__D003868 1991-01-01
% 209.58/209.77  |- skos__altLabel mesh__D003868 Sorot
% 209.58/209.77  |- skos__altLabel mesh__D003868 LAB Brand of Dequalinium Chloride
% 209.58/209.77  |- skos__hiddenLabel mesh__D003868 Diundecenoate, Dequalinium
% 209.58/209.77  |- skos__altLabel mesh__D003868 Dequalinium Diacetate
% 209.58/209.77  |- mesh__recordOriginator mesh__D003868 SH
% 209.58/209.77  |- mesh__publicMeSHNote mesh__D003868
% 209.58/209.77       1991; see QUINOLINIUM COMPOUNDS 1976-90; for DECHALINIUM %26% DEQUALONUM see DEQUALINIUM 1976-1993; DYNEXAN-MHP was indexed under DEQUALINIUM, POLYETHYLENES %26% SESQUITERPENES 1977-2000 and under POLYMERS %26% QUINOLINIUM COMPOUNDS 1974-1976%A%  
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D003868 2006
% 209.58/209.77  |- mesh__historyNote mesh__D003868
% 209.58/209.77       1991%28%1976%29%; see QUINOLINIUM COMPOUNDS 1976-1990; for DECHALINIUM %26% DEQUALONUM see DEQUALINIUM 1976-1993%A%  
% 209.58/209.77  |- skos__altLabel mesh__D003868 Decamine
% 209.58/209.77  |- skos__altLabel mesh__D003868 Vemedia Brand of Dequalinium Chloride
% 209.58/209.77  |- skos__altLabel mesh__D003868 Merckle Brand of Dequalinium Chloride
% 209.58/209.77  |- mesh__recordMaintainer mesh__D003868 exl
% 209.58/209.77  |- skos__altLabel mesh__D003868 Ravensberg Brand of Dequalinium Chloride
% 209.58/209.77  |- skos__hiddenLabel mesh__D003868 Di-10-undecenoate, Dequalinium
% 209.58/209.77  |- skos__altLabel mesh__D003868 ratiopharm Brand of Dequalinium Chloride
% 209.58/209.77  |- mesh__dateRevised mesh__D003868 2005-06-30
% 209.58/209.77  |- skos__hiddenLabel mesh__D003868 Diiodide, Dequalinium
% 209.58/209.77  |- skos__altLabel mesh__D003868 Nourypharma Brand of Dequalinium Chloride
% 209.58/209.77  |- mesh__dateCreated mesh__D003868 1975-07-23
% 209.58/209.77  |- skos__hiddenLabel mesh__D003868 Acetate, Dequalinium
% 209.58/209.77  |- rdf__type mesh__D003868sskos__Concept
% 209.58/209.77  |- skos__altLabel mesh__D003868 Dequalinium Dichloride
% 209.58/209.77  |- skos__hiddenLabel mesh__D003868 Dynexan MHP
% 209.58/209.77  |- skos__hiddenLabel mesh__D003868 Dibromide, Dequalinium
% 209.58/209.77  |- skos__altLabel mesh__D003868 Wellspring Brand of Dequalinium Chloride
% 209.58/209.77  |- skos__altLabel mesh__D003868 Boots Brand of Dequalinium Chloride
% 209.58/209.77  |- skos__altLabel mesh__D003868 Inibsa Brand of Dequalinium Chloride
% 209.58/209.77  |- mesh__recordAuthorizer mesh__D003868 sjn
% 209.58/209.77  |- skos__hiddenLabel mesh__D003868 Chloride, Dequalinium
% 209.58/209.77  |- skos__prefLabel mesh__D003868 Dequalinium
% 209.58/209.77  |- skos__historyNote mesh__D003868 Quinolinium Compounds %28%1970-1975%29%
% 209.58/209.77  |- skos__scopeNote mesh__D003868
% 209.58/209.77       A topical bacteriostat that is available as various salts. It is used in wound dressings and mouth infections and may also have antifungal action, but may cause skin ulceration.%A%    
% 209.58/209.77  |- skos__hiddenLabel mesh__D003868 Diacetate, Dequalinium
% 209.58/209.77  |- skos__altLabel mesh__D003868
% 209.58/209.77       Allen %26% Hanburys Brand of Dequalinium Chloride
% 209.58/209.77  |- skos__hiddenLabel mesh__D003868 Dichloride, Dequalinium
% 209.58/209.77  |- skos__related mesh__D014590smesh__D018590
% 209.58/209.77  |- skos__altLabel mesh__D014590 Myometrial Contraction
% 209.58/209.77  |- skos__related mesh__D014590smesh__D010120
% 209.58/209.77  |- rdf__type mesh__D014590sskos__Concept
% 209.58/209.77  |- skos__hiddenLabel mesh__D014590 Contractions, Myometrial
% 209.58/209.77  |- mesh__recordAuthorizer mesh__D014590 NLM
% 209.58/209.77  |- mesh__dateEstablished mesh__D014590 1975-09-01
% 209.58/209.77  |- skos__historyNote mesh__D014590 Uterus %28%1966-1974%29%
% 209.58/209.77  |- skos__hiddenLabel mesh__D014590 Contraction, Myometrial
% 209.58/209.77  |- mesh__recordOriginator mesh__D014590 NLM
% 209.58/209.77  |- skos__broader mesh__D014590smesh__D007743
% 209.58/209.77  |- skos__hiddenLabel mesh__D014590 Myometrial Contractions
% 209.58/209.77  |- skos__broader mesh__D014590smesh__D009119
% 209.58/209.77  |- skos__hiddenLabel mesh__D014590 Contractions, Uterine
% 209.58/209.77  |- mesh__dateRevised mesh__D014590 2005-07-06
% 209.58/209.77  |- mesh__publicMeSHNote mesh__D014590 75   
% 209.58/209.77  |- skos__scopeNote mesh__D014590 Contraction of the UTERINE MUSCLE.     
% 209.58/209.77  |- mesh__historyNote mesh__D014590 75   
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D014590 2006
% 209.58/209.77  |- mesh__recordMaintainer mesh__D014590 NLM
% 209.58/209.77  |- skos__prefLabel mesh__D014590 Uterine Contraction
% 209.58/209.77  |- skos__hiddenLabel mesh__D014590 Uterine Contractions
% 209.58/209.77  |- mesh__dateCreated mesh__D014590 1974-11-11
% 209.58/209.77  |- skos__related mesh__D014590smesh__D015149
% 209.58/209.77  |- skos__related mesh__D014590smesh__D007752
% 209.58/209.77  |- skos__hiddenLabel mesh__D014590 Contraction, Uterine
% 209.58/209.77  |- skos__related mesh__D014590smesh__D015148
% 209.58/209.77  |- mesh__dateCreated mesh__D008553 1977-12-15
% 209.58/209.77  |- mesh__recordMaintainer mesh__D008553 ssb
% 209.58/209.77  |- skos__scopeNote mesh__D008553
% 209.58/209.77       A disaccharide consisting of one galactose and one glucose moiety in an alpha %28%1-6%29% glycosidic linkage.%A%    
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D008553 2006
% 209.58/209.77  |- skos__historyNote mesh__D008553 Disaccharides %28%1966-1978%29%
% 209.58/209.77  |- mesh__recordAuthorizer mesh__D008553 sjn
% 209.58/209.77  |- rdf__type mesh__D008553sskos__Concept
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D008553 2005
% 209.58/209.77  |- mesh__publicMeSHNote mesh__D008553
% 209.58/209.77       91; was see under DISACCHARIDES 1979-90   
% 209.58/209.77  |- mesh__dateRevised mesh__D008553 2004-07-07
% 209.58/209.77  |- skos__broader mesh__D008553smesh__D004187
% 209.58/209.77  |- skos__prefLabel mesh__D008553 Melibiose
% 209.58/209.77  |- mesh__recordOriginator mesh__D008553 RLS
% 209.58/209.77  |- mesh__historyNote mesh__D008553
% 209.58/209.77       91%28%79%29%; was see under DISACCHARIDES 1979-90   
% 209.58/209.77  |- mesh__dateEstablished mesh__D008553 1991-01-01
% 209.58/209.77  |- mesh__dateRevised mesh__D000570 1992-03-25
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000570 2001
% 209.58/209.77  |- skos__hiddenLabel mesh__D000570 Societies, American Cancer
% 209.58/209.77  |- skos__historyNote mesh__D000570 Neoplasms %28%1966-1974%29%
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000570 2005
% 209.58/209.77  |- skos__hiddenLabel mesh__D000570 Cancer Society, American
% 209.58/209.77  |- skos__hiddenLabel mesh__D000570 Cancer Societies, American
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000570 1996
% 209.58/209.77  |- mesh__onlineNote mesh__D000570
% 209.58/209.77       search VOLUNTARY HEALTH AGENCIES 1967-74   
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000570 1993
% 209.58/209.77  |- skos__scopeNote mesh__D000570
% 209.58/209.77       A voluntary organization concerned with the prevention and treatment of cancer through education and research.%A%    
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000570 2000
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000570 1999
% 209.58/209.77  |- mesh__publicMeSHNote mesh__D000570
% 209.58/209.77       91; was see under VOLUNTARY HEALTH AGENCIES 1975-90   
% 209.58/209.77  |- skos__annotation mesh__D000570
% 209.58/209.77       add UNITED STATES or specific state %28%NIM%29%      CATALOG: use NAF entry%A%  
% 209.58/209.77  |- skos__historyNote mesh__D000570 Societies, Scientific %28%1966-1974%29%
% 209.58/209.77  |- skos__hiddenLabel mesh__D000570 Society, American Cancer
% 209.58/209.77  |- mesh__recordMaintainer mesh__D000570 TAP
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000570 1995
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000570 1998
% 209.58/209.77  |- skos__historyNote mesh__D000570 Societies, Medical %28%1966-1974%29%
% 209.58/209.77  |- mesh__recordOriginator mesh__D000570 NLM
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000570 2004
% 209.58/209.77  |- skos__historyNote mesh__D000570
% 209.58/209.77       Voluntary Health Agencies %28%1966-1974%29%
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000570 2002
% 209.58/209.77  |- skos__broader mesh__D000570smesh__D014837
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000570 1994
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000570 2003
% 209.58/209.77  |- skos__historyNote mesh__D000570 specific neoplasm
% 209.58/209.77  |- mesh__historyNote mesh__D000570
% 209.58/209.77       91%28%75%29%; was see under VOLUNTARY HEALTH AGENCIES 1975-90   
% 209.58/209.77  |- mesh__recordAuthorizer mesh__D000570 PLS
% 209.58/209.77  |- skos__prefLabel mesh__D000570 American Cancer Society
% 209.58/209.77  |- skos__hiddenLabel mesh__D000570 American Cancer Societies
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000570 2006
% 209.58/209.77  |- rdf__type mesh__D000570sskos__Concept
% 209.58/209.77  |- mesh__dateCreated mesh__D000570 1999-01-01
% 209.58/209.77  |- mesh__dateEstablished mesh__D000570 1991-01-01
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000570 1997
% 209.58/209.77  |- skos__scopeNote mesh__D013498
% 209.58/209.77       A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. %28%From AMA Drug Evaluations Annual, 1992, p1643%29% It has also been shown to have potent antineoplastic properties.%A%    
% 209.58/209.77  |- mesh__recordAuthorizer mesh__D013498 sjn
% 209.58/209.77  |- skos__hiddenLabel mesh__D013498 Salt Suramin, Monosodium
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D013498 2002
% 209.58/209.77  |- skos__hiddenLabel mesh__D013498 Sodium, Suramin
% 209.58/209.77  |- skos__altLabel mesh__D013498 Suramin, Hexasodium Salt
% 209.58/209.77  |- skos__broader mesh__D013498smesh__D009282
% 209.58/209.77  |- rdf__type mesh__D013498sskos__Concept
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D013498 2003
% 209.58/209.77  |- mesh__dateRevised mesh__D013498 2000-06-22
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D013498 2005
% 209.58/209.77  |- mesh__recordMaintainer mesh__D013498 jmp
% 209.58/209.77  |- mesh__dateCreated mesh__D013498 1999-01-01
% 209.58/209.77  |- skos__hiddenLabel mesh__D013498 Monosodium Salt Suramin
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D013498 2004
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D013498 2001
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D013498 2006
% 209.58/209.77  |- skos__hiddenLabel mesh__D013498 Hexasodium Salt Suramin
% 209.58/209.77  |- mesh__recordOriginator mesh__D013498 NLM
% 209.58/209.77  |- skos__prefLabel mesh__D013498 Suramin
% 209.58/209.77  |- skos__hiddenLabel mesh__D013498 Salt Suramin, Hexasodium
% 209.58/209.77  |- skos__scopeNote mesh__D018981
% 209.58/209.77       An inborn error of carbohydrate metabolism manifesting as a genetic multisystem disorder of autosomal recessive inheritance. A predominant feature is severe central and peripheral nervous system involvement resulting in psychomotor retardation, seizures, cerebellar ataxia, and other symptoms which include growth retardation, retinitis pigmentosa, hypothyroidism, and fatty liver. The notable biochemical feature is the deficiency of a large number of blood glycoproteins and decreased activities of various blood coagulation factors.%A%    
% 209.58/209.77  |- mesh__recordOriginator mesh__D018981 TGC
% 209.58/209.77  |- mesh__recordMaintainer mesh__D018981 nns
% 209.58/209.77  |- rdf__type mesh__D018981sskos__Concept
% 209.58/209.77  |- mesh__dateEstablished mesh__D018981 1996-01-01
% 209.58/209.77  |- skos__broader mesh__D018981smesh__D002239
% 209.58/209.77  |- skos__historyNote mesh__D018981 Glycoproteins %28%1977-1995%29%
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D018981 2006
% 209.58/209.77  |- skos__hiddenLabel mesh__D018981
% 209.58/209.77       Syndrome, Carbohydrate-Deficient Glycoprotein
% 209.58/209.77  |- skos__hiddenLabel mesh__D018981
% 209.58/209.77       Glycoprotein Syndromes, Carbohydrate-Deficient
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D018981 2004
% 209.58/209.77  |- skos__historyNote mesh__D018981
% 209.58/209.77       Carbohydrate Metabolism, Inborn Errors %28%1991-1995%29%
% 209.58/209.77  |- skos__hiddenLabel mesh__D018981
% 209.58/209.77       Syndromes, Carbohydrate-Deficient Glycoprotein
% 209.58/209.77  |- skos__hiddenLabel mesh__D018981
% 209.58/209.77       Carbohydrate-Deficient Glycoprotein Syndromes
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D018981 2005
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D018981 2002
% 209.58/209.77  |- mesh__recordAuthorizer mesh__D018981 sjn
% 209.58/209.77  |- mesh__historyNote mesh__D018981 96   
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D018981 2003
% 209.58/209.77  |- skos__annotation mesh__D018981
% 209.58/209.77       an inborn error of carbohydrate metab; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: CARB DEFIC GLYCOPROTEIN SYNDROME%A%  
% 209.58/209.77  |- skos__hiddenLabel mesh__D018981
% 209.58/209.77       Glycoprotein Syndrome, Carbohydrate Deficient
% 209.58/209.77  |- mesh__dateCreated mesh__D018981 1995-05-24
% 209.58/209.77  |- mesh__publicMeSHNote mesh__D018981 96   
% 209.58/209.77  |- mesh__dateRevised mesh__D018981 2001-07-25
% 209.58/209.77  |- skos__altLabel mesh__D018981
% 209.58/209.77       Glycoprotein Syndrome, Carbohydrate-Deficient
% 209.58/209.77  |- skos__hiddenLabel mesh__D018981
% 209.58/209.77       Carbohydrate Deficient Glycoprotein Syndrome
% 209.58/209.77  |- skos__prefLabel mesh__D018981
% 209.58/209.77       Carbohydrate-Deficient Glycoprotein Syndrome
% 209.58/209.77  |- skos__altLabel mesh__D018183 Transplantation Chimeras
% 209.58/209.77  |- skos__altLabel mesh__D018183 Chimera, Transplantation
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D018183 2005
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D018183 2004
% 209.58/209.77  |- skos__historyNote mesh__D018183 Chimera %28%1978-1993%29%
% 209.58/209.77  |- skos__broader mesh__D018183smesh__D002678
% 209.58/209.77  |- mesh__publicMeSHNote mesh__D018183 94   
% 209.58/209.77  |- mesh__recordOriginator mesh__D018183 PXP
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D018183 2006
% 209.58/209.77  |- mesh__dateRevised mesh__D018183 2003-07-09
% 209.58/209.77  |- rdf__type mesh__D018183sskos__Concept
% 209.58/209.77  |- skos__altLabel mesh__D018183 Chimeras, Transplantation
% 209.58/209.77  |- mesh__historyNote mesh__D018183 94   
% 209.58/209.77  |- mesh__dateCreated mesh__D018183 1993-06-03
% 209.58/209.77  |- skos__annotation mesh__D018183 DF: TRANSPL CHIMERA   
% 209.58/209.77  |- mesh__dateEstablished mesh__D018183 1994-01-01
% 209.58/209.77  |- mesh__recordMaintainer mesh__D018183 ags
% 209.58/209.77  |- mesh__recordAuthorizer mesh__D018183 sjn
% 209.58/209.77  |- skos__scopeNote mesh__D018183
% 209.58/209.77       An organism that, as a result of transplantation of donor tissue or cells, consists of two or more cell lines descended from at least two zygotes. This state may result in the induction of donor-specific TRANSPLANTATION TOLERANCE.%A%    
% 209.58/209.77  |- skos__prefLabel mesh__D018183 Transplantation Chimera
% 209.58/209.77  |- mesh__recordMaintainer mesh__D004961 exl
% 209.58/209.77  |- skos__hiddenLabel mesh__D004961 Leo275
% 209.58/209.77  |- mesh__recordOriginator mesh__D004961 NLM
% 209.58/209.77  |- mesh__dateEstablished mesh__D004961 1991-01-01
% 209.58/209.77  |- mesh__onlineNote mesh__D004961
% 209.58/209.77       use ESTRAMUSTINE to search ESTRAMUSTINPHOSPHATE 1975-79   
% 209.58/209.77  |- skos__prefLabel mesh__D004961 Estramustine
% 209.58/209.77  |- mesh__recordAuthorizer mesh__D004961 sjn
% 209.58/209.77  |- mesh__historyNote mesh__D004961
% 209.58/209.77       91%28%80%29%; was see under NITROGEN MUSTARD COMPOUNDS 1980-90; was ESTRAMUSTINPHOSPHATE see under NITROGEN MUSTARD COMPOUNDS 1975-79%A%  
% 209.58/209.77  |- skos__scopeNote mesh__D004961
% 209.58/209.77       A nitrogen mustard linked to estradiol, usually as phosphate; used to treat prostatic neoplasms; also has radiation protective properties.%A%    
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D004961 2006
% 209.58/209.77  |- skos__historyNote mesh__D004961 Estranes %28%1972-1974%29%
% 209.58/209.77  |- skos__hiddenLabel mesh__D004961 Phosphate Sodium, Estramustine
% 209.58/209.77  |- skos__broader mesh__D004961smesh__D004958
% 209.58/209.77  |- mesh__dateRevised mesh__D004961 2005-06-30
% 209.58/209.77  |- skos__hiddenLabel mesh__D004961 Leo 275
% 209.58/209.77  |- skos__broader mesh__D004961smesh__D009588
% 209.58/209.77  |- rdf__type mesh__D004961sskos__Concept
% 209.58/209.77  |- skos__historyNote mesh__D004961
% 209.58/209.77       Nitrogen Mustard Compounds %28%1972-1974%29%
% 209.58/209.77  |- mesh__publicMeSHNote mesh__D004961
% 209.58/209.77       91; was see under NITROGEN MUSTARD COMPOUNDS 1980-90; was ESTRAMUSTINPHOSPHATE see under NITROGEN MUSTARD COMPOUNDS 1975-79%A%  
% 209.58/209.77  |- skos__hiddenLabel mesh__D004961 NSC 89199
% 209.58/209.77  |- skos__historyNote mesh__D004961
% 209.58/209.77       Organophosphorus Compounds %28%1973-1974%29%
% 209.58/209.77  |- mesh__dateCreated mesh__D004961 1974-11-19
% 209.58/209.77  |- skos__hiddenLabel mesh__D004961 Sodium, Estramustine Phosphate
% 209.58/209.77  |- skos__hiddenLabel mesh__D004961 NSC89199
% 209.58/209.77  |- skos__historyNote mesh__D004961 Carbamates %28%1972-1974%29%
% 209.58/209.77  |- skos__prefLabel mesh__D004163 Diphosphoglyceric Acids
% 209.58/209.77  |- mesh__historyNote mesh__D004163 74%28%73%29%   
% 209.58/209.77  |- skos__historyNote mesh__D004163 Glyceric Acids %28%1968-1972%29%
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D004163 2005
% 209.58/209.77  |- skos__hiddenLabel mesh__D004163 Acids, Diphosphoglyceric
% 209.58/209.77  |- mesh__publicMeSHNote mesh__D004163 74   
% 209.58/209.77  |- mesh__recordOriginator mesh__D004163 NLM
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D004163 2006
% 209.58/209.77  |- mesh__dateRevised mesh__D004163 2004-07-07
% 209.58/209.77  |- mesh__recordAuthorizer mesh__D004163 sjn
% 209.58/209.77  |- mesh__dateCreated mesh__D004163 1999-01-01
% 209.58/209.77  |- mesh__dateEstablished mesh__D004163 1974-01-01
% 209.58/209.77  |- skos__historyNote mesh__D004163
% 209.58/209.77       Organophosphorus Compounds %28%1971-1972%29%
% 209.58/209.77  |- skos__broader mesh__D004163smesh__D005988
% 209.58/209.77  |- skos__altLabel mesh__D004163 Bisphosphoglycerates
% 209.58/209.77  |- mesh__recordMaintainer mesh__D004163 ssb
% 209.58/209.77  |- rdf__type mesh__D004163sskos__Concept
% 209.58/209.77  |- skos__broader mesh__D004163smesh__D009943
% 209.58/209.77  |- mesh__dateRevised mesh__D017889 1995-06-08
% 209.58/209.77  |- mesh__recordOriginator mesh__D017889 TGC
% 209.58/209.77  |- skos__hiddenLabel mesh__D017889 Syndromes, Exfoliation
% 209.58/209.77  |- skos__hiddenLabel mesh__D017889 Syndrome, Exfoliative
% 209.58/209.77  |- skos__hiddenLabel mesh__D017889 Pseudo-Exfoliation Syndromes
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D017889 1998
% 209.58/209.77  |- skos__prefLabel mesh__D017889 Exfoliation Syndrome
% 209.58/209.77  |- skos__scopeNote mesh__D017889
% 209.58/209.77       The deposition of flaky, translucent fibrillar material most conspicuous on the anterior lens capsule and pupillary margin but also in both surfaces of the iris, the zonules, trabecular meshwork, ciliary body, corneal endothelium, and orbital blood vessels. It sometimes forms a membrane on the anterior iris surface. Exfoliation refers to the shedding of pigment by the iris. %28%Newell, Ophthalmology, 7th ed, p380%29%%A%    
% 209.58/209.77  |- skos__historyNote mesh__D017889 Lens Diseases %28%1977-1993%29%
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D017889 1997
% 209.58/209.77  |- mesh__recordMaintainer mesh__D017889 TAP
% 209.58/209.77  |- skos__altLabel mesh__D017889 Glaucoma Capsulare
% 209.58/209.77  |- skos__hiddenLabel mesh__D017889 Syndrome, Pseudo-Exfoliation
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D017889 2001
% 209.58/209.77  |- mesh__dateEstablished mesh__D017889 1994-01-01
% 209.58/209.77  |- skos__hiddenLabel mesh__D017889 Pseudo Exfoliation Syndrome
% 209.58/209.77  |- skos__annotation mesh__D017889 shedding of pigment from the iris   
% 209.58/209.77  |- skos__historyNote mesh__D017889 Eye Diseases %28%1966-1976%29%
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D017889 2006
% 209.58/209.77  |- skos__related mesh__D017889smesh__D005902
% 209.58/209.77  |- skos__hiddenLabel mesh__D017889 Syndrome, Exfoliation
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D017889 1996
% 209.58/209.77  |- skos__hiddenLabel mesh__D017889 Syndromes, Exfoliative
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D017889 2000
% 209.58/209.77  |- mesh__publicMeSHNote mesh__D017889 94   
% 209.58/209.77  |- skos__historyNote mesh__D017889 Glaucoma %28%1972-1993%29%
% 209.58/209.77  |- rdf__type mesh__D017889sskos__Concept
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D017889 2005
% 209.58/209.77  |- skos__hiddenLabel mesh__D017889 Syndromes, Pseudoexfoliation
% 209.58/209.77  |- skos__historyNote mesh__D017889 Glaucoma, Open-Angle %28%1982-1993%29%
% 209.58/209.77  |- skos__altLabel mesh__D017889 Exfoliative Syndrome
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D017889 2004
% 209.58/209.77  |- skos__altLabel mesh__D017889 Pseudoexfoliation Syndrome
% 209.58/209.77  |- mesh__historyNote mesh__D017889 94   
% 209.58/209.77  |- skos__hiddenLabel mesh__D017889 Syndromes, Pseudo-Exfoliation
% 209.58/209.77  |- mesh__dateCreated mesh__D017889 1993-06-03
% 209.58/209.77  |- skos__historyNote mesh__D017889 Lens, Crystalline %28%1966-1976%29%
% 209.58/209.77  |- skos__hiddenLabel mesh__D017889 Pseudoexfoliation Syndromes
% 209.58/209.77  |- skos__altLabel mesh__D017889 Pseudo-Exfoliation Syndrome
% 209.58/209.77  |- skos__hiddenLabel mesh__D017889 Exfoliation Syndromes
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D017889 2003
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D017889 2002
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D017889 1999
% 209.58/209.77  |- mesh__recordAuthorizer mesh__D017889 PLS
% 209.58/209.77  |- skos__hiddenLabel mesh__D017889 Syndrome, Pseudoexfoliation
% 209.58/209.77  |- skos__broader mesh__D017889smesh__D007499
% 209.58/209.77  |- skos__hiddenLabel mesh__D017889 Exfoliative Syndromes
% 209.58/209.77  |- mesh__recordAuthorizer mesh__D042282 sjn
% 209.58/209.77  |- mesh__publicMeSHNote mesh__D042282 2004   
% 209.58/209.77  |- mesh__recordMaintainer mesh__D042282 nns
% 209.58/209.77  |- mesh__recordOriginator mesh__D042282 nns
% 209.58/209.77  |- rdf__type mesh__D042282sskos__Concept
% 209.58/209.77  |- mesh__dateCreated mesh__D042282 2003-07-22
% 209.58/209.77  |- skos__related mesh__D042282smesh__D008866
% 209.58/209.77  |- mesh__dateRevised mesh__D042282 2004-07-07
% 209.58/209.77  |- skos__scopeNote mesh__D042282
% 209.58/209.77       The performance of dissections with the aid of a microscope.%A%    
% 209.58/209.77  |- skos__hiddenLabel mesh__D042282 Microdissections
% 209.58/209.77  |- mesh__dateEstablished mesh__D042282 2004-01-01
% 209.58/209.77  |- mesh__historyNote mesh__D042282 2004   
% 209.58/209.77  |- skos__broader mesh__D042282smesh__D004210
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D042282 2005
% 209.58/209.77  |- skos__prefLabel mesh__D042282 Microdissection
% 209.58/209.77  |- skos__historyNote mesh__D042282 Dissection %28%1966-2003%29%
% 209.58/209.77  |- skos__broader mesh__D042282smesh__D008846
% 209.58/209.77  |- skos__broader mesh__D042282smesh__D016591
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D042282 2006
% 209.58/209.77  |- mesh__recordOriginator mesh__D003869 NLM
% 209.58/209.77  |- rdf__type mesh__D003869sskos__Concept
% 209.58/209.77  |- skos__prefLabel mesh__D003869 Dermabrasion
% 209.58/209.77  |- mesh__recordAuthorizer mesh__D003869 sjn
% 209.58/209.77  |- mesh__dateRevised mesh__D003869 2004-07-07
% 209.58/209.77  |- mesh__dateCreated mesh__D003869 1999-01-01
% 209.58/209.77  |- mesh__recordMaintainer mesh__D003869 nns
% 209.58/209.77  |- skos__broader mesh__D003869smesh__D003357
% 209.58/209.77  |- skos__scopeNote mesh__D003869
% 209.58/209.77       The mechanical planing of the SKIN with sand paper, emery paper, or wire brushes, to promote reepithelialization and smoothing of skin disfigured by ACNE scars or dermal NEVI.%A%    
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D003869 2006
% 209.58/209.77  |- skos__broader mesh__D003869smesh__D019651
% 209.58/209.77  |- skos__hiddenLabel mesh__D003869 Dermabrasions
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D003869 2005
% 209.58/209.77  |- rdf__type mesh__D014591sskos__Concept
% 209.58/209.77  |- mesh__recordAuthorizer mesh__D014591 sjn
% 209.58/209.77  |- skos__hiddenLabel mesh__D014591 Diseases, Uterine
% 209.58/209.77  |- mesh__publicMeSHNote mesh__D014591 66   
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D014591 2006
% 209.58/209.77  |- skos__hiddenLabel mesh__D014591 Disease, Uterine
% 209.58/209.77  |- mesh__dateCreated mesh__D014591 1999-01-01
% 209.58/209.77  |- skos__broader mesh__D014591smesh__D005831
% 209.58/209.77  |- skos__scopeNote mesh__D014591
% 209.58/209.77       Pathological processes involving any part of the UTERUS.%A%    
% 209.58/209.77  |- mesh__historyNote mesh__D014591 66   
% 209.58/209.77  |- mesh__recordOriginator mesh__D014591 NLM
% 209.58/209.77  |- mesh__dateEstablished mesh__D014591 1966-01-01
% 209.58/209.77  |- mesh__recordMaintainer mesh__D014591 lkt
% 209.58/209.77  |- skos__hiddenLabel mesh__D014591 Uterine Disease
% 209.58/209.77  |- mesh__dateRevised mesh__D014591 2005-06-30
% 209.58/209.77  |- skos__prefLabel mesh__D014591 Uterine Diseases
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D008554 2006
% 209.58/209.77  |- mesh__recordMaintainer mesh__D008554 PXP
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D008554 1997
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D008554 2005
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D008554 1996
% 209.58/209.77  |- rdf__type mesh__D008554sskos__Concept
% 209.58/209.77  |- mesh__recordAuthorizer mesh__D008554 PLS
% 209.58/209.77  |- skos__scopeNote mesh__D008554
% 209.58/209.77       A disease of humans and animals that resembles GLANDERS. It is caused by BURKHOLDERIA PSEUDOMALLEI and may range from a dormant infection to a condition that causes multiple abscesses, pneumonia, and bacteremia.%A%    
% 209.58/209.77  |- skos__broader mesh__D008554smesh__D019121
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D008554 2004
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D008554 2002
% 209.58/209.77  |- skos__annotation mesh__D008554
% 209.58/209.77       caused by Burkholderia pseudomallei; in India, Malay %26% Indonesia%A%  
% 209.58/209.77  |- skos__hiddenLabel mesh__D008554 Melioidoses
% 209.58/209.77  |- skos__prefLabel mesh__D008554 Melioidosis
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D008554 2003
% 209.58/209.77  |- mesh__dateCreated mesh__D008554 1999-01-01
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D008554 2001
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D008554 1999
% 209.58/209.77  |- mesh__dateRevised mesh__D008554 1995-05-31
% 209.58/209.77  |- mesh__recordOriginator mesh__D008554 NLM
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D008554 1998
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D008554 2000
% 209.58/209.77  |- skos__annotation mesh__D000571
% 209.58/209.77       add UNITED STATES %28%NIM%29%; DF: ADA      CATALOG: use NAF entry%A%  
% 209.58/209.77  |- skos__hiddenLabel mesh__D000571 Association, American Dental
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000571 1998
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000571 1993
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000571 1994
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000571 2000
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000571 1999
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000571 2003
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000571 2001
% 209.58/209.77  |- mesh__dateEstablished mesh__D000571 1966-01-01
% 209.58/209.77  |- skos__hiddenLabel mesh__D000571 Dental Association, American
% 209.58/209.77  |- mesh__historyNote mesh__D000571 66   
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000571 1995
% 209.58/209.77  |- mesh__dateCreated mesh__D000571 1999-01-01
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000571 2004
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000571 2002
% 209.58/209.77  |- skos__prefLabel mesh__D000571 American Dental Association
% 209.58/209.77  |- skos__scopeNote mesh__D000571
% 209.58/209.77       Professional society representing the field of dentistry.%A%    
% 209.58/209.77  |- skos__broader mesh__D000571smesh__D012953
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000571 2005
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000571 1996
% 209.58/209.77  |- mesh__recordMaintainer mesh__D000571 TAP
% 209.58/209.77  |- mesh__recordAuthorizer mesh__D000571 PLS
% 209.58/209.77  |- mesh__activeMeSHYear mesh__D000571 2006
% 209.58/209.78  |- mesh__recordOriginator mesh__D000571 NLM
% 209.58/209.78  |- rdf__type mesh__D000571sskos__Concept
% 209.58/209.78  |- mesh__publicMeSHNote mesh__D000571 66   
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000571 1997
% 209.58/209.78  |- mesh__dateRevised mesh__D000571 1992-03-25
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D013499 1994
% 209.58/209.78  |- rdf__type mesh__D013499sskos__Concept
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D013499 1999
% 209.58/209.78  |- skos__hiddenLabel mesh__D013499 Surface Property
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D013499 2003
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D013499 1993
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D013499 2001
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D013499 2005
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D013499 1995
% 209.58/209.78  |- mesh__dateCreated mesh__D013499 1999-01-01
% 209.58/209.78  |- mesh__recordOriginator mesh__D013499 NLM
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D013499 2004
% 209.58/209.78  |- mesh__historyNote mesh__D013499 70%28%68%29%   
% 209.58/209.78  |- mesh__recordAuthorizer mesh__D013499 PLS
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D013499 2006
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D013499 2002
% 209.58/209.78  |- skos__hiddenLabel mesh__D013499 Properties, Surface
% 209.58/209.78  |- mesh__dateRevised mesh__D013499 1992-05-26
% 209.58/209.78  |- mesh__dateEstablished mesh__D013499 1970-01-01
% 209.58/209.78  |- skos__hiddenLabel mesh__D013499 Property, Surface
% 209.58/209.78  |- skos__broader mesh__D013499smesh__D002627
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D013499 1996
% 209.58/209.78  |- skos__annotation mesh__D013499 NIM   
% 209.58/209.78  |- skos__prefLabel mesh__D013499 Surface Properties
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D013499 1998
% 209.58/209.78  |- mesh__recordMaintainer mesh__D013499 TAP
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D013499 2000
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D013499 1997
% 209.58/209.78  |- mesh__publicMeSHNote mesh__D013499 70   
% 209.58/209.78  |- rdf__type mesh__D018184sskos__Concept
% 209.58/209.78  |- mesh__dateCreated mesh__D018184 1993-06-04
% 209.58/209.78  |- skos__altLabel mesh__D018184 Infections, Paramyxoviridae
% 209.58/209.78  |- mesh__dateEstablished mesh__D018184 1994-01-01
% 209.58/209.78  |- skos__annotation mesh__D018184 GEN or unspecified; prefer specifics   
% 209.58/209.78  |- skos__hiddenLabel mesh__D018184 Paramyxoviridae Infection
% 209.58/209.78  |- skos__hiddenLabel mesh__D018184 Infection, Paramyxoviridae
% 209.58/209.78  |- mesh__recordAuthorizer mesh__D018184 sjn
% 209.58/209.78  |- skos__hiddenLabel mesh__D018184 Parainfluenza Virus Infection
% 209.58/209.78  |- skos__scopeNote mesh__D018184
% 209.58/209.78       Infections with viruses of the family PARAMYXOVIRIDAE. This includes MORBILLIVIRUS INFECTIONS; RESPIROVIRUS INFECTIONS; PNEUMOVIRUS INFECTIONS; HENIPAVIRUS INFECTIONS; AVULAVIRUS INFECTIONS; and RUBULAVIRUS INFECTIONS.%A%    
% 209.58/209.78  |- skos__hiddenLabel mesh__D018184 Virus Infection, Parainfluenza
% 209.58/209.78  |- skos__prefLabel mesh__D018184 Paramyxoviridae Infections
% 209.58/209.78  |- mesh__publicMeSHNote mesh__D018184
% 209.58/209.78       94; PARAINFLUENZA was heading 1994-96; was PARA-INFLUENZA 1963-93 %28%see under MYXOVIRUS INFECTIONS %28%now ORTHOMYXOVIRUS INFECTIONS%29% 1963-69%29%%A%  
% 209.58/209.78  |- skos__hiddenLabel mesh__D018184 Infections, Parainfluenza Virus
% 209.58/209.78  |- skos__hiddenLabel mesh__D018184 Infection, Parainfluenza Virus
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D018184 2005
% 209.58/209.78  |- mesh__recordMaintainer mesh__D018184 ags
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D018184 2004
% 209.58/209.78  |- skos__hiddenLabel mesh__D018184 Virus Infections, Parainfluenza
% 209.58/209.78  |- skos__historyNote mesh__D018184
% 209.58/209.78       Paramyxovirus Infections %28%1977-1993%29%
% 209.58/209.78  |- mesh__onlineNote mesh__D018184
% 209.58/209.78       use PARAMYXOVIRIDAE INFECTIONS to search PARAINFLUENZA 1994-96 %26% PARA-INFLUENZA 1966-93%A%  
% 209.58/209.78  |- skos__broader mesh__D018184smesh__D018701
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D018184 2006
% 209.58/209.78  |- mesh__recordOriginator mesh__D018184 AGS
% 209.58/209.78  |- mesh__dateRevised mesh__D018184 2003-07-09
% 209.58/209.78  |- mesh__historyNote mesh__D018184
% 209.58/209.78       94; PARAINFLUENZA was heading 1994-96; was PARA-INFLUENZA 1963-93 %28%see under MYXOVIRUS INFECTIONS %28%now ORTHOMYXOVIRUS INFECTIONS%29% 1963-69%29%%A%  
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004962 1996
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004962 2006
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004962 1999
% 209.58/209.78  |- skos__prefLabel mesh__D004962 Estranes
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004962 2001
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004962 2005
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004962 1995
% 209.58/209.78  |- mesh__recordOriginator mesh__D004962 NLM
% 209.58/209.78  |- skos__altLabel mesh__D004962 19-Norandrostanes
% 209.58/209.78  |- mesh__publicMeSHNote mesh__D004962 68   
% 209.58/209.78  |- skos__broader mesh__D004962smesh__D013256
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004962 1998
% 209.58/209.78  |- mesh__dateEstablished mesh__D004962 1968-01-01
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004962 2000
% 209.58/209.78  |- mesh__recordAuthorizer mesh__D004962 PLS
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004962 1994
% 209.58/209.78  |- skos__hiddenLabel mesh__D004962 19 Norandrostanes
% 209.58/209.78  |- mesh__historyNote mesh__D004962 68   
% 209.58/209.78  |- rdf__type mesh__D004962sskos__Concept
% 209.58/209.78  |- mesh__recordMaintainer mesh__D004962 PLS
% 209.58/209.78  |- mesh__dateRevised mesh__D004962 1993-06-03
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004962 2004
% 209.58/209.78  |- mesh__dateCreated mesh__D004962 1999-01-01
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004962 2002
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004962 1997
% 209.58/209.78  |- skos__scopeNote mesh__D004962
% 209.58/209.78       A group of compounds forming the nucleus of the estrogenic steroid family.%A%    
% 209.58/209.78  |- skos__annotation mesh__D004962 do not confuse with ESTRENES   
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004962 2003
% 209.58/209.78  |- mesh__publicMeSHNote mesh__D004164 77   
% 209.58/209.78  |- mesh__recordMaintainer mesh__D004164 ssb
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004164 2006
% 209.58/209.78  |- mesh__dateRevised mesh__D004164 2005-06-30
% 209.58/209.78  |- skos__scopeNote mesh__D004164
% 209.58/209.78       Organic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents.%A%    
% 209.58/209.78  |- mesh__dateCreated mesh__D004164 1976-04-16
% 209.58/209.78  |- skos__altLabel mesh__D004164 Bisphosphonates
% 209.58/209.78  |- mesh__recordOriginator mesh__D004164 RLS
% 209.58/209.78  |- mesh__recordAuthorizer mesh__D004164 sjn
% 209.58/209.78  |- mesh__dateEstablished mesh__D004164 1977-01-01
% 209.58/209.78  |- mesh__historyNote mesh__D004164 77   
% 209.58/209.78  |- rdf__type mesh__D004164sskos__Concept
% 209.58/209.78  |- skos__prefLabel mesh__D004164 Diphosphonates
% 209.58/209.78  |- skos__broader mesh__D004164smesh__D009943
% 209.58/209.78  |- skos__historyNote mesh__D004164 Phosphonic Acids %28%1966-1976%29%
% 209.58/209.78  |- skos__historyNote mesh__D004164
% 209.58/209.78       Organophosphorus Compounds %28%1971-1976%29%
% 209.58/209.78  |- skos__prefLabel mesh__D014592 Uterine Hemorrhage
% 209.58/209.78  |- mesh__dateRevised mesh__D014592 2005-06-30
% 209.58/209.78  |- skos__hiddenLabel mesh__D014592 Uterine Bleedings
% 209.58/209.78  |- skos__annotation mesh__D014592
% 209.58/209.78       %22%vaginal bleeding%22% usually refers to uterine bleeding through the vagina %26% goes here but check text for bleeding from vaginal injuries, vaginal diseases, vaginal tumors, etc %28%index under proper VAGINA term%29%%A%  
% 209.58/209.78  |- skos__hiddenLabel mesh__D014592 Uterine Hemorrhages
% 209.58/209.78  |- skos__altLabel mesh__D014592 Hemorrhage, Uterine
% 209.58/209.78  |- skos__broader mesh__D014592smesh__D014591
% 209.58/209.78  |- mesh__recordAuthorizer mesh__D014592 sjn
% 209.58/209.78  |- rdf__type mesh__D014592sskos__Concept
% 209.58/209.78  |- skos__hiddenLabel mesh__D014592 Bleeding, Uterine
% 209.58/209.78  |- skos__broader mesh__D014592smesh__D006470
% 209.58/209.78  |- skos__altLabel mesh__D014592 Uterine Bleeding
% 209.58/209.78  |- mesh__recordMaintainer mesh__D014592 lkt
% 209.58/209.78  |- skos__related mesh__D014592smesh__D008796
% 209.58/209.78  |- skos__scopeNote mesh__D014592
% 209.58/209.78       Bleeding from blood vessels in the UTERUS, sometimes manifested as vaginal bleeding.%A%    
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D014592 2006
% 209.58/209.78  |- skos__related mesh__D014592smesh__D008595
% 209.58/209.78  |- mesh__recordOriginator mesh__D014592 NLM
% 209.58/209.78  |- mesh__dateCreated mesh__D014592 1999-01-01
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D008555 2006
% 209.58/209.78  |- skos__prefLabel mesh__D008555 Melitten
% 209.58/209.78  |- mesh__historyNote mesh__D008555
% 209.58/209.78       91%28%75%29%; was see under BEE VENOMS 1978-90; was see under VENOMS 1975-77%A%  
% 209.58/209.78  |- mesh__dateEstablished mesh__D008555 1991-01-01
% 209.58/209.78  |- skos__annotation mesh__D008555
% 209.58/209.78       a bee venom; /antag permitted but consider also ANTIVENINS%A%  
% 209.58/209.78  |- skos__scopeNote mesh__D008555
% 209.58/209.78       Basic polypeptide from the venom of the honey bee %28%Apis mellifera%29%; it contains 62 amino acids, has cytolytic properties, causes contracture of muscle, releases histamine and disrupts surface tension, probably due to lysis of cell and mitochondrial membranes. Synonyms: melittin; melliten.%A%    
% 209.58/209.78  |- mesh__recordOriginator mesh__D008555 NLM
% 209.58/209.78  |- mesh__dateRevised mesh__D008555 2005-06-30
% 209.58/209.78  |- rdf__type mesh__D008555sskos__Concept
% 209.58/209.78  |- skos__altLabel mesh__D008555 Melittin
% 209.58/209.78  |- mesh__recordMaintainer mesh__D008555 ssb
% 209.58/209.78  |- skos__broader mesh__D008555smesh__D001514
% 209.58/209.78  |- skos__altLabel mesh__D008555 Mellitin
% 209.58/209.78  |- skos__historyNote mesh__D008555 Peptides %28%1973-1974%29%
% 209.58/209.78  |- skos__historyNote mesh__D008555 Bees %28%1973-1974%29%
% 209.58/209.78  |- skos__historyNote mesh__D008555 Venoms %28%1973-1974%29%
% 209.58/209.78  |- mesh__dateCreated mesh__D008555 1974-11-19
% 209.58/209.78  |- mesh__publicMeSHNote mesh__D008555
% 209.58/209.78       91; was see under BEE VENOMS 1978-90; was see under VENOMS 1975-77%A%  
% 209.58/209.78  |- mesh__recordAuthorizer mesh__D008555 sjn
% 209.58/209.78  |- skos__historyNote mesh__D000572
% 209.58/209.78       Voluntary Health Agencies %28%1966-1974%29%
% 209.58/209.78  |- mesh__recordAuthorizer mesh__D000572 PLS
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000572 1999
% 209.58/209.78  |- skos__hiddenLabel mesh__D000572 Association, American Heart
% 209.58/209.78  |- mesh__dateEstablished mesh__D000572 1991-01-01
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000572 2003
% 209.58/209.78  |- mesh__recordOriginator mesh__D000572 NLM
% 209.58/209.78  |- skos__annotation mesh__D000572
% 209.58/209.78       add UNITED STATES or specific state %28%NIM%29%: DF: AMERICAN HEART ASSOC      CATALOG: use NAF entry%A%  
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000572 1995
% 209.58/209.78  |- skos__historyNote mesh__D000572
% 209.58/209.78       Cardiovascular Diseases %28%1966-1974%29%
% 209.58/209.78  |- mesh__dateCreated mesh__D000572 1999-01-01
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000572 2004
% 209.58/209.78  |- skos__historyNote mesh__D000572 Heart Diseases %28%1966-1974%29%
% 209.58/209.78  |- skos__hiddenLabel mesh__D000572 Heart Associations, American
% 209.58/209.78  |- skos__hiddenLabel mesh__D000572 Heart Association, American
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000572 2000
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000572 2005
% 209.58/209.78  |- mesh__dateRevised mesh__D000572 1994-05-12
% 209.58/209.78  |- skos__prefLabel mesh__D000572 American Heart Association
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000572 1996
% 209.58/209.78  |- skos__scopeNote mesh__D000572
% 209.58/209.78       A voluntary organization concerned with the prevention and treatment of heart and vascular diseases.%A%    
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000572 2001
% 209.58/209.78  |- mesh__historyNote mesh__D000572
% 209.58/209.78       91%28%75%29%; was see under VOLUNTARY HEALTH AGENCIES 1975-90   
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000572 2006
% 209.58/209.78  |- skos__hiddenLabel mesh__D000572 Associations, American Heart
% 209.58/209.78  |- skos__hiddenLabel mesh__D000572 American Heart Associations
% 209.58/209.78  |- rdf__type mesh__D000572sskos__Concept
% 209.58/209.78  |- skos__historyNote mesh__D000572 Societies, Medical %28%1966-1974%29%
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000572 1997
% 209.58/209.78  |- mesh__onlineNote mesh__D000572
% 209.58/209.78       search VOLUNTARY HEALTH AGENCIES 1967-74   
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000572 2002
% 209.58/209.78  |- skos__broader mesh__D000572smesh__D014837
% 209.58/209.78  |- mesh__recordMaintainer mesh__D000572 TGC
% 209.58/209.78  |- mesh__publicMeSHNote mesh__D000572
% 209.58/209.78       91; was see under VOLUNTARY HEALTH AGENCIES 1975-90   
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000572 1998
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D018983 2003
% 209.58/209.78  |- rdf__type mesh__D018983sskos__Concept
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D018983 2006
% 209.58/209.78  |- skos__hiddenLabel mesh__D018983 DNA Footprint
% 209.58/209.78  |- skos__hiddenLabel mesh__D018983 DNA Footprints
% 209.58/209.78  |- mesh__publicMeSHNote mesh__D018983 96   
% 209.58/209.78  |- skos__broader mesh__D018983smesh__D005821
% 209.58/209.78  |- skos__scopeNote mesh__D018983
% 209.58/209.78       A method for determining the sequence specificity of DNA-binding proteins. DNA footprinting utilizes a DNA damaging agent %28%either a chemical reagent or a nuclease%29% which cleaves DNA at every base pair. DNA cleavage is inhibited where the ligand binds to DNA. %28%from Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A%    
% 209.58/209.78  |- mesh__historyNote mesh__D018983 96   
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D018983 2004
% 209.58/209.78  |- skos__broader mesh__D018983smesh__D023282
% 209.58/209.78  |- mesh__dateCreated mesh__D018983 1995-05-24
% 209.58/209.78  |- mesh__dateRevised mesh__D018983 2000-06-22
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D018983 2001
% 209.58/209.78  |- skos__hiddenLabel mesh__D018983 Footprinting, DNA
% 209.58/209.78  |- mesh__dateEstablished mesh__D018983 1996-01-01
% 209.58/209.78  |- skos__hiddenLabel mesh__D018983 DNA Footprintings
% 209.58/209.78  |- skos__hiddenLabel mesh__D018983 Footprint, DNA
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D018983 2002
% 209.58/209.78  |- skos__prefLabel mesh__D018983 DNA Footprinting
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D018983 2005
% 209.58/209.78  |- skos__annotation mesh__D018983 DNA FINGERPRINTING is available   
% 209.58/209.78  |- skos__hiddenLabel mesh__D018983 Footprintings, DNA
% 209.58/209.78  |- mesh__dateRevised mesh__D018185 1994-05-12
% 209.58/209.78  |- skos__broader mesh__D018185smesh__D018184
% 209.58/209.78  |- skos__annotation mesh__D018185
% 209.58/209.78       caused by a member of the Paramyxoviridae family; GEN or unspecified; prefer specifics%A%  
% 209.58/209.78  |- mesh__recordOriginator mesh__D018185 AGS
% 209.58/209.78  |- mesh__historyNote mesh__D018185 94   
% 209.58/209.78  |- mesh__dateCreated mesh__D018185 1993-06-04
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D018185 2002
% 209.58/209.78  |- mesh__dateEstablished mesh__D018185 1994-01-01
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D018185 1996
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D018185 2003
% 209.58/209.78  |- skos__prefLabel mesh__D018185 Morbillivirus Infections
% 209.58/209.78  |- mesh__recordAuthorizer mesh__D018185 PLS
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D018185 1998
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D018185 2005
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D018185 1997
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D018185 2004
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D018185 2000
% 209.58/209.78  |- skos__hiddenLabel mesh__D018185 Infection, Morbillivirus
% 209.58/209.78  |- skos__scopeNote mesh__D018185
% 209.58/209.78       Infections with viruses of the genus MORBILLIVIRUS, family PARAMYXOVIRIDAE. Infections mainly cause acute disease in their hosts, although in some cases infection is persistent and leads to degenerative conditions.%A%    
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D018185 1999
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D018185 2006
% 209.58/209.78  |- skos__altLabel mesh__D018185 Infections, Morbillivirus
% 209.58/209.78  |- mesh__recordMaintainer mesh__D018185 AGS
% 209.58/209.78  |- mesh__publicMeSHNote mesh__D018185 94   
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D018185 2001
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D018185 1995
% 209.58/209.78  |- rdf__type mesh__D018185sskos__Concept
% 209.58/209.78  |- skos__hiddenLabel mesh__D018185 Morbillivirus Infection
% 209.58/209.78  |- mesh__historyNote mesh__D004963 75; was see under ESTRANES 1973-74   
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004963 2006
% 209.58/209.78  |- skos__hiddenLabel mesh__D004963 19 Norandrostenes
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004963 1994
% 209.58/209.78  |- mesh__dateRevised mesh__D004963 1993-06-03
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004963 1999
% 209.58/209.78  |- mesh__recordMaintainer mesh__D004963 PLS
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004963 1995
% 209.58/209.78  |- skos__scopeNote mesh__D004963
% 209.58/209.78       Unsaturated derivatives of the ESTRANES with methyl groups at carbon-13, with no carbon at carbon-10, and with no more than one carbon at carbon-17. They must contain one or more double bonds.%A%    
% 209.58/209.78  |- skos__broader mesh__D004963smesh__D004962
% 209.58/209.78  |- mesh__dateCreated mesh__D004963 1999-01-01
% 209.58/209.78  |- mesh__publicMeSHNote mesh__D004963 75; was see under ESTRANES 1973-74   
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004963 2000
% 209.58/209.78  |- skos__annotation mesh__D004963 do not confuse with ESTRANES   
% 209.58/209.78  |- mesh__recordAuthorizer mesh__D004963 PLS
% 209.58/209.78  |- rdf__type mesh__D004963sskos__Concept
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004963 2003
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004963 2001
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004963 1996
% 209.58/209.78  |- skos__prefLabel mesh__D004963 Estrenes
% 209.58/209.78  |- mesh__recordOriginator mesh__D004963 NLM
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004963 2004
% 209.58/209.78  |- skos__altLabel mesh__D004963 19-Norandrostenes
% 209.58/209.78  |- skos__historyNote mesh__D004963 Estranes %28%1968-1974%29%
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004963 2002
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004963 1997
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004963 2005
% 209.58/209.78  |- mesh__dateEstablished mesh__D004963 1975-09-01
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004963 1998
% 209.58/209.78  |- mesh__onlineNote mesh__D004963 search ESTRANES 1973-74   
% 209.58/209.78  |- skos__broader mesh__D002791Q000737smesh__D002791
% 209.58/209.78  |- mesh__preferredCombination mesh__D002791Q000737smesh__D002784Q000737
% 209.58/209.78  |- rdf__type mesh__D002791Q000737smesh__CompoundConcept
% 209.58/209.78  |- skos__annotation mesh__D004165 caused by Corynebacterium diphtheriae   
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004165 2004
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004165 1997
% 209.58/209.78  |- skos__prefLabel mesh__D004165 Diphtheria
% 209.58/209.78  |- skos__broader mesh__D004165smesh__D003354
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004165 2002
% 209.58/209.78  |- skos__hiddenLabel mesh__D004165 Diphtherias
% 209.58/209.78  |- rdf__type mesh__D004165sskos__Concept
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004165 2005
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004165 1998
% 209.58/209.78  |- skos__scopeNote mesh__D004165
% 209.58/209.78       A localized infection of mucous membranes or skin caused by toxigenic strains of CORYNEBACTERIUM DIPHTHERIAE. It is characterized by the presence of a pseudomembrane at the site of infection. DIPHTHERIA TOXIN, produced by C. diphtheriae, can cause myocarditis, polyneuritis, and other systemic toxic effects.%A%    
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004165 2006
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004165 1999
% 209.58/209.78  |- mesh__dateRevised mesh__D004165 1995-05-25
% 209.58/209.78  |- mesh__recordMaintainer mesh__D004165 PLS
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004165 2000
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004165 2003
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004165 1996
% 209.58/209.78  |- mesh__dateCreated mesh__D004165 1999-01-01
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D004165 2001
% 209.58/209.78  |- mesh__recordOriginator mesh__D004165 NLM
% 209.58/209.78  |- mesh__recordAuthorizer mesh__D004165 PLS
% 209.58/209.78  |- skos__hiddenLabel mesh__D050716 C4bC3bINA Cofactor
% 209.58/209.78  |- mesh__recordOriginator mesh__D050716 lkt
% 209.58/209.78  |- skos__altLabel mesh__D050716 Complement C3b-C4b Inactivator Cofactor
% 209.58/209.78  |- skos__altLabel mesh__D050716 Complement Component 4b-Binding Protein
% 209.58/209.78  |- mesh__historyNote mesh__D050716 2006   
% 209.58/209.78  |- skos__historyNote mesh__D050716
% 209.58/209.78       Complement Inactivator Proteins %28%1981-2005%29%
% 209.58/209.78  |- skos__hiddenLabel mesh__D050716 C4b Binding Protein
% 209.58/209.78  |- skos__altLabel mesh__D050716 C4b-C3b Inactivator Cofactor
% 209.58/209.78  |- skos__broader mesh__D050716smesh__D003169
% 209.58/209.78  |- skos__hiddenLabel mesh__D050716 Complement C3b C4b Inactivator Cofactor
% 209.58/209.78  |- mesh__dateEstablished mesh__D050716 2006-01-01
% 209.58/209.78  |- skos__hiddenLabel mesh__D050716 Protein, Complement C4b-Binding
% 209.58/209.78  |- skos__hiddenLabel mesh__D050716 Complement C4b Binding Protein
% 209.58/209.78  |- skos__hiddenLabel mesh__D050716 Complement Component 4b Binding Protein
% 209.58/209.78  |- mesh__publicMeSHNote mesh__D050716 2006   
% 209.58/209.78  |- mesh__recordAuthorizer mesh__D050716 sjn
% 209.58/209.78  |- skos__prefLabel mesh__D050716 Complement C4b-Binding Protein
% 209.58/209.78  |- skos__altLabel mesh__D050716 Complement 4b Binding Protein
% 209.58/209.78  |- skos__altLabel mesh__D050716 C4b-Binding Protein
% 209.58/209.78  |- mesh__dateCreated mesh__D050716 2005-06-30
% 209.58/209.78  |- skos__hiddenLabel mesh__D050716 Protein, C4b-Binding
% 209.58/209.78  |- skos__scopeNote mesh__D050716
% 209.58/209.78       A serum protein that regulates the CLASSICAL COMPLEMENT ACTIVATION PATHWAY. It binds as a cofactor to COMPLEMENT FACTOR I which then hydrolyzes the COMPLEMENT C4B in the CLASSICAL PATHWAY C3 CONVERTASE %28%C4bC2a%29%.%A%    
% 209.58/209.78  |- skos__hiddenLabel mesh__D050716 C4b-Binding Protein, Complement
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D050716 2006
% 209.58/209.78  |- mesh__recordMaintainer mesh__D050716 lkt
% 209.58/209.78  |- skos__hiddenLabel mesh__D050716 C4b C3b Inactivator Cofactor
% 209.58/209.78  |- skos__hiddenLabel mesh__D050716 Cofactor, C4b-C3b Inactivator
% 209.58/209.78  |- skos__altLabel mesh__D050716 C4bC3bINA-Cofactor
% 209.58/209.78  |- rdf__type mesh__D050716sskos__Concept
% 209.58/209.78  |- mesh__recordMaintainer mesh__D014593 lkt
% 209.58/209.78  |- mesh__publicMeSHNote mesh__D014593 67   
% 209.58/209.78  |- skos__annotation mesh__D014593 check tags FEMALE and PREGNANCY   
% 209.58/209.78  |- skos__altLabel mesh__D014593 Uterine Atony
% 209.58/209.78  |- skos__hiddenLabel mesh__D014593 Inertia, Uterine
% 209.58/209.78  |- mesh__recordOriginator mesh__D014593 NLM
% 209.58/209.78  |- skos__broader mesh__D014593smesh__D004420
% 209.58/209.78  |- mesh__historyNote mesh__D014593 67%28%64%29%   
% 209.58/209.78  |- mesh__dateEstablished mesh__D014593 1967-01-01
% 209.58/209.78  |- mesh__dateRevised mesh__D014593 2005-06-30
% 209.58/209.78  |- rdf__type mesh__D014593sskos__Concept
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D014593 2006
% 209.58/209.78  |- skos__prefLabel mesh__D014593 Uterine Inertia
% 209.58/209.78  |- mesh__recordAuthorizer mesh__D014593 sjn
% 209.58/209.78  |- mesh__dateCreated mesh__D014593 1999-01-01
% 209.58/209.78  |- skos__scopeNote mesh__D014593
% 209.58/209.78       Failure of the UTERUS to contract with normal strength, duration, and intervals during childbirth %28%LABOR, OBSTETRIC%29%. It is also called uterine atony.%A%    
% 209.58/209.78  |- skos__hiddenLabel mesh__D014593 Atony, Uterine
% 209.58/209.78  |- skos__broader mesh__D019308Q000031smesh__D019308
% 209.58/209.78  |- mesh__preferredCombination mesh__D019308Q000031smesh__D010169
% 209.58/209.78  |- rdf__type mesh__D019308Q000031smesh__CompoundConcept
% 209.58/209.78  |- skos__altLabel mesh__D008556 Rosenthal-Melkerson Syndrome
% 209.58/209.78  |- skos__hiddenLabel mesh__D008556 Melkersson Rosenthal Syndrome
% 209.58/209.78  |- skos__altLabel mesh__D008556 Cheilitis Granulomatosa
% 209.58/209.78  |- skos__altLabel mesh__D008556 Syndrome, Melkerson Rosenthal
% 209.58/209.78  |- skos__hiddenLabel mesh__D008556
% 209.58/209.78       Granulomatous Cheilitis, Miescher-Melkersson-Rosenthal
% 209.58/209.78  |- skos__altLabel mesh__D008556
% 209.58/209.78       Cheilitis Granulomatosa, Facial Neuropathy, Orofacial Edema
% 209.58/209.78  |- mesh__dateRevised mesh__D008556 2001-07-25
% 209.58/209.78  |- skos__altLabel mesh__D008556 Melkersson Syndrome
% 209.58/209.78  |- mesh__recordOriginator mesh__D008556 NLM
% 209.58/209.78  |- skos__hiddenLabel mesh__D008556 Rosenthal Melkerson Syndrome
% 209.58/209.78  |- skos__altLabel mesh__D008556
% 209.58/209.78       Facial Neuropathy, Orofacial Edema, Cheilitis Granulomatosa
% 209.58/209.78  |- mesh__publicMeSHNote mesh__D008556 64   
% 209.58/209.78  |- skos__altLabel mesh__D008556
% 209.58/209.78       Miescher-Melkersson-Rosenthal Granulomatous Cheilitis
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D008556 2005
% 209.58/209.78  |- skos__broader mesh__D008556smesh__D009059
% 209.58/209.78  |- skos__hiddenLabel mesh__D008556 Rosenthal Melkersson Syndrome
% 209.58/209.78  |- rdf__type mesh__D008556sskos__Concept
% 209.58/209.78  |- skos__altLabel mesh__D008556
% 209.58/209.78       Orofacial Edema, Facial Neuropathy, Cheilitis Granulomatosa
% 209.58/209.78  |- mesh__recordMaintainer mesh__D008556 ags
% 209.58/209.78  |- mesh__historyNote mesh__D008556 64%28%63%29%   
% 209.58/209.78  |- mesh__dateCreated mesh__D008556 1999-01-01
% 209.58/209.78  |- skos__hiddenLabel mesh__D008556 Melkerson Rosenthal Syndrome
% 209.58/209.78  |- skos__altLabel mesh__D008556 Macrocheilia, Facial Palsy, Edema
% 209.58/209.78  |- mesh__dateEstablished mesh__D008556 1964-01-01
% 209.58/209.78  |- skos__hiddenLabel mesh__D008556
% 209.58/209.78       Cheilitis, Miescher-Melkersson-Rosenthal Granulomatous
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D008556 2004
% 209.58/209.78  |- mesh__recordAuthorizer mesh__D008556 sjn
% 209.58/209.78  |- skos__altLabel mesh__D008556 Melkerson-Rosenthal Syndrome
% 209.58/209.78  |- skos__broader mesh__D008556smesh__D005155
% 209.58/209.78  |- skos__hiddenLabel mesh__D008556 Melkersson Rosenthal Miescher Syndrome
% 209.58/209.78  |- skos__altLabel mesh__D008556 Melkersson-Rosenthal-Miescher Syndrome
% 209.58/209.78  |- skos__prefLabel mesh__D008556 Melkersson-Rosenthal Syndrome
% 209.58/209.78  |- skos__altLabel mesh__D008556
% 209.58/209.78       Facial Neuropathy, Cheilitis Granulomatosa, Orofacial Edema
% 209.58/209.78  |- skos__hiddenLabel mesh__D008556
% 209.58/209.78       Miescher Melkersson Rosenthal Granulomatous Cheilitis
% 209.58/209.78  |- skos__scopeNote mesh__D008556
% 209.58/209.78       An idiopathic syndrome characterized by one or more of the following; recurrent orofacial swelling, relapsing facial paralysis, and fissured tongue %28%lingua plicata%29%. The onset is usually in childhood and relapses are common. Cheilitis granulomatosa is a monosymptomatic variant of this condition. %28%Dermatol Clin 1996 Apr;14%28%2%29%:371-9; Magalini %26% Magalini, Dictionary of Medical Syndromes, 4th ed, p531%29%%A%    
% 209.58/209.78  |- skos__altLabel mesh__D008556
% 209.58/209.78       Orofacial Edema, Cheilitis Granulomatosa, Facial Neuropathy
% 209.58/209.78  |- skos__altLabel mesh__D008556 Rosenthal-Melkersson Syndrome
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D008556 2003
% 209.58/209.78  |- skos__altLabel mesh__D008556
% 209.58/209.78       Cheilitis Granulomatosa, Orofacial Edema, Facial Neuropathy
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D008556 2002
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D008556 2006
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000573 2001
% 209.58/209.78  |- skos__broader mesh__D000573smesh__D012954
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000573 2005
% 209.58/209.78  |- mesh__recordOriginator mesh__D000573 EC
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000573 2002
% 209.58/209.78  |- skos__annotation mesh__D000573
% 209.58/209.78       add UNITED STATES %28%NIM%29%; DF: AHA      CATALOG: use NAF entry%A%  
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000573 2006
% 209.58/209.78  |- rdf__type mesh__D000573sskos__Concept
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000573 1997
% 209.58/209.78  |- skos__prefLabel mesh__D000573 American Hospital Association
% 209.58/209.78  |- mesh__recordAuthorizer mesh__D000573 PLS
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000573 1998
% 209.58/209.78  |- skos__altLabel mesh__D000573 Association, American Hospital
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000573 1999
% 209.58/209.78  |- mesh__dateCreated mesh__D000573 1977-05-05
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000573 2003
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000573 2000
% 209.58/209.78  |- mesh__dateRevised mesh__D000573 1996-06-10
% 209.58/209.78  |- mesh__activeMeSHYear mesh__D000573 2004
% 209.58/209.78  |- mesh__dateEstablished mesh__D000573 1978-01-01
% 209.58/209.78  |- skos__scopeNote mesh__D000573
% 209.58/209.78       A professional society in the United States whose membership is composed of hospitals.%A%    
% 209.58/209.78  |- mesh__historyNote mesh__D000573 78   
% 209.58/209.79  |- mesh__publicMeSHNote mesh__D000573 78   
% 209.58/209.79  |- mesh__recordMaintainer mesh__D000573 KEV
% 209.58/209.79  |- skos__altLabel mesh__D018984 T-Cell Epitope
% 209.58/209.79  |- mesh__dateCreated mesh__D018984 1995-05-24
% 209.58/209.79  |- skos__altLabel mesh__D018984 T-Lymphocyte Epitopes
% 209.58/209.79  |- skos__prefLabel mesh__D018984 Epitopes, T-Lymphocyte
% 209.58/209.79  |- mesh__recordOriginator mesh__D018984 AGS
% 209.58/209.79  |- skos__hiddenLabel mesh__D018984 T Lymphocyte Epitopes
% 209.58/209.79  |- skos__hiddenLabel mesh__D018984 Epitope, T-Cell
% 209.58/209.79  |- skos__historyNote mesh__D018984 Epitopes %28%1983-1995%29%
% 209.58/209.79  |- skos__annotation mesh__D018984
% 209.58/209.79       sites on antigens recognized by T-lymphocytes; DF: note short X ref%A%  
% 209.58/209.79  |- skos__hiddenLabel mesh__D018984 Epitope, T-Lymphocyte
% 209.58/209.79  |- mesh__recordAuthorizer mesh__D018984 sjn
% 209.58/209.79  |- mesh__publicMeSHNote mesh__D018984 96   
% 209.58/209.79  |- rdf__type mesh__D018984sskos__Concept
% 209.58/209.79  |- skos__scopeNote mesh__D018984
% 209.58/209.79       Antigenic determinants recognized and bound by the T-cell receptor. Epitopes recognized by the T-cell receptor are often located in the inner, unexposed side of the antigen, and become accessible to the T-cell receptors after proteolytic processing of the antigen.%A%    
% 209.58/209.79  |- skos__broader mesh__D018984smesh__D000939
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D018984 2006
% 209.58/209.79  |- mesh__recordMaintainer mesh__D018984 ssb
% 209.58/209.79  |- skos__hiddenLabel mesh__D018984 Epitopes, T-Cell
% 209.58/209.79  |- skos__altLabel mesh__D018984 T-Cell Epitopes
% 209.58/209.79  |- skos__hiddenLabel mesh__D018984 T Cell Epitopes
% 209.58/209.79  |- mesh__dateEstablished mesh__D018984 1996-01-01
% 209.58/209.79  |- skos__altLabel mesh__D018984 T-Lymphocyte Epitope
% 209.58/209.79  |- skos__hiddenLabel mesh__D018984 T Lymphocyte Epitope
% 209.58/209.79  |- mesh__historyNote mesh__D018984 96   
% 209.58/209.79  |- skos__hiddenLabel mesh__D018984 Epitopes, T Lymphocyte
% 209.58/209.79  |- mesh__dateRevised mesh__D018984 2005-06-30
% 209.58/209.79  |- skos__hiddenLabel mesh__D018984 T Cell Epitope
% 209.58/209.79  |- rdf__type mesh__D018186sskos__Concept
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D018186 2005
% 209.58/209.79  |- skos__hiddenLabel mesh__D018186 Infection, Pneumovirus
% 209.58/209.79  |- mesh__publicMeSHNote mesh__D018186 94   
% 209.58/209.79  |- mesh__dateCreated mesh__D018186 1993-06-04
% 209.58/209.79  |- mesh__recordMaintainer mesh__D018186 sjn
% 209.58/209.79  |- skos__annotation mesh__D018186
% 209.58/209.79       caused by a RESPIROVIRUS; GEN or unspecified   
% 209.58/209.79  |- mesh__historyNote mesh__D018186 94   
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D018186 2004
% 209.58/209.79  |- mesh__dateEstablished mesh__D018186 1994-01-01
% 209.58/209.79  |- skos__scopeNote mesh__D018186
% 209.58/209.79       Infections with viruses of the genus PNEUMOVIRUS, family PARAMYXOVIRIDAE. This includes RESPIRATORY SYNCYTIAL VIRUS INFECTIONS, an important cause of respiratory disease in humans.%A%    
% 209.58/209.79  |- skos__hiddenLabel mesh__D018186 Pneumovirus Infection
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D018186 2003
% 209.58/209.79  |- mesh__dateRevised mesh__D018186 2001-08-03
% 209.58/209.79  |- skos__broader mesh__D018186smesh__D018184
% 209.58/209.79  |- skos__prefLabel mesh__D018186 Pneumovirus Infections
% 209.58/209.79  |- mesh__recordAuthorizer mesh__D018186 sjn
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D018186 2006
% 209.58/209.79  |- mesh__recordOriginator mesh__D018186 AGS
% 209.58/209.79  |- skos__altLabel mesh__D018186 Infections, Pneumovirus
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D018186 2002
% 209.58/209.79  |- skos__scopeNote mesh__D004964
% 209.58/209.79       A hydroxylated metabolite of ESTRADIOL or ESTRONE that has a hydroxyl group at C3-beta, 16-alpha, and 17-beta position. Estriol is a major urinary estrogen. During PREGNANCY, large amount of estriol is produced by the PLACENTA. Isomers with inversion of the hydroxyl group or groups are called epiestriol.%A%    
% 209.58/209.79  |- skos__broader mesh__D004964smesh__D045166
% 209.58/209.79  |- mesh__dateCreated mesh__D004964 1999-01-01
% 209.58/209.79  |- skos__prefLabel mesh__D004964 Estriol
% 209.58/209.79  |- mesh__dateRevised mesh__D004964 2005-06-30
% 209.58/209.79  |- rdf__type mesh__D004964sskos__Concept
% 209.58/209.79  |- skos__altLabel mesh__D004964 16-Hydroxyestradiol
% 209.58/209.79  |- skos__hiddenLabel mesh__D004964 16 Epiestriol
% 209.58/209.79  |- mesh__recordMaintainer mesh__D004964 exl
% 209.58/209.79  |- skos__hiddenLabel mesh__D004964 17 Epiestriol
% 209.58/209.79  |- skos__hiddenLabel mesh__D004964 16 Hydroxyestradiol
% 209.58/209.79  |- skos__hiddenLabel mesh__D004964 16,17 Epiestriol
% 209.58/209.79  |- skos__altLabel mesh__D004964 16-alpha-Hydroxy-Estradiol
% 209.58/209.79  |- mesh__recordOriginator mesh__D004964 NLM
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D004964 2006
% 209.58/209.79  |- skos__hiddenLabel mesh__D004964 16 alpha Hydroxy Estradiol
% 209.58/209.79  |- skos__broader mesh__D004964smesh__D004963
% 209.58/209.79  |- mesh__recordAuthorizer mesh__D004964 sjn
% 209.58/209.79  |- mesh__recordOriginator mesh__D004166 NLM
% 209.58/209.79  |- skos__scopeNote mesh__D004166
% 209.58/209.79       An antitoxin produced against the toxin of CORYNEBACTERIUM DIPHTHERIAE that is used for the treatment of DIPHTHERIA.%A%    
% 209.58/209.79  |- mesh__recordAuthorizer mesh__D004166 sjn
% 209.58/209.79  |- rdf__type mesh__D004166sskos__Concept
% 209.58/209.79  |- skos__prefLabel mesh__D004166 Diphtheria Antitoxin
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D004166 2006
% 209.58/209.79  |- mesh__dateCreated mesh__D004166 1999-01-01
% 209.58/209.79  |- mesh__recordMaintainer mesh__D004166 ssb
% 209.58/209.79  |- skos__broader mesh__D004166smesh__D000992
% 209.58/209.79  |- mesh__dateRevised mesh__D004166 2005-06-30
% 209.58/209.79  |- skos__hiddenLabel mesh__D004166 Antitoxin, Diphtheria
% 209.58/209.79  |- mesh__dateEstablished mesh__D050717 2006-01-01
% 209.58/209.79  |- mesh__dateCreated mesh__D050717 2005-06-30
% 209.58/209.79  |- skos__hiddenLabel mesh__D050717 Retinoblastoma Like Protein 2
% 209.58/209.79  |- skos__altLabel mesh__D050717 Retinoblastoma Like Protein p130
% 209.58/209.79  |- skos__altLabel mesh__D050717 RBL2 Protein
% 209.58/209.79  |- mesh__historyNote mesh__D050717 2006%28%1994%29%   
% 209.58/209.79  |- mesh__recordOriginator mesh__D050717 DRC
% 209.58/209.79  |- skos__scopeNote mesh__D050717
% 209.58/209.79       A negative regulator of the CELL CYCLE that undergoes PHOSPHORYLATION by CYCLIN-DEPENDENT KINASES. RBL2 contains a conserved pocket region that binds E2F4 TRANSCRIPTION FACTOR and E2F5 TRANSCRIPTION FACTOR. RBL2 also interacts with viral ONCOPROTEINS such as POLYOMAVIRUS TUMOR ANTIGENS; ADENOVIRUS E1A PROTEINS; and PAPILLOMAVIRUS E7 PROTEINS.%A%    
% 209.58/209.79  |- mesh__recordMaintainer mesh__D050717 DRC
% 209.58/209.79  |- skos__broader mesh__D050717smesh__D009687
% 209.58/209.79  |- skos__broader mesh__D050717smesh__D010750
% 209.58/209.79  |- skos__broader mesh__D050717smesh__D025521
% 209.58/209.79  |- skos__altLabel mesh__D050717 Retinoblastoma-Like Protein 2
% 209.58/209.79  |- mesh__publicMeSHNote mesh__D050717
% 209.58/209.79       2006; RETINOBLASTOMA-LIKE PROTEIN P130 was indexed under PROTEIN 2004-2005, under ADAPTOR PROTEINS 2004, under PHOSPHOPROTEINS 1996-2004, %26% under PROTEINS 1994-1995%A%  
% 209.58/209.79  |- skos__hiddenLabel mesh__D050717 p130, Retinoblastoma-Like Protein
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D050717 2006
% 209.58/209.79  |- skos__prefLabel mesh__D050717 Retinoblastoma-Like Protein p130
% 209.58/209.79  |- mesh__recordAuthorizer mesh__D050717 sjn
% 209.58/209.79  |- rdf__type mesh__D050717sskos__Concept
% 209.58/209.79  |- skos__hiddenLabel mesh__D014594 Uterus Cancers
% 209.58/209.79  |- skos__hiddenLabel mesh__D014594 Cancer, Uterine
% 209.58/209.79  |- skos__broader mesh__D014594smesh__D005833
% 209.58/209.79  |- skos__annotation mesh__D014594
% 209.58/209.79       fibroma = LEIOMYOMA %28%IM%29% + UTERINE NEOPLASMS %28%IM%29%; coord IM with histol type of neopl %28%IM%29%; UTERINE CERVICAL NEOPLASMS %26% ENDOMETRIAL NEOPLASMS are available%A%  
% 209.58/209.79  |- skos__altLabel mesh__D014594 Neoplasms, Uterine
% 209.58/209.79  |- skos__altLabel mesh__D014594 Uterus Neoplasms
% 209.58/209.79  |- mesh__recordAuthorizer mesh__D014594 sjn
% 209.58/209.79  |- skos__hiddenLabel mesh__D014594 Uterine Neoplasm
% 209.58/209.79  |- skos__hiddenLabel mesh__D014594 Neoplasm, Uterus
% 209.58/209.79  |- skos__scopeNote mesh__D014594 Tumors or cancer of the UTERUS.     
% 209.58/209.79  |- skos__hiddenLabel mesh__D014594 Uterus Neoplasm
% 209.58/209.79  |- skos__hiddenLabel mesh__D014594 Uterine Cancers
% 209.58/209.79  |- skos__altLabel mesh__D014594 Uterine Cancer
% 209.58/209.79  |- skos__altLabel mesh__D014594 Neoplasms, Uterus
% 209.58/209.79  |- mesh__dateRevised mesh__D014594 2005-07-01
% 209.58/209.79  |- skos__altLabel mesh__D014594 Uterus Cancer
% 209.58/209.79  |- skos__hiddenLabel mesh__D014594 Cancers, Uterus
% 209.58/209.79  |- mesh__recordOriginator mesh__D014594 NLM
% 209.58/209.79  |- skos__altLabel mesh__D014594 Cancer of the Uterus
% 209.58/209.79  |- skos__prefLabel mesh__D014594 Uterine Neoplasms
% 209.58/209.79  |- skos__broader mesh__D014594smesh__D014591
% 209.58/209.79  |- mesh__dateCreated mesh__D014594 1999-01-01
% 209.58/209.79  |- mesh__recordMaintainer mesh__D014594 sjn
% 209.58/209.79  |- rdf__type mesh__D014594sskos__Concept
% 209.58/209.79  |- skos__hiddenLabel mesh__D014594 Cancer, Uterus
% 209.58/209.79  |- skos__hiddenLabel mesh__D014594 Neoplasm, Uterine
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D014594 2006
% 209.58/209.79  |- skos__hiddenLabel mesh__D014594 Cancers, Uterine
% 209.58/209.79  |- skos__hiddenLabel mesh__D008557 Melorheostoses
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D008557 2002
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D008557 1999
% 209.58/209.79  |- skos__prefLabel mesh__D008557 Melorheostosis
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D008557 2005
% 209.58/209.79  |- mesh__recordMaintainer mesh__D008557 TGC
% 209.58/209.79  |- skos__scopeNote mesh__D008557
% 209.58/209.79       A form of osteosclerosis or hyperostosis extending in a linear track through one of the long bones of an extremity, and consisting of proliferated ivory-like new bone. %22%Melo-%22% is from the Greek, limb and %22%-rheostosis%22% refers to streaks %28%rheo- from the Greek, flow%29%, in the bones. %28%Dorland, 27th ed%29%%A%    
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D008557 1996
% 209.58/209.79  |- skos__annotation mesh__D008557 a form of osteosclerosis   
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D008557 2006
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D008557 2000
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D008557 1997
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D008557 1994
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D008557 2003
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D008557 2001
% 209.58/209.79  |- mesh__dateCreated mesh__D008557 1999-01-01
% 209.58/209.79  |- mesh__dateRevised mesh__D008557 1993-06-02
% 209.58/209.79  |- rdf__type mesh__D008557sskos__Concept
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D008557 1995
% 209.58/209.79  |- mesh__recordOriginator mesh__D008557 NLM
% 209.58/209.79  |- skos__broader mesh__D008557smesh__D010026
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D008557 2004
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D008557 1998
% 209.58/209.79  |- mesh__recordAuthorizer mesh__D008557 PLS
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D000574 1996
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D000574 2006
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D000574 2000
% 209.58/209.79  |- rdf__type mesh__D000574sskos__Concept
% 209.58/209.79  |- skos__annotation mesh__D000574
% 209.58/209.79       add UNITED STATES %28%NIM%29%; DF: AMA      CATALOG: use NAF entry%A%  
% 209.58/209.79  |- mesh__publicMeSHNote mesh__D000574 66   
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D000574 1997
% 209.58/209.79  |- mesh__historyNote mesh__D000574 66   
% 209.58/209.79  |- mesh__dateRevised mesh__D000574 1992-03-25
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D000574 2001
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D000574 1998
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D000574 1993
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D000574 2002
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D000574 1994
% 209.58/209.79  |- skos__prefLabel mesh__D000574 American Medical Association
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D000574 1999
% 209.58/209.79  |- skos__scopeNote mesh__D000574
% 209.58/209.79       Professional society representing the field of medicine.%A%    
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D000574 2003
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D000574 1995
% 209.58/209.79  |- mesh__recordMaintainer mesh__D000574 TAP
% 209.58/209.79  |- mesh__recordAuthorizer mesh__D000574 PLS
% 209.58/209.79  |- skos__hiddenLabel mesh__D000574 Medical Association, American
% 209.58/209.79  |- skos__hiddenLabel mesh__D000574 Association, American Medical
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D000574 2004
% 209.58/209.79  |- mesh__dateCreated mesh__D000574 1999-01-01
% 209.58/209.79  |- mesh__recordOriginator mesh__D000574 NLM
% 209.58/209.79  |- skos__broader mesh__D000574smesh__D012955
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D000574 2005
% 209.58/209.79  |- mesh__dateEstablished mesh__D000574 1966-01-01
% 209.58/209.79  |- mesh__dateEstablished mesh__D018985 1996-01-01
% 209.58/209.79  |- skos__hiddenLabel mesh__D018985 Epitope, B-Lymphocyte
% 209.58/209.79  |- mesh__dateRevised mesh__D018985 2005-06-30
% 209.58/209.79  |- skos__historyNote mesh__D018985 Epitopes %28%1987-1995%29%
% 209.58/209.79  |- skos__hiddenLabel mesh__D018985 B Cell Epitope
% 209.58/209.79  |- skos__altLabel mesh__D018985 B-Lymphocyte Epitopes
% 209.58/209.79  |- skos__hiddenLabel mesh__D018985 B Lymphocyte Epitope
% 209.58/209.79  |- mesh__recordOriginator mesh__D018985 AGS
% 209.58/209.79  |- mesh__dateCreated mesh__D018985 1995-06-08
% 209.58/209.79  |- skos__altLabel mesh__D018985 B-Cell Epitopes
% 209.58/209.79  |- rdf__type mesh__D018985sskos__Concept
% 209.58/209.79  |- skos__broader mesh__D018985smesh__D000939
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D018985 2006
% 209.58/209.79  |- skos__hiddenLabel mesh__D018985 Epitopes, B-Cell
% 209.58/209.79  |- skos__hiddenLabel mesh__D018985 B Lymphocyte Epitopes
% 209.58/209.79  |- skos__hiddenLabel mesh__D018985 Epitopes, B Lymphocyte
% 209.58/209.79  |- mesh__historyNote mesh__D018985 96   
% 209.58/209.79  |- skos__hiddenLabel mesh__D018985 Epitope, B-Cell
% 209.58/209.79  |- skos__altLabel mesh__D018985 B-Cell Epitope
% 209.58/209.79  |- mesh__recordAuthorizer mesh__D018985 sjn
% 209.58/209.79  |- mesh__publicMeSHNote mesh__D018985 96   
% 209.58/209.79  |- skos__scopeNote mesh__D018985
% 209.58/209.79       Antigenic determinants recognized and bound by the B-cell receptor. Epitopes recognized by the B-cell receptor are located on the surface of the antigen.%A%    
% 209.58/209.79  |- skos__annotation mesh__D018985
% 209.58/209.79       sites on antigens recognized by B-lymphocytes; DF: note short X ref%A%  
% 209.58/209.79  |- mesh__recordMaintainer mesh__D018985 ssb
% 209.58/209.79  |- skos__altLabel mesh__D018985 B-Lymphocyte Epitope
% 209.58/209.79  |- skos__hiddenLabel mesh__D018985 B Cell Epitopes
% 209.58/209.79  |- skos__prefLabel mesh__D018985 Epitopes, B-Lymphocyte
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D018187 1994
% 209.58/209.79  |- skos__scopeNote mesh__D018187
% 209.58/209.79       A psychological theory based on dimensions or categories used by a given person in describing or explaining the personality and behavior of others or of himself. The basic idea is that different people will use consistently different categories. The theory was formulated in the fifties by George Kelly. Two tests devised by him are the role construct repertory test and the repertory grid test. %28%From Stuart Sutherland, The International Dictionary of Psychology, 1989%29%%A%    
% 209.58/209.79  |- skos__hiddenLabel mesh__D018187 Theories, Personal Construct
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D018187 2002
% 209.58/209.79  |- mesh__historyNote mesh__D018187 94   
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D018187 1997
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D018187 2004
% 209.58/209.79  |- skos__hiddenLabel mesh__D018187 Construct Theories, Personal
% 209.58/209.79  |- skos__hiddenLabel mesh__D018187 Theory, Personal Construct
% 209.58/209.79  |- mesh__publicMeSHNote mesh__D018187 94   
% 209.58/209.79  |- skos__hiddenLabel mesh__D018187 Construct Theory, Personal
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D018187 1996
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D018187 2003
% 209.58/209.79  |- mesh__dateCreated mesh__D018187 1993-06-02
% 209.58/209.79  |- skos__annotation mesh__D018187
% 209.58/209.79       no qualif; includes personal construct, personal construct method, personal construct organization, etc.; for personal construct ther, coord IM with PSYCHOTHERAPY %28%IM%29%%A%  
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D018187 2006
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D018187 2001
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D018187 1999
% 209.58/209.79  |- mesh__dateEstablished mesh__D018187 1994-01-01
% 209.58/209.79  |- skos__broader mesh__D018187smesh__D011582
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D018187 2000
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D018187 1995
% 209.58/209.79  |- skos__hiddenLabel mesh__D018187 Personal Construct Theories
% 209.58/209.79  |- rdf__type mesh__D018187sskos__Concept
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D018187 1998
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D018187 2005
% 209.58/209.79  |- skos__prefLabel mesh__D018187 Personal Construct Theory
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D004965 2006
% 209.58/209.79  |- skos__related mesh__D004965smesh__D004967
% 209.58/209.79  |- skos__broader mesh__D004965smesh__D020847
% 209.58/209.79  |- mesh__recordMaintainer mesh__D004965 lkt
% 209.58/209.79  |- skos__prefLabel mesh__D004965 Estrogen Antagonists
% 209.58/209.79  |- mesh__dateRevised mesh__D004965 2003-07-09
% 209.58/209.79  |- rdf__type mesh__D004965sskos__Concept
% 209.58/209.79  |- skos__historyNote mesh__D004965 specific estrogen %28%1966-1977%29%
% 209.58/209.79  |- skos__hiddenLabel mesh__D004965 Antagonists, Estrogen
% 209.58/209.79  |- mesh__publicMeSHNote mesh__D004965 78   
% 209.58/209.79  |- mesh__recordOriginator mesh__D004965 RLS
% 209.58/209.79  |- mesh__dateCreated mesh__D004965 1999-11-08
% 209.58/209.79  |- skos__related mesh__D004965smesh__D020847
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D004965 2004
% 209.58/209.79  |- skos__scopeNote mesh__D004965
% 209.58/209.79       Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds.%A%    
% 209.58/209.79  |- mesh__dateEstablished mesh__D004965 1978-01-01
% 209.58/209.79  |- skos__historyNote mesh__D004965 Estrogens %28%1966-1977%29%
% 209.58/209.79  |- mesh__historyNote mesh__D004965 78   
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D004965 2005
% 209.58/209.79  |- skos__annotation mesh__D004965
% 209.58/209.79       DF: ESTROGEN ANTAG; do not confuse with ANTIESTROGENS see ESTROGEN RECEPT MODULATORS%A%  
% 209.58/209.79  |- mesh__recordAuthorizer mesh__D004965 sjn
% 209.58/209.79  |- skos__historyNote mesh__D037341 Mycotoxins %28%1992-1997%29%
% 209.58/209.79  |- mesh__dateCreated mesh__D037341 2002-07-03
% 209.58/209.79  |- mesh__publicMeSHNote mesh__D037341 2003   
% 209.58/209.79  |- rdf__type mesh__D037341sskos__Concept
% 209.58/209.79  |- mesh__dateEstablished mesh__D037341 2003-01-01
% 209.58/209.79  |- mesh__historyNote mesh__D037341 2003   
% 209.58/209.79  |- skos__scopeNote mesh__D037341
% 209.58/209.79       A group of MYCOTOXINS found in CORN contaminated with FUSARIUM fungus. They are chains of about 20 carbons with acidic ester, acetylamino and sometimes other substituents. They inhibit ceramide synthetase conversion of SPHINGOLIPIDS to CERAMIDES.%A%    
% 209.58/209.79  |- mesh__recordOriginator mesh__D037341 ssb
% 209.58/209.79  |- mesh__recordMaintainer mesh__D037341 ssb
% 209.58/209.79  |- skos__broader mesh__D037341smesh__D009183
% 209.58/209.79  |- skos__historyNote mesh__D037341 Carboxylic Acids %28%1992-2002%29%
% 209.58/209.79  |- mesh__recordAuthorizer mesh__D037341 sjn
% 209.58/209.79  |- skos__prefLabel mesh__D037341 Fumonisins
% 209.58/209.79  |- mesh__dateRevised mesh__D037341 2005-06-30
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D037341 2006
% 209.58/209.79  |- skos__broader mesh__D037341smesh__D000473
% 209.58/209.79  |- mesh__dateCreated mesh__D004167 1999-01-01
% 209.58/209.79  |- mesh__dateRevised mesh__D004167 2005-07-20
% 209.58/209.79  |- skos__annotation mesh__D004167
% 209.58/209.79       /antag permitted but consider also DIPHTHERIA ANTITOXIN   
% 209.58/209.79  |- skos__scopeNote mesh__D004167
% 209.58/209.79       An ADP-ribosylating EXOTOXIN produced by CORYNEBACTERIUM DIPHTHERIAE that causes the signs and symptoms of DIPHTHERIA. It can be broken into two unequal domains: the smaller, catalytic A domain is the lethal moiety and contains mono ADPribose transferase which transfers ADP RIBOSE to PEPTIDE ELONGATION FACTOR 2 thereby inhibiting protein synthesis; and the larger B domain that is needed for entry into cells.%A%    
% 209.58/209.79  |- mesh__recordMaintainer mesh__D004167 ags
% 209.58/209.79  |- skos__altLabel mesh__D004167 Toxin, Corynebacterium Diphtheriae
% 209.58/209.79  |- skos__altLabel mesh__D004167 Corynebacterium Diphtheriae Toxin
% 209.58/209.79  |- skos__prefLabel mesh__D004167 Diphtheria Toxin
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D004167 2006A
% 209.58/209.79  |- rdf__type mesh__D004167sskos__Concept
% 209.58/209.79  |- mesh__recordOriginator mesh__D004167 NLM
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D004167 2006
% 209.58/209.79  |- mesh__recordAuthorizer mesh__D004167 ags
% 209.58/209.79  |- skos__broader mesh__D004167smesh__D001427
% 209.58/209.79  |- skos__broader mesh__D004167smesh__D036002
% 209.58/209.79  |- skos__broader mesh__D009650smesh__D009654
% 209.58/209.79  |- rdf__type mesh__D009650sskos__Concept
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D009650 2003
% 209.58/209.79  |- mesh__dateEstablished mesh__D009650 1974-01-01
% 209.58/209.79  |- skos__scopeNote mesh__D009650
% 209.58/209.79       Pregnanes which have undergone ring contractions or are lacking carbon-18 or carbon-19. Unsaturation in the steroid ring system is not included.%A%    
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D009650 1998
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D009650 2000
% 209.58/209.79  |- skos__annotation mesh__D009650 do not confuse with NORPREGNENES   
% 209.58/209.79  |- mesh__publicMeSHNote mesh__D009650 74   
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D009650 2004
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D009650 1999
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D009650 1994
% 209.58/209.79  |- mesh__historyNote mesh__D009650 74   
% 209.58/209.79  |- mesh__dateCreated mesh__D009650 1999-01-01
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D009650 2001
% 209.58/209.79  |- mesh__recordMaintainer mesh__D009650 PLS
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D009650 1995
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D009650 2005
% 209.58/209.79  |- mesh__recordOriginator mesh__D009650 NLM
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D009650 2002
% 209.58/209.79  |- skos__prefLabel mesh__D009650 Norpregnanes
% 209.58/209.79  |- mesh__recordAuthorizer mesh__D009650 PLS
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D009650 2006
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D009650 1996
% 209.58/209.79  |- mesh__dateRevised mesh__D009650 1993-06-03
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D009650 1997
% 209.58/209.79  |- mesh__publicMeSHNote mesh__D023321 2001   
% 209.58/209.79  |- mesh__recordMaintainer mesh__D023321 ssb
% 209.58/209.79  |- skos__hiddenLabel mesh__D023321 Vaccines, Poliovirus
% 209.58/209.79  |- skos__prefLabel mesh__D023321 Poliovirus Vaccines
% 209.58/209.79  |- mesh__recordOriginator mesh__D023321 ags
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D023321 2006
% 209.58/209.79  |- skos__scopeNote mesh__D023321
% 209.58/209.79       Vaccines used to prevent POLIOMYELITIS. They include inactivated  %28%POLIOVIRUS VACCINE, INACTIVATED%29% and oral vaccines %28%POLIOVIRUS VACCINE, ORAL%29%.%A%    
% 209.58/209.79  |- skos__broader mesh__D023321smesh__D014765
% 209.58/209.79  |- mesh__historyNote mesh__D023321 2001   
% 209.58/209.79  |- rdf__type mesh__D023321sskos__Concept
% 209.58/209.79  |- mesh__dateRevised mesh__D023321 2005-06-30
% 209.58/209.79  |- mesh__recordAuthorizer mesh__D023321 sjn
% 209.58/209.79  |- mesh__dateEstablished mesh__D023321 2001-01-01
% 209.58/209.79  |- mesh__dateCreated mesh__D023321 2000-06-22
% 209.58/209.79  |- skos__scopeNote mesh__D050718
% 209.58/209.79       An endogenous serine protease inhibitor %28%SERPINS%29%. It is a 105-kDA plasma glycoprotein, encoded by C1NH gene and produced primarily by the liver and monocytes. It inhibits a broad spectrum of proteases, including the COMPLEMENT C1R and the COMPLEMENT C1S proteases of the CLASSICAL COMPLEMENT PATHWAY, and the MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES. C1-INH-deficient individuals suffer from hereditary ANGIONEUROTIC EDEMA.%A%    
% 209.58/209.79  |- skos__hiddenLabel mesh__D050718 C1 Inhibitor Protein
% 209.58/209.79  |- mesh__recordAuthorizer mesh__D050718 sjn
% 209.58/209.79  |- skos__broader mesh__D050718smesh__D003174
% 209.58/209.79  |- skos__altLabel mesh__D050718 C1-INH Protein
% 209.58/209.79  |- mesh__dateEstablished mesh__D050718 2006-01-01
% 209.58/209.79  |- skos__altLabel mesh__D050718 Complement C1-Inhibitor Protein
% 209.58/209.79  |- mesh__dateCreated mesh__D050718 2005-06-30
% 209.58/209.79  |- mesh__publicMeSHNote mesh__D050718 2006   
% 209.58/209.79  |- skos__altLabel mesh__D050718 C1-Inhibitor Protein
% 209.58/209.79  |- skos__altLabel mesh__D050718 Plasma Protease C1 Inhibitor
% 209.58/209.79  |- skos__prefLabel mesh__D050718 Complement C1 Inhibitor Protein
% 209.58/209.79  |- skos__hiddenLabel mesh__D050718 C1 INH Protein
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D050718 2006
% 209.58/209.79  |- mesh__recordMaintainer mesh__D050718 lkt
% 209.58/209.79  |- skos__historyNote mesh__D050718
% 209.58/209.79       Complement C1 Inactivator Proteins %28%1970-2005%29%
% 209.58/209.79  |- skos__hiddenLabel mesh__D050718 Protein, Complement C1-Inhibitor
% 209.58/209.79  |- mesh__historyNote mesh__D050718 2006   
% 209.58/209.79  |- rdf__type mesh__D050718sskos__Concept
% 209.58/209.79  |- skos__hiddenLabel mesh__D050718 Protein, C1-INH
% 209.58/209.79  |- mesh__recordOriginator mesh__D050718 lkt
% 209.58/209.79  |- skos__annotation mesh__D050718
% 209.58/209.79       do not confuse with COMPLEMENT C1 INACTIVATOR PROTEINS   
% 209.58/209.79  |- skos__hiddenLabel mesh__D050718 Protein, C1-Inhibitor
% 209.58/209.79  |- skos__prefLabel mesh__D014595 Uterine Perforation
% 209.58/209.79  |- skos__hiddenLabel mesh__D014595 Perforation, Uterine
% 209.58/209.79  |- skos__broader mesh__D014595smesh__D014597
% 209.58/209.79  |- mesh__recordAuthorizer mesh__D014595 sjn
% 209.58/209.79  |- skos__scopeNote mesh__D014595
% 209.58/209.79       A hole or break through the wall of the UTERUS, usually made by the placement of an instrument or INTRAUTERINE DEVICES.%A%    
% 209.58/209.79  |- mesh__dateEstablished mesh__D014595 1991-01-01
% 209.58/209.79  |- mesh__dateCreated mesh__D014595 1974-11-11
% 209.58/209.79  |- rdf__type mesh__D014595sskos__Concept
% 209.58/209.79  |- mesh__historyNote mesh__D014595
% 209.58/209.79       91%28%75%29%; was see under UTERINE RUPTURE 1975-90   
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D014595 2006
% 209.58/209.79  |- skos__hiddenLabel mesh__D014595 Perforations, Uterine
% 209.58/209.79  |- mesh__recordOriginator mesh__D014595 NLM
% 209.58/209.79  |- mesh__recordMaintainer mesh__D014595 lkt
% 209.58/209.79  |- skos__hiddenLabel mesh__D014595 Uterine Perforations
% 209.58/209.79  |- mesh__publicMeSHNote mesh__D014595
% 209.58/209.79       91; was see under UTERINE RUPTURE 1975-90   
% 209.58/209.79  |- mesh__dateRevised mesh__D014595 2005-06-30
% 209.58/209.79  |- skos__altLabel mesh__D008558 Phenylalanine Mustard
% 209.58/209.79  |- skos__prefLabel mesh__D008558 Melphalan
% 209.58/209.79  |- mesh__dateRevised mesh__D008558 2005-06-30
% 209.58/209.79  |- mesh__recordOriginator mesh__D008558 NLM
% 209.58/209.79  |- mesh__recordMaintainer mesh__D008558 ssb
% 209.58/209.79  |- skos__altLabel mesh__D008558
% 209.58/209.79       4-%28%Bis%28%2-chloroethyl%29%amino%29%phenylalanine
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D008558 2006
% 209.58/209.79  |- skos__hiddenLabel mesh__D008558 Mustard, Phenylalanine
% 209.58/209.79  |- skos__scopeNote mesh__D008558
% 209.58/209.79       An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen.%A%    
% 209.58/209.79  |- mesh__dateCreated mesh__D008558 1999-01-01
% 209.58/209.79  |- skos__broader mesh__D008558smesh__D010649
% 209.58/209.79  |- skos__altLabel mesh__D008558 L-PAM
% 209.58/209.79  |- rdf__type mesh__D008558sskos__Concept
% 209.58/209.79  |- mesh__publicMeSHNote mesh__D008558
% 209.58/209.79       PEPTICHEMIO was see under NITROGEN MUSTARD COMPOUNDS 1975-80%A%  
% 209.58/209.79  |- mesh__recordAuthorizer mesh__D008558 sjn
% 209.58/209.79  |- skos__altLabel mesh__D008558 Sarcolysine
% 209.58/209.79  |- skos__altLabel mesh__D008558 Merphalan
% 209.58/209.79  |- skos__broader mesh__D008558smesh__D009588
% 209.58/209.79  |- skos__hiddenLabel mesh__D000575 Nurses%27% Association, American
% 209.58/209.79  |- mesh__recordMaintainer mesh__D000575 TAP
% 209.58/209.79  |- skos__prefLabel mesh__D000575 American Nurses%27% Association
% 209.58/209.79  |- mesh__recordOriginator mesh__D000575 NLM
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D000575 1997
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D000575 2002
% 209.58/209.79  |- mesh__dateRevised mesh__D000575 1992-03-25
% 209.58/209.79  |- mesh__activeMeSHYear mesh__D000575 2006
% 209.58/209.79  |- rdf__type mesh__D000575sskos__Concept
% 209.58/209.80  |- skos__scopeNote mesh__D000575
% 209.58/209.80       Professional society representing the field of nursing.%A%    
% 209.58/209.80  |- mesh__historyNote mesh__D000575 67%28%65%29%   
% 209.58/209.80  |- mesh__activeMeSHYear mesh__D000575 2001
% 209.58/209.80  |- mesh__activeMeSHYear mesh__D000575 1996
% 209.58/209.80  |- mesh__activeMeSHYear mesh__D000575 1995
% 209.58/209.80  |- skos__hiddenLabel mesh__D000575 Associations, American Nurses%27%
% 209.58/209.80  |- skos__broader mesh__D000575smesh__D012956
% 209.58/209.80  |- skos__annotation mesh__D000575
% 209.58/209.80       add UNITED STATES %28%NIM%29%; DF: ANA      CATALOG: use NAF entry%A%  
% 209.58/209.80  |- skos__hiddenLabel mesh__D000575 Association, American Nurses%27%
% 209.58/209.80  |- mesh__activeMeSHYear mesh__D000575 2005
% 209.58/209.80  |- skos__hiddenLabel mesh__D000575 American Nurses%27% Associations
% 209.58/209.80  |- mesh__dateCreated mesh__D000575 1999-01-01
% 209.58/209.80  |- mesh__activeMeSHYear mesh__D000575 2000
% 209.58/209.80  |- mesh__activeMeSHYear mesh__D000575 1994
% 209.58/209.80  |- mesh__recordAuthorizer mesh__D000575 PLS
% 209.58/209.80  |- mesh__activeMeSHYear mesh__D000575 2004
% 209.58/209.80  |- mesh__activeMeSHYear mesh__D000575 1999
% 209.65/209.80  |- mesh__publicMeSHNote mesh__D000575 67   
% 209.65/209.80  |- skos__hiddenLabel mesh__D000575 American Nurses Association
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D000575 1993
% 209.65/209.80  |- mesh__dateEstablished mesh__D000575 1967-01-01
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D000575 2003
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D000575 1998
% 209.65/209.80  |- skos__hiddenLabel mesh__D000575 Nurses%27% Associations, American
% 209.65/209.80  |- mesh__recordOriginator mesh__D019280 JLS
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D019280 2006
% 209.65/209.80  |- skos__hiddenLabel mesh__D019280 Syndrome, BOR
% 209.65/209.80  |- skos__broader mesh__D019280smesh__D000015
% 209.65/209.80  |- skos__altLabel mesh__D019280 BOR Syndrome
% 209.65/209.80  |- skos__hiddenLabel mesh__D019280 Syndrome, Branchio-Oculo-Facial
% 209.65/209.80  |- skos__hiddenLabel mesh__D019280 Branchio Otorenal Syndrome
% 209.65/209.80  |- skos__hiddenLabel mesh__D019280 Dysplasias, Branchio-Otorenal
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D019280 2003
% 209.65/209.80  |- skos__hiddenLabel mesh__D019280 Branchio-Oculo-Facial Syndromes
% 209.65/209.80  |- rdf__type mesh__D019280sskos__Concept
% 209.65/209.80  |- skos__broader mesh__D019280smesh__D025063
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D019280 2002
% 209.65/209.80  |- skos__historyNote mesh__D019280
% 209.65/209.80       Chromosome Abnormalities %28%1966-1996%29%
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D019280 2004
% 209.65/209.80  |- skos__hiddenLabel mesh__D019280 Syndromes, BOR
% 209.65/209.80  |- skos__hiddenLabel mesh__D019280 Syndrome, Branchio-Otorenal
% 209.65/209.80  |- mesh__dateCreated mesh__D019280 1996-06-10
% 209.65/209.80  |- skos__altLabel mesh__D019280 Branchio-Otorenal Syndrome
% 209.65/209.80  |- skos__hiddenLabel mesh__D019280 Branchio-Otorenal Syndromes
% 209.65/209.80  |- skos__hiddenLabel mesh__D019280 Syndromes, Branchio-Otorenal
% 209.65/209.80  |- skos__historyNote mesh__D019280
% 209.65/209.80       Abnormalities, Multiple %28%1966-1996%29%
% 209.65/209.80  |- mesh__publicMeSHNote mesh__D019280 97   
% 209.65/209.80  |- mesh__recordAuthorizer mesh__D019280 sjn
% 209.65/209.80  |- skos__hiddenLabel mesh__D019280 Syndromes, Branchio-Oto-Renal
% 209.65/209.80  |- skos__hiddenLabel mesh__D019280 Syndromes, Branchio-Oculo-Facial
% 209.65/209.80  |- mesh__dateRevised mesh__D019280 2001-07-25
% 209.65/209.80  |- skos__hiddenLabel mesh__D019280 BOR Syndromes
% 209.65/209.80  |- skos__annotation mesh__D019280
% 209.65/209.80       multiple abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: note short X ref%A%  
% 209.65/209.80  |- mesh__recordMaintainer mesh__D019280 nns
% 209.65/209.80  |- mesh__dateEstablished mesh__D019280 1997-01-01
% 209.65/209.80  |- skos__hiddenLabel mesh__D019280 Branchio Oculo Facial Syndrome
% 209.65/209.80  |- skos__scopeNote mesh__D019280
% 209.65/209.80       An autosomal dominant disorder manifested by various combinations of preauricular pits, branchial fistulae or cysts, lacrimal duct stenosis, hearing loss, structural defects of the outer, middle, or inner ear, and renal dysplasia. Associated defects include asthenic habitus, long narrow facies, constricted palate, deep overbite, and myopia. Hearing loss may be due to Mondini type cochlear defect and stapes fixation. %28%Jablonski%27%s Dictionary of Syndromes %26% Eponymic Diseases, 2d ed%29%%A%    
% 209.65/209.80  |- skos__hiddenLabel mesh__D019280 Dysplasia, Branchio-Otorenal
% 209.65/209.80  |- skos__hiddenLabel mesh__D019280 Branchio Otorenal Dysplasia
% 209.65/209.80  |- skos__prefLabel mesh__D019280 Branchio-Oto-Renal Syndrome
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D019280 2005
% 209.65/209.80  |- skos__hiddenLabel mesh__D019280 Branchio-Oto-Renal Syndromes
% 209.65/209.80  |- skos__hiddenLabel mesh__D019280 Branchio Oto Renal Syndrome
% 209.65/209.80  |- skos__hiddenLabel mesh__D019280 Syndrome, Branchio-Oto-Renal
% 209.65/209.80  |- mesh__historyNote mesh__D019280 97   
% 209.65/209.80  |- skos__hiddenLabel mesh__D019280 Branchio-Otorenal Dysplasias
% 209.65/209.80  |- skos__altLabel mesh__D019280 Branchio-Otorenal Dysplasia
% 209.65/209.80  |- mesh__recordAuthorizer mesh__D005260 sjn
% 209.65/209.80  |- mesh__historyNote mesh__D005260 1966; for FEMALES use WOMEN 1978-2005   
% 209.65/209.80  |- skos__annotation mesh__D005260
% 209.65/209.80       check tag only for female organs, diseases, physiol processes, genetics, etc.; do not confuse with WOMEN as a social, cultural, political, economic force; Manual 18.9+, 34.12; 35.6.2      CATALOG: do not use: for indexers only%A%  
% 209.65/209.80  |- skos__prefLabel mesh__D005260 Female
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D005260 2006
% 209.65/209.80  |- mesh__recordOriginator mesh__D005260 NLM
% 209.65/209.80  |- mesh__dateRevised mesh__D005260 2005-06-30
% 209.65/209.80  |- mesh__dateCreated mesh__D005260 1999-01-01
% 209.65/209.80  |- mesh__recordMaintainer mesh__D005260 ags
% 209.65/209.80  |- skos__altLabel mesh__D005260 Females
% 209.65/209.80  |- skos__hiddenLabel mesh__D018986 Motor Vehicle
% 209.65/209.80  |- mesh__recordAuthorizer mesh__D018986 sjn
% 209.65/209.80  |- skos__broader mesh__D018986smesh__D014186
% 209.65/209.80  |- skos__scopeNote mesh__D018986
% 209.65/209.80       AUTOMOBILES, trucks, buses, or similar engine-driven conveyances. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 209.65/209.80  |- mesh__dateCreated mesh__D018986 1995-06-20
% 209.65/209.80  |- skos__related mesh__D018986smesh__D000063
% 209.65/209.80  |- skos__historyNote mesh__D018986 Transportation %28%1966-1995%29%
% 209.65/209.80  |- skos__hiddenLabel mesh__D018986 Vehicle, Motor
% 209.65/209.80  |- mesh__dateEstablished mesh__D018986 1996-01-01
% 209.65/209.80  |- mesh__dateRevised mesh__D018986 2005-06-30
% 209.65/209.80  |- skos__historyNote mesh__D018986 specific vehicles %28%1966-1995%29%
% 209.65/209.80  |- mesh__recordOriginator mesh__D018986 JLS
% 209.65/209.80  |- mesh__publicMeSHNote mesh__D018986 96   
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D018986 2006
% 209.65/209.80  |- rdf__type mesh__D018986sskos__Concept
% 209.65/209.80  |- skos__prefLabel mesh__D018986 Motor Vehicles
% 209.65/209.80  |- mesh__recordMaintainer mesh__D018986 ssb
% 209.65/209.80  |- mesh__historyNote mesh__D018986 96   
% 209.65/209.80  |- skos__hiddenLabel mesh__D018986 Truck
% 209.65/209.80  |- skos__altLabel mesh__D018986 Vehicles, Motor
% 209.65/209.80  |- skos__annotation mesh__D018986
% 209.65/209.80       general or unspecified; prefer specific indentions   
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D018188 2001
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D018188 1996
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D018188 2003
% 209.65/209.80  |- skos__annotation mesh__D018188 caused by a picornavirus   
% 209.65/209.80  |- skos__scopeNote mesh__D018188
% 209.65/209.80       Infections caused by viruses of the genus CARDIOVIRUS, family PICORNAVIRIDAE.%A%    
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D018188 2000
% 209.65/209.80  |- skos__hiddenLabel mesh__D018188 Infection, Cardiovirus
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D018188 1999
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D018188 2006
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D018188 1995
% 209.65/209.80  |- rdf__type mesh__D018188sskos__Concept
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D018188 1998
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D018188 2005
% 209.65/209.80  |- skos__prefLabel mesh__D018188 Cardiovirus Infections
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D018188 2002
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D018188 1994
% 209.65/209.80  |- skos__hiddenLabel mesh__D018188 Cardiovirus Infection
% 209.65/209.80  |- skos__broader mesh__D018188smesh__D010850
% 209.65/209.80  |- mesh__dateCreated mesh__D018188 1993-06-04
% 209.65/209.80  |- mesh__publicMeSHNote mesh__D018188 94   
% 209.65/209.80  |- mesh__historyNote mesh__D018188 94   
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D018188 1997
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D018188 2004
% 209.65/209.80  |- mesh__dateEstablished mesh__D018188 1994-01-01
% 209.65/209.80  |- skos__altLabel mesh__D018188 Infections, Cardiovirus
% 209.65/209.80  |- mesh__recordMaintainer mesh__D004966 exl
% 209.65/209.80  |- skos__altLabel mesh__D004966 Conjugated Estrogens
% 209.65/209.80  |- skos__altLabel mesh__D004966 Wyeth Brand of Estrogens, Conjugated
% 209.65/209.80  |- skos__altLabel mesh__D004966 Almirall Brand of Estrogens, Conjugated
% 209.65/209.80  |- mesh__recordOriginator mesh__D004966 NLM
% 209.65/209.80  |- skos__altLabel mesh__D004966 Climopax
% 209.65/209.80  |- skos__altLabel mesh__D004966 Climarest
% 209.65/209.80  |- skos__hiddenLabel mesh__D004966 Equine Estrogens, Conjugated
% 209.65/209.80  |- skos__hiddenLabel mesh__D004966 Conjugated Estrogenic Hormones
% 209.65/209.80  |- skos__altLabel mesh__D004966 Transannon
% 209.65/209.80  |- mesh__recordAuthorizer mesh__D004966 sjn
% 209.65/209.80  |- skos__altLabel mesh__D004966 Estrogenic Substances, Conjugated
% 209.65/209.80  |- skos__scopeNote mesh__D004966
% 209.65/209.80       A pharmaceutical preparation containing a mixture of water-soluble, conjugated estrogens derived wholly or in part from URINE of pregnant mares or synthetically from ESTRONE and EQUILIN. It contains a sodium-salt mixture of estrone sulfate %28%52-62%25%%29% and equilin sulfate %28%22-30%25%%29% with a total of the two between 80-88%25%. Other concomitant conjugates include 17-alpha-dihydroequilin, 17-alpha-estradiol, and 17-beta-dihydroequilin. The potency of the preparation is expressed in terms of an equivalent quantity of sodium estrone sulfate.%A%    
% 209.65/209.80  |- skos__altLabel mesh__D004966 Trianon Brand of Estrogens, Conjugated
% 209.65/209.80  |- skos__altLabel mesh__D004966 Solvay Brand of Estrogens, Conjugated
% 209.65/209.80  |- skos__altLabel mesh__D004966 Progens
% 209.65/209.80  |- skos__altLabel mesh__D004966 Oestrofeminal
% 209.65/209.80  |- skos__prefLabel mesh__D004966 Estrogens, Conjugated %28%USP%29%
% 209.65/209.80  |- skos__altLabel mesh__D004966 ASTA Medica Brand of Estrogens, Conjugated
% 209.65/209.80  |- skos__altLabel mesh__D004966 Estrogenic Hormones, Conjugated
% 209.65/209.80  |- skos__altLabel mesh__D004966 Duramed Brand of Estrogens, Conjugated
% 209.65/209.80  |- mesh__historyNote mesh__D004966
% 209.65/209.80       2004 %28%1973%29%; for CENESTIN use ESTROGENS, CONJUGATED %28%NM%29% 1999-2002%A%  
% 209.65/209.80  |- skos__altLabel mesh__D004966 Prelestrin
% 209.65/209.80  |- skos__altLabel mesh__D004966 Femavit
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D004966 2006
% 209.65/209.80  |- mesh__dateCreated mesh__D004966 1999-01-01
% 209.65/209.80  |- skos__altLabel mesh__D004966 Estrogens, Conjugated
% 209.65/209.80  |- mesh__publicMeSHNote mesh__D004966
% 209.65/209.80       2004; see ESTROGENS, CONJUGATED 1994-2003, see ESTROGENIC SUBSTANCES, CONJUGATED 1973-1993; CENESTIN was indexed under ESTROGENS, CONJUGATED 1999-2002; PRESOMEN was indexed under ESTROGENIC SUBSTANCES, CONJUGATED 1987-1998; for PREMARIN see PREMARIN 1991-1993, see ESTROGENIC SUBSTANCES, CONJUGATED 1975-1990%A%  
% 209.65/209.80  |- mesh__dateRevised mesh__D004966 2005-06-30
% 209.65/209.80  |- skos__broader mesh__D004966smesh__D045166
% 209.65/209.80  |- rdf__type mesh__D004966sskos__Concept
% 209.65/209.80  |- skos__hiddenLabel mesh__D004966 Conjugated Estrogenic Substances
% 209.65/209.80  |- skos__annotation mesh__D004966
% 209.65/209.80       do not confuse with ESTRADIOL CONGENERS   
% 209.65/209.80  |- skos__hiddenLabel mesh__D037342 Pertussis Toxin, IAP
% 209.65/209.80  |- skos__hiddenLabel mesh__D037342 Islets Activating Protein
% 209.65/209.80  |- mesh__recordAuthorizer mesh__D037342 ags
% 209.65/209.80  |- skos__broader mesh__D037342smesh__D036002
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D037342 2006
% 209.65/209.80  |- skos__altLabel mesh__D037342 IAP Pertussis Toxin
% 209.65/209.80  |- skos__historyNote mesh__D037342
% 209.65/209.80       Virulence Factors, Bordetella %28%1977-2002%29%
% 209.65/209.80  |- skos__hiddenLabel mesh__D037342 Histamine Sensitizing Factor
% 209.65/209.80  |- skos__altLabel mesh__D037342 Pertussigen
% 209.65/209.80  |- skos__broader mesh__D037342smesh__D010566
% 209.65/209.80  |- skos__hiddenLabel mesh__D037342 Toxin, IAP Pertussis
% 209.65/209.80  |- mesh__publicMeSHNote mesh__D037342
% 209.65/209.80       2003; see PERTUSSIS TOXINS 1986-2002;  for PERTUSSIGEN, ISLET-ACTIVATING PROTEIN, IAP PERTUSSIS TOXIN, and HISTAMINE-SENSITIZING FACTOR see PERTUSSIS TOXINS 1986-2002%A%  
% 209.65/209.80  |- mesh__recordMaintainer mesh__D037342 ags
% 209.65/209.80  |- rdf__type mesh__D037342sskos__Concept
% 209.65/209.80  |- mesh__historyNote mesh__D037342
% 209.65/209.80       2003; use VIRULENCE FACTORS, BORDETELLA 1986-2002;  for PERTUSSIGEN, ISLET-ACTIVATING PROTEIN, IAP PERTUSSIS TOXIN, and HISTAMINE-SENSITIZING FACTOR use VIRULENCE FACTORS, BORDETELLA 1986-2002%A%  
% 209.65/209.80  |- mesh__dateRevised mesh__D037342 2005-07-20
% 209.65/209.80  |- skos__hiddenLabel mesh__D037342 Lymphocytosis Promoting Factor
% 209.65/209.80  |- skos__altLabel mesh__D037342 Islet-Activating Protein
% 209.65/209.80  |- skos__prefLabel mesh__D037342 Pertussis Toxin
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D037342 2006A
% 209.65/209.80  |- skos__altLabel mesh__D037342 Lymphocytosis-Promoting Factor
% 209.65/209.80  |- skos__hiddenLabel mesh__D037342 Islet Activating Protein
% 209.65/209.80  |- mesh__dateEstablished mesh__D037342 2003-01-01
% 209.65/209.80  |- mesh__recordOriginator mesh__D037342 nns
% 209.65/209.80  |- mesh__dateCreated mesh__D037342 2002-07-03
% 209.65/209.80  |- skos__scopeNote mesh__D037342
% 209.65/209.80       One of the virulence factors produced by BORDETELLA PERTUSSIS. It is a multimeric protein composed of five subunits S1 - S5. S1 contains mono ADPribose transferase activity.%A%    
% 209.65/209.80  |- skos__hiddenLabel mesh__D037342 Toxin, Pertussis
% 209.65/209.80  |- skos__altLabel mesh__D037342 Islets-Activating Protein
% 209.65/209.80  |- skos__altLabel mesh__D037342 Histamine-Sensitizing Factor
% 209.65/209.80  |- skos__prefLabel mesh__D004168 Diphtheria Toxoid
% 209.65/209.80  |- skos__altLabel mesh__D004168 Diphtheria Vaccine
% 209.65/209.80  |- skos__hiddenLabel mesh__D004168 Vaccine, Diphtheria
% 209.65/209.80  |- skos__scopeNote mesh__D004168
% 209.65/209.80       The formaldehyde-inactivated toxin of Corynebacterium diphtheriae. It is generally used in mixtures with TETANUS TOXOID and PERTUSSIS VACCINE; %28%DTP%29%; or with tetanus toxoid alone %28%DT for pediatric use and Td, which contains 5- to 10-fold less diphtheria toxoid, for other use%29%. Diphtheria toxoid is used for the prevention of diphtheria; DIPHTHERIA ANTITOXIN is for treatment. %28%From Dorland, 28th ed%29%%A%    
% 209.65/209.80  |- rdf__type mesh__D004168sskos__Concept
% 209.65/209.80  |- skos__hiddenLabel mesh__D004168 Toxoid, Diphtheria
% 209.65/209.80  |- skos__related mesh__D004168smesh__D015721
% 209.65/209.80  |- mesh__dateRevised mesh__D004168 2005-06-30
% 209.65/209.80  |- skos__broader mesh__D004168smesh__D014121
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D004168 2006
% 209.65/209.80  |- mesh__recordOriginator mesh__D004168 NLM
% 209.65/209.80  |- mesh__recordAuthorizer mesh__D004168 sjn
% 209.65/209.80  |- mesh__dateCreated mesh__D004168 1999-01-01
% 209.65/209.80  |- mesh__recordMaintainer mesh__D004168 ssb
% 209.65/209.80  |- mesh__dateEstablished mesh__D009651 1975-09-01
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D009651 1998
% 209.65/209.80  |- mesh__onlineNote mesh__D009651 search NORPREGNANES 1974   
% 209.65/209.80  |- skos__prefLabel mesh__D009651 Norpregnatrienes
% 209.65/209.80  |- mesh__dateRevised mesh__D009651 1993-06-03
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D009651 2004
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D009651 1994
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D009651 1999
% 209.65/209.80  |- mesh__dateCreated mesh__D009651 1999-01-01
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D009651 1995
% 209.65/209.80  |- skos__historyNote mesh__D009651 Norpregnanes %28%1974%29%
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D009651 2005
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D009651 2000
% 209.65/209.80  |- mesh__publicMeSHNote mesh__D009651
% 209.65/209.80       75; was see under NORPREGNANES 1974   
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D009651 2006
% 209.65/209.80  |- skos__scopeNote mesh__D009651
% 209.65/209.80       Pregnatrienes which have undergone ring contractions or are lacking carbon-18 or carbon-19.%A%    
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D009651 1996
% 209.65/209.80  |- mesh__historyNote mesh__D009651 75; was see under NORPREGNANES 1974   
% 209.65/209.80  |- skos__broader mesh__D009651smesh__D009650
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D009651 2001
% 209.65/209.80  |- mesh__recordMaintainer mesh__D009651 PLS
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D009651 1997
% 209.65/209.80  |- mesh__recordOriginator mesh__D009651 NLM
% 209.65/209.80  |- rdf__type mesh__D009651sskos__Concept
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D009651 2002
% 209.65/209.80  |- mesh__recordAuthorizer mesh__D009651 PLS
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D009651 2003
% 209.65/209.80  |- skos__hiddenLabel mesh__D050719 p130 Crk Associated Substrate
% 209.65/209.80  |- skos__altLabel mesh__D050719 p130Cas Protein
% 209.65/209.80  |- skos__hiddenLabel mesh__D050719 Substrate, p130 Crk-Associated
% 209.65/209.80  |- skos__hiddenLabel mesh__D050719 Cas Protein, p130
% 209.65/209.80  |- skos__altLabel mesh__D050719 p130 Crk-Associated Substrate
% 209.65/209.80  |- mesh__publicMeSHNote mesh__D050719
% 209.65/209.80       2006; CRK-ASSOCIATED SUBSTRATE was indexed under PROTEINS 2004-2005%A%  
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D050719 2006
% 209.65/209.80  |- skos__hiddenLabel mesh__D050719 Crk Associated Substrate
% 209.65/209.80  |- mesh__dateEstablished mesh__D050719 2006-01-01
% 209.65/209.80  |- skos__altLabel mesh__D050719 p130 Cas Protein
% 209.65/209.80  |- skos__altLabel mesh__D050719
% 209.65/209.80       Breast Cancer Anti-Estrogen Resistance 1 Protein
% 209.65/209.80  |- rdf__type mesh__D050719sskos__Concept
% 209.65/209.80  |- skos__hiddenLabel mesh__D050719 Crk Associated Substrate Protein
% 209.65/209.80  |- skos__altLabel mesh__D050719 Crk-Associated Substrate
% 209.65/209.80  |- mesh__recordMaintainer mesh__D050719 DRC
% 209.65/209.80  |- skos__altLabel mesh__D050719 BCAR1 Protein
% 209.65/209.80  |- mesh__recordAuthorizer mesh__D050719 sjn
% 209.65/209.80  |- mesh__dateCreated mesh__D050719 2005-06-30
% 209.65/209.80  |- skos__hiddenLabel mesh__D050719 Crk-Associated Substrate, p130
% 209.65/209.80  |- skos__scopeNote mesh__D050719
% 209.65/209.80       Crk-associated substrate was originally identified as a highly phosphorylated 130 kDa protein that associates with ONCOGENE PROTEIN CRK and ONCOGENE PROTEIN SRC. It is a signal transducing adaptor protein that undergoes tyrosine PHOSPHORYLATION in signaling pathways that regulate CELL MIGRATION and CELL PROLIFERATION.%A%    
% 209.65/209.80  |- skos__broader mesh__D050719smesh__D048868
% 209.65/209.80  |- skos__hiddenLabel mesh__D050719 Substrate Protein, Crk-Associated
% 209.65/209.80  |- skos__prefLabel mesh__D050719 Crk-Associated Substrate Protein
% 209.65/209.80  |- mesh__historyNote mesh__D050719 2006%28%2004%29%   
% 209.65/209.80  |- mesh__recordOriginator mesh__D050719 DRC
% 209.65/209.80  |- skos__broader mesh__D050719smesh__D010750
% 209.65/209.80  |- skos__hiddenLabel mesh__D050719
% 209.65/209.80       Breast Cancer Anti Estrogen Resistance 1 Protein
% 209.65/209.80  |- skos__altLabel mesh__D050719 CKRAS Protein
% 209.65/209.80  |- mesh__recordMaintainer mesh__D014596 lkt
% 209.65/209.80  |- skos__broader mesh__D014596smesh__D014591
% 209.65/209.80  |- mesh__dateCreated mesh__D014596 1999-01-01
% 209.65/209.80  |- rdf__type mesh__D014596sskos__Concept
% 209.65/209.80  |- mesh__recordOriginator mesh__D014596 NLM
% 209.65/209.80  |- skos__hiddenLabel mesh__D014596 Vaginal Prolapses
% 209.65/209.80  |- skos__hiddenLabel mesh__D014596 Prolapses, Vaginal
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D014596 2006
% 209.65/209.80  |- mesh__dateRevised mesh__D014596 2005-06-30
% 209.65/209.80  |- skos__hiddenLabel mesh__D014596 Uterine Prolapses
% 209.65/209.80  |- skos__prefLabel mesh__D014596 Uterine Prolapse
% 209.65/209.80  |- skos__scopeNote mesh__D014596
% 209.65/209.80       Downward displacement of the UTERUS. It is classified in various degrees: in the first degree the UTERINE CERVIX is within the vaginal orifice; in the second degree the cervix is outside the orifice; in the third degree the entire uterus is outside the orifice.%A%    
% 209.65/209.80  |- skos__hiddenLabel mesh__D014596 Prolapse, Uterine
% 209.65/209.80  |- skos__annotation mesh__D014596 do not confuse with UTERINE INVERSION   
% 209.65/209.80  |- mesh__recordAuthorizer mesh__D014596 sjn
% 209.65/209.80  |- skos__hiddenLabel mesh__D014596 Prolapse, Vaginal
% 209.65/209.80  |- skos__hiddenLabel mesh__D014596 Prolapses, Uterine
% 209.65/209.80  |- mesh__onlineNote mesh__D008559 use MEMANTINE to search D 145 1976-83   
% 209.65/209.80  |- skos__altLabel mesh__D008559 1-Amino-3,5-dimethyladamantane
% 209.65/209.80  |- mesh__recordAuthorizer mesh__D008559 sjn
% 209.65/209.80  |- skos__altLabel mesh__D008559 Merz Brand of Memantine Hydrochloride
% 209.65/209.80  |- skos__altLabel mesh__D008559 D145
% 209.65/209.80  |- skos__altLabel mesh__D008559 Lundbeck Brand of Memantine Hydrochloride
% 209.65/209.80  |- mesh__dateCreated mesh__D008559 1975-07-23
% 209.65/209.80  |- mesh__recordMaintainer mesh__D008559 CCR
% 209.65/209.80  |- mesh__recordOriginator mesh__D008559 SH
% 209.65/209.80  |- mesh__historyNote mesh__D008559
% 209.65/209.80       91%28%84%29%; was see under AMANTADINE 1984-90; was D 145 see under AMANTADINE 1976-83%A%  
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D008559 2006
% 209.65/209.80  |- skos__historyNote mesh__D008559
% 209.65/209.80       Amantadine %28%1974%29%/analogs %26% derivatives %28%1975%29%
% 209.65/209.80  |- mesh__dateRevised mesh__D008559 2005-06-30
% 209.65/209.80  |- mesh__publicMeSHNote mesh__D008559
% 209.65/209.80       91; was see under AMANTADINE 1984-90; was D 145 see under AMANTADINE 1976-83%A%  
% 209.65/209.80  |- skos__hiddenLabel mesh__D008559 D 145
% 209.65/209.80  |- skos__prefLabel mesh__D008559 Memantine
% 209.65/209.80  |- rdf__type mesh__D008559sskos__Concept
% 209.65/209.80  |- skos__altLabel mesh__D008559 Memantin
% 209.65/209.80  |- skos__scopeNote mesh__D008559
% 209.65/209.80       AMANTADINE derivative that has some dopaminergic effects. It has been proposed as an antiparkinson agent.%A%    
% 209.65/209.80  |- skos__broader mesh__D008559smesh__D000547
% 209.65/209.80  |- mesh__dateEstablished mesh__D008559 1991-01-01
% 209.65/209.80  |- skos__altLabel mesh__D008559 1,3-Dimethyl-5-aminoadamantane
% 209.65/209.80  |- skos__annotation mesh__D000576 naturally radioactive; IM   
% 209.65/209.80  |- skos__broader mesh__D000576smesh__D019216
% 209.65/209.80  |- mesh__recordAuthorizer mesh__D000576 sjn
% 209.65/209.80  |- rdf__type mesh__D000576sskos__Concept
% 209.65/209.80  |- skos__broader mesh__D000576smesh__D008671
% 209.65/209.80  |- mesh__dateCreated mesh__D000576 1999-01-01
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D000576 2006
% 209.65/209.80  |- mesh__dateRevised mesh__D000576 2005-06-30
% 209.65/209.80  |- skos__prefLabel mesh__D000576 Americium
% 209.65/209.80  |- skos__scopeNote mesh__D000576
% 209.65/209.80       Americium. A completely man-made radioactive actinide with atomic symbol Am, atomic number 95, and atomic weight 243. Its valence can range from +3 to +6. Because of its nonmagnetic ground state, it is an excellent superconductor. It is also used in bone mineral analysis and as a radiation source for radiotherapy.%A%    
% 209.65/209.80  |- mesh__recordMaintainer mesh__D000576 jmp
% 209.65/209.80  |- mesh__recordOriginator mesh__D000576 NLM
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D019281 1998
% 209.65/209.80  |- skos__scopeNote mesh__D019281
% 209.65/209.80       The process by which two molecules of the same chemical composition form a condensation product or polymer.%A%    
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D019281 2001
% 209.65/209.80  |- mesh__recordOriginator mesh__D019281 TPW
% 209.65/209.80  |- skos__broader mesh__D019281smesh__D002627
% 209.65/209.80  |- mesh__dateEstablished mesh__D019281 1997-01-01
% 209.65/209.80  |- mesh__recordAuthorizer mesh__D019281 SJN
% 209.65/209.80  |- mesh__historyNote mesh__D019281 97   
% 209.65/209.80  |- skos__prefLabel mesh__D019281 Dimerization
% 209.65/209.80  |- skos__annotation mesh__D019281
% 209.65/209.80       NIM; no qualif; coord with substance processed %28%IM or NIM%29%%A%  
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D019281 2000
% 209.65/209.80  |- mesh__dateCreated mesh__D019281 1996-06-10
% 209.65/209.80  |- mesh__recordMaintainer mesh__D019281 PXP
% 209.65/209.80  |- rdf__type mesh__D019281sskos__Concept
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D019281 2004
% 209.65/209.80  |- mesh__publicMeSHNote mesh__D019281 97   
% 209.65/209.80  |- skos__hiddenLabel mesh__D019281 Dimerizations
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D019281 2006
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D019281 2003
% 209.65/209.80  |- skos__broader mesh__D019281smesh__D008660
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D019281 1999
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D019281 2005
% 209.65/209.80  |- mesh__dateRevised mesh__D019281 1997-06-20
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D019281 2002
% 209.65/209.80  |- skos__prefLabel mesh__D005261
% 209.65/209.80       Female Genital Diseases and Pregnancy Complications
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D005261 2006
% 209.65/209.80  |- mesh__historyNote mesh__D005261 98; use explode 1979-97   
% 209.65/209.80  |- mesh__dateCreated mesh__D005261 1999-01-01
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D005261 2005
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D005261 2002
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D005261 2004
% 209.65/209.80  |- mesh__dateEstablished mesh__D005261 1998-01-01
% 209.65/209.80  |- skos__annotation mesh__D005261
% 209.65/209.80       not used for indexing      CATALOG: do not use   
% 209.65/209.80  |- rdf__type mesh__D005261sskos__Concept
% 209.65/209.80  |- mesh__runningHead mesh__D005261
% 209.65/209.80       C13 - DISEASES-FEMALE GENITAL AND PREGNANCY COMPLICATIONS%A%  
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D005261 2001
% 209.65/209.80  |- mesh__recordMaintainer mesh__D005261 MSR
% 209.65/209.80  |- mesh__recordOriginator mesh__D005261 NLM
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D005261 2003
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D005261 2000
% 209.65/209.80  |- mesh__recordAuthorizer mesh__D005261 SJN
% 209.65/209.80  |- mesh__publicMeSHNote mesh__D005261 98   
% 209.65/209.80  |- mesh__dateRevised mesh__D005261 1998-06-10
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D005261 1999
% 209.65/209.80  |- skos__scopeNote mesh__D018987
% 209.65/209.80       Any of the ducts which transport saliva. Salivary ducts include the parotid duct, the major and minor sublingual ducts, and the submandibular duct.%A%    
% 209.65/209.80  |- skos__hiddenLabel mesh__D018987 Whartons Duct
% 209.65/209.80  |- skos__hiddenLabel mesh__D018987 Stensen Duct
% 209.65/209.80  |- mesh__recordOriginator mesh__D018987 PXP
% 209.65/209.80  |- mesh__dateRevised mesh__D018987 2003-07-09
% 209.65/209.80  |- skos__historyNote mesh__D018987 Salivary Glands %28%1966-1995%29%
% 209.65/209.80  |- skos__prefLabel mesh__D018987 Salivary Ducts
% 209.65/209.80  |- skos__hiddenLabel mesh__D018987 Wharton Duct
% 209.65/209.80  |- mesh__recordAuthorizer mesh__D018987 sjn
% 209.65/209.80  |- skos__hiddenLabel mesh__D018987 Ducts, Salivary
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D018987 2004
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D018987 2006
% 209.65/209.80  |- rdf__type mesh__D018987sskos__Concept
% 209.65/209.80  |- skos__hiddenLabel mesh__D018987 Duct, Wharton%27%s
% 209.65/209.80  |- skos__broader mesh__D018987smesh__D012469
% 209.65/209.80  |- skos__hiddenLabel mesh__D018987 Stensens Duct
% 209.65/209.80  |- mesh__dateCreated mesh__D018987 1995-05-24
% 209.65/209.80  |- skos__hiddenLabel mesh__D018987 Duct, Salivary
% 209.65/209.80  |- mesh__activeMeSHYear mesh__D018987 2005
% 209.65/209.80  |- skos__hiddenLabel mesh__D018987 Salivary Duct
% 209.65/209.80  |- mesh__dateEstablished mesh__D018987 1996-01-01
% 209.65/209.80  |- mesh__historyNote mesh__D018987 96   
% 209.65/209.80  |- mesh__recordMaintainer mesh__D018987 lkt
% 209.65/209.80  |- mesh__publicMeSHNote mesh__D018987 96   
% 209.65/209.80  |- skos__annotation mesh__D018987
% 209.65/209.80       dis of salivary ducts: coord IM with SALIVARY GLAND DISEASES %28%IM%29%; dis of ducts of a specific salivary gland: coord IM with specific salivary gland disease %28%IM%29% or specific salivary gland %28%IM%29% and SALIVARY GLAND DISEASES %28%IM%29%; /radiogr = SIALOGRAPHY %26% do not add SALIVARY DUCTS unless particularly discussed%A%  
% 209.65/209.80  |- skos__hiddenLabel mesh__D018987 Duct, Stensen%27%s
% 209.65/209.81  |- mesh__publicMeSHNote mesh__D018189 94   
% 209.65/209.81  |- skos__altLabel mesh__D018189 Immunomagnetic Purging
% 209.65/209.81  |- skos__hiddenLabel mesh__D018189 Immunomagnetic Bead Techniques
% 209.65/209.81  |- skos__hiddenLabel mesh__D018189 Purging, Immunomagnetic
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D018189 2006
% 209.65/209.81  |- mesh__dateEstablished mesh__D018189 1994-01-01
% 209.65/209.81  |- skos__hiddenLabel mesh__D018189 Separation, Immunomagnetic
% 209.65/209.81  |- skos__hiddenLabel mesh__D018189 Separation, Immunomagnetic Cell
% 209.65/209.81  |- rdf__type mesh__D018189sskos__Concept
% 209.65/209.81  |- skos__hiddenLabel mesh__D018189 Immunomagnetic Separations
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D018189 2001
% 209.65/209.81  |- skos__broader mesh__D018189smesh__D002469
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D018189 2005
% 209.65/209.81  |- skos__hiddenLabel mesh__D018189 Bead Techniques, Immunomagnetic
% 209.65/209.81  |- skos__historyNote mesh__D018189 Cell Separation %28%1983-1993%29%
% 209.65/209.81  |- skos__altLabel mesh__D018189 Immunomagnetic Bead Technique
% 209.65/209.81  |- skos__hiddenLabel mesh__D018189 Immunomagnetic Cell Separations
% 209.65/209.81  |- skos__hiddenLabel mesh__D018189 Immunomagnetic Purgings
% 209.65/209.81  |- skos__scopeNote mesh__D018189
% 209.65/209.81       A cell-separation technique where magnetizable microspheres or beads are first coated with monoclonal antibody, allowed to search and bind to target cells, and are then selectively removed when passed through a magnetic field. Among other applications, the technique is commonly used to remove tumor cells from the marrow %28%BONE MARROW PURGING%29% of patients who are to undergo autologous bone marrow transplantation.%A%    
% 209.65/209.81  |- mesh__historyNote mesh__D018189 94   
% 209.65/209.81  |- skos__hiddenLabel mesh__D018189 Separations, Immunomagnetic
% 209.65/209.81  |- skos__hiddenLabel mesh__D018189 Cell Separations, Immunomagnetic
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D018189 2004
% 209.65/209.81  |- mesh__recordOriginator mesh__D018189 AGS
% 209.65/209.81  |- mesh__recordAuthorizer mesh__D018189 sjn
% 209.65/209.81  |- mesh__recordMaintainer mesh__D018189 nns
% 209.65/209.81  |- skos__hiddenLabel mesh__D018189 Bead Technique, Immunomagnetic
% 209.65/209.81  |- mesh__dateRevised mesh__D018189 2000-06-22
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D018189 2002
% 209.65/209.81  |- skos__altLabel mesh__D018189 Immunomagnetic Cell Separation
% 209.65/209.81  |- skos__hiddenLabel mesh__D018189 Separations, Immunomagnetic Cell
% 209.65/209.81  |- skos__hiddenLabel mesh__D018189 Purgings, Immunomagnetic
% 209.65/209.81  |- skos__prefLabel mesh__D018189 Immunomagnetic Separation
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D018189 2003
% 209.65/209.81  |- skos__related mesh__D018189smesh__D016465
% 209.65/209.81  |- skos__hiddenLabel mesh__D018189 Cell Separation, Immunomagnetic
% 209.65/209.81  |- mesh__dateCreated mesh__D018189 1993-06-04
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D004967 2004
% 209.65/209.81  |- mesh__historyNote mesh__D004967
% 209.65/209.81       1963; /therapeutic use was ESTROGENS, THERAPEUTIC 1965   
% 209.65/209.81  |- skos__related mesh__D004967smesh__D020847
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D004967 2005
% 209.65/209.81  |- mesh__publicMeSHNote mesh__D004967
% 209.65/209.81       1963; /therapeutic use was ESTROGENS, THERAPEUTIC 1965   
% 209.65/209.81  |- skos__annotation mesh__D004967
% 209.65/209.81       /defic: consider also HYPOGONADISM %26% other gonadal disorders in Cat C19; for antagonists consider ANTIESTROGENS or ESTROGEN ANTAGONISTS%A%  
% 209.65/209.81  |- mesh__recordOriginator mesh__D004967 NLM
% 209.65/209.81  |- skos__prefLabel mesh__D004967 Estrogens
% 209.65/209.81  |- skos__altLabel mesh__D004967 Estrogen
% 209.65/209.81  |- skos__altLabel mesh__D004967 Estrogenic Agents
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D004967 2006
% 209.65/209.81  |- mesh__dateCreated mesh__D004967 1999-01-01
% 209.65/209.81  |- mesh__recordAuthorizer mesh__D004967 sjn
% 209.65/209.81  |- mesh__recordMaintainer mesh__D004967 lkt
% 209.65/209.81  |- rdf__type mesh__D004967sskos__Concept
% 209.65/209.81  |- mesh__dateRevised mesh__D004967 2003-07-09
% 209.65/209.81  |- skos__scopeNote mesh__D004967
% 209.65/209.81       Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds.%A%    
% 209.65/209.81  |- skos__altLabel mesh__D004967 Estrogenic Compounds
% 209.65/209.81  |- skos__hiddenLabel mesh__D004967 Agents, Estrogenic
% 209.65/209.81  |- skos__related mesh__D004967smesh__D011960
% 209.65/209.81  |- skos__broader mesh__D004967smesh__D006728
% 209.65/209.81  |- skos__related mesh__D004967smesh__D004965
% 209.65/209.81  |- skos__hiddenLabel mesh__D004967 Compounds, Estrogenic
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D004169 2006
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D004169 1999
% 209.65/209.81  |- skos__related mesh__D004169smesh__D013031
% 209.65/209.81  |- mesh__recordOriginator mesh__D004169 NLM
% 209.65/209.81  |- skos__prefLabel mesh__D004169 Diphyllobothriasis
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D004169 2004
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D004169 1997
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D004169 2005
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D004169 1998
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D004169 2001
% 209.65/209.81  |- skos__historyNote mesh__D004169 Cestode Infections %28%1966-1967%29%
% 209.65/209.81  |- mesh__dateCreated mesh__D004169 1999-01-01
% 209.65/209.81  |- mesh__recordMaintainer mesh__D004169 JLS
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D004169 2003
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D004169 1996
% 209.65/209.81  |- mesh__publicMeSHNote mesh__D004169 68   
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D004169 2000
% 209.65/209.81  |- mesh__dateRevised mesh__D004169 1993-06-04
% 209.65/209.81  |- mesh__dateEstablished mesh__D004169 1968-01-01
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D004169 1995
% 209.65/209.81  |- mesh__recordAuthorizer mesh__D004169 PLS
% 209.65/209.81  |- rdf__type mesh__D004169sskos__Concept
% 209.65/209.81  |- skos__scopeNote mesh__D004169
% 209.65/209.81       Infection with tapeworms of the genus Diphyllobothrium.%A%    
% 209.65/209.81  |- skos__hiddenLabel mesh__D004169 Diphyllobothriases
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D004169 2002
% 209.65/209.81  |- skos__annotation mesh__D004169
% 209.65/209.81       tapeworm infect; consider also SPARGANOSIS %28%infection at larval stage%29%%A%  
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D004169 1994
% 209.65/209.81  |- mesh__historyNote mesh__D004169 68   
% 209.65/209.81  |- skos__broader mesh__D004169smesh__D002590
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009652 2000
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009652 2005
% 209.65/209.81  |- skos__broader mesh__D009652smesh__D009650
% 209.65/209.81  |- mesh__dateCreated mesh__D009652 1999-01-01
% 209.65/209.81  |- rdf__type mesh__D009652sskos__Concept
% 209.65/209.81  |- mesh__publicMeSHNote mesh__D009652
% 209.65/209.81       75; was see under NORPREGNANES 1974   
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009652 1995
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009652 2004
% 209.65/209.81  |- skos__annotation mesh__D009652 do not confuse with NORPREGNANES   
% 209.65/209.81  |- mesh__recordOriginator mesh__D009652 NLM
% 209.65/209.81  |- mesh__dateRevised mesh__D009652 1993-06-03
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009652 1994
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009652 2003
% 209.65/209.81  |- mesh__onlineNote mesh__D009652 search NORPREGNANES 1974   
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009652 1999
% 209.65/209.81  |- mesh__recordMaintainer mesh__D009652 PLS
% 209.65/209.81  |- skos__historyNote mesh__D009652 Norpregnanes %28%1974%29%
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009652 2002
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009652 1998
% 209.65/209.81  |- skos__prefLabel mesh__D009652 Norpregnenes
% 209.65/209.81  |- skos__scopeNote mesh__D009652
% 209.65/209.81       Pregnenes with one double bond or more than three double bonds which have undergone ring contractions or are lacking carbon-18 or carbon-19..%A%    
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009652 1997
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009652 2006
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009652 2001
% 209.65/209.81  |- mesh__historyNote mesh__D009652 75; was see under NORPREGNANES 1974   
% 209.65/209.81  |- mesh__dateEstablished mesh__D009652 1975-09-01
% 209.65/209.81  |- mesh__recordAuthorizer mesh__D009652 PLS
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009652 1996
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D014597 2006
% 209.65/209.81  |- skos__broader mesh__D014597smesh__D014591
% 209.65/209.81  |- mesh__recordMaintainer mesh__D014597 lkt
% 209.65/209.81  |- skos__hiddenLabel mesh__D014597 Uterine Ruptures
% 209.65/209.81  |- skos__annotation mesh__D014597
% 209.65/209.81       spontaneous or traumatic but do not coordinate with RUPTURE or RUPTURE, SPONTANEOUS%A%  
% 209.65/209.81  |- mesh__recordOriginator mesh__D014597 NLM
% 209.65/209.81  |- skos__scopeNote mesh__D014597
% 209.65/209.81       A complete separation or tear in the wall of the UTERUS with or without expulsion of the FETUS. It may be due to injuries, multiple pregnancies, large fetus, previous scarring, or obstruction.%A%    
% 209.65/209.81  |- skos__broader mesh__D014597smesh__D012421
% 209.65/209.81  |- mesh__dateRevised mesh__D014597 2005-06-30
% 209.65/209.81  |- skos__broader mesh__D014597smesh__D007744
% 209.65/209.81  |- skos__hiddenLabel mesh__D014597 Ruptures, Uterine
% 209.65/209.81  |- skos__prefLabel mesh__D014597 Uterine Rupture
% 209.65/209.81  |- mesh__dateCreated mesh__D014597 1999-01-01
% 209.65/209.81  |- skos__hiddenLabel mesh__D014597 Rupture, Uterine
% 209.65/209.81  |- mesh__recordAuthorizer mesh__D014597 sjn
% 209.65/209.81  |- rdf__type mesh__D014597sskos__Concept
% 209.65/209.81  |- rdf__type mesh__D000577sskos__Concept
% 209.65/209.81  |- mesh__recordOriginator mesh__D000577 NLM
% 209.65/209.81  |- skos__broader mesh__D000577smesh__D009930
% 209.65/209.81  |- mesh__dateCreated mesh__D000577 1999-01-01
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D000577 2006
% 209.65/209.81  |- mesh__recordMaintainer mesh__D000577 TGC
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D000577 2002
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D000577 2005
% 209.65/209.81  |- mesh__dateRevised mesh__D000577 1995-03-16
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D000577 1999
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D000577 2001
% 209.65/209.81  |- skos__prefLabel mesh__D000577 Amides
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D000577 2004
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D000577 1998
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D000577 2000
% 209.65/209.81  |- mesh__recordAuthorizer mesh__D000577 PLS
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D000577 2003
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D000577 1997
% 209.65/209.81  |- skos__scopeNote mesh__D000577
% 209.65/209.81       Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D000577 1996
% 209.65/209.81  |- skos__broader mesh__D019282smesh__D008659
% 209.65/209.81  |- skos__related mesh__D019282smesh__D002100
% 209.65/209.81  |- skos__scopeNote mesh__D019282
% 209.65/209.81       Any disease marked especially by progressive emaciation and weakness. %28%Dorland, 28th ed, p490%29%%A%    
% 209.65/209.81  |- mesh__historyNote mesh__D019282 97   
% 209.65/209.81  |- mesh__dateRevised mesh__D019282 1997-06-20
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D019282 2004
% 209.65/209.81  |- skos__hiddenLabel mesh__D019282 Wasting Syndromes
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D019282 2002
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D019282 2003
% 209.65/209.81  |- rdf__type mesh__D019282sskos__Concept
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D019282 2006
% 209.65/209.81  |- skos__altLabel mesh__D019282 Wasting Disease
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D019282 2001
% 209.65/209.81  |- mesh__recordAuthorizer mesh__D019282 SJN
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D019282 2005
% 209.65/209.81  |- mesh__recordOriginator mesh__D019282 AGS
% 209.65/209.81  |- mesh__dateEstablished mesh__D019282 1997-01-01
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D019282 2000
% 209.65/209.81  |- skos__hiddenLabel mesh__D019282 Wasting Diseases
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D019282 1999
% 209.65/209.81  |- mesh__dateCreated mesh__D019282 1996-06-10
% 209.65/209.81  |- mesh__recordMaintainer mesh__D019282 TGC
% 209.65/209.81  |- mesh__publicMeSHNote mesh__D019282 97   
% 209.65/209.81  |- skos__broader mesh__D019282smesh__D009748
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D019282 1998
% 209.65/209.81  |- skos__annotation mesh__D019282
% 209.65/209.81       do not confuse with CACHEXIA: do not make diagnoses, use words of text; HIV WASTING SYNDROME is also available%A%  
% 209.65/209.81  |- skos__prefLabel mesh__D019282 Wasting Syndrome
% 209.65/209.81  |- skos__prefLabel mesh__D005262 Feminization
% 209.65/209.81  |- rdf__type mesh__D005262sskos__Concept
% 209.65/209.81  |- mesh__publicMeSHNote mesh__D005262 72   
% 209.65/209.81  |- skos__hiddenLabel mesh__D005262 Feminizations
% 209.65/209.81  |- skos__scopeNote mesh__D005262
% 209.65/209.81       Development of female secondary SEX CHARACTERISTICS in the MALE. It is due to the effects of estrogenic metabolites of precursors from endogenous or exogenous sources, such as ADRENAL GLANDS or therapeutic drugs.%A%    
% 209.65/209.81  |- mesh__historyNote mesh__D005262 72%28%67%29%   
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D005262 2006
% 209.65/209.81  |- mesh__recordAuthorizer mesh__D005262 sjn
% 209.65/209.81  |- skos__broader mesh__D005262smesh__D012816
% 209.65/209.81  |- mesh__dateCreated mesh__D005262 1999-01-01
% 209.65/209.81  |- skos__historyNote mesh__D005262 Sex Characteristics %28%1966%29%
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D005262 2005
% 209.65/209.81  |- mesh__dateRevised mesh__D005262 2004-07-07
% 209.65/209.81  |- mesh__recordMaintainer mesh__D005262 lkt
% 209.65/209.81  |- mesh__dateEstablished mesh__D005262 1972-01-01
% 209.65/209.81  |- mesh__recordOriginator mesh__D005262 NLM
% 209.65/209.81  |- skos__annotation mesh__D005262 check the tag MALE   
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D018988 2004
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D018988 2000
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D018988 2006
% 209.65/209.81  |- rdf__type mesh__D018988sskos__Concept
% 209.65/209.81  |- mesh__dateCreated mesh__D018988 1995-06-29
% 209.65/209.81  |- skos__annotation mesh__D018988
% 209.65/209.81       %22%passage of viable bact from the gastrointest tract to extra-intest sites%22%; coord IM with specific bact /physiol %28%IM%29%%A%  
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D018988 2003
% 209.65/209.81  |- skos__historyNote mesh__D018988 Cell Movement %28%1972-1995%29%
% 209.65/209.81  |- mesh__publicMeSHNote mesh__D018988 96   
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D018988 1997
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D018988 2005
% 209.65/209.81  |- mesh__historyNote mesh__D018988 96   
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D018988 1999
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D018988 1996
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D018988 1998
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D018988 2002
% 209.65/209.81  |- skos__broader mesh__D018988smesh__D018407
% 209.65/209.81  |- skos__prefLabel mesh__D018988 Bacterial Translocation
% 209.65/209.81  |- skos__scopeNote mesh__D018988
% 209.65/209.81       The passage of viable bacteria from the gastrointestinal tract to extra-intestinal sites, such as the mesenteric lymph node complex, liver, spleen, kidney, and blood. Factors that promote bacterial translocation include overgrowth with gram-negative enteric bacilli, impaired host immune defenses, and injury to the intestinal mucosa resulting in increased intestinal permeability. These mechanisms can act in concert to promote synergistically the systemic spread of indigenous translocating bacteria to cause lethal sepsis.%A%    
% 209.65/209.81  |- skos__altLabel mesh__D018988 Translocation, Bacterial
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D018988 2001
% 209.65/209.81  |- mesh__dateEstablished mesh__D018988 1996-01-01
% 209.65/209.81  |- skos__hiddenLabel mesh__D004968 Nonsteroidal Estrogens
% 209.65/209.81  |- skos__broader mesh__D004968smesh__D004967
% 209.65/209.81  |- skos__historyNote mesh__D004968 Estrogens %28%1966-1974%29%
% 209.65/209.81  |- mesh__dateRevised mesh__D004968 2003-07-09
% 209.65/209.81  |- mesh__recordMaintainer mesh__D004968 lkt
% 209.65/209.81  |- skos__hiddenLabel mesh__D004968 Estrogens, Non Steroidal
% 209.65/209.81  |- skos__scopeNote mesh__D004968
% 209.65/209.81       Non-steroidal compounds with estrogenic activity.     
% 209.65/209.81  |- mesh__dateEstablished mesh__D004968 1975-09-01
% 209.65/209.81  |- skos__altLabel mesh__D004968 Estrogens, Nonsteroidal
% 209.65/209.81  |- mesh__historyNote mesh__D004968 75   
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D004968 2006
% 209.65/209.81  |- mesh__recordOriginator mesh__D004968 NLM
% 209.65/209.81  |- skos__prefLabel mesh__D004968 Estrogens, Non-Steroidal
% 209.65/209.81  |- mesh__publicMeSHNote mesh__D004968 75   
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D004968 2005
% 209.65/209.81  |- mesh__recordAuthorizer mesh__D004968 sjn
% 209.65/209.81  |- rdf__type mesh__D004968sskos__Concept
% 209.65/209.81  |- skos__hiddenLabel mesh__D004968 Non-Steroidal Estrogens
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D004968 2004
% 209.65/209.81  |- mesh__dateCreated mesh__D004968 1974-11-11
% 209.65/209.81  |- mesh__dateCreated mesh__D009653 1974-11-11
% 209.65/209.81  |- skos__historyNote mesh__D009653 Progesterone %28%1974%29%
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009653 2001
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009653 1994
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009653 2003
% 209.65/209.81  |- mesh__recordAuthorizer mesh__D009653 PLS
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009653 2000
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009653 1999
% 209.65/209.81  |- skos__prefLabel mesh__D009653 Norprogesterones
% 209.65/209.81  |- mesh__dateEstablished mesh__D009653 1991-01-01
% 209.65/209.81  |- skos__scopeNote mesh__D009653
% 209.65/209.81       Progesterones which have undergone ring contraction or which are lacking carbon 18 or 19.%A%    
% 209.65/209.81  |- mesh__recordOriginator mesh__D009653 NLM
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009653 1998
% 209.65/209.81  |- mesh__dateRevised mesh__D009653 1993-06-03
% 209.65/209.81  |- skos__broader mesh__D009653smesh__D009652
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009653 1997
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009653 2006
% 209.65/209.81  |- mesh__publicMeSHNote mesh__D009653
% 209.65/209.81       91; was see under NORPREGNENES 1975-90   
% 209.65/209.81  |- mesh__recordMaintainer mesh__D009653 PLS
% 209.65/209.81  |- skos__historyNote mesh__D009653 Norpregnanes %28%1974%29%
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009653 1996
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009653 2005
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009653 2002
% 209.65/209.81  |- rdf__type mesh__D009653sskos__Concept
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009653 1995
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D009653 2004
% 209.65/209.81  |- mesh__historyNote mesh__D009653
% 209.65/209.81       91%28%75%29%; was see under NORPREGNENES 1975-90   
% 209.65/209.81  |- skos__prefLabel mesh__D001670
% 209.65/209.81       Biochemical Phenomena, Metabolism, and Nutrition
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D001670 1999
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D001670 2005
% 209.65/209.81  |- mesh__onlineNote mesh__D001670
% 209.65/209.81       pre-explosion = BIOCHEM PHENOM METAB %28%PX%29%   
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D001670 1998
% 209.65/209.81  |- skos__altLabel mesh__D001670
% 209.65/209.81       Metabolism, Nutrition, and Biochemical Phenomena
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D001670 2002
% 209.65/209.81  |- mesh__recordOriginator mesh__D001670 NLM
% 209.65/209.81  |- mesh__historyNote mesh__D001670 98; use pre-explosion   
% 209.65/209.81  |- mesh__recordMaintainer mesh__D001670 TGC
% 209.65/209.81  |- mesh__publicMeSHNote mesh__D001670 98   
% 209.65/209.81  |- rdf__type mesh__D001670sskos__Concept
% 209.65/209.81  |- mesh__runningHead mesh__D001670
% 209.65/209.81       G6 - BIOCHEMICAL PHENOMENA, METABOLISM, AND NUTRITION   
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D001670 2004
% 209.65/209.81  |- mesh__dateRevised mesh__D001670 1997-06-27
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D001670 2001
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D001670 2003
% 209.65/209.81  |- skos__annotation mesh__D001670
% 209.65/209.81       not used for indexing      CATALOG: do not use   
% 209.65/209.81  |- mesh__recordAuthorizer mesh__D001670 SJN
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D001670 2006
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D001670 2000
% 209.65/209.81  |- mesh__dateCreated mesh__D001670 1999-01-01
% 209.65/209.81  |- mesh__dateEstablished mesh__D001670 1998-01-01
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D014598 2004
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D014598 2002
% 209.65/209.81  |- mesh__activeMeSHYear mesh__D014598 2006
% 209.65/209.81  |- skos__altLabel mesh__D014598 Blastokinin
% 209.65/209.81  |- mesh__publicMeSHNote mesh__D014598
% 209.65/209.81       91; was see under GLYCOPROTEINS 1975-90   
% 209.74/209.92  |- mesh__recordMaintainer mesh__D014598 KEV
% 209.74/209.92  |- mesh__activeMeSHYear mesh__D014598 1996
% 209.74/209.92  |- mesh__activeMeSHYear mesh__D014598 1998
% 209.74/209.92  |- mesh__dateEstablished mesh__D014598 1991-01-01
% 209.74/209.92  |- mesh__activeMeSHYear mesh__D014598 1997
% 209.74/209.92  |- mesh__activeMeSHYear mesh__D014598 2000
% 209.74/209.92  |- mesh__activeMeSHYear mesh__D014598 1999
% 209.74/209.92  |- mesh__historyNote mesh__D014598
% 209.74/209.92       91%28%75%29%; was see under GLYCOPROTEINS 1975-90   
% 209.74/209.92  |- mesh__activeMeSHYear mesh__D014598 2001
% 209.74/209.92  |- skos__scopeNote mesh__D014598
% 209.74/209.92       A protein fraction of pregnant uterine fluid which can induce and regulate blastocystic development. Blastokinin is thought to be similar or identical to uteroglobin. Presence in uterine fluid regulated by progesterone.%A%    
% 209.74/209.92  |- skos__annotation mesh__D014598
% 209.74/209.92       a glycoprotein in pregnant uterine fluid; /biosyn /physiol permitted%A%  
% 209.74/209.92  |- skos__prefLabel mesh__D014598 Uteroglobin
% 209.74/209.92  |- mesh__recordOriginator mesh__D014598 NLM
% 209.74/209.92  |- mesh__dateRevised mesh__D014598 1995-05-22
% 209.74/209.92  |- mesh__dateCreated mesh__D014598 1974-11-19
% 209.74/209.92  |- mesh__activeMeSHYear mesh__D014598 2003
% 209.74/209.92  |- skos__broader mesh__D014598smesh__D006023
% 209.74/209.92  |- skos__historyNote mesh__D014598 Glycoproteins %28%1971-1974%29%
% 209.74/209.92  |- mesh__activeMeSHYear mesh__D014598 2005
% 209.74/209.92  |- rdf__type mesh__D014598sskos__Concept
% 209.74/209.92  |- mesh__recordAuthorizer mesh__D014598 PLS
% 209.74/209.92  |- mesh__activeMeSHYear mesh__D000578 2005
% 209.74/209.92  |- mesh__recordMaintainer mesh__D000578 TGC
% 209.74/209.92  |- mesh__activeMeSHYear mesh__D000578 2000
% 209.74/209.92  |- mesh__activeMeSHYear mesh__D000578 1999
% 209.74/209.92  |- mesh__dateRevised mesh__D000578 1992-05-07
% 209.74/209.92  |- mesh__recordAuthorizer mesh__D000578 PLS
% 209.74/209.92  |- mesh__activeMeSHYear mesh__D000578 1994
% 209.74/209.92  |- mesh__activeMeSHYear mesh__D000578 2004
% 209.74/209.92  |- mesh__activeMeSHYear mesh__D000578 1998
% 209.74/209.92  |- skos__prefLabel mesh__D000578 Amidines
% 209.74/209.92  |- mesh__activeMeSHYear mesh__D000578 1993
% 209.74/209.92  |- mesh__activeMeSHYear mesh__D000578 2003
% 209.74/209.92  |- mesh__activeMeSHYear mesh__D000578 1997
% 209.74/209.92  |- mesh__recordOriginator mesh__D000578 NLM
% 209.74/209.92  |- mesh__activeMeSHYear mesh__D000578 1996
% 209.74/209.93  |- rdf__type mesh__D000578sskos__Concept
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D000578 2002
% 209.74/209.93  |- skos__broader mesh__D000578smesh__D009930
% 209.74/209.93  |- mesh__dateCreated mesh__D000578 1999-01-01
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D000578 2006
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D000578 2001
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D000578 1995
% 209.74/209.93  |- mesh__historyNote mesh__D019283 97   
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D019283 2005
% 209.74/209.93  |- mesh__dateEstablished mesh__D019283 1997-01-01
% 209.74/209.93  |- mesh__dateCreated mesh__D019283 1996-06-10
% 209.74/209.93  |- mesh__dateRevised mesh__D019283 2004-07-07
% 209.74/209.93  |- mesh__publicMeSHNote mesh__D019283 97   
% 209.74/209.93  |- mesh__recordOriginator mesh__D019283 JLS
% 209.74/209.93  |- rdf__type mesh__D019283sskos__Concept
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D019283 2006
% 209.74/209.93  |- skos__broader mesh__D019283smesh__D010195
% 209.74/209.93  |- mesh__recordAuthorizer mesh__D019283 sjn
% 209.74/209.93  |- skos__altLabel mesh__D019283 Necrotizing Pancreatitis, Acute
% 209.74/209.93  |- skos__prefLabel mesh__D019283 Pancreatitis, Acute Necrotizing
% 209.74/209.93  |- skos__altLabel mesh__D019283 Acute Necrotizing Pancreatitis
% 209.74/209.93  |- skos__scopeNote mesh__D019283
% 209.74/209.93       A severe form of acute INFLAMMATION of the PANCREAS characterized by one or more areas of NECROSIS in the pancreas with varying degree of involvement of the surrounding tissues or organ systems. Massive pancreatic necrosis may lead to DIABETES MELLITUS, and malabsorption.%A%    
% 209.74/209.93  |- mesh__recordMaintainer mesh__D019283 lkt
% 209.74/209.93  |- skos__historyNote mesh__D019283 Pancreatitis %28%1990-1996%29%
% 209.74/209.93  |- skos__hiddenLabel mesh__D005263 Artery, Femoral
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D005263 1995
% 209.74/209.93  |- mesh__dateRevised mesh__D005263 1992-05-15
% 209.74/209.93  |- mesh__recordAuthorizer mesh__D005263 PLS
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D005263 2001
% 209.74/209.93  |- mesh__recordOriginator mesh__D005263 NLM
% 209.74/209.93  |- skos__hiddenLabel mesh__D005263 Femoral Arteries
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D005263 2000
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D005263 1994
% 209.74/209.93  |- mesh__recordMaintainer mesh__D005263 TAP
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D005263 1993
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D005263 1999
% 209.74/209.93  |- skos__broader mesh__D005263smesh__D001158
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D005263 2006
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D005263 1998
% 209.74/209.93  |- mesh__dateCreated mesh__D005263 1999-01-01
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D005263 2005
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D005263 1997
% 209.74/209.93  |- skos__hiddenLabel mesh__D005263 Arteries, Femoral
% 209.74/209.93  |- skos__prefLabel mesh__D005263 Femoral Artery
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D005263 2004
% 209.74/209.93  |- rdf__type mesh__D005263sskos__Concept
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D005263 2002
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D005263 1996
% 209.74/209.93  |- skos__scopeNote mesh__D005263
% 209.74/209.93       The main artery of the thigh, a continuation of the external iliac artery.%A%    
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D005263 2003
% 209.74/209.93  |- skos__altLabel mesh__D043382 FAPY-DNA Glycosylase
% 209.74/209.93  |- skos__historyNote mesh__D043382 N-Glycosyl Hydrolases %28%1981-2003%29%
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D043382 2005
% 209.74/209.93  |- mesh__recordMaintainer mesh__D043382 jmp
% 209.74/209.93  |- mesh__dateCreated mesh__D043382 2003-07-09
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D043382 2006
% 209.74/209.93  |- mesh__recordOriginator mesh__D043382 AKE
% 209.74/209.93  |- mesh__historyNote mesh__D043382
% 209.74/209.93       2004; use DNA-FORMAMIDOPYRIMIDINE GLYCOSYLASE %28%NM%29% 1981-2003%A%  
% 209.74/209.93  |- skos__hiddenLabel mesh__D043382 DNA Formamidopyrimidine Glycosylase
% 209.74/209.93  |- skos__hiddenLabel mesh__D043382 FAPY DNA Glycosylase
% 209.74/209.93  |- mesh__dateEstablished mesh__D043382 2004-01-01
% 209.74/209.93  |- rdf__type mesh__D043382sskos__Concept
% 209.74/209.93  |- skos__prefLabel mesh__D043382 DNA-Formamidopyrimidine Glycosylase
% 209.74/209.93  |- skos__scopeNote mesh__D043382
% 209.74/209.93       A DNA repair enzyme that is an N-glycosyl hydrolase with specificity for DNA-containing ring-opened N%28%7%29%-methylguanine residues.%A%    
% 209.74/209.93  |- skos__altLabel mesh__D043382 Formamidopyrimidine-DNA Glycosylase
% 209.74/209.93  |- skos__related mesh__D043382smesh__D004260
% 209.74/209.93  |- skos__broader mesh__D043382smesh__D045647
% 209.74/209.93  |- mesh__recordAuthorizer mesh__D043382 sjn
% 209.74/209.93  |- mesh__publicMeSHNote mesh__D043382
% 209.74/209.93       2004; DNA-FORMAIDOPYRIMIDINE GLYCOSYLASE was indexed under N-GLYCOSYL HYDROLASES 1981-2003%A%  
% 209.74/209.93  |- skos__hiddenLabel mesh__D043382 Formamidopyrimidine DNA Glycosylase
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D043382 2004
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009654 2006
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009654 2002
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009654 1997
% 209.74/209.93  |- mesh__historyNote mesh__D009654 68   
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009654 2005
% 209.74/209.93  |- skos__scopeNote mesh__D009654
% 209.74/209.93       Steroids which have undergone contraction in ring size or reduction in side chains.%A%    
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009654 2001
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009654 1996
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009654 1995
% 209.74/209.93  |- mesh__dateCreated mesh__D009654 1999-01-01
% 209.74/209.93  |- rdf__type mesh__D009654sskos__Concept
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009654 2004
% 209.74/209.93  |- skos__broader mesh__D009654smesh__D013256
% 209.74/209.93  |- mesh__recordAuthorizer mesh__D009654 PLS
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009654 1994
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009654 2000
% 209.74/209.93  |- mesh__dateEstablished mesh__D009654 1968-01-01
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009654 2003
% 209.74/209.93  |- skos__prefLabel mesh__D009654 Norsteroids
% 209.74/209.93  |- mesh__dateRevised mesh__D009654 1993-06-03
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009654 1999
% 209.74/209.93  |- mesh__recordOriginator mesh__D009654 NLM
% 209.74/209.93  |- mesh__recordMaintainer mesh__D009654 PLS
% 209.74/209.93  |- mesh__publicMeSHNote mesh__D009654 68   
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009654 1998
% 209.74/209.93  |- skos__prefLabel mesh__D001671 Biochemistry
% 209.74/209.93  |- mesh__recordMaintainer mesh__D001671 jls
% 209.74/209.93  |- rdf__type mesh__D001671sskos__Concept
% 209.74/209.93  |- skos__broader mesh__D001671smesh__D001690
% 209.74/209.93  |- skos__broader mesh__D001671smesh__D002621
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D001671 2004
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D001671 2002
% 209.74/209.93  |- mesh__recordOriginator mesh__D001671 NLM
% 209.74/209.93  |- mesh__recordAuthorizer mesh__D001671 sjn
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D001671 2003
% 209.74/209.93  |- mesh__dateRevised mesh__D001671 2001-07-25
% 209.74/209.93  |- mesh__dateCreated mesh__D001671 1999-01-01
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D001671 2006
% 209.74/209.93  |- skos__annotation mesh__D001671
% 209.74/209.93       SPEC only: do not use as NIM coord for chemistry of biol matter%A%  
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D001671 2005
% 209.74/209.93  |- skos__annotation mesh__D014599
% 209.74/209.93       /blood supply: consider PLACENTAL CIRCULATION; /surg: consider HYSTERECTOMY or HYSTEROTOMY; inflammation = ENDOMETRITIS%A%  
% 209.74/209.93  |- mesh__recordOriginator mesh__D014599 NLM
% 209.74/209.93  |- mesh__recordMaintainer mesh__D014599 lkt
% 209.74/209.93  |- skos__broader mesh__D014599smesh__D005836
% 209.74/209.93  |- skos__related mesh__D014599smesh__D007044
% 209.74/209.93  |- mesh__dateCreated mesh__D014599 1999-01-01
% 209.74/209.93  |- skos__prefLabel mesh__D014599 Uterus
% 209.74/209.93  |- skos__related mesh__D014599smesh__D015907
% 209.74/209.93  |- mesh__recordAuthorizer mesh__D014599 sjn
% 209.74/209.93  |- mesh__considerAlso mesh__D014599 consider also terms at HYSTER-   
% 209.74/209.93  |- skos__related mesh__D014599smesh__D007047
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D014599 2003
% 209.74/209.93  |- mesh__dateRevised mesh__D014599 2002-07-03
% 209.74/209.93  |- rdf__type mesh__D014599sskos__Concept
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D014599 2005
% 209.74/209.93  |- skos__scopeNote mesh__D014599
% 209.74/209.93       The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus %28%the body%29% which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI %28%the neck%29% opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.%A%    
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D014599 2004
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D014599 2006
% 209.74/209.93  |- skos__altLabel mesh__D014599 Uteri
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D000579 2004
% 209.74/209.93  |- mesh__historyNote mesh__D000579 74%28%73%29%   
% 209.74/209.93  |- mesh__recordAuthorizer mesh__D000579 sjn
% 209.74/209.93  |- skos__scopeNote mesh__D000579
% 209.74/209.93       Enzymes of a subclass of TRANSFERASES that catalyze the transfer of an amidino group from donor to acceptor. EC 2.1.4.%A%    
% 209.74/209.93  |- skos__prefLabel mesh__D000579 Amidinotransferases
% 209.74/209.93  |- mesh__dateEstablished mesh__D000579 1974-01-01
% 209.74/209.93  |- mesh__publicMeSHNote mesh__D000579 74   
% 209.74/209.93  |- rdf__type mesh__D000579sskos__Concept
% 209.74/209.93  |- skos__broader mesh__D000579smesh__D019875
% 209.74/209.93  |- mesh__recordMaintainer mesh__D000579 ssb
% 209.74/209.93  |- mesh__dateCreated mesh__D000579 1999-01-01
% 209.74/209.93  |- mesh__dateRevised mesh__D000579 2003-07-09
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D000579 2006
% 209.74/209.93  |- skos__altLabel mesh__D000579 Transamidinases
% 209.74/209.93  |- mesh__recordOriginator mesh__D000579 NLM
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D000579 2005
% 209.74/209.93  |- mesh__historyNote mesh__D019284
% 209.74/209.93       97; was THAPSIGARGIN %28%NM%29% 1979-96   
% 209.74/209.93  |- mesh__onlineNote mesh__D019284
% 209.74/209.93       use THAPSIGARGIN %28%NM%29% to search THAPSIGARGIN 1980-96   
% 209.74/209.93  |- rdf__type mesh__D019284sskos__Concept
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D019284 2006
% 209.74/209.93  |- mesh__publicMeSHNote mesh__D019284
% 209.74/209.93       97; THAPSIGARGIN was indexed under TERPENES 1979-96   
% 209.74/209.93  |- skos__historyNote mesh__D019284 Terpenes %28%1979-1996%29%
% 209.74/209.93  |- mesh__dateEstablished mesh__D019284 1997-01-01
% 209.74/209.93  |- mesh__recordMaintainer mesh__D019284 ssb
% 209.74/209.93  |- mesh__dateCreated mesh__D019284 1996-06-10
% 209.74/209.93  |- mesh__dateRevised mesh__D019284 2003-07-09
% 209.74/209.93  |- mesh__recordAuthorizer mesh__D019284 sjn
% 209.74/209.93  |- skos__scopeNote mesh__D019284
% 209.74/209.93       A potent skin irritating sesquiterpene lactone isolated from the roots of Thapsia garganica L. %28%Apiaceae%29%. It also acts as a non-phorbol-ester-type tumor promoter which discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca%28%2+%29%-ATPase. %28%Biochem Pharmacol 1987;36%28%5%29%:621-6; Proc Natl Acad Sci USA 1991;88%28%16%29%:7096-100%29%%A%    
% 209.74/209.93  |- mesh__recordOriginator mesh__D019284 ADP
% 209.74/209.93  |- skos__broader mesh__D019284smesh__D012717
% 209.74/209.93  |- skos__prefLabel mesh__D019284 Thapsigargin
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D019284 2005
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D019284 2004
% 209.74/209.93  |- mesh__dateCreated mesh__D005264 1999-01-01
% 209.74/209.93  |- mesh__recordAuthorizer mesh__D005264 sjn
% 209.74/209.93  |- skos__hiddenLabel mesh__D005264 Fractures, Femoral
% 209.74/209.93  |- skos__scopeNote mesh__D005264 Fractures of the femur.     
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D005264 2006
% 209.74/209.93  |- skos__broader mesh__D005264smesh__D007869
% 209.74/209.93  |- mesh__recordOriginator mesh__D005264 NLM
% 209.74/209.93  |- mesh__dateRevised mesh__D005264 2005-06-30
% 209.74/209.93  |- mesh__recordMaintainer mesh__D005264 ssb
% 209.74/209.93  |- skos__annotation mesh__D005264
% 209.74/209.93       of femoral shaft only; see X refs %26% note at HIP FRACTURES%A%  
% 209.74/209.93  |- skos__hiddenLabel mesh__D005264 Femoral Fracture
% 209.74/209.93  |- skos__broader mesh__D005264smesh__D050723
% 209.74/209.93  |- skos__hiddenLabel mesh__D005264 Fracture, Femoral
% 209.74/209.93  |- skos__prefLabel mesh__D005264 Femoral Fractures
% 209.74/209.93  |- rdf__type mesh__D005264sskos__Concept
% 209.74/209.93  |- skos__altLabel mesh__D043383 SAH Hydrolase
% 209.74/209.93  |- skos__broader mesh__D043383smesh__D006867
% 209.74/209.93  |- rdf__type mesh__D043383sskos__Concept
% 209.74/209.93  |- mesh__publicMeSHNote mesh__D043383
% 209.74/209.93       2004; ADENOSYLHOMOCYSTEINASE was indexed under HYDROLASES 1976-2003%A%  
% 209.74/209.93  |- skos__hiddenLabel mesh__D043383 Hydrolase, S-adenosylhomocysteine
% 209.74/209.93  |- skos__historyNote mesh__D043383 Hydrolases %28%1976-2003%29%
% 209.74/209.93  |- skos__hiddenLabel mesh__D043383 S adenosylhomocysteine Hydrolase
% 209.74/209.93  |- skos__scopeNote mesh__D043383
% 209.74/209.93       An enzyme which catalyzes the catabolism of S-ADENOSYLHOMOCYSTEINE to ADENOSINE and HOMOCYSTEINE. It may play a role in regulating the concentration of intracellular adenosylhomocysteine.%A%    
% 209.74/209.93  |- skos__altLabel mesh__D043383 S-adenosylhomocysteine Hydrolase
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D043383 2004
% 209.74/209.93  |- mesh__dateEstablished mesh__D043383 2004-01-01
% 209.74/209.93  |- mesh__historyNote mesh__D043383
% 209.74/209.93       2004; use ADENOSYLHOMOCYSTEINASE %28%NM%29% 1980-2003   
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D043383 2005
% 209.74/209.93  |- skos__prefLabel mesh__D043383 Adenosylhomocysteinase
% 209.74/209.93  |- skos__altLabel mesh__D043383 S-adenosylhomocysteine Synthase
% 209.74/209.93  |- mesh__dateCreated mesh__D043383 2003-07-09
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D043383 2006
% 209.74/209.93  |- skos__hiddenLabel mesh__D043383 S adenosylhomocysteine Synthase
% 209.74/209.93  |- mesh__historyNote mesh__D051017 2006   
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D051017 2006
% 209.74/209.93  |- skos__altLabel mesh__D051017 Programmed Cell Death Proteins
% 209.74/209.93  |- mesh__dateEstablished mesh__D051017 2006-01-01
% 209.74/209.93  |- mesh__dateCreated mesh__D051017 2005-06-30
% 209.74/209.93  |- mesh__publicMeSHNote mesh__D051017 2006   
% 209.74/209.93  |- rdf__type mesh__D051017sskos__Concept
% 209.74/209.93  |- mesh__recordOriginator mesh__D051017 DRC
% 209.74/209.93  |- mesh__recordAuthorizer mesh__D051017 sjn
% 209.74/209.93  |- skos__altLabel mesh__D051017 Pro-Apoptotic Proteins
% 209.74/209.93  |- skos__altLabel mesh__D051017 Survival Factors %28%Apoptosis%29%
% 209.74/209.93  |- mesh__recordMaintainer mesh__D051017 DRC
% 209.74/209.93  |- skos__altLabel mesh__D051017 Anti-Apoptotic Proteins
% 209.74/209.93  |- skos__altLabel mesh__D051017 Death Factors %28%Apoptosis%29%
% 209.74/209.93  |- skos__scopeNote mesh__D051017
% 209.74/209.93       A large group of proteins that control APOPTOSIS. This family of proteins includes many ONCOGENE PROTEINS as well as a wide variety of classes of INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS such as CASPASES.%A%    
% 209.74/209.93  |- skos__broader mesh__D051017smesh__D047908
% 209.74/209.93  |- skos__hiddenLabel mesh__D051017 Regulatory Proteins, Apoptosis
% 209.74/209.93  |- skos__prefLabel mesh__D051017 Apoptosis Regulatory Proteins
% 209.74/209.93  |- skos__altLabel mesh__D009655 para-Octopamine
% 209.74/209.93  |- mesh__onlineNote mesh__D009655
% 209.74/209.93       use OCTOPAMINE to search NORSYNEPHRINE 1966-90   
% 209.74/209.93  |- skos__prefLabel mesh__D009655 Octopamine
% 209.74/209.93  |- mesh__recordOriginator mesh__D009655 NLM
% 209.74/209.93  |- mesh__historyNote mesh__D009655 91; NORSYNEPHRINE was heading 1963-90   
% 209.74/209.93  |- skos__altLabel mesh__D009655 Norsynephrine
% 209.74/209.93  |- mesh__dateCreated mesh__D009655 1999-01-01
% 209.74/209.93  |- mesh__recordAuthorizer mesh__D009655 sjn
% 209.74/209.93  |- rdf__type mesh__D009655sskos__Concept
% 209.74/209.93  |- skos__altLabel mesh__D009655 Norsympatol
% 209.74/209.93  |- mesh__publicMeSHNote mesh__D009655
% 209.74/209.93       91; NORSYNEPHRINE was heading 1963-90   
% 209.74/209.93  |- skos__altLabel mesh__D009655 4-Octopamine
% 209.74/209.93  |- mesh__dateRevised mesh__D009655 2005-06-30
% 209.74/209.93  |- skos__broader mesh__D009655smesh__D010627
% 209.74/209.93  |- skos__altLabel mesh__D009655 p-Octopamine
% 209.74/209.93  |- mesh__recordMaintainer mesh__D009655 ssb
% 209.74/209.93  |- skos__scopeNote mesh__D009655
% 209.74/209.93       An alpha-adrenergic sympathomimetic amine, biosynthesized from tyramine in the CNS and platelets and also in invertebrate nervous systems. It is used to treat hypotension and as a cardiotonic. The natural D%28%-%29% form is more potent than the L%28%+%29% form in producing cardiovascular adrenergic responses. It is also a neurotransmitter in some invertebrates.%A%    
% 209.74/209.93  |- skos__altLabel mesh__D009655
% 209.74/209.93       alpha-%28%Aminoethyl%29%-4-hydroxybenzenemethanol
% 209.74/209.93  |- skos__broader mesh__D009655smesh__D014439
% 209.74/209.93  |- skos__broader mesh__D009655smesh__D004983
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009655 2006
% 209.74/209.93  |- mesh__dateEstablished mesh__D001672 1973-01-01
% 209.74/209.93  |- mesh__historyNote mesh__D001672 73%28%72%29%   
% 209.74/209.93  |- skos__related mesh__D001672smesh__D008422
% 209.74/209.93  |- rdf__type mesh__D001672sskos__Concept
% 209.74/209.93  |- mesh__recordMaintainer mesh__D001672 nns
% 209.74/209.93  |- skos__hiddenLabel mesh__D001672 Materials, Biocompatible
% 209.74/209.93  |- mesh__dateCreated mesh__D001672 1999-01-01
% 209.74/209.93  |- skos__scopeNote mesh__D001672
% 209.74/209.93       Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function.%A%    
% 209.74/209.93  |- skos__prefLabel mesh__D001672 Biocompatible Materials
% 209.74/209.93  |- mesh__dateRevised mesh__D001672 2005-06-30
% 209.74/209.93  |- skos__hiddenLabel mesh__D001672 Materials, Hemocompatible
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D001672 2006
% 209.74/209.93  |- skos__historyNote mesh__D001672 Prosthesis %28%1966-1971%29%
% 209.74/209.93  |- skos__broader mesh__D001672smesh__D001697
% 209.74/209.93  |- skos__altLabel mesh__D001672 Biomaterials
% 209.74/209.93  |- skos__related mesh__D001672smesh__D040761
% 209.74/209.93  |- mesh__recordAuthorizer mesh__D001672 sjn
% 209.74/209.93  |- mesh__recordOriginator mesh__D001672 NLM
% 209.74/209.93  |- mesh__publicMeSHNote mesh__D001672 73   
% 209.74/209.93  |- skos__broader mesh__D005265smesh__D006620
% 209.74/209.93  |- skos__altLabel mesh__D005265 Femur Neck Fractures
% 209.74/209.93  |- mesh__dateCreated mesh__D005265 1999-01-01
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D005265 2006
% 209.74/209.93  |- skos__hiddenLabel mesh__D005265 Femur Neck Fracture
% 209.74/209.93  |- mesh__recordAuthorizer mesh__D005265 sjn
% 209.74/209.93  |- skos__prefLabel mesh__D005265 Femoral Neck Fractures
% 209.74/209.93  |- skos__hiddenLabel mesh__D005265 Femoral Neck Fracture
% 209.74/209.93  |- skos__scopeNote mesh__D005265
% 209.74/209.93       Fractures of the short, constricted portion of the thigh bone between the femur head and the trochanters. It excludes intertrochanteric fractures which are HIP FRACTURES.%A%    
% 209.74/209.93  |- mesh__recordOriginator mesh__D005265 NLM
% 209.74/209.93  |- rdf__type mesh__D005265sskos__Concept
% 209.74/209.93  |- mesh__dateRevised mesh__D005265 2005-06-30
% 209.74/209.93  |- mesh__recordMaintainer mesh__D005265 ssb
% 209.74/209.93  |- skos__broader mesh__D043384smesh__D045727
% 209.74/209.93  |- skos__broader mesh__D043384smesh__D000626
% 209.74/209.93  |- skos__altLabel mesh__D043384 Angiotensinase A
% 209.74/209.93  |- skos__scopeNote mesh__D043384
% 209.74/209.93       A ZINC-dependent membrane-bound aminopeptidase that catalyzes the N-terminal peptide cleavage of GLUTAMATE %28%and to a lesser extent ASPARTATE%29%. The enzyme appears to play a role in the catabolic pathway of the RENIN-ANGIOTENSIN SYSTEM.%A%    
% 209.74/209.93  |- mesh__publicMeSHNote mesh__D043384
% 209.74/209.93       2004; GLUTAMYL AMINOPEPTIDASE was indexed under AMINOPEPTIDASES 1981-2003 %26% ASPARTIC ACID 1978-1980%A%  
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D043384 2004
% 209.74/209.93  |- skos__hiddenLabel mesh__D043384 Aminopeptidase, Aspartyl
% 209.74/209.93  |- skos__historyNote mesh__D043384 Aspartic Acid %28%1978-1980%29%
% 209.74/209.93  |- skos__altLabel mesh__D043384 Aspartyl Aminopeptidase
% 209.74/209.93  |- skos__altLabel mesh__D043384 Aspartate Aminopeptidase
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D043384 2005
% 209.74/209.93  |- skos__prefLabel mesh__D043384 Glutamyl Aminopeptidase
% 209.74/209.93  |- skos__historyNote mesh__D043384 Aminopeptidases %28%1981-2003%29%
% 209.74/209.93  |- mesh__dateCreated mesh__D043384 2003-07-09
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D043384 2006
% 209.74/209.93  |- skos__hiddenLabel mesh__D043384 Aminopeptidase, Glutamyl
% 209.74/209.93  |- skos__hiddenLabel mesh__D043384 Aminopeptidase, Aspartate
% 209.74/209.93  |- mesh__dateEstablished mesh__D043384 2004-01-01
% 209.74/209.93  |- rdf__type mesh__D043384sskos__Concept
% 209.74/209.93  |- mesh__historyNote mesh__D043384
% 209.74/209.93       2004; use GLUTAMYL AMINPEPTIDASE %28%NM%29% 1980-2003   
% 209.74/209.93  |- skos__altLabel mesh__D043384 Aminopeptidase A
% 209.74/209.93  |- mesh__historyNote mesh__D051816 2006%28%1991%29%   
% 209.74/209.93  |- mesh__publicMeSHNote mesh__D051816
% 209.74/209.93       2006; TRISTETRAPROLIN was indexed under DNA-BINDING PROTEINS 2001-2005, %26% under IMMEDIATE-EARLY PROTEINS 1991-2005, %26% under PROTEINS 1998-2000%A%  
% 209.74/209.93  |- mesh__dateRevised mesh__D051816 2005-07-21
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D051816 2006C
% 209.74/209.93  |- mesh__recordAuthorizer mesh__D051816 ags
% 209.74/209.93  |- skos__broader mesh__D051816smesh__D004268
% 209.74/209.93  |- skos__broader mesh__D051816smesh__D017874
% 209.74/209.93  |- skos__hiddenLabel mesh__D051816 G0 G1 Switch Regulatory Protein 24
% 209.74/209.93  |- skos__prefLabel mesh__D051816 Tristetraprolin
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D051816 2006B
% 209.74/209.93  |- skos__altLabel mesh__D051816 G0-G1 Switch Regulatory Protein 24
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D051816 2006
% 209.74/209.93  |- skos__broader mesh__D051816smesh__D014157
% 209.74/209.93  |- mesh__dateEstablished mesh__D051816 2006-01-01
% 209.74/209.93  |- mesh__recordMaintainer mesh__D051816 ags
% 209.74/209.93  |- rdf__type mesh__D051816sskos__Concept
% 209.74/209.93  |- skos__scopeNote mesh__D051816
% 209.74/209.93       A ZINC FINGER MOTIF containing transcription factor that was originally identified as one of the IMMEDIATE-EARLY PROTEINS. It shuttles between the CYTOPLASM and the CELL NUCLEUS and is involved in destabilization of mRNAs for TUMOR NECROSIS FACTOR-ALPHA.%A%    
% 209.74/209.93  |- skos__altLabel mesh__D051816 Tristetraprolin Protein
% 209.74/209.93  |- skos__altLabel mesh__D051816 Zinc Finger Protein 36
% 209.74/209.93  |- mesh__recordOriginator mesh__D051816 DRC
% 209.74/209.93  |- mesh__dateCreated mesh__D051816 2005-06-30
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D051816 2006A
% 209.74/209.93  |- skos__hiddenLabel mesh__D015693 HIV 3%27% orf Protein
% 209.74/209.93  |- skos__scopeNote mesh__D015693
% 209.74/209.93       Products of the HIV nef gene %28%formerly 3%27%-orf gene%29%. The products trans-suppress viral replication and function as negative regulators of transcription. nef stands for negative factor.%A%    
% 209.74/209.93  |- mesh__dateCreated mesh__D015693 1989-10-20
% 209.74/209.93  |- skos__altLabel mesh__D015693 nef Gene Products
% 209.74/209.93  |- mesh__publicMeSHNote mesh__D015693
% 209.74/209.93       91; was see under VIRAL REGULATORY PROTEINS 1990   
% 209.74/209.93  |- mesh__dateRevised mesh__D015693 2005-06-30
% 209.74/209.93  |- skos__broader mesh__D015693smesh__D015520
% 209.74/209.93  |- skos__hiddenLabel mesh__D015693 Product, nef Gene
% 209.74/209.93  |- skos__hiddenLabel mesh__D015693 3%27% orf Protein
% 209.74/209.93  |- skos__hiddenLabel mesh__D015693 HIV F Protein
% 209.74/209.93  |- mesh__recordMaintainer mesh__D015693 SYSTEM
% 209.74/209.93  |- skos__historyNote mesh__D015693 Viral Proteins %28%1987-1988%29%
% 209.74/209.93  |- skos__hiddenLabel mesh__D015693 Protein, 3%27%-orf
% 209.74/209.93  |- skos__prefLabel mesh__D015693 Gene Products, nef
% 209.74/209.93  |- mesh__recordOriginator mesh__D015693 AGS
% 209.74/209.93  |- rdf__type mesh__D015693sskos__Concept
% 209.74/209.93  |- skos__hiddenLabel mesh__D015693 nef Gene Product
% 209.74/209.93  |- skos__altLabel mesh__D015693 Gene Product, nef
% 209.74/209.93  |- skos__annotation mesh__D015693
% 209.74/209.93       nef stands for %22%negative factor%22%; IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 209.74/209.93  |- skos__hiddenLabel mesh__D015693 Protein, nef
% 209.74/209.93  |- skos__historyNote mesh__D015693 Retroviridae Proteins %28%1987-1989%29%
% 209.74/209.93  |- mesh__recordAuthorizer mesh__D015693 sjn
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D015693 2006
% 209.74/209.93  |- skos__hiddenLabel mesh__D015693 Protein, HIV-F
% 209.74/209.93  |- mesh__dateEstablished mesh__D015693 1991-01-01
% 209.74/209.93  |- skos__hiddenLabel mesh__D015693 Protein, HIV-3%27%-orf
% 209.74/209.93  |- mesh__historyNote mesh__D015693
% 209.74/209.93       91%28%90%29%; was see under VIRAL REGULATORY PROTEINS 1990   
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009656 2001
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009656 1997
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009656 1994
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009656 2003
% 209.74/209.93  |- skos__prefLabel mesh__D009656 North America
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009656 1995
% 209.74/209.93  |- rdf__type mesh__D009656sskos__Concept
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009656 2004
% 209.74/209.93  |- mesh__dateRevised mesh__D009656 1993-06-03
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009656 1998
% 209.74/209.93  |- skos__broader mesh__D009656smesh__D000569
% 209.74/209.93  |- mesh__recordOriginator mesh__D009656 NLM
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009656 2002
% 209.74/209.93  |- skos__annotation mesh__D009656 includes Mexico   
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009656 1999
% 209.74/209.93  |- mesh__recordMaintainer mesh__D009656 PLS
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009656 2005
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009656 1996
% 209.74/209.93  |- mesh__recordAuthorizer mesh__D009656 PLS
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009656 2000
% 209.74/209.93  |- mesh__dateCreated mesh__D009656 1999-01-01
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D009656 2006
% 209.74/209.93  |- rdf__type mesh__D001673sskos__Concept
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D001673 2003
% 209.74/209.93  |- mesh__recordAuthorizer mesh__D001673 sjn
% 209.74/209.93  |- mesh__dateCreated mesh__D001673 1999-01-01
% 209.74/209.93  |- mesh__recordOriginator mesh__D001673 NLM
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D001673 2004
% 209.74/209.93  |- mesh__historyNote mesh__D001673
% 209.74/209.93       78%28%69%29%; was see under SANITARY ENGINEERING 1975-77   
% 209.74/209.93  |- skos__hiddenLabel mesh__D001673 Bioremediations
% 209.74/209.93  |- skos__broader mesh__D001673smesh__D012498
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D001673 2005
% 209.74/209.93  |- skos__historyNote mesh__D001673 Biophysics %28%1966-1968%29%
% 209.74/209.93  |- skos__historyNote mesh__D001673 appropriate material
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D001673 2001
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D001673 2006
% 209.74/209.93  |- mesh__recordMaintainer mesh__D001673 jmp
% 209.74/209.93  |- skos__hiddenLabel mesh__D001673 Biodegradations
% 209.74/209.93  |- mesh__publicMeSHNote mesh__D001673
% 209.74/209.93       78; was see under SANITARY ENGINEERING 1975-77   
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D001673 2002
% 209.74/209.93  |- skos__historyNote mesh__D001673 Sanitary Engineering %28%1966-1968%29%
% 209.74/209.93  |- skos__prefLabel mesh__D001673 Biodegradation
% 209.74/209.93  |- skos__scopeNote mesh__D001673
% 209.74/209.93       The series of processes by which living organisms degrade pollutant chemicals, organic wastes, pesticides, and implantable materials.%A%    
% 209.74/209.93  |- mesh__dateRevised mesh__D001673 2000-06-22
% 209.74/209.93  |- mesh__dateEstablished mesh__D001673 1978-01-01
% 209.74/209.93  |- skos__annotation mesh__D001673
% 209.74/209.93       NIM when specific substance is IM; do not confuse with BIOTRANSFORMATION: see note there%A%  
% 209.74/209.93  |- skos__broader mesh__D001673smesh__D001686
% 209.74/209.93  |- mesh__historyNote mesh__D019286
% 209.74/209.93       97; was ENDOPEPTIDASE K %28%NM%29% 1979-96   
% 209.74/209.93  |- skos__historyNote mesh__D019286
% 209.74/209.93       Peptide Peptidohydrolases %28%1979-1987%29%
% 209.74/209.93  |- skos__hiddenLabel mesh__D019286 Proteinase, Tritirachium Alkaline
% 209.74/209.93  |- skos__altLabel mesh__D019286 Tritirachium Alkaline Proteinase
% 209.74/209.93  |- mesh__recordAuthorizer mesh__D019286 sjn
% 209.74/209.93  |- skos__scopeNote mesh__D019286
% 209.74/209.93       An enzyme that catalyzes the hydrolysis of keratin, and of other proteins with subtilisin-like specificity. It hydrolyses peptide amides. Endopeptidase K is from the mold Tritirachium album Limber. %28%Enzyme Nomenclature, 1992%29% EC 3.4.21.64.%A%    
% 209.74/209.93  |- skos__altLabel mesh__D019286 Proteinase K
% 209.74/209.93  |- skos__altLabel mesh__D019286 Protease K
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D019286 2004
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D019286 2005
% 209.74/209.93  |- mesh__recordOriginator mesh__D019286 TPW
% 209.74/209.93  |- skos__prefLabel mesh__D019286 Endopeptidase K
% 209.74/209.93  |- rdf__type mesh__D019286sskos__Concept
% 209.74/209.93  |- mesh__activeMeSHYear mesh__D019286 2006
% 209.74/209.93  |- mesh__onlineNote mesh__D019286
% 209.74/209.93       use ENDOPEPTIDASE K %28%NM%29% to search ENDOPEPTIDASE K 1980-96%A%  
% 209.74/209.93  |- skos__broader mesh__D019286smesh__D012697
% 209.74/209.93  |- mesh__dateEstablished mesh__D019286 1997-01-01
% 209.74/209.93  |- mesh__publicMeSHNote mesh__D019286
% 209.74/209.93       97; ENDOPEPTIDASE K was indexed under SERINE PROTEINASES 1988-96 %26% PEPTIDE PEPTIDOHYDROLASES 1979-87%A%  
% 209.74/209.93  |- skos__hiddenLabel mesh__D019286 Alkaline Proteinase, Tritirachium
% 209.74/209.93  |- mesh__dateRevised mesh__D019286 2003-07-09
% 209.74/209.93  |- skos__historyNote mesh__D019286 Serine Proteinases %28%1988-1996%29%
% 209.74/209.94  |- mesh__dateCreated mesh__D019286 1996-06-10
% 209.74/209.94  |- mesh__recordMaintainer mesh__D019286 ssb
% 209.74/209.94  |- skos__hiddenLabel mesh__D005266 Neoplasm, Femoral
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D005266 2003
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D005266 2001
% 209.74/209.94  |- mesh__dateRevised mesh__D005266 1995-06-08
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D005266 1997
% 209.74/209.94  |- mesh__recordOriginator mesh__D005266 NLM
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D005266 2004
% 209.74/209.94  |- skos__broader mesh__D005266smesh__D001859
% 209.74/209.94  |- rdf__type mesh__D005266sskos__Concept
% 209.74/209.94  |- skos__hiddenLabel mesh__D005266 Neoplasms, Femoral
% 209.74/209.94  |- skos__hiddenLabel mesh__D005266 Femoral Neoplasm
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D005266 2002
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D005266 1998
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D005266 2005
% 209.74/209.94  |- skos__prefLabel mesh__D005266 Femoral Neoplasms
% 209.74/209.94  |- skos__annotation mesh__D005266
% 209.74/209.94       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with specific FEMUR HEAD or FEMUR NECK %28%NIM%29% as merely locational + histol type of neopl %28%IM%29%%A%  
% 209.74/209.94  |- mesh__dateCreated mesh__D005266 1999-01-01
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D005266 1999
% 209.74/209.94  |- mesh__recordAuthorizer mesh__D005266 PLS
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D005266 2006
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D005266 2000
% 209.74/209.94  |- mesh__recordMaintainer mesh__D005266 KEV
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D005266 1996
% 209.74/209.94  |- skos__altLabel mesh__D010400 Medical Brand of Penicillin G Potassium
% 209.74/209.94  |- skos__altLabel mesh__D010400 CSL Brand of Penicillin G Sodium
% 209.74/209.94  |- skos__altLabel mesh__D010400 Ern Brand of Penicillin G Sodium
% 209.74/209.94  |- skos__altLabel mesh__D010400 Benzylpenicillin
% 209.74/209.94  |- mesh__recordAuthorizer mesh__D010400 sjn
% 209.74/209.94  |- mesh__recordOriginator mesh__D010400 NLM
% 209.74/209.94  |- skos__altLabel mesh__D010400 Medical Brand of Penicillin G Sodium
% 209.74/209.94  |- skos__prefLabel mesh__D010400 Penicillin G
% 209.74/209.94  |- skos__altLabel mesh__D010400 Bioniche Brand of Penicillin G Sodium
% 209.74/209.94  |- rdf__type mesh__D010400sskos__Concept
% 209.74/209.94  |- mesh__recordMaintainer mesh__D010400 lkw
% 209.74/209.94  |- skos__altLabel mesh__D010400 Sodium Benzylpenicillin
% 209.74/209.94  |- skos__altLabel mesh__D010400 Vangard Brand of Penicillin G Potassium
% 209.74/209.94  |- skos__altLabel mesh__D010400 Ortega Brand of Penicillin G Potassium
% 209.74/209.94  |- skos__altLabel mesh__D010400 Antibioticos Brand of Penicillin G Sodium
% 209.74/209.94  |- skos__scopeNote mesh__D010400
% 209.74/209.94       A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission.%A%    
% 209.74/209.94  |- skos__altLabel mesh__D010400 Parmed Brand of Penicillin G Potassium
% 209.74/209.94  |- skos__altLabel mesh__D010400 CEPA Brand of Penicillin G Sodium
% 209.74/209.94  |- mesh__dateCreated mesh__D010400 1999-01-01
% 209.74/209.94  |- skos__altLabel mesh__D010400 Sodium Penicillin
% 209.74/209.94  |- skos__altLabel mesh__D010400 Jenapharm Brand of Penicillin G Sodium
% 209.74/209.94  |- skos__annotation mesh__D010400 GEN or unspecified; prefer specifics   
% 209.74/209.94  |- skos__broader mesh__D010400smesh__D010406
% 209.74/209.94  |- skos__altLabel mesh__D010400 Lakeside Brand of Penicillin G Sodium
% 209.74/209.94  |- skos__altLabel mesh__D010400 Normon Brand of Penicillin G Sodium
% 209.74/209.94  |- skos__altLabel mesh__D010400 Unicilina
% 209.74/209.94  |- skos__altLabel mesh__D010400 Pfizer Brand of Penicillin G Potassium
% 209.74/209.94  |- skos__altLabel mesh__D010400 Llorente Brand of Penicillin G Sodium
% 209.74/209.94  |- mesh__dateRevised mesh__D010400 2005-06-30
% 209.74/209.94  |- skos__altLabel mesh__D010400
% 209.74/209.94       Gr%C3%%BC%nenthal Brand of Penicillin G Potassium
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D010400 2006
% 209.74/209.94  |- skos__altLabel mesh__D010400 Clonmel Brand of Penicillin G Sodium
% 209.74/209.94  |- skos__altLabel mesh__D010400 Britannia Brand of Penicillin G Sodium
% 209.74/209.94  |- skos__altLabel mesh__D010400 UCB Brand of Penicillin G Sodium
% 209.74/209.94  |- skos__altLabel mesh__D010400 Benzylpenicillin Potassium
% 209.74/209.94  |- skos__altLabel mesh__D051817 Early Response Factor Berg36
% 209.74/209.94  |- mesh__dateCreated mesh__D051817 2005-06-30
% 209.74/209.94  |- skos__broader mesh__D051817smesh__D004268
% 209.74/209.94  |- skos__broader mesh__D051817smesh__D017874
% 209.74/209.94  |- mesh__publicMeSHNote mesh__D051817
% 209.74/209.94       2006; BUTYRATE RESPONSE FACTOR 1 was indexed under DNA-BINDING PROTEINS 2001-2005, %26% under IMMEDIATE-EARLY PROTEINS 1991-2005, %26% under PROTEINS 1998-2000%A%  
% 209.74/209.94  |- skos__scopeNote mesh__D051817
% 209.74/209.94       A ZINC FINGER MOTIF containing immediate early protein that is closely related to TRISTETRAPROLIN. It interacts with and helps destabilize VASCULAR ENDOTHELIAL GROWTH FACTOR mRNA.%A%    
% 209.74/209.94  |- mesh__historyNote mesh__D051817 2006%28%1991%29%   
% 209.74/209.94  |- skos__prefLabel mesh__D051817 Butyrate Response Factor 1
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D051817 2006
% 209.74/209.94  |- rdf__type mesh__D051817sskos__Concept
% 209.74/209.94  |- mesh__recordMaintainer mesh__D051817 DRC
% 209.74/209.94  |- mesh__recordOriginator mesh__D051817 DRC
% 209.74/209.94  |- skos__broader mesh__D051817smesh__D016601
% 209.74/209.94  |- mesh__recordAuthorizer mesh__D051817 sjn
% 209.74/209.94  |- mesh__dateEstablished mesh__D051817 2006-01-01
% 209.74/209.94  |- skos__hiddenLabel mesh__D015694 art trs Gene Protein, HIV
% 209.74/209.94  |- skos__hiddenLabel mesh__D015694 Products, rev Gene
% 209.74/209.94  |- skos__hiddenLabel mesh__D015694 HIV Transactivator Protein
% 209.74/209.94  |- skos__prefLabel mesh__D015694 Gene Products, rev
% 209.74/209.94  |- skos__historyNote mesh__D015694 Retroviridae Proteins %28%1986-1989%29%
% 209.74/209.94  |- skos__hiddenLabel mesh__D015694 Protein, HIV Trans-Activator
% 209.74/209.94  |- mesh__historyNote mesh__D015694
% 209.74/209.94       91%28%90%29%; was see under TRANS-ACTIVATORS 1990   
% 209.74/209.94  |- skos__hiddenLabel mesh__D015694 Product, rev Gene
% 209.74/209.94  |- mesh__recordMaintainer mesh__D015694 SYSTEM
% 209.74/209.94  |- mesh__dateCreated mesh__D015694 1989-07-06
% 209.74/209.94  |- skos__hiddenLabel mesh__D015694 HIV trs art Gene Protein
% 209.74/209.94  |- skos__altLabel mesh__D015694 Gene Product, rev
% 209.74/209.94  |- mesh__publicMeSHNote mesh__D015694
% 209.74/209.94       91; was see under TRANS-ACTIVATORS 1990   
% 209.74/209.94  |- rdf__type mesh__D015694sskos__Concept
% 209.74/209.94  |- skos__hiddenLabel mesh__D015694 rev Gene Product
% 209.74/209.94  |- skos__altLabel mesh__D015694 rev Gene Products
% 209.74/209.94  |- mesh__dateRevised mesh__D015694 2005-06-30
% 209.74/209.94  |- skos__historyNote mesh__D015694 Viral Proteins %28%1986-1989%29%
% 209.74/209.94  |- skos__altLabel mesh__D015694 Transactivator Protein, HIV
% 209.74/209.94  |- skos__hiddenLabel mesh__D015694 trs art Gene Protein, HIV
% 209.74/209.94  |- skos__hiddenLabel mesh__D015694 Trans Activator Protein, HIV
% 209.74/209.94  |- skos__hiddenLabel mesh__D015694 HIV Trans-Activator Protein
% 209.74/209.94  |- skos__altLabel mesh__D015694 HIV art-trs Gene Protein
% 209.74/209.94  |- skos__scopeNote mesh__D015694
% 209.74/209.94       Trans-acting nuclear proteins whose functional expression are required for HIV viral replication. Specifically, the rev gene products are required for processing and translation of the HIV gag and env mRNAs, and thus rev regulates the expression of the viral structural proteins. rev can also regulate viral regulatory proteins. A cis-acting antirepression sequence %28%CAR%29% in env, also known as the rev-responsive element %28%RRE%29%, is responsive to the rev gene product. rev is short for regulator of virion.%A%    
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D015694 2006
% 209.74/209.94  |- mesh__recordOriginator mesh__D015694 AGS
% 209.74/209.94  |- mesh__dateEstablished mesh__D015694 1991-01-01
% 209.74/209.94  |- skos__hiddenLabel mesh__D015694 Protein, rev
% 209.74/209.94  |- skos__hiddenLabel mesh__D015694 HIV art trs Gene Protein
% 209.74/209.94  |- skos__hiddenLabel mesh__D015694 Protein, HIV Transactivator
% 209.74/209.94  |- skos__altLabel mesh__D015694 art-trs Gene Protein, HIV
% 209.74/209.94  |- skos__altLabel mesh__D015694 HIV trs-art Gene Protein
% 209.74/209.94  |- skos__annotation mesh__D015694
% 209.74/209.94       Rev stands for %22%regulator of virion%22%; IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 209.74/209.94  |- skos__broader mesh__D015694smesh__D015534
% 209.74/209.94  |- mesh__recordAuthorizer mesh__D015694 sjn
% 209.74/209.94  |- mesh__dateEstablished mesh__D048070 2005-01-01
% 209.74/209.94  |- skos__broader mesh__D048070smesh__D005315
% 209.74/209.94  |- mesh__recordOriginator mesh__D048070 lkt
% 209.74/209.94  |- mesh__dateRevised mesh__D048070 2005-06-30
% 209.74/209.94  |- mesh__publicMeSHNote mesh__D048070
% 209.74/209.94       2005; see PLACENTA  INSUFFICIENCY 1998-2004   
% 209.74/209.94  |- skos__altLabel mesh__D048070 Malnutrition, Fetal
% 209.74/209.94  |- skos__historyNote mesh__D048070 Fetal Diseases %28%1965-1981%29%
% 209.74/209.94  |- skos__hiddenLabel mesh__D048070 Fetal Nutrition Disorder
% 209.74/209.94  |- skos__altLabel mesh__D048070 Nutrition Disorders, Fetal
% 209.74/209.94  |- mesh__dateCreated mesh__D048070 2004-07-07
% 209.74/209.94  |- mesh__recordAuthorizer mesh__D048070 sjn
% 209.74/209.94  |- mesh__recordMaintainer mesh__D048070 lkt
% 209.74/209.94  |- skos__scopeNote mesh__D048070
% 209.74/209.94       Disorders caused by nutritional imbalance, either overnutrition or undernutrition, in the FETUS in utero.%A%    
% 209.74/209.94  |- skos__historyNote mesh__D048070
% 209.74/209.94       Placental Insufficiency %28%1982-2004%29%
% 209.74/209.94  |- skos__prefLabel mesh__D048070 Fetal Nutrition Disorders
% 209.74/209.94  |- skos__hiddenLabel mesh__D048070 Nutrition Disorder, Fetal
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D048070 2006
% 209.74/209.94  |- skos__broader mesh__D048070smesh__D044342
% 209.74/209.94  |- rdf__type mesh__D048070sskos__Concept
% 209.74/209.94  |- mesh__historyNote mesh__D048070
% 209.74/209.94       2005; use PLACENTA  INSUFFICIENCY 1998-2004   
% 209.74/209.94  |- mesh__dateRevised mesh__D009657 1997-06-20
% 209.74/209.94  |- skos__broader mesh__D009657smesh__D015144
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D009657 2000
% 209.74/209.94  |- rdf__type mesh__D009657sskos__Concept
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D009657 2004
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D009657 1998
% 209.74/209.94  |- skos__prefLabel mesh__D009657 North Carolina
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D009657 2001
% 209.74/209.94  |- skos__broader mesh__D009657smesh__D001061
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D009657 1999
% 209.74/209.94  |- mesh__recordMaintainer mesh__D009657 PXP
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D009657 2005
% 209.74/209.94  |- mesh__recordOriginator mesh__D009657 NLM
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D009657 2002
% 209.74/209.94  |- mesh__recordAuthorizer mesh__D009657 SJN
% 209.74/209.94  |- mesh__dateCreated mesh__D009657 1999-01-01
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D009657 2006
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D009657 2003
% 209.74/209.94  |- skos__broader mesh__D001674smesh__D011211
% 209.74/209.94  |- skos__hiddenLabel mesh__D001674 Biological Energy Source
% 209.74/209.94  |- skos__hiddenLabel mesh__D001674 Energy Sources, Biologic
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D001674 2006
% 209.74/209.94  |- mesh__dateRevised mesh__D001674 2005-06-30
% 209.74/209.94  |- mesh__publicMeSHNote mesh__D001674 74   
% 209.74/209.94  |- skos__hiddenLabel mesh__D001674 Sources, Bioelectric Energy
% 209.74/209.94  |- skos__hiddenLabel mesh__D001674 Power Source, Bioelectric
% 209.74/209.94  |- skos__hiddenLabel mesh__D001674 Bioelectric Energy Source
% 209.74/209.94  |- skos__annotation mesh__D001674
% 209.74/209.94       includes biofuels, ionic concentration cells, biogalvanic cells, etc.%A%  
% 209.74/209.94  |- skos__hiddenLabel mesh__D001674 Energy Source, Bioelectric
% 209.74/209.94  |- skos__hiddenLabel mesh__D001674 Bioelectric Power Source
% 209.74/209.94  |- skos__hiddenLabel mesh__D001674 Energy Source, Biologic
% 209.74/209.94  |- mesh__recordMaintainer mesh__D001674 ags
% 209.74/209.94  |- mesh__historyNote mesh__D001674 74   
% 209.74/209.94  |- skos__hiddenLabel mesh__D001674 Sources, Bioelectric Power
% 209.74/209.94  |- mesh__recordOriginator mesh__D001674 NLM
% 209.74/209.94  |- mesh__recordAuthorizer mesh__D001674 sjn
% 209.74/209.94  |- rdf__type mesh__D001674sskos__Concept
% 209.74/209.94  |- skos__altLabel mesh__D001674 Biologic Energy Source
% 209.74/209.94  |- skos__scopeNote mesh__D001674
% 209.74/209.94       Implantable devices which convert biological energy %28%chemical energy of the metabolism of continuously regenerating body fluids or mechanical energy of periodic movements%29% to electrical energy. The sources include biogalvanic cells, biofuel cells, and ionic concentration cells.%A%    
% 209.74/209.94  |- skos__hiddenLabel mesh__D001674 Sources, Biological Energy
% 209.74/209.94  |- skos__hiddenLabel mesh__D001674 Source, Bioelectric Energy
% 209.74/209.94  |- mesh__dateEstablished mesh__D001674 1974-01-01
% 209.74/209.94  |- skos__altLabel mesh__D001674 Energy Source, Biological
% 209.74/209.94  |- mesh__dateCreated mesh__D001674 1999-01-01
% 209.74/209.94  |- skos__hiddenLabel mesh__D001674 Sources, Biologic Energy
% 209.74/209.94  |- skos__altLabel mesh__D001674 Energy Sources, Biological
% 209.74/209.94  |- skos__altLabel mesh__D001674 Biological Energy Sources
% 209.74/209.94  |- skos__hiddenLabel mesh__D001674 Energy Sources, Bioelectric
% 209.74/209.94  |- skos__hiddenLabel mesh__D001674 Bioelectric Power Sources
% 209.74/209.94  |- skos__hiddenLabel mesh__D001674 Biologic Energy Sources
% 209.74/209.94  |- skos__prefLabel mesh__D001674 Bioelectric Energy Sources
% 209.74/209.94  |- skos__hiddenLabel mesh__D001674 Source, Biologic Energy
% 209.74/209.94  |- skos__hiddenLabel mesh__D001674 Source, Bioelectric Power
% 209.74/209.94  |- skos__hiddenLabel mesh__D001674 Source, Biological Energy
% 209.74/209.94  |- mesh__recordMaintainer mesh__D020030 ssb
% 209.74/209.94  |- mesh__recordAuthorizer mesh__D020030 sjn
% 209.74/209.94  |- mesh__publicMeSHNote mesh__D020030 99   
% 209.74/209.94  |- mesh__dateEstablished mesh__D020030 1999-01-01
% 209.74/209.94  |- mesh__dateRevised mesh__D020030 2005-06-30
% 209.74/209.94  |- skos__broader mesh__D020030smesh__D045504
% 209.74/209.94  |- skos__scopeNote mesh__D020030
% 209.74/209.94       A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. %28%Adv Pharmacol 1995;34:361-81%29%%A%    
% 209.74/209.94  |- skos__historyNote mesh__D020030 Nitric Oxide %28%1990-1998%29%
% 209.74/209.94  |- skos__prefLabel mesh__D020030 Nitric Oxide Donors
% 209.74/209.94  |- skos__related mesh__D020030smesh__D009569
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D020030 2006
% 209.74/209.94  |- rdf__type mesh__D020030sskos__Concept
% 209.74/209.94  |- skos__hiddenLabel mesh__D020030 Donors, Nitric Oxide
% 209.74/209.94  |- skos__hiddenLabel mesh__D020030 Oxide Donors, Nitric
% 209.74/209.94  |- mesh__recordOriginator mesh__D020030 ADP
% 209.74/209.94  |- mesh__historyNote mesh__D020030 99   
% 209.74/209.94  |- skos__broader mesh__D020030smesh__D002317
% 209.74/209.94  |- mesh__dateCreated mesh__D020030 1998-06-10
% 209.74/209.94  |- skos__historyNote mesh__D019287 Zinc %28%1979-1993%29%
% 209.74/209.94  |- skos__historyNote mesh__D019287 Sulfates %28%1979-1996%29%
% 209.74/209.94  |- mesh__publicMeSHNote mesh__D019287
% 209.74/209.94       97; ZINC SULFATE was indexed under ZINC COMPOUNDS 1994-96, SULFATES 1979-96, %26% ZINC 1979-93%A%  
% 209.74/209.94  |- skos__scopeNote mesh__D019287
% 209.74/209.94       A compound given in the treatment of conditions associated with zinc deficiency such as acrodermatitis enteropathica. Externally, zinc sulfate is used as an astringent in lotions and eye drops. %28%Reynolds JEF%28%Ed%29%: Martindale: The Extra Pharmacopoeia %28%electronic version%29%. Micromedex, Inc, Englewood, CO, 1995%29%%A%    
% 209.74/209.94  |- mesh__recordMaintainer mesh__D019287 WXM
% 209.74/209.94  |- skos__broader mesh__D019287smesh__D017967
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D019287 2004
% 209.74/209.94  |- mesh__onlineNote mesh__D019287
% 209.74/209.94       use ZINC SULFATE %28%NM%29% to search ZINC SULFATE 1980-96   
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D019287 2003
% 209.74/209.94  |- mesh__dateEstablished mesh__D019287 1997-01-01
% 209.74/209.94  |- mesh__dateCreated mesh__D019287 1996-06-10
% 209.74/209.94  |- mesh__dateRevised mesh__D019287 2001-07-25
% 209.74/209.94  |- skos__hiddenLabel mesh__D019287 Sulfate, Zinc
% 209.74/209.94  |- mesh__recordAuthorizer mesh__D019287 sjn
% 209.74/209.94  |- skos__prefLabel mesh__D019287 Zinc Sulfate
% 209.74/209.94  |- skos__historyNote mesh__D019287 Zinc Compounds %28%1994-1996%29%
% 209.74/209.94  |- rdf__type mesh__D019287sskos__Concept
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D019287 2006
% 209.74/209.94  |- mesh__recordOriginator mesh__D019287 ADP
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D019287 2002
% 209.74/209.94  |- skos__broader mesh__D019287smesh__D013431
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D019287 2005
% 209.74/209.94  |- mesh__historyNote mesh__D019287
% 209.74/209.94       97; was ZINC SULFATE %28%NM%29% 1979-96   
% 209.74/209.94  |- skos__scopeNote mesh__D038441
% 209.74/209.94       A diet typical of the Mediterranean region characterized by a pattern high in fruits and vegetables, cereals and bread, potatoes, poultry, beans, nuts, olive oil and fish while low in red meat and dairy and moderate in alcohol consumption.%A%    
% 209.74/209.94  |- mesh__publicMeSHNote mesh__D038441 2003   
% 209.74/209.94  |- mesh__dateCreated mesh__D038441 2002-07-03
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D038441 2004
% 209.74/209.94  |- skos__altLabel mesh__D038441 Mediterranean Diet
% 209.74/209.94  |- skos__prefLabel mesh__D038441 Diet, Mediterranean
% 209.74/209.94  |- mesh__dateEstablished mesh__D038441 2003-01-01
% 209.74/209.94  |- mesh__historyNote mesh__D038441 2003   
% 209.74/209.94  |- skos__annotation mesh__D038441 coord with specific disease or edible   
% 209.74/209.94  |- skos__broader mesh__D038441smesh__D004032
% 209.74/209.94  |- skos__hiddenLabel mesh__D038441 Mediterranean Diets
% 209.74/209.94  |- rdf__type mesh__D038441sskos__Concept
% 209.74/209.94  |- skos__historyNote mesh__D038441 Diet %28%1984-2002%29%
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D038441 2005
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D038441 2003
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D038441 2006
% 209.74/209.94  |- skos__hiddenLabel mesh__D038441 Diets, Mediterranean
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D005267 2004
% 209.74/209.94  |- mesh__recordAuthorizer mesh__D005267 sjn
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D005267 2000
% 209.74/209.94  |- skos__annotation mesh__D005267
% 209.74/209.94       dis = FEMORAL NEUROPATHY; neopl = FEMORAL NEUROPATHY %28%IM%29% + PERIPHERAL NERVOUS SYSTEM NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%; posterior femoral cutaneous nerve: index under PERIPHERAL NERVES%A%  
% 209.74/209.94  |- skos__hiddenLabel mesh__D005267 Femoral Nerves
% 209.74/209.94  |- rdf__type mesh__D005267sskos__Concept
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D005267 2001
% 209.74/209.94  |- mesh__recordOriginator mesh__D005267 NLM
% 209.74/209.94  |- skos__prefLabel mesh__D005267 Femoral Nerve
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D005267 2005
% 209.74/209.94  |- mesh__dateRevised mesh__D005267 1999-11-05
% 209.74/209.94  |- skos__broader mesh__D005267smesh__D008160
% 209.74/209.94  |- mesh__dateCreated mesh__D005267 1999-01-01
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D005267 2006
% 209.74/209.94  |- skos__scopeNote mesh__D005267
% 209.74/209.94       A nerve originating in the lumbar spinal cord %28%usually L2 to L4%29% and traveling through the lumbar plexus to provide motor innervation to extensors of the thigh and sensory innervation to parts of the thigh, lower leg, and foot, and to the hip and knee joints.%A%    
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D005267 2002
% 209.74/209.94  |- mesh__recordMaintainer mesh__D005267 KEV
% 209.74/209.94  |- skos__hiddenLabel mesh__D005267 Nerve, Femoral
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D005267 2003
% 209.74/209.94  |- skos__hiddenLabel mesh__D005267 Nerves, Femoral
% 209.74/209.94  |- skos__hiddenLabel mesh__D010401 Bicillin LA
% 209.74/209.94  |- skos__hiddenLabel mesh__D010401 Penicillin, Benzathine
% 209.74/209.94  |- skos__altLabel mesh__D010401 Bayer Brand of Benzathine Benzylpenicillin
% 209.74/209.94  |- mesh__dateCreated mesh__D010401 1999-01-01
% 209.74/209.94  |- mesh__publicMeSHNote mesh__D010401
% 209.74/209.94       91; was see under PENICILLIN G 1985-90; was heading 1963-84%A%  
% 209.74/209.94  |- skos__altLabel mesh__D010401 Penicillin G Benzathine
% 209.74/209.94  |- mesh__historyNote mesh__D010401
% 209.74/209.94       91%28%85%29%63; was see under PENICILLIN G 1985-90; was heading 1963-84%A%  
% 209.74/209.94  |- skos__altLabel mesh__D010401 Bicillin L-A
% 209.74/209.94  |- skos__altLabel mesh__D010401 Roerig Brand of Benzathine Benzylpenicillin
% 209.74/209.94  |- skos__altLabel mesh__D010401
% 209.74/209.94       Jenapharm Brand of Benzathine Benzylpenicillin
% 209.74/209.94  |- skos__hiddenLabel mesh__D010401 Benzatina, Provipen
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D010401 2005
% 209.74/209.94  |- skos__altLabel mesh__D010401
% 209.74/209.94       I Farmacologia Brand of Benzathine Benzylpenicillin
% 209.74/209.94  |- skos__hiddenLabel mesh__D010401
% 209.74/209.94       Benzylp%C3%%A9%nicilline Panpharma, Benzathine
% 209.74/209.94  |- rdf__type mesh__D010401sskos__Concept
% 209.74/209.94  |- skos__hiddenLabel mesh__D010401 Benzathine, Penicillin G
% 209.74/209.94  |- skos__altLabel mesh__D010401 Wyeth Brand of Benzathine Benzylpenicillin
% 209.74/209.94  |- mesh__recordOriginator mesh__D010401 NLM
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D010401 2006
% 209.74/209.94  |- skos__hiddenLabel mesh__D010401 G Benzathine, Penicillin
% 209.74/209.94  |- skos__hiddenLabel mesh__D010401 Benzathine Penicillin G
% 209.74/209.94  |- skos__altLabel mesh__D010401
% 209.74/209.94       Sabater Brand of Benzathine Benzylpenicillin
% 209.74/209.94  |- mesh__dateRevised mesh__D010401 2004-07-07
% 209.74/209.94  |- mesh__dateEstablished mesh__D010401 1991-01-01
% 209.74/209.94  |- skos__scopeNote mesh__D010401
% 209.74/209.94       Semisynthetic antibiotic prepared by combining the sodium salt of penicillin G with N,N%27%-dibenzylethylenediamine.%A%    
% 209.74/209.94  |- skos__altLabel mesh__D010401 CSL Brand of Benzathine Benzylpenicillin
% 209.74/209.94  |- skos__altLabel mesh__D010401 Roger Brand of Benzathine Benzylpenicillin
% 209.74/209.94  |- skos__prefLabel mesh__D010401 Penicillin G, Benzathine
% 209.74/209.94  |- skos__altLabel mesh__D010401
% 209.74/209.94       Pharmacia Brand of Benzathine Benzylpenicillin
% 209.74/209.94  |- skos__altLabel mesh__D010401 Benzathine Benzylpenicillin
% 209.74/209.94  |- skos__altLabel mesh__D010401
% 209.74/209.94       Wassermann Brand of Benzathine Benzylpenicillin
% 209.74/209.94  |- skos__broader mesh__D010401smesh__D010400
% 209.74/209.94  |- skos__hiddenLabel mesh__D010401 Bicillin L A
% 209.74/209.94  |- skos__altLabel mesh__D010401 Specia Brand of Benzathine Benzylpenicillin
% 209.74/209.94  |- skos__hiddenLabel mesh__D010401
% 209.74/209.94       Panpharma, Benzathine Benzylp%C3%%A9%nicilline
% 209.74/209.94  |- skos__hiddenLabel mesh__D010401 Retard, Peniroger
% 209.74/209.94  |- skos__altLabel mesh__D010401
% 209.74/209.94       Yamanouchi Brand of Benzathine Benzylpenicillin
% 209.74/209.94  |- mesh__recordMaintainer mesh__D010401 ssb
% 209.74/209.94  |- skos__altLabel mesh__D010401 Benzathine Penicillin
% 209.74/209.94  |- mesh__recordAuthorizer mesh__D010401 sjn
% 209.74/209.94  |- skos__altLabel mesh__D010401
% 209.74/209.94       Panpharma Brand of Benzathine Benzylpenicillin
% 209.74/209.94  |- skos__hiddenLabel mesh__D010401 Benzylpenicillin, Benzathine
% 209.74/209.94  |- skos__altLabel mesh__D010401
% 209.74/209.94       Antibioticos Brand of Benzathine Benzylpenicillin
% 209.74/209.94  |- skos__altLabel mesh__D051818 Activator 1 Protein, 40 kDa Subunit
% 209.74/209.94  |- skos__broader mesh__D051818smesh__D004268
% 209.74/209.94  |- skos__altLabel mesh__D051818 Activator 1 Protein, 36 kDa Subunit
% 209.74/209.94  |- mesh__recordOriginator mesh__D051818 DRC
% 209.74/209.94  |- mesh__recordMaintainer mesh__D051818 ags
% 209.74/209.94  |- skos__altLabel mesh__D051818 Activator 1 p40
% 209.74/209.94  |- skos__altLabel mesh__D051818 Activator 1 Protein
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D051818 2006
% 209.74/209.94  |- mesh__dateEstablished mesh__D051818 2006-01-01
% 209.74/209.94  |- mesh__dateRevised mesh__D051818 2005-07-13
% 209.74/209.94  |- rdf__type mesh__D051818sskos__Concept
% 209.74/209.94  |- mesh__dateCreated mesh__D051818 2005-06-30
% 209.74/209.94  |- skos__altLabel mesh__D051818 Activator 1 Protein, 38 kDa Subunit
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D051818 2006A
% 209.74/209.94  |- skos__altLabel mesh__D051818 Activator 1 Protein, 145 kDa Subunit
% 209.74/209.94  |- mesh__recordAuthorizer mesh__D051818 ags
% 209.74/209.94  |- mesh__historyNote mesh__D051818 2006%28%1992%29%   
% 209.74/209.94  |- mesh__publicMeSHNote mesh__D051818
% 209.74/209.94       2006; REPLICATION FACTOR C was indexed under DNA-BINDING PROTEINS 1992-2005%A%  
% 209.74/209.94  |- skos__altLabel mesh__D051818 Activator 1 Protein, 37 kDa Subunit
% 209.74/209.94  |- skos__scopeNote mesh__D051818
% 209.74/209.94       A DNA-binding protein that consists of 5 polypeptides and plays an essential role in DNA REPLICATION in eukaryotes. It binds DNA PRIMER-template junctions and recruits PROLIFERATING CELL NUCLEAR ANTIGEN and DNA POLYMERASES to the site of DNA synthesis.%A%    
% 209.74/209.94  |- skos__prefLabel mesh__D051818 Replication Factor C
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D009658 2002
% 209.74/209.94  |- mesh__recordAuthorizer mesh__D009658 SJN
% 209.74/209.94  |- mesh__recordOriginator mesh__D009658 NLM
% 209.74/209.94  |- skos__broader mesh__D009658smesh__D015146
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D009658 2005
% 209.74/209.94  |- mesh__dateCreated mesh__D009658 1999-01-01
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D009658 2006
% 209.74/209.94  |- skos__prefLabel mesh__D009658 North Dakota
% 209.74/209.94  |- mesh__dateRevised mesh__D009658 1997-06-20
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D009658 2000
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D009658 2003
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D009658 2001
% 209.74/209.94  |- rdf__type mesh__D009658sskos__Concept
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D009658 2004
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D009658 1998
% 209.74/209.94  |- mesh__recordMaintainer mesh__D009658 PXP
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D009658 1999
% 209.74/209.94  |- mesh__recordMaintainer mesh__D001675 jls
% 209.74/209.94  |- skos__prefLabel mesh__D001675 Bioethics
% 209.74/209.94  |- skos__related mesh__D001675smesh__D004992
% 209.74/209.94  |- skos__annotation mesh__D001675
% 209.74/209.94       SPEC only; for issues in bioethics use BIOETHICAL ISSUES or its specifics; ETHICISTS is also available%A%  
% 209.74/209.94  |- mesh__dateEstablished mesh__D001675 1978-01-01
% 209.74/209.94  |- rdf__type mesh__D001675sskos__Concept
% 209.74/209.94  |- mesh__dateRevised mesh__D001675 2003-07-09
% 209.74/209.94  |- skos__broader mesh__D001675smesh__D004989
% 209.74/209.94  |- skos__related mesh__D001675smesh__D026822
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D001675 2004
% 209.74/209.94  |- mesh__recordOriginator mesh__D001675 EC
% 209.74/209.94  |- mesh__historyNote mesh__D001675 78   
% 209.74/209.94  |- skos__hiddenLabel mesh__D001675 Ethics, Biomedical
% 209.74/209.94  |- mesh__publicMeSHNote mesh__D001675 78   
% 209.74/209.94  |- skos__scopeNote mesh__D001675
% 209.74/209.94       A branch of applied ethics that studies the value implications of practices and developments in life sciences, medicine, and health care.%A%    
% 209.74/209.94  |- mesh__dateCreated mesh__D001675 1977-04-22
% 209.74/209.94  |- mesh__recordAuthorizer mesh__D001675 sjn
% 209.74/209.94  |- skos__hiddenLabel mesh__D001675 Ethics, Health Care
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D001675 2005
% 209.74/209.94  |- skos__historyNote mesh__D001675 Ethics, Medical %28%1966-1977%29%
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D001675 2006
% 209.74/209.94  |- rdf__type mesh__D006360sskos__Concept
% 209.74/209.94  |- skos__hiddenLabel mesh__D006360 Heat Shock Protein Chlamydomonas
% 209.74/209.94  |- skos__prefLabel mesh__D006360 Heat-Shock Proteins
% 209.74/209.94  |- skos__scopeNote mesh__D006360
% 209.74/209.94       Proteins which are synthesized in eukaryotic organisms and bacteria in response to hyperthermia and other environmental stresses. They increase thermal tolerance and perform functions essential to cell survival under these conditions.%A%    
% 209.74/209.94  |- skos__hiddenLabel mesh__D006360 Proteins, Heat-Shock
% 209.74/209.94  |- skos__hiddenLabel mesh__D006360 Protein 34, Stress
% 209.74/209.94  |- mesh__publicMeSHNote mesh__D006360 84   
% 209.74/209.94  |- skos__hiddenLabel mesh__D006360 Heat Shock Proteins
% 209.74/209.94  |- skos__hiddenLabel mesh__D006360 Chlamydomonas, Heat-Shock Protein
% 209.74/209.94  |- skos__hiddenLabel mesh__D006360 Proteins, Stress
% 209.74/209.94  |- skos__related mesh__D006360smesh__D018832
% 209.74/209.94  |- mesh__dateEstablished mesh__D006360 1984-01-01
% 209.74/209.94  |- skos__altLabel mesh__D006360 Heat-Shock Protein
% 209.74/209.94  |- mesh__dateRevised mesh__D006360 2005-06-30
% 209.74/209.94  |- skos__hiddenLabel mesh__D006360 Heat Shock Protein
% 209.74/209.94  |- skos__hiddenLabel mesh__D006360 Protein 27, Heat-Shock
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D006360 2006
% 209.74/209.94  |- skos__hiddenLabel mesh__D006360 Heat Shock Protein 27
% 209.74/209.94  |- skos__hiddenLabel mesh__D006360 Protein, Heat-Shock
% 209.74/209.94  |- skos__historyNote mesh__D006360 Proteins %28%1966-1983%29%
% 209.74/209.94  |- skos__historyNote mesh__D006360 Heat %28%1966-1983%29%
% 209.74/209.94  |- mesh__dateCreated mesh__D006360 1983-06-16
% 209.74/209.94  |- skos__altLabel mesh__D006360 Stress Proteins
% 209.74/209.94  |- mesh__recordMaintainer mesh__D006360 SYSTEM
% 209.74/209.94  |- mesh__historyNote mesh__D006360 84   
% 209.74/209.94  |- skos__broader mesh__D006360smesh__D011506
% 209.74/209.94  |- skos__hiddenLabel mesh__D006360 Protein 71, Stress
% 209.74/209.94  |- mesh__recordOriginator mesh__D006360 RLS
% 209.74/209.94  |- mesh__recordAuthorizer mesh__D006360 sjn
% 209.74/209.94  |- skos__annotation mesh__D006360
% 209.74/209.94       /biosyn /drug eff /physiol /ultrastruct permitted; do not use /analogs%A%  
% 209.74/209.94  |- skos__broader mesh__D020031smesh__D014412
% 209.74/209.94  |- mesh__historyNote mesh__D020031 99   
% 209.74/209.94  |- skos__altLabel mesh__D020031 Infections, EBV
% 209.74/209.94  |- mesh__dateCreated mesh__D020031 1998-06-10
% 209.74/209.94  |- skos__altLabel mesh__D020031 Herpesvirus 4 Infections, Human
% 209.74/209.94  |- mesh__recordAuthorizer mesh__D020031 sjn
% 209.74/209.94  |- mesh__activeMeSHYear mesh__D020031 2006
% 209.74/209.95  |- mesh__recordMaintainer mesh__D020031 ags
% 209.74/209.95  |- mesh__dateEstablished mesh__D020031 1999-01-01
% 209.74/209.95  |- rdf__type mesh__D020031sskos__Concept
% 209.74/209.95  |- skos__broader mesh__D020031smesh__D006566
% 209.74/209.95  |- mesh__dateRevised mesh__D020031 2005-06-30
% 209.74/209.95  |- skos__hiddenLabel mesh__D020031 EBV Infection
% 209.74/209.95  |- skos__scopeNote mesh__D020031
% 209.74/209.95       Infection with human herpesvirus 4 %28%HERPESVIRUS 4, HUMAN%29%; which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA %28%African type%29%, INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia %28%LEUKOPLAKIA, HAIRY%29%.%A%    
% 209.74/209.95  |- skos__prefLabel mesh__D020031 Epstein-Barr Virus Infections
% 209.74/209.95  |- skos__hiddenLabel mesh__D020031 Virus Infections, Epstein-Barr
% 209.74/209.95  |- skos__altLabel mesh__D020031 Infections, Epstein-Barr Virus
% 209.74/209.95  |- skos__altLabel mesh__D020031 EBV Infections
% 209.74/209.95  |- skos__altLabel mesh__D020031 Human Herpesvirus 4 Infections
% 209.74/209.95  |- skos__historyNote mesh__D020031
% 209.74/209.95       Herpesviridae Infections %28%1970-1998%29%
% 209.74/209.95  |- skos__altLabel mesh__D020031 Human Herpes Virus 4 Infections
% 209.74/209.95  |- mesh__publicMeSHNote mesh__D020031 99   
% 209.74/209.95  |- skos__hiddenLabel mesh__D020031 Epstein Barr Virus Infections
% 209.74/209.95  |- mesh__recordOriginator mesh__D020031 AGS
% 209.74/209.95  |- skos__altLabel mesh__D019288 KSHV
% 209.74/209.95  |- skos__prefLabel mesh__D019288 Herpesvirus 8, Human
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D019288 2002
% 209.74/209.95  |- skos__hiddenLabel mesh__D019288
% 209.74/209.95       Kaposi%27%s Sarcoma Associated Herpesvirus
% 209.74/209.95  |- skos__altLabel mesh__D019288 HHV-8
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D019288 2004
% 209.74/209.95  |- skos__altLabel mesh__D019288 Herpesvirus, Kaposi%27%s Sarcoma-Associated
% 209.74/209.95  |- skos__hiddenLabel mesh__D019288
% 209.74/209.95       Herpesviruses, Kaposi%27%s Sarcoma-Associated
% 209.74/209.95  |- skos__scopeNote mesh__D019288
% 209.74/209.95       A species in the genus RHADINOVIRUS, subfamily GAMMAHERPESVIRINAE, isolated from patients with AIDS-related and %22%classical%22% Kaposi sarcoma.%A%    
% 209.74/209.95  |- skos__altLabel mesh__D019288 Kaposi Sarcoma-Associated Herpesvirus
% 209.74/209.95  |- mesh__recordOriginator mesh__D019288 AGS
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D019288 2003
% 209.74/209.95  |- skos__hiddenLabel mesh__D019288 Herpesvirus, Kaposi Sarcoma Associated
% 209.74/209.95  |- skos__altLabel mesh__D019288 Human herpesvirus 8
% 209.74/209.95  |- skos__broader mesh__D019288smesh__D018144
% 209.74/209.95  |- rdf__type mesh__D019288sskos__Concept
% 209.74/209.95  |- skos__hiddenLabel mesh__D019288
% 209.74/209.95       Herpesvirus, Kaposi%27%s Sarcoma Associated
% 209.74/209.95  |- skos__hiddenLabel mesh__D019288 Kaposis Sarcoma-Associated Herpesvirus
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D019288 2006
% 209.74/209.95  |- mesh__recordMaintainer mesh__D019288 ags
% 209.74/209.95  |- skos__hiddenLabel mesh__D019288
% 209.74/209.95       Sarcoma-Associated Herpesviruses, Kaposi%27%s
% 209.74/209.95  |- skos__hiddenLabel mesh__D019288 Sarcoma-Associated Herpesvirus, Kaposi
% 209.74/209.95  |- skos__altLabel mesh__D019288 Herpesvirus, Kaposi Sarcoma-Associated
% 209.74/209.95  |- mesh__historyNote mesh__D019288 2002%28%1997%29%   
% 209.74/209.95  |- skos__hiddenLabel mesh__D019288 Herpesvirus, Kaposis Sarcoma-Associated
% 209.74/209.95  |- skos__hiddenLabel mesh__D019288
% 209.74/209.95       Kaposi%27%s Sarcoma-Associated Herpesviruses
% 209.74/209.95  |- skos__hiddenLabel mesh__D019288 Kaposi Sarcoma Associated Herpesvirus
% 209.74/209.95  |- mesh__dateEstablished mesh__D019288 1997-01-01
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D019288 2005
% 209.74/209.95  |- mesh__dateCreated mesh__D019288 1996-06-10
% 209.74/209.95  |- mesh__dateRevised mesh__D019288 2001-07-25
% 209.74/209.95  |- mesh__recordAuthorizer mesh__D019288 sjn
% 209.74/209.95  |- skos__altLabel mesh__D019288 Kaposi%27%s Sarcoma-Associated Herpesvirus
% 209.74/209.95  |- skos__annotation mesh__D019288
% 209.74/209.95       infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29% or KAPOSI SARCOMA if so specified by author%A%  
% 209.74/209.95  |- mesh__publicMeSHNote mesh__D019288
% 209.74/209.95       2002; see HERPESVIRUS, KAPOSI SARCOMA-ASSOCIATED 1998-2001, see HERPESVIRUS, KAPOSI%27%S SARCOMA-ASSOCIATED 1997; KAPOSI SARCOMA-ASSOCIATED HERPESVIRUS was KAPOSI%27%S SARCOMA-ASSOCIATED HERPESVIRUS 1997%A%  
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D005268 2005
% 209.74/209.95  |- mesh__recordAuthorizer mesh__D005268 PLS
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D005268 2004
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D005268 1996
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D005268 2000
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D005268 2003
% 209.74/209.95  |- skos__hiddenLabel mesh__D005268 Vein, Femoral
% 209.74/209.95  |- skos__hiddenLabel mesh__D005268 Veins, Femoral
% 209.74/209.95  |- rdf__type mesh__D005268sskos__Concept
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D005268 1995
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D005268 2002
% 209.74/209.95  |- skos__scopeNote mesh__D005268
% 209.74/209.95       The vein accompanying the femoral artery in the same sheath; it is a continuation of the popliteal vein and becomes the external iliac vein.%A%    
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D005268 1993
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D005268 1994
% 209.74/209.95  |- skos__broader mesh__D005268smesh__D014680
% 209.74/209.95  |- skos__prefLabel mesh__D005268 Femoral Vein
% 209.74/209.95  |- skos__hiddenLabel mesh__D005268 Femoral Veins
% 209.74/209.95  |- mesh__recordOriginator mesh__D005268 NLM
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D005268 1999
% 209.74/209.95  |- mesh__recordMaintainer mesh__D005268 TAP
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D005268 2006
% 209.74/209.95  |- mesh__dateRevised mesh__D005268 1992-05-15
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D005268 2001
% 209.74/209.95  |- mesh__dateCreated mesh__D005268 1999-01-01
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D005268 1998
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D005268 1997
% 209.74/209.95  |- skos__altLabel mesh__D024422 Aneugenic Agents
% 209.74/209.95  |- skos__hiddenLabel mesh__D024422 Polyploidy Inducing Agents
% 209.74/209.95  |- skos__hiddenLabel mesh__D024422 Aneuploidy Inducing Agents
% 209.74/209.95  |- skos__scopeNote mesh__D024422
% 209.74/209.95       Agents which affect CELL DIVISION and the MITOTIC SPINDLE APPARATUS resulting in the loss or gain of whole CHROMOSOMES, thereby inducing an ANEUPLOIDY.%A%    
% 209.74/209.95  |- skos__broader mesh__D024422smesh__D009153
% 209.74/209.95  |- skos__historyNote mesh__D024422 Aneuploidy %28%1989-2001%29%
% 209.74/209.95  |- skos__hiddenLabel mesh__D024422 Agents, Polyploidy-Inducing
% 209.74/209.95  |- skos__historyNote mesh__D024422 Mutagens %28%1988-2001%29%
% 209.74/209.95  |- skos__hiddenLabel mesh__D024422 Agents, Aneugenic
% 209.74/209.95  |- mesh__dateCreated mesh__D024422 2001-07-25
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D024422 2004
% 209.74/209.95  |- mesh__publicMeSHNote mesh__D024422 2002   
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D024422 2005
% 209.74/209.95  |- mesh__historyNote mesh__D024422 2002   
% 209.74/209.95  |- skos__related mesh__D024422smesh__D000782
% 209.74/209.95  |- skos__altLabel mesh__D024422 Aneuploidy-Inducing Agents
% 209.74/209.95  |- mesh__dateRevised mesh__D024422 2003-07-09
% 209.74/209.95  |- mesh__dateEstablished mesh__D024422 2002-01-01
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D024422 2006
% 209.74/209.95  |- skos__prefLabel mesh__D024422 Aneugens
% 209.74/209.95  |- skos__hiddenLabel mesh__D024422 Agents, Aneuploidy-Inducing
% 209.74/209.95  |- rdf__type mesh__D024422sskos__Concept
% 209.74/209.95  |- rdf__type mesh__D010402sskos__Concept
% 209.74/209.95  |- skos__hiddenLabel mesh__D010402 Procaine, Penicillin G
% 209.74/209.95  |- skos__hiddenLabel mesh__D010402 Penicillin, Procaine
% 209.74/209.95  |- skos__broader mesh__D010402smesh__D011343
% 209.74/209.95  |- skos__hiddenLabel mesh__D010402 Procaine Penicillin G
% 209.74/209.95  |- skos__altLabel mesh__D010402 Benzylpenicillin Procaine
% 209.74/209.95  |- mesh__publicMeSHNote mesh__D010402
% 209.74/209.95       91; was see under PENICILLIN G 1985-90; was heading 1963-84%A%  
% 209.74/209.95  |- skos__broader mesh__D010402smesh__D010400
% 209.74/209.95  |- mesh__dateEstablished mesh__D010402 1991-01-01
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D010402 2005
% 209.74/209.95  |- skos__altLabel mesh__D010402 Penicillin G Procaine
% 209.74/209.95  |- skos__altLabel mesh__D010402 Procaine Penicillin
% 209.74/209.95  |- skos__hiddenLabel mesh__D010402 Procaine, Benzylpenicillin
% 209.74/209.95  |- mesh__recordAuthorizer mesh__D010402 sjn
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D010402 2006
% 209.74/209.95  |- mesh__recordOriginator mesh__D010402 NLM
% 209.74/209.95  |- mesh__historyNote mesh__D010402
% 209.74/209.95       91%28%85%29%63; was see under PENICILLIN G 1985-90; was heading 1963-84%A%  
% 209.74/209.95  |- skos__scopeNote mesh__D010402
% 209.74/209.95       Semisynthetic antibiotic prepared by combining penicillin G with PROCAINE.%A%    
% 209.74/209.95  |- skos__hiddenLabel mesh__D010402 G Procaine, Penicillin
% 209.74/209.95  |- skos__prefLabel mesh__D010402 Penicillin G, Procaine
% 209.74/209.95  |- mesh__dateCreated mesh__D010402 1999-01-01
% 209.74/209.95  |- mesh__dateRevised mesh__D010402 2004-07-07
% 209.74/209.95  |- mesh__recordMaintainer mesh__D010402 ssb
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D051819 2006
% 209.74/209.95  |- mesh__historyNote mesh__D051819 2006%28%1992%29%   
% 209.74/209.95  |- mesh__recordOriginator mesh__D051819 DRC
% 209.74/209.95  |- skos__scopeNote mesh__D051819
% 209.74/209.95       A ubiquitously expressed sequence-specific transcriptional repressor that is normally the target of signaling by NOTCH PROTEINS.%A%    
% 209.74/209.95  |- skos__hiddenLabel mesh__D051819
% 209.74/209.95       Immunoglobulin J Recombination Signal Sequence Binding Protein
% 209.74/209.95  |- skos__altLabel mesh__D051819 RBP-Jkappa Protein
% 209.74/209.95  |- rdf__type mesh__D051819sskos__Concept
% 209.74/209.95  |- skos__hiddenLabel mesh__D051819 RBP Jkappa Protein
% 209.74/209.95  |- mesh__recordAuthorizer mesh__D051819 sjn
% 209.74/209.95  |- skos__hiddenLabel mesh__D051819 C Promotor Binding Factor 1
% 209.74/209.95  |- mesh__dateEstablished mesh__D051819 2006-01-01
% 209.74/209.95  |- skos__altLabel mesh__D051819 Recombination Binding Protein J
% 209.74/209.95  |- mesh__dateCreated mesh__D051819 2005-06-30
% 209.74/209.95  |- skos__broader mesh__D051819smesh__D009687
% 209.74/209.95  |- skos__broader mesh__D051819smesh__D014157
% 209.74/209.95  |- skos__prefLabel mesh__D051819
% 209.74/209.95       Immunoglobulin J Recombination Signal Sequence-Binding Protein
% 209.74/209.95  |- mesh__publicMeSHNote mesh__D051819
% 209.74/209.95       2006; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS 1992-2005%A%  
% 209.74/209.95  |- mesh__recordMaintainer mesh__D051819 DRC
% 209.74/209.95  |- skos__broader mesh__D051819smesh__D004268
% 209.74/209.95  |- skos__altLabel mesh__D051819 C-Promotor-Binding Factor 1
% 209.74/209.95  |- mesh__dateEstablished mesh__D015696 1991-01-01
% 209.74/209.95  |- skos__altLabel mesh__D015696 Gene Product, tat
% 209.74/209.95  |- skos__hiddenLabel mesh__D015696 Trans Acting Transcription Factor, HIV
% 209.74/209.95  |- skos__hiddenLabel mesh__D015696 Products, tat Gene
% 209.74/209.95  |- skos__historyNote mesh__D015696 Transcription Factors %28%1988-1989%29%
% 209.74/209.95  |- skos__altLabel mesh__D015696 tat Gene Products
% 209.74/209.95  |- skos__broader mesh__D015696smesh__D015534
% 209.74/209.95  |- rdf__type mesh__D015696sskos__Concept
% 209.74/209.95  |- skos__hiddenLabel mesh__D015696 tat Gene Product
% 209.74/209.95  |- mesh__dateCreated mesh__D015696 1989-07-07
% 209.74/209.95  |- mesh__recordAuthorizer mesh__D015696 sjn
% 209.74/209.95  |- skos__scopeNote mesh__D015696
% 209.74/209.95       Trans-acting transcription factors. Nuclear proteins whose expression is required for HIV viral replication. The tat protein stimulates HIV-LTR-driven RNA synthesis for both viral regulatory and viral structural proteins. tat stands for trans-activation of transcription.%A%    
% 209.74/209.95  |- skos__annotation mesh__D015696
% 209.74/209.95       Tat stands for %22%trans-activation of transcription%22%; IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 209.74/209.95  |- skos__hiddenLabel mesh__D015696 Product, tat Gene
% 209.74/209.95  |- mesh__recordOriginator mesh__D015696 AGS
% 209.74/209.95  |- skos__hiddenLabel mesh__D015696 Protein, tat
% 209.74/209.95  |- skos__prefLabel mesh__D015696 Gene Products, tat
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D015696 2006
% 209.74/209.95  |- skos__hiddenLabel mesh__D015696 Protein, HIV tat
% 209.74/209.95  |- mesh__recordMaintainer mesh__D015696 SYSTEM
% 209.74/209.95  |- mesh__publicMeSHNote mesh__D015696
% 209.74/209.95       91; was see under TRANS-ACTIVATORS 1990   
% 209.74/209.95  |- mesh__dateRevised mesh__D015696 2005-06-30
% 209.74/209.95  |- mesh__historyNote mesh__D015696
% 209.74/209.95       91%28%90%29%; was see under TRANS-ACTIVATORS 1990   
% 209.74/209.95  |- skos__hiddenLabel mesh__D015696 tat Protein, HIV
% 209.74/209.95  |- skos__broader mesh__D009659smesh__D001267
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D009659 1996
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D009659 2006
% 209.74/209.95  |- mesh__dateCreated mesh__D009659 1986-04-02
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D009659 1997
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D009659 2002
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D009659 1994
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D009659 2003
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D009659 1995
% 209.74/209.95  |- mesh__recordOriginator mesh__D009659 RC
% 209.74/209.95  |- mesh__dateEstablished mesh__D009659 1987-01-01
% 209.74/209.95  |- rdf__type mesh__D009659sskos__Concept
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D009659 2004
% 209.74/209.95  |- mesh__historyNote mesh__D009659 87   
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D009659 1998
% 209.74/209.95  |- mesh__recordAuthorizer mesh__D009659 PLS
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D009659 2000
% 209.74/209.95  |- skos__annotation mesh__D009659 no qualif   
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D009659 1999
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D009659 2001
% 209.74/209.95  |- skos__prefLabel mesh__D009659 North Sea
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D009659 1993
% 209.74/209.95  |- mesh__recordMaintainer mesh__D009659 TGC
% 209.74/209.95  |- mesh__dateRevised mesh__D009659 1992-05-15
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D009659 2005
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D001676 2006
% 209.74/209.95  |- skos__broader mesh__D001676smesh__D026441
% 209.74/209.95  |- mesh__recordMaintainer mesh__D001676 sjn
% 209.74/209.95  |- skos__broader mesh__D001676smesh__D011613
% 209.74/209.95  |- rdf__type mesh__D001676sskos__Concept
% 209.74/209.95  |- skos__altLabel mesh__D001676 Psychophysiologic Feedback
% 209.74/209.95  |- skos__prefLabel mesh__D001676 Biofeedback %28%Psychology%29%
% 209.74/209.95  |- skos__broader mesh__D001676smesh__D001521
% 209.74/209.95  |- mesh__publicMeSHNote mesh__D001676 77   
% 209.74/209.95  |- mesh__dateRevised mesh__D001676 2004-07-13
% 209.74/209.95  |- skos__hiddenLabel mesh__D001676 Biofeedbacks %28%Psychology%29%
% 209.74/209.95  |- mesh__recordAuthorizer mesh__D001676 sjn
% 209.74/209.95  |- mesh__recordOriginator mesh__D001676 EC
% 209.74/209.95  |- mesh__historyNote mesh__D001676 77   
% 209.74/209.95  |- mesh__dateEstablished mesh__D001676 1977-01-01
% 209.74/209.95  |- skos__altLabel mesh__D001676 Biofeedback
% 209.74/209.95  |- skos__scopeNote mesh__D001676
% 209.74/209.95       Process by which a person uses biofeedback information to gain voluntary control over processes or functions which are primarily under autonomic control. It is used in experimental or treatment settings with human subjects. %28%From APA Thesaurus of Psychological Terms, 8th ed%29%%A%    
% 209.74/209.95  |- skos__altLabel mesh__D001676 Feedback, Psychophysiologic
% 209.74/209.95  |- mesh__dateCreated mesh__D001676 1976-04-16
% 209.74/209.95  |- skos__altLabel mesh__D001676 Feedback, Psychophysiological
% 209.74/209.95  |- skos__broader mesh__D001676smesh__D011603
% 209.74/209.95  |- skos__annotation mesh__D001676
% 209.74/209.95       differentiate from FEEDBACK as a physiol concept %28%G%29% %26% as an information concept %28%L%29%; DF: BIOFEEDBACK%A%  
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D001676 2005
% 209.74/209.95  |- skos__historyNote mesh__D001676 Feedback %28%1966-1976%29%
% 209.74/209.95  |- skos__annotation mesh__D020830 DF: RAC1 PROTEIN   
% 209.74/209.95  |- skos__prefLabel mesh__D020830 rac1 GTP-Binding Protein
% 209.74/209.95  |- skos__hiddenLabel mesh__D020830 TC 25 GTP Binding Protein
% 209.74/209.95  |- skos__hiddenLabel mesh__D020830 GTP-Binding Protein, TC-25
% 209.74/209.95  |- mesh__dateCreated mesh__D020830 1999-11-03
% 209.74/209.95  |- mesh__dateRevised mesh__D020830 2005-06-30
% 209.74/209.95  |- skos__hiddenLabel mesh__D020830
% 209.74/209.95       ras Related C3 Botulinum Toxin Substrate 1
% 209.74/209.95  |- skos__historyNote mesh__D020830 G-Proteins %28%1991-1999%29%
% 209.74/209.95  |- mesh__publicMeSHNote mesh__D020830
% 209.74/209.95       2000; RAC1 GENE PRODUCT was indexed under G-PROTEINS 1991-1999 %26% PROTEINS 1989-1990%A%  
% 209.74/209.95  |- mesh__recordAuthorizer mesh__D020830 sjn
% 209.74/209.95  |- skos__altLabel mesh__D020830 TC-25 GTP-Binding Protein
% 209.74/209.95  |- skos__broader mesh__D020830smesh__D020744
% 209.74/209.95  |- skos__altLabel mesh__D020830 ras-Related C3 Botulinum Toxin Substrate 1
% 209.74/209.95  |- rdf__type mesh__D020830sskos__Concept
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D020830 2006
% 209.74/209.95  |- mesh__recordOriginator mesh__D020830 jmp
% 209.74/209.95  |- skos__hiddenLabel mesh__D020830 rac1 GTP Binding Protein
% 209.74/209.95  |- skos__hiddenLabel mesh__D020830 GTP-Binding Protein, rac1
% 209.74/209.95  |- mesh__dateEstablished mesh__D020830 2000-01-01
% 209.74/209.95  |- mesh__historyNote mesh__D020830
% 209.74/209.95       2000; for RAC1 GENE PRODUCT use RAC GTP-BINDING PROTEINS %28%NM%29% 1989-1999%A%  
% 209.74/209.95  |- skos__altLabel mesh__D020830 rac1 Protein
% 209.74/209.95  |- mesh__recordMaintainer mesh__D020830 jmp
% 209.74/209.95  |- skos__scopeNote mesh__D020830
% 209.74/209.95       A rac GTP-binding protein involved in regulating actin filaments at the plasma membrane. It controls the development of filopodia and lamellipodia in cells and thereby influences cellular motility and adhesion. It is also involved in activation of NADPH OXIDASE. This enzyme was formerly listed as EC 3.6.1.47.%A%    
% 209.74/209.95  |- skos__broader mesh__D006361smesh__D004780
% 209.74/209.95  |- mesh__recordOriginator mesh__D006361 NLM
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D006361 1996
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D006361 2003
% 209.74/209.95  |- skos__scopeNote mesh__D006361
% 209.74/209.95       The application of heat to raise the temperature of the environment, ambient or local, or the systems for accomplishing this effect. It is distinguished from HEAT, the physical property and principle of physics.%A%    
% 209.74/209.95  |- rdf__type mesh__D006361sskos__Concept
% 209.74/209.95  |- skos__annotation mesh__D006361
% 209.74/209.95       the environment: differentiate from HEAT, the principle of physics; /adv eff permitted but do not confuse with HEAT /adv eff%A%  
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D006361 2002
% 209.74/209.95  |- skos__prefLabel mesh__D006361 Heating
% 209.74/209.95  |- mesh__dateCreated mesh__D006361 1999-01-01
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D006361 1999
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D006361 2006
% 209.74/209.95  |- mesh__dateRevised mesh__D006361 1995-05-18
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D006361 2001
% 209.74/209.95  |- mesh__recordAuthorizer mesh__D006361 PLS
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D006361 1998
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D006361 2000
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D006361 2005
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D006361 1997
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D006361 2004
% 209.74/209.95  |- mesh__recordMaintainer mesh__D006361 TGC
% 209.74/209.95  |- skos__broader mesh__D020032smesh__D001597
% 209.74/209.95  |- skos__prefLabel mesh__D020032 Tyrphostins
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D020032 2003
% 209.74/209.95  |- mesh__dateCreated mesh__D020032 1998-06-11
% 209.74/209.95  |- skos__historyNote mesh__D020032 Benzylidene Compounds %28%1989-1998%29%
% 209.74/209.95  |- mesh__historyNote mesh__D020032 99   
% 209.74/209.95  |- skos__historyNote mesh__D020032
% 209.74/209.95       Protein-Tyrosine Kinase/antagonists %26% inhibitors %28%1989-1998%29%
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D020032 2002
% 209.74/209.95  |- skos__scopeNote mesh__D020032
% 209.74/209.95       A family of synthetic protein tyrosine kinase inhibitors. They selectively inhibit receptor autophosphorylation and are used to study receptor function.%A%    
% 209.74/209.95  |- mesh__publicMeSHNote mesh__D020032 99   
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D020032 1999
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D020032 2006
% 209.74/209.95  |- rdf__type mesh__D020032sskos__Concept
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D020032 2001
% 209.74/209.95  |- skos__historyNote mesh__D020032 Nitriles %28%1989-1998%29%
% 209.74/209.95  |- skos__broader mesh__D020032smesh__D009570
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D020032 2005
% 209.74/209.95  |- skos__broader mesh__D020032smesh__D011810
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D020032 2000
% 209.74/209.95  |- mesh__dateEstablished mesh__D020032 1999-01-01
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D020032 2004
% 209.74/209.95  |- skos__prefLabel mesh__D019289 Pyruvic Acid
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D019289 2000
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D019289 1997
% 209.74/209.95  |- rdf__type mesh__D019289sskos__Concept
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D019289 2006
% 209.74/209.95  |- skos__historyNote mesh__D019289 Pyruvates %28%1981-1996%29%
% 209.74/209.95  |- mesh__dateCreated mesh__D019289 1996-06-10
% 209.74/209.95  |- mesh__publicMeSHNote mesh__D019289
% 209.74/209.95       97; PYRUVIC ACID was indexed under PYRUVATES 1981-96   
% 209.74/209.95  |- mesh__historyNote mesh__D019289
% 209.74/209.95       97; was PYRUVIC ACID %28%NM%29% 1981-96   
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D019289 2005
% 209.74/209.95  |- skos__scopeNote mesh__D019289
% 209.74/209.95       An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. %28%From Stedman, 26th ed%29%%A%    
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D019289 2002
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D019289 1999
% 209.74/209.95  |- skos__annotation mesh__D019289
% 209.74/209.95       do not confuse X ref PYRUVATE with PYRUVATES   
% 209.74/209.95  |- skos__broader mesh__D019289smesh__D011773
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D019289 2004
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D019289 1998
% 209.74/209.95  |- mesh__onlineNote mesh__D019289
% 209.74/209.95       use PYRUVIC ACID %28%NM%29% to search PYRUVIC ACID 1981-96   
% 209.74/209.95  |- skos__hiddenLabel mesh__D019289 Acid, Pyruvic
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D019289 2001
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D019289 2003
% 209.74/209.95  |- mesh__dateEstablished mesh__D019289 1997-01-01
% 209.74/209.95  |- mesh__dateRevised mesh__D005269 2005-06-30
% 209.74/209.95  |- mesh__recordMaintainer mesh__D005269 ags
% 209.74/209.95  |- skos__annotation mesh__D005269
% 209.74/209.95       fractures: FEMORAL FRACTURES %26% FEMORAL NECK FRACTURES are available but see note under HIP FRACTURES; do not index under FEMUR when THIGH is meant: see note there%A%  
% 209.74/209.95  |- rdf__type mesh__D005269sskos__Concept
% 209.74/209.95  |- skos__hiddenLabel mesh__D005269 Trochanters
% 209.74/209.95  |- skos__prefLabel mesh__D005269 Femur
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D005269 2006
% 209.74/209.95  |- mesh__dateCreated mesh__D005269 1999-01-01
% 209.74/209.95  |- mesh__recordAuthorizer mesh__D005269 sjn
% 209.74/209.95  |- skos__hiddenLabel mesh__D005269 Femurs
% 209.74/209.95  |- skos__scopeNote mesh__D005269
% 209.74/209.95       The longest and largest bone of the skeleton, it is situated between the hip and the knee.%A%    
% 209.74/209.95  |- skos__broader mesh__D005269smesh__D007867
% 209.74/209.95  |- mesh__recordOriginator mesh__D005269 NLM
% 209.74/209.95  |- skos__hiddenLabel mesh__D010403 Resistances, Penicillin
% 209.74/209.95  |- mesh__publicMeSHNote mesh__D010403 64   
% 209.74/209.95  |- mesh__recordMaintainer mesh__D010403 ssb
% 209.74/209.95  |- skos__scopeNote mesh__D010403
% 209.74/209.95       Nonsusceptibility of an organism to the action of penicillins.%A%    
% 209.74/209.95  |- mesh__dateRevised mesh__D010403 2003-07-09
% 209.74/209.95  |- skos__hiddenLabel mesh__D010403 Penicillin Resistances
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D010403 2005
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D010403 2006
% 209.74/209.95  |- mesh__dateEstablished mesh__D010403 1964-01-01
% 209.74/209.95  |- skos__broader mesh__D010403smesh__D018440
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D010403 2004
% 209.74/209.95  |- skos__prefLabel mesh__D010403 Penicillin Resistance
% 209.74/209.95  |- skos__hiddenLabel mesh__D010403 Resistance, Penicillin
% 209.74/209.95  |- mesh__dateCreated mesh__D010403 1999-01-01
% 209.74/209.95  |- mesh__historyNote mesh__D010403 64   
% 209.74/209.95  |- rdf__type mesh__D010403sskos__Concept
% 209.74/209.95  |- mesh__recordAuthorizer mesh__D010403 sjn
% 209.74/209.95  |- mesh__recordOriginator mesh__D010403 NLM
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D020831 2004
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D020831 2005
% 209.74/209.95  |- mesh__historyNote mesh__D020831 2000   
% 209.74/209.95  |- skos__historyNote mesh__D020831 Acupuncture Therapy %28%1989-1999%29%
% 209.74/209.95  |- rdf__type mesh__D020831sskos__Concept
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D020831 2006
% 209.74/209.95  |- skos__broader mesh__D020831smesh__D015670
% 209.74/209.95  |- skos__prefLabel mesh__D020831 Acupuncture, Ear
% 209.74/209.95  |- skos__altLabel mesh__D020831 Auricular Acupuncture
% 209.74/209.95  |- skos__hiddenLabel mesh__D020831 Auricular Acupunctures
% 209.74/209.95  |- skos__hiddenLabel mesh__D020831 Acupunctures, Ear
% 209.74/209.95  |- skos__altLabel mesh__D020831 Ear Acupuncture
% 209.74/209.95  |- mesh__dateCreated mesh__D020831 1999-11-03
% 209.74/209.95  |- skos__hiddenLabel mesh__D020831 Ear Acupunctures
% 209.74/209.95  |- mesh__dateEstablished mesh__D020831 2000-01-01
% 209.74/209.95  |- mesh__dateRevised mesh__D020831 2002-07-02
% 209.74/209.95  |- skos__historyNote mesh__D020831 Acupuncture %28%1972-1990%29%
% 209.74/209.95  |- mesh__recordAuthorizer mesh__D020831 sjn
% 209.74/209.95  |- mesh__recordOriginator mesh__D020831 ags
% 209.74/209.95  |- skos__scopeNote mesh__D020831
% 209.74/209.95       Acupuncture therapy by inserting needles in the ear. It is used to control pain and for treating various ailments.%A%    
% 209.74/209.95  |- mesh__recordMaintainer mesh__D020831 ags
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D020831 2003
% 209.74/209.95  |- skos__hiddenLabel mesh__D020831 Acupunctures, Auricular
% 209.74/209.95  |- skos__altLabel mesh__D020831 Acupuncture, Auricular
% 209.74/209.95  |- mesh__publicMeSHNote mesh__D020831 2000   
% 209.74/209.95  |- rdf__type mesh__D006362sskos__Concept
% 209.74/209.95  |- skos__hiddenLabel mesh__D006362 mu Chain Disease
% 209.74/209.95  |- skos__prefLabel mesh__D006362 Heavy Chain Disease
% 209.74/209.95  |- skos__related mesh__D006362smesh__D007143
% 209.74/209.95  |- skos__hiddenLabel mesh__D006362 Franklins Disease
% 209.74/209.95  |- skos__altLabel mesh__D006362 Franklin%27%s Disease
% 209.74/209.95  |- skos__hiddenLabel mesh__D006362 Heavy Chain Diseases
% 209.74/209.95  |- mesh__dateEstablished mesh__D006362 1966-01-01
% 209.74/209.95  |- mesh__dateRevised mesh__D006362 2005-07-01
% 209.74/209.95  |- skos__hiddenLabel mesh__D006362 gamma Chain Disease
% 209.74/209.95  |- mesh__recordOriginator mesh__D006362 NLM
% 209.74/209.95  |- skos__broader mesh__D006362smesh__D008232
% 209.74/209.95  |- mesh__publicMeSHNote mesh__D006362 66   
% 209.74/209.95  |- mesh__dateCreated mesh__D006362 1999-01-01
% 209.74/209.95  |- skos__scopeNote mesh__D006362
% 209.74/209.95       A disorder of immunoglobulin synthesis in which large quantities of abnormal heavy chains are excreted in the urine. The amino acid sequences of the N-%28%amino-%29% terminal regions of these chains are normal, but they have a deletion extending from part of the variable domain through the first domain of the constant region, so that they cannot form cross-links to the light chains. The defect arises through faulty coupling of the variable %28%V%29% and constant %28%C%29% region genes.%A%    
% 209.74/209.95  |- skos__hiddenLabel mesh__D006362 mu-Chain Diseases
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D006362 2006
% 209.74/209.95  |- skos__broader mesh__D006362smesh__D010265
% 209.74/209.95  |- mesh__recordAuthorizer mesh__D006362 sjn
% 209.74/209.95  |- mesh__historyNote mesh__D006362 66%28%64%29%   
% 209.74/209.95  |- skos__altLabel mesh__D006362 Franklin Disease
% 209.74/209.95  |- skos__annotation mesh__D006362
% 209.74/209.95       specify the immunoglobulin fragment coord NIM, as gamma chain dis = HEAVY CHAIN DISEASE %28%IM%29% + IMMUNOGLOBULIN GAMMA-CHAINS %28%NIM%29%; ALPHA-CHAIN DISEASE see IMMUNOPROLIFERATIVE SMALL INTESTINAL DISEASE is available%A%  
% 209.74/209.95  |- skos__hiddenLabel mesh__D006362 gamma-Chain Diseases
% 209.74/209.95  |- mesh__recordMaintainer mesh__D006362 sjn
% 209.74/209.95  |- mesh__dateEstablished mesh__D020033 1999-01-01
% 209.74/209.95  |- skos__prefLabel mesh__D020033 Protein Isoforms
% 209.74/209.95  |- mesh__publicMeSHNote mesh__D020033 99   
% 209.74/209.95  |- rdf__type mesh__D020033sskos__Concept
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D020033 2006
% 209.74/209.95  |- skos__altLabel mesh__D020033 Isoforms
% 209.74/209.95  |- skos__scopeNote mesh__D020033
% 209.74/209.95       Different forms of a protein that may be produced from different genes, or from the same gene by alternative splicing.%A%    
% 209.74/209.95  |- mesh__recordOriginator mesh__D020033 NNS
% 209.74/209.95  |- skos__hiddenLabel mesh__D020033 Isoforms, Protein
% 209.74/209.95  |- mesh__historyNote mesh__D020033 99   
% 209.74/209.95  |- mesh__dateRevised mesh__D020033 2001-07-25
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D020033 2005
% 209.74/209.95  |- mesh__activeMeSHYear mesh__D020033 2002
% 209.74/209.95  |- skos__annotation mesh__D020033
% 209.74/209.95       IM general only; coord NIM with specific protein %28%IM%29%; for enzymes use ISOENZYMES%A%  
% 209.74/209.95  |- mesh__dateCreated mesh__D020033 1998-06-10
% 209.74/209.96  |- skos__broader mesh__D020033smesh__D011506
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D020033 2004
% 209.74/209.96  |- mesh__recordAuthorizer mesh__D020033 sjn
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D020033 2003
% 209.74/209.96  |- mesh__recordMaintainer mesh__D020033 nns
% 209.74/209.96  |- mesh__historyNote mesh__D016790 92   
% 209.74/209.96  |- skos__prefLabel mesh__D016790 Plasmodium knowlesi
% 209.74/209.96  |- mesh__recordMaintainer mesh__D016790 ags
% 209.74/209.96  |- mesh__recordAuthorizer mesh__D016790 sjn
% 209.74/209.96  |- mesh__dateRevised mesh__D016790 2003-07-09
% 209.74/209.96  |- skos__annotation mesh__D016790
% 209.74/209.96       in monkeys; infection: coord IM with MALARIA %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 209.74/209.96  |- mesh__publicMeSHNote mesh__D016790 92   
% 209.74/209.96  |- mesh__recordOriginator mesh__D016790 PXP
% 209.74/209.96  |- mesh__dateCreated mesh__D016790 1991-05-02
% 209.74/209.96  |- skos__scopeNote mesh__D016790
% 209.74/209.96       A protozoan parasite from Southeast Asia that causes monkey malaria. It is naturally acquired by man in Malaysia and can also be transmitted experimentally to humans.%A%    
% 209.74/209.96  |- mesh__dateEstablished mesh__D016790 1992-01-01
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D016790 2006
% 209.74/209.96  |- skos__historyNote mesh__D016790 Plasmodium %28%1966-1991%29%
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D016790 2004
% 209.74/209.96  |- skos__broader mesh__D016790smesh__D010961
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D016790 2005
% 209.74/209.96  |- rdf__type mesh__D016790sskos__Concept
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002770 1995
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002770 1998
% 209.74/209.96  |- skos__scopeNote mesh__D002770
% 209.74/209.96       Unsaturated derivatives of cholane with methyl groups at C-10 and C-13 and a branched five-carbon chain at C-17. They must have at least one double bond in the ring system.%A%    
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002770 1994
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002770 2002
% 209.74/209.96  |- skos__historyNote mesh__D002770 Cholanes %28%1968-1974%29%
% 209.74/209.96  |- skos__broader mesh__D002770smesh__D002757
% 209.74/209.96  |- mesh__recordMaintainer mesh__D002770 PLS
% 209.74/209.96  |- skos__prefLabel mesh__D002770 Cholenes
% 209.74/209.96  |- rdf__type mesh__D002770sskos__Concept
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002770 2004
% 209.74/209.96  |- mesh__onlineNote mesh__D002770 search CHOLANES 1973-74   
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002770 1997
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002770 2003
% 209.74/209.96  |- mesh__recordAuthorizer mesh__D002770 PLS
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002770 2001
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002770 1996
% 209.74/209.96  |- mesh__dateRevised mesh__D002770 1993-06-03
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002770 2006
% 209.74/209.96  |- skos__annotation mesh__D002770
% 209.74/209.96       do not confuse with CHOLANES or CHOLINE; includes choladienes, cholatrienes%A%  
% 209.74/209.96  |- mesh__historyNote mesh__D002770 75; was see under CHOLANES 1973-74   
% 209.74/209.96  |- mesh__recordOriginator mesh__D002770 NLM
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002770 1999
% 209.74/209.96  |- mesh__dateCreated mesh__D002770 1999-01-01
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002770 2005
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002770 2000
% 209.74/209.96  |- mesh__dateEstablished mesh__D002770 1975-01-01
% 209.74/209.96  |- mesh__publicMeSHNote mesh__D002770 75; was see under CHOLANES 1973-74   
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D010404 2006
% 209.74/209.96  |- skos__hiddenLabel mesh__D010404 Penicillin Berromycin
% 209.74/209.96  |- skos__hiddenLabel mesh__D010404 Penicillin Beromycin
% 209.74/209.96  |- skos__altLabel mesh__D010404 Phenoxymethylpenicillin
% 209.74/209.96  |- mesh__recordAuthorizer mesh__D010404 sjn
% 209.74/209.96  |- mesh__onlineNote mesh__D010404
% 209.74/209.96       use PENICILLIN V to search PENICILLIN, PHENOXYMETHYL 1966-91; use PENICILLIN V/AA to search PROPICILLIN 1966-84 %28%as Prov 1966-72%29%%A%  
% 209.74/209.96  |- mesh__dateCreated mesh__D010404 1999-01-01
% 209.74/209.96  |- mesh__dateRevised mesh__D010404 2004-07-07
% 209.74/209.96  |- skos__hiddenLabel mesh__D010404 V Cillin K
% 209.74/209.96  |- mesh__recordOriginator mesh__D010404 NLM
% 209.74/209.96  |- skos__altLabel mesh__D010404 Beromycin, Penicillin
% 209.74/209.96  |- rdf__type mesh__D010404sskos__Concept
% 209.74/209.96  |- skos__altLabel mesh__D010404 Penicillin, Phenoxymethyl
% 209.74/209.96  |- skos__altLabel mesh__D010404 Fenoxymethylpenicillin
% 209.74/209.96  |- skos__hiddenLabel mesh__D010404 Phenoxymethyl Penicillin
% 209.74/209.96  |- mesh__recordMaintainer mesh__D010404 ssb
% 209.74/209.96  |- skos__altLabel mesh__D010404 Berromycin, Penicillin
% 209.74/209.96  |- mesh__publicMeSHNote mesh__D010404
% 209.74/209.96       92; was PENICILLIN, PHENOXYMETHYL 1963-91; PENICILLIN V was see PENICILLIN, PHENOXYMETHYL 1963-91; PROPICILLIN was heading 1973-84%A%  
% 209.74/209.96  |- skos__hiddenLabel mesh__D010404 Sodium, Penicillin V
% 209.74/209.96  |- skos__hiddenLabel mesh__D010404 Potassium, Penicillin V
% 209.74/209.96  |- skos__hiddenLabel mesh__D010404 VCillin K
% 209.74/209.96  |- skos__scopeNote mesh__D010404
% 209.74/209.96       A broad-spectrum penicillin antibiotic used orally in the treatment of mild to moderate infections by susceptible gram-positive organisms.%A%    
% 209.74/209.96  |- mesh__historyNote mesh__D010404
% 209.74/209.96       92; was PENICILLIN, PHENOXYMETHYL 1963-91; PENICILLIN V was see PENICILLIN, PHENOXYMETHYL 1963-91; PROPICILLIN was heading 1964-84 %28%Prov 1964-72%29%%A%  
% 209.74/209.96  |- skos__hiddenLabel mesh__D010404 V Sodium, Penicillin
% 209.74/209.96  |- skos__altLabel mesh__D010404 Penicillin VK
% 209.74/209.96  |- skos__prefLabel mesh__D010404 Penicillin V
% 209.74/209.96  |- skos__broader mesh__D010404smesh__D010406
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D010404 2005
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D015698 2006
% 209.74/209.96  |- skos__altLabel mesh__D015698 Genome Library
% 209.74/209.96  |- skos__hiddenLabel mesh__D015698 Library, Genome
% 209.74/209.96  |- mesh__recordAuthorizer mesh__D015698 sjn
% 209.74/209.96  |- mesh__recordOriginator mesh__D015698 PXP
% 209.74/209.96  |- mesh__recordMaintainer mesh__D015698 NLM
% 209.74/209.96  |- skos__related mesh__D015698smesh__D018244
% 209.74/209.96  |- mesh__dateRevised mesh__D015698 2002-07-03
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D015698 2003
% 209.74/209.96  |- skos__hiddenLabel mesh__D015698 Library, Genomic
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D015698 2005
% 209.74/209.96  |- skos__related mesh__D015698smesh__D004274
% 209.74/209.96  |- skos__hiddenLabel mesh__D015698 Genomic Libraries
% 209.74/209.96  |- mesh__dateEstablished mesh__D015698 1990-01-01
% 209.74/209.96  |- mesh__dateCreated mesh__D015698 1989-06-06
% 209.74/209.96  |- skos__annotation mesh__D015698
% 209.74/209.96       a form of gene library containing complete DNA seq; no qualif%A%  
% 209.74/209.96  |- skos__hiddenLabel mesh__D015698 Genome Libraries
% 209.74/209.96  |- skos__scopeNote mesh__D015698
% 209.74/209.96       A form of GENE LIBRARY containing the complete DNA sequences present in the genome of a given organism. It contrasts with a cDNA library which contains only sequences utilized in protein coding %28%lacking introns%29%.%A%    
% 209.74/209.96  |- skos__prefLabel mesh__D015698 Genomic Library
% 209.74/209.96  |- skos__broader mesh__D015698smesh__D015723
% 209.74/209.96  |- skos__broader mesh__D015698smesh__D016678
% 209.74/209.96  |- skos__historyNote mesh__D015698 Cloning, Molecular %28%1980-1989%29%
% 209.74/209.96  |- rdf__type mesh__D015698sskos__Concept
% 209.74/209.96  |- mesh__publicMeSHNote mesh__D015698 90   
% 209.74/209.96  |- skos__related mesh__D015698smesh__D016045
% 209.74/209.96  |- mesh__historyNote mesh__D015698 90   
% 209.74/209.96  |- skos__historyNote mesh__D015698
% 209.74/209.96       Nucleic Acid Hybridization %28%1980-1989%29%
% 209.74/209.96  |- skos__hiddenLabel mesh__D015698 Libraries, Genomic
% 209.74/209.96  |- skos__historyNote mesh__D015698
% 209.74/209.96       Molecular Sequence Data %28%1988-1989%29%
% 209.74/209.96  |- skos__historyNote mesh__D015698 Base Sequence %28%1980-1989%29%
% 209.74/209.96  |- skos__hiddenLabel mesh__D015698 Libraries, Genome
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D015698 2004
% 209.74/209.96  |- mesh__dateCreated mesh__D001678 1999-01-01
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D001678 2006
% 209.74/209.96  |- mesh__recordOriginator mesh__D001678 NLM
% 209.74/209.96  |- mesh__recordAuthorizer mesh__D001678 sjn
% 209.74/209.96  |- skos__hiddenLabel mesh__D001678 Biogeneses
% 209.74/209.96  |- rdf__type mesh__D001678sskos__Concept
% 209.74/209.96  |- skos__altLabel mesh__D001678 Origin of Life
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D001678 2005
% 209.74/209.96  |- skos__annotation mesh__D001678
% 209.74/209.96       see scope note; not for biogenesis of substances, organs, cells or subcellular elements%A%  
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D001678 2004
% 209.74/209.96  |- skos__prefLabel mesh__D001678 Biogenesis
% 209.74/209.96  |- skos__hiddenLabel mesh__D001678 Life Origin
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D001678 2003
% 209.74/209.96  |- skos__scopeNote mesh__D001678
% 209.74/209.96       The origin of life. It includes studies of the potential basis for life in organic compounds but excludes studies of the development of altered forms of life through mutation and natural selection, which is EVOLUTION.%A%    
% 209.74/209.96  |- mesh__recordMaintainer mesh__D001678 hjn
% 209.74/209.96  |- skos__broader mesh__D001678smesh__D001686
% 209.74/209.96  |- mesh__dateRevised mesh__D001678 2002-07-02
% 209.74/209.96  |- skos__hiddenLabel mesh__D001678 Life Origins
% 209.74/209.96  |- skos__broader mesh__D001921Q000736smesh__D001921
% 209.74/209.96  |- mesh__preferredCombination mesh__D001921Q000736smesh__D004453
% 209.74/209.96  |- rdf__type mesh__D001921Q000736smesh__CompoundConcept
% 209.74/209.96  |- mesh__recordAuthorizer mesh__D020832 sjn
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D020832 2006
% 209.74/209.96  |- mesh__dateRevised mesh__D020832 2004-07-07
% 209.74/209.96  |- mesh__publicMeSHNote mesh__D020832 2000   
% 209.74/209.96  |- mesh__recordMaintainer mesh__D020832 nns
% 209.74/209.96  |- skos__hiddenLabel mesh__D020832 Hands, EF
% 209.74/209.96  |- skos__scopeNote mesh__D020832
% 209.74/209.96       Calcium-binding motifs composed of two helixes %28%E and F%29% joined by a loop. Calcium is bound by the loop region. These motifs are found in many proteins that are regulated by calcium.%A%    
% 209.74/209.96  |- skos__hiddenLabel mesh__D020832 EF Hand
% 209.74/209.96  |- skos__altLabel mesh__D020832 EF Hands
% 209.74/209.96  |- skos__hiddenLabel mesh__D020832 Motif, EF Hand
% 209.74/209.96  |- mesh__dateEstablished mesh__D020832 2000-01-01
% 209.74/209.96  |- skos__prefLabel mesh__D020832 EF Hand Motifs
% 209.74/209.96  |- mesh__dateCreated mesh__D020832 1999-11-03
% 209.74/209.96  |- skos__broader mesh__D020832smesh__D018257
% 209.74/209.96  |- skos__hiddenLabel mesh__D020832 EF Hand Motif
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D020832 2005
% 209.74/209.96  |- mesh__recordOriginator mesh__D020832 nns
% 209.74/209.96  |- mesh__historyNote mesh__D020832 2000   
% 209.74/209.96  |- rdf__type mesh__D020832sskos__Concept
% 209.74/209.96  |- skos__hiddenLabel mesh__D020832 Hand, EF
% 209.74/209.96  |- skos__hiddenLabel mesh__D020832 Motifs, EF Hand
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D006363 1999
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D006363 2006
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D006363 2002
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D006363 1998
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D006363 2005
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D006363 2001
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D006363 1997
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D006363 2004
% 209.74/209.96  |- skos__prefLabel mesh__D006363 Hebrides
% 209.74/209.96  |- mesh__recordAuthorizer mesh__D006363 PLS
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D006363 2000
% 209.74/209.96  |- skos__broader mesh__D006363smesh__D006113
% 209.74/209.96  |- skos__annotation mesh__D006363 a group of islands west of Scotland   
% 209.74/209.96  |- skos__scopeNote mesh__D006363
% 209.74/209.96       A group of islands in the Atlantic Ocean west of Scotland, comprising the Outer Hebrides and the Inner Hebrides. They were the scene of frequent incursions of Scandinavian settlers from the 6th century A.D. They were ceded to Scotland by Norway in the 13th century. The origin of the name is uncertain. It is suggested that it is the result of a miscopying of the Roman name Ebudae or Hebudae with ri for u. %28%From Webster%27%s New Geographical Dictionary, 1988, p496 %26% Room, Brewer%27%s Dictionary of Names, 1992, p235%29%%A%    
% 209.74/209.96  |- mesh__recordMaintainer mesh__D006363 TGC
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D006363 1996
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D006363 2003
% 209.74/209.96  |- rdf__type mesh__D006363sskos__Concept
% 209.74/209.96  |- mesh__recordOriginator mesh__D006363 NLM
% 209.74/209.96  |- mesh__dateRevised mesh__D006363 1995-02-17
% 209.74/209.96  |- mesh__dateCreated mesh__D006363 1999-01-01
% 209.74/209.96  |- skos__scopeNote mesh__D020034
% 209.74/209.96       Synthetic organosiloxane gels that are formed from synthetic polymers of silicone oxide with organic sidechains %28%polydimethylsiloxane%29% by lengthening the polymer chains. Unlike silicone elastomers, they are not treated with amorphous silica. They are used as fillers in breast implants.%A%    
% 209.74/209.96  |- skos__broader mesh__D020034smesh__D012828
% 209.74/209.96  |- mesh__dateRevised mesh__D020034 2004-07-07
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D020034 2005
% 209.74/209.96  |- mesh__recordAuthorizer mesh__D020034 sjn
% 209.74/209.96  |- mesh__dateEstablished mesh__D020034 1999-01-01
% 209.74/209.96  |- skos__related mesh__D020034smesh__D018427
% 209.74/209.96  |- mesh__recordOriginator mesh__D020034 ADP
% 209.74/209.96  |- skos__hiddenLabel mesh__D020034 Gels, Silicone
% 209.74/209.96  |- mesh__dateCreated mesh__D020034 1998-06-11
% 209.74/209.96  |- skos__historyNote mesh__D020034 Silicones %28%1970-1998%29%
% 209.74/209.96  |- mesh__recordMaintainer mesh__D020034 jmp
% 209.74/209.96  |- mesh__publicMeSHNote mesh__D020034 99   
% 209.74/209.96  |- mesh__historyNote mesh__D020034 99   
% 209.74/209.96  |- skos__prefLabel mesh__D020034 Silicone Gels
% 209.74/209.96  |- rdf__type mesh__D020034sskos__Concept
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D020034 2006
% 209.74/209.96  |- skos__annotation mesh__D020034
% 209.74/209.96       silicones in breast implants probably goes here unless specified as elastomers %28%SILICONE ELASTOMERS%29%; for prosthetic implants do not use /ther use%A%  
% 209.74/209.96  |- skos__historyNote mesh__D020034 Silicone Elastomers %28%1973-1998%29%
% 209.74/209.96  |- rdf__type mesh__D044482sskos__Concept
% 209.74/209.96  |- mesh__dateRevised mesh__D044482 2004-07-07
% 209.74/209.96  |- mesh__recordOriginator mesh__D044482 ssb
% 209.74/209.96  |- mesh__recordAuthorizer mesh__D044482 sjn
% 209.74/209.96  |- mesh__publicMeSHNote mesh__D044482 2004   
% 209.74/209.96  |- skos__prefLabel mesh__D044482 Benzeneacetamides
% 209.74/209.96  |- mesh__dateEstablished mesh__D044482 2004-01-01
% 209.74/209.96  |- skos__altLabel mesh__D044482 2-Phenylacetamides
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D044482 2005
% 209.74/209.96  |- skos__broader mesh__D044482smesh__D001555
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D044482 2006
% 209.74/209.96  |- mesh__dateCreated mesh__D044482 2003-07-09
% 209.74/209.96  |- mesh__historyNote mesh__D044482 2004   
% 209.74/209.96  |- skos__scopeNote mesh__D044482
% 209.74/209.96       Compounds based on benzeneacetamide, that are similar in structure to ACETANILIDES.%A%    
% 209.74/209.96  |- mesh__recordMaintainer mesh__D044482 ssb
% 209.74/209.96  |- skos__related mesh__D044482smesh__D000083
% 209.74/209.96  |- skos__broader mesh__D044482smesh__D000081
% 209.74/209.96  |- mesh__dateRevised mesh__D016791 2003-07-09
% 209.74/209.96  |- skos__prefLabel mesh__D016791 Piroplasmia
% 209.74/209.96  |- mesh__recordOriginator mesh__D016791 PXP
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D016791 2006
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D016791 2004
% 209.74/209.96  |- mesh__recordAuthorizer mesh__D016791 sjn
% 209.74/209.96  |- skos__broader mesh__D016791smesh__D016782
% 209.74/209.96  |- mesh__publicMeSHNote mesh__D016791 92   
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D016791 2005
% 209.74/209.96  |- mesh__dateCreated mesh__D016791 1991-05-02
% 209.74/209.96  |- rdf__type mesh__D016791sskos__Concept
% 209.74/209.96  |- mesh__dateEstablished mesh__D016791 1992-01-01
% 209.74/209.96  |- skos__annotation mesh__D016791
% 209.74/209.96       a subclass of tick-borne protozoa: do not confuse with order PIROPLASMIDA%A%  
% 209.74/209.96  |- skos__scopeNote mesh__D016791
% 209.74/209.96       A subclass of heteroxenous parasitic protozoa usually transmitted by ticks. Its organisms are rod-shaped or amoeboid with conoid, oocysts, spores, and pseudocysts absent. Locomotion is by body flexion, gliding, or, in sexual stages, by large axopodium-like organelles.%A%    
% 209.74/209.96  |- mesh__historyNote mesh__D016791 92   
% 209.74/209.96  |- mesh__recordMaintainer mesh__D016791 ags
% 209.74/209.96  |- skos__related mesh__D052116smesh__D012794
% 209.74/209.96  |- mesh__historyNote mesh__D052116
% 209.74/209.96       2006%28%1980%29%; use SIALIC ACIDS %26% MUCOPROTEINS 1976-1979   
% 209.74/209.96  |- skos__scopeNote mesh__D052116
% 209.74/209.96       A subcategory of mucins that contain SIALIC ACID.     
% 209.74/209.96  |- mesh__dateCreated mesh__D052116 2005-06-30
% 209.74/209.96  |- skos__altLabel mesh__D052116 Sialomucin
% 209.74/209.96  |- skos__altLabel mesh__D052116 Endothelial-Specific Sialomucin
% 209.74/209.96  |- skos__hiddenLabel mesh__D052116 Sialomucin, Endothelial-Specific
% 209.74/209.96  |- skos__prefLabel mesh__D052116 Sialomucins
% 209.74/209.96  |- mesh__recordOriginator mesh__D052116 jmp
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D052116 2006
% 209.74/209.96  |- mesh__recordAuthorizer mesh__D052116 sjn
% 209.74/209.96  |- mesh__publicMeSHNote mesh__D052116
% 209.74/209.96       2006; SIALOMUCINS was indexed under MUCINS 1982-2005, under SIALIC ACIDS, %26% under MUCOPROTEINS 1976-1981%A%  
% 209.74/209.96  |- mesh__recordMaintainer mesh__D052116 jmp
% 209.74/209.96  |- skos__altLabel mesh__D052116 Endomucin
% 209.74/209.96  |- skos__broader mesh__D052116smesh__D009077
% 209.74/209.96  |- mesh__dateEstablished mesh__D052116 2006-01-01
% 209.74/209.96  |- rdf__type mesh__D052116sskos__Concept
% 209.74/209.96  |- skos__hiddenLabel mesh__D052116 Endothelial Specific Sialomucin
% 209.74/209.96  |- mesh__recordAuthorizer mesh__D002771 PLS
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002771 2001
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002771 2003
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002771 1997
% 209.74/209.96  |- mesh__recordOriginator mesh__D002771 NLM
% 209.74/209.96  |- skos__scopeNote mesh__D002771
% 209.74/209.96       An acute diarrheal disease endemic in India and Southeast Asia whose causative agent is VIBRIO CHOLERAE. This condition can lead to severe dehydration in a matter of hours unless quickly treated.%A%    
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002771 2000
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002771 1996
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002771 2006
% 209.74/209.96  |- skos__hiddenLabel mesh__D002771 Choleras
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002771 2005
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002771 1999
% 209.74/209.96  |- mesh__dateCreated mesh__D002771 1999-01-01
% 209.74/209.96  |- mesh__recordMaintainer mesh__D002771 PLS
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002771 2002
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002771 1998
% 209.74/209.96  |- skos__annotation mesh__D002771 caused by Vibrio cholerae   
% 209.74/209.96  |- mesh__dateRevised mesh__D002771 1995-05-25
% 209.74/209.96  |- rdf__type mesh__D002771sskos__Concept
% 209.74/209.96  |- skos__broader mesh__D002771smesh__D014735
% 209.74/209.96  |- skos__prefLabel mesh__D002771 Cholera
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D002771 2004
% 209.74/209.96  |- skos__hiddenLabel mesh__D010405 AER I beta Lactamase
% 209.74/209.96  |- mesh__historyNote mesh__D010405
% 209.74/209.96       84%28%79%29%63; was see under BETA-LACTAMASES 1979-83   
% 209.74/209.96  |- skos__prefLabel mesh__D010405 Penicillinase
% 209.74/209.96  |- mesh__dateCreated mesh__D010405 1999-01-01
% 209.74/209.96  |- rdf__type mesh__D010405sskos__Concept
% 209.74/209.96  |- mesh__dateEstablished mesh__D010405 1984-01-01
% 209.74/209.96  |- skos__broader mesh__D010405smesh__D001618
% 209.74/209.96  |- skos__hiddenLabel mesh__D010405 beta-Lactamase, AER-I
% 209.74/209.96  |- mesh__publicMeSHNote mesh__D010405
% 209.74/209.96       84,63-78; was see under BETA-LACTAMASES 1979-83   
% 209.74/209.96  |- skos__scopeNote mesh__D010405
% 209.74/209.96       A beta-lactamase preferentially cleaving penicillins. %28%Dorland, 28th ed%29% EC 3.5.2.-.%A%    
% 209.74/209.96  |- skos__hiddenLabel mesh__D010405 gamma Penicillinase
% 209.74/209.96  |- mesh__recordAuthorizer mesh__D010405 sjn
% 209.74/209.96  |- skos__hiddenLabel mesh__D010405 Lactamase III, beta
% 209.74/209.96  |- mesh__recordOriginator mesh__D010405 NLM
% 209.74/209.96  |- mesh__dateRevised mesh__D010405 2003-07-09
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D010405 2005
% 209.74/209.96  |- mesh__recordMaintainer mesh__D010405 ssb
% 209.74/209.96  |- skos__hiddenLabel mesh__D010405 Lactamase RP4, beta
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D010405 2006
% 209.74/209.96  |- skos__hiddenLabel mesh__D010405 beta Lactamase I
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D010405 2004
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D015699 2006
% 209.74/209.96  |- skos__hiddenLabel mesh__D015699 HTLV III gp120
% 209.74/209.96  |- skos__hiddenLabel mesh__D015699 gp120, HTLV-III
% 209.74/209.96  |- mesh__dateEstablished mesh__D015699 1990-01-01
% 209.74/209.96  |- skos__related mesh__D015699smesh__D015717
% 209.74/209.96  |- mesh__recordOriginator mesh__D015699 AGS
% 209.74/209.96  |- skos__prefLabel mesh__D015699 HIV Envelope Protein gp120
% 209.74/209.96  |- mesh__historyNote mesh__D015699 90   
% 209.74/209.96  |- skos__altLabel mesh__D015699 gp120 Envelope Glycoprotein, HIV
% 209.74/209.96  |- skos__altLabel mesh__D015699 HTLV-III gp120
% 209.74/209.96  |- mesh__recordAuthorizer mesh__D015699 sjn
% 209.74/209.96  |- skos__altLabel mesh__D015699 env Protein gp120, HIV
% 209.74/209.96  |- mesh__publicMeSHNote mesh__D015699 90   
% 209.74/209.96  |- skos__altLabel mesh__D015699 HIV Envelope Glycoprotein gp120
% 209.74/209.96  |- skos__broader mesh__D015699smesh__D015686
% 209.74/209.96  |- rdf__type mesh__D015699sskos__Concept
% 209.74/209.96  |- skos__historyNote mesh__D015699
% 209.74/209.96       Viral Envelope Proteins %28%1983-1989%29%
% 209.74/209.96  |- skos__altLabel mesh__D015699 gp120%28%HIV%29%
% 209.74/209.96  |- skos__scopeNote mesh__D015699
% 209.74/209.96       External envelope protein of the human immunodeficiency virus which is encoded by the HIV env gene. It has a molecular weight of 120 kDa and contains numerous glycosylation sites. Gp120 binds to cells expressing CD4 cell-surface antigens, most notably T4-lymphocytes and monocytes/macrophages. Gp120 has been shown to interfere with the normal function of CD4 and is at least partly responsible for the cytopathic effect of HIV.%A%    
% 209.74/209.96  |- skos__broader mesh__D015699smesh__D015488
% 209.74/209.96  |- skos__annotation mesh__D015699
% 209.74/209.96       IM; despite X refs, coord with HIV-1 or HIV-2 %28%IM%29%; /drug eff /ultrastruct permitted; DF: GP120%A%  
% 209.74/209.96  |- skos__altLabel mesh__D015699 Envelope Glycoprotein gp120, HIV
% 209.74/209.96  |- mesh__recordMaintainer mesh__D015699 ssb
% 209.74/209.96  |- mesh__dateRevised mesh__D015699 2005-06-30
% 209.74/209.96  |- skos__historyNote mesh__D015699 Retroviridae Proteins %28%1986-1989%29%
% 209.74/209.96  |- mesh__dateCreated mesh__D015699 1989-06-19
% 209.74/209.96  |- skos__hiddenLabel mesh__D015699 HIV 2 Envelope Protein gp120
% 209.74/209.96  |- skos__hiddenLabel mesh__D015699 HIV 1 Envelope Protein gp120
% 209.74/209.96  |- skos__annotation mesh__D001679
% 209.74/209.96       GEN or unspecified: prefer specific biogenic amine group term or specific biogenic amine indented under each%A%  
% 209.74/209.96  |- skos__broader mesh__D001679smesh__D000588
% 209.74/209.96  |- skos__hiddenLabel mesh__D001679 Amine, Biogenic
% 209.74/209.96  |- skos__altLabel mesh__D001679 Biogenic Amine
% 209.74/209.96  |- skos__historyNote mesh__D001679 Amines %28%1966-1970%29%
% 209.74/209.96  |- skos__prefLabel mesh__D001679 Biogenic Amines
% 209.74/209.96  |- mesh__historyNote mesh__D001679 73%28%71%29%   
% 209.74/209.96  |- mesh__dateRevised mesh__D001679 2005-06-30
% 209.74/209.96  |- mesh__dateEstablished mesh__D001679 1973-01-01
% 209.74/209.96  |- mesh__publicMeSHNote mesh__D001679 73   
% 209.74/209.96  |- mesh__recordOriginator mesh__D001679 NLM
% 209.74/209.96  |- mesh__recordAuthorizer mesh__D001679 sjn
% 209.74/209.96  |- skos__altLabel mesh__D001679 Amines, Biogenic
% 209.74/209.96  |- mesh__dateCreated mesh__D001679 1999-01-01
% 209.74/209.96  |- skos__related mesh__D001679smesh__D017982
% 209.74/209.96  |- skos__scopeNote mesh__D001679
% 209.74/209.96       A group of naturally occurring amines derived by enzymatic decarboxylation of the natural amino acids. Many have powerful physiological effects %28%e.g., histamine, serotonin, epinephrine, tyramine%29%. Those derived from aromatic amino acids, and also their synthetic analogs %28%e.g., amphetamine%29%, are of use in pharmacology.%A%    
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D001679 2006
% 209.74/209.96  |- mesh__recordMaintainer mesh__D001679 ssb
% 209.74/209.96  |- rdf__type mesh__D001679sskos__Concept
% 209.74/209.96  |- skos__broader mesh__D001921Q000737smesh__D001921
% 209.74/209.96  |- mesh__preferredCombination mesh__D001921Q000737smesh__D001923
% 209.74/209.96  |- rdf__type mesh__D001921Q000737smesh__CompoundConcept
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D020833 2003
% 209.74/209.96  |- skos__hiddenLabel mesh__D020833 Injury, Diffuse Axonal
% 209.74/209.96  |- skos__hiddenLabel mesh__D020833 Axonal Injuries, Diffuse
% 209.74/209.96  |- rdf__type mesh__D020833sskos__Concept
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D020833 2002
% 209.74/209.96  |- skos__prefLabel mesh__D020833 Diffuse Axonal Injury
% 209.74/209.96  |- skos__historyNote mesh__D020833 Brain Injuries %28%1982-1999%29%
% 209.74/209.96  |- mesh__publicMeSHNote mesh__D020833 2000   
% 209.74/209.96  |- mesh__historyNote mesh__D020833 2000   
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D020833 2006
% 209.74/209.96  |- skos__hiddenLabel mesh__D020833 DAIs %28%Diffuse Axonal Injury%29%
% 209.74/209.96  |- skos__scopeNote mesh__D020833
% 209.74/209.96       A relatively common sequela of blunt head injury, characterized by a global disruption of axons throughout the brain. Associated clinical features may include NEUROBEHAVIORAL MANIFESTATIONS; PERSISTENT VEGETATIVE STATE; DEMENTIA; and other disorders.%A%    
% 209.74/209.96  |- skos__hiddenLabel mesh__D020833 Diffuse Axonal Injuries
% 209.74/209.96  |- skos__broader mesh__D020833smesh__D001930
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D020833 2005
% 209.74/209.96  |- skos__hiddenLabel mesh__D020833 Injuries, Diffuse Axonal
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D020833 2001
% 209.74/209.96  |- mesh__dateCreated mesh__D020833 1999-11-08
% 209.74/209.96  |- mesh__dateEstablished mesh__D020833 2000-01-01
% 209.74/209.96  |- skos__altLabel mesh__D020833 Axonal Injury, Diffuse
% 209.74/209.96  |- skos__altLabel mesh__D020833 DAI %28%Diffuse Axonal Injury%29%
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D020833 2000
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D020833 2004
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D006364 2005
% 209.74/209.96  |- skos__hiddenLabel mesh__D006364 Hedgehog
% 209.74/209.96  |- mesh__historyNote mesh__D006364 72   
% 209.74/209.96  |- mesh__dateEstablished mesh__D006364 1972-01-01
% 209.74/209.96  |- mesh__recordAuthorizer mesh__D006364 sjn
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D006364 2004
% 209.74/209.96  |- skos__broader mesh__D006364smesh__D007312
% 209.74/209.96  |- skos__prefLabel mesh__D006364 Hedgehogs
% 209.74/209.96  |- skos__scopeNote mesh__D006364
% 209.74/209.96       The family Erinaceidae, in the order INSECTIVORA. Most are true hedgehogs possessing a coat of spines and a very short tail. Those members of the family found in Southeast Asia %28%moonrats or gymnures%29% have normal body hair and a long tail.%A%    
% 209.74/209.96  |- rdf__type mesh__D006364sskos__Concept
% 209.74/209.96  |- mesh__recordMaintainer mesh__D006364 ags
% 209.74/209.96  |- mesh__publicMeSHNote mesh__D006364 72   
% 209.74/209.96  |- skos__altLabel mesh__D006364 Erinaceidae
% 209.74/209.96  |- mesh__dateRevised mesh__D006364 2003-07-09
% 209.74/209.96  |- skos__historyNote mesh__D006364 Insectivora %28%1966-1971%29%
% 209.74/209.96  |- mesh__dateCreated mesh__D006364 1999-01-01
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D006364 2006
% 209.74/209.96  |- mesh__recordOriginator mesh__D006364 NLM
% 209.74/209.96  |- skos__broader mesh__D020035smesh__D004798
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D020035 2006
% 209.74/209.96  |- skos__annotation mesh__D020035
% 209.74/209.96       IM GEN only; coord NIM with specific enzyme %28%IM%29%   
% 209.74/209.96  |- mesh__dateEstablished mesh__D020035 1999-01-01
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D020035 2005
% 209.74/209.96  |- skos__scopeNote mesh__D020035
% 209.74/209.96       Catalytically active enzymes that are formed by the combination of an apoenzyme %28%APOENZYMES%29% and its appropriate cofactors and prosthetic groups.%A%    
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D020035 2004
% 209.74/209.96  |- mesh__dateRevised mesh__D020035 2003-07-09
% 209.74/209.96  |- mesh__historyNote mesh__D020035 99; use COENZYMES 1996-98   
% 209.74/209.96  |- skos__prefLabel mesh__D020035 Holoenzymes
% 209.74/209.96  |- rdf__type mesh__D020035sskos__Concept
% 209.74/209.96  |- skos__historyNote mesh__D020035 Coenzymes %28%1966-1998%29%
% 209.74/209.96  |- mesh__dateCreated mesh__D020035 1998-06-10
% 209.74/209.96  |- mesh__publicMeSHNote mesh__D020035 99; see COENZYMES 1996-98   
% 209.74/209.96  |- skos__scopeNote mesh__D044483
% 209.74/209.96       The growth of INTESTINAL POLYPS. Growth processes include neoplastic %28%ADENOMA and CARCINOMA%29% and non-neoplastic %28%hyperplastic, mucosal, inflammatory, and other polyps%29%.%A%    
% 209.74/209.96  |- skos__historyNote mesh__D044483 Polyps %28%1966-1973%29%
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D044483 2004
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D044483 2005
% 209.74/209.96  |- skos__prefLabel mesh__D044483 Intestinal Polyposis
% 209.74/209.96  |- mesh__publicMeSHNote mesh__D044483
% 209.74/209.96       2004; see INTESTINAL POLYPS 1996-2003; for CRONKHITE-CANADA SYNDROME see CHURG-STRAUSS SYNDROME 1992-1995%A%  
% 209.74/209.96  |- mesh__activeMeSHYear mesh__D044483 2006
% 209.74/209.96  |- mesh__dateCreated mesh__D044483 2003-07-09
% 209.74/209.96  |- skos__broader mesh__D044483smesh__D007410
% 209.74/209.96  |- skos__hiddenLabel mesh__D044483 Polyposis, Intestinal
% 209.74/209.96  |- mesh__dateEstablished mesh__D044483 2004-01-01
% 209.74/209.96  |- rdf__type mesh__D044483sskos__Concept
% 209.74/209.96  |- skos__annotation mesh__D044483
% 209.74/209.96       INTESTINAL POLYPS is also available; familial: consider also ADENOMATOUS POLYPOSIS COLI%A%  
% 209.74/209.96  |- skos__historyNote mesh__D044483 Intestinal Polyps %28%1973-2003%29%
% 209.74/209.96  |- mesh__historyNote mesh__D044483
% 209.74/209.96       2004; use INTESTINAL POLYPS 1996-2003; for CRONKHITE-CANADA SYNDROME use CHURG-STRAUSS SYNDROME 1992-1995%A%  
% 209.74/209.97  |- skos__broader mesh__D016792smesh__D016791
% 209.74/209.97  |- skos__annotation mesh__D016792
% 209.74/209.97       an order of tick-borne protozoa: do not confuse with subclass PIROPLASMIA%A%  
% 209.74/209.97  |- mesh__dateRevised mesh__D016792 2003-07-09
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D016792 2005
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D016792 2006
% 209.74/209.97  |- skos__prefLabel mesh__D016792 Piroplasmida
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D016792 2004
% 209.74/209.97  |- mesh__recordOriginator mesh__D016792 PXP
% 209.74/209.97  |- mesh__dateCreated mesh__D016792 1991-05-02
% 209.74/209.97  |- rdf__type mesh__D016792sskos__Concept
% 209.74/209.97  |- mesh__recordMaintainer mesh__D016792 ags
% 209.74/209.97  |- skos__scopeNote mesh__D016792
% 209.74/209.97       An order of protozoa comprising heteroxenous tick-borne blood parasites. Representative genera include BABESIA, Dactylosoma, and THEILERIA.%A%    
% 209.74/209.97  |- mesh__historyNote mesh__D016792 92   
% 209.74/209.97  |- mesh__recordAuthorizer mesh__D016792 sjn
% 209.74/209.97  |- mesh__dateEstablished mesh__D016792 1992-01-01
% 209.74/209.97  |- mesh__publicMeSHNote mesh__D016792 92   
% 209.74/209.97  |- mesh__recordAuthorizer mesh__D052117 sjn
% 209.74/209.97  |- mesh__recordMaintainer mesh__D052117 ssb
% 209.74/209.97  |- skos__hiddenLabel mesh__D052117 1,3 Dioxindans
% 209.74/209.97  |- mesh__publicMeSHNote mesh__D052117 2006   
% 209.74/209.97  |- skos__altLabel mesh__D052117 Methylenedioxybenzenes
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D052117 2006
% 209.74/209.97  |- skos__altLabel mesh__D052117 1,3-Dioxindans
% 209.74/209.97  |- skos__broader mesh__D052117smesh__D006574
% 209.74/209.97  |- mesh__recordOriginator mesh__D052117 ssb
% 209.74/209.97  |- rdf__type mesh__D052117sskos__Concept
% 209.74/209.97  |- skos__historyNote mesh__D052117 Dioxoles %28%1970-2005%29%
% 209.74/209.97  |- skos__broader mesh__D052117smesh__D004149
% 209.74/209.97  |- mesh__dateCreated mesh__D052117 2005-06-30
% 209.74/209.97  |- skos__hiddenLabel mesh__D052117 1,3 Dioxaindans
% 209.74/209.97  |- skos__altLabel mesh__D052117 1,3-Dioxaindans
% 209.74/209.97  |- mesh__historyNote mesh__D052117 2006   
% 209.74/209.97  |- mesh__dateEstablished mesh__D052117 2006-01-01
% 209.74/209.97  |- skos__prefLabel mesh__D052117 Benzodioxoles
% 209.74/209.97  |- skos__scopeNote mesh__D052117
% 209.74/209.97       Compounds based on benzene fused to oxole. They can be formed from methylated CATECHOLS such as EUGENOL.%A%    
% 209.74/209.97  |- skos__historyNote mesh__D002772 Bacterial Proteins %28%1966-1977%29%
% 209.74/209.97  |- skos__prefLabel mesh__D002772 Cholera Toxin
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D002772 2006
% 209.74/209.97  |- mesh__historyNote mesh__D002772 78   
% 209.74/209.97  |- skos__altLabel mesh__D002772 Choleragen
% 209.74/209.97  |- mesh__recordAuthorizer mesh__D002772 sjn
% 209.74/209.97  |- skos__altLabel mesh__D002772 Cholera Exotoxin
% 209.74/209.97  |- skos__annotation mesh__D002772
% 209.74/209.97       /antag permitted but consider also ANTITOXINS   
% 209.74/209.97  |- mesh__recordMaintainer mesh__D002772 ssb
% 209.74/209.97  |- skos__broader mesh__D002772smesh__D036002
% 209.74/209.97  |- skos__broader mesh__D002772smesh__D001427
% 209.74/209.97  |- mesh__dateRevised mesh__D002772 2005-06-30
% 209.74/209.97  |- skos__hiddenLabel mesh__D002772 Toxin, Cholera
% 209.74/209.97  |- skos__historyNote mesh__D002772 Enterotoxins %28%1966-1977%29%
% 209.74/209.97  |- skos__altLabel mesh__D002772 Cholera Toxin B Subunit
% 209.74/209.97  |- skos__historyNote mesh__D002772 Bacterial Toxins %28%1977%29%
% 209.74/209.97  |- skos__altLabel mesh__D002772 Cholera Toxin Protomer B
% 209.74/209.97  |- skos__hiddenLabel mesh__D002772 Exotoxin, Cholera
% 209.74/209.97  |- rdf__type mesh__D002772sskos__Concept
% 209.74/209.97  |- skos__historyNote mesh__D002772 Toxins %28%1966-1967%29%
% 209.74/209.97  |- skos__scopeNote mesh__D002772
% 209.74/209.97       An ENTEROTOXIN from VIBRIO CHOLERAE. It consists of two major protomers, the heavy %28%H%29% or A subunit and the B protomer which consists of 5 light %28%L%29% or B subunits. The catalytic A subunit is proteolytically cleaved into fragments A1 and A2. The A1 fragment is a MONO%28%ADP-RIBOSE%29% TRANSFERASE.  The B protomer binds cholera toxin to intestinal epithelial cells, and facilitates the uptake of the A1 fragment. The A1 catalyzed transfer of ADP-RIBOSE to the alpha subunits of heterotrimeric G PROTEINS activates the production of CYCLIC AMP. Increased levels of cyclic AMP are thought to modulate release of fluid and electrolytes from intestinal crypt cells.%A%    
% 209.74/209.97  |- mesh__dateCreated mesh__D002772 1977-04-22
% 209.74/209.97  |- mesh__publicMeSHNote mesh__D002772 78   
% 209.74/209.97  |- skos__hiddenLabel mesh__D002772 Enterotoxin CT, Cholera
% 209.74/209.97  |- skos__broader mesh__D002772smesh__D004768
% 209.74/209.97  |- skos__altLabel mesh__D002772 Cholera Toxin A Subunit
% 209.74/209.97  |- skos__altLabel mesh__D002772 Cholera Enterotoxin CT
% 209.74/209.97  |- skos__hiddenLabel mesh__D002772 CT, Cholera Enterotoxin
% 209.74/209.97  |- mesh__recordOriginator mesh__D002772 SH
% 209.74/209.97  |- mesh__dateEstablished mesh__D002772 1978-01-01
% 209.74/209.97  |- skos__hiddenLabel mesh__D010406 Penicillin Antibiotics
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D010406 2006
% 209.74/209.97  |- skos__scopeNote mesh__D010406
% 209.74/209.97       A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. %28%Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 8th ed, p1065%29%%A%    
% 209.74/209.97  |- skos__broader mesh__D010406smesh__D047090
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D010406 2005
% 209.74/209.97  |- mesh__historyNote mesh__D010406
% 209.74/209.97       75; was PENICILLIN 1963-74; /adv eff-pois-tox was PENICILLIN TOXICOLOGY 1963-65; HETACILLIN was heading 1974-84%A%  
% 209.74/209.97  |- rdf__type mesh__D010406sskos__Concept
% 209.74/209.97  |- skos__altLabel mesh__D010406 Antibiotics, Penicillin
% 209.74/209.97  |- mesh__dateRevised mesh__D010406 2004-07-07
% 209.74/209.97  |- skos__broader mesh__D010406smesh__D019086
% 209.74/209.97  |- skos__annotation mesh__D010406 check text for a specific if possible   
% 209.74/209.97  |- skos__prefLabel mesh__D010406 Penicillins
% 209.74/209.97  |- mesh__recordMaintainer mesh__D010406 ssb
% 209.74/209.97  |- mesh__publicMeSHNote mesh__D010406
% 209.74/209.97       75; was PENICILLIN 1963-74; /adverse effects /poisoning /toxicity were PENICILLIN TOXICOLOGY 1963-65; HETACILLIN was heading 1974-84%A%  
% 209.74/209.97  |- mesh__recordAuthorizer mesh__D010406 sjn
% 209.74/209.97  |- mesh__onlineNote mesh__D010406
% 209.74/209.97       use PENICILLINS to search PENICILLIN 1966-74 %26% HETACILLIN 1974-84%A%  
% 209.74/209.97  |- mesh__recordOriginator mesh__D010406 NLM
% 209.74/209.97  |- mesh__dateCreated mesh__D010406 1999-01-01
% 209.74/209.97  |- mesh__historyNote mesh__D020834 2000   
% 209.74/209.97  |- skos__related mesh__D020834smesh__D019448
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D020834 2006
% 209.74/209.97  |- skos__prefLabel mesh__D020834 Ethnopharmacology
% 209.74/209.97  |- skos__broader mesh__D020834smesh__D008519
% 209.74/209.97  |- skos__scopeNote mesh__D020834
% 209.74/209.97       The study of the actions and properties of medicinal agents, often derived from PLANTS, indigenous to populations or ETHNIC GROUPS.%A%    
% 209.74/209.97  |- skos__annotation mesh__D020834
% 209.74/209.97       specialty; coordinate with geographic term or ethnic group if pertinent; coordinate NIM with specific drug or plant %28%IM%29% for ethnopharmacologic aspects of the drug or plant%A%  
% 209.74/209.97  |- skos__historyNote mesh__D020834 Pharmacology %28%1983-1999%29%
% 209.74/209.97  |- skos__historyNote mesh__D020834 Medicine, Traditional %28%1979-1999%29%
% 209.74/209.97  |- skos__broader mesh__D020834smesh__D010600
% 209.74/209.97  |- mesh__publicMeSHNote mesh__D020834 2000   
% 209.74/209.97  |- mesh__dateEstablished mesh__D020834 2000-01-01
% 209.74/209.97  |- mesh__dateRevised mesh__D020834 2005-06-30
% 209.74/209.97  |- mesh__recordOriginator mesh__D020834 ags
% 209.74/209.97  |- mesh__recordAuthorizer mesh__D020834 sjn
% 209.74/209.97  |- skos__related mesh__D020834smesh__D010944
% 209.74/209.97  |- skos__related mesh__D020834smesh__D010598
% 209.74/209.97  |- mesh__recordMaintainer mesh__D020834 ssb
% 209.74/209.97  |- mesh__dateCreated mesh__D020834 1999-11-08
% 209.74/209.97  |- rdf__type mesh__D020834sskos__Concept
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D006365 2003
% 209.74/209.97  |- skos__related mesh__D006365smesh__D013628
% 209.74/209.97  |- skos__broader mesh__D006365smesh__D005528
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D006365 2004
% 209.74/209.97  |- skos__hiddenLabel mesh__D006365 Heels
% 209.74/209.97  |- mesh__recordOriginator mesh__D006365 NLM
% 209.74/209.97  |- mesh__dateCreated mesh__D006365 1999-01-01
% 209.74/209.97  |- rdf__type mesh__D006365sskos__Concept
% 209.74/209.97  |- mesh__recordAuthorizer mesh__D006365 sjn
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D006365 2005
% 209.74/209.97  |- skos__related mesh__D006365smesh__D000125
% 209.74/209.97  |- skos__annotation mesh__D006365 primates only   
% 209.74/209.97  |- mesh__dateRevised mesh__D006365 2002-07-03
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D006365 2006
% 209.74/209.97  |- skos__related mesh__D006365smesh__D002111
% 209.74/209.97  |- skos__prefLabel mesh__D006365 Heel
% 209.74/209.97  |- mesh__recordMaintainer mesh__D006365 PLS
% 209.74/209.97  |- skos__broader mesh__D020036smesh__D001203
% 209.74/209.97  |- skos__related mesh__D020036smesh__D001758
% 209.74/209.97  |- mesh__dateCreated mesh__D020036 1998-06-10
% 209.74/209.97  |- mesh__historyNote mesh__D020036 99   
% 209.74/209.97  |- mesh__recordAuthorizer mesh__D020036 sjn
% 209.74/209.97  |- mesh__recordMaintainer mesh__D020036 SYSTEM
% 209.74/209.97  |- mesh__dateEstablished mesh__D020036 1999-01-01
% 209.74/209.97  |- mesh__recordOriginator mesh__D020036 AGS
% 209.74/209.97  |- skos__related mesh__D020036smesh__D002912
% 209.74/209.97  |- rdf__type mesh__D020036sskos__Concept
% 209.74/209.97  |- mesh__dateRevised mesh__D020036 2005-06-30
% 209.74/209.97  |- mesh__publicMeSHNote mesh__D020036 99   
% 209.74/209.97  |- skos__prefLabel mesh__D020036 Onygenales
% 209.74/209.97  |- skos__scopeNote mesh__D020036
% 209.74/209.97       An order of fungi in the phylum ASCOMYCOTA containing many medically important species. There are four families and mitosporic %28%anamorphic%29% forms are prominent.%A%    
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D020036 2006
% 209.74/209.97  |- skos__prefLabel mesh__D016793 Babesia bovis
% 209.74/209.97  |- skos__annotation mesh__D016793
% 209.74/209.97       infection = BABESIOSIS %28%IM%29% + CATTLE DISEASES %28%IM%29% + check tags ANIMALS %26% CATTLE%A%  
% 209.74/209.97  |- mesh__dateEstablished mesh__D016793 1992-01-01
% 209.74/209.97  |- mesh__dateRevised mesh__D016793 2003-07-30
% 209.74/209.97  |- mesh__publicMeSHNote mesh__D016793 92   
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D016793 2006
% 209.74/209.97  |- mesh__recordAuthorizer mesh__D016793 sjn
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D016793 2004
% 209.74/209.97  |- skos__scopeNote mesh__D016793
% 209.74/209.97       A species of protozoa that is a cause of bovine babesiosis. Ticks of the genera Boophilus, Rhipicephalus, and IXODES are the chief vectors.%A%    
% 209.74/209.97  |- skos__historyNote mesh__D016793 Babesia %28%1975-1991%29%
% 209.74/209.97  |- mesh__recordOriginator mesh__D016793 PXP
% 209.74/209.97  |- mesh__historyNote mesh__D016793 92   
% 209.74/209.97  |- mesh__recordMaintainer mesh__D016793 ags
% 209.74/209.97  |- rdf__type mesh__D016793sskos__Concept
% 209.74/209.97  |- mesh__dateCreated mesh__D016793 1991-05-02
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D016793 2005
% 209.74/209.97  |- skos__broader mesh__D016793smesh__D001403
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D052118 2006
% 209.74/209.97  |- rdf__type mesh__D052118sskos__Concept
% 209.74/209.97  |- skos__scopeNote mesh__D052118
% 209.74/209.97       An abundant lysosomal-associated membrane protein that has been found to shuttle between LYSOSOMES; ENDOSOMES; and the PLASMA MEMBRANE. In PLATELETS and T-LYMPHOCYTES it may play a role in the cellular degranulation process.%A%    
% 209.74/209.97  |- mesh__dateEstablished mesh__D052118 2006-01-01
% 209.74/209.97  |- mesh__recordOriginator mesh__D052118 jmp
% 209.74/209.97  |- skos__altLabel mesh__D052118 Antigens, CD107a
% 209.74/209.97  |- mesh__recordAuthorizer mesh__D052118 sjn
% 209.74/209.97  |- skos__broader mesh__D052118smesh__D051907
% 209.74/209.97  |- mesh__recordMaintainer mesh__D052118 jmp
% 209.74/209.97  |- mesh__historyNote mesh__D052118 2006%28%1986%29%   
% 209.74/209.97  |- skos__altLabel mesh__D052118 CD107a Antigens
% 209.74/209.97  |- skos__altLabel mesh__D052118 CD107a Antigen
% 209.74/209.97  |- skos__altLabel mesh__D052118 LAMP1 Protein
% 209.74/209.97  |- skos__altLabel mesh__D052118 LAMPA Protein
% 209.74/209.97  |- skos__prefLabel mesh__D052118 Lysosomal-Associated Membrane Protein 1
% 209.74/209.97  |- skos__broader mesh__D052118smesh__D015703
% 209.74/209.97  |- mesh__dateCreated mesh__D052118 2005-06-30
% 209.74/209.97  |- mesh__publicMeSHNote mesh__D052118
% 209.74/209.97       2006; CD107A ANTIGEN was indexed under ANTIGENS, CD 1986-2005%A%  
% 209.74/209.97  |- skos__hiddenLabel mesh__D052118 Lysosomal Associated Membrane Protein 1
% 209.74/209.97  |- skos__altLabel mesh__D052118 LGP120 Protein
% 209.74/209.97  |- skos__broader mesh__D052118smesh__D010980
% 209.74/209.97  |- mesh__dateCreated mesh__D029910 2001-07-25
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D029910 2002
% 209.74/209.97  |- skos__prefLabel mesh__D029910 Trigonella
% 209.74/209.97  |- skos__altLabel mesh__D029910 Fenugreek
% 209.74/209.97  |- mesh__historyNote mesh__D029910 2002   
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D029910 2004
% 209.74/209.97  |- skos__annotation mesh__D029910
% 209.74/209.97       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.74/209.97  |- mesh__publicMeSHNote mesh__D029910 2002   
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D029910 2003
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D029910 2006
% 209.74/209.97  |- mesh__dateEstablished mesh__D029910 2002-01-01
% 209.74/209.97  |- skos__altLabel mesh__D029910 Poenumgraecum
% 209.74/209.97  |- skos__scopeNote mesh__D029910 A plant genus of the family FABACEAE.     
% 209.74/209.97  |- skos__altLabel mesh__D029910 Foenumgraecum
% 209.74/209.97  |- rdf__type mesh__D029910sskos__Concept
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D029910 2005
% 209.74/209.97  |- skos__broader mesh__D029910smesh__D007887
% 209.74/209.97  |- mesh__recordOriginator mesh__D010407 NLM
% 209.74/209.97  |- mesh__recordAuthorizer mesh__D010407 sjn
% 209.74/209.97  |- rdf__type mesh__D010407sskos__Concept
% 209.74/209.97  |- skos__scopeNote mesh__D010407
% 209.74/209.97       A mitosporic Trichocomaceae fungal genus that develops fruiting organs resembling a broom. When identified, teleomorphs include Eupenicillium and TALAROMYCES. Several species %28%but especially PENICILLIUM CHRYSOGENUM%29% are sources of the antibiotic penicillin.%A%    
% 209.74/209.97  |- skos__prefLabel mesh__D010407 Penicillium
% 209.74/209.97  |- mesh__dateCreated mesh__D010407 1999-01-01
% 209.74/209.97  |- mesh__recordMaintainer mesh__D010407 SYSTEM
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D010407 2006
% 209.74/209.97  |- mesh__dateRevised mesh__D010407 2005-06-30
% 209.74/209.97  |- skos__broader mesh__D010407smesh__D003904
% 209.74/209.97  |- mesh__historyNote mesh__D020835
% 209.74/209.97       2000; for KAMPO %26% KANPO use MEDICINE, CHINESE TRADITIONAL 1994-1999%A%  
% 209.74/209.97  |- mesh__recordAuthorizer mesh__D020835 sjn
% 209.74/209.97  |- skos__altLabel mesh__D020835 Kampo Medicine
% 209.74/209.97  |- mesh__dateEstablished mesh__D020835 2000-01-01
% 209.74/209.97  |- skos__altLabel mesh__D020835 Kanpo
% 209.74/209.97  |- skos__broader mesh__D020835smesh__D008518
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D020835 2004
% 209.74/209.97  |- mesh__recordMaintainer mesh__D020835 ssb
% 209.74/209.97  |- skos__hiddenLabel mesh__D020835 Medicine, Kanpo
% 209.74/209.97  |- skos__altLabel mesh__D020835 Kanpo Medicine
% 209.74/209.97  |- skos__broader mesh__D020835smesh__D008519
% 209.74/209.97  |- skos__prefLabel mesh__D020835 Medicine, Kampo
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D020835 2003
% 209.74/209.97  |- skos__annotation mesh__D020835
% 209.74/209.97       coord with DRUGS, CHINESE HERBAL or MATERIA MEDICA if pertinent; MEDICINE, CHINESE TRADITIONAL is also available%A%  
% 209.74/209.97  |- rdf__type mesh__D020835sskos__Concept
% 209.74/209.97  |- mesh__publicMeSHNote mesh__D020835
% 209.74/209.97       2000; for KAMPO %26% KAMPO use MEDICINE, CHINESE TRADITIONAL 1994-1999%A%  
% 209.74/209.97  |- skos__altLabel mesh__D020835 Kampo
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D020835 2006
% 209.74/209.97  |- skos__scopeNote mesh__D020835
% 209.74/209.97       System of herbal medicine practiced in Japan by both herbalists and practitioners of modern medicine. Kampo originated in China and is based on Chinese herbal medicine %28%MEDICINE, CHINESE TRADITIONAL%29%.%A%    
% 209.74/209.97  |- mesh__dateRevised mesh__D020835 2001-07-25
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D020835 2002
% 209.74/209.97  |- mesh__dateCreated mesh__D020835 1999-11-03
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D020835 2005
% 209.74/209.97  |- skos__related mesh__D020835smesh__D008516
% 209.74/209.97  |- skos__historyNote mesh__D020835
% 209.74/209.97       Medicine, Chinese Traditional %28%1994-1999%29%
% 209.74/209.97  |- mesh__recordOriginator mesh__D020835 ags
% 209.74/209.97  |- mesh__dateEstablished mesh__D006366 1968-01-01
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D006366 2004
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D006366 2001
% 209.74/209.97  |- mesh__publicMeSHNote mesh__D006366 68   
% 209.74/209.97  |- skos__prefLabel mesh__D006366 Heinz Bodies
% 209.74/209.97  |- skos__broader mesh__D006366smesh__D004908
% 209.74/209.97  |- skos__hiddenLabel mesh__D006366 Bodies, Heinz
% 209.74/209.97  |- mesh__dateCreated mesh__D006366 1999-01-01
% 209.74/209.97  |- rdf__type mesh__D006366sskos__Concept
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D006366 2005
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D006366 2002
% 209.74/209.97  |- mesh__recordOriginator mesh__D006366 NLM
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D006366 2006
% 209.74/209.97  |- mesh__dateRevised mesh__D006366 2000-06-22
% 209.74/209.97  |- mesh__historyNote mesh__D006366 68%28%63%29%   
% 209.74/209.97  |- skos__scopeNote mesh__D006366
% 209.74/209.97       Abnormal intracellular inclusions, composed of denatured hemoglobin, found on the membrane of red blood cells. They are seen in thalassemias, enzymopathies, hemoglobinopathies, and after splenectomy.%A%    
% 209.74/209.97  |- mesh__recordMaintainer mesh__D006366 KEV
% 209.74/209.97  |- mesh__recordAuthorizer mesh__D006366 sjn
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D006366 2003
% 209.74/209.97  |- skos__prefLabel mesh__D020037 Sordariales
% 209.74/209.97  |- mesh__dateRevised mesh__D020037 2005-06-30
% 209.74/209.97  |- mesh__historyNote mesh__D020037 99   
% 209.74/209.97  |- skos__scopeNote mesh__D020037
% 209.74/209.97       An order of fungi in the phylum ASCOMYCOTA that includes many valuable experimental organisms. There are eight families and very few anamorphic forms.%A%    
% 209.74/209.97  |- skos__broader mesh__D020037smesh__D001203
% 209.74/209.97  |- mesh__recordOriginator mesh__D020037 AGS
% 209.74/209.97  |- mesh__publicMeSHNote mesh__D020037 99   
% 209.74/209.97  |- mesh__dateCreated mesh__D020037 1998-06-11
% 209.74/209.97  |- rdf__type mesh__D020037sskos__Concept
% 209.74/209.97  |- mesh__recordAuthorizer mesh__D020037 sjn
% 209.74/209.97  |- mesh__recordMaintainer mesh__D020037 SYSTEM
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D020037 2006
% 209.74/209.97  |- mesh__dateEstablished mesh__D020037 1999-01-01
% 209.74/209.97  |- skos__scopeNote mesh__D011500
% 209.74/209.97       Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins.%A%    
% 209.74/209.97  |- skos__historyNote mesh__D011500 Proteins/biosynthesis %28%1966-1987%29%
% 209.74/209.97  |- mesh__historyNote mesh__D011500 88   
% 209.74/209.97  |- mesh__dateCreated mesh__D011500 1987-04-09
% 209.74/209.97  |- skos__broader mesh__D011500smesh__D004791
% 209.74/209.97  |- mesh__recordMaintainer mesh__D011500 jls
% 209.74/209.97  |- mesh__recordOriginator mesh__D011500 RLS
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D011500 2006
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D011500 2004
% 209.74/209.97  |- skos__annotation mesh__D011500 enzyme inhib; DF: PROTEIN SYN INHIB   
% 209.74/209.97  |- rdf__type mesh__D011500sskos__Concept
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D011500 2005A
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D011500 2005
% 209.74/209.97  |- skos__prefLabel mesh__D011500 Protein Synthesis Inhibitors
% 209.74/209.97  |- mesh__dateRevised mesh__D011500 2004-07-30
% 209.74/209.97  |- skos__hiddenLabel mesh__D011500 Inhibitors, Protein Synthesis
% 209.74/209.97  |- mesh__recordAuthorizer mesh__D011500 jls
% 209.74/209.97  |- mesh__dateEstablished mesh__D011500 1988-01-01
% 209.74/209.97  |- skos__altLabel mesh__D011500 Protein Synthesis Antagonists
% 209.74/209.97  |- mesh__publicMeSHNote mesh__D011500 88   
% 209.74/209.97  |- skos__hiddenLabel mesh__D011500 Antagonists, Protein Synthesis
% 209.74/209.97  |- skos__scopeNote mesh__D016794
% 209.74/209.97       A genus of tick-borne protozoa parasitic in the lymphocytes, erythrocytes, and endothelial cells of mammals. Its organisms multiply asexually and then invade erythrocytes, where they undergo no further reproduction until ingested by a transmitting tick.%A%    
% 209.74/209.97  |- mesh__dateCreated mesh__D016794 1991-05-02
% 209.74/209.97  |- mesh__historyNote mesh__D016794 92   
% 209.74/209.97  |- rdf__type mesh__D016794sskos__Concept
% 209.74/209.97  |- mesh__recordOriginator mesh__D016794 PXP
% 209.74/209.97  |- mesh__dateEstablished mesh__D016794 1992-01-01
% 209.74/209.97  |- mesh__recordMaintainer mesh__D016794 ags
% 209.74/209.97  |- mesh__dateRevised mesh__D016794 2003-07-09
% 209.74/209.97  |- mesh__publicMeSHNote mesh__D016794 92   
% 209.74/209.97  |- skos__prefLabel mesh__D016794 Theileria
% 209.74/209.97  |- skos__annotation mesh__D016794
% 209.74/209.97       a tick-borne protozoon; infection = THEILERIASIS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D016794 2005
% 209.74/209.97  |- mesh__recordAuthorizer mesh__D016794 sjn
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D016794 2006
% 209.74/209.97  |- skos__historyNote mesh__D016794 Sporozoea %28%1966-1991%29%
% 209.74/209.97  |- skos__broader mesh__D016794smesh__D016792
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D016794 2004
% 209.74/209.97  |- skos__hiddenLabel mesh__D052119 Lysosomal Associated Membrane Protein 2
% 209.74/209.97  |- skos__altLabel mesh__D052119 LAMP2 Protein
% 209.74/209.97  |- skos__altLabel mesh__D052119 CD107b Antigens
% 209.74/209.97  |- mesh__recordMaintainer mesh__D052119 jmp
% 209.74/209.97  |- skos__prefLabel mesh__D052119 Lysosomal-Associated Membrane Protein 2
% 209.74/209.97  |- mesh__dateCreated mesh__D052119 2005-06-30
% 209.74/209.97  |- rdf__type mesh__D052119sskos__Concept
% 209.74/209.97  |- skos__broader mesh__D052119smesh__D015703
% 209.74/209.97  |- mesh__publicMeSHNote mesh__D052119
% 209.74/209.97       2006; ANTIGENS CD107B was indexed under ANTIGENS, CD 2003-2005, %26% under MEMBRANE GLYCOPROTEINS 1986-2002%A%  
% 209.74/209.97  |- mesh__historyNote mesh__D052119 2006%28%1986%29%   
% 209.74/209.97  |- skos__altLabel mesh__D052119 Antigens, CD107b
% 209.74/209.97  |- skos__altLabel mesh__D052119 LGP110 Protein
% 209.74/209.97  |- mesh__recordOriginator mesh__D052119 jmp
% 209.74/209.97  |- skos__scopeNote mesh__D052119
% 209.74/209.97       An abundant lysosomal-associated membrane protein that has been found to shuttle between LYSOSOMES; ENDOSOMES; and the PLASMA MEMBRANE. Loss of expression of lysosomal-associated membrane protein 2 is associated with GLYCOGEN STORAGE DISEASE TYPE IIB.%A%    
% 209.74/209.97  |- mesh__recordAuthorizer mesh__D052119 sjn
% 209.74/209.97  |- skos__altLabel mesh__D052119 LGP-B Protein
% 209.74/209.97  |- skos__hiddenLabel mesh__D052119 LGP B Protein
% 209.74/209.97  |- mesh__dateEstablished mesh__D052119 2006-01-01
% 209.74/209.97  |- skos__broader mesh__D052119smesh__D051907
% 209.74/209.97  |- skos__altLabel mesh__D052119 CD107b Antigen
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D052119 2006
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D002774 1994
% 209.74/209.97  |- mesh__publicMeSHNote mesh__D002774 75; was see under CHOLESTENES 1974   
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D002774 1999
% 209.74/209.97  |- mesh__dateEstablished mesh__D002774 1975-01-01
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D002774 1995
% 209.74/209.97  |- skos__annotation mesh__D002774 do not confuse with CHOLESTADIENOLS   
% 209.74/209.97  |- skos__prefLabel mesh__D002774 Cholestadienes
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D002774 2003
% 209.74/209.97  |- mesh__recordAuthorizer mesh__D002774 PLS
% 209.74/209.97  |- mesh__historyNote mesh__D002774 75; was see under CHOLESTENES 1974   
% 209.74/209.97  |- rdf__type mesh__D002774sskos__Concept
% 209.74/209.97  |- mesh__recordMaintainer mesh__D002774 PLS
% 209.74/209.97  |- skos__broader mesh__D002774smesh__D002782
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D002774 1996
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D002774 2004
% 209.74/209.97  |- skos__historyNote mesh__D002774 Cholestenes %28%1973-1974%29%
% 209.74/209.97  |- mesh__dateCreated mesh__D002774 1999-01-01
% 209.74/209.97  |- skos__scopeNote mesh__D002774
% 209.74/209.97       Cholene derivatives with methyl groups at C-10 and C-13 and a branched 8-carbon chain at C-17. They must have two double bonds in the ring system.%A%    
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D002774 2000
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D002774 1997
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D002774 2005
% 209.74/209.97  |- mesh__onlineNote mesh__D002774 search CHOLESTENES 1974   
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D002774 2001
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D002774 1998
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D002774 2006
% 209.74/209.97  |- mesh__dateRevised mesh__D002774 1993-06-03
% 209.74/209.97  |- mesh__recordOriginator mesh__D002774 NLM
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D002774 2002
% 209.74/209.97  |- mesh__publicMeSHNote mesh__D029911 2002   
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D029911 2003
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D029911 2006
% 209.74/209.97  |- mesh__recordMaintainer mesh__D029911 ssb
% 209.74/209.97  |- mesh__recordAuthorizer mesh__D029911 sjn
% 209.74/209.97  |- rdf__type mesh__D029911sskos__Concept
% 209.74/209.97  |- mesh__dateEstablished mesh__D029911 2002-01-01
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D029911 2005
% 209.74/209.97  |- skos__annotation mesh__D029911
% 209.74/209.97       CAT%27%S CLAW is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.74/209.97  |- mesh__dateCreated mesh__D029911 2001-07-25
% 209.74/209.97  |- skos__broader mesh__D029911smesh__D007887
% 209.74/209.97  |- skos__scopeNote mesh__D029911
% 209.74/209.97       A plant genus of the family FABACEAE.  The common name of %22%Bird-Of-Paradise%22% is also used for other plants such as Heliconia %28%HELICONIACEAE%29% and Strelitzia %28%STRELITZIACEAE%29% and some birds.  The common name of %22%Cat%27%s-Claw%22% is more often used with UNCARIA. The common name of %22%Pernambuco%22% also refers to a state in Brazil. Furanoditerpenoid lactones and caesalpin are produced by members of this genus.%A%    
% 209.74/209.97  |- mesh__historyNote mesh__D029911 2002   
% 209.74/209.97  |- skos__prefLabel mesh__D029911 Caesalpinia
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D029911 2004
% 209.74/209.97  |- mesh__dateRevised mesh__D029911 2002-07-02
% 209.74/209.97  |- mesh__recordOriginator mesh__D029911 ssb
% 209.74/209.97  |- mesh__dateEstablished mesh__D010408 1991-01-01
% 209.74/209.97  |- mesh__historyNote mesh__D010408 91%28%72%29%   
% 209.74/209.97  |- skos__scopeNote mesh__D010408
% 209.74/209.97       A mitosporic fungal species used in the production of penicillin.%A%    
% 209.74/209.97  |- mesh__dateRevised mesh__D010408 2005-06-30
% 209.74/209.97  |- mesh__publicMeSHNote mesh__D010408 91; see PENICILLIUM 1972-90   
% 209.74/209.97  |- mesh__dateCreated mesh__D010408 1999-01-01
% 209.74/209.97  |- mesh__recordOriginator mesh__D010408 NLM
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D010408 2006
% 209.74/209.97  |- mesh__recordAuthorizer mesh__D010408 sjn
% 209.74/209.97  |- mesh__recordMaintainer mesh__D010408 SYSTEM
% 209.74/209.97  |- skos__altLabel mesh__D010408 Penicillium notatum
% 209.74/209.97  |- skos__prefLabel mesh__D010408 Penicillium chrysogenum
% 209.74/209.97  |- skos__historyNote mesh__D010408 Penicillium %28%1966-1971%29%
% 209.74/209.97  |- skos__broader mesh__D010408smesh__D010407
% 209.74/209.97  |- rdf__type mesh__D010408sskos__Concept
% 209.74/209.97  |- mesh__dateEstablished mesh__D020836 2000-01-01
% 209.74/209.97  |- mesh__historyNote mesh__D020836
% 209.74/209.97       2000; use PROTEIN CONFORMATION %28%1993-1999%29%   
% 209.74/209.97  |- mesh__recordMaintainer mesh__D020836 jmp
% 209.74/209.97  |- skos__related mesh__D020836smesh__D046912
% 209.74/209.97  |- mesh__dateCreated mesh__D020836 1999-11-04
% 209.74/209.97  |- skos__broader mesh__D020836smesh__D011487
% 209.74/209.97  |- mesh__recordAuthorizer mesh__D020836 sjn
% 209.74/209.97  |- skos__hiddenLabel mesh__D020836 Protein Structures, Quaternary
% 209.74/209.97  |- rdf__type mesh__D020836sskos__Concept
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D020836 2006
% 209.74/209.97  |- mesh__recordOriginator mesh__D020836 nns
% 209.74/209.97  |- skos__altLabel mesh__D020836 Quaternary Protein Structure
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D020836 2005
% 209.74/209.97  |- skos__scopeNote mesh__D020836
% 209.74/209.97       The characteristic 3-dimensional shape and arrangement of multimeric proteins %28%aggregates of more than one polypeptide chain%29%.%A%    
% 209.74/209.97  |- skos__historyNote mesh__D020836
% 209.74/209.97       Macromolecular Protein Complexes %28%1966-1999%29%
% 209.74/209.97  |- skos__historyNote mesh__D020836 Protein Conformation %28%1972-1999%29%
% 209.74/209.97  |- mesh__dateRevised mesh__D020836 2004-07-07
% 209.74/209.97  |- skos__hiddenLabel mesh__D020836 Quaternary Protein Structures
% 209.74/209.97  |- mesh__publicMeSHNote mesh__D020836
% 209.74/209.97       2000; see PROTEIN CONFORMATION %28%1993-1999%29%   
% 209.74/209.97  |- skos__annotation mesh__D020836
% 209.74/209.97       for multimeric proteins; for the 3-dimensional shape of a single polypeptide chain use PROTEIN CONFORMATION%A%  
% 209.74/209.97  |- skos__prefLabel mesh__D020836 Protein Structure, Quaternary
% 209.74/209.97  |- skos__scopeNote mesh__D006367
% 209.74/209.97       The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks %28%one of several pseudonyms%29%. These cells are used for VIRUS CULTIVATION and antitumor drug screening assays.%A%    
% 209.74/209.97  |- skos__hiddenLabel mesh__D006367 Hela Cell
% 209.74/209.97  |- skos__hiddenLabel mesh__D006367 Cell, Hela
% 209.74/209.97  |- mesh__recordAuthorizer mesh__D006367 sjn
% 209.74/209.97  |- mesh__activeMeSHYear mesh__D006367 2006
% 209.74/209.97  |- skos__broader mesh__D006367smesh__D004847
% 209.74/209.98  |- skos__broader mesh__D006367smesh__D045744
% 209.74/209.98  |- mesh__dateRevised mesh__D006367 2005-07-01
% 209.74/209.98  |- skos__annotation mesh__D006367
% 209.74/209.98       almost always NIM with no subheadings; check HUMAN; do not routinely add UTERINE CERVICAL NEOPLASMS%A%  
% 209.74/209.98  |- mesh__historyNote mesh__D006367 68%28%65%29%   
% 209.74/209.98  |- mesh__dateEstablished mesh__D006367 1968-01-01
% 209.74/209.98  |- skos__prefLabel mesh__D006367 Hela Cells
% 209.74/209.98  |- skos__hiddenLabel mesh__D006367 Cells, Hela
% 209.74/209.98  |- mesh__publicMeSHNote mesh__D006367 68   
% 209.74/209.98  |- mesh__recordMaintainer mesh__D006367 sjn
% 209.74/209.98  |- mesh__dateCreated mesh__D006367 1999-01-01
% 209.74/209.98  |- rdf__type mesh__D006367sskos__Concept
% 209.74/209.98  |- mesh__recordOriginator mesh__D006367 NLM
% 209.74/209.98  |- skos__hiddenLabel mesh__D020038 Leader, Spliced
% 209.74/209.98  |- skos__hiddenLabel mesh__D020038 Leader Sequences, Spliced
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D020038 2004
% 209.74/209.98  |- skos__historyNote mesh__D020038 RNA, Messenger %28%1983-1995%29%
% 209.74/209.98  |- skos__hiddenLabel mesh__D020038 Sequence, SL2
% 209.74/209.98  |- mesh__dateEstablished mesh__D020038 1999-01-01
% 209.74/209.98  |- skos__hiddenLabel mesh__D020038 Sequences, Spliced Leader
% 209.74/209.98  |- skos__altLabel mesh__D020038 Spliced Leader Sequences
% 209.74/209.98  |- skos__prefLabel mesh__D020038 RNA, Spliced Leader
% 209.74/209.98  |- skos__altLabel mesh__D020038 Spliced Leader
% 209.74/209.98  |- mesh__publicMeSHNote mesh__D020038 99   
% 209.74/209.98  |- skos__altLabel mesh__D020038 SL RNA
% 209.74/209.98  |- skos__hiddenLabel mesh__D020038 Leader Sequences, Trans-Spliced
% 209.74/209.98  |- mesh__dateCreated mesh__D020038 1998-06-11
% 209.74/209.98  |- skos__hiddenLabel mesh__D020038 Sequence, SL1
% 209.74/209.98  |- skos__hiddenLabel mesh__D020038 Sequence, SL4
% 209.74/209.98  |- skos__related mesh__D020038smesh__D020040
% 209.74/209.98  |- rdf__type mesh__D020038sskos__Concept
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D020038 2002
% 209.74/209.98  |- skos__hiddenLabel mesh__D020038 Sequences, Trans-Spliced Leader
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D020038 2005
% 209.74/209.98  |- mesh__historyNote mesh__D020038 99   
% 209.74/209.98  |- skos__hiddenLabel mesh__D020038 Trans Spliced Leader Sequences
% 209.74/209.98  |- skos__hiddenLabel mesh__D020038 Sequence, SL3
% 209.74/209.98  |- skos__broader mesh__D020038smesh__D022661
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D020038 2006
% 209.74/209.98  |- skos__hiddenLabel mesh__D020038 Leader RNA, Spliced
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D020038 2003
% 209.74/209.98  |- mesh__dateRevised mesh__D020038 2000-06-22
% 209.74/209.98  |- skos__altLabel mesh__D020038 Spliced Leader RNA
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D020038 2001
% 209.74/209.98  |- skos__annotation mesh__D020038
% 209.74/209.98       do not confuse with LEADER SEQUENCES, MRNA see 5%27% UNTRANSLATED REGION%A%  
% 209.74/209.98  |- skos__scopeNote mesh__D020038
% 209.74/209.98       The small RNAs which provide spliced leader sequences, SL1, SL2, SL3, SL4 and SL5 %28%short sequences which are joined to the 5%27% ends of pre-mRNAs by TRANS-SPLICING%29%. They are found primarily in primitive eukaryotes %28%protozoans and nematodes%29%.%A%    
% 209.74/209.98  |- skos__hiddenLabel mesh__D020038 Sequence, SL5
% 209.74/209.98  |- skos__historyNote mesh__D020038 Signal Peptides %28%1987-1998%29%
% 209.74/209.98  |- skos__hiddenLabel mesh__D025521 Proteins, Tumor Suppressor
% 209.74/209.98  |- skos__scopeNote mesh__D025521
% 209.74/209.98       Proteins that are normally involved in holding cellular growth in check. Deficiencies or abnormalities in these proteins may lead to unregulated cell growth and tumor development.%A%    
% 209.74/209.98  |- mesh__recordMaintainer mesh__D025521 SYSTEM
% 209.74/209.98  |- skos__hiddenLabel mesh__D025521 Proteins, Metastasis Suppressor
% 209.74/209.98  |- mesh__dateRevised mesh__D025521 2005-06-30
% 209.74/209.98  |- mesh__recordAuthorizer mesh__D025521 sjn
% 209.74/209.98  |- mesh__dateEstablished mesh__D025521 2002-01-01
% 209.74/209.98  |- mesh__publicMeSHNote mesh__D025521 2002   
% 209.74/209.98  |- mesh__recordOriginator mesh__D025521 nns
% 209.74/209.98  |- skos__prefLabel mesh__D025521 Tumor Suppressor Proteins
% 209.74/209.98  |- rdf__type mesh__D025521sskos__Concept
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D025521 2006
% 209.74/209.98  |- skos__broader mesh__D025521smesh__D009363
% 209.74/209.98  |- mesh__dateCreated mesh__D025521 2001-07-25
% 209.74/209.98  |- skos__hiddenLabel mesh__D025521 Proteins, Growth Suppressor
% 209.74/209.98  |- skos__related mesh__D025521smesh__D016147
% 209.74/209.98  |- mesh__historyNote mesh__D025521 2002   
% 209.74/209.98  |- rdf__type mesh__D002775sskos__Concept
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D002775 2000
% 209.74/209.98  |- mesh__dateEstablished mesh__D002775 1974-01-01
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D002775 1996
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D002775 2004
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D002775 2001
% 209.74/209.98  |- mesh__dateCreated mesh__D002775 1999-01-01
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D002775 1997
% 209.74/209.98  |- mesh__dateRevised mesh__D002775 1993-06-03
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D002775 2005
% 209.74/209.98  |- mesh__recordOriginator mesh__D002775 NLM
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D002775 2002
% 209.74/209.98  |- skos__prefLabel mesh__D002775 Cholestadienols
% 209.74/209.98  |- skos__broader mesh__D002775smesh__D002774
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D002775 1998
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D002775 2006
% 209.74/209.98  |- mesh__historyNote mesh__D002775 74   
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D002775 1994
% 209.74/209.98  |- skos__annotation mesh__D002775 do not confuse with CHOLESTADIENES   
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D002775 1999
% 209.74/209.98  |- mesh__recordMaintainer mesh__D002775 PLS
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D002775 1995
% 209.74/209.98  |- mesh__publicMeSHNote mesh__D002775 74   
% 209.74/209.98  |- mesh__recordAuthorizer mesh__D002775 PLS
% 209.74/209.98  |- skos__scopeNote mesh__D002775
% 209.74/209.98       Cholestadiene derivatives containing a hydroxy group anywhere in the molecule.%A%    
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D002775 2003
% 209.74/209.98  |- mesh__dateRevised mesh__D029912 2002-07-02
% 209.74/209.98  |- rdf__type mesh__D029912sskos__Concept
% 209.74/209.98  |- mesh__dateEstablished mesh__D029912 2002-01-01
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D029912 2005
% 209.74/209.98  |- skos__broader mesh__D029912smesh__D007887
% 209.74/209.98  |- skos__scopeNote mesh__D029912
% 209.74/209.98       A plant genus of the family FABACEAE. Members contain ABRIN.%A%    
% 209.74/209.98  |- mesh__recordMaintainer mesh__D029912 ssb
% 209.74/209.98  |- mesh__recordAuthorizer mesh__D029912 sjn
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D029912 2004
% 209.74/209.98  |- mesh__dateCreated mesh__D029912 2001-07-25
% 209.74/209.98  |- skos__annotation mesh__D029912
% 209.74/209.98       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.74/209.98  |- mesh__recordOriginator mesh__D029912 ssb
% 209.74/209.98  |- skos__prefLabel mesh__D029912 Abrus
% 209.74/209.98  |- skos__altLabel mesh__D029912 Precatory Bean Plant
% 209.74/209.98  |- mesh__publicMeSHNote mesh__D029912 2002   
% 209.74/209.98  |- mesh__historyNote mesh__D029912 2002   
% 209.74/209.98  |- skos__altLabel mesh__D029912 Bean Plant, Precatory
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D029912 2003
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D029912 2006
% 209.74/209.98  |- skos__hiddenLabel mesh__D010409 Penile Disease
% 209.74/209.98  |- skos__prefLabel mesh__D010409 Penile Diseases
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D010409 2002
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D010409 1999
% 209.74/209.98  |- mesh__dateEstablished mesh__D010409 1966-01-01
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D010409 2004
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D010409 2001
% 209.74/209.98  |- skos__hiddenLabel mesh__D010409 Disease, Penile
% 209.74/209.98  |- mesh__dateCreated mesh__D010409 1999-01-01
% 209.74/209.98  |- mesh__publicMeSHNote mesh__D010409 66   
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D010409 2006
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D010409 2003
% 209.74/209.98  |- mesh__recordAuthorizer mesh__D010409 SJN
% 209.74/209.98  |- mesh__recordMaintainer mesh__D010409 NDW
% 209.74/209.98  |- skos__hiddenLabel mesh__D010409 Penis Disease
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D010409 2005
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D010409 2000
% 209.74/209.98  |- mesh__dateRevised mesh__D010409 1998-06-10
% 209.74/209.98  |- skos__hiddenLabel mesh__D010409 Diseases, Penis
% 209.74/209.98  |- skos__hiddenLabel mesh__D010409 Disease, Penis
% 209.74/209.98  |- mesh__historyNote mesh__D010409 66   
% 209.74/209.98  |- mesh__recordOriginator mesh__D010409 NLM
% 209.74/209.98  |- rdf__type mesh__D010409sskos__Concept
% 209.74/209.98  |- skos__altLabel mesh__D010409 Penis Diseases
% 209.74/209.98  |- skos__hiddenLabel mesh__D010409 Diseases, Penile
% 209.74/209.98  |- skos__annotation mesh__D010409
% 209.74/209.98       inflamm dis = BALANITIS; penile fract: index under PENIS /inj %28%IM%29% + RUPTURE %28%NIM%29%%A%  
% 209.74/209.98  |- skos__broader mesh__D010409smesh__D005832
% 209.74/209.98  |- skos__historyNote mesh__D007460 Amides %28%1972-1974%29%
% 209.74/209.98  |- skos__broader mesh__D007460smesh__D019807
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D007460 2002
% 209.74/209.98  |- skos__broader mesh__D007460smesh__D000081
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D007460 2006
% 209.74/209.98  |- mesh__publicMeSHNote mesh__D007460
% 209.74/209.98       91; was see under IODOACETATES 1975-90   
% 209.74/209.98  |- mesh__recordMaintainer mesh__D007460 adp
% 209.74/209.98  |- mesh__dateEstablished mesh__D007460 1991-01-01
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D007460 2003
% 209.74/209.98  |- mesh__dateRevised mesh__D007460 1999-11-03
% 209.74/209.98  |- mesh__recordOriginator mesh__D007460 NLM
% 209.74/209.98  |- rdf__type mesh__D007460sskos__Concept
% 209.74/209.98  |- mesh__historyNote mesh__D007460
% 209.74/209.98       91%28%75%29%; was see under IODOACETATES 1975-90   
% 209.74/209.98  |- skos__historyNote mesh__D007460 Iodoacetates %28%1969-1974%29%
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D007460 2000
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D007460 2004
% 209.74/209.98  |- mesh__recordAuthorizer mesh__D007460 sjn
% 209.74/209.98  |- mesh__dateCreated mesh__D007460 1974-11-19
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D007460 2001
% 209.74/209.98  |- skos__prefLabel mesh__D007460 Iodoacetamide
% 209.74/209.98  |- skos__scopeNote mesh__D007460
% 209.74/209.98       An alkylating sulfhydryl reagent. Its actions are similar to those of iodoacetate.%A%    
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D007460 2005
% 209.74/209.98  |- skos__historyNote mesh__D020837 Fungal Proteins %28%1992-1999%29%
% 209.74/209.98  |- skos__prefLabel mesh__D020837 SOS1 Protein
% 209.74/209.98  |- skos__scopeNote mesh__D020837
% 209.74/209.98       A mammalian homolog of the DROSOPHILA SON OF SEVENLESS PROTEIN. It is a guanine nucleotide exchange factor for RAS PROTEINS.%A%    
% 209.74/209.98  |- mesh__publicMeSHNote mesh__D020837
% 209.74/209.98       2000; SOS1 PROTEIN was indexed under REPRESSOR PROTEINS 1993-1999; MSOS1 PROTEIN was indexed under PROTEINS 1993-1999%A%  
% 209.74/209.98  |- skos__altLabel mesh__D020837 Son of Sevenless Homolog 1
% 209.74/209.98  |- skos__broader mesh__D020837smesh__D020664
% 209.74/209.98  |- rdf__type mesh__D020837sskos__Concept
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D020837 2006
% 209.74/209.98  |- mesh__dateEstablished mesh__D020837 2000-01-01
% 209.74/209.98  |- mesh__dateCreated mesh__D020837 1999-11-03
% 209.74/209.98  |- mesh__dateRevised mesh__D020837 2005-06-30
% 209.74/209.98  |- mesh__historyNote mesh__D020837
% 209.74/209.98       2000; use SOS1 PROTEIN %28%NM%29% 1992-1999; for MSOS1 PROTEIN use GUANINE NUCLEOTIDE EXCHANGE FACTORS %28%NM%29% 1996-1999%A%  
% 209.74/209.98  |- skos__historyNote mesh__D020837 Membrane Proteins %28%1992-1999%29%
% 209.74/209.98  |- mesh__recordAuthorizer mesh__D020837 sjn
% 209.74/209.98  |- skos__historyNote mesh__D020837 Repressor Proteins %28%1992-1999%29%
% 209.74/209.98  |- mesh__recordMaintainer mesh__D020837 ags
% 209.74/209.98  |- mesh__recordOriginator mesh__D020837 jmp
% 209.74/209.98  |- skos__altLabel mesh__D020837 mSOS1 Protein
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D006368 2006
% 209.74/209.98  |- skos__prefLabel mesh__D006368 Helianthus
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D006368 2002
% 209.74/209.98  |- mesh__recordOriginator mesh__D006368 NLM
% 209.74/209.98  |- skos__annotation mesh__D006368
% 209.74/209.98       for sunflower seeds coord IM with SEEDS %28%IM%29%; do not confuse X ref JERUSALEM ARTICHOKE with plain artichoke %28%index probably VEGETABLES%29%%A%  
% 209.74/209.98  |- skos__hiddenLabel mesh__D006368 Artichoke, Jerusalem
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D006368 2003
% 209.74/209.98  |- mesh__dateRevised mesh__D006368 1998-06-10
% 209.74/209.98  |- mesh__recordAuthorizer mesh__D006368 SJN
% 209.74/209.98  |- skos__broader mesh__D006368smesh__D000821
% 209.74/209.98  |- mesh__recordMaintainer mesh__D006368 NNS
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D006368 2004
% 209.74/209.98  |- skos__hiddenLabel mesh__D006368 Sunflowers
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D006368 2000
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D006368 2001
% 209.74/209.98  |- mesh__dateCreated mesh__D006368 1999-01-01
% 209.74/209.98  |- rdf__type mesh__D006368sskos__Concept
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D006368 2005
% 209.74/209.98  |- skos__broader mesh__D006368smesh__D019659
% 209.74/209.98  |- skos__scopeNote mesh__D006368
% 209.74/209.98       A genus of tall, erect American herbs of the Compositae. The seeds yield oil and are used as food and animal feed; the roots of Helianthus tuberosum %28%Jerusalem artichoke%29% are edible.%A%    
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D006368 1999
% 209.74/209.98  |- skos__historyNote mesh__D017090 Orthodontic Appliances %28%1969-1992%29%
% 209.74/209.98  |- mesh__historyNote mesh__D017090 93   
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D017090 2001
% 209.74/209.98  |- skos__scopeNote mesh__D017090
% 209.74/209.98       Rigid or flexible appliances that overlay the occlusal surfaces of the teeth. They are used to treat clenching and bruxism and their sequelae, and to provide temporary relief from muscle or temporomandibular joint pain.%A%    
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D017090 2004
% 209.74/209.98  |- mesh__recordMaintainer mesh__D017090 JLS
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D017090 2000
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D017090 2006
% 209.74/209.98  |- skos__altLabel mesh__D017090 Splints, Occlusal
% 209.74/209.98  |- mesh__dateRevised mesh__D017090 1996-06-21
% 209.74/209.98  |- mesh__dateCreated mesh__D017090 1992-05-22
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D017090 2003
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D017090 1997
% 209.74/209.98  |- mesh__publicMeSHNote mesh__D017090 93   
% 209.74/209.98  |- skos__prefLabel mesh__D017090 Occlusal Splints
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D017090 2005
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D017090 1999
% 209.74/209.98  |- skos__hiddenLabel mesh__D017090 Occlusal Splint
% 209.74/209.98  |- rdf__type mesh__D017090sskos__Concept
% 209.74/209.98  |- mesh__recordOriginator mesh__D017090 MXR
% 209.74/209.98  |- mesh__recordAuthorizer mesh__D017090 PLS
% 209.74/209.98  |- mesh__dateEstablished mesh__D017090 1993-01-01
% 209.74/209.98  |- skos__annotation mesh__D017090
% 209.74/209.98       rigid or flexible splint used in orthodontics %26% treatment of clenching %26% bruxism%A%  
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D017090 1998
% 209.74/209.98  |- skos__hiddenLabel mesh__D017090 Splint, Occlusal
% 209.74/209.98  |- skos__broader mesh__D017090smesh__D009967
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D017090 2002
% 209.74/209.98  |- mesh__dateEstablished mesh__D025522 2002-01-01
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D025522 2004
% 209.74/209.98  |- skos__hiddenLabel mesh__D025522 Phage, N4
% 209.74/209.98  |- skos__broader mesh__D025522smesh__D017902
% 209.74/209.98  |- skos__altLabel mesh__D025522 Enterobacteria phage N4
% 209.74/209.98  |- skos__scopeNote mesh__D025522
% 209.74/209.98       A species with unassigned genus in the family PODOVIRIDAE.%A%    
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D025522 2005
% 209.74/209.98  |- rdf__type mesh__D025522sskos__Concept
% 209.74/209.98  |- skos__altLabel mesh__D025522 Phage N4
% 209.74/209.98  |- skos__prefLabel mesh__D025522 Bacteriophage N4
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D025522 2006
% 209.74/209.98  |- skos__hiddenLabel mesh__D025522 Phages, N4
% 209.74/209.98  |- skos__hiddenLabel mesh__D025522 N4 Phages
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D025522 2002
% 209.74/209.98  |- skos__broader mesh__D025522smesh__D003090
% 209.74/209.98  |- skos__historyNote mesh__D025522 Coliphages %28%1977-1993%29%
% 209.74/209.98  |- skos__altLabel mesh__D025522 Coliphage N4
% 209.74/209.98  |- mesh__historyNote mesh__D025522 2002; use PODOVIRIDAE 1994-2001   
% 209.74/209.98  |- mesh__publicMeSHNote mesh__D025522 2002; see PODOVIRIDAE 1994-2001   
% 209.74/209.98  |- skos__altLabel mesh__D025522 N4 Phage
% 209.74/209.98  |- mesh__dateCreated mesh__D025522 2001-07-25
% 209.74/209.98  |- skos__historyNote mesh__D025522 Podoviridae %28%1993-2001%29%
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D025522 2003
% 209.74/209.98  |- skos__historyNote mesh__D003070 Ribonucleosides %28%1971-1978%29%
% 209.74/209.98  |- mesh__recordMaintainer mesh__D003070 JRT
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D003070 2005
% 209.74/209.98  |- mesh__historyNote mesh__D003070
% 209.74/209.98       90%28%79%29%; was see under RIBONUCLEOSIDES 1979-89   
% 209.74/209.98  |- skos__historyNote mesh__D003070 Azepines %28%1966-1978%29%
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D003070 2000
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D003070 1999
% 209.74/209.98  |- skos__historyNote mesh__D003070 Nucleosides %28%1966-1970%29%
% 209.74/209.98  |- rdf__type mesh__D003070sskos__Concept
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D003070 2004
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D003070 1998
% 209.74/209.98  |- mesh__recordOriginator mesh__D003070 SH
% 209.74/209.98  |- mesh__dateRevised mesh__D003070 1995-06-08
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D003070 2003
% 209.74/209.98  |- mesh__publicMeSHNote mesh__D003070
% 209.74/209.98       90; was see under RIBONUCLEOSIDES 1979-89   
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D003070 1997
% 209.74/209.98  |- mesh__recordAuthorizer mesh__D003070 PLS
% 209.74/209.98  |- skos__annotation mesh__D003070
% 209.74/209.98       an enzyme inhib %26% antineoplastic antibiotic   
% 209.74/209.98  |- skos__prefLabel mesh__D003070 Coformycin
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D003070 1996
% 209.74/209.98  |- mesh__dateEstablished mesh__D003070 1990-01-01
% 209.74/209.98  |- skos__broader mesh__D003070smesh__D005573
% 209.74/209.98  |- mesh__dateCreated mesh__D003070 1977-12-08
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D003070 2002
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D003070 2006
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D003070 2001
% 209.74/209.98  |- skos__scopeNote mesh__D003070
% 209.74/209.98       A ribonucleoside antibiotic synergist and adenosine deaminase inhibitor isolated from Nocardia interforma and Streptomyces kaniharaensis. It is proposed as an antineoplastic synergist and immunosuppressant.%A%    
% 209.74/209.98  |- skos__annotation mesh__D011502 consider also KWASHIORKOR   
% 209.74/209.98  |- mesh__publicMeSHNote mesh__D011502
% 209.74/209.98       92; was PROTEIN-CALORIE MALNUTRITION 1974-91   
% 209.74/209.98  |- mesh__dateCreated mesh__D011502 1999-01-01
% 209.74/209.98  |- skos__historyNote mesh__D011502 Nutrition Disorders %28%1966-1971%29%
% 209.74/209.98  |- mesh__recordMaintainer mesh__D011502 nns
% 209.74/209.98  |- skos__hiddenLabel mesh__D011502 Malnutrition, Protein-Energy
% 209.74/209.98  |- skos__hiddenLabel mesh__D011502 Malnutritions, Protein-Energy
% 209.74/209.98  |- skos__prefLabel mesh__D011502 Protein-Energy Malnutrition
% 209.74/209.98  |- skos__related mesh__D011502smesh__D004614
% 209.74/209.98  |- skos__historyNote mesh__D011502
% 209.74/209.98       Infant Nutrition Disorders %28%1966-1971%29%
% 209.74/209.98  |- mesh__dateRevised mesh__D011502 2004-07-07
% 209.74/209.98  |- skos__scopeNote mesh__D011502
% 209.74/209.98       The lack of sufficient energy or protein to meet the body%27%s metabolic demands, as a result of either an inadequate dietary intake of protein, intake of poor quality dietary protein, increased demands due to disease, or increased nutrient losses.%A%    
% 209.74/209.98  |- mesh__historyNote mesh__D011502
% 209.74/209.98       92; was PROTEIN-CALORIE MALNUTRITION 1972-91 %28%Prov 1972-73%29%%A%  
% 209.74/209.98  |- mesh__recordAuthorizer mesh__D011502 sjn
% 209.74/209.98  |- mesh__onlineNote mesh__D011502
% 209.74/209.98       use PROTEIN-ENERGY MALNUTRITION to search PROTEIN-CALORIE MALNUTRITION 1972-91 %28%as Prov 1972-73%29%%A%  
% 209.74/209.98  |- skos__altLabel mesh__D011502 Protein-Calorie Malnutrition
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D011502 2006
% 209.74/209.98  |- skos__hiddenLabel mesh__D011502 Protein Calorie Malnutrition
% 209.74/209.98  |- rdf__type mesh__D011502sskos__Concept
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D011502 2005
% 209.74/209.98  |- mesh__recordOriginator mesh__D011502 NLM
% 209.74/209.98  |- skos__hiddenLabel mesh__D011502 Protein Energy Malnutrition
% 209.74/209.98  |- skos__broader mesh__D011502smesh__D011488
% 209.74/209.98  |- mesh__dateEstablished mesh__D011502 1974-01-01
% 209.74/209.98  |- skos__hiddenLabel mesh__D011502 Malnutrition, Protein-Calorie
% 209.74/209.98  |- skos__altLabel mesh__D049970 Ophthalmopathy, Thyroid-Associated
% 209.74/209.98  |- skos__hiddenLabel mesh__D049970 Congestive Ophthalmopathies
% 209.74/209.98  |- mesh__recordAuthorizer mesh__D049970 sjn
% 209.74/209.98  |- mesh__recordMaintainer mesh__D049970 lkt
% 209.74/209.98  |- skos__hiddenLabel mesh__D049970 Ophthalmopathies, Infiltrative
% 209.74/209.98  |- skos__hiddenLabel mesh__D049970 Ophthalmopathy, Congestive
% 209.74/209.98  |- skos__altLabel mesh__D049970 Thyroid-Associated Ophthalmopathy
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D049970 2006
% 209.74/209.98  |- skos__hiddenLabel mesh__D049970 Ophthalmopathies, Dysthyroid
% 209.74/209.98  |- skos__altLabel mesh__D049970 Edematous Ophthalmopathy
% 209.74/209.98  |- skos__hiddenLabel mesh__D049970 Infiltrative Ophthalmopathy
% 209.74/209.98  |- skos__scopeNote mesh__D049970
% 209.74/209.98       An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive %28%inflammation of the orbital connective tissue%29%, myopathic %28%swelling and dysfunction of the extraocular muscles%29%, and mixed congestive-myopathic ophthalmopathy.%A%    
% 209.74/209.98  |- skos__hiddenLabel mesh__D049970 Edematous Ophthalmopathies
% 209.74/209.98  |- mesh__dateEstablished mesh__D049970 2006-01-01
% 209.74/209.98  |- skos__hiddenLabel mesh__D049970 Dysthyroid Ophthalmopathies
% 209.74/209.98  |- skos__historyNote mesh__D049970 Graves Disease %28%1987-2005%29%
% 209.74/209.98  |- skos__hiddenLabel mesh__D049970 Thyroid Associated Ophthalmopathy
% 209.74/209.98  |- skos__hiddenLabel mesh__D049970 Ophthalmopathies, Myopathic
% 209.74/209.98  |- skos__hiddenLabel mesh__D049970 Infiltrative Ophthalmopathies
% 209.74/209.98  |- skos__altLabel mesh__D049970 Ophthalmopathies, Thyroid-Associated
% 209.74/209.98  |- skos__altLabel mesh__D049970 Dysthyroid Ophthalmopathy
% 209.74/209.98  |- mesh__dateCreated mesh__D049970 2005-06-30
% 209.74/209.98  |- skos__hiddenLabel mesh__D049970 Ophthalmopathies, Congestive
% 209.74/209.98  |- skos__hiddenLabel mesh__D049970 Ophthalmopathy, Myopathic
% 209.74/209.98  |- skos__altLabel mesh__D049970 Thyroid-Associated Ophthalmopathies
% 209.74/209.98  |- skos__broader mesh__D049970smesh__D006111
% 209.74/209.98  |- skos__prefLabel mesh__D049970 Graves Ophthalmopathy
% 209.74/209.98  |- skos__altLabel mesh__D049970 Ophthalmopathy, Infiltrative
% 209.74/209.98  |- skos__hiddenLabel mesh__D049970 Ophthalmopathy, Graves
% 209.74/209.98  |- mesh__historyNote mesh__D049970 2006; use GRAVES DISEASE 1997-2005   
% 209.74/209.98  |- skos__hiddenLabel mesh__D049970 Thyroid Associated Ophthalmopathies
% 209.74/209.98  |- skos__hiddenLabel mesh__D049970 Ophthalmopathy, Dysthyroid
% 209.74/209.98  |- skos__broader mesh__D049970smesh__D015785
% 209.74/209.98  |- skos__hiddenLabel mesh__D049970 Myopathic Ophthalmopathies
% 209.74/209.98  |- skos__hiddenLabel mesh__D049970 Ophthalmopathies, Edematous
% 209.74/209.98  |- mesh__publicMeSHNote mesh__D049970
% 209.74/209.98       2006; see GRAVES%27% DISEASE 1997-2005   
% 209.74/209.98  |- skos__hiddenLabel mesh__D049970 Ophthalmopathies, Thyroid Associated
% 209.74/209.98  |- skos__hiddenLabel mesh__D049970 Ophthalmopathy, Thyroid Associated
% 209.74/209.98  |- mesh__recordOriginator mesh__D049970 lkt
% 209.74/209.98  |- skos__hiddenLabel mesh__D049970 Ophthalmopathy, Edematous
% 209.74/209.98  |- rdf__type mesh__D049970sskos__Concept
% 209.74/209.98  |- mesh__recordAuthorizer mesh__D016796 sjn
% 209.74/209.98  |- skos__broader mesh__D016796smesh__D016794
% 209.74/209.98  |- mesh__historyNote mesh__D016796 92   
% 209.74/209.98  |- mesh__recordOriginator mesh__D016796 PXP
% 209.74/209.98  |- mesh__dateRevised mesh__D016796 2003-07-30
% 209.74/209.98  |- rdf__type mesh__D016796sskos__Concept
% 209.74/209.98  |- skos__prefLabel mesh__D016796 Theileria annulata
% 209.74/209.98  |- mesh__dateEstablished mesh__D016796 1992-01-01
% 209.74/209.98  |- skos__scopeNote mesh__D016796
% 209.74/209.98       A protozoan parasite causing tropical theileriasis in cattle. It is transmitted by ticks of the Hyalomma genus.%A%    
% 209.74/209.98  |- skos__annotation mesh__D016796
% 209.74/209.98       a tick-borne protozoon; infection: coord IM with THEILERIASIS %28%IM%29% + check tags ANIMALS %26% CATTLE but not also CATTLE DISEASES; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 209.74/209.98  |- mesh__publicMeSHNote mesh__D016796 92   
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D016796 2004
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D016796 2006
% 209.74/209.98  |- mesh__recordMaintainer mesh__D016796 sjn
% 209.74/209.98  |- mesh__dateCreated mesh__D016796 1991-05-02
% 209.74/209.98  |- skos__historyNote mesh__D016796 Sporozoea %28%1966-1991%29%
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D016796 2005
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D002776 2003
% 209.74/209.98  |- mesh__dateEstablished mesh__D002776 1968-01-01
% 209.74/209.98  |- mesh__dateCreated mesh__D002776 1999-01-01
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D002776 2001
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D002776 1997
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D002776 2004
% 209.74/209.98  |- mesh__recordOriginator mesh__D002776 NLM
% 209.74/209.98  |- mesh__dateRevised mesh__D002776 1993-06-03
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D002776 2002
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D002776 1998
% 209.74/209.98  |- skos__scopeNote mesh__D002776
% 209.74/209.98       Derivatives of the saturated steroid cholestane with methyl groups at C-18 and C-19 and an iso-octyl side chain at C-17.%A%    
% 209.74/209.98  |- mesh__activeMeSHYear mesh__D002776 2005
% 209.74/209.98  |- mesh__publicMeSHNote mesh__D002776 68   
% 209.84/209.98  |- mesh__activeMeSHYear mesh__D002776 1999
% 209.84/209.98  |- mesh__activeMeSHYear mesh__D002776 2006
% 209.84/209.98  |- mesh__recordAuthorizer mesh__D002776 PLS
% 209.84/209.98  |- skos__annotation mesh__D002776 do not confuse with CHOLESTENES   
% 209.84/209.98  |- mesh__activeMeSHYear mesh__D002776 1994
% 209.84/209.98  |- mesh__historyNote mesh__D002776 68   
% 209.84/209.98  |- skos__prefLabel mesh__D002776 Cholestanes
% 209.84/209.98  |- mesh__recordMaintainer mesh__D002776 PLS
% 209.84/209.98  |- skos__broader mesh__D002776smesh__D013256
% 209.84/209.98  |- mesh__activeMeSHYear mesh__D002776 2000
% 209.84/209.98  |- mesh__activeMeSHYear mesh__D002776 1995
% 209.84/209.98  |- mesh__activeMeSHYear mesh__D002776 1996
% 209.84/209.98  |- rdf__type mesh__D002776sskos__Concept
% 209.84/209.98  |- mesh__publicMeSHNote mesh__D007461
% 209.84/209.98       63; SODIUM IODOACETATE was indexed under IODOACETATES 1988-98; IODOACETATE was indexed under IODOACETATES 1980-98%A%  
% 209.84/209.98  |- mesh__activeMeSHYear mesh__D007461 2001
% 209.84/209.98  |- mesh__dateCreated mesh__D007461 1999-01-01
% 209.84/209.98  |- mesh__historyNote mesh__D007461
% 209.84/209.98       63; for SODIUM IODOACETATE use IODOACETATES %28%NM%29% 1988-98; for IODOACETATE use IODOACETATES %28%NM%29% 1980-98%A%  
% 209.84/209.98  |- mesh__recordMaintainer mesh__D007461 adp
% 209.84/209.98  |- mesh__activeMeSHYear mesh__D007461 2002
% 209.84/209.98  |- skos__broader mesh__D007461smesh__D019807
% 209.84/209.98  |- mesh__activeMeSHYear mesh__D007461 2003
% 209.84/209.98  |- skos__prefLabel mesh__D007461 Iodoacetates
% 209.84/209.98  |- rdf__type mesh__D007461sskos__Concept
% 209.84/209.98  |- skos__hiddenLabel mesh__D007461 Iodoacetate, Sodium
% 209.84/209.98  |- skos__broader mesh__D007461smesh__D000085
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D007461 2004
% 209.84/209.99  |- mesh__dateRevised mesh__D007461 1999-11-03
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D007461 2005
% 209.84/209.99  |- mesh__recordOriginator mesh__D007461 NLM
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D007461 2000
% 209.84/209.99  |- skos__scopeNote mesh__D007461
% 209.84/209.99       Iodinated derivatives of acetic acid. Iodoacetates are commonly used as alkylating sulfhydryl reagents and enzyme inhibitors in biochemical research.%A%    
% 209.84/209.99  |- mesh__recordAuthorizer mesh__D007461 sjn
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D007461 2006
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D020838 2005
% 209.84/209.99  |- rdf__type mesh__D020838sskos__Concept
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D020838 2006
% 209.84/209.99  |- mesh__dateEstablished mesh__D020838 2000-01-01
% 209.84/209.99  |- mesh__publicMeSHNote mesh__D020838 2000   
% 209.84/209.99  |- mesh__dateRevised mesh__D020838 2002-07-03
% 209.84/209.99  |- skos__prefLabel mesh__D020838 Calendula
% 209.84/209.99  |- skos__scopeNote mesh__D020838
% 209.84/209.99       A plant genus of the family ASTERACEAE. Members contain CAROTENOIDS, essential oils %28%OILS, VOLATILE%29%, flavonoids, mucilage, SAPONINS, and STEROLS. The plants are used both topically and internally.  The common name of Marigold is also used for TAGETES.%A%    
% 209.84/209.99  |- skos__historyNote mesh__D020838 Plants, Medicinal %28%1970-1999%29%
% 209.84/209.99  |- skos__broader mesh__D020838smesh__D019659
% 209.84/209.99  |- skos__annotation mesh__D020838
% 209.84/209.99       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D020838 2003
% 209.84/209.99  |- mesh__recordOriginator mesh__D020838 ags
% 209.84/209.99  |- mesh__recordMaintainer mesh__D020838 ssb
% 209.84/209.99  |- mesh__dateCreated mesh__D020838 1999-11-03
% 209.84/209.99  |- mesh__recordAuthorizer mesh__D020838 sjn
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D020838 2004
% 209.84/209.99  |- mesh__historyNote mesh__D020838 2000   
% 209.84/209.99  |- mesh__publicMeSHNote mesh__D006369 86   
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D006369 2006
% 209.84/209.99  |- mesh__dateEstablished mesh__D006369 1986-01-01
% 209.84/209.99  |- mesh__recordOriginator mesh__D006369 EC
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D006369 2004
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D006369 2005
% 209.84/209.99  |- mesh__dateCreated mesh__D006369 1985-03-11
% 209.84/209.99  |- skos__broader mesh__D006369smesh__D017183
% 209.84/209.99  |- mesh__recordAuthorizer mesh__D006369 sjn
% 209.84/209.99  |- skos__scopeNote mesh__D006369
% 209.84/209.99       A superfamily of parasitic nematodes which were formerly considered a part of TRICHOSTRONGYLOIDEA. It includes the following genera: Heligmosomum, NEMATOSPIROIDES, and NIPPOSTRONGYLUS. The hosts are rodents.%A%    
% 209.84/209.99  |- mesh__recordMaintainer mesh__D006369 ags
% 209.84/209.99  |- mesh__dateRevised mesh__D006369 2003-07-09
% 209.84/209.99  |- skos__annotation mesh__D006369
% 209.84/209.99       a superfamily of nematodes; infection: coord IM with STRONGYLIDA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 209.84/209.99  |- rdf__type mesh__D006369sskos__Concept
% 209.84/209.99  |- mesh__historyNote mesh__D006369 86   
% 209.84/209.99  |- skos__prefLabel mesh__D006369 Heligmosomatoidea
% 209.84/209.99  |- mesh__dateEstablished mesh__D017091 1993-01-01
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D017091 2006
% 209.84/209.99  |- mesh__recordMaintainer mesh__D017091 lkt
% 209.84/209.99  |- skos__altLabel mesh__D017091 Ischemic Colitis
% 209.84/209.99  |- mesh__dateCreated mesh__D017091 1992-05-07
% 209.84/209.99  |- skos__broader mesh__D017091smesh__D003092
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D017091 2005
% 209.84/209.99  |- rdf__type mesh__D017091sskos__Concept
% 209.84/209.99  |- mesh__dateRevised mesh__D017091 2003-07-09
% 209.84/209.99  |- skos__broader mesh__D017091smesh__D007511
% 209.84/209.99  |- mesh__recordOriginator mesh__D017091 TGC
% 209.84/209.99  |- skos__historyNote mesh__D017091 Colitis %28%1967-1992%29%
% 209.84/209.99  |- mesh__recordAuthorizer mesh__D017091 sjn
% 209.84/209.99  |- skos__historyNote mesh__D017091 Ischemia %28%1967-1992%29%
% 209.84/209.99  |- mesh__historyNote mesh__D017091 93   
% 209.84/209.99  |- skos__prefLabel mesh__D017091 Colitis, Ischemic
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D017091 2004
% 209.84/209.99  |- mesh__publicMeSHNote mesh__D017091 93   
% 209.84/209.99  |- skos__scopeNote mesh__D017091
% 209.84/209.99       Inflammation of the COLON due to colonic ISCHEMIA resulting from alterations in systemic circulation or local vasculature.%A%    
% 209.84/209.99  |- skos__prefLabel mesh__D025523 Bacteriophage HK022
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D025523 2006
% 209.84/209.99  |- mesh__publicMeSHNote mesh__D025523
% 209.84/209.99       2002; see BACTERIOPHAGE LAMBDA 1994-2001   
% 209.84/209.99  |- mesh__dateCreated mesh__D025523 2001-07-25
% 209.84/209.99  |- mesh__historyNote mesh__D025523
% 209.84/209.99       2002; use BACTERIOPHAGE LAMBDA 1994-2001   
% 209.84/209.99  |- skos__historyNote mesh__D025523 Bacteriophage lambda %28%1990-2001%29%
% 209.84/209.99  |- skos__hiddenLabel mesh__D025523 HK022, Bacteriophage
% 209.84/209.99  |- skos__scopeNote mesh__D025523
% 209.84/209.99       A tentative species in the genus lambda-like Viruses, family SIPHOVIRIDAE.%A%    
% 209.84/209.99  |- skos__historyNote mesh__D025523 Coliphages %28%1976-2001%29%
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D025523 2003
% 209.84/209.99  |- skos__altLabel mesh__D025523 Enterobacteria phage HK022
% 209.84/209.99  |- skos__hiddenLabel mesh__D025523 HK022, Enterobacteria phage
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D025523 2004
% 209.84/209.99  |- skos__broader mesh__D025523smesh__D017906
% 209.84/209.99  |- mesh__dateEstablished mesh__D025523 2002-01-01
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D025523 2005
% 209.84/209.99  |- skos__broader mesh__D025523smesh__D003090
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D025523 2002
% 209.84/209.99  |- rdf__type mesh__D025523sskos__Concept
% 209.84/209.99  |- rdf__type mesh__D003071sskos__Concept
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D003071 2004
% 209.84/209.99  |- mesh__dateCreated mesh__D003071 1999-01-01
% 209.84/209.99  |- skos__broader mesh__D003071smesh__D008606
% 209.84/209.99  |- mesh__recordMaintainer mesh__D003071 jrf
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D003071 2003
% 209.84/209.99  |- skos__prefLabel mesh__D003071 Cognition
% 209.84/209.99  |- mesh__dateRevised mesh__D003071 2002-07-03
% 209.84/209.99  |- skos__scopeNote mesh__D003071
% 209.84/209.99       Intellectual or mental process whereby an organism becomes aware of or obtains knowledge.%A%    
% 209.84/209.99  |- mesh__recordOriginator mesh__D003071 NLM
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D003071 2006
% 209.84/209.99  |- mesh__recordAuthorizer mesh__D003071 sjn
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D003071 2005
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D011503 2006A
% 209.84/209.99  |- skos__scopeNote mesh__D011503
% 209.84/209.99       Transglutaminases catalyze cross-linking of proteins at a GLUTAMINE in one chain with LYSINE in another chain.  They include keratinocyte transglutaminase %28%TGM1 or TGK%29%, tissue transglutaminase %28%TGM2 or TGC%29%, plasma transglutaminase involved with coagulation %28%FACTOR XIII and FACTOR XIIIa%29%, hair follicle transglutaminase, and prostate transglutaminase. Although structures differ, they share an active site %28%YGQCW%29% and strict CALCIUM dependence.%A%    
% 209.84/209.99  |- mesh__dateEstablished mesh__D011503 1986-01-01
% 209.84/209.99  |- skos__hiddenLabel mesh__D011503
% 209.84/209.99       Gamma-Glutamyltransferases, Glutaminyl-Peptide
% 209.84/209.99  |- skos__historyNote mesh__D011503 Acyltransferases %28%1966-1985%29%
% 209.84/209.99  |- mesh__historyNote mesh__D011503 2002%28%1986%29%   
% 209.84/209.99  |- mesh__recordOriginator mesh__D011503 RLS
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D011503 2006B
% 209.84/209.99  |- skos__hiddenLabel mesh__D011503
% 209.84/209.99       Protein Glutamine gamma Glutamyltransferases
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D011503 2005
% 209.84/209.99  |- mesh__recordMaintainer mesh__D011503 ags
% 209.84/209.99  |- mesh__publicMeSHNote mesh__D011503
% 209.84/209.99       2002; see PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE 1986-2002; for TRANSGLUTAMINASES see TRANSGLUTAMINASES 1986-2002%A%  
% 209.84/209.99  |- mesh__dateCreated mesh__D011503 1985-04-24
% 209.84/209.99  |- mesh__dateRevised mesh__D011503 2005-08-02
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D011503 2006
% 209.84/209.99  |- skos__altLabel mesh__D011503
% 209.84/209.99       Glutaminyl-Peptide Gamma-Glutamyltransferases
% 209.84/209.99  |- skos__prefLabel mesh__D011503 Transglutaminases
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D011503 2004
% 209.84/209.99  |- mesh__recordAuthorizer mesh__D011503 ags
% 209.84/209.99  |- skos__broader mesh__D011503smesh__D019881
% 209.84/209.99  |- rdf__type mesh__D011503sskos__Concept
% 209.84/209.99  |- skos__annotation mesh__D011503
% 209.84/209.99       distinguish X refs GLUTAMINYL-PEPTIDE GAMMA-GLUTAMYLTRANSFERASES and TRANSGLUTAMINASES from GAMMA-GLUTAMYL TRANSPEPTIDASE which is involved with glutathione metabolism; PLASMA TRANSGLUTAMINASE see FACTOR XIIIA is also available%A%  
% 209.84/209.99  |- skos__hiddenLabel mesh__D011503
% 209.84/209.99       Glutaminyl Peptide Gamma Glutamyltransferases
% 209.84/209.99  |- skos__altLabel mesh__D011503
% 209.84/209.99       Protein-Glutamine gamma-Glutamyltransferases
% 209.84/209.99  |- skos__hiddenLabel mesh__D011503
% 209.84/209.99       gamma-Glutamyltransferases, Protein-Glutamine
% 209.84/209.99  |- skos__prefLabel mesh__D049971 Thiazides
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D049971 2006
% 209.84/209.99  |- mesh__recordMaintainer mesh__D049971 ssb
% 209.84/209.99  |- rdf__type mesh__D049971sskos__Concept
% 209.84/209.99  |- mesh__historyNote mesh__D049971 2006   
% 209.84/209.99  |- mesh__dateEstablished mesh__D049971 2006-01-01
% 209.84/209.99  |- mesh__recordAuthorizer mesh__D049971 sjn
% 209.84/209.99  |- skos__historyNote mesh__D049971 Benzothiadiazines %28%1963-2005%29%
% 209.84/209.99  |- mesh__publicMeSHNote mesh__D049971 2006   
% 209.84/209.99  |- skos__scopeNote mesh__D049971
% 209.84/209.99       Heterocyclic compounds with SULFUR and NITROGEN in the ring. This term commonly refers to the BENZOTHIADIAZINES that inhibit SODIUM-POTASSIUM-CHLORIDE SYMPORTERS and are used as DIURETICS.%A%    
% 209.84/209.99  |- mesh__recordOriginator mesh__D049971 ssb
% 209.84/209.99  |- skos__broader mesh__D049971smesh__D013457
% 209.84/209.99  |- mesh__dateCreated mesh__D049971 2005-06-30
% 209.84/209.99  |- skos__broader mesh__D016797smesh__D016794
% 209.84/209.99  |- mesh__recordOriginator mesh__D016797 PXP
% 209.84/209.99  |- rdf__type mesh__D016797sskos__Concept
% 209.84/209.99  |- mesh__historyNote mesh__D016797 92   
% 209.84/209.99  |- mesh__dateRevised mesh__D016797 2003-07-30
% 209.84/209.99  |- mesh__dateCreated mesh__D016797 1991-05-02
% 209.84/209.99  |- mesh__recordMaintainer mesh__D016797 sjn
% 209.84/209.99  |- mesh__recordAuthorizer mesh__D016797 sjn
% 209.84/209.99  |- skos__prefLabel mesh__D016797 Theileria parva
% 209.84/209.99  |- skos__annotation mesh__D016797
% 209.84/209.99       a tick-borne protozoon; infection: coord IM with THEILERIASIS %28%IM%29% + check tags ANIMALS %26% CATTLE but not also CATTLE DISEASES; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D016797 2004
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D016797 2006
% 209.84/209.99  |- mesh__dateEstablished mesh__D016797 1992-01-01
% 209.84/209.99  |- skos__scopeNote mesh__D016797
% 209.84/209.99       A protozoan parasite that is the etiologic agent of East Coast fever %28%THEILERIASIS%29%. Transmission is by ticks of the Physicephalus and Hyalomma genera.%A%    
% 209.84/209.99  |- skos__historyNote mesh__D016797 Sporozoea %28%1966-1991%29%
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D016797 2005
% 209.84/209.99  |- mesh__publicMeSHNote mesh__D016797 92   
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D002777 2004
% 209.84/209.99  |- mesh__recordMaintainer mesh__D002777 PLS
% 209.84/209.99  |- mesh__historyNote mesh__D002777 78   
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D002777 2000
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D002777 1998
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D002777 2005
% 209.84/209.99  |- skos__altLabel mesh__D002777 Hydroxycholestanes
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D002777 2001
% 209.84/209.99  |- skos__altLabel mesh__D002777 Bile Alcohols
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D002777 1999
% 209.84/209.99  |- skos__scopeNote mesh__D002777
% 209.84/209.99       Cholestanes substituted in any position with one or more hydroxy groups. They are found in feces and bile. In contrast to bile acids and salts, they are not reabsorbed.%A%    
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D002777 2006
% 209.84/209.99  |- skos__historyNote mesh__D002777 Sterols %28%1966-1977%29%
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D002777 1994
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D002777 2002
% 209.84/209.99  |- mesh__recordOriginator mesh__D002777 RLS
% 209.84/209.99  |- mesh__publicMeSHNote mesh__D002777 78   
% 209.84/209.99  |- skos__historyNote mesh__D002777 Cholestanes %28%1968-1977%29%
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D002777 1995
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D002777 1996
% 209.84/209.99  |- mesh__dateCreated mesh__D002777 1977-04-15
% 209.84/209.99  |- rdf__type mesh__D002777sskos__Concept
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D002777 2003
% 209.84/209.99  |- skos__prefLabel mesh__D002777 Cholestanols
% 209.84/209.99  |- mesh__dateRevised mesh__D002777 1993-06-02
% 209.84/209.99  |- mesh__recordAuthorizer mesh__D002777 PLS
% 209.84/209.99  |- skos__annotation mesh__D002777
% 209.84/209.99       do not confuse with CHOLESTANOL; beta-cholestanol = BETA-CHOLESTANOL see CHOLESTANOL%A%  
% 209.84/209.99  |- skos__hiddenLabel mesh__D002777 Alcohols, Bile
% 209.84/209.99  |- skos__broader mesh__D002777smesh__D002776
% 209.84/209.99  |- mesh__dateEstablished mesh__D002777 1978-01-01
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D002777 1997
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D007462 2002
% 209.84/209.99  |- mesh__recordAuthorizer mesh__D007462 PLS
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D007462 2006
% 209.84/209.99  |- mesh__recordOriginator mesh__D007462 NLM
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D007462 1998
% 209.84/209.99  |- skos__broader mesh__D007462smesh__D001555
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D007462 2001
% 209.84/209.99  |- skos__prefLabel mesh__D007462 Iodobenzenes
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D007462 1997
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D007462 2000
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D007462 2005
% 209.84/209.99  |- skos__broader mesh__D007462smesh__D006847
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D007462 2004
% 209.84/209.99  |- mesh__historyNote mesh__D007462 73%28%72%29%   
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D007462 1996
% 209.84/209.99  |- rdf__type mesh__D007462sskos__Concept
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D007462 1995
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D007462 2003
% 209.84/209.99  |- mesh__dateRevised mesh__D007462 1992-05-19
% 209.84/209.99  |- skos__historyNote mesh__D007462 Benzene Derivatives %28%1968-1971%29%
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D007462 1994
% 209.84/209.99  |- mesh__publicMeSHNote mesh__D007462 73   
% 209.84/209.99  |- mesh__dateEstablished mesh__D007462 1973-01-01
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D007462 1993
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D007462 1999
% 209.84/209.99  |- mesh__dateCreated mesh__D007462 1999-01-01
% 209.84/209.99  |- mesh__recordMaintainer mesh__D007462 TAP
% 209.84/209.99  |- skos__broader mesh__D020839smesh__D020664
% 209.84/209.99  |- skos__annotation mesh__D020839
% 209.84/209.99       SON OF SEVENLESS PROTEINS is also available   
% 209.84/209.99  |- skos__altLabel mesh__D020839 Drosophila SOS Protein
% 209.84/209.99  |- mesh__dateRevised mesh__D020839 2005-06-30
% 209.84/209.99  |- skos__altLabel mesh__D020839 Drosophila Son of Sevenless Protein
% 209.84/209.99  |- mesh__recordAuthorizer mesh__D020839 sjn
% 209.84/209.99  |- skos__historyNote mesh__D020839 Membrane Proteins %28%1992-1999%29%
% 209.84/209.99  |- skos__hiddenLabel mesh__D020839 Protein, Drosophila SOS
% 209.84/209.99  |- skos__altLabel mesh__D020839 SOS Protein
% 209.84/209.99  |- mesh__recordMaintainer mesh__D020839 jmp
% 209.84/209.99  |- skos__scopeNote mesh__D020839
% 209.84/209.99       A guanine nucleotide exchange factor from DROSOPHILA. Sevenless refers to genetic mutations in DROSOPHILA that cause loss of the R7 photoreceptor which is required to see UV light.%A%    
% 209.84/209.99  |- mesh__recordOriginator mesh__D020839 jmp
% 209.84/209.99  |- mesh__publicMeSHNote mesh__D020839
% 209.84/209.99       2000; SOS PROTEIN was indexed under MEMBRANE PROTEINS 1995-1999%A%  
% 209.84/209.99  |- mesh__historyNote mesh__D020839
% 209.84/209.99       2000; for SOS PROTEIN use SON OF SEVENLESS PROTEINS 1995-1999%A%  
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D020839 2006
% 209.84/209.99  |- rdf__type mesh__D020839sskos__Concept
% 209.84/209.99  |- skos__prefLabel mesh__D020839 Son of Sevenless Protein, Drosophila
% 209.84/209.99  |- skos__hiddenLabel mesh__D020839 SOS Protein, Drosophila
% 209.84/209.99  |- mesh__dateCreated mesh__D020839 1999-11-03
% 209.84/209.99  |- mesh__dateEstablished mesh__D020839 2000-01-01
% 209.84/209.99  |- mesh__historyNote mesh__D017890 94   
% 209.84/209.99  |- skos__scopeNote mesh__D017890
% 209.84/209.99       The spontaneous transplantation of splenic tissue to unusual sites after open splenic trauma, e.g., after automobile accidents, gunshot or stab wounds. The splenic pulp implants appear as red-blue nodules on the peritoneum, omentum, and mesentery, morphologically similar to multifocal pelvic endometriosis. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D017890 2001
% 209.84/209.99  |- skos__broader mesh__D017890smesh__D013161
% 209.84/209.99  |- mesh__dateEstablished mesh__D017890 1994-01-01
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D017890 2000
% 209.84/209.99  |- skos__historyNote mesh__D017890 Splenic Diseases %28%1966-1993%29%
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D017890 1999
% 209.84/209.99  |- mesh__recordAuthorizer mesh__D017890 PLS
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D017890 1997
% 209.84/209.99  |- mesh__dateCreated mesh__D017890 1993-02-16
% 209.84/209.99  |- skos__historyNote mesh__D017890 Splenic Rupture %28%1966-1993%29%
% 209.84/209.99  |- skos__historyNote mesh__D017890 Spleen %28%1966-1993%29%
% 209.84/209.99  |- rdf__type mesh__D017890sskos__Concept
% 209.84/209.99  |- skos__prefLabel mesh__D017890 Splenosis
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D017890 2006
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D017890 1998
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D017890 2002
% 209.84/209.99  |- skos__hiddenLabel mesh__D017890 Splenoses
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D017890 2004
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D017890 1996
% 209.84/209.99  |- mesh__recordMaintainer mesh__D017890 TAP
% 209.84/209.99  |- mesh__publicMeSHNote mesh__D017890 94   
% 209.84/209.99  |- skos__annotation mesh__D017890
% 209.84/209.99       spontaneous intra-abdom transpl of spleen tissue to other tissue, usually after trauma%A%  
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D017890 2005
% 209.84/209.99  |- mesh__dateRevised mesh__D017890 1995-06-08
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D017890 2003
% 209.84/209.99  |- mesh__recordOriginator mesh__D017890 TGC
% 209.84/209.99  |- mesh__dateRevised mesh__D031561 2003-07-09
% 209.84/209.99  |- mesh__publicMeSHNote mesh__D031561 2003   
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D031561 2006
% 209.84/209.99  |- mesh__dateCreated mesh__D031561 2002-07-03
% 209.84/209.99  |- skos__scopeNote mesh__D031561
% 209.84/209.99       A plant genus of the family LYTHRACEAE that contains ALKALOIDS.%A%    
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D031561 2004
% 209.84/209.99  |- mesh__recordMaintainer mesh__D031561 ssb
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D031561 2005
% 209.84/209.99  |- mesh__recordAuthorizer mesh__D031561 sjn
% 209.84/209.99  |- mesh__historyNote mesh__D031561 2003   
% 209.84/209.99  |- skos__prefLabel mesh__D031561 Lythrum
% 209.84/209.99  |- mesh__recordOriginator mesh__D031561 ssb
% 209.84/209.99  |- mesh__dateEstablished mesh__D031561 2003-01-01
% 209.84/209.99  |- rdf__type mesh__D031561sskos__Concept
% 209.84/209.99  |- skos__annotation mesh__D031561
% 209.84/209.99       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.84/209.99  |- skos__altLabel mesh__D031561 Loosestrife
% 209.84/209.99  |- skos__broader mesh__D031561smesh__D029561
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D017092 2005
% 209.84/209.99  |- rdf__type mesh__D017092sskos__Concept
% 209.84/209.99  |- mesh__dateCreated mesh__D017092 1992-05-22
% 209.84/209.99  |- skos__hiddenLabel mesh__D017092 Porphyrias, Congenital Erythropoietic
% 209.84/209.99  |- skos__broader mesh__D017092smesh__D011164
% 209.84/209.99  |- skos__hiddenLabel mesh__D017092 Porphyria, Congenital Erythropoietic
% 209.84/209.99  |- mesh__publicMeSHNote mesh__D017092 93   
% 209.84/209.99  |- mesh__dateEstablished mesh__D017092 1993-01-01
% 209.84/209.99  |- skos__hiddenLabel mesh__D017092 Erythropoietic Porphyrias, Congenital
% 209.84/209.99  |- skos__altLabel mesh__D017092 Gunther Disease
% 209.84/209.99  |- mesh__recordMaintainer mesh__D017092 lkt
% 209.84/209.99  |- mesh__dateRevised mesh__D017092 2004-07-15
% 209.84/209.99  |- skos__annotation mesh__D017092
% 209.84/209.99       do not confuse with PROTOPORPHYRIA, ERYTHROPOIETIC or PORPHYRIA, HEPATOERYTHROPOIETIC%A%  
% 209.84/209.99  |- skos__broader mesh__D017092smesh__D012873
% 209.84/209.99  |- skos__prefLabel mesh__D017092 Porphyria, Erythropoietic
% 209.84/209.99  |- skos__broader mesh__D017092smesh__D008661
% 209.84/209.99  |- mesh__historyNote mesh__D017092 93   
% 209.84/209.99  |- skos__historyNote mesh__D017092 Porphyria %28%1966-1992%29%
% 209.84/209.99  |- skos__hiddenLabel mesh__D017092 Disease, Gunther%27%s
% 209.84/209.99  |- skos__altLabel mesh__D017092 Porphyria, Erythropoietic, Congenital
% 209.84/209.99  |- skos__altLabel mesh__D017092 Gunther%27%s Disease
% 209.84/209.99  |- mesh__recordOriginator mesh__D017092 PXP
% 209.84/209.99  |- skos__hiddenLabel mesh__D017092 Erythropoietic Porphyrias
% 209.84/209.99  |- skos__hiddenLabel mesh__D017092 Erythropoietic Porphyria, Congenital
% 209.84/209.99  |- skos__hiddenLabel mesh__D017092 Porphyrias, Erythropoietic
% 209.84/209.99  |- skos__scopeNote mesh__D017092
% 209.84/209.99       An autosomal recessive porphyria that is due to a deficiency of UROPORPHYRINOGEN III SYNTHASE in the BONE MARROW; also known as congenital erythropoietic porphyria. This disease is characterized by SPLENOMEGALY; ANEMIA; photosensitivity; cutaneous lesions; accumulation of hydroxymethylbilane; and increased excretion of UROPORPHYRINS and COPROPORPHYRINS.%A%    
% 209.84/209.99  |- skos__hiddenLabel mesh__D017092 Disease, Gunther
% 209.84/209.99  |- mesh__recordAuthorizer mesh__D017092 sjn
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D017092 2006
% 209.84/209.99  |- skos__altLabel mesh__D017092 Congenital Erythropoietic Porphyria
% 209.84/209.99  |- skos__hiddenLabel mesh__D017092 Congenital Erythropoietic Porphyrias
% 209.84/209.99  |- skos__hiddenLabel mesh__D017092 Gunthers Disease
% 209.84/209.99  |- skos__altLabel mesh__D017092 Erythropoietic Porphyria
% 209.84/209.99  |- mesh__dateEstablished mesh__D003870 1991-01-01
% 209.84/209.99  |- skos__annotation mesh__D003870
% 209.84/209.99       infestation: coord IM with TICK INFESTATIONS %28%IM%29%   
% 209.84/209.99  |- skos__historyNote mesh__D003870 Ticks %28%1966-1972%29%
% 209.84/209.99  |- mesh__recordAuthorizer mesh__D003870 sjn
% 209.84/209.99  |- mesh__publicMeSHNote mesh__D003870 91; was see under TICKS 1973-90   
% 209.84/209.99  |- rdf__type mesh__D003870sskos__Concept
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D003870 2004
% 209.84/209.99  |- mesh__recordOriginator mesh__D003870 NLM
% 209.84/209.99  |- mesh__historyNote mesh__D003870
% 209.84/209.99       91%28%73%29%; was see under TICKS 1973-90   
% 209.84/209.99  |- skos__scopeNote mesh__D003870
% 209.84/209.99       A widely distributed genus of TICKS, in the family IXODIDAE, including a number that infest humans and other mammals. Several are vectors of diseases such as TULAREMIA; ROCKY MOUNTAIN SPOTTED FEVER; COLORADO TICK FEVER; and ANAPLASMOSIS.%A%    
% 209.84/209.99  |- mesh__dateRevised mesh__D003870 2003-07-09
% 209.84/209.99  |- mesh__dateCreated mesh__D003870 1999-01-01
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D003870 2006
% 209.84/209.99  |- mesh__recordMaintainer mesh__D003870 ags
% 209.84/209.99  |- skos__prefLabel mesh__D003870 Dermacentor
% 209.84/209.99  |- skos__broader mesh__D003870smesh__D026863
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D003870 2005
% 209.84/209.99  |- mesh__historyNote mesh__D003072 69   
% 209.84/209.99  |- mesh__recordAuthorizer mesh__D003072 PLS
% 209.84/209.99  |- skos__prefLabel mesh__D003072 Cognition Disorders
% 209.84/209.99  |- skos__historyNote mesh__D003072 Cognition %28%1966-1968%29%
% 209.84/209.99  |- mesh__recordOriginator mesh__D003072 NLM
% 209.84/209.99  |- skos__broader mesh__D003072smesh__D019965
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D003072 2006
% 209.84/209.99  |- mesh__dateEstablished mesh__D003072 1969-01-01
% 209.84/209.99  |- skos__hiddenLabel mesh__D003072 Disorders, Cognition
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D003072 2002
% 209.84/209.99  |- skos__scopeNote mesh__D003072
% 209.84/209.99       Disturbances in the mental process related to thinking, reasoning, and judgment.%A%    
% 209.84/209.99  |- skos__historyNote mesh__D003072 specific disorder
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D003072 2005
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D003072 1999
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D003072 2001
% 209.84/209.99  |- rdf__type mesh__D003072sskos__Concept
% 209.84/209.99  |- skos__hiddenLabel mesh__D003072 Disorder, Cognition
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D003072 2004
% 209.84/209.99  |- mesh__dateCreated mesh__D003072 1999-01-01
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D003072 2000
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D003072 1998
% 209.84/209.99  |- mesh__dateRevised mesh__D003072 1997-09-12
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D003072 2003
% 209.84/209.99  |- mesh__recordMaintainer mesh__D003072 SJN
% 209.84/209.99  |- mesh__publicMeSHNote mesh__D003072 69   
% 209.84/209.99  |- skos__related mesh__D011504smesh__D008231
% 209.84/209.99  |- mesh__dateRevised mesh__D011504 2005-07-18
% 209.84/209.99  |- skos__hiddenLabel mesh__D011504 Enteropathy, Protein-Losing
% 209.84/209.99  |- skos__hiddenLabel mesh__D011504
% 209.84/209.99       Idiopathic Hypercatabolic Hypoproteinemias
% 209.84/209.99  |- skos__hiddenLabel mesh__D011504
% 209.84/209.99       Hypoproteinemias, Idiopathic Hypercatabolic
% 209.84/209.99  |- skos__hiddenLabel mesh__D011504
% 209.84/209.99       Hypercatabolic Hypoproteinemias, Idiopathic
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D011504 2005
% 209.84/209.99  |- mesh__recordMaintainer mesh__D011504 ags
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D011504 2006A
% 209.84/209.99  |- skos__hiddenLabel mesh__D011504
% 209.84/209.99       Hypoproteinemia, Idiopathic Hypercatabolic
% 209.84/209.99  |- skos__prefLabel mesh__D011504 Protein-Losing Enteropathies
% 209.84/209.99  |- skos__hiddenLabel mesh__D011504 Exudative Enteropathy
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D011504 2006
% 209.84/209.99  |- mesh__dateEstablished mesh__D011504 1966-01-01
% 209.84/209.99  |- skos__related mesh__D011504smesh__D000361
% 209.84/209.99  |- mesh__dateCreated mesh__D011504 1999-01-01
% 209.84/209.99  |- mesh__historyNote mesh__D011504 66   
% 209.84/209.99  |- mesh__recordOriginator mesh__D011504 NLM
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D011504 2006B
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D011504 2004
% 209.84/209.99  |- mesh__recordAuthorizer mesh__D011504 ags
% 209.84/209.99  |- rdf__type mesh__D011504sskos__Concept
% 209.84/209.99  |- skos__scopeNote mesh__D011504
% 209.84/209.99       Pathological conditions in the INTESTINES that are characterized by the gastrointestinal loss of serum proteins, including SERUM ALBUMIN; IMMUNOGLOBULINS; and at times LYMPHOCYTES. Severe condition can result in HYPOGAMMAGLOBULINEMIA or LYMPHOPENIA. Protein-losing enteropathies are associated with a number of diseases including INTESTINAL LYMPHANGIECTASIA; WHIPPLE%27%S DISEASE; and NEOPLASMS of the SMALL INTESTINE.%A%    
% 209.84/209.99  |- skos__altLabel mesh__D011504 Protein-Losing Enteropathy
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D011504 2005A
% 209.84/209.99  |- skos__hiddenLabel mesh__D011504 Protein Losing Enteropathies
% 209.84/209.99  |- skos__broader mesh__D011504smesh__D007410
% 209.84/209.99  |- skos__hiddenLabel mesh__D011504
% 209.84/209.99       Hypercatabolic Hypoproteinemia, Idiopathic
% 209.84/209.99  |- skos__hiddenLabel mesh__D011504 Enteropathies, Protein-Losing
% 209.84/209.99  |- skos__related mesh__D011504smesh__D007019
% 209.84/209.99  |- skos__hiddenLabel mesh__D011504 Exudative Enteropathies
% 209.84/209.99  |- skos__hiddenLabel mesh__D011504 Enteropathies, Exudative
% 209.84/209.99  |- mesh__publicMeSHNote mesh__D011504 66   
% 209.84/209.99  |- skos__hiddenLabel mesh__D011504 Protein Losing Enteropathy
% 209.84/209.99  |- skos__altLabel mesh__D011504 Enteropathy, Exudative
% 209.84/209.99  |- mesh__publicMeSHNote mesh__D016798 92; CILIATA was heading 1963-91   
% 209.84/209.99  |- mesh__activeMeSHYear mesh__D016798 2004
% 209.84/209.99  |- skos__annotation mesh__D016798
% 209.84/209.99       infection = CILIOPHORA INFECTIONS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 209.84/210.00  |- skos__broader mesh__D016798smesh__D011527
% 209.84/210.00  |- mesh__dateRevised mesh__D016798 2003-07-09
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D016798 2006
% 209.84/210.00  |- mesh__historyNote mesh__D016798 92; CILIATA was heading 1963-91   
% 209.84/210.00  |- skos__prefLabel mesh__D016798 Ciliophora
% 209.84/210.00  |- mesh__recordMaintainer mesh__D016798 ags
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D016798 2005
% 209.84/210.00  |- mesh__dateCreated mesh__D016798 1991-05-02
% 209.84/210.00  |- mesh__onlineNote mesh__D016798
% 209.84/210.00       use CILIOPHORA to search CILIATA 1966-91   
% 209.84/210.00  |- skos__scopeNote mesh__D016798
% 209.84/210.00       A phylum of protozoa characterized by the presence of cilia at some time during the life cycle. It comprises three classes: KINETOFRAGMINOPHOREA; OLIGOHYMENOPHOREA; and POLYMENOPHOREA.%A%    
% 209.84/210.00  |- rdf__type mesh__D016798sskos__Concept
% 209.84/210.00  |- mesh__recordAuthorizer mesh__D016798 sjn
% 209.84/210.00  |- mesh__recordOriginator mesh__D016798 PXP
% 209.84/210.00  |- mesh__dateEstablished mesh__D016798 1992-01-01
% 209.84/210.00  |- skos__historyNote mesh__D016798 Protozoa %28%1975-1991%29%
% 209.84/210.00  |- skos__broader mesh__D005343Q000037smesh__D005343
% 209.84/210.00  |- mesh__preferredCombination mesh__D005343Q000037smesh__D000933
% 209.84/210.00  |- rdf__type mesh__D005343Q000037smesh__CompoundConcept
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D002778 2004
% 209.84/210.00  |- skos__broader mesh__D002778smesh__D002776
% 209.84/210.00  |- mesh__dateCreated mesh__D002778 1974-11-11
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D002778 1996
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D002778 2003
% 209.84/210.00  |- skos__scopeNote mesh__D002778
% 209.84/210.00       CHOLESTANES substituted with any number of keto groups.%A%    
% 209.84/210.00  |- mesh__dateEstablished mesh__D002778 1991-01-01
% 209.84/210.00  |- skos__historyNote mesh__D002778 Cholestanes %28%1968-1974%29%
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D002778 2002
% 209.84/210.00  |- mesh__publicMeSHNote mesh__D002778
% 209.84/210.00       91; was see under CHOLESTANES 1975-90   
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D002778 1995
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D002778 2001
% 209.84/210.00  |- mesh__dateRevised mesh__D002778 1993-06-03
% 209.84/210.00  |- skos__prefLabel mesh__D002778 Cholestanones
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D002778 1999
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D002778 1994
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D002778 2006
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D002778 2000
% 209.84/210.00  |- skos__annotation mesh__D002778
% 209.84/210.00       do not confuse with CHOLESTENONES; includes cholestanediones, cholestanetriones%A%  
% 209.84/210.00  |- mesh__historyNote mesh__D002778
% 209.84/210.00       91%28%75%29%; was see under CHOLESTANES 1975-90   
% 209.84/210.00  |- mesh__recordOriginator mesh__D002778 NLM
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D002778 1998
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D002778 2005
% 209.84/210.00  |- mesh__recordMaintainer mesh__D002778 PLS
% 209.84/210.00  |- mesh__recordAuthorizer mesh__D002778 PLS
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D002778 1997
% 209.84/210.00  |- rdf__type mesh__D002778sskos__Concept
% 209.84/210.00  |- skos__broader mesh__D001769Q000201smesh__D001769
% 209.84/210.00  |- mesh__preferredCombination mesh__D001769Q000201smesh__D004798Q000097
% 209.84/210.00  |- rdf__type mesh__D001769Q000201smesh__CompoundConcept
% 209.84/210.00  |- skos__broader mesh__D007463smesh__D001565
% 209.84/210.00  |- skos__scopeNote mesh__D007463
% 209.84/210.00       Benzoic acid esters or salts substituted with one or more iodine atoms.%A%    
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D007463 2005
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D007463 2002
% 209.84/210.00  |- mesh__dateEstablished mesh__D007463 1974-01-01
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D007463 2004
% 209.84/210.00  |- mesh__dateRevised mesh__D007463 1998-06-10
% 209.84/210.00  |- rdf__type mesh__D007463sskos__Concept
% 209.84/210.00  |- mesh__recordOriginator mesh__D007463 NLM
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D007463 2001
% 209.84/210.00  |- mesh__publicMeSHNote mesh__D007463 74   
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D007463 2003
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D007463 2000
% 209.84/210.00  |- mesh__recordAuthorizer mesh__D007463 SJN
% 209.84/210.00  |- mesh__recordMaintainer mesh__D007463 ADP
% 209.84/210.00  |- mesh__dateCreated mesh__D007463 1999-01-01
% 209.84/210.00  |- mesh__historyNote mesh__D007463 74%28%72%29%   
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D007463 1999
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D007463 2006
% 209.84/210.00  |- skos__historyNote mesh__D007463 Benzoates %28%1966-1971%29%
% 209.84/210.00  |- skos__prefLabel mesh__D007463 Iodobenzoates
% 209.84/210.00  |- mesh__recordMaintainer mesh__D045582 SYSTEM
% 209.84/210.00  |- skos__historyNote mesh__D045582 Mollicutes %28%1995-2003%29%
% 209.84/210.00  |- mesh__publicMeSHNote mesh__D045582 2004   
% 209.84/210.00  |- skos__broader mesh__D045582smesh__D000129
% 209.84/210.00  |- skos__historyNote mesh__D045582 Mycoplasma %28%1996-1998%29%
% 209.84/210.00  |- mesh__dateEstablished mesh__D045582 2004-01-01
% 209.84/210.00  |- skos__prefLabel mesh__D045582 Phytoplasma
% 209.84/210.00  |- skos__scopeNote mesh__D045582
% 209.84/210.00       A genus of minute bacteria in the family ACHOLEPLASMATACEAE that inhabit phloem sieve elements of infected PLANTS and cause symptoms such as yellowing, phyllody, and witches%27% brooms. Organisms lack a CELL WALL and thus are similar to MYCOPLASMA in animals. They are transmitted by over 100 species of INSECTS especially leafhoppers, planthoppers, and PSYLLIDS.%A%    
% 209.84/210.00  |- mesh__dateCreated mesh__D045582 2003-07-09
% 209.84/210.00  |- mesh__recordOriginator mesh__D045582 ags
% 209.84/210.00  |- mesh__recordAuthorizer mesh__D045582 sjn
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D045582 2006
% 209.84/210.00  |- rdf__type mesh__D045582sskos__Concept
% 209.84/210.00  |- mesh__dateRevised mesh__D045582 2005-06-30
% 209.84/210.00  |- mesh__historyNote mesh__D045582 2004   
% 209.84/210.00  |- skos__altLabel mesh__D017891 Epidemiology, Pharmaceutical
% 209.84/210.00  |- skos__historyNote mesh__D017891 Epidemiologic Methods %28%1985-1993%29%
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017891 2002
% 209.84/210.00  |- skos__broader mesh__D017891smesh__D004813
% 209.84/210.00  |- skos__prefLabel mesh__D017891 Pharmacoepidemiology
% 209.84/210.00  |- skos__scopeNote mesh__D017891
% 209.84/210.00       The science concerned with the benefit and risk of drugs used in populations and the analysis of the outcomes of drug therapies. Pharmacoepidemiologic data come from both clinical trials and epidemiological studies with emphasis on methods for the detection and evaluation of drug-related adverse effects, assessment of risk vs benefit ratios in drug therapy, patterns of drug utilization, the cost-effectiveness of specific drugs, methodology of postmarketing surveillance, and the relation between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines. %28%Pharmacoepidemiol Drug Saf 1992;1%28%1%29%; J Pharmacoepidemiol 1990;1%28%1%29%%29%%A%    
% 209.84/210.00  |- skos__hiddenLabel mesh__D017891 Epidemiologies, Pharmaceutical
% 209.84/210.00  |- mesh__publicMeSHNote mesh__D017891 94   
% 209.84/210.00  |- mesh__recordMaintainer mesh__D017891 jls
% 209.84/210.00  |- mesh__dateCreated mesh__D017891 1993-02-16
% 209.84/210.00  |- rdf__type mesh__D017891sskos__Concept
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017891 2006
% 209.84/210.00  |- skos__altLabel mesh__D017891 Pharmaceutical Epidemiology
% 209.84/210.00  |- skos__hiddenLabel mesh__D017891 Pharmaceutical Epidemiologies
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017891 2004
% 209.84/210.00  |- mesh__recordAuthorizer mesh__D017891 sjn
% 209.84/210.00  |- mesh__recordOriginator mesh__D017891 TGC
% 209.84/210.00  |- mesh__dateEstablished mesh__D017891 1994-01-01
% 209.84/210.00  |- skos__historyNote mesh__D017891 Pharmacology %28%1984-1993%29%
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017891 2005
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017891 2003
% 209.84/210.00  |- mesh__historyNote mesh__D017891 94   
% 209.84/210.00  |- skos__broader mesh__D017891smesh__D010600
% 209.84/210.00  |- skos__historyNote mesh__D017891 Epidemiology %28%1984-1993%29%
% 209.84/210.00  |- mesh__dateRevised mesh__D017891 2001-07-25
% 209.84/210.00  |- skos__annotation mesh__D017891
% 209.84/210.00       SPEC: SPEC qualif; DF: PHARMACOEPIDEMIOL   
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D031562 2004
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D031562 2005
% 209.84/210.00  |- skos__prefLabel mesh__D031562 Cuphea
% 209.84/210.00  |- mesh__historyNote mesh__D031562 2003   
% 209.84/210.00  |- skos__broader mesh__D031562smesh__D029561
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D031562 2003
% 209.84/210.00  |- skos__scopeNote mesh__D031562
% 209.84/210.00       A plant genus of the family LYTHRACEAE. Members contain lauric acid and cuphiin.%A%    
% 209.84/210.00  |- rdf__type mesh__D031562sskos__Concept
% 209.84/210.00  |- skos__annotation mesh__D031562
% 209.84/210.00       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.84/210.00  |- mesh__dateCreated mesh__D031562 2002-07-03
% 209.84/210.00  |- mesh__publicMeSHNote mesh__D031562 2003   
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D031562 2006
% 209.84/210.00  |- mesh__dateEstablished mesh__D031562 2003-01-01
% 209.84/210.00  |- skos__broader mesh__D017093smesh__D048550
% 209.84/210.00  |- mesh__recordOriginator mesh__D017093 TGC
% 209.84/210.00  |- rdf__type mesh__D017093sskos__Concept
% 209.84/210.00  |- mesh__historyNote mesh__D017093
% 209.84/210.00       1993; for FULMINATING HEPATIC FAILURE; HEPATIC FAILURE, FULMINANT; and LIVER FAILURE, FULMINANT use HEPATIC ENCEPHALOPATHY 1993-1999%A%  
% 209.84/210.00  |- mesh__recordAuthorizer mesh__D017093 sjn
% 209.84/210.00  |- mesh__dateCreated mesh__D017093 1992-05-22
% 209.84/210.00  |- mesh__publicMeSHNote mesh__D017093
% 209.84/210.00       1993; for FULMINATING HEPATIC FAILURE; HEPATIC FAILURE, FULMINANT; and LIVER FAILURE, FULMINANT see HEPATIC ENCEPHALOPATHY 1993-1999%A%  
% 209.84/210.00  |- skos__historyNote mesh__D017093 Hepatic Encephalopathy %28%1967-1992%29%
% 209.84/210.00  |- skos__historyNote mesh__D017093 Liver Diseases %28%1966-1992%29%
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017093 2005
% 209.84/210.00  |- skos__annotation mesh__D017093
% 209.84/210.00       if coma is present, index under HEPATIC ENCEPHALOPATHY; LIVER FAILURE, ACUTE is also available%A%  
% 209.84/210.00  |- skos__prefLabel mesh__D017093 Liver Failure
% 209.84/210.00  |- mesh__recordMaintainer mesh__D017093 lkt
% 209.84/210.00  |- skos__scopeNote mesh__D017093
% 209.84/210.00       Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTIC DEHYDROGENASE; and albumin/globulin ratio. %28%Blakiston%27%s Gould Medical Dictionary, 4th ed%29%%A%    
% 209.84/210.00  |- mesh__dateEstablished mesh__D017093 1993-01-01
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017093 2006
% 209.84/210.00  |- skos__altLabel mesh__D017093 Hepatic Failure
% 209.84/210.00  |- mesh__dateRevised mesh__D017093 2004-07-07
% 209.84/210.00  |- rdf__type mesh__D003871sskos__Concept
% 209.84/210.00  |- skos__hiddenLabel mesh__D003871 Sulfate, Dermatan
% 209.84/210.00  |- skos__hiddenLabel mesh__D003871 beta Heparin
% 209.84/210.00  |- skos__broader mesh__D003871smesh__D002807
% 209.84/210.00  |- mesh__recordAuthorizer mesh__D003871 sjn
% 209.84/210.00  |- skos__prefLabel mesh__D003871 Dermatan Sulfate
% 209.84/210.00  |- skos__altLabel mesh__D003871 Chondroitin Sulfate B
% 209.84/210.00  |- mesh__recordMaintainer mesh__D003871 ssb
% 209.84/210.00  |- mesh__dateCreated mesh__D003871 1999-01-01
% 209.84/210.00  |- skos__altLabel mesh__D003871 beta-Heparin
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003871 2006
% 209.84/210.00  |- skos__hiddenLabel mesh__D003871 Sulfate B, Chondroitin
% 209.84/210.00  |- mesh__dateRevised mesh__D003871 2004-07-07
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003871 2005
% 209.84/210.00  |- mesh__recordOriginator mesh__D003871 NLM
% 209.84/210.00  |- mesh__publicMeSHNote mesh__D003871 91; see CHONDROITIN 1975-90   
% 209.84/210.00  |- mesh__historyNote mesh__D003871 91%28%75%29%   
% 209.84/210.00  |- mesh__dateEstablished mesh__D003871 1991-01-01
% 209.84/210.00  |- skos__scopeNote mesh__D003871
% 209.84/210.00       A naturally occurring glycosaminoglycan found mostly in the skin and in connective tissue. It differs from CHONDROITIN SULFATE A %28%see CHONDROITIN SULFATES%29% by containing IDURONIC ACID in place of glucuronic acid, its epimer, at carbon atom 5. %28%from Merck, 12th ed%29%%A%    
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003073 2006
% 209.84/210.00  |- mesh__dateEstablished mesh__D003073 1969-01-01
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003073 1994
% 209.84/210.00  |- mesh__historyNote mesh__D003073 69   
% 209.84/210.00  |- mesh__recordAuthorizer mesh__D003073 PLS
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003073 2005
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003073 1993
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003073 1999
% 209.84/210.00  |- mesh__recordOriginator mesh__D003073 NLM
% 209.84/210.00  |- mesh__dateRevised mesh__D003073 1989-04-28
% 209.84/210.00  |- rdf__type mesh__D003073sskos__Concept
% 209.84/210.00  |- skos__scopeNote mesh__D003073
% 209.84/210.00       Motivational state produced by inconsistencies between simultaneously held cognitions or between a cognition and behavior; e.g., smoking enjoyment and believing smoking is harmful are dissonant.%A%    
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003073 2004
% 209.84/210.00  |- mesh__dateCreated mesh__D003073 1999-01-01
% 209.84/210.00  |- mesh__recordMaintainer mesh__D003073 TGC
% 209.84/210.00  |- skos__prefLabel mesh__D003073 Cognitive Dissonance
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003073 1991
% 209.84/210.00  |- skos__historyNote mesh__D003073 Motivation %28%1966-1968%29%
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003073 1992
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003073 1998
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003073 2002
% 209.84/210.00  |- skos__hiddenLabel mesh__D003073 Dissonance, Cognitive
% 209.84/210.00  |- skos__hiddenLabel mesh__D003073 Dissonances, Cognitive
% 209.84/210.00  |- skos__hiddenLabel mesh__D003073 Cognitive Dissonances
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003073 2003
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003073 1997
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003073 1990
% 209.84/210.00  |- skos__annotation mesh__D003073 no qualif   
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003073 2001
% 209.84/210.00  |- skos__broader mesh__D003073smesh__D003071
% 209.84/210.00  |- mesh__publicMeSHNote mesh__D003073 69   
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003073 1996
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003073 2000
% 209.84/210.00  |- skos__historyNote mesh__D003073 Cognition %28%1966-1968%29%
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003073 1995
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D011505 2006
% 209.84/210.00  |- mesh__recordMaintainer mesh__D011505 ssb
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D011505 2004
% 209.84/210.00  |- rdf__type mesh__D011505sskos__Concept
% 209.84/210.00  |- mesh__publicMeSHNote mesh__D011505 86   
% 209.84/210.00  |- skos__altLabel mesh__D011505 Tyrosine-Specific Protein Kinase
% 209.84/210.00  |- skos__hiddenLabel mesh__D011505 Protein Tyrosine Kinase
% 209.84/210.00  |- skos__hiddenLabel mesh__D011505 Kinase, Tyrosine Protein
% 209.84/210.00  |- skos__historyNote mesh__D011505 Protein Kinases %28%1973-1985%29%
% 209.84/210.00  |- skos__hiddenLabel mesh__D011505 Kinase, Tyrosine
% 209.84/210.00  |- skos__prefLabel mesh__D011505 Protein-Tyrosine Kinase
% 209.84/210.00  |- skos__hiddenLabel mesh__D011505 Tyrosine Specific Protein Kinase
% 209.84/210.00  |- skos__hiddenLabel mesh__D011505 Kinase, Tyrosine-Specific Protein
% 209.84/210.00  |- mesh__recordAuthorizer mesh__D011505 sjn
% 209.84/210.00  |- mesh__dateRevised mesh__D011505 2003-07-09
% 209.84/210.00  |- mesh__dateEstablished mesh__D011505 1986-01-01
% 209.84/210.00  |- mesh__recordOriginator mesh__D011505 RLS
% 209.84/210.00  |- skos__related mesh__D011505smesh__D015688
% 209.84/210.00  |- skos__altLabel mesh__D011505 Tyrosylprotein Kinase
% 209.84/210.00  |- skos__broader mesh__D011505smesh__D011494
% 209.84/210.00  |- skos__historyNote mesh__D011505 Phosphotransferases %28%1966-1972%29%
% 209.84/210.00  |- skos__hiddenLabel mesh__D011505 Protein Kinase, Tyrosine-Specific
% 209.84/210.00  |- mesh__dateCreated mesh__D011505 1985-04-25
% 209.84/210.00  |- skos__hiddenLabel mesh__D011505 Kinase, Protein-Tyrosine
% 209.84/210.00  |- skos__related mesh__D011505smesh__D018909
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D011505 2005
% 209.84/210.00  |- skos__scopeNote mesh__D011505
% 209.84/210.00       An enzyme that catalyzes the phosphorylation of tyrosine residues in proteins with ATP or other nucleotides as phosphate donors. EC 2.7.1.112.%A%    
% 209.84/210.00  |- skos__altLabel mesh__D011505 Tyrosine Protein Kinase
% 209.84/210.00  |- skos__altLabel mesh__D011505 Tyrosine Kinase
% 209.84/210.00  |- skos__hiddenLabel mesh__D011505 Kinase, Tyrosylprotein
% 209.84/210.00  |- mesh__historyNote mesh__D011505 86   
% 209.84/210.00  |- mesh__historyNote mesh__D016799
% 209.84/210.00       92; SUCTORIA was see CILIATA 1985-91, was heading 1963-84%A%  
% 209.84/210.00  |- mesh__dateEstablished mesh__D016799 1992-01-01
% 209.84/210.00  |- mesh__recordMaintainer mesh__D016799 ags
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D016799 2005
% 209.84/210.00  |- mesh__onlineNote mesh__D016799
% 209.84/210.00       use CILIOPHORA to search SUCTORIA 1966-91   
% 209.84/210.00  |- skos__scopeNote mesh__D016799
% 209.84/210.00       A class of ciliate protozoa. Prominent cytopharyngeal apparatus is characteristic of this class as is only a slight distinction between oral and somatic cilia.%A%    
% 209.84/210.00  |- rdf__type mesh__D016799sskos__Concept
% 209.84/210.00  |- skos__annotation mesh__D016799
% 209.84/210.00       a class of CILIOPHORA %28%formerly CILIATA%29%   
% 209.84/210.00  |- mesh__recordOriginator mesh__D016799 PXP
% 209.84/210.00  |- skos__broader mesh__D016799smesh__D016798
% 209.84/210.00  |- mesh__dateCreated mesh__D016799 1991-05-02
% 209.84/210.00  |- skos__prefLabel mesh__D016799 Kinetofragminophorea
% 209.84/210.00  |- mesh__recordAuthorizer mesh__D016799 sjn
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D016799 2004
% 209.84/210.00  |- mesh__publicMeSHNote mesh__D016799
% 209.84/210.00       92; SUCTORIA was see CILIATA 1985-91, was heading 1963-84%A%  
% 209.84/210.00  |- mesh__dateRevised mesh__D016799 2003-07-09
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D016799 2006
% 209.84/210.00  |- mesh__dateRevised mesh__D002779 2003-07-09
% 209.84/210.00  |- skos__related mesh__D002779smesh__D041781
% 209.84/210.00  |- skos__hiddenLabel mesh__D002779 Obstruction, Bile Duct
% 209.84/210.00  |- skos__hiddenLabel mesh__D002779 Duct Obstruction, Bile
% 209.84/210.00  |- mesh__historyNote mesh__D002779 1972 %28%1969%29%   
% 209.84/210.00  |- skos__hiddenLabel mesh__D002779 Cholestases
% 209.84/210.00  |- skos__altLabel mesh__D002779 Biliary Stasis
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D002779 2006
% 209.84/210.00  |- skos__altLabel mesh__D002779 Bile Duct Obstruction
% 209.84/210.00  |- mesh__dateCreated mesh__D002779 1999-01-01
% 209.84/210.00  |- mesh__publicMeSHNote mesh__D002779 1972   
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D002779 2005
% 209.84/210.00  |- skos__prefLabel mesh__D002779 Cholestasis
% 209.84/210.00  |- skos__broader mesh__D002779smesh__D001649
% 209.84/210.00  |- rdf__type mesh__D002779sskos__Concept
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D002779 2004
% 209.84/210.00  |- mesh__recordAuthorizer mesh__D002779 sjn
% 209.84/210.00  |- skos__scopeNote mesh__D002779
% 209.84/210.00       Impairment of bile flow due to obstruction in small bile ducts %28%INTRAHEPATIC CHOLESTASIS%29% or obstruction in large bile ducts %28%EXTRAHEPATIC CHOLESTASIS%29%.%A%    
% 209.84/210.00  |- skos__hiddenLabel mesh__D002779 Stases, Biliary
% 209.84/210.00  |- skos__hiddenLabel mesh__D002779 Duct Obstructions, Bile
% 209.84/210.00  |- skos__hiddenLabel mesh__D002779 Obstructions, Bile Duct
% 209.84/210.00  |- skos__hiddenLabel mesh__D002779 Bile Duct Obstructions
% 209.84/210.00  |- mesh__recordMaintainer mesh__D002779 lkt
% 209.84/210.00  |- skos__hiddenLabel mesh__D002779 Stasis, Biliary
% 209.84/210.00  |- mesh__dateEstablished mesh__D002779 1972-01-01
% 209.84/210.00  |- skos__hiddenLabel mesh__D002779 Biliary Stases
% 209.84/210.00  |- mesh__recordOriginator mesh__D002779 NLM
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D007464 2003
% 209.84/210.00  |- mesh__dateRevised mesh__D007464 2000-06-22
% 209.84/210.00  |- skos__broader mesh__D007464smesh__D015125
% 209.84/210.00  |- skos__hiddenLabel mesh__D007464 Entero Septol
% 209.84/210.00  |- skos__altLabel mesh__D007464 Chloroiodoquine
% 209.84/210.00  |- mesh__dateEstablished mesh__D007464 1963-01-01
% 209.84/210.00  |- mesh__historyNote mesh__D007464
% 209.84/210.00       93; was IODOCHLORHYDROXYQUIN 1963-92 %28%see under HYDROXYQUINOLINES 1983-90%29%; CLIOQUINOL was see IODOCHLORHYDROXYQUIN 1976-92%A%  
% 209.84/210.00  |- mesh__onlineNote mesh__D007464
% 209.84/210.00       use CLIOQUINOL to search IODOCHLORHYDROXYQUIN 1966-92   
% 209.84/210.00  |- mesh__recordMaintainer mesh__D007464 TWD
% 209.84/210.00  |- skos__hiddenLabel mesh__D007464 EnteroSeptol
% 209.84/210.00  |- mesh__dateCreated mesh__D007464 1999-01-01
% 209.84/210.00  |- skos__prefLabel mesh__D007464 Clioquinol
% 209.84/210.00  |- skos__hiddenLabel mesh__D007464 EnteroVioform
% 209.84/210.00  |- skos__scopeNote mesh__D007464
% 209.84/210.00       A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.%A%    
% 209.84/210.00  |- skos__hiddenLabel mesh__D007464 5 Chloro 7 iodo 8 quinolinol
% 209.84/210.00  |- mesh__publicMeSHNote mesh__D007464
% 209.84/210.00       93; was IODOCHLORHYDROXYQUIN 1963-92 %28%see under HYDROXYQUINOLINES 1983-90%29%; CLIOQUINOL was see IODOCHLORHYDROXYQUIN 1976-92%A%  
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D007464 2006
% 209.84/210.00  |- skos__hiddenLabel mesh__D007464 Entero Vioform
% 209.84/210.00  |- skos__altLabel mesh__D007464 Iodochloroxyquinoline
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D007464 2002
% 209.84/210.00  |- mesh__recordOriginator mesh__D007464 NLM
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D007464 2005
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D007464 2001
% 209.84/210.00  |- skos__altLabel mesh__D007464 5-Chloro-7-iodo-8-quinolinol
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D007464 2004
% 209.84/210.00  |- mesh__recordAuthorizer mesh__D007464 sjn
% 209.84/210.00  |- skos__altLabel mesh__D007464 Iodochlorhydroxyquin
% 209.84/210.00  |- rdf__type mesh__D007464sskos__Concept
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017892 2006
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017892 1998
% 209.84/210.00  |- skos__annotation mesh__D017892
% 209.84/210.00       inorganic; GEN or unspecified; prefer specifics; DF: OSMIUM CPDS%A%  
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017892 2004
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017892 1996
% 209.84/210.00  |- skos__hiddenLabel mesh__D017892 Compounds, Osmium
% 209.84/210.00  |- skos__prefLabel mesh__D017892 Osmium Compounds
% 209.84/210.00  |- skos__broader mesh__D017892smesh__D007287
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017892 2005
% 209.84/210.00  |- mesh__dateCreated mesh__D017892 1993-06-21
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017892 2002
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017892 2003
% 209.84/210.00  |- mesh__publicMeSHNote mesh__D017892 94   
% 209.84/210.00  |- skos__scopeNote mesh__D017892
% 209.84/210.00       Inorganic compounds that contain osmium as an integral part of the molecule.%A%    
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017892 1995
% 209.84/210.00  |- mesh__historyNote mesh__D017892 94   
% 209.84/210.00  |- mesh__dateEstablished mesh__D017892 1994-01-01
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017892 1994
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017892 2001
% 209.84/210.00  |- skos__historyNote mesh__D017892 Osmium %28%1966-1993%29%
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017892 1999
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017892 2000
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017892 1997
% 209.84/210.00  |- rdf__type mesh__D017892sskos__Concept
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D031563 2004
% 209.84/210.00  |- mesh__dateEstablished mesh__D031563 2003-01-01
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D031563 2005
% 209.84/210.00  |- mesh__historyNote mesh__D031563 2003   
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D031563 2003
% 209.84/210.00  |- skos__broader mesh__D031563smesh__D029561
% 209.84/210.00  |- rdf__type mesh__D031563sskos__Concept
% 209.84/210.00  |- skos__prefLabel mesh__D031563 Lagerstroemia
% 209.84/210.00  |- skos__annotation mesh__D031563
% 209.84/210.00       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.84/210.00  |- mesh__dateCreated mesh__D031563 2002-07-03
% 209.84/210.00  |- mesh__publicMeSHNote mesh__D031563 2003   
% 209.84/210.00  |- skos__scopeNote mesh__D031563
% 209.84/210.00       A plant genus of the family LYTHRACEAE. Members contain lagertannin and have hypoglycemic effects.%A%    
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D031563 2006
% 209.84/210.00  |- skos__historyNote mesh__D017094 Porphyria %28%1966-1992%29%
% 209.84/210.00  |- skos__broader mesh__D017094smesh__D012873
% 209.84/210.00  |- mesh__historyNote mesh__D017094 2005 %28%1993%29%   
% 209.84/210.00  |- skos__annotation mesh__D017094
% 209.84/210.00       do not confuse with PORPHYRIA, ERYTHROHEPATIC   
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017094 2005
% 209.84/210.00  |- mesh__recordAuthorizer mesh__D017094 sjn
% 209.84/210.00  |- skos__altLabel mesh__D017094 Hepatic Porphyria
% 209.84/210.00  |- mesh__dateCreated mesh__D017094 1992-05-22
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D017094 2006
% 209.84/210.00  |- skos__broader mesh__D017094smesh__D008107
% 209.84/210.00  |- mesh__dateRevised mesh__D017094 2004-07-07
% 209.84/210.00  |- mesh__publicMeSHNote mesh__D017094
% 209.84/210.00       2005; see PORPHYRIA, HEPATIC 1993-2004   
% 209.84/210.00  |- skos__broader mesh__D017094smesh__D008661
% 209.84/210.00  |- skos__hiddenLabel mesh__D017094 Hepatic Porphyrias
% 209.84/210.00  |- skos__altLabel mesh__D017094 Porphyria, Hepatic
% 209.84/210.00  |- mesh__recordMaintainer mesh__D017094 lkt
% 209.84/210.00  |- skos__broader mesh__D017094smesh__D011164
% 209.84/210.00  |- mesh__recordOriginator mesh__D017094 PXP
% 209.84/210.00  |- rdf__type mesh__D017094sskos__Concept
% 209.84/210.00  |- skos__prefLabel mesh__D017094 Porphyrias, Hepatic
% 209.84/210.00  |- mesh__dateEstablished mesh__D017094 1993-01-01
% 209.84/210.00  |- skos__scopeNote mesh__D017094
% 209.84/210.00       A group of metabolic diseases due to deficiency of one of a number of LIVER enzymes in the biosynthetic pathway of HEME. They are characterized by the accumulation and increased excretion of PORPHYRINS or its precursors. Clinical features include neurological symptoms %28%PORPHYRIA, ACUTE INTERMITTENT%29%, cutaneous lesions due to photosensitivity %28%PORPHYRIA CUTANEA TARDA%29%, or both %28%HEREDITARY COPROPORPHYRIA%29%. Hepatic porphyrias can be hereditary or acquired as a result of toxicity to the hepatic tissues.%A%    
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003872 2000
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003872 2006
% 209.84/210.00  |- mesh__recordOriginator mesh__D003872 NLM
% 209.84/210.00  |- mesh__recordAuthorizer mesh__D003872 PLS
% 209.84/210.00  |- mesh__recordMaintainer mesh__D003872 TAP
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003872 1997
% 209.84/210.00  |- mesh__dateRevised mesh__D003872 1993-06-02
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003872 2005
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003872 2002
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003872 1996
% 209.84/210.00  |- skos__prefLabel mesh__D003872 Dermatitis
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003872 1999
% 209.84/210.00  |- skos__scopeNote mesh__D003872 Any inflammation of the skin.     
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003872 1995
% 209.84/210.00  |- rdf__type mesh__D003872sskos__Concept
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003872 1998
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003872 2004
% 209.84/210.00  |- skos__hiddenLabel mesh__D003872 Dermatitides
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003872 2001
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003872 1994
% 209.84/210.00  |- skos__broader mesh__D003872smesh__D012871
% 209.84/210.00  |- skos__annotation mesh__D003872
% 209.84/210.00       any skin inflamm; /chem ind = DERMATITIS MEDICAMENTOSA see DRUG ERUPTIONS or DERMATITIS, CONTACT%A%  
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003872 2003
% 209.84/210.00  |- mesh__dateCreated mesh__D003872 1999-01-01
% 209.84/210.00  |- skos__scopeNote mesh__D003074
% 209.84/210.00       Solitary, round, circumscribed shadows found in the lungs in x-ray examinations. Common causes are tuberculosis, neoplasms, cysts, or vascular anomalies. %28%Stedman, 25th ed%29%%A%    
% 209.84/210.00  |- mesh__dateCreated mesh__D003074 1999-01-01
% 209.84/210.00  |- skos__hiddenLabel mesh__D003074 Lesion, Pulmonary Coin
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003074 2006
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003074 1998
% 209.84/210.00  |- mesh__dateRevised mesh__D003074 1996-06-10
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003074 2001
% 209.84/210.00  |- mesh__dateEstablished mesh__D003074 1965-01-01
% 209.84/210.00  |- skos__broader mesh__D003074smesh__D008175
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003074 2003
% 209.84/210.00  |- skos__altLabel mesh__D003074 Nodules, Solitary Pulmonary
% 209.84/210.00  |- mesh__recordAuthorizer mesh__D003074 PLS
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003074 1999
% 209.84/210.00  |- rdf__type mesh__D003074sskos__Concept
% 209.84/210.00  |- skos__altLabel mesh__D003074 Pulmonary Nodule, Solitary
% 209.84/210.00  |- skos__altLabel mesh__D003074 Coin Lesions, Pulmonary
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003074 2004
% 209.84/210.00  |- skos__altLabel mesh__D003074 Pulmonary Coin Lesion
% 209.84/210.00  |- mesh__historyNote mesh__D003074 65   
% 209.84/210.00  |- skos__altLabel mesh__D003074 Pulmonary Nodules, Solitary
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003074 2002
% 209.84/210.00  |- skos__altLabel mesh__D003074 Nodule, Solitary Pulmonary
% 209.84/210.00  |- skos__altLabel mesh__D003074 Solitary Pulmonary Nodule
% 209.84/210.00  |- mesh__activeMeSHYear mesh__D003074 1997
% 209.84/210.00  |- skos__prefLabel mesh__D003074 Coin Lesion, Pulmonary
% 209.84/210.00  |- mesh__recordMaintainer mesh__D003074 TPW
% 209.84/210.00  |- mesh__recordOriginator mesh__D003074 NLM
% 209.84/210.01  |- skos__altLabel mesh__D003074 Solitary Pulmonary Nodules
% 209.84/210.01  |- skos__altLabel mesh__D003074 Pulmonary Coin Lesions
% 209.84/210.01  |- mesh__publicMeSHNote mesh__D003074 65   
% 209.84/210.01  |- skos__hiddenLabel mesh__D003074 Lesions, Pulmonary Coin
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D003074 2000
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D003074 2005
% 209.84/210.01  |- skos__annotation mesh__D003074
% 209.84/210.01       if neopl, coord IM with LUNG NEOPLASMS %28%NIM%29%; if non-neopl, do not coord with LUNG DISEASES; DF: COIN LESION PULM%A%  
% 209.84/210.01  |- skos__broader mesh__D003074smesh__D008171
% 209.84/210.01  |- skos__altLabel mesh__D011506 Gene Proteins
% 209.84/210.01  |- mesh__recordOriginator mesh__D011506 NLM
% 209.84/210.01  |- skos__related mesh__D011506smesh__D000595
% 209.84/210.01  |- mesh__historyNote mesh__D011506
% 209.84/210.01       /metabolism was PROTEIN METABOLISM 1963-65; PROTEIN METABOLISM DISORDERS was heading 1963-64%A%  
% 209.84/210.01  |- skos__related mesh__D011506smesh__D001798
% 209.84/210.01  |- skos__hiddenLabel mesh__D011506 Proteins, Gene
% 209.84/210.01  |- skos__broader mesh__D011506smesh__D000602
% 209.84/210.01  |- mesh__publicMeSHNote mesh__D011506
% 209.84/210.01       /metabolism was PROTEIN METABOLISM 1963-65; PROTEIN METABOLISM DISORDERS was heading 1963-64%A%  
% 209.84/210.01  |- skos__related mesh__D011506smesh__D011487
% 209.84/210.01  |- skos__hiddenLabel mesh__D011506 Protein Gene Products
% 209.84/210.01  |- skos__annotation mesh__D011506
% 209.84/210.01       general only; prefer specific protein or specific precoordinated protein group terms such as EYE PROTEINS, BACTERIAL PROTEINS, DIETARY PROTEINS, etc.; primary protein structure = AMINO ACID SEQUENCE; protein structure referring to protein architecture = PROTEIN CONFORMATION or its specifics: PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; or PROTEIN STRUCTURE, QUATERNARY%A%  
% 209.84/210.01  |- skos__scopeNote mesh__D011506
% 209.84/210.01       Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.%A%    
% 209.84/210.01  |- mesh__onlineNote mesh__D011506 pre-explosion = PROTEINS %28%PX%29%   
% 209.84/210.01  |- skos__prefLabel mesh__D011506 Proteins
% 209.84/210.01  |- mesh__dateRevised mesh__D011506 2005-07-27
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D011506 2006
% 209.84/210.01  |- mesh__recordMaintainer mesh__D011506 ags
% 209.84/210.01  |- mesh__dateCreated mesh__D011506 1999-01-01
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D011506 2006A
% 209.84/210.01  |- mesh__recordAuthorizer mesh__D011506 ags
% 209.84/210.01  |- rdf__type mesh__D011506sskos__Concept
% 209.84/210.01  |- mesh__recordOriginator mesh__D007465 NLM
% 209.84/210.01  |- mesh__recordMaintainer mesh__D007465 jls
% 209.84/210.01  |- skos__annotation mesh__D007465
% 209.84/210.01       for radiolabeled cpd coord IM with IODINE RADIOISOTOPES %28%NIM%29%%A%  
% 209.84/210.01  |- mesh__historyNote mesh__D007465
% 209.84/210.01       66; RADIO-HIPPURAN was see under IUDOHIPPURIC ACID 1966-77; HIPPURAN was see IODOHIPPURIC ACID 1975-77, was see under IODOHIPPURIC ACID 1966-74, was see under CONTRAST MEDIA 1963-65%A%  
% 209.84/210.01  |- skos__hiddenLabel mesh__D007465 o-Iodohippurate, Sodium
% 209.84/210.01  |- skos__hiddenLabel mesh__D007465 Sodium o Iodohippurate
% 209.84/210.01  |- skos__hiddenLabel mesh__D007465 RadioHippuran
% 209.84/210.01  |- skos__hiddenLabel mesh__D007465 I OIH
% 209.84/210.01  |- skos__hiddenLabel mesh__D007465 Iodohippurate, Sodium
% 209.84/210.01  |- mesh__dateCreated mesh__D007465 1999-01-01
% 209.84/210.01  |- skos__prefLabel mesh__D007465 Iodohippuric Acid
% 209.84/210.01  |- mesh__dateRevised mesh__D007465 2004-07-28
% 209.84/210.01  |- mesh__dateEstablished mesh__D007465 1966-01-01
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D007465 2006
% 209.84/210.01  |- skos__hiddenLabel mesh__D007465 Acid, Iodohippuric
% 209.84/210.01  |- skos__altLabel mesh__D007465 ortho-Iodohippurate
% 209.84/210.01  |- skos__hiddenLabel mesh__D007465 Radio Hippuran
% 209.84/210.01  |- skos__altLabel mesh__D007465 Iodobenzoylglycine
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D007465 2005A
% 209.84/210.01  |- skos__altLabel mesh__D007465 I-OIH
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D007465 2005
% 209.84/210.01  |- mesh__onlineNote mesh__D007465
% 209.84/210.01       use IODOHIPPURIC ACID to search RADIO-HIPPURAN %26% HIPPURAN 1966-77%A%  
% 209.84/210.01  |- skos__broader mesh__D007465smesh__D006626
% 209.84/210.01  |- mesh__publicMeSHNote mesh__D007465
% 209.84/210.01       66; HIPPURAN was see under IODOHIPPURIC ACID 1975-77, was see under IODOHIPPURIC ACID 1966-74, was see under CONTRAST MEDIA 1963-65%A%  
% 209.84/210.01  |- skos__altLabel mesh__D007465 Orthoiodohippurate
% 209.84/210.01  |- skos__hiddenLabel mesh__D007465 ortho Iodohippurate
% 209.84/210.01  |- skos__altLabel mesh__D007465 I-Hippuran
% 209.84/210.01  |- mesh__recordAuthorizer mesh__D007465 jls
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D007465 2004
% 209.84/210.01  |- skos__scopeNote mesh__D007465
% 209.84/210.01       An iodine-containing compound used in pyelography as a radiopaque medium. If labeled with radioiodine, it can be used for studies of renal function.%A%    
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D007465 2002
% 209.84/210.01  |- skos__altLabel mesh__D007465 Sodium o-Iodohippurate
% 209.84/210.01  |- rdf__type mesh__D007465sskos__Concept
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D007465 2003
% 209.84/210.01  |- skos__hiddenLabel mesh__D007465 I Hippuran
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D007465 2001
% 209.84/210.01  |- skos__broader mesh__D007465smesh__D001549
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D045584 2004
% 209.84/210.01  |- mesh__dateEstablished mesh__D045584 2004-01-01
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D045584 2005
% 209.84/210.01  |- mesh__dateCreated mesh__D045584 2003-07-09
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D045584 2006
% 209.84/210.01  |- mesh__historyNote mesh__D045584 2004   
% 209.84/210.01  |- skos__hiddenLabel mesh__D045584 Positioning, Chromosome
% 209.84/210.01  |- rdf__type mesh__D045584sskos__Concept
% 209.84/210.01  |- skos__related mesh__D045584smesh__D042581
% 209.84/210.01  |- skos__prefLabel mesh__D045584 Chromosome Positioning
% 209.84/210.01  |- skos__scopeNote mesh__D045584
% 209.84/210.01       The mechanisms of eukaryotic CELLS that place or keep the CHROMOSOMES in a particular SUBNUCLEAR SPACE.%A%    
% 209.84/210.01  |- skos__broader mesh__D045584smesh__D002451
% 209.84/210.01  |- mesh__publicMeSHNote mesh__D045584 2004   
% 209.84/210.01  |- skos__hiddenLabel mesh__D017893 Photopheresis, Extracorporeal
% 209.84/210.01  |- rdf__type mesh__D017893sskos__Concept
% 209.84/210.01  |- mesh__recordOriginator mesh__D017893 TGC
% 209.84/210.01  |- skos__altLabel mesh__D017893 Extracorporeal Photopheresis
% 209.84/210.01  |- skos__broader mesh__D017893smesh__D005112
% 209.84/210.01  |- skos__historyNote mesh__D017893 Photochemotherapy %28%1984-1993%29%
% 209.84/210.01  |- skos__historyNote mesh__D017893 Methoxsalen %28%1986-1993%29%
% 209.84/210.01  |- skos__annotation mesh__D017893 a form of PUVA ther   
% 209.84/210.01  |- mesh__historyNote mesh__D017893 94   
% 209.84/210.01  |- mesh__dateRevised mesh__D017893 2005-06-30
% 209.84/210.01  |- skos__historyNote mesh__D017893 PUVA Therapy %28%1984-1993%29%
% 209.84/210.01  |- skos__hiddenLabel mesh__D017893 Extracorporeal Photochemotherapies
% 209.84/210.01  |- skos__broader mesh__D017893smesh__D011701
% 209.84/210.01  |- mesh__publicMeSHNote mesh__D017893 94   
% 209.84/210.01  |- skos__scopeNote mesh__D017893
% 209.84/210.01       A process in which peripheral blood is exposed in an extracorporeal flow system to photoactivated 8-methoxypsoralen %28%METHOXSALEN%29% and ultraviolet light - a procedure known as PUVA THERAPY. Photopheresis is at present a standard therapy for advanced cutaneous T-cell lymphoma; it shows promise in the treatment of autoimmune diseases.%A%    
% 209.84/210.01  |- skos__altLabel mesh__D017893 Photochemotherapy, Extracorporeal
% 209.84/210.01  |- skos__altLabel mesh__D017893 Extracorporeal Photochemotherapy
% 209.84/210.01  |- skos__prefLabel mesh__D017893 Photopheresis
% 209.84/210.01  |- mesh__dateEstablished mesh__D017893 1994-01-01
% 209.84/210.01  |- mesh__dateCreated mesh__D017893 1993-02-16
% 209.84/210.01  |- skos__hiddenLabel mesh__D017893 Photochemotherapies, Extracorporeal
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D017893 2006
% 209.84/210.01  |- mesh__recordAuthorizer mesh__D017893 sjn
% 209.84/210.01  |- mesh__recordMaintainer mesh__D017893 lkt
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D031564 2003
% 209.84/210.01  |- rdf__type mesh__D031564sskos__Concept
% 209.84/210.01  |- skos__annotation mesh__D031564
% 209.84/210.01       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.84/210.01  |- mesh__dateEstablished mesh__D031564 2003-01-01
% 209.84/210.01  |- mesh__historyNote mesh__D031564 2003   
% 209.84/210.01  |- skos__altLabel mesh__D031564 Henna Plant
% 209.84/210.01  |- skos__scopeNote mesh__D031564
% 209.84/210.01       A plant genus of the family LYTHRACEAE that is the source of henna and has cytotoxic activity.%A%    
% 209.84/210.01  |- skos__broader mesh__D031564smesh__D029561
% 209.84/210.01  |- skos__prefLabel mesh__D031564 Lawsonia Plant
% 209.84/210.01  |- mesh__publicMeSHNote mesh__D031564 2003   
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D031564 2006
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D031564 2004
% 209.84/210.01  |- mesh__dateCreated mesh__D031564 2002-07-03
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D031564 2005
% 209.84/210.01  |- mesh__publicMeSHNote mesh__D017095 93   
% 209.84/210.01  |- mesh__recordMaintainer mesh__D017095 lkt
% 209.84/210.01  |- skos__hiddenLabel mesh__D017095 Failure, Renal
% 209.84/210.01  |- mesh__dateEstablished mesh__D017095 1993-01-01
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D017095 2006
% 209.84/210.01  |- mesh__dateRevised mesh__D017095 2005-06-30
% 209.84/210.01  |- mesh__dateCreated mesh__D017095 1992-05-20
% 209.84/210.01  |- skos__historyNote mesh__D017095 Kidney Failure, Acute %28%1966-1992%29%
% 209.84/210.01  |- skos__hiddenLabel mesh__D017095 Failures, Kidney
% 209.84/210.01  |- skos__hiddenLabel mesh__D017095 Kidney Failures
% 209.84/210.01  |- skos__altLabel mesh__D017095 Renal Failure
% 209.84/210.01  |- skos__hiddenLabel mesh__D017095 Renal Failures
% 209.84/210.01  |- rdf__type mesh__D017095sskos__Concept
% 209.84/210.01  |- skos__hiddenLabel mesh__D017095 Failures, Renal
% 209.84/210.01  |- skos__hiddenLabel mesh__D017095 Failure, Kidney
% 209.84/210.01  |- mesh__recordOriginator mesh__D017095 TGC
% 209.84/210.01  |- skos__annotation mesh__D017095
% 209.84/210.01       for renal failure unspecified as %22%acute%22% %28%KIDNEY FAILURE, ACUTE%29% or %22%chronic%22% %28%KIDNEY FAILURE, CHRONIC%29% but check text for clues at those annotations; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; and RENAL INSUFFICIENCY are also available%A%  
% 209.84/210.01  |- skos__scopeNote mesh__D017095
% 209.84/210.01       A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal failure, either acute %28%KIDNEY FAILURE, ACUTE%29% or chronic %28%KIDNEY FAILURE, CHRONIC%29%, requires HEMODIALYSIS.%A%    
% 209.84/210.01  |- mesh__historyNote mesh__D017095 93   
% 209.84/210.01  |- skos__broader mesh__D017095smesh__D051437
% 209.84/210.01  |- skos__historyNote mesh__D017095 Kidney Diseases %28%1966-1992%29%
% 209.84/210.01  |- mesh__recordAuthorizer mesh__D017095 sjn
% 209.84/210.01  |- skos__historyNote mesh__D017095
% 209.84/210.01       Kidney Failure, Chronic %28%1966-1992%29%
% 209.84/210.01  |- skos__prefLabel mesh__D017095 Kidney Failure
% 209.84/210.01  |- skos__altLabel mesh__D003873 Dermatitis Exfoliativa
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D003873 2001
% 209.84/210.01  |- skos__hiddenLabel mesh__D003873 Dermatitides, Exfoliative
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D003873 2005
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D003873 1993
% 209.84/210.01  |- skos__scopeNote mesh__D003873
% 209.84/210.01       The widespread involvement of the skin by a scaly, erythematous dermatitis occurring either as a secondary or reactive process to an underlying cutaneous disorder %28%e.g., atopic dermatitis, psoriasis, etc.%29%, or as a primary or idiopathic disease. It is often associated with the loss of hair and nails, hyperkeratosis of the palms and soles, and pruritus. %28%From Dorland, 27th ed%29%%A%    
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D003873 1996
% 209.84/210.01  |- mesh__dateRevised mesh__D003873 1992-05-20
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D003873 2000
% 209.84/210.01  |- mesh__publicMeSHNote mesh__D003873
% 209.84/210.01       93; was DERMATITIS EXFOLIATIVA 1963-92; ERYTHRODERMA was heading 1963-92%A%  
% 209.84/210.01  |- skos__altLabel mesh__D003873 Erythroderma
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D003873 1999
% 209.84/210.01  |- mesh__recordOriginator mesh__D003873 NLM
% 209.84/210.01  |- mesh__recordAuthorizer mesh__D003873 PLS
% 209.84/210.01  |- mesh__recordMaintainer mesh__D003873 PLS
% 209.84/210.01  |- skos__broader mesh__D003873smesh__D003872
% 209.84/210.01  |- skos__prefLabel mesh__D003873 Dermatitis, Exfoliative
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D003873 1995
% 209.84/210.01  |- rdf__type mesh__D003873sskos__Concept
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D003873 1998
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D003873 2004
% 209.84/210.01  |- skos__broader mesh__D003873smesh__D017443
% 209.84/210.01  |- mesh__historyNote mesh__D003873
% 209.84/210.01       93; was DERMATITIS EXFOLIATIVA 1963-92; ERYTHRODERMA was heading 1963-92%A%  
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D003873 2002
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D003873 1994
% 209.84/210.01  |- skos__hiddenLabel mesh__D003873 Exfoliative Dermatitis
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D003873 2003
% 209.84/210.01  |- mesh__dateCreated mesh__D003873 1999-01-01
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D003873 2006
% 209.84/210.01  |- skos__hiddenLabel mesh__D003873 Exfoliative Dermatitides
% 209.84/210.01  |- mesh__onlineNote mesh__D003873
% 209.84/210.01       use DERMATITIS, EXFOLIATIVE to search DERMATITIS EXFOLIATIVA %26% ERYTHRODERMA 1966-92%A%  
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D003873 1997
% 209.84/210.01  |- skos__hiddenLabel mesh__D003873 Erythrodermas
% 209.84/210.01  |- skos__hiddenLabel mesh__D003075 Coital Frequencies
% 209.84/210.01  |- skos__hiddenLabel mesh__D003075 Intercourse, First
% 209.84/210.01  |- skos__prefLabel mesh__D003075 Coitus
% 209.84/210.01  |- skos__altLabel mesh__D003075 Sexual Intercourse
% 209.84/210.01  |- rdf__type mesh__D003075sskos__Concept
% 209.84/210.01  |- skos__broader mesh__D003075smesh__D012725
% 209.84/210.01  |- mesh__recordMaintainer mesh__D003075 sjn
% 209.84/210.01  |- skos__hiddenLabel mesh__D003075 First Intercourses
% 209.84/210.01  |- skos__scopeNote mesh__D003075
% 209.84/210.01       The sexual union of a male and a female, a term used for human only.%A%    
% 209.84/210.01  |- mesh__dateRevised mesh__D003075 2004-07-13
% 209.84/210.01  |- skos__hiddenLabel mesh__D003075 Intercourse, Sexual
% 209.84/210.01  |- skos__hiddenLabel mesh__D003075 Frequencies, Coital
% 209.84/210.01  |- skos__broader mesh__D003075smesh__D012098
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D003075 2005
% 209.84/210.01  |- skos__hiddenLabel mesh__D003075 Intercourses, First
% 209.84/210.01  |- skos__hiddenLabel mesh__D003075 Frequency, Coital
% 209.84/210.01  |- mesh__dateCreated mesh__D003075 1999-01-01
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D003075 2006
% 209.84/210.01  |- mesh__recordOriginator mesh__D003075 NLM
% 209.84/210.01  |- skos__annotation mesh__D003075
% 209.84/210.01       human only: animal = COPULATION; for anal or oral sex index under SEX BEHAVIOR%A%  
% 209.84/210.01  |- mesh__recordAuthorizer mesh__D003075 sjn
% 209.84/210.01  |- skos__hiddenLabel mesh__D011507 Proteinurias
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D011507 2003
% 209.84/210.01  |- mesh__recordAuthorizer mesh__D011507 sjn
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D011507 2005
% 209.84/210.01  |- skos__scopeNote mesh__D011507
% 209.84/210.01       The presence of proteins in the urine, an indicator of KIDNEY DISEASES.%A%    
% 209.84/210.01  |- mesh__recordMaintainer mesh__D011507 lkt
% 209.84/210.01  |- rdf__type mesh__D011507sskos__Concept
% 209.84/210.01  |- mesh__recordOriginator mesh__D011507 NLM
% 209.84/210.01  |- skos__annotation mesh__D011507
% 209.84/210.01       EPH %28%Edema, Proteinuria, Hypertension%29% = GESTOSIS, EPH %26% do not index under PROTEINURIA unless it is particularly discussed%A%  
% 209.84/210.01  |- skos__broader mesh__D011507smesh__D014570
% 209.84/210.01  |- skos__prefLabel mesh__D011507 Proteinuria
% 209.84/210.01  |- mesh__dateCreated mesh__D011507 1999-01-01
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D011507 2004
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D011507 2006
% 209.84/210.01  |- mesh__dateRevised mesh__D011507 2002-07-03
% 209.84/210.01  |- skos__broader mesh__D001415Q000293smesh__D001415
% 209.84/210.01  |- mesh__preferredCombination mesh__D001415Q000293smesh__D019567
% 209.84/210.01  |- rdf__type mesh__D001415Q000293smesh__CompoundConcept
% 209.84/210.01  |- mesh__publicMeSHNote mesh__D007466 91; was see under IODINE 1975-90   
% 209.84/210.01  |- mesh__recordMaintainer mesh__D007466 ssb
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D007466 2005
% 209.84/210.01  |- mesh__dateCreated mesh__D007466 1974-11-19
% 209.84/210.01  |- skos__related mesh__D007466smesh__D000891
% 209.84/210.01  |- skos__annotation mesh__D007466
% 209.84/210.01       an iodophor is a complex of iodine %26% a non-ionic surface-active agent; D25-26 qualif%A%  
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D007466 2006
% 209.84/210.01  |- mesh__recordOriginator mesh__D007466 NLM
% 209.84/210.01  |- skos__scopeNote mesh__D007466
% 209.84/210.01       Complexes of iodine and non-ionic surface-active agent acting as carrier and solubilizing agent for the iodine in water. Iodophors usually enhance bactericidal activity of iodine, reduce vapor pressure and odor, minimize staining, and allow wide dilution with water. %28%From Merck Index, 11th ed%29%%A%    
% 209.84/210.01  |- mesh__dateRevised mesh__D007466 2003-07-09
% 209.84/210.01  |- mesh__dateEstablished mesh__D007466 1991-01-01
% 209.84/210.01  |- mesh__recordAuthorizer mesh__D007466 sjn
% 209.84/210.01  |- mesh__historyNote mesh__D007466
% 209.84/210.01       91%28%75%29%; was see under IODINE 1975-90   
% 209.84/210.01  |- skos__hiddenLabel mesh__D007466 Iodine, Tamed
% 209.84/210.01  |- skos__prefLabel mesh__D007466 Iodophors
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D007466 2004
% 209.84/210.01  |- skos__altLabel mesh__D007466 Tamed Iodine
% 209.84/210.01  |- rdf__type mesh__D007466sskos__Concept
% 209.84/210.01  |- skos__historyNote mesh__D007466 Iodine %28%1971-1974%29%
% 209.84/210.01  |- skos__broader mesh__D007466smesh__D013501
% 209.84/210.01  |- mesh__dateCreated mesh__D045585 2003-07-09
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D045585 2006
% 209.84/210.01  |- skos__altLabel mesh__D045585 Fen1 Protein
% 209.84/210.01  |- skos__prefLabel mesh__D045585 Flap Endonucleases
% 209.84/210.01  |- rdf__type mesh__D045585sskos__Concept
% 209.84/210.01  |- mesh__dateEstablished mesh__D045585 2004-01-01
% 209.84/210.01  |- mesh__publicMeSHNote mesh__D045585
% 209.84/210.01       2004; FLAP ENDONUCLEASES was indexed under ENDODEOYRIBONUCLEASES 1994-2003; FEN1 PROTEIN was indexed under EXODEOXYRIBNUCLEASES 1997-2003; RTH-1 NUCLEASE was indexed under EXODEOXYRIBNUCLEASES 1996-2003%A%  
% 209.84/210.01  |- skos__hiddenLabel mesh__D045585 RAD2 Homolog 1 Nuclease
% 209.84/210.01  |- mesh__recordOriginator mesh__D045585 jmp
% 209.84/210.01  |- skos__altLabel mesh__D045585 FEN-1
% 209.84/210.01  |- skos__hiddenLabel mesh__D045585 Nuclease, RTH-1
% 209.84/210.01  |- skos__hiddenLabel mesh__D045585 Flap Endonuclease 1
% 209.84/210.01  |- mesh__recordMaintainer mesh__D045585 jmp
% 209.84/210.01  |- mesh__recordAuthorizer mesh__D045585 sjn
% 209.84/210.01  |- skos__scopeNote mesh__D045585
% 209.84/210.01       Endonucleases that remove 5%27% DNA sequences from a DNA structure called a DNA flap. The DNA flap structure occurs in double-stranded DNA containing a single-stranded break where the 5%27% portion of the downstream strand is too long and overlaps the 3%27% end of the upstream strand. Flap endonucleases cleave the downstream strand of the overlap flap structure precisely after the first base-paired nucleotide, creating a ligatable nick.%A%    
% 209.84/210.01  |- skos__hiddenLabel mesh__D045585 RTH 1 Nuclease
% 209.84/210.01  |- mesh__historyNote mesh__D045585
% 209.84/210.01       2004; use FLAP ENDONUCLEASES %28%NM%29% 1994-2003; for FEN1 PROTEIN use EXODEOXYRIBONUCLEASE V 1997-2003; for RTH-1 NUCLEASE use EXODEOXYRIBONUCLEASE V 1996-2003%A%  
% 209.84/210.01  |- skos__altLabel mesh__D045585 RTH-1 Nuclease
% 209.84/210.01  |- skos__historyNote mesh__D045585 Endodeoxyribonucleases %28%1994-2003%29%
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D045585 2004
% 209.84/210.01  |- skos__hiddenLabel mesh__D045585 Endonuclease-1, Flap
% 209.84/210.01  |- skos__hiddenLabel mesh__D045585 Endonucleases, Flap
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D045585 2005
% 209.84/210.01  |- skos__altLabel mesh__D045585 RAD2 Homolog-1 Nuclease
% 209.84/210.01  |- skos__broader mesh__D045585smesh__D004706
% 209.84/210.01  |- skos__broader mesh__D011574Q000266smesh__D011574
% 209.84/210.01  |- mesh__preferredCombination mesh__D011574Q000266smesh__D011572Q000266
% 209.84/210.01  |- rdf__type mesh__D011574Q000266smesh__CompoundConcept
% 209.84/210.01  |- skos__prefLabel mesh__D012600 Scoliosis
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D012600 2002
% 209.84/210.01  |- mesh__recordMaintainer mesh__D012600 TGC
% 209.84/210.01  |- skos__broader mesh__D012600smesh__D013121
% 209.84/210.01  |- skos__scopeNote mesh__D012600
% 209.84/210.01       An appreciable lateral deviation in the normally straight vertical line of the spine. %28%Dorland, 27th ed%29%%A%    
% 209.84/210.01  |- mesh__recordOriginator mesh__D012600 NLM
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D012600 1995
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D012600 2001
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D012600 1999
% 209.84/210.01  |- mesh__recordAuthorizer mesh__D012600 PLS
% 209.84/210.01  |- mesh__dateCreated mesh__D012600 1999-01-01
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D012600 2006
% 209.84/210.01  |- mesh__dateRevised mesh__D012600 1994-04-11
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D012600 1997
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D012600 2000
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D012600 1998
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D012600 2004
% 209.84/210.01  |- skos__hiddenLabel mesh__D012600 Scolioses
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D012600 1996
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D012600 2005
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D012600 2003
% 209.84/210.01  |- rdf__type mesh__D012600sskos__Concept
% 209.84/210.01  |- skos__annotation mesh__D012600 a type of spinal curvature   
% 209.84/210.01  |- skos__broader mesh__D031565smesh__D029561
% 209.84/210.01  |- rdf__type mesh__D031565sskos__Concept
% 209.84/210.01  |- skos__scopeNote mesh__D031565
% 209.84/210.01       A plant genus of the family LYTHRACEAE. Members contain woodfordins.%A%    
% 209.84/210.01  |- skos__prefLabel mesh__D031565 Woodfordia
% 209.84/210.01  |- skos__annotation mesh__D031565
% 209.84/210.01       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.84/210.01  |- mesh__dateCreated mesh__D031565 2002-07-03
% 209.84/210.01  |- mesh__dateEstablished mesh__D031565 2003-01-01
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D031565 2005
% 209.84/210.01  |- mesh__publicMeSHNote mesh__D031565 2003   
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D031565 2003
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D031565 2006
% 209.84/210.01  |- mesh__historyNote mesh__D031565 2003   
% 209.84/210.01  |- mesh__activeMeSHYear mesh__D031565 2004
% 209.84/210.01  |- mesh__publicMeSHNote mesh__D017096 1993   
% 209.87/210.01  |- skos__altLabel mesh__D017096 Transmissible Spongiform Encephalopathies
% 209.87/210.01  |- skos__hiddenLabel mesh__D017096 Spongiform Encephalopathy, Transmissible
% 209.87/210.01  |- skos__scopeNote mesh__D017096
% 209.87/210.01       A group of genetic, infectious, or sporadic degenerative human and animal nervous system disorders associated with abnormal PRIONS. These diseases are characterized by conversion of the normal prion protein to an abnormal configuration via a post-translational process. In humans, these conditions generally feature DEMENTIA; ATAXIA; and a fatal outcome. Pathologic features include a spongiform encephalopathy without evidence of inflammation. The older literature occasionally refers to these as unconventional SLOW VIRUS DISEASES. %28%From Proc Natl Acad Sci USA 1998 Nov 10;95%28%23%29%:13363-83%29%%A%    
% 209.87/210.01  |- mesh__dateCreated mesh__D017096 1992-05-22
% 209.87/210.01  |- skos__hiddenLabel mesh__D017096 Encephalopathy, Transmissible Spongiform
% 209.87/210.01  |- skos__prefLabel mesh__D017096 Prion Diseases
% 209.87/210.01  |- skos__hiddenLabel mesh__D017096 Disorder, Prion-Induced
% 209.87/210.01  |- mesh__historyNote mesh__D017096 1993   
% 209.87/210.01  |- skos__broader mesh__D017096smesh__D002494
% 209.87/210.01  |- skos__altLabel mesh__D017096 Transmissible Dementias
% 209.87/210.01  |- rdf__type mesh__D017096sskos__Concept
% 209.87/210.01  |- skos__altLabel mesh__D017096 Prion-Induced Disorder
% 209.87/210.01  |- mesh__dateEstablished mesh__D017096 1993-01-01
% 209.87/210.01  |- skos__hiddenLabel mesh__D017096 Prion-Induced Disorders
% 209.87/210.01  |- skos__hiddenLabel mesh__D017096 Prion Protein Disease
% 209.87/210.01  |- skos__hiddenLabel mesh__D017096 Dementia, Transmissible
% 209.87/210.01  |- skos__altLabel mesh__D017096 Dementias, Transmissible
% 209.87/210.01  |- skos__altLabel mesh__D017096 Prion Protein Diseases
% 209.87/210.01  |- skos__historyNote mesh__D017096 Slow Virus Diseases %28%1966-1992%29%
% 209.87/210.01  |- mesh__recordAuthorizer mesh__D017096 ags
% 209.87/210.01  |- mesh__recordMaintainer mesh__D017096 ags
% 209.87/210.01  |- skos__annotation mesh__D017096 GEN or unspecified: prefer specifics   
% 209.87/210.01  |- skos__hiddenLabel mesh__D017096 Transmissible Dementia
% 209.87/210.01  |- skos__hiddenLabel mesh__D017096 Prion Disease
% 209.87/210.01  |- skos__hiddenLabel mesh__D017096 Disorders, Prion-Induced
% 209.87/210.01  |- skos__altLabel mesh__D017096
% 209.87/210.01       Inherited Human Transmissible Spongiform Encephalopathies
% 209.87/210.01  |- mesh__activeMeSHYear mesh__D017096 2005
% 209.87/210.01  |- mesh__activeMeSHYear mesh__D017096 2006A
% 209.87/210.01  |- skos__hiddenLabel mesh__D017096
% 209.87/210.01       Encephalopathies, Transmissible Spongiform
% 209.87/210.01  |- skos__altLabel mesh__D017096 Encephalopathies, Spongiform, Transmissible
% 209.87/210.01  |- mesh__recordOriginator mesh__D017096 AGS
% 209.87/210.01  |- mesh__dateRevised mesh__D017096 2005-07-13
% 209.87/210.01  |- skos__broader mesh__D017096smesh__D019636
% 209.87/210.01  |- skos__hiddenLabel mesh__D017096 Transmissible Spongiform Encephalopathy
% 209.87/210.01  |- skos__hiddenLabel mesh__D017096 Prion Induced Disorder
% 209.87/210.01  |- skos__altLabel mesh__D017096 Spongiform Encephalopathies, Transmissible
% 209.87/210.01  |- mesh__activeMeSHYear mesh__D017096 2006
% 209.87/210.01  |- skos__hiddenLabel mesh__D003874 Disease, Duhring%27%s
% 209.87/210.01  |- mesh__activeMeSHYear mesh__D003874 1993
% 209.87/210.01  |- skos__scopeNote mesh__D003874
% 209.87/210.01       Rare, chronic, papulo-vesicular disease characterized by an intensely pruritic eruption consisting of various combinations of symmetrical, erythematous, papular, vesicular, or bullous lesions. The disease is strongly associated with the presence of HLA-B8 and HLA-DR3 antigens. A variety of different autoantibodies has been detected in small numbers in patients with dermatitis herpetiformis.%A%    
% 209.87/210.01  |- mesh__activeMeSHYear mesh__D003874 1998
% 209.87/210.01  |- skos__hiddenLabel mesh__D003874 Disease, Duhring
% 209.87/210.01  |- mesh__activeMeSHYear mesh__D003874 2000
% 209.87/210.01  |- mesh__activeMeSHYear mesh__D003874 1994
% 209.87/210.01  |- mesh__activeMeSHYear mesh__D003874 1999
% 209.87/210.01  |- skos__altLabel mesh__D003874 Duhring%27%s Disease
% 209.87/210.01  |- mesh__recordAuthorizer mesh__D003874 PLS
% 209.87/210.01  |- skos__broader mesh__D003874smesh__D003872
% 209.87/210.01  |- mesh__activeMeSHYear mesh__D003874 2003
% 209.87/210.01  |- skos__broader mesh__D003874smesh__D001327
% 209.87/210.01  |- rdf__type mesh__D003874sskos__Concept
% 209.87/210.01  |- mesh__dateCreated mesh__D003874 1999-01-01
% 209.87/210.01  |- mesh__activeMeSHYear mesh__D003874 2001
% 209.87/210.01  |- mesh__activeMeSHYear mesh__D003874 1995
% 209.87/210.01  |- mesh__activeMeSHYear mesh__D003874 2004
% 209.87/210.01  |- skos__broader mesh__D003874smesh__D012872
% 209.87/210.01  |- mesh__activeMeSHYear mesh__D003874 2002
% 209.87/210.01  |- mesh__dateRevised mesh__D003874 1992-05-20
% 209.87/210.01  |- mesh__recordOriginator mesh__D003874 NLM
% 209.87/210.01  |- mesh__activeMeSHYear mesh__D003874 2005
% 209.87/210.01  |- mesh__activeMeSHYear mesh__D003874 1996
% 209.87/210.01  |- skos__altLabel mesh__D003874 Duhring Disease
% 209.87/210.01  |- mesh__activeMeSHYear mesh__D003874 2006
% 209.87/210.01  |- skos__annotation mesh__D003874
% 209.87/210.01       a bullous skin dis: nothing to do with herpes   
% 209.87/210.01  |- skos__prefLabel mesh__D003874 Dermatitis Herpetiformis
% 209.87/210.01  |- mesh__recordMaintainer mesh__D003874 PLS
% 209.87/210.01  |- mesh__activeMeSHYear mesh__D003874 1997
% 209.87/210.01  |- skos__hiddenLabel mesh__D003874 Duhrings Disease
% 209.87/210.01  |- skos__broader mesh__D003076smesh__D003075
% 209.87/210.01  |- skos__scopeNote mesh__D003076
% 209.87/210.01       A contraceptive method whereby coitus is purposely interrupted in order to prevent EJACULATION of SEMEN into the VAGINA.%A%    
% 209.87/210.01  |- mesh__recordMaintainer mesh__D003076 lkt
% 209.87/210.01  |- mesh__recordOriginator mesh__D003076 NLM
% 209.87/210.01  |- mesh__activeMeSHYear mesh__D003076 2006
% 209.87/210.01  |- mesh__recordAuthorizer mesh__D003076 sjn
% 209.87/210.01  |- mesh__dateEstablished mesh__D003076 1975-09-01
% 209.87/210.01  |- skos__historyNote mesh__D003076 Contraception %28%1966-1974%29%
% 209.87/210.01  |- skos__hiddenLabel mesh__D003076 Interruptus, Coitus
% 209.87/210.01  |- skos__broader mesh__D003076smesh__D003267
% 209.87/210.01  |- mesh__publicMeSHNote mesh__D003076 75   
% 209.87/210.01  |- mesh__dateCreated mesh__D003076 1974-11-19
% 209.87/210.01  |- skos__prefLabel mesh__D003076 Coitus Interruptus
% 209.87/210.01  |- mesh__dateRevised mesh__D003076 2005-06-30
% 209.87/210.01  |- rdf__type mesh__D003076sskos__Concept
% 209.87/210.01  |- mesh__historyNote mesh__D003076 75   
% 209.87/210.01  |- skos__historyNote mesh__D003076 Coitus %28%1966-1974%29%
% 209.87/210.01  |- mesh__publicMeSHNote mesh__D011508
% 209.87/210.01       91; was see under PROTEOGLYCANS 1977-90; was see under MUCOPOLYSACCHARIDES 1976%A%  
% 209.87/210.01  |- rdf__type mesh__D011508sskos__Concept
% 209.87/210.01  |- skos__historyNote mesh__D011508 Mucoproteins %28%1973-1974%29%
% 209.87/210.01  |- skos__hiddenLabel mesh__D011508 Sulfates, Proteochondroitin
% 209.87/210.01  |- skos__scopeNote mesh__D011508
% 209.87/210.01       Proteoglycans found in cartilage. They consist of several chondroitin sulfate molecules linked to protein%28%s%29% by neutral sugar linkage regions.%A%    
% 209.87/210.01  |- mesh__dateCreated mesh__D011508 1975-07-25
% 209.87/210.01  |- mesh__recordMaintainer mesh__D011508 SYSTEM
% 209.87/210.01  |- mesh__recordOriginator mesh__D011508 RLS
% 209.87/210.01  |- mesh__recordAuthorizer mesh__D011508 sjn
% 209.87/210.01  |- mesh__dateRevised mesh__D011508 2005-06-30
% 209.87/210.01  |- skos__hiddenLabel mesh__D011508 Sulfate Proteoglycan, Chondroitin
% 209.87/210.01  |- skos__hiddenLabel mesh__D011508 Proteoglycan, Chondroitin Sulfate
% 209.87/210.01  |- mesh__historyNote mesh__D011508
% 209.87/210.01       91%28%76%29%; was see under PROTEOGLYCANS 1977-90; was see under MUCOPOLYSACCHARIDES 1976%A%  
% 209.87/210.02  |- skos__hiddenLabel mesh__D011508 Sulfate, Proteochondroitin
% 209.87/210.02  |- skos__broader mesh__D011508smesh__D011509
% 209.87/210.02  |- skos__historyNote mesh__D011508 Chondroitin %28%1973-1974%29%
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D011508 2006
% 209.87/210.02  |- skos__prefLabel mesh__D011508 Proteochondroitin Sulfates
% 209.87/210.02  |- mesh__dateEstablished mesh__D011508 1991-01-01
% 209.87/210.02  |- mesh__recordMaintainer mesh__D007467 SYSTEM
% 209.87/210.02  |- skos__historyNote mesh__D007467 Iodine %28%1966-1967%29%
% 209.87/210.02  |- skos__broader mesh__D007467smesh__D011506
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D007467 2006
% 209.87/210.02  |- skos__related mesh__D007467smesh__D012711
% 209.87/210.02  |- mesh__publicMeSHNote mesh__D007467 72   
% 209.87/210.02  |- skos__historyNote mesh__D007467 Proteins %28%1966-1967%29%
% 209.87/210.02  |- mesh__dateRevised mesh__D007467 2005-06-30
% 209.87/210.02  |- skos__prefLabel mesh__D007467 Iodoproteins
% 209.87/210.02  |- mesh__dateEstablished mesh__D007467 1972-01-01
% 209.87/210.02  |- mesh__recordOriginator mesh__D007467 NLM
% 209.87/210.02  |- rdf__type mesh__D007467sskos__Concept
% 209.87/210.02  |- mesh__dateCreated mesh__D007467 1999-01-01
% 209.87/210.02  |- mesh__recordAuthorizer mesh__D007467 sjn
% 209.87/210.02  |- mesh__historyNote mesh__D007467 72%28%68%29%   
% 209.87/210.02  |- skos__hiddenLabel mesh__D045586 Nuclear Inclusion
% 209.87/210.02  |- rdf__type mesh__D045586sskos__Concept
% 209.87/210.02  |- skos__hiddenLabel mesh__D045586 Intranuclear Inclusion Body
% 209.87/210.02  |- skos__hiddenLabel mesh__D045586 Inclusions, Intranuclear
% 209.87/210.02  |- mesh__historyNote mesh__D045586 2004   
% 209.87/210.02  |- skos__hiddenLabel mesh__D045586 Nuclear Inclusion Body
% 209.87/210.02  |- skos__historyNote mesh__D045586
% 209.87/210.02       Inclusion Bodies or specifics %28%1965-2003%29%
% 209.87/210.02  |- skos__broader mesh__D045586smesh__D002479
% 209.87/210.02  |- skos__hiddenLabel mesh__D045586 Intranuclear Inclusion
% 209.87/210.02  |- mesh__publicMeSHNote mesh__D045586 2004   
% 209.87/210.02  |- skos__hiddenLabel mesh__D045586 Inclusion, Nuclear
% 209.87/210.02  |- skos__prefLabel mesh__D045586 Intranuclear Inclusion Bodies
% 209.87/210.02  |- skos__related mesh__D045586smesh__D007181
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D045586 2004
% 209.87/210.02  |- mesh__dateEstablished mesh__D045586 2004-01-01
% 209.87/210.02  |- skos__altLabel mesh__D045586 Nuclear Inclusions
% 209.87/210.02  |- skos__altLabel mesh__D045586 Inclusion Bodies, Intranuclear
% 209.87/210.02  |- skos__hiddenLabel mesh__D045586 Inclusion Bodies, Nuclear
% 209.87/210.02  |- skos__altLabel mesh__D045586 Intranuclear Inclusions
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D045586 2005
% 209.87/210.02  |- skos__hiddenLabel mesh__D045586 Inclusion Body, Intranuclear
% 209.87/210.02  |- skos__hiddenLabel mesh__D045586 Inclusion, Intranuclear
% 209.87/210.02  |- skos__hiddenLabel mesh__D045586 Inclusions, Nuclear
% 209.87/210.02  |- skos__altLabel mesh__D045586 Nuclear Inclusion Bodies
% 209.87/210.02  |- mesh__dateCreated mesh__D045586 2003-07-09
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D045586 2006
% 209.87/210.02  |- skos__hiddenLabel mesh__D045586 Inclusion Body, Nuclear
% 209.87/210.02  |- skos__scopeNote mesh__D045586
% 209.87/210.02       Circumscribed masses of foreign or metabolically inactive materials, within the CELL NUCLEUS. Some are VIRAL INCLUSION BODIES.%A%    
% 209.87/210.02  |- skos__altLabel mesh__D012601 Roche Brand of Scopolamine Hydrobromide
% 209.87/210.02  |- skos__altLabel mesh__D012601
% 209.87/210.02       Novartis Consumer Health Brand of Scopolamine
% 209.87/210.02  |- skos__broader mesh__D012601smesh__D014326
% 209.87/210.02  |- skos__broader mesh__D012601smesh__D001533
% 209.87/210.02  |- skos__hiddenLabel mesh__D012601 Hydrobromide, Scopolamine
% 209.87/210.02  |- skos__scopeNote mesh__D012601
% 209.87/210.02       An alkaloid from Solanaceae, especially Datura metel L. and Scopola carniolica. Scopolamine and its quaternary derivatives act as antimuscarinics like atropine, but may have more central nervous system effects. Among the many uses are as an anesthetic premedication, in urinary incontinence, in motion sickness, as an antispasmodic, and as a mydriatic and cycloplegic.%A%    
% 209.87/210.02  |- skos__altLabel mesh__D012601 Hamilton Brand of Scopolamine Hydrobromide
% 209.87/210.02  |- skos__altLabel mesh__D012601 Hyoscine
% 209.87/210.02  |- mesh__recordMaintainer mesh__D012601 wdj
% 209.87/210.02  |- skos__altLabel mesh__D012601 Renaudin Brand of Scopolamine Hydrobromide
% 209.87/210.02  |- mesh__dateCreated mesh__D012601 1999-01-01
% 209.87/210.02  |- skos__prefLabel mesh__D012601 Scopolamine
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D012601 2006
% 209.87/210.02  |- mesh__recordOriginator mesh__D012601 NLM
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D012601 2006B
% 209.87/210.02  |- skos__altLabel mesh__D012601 Alcon Brand of Scopolamine Hydrobromide
% 209.87/210.02  |- skos__hiddenLabel mesh__D012601 Transderm V
% 209.87/210.02  |- skos__altLabel mesh__D012601 Cooper Brand of Scopolamine Hydrobromide
% 209.87/210.02  |- skos__altLabel mesh__D012601 Transderm-V
% 209.87/210.02  |- skos__altLabel mesh__D012601 Hope Brand of Scopolamine
% 209.87/210.02  |- mesh__recordAuthorizer mesh__D012601 wdj
% 209.87/210.02  |- rdf__type mesh__D012601sskos__Concept
% 209.87/210.02  |- skos__altLabel mesh__D012601 Inibisa Brand of Scopolamine Hydrobromide
% 209.87/210.02  |- mesh__dateRevised mesh__D012601 2005-07-22
% 209.87/210.02  |- skos__altLabel mesh__D012601 Scopoderm TTS
% 209.87/210.02  |- skos__altLabel mesh__D012601 Novartis Brand of Scopolamine
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D012601 2006A
% 209.87/210.02  |- skos__hiddenLabel mesh__D017895 Compounds, Manganese
% 209.87/210.02  |- skos__annotation mesh__D017895
% 209.87/210.02       inorganic; GEN or unspecified; prefer specifics; DF: MANGANESE CPDS%A%  
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D017895 2005
% 209.87/210.02  |- mesh__dateEstablished mesh__D017895 1994-01-01
% 209.87/210.02  |- mesh__dateCreated mesh__D017895 1993-06-21
% 209.87/210.02  |- mesh__recordOriginator mesh__D017895 TPW
% 209.87/210.02  |- mesh__publicMeSHNote mesh__D017895 94   
% 209.87/210.02  |- mesh__dateRevised mesh__D017895 1999-11-03
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D017895 2003
% 209.87/210.02  |- skos__scopeNote mesh__D017895
% 209.87/210.02       Inorganic chemicals that contain manganese as an integral part of the molecule.%A%    
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D017895 2006
% 209.87/210.02  |- rdf__type mesh__D017895sskos__Concept
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D017895 2000
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D017895 2004
% 209.87/210.02  |- mesh__recordAuthorizer mesh__D017895 sjn
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D017895 2001
% 209.87/210.02  |- skos__historyNote mesh__D017895 Manganese %28%1966-1993%29%
% 209.87/210.02  |- skos__prefLabel mesh__D017895 Manganese Compounds
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D017895 2002
% 209.87/210.02  |- mesh__historyNote mesh__D017895 94   
% 209.87/210.02  |- skos__broader mesh__D017895smesh__D007287
% 209.87/210.02  |- mesh__recordMaintainer mesh__D017895 tpw
% 209.87/210.02  |- mesh__historyNote mesh__D031566 2003   
% 209.87/210.02  |- skos__annotation mesh__D031566
% 209.87/210.02       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.87/210.02  |- skos__broader mesh__D031566smesh__D029562
% 209.87/210.02  |- skos__scopeNote mesh__D031566
% 209.87/210.02       A plant genus of the family MAGNOLIACEAE. The germacranolide sesquiterpene lactones costunolide, parthenolide, and costunolide diepoxide have been isolated from the leaves. Bark contains honokiol and magnolol. Parts are an ingredient of Banxia Houpo Tang.%A%    
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D031566 2005
% 209.87/210.02  |- mesh__publicMeSHNote mesh__D031566 2003   
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D031566 2003
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D031566 2006
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D031566 2004
% 209.87/210.02  |- mesh__dateEstablished mesh__D031566 2003-01-01
% 209.87/210.02  |- skos__altLabel mesh__D031566 Sweet Bay
% 209.87/210.02  |- skos__prefLabel mesh__D031566 Magnolia
% 209.87/210.02  |- rdf__type mesh__D031566sskos__Concept
% 209.87/210.02  |- mesh__dateCreated mesh__D031566 2002-07-02
% 209.87/210.02  |- skos__altLabel mesh__D031566 Bay, Sweet
% 209.87/210.02  |- skos__altLabel mesh__D050720 Retinoblastoma Like Protein p107
% 209.87/210.02  |- skos__altLabel mesh__D050720 p107 Tumor Suppressor Protein
% 209.87/210.02  |- mesh__dateEstablished mesh__D050720 2006-01-01
% 209.87/210.02  |- skos__broader mesh__D050720smesh__D010750
% 209.87/210.02  |- skos__altLabel mesh__D050720 Retinoblastoma-Like Protein 1
% 209.87/210.02  |- mesh__recordAuthorizer mesh__D050720 sjn
% 209.87/210.02  |- skos__prefLabel mesh__D050720 Retinoblastoma-Like Protein p107
% 209.87/210.02  |- skos__broader mesh__D050720smesh__D009687
% 209.87/210.02  |- mesh__publicMeSHNote mesh__D050720
% 209.87/210.02       2006; RETINOBLASTOMA-LIKE PROTEIN P107 was indexed under NUCLEAR PROTEINS 1995-2005 %26% under PROTEINS 1991-1994%A%  
% 209.87/210.02  |- mesh__historyNote mesh__D050720 2006%28%1991%29%   
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D050720 2006
% 209.87/210.02  |- skos__hiddenLabel mesh__D050720 Retinoblastoma Like Protein 1
% 209.87/210.02  |- rdf__type mesh__D050720sskos__Concept
% 209.87/210.02  |- skos__hiddenLabel mesh__D050720 p107, Retinoblastoma-Like Protein
% 209.87/210.02  |- mesh__recordOriginator mesh__D050720 DRC
% 209.87/210.02  |- mesh__dateCreated mesh__D050720 2005-06-30
% 209.87/210.02  |- skos__broader mesh__D050720smesh__D025521
% 209.87/210.02  |- skos__scopeNote mesh__D050720
% 209.87/210.02       A negative regulator of the CELL CYCLE that undergoes PHOSPHORYLATION by CYCLIN-DEPENDENT KINASES. It contains a conserved pocket region that binds E2F4 TRANSCRIPTION FACTOR and interacts with viral ONCOPROTEINS such as POLYOMAVIRUS TUMOR ANTIGENS; ADENOVIRUS E1A PROTEINS; and PAPILLOMAVIRUS E7 PROTEINS.%A%    
% 209.87/210.02  |- mesh__recordMaintainer mesh__D050720 DRC
% 209.87/210.02  |- skos__altLabel mesh__D050720 RBL1 Protein
% 209.87/210.02  |- skos__hiddenLabel mesh__D017097 Resistance, Electrical
% 209.87/210.02  |- skos__altLabel mesh__D017097 Biolectric Impedance
% 209.87/210.02  |- skos__hiddenLabel mesh__D017097 Resistances, Ohmic
% 209.87/210.02  |- skos__hiddenLabel mesh__D017097 Impedance, Bioelectrical
% 209.87/210.02  |- mesh__dateEstablished mesh__D017097 1993-01-01
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D017097 2006
% 209.87/210.02  |- skos__broader mesh__D017097smesh__D004553
% 209.87/210.02  |- skos__altLabel mesh__D017097 Impedance
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D017097 2002
% 209.87/210.02  |- skos__scopeNote mesh__D017097
% 209.87/210.02       The resistance to the flow of either alternating or direct electrical current.%A%    
% 209.87/210.02  |- skos__historyNote mesh__D017097 Electrophysiology %28%1966-1967%29%
% 209.87/210.02  |- skos__historyNote mesh__D017097 Electric Conductivity %28%1968-1992%29%
% 209.87/210.02  |- skos__hiddenLabel mesh__D017097 Resistance, Electric
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D017097 2005
% 209.87/210.02  |- mesh__dateCreated mesh__D017097 1992-05-08
% 209.87/210.02  |- mesh__recordAuthorizer mesh__D017097 sjn
% 209.87/210.02  |- mesh__recordOriginator mesh__D017097 TGC
% 209.87/210.02  |- rdf__type mesh__D017097sskos__Concept
% 209.87/210.02  |- mesh__publicMeSHNote mesh__D017097 93   
% 209.87/210.02  |- skos__annotation mesh__D017097
% 209.87/210.02       NIM; bioelectric impedance anal of body composition: coord with BODY COMPOSITION%A%  
% 209.87/210.02  |- skos__altLabel mesh__D017097 Electrical Impedance
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D017097 2004
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D017097 2001
% 209.87/210.02  |- skos__hiddenLabel mesh__D017097 Impedance, Biolectric
% 209.87/210.02  |- mesh__historyNote mesh__D017097 93   
% 209.87/210.02  |- skos__hiddenLabel mesh__D017097 Resistance, Ohmic
% 209.87/210.02  |- skos__hiddenLabel mesh__D017097 Ohmic Resistances
% 209.87/210.02  |- skos__prefLabel mesh__D017097 Electric Impedance
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D017097 2000
% 209.87/210.02  |- mesh__dateRevised mesh__D017097 1999-11-03
% 209.87/210.02  |- skos__hiddenLabel mesh__D017097 Impedance, Electrical
% 209.87/210.02  |- skos__altLabel mesh__D017097 Electrical Resistance
% 209.87/210.02  |- mesh__recordMaintainer mesh__D017097 KEV
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D017097 2003
% 209.87/210.02  |- skos__hiddenLabel mesh__D017097 Impedance, Electric
% 209.87/210.02  |- skos__hiddenLabel mesh__D003875 Eruptions, Drug
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003875 1994
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003875 1999
% 209.87/210.02  |- mesh__publicMeSHNote mesh__D003875
% 209.87/210.02       93; was DERMATITIS MEDICAMENTOSA 1963-92; DRUG ERUPTIONS was see DERMATITIS MEDICAMENTOSA 1975-92, was see under DERMATITIS MEDICAMENTOSA 1971-74%A%  
% 209.87/210.02  |- mesh__recordMaintainer mesh__D003875 PLS
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003875 2003
% 209.87/210.02  |- mesh__dateRevised mesh__D003875 1992-05-14
% 209.87/210.02  |- skos__broader mesh__D003875smesh__D003872
% 209.87/210.02  |- rdf__type mesh__D003875sskos__Concept
% 209.87/210.02  |- mesh__dateCreated mesh__D003875 1999-01-01
% 209.87/210.02  |- skos__hiddenLabel mesh__D003875 Eruption, Drug
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003875 1995
% 209.87/210.02  |- skos__annotation mesh__D003875
% 209.87/210.02       for any skin dis caused by ther agent whether prescribed by MD or not, or through any route of admin%A%  
% 209.87/210.02  |- skos__broader mesh__D003875smesh__D004342
% 209.87/210.02  |- skos__scopeNote mesh__D003875
% 209.87/210.02       Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions.%A%    
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003875 2004
% 209.87/210.02  |- skos__broader mesh__D003875smesh__D004362
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003875 2000
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003875 2005
% 209.87/210.02  |- mesh__recordAuthorizer mesh__D003875 PLS
% 209.87/210.02  |- mesh__onlineNote mesh__D003875
% 209.87/210.02       use DRUG ERUPTIONS to search DERMATITIS MEDICAMENTOSA 1966-92%A%  
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003875 1996
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003875 2001
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003875 2006
% 209.87/210.02  |- skos__altLabel mesh__D003875 Dermatitis Medicamentosa
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003875 1997
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003875 2002
% 209.87/210.02  |- skos__altLabel mesh__D003875 Dermatitis, Adverse Drug Reaction
% 209.87/210.02  |- skos__prefLabel mesh__D003875 Drug Eruptions
% 209.87/210.02  |- skos__hiddenLabel mesh__D003875 Drug Eruption
% 209.87/210.02  |- mesh__recordOriginator mesh__D003875 NLM
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003875 1993
% 209.87/210.02  |- mesh__historyNote mesh__D003875
% 209.87/210.02       93; was DERMATITIS MEDICAMENTOSA 1963-92; DRUG ERUPTIONS was see DERMATITIS MEDICAMENTOSA 1975-92, was see under DERMATITIS MEDICAMENTOSA 1971-74%A%  
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003875 1998
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003077 2005
% 209.87/210.02  |- skos__annotation mesh__D003077 a coal residue used as fuel   
% 209.87/210.02  |- mesh__historyNote mesh__D003077
% 209.87/210.02       91%28%75%29%; was see under COAL 1975-90; was in Cat J only 1975-81%A%  
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003077 2006
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003077 1998
% 209.87/210.02  |- skos__scopeNote mesh__D003077
% 209.87/210.02       A residue of coal, left after dry %28%destructive%29% distillation, used as a fuel.%A%    
% 209.87/210.02  |- mesh__dateCreated mesh__D003077 1999-01-01
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003077 2002
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003077 2003
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003077 1999
% 209.87/210.02  |- mesh__recordMaintainer mesh__D003077 JLS
% 209.87/210.02  |- skos__prefLabel mesh__D003077 Coke
% 209.87/210.02  |- mesh__recordOriginator mesh__D003077 NLM
% 209.87/210.02  |- rdf__type mesh__D003077sskos__Concept
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003077 2004
% 209.87/210.02  |- mesh__dateRevised mesh__D003077 1997-06-20
% 209.87/210.02  |- skos__broader mesh__D003077smesh__D003031
% 209.87/210.02  |- mesh__publicMeSHNote mesh__D003077
% 209.87/210.02       91; was see under COAL 1975-90; was in Cat J only 1975-81%A%  
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003077 2000
% 209.87/210.02  |- skos__hiddenLabel mesh__D003077 Cokes
% 209.87/210.02  |- mesh__recordAuthorizer mesh__D003077 SJN
% 209.87/210.02  |- mesh__onlineNote mesh__D003077 search COAL 1968-74   
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D003077 2001
% 209.87/210.02  |- mesh__dateEstablished mesh__D003077 1991-01-01
% 209.87/210.02  |- mesh__recordOriginator mesh__D011509 NLM
% 209.87/210.02  |- mesh__recordMaintainer mesh__D011509 SYSTEM
% 209.87/210.02  |- mesh__publicMeSHNote mesh__D011509
% 209.87/210.02       77; was see under MUCOPOLYSACCHARIDES 1975-76; PROTEOCHONDROITIN SULFATES was see under MUCOPOLYSACCHARIDES 1976%A%  
% 209.87/210.02  |- skos__altLabel mesh__D011509 Proteoglycan
% 209.87/210.02  |- mesh__dateEstablished mesh__D011509 1977-01-01
% 209.87/210.02  |- mesh__dateCreated mesh__D011509 1999-01-01
% 209.87/210.02  |- skos__annotation mesh__D011509 polysaccharides   
% 209.87/210.02  |- mesh__onlineNote mesh__D011509 search MUCOPOLYSACCHARIDES 1973-74   
% 209.87/210.02  |- skos__prefLabel mesh__D011509 Proteoglycans
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D011509 2006
% 209.87/210.02  |- skos__historyNote mesh__D011509 Mucopolysaccharides %28%1966-1974%29%
% 209.87/210.02  |- skos__broader mesh__D011509smesh__D006023
% 209.87/210.02  |- skos__scopeNote mesh__D011509
% 209.87/210.02       Glycoproteins which have a very high polysaccharide content.%A%    
% 209.87/210.02  |- skos__broader mesh__D011509smesh__D011134
% 209.87/210.02  |- mesh__historyNote mesh__D011509
% 209.87/210.02       77%28%75%29%; was see under MUCOPOLYSACCHARIDES 1975-76   
% 209.87/210.02  |- rdf__type mesh__D011509sskos__Concept
% 209.87/210.02  |- mesh__recordAuthorizer mesh__D011509 sjn
% 209.87/210.02  |- mesh__dateRevised mesh__D011509 2005-06-30
% 209.87/210.02  |- mesh__historyNote mesh__D008560 79   
% 209.87/210.02  |- skos__scopeNote mesh__D008560
% 209.87/210.02       The motion of phospholipid molecules within the lipid bilayer, dependent on the classes of phospholipids present, their fatty acid composition and degree of unsaturation of the acyl chains, the cholesterol concentration, and temperature.%A%    
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D008560 2003
% 209.87/210.02  |- skos__hiddenLabel mesh__D008560 Fluidities, Bilayer
% 209.87/210.02  |- mesh__recordMaintainer mesh__D008560 TAP
% 209.87/210.02  |- skos__prefLabel mesh__D008560 Membrane Fluidity
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D008560 1993
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D008560 1998
% 209.87/210.02  |- mesh__recordOriginator mesh__D008560 VDK
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D008560 2004
% 209.87/210.02  |- mesh__dateRevised mesh__D008560 1992-05-15
% 209.87/210.02  |- skos__historyNote mesh__D008560 Membranes %28%1966-1976%29%
% 209.87/210.02  |- skos__historyNote mesh__D008560 Cell Membrane %28%1966-1978%29%
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D008560 1994
% 209.87/210.02  |- mesh__recordAuthorizer mesh__D008560 PLS
% 209.87/210.02  |- mesh__publicMeSHNote mesh__D008560 79   
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D008560 1999
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D008560 2000
% 209.87/210.02  |- skos__broader mesh__D008560smesh__D001669
% 209.87/210.02  |- skos__hiddenLabel mesh__D008560 Fluidity, Membrane
% 209.87/210.02  |- mesh__dateCreated mesh__D008560 1978-05-19
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D008560 2005
% 209.87/210.02  |- skos__hiddenLabel mesh__D008560 Fluidities, Membrane
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D008560 1995
% 209.87/210.02  |- skos__historyNote mesh__D008560 Phospholipids %28%1966-1976%29%
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D008560 2001
% 209.87/210.02  |- skos__historyNote mesh__D008560 Lipids %28%1966-1976%29%
% 209.87/210.02  |- skos__hiddenLabel mesh__D008560 Bilayer Fluidities
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D008560 2006
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D008560 1996
% 209.87/210.02  |- skos__altLabel mesh__D008560 Bilayer Fluidity
% 209.87/210.02  |- skos__hiddenLabel mesh__D008560 Membrane Fluidities
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D008560 2002
% 209.87/210.02  |- skos__historyNote mesh__D008560 Membrane Lipids %28%1977-1978%29%
% 209.87/210.02  |- mesh__dateEstablished mesh__D008560 1979-01-01
% 209.87/210.02  |- skos__annotation mesh__D008560 IM; permitted with artif membranes   
% 209.87/210.02  |- skos__hiddenLabel mesh__D008560 Fluidity, Bilayer
% 209.87/210.02  |- rdf__type mesh__D008560sskos__Concept
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D008560 1997
% 209.87/210.02  |- mesh__dateRevised mesh__D007468 2001-07-25
% 209.87/210.02  |- skos__altLabel mesh__D007468 Cardiotrast
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D007468 2004
% 209.87/210.02  |- mesh__recordAuthorizer mesh__D007468 sjn
% 209.87/210.02  |- rdf__type mesh__D007468sskos__Concept
% 209.87/210.02  |- mesh__dateCreated mesh__D007468 1999-01-01
% 209.87/210.02  |- skos__altLabel mesh__D007468 Diodone
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D007468 2002
% 209.87/210.02  |- skos__altLabel mesh__D007468 Kardiotrast
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D007468 2005
% 209.87/210.02  |- skos__prefLabel mesh__D007468 Iodopyracet
% 209.87/210.02  |- skos__scopeNote mesh__D007468
% 209.87/210.02       An ionic monomeric contrast medium that was formerly used for a variety of diagnostic procedures. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p706%29%%A%    
% 209.87/210.02  |- mesh__recordMaintainer mesh__D007468 ssb
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D007468 2006
% 209.87/210.02  |- skos__broader mesh__D007468smesh__D007469
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D007468 2003
% 209.87/210.02  |- mesh__recordOriginator mesh__D007468 NLM
% 209.87/210.02  |- skos__annotation mesh__D007468 D25-26 qualif   
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D018190 2005
% 209.87/210.02  |- skos__prefLabel mesh__D018190 Lymphatic Vessel Tumors
% 209.87/210.02  |- skos__broader mesh__D018190smesh__D009370
% 209.87/210.02  |- mesh__recordAuthorizer mesh__D018190 PLS
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D018190 2001
% 209.87/210.02  |- skos__annotation mesh__D018190
% 209.87/210.02       neoplasms composed of lymphatic tissue, not located in lymphatic tissue: TN 135; /blood supply /chem /second /secret /ultrastruct permitted; coord with precoord organ/neopl term; restricted use: Manual 24.2.2.5%A%  
% 209.87/210.02  |- mesh__recordMaintainer mesh__D018190 KEV
% 209.87/210.02  |- skos__hiddenLabel mesh__D018190 Tumor, Lymphatic Vessel
% 209.87/210.02  |- skos__hiddenLabel mesh__D018190 Lymphatic Vessel Tumor
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D018190 2000
% 209.87/210.02  |- skos__hiddenLabel mesh__D018190 Tumors, Lymphatic Vessel
% 209.87/210.02  |- mesh__publicMeSHNote mesh__D018190 94   
% 209.87/210.02  |- mesh__historyNote mesh__D018190 94   
% 209.87/210.02  |- mesh__dateEstablished mesh__D018190 1994-01-01
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D018190 1997
% 209.87/210.02  |- mesh__recordOriginator mesh__D018190 PLS
% 209.87/210.02  |- mesh__dateRevised mesh__D018190 1995-06-08
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D018190 1999
% 209.87/210.02  |- skos__scopeNote mesh__D018190
% 209.87/210.02       Neoplasms composed of lymphoid tissue, a lattice work of reticular tissue the interspaces of which contain lymphocytes. The concept does not refer to neoplasms located in lymphatic vessels.%A%    
% 209.87/210.02  |- skos__historyNote mesh__D018190 Lymphoma %28%1970-1993%29%
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D018190 2004
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D018190 1996
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D018190 2006
% 209.87/210.02  |- mesh__dateCreated mesh__D018190 1993-06-24
% 209.87/210.02  |- skos__historyNote mesh__D018190 Lymphatic Metastasis %28%1980-1989%29%
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D018190 1998
% 209.87/210.02  |- rdf__type mesh__D018190sskos__Concept
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D018190 2003
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D018190 2002
% 209.87/210.02  |- rdf__type mesh__D004170sskos__Concept
% 209.87/210.02  |- mesh__recordOriginator mesh__D004170 NLM
% 209.87/210.02  |- mesh__activeMeSHYear mesh__D004170 2005
% 209.88/210.02  |- mesh__dateRevised mesh__D004170 2003-07-09
% 209.88/210.02  |- mesh__dateCreated mesh__D004170 1999-01-01
% 209.88/210.02  |- mesh__recordAuthorizer mesh__D004170 sjn
% 209.88/210.02  |- mesh__activeMeSHYear mesh__D004170 2006
% 209.88/210.02  |- mesh__recordMaintainer mesh__D004170 ags
% 209.88/210.02  |- skos__broader mesh__D004170smesh__D002589
% 209.88/210.02  |- skos__scopeNote mesh__D004170
% 209.88/210.02       A genus of tapeworm containing several species which occurs in the intestine of fish, birds, and mammals including man. Infection in humans is usually by eating uncooked fish. The larval stage is known as SPARGANUM.%A%    
% 209.88/210.02  |- skos__prefLabel mesh__D004170 Diphyllobothrium
% 209.88/210.02  |- mesh__activeMeSHYear mesh__D004170 2004
% 209.88/210.02  |- skos__annotation mesh__D004170
% 209.88/210.02       infection = DIPHYLLOBOTHRIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 209.88/210.02  |- mesh__activeMeSHYear mesh__D012602 1997
% 209.88/210.02  |- mesh__activeMeSHYear mesh__D012602 2006
% 209.88/210.02  |- mesh__activeMeSHYear mesh__D012602 2001
% 209.88/210.02  |- mesh__activeMeSHYear mesh__D012602 1998
% 209.88/210.02  |- mesh__activeMeSHYear mesh__D012602 2004
% 209.88/210.02  |- mesh__recordAuthorizer mesh__D012602 PLS
% 209.88/210.02  |- mesh__activeMeSHYear mesh__D012602 1996
% 209.88/210.02  |- mesh__activeMeSHYear mesh__D012602 2005
% 209.88/210.02  |- mesh__activeMeSHYear mesh__D012602 2000
% 209.88/210.02  |- mesh__recordMaintainer mesh__D012602 TAP
% 209.88/210.02  |- rdf__type mesh__D012602sskos__Concept
% 209.88/210.02  |- mesh__activeMeSHYear mesh__D012602 2003
% 209.88/210.02  |- mesh__historyNote mesh__D012602
% 209.88/210.02       78%28%75%29%; was see under SCOPOLAMINE 1975-77, was see under TROPANES 1969-74%A%  
% 209.88/210.02  |- mesh__dateEstablished mesh__D012602 1978-01-01
% 209.88/210.02  |- mesh__dateRevised mesh__D012602 1992-05-20
% 209.88/210.02  |- mesh__onlineNote mesh__D012602
% 209.88/210.02       search SCOPOLAMINE 1966-74 %26% TROPANES 1969-74   
% 209.88/210.02  |- skos__broader mesh__D012602smesh__D012601
% 209.88/210.02  |- mesh__activeMeSHYear mesh__D012602 2002
% 209.88/210.02  |- skos__historyNote mesh__D012602 Tropanes %28%1966-1974%29%
% 209.88/210.02  |- skos__scopeNote mesh__D012602
% 209.88/210.02       Analogs or derivatives of scopolamine.     
% 209.88/210.02  |- skos__hiddenLabel mesh__D012602 Derivatives, Scopolamine
% 209.88/210.02  |- skos__historyNote mesh__D012602 Scopolamine %28%1966-1974%29%
% 209.88/210.02  |- skos__prefLabel mesh__D012602 Scopolamine Derivatives
% 209.88/210.02  |- mesh__activeMeSHYear mesh__D012602 1995
% 209.88/210.02  |- mesh__recordOriginator mesh__D012602 NLM
% 209.88/210.02  |- mesh__activeMeSHYear mesh__D012602 1993
% 209.88/210.02  |- mesh__activeMeSHYear mesh__D012602 1999
% 209.88/210.02  |- mesh__publicMeSHNote mesh__D012602
% 209.88/210.02       78; was see under SCOPOLAMINE 1975-77, was see under TROPANES 1969-74; BUTYLSCOPOLAMMONIUM BROMIDE was see under SCOPOLAMINE 1976-77%A%  
% 209.88/210.02  |- mesh__activeMeSHYear mesh__D012602 1994
% 209.88/210.02  |- mesh__dateCreated mesh__D012602 1999-01-01
% 209.88/210.02  |- mesh__publicMeSHNote mesh__D031567 2003   
% 209.88/210.02  |- mesh__activeMeSHYear mesh__D031567 2003
% 209.88/210.02  |- skos__prefLabel mesh__D031567 Liriodendron
% 209.88/210.02  |- mesh__activeMeSHYear mesh__D031567 2006
% 209.88/210.02  |- mesh__activeMeSHYear mesh__D031567 2004
% 209.88/210.02  |- skos__broader mesh__D031567smesh__D029562
% 209.88/210.02  |- skos__altLabel mesh__D031567 Yellow Poplar
% 209.88/210.02  |- mesh__historyNote mesh__D031567 2003   
% 209.88/210.02  |- rdf__type mesh__D031567sskos__Concept
% 209.88/210.02  |- skos__altLabel mesh__D031567 Tulip Tree
% 209.88/210.03  |- skos__annotation mesh__D031567
% 209.88/210.03       X ref YELLOW POPLAR: POPLAR, TRUE see POPULUS is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.88/210.03  |- skos__altLabel mesh__D031567 Poplar, Yellow
% 209.88/210.03  |- skos__scopeNote mesh__D031567
% 209.88/210.03       A plant genus of the family MAGNOLIACEAE. Members include hardwood trees of eastern North America with distinct large tuliplike flowers.%A%    
% 209.88/210.03  |- mesh__dateCreated mesh__D031567 2002-07-03
% 209.88/210.03  |- mesh__dateEstablished mesh__D031567 2003-01-01
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D031567 2005
% 209.88/210.03  |- mesh__recordAuthorizer mesh__D050721 sjn
% 209.88/210.03  |- skos__hiddenLabel mesh__D050721 c-cbl, Proto-Oncogene Proteins
% 209.88/210.03  |- mesh__dateEstablished mesh__D050721 2006-01-01
% 209.88/210.03  |- mesh__historyNote mesh__D050721 2006%28%1991%29%   
% 209.88/210.03  |- skos__prefLabel mesh__D050721 Proto-Oncogene Proteins c-cbl
% 209.88/210.03  |- skos__broader mesh__D050721smesh__D044767
% 209.88/210.03  |- mesh__recordMaintainer mesh__D050721 DRC
% 209.88/210.03  |- mesh__publicMeSHNote mesh__D050721
% 209.88/210.03       2006; PROTO-ONCOGENE PROTEINS C-CBL was indexed under UBIQUITIN-PROTEIN LIGASES 2005, %26% under LIGASES %26% PROTO-ONCOGENE PROTEINS 1991-2005%A%  
% 209.88/210.03  |- mesh__dateCreated mesh__D050721 2005-06-30
% 209.88/210.03  |- skos__scopeNote mesh__D050721
% 209.88/210.03       Proto-oncogene proteins that negatively regulate RECEPTOR PROTEIN-TYROSINE KINASE signaling. It is a UBIQUITIN-PROTEIN LIGASE and the cellular homologue of ONCOGENE PROTEIN V-CBL.%A%    
% 209.88/210.03  |- skos__hiddenLabel mesh__D050721 c-cbl, Proto-Oncogene Protein
% 209.88/210.03  |- skos__hiddenLabel mesh__D050721 Proteins c-cbl, Proto-Oncogene
% 209.88/210.03  |- skos__altLabel mesh__D050721 Proto-Oncogene Protein c-cbl
% 209.88/210.03  |- skos__altLabel mesh__D050721 CBL E3 Ubiquitin Protein Ligase
% 209.88/210.03  |- skos__hiddenLabel mesh__D050721 Proto-Oncogene Protein, cbl
% 209.88/210.03  |- mesh__recordOriginator mesh__D050721 DRC
% 209.88/210.03  |- skos__altLabel mesh__D050721 cbl Proto-Oncogene Protein
% 209.88/210.03  |- skos__broader mesh__D050721smesh__D011518
% 209.88/210.03  |- skos__hiddenLabel mesh__D050721 Proto Oncogene Proteins c cbl
% 209.88/210.03  |- skos__hiddenLabel mesh__D050721 c cbl Proto Oncogene Protein
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D050721 2006
% 209.88/210.03  |- rdf__type mesh__D050721sskos__Concept
% 209.88/210.03  |- skos__hiddenLabel mesh__D050721 Proto-Oncogene Protein, c-cbl
% 209.88/210.03  |- skos__hiddenLabel mesh__D050721 Proto Oncogene Protein c cbl
% 209.88/210.03  |- skos__altLabel mesh__D050721 c-cbl Proto-Oncogene Protein
% 209.88/210.03  |- skos__hiddenLabel mesh__D050721 cbl Proto Oncogene Protein
% 209.88/210.03  |- skos__altLabel mesh__D050721 c-cbl Protein
% 209.88/210.03  |- skos__annotation mesh__D017098 DF: IGA DEFIC   
% 209.88/210.03  |- skos__hiddenLabel mesh__D017098 IgA Deficiencies
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D017098 2005
% 209.88/210.03  |- mesh__dateCreated mesh__D017098 1992-05-20
% 209.88/210.03  |- skos__prefLabel mesh__D017098 IgA Deficiency
% 209.88/210.03  |- skos__historyNote mesh__D017098 IgA/deficiency %28%1971-1992%29%
% 209.88/210.03  |- skos__broader mesh__D017098smesh__D004406
% 209.88/210.03  |- skos__scopeNote mesh__D017098
% 209.88/210.03       A dysgammaglobulinemia characterized by a deficiency of IMMUNOGLOBULIN A.%A%    
% 209.88/210.03  |- mesh__dateRevised mesh__D017098 2001-08-03
% 209.88/210.03  |- rdf__type mesh__D017098sskos__Concept
% 209.88/210.03  |- mesh__dateEstablished mesh__D017098 1993-01-01
% 209.88/210.03  |- skos__historyNote mesh__D017098 Dysgammaglobulinemia %28%1975-1992%29%
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D017098 2002
% 209.88/210.03  |- skos__hiddenLabel mesh__D017098 Deficiencies, IgA
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D017098 2004
% 209.88/210.03  |- mesh__historyNote mesh__D017098 93   
% 209.88/210.03  |- skos__altLabel mesh__D017098 Deficiency, IgA
% 209.88/210.03  |- mesh__recordAuthorizer mesh__D017098 sjn
% 209.88/210.03  |- mesh__recordOriginator mesh__D017098 TGC
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D017098 2003
% 209.88/210.03  |- mesh__publicMeSHNote mesh__D017098 93   
% 209.88/210.03  |- mesh__recordMaintainer mesh__D017098 sjn
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D017098 2006
% 209.88/210.03  |- skos__altLabel mesh__D003876 Neurodermatitis, Atopic
% 209.88/210.03  |- skos__broader mesh__D003876smesh__D006969
% 209.88/210.03  |- skos__hiddenLabel mesh__D003876 Atopic Neurodermatitis
% 209.88/210.03  |- mesh__dateCreated mesh__D003876 1999-01-01
% 209.88/210.03  |- rdf__type mesh__D003876sskos__Concept
% 209.88/210.03  |- skos__hiddenLabel mesh__D003876 Neurodermatitides, Atopic
% 209.88/210.03  |- mesh__dateRevised mesh__D003876 2001-07-25
% 209.88/210.03  |- skos__hiddenLabel mesh__D003876 Atopic Dermatitis
% 209.88/210.03  |- skos__hiddenLabel mesh__D003876 Dermatitides, Atopic
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003876 2003
% 209.88/210.03  |- skos__broader mesh__D003876smesh__D012873
% 209.88/210.03  |- skos__altLabel mesh__D003876 Neurodermatitis, Disseminated
% 209.88/210.03  |- skos__broader mesh__D003876smesh__D017443
% 209.88/210.03  |- mesh__recordAuthorizer mesh__D003876 sjn
% 209.88/210.03  |- skos__broader mesh__D003876smesh__D003872
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003876 2004
% 209.88/210.03  |- skos__hiddenLabel mesh__D003876 Atopic Neurodermatitides
% 209.88/210.03  |- skos__annotation mesh__D003876 a type of immediate hypersensitivity   
% 209.88/210.03  |- skos__altLabel mesh__D003876 Eczema, Atopic
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003876 2005
% 209.88/210.03  |- skos__prefLabel mesh__D003876 Dermatitis, Atopic
% 209.88/210.03  |- skos__scopeNote mesh__D003876
% 209.88/210.03       A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin %28%IgE%29%, with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.%A%    
% 209.88/210.03  |- skos__hiddenLabel mesh__D003876 Neurodermatitides, Disseminated
% 209.88/210.03  |- mesh__recordOriginator mesh__D003876 NLM
% 209.88/210.03  |- mesh__recordMaintainer mesh__D003876 nns
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003876 2002
% 209.88/210.03  |- skos__hiddenLabel mesh__D003876 Disseminated Neurodermatitides
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003876 2006
% 209.88/210.03  |- skos__hiddenLabel mesh__D003876 Atopic Eczema
% 209.88/210.03  |- skos__hiddenLabel mesh__D003876 Atopic Dermatitides
% 209.88/210.03  |- skos__hiddenLabel mesh__D003876 Infantile Eczema
% 209.88/210.03  |- skos__hiddenLabel mesh__D003876 Disseminated Neurodermatitis
% 209.88/210.03  |- mesh__recordAuthorizer mesh__D003078 sjn
% 209.88/210.03  |- skos__scopeNote mesh__D003078
% 209.88/210.03       A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever %28%PERIODIC DISEASE%29%.%A%    
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003078 2002
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003078 2006
% 209.88/210.03  |- mesh__dateRevised mesh__D003078 2001-07-25
% 209.88/210.03  |- mesh__recordMaintainer mesh__D003078 CCR
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003078 2005
% 209.88/210.03  |- mesh__dateCreated mesh__D003078 1999-01-01
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003078 2004
% 209.88/210.03  |- skos__broader mesh__D003078smesh__D000470
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003078 2003
% 209.88/210.03  |- rdf__type mesh__D003078sskos__Concept
% 209.88/210.03  |- mesh__recordOriginator mesh__D003078 NLM
% 209.88/210.03  |- skos__prefLabel mesh__D003078 Colchicine
% 209.88/210.03  |- skos__related mesh__D008561smesh__D023581
% 209.88/210.03  |- skos__hiddenLabel mesh__D008561 Membrane Fusions
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D008561 2005
% 209.88/210.03  |- skos__scopeNote mesh__D008561
% 209.88/210.03       The adherence and merging of cell membranes, intracellular membranes, or artificial membranes to each other or to viruses, parasites, or interstitial particles through a variety of chemical and physical processes.%A%    
% 209.88/210.03  |- skos__prefLabel mesh__D008561 Membrane Fusion
% 209.88/210.03  |- mesh__historyNote mesh__D008561 82   
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D008561 2002
% 209.88/210.03  |- skos__hiddenLabel mesh__D008561 Fusion, Membrane
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D008561 2006
% 209.88/210.03  |- skos__historyNote mesh__D008561 Cell Fusion %28%1971-1981%29%
% 209.88/210.03  |- mesh__dateEstablished mesh__D008561 1982-01-01
% 209.88/210.03  |- rdf__type mesh__D008561sskos__Concept
% 209.88/210.03  |- mesh__publicMeSHNote mesh__D008561 82   
% 209.88/210.03  |- mesh__recordMaintainer mesh__D008561 nns
% 209.88/210.03  |- mesh__recordAuthorizer mesh__D008561 sjn
% 209.88/210.03  |- skos__hiddenLabel mesh__D008561 Fusions, Membrane
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D008561 2003
% 209.88/210.03  |- skos__historyNote mesh__D008561 Cell Membrane %28%1966-1981%29%
% 209.88/210.03  |- skos__broader mesh__D008561smesh__D002468
% 209.88/210.03  |- mesh__dateCreated mesh__D008561 1981-05-20
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D008561 2004
% 209.88/210.03  |- mesh__recordOriginator mesh__D008561 AEP
% 209.88/210.03  |- mesh__dateRevised mesh__D008561 2001-07-25
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D007469 2000
% 209.88/210.03  |- rdf__type mesh__D007469sskos__Concept
% 209.88/210.03  |- mesh__dateCreated mesh__D007469 1999-01-01
% 209.88/210.03  |- skos__annotation mesh__D007469 contrast media; D25-26 qualif   
% 209.88/210.03  |- mesh__dateRevised mesh__D007469 1995-06-08
% 209.88/210.03  |- mesh__recordMaintainer mesh__D007469 JRT
% 209.88/210.03  |- skos__broader mesh__D007469smesh__D011728
% 209.88/210.03  |- skos__scopeNote mesh__D007469
% 209.88/210.03       Iodinated pyridine derivatives that are often used as contrast media.%A%    
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D007469 1998
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D007469 2001
% 209.88/210.03  |- mesh__recordOriginator mesh__D007469 NLM
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D007469 2005
% 209.88/210.03  |- skos__historyNote mesh__D007469 Contrast Media %28%1966-1967%29%
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D007469 1999
% 209.88/210.03  |- mesh__dateEstablished mesh__D007469 1968-01-01
% 209.88/210.03  |- mesh__historyNote mesh__D007469 68   
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D007469 2006
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D007469 2002
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D007469 1996
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D007469 2003
% 209.88/210.03  |- mesh__publicMeSHNote mesh__D007469
% 209.88/210.03       68; PROPYLIODONE was see under CONTRAST MEDIA 1963-74   
% 209.88/210.03  |- mesh__recordAuthorizer mesh__D007469 PLS
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D007469 1997
% 209.88/210.03  |- skos__prefLabel mesh__D007469 Iodopyridones
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D007469 2004
% 209.88/210.03  |- mesh__dateCreated mesh__D018191 1993-06-24
% 209.88/210.03  |- skos__hiddenLabel mesh__D018191 Cystic Lymphangiomas
% 209.88/210.03  |- skos__annotation mesh__D018191
% 209.88/210.03       coord IM with precoord organ/neopl term %28%IM%29%   
% 209.88/210.03  |- mesh__recordAuthorizer mesh__D018191 sjn
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D018191 2002
% 209.88/210.03  |- skos__broader mesh__D018191smesh__D008202
% 209.88/210.03  |- skos__hiddenLabel mesh__D018191 Cystic Hygromas
% 209.88/210.03  |- mesh__historyNote mesh__D018191 94   
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D018191 2001
% 209.88/210.03  |- mesh__recordOriginator mesh__D018191 PLS
% 209.88/210.03  |- skos__hiddenLabel mesh__D018191 Lymphangiomas, Cystic
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D018191 2004
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D018191 2000
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D018191 2006
% 209.88/210.03  |- skos__hiddenLabel mesh__D018191 Hygromas
% 209.88/210.03  |- rdf__type mesh__D018191sskos__Concept
% 209.88/210.03  |- skos__hiddenLabel mesh__D018191 Hygromas, Cystic
% 209.88/210.03  |- skos__hiddenLabel mesh__D018191 Cystic Lymphangioma
% 209.88/210.03  |- mesh__publicMeSHNote mesh__D018191 94   
% 209.88/210.03  |- skos__altLabel mesh__D018191 Hygroma, Cystic
% 209.88/210.03  |- skos__prefLabel mesh__D018191 Lymphangioma, Cystic
% 209.88/210.03  |- mesh__dateRevised mesh__D018191 1999-11-03
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D018191 2003
% 209.88/210.03  |- mesh__dateEstablished mesh__D018191 1994-01-01
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D018191 2005
% 209.88/210.03  |- skos__historyNote mesh__D018191 Lymphangioma %28%1966-1993%29%
% 209.88/210.03  |- skos__scopeNote mesh__D018191
% 209.88/210.03       A cystic growth originating from lymphatic tissue. It is usually found in the neck, axilla, or groin.%A%    
% 209.88/210.03  |- skos__altLabel mesh__D018191 Hygroma
% 209.88/210.03  |- mesh__recordMaintainer mesh__D018191 KEV
% 209.88/210.03  |- skos__hiddenLabel mesh__D018191 Cystic Hygroma
% 209.88/210.03  |- skos__hiddenLabel mesh__D004171 Diploids
% 209.88/210.03  |- mesh__dateCreated mesh__D004171 1999-01-01
% 209.88/210.03  |- skos__hiddenLabel mesh__D004171 Cells, Diploid
% 209.88/210.03  |- mesh__dateEstablished mesh__D004171 1968-01-01
% 209.88/210.03  |- skos__annotation mesh__D004171 no qualif   
% 209.88/210.03  |- rdf__type mesh__D004171sskos__Concept
% 209.88/210.03  |- skos__hiddenLabel mesh__D004171 Cell, Diploid
% 209.88/210.03  |- mesh__recordOriginator mesh__D004171 NLM
% 209.88/210.03  |- mesh__historyNote mesh__D004171 68   
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D004171 2006
% 209.88/210.03  |- mesh__dateRevised mesh__D004171 2003-07-09
% 209.88/210.03  |- mesh__recordAuthorizer mesh__D004171 sjn
% 209.88/210.03  |- skos__broader mesh__D004171smesh__D011003
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D004171 2005
% 209.88/210.03  |- skos__altLabel mesh__D004171 Diploid
% 209.88/210.03  |- skos__historyNote mesh__D004171 Chromosomes %28%1966-1967%29%
% 209.88/210.03  |- mesh__recordMaintainer mesh__D004171 nns
% 209.88/210.03  |- skos__hiddenLabel mesh__D004171 Diploidies
% 209.88/210.03  |- skos__scopeNote mesh__D004171
% 209.88/210.03       The chromosomal constitution of cells, in which each type of CHROMOSOME is represented twice. Symbol: 2N or 2X.%A%    
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D004171 2004
% 209.88/210.03  |- skos__hiddenLabel mesh__D004171 Diploid Cells
% 209.88/210.03  |- skos__prefLabel mesh__D004171 Diploidy
% 209.88/210.03  |- mesh__publicMeSHNote mesh__D004171 68   
% 209.88/210.03  |- skos__scopeNote mesh__D012603
% 209.88/210.03       Plant growth factor derived from the root of Scopolia carniolica or Scopolia japonica.%A%    
% 209.88/210.03  |- rdf__type mesh__D012603sskos__Concept
% 209.88/210.03  |- mesh__recordOriginator mesh__D012603 NLM
% 209.88/210.03  |- mesh__dateEstablished mesh__D012603 1991-01-01
% 209.88/210.03  |- skos__broader mesh__D012603smesh__D014468
% 209.88/210.03  |- mesh__dateRevised mesh__D012603 2005-06-30
% 209.88/210.03  |- skos__hiddenLabel mesh__D012603 Acid, Chrysotropic
% 209.88/210.03  |- mesh__publicMeSHNote mesh__D012603
% 209.88/210.03       91; was see under UMBELLIFERONES 1977-90; was see under COUMARINS 1975-76%A%  
% 209.88/210.03  |- mesh__dateCreated mesh__D012603 1974-11-19
% 209.88/210.03  |- skos__prefLabel mesh__D012603 Scopoletin
% 209.88/210.03  |- skos__altLabel mesh__D012603 Gelseminic Acid
% 209.88/210.03  |- skos__altLabel mesh__D012603 Methylesculetin
% 209.88/210.03  |- skos__hiddenLabel mesh__D012603 Acid, Gelseminic
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D012603 2006
% 209.88/210.03  |- skos__altLabel mesh__D012603 Chrysotropic Acid
% 209.88/210.03  |- skos__historyNote mesh__D012603 Bioflavonoids %28%1972-1974%29%
% 209.88/210.03  |- mesh__historyNote mesh__D012603
% 209.88/210.03       91%28%75%29%; was see under UMBELLIFERONES 1977-90; was see under COUMARINS 1975-76%A%  
% 209.88/210.03  |- mesh__recordMaintainer mesh__D012603 ssb
% 209.88/210.03  |- skos__historyNote mesh__D012603 Coumarins %28%1969-1974%29%
% 209.88/210.03  |- mesh__recordAuthorizer mesh__D012603 sjn
% 209.88/210.03  |- mesh__publicMeSHNote mesh__D050722
% 209.88/210.03       2006; ONCOGENE PROTEIN V-CBL was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-2005, %26% under RETROVIRIDAE PROTEINS 1989%A%  
% 209.88/210.03  |- skos__altLabel mesh__D050722 v-cbl Protein
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D050722 2006A
% 209.88/210.03  |- mesh__historyNote mesh__D050722 2006%28%1989%29%   
% 209.88/210.03  |- mesh__recordOriginator mesh__D050722 DRC
% 209.88/210.03  |- skos__hiddenLabel mesh__D050722 70Z Cbl Protein
% 209.88/210.03  |- skos__scopeNote mesh__D050722
% 209.88/210.03       An oncoprotein from the Cas NS-1 murine retrovirus that induces pre- B-CELL LYMPHOMA and MYELOID LEUKEMIAS. v-cbl protein is a tyrosine-phosphorylated, truncated form of its cellular homologue, PROTO-ONCOGENE PROTEIN C-CBL.%A%    
% 209.88/210.03  |- skos__altLabel mesh__D050722 cbl Oncogene Protein
% 209.88/210.03  |- skos__altLabel mesh__D050722 Casitas B-Lineage Lymphoma Protein
% 209.88/210.03  |- mesh__dateEstablished mesh__D050722 2006-01-01
% 209.88/210.03  |- skos__altLabel mesh__D050722 Oncogene Protein 70Z-Cbl
% 209.88/210.03  |- skos__hiddenLabel mesh__D050722 cbl, Oncogene Protein
% 209.88/210.03  |- skos__hiddenLabel mesh__D050722 Oncogene Protein, cbl
% 209.88/210.03  |- mesh__dateCreated mesh__D050722 2005-06-30
% 209.88/210.03  |- skos__altLabel mesh__D050722 v-cbl Oncogene Protein
% 209.88/210.03  |- mesh__recordMaintainer mesh__D050722 ags
% 209.88/210.03  |- skos__hiddenLabel mesh__D050722 v-cbl, Oncogene Protein
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D050722 2006
% 209.88/210.03  |- skos__hiddenLabel mesh__D050722 Oncogene Protein, v-cbl
% 209.88/210.03  |- skos__prefLabel mesh__D050722 Oncogene Protein v-cbl
% 209.88/210.03  |- skos__hiddenLabel mesh__D050722 v cbl Oncogene Protein
% 209.88/210.03  |- skos__hiddenLabel mesh__D050722 Oncogene Protein 70Z Cbl
% 209.88/210.03  |- mesh__dateRevised mesh__D050722 2005-07-12
% 209.88/210.03  |- skos__broader mesh__D050722smesh__D015682
% 209.88/210.03  |- rdf__type mesh__D050722sskos__Concept
% 209.88/210.03  |- skos__hiddenLabel mesh__D050722 Oncogene Protein v cbl
% 209.88/210.03  |- skos__altLabel mesh__D050722 Oncogene Protein cbl
% 209.88/210.03  |- mesh__recordAuthorizer mesh__D050722 ags
% 209.88/210.03  |- skos__hiddenLabel mesh__D050722 70Z-Cbl, Oncogene Protein
% 209.88/210.03  |- skos__hiddenLabel mesh__D050722 Casitas B Lineage Lymphoma Protein
% 209.88/210.03  |- mesh__recordMaintainer mesh__D017099 sjn
% 209.88/210.03  |- mesh__recordAuthorizer mesh__D017099 sjn
% 209.88/210.03  |- skos__annotation mesh__D017099 DF: IGG DEFIC   
% 209.88/210.03  |- mesh__recordOriginator mesh__D017099 TGC
% 209.88/210.03  |- skos__prefLabel mesh__D017099 IgG Deficiency
% 209.88/210.03  |- skos__scopeNote mesh__D017099
% 209.88/210.03       A dysgammaglobulinemia characterized by a deficiency of IMMUNOGLOBULIN G.%A%    
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D017099 2004
% 209.88/210.03  |- mesh__publicMeSHNote mesh__D017099 93   
% 209.88/210.03  |- mesh__historyNote mesh__D017099 93   
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D017099 2003
% 209.88/210.03  |- skos__hiddenLabel mesh__D017099 IgG Deficiencies
% 209.88/210.03  |- mesh__dateRevised mesh__D017099 2001-08-07
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D017099 2006
% 209.88/210.03  |- mesh__dateEstablished mesh__D017099 1993-01-01
% 209.88/210.03  |- mesh__dateCreated mesh__D017099 1992-05-20
% 209.88/210.03  |- skos__altLabel mesh__D017099 Deficiency, IgG
% 209.88/210.03  |- skos__broader mesh__D017099smesh__D004406
% 209.88/210.03  |- skos__historyNote mesh__D017099 IgG/deficiency %28%1973-1992%29%
% 209.88/210.03  |- skos__hiddenLabel mesh__D017099 Deficiencies, IgG
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D017099 2005
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D017099 2002
% 209.88/210.03  |- skos__historyNote mesh__D017099 IgG %28%1971-1972%29%
% 209.88/210.03  |- rdf__type mesh__D017099sskos__Concept
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003877 2004
% 209.88/210.03  |- skos__hiddenLabel mesh__D003877 Contact Eczema
% 209.88/210.03  |- skos__hiddenLabel mesh__D003877 Hypersensitivities, Contact
% 209.88/210.03  |- mesh__recordOriginator mesh__D003877 NLM
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003877 2002
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003877 2005
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003877 1997
% 209.88/210.03  |- skos__hiddenLabel mesh__D003877 Contact Dermatitides
% 209.88/210.03  |- skos__altLabel mesh__D003877 Eczema, Contact
% 209.88/210.03  |- skos__hiddenLabel mesh__D003877 Dermatitides, Contact
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003877 2006
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003877 1998
% 209.88/210.03  |- skos__hiddenLabel mesh__D003877 Contact Hypersensitivity
% 209.88/210.03  |- skos__altLabel mesh__D003877 Dermatitis Venenata
% 209.88/210.03  |- skos__scopeNote mesh__D003877
% 209.88/210.03       A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.%A%    
% 209.88/210.03  |- skos__hiddenLabel mesh__D003877 Contact Hypersensitivities
% 209.88/210.03  |- skos__altLabel mesh__D003877 Contact Dermatitis
% 209.88/210.03  |- rdf__type mesh__D003877sskos__Concept
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003877 1999
% 209.88/210.03  |- mesh__dateCreated mesh__D003877 1999-01-01
% 209.88/210.03  |- mesh__dateRevised mesh__D003877 1996-06-10
% 209.88/210.03  |- skos__prefLabel mesh__D003877 Dermatitis, Contact
% 209.88/210.03  |- skos__annotation mesh__D003877
% 209.88/210.03       unspecified as allergic or non-allergic but DERMATITIS, ALLERGIC CONTACT is available%A%  
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003877 2000
% 209.88/210.03  |- skos__hiddenLabel mesh__D003877 Contact Sensitivities
% 209.88/210.03  |- skos__altLabel mesh__D003877 Sensitivity, Contact
% 209.88/210.03  |- skos__hiddenLabel mesh__D003877 Contact Sensitivity
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003877 2003
% 209.88/210.03  |- mesh__recordAuthorizer mesh__D003877 PLS
% 209.88/210.03  |- skos__broader mesh__D003877smesh__D017443
% 209.88/210.03  |- skos__related mesh__D003877smesh__D009783
% 209.88/210.03  |- mesh__recordMaintainer mesh__D003877 TGC
% 209.88/210.03  |- skos__hiddenLabel mesh__D003877 Sensitivities, Contact
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003877 2001
% 209.88/210.03  |- skos__broader mesh__D003877smesh__D003872
% 209.88/210.03  |- skos__annotation mesh__D003079
% 209.88/210.03       COLCHICINE is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.88/210.03  |- mesh__historyNote mesh__D003079
% 209.88/210.03       91%28%86%29%63; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85%A%  
% 209.88/210.03  |- mesh__recordOriginator mesh__D003079 NLM
% 209.88/210.03  |- skos__altLabel mesh__D003079 Crocus, Autumn
% 209.88/210.03  |- mesh__dateEstablished mesh__D003079 1991-01-01
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003079 2006
% 209.88/210.03  |- mesh__recordAuthorizer mesh__D003079 sjn
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003079 2002
% 209.88/210.03  |- skos__altLabel mesh__D003079 Meadow Saffron
% 209.88/210.03  |- skos__broader mesh__D003079smesh__D019668
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003079 2005
% 209.88/210.03  |- mesh__dateCreated mesh__D003079 1999-01-01
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003079 2004
% 209.88/210.03  |- skos__prefLabel mesh__D003079 Colchicum
% 209.88/210.03  |- skos__altLabel mesh__D003079 Autumn Crocus
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D003079 2003
% 209.88/210.03  |- mesh__publicMeSHNote mesh__D003079
% 209.88/210.03       91,63-85; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85%A%  
% 209.88/210.03  |- rdf__type mesh__D003079sskos__Concept
% 209.88/210.03  |- skos__scopeNote mesh__D003079
% 209.88/210.03       A genus of poisonous, liliaceous plants. The roots %28%corms%29% of Colchicum autumnale, the fall crocus or meadow saffron, yield COLCHICINE, which is used as a biochemical tool and to treat gout. Other members of this genus yield saffron dye, flavoring agents, and aromatics.%A%    
% 209.88/210.03  |- skos__related mesh__D003079smesh__D003078
% 209.88/210.03  |- skos__altLabel mesh__D003079 Fall Crocus
% 209.88/210.03  |- mesh__dateRevised mesh__D003079 2001-07-25
% 209.88/210.03  |- mesh__recordMaintainer mesh__D003079 ssb
% 209.88/210.03  |- skos__hiddenLabel mesh__D008562 Glycoproteins, Surface
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D008562 2006
% 209.88/210.03  |- mesh__dateCreated mesh__D008562 1987-05-05
% 209.88/210.03  |- mesh__dateRevised mesh__D008562 2005-06-30
% 209.88/210.03  |- skos__altLabel mesh__D008562 Surface Glycoproteins
% 209.88/210.03  |- skos__hiddenLabel mesh__D008562 Glycoprotein, Membrane
% 209.88/210.03  |- skos__historyNote mesh__D008562 Membrane Proteins %28%1977-1987%29%
% 209.88/210.03  |- skos__hiddenLabel mesh__D008562 Glycoproteins, Membrane
% 209.88/210.03  |- rdf__type mesh__D008562sskos__Concept
% 209.88/210.03  |- skos__hiddenLabel mesh__D008562 Surface Glycoproteins, Cell
% 209.88/210.03  |- skos__hiddenLabel mesh__D008562 Glycoprotein, Cell Surface
% 209.88/210.03  |- skos__hiddenLabel mesh__D008562 Surface Glycoprotein, Cell
% 209.88/210.03  |- skos__prefLabel mesh__D008562 Membrane Glycoproteins
% 209.88/210.03  |- skos__scopeNote mesh__D008562
% 209.88/210.03       Glycoproteins found on the membrane or surface of cells.%A%    
% 209.88/210.03  |- mesh__historyNote mesh__D008562 88   
% 209.88/210.03  |- mesh__dateEstablished mesh__D008562 1988-01-01
% 209.88/210.03  |- mesh__recordMaintainer mesh__D008562 SYSTEM
% 209.88/210.03  |- skos__altLabel mesh__D008562 Membrane Glycoprotein
% 209.88/210.03  |- mesh__recordOriginator mesh__D008562 RR
% 209.88/210.03  |- skos__altLabel mesh__D008562 Cell Surface Glycoprotein
% 209.88/210.03  |- skos__historyNote mesh__D008562 Glycoproteins %28%1966-1987%29%
% 209.88/210.03  |- skos__altLabel mesh__D008562 Cell Surface Glycoproteins
% 209.88/210.03  |- mesh__recordAuthorizer mesh__D008562 sjn
% 209.88/210.03  |- skos__broader mesh__D008562smesh__D006023
% 209.88/210.03  |- skos__hiddenLabel mesh__D008562 Glycoproteins, Cell Surface
% 209.88/210.03  |- mesh__publicMeSHNote mesh__D008562 88   
% 209.88/210.03  |- skos__altLabel mesh__D008562 Surface Glycoprotein
% 209.88/210.03  |- skos__broader mesh__D008562smesh__D008565
% 209.88/210.03  |- skos__hiddenLabel mesh__D008562 Glycoprotein, Surface
% 209.88/210.03  |- mesh__recordMaintainer mesh__D032661 SYSTEM
% 209.88/210.03  |- mesh__dateRevised mesh__D032661 2005-06-30
% 209.88/210.03  |- skos__scopeNote mesh__D032661
% 209.88/210.03       A genus of ascomycetous fungi %28%ASCOMYCOTA%29%, family Clavicipitaceae, order HYPOCREALES, that grows by infecting insect larvae or mature insects with spores that germinate often before the cocoon is formed.%A%    
% 209.88/210.03  |- mesh__dateEstablished mesh__D032661 2003-01-01
% 209.88/210.03  |- mesh__recordAuthorizer mesh__D032661 sjn
% 209.88/210.03  |- skos__historyNote mesh__D032661 Ascomycota %28%1968-2002%29%
% 209.88/210.03  |- skos__prefLabel mesh__D032661 Cordyceps
% 209.88/210.03  |- rdf__type mesh__D032661sskos__Concept
% 209.88/210.03  |- mesh__historyNote mesh__D032661 2003   
% 209.88/210.03  |- mesh__dateCreated mesh__D032661 2002-07-03
% 209.88/210.03  |- mesh__publicMeSHNote mesh__D032661 2003   
% 209.88/210.03  |- skos__broader mesh__D032661smesh__D006999
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D032661 2006
% 209.88/210.03  |- mesh__recordOriginator mesh__D032661 ags
% 209.88/210.03  |- mesh__publicMeSHNote mesh__D018192
% 209.88/210.03       2006; see LYMPHANGIOMYOMATOSIS 1994-2005   
% 209.88/210.03  |- skos__broader mesh__D018192smesh__D008203
% 209.88/210.03  |- mesh__activeMeSHYear mesh__D018192 2006
% 209.88/210.03  |- mesh__dateRevised mesh__D018192 2005-06-30
% 209.88/210.03  |- skos__hiddenLabel mesh__D018192 Lymphangiomyomatoses
% 209.88/210.03  |- rdf__type mesh__D018192sskos__Concept
% 209.88/210.03  |- mesh__historyNote mesh__D018192 2006 %28%1994%29%   
% 209.88/210.03  |- skos__scopeNote mesh__D018192
% 209.88/210.03       A disease characterized by the progressive invasion of SMOOTH MUSCLE CELLS into the LYMPHATIC VESSELS, and the BLOOD VESSELS. The majority of the cases occur in the LUNGS of women of child-bearing age, eventually blocking the flow of air, blood, and lymph. The common symptom is shortness of breath %28%DYSPNEA%29%.%A%    
% 209.88/210.03  |- mesh__dateCreated mesh__D018192 1993-06-24
% 209.88/210.03  |- skos__altLabel mesh__D018192 Lymphangiomyomatosis
% 209.88/210.03  |- mesh__recordAuthorizer mesh__D018192 sjn
% 209.88/210.04  |- skos__prefLabel mesh__D018192 Lymphangioleiomyomatosis
% 209.88/210.04  |- skos__hiddenLabel mesh__D018192 Lymphangioleiomyomatoses
% 209.88/210.04  |- skos__annotation mesh__D018192
% 209.88/210.04       differentiate from LYMPHANGIOMYOMA; coordinate IM with precoordinated organ/neoplasm terms %28%IM%29% if relevant%A%  
% 209.88/210.04  |- skos__historyNote mesh__D018192 Lymphangioma %28%1968-1993%29%
% 209.88/210.04  |- mesh__dateEstablished mesh__D018192 1994-01-01
% 209.88/210.04  |- mesh__recordOriginator mesh__D018192 PLS
% 209.88/210.04  |- mesh__recordMaintainer mesh__D018192 lkt
% 209.88/210.04  |- skos__broader mesh__D004970smesh__D015068
% 209.88/210.04  |- mesh__dateRevised mesh__D004970 2005-06-30
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D004970 2006
% 209.88/210.04  |- skos__altLabel mesh__D004970 Hauck Brand of Estrone
% 209.88/210.04  |- mesh__recordMaintainer mesh__D004970 CCR
% 209.88/210.04  |- skos__altLabel mesh__D004970 Vortech Brand of Estrone
% 209.88/210.04  |- skos__broader mesh__D004970smesh__D045166
% 209.88/210.04  |- skos__broader mesh__D004970smesh__D004963
% 209.88/210.04  |- mesh__recordOriginator mesh__D004970 NLM
% 209.88/210.04  |- rdf__type mesh__D004970sskos__Concept
% 209.88/210.04  |- skos__scopeNote mesh__D004970
% 209.88/210.04       An aromatized C18 steroid with a 3-hydroxyl group and a 17-ketone, a major mammalian estrogen. It is converted from ANDROSTENEDIONE directly, or from TESTOSTERONE via ESTRADIOL. In humans, it is produced primarily by the cyclic ovaries, PLACENTA, and the ADIPOSE TISSUE of men and postmenopausal women.%A%    
% 209.88/210.04  |- mesh__dateCreated mesh__D004970 1999-01-01
% 209.88/210.04  |- skos__altLabel mesh__D004970 Hyrex Brand of Estrone
% 209.88/210.04  |- mesh__recordAuthorizer mesh__D004970 sjn
% 209.88/210.04  |- skos__prefLabel mesh__D004970 Estrone
% 209.88/210.04  |- skos__broader mesh__D004172smesh__D014786
% 209.88/210.04  |- rdf__type mesh__D004172sskos__Concept
% 209.88/210.04  |- mesh__recordMaintainer mesh__D004172 nns
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Horizontal Diplopias
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Diplopias, Refractive
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Diplopias
% 209.88/210.04  |- skos__scopeNote mesh__D004172
% 209.88/210.04       A visual symptom in which a single object is perceived by the visual cortex as two objects rather than one. Disorders associated with this condition include REFRACTIVE ERRORS; STRABISMUS; OCULOMOTOR NERVE DISEASES; TROCHLEAR NERVE DISEASES; ABDUCENS NERVE DISEASES; and diseases of the BRAIN STEM and OCCIPITAL LOBE.%A%    
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Polyopsias
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Unilateral Diplopias
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Vertical Diplopia
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Diplopias, Unilateral
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Monocular Diplopia
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D004172 2006
% 209.88/210.04  |- skos__altLabel mesh__D004172 Double Vision
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Diplopias, Monocular
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Diplopias, Intermittent
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D004172 2005
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Diplopias, Cortical
% 209.88/210.04  |- skos__altLabel mesh__D004172 Diplopia, Monocular
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Refractive Diplopias
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Intermittent Diplopia
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Unilateral Diplopia
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Cortical Diplopia
% 209.88/210.04  |- mesh__recordOriginator mesh__D004172 NLM
% 209.88/210.04  |- mesh__dateRevised mesh__D004172 2004-07-07
% 209.88/210.04  |- skos__prefLabel mesh__D004172 Diplopia
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Monocular Diplopias
% 209.88/210.04  |- mesh__recordAuthorizer mesh__D004172 sjn
% 209.88/210.04  |- mesh__dateCreated mesh__D004172 1999-01-01
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Diplopias, Horizontal
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Vision, Double
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Refractive Diplopia
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Vertical Diplopias
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Intermittent Diplopias
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Diplopias, Vertical
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Cortical Diplopias
% 209.88/210.04  |- skos__hiddenLabel mesh__D004172 Horizontal Diplopia
% 209.88/210.04  |- rdf__type mesh__D012604sskos__Concept
% 209.88/210.04  |- skos__hiddenLabel mesh__D012604 beta Scorpion Toxin
% 209.88/210.04  |- skos__hiddenLabel mesh__D012604 Toxin, gamma-Scorpion
% 209.88/210.04  |- skos__historyNote mesh__D012604 Scorpions %28%1966-1977%29%
% 209.88/210.04  |- skos__hiddenLabel mesh__D012604 Venoms, Scorpion
% 209.88/210.04  |- mesh__publicMeSHNote mesh__D012604 78   
% 209.88/210.04  |- skos__hiddenLabel mesh__D012604 Toxin, alpha-Scorpion
% 209.88/210.04  |- skos__scopeNote mesh__D012604
% 209.88/210.04       Venoms from animals of the order Scorpionida of the class Arachnida. They contain neuro- and hemotoxins, enzymes, and various other factors that may release acetylcholine and catecholamines from nerve endings. Of the several protein toxins that have been characterized, most are immunogenic.%A%    
% 209.88/210.04  |- mesh__recordAuthorizer mesh__D012604 sjn
% 209.88/210.04  |- skos__altLabel mesh__D012604 Scorpion Venom
% 209.88/210.04  |- mesh__historyNote mesh__D012604 78   
% 209.88/210.04  |- skos__prefLabel mesh__D012604 Scorpion Venoms
% 209.88/210.04  |- skos__hiddenLabel mesh__D012604 Venom, Scorpion
% 209.88/210.04  |- skos__broader mesh__D012604smesh__D001180
% 209.88/210.04  |- skos__annotation mesh__D012604
% 209.88/210.04       /antag permitted but consider also ANTIVENINS; /enzymol permitted%A%  
% 209.88/210.04  |- skos__hiddenLabel mesh__D012604 Toxin, beta-Scorpion
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D012604 2006
% 209.88/210.04  |- skos__hiddenLabel mesh__D012604 alpha Scorpion Toxin
% 209.88/210.04  |- mesh__dateRevised mesh__D012604 2005-06-30
% 209.88/210.04  |- mesh__dateEstablished mesh__D012604 1978-01-01
% 209.88/210.04  |- mesh__recordOriginator mesh__D012604 SH
% 209.88/210.04  |- skos__historyNote mesh__D012604 Venoms %28%1966-1977%29%
% 209.88/210.04  |- mesh__dateCreated mesh__D012604 1977-04-22
% 209.88/210.04  |- mesh__recordMaintainer mesh__D012604 ssb
% 209.88/210.04  |- skos__hiddenLabel mesh__D012604 gamma Scorpion Toxin
% 209.88/210.04  |- mesh__historyNote mesh__D017898 94   
% 209.88/210.04  |- mesh__dateRevised mesh__D017898 1996-06-10
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D017898 1997
% 209.88/210.04  |- skos__hiddenLabel mesh__D017898 Tobamoviruses
% 209.88/210.04  |- skos__scopeNote mesh__D017898
% 209.88/210.04       A genus of plant viruses in which the virion is a rigid filament. Transmission is by mechanical inoculation or seed. The type species is TOBACCO MOSAIC VIRUS.%A%    
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D017898 1999
% 209.88/210.04  |- mesh__dateEstablished mesh__D017898 1994-01-01
% 209.88/210.04  |- mesh__recordOriginator mesh__D017898 AGS
% 209.88/210.04  |- mesh__dateCreated mesh__D017898 1993-06-04
% 209.88/210.04  |- skos__prefLabel mesh__D017898 Tobamovirus
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D017898 2002
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D017898 1998
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D017898 2004
% 209.88/210.04  |- rdf__type mesh__D017898sskos__Concept
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D017898 2001
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D017898 2006
% 209.88/210.04  |- skos__annotation mesh__D017898
% 209.88/210.04       a genus of mosaic viruses of which TOBACCO MOSAIC VIRUS is the type species; from TOBAcco MOsaic virus; coord IM with specific plant /virol %28%IM or NIM%29%%A%  
% 209.88/210.04  |- skos__historyNote mesh__D017898 RNA Viruses %28%1990-1993%29%
% 209.88/210.04  |- skos__historyNote mesh__D017898 Plant Viruses %28%1990-1993%29%
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D017898 2003
% 209.88/210.04  |- mesh__recordMaintainer mesh__D017898 AGS
% 209.88/210.04  |- mesh__publicMeSHNote mesh__D017898 94   
% 209.88/210.04  |- mesh__recordAuthorizer mesh__D017898 PLS
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D017898 2000
% 209.88/210.04  |- skos__broader mesh__D017898smesh__D009029
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D017898 2005
% 209.88/210.04  |- mesh__recordOriginator mesh__D050723 ssb
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D050723 2006
% 209.88/210.04  |- mesh__recordMaintainer mesh__D050723 ssb
% 209.88/210.04  |- skos__scopeNote mesh__D050723 Breaks in bones.     
% 209.88/210.04  |- skos__hiddenLabel mesh__D050723 Broken Bone
% 209.88/210.04  |- skos__hiddenLabel mesh__D050723 Bones, Broken
% 209.88/210.04  |- rdf__type mesh__D050723sskos__Concept
% 209.88/210.04  |- mesh__historyNote mesh__D050723 2006   
% 209.88/210.04  |- skos__annotation mesh__D050723
% 209.88/210.04       coord IM with specific bone /inj %28%IM%29% but note many precoordinated Bone/Fracture terms and many specific types of fractures%A%  
% 209.88/210.04  |- skos__prefLabel mesh__D050723 Fractures, Bone
% 209.88/210.04  |- skos__altLabel mesh__D050723 Broken Bones
% 209.88/210.04  |- mesh__dateEstablished mesh__D050723 2006-01-01
% 209.88/210.04  |- mesh__recordAuthorizer mesh__D050723 sjn
% 209.88/210.04  |- skos__hiddenLabel mesh__D050723 Bone, Broken
% 209.88/210.04  |- skos__hiddenLabel mesh__D050723 Bone Fracture
% 209.88/210.04  |- mesh__dateCreated mesh__D050723 2005-06-30
% 209.88/210.04  |- skos__hiddenLabel mesh__D050723 Fracture, Bone
% 209.88/210.04  |- mesh__publicMeSHNote mesh__D050723 2006   
% 209.88/210.04  |- skos__altLabel mesh__D050723 Bone Fractures
% 209.88/210.04  |- skos__broader mesh__D050723smesh__D014947
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D003878 2005
% 209.88/210.04  |- mesh__dateRevised mesh__D003878 2003-07-09
% 209.88/210.04  |- skos__scopeNote mesh__D003878
% 209.88/210.04       The study of the patterns of ridges of the skin of the fingers, palms, toes, and soles.%A%    
% 209.88/210.04  |- mesh__historyNote mesh__D003878
% 209.88/210.04       66; FINGERPRINTS was see under DERMATOGLYPHICS 1966-78, was heading 1963-65; PLANTAR PRINTS was see under DERMATOGLYPHICS 1966-78%A%  
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D003878 2006
% 209.88/210.04  |- mesh__recordMaintainer mesh__D003878 lkt
% 209.88/210.04  |- mesh__recordOriginator mesh__D003878 NLM
% 209.88/210.04  |- mesh__onlineNote mesh__D003878
% 209.88/210.04       use DERMATOGLYPHICS to search FINGERPRINTS %26% PLANTAR PRINTS 1966-78%A%  
% 209.88/210.04  |- skos__hiddenLabel mesh__D003878 Print, Plantar
% 209.88/210.04  |- mesh__publicMeSHNote mesh__D003878
% 209.88/210.04       66; FINGERPRINTS was see under DERMATOGLYPHICS 1966-78, was heading 1963-65; PLANTAR PRINTS was see under DERMATOGLYPHICS 1966-78%A%  
% 209.88/210.04  |- mesh__dateCreated mesh__D003878 1999-01-01
% 209.88/210.04  |- rdf__type mesh__D003878sskos__Concept
% 209.88/210.04  |- skos__hiddenLabel mesh__D003878 Dermatoglyphic
% 209.88/210.04  |- skos__hiddenLabel mesh__D003878 Plantar Print
% 209.88/210.04  |- skos__broader mesh__D003878smesh__D008919
% 209.88/210.04  |- skos__prefLabel mesh__D003878 Dermatoglyphics
% 209.88/210.04  |- skos__broader mesh__D003878smesh__D005554
% 209.88/210.04  |- skos__hiddenLabel mesh__D003878 Prints, Plantar
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D003878 2004
% 209.88/210.04  |- skos__hiddenLabel mesh__D003878 Fingerprint
% 209.88/210.04  |- mesh__dateEstablished mesh__D003878 1966-01-01
% 209.88/210.04  |- mesh__recordAuthorizer mesh__D003878 sjn
% 209.88/210.04  |- skos__prefLabel mesh__D008563 Membrane Lipids
% 209.88/210.04  |- skos__historyNote mesh__D008563 Lipids %28%1966-1976%29%
% 209.88/210.04  |- skos__scopeNote mesh__D008563
% 209.88/210.04       Lipids, predominantly phospholipids, cholesterol and small amounts of glycolipids found in membranes including cellular and intracellular membranes. These lipids may be arranged in bilayers in the membranes with integral proteins between the layers and peripheral proteins attached to the outside. Membrane lipids are required for active transport, several enzymatic activities and membrane formation.%A%    
% 209.88/210.04  |- skos__broader mesh__D008563smesh__D008055
% 209.88/210.04  |- mesh__recordAuthorizer mesh__D008563 sjn
% 209.88/210.04  |- skos__altLabel mesh__D008563 Cell Membrane Lipids
% 209.88/210.04  |- skos__historyNote mesh__D008563 Membranes %28%1968-1976%29%
% 209.88/210.04  |- skos__hiddenLabel mesh__D008563 Lipids, Membrane
% 209.88/210.04  |- mesh__dateRevised mesh__D008563 2003-07-09
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D008563 2006
% 209.88/210.04  |- mesh__historyNote mesh__D008563 77   
% 209.88/210.04  |- skos__hiddenLabel mesh__D008563 Membrane Lipids, Cell
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D008563 2005
% 209.88/210.04  |- skos__annotation mesh__D008563 /biosyn /physiol permitted   
% 209.88/210.04  |- rdf__type mesh__D008563sskos__Concept
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D008563 2004
% 209.88/210.04  |- skos__historyNote mesh__D008563 Cell Membrane %28%1966-1976%29%
% 209.88/210.04  |- skos__historyNote mesh__D008563 Phospholipids %28%1966-1976%29%
% 209.88/210.04  |- mesh__dateCreated mesh__D008563 1976-04-27
% 209.88/210.04  |- skos__hiddenLabel mesh__D008563 Lipids, Cell Membrane
% 209.88/210.04  |- mesh__publicMeSHNote mesh__D008563 77   
% 209.88/210.04  |- mesh__recordOriginator mesh__D008563 RLS
% 209.88/210.04  |- mesh__dateEstablished mesh__D008563 1977-01-01
% 209.88/210.04  |- mesh__recordMaintainer mesh__D008563 ssb
% 209.88/210.04  |- skos__hiddenLabel mesh__D000580 C.I. 20470
% 209.88/210.04  |- skos__scopeNote mesh__D000580
% 209.88/210.04       A dye used to stain proteins in electrophoretic techniques. It is used interchangeably with its acid form.%A%    
% 209.88/210.04  |- mesh__dateCreated mesh__D000580 1975-07-23
% 209.88/210.04  |- skos__hiddenLabel mesh__D000580 Black, Amido
% 209.88/210.04  |- skos__prefLabel mesh__D000580 Amido Black
% 209.88/210.04  |- skos__hiddenLabel mesh__D000580 C.I.20470
% 209.88/210.04  |- mesh__recordOriginator mesh__D000580 SH
% 209.88/210.04  |- skos__broader mesh__D000580smesh__D001391
% 209.88/210.04  |- skos__broader mesh__D000580smesh__D009282
% 209.88/210.04  |- mesh__recordMaintainer mesh__D000580 NLM
% 209.88/210.04  |- mesh__publicMeSHNote mesh__D000580
% 209.88/210.04       91; was see under AZO COMPOUNDS 1976-90; ACID BLACK 1, NAPHTHOL BLUE BLACK, %26% C.I. ACID BLACK 1 were see AMIDO BLACK 1976-93%A%  
% 209.88/210.04  |- mesh__dateRevised mesh__D000580 2005-07-06
% 209.88/210.04  |- mesh__dateEstablished mesh__D000580 1991-01-01
% 209.88/210.04  |- mesh__onlineNote mesh__D000580
% 209.88/210.04       use AMIDO BLACK to search ACID BLACK 1, NAPHTHOL BLUE BLACK, %26% C.I. ACID BLACK 1 1976-93%A%  
% 209.88/210.04  |- skos__historyNote mesh__D000580 Azo Compounds %28%1969-1975%29%
% 209.88/210.04  |- skos__historyNote mesh__D000580 Naphthalenesulfonates %28%1974-1975%29%
% 209.88/210.04  |- mesh__historyNote mesh__D000580
% 209.88/210.04       91%28%76%29%; was see under AZO COMPOUNDS 1976-90; ACID BLACK 1, NAPHTHOL BLUE BLACK, %26%  C.I. ACID BLACK 1 were see AMIDO BLACK 1976-93%A%  
% 209.88/210.04  |- mesh__recordAuthorizer mesh__D000580 NLM
% 209.88/210.04  |- skos__historyNote mesh__D000580 Nitrobenzenes %28%1974-1975%29%
% 209.88/210.04  |- skos__annotation mesh__D000580 D25-26 qualif   
% 209.88/210.04  |- rdf__type mesh__D000580sskos__Concept
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D000580 2006
% 209.88/210.04  |- skos__broader mesh__D014835Q000295smesh__D014835
% 209.88/210.04  |- mesh__preferredCombination mesh__D014835Q000295smesh__D009330
% 209.88/210.04  |- rdf__type mesh__D014835Q000295smesh__CompoundConcept
% 209.88/210.04  |- skos__hiddenLabel mesh__D018991 Folch PI Proteolipid Protein
% 209.88/210.04  |- skos__altLabel mesh__D018991 Folch-Lees Protein
% 209.88/210.04  |- mesh__onlineNote mesh__D018991
% 209.88/210.04       use MYELIN PROTEOLIPID PROTEIN %28%NM%29% to search FOLCH-PI PROTEOLIPID PROTEIN 1981-95%A%  
% 209.88/210.04  |- skos__altLabel mesh__D018991 Proteolipid Protein, Myelin
% 209.88/210.04  |- skos__historyNote mesh__D018991 Myelin Proteins %28%1979-1995%29%
% 209.88/210.04  |- skos__prefLabel mesh__D018991 Myelin Proteolipid Protein
% 209.88/210.04  |- skos__hiddenLabel mesh__D018991 Proteolipid Protein, Folch-PI
% 209.88/210.04  |- skos__altLabel mesh__D018991 Myelin PLP
% 209.88/210.04  |- rdf__type mesh__D018991sskos__Concept
% 209.88/210.04  |- mesh__recordOriginator mesh__D018991 TPW
% 209.88/210.04  |- skos__broader mesh__D018991smesh__D009185
% 209.88/210.04  |- skos__related mesh__D018991smesh__D020371
% 209.88/210.04  |- skos__hiddenLabel mesh__D018991 Protein, Folch-PI Proteolipid
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D018991 2006
% 209.88/210.04  |- mesh__dateEstablished mesh__D018991 1996-01-01
% 209.88/210.04  |- mesh__recordAuthorizer mesh__D018991 sjn
% 209.88/210.04  |- skos__altLabel mesh__D018991 Folch-PI Proteolipid Protein
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D018991 2004
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D018991 2005
% 209.88/210.04  |- skos__annotation mesh__D018991
% 209.88/210.04       /biosyn /drug eff /physiol /ultrastruct permitted   
% 209.88/210.04  |- mesh__historyNote mesh__D018991
% 209.88/210.04       96; was FOLCH-PI PROTEOLIPID PROTEIN %28%NM%29% 1979-95   
% 209.88/210.04  |- mesh__publicMeSHNote mesh__D018991
% 209.88/210.04       96; FOLCH-PI PROTEOLIPID PROTEIN was indexed under MYELIN PROTEINS 1979-95%A%  
% 209.88/210.04  |- mesh__dateCreated mesh__D018991 1995-06-05
% 209.88/210.04  |- skos__hiddenLabel mesh__D018991 Protein, Myelin Proteolipid
% 209.88/210.04  |- skos__hiddenLabel mesh__D018991 PLP, Myelin
% 209.88/210.04  |- skos__scopeNote mesh__D018991
% 209.88/210.04       A myelin protein that is the major component of the organic solvent extractable lipoprotein complexes of whole brain. It has been the subject of much study because of its unusual physical properties. It remains soluble in chloroform even after essentially all of its bound lipids have been removed. %28%From Siegel et al., Basic Neurochemistry, 4th ed, p122%29%%A%    
% 209.88/210.04  |- skos__hiddenLabel mesh__D018991 Folch Lees Protein
% 209.88/210.04  |- mesh__recordMaintainer mesh__D018991 ssb
% 209.88/210.04  |- skos__broader mesh__D018991smesh__D011510
% 209.88/210.04  |- mesh__dateRevised mesh__D018991 2003-07-09
% 209.88/210.04  |- skos__hiddenLabel mesh__D018991 Protein, Folch-Lees
% 209.88/210.04  |- skos__broader mesh__D012701Q000037smesh__D012701
% 209.88/210.04  |- mesh__preferredCombination mesh__D012701Q000037smesh__D012702
% 209.88/210.04  |- rdf__type mesh__D012701Q000037smesh__CompoundConcept
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D018193 2005
% 209.88/210.04  |- mesh__publicMeSHNote mesh__D018193 98   
% 209.88/210.04  |- rdf__type mesh__D018193sskos__Concept
% 209.88/210.04  |- skos__historyNote mesh__D018193 specific neoplasm %28%1966-1997%29%
% 209.88/210.04  |- skos__prefLabel mesh__D018193 Neoplasms, Complex and Mixed
% 209.88/210.04  |- mesh__historyNote mesh__D018193 98; use explode 1994-97   
% 209.88/210.04  |- skos__altLabel mesh__D018193 Complex and Mixed Neoplasms
% 209.88/210.04  |- skos__broader mesh__D018193smesh__D009370
% 209.88/210.04  |- skos__annotation mesh__D018193
% 209.88/210.04       neopl composed of more than one type of neopl tissue; indexing policy: Manual section 24; also TN Suppl: Tumor Key for human %26% corresponding vet tumors %28%does not contain exper tumors%29%; TN 135: correct use of tissue type terms; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; DF: NEOPL COMPLEX MIXED%A%  
% 209.88/210.04  |- mesh__dateRevised mesh__D018193 2004-07-13
% 209.88/210.04  |- mesh__recordAuthorizer mesh__D018193 sjn
% 209.88/210.04  |- mesh__dateEstablished mesh__D018193 1998-01-01
% 209.88/210.04  |- mesh__recordOriginator mesh__D018193 PLS
% 209.88/210.04  |- mesh__dateCreated mesh__D018193 1993-08-26
% 209.88/210.04  |- skos__scopeNote mesh__D018193
% 209.88/210.04       Neoplasms composed of more than one type of neoplastic tissue.%A%    
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D018193 2006
% 209.88/210.04  |- mesh__recordMaintainer mesh__D018193 sjn
% 209.88/210.04  |- mesh__dateCreated mesh__D004971 1999-01-01
% 209.88/210.04  |- mesh__recordAuthorizer mesh__D004971 sjn
% 209.88/210.04  |- skos__broader mesh__D004971smesh__D030762
% 209.88/210.04  |- mesh__recordMaintainer mesh__D004971 lkt
% 209.88/210.04  |- skos__annotation mesh__D004971 non-primate mammals only   
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D004971 2006
% 209.88/210.04  |- mesh__dateRevised mesh__D004971 2004-07-07
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D004971 2005
% 209.88/210.04  |- skos__scopeNote mesh__D004971
% 209.88/210.04       The period in the ESTROUS CYCLE associated with maximum sexual receptivity and fertility in non-primate female mammals.%A%    
% 209.88/210.04  |- rdf__type mesh__D004971sskos__Concept
% 209.88/210.04  |- skos__prefLabel mesh__D004971 Estrus
% 209.88/210.04  |- mesh__recordOriginator mesh__D004971 NLM
% 209.88/210.04  |- mesh__dateEstablished mesh__D004173 1991-01-01
% 209.88/210.04  |- mesh__recordOriginator mesh__D004173 NLM
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D004173 2005
% 209.88/210.04  |- mesh__recordMaintainer mesh__D004173 sjn
% 209.88/210.04  |- mesh__recordAuthorizer mesh__D004173 sjn
% 209.88/210.04  |- mesh__publicMeSHNote mesh__D004173
% 209.88/210.04       91; was see under RODENTIA 1982-90; was KANGAROO RATS see under RODENTS 1975-81%A%  
% 209.88/210.04  |- skos__broader mesh__D004173smesh__D012377
% 209.88/210.04  |- skos__altLabel mesh__D004173 Rats, Kangaroo
% 209.88/210.04  |- mesh__dateRevised mesh__D004173 2004-07-13
% 209.88/210.04  |- skos__hiddenLabel mesh__D004173 Rat, Kangaroo
% 209.88/210.04  |- mesh__onlineNote mesh__D004173
% 209.88/210.04       use DIPODOMYS to search KANGAROO RATS 1975-81   
% 209.88/210.04  |- skos__altLabel mesh__D004173 Kangaroo Rats
% 209.88/210.04  |- skos__scopeNote mesh__D004173
% 209.88/210.04       A genus of the family Heteromyidae which contains 22 species. Their physiology is adapted for the conservation of water, and they seldom drink water. They are found in arid or desert habitats and travel by hopping on their hind limbs.%A%    
% 209.88/210.04  |- rdf__type mesh__D004173sskos__Concept
% 209.88/210.04  |- skos__prefLabel mesh__D004173 Dipodomys
% 209.88/210.04  |- skos__hiddenLabel mesh__D004173 Kangaroo Rat
% 209.88/210.04  |- mesh__dateCreated mesh__D004173 1974-12-12
% 209.88/210.04  |- skos__annotation mesh__D004173
% 209.88/210.04        do not confuse X ref KANGAROO RATS with rat kangaroos %28% = MACROPODIDAE%29%; NIM when exper animal: no qualif; when IM, qualif permitted; do not check tag RATS%A%  
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D004173 2006
% 209.88/210.04  |- mesh__historyNote mesh__D004173
% 209.88/210.04       91%28%82%29%; was see under RODENTIA 1982-90; was KANGAROO RATS see under RODENTS 1975-81%A%  
% 209.88/210.04  |- skos__annotation mesh__D012605
% 209.88/210.04       /microbiol /parasitol /virol permitted; scorpion sting: coord NIM with ARACHNIDISM %28%IM%29%; several genera: Androctonus, Buthus, Centruoides, Leiurus, Nebo, Tityus%A%  
% 209.88/210.04  |- skos__prefLabel mesh__D012605 Scorpions
% 209.88/210.04  |- mesh__dateCreated mesh__D012605 1999-01-01
% 209.88/210.04  |- skos__broader mesh__D012605smesh__D001097
% 209.88/210.04  |- skos__scopeNote mesh__D012605
% 209.88/210.04       Arthropods of the order Scorpiones, of which 1500 to 2000 species have been described. The most common live in tropical or subtropical areas. They are nocturnal and feed principally on insects and other arthropods. They are large arachnids but do not attack man spontaneously. They have a venomous sting. Their medical significance varies considerably and is dependent on their habits and venom potency rather than on their size. At most, the sting is equivalent to that of a hornet but certain species possess a highly toxic venom potentially fatal to humans. %28%From Dorland, 27th ed; Smith, Insects and Other Arthropods of Medical Importance, 1973, p417; Barnes, Invertebrate Zoology, 5th ed, p503%29%%A%    
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D012605 2005A
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D012605 2005
% 209.88/210.04  |- mesh__dateRevised mesh__D012605 2004-08-02
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D012605 2006
% 209.88/210.04  |- mesh__recordOriginator mesh__D012605 NLM
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D012605 2004
% 209.88/210.04  |- mesh__recordMaintainer mesh__D012605 jls
% 209.88/210.04  |- mesh__recordAuthorizer mesh__D012605 jls
% 209.88/210.04  |- rdf__type mesh__D012605sskos__Concept
% 209.88/210.04  |- skos__scopeNote mesh__D017899
% 209.88/210.04       An order comprising three families of tailed bacteriophages: MYOVIRIDAE; PODOVIRIDAE; and SIPHOVIRIDAE.%A%    
% 209.88/210.04  |- skos__annotation mesh__D017899
% 209.88/210.04       an order of tailed %28%caudo-%29% bacteriophages   
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D017899 2004
% 209.88/210.04  |- skos__broader mesh__D017899smesh__D001435
% 209.88/210.04  |- rdf__type mesh__D017899sskos__Concept
% 209.88/210.04  |- mesh__publicMeSHNote mesh__D017899 94   
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D017899 2006
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D017899 2003
% 209.88/210.04  |- mesh__dateEstablished mesh__D017899 1994-01-01
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D017899 2005
% 209.88/210.04  |- mesh__dateRevised mesh__D017899 2001-07-25
% 209.88/210.04  |- skos__prefLabel mesh__D017899 Caudovirales
% 209.88/210.04  |- skos__broader mesh__D017899smesh__D004267
% 209.88/210.04  |- mesh__recordAuthorizer mesh__D017899 sjn
% 209.88/210.04  |- mesh__historyNote mesh__D017899 94   
% 209.88/210.04  |- mesh__recordOriginator mesh__D017899 AGS
% 209.88/210.04  |- mesh__dateCreated mesh__D017899 1993-06-04
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D017899 2002
% 209.88/210.04  |- mesh__recordMaintainer mesh__D017899 mdb
% 209.88/210.04  |- mesh__dateCreated mesh__D050724 2005-06-30
% 209.88/210.04  |- rdf__type mesh__D050724sskos__Concept
% 209.88/210.04  |- skos__hiddenLabel mesh__D050724 Fracture, Cartilage
% 209.88/210.04  |- skos__broader mesh__D050724smesh__D014947
% 209.88/210.04  |- mesh__recordMaintainer mesh__D050724 ssb
% 209.88/210.04  |- skos__scopeNote mesh__D050724 Breaks in CARTILAGE.     
% 209.88/210.04  |- skos__altLabel mesh__D050724 Cartilage Fractures
% 209.88/210.04  |- skos__historyNote mesh__D050724 Fractures, Bone %28%1963-2005%29%
% 209.88/210.04  |- mesh__historyNote mesh__D050724 2006   
% 209.88/210.04  |- skos__hiddenLabel mesh__D050724 Cartilage Fracture
% 209.88/210.04  |- mesh__publicMeSHNote mesh__D050724 2006   
% 209.88/210.04  |- mesh__dateEstablished mesh__D050724 2006-01-01
% 209.88/210.04  |- skos__annotation mesh__D050724
% 209.88/210.04       coordinate IM with specific type of cartilage /inj %28%IM%29%   
% 209.88/210.04  |- mesh__recordOriginator mesh__D050724 ssb
% 209.88/210.04  |- mesh__recordAuthorizer mesh__D050724 sjn
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D050724 2006
% 209.88/210.04  |- skos__prefLabel mesh__D050724 Fractures, Cartilage
% 209.88/210.04  |- skos__altLabel mesh__D003879 Agent, Dermatologic
% 209.88/210.04  |- skos__hiddenLabel mesh__D003879 Dermatological Agent
% 209.88/210.04  |- mesh__historyNote mesh__D003879 67   
% 209.88/210.04  |- skos__altLabel mesh__D003879 Dermatological Agents
% 209.88/210.04  |- mesh__recordMaintainer mesh__D003879 sjn
% 209.88/210.04  |- skos__altLabel mesh__D003879 Dermatologic Agent
% 209.88/210.04  |- skos__hiddenLabel mesh__D003879 Agents, Dermatological
% 209.88/210.04  |- mesh__dateCreated mesh__D003879 1999-01-01
% 209.88/210.04  |- mesh__recordAuthorizer mesh__D003879 sjn
% 209.88/210.04  |- skos__broader mesh__D003879smesh__D045506
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D003879 2006
% 209.88/210.04  |- skos__annotation mesh__D003879
% 209.88/210.04       GEN or unspecified; prefer specifics; consider also SKIN /drug eff %26% SKIN DISEASES /drug ther; DF: DERMATOL AGENTS%A%  
% 209.88/210.04  |- skos__prefLabel mesh__D003879 Dermatologic Agents
% 209.88/210.04  |- skos__altLabel mesh__D003879 Agent, Dermatological
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D003879 2006A
% 209.88/210.04  |- skos__altLabel mesh__D003879 Agents, Dermatologic
% 209.88/210.04  |- mesh__dateEstablished mesh__D003879 1967-01-01
% 209.88/210.04  |- mesh__recordOriginator mesh__D003879 NLM
% 209.88/210.04  |- mesh__dateRevised mesh__D003879 2005-08-15
% 209.88/210.04  |- rdf__type mesh__D003879sskos__Concept
% 209.88/210.04  |- mesh__publicMeSHNote mesh__D003879 67   
% 209.88/210.04  |- skos__related mesh__D003879smesh__D000891
% 209.88/210.04  |- skos__scopeNote mesh__D003879
% 209.88/210.04       Drugs used to treat or prevent skin disorders or for the routine care of skin.%A%    
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D008564 1994
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D008564 1999
% 209.88/210.04  |- skos__prefLabel mesh__D008564 Membrane Potentials
% 209.88/210.04  |- skos__broader mesh__D008564smesh__D004594
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D008564 2001
% 209.88/210.04  |- skos__broader mesh__D008564smesh__D001693
% 209.88/210.04  |- skos__hiddenLabel mesh__D008564 Potentials, Transmembrane
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D008564 2003
% 209.88/210.04  |- skos__altLabel mesh__D008564 Resting Potentials
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D008564 1995
% 209.88/210.04  |- skos__hiddenLabel mesh__D008564 Potential, Membrane
% 209.88/210.04  |- skos__broader mesh__D008564smesh__D009424
% 209.88/210.04  |- skos__annotation mesh__D008564
% 209.88/210.04       NIM; coord with organ /physiol %28%IM%29%   
% 209.88/210.04  |- mesh__dateEstablished mesh__D008564 1968-01-01
% 209.88/210.04  |- skos__hiddenLabel mesh__D008564 Transmembrane Potential
% 209.88/210.04  |- skos__hiddenLabel mesh__D008564 Potential, Transmembrane
% 209.88/210.04  |- mesh__historyNote mesh__D008564 68%28%67%29%   
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D008564 2002
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D008564 2004
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D008564 1996
% 209.88/210.04  |- skos__scopeNote mesh__D008564
% 209.88/210.04       Ratio of inside versus outside concentration of potassium, sodium, chloride and other ions in diffusible tissues or cells. Also called transmembrane and resting potentials, they are measured by recording electrophysiologic responses in voltage-dependent ionic channels of %28%e.g.%29% nerve, muscle and blood cells as well as artificial membranes.%A%    
% 209.88/210.04  |- mesh__recordMaintainer mesh__D008564 TAP
% 209.88/210.04  |- skos__broader mesh__D008564smesh__D001703
% 209.88/210.04  |- mesh__recordOriginator mesh__D008564 NLM
% 209.88/210.04  |- mesh__publicMeSHNote mesh__D008564 68   
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D008564 2005
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D008564 1997
% 209.88/210.04  |- skos__hiddenLabel mesh__D008564 Potential, Resting
% 209.88/210.04  |- mesh__recordAuthorizer mesh__D008564 PLS
% 209.88/210.04  |- skos__hiddenLabel mesh__D008564 Resting Potential
% 209.88/210.04  |- skos__altLabel mesh__D008564 Transmembrane Potentials
% 209.88/210.04  |- skos__hiddenLabel mesh__D008564 Potentials, Resting
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D008564 1993
% 209.88/210.04  |- skos__hiddenLabel mesh__D008564 Potentials, Membrane
% 209.88/210.04  |- mesh__dateCreated mesh__D008564 1999-01-01
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D008564 2006
% 209.88/210.04  |- rdf__type mesh__D008564sskos__Concept
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D008564 1998
% 209.88/210.04  |- skos__historyNote mesh__D008564 Electrophysiology %28%1966%29%
% 209.88/210.04  |- mesh__dateRevised mesh__D008564 1992-05-15
% 209.88/210.04  |- skos__hiddenLabel mesh__D008564 Membrane Potential
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D008564 2000
% 209.88/210.04  |- mesh__recordAuthorizer mesh__D000581 sjn
% 209.88/210.04  |- mesh__activeMeSHYear mesh__D000581 2004
% 209.88/210.04  |- mesh__recordMaintainer mesh__D000581 ssb
% 209.88/210.04  |- mesh__dateRevised mesh__D000581 2003-07-09
% 209.88/210.04  |- skos__broader mesh__D000581smesh__D006867
% 209.88/210.05  |- mesh__dateCreated mesh__D000581 1999-01-01
% 209.88/210.05  |- rdf__type mesh__D000581sskos__Concept
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D000581 2006
% 209.88/210.05  |- skos__altLabel mesh__D000581 Amidases
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D000581 2005
% 209.88/210.05  |- skos__prefLabel mesh__D000581 Amidohydrolases
% 209.88/210.05  |- mesh__recordOriginator mesh__D000581 NLM
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018992 2006
% 209.88/210.05  |- skos__prefLabel mesh__D018992 Myelin-Associated Glycoprotein
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018992 2004
% 209.88/210.05  |- skos__altLabel mesh__D018992 MAG Protein
% 209.88/210.05  |- skos__altLabel mesh__D018992 Pleural Glycoproteins
% 209.88/210.05  |- skos__scopeNote mesh__D018992
% 209.88/210.05       A myelin protein found in the periaxonal membrane of both the central and peripheral nervous systems myelin sheaths. It has a structure that is similar to members of the Ig superfamily that participate in cell adhesion. %28%From Siegel et al., Basic Neurochemistry, 5th ed, p132%29%%A%    
% 209.88/210.05  |- skos__annotation mesh__D018992
% 209.88/210.05       /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X ref%A%  
% 209.88/210.05  |- skos__hiddenLabel mesh__D018992 Glycoproteins, Pleural
% 209.88/210.05  |- mesh__historyNote mesh__D018992
% 209.88/210.05       96; was PLEURAL GLYCOPROTEINS %28%NM%29% 1982-95   
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018992 2005
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018992 2001
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018992 1999
% 209.88/210.05  |- skos__hiddenLabel mesh__D018992
% 209.88/210.05       Large Myelin Associated Glycoprotein Isoform
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018992 2003
% 209.88/210.05  |- mesh__publicMeSHNote mesh__D018992
% 209.88/210.05       96; PLEURAL GLYCOPROTEINS was indexed under MYELIN PROTEINS 1982-95%A%  
% 209.88/210.05  |- mesh__dateCreated mesh__D018992 1995-06-05
% 209.88/210.05  |- skos__altLabel mesh__D018992
% 209.88/210.05       Large Myelin-Associated Glycoprotein Isoform
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018992 1997
% 209.88/210.05  |- skos__broader mesh__D018992smesh__D008562
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018992 2000
% 209.88/210.05  |- skos__hiddenLabel mesh__D018992 Glycoprotein, Myelin-Associated
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018992 1998
% 209.88/210.05  |- skos__hiddenLabel mesh__D018992 Myelin Associated Glycoprotein
% 209.88/210.05  |- skos__hiddenLabel mesh__D018992 L MAG
% 209.88/210.05  |- skos__broader mesh__D018992smesh__D009185
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018992 1996
% 209.88/210.05  |- skos__hiddenLabel mesh__D018992 S MAG
% 209.88/210.05  |- skos__altLabel mesh__D018992 S-MAG
% 209.88/210.05  |- mesh__dateEstablished mesh__D018992 1996-01-01
% 209.88/210.05  |- skos__hiddenLabel mesh__D018992
% 209.88/210.05       Small Myelin Associated Glycoprotein Isoform
% 209.88/210.05  |- skos__hiddenLabel mesh__D018992 Protein, MAG
% 209.88/210.05  |- skos__historyNote mesh__D018992 Myelin Proteins %28%1982-1995%29%
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018992 2002
% 209.88/210.05  |- mesh__onlineNote mesh__D018992
% 209.88/210.05       use MYELIN-ASSOCIATED GLYCOPROTEIN %28%NM%29% to search PLEURAL GLYCOPROTEINS 1982-95%A%  
% 209.88/210.05  |- rdf__type mesh__D018992sskos__Concept
% 209.88/210.05  |- mesh__recordAuthorizer mesh__D018194 PLS
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018194 1999
% 209.88/210.05  |- skos__historyNote mesh__D018194 Endometriosis %28%1975-1993%29%
% 209.88/210.05  |- skos__scopeNote mesh__D018194
% 209.88/210.05       A benign neoplasm of muscle %28%usually smooth muscle%29% with glandular elements. It occurs most frequently in the uterus and uterine ligaments. %28%Stedman, 25th ed%29%%A%    
% 209.88/210.05  |- mesh__dateEstablished mesh__D018194 1994-01-01
% 209.88/210.05  |- rdf__type mesh__D018194sskos__Concept
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018194 2000
% 209.88/210.05  |- skos__annotation mesh__D018194
% 209.88/210.05       /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 209.88/210.05  |- mesh__publicMeSHNote mesh__D018194 94   
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018194 2001
% 209.88/210.05  |- mesh__historyNote mesh__D018194 94   
% 209.88/210.05  |- skos__broader mesh__D018194smesh__D018193
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018194 2003
% 209.88/210.05  |- mesh__recordMaintainer mesh__D018194 KEV
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018194 1996
% 209.88/210.05  |- skos__hiddenLabel mesh__D018194 Adenomyomas
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018194 2005
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018194 2004
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018194 1998
% 209.88/210.05  |- skos__prefLabel mesh__D018194 Adenomyoma
% 209.88/210.05  |- mesh__recordOriginator mesh__D018194 PLS
% 209.88/210.05  |- mesh__dateCreated mesh__D018194 1993-06-24
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018194 1997
% 209.88/210.05  |- mesh__dateRevised mesh__D018194 1995-06-08
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018194 2002
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018194 2006
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D004972 2003
% 209.88/210.05  |- mesh__publicMeSHNote mesh__D004972 91; was see under BREEDING 1975-90   
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D004972 2006
% 209.88/210.05  |- skos__annotation mesh__D004972 animal only   
% 209.88/210.05  |- mesh__historyNote mesh__D004972
% 209.88/210.05       91%28%75%29%; was see under BREEDING 1975-90   
% 209.88/210.05  |- mesh__recordOriginator mesh__D004972 NLM
% 209.88/210.05  |- mesh__dateCreated mesh__D004972 1974-11-19
% 209.88/210.05  |- skos__hiddenLabel mesh__D004972 Detection, Estrus
% 209.88/210.05  |- mesh__recordAuthorizer mesh__D004972 sjn
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D004972 2005
% 209.88/210.05  |- mesh__recordMaintainer mesh__D004972 lkt
% 209.88/210.05  |- skos__broader mesh__D004972smesh__D001947
% 209.88/210.05  |- skos__hiddenLabel mesh__D004972 Estrus Detections
% 209.88/210.05  |- skos__prefLabel mesh__D004972 Estrus Detection
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D004972 2002
% 209.88/210.05  |- rdf__type mesh__D004972sskos__Concept
% 209.88/210.05  |- mesh__dateEstablished mesh__D004972 1991-01-01
% 209.88/210.05  |- mesh__dateRevised mesh__D004972 2001-07-25
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D004972 2004
% 209.88/210.05  |- skos__hiddenLabel mesh__D004972 Detections, Estrus
% 209.88/210.05  |- skos__scopeNote mesh__D004972
% 209.88/210.05       Methods for recognizing the state of ESTRUS.     
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D004174 2004
% 209.88/210.05  |- mesh__historyNote mesh__D004174
% 209.88/210.05       91%28%76%29%; was see under MORPHINANS 1976-90   
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D004174 2002
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D004174 2003
% 209.88/210.05  |- mesh__recordOriginator mesh__D004174 SH
% 209.88/210.05  |- mesh__recordAuthorizer mesh__D004174 sjn
% 209.88/210.05  |- rdf__type mesh__D004174sskos__Concept
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D004174 2001
% 209.88/210.05  |- skos__historyNote mesh__D004174 Morphinans %28%1973-1975%29%
% 209.88/210.05  |- skos__prefLabel mesh__D004174 Diprenorphine
% 209.88/210.05  |- skos__broader mesh__D004174smesh__D009019
% 209.88/210.05  |- skos__hiddenLabel mesh__D004174 Hydrochloride, Diprenorphine
% 209.88/210.05  |- mesh__dateCreated mesh__D004174 1975-07-23
% 209.88/210.05  |- skos__scopeNote mesh__D004174
% 209.88/210.05       A narcotic antagonist similar in action to NALOXONE. It is used to remobilize animals after ETORPHINE neuroleptanalgesia and is considered a specific antagonist to etorphine.%A%    
% 209.88/210.05  |- mesh__publicMeSHNote mesh__D004174
% 209.88/210.05       91; was see under MORPHINANS 1976-90   
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D004174 2006
% 209.88/210.05  |- skos__historyNote mesh__D004174 Cyclopropanes %28%1973-1975%29%
% 209.88/210.05  |- mesh__dateRevised mesh__D004174 2000-06-22
% 209.88/210.05  |- mesh__recordMaintainer mesh__D004174 TWD
% 209.88/210.05  |- mesh__dateEstablished mesh__D004174 1991-01-01
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D004174 2005
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D012606 1996
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D012606 2005
% 209.88/210.05  |- mesh__recordOriginator mesh__D012606 NLM
% 209.88/210.05  |- mesh__recordMaintainer mesh__D012606 KEV
% 209.88/210.05  |- skos__broader mesh__D012606smesh__D006113
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D012606 1999
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D012606 2003
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D012606 1997
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D012606 2006
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D012606 2001
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D012606 2004
% 209.88/210.05  |- rdf__type mesh__D012606sskos__Concept
% 209.88/210.05  |- skos__prefLabel mesh__D012606 Scotland
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D012606 2002
% 209.88/210.05  |- mesh__dateRevised mesh__D012606 1995-05-23
% 209.88/210.05  |- mesh__dateCreated mesh__D012606 1999-01-01
% 209.88/210.05  |- mesh__recordAuthorizer mesh__D012606 PLS
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D012606 1998
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D012606 2000
% 209.88/210.05  |- skos__broader mesh__D050725smesh__D009856
% 209.88/210.05  |- mesh__recordMaintainer mesh__D050725 ags
% 209.88/210.05  |- skos__altLabel mesh__D050725 E7 Oncogene Proteins
% 209.88/210.05  |- skos__prefLabel mesh__D050725 Papillomavirus E7 Proteins
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D050725 2006
% 209.88/210.05  |- rdf__type mesh__D050725sskos__Concept
% 209.88/210.05  |- mesh__dateEstablished mesh__D050725 2006-01-01
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D050725 2006A
% 209.88/210.05  |- mesh__dateCreated mesh__D050725 2005-06-30
% 209.88/210.05  |- skos__hiddenLabel mesh__D050725 E7 Proteins, Papillomavirus
% 209.88/210.05  |- skos__hiddenLabel mesh__D050725 Oncogene Proteins, E7
% 209.88/210.05  |- skos__scopeNote mesh__D050725
% 209.88/210.05       ONCOGENE PROTEINS from PAPILLOMAVIRUS that deregulate the CELL CYCLE of infected cells and lead to NEOPLASTIC CELL TRANSFORMATION. Papillomavirus E7 proteins have been shown to interact with various regulators of the cell cycle including RETINOBLASTOMA PROTEIN and certain cyclin-dependent kinase inhibitors.%A%    
% 209.88/210.05  |- mesh__recordAuthorizer mesh__D050725 ags
% 209.88/210.05  |- mesh__publicMeSHNote mesh__D050725 2006   
% 209.88/210.05  |- mesh__dateRevised mesh__D050725 2005-07-12
% 209.88/210.05  |- mesh__historyNote mesh__D050725 2006   
% 209.88/210.05  |- skos__altLabel mesh__D050725 Oncogene Protein E7, Papillomavirus
% 209.88/210.05  |- mesh__recordOriginator mesh__D050725 DRC
% 209.88/210.05  |- skos__hiddenLabel mesh__D008565 Proteins, Cell Surface
% 209.88/210.05  |- rdf__type mesh__D008565sskos__Concept
% 209.88/210.05  |- skos__historyNote mesh__D008565 Proteins %28%1966-1976%29%
% 209.88/210.05  |- skos__hiddenLabel mesh__D008565 Proteins, Surface
% 209.88/210.05  |- skos__hiddenLabel mesh__D008565 Protein, Integral Membrane
% 209.88/210.05  |- skos__altLabel mesh__D008565 Membrane Protein
% 209.88/210.05  |- skos__hiddenLabel mesh__D008565 Membrane Associated Proteins
% 209.88/210.05  |- mesh__dateRevised mesh__D008565 2005-06-30
% 209.88/210.05  |- skos__hiddenLabel mesh__D008565 Membrane Proteins, Integral
% 209.88/210.05  |- skos__annotation mesh__D008565
% 209.88/210.05       /biosyn /drug eff /physiol /ultrastruct permitted   
% 209.88/210.05  |- skos__hiddenLabel mesh__D008565 Proteins, Cell Membrane
% 209.88/210.05  |- mesh__recordOriginator mesh__D008565 RLS
% 209.88/210.05  |- mesh__publicMeSHNote mesh__D008565 77   
% 209.88/210.05  |- mesh__dateCreated mesh__D008565 1976-04-27
% 209.88/210.05  |- mesh__dateEstablished mesh__D008565 1977-01-01
% 209.88/210.05  |- skos__scopeNote mesh__D008565
% 209.88/210.05       Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors.%A%    
% 209.88/210.05  |- skos__hiddenLabel mesh__D008565 Membrane Protein, Integral
% 209.88/210.05  |- skos__altLabel mesh__D008565 Membrane-Associated Proteins
% 209.88/210.05  |- skos__prefLabel mesh__D008565 Membrane Proteins
% 209.88/210.05  |- skos__hiddenLabel mesh__D008565 Protein, Membrane
% 209.88/210.05  |- skos__broader mesh__D008565smesh__D011506
% 209.88/210.05  |- skos__historyNote mesh__D008565 Cell Membranes %28%1966-1976%29%
% 209.88/210.05  |- skos__hiddenLabel mesh__D008565 Proteins, Integral Membrane
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D008565 2006
% 209.88/210.05  |- skos__historyNote mesh__D008565 Membranes %28%1968-1976%29%
% 209.88/210.05  |- skos__hiddenLabel mesh__D008565 Proteins, Membrane-Associated
% 209.88/210.05  |- skos__altLabel mesh__D008565 Surface Proteins
% 209.88/210.05  |- skos__hiddenLabel mesh__D008565 Proteins, Membrane
% 209.88/210.05  |- mesh__recordAuthorizer mesh__D008565 sjn
% 209.88/210.05  |- skos__altLabel mesh__D008565 Integral Membrane Protein
% 209.88/210.05  |- mesh__historyNote mesh__D008565 77   
% 209.88/210.05  |- mesh__recordMaintainer mesh__D008565 SYSTEM
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D000582 2004
% 209.88/210.05  |- skos__historyNote mesh__D000582 Pyrophosphoric Acids %28%1974%29%
% 209.88/210.05  |- mesh__recordOriginator mesh__D000582 NLM
% 209.88/210.05  |- skos__hiddenLabel mesh__D000582
% 209.88/210.05       Amidotransferase, Phosphoribosyl Pyrophosphate
% 209.88/210.05  |- mesh__dateRevised mesh__D000582 2003-07-09
% 209.88/210.05  |- mesh__dateEstablished mesh__D000582 1991-01-01
% 209.88/210.05  |- skos__historyNote mesh__D000582 Pentosyltransferases %28%1974%29%
% 209.88/210.05  |- rdf__type mesh__D000582sskos__Concept
% 209.88/210.05  |- mesh__recordAuthorizer mesh__D000582 sjn
% 209.88/210.05  |- skos__hiddenLabel mesh__D000582 Glutamine Amidophosphoribosyltransferase
% 209.88/210.05  |- mesh__dateCreated mesh__D000582 1974-11-19
% 209.88/210.05  |- skos__historyNote mesh__D000582 Pentosephosphates %28%1974%29%
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D000582 2006
% 209.88/210.05  |- skos__altLabel mesh__D000582
% 209.88/210.05       Phosphoribosyldiphosphate 5-Amidotransferase
% 209.88/210.05  |- skos__historyNote mesh__D000582 Glutamine %28%1974%29%
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D000582 2005
% 209.88/210.05  |- skos__hiddenLabel mesh__D000582
% 209.88/210.05       Pyrophosphate Amidotransferase, Phosphoribosyl
% 209.88/210.05  |- mesh__recordMaintainer mesh__D000582 ssb
% 209.88/210.05  |- skos__altLabel mesh__D000582
% 209.88/210.05       Glutamine Phosphoribosyl Pyrophosphate Amidotransferase
% 209.88/210.05  |- skos__altLabel mesh__D000582
% 209.88/210.05       Phosphoribosyl Pyrophosphate Amidotransferase
% 209.88/210.05  |- mesh__historyNote mesh__D000582
% 209.88/210.05       91%28%75%29%; was see under PENTOSYLTRANSFERASES 1975-90   
% 209.88/210.05  |- skos__scopeNote mesh__D000582
% 209.88/210.05       An enzyme, involved in the early steps of purine nucleotide biosynthesis, that catalyzes the formation of 5-phosphoribosylamine from glutamine and phosphoribosylpyrophosphate. EC 2.4.2.14.%A%    
% 209.88/210.05  |- skos__hiddenLabel mesh__D000582
% 209.88/210.05       Phosphoribosyldiphosphate 5 Amidotransferase
% 209.88/210.05  |- mesh__publicMeSHNote mesh__D000582
% 209.88/210.05       91; was see under PENTOSYLTRANSFERASES 1975-90   
% 209.88/210.05  |- skos__altLabel mesh__D000582 Glutamine-Amidophosphoribosyltransferase
% 209.88/210.05  |- skos__broader mesh__D000582smesh__D010430
% 209.88/210.05  |- skos__hiddenLabel mesh__D000582
% 209.88/210.05       5-Amidotransferase, Phosphoribosyldiphosphate
% 209.88/210.05  |- skos__prefLabel mesh__D000582 Amidophosphoribosyltransferase
% 209.88/210.05  |- skos__hiddenLabel mesh__D018993 Zero, Myelin Protein
% 209.88/210.05  |- skos__altLabel mesh__D018993 Myelin Protein Zero
% 209.88/210.05  |- skos__broader mesh__D018993smesh__D006023
% 209.88/210.05  |- mesh__recordAuthorizer mesh__D018993 sjn
% 209.88/210.05  |- mesh__dateCreated mesh__D018993 1995-06-05
% 209.88/210.05  |- skos__historyNote mesh__D018993 Myelin Proteins %28%1981-1995%29%
% 209.88/210.05  |- skos__altLabel mesh__D018993 P0 Glycoprotein
% 209.88/210.05  |- mesh__publicMeSHNote mesh__D018993
% 209.88/210.05       96; PROTEIN ZERO, PERIPHERAL NERVE MYELIN was indexed under MYELIN PROTEINS 1981-95%A%  
% 209.88/210.05  |- skos__hiddenLabel mesh__D018993 Protein Zero, Myelin
% 209.88/210.05  |- mesh__historyNote mesh__D018993
% 209.88/210.05       96; was PROTEIN ZERO, PERIPHERAL NERVE MYELIN %28%NM%29% 1981-95%A%  
% 209.88/210.05  |- skos__hiddenLabel mesh__D018993 Protein, Myelin P0
% 209.88/210.05  |- skos__altLabel mesh__D018993 Protein Zero, Peripheral Nerve Myelin
% 209.88/210.05  |- mesh__dateRevised mesh__D018993 2005-06-30
% 209.88/210.05  |- mesh__recordMaintainer mesh__D018993 ssb
% 209.88/210.05  |- skos__scopeNote mesh__D018993
% 209.88/210.05       A protein that accounts for more than half of the peripheral nervous system myelin protein. The extracellular domain of this protein is believed to engage in adhesive interactions and thus hold the myelin membrane compact. It can behave as a homophilic adhesion molecule through interactions with its extracellular domains. %28%From J Cell Biol 1994;126%28%4%29%:1089-97%29%%A%    
% 209.88/210.05  |- skos__hiddenLabel mesh__D018993 P0 Protein, Myelin
% 209.88/210.05  |- skos__altLabel mesh__D018993 P0 Protein
% 209.88/210.05  |- skos__hiddenLabel mesh__D018993 Glycoprotein, P0
% 209.88/210.05  |- skos__prefLabel mesh__D018993 Myelin P0 Protein
% 209.88/210.05  |- skos__annotation mesh__D018993
% 209.88/210.05       0 in P0 is the digit, not the letter O; /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X ref%A%  
% 209.88/210.05  |- skos__broader mesh__D018993smesh__D009185
% 209.88/210.05  |- mesh__dateEstablished mesh__D018993 1996-01-01
% 209.88/210.05  |- mesh__recordOriginator mesh__D018993 TPW
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018993 2006
% 209.88/210.05  |- rdf__type mesh__D018993sskos__Concept
% 209.88/210.05  |- skos__related mesh__D018993smesh__D002607
% 209.88/210.05  |- mesh__onlineNote mesh__D018993
% 209.88/210.05       use MYELIN P0 PROTEIN %28%NM%29% to search PROTEIN ZERO, PERIPHERAL NERVE MYELIN 1981-95%A%  
% 209.88/210.05  |- skos__hiddenLabel mesh__D018993 Protein, P0
% 209.88/210.05  |- skos__broader mesh__D018993smesh__D015816
% 209.88/210.05  |- skos__broader mesh__D000990Q000172smesh__D000990
% 209.88/210.05  |- mesh__preferredCombination mesh__D000990Q000172smesh__D020152
% 209.88/210.05  |- rdf__type mesh__D000990Q000172smesh__CompoundConcept
% 209.88/210.05  |- skos__historyNote mesh__D018195
% 209.88/210.05       Neoplasms, Germ Cell and Embryonal %28%1977-1993%29%
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018195 2002
% 209.88/210.05  |- skos__hiddenLabel mesh__D018195 Adenosarcomas
% 209.88/210.05  |- skos__scopeNote mesh__D018195
% 209.88/210.05       A malignant neoplasm arising simultaneously or consecutively in mesodermal tissue and glandular epithelium of the same part. %28%Stedman, 25th ed%29%%A%    
% 209.88/210.05  |- mesh__recordAuthorizer mesh__D018195 PLS
% 209.88/210.05  |- skos__annotation mesh__D018195
% 209.88/210.05       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 209.88/210.05  |- mesh__historyNote mesh__D018195 94   
% 209.88/210.05  |- mesh__recordMaintainer mesh__D018195 KEV
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018195 2003
% 209.88/210.05  |- mesh__dateEstablished mesh__D018195 1994-01-01
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018195 1996
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018195 2000
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018195 2005
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018195 2004
% 209.88/210.05  |- mesh__recordOriginator mesh__D018195 PLS
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018195 1998
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018195 1997
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018195 2001
% 209.88/210.05  |- mesh__publicMeSHNote mesh__D018195 94   
% 209.88/210.05  |- mesh__dateRevised mesh__D018195 1995-06-08
% 209.88/210.05  |- skos__broader mesh__D018195smesh__D018193
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018195 2006
% 209.88/210.05  |- mesh__dateCreated mesh__D018195 1993-06-25
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D018195 1999
% 209.88/210.05  |- skos__historyNote mesh__D018195 Nephroblastoma %28%1966-1993%29%
% 209.88/210.05  |- rdf__type mesh__D018195sskos__Concept
% 209.88/210.05  |- skos__prefLabel mesh__D018195 Adenosarcoma
% 209.88/210.05  |- skos__broader mesh__D018195smesh__D012509
% 209.88/210.05  |- mesh__dateCreated mesh__D004973 1974-11-11
% 209.88/210.05  |- mesh__publicMeSHNote mesh__D004973 76; was see under ESTRUS 1975   
% 209.88/210.05  |- skos__hiddenLabel mesh__D004973 Synchronization, Estrus
% 209.88/210.05  |- skos__scopeNote mesh__D004973
% 209.88/210.05       Occurrence or induction of ESTRUS in all of the females in a group at the same time, applies only to non-primate mammals with ESTROUS CYCLE.%A%    
% 209.88/210.05  |- rdf__type mesh__D004973sskos__Concept
% 209.88/210.05  |- skos__hiddenLabel mesh__D004973 Synchronizations, Estrus
% 209.88/210.05  |- skos__hiddenLabel mesh__D004973 Estrus Synchronizations
% 209.88/210.05  |- skos__prefLabel mesh__D004973 Estrus Synchronization
% 209.88/210.05  |- mesh__recordOriginator mesh__D004973 NLM
% 209.88/210.05  |- mesh__recordMaintainer mesh__D004973 lkt
% 209.88/210.05  |- skos__historyNote mesh__D004973 Estrus %28%1966-1974%29%
% 209.88/210.05  |- mesh__historyNote mesh__D004973
% 209.88/210.05       76%28%75%29%; was see under ESTRUS 1975   
% 209.88/210.05  |- mesh__recordAuthorizer mesh__D004973 sjn
% 209.88/210.05  |- skos__broader mesh__D004973smesh__D004971
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D004973 2006
% 209.88/210.05  |- skos__broader mesh__D004973smesh__D001947
% 209.88/210.05  |- skos__annotation mesh__D004973 non-primate mammals only   
% 209.88/210.05  |- mesh__dateRevised mesh__D004973 2004-07-07
% 209.88/210.05  |- mesh__dateEstablished mesh__D004973 1976-01-01
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D004973 2005
% 209.88/210.05  |- skos__altLabel mesh__D051020 bcl-Xlong Protein
% 209.88/210.05  |- skos__hiddenLabel mesh__D051020 bcl XS Protein
% 209.88/210.05  |- mesh__historyNote mesh__D051020 2006%28%1993%29%   
% 209.88/210.05  |- mesh__recordOriginator mesh__D051020 DRC
% 209.88/210.05  |- skos__altLabel mesh__D051020 bcl2L1 Protein
% 209.88/210.05  |- skos__hiddenLabel mesh__D051020 bcl Xlong Protein
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D051020 2006A
% 209.88/210.05  |- mesh__dateEstablished mesh__D051020 2006-01-01
% 209.88/210.05  |- rdf__type mesh__D051020sskos__Concept
% 209.88/210.05  |- skos__hiddenLabel mesh__D051020 bcl Xbeta Protein
% 209.88/210.05  |- skos__prefLabel mesh__D051020 bcl-X Protein
% 209.88/210.05  |- skos__hiddenLabel mesh__D051020 bcl Xshort Protein
% 209.88/210.05  |- skos__altLabel mesh__D051020 bcl-Xa Protein
% 209.88/210.05  |- skos__altLabel mesh__D051020 bcl-Xb Protein
% 209.88/210.05  |- skos__altLabel mesh__D051020 bcl-X%28%S%29% Protein
% 209.88/210.05  |- skos__altLabel mesh__D051020 bcl-x%28%beta%29% Protein
% 209.88/210.05  |- skos__altLabel mesh__D051020 bcl2-Like 1 Protein
% 209.88/210.05  |- skos__hiddenLabel mesh__D051020 bcl Xa Protein
% 209.88/210.05  |- mesh__recordMaintainer mesh__D051020 ags
% 209.88/210.05  |- skos__altLabel mesh__D051020 bcl-Xshort Protein
% 209.88/210.05  |- skos__hiddenLabel mesh__D051020 bcl Xb Protein
% 209.88/210.05  |- mesh__recordAuthorizer mesh__D051020 ags
% 209.88/210.05  |- mesh__dateRevised mesh__D051020 2005-07-08
% 209.88/210.05  |- mesh__publicMeSHNote mesh__D051020
% 209.88/210.05       2006; BCL-X PROTEIN was indexed under PROTO-ONCOGENE PROTEINS 1993-2004, %26% under PROTO-ONCOGENE PROTEINS C-BCL-2 2005%A%  
% 209.88/210.05  |- skos__hiddenLabel mesh__D051020 bcl2 Like 1 Protein
% 209.88/210.05  |- skos__altLabel mesh__D051020 bcl-X%28%L%29% Protein
% 209.88/210.05  |- skos__hiddenLabel mesh__D051020 bcl X Protein
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D051020 2006
% 209.88/210.05  |- skos__scopeNote mesh__D051020
% 209.88/210.05       A member of the bcl-2 protein family that plays a role in the regulation of APOPTOSIS. Two major isoforms of the protein exist due to ALTERNATIVE SPLICING of the BCL2L1 mRNA and are referred to as Bcl-XS and Bcl-XL.%A%    
% 209.88/210.05  |- mesh__dateCreated mesh__D051020 2005-06-30
% 209.88/210.05  |- skos__hiddenLabel mesh__D051020 bcl XL Protein
% 209.88/210.05  |- skos__annotation mesh__D051020
% 209.88/210.05       Don%27%t confuse with the closely related BCL2-ASSOCIATED X PROTEIN%A%  
% 209.88/210.05  |- skos__hiddenLabel mesh__D051020 bcl Xalpha Protein
% 209.88/210.05  |- skos__broader mesh__D051020smesh__D019253
% 209.88/210.05  |- skos__prefLabel mesh__D004175 Diptera
% 209.88/210.05  |- mesh__recordMaintainer mesh__D004175 ags
% 209.88/210.05  |- skos__altLabel mesh__D004175 Flies, True
% 209.88/210.05  |- mesh__dateRevised mesh__D004175 2005-07-18
% 209.88/210.05  |- mesh__recordAuthorizer mesh__D004175 ags
% 209.88/210.05  |- skos__broader mesh__D004175smesh__D007313
% 209.88/210.05  |- rdf__type mesh__D004175sskos__Concept
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D004175 2006A
% 209.88/210.05  |- mesh__historyNote mesh__D004175
% 209.88/210.05       81, 63-74; FLIES was heading 1975-80; was see under DIPTERA 1963-74%A%  
% 209.88/210.05  |- mesh__publicMeSHNote mesh__D004175
% 209.88/210.05       81, 63-74; FLIES was heading 1975-80; was see under DIPTERA 1963-74; MIDGES %28%either MIDGES, BITING see CERATOPOGONIDAE or MIDGES, NONBITING see CHIRONOMIDAE as of 1981%29% was see under DIPTERA 1975-80; CERATOPOGONIDAE was see CULICOIDES 1975-80; CULICOIDES %28%see CERATOPOGONIDAE as of 1981%29% was heading 1963-80%A%  
% 209.88/210.05  |- skos__scopeNote mesh__D004175
% 209.88/210.05       An order of the class Insecta. Wings, when present, number two and distinguish Diptera from other so-called flies, while the halteres, or reduced hindwings, separate Diptera from other insects with one pair of wings. The order includes the families Calliphoridae, Oestridae, Phoridae, Sarcophagidae, Scatophagidae, Sciaridae, SIMULIIDAE, Tabanidae, Therevidae, Trypetidae, CERATOPOGONIDAE; CHIRONOMIDAE; CULICIDAE; DROSOPHILIDAE; GLOSSINIDAE; MUSCIDAE; TEPHRITIDAE; and PSYCHODIDAE. The larval form of Diptera species are called maggots %28%see LARVA%29%.%A%    
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D004175 2005
% 209.88/210.05  |- mesh__onlineNote mesh__D004175 use DIPTERA to search FLIES 1966-80   
% 209.88/210.05  |- mesh__recordOriginator mesh__D004175 NLM
% 209.88/210.05  |- skos__altLabel mesh__D004175 Flies
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D004175 2006
% 209.88/210.05  |- skos__annotation mesh__D004175
% 209.88/210.05       do not use /drug eff for insecticides; index caddisfly, dragonfly, mayfly %26% stonefly under INSECTS; FIREFLIES see BEETLES is available, sawfly %26% ichneumon fly under HYMENOPTERA; infestation by fly maggots = MYIASIS%A%  
% 209.88/210.05  |- mesh__dateCreated mesh__D004175 1999-01-01
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D012607 2003
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Scotomas, Altitudinal
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Central Scotoma
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D012607 2006
% 209.88/210.05  |- skos__prefLabel mesh__D012607 Scotoma
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Scotomas, Bjerrum
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Paracecal Scotoma
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Centrocecal Scotoma
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Scotomas
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Altitudinal Scotomas
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Paracentral Scotoma
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Scotomas, Paracecal
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Ring Scotomas
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D012607 2005
% 209.88/210.05  |- skos__broader mesh__D012607smesh__D014786
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Peripheral Scotoma
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Ring Scotoma
% 209.88/210.05  |- rdf__type mesh__D012607sskos__Concept
% 209.88/210.05  |- skos__annotation mesh__D012607
% 209.88/210.05       differentiate from physiol blind spot %28% = BLIND SPOT%29%   
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Scotomas, Scintillating
% 209.88/210.05  |- mesh__dateRevised mesh__D012607 2001-07-25
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Sector Scotomas
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Arcuate Scotomas
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Scintillating Scotoma
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Central Scotomas
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Peripheral Scotomas
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Centrocecal Scotomas
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Sector Scotoma
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Scotomas, Peripheral
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Bjerrum Scotomas
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Arcuate Scotoma
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Scotomas, Arcuate
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Scotomas, Centrocecal
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Scotomas, Central
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Scotomas, Ring
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Scotomas, Sector
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D012607 2004
% 209.88/210.05  |- mesh__recordAuthorizer mesh__D012607 sjn
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Scintillating Scotomas
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Scotomas, Paracentral
% 209.88/210.05  |- mesh__recordOriginator mesh__D012607 NLM
% 209.88/210.05  |- mesh__dateCreated mesh__D012607 1999-01-01
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Bjerrum Scotoma
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Paracecal Scotomas
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Altitudinal Scotoma
% 209.88/210.05  |- mesh__activeMeSHYear mesh__D012607 2002
% 209.88/210.05  |- skos__hiddenLabel mesh__D012607 Paracentral Scotomas
% 209.88/210.05  |- mesh__recordMaintainer mesh__D012607 mdb
% 209.88/210.05  |- skos__scopeNote mesh__D012607
% 209.88/210.05       A localized defect in the visual field bordered by an area of normal vision. This occurs with a variety of EYE DISEASES %28%e.g., RETINAL DISEASES and GLAUCOMA%29%; OPTIC NERVE DISEASES, and other conditions.%A%    
% 209.88/210.05  |- skos__related mesh__D008566smesh__D002462
% 209.88/210.05  |- skos__related mesh__D008566smesh__D002473
% 209.88/210.05  |- mesh__recordAuthorizer mesh__D008566 sjn
% 209.88/210.05  |- mesh__dateCreated mesh__D008566 1999-01-01
% 209.88/210.05  |- skos__related mesh__D008566smesh__D007425
% 209.88/210.05  |- mesh__publicMeSHNote mesh__D008566 68   
% 209.88/210.05  |- skos__related mesh__D008566smesh__D013583
% 209.88/210.05  |- skos__related mesh__D008566smesh__D008563
% 209.88/210.05  |- skos__annotation mesh__D008566
% 209.88/210.05       general; prefer specifics; almost never IM   
% 209.88/210.05  |- skos__related mesh__D008566smesh__D008565
% 209.88/210.05  |- skos__hiddenLabel mesh__D008566 Tissues, Membrane
% 209.88/210.05  |- skos__hiddenLabel mesh__D008566 Membrane
% 209.88/210.05  |- mesh__recordOriginator mesh__D008566 NLM
% 209.88/210.05  |- skos__hiddenLabel mesh__D008566 Membrane Tissues
% 209.88/210.05  |- mesh__dateRevised mesh__D008566 2005-06-30
% 209.88/210.06  |- skos__related mesh__D008566smesh__D009441
% 209.88/210.06  |- skos__related mesh__D008566smesh__D009685
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D008566 2006
% 209.88/210.06  |- mesh__historyNote mesh__D008566 68%28%66%29%   
% 209.88/210.06  |- skos__broader mesh__D008566smesh__D014024
% 209.88/210.06  |- skos__scopeNote mesh__D008566
% 209.88/210.06       Thin layers of tissue which cover parts of the body, separate adjacent cavities, or connect adjacent structures.%A%    
% 209.88/210.06  |- skos__prefLabel mesh__D008566 Membranes
% 209.88/210.06  |- skos__altLabel mesh__D008566 Membrane Tissue
% 209.88/210.06  |- mesh__recordMaintainer mesh__D008566 lkt
% 209.88/210.06  |- rdf__type mesh__D008566sskos__Concept
% 209.88/210.06  |- skos__hiddenLabel mesh__D008566 Tissue, Membrane
% 209.88/210.06  |- mesh__dateEstablished mesh__D008566 1968-01-01
% 209.88/210.06  |- skos__altLabel mesh__D000583 Mead Johnson Brand of Amikacin Sulfate
% 209.88/210.06  |- skos__hiddenLabel mesh__D000583
% 209.88/210.06       Bristol Myers Squibb Brand of Amikacin Sulfate
% 209.88/210.06  |- skos__altLabel mesh__D000583 Collins Brand of Amikacin Sulfate
% 209.88/210.06  |- skos__altLabel mesh__D000583 Lemery Brand of Amikacin Sulfate
% 209.88/210.06  |- skos__altLabel mesh__D000583 Amiklin
% 209.88/210.06  |- skos__altLabel mesh__D000583 Apothecon Brand of Amikacin Sulfate
% 209.88/210.06  |- skos__altLabel mesh__D000583 Biclin
% 209.88/210.06  |- skos__altLabel mesh__D000583 Fustery Brand of Amikacin Sulfate
% 209.88/210.06  |- skos__altLabel mesh__D000583 Cryopharma Brand of Amikacin Sulfate
% 209.88/210.06  |- skos__hiddenLabel mesh__D000583 BBK 8
% 209.88/210.06  |- skos__historyNote mesh__D000583 Kanamycin %28%1973-1974%29%
% 209.88/210.06  |- mesh__dateEstablished mesh__D000583 1987-01-01
% 209.88/210.06  |- mesh__historyNote mesh__D000583
% 209.88/210.06       87%28%75%29%; was see under KANAMYCIN 1975-86   
% 209.88/210.06  |- mesh__recordMaintainer mesh__D000583 CCR
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D000583 2006
% 209.88/210.06  |- mesh__dateCreated mesh__D000583 1974-11-19
% 209.88/210.06  |- skos__altLabel mesh__D000583 Grossmann Brand of Amikacin Sulfate
% 209.88/210.06  |- skos__hiddenLabel mesh__D000583 Medical, Amikacina
% 209.88/210.06  |- skos__historyNote mesh__D000583 Aminobutyric Acids %28%1973-1974%29%
% 209.88/210.06  |- skos__hiddenLabel mesh__D000583 BB K 8
% 209.88/210.06  |- rdf__type mesh__D000583sskos__Concept
% 209.88/210.06  |- skos__altLabel mesh__D000583 Norman Brand of Amikacin Sulfate
% 209.88/210.06  |- skos__altLabel mesh__D000583 Son%27%s Brand of Amikacin Sulfate
% 209.88/210.06  |- mesh__dateRevised mesh__D000583 2005-06-30
% 209.88/210.06  |- mesh__recordAuthorizer mesh__D000583 sjn
% 209.88/210.06  |- skos__altLabel mesh__D000583 Rovi Brand of Amikacin Sulfate
% 209.88/210.06  |- skos__altLabel mesh__D000583 Galen Brand of Amikacin Sulfate
% 209.88/210.06  |- skos__hiddenLabel mesh__D000583 Normon, Amikacina
% 209.88/210.06  |- skos__broader mesh__D000583smesh__D007612
% 209.88/210.06  |- mesh__recordOriginator mesh__D000583 NLM
% 209.88/210.06  |- skos__altLabel mesh__D000583 Amukin
% 209.88/210.06  |- mesh__publicMeSHNote mesh__D000583
% 209.88/210.06       87; was see under KANAMYCIN 1975-86   
% 209.88/210.06  |- skos__prefLabel mesh__D000583 Amikacin
% 209.88/210.06  |- skos__altLabel mesh__D000583
% 209.88/210.06       Bristol-Myers Squibb Brand of Amikacin Sulfate
% 209.88/210.06  |- skos__altLabel mesh__D000583 Medical Brand of Amikacin Sulfate
% 209.88/210.06  |- skos__altLabel mesh__D000583 Pisa Brand of Amikacin Sulfate
% 209.88/210.06  |- skos__scopeNote mesh__D000583
% 209.88/210.06       A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics.%A%    
% 209.88/210.06  |- skos__altLabel mesh__D000583 BB-K 8
% 209.88/210.06  |- skos__hiddenLabel mesh__D000583 BBK8
% 209.88/210.06  |- skos__altLabel mesh__D000583 Biklin
% 209.88/210.06  |- skos__hiddenLabel mesh__D000583 BB K8
% 209.88/210.06  |- skos__hiddenLabel mesh__D000583 Sulfate, Amikacin
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D013700 2002
% 209.88/210.06  |- skos__hiddenLabel mesh__D013700 Arteritides, Giant Cell
% 209.88/210.06  |- skos__altLabel mesh__D013700 Horton Disease
% 209.88/210.06  |- skos__prefLabel mesh__D013700 Temporal Arteritis
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D013700 2003
% 209.88/210.06  |- skos__altLabel mesh__D013700 Horton%27%s Giant Cell Arteritis
% 209.88/210.06  |- skos__broader mesh__D013700smesh__D017445
% 209.88/210.06  |- skos__altLabel mesh__D013700 Giant Cell Arteritis
% 209.88/210.06  |- skos__hiddenLabel mesh__D013700 Disease, Horton%27%s
% 209.88/210.06  |- skos__altLabel mesh__D013700 Aortitis, Giant Cell
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D013700 2006
% 209.88/210.06  |- mesh__recordOriginator mesh__D013700 NLM
% 209.88/210.06  |- skos__altLabel mesh__D013700 Giant Cell Aortitis, Horton%27%s
% 209.88/210.06  |- skos__hiddenLabel mesh__D013700 Disease, Horton
% 209.88/210.06  |- skos__altLabel mesh__D013700 Arteritis, Temporal
% 209.88/210.06  |- skos__hiddenLabel mesh__D013700 Arteritis, Cranial
% 209.88/210.06  |- skos__hiddenLabel mesh__D013700 Juvenile Temporal Arteritides
% 209.88/210.06  |- skos__broader mesh__D013700smesh__D020293
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D013700 2001
% 209.88/210.06  |- skos__altLabel mesh__D013700 Giant Cell Arteritis, Horton
% 209.88/210.06  |- skos__hiddenLabel mesh__D013700 Arteritis, Juvenile Temporal
% 209.88/210.06  |- skos__hiddenLabel mesh__D013700 Arteritides, Cranial
% 209.88/210.06  |- skos__altLabel mesh__D013700 Horton%27%s Disease
% 209.88/210.06  |- mesh__recordMaintainer mesh__D013700 KEV
% 209.88/210.06  |- skos__altLabel mesh__D013700 Giant Cell Aortic Arteritis
% 209.88/210.06  |- skos__altLabel mesh__D013700 Arteritis, Giant Cell, Horton
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D013700 2005
% 209.88/210.06  |- mesh__recordAuthorizer mesh__D013700 sjn
% 209.88/210.06  |- skos__related mesh__D013700smesh__D011111
% 209.88/210.06  |- skos__altLabel mesh__D013700 Arteritis, Giant Cell, Horton%27%s
% 209.88/210.06  |- skos__hiddenLabel mesh__D013700 Aortitides, Giant Cell
% 209.88/210.06  |- skos__hiddenLabel mesh__D013700 Hortons Disease
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D013700 2000
% 209.88/210.06  |- skos__hiddenLabel mesh__D013700 Temporal Arteritis, Juvenile
% 209.88/210.06  |- skos__hiddenLabel mesh__D013700 Temporal Arteritides
% 209.88/210.06  |- skos__hiddenLabel mesh__D013700 Arteritides, Juvenile Temporal
% 209.88/210.06  |- mesh__dateRevised mesh__D013700 1999-11-08
% 209.88/210.06  |- skos__hiddenLabel mesh__D013700 Cranial Arteritides
% 209.88/210.06  |- skos__hiddenLabel mesh__D013700 Giant Cell Aortitides
% 209.88/210.06  |- skos__altLabel mesh__D013700 Horton Giant Cell Arteritis
% 209.88/210.06  |- skos__altLabel mesh__D013700 Cranial Arteritis
% 209.88/210.06  |- skos__hiddenLabel mesh__D013700 Temporal Arteritides, Juvenile
% 209.88/210.06  |- skos__hiddenLabel mesh__D013700 Arteritis, Giant Cell
% 209.88/210.06  |- skos__hiddenLabel mesh__D013700 Arteritides, Temporal
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D013700 2004
% 209.88/210.06  |- skos__altLabel mesh__D013700 Giant Cell Aortitis
% 209.88/210.06  |- skos__hiddenLabel mesh__D013700 Giant Cell Arteritides
% 209.88/210.06  |- skos__scopeNote mesh__D013700
% 209.88/210.06       A systemic autoimmune vasculitis occurring primarily in people over the age of 50. Pathologic features include a necrotizing panarteritis including granulomas and giant cells. There is a predilection for involvement of central nervous system blood vessels and the most frequent neurologic complication is an OPTIC NEUROPATHY, ISCHEMIC. Large blood vessels may become involved, including the aorta. Clinical manifestations may include myalgias, weight loss, headache, visual loss, necrosis of the skin or tongue, and chest discomfort. Superficial scalp arteries may become tender and enlarged. A related condition, juvenile temporal arteritis, tends to occur in the first or second decade of life. %28%From Adams et al., Principles of Neurology, 6th ed, p856%29%%A%    
% 209.88/210.06  |- rdf__type mesh__D013700sskos__Concept
% 209.88/210.06  |- skos__broader mesh__D013700smesh__D001167
% 209.88/210.06  |- mesh__dateCreated mesh__D013700 1999-01-01
% 209.88/210.06  |- mesh__publicMeSHNote mesh__D018994
% 209.88/210.06       1996; for MYOSIN LIGHT CHAIN see MYOSINS 1982-1995; for MYOSIN ALKALI LIGHT CHAINS see MYOSINS 1990-1995%A%  
% 209.88/210.06  |- skos__scopeNote mesh__D018994
% 209.88/210.06       The smaller subunits of MYOSINS that bind near the head groups of MYOSIN HEAVY CHAINS.  The myosin light chains have a molecular weight of about 20 KDa and there are usually one essential and one regulatory pair of light chains associated with each heavy chain. Many myosin light chains that bind calcium are considered %22%calmodulin-like%22% proteins.%A%    
% 209.88/210.06  |- mesh__historyNote mesh__D018994
% 209.88/210.06       1996; for MYOSIN LIGHT CHAIN use MYOSINS 1982-1995; for MYOSIN ALKALI LIGHT CHAINS use MYOSINS 1990-1995%A%  
% 209.88/210.06  |- skos__broader mesh__D018994smesh__D002135
% 209.88/210.06  |- skos__altLabel mesh__D018994 Myosin Alkali Light Chains
% 209.88/210.06  |- mesh__recordOriginator mesh__D018994 TPW
% 209.88/210.06  |- mesh__recordMaintainer mesh__D018994 DRC
% 209.88/210.06  |- skos__historyNote mesh__D018994 Myosin %28%1969-1995%29%
% 209.88/210.06  |- mesh__recordAuthorizer mesh__D018994 sjn
% 209.88/210.06  |- skos__altLabel mesh__D018994 Myosin Regulatory Light Chains
% 209.88/210.06  |- skos__prefLabel mesh__D018994 Myosin Light Chains
% 209.88/210.06  |- skos__hiddenLabel mesh__D018994 Light Chain, Myosin
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018994 2006
% 209.88/210.06  |- mesh__dateCreated mesh__D018994 1995-06-05
% 209.88/210.06  |- rdf__type mesh__D018994sskos__Concept
% 209.88/210.06  |- skos__altLabel mesh__D018994 Myosin Essential Light Chain
% 209.88/210.06  |- mesh__dateRevised mesh__D018994 2005-06-30
% 209.88/210.06  |- skos__broader mesh__D018994smesh__D009218
% 209.88/210.06  |- skos__altLabel mesh__D018994 Myosin Alkali Light Chain
% 209.88/210.06  |- skos__hiddenLabel mesh__D018994 Light Chains, Myosin
% 209.88/210.06  |- mesh__dateEstablished mesh__D018994 1996-01-01
% 209.88/210.06  |- skos__altLabel mesh__D018994 Myosin Light Chain
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018196 1996
% 209.88/210.06  |- skos__scopeNote mesh__D018196
% 209.88/210.06       A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.%A%    
% 209.88/210.06  |- mesh__publicMeSHNote mesh__D018196 94   
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018196 2001
% 209.88/210.06  |- skos__annotation mesh__D018196
% 209.88/210.06       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with organ/neopl term %28%IM%29%%A%  
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018196 2005
% 209.88/210.06  |- mesh__dateCreated mesh__D018196 1993-06-25
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018196 2004
% 209.88/210.06  |- mesh__recordOriginator mesh__D018196 PLS
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018196 1998
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018196 1997
% 209.88/210.06  |- mesh__dateRevised mesh__D018196 1995-06-08
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018196 2006
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018196 1999
% 209.88/210.06  |- skos__hiddenLabel mesh__D018196 Adenosquamous Carcinoma
% 209.88/210.06  |- skos__historyNote mesh__D018196
% 209.88/210.06       Carcinoma, Squamous Cell %28%1968-1993%29%
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018196 2002
% 209.88/210.06  |- rdf__type mesh__D018196sskos__Concept
% 209.88/210.06  |- mesh__dateEstablished mesh__D018196 1994-01-01
% 209.88/210.06  |- mesh__recordAuthorizer mesh__D018196 PLS
% 209.88/210.06  |- skos__prefLabel mesh__D018196 Carcinoma, Adenosquamous
% 209.88/210.06  |- skos__hiddenLabel mesh__D018196 Adenosquamous Carcinomas
% 209.88/210.06  |- skos__historyNote mesh__D018196 Adenocarcinoma %28%1968-1993%29%
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018196 2000
% 209.88/210.06  |- skos__broader mesh__D018196smesh__D018193
% 209.88/210.06  |- skos__broader mesh__D018196smesh__D002277
% 209.88/210.06  |- mesh__historyNote mesh__D018196 94   
% 209.88/210.06  |- skos__hiddenLabel mesh__D018196 Carcinomas, Adenosquamous
% 209.88/210.06  |- mesh__recordMaintainer mesh__D018196 KEV
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018196 2003
% 209.88/210.06  |- mesh__historyNote mesh__D004974
% 209.88/210.06       91%28%80%29%; was see under NICOTINIC ACIDS 1980-90; was SQ 20009 see under NICOTINIC ACIDS 1976-79%A%  
% 209.88/210.06  |- rdf__type mesh__D004974sskos__Concept
% 209.88/210.06  |- mesh__recordOriginator mesh__D004974 RLS
% 209.88/210.06  |- mesh__onlineNote mesh__D004974
% 209.88/210.06       use ETAZOLATE to search SQ 20009 1976-79   
% 209.88/210.06  |- mesh__publicMeSHNote mesh__D004974
% 209.88/210.06       91; was see under NICOTINIC ACIDS 1980-90; was SQ 20009 see under NICOTINIC ACIDS 1976-79%A%  
% 209.88/210.06  |- skos__historyNote mesh__D004974 Hydrazines %28%1973-1975%29%
% 209.88/210.06  |- skos__prefLabel mesh__D004974 Etazolate
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D004974 2004
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D004974 2002
% 209.88/210.06  |- skos__historyNote mesh__D004974 Pyrazoles %28%1973-1975%29%
% 209.88/210.06  |- mesh__dateEstablished mesh__D004974 1991-01-01
% 209.88/210.06  |- skos__scopeNote mesh__D004974
% 209.88/210.06       A potent phosphodiesterase inhibitor proposed as an antipsychotic agent.%A%    
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D004974 2003
% 209.88/210.06  |- mesh__dateRevised mesh__D004974 2000-06-21
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D004974 2006
% 209.88/210.06  |- skos__historyNote mesh__D004974 Nicotinic Acids %28%1975%29%
% 209.88/210.06  |- skos__hiddenLabel mesh__D004974 SQ20009
% 209.88/210.06  |- skos__hiddenLabel mesh__D004974 SQ 20009
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D004974 2001
% 209.88/210.06  |- mesh__dateCreated mesh__D004974 1975-07-25
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D004974 2005
% 209.88/210.06  |- skos__historyNote mesh__D004974 Pyridines %28%1973-1974%29%
% 209.88/210.06  |- skos__broader mesh__D004974smesh__D009539
% 209.88/210.06  |- skos__hiddenLabel mesh__D004974 Hydrochloride, Etazolate
% 209.88/210.06  |- mesh__recordAuthorizer mesh__D004974 sjn
% 209.88/210.06  |- mesh__recordMaintainer mesh__D004974 jmp
% 209.88/210.06  |- mesh__recordAuthorizer mesh__D004176 sjn
% 209.88/210.06  |- skos__broader mesh__D004176smesh__D011743
% 209.88/210.06  |- skos__altLabel mesh__D004176 Curantyl
% 209.88/210.06  |- skos__altLabel mesh__D004176 Belmac Brand of Dipyridamole
% 209.88/210.06  |- skos__altLabel mesh__D004176 Ashbourne Brand of Dipyridamole
% 209.88/210.06  |- rdf__type mesh__D004176sskos__Concept
% 209.88/210.06  |- mesh__dateEstablished mesh__D004176 1966-01-01
% 209.88/210.06  |- mesh__publicMeSHNote mesh__D004176 66; was PERSANTIN 1963-65   
% 209.88/210.06  |- skos__prefLabel mesh__D004176 Dipyridamole
% 209.88/210.06  |- skos__altLabel mesh__D004176 IPRAD Brand of Dipyridamole
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D004176 2006
% 209.88/210.06  |- skos__altLabel mesh__D004176 Novopharm Brand of Dipyridamole
% 209.88/210.06  |- skos__altLabel mesh__D004176 Apotex Brand of Dipyridamole
% 209.88/210.06  |- mesh__historyNote mesh__D004176 66; was PERSANTIN 1963-65   
% 209.88/210.06  |- skos__altLabel mesh__D004176 Boehringer Ingelheim Brand of Dipyridamole
% 209.88/210.06  |- skos__altLabel mesh__D004176 Persantin
% 209.88/210.06  |- mesh__dateRevised mesh__D004176 2005-06-30
% 209.88/210.06  |- mesh__dateCreated mesh__D004176 1999-01-01
% 209.88/210.06  |- skos__altLabel mesh__D004176 Dipyramidole
% 209.88/210.06  |- skos__altLabel mesh__D004176 Kurantil
% 209.88/210.06  |- skos__hiddenLabel mesh__D004176 Berlin Chemie Brand of Dipyridamole
% 209.88/210.06  |- skos__scopeNote mesh__D004176
% 209.88/210.06       A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. %28%From AMA Drug Evaluations Annual, 1994, p752%29%%A%    
% 209.88/210.06  |- mesh__recordMaintainer mesh__D004176 exl
% 209.88/210.06  |- mesh__recordOriginator mesh__D004176 NLM
% 209.88/210.06  |- skos__altLabel mesh__D004176 Berlin-Chemie Brand of Dipyridamole
% 209.88/210.06  |- rdf__type mesh__D012608sskos__Concept
% 209.88/210.06  |- skos__related mesh__D012608smesh__D017096
% 209.88/210.06  |- skos__broader mesh__D012608smesh__D017096
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D012608 2001
% 209.88/210.06  |- skos__related mesh__D012608smesh__D011328
% 209.88/210.06  |- mesh__recordOriginator mesh__D012608 NLM
% 209.88/210.06  |- skos__annotation mesh__D012608
% 209.88/210.06       a prion dis; usually animal: check tag ANIMAL; if in sheep, coord IM with SHEEP %28%NIM%29% but do not index under SHEEP DISEASES; if in goats, coord IM with GOAT DISEASES %28%IM%29% %26% GOATS %28%NIM%29%%A%  
% 209.88/210.06  |- mesh__dateEstablished mesh__D012608 1968-01-01
% 209.88/210.06  |- mesh__publicMeSHNote mesh__D012608 68   
% 209.88/210.06  |- mesh__dateCreated mesh__D012608 1999-01-01
% 209.88/210.06  |- skos__related mesh__D012608smesh__D018620
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D012608 2000
% 209.88/210.06  |- mesh__dateRevised mesh__D012608 1999-11-08
% 209.88/210.06  |- skos__altLabel mesh__D012608 Rida
% 209.88/210.06  |- mesh__recordAuthorizer mesh__D012608 sjn
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D012608 2004
% 209.88/210.06  |- mesh__recordMaintainer mesh__D012608 KEV
% 209.88/210.06  |- skos__prefLabel mesh__D012608 Scrapie
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D012608 2006
% 209.88/210.06  |- skos__scopeNote mesh__D012608
% 209.88/210.06       A fatal disease of the nervous system in sheep and goats, characterized by pruritus, debility, and locomotor incoordination. It is caused by proteinaceous infectious particles called PRIONS.%A%    
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D012608 2003
% 209.88/210.06  |- skos__broader mesh__D012608smesh__D012757
% 209.88/210.06  |- mesh__historyNote mesh__D012608 68%28%66%29%   
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D012608 2002
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D012608 2005
% 209.88/210.06  |- skos__prefLabel mesh__D050727 Benzaldehyde Dehydrogenase %28%NADP+%29%
% 209.88/210.06  |- skos__altLabel mesh__D050727 NADP-Linked Benzaldehyde Dehydrogenase
% 209.88/210.06  |- mesh__historyNote mesh__D050727
% 209.88/210.06       2006%28%1980%29%; use ALDEHYDE OXIDOREDUCTASES 1978-1979   
% 209.88/210.06  |- mesh__recordOriginator mesh__D050727 AKE
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D050727 2006
% 209.88/210.06  |- mesh__publicMeSHNote mesh__D050727
% 209.88/210.06       2006; BENZALDEHYDE DEHYDROGENASE %28%NADP+%29% was indexed under ALDEHYDE OXIDOREDUCTASES 1978-2005%A%  
% 209.88/210.06  |- skos__hiddenLabel mesh__D050727 Benzaldehyde Dehydrogenase, NADP-Linked
% 209.88/210.06  |- skos__hiddenLabel mesh__D050727 NADP Linked Benzaldehyde Dehydrogenase
% 209.88/210.06  |- skos__hiddenLabel mesh__D050727 Dehydrogenase, NADP-Linked Benzaldehyde
% 209.88/210.06  |- mesh__dateEstablished mesh__D050727 2006-01-01
% 209.88/210.06  |- rdf__type mesh__D050727sskos__Concept
% 209.88/210.06  |- skos__altLabel mesh__D050727 Benzaldehyde Dehydrogenase %28%NADP%29%
% 209.88/210.06  |- skos__broader mesh__D050727smesh__D000445
% 209.88/210.06  |- mesh__recordAuthorizer mesh__D050727 sjn
% 209.88/210.06  |- skos__scopeNote mesh__D050727
% 209.88/210.06       An NADP+ dependent enzyme that catalyzes the oxidation of BENZALDEHYDE to BENZOIC ACID. It also plays a role in the degradation of TOLUENE and XYLENE.%A%    
% 209.88/210.06  |- mesh__recordMaintainer mesh__D050727 AKE
% 209.88/210.06  |- mesh__dateCreated mesh__D050727 2005-06-30
% 209.88/210.06  |- skos__prefLabel mesh__D008567 Membranes, Artificial
% 209.88/210.06  |- mesh__publicMeSHNote mesh__D008567 68   
% 209.88/210.06  |- mesh__recordMaintainer mesh__D008567 nns
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D008567 2005
% 209.88/210.06  |- skos__broader mesh__D008567smesh__D001697
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D008567 2006
% 209.88/210.06  |- mesh__recordAuthorizer mesh__D008567 sjn
% 209.88/210.06  |- mesh__dateEstablished mesh__D008567 1968-01-01
% 209.88/210.06  |- mesh__dateRevised mesh__D008567 2004-07-07
% 209.88/210.06  |- skos__altLabel mesh__D008567 Artificial Membranes
% 209.88/210.06  |- skos__hiddenLabel mesh__D008567 Artificial Membrane
% 209.88/210.06  |- skos__scopeNote mesh__D008567
% 209.88/210.06       Artificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis %28%RENAL DIALYSIS%29%, monomolecular and bimolecular membranes used as models to simulate biological CELL MEMBRANES. These membranes are also used in the process of GUIDED TISSUE REGENERATION.%A%    
% 209.88/210.06  |- skos__broader mesh__D008567smesh__D040761
% 209.88/210.06  |- mesh__dateCreated mesh__D008567 1999-01-01
% 209.88/210.06  |- mesh__recordOriginator mesh__D008567 NLM
% 209.88/210.06  |- rdf__type mesh__D008567sskos__Concept
% 209.88/210.06  |- skos__hiddenLabel mesh__D008567 Membrane, Artificial
% 209.88/210.06  |- mesh__historyNote mesh__D008567 68%28%66%29%   
% 209.88/210.06  |- skos__altLabel mesh__D000584 Amrad Brand of Amiloride Hydrochloride
% 209.88/210.06  |- skos__hiddenLabel mesh__D000584 Hydrochloride, Amiloride
% 209.88/210.06  |- rdf__type mesh__D000584sskos__Concept
% 209.88/210.06  |- skos__prefLabel mesh__D000584 Amiloride
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D000584 2006
% 209.88/210.06  |- mesh__dateRevised mesh__D000584 2005-06-30
% 209.88/210.06  |- skos__hiddenLabel mesh__D000584 Anhydrous Amiloride Hydrochloride
% 209.88/210.06  |- skos__altLabel mesh__D000584 Modamide
% 209.88/210.06  |- skos__altLabel mesh__D000584 Douglas Brand of Amiloride Hydrochloride
% 209.88/210.06  |- skos__altLabel mesh__D000584
% 209.88/210.06       Cahill May Roberts Brand of Amiloride Hydrochloride
% 209.88/210.06  |- skos__broader mesh__D000584smesh__D011719
% 209.88/210.06  |- skos__historyNote mesh__D000584 Diuretics %28%1966-1971%29%
% 209.88/210.06  |- skos__altLabel mesh__D000584
% 209.88/210.06       Trommsdorff Brand of Amiloride Hydrochloride
% 209.88/210.06  |- skos__altLabel mesh__D000584 Merck Brand of Amiloride Hydrochloride
% 209.88/210.06  |- mesh__dateCreated mesh__D000584 1999-01-01
% 209.88/210.06  |- mesh__dateEstablished mesh__D000584 1986-01-01
% 209.88/210.06  |- mesh__historyNote mesh__D000584
% 209.88/210.06       86%28%72%29%; was see under PYRAZINES 1975-85, was Prov 1972-74%A%  
% 209.88/210.06  |- skos__hiddenLabel mesh__D000584 Trom, Amiduret
% 209.88/210.06  |- skos__altLabel mesh__D000584 Berolina Brand of Amiloride Hydrochloride
% 209.88/210.06  |- mesh__recordOriginator mesh__D000584 NLM
% 209.88/210.06  |- mesh__recordMaintainer mesh__D000584 ssb
% 209.88/210.06  |- skos__altLabel mesh__D000584 Alphapharm Brand of Amiloride Hydrochloride
% 209.88/210.06  |- mesh__publicMeSHNote mesh__D000584
% 209.88/210.06       86; was see under PYRAZINES 1975-85   
% 209.88/210.06  |- mesh__recordAuthorizer mesh__D000584 sjn
% 209.88/210.06  |- skos__hiddenLabel mesh__D000584 Hydrochloride, Anhydrous Amiloride
% 209.88/210.06  |- skos__altLabel mesh__D000584
% 209.88/210.06       Merck Sharp %26% Dohme Brand of Amiloride Hydrochloride
% 209.88/210.06  |- skos__scopeNote mesh__D000584
% 209.88/210.06       A pyrazine compound inhibiting SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS. This inhibition creates a negative potential in the luminal membranes of principal cells, located in the distal convoluted tubule and collecting duct. Negative potential reduces secretion of potassium and hydrogen ions. Amiloride is used in conjunction with DIURETICS to spare POTASSIUM loss. %28%From Gilman et al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 9th ed, p705%29%%A%    
% 209.88/210.06  |- skos__historyNote mesh__D000584 Pyrazines %28%1966-1971%29%
% 209.88/210.06  |- mesh__recordOriginator mesh__D027721 ssb
% 209.88/210.06  |- mesh__dateRevised mesh__D027721 2002-07-02
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D027721 2003
% 209.88/210.06  |- mesh__historyNote mesh__D027721 2002   
% 209.88/210.06  |- skos__prefLabel mesh__D027721 Amaranthus
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D027721 2006
% 209.88/210.06  |- mesh__recordAuthorizer mesh__D027721 sjn
% 209.88/210.06  |- mesh__recordMaintainer mesh__D027721 ssb
% 209.88/210.06  |- skos__scopeNote mesh__D027721
% 209.88/210.06       A plant genus, in the family AMARANTHACEAE, best known as a source of high-protein grain crops and of Red Dye No. 2 %28%AMARANTH DYE%29%. Tumbleweed sometimes refers to Amaranthus but more often refers to SALSOLA.%A%    
% 209.88/210.06  |- skos__historyNote mesh__D027721 Amaranth Dye %28%1988-2001%29%
% 209.88/210.06  |- skos__broader mesh__D027721smesh__D027703
% 209.88/210.06  |- mesh__dateEstablished mesh__D027721 2002-01-01
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D027721 2005
% 209.88/210.06  |- mesh__publicMeSHNote mesh__D027721 2002   
% 209.88/210.06  |- skos__historyNote mesh__D027721 Phytotherapy %28%1981-2001%29%
% 209.88/210.06  |- mesh__dateCreated mesh__D027721 2001-07-25
% 209.88/210.06  |- rdf__type mesh__D027721sskos__Concept
% 209.88/210.06  |- skos__annotation mesh__D027721
% 209.88/210.06       X ref REDROOT PIGWEED: REDROOT see SANGUINARIA is also available; AMARANTH DYE is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.88/210.06  |- skos__altLabel mesh__D027721 Amaranth Plant
% 209.88/210.06  |- skos__historyNote mesh__D027721 Cereals %28%1980-2001%29%
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D027721 2004
% 209.88/210.06  |- skos__hiddenLabel mesh__D013701 Temporal Bones
% 209.88/210.06  |- skos__hiddenLabel mesh__D013701 Bone, Temporal
% 209.88/210.06  |- skos__related mesh__D013701smesh__D007758
% 209.88/210.06  |- mesh__recordAuthorizer mesh__D013701 NLM
% 209.88/210.06  |- skos__broader mesh__D013701smesh__D012886
% 209.88/210.06  |- mesh__recordOriginator mesh__D013701 NLM
% 209.88/210.06  |- skos__prefLabel mesh__D013701 Temporal Bone
% 209.88/210.06  |- mesh__recordMaintainer mesh__D013701 NLM
% 209.88/210.06  |- mesh__dateCreated mesh__D013701 1999-01-01
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D013701 2006
% 209.88/210.06  |- mesh__dateRevised mesh__D013701 2005-07-06
% 209.88/210.06  |- rdf__type mesh__D013701sskos__Concept
% 209.88/210.06  |- skos__hiddenLabel mesh__D013701 Bones, Temporal
% 209.88/210.06  |- skos__annotation mesh__D013701
% 209.88/210.06       fractures: coord TEMPORAL BONE /inj %28%IM%29% + SKULL FRACTURES %28%IM%29%; neopl: coord IM with SKULL NEOPLASMS %28%IM%29%%A%  
% 209.88/210.06  |- skos__prefLabel mesh__D018995 Myosin Heavy Chains
% 209.88/210.06  |- mesh__dateRevised mesh__D018995 2005-06-30
% 209.88/210.06  |- mesh__dateEstablished mesh__D018995 1996-01-01
% 209.88/210.06  |- skos__hiddenLabel mesh__D018995 Heavy Chains, Myosin
% 209.88/210.06  |- skos__historyNote mesh__D018995 Myosin %28%1971-1995%29%
% 209.88/210.06  |- skos__scopeNote mesh__D018995
% 209.88/210.06       The larger subunits of MYOSINS. The heavy chains have a molecular weight of about 230 kDa and each heavy chain is usually associated with a dissimilar pair of MYOSIN LIGHT CHAINS.%A%    
% 209.88/210.06  |- mesh__recordOriginator mesh__D018995 TPW
% 209.88/210.06  |- mesh__dateCreated mesh__D018995 1995-06-05
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018995 2006
% 209.88/210.06  |- rdf__type mesh__D018995sskos__Concept
% 209.88/210.06  |- mesh__recordMaintainer mesh__D018995 DRC
% 209.88/210.06  |- skos__broader mesh__D018995smesh__D009218
% 209.88/210.06  |- mesh__recordAuthorizer mesh__D018995 sjn
% 209.88/210.06  |- mesh__publicMeSHNote mesh__D018995
% 209.88/210.06       1996; for MYOSIN HEAVY CHAIN see MYOSINS 1982-1995   
% 209.88/210.06  |- skos__altLabel mesh__D018995 Myosin Heavy Chain
% 209.88/210.06  |- skos__hiddenLabel mesh__D018995 Heavy Chain, Myosin
% 209.88/210.06  |- mesh__historyNote mesh__D018995
% 209.88/210.06       1996; for MYOSIN HEAVY CHAIN use MYOSINS 1982-1995   
% 209.88/210.06  |- mesh__dateCreated mesh__D051820 2005-06-30
% 209.88/210.06  |- mesh__historyNote mesh__D051820 2006   
% 209.88/210.06  |- skos__hiddenLabel mesh__D051820 Transcription Factors, LEF
% 209.88/210.06  |- mesh__recordMaintainer mesh__D051820 DRC
% 209.88/210.06  |- skos__hiddenLabel mesh__D051820 Transcription Factors, TCF
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D051820 2006
% 209.88/210.06  |- skos__broader mesh__D051820smesh__D004268
% 209.88/210.06  |- skos__broader mesh__D051820smesh__D014157
% 209.88/210.06  |- rdf__type mesh__D051820sskos__Concept
% 209.88/210.06  |- mesh__publicMeSHNote mesh__D051820 2006   
% 209.88/210.06  |- mesh__recordAuthorizer mesh__D051820 sjn
% 209.88/210.06  |- skos__altLabel mesh__D051820 Lymphoid Enhancer Factors
% 209.88/210.06  |- mesh__dateEstablished mesh__D051820 2006-01-01
% 209.88/210.06  |- skos__altLabel mesh__D051820 LEF Transcription Factors
% 209.88/210.06  |- skos__altLabel mesh__D051820 T-Cell Factors
% 209.88/210.06  |- skos__scopeNote mesh__D051820
% 209.88/210.06       A family of DNA-binding proteins that are primarily expressed in T-LYMPHOCYTES. They interact with BETA CATENIN and serve as transcriptional activators and repressors in a variety of developmental processes.%A%    
% 209.88/210.06  |- skos__broader mesh__D051820smesh__D006609
% 209.88/210.06  |- skos__hiddenLabel mesh__D051820 T Cell Factors
% 209.88/210.06  |- skos__prefLabel mesh__D051820 TCF Transcription Factors
% 209.88/210.06  |- mesh__recordOriginator mesh__D051820 DRC
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018197 1997
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018197 1998
% 209.88/210.06  |- mesh__recordOriginator mesh__D018197 PLS
% 209.88/210.06  |- mesh__dateRevised mesh__D018197 1995-06-08
% 209.88/210.06  |- skos__broader mesh__D018197smesh__D018193
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018197 2006
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018197 1999
% 209.88/210.06  |- mesh__publicMeSHNote mesh__D018197 94   
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018197 2001
% 209.88/210.06  |- skos__scopeNote mesh__D018197
% 209.88/210.06       A malignant neoplasm occurring in young children, primarily in the liver, composed of tissue resembling embryonal or fetal hepatic epithelium, or mixed epithelial and mesenchymal tissues. %28%Stedman, 25th ed%29%%A%    
% 209.88/210.06  |- rdf__type mesh__D018197sskos__Concept
% 209.88/210.06  |- mesh__dateCreated mesh__D018197 1993-06-25
% 209.88/210.06  |- skos__historyNote mesh__D018197
% 209.88/210.06       Carcinoma, Hepatocellular %28%1966-1993%29%
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018197 2002
% 209.88/210.06  |- mesh__recordMaintainer mesh__D018197 KEV
% 209.88/210.06  |- mesh__historyNote mesh__D018197 94   
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018197 2003
% 209.88/210.06  |- mesh__recordAuthorizer mesh__D018197 PLS
% 209.88/210.06  |- mesh__dateEstablished mesh__D018197 1994-01-01
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018197 1996
% 209.88/210.06  |- skos__prefLabel mesh__D018197 Hepatoblastoma
% 209.88/210.06  |- skos__hiddenLabel mesh__D018197 Hepatoblastomas
% 209.88/210.06  |- skos__annotation mesh__D018197
% 209.88/210.06       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with LIVER NEOPLASMS %28%IM%29%%A%  
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018197 2004
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018197 2005
% 209.88/210.06  |- mesh__activeMeSHYear mesh__D018197 2000
% 209.88/210.06  |- mesh__recordMaintainer mesh__D004975 CCR
% 209.88/210.06  |- skos__hiddenLabel mesh__D004975 Monohydrate, Ethacridine
% 209.88/210.06  |- skos__historyNote mesh__D004975 Diamines %28%1973-1974%29%
% 209.88/210.06  |- rdf__type mesh__D004975sskos__Concept
% 209.88/210.06  |- skos__hiddenLabel mesh__D004975 Monohydrate Ethacridine Lactate
% 209.88/210.06  |- skos__altLabel mesh__D004975 Fresenius Brand of Ethacridine Lactate
% 209.88/210.06  |- mesh__recordOriginator mesh__D004975 NLM
% 209.88/210.06  |- skos__altLabel mesh__D004975 Chinosol Brand of Ethacridine Lactate
% 209.88/210.06  |- skos__altLabel mesh__D004975 Acrinol
% 209.88/210.06  |- mesh__recordAuthorizer mesh__D004975 sjn
% 209.88/210.06  |- skos__prefLabel mesh__D004975 Ethacridine
% 209.88/210.07  |- skos__hiddenLabel mesh__D004975
% 209.88/210.07       Cassella med Brand of Ethacridine Lactate
% 209.88/210.07  |- skos__altLabel mesh__D004975 2,5-Diamino-7-ethoxyacridine
% 209.88/210.07  |- skos__hiddenLabel mesh__D004975 2,5 Diamino 7 ethoxyacridine
% 209.88/210.07  |- mesh__dateCreated mesh__D004975 1974-11-11
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D004975 2006
% 209.88/210.07  |- skos__altLabel mesh__D004975 Neo Chinosol
% 209.88/210.07  |- mesh__publicMeSHNote mesh__D004975
% 209.88/210.07       91; was see under ACRIDINES 1975-90   
% 209.88/210.07  |- mesh__dateRevised mesh__D004975 2005-06-30
% 209.88/210.07  |- skos__historyNote mesh__D004975 Lactates %28%1968-1974%29%
% 209.88/210.07  |- skos__altLabel mesh__D004975 Cassella-med Brand of Ethacridine Lactate
% 209.88/210.07  |- skos__scopeNote mesh__D004975
% 209.88/210.07       A topically applied anti-infective agent.     
% 209.88/210.07  |- mesh__dateEstablished mesh__D004975 1991-01-01
% 209.88/210.07  |- skos__historyNote mesh__D004975 Acridines %28%1968-1974%29%
% 209.88/210.07  |- mesh__historyNote mesh__D004975
% 209.88/210.07       91%28%75%29%; was see under ACRIDINES 1975-90   
% 209.88/210.07  |- skos__hiddenLabel mesh__D004975 Lactate, Ethacridine
% 209.88/210.07  |- skos__broader mesh__D004975smesh__D000609
% 209.88/210.07  |- skos__altLabel mesh__D004177 Metamizole
% 209.88/210.07  |- mesh__dateRevised mesh__D004177 2005-06-30
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D004177 2006
% 209.88/210.07  |- mesh__historyNote mesh__D004177
% 209.88/210.07       91%28%75%29%; was see under AMINOPYRINE 1975-90   
% 209.88/210.07  |- skos__altLabel mesh__D004177 Methamizole
% 209.88/210.07  |- mesh__dateCreated mesh__D004177 1974-11-19
% 209.88/210.07  |- skos__historyNote mesh__D004177 Antipyrine %28%1972-1974%29%
% 209.88/210.07  |- skos__hiddenLabel mesh__D004177 Methanesulfonate, Noramidopyrine
% 209.88/210.07  |- skos__altLabel mesh__D004177 Dipyronium
% 209.88/210.07  |- skos__broader mesh__D004177smesh__D000632
% 209.88/210.07  |- skos__annotation mesh__D004177
% 209.88/210.07       a non-steroidal anti-inflamm agent; do not confuse with DIPYRINE see AMINOPYRINE, also an non-steroidal anti-inflamm agent%A%  
% 209.88/210.07  |- mesh__recordOriginator mesh__D004177 NLM
% 209.88/210.07  |- skos__scopeNote mesh__D004177
% 209.88/210.07       A drug that has analgesic, anti-inflammatory, and antipyretic properties. It is the sodium sulfonate of AMINOPYRINE. Because of the risk of serious adverse effects its use is justified only in serious situations where no alternative is available or suitable. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p13%29%%A%    
% 209.88/210.07  |- mesh__recordAuthorizer mesh__D004177 sjn
% 209.88/210.07  |- skos__hiddenLabel mesh__D004177 Methanesulfonate Sodium, Noramidopyrine
% 209.88/210.07  |- mesh__publicMeSHNote mesh__D004177
% 209.88/210.07       91; was see under AMINOPYRINE 1975-90   
% 209.88/210.07  |- skos__historyNote mesh__D004177 Methanesulfonates %28%1974%29%
% 209.88/210.07  |- skos__altLabel mesh__D004177 Noramidopyrine Methanesulfonate Sodium
% 209.88/210.07  |- skos__altLabel mesh__D004177 Methampyrone
% 209.88/210.07  |- skos__altLabel mesh__D004177 Metamizol
% 209.88/210.07  |- skos__prefLabel mesh__D004177 Dipyrone
% 209.88/210.07  |- rdf__type mesh__D004177sskos__Concept
% 209.88/210.07  |- mesh__dateEstablished mesh__D004177 1991-01-01
% 209.88/210.07  |- skos__altLabel mesh__D004177 Novamidazophen
% 209.88/210.07  |- mesh__recordMaintainer mesh__D004177 ssb
% 209.88/210.07  |- rdf__type mesh__D009660sskos__Concept
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D009660 1998
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D009660 2000
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D009660 1994
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D009660 2003
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D009660 1999
% 209.88/210.07  |- mesh__recordMaintainer mesh__D009660 PLS
% 209.88/210.07  |- mesh__dateCreated mesh__D009660 1999-01-01
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D009660 2001
% 209.88/210.07  |- skos__prefLabel mesh__D009660 Northern Ireland
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D009660 1995
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D009660 2004
% 209.88/210.07  |- mesh__recordAuthorizer mesh__D009660 PLS
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D009660 2002
% 209.88/210.07  |- mesh__recordOriginator mesh__D009660 NLM
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D009660 1996
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D009660 2005
% 209.88/210.07  |- mesh__dateRevised mesh__D009660 1993-06-03
% 209.88/210.07  |- skos__annotation mesh__D009660
% 209.88/210.07       capital, Belfast; differentiate from IRELAND %28%Irish Free State, Eire%29%%A%  
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D009660 1997
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D009660 2006
% 209.88/210.07  |- skos__broader mesh__D009660smesh__D006113
% 209.88/210.07  |- skos__scopeNote mesh__D050728
% 209.88/210.07       An NAD+ dependent enzyme that catalyzes the oxidation of betain aldehyde to BETAINE.%A%    
% 209.88/210.07  |- mesh__recordAuthorizer mesh__D050728 sjn
% 209.88/210.07  |- mesh__publicMeSHNote mesh__D050728
% 209.88/210.07       2006; BETAINE-ALDEHYDE DEHYDROGENASE was indexed under ALDEHYDE OXIDOREDUCTASES 1979-2005, %26% under NAD, OXIDOREDUCTASES %26% ALDEHYDES 1972-1978%A%  
% 209.88/210.07  |- skos__prefLabel mesh__D050728 Betaine-Aldehyde Dehydrogenase
% 209.88/210.07  |- skos__hiddenLabel mesh__D050728 Aldehyde Oxidase, Betaine
% 209.88/210.07  |- skos__hiddenLabel mesh__D050728 Oxidase, Betaine Aldehyde
% 209.88/210.07  |- mesh__dateCreated mesh__D050728 2005-06-30
% 209.88/210.07  |- skos__hiddenLabel mesh__D050728 Dehydrogenase, Betaine Aldehyde
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D050728 2006
% 209.88/210.07  |- skos__hiddenLabel mesh__D050728 Dehydrogenase, Betaine-Aldehyde
% 209.88/210.07  |- mesh__recordOriginator mesh__D050728 AKE
% 209.88/210.07  |- skos__altLabel mesh__D050728 Betaine Aldehyde Dehydrogenase
% 209.88/210.07  |- rdf__type mesh__D050728sskos__Concept
% 209.88/210.07  |- skos__hiddenLabel mesh__D050728 Aldehyde Dehydrogenase, Betaine
% 209.88/210.07  |- skos__altLabel mesh__D050728 Betaine Aldehyde Oxidase
% 209.88/210.07  |- skos__altLabel mesh__D050728 Glycine Betaine Aldehyde Dehydrogenase
% 209.88/210.07  |- mesh__recordMaintainer mesh__D050728 AKE
% 209.88/210.07  |- mesh__historyNote mesh__D050728
% 209.88/210.07       2006%28%1980%29%; use ALDEHYDE OXIDOREDUCTASES 1979, %26% OXIDOREDUCTASES %26% ALDEHYDES 1972-1978%A%  
% 209.88/210.07  |- mesh__dateEstablished mesh__D050728 2006-01-01
% 209.88/210.07  |- skos__broader mesh__D050728smesh__D000445
% 209.88/210.07  |- mesh__dateRevised mesh__D008568 2005-06-30
% 209.88/210.07  |- skos__prefLabel mesh__D008568 Memory
% 209.88/210.07  |- skos__annotation mesh__D008568 human %26% animal   
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D008568 2006
% 209.88/210.07  |- mesh__recordMaintainer mesh__D008568 jls
% 209.88/210.07  |- mesh__dateCreated mesh__D008568 1999-01-01
% 209.88/210.07  |- skos__scopeNote mesh__D008568
% 209.88/210.07       Complex mental function having four distinct phases: %28%1%29% memorizing or learning, %28%2%29% retention, %28%3%29% recall, and %28%4%29% recognition. Clinically, it is usually subdivided into immediate, recent, and remote memory.%A%    
% 209.88/210.07  |- rdf__type mesh__D008568sskos__Concept
% 209.88/210.07  |- mesh__recordAuthorizer mesh__D008568 sjn
% 209.88/210.07  |- skos__broader mesh__D008568smesh__D007858
% 209.88/210.07  |- mesh__recordOriginator mesh__D008568 NLM
% 209.88/210.07  |- skos__annotation mesh__D000585 D25-26 qualif   
% 209.88/210.07  |- skos__altLabel mesh__D000585 Beutlich Brand of Aminacrine Hydrochloride
% 209.88/210.07  |- mesh__dateCreated mesh__D000585 1979-02-28
% 209.88/210.07  |- skos__altLabel mesh__D000585 Aminoacridine Hydrochloride
% 209.88/210.07  |- skos__altLabel mesh__D000585 Acridinamine
% 209.88/210.07  |- mesh__dateEstablished mesh__D000585 1991-01-01
% 209.88/210.07  |- skos__historyNote mesh__D000585 Acridines %28%1966-1979%29%
% 209.88/210.07  |- skos__scopeNote mesh__D000585
% 209.88/210.07       A highly fluorescent anti-infective dye used clinically as a topical antiseptic and experimentally as a mutagen, due to its interaction with DNA. It is also used as an intracellular pH indicator.%A%    
% 209.88/210.07  |- mesh__recordAuthorizer mesh__D000585 sjn
% 209.88/210.07  |- mesh__recordOriginator mesh__D000585 SH
% 209.88/210.07  |- mesh__dateRevised mesh__D000585 2004-07-07
% 209.88/210.07  |- skos__hiddenLabel mesh__D000585 Hydrochloride, Aminoacridine
% 209.88/210.07  |- mesh__historyNote mesh__D000585
% 209.88/210.07       91%28%80%29%; was see under AMINOACRIDINES 1980-90   
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D000585 2005
% 209.88/210.07  |- skos__altLabel mesh__D000585 Sigma Brand of Aminacrine Hydrochloride
% 209.88/210.07  |- rdf__type mesh__D000585sskos__Concept
% 209.88/210.07  |- mesh__publicMeSHNote mesh__D000585
% 209.88/210.07       91; was see under AMINOACRIDINES 1980-90   
% 209.88/210.07  |- skos__hiddenLabel mesh__D000585 Hydrochloride, Aminacrine
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D000585 2006
% 209.88/210.07  |- skos__prefLabel mesh__D000585 Aminacrine
% 209.88/210.07  |- skos__hiddenLabel mesh__D000585 9 Aminoacridine
% 209.88/210.07  |- mesh__recordMaintainer mesh__D000585 mdb
% 209.88/210.07  |- skos__altLabel mesh__D000585 Aminoacridine
% 209.88/210.07  |- skos__broader mesh__D000585smesh__D000609
% 209.88/210.07  |- skos__altLabel mesh__D000585 9-Aminoacridine
% 209.88/210.07  |- skos__hiddenLabel mesh__D019290 Nu Pharm Brand of Megestrol Acetate
% 209.88/210.07  |- mesh__publicMeSHNote mesh__D019290 97   
% 209.88/210.07  |- skos__hiddenLabel mesh__D019290 Lin Megestrol
% 209.88/210.07  |- skos__hiddenLabel mesh__D019290 LinMegestrol
% 209.88/210.07  |- skos__altLabel mesh__D019290 Lemery Brand of Megestrol Acetate
% 209.88/210.07  |- skos__altLabel mesh__D019290 Bristol-Myers Brand of Megestrol Acetate
% 209.88/210.07  |- mesh__recordMaintainer mesh__D019290 CCR
% 209.88/210.07  |- mesh__recordOriginator mesh__D019290 TPW
% 209.88/210.07  |- skos__hiddenLabel mesh__D019290
% 209.88/210.07       Bristol Myers Squibb Brand of Megestrol Acetate
% 209.88/210.07  |- skos__hiddenLabel mesh__D019290 Bristol Myers Brand of Megestrol Acetate
% 209.88/210.07  |- mesh__recordAuthorizer mesh__D019290 sjn
% 209.88/210.07  |- rdf__type mesh__D019290sskos__Concept
% 209.88/210.07  |- skos__hiddenLabel mesh__D019290 Nu Megestrol
% 209.88/210.07  |- skos__altLabel mesh__D019290 Megestat
% 209.88/210.07  |- skos__hiddenLabel mesh__D019290 Acetate, Megestrol
% 209.88/210.07  |- skos__hiddenLabel mesh__D019290 Apo Megestrol
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D019290 2006
% 209.88/210.07  |- mesh__dateEstablished mesh__D019290 1997-01-01
% 209.88/210.07  |- skos__altLabel mesh__D019290 Apotex Brand of Megestrol Acetate
% 209.88/210.07  |- skos__scopeNote mesh__D019290
% 209.88/210.07       Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. %28%From Reynolds JEF%28%Ed%29%: Martindale: The Extra Pharmacopoeia %28%electronic version%29%. Micromedex, Inc, Englewood, CO, 1995%29%%A%    
% 209.88/210.07  |- skos__altLabel mesh__D019290 Megostat
% 209.88/210.07  |- skos__altLabel mesh__D019290 Nu-Pharm Brand of Megestrol Acetate
% 209.88/210.07  |- mesh__dateCreated mesh__D019290 1996-06-10
% 209.88/210.07  |- mesh__historyNote mesh__D019290 97;   
% 209.88/210.07  |- mesh__dateRevised mesh__D019290 2005-06-30
% 209.88/210.07  |- skos__altLabel mesh__D019290 Madaus Brand of Megestrol Acetate
% 209.88/210.07  |- skos__hiddenLabel mesh__D019290 ApoMegestrol
% 209.88/210.07  |- skos__prefLabel mesh__D019290 Megestrol Acetate
% 209.88/210.07  |- skos__altLabel mesh__D019290 Prasfarma Brand of Megestrol Acetate
% 209.88/210.07  |- skos__hiddenLabel mesh__D019290 NuMegestrol
% 209.88/210.07  |- skos__broader mesh__D019290smesh__D008535
% 209.88/210.07  |- skos__altLabel mesh__D019290 Linson Pharma Brand of Megestrol Acetate
% 209.88/210.07  |- skos__altLabel mesh__D019290 Squibb Brand of Megestrol Acetate
% 209.88/210.07  |- skos__historyNote mesh__D019290
% 209.88/210.07       Megestrol/analogs %26% derivatives %28%1980-1996%29%
% 209.88/210.07  |- skos__altLabel mesh__D019290
% 209.88/210.07       Bristol-Myers Squibb Brand of Megestrol Acetate
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D027722 2003
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D027722 2006
% 209.88/210.07  |- skos__prefLabel mesh__D027722 Convolvulaceae
% 209.88/210.07  |- mesh__dateEstablished mesh__D027722 2002-01-01
% 209.88/210.07  |- skos__scopeNote mesh__D027722
% 209.88/210.07       The morning glory family of flowering plants, of the order Solanales, which includes about 50 genera and at least 1,400 species.  Leaves are alternate and flowers are funnel-shaped. Most are twining and erect herbs, with a few woody vines, trees, and shrubs.%A%    
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D027722 2005
% 209.88/210.07  |- mesh__publicMeSHNote mesh__D027722 2002   
% 209.88/210.07  |- mesh__historyNote mesh__D027722 2002   
% 209.88/210.07  |- mesh__recordMaintainer mesh__D027722 ssb
% 209.88/210.07  |- mesh__recordAuthorizer mesh__D027722 sjn
% 209.88/210.07  |- rdf__type mesh__D027722sskos__Concept
% 209.88/210.07  |- mesh__dateRevised mesh__D027722 2002-07-03
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D027722 2004
% 209.88/210.07  |- skos__broader mesh__D027722smesh__D019684
% 209.88/210.07  |- skos__annotation mesh__D027722
% 209.88/210.07       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.88/210.07  |- mesh__recordOriginator mesh__D027722 ssb
% 209.88/210.07  |- mesh__dateCreated mesh__D027722 2001-07-25
% 209.88/210.07  |- skos__hiddenLabel mesh__D005270 Head, Femur
% 209.88/210.07  |- skos__broader mesh__D005270smesh__D005269
% 209.88/210.07  |- rdf__type mesh__D005270sskos__Concept
% 209.88/210.07  |- mesh__recordOriginator mesh__D005270 NLM
% 209.88/210.07  |- skos__hiddenLabel mesh__D005270 Femur Heads
% 209.88/210.07  |- mesh__dateCreated mesh__D005270 1999-01-01
% 209.88/210.07  |- mesh__dateRevised mesh__D005270 2005-06-30
% 209.88/210.07  |- skos__hiddenLabel mesh__D005270 Heads, Femur
% 209.88/210.07  |- skos__scopeNote mesh__D005270
% 209.88/210.07       The hemispheric articular surface at the upper extremity of the thigh bone. %28%Stedman, 26th ed%29%%A%    
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D005270 2006
% 209.88/210.07  |- mesh__recordMaintainer mesh__D005270 ags
% 209.88/210.07  |- skos__annotation mesh__D005270
% 209.88/210.07       fract = FEMUR HEAD /inj %28%IM%29% + HIP FRACTURES %28%IM%29%; avascular or aseptic necrosis of hip goes under FEMUR HEAD NECROSIS%A%  
% 209.88/210.07  |- mesh__recordAuthorizer mesh__D005270 sjn
% 209.88/210.07  |- skos__prefLabel mesh__D005270 Femur Head
% 209.88/210.07  |- skos__scopeNote mesh__D013702
% 209.88/210.07       Lower lateral part of the cerebral hemisphere.     
% 209.88/210.07  |- mesh__dateRevised mesh__D013702 1998-06-11
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D013702 2002
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D013702 1999
% 209.88/210.07  |- skos__hiddenLabel mesh__D013702 Temporal Lobes
% 209.88/210.07  |- mesh__dateCreated mesh__D013702 1999-01-01
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D013702 2006
% 209.88/210.07  |- rdf__type mesh__D013702sskos__Concept
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D013702 2004
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D013702 2005
% 209.88/210.07  |- mesh__recordMaintainer mesh__D013702 TPW
% 209.88/210.07  |- skos__hiddenLabel mesh__D013702 Lobe, Temporal
% 209.88/210.07  |- skos__annotation mesh__D013702
% 209.88/210.07       dis: coord IM with BRAIN DISEASES %28%IM%29%; neopl: coord IM with BRAIN NEOPLASMS %28%IM%29%%A%  
% 209.88/210.07  |- mesh__recordOriginator mesh__D013702 NLM
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D013702 2001
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D013702 2003
% 209.88/210.07  |- skos__hiddenLabel mesh__D013702 Lobes, Temporal
% 209.88/210.07  |- skos__prefLabel mesh__D013702 Temporal Lobe
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D013702 2000
% 209.88/210.07  |- mesh__recordAuthorizer mesh__D013702 SJN
% 209.88/210.07  |- skos__hiddenLabel mesh__D013702 Area, Wernicke
% 209.88/210.07  |- skos__broader mesh__D013702smesh__D002540
% 209.88/210.07  |- skos__annotation mesh__D018996
% 209.88/210.07       /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X ref%A%  
% 209.88/210.07  |- skos__hiddenLabel mesh__D018996 P2 Protein, Myelin
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018996 2003
% 209.88/210.07  |- mesh__dateCreated mesh__D018996 1995-06-08
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018996 2006
% 209.88/210.07  |- rdf__type mesh__D018996sskos__Concept
% 209.88/210.07  |- skos__altLabel mesh__D018996 Myelin Basic Protein P2
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018996 1998
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018996 2000
% 209.88/210.07  |- skos__hiddenLabel mesh__D018996 Protein, P2
% 209.88/210.07  |- skos__altLabel mesh__D018996 P2 Protein
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018996 2004
% 209.88/210.07  |- mesh__dateEstablished mesh__D018996 1996-01-01
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018996 2001
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018996 1996
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018996 1999
% 209.88/210.07  |- mesh__publicMeSHNote mesh__D018996
% 209.88/210.07       96; MYELIN P2 PROTEINS was indexed under ENCEPHALITOGENIC BASIC PROTEINS 1982-95 %26% MYELIN PROTEINS 1980-81%A%  
% 209.88/210.07  |- skos__broader mesh__D018996smesh__D004676
% 209.88/210.07  |- skos__scopeNote mesh__D018996
% 209.88/210.07       A positively charged protein found in peripheral nervous system myelin. Sensitive immunological techniques have demonstrated that P2 is expressed in small amounts of central nervous system myelin sheaths of some species. It is an antigen for experimental allergic neuritis %28%NEURITIS, EXPERIMENTAL ALLERGIC%29%, the peripheral nervous system counterpart of experimental allergic encephalomyelitis. %28%From Siegel et al., Basic Neurochemistry, 5th ed, p133%29%%A%    
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018996 2002
% 209.88/210.07  |- skos__hiddenLabel mesh__D018996 Protein, Myelin P2
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018996 1997
% 209.88/210.07  |- skos__historyNote mesh__D018996 Myelin Basic Proteins %28%1982-1995%29%
% 209.88/210.07  |- mesh__historyNote mesh__D018996
% 209.88/210.07       96; was MYELIN P2 PROTEINS %28%NM%29% 1980-95   
% 209.88/210.07  |- skos__historyNote mesh__D018996 Myelin Proteins %28%1980-1981%29%
% 209.88/210.07  |- skos__prefLabel mesh__D018996 Myelin P2 Protein
% 209.88/210.07  |- mesh__onlineNote mesh__D018996
% 209.88/210.07       use MYELIN P2 PROTEIN %28%NM%29% to search MYELIN P2 PROTEINS 1980-95%A%  
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018996 2005
% 209.88/210.07  |- mesh__historyNote mesh__D051821 2006%28%1991%29%   
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D051821 2006
% 209.88/210.07  |- skos__prefLabel mesh__D051821 Lymphoid Enhancer-Binding Factor 1
% 209.88/210.07  |- mesh__dateCreated mesh__D051821 2005-06-30
% 209.88/210.07  |- rdf__type mesh__D051821sskos__Concept
% 209.88/210.07  |- skos__altLabel mesh__D051821 LEF-1 Transcription Factor
% 209.88/210.07  |- mesh__recordMaintainer mesh__D051821 DRC
% 209.88/210.07  |- skos__scopeNote mesh__D051821
% 209.88/210.07       A T-cell factor that plays an essential role in EMBRYONIC DEVELOPMENT.%A%    
% 209.88/210.07  |- skos__hiddenLabel mesh__D051821 LEF 1 Transcription Factor
% 209.88/210.07  |- skos__broader mesh__D051821smesh__D051820
% 209.88/210.07  |- mesh__publicMeSHNote mesh__D051821
% 209.88/210.07       2006; LYMPHOID ENHANCER-BINDING FACTOR 1 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1995-2005, %26% under NUCLEAR PROTEINS 1991-1994%A%  
% 209.88/210.07  |- skos__hiddenLabel mesh__D051821 Transcription Factor, LEF-1
% 209.88/210.07  |- mesh__recordOriginator mesh__D051821 DRC
% 209.88/210.07  |- mesh__recordAuthorizer mesh__D051821 sjn
% 209.88/210.07  |- skos__hiddenLabel mesh__D051821 Lymphoid Enhancer Binding Factor 1
% 209.88/210.07  |- mesh__dateEstablished mesh__D051821 2006-01-01
% 209.88/210.07  |- mesh__recordOriginator mesh__D018198 PLS
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018198 2000
% 209.88/210.07  |- mesh__dateRevised mesh__D018198 1995-06-08
% 209.88/210.07  |- skos__historyNote mesh__D018198
% 209.88/210.07       Neoplasms, Germ Cell and Embryonal %28%1966-1993%29%
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018198 2003
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018198 1996
% 209.88/210.07  |- skos__broader mesh__D018198smesh__D018193
% 209.88/210.07  |- skos__scopeNote mesh__D018198
% 209.88/210.07       A malignant tumor composed of more than one type of neoplastic tissue. %28%Dorland, 27th ed%29%%A%    
% 209.88/210.07  |- skos__annotation mesh__D018198
% 209.88/210.07       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with organ/neopl term %28%IM%29%%A%  
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018198 2006
% 209.88/210.07  |- skos__historyNote mesh__D018198 Adenoma, Pleomorphic %28%1966-1993%29%
% 209.88/210.07  |- skos__hiddenLabel mesh__D018198 Tumors, Malignant Mixed
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018198 1999
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018198 2002
% 209.88/210.07  |- rdf__type mesh__D018198sskos__Concept
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018198 2005
% 209.88/210.07  |- skos__hiddenLabel mesh__D018198 Malignant Mixed Tumor
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018198 1998
% 209.88/210.07  |- mesh__publicMeSHNote mesh__D018198 94   
% 209.88/210.07  |- mesh__recordMaintainer mesh__D018198 KEV
% 209.88/210.07  |- skos__hiddenLabel mesh__D018198 Tumor, Malignant Mixed
% 209.88/210.07  |- mesh__dateCreated mesh__D018198 1993-06-25
% 209.88/210.07  |- skos__hiddenLabel mesh__D018198 Malignant Mixed Tumors
% 209.88/210.07  |- mesh__recordAuthorizer mesh__D018198 PLS
% 209.88/210.07  |- skos__hiddenLabel mesh__D018198 Mixed Tumors, Malignant
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018198 2004
% 209.88/210.07  |- skos__prefLabel mesh__D018198 Mixed Tumor, Malignant
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018198 2001
% 209.88/210.07  |- mesh__historyNote mesh__D018198 94   
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D018198 1997
% 209.88/210.07  |- mesh__dateEstablished mesh__D018198 1994-01-01
% 209.88/210.07  |- mesh__recordOriginator mesh__D004976 NLM
% 209.88/210.07  |- skos__altLabel mesh__D004976 Etacrynic Acid
% 209.88/210.07  |- skos__altLabel mesh__D004976 Ethacrinic Acid
% 209.88/210.07  |- mesh__recordMaintainer mesh__D004976 exl
% 209.88/210.07  |- skos__hiddenLabel mesh__D004976 Acid, Etacrynic
% 209.88/210.07  |- mesh__recordAuthorizer mesh__D004976 sjn
% 209.88/210.07  |- skos__hiddenLabel mesh__D004976 Acid, Ethacrynic
% 209.88/210.07  |- mesh__publicMeSHNote mesh__D004976 66   
% 209.88/210.07  |- skos__prefLabel mesh__D004976 Ethacrynic Acid
% 209.88/210.07  |- skos__hiddenLabel mesh__D004976 Sodium, Ethacrynate
% 209.88/210.07  |- mesh__dateEstablished mesh__D004976 1966-01-01
% 209.88/210.07  |- mesh__dateCreated mesh__D004976 1999-01-01
% 209.88/210.07  |- mesh__dateRevised mesh__D004976 2005-06-30
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D004976 2006
% 209.88/210.07  |- skos__broader mesh__D004976smesh__D010642
% 209.88/210.07  |- skos__altLabel mesh__D004976 Ethacrynic Acid, Sodium Salt
% 209.88/210.07  |- skos__scopeNote mesh__D004976
% 209.88/210.07       A compound that inhibits symport of sodium, potassium, and chloride primarily in the ascending limb of Henle, but also in the proximal and distal tubules. This pharmacological action results in excretion of these ions, increased urinary output, and reduction in extracellular fluid. This compound has been classified as a loop or high ceiling diuretic.%A%    
% 209.88/210.07  |- skos__hiddenLabel mesh__D004976 Acid, Ethacrinic
% 209.88/210.07  |- mesh__historyNote mesh__D004976 66%28%63%29%   
% 209.88/210.07  |- rdf__type mesh__D004976sskos__Concept
% 209.88/210.07  |- mesh__publicMeSHNote mesh__D051023
% 209.88/210.07       2006; BID PROTEIN was indexed under CARRIER PROTEINS 1996-2005%A%  
% 209.88/210.07  |- rdf__type mesh__D051023sskos__Concept
% 209.88/210.07  |- mesh__recordAuthorizer mesh__D051023 ags
% 209.88/210.07  |- skos__scopeNote mesh__D051023
% 209.88/210.07       A member of the Bcl-2 protein family that reversibly binds MEMBRANES. It is a pro-apoptotic protein that is activated by caspase cleavage.%A%    
% 209.88/210.07  |- mesh__dateEstablished mesh__D051023 2006-01-01
% 209.88/210.07  |- skos__altLabel mesh__D051023 Bid Protein
% 209.88/210.07  |- mesh__recordMaintainer mesh__D051023 ags
% 209.88/210.07  |- mesh__dateRevised mesh__D051023 2005-07-11
% 209.88/210.07  |- mesh__recordOriginator mesh__D051023 DRC
% 209.88/210.07  |- mesh__historyNote mesh__D051023 2006%28%1996%29%   
% 209.88/210.07  |- mesh__dateCreated mesh__D051023 2005-06-30
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D051023 2006A
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D051023 2006
% 209.88/210.07  |- skos__altLabel mesh__D051023 Truncated Bid Protein
% 209.88/210.07  |- skos__prefLabel mesh__D051023
% 209.88/210.07       BH3 Interacting Domain Death Agonist Protein
% 209.88/210.07  |- skos__broader mesh__D051023smesh__D019253
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D004178 2002
% 209.88/210.07  |- skos__scopeNote mesh__D004178
% 209.88/210.07       A contact herbicide used also to produce desiccation and defoliation. %28%From Merck Index, 11th ed%29%%A%    
% 209.88/210.07  |- mesh__recordMaintainer mesh__D004178 JRT
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D004178 2003
% 209.88/210.07  |- mesh__dateCreated mesh__D004178 1999-01-01
% 209.88/210.07  |- mesh__dateRevised mesh__D004178 1995-06-08
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D004178 1996
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D004178 2004
% 209.88/210.07  |- mesh__historyNote mesh__D004178
% 209.88/210.07       91%28%71%29%; was see under PYRIDINIUM COMPOUNDS 1971-90   
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D004178 1997
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D004178 2000
% 209.88/210.07  |- skos__hiddenLabel mesh__D004178 Dibromide, Diquat
% 209.88/210.07  |- mesh__recordOriginator mesh__D004178 NLM
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D004178 2001
% 209.88/210.07  |- skos__historyNote mesh__D004178 Pyridinium Compounds %28%1968-1970%29%
% 209.88/210.07  |- mesh__recordAuthorizer mesh__D004178 PLS
% 209.88/210.07  |- mesh__publicMeSHNote mesh__D004178
% 209.88/210.07       91; was see under PYRIDINIUM COMPOUNDS 1971-90   
% 209.88/210.07  |- rdf__type mesh__D004178sskos__Concept
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D004178 2005
% 209.88/210.07  |- skos__broader mesh__D004178smesh__D011726
% 209.88/210.07  |- skos__historyNote mesh__D004178 Herbicides %28%1966-1970%29%
% 209.88/210.07  |- mesh__dateEstablished mesh__D004178 1991-01-01
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D004178 1998
% 209.88/210.07  |- skos__prefLabel mesh__D004178 Diquat
% 209.88/210.07  |- skos__annotation mesh__D004178 an herbicide   
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D004178 2006
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D004178 1999
% 209.88/210.07  |- skos__altLabel mesh__D009661 Paxtibi
% 209.88/210.07  |- mesh__dateCreated mesh__D009661 1999-01-01
% 209.88/210.07  |- skos__altLabel mesh__D009661 Dista Brand of Nortriptyline Hydrochloride
% 209.88/210.07  |- skos__prefLabel mesh__D009661 Nortriptyline
% 209.88/210.07  |- skos__altLabel mesh__D009661
% 209.88/210.07       Reig Jofre Brand of Nortriptyline Hydrochloride
% 209.88/210.07  |- skos__altLabel mesh__D009661 Allegron
% 209.88/210.07  |- mesh__dateRevised mesh__D009661 2005-07-07
% 209.88/210.07  |- skos__hiddenLabel mesh__D009661
% 209.88/210.07       Nu Pharm Brand of Nortriptyline Hydrochloride
% 209.88/210.07  |- skos__altLabel mesh__D009661 Desitriptyline
% 209.88/210.07  |- skos__hiddenLabel mesh__D009661 Nu Nortriptyline
% 209.88/210.07  |- skos__hiddenLabel mesh__D009661 Apo Nortriptyline
% 209.88/210.07  |- skos__hiddenLabel mesh__D009661 Gen Nortriptyline
% 209.88/210.07  |- skos__altLabel mesh__D009661
% 209.88/210.07       Genpharm Brand of Nortriptyline Hydrochloride
% 209.88/210.07  |- mesh__recordAuthorizer mesh__D009661 ags
% 209.88/210.07  |- skos__broader mesh__D009661smesh__D003986
% 209.88/210.07  |- skos__altLabel mesh__D009661 Lilly Brand of Nortriptyline Hydrochloride
% 209.88/210.07  |- skos__altLabel mesh__D009661 Apotex Brand of Nortriptyline Hydrochloride
% 209.88/210.07  |- skos__altLabel mesh__D009661
% 209.88/210.07       Lundbeck Brand of Nortriptyline Hydrochloride
% 209.88/210.07  |- skos__hiddenLabel mesh__D009661 ratio Nortriptyline
% 209.88/210.07  |- skos__hiddenLabel mesh__D009661 PMS Nortriptyline
% 209.88/210.07  |- mesh__historyNote mesh__D009661 68%28%65%29%   
% 209.88/210.07  |- skos__hiddenLabel mesh__D009661 Novo Nortriptyline
% 209.88/210.07  |- mesh__dateEstablished mesh__D009661 1968-01-01
% 209.88/210.07  |- skos__altLabel mesh__D009661 Desmethylamitriptylin
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D009661 2006
% 209.88/210.07  |- skos__altLabel mesh__D009661
% 209.88/210.07       Ratiopharm Brand of Nortriptyline Hydrochloride
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D009661 2006A
% 209.88/210.07  |- skos__altLabel mesh__D009661
% 209.88/210.07       Nu-Pharm Brand of Nortriptyline Hydrochloride
% 209.88/210.07  |- skos__altLabel mesh__D009661
% 209.88/210.07       Novopharm Brand of Nortriptyline Hydrochloride
% 209.88/210.07  |- rdf__type mesh__D009661sskos__Concept
% 209.88/210.07  |- mesh__recordOriginator mesh__D009661 NLM
% 209.88/210.07  |- skos__altLabel mesh__D009661
% 209.88/210.07       Pharmascience Brand of Nortriptyline Hydrochloride
% 209.88/210.07  |- skos__hiddenLabel mesh__D009661 Hydrochloride, Nortriptyline
% 209.88/210.07  |- skos__scopeNote mesh__D009661
% 209.88/210.07       A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.%A%    
% 209.88/210.07  |- skos__altLabel mesh__D009661
% 209.88/210.07       Mallinckrodt Brand of Nortriptyline Hydrochloride
% 209.88/210.07  |- mesh__recordMaintainer mesh__D009661 ags
% 209.88/210.07  |- mesh__publicMeSHNote mesh__D009661 68   
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D008569 2005
% 209.88/210.07  |- mesh__dateRevised mesh__D008569 1999-12-06
% 209.88/210.07  |- skos__hiddenLabel mesh__D008569 Memory Losses
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D008569 2000
% 209.88/210.07  |- skos__broader mesh__D008569smesh__D019954
% 209.88/210.07  |- mesh__dateEstablished mesh__D008569 1969-01-01
% 209.88/210.07  |- mesh__historyNote mesh__D008569 1969   
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D008569 2000A
% 209.88/210.07  |- skos__hiddenLabel mesh__D008569 Cognitive Retention Disorders
% 209.88/210.07  |- mesh__dateCreated mesh__D008569 1999-01-01
% 209.88/210.07  |- skos__hiddenLabel mesh__D008569 Deficit, Memory
% 209.88/210.07  |- skos__hiddenLabel mesh__D008569 Memory Deficit
% 209.88/210.07  |- mesh__recordOriginator mesh__D008569 NLM
% 209.88/210.07  |- skos__hiddenLabel mesh__D008569 Semantic Memory Disorders
% 209.88/210.07  |- skos__hiddenLabel mesh__D008569 Memory Disorders, Semantic
% 209.88/210.07  |- skos__historyNote mesh__D008569 Memory %28%1966-1968%29%
% 209.88/210.07  |- skos__hiddenLabel mesh__D008569 Spatial Memory Disorders
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D008569 2004
% 209.88/210.07  |- skos__hiddenLabel mesh__D008569 Memory Disorders, Spatial
% 209.88/210.07  |- mesh__activeMeSHYear mesh__D008569 2002
% 209.88/210.08  |- skos__hiddenLabel mesh__D008569 Cognitive Retention Disorder
% 209.88/210.08  |- skos__altLabel mesh__D008569 Retention Disorders, Cognitive
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D008569 2003
% 209.88/210.08  |- skos__hiddenLabel mesh__D008569 Retention Disorder, Cognitive
% 209.88/210.08  |- skos__altLabel mesh__D008569 Semantic Memory Disorder
% 209.88/210.08  |- mesh__recordAuthorizer mesh__D008569 ags
% 209.88/210.08  |- skos__hiddenLabel mesh__D008569 Memory Disorders, Age Related
% 209.88/210.08  |- mesh__recordMaintainer mesh__D008569 ags
% 209.88/210.08  |- skos__altLabel mesh__D008569 Spatial Memory Disorder
% 209.88/210.08  |- skos__hiddenLabel mesh__D008569 Deficits, Memory
% 209.88/210.08  |- skos__prefLabel mesh__D008569 Memory Disorders
% 209.88/210.08  |- skos__hiddenLabel mesh__D008569 Memory Disorder, Age-Related
% 209.88/210.08  |- skos__historyNote mesh__D008569 Deja Vu %28%1968%29%
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D008569 2006
% 209.88/210.08  |- skos__scopeNote mesh__D008569
% 209.88/210.08       Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM %28%see also ALCOHOL AMNESTIC DISORDER%29%; SCHIZOPHRENIA; and other conditions.%A%    
% 209.88/210.08  |- skos__altLabel mesh__D008569 Memory Disorders, Age-Related
% 209.88/210.08  |- skos__historyNote mesh__D008569 Amnesia %28%1966-1968%29%
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D008569 2001
% 209.88/210.08  |- rdf__type mesh__D008569sskos__Concept
% 209.88/210.08  |- skos__hiddenLabel mesh__D008569 Age-Related Memory Disorder
% 209.88/210.08  |- skos__hiddenLabel mesh__D008569 Memory Disorder
% 209.88/210.08  |- skos__hiddenLabel mesh__D008569 Age Related Memory Disorders
% 209.88/210.08  |- mesh__publicMeSHNote mesh__D008569 1969   
% 209.88/210.08  |- skos__broader mesh__D007106Q000627smesh__D007106
% 209.88/210.08  |- mesh__preferredCombination mesh__D007106Q000627smesh__D007116
% 209.88/210.08  |- rdf__type mesh__D007106Q000627smesh__CompoundConcept
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D000586 2003
% 209.88/210.08  |- mesh__dateCreated mesh__D000586 1999-01-01
% 209.88/210.08  |- skos__historyNote mesh__D000586 Chemistry, Organic %28%1966-1970%29%
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D000586 2004
% 209.88/210.08  |- skos__broader mesh__D000586smesh__D002625
% 209.88/210.08  |- mesh__recordOriginator mesh__D000586 NLM
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D000586 2005
% 209.88/210.08  |- skos__annotation mesh__D000586
% 209.88/210.08       almost never IM; enzymatic amination: coord NIM with TRANSAMINASES %28%IM%29% + substrate %28%NIM%29% or specific transaminase %28%IM%29%%A%  
% 209.88/210.08  |- mesh__recordAuthorizer mesh__D000586 sjn
% 209.88/210.08  |- rdf__type mesh__D000586sskos__Concept
% 209.88/210.08  |- skos__hiddenLabel mesh__D000586 Aminations
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D000586 2006
% 209.88/210.08  |- skos__prefLabel mesh__D000586 Amination
% 209.88/210.08  |- skos__broader mesh__D000586smesh__D008660
% 209.88/210.08  |- skos__scopeNote mesh__D000586
% 209.88/210.08       The creation of an amine. It can be produced by the addition of an amino group to an organic compound or reduction of a nitro group.%A%    
% 209.88/210.08  |- mesh__dateEstablished mesh__D000586 1974-01-01
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D000586 2001
% 209.88/210.08  |- mesh__publicMeSHNote mesh__D000586 74   
% 209.88/210.08  |- mesh__historyNote mesh__D000586 74%28%71%29%   
% 209.88/210.08  |- skos__related mesh__D000586smesh__D003641
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D000586 2002
% 209.88/210.08  |- mesh__dateRevised mesh__D000586 2000-06-21
% 209.88/210.08  |- mesh__recordMaintainer mesh__D000586 adp
% 209.88/210.08  |- skos__hiddenLabel mesh__D019291 Base, Cranial
% 209.88/210.08  |- mesh__recordOriginator mesh__D019291 TGC
% 209.88/210.08  |- skos__altLabel mesh__D019291 Basicranium
% 209.88/210.08  |- skos__altLabel mesh__D019291 Basis cranii
% 209.88/210.08  |- skos__altLabel mesh__D019291 Cranial Base
% 209.88/210.08  |- skos__broader mesh__D019291smesh__D006257
% 209.88/210.08  |- mesh__historyNote mesh__D019291 97   
% 209.88/210.08  |- mesh__dateEstablished mesh__D019291 1997-01-01
% 209.88/210.08  |- mesh__dateCreated mesh__D019291 1996-06-10
% 209.88/210.08  |- mesh__publicMeSHNote mesh__D019291 97   
% 209.88/210.08  |- skos__annotation mesh__D019291
% 209.88/210.08       GEN: prefer specifics; NIM when merely locational; neopl = SKULL BASE NEOPLASMS%A%  
% 209.88/210.08  |- rdf__type mesh__D019291sskos__Concept
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D019291 2004
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D019291 2006
% 209.88/210.08  |- mesh__recordAuthorizer mesh__D019291 sjn
% 209.88/210.08  |- skos__altLabel mesh__D019291 Base of Skull
% 209.88/210.08  |- mesh__dateRevised mesh__D019291 2002-07-02
% 209.88/210.08  |- skos__prefLabel mesh__D019291 Skull Base
% 209.88/210.08  |- skos__scopeNote mesh__D019291
% 209.88/210.08       The inferior region of the skull consisting of an internal %28%cerebral%29%, and an external %28%basilar%29% surface.%A%    
% 209.88/210.08  |- skos__broader mesh__D019291smesh__D012886
% 209.88/210.08  |- skos__historyNote mesh__D019291 Skull %28%1966-1996%29%
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D019291 2003
% 209.88/210.08  |- mesh__recordMaintainer mesh__D019291 ags
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D019291 2005
% 209.88/210.08  |- skos__hiddenLabel mesh__D019291 Base, Skull
% 209.88/210.08  |- skos__related mesh__D027723smesh__D027742
% 209.88/210.08  |- skos__annotation mesh__D027723
% 209.88/210.08       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D027723 2006
% 209.88/210.08  |- skos__altLabel mesh__D027723 Pseudo-Yam
% 209.88/210.08  |- mesh__recordOriginator mesh__D027723 ssb
% 209.88/210.08  |- skos__scopeNote mesh__D027723
% 209.88/210.08       A plant species of the genus IPOMOEA, family CONVOLVULACEAE. Some cultivars are sweet and edible whereas bitter varieties are a source of SAPONINS. This sweet potato is sometimes referred to as a yam %28%DIOSCOREA%29%.%A%    
% 209.88/210.08  |- mesh__historyNote mesh__D027723 2002; use Solanaceae 1998-2001   
% 209.88/210.08  |- rdf__type mesh__D027723sskos__Concept
% 209.88/210.08  |- mesh__recordMaintainer mesh__D027723 ssb
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D027723 2003
% 209.88/210.08  |- mesh__dateEstablished mesh__D027723 2002-01-01
% 209.88/210.08  |- mesh__publicMeSHNote mesh__D027723 2002; see Solanaceae 1998-2001   
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D027723 2004
% 209.88/210.08  |- skos__prefLabel mesh__D027723 Ipomoea batatas
% 209.88/210.08  |- skos__altLabel mesh__D027723 Yam, Pseudo
% 209.88/210.08  |- skos__historyNote mesh__D027723 Solanaceae %28%1998-2001%29%
% 209.88/210.08  |- skos__broader mesh__D027723smesh__D027741
% 209.88/210.08  |- mesh__recordAuthorizer mesh__D027723 sjn
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D027723 2005
% 209.88/210.08  |- mesh__dateRevised mesh__D027723 2002-07-03
% 209.88/210.08  |- mesh__dateCreated mesh__D027723 2001-07-25
% 209.88/210.08  |- rdf__type mesh__D005271sskos__Concept
% 209.88/210.08  |- skos__altLabel mesh__D005271 Avascular Necrosis of Femur Head
% 209.88/210.08  |- mesh__dateCreated mesh__D005271 1999-01-01
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D005271 2004
% 209.88/210.08  |- mesh__dateEstablished mesh__D005271 1973-01-01
% 209.88/210.08  |- mesh__recordAuthorizer mesh__D005271 sjn
% 209.88/210.08  |- skos__altLabel mesh__D005271 Necrosis, Aseptic, of Femur Head
% 209.88/210.08  |- skos__scopeNote mesh__D005271
% 209.88/210.08       Aseptic or avascular necrosis of the femoral head. The major types are idiopathic %28%primary%29%, as a complication of fractures or dislocations, and LEGG-PERTHES DISEASE.%A%    
% 209.88/210.08  |- skos__historyNote mesh__D005271 Femur Head %28%1966-1972%29%
% 209.88/210.08  |- skos__hiddenLabel mesh__D005271 Head Necrosis, Femur
% 209.88/210.08  |- skos__historyNote mesh__D005271 Bone Diseases %28%1966-1972%29%
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D005271 2005
% 209.88/210.08  |- skos__hiddenLabel mesh__D005271 Necrosis, Femur Head
% 209.88/210.08  |- mesh__historyNote mesh__D005271 73   
% 209.88/210.08  |- skos__broader mesh__D005271smesh__D010020
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D005271 2000
% 209.88/210.08  |- mesh__recordOriginator mesh__D005271 NLM
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D005271 2006
% 209.88/210.08  |- mesh__publicMeSHNote mesh__D005271
% 209.88/210.08       73; LEGG-PERTHES DISEASE was see under OSTEOCHONDRITIS 1963-78%A%  
% 209.88/210.08  |- skos__prefLabel mesh__D005271 Femur Head Necrosis
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D005271 2001
% 209.88/210.08  |- skos__historyNote mesh__D005271 Necrosis %28%1966-1972%29%
% 209.88/210.08  |- mesh__recordMaintainer mesh__D005271 TGC
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D005271 2002
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D005271 2003
% 209.88/210.08  |- mesh__dateRevised mesh__D005271 1999-11-03
% 209.88/210.08  |- skos__hiddenLabel mesh__D005271 Femur Head Necroses
% 209.88/210.08  |- skos__scopeNote mesh__D046688
% 209.88/210.08       Number of deaths of children between one year of age to 12 years of age in a given population.%A%    
% 209.88/210.08  |- mesh__recordMaintainer mesh__D046688 lkt
% 209.88/210.08  |- mesh__recordAuthorizer mesh__D046688 sjn
% 209.88/210.08  |- skos__hiddenLabel mesh__D046688 Child Mortalities
% 209.88/210.08  |- skos__broader mesh__D046688smesh__D009026
% 209.88/210.08  |- mesh__dateCreated mesh__D046688 2004-07-07
% 209.88/210.08  |- skos__altLabel mesh__D046688 Mortality, Child
% 209.88/210.08  |- skos__annotation mesh__D046688
% 209.88/210.08       a statistical concept; check the tag CHILD, PRESCHOOL or CHILD%A%  
% 209.88/210.08  |- skos__prefLabel mesh__D046688 Child Mortality
% 209.88/210.08  |- mesh__dateEstablished mesh__D046688 2005-01-01
% 209.88/210.08  |- rdf__type mesh__D046688sskos__Concept
% 209.88/210.08  |- mesh__recordOriginator mesh__D046688 lkt
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D046688 2005
% 209.88/210.08  |- skos__historyNote mesh__D046688 Infant Mortality %28%1980-2004%29%
% 209.88/210.08  |- skos__hiddenLabel mesh__D046688 Mortalities, Child
% 209.88/210.08  |- mesh__historyNote mesh__D046688 2005; use INFANT MORTALITY 1980-2004   
% 209.88/210.08  |- mesh__publicMeSHNote mesh__D046688
% 209.88/210.08       2005; see INFANT MORTALITY 1980-2004   
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D046688 2006
% 209.88/210.08  |- skos__historyNote mesh__D046688 Mortality %28%1966-2004%29%
% 209.88/210.08  |- skos__historyNote mesh__D013703 Muscles %28%1966-1979%29%
% 209.88/210.08  |- rdf__type mesh__D013703sskos__Concept
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D013703 2004
% 209.88/210.08  |- mesh__recordOriginator mesh__D013703 SMH
% 209.88/210.08  |- skos__historyNote mesh__D013703 Facial Muscles %28%1966-1979%29%
% 209.88/210.08  |- mesh__recordMaintainer mesh__D013703 nns
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D013703 2005
% 209.88/210.08  |- skos__scopeNote mesh__D013703
% 209.88/210.08       A masticatory muscle whose action is closing the jaws; its posterior portion retracts the mandible.%A%    
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D013703 2003
% 209.88/210.08  |- skos__hiddenLabel mesh__D013703 Temporal Muscles
% 209.88/210.08  |- skos__historyNote mesh__D013703 Masticatory Muscles %28%1966-1979%29%
% 209.88/210.08  |- mesh__historyNote mesh__D013703
% 209.88/210.08       91%28%80%29%; was see under MASTICATORY MUSCLES 1980-90   
% 209.88/210.08  |- skos__hiddenLabel mesh__D013703 Muscles, Temporal
% 209.88/210.08  |- mesh__dateRevised mesh__D013703 2001-07-25
% 209.88/210.08  |- mesh__recordAuthorizer mesh__D013703 sjn
% 209.88/210.08  |- mesh__publicMeSHNote mesh__D013703
% 209.88/210.08       91; was see under MASTICATORY MUSCLES 1980-90   
% 209.88/210.08  |- skos__prefLabel mesh__D013703 Temporal Muscle
% 209.88/210.08  |- mesh__dateEstablished mesh__D013703 1991-01-01
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D013703 2002
% 209.88/210.08  |- mesh__dateCreated mesh__D013703 1979-03-12
% 209.88/210.08  |- skos__broader mesh__D013703smesh__D008410
% 209.88/210.08  |- skos__annotation mesh__D013703
% 209.88/210.08       /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 209.88/210.08  |- skos__hiddenLabel mesh__D013703 Muscle, Temporal
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D013703 2006
% 209.88/210.08  |- skos__altLabel mesh__D018997 HCG, beta Subunit
% 209.88/210.08  |- skos__altLabel mesh__D018997 HCG-beta
% 209.88/210.08  |- skos__prefLabel mesh__D018997
% 209.88/210.08       Chorionic Gonadotropin, beta Subunit, Human
% 209.88/210.08  |- skos__altLabel mesh__D018997
% 209.88/210.08       Chorionic Gonadotropin, beta Polypeptide, Human
% 209.88/210.08  |- mesh__recordAuthorizer mesh__D018997 sjn
% 209.88/210.08  |- skos__broader mesh__D018997smesh__D015415
% 209.88/210.08  |- skos__historyNote mesh__D018997
% 209.88/210.08       Gonadotropins, Chorionic %28%1977-1995%29%
% 209.88/210.08  |- skos__altLabel mesh__D018997 Chorionic Gonadotropin, beta Chain, Human
% 209.88/210.08  |- skos__historyNote mesh__D018997 Peptide Fragments %28%1977-1995%29%
% 209.88/210.08  |- mesh__recordMaintainer mesh__D018997 ssb
% 209.88/210.08  |- mesh__onlineNote mesh__D018997
% 209.88/210.08       use CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN %28%NM%29% to search HCG-BETA 1978-95%A%  
% 209.88/210.08  |- mesh__historyNote mesh__D018997 96; was HCG-BETA %28%NM%29% 1977-95   
% 209.88/210.08  |- skos__broader mesh__D018997smesh__D014408
% 209.88/210.08  |- skos__hiddenLabel mesh__D018997 HCG beta
% 209.88/210.08  |- mesh__publicMeSHNote mesh__D018997
% 209.88/210.08       96; HCG-BETA was indexed under GONADOTROPINS, CHORIONIC %26% PEPTIDE FRAGMENTS 1977-95%A%  
% 209.88/210.08  |- mesh__dateEstablished mesh__D018997 1996-01-01
% 209.88/210.08  |- mesh__dateRevised mesh__D018997 2005-06-30
% 209.88/210.08  |- skos__altLabel mesh__D018997 Human Chorionic Gonadotropin, beta Subunit
% 209.88/210.08  |- skos__broader mesh__D018997smesh__D006063
% 209.88/210.08  |- skos__scopeNote mesh__D018997
% 209.88/210.08       The beta subunit of human CHORIONIC GONADOTROPIN. Its structure is similar to the beta subunit of LUTEINIZING HORMONE, except for the additional 30 amino acids at the carboxy end with the associated carbohydrate residues. HCG-beta is used as a diagnostic marker for early detection of pregnancy, spontaneous abortion %28%ABORTION, SPONTANEOUS%29%; ECTOPIC PREGNANCY; HYDATIDIFORM MOLE; CHORIOCARCINOMA; or DOWN SYNDROME.%A%    
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D018997 2006
% 209.88/210.08  |- rdf__type mesh__D018997sskos__Concept
% 209.88/210.08  |- mesh__recordOriginator mesh__D018997 TPW
% 209.88/210.08  |- mesh__dateCreated mesh__D018997 1995-06-05
% 209.88/210.08  |- skos__broader mesh__D051822smesh__D051820
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D051822 2006
% 209.88/210.08  |- mesh__recordAuthorizer mesh__D051822 sjn
% 209.88/210.08  |- skos__scopeNote mesh__D051822
% 209.88/210.08       A TCF transcription factor that was originally identified as a DNA-binding protein that interacts with the ENHANCERS of T-CELL RECEPTOR ALPHA GENES. It is a plays a role in T-LYMPHOCYTE development.%A%    
% 209.88/210.08  |- rdf__type mesh__D051822sskos__Concept
% 209.88/210.08  |- mesh__recordOriginator mesh__D051822 DRC
% 209.88/210.08  |- skos__hiddenLabel mesh__D051822 TCF 1 Transcription Factor
% 209.88/210.08  |- skos__prefLabel mesh__D051822 T Cell Transcription Factor 1
% 209.88/210.08  |- skos__altLabel mesh__D051822 T Cell Factor 1
% 209.88/210.08  |- skos__hiddenLabel mesh__D051822 Transcription Factor, TCF-1
% 209.88/210.08  |- mesh__historyNote mesh__D051822 2006%28%1991%29%   
% 209.88/210.08  |- mesh__dateEstablished mesh__D051822 2006-01-01
% 209.88/210.08  |- mesh__dateCreated mesh__D051822 2005-06-30
% 209.88/210.08  |- mesh__publicMeSHNote mesh__D051822
% 209.88/210.08       2006; T CELL FACTOR 1 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1995-2005, %26% under NUCLEAR PROTEINS 1991-1994%A%  
% 209.88/210.08  |- mesh__recordMaintainer mesh__D051822 DRC
% 209.88/210.08  |- skos__altLabel mesh__D051822 TCF-1 Transcription Factor
% 209.88/210.08  |- mesh__recordAuthorizer mesh__D018199 PLS
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D018199 1996
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D018199 2001
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D018199 2006
% 209.88/210.08  |- mesh__dateEstablished mesh__D018199 1994-01-01
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D018199 1999
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D018199 2000
% 209.88/210.08  |- skos__hiddenLabel mesh__D018199 Tumors, Mesodermal Mixed
% 209.88/210.08  |- skos__hiddenLabel mesh__D018199 Tumor, Mesodermal Mixed
% 209.88/210.08  |- skos__hiddenLabel mesh__D018199 Mesodermal Mixed Tumor
% 209.88/210.08  |- rdf__type mesh__D018199sskos__Concept
% 209.88/210.08  |- skos__historyNote mesh__D018199
% 209.88/210.08       Neoplasms, Germ Cell and Embryonal %28%1968-1993%29%
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D018199 2005
% 209.88/210.08  |- skos__broader mesh__D018199smesh__D012509
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D018199 1998
% 209.88/210.08  |- skos__broader mesh__D018199smesh__D018193
% 209.88/210.08  |- mesh__recordMaintainer mesh__D018199 KEV
% 209.88/210.08  |- skos__prefLabel mesh__D018199 Mixed Tumor, Mesodermal
% 209.88/210.08  |- skos__scopeNote mesh__D018199
% 209.88/210.08       A sarcoma of the body of the uterus arising in older women, composed of more than one mesenchymal tissue, especially including striated muscle cells. It is associated with previous pelvic radiation exposure in 20%25% of patients. %28%Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1702%29%%A%    
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D018199 2002
% 209.88/210.08  |- skos__annotation mesh__D018199
% 209.88/210.08       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with probably UTERINE NEOPLASMS %28%IM%29%%A%  
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D018199 2004
% 209.88/210.08  |- mesh__historyNote mesh__D018199 94   
% 209.88/210.08  |- skos__hiddenLabel mesh__D018199 Mixed Tumors, Mesodermal
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D018199 1997
% 209.88/210.08  |- mesh__recordOriginator mesh__D018199 PLS
% 209.88/210.08  |- skos__hiddenLabel mesh__D018199 Mesodermal Mixed Tumors
% 209.88/210.08  |- mesh__dateRevised mesh__D018199 1995-06-08
% 209.88/210.08  |- mesh__publicMeSHNote mesh__D018199 94   
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D018199 2003
% 209.88/210.08  |- mesh__dateCreated mesh__D018199 1993-06-25
% 209.88/210.08  |- skos__altLabel mesh__D004977 EMB-Fatol
% 209.88/210.08  |- skos__altLabel mesh__D004977 Llorente Brand of Ethambutol Hydrochloride
% 209.88/210.08  |- skos__altLabel mesh__D004977 Lederle Brand of Ethambutol Hydrochloride
% 209.88/210.08  |- mesh__recordMaintainer mesh__D004977 CCR
% 209.88/210.08  |- skos__altLabel mesh__D004977 SERB Brand of Ethambutol Hydrochloride
% 209.88/210.08  |- skos__prefLabel mesh__D004977 Ethambutol
% 209.88/210.08  |- mesh__recordOriginator mesh__D004977 NLM
% 209.88/210.08  |- skos__hiddenLabel mesh__D004977 EMB Fatol
% 209.88/210.08  |- skos__hiddenLabel mesh__D004977 Llorente, Etambutol
% 209.88/210.08  |- skos__altLabel mesh__D004977 AHP Brand of Ethambutol Hydrochloride
% 209.88/210.08  |- mesh__recordAuthorizer mesh__D004977 sjn
% 209.88/210.08  |- skos__hiddenLabel mesh__D004977 EMB Hefa
% 209.88/210.08  |- skos__altLabel mesh__D004977 Miambutol
% 209.88/210.08  |- skos__altLabel mesh__D004977 Riemser Brand of Ethambutol Hydrochloride
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D004977 2006
% 209.88/210.08  |- mesh__dateEstablished mesh__D004977 1968-01-01
% 209.88/210.08  |- mesh__dateCreated mesh__D004977 1999-01-01
% 209.88/210.08  |- skos__altLabel mesh__D004977 Genopharm Brand of Ethambutol Hydrochloride
% 209.88/210.08  |- skos__altLabel mesh__D004977 Fatol Brand of Ethambutol Hydrochloride
% 209.88/210.08  |- skos__broader mesh__D004977smesh__D005029
% 209.88/210.08  |- skos__altLabel mesh__D004977 Wyeth Brand of Ethambutol Hydrochloride
% 209.88/210.08  |- skos__altLabel mesh__D004977 Elan Brand of Ethambutol Hydrochloride
% 209.88/210.08  |- skos__hiddenLabel mesh__D004977 Hydrochloride, Ethambutol
% 209.88/210.08  |- skos__altLabel mesh__D004977 ICN Brand of Ethambutol Hydrochloride
% 209.88/210.08  |- mesh__publicMeSHNote mesh__D004977 68   
% 209.88/210.08  |- skos__scopeNote mesh__D004977
% 209.88/210.08       An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. %28%From Smith and Reynard, Textbook of Pharmacology, 1992, p863%29%%A%    
% 209.88/210.08  |- mesh__historyNote mesh__D004977 68%28%63%29%   
% 209.88/210.08  |- rdf__type mesh__D004977sskos__Concept
% 209.88/210.08  |- mesh__dateRevised mesh__D004977 2005-06-30
% 209.88/210.08  |- skos__altLabel mesh__D004977 Sanavita Brand of Ethambutol Hydrochloride
% 209.88/210.08  |- skos__altLabel mesh__D004977
% 209.88/210.08       Wernigerode Brand of Ethambutol Hydrochloride
% 209.88/210.08  |- skos__hiddenLabel mesh__D004179 II, Cardiotoxin
% 209.88/210.08  |- skos__hiddenLabel mesh__D004179 I, Cardiotoxin
% 209.88/210.08  |- mesh__recordAuthorizer mesh__D004179 sjn
% 209.88/210.08  |- skos__hiddenLabel mesh__D004179 Gamma, Cobra Toxin
% 209.88/210.08  |- skos__broader mesh__D004179smesh__D003040
% 209.88/210.08  |- skos__historyNote mesh__D004179 Proteins %28%1966-1977%29%
% 209.88/210.08  |- mesh__publicMeSHNote mesh__D004179
% 209.88/210.08       91; was see under COBRA VENOMS 1978-90   
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D004179 2006
% 209.88/210.08  |- mesh__dateEstablished mesh__D004179 1991-01-01
% 209.88/210.08  |- skos__hiddenLabel mesh__D004179 Cardiotoxin, Cobra
% 209.88/210.08  |- mesh__recordMaintainer mesh__D004179 ssb
% 209.88/210.08  |- skos__hiddenLabel mesh__D004179 Elapid Cardiotoxins
% 209.88/210.08  |- skos__annotation mesh__D004179
% 209.88/210.08       proteins in cobra venom; /antag permitted but consider also ANTIVENINS%A%  
% 209.88/210.08  |- skos__hiddenLabel mesh__D004179 Factors, Direct Lytic
% 209.88/210.08  |- skos__hiddenLabel mesh__D004179 4, Cardiotoxin VII
% 209.88/210.08  |- skos__scopeNote mesh__D004179
% 209.88/210.08       Most abundant proteins in cobra %28%Naja of the Elapids%29% venom; basic polypeptides of 57 to 62 amino acids with four disulfide bonds and a molecular weight of less than 7000; causes skeletal and cardiac muscle contracture, interferes with neuromuscular and ganglionic transmission, depolarizes nerve, muscle and blood cell membranes, thus causing hemolysis. Synonyms: cobramine A; cobramine B; cobra cytotoxin; gamma toxin; membrane-active polypeptide.%A%    
% 209.88/210.08  |- skos__hiddenLabel mesh__D004179 VII 4, Cardiotoxin
% 209.88/210.08  |- skos__hiddenLabel mesh__D004179 Basic Polypeptide, Cardiotoxin-Like
% 209.88/210.08  |- skos__altLabel mesh__D004179 Cardiotoxin
% 209.88/210.08  |- skos__historyNote mesh__D004179 Snakes %28%1966-1974%29%
% 209.88/210.08  |- skos__hiddenLabel mesh__D004179 Polypeptide, Cardiotoxin-Like Basic
% 209.88/210.08  |- skos__altLabel mesh__D004179 Cardiotoxin-Like Basic Polypeptide
% 209.88/210.08  |- skos__hiddenLabel mesh__D004179 VII2, Cardiotoxin
% 209.88/210.08  |- skos__hiddenLabel mesh__D004179 Toxin Gamma, Cobra
% 209.88/210.08  |- skos__hiddenLabel mesh__D004179 Lytic Factors, Direct
% 209.88/210.08  |- skos__hiddenLabel mesh__D004179 Cardiotoxin Like Basic Polypeptide
% 209.88/210.08  |- mesh__dateRevised mesh__D004179 2005-06-30
% 209.88/210.08  |- mesh__recordOriginator mesh__D004179 SH
% 209.88/210.08  |- skos__altLabel mesh__D004179 Cobra Cardiotoxin
% 209.88/210.08  |- mesh__dateCreated mesh__D004179 1977-04-27
% 209.88/210.08  |- skos__historyNote mesh__D004179 Snake Venoms %28%1975-1977%29%
% 209.88/210.08  |- skos__historyNote mesh__D004179 Peptides %28%1966-1977%29%
% 209.88/210.08  |- skos__prefLabel mesh__D004179 Direct Lytic Factors
% 209.88/210.08  |- mesh__historyNote mesh__D004179
% 209.88/210.08       91%28%78%29%; was see under COBRA VENOMS 1978-90   
% 209.88/210.08  |- rdf__type mesh__D004179sskos__Concept
% 209.88/210.08  |- skos__historyNote mesh__D004179 Venoms %28%1966-1974%29%
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D009662 2001
% 209.88/210.08  |- mesh__dateRevised mesh__D009662 1992-05-19
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D009662 2005
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D009662 1996
% 209.88/210.08  |- mesh__recordAuthorizer mesh__D009662 PLS
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D009662 2002
% 209.88/210.08  |- skos__prefLabel mesh__D009662 Nortropanes
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D009662 2006
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D009662 1997
% 209.88/210.08  |- mesh__recordOriginator mesh__D009662 NLM
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D009662 1993
% 209.88/210.08  |- rdf__type mesh__D009662sskos__Concept
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D009662 1998
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D009662 1994
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D009662 2003
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D009662 1999
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D009662 2000
% 209.88/210.08  |- mesh__dateCreated mesh__D009662 1999-01-01
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D009662 1995
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D009662 2004
% 209.88/210.08  |- mesh__recordMaintainer mesh__D009662 TAP
% 209.88/210.08  |- skos__broader mesh__D009662smesh__D014326
% 209.88/210.08  |- mesh__dateCreated mesh__D033761 2002-07-03
% 209.88/210.08  |- rdf__type mesh__D033761sskos__Concept
% 209.88/210.08  |- mesh__publicMeSHNote mesh__D033761 2003   
% 209.88/210.08  |- skos__annotation mesh__D033761
% 209.88/210.08       sporulation: coord organism /physiol %28%IM%29% + SPORES, PROTOZOAN %28%NIM%29%; Manual 23.31%A%  
% 209.88/210.08  |- mesh__recordAuthorizer mesh__D033761 sjn
% 209.88/210.08  |- mesh__historyNote mesh__D033761 2003   
% 209.88/210.08  |- mesh__recordMaintainer mesh__D033761 sjn
% 209.88/210.08  |- skos__prefLabel mesh__D033761 Spores, Protozoan
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D033761 2006
% 209.88/210.08  |- mesh__recordOriginator mesh__D033761 ags
% 209.88/210.08  |- skos__broader mesh__D033761smesh__D013170
% 209.88/210.08  |- mesh__dateRevised mesh__D033761 2005-07-01
% 209.88/210.08  |- mesh__dateEstablished mesh__D033761 2003-01-01
% 209.88/210.08  |- skos__scopeNote mesh__D033761
% 209.88/210.08       A vegetative stage in the life cycle of sporozoan PROTOZOA.  It is characteristic of members of the phyla APICOMPLEXA and MICROSPORIDIA.%A%    
% 209.88/210.08  |- skos__altLabel mesh__D000587 Secondary Amine Oxidoreductases
% 209.88/210.08  |- skos__broader mesh__D000587smesh__D010088
% 209.88/210.08  |- mesh__recordMaintainer mesh__D000587 jmp
% 209.88/210.08  |- mesh__recordOriginator mesh__D000587 NLM
% 209.88/210.08  |- skos__scopeNote mesh__D000587
% 209.88/210.08       Enzymes catalyzing the dehydrogenation of secondary amines, introducing a C=N double bond as the primary reaction. In some cases this is later hydrolyzed.%A%    
% 209.88/210.08  |- mesh__recordAuthorizer mesh__D000587 sjn
% 209.88/210.08  |- rdf__type mesh__D000587sskos__Concept
% 209.88/210.08  |- skos__historyNote mesh__D000587 Oxidoreductases %28%1966-1974%29%
% 209.88/210.08  |- mesh__dateEstablished mesh__D000587 1975-01-01
% 209.88/210.08  |- skos__hiddenLabel mesh__D000587 Oxidoreductases, Secondary Amine
% 209.88/210.08  |- skos__altLabel mesh__D000587 Amine Oxidoreductases, Secondary Amine
% 209.88/210.08  |- skos__annotation mesh__D000587
% 209.88/210.08       do not confuse with OXIDOREDUCTASES ACTING ON CH-NH2 GROUP DONORS%A%  
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D000587 2006
% 209.88/210.08  |- skos__prefLabel mesh__D000587
% 209.88/210.08       Oxidoreductases Acting on CH-NH Group Donors
% 209.88/210.08  |- skos__hiddenLabel mesh__D000587
% 209.88/210.08       Oxidoreductases Acting on CH NH Group Donors
% 209.88/210.08  |- mesh__historyNote mesh__D000587 2006%28%1975%29%   
% 209.88/210.08  |- mesh__dateRevised mesh__D000587 2005-06-30
% 209.88/210.08  |- mesh__publicMeSHNote mesh__D000587
% 209.88/210.08       2006; see AMINE OXIDOREDUCTASES 1975-2005   
% 209.88/210.08  |- mesh__dateCreated mesh__D000587 1999-01-01
% 209.88/210.08  |- skos__hiddenLabel mesh__D000587 Amine Oxidoreductases, Secondary
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D019292 2002
% 209.88/210.08  |- skos__annotation mesh__D019292
% 209.88/210.08       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with specific histol type of neopl %28%IM%29%%A%  
% 209.88/210.08  |- skos__prefLabel mesh__D019292 Skull Base Neoplasms
% 209.88/210.08  |- mesh__historyNote mesh__D019292 97   
% 209.88/210.08  |- skos__altLabel mesh__D019292 Neoplasms, Skull Base
% 209.88/210.08  |- skos__hiddenLabel mesh__D019292 Skull Base Neoplasm
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D019292 2001
% 209.88/210.08  |- mesh__dateRevised mesh__D019292 2000-06-22
% 209.88/210.08  |- skos__broader mesh__D019292smesh__D012888
% 209.88/210.08  |- rdf__type mesh__D019292sskos__Concept
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D019292 2004
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D019292 2006
% 209.88/210.08  |- mesh__dateEstablished mesh__D019292 1997-01-01
% 209.88/210.08  |- mesh__dateCreated mesh__D019292 1996-06-10
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D019292 2003
% 209.88/210.08  |- mesh__publicMeSHNote mesh__D019292 97   
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D019292 2005
% 209.88/210.08  |- skos__historyNote mesh__D019292 Skull Neoplasms %28%1966-1996%29%
% 209.88/210.08  |- skos__scopeNote mesh__D019292
% 209.88/210.08       Neoplasms of the base of the skull specifically, differentiated from neoplasms of unspecified sites or bones of the skull %28%SKULL NEOPLASMS%29%.%A%    
% 209.88/210.08  |- skos__hiddenLabel mesh__D019292 Neoplasm, Skull Base
% 209.88/210.08  |- mesh__dateRevised mesh__D027724 2005-07-06
% 209.88/210.08  |- mesh__recordMaintainer mesh__D027724 ags
% 209.88/210.08  |- skos__historyNote mesh__D027724
% 209.88/210.08       Reproduction Techniques %28%1989-2001%29%
% 209.88/210.08  |- skos__hiddenLabel mesh__D027724 Technics, Assisted Reproductive
% 209.88/210.08  |- skos__historyNote mesh__D027724 Fertilization in Vitro %28%1989-2001%29%
% 209.88/210.08  |- skos__hiddenLabel mesh__D027724 Technic, Assisted Reproductive
% 209.88/210.08  |- skos__hiddenLabel mesh__D027724 Assisted Reproductive Technologies
% 209.88/210.08  |- skos__altLabel mesh__D027724 Assisted Reproductive Technics
% 209.88/210.08  |- skos__altLabel mesh__D027724 Assisted Reproductive Techniques
% 209.88/210.08  |- mesh__activeMeSHYear mesh__D027724 2006
% 209.88/210.08  |- skos__hiddenLabel mesh__D027724 Assisted Reproductive Technic
% 209.88/210.08  |- skos__broader mesh__D027724smesh__D012099
% 209.88/210.08  |- skos__hiddenLabel mesh__D027724 Technology, Assisted Reproductive
% 209.88/210.08  |- skos__hiddenLabel mesh__D027724 Reproductive Technics, Assisted
% 209.88/210.08  |- skos__hiddenLabel mesh__D027724 Assisted Reproductive Technology
% 209.88/210.08  |- mesh__recordOriginator mesh__D027724 lkt
% 209.88/210.08  |- rdf__type mesh__D027724sskos__Concept
% 209.88/210.08  |- skos__prefLabel mesh__D027724 Reproductive Techniques, Assisted
% 209.88/210.08  |- skos__hiddenLabel mesh__D027724 Reproductive Technologies, Assisted
% 209.88/210.08  |- skos__hiddenLabel mesh__D027724 Assisted Reproductive Technique
% 209.88/210.09  |- mesh__publicMeSHNote mesh__D027724 2002   
% 209.88/210.09  |- skos__hiddenLabel mesh__D027724 Technique, Assisted Reproductive
% 209.88/210.09  |- mesh__dateEstablished mesh__D027724 2002-01-01
% 209.88/210.09  |- skos__hiddenLabel mesh__D027724 Reproductive Technique, Assisted
% 209.88/210.09  |- mesh__recordAuthorizer mesh__D027724 sjn
% 209.88/210.09  |- skos__hiddenLabel mesh__D027724 Techniques, Assisted Reproductive
% 209.88/210.09  |- skos__hiddenLabel mesh__D027724 Technologies, Assisted Reproductive
% 209.88/210.09  |- skos__annotation mesh__D027724
% 209.88/210.09       usually for humans; may be used for animals if specified; otherwise use BREEDING or its specifics; REPRODUCTIVE TECHNIQUES is also available%A%  
% 209.88/210.09  |- skos__scopeNote mesh__D027724
% 209.88/210.09       Clinical and laboratory techniques used to enhance fertility in humans and animals.%A%    
% 209.88/210.09  |- skos__hiddenLabel mesh__D027724 Reproductive Technic, Assisted
% 209.88/210.09  |- mesh__dateCreated mesh__D027724 2001-07-25
% 209.88/210.09  |- mesh__historyNote mesh__D027724 2002   
% 209.88/210.09  |- skos__prefLabel mesh__D005272 Femur Neck
% 209.88/210.09  |- skos__annotation mesh__D005272 fract = FEMORAL NECK FRACTURES   
% 209.88/210.09  |- skos__hiddenLabel mesh__D005272 Neck, Femur
% 209.88/210.09  |- skos__hiddenLabel mesh__D005272 Necks, Femur
% 209.88/210.09  |- mesh__recordMaintainer mesh__D005272 ags
% 209.88/210.09  |- rdf__type mesh__D005272sskos__Concept
% 209.88/210.09  |- mesh__recordAuthorizer mesh__D005272 sjn
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D005272 2006
% 209.88/210.09  |- skos__hiddenLabel mesh__D005272 Femur Necks
% 209.88/210.09  |- skos__broader mesh__D005272smesh__D005269
% 209.88/210.09  |- mesh__dateCreated mesh__D005272 1999-01-01
% 209.88/210.09  |- mesh__recordOriginator mesh__D005272 NLM
% 209.88/210.09  |- mesh__dateRevised mesh__D005272 2005-06-30
% 209.88/210.09  |- skos__hiddenLabel mesh__D046689 Fetal Mortality, Late
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D046689 2006
% 209.88/210.09  |- skos__historyNote mesh__D046689 Fetal Death %28%1966-2004%29%
% 209.88/210.09  |- skos__hiddenLabel mesh__D046689 Fetal Mortalities, Late
% 209.88/210.09  |- mesh__dateCreated mesh__D046689 2004-07-07
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D046689 2005
% 209.88/210.09  |- skos__hiddenLabel mesh__D046689 Mortality, Late Fetal
% 209.88/210.09  |- mesh__recordOriginator mesh__D046689 lkt
% 209.88/210.09  |- mesh__publicMeSHNote mesh__D046689 2005   
% 209.88/210.09  |- skos__broader mesh__D046689smesh__D009026
% 209.88/210.09  |- skos__hiddenLabel mesh__D046689 Late Fetal Mortalities
% 209.88/210.09  |- skos__scopeNote mesh__D046689
% 209.88/210.09       Number of fetal deaths with stated or presumed gestation of 20 weeks or more in a given population. Late fetal mortality is death after of 28 weeks or more.%A%    
% 209.88/210.09  |- skos__prefLabel mesh__D046689 Fetal Mortality
% 209.88/210.09  |- skos__annotation mesh__D046689
% 209.88/210.09       do not confuse with FETAL DEATH, a non-statistical concept%A%  
% 209.88/210.09  |- mesh__recordAuthorizer mesh__D046689 sjn
% 209.88/210.09  |- skos__hiddenLabel mesh__D046689 Mortalities, Late Fetal
% 209.88/210.09  |- mesh__recordMaintainer mesh__D046689 lkt
% 209.88/210.09  |- mesh__dateEstablished mesh__D046689 2005-01-01
% 209.88/210.09  |- skos__altLabel mesh__D046689 Mortality, Fetal
% 209.88/210.09  |- skos__hiddenLabel mesh__D046689 Fetal Mortalities
% 209.88/210.09  |- skos__hiddenLabel mesh__D046689 Mortalities, Fetal
% 209.88/210.09  |- rdf__type mesh__D046689sskos__Concept
% 209.88/210.09  |- mesh__historyNote mesh__D046689 2005   
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D013704 2005
% 209.88/210.09  |- skos__prefLabel mesh__D013704 Temporomandibular Joint
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D013704 2003
% 209.88/210.09  |- skos__hiddenLabel mesh__D013704 Joint, Temporomandibular
% 209.88/210.09  |- skos__broader mesh__D013704smesh__D007596
% 209.88/210.09  |- skos__broader mesh__D013704smesh__D013284
% 209.88/210.09  |- mesh__recordOriginator mesh__D013704 NLM
% 209.88/210.09  |- skos__altLabel mesh__D013704 TMJ
% 209.88/210.09  |- mesh__recordMaintainer mesh__D013704 ags
% 209.88/210.09  |- skos__scopeNote mesh__D013704
% 209.88/210.09       An articulation between the condyle of the mandible and the articular tubercle of the temporal bone.%A%    
% 209.88/210.09  |- mesh__dateRevised mesh__D013704 2001-07-25
% 209.88/210.09  |- mesh__recordAuthorizer mesh__D013704 sjn
% 209.88/210.09  |- mesh__dateCreated mesh__D013704 1999-01-01
% 209.88/210.09  |- skos__hiddenLabel mesh__D013704 Temporomandibular Joints
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D013704 2006
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D013704 2002
% 209.88/210.09  |- skos__related mesh__D013704smesh__D016302
% 209.88/210.09  |- rdf__type mesh__D013704sskos__Concept
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D013704 2004
% 209.88/210.09  |- skos__hiddenLabel mesh__D013704 Joints, Temporomandibular
% 209.88/210.09  |- mesh__recordOriginator mesh__D018998 TPW
% 209.88/210.09  |- mesh__dateEstablished mesh__D018998 1996-01-01
% 209.88/210.09  |- skos__altLabel mesh__D018998 WGA-HRP
% 209.88/210.09  |- skos__historyNote mesh__D018998 Wheat Germ Agglutinins %28%1987-1995%29%
% 209.88/210.09  |- mesh__dateRevised mesh__D018998 2005-06-30
% 209.88/210.09  |- skos__annotation mesh__D018998 DF: note short X ref   
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D018998 2006
% 209.88/210.09  |- skos__broader mesh__D018998smesh__D014909
% 209.88/210.09  |- mesh__onlineNote mesh__D018998
% 209.88/210.09       use WHEAT GERM AGGLUTININ-HORSERADISH PEROXIDASE CONJUGATE %28%NM%29% to search WHEAT GERM AGGLUTININ-HORSERADISH PEROXIDASE CONJUGATE 1986-95%A%  
% 209.88/210.09  |- rdf__type mesh__D018998sskos__Concept
% 209.88/210.09  |- skos__historyNote mesh__D018998 Horseradish Peroxidase %28%1986-1995%29%
% 209.88/210.09  |- skos__hiddenLabel mesh__D018998
% 209.88/210.09       Wheat Germ Agglutinin Horseradish Peroxidase Conjugate
% 209.88/210.09  |- mesh__dateCreated mesh__D018998 1995-06-05
% 209.88/210.09  |- skos__prefLabel mesh__D018998
% 209.88/210.09       Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate
% 209.88/210.09  |- mesh__recordMaintainer mesh__D018998 ssb
% 209.88/210.09  |- skos__broader mesh__D018998smesh__D006735
% 209.88/210.09  |- mesh__historyNote mesh__D018998
% 209.88/210.09       96; was WHEAT GERM AGGLUTININ-HORSERADISH PEROXIDASE CONJUGATE %28%NM%29% 1986-95%A%  
% 209.88/210.09  |- mesh__recordAuthorizer mesh__D018998 sjn
% 209.88/210.09  |- skos__scopeNote mesh__D018998
% 209.88/210.09       The lectin wheatgerm agglutinin conjugated to the enzyme HORSERADISH PEROXIDASE. It is widely used for tracing neural pathways.%A%    
% 209.88/210.09  |- mesh__publicMeSHNote mesh__D018998
% 209.88/210.09       96; WHEAT GERM AGGLUTININ-HORSERADISH PEROXIDASE CONJUGATE was indexed under HORSERADISH PEROXIDASE 1986-95, WHEAT GERM AGGLUTININS 1987-95, %26% LECTINS 1986%A%  
% 209.88/210.09  |- skos__historyNote mesh__D018998 Lectins %28%1986%29%
% 209.88/210.09  |- skos__hiddenLabel mesh__D004978 MER 25
% 209.88/210.09  |- skos__prefLabel mesh__D004978 Ethamoxytriphetol
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D004978 2006
% 209.88/210.09  |- mesh__historyNote mesh__D004978
% 209.88/210.09       91%28%75%29%; was see under ALCOHOL, ETHYL 1975-90   
% 209.88/210.09  |- skos__scopeNote mesh__D004978 A non-steroidal estrogen antagonist.     
% 209.88/210.09  |- mesh__dateEstablished mesh__D004978 1991-01-01
% 209.88/210.09  |- mesh__publicMeSHNote mesh__D004978
% 209.88/210.09       91; was see under ALCOHOL, ETHYL 1975-90   
% 209.88/210.09  |- mesh__recordMaintainer mesh__D004978 CCR
% 209.88/210.09  |- skos__historyNote mesh__D004978 Diethylamines %28%1974%29%
% 209.88/210.09  |- rdf__type mesh__D004978sskos__Concept
% 209.88/210.09  |- skos__hiddenLabel mesh__D004978 MER25
% 209.88/210.09  |- skos__historyNote mesh__D004978 Alcohol, Ethyl %28%1969-1974%29%
% 209.88/210.09  |- skos__broader mesh__D004978smesh__D000431
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D004978 2003
% 209.88/210.09  |- mesh__recordOriginator mesh__D004978 NLM
% 209.88/210.09  |- mesh__dateRevised mesh__D004978 2000-06-22
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D004978 2001
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D004978 2004
% 209.88/210.09  |- mesh__recordAuthorizer mesh__D004978 sjn
% 209.88/210.09  |- skos__historyNote mesh__D004978 Phenyl Ethers %28%1974%29%
% 209.88/210.09  |- mesh__dateCreated mesh__D004978 1974-11-11
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D004978 2002
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D004978 2005
% 209.88/210.09  |- skos__broader mesh__D051025smesh__D010750
% 209.88/210.09  |- skos__altLabel mesh__D051025 bcl2-Antagonist of Cell Death Protein
% 209.88/210.09  |- skos__altLabel mesh__D051025 Bad Protein
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D051025 2006
% 209.88/210.09  |- mesh__dateCreated mesh__D051025 2005-06-30
% 209.88/210.09  |- mesh__recordMaintainer mesh__D051025 DRC
% 209.88/210.09  |- skos__broader mesh__D051025smesh__D019253
% 209.88/210.09  |- skos__scopeNote mesh__D051025
% 209.88/210.09       A pro-apoptotic protein and member of the Bcl-2 protein family that is regulated by PHOSPHORYLATION. Unphosphorylated Bad protein inhibits the activity of BCL-XL PROTEIN.%A%    
% 209.88/210.09  |- rdf__type mesh__D051025sskos__Concept
% 209.88/210.09  |- skos__hiddenLabel mesh__D051025 Death Protein, bcl-Associated
% 209.88/210.09  |- mesh__dateEstablished mesh__D051025 2006-01-01
% 209.88/210.09  |- mesh__publicMeSHNote mesh__D051025
% 209.88/210.09       2006; BAD PROTEIN was indexed under CARRIER PROTEINS 1995-2005%A%  
% 209.88/210.09  |- skos__prefLabel mesh__D051025 bcl-Associated Death Protein
% 209.88/210.09  |- skos__hiddenLabel mesh__D051025 bcl2 Antagonist of Cell Death Protein
% 209.88/210.09  |- mesh__recordAuthorizer mesh__D051025 sjn
% 209.88/210.09  |- skos__hiddenLabel mesh__D051025 bcl Associated Death Protein
% 209.88/210.09  |- mesh__recordOriginator mesh__D051025 DRC
% 209.88/210.09  |- mesh__historyNote mesh__D051025 2006%28%1995%29%   
% 209.88/210.09  |- mesh__onlineNote mesh__D009663
% 209.88/210.09       use NORWALK VIRUS to search NORWALK AGENT 1982-93   
% 209.88/210.09  |- mesh__dateEstablished mesh__D009663 1982-01-01
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D009663 2006
% 209.88/210.09  |- mesh__publicMeSHNote mesh__D009663 94; was NORWALK AGENT 1982-93   
% 209.88/210.09  |- mesh__historyNote mesh__D009663 94; was NORWALK AGENT 1982-93   
% 209.88/210.09  |- skos__annotation mesh__D009663
% 209.88/210.09       infection: coord IM with CALICIVIRIDAE INFECTIONS %28%IM%29% + probably GASTROENTERITIS %28%IM%29%%A%  
% 209.88/210.09  |- rdf__type mesh__D009663sskos__Concept
% 209.88/210.09  |- skos__scopeNote mesh__D009663
% 209.88/210.09       The type species in the genus NOROVIRUS, first isolated in 1968 from the stools of school children in Norwalk, Ohio, who were suffering from GASTROENTERITIS. The virions are non-enveloped spherical particles containing a single protein. Multiple strains are named after the places where  outbreaks have occurred.%A%    
% 209.88/210.09  |- mesh__dateRevised mesh__D009663 2003-07-09
% 209.88/210.09  |- skos__broader mesh__D009663smesh__D029322
% 209.88/210.09  |- mesh__recordMaintainer mesh__D009663 ags
% 209.88/210.09  |- mesh__recordAuthorizer mesh__D009663 sjn
% 209.88/210.09  |- mesh__dateCreated mesh__D009663 1981-05-20
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D009663 2004
% 209.88/210.09  |- skos__prefLabel mesh__D009663 Norwalk virus
% 209.88/210.09  |- skos__altLabel mesh__D009663 Norwalk Agent
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D009663 2005
% 209.88/210.09  |- mesh__recordOriginator mesh__D009663 RC
% 209.88/210.09  |- skos__historyNote mesh__D009663 Gastroenteritis %28%1966-1981%29%
% 209.88/210.09  |- mesh__dateCreated mesh__D001680 1999-01-01
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D001680 2006
% 209.88/210.09  |- mesh__recordMaintainer mesh__D001680 jls
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D001680 2002
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D001680 2005
% 209.88/210.09  |- mesh__recordAuthorizer mesh__D001680 sjn
% 209.88/210.09  |- mesh__recordOriginator mesh__D001680 NLM
% 209.88/210.09  |- mesh__dateRevised mesh__D001680 1999-11-09
% 209.88/210.09  |- skos__prefLabel mesh__D001680 Biography
% 209.88/210.09  |- skos__scopeNote mesh__D001680
% 209.88/210.09       A written account of a person%27%s life and the branch of literature concerned with the lives of people. %28%Harrod%27%s Librarians%27% Glossary, 7th ed%29%%A%    
% 209.88/210.09  |- skos__altLabel mesh__D001680 Biographies
% 209.88/210.09  |- rdf__type mesh__D001680sskos__Concept
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D001680 2001
% 209.88/210.09  |- skos__annotation mesh__D001680
% 209.88/210.09       biog as a subject, not for biogs of persons: Manual 32.10; do not confuse with Publication Type BIOGRAPHY %28%Manual 17.17+%29%; IM; no qualif; memoirs as a subject go here or under AUTOBIOGRAPHY if pertinent; DF: BIOG or BIOGR%A%  
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D001680 2004
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D001680 2000
% 209.88/210.09  |- skos__related mesh__D001680smesh__D001325
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D001680 2003
% 209.88/210.09  |- skos__broader mesh__D001680smesh__D008091
% 209.88/210.09  |- mesh__recordMaintainer mesh__D000588 TPW
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D000588 2005
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D000588 1998
% 209.88/210.09  |- skos__broader mesh__D000588smesh__D009930
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D000588 2004
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D000588 1997
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D000588 2003
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D000588 1996
% 209.88/210.09  |- mesh__dateRevised mesh__D000588 1995-03-16
% 209.88/210.09  |- mesh__recordOriginator mesh__D000588 NLM
% 209.88/210.09  |- rdf__type mesh__D000588sskos__Concept
% 209.88/210.09  |- skos__prefLabel mesh__D000588 Amines
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D000588 2002
% 209.88/210.09  |- mesh__dateCreated mesh__D000588 1999-01-01
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D000588 2001
% 209.88/210.09  |- mesh__recordAuthorizer mesh__D000588 PLS
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D000588 2006
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D000588 2000
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D000588 1999
% 209.88/210.09  |- skos__scopeNote mesh__D000588
% 209.88/210.09       A group of compounds derived from ammonia by substituting organic radicals for the hydrogens. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 209.88/210.09  |- skos__broader mesh__D006761Q000295smesh__D006761
% 209.88/210.09  |- mesh__preferredCombination mesh__D006761Q000295smesh__D004865
% 209.88/210.09  |- rdf__type mesh__D006761Q000295smesh__CompoundConcept
% 209.88/210.09  |- rdf__type mesh__D005273sskos__Concept
% 209.88/210.09  |- skos__historyNote mesh__D005273 Carbamates %28%1974-1976%29%
% 209.88/210.09  |- skos__prefLabel mesh__D005273 Fenbendazole
% 209.88/210.09  |- mesh__dateCreated mesh__D005273 1976-04-16
% 209.88/210.09  |- mesh__dateRevised mesh__D005273 2005-06-30
% 209.88/210.09  |- mesh__historyNote mesh__D005273
% 209.88/210.09       91%28%77%29%; was see under BENZIMIDAZOLES 1977-90   
% 209.88/210.09  |- skos__scopeNote mesh__D005273
% 209.88/210.09       Antinematodal benzimidazole used in veterinary medicine.%A%    
% 209.88/210.09  |- mesh__dateEstablished mesh__D005273 1991-01-01
% 209.88/210.09  |- skos__historyNote mesh__D005273 Benzimidazoles %28%1974-1976%29%
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D005273 2006
% 209.88/210.09  |- skos__broader mesh__D005273smesh__D001562
% 209.88/210.09  |- skos__altLabel mesh__D005273 Phenbendasol
% 209.88/210.09  |- mesh__publicMeSHNote mesh__D005273
% 209.88/210.09       91; was see under BENZIMIDAZOLES 1977-90   
% 209.88/210.09  |- mesh__recordAuthorizer mesh__D005273 sjn
% 209.88/210.09  |- mesh__recordMaintainer mesh__D005273 exl
% 209.88/210.09  |- skos__broader mesh__D005273smesh__D002219
% 209.88/210.09  |- skos__historyNote mesh__D005273 Sulfides %28%1974%29%
% 209.88/210.09  |- mesh__recordOriginator mesh__D005273 SH
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D013705 1999
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D013705 2000
% 209.88/210.09  |- mesh__recordOriginator mesh__D013705 RC
% 209.88/210.09  |- skos__hiddenLabel mesh__D013705 Temporomandibular Joint Disorder
% 209.88/210.09  |- skos__hiddenLabel mesh__D013705 Joint Disease, Temporomandibular
% 209.88/210.09  |- skos__altLabel mesh__D013705 TMJ Diseases
% 209.88/210.09  |- skos__annotation mesh__D013705
% 209.88/210.09       GEN or unspecified; TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME is also available; DF: TMJ DIS%A%  
% 209.88/210.09  |- mesh__publicMeSHNote mesh__D013705
% 209.88/210.09       97; was TEMPOROMANDIBULAR JOINT DISEASES 1982-96   
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D013705 1998
% 209.88/210.09  |- skos__altLabel mesh__D013705 TMJ Disorders
% 209.88/210.09  |- rdf__type mesh__D013705sskos__Concept
% 209.88/210.09  |- skos__hiddenLabel mesh__D013705 Disorders, TMJ
% 209.88/210.09  |- skos__hiddenLabel mesh__D013705 Joint Diseases, Temporomandibular
% 209.88/210.09  |- skos__broader mesh__D013705smesh__D017271
% 209.88/210.09  |- skos__hiddenLabel mesh__D013705 Disease, TMJ
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D013705 2004
% 209.88/210.09  |- mesh__dateCreated mesh__D013705 1981-02-24
% 209.88/210.09  |- skos__hiddenLabel mesh__D013705 Disorder, Temporomandibular
% 209.88/210.09  |- skos__hiddenLabel mesh__D013705 Disorder, TMJ
% 209.88/210.09  |- mesh__recordMaintainer mesh__D013705 TGC
% 209.88/210.09  |- mesh__dateRevised mesh__D013705 1996-06-10
% 209.88/210.09  |- skos__hiddenLabel mesh__D013705 Diseases, Temporomandibular Joint
% 209.88/210.09  |- mesh__recordAuthorizer mesh__D013705 PLS
% 209.88/210.09  |- skos__hiddenLabel mesh__D013705 Temporomandibular Disorder
% 209.88/210.09  |- mesh__dateEstablished mesh__D013705 1982-01-01
% 209.88/210.09  |- skos__hiddenLabel mesh__D013705 Diseases, TMJ
% 209.88/210.09  |- skos__hiddenLabel mesh__D013705 Disorders, Temporomandibular Joint
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D013705 2003
% 209.88/210.09  |- skos__hiddenLabel mesh__D013705 TMJ Disease
% 209.88/210.09  |- skos__hiddenLabel mesh__D013705 Temporomandibular Joint Disease
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D013705 2002
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D013705 2006
% 209.88/210.09  |- skos__prefLabel mesh__D013705 Temporomandibular Joint Disorders
% 209.88/210.09  |- skos__hiddenLabel mesh__D013705 Joint Disorders, Temporomandibular
% 209.88/210.09  |- skos__hiddenLabel mesh__D013705 TMJ Disorder
% 209.88/210.09  |- skos__hiddenLabel mesh__D013705 Joint Disorder, Temporomandibular
% 209.88/210.09  |- skos__hiddenLabel mesh__D013705 Disorders, Temporomandibular
% 209.88/210.09  |- skos__hiddenLabel mesh__D013705 Disorder, Temporomandibular Joint
% 209.88/210.09  |- skos__scopeNote mesh__D013705
% 209.88/210.09       A variety of conditions affecting the anatomic and functional characteristics of the temporomandibular joint. Factors contributing to the complexity of temporomandibular diseases are its relation to dentition and mastication and the symptomatic effects in other areas which account for referred pain to the joint and the difficulties in applying traditional diagnostic procedures to temporomandibular joint pathology where tissue is rarely obtained and x-rays are often inadequate or nonspecific. Common diseases are developmental abnormalities, trauma, subluxation, luxation, arthritis, and neoplasia. %28%From Thoma%27%s Oral Pathology, 6th ed, pp577-600%29%%A%    
% 209.88/210.09  |- skos__historyNote mesh__D013705 Joint Diseases %28%1966-1981%29%
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D013705 1997
% 209.88/210.09  |- skos__hiddenLabel mesh__D013705 Disease, Temporomandibular Joint
% 209.88/210.09  |- skos__altLabel mesh__D013705 Temporomandibular Joint Diseases
% 209.88/210.09  |- mesh__historyNote mesh__D013705
% 209.88/210.09       97; was TEMPOROMANDIBULAR JOINT DISEASES 1982-96   
% 209.88/210.09  |- skos__broader mesh__D013705smesh__D007592
% 209.88/210.09  |- skos__historyNote mesh__D013705
% 209.88/210.09       Temporomandibular Joint %28%1966-1981%29%
% 209.88/210.09  |- skos__broader mesh__D013705smesh__D009057
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D013705 2001
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D013705 2005
% 209.88/210.09  |- skos__altLabel mesh__D013705 Temporomandibular Disorders
% 209.88/210.09  |- skos__hiddenLabel mesh__D018999 Toxin, CTX
% 209.88/210.09  |- rdf__type mesh__D018999sskos__Concept
% 209.88/210.09  |- mesh__dateCreated mesh__D018999 1995-05-24
% 209.88/210.09  |- mesh__recordOriginator mesh__D018999 TPW
% 209.88/210.09  |- mesh__dateEstablished mesh__D018999 1996-01-01
% 209.88/210.09  |- mesh__dateRevised mesh__D018999 2005-06-30
% 209.88/210.09  |- skos__prefLabel mesh__D018999 Charybdotoxin
% 209.88/210.09  |- skos__historyNote mesh__D018999 Scorpion Venoms %28%1984-1995%29%
% 209.88/210.09  |- skos__scopeNote mesh__D018999
% 209.88/210.09       A 37-amino acid residue peptide isolated from the scorpion Leiurus quinquestriatus hebraeus. It is a neurotoxin that inhibits calcium activated potassium channels.%A%    
% 209.88/210.09  |- skos__hiddenLabel mesh__D018999 Toxin, Quinquestriatus
% 209.88/210.09  |- skos__broader mesh__D018999smesh__D012604
% 209.88/210.09  |- mesh__recordMaintainer mesh__D018999 ssb
% 209.88/210.09  |- skos__broader mesh__D018999smesh__D010455
% 209.88/210.09  |- mesh__historyNote mesh__D018999
% 209.88/210.09       96; was QUINQUESTRIATUS TOXIN %28%NM%29% 1984-95   
% 209.88/210.09  |- mesh__onlineNote mesh__D018999
% 209.88/210.09       use CHARYBDOTOXIN %28%NM%29% to search QUINQUESTRIATUS TOXIN 1984-95%A%  
% 209.88/210.09  |- mesh__recordAuthorizer mesh__D018999 sjn
% 209.88/210.09  |- skos__altLabel mesh__D018999 Quinquestriatus Toxin
% 209.88/210.09  |- mesh__publicMeSHNote mesh__D018999
% 209.88/210.09       96; QUINQUESTRIATUS TOXIN was indexed under SCORPION VENOMS 1984-95%A%  
% 209.88/210.09  |- skos__altLabel mesh__D018999 CTX Toxin
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D018999 2006
% 209.88/210.09  |- skos__altLabel mesh__D018999 ChTX
% 209.88/210.09  |- skos__altLabel mesh__D004979 Sanofi Synthelabo Brand of Ethamsylate
% 209.88/210.09  |- mesh__dateEstablished mesh__D004979 1991-01-01
% 209.88/210.09  |- rdf__type mesh__D004979sskos__Concept
% 209.88/210.09  |- skos__broader mesh__D004979smesh__D001557
% 209.88/210.09  |- skos__altLabel mesh__D004979 Esteve Brand of Ethamsylate
% 209.88/210.09  |- skos__historyNote mesh__D004979 Hydroquinones %28%1974%29%
% 209.88/210.09  |- mesh__dateCreated mesh__D004979 1974-11-19
% 209.88/210.09  |- skos__altLabel mesh__D004979 Allphar Brand of Ethamsylate
% 209.88/210.09  |- skos__altLabel mesh__D004979 Cyclonamine
% 209.88/210.09  |- mesh__publicMeSHNote mesh__D004979
% 209.88/210.09       91; was see under BENZENESULFONATES 1975-90   
% 209.88/210.09  |- mesh__dateRevised mesh__D004979 2005-06-30
% 209.88/210.09  |- mesh__recordMaintainer mesh__D004979 CCR
% 209.88/210.09  |- skos__altLabel mesh__D004979 Etamsylate
% 209.88/210.09  |- skos__historyNote mesh__D004979 Benzenesulfonates %28%1974%29%
% 209.88/210.09  |- skos__altLabel mesh__D004979 Dicynene
% 209.88/210.09  |- skos__scopeNote mesh__D004979
% 209.88/210.09       Benzenesulfonate derivative used as a systemic hemostatic.%A%    
% 209.88/210.09  |- mesh__recordOriginator mesh__D004979 NLM
% 209.88/210.09  |- skos__altLabel mesh__D004979 OM Brand of Ethamsylate
% 209.88/210.09  |- mesh__historyNote mesh__D004979
% 209.88/210.09       91%28%75%29%; was see under BENZENESULFONATES 1975-90   
% 209.88/210.09  |- skos__prefLabel mesh__D004979 Ethamsylate
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D004979 2006
% 209.88/210.09  |- mesh__recordAuthorizer mesh__D004979 sjn
% 209.88/210.09  |- skos__hiddenLabel mesh__D051026
% 209.88/210.09       Formyltransferase, Phosphoribosylglycinamide
% 209.88/210.09  |- mesh__dateCreated mesh__D051026 2005-06-30
% 209.88/210.09  |- mesh__dateEstablished mesh__D051026 2006-01-01
% 209.88/210.09  |- mesh__recordAuthorizer mesh__D051026 sjn
% 209.88/210.09  |- skos__hiddenLabel mesh__D051026
% 209.88/210.09       Transformylase, 5%27%-Phosphoribosylglycinamide
% 209.88/210.09  |- skos__altLabel mesh__D051026
% 209.88/210.09       2-Amino-N-Ribosylacetamide 5%27%-Phosphate Transformylase
% 209.88/210.09  |- skos__altLabel mesh__D051026 GARTFase
% 209.88/210.09  |- skos__scopeNote mesh__D051026
% 209.88/210.09       An enzyme that catalyzes the transfer of a formyl group from N10-formyltetrahydrofolate to N1-%28%5-phospho-D-ribosyl%29%glycinamide to yield  N2-formyl-N1-%28%5-phospho-D-ribosyl%29%glycinamide and TETRAHYDROFOLATE. It plays a role in the de novo PURINE biosynthetic pathway.%A%    
% 209.88/210.09  |- skos__altLabel mesh__D051026 GAR Transformylase
% 209.88/210.09  |- skos__hiddenLabel mesh__D051026
% 209.88/210.09       Transformylase, 2-Amino-N-Ribosylacetamide 5%27%-Phosphate
% 209.88/210.09  |- mesh__recordMaintainer mesh__D051026 AKE
% 209.88/210.09  |- skos__altLabel mesh__D051026 Glycinamide Ribonucleotide Transformylase
% 209.88/210.09  |- skos__prefLabel mesh__D051026
% 209.88/210.09       Phosphoribosylglycinamide Formyltransferase
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D051026 2006
% 209.88/210.09  |- skos__hiddenLabel mesh__D051026 Transformylase, GAR
% 209.88/210.09  |- skos__hiddenLabel mesh__D051026
% 209.88/210.09       Ribonucleotide Transformylase, Glycinamide
% 209.88/210.09  |- skos__altLabel mesh__D051026 Glycinamideribotide Transformylase
% 209.88/210.09  |- skos__hiddenLabel mesh__D051026 Formyltransferase, GAR
% 209.88/210.09  |- skos__altLabel mesh__D051026
% 209.88/210.09       5%27%-Phosphoribosylglycinamide Transformylase
% 209.88/210.09  |- skos__hiddenLabel mesh__D051026
% 209.88/210.09       5%27%-Phosphate Transformylase, 2-Amino-N-Ribosylacetamide
% 209.88/210.09  |- skos__hiddenLabel mesh__D051026
% 209.88/210.09       5%27% Phosphoribosylglycinamide Transformylase
% 209.88/210.09  |- skos__hiddenLabel mesh__D051026
% 209.88/210.09       2 Amino N Ribosylacetamide 5%27% Phosphate Transformylase
% 209.88/210.09  |- skos__altLabel mesh__D051026 GAR Formyltransferase
% 209.88/210.09  |- skos__broader mesh__D051026smesh__D019877
% 209.88/210.09  |- skos__hiddenLabel mesh__D051026
% 209.88/210.09       Transformylase, Glycinamide Ribonucleotide
% 209.88/210.09  |- mesh__historyNote mesh__D051026
% 209.88/210.09       2006%28%1980%29%; use ACYLTRANSFERASES 1979, GLYCINE 1974-1979, FORMIC ACIDS 1974-1979,  PENTOSEPHOSPHATES 1974-1975, RIBOSEMONOPHOSPHATES 1975-1979, %26% TRANSFERASES 1974-1978%A%  
% 209.88/210.09  |- rdf__type mesh__D051026sskos__Concept
% 209.88/210.09  |- mesh__publicMeSHNote mesh__D051026
% 209.88/210.09       2006; PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE was indexed under HYDROXYMETHYL AND FORMYL TRANSFERASES 1998-2005, ACYLTRANSFERASES 1979-1997, GLYCINE 1974-1980, FORMIC ACIDS 1974-1982, GLYCINE 1980-1982, PENTOSEPHOSPHATES 1974-1975, RIBOSEMONOPHOSPHATES 1975-1980, %26% under TRANSFERASES 1974-1978%A%  
% 209.88/210.09  |- skos__hiddenLabel mesh__D051026 Transformylase, Glycinamideribotide
% 209.88/210.09  |- mesh__recordOriginator mesh__D051026 AKE
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D009664 1997
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D009664 2002
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D009664 1996
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D009664 2006
% 209.88/210.09  |- mesh__recordAuthorizer mesh__D009664 PLS
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D009664 1995
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D009664 2001
% 209.88/210.09  |- mesh__dateCreated mesh__D009664 1999-01-01
% 209.88/210.09  |- rdf__type mesh__D009664sskos__Concept
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D009664 2000
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D009664 2005
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D009664 1994
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D009664 2004
% 209.88/210.09  |- skos__broader mesh__D009664smesh__D012537
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D009664 1999
% 209.88/210.09  |- skos__prefLabel mesh__D009664 Norway
% 209.88/210.09  |- mesh__dateRevised mesh__D009664 1993-06-03
% 209.88/210.09  |- mesh__recordMaintainer mesh__D009664 PLS
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D009664 2003
% 209.88/210.09  |- mesh__recordOriginator mesh__D009664 NLM
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D009664 1998
% 209.88/210.09  |- skos__altLabel mesh__D001681 Assay, Biological
% 209.88/210.09  |- mesh__recordAuthorizer mesh__D001681 PLS
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D001681 2005
% 209.88/210.09  |- skos__prefLabel mesh__D001681 Biological Assay
% 209.88/210.09  |- skos__hiddenLabel mesh__D001681 Assay, Biologic
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D001681 2000
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D001681 1995
% 209.88/210.09  |- skos__annotation mesh__D001681
% 209.88/210.09       assays using living-matter intermediate; check text: not all %22%bioassays%22% are MeSH term BIOLOGICAL ASSAY; Manual 22.27; DF: BIOL ASSAY%A%  
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D001681 1998
% 209.88/210.09  |- skos__broader mesh__D001681smesh__D008919
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D001681 1994
% 209.88/210.09  |- rdf__type mesh__D001681sskos__Concept
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D001681 2002
% 209.88/210.09  |- skos__altLabel mesh__D001681 Bioassay
% 209.88/210.09  |- mesh__recordOriginator mesh__D001681 NLM
% 209.88/210.09  |- skos__altLabel mesh__D001681 Assays, Biological
% 209.88/210.09  |- mesh__recordMaintainer mesh__D001681 TAP
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D001681 2004
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D001681 1997
% 209.88/210.09  |- skos__altLabel mesh__D001681 Biologic Assay
% 209.88/210.09  |- skos__hiddenLabel mesh__D001681 Biological Assays
% 209.88/210.09  |- skos__altLabel mesh__D001681 Biologic Assays
% 209.88/210.09  |- mesh__dateRevised mesh__D001681 1992-03-25
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D001681 2003
% 209.88/210.09  |- skos__hiddenLabel mesh__D001681 Bioassays
% 209.88/210.09  |- skos__scopeNote mesh__D001681
% 209.88/210.09       A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc.%A%    
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D001681 1996
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D001681 1993
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D001681 2001
% 209.88/210.09  |- mesh__dateCreated mesh__D001681 1999-01-01
% 209.88/210.09  |- skos__hiddenLabel mesh__D001681 Assays, Biologic
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D001681 2006
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D001681 1999
% 209.88/210.09  |- mesh__activeMeSHYear mesh__D019294 2005
% 209.88/210.09  |- skos__prefLabel mesh__D019294 Xanthomatosis, Cerebrotendinous
% 209.88/210.09  |- mesh__dateEstablished mesh__D019294 1997-01-01
% 209.88/210.09  |- skos__historyNote mesh__D019294 Xanthomatosis %28%1968-1996%29%
% 209.88/210.09  |- skos__altLabel mesh__D019294 Van Bogaert-Scherer-Epstein Disease
% 209.88/210.09  |- mesh__dateRevised mesh__D019294 2001-07-25
% 209.88/210.09  |- mesh__dateCreated mesh__D019294 1996-06-10
% 209.88/210.09  |- skos__broader mesh__D019294smesh__D008052
% 209.88/210.09  |- mesh__publicMeSHNote mesh__D019294 97   
% 209.88/210.09  |- mesh__recordMaintainer mesh__D019294 nns
% 209.88/210.09  |- skos__hiddenLabel mesh__D019294 Cerebrotendinous Xanthomatoses
% 209.88/210.09  |- skos__hiddenLabel mesh__D019294 Disease, Van Bogaert-Scherer-Epstein
% 209.88/210.09  |- mesh__recordAuthorizer mesh__D019294 sjn
% 209.88/210.09  |- mesh__historyNote mesh__D019294 97   
% 209.88/210.09  |- skos__broader mesh__D019294smesh__D014973
% 209.88/210.10  |- skos__hiddenLabel mesh__D019294 Bogaert-Scherer-Epstein Disease, Van
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D019294 2004
% 209.88/210.10  |- skos__annotation mesh__D019294 a lipid storage dis   
% 209.88/210.10  |- skos__hiddenLabel mesh__D019294 Van Bogaert Scherer Epstein Disease
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D019294 2002
% 209.88/210.10  |- skos__scopeNote mesh__D019294
% 209.88/210.10       A lipid storage disease, inherited as an autosomal recessive trait, characterized by xanthomas of the tendons, the white matter of the brain, and the lungs, and by spasticity, ataxia, pyramidal paresis, mental retardation, dementia, early cataracts, and atherosclerosis. It is associated with elevated plasma and tissue levels of cholestanol and defective bile synthesis, with the deposition of cholestanol in the central nervous system and myelin of peripheral nerves. The lesions contain cholesterol and dehydrocholesterol. %28%Dorland, 28th ed%29%%A%    
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D019294 2003
% 209.88/210.10  |- skos__hiddenLabel mesh__D019294 Xanthomatoses, Cerebrotendinous
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D019294 2006
% 209.88/210.10  |- rdf__type mesh__D019294sskos__Concept
% 209.88/210.10  |- skos__hiddenLabel mesh__D019294 Cerebrotendinous Xanthomatosis
% 209.88/210.10  |- mesh__recordOriginator mesh__D019294 TGC
% 209.88/210.10  |- skos__broader mesh__D013706smesh__D009209
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D013706 2002
% 209.88/210.10  |- skos__hiddenLabel mesh__D013706 Joint Syndrome, Temporomandibular
% 209.88/210.10  |- skos__altLabel mesh__D013706
% 209.88/210.10       Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint
% 209.88/210.10  |- mesh__historyNote mesh__D013706
% 209.88/210.10       97; was TEMPOROMANDIBULAR JOINT SYNDROME 1973-96, was COSTEN%27%S SYNDROME 1966-72; COSTEN%27%S SYNDROME was see TEMPOROMANDIBULAR JOINT SYNDROME 1973-96%A%  
% 209.88/210.10  |- skos__hiddenLabel mesh__D013706 Costens Syndrome
% 209.88/210.10  |- mesh__dateRevised mesh__D013706 1996-06-13
% 209.88/210.10  |- skos__hiddenLabel mesh__D013706 Costen Syndrome
% 209.88/210.10  |- mesh__dateCreated mesh__D013706 1999-01-01
% 209.88/210.10  |- skos__prefLabel mesh__D013706
% 209.88/210.10       Temporomandibular Joint Dysfunction Syndrome
% 209.88/210.10  |- skos__broader mesh__D013706smesh__D013705
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D013706 1998
% 209.88/210.10  |- mesh__recordAuthorizer mesh__D013706 PLS
% 209.88/210.10  |- mesh__onlineNote mesh__D013706
% 209.88/210.10       use TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME to search TEMPOROMANDIBULAR JOINT SYNDROME 1973-96 %26% COSTEN%27%S SYNDROME 1966-96%A%  
% 209.88/210.10  |- skos__hiddenLabel mesh__D013706 Syndrome, TMJ
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D013706 2005
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D013706 1999
% 209.88/210.10  |- mesh__recordMaintainer mesh__D013706 TGC
% 209.88/210.10  |- skos__scopeNote mesh__D013706
% 209.88/210.10       A symptom complex consisting of pain, muscle tenderness, clicking in the joint, and limitation or alteration of mandibular movement. The symptoms are subjective and manifested primarily in the masticatory muscles rather than the temporomandibular joint itself. Etiologic factors are uncertain but include occlusal dysharmony and psychophysiologic factors.%A%    
% 209.88/210.10  |- mesh__publicMeSHNote mesh__D013706
% 209.88/210.10       97; was TEMPOROMANDIBULAR JOINT SYNDROME 1973-96, was COSTEN%27%S SYNDROME 1966-72; COSTEN%27%S SYNDROME was see TEMPOROMANDIBULAR JOINT SYNDROME 1973-96%A%  
% 209.88/210.10  |- skos__annotation mesh__D013706 DF: note short X ref TMJ SYNDROME   
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D013706 2003
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D013706 1997
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D013706 2006
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D013706 2000
% 209.88/210.10  |- skos__altLabel mesh__D013706 Costen%27%s Syndrome
% 209.88/210.10  |- rdf__type mesh__D013706sskos__Concept
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D013706 2004
% 209.88/210.10  |- skos__altLabel mesh__D013706 TMJ Syndrome
% 209.88/210.10  |- skos__hiddenLabel mesh__D013706 Syndrome, Costen%27%s
% 209.88/210.10  |- skos__hiddenLabel mesh__D013706 Syndrome, Temporomandibular Joint
% 209.88/210.10  |- mesh__recordOriginator mesh__D013706 NLM
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D013706 2001
% 209.88/210.10  |- mesh__dateEstablished mesh__D013706 1973-01-01
% 209.88/210.10  |- skos__altLabel mesh__D013706 Temporomandibular Joint Syndrome
% 209.88/210.10  |- skos__broader mesh__D005384Q000293smesh__D005384
% 209.88/210.10  |- mesh__preferredCombination mesh__D005384Q000293smesh__D005383
% 209.88/210.10  |- rdf__type mesh__D005384Q000293smesh__CompoundConcept
% 209.88/210.10  |- skos__hiddenLabel mesh__D051027
% 209.88/210.10       Formyltransferase, Phosphoribosylaminoimidazolecarboxamide
% 209.88/210.10  |- skos__scopeNote mesh__D051027
% 209.88/210.10       An enzyme that catalyzes the conversion of aminoimidazole-4-carboxamide ribonucleotide to 5-formyl-aminoimidazole-4-carboxamide ribonucleotide in the PURINE de novo synthesis pathway. It requires the cofactor N%28%10%29%-FORMYLTETRAHYDROFOLATE as the formyl donor.%A%    
% 209.88/210.10  |- mesh__recordOriginator mesh__D051027 AKE
% 209.88/210.10  |- skos__hiddenLabel mesh__D051027 Transformylase, AICAR
% 209.88/210.10  |- mesh__historyNote mesh__D051027
% 209.88/210.10       2006%28%1980%29%; use FORMIC ACIDS 1974-1980, AMINOIMIDAZOLE CARBOXAMIDE 1979-1980, IMIDAZOLES 1974-1979, PENTOSEPHOSPHATES 1974-1979, TRANSFERASES 1974-1979%A%  
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D051027 2006A
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D051027 2006
% 209.88/210.10  |- skos__hiddenLabel mesh__D051027
% 209.88/210.10       Ribonucleotide Transformylase, Aminoimidazolecarboxamide
% 209.88/210.10  |- mesh__recordMaintainer mesh__D051027 ags
% 209.88/210.10  |- skos__hiddenLabel mesh__D051027 Formyltransferase, AICAR
% 209.88/210.10  |- mesh__dateCreated mesh__D051027 2005-06-30
% 209.88/210.10  |- mesh__dateEstablished mesh__D051027 2006-01-01
% 209.88/210.10  |- mesh__recordAuthorizer mesh__D051027 ags
% 209.88/210.10  |- skos__hiddenLabel mesh__D051027
% 209.88/210.10       Transformylase, Aminoimidazolecarboxamide Ribonucleotide
% 209.88/210.10  |- skos__altLabel mesh__D051027 AICAR Formyltransferase
% 209.88/210.10  |- skos__broader mesh__D051027smesh__D019877
% 209.88/210.10  |- mesh__dateRevised mesh__D051027 2005-07-14
% 209.88/210.10  |- skos__altLabel mesh__D051027 AICARTFase
% 209.88/210.10  |- skos__altLabel mesh__D051027
% 209.88/210.10       Aminoimidazolecarboxamide Ribonucleotide Transformylase
% 209.88/210.10  |- rdf__type mesh__D051027sskos__Concept
% 209.88/210.10  |- mesh__publicMeSHNote mesh__D051027
% 209.88/210.10       2006; PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXAMIDE FORMYLTRANSFERASE was indexed under HYDROXYMETHYL AND FORMYL TRANSFERASES 1998-2005, ACYLTRANSFERASES 1980-1997, FORMIC ACIDS 1974-1980, AMINOIMIDAZOLE CARBOXAMIDE 1979-1980, IMIDAZOLES 1974-1979, PENTOSEPHOSPHATES 1974-1979, TRANSFERASES 1974-1979%A%  
% 209.88/210.10  |- skos__altLabel mesh__D051027 AICAR Transformylase
% 209.88/210.10  |- skos__prefLabel mesh__D051027
% 209.88/210.10       Phosphoribosylaminoimidazolecarboxamide Formyltransferase
% 209.88/210.10  |- skos__broader mesh__D009665smesh__D007546
% 209.88/210.10  |- mesh__recordMaintainer mesh__D009665 lkw
% 209.88/210.10  |- skos__altLabel mesh__D009665 Dreluso Brand of Noscapine Hydrochloride
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D009665 2006
% 209.88/210.10  |- mesh__recordOriginator mesh__D009665 NLM
% 209.88/210.10  |- skos__prefLabel mesh__D009665 Noscapine
% 209.88/210.10  |- skos__hiddenLabel mesh__D009665 Tropfen, Capval
% 209.88/210.10  |- skos__hiddenLabel mesh__D009665 Hydrogen Embonate, Noscapine
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D009665 2005
% 209.88/210.10  |- mesh__recordAuthorizer mesh__D009665 sjn
% 209.88/210.10  |- skos__hiddenLabel mesh__D009665 Noscapine Dreluso Brand
% 209.88/210.10  |- mesh__dateCreated mesh__D009665 1999-01-01
% 209.88/210.10  |- skos__hiddenLabel mesh__D009665 Embonate, Noscapine Hydrogen
% 209.88/210.10  |- rdf__type mesh__D009665sskos__Concept
% 209.88/210.10  |- skos__altLabel mesh__D009665 Byk Brand of Noscapine Hydrochloride
% 209.88/210.10  |- mesh__dateRevised mesh__D009665 2004-07-07
% 209.88/210.10  |- skos__altLabel mesh__D009665 Dreluso Brand of Noscapine
% 209.88/210.10  |- skos__altLabel mesh__D009665 Berna Brand of Noscapine Hydrochloride
% 209.88/210.10  |- skos__hiddenLabel mesh__D009665 Hydrochloride, Noscapine
% 209.88/210.10  |- skos__altLabel mesh__D009665 Boots Brand of Noscapine Hydrochloride
% 209.88/210.10  |- skos__hiddenLabel mesh__D009665 prikkelhoest, Librochin
% 209.88/210.10  |- skos__broader mesh__D009665smesh__D009892
% 209.88/210.10  |- skos__scopeNote mesh__D009665
% 209.88/210.10       A naturally occurring opium alkaloid that is a centrally acting antitussive agent.%A%    
% 209.88/210.10  |- skos__altLabel mesh__D009665 Narcotine
% 209.88/210.10  |- skos__historyNote mesh__D001682 Pharmacology %28%1966-1969%29%
% 209.88/210.10  |- skos__hiddenLabel mesh__D001682 Biological Availabilities
% 209.88/210.10  |- skos__scopeNote mesh__D001682
% 209.88/210.10       The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action.%A%    
% 209.88/210.10  |- skos__hiddenLabel mesh__D001682 Equivalencies, Availability
% 209.88/210.10  |- skos__hiddenLabel mesh__D001682 Availabilities, Physiologic
% 209.88/210.10  |- skos__hiddenLabel mesh__D001682 Availabilities, Biologic
% 209.88/210.10  |- skos__prefLabel mesh__D001682 Biological Availability
% 209.88/210.10  |- skos__altLabel mesh__D001682 Availability, Physiologic
% 209.88/210.10  |- mesh__onlineNote mesh__D001682
% 209.88/210.10       use BIOLOGICAL AVAILABILITY to search AVAILABILITY EQUIVALENCY 1980-86, BIOLOGIC AVAILABILITY %26% PHYSIOLOGIC AVAILABILITY 1975-79, %26% BIOPHARMACEUTICS 1970-74%A%  
% 209.88/210.10  |- mesh__dateRevised mesh__D001682 2004-07-07
% 209.88/210.10  |- skos__hiddenLabel mesh__D001682 Physiologic Availabilities
% 209.88/210.10  |- skos__altLabel mesh__D001682 Availability, Biologic
% 209.88/210.10  |- skos__hiddenLabel mesh__D001682 Bioavailabilities
% 209.88/210.10  |- skos__altLabel mesh__D001682 Biologic Availability
% 209.88/210.10  |- skos__altLabel mesh__D001682 Bioavailability
% 209.88/210.10  |- mesh__historyNote mesh__D001682
% 209.88/210.10       79; was BIOLOGIC AVAILABILITY see under BIOPHARMACEUTICS 1970-78; PHYSIOLOGIC AVAILABILITY was see under BIOPHARMACEUTICS 1970-79; AVAILABILITY EQUIVALENCY was see under BIOPHARMACEUTICS 1970-79 and see under BIOLOGICAL AVAILABILITY 1980-86%A%  
% 209.88/210.10  |- mesh__publicMeSHNote mesh__D001682
% 209.88/210.10       79; was BIOLOGIC AVAILABILITY see under BIOPHARMACEUTICS 1970-78; AVAILABILITY EQUIVALENCY %26% PHYSIOLOGIC AVAILABILITY were see under BIOPHARMACEUTICS 1970-79; AVAILABILITY EQUIVALENCY was see under BIOLOGICAL AVAILABILITY 1980-86%A%  
% 209.88/210.10  |- mesh__dateCreated mesh__D001682 1999-01-01
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D001682 2006
% 209.88/210.10  |- skos__hiddenLabel mesh__D001682 Availability Equivalencies
% 209.88/210.10  |- skos__historyNote mesh__D001682 Drug Compounding %28%1966-1969%29%
% 209.88/210.10  |- skos__historyNote mesh__D001682 Biopharmaceutics %28%1966-1974%29%
% 209.88/210.10  |- skos__hiddenLabel mesh__D001682 Biologic Availabilities
% 209.88/210.10  |- skos__annotation mesh__D001682
% 209.88/210.10       NIM with specific drug /pharmacokin %28%IM%29%; no qualif; DF: BIOL AVAILABILITY%A%  
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D001682 2005
% 209.88/210.10  |- skos__hiddenLabel mesh__D001682 Equivalency, Availability
% 209.88/210.10  |- skos__altLabel mesh__D001682 Availability, Biological
% 209.88/210.10  |- skos__broader mesh__D001682smesh__D010599
% 209.88/210.10  |- skos__hiddenLabel mesh__D001682 Availabilities, Biological
% 209.88/210.10  |- mesh__recordAuthorizer mesh__D001682 sjn
% 209.88/210.10  |- mesh__recordOriginator mesh__D001682 NLM
% 209.88/210.10  |- mesh__dateEstablished mesh__D001682 1979-01-01
% 209.88/210.10  |- skos__historyNote mesh__D001682 Drugs %28%1966-1969%29%
% 209.88/210.10  |- mesh__recordMaintainer mesh__D001682 ssb
% 209.88/210.10  |- rdf__type mesh__D001682sskos__Concept
% 209.88/210.10  |- skos__altLabel mesh__D001682 Physiologic Availability
% 209.88/210.10  |- mesh__historyNote mesh__D028021
% 209.88/210.10       2002; use SODIUM-POTASSIUM-CHLORIDE COTRANSPORTERS 1984-2001%A%  
% 209.88/210.10  |- mesh__dateRevised mesh__D028021 2005-06-30
% 209.88/210.10  |- skos__historyNote mesh__D028021 Carrier Proteins %28%1984-2001%29%
% 209.88/210.10  |- mesh__recordAuthorizer mesh__D028021 sjn
% 209.88/210.10  |- rdf__type mesh__D028021sskos__Concept
% 209.88/210.10  |- mesh__publicMeSHNote mesh__D028021
% 209.88/210.10       2002; SODIUM, POTASSIUM, CHLORIDE-COTRANSPORTER was indexed under CARRIER PROTEINS 1984-2001%A%  
% 209.88/210.10  |- mesh__recordOriginator mesh__D028021 jmp
% 209.88/210.10  |- skos__altLabel mesh__D028021 Sodium-Potassium-Chloride Cotransporter
% 209.88/210.10  |- mesh__dateCreated mesh__D028021 2001-07-25
% 209.88/210.10  |- skos__hiddenLabel mesh__D028021 Sodium Potassium Chloride Cotransporter
% 209.88/210.10  |- skos__hiddenLabel mesh__D028021 Na K Cl Transporter
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D028021 2006
% 209.88/210.10  |- skos__hiddenLabel mesh__D028021 Cotransporter, NaCl-KCl
% 209.88/210.10  |- skos__hiddenLabel mesh__D028021 Na K Cl Symporter
% 209.88/210.10  |- skos__altLabel mesh__D028021 NaCl-KCl Cotransporter
% 209.88/210.10  |- skos__hiddenLabel mesh__D028021 Sodium Potassium Chloride Cotransporters
% 209.88/210.10  |- skos__altLabel mesh__D028021
% 209.88/210.10       Na%28%+%29%, K%28%+%29%, Cl%28%-%29%-Cotransporter
% 209.88/210.10  |- skos__hiddenLabel mesh__D028021
% 209.88/210.10       Cotransporters, Sodium-Potassium-Chloride
% 209.88/210.10  |- skos__altLabel mesh__D028021 Na-K-Cl-Symporter
% 209.88/210.10  |- skos__prefLabel mesh__D028021 Sodium-Potassium-Chloride Symporters
% 209.88/210.10  |- skos__altLabel mesh__D028021 Sodium-Potassium-Chloride Cotransporters
% 209.88/210.10  |- skos__hiddenLabel mesh__D028021 NaCl KCl Cotransporter
% 209.88/210.10  |- skos__altLabel mesh__D028021 Sodium, Potassium, Chloride-Cotransporter
% 209.88/210.10  |- skos__broader mesh__D028021smesh__D027981
% 209.88/210.10  |- skos__scopeNote mesh__D028021
% 209.88/210.10       A subclass of symporters that specifically transport SODIUM CHLORIDE and POTASSIUM CHLORIDE across cellular membranes in a tightly coupled process.%A%    
% 209.88/210.10  |- skos__hiddenLabel mesh__D028021 Cotransporter, Sodium-Potassium-Chloride
% 209.88/210.10  |- mesh__recordMaintainer mesh__D028021 SYSTEM
% 209.88/210.10  |- skos__hiddenLabel mesh__D028021 Sodium Potassium Chloride Symporters
% 209.88/210.10  |- skos__hiddenLabel mesh__D028021 Symporters, Sodium-Potassium-Chloride
% 209.88/210.10  |- skos__altLabel mesh__D028021 NaK2Cl Symporter
% 209.88/210.10  |- mesh__dateEstablished mesh__D028021 2002-01-01
% 209.88/210.10  |- skos__hiddenLabel mesh__D028021 Symporter, NaK2Cl
% 209.88/210.10  |- skos__altLabel mesh__D028021 Na-K-Cl-Transporter
% 209.88/210.10  |- skos__prefLabel mesh__D014001 Tin
% 209.88/210.10  |- mesh__recordOriginator mesh__D014001 NLM
% 209.88/210.10  |- skos__annotation mesh__D014001
% 209.88/210.10       Sn-118; Sn-112, 114-117, 119, 122, 124 = TIN %28%IM%29% + ISOTOPES %28%NIM%29%; Sn-108-111, 113, 120, 121, 123, 125-128 = TIN RADIOISOTOPES %28%IM%29%%A%  
% 209.88/210.10  |- skos__broader mesh__D014001smesh__D019216
% 209.88/210.10  |- skos__related mesh__D014001smesh__D009947
% 209.88/210.10  |- skos__altLabel mesh__D014001 Stannum
% 209.88/210.10  |- mesh__dateCreated mesh__D014001 1999-01-01
% 209.88/210.10  |- mesh__recordMaintainer mesh__D014001 ssb
% 209.88/210.10  |- skos__scopeNote mesh__D014001
% 209.88/210.10       A trace element that is required in bone formation. It has the atomic symbol Sn, atomic number 50, and atomic weight 118.71.%A%    
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D014001 2006
% 209.88/210.10  |- mesh__recordAuthorizer mesh__D014001 sjn
% 209.88/210.10  |- mesh__dateRevised mesh__D014001 2005-06-30
% 209.88/210.10  |- rdf__type mesh__D014001sskos__Concept
% 209.88/210.10  |- skos__related mesh__D014001smesh__D014004
% 209.88/210.10  |- mesh__dateCreated mesh__D019295 1996-06-13
% 209.88/210.10  |- skos__broader mesh__D019295smesh__D001695
% 209.88/210.10  |- skos__related mesh__D019295smesh__D008490
% 209.88/210.10  |- skos__altLabel mesh__D019295 Molecular Biology, Computational
% 209.88/210.10  |- mesh__recordMaintainer mesh__D019295 jls
% 209.88/210.10  |- skos__scopeNote mesh__D019295
% 209.88/210.10       A field of biology concerned with the development of techniques for the collection and manipulation of biological data, and the use of such data to make biological discoveries or predictions. This field encompasses all computational methods and theories applicable to MOLECULAR BIOLOGY and areas of computer-based techniques for solving biological problems including manipulation of models and datasets.%A%    
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D019295 2003
% 209.88/210.10  |- mesh__dateRevised mesh__D019295 2002-07-02
% 209.88/210.10  |- skos__annotation mesh__D019295
% 209.88/210.10       SPEC; SPEC qualif; coord IM with specific biol spec %28%IM%29%; DF: COMPUTATIONAL BIOL%A%  
% 209.88/210.10  |- mesh__historyNote mesh__D019295 97   
% 209.88/210.10  |- skos__altLabel mesh__D019295 Biology, Computational
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D019295 2005
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D019295 2004
% 209.88/210.10  |- mesh__dateEstablished mesh__D019295 1997-01-01
% 209.88/210.10  |- mesh__publicMeSHNote mesh__D019295 97   
% 209.88/210.10  |- mesh__recordOriginator mesh__D019295 JLS
% 209.88/210.10  |- skos__historyNote mesh__D019295 Molecular Biology %28%1992-1996%29%
% 209.88/210.10  |- rdf__type mesh__D019295sskos__Concept
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D019295 2006
% 209.88/210.10  |- skos__altLabel mesh__D019295 Bioinformatics
% 209.88/210.10  |- skos__prefLabel mesh__D019295 Computational Biology
% 209.88/210.10  |- mesh__recordAuthorizer mesh__D019295 sjn
% 209.88/210.10  |- skos__hiddenLabel mesh__D052120
% 209.88/210.10       X Linked Vacuolar Cardiomyopathy and Myopathy
% 209.88/210.10  |- mesh__dateEstablished mesh__D052120 2006-01-01
% 209.88/210.10  |- mesh__dateCreated mesh__D052120 2005-06-30
% 209.88/210.10  |- mesh__historyNote mesh__D052120 2006   
% 209.88/210.10  |- mesh__dateRevised mesh__D052120 2005-07-19
% 209.88/210.10  |- skos__altLabel mesh__D052120
% 209.88/210.10       Vacuolar Cardiomyopathy and Myopathy, X-linked
% 209.88/210.10  |- skos__broader mesh__D052120smesh__D009202
% 209.88/210.10  |- skos__broader mesh__D052120smesh__D040181
% 209.88/210.10  |- skos__prefLabel mesh__D052120 Glycogen Storage Disease Type IIb
% 209.88/210.10  |- skos__hiddenLabel mesh__D052120
% 209.88/210.10       Vacuolar Cardiomyopathy and Myopathy, X linked
% 209.88/210.10  |- skos__altLabel mesh__D052120 Danon Disease
% 209.88/210.10  |- rdf__type mesh__D052120sskos__Concept
% 209.88/210.10  |- skos__altLabel mesh__D052120
% 209.88/210.10       X-Linked Vacuolar Cardiomyopathy and Myopathy
% 209.88/210.10  |- mesh__recordAuthorizer mesh__D052120 ags
% 209.88/210.10  |- mesh__recordMaintainer mesh__D052120 ags
% 209.88/210.10  |- skos__hiddenLabel mesh__D052120 Disease, Danon
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D052120 2006A
% 209.88/210.10  |- skos__scopeNote mesh__D052120
% 209.88/210.10       An X-linked dominant multisystem disorder resulting in cardiomyopathy, myopathy and MENTAL RETARDATION. It is caused by mutation in the gene encoding LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2.%A%    
% 209.88/210.10  |- mesh__publicMeSHNote mesh__D052120 2006   
% 209.88/210.10  |- skos__broader mesh__D052120smesh__D006008
% 209.88/210.10  |- mesh__recordOriginator mesh__D052120 jmp
% 209.88/210.10  |- skos__broader mesh__D052120smesh__D038901
% 209.88/210.10  |- skos__altLabel mesh__D052120 Glycogen Storage Disease IIb
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D052120 2006
% 209.88/210.10  |- skos__hiddenLabel mesh__D005275 Hydrochloride, Fendiline
% 209.88/210.10  |- mesh__historyNote mesh__D005275
% 209.88/210.10       91%28%80%29%; was see under PHENETHYLAMINES 1980-90   
% 209.88/210.10  |- mesh__dateCreated mesh__D005275 1979-03-01
% 209.88/210.10  |- skos__altLabel mesh__D005275 Celltech Brand of Fendiline Hydrochloride
% 209.88/210.10  |- skos__prefLabel mesh__D005275 Fendiline
% 209.88/210.10  |- skos__broader mesh__D005275smesh__D010627
% 209.88/210.10  |- skos__altLabel mesh__D005275 Senzit
% 209.88/210.10  |- mesh__recordAuthorizer mesh__D005275 sjn
% 209.88/210.10  |- mesh__recordOriginator mesh__D005275 SH
% 209.88/210.10  |- rdf__type mesh__D005275sskos__Concept
% 209.88/210.10  |- mesh__recordMaintainer mesh__D005275 CCR
% 209.88/210.10  |- mesh__dateRevised mesh__D005275 2005-06-30
% 209.88/210.10  |- skos__altLabel mesh__D005275 Fendilin
% 209.88/210.10  |- skos__historyNote mesh__D005275 Phenethylamines %28%1966-1979%29%
% 209.88/210.10  |- mesh__publicMeSHNote mesh__D005275
% 209.88/210.10       91; was see under PHENETHYLAMINES 1980-90   
% 209.88/210.10  |- mesh__dateEstablished mesh__D005275 1991-01-01
% 209.88/210.10  |- skos__scopeNote mesh__D005275
% 209.88/210.10       Coronary vasodilator; inhibits calcium function in muscle cells in excitation-contraction coupling; proposed as antiarrhythmic and antianginal agents.%A%    
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D005275 2006
% 209.88/210.10  |- skos__broader mesh__D016572Q000031smesh__D016572
% 209.88/210.10  |- mesh__preferredCombination mesh__D016572Q000031smesh__D003524
% 209.88/210.10  |- rdf__type mesh__D016572Q000031smesh__CompoundConcept
% 209.88/210.10  |- mesh__recordMaintainer mesh__D051028 ags
% 209.88/210.10  |- rdf__type mesh__D051028sskos__Concept
% 209.88/210.10  |- skos__hiddenLabel mesh__D051028 bcl2 Associated X Protein Isoform omega
% 209.88/210.10  |- mesh__dateCreated mesh__D051028 2005-07-06
% 209.88/210.10  |- skos__scopeNote mesh__D051028
% 209.88/210.10       A member of the Bcl-2 protein family and homologous partner of C-BCL-2 PROTO-ONCOGENE PROTEIN. It regulates the release of CYTOCHROME C and APOPTOSIS INDUCING FACTOR from the MITOCHONDRIA. Several isoforms of BCL2-associated X protein occur due to ALTERNATIVE SPLICING of the mRNA for this protein.%A%    
% 209.88/210.10  |- skos__hiddenLabel mesh__D051028 bcl2 Associated X Protein Isoform delta
% 209.88/210.10  |- skos__altLabel mesh__D051028 Bax-delta Protein
% 209.88/210.10  |- skos__altLabel mesh__D051028 Bax-beta Protein
% 209.88/210.10  |- mesh__publicMeSHNote mesh__D051028
% 209.88/210.10       2006; BCL2-ASSOCIATED X-PROTEIN was indexed under PROTO-ONCOGENE PROTEINS C-BCL-2 1993-2005%A%  
% 209.88/210.10  |- mesh__recordOriginator mesh__D051028 DRC
% 209.88/210.10  |- skos__altLabel mesh__D051028 Bax-alpha Protein
% 209.88/210.10  |- skos__hiddenLabel mesh__D051028 bcl 2 Associated X Protein
% 209.88/210.10  |- skos__altLabel mesh__D051028 bcl2-Associated X Protein
% 209.88/210.10  |- skos__hiddenLabel mesh__D051028 Bax omega Protein
% 209.88/210.10  |- skos__hiddenLabel mesh__D051028 bcl2 Associated X Protein Isoform sigma
% 209.88/210.10  |- skos__hiddenLabel mesh__D051028 bcl2 Associated X Protein Isoform beta
% 209.88/210.10  |- skos__hiddenLabel mesh__D051028 bcl2 Associated X Protein
% 209.88/210.10  |- skos__hiddenLabel mesh__D051028 Protein, bcl-2-Associated X
% 209.88/210.10  |- mesh__dateRevised mesh__D051028 2005-07-08
% 209.88/210.10  |- mesh__dateEstablished mesh__D051028 2006-01-01
% 209.88/210.10  |- skos__hiddenLabel mesh__D051028 X Protein, bcl-2-Associated
% 209.88/210.10  |- skos__hiddenLabel mesh__D051028 bcl2 Associated X Protein Isoform alpha
% 209.88/210.10  |- skos__altLabel mesh__D051028 Bax Protein
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D051028 2006A
% 209.88/210.10  |- skos__annotation mesh__D051028
% 209.88/210.10       Don%27%t confuse with the closely related BCL-X PROTEIN   
% 209.88/210.10  |- skos__broader mesh__D051028smesh__D019253
% 209.88/210.10  |- skos__hiddenLabel mesh__D051028 Bax delta Protein
% 209.88/210.10  |- skos__altLabel mesh__D051028 Bax-sigma Protein
% 209.88/210.10  |- skos__altLabel mesh__D051028 Bax-omega Protein
% 209.88/210.10  |- skos__altLabel mesh__D051028 Bax Apoptosis Regulator Protein
% 209.88/210.10  |- skos__prefLabel mesh__D051028 bcl-2-Associated X Protein
% 209.88/210.10  |- mesh__historyNote mesh__D051028 2006%28%1993%29%   
% 209.88/210.10  |- skos__hiddenLabel mesh__D051028 Bax alpha Protein
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D051028 2006
% 209.88/210.10  |- skos__hiddenLabel mesh__D051028 Bax beta Protein
% 209.88/210.10  |- skos__hiddenLabel mesh__D051028 Bax sigma Protein
% 209.88/210.10  |- mesh__recordAuthorizer mesh__D051028 ags
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D009666 1999
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D009666 2004
% 209.88/210.10  |- skos__prefLabel mesh__D009666 Nose
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D009666 2000
% 209.88/210.10  |- mesh__dateRevised mesh__D009666 1997-06-20
% 209.88/210.10  |- skos__hiddenLabel mesh__D009666 Noses
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D009666 1998
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D009666 2003
% 209.88/210.10  |- mesh__recordMaintainer mesh__D009666 TPW
% 209.88/210.10  |- mesh__considerAlso mesh__D009666
% 209.88/210.10       consider also terms at NAS- and RHIN-   
% 209.88/210.10  |- skos__scopeNote mesh__D009666
% 209.88/210.10       A specialized structure that serves as an organ of the sense of smell as well as part of the respiratory system; the term includes both the external nose and the nasal cavity.%A%    
% 209.88/210.10  |- skos__annotation mesh__D009666
% 209.88/210.10       %22%nose%22% unspecified as NASAL BONE or NASAL CAVITY; /abnorm permitted for congen deform but acquired deform = NOSE DEFORMITIES, ACQUIRED; /secret = NASAL MUCOSA /secret; /surg: consider also RHINOPLASTY%A%  
% 209.88/210.10  |- skos__broader mesh__D009666smesh__D012137
% 209.88/210.10  |- mesh__recordOriginator mesh__D009666 NLM
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D009666 2006
% 209.88/210.10  |- skos__broader mesh__D009666smesh__D012679
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D009666 2002
% 209.88/210.10  |- skos__related mesh__D009666smesh__D012225
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D009666 2005
% 209.88/210.10  |- mesh__dateCreated mesh__D009666 1999-01-01
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D009666 2001
% 209.88/210.10  |- skos__broader mesh__D009666smesh__D005145
% 209.88/210.10  |- rdf__type mesh__D009666sskos__Concept
% 209.88/210.10  |- mesh__recordAuthorizer mesh__D009666 SJN
% 209.88/210.10  |- skos__altLabel mesh__D001683 Biological Pacemakers
% 209.88/210.10  |- skos__hiddenLabel mesh__D001683 Biologic Clocks
% 209.88/210.10  |- skos__altLabel mesh__D001683 Biologic Clock
% 209.88/210.10  |- skos__altLabel mesh__D001683 Oscillators, Endogenous
% 209.88/210.10  |- skos__hiddenLabel mesh__D001683 Biologic Pacemaker
% 209.88/210.10  |- skos__hiddenLabel mesh__D001683 Biologic Oscillators
% 209.88/210.10  |- skos__hiddenLabel mesh__D001683 Oscillators, Biologic
% 209.88/210.10  |- mesh__dateRevised mesh__D001683 2003-07-22
% 209.88/210.10  |- skos__altLabel mesh__D001683 Clocks, Biological
% 209.88/210.10  |- skos__hiddenLabel mesh__D001683 Clock, Biological
% 209.88/210.10  |- skos__altLabel mesh__D001683 Pacemaker, Biologic
% 209.88/210.10  |- skos__altLabel mesh__D001683 Pacemakers, Biologic
% 209.88/210.10  |- skos__altLabel mesh__D001683 Clock, Biologic
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D001683 2005
% 209.88/210.10  |- skos__annotation mesh__D001683 IM; DF: BIOL CLOCKS   
% 209.88/210.10  |- skos__hiddenLabel mesh__D001683 Clocks, Biologic
% 209.88/210.10  |- skos__hiddenLabel mesh__D001683 Biological Clock
% 209.88/210.10  |- skos__hiddenLabel mesh__D001683 Endogenous Oscillator
% 209.88/210.10  |- skos__altLabel mesh__D001683 Biologic Oscillator
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D001683 2006
% 209.88/210.10  |- skos__scopeNote mesh__D001683
% 209.88/210.10       The physiological mechanisms that govern the rhythmic occurrence of certain biochemical, physiological, and behavioral phenomena in plants and animals.%A%    
% 209.88/210.10  |- mesh__recordMaintainer mesh__D001683 ags
% 209.88/210.10  |- mesh__recordAuthorizer mesh__D001683 sjn
% 209.88/210.10  |- skos__altLabel mesh__D001683 Biological Oscillators
% 209.88/210.10  |- mesh__publicMeSHNote mesh__D001683 67   
% 209.88/210.10  |- skos__hiddenLabel mesh__D001683 Oscillator, Biological
% 209.88/210.10  |- mesh__recordOriginator mesh__D001683 NLM
% 209.88/210.10  |- rdf__type mesh__D001683sskos__Concept
% 209.88/210.10  |- skos__prefLabel mesh__D001683 Biological Clocks
% 209.88/210.10  |- skos__hiddenLabel mesh__D001683 Pacemaker, Biological
% 209.88/210.10  |- mesh__dateEstablished mesh__D001683 1967-01-01
% 209.88/210.10  |- skos__altLabel mesh__D001683 Oscillator, Biologic
% 209.88/210.10  |- skos__related mesh__D001683smesh__D020178
% 209.88/210.10  |- skos__hiddenLabel mesh__D001683 Oscillator, Endogenous
% 209.88/210.10  |- skos__hiddenLabel mesh__D001683 Biological Oscillator
% 209.88/210.10  |- skos__altLabel mesh__D001683 Pacemakers, Biological
% 209.88/210.10  |- skos__hiddenLabel mesh__D001683 Endogenous Oscillators
% 209.88/210.10  |- skos__related mesh__D001683smesh__D002940
% 209.88/210.10  |- skos__hiddenLabel mesh__D001683 Biologic Pacemakers
% 209.88/210.10  |- skos__hiddenLabel mesh__D001683 Biological Pacemaker
% 209.88/210.10  |- mesh__historyNote mesh__D001683 67%28%64%29%   
% 209.88/210.10  |- skos__broader mesh__D001683smesh__D002909
% 209.88/210.10  |- mesh__dateCreated mesh__D001683 1999-01-01
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D001683 2004
% 209.88/210.10  |- skos__hiddenLabel mesh__D028022 Laser Therapies, Low-Level
% 209.88/210.10  |- mesh__recordMaintainer mesh__D028022 lkt
% 209.88/210.10  |- skos__altLabel mesh__D028022 Low-Level Laser Therapy
% 209.88/210.10  |- skos__altLabel mesh__D028022 Laser Therapy, Low-Power
% 209.88/210.10  |- skos__hiddenLabel mesh__D028022 Irradiation, Low-Power Laser
% 209.88/210.10  |- skos__altLabel mesh__D028022 Low-Power Laser Therapy
% 209.88/210.10  |- skos__annotation mesh__D028022
% 209.88/210.10       coord IM with disease /radiother %28%IM%29%   
% 209.88/210.10  |- skos__hiddenLabel mesh__D028022 Biostimulation, Laser
% 209.88/210.10  |- skos__broader mesh__D028022smesh__D010789
% 209.88/210.10  |- mesh__historyNote mesh__D028022 2002   
% 209.88/210.10  |- skos__scopeNote mesh__D028022
% 209.88/210.10       Treatment using irradiation with light at low power intensities and with wavelengths in the range 540nm-830nm. The effects are thought to be mediated by a photochemical reaction that alters CELL MEMBRANE PERMEABILITY, leading to increased mRNA synthesis and CELL PROLIFERATION. The effects are not due to heat, as in LASER SURGERY. Low-level laser therapy has been used in general medicine, veterinary medicine, and dentistry for a wide variety of conditions, but most frequently for wound healing and pain control.%A%    
% 209.88/210.10  |- skos__altLabel mesh__D028022 Laser Irradiation, Low-Power
% 209.88/210.10  |- mesh__recordOriginator mesh__D028022 ags
% 209.88/210.10  |- skos__hiddenLabel mesh__D028022 Low Power Laser Therapy
% 209.88/210.10  |- skos__hiddenLabel mesh__D028022 Laser Therapy, Low Level
% 209.88/210.10  |- mesh__publicMeSHNote mesh__D028022 2002   
% 209.88/210.10  |- skos__altLabel mesh__D028022 Laser Biostimulation
% 209.88/210.10  |- skos__prefLabel mesh__D028022 Laser Therapy, Low-Level
% 209.88/210.10  |- mesh__dateRevised mesh__D028022 2005-06-30
% 209.88/210.10  |- skos__hiddenLabel mesh__D028022 Low Power Laser Irradiation
% 209.88/210.10  |- skos__hiddenLabel mesh__D028022 Laser Therapy, Low Power
% 209.88/210.10  |- skos__hiddenLabel mesh__D028022 Laser Therapies, Low-Power
% 209.88/210.10  |- skos__historyNote mesh__D028022
% 209.88/210.10       specific disease/radiotherapy %28%1985-2001%29%
% 209.88/210.10  |- mesh__recordAuthorizer mesh__D028022 sjn
% 209.88/210.10  |- mesh__dateCreated mesh__D028022 2001-07-25
% 209.88/210.10  |- skos__hiddenLabel mesh__D028022 Low-Power Laser Therapies
% 209.88/210.10  |- skos__historyNote mesh__D028022 Lasers/therapeutic use %28%1983-2001%29%
% 209.88/210.10  |- mesh__dateEstablished mesh__D028022 2002-01-01
% 209.88/210.10  |- skos__altLabel mesh__D028022 LLLT
% 209.88/210.10  |- rdf__type mesh__D028022sskos__Concept
% 209.88/210.10  |- skos__hiddenLabel mesh__D028022 Low-Level Laser Therapies
% 209.88/210.10  |- skos__altLabel mesh__D028022 Low-Power Laser Irradiation
% 209.88/210.10  |- skos__hiddenLabel mesh__D028022 Low Level Laser Therapy
% 209.88/210.10  |- skos__hiddenLabel mesh__D028022 Laser Irradiation, Low Power
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D028022 2006
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D014800 1995
% 209.88/210.10  |- skos__hiddenLabel mesh__D014800 Cobalt Chromium Molybdenum Alloy
% 209.88/210.10  |- skos__prefLabel mesh__D014800 Vitallium
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D014800 1999
% 209.88/210.10  |- skos__annotation mesh__D014800
% 209.88/210.10       used for dentures %26% other non-dent prosthesis; D25-26 qualif%A%  
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D014800 2005
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D014800 2000
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D014800 1996
% 209.88/210.10  |- skos__broader mesh__D014800smesh__D002858
% 209.88/210.10  |- mesh__dateRevised mesh__D014800 1993-06-04
% 209.88/210.10  |- skos__scopeNote mesh__D014800
% 209.88/210.10       An alloy of 60%25% cobalt, 20%25% chromium, 5%25% molybdenum, and traces of other substances. It is used in dentures, certain surgical appliances, prostheses, implants, and instruments.%A%    
% 209.88/210.10  |- mesh__publicMeSHNote mesh__D014800
% 209.88/210.10       91,63-64; was see under CHROMIUM ALLOYS 1982-90; was see under CHROMIUM-COBALT ALLOYS 1965-81; was heading 1963-64%A%  
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D014800 2006
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D014800 2001
% 209.88/210.10  |- mesh__activeMeSHYear mesh__D014800 1997
% 209.88/210.10  |- mesh__dateCreated mesh__D014800 1999-01-01
% 209.88/210.10  |- mesh__onlineNote mesh__D014800
% 209.88/210.10       use CHROMIUM ALLOYS to search VITALLIUM 1966-74   
% 209.88/210.11  |- mesh__historyNote mesh__D014800
% 209.88/210.11       91%28%75%29%63-64; was see under CHROMIUM ALLOYS 1982-90; was see under CHROMIUM-COBALT ALLOYS 1965-81; was heading 1963-64%A%  
% 209.88/210.11  |- mesh__recordMaintainer mesh__D014800 TPW
% 209.88/210.11  |- mesh__activeMeSHYear mesh__D014800 2003
% 209.88/210.11  |- mesh__recordAuthorizer mesh__D014800 PLS
% 209.88/210.11  |- mesh__activeMeSHYear mesh__D014800 2004
% 209.88/210.11  |- skos__hiddenLabel mesh__D014800 Alloy, Cobalt-Chromium-Molybdenum
% 209.88/210.11  |- mesh__activeMeSHYear mesh__D014800 1994
% 209.88/210.11  |- rdf__type mesh__D014800sskos__Concept
% 209.88/210.11  |- mesh__recordOriginator mesh__D014800 NLM
% 209.88/210.11  |- mesh__activeMeSHYear mesh__D014800 2002
% 209.88/210.11  |- mesh__activeMeSHYear mesh__D014800 1998
% 209.88/210.11  |- mesh__dateEstablished mesh__D014800 1991-01-01
% 209.88/210.11  |- skos__scopeNote mesh__D014002
% 209.88/210.11       Inorganic fluorides of tin. They include both stannic fluoride %28%tin tetrafluoride%29% and stannous fluoride %28%tin difluoride%29%. The latter is used in the prevention of dental caries.%A%    
% 209.88/210.11  |- skos__hiddenLabel mesh__D014002 Fluorides, Tin
% 209.88/210.11  |- skos__historyNote mesh__D014002 Fluorides %28%1966-1976%29%
% 209.88/210.11  |- skos__hiddenLabel mesh__D014002 Tetrafluoride, Tin
% 209.88/210.11  |- skos__altLabel mesh__D014002 Young Dental Brand of Tin Difluoride
% 209.88/210.11  |- mesh__recordOriginator mesh__D014002 RLS
% 209.88/210.11  |- skos__altLabel mesh__D014002 Stannic Fluoride
% 209.88/210.11  |- skos__historyNote mesh__D014002 Fluorides, Topical %28%1966-1976%29%
% 209.88/210.11  |- skos__prefLabel mesh__D014002 Tin Fluorides
% 209.88/210.11  |- mesh__activeMeSHYear mesh__D014002 2006
% 209.88/210.11  |- skos__broader mesh__D014002smesh__D017971
% 209.88/210.11  |- skos__altLabel mesh__D014002 Omnii Brand 1 of Tin Difluoride
% 209.88/210.11  |- skos__altLabel mesh__D014002 Stannous Fluoride
% 209.88/210.11  |- skos__historyNote mesh__D014002 Tin %28%1966-1976%29%
% 209.88/210.11  |- skos__hiddenLabel mesh__D014002 Difluoride, Tin
% 209.88/210.11  |- skos__annotation mesh__D014002
% 209.88/210.11       X ref STANNOUS FLUORIDE used in dent caries prev   
% 209.88/210.11  |- skos__altLabel mesh__D014002 Colgate Brand of Tin Difluoride
% 209.88/210.11  |- mesh__publicMeSHNote mesh__D014002
% 209.88/210.11       91; was see under FLUORIDES 1977-90   
% 209.88/210.11  |- skos__broader mesh__D014002smesh__D002327
% 209.88/210.11  |- mesh__historyNote mesh__D014002
% 209.88/210.11       91%28%77%29%; was see under FLUORIDES 1977-90   
% 209.88/210.11  |- skos__altLabel mesh__D014002 Ortho Brand of Tin Difluoride
% 209.88/210.11  |- skos__altLabel mesh__D014002 Omnii Brand 2 of Tin Difluoride
% 209.88/210.11  |- mesh__dateEstablished mesh__D014002 1991-01-01
% 209.88/210.11  |- mesh__dateCreated mesh__D014002 1976-04-16
% 209.88/210.11  |- rdf__type mesh__D014002sskos__Concept
% 209.88/210.11  |- skos__altLabel mesh__D014002 McGloin Brand of Tin Difluoride
% 209.88/210.11  |- mesh__recordAuthorizer mesh__D014002 sjn
% 209.88/210.11  |- mesh__dateRevised mesh__D014002 2005-06-30
% 209.88/210.11  |- skos__hiddenLabel mesh__D014002 Fluoride, Stannous
% 209.88/210.11  |- skos__altLabel mesh__D014002 Palisades Brand of Tin Difluoride
% 209.88/210.11  |- skos__broader mesh__D014002smesh__D005459
% 209.88/210.11  |- skos__hiddenLabel mesh__D014002 Fluoride, Stannic
% 209.88/210.11  |- mesh__recordMaintainer mesh__D014002 lkw
% 209.88/210.11  |- skos__historyNote mesh__D019296 Carbon Dioxide %28%1966-1996%29%
% 209.88/210.11  |- mesh__activeMeSHYear mesh__D019296 2002
% 209.88/210.11  |- skos__scopeNote mesh__D019296
% 209.88/210.11       Continuous recording of the carbon dioxide content of expired air.%A%    
% 209.88/210.11  |- mesh__recordAuthorizer mesh__D019296 sjn
% 209.88/210.11  |- mesh__activeMeSHYear mesh__D019296 2003
% 209.88/210.11  |- skos__broader mesh__D019296smesh__D012129
% 209.88/210.11  |- mesh__activeMeSHYear mesh__D019296 2000
% 209.88/210.11  |- skos__annotation mesh__D019296 DF: CAPNOGR   
% 209.88/210.11  |- mesh__historyNote mesh__D019296 97   
% 209.88/210.11  |- mesh__dateRevised mesh__D019296 1999-11-03
% 209.88/210.11  |- mesh__activeMeSHYear mesh__D019296 2005
% 209.88/210.11  |- mesh__recordMaintainer mesh__D019296 KEV
% 209.88/210.11  |- mesh__activeMeSHYear mesh__D019296 2004
% 209.88/210.11  |- mesh__recordOriginator mesh__D019296 TGC
% 209.88/210.11  |- mesh__activeMeSHYear mesh__D019296 2001
% 209.88/210.11  |- rdf__type mesh__D019296sskos__Concept
% 209.88/210.11  |- mesh__activeMeSHYear mesh__D019296 2006
% 209.88/210.11  |- skos__prefLabel mesh__D019296 Capnography
% 209.88/210.11  |- skos__hiddenLabel mesh__D019296 Capnographies
% 209.88/210.11  |- mesh__dateEstablished mesh__D019296 1997-01-01
% 209.88/210.11  |- mesh__dateCreated mesh__D019296 1996-06-10
% 209.88/210.11  |- mesh__publicMeSHNote mesh__D019296 97   
% 209.88/210.11  |- mesh__dateRevised mesh__D005276 1997-06-20
% 209.88/210.11  |- mesh__activeMeSHYear mesh__D005276 2003
% 209.88/210.11  |- mesh__recordMaintainer mesh__D005276 PXP
% 209.88/210.11  |- mesh__recordOriginator mesh__D005276 NLM
% 209.88/210.11  |- mesh__historyNote mesh__D005276 97; was FENESTRATION 1966-96   
% 209.88/210.11  |- skos__broader mesh__D005276smesh__D013506
% 209.88/210.11  |- mesh__publicMeSHNote mesh__D005276 97; was FENESTRATION 1963-96   
% 209.88/210.11  |- skos__hiddenLabel mesh__D005276 Fenestrations, Labyrinth
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D005276 2004
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D005276 2002
% 209.97/210.11  |- skos__hiddenLabel mesh__D005276 Labyrinth Fenestrations
% 209.97/210.11  |- rdf__type mesh__D005276sskos__Concept
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D005276 1998
% 209.97/210.11  |- skos__prefLabel mesh__D005276 Fenestration, Labyrinth
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D005276 2005
% 209.97/210.11  |- skos__hiddenLabel mesh__D005276 Labyrinth Fenestration
% 209.97/210.11  |- skos__scopeNote mesh__D005276
% 209.97/210.11       The surgical creation of a new opening in the labyrinth of the ear for the restoration of hearing in cases of OTOSCLEROSIS. %28%Dorland, 27th ed%29%%A%    
% 209.97/210.11  |- mesh__dateCreated mesh__D005276 1999-01-01
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D005276 2000
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D005276 1999
% 209.97/210.11  |- skos__annotation mesh__D005276
% 209.97/210.11       to cure otosclerosis; do not use /util except by MeSH definition%A%  
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D005276 2006
% 209.97/210.11  |- mesh__recordAuthorizer mesh__D005276 SJN
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D005276 2001
% 209.97/210.11  |- mesh__onlineNote mesh__D005276
% 209.97/210.11       use FENESTRATION, LABYRINTH to search FENESTRATION 1966-96%A%  
% 209.97/210.11  |- mesh__historyNote mesh__D013708 73; was TENDON INJURY 1963-72   
% 209.97/210.11  |- rdf__type mesh__D013708sskos__Concept
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D013708 2004
% 209.97/210.11  |- mesh__recordMaintainer mesh__D013708 TPW
% 209.97/210.11  |- mesh__dateRevised mesh__D013708 1997-06-20
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D013708 2000
% 209.97/210.11  |- mesh__recordAuthorizer mesh__D013708 SJN
% 209.97/210.11  |- mesh__dateEstablished mesh__D013708 1973-01-01
% 209.97/210.11  |- mesh__publicMeSHNote mesh__D013708 73; was TENDON INJURY 1963-72   
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D013708 2001
% 209.97/210.11  |- skos__scopeNote mesh__D013708
% 209.97/210.11       Injuries to the fibrous cords of connective tissue which attach muscles to bones or other structures.%A%    
% 209.97/210.11  |- skos__hiddenLabel mesh__D013708 Tendon Injury
% 209.97/210.11  |- mesh__recordOriginator mesh__D013708 NLM
% 209.97/210.11  |- skos__broader mesh__D013708smesh__D014947
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D013708 2002
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D013708 1998
% 209.97/210.11  |- mesh__onlineNote mesh__D013708
% 209.97/210.11       use TENDON INJURIES to search TENDON INJURY 1966-72   
% 209.97/210.11  |- mesh__dateCreated mesh__D013708 1999-01-01
% 209.97/210.11  |- skos__hiddenLabel mesh__D013708 Injury, Tendon
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D013708 2005
% 209.97/210.11  |- skos__altLabel mesh__D013708 Injuries, Tendon
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D013708 1999
% 209.97/210.11  |- skos__prefLabel mesh__D013708 Tendon Injuries
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D013708 2003
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D013708 2006
% 209.97/210.11  |- mesh__recordAuthorizer mesh__D010410 sjn
% 209.97/210.11  |- skos__scopeNote mesh__D010410
% 209.97/210.11       The state of the PENIS when the erectile tissue becomes filled or swollen %28%tumid%29% with BLOOD and causes the penis to become rigid and elevated. It is a complex process involving CENTRAL NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEMS; HORMONES; SMOOTH MUSCLES; and vascular functions.%A%    
% 209.97/210.11  |- skos__historyNote mesh__D010410 Penis %28%1966-1985%29%
% 209.97/210.11  |- mesh__dateCreated mesh__D010410 1985-06-06
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D010410 2005
% 209.97/210.11  |- skos__hiddenLabel mesh__D010410 Erection, Penile
% 209.97/210.11  |- rdf__type mesh__D010410sskos__Concept
% 209.97/210.11  |- skos__hiddenLabel mesh__D010410 Tumescence, Nocturnal Penile
% 209.97/210.11  |- mesh__recordOriginator mesh__D010410 EC
% 209.97/210.11  |- mesh__recordMaintainer mesh__D010410 lkt
% 209.97/210.11  |- skos__prefLabel mesh__D010410 Penile Erection
% 209.97/210.11  |- mesh__historyNote mesh__D010410 86   
% 209.97/210.11  |- mesh__dateEstablished mesh__D010410 1986-01-01
% 209.97/210.11  |- skos__hiddenLabel mesh__D010410 Penile Tumescence, Nocturnal
% 209.97/210.11  |- mesh__dateRevised mesh__D010410 2004-07-07
% 209.97/210.11  |- mesh__publicMeSHNote mesh__D010410 86   
% 209.97/210.11  |- skos__altLabel mesh__D010410 Tumescence, Penile
% 209.97/210.11  |- skos__broader mesh__D010410smesh__D012098
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D010410 2006
% 209.97/210.11  |- skos__hiddenLabel mesh__D009667 Acquired Nose Deformities
% 209.97/210.11  |- skos__hiddenLabel mesh__D009667 Deformities, Acquired Nose
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D009667 1998
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D009667 2003
% 209.97/210.11  |- skos__broader mesh__D009667smesh__D009668
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D009667 2001
% 209.97/210.11  |- mesh__recordMaintainer mesh__D009667 TGC
% 209.97/210.11  |- mesh__recordAuthorizer mesh__D009667 PLS
% 209.97/210.11  |- mesh__publicMeSHNote mesh__D009667 78; was NOSE DEFORMITIES 1968-77   
% 209.97/210.11  |- skos__prefLabel mesh__D009667 Nose Deformities, Acquired
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D009667 1997
% 209.97/210.11  |- skos__hiddenLabel mesh__D009667 Acquired Nose Deformity
% 209.97/210.11  |- skos__scopeNote mesh__D009667
% 209.97/210.11       Deformities of the nose acquired after birth from injury or disease.%A%    
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D009667 2000
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D009667 2006
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D009667 1996
% 209.97/210.11  |- skos__hiddenLabel mesh__D009667 Deformity, Acquired Nose
% 209.97/210.11  |- mesh__historyNote mesh__D009667 78; was NOSE DEFORMITIES 1968-77   
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D009667 1995
% 209.97/210.11  |- mesh__dateRevised mesh__D009667 1992-05-15
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D009667 2005
% 209.97/210.11  |- mesh__recordOriginator mesh__D009667 NLM
% 209.97/210.11  |- mesh__dateCreated mesh__D009667 1999-01-01
% 209.97/210.11  |- skos__annotation mesh__D009667
% 209.97/210.11       = deformities acquired from inj or dis; congenital deformities = NOSE /abnorm %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D009667 1994
% 209.97/210.11  |- rdf__type mesh__D009667sskos__Concept
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D009667 1999
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D009667 2004
% 209.97/210.11  |- mesh__onlineNote mesh__D009667
% 209.97/210.11       use NOSE DEFORMITIES, ACQUIRED to search NOSE DEFORMITIES 1968-77%A%  
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D009667 2002
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D009667 1993
% 209.97/210.11  |- skos__hiddenLabel mesh__D009667 Nose Deformity, Acquired
% 209.97/210.11  |- mesh__recordOriginator mesh__D001684 SMH
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D001684 2002
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D001684 1997
% 209.97/210.11  |- skos__altLabel mesh__D001684 Xenograft Dressings
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Dressings, Homograft
% 209.97/210.11  |- skos__altLabel mesh__D001684 Allograft Dressings
% 209.97/210.11  |- mesh__dateRevised mesh__D001684 1992-03-25
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Amniotic Membrane Dressing
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Dressing, Xenograft
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Pig Skin Dressing
% 209.97/210.11  |- skos__altLabel mesh__D001684 Dressing, Biological
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Dressing, Heterograft
% 209.97/210.11  |- skos__altLabel mesh__D001684 Biologic Dressing
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D001684 2001
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Xenograft Dressings, Porcine
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D001684 1996
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Xenograft Dressing, Porcine
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Dressings, Heterograft
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Dressings, Biologic
% 209.97/210.11  |- skos__altLabel mesh__D001684 Dressings, Biological
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D001684 2006
% 209.97/210.11  |- rdf__type mesh__D001684sskos__Concept
% 209.97/210.11  |- skos__prefLabel mesh__D001684 Biological Dressings
% 209.97/210.11  |- mesh__dateCreated mesh__D001684 1977-03-01
% 209.97/210.11  |- skos__broader mesh__D001684smesh__D001458
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Biologic Dressings
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D001684 1995
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D001684 2000
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Allograft Dressing
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Dressings, Xenograft
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Dressing, Homograft
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D001684 1993
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Dressings, Allograft
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D001684 2005
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Dressing, Amniotic Membrane
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Dressings, Porcine Xenograft
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D001684 1999
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D001684 1994
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Dressing, Allograft
% 209.97/210.11  |- mesh__recordMaintainer mesh__D001684 TAP
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Heterograft Dressing
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Xenograft Dressing
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Dressing, Porcine Xenograft
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D001684 2004
% 209.97/210.11  |- mesh__publicMeSHNote mesh__D001684 91; was see under BANDAGES 1978-90   
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Homograft Dressing
% 209.97/210.11  |- mesh__dateEstablished mesh__D001684 1991-01-01
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D001684 1998
% 209.97/210.11  |- skos__annotation mesh__D001684
% 209.97/210.11       %22%human or animal tissue used as temporary wound covering%22%; do not specify source unless especially discussed %26% do not coord with TRANSPLANTATION, HETEROLOGOUS; note X refs below; DF: BIOL DRESSINGS%A%  
% 209.97/210.11  |- skos__historyNote mesh__D001684 Skin/transplantation %28%1966-1977%29%
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Dressing, Biologic
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Dressings, Amniotic Membrane
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Porcine Xenograft Dressing
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Biological Dressing
% 209.97/210.11  |- mesh__recordAuthorizer mesh__D001684 PLS
% 209.97/210.11  |- skos__altLabel mesh__D001684 Pig Skin Dressings
% 209.97/210.11  |- skos__scopeNote mesh__D001684
% 209.97/210.11       Human or animal tissue used as temporary wound coverings.%A%    
% 209.97/210.11  |- skos__historyNote mesh__D001684 Bandages %28%1966-1977%29%
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Dressing, Pig Skin
% 209.97/210.11  |- mesh__historyNote mesh__D001684
% 209.97/210.11       91%28%78%29%; was see under BANDAGES 1978-90   
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D001684 2003
% 209.97/210.11  |- skos__hiddenLabel mesh__D001684 Dressings, Pig Skin
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D028023 2004
% 209.97/210.11  |- skos__altLabel mesh__D028023 Pijiguao
% 209.97/210.11  |- mesh__publicMeSHNote mesh__D028023 2002   
% 209.97/210.11  |- skos__broader mesh__D028023smesh__D019684
% 209.97/210.11  |- skos__scopeNote mesh__D028023
% 209.97/210.11       The palm family of order Arecales, subclass Arecidae, class Liliopsida.%A%    
% 209.97/210.11  |- skos__annotation mesh__D028023
% 209.97/210.11       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.97/210.11  |- mesh__dateEstablished mesh__D028023 2002-01-01
% 209.97/210.11  |- mesh__historyNote mesh__D028023 2002   
% 209.97/210.11  |- rdf__type mesh__D028023sskos__Concept
% 209.97/210.11  |- mesh__recordOriginator mesh__D028023 ssb
% 209.97/210.11  |- skos__altLabel mesh__D028023 Peach Palm
% 209.97/210.11  |- mesh__recordMaintainer mesh__D028023 ssb
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D028023 2006
% 209.97/210.11  |- mesh__recordAuthorizer mesh__D028023 sjn
% 209.97/210.11  |- mesh__dateRevised mesh__D028023 2003-07-09
% 209.97/210.11  |- skos__prefLabel mesh__D028023 Arecaceae
% 209.97/210.11  |- skos__altLabel mesh__D028023 Pejibaye
% 209.97/210.11  |- mesh__dateCreated mesh__D028023 2001-07-25
% 209.97/210.11  |- skos__altLabel mesh__D028023 Palm, Peach
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D028023 2005
% 209.97/210.11  |- skos__related mesh__D020040smesh__D020038
% 209.97/210.11  |- skos__prefLabel mesh__D020040 Trans-Splicing
% 209.97/210.11  |- skos__altLabel mesh__D020040 Trans Splicing
% 209.97/210.11  |- skos__altLabel mesh__D020040 Trans RNA Splicing
% 209.97/210.11  |- skos__altLabel mesh__D020040 RNA Trans-Splicing
% 209.97/210.11  |- mesh__recordOriginator mesh__D020040 NNS
% 209.97/210.11  |- skos__broader mesh__D020040smesh__D012326
% 209.97/210.11  |- skos__hiddenLabel mesh__D020040 RNA Trans Splicing
% 209.97/210.11  |- mesh__publicMeSHNote mesh__D020040 99   
% 209.97/210.11  |- skos__scopeNote mesh__D020040
% 209.97/210.11       The joining of RNA from two different genes. One type of trans-splicing is the %22%spliced leader%22% type %28%primarily found in protozoans such as trypanosomes and in lower invertebrates such as nematodes%29% which results in the addition of a capped, noncoding, spliced leader sequence to the 5%27% end of mRNAs. Another type of trans-splicing is the %22%discontinuous group II introns%22% type %28%found in plant/algal chloroplasts and plant mitochondria%29% which results in the joining of two independently transcribed coding sequences. Both are mechanistically similar to conventional nuclear pre-mRNA cis-splicing. Mammalian cells are also capable of trans-splicing.%A%    
% 209.97/210.11  |- skos__hiddenLabel mesh__D020040 Trans-Splicings, RNA
% 209.97/210.11  |- mesh__dateEstablished mesh__D020040 1999-01-01
% 209.97/210.11  |- skos__historyNote mesh__D020040 RNA Splicing %28%1982-1998%29%
% 209.97/210.11  |- skos__hiddenLabel mesh__D020040 Splicing, Trans
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D020040 2005
% 209.97/210.11  |- mesh__recordMaintainer mesh__D020040 ags
% 209.97/210.11  |- skos__hiddenLabel mesh__D020040 RNA Splicing, Trans
% 209.97/210.11  |- mesh__dateCreated mesh__D020040 1998-06-11
% 209.97/210.11  |- mesh__dateRevised mesh__D020040 2005-07-28
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D020040 2006
% 209.97/210.11  |- rdf__type mesh__D020040sskos__Concept
% 209.97/210.11  |- mesh__historyNote mesh__D020040 99   
% 209.97/210.11  |- skos__annotation mesh__D020040
% 209.97/210.11       note category: a physiol process taking place within the cell nucleus; do not confuse with DNA, RECOMBINANT; CLONING, MOLECULAR; or GENETIC ENGINEERING%A%  
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D020040 2006A
% 209.97/210.11  |- mesh__recordAuthorizer mesh__D020040 ags
% 209.97/210.11  |- skos__altLabel mesh__D014801 All-Trans-Retinol
% 209.97/210.11  |- mesh__dateRevised mesh__D014801 2005-06-30
% 209.97/210.11  |- mesh__recordOriginator mesh__D014801 NLM
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D014801 2006
% 209.97/210.11  |- mesh__recordAuthorizer mesh__D014801 sjn
% 209.97/210.11  |- mesh__dateCreated mesh__D014801 1999-01-01
% 209.97/210.11  |- mesh__onlineNote mesh__D014801
% 209.97/210.11       use VITAMIN A to search RETINOL 1969-76   
% 209.97/210.11  |- skos__prefLabel mesh__D014801 Vitamin A
% 209.97/210.11  |- skos__broader mesh__D014801smesh__D012176
% 209.97/210.11  |- mesh__recordMaintainer mesh__D014801 ssb
% 209.97/210.11  |- skos__scopeNote mesh__D014801
% 209.97/210.11       Retinol and derivatives of retinol that play an essential role in metabolic functioning of the retina, the growth of and differentiation of epithelial tissue, the growth of bone, reproduction, and the immune response. Dietary vitamin A is derived from a variety of CAROTENOIDS found in plants. It is enriched in the liver, egg yolks, and the fat component of dairy products.%A%    
% 209.97/210.11  |- skos__altLabel mesh__D014801 Vitamin A1
% 209.97/210.11  |- skos__annotation mesh__D014801
% 209.97/210.11       /ther use: coordinate disease with /drug ther, not /diet ther%A%  
% 209.97/210.11  |- rdf__type mesh__D014801sskos__Concept
% 209.97/210.11  |- skos__hiddenLabel mesh__D014801 All Trans Retinol
% 209.97/210.11  |- skos__altLabel mesh__D014801
% 209.97/210.11       3,7-dimethyl-9-%28%2,6,6-trimethyl-1-cyclohexen-1-yl%29%-2,4,6,8-nonatetraen-1-ol, %28%all-E%29%-Isomer
% 209.97/210.11  |- mesh__historyNote mesh__D014801
% 209.97/210.11       RETINOL was see under VITAMIN A 1971-76, was see VITAMIN A 1969-70%A%  
% 209.97/210.11  |- skos__hiddenLabel mesh__D014003 Polyphosphates, Stannous
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D014003 2003
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D014003 1997
% 209.97/210.11  |- skos__prefLabel mesh__D014003 Tin Polyphosphates
% 209.97/210.11  |- skos__hiddenLabel mesh__D014003 Pyrophosphates, Stannous
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D014003 2005
% 209.97/210.11  |- skos__hiddenLabel mesh__D014003 Pyrophosphates, Tin
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D014003 1999
% 209.97/210.11  |- mesh__recordMaintainer mesh__D014003 TPW
% 209.97/210.11  |- skos__historyNote mesh__D014003 Tin %28%1966-1976%29%
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D014003 1996
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D014003 1995
% 209.97/210.11  |- mesh__publicMeSHNote mesh__D014003
% 209.97/210.11       91; was see under POLYPHOSPHATES 1978-90; was see under PHOSPHATES 1977%A%  
% 209.97/210.11  |- mesh__dateCreated mesh__D014003 1976-04-16
% 209.97/210.11  |- mesh__dateRevised mesh__D014003 1993-06-03
% 209.97/210.11  |- mesh__recordOriginator mesh__D014003 RLS
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D014003 1998
% 209.97/210.11  |- rdf__type mesh__D014003sskos__Concept
% 209.97/210.11  |- mesh__recordAuthorizer mesh__D014003 PLS
% 209.97/210.11  |- skos__hiddenLabel mesh__D014003 Polyphosphates, Tin
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D014003 2002
% 209.97/210.11  |- mesh__dateEstablished mesh__D014003 1991-01-01
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D014003 1994
% 209.97/210.11  |- skos__scopeNote mesh__D014003
% 209.97/210.11       Poly or pyrophosphates of tin. In conjunction with radioactive technetium these compounds are used as bone-scanning agents and in scintigraphy to diagnose myocardial and cerebral infarction.%A%    
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D014003 2001
% 209.97/210.11  |- skos__broader mesh__D014003smesh__D011122
% 209.97/210.11  |- mesh__historyNote mesh__D014003
% 209.97/210.11       91%28%77%29%; was see under POLYPHOSPHATES 1978-90; was see under PHOSPHATES 1977%A%  
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D014003 2004
% 209.97/210.11  |- skos__historyNote mesh__D014003 Phosphates %28%1966-1976%29%
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D014003 2000
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D014003 2006
% 209.97/210.11  |- skos__historyNote mesh__D014003 Pyrophosphates %28%1966-1976%29%
% 209.97/210.11  |- skos__broader mesh__D014003smesh__D017971
% 209.97/210.11  |- mesh__dateEstablished mesh__D019297 1997-01-01
% 209.97/210.11  |- skos__broader mesh__D019297smesh__D004140
% 209.97/210.11  |- mesh__historyNote mesh__D019297
% 209.97/210.11       97; was 2,4-DINITROPHENOL %28%NM%29% 1980-96   
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D019297 2006
% 209.97/210.11  |- rdf__type mesh__D019297sskos__Concept
% 209.97/210.11  |- mesh__dateCreated mesh__D019297 1996-06-10
% 209.97/210.11  |- skos__annotation mesh__D019297 DF: note short X ref   
% 209.97/210.11  |- mesh__dateRevised mesh__D019297 2005-07-06
% 209.97/210.11  |- skos__hiddenLabel mesh__D019297 2,4 Dinitrophenol
% 209.97/210.11  |- skos__altLabel mesh__D019297 2,4-DNP
% 209.97/210.11  |- mesh__onlineNote mesh__D019297
% 209.97/210.11       use 2,4-DINITROPHENOL %28%NM%29% to search 2,4-DINITROPHENOL 1980-96%A%  
% 209.97/210.11  |- mesh__publicMeSHNote mesh__D019297
% 209.97/210.11       97; 2,4-DINITROPHENOL was indexed under DINITROPHENOLS 1980-96%A%  
% 209.97/210.11  |- mesh__recordOriginator mesh__D019297 ADP
% 209.97/210.11  |- mesh__recordMaintainer mesh__D019297 NLM
% 209.97/210.11  |- skos__prefLabel mesh__D019297 2,4-Dinitrophenol
% 209.97/210.11  |- mesh__recordAuthorizer mesh__D019297 NLM
% 209.97/210.11  |- skos__scopeNote mesh__D019297
% 209.97/210.11       A toxic dye, chemically related to trinitrophenol %28%picric acid%29%, used in biochemical studies of oxidative processes where it uncouples oxidative phosphorylation. It is also used as a metabolic stimulant. %28%Stedman, 26th ed%29%%A%    
% 209.97/210.11  |- skos__historyNote mesh__D019297 Dinitrophenols %28%1980-1996%29%
% 209.97/210.11  |- mesh__historyNote mesh__D005277 72%28%66%29%   
% 209.97/210.11  |- mesh__dateEstablished mesh__D005277 1972-01-01
% 209.97/210.11  |- skos__hiddenLabel mesh__D005277 Fenfluramine, R Isomer
% 209.97/210.11  |- mesh__recordOriginator mesh__D005277 NLM
% 209.97/210.11  |- rdf__type mesh__D005277sskos__Concept
% 209.97/210.11  |- mesh__dateRevised mesh__D005277 2005-06-30
% 209.97/210.11  |- skos__hiddenLabel mesh__D005277 Fenfluramine Hydrochloride, R Isomer
% 209.97/210.11  |- mesh__recordMaintainer mesh__D005277 CCR
% 209.97/210.11  |- skos__prefLabel mesh__D005277 Fenfluramine
% 209.97/210.11  |- skos__broader mesh__D005277smesh__D010627
% 209.97/210.11  |- mesh__publicMeSHNote mesh__D005277 72   
% 209.97/210.11  |- mesh__dateCreated mesh__D005277 1999-01-01
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D005277 2006
% 209.97/210.11  |- skos__hiddenLabel mesh__D005277 Hydrochloride, Fenfluramine
% 209.97/210.11  |- skos__altLabel mesh__D005277 Robins Brand of Fenfluramine Hydrochloride
% 209.97/210.11  |- skos__scopeNote mesh__D005277
% 209.97/210.11       A centrally active drug that apparently both blocks serotonin uptake and provokes transport-mediated serotonin release.%A%    
% 209.97/210.11  |- mesh__recordAuthorizer mesh__D005277 sjn
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D013709 1999
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D013709 2004
% 209.97/210.11  |- mesh__historyNote mesh__D013709 73%28%69%29%   
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D013709 2006
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D013709 1998
% 209.97/210.11  |- mesh__dateRevised mesh__D013709 1997-06-20
% 209.97/210.11  |- skos__hiddenLabel mesh__D013709 Transfer, Tendon
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D013709 2003
% 209.97/210.11  |- skos__prefLabel mesh__D013709 Tendon Transfer
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D013709 2002
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D013709 2005
% 209.97/210.11  |- rdf__type mesh__D013709sskos__Concept
% 209.97/210.11  |- mesh__recordAuthorizer mesh__D013709 SJN
% 209.97/210.11  |- mesh__publicMeSHNote mesh__D013709 73   
% 209.97/210.11  |- mesh__dateCreated mesh__D013709 1999-01-01
% 209.97/210.11  |- skos__hiddenLabel mesh__D013709 Transfers, Tendon
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D013709 2001
% 209.97/210.11  |- mesh__recordMaintainer mesh__D013709 PXP
% 209.97/210.11  |- skos__annotation mesh__D013709
% 209.97/210.11       do not use /util except by MeSH definition; do not confuse with TENDONS /transpl%A%  
% 209.97/210.11  |- mesh__dateEstablished mesh__D013709 1973-01-01
% 209.97/210.11  |- skos__broader mesh__D013709smesh__D019637
% 209.97/210.11  |- skos__historyNote mesh__D013709 Tendons/surgery %28%1966-1968%29%
% 209.97/210.11  |- mesh__activeMeSHYear mesh__D013709 2000
% 209.97/210.11  |- mesh__recordOriginator mesh__D013709 NLM
% 209.97/210.12  |- skos__scopeNote mesh__D013709
% 209.97/210.12       Surgical procedure by which a tendon is incised at its insertion and placed at an anatomical site distant from the original insertion. The tendon remains attached at the point of origin and takes over the function of a muscle inactivated by trauma or disease.%A%    
% 209.97/210.12  |- skos__hiddenLabel mesh__D013709 Tendon Transfers
% 209.97/210.12  |- skos__hiddenLabel mesh__D010411 Fibrous Cavernitides
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D010411 2001
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D010411 2003
% 209.97/210.12  |- skos__hiddenLabel mesh__D010411 Fibrous Cavernitis
% 209.97/210.12  |- skos__hiddenLabel mesh__D010411 Cavernitides, Fibrous
% 209.97/210.12  |- skos__altLabel mesh__D010411 Peyronie Disease
% 209.97/210.12  |- mesh__dateRevised mesh__D010411 1993-06-02
% 209.97/210.12  |- rdf__type mesh__D010411sskos__Concept
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D010411 2000
% 209.97/210.12  |- mesh__recordOriginator mesh__D010411 NLM
% 209.97/210.12  |- skos__hiddenLabel mesh__D010411 Penile Indurations
% 209.97/210.12  |- skos__broader mesh__D010411smesh__D010409
% 209.97/210.12  |- skos__annotation mesh__D010411 hardening of the corpora cavernosa   
% 209.97/210.12  |- skos__hiddenLabel mesh__D010411 Peyronies Disease
% 209.97/210.12  |- mesh__dateCreated mesh__D010411 1999-01-01
% 209.97/210.12  |- skos__prefLabel mesh__D010411 Penile Induration
% 209.97/210.12  |- skos__hiddenLabel mesh__D010411 Induration, Penile
% 209.97/210.12  |- skos__altLabel mesh__D010411 Peyronie%27%s Disease
% 209.97/210.12  |- skos__hiddenLabel mesh__D010411 Indurations, Penile
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D010411 1995
% 209.97/210.12  |- skos__scopeNote mesh__D010411
% 209.97/210.12       A disease of unknown etiology in which there are plaques or strands of dense fibrous tissue causing induration of the corpora cavernosa of the penis. The condition produces a painful deformity and is sometimes seen in cases of DUPUYTREN%27%S CONTRACTURE.%A%    
% 209.97/210.12  |- skos__hiddenLabel mesh__D010411 Disease, Peyronie
% 209.97/210.12  |- skos__broader mesh__D010411smesh__D003240
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D010411 2002
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D010411 1999
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D010411 1994
% 209.97/210.12  |- skos__hiddenLabel mesh__D010411 Disease, Peyronie%27%s
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D010411 1997
% 209.97/210.12  |- mesh__recordAuthorizer mesh__D010411 PLS
% 209.97/210.12  |- skos__altLabel mesh__D010411 Cavernitis, Fibrous
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D010411 2006
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D010411 1998
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D010411 2004
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D010411 1996
% 209.97/210.12  |- mesh__recordMaintainer mesh__D010411 TAP
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D010411 2005
% 209.97/210.12  |- mesh__recordOriginator mesh__D009668 NLM
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009668 1996
% 209.97/210.12  |- skos__hiddenLabel mesh__D009668 Nose Disease
% 209.97/210.12  |- mesh__publicMeSHNote mesh__D009668 66   
% 209.97/210.12  |- skos__broader mesh__D009668smesh__D012140
% 209.97/210.12  |- mesh__recordAuthorizer mesh__D009668 PLS
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009668 2005
% 209.97/210.12  |- mesh__dateCreated mesh__D009668 1999-01-01
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009668 1997
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009668 1994
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009668 2000
% 209.97/210.12  |- skos__broader mesh__D009668smesh__D010038
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009668 2006
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009668 2001
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009668 1995
% 209.97/210.12  |- mesh__dateRevised mesh__D009668 1990-03-22
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009668 2003
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009668 1998
% 209.97/210.12  |- mesh__dateEstablished mesh__D009668 1966-01-01
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009668 1992
% 209.97/210.12  |- rdf__type mesh__D009668sskos__Concept
% 209.97/210.12  |- mesh__historyNote mesh__D009668 66   
% 209.97/210.12  |- skos__scopeNote mesh__D009668
% 209.97/210.12       Disorders of the nose, general or unspecified.     
% 209.97/210.12  |- skos__hiddenLabel mesh__D009668 Diseases, Nose
% 209.97/210.12  |- skos__annotation mesh__D009668 inflamm dis = RHINITIS   
% 209.97/210.12  |- skos__prefLabel mesh__D009668 Nose Diseases
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009668 1999
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009668 2004
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009668 1993
% 209.97/210.12  |- mesh__recordMaintainer mesh__D009668 TGC
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009668 2002
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009668 1991
% 209.97/210.12  |- skos__hiddenLabel mesh__D009668 Disease, Nose
% 209.97/210.12  |- skos__scopeNote mesh__D001685
% 209.97/210.12       Compounds made by living organisms that contribute to or influence a phenomenon or process. They have biological or physiological activities.%A%    
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D001685 2006
% 209.97/210.12  |- skos__hiddenLabel mesh__D001685 Biologic Factor
% 209.97/210.12  |- skos__altLabel mesh__D001685 Biologic Factors
% 209.97/210.12  |- mesh__dateRevised mesh__D001685 2005-06-30
% 209.97/210.12  |- mesh__recordMaintainer mesh__D001685 ssb
% 209.97/210.12  |- skos__prefLabel mesh__D001685 Biological Factors
% 209.97/210.12  |- skos__altLabel mesh__D001685 Biological Factor
% 209.97/210.12  |- mesh__publicMeSHNote mesh__D001685 89   
% 209.97/210.12  |- skos__altLabel mesh__D001685 Factor, Biologic
% 209.97/210.12  |- mesh__dateEstablished mesh__D001685 1989-01-01
% 209.97/210.12  |- rdf__type mesh__D001685sskos__Concept
% 209.97/210.12  |- skos__altLabel mesh__D001685 Factors, Biological
% 209.97/210.12  |- skos__altLabel mesh__D001685 Factor, Biological
% 209.97/210.12  |- mesh__recordAuthorizer mesh__D001685 sjn
% 209.97/210.12  |- mesh__historyNote mesh__D001685 89; was Non-MeSH before 1989   
% 209.97/210.12  |- mesh__dateCreated mesh__D001685 1999-01-01
% 209.97/210.12  |- mesh__recordOriginator mesh__D001685 NLM
% 209.97/210.12  |- mesh__runningHead mesh__D001685 D23 - BIOLOGICAL FACTORS   
% 209.97/210.12  |- skos__annotation mesh__D001685
% 209.97/210.12       differentiate from BIOLOGICAL PRODUCTS; DF: BIOL FACTORS   
% 209.97/210.12  |- skos__hiddenLabel mesh__D001685 Factors, Biologic
% 209.97/210.12  |- skos__hiddenLabel mesh__D034061 Thrombocytopoieses
% 209.97/210.12  |- skos__prefLabel mesh__D034061 Thrombopoiesis
% 209.97/210.12  |- skos__altLabel mesh__D034061 Thrombocytopoiesis
% 209.97/210.12  |- mesh__dateRevised mesh__D034061 2003-07-09
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D034061 2005
% 209.97/210.12  |- mesh__publicMeSHNote mesh__D034061 2003   
% 209.97/210.12  |- skos__hiddenLabel mesh__D034061 Megakaryocytopoieses
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D034061 2006
% 209.97/210.12  |- mesh__dateEstablished mesh__D034061 2003-01-01
% 209.97/210.12  |- skos__broader mesh__D034061smesh__D006410
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D034061 2004
% 209.97/210.12  |- skos__hiddenLabel mesh__D034061 Thrombopoieses
% 209.97/210.12  |- mesh__dateCreated mesh__D034061 2002-07-03
% 209.97/210.12  |- mesh__historyNote mesh__D034061 2003   
% 209.97/210.12  |- skos__historyNote mesh__D034061 Blood Platelets %28%1965-2002%29%
% 209.97/210.12  |- rdf__type mesh__D034061sskos__Concept
% 209.97/210.12  |- skos__historyNote mesh__D034061 Hematopoiesis %28%1965-2002%29%
% 209.97/210.12  |- skos__scopeNote mesh__D034061
% 209.97/210.12       The process of generating thrombocytes %28%BLOOD PLATELETS%29% from the pluripotent HEMATOPOIETIC STEM CELLS in the BONE MARROW via the MEGAKARYOCYTES. The humoral factor with thrombopoiesis-stimulating activity is designated THROMBOPOIETIN.%A%    
% 209.97/210.12  |- mesh__publicMeSHNote mesh__D006370
% 209.97/210.12       91; was see under PHOTOTHERAPY 1986-90; was see under PHYSICAL THERAPY 1975-85; was see under SUNLIGHT 1966-74%A%  
% 209.97/210.12  |- mesh__recordAuthorizer mesh__D006370 sjn
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D006370 2006
% 209.97/210.12  |- skos__scopeNote mesh__D006370
% 209.97/210.12       The treatment of disease by exposing the body to the sun%27%s rays; the therapeutic use of sunbathing. %28%From Dorland, 27th ed%29%%A%    
% 209.97/210.12  |- skos__annotation mesh__D006370
% 209.97/210.12       note X ref; do not use /util except by MeSH definition   
% 209.97/210.12  |- mesh__recordOriginator mesh__D006370 NLM
% 209.97/210.12  |- skos__broader mesh__D006370smesh__D010789
% 209.97/210.12  |- rdf__type mesh__D006370sskos__Concept
% 209.97/210.12  |- mesh__dateCreated mesh__D006370 1999-01-01
% 209.97/210.12  |- mesh__dateRevised mesh__D006370 2005-06-30
% 209.97/210.12  |- mesh__recordMaintainer mesh__D006370 lkt
% 209.97/210.12  |- mesh__historyNote mesh__D006370
% 209.97/210.12       91%28%75%29%; was see under PHOTOTHERAPY 1986-90; was see under PHYSICAL THERAPY 1975-85; was see under SUNLIGHT 1963-74%A%  
% 209.97/210.12  |- skos__prefLabel mesh__D006370 Heliotherapy
% 209.97/210.12  |- mesh__onlineNote mesh__D006370
% 209.97/210.12       use SUNLIGHT to search HELIOTHERAPY 1966-74   
% 209.97/210.12  |- mesh__dateEstablished mesh__D006370 1991-01-01
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D028024 2004
% 209.97/210.12  |- skos__scopeNote mesh__D028024
% 209.97/210.12       A plant genus in the family ARECACEAE, order Arecales, subclass Arecidae. The fruit or the extract %28%Permixon%29% is used for PROSTATIC HYPERPLASIA.%A%    
% 209.97/210.12  |- mesh__publicMeSHNote mesh__D028024 2002   
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D028024 2002
% 209.97/210.12  |- skos__altLabel mesh__D028024 Serenoa serrulata
% 209.97/210.12  |- skos__annotation mesh__D028024
% 209.97/210.12       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.97/210.12  |- skos__historyNote mesh__D028024 Plants, Medicinal %28%1969-2001%29%
% 209.97/210.12  |- skos__prefLabel mesh__D028024 Serenoa
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D028024 2005
% 209.97/210.12  |- rdf__type mesh__D028024sskos__Concept
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D028024 2006
% 209.97/210.12  |- skos__altLabel mesh__D028024 Sabal
% 209.97/210.12  |- skos__altLabel mesh__D028024 Sabal serrulata
% 209.97/210.12  |- skos__broader mesh__D028024smesh__D028023
% 209.97/210.12  |- mesh__historyNote mesh__D028024 2002   
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D028024 2003
% 209.97/210.12  |- mesh__dateCreated mesh__D028024 2001-07-25
% 209.97/210.12  |- mesh__dateEstablished mesh__D028024 2002-01-01
% 209.97/210.12  |- skos__related mesh__D014802smesh__D014985
% 209.97/210.12  |- skos__altLabel mesh__D014802 Deficiency, Vitamin A
% 209.97/210.12  |- skos__hiddenLabel mesh__D014802 Vitamin A Deficiencies
% 209.97/210.12  |- skos__prefLabel mesh__D014802 Vitamin A Deficiency
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D014802 2006
% 209.97/210.12  |- mesh__recordOriginator mesh__D014802 NLM
% 209.97/210.12  |- skos__hiddenLabel mesh__D014802 Deficiencies, Vitamin A
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D014802 2004
% 209.97/210.12  |- skos__related mesh__D014802smesh__D009755
% 209.97/210.12  |- skos__broader mesh__D014802smesh__D001361
% 209.97/210.12  |- mesh__recordAuthorizer mesh__D014802 sjn
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D014802 2005
% 209.97/210.12  |- mesh__dateCreated mesh__D014802 1999-01-01
% 209.97/210.12  |- mesh__recordMaintainer mesh__D014802 lkt
% 209.97/210.12  |- skos__scopeNote mesh__D014802
% 209.97/210.12       A nutritional condition produced by a deficiency of VITAMIN A in the diet, characterized by NIGHT BLINDNESS and other ocular manifestations such as dryness of the conjunctiva and later of the cornea %28%XEROPHTHALMIA%29%. Vitamin A deficiency is a very common problem worldwide, particularly in developing countries as a consequence of famine or shortages of vitamin A-rich foods. In the United States it is found among the urban poor, the elderly, alcoholics, and patients with malabsorption. %28%From Cecil Textbook of Medicine, 19th ed, p1179%29%%A%    
% 209.97/210.12  |- skos__annotation mesh__D014802 DF: VITAMIN A DEFIC   
% 209.97/210.12  |- mesh__dateRevised mesh__D014802 2003-07-09
% 209.97/210.12  |- rdf__type mesh__D014802sskos__Concept
% 209.97/210.12  |- mesh__recordMaintainer mesh__D014004 TPW
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D014004 2000
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D014004 1996
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D014004 1995
% 209.97/210.12  |- skos__broader mesh__D014004smesh__D011868
% 209.97/210.12  |- skos__scopeNote mesh__D014004
% 209.97/210.12       Unstable isotopes of tin that decay or disintegrate emitting radiation. Sn atoms with atomic weights 108-111, 113, 120-121, 123 and 125-128 are tin radioisotopes.%A%    
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D014004 1998
% 209.97/210.12  |- rdf__type mesh__D014004sskos__Concept
% 209.97/210.12  |- mesh__historyNote mesh__D014004 88   
% 209.97/210.12  |- skos__historyNote mesh__D014004 Radioisotopes %28%1966-1987%29%
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D014004 1994
% 209.97/210.12  |- skos__hiddenLabel mesh__D014004 Radioisotopes, Tin
% 209.97/210.12  |- skos__annotation mesh__D014004
% 209.97/210.12       Sn-108-111, 113, 120-121, 123, 125-128; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 209.97/210.12  |- mesh__dateCreated mesh__D014004 1987-04-08
% 209.97/210.12  |- mesh__dateRevised mesh__D014004 1993-06-03
% 209.97/210.12  |- mesh__recordOriginator mesh__D014004 RLS
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D014004 2004
% 209.97/210.12  |- mesh__recordAuthorizer mesh__D014004 PLS
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D014004 2002
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D014004 2006
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D014004 2003
% 209.97/210.12  |- mesh__dateEstablished mesh__D014004 1988-01-01
% 209.97/210.12  |- skos__prefLabel mesh__D014004 Tin Radioisotopes
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D014004 2001
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D014004 1997
% 209.97/210.12  |- skos__historyNote mesh__D014004 Tin %28%1966-1987%29%
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D014004 2005
% 209.97/210.12  |- mesh__publicMeSHNote mesh__D014004 88   
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D014004 1999
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D019298 2006
% 209.97/210.12  |- rdf__type mesh__D019298sskos__Concept
% 209.97/210.12  |- skos__historyNote mesh__D019298 Glucosephosphates %28%1981-1996%29%
% 209.97/210.12  |- mesh__dateEstablished mesh__D019298 1997-01-01
% 209.97/210.12  |- skos__broader mesh__D019298smesh__D005958
% 209.97/210.12  |- skos__prefLabel mesh__D019298 Glucose-6-Phosphate
% 209.97/210.12  |- mesh__dateCreated mesh__D019298 1996-06-10
% 209.97/210.12  |- mesh__recordMaintainer mesh__D019298 ssb
% 209.97/210.12  |- mesh__recordAuthorizer mesh__D019298 sjn
% 209.97/210.12  |- skos__hiddenLabel mesh__D019298 Glucose 6 Phosphate
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D019298 2005
% 209.97/210.12  |- mesh__onlineNote mesh__D019298
% 209.97/210.12       use GLUCOSE-6-PHOSPHATE %28%NM%29% to search GLUCOSE-6-PHOSPHATE 1981-96%A%  
% 209.97/210.12  |- mesh__dateRevised mesh__D019298 2004-07-07
% 209.97/210.12  |- mesh__historyNote mesh__D019298
% 209.97/210.12       97; was GLUCOSE-6-PHOSPHATE %28%NM%29% 1981-96   
% 209.97/210.12  |- mesh__publicMeSHNote mesh__D019298
% 209.97/210.12       97; GLUCOSE-6-PHOSPHATE was indexed under GLUCOSEPHOSPHATES 1981-96%A%  
% 209.97/210.12  |- skos__scopeNote mesh__D019298
% 209.97/210.12       An ester of glucose with phosphoric acid, made in the course of glucose metabolism by mammalian and other cells. It is a normal constituent of resting muscle and probably is in constant equilibrium with fructose-6-phosphate. %28%Stedman, 26th ed%29%%A%    
% 209.97/210.12  |- mesh__recordOriginator mesh__D019298 ADP
% 209.97/210.12  |- skos__broader mesh__D005278smesh__D009946
% 209.97/210.12  |- skos__altLabel mesh__D005278 Metathion
% 209.97/210.12  |- mesh__dateCreated mesh__D005278 1999-01-01
% 209.97/210.12  |- mesh__dateEstablished mesh__D005278 1974-01-01
% 209.97/210.12  |- skos__annotation mesh__D005278 TN 111 for eff on insects   
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D005278 2006
% 209.97/210.12  |- skos__scopeNote mesh__D005278
% 209.97/210.12       An organothiophosphate cholinesterase inhibitor that is used as an insecticide.%A%    
% 209.97/210.12  |- mesh__publicMeSHNote mesh__D005278 74   
% 209.97/210.12  |- mesh__recordAuthorizer mesh__D005278 sjn
% 209.97/210.12  |- mesh__historyNote mesh__D005278 74%28%72%29%   
% 209.97/210.12  |- skos__historyNote mesh__D005278 Insecticides %28%1966-1971%29%
% 209.97/210.12  |- skos__prefLabel mesh__D005278 Fenitrothion
% 209.97/210.12  |- mesh__recordOriginator mesh__D005278 NLM
% 209.97/210.12  |- skos__hiddenLabel mesh__D005278 1050, Agria
% 209.97/210.12  |- mesh__dateRevised mesh__D005278 2005-06-30
% 209.97/210.12  |- skos__altLabel mesh__D005278 Sumithione
% 209.97/210.12  |- mesh__recordMaintainer mesh__D005278 ssb
% 209.97/210.12  |- rdf__type mesh__D005278sskos__Concept
% 209.97/210.12  |- mesh__dateCreated mesh__D010412 1999-01-01
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D010412 2002
% 209.97/210.12  |- skos__broader mesh__D010412smesh__D010409
% 209.97/210.12  |- skos__hiddenLabel mesh__D010412 Cancers, Penile
% 209.97/210.12  |- skos__scopeNote mesh__D010412
% 209.97/210.12       Cancers or tumors of the PENIS or of its component tissues.%A%    
% 209.97/210.12  |- skos__altLabel mesh__D010412 Penile Cancer
% 209.97/210.12  |- skos__hiddenLabel mesh__D010412 Cancer, Penis
% 209.97/210.12  |- mesh__dateRevised mesh__D010412 1999-11-08
% 209.97/210.12  |- skos__altLabel mesh__D010412 Penis Neoplasms
% 209.97/210.12  |- skos__altLabel mesh__D010412 Penis Cancer
% 209.97/210.12  |- mesh__recordMaintainer mesh__D010412 adp
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D010412 2006
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D010412 2001
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D010412 2004
% 209.97/210.12  |- skos__broader mesh__D010412smesh__D005834
% 209.97/210.12  |- skos__altLabel mesh__D010412 Neoplasms, Penile
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D010412 2005
% 209.97/210.12  |- mesh__recordOriginator mesh__D010412 NLM
% 209.97/210.12  |- mesh__recordAuthorizer mesh__D010412 sjn
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D010412 2000
% 209.97/210.12  |- skos__hiddenLabel mesh__D010412 Penile Neoplasm
% 209.97/210.12  |- skos__altLabel mesh__D010412 Cancer of the Penis
% 209.97/210.12  |- skos__hiddenLabel mesh__D010412 Cancers, Penis
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D010412 2003
% 209.97/210.12  |- skos__hiddenLabel mesh__D010412 Penile Cancers
% 209.97/210.12  |- skos__hiddenLabel mesh__D010412 Cancer, Penile
% 209.97/210.12  |- rdf__type mesh__D010412sskos__Concept
% 209.97/210.12  |- skos__hiddenLabel mesh__D010412 Penis Cancers
% 209.97/210.12  |- skos__hiddenLabel mesh__D010412 Neoplasm, Penile
% 209.97/210.12  |- skos__hiddenLabel mesh__D010412 Neoplasm, Penis
% 209.97/210.12  |- skos__annotation mesh__D010412
% 209.97/210.12       coord IM with histol type of neopl %28%IM%29%   
% 209.97/210.12  |- skos__hiddenLabel mesh__D010412 Penis Neoplasm
% 209.97/210.12  |- skos__prefLabel mesh__D010412 Penile Neoplasms
% 209.97/210.12  |- skos__altLabel mesh__D010412 Neoplasms, Penis
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009669 2005
% 209.97/210.12  |- mesh__dateCreated mesh__D009669 1999-01-01
% 209.97/210.12  |- mesh__recordMaintainer mesh__D009669 nns
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009669 2002
% 209.97/210.12  |- skos__hiddenLabel mesh__D009669 Cancer, Nose
% 209.97/210.12  |- skos__scopeNote mesh__D009669 Tumors or cancer of the NOSE.     
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009669 2006
% 209.97/210.12  |- mesh__recordOriginator mesh__D009669 NLM
% 209.97/210.12  |- skos__annotation mesh__D009669
% 209.97/210.12       soft or bony tissue; coord IM with specific site in nose %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 209.97/210.12  |- mesh__dateRevised mesh__D009669 2000-06-22
% 209.97/210.12  |- skos__hiddenLabel mesh__D009669 Nose Cancers
% 209.97/210.12  |- mesh__recordAuthorizer mesh__D009669 sjn
% 209.97/210.12  |- skos__broader mesh__D009669smesh__D012142
% 209.97/210.12  |- skos__hiddenLabel mesh__D009669 Nose Neoplasm
% 209.97/210.12  |- skos__broader mesh__D009669smesh__D010039
% 209.97/210.12  |- skos__altLabel mesh__D009669 Cancer of the Nose
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009669 2003
% 209.97/210.12  |- skos__altLabel mesh__D009669 Neoplasms, Nose
% 209.97/210.12  |- rdf__type mesh__D009669sskos__Concept
% 209.97/210.12  |- skos__broader mesh__D009669smesh__D012888
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009669 2004
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D009669 2001
% 209.97/210.12  |- skos__hiddenLabel mesh__D009669 Cancers, Nose
% 209.97/210.12  |- skos__altLabel mesh__D009669 Nose Cancer
% 209.97/210.12  |- skos__broader mesh__D009669smesh__D009668
% 209.97/210.12  |- skos__hiddenLabel mesh__D009669 Neoplasm, Nose
% 209.97/210.12  |- skos__prefLabel mesh__D009669 Nose Neoplasms
% 209.97/210.12  |- mesh__recordOriginator mesh__D001686 NLM
% 209.97/210.12  |- rdf__type mesh__D001686sskos__Concept
% 209.97/210.12  |- mesh__publicMeSHNote mesh__D001686 98   
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D001686 2003
% 209.97/210.12  |- mesh__recordAuthorizer mesh__D001686 SJN
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D001686 2000
% 209.97/210.12  |- mesh__dateCreated mesh__D001686 1999-01-01
% 209.97/210.12  |- skos__scopeNote mesh__D001686
% 209.97/210.12       Biological functions and activities at the organic and molecular levels in humans, animals, microorganisms, and plants. For biochemical and metabolic processes, BIOCHEMICAL PHENOMENA is available.%A%    
% 209.97/210.12  |- mesh__dateRevised mesh__D001686 1997-06-20
% 209.97/210.12  |- mesh__dateEstablished mesh__D001686 1998-01-01
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D001686 2004
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D001686 2001
% 209.97/210.12  |- skos__altLabel mesh__D001686 Biologic Phenomena
% 209.97/210.12  |- skos__broader mesh__D001686smesh__D001687
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D001686 2005
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D001686 1998
% 209.97/210.12  |- skos__hiddenLabel mesh__D001686 Phenomena, Biologic
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D001686 2002
% 209.97/210.12  |- skos__annotation mesh__D001686
% 209.97/210.12       GEN or unspecified; prefer specifics; BIOCHEMICAL PHENOMENA is also available%A%  
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D001686 2006
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D001686 1999
% 209.97/210.12  |- mesh__historyNote mesh__D001686 98; use explode 1970-97   
% 209.97/210.12  |- skos__prefLabel mesh__D001686 Biological Phenomena
% 209.97/210.12  |- skos__altLabel mesh__D001686 Phenomena, Biological
% 209.97/210.12  |- mesh__recordMaintainer mesh__D001686 TGC
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D034062 2005
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D034062 2003
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D034062 2006
% 209.97/210.12  |- skos__broader mesh__D034062smesh__D017096
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D034062 2004
% 209.97/210.12  |- skos__hiddenLabel mesh__D034062 Insomnias, Fatal Familial
% 209.97/210.12  |- skos__prefLabel mesh__D034062 Insomnia, Fatal Familial
% 209.97/210.12  |- mesh__publicMeSHNote mesh__D034062 2003; see PRION DISEASES 1993-2002   
% 209.97/210.12  |- skos__broader mesh__D034062smesh__D007319
% 209.97/210.12  |- mesh__historyNote mesh__D034062 2003; use PRION DISEASES 1993-2002   
% 209.97/210.12  |- skos__hiddenLabel mesh__D034062 Fatal Familial Insomnias
% 209.97/210.12  |- skos__scopeNote mesh__D034062
% 209.97/210.12       An autosomal dominant disorder characterized by degeneration of the THALAMUS and progressive insomnia. It is caused by a mutation in the prion protein %28%PRIONS%29%.%A%    
% 209.97/210.12  |- mesh__dateEstablished mesh__D034062 2003-01-01
% 209.97/210.12  |- skos__historyNote mesh__D034062 Prion Diseases %28%1992-2002%29%
% 209.97/210.12  |- rdf__type mesh__D034062sskos__Concept
% 209.97/210.12  |- skos__altLabel mesh__D034062 Fatal Familial Insomnia
% 209.97/210.12  |- skos__historyNote mesh__D034062
% 209.97/210.12       Sleep Initiation and Maintenance Disorders %28%1986-1992%29%
% 209.97/210.12  |- mesh__dateCreated mesh__D034062 2002-07-03
% 209.97/210.12  |- skos__historyNote mesh__D020840 Kallikreins %28%1983-1999%29%
% 209.97/210.12  |- skos__altLabel mesh__D020840 hK2 Kallikrein
% 209.97/210.12  |- skos__altLabel mesh__D020840 Kallikrein 2
% 209.97/210.12  |- skos__hiddenLabel mesh__D020840 Kallikreins, Human Glandular
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D020840 2006
% 209.97/210.12  |- skos__altLabel mesh__D020840 Pancreatic Kallikrein
% 209.97/210.12  |- skos__altLabel mesh__D020840 Glandular Kallikrein
% 209.97/210.12  |- mesh__historyNote mesh__D020840
% 209.97/210.12       2000; use TISSUE KALLIKREIN %28%NM%29% 1983-1999   
% 209.97/210.12  |- rdf__type mesh__D020840sskos__Concept
% 209.97/210.12  |- skos__prefLabel mesh__D020840 Tissue Kallikreins
% 209.97/210.12  |- mesh__recordMaintainer mesh__D020840 ssb
% 209.97/210.12  |- mesh__recordAuthorizer mesh__D020840 sjn
% 209.97/210.12  |- skos__hiddenLabel mesh__D020840 Kallikrein, Glandular
% 209.97/210.12  |- skos__hiddenLabel mesh__D020840 Glandular Kallikrein 1
% 209.97/210.12  |- mesh__publicMeSHNote mesh__D020840
% 209.97/210.12       2000; TISSUE KALLIKREIN was indexed under KALLIKREIN 1983-1999 %26% PEPTIDE PEPTIDOHYDROLASES 1982-1983%A%  
% 209.97/210.12  |- skos__hiddenLabel mesh__D020840 Kallikrein, hK2
% 209.97/210.12  |- skos__hiddenLabel mesh__D020840 Kallikrein, Prostate Specific
% 209.97/210.12  |- mesh__dateEstablished mesh__D020840 2000-01-01
% 209.97/210.12  |- skos__broader mesh__D020840smesh__D014408
% 209.97/210.12  |- skos__altLabel mesh__D020840 hK1 Kallikrein
% 209.97/210.12  |- skos__altLabel mesh__D020840 Human Glandular Kallikreins
% 209.97/210.12  |- skos__hiddenLabel mesh__D020840 1, Kallikrein
% 209.97/210.12  |- skos__annotation mesh__D020840
% 209.97/210.12       do not confuse PROSTATE SPECIFIC KALLIKREIN with PROSTATE SPECIFIC ANTIGEN%A%  
% 209.97/210.12  |- skos__broader mesh__D020840smesh__D007610
% 209.97/210.12  |- mesh__dateRevised mesh__D020840 2005-06-30
% 209.97/210.12  |- skos__altLabel mesh__D020840 Glandular Kallikrein-1
% 209.97/210.12  |- skos__scopeNote mesh__D020840
% 209.97/210.12       A family of trypsin-like SERINE ENDOPEPTIDASES that are expressed in a variety of cell types including human prostate epithelial cells. They are formed from tissue prokallikrein by action with TRYPSIN. They are highly similar to PROSTATE-SPECIFIC ANTIGEN. EC 3.4.21.35.%A%    
% 209.97/210.12  |- skos__hiddenLabel mesh__D020840 Kallikrein-1, Glandular
% 209.97/210.12  |- skos__hiddenLabel mesh__D020840 Kallikrein, hK1
% 209.97/210.12  |- skos__hiddenLabel mesh__D020840 Kallikrein, Tissue
% 209.97/210.12  |- skos__altLabel mesh__D020840 Prostate Specific Kallikrein
% 209.97/210.12  |- mesh__recordOriginator mesh__D020840 adp
% 209.97/210.12  |- skos__hiddenLabel mesh__D020840 Kallikrein, Urinary
% 209.97/210.12  |- skos__altLabel mesh__D020840 Tissue Kallikrein
% 209.97/210.12  |- skos__altLabel mesh__D020840 Kallikrein 1
% 209.97/210.12  |- skos__altLabel mesh__D020840 Urinary Kallikrein
% 209.97/210.12  |- skos__historyNote mesh__D020840 Endopeptidases %28%1982-1983%29%
% 209.97/210.12  |- skos__hiddenLabel mesh__D020840 2, Kallikrein
% 209.97/210.12  |- skos__hiddenLabel mesh__D020840 Specific Kallikrein, Prostate
% 209.97/210.12  |- skos__hiddenLabel mesh__D020840 Kallikrein, Pancreatic
% 209.97/210.12  |- skos__hiddenLabel mesh__D020840 Kallikreins, Tissue
% 209.97/210.12  |- skos__hiddenLabel mesh__D020840 Glandular Kallikreins, Human
% 209.97/210.12  |- mesh__dateCreated mesh__D020840 1999-11-09
% 209.97/210.12  |- skos__altLabel mesh__D047788 Revolutionary War
% 209.97/210.12  |- skos__hiddenLabel mesh__D047788 American Revolution, 1775 1783
% 209.97/210.12  |- mesh__dateEstablished mesh__D047788 2005-01-01
% 209.97/210.12  |- mesh__dateCreated mesh__D047788 2004-07-07
% 209.97/210.12  |- mesh__publicMeSHNote mesh__D047788 2005   
% 209.97/210.12  |- skos__broader mesh__D047788smesh__D049671
% 209.97/210.12  |- mesh__historyNote mesh__D047788 2005   
% 209.97/210.12  |- mesh__recordOriginator mesh__D047788 jls
% 209.97/210.12  |- skos__hiddenLabel mesh__D047788 War, Revolutionary
% 209.97/210.12  |- mesh__recordMaintainer mesh__D047788 jls
% 209.97/210.12  |- mesh__recordAuthorizer mesh__D047788 sjn
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D047788 2005
% 209.97/210.12  |- skos__altLabel mesh__D047788 American Revolution, 1775-1783
% 209.97/210.12  |- skos__hiddenLabel mesh__D047788 Revolution, American
% 209.97/210.12  |- skos__scopeNote mesh__D047788
% 209.97/210.12       Armed conflict that resulted in separation of American colonies from Britain and established the United States of America.%A%    
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D047788 2006
% 209.97/210.12  |- rdf__type mesh__D047788sskos__Concept
% 209.97/210.12  |- skos__hiddenLabel mesh__D047788 Revolutions, American
% 209.97/210.12  |- skos__prefLabel mesh__D047788 American Revolution
% 209.97/210.12  |- skos__altLabel mesh__D047788 American War of Independence
% 209.97/210.12  |- skos__hiddenLabel mesh__D047788 American Revolutions
% 209.97/210.12  |- mesh__dateRevised mesh__D006371 1993-06-04
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D006371 1998
% 209.97/210.12  |- mesh__activeMeSHYear mesh__D006371 2003
% 209.97/210.12  |- mesh__recordMaintainer mesh__D006371 TPW
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D006371 1994
% 209.97/210.13  |- rdf__type mesh__D006371sskos__Concept
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D006371 2000
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D006371 1999
% 209.97/210.13  |- mesh__dateCreated mesh__D006371 1999-01-01
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D006371 2004
% 209.97/210.13  |- skos__prefLabel mesh__D006371 Helium
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D006371 1995
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D006371 2001
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D006371 2005
% 209.97/210.13  |- skos__annotation mesh__D006371
% 209.97/210.13       a rare gas; He-4; He-3 = HELIUM %28%IM%29% + ISOTOPES %28%NIM%29%; He-5, 6, 8 = HELIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D006371 1996
% 209.97/210.13  |- skos__broader mesh__D006371smesh__D005741
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D006371 2002
% 209.97/210.13  |- mesh__recordOriginator mesh__D006371 NLM
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D006371 2006
% 209.97/210.13  |- skos__scopeNote mesh__D006371
% 209.97/210.13       Helium. A noble gas with the atomic symbol He, atomic number 2, and atomic weight 4.003. It is a colorless, odorless, tasteless gas that is not combustible and does not support combustion. It was first detected in the sun and is now obtained from natural gas. Medically it is used as a diluent for other gases, being especially useful with oxygen in the treatment of certain cases of respiratory obstruction, and as a vehicle for general anesthetics. %28%Dorland, 27th ed%29%%A%    
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D006371 1997
% 209.97/210.13  |- mesh__recordAuthorizer mesh__D006371 PLS
% 209.97/210.13  |- rdf__type mesh__D020042sskos__Concept
% 209.97/210.13  |- skos__scopeNote mesh__D020042
% 209.97/210.13       Development of lesions in the lymph node characterized by infiltration of the cortex or paracortex by large collections of proliferating histiocytes and complete or, more often, incomplete necrosis of lymphoid tissue.%A%    
% 209.97/210.13  |- skos__altLabel mesh__D020042 Lymphadenitis, Histiocytic Necrotizing
% 209.97/210.13  |- skos__altLabel mesh__D020042 Kikuchi-Fujimoto Disease
% 209.97/210.13  |- skos__hiddenLabel mesh__D020042 Disease, Kikuchi
% 209.97/210.13  |- mesh__historyNote mesh__D020042 99   
% 209.97/210.13  |- mesh__dateCreated mesh__D020042 1998-06-10
% 209.97/210.13  |- skos__hiddenLabel mesh__D020042 Disease, Kikuchi-Fujimoto
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D020042 2003
% 209.97/210.13  |- skos__hiddenLabel mesh__D020042 Disease, Kikuchi%27%s
% 209.97/210.13  |- mesh__publicMeSHNote mesh__D020042 99   
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D020042 2000
% 209.97/210.13  |- skos__broader mesh__D020042smesh__D008199
% 209.97/210.13  |- skos__hiddenLabel mesh__D020042 Necrotizing Lymphadenitis, Histiocytic
% 209.97/210.13  |- mesh__dateEstablished mesh__D020042 1999-01-01
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D020042 2004
% 209.97/210.13  |- skos__prefLabel mesh__D020042 Histiocytic Necrotizing Lymphadenitis
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D020042 2001
% 209.97/210.13  |- skos__altLabel mesh__D020042 Kikuchi Disease
% 209.97/210.13  |- skos__hiddenLabel mesh__D020042 Kikuchi Fujimoto Disease
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D020042 2005
% 209.97/210.13  |- skos__altLabel mesh__D020042 Kikuchi%27%s Disease
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D020042 2002
% 209.97/210.13  |- skos__historyNote mesh__D020042 Lymphadenitis %28%1983-1998%29%
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D020042 1999
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D020042 2006
% 209.97/210.13  |- skos__hiddenLabel mesh__D020042 Kikuchis Disease
% 209.97/210.13  |- skos__altLabel mesh__D014803 Neurobion
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014803 2006
% 209.97/210.13  |- skos__scopeNote mesh__D014803
% 209.97/210.13       A group of water-soluble vitamins, some of which are COENZYMES.%A%    
% 209.97/210.13  |- mesh__dateCreated mesh__D014803 1999-01-01
% 209.97/210.13  |- mesh__dateRevised mesh__D014803 2005-06-30
% 209.97/210.13  |- skos__prefLabel mesh__D014803 Vitamin B Complex
% 209.97/210.13  |- rdf__type mesh__D014803sskos__Concept
% 209.97/210.13  |- skos__annotation mesh__D014803
% 209.97/210.13       GEN or unspecified B vitamins; prefer specific vitamin B; /defic = VITAMIN B DEFICIENCY or PELLAGRA; /ther use: coord disease with /drug ther, not /diet ther%A%  
% 209.97/210.13  |- mesh__recordOriginator mesh__D014803 NLM
% 209.97/210.13  |- mesh__recordMaintainer mesh__D014803 ssb
% 209.97/210.13  |- mesh__recordAuthorizer mesh__D014803 sjn
% 209.97/210.13  |- skos__altLabel mesh__D014803 B Vitamins
% 209.97/210.13  |- skos__broader mesh__D014803smesh__D014815
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014005 2000
% 209.97/210.13  |- skos__hiddenLabel mesh__D014005 Epidermophytoses
% 209.97/210.13  |- mesh__dateCreated mesh__D014005 1999-01-01
% 209.97/210.13  |- rdf__type mesh__D014005sskos__Concept
% 209.97/210.13  |- mesh__recordOriginator mesh__D014005 NLM
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014005 2001
% 209.97/210.13  |- skos__scopeNote mesh__D014005
% 209.97/210.13       A general term describing various dermatophytoses. Specific types include TINEA CAPITIS %28%ringworm of the scalp%29%, TINEA FAVOSA %28%of scalp and skin%29%, TINEA PEDIS %28%athlete%27%s foot%29%, and tinea unguium %28%see ONYCHOMYCOSIS, ringworm of the nails%29%. %28%Dorland, 27th ed%29%%A%    
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014005 2003
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014005 2005
% 209.97/210.13  |- skos__annotation mesh__D014005
% 209.97/210.13       the disease ringworm: do not confuse with TAENIA, tapeworm; GEN or unspecified: prefer specifics%A%  
% 209.97/210.13  |- skos__broader mesh__D014005smesh__D003881
% 209.97/210.13  |- mesh__dateRevised mesh__D014005 1996-06-10
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014005 2004
% 209.97/210.13  |- skos__prefLabel mesh__D014005 Tinea
% 209.97/210.13  |- mesh__recordAuthorizer mesh__D014005 PLS
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014005 2002
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014005 2006
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014005 1998
% 209.97/210.13  |- skos__hiddenLabel mesh__D014005 Trichophytoses
% 209.97/210.13  |- skos__hiddenLabel mesh__D014005 Tineas
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014005 1997
% 209.97/210.13  |- mesh__recordMaintainer mesh__D014005 TGC
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014005 1999
% 209.97/210.13  |- skos__altLabel mesh__D014005 Ringworm
% 209.97/210.13  |- skos__broader mesh__D008214Q000637smesh__D008214
% 209.97/210.13  |- mesh__preferredCombination mesh__D008214Q000637smesh__D017710
% 209.97/210.13  |- rdf__type mesh__D008214Q000637smesh__CompoundConcept
% 209.97/210.13  |- mesh__historyNote mesh__D019299 97   
% 209.97/210.13  |- skos__historyNote mesh__D019299
% 209.97/210.13       specific disease/surgery %28%1966-1996%29%
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D019299 2003
% 209.97/210.13  |- mesh__dateEstablished mesh__D019299 1997-01-01
% 209.97/210.13  |- skos__prefLabel mesh__D019299 Decompression, Surgical
% 209.97/210.13  |- mesh__dateCreated mesh__D019299 1996-06-10
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D019299 1997
% 209.97/210.13  |- skos__scopeNote mesh__D019299
% 209.97/210.13       A surgical operation for the relief of pressure in a body compartment or on a body part. %28%From Dorland, 28th ed%29%%A%    
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D019299 2006
% 209.97/210.13  |- rdf__type mesh__D019299sskos__Concept
% 209.97/210.13  |- skos__hiddenLabel mesh__D019299 Surgical Decompressions
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D019299 2002
% 209.97/210.13  |- skos__broader mesh__D019299smesh__D013514
% 209.97/210.13  |- skos__hiddenLabel mesh__D019299 Decompressions, Surgical
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D019299 2005
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D019299 1999
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D019299 2004
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D019299 2001
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D019299 1998
% 209.97/210.13  |- skos__altLabel mesh__D019299 Surgical Decompression
% 209.97/210.13  |- mesh__publicMeSHNote mesh__D019299 97   
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D019299 2000
% 209.97/210.13  |- skos__annotation mesh__D019299
% 209.97/210.13       do not use /util except by MeSH definition   
% 209.97/210.13  |- mesh__publicMeSHNote mesh__D005279
% 209.97/210.13       91; was see under PHENYLPROPIONATES 1975-90   
% 209.97/210.13  |- skos__historyNote mesh__D005279 Ethers %28%1972%29%
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D005279 2006
% 209.97/210.13  |- skos__historyNote mesh__D005279 Propionates %28%1972-1974%29%
% 209.97/210.13  |- skos__hiddenLabel mesh__D005279 Calcium, Fenoprofen
% 209.97/210.13  |- skos__prefLabel mesh__D005279 Fenoprofen
% 209.97/210.13  |- skos__historyNote mesh__D005279
% 209.97/210.13       Anti-Inflammatory Agents %28%1972-1974%29%
% 209.97/210.13  |- skos__broader mesh__D005279smesh__D010666
% 209.97/210.13  |- mesh__recordMaintainer mesh__D005279 exl
% 209.97/210.13  |- skos__historyNote mesh__D005279 Phenols %28%1973%29%
% 209.97/210.13  |- skos__scopeNote mesh__D005279
% 209.97/210.13       An anti-inflammatory analgesic and antipyretic highly bound to plasma proteins. It is pharmacologically similar to ASPIRIN, but causes less gastrointestinal bleeding.%A%    
% 209.97/210.13  |- mesh__historyNote mesh__D005279
% 209.97/210.13       91%28%75%29%; was see under PHENYLPROPIONATES 1975-90   
% 209.97/210.13  |- skos__historyNote mesh__D005279 Phenyl Ethers %28%1974%29%
% 209.97/210.13  |- mesh__recordAuthorizer mesh__D005279 sjn
% 209.97/210.13  |- skos__altLabel mesh__D005279 Fenoprofen Dihydrate, Calcium Salt
% 209.97/210.13  |- rdf__type mesh__D005279sskos__Concept
% 209.97/210.13  |- mesh__dateEstablished mesh__D005279 1991-01-01
% 209.97/210.13  |- mesh__dateCreated mesh__D005279 1974-11-11
% 209.97/210.13  |- mesh__recordOriginator mesh__D005279 NLM
% 209.97/210.13  |- mesh__dateRevised mesh__D005279 2005-06-30
% 209.97/210.13  |- mesh__recordMaintainer mesh__D010413 mdb
% 209.97/210.13  |- skos__prefLabel mesh__D010413 Penis
% 209.97/210.13  |- skos__broader mesh__D010413smesh__D005837
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D010413 2006
% 209.97/210.13  |- skos__scopeNote mesh__D010413
% 209.97/210.13       The external reproductive organ of males. It is composed of a mass of erectile tissue enclosed in three cylindrical fibrous compartments. Two of the three compartments, the corpus cavernosa, are placed side-by-side along the upper part of the organ. The third compartment below, the corpus spongiosum, houses the urethra.%A%    
% 209.97/210.13  |- skos__related mesh__D010413smesh__D002944
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D010413 2004
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D010413 2005
% 209.97/210.13  |- mesh__considerAlso mesh__D010413 consider also terms at PENILE   
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D010413 2003
% 209.97/210.13  |- rdf__type mesh__D010413sskos__Concept
% 209.97/210.13  |- mesh__recordOriginator mesh__D010413 NLM
% 209.97/210.13  |- mesh__recordAuthorizer mesh__D010413 sjn
% 209.97/210.13  |- mesh__dateCreated mesh__D010413 1999-01-01
% 209.97/210.13  |- skos__annotation mesh__D010413
% 209.97/210.13       inflammation = BALANITIS; penile fract: index under PENIS /inj %28%IM%29% + RUPTURE %28%NIM%29%%A%  
% 209.97/210.13  |- mesh__dateRevised mesh__D010413 2002-07-03
% 209.97/210.13  |- skos__scopeNote mesh__D034861
% 209.97/210.13       The outer margins of the ABDOMEN, extending from the osteocartilaginous thoracic cage to the PELVIS. Though its major part is muscular, the abdominal wall consists of at least seven layers: the SKIN, subcutaneous fat, deep FASCIA; ABDOMINAL MUSCLES, transversalis fascia, extraperitoneal fat, and the parietal PERITONEUM.%A%    
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D034861 2005
% 209.97/210.13  |- mesh__publicMeSHNote mesh__D034861
% 209.97/210.13       2003; see ABDOMINAL MUSCLES 1966-1992   
% 209.97/210.13  |- skos__hiddenLabel mesh__D034861 Wall, Abdominal
% 209.97/210.13  |- mesh__dateEstablished mesh__D034861 2003-01-01
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D034861 2006
% 209.97/210.13  |- skos__broader mesh__D034861smesh__D000005
% 209.97/210.13  |- mesh__historyNote mesh__D034861 2003; use ABDOMINAL MUSCLES 1966-1992   
% 209.97/210.13  |- mesh__dateCreated mesh__D034861 2002-07-02
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D034861 2003
% 209.97/210.13  |- skos__related mesh__D034861smesh__D000009
% 209.97/210.13  |- rdf__type mesh__D034861sskos__Concept
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D034861 2004
% 209.97/210.13  |- skos__prefLabel mesh__D034861 Abdominal Wall
% 209.97/210.13  |- skos__historyNote mesh__D034861 Abdominal Muscles %28%1965-2002%29%
% 209.97/210.13  |- rdf__type mesh__D001687sskos__Concept
% 209.97/210.13  |- mesh__recordAuthorizer mesh__D001687 SJN
% 209.97/210.13  |- skos__altLabel mesh__D001687
% 209.97/210.13       Biologic Phenomena, Cell Phenomena, and Immunity
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D001687 2000
% 209.97/210.13  |- mesh__dateCreated mesh__D001687 1999-01-01
% 209.97/210.13  |- mesh__dateEstablished mesh__D001687 1998-01-01
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D001687 2003
% 209.97/210.13  |- mesh__recordMaintainer mesh__D001687 TGC
% 209.97/210.13  |- skos__prefLabel mesh__D001687
% 209.97/210.13       Biological Phenomena, Cell Phenomena, and Immunity
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D001687 2001
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D001687 2004
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D001687 1998
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D001687 2002
% 209.97/210.13  |- mesh__historyNote mesh__D001687 98; use explode   
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D001687 2005
% 209.97/210.13  |- mesh__runningHead mesh__D001687
% 209.97/210.13       G4 - BIOLOGIC, CYTOLOGIC, AND IMMUNOLOGIC PHENOMENA   
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D001687 1999
% 209.97/210.13  |- skos__annotation mesh__D001687
% 209.97/210.13       not used for indexing      CATALOG: do not use   
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D001687 2006
% 209.97/210.13  |- mesh__dateRevised mesh__D001687 1997-06-27
% 209.97/210.13  |- skos__altLabel mesh__D001687
% 209.97/210.13       Immunity, Biological Phenomena, and Cell Phenomena
% 209.97/210.13  |- mesh__recordOriginator mesh__D001687 NLM
% 209.97/210.13  |- mesh__publicMeSHNote mesh__D001687 98   
% 209.97/210.13  |- mesh__recordAuthorizer mesh__D047789 jls
% 209.97/210.13  |- mesh__dateRevised mesh__D047789 2004-08-03
% 209.97/210.13  |- mesh__recordOriginator mesh__D047789 jls
% 209.97/210.13  |- skos__hiddenLabel mesh__D047789 1939-1945 World War
% 209.97/210.13  |- skos__hiddenLabel mesh__D047789 War, 1939-1945 World
% 209.97/210.13  |- skos__hiddenLabel mesh__D047789 War II, World
% 209.97/210.13  |- skos__hiddenLabel mesh__D047789 2nd World Wars
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D047789 2005
% 209.97/210.13  |- mesh__dateEstablished mesh__D047789 2005-01-01
% 209.97/210.13  |- skos__hiddenLabel mesh__D047789 War, Second World
% 209.97/210.13  |- skos__hiddenLabel mesh__D047789 World War, 1939 1945
% 209.97/210.13  |- skos__hiddenLabel mesh__D047789 War, 2nd World
% 209.97/210.13  |- skos__hiddenLabel mesh__D047789 World Wars, 2nd
% 209.97/210.13  |- mesh__historyNote mesh__D047789 2005   
% 209.97/210.13  |- skos__scopeNote mesh__D047789
% 209.97/210.13       Global conflict involving countries of Europe, Africa, Asia, and North America that occurred between 1939 and 1945.%A%    
% 209.97/210.13  |- skos__hiddenLabel mesh__D047789 World Wars, Second
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D047789 2006
% 209.97/210.13  |- skos__prefLabel mesh__D047789 World War II
% 209.97/210.13  |- skos__hiddenLabel mesh__D047789 World War, 2nd
% 209.97/210.13  |- mesh__recordMaintainer mesh__D047789 jls
% 209.97/210.13  |- rdf__type mesh__D047789sskos__Concept
% 209.97/210.13  |- skos__hiddenLabel mesh__D047789 Wars, 2nd World
% 209.97/210.13  |- skos__altLabel mesh__D047789 World War, 1939-1945
% 209.97/210.13  |- skos__hiddenLabel mesh__D047789 Wars, Second World
% 209.97/210.13  |- skos__broader mesh__D047789smesh__D049673
% 209.97/210.13  |- skos__altLabel mesh__D047789 2nd World War
% 209.97/210.13  |- skos__hiddenLabel mesh__D047789 World War, Second
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D047789 2005A
% 209.97/210.13  |- skos__altLabel mesh__D047789 Second World War
% 209.97/210.13  |- mesh__dateCreated mesh__D047789 2004-07-07
% 209.97/210.13  |- mesh__publicMeSHNote mesh__D047789 2005   
% 209.97/210.13  |- skos__hiddenLabel mesh__D047789 Second World Wars
% 209.97/210.13  |- skos__historyNote mesh__D006372 Snails %28%1966-1974%29%
% 209.97/210.13  |- skos__scopeNote mesh__D006372
% 209.97/210.13       A genus of chiefly Eurasian and African land snails including the principal edible snails as well as several pests of cultivated plants.%A%    
% 209.97/210.13  |- skos__annotation mesh__D006372
% 209.97/210.13       /microbiol /parasitol /virol permitted; DF: HELIX   
% 209.97/210.13  |- mesh__publicMeSHNote mesh__D006372 78; was see under SNAILS 1975-77   
% 209.97/210.13  |- mesh__historyNote mesh__D006372
% 209.97/210.13       78%28%75%29%; was see under SNAILS 1975-77   
% 209.97/210.13  |- mesh__recordMaintainer mesh__D006372 ags
% 209.97/210.13  |- mesh__dateRevised mesh__D006372 2005-06-30
% 209.97/210.13  |- mesh__dateEstablished mesh__D006372 1978-01-01
% 209.97/210.13  |- mesh__dateCreated mesh__D006372 1974-12-12
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D006372 2006
% 209.97/210.13  |- mesh__recordAuthorizer mesh__D006372 sjn
% 209.97/210.13  |- skos__broader mesh__D006372smesh__D012908
% 209.97/210.13  |- mesh__recordOriginator mesh__D006372 NLM
% 209.97/210.13  |- rdf__type mesh__D006372sskos__Concept
% 209.97/210.13  |- skos__prefLabel mesh__D006372 Helix %28%Snails%29%
% 209.97/210.13  |- skos__hiddenLabel mesh__D020043 Essential Gene
% 209.97/210.13  |- skos__broader mesh__D020043smesh__D005796
% 209.97/210.13  |- skos__scopeNote mesh__D020043
% 209.97/210.13       Those genes found in an organism which are necessary for its viability and normal function.%A%    
% 209.97/210.13  |- mesh__publicMeSHNote mesh__D020043 99   
% 209.97/210.13  |- skos__prefLabel mesh__D020043 Genes, Essential
% 209.97/210.13  |- skos__hiddenLabel mesh__D020043 Essential Genes
% 209.97/210.13  |- mesh__historyNote mesh__D020043 99   
% 209.97/210.13  |- mesh__recordMaintainer mesh__D020043 nns
% 209.97/210.13  |- skos__hiddenLabel mesh__D020043 Gene, Essential
% 209.97/210.13  |- mesh__dateCreated mesh__D020043 1998-06-10
% 209.97/210.13  |- mesh__recordOriginator mesh__D020043 NDW
% 209.97/210.13  |- mesh__recordAuthorizer mesh__D020043 sjn
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D020043 2006
% 209.97/210.13  |- mesh__dateEstablished mesh__D020043 1999-01-01
% 209.97/210.13  |- rdf__type mesh__D020043sskos__Concept
% 209.97/210.13  |- mesh__dateRevised mesh__D020043 2005-06-30
% 209.97/210.13  |- skos__annotation mesh__D020043 coord NIM with specific genes   
% 209.97/210.13  |- mesh__dateCreated mesh__D014804 1999-01-01
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014804 2005
% 209.97/210.13  |- skos__broader mesh__D014804smesh__D001361
% 209.97/210.13  |- mesh__recordOriginator mesh__D014804 NLM
% 209.97/210.13  |- mesh__recordMaintainer mesh__D014804 lkt
% 209.97/210.13  |- skos__related mesh__D014804smesh__D010383
% 209.97/210.13  |- skos__hiddenLabel mesh__D014804 Vitamin B Deficiencies
% 209.97/210.13  |- mesh__recordAuthorizer mesh__D014804 sjn
% 209.97/210.13  |- rdf__type mesh__D014804sskos__Concept
% 209.97/210.13  |- skos__altLabel mesh__D014804 Deficiency, Vitamin B
% 209.97/210.13  |- mesh__dateRevised mesh__D014804 2003-07-09
% 209.97/210.13  |- skos__prefLabel mesh__D014804 Vitamin B Deficiency
% 209.97/210.13  |- skos__hiddenLabel mesh__D014804 Deficiencies, Vitamin B
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014804 2006
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014804 2004
% 209.97/210.13  |- skos__prefLabel mesh__D014006 Tinea Capitis
% 209.97/210.13  |- mesh__dateRevised mesh__D014006 1992-05-22
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014006 2003
% 209.97/210.13  |- skos__annotation mesh__D014006
% 209.97/210.13       ringworm of the scalp; do not coord with SCALP or SCALP DERMATOSES%A%  
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014006 2000
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014006 2005
% 209.97/210.13  |- skos__scopeNote mesh__D014006
% 209.97/210.13       Ringworm of the scalp caused by species of Microsporum and Trichophyton, which may occasionally involve the eyebrows and eyelashes. %28%Dorland, 27th ed%29%%A%    
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014006 2004
% 209.97/210.13  |- mesh__recordOriginator mesh__D014006 NLM
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014006 2001
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014006 2006
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014006 1996
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014006 1998
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014006 1997
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014006 1994
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014006 1999
% 209.97/210.13  |- skos__broader mesh__D014006smesh__D012536
% 209.97/210.13  |- skos__broader mesh__D014006smesh__D014005
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014006 1993
% 209.97/210.13  |- mesh__recordAuthorizer mesh__D014006 PLS
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014006 2002
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D014006 1995
% 209.97/210.13  |- mesh__dateCreated mesh__D014006 1999-01-01
% 209.97/210.13  |- rdf__type mesh__D014006sskos__Concept
% 209.97/210.13  |- mesh__recordMaintainer mesh__D014006 MXR
% 209.97/210.13  |- skos__broader mesh__D019346Q000031smesh__D019346
% 209.97/210.13  |- mesh__preferredCombination mesh__D019346Q000031smesh__D000085
% 209.97/210.13  |- rdf__type mesh__D019346Q000031smesh__CompoundConcept
% 209.97/210.13  |- mesh__dateCreated mesh__D002780 1979-05-29
% 209.97/210.13  |- skos__historyNote mesh__D002780 Cholestasis %28%1966-1979%29%
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D002780 2004
% 209.97/210.13  |- skos__hiddenLabel mesh__D002780 Intrahepatic Cholestases
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D002780 2006
% 209.97/210.13  |- skos__hiddenLabel mesh__D002780 Intrahepatic Biliary Stasis
% 209.97/210.13  |- skos__altLabel mesh__D002780 Intrahepatic Cholestasis
% 209.97/210.13  |- skos__altLabel mesh__D002780 Bile Duct Obstruction, Intrahepatic
% 209.97/210.13  |- mesh__dateEstablished mesh__D002780 1980-01-01
% 209.97/210.13  |- skos__prefLabel mesh__D002780 Cholestasis, Intrahepatic
% 209.97/210.13  |- skos__altLabel mesh__D002780 Biliary Stasis, Intrahepatic
% 209.97/210.13  |- skos__scopeNote mesh__D002780
% 209.97/210.13       Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts %28%BILE DUCTS, INTRAHEPATIC%29%.%A%    
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D002780 2006A
% 209.97/210.13  |- skos__hiddenLabel mesh__D002780 Intrahepatic Biliary Stases
% 209.97/210.13  |- mesh__recordAuthorizer mesh__D002780 ags
% 209.97/210.13  |- mesh__dateRevised mesh__D002780 2005-07-18
% 209.97/210.13  |- skos__broader mesh__D002780smesh__D002779
% 209.97/210.13  |- skos__historyNote mesh__D002780 Liver %28%1966-1979%29%
% 209.97/210.13  |- mesh__recordOriginator mesh__D002780 SMH
% 209.97/210.13  |- skos__broader mesh__D002780smesh__D008107
% 209.97/210.13  |- mesh__publicMeSHNote mesh__D002780 80   
% 209.97/210.13  |- mesh__recordMaintainer mesh__D002780 ags
% 209.97/210.13  |- rdf__type mesh__D002780sskos__Concept
% 209.97/210.13  |- skos__historyNote mesh__D002780
% 209.97/210.13       Bile Ducts, Intrahepatic %28%1966-1979%29%
% 209.97/210.13  |- skos__hiddenLabel mesh__D002780 Biliary Stases, Intrahepatic
% 209.97/210.13  |- mesh__historyNote mesh__D002780 80   
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D002780 2005
% 209.97/210.13  |- skos__hiddenLabel mesh__D002780 Cholestases, Intrahepatic
% 209.97/210.13  |- skos__related mesh__D002780smesh__D041781
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D010414 2005
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D010414 2001
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D010414 1999
% 209.97/210.13  |- mesh__recordMaintainer mesh__D010414 PXP
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D010414 2003
% 209.97/210.13  |- skos__broader mesh__D010414smesh__D001061
% 209.97/210.13  |- skos__broader mesh__D010414smesh__D008873
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D010414 2006
% 209.97/210.13  |- mesh__recordAuthorizer mesh__D010414 SJN
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D010414 2002
% 209.97/210.13  |- mesh__recordOriginator mesh__D010414 NLM
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D010414 2004
% 209.97/210.13  |- skos__broader mesh__D010414smesh__D006114
% 209.97/210.13  |- mesh__dateCreated mesh__D010414 1999-01-01
% 209.97/210.13  |- rdf__type mesh__D010414sskos__Concept
% 209.97/210.13  |- skos__prefLabel mesh__D010414 Pennsylvania
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D010414 2000
% 209.97/210.13  |- skos__annotation mesh__D010414 PHILADELPHIA is also available   
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D010414 1998
% 209.97/210.13  |- mesh__dateRevised mesh__D010414 1997-06-20
% 209.97/210.13  |- skos__altLabel mesh__D001688 Biologic Products
% 209.97/210.13  |- skos__annotation mesh__D001688
% 209.97/210.13       manufactured products: differentiate from BIOLOGICAL FACTORS, natural substances; includes sera, vaccines, antitoxins, tissue %26% hormonal prep; /ther use of sera, vaccines %26% antitoxins: coord with disease /ther, not /drug ther; /ther use of tissue %26% hormonal prep: coord with disease /ther, not /drug ther; DF: BIOL PRODUCTS%A%  
% 209.97/210.13  |- mesh__recordOriginator mesh__D001688 NLM
% 209.97/210.13  |- skos__hiddenLabel mesh__D001688 Products, Natural
% 209.97/210.13  |- mesh__dateRevised mesh__D001688 2005-11-09
% 209.97/210.13  |- skos__altLabel mesh__D001688 Biologics
% 209.97/210.13  |- mesh__publicMeSHNote mesh__D001688
% 209.97/210.13       1963; for NATURAL PRODUCTS see BIOLOGICAL FACTORS 2000-2005%A%  
% 209.97/210.13  |- mesh__historyNote mesh__D001688
% 209.97/210.13       1963; for NATURAL PRODUCTS also use BIOLOGICAL FACTORS 2000-2005%A%  
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D001688 2006A
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D001688 2006
% 209.97/210.13  |- skos__prefLabel mesh__D001688 Biological Products
% 209.97/210.13  |- mesh__recordAuthorizer mesh__D001688 ags
% 209.97/210.13  |- skos__broader mesh__D001688smesh__D045424
% 209.97/210.13  |- rdf__type mesh__D001688sskos__Concept
% 209.97/210.13  |- skos__scopeNote mesh__D001688
% 209.97/210.13       Complex pharmaceutical substances, preparations, or agents of organic origin, usually obtained by biological methods or assay, that depend for their action on the processes affecting immunity. They are used especially in diagnosis and treatment of disease %28%as vaccines or pollen extracts%29%. Biological products are differentiated from BIOLOGICAL FACTORS in that the latter are compounds with biological or physiological activity made by living organisms. %28%From Webster%27%s 3d ed%29%%A%    
% 209.97/210.13  |- mesh__recordMaintainer mesh__D001688 ags
% 209.97/210.13  |- skos__altLabel mesh__D001688 Products, Biological
% 209.97/210.13  |- mesh__dateCreated mesh__D001688 1999-01-01
% 209.97/210.13  |- skos__hiddenLabel mesh__D001688 Products, Biologic
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D020842 2006
% 209.97/210.13  |- skos__scopeNote mesh__D020842
% 209.97/210.13       A peptidohydrolytic enzyme that is formed from PREKALLIKREIN by FACTOR XIIA. It activates FACTOR XII; FACTOR VII; and PLASMINOGEN. It is selective for both ARGININE and to a lesser extent LYSINE bonds. EC 3.4.21.34.%A%    
% 209.97/210.13  |- skos__hiddenLabel mesh__D020842 Kallikrein, Plasma
% 209.97/210.13  |- skos__altLabel mesh__D020842 Serum Kallikrein
% 209.97/210.13  |- mesh__dateRevised mesh__D020842 2003-07-09
% 209.97/210.13  |- skos__prefLabel mesh__D020842 Plasma Kallikrein
% 209.97/210.13  |- mesh__publicMeSHNote mesh__D020842 2000   
% 209.97/210.13  |- skos__altLabel mesh__D020842 Kininogenin
% 209.97/210.13  |- mesh__dateEstablished mesh__D020842 2000-01-01
% 209.97/210.13  |- mesh__recordMaintainer mesh__D020842 ssb
% 209.97/210.13  |- skos__historyNote mesh__D020842 Kallikreins %28%1965-1999%29%
% 209.97/210.13  |- skos__altLabel mesh__D020842 Kallikrein I
% 209.97/210.13  |- mesh__recordOriginator mesh__D020842 adp
% 209.97/210.13  |- mesh__historyNote mesh__D020842 2000   
% 209.97/210.13  |- mesh__dateCreated mesh__D020842 1999-11-08
% 209.97/210.13  |- rdf__type mesh__D020842sskos__Concept
% 209.97/210.13  |- mesh__recordAuthorizer mesh__D020842 sjn
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D020842 2004
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D020842 2005
% 209.97/210.13  |- skos__broader mesh__D020842smesh__D007610
% 209.97/210.13  |- skos__hiddenLabel mesh__D020842 Kallikrein, Serum
% 209.97/210.13  |- mesh__recordAuthorizer mesh__D006373 sjn
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D006373 2004
% 209.97/210.13  |- mesh__onlineNote mesh__D006373
% 209.97/210.13       use HELMINTHIASIS to search NEMATOMORPHA INFECTIONS 1975-91%A%  
% 209.97/210.13  |- rdf__type mesh__D006373sskos__Concept
% 209.97/210.13  |- skos__related mesh__D006373smesh__D000871
% 209.97/210.13  |- mesh__publicMeSHNote mesh__D006373
% 209.97/210.13       NEMATOMORPHA INFECTIONS was heading 1991, see under HELMINTHIASIS 1975-90%A%  
% 209.97/210.13  |- skos__annotation mesh__D006373
% 209.97/210.13       GEN; infections in the intestines: coord IM with INTESTINAL DISEASES, PARASITIC %28%IM%29%%A%  
% 209.97/210.13  |- mesh__recordOriginator mesh__D006373 NLM
% 209.97/210.13  |- skos__scopeNote mesh__D006373
% 209.97/210.13       Infestation with parasitic worms of the helminth class.%A%    
% 209.97/210.13  |- skos__altLabel mesh__D006373 Nematomorpha Infections
% 209.97/210.13  |- mesh__historyNote mesh__D006373
% 209.97/210.13       NEMATOMORPHA INFECTIONS was heading 1975-91 %28%see under HELMINTHIASIS 1975-90%29%%A%  
% 209.97/210.13  |- skos__broader mesh__D006373smesh__D010272
% 209.97/210.13  |- mesh__activeMeSHYear mesh__D006373 2006
% 209.97/210.13  |- mesh__dateRevised mesh__D006373 2003-07-09
% 209.97/210.13  |- mesh__recordMaintainer mesh__D006373 lkt
% 209.97/210.13  |- skos__hiddenLabel mesh__D006373 Nematomorpha Infection
% 209.97/210.13  |- skos__prefLabel mesh__D006373 Helminthiasis
% 209.97/210.13  |- mesh__dateCreated mesh__D006373 1999-01-01
% 209.97/210.13  |- skos__hiddenLabel mesh__D006373 Infection, Nematomorpha
% 209.97/210.13  |- skos__hiddenLabel mesh__D006373 Helminthiases
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D006373 2005
% 209.97/210.14  |- skos__annotation mesh__D014805
% 209.97/210.14       ther use: coordinate disease with /drug ther, not /diet ther%A%  
% 209.97/210.14  |- skos__prefLabel mesh__D014805 Vitamin B 12
% 209.97/210.14  |- rdf__type mesh__D014805sskos__Concept
% 209.97/210.14  |- skos__hiddenLabel mesh__D014805 B12, Vitamin
% 209.97/210.14  |- skos__altLabel mesh__D014805 Cobalamin
% 209.97/210.14  |- mesh__dateRevised mesh__D014805 2005-06-30
% 209.97/210.14  |- mesh__recordOriginator mesh__D014805 NLM
% 209.97/210.14  |- skos__related mesh__D014805smesh__D012546
% 209.97/210.14  |- mesh__recordMaintainer mesh__D014805 ssb
% 209.97/210.14  |- skos__broader mesh__D014805smesh__D045728
% 209.97/210.14  |- skos__hiddenLabel mesh__D014805 B 12, Vitamin
% 209.97/210.14  |- mesh__recordAuthorizer mesh__D014805 sjn
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014805 2006
% 209.97/210.14  |- skos__scopeNote mesh__D014805
% 209.97/210.14       A cobalt-containing coordination compound produced by intestinal micro-organisms and found also in soil and water. Higher plants do not concentrate vitamin B 12 from the soil and so are a poor source of the substance as compared with animal tissues.%A%    
% 209.97/210.14  |- skos__altLabel mesh__D014805 Vitamin B12
% 209.97/210.14  |- mesh__dateCreated mesh__D014805 1999-01-01
% 209.97/210.14  |- skos__altLabel mesh__D014805 Cyanocobalamin
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014007 1995
% 209.97/210.14  |- mesh__dateRevised mesh__D014007 1993-06-03
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014007 2000
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014007 2003
% 209.97/210.14  |- mesh__recordOriginator mesh__D014007 NLM
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014007 1996
% 209.97/210.14  |- skos__annotation mesh__D014007
% 209.97/210.14       ringworm of the scalp; caused by Trichophyton schoenleini%A%  
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014007 2001
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014007 2005
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014007 2004
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014007 1998
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014007 1997
% 209.97/210.14  |- mesh__recordMaintainer mesh__D014007 TAP
% 209.97/210.14  |- skos__scopeNote mesh__D014007
% 209.97/210.14       A disease of the scalp that may affect the glabrous skin and the nails and is recognized by the concave sulfur-yellow crusts that form around loose, wiry hairs. Atrophy ensues, leaving a smooth, glossy, thin, paper-white patch. This type of disease is rare in the United States and more frequently seen in the Middle East, Africa, Southeastern Europe, and other countries bordering the Mediterranean Sea. %28%Arnold, Odom, and James, Andrew%27%s Diseases of the Skin, 8th ed, p319%29%%A%    
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014007 2006
% 209.97/210.14  |- skos__altLabel mesh__D014007 Favus
% 209.97/210.14  |- skos__broader mesh__D014007smesh__D014006
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014007 1999
% 209.97/210.14  |- mesh__recordAuthorizer mesh__D014007 PLS
% 209.97/210.14  |- mesh__dateCreated mesh__D014007 1999-01-01
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014007 2002
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014007 1994
% 209.97/210.14  |- rdf__type mesh__D014007sskos__Concept
% 209.97/210.14  |- skos__prefLabel mesh__D014007 Tinea Favosa
% 209.97/210.14  |- mesh__recordOriginator mesh__D002781 NLM
% 209.97/210.14  |- rdf__type mesh__D002781sskos__Concept
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D002781 2004
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D002781 2000
% 209.97/210.14  |- mesh__recordMaintainer mesh__D002781 KEV
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D002781 2003
% 209.97/210.14  |- skos__hiddenLabel mesh__D002781 Cholesteatomas
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D002781 2006
% 209.97/210.14  |- skos__scopeNote mesh__D002781
% 209.97/210.14       A non-neoplastic keratinizing mass with stratified squamous epithelium, frequently occurring in the meninges, central nervous system, bones of the skull, and most commonly in the middle ear and mastoid region.%A%    
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D002781 2002
% 209.97/210.14  |- mesh__dateRevised mesh__D002781 1999-11-03
% 209.97/210.14  |- mesh__dateCreated mesh__D002781 1999-01-01
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D002781 2005
% 209.97/210.14  |- skos__broader mesh__D002781smesh__D007642
% 209.97/210.14  |- skos__prefLabel mesh__D002781 Cholesteatoma
% 209.97/210.14  |- skos__annotation mesh__D002781
% 209.97/210.14       non-neoplastic: coord IM with organ/dis %28%IM%29% but CHOLESTEATOMA, MIDDLE EAR is available%A%  
% 209.97/210.14  |- mesh__recordAuthorizer mesh__D002781 sjn
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D002781 2001
% 209.97/210.14  |- skos__broader mesh__D010415smesh__D007182
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D010415 2004
% 209.97/210.14  |- mesh__dateCreated mesh__D010415 1999-01-01
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D010415 2001
% 209.97/210.14  |- rdf__type mesh__D010415sskos__Concept
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D010415 2002
% 209.97/210.14  |- mesh__recordOriginator mesh__D010415 NLM
% 209.97/210.14  |- skos__hiddenLabel mesh__D010415 Pension
% 209.97/210.14  |- mesh__recordMaintainer mesh__D010415 PLS
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D010415 1994
% 209.97/210.14  |- mesh__recordAuthorizer mesh__D010415 PLS
% 209.97/210.14  |- skos__altLabel mesh__D010415 Retirement Benefits
% 209.97/210.14  |- skos__hiddenLabel mesh__D010415 Retirement Benefit
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D010415 1998
% 209.97/210.14  |- skos__prefLabel mesh__D010415 Pensions
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D010415 1995
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D010415 1993
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D010415 1996
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D010415 2005
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D010415 1999
% 209.97/210.14  |- skos__hiddenLabel mesh__D010415 Benefit, Retirement
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D010415 2003
% 209.97/210.14  |- skos__hiddenLabel mesh__D010415 Benefits, Retirement
% 209.97/210.14  |- mesh__dateRevised mesh__D010415 1992-05-15
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D010415 1997
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D010415 2006
% 209.97/210.14  |- skos__scopeNote mesh__D010415
% 209.97/210.14       Fixed sums paid regularly to individuals.     
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D010415 2000
% 209.97/210.14  |- rdf__type mesh__D015100sskos__Concept
% 209.97/210.14  |- skos__historyNote mesh__D015100 Biphenyl Compounds %28%1970-1974%29%
% 209.97/210.14  |- mesh__recordMaintainer mesh__D015100 CCR
% 209.97/210.14  |- mesh__dateCreated mesh__D015100 1974-11-19
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D015100 2005
% 209.97/210.14  |- mesh__publicMeSHNote mesh__D015100
% 209.97/210.14       91; was see under BENZIDINES 1977-90; was see under AMINOBIPHENYL COMPOUNDS 1975-76%A%  
% 209.97/210.14  |- skos__historyNote mesh__D015100 Phenylenediamines %28%1974%29%
% 209.97/210.14  |- skos__hiddenLabel mesh__D015100 Diaminobenzidine, 3,3%27%
% 209.97/210.14  |- mesh__dateRevised mesh__D015100 2000-06-22
% 209.97/210.14  |- skos__altLabel mesh__D015100 3,3-Diaminobenzidine
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D015100 2003
% 209.97/210.14  |- skos__hiddenLabel mesh__D015100 Diaminobenzidine, 3,3
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D015100 2006
% 209.97/210.14  |- skos__broader mesh__D015100smesh__D001713
% 209.97/210.14  |- skos__altLabel mesh__D015100 3,3%27% Diaminobenzidine
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D015100 2004
% 209.97/210.14  |- skos__prefLabel mesh__D015100 3,3%27%-Diaminobenzidine
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D015100 2001
% 209.97/210.14  |- mesh__recordOriginator mesh__D015100 NLM
% 209.97/210.14  |- skos__altLabel mesh__D015100 3,3 Diaminobenzidine
% 209.97/210.14  |- mesh__recordAuthorizer mesh__D015100 sjn
% 209.97/210.14  |- mesh__historyNote mesh__D015100
% 209.97/210.14       91%28%75%29%; was see under BENZIDINES 1977-90; was see under AMINOBIPHENYL COMPOUNDS 1975-76%A%  
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D015100 2002
% 209.97/210.14  |- mesh__dateEstablished mesh__D015100 1991-01-01
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D001689 2005
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D001689 1997
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D001689 1992
% 209.97/210.14  |- skos__prefLabel mesh__D001689 Biological Psychiatry
% 209.97/210.14  |- skos__annotation mesh__D001689
% 209.97/210.14       SPEC only: SPEC qualif; DF: BIOL PSYCHIATRY   
% 209.97/210.14  |- mesh__dateRevised mesh__D001689 1991-08-23
% 209.97/210.14  |- mesh__historyNote mesh__D001689 84   
% 209.97/210.14  |- skos__hiddenLabel mesh__D001689 Psychiatry, Biologic
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D001689 2004
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D001689 1996
% 209.97/210.14  |- skos__historyNote mesh__D001689 Psychiatry %28%1966-1983%29%
% 209.97/210.14  |- mesh__recordAuthorizer mesh__D001689 PLS
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D001689 2003
% 209.97/210.14  |- skos__altLabel mesh__D001689 Psychiatry, Biological
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D001689 2002
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D001689 1995
% 209.97/210.14  |- mesh__recordOriginator mesh__D001689 EC
% 209.97/210.14  |- skos__altLabel mesh__D001689 Biologic Psychiatry
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D001689 2001
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D001689 1999
% 209.97/210.14  |- mesh__publicMeSHNote mesh__D001689 84   
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D001689 1994
% 209.97/210.14  |- mesh__recordMaintainer mesh__D001689 TGC
% 209.97/210.14  |- mesh__dateEstablished mesh__D001689 1984-01-01
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D001689 2006
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D001689 2000
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D001689 1998
% 209.97/210.14  |- skos__scopeNote mesh__D001689
% 209.97/210.14       An interdisciplinary science concerned with studies of the biological bases of behavior - biochemical, genetic, physiological, and neurological - and applying these to the understanding and treatment of mental illness.%A%    
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D001689 1993
% 209.97/210.14  |- mesh__dateCreated mesh__D001689 1983-06-10
% 209.97/210.14  |- skos__broader mesh__D001689smesh__D011570
% 209.97/210.14  |- rdf__type mesh__D001689sskos__Concept
% 209.97/210.14  |- mesh__dateCreated mesh__D020843 1999-11-08
% 209.97/210.14  |- mesh__dateRevised mesh__D020843 2002-07-03
% 209.97/210.14  |- mesh__dateEstablished mesh__D020843 2000-01-01
% 209.97/210.14  |- mesh__recordAuthorizer mesh__D020843 sjn
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D020843 2003
% 209.97/210.14  |- mesh__recordOriginator mesh__D020843 ags
% 209.97/210.14  |- skos__broader mesh__D020843smesh__D019659
% 209.97/210.14  |- mesh__historyNote mesh__D020843 2000   
% 209.97/210.14  |- skos__historyNote mesh__D020843 Plants, Medicinal %28%1965-1999%29%
% 209.97/210.14  |- rdf__type mesh__D020843sskos__Concept
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D020843 2004
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D020843 2005
% 209.97/210.14  |- skos__scopeNote mesh__D020843
% 209.97/210.14       Common name for several daisy-like plants %28%MATRICARIA; TRIPLEUROSPERMUM; ANTHEMIS; CHAMAEMELUM%29% native to Europe and Western Asia, now naturalized in the United States and Australia.%A%    
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D020843 2006
% 209.97/210.14  |- skos__altLabel mesh__D020843 Camomile
% 209.97/210.14  |- skos__annotation mesh__D020843
% 209.97/210.14       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.97/210.14  |- mesh__publicMeSHNote mesh__D020843
% 209.97/210.14       2000; CHAMOMILE was indexed under FLAVONES 1989-1999 %26% OILS, VOLATILE 1981-1999%A%  
% 209.97/210.14  |- mesh__recordMaintainer mesh__D020843 ssb
% 209.97/210.14  |- skos__prefLabel mesh__D020843 Chamomile
% 209.97/210.14  |- rdf__type mesh__D006374sskos__Concept
% 209.97/210.14  |- mesh__historyNote mesh__D006374 98; use explode 1975-97   
% 209.97/210.14  |- mesh__publicMeSHNote mesh__D006374 98   
% 209.97/210.14  |- mesh__recordAuthorizer mesh__D006374 sjn
% 209.97/210.14  |- skos__broader mesh__D006374smesh__D006373
% 209.97/210.14  |- skos__scopeNote mesh__D006374
% 209.97/210.14       Infestation of animals with parasitic worms of the helminth class. The infestation may be experimental or veterinary.%A%    
% 209.97/210.14  |- skos__hiddenLabel mesh__D006374 Helminthiases, Animal
% 209.97/210.14  |- mesh__recordOriginator mesh__D006374 NLM
% 209.97/210.14  |- skos__prefLabel mesh__D006374 Helminthiasis, Animal
% 209.97/210.14  |- skos__historyNote mesh__D006374
% 209.97/210.14       Helminthiasis/veterinary %28%1966-1997%29%
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D006374 2006
% 209.97/210.14  |- mesh__recordMaintainer mesh__D006374 ags
% 209.97/210.14  |- skos__broader mesh__D006374smesh__D010273
% 209.97/210.14  |- mesh__dateCreated mesh__D006374 1999-01-01
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D006374 2005
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D006374 2004
% 209.97/210.14  |- skos__annotation mesh__D006374
% 209.97/210.14       exper or vet; GEN or unspecified; prefer specifics; don%27%t forget to check tag ANIMALS%A%  
% 209.97/210.14  |- mesh__dateEstablished mesh__D006374 1998-01-01
% 209.97/210.14  |- skos__hiddenLabel mesh__D006374 Animal Helminthiasis
% 209.97/210.14  |- mesh__dateRevised mesh__D006374 2003-07-30
% 209.97/210.14  |- skos__hiddenLabel mesh__D006374 Animal Helminthiases
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D020045 2005
% 209.97/210.14  |- skos__broader mesh__D020045smesh__D004141
% 209.97/210.14  |- mesh__dateCreated mesh__D020045 1998-06-10
% 209.97/210.14  |- mesh__dateRevised mesh__D020045 2003-07-09
% 209.97/210.14  |- skos__annotation mesh__D020045
% 209.97/210.14       infection: coord IM with PROTOZOAN INFECTIONS %28%IM%29%   
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D020045 2004
% 209.97/210.14  |- skos__prefLabel mesh__D020045 Pfiesteria piscicida
% 209.97/210.14  |- mesh__dateEstablished mesh__D020045 1999-01-01
% 209.97/210.14  |- skos__scopeNote mesh__D020045
% 209.97/210.14       A dinoflagellate with a life cycle that includes numerous flagellated, amoeboid, and encysted stages. Both the flagellated and amoeboid forms produce toxins which cause open wounds on fish. Pfiesteria piscicida feeds on tissue sloughed from these wounds, as well as on bacteria and algae. It is found in Atlantic estuaries of the United States.%A%    
% 209.97/210.14  |- skos__historyNote mesh__D020045 Dinoflagellida %28%1998%29%
% 209.97/210.14  |- mesh__publicMeSHNote mesh__D020045 99   
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D020045 2006
% 209.97/210.14  |- rdf__type mesh__D020045sskos__Concept
% 209.97/210.14  |- mesh__historyNote mesh__D020045 99   
% 209.97/210.14  |- skos__annotation mesh__D014806
% 209.97/210.14       coord IM with specific B 12 vitamin /defic %28%IM%29%; DF: VITAMIN B 12 DEFIC%A%  
% 209.97/210.14  |- skos__altLabel mesh__D014806 Deficiency, Vitamin B 12
% 209.97/210.14  |- rdf__type mesh__D014806sskos__Concept
% 209.97/210.14  |- mesh__dateRevised mesh__D014806 2003-07-09
% 209.97/210.14  |- skos__scopeNote mesh__D014806
% 209.97/210.14       A nutritional condition produced by a deficiency of VITAMIN B 12 in the diet, characterized by megaloblastic anemia. Since vitamin B 12 is not present in plants, humans have obtained their supply from animal products, from multivitamin supplements in the form of pills, and as additives to food preparations. A wide variety of neuropsychiatric abnormalities is also seen in vitamin B 12 deficiency and appears to be due to an undefined defect involving myelin synthesis. %28%From Cecil Textbook of Medicine, 19th ed, p848%29%%A%    
% 209.97/210.14  |- skos__broader mesh__D014806smesh__D014804
% 209.97/210.14  |- skos__prefLabel mesh__D014806 Vitamin B 12 Deficiency
% 209.97/210.14  |- mesh__dateCreated mesh__D014806 1999-01-01
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014806 2005
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014806 2006
% 209.97/210.14  |- mesh__recordOriginator mesh__D014806 NLM
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014806 2004
% 209.97/210.14  |- mesh__recordAuthorizer mesh__D014806 sjn
% 209.97/210.14  |- skos__hiddenLabel mesh__D014806 Deficiencies, Vitamin B12
% 209.97/210.14  |- skos__hiddenLabel mesh__D014806 Vitamin B12 Deficiencies
% 209.97/210.14  |- skos__altLabel mesh__D014806 Deficiency, Vitamin B12
% 209.97/210.14  |- mesh__recordMaintainer mesh__D014806 lkt
% 209.97/210.14  |- skos__altLabel mesh__D014806 Vitamin B12 Deficiency
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014008 2005
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014008 2004
% 209.97/210.14  |- mesh__recordMaintainer mesh__D014008 KEV
% 209.97/210.14  |- skos__altLabel mesh__D014008 Athlete%27%s Foot
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014008 2002
% 209.97/210.14  |- mesh__recordAuthorizer mesh__D014008 sjn
% 209.97/210.14  |- skos__annotation mesh__D014008
% 209.97/210.14       do not coord with FOOT or FOOT DERMATOSES   
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014008 2006
% 209.97/210.14  |- skos__broader mesh__D014008smesh__D005533
% 209.97/210.14  |- mesh__dateCreated mesh__D014008 1999-01-01
% 209.97/210.14  |- rdf__type mesh__D014008sskos__Concept
% 209.97/210.14  |- skos__hiddenLabel mesh__D014008 Athlete Foot
% 209.97/210.14  |- skos__broader mesh__D014008smesh__D014005
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014008 2000
% 209.97/210.14  |- mesh__dateRevised mesh__D014008 1999-11-08
% 209.97/210.14  |- mesh__recordOriginator mesh__D014008 NLM
% 209.97/210.14  |- skos__prefLabel mesh__D014008 Tinea Pedis
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014008 2001
% 209.97/210.14  |- skos__scopeNote mesh__D014008
% 209.97/210.14       Dermatological pruritic lesion in the feet, caused by Trichophyton rubrum, T. mentagrophytes, or Epidermophyton floccosum.%A%    
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014008 2003
% 209.97/210.14  |- skos__hiddenLabel mesh__D014008 Athletes Foot
% 209.97/210.14  |- skos__broader mesh__D014008smesh__D011537
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D002782 2003
% 209.97/210.14  |- skos__historyNote mesh__D002782 Cholestanes %28%1968-1972%29%
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D002782 1997
% 209.97/210.14  |- mesh__recordAuthorizer mesh__D002782 PLS
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D002782 2001
% 209.97/210.14  |- mesh__dateRevised mesh__D002782 1993-06-03
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D002782 2006
% 209.97/210.14  |- mesh__recordOriginator mesh__D002782 NLM
% 209.97/210.14  |- skos__annotation mesh__D002782
% 209.97/210.14       do not confuse with CHOLESTANES; includes cholestatrienes%A%  
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D002782 1996
% 209.97/210.14  |- mesh__historyNote mesh__D002782 73   
% 209.97/210.14  |- skos__scopeNote mesh__D002782
% 209.97/210.14       Steroids with methyl groups at C-10 and C-13 and a branched 8-carbon chain at C-17. Members include compounds with any degree of unsaturation; however, CHOLESTADIENES is available for derivatives containing two double bonds.%A%    
% 209.97/210.14  |- mesh__dateCreated mesh__D002782 1999-01-01
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D002782 2005
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D002782 2000
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D002782 1999
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D002782 1998
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D002782 1995
% 209.97/210.14  |- mesh__dateEstablished mesh__D002782 1973-01-01
% 209.97/210.14  |- mesh__publicMeSHNote mesh__D002782 73   
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D002782 2002
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D002782 1994
% 209.97/210.14  |- skos__broader mesh__D002782smesh__D002776
% 209.97/210.14  |- skos__prefLabel mesh__D002782 Cholestenes
% 209.97/210.14  |- rdf__type mesh__D002782sskos__Concept
% 209.97/210.14  |- mesh__recordMaintainer mesh__D002782 PLS
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D002782 2004
% 209.97/210.14  |- skos__broader mesh__D010416smesh__D002733
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D010416 2005
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D010416 2003
% 209.97/210.14  |- skos__scopeNote mesh__D010416
% 209.97/210.14       An insecticide and herbicide that has also been used as a wood preservative. Pentachlorphenol is a widespread environmental pollutant. Both chronic and acute pentachlorophenol poisoning are medical concerns. The range of its biological actions is still being actively explored, but it is clearly a potent enzyme inhibitor and has been used as such as an experimental tool.%A%    
% 209.97/210.14  |- skos__historyNote mesh__D010416 Herbicides %28%1966-1970%29%
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D010416 2006
% 209.97/210.14  |- mesh__publicMeSHNote mesh__D010416
% 209.97/210.14       91; was see under CHLOROPHENOLS 1977-90; was see under PHENOLS 1971-76%A%  
% 209.97/210.14  |- mesh__dateEstablished mesh__D010416 1991-01-01
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D010416 2001
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D010416 2004
% 209.97/210.14  |- mesh__historyNote mesh__D010416
% 209.97/210.14       91%28%71%29%; was see under CHLOROPHENOLS 1977-90; was see under PHENOLS 1971-76%A%  
% 209.97/210.14  |- mesh__dateCreated mesh__D010416 1999-01-01
% 209.97/210.14  |- mesh__recordAuthorizer mesh__D010416 sjn
% 209.97/210.14  |- mesh__recordMaintainer mesh__D010416 CCR
% 209.97/210.14  |- mesh__recordOriginator mesh__D010416 NLM
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D010416 2002
% 209.97/210.14  |- mesh__dateRevised mesh__D010416 2000-06-22
% 209.97/210.14  |- skos__historyNote mesh__D010416 Phenols %28%1966-1970%29%
% 209.97/210.14  |- rdf__type mesh__D010416sskos__Concept
% 209.97/210.14  |- skos__hiddenLabel mesh__D010416 Pentachlorophenate, Sodium
% 209.97/210.14  |- skos__prefLabel mesh__D010416 Pentachlorophenol
% 209.97/210.14  |- skos__altLabel mesh__D029121 Metapneumovirus, Avian
% 209.97/210.14  |- skos__annotation mesh__D029121
% 209.97/210.14       infection: coord IM with PARAMYXOVIRIDAE INFECTIONS %28%IM%29%   
% 209.97/210.14  |- skos__broader mesh__D029121smesh__D018099
% 209.97/210.14  |- mesh__publicMeSHNote mesh__D029121
% 209.97/210.14       2002; for RHINOTRACHEITIS VIRUS, TURKEY see PNEUMOVIRUS 1994-2001%A%  
% 209.97/210.14  |- mesh__recordOriginator mesh__D029121 ags
% 209.97/210.14  |- skos__altLabel mesh__D029121 Turkey rhinotracheitis virus
% 209.97/210.14  |- skos__altLabel mesh__D029121 Pneumovirus, Avian
% 209.97/210.14  |- skos__scopeNote mesh__D029121
% 209.97/210.14       A genus of the subfamily PNEUMOVIRINAE, containing two members: Turkey rhinotracheitis virus and a human Metapneumovirus. Virions lack HEMAGGLUTININ and NEURAMINIDASE.%A%    
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D029121 2006
% 209.97/210.14  |- mesh__historyNote mesh__D029121
% 209.97/210.14       2002; for RHINOTRACHEITIS VIRUS, TURKEY use PNEUMOVIRUS 1994-2001%A%  
% 209.97/210.14  |- mesh__dateEstablished mesh__D029121 2002-01-01
% 209.97/210.14  |- skos__altLabel mesh__D029121 Human Metapneumovirus
% 209.97/210.14  |- skos__altLabel mesh__D029121 Rhinotracheitis Virus, Turkey
% 209.97/210.14  |- mesh__dateRevised mesh__D029121 2004-07-13
% 209.97/210.14  |- skos__hiddenLabel mesh__D029121 Metapneumoviruses
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D029121 2005
% 209.97/210.14  |- mesh__recordMaintainer mesh__D029121 sjn
% 209.97/210.14  |- mesh__recordAuthorizer mesh__D029121 sjn
% 209.97/210.14  |- mesh__dateCreated mesh__D029121 2001-07-25
% 209.97/210.14  |- rdf__type mesh__D029121sskos__Concept
% 209.97/210.14  |- skos__prefLabel mesh__D029121 Metapneumovirus
% 209.97/210.14  |- skos__altLabel mesh__D029121 Avian Metapneumovirus
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D015101 2005
% 209.97/210.14  |- mesh__dateCreated mesh__D015101 1976-04-21
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D015101 2002
% 209.97/210.14  |- mesh__dateRevised mesh__D015101 2000-06-22
% 209.97/210.14  |- skos__scopeNote mesh__D015101
% 209.97/210.14       A material used in the manufacture of azo dyes that is toxic to skin and carcinogenic in several species.%A%    
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D015101 2003
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D015101 2006
% 209.97/210.14  |- skos__hiddenLabel mesh__D015101 3,3%27% Dichlorobenzidine
% 209.97/210.14  |- skos__hiddenLabel mesh__D015101 3,3 Dichlorobenzidine
% 209.97/210.14  |- mesh__recordMaintainer mesh__D015101 CCR
% 209.97/210.14  |- skos__historyNote mesh__D015101 Biphenyl Compounds %28%1969-1974%29%
% 209.97/210.14  |- mesh__publicMeSHNote mesh__D015101
% 209.97/210.14       91; was see under BENZIDINES 1977-90   
% 209.97/210.14  |- skos__prefLabel mesh__D015101 3,3%27%-Dichlorobenzidine
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D015101 2004
% 209.97/210.14  |- skos__historyNote mesh__D015101 Aniline Compounds %28%1969-1974%29%
% 209.97/210.14  |- mesh__historyNote mesh__D015101
% 209.97/210.14       91%28%77%29%; was see under BENZIDINES 1977-90   
% 209.97/210.14  |- skos__altLabel mesh__D015101 3,3-Dichlorobenzidine
% 209.97/210.14  |- mesh__recordOriginator mesh__D015101 SH
% 209.97/210.14  |- mesh__dateEstablished mesh__D015101 1991-01-01
% 209.97/210.14  |- skos__broader mesh__D015101smesh__D001713
% 209.97/210.14  |- rdf__type mesh__D015101sskos__Concept
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D015101 2001
% 209.97/210.14  |- skos__historyNote mesh__D015101 Benzidines/AA %28%1975-1976%29%
% 209.97/210.14  |- mesh__recordAuthorizer mesh__D015101 sjn
% 209.97/210.14  |- skos__scopeNote mesh__D020844
% 209.97/210.14       Perennial herb Symphytum officinale, in the family Boraginaceae, used topically for wound healing. It contains ALLANTOIN, carotene, essential oils %28%OILS, VOLATILE%29%; GLYCOSIDES; mucilage, resin, SAPONINS; TANNINS; triterpenoids, VITAMIN B12, and ZINC. Comfrey also contains PYRROLIZIDINE ALKALOIDS and is hepatotoxic if ingested.%A%    
% 209.97/210.14  |- mesh__recordMaintainer mesh__D020844 ssb
% 209.97/210.14  |- mesh__dateEstablished mesh__D020844 2000-01-01
% 209.97/210.14  |- mesh__dateCreated mesh__D020844 1999-11-04
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D020844 2003
% 209.97/210.14  |- skos__historyNote mesh__D020844 Plants, Medicinal %28%1967-1999%29%
% 209.97/210.14  |- mesh__historyNote mesh__D020844 2000   
% 209.97/210.14  |- rdf__type mesh__D020844sskos__Concept
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D020844 2004
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D020844 2005
% 209.97/210.14  |- mesh__recordAuthorizer mesh__D020844 sjn
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D020844 2006
% 209.97/210.14  |- mesh__recordOriginator mesh__D020844 ags
% 209.97/210.14  |- skos__prefLabel mesh__D020844 Comfrey
% 209.97/210.14  |- mesh__publicMeSHNote mesh__D020844 2000   
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D020844 2002
% 209.97/210.14  |- skos__altLabel mesh__D020844 Symphytum officinale
% 209.97/210.14  |- mesh__dateRevised mesh__D020844 2001-07-25
% 209.97/210.14  |- skos__broader mesh__D020844smesh__D028082
% 209.97/210.14  |- mesh__dateCreated mesh__D006375 1974-12-12
% 209.97/210.14  |- skos__broader mesh__D006375smesh__D003904
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D006375 2006
% 209.97/210.14  |- mesh__recordMaintainer mesh__D006375 SYSTEM
% 209.97/210.14  |- mesh__dateRevised mesh__D006375 2005-06-30
% 209.97/210.14  |- mesh__historyNote mesh__D006375 91%28%75%29%   
% 209.97/210.14  |- mesh__dateEstablished mesh__D006375 1991-01-01
% 209.97/210.14  |- rdf__type mesh__D006375sskos__Concept
% 209.97/210.14  |- mesh__recordAuthorizer mesh__D006375 sjn
% 209.97/210.14  |- skos__prefLabel mesh__D006375 Helminthosporium
% 209.97/210.14  |- skos__scopeNote mesh__D006375
% 209.97/210.14       A mitosporic fungal genus including both saprophytes and plant parasites.%A%    
% 209.97/210.14  |- mesh__recordOriginator mesh__D006375 NLM
% 209.97/210.14  |- mesh__publicMeSHNote mesh__D006375
% 209.97/210.14       91; see HYPHOMYCETES 1986-90, see MONILIALES 1975-85   
% 209.97/210.14  |- rdf__type mesh__D014807sskos__Concept
% 209.97/210.14  |- skos__prefLabel mesh__D014807 Vitamin D
% 209.97/210.14  |- mesh__recordAuthorizer mesh__D014807 sjn
% 209.97/210.14  |- skos__scopeNote mesh__D014807
% 209.97/210.14       A vitamin that includes both CHOLECALCIFEROLS and ERGOCALCIFEROLS, which have the common effect of preventing or curing RICKETS in animals. It can also be viewed as a hormone since it can be formed in SKIN by action of ULTRAVIOLET RAYS upon the precursors, 7-dehydrocholesterol and ERGOSTEROL, and acts on VITAMIN D RECEPTORS to regulate CALCIUM in opposition to PARATHYROID HORMONE.%A%    
% 209.97/210.14  |- mesh__dateCreated mesh__D014807 1999-01-01
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014807 2006
% 209.97/210.14  |- skos__related mesh__D014807smesh__D018167
% 209.97/210.14  |- mesh__recordMaintainer mesh__D014807 ssb
% 209.97/210.14  |- skos__annotation mesh__D014807
% 209.97/210.14       /defic = VITAMIN D DEFICIENCY or RICKETS; /ther use: coordinate disease with /drug ther, not /diet ther%A%  
% 209.97/210.14  |- skos__broader mesh__D014807smesh__D012632
% 209.97/210.14  |- mesh__dateRevised mesh__D014807 2005-06-30
% 209.97/210.14  |- mesh__recordOriginator mesh__D014807 NLM
% 209.97/210.14  |- skos__broader mesh__D006321Q000201smesh__D006321
% 209.97/210.14  |- mesh__preferredCombination mesh__D006321Q000201smesh__D009206Q000201
% 209.97/210.14  |- rdf__type mesh__D006321Q000201smesh__CompoundConcept
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014009 2006
% 209.97/210.14  |- mesh__historyNote mesh__D014009
% 209.97/210.14       93; was TINEA UNGUIUM 1963-92; ONYCHOMYCOSIS was see TINEA UNGUIUM 1963-92%A%  
% 209.97/210.14  |- mesh__onlineNote mesh__D014009
% 209.97/210.14       use ONYCHOMYCOSIS to search TINEA UNGUIUM 1966-92   
% 209.97/210.14  |- skos__prefLabel mesh__D014009 Onychomycosis
% 209.97/210.14  |- mesh__dateCreated mesh__D014009 1999-01-01
% 209.97/210.14  |- rdf__type mesh__D014009sskos__Concept
% 209.97/210.14  |- mesh__publicMeSHNote mesh__D014009
% 209.97/210.14       93; was TINEA UNGUIUM 1963-92; ONYCHOMYCOSIS was see TINEA UNGUIUM 1963-92%A%  
% 209.97/210.14  |- skos__broader mesh__D014009smesh__D014005
% 209.97/210.14  |- mesh__dateRevised mesh__D014009 2001-07-25
% 209.97/210.14  |- skos__altLabel mesh__D014009 Tinea Unguium
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014009 2002
% 209.97/210.14  |- mesh__recordAuthorizer mesh__D014009 sjn
% 209.97/210.14  |- skos__annotation mesh__D014009
% 209.97/210.14       ringworm of the nails; do not coord with NAILS; specify FOOT DERMATOSES %28%NIM%29% or HAND DERMATOSES %28%NIM%29%%A%  
% 209.97/210.14  |- skos__scopeNote mesh__D014009
% 209.97/210.14       A fungal infection of the nail plate, usually caused by a species of Epidermophyton, Microsporum, or Trichophyton, and producing opaque, white, thickened, friable, and brittle nails. %28%Dorland, 27th ed%29%%A%    
% 209.97/210.14  |- skos__hiddenLabel mesh__D014009 Onychomycoses
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014009 2003
% 209.97/210.14  |- mesh__recordMaintainer mesh__D014009 lkt
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014009 2005
% 209.97/210.14  |- mesh__recordOriginator mesh__D014009 NLM
% 209.97/210.14  |- mesh__activeMeSHYear mesh__D014009 2004
% 209.97/210.14  |- skos__broader mesh__D014009smesh__D009260
% 209.97/210.15  |- skos__scopeNote mesh__D002783
% 209.97/210.15       CHOLESTENES with one or more double bonds and substituted by any number of keto groups.%A%    
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D002783 2002
% 209.97/210.15  |- mesh__recordMaintainer mesh__D002783 PLS
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D002783 1995
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D002783 1998
% 209.97/210.15  |- mesh__dateCreated mesh__D002783 1974-11-11
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D002783 1994
% 209.97/210.15  |- mesh__historyNote mesh__D002783
% 209.97/210.15       91%28%75%29%; was see under CHOLESTENES 1975-90   
% 209.97/210.15  |- skos__prefLabel mesh__D002783 Cholestenones
% 209.97/210.15  |- skos__annotation mesh__D002783
% 209.97/210.15       do not confuse with CHOLESTANONES; includes cholestenediones, cholestenetriones%A%  
% 209.97/210.15  |- rdf__type mesh__D002783sskos__Concept
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D002783 2004
% 209.97/210.15  |- mesh__recordAuthorizer mesh__D002783 PLS
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D002783 2001
% 209.97/210.15  |- mesh__dateRevised mesh__D002783 1993-06-03
% 209.97/210.15  |- mesh__publicMeSHNote mesh__D002783
% 209.97/210.15       91; was see under CHOLESTENES 1975-90   
% 209.97/210.15  |- mesh__recordOriginator mesh__D002783 NLM
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D002783 2003
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D002783 1997
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D002783 2000
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D002783 2006
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D002783 1996
% 209.97/210.15  |- skos__broader mesh__D002783smesh__D002782
% 209.97/210.15  |- mesh__dateEstablished mesh__D002783 1991-01-01
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D002783 2005
% 209.97/210.15  |- skos__historyNote mesh__D002783 Cholestenes %28%1973-1974%29%
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D002783 1999
% 209.97/210.15  |- mesh__recordOriginator mesh__D010417 NLM
% 209.97/210.15  |- skos__altLabel mesh__D010417
% 209.97/210.15       Alpharma Brand of Pentaerythritol Tetranitrate
% 209.97/210.15  |- skos__scopeNote mesh__D010417
% 209.97/210.15       A vasodilator with general properties similar to NITROGLYCERIN but with a more prolonged duration of action. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1025%29%%A%    
% 209.97/210.15  |- skos__hiddenLabel mesh__D010417 Tetranitrate, Pentaerythritol
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D010417 2006
% 209.97/210.15  |- skos__broader mesh__D010417smesh__D011409
% 209.97/210.15  |- skos__altLabel mesh__D010417 Pentalog
% 209.97/210.15  |- skos__altLabel mesh__D010417
% 209.97/210.15       Parke Davis Brand of Pentaerythritol Tetranitrate
% 209.97/210.15  |- mesh__dateCreated mesh__D010417 1999-01-01
% 209.97/210.15  |- skos__altLabel mesh__D010417
% 209.97/210.15       Ravensberg Brand of Pentaerythritol Tetranitrate
% 209.97/210.15  |- rdf__type mesh__D010417sskos__Concept
% 209.97/210.15  |- skos__altLabel mesh__D010417
% 209.97/210.15       Vanguard Brand of Pentaerythritol Tetranitrate
% 209.97/210.15  |- mesh__recordMaintainer mesh__D010417 lkw
% 209.97/210.15  |- skos__altLabel mesh__D010417 Dexo Brand of Pentaerythritol Tetranitrate
% 209.97/210.15  |- mesh__dateRevised mesh__D010417 2005-06-30
% 209.97/210.15  |- skos__prefLabel mesh__D010417 Pentaerythritol Tetranitrate
% 209.97/210.15  |- mesh__recordAuthorizer mesh__D010417 sjn
% 209.97/210.15  |- skos__hiddenLabel mesh__D029122 pneumonia viruses, Murine
% 209.97/210.15  |- skos__altLabel mesh__D029122 Pneumonia Virus of Mice
% 209.97/210.15  |- skos__prefLabel mesh__D029122 Murine pneumonia virus
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D029122 2006
% 209.97/210.15  |- mesh__dateEstablished mesh__D029122 2002-01-01
% 209.97/210.15  |- skos__historyNote mesh__D029122 Paramyxoviridae %28%1974-1993%29%
% 209.97/210.15  |- skos__hiddenLabel mesh__D029122 pneumonia virus, Murine
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D029122 2005
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D029122 2002
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D029122 2004
% 209.97/210.15  |- skos__broader mesh__D029122smesh__D018111
% 209.97/210.15  |- rdf__type mesh__D029122sskos__Concept
% 209.97/210.15  |- skos__annotation mesh__D029122
% 209.97/210.15       infection: coord IM with PNEUMOVIRUS INFECTIONS; index also PNEUMONIA, VIRAL if pertinent%A%  
% 209.97/210.15  |- skos__scopeNote mesh__D029122
% 209.97/210.15       A species of the genus PNEUMOVIRUS causing pneumonia in mice.%A%    
% 209.97/210.15  |- skos__hiddenLabel mesh__D029122 Mice Pneumonia Virus
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D029122 2003
% 209.97/210.15  |- mesh__publicMeSHNote mesh__D029122 2002; see PNEUMOVIRUS 1994-2001   
% 209.97/210.15  |- skos__historyNote mesh__D029122 Orthomyxoviridae %28%1967-1973%29%
% 209.97/210.15  |- skos__hiddenLabel mesh__D029122 Murine pneumonia viruses
% 209.97/210.15  |- mesh__historyNote mesh__D029122 2002; use PNEUMOVIRUS 1994-2001   
% 209.97/210.15  |- skos__hiddenLabel mesh__D029122 Mice Pneumonia Viruses
% 209.97/210.15  |- skos__historyNote mesh__D029122 Pneumovirus %28%1994-2001%29%
% 209.97/210.15  |- mesh__dateCreated mesh__D029122 2001-07-25
% 209.97/210.15  |- mesh__dateEstablished mesh__D015900 1990-01-01
% 209.97/210.15  |- rdf__type mesh__D015900sskos__Concept
% 209.97/210.15  |- skos__altLabel mesh__D015900 Radiography, Dual Energy Scanned Projection
% 209.97/210.15  |- mesh__historyNote mesh__D015900 90   
% 209.97/210.15  |- skos__prefLabel mesh__D015900
% 209.97/210.15       Radiography, Dual-Energy Scanned Projection
% 209.97/210.15  |- mesh__recordMaintainer mesh__D015900 jls
% 209.97/210.15  |- skos__altLabel mesh__D015900 Dual Energy Scanned Projection Radiography
% 209.97/210.15  |- skos__annotation mesh__D015900
% 209.97/210.15       do not use /util except by MeSH definition; DF: D SCAN RADIOGR%A%  
% 209.97/210.15  |- mesh__dateCreated mesh__D015900 1989-05-16
% 209.97/210.15  |- skos__altLabel mesh__D015900 Dual-Energy Scanned Projection Radiography
% 209.97/210.15  |- skos__altLabel mesh__D015900
% 209.97/210.15       Digital Scanned Projection Radiography, Dual-Energy
% 209.97/210.15  |- mesh__publicMeSHNote mesh__D015900 90   
% 209.97/210.15  |- skos__historyNote mesh__D015900 Subtraction Technique %28%1981-1989%29%
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D015900 2005
% 209.97/210.15  |- skos__altLabel mesh__D015900
% 209.97/210.15       Digital Scan Projection Radiography, Dual Energy
% 209.97/210.15  |- mesh__dateRevised mesh__D015900 2004-07-07
% 209.97/210.15  |- skos__historyNote mesh__D015900
% 209.97/210.15       Radiographic Image Enhancement %28%1983-1989%29%
% 209.97/210.15  |- skos__altLabel mesh__D015900
% 209.97/210.15       Digital Scan Projection Radiography, Dual-Energy
% 209.97/210.15  |- skos__broader mesh__D015900smesh__D011856
% 209.97/210.15  |- skos__altLabel mesh__D015900
% 209.97/210.15       Digital Scanned Projection Radiography, Dual Energy
% 209.97/210.15  |- mesh__recordOriginator mesh__D015900 PLS
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D015900 2006
% 209.97/210.15  |- mesh__recordAuthorizer mesh__D015900 sjn
% 209.97/210.15  |- skos__scopeNote mesh__D015900
% 209.97/210.15       A method of producing a high-quality scan by digitizing and subtracting the images produced by high- and low-energy x-rays.%A%    
% 209.97/210.15  |- skos__broader mesh__D015900smesh__D013382
% 209.97/210.15  |- skos__broader mesh__D015900smesh__D007089
% 209.97/210.15  |- skos__altLabel mesh__D015102 DOPAC
% 209.97/210.15  |- mesh__dateRevised mesh__D015102 2005-06-30
% 209.97/210.15  |- skos__historyNote mesh__D015102 Catechols %28%1972-1974%29%
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D015102 2006
% 209.97/210.15  |- skos__hiddenLabel mesh__D015102 3,4 Dihydroxyphenylacetic Acid
% 209.97/210.15  |- skos__historyNote mesh__D015102 Phenylacetates %28%1972-1974%29%
% 209.97/210.15  |- skos__scopeNote mesh__D015102 A deaminated metabolite of LEVODOPA.     
% 209.97/210.15  |- mesh__recordAuthorizer mesh__D015102 sjn
% 209.97/210.15  |- skos__altLabel mesh__D015102 Homoprotocatechuic Acid
% 209.97/210.15  |- mesh__onlineNote mesh__D015102
% 209.97/210.15       use 3,4-DIHYDROXYPHENYLACETIC ACID to search DOPACETIC ACID 1975-93%A%  
% 209.97/210.15  |- mesh__recordMaintainer mesh__D015102 ssb
% 209.97/210.15  |- skos__broader mesh__D015102smesh__D010648
% 209.97/210.15  |- mesh__historyNote mesh__D015102
% 209.97/210.15       91%28%75%29%; was see under PHENYLACETATES 1975-90; DOPACETIC ACID was see 3,4-DIHYDROXYPHENYLACETIC ACID 1975-93%A%  
% 209.97/210.15  |- rdf__type mesh__D015102sskos__Concept
% 209.97/210.15  |- mesh__dateCreated mesh__D015102 1974-11-19
% 209.97/210.15  |- mesh__recordOriginator mesh__D015102 NLM
% 209.97/210.15  |- skos__prefLabel mesh__D015102 3,4-Dihydroxyphenylacetic Acid
% 209.97/210.15  |- mesh__publicMeSHNote mesh__D015102
% 209.97/210.15       91; was see under PHENYLACETATES 1975-90; DOPACETIC ACID was see 3,4-DIHYDROXYPHENYLACETIC ACID 1975-93%A%  
% 209.97/210.15  |- mesh__dateEstablished mesh__D015102 1991-01-01
% 209.97/210.15  |- mesh__recordMaintainer mesh__D020845 ssb
% 209.97/210.15  |- mesh__recordOriginator mesh__D020845 adp
% 209.97/210.15  |- skos__historyNote mesh__D020845 Receptors, Estrogen %28%1996-1999%29%
% 209.97/210.15  |- skos__scopeNote mesh__D020845
% 209.97/210.15       A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate  estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. %28%Horm Res 1997;48:155-63%29%%A%    
% 209.97/210.15  |- mesh__dateCreated mesh__D020845 1999-11-08
% 209.97/210.15  |- mesh__dateEstablished mesh__D020845 2000-01-01
% 209.97/210.15  |- skos__altLabel mesh__D020845 SERM
% 209.97/210.15  |- skos__broader mesh__D020845smesh__D020847
% 209.97/210.15  |- skos__altLabel mesh__D020845 Estrogen Receptor Modulator, Selective
% 209.97/210.15  |- skos__annotation mesh__D020845
% 209.97/210.15       do not confuse with ESTROGEN RECEPTOR MODULATORS   
% 209.97/210.15  |- rdf__type mesh__D020845sskos__Concept
% 209.97/210.15  |- skos__altLabel mesh__D020845 Estrogen Receptor Modulators, Selective
% 209.97/210.15  |- skos__related mesh__D020845smesh__D050071
% 209.97/210.15  |- mesh__historyNote mesh__D020845 2000   
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D020845 2006
% 209.97/210.15  |- skos__altLabel mesh__D020845 Selective Estrogen Receptor Modulator
% 209.97/210.15  |- mesh__publicMeSHNote mesh__D020845 2000   
% 209.97/210.15  |- mesh__recordAuthorizer mesh__D020845 sjn
% 209.97/210.15  |- skos__prefLabel mesh__D020845 Selective Estrogen Receptor Modulators
% 209.97/210.15  |- skos__altLabel mesh__D020845 SERMs
% 209.97/210.15  |- mesh__dateRevised mesh__D020845 2005-06-30
% 209.97/210.15  |- skos__scopeNote mesh__D006376
% 209.97/210.15       Commonly known as parasitic worms, this group includes the ACANTHOCEPHALA; NEMATODA; and PLATYHELMINTHS. Some authors consider certain species of LEECHES that can become temporarily parasitic as helminths.%A%    
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D006376 2005
% 209.97/210.15  |- mesh__publicMeSHNote mesh__D006376 ASCHELMINTHES was heading 1976-85   
% 209.97/210.15  |- mesh__recordOriginator mesh__D006376 NLM
% 209.97/210.15  |- mesh__dateCreated mesh__D006376 1999-01-01
% 209.97/210.15  |- mesh__recordMaintainer mesh__D006376 ags
% 209.97/210.15  |- skos__broader mesh__D006376smesh__D007448
% 209.97/210.15  |- skos__prefLabel mesh__D006376 Helminths
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D006376 2004
% 209.97/210.15  |- skos__altLabel mesh__D006376 Worms, Parasitic
% 209.97/210.15  |- mesh__historyNote mesh__D006376 ASCHELMINTHES was heading 1976-85   
% 209.97/210.15  |- skos__altLabel mesh__D006376 Parasitic Worms
% 209.97/210.15  |- rdf__type mesh__D006376sskos__Concept
% 209.97/210.15  |- mesh__onlineNote mesh__D006376
% 209.97/210.15       use HELMINTHS to search ASCHELMINTHES 1976-85   
% 209.97/210.15  |- skos__annotation mesh__D006376
% 209.97/210.15       GEN or unspecified; prefer specifics; infection = HELMINTHIASIS; coord with specific precoord helminth terms %28%e.g., ANTIGENS, HELMINTH%29% if pertinent%A%  
% 209.97/210.15  |- mesh__recordAuthorizer mesh__D006376 sjn
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D006376 2006
% 209.97/210.15  |- mesh__dateRevised mesh__D006376 2003-07-09
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D020047 2003
% 209.97/210.15  |- skos__broader mesh__D020047smesh__D012002
% 209.97/210.15  |- mesh__dateCreated mesh__D020047 1998-06-11
% 209.97/210.15  |- skos__hiddenLabel mesh__D020047 Rectoceles
% 209.97/210.15  |- skos__prefLabel mesh__D020047 Rectocele
% 209.97/210.15  |- rdf__type mesh__D020047sskos__Concept
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D020047 1999
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D020047 2002
% 209.97/210.15  |- skos__altLabel mesh__D020047 Proctocele
% 209.97/210.15  |- skos__hiddenLabel mesh__D020047 Proctoceles
% 209.97/210.15  |- mesh__publicMeSHNote mesh__D020047 99   
% 209.97/210.15  |- mesh__historyNote mesh__D020047 99   
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D020047 2006
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D020047 2001
% 209.97/210.15  |- skos__historyNote mesh__D020047 Rectal Diseases %28%1966-1998%29%
% 209.97/210.15  |- mesh__dateEstablished mesh__D020047 1999-01-01
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D020047 2005
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D020047 2000
% 209.97/210.15  |- skos__scopeNote mesh__D020047
% 209.97/210.15       A hernial protrusion of part of the rectum into the vagina. %28%Dorland, 28th ed%29%%A%    
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D020047 2004
% 209.97/210.15  |- skos__hiddenLabel mesh__D014808 Vitamin D Deficiencies
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D014808 2006
% 209.97/210.15  |- skos__broader mesh__D014808smesh__D001361
% 209.97/210.15  |- skos__hiddenLabel mesh__D014808 Deficiencies, Vitamin D
% 209.97/210.15  |- skos__altLabel mesh__D014808 Deficiency, Vitamin D
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D014808 2004
% 209.97/210.15  |- skos__annotation mesh__D014808 DF: VITAMIN D DEFIC   
% 209.97/210.15  |- mesh__recordOriginator mesh__D014808 NLM
% 209.97/210.15  |- mesh__recordMaintainer mesh__D014808 lkt
% 209.97/210.15  |- mesh__dateRevised mesh__D014808 2003-07-09
% 209.97/210.15  |- skos__prefLabel mesh__D014808 Vitamin D Deficiency
% 209.97/210.15  |- mesh__recordAuthorizer mesh__D014808 sjn
% 209.97/210.15  |- skos__scopeNote mesh__D014808
% 209.97/210.15       A nutritional condition produced by a deficiency of VITAMIN D in the diet, insufficient production of vitamin D in the skin, inadequate absorption of vitamin D from the diet, or abnormal conversion of vitamin D to its bioactive metabolites. It is manifested clinically as RICKETS in children and OSTEOMALACIA in adults. %28%From Cecil Textbook of Medicine, 19th ed, p1406%29%%A%    
% 209.97/210.15  |- rdf__type mesh__D014808sskos__Concept
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D014808 2005
% 209.97/210.15  |- skos__related mesh__D014808smesh__D012279
% 209.97/210.15  |- mesh__dateCreated mesh__D014808 1999-01-01
% 209.97/210.15  |- skos__related mesh__D011510smesh__D008074
% 209.97/210.15  |- mesh__publicMeSHNote mesh__D011510 77   
% 209.97/210.15  |- mesh__historyNote mesh__D011510 77   
% 209.97/210.15  |- skos__prefLabel mesh__D011510 Proteolipids
% 209.97/210.15  |- skos__broader mesh__D011510smesh__D008563
% 209.97/210.15  |- mesh__recordMaintainer mesh__D011510 SYSTEM
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D011510 2006
% 209.97/210.15  |- mesh__recordOriginator mesh__D011510 RLS
% 209.97/210.15  |- mesh__dateCreated mesh__D011510 1976-05-19
% 209.97/210.15  |- mesh__dateEstablished mesh__D011510 1977-01-01
% 209.97/210.15  |- mesh__recordAuthorizer mesh__D011510 sjn
% 209.97/210.15  |- rdf__type mesh__D011510sskos__Concept
% 209.97/210.15  |- skos__annotation mesh__D011510 do not confuse with LIPOPROTEINS   
% 209.97/210.15  |- skos__scopeNote mesh__D011510
% 209.97/210.15       Protein-lipid combinations abundant in brain tissue, but also present in a wide variety of animal and plant tissues. In contrast to lipoproteins, they are insoluble in water, but soluble in a chloroform-methanol mixture. The protein moiety has a high content of hydrophobic amino acids. The associated lipids consist of a mixture of GLYCEROPHOSPHATES; CEREBROSIDES; and SULFOGLYCOSPHINGOLIPIDS; while lipoproteins contain PHOSPHOLIPIDS; CHOLESTEROL; and TRIGLYCERIDES.%A%    
% 209.97/210.15  |- mesh__dateRevised mesh__D011510 2005-06-30
% 209.97/210.15  |- skos__historyNote mesh__D011510 Lipoproteins %28%1966-1976%29%
% 209.97/210.15  |- skos__historyNote mesh__D011510 specific lipoprotein%28%1966-1976%29%
% 209.97/210.15  |- skos__broader mesh__D011510smesh__D011506
% 209.97/210.15  |- rdf__type mesh__D002784sskos__Concept
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D002784 2004
% 209.97/210.15  |- mesh__publicMeSHNote mesh__D002784
% 209.97/210.15       /blood was BLOOD CHOLESTEROL 1963-67   
% 209.97/210.15  |- skos__annotation mesh__D002784
% 209.97/210.15       GEN or unspecified; prefer specifics; /biosyn /physiol permitted; /blood: consider also HYPERCHOLESTEROLEMIA %26% specifics; cholesterol granuloma = CHOLESTEROL + GRANULOMA, FOREIGN-BODY%A%  
% 209.97/210.15  |- skos__broader mesh__D002784smesh__D013261
% 209.97/210.15  |- mesh__onlineNote mesh__D002784
% 209.97/210.15       use CHOLESTEROL to search BLOOD CHOLESTEROL 1966-67   
% 209.97/210.15  |- skos__related mesh__D002784smesh__D006937
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D002784 2006
% 209.97/210.15  |- skos__related mesh__D002784smesh__D017700
% 209.97/210.15  |- mesh__recordMaintainer mesh__D002784 ssb
% 209.97/210.15  |- mesh__recordAuthorizer mesh__D002784 sjn
% 209.97/210.15  |- skos__prefLabel mesh__D002784 Cholesterol
% 209.97/210.15  |- skos__broader mesh__D002784smesh__D002782
% 209.97/210.15  |- mesh__dateCreated mesh__D002784 1999-01-01
% 209.97/210.15  |- mesh__historyNote mesh__D002784 /blood was BLOOD CHOLESTEROL 1963-67   
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D002784 2005
% 209.97/210.15  |- mesh__recordOriginator mesh__D002784 NLM
% 209.97/210.15  |- skos__scopeNote mesh__D002784
% 209.97/210.15       The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.%A%    
% 209.97/210.15  |- mesh__dateRevised mesh__D002784 2003-07-09
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D029921 2003
% 209.97/210.15  |- mesh__dateCreated mesh__D029921 2001-07-25
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D029921 2006A
% 209.97/210.15  |- mesh__publicMeSHNote mesh__D029921 2002   
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D029921 2006
% 209.97/210.15  |- skos__annotation mesh__D029921
% 209.97/210.15       note X ref RED CLOVER: CLOVER see MEDICAGO; BUSH CLOVER see LESPEDEZA; and SWEET CLOVER see MELILOTUS are also available;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.97/210.15  |- rdf__type mesh__D029921sskos__Concept
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D029921 2002
% 209.97/210.15  |- skos__altLabel mesh__D029921 Red clover
% 209.97/210.15  |- mesh__historyNote mesh__D029921 2002   
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D029921 2005
% 209.97/210.15  |- skos__scopeNote mesh__D029921 A plant genus of the family FABACEAE.     
% 209.97/210.15  |- mesh__recordOriginator mesh__D029921 ssb
% 209.97/210.15  |- skos__altLabel mesh__D029921 Clover, Red
% 209.97/210.15  |- skos__broader mesh__D029921smesh__D007887
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D029921 2004
% 209.97/210.15  |- skos__prefLabel mesh__D029921 Trifolium
% 209.97/210.15  |- mesh__dateRevised mesh__D029921 2005-07-19
% 209.97/210.15  |- mesh__recordAuthorizer mesh__D029921 ags
% 209.97/210.15  |- mesh__dateEstablished mesh__D029921 2002-01-01
% 209.97/210.15  |- mesh__recordMaintainer mesh__D029921 ags
% 209.97/210.15  |- mesh__dateEstablished mesh__D010418 1973-01-01
% 209.97/210.15  |- skos__altLabel mesh__D010418 Gastrin Pentapeptide
% 209.97/210.15  |- rdf__type mesh__D010418sskos__Concept
% 209.97/210.15  |- skos__broader mesh__D010418smesh__D005755
% 209.97/210.15  |- skos__broader mesh__D010418smesh__D009842
% 209.97/210.15  |- mesh__recordMaintainer mesh__D010418 ssb
% 209.97/210.15  |- skos__hiddenLabel mesh__D010418 Pentapeptide, Gastrin
% 209.97/210.15  |- skos__historyNote mesh__D010418
% 209.97/210.15       Gastrointestinal Hormones %28%1966-1971%29%
% 209.97/210.15  |- mesh__recordAuthorizer mesh__D010418 sjn
% 209.97/210.15  |- mesh__recordOriginator mesh__D010418 NLM
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D010418 2004
% 209.97/210.15  |- skos__prefLabel mesh__D010418 Pentagastrin
% 209.97/210.15  |- mesh__dateCreated mesh__D010418 1999-01-01
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D010418 2006
% 209.97/210.15  |- mesh__publicMeSHNote mesh__D010418 73   
% 209.97/210.15  |- skos__historyNote mesh__D010418 Peptides %28%1966-1971%29%
% 209.97/210.15  |- mesh__historyNote mesh__D010418 73%28%72%29%   
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D010418 2003
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D010418 2002
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D010418 2005
% 209.97/210.15  |- skos__related mesh__D010418smesh__D005765
% 209.97/210.15  |- skos__scopeNote mesh__D010418
% 209.97/210.15       A synthetic pentapeptide that has effects like gastrin when given parenterally. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid.%A%    
% 209.97/210.15  |- mesh__dateRevised mesh__D010418 2001-07-25
% 209.97/210.15  |- skos__scopeNote mesh__D015901
% 209.97/210.15       A method of delineating blood vessels by subtracting a tissue background image from an image of tissue plus intravascular contrast material that attenuates the X-ray photons. The background image is determined from a digitized image taken a few moments before injection of the contrast material. The resulting angiogram is a high-contrast image of the vessel. This subtraction technique allows extraction of a high-intensity signal from the superimposed background information. The image is thus the result of the differential absorption of X-rays by different tissues.%A%    
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D015901 1999
% 209.97/210.15  |- skos__broader mesh__D015901smesh__D013382
% 209.97/210.15  |- skos__historyNote mesh__D015901 Subtraction Technique %28%1980-1989%29%
% 209.97/210.15  |- skos__broader mesh__D015901smesh__D011856
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D015901 2005
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D015901 2000
% 209.97/210.15  |- mesh__recordMaintainer mesh__D015901 PXP
% 209.97/210.15  |- mesh__publicMeSHNote mesh__D015901 90   
% 209.97/210.15  |- skos__historyNote mesh__D015901 Angiography %28%1980-1989%29%
% 209.97/210.15  |- mesh__recordAuthorizer mesh__D015901 SJN
% 209.97/210.15  |- mesh__recordOriginator mesh__D015901 PLS
% 209.97/210.15  |- skos__altLabel mesh__D015901 Subtraction Angiography, Digital
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D015901 2006
% 209.97/210.15  |- mesh__historyNote mesh__D015901 90   
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D015901 2001
% 209.97/210.15  |- mesh__dateRevised mesh__D015901 1997-06-20
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D015901 2003
% 209.97/210.15  |- skos__altLabel mesh__D015901 Digital Subtraction Angiography
% 209.97/210.15  |- rdf__type mesh__D015901sskos__Concept
% 209.97/210.15  |- skos__annotation mesh__D015901
% 209.97/210.15       /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: DS ANGIOGR%A%  
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D015901 2004
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D015901 1998
% 209.97/210.15  |- skos__prefLabel mesh__D015901 Angiography, Digital Subtraction
% 209.97/210.15  |- mesh__dateEstablished mesh__D015901 1990-01-01
% 209.97/210.15  |- mesh__dateCreated mesh__D015901 1989-05-15
% 209.97/210.15  |- skos__broader mesh__D015901smesh__D000792
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D015901 2002
% 209.97/210.15  |- rdf__type mesh__D048088sskos__Concept
% 209.97/210.15  |- mesh__dateCreated mesh__D048088 2004-07-07
% 209.97/210.15  |- mesh__publicMeSHNote mesh__D048088 2005   
% 209.97/210.15  |- skos__annotation mesh__D048088 general; prefer specifics   
% 209.97/210.15  |- mesh__recordOriginator mesh__D048088 jls
% 209.97/210.15  |- skos__historyNote mesh__D048088 Information Systems %28%1979-2004%29%
% 209.97/210.15  |- skos__scopeNote mesh__D048088
% 209.97/210.15       The field of information science concerned with the analysis and dissemination of data through the application of computers.%A%    
% 209.97/210.15  |- skos__prefLabel mesh__D048088 Informatics
% 209.97/210.15  |- mesh__historyNote mesh__D048088 2005   
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D048088 2005
% 209.97/210.15  |- mesh__dateEstablished mesh__D048088 2005-01-01
% 209.97/210.15  |- skos__broader mesh__D048088smesh__D007254
% 209.97/210.15  |- mesh__recordMaintainer mesh__D048088 jls
% 209.97/210.15  |- mesh__recordAuthorizer mesh__D048088 sjn
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D048088 2006
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D015103 2005
% 209.97/210.15  |- mesh__recordMaintainer mesh__D015103 CCR
% 209.97/210.15  |- rdf__type mesh__D015103sskos__Concept
% 209.97/210.15  |- skos__historyNote mesh__D015103 Serine %28%1971-1974%29%
% 209.97/210.15  |- mesh__publicMeSHNote mesh__D015103
% 209.97/210.15       97; was 3,4-DIHYDROXYPHENYLSERINE 1975-96 %28%see under SERINE 1975-90%29%; DOPS was see DIHYDROXYPHENYLSERINE 1975-96%A%  
% 209.97/210.15  |- skos__hiddenLabel mesh__D015103 erythro 3,4 Dihydroxyphenylserine
% 209.97/210.15  |- skos__altLabel mesh__D015103 DL-threo-3,4-Dihydroxyphenylserine
% 209.97/210.15  |- mesh__dateRevised mesh__D015103 2000-06-22
% 209.97/210.15  |- skos__prefLabel mesh__D015103 Droxidopa
% 209.97/210.15  |- skos__altLabel mesh__D015103 threo-DOPS
% 209.97/210.15  |- mesh__dateCreated mesh__D015103 1974-11-27
% 209.97/210.15  |- skos__broader mesh__D015103smesh__D009638
% 209.97/210.15  |- mesh__recordAuthorizer mesh__D015103 sjn
% 209.97/210.15  |- skos__hiddenLabel mesh__D015103 DL threo 3,4 Dihydroxyphenylserine
% 209.97/210.15  |- skos__historyNote mesh__D015103 Catechols %28%1971-1974%29%
% 209.97/210.15  |- mesh__historyNote mesh__D015103
% 209.97/210.15       97; was 3,4-DIHYDROXYPHENYLSERINE 1975-96 %28%see under SERINE 1975-90%29%; DOPS was see DIHYDROXYPHENYLSERINE 1975-96%A%  
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D015103 2002
% 209.97/210.15  |- skos__broader mesh__D015103smesh__D012694
% 209.97/210.15  |- mesh__dateEstablished mesh__D015103 1991-01-01
% 209.97/210.15  |- skos__scopeNote mesh__D015103
% 209.97/210.15       A precursor of noradrenaline that is used in the treatment of parkinsonism. The racemic form %28%DL-threo-3,4-dihydroxyphenylserine%29% has also been used, and has been investigated in the treatment of orthostatic hypotension. There is a deficit of noradrenaline as well as of dopamine in Parkinson%27%s disease and it has been proposed that this underlies the sudden transient freezing seen usually in advanced disease. Administration of DL-threo-3,4-dihydroxyphenylserine has been claimed to result in an improvement in this phenomenon but controlled studies have failed to demonstrate improvement. %28%Reynolds JEF%28%Ed%29%: Martindale: The Extra Pharmacopoeia %28%electronic version%29%. Micromedex, Inc, Englewood, CO, 1995%29%%A%    
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D015103 2004
% 209.97/210.15  |- mesh__onlineNote mesh__D015103 use DROXIDOPA to search DOPS 1975-96   
% 209.97/210.15  |- skos__hiddenLabel mesh__D015103 threo DOPS
% 209.97/210.15  |- skos__hiddenLabel mesh__D015103 3,4 threo DOPS
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D015103 2001
% 209.97/210.15  |- skos__altLabel mesh__D015103 3,4-threo-DOPS
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D015103 2006
% 209.97/210.15  |- skos__hiddenLabel mesh__D015103 3,4 Dihydroxyphenylserine
% 209.97/210.15  |- mesh__recordOriginator mesh__D015103 NLM
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D015103 2003
% 209.97/210.15  |- mesh__dateEstablished mesh__D020846 2000-01-01
% 209.97/210.15  |- skos__altLabel mesh__D020846 cdc42 Protein, Yeast
% 209.97/210.15  |- mesh__dateCreated mesh__D020846 1999-11-03
% 209.97/210.15  |- mesh__recordAuthorizer mesh__D020846 sjn
% 209.97/210.15  |- mesh__historyNote mesh__D020846
% 209.97/210.15       2002%28%2000%29%; use CDC42 GTP-BINDING PROTEIN, SACCHAROMYCES CEREVISIAE %28%NM%29% 1991-1999%A%  
% 209.97/210.15  |- skos__annotation mesh__D020846
% 209.97/210.15       CDC42 GTP-BINDING PROTEIN is also available   
% 209.97/210.15  |- mesh__dateRevised mesh__D020846 2005-06-30
% 209.97/210.15  |- rdf__type mesh__D020846sskos__Concept
% 209.97/210.15  |- mesh__recordOriginator mesh__D020846 jmp
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D020846 2006
% 209.97/210.15  |- skos__hiddenLabel mesh__D020846 cdc42 GTP Binding Protein, Yeast
% 209.97/210.15  |- skos__hiddenLabel mesh__D020846
% 209.97/210.15       cdc42 GTP Binding Protein, Saccharomyces cerevisiae
% 209.97/210.15  |- skos__broader mesh__D020846smesh__D029701
% 209.97/210.15  |- mesh__publicMeSHNote mesh__D020846
% 209.97/210.15       2002; CDC42 PROTEIN, FUNGAL %28%now CDC42 GTP-BINDING PROTEIN, SACCHAROMYCES CEREVISIAE%29% was indexed under CELL CYCLE PROTEINS %26% G-PROTEINS 1996-1999 %26% FUNGAL PROTEINS 1991-1995%A%  
% 209.97/210.15  |- skos__broader mesh__D020846smesh__D020741
% 209.97/210.15  |- mesh__recordMaintainer mesh__D020846 jmp
% 209.97/210.15  |- skos__scopeNote mesh__D020846
% 209.97/210.15       A member of the Rho family of MONOMERIC GTP-BINDING PROTEINS from SACCHAROMYCES CEREVISIAE. It is involved in morphological events related to the cell cycle. This enzyme was formerly listed as EC 3.6.1.47.%A%    
% 209.97/210.15  |- skos__historyNote mesh__D020846 G-Proteins %28%1996-1999%29%
% 209.97/210.15  |- skos__hiddenLabel mesh__D020846 Yeast cdc42 Protein
% 209.97/210.15  |- skos__prefLabel mesh__D020846
% 209.97/210.15       cdc42 GTP-Binding Protein, Saccharomyces cerevisiae
% 209.97/210.15  |- skos__broader mesh__D020846smesh__D020764
% 209.97/210.15  |- skos__historyNote mesh__D020846 Cell Cycle Proteins %28%1996-1999%29%
% 209.97/210.15  |- skos__altLabel mesh__D006377 T-Lymphocytes, Helper
% 209.97/210.15  |- skos__hiddenLabel mesh__D006377 T-Lymphocyte, Helper-Inducer
% 209.97/210.15  |- skos__hiddenLabel mesh__D006377 Helper-Inducer T-Cell
% 209.97/210.15  |- skos__hiddenLabel mesh__D006377 T-Lymphocyte, Inducer
% 209.97/210.15  |- skos__hiddenLabel mesh__D006377 T-Cell, Helper
% 209.97/210.15  |- mesh__dateCreated mesh__D006377 1982-04-29
% 209.97/210.15  |- skos__related mesh__D006377smesh__D008211
% 209.97/210.15  |- skos__hiddenLabel mesh__D006377 Helper-Inducer T-Lymphocyte
% 209.97/210.15  |- skos__hiddenLabel mesh__D006377 Helper T Cells
% 209.97/210.15  |- skos__hiddenLabel mesh__D006377 Helper Cell
% 209.97/210.15  |- mesh__dateEstablished mesh__D006377 1983-01-01
% 209.97/210.15  |- skos__hiddenLabel mesh__D006377 T Lymphocytes, Inducer
% 209.97/210.15  |- mesh__historyNote mesh__D006377
% 209.97/210.15       93; was HELPER CELLS 1983-92; was see T-LYMPHOCYTES 1979-82; was see LYMPHOCYTE COOPERATION 1978%A%  
% 209.97/210.15  |- skos__altLabel mesh__D006377 T-Cells, Helper-Inducer
% 209.97/210.15  |- skos__related mesh__D006377smesh__D007376
% 209.97/210.15  |- skos__scopeNote mesh__D006377
% 209.97/210.15       Subpopulation of CD4+ lymphocytes that cooperate with other lymphocytes %28%either T or B%29% to initiate a variety of immune functions. For example, helper-inducer T-cells cooperate with B-cells to produce antibodies to thymus-dependent antigens and with other subpopulations of T-cells to initiate a variety of cell-mediated immune functions.%A%    
% 209.97/210.15  |- skos__altLabel mesh__D006377 Inducer Cells
% 209.97/210.15  |- skos__hiddenLabel mesh__D006377 T-Lymphocyte, Helper
% 209.97/210.15  |- skos__hiddenLabel mesh__D006377 Inducer T-Lymphocytes
% 209.97/210.15  |- skos__broader mesh__D006377smesh__D015496
% 209.97/210.15  |- mesh__activeMeSHYear mesh__D006377 2006
% 209.97/210.15  |- mesh__onlineNote mesh__D006377
% 209.97/210.15       use T-LYMPHOCYTES, HELPER-INDUCER to search HELPER CELLS 1983-92; use T-LYMPHOCYTES 1979-82 %26% LYMPHOCYTE COOPERATION 1978%A%  
% 209.97/210.15  |- skos__historyNote mesh__D006377 T-Lymphocytes %28%1973-1982%29%
% 209.97/210.15  |- skos__hiddenLabel mesh__D006377 Inducer Cell
% 209.97/210.15  |- mesh__recordOriginator mesh__D006377 SAG
% 209.97/210.15  |- skos__hiddenLabel mesh__D006377 T Cells, Helper Inducer
% 209.97/210.15  |- skos__hiddenLabel mesh__D006377 Helper-Inducer T-Cells
% 209.97/210.15  |- skos__historyNote mesh__D006377 Antibody Formation %28%1972-1973%29%
% 209.97/210.15  |- mesh__publicMeSHNote mesh__D006377
% 209.97/210.15       93; was HELPER CELLS 1983-92; was see T-LYMPHOCYTES 1979-82; was see LYMPHOCYTE COOPERATION 1978%A%  
% 209.97/210.15  |- skos__hiddenLabel mesh__D006377 Inducer T-Lymphocyte
% 209.97/210.15  |- mesh__recordMaintainer mesh__D006377 ags
% 209.97/210.15  |- skos__hiddenLabel mesh__D006377 Helper T-Lymphocyte
% 209.97/210.15  |- mesh__dateRevised mesh__D006377 2005-06-30
% 209.97/210.15  |- skos__hiddenLabel mesh__D006377 T-Cell, Helper-Inducer
% 209.97/210.15  |- mesh__recordAuthorizer mesh__D006377 sjn
% 209.97/210.16  |- skos__hiddenLabel mesh__D006377 Helper T-Cell
% 209.97/210.16  |- rdf__type mesh__D006377sskos__Concept
% 209.97/210.16  |- skos__altLabel mesh__D006377 Helper-Inducer T-Lymphocytes
% 209.97/210.16  |- skos__hiddenLabel mesh__D006377 Helper T-Lymphocytes
% 209.97/210.16  |- skos__annotation mesh__D006377
% 209.97/210.16       subpopulations: coordinate IM with T-LYMPHOCYTE SUBSETS %28%IM%29%%A%  
% 209.97/210.16  |- skos__hiddenLabel mesh__D006377 T-Cells, Helper
% 209.97/210.16  |- skos__hiddenLabel mesh__D006377 Helper Inducer T Lymphocytes
% 209.97/210.16  |- skos__hiddenLabel mesh__D006377 T Lymphocytes, Helper
% 209.97/210.16  |- skos__altLabel mesh__D006377 Helper T-Cells
% 209.97/210.16  |- skos__prefLabel mesh__D006377 T-Lymphocytes, Helper-Inducer
% 209.97/210.16  |- skos__altLabel mesh__D006377 T-Lymphocytes, Inducer
% 209.97/210.16  |- skos__hiddenLabel mesh__D006377 T Lymphocytes, Helper Inducer
% 209.97/210.16  |- skos__altLabel mesh__D006377 Helper Cells
% 209.97/210.16  |- skos__historyNote mesh__D020048 Cockroaches %28%1965-1998%29%
% 209.97/210.16  |- skos__scopeNote mesh__D020048
% 209.97/210.16       A family of insects, in the order Dictyoptera %28%COCKROACHES%29%, including genera Blattella, Parcoblatta, and Symploce.%A%    
% 209.97/210.16  |- rdf__type mesh__D020048sskos__Concept
% 209.97/210.16  |- skos__prefLabel mesh__D020048 Blattellidae
% 209.97/210.16  |- mesh__publicMeSHNote mesh__D020048 99   
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D020048 2006
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D020048 2005
% 209.97/210.16  |- skos__broader mesh__D020048smesh__D003058
% 209.97/210.16  |- mesh__dateCreated mesh__D020048 1998-06-10
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D020048 2004
% 209.97/210.16  |- mesh__dateRevised mesh__D020048 2003-07-09
% 209.97/210.16  |- mesh__historyNote mesh__D020048 99   
% 209.97/210.16  |- mesh__dateEstablished mesh__D020048 1999-01-01
% 209.97/210.16  |- skos__hiddenLabel mesh__D014809 25 HCC Binding Protein
% 209.97/210.16  |- mesh__recordOriginator mesh__D014809 RLS
% 209.97/210.16  |- skos__scopeNote mesh__D014809
% 209.97/210.16       An alpha-globulin found in the plasma of man and other vertebrates. It is apparently synthesized in the liver and carries vitamin D and its metabolites through the circulation and mediates the response of tissue. It is also known as group-specific component %28%Gc%29%. Gc subtypes are used to determine specific phenotypes and gene frequencies. These data are employed in the classification of population groups, paternity investigations, and in forensic medicine.%A%    
% 209.97/210.16  |- skos__altLabel mesh__D014809 Group-Specific Component Globulin
% 209.97/210.16  |- mesh__dateRevised mesh__D014809 2004-07-07
% 209.97/210.16  |- skos__hiddenLabel mesh__D014809 Globulin, Vitamin D-Binding
% 209.97/210.16  |- skos__hiddenLabel mesh__D014809 Component Globulin, Group-Specific
% 209.97/210.16  |- skos__hiddenLabel mesh__D014809
% 209.97/210.16       25 Hydroxycholecalciferol Binding Protein
% 209.97/210.16  |- skos__hiddenLabel mesh__D014809 Globulin, Gc
% 209.97/210.16  |- mesh__recordMaintainer mesh__D014809 jmp
% 209.97/210.16  |- mesh__historyNote mesh__D014809 85   
% 209.97/210.16  |- skos__hiddenLabel mesh__D014809 Group Specific Component Globulin
% 209.97/210.16  |- rdf__type mesh__D014809sskos__Concept
% 209.97/210.16  |- skos__historyNote mesh__D014809 Proteins %28%1966-1971%29%
% 209.97/210.16  |- skos__hiddenLabel mesh__D014809 Globulin, Group-Specific Component
% 209.97/210.16  |- skos__historyNote mesh__D014809 Vitamin D %28%1966-1984%29%
% 209.97/210.16  |- skos__altLabel mesh__D014809 Gc Globulin
% 209.97/210.16  |- skos__historyNote mesh__D014809 Carrier Proteins %28%1971-1984%29%
% 209.97/210.16  |- skos__altLabel mesh__D014809 25-Hydroxyvitamin D-Binding Protein
% 209.97/210.16  |- skos__prefLabel mesh__D014809 Vitamin D-Binding Protein
% 209.97/210.16  |- mesh__dateEstablished mesh__D014809 1985-01-01
% 209.97/210.16  |- skos__hiddenLabel mesh__D014809 Vitamin D Binding Globulin
% 209.97/210.16  |- skos__hiddenLabel mesh__D014809 25 Hydroxyvitamin D Binding Protein
% 209.97/210.16  |- skos__hiddenLabel mesh__D014809 Vitamin D Binding Protein
% 209.97/210.16  |- mesh__dateCreated mesh__D014809 1984-05-30
% 209.97/210.16  |- skos__hiddenLabel mesh__D014809 Calciferol Binding Protein
% 209.97/210.16  |- skos__historyNote mesh__D014809 Alpha Globulins %28%1966-1984%29%
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D014809 2005
% 209.97/210.16  |- mesh__recordAuthorizer mesh__D014809 sjn
% 209.97/210.16  |- skos__altLabel mesh__D014809 Transcalciferin
% 209.97/210.16  |- skos__altLabel mesh__D014809 Vitamin D-Binding Globulin
% 209.97/210.16  |- skos__altLabel mesh__D014809 Calciferol-Binding Protein
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D014809 2006
% 209.97/210.16  |- skos__altLabel mesh__D014809 25-Hydroxycholecalciferol-Binding Protein
% 209.97/210.16  |- mesh__publicMeSHNote mesh__D014809 85   
% 209.97/210.16  |- skos__broader mesh__D014809smesh__D002352
% 209.97/210.16  |- skos__altLabel mesh__D014809 25-HCC-Binding Protein
% 209.97/210.16  |- rdf__type mesh__D011511sskos__Concept
% 209.97/210.16  |- skos__scopeNote mesh__D011511
% 209.97/210.16       A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the intestines of humans and a wide variety of animals, as well as in manure, soil, and polluted waters. Its species are pathogenic, causing urinary tract infections and are also considered secondary invaders, causing septic lesions at other sites of the body.%A%    
% 209.97/210.16  |- skos__broader mesh__D011511smesh__D004755
% 209.97/210.16  |- mesh__recordAuthorizer mesh__D011511 sjn
% 209.97/210.16  |- mesh__dateCreated mesh__D011511 1999-01-01
% 209.97/210.16  |- mesh__dateRevised mesh__D011511 2005-06-30
% 209.97/210.16  |- skos__annotation mesh__D011511 GEN; infection = PROTEUS INFECTIONS   
% 209.97/210.16  |- mesh__recordOriginator mesh__D011511 NLM
% 209.97/210.16  |- skos__prefLabel mesh__D011511 Proteus
% 209.97/210.16  |- mesh__recordMaintainer mesh__D011511 SYSTEM
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D011511 2006
% 209.97/210.16  |- skos__prefLabel mesh__D002785 Sterol O-Acyltransferase
% 209.97/210.16  |- mesh__recordAuthorizer mesh__D002785 sjn
% 209.97/210.16  |- skos__hiddenLabel mesh__D002785 Sterol O Acyltransferase
% 209.97/210.16  |- skos__hiddenLabel mesh__D002785 Esterifying Enzyme, Cholesterol
% 209.97/210.16  |- skos__scopeNote mesh__D002785
% 209.97/210.16       An enzyme that catalyzes the formation of cholesterol esters by the direct transfer of the fatty acid group from a fatty acyl CoA derivative. This enzyme has been found in the adrenal gland, gonads, liver, intestinal mucosa, and aorta of many mammalian species. EC 2.3.1.26.%A%    
% 209.97/210.16  |- rdf__type mesh__D002785sskos__Concept
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D002785 2004
% 209.97/210.16  |- skos__hiddenLabel mesh__D002785 Enzyme, Cholesterol Esterifying
% 209.97/210.16  |- skos__altLabel mesh__D002785 Acyl-CoA-Cholesterol Acyltransferase
% 209.97/210.16  |- skos__hiddenLabel mesh__D002785 Acyl CoA Cholesterol Acyltransferase
% 209.97/210.16  |- skos__hiddenLabel mesh__D002785 Acyltransferase, Cholesterol
% 209.97/210.16  |- mesh__publicMeSHNote mesh__D002785
% 209.97/210.16       98; see CHOLESTEROL ACYLTRANSFERASE 1985-97; see ACYLTRANSFERASES 1976-84%A%  
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D002785 2005
% 209.97/210.16  |- mesh__historyNote mesh__D002785 98%28%76%29%   
% 209.97/210.16  |- skos__altLabel mesh__D002785 Cholesterol Esterifying Enzyme
% 209.97/210.16  |- mesh__recordOriginator mesh__D002785 RLS
% 209.97/210.16  |- skos__historyNote mesh__D002785 Cholesterol %28%1973-1975%29%
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D002785 2006
% 209.97/210.16  |- mesh__recordMaintainer mesh__D002785 ssb
% 209.97/210.16  |- skos__broader mesh__D002785smesh__D000217
% 209.97/210.16  |- skos__historyNote mesh__D002785 Coenzyme A %28%1973-1975%29%
% 209.97/210.16  |- skos__hiddenLabel mesh__D002785 O-Acyltransferase, Sterol
% 209.97/210.16  |- mesh__dateEstablished mesh__D002785 1985-01-01
% 209.97/210.16  |- skos__historyNote mesh__D002785 Acyltransferases %28%1973-1975%29%
% 209.97/210.16  |- skos__altLabel mesh__D002785 Cholesterol Acyltransferase
% 209.97/210.16  |- mesh__dateCreated mesh__D002785 1975-07-25
% 209.97/210.16  |- mesh__dateRevised mesh__D002785 2003-07-09
% 209.97/210.16  |- skos__hiddenLabel mesh__D002785 Acyltransferase, Acyl-CoA-Cholesterol
% 209.97/210.16  |- mesh__dateEstablished mesh__D035161 2003-01-01
% 209.97/210.16  |- rdf__type mesh__D035161sskos__Concept
% 209.97/210.16  |- skos__broader mesh__D035161smesh__D019684
% 209.97/210.16  |- skos__scopeNote mesh__D035161
% 209.97/210.16       A plant family of the order Malvales, subclass Dilleniidae, class Magnoliopsida of tropical trees.%A%    
% 209.97/210.16  |- skos__prefLabel mesh__D035161 Bombacaceae
% 209.97/210.16  |- mesh__publicMeSHNote mesh__D035161 2003   
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D035161 2005
% 209.97/210.16  |- mesh__historyNote mesh__D035161 2003   
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D035161 2003
% 209.97/210.16  |- skos__altLabel mesh__D035161 Balsa
% 209.97/210.16  |- skos__annotation mesh__D035161
% 209.97/210.16       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.97/210.16  |- skos__altLabel mesh__D035161 Durian
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D035161 2006
% 209.97/210.16  |- mesh__dateCreated mesh__D035161 2002-07-02
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D035161 2004
% 209.97/210.16  |- skos__prefLabel mesh__D010419 Pentamidine
% 209.97/210.16  |- mesh__dateEstablished mesh__D010419 1990-01-01
% 209.97/210.16  |- mesh__recordMaintainer mesh__D010419 lkw
% 209.97/210.16  |- mesh__historyNote mesh__D010419
% 209.97/210.16       90%28%75%29%; was see under AMIDINES 1975-89   
% 209.97/210.16  |- skos__altLabel mesh__D010419 Sicor Brand of Pentamidine Isethionate
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D010419 2006
% 209.97/210.16  |- skos__altLabel mesh__D010419 Pentamidin
% 209.97/210.16  |- skos__historyNote mesh__D010419 Amidines %28%1972-1974%29%
% 209.97/210.16  |- mesh__publicMeSHNote mesh__D010419 90; was see under AMIDINES 1975-89   
% 209.97/210.16  |- mesh__dateRevised mesh__D010419 2005-06-30
% 209.97/210.16  |- mesh__dateCreated mesh__D010419 1974-11-19
% 209.97/210.16  |- skos__altLabel mesh__D010419
% 209.97/210.16       American Pharmaceutical Partners Brand 2 of Pentamidine Isethionate
% 209.97/210.16  |- mesh__recordAuthorizer mesh__D010419 sjn
% 209.97/210.16  |- mesh__recordOriginator mesh__D010419 NLM
% 209.97/210.16  |- skos__historyNote mesh__D010419 Phenyl Ethers %28%1974%29%
% 209.97/210.16  |- skos__altLabel mesh__D010419
% 209.97/210.16       Rh%C3%%B4%ne-Poulenc Rorer Brand of Pentamidine Isethionate
% 209.97/210.16  |- skos__altLabel mesh__D010419
% 209.97/210.16       American Pharmaceutical Partners Brand 1 of Pentamidine Isethionate
% 209.97/210.16  |- rdf__type mesh__D010419sskos__Concept
% 209.97/210.16  |- skos__scopeNote mesh__D010419
% 209.97/210.16       Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.%A%    
% 209.97/210.16  |- skos__altLabel mesh__D010419
% 209.97/210.16       GlaxoSmithKline Brand of Pentamidine Isethionate
% 209.97/210.16  |- skos__broader mesh__D010419smesh__D001550
% 209.97/210.16  |- skos__altLabel mesh__D010419 JHC Brand of Pentamidine Isethionate
% 209.97/210.16  |- skos__altLabel mesh__D010419 Aventis Brand of Pentamidine Isethionate
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D007470 2005
% 209.97/210.16  |- skos__broader mesh__D007470smesh__D014443
% 209.97/210.16  |- skos__historyNote mesh__D007470 Tyrosine %28%1966-1967%29%
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D007470 2006
% 209.97/210.16  |- mesh__historyNote mesh__D007470 72%28%68%29%   
% 209.97/210.16  |- skos__prefLabel mesh__D007470 Monoiodotyrosine
% 209.97/210.16  |- mesh__dateEstablished mesh__D007470 1972-01-01
% 209.97/210.16  |- mesh__dateCreated mesh__D007470 1999-01-01
% 209.97/210.16  |- mesh__recordOriginator mesh__D007470 NLM
% 209.97/210.16  |- mesh__recordMaintainer mesh__D007470 nns
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D007470 2003
% 209.97/210.16  |- mesh__recordAuthorizer mesh__D007470 sjn
% 209.97/210.16  |- skos__altLabel mesh__D007470 Iodotyrosine
% 209.97/210.16  |- rdf__type mesh__D007470sskos__Concept
% 209.97/210.16  |- skos__broader mesh__D007470smesh__D013963
% 209.97/210.16  |- skos__historyNote mesh__D007470 Thyroid Hormones %28%1966-1967%29%
% 209.97/210.16  |- mesh__publicMeSHNote mesh__D007470 72   
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D007470 2004
% 209.97/210.16  |- mesh__dateRevised mesh__D007470 2001-07-25
% 209.97/210.16  |- skos__scopeNote mesh__D007470
% 209.97/210.16       A product from the iodination of tyrosine. In the biosynthesis of thyroid hormones %28%THYROXINE and TRIIODOTHYRONINE%29%, tyrosine is first iodized to monoiodotyrosine.%A%    
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D007470 2002
% 209.97/210.16  |- skos__altLabel mesh__D021141 Technics, Nucleic Acid Amplification
% 209.97/210.16  |- skos__hiddenLabel mesh__D021141 Techniques, DNA Amplification
% 209.97/210.16  |- rdf__type mesh__D021141sskos__Concept
% 209.97/210.16  |- skos__altLabel mesh__D021141 RNA Amplification Technics
% 209.97/210.16  |- skos__hiddenLabel mesh__D021141 Technics, RNA Amplification
% 209.97/210.16  |- mesh__recordOriginator mesh__D021141 jmp
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D021141 2005A
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D021141 2004
% 209.97/210.16  |- skos__hiddenLabel mesh__D021141 DNA Amplification Technic
% 209.97/210.16  |- skos__hiddenLabel mesh__D021141 Techniques, RNA Amplification
% 209.97/210.16  |- mesh__dateRevised mesh__D021141 2004-07-29
% 209.97/210.16  |- skos__altLabel mesh__D021141 Amplification Technics, Nucleic Acid
% 209.97/210.16  |- skos__historyNote mesh__D021141 Gene Amplification %28%1980-2000%29%
% 209.97/210.16  |- skos__broader mesh__D021141smesh__D005821
% 209.97/210.16  |- skos__altLabel mesh__D021141 Techniques, Nucleic Acid Amplification
% 209.97/210.16  |- skos__hiddenLabel mesh__D021141 Amplification Technique, RNA
% 209.97/210.16  |- skos__hiddenLabel mesh__D021141 Amplification Technics, DNA
% 209.97/210.16  |- skos__prefLabel mesh__D021141 Nucleic Acid Amplification Techniques
% 209.97/210.16  |- skos__hiddenLabel mesh__D021141 Amplification Techniques, DNA
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D021141 2003
% 209.97/210.16  |- mesh__recordMaintainer mesh__D021141 jls
% 209.97/210.16  |- skos__hiddenLabel mesh__D021141 Technic, DNA Amplification
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D021141 2002
% 209.97/210.16  |- skos__altLabel mesh__D021141 DNA Amplification Technics
% 209.97/210.16  |- skos__hiddenLabel mesh__D021141 Technique, RNA Amplification
% 209.97/210.16  |- skos__hiddenLabel mesh__D021141 Technique, DNA Amplification
% 209.97/210.16  |- skos__altLabel mesh__D021141 Amplification Techniques, Nucleic Acid
% 209.97/210.16  |- skos__hiddenLabel mesh__D021141 RNA Amplification Technic
% 209.97/210.16  |- skos__hiddenLabel mesh__D021141 DNA Amplification Technique
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D021141 2001
% 209.97/210.16  |- skos__hiddenLabel mesh__D021141 Amplification Technic, DNA
% 209.97/210.16  |- mesh__dateCreated mesh__D021141 2000-06-21
% 209.97/210.16  |- skos__hiddenLabel mesh__D021141 Technic, RNA Amplification
% 209.97/210.16  |- mesh__historyNote mesh__D021141 2001   
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D021141 2006
% 209.97/210.16  |- mesh__publicMeSHNote mesh__D021141 2001   
% 209.97/210.16  |- skos__hiddenLabel mesh__D021141 Amplification Techniques, RNA
% 209.97/210.16  |- skos__hiddenLabel mesh__D021141 Amplification Technic, RNA
% 209.97/210.16  |- skos__altLabel mesh__D021141 Nucleic Acid Amplification Technics
% 209.97/210.16  |- skos__scopeNote mesh__D021141
% 209.97/210.16       Laboratory techniques that involve the in-vitro synthesis of many copies of DNA or RNA from one original template.%A%    
% 209.97/210.16  |- skos__hiddenLabel mesh__D021141 Amplification Technique, DNA
% 209.97/210.16  |- skos__hiddenLabel mesh__D021141 RNA Amplification Technique
% 209.97/210.16  |- skos__hiddenLabel mesh__D021141 Amplification Technics, RNA
% 209.97/210.16  |- mesh__dateEstablished mesh__D021141 2001-01-01
% 209.97/210.16  |- skos__hiddenLabel mesh__D021141 Technics, DNA Amplification
% 209.97/210.16  |- mesh__recordAuthorizer mesh__D021141 jls
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D021141 2005
% 209.97/210.16  |- skos__historyNote mesh__D015902
% 209.97/210.16       Radionuclide Imaging/instrumentation %28%1966-1989%29%
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D015902 2005
% 209.97/210.16  |- skos__historyNote mesh__D015902 Radiometry %28%1966-1972%29%
% 209.97/210.16  |- skos__hiddenLabel mesh__D015902 Cameras, Nuclear
% 209.97/210.16  |- skos__altLabel mesh__D015902 Scintillation Cameras
% 209.97/210.16  |- mesh__publicMeSHNote mesh__D015902 90   
% 209.97/210.16  |- skos__historyNote mesh__D015902 Scintillation Counting %28%1979-1989%29%
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D015902 2002
% 209.97/210.16  |- skos__hiddenLabel mesh__D015902 Nuclear Camera
% 209.97/210.16  |- mesh__recordOriginator mesh__D015902 PLS
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D015902 2006
% 209.97/210.16  |- skos__prefLabel mesh__D015902 Gamma Cameras
% 209.97/210.16  |- skos__broader mesh__D015902smesh__D004864
% 209.97/210.16  |- skos__scopeNote mesh__D015902
% 209.97/210.16       Electronic instruments that produce photographs or cathode-ray tube images of the gamma-ray emissions from organs containing radionuclide tracers.%A%    
% 209.97/210.16  |- skos__hiddenLabel mesh__D015902 Cameras, Scintillation
% 209.97/210.16  |- skos__hiddenLabel mesh__D015902 Cameras, Gamma
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D015902 2003
% 209.97/210.16  |- skos__hiddenLabel mesh__D015902 Scinti-Camera
% 209.97/210.16  |- skos__hiddenLabel mesh__D015902 Camera, Gamma
% 209.97/210.16  |- skos__annotation mesh__D015902
% 209.97/210.16       do not use /util except by MeSH definition   
% 209.97/210.16  |- rdf__type mesh__D015902sskos__Concept
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D015902 2000
% 209.97/210.16  |- mesh__recordMaintainer mesh__D015902 PXP
% 209.97/210.16  |- skos__hiddenLabel mesh__D015902 Scinti Cameras
% 209.97/210.16  |- skos__hiddenLabel mesh__D015902 Camera, Scintillation
% 209.97/210.16  |- skos__altLabel mesh__D015902 Scinti-Cameras
% 209.97/210.16  |- skos__hiddenLabel mesh__D015902 Gamma Camera
% 209.97/210.16  |- mesh__recordAuthorizer mesh__D015902 SJN
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D015902 2004
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D015902 1998
% 209.97/210.16  |- mesh__historyNote mesh__D015902 90   
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D015902 2001
% 209.97/210.16  |- mesh__dateRevised mesh__D015902 1997-06-20
% 209.97/210.16  |- mesh__dateEstablished mesh__D015902 1990-01-01
% 209.97/210.16  |- mesh__dateCreated mesh__D015902 1989-05-15
% 209.97/210.16  |- skos__hiddenLabel mesh__D015902 Camera, Nuclear
% 209.97/210.16  |- skos__hiddenLabel mesh__D015902 Scintillation Camera
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D015902 1999
% 209.97/210.16  |- skos__altLabel mesh__D015902 Nuclear Cameras
% 209.97/210.16  |- skos__broader mesh__D048089smesh__D018410
% 209.97/210.16  |- mesh__publicMeSHNote mesh__D048089 2005   
% 209.97/210.16  |- mesh__recordAuthorizer mesh__D048089 sjn
% 209.97/210.16  |- skos__broader mesh__D048089smesh__D048090
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D048089 2005
% 209.97/210.16  |- skos__altLabel mesh__D048089 Enzootic Calf Pneumonia
% 209.97/210.16  |- skos__prefLabel mesh__D048089 Pneumonia of Calves, Enzootic
% 209.97/210.16  |- skos__hiddenLabel mesh__D048089 Pneumonia, Enzootic Calf
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D048089 2006
% 209.97/210.16  |- skos__scopeNote mesh__D048089
% 209.97/210.16       Chronic endemic respiratory disease of dairy calves and an important component of bovine respiratory disease complex. It primarily affects calves up to six months of age and the etiology is multifactorial. Stress plus a primary viral infection is followed by a secondary bacterial infection. The latter is most commonly associated with PASTEURELLA MULTOCIDA producing a purulent BRONCHOPNEUMONIA. Sometimes present are MANNHEIMIA HAEMOLYTICA; HAEMOPHILUS SOMNUS and mycoplasma species.%A%    
% 209.97/210.16  |- skos__hiddenLabel mesh__D048089 Enzootic Calf Pneumonias
% 209.97/210.16  |- skos__hiddenLabel mesh__D048089 Pneumonias, Enzootic Calf
% 209.97/210.16  |- skos__altLabel mesh__D048089 Enzootic Pneumonia of Calves
% 209.97/210.16  |- mesh__historyNote mesh__D048089 2005   
% 209.97/210.16  |- skos__annotation mesh__D048089
% 209.97/210.16       infection: coordinate IM with PASTEURELLA MULTOCIDA %28%IM%29%, MANNHEIMIA HAEMOLYTICA %28%IM%29% or HAEMOPHILUS SOMNUS %28%IM%29% only if particularly discussed; check the tag CATTLE%A%  
% 209.97/210.16  |- skos__hiddenLabel mesh__D048089 Calf Pneumonia, Enzootic
% 209.97/210.16  |- mesh__recordOriginator mesh__D048089 ags
% 209.97/210.16  |- rdf__type mesh__D048089sskos__Concept
% 209.97/210.16  |- mesh__recordMaintainer mesh__D048089 ags
% 209.97/210.16  |- mesh__dateCreated mesh__D048089 2004-07-07
% 209.97/210.16  |- mesh__dateEstablished mesh__D048089 2005-01-01
% 209.97/210.16  |- mesh__publicMeSHNote mesh__D015104
% 209.97/210.16       91; was see under AMPHETAMINES 1977-90   
% 209.97/210.16  |- skos__historyNote mesh__D015104 Amphetamine %28%1973-1976%29%
% 209.97/210.16  |- mesh__dateRevised mesh__D015104 2000-06-22
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D015104 2001
% 209.97/210.16  |- mesh__dateCreated mesh__D015104 1976-04-13
% 209.97/210.16  |- skos__scopeNote mesh__D015104
% 209.97/210.16       An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.%A%    
% 209.97/210.16  |- skos__hiddenLabel mesh__D015104 3,4 Methylenedioxyamphetamine
% 209.97/210.16  |- skos__historyNote mesh__D015104 Methyl Ethers %28%1973%29%
% 209.97/210.16  |- skos__historyNote mesh__D015104 Dioxoles %28%1974-1975%29%
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D015104 2004
% 209.97/210.16  |- mesh__historyNote mesh__D015104
% 209.97/210.16       91%28%77%29%; was see under AMPHETAMINES 1977-90   
% 209.97/210.16  |- mesh__recordMaintainer mesh__D015104 CCR
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D015104 2006
% 209.97/210.16  |- mesh__dateEstablished mesh__D015104 1991-01-01
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D015104 2003
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D015104 2005
% 209.97/210.16  |- mesh__recordOriginator mesh__D015104 SH
% 209.97/210.16  |- skos__prefLabel mesh__D015104 3,4-Methylenedioxyamphetamine
% 209.97/210.16  |- mesh__recordAuthorizer mesh__D015104 sjn
% 209.97/210.16  |- rdf__type mesh__D015104sskos__Concept
% 209.97/210.16  |- skos__broader mesh__D015104smesh__D000662
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D015104 2002
% 209.97/210.16  |- rdf__type mesh__D020847sskos__Concept
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D020847 2006
% 209.97/210.16  |- skos__related mesh__D020847smesh__D004965
% 209.97/210.16  |- mesh__publicMeSHNote mesh__D020847
% 209.97/210.16       2000; see ESTROGEN ANTAGONISTS 1978-1999   
% 209.97/210.16  |- skos__hiddenLabel mesh__D020847 Receptor Modulator, Estrogen
% 209.97/210.16  |- skos__hiddenLabel mesh__D020847 Modulator, Estrogen Receptor
% 209.97/210.16  |- skos__hiddenLabel mesh__D020847 Modulators, Estrogen Receptor
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D020847 2005
% 209.97/210.16  |- mesh__recordMaintainer mesh__D020847 lkt
% 209.97/210.16  |- mesh__dateCreated mesh__D020847 1999-11-03
% 209.97/210.16  |- skos__altLabel mesh__D020847 Antiestrogen
% 209.97/210.16  |- skos__annotation mesh__D020847
% 209.97/210.16       do not confuse with SELECTIVE ESTROGEN RECEPTOR MODULATORS%A%  
% 209.97/210.16  |- skos__prefLabel mesh__D020847 Estrogen Receptor Modulators
% 209.97/210.16  |- mesh__recordAuthorizer mesh__D020847 sjn
% 209.97/210.16  |- skos__broader mesh__D020847smesh__D006727
% 209.97/210.16  |- mesh__recordOriginator mesh__D020847 adp
% 209.97/210.16  |- skos__related mesh__D020847smesh__D004967
% 209.97/210.16  |- skos__hiddenLabel mesh__D020847 Receptor Modulators, Estrogen
% 209.97/210.16  |- skos__altLabel mesh__D020847 Estrogen Receptor Modulator
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D020847 2004
% 209.97/210.16  |- skos__altLabel mesh__D020847 Antiestrogens
% 209.97/210.16  |- mesh__dateEstablished mesh__D020847 2000-01-01
% 209.97/210.16  |- mesh__dateRevised mesh__D020847 2003-07-09
% 209.97/210.16  |- mesh__historyNote mesh__D020847
% 209.97/210.16       2000; use ESTROGEN ANTAGONISTS 1978-1999   
% 209.97/210.16  |- skos__scopeNote mesh__D020847
% 209.97/210.16       Substances that possess antiestrogenic actions but can also produce estrogenic effects as well. They act as complete or partial agonist or as antagonist. They can be either steroidal or nonsteroidal in structure.%A%    
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D006378 1998
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D006378 2000
% 209.97/210.16  |- skos__hiddenLabel mesh__D006378 Virus, Helper
% 209.97/210.16  |- skos__scopeNote mesh__D006378
% 209.97/210.16       Viruses which enable defective viruses to replicate or to form a protein coat by complementing the missing gene function of the defective %28%satellite%29% virus. Helper and satellite may be of the same or different genus.%A%    
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D006378 2004
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D006378 2001
% 209.97/210.16  |- skos__annotation mesh__D006378
% 209.97/210.16       enable defective viruses to replicate or to form a protein coat; coord IM with specific virus %28%IM%29%%A%  
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D006378 1999
% 209.97/210.16  |- mesh__recordAuthorizer mesh__D006378 PLS
% 209.97/210.16  |- rdf__type mesh__D006378sskos__Concept
% 209.97/210.16  |- mesh__dateEstablished mesh__D006378 1973-01-01
% 209.97/210.16  |- skos__hiddenLabel mesh__D006378 Viruses, Helper
% 209.97/210.16  |- mesh__historyNote mesh__D006378
% 209.97/210.16       75; was HELPER VIRUS 1967-74 %28%Prov 1967-72%29%   
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D006378 1996
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D006378 2005
% 209.97/210.16  |- skos__hiddenLabel mesh__D006378 Helper Virus
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D006378 2002
% 209.97/210.16  |- mesh__dateCreated mesh__D006378 1999-01-01
% 209.97/210.16  |- mesh__publicMeSHNote mesh__D006378 75; was HELPER VIRUS 1973-74   
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D006378 1997
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D006378 1994
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D006378 2006
% 209.97/210.16  |- mesh__dateRevised mesh__D006378 1993-06-04
% 209.97/210.16  |- mesh__recordOriginator mesh__D006378 NLM
% 209.97/210.16  |- skos__related mesh__D006378smesh__D012526
% 209.97/210.16  |- skos__broader mesh__D006378smesh__D014780
% 209.97/210.16  |- skos__historyNote mesh__D006378 specific virus %28%1966%29%
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D006378 1995
% 209.97/210.16  |- mesh__onlineNote mesh__D006378
% 209.97/210.16       use HELPER VIRUSES to search HELPER VIRUS 1967-74 %28%as Prov 1967-72%29%%A%  
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D006378 2003
% 209.97/210.16  |- skos__prefLabel mesh__D006378 Helper Viruses
% 209.97/210.16  |- mesh__recordMaintainer mesh__D006378 AGS
% 209.97/210.16  |- mesh__dateCreated mesh__D020049 1998-06-10
% 209.97/210.16  |- rdf__type mesh__D020049sskos__Concept
% 209.97/210.16  |- skos__historyNote mesh__D020049 Insects %28%1966-1998%29%
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D020049 2005
% 209.97/210.16  |- skos__broader mesh__D020049smesh__D007313
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D020049 2006
% 209.97/210.16  |- skos__altLabel mesh__D020049 Termites
% 209.97/210.16  |- mesh__dateEstablished mesh__D020049 1999-01-01
% 209.97/210.16  |- skos__scopeNote mesh__D020049
% 209.97/210.16       An order of insects, restricted mostly to the tropics, containing at least eight families. A few species occur in temperate regions of North America.%A%    
% 209.97/210.16  |- skos__prefLabel mesh__D020049 Isoptera
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D020049 2004
% 209.97/210.16  |- mesh__dateRevised mesh__D020049 2003-07-09
% 209.97/210.16  |- mesh__historyNote mesh__D020049 99   
% 209.97/210.16  |- skos__annotation mesh__D020049
% 209.97/210.16       do not use /drug eff for insecticides: TN 111   
% 209.97/210.16  |- mesh__publicMeSHNote mesh__D020049 99   
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D003080 2001
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D003080 1998
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D003080 2005
% 209.97/210.16  |- skos__related mesh__D003080smesh__D005627
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D003080 2002
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D003080 1999
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D003080 2006
% 209.97/210.16  |- skos__broader mesh__D003080smesh__D013696
% 209.97/210.16  |- skos__related mesh__D003080smesh__D007102
% 209.97/210.16  |- skos__prefLabel mesh__D003080 Cold
% 209.97/210.16  |- mesh__recordOriginator mesh__D003080 NLM
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D003080 1995
% 209.97/210.16  |- mesh__considerAlso mesh__D003080 consider also terms at CRYO-   
% 209.97/210.16  |- skos__related mesh__D003080smesh__D015925
% 209.97/210.16  |- rdf__type mesh__D003080sskos__Concept
% 209.97/210.16  |- mesh__recordAuthorizer mesh__D003080 PLS
% 209.97/210.16  |- skos__annotation mesh__D003080
% 209.97/210.16       cooling of organs during surg goes under HYPOTHERMIA, INDUCED%A%  
% 209.97/210.16  |- skos__related mesh__D003080smesh__D017679
% 209.97/210.16  |- mesh__dateRevised mesh__D003080 1994-05-24
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D003080 1996
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D003080 2003
% 209.97/210.16  |- skos__related mesh__D003080smesh__D007036
% 209.97/210.16  |- mesh__recordMaintainer mesh__D003080 TGC
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D003080 2000
% 209.97/210.16  |- skos__related mesh__D003080smesh__D007035
% 209.97/210.16  |- skos__related mesh__D003080smesh__D003452
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D003080 1997
% 209.97/210.16  |- mesh__dateCreated mesh__D003080 1999-01-01
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D003080 2004
% 209.97/210.16  |- skos__related mesh__D003080smesh__D012768
% 209.97/210.16  |- skos__scopeNote mesh__D003080
% 209.97/210.16       An absence of warmth or heat or a temperature notably below an accustomed norm.%A%    
% 209.97/210.16  |- skos__related mesh__D003080smesh__D012034
% 209.97/210.16  |- mesh__dateRevised mesh__D011512 1996-06-10
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D011512 1998
% 209.97/210.16  |- mesh__activeMeSHYear mesh__D011512 2000
% 209.97/210.16  |- mesh__dateCreated mesh__D011512 1999-01-01
% 209.97/210.16  |- skos__hiddenLabel mesh__D011512 Infection, Proteus
% 209.97/210.16  |- skos__altLabel mesh__D011512 Infections, Proteus
% 209.97/210.16  |- skos__hiddenLabel mesh__D011512 Proteus Infection
% 209.97/210.16  |- mesh__recordMaintainer mesh__D011512 TGC
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D011512 2002
% 209.97/210.17  |- skos__broader mesh__D011512smesh__D004756
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D011512 2006
% 209.97/210.17  |- mesh__recordOriginator mesh__D011512 NLM
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D011512 2004
% 209.97/210.17  |- skos__scopeNote mesh__D011512
% 209.97/210.17       Infections with bacteria of the genus PROTEUS.     
% 209.97/210.17  |- rdf__type mesh__D011512sskos__Concept
% 209.97/210.17  |- skos__prefLabel mesh__D011512 Proteus Infections
% 209.97/210.17  |- skos__annotation mesh__D011512
% 209.97/210.17       gram-neg bact infect; GEN; coord IM with various species %28%IM%29%%A%  
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D011512 2005
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D011512 1999
% 209.97/210.17  |- mesh__recordAuthorizer mesh__D011512 PLS
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D011512 2001
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D011512 2003
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D011512 1997
% 209.97/210.17  |- rdf__type mesh__D002786sskos__Concept
% 209.97/210.17  |- mesh__publicMeSHNote mesh__D002786
% 209.97/210.17       2003; see CHOLESTEROL MONOOXYGENASE 1997-2002, see CHOLESTEROL DESMOLASE 1988-1996, see OXIDOREDUCTASES 1975-1987%A%  
% 209.97/210.17  |- mesh__dateCreated mesh__D002786 1974-11-19
% 209.97/210.17  |- mesh__historyNote mesh__D002786 2003 %28%1975%29%   
% 209.97/210.17  |- skos__altLabel mesh__D002786 Cytochrome P450scc
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D002786 2005
% 209.97/210.17  |- skos__altLabel mesh__D002786 Cytochrome P-450 CYP11A1
% 209.97/210.17  |- mesh__dateRevised mesh__D002786 2005-07-11
% 209.97/210.17  |- skos__broader mesh__D002786smesh__D013250
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D002786 2006
% 209.97/210.17  |- mesh__recordOriginator mesh__D002786 NLM
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D002786 2006A
% 209.97/210.17  |- skos__prefLabel mesh__D002786 Cholesterol Side-Chain Cleavage Enzyme
% 209.97/210.17  |- skos__hiddenLabel mesh__D002786 Cholesterol Side Chain Cleavage Enzyme
% 209.97/210.17  |- skos__altLabel mesh__D002786 CYP11A1
% 209.97/210.17  |- skos__hiddenLabel mesh__D002786 Cytochrome P 450 CYP11A1
% 209.97/210.17  |- skos__scopeNote mesh__D002786
% 209.97/210.17       A mitochondrial cytochrome P450 enzyme that catalyzes the side-chain cleavage of C27 cholesterol to C21 pregnenolone in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP11A1 gene, catalyzes the breakage between C20 and C22 which is the initial and rate-limiting step in the biosynthesis of various gonadal and adrenal steroid hormones.%A%    
% 209.97/210.17  |- skos__altLabel mesh__D002786 Cytochrome P450 11A1
% 209.97/210.17  |- skos__historyNote mesh__D002786 Oxidoreductases %28%1971-1974%29%
% 209.97/210.17  |- skos__altLabel mesh__D002786 Cholesterol Desmolase
% 209.97/210.17  |- skos__historyNote mesh__D002786 Multienzyme Complexes %28%1973-1974%29%
% 209.97/210.17  |- mesh__recordAuthorizer mesh__D002786 ags
% 209.97/210.17  |- skos__historyNote mesh__D002786 Cholesterol %28%1971-1974%29%
% 209.97/210.17  |- skos__altLabel mesh__D002786 Cytochrome P-450%28%scc%29%
% 209.97/210.17  |- mesh__dateEstablished mesh__D002786 1988-01-01
% 209.97/210.17  |- mesh__recordMaintainer mesh__D002786 ags
% 209.97/210.17  |- skos__altLabel mesh__D002786 CYP 11A1
% 209.97/210.17  |- skos__broader mesh__D002786smesh__D009097
% 209.97/210.17  |- skos__hiddenLabel mesh__D002786 20,22 Desmolase
% 209.97/210.17  |- skos__altLabel mesh__D002786 20,22-Desmolase
% 209.97/210.17  |- skos__altLabel mesh__D002786
% 209.97/210.17       Cholesterol Monooxygenase %28%Side-Chain-Cleaving%29%
% 209.97/210.17  |- mesh__publicMeSHNote mesh__D035162 2003   
% 209.97/210.17  |- mesh__dateCreated mesh__D035162 2002-07-02
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D035162 2005
% 209.97/210.17  |- skos__broader mesh__D035162smesh__D035161
% 209.97/210.17  |- skos__prefLabel mesh__D035162 Adansonia
% 209.97/210.17  |- skos__scopeNote mesh__D035162
% 209.97/210.17       A plant genus of the family BOMBACACEAE that is used for FOOD and MEDICINE, TRADITIONAL.%A%    
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D035162 2003
% 209.97/210.17  |- skos__annotation mesh__D035162
% 209.97/210.17       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.97/210.17  |- mesh__dateEstablished mesh__D035162 2003-01-01
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D035162 2006
% 209.97/210.17  |- skos__altLabel mesh__D035162 Baobab
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D035162 2004
% 209.97/210.17  |- rdf__type mesh__D035162sskos__Concept
% 209.97/210.17  |- mesh__historyNote mesh__D035162 2003   
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D007471 2006
% 209.97/210.17  |- mesh__dateCreated mesh__D007471 1974-11-19
% 209.97/210.17  |- skos__historyNote mesh__D007471 Amides %28%1966-1974%29%
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D007471 2002
% 209.97/210.17  |- mesh__dateEstablished mesh__D007471 1991-01-01
% 209.97/210.17  |- skos__historyNote mesh__D007471 Glycolates %28%1966-1974%29%
% 209.97/210.17  |- skos__annotation mesh__D007471 D25-26 qualif   
% 209.97/210.17  |- mesh__historyNote mesh__D007471
% 209.97/210.17       91%28%75%29%; was see under IODOBENZOATES 1975-90   
% 209.97/210.17  |- skos__broader mesh__D007471smesh__D014283
% 209.97/210.17  |- skos__prefLabel mesh__D007471 Ioglycamic Acid
% 209.97/210.17  |- mesh__recordMaintainer mesh__D007471 CCR
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D007471 2003
% 209.97/210.17  |- mesh__dateRevised mesh__D007471 2000-06-21
% 209.97/210.17  |- rdf__type mesh__D007471sskos__Concept
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D007471 2004
% 209.97/210.17  |- skos__hiddenLabel mesh__D007471 Acid, Ioglycamic
% 209.97/210.17  |- mesh__recordOriginator mesh__D007471 NLM
% 209.97/210.17  |- skos__historyNote mesh__D007471 Iodobenzoates %28%1974%29%
% 209.97/210.17  |- skos__historyNote mesh__D007471 Benzoates %28%1966-1973%29%
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D007471 2005
% 209.97/210.17  |- mesh__recordAuthorizer mesh__D007471 sjn
% 209.97/210.17  |- mesh__publicMeSHNote mesh__D007471
% 209.97/210.17       91; was see under IODOBENZOATES 1975-90   
% 209.97/210.17  |- skos__scopeNote mesh__D007471
% 209.97/210.17       A radiopaque medium. It is a mixture of its meglumine and sodium salts and is used to visualize the biliary tract.%A%    
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D007471 2001
% 209.97/210.17  |- mesh__recordMaintainer mesh__D048888 ags
% 209.97/210.17  |- mesh__recordOriginator mesh__D048888 ags
% 209.97/210.17  |- skos__broader mesh__D048888smesh__D001517
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D048888 2005
% 209.97/210.17  |- skos__altLabel mesh__D048888 Firefly
% 209.97/210.17  |- mesh__dateEstablished mesh__D048888 2005-01-01
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D048888 2006
% 209.97/210.17  |- rdf__type mesh__D048888sskos__Concept
% 209.97/210.17  |- mesh__historyNote mesh__D048888 2005; use BEETLES 1993-2004   
% 209.97/210.17  |- mesh__recordAuthorizer mesh__D048888 sjn
% 209.97/210.17  |- mesh__publicMeSHNote mesh__D048888 2005; see BEETLES 1993-2004   
% 209.97/210.17  |- skos__historyNote mesh__D048888 Beetles %28%1965-2004%29%
% 209.97/210.17  |- mesh__dateCreated mesh__D048888 2004-07-15
% 209.97/210.17  |- skos__prefLabel mesh__D048888 Fireflies
% 209.97/210.17  |- skos__altLabel mesh__D048888 Lampyridae
% 209.97/210.17  |- skos__scopeNote mesh__D048888
% 209.97/210.17       The family Lampyidae, which are bioluminescent BEETLES. They contain FIREFLY LUCIFERIN and LUCIFERASES. Oxidation of firefly luciferin results in luminescence.%A%    
% 209.97/210.17  |- skos__historyNote mesh__D015903 Photogrammetry %28%1974-1989%29%
% 209.97/210.17  |- skos__hiddenLabel mesh__D015903 Photograph, Moire
% 209.97/210.17  |- mesh__dateRevised mesh__D015903 2001-08-13
% 209.97/210.17  |- skos__hiddenLabel mesh__D015903 Pattern, Moire
% 209.97/210.17  |- mesh__recordOriginator mesh__D015903 PLS
% 209.97/210.17  |- mesh__dateCreated mesh__D015903 1989-05-15
% 209.97/210.17  |- skos__historyNote mesh__D015903 Interferometry %28%1977-1989%29%
% 209.97/210.17  |- skos__broader mesh__D015903smesh__D010780
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D015903 2006
% 209.97/210.17  |- skos__hiddenLabel mesh__D015903 Photographs, Moire
% 209.97/210.17  |- mesh__historyNote mesh__D015903 90   
% 209.97/210.17  |- skos__annotation mesh__D015903
% 209.97/210.17       in titles %26% translations spell moir%C3%%A9%; DF: MOIRE TOPOGR   
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D015903 2004
% 209.97/210.17  |- skos__hiddenLabel mesh__D015903 Moire Photograph
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D015903 2005
% 209.97/210.17  |- skos__hiddenLabel mesh__D015903 Patterns, Moire
% 209.97/210.17  |- rdf__type mesh__D015903sskos__Concept
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D015903 2003
% 209.97/210.17  |- mesh__dateEstablished mesh__D015903 1990-01-01
% 209.97/210.17  |- mesh__recordAuthorizer mesh__D015903 sjn
% 209.97/210.17  |- skos__broader mesh__D015903smesh__D007368
% 209.97/210.17  |- skos__scopeNote mesh__D015903
% 209.97/210.17       A method of three-dimensional morphometry in which contour maps are produced from the overlapping interference fringes created when an object is illuminated by beams of coherent light issuing from two different point sources.%A%    
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D015903 2002
% 209.97/210.17  |- skos__hiddenLabel mesh__D015903 Moire Pattern
% 209.97/210.17  |- skos__prefLabel mesh__D015903 Moire Topography
% 209.97/210.17  |- mesh__publicMeSHNote mesh__D015903 90   
% 209.97/210.17  |- mesh__recordMaintainer mesh__D015903 jls
% 209.97/210.17  |- skos__altLabel mesh__D015903 Topography, Moire
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D015105 2004
% 209.97/210.17  |- mesh__onlineNote mesh__D015105
% 209.97/210.17       use 3%27%,5%27%-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE to search 3%27%,5%27%-CYCLIC AMP PHOSPHODIESTERASE 1975-93%A%  
% 209.97/210.17  |- skos__hiddenLabel mesh__D015105 3,5 Cyclic AMP 5 Nucleotidohydrolase
% 209.97/210.17  |- rdf__type mesh__D015105sskos__Concept
% 209.97/210.17  |- skos__hiddenLabel mesh__D015105 3%27%,5%27% Nucleotide Phosphodiesterase
% 209.97/210.17  |- skos__hiddenLabel mesh__D015105
% 209.97/210.17       3%27%,5%27% Cyclic AMP 5%27% Nucleotidohydrolase
% 209.97/210.17  |- skos__hiddenLabel mesh__D015105
% 209.97/210.17       Phosphodiesterase, 3%27%,5%27%-Cyclic Nucleotide
% 209.97/210.17  |- mesh__dateEstablished mesh__D015105 1978-01-01
% 209.97/210.17  |- mesh__historyNote mesh__D015105
% 209.97/210.17       94; was 3%27%,5%27%-CYCLIC AMP PHOSPHODIESTERASE 1975-93 %28%see under PHOSPHODIESTERASES 1975-77%29%%A%  
% 209.97/210.17  |- skos__altLabel mesh__D015105 3%27%,5%27%-Cyclic AMP Phosphodiesterase
% 209.97/210.17  |- mesh__dateRevised mesh__D015105 2003-07-09
% 209.97/210.17  |- skos__hiddenLabel mesh__D015105
% 209.97/210.17       Phosphodiesterase, 3%27%,5%27%-Cyclic AMP
% 209.97/210.17  |- skos__hiddenLabel mesh__D015105
% 209.97/210.17       AMP 5%27%-Nucleotidohydrolase, 3%27%,5%27%-Cyclic
% 209.97/210.17  |- skos__altLabel mesh__D015105
% 209.97/210.17       3%27%,5%27%-Cyclic AMP 5%27%-Nucleotidohydrolase
% 209.97/210.17  |- skos__scopeNote mesh__D015105
% 209.97/210.17       An enzyme that catalyzes the hydrolysis of cyclic AMP to form adenosine 5%27%-phosphate. The enzyme is widely distributed in animal tissue and controls the level of intracellular cyclic AMP. Also acts on 3%27%,5%27%-cyclic IMP and 3%27%,5%27%-cyclic GMP. EC 3.1.4.17.%A%    
% 209.97/210.17  |- mesh__dateCreated mesh__D015105 1974-11-11
% 209.97/210.17  |- skos__altLabel mesh__D015105 CAMP Phosphodiesterase
% 209.97/210.17  |- skos__prefLabel mesh__D015105
% 209.97/210.17       3%27%,5%27%-Cyclic-Nucleotide Phosphodiesterase
% 209.97/210.17  |- skos__historyNote mesh__D015105 Phosphodiesterases %28%1973-1974%29%
% 209.97/210.17  |- skos__broader mesh__D015105smesh__D010727
% 209.97/210.17  |- mesh__recordOriginator mesh__D015105 NLM
% 209.97/210.17  |- skos__hiddenLabel mesh__D015105
% 209.97/210.17       AMP Phosphodiesterase, 3%27%,5%27%-Cyclic
% 209.97/210.17  |- skos__hiddenLabel mesh__D015105 AMP Phosphodiesterase, 3,5-Cyclic
% 209.97/210.17  |- skos__altLabel mesh__D015105
% 209.97/210.17       3%27%,5%27%-Cyclic Nucleotide Phosphodiesterase
% 209.97/210.17  |- skos__altLabel mesh__D015105 3%27%,5%27% Cyclic AMP Phosphodiesterase
% 209.97/210.17  |- mesh__recordMaintainer mesh__D015105 ssb
% 209.97/210.17  |- skos__hiddenLabel mesh__D015105 Phosphodiesterase, CAMP
% 209.97/210.17  |- skos__annotation mesh__D015105
% 209.97/210.17       regulation: consider also CALMODULIN; DF: 3 5 CYCL NPD   
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D015105 2005
% 209.97/210.17  |- mesh__recordAuthorizer mesh__D015105 sjn
% 209.97/210.17  |- skos__hiddenLabel mesh__D015105 5-Nucleotidohydrolase, 3,5-Cyclic AMP
% 209.97/210.17  |- skos__hiddenLabel mesh__D015105
% 209.97/210.17       Phosphodiesterase, 3%27%,5%27%-Cyclic-Nucleotide
% 209.97/210.17  |- skos__historyNote mesh__D015105
% 209.97/210.17       Adenosine Cyclic Monophosphate %28%1973-1974%29%
% 209.97/210.17  |- skos__hiddenLabel mesh__D015105 AMP 5-Nucleotidohydrolase, 3,5-Cyclic
% 209.97/210.17  |- skos__hiddenLabel mesh__D015105
% 209.97/210.17       Nucleotide Phosphodiesterase, 3%27%,5%27%-Cyclic
% 209.97/210.17  |- skos__hiddenLabel mesh__D015105
% 209.97/210.17       Phosphodiesterase, 3%27%,5%27%-Cyclic-AMP
% 209.97/210.17  |- skos__hiddenLabel mesh__D015105
% 209.97/210.17       Phosphodiesterase, 3%27%,5%27%-Nucleotide
% 209.97/210.17  |- skos__hiddenLabel mesh__D015105 Calmodulin Dependent Phosphodiesterase
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D015105 2006
% 209.97/210.17  |- skos__hiddenLabel mesh__D015105
% 209.97/210.17       5%27%-Nucleotidohydrolase, 3%27%,5%27%-Cyclic AMP
% 209.97/210.17  |- skos__altLabel mesh__D015105 3,5-Cyclic AMP 5-Nucleotidohydrolase
% 209.97/210.17  |- skos__altLabel mesh__D015105 3%27%,5%27%-Nucleotide Phosphodiesterase
% 209.97/210.17  |- skos__altLabel mesh__D015105 3%27%,5%27%-Cyclic-AMP Phosphodiesterase
% 209.97/210.17  |- skos__hiddenLabel mesh__D015105
% 209.97/210.17       3%27%,5%27% Cyclic Nucleotide Phosphodiesterase
% 209.97/210.17  |- skos__hiddenLabel mesh__D015105 Phosphodiesterase, 3,5-Cyclic AMP
% 209.97/210.17  |- mesh__publicMeSHNote mesh__D015105
% 209.97/210.17       94; was 3%27%,5%27%-CYCLIC AMP PHOSPHODIESTERASE 1975-93 %28%see under PHOSPHODIESTERASES 1975-77%29%%A%  
% 209.97/210.17  |- skos__hiddenLabel mesh__D015105 3,5 Cyclic AMP Phosphodiesterase
% 209.97/210.17  |- skos__altLabel mesh__D015105 3,5-Cyclic AMP Phosphodiesterase
% 209.97/210.17  |- skos__hiddenLabel mesh__D020848 alpha 1 Chimaerin
% 209.97/210.17  |- mesh__recordOriginator mesh__D020848 jmp
% 209.97/210.17  |- skos__broader mesh__D020848smesh__D020740
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D020848 2005
% 209.97/210.17  |- skos__altLabel mesh__D020848 rhoGAP2 Protein
% 209.97/210.17  |- skos__altLabel mesh__D020848 alpha-1 Chimaerin
% 209.97/210.17  |- skos__hiddenLabel mesh__D020848 Chimaerin, alpha-2
% 209.97/210.17  |- mesh__historyNote mesh__D020848
% 209.97/210.17       2000; use CHIMERIN 1 %28%NM%29% 1990-1999; for ALPHA1-CHIMAERIN use GTPASE-ACTIVATING PROTEINS %28%NM%29% 1996-1999%A%  
% 209.97/210.17  |- skos__altLabel mesh__D020848 alpha-2 Chimaerin
% 209.97/210.17  |- skos__altLabel mesh__D020848 alpha-Chimerin
% 209.97/210.17  |- skos__altLabel mesh__D020848 alpha-Chimaerin
% 209.97/210.17  |- skos__hiddenLabel mesh__D020848 alpha Chimaerin
% 209.97/210.17  |- skos__hiddenLabel mesh__D020848 alpha 1 Chimerin
% 209.97/210.17  |- skos__altLabel mesh__D020848 arhGAP2 Protein
% 209.97/210.17  |- mesh__recordMaintainer mesh__D020848 jmp
% 209.97/210.17  |- skos__hiddenLabel mesh__D020848 Chimerin, alpha-2
% 209.97/210.17  |- skos__altLabel mesh__D020848 alpha-1 Chimerin
% 209.97/210.17  |- mesh__dateRevised mesh__D020848 2004-07-07
% 209.97/210.17  |- skos__hiddenLabel mesh__D020848 n Chimaerin
% 209.97/210.17  |- skos__hiddenLabel mesh__D020848 alpha 2 Chimaerin
% 209.97/210.17  |- mesh__publicMeSHNote mesh__D020848
% 209.97/210.17       2000; N-CHIMAERIN %28%now CHIMERIN 1%29% was indexed under NERVE TISSUE PROTEINS 1990-1999; ALPHA1-CHIMAERIN was indexed under PROTEINS 1996-1999%A%  
% 209.97/210.17  |- skos__hiddenLabel mesh__D020848 alpha1 Chimaerin
% 209.97/210.17  |- skos__altLabel mesh__D020848 n-Chimaerin
% 209.97/210.17  |- mesh__dateCreated mesh__D020848 1999-11-03
% 209.97/210.17  |- skos__hiddenLabel mesh__D020848 alpha 2 Chimerin
% 209.97/210.17  |- mesh__dateEstablished mesh__D020848 2000-01-01
% 209.97/210.17  |- skos__historyNote mesh__D020848 Nerve Tissue Proteins %28%1991-1999%29%
% 209.97/210.17  |- skos__altLabel mesh__D020848 n-Chimerin
% 209.97/210.17  |- skos__prefLabel mesh__D020848 Chimerin 1
% 209.97/210.17  |- mesh__recordAuthorizer mesh__D020848 sjn
% 209.97/210.17  |- rdf__type mesh__D020848sskos__Concept
% 209.97/210.17  |- skos__scopeNote mesh__D020848
% 209.97/210.17       A GTPase activating protein that is specific for RAC GTP-BINDING PROTEINS. It is expressed primarily in the brain and may be involved in signal transduction. The alternatively spliced form of CHIMERIN 1 %28%alpha-2 Chimerin%29% contains an additional src homology domain and is expressed in both the brain and testes.%A%    
% 209.97/210.17  |- skos__hiddenLabel mesh__D020848 Chimerin, alpha-1
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D020848 2006
% 209.97/210.17  |- skos__hiddenLabel mesh__D020848 alpha Chimerin
% 209.97/210.17  |- skos__hiddenLabel mesh__D020848 Chimaerin, alpha-1
% 209.97/210.17  |- skos__altLabel mesh__D020848 alpha1-Chimaerin
% 209.97/210.17  |- skos__altLabel mesh__D020848 Chimaerin 1
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D006379 2005
% 209.97/210.17  |- mesh__recordOriginator mesh__D006379 NLM
% 209.97/210.17  |- mesh__dateEstablished mesh__D006379 1979-01-01
% 209.97/210.17  |- skos__annotation mesh__D006379 no qualif   
% 209.97/210.17  |- mesh__dateCreated mesh__D006379 1974-11-19
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D006379 2006
% 209.97/210.17  |- skos__hiddenLabel mesh__D006379 Behavior, Helping
% 209.97/210.17  |- skos__hiddenLabel mesh__D006379 Helping Behaviors
% 209.97/210.17  |- skos__prefLabel mesh__D006379 Helping Behavior
% 209.97/210.17  |- mesh__recordMaintainer mesh__D006379 JLS
% 209.97/210.17  |- mesh__historyNote mesh__D006379
% 209.97/210.17       79%28%75%29%; was see under SOCIAL BEHAVIOR 1975-78   
% 209.97/210.17  |- skos__hiddenLabel mesh__D006379 Behaviors, Helping
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D006379 2003
% 209.97/210.17  |- mesh__dateRevised mesh__D006379 2002-07-02
% 209.97/210.17  |- skos__scopeNote mesh__D006379
% 209.97/210.17       Behaviors associated with the giving of assistance or aid to individuals.%A%    
% 209.97/210.17  |- skos__historyNote mesh__D006379
% 209.97/210.17       Interpersonal Relations %28%1969-1974%29%
% 209.97/210.17  |- mesh__publicMeSHNote mesh__D006379
% 209.97/210.17       79; was see under SOCIAL BEHAVIOR 1975-78   
% 209.97/210.17  |- skos__broader mesh__D006379smesh__D012919
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D006379 2004
% 209.97/210.17  |- skos__historyNote mesh__D006379 Social Behavior %28%1969-1974%29%
% 209.97/210.17  |- rdf__type mesh__D006379sskos__Concept
% 209.97/210.17  |- mesh__recordAuthorizer mesh__D006379 sjn
% 209.97/210.17  |- skos__historyNote mesh__D006379 specific interpersonal relations heading
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D003081 2000
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D003081 1994
% 209.97/210.17  |- skos__hiddenLabel mesh__D003081 Cold Climates
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D003081 1999
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D003081 2006
% 209.97/210.17  |- skos__hiddenLabel mesh__D003081 Polar Region
% 209.97/210.17  |- skos__broader mesh__D003081smesh__D002980
% 209.97/210.17  |- skos__hiddenLabel mesh__D003081 Climates, Cold
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D003081 2001
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D003081 1995
% 209.97/210.17  |- rdf__type mesh__D003081sskos__Concept
% 209.97/210.17  |- skos__hiddenLabel mesh__D003081 Region, Polar
% 209.97/210.17  |- skos__hiddenLabel mesh__D003081 Regions, Polar
% 209.97/210.17  |- skos__prefLabel mesh__D003081 Cold Climate
% 209.97/210.17  |- mesh__onlineNote mesh__D003081
% 209.97/210.17       use COLD CLIMATE to search POLAR REGIONS 1966-77   
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D003081 2002
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D003081 1996
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D003081 2003
% 209.97/210.17  |- mesh__recordOriginator mesh__D003081 NLM
% 209.97/210.17  |- skos__hiddenLabel mesh__D003081 Climate, Cold
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D003081 1997
% 209.97/210.17  |- mesh__dateCreated mesh__D003081 1999-01-01
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D003081 2004
% 209.97/210.17  |- mesh__dateRevised mesh__D003081 1992-05-18
% 209.97/210.17  |- mesh__recordAuthorizer mesh__D003081 PLS
% 209.97/210.17  |- mesh__recordMaintainer mesh__D003081 TAP
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D003081 1993
% 209.97/210.17  |- mesh__historyNote mesh__D003081
% 209.97/210.17       POLAR REGIONS was see under COLD CLIMATE 1963-77   
% 209.97/210.17  |- skos__annotation mesh__D003081
% 209.97/210.17       specify for Polar Region cold climate ARCTIC REGIONS or ANTARCTIC REGIONS if pertinent; specify other geog for cold climate if pertinent%A%  
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D003081 1998
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D003081 2005
% 209.97/210.17  |- skos__annotation mesh__D011513
% 209.97/210.17       infection: coord IM with PROTEUS INFECTIONS %28%IM%29%   
% 209.97/210.17  |- skos__broader mesh__D011513smesh__D011511
% 209.97/210.17  |- mesh__recordOriginator mesh__D011513 NLM
% 209.97/210.17  |- mesh__dateEstablished mesh__D011513 1974-01-01
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D011513 2006
% 209.97/210.17  |- rdf__type mesh__D011513sskos__Concept
% 209.97/210.17  |- mesh__recordMaintainer mesh__D011513 SYSTEM
% 209.97/210.17  |- mesh__historyNote mesh__D011513 74%28%72%29%   
% 209.97/210.17  |- skos__prefLabel mesh__D011513 Proteus mirabilis
% 209.97/210.17  |- mesh__dateCreated mesh__D011513 1999-01-01
% 209.97/210.17  |- mesh__recordAuthorizer mesh__D011513 sjn
% 209.97/210.17  |- skos__scopeNote mesh__D011513
% 209.97/210.17       A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that is frequently isolated from clinical specimens. Its most common site of infection is the urinary tract.%A%    
% 209.97/210.17  |- mesh__publicMeSHNote mesh__D011513 74   
% 209.97/210.17  |- mesh__dateRevised mesh__D011513 2005-06-30
% 209.97/210.17  |- skos__historyNote mesh__D011513 Proteus %28%1966-1971%29%
% 209.97/210.17  |- skos__prefLabel mesh__D035961 Alismatidae
% 209.97/210.17  |- mesh__dateEstablished mesh__D035961 2003-01-01
% 209.97/210.17  |- rdf__type mesh__D035961sskos__Concept
% 209.97/210.17  |- mesh__dateCreated mesh__D035961 2002-07-02
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D035961 2005
% 209.97/210.17  |- skos__scopeNote mesh__D035961
% 209.97/210.17       A plant subclass of the class Liliopsida %28%monocotyledons%29% in the Chronquist classification system. This is equivalent to the Alismatales order in the APG classification system. It is a primitive group of more or less aquatic plants.%A%    
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D035961 2006
% 209.97/210.17  |- mesh__publicMeSHNote mesh__D035961 2003   
% 209.97/210.17  |- skos__annotation mesh__D035961
% 209.97/210.17       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D035961 2003
% 209.97/210.17  |- skos__broader mesh__D035961smesh__D019684
% 209.97/210.17  |- skos__altLabel mesh__D035961 Alismatales
% 209.97/210.17  |- mesh__historyNote mesh__D035961 2003   
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D035961 2004
% 209.97/210.17  |- skos__hiddenLabel mesh__D002787 Steroid Esterase, Lipoidal
% 209.97/210.17  |- skos__altLabel mesh__D002787 Sterol Ester Acylhydrolase
% 209.97/210.17  |- mesh__dateCreated mesh__D002787 1974-11-19
% 209.97/210.17  |- skos__hiddenLabel mesh__D002787 Hydrolase, 15-Ketosteryl Oleate
% 209.97/210.17  |- skos__altLabel mesh__D002787 Hormone-Sensitive Lipase
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D002787 2004
% 209.97/210.17  |- mesh__recordAuthorizer mesh__D002787 sjn
% 209.97/210.17  |- skos__hiddenLabel mesh__D002787 Lipase, Acylcholesterol
% 209.97/210.17  |- skos__altLabel mesh__D002787 Cholesterylester Hydrolase
% 209.97/210.17  |- skos__hiddenLabel mesh__D002787 Lipase, Hormone-Sensitive
% 209.97/210.17  |- skos__altLabel mesh__D002787 Acylcholesterol Lipase
% 209.97/210.17  |- mesh__recordOriginator mesh__D002787 NLM
% 209.97/210.17  |- skos__altLabel mesh__D002787 Cholesterol Ester Hydrolase
% 209.97/210.17  |- skos__historyNote mesh__D002787 Cholesterol %28%1973-1974%29%
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D002787 2005
% 209.97/210.17  |- skos__hiddenLabel mesh__D002787 Hydrolase, Cholesteryl Oleate
% 209.97/210.17  |- skos__hiddenLabel mesh__D002787 Hydrolase, Cholesterol Ester
% 209.97/210.17  |- skos__hiddenLabel mesh__D002787 15 Ketosteryl Oleate Hydrolase
% 209.97/210.17  |- skos__altLabel mesh__D002787 Steroid Hormone Esterase
% 209.97/210.17  |- skos__hiddenLabel mesh__D002787 Esterase, Lipoidal Steroid
% 209.97/210.17  |- skos__hiddenLabel mesh__D002787 Esterase, Cholesterol
% 209.97/210.17  |- skos__hiddenLabel mesh__D002787 Acylhydrolase, Sterol Ester
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D002787 2006
% 209.97/210.17  |- mesh__historyNote mesh__D002787
% 209.97/210.17       91%28%75%29%; was see under CARBOXYLIC ESTER HYDROLASES 1976-90; was see under ESTERASES 1975%A%  
% 209.97/210.17  |- skos__altLabel mesh__D002787 Lipoidal Steroid Esterase
% 209.97/210.17  |- skos__hiddenLabel mesh__D002787 Hydrolase, Cholesterylester
% 209.97/210.17  |- skos__broader mesh__D002787smesh__D002265
% 209.97/210.17  |- skos__scopeNote mesh__D002787
% 209.97/210.17       An enzyme that catalyzes the hydrolysis of cholesterol and some other sterol esters, to liberate cholesterol plus a fatty acid anion. EC 3.1.1.13.%A%    
% 209.97/210.17  |- mesh__recordMaintainer mesh__D002787 ssb
% 209.97/210.17  |- skos__altLabel mesh__D002787 Cholesteryl Oleate Hydrolase
% 209.97/210.17  |- mesh__dateEstablished mesh__D002787 1991-01-01
% 209.97/210.17  |- skos__hiddenLabel mesh__D002787 Esterase, Steroid Hormone
% 209.97/210.17  |- mesh__dateRevised mesh__D002787 2003-07-09
% 209.97/210.17  |- rdf__type mesh__D002787sskos__Concept
% 209.97/210.17  |- skos__prefLabel mesh__D002787 Cholesterol Esterase
% 209.97/210.17  |- skos__historyNote mesh__D002787 Esterases %28%1973-1974%29%
% 209.97/210.17  |- skos__hiddenLabel mesh__D002787 Hormone Sensitive Lipase
% 209.97/210.17  |- mesh__publicMeSHNote mesh__D002787
% 209.97/210.17       91; was see under CARBOXYLIC ESTER HYDROLASES 1976-90; was see under ESTERASES 1975%A%  
% 209.97/210.17  |- skos__altLabel mesh__D035163 Salmalia malabaricum
% 209.97/210.17  |- skos__scopeNote mesh__D035163
% 209.97/210.17       A plant genus of the family BOMBACACEAE. The fine silky hairs covering the seeds have been used like kapok %28%CEIBA%29% for floatation, stuffing, and insulation.%A%    
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D035163 2004
% 209.97/210.17  |- mesh__dateCreated mesh__D035163 2002-07-02
% 209.97/210.17  |- mesh__dateEstablished mesh__D035163 2003-01-01
% 209.97/210.17  |- skos__broader mesh__D035163smesh__D035161
% 209.97/210.17  |- skos__prefLabel mesh__D035163 Bombax
% 209.97/210.17  |- rdf__type mesh__D035163sskos__Concept
% 209.97/210.17  |- mesh__publicMeSHNote mesh__D035163 2003   
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D035163 2005
% 209.97/210.17  |- skos__annotation mesh__D035163
% 209.97/210.17       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D035163 2003
% 209.97/210.17  |- mesh__historyNote mesh__D035163 2003   
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D035163 2006
% 209.97/210.17  |- mesh__recordAuthorizer mesh__D021941 sjn
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D021941 2004
% 209.97/210.17  |- mesh__recordOriginator mesh__D021941 nns
% 209.97/210.17  |- rdf__type mesh__D021941sskos__Concept
% 209.97/210.17  |- skos__broader mesh__D021941smesh__D003034
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D021941 2006
% 209.97/210.17  |- skos__broader mesh__D021941smesh__D018699
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D021941 2005
% 209.97/210.17  |- skos__prefLabel mesh__D021941 Caveolae
% 209.97/210.17  |- skos__broader mesh__D021941smesh__D021962
% 209.97/210.17  |- mesh__recordMaintainer mesh__D021941 nns
% 209.97/210.17  |- skos__related mesh__D021941smesh__D022461
% 209.97/210.17  |- skos__hiddenLabel mesh__D021941 Caveolas
% 209.97/210.17  |- mesh__dateCreated mesh__D021941 2000-06-27
% 209.97/210.17  |- mesh__historyNote mesh__D021941 2001   
% 209.97/210.17  |- skos__scopeNote mesh__D021941
% 209.97/210.17       Endocytic/exocytic CELL MEMBRANE STRUCTURES rich in glycosphingolipids, cholesterol, and lipid-anchored membrane proteins that function in  ENDOCYTOSIS %28%potocytosis%29%, transcytosis, and SIGNAL TRANSDUCTION. Caveolae assume various shapes from open pits to closed vesicles. Caveolar coats are composed of CAVEOLINS.%A%    
% 209.97/210.17  |- mesh__publicMeSHNote mesh__D021941 2001   
% 209.97/210.17  |- skos__historyNote mesh__D021941 Cell Membrane %28%1971-2000%29%
% 209.97/210.17  |- mesh__dateRevised mesh__D021941 2003-07-09
% 209.97/210.17  |- mesh__dateEstablished mesh__D021941 2001-01-01
% 209.97/210.17  |- skos__altLabel mesh__D021941 Caveola
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D007472 2003
% 209.97/210.17  |- rdf__type mesh__D007472sskos__Concept
% 209.97/210.17  |- mesh__recordOriginator mesh__D007472 RLS
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D007472 2004
% 209.97/210.17  |- mesh__recordAuthorizer mesh__D007472 sjn
% 209.97/210.17  |- mesh__dateRevised mesh__D007472 2001-07-25
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D007472 2005
% 209.97/210.17  |- mesh__historyNote mesh__D007472 87   
% 209.97/210.17  |- skos__broader mesh__D007472smesh__D014283
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D007472 2002
% 209.97/210.17  |- mesh__dateCreated mesh__D007472 1986-06-03
% 209.97/210.17  |- mesh__activeMeSHYear mesh__D007472 2006
% 209.97/210.17  |- mesh__dateEstablished mesh__D007472 1987-01-01
% 209.97/210.17  |- mesh__recordMaintainer mesh__D007472 jmp
% 209.97/210.17  |- skos__historyNote mesh__D007472 Triiodobenzoic Acids %28%1972-1986%29%
% 209.97/210.17  |- mesh__publicMeSHNote mesh__D007472 87   
% 209.97/210.17  |- skos__altLabel mesh__D007472 Iohexol 350
% 209.97/210.17  |- skos__prefLabel mesh__D007472 Iohexol
% 209.97/210.17  |- skos__scopeNote mesh__D007472
% 209.97/210.17       An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.%A%    
% 209.97/210.17  |- skos__historyNote mesh__D048889 Beetles %28%1965-2004%29%
% 209.97/210.17  |- skos__prefLabel mesh__D048889 Weevils
% 209.97/210.17  |- mesh__dateCreated mesh__D048889 2004-07-07
% 209.97/210.17  |- rdf__type mesh__D048889sskos__Concept
% 209.97/210.17  |- skos__historyNote mesh__D048889 Coleoptera %28%1974-2004%29%
% 209.97/210.17  |- mesh__recordOriginator mesh__D048889 ags
% 209.97/210.17  |- mesh__dateEstablished mesh__D048889 2005-01-01
% 209.97/210.17  |- skos__broader mesh__D048889smesh__D001517
% 209.97/210.18  |- mesh__publicMeSHNote mesh__D048889 2005   
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D048889 2005
% 209.97/210.18  |- skos__scopeNote mesh__D048889
% 209.97/210.18       BEETLES in the family Curculionidae and the largest family in the order COLEOPTERA. They have a markedly convex shape and many are considered pests.%A%    
% 209.97/210.18  |- mesh__recordMaintainer mesh__D048889 ags
% 209.97/210.18  |- mesh__historyNote mesh__D048889 2005   
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D048889 2006
% 209.97/210.18  |- mesh__recordAuthorizer mesh__D048889 sjn
% 209.97/210.18  |- skos__altLabel mesh__D048889 Curculionidae
% 209.97/210.18  |- skos__hiddenLabel mesh__D015904 Bilio Pancreatic Bypass
% 209.97/210.18  |- mesh__dateCreated mesh__D015904 1989-05-15
% 209.97/210.18  |- skos__hiddenLabel mesh__D015904 Bypasses, Bilio Pancreatic
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D015904 2003
% 209.97/210.18  |- skos__altLabel mesh__D015904 Bilio-Pancreatic Diversion
% 209.97/210.18  |- skos__hiddenLabel mesh__D015904 Pancreatic Diversions, Bilio
% 209.97/210.18  |- skos__hiddenLabel mesh__D015904 Bilio-Pancreatic Bypasses
% 209.97/210.18  |- skos__hiddenLabel mesh__D015904 Pancreatic Diversion, Bilio
% 209.97/210.18  |- skos__hiddenLabel mesh__D015904 Biliopancreatic Bypasses
% 209.97/210.18  |- skos__annotation mesh__D015904
% 209.97/210.18       do not use /util except by MeSH definition   
% 209.97/210.18  |- skos__altLabel mesh__D015904 Biliopancreatic Bypass
% 209.97/210.18  |- skos__historyNote mesh__D015904 Jejunoileal Bypass %28%1987-1989%29%
% 209.97/210.18  |- skos__historyNote mesh__D015904 Duodenum/surgery %28%1977-1986%29%
% 209.97/210.18  |- skos__hiddenLabel mesh__D015904 Bypasses, Biliopancreatic
% 209.97/210.18  |- skos__altLabel mesh__D015904 Bilio Pancreatic Bypasses
% 209.97/210.18  |- skos__historyNote mesh__D015904 Jejunum/surgery %28%1977-1986%29%
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D015904 2004
% 209.97/210.18  |- skos__hiddenLabel mesh__D015904 Bypass, Bilio-Pancreatic
% 209.97/210.18  |- mesh__historyNote mesh__D015904 90   
% 209.97/210.18  |- mesh__recordOriginator mesh__D015904 PLS
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D015904 2005
% 209.97/210.18  |- mesh__dateRevised mesh__D015904 2002-10-23
% 209.97/210.18  |- skos__prefLabel mesh__D015904 Biliopancreatic Diversion
% 209.97/210.18  |- skos__hiddenLabel mesh__D015904 Diversions, Bilio-Pancreatic
% 209.97/210.18  |- skos__hiddenLabel mesh__D015904 Pancreatic Bypasses, Bilio
% 209.97/210.18  |- skos__hiddenLabel mesh__D015904 Diversions, Bilio Pancreatic
% 209.97/210.18  |- skos__historyNote mesh__D015904 Obesity/therapy %28%1977-1989%29%
% 209.97/210.18  |- mesh__recordMaintainer mesh__D015904 sjn
% 209.97/210.18  |- skos__hiddenLabel mesh__D015904 Bilio-Pancreatic Diversions
% 209.97/210.18  |- skos__hiddenLabel mesh__D015904 Diversion, Bilio-Pancreatic
% 209.97/210.18  |- skos__hiddenLabel mesh__D015904 Diversions, Biliopancreatic
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D015904 2006
% 209.97/210.18  |- skos__altLabel mesh__D015904 Bilio-Pancreatic Bypass
% 209.97/210.18  |- skos__broader mesh__D015904smesh__D013505
% 209.97/210.18  |- skos__historyNote mesh__D015904
% 209.97/210.18       Obesity, Morbid/therapy %28%1987-1989%29%
% 209.97/210.18  |- skos__scopeNote mesh__D015904
% 209.97/210.18       A surgical procedure which diverts pancreatobiliary secretions via the duodenum and the jejunum into the colon, the remaining small intestine being anastomosed to the stomach after antrectomy. The procedure produces less diarrhea than does jejunoileal bypass.%A%    
% 209.97/210.18  |- mesh__recordAuthorizer mesh__D015904 sjn
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D015904 2003A
% 209.97/210.18  |- mesh__publicMeSHNote mesh__D015904 90   
% 209.97/210.18  |- skos__hiddenLabel mesh__D015904 Bypass, Biliopancreatic
% 209.97/210.18  |- skos__hiddenLabel mesh__D015904 Bilio Pancreatic Diversion
% 209.97/210.18  |- skos__altLabel mesh__D015904 Bilio Pancreatic Diversions
% 209.97/210.18  |- skos__broader mesh__D015904smesh__D001662
% 209.97/210.18  |- rdf__type mesh__D015904sskos__Concept
% 209.97/210.18  |- skos__hiddenLabel mesh__D015904 Bypasses, Bilio-Pancreatic
% 209.97/210.18  |- skos__hiddenLabel mesh__D015904 Diversion, Bilio Pancreatic
% 209.97/210.18  |- mesh__dateEstablished mesh__D015904 1990-01-01
% 209.97/210.18  |- skos__historyNote mesh__D015904 Gastric Bypass %28%1989%29%
% 209.97/210.18  |- skos__hiddenLabel mesh__D015904 Biliopancreatic Diversions
% 209.97/210.18  |- mesh__onlineNote mesh__D015106
% 209.97/210.18       use 3%27%,5%27%-CYCLIC-GMP PHOSPHODIESTERASE to search 3%27%,5%27%-CYCLIC GMP PHOSPHODIESTERASE 1978-93%A%  
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D015106 2005
% 209.97/210.18  |- skos__hiddenLabel mesh__D015106
% 209.97/210.18       Phosphodiesterase, 3%27%,5%27%-Cyclic-GMP
% 209.97/210.18  |- skos__hiddenLabel mesh__D015106
% 209.97/210.18       GMP Phosphodiesterase, 3%27%,5%27%-Cyclic
% 209.97/210.18  |- skos__hiddenLabel mesh__D015106
% 209.97/210.18       3%27%,5%27% Cyclic GMP 5%27% Nucleotidohydrolase
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D015106 2004
% 209.97/210.18  |- mesh__recordMaintainer mesh__D015106 ssb
% 209.97/210.18  |- mesh__historyNote mesh__D015106
% 209.97/210.18       94; was 3%27%,5%27%-CYCLIC GMP PHOSPHODIESTERASE 1978-93   
% 209.97/210.18  |- skos__prefLabel mesh__D015106 3%27%,5%27%-Cyclic-GMP Phosphodiesterase
% 209.97/210.18  |- mesh__recordOriginator mesh__D015106 RLS
% 209.97/210.18  |- skos__hiddenLabel mesh__D015106 GMP Phosphodiesterase, 3,5-Cyclic
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D015106 2006
% 209.97/210.18  |- skos__hiddenLabel mesh__D015106 5-Nucleotidohydrolase, 3,5-Cyclic GMP
% 209.97/210.18  |- skos__altLabel mesh__D015106 3,5-Cyclic GMP Phosphodiesterase
% 209.97/210.18  |- mesh__dateEstablished mesh__D015106 1978-01-01
% 209.97/210.18  |- skos__hiddenLabel mesh__D015106 3,5 Cyclic GMP 5 Nucleotidohydrolase
% 209.97/210.18  |- skos__hiddenLabel mesh__D015106 Phosphodiesterase, 3,5-Cyclic GMP
% 209.97/210.18  |- skos__broader mesh__D015106smesh__D010727
% 209.97/210.18  |- skos__historyNote mesh__D015106 Phosphodiesterases %28%1972-1977%29%
% 209.97/210.18  |- mesh__recordAuthorizer mesh__D015106 sjn
% 209.97/210.18  |- skos__annotation mesh__D015106 DF: CYCL GMP PHOSPHODIESTERASE   
% 209.97/210.18  |- skos__hiddenLabel mesh__D015106 3,5 Cyclic GMP Phosphodiesterase
% 209.97/210.18  |- rdf__type mesh__D015106sskos__Concept
% 209.97/210.18  |- skos__altLabel mesh__D015106 3%27%,5%27%-Cyclic GMP Phosphodiesterase
% 209.97/210.18  |- skos__historyNote mesh__D015106
% 209.97/210.18       Guanosine Cyclic Monophosphate %28%1971-1977%29%
% 209.97/210.18  |- mesh__dateRevised mesh__D015106 2003-07-09
% 209.97/210.18  |- skos__scopeNote mesh__D015106
% 209.97/210.18       An enzyme that catalyzes the hydrolysis of cyclic GMP to yield guanosine-5%27%-phosphate. EC 3.1.4.35.%A%    
% 209.97/210.18  |- mesh__publicMeSHNote mesh__D015106
% 209.97/210.18       94; was 3%27%,5%27%-CYCLIC GMP PHOSPHODIESTERASE 1978-93   
% 209.97/210.18  |- skos__hiddenLabel mesh__D015106 GMP 5-Nucleotidohydrolase, 3,5-Cyclic
% 209.97/210.18  |- skos__altLabel mesh__D015106 3,5-Cyclic GMP 5-Nucleotidohydrolase
% 209.97/210.18  |- skos__hiddenLabel mesh__D015106
% 209.97/210.18       GMP 5%27%-Nucleotidohydrolase, 3%27%,5%27%-Cyclic
% 209.97/210.18  |- skos__hiddenLabel mesh__D015106 3%27%,5%27% Cyclic GMP Phosphodiesterase
% 209.97/210.18  |- skos__altLabel mesh__D015106
% 209.97/210.18       3%27%,5%27%-Cyclic GMP 5%27%-Nucleotidohydrolase
% 209.97/210.18  |- mesh__dateCreated mesh__D015106 1977-05-20
% 209.97/210.18  |- skos__hiddenLabel mesh__D015106
% 209.97/210.18       Phosphodiesterase, 3%27%,5%27%-Cyclic GMP
% 209.97/210.18  |- mesh__dateEstablished mesh__D020849 2000-01-01
% 209.97/210.18  |- skos__altLabel mesh__D020849 Keoxifene
% 209.97/210.18  |- mesh__historyNote mesh__D020849
% 209.97/210.18       2000; use RALOXIFENE %28%NM%29% 1983-1999   
% 209.97/210.18  |- mesh__dateCreated mesh__D020849 1999-11-03
% 209.97/210.18  |- mesh__recordAuthorizer mesh__D020849 sjn
% 209.97/210.18  |- mesh__dateRevised mesh__D020849 2005-06-30
% 209.97/210.18  |- skos__hiddenLabel mesh__D020849 139481, LY
% 209.97/210.18  |- mesh__publicMeSHNote mesh__D020849
% 209.97/210.18       2000; LY 139481 %28%now RALOXIFENE%29% was indexed under PIPERIDINES 1983-1999%A%  
% 209.97/210.18  |- skos__altLabel mesh__D020849 LY 139481
% 209.97/210.18  |- skos__altLabel mesh__D020849 LY 156758
% 209.97/210.18  |- skos__hiddenLabel mesh__D020849 Hydrochloride, Keoxifene
% 209.97/210.18  |- skos__historyNote mesh__D020849 Piperidines %28%1983-1999%29%
% 209.97/210.18  |- skos__hiddenLabel mesh__D020849 LY156758
% 209.97/210.18  |- skos__prefLabel mesh__D020849 Raloxifene
% 209.97/210.18  |- skos__hiddenLabel mesh__D020849 LY139481
% 209.97/210.18  |- skos__broader mesh__D020849smesh__D013629
% 209.97/210.18  |- rdf__type mesh__D020849sskos__Concept
% 209.97/210.18  |- skos__scopeNote mesh__D020849
% 209.97/210.18       A second generation selective estrogen receptor modulator %28%SERM%29% used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue.%A%    
% 209.97/210.18  |- mesh__recordOriginator mesh__D020849 adp
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D020849 2006
% 209.97/210.18  |- mesh__recordMaintainer mesh__D020849 ssb
% 209.97/210.18  |- skos__hiddenLabel mesh__D020849 156758, LY
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D003880 2004
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D003880 2006
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D003880 1996
% 209.97/210.18  |- skos__prefLabel mesh__D003880 Dermatology
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D003880 2002
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D003880 1998
% 209.97/210.18  |- mesh__recordOriginator mesh__D003880 NLM
% 209.97/210.18  |- skos__scopeNote mesh__D003880
% 209.97/210.18       A medical specialty concerned with the skin, its structure, functions, diseases, and treatment.%A%    
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D003880 1997
% 209.97/210.18  |- skos__related mesh__D003880smesh__D012871
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D003880 1999
% 209.97/210.18  |- mesh__dateRevised mesh__D003880 1994-02-08
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D003880 1995
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D003880 2000
% 209.97/210.18  |- rdf__type mesh__D003880sskos__Concept
% 209.97/210.18  |- skos__annotation mesh__D003880 SPEC: SPEC qualif; DF: DERMATOL   
% 209.97/210.18  |- mesh__recordAuthorizer mesh__D003880 PLS
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D003880 2003
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D003880 2001
% 209.97/210.18  |- mesh__recordMaintainer mesh__D003880 TGC
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D003880 2005
% 209.97/210.18  |- mesh__dateCreated mesh__D003880 1999-01-01
% 209.97/210.18  |- skos__broader mesh__D003880smesh__D013040
% 209.97/210.18  |- mesh__recordOriginator mesh__D003082 NLM
% 209.97/210.18  |- skos__annotation mesh__D003082
% 209.97/210.18       do not use /util except by MeSH definition   
% 209.97/210.18  |- skos__scopeNote mesh__D003082
% 209.97/210.18       Excision of a portion of the colon or of the whole colon. %28%Dorland, 28th ed%29%%A%    
% 209.97/210.18  |- skos__prefLabel mesh__D003082 Colectomy
% 209.97/210.18  |- mesh__publicMeSHNote mesh__D003082 65   
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D003082 2002
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D003082 2006
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D003082 1999
% 209.97/210.18  |- mesh__historyNote mesh__D003082 65   
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D003082 2001
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D003082 2005
% 209.97/210.18  |- mesh__activeMeSHYear mesh__D003082 1998
% 209.97/210.18  |- skos__hiddenLabel mesh__D003082 Colectomies
% 209.97/210.18  |- mesh__dateCreated mesh__D003082 1999-01-01
% 210.03/210.18  |- mesh__dateRevised mesh__D003082 1997-06-20
% 210.03/210.18  |- rdf__type mesh__D003082sskos__Concept
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D003082 2000
% 210.03/210.18  |- mesh__dateEstablished mesh__D003082 1965-01-01
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D003082 2004
% 210.03/210.18  |- mesh__recordMaintainer mesh__D003082 PXP
% 210.03/210.18  |- mesh__recordAuthorizer mesh__D003082 SJN
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D003082 2003
% 210.03/210.18  |- skos__broader mesh__D003082smesh__D013505
% 210.03/210.18  |- mesh__publicMeSHNote mesh__D011514 74   
% 210.03/210.18  |- skos__scopeNote mesh__D011514
% 210.03/210.18       A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in soil, fecal matter, and sewage. It is an opportunistic pathogen and causes cystitis and pyelonephritis.%A%    
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D011514 2006
% 210.03/210.18  |- mesh__dateRevised mesh__D011514 2005-06-30
% 210.03/210.18  |- skos__historyNote mesh__D011514 Proteus %28%1966-1971%29%
% 210.03/210.18  |- skos__annotation mesh__D011514
% 210.03/210.18       infection: coord IM with PROTEUS INFECTIONS %28%IM%29%   
% 210.03/210.18  |- rdf__type mesh__D011514sskos__Concept
% 210.03/210.18  |- skos__broader mesh__D011514smesh__D011511
% 210.03/210.18  |- mesh__recordMaintainer mesh__D011514 SYSTEM
% 210.03/210.18  |- mesh__recordOriginator mesh__D011514 NLM
% 210.03/210.18  |- mesh__dateCreated mesh__D011514 1999-01-01
% 210.03/210.18  |- mesh__dateEstablished mesh__D011514 1974-01-01
% 210.03/210.18  |- mesh__historyNote mesh__D011514 74%28%72%29%   
% 210.03/210.18  |- skos__prefLabel mesh__D011514 Proteus vulgaris
% 210.03/210.18  |- mesh__recordAuthorizer mesh__D011514 sjn
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D035962 2006
% 210.03/210.18  |- mesh__publicMeSHNote mesh__D035962 2003   
% 210.03/210.18  |- skos__annotation mesh__D035962
% 210.03/210.18       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.03/210.18  |- mesh__historyNote mesh__D035962 2003   
% 210.03/210.18  |- skos__broader mesh__D035962smesh__D035961
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D035962 2003
% 210.03/210.18  |- mesh__dateEstablished mesh__D035962 2003-01-01
% 210.03/210.18  |- mesh__dateCreated mesh__D035962 2002-07-03
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D035962 2004
% 210.03/210.18  |- skos__prefLabel mesh__D035962 Zosteraceae
% 210.03/210.18  |- skos__scopeNote mesh__D035962
% 210.03/210.18       A plant family of the order Najadales, subclass ALISMATIDAE, class Liliopsida  %28%monocotyledons%29%. This is a group of perennial aquatic herbs with basal leaves.%A%    
% 210.03/210.18  |- rdf__type mesh__D035962sskos__Concept
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D035962 2005
% 210.03/210.18  |- skos__hiddenLabel mesh__D002788 Esters, Cholesteryl
% 210.03/210.18  |- mesh__recordMaintainer mesh__D002788 ssb
% 210.03/210.18  |- mesh__historyNote mesh__D002788
% 210.03/210.18       78%28%76%29%; was see under CHOLESTEROL 1976-77   
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D002788 2006
% 210.03/210.18  |- skos__historyNote mesh__D002788 Cholesterol %28%1966-1977%29%
% 210.03/210.18  |- skos__broader mesh__D002788smesh__D002784
% 210.03/210.18  |- skos__prefLabel mesh__D002788 Cholesterol Esters
% 210.03/210.18  |- mesh__dateCreated mesh__D002788 1975-07-25
% 210.03/210.18  |- skos__hiddenLabel mesh__D002788 Esters, Cholesterol
% 210.03/210.18  |- skos__scopeNote mesh__D002788
% 210.03/210.18       Fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in the plasma. The accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis.%A%    
% 210.03/210.18  |- rdf__type mesh__D002788sskos__Concept
% 210.03/210.18  |- mesh__dateRevised mesh__D002788 2003-07-09
% 210.03/210.18  |- mesh__recordAuthorizer mesh__D002788 sjn
% 210.03/210.18  |- skos__altLabel mesh__D002788 Cholesteryl Esters
% 210.03/210.18  |- mesh__dateEstablished mesh__D002788 1978-01-01
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D002788 2004
% 210.03/210.18  |- skos__historyNote mesh__D002788 Esters %28%1968-1977%29%
% 210.03/210.18  |- mesh__publicMeSHNote mesh__D002788
% 210.03/210.18       78; was see under CHOLESTEROL 1976-77   
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D002788 2005
% 210.03/210.18  |- mesh__recordOriginator mesh__D002788 RLS
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D035164 2004
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D035164 2006
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D035164 2003
% 210.03/210.18  |- skos__broader mesh__D035164smesh__D035161
% 210.03/210.18  |- skos__annotation mesh__D035164
% 210.03/210.18       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D035164 2005
% 210.03/210.18  |- skos__scopeNote mesh__D035164
% 210.03/210.18       A plant genus of the family BOMBACACEAE. The fine silky hairs covering the seeds have been used for floatation, stuffing, and insulation.%A%    
% 210.03/210.18  |- skos__prefLabel mesh__D035164 Ceiba
% 210.03/210.18  |- mesh__dateCreated mesh__D035164 2002-07-03
% 210.03/210.18  |- mesh__dateEstablished mesh__D035164 2003-01-01
% 210.03/210.18  |- skos__altLabel mesh__D035164 Kapok Tree
% 210.03/210.18  |- rdf__type mesh__D035164sskos__Concept
% 210.03/210.18  |- mesh__historyNote mesh__D035164 2003   
% 210.03/210.18  |- mesh__publicMeSHNote mesh__D035164 2003   
% 210.03/210.18  |- skos__hiddenLabel mesh__D007473 Channels, Ionic
% 210.03/210.18  |- mesh__dateCreated mesh__D007473 1978-05-19
% 210.03/210.18  |- mesh__publicMeSHNote mesh__D007473 79   
% 210.03/210.18  |- mesh__recordMaintainer mesh__D007473 SYSTEM
% 210.03/210.18  |- skos__altLabel mesh__D007473 Ionic Channel
% 210.03/210.18  |- skos__historyNote mesh__D007473 Cell Membrane %28%1966-1978%29%
% 210.03/210.18  |- skos__related mesh__D007473smesh__D015640
% 210.03/210.18  |- skos__hiddenLabel mesh__D007473 Channel, Ionic
% 210.03/210.18  |- skos__broader mesh__D007473smesh__D026901
% 210.03/210.18  |- skos__historyNote mesh__D007473 Electric Conductivity %28%1968-1978%29%
% 210.03/210.18  |- mesh__recordOriginator mesh__D007473 VDK
% 210.03/210.18  |- skos__prefLabel mesh__D007473 Ion Channels
% 210.03/210.18  |- mesh__recordAuthorizer mesh__D007473 sjn
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D007473 2006
% 210.03/210.18  |- mesh__historyNote mesh__D007473 79   
% 210.03/210.18  |- skos__altLabel mesh__D007473 Ion Channel
% 210.03/210.18  |- skos__altLabel mesh__D007473 Ionic Channels
% 210.03/210.18  |- skos__hiddenLabel mesh__D007473 Channels, Ion
% 210.03/210.18  |- skos__annotation mesh__D007473
% 210.03/210.18       IM; GEN: prefer specifics; coord IM with specific ion /metab %28%IM%29%; for disorders caused by dysfunction %28%channelopathy%29% use /physiopathology%A%  
% 210.03/210.18  |- skos__altLabel mesh__D007473 Membrane Channels
% 210.03/210.18  |- skos__historyNote mesh__D007473 Membrane Potentials %28%1967-1978%29%
% 210.03/210.18  |- skos__related mesh__D007473smesh__D016623
% 210.03/210.18  |- skos__broader mesh__D007473smesh__D008562
% 210.03/210.18  |- skos__scopeNote mesh__D007473
% 210.03/210.18       Gated, ion-selective glycoproteins that traverse membranes. The stimulus for channel gating can be a membrane potential, drug, transmitter, cytoplasmic messenger, or a mechanical deformation. Ion channels which are integral parts of ionotropic neurotransmitter receptors are not included.%A%    
% 210.03/210.18  |- skos__hiddenLabel mesh__D007473 Channel, Ion
% 210.03/210.18  |- rdf__type mesh__D007473sskos__Concept
% 210.03/210.18  |- skos__hiddenLabel mesh__D007473 Channel, Membrane
% 210.03/210.18  |- mesh__dateEstablished mesh__D007473 1979-01-01
% 210.03/210.18  |- skos__altLabel mesh__D007473 Membrane Channel
% 210.03/210.18  |- mesh__dateRevised mesh__D007473 2005-06-30
% 210.03/210.18  |- skos__hiddenLabel mesh__D007473 Channels, Membrane
% 210.03/210.18  |- skos__historyNote mesh__D015905 Implants, Artificial %28%1987-1989%29%
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D015905 2002
% 210.03/210.18  |- skos__historyNote mesh__D015905 Balloon Dilatation %28%1988-1989%29%
% 210.03/210.18  |- skos__annotation mesh__D015905
% 210.03/210.18       note category: an inflatable device; do not confuse with digestive gases; used in ther of morbid obesity: note XR %26% do not coord with OBESITY, MORBID unless particularly discussed%A%  
% 210.03/210.18  |- skos__historyNote mesh__D015905
% 210.03/210.18       Intubation, Gastrointestinal %28%1974-1979%29%
% 210.03/210.18  |- mesh__dateCreated mesh__D015905 1989-05-15
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D015905 1998
% 210.03/210.18  |- skos__hiddenLabel mesh__D015905 Bubble, Gastric
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D015905 2003
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D015905 1999
% 210.03/210.18  |- mesh__dateRevised mesh__D015905 1997-06-20
% 210.03/210.18  |- skos__hiddenLabel mesh__D015905 Balloons, Gastric
% 210.03/210.18  |- skos__hiddenLabel mesh__D015905 Gastric Bubble, Garren-Edwards
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D015905 2004
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D015905 2000
% 210.03/210.18  |- mesh__recordOriginator mesh__D015905 PLS
% 210.03/210.18  |- skos__broader mesh__D015905smesh__D004864
% 210.03/210.18  |- skos__historyNote mesh__D015905 Dilatation %28%1980-1987%29%
% 210.03/210.18  |- skos__hiddenLabel mesh__D015905 Balloon, Ballobes
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D015905 2005
% 210.03/210.18  |- skos__hiddenLabel mesh__D015905 Gastric Balloons
% 210.03/210.18  |- skos__prefLabel mesh__D015905 Gastric Balloon
% 210.03/210.18  |- skos__hiddenLabel mesh__D015905 Bubbles, Gastric
% 210.03/210.18  |- skos__hiddenLabel mesh__D015905 Garren Edwards Gastric Bubble
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D015905 2001
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D015905 2006
% 210.03/210.18  |- skos__hiddenLabel mesh__D015905 Gastric Bubbles
% 210.03/210.18  |- skos__historyNote mesh__D015905 Obesity %28%1977-1987%29%
% 210.03/210.18  |- skos__hiddenLabel mesh__D015905 Balloon, Gastric
% 210.03/210.18  |- skos__altLabel mesh__D015905 Gastric Bubble
% 210.03/210.18  |- skos__hiddenLabel mesh__D015905 Ballobes Balloons
% 210.03/210.18  |- skos__hiddenLabel mesh__D015905 Bubble, Garren-Edwards Gastric
% 210.03/210.18  |- mesh__dateEstablished mesh__D015905 1990-01-01
% 210.03/210.18  |- skos__scopeNote mesh__D015905
% 210.03/210.18       An inflatable device implanted in the stomach as an adjunct to therapy of morbid obesity. Specific types include the silicone Garren-Edwards Gastric Bubble %28%GEGB%29%, approved by the FDA in 1985, and the Ballobes Balloon.%A%    
% 210.03/210.18  |- mesh__historyNote mesh__D015905
% 210.03/210.18       98; was GASTRIC BUBBLE 1990-97; GASTRIC BALLOON was see GASTRIC BUBBLE 1990-97%A%  
% 210.03/210.18  |- skos__hiddenLabel mesh__D015905 Balloons, Ballobes
% 210.03/210.18  |- mesh__recordMaintainer mesh__D015905 PXP
% 210.03/210.18  |- mesh__publicMeSHNote mesh__D015905
% 210.03/210.18       98; was GASTRIC BUBBLE 1990-97; GASTRIC BALLOON was see GASTRIC BUBBLE 1990-97%A%  
% 210.03/210.18  |- rdf__type mesh__D015905sskos__Concept
% 210.03/210.18  |- mesh__recordAuthorizer mesh__D015905 SJN
% 210.03/210.18  |- skos__historyNote mesh__D015905 Obesity, Morbid %28%1987-1989%29%
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D015107 2003
% 210.03/210.18  |- skos__hiddenLabel mesh__D015107 1,4 Butanolide
% 210.03/210.18  |- skos__altLabel mesh__D015107 Furanone, tetrahydro-2-
% 210.03/210.18  |- mesh__recordMaintainer mesh__D015107 ssb
% 210.03/210.18  |- skos__altLabel mesh__D015107 4-Hydroxybutyric Acid Lactone
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D015107 2005
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D015107 2004
% 210.03/210.18  |- mesh__dateCreated mesh__D015107 1975-07-23
% 210.03/210.18  |- skos__altLabel mesh__D015107 1,4-Butanolide
% 210.03/210.18  |- mesh__recordOriginator mesh__D015107 RLS
% 210.03/210.18  |- mesh__recordAuthorizer mesh__D015107 sjn
% 210.03/210.18  |- skos__hiddenLabel mesh__D015107 4 Butyrolactone
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D015107 2006
% 210.03/210.18  |- skos__altLabel mesh__D015107 Dihydro-2%28%3H%29%-furanone
% 210.03/210.18  |- rdf__type mesh__D015107sskos__Concept
% 210.03/210.18  |- mesh__historyNote mesh__D015107
% 210.03/210.18       91%28%77%29%; was see under FURANS 1977-90; was GAMMA BUTYROLACTONE see under FURANS 1976%A%  
% 210.03/210.18  |- skos__scopeNote mesh__D015107
% 210.03/210.18       One of the FURANS with a carbonyl thereby forming a cyclic lactone.  It is an endogenous compound made from gamma-aminobutyrate and is the precursor of gamma-hydroxybutyrate.  It is also used as a pharmacological agent and solvent.%A%    
% 210.03/210.18  |- mesh__dateEstablished mesh__D015107 1991-01-01
% 210.03/210.18  |- skos__hiddenLabel mesh__D015107 Lactone, 4-Hydroxybutyric Acid
% 210.03/210.18  |- mesh__dateRevised mesh__D015107 2002-07-02
% 210.03/210.18  |- skos__historyNote mesh__D015107 Lactones %28%1969-1975%29%
% 210.03/210.18  |- skos__historyNote mesh__D015107 Furans %28%1969-1975%29%
% 210.03/210.18  |- skos__altLabel mesh__D015107 gamma-Butyrolactone
% 210.03/210.18  |- skos__hiddenLabel mesh__D015107 gamma Butyrolactone
% 210.03/210.18  |- mesh__onlineNote mesh__D015107
% 210.03/210.18       use 4-BUTYROLACTONE to search GAMMA BUTYROLACTONE 1976   
% 210.03/210.18  |- skos__hiddenLabel mesh__D015107 4 Hydroxybutyric Acid Lactone
% 210.03/210.18  |- skos__prefLabel mesh__D015107 4-Butyrolactone
% 210.03/210.18  |- skos__broader mesh__D015107smesh__D005663
% 210.03/210.18  |- skos__broader mesh__D015107smesh__D007783
% 210.03/210.18  |- skos__hiddenLabel mesh__D015107 Furanone, tetrahydro 2 
% 210.03/210.18  |- mesh__publicMeSHNote mesh__D015107
% 210.03/210.18       91; was see under FURANS 1977-90; was GAMMA BUTYROLACTONE see under FURANS 1976%A%  
% 210.03/210.18  |- mesh__recordAuthorizer mesh__D003881 PLS
% 210.03/210.18  |- skos__hiddenLabel mesh__D003881 Skin Disease, Fungal
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D003881 2001
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D003881 1996
% 210.03/210.18  |- skos__hiddenLabel mesh__D003881 Fungal Skin Disease
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D003881 1998
% 210.03/210.18  |- skos__altLabel mesh__D003881 Dermatomycosis
% 210.03/210.18  |- mesh__historyNote mesh__D003881 77; was DERMATOMYCOSIS 1963-76   
% 210.03/210.18  |- skos__altLabel mesh__D003881 Skin Diseases, Fungal
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D003881 1997
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D003881 1994
% 210.03/210.18  |- skos__annotation mesh__D003881
% 210.03/210.18       fungus dis of skin; coord IM with specific fungus or fungal dis %28%IM%29%%A%  
% 210.03/210.18  |- mesh__onlineNote mesh__D003881
% 210.03/210.18       use DERMATOMYCOSES to search DERMATOMYCOSIS 1966-76   
% 210.03/210.18  |- mesh__dateRevised mesh__D003881 1993-06-02
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D003881 1999
% 210.03/210.18  |- skos__altLabel mesh__D003881 Dermatophytoses
% 210.03/210.18  |- skos__prefLabel mesh__D003881 Dermatomycoses
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D003881 2002
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D003881 1995
% 210.03/210.18  |- rdf__type mesh__D003881sskos__Concept
% 210.03/210.18  |- skos__broader mesh__D003881smesh__D012874
% 210.03/210.18  |- mesh__recordOriginator mesh__D003881 NLM
% 210.03/210.18  |- mesh__recordMaintainer mesh__D003881 TAP
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D003881 2003
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D003881 2005
% 210.03/210.18  |- mesh__dateCreated mesh__D003881 1999-01-01
% 210.03/210.18  |- mesh__publicMeSHNote mesh__D003881 77; was DERMATOMYCOSIS 1963-76   
% 210.03/210.18  |- skos__broader mesh__D003881smesh__D009181
% 210.03/210.18  |- skos__scopeNote mesh__D003881
% 210.03/210.18       Superficial infections of the skin or its appendages by any of various fungi.%A%    
% 210.03/210.18  |- skos__altLabel mesh__D003881 Fungal Skin Diseases
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D003881 2004
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D003881 2006
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D003881 2000
% 210.03/210.18  |- skos__altLabel mesh__D011515 Fatol Brand of Prothionamide
% 210.03/210.18  |- mesh__activeMeSHYear mesh__D011515 2006
% 210.03/210.18  |- rdf__type mesh__D011515sskos__Concept
% 210.03/210.18  |- skos__broader mesh__D011515smesh__D007539
% 210.03/210.18  |- mesh__historyNote mesh__D011515
% 210.03/210.18       91%28%75%29%; was see under ISONICOTINIC ACIDS 1975-90   
% 210.03/210.18  |- mesh__recordAuthorizer mesh__D011515 sjn
% 210.03/210.18  |- skos__prefLabel mesh__D011515 Prothionamide
% 210.03/210.18  |- mesh__dateRevised mesh__D011515 2005-06-30
% 210.03/210.18  |- skos__altLabel mesh__D011515 Sanavita Brand of Prothionamide
% 210.03/210.18  |- skos__historyNote mesh__D011515 Isonicotinic Acids %28%1970-1974%29%
% 210.03/210.18  |- skos__altLabel mesh__D011515 Wernigerode Brand of Prothionamide
% 210.03/210.18  |- mesh__dateCreated mesh__D011515 1974-11-19
% 210.03/210.18  |- mesh__recordMaintainer mesh__D011515 lkw
% 210.03/210.18  |- mesh__publicMeSHNote mesh__D011515
% 210.03/210.18       91; was see under ISONICOTINIC ACIDS 1975-90   
% 210.03/210.18  |- mesh__recordOriginator mesh__D011515 NLM
% 210.03/210.18  |- mesh__dateEstablished mesh__D011515 1991-01-01
% 210.03/210.18  |- skos__altLabel mesh__D011515 Protionamide
% 210.03/210.18  |- skos__historyNote mesh__D011515 Sulfides %28%1972-1974%29%
% 210.03/210.18  |- skos__scopeNote mesh__D011515
% 210.03/210.18       Antitubercular agent similar in action and side effects to ETHIONAMIDE. It is used mostly in combination with other agents.%A%    
% 210.03/210.18  |- rdf__type mesh__D016200sskos__Concept
% 210.03/210.18  |- mesh__dateCreated mesh__D016200 1990-06-17
% 210.03/210.18  |- skos__hiddenLabel mesh__D016200 Histone H1 Kinase, Growth Associated
% 210.03/210.18  |- skos__hiddenLabel mesh__D016200 Mitosis Promoting Factor
% 210.03/210.18  |- skos__altLabel mesh__D016200 M Phase-Promoting Factor
% 210.03/210.18  |- skos__broader mesh__D016200smesh__D018844
% 210.03/210.18  |- mesh__recordAuthorizer mesh__D016200 sjn
% 210.03/210.18  |- skos__altLabel mesh__D016200 Histone H1 Kinase, Growth-Associated
% 210.03/210.18  |- skos__broader mesh__D016200smesh__D006133
% 210.03/210.18  |- skos__hiddenLabel mesh__D016200 M Phase Promoting Factor
% 210.03/210.18  |- skos__related mesh__D016200smesh__D016213
% 210.03/210.19  |- mesh__historyNote mesh__D016200
% 210.03/210.19       91; HISTONE H1 KINASE, M-PHASE-SPECIFIC was HISTONE H1 KINASE, M PHASE-SPECIFIC 1991-93%A%  
% 210.03/210.19  |- skos__historyNote mesh__D016200 Growth Substances %28%1979-1990%29%
% 210.03/210.19  |- mesh__recordOriginator mesh__D016200 AGS
% 210.03/210.19  |- skos__hiddenLabel mesh__D016200 Maturation Promoting Factor
% 210.03/210.19  |- mesh__recordMaintainer mesh__D016200 ssb
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D016200 2006
% 210.03/210.19  |- skos__hiddenLabel mesh__D016200 Histone H1 Kinase, M Phase Specific
% 210.03/210.19  |- skos__annotation mesh__D016200
% 210.03/210.19       a protein kinase; /drug eff permitted; DF: MPF   
% 210.03/210.19  |- skos__altLabel mesh__D016200 Mitosis-Promoting Factor
% 210.03/210.19  |- mesh__publicMeSHNote mesh__D016200
% 210.03/210.19       91; HISTONE H1 KINASE, M-PHASE-SPECIFIC was HISTONE H1 KINASE, M PHASE-SPECIFIC 1991-93%A%  
% 210.03/210.19  |- mesh__dateRevised mesh__D016200 2005-06-30
% 210.03/210.19  |- skos__scopeNote mesh__D016200
% 210.03/210.19       Protein kinase that drives both the mitotic and meiotic cycles in all eukaryotic organisms. In meiosis it induces immature oocytes to undergo meiotic maturation. In mitosis it has a role in the G2/M phase transition. Once activated by CYCLINS; MPF directly phosphorylates some of the proteins involved in nuclear envelope breakdown, chromosome condensation, spindle assembly, and the degradation of cyclins. The catalytic subunit of MPF is PROTEIN P34CDC2.%A%    
% 210.03/210.19  |- skos__altLabel mesh__D016200 Histone H1 Kinase, M-Phase-Specific
% 210.03/210.19  |- skos__prefLabel mesh__D016200 Maturation-Promoting Factor
% 210.03/210.19  |- mesh__dateEstablished mesh__D016200 1991-01-01
% 210.03/210.19  |- mesh__publicMeSHNote mesh__D002789
% 210.03/210.19       91; was see under 3-HYDROXYSTEROID DEHYDROGENASES 1978-90%A%  
% 210.03/210.19  |- skos__hiddenLabel mesh__D002789 Oxidase, Cholesterol
% 210.03/210.19  |- mesh__recordOriginator mesh__D002789 RLS
% 210.03/210.19  |- rdf__type mesh__D002789sskos__Concept
% 210.03/210.19  |- mesh__dateRevised mesh__D002789 2003-07-09
% 210.03/210.19  |- mesh__dateCreated mesh__D002789 1977-04-15
% 210.03/210.19  |- mesh__recordMaintainer mesh__D002789 ssb
% 210.03/210.19  |- skos__prefLabel mesh__D002789 Cholesterol Oxidase
% 210.03/210.19  |- mesh__dateEstablished mesh__D002789 1991-01-01
% 210.03/210.19  |- skos__historyNote mesh__D002789
% 210.03/210.19       Hydroxysteroid Dehydrogenases %28%1966-1977%29%
% 210.03/210.19  |- skos__historyNote mesh__D002789 Cholesterol %28%1966-1977%29%
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D002789 2004
% 210.03/210.19  |- mesh__historyNote mesh__D002789
% 210.03/210.19       91%28%78%29%; was see under 3-HYDROXYSTEROID DEHYDROGENASES 1978-90%A%  
% 210.03/210.19  |- mesh__recordAuthorizer mesh__D002789 sjn
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D002789 2005
% 210.03/210.19  |- skos__scopeNote mesh__D002789
% 210.03/210.19       An enzyme that catalyzes the oxidation of cholesterol in the presence of molecular oxygen to 4-cholesten-3-one and hydrogen peroxide. The enzyme is not specific for cholesterol, but will also oxidize other 3-hydroxysteroids. EC 1.1.3.6.%A%    
% 210.03/210.19  |- skos__broader mesh__D002789smesh__D015096
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D002789 2006
% 210.03/210.19  |- mesh__dateEstablished mesh__D035165 2003-01-01
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D035165 2006
% 210.03/210.19  |- mesh__historyNote mesh__D035165 2003   
% 210.03/210.19  |- skos__broader mesh__D035165smesh__D014157
% 210.03/210.19  |- mesh__dateRevised mesh__D035165 2005-06-30
% 210.03/210.19  |- mesh__recordAuthorizer mesh__D035165 sjn
% 210.03/210.19  |- skos__broader mesh__D035165smesh__D004268
% 210.03/210.19  |- rdf__type mesh__D035165sskos__Concept
% 210.03/210.19  |- mesh__recordOriginator mesh__D035165 jmp
% 210.03/210.19  |- mesh__publicMeSHNote mesh__D035165 2003   
% 210.03/210.19  |- mesh__recordMaintainer mesh__D035165 ags
% 210.03/210.19  |- skos__altLabel mesh__D035165 General Transcription Factors
% 210.03/210.19  |- mesh__dateCreated mesh__D035165 2002-07-03
% 210.03/210.19  |- skos__scopeNote mesh__D035165
% 210.03/210.19       Transcription factors that form transcription initiation complexes on DNA, bind to specific DNA-DIRECTED RNA POLYMERASES and are required to initiate transcription.  Although their binding may be localized to distinct sequence and structural motifs within the DNA they are considered non-specific with regard to the specific gene being transcribed.%A%    
% 210.03/210.19  |- skos__prefLabel mesh__D035165 Transcription Factors, General
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D007474 1996
% 210.03/210.19  |- rdf__type mesh__D007474sskos__Concept
% 210.03/210.19  |- mesh__recordAuthorizer mesh__D007474 ags
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D007474 1995
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D007474 2003
% 210.03/210.19  |- skos__prefLabel mesh__D007474 Ion Exchange
% 210.03/210.19  |- mesh__recordMaintainer mesh__D007474 ags
% 210.03/210.19  |- skos__scopeNote mesh__D007474
% 210.03/210.19       Reversible chemical reaction between a solid, often one of the ION EXCHANGE RESINS, and a fluid whereby ions may be exchanged from one substance to another. This technique is used in water purification, in research, and in industry.%A%    
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D007474 1994
% 210.03/210.19  |- skos__annotation mesh__D007474
% 210.03/210.19       a physicochem process: do not confuse with ION TRANSPORT, which takes place in biol systems; NIM; no qualif%A%  
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D007474 2006A
% 210.03/210.19  |- mesh__dateCreated mesh__D007474 1999-01-01
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D007474 1993
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D007474 1999
% 210.03/210.19  |- skos__broader mesh__D007474smesh__D002627
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D007474 2002
% 210.03/210.19  |- skos__hiddenLabel mesh__D007474 Exchange, Ion
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D007474 2006
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D007474 1998
% 210.03/210.19  |- mesh__recordOriginator mesh__D007474 NLM
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D007474 2001
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D007474 1997
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D007474 2000
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D007474 2005
% 210.03/210.19  |- mesh__dateRevised mesh__D007474 2005-07-18
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D007474 2004
% 210.03/210.19  |- mesh__recordAuthorizer mesh__D015906 SJN
% 210.03/210.19  |- mesh__dateCreated mesh__D015906 1989-05-15
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D015906 1998
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D015906 2002
% 210.03/210.19  |- skos__altLabel mesh__D015906 Angioplasty, Coronary Balloon
% 210.03/210.19  |- skos__altLabel mesh__D015906 Coronary Angioplasty, Transluminal Balloon
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D015906 2003
% 210.03/210.19  |- skos__prefLabel mesh__D015906
% 210.03/210.19       Angioplasty, Transluminal, Percutaneous Coronary
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D015906 1999
% 210.03/210.19  |- skos__scopeNote mesh__D015906
% 210.03/210.19       Dilatation of an occluded coronary artery %28%or arteries%29% by means of a balloon catheter to restore myocardial blood supply.%A%    
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D015906 2004
% 210.03/210.19  |- mesh__dateRevised mesh__D015906 1997-06-20
% 210.03/210.19  |- mesh__historyNote mesh__D015906 90   
% 210.03/210.19  |- mesh__recordOriginator mesh__D015906 PLS
% 210.03/210.19  |- skos__historyNote mesh__D015906 Dilatation %28%1978-1981%29%
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D015906 2005
% 210.03/210.19  |- skos__hiddenLabel mesh__D015906 Angioplasties, Coronary Balloon
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D015906 2000
% 210.03/210.19  |- skos__broader mesh__D015906smesh__D000800
% 210.03/210.19  |- skos__historyNote mesh__D015906
% 210.03/210.19       Angioplasty, Transluminal %28%1982-1989%29%
% 210.03/210.19  |- skos__annotation mesh__D015906
% 210.03/210.19       coord IM with disease /ther %28%IM%29%, not /surg; do not use /util except by MeSH definition; if laser, coord IM with ANGIOPLASTY, BALLOON, LASER-ASSISTED %28%IM%29%; DF: note short X ref%A%  
% 210.03/210.19  |- mesh__publicMeSHNote mesh__D015906 90   
% 210.03/210.19  |- skos__altLabel mesh__D015906 PTCA
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D015906 2006
% 210.03/210.19  |- skos__hiddenLabel mesh__D015906 Balloon Angioplasties, Coronary
% 210.03/210.19  |- skos__hiddenLabel mesh__D015906 Balloon Angioplasty, Coronary
% 210.03/210.19  |- skos__historyNote mesh__D015906 Heart Catheterization %28%1976-1981%29%
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D015906 2001
% 210.03/210.19  |- skos__historyNote mesh__D015906 Coronary Vessels %28%1978-1989%29%
% 210.03/210.19  |- mesh__dateEstablished mesh__D015906 1990-01-01
% 210.03/210.19  |- skos__broader mesh__D015906smesh__D009204
% 210.03/210.19  |- skos__historyNote mesh__D015906 Coronary Disease %28%1980-1989%29%
% 210.03/210.19  |- rdf__type mesh__D015906sskos__Concept
% 210.03/210.19  |- skos__altLabel mesh__D015906
% 210.03/210.19       Percutaneous Transluminal Coronary Angioplasty
% 210.03/210.19  |- skos__altLabel mesh__D015906 Angioplasty, Balloon, Coronary
% 210.03/210.19  |- skos__altLabel mesh__D015906 Balloon Dilatation, Coronary Artery
% 210.03/210.19  |- mesh__recordMaintainer mesh__D015906 PXP
% 210.03/210.19  |- skos__altLabel mesh__D015906 Transluminal Coronary Balloon Dilatation
% 210.03/210.19  |- skos__hiddenLabel mesh__D015906 Coronary Balloon Angioplasty
% 210.03/210.19  |- skos__hiddenLabel mesh__D015906 Coronary Balloon Angioplasties
% 210.03/210.19  |- skos__broader mesh__D011453Q000031smesh__D011453
% 210.03/210.19  |- mesh__preferredCombination mesh__D011453Q000031smesh__D011465
% 210.03/210.19  |- rdf__type mesh__D011453Q000031smesh__CompoundConcept
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D015108 2004
% 210.03/210.19  |- skos__hiddenLabel mesh__D015108 4 Hydroxyaminoquinoline N oxide
% 210.03/210.19  |- skos__broader mesh__D015108smesh__D003497
% 210.03/210.19  |- skos__scopeNote mesh__D015108
% 210.03/210.19       A potent mutagen and carcinogen. It is a reduction product of 4-NITROQUINOLINE-1-OXIDE. It binds with nucleic acids and inactivates both bacteria and bacteriophage.%A%    
% 210.03/210.19  |- skos__historyNote mesh__D015108 Cyclic N-Oxides %28%1972-1974%29%
% 210.03/210.19  |- mesh__dateRevised mesh__D015108 2000-06-22
% 210.03/210.19  |- skos__hiddenLabel mesh__D015108 4 Hydroxyaminoquinoline 1 oxide
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D015108 2006
% 210.03/210.19  |- mesh__dateCreated mesh__D015108 1974-11-14
% 210.03/210.19  |- mesh__recordMaintainer mesh__D015108 CCR
% 210.03/210.19  |- rdf__type mesh__D015108sskos__Concept
% 210.03/210.19  |- mesh__dateEstablished mesh__D015108 1991-01-01
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D015108 2002
% 210.03/210.19  |- skos__historyNote mesh__D015108 Hydroxylamines %28%1974%29%
% 210.03/210.19  |- skos__prefLabel mesh__D015108 4-Hydroxyaminoquinoline-1-oxide
% 210.03/210.19  |- mesh__recordAuthorizer mesh__D015108 sjn
% 210.03/210.19  |- mesh__publicMeSHNote mesh__D015108
% 210.03/210.19       91; was see under AMINOQUINOLINES 1975-90   
% 210.03/210.19  |- mesh__historyNote mesh__D015108
% 210.03/210.19       91%28%75%29%; was see under AMINOQUINOLINES 1975-90   
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D015108 2003
% 210.03/210.19  |- skos__broader mesh__D015108smesh__D006898
% 210.03/210.19  |- skos__historyNote mesh__D015108 Quinolines %28%1972-1974%29%
% 210.03/210.19  |- skos__broader mesh__D015108smesh__D000634
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D015108 2001
% 210.03/210.19  |- skos__annotation mesh__D015108 D25-26 qualif   
% 210.03/210.19  |- skos__altLabel mesh__D015108 4-Hydroxyaminoquinoline-N-oxide
% 210.03/210.19  |- mesh__recordOriginator mesh__D015108 NLM
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D015108 2005
% 210.03/210.19  |- skos__broader mesh__D003882smesh__D012871
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D003882 2003
% 210.03/210.19  |- skos__hiddenLabel mesh__D003882 Dermatomyositides, Childhood Type
% 210.03/210.19  |- skos__hiddenLabel mesh__D003882 Dermatomyositides, Adult Type
% 210.03/210.19  |- skos__broader mesh__D003882smesh__D017285
% 210.03/210.19  |- mesh__dateCreated mesh__D003882 1999-01-01
% 210.03/210.19  |- skos__hiddenLabel mesh__D003882 Dermatopolymyositides
% 210.03/210.19  |- skos__annotation mesh__D003882
% 210.03/210.19       coord IM with PARANEOPLASTIC SYNDROMES %28%IM%29% if pertinent   
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D003882 2006
% 210.03/210.19  |- skos__hiddenLabel mesh__D003882 Adult Type Dermatomyositis
% 210.03/210.19  |- skos__prefLabel mesh__D003882 Dermatomyositis
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D003882 2002
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D003882 2005
% 210.03/210.19  |- mesh__dateRevised mesh__D003882 1999-11-03
% 210.03/210.19  |- skos__hiddenLabel mesh__D003882 Childhood Type Dermatomyositis
% 210.03/210.19  |- skos__altLabel mesh__D003882 Dermatopolymyositis
% 210.03/210.19  |- skos__hiddenLabel mesh__D003882 Polymyositis Dermatomyositis
% 210.03/210.19  |- skos__hiddenLabel mesh__D003882 Dermatomyositides
% 210.03/210.19  |- skos__hiddenLabel mesh__D003882 Polymyositis-Dermatomyositides
% 210.03/210.19  |- mesh__recordAuthorizer mesh__D003882 sjn
% 210.03/210.19  |- skos__broader mesh__D003882smesh__D009220
% 210.03/210.19  |- mesh__recordMaintainer mesh__D003882 KEV
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D003882 2001
% 210.03/210.19  |- skos__hiddenLabel mesh__D003882 Childhood Type Dermatomyositides
% 210.03/210.19  |- skos__hiddenLabel mesh__D003882 Adult Type Dermatomyositides
% 210.03/210.19  |- skos__scopeNote mesh__D003882
% 210.03/210.19       A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash %28%or less often an exfoliative dermatitis%29% involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. %28%From Adams et al., Principles of Neurology, 6th ed, pp1405-6%29%%A%    
% 210.03/210.19  |- rdf__type mesh__D003882sskos__Concept
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D003882 2004
% 210.03/210.19  |- skos__altLabel mesh__D003882 Polymyositis-Dermatomyositis
% 210.03/210.19  |- skos__broader mesh__D003882smesh__D003240
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D003882 2000
% 210.03/210.19  |- mesh__recordOriginator mesh__D003882 NLM
% 210.03/210.19  |- mesh__historyNote mesh__D003084
% 210.03/210.19       91%28%75%29%; was see under POLYAMINES 1975-90   
% 210.03/210.19  |- mesh__dateRevised mesh__D003084 2004-07-07
% 210.03/210.19  |- mesh__publicMeSHNote mesh__D003084
% 210.03/210.19       91; was see under POLYAMINES 1975-90   
% 210.03/210.19  |- skos__altLabel mesh__D003084 Colestipol HCl
% 210.03/210.19  |- skos__broader mesh__D003084smesh__D011073
% 210.03/210.19  |- mesh__recordMaintainer mesh__D003084 jmp
% 210.03/210.19  |- skos__historyNote mesh__D003084 Polymers %28%1971-1974%29%
% 210.03/210.19  |- skos__broader mesh__D003084smesh__D011108
% 210.03/210.19  |- skos__prefLabel mesh__D003084 Colestipol
% 210.03/210.19  |- mesh__dateCreated mesh__D003084 1974-11-27
% 210.03/210.19  |- skos__historyNote mesh__D003084 Polyamines %28%1972-1974%29%
% 210.03/210.19  |- skos__hiddenLabel mesh__D003084 U 26,597 A
% 210.03/210.19  |- skos__scopeNote mesh__D003084
% 210.03/210.19       Highly crosslinked and insoluble basic anion exchange resin used as anticholesteremic. It may also may reduce triglyceride levels.%A%    
% 210.03/210.19  |- mesh__dateEstablished mesh__D003084 1991-01-01
% 210.03/210.19  |- mesh__recordAuthorizer mesh__D003084 sjn
% 210.03/210.19  |- mesh__recordOriginator mesh__D003084 NLM
% 210.03/210.19  |- skos__historyNote mesh__D003084 Ethers, Cyclic %28%1972-1974%29%
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D003084 2006
% 210.03/210.19  |- skos__hiddenLabel mesh__D003084 Hydrochloride, Colestipol
% 210.03/210.19  |- skos__hiddenLabel mesh__D003084 HCl, Colestipol
% 210.03/210.19  |- rdf__type mesh__D003084sskos__Concept
% 210.03/210.19  |- skos__hiddenLabel mesh__D003084 U26,597 A
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D003084 2005
% 210.03/210.19  |- rdf__type mesh__D011516sskos__Concept
% 210.03/210.19  |- skos__altLabel mesh__D011516 Blood Coagulation Factor II
% 210.03/210.19  |- skos__altLabel mesh__D011516 Differentiation Reversal Factor
% 210.03/210.19  |- mesh__recordMaintainer mesh__D011516 ssb
% 210.03/210.19  |- skos__hiddenLabel mesh__D011516 II, Coagulation Factor
% 210.03/210.19  |- skos__related mesh__D011516smesh__D003029
% 210.03/210.19  |- skos__broader mesh__D011516smesh__D004792
% 210.03/210.19  |- skos__altLabel mesh__D011516 Factor II
% 210.03/210.19  |- skos__hiddenLabel mesh__D011516 Factor II, Coagulation
% 210.03/210.19  |- mesh__recordAuthorizer mesh__D011516 sjn
% 210.03/210.19  |- skos__prefLabel mesh__D011516 Prothrombin
% 210.03/210.19  |- skos__hiddenLabel mesh__D011516 Factor, Differentiation Reversal
% 210.03/210.19  |- skos__annotation mesh__D011516
% 210.03/210.19       a blood coag factor; an enzyme precursor   
% 210.03/210.19  |- mesh__dateRevised mesh__D011516 2005-06-30
% 210.03/210.19  |- skos__scopeNote mesh__D011516
% 210.03/210.19       A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia.%A%    
% 210.03/210.19  |- skos__broader mesh__D011516smesh__D001779
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D011516 2006
% 210.03/210.19  |- mesh__dateCreated mesh__D011516 1999-01-01
% 210.03/210.19  |- mesh__recordOriginator mesh__D011516 NLM
% 210.03/210.19  |- skos__altLabel mesh__D011516 Coagulation Factor II
% 210.03/210.19  |- skos__prefLabel mesh__D016201 Receptors, Lymphocyte Homing
% 210.03/210.19  |- mesh__historyNote mesh__D016201
% 210.03/210.19       91; ANTIGENS, CD44, CD44 ANTIGENS %26% PgP-1 ANTIGEN were see RECEPTORS, LYMPHOCYTE HOMING 1991-93;ANTIGENS, CD44 was ANTIGEN, CD44 see RECEPTORS, LYMPHOCYTE HOMING 1991-92; CD44 ANTIGENS was CD44 ANTIGEN see RECEPTORS, LYMPHOCYTE HOMING 1991-92%A%  
% 210.03/210.19  |- skos__hiddenLabel mesh__D016201 Antigen Family, Hermes
% 210.03/210.19  |- skos__annotation mesh__D016201 DF: RECEPT LYMPHOCYTE HOMING   
% 210.03/210.19  |- skos__broader mesh__D016201smesh__D015815
% 210.03/210.19  |- skos__broader mesh__D016201smesh__D011971
% 210.03/210.19  |- skos__hiddenLabel mesh__D016201 Homing Receptors, Lymphocyte
% 210.03/210.19  |- skos__scopeNote mesh__D016201
% 210.03/210.19       Cell surface glycoproteins on lymphocytes and other leukocytes that mediate adhesion to specialized blood vessels called high endothelial venules. Several different classes of lymphocyte homing receptors have been identified, and they appear to target different surface molecules %28%addressins%29% on high endothelial venules in different tissues. The adhesion plays a crucial role in the trafficking of lymphocytes.%A%    
% 210.03/210.19  |- skos__altLabel mesh__D016201 Homing Receptor, Lymph Node
% 210.03/210.19  |- skos__altLabel mesh__D016201 Lymph Node Homing Receptor
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D016201 2006
% 210.03/210.19  |- skos__historyNote mesh__D016201 Cell Adhesion Molecules %28%1990%29%
% 210.03/210.19  |- mesh__dateRevised mesh__D016201 2005-06-30
% 210.03/210.19  |- skos__altLabel mesh__D016201 Receptor, Lymph Node Homing
% 210.03/210.19  |- skos__hiddenLabel mesh__D016201 Receptors, T-Cell Homing
% 210.03/210.19  |- mesh__dateCreated mesh__D016201 1990-04-24
% 210.03/210.19  |- mesh__recordOriginator mesh__D016201 RLS
% 210.03/210.19  |- mesh__publicMeSHNote mesh__D016201
% 210.03/210.19       91; ANTIGENS, CD44, CD44 ANTIGENS %26% PgP-1 ANTIGENSwere see RECEPTORS, LYMPHOCYTE HOMING 1991-93; ANTIGENS, CD44 was ANTIGEN, CD44 see RECEPTORS, LYMPHOCYTE HOMING 1991-92; CD44 ANTIGENS was CD44 ANTIGEN see RECEPTORS, LYMPHOCYTE HOMING 1991-92%A%  
% 210.03/210.19  |- skos__altLabel mesh__D016201 Lymphocyte Homing Receptors
% 210.03/210.19  |- rdf__type mesh__D016201sskos__Concept
% 210.03/210.19  |- skos__historyNote mesh__D016201 Antigens, CD %28%1990%29%
% 210.03/210.19  |- skos__hiddenLabel mesh__D016201 Homing Receptors, T Cell
% 210.03/210.19  |- mesh__recordAuthorizer mesh__D016201 sjn
% 210.03/210.19  |- skos__historyNote mesh__D016201
% 210.03/210.19       Antigens, Differentiation %28%1988-1990%29%
% 210.03/210.19  |- skos__hiddenLabel mesh__D016201 T-Cell Homing Receptors
% 210.03/210.19  |- mesh__dateEstablished mesh__D016201 1991-01-01
% 210.03/210.19  |- mesh__onlineNote mesh__D016201
% 210.03/210.19       use RECEPTORS, LYMPHOCYTE HOMING to search ANTIGENS, CD44, CD44 ANTIGENS %26% PgP-1 ANTIGEN 1991-93 %26% ANTIGEN, CD44 %26% CD44 ANTIGEN 1991-92%A%  
% 210.03/210.19  |- skos__broader mesh__D016201smesh__D015703
% 210.03/210.19  |- mesh__recordMaintainer mesh__D016201 ssb
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D035964 2006
% 210.03/210.19  |- mesh__publicMeSHNote mesh__D035964 2003   
% 210.03/210.19  |- skos__broader mesh__D035964smesh__D006573
% 210.03/210.19  |- mesh__recordMaintainer mesh__D035964 ssb
% 210.03/210.19  |- mesh__recordAuthorizer mesh__D035964 sjn
% 210.03/210.19  |- mesh__dateRevised mesh__D035964 2004-07-07
% 210.03/210.19  |- skos__prefLabel mesh__D035964 Oxocins
% 210.03/210.19  |- rdf__type mesh__D035964sskos__Concept
% 210.03/210.19  |- skos__altLabel mesh__D035964 Oxocenes
% 210.03/210.19  |- skos__scopeNote mesh__D035964
% 210.03/210.19       Compounds based on an 8-membered heterocyclic ring including an oxygen. They can be considered medium ring ethers.%A%    
% 210.03/210.19  |- mesh__recordOriginator mesh__D035964 ssb
% 210.03/210.19  |- mesh__historyNote mesh__D035964 2003   
% 210.03/210.19  |- mesh__dateEstablished mesh__D035964 2003-01-01
% 210.03/210.19  |- mesh__dateCreated mesh__D035964 2002-07-03
% 210.03/210.19  |- skos__broader mesh__D035964smesh__D004988
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D035964 2005
% 210.03/210.19  |- mesh__dateCreated mesh__D007475 1999-01-01
% 210.03/210.19  |- skos__hiddenLabel mesh__D007475 Resins, Ion Exchange
% 210.03/210.19  |- skos__annotation mesh__D007475 D25-26 qualif   
% 210.03/210.19  |- skos__scopeNote mesh__D007475
% 210.03/210.19       High molecular weight, insoluble polymers which contain functional groups that are capable of undergoing exchange reactions %28%ION EXCHANGE%29% with either cations or anions.%A%    
% 210.03/210.19  |- skos__broader mesh__D007475smesh__D019995
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D007475 2006
% 210.03/210.19  |- skos__related mesh__D007475smesh__D002852
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D007475 2005
% 210.03/210.19  |- mesh__dateRevised mesh__D007475 2003-07-09
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D007475 2004
% 210.03/210.19  |- mesh__recordMaintainer mesh__D007475 ssb
% 210.03/210.19  |- rdf__type mesh__D007475sskos__Concept
% 210.03/210.19  |- skos__hiddenLabel mesh__D007475 Exchange Resins, Ion
% 210.03/210.19  |- mesh__recordOriginator mesh__D007475 NLM
% 210.03/210.19  |- skos__prefLabel mesh__D007475 Ion Exchange Resins
% 210.03/210.19  |- mesh__recordAuthorizer mesh__D007475 sjn
% 210.03/210.19  |- skos__broader mesh__D015907smesh__D004724
% 210.03/210.19  |- mesh__recordAuthorizer mesh__D015907 sjn
% 210.03/210.19  |- skos__related mesh__D015907smesh__D007047
% 210.03/210.19  |- skos__altLabel mesh__D015907 Uteroscopy
% 210.03/210.19  |- mesh__publicMeSHNote mesh__D015907 90; was see ENDOSCOPY 1979-89   
% 210.03/210.19  |- skos__prefLabel mesh__D015907 Hysteroscopy
% 210.03/210.19  |- mesh__recordMaintainer mesh__D015907 KEV
% 210.03/210.19  |- skos__scopeNote mesh__D015907
% 210.03/210.19       Endoscopic examination, therapy or surgery of the interior of the uterus.%A%    
% 210.03/210.19  |- skos__altLabel mesh__D015907 Surgical Procedures, Hysteroscopic
% 210.03/210.19  |- mesh__dateRevised mesh__D015907 2002-07-03
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D015907 2005
% 210.03/210.19  |- skos__hiddenLabel mesh__D015907 Surgeries, Hysteroscopic
% 210.03/210.19  |- skos__hiddenLabel mesh__D015907 Uteroscopies
% 210.03/210.19  |- skos__hiddenLabel mesh__D015907 Uterine Endoscopies
% 210.03/210.19  |- skos__broader mesh__D015907smesh__D013509
% 210.03/210.19  |- skos__broader mesh__D015907smesh__D003944
% 210.03/210.19  |- skos__hiddenLabel mesh__D015907 Surgical Procedure, Hysteroscopic
% 210.03/210.19  |- skos__altLabel mesh__D015907 Surgery, Hysteroscopic
% 210.03/210.19  |- skos__altLabel mesh__D015907 Endoscopy, Uterine
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D015907 2003
% 210.03/210.19  |- skos__hiddenLabel mesh__D015907 Procedures, Hysteroscopic Surgical
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D015907 2006
% 210.03/210.19  |- skos__hiddenLabel mesh__D015907 Hysteroscopies
% 210.03/210.19  |- mesh__historyNote mesh__D015907 90; was see ENDOSCOPY 1979-89   
% 210.03/210.19  |- mesh__dateCreated mesh__D015907 1989-10-04
% 210.03/210.19  |- skos__hiddenLabel mesh__D015907 Hysteroscopic Surgical Procedure
% 210.03/210.19  |- skos__historyNote mesh__D015907 Endoscopy %28%1966-1989%29%
% 210.03/210.19  |- skos__hiddenLabel mesh__D015907 Endoscopies, Uterine
% 210.03/210.19  |- skos__broader mesh__D015907smesh__D013513
% 210.03/210.19  |- skos__altLabel mesh__D015907 Hysteroscopic Surgery
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D015907 2004
% 210.03/210.19  |- mesh__recordOriginator mesh__D015907 AGS
% 210.03/210.19  |- skos__hiddenLabel mesh__D015907 Hysteroscopic Surgeries
% 210.03/210.19  |- rdf__type mesh__D015907sskos__Concept
% 210.03/210.19  |- skos__altLabel mesh__D015907 Uterine Endoscopy
% 210.03/210.19  |- mesh__dateEstablished mesh__D015907 1990-01-01
% 210.03/210.19  |- skos__hiddenLabel mesh__D015907 Procedure, Hysteroscopic Surgical
% 210.03/210.19  |- mesh__onlineNote mesh__D015907
% 210.03/210.19       use ENDOSCOPY to search HYSTEROSCOPY 1979-89   
% 210.03/210.19  |- skos__hiddenLabel mesh__D015109 Hydroxylase, p-Hydroxybenzoate
% 210.03/210.19  |- skos__historyNote mesh__D015109 Hydroxylases %28%1971-1974%29%
% 210.03/210.19  |- mesh__dateEstablished mesh__D015109 1991-01-01
% 210.03/210.19  |- skos__broader mesh__D015109smesh__D006899
% 210.03/210.19  |- skos__scopeNote mesh__D015109
% 210.03/210.19       A flavoprotein that catalyzes the synthesis of protocatechuic acid from 4-hydroxybenzoate in the presence of molecular oxygen. EC 1.14.13.2.%A%    
% 210.03/210.19  |- mesh__publicMeSHNote mesh__D015109
% 210.03/210.19       91; was see under HYDROXYLASES 1975-90   
% 210.03/210.19  |- skos__altLabel mesh__D015109 p-Hydroxybenzoate Hydroxylase
% 210.03/210.19  |- mesh__recordOriginator mesh__D015109 NLM
% 210.03/210.19  |- skos__hiddenLabel mesh__D015109 4 Hydroxybenzoate 3 Monooxygenase
% 210.03/210.19  |- mesh__dateRevised mesh__D015109 2004-07-07
% 210.03/210.19  |- skos__hiddenLabel mesh__D015109 p Hydroxybenzoate Hydroxylase
% 210.03/210.19  |- skos__historyNote mesh__D015109 Phenols %28%1971-1974%29%
% 210.03/210.19  |- skos__prefLabel mesh__D015109 4-Hydroxybenzoate-3-Monooxygenase
% 210.03/210.19  |- skos__hiddenLabel mesh__D015109 para Hydroxybenzoate Hydroxylase
% 210.03/210.19  |- mesh__historyNote mesh__D015109
% 210.03/210.19       91%28%75%29%; was see under HYDROXYLASES 1975-90   
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D015109 2005
% 210.03/210.19  |- mesh__recordMaintainer mesh__D015109 ssb
% 210.03/210.19  |- mesh__dateCreated mesh__D015109 1974-11-19
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D015109 2006
% 210.03/210.19  |- skos__altLabel mesh__D015109 para-Hydroxybenzoate Hydroxylase
% 210.03/210.19  |- skos__historyNote mesh__D015109 Benzoates %28%1971-1974%29%
% 210.03/210.19  |- rdf__type mesh__D015109sskos__Concept
% 210.03/210.19  |- skos__hiddenLabel mesh__D015109 Hydroxylase, para-Hydroxybenzoate
% 210.03/210.19  |- mesh__recordAuthorizer mesh__D015109 sjn
% 210.03/210.19  |- skos__scopeNote mesh__D003883
% 210.03/210.19       A family of ascomycetous fungi, order Onygenales, characterized by smooth ascospores. The two genera in the family are Arthroderma and Ctenomyces. Several well-known anamorphic forms are parasitic upon the skin.%A%    
% 210.03/210.19  |- skos__related mesh__D003883smesh__D008864
% 210.03/210.19  |- skos__prefLabel mesh__D003883 Arthrodermataceae
% 210.03/210.19  |- mesh__historyNote mesh__D003883
% 210.03/210.19       99; for ARTHRODERMA use ASCOMYCOTA 1975-98; for NANNIZZIA use MICROSPORUM 1975-98%A%  
% 210.03/210.19  |- mesh__recordOriginator mesh__D003883 NLM
% 210.03/210.19  |- skos__altLabel mesh__D003883 Dermatophytes
% 210.03/210.19  |- mesh__recordMaintainer mesh__D003883 SYSTEM
% 210.03/210.19  |- skos__broader mesh__D003883smesh__D020036
% 210.03/210.19  |- skos__related mesh__D003883smesh__D004821
% 210.03/210.19  |- rdf__type mesh__D003883sskos__Concept
% 210.03/210.19  |- mesh__dateRevised mesh__D003883 2005-06-30
% 210.03/210.19  |- skos__altLabel mesh__D003883 Cutaneous Fungus
% 210.03/210.19  |- skos__related mesh__D003883smesh__D014249
% 210.03/210.19  |- skos__altLabel mesh__D003883 Dermatomyces
% 210.03/210.19  |- mesh__publicMeSHNote mesh__D003883
% 210.03/210.19       99; see DERMATOPHYTES 1963-98; for ARTHRODERMA see ASCOMYCOTA 1975-98; for NANNIZZIA see MICROSPORUM 1975-98%A%  
% 210.03/210.19  |- mesh__recordAuthorizer mesh__D003883 sjn
% 210.03/210.19  |- skos__altLabel mesh__D003883 Cutaneous Fungi
% 210.03/210.19  |- mesh__dateCreated mesh__D003883 1999-01-01
% 210.03/210.19  |- skos__annotation mesh__D003883 infection = DERMATOMYCOSES   
% 210.03/210.19  |- skos__altLabel mesh__D003883 Arthroderma
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D003883 2006
% 210.03/210.19  |- skos__annotation mesh__D003085
% 210.03/210.19       coord IM with organ/diseases %28%IM%29%, as renal colic = COLIC %28%IM%29% + KIDNEY DISEASES %28%IM%29%, biliary colic = COLIC %28%IM%29% + BILIARY TRACT DISEASES or specific %28%IM%29%%A%  
% 210.03/210.19  |- skos__hiddenLabel mesh__D003085 Colic, Infantile
% 210.03/210.19  |- skos__broader mesh__D003085smesh__D015746
% 210.03/210.19  |- skos__altLabel mesh__D003085 Colicky Pain
% 210.03/210.19  |- skos__prefLabel mesh__D003085 Colic
% 210.03/210.19  |- skos__hiddenLabel mesh__D003085 Pain, Colicky
% 210.03/210.19  |- skos__scopeNote mesh__D003085
% 210.03/210.19       A clinical syndrome with intermittent abdominal pain characterized by sudden onset and cessation. It is usually associated with obstruction of the INTESTINES; of the CYSTIC DUCT; or of the URINARY TRACT.%A%    
% 210.03/210.19  |- skos__hiddenLabel mesh__D003085 Cramps, Abdominal
% 210.03/210.19  |- skos__hiddenLabel mesh__D003085 Abdominal Cramp
% 210.03/210.19  |- mesh__recordMaintainer mesh__D003085 lkt
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D003085 2006
% 210.03/210.19  |- skos__hiddenLabel mesh__D003085 Cramp, Abdominal
% 210.03/210.19  |- mesh__dateRevised mesh__D003085 2003-07-09
% 210.03/210.19  |- mesh__dateCreated mesh__D003085 1999-01-01
% 210.03/210.19  |- rdf__type mesh__D003085sskos__Concept
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D003085 2005
% 210.03/210.19  |- mesh__recordOriginator mesh__D003085 NLM
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D003085 2004
% 210.03/210.19  |- mesh__recordAuthorizer mesh__D003085 sjn
% 210.03/210.19  |- skos__related mesh__D011517smesh__D001777
% 210.03/210.19  |- skos__scopeNote mesh__D011517
% 210.03/210.19       Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS.%A%    
% 210.03/210.19  |- skos__hiddenLabel mesh__D011517 Prothrombin Times
% 210.03/210.19  |- mesh__recordMaintainer mesh__D011517 nns
% 210.03/210.19  |- skos__altLabel mesh__D011517 Russell Viper Venom Time
% 210.03/210.19  |- skos__broader mesh__D011517smesh__D045122
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D011517 2005
% 210.03/210.19  |- skos__prefLabel mesh__D011517 Prothrombin Time
% 210.03/210.19  |- mesh__recordOriginator mesh__D011517 NLM
% 210.03/210.19  |- skos__altLabel mesh__D011517 Russells Viper Venom Time
% 210.03/210.19  |- mesh__activeMeSHYear mesh__D011517 2006
% 210.03/210.20  |- mesh__dateCreated mesh__D011517 1999-01-01
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D011517 2004
% 210.03/210.20  |- skos__hiddenLabel mesh__D011517 Test, Quick
% 210.03/210.20  |- rdf__type mesh__D011517sskos__Concept
% 210.03/210.20  |- skos__broader mesh__D011517smesh__D001780
% 210.03/210.20  |- skos__hiddenLabel mesh__D011517 Time, Prothrombin
% 210.03/210.20  |- skos__hiddenLabel mesh__D011517 Times, Prothrombin
% 210.03/210.20  |- mesh__recordAuthorizer mesh__D011517 sjn
% 210.03/210.20  |- mesh__dateRevised mesh__D011517 2003-07-09
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D016202 2003
% 210.03/210.20  |- skos__hiddenLabel mesh__D016202 N Methyl D aspartate
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D016202 2006
% 210.03/210.20  |- skos__historyNote mesh__D016202 Convulsants %28%1975-1990%29%
% 210.03/210.20  |- mesh__historyNote mesh__D016202 91   
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D016202 2004
% 210.03/210.20  |- rdf__type mesh__D016202sskos__Concept
% 210.03/210.20  |- mesh__recordMaintainer mesh__D016202 nns
% 210.03/210.20  |- skos__broader mesh__D016202smesh__D001224
% 210.03/210.20  |- skos__hiddenLabel mesh__D016202 N Methylaspartate
% 210.03/210.20  |- skos__hiddenLabel mesh__D016202 Acid, N-Methyl-D-aspartic
% 210.03/210.20  |- skos__hiddenLabel mesh__D016202 N Methyl D aspartic Acid
% 210.03/210.20  |- mesh__dateEstablished mesh__D016202 1991-01-01
% 210.03/210.20  |- mesh__dateRevised mesh__D016202 2001-07-25
% 210.03/210.20  |- mesh__recordOriginator mesh__D016202 RLS
% 210.03/210.20  |- skos__altLabel mesh__D016202 NMDA
% 210.03/210.20  |- skos__related mesh__D016202smesh__D016194
% 210.03/210.20  |- skos__annotation mesh__D016202
% 210.03/210.20       a glutamate agonist; /biosyn /physiol permitted; DF: note short X ref%A%  
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D016202 2005
% 210.03/210.20  |- mesh__dateCreated mesh__D016202 1990-06-29
% 210.03/210.20  |- skos__prefLabel mesh__D016202 N-Methylaspartate
% 210.03/210.20  |- skos__scopeNote mesh__D016202
% 210.03/210.20       An amino acid that, as the D-isomer, is the defining agonist for the NMDA receptor subtype of glutamate receptors %28%RECEPTORS, NMDA%29%.%A%    
% 210.03/210.20  |- skos__altLabel mesh__D016202 N-Methyl-D-aspartate
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D016202 2002
% 210.03/210.20  |- skos__historyNote mesh__D016202 Aspartic Acid %28%1966-1990%29%
% 210.03/210.20  |- mesh__recordAuthorizer mesh__D016202 sjn
% 210.03/210.20  |- mesh__publicMeSHNote mesh__D016202 91   
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D007476 2006
% 210.03/210.20  |- mesh__dateRevised mesh__D007476 2005-06-30
% 210.03/210.20  |- mesh__historyNote mesh__D007476 76   
% 210.03/210.20  |- skos__historyNote mesh__D007476 Uncoupling Agents %28%1972-1975%29%
% 210.03/210.20  |- skos__historyNote mesh__D007476 Antibiotics %28%1966-1975%29%
% 210.03/210.20  |- mesh__recordMaintainer mesh__D007476 ssb
% 210.03/210.20  |- skos__prefLabel mesh__D007476 Ionophores
% 210.03/210.20  |- mesh__dateCreated mesh__D007476 1975-07-25
% 210.03/210.20  |- mesh__recordAuthorizer mesh__D007476 sjn
% 210.03/210.20  |- skos__historyNote mesh__D007476 Biological Transport %28%1966-1975%29%
% 210.03/210.20  |- rdf__type mesh__D007476sskos__Concept
% 210.03/210.20  |- skos__broader mesh__D007476smesh__D049990
% 210.03/210.20  |- mesh__dateEstablished mesh__D007476 1976-01-01
% 210.03/210.20  |- skos__broader mesh__D007476smesh__D020313
% 210.03/210.20  |- skos__related mesh__D007476smesh__D002463
% 210.03/210.20  |- skos__scopeNote mesh__D007476
% 210.03/210.20       Chemical agents that increase the permeability of biological or artificial lipid membranes to specific ions. Most ionophores are relatively small organic molecules that act as mobile carriers within membranes or coalesce to form ion permeable channels across membranes. Many are antibiotics, and many act as uncoupling agents by short-circuiting the proton gradient across mitochondrial membranes.%A%    
% 210.03/210.20  |- mesh__publicMeSHNote mesh__D007476 76   
% 210.03/210.20  |- mesh__recordOriginator mesh__D007476 RLS
% 210.03/210.20  |- skos__annotation mesh__D015908
% 210.03/210.20       a type of assisted circulation; do not use /util except by MeSH definition%A%  
% 210.03/210.20  |- mesh__recordMaintainer mesh__D015908 PLS
% 210.03/210.20  |- skos__related mesh__D015908smesh__D006353
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D015908 1997
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D015908 2005
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D015908 1991
% 210.03/210.20  |- mesh__recordOriginator mesh__D015908 PLS
% 210.03/210.20  |- skos__historyNote mesh__D015908
% 210.03/210.20       Intra-Aortic Balloon Pumping %28%1977-1989%29%
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D015908 2003
% 210.03/210.20  |- skos__historyNote mesh__D015908 Heart-Assist Devices %28%1986-1989%29%
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D015908 2006
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D015908 2000
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D015908 2004
% 210.03/210.20  |- skos__hiddenLabel mesh__D015908 External Counterpulsation
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D015908 1994
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D015908 2001
% 210.03/210.20  |- skos__scopeNote mesh__D015908
% 210.03/210.20       A technique for assisting the circulation by decreasing the afterload of the left ventricle and augmenting the diastolic pressure. It may be achieved by intra-aortic balloon, or by implanting a special pumping device in the chest, or externally by applying a negative pressure to the lower extremities during cardiac systole.%A%    
% 210.03/210.20  |- mesh__recordAuthorizer mesh__D015908 PLS
% 210.03/210.20  |- skos__historyNote mesh__D015908 Blood Pressure %28%1966-1989%29%
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D015908 1998
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D015908 1992
% 210.03/210.20  |- mesh__dateEstablished mesh__D015908 1990-01-01
% 210.03/210.20  |- rdf__type mesh__D015908sskos__Concept
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D015908 1995
% 210.03/210.20  |- skos__prefLabel mesh__D015908 Counterpulsation
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D015908 2002
% 210.03/210.20  |- skos__broader mesh__D015908smesh__D001243
% 210.03/210.20  |- skos__historyNote mesh__D015908 Assisted Circulation %28%1967-1989%29%
% 210.03/210.20  |- skos__hiddenLabel mesh__D015908 Counterpulsation, Diastolic
% 210.03/210.20  |- mesh__historyNote mesh__D015908 90   
% 210.03/210.20  |- mesh__publicMeSHNote mesh__D015908 90   
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D015908 1996
% 210.03/210.20  |- mesh__dateRevised mesh__D015908 1990-02-16
% 210.03/210.20  |- mesh__dateCreated mesh__D015908 1989-05-15
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D015908 1999
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D015908 1993
% 210.03/210.20  |- skos__altLabel mesh__D040301 Fetal Liver Kinase-1
% 210.03/210.20  |- skos__hiddenLabel mesh__D040301 Flk-1, VEGF Receptor
% 210.03/210.20  |- skos__hiddenLabel mesh__D040301 VEGF Receptor Flk 1
% 210.03/210.20  |- mesh__dateCreated mesh__D040301 2002-07-03
% 210.03/210.20  |- skos__hiddenLabel mesh__D040301
% 210.03/210.20       Vascular Endothelial Growth Factor Receptor 2
% 210.03/210.20  |- skos__altLabel mesh__D040301 Kinase Insert Domain Receptor
% 210.03/210.20  |- skos__altLabel mesh__D040301 VEGFR-2
% 210.03/210.20  |- mesh__recordOriginator mesh__D040301 MDJ
% 210.03/210.20  |- mesh__historyNote mesh__D040301
% 210.03/210.20       2003; for FETAL LIVER KINASE-1, KDR TYROSINE KINASE, FLK-1 RECEPTOR TYROSINE KINASE %26% FLK-1 PROTEIN use RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR 1993-2002; for VEGFR-2 use RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR 1996-2002%A%  
% 210.03/210.20  |- skos__altLabel mesh__D040301 Flk-1 Receptor Tyrosine Kinase
% 210.03/210.20  |- skos__altLabel mesh__D040301 Flk-1 Protein
% 210.03/210.20  |- skos__hiddenLabel mesh__D040301 Flk 1 Receptor Tyrosine Kinase
% 210.03/210.20  |- skos__broader mesh__D040301smesh__D040262
% 210.03/210.20  |- skos__hiddenLabel mesh__D040301 Fetal Liver Kinase 1
% 210.03/210.20  |- skos__altLabel mesh__D040301 KDR Tyrosine Kinase
% 210.03/210.20  |- skos__altLabel mesh__D040301 VEGF Receptor KDR
% 210.03/210.20  |- skos__hiddenLabel mesh__D040301 Flk 1 Protein
% 210.03/210.20  |- mesh__recordMaintainer mesh__D040301 jmp
% 210.03/210.20  |- skos__scopeNote mesh__D040301
% 210.03/210.20       A 200-230-kDa tyrosine kinase receptor for vascular endothelial growth factors found primarily in endothelial and hematopoietic cells and their precursors. VEGFR-2 is important for vascular and hematopoietic development, and mediates almost all endothelial cell responses to VEGF.%A%    
% 210.03/210.20  |- skos__hiddenLabel mesh__D040301 Tyrosine Kinase, KDR
% 210.03/210.20  |- rdf__type mesh__D040301sskos__Concept
% 210.03/210.20  |- skos__historyNote mesh__D040301
% 210.03/210.20       Receptor Protein-Tyrosine Kinases %28%1994-2002%29%
% 210.03/210.20  |- skos__historyNote mesh__D040301 Protein-Tyrosine Kinase %28%1993%29%
% 210.03/210.20  |- mesh__recordAuthorizer mesh__D040301 sjn
% 210.03/210.20  |- mesh__dateRevised mesh__D040301 2005-06-30
% 210.03/210.20  |- mesh__publicMeSHNote mesh__D040301
% 210.03/210.20       2003; VEGFR-2 was indexed under RECEPTORS, PROTEIN-TYROSINE KINASES 1996-2002%A%  
% 210.03/210.20  |- skos__hiddenLabel mesh__D040301 KDR, VEGF Receptor
% 210.03/210.20  |- mesh__dateEstablished mesh__D040301 2003-01-01
% 210.03/210.20  |- skos__prefLabel mesh__D040301
% 210.03/210.20       Vascular Endothelial Growth Factor Receptor-2
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D040301 2006
% 210.03/210.20  |- skos__altLabel mesh__D040301 VEGF Receptor Flk-1
% 210.03/210.20  |- skos__historyNote mesh__D040301
% 210.03/210.20       Receptors, Growth Factor %28%1993-2002%29%
% 210.03/210.20  |- mesh__historyNote mesh__D012610
% 210.03/210.20       91%28%75%29%; was see under MYIASIS 1975-90   
% 210.03/210.20  |- mesh__dateEstablished mesh__D012610 1991-01-01
% 210.03/210.20  |- skos__annotation mesh__D012610
% 210.03/210.20       caused by Cochliomyia hominivorax %28% = DIPTERA%29%   
% 210.03/210.20  |- mesh__dateRevised mesh__D012610 2005-06-30
% 210.03/210.20  |- mesh__recordAuthorizer mesh__D012610 sjn
% 210.03/210.20  |- skos__hiddenLabel mesh__D012610 Screw Worm Infections
% 210.03/210.20  |- skos__hiddenLabel mesh__D012610 Infections, Screw Worm
% 210.03/210.20  |- skos__prefLabel mesh__D012610 Screw Worm Infection
% 210.03/210.20  |- skos__altLabel mesh__D012610 Infection, Screw Worm
% 210.03/210.20  |- mesh__onlineNote mesh__D012610 search MYIASIS 1968-74   
% 210.03/210.20  |- mesh__recordMaintainer mesh__D012610 ags
% 210.03/210.20  |- mesh__publicMeSHNote mesh__D012610 91; was see under MYIASIS 1975-90   
% 210.03/210.20  |- mesh__recordOriginator mesh__D012610 NLM
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D012610 2006
% 210.03/210.20  |- skos__scopeNote mesh__D012610
% 210.03/210.20       Infection with larvae of the blow fly Cochliomyia hominivorax %28%Callitroga americanum%29%, a common cause of disease in livestock in the southern and southwestern U.S.A.%A%    
% 210.03/210.20  |- mesh__dateCreated mesh__D012610 1999-01-01
% 210.03/210.20  |- rdf__type mesh__D012610sskos__Concept
% 210.03/210.20  |- skos__broader mesh__D012610smesh__D009198
% 210.03/210.20  |- rdf__type mesh__D003884sskos__Concept
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D003884 2004
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D003884 2006A
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D003884 2001
% 210.03/210.20  |- skos__prefLabel mesh__D003884 Dermoid Cyst
% 210.03/210.20  |- skos__broader mesh__D003884smesh__D003560
% 210.03/210.20  |- skos__hiddenLabel mesh__D003884 Dermoids
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D003884 2003
% 210.03/210.20  |- mesh__publicMeSHNote mesh__D003884 DERMOID was heading 1968-80   
% 210.03/210.20  |- mesh__dateCreated mesh__D003884 1999-01-01
% 210.03/210.20  |- mesh__historyNote mesh__D003884 DERMOID was heading 1968-80   
% 210.03/210.20  |- skos__broader mesh__D003884smesh__D009373
% 210.03/210.20  |- skos__scopeNote mesh__D003884
% 210.03/210.20       A tumor consisting of displaced ectodermal structures along the lines of embryonic fusion, the wall being formed of epithelium-lined connective tissue, including skin appendages, and containing keratin, sebum, and hair. %28%Stedman, 25th ed%29%%A%    
% 210.03/210.20  |- skos__hiddenLabel mesh__D003884 Cysts, Dermoid
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D003884 2000
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D003884 2006
% 210.03/210.20  |- mesh__recordAuthorizer mesh__D003884 ags
% 210.03/210.20  |- mesh__dateRevised mesh__D003884 2005-07-12
% 210.03/210.20  |- skos__hiddenLabel mesh__D003884 Dermoid Cysts
% 210.03/210.20  |- mesh__recordOriginator mesh__D003884 NLM
% 210.03/210.20  |- skos__altLabel mesh__D003884 Dermoid
% 210.03/210.20  |- mesh__onlineNote mesh__D003884
% 210.03/210.20       use DERMOID CYST to search DERMOID 1968-80   
% 210.03/210.20  |- skos__annotation mesh__D003884
% 210.03/210.20       neoplastic; coord IM with precoord organ/neopl term %28%IM%29%   
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D003884 2005
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D003884 2002
% 210.03/210.20  |- mesh__recordMaintainer mesh__D003884 ags
% 210.03/210.20  |- skos__hiddenLabel mesh__D003884 Cyst, Dermoid
% 210.03/210.20  |- skos__hiddenLabel mesh__D003086 Factor, Colicin
% 210.03/210.20  |- skos__hiddenLabel mesh__D003086 Factor, Bacteriocin
% 210.03/210.20  |- skos__hiddenLabel mesh__D003086 Plasmid, Bacteriocin
% 210.03/210.20  |- skos__scopeNote mesh__D003086
% 210.03/210.20       Plasmids encoding bacterial exotoxins %28%BACTERIOCINS%29%.     
% 210.03/210.20  |- mesh__recordOriginator mesh__D003086 AEP
% 210.03/210.20  |- mesh__recordMaintainer mesh__D003086 nns
% 210.03/210.20  |- skos__historyNote mesh__D003086
% 210.03/210.20       Extrachromosomal Inheritance %28%1968-1977%29%
% 210.03/210.20  |- skos__hiddenLabel mesh__D003086 Bacteriocin Plasmid
% 210.03/210.20  |- mesh__dateRevised mesh__D003086 2003-07-25
% 210.03/210.20  |- skos__hiddenLabel mesh__D003086 Plasmid, Colicin
% 210.03/210.20  |- skos__hiddenLabel mesh__D003086 Factors, Bacteriocin
% 210.03/210.20  |- skos__altLabel mesh__D003086 Colicin Factors
% 210.03/210.20  |- mesh__recordAuthorizer mesh__D003086 sjn
% 210.03/210.20  |- skos__altLabel mesh__D003086 Bacteriocin Factors
% 210.03/210.20  |- skos__historyNote mesh__D003086 Plasmids %28%1975-1977%29%
% 210.03/210.20  |- skos__hiddenLabel mesh__D003086 Factor, Col
% 210.03/210.20  |- skos__hiddenLabel mesh__D003086 Col Factor
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D003086 2005
% 210.03/210.20  |- mesh__historyNote mesh__D003086 2004%28%1978%29%   
% 210.03/210.20  |- skos__hiddenLabel mesh__D003086 Plasmids, Colicin
% 210.03/210.20  |- skos__prefLabel mesh__D003086 Bacteriocin Plasmids
% 210.03/210.20  |- skos__hiddenLabel mesh__D003086 Factors, Colicin
% 210.03/210.20  |- skos__broader mesh__D003086smesh__D010957
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D003086 2006
% 210.03/210.20  |- mesh__publicMeSHNote mesh__D003086
% 210.03/210.20       2004; see COLICIN FACTORS 1991-2003, see PLASMIDS 1978-1990%A%  
% 210.03/210.20  |- skos__hiddenLabel mesh__D003086 Colicin Plasmid
% 210.03/210.20  |- rdf__type mesh__D003086sskos__Concept
% 210.03/210.20  |- skos__hiddenLabel mesh__D003086 Factors, Col
% 210.03/210.20  |- mesh__dateEstablished mesh__D003086 1991-01-01
% 210.03/210.20  |- mesh__dateCreated mesh__D003086 1977-05-09
% 210.03/210.20  |- skos__hiddenLabel mesh__D003086 Bacteriocin Factor
% 210.03/210.20  |- skos__historyNote mesh__D003086 Colicins %28%1966-1977%29%
% 210.03/210.20  |- skos__hiddenLabel mesh__D003086 Colicin Factor
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D003086 2004
% 210.03/210.20  |- skos__altLabel mesh__D003086 Col Factors
% 210.03/210.20  |- skos__hiddenLabel mesh__D003086 Plasmids, Bacteriocin
% 210.03/210.20  |- mesh__dateCreated mesh__D011518 1985-04-25
% 210.03/210.20  |- skos__hiddenLabel mesh__D011518 Proto-Oncogene Proteins, Cellular
% 210.03/210.20  |- skos__scopeNote mesh__D011518
% 210.03/210.20       Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity.%A%    
% 210.03/210.20  |- skos__broader mesh__D011518smesh__D015513
% 210.03/210.20  |- skos__hiddenLabel mesh__D011518 c onc Proteins
% 210.03/210.20  |- skos__hiddenLabel mesh__D011518 Cellular Proto-Oncogene Products
% 210.03/210.20  |- mesh__dateEstablished mesh__D011518 1986-01-01
% 210.03/210.20  |- mesh__publicMeSHNote mesh__D011518
% 210.03/210.20       91; was PROTO-ONCOGENE PROTEINS, CELLULAR 1986-90   
% 210.03/210.20  |- mesh__recordAuthorizer mesh__D011518 sjn
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D011518 2006
% 210.03/210.20  |- mesh__recordOriginator mesh__D011518 RLS
% 210.03/210.20  |- skos__prefLabel mesh__D011518 Proto-Oncogene Proteins
% 210.03/210.20  |- mesh__dateRevised mesh__D011518 2005-06-30
% 210.03/210.20  |- skos__altLabel mesh__D011518 Cellular Proto-Oncogene Proteins
% 210.03/210.20  |- skos__hiddenLabel mesh__D011518 Cellular Proto Oncogene Proteins
% 210.03/210.20  |- skos__historyNote mesh__D011518 Proteins %28%1966-1985%29%
% 210.03/210.20  |- mesh__recordMaintainer mesh__D011518 DRC
% 210.03/210.20  |- rdf__type mesh__D011518sskos__Concept
% 210.03/210.20  |- skos__historyNote mesh__D011518 Oncogenes %28%1983-1985%29%
% 210.03/210.20  |- mesh__onlineNote mesh__D011518
% 210.03/210.20       use PROTO-ONCOGENE PROTEINS to search PROTO-ONCOGENE PROTEINS, CELLULAR 1986-90%A%  
% 210.03/210.20  |- skos__historyNote mesh__D011518 Cell Differentiation %28%1966-1985%29%
% 210.03/210.20  |- skos__altLabel mesh__D011518 Proto Oncogene Proteins, Cellular
% 210.03/210.20  |- mesh__historyNote mesh__D011518
% 210.03/210.20       91; was PROTO-ONCOGENE PROTEINS, CELLULAR 1986-90   
% 210.03/210.20  |- skos__hiddenLabel mesh__D011518 Proto Oncogene Products, Cellular
% 210.03/210.20  |- skos__historyNote mesh__D011518
% 210.03/210.20       Gene Expression Regulation %28%1981-1985%29%
% 210.03/210.20  |- skos__annotation mesh__D011518
% 210.03/210.20       GEN or unspecified; prefer specifics; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 210.03/210.20  |- skos__hiddenLabel mesh__D011518 Proto Oncogene Proteins
% 210.03/210.20  |- skos__altLabel mesh__D011518 c-onc Proteins
% 210.03/210.20  |- skos__altLabel mesh__D011518 Proto-Oncogene Products, Cellular
% 210.03/210.20  |- rdf__type mesh__D049188sskos__Concept
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D049188 2006
% 210.03/210.20  |- skos__broader mesh__D049188smesh__D011248
% 210.03/210.20  |- mesh__historyNote mesh__D049188
% 210.03/210.20       2005; use PRENATAL EXPOSURE DELAYED EFFECTS 1991-2004   
% 210.03/210.20  |- mesh__dateCreated mesh__D049188 2004-07-07
% 210.03/210.20  |- skos__historyNote mesh__D049188 Pregnancy %28%1976-2004%29%
% 210.03/210.20  |- mesh__dateRevised mesh__D049188 2005-06-30
% 210.03/210.20  |- mesh__recordMaintainer mesh__D049188 lkt
% 210.03/210.20  |- skos__prefLabel mesh__D049188 Prenatal Injuries
% 210.03/210.20  |- skos__historyNote mesh__D049188
% 210.03/210.20       Prenatal Exposure Delayed Effects %28%1977-2004%29%
% 210.03/210.20  |- skos__hiddenLabel mesh__D049188 Prenatal Injury
% 210.03/210.20  |- skos__hiddenLabel mesh__D049188 Injury, Prenatal
% 210.03/210.20  |- skos__annotation mesh__D049188
% 210.03/210.20       for any damage to the EMBRYO or FETUS; not limited to traumatic injuries%A%  
% 210.03/210.20  |- skos__scopeNote mesh__D049188
% 210.03/210.20       Damages to the EMBRYO or the FETUS before BIRTH. Damages can be caused by any factors including biological, chemical, or physical.%A%    
% 210.03/210.20  |- mesh__recordOriginator mesh__D049188 lkt
% 210.03/210.20  |- mesh__dateEstablished mesh__D049188 2005-01-01
% 210.03/210.20  |- skos__altLabel mesh__D049188 Injuries, Prenatal
% 210.03/210.20  |- mesh__publicMeSHNote mesh__D049188
% 210.03/210.20       2005; see PRENATAL EXPOSURE DELAYED EFFECTS 1991-2004   
% 210.03/210.20  |- mesh__recordAuthorizer mesh__D049188 sjn
% 210.03/210.20  |- skos__broader mesh__D016203smesh__D042846
% 210.03/210.20  |- skos__altLabel mesh__D016203 cdk1 Kinase
% 210.03/210.20  |- skos__altLabel mesh__D016203 Protein p34cdc2
% 210.03/210.20  |- skos__hiddenLabel mesh__D016203 Cyclin Dependent Kinase 1
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D016203 2006
% 210.03/210.20  |- mesh__recordAuthorizer mesh__D016203 sjn
% 210.03/210.20  |- mesh__recordMaintainer mesh__D016203 ssb
% 210.03/210.20  |- skos__prefLabel mesh__D016203 CDC2 Protein Kinase
% 210.03/210.20  |- mesh__dateCreated mesh__D016203 1990-06-19
% 210.03/210.20  |- skos__broader mesh__D016203smesh__D010750
% 210.03/210.20  |- skos__altLabel mesh__D016203 Cyclin-Dependent Kinase 1
% 210.03/210.20  |- mesh__historyNote mesh__D016203 2004%28%1991%29%   
% 210.03/210.20  |- skos__altLabel mesh__D016203 Cdk1 Protein Kinase
% 210.03/210.20  |- mesh__publicMeSHNote mesh__D016203
% 210.03/210.20       2004; see PROTEIN P34CDC2 1991-2003   
% 210.03/210.20  |- skos__altLabel mesh__D016203 Histone Kinase p34%28%cdc2%29%
% 210.03/210.20  |- skos__hiddenLabel mesh__D016203 Protein Kinase, Cdk1
% 210.03/210.20  |- rdf__type mesh__D016203sskos__Concept
% 210.03/210.20  |- skos__hiddenLabel mesh__D016203 p34cdc2, Protein
% 210.03/210.20  |- skos__broader mesh__D016203smesh__D016200
% 210.03/210.20  |- skos__scopeNote mesh__D016203
% 210.03/210.20       Phosphoprotein with protein kinase activity that functions in the G2/M phase transition of the CELL CYCLE. It is the catalytic subunit of the MATURATION-PROMOTING FACTOR and complexes with both CYCLIN A and CYCLIN B in mammalian cells. The maximal activity of cyclin-dependent kinase 1 is achieved when it is fully dephosphorylated.%A%    
% 210.03/210.20  |- skos__altLabel mesh__D016203 cdc2+ Protein
% 210.03/210.20  |- mesh__dateRevised mesh__D016203 2005-06-30
% 210.03/210.20  |- mesh__recordOriginator mesh__D016203 AGS
% 210.03/210.20  |- mesh__dateEstablished mesh__D016203 1991-01-01
% 210.03/210.20  |- skos__historyNote mesh__D016203 Phosphoproteins %28%1987-1990%29%
% 210.03/210.20  |- skos__hiddenLabel mesh__D016203 Protein Kinase, CDC2
% 210.03/210.20  |- skos__broader mesh__D007477smesh__D004573
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D007477 2004
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D007477 2002
% 210.03/210.20  |- mesh__recordMaintainer mesh__D007477 adp
% 210.03/210.20  |- rdf__type mesh__D007477sskos__Concept
% 210.03/210.20  |- skos__annotation mesh__D007477
% 210.03/210.20       avoid: too general; GEN; ionization chamber: index under RADIOMETRY /instrum%A%  
% 210.03/210.20  |- mesh__dateRevised mesh__D007477 2000-06-22
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D007477 2003
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D007477 2001
% 210.03/210.20  |- mesh__recordOriginator mesh__D007477 NLM
% 210.03/210.20  |- skos__prefLabel mesh__D007477 Ions
% 210.03/210.20  |- mesh__recordAuthorizer mesh__D007477 sjn
% 210.03/210.20  |- mesh__dateCreated mesh__D007477 1999-01-01
% 210.03/210.20  |- skos__scopeNote mesh__D007477
% 210.03/210.20       An atom or group of atoms that have a positive or negative electric charge due to a gain %28%negative charge%29% or loss %28%positive charge%29% of one or more electrons. Atoms with a positive charge are known as CATIONS; those with a negative charge are ANIONS.%A%    
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D007477 2006
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D007477 2005
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D012611 1989
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D012611 1992
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D012611 1999
% 210.03/210.20  |- skos__broader mesh__D012611smesh__D005837
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D012611 2005
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D012611 1996
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D012611 1993
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D012611 2002
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D012611 1990
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D012611 2006
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D012611 1997
% 210.03/210.20  |- mesh__dateCreated mesh__D012611 1999-01-01
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D012611 2003
% 210.03/210.20  |- rdf__type mesh__D012611sskos__Concept
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D012611 2000
% 210.03/210.20  |- skos__hiddenLabel mesh__D012611 Scrotums
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D012611 1994
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D012611 2004
% 210.03/210.20  |- skos__prefLabel mesh__D012611 Scrotum
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D012611 1991
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D012611 2001
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D012611 1998
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D012611 1995
% 210.03/210.20  |- skos__scopeNote mesh__D003885
% 210.03/210.20       Specific substances elaborated by plants, microorganisms or animals that cause damage to the skin; they may be proteins or other specific factors or substances; constituents of spider, jellyfish or other venoms cause dermonecrosis and certain bacteria synthesize dermolytic agents.%A%    
% 210.03/210.20  |- skos__historyNote mesh__D003885 specific skin heading %28%1966-1977%29%
% 210.03/210.20  |- mesh__dateRevised mesh__D003885 2005-06-30
% 210.03/210.20  |- skos__annotation mesh__D003885
% 210.03/210.20       /antag permitted but consider also ANTITOXINS; coord IM with source of dermotoxin %28%IM or NIM%29%; do not use for dermatoxicity of various chemicals %26% drugs %28% = SKIN /drug eff or skin dis heading /chem ind + Cat D term /adv eff-pois-tox%29%%A%  
% 210.03/210.20  |- mesh__recordOriginator mesh__D003885 SH
% 210.03/210.20  |- skos__historyNote mesh__D003885 Skin %28%1966-1977%29%
% 210.03/210.20  |- skos__altLabel mesh__D003885 Dermatotoxins
% 210.03/210.20  |- mesh__recordAuthorizer mesh__D003885 sjn
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D003885 2006
% 210.03/210.20  |- skos__broader mesh__D003885smesh__D009676
% 210.03/210.20  |- mesh__recordMaintainer mesh__D003885 ssb
% 210.03/210.20  |- mesh__dateEstablished mesh__D003885 1978-01-01
% 210.03/210.20  |- mesh__historyNote mesh__D003885 78   
% 210.03/210.20  |- skos__prefLabel mesh__D003885 Dermotoxins
% 210.03/210.20  |- skos__historyNote mesh__D003885 Toxins %28%1966-1977%29%
% 210.03/210.20  |- mesh__publicMeSHNote mesh__D003885 78   
% 210.03/210.20  |- rdf__type mesh__D003885sskos__Concept
% 210.03/210.20  |- mesh__dateCreated mesh__D003885 1977-04-22
% 210.03/210.20  |- rdf__type mesh__D036261sskos__Concept
% 210.03/210.20  |- mesh__recordAuthorizer mesh__D036261 sjn
% 210.03/210.20  |- mesh__historyNote mesh__D036261
% 210.03/210.20       2003; use RECEPTOR, EPHB6 %28%NM%29% 1996-2002   
% 210.03/210.20  |- skos__historyNote mesh__D036261 Membrane Proteins %28%1996-2002%29%
% 210.03/210.20  |- mesh__dateRevised mesh__D036261 2005-06-30
% 210.03/210.20  |- skos__altLabel mesh__D036261 Mep Protein
% 210.03/210.20  |- skos__prefLabel mesh__D036261 Receptor, EphB6
% 210.03/210.20  |- mesh__dateEstablished mesh__D036261 2003-01-01
% 210.03/210.20  |- skos__broader mesh__D036261smesh__D036081
% 210.03/210.20  |- skos__hiddenLabel mesh__D036261 EphB6, Ephrin Receptor
% 210.03/210.20  |- skos__altLabel mesh__D036261 Ephrin Receptor EphB6
% 210.03/210.20  |- skos__scopeNote mesh__D036261
% 210.03/210.20       An eph family receptor found primarily in BRAIN and THYMUS. The EphB6 receptor is unusual in that its tyrosine kinase domain shares little homology with other members of this class. The unusual tyrosine kinase domain of this receptor appears to result in its lack of tyrosine kinase activity.%A%    
% 210.03/210.20  |- skos__altLabel mesh__D036261 EphB6 Receptor
% 210.03/210.20  |- mesh__dateCreated mesh__D036261 2002-07-03
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D036261 2006
% 210.03/210.20  |- mesh__publicMeSHNote mesh__D036261
% 210.03/210.20       2003; MEP PROTEIN %28%now RECEPTOR, EPHB6%29% was indexed under MEMBRANE PROTEINS 1996-2002, EPHB6 RECEPTOR was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 2001-2002%A%  
% 210.03/210.20  |- mesh__recordMaintainer mesh__D036261 jmp
% 210.03/210.20  |- skos__historyNote mesh__D036261
% 210.03/210.20       Receptor Protein-Tyrosine Kinases %28%2001-2002%29%
% 210.03/210.20  |- skos__hiddenLabel mesh__D036261 Receptor EphB6, Ephrin
% 210.03/210.20  |- mesh__recordOriginator mesh__D036261 jmp
% 210.03/210.20  |- mesh__recordMaintainer mesh__D003087 SYSTEM
% 210.03/210.20  |- skos__broader mesh__D003087smesh__D001426
% 210.03/210.20  |- skos__altLabel mesh__D003087 Colicin E
% 210.03/210.20  |- skos__hiddenLabel mesh__D003087 Colicin K K235
% 210.03/210.20  |- mesh__dateRevised mesh__D003087 2005-06-30
% 210.03/210.20  |- mesh__dateCreated mesh__D003087 1999-01-01
% 210.03/210.20  |- skos__prefLabel mesh__D003087 Colicins
% 210.03/210.20  |- skos__broader mesh__D003087smesh__D029968
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D003087 2006
% 210.03/210.20  |- mesh__dateEstablished mesh__D003087 1966-01-01
% 210.03/210.20  |- mesh__recordOriginator mesh__D003087 NLM
% 210.03/210.20  |- mesh__recordAuthorizer mesh__D003087 sjn
% 210.03/210.20  |- rdf__type mesh__D003087sskos__Concept
% 210.03/210.20  |- mesh__publicMeSHNote mesh__D003087 66   
% 210.03/210.20  |- skos__scopeNote mesh__D003087
% 210.03/210.20       Bacteriocins elaborated by strains of Escherichia coli and related species. They are proteins or protein-lipopolysaccharide complexes lethal to other strains of the same species.%A%    
% 210.03/210.20  |- skos__altLabel mesh__D003087 Colicines
% 210.03/210.20  |- mesh__historyNote mesh__D003087 66%28%65%29%   
% 210.03/210.20  |- mesh__recordMaintainer mesh__D011519 nns
% 210.03/210.20  |- skos__scopeNote mesh__D011519
% 210.03/210.20       Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc.%A%    
% 210.03/210.20  |- skos__broader mesh__D011519smesh__D009857
% 210.03/210.20  |- skos__prefLabel mesh__D011519 Proto-Oncogenes
% 210.03/210.20  |- skos__hiddenLabel mesh__D011519 Proto Oncogene
% 210.03/210.20  |- skos__altLabel mesh__D011519 Proto-Oncogene
% 210.03/210.20  |- skos__hiddenLabel mesh__D011519 Proto Oncogenes
% 210.03/210.20  |- mesh__dateCreated mesh__D011519 1985-03-20
% 210.03/210.20  |- skos__annotation mesh__D011519
% 210.03/210.20       %22%normal cellular genes homologous to viral oncogenes%22%   
% 210.03/210.20  |- mesh__recordOriginator mesh__D011519 AEP
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D011519 2006
% 210.03/210.20  |- mesh__historyNote mesh__D011519 86; was see ONCOGENES 1983-85   
% 210.03/210.20  |- mesh__recordAuthorizer mesh__D011519 sjn
% 210.03/210.20  |- mesh__dateEstablished mesh__D011519 1986-01-01
% 210.03/210.20  |- skos__historyNote mesh__D011519 Genes %28%1966-1977%29%
% 210.03/210.20  |- mesh__dateRevised mesh__D011519 2005-06-30
% 210.03/210.20  |- rdf__type mesh__D011519sskos__Concept
% 210.03/210.20  |- skos__historyNote mesh__D011519 Genes, Viral %28%1978-1982%29%
% 210.03/210.20  |- mesh__onlineNote mesh__D011519 search ONCOGENES 1983-85   
% 210.03/210.20  |- mesh__publicMeSHNote mesh__D011519 86; was see ONCOGENES 1983-85   
% 210.03/210.20  |- skos__historyNote mesh__D011519 Oncogenes %28%1983-1985%29%
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D008570 2005
% 210.03/210.20  |- mesh__activeMeSHYear mesh__D008570 2001
% 210.03/210.20  |- skos__altLabel mesh__D008570 Memory, Shortterm
% 210.03/210.21  |- mesh__publicMeSHNote mesh__D008570 69   
% 210.03/210.21  |- skos__prefLabel mesh__D008570 Memory, Short-Term
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D008570 1997
% 210.03/210.21  |- skos__hiddenLabel mesh__D008570 Immediate Memory
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D008570 2006
% 210.03/210.21  |- skos__hiddenLabel mesh__D008570 Memories, Immediate
% 210.03/210.21  |- skos__hiddenLabel mesh__D008570 Immediate Recalls
% 210.03/210.21  |- skos__historyNote mesh__D008570 Memory %28%1966-1968%29%
% 210.03/210.21  |- mesh__dateRevised mesh__D008570 1995-06-08
% 210.03/210.21  |- mesh__dateEstablished mesh__D008570 1969-01-01
% 210.03/210.21  |- mesh__dateCreated mesh__D008570 1999-01-01
% 210.03/210.21  |- skos__hiddenLabel mesh__D008570 Memory, Short Term
% 210.03/210.21  |- skos__broader mesh__D008570smesh__D008568
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D008570 2002
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D008570 2003
% 210.03/210.21  |- skos__scopeNote mesh__D008570
% 210.03/210.21       Temporary storage of information for a few seconds to hours, as opposed to long-term memory which refers to material stored for days, years, or a lifetime.%A%    
% 210.03/210.21  |- skos__hiddenLabel mesh__D008570 Memories, Shortterm
% 210.03/210.21  |- skos__hiddenLabel mesh__D008570 Shortterm Memories
% 210.03/210.21  |- mesh__historyNote mesh__D008570
% 210.03/210.21       69; IMMEDIATE RECALL was see under MEMORY, SHORT-TERM 1969-78%A%  
% 210.03/210.21  |- mesh__onlineNote mesh__D008570
% 210.03/210.21       use MEMORY, SHORT-TERM to search IMMEDIATE RECALL 1969-78%A%  
% 210.03/210.21  |- skos__hiddenLabel mesh__D008570 Recall, Immediate
% 210.03/210.21  |- mesh__recordMaintainer mesh__D008570 RAZ
% 210.03/210.21  |- skos__hiddenLabel mesh__D008570 Short-Term Memories
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D008570 1998
% 210.03/210.21  |- skos__hiddenLabel mesh__D008570 Shortterm Memory
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D008570 2004
% 210.03/210.21  |- skos__hiddenLabel mesh__D008570 Recalls, Immediate
% 210.03/210.21  |- skos__hiddenLabel mesh__D008570 Memories, Short-Term
% 210.03/210.21  |- skos__hiddenLabel mesh__D008570 Immediate Memories
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D008570 1999
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D008570 2000
% 210.03/210.21  |- skos__hiddenLabel mesh__D008570 Short-Term Memory
% 210.03/210.21  |- mesh__recordAuthorizer mesh__D008570 PLS
% 210.03/210.21  |- rdf__type mesh__D008570sskos__Concept
% 210.03/210.21  |- skos__altLabel mesh__D008570 Memory, Immediate
% 210.03/210.21  |- mesh__recordOriginator mesh__D008570 NLM
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D008570 1996
% 210.03/210.21  |- skos__historyNote mesh__D022241 Viral Vaccines %28%1964-2000%29%
% 210.03/210.21  |- skos__hiddenLabel mesh__D022241 Vaccines, Parainfluenza
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D022241 2006
% 210.03/210.21  |- mesh__dateRevised mesh__D022241 2005-06-30
% 210.03/210.21  |- rdf__type mesh__D022241sskos__Concept
% 210.03/210.21  |- skos__scopeNote mesh__D022241
% 210.03/210.21       Vaccines or candidate vaccines used to prevent infection with parainfluenza viruses in humans and animals.%A%    
% 210.03/210.21  |- mesh__recordOriginator mesh__D022241 ags
% 210.03/210.21  |- mesh__dateCreated mesh__D022241 2000-06-22
% 210.03/210.21  |- skos__broader mesh__D022241smesh__D014765
% 210.03/210.21  |- mesh__historyNote mesh__D022241 2001   
% 210.03/210.21  |- mesh__recordAuthorizer mesh__D022241 sjn
% 210.03/210.21  |- skos__annotation mesh__D022241
% 210.03/210.21       coord IM with specific parainfluenza virus /immunol %28%IM%29%   
% 210.03/210.21  |- mesh__dateEstablished mesh__D022241 2001-01-01
% 210.03/210.21  |- mesh__publicMeSHNote mesh__D022241 2001   
% 210.03/210.21  |- mesh__recordMaintainer mesh__D022241 ssb
% 210.03/210.21  |- skos__prefLabel mesh__D022241 Parainfluenza Vaccines
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D007478 2003
% 210.03/210.21  |- mesh__recordAuthorizer mesh__D007478 sjn
% 210.03/210.21  |- skos__scopeNote mesh__D007478
% 210.03/210.21       Therapeutic introduction of ions of soluble salts into tissues by means of electric current. In medical literature it is commonly used to indicate the process of increasing the penetration of drugs into surface tissues by the application of electric current. It has nothing to do with ION EXCHANGE; AIR IONIZATION nor PHONOPHORESIS, none of which requires current.%A%    
% 210.03/210.21  |- skos__hiddenLabel mesh__D007478 Iontophoreses
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D007478 2004
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D007478 2002
% 210.03/210.21  |- rdf__type mesh__D007478sskos__Concept
% 210.03/210.21  |- mesh__dateCreated mesh__D007478 1999-01-01
% 210.03/210.21  |- mesh__recordMaintainer mesh__D007478 mdb
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D007478 2005
% 210.03/210.21  |- skos__broader mesh__D007478smesh__D004333
% 210.03/210.21  |- skos__prefLabel mesh__D007478 Iontophoresis
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D007478 2006
% 210.03/210.21  |- skos__broader mesh__D007478smesh__D004586
% 210.03/210.21  |- mesh__dateRevised mesh__D007478 2001-07-25
% 210.03/210.21  |- mesh__recordOriginator mesh__D007478 NLM
% 210.03/210.21  |- mesh__recordOriginator mesh__D004180 NLM
% 210.03/210.21  |- mesh__dateRevised mesh__D004180 1997-06-20
% 210.03/210.21  |- skos__annotation mesh__D004180 DF: DIRECT SERV COSTS   
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D004180 2000
% 210.03/210.21  |- rdf__type mesh__D004180sskos__Concept
% 210.03/210.21  |- skos__scopeNote mesh__D004180
% 210.03/210.21       Costs which are directly identifiable with a particular service.%A%    
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D004180 2005
% 210.03/210.21  |- skos__hiddenLabel mesh__D004180 Cost, Direct Service
% 210.03/210.21  |- skos__broader mesh__D004180smesh__D017048
% 210.03/210.21  |- mesh__publicMeSHNote mesh__D004180
% 210.03/210.21       91; was see under COSTS AND COST ANALYSIS 1975-90   
% 210.03/210.21  |- mesh__onlineNote mesh__D004180 search COSTS AND COST ANALYSIS 1968-74   
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D004180 1998
% 210.03/210.21  |- mesh__recordAuthorizer mesh__D004180 SJN
% 210.03/210.21  |- mesh__dateCreated mesh__D004180 1999-01-01
% 210.03/210.21  |- skos__prefLabel mesh__D004180 Direct Service Costs
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D004180 2001
% 210.03/210.21  |- skos__hiddenLabel mesh__D004180 Service Cost, Direct
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D004180 2006
% 210.03/210.21  |- mesh__historyNote mesh__D004180
% 210.03/210.21       91%28%75%29%; was see under COSTS AND COST ANALYSIS 1975-90   
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D004180 1999
% 210.03/210.21  |- skos__altLabel mesh__D004180 Costs, Direct Service
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D004180 2002
% 210.03/210.21  |- skos__hiddenLabel mesh__D004180 Direct Service Cost
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D004180 2003
% 210.03/210.21  |- mesh__recordMaintainer mesh__D004180 TPW
% 210.03/210.21  |- mesh__dateEstablished mesh__D004180 1991-01-01
% 210.03/210.21  |- skos__altLabel mesh__D004180 Service Costs, Direct
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D004180 2004
% 210.03/210.21  |- mesh__recordMaintainer mesh__D012612 ags
% 210.03/210.21  |- mesh__recordOriginator mesh__D012612 NLM
% 210.03/210.21  |- skos__prefLabel mesh__D012612 Scrub Typhus
% 210.03/210.21  |- skos__altLabel mesh__D012612 Tsutsugamushi Fever
% 210.03/210.21  |- skos__hiddenLabel mesh__D012612 Tsutsugamushi Diseases
% 210.03/210.21  |- skos__scopeNote mesh__D012612
% 210.03/210.21       An acute infectious disease caused by ORIENTIA TSUTSUGAMUSHI. It is limited to eastern and southeastern Asia, India, northern Australia, and the adjacent islands. Characteristics include the formation of a primary cutaneous lesion at the site of the bite of an infected mite, fever lasting about two weeks, and a maculopapular rash.%A%    
% 210.03/210.21  |- mesh__publicMeSHNote mesh__D012612
% 210.03/210.21       TSUTSUGAMUSHI DISEASE was TSUTSUGAMUSHI see SCRUB TYPHUS 1963-91%A%  
% 210.03/210.21  |- skos__hiddenLabel mesh__D012612 Fever, Tsutsugamushi
% 210.03/210.21  |- skos__annotation mesh__D012612 caused by ORIENTIA TSUTSUGAMUSHI   
% 210.03/210.21  |- skos__altLabel mesh__D012612 Tsutsugamushi Disease
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D012612 2006
% 210.03/210.21  |- mesh__recordAuthorizer mesh__D012612 sjn
% 210.03/210.21  |- mesh__onlineNote mesh__D012612
% 210.03/210.21       use SCRUB TYPHUS to search TSUTSUGAMUSHI 1966-91   
% 210.03/210.21  |- skos__hiddenLabel mesh__D012612 Fevers, Tsutsugamushi
% 210.03/210.21  |- skos__hiddenLabel mesh__D012612 Disease, Tsutsugamushi
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D012612 2004
% 210.03/210.21  |- rdf__type mesh__D012612sskos__Concept
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D012612 2005
% 210.03/210.21  |- mesh__dateCreated mesh__D012612 1999-01-01
% 210.03/210.21  |- skos__broader mesh__D012612smesh__D012288
% 210.03/210.21  |- skos__hiddenLabel mesh__D012612 Diseases, Tsutsugamushi
% 210.03/210.21  |- mesh__dateRevised mesh__D012612 2003-07-09
% 210.03/210.21  |- mesh__historyNote mesh__D012612
% 210.03/210.21       TSUTSUGAMUSHI DISEASE was TSUTSUGAMUSHI see SCRUB TYPHUS 1963-91%A%  
% 210.03/210.21  |- skos__hiddenLabel mesh__D012612 Tsutsugamushi Fevers
% 210.03/210.21  |- skos__altLabel mesh__D012612 Typhus, Scrub
% 210.03/210.21  |- mesh__recordMaintainer mesh__D003886 lkt
% 210.03/210.21  |- mesh__recordOriginator mesh__D003886 NLM
% 210.03/210.21  |- mesh__historyNote mesh__D003886 2006 %28%1964%29%   
% 210.03/210.21  |- skos__scopeNote mesh__D003886
% 210.03/210.21       A layer of the cornea. It is the basal lamina of the CORNEAL ENDOTHELIUM %28%from which it is secreted%29% separating it from the CORNEAL STROMA. It is a homogeneous structure composed of fine collagenous filaments, and slowly increases in thickness with age.%A%    
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D003886 2006
% 210.03/210.21  |- skos__hiddenLabel mesh__D003886 Membrane, Descemet
% 210.03/210.21  |- skos__altLabel mesh__D003886 Lamina Elastica Posterior
% 210.03/210.21  |- skos__hiddenLabel mesh__D003886 Elastica Posterior, Lamina
% 210.03/210.21  |- skos__broader mesh__D003886smesh__D003315
% 210.03/210.21  |- skos__hiddenLabel mesh__D003886 Lamina Elastica Posteriors
% 210.03/210.21  |- mesh__publicMeSHNote mesh__D003886
% 210.03/210.21       2006; see DESCEMENT%27%S MEMBRANE 1964-2005   
% 210.03/210.21  |- skos__hiddenLabel mesh__D003886 Membrane, Descemet%27%s
% 210.03/210.21  |- skos__hiddenLabel mesh__D003886 Descemet Membranes
% 210.03/210.21  |- mesh__dateRevised mesh__D003886 2005-06-30
% 210.03/210.21  |- skos__hiddenLabel mesh__D003886 Elastica Posteriors, Lamina
% 210.03/210.21  |- skos__hiddenLabel mesh__D003886 Descemets Membrane
% 210.03/210.21  |- skos__broader mesh__D003886smesh__D001485
% 210.03/210.21  |- skos__altLabel mesh__D003886 Descemet%27%s Membrane
% 210.03/210.21  |- mesh__recordAuthorizer mesh__D003886 sjn
% 210.03/210.21  |- skos__hiddenLabel mesh__D003886 Membranes, Descemet
% 210.03/210.21  |- mesh__dateCreated mesh__D003886 1999-01-01
% 210.03/210.21  |- skos__hiddenLabel mesh__D003886 Posterior, Lamina Elastica
% 210.03/210.21  |- rdf__type mesh__D003886sskos__Concept
% 210.03/210.21  |- skos__hiddenLabel mesh__D003886 Posteriors, Lamina Elastica
% 210.03/210.21  |- mesh__dateEstablished mesh__D003886 1974-01-01
% 210.03/210.21  |- skos__prefLabel mesh__D003886 Descemet Membrane
% 210.03/210.21  |- skos__scopeNote mesh__D036262
% 210.03/210.21       The study, based on direct observation, use of statistical records, interviews, or experimental methods, of actual practices or the actual impact of practices or policies.%A%    
% 210.03/210.21  |- skos__related mesh__D036262smesh__D003625
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D036262 2005
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D036262 2003
% 210.03/210.21  |- mesh__dateEstablished mesh__D036262 2003-01-01
% 210.03/210.21  |- mesh__historyNote mesh__D036262 2003   
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D036262 2006
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D036262 2004
% 210.03/210.21  |- skos__prefLabel mesh__D036262 Empirical Research
% 210.03/210.21  |- rdf__type mesh__D036262sskos__Concept
% 210.03/210.21  |- mesh__dateCreated mesh__D036262 2002-07-03
% 210.03/210.21  |- mesh__publicMeSHNote mesh__D036262 2003   
% 210.03/210.21  |- skos__broader mesh__D036262smesh__D012106
% 210.03/210.21  |- skos__hiddenLabel mesh__D036262 Research, Empirical
% 210.03/210.21  |- mesh__dateRevised mesh__D003088 2004-07-07
% 210.03/210.21  |- skos__hiddenLabel mesh__D003088 Bobwhites
% 210.03/210.21  |- skos__hiddenLabel mesh__D003088 Bob White
% 210.03/210.21  |- rdf__type mesh__D003088sskos__Concept
% 210.03/210.21  |- skos__altLabel mesh__D003088 Colinis
% 210.03/210.21  |- skos__scopeNote mesh__D003088
% 210.03/210.21       A genus of QUAIL, in the family Odontophoridae, comprised of at least four different species of bobwhites.%A%    
% 210.03/210.21  |- skos__altLabel mesh__D003088 Bobwhite
% 210.03/210.21  |- mesh__dateEstablished mesh__D003088 1991-01-01
% 210.03/210.21  |- skos__broader mesh__D003088smesh__D011784
% 210.03/210.21  |- mesh__historyNote mesh__D003088
% 210.03/210.21       91%28%75%29%; was see under QUAIL 1975-90; BOBWHITE was BOB-WHITE 1975-94%A%  
% 210.03/210.21  |- skos__altLabel mesh__D003088 Bob-White
% 210.03/210.21  |- mesh__recordMaintainer mesh__D003088 ags
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D003088 2005
% 210.03/210.21  |- mesh__publicMeSHNote mesh__D003088
% 210.03/210.21       91; was see under QUAIL 1975-90; BOBWHITE was BOB-WHITE 1975-94%A%  
% 210.03/210.21  |- skos__prefLabel mesh__D003088 Colinus
% 210.03/210.21  |- skos__annotation mesh__D003088
% 210.03/210.21       diseases: coord IM with BIRD DISEASES %28%IM%29%   
% 210.03/210.21  |- skos__hiddenLabel mesh__D003088 Bob-Whites
% 210.03/210.21  |- mesh__recordOriginator mesh__D003088 NLM
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D003088 2006
% 210.03/210.21  |- mesh__recordAuthorizer mesh__D003088 sjn
% 210.03/210.21  |- mesh__dateCreated mesh__D003088 1974-11-19
% 210.03/210.21  |- skos__historyNote mesh__D008571 Male %28%1966-1979%29%
% 210.03/210.21  |- skos__broader mesh__D008571smesh__D009272
% 210.03/210.21  |- mesh__publicMeSHNote mesh__D008571 80   
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D008571 2006
% 210.03/210.21  |- mesh__recordMaintainer mesh__D008571 ags
% 210.03/210.21  |- skos__prefLabel mesh__D008571 Men
% 210.03/210.21  |- mesh__recordAuthorizer mesh__D008571 sjn
% 210.03/210.21  |- mesh__dateCreated mesh__D008571 1979-04-27
% 210.03/210.21  |- mesh__recordOriginator mesh__D008571 SMH
% 210.03/210.21  |- skos__annotation mesh__D008571
% 210.03/210.21       for men only as a cultural, social, sociological, political, economic force; do not confuse with the check tag MALE; when indexing MEN, check the tags HUMANS %26% MALE; Manual 18.9.6, 34.12%A%  
% 210.03/210.21  |- rdf__type mesh__D008571sskos__Concept
% 210.03/210.21  |- mesh__historyNote mesh__D008571 80   
% 210.03/210.21  |- mesh__dateEstablished mesh__D008571 1980-01-01
% 210.03/210.21  |- skos__scopeNote mesh__D008571
% 210.03/210.21       Human adult males as cultural, psychological, sociological, political, and economic entities.%A%    
% 210.03/210.21  |- mesh__dateRevised mesh__D008571 2005-06-30
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D022242 2006
% 210.03/210.21  |- skos__scopeNote mesh__D022242
% 210.03/210.21       Vaccines or candidate vaccines used to prevent infections with STREPTOCOCCUS PNEUMONIAE.%A%    
% 210.03/210.21  |- mesh__historyNote mesh__D022242
% 210.03/210.21       2001; use PNEUMOCOCCAL VACCINES %28%NM%29% to search PNEUMOVAX  1978-2000%A%  
% 210.03/210.21  |- skos__broader mesh__D022242smesh__D022541
% 210.03/210.21  |- skos__prefLabel mesh__D022242 Pneumococcal Vaccines
% 210.03/210.21  |- rdf__type mesh__D022242sskos__Concept
% 210.03/210.21  |- skos__hiddenLabel mesh__D022242 Vaccines, Pneumococcal
% 210.03/210.21  |- mesh__dateEstablished mesh__D022242 2001-01-01
% 210.03/210.21  |- skos__hiddenLabel mesh__D022242 Vaccine, Pneumococcal Polysaccharide
% 210.03/210.21  |- mesh__dateRevised mesh__D022242 2005-06-30
% 210.03/210.21  |- mesh__recordMaintainer mesh__D022242 ags
% 210.03/210.21  |- mesh__publicMeSHNote mesh__D022242
% 210.03/210.21       2001; PNEUMOVAX %28%now PNEUMOCOCCAL VACCINES%29% was indexed under BACTERIAL VACCINES 1983-2000 %26% POLYSACCHARIDES, BACTERIAL 1978-1982%A%  
% 210.03/210.21  |- skos__hiddenLabel mesh__D022242 Pnu Imune Vaccine
% 210.03/210.21  |- mesh__dateCreated mesh__D022242 2000-06-22
% 210.03/210.21  |- mesh__recordOriginator mesh__D022242 ags
% 210.03/210.21  |- mesh__recordAuthorizer mesh__D022242 sjn
% 210.03/210.21  |- skos__historyNote mesh__D022242 Bacterial Vaccines %28%1965-2000%29%
% 210.03/210.21  |- skos__hiddenLabel mesh__D022242 Polysaccharide Vaccine, Pneumococcal
% 210.03/210.21  |- skos__hiddenLabel mesh__D022242 PnuImune Vaccine
% 210.03/210.21  |- skos__hiddenLabel mesh__D016205 Rat, Rice
% 210.03/210.21  |- rdf__type mesh__D016205sskos__Concept
% 210.03/210.21  |- skos__hiddenLabel mesh__D016205 Rice Rats
% 210.03/210.21  |- skos__historyNote mesh__D016205 Rodentia %28%1966-1981%29%
% 210.03/210.21  |- skos__hiddenLabel mesh__D016205 Cotton Rat
% 210.03/210.21  |- mesh__publicMeSHNote mesh__D016205
% 210.03/210.21       2006; see HESPEROMYINAE 1991-2005; for NEOTOMA, SIGMODON, and RATS, COTTON see CRICETIDAE 1982-1990%A%  
% 210.03/210.21  |- mesh__historyNote mesh__D016205
% 210.03/210.21       2006 %28%1991%29%; for NEOTOMA, SIGMODON, and RATS, COTTON use ARVICOLINAE 1982-1990%A%  
% 210.03/210.21  |- skos__altLabel mesh__D016205 Hesperomyinae
% 210.03/210.21  |- skos__historyNote mesh__D016205 Microtinae %28%1982-1990%29%
% 210.03/210.21  |- skos__broader mesh__D016205smesh__D009115
% 210.03/210.21  |- mesh__recordOriginator mesh__D016205 PXP
% 210.03/210.21  |- skos__scopeNote mesh__D016205
% 210.03/210.21       A subfamily of the family MURIDAE comprised of 69 genera. New World mice and rats are included in this subfamily.%A%    
% 210.03/210.21  |- mesh__dateRevised mesh__D016205 2005-06-30
% 210.03/210.21  |- skos__hiddenLabel mesh__D016205 Rat, Cotton
% 210.03/210.21  |- skos__hiddenLabel mesh__D016205 Cotton Rats
% 210.03/210.21  |- skos__annotation mesh__D016205
% 210.03/210.21       for entry term RATS, RICE and other species commonly called %22%rats%22% but taxonomically SIGMODONTINAE, do not use the check tag RATS.%A%  
% 210.03/210.21  |- mesh__dateCreated mesh__D016205 1990-06-06
% 210.03/210.21  |- skos__hiddenLabel mesh__D016205 Rice Rat
% 210.03/210.21  |- mesh__dateEstablished mesh__D016205 1991-01-01
% 210.03/210.21  |- mesh__recordMaintainer mesh__D016205 ags
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D016205 2006
% 210.03/210.21  |- skos__historyNote mesh__D016205 Rats %28%1966-1981%29%
% 210.03/210.21  |- mesh__recordAuthorizer mesh__D016205 sjn
% 210.03/210.21  |- skos__altLabel mesh__D016205 Hesperomyines
% 210.03/210.21  |- skos__prefLabel mesh__D016205 Sigmodontinae
% 210.03/210.21  |- mesh__publicMeSHNote mesh__D046690
% 210.03/210.21       2005;  for ELECTRICAL STIMULATION OF THE BRAIN see ELECTRIC STIMULATION 1997-2003%A%  
% 210.03/210.21  |- skos__hiddenLabel mesh__D046690 Brain Stimulations, Deep
% 210.03/210.21  |- mesh__dateEstablished mesh__D046690 2005-01-01
% 210.03/210.21  |- skos__scopeNote mesh__D046690
% 210.03/210.21       Therapy for MOVEMENT DISORDERS, especially PARKINSON DISEASE, that applies electricity via stereotactic implantation of ELECTRODES in specific areas of the BRAIN such as the THALAMUS. The electrodes are attached to a neurostimulator placed subcutaneously.%A%    
% 210.03/210.21  |- skos__historyNote mesh__D046690
% 210.03/210.21       Electric Stimulation Therapy %28%1973-2004%29%
% 210.03/210.21  |- skos__prefLabel mesh__D046690 Deep Brain Stimulation
% 210.03/210.21  |- mesh__recordAuthorizer mesh__D046690 sjn
% 210.03/210.21  |- mesh__historyNote mesh__D046690
% 210.03/210.21       2005; for ELECTRICAL STIMULATION OF THE BRAIN use ELECTRIC STIMULATION 1997-2003%A%  
% 210.03/210.21  |- mesh__dateRevised mesh__D046690 2005-06-30
% 210.03/210.21  |- skos__hiddenLabel mesh__D046690 Deep Brain Stimulations
% 210.03/210.21  |- mesh__recordOriginator mesh__D046690 ags
% 210.03/210.21  |- skos__historyNote mesh__D046690 Electric Stimulation %28%1973-2004%29%
% 210.03/210.21  |- skos__annotation mesh__D046690 coord with disease /ther   
% 210.03/210.21  |- skos__altLabel mesh__D046690 Brain Stimulation, Deep
% 210.03/210.21  |- skos__related mesh__D046690smesh__D004558
% 210.03/210.21  |- mesh__dateCreated mesh__D046690 2004-07-07
% 210.03/210.21  |- skos__broader mesh__D046690smesh__D013514
% 210.03/210.21  |- rdf__type mesh__D046690sskos__Concept
% 210.03/210.21  |- skos__hiddenLabel mesh__D046690 Stimulations, Deep Brain
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D046690 2006
% 210.03/210.21  |- skos__hiddenLabel mesh__D046690 Stimulation, Deep Brain
% 210.03/210.21  |- mesh__recordMaintainer mesh__D046690 lkt
% 210.03/210.21  |- skos__broader mesh__D046690smesh__D004599
% 210.03/210.21  |- skos__historyNote mesh__D007479
% 210.03/210.21       Iothalamic Acid/analogs %26% derivatives %28%1975-1986%29%
% 210.03/210.21  |- skos__historyNote mesh__D007479 Iothalamic Acid %28%1968-1974%29%
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D007479 2004
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D007479 2001
% 210.03/210.21  |- mesh__dateEstablished mesh__D007479 1987-01-01
% 210.03/210.21  |- skos__hiddenLabel mesh__D007479 B15,000
% 210.03/210.21  |- rdf__type mesh__D007479sskos__Concept
% 210.03/210.21  |- skos__hiddenLabel mesh__D007479 B 15000
% 210.03/210.21  |- skos__broader mesh__D007479smesh__D014283
% 210.03/210.21  |- mesh__recordAuthorizer mesh__D007479 sjn
% 210.03/210.21  |- skos__prefLabel mesh__D007479 Iopamidol
% 210.03/210.21  |- mesh__recordMaintainer mesh__D007479 CCR
% 210.03/210.21  |- mesh__publicMeSHNote mesh__D007479 87   
% 210.03/210.21  |- skos__altLabel mesh__D007479 B-15000
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D007479 2005
% 210.03/210.21  |- skos__hiddenLabel mesh__D007479 B15000
% 210.03/210.21  |- skos__altLabel mesh__D007479 Jopamidol
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D007479 2002
% 210.03/210.21  |- skos__scopeNote mesh__D007479
% 210.03/210.21       A non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiological procedures.%A%    
% 210.03/210.21  |- mesh__historyNote mesh__D007479 87   
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D007479 2006
% 210.03/210.21  |- skos__hiddenLabel mesh__D007479 B 15,000
% 210.03/210.21  |- mesh__dateRevised mesh__D007479 2000-06-21
% 210.03/210.21  |- mesh__dateCreated mesh__D007479 1986-06-02
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D007479 2003
% 210.03/210.21  |- mesh__recordOriginator mesh__D007479 RLS
% 210.03/210.21  |- skos__broader mesh__D004181smesh__D012013
% 210.03/210.21  |- skos__annotation mesh__D004181
% 210.03/210.21       IM for directories as a subject; do not confuse with Publication Type DIRECTORY; for directories %26% lists of members of societies %26% acad, etc. index under specialty %28%IM%29% + SOCIETIES or other specific corporate heading %28%IM%29% + geog %28%NIM%29% + DIRECTORY %28%PT%29%; no qualif; policy: Manual 33.13%A%  
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D004181 2006
% 210.03/210.21  |- skos__scopeNote mesh__D004181
% 210.03/210.21       Lists of persons or organizations, systematically arranged, usually in alphabetic or classed order, giving address, affiliations, etc., for individuals, and giving address, officers, functions, and similar data for organizations. %28%ALA Glossary of Library and Information Science, 1983%29%%A%    
% 210.03/210.21  |- skos__prefLabel mesh__D004181 Directories
% 210.03/210.21  |- mesh__dateRevised mesh__D004181 1999-11-03
% 210.03/210.21  |- mesh__recordMaintainer mesh__D004181 kle
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D004181 2003
% 210.03/210.21  |- mesh__recordOriginator mesh__D004181 NLM
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D004181 2000
% 210.03/210.21  |- mesh__recordAuthorizer mesh__D004181 sjn
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D004181 2004
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D004181 2001
% 210.03/210.21  |- rdf__type mesh__D004181sskos__Concept
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D004181 2005
% 210.03/210.21  |- mesh__dateCreated mesh__D004181 1999-01-01
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D004181 2002
% 210.03/210.21  |- mesh__historyNote mesh__D012613
% 210.03/210.21       91%28%75%29%; was see under ART 1975-90   
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D012613 1995
% 210.03/210.21  |- mesh__dateEstablished mesh__D012613 1991-01-01
% 210.03/210.21  |- mesh__recordAuthorizer mesh__D012613 PLS
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D012613 1993
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D012613 1999
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D012613 1994
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D012613 1997
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D012613 2002
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D012613 1998
% 210.03/210.21  |- mesh__recordMaintainer mesh__D012613 TAP
% 210.03/210.21  |- skos__prefLabel mesh__D012613 Sculpture
% 210.03/210.21  |- mesh__recordOriginator mesh__D012613 NLM
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D012613 1996
% 210.03/210.21  |- mesh__onlineNote mesh__D012613 search ART 1966-74   
% 210.03/210.21  |- skos__hiddenLabel mesh__D012613 Sculptures
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D012613 2006
% 210.03/210.21  |- mesh__dateRevised mesh__D012613 1992-05-18
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D012613 2004
% 210.03/210.21  |- mesh__publicMeSHNote mesh__D012613 91; was see under ART 1975-90   
% 210.03/210.21  |- rdf__type mesh__D012613sskos__Concept
% 210.03/210.21  |- skos__broader mesh__D012613smesh__D001154
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D012613 2005
% 210.03/210.21  |- mesh__dateCreated mesh__D012613 1999-01-01
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D012613 2001
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D012613 2003
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D012613 2000
% 210.03/210.21  |- skos__altLabel mesh__D003887 Psychologic Desensitization
% 210.03/210.21  |- mesh__recordOriginator mesh__D003887 NLM
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D003887 2002
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D003887 2004
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D003887 1996
% 210.03/210.21  |- mesh__dateEstablished mesh__D003887 1991-01-01
% 210.03/210.21  |- mesh__historyNote mesh__D003887
% 210.03/210.21       95; was DESENSITIZATION %28%PSYCHOLOGY%29% 1975-94 %28%see under BEHAVIOR THERAPY 1975-90%29%%A%  
% 210.03/210.21  |- skos__altLabel mesh__D003887 Desensitization, Psychological
% 210.03/210.21  |- skos__altLabel mesh__D003887 Psychological Desensitization
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D003887 2005
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D003887 1997
% 210.03/210.21  |- skos__prefLabel mesh__D003887 Desensitization, Psychologic
% 210.03/210.21  |- skos__scopeNote mesh__D003887
% 210.03/210.21       A behavior therapy technique in which deep muscle relaxation is used to inhibit the effects of graded anxiety-evoking stimuli.%A%    
% 210.03/210.21  |- skos__broader mesh__D003887smesh__D001521
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D003887 2006
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D003887 1998
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D003887 2000
% 210.03/210.21  |- mesh__recordAuthorizer mesh__D003887 PLS
% 210.03/210.21  |- mesh__publicMeSHNote mesh__D003887
% 210.03/210.21       95; was DESENSITIZATION %28%PSYCHOLOGY%29% 1975-94 %28%see under BEHAVIOR THERAPY 1975-90%29%%A%  
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D003887 1999
% 210.03/210.21  |- mesh__dateCreated mesh__D003887 1999-01-01
% 210.03/210.21  |- mesh__onlineNote mesh__D003887
% 210.03/210.21       use DESENSITIZATION, PSYCHOLOGIC to search DESENSITIZATION %28%PSYCHOLOGY%29% 1975-94; use BEHAVIOR THERAPY 1969-74%A%  
% 210.03/210.21  |- skos__altLabel mesh__D003887 Desensitization %28%Psychology%29%
% 210.03/210.21  |- mesh__recordMaintainer mesh__D003887 TGC
% 210.03/210.21  |- skos__annotation mesh__D003887
% 210.03/210.21       a behavior ther technique; DF: DESENSITIZATION PSYCHOL   
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D003887 2001
% 210.03/210.21  |- mesh__dateRevised mesh__D003887 1995-05-31
% 210.03/210.21  |- rdf__type mesh__D003887sskos__Concept
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D003887 2003
% 210.03/210.21  |- skos__hiddenLabel mesh__D003887 Desensitizations %28%Psychology%29%
% 210.03/210.21  |- rdf__type mesh__D003089sskos__Concept
% 210.03/210.21  |- skos__hiddenLabel mesh__D003089 B, Colipase
% 210.03/210.21  |- skos__hiddenLabel mesh__D003089 A, Colipase
% 210.03/210.21  |- mesh__recordAuthorizer mesh__D003089 sjn
% 210.03/210.21  |- mesh__dateEstablished mesh__D003089 1991-01-01
% 210.03/210.21  |- mesh__historyNote mesh__D003089
% 210.03/210.21       91%28%76%29%; was see under PROTEINS 1976-90   
% 210.03/210.21  |- skos__broader mesh__D003089smesh__D011506
% 210.03/210.21  |- mesh__publicMeSHNote mesh__D003089 91; was see under PROTEINS 1976-90   
% 210.03/210.21  |- skos__prefLabel mesh__D003089 Colipases
% 210.03/210.21  |- mesh__recordMaintainer mesh__D003089 SYSTEM
% 210.03/210.21  |- skos__historyNote mesh__D003089 Proteins %28%1974-1975%29%
% 210.03/210.21  |- skos__annotation mesh__D003089
% 210.03/210.21       a protein: not an enzyme despite -ase; /biosyn /physiol permitted%A%  
% 210.03/210.21  |- skos__scopeNote mesh__D003089
% 210.03/210.21       Colipase I and II, consisting of 94-95 and 84-85 amino acid residues, respectively, have been isolated from porcine pancreas. Their role is to prevent the inhibitory effect of bile salts on the lipase-catalyzed intraduodenal hydrolysis of dietary long-chain triglycerides.%A%    
% 210.03/210.21  |- mesh__dateRevised mesh__D003089 2005-06-30
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D003089 2006
% 210.03/210.21  |- mesh__dateCreated mesh__D003089 1975-07-23
% 210.03/210.21  |- mesh__recordOriginator mesh__D003089 RLS
% 210.03/210.21  |- skos__historyNote mesh__D003089 Lipase %28%1974-1975%29%
% 210.03/210.21  |- mesh__recordOriginator mesh__D008572 NLM
% 210.03/210.21  |- mesh__dateCreated mesh__D008572 1999-01-01
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D008572 2006
% 210.03/210.21  |- mesh__dateEstablished mesh__D008572 1973-01-01
% 210.03/210.21  |- skos__prefLabel mesh__D008572 Menarche
% 210.03/210.21  |- skos__historyNote mesh__D008572 Puberty %28%1966-1968%29%
% 210.03/210.21  |- mesh__dateRevised mesh__D008572 2004-07-07
% 210.03/210.21  |- rdf__type mesh__D008572sskos__Concept
% 210.03/210.21  |- skos__scopeNote mesh__D008572
% 210.03/210.21       The first MENSTRUAL CYCLE marked by the initiation of MENSTRUATION.%A%    
% 210.03/210.21  |- mesh__recordMaintainer mesh__D008572 lkt
% 210.03/210.21  |- mesh__historyNote mesh__D008572 73%28%69%29%   
% 210.03/210.21  |- mesh__recordAuthorizer mesh__D008572 sjn
% 210.03/210.21  |- mesh__publicMeSHNote mesh__D008572 73   
% 210.03/210.21  |- skos__historyNote mesh__D008572 Menstruation %28%1966-1968%29%
% 210.03/210.21  |- skos__broader mesh__D008572smesh__D011627
% 210.03/210.21  |- mesh__activeMeSHYear mesh__D008572 2005
% 210.03/210.22  |- mesh__recordOriginator mesh__D022243 ags
% 210.03/210.22  |- mesh__publicMeSHNote mesh__D022243 2001   
% 210.03/210.22  |- skos__scopeNote mesh__D022243
% 210.03/210.22       Vaccines or candidate vaccines used to prevent infection with ROTAVIRUS.%A%    
% 210.03/210.22  |- mesh__recordAuthorizer mesh__D022243 sjn
% 210.03/210.22  |- rdf__type mesh__D022243sskos__Concept
% 210.03/210.22  |- skos__historyNote mesh__D022243 Viral Vaccines %28%1979-2000%29%
% 210.03/210.22  |- mesh__recordMaintainer mesh__D022243 ssb
% 210.03/210.22  |- mesh__dateEstablished mesh__D022243 2001-01-01
% 210.03/210.22  |- skos__prefLabel mesh__D022243 Rotavirus Vaccines
% 210.03/210.22  |- mesh__dateCreated mesh__D022243 2000-06-22
% 210.03/210.22  |- mesh__dateRevised mesh__D022243 2005-06-30
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D022243 2006
% 210.03/210.22  |- skos__broader mesh__D022243smesh__D014765
% 210.03/210.22  |- mesh__historyNote mesh__D022243 2001   
% 210.03/210.22  |- skos__hiddenLabel mesh__D022243 Vaccines, Rotavirus
% 210.03/210.22  |- mesh__recordAuthorizer mesh__D016206 sjn
% 210.03/210.22  |- mesh__recordMaintainer mesh__D016206 jls
% 210.03/210.22  |- skos__annotation mesh__D016206
% 210.03/210.22       collections of bibliographic refs: differentiate from DATABASES, FACTUAL, collections of facts%A%  
% 210.03/210.22  |- mesh__dateCreated mesh__D016206 1990-08-14
% 210.03/210.22  |- skos__broader mesh__D016206smesh__D019992
% 210.03/210.22  |- skos__hiddenLabel mesh__D016206 Database, Bibliographic
% 210.03/210.22  |- mesh__dateEstablished mesh__D016206 1991-01-01
% 210.03/210.22  |- mesh__publicMeSHNote mesh__D016206
% 210.03/210.22       91; DATABASES was see INFORMATION SYSTEMS 1982-90   
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D016206 2006
% 210.03/210.22  |- mesh__dateRevised mesh__D016206 2004-07-07
% 210.03/210.22  |- skos__historyNote mesh__D016206 Bibliography %28%1966-1990%29%
% 210.03/210.22  |- skos__prefLabel mesh__D016206 Databases, Bibliographic
% 210.03/210.22  |- skos__broader mesh__D016206smesh__D001634
% 210.03/210.22  |- skos__hiddenLabel mesh__D016206 Bibliographic Databases
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D016206 2005
% 210.03/210.22  |- skos__historyNote mesh__D016206 Information Systems %28%1966-1981%29%
% 210.03/210.22  |- skos__hiddenLabel mesh__D016206 Bibliographic Database
% 210.03/210.22  |- skos__scopeNote mesh__D016206
% 210.03/210.22       Extensive collections, reputedly complete, of references and citations to books, articles, publications, etc., generally on a single subject or specialized subject area. Databases can operate through automated files, libraries, or computer disks. The concept should be differentiated from DATABASES, FACTUAL which is used for collections of data and facts apart from bibliographic references to them.%A%    
% 210.03/210.22  |- mesh__historyNote mesh__D016206
% 210.03/210.22       91; DATABASES was see INFORMATION SYSTEMS 1982-90   
% 210.03/210.22  |- mesh__recordOriginator mesh__D016206 TGC
% 210.03/210.22  |- rdf__type mesh__D016206sskos__Concept
% 210.03/210.22  |- mesh__onlineNote mesh__D016206
% 210.03/210.22       use INFORMATION SYSTEMS to search DATABASES 1982-90   
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004980 2000
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004980 1996
% 210.03/210.22  |- mesh__dateRevised mesh__D004980 1992-05-19
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004980 2004
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004980 2001
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004980 1998
% 210.03/210.22  |- mesh__recordMaintainer mesh__D004980 TAP
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004980 2006
% 210.03/210.22  |- mesh__recordAuthorizer mesh__D004980 PLS
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004980 1997
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004980 1994
% 210.03/210.22  |- mesh__publicMeSHNote mesh__D004980 73   
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004980 1999
% 210.03/210.22  |- skos__historyNote mesh__D004980 Alkanes %28%1966-1972%29%
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004980 1993
% 210.03/210.22  |- mesh__dateEstablished mesh__D004980 1973-01-01
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004980 1995
% 210.03/210.22  |- skos__broader mesh__D004980smesh__D000473
% 210.03/210.22  |- mesh__recordOriginator mesh__D004980 NLM
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004980 2002
% 210.03/210.22  |- rdf__type mesh__D004980sskos__Concept
% 210.03/210.22  |- skos__prefLabel mesh__D004980 Ethane
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004980 2003
% 210.03/210.22  |- mesh__dateCreated mesh__D004980 1999-01-01
% 210.03/210.22  |- mesh__historyNote mesh__D004980 73   
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004980 2005
% 210.03/210.22  |- skos__broader mesh__D011453Q000037smesh__D011453
% 210.03/210.22  |- mesh__preferredCombination mesh__D011453Q000037smesh__D011448
% 210.03/210.22  |- rdf__type mesh__D011453Q000037smesh__CompoundConcept
% 210.03/210.22  |- mesh__publicMeSHNote mesh__D004182
% 210.03/210.22       91; was see under FILARIOIDEA 1975-90   
% 210.03/210.22  |- mesh__onlineNote mesh__D004182 search FILARIOIDEA 1966-74   
% 210.03/210.22  |- skos__prefLabel mesh__D004182 Dirofilaria
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004182 2004
% 210.03/210.22  |- rdf__type mesh__D004182sskos__Concept
% 210.03/210.22  |- mesh__dateEstablished mesh__D004182 1991-01-01
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004182 2005
% 210.03/210.22  |- mesh__historyNote mesh__D004182
% 210.03/210.22       91%28%75%29%; was see under FILARIOIDEA 1975-90   
% 210.03/210.22  |- mesh__recordOriginator mesh__D004182 NLM
% 210.03/210.22  |- mesh__dateRevised mesh__D004182 2003-07-09
% 210.03/210.22  |- skos__annotation mesh__D004182
% 210.03/210.22       infection = DIROFILARIASIS; coord with specific helminth term %28%ANTIGENS, HELMINTH, etc%29% if pertinent; /drug eff: consider FILARICIDES%A%  
% 210.03/210.22  |- mesh__dateCreated mesh__D004182 1999-01-01
% 210.03/210.22  |- mesh__recordAuthorizer mesh__D004182 sjn
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004182 2006
% 210.03/210.22  |- skos__scopeNote mesh__D004182
% 210.03/210.22       A genus of filarial nematodes. Various immature species have been found to infect the eyes or subcutaneous tissue in humans.%A%    
% 210.03/210.22  |- skos__broader mesh__D004182smesh__D005370
% 210.03/210.22  |- mesh__recordMaintainer mesh__D004182 ags
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D012614 2006
% 210.03/210.22  |- skos__hiddenLabel mesh__D012614 Scurvies
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D012614 2004
% 210.03/210.22  |- rdf__type mesh__D012614sskos__Concept
% 210.03/210.22  |- skos__related mesh__D012614smesh__D001206
% 210.03/210.22  |- mesh__dateCreated mesh__D012614 1999-01-01
% 210.03/210.22  |- mesh__recordAuthorizer mesh__D012614 sjn
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D012614 2005
% 210.03/210.22  |- mesh__dateRevised mesh__D012614 2003-07-09
% 210.03/210.22  |- skos__broader mesh__D012614smesh__D020141
% 210.03/210.22  |- skos__altLabel mesh__D012614 Scorbutus
% 210.03/210.22  |- mesh__recordMaintainer mesh__D012614 lkt
% 210.03/210.22  |- mesh__recordOriginator mesh__D012614 NLM
% 210.03/210.22  |- skos__scopeNote mesh__D012614
% 210.03/210.22       A condition due to deficiency of ASCORBIC ACID %28%vitamin C%29% in the diet and marked by weakness, anemia, spongy gums, a tendency to mucocutaneous hemorrhages and a brawny induration of the muscles of the calves and legs. %28%Dorland, 27th ed%29%%A%    
% 210.03/210.22  |- skos__broader mesh__D012614smesh__D001206
% 210.03/210.22  |- skos__prefLabel mesh__D012614 Scurvy
% 210.03/210.22  |- skos__hiddenLabel mesh__D003888 Allergen Immunotherapies
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D003888 2005
% 210.03/210.22  |- mesh__historyNote mesh__D003888
% 210.03/210.22       80; was DESENSITIZATION 1963-79 %28%Prov 1963-64%29%   
% 210.03/210.22  |- skos__hiddenLabel mesh__D003888 Immunotherapies, Allergen
% 210.03/210.22  |- mesh__recordOriginator mesh__D003888 NLM
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D003888 2002
% 210.03/210.22  |- skos__hiddenLabel mesh__D003888 Hyposensitization Therapies
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D003888 2006
% 210.03/210.22  |- mesh__recordMaintainer mesh__D003888 sjn
% 210.03/210.22  |- mesh__dateRevised mesh__D003888 2001-08-07
% 210.03/210.22  |- skos__scopeNote mesh__D003888
% 210.03/210.22       Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity.%A%    
% 210.03/210.22  |- skos__prefLabel mesh__D003888 Desensitization, Immunologic
% 210.03/210.22  |- mesh__dateEstablished mesh__D003888 1965-01-01
% 210.03/210.22  |- skos__annotation mesh__D003888
% 210.03/210.22       do not use /util except by MeSH definition; DF: DESENSITIZATION IMMUNOL%A%  
% 210.03/210.22  |- mesh__dateCreated mesh__D003888 1999-01-01
% 210.03/210.22  |- skos__broader mesh__D003888smesh__D007165
% 210.03/210.22  |- rdf__type mesh__D003888sskos__Concept
% 210.03/210.22  |- skos__altLabel mesh__D003888 Immunotherapy, Allergen
% 210.03/210.22  |- skos__altLabel mesh__D003888 Immunologic Desensitization
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D003888 2003
% 210.03/210.22  |- skos__altLabel mesh__D003888 Hyposensitization Therapy
% 210.03/210.22  |- mesh__onlineNote mesh__D003888
% 210.03/210.22       use DESENSITIZATION, IMMUNOLOGIC to search DESENSITIZATION 1966-79%A%  
% 210.03/210.22  |- skos__altLabel mesh__D003888 Therapy, Hyposensitization
% 210.03/210.22  |- mesh__recordAuthorizer mesh__D003888 sjn
% 210.03/210.22  |- skos__hiddenLabel mesh__D003888 Desensitizations, Immunologic
% 210.03/210.22  |- skos__hiddenLabel mesh__D003888 Immunologic Desensitizations
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D003888 2004
% 210.03/210.22  |- mesh__publicMeSHNote mesh__D003888 80; was DESENSITIZATION 1965-79   
% 210.03/210.22  |- skos__hiddenLabel mesh__D003888 Therapies, Hyposensitization
% 210.03/210.22  |- rdf__type mesh__D008573sskos__Concept
% 210.03/210.22  |- mesh__recordAuthorizer mesh__D008573 sjn
% 210.03/210.22  |- skos__broader mesh__D008573smesh__D008671
% 210.03/210.22  |- mesh__recordOriginator mesh__D008573 NLM
% 210.03/210.22  |- mesh__dateRevised mesh__D008573 2005-06-30
% 210.03/210.22  |- skos__annotation mesh__D008573 man-made radioactive element; IM   
% 210.03/210.22  |- skos__prefLabel mesh__D008573 Mendelevium
% 210.03/210.22  |- mesh__recordMaintainer mesh__D008573 jmp
% 210.03/210.22  |- mesh__dateCreated mesh__D008573 1999-01-01
% 210.03/210.22  |- skos__broader mesh__D008573smesh__D019216
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D008573 2006
% 210.03/210.22  |- skos__scopeNote mesh__D008573
% 210.03/210.22       Mendelevium. A man-made radioactive element of the actinide family with atomic symbol Md, atomic number 101, and atomic weight 258.%A%    
% 210.03/210.22  |- skos__hiddenLabel mesh__D000590 Ketones, Peptide Chloromethyl
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D000590 2003
% 210.03/210.22  |- mesh__recordMaintainer mesh__D000590 KEV
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D000590 2005
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D000590 2004
% 210.03/210.22  |- skos__historyNote mesh__D000590 Peptides %28%1966-1976%29%
% 210.03/210.22  |- mesh__historyNote mesh__D000590 77   
% 210.03/210.22  |- rdf__type mesh__D000590sskos__Concept
% 210.03/210.22  |- skos__prefLabel mesh__D000590 Amino Acid Chloromethyl Ketones
% 210.03/210.22  |- mesh__publicMeSHNote mesh__D000590
% 210.03/210.22       77; TOSYLLYSINE CHLOROMETHYL KETONE was see under LYSINE 1975-76; TOSYLPHENYLALANYL CHLOROMETHYL KETONE was see under PHENYLALANINE 1975-76%A%  
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D000590 2006
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D000590 2000
% 210.03/210.22  |- skos__altLabel mesh__D000590 Peptide Chloromethyl Ketones
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D000590 2001
% 210.03/210.22  |- mesh__recordAuthorizer mesh__D000590 sjn
% 210.03/210.22  |- mesh__dateEstablished mesh__D000590 1977-01-01
% 210.03/210.22  |- mesh__dateRevised mesh__D000590 1999-11-09
% 210.03/210.22  |- mesh__dateCreated mesh__D000590 1976-05-19
% 210.03/210.22  |- skos__scopeNote mesh__D000590
% 210.03/210.22       Inhibitors of SERINE ENDOPEPTIDASES and sulfhydryl group-containing enzymes. They act as alkylating agents and are known to interfere in the translation process.%A%    
% 210.03/210.22  |- mesh__recordOriginator mesh__D000590 RLS
% 210.03/210.22  |- skos__historyNote mesh__D000590 specific amino acid %28%1966-1976%29%
% 210.03/210.22  |- skos__broader mesh__D000590smesh__D000596
% 210.03/210.22  |- skos__hiddenLabel mesh__D000590 Chloromethyl Ketones, Peptide
% 210.03/210.22  |- skos__annotation mesh__D000590 serine proteinase inhib; DF: AACK   
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D000590 2002
% 210.03/210.22  |- skos__historyNote mesh__D016207 Biological Products %28%1976-1988%29%
% 210.03/210.22  |- mesh__dateEstablished mesh__D016207 1991-01-01
% 210.03/210.22  |- mesh__historyNote mesh__D016207 91   
% 210.03/210.22  |- mesh__publicMeSHNote mesh__D016207 91   
% 210.03/210.22  |- skos__broader mesh__D016207smesh__D036341
% 210.03/210.22  |- mesh__recordOriginator mesh__D016207 AGS
% 210.03/210.22  |- skos__prefLabel mesh__D016207 Cytokines
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D016207 2006
% 210.03/210.22  |- mesh__dateRevised mesh__D016207 2005-06-30
% 210.03/210.22  |- rdf__type mesh__D016207sskos__Concept
% 210.03/210.22  |- skos__historyNote mesh__D016207 Biological Factors %28%1989-1990%29%
% 210.03/210.22  |- mesh__recordAuthorizer mesh__D016207 sjn
% 210.03/210.22  |- mesh__recordMaintainer mesh__D016207 ssb
% 210.03/210.22  |- skos__scopeNote mesh__D016207
% 210.03/210.22       Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner.%A%    
% 210.03/210.22  |- mesh__dateCreated mesh__D016207 1990-04-24
% 210.03/210.22  |- skos__broader mesh__D019811Q000031smesh__D019811
% 210.03/210.22  |- mesh__preferredCombination mesh__D019811Q000031smesh__D006898
% 210.03/210.22  |- rdf__type mesh__D019811Q000031smesh__CompoundConcept
% 210.03/210.22  |- skos__hiddenLabel mesh__D004981 Deaminase, Ethanolamine
% 210.03/210.22  |- mesh__publicMeSHNote mesh__D004981
% 210.03/210.22       91; was see under AMMONIA-LYASES 1975-90   
% 210.03/210.22  |- skos__hiddenLabel mesh__D004981 Ethanolamine Ammonia Lyase
% 210.03/210.22  |- rdf__type mesh__D004981sskos__Concept
% 210.03/210.22  |- mesh__dateCreated mesh__D004981 1974-11-19
% 210.03/210.22  |- mesh__dateEstablished mesh__D004981 1991-01-01
% 210.03/210.22  |- mesh__dateRevised mesh__D004981 2003-07-09
% 210.03/210.22  |- mesh__recordMaintainer mesh__D004981 ssb
% 210.03/210.22  |- skos__prefLabel mesh__D004981 Ethanolamine Ammonia-Lyase
% 210.03/210.22  |- skos__broader mesh__D004981smesh__D000642
% 210.03/210.22  |- skos__scopeNote mesh__D004981
% 210.03/210.22       An enzyme that catalyzes the deamination of ethanolamine to acetaldehyde. EC 4.3.1.7.%A%    
% 210.03/210.22  |- skos__altLabel mesh__D004981 Ethanolamine Deaminase
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004981 2005
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004981 2004
% 210.03/210.22  |- mesh__historyNote mesh__D004981
% 210.03/210.22       91%28%75%29%; was see under AMMONIA-LYASES 1975-90   
% 210.03/210.22  |- skos__historyNote mesh__D004981 Ammonia-Lyases %28%1973-1974%29%
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004981 2006
% 210.03/210.22  |- skos__hiddenLabel mesh__D004981 Ammonia-Lyase, Ethanolamine
% 210.03/210.22  |- skos__historyNote mesh__D004981 Ethanolamines %28%1973-1974%29%
% 210.03/210.22  |- mesh__recordOriginator mesh__D004981 NLM
% 210.03/210.22  |- mesh__recordAuthorizer mesh__D004981 sjn
% 210.03/210.22  |- skos__altLabel mesh__D004183 Dog Heartworm
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004183 2006
% 210.03/210.22  |- mesh__recordOriginator mesh__D004183 NLM
% 210.03/210.22  |- mesh__recordAuthorizer mesh__D004183 sjn
% 210.03/210.22  |- mesh__dateRevised mesh__D004183 2003-07-09
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004183 2005
% 210.03/210.22  |- skos__scopeNote mesh__D004183
% 210.03/210.22       A filarial parasite primarily of dogs but occurring also in foxes, wolves, and humans. The parasite is transmitted by mosquitoes.%A%    
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004183 2004
% 210.03/210.22  |- mesh__historyNote mesh__D004183
% 210.03/210.22       91%28%75%29%; was see under FILARIOIDEA 1975-90   
% 210.03/210.22  |- mesh__recordMaintainer mesh__D004183 ags
% 210.03/210.22  |- mesh__publicMeSHNote mesh__D004183
% 210.03/210.22       91; was see under FILARIOIDEA 1975-90   
% 210.03/210.22  |- skos__annotation mesh__D004183
% 210.03/210.22       infection = DIROFILARIASIS; coord with specific helminth term %28%ANTIGENS, HELMINTH, etc%29% if pertinent; /drug eff: consider FILARICIDES%A%  
% 210.03/210.22  |- skos__broader mesh__D004183smesh__D004182
% 210.03/210.22  |- rdf__type mesh__D004183sskos__Concept
% 210.03/210.22  |- skos__prefLabel mesh__D004183 Dirofilaria immitis
% 210.03/210.22  |- mesh__dateEstablished mesh__D004183 1991-01-01
% 210.03/210.22  |- mesh__dateCreated mesh__D004183 1974-12-12
% 210.03/210.22  |- rdf__type mesh__D012615sskos__Concept
% 210.03/210.22  |- skos__scopeNote mesh__D012615
% 210.03/210.22       The order Actiniaria, in the class ANTHOZOA, comprised of large, solitary polyps. All species are carnivorous.%A%    
% 210.03/210.22  |- mesh__recordOriginator mesh__D012615 NLM
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D012615 2005
% 210.03/210.22  |- mesh__dateRevised mesh__D012615 2003-07-09
% 210.03/210.22  |- skos__altLabel mesh__D012615 Actiniaria
% 210.03/210.22  |- mesh__dateCreated mesh__D012615 1974-12-12
% 210.03/210.22  |- skos__broader mesh__D012615smesh__D037421
% 210.03/210.22  |- skos__prefLabel mesh__D012615 Sea Anemones
% 210.03/210.22  |- mesh__recordAuthorizer mesh__D012615 sjn
% 210.03/210.22  |- mesh__recordMaintainer mesh__D012615 ags
% 210.03/210.22  |- mesh__dateEstablished mesh__D012615 1991-01-01
% 210.03/210.22  |- mesh__publicMeSHNote mesh__D012615
% 210.03/210.22       91; was see under COELENTERATA 1975-90   
% 210.03/210.22  |- mesh__historyNote mesh__D012615
% 210.03/210.22       91%28%75%29%; was see under COELENTERATA 1975-90   
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D012615 2006
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D012615 2004
% 210.03/210.22  |- skos__hiddenLabel mesh__D017300 Dihydrate Pipecuronium Dibromide
% 210.03/210.22  |- mesh__dateEstablished mesh__D017300 1993-01-01
% 210.03/210.22  |- mesh__dateRevised mesh__D017300 2003-07-09
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D017300 2006
% 210.03/210.22  |- mesh__dateCreated mesh__D017300 1992-05-19
% 210.03/210.22  |- skos__broader mesh__D017300smesh__D010879
% 210.03/210.22  |- skos__altLabel mesh__D017300 Pipecurium
% 210.03/210.22  |- skos__scopeNote mesh__D017300
% 210.03/210.22       A piperazinyl androstane derivative which is a non-depolarizing neuromuscular blocking agent %28%NEUROMUSCULAR NONDEPOLARIZING AGENTS%29%. It is used as a muscle relaxant during ANESTHESIA and surgical procedures.%A%    
% 210.03/210.22  |- skos__hiddenLabel mesh__D017300 RGH1106
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D017300 2004
% 210.03/210.22  |- skos__hiddenLabel mesh__D017300 Bromide, Pipecurium
% 210.03/210.22  |- mesh__publicMeSHNote mesh__D017300
% 210.03/210.22       93; PIPECURIUM was indexed under PIPERAZINES %26% ANDROSTANES 1980-92 %26% STEROIDS 1979-80%A%  
% 210.03/210.22  |- skos__historyNote mesh__D017300 Piperazines %28%1980-1992%29%
% 210.03/210.22  |- skos__hiddenLabel mesh__D017300 Bromide, Pipecuronium
% 210.03/210.22  |- mesh__historyNote mesh__D017300 93; was PIPECURIUM %28%NM%29% 1979-92   
% 210.03/210.22  |- rdf__type mesh__D017300sskos__Concept
% 210.03/210.22  |- skos__prefLabel mesh__D017300 Pipecuronium
% 210.03/210.22  |- skos__historyNote mesh__D017300
% 210.03/210.22       5-Androstane-3,17-diol/analogs %26% derivatives %28%1980-1992%29%
% 210.03/210.22  |- skos__altLabel mesh__D017300 Pipecurium Bromide
% 210.03/210.22  |- mesh__recordOriginator mesh__D017300 TPW
% 210.03/210.22  |- skos__hiddenLabel mesh__D017300 RGH 1106
% 210.03/210.22  |- mesh__onlineNote mesh__D017300
% 210.03/210.22       use PIPECURONIUM %28%NM%29% to search PIPECURIUM 1979-92   
% 210.03/210.22  |- skos__hiddenLabel mesh__D017300 Dibromide Pipecuronium
% 210.03/210.22  |- mesh__recordMaintainer mesh__D017300 lkt
% 210.03/210.22  |- skos__historyNote mesh__D017300 Steroids %28%1979-1980%29%
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D017300 2005
% 210.03/210.22  |- mesh__recordAuthorizer mesh__D017300 sjn
% 210.03/210.22  |- skos__hiddenLabel mesh__D017300 Dibromide, Dihydrate Pipecuronium
% 210.03/210.22  |- mesh__dateRevised mesh__D003889 1999-11-03
% 210.03/210.22  |- skos__hiddenLabel mesh__D003889 Desert Climates
% 210.03/210.22  |- mesh__dateCreated mesh__D003889 1999-01-01
% 210.03/210.22  |- mesh__recordAuthorizer mesh__D003889 sjn
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D003889 2000
% 210.03/210.22  |- rdf__type mesh__D003889sskos__Concept
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D003889 2003
% 210.03/210.22  |- skos__scopeNote mesh__D003889
% 210.03/210.22       A type of climate characterized by insufficient moisture to support appreciable plant life. It is a climate of extreme aridity, usually of extreme heat, and of negligible rainfall. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D003889 2001
% 210.03/210.22  |- skos__annotation mesh__D003889 specify geog if pertinent   
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D003889 2004
% 210.03/210.22  |- mesh__recordMaintainer mesh__D003889 kle
% 210.03/210.22  |- mesh__recordOriginator mesh__D003889 NLM
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D003889 2002
% 210.03/210.22  |- skos__hiddenLabel mesh__D003889 Climates, Desert
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D003889 2005
% 210.03/210.22  |- skos__prefLabel mesh__D003889 Desert Climate
% 210.03/210.22  |- skos__broader mesh__D003889smesh__D002980
% 210.03/210.22  |- skos__hiddenLabel mesh__D003889 Climate, Desert
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D003889 2006
% 210.03/210.22  |- mesh__historyNote mesh__D008574 94; was MENGO VIRUS 1973-93   
% 210.03/210.22  |- mesh__dateRevised mesh__D008574 2001-08-07
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D008574 2004
% 210.03/210.22  |- skos__annotation mesh__D008574
% 210.03/210.22       a strain of ENCEPHALOMYOCARDITIS VIRUS; Mengo is in Uganda; infection: coord IM with CARDIOVIRUS INFECTIONS %28%IM%29%%A%  
% 210.03/210.22  |- mesh__onlineNote mesh__D008574
% 210.03/210.22       use MENGOVIRUS to search MENGO VIRUS 1973-93   
% 210.03/210.22  |- skos__hiddenLabel mesh__D008574 Virus, Mengo
% 210.03/210.22  |- mesh__recordAuthorizer mesh__D008574 sjn
% 210.03/210.22  |- skos__altLabel mesh__D008574 Mengo Virus
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D008574 2005
% 210.03/210.22  |- mesh__dateCreated mesh__D008574 1999-01-01
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D008574 2006
% 210.03/210.22  |- mesh__recordOriginator mesh__D008574 NLM
% 210.03/210.22  |- mesh__publicMeSHNote mesh__D008574 94; was MENGO VIRUS 1973-93   
% 210.03/210.22  |- skos__historyNote mesh__D008574
% 210.03/210.22       Encephalomyocarditis Viruses %28%1966-1972%29%
% 210.03/210.22  |- skos__scopeNote mesh__D008574
% 210.03/210.22       A strain of ENCEPHALOMYOCARDITIS VIRUS, a species of CARDIOVIRUS, isolated from rodents and lagomorphs and occasionally causing febrile illness in man.%A%    
% 210.03/210.22  |- skos__broader mesh__D008574smesh__D004686
% 210.03/210.22  |- skos__prefLabel mesh__D008574 Mengovirus
% 210.03/210.22  |- mesh__dateEstablished mesh__D008574 1973-01-01
% 210.03/210.22  |- mesh__recordMaintainer mesh__D008574 sjn
% 210.03/210.22  |- rdf__type mesh__D008574sskos__Concept
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D008574 2002
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D008574 2003
% 210.03/210.22  |- skos__hiddenLabel mesh__D000591 Isomerases, Amino Acid
% 210.03/210.22  |- skos__prefLabel mesh__D000591 Amino Acid Isomerases
% 210.03/210.22  |- mesh__publicMeSHNote mesh__D000591 74   
% 210.03/210.22  |- mesh__recordMaintainer mesh__D000591 ssb
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D000591 2004
% 210.03/210.22  |- mesh__dateRevised mesh__D000591 2003-07-09
% 210.03/210.22  |- skos__historyNote mesh__D000591 specific amino acid %28%1966-1971%29%
% 210.03/210.22  |- mesh__dateCreated mesh__D000591 1999-01-01
% 210.03/210.22  |- mesh__historyNote mesh__D000591 74%28%72%29%   
% 210.03/210.22  |- skos__hiddenLabel mesh__D000591 Racemases, Amino Acid
% 210.03/210.22  |- skos__broader mesh__D000591smesh__D019998
% 210.03/210.22  |- rdf__type mesh__D000591sskos__Concept
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D000591 2006
% 210.03/210.22  |- mesh__dateEstablished mesh__D000591 1974-01-01
% 210.03/210.22  |- skos__hiddenLabel mesh__D000591 Acid Isomerases, Amino
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D000591 2005
% 210.03/210.22  |- mesh__recordOriginator mesh__D000591 NLM
% 210.03/210.22  |- skos__scopeNote mesh__D000591
% 210.03/210.22       Enzymes that catalyze either the racemization or epimerization of chiral centers within amino acids or derivatives. EC 5.1.1.%A%    
% 210.03/210.22  |- mesh__recordAuthorizer mesh__D000591 sjn
% 210.03/210.22  |- skos__hiddenLabel mesh__D000591 Acid Racemases, Amino
% 210.03/210.22  |- skos__historyNote mesh__D000591 Isomerases %28%1966-1971%29%
% 210.03/210.22  |- mesh__publicMeSHNote mesh__D016208 1991   
% 210.03/210.22  |- skos__hiddenLabel mesh__D016208 Factual Data Banks
% 210.03/210.22  |- skos__hiddenLabel mesh__D016208 Data Base, Factual
% 210.03/210.22  |- mesh__recordMaintainer mesh__D016208 jls
% 210.03/210.22  |- mesh__recordOriginator mesh__D016208 TGC
% 210.03/210.22  |- skos__altLabel mesh__D016208 Databanks, Factual
% 210.03/210.22  |- mesh__dateRevised mesh__D016208 2004-07-07
% 210.03/210.22  |- skos__hiddenLabel mesh__D016208 Factual Data Bases
% 210.03/210.22  |- skos__hiddenLabel mesh__D016208 Factual Databanks
% 210.03/210.22  |- skos__hiddenLabel mesh__D016208 Factual Data Base
% 210.03/210.22  |- skos__hiddenLabel mesh__D016208 Data Bank, Factual
% 210.03/210.22  |- mesh__recordAuthorizer mesh__D016208 sjn
% 210.03/210.22  |- skos__hiddenLabel mesh__D016208 Factual Data Bank
% 210.03/210.22  |- mesh__dateCreated mesh__D016208 1990-05-07
% 210.03/210.22  |- skos__historyNote mesh__D016208 Information Systems %28%1966-1990%29%
% 210.03/210.22  |- skos__hiddenLabel mesh__D016208 Database, Factual
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D016208 2005
% 210.03/210.22  |- skos__hiddenLabel mesh__D016208 Databank, Factual
% 210.03/210.22  |- skos__scopeNote mesh__D016208
% 210.03/210.22       Extensive collections, reputedly complete, of facts and data garnered from material of a specialized subject area and made available for analysis and application. The collection can be automated by various contemporary methods for retrieval. The concept should be differentiated from DATABASES, BIBLIOGRAPHIC which is restricted to collections of bibliographic references.%A%    
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D016208 2006
% 210.03/210.22  |- skos__hiddenLabel mesh__D016208 Factual Databases
% 210.03/210.22  |- mesh__dateEstablished mesh__D016208 1991-01-01
% 210.03/210.22  |- skos__altLabel mesh__D016208 Data Banks, Factual
% 210.03/210.22  |- skos__hiddenLabel mesh__D016208 Factual Database
% 210.03/210.22  |- rdf__type mesh__D016208sskos__Concept
% 210.03/210.22  |- skos__hiddenLabel mesh__D016208 Factual Databank
% 210.03/210.22  |- mesh__historyNote mesh__D016208 1991   
% 210.03/210.22  |- skos__broader mesh__D016208smesh__D019992
% 210.03/210.22  |- skos__prefLabel mesh__D016208 Databases, Factual
% 210.03/210.22  |- skos__altLabel mesh__D016208 Data Bases, Factual
% 210.03/210.22  |- skos__broader mesh__D009206Q000637smesh__D009206
% 210.03/210.22  |- mesh__preferredCombination mesh__D009206Q000637smesh__D016027
% 210.03/210.22  |- rdf__type mesh__D009206Q000637smesh__CompoundConcept
% 210.03/210.22  |- rdf__type mesh__D004982sskos__Concept
% 210.03/210.22  |- mesh__recordOriginator mesh__D004982 RLS
% 210.03/210.22  |- mesh__dateEstablished mesh__D004982 1991-01-01
% 210.03/210.22  |- mesh__dateRevised mesh__D004982 2003-07-09
% 210.03/210.22  |- skos__historyNote mesh__D004982 Amino Alcohols %28%1966-1972%29%
% 210.03/210.22  |- mesh__recordAuthorizer mesh__D004982 sjn
% 210.03/210.22  |- skos__historyNote mesh__D004982 Ethanolamines %28%1973-1978%29%
% 210.03/210.22  |- mesh__publicMeSHNote mesh__D004982
% 210.03/210.22       91; was see under PHOSPHOTRANSFERASES 1979-90   
% 210.03/210.22  |- skos__altLabel mesh__D004982
% 210.03/210.22       sn-1,2-Diacylglycerol Ethanolaminephosphotransferase
% 210.03/210.22  |- skos__altLabel mesh__D004982 Phosphoethanolaminetransferase
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004982 2005
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004982 2004
% 210.03/210.22  |- mesh__historyNote mesh__D004982
% 210.03/210.22       91%28%79%29%; was see under PHOSPHOTRANSFERASES 1979-90   
% 210.03/210.22  |- mesh__recordMaintainer mesh__D004982 ssb
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004982 2006
% 210.03/210.22  |- skos__prefLabel mesh__D004982 Ethanolaminephosphotransferase
% 210.03/210.22  |- skos__scopeNote mesh__D004982
% 210.03/210.22       An enzyme that catalyzes reversibly the transfer of phosphoethanolamine from CDP-ethanolamine to diacylglycerol to yield phosphatidylethanolamine %28%cephalin%29% and CMP. The enzyme is found in the endoplasmic reticulum. EC 2.7.8.1.%A%    
% 210.03/210.22  |- skos__hiddenLabel mesh__D004982
% 210.03/210.22       Ethanolaminephosphotransferase, sn-1,2-Diacylglycerol
% 210.03/210.22  |- skos__historyNote mesh__D004982 Phosphotransferases %28%1966-1978%29%
% 210.03/210.22  |- skos__hiddenLabel mesh__D004982
% 210.03/210.22       sn 1,2 Diacylglycerol Ethanolaminephosphotransferase
% 210.03/210.22  |- mesh__dateCreated mesh__D004982 1978-03-08
% 210.03/210.22  |- skos__broader mesh__D004982smesh__D017855
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004184 2005
% 210.03/210.22  |- mesh__activeMeSHYear mesh__D004184 2004
% 210.03/210.22  |- skos__prefLabel mesh__D004184 Dirofilariasis
% 210.03/210.22  |- skos__historyNote mesh__D004184 Filariasis %28%1966-1967%29%
% 210.03/210.22  |- mesh__historyNote mesh__D004184 68   
% 210.03/210.22  |- mesh__publicMeSHNote mesh__D004184 68   
% 210.03/210.22  |- skos__broader mesh__D004184smesh__D005368
% 210.03/210.22  |- mesh__recordOriginator mesh__D004184 NLM
% 210.03/210.22  |- skos__hiddenLabel mesh__D004184 Disease, Heartworm
% 210.03/210.22  |- mesh__recordAuthorizer mesh__D004184 sjn
% 210.03/210.23  |- mesh__dateCreated mesh__D004184 1999-01-01
% 210.03/210.23  |- mesh__recordMaintainer mesh__D004184 ags
% 210.03/210.23  |- skos__altLabel mesh__D004184 Heartworm Disease
% 210.03/210.23  |- skos__hiddenLabel mesh__D004184 Dirofilariases
% 210.03/210.23  |- mesh__dateEstablished mesh__D004184 1968-01-01
% 210.03/210.23  |- skos__broader mesh__D004184smesh__D006374
% 210.03/210.23  |- rdf__type mesh__D004184sskos__Concept
% 210.03/210.23  |- skos__annotation mesh__D004184
% 210.03/210.23       usually in animals, espec dogs; coord IM with precoord animal/dis term %28%IM%29% + specific animal %28%NIM%29%; check also tag ANIMALS; drug ther: consider FILARICIDES%A%  
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D004184 2006
% 210.03/210.23  |- mesh__dateRevised mesh__D004184 2003-07-30
% 210.03/210.23  |- skos__scopeNote mesh__D004184
% 210.03/210.23       Infection with nematodes of the genus DIROFILARIA, usually in animals, especially dogs, but occasionally in man.%A%    
% 210.03/210.23  |- skos__prefLabel mesh__D012616 Sea Cucumbers
% 210.03/210.23  |- skos__altLabel mesh__D012616 Holothuroidea
% 210.03/210.23  |- mesh__dateEstablished mesh__D012616 1991-01-01
% 210.03/210.23  |- mesh__recordOriginator mesh__D012616 AEP
% 210.03/210.23  |- mesh__historyNote mesh__D012616
% 210.03/210.23       91%28%78%29%; was see under ECHINODERMATA 1978-90   
% 210.03/210.23  |- skos__scopeNote mesh__D012616
% 210.03/210.23       A class of Echinodermata characterized by long, slender bodies.%A%    
% 210.03/210.23  |- mesh__recordMaintainer mesh__D012616 ags
% 210.03/210.23  |- skos__annotation mesh__D012616 note specifics   
% 210.03/210.23  |- skos__historyNote mesh__D012616 Echinodermata %28%1966-1977%29%
% 210.03/210.23  |- mesh__publicMeSHNote mesh__D012616
% 210.03/210.23       91; was see under ECHINODERMATA 1978-90   
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D012616 2005
% 210.03/210.23  |- mesh__dateRevised mesh__D012616 2004-07-07
% 210.03/210.23  |- skos__broader mesh__D012616smesh__D004447
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D012616 2006
% 210.03/210.23  |- mesh__recordAuthorizer mesh__D012616 sjn
% 210.03/210.23  |- mesh__dateCreated mesh__D012616 1977-03-01
% 210.03/210.23  |- rdf__type mesh__D012616sskos__Concept
% 210.03/210.23  |- skos__altLabel mesh__D017301 Calcium Magnesium ATPase
% 210.03/210.23  |- mesh__recordMaintainer mesh__D017301 ssb
% 210.03/210.23  |- skos__scopeNote mesh__D017301
% 210.03/210.23       An enzyme that catalyzes the hydrolysis of ATP and is activated by millimolar concentrations of either Ca%28%2+%29% or Mg%28%2+%29%. Unlike CA%28%2+%29%-TRANSPORTING ATPASE it does not require the second divalent cation for its activity, and is not sensitive to orthovanadate. %28%Prog Biophys Mol Biol 1988;52%28%1%29%:1%29%. A subgroup of EC 3.6.1.3.%A%    
% 210.03/210.23  |- skos__altLabel mesh__D017301 Adenosinetriphosphatase, Calcium, Magnesium
% 210.03/210.23  |- skos__altLabel mesh__D017301 Ca2+-Mg2+ ATPase
% 210.03/210.23  |- mesh__onlineNote mesh__D017301
% 210.03/210.23       use CA%28%2+%29% MG%28%2+%29%-ATPASE %28%NM%29% to search CALCIUM MAGNESIUM ATPASE 1979-92, ADENOSINE TRIPHOSPHATASE, MAGNESIUM, MAGNESIUM ATPASE %26% ATPASE, MAGNESIUM  1986-92, %26% MAGNESIUM ADENOSINE TRIPHOSPHATASE 1989-92%A%  
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D017301 2006
% 210.03/210.23  |- skos__altLabel mesh__D017301 Ca Mg-ATPase
% 210.03/210.23  |- skos__hiddenLabel mesh__D017301 Magnesium Adenosine Triphosphatase
% 210.03/210.23  |- skos__altLabel mesh__D017301 Magnesium ATPase
% 210.03/210.23  |- mesh__dateEstablished mesh__D017301 1993-01-01
% 210.03/210.23  |- skos__altLabel mesh__D017301 ATPase, Calcium Magnesium
% 210.03/210.23  |- skos__altLabel mesh__D017301 Calcium Magnesium Adenosinetriphosphatase
% 210.03/210.23  |- skos__hiddenLabel mesh__D017301 Ca Mg ATPase
% 210.03/210.23  |- mesh__publicMeSHNote mesh__D017301
% 210.03/210.23       93; ADENOSINE TRIPHOSPHATASE, MAGNESIUM was heading 1986-92; CALCIUM MAGNESIUM ATPASE was indexed under ADENOSINE TRIPHOSPHATASE, CALCIUM %26% ADENOSINE TRIPHOSPHATASE, MAGNESIUM 1986-92, ADENOSINE TRIPHOSPHATASE 1981-92, %26% MAGNESIUM 1979-80; MAGNESIUM ADENOSINE TRIPHOSPHATASE was see ADENOSINE TRIPHOSPHATASE 1989-92; MAGNESIUM ATPASE %26% ATPASE, MAGNESIUM were see ADENOSINE TRIPHOSPHATASE, MAGNESIUM 1986-92%A%  
% 210.03/210.23  |- skos__altLabel mesh__D017301 Adenosinetriphosphatase, Magnesium
% 210.03/210.23  |- skos__historyNote mesh__D017301 Magnesium %28%1979-1980%29%
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D017301 2005
% 210.03/210.23  |- skos__altLabel mesh__D017301 Mg2+-ATPase
% 210.03/210.23  |- skos__hiddenLabel mesh__D017301 ATPase, Mg2+-Dependent
% 210.03/210.23  |- skos__historyNote mesh__D017301
% 210.03/210.23       Ca%28%2+%29%-Transporting ATPase %28%1986-1992%29%
% 210.03/210.23  |- skos__altLabel mesh__D017301
% 210.03/210.23       Adenosine Triphosphatase, Calcium, Magnesium
% 210.03/210.23  |- skos__prefLabel mesh__D017301 Ca%28%2+%29% Mg%28%2+%29%-ATPase
% 210.03/210.23  |- skos__hiddenLabel mesh__D017301
% 210.03/210.23       Adenosinetriphosphatase, Calcium Magnesium
% 210.03/210.23  |- skos__related mesh__D017301smesh__D000252
% 210.03/210.23  |- mesh__dateRevised mesh__D017301 2003-07-09
% 210.03/210.23  |- skos__annotation mesh__D017301 DF: CA MG ATPASE   
% 210.03/210.23  |- skos__hiddenLabel mesh__D017301 Mg2+ ATPase
% 210.03/210.23  |- skos__hiddenLabel mesh__D017301 Mg2+ Dependent ATPase
% 210.03/210.23  |- skos__hiddenLabel mesh__D017301 ATPase, Ca2+-Mg2+
% 210.03/210.23  |- skos__broader mesh__D017301smesh__D000251
% 210.03/210.23  |- skos__historyNote mesh__D017301
% 210.03/210.23       Adenosine Triphosphatase, Magnesium %28%1986-1992%29%
% 210.03/210.23  |- skos__altLabel mesh__D017301 Calcium Magnesium Adenosine Triphosphatase
% 210.03/210.23  |- mesh__recordOriginator mesh__D017301 TPW
% 210.03/210.23  |- mesh__recordAuthorizer mesh__D017301 sjn
% 210.03/210.23  |- skos__altLabel mesh__D017301 ATPase, Magnesium
% 210.03/210.23  |- rdf__type mesh__D017301sskos__Concept
% 210.03/210.23  |- skos__altLabel mesh__D017301 Mg2+-Dependent ATPase
% 210.03/210.23  |- skos__historyNote mesh__D017301
% 210.03/210.23       Adenosinetriphosphatase %28%1981-1985%29%
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D017301 2004
% 210.03/210.23  |- skos__altLabel mesh__D017301 Adenosine Triphosphatase, Magnesium
% 210.03/210.23  |- skos__altLabel mesh__D017301 Magnesium Adenosinetriphosphatase
% 210.03/210.23  |- mesh__dateCreated mesh__D017301 1992-06-29
% 210.03/210.23  |- mesh__historyNote mesh__D017301
% 210.03/210.23       93; ADENOSINE TRIPHOSPHATASE, MAGNESIUM was heading 1986-92; CALCIUM MAGNESIUM ATPASE was NM 1979-92; MAGNESIUM ADENOSINE TRIPHOSPHATASE was see ADENOSINE TRIPHOSPHATASE, MAGNESIUM 1989-92; MAGNESIUM ATPASE %26% ATPASE, MAGNESIUM were see ADENOSINE TRIPHOSPHATASE, MAGNESIUM 1986-92%A%  
% 210.03/210.23  |- skos__hiddenLabel mesh__D017301 Ca2+ Mg2+ ATPase
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D008575 2005
% 210.03/210.23  |- mesh__dateRevised mesh__D008575 2001-08-13
% 210.03/210.23  |- rdf__type mesh__D008575sskos__Concept
% 210.03/210.23  |- skos__hiddenLabel mesh__D008575 Disease, Meniere
% 210.03/210.23  |- skos__altLabel mesh__D008575 Meniere%27%s Syndrome
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D008575 2004
% 210.03/210.23  |- skos__prefLabel mesh__D008575 Meniere%27%s Disease
% 210.03/210.23  |- skos__scopeNote mesh__D008575
% 210.03/210.23       A disease of the inner ear characterized by vertigo, tinnitus, and fluctuating hearing loss often accompanied by fullness in the affected ear. ENDOLYMPHATIC HYDROPS %28%swelling of the endolymph-containing structures%29% is the main pathologic finding.%A%    
% 210.03/210.23  |- skos__hiddenLabel mesh__D008575 Menieres Syndrome
% 210.03/210.23  |- mesh__dateCreated mesh__D008575 1999-01-01
% 210.03/210.23  |- skos__hiddenLabel mesh__D008575 Syndrome, Meniere%27%s
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D008575 2003
% 210.03/210.23  |- skos__broader mesh__D008575smesh__D018159
% 210.03/210.23  |- skos__hiddenLabel mesh__D008575 Meniere Syndrome
% 210.03/210.23  |- skos__hiddenLabel mesh__D008575 Menieres Disease
% 210.03/210.23  |- skos__hiddenLabel mesh__D008575 Disease, Meniere%27%s
% 210.03/210.23  |- skos__hiddenLabel mesh__D008575 Aural Vertigo
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D008575 2002
% 210.03/210.23  |- mesh__recordAuthorizer mesh__D008575 sjn
% 210.03/210.23  |- mesh__recordMaintainer mesh__D008575 jls
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D008575 2006
% 210.03/210.23  |- skos__altLabel mesh__D008575 Meniere Disease
% 210.03/210.23  |- skos__annotation mesh__D008575
% 210.03/210.23       an inner ear dis; spell with one accent %28%Meni%C3%%A8%re%27%s%29% in translations; note see related%A%  
% 210.03/210.23  |- skos__related mesh__D008575smesh__D018159
% 210.03/210.23  |- mesh__recordOriginator mesh__D008575 NLM
% 210.03/210.23  |- skos__altLabel mesh__D000592 Inborn Errors, Amino Acid Metabolism
% 210.03/210.23  |- skos__altLabel mesh__D000592 Amino Acidopathies, Inborn
% 210.03/210.23  |- mesh__recordOriginator mesh__D000592 NLM
% 210.03/210.23  |- skos__hiddenLabel mesh__D000592 Inborn Amino Acidopathy
% 210.03/210.23  |- skos__annotation mesh__D000592
% 210.03/210.23       coord IM with specific amino acid /metab %28%IM%29%; DF: AA METAB INBORN ERR%A%  
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D000592 2004
% 210.03/210.23  |- mesh__historyNote mesh__D000592
% 210.03/210.23       1965; PROTEIN METABOLISM DISORDERS was heading 1963-1964   
% 210.03/210.23  |- mesh__recordAuthorizer mesh__D000592 sjn
% 210.03/210.23  |- skos__scopeNote mesh__D000592
% 210.03/210.23       Disorders affecting amino acid metabolism. The majority of these disorders are inherited and present in the neonatal period with metabolic disturbances %28%e.g., ACIDOSIS%29% and neurologic manifestations. They are present at birth, although they may not become symptomatic until later in life.%A%    
% 210.03/210.23  |- skos__hiddenLabel mesh__D000592 Inborn Amino Acidopathies
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D000592 2003
% 210.03/210.23  |- mesh__publicMeSHNote mesh__D000592
% 210.03/210.23       1965; PROTEIN METABOLISM DISORDERS was heading 1963-1964   
% 210.03/210.23  |- mesh__dateCreated mesh__D000592 1999-01-01
% 210.03/210.23  |- rdf__type mesh__D000592sskos__Concept
% 210.03/210.23  |- skos__hiddenLabel mesh__D000592 Congenital Amino Acidopathy
% 210.03/210.23  |- skos__altLabel mesh__D000592 Amino Acid Metabolism Disorders, Inborn
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D000592 2006
% 210.03/210.23  |- skos__altLabel mesh__D000592 Amino Acid Metabolism, Inborn Error
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D000592 2005
% 210.03/210.23  |- skos__altLabel mesh__D000592 Congenital Amino Acidopathies
% 210.03/210.23  |- mesh__dateRevised mesh__D000592 2001-07-25
% 210.03/210.23  |- skos__broader mesh__D000592smesh__D008661
% 210.03/210.23  |- mesh__recordMaintainer mesh__D000592 nns
% 210.03/210.23  |- skos__altLabel mesh__D000592 Inherited Errors of Amino Acid Metabolism
% 210.03/210.23  |- skos__hiddenLabel mesh__D000592 Amino Acidopathy, Congenital
% 210.03/210.23  |- skos__hiddenLabel mesh__D000592 Amino Acidopathy, Inborn
% 210.03/210.23  |- skos__altLabel mesh__D000592 Amino Acidopathies, Congenital
% 210.03/210.23  |- skos__prefLabel mesh__D000592 Amino Acid Metabolism, Inborn Errors
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D000592 2002
% 210.03/210.23  |- skos__hiddenLabel mesh__D016209 Anionic Neutrophil Activating Peptide
% 210.03/210.23  |- skos__hiddenLabel mesh__D016209 Activation Factor, Neutrophil
% 210.03/210.23  |- mesh__dateCreated mesh__D016209 1990-04-24
% 210.03/210.23  |- skos__altLabel mesh__D016209 Chemotactic Factor, Neutrophil
% 210.03/210.23  |- mesh__recordMaintainer mesh__D016209 ssb
% 210.03/210.23  |- skos__scopeNote mesh__D016209
% 210.03/210.23       A cytokine that activates neutrophils and attracts neutrophils and T-lymphocytes. It is released by several cell types including monocytes, macrophages, T-lymphocytes, fibroblasts, endothelial cells, and keratinocytes by an inflammatory stimulus. IL-8 is a member of the beta-thromboglobulin superfamily and structurally related to platelet factor 4.%A%    
% 210.03/210.23  |- skos__altLabel mesh__D016209 Chemotactic Factor, Macrophage-Derived
% 210.03/210.23  |- skos__hiddenLabel mesh__D016209 Activating Peptide, Neutrophil
% 210.03/210.23  |- mesh__recordOriginator mesh__D016209 AGS
% 210.03/210.23  |- skos__hiddenLabel mesh__D016209
% 210.03/210.23       Peptides, Fibroblast-Derived Neutrophil-Activating
% 210.03/210.23  |- skos__hiddenLabel mesh__D016209 Neutrophil-Activating Peptide, Anionic
% 210.03/210.23  |- skos__broader mesh__D016209smesh__D007378
% 210.03/210.23  |- skos__altLabel mesh__D016209 Neutrophil Activating Peptide
% 210.03/210.23  |- skos__hiddenLabel mesh__D016209 Chemotactic Factor, Macrophage Derived
% 210.03/210.23  |- skos__hiddenLabel mesh__D016209 Neutrophil Chemotactic Factor
% 210.03/210.23  |- skos__altLabel mesh__D016209 Neutrophil Activation Factor
% 210.03/210.23  |- skos__hiddenLabel mesh__D016209 Macrophage-Derived Chemotactic Factor
% 210.03/210.23  |- skos__hiddenLabel mesh__D016209 Interleukin 8
% 210.03/210.23  |- mesh__publicMeSHNote mesh__D016209 91   
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D016209 2006
% 210.03/210.23  |- skos__related mesh__D016209smesh__D018375
% 210.03/210.23  |- skos__hiddenLabel mesh__D016209
% 210.03/210.23       Monocyte-Derived Neutrophil-Activating Peptide
% 210.03/210.23  |- skos__broader mesh__D016209smesh__D018925
% 210.03/210.23  |- skos__altLabel mesh__D016209
% 210.03/210.23       Neutrophil-Activating Peptide, Monocyte-Derived
% 210.03/210.23  |- skos__hiddenLabel mesh__D016209
% 210.03/210.23       Chemotactic Peptide-Interleukin-8, Granulocyte
% 210.03/210.23  |- mesh__dateEstablished mesh__D016209 1991-01-01
% 210.03/210.23  |- skos__hiddenLabel mesh__D016209
% 210.03/210.23       Granulocyte Chemotactic Peptide Interleukin 8
% 210.03/210.23  |- skos__altLabel mesh__D016209
% 210.03/210.23       Monocyte-Derived Neutrophil Chemotactic Factor
% 210.03/210.23  |- mesh__historyNote mesh__D016209 91   
% 210.03/210.23  |- skos__historyNote mesh__D016209 Interleukins %28%1988-1990%29%
% 210.03/210.23  |- skos__hiddenLabel mesh__D016209
% 210.03/210.23       Lymphocyte-Derived Neutrophil-Activating Peptide
% 210.03/210.23  |- skos__altLabel mesh__D016209 Neutrophil Activation Peptide
% 210.03/210.23  |- skos__altLabel mesh__D016209 Anionic Neutrophil-Activating Peptide
% 210.03/210.23  |- rdf__type mesh__D016209sskos__Concept
% 210.03/210.23  |- skos__altLabel mesh__D016209
% 210.03/210.23       Chemotactic Factor, Neutrophil, Monocyte-Derived
% 210.03/210.23  |- skos__altLabel mesh__D016209 Leukocyte Adhesion Inhibitor
% 210.03/210.23  |- skos__altLabel mesh__D016209 GCP-IL-8
% 210.03/210.23  |- mesh__dateRevised mesh__D016209 2005-06-30
% 210.03/210.23  |- skos__annotation mesh__D016209 DF: IL 8 or IL8   
% 210.03/210.23  |- skos__hiddenLabel mesh__D016209
% 210.03/210.23       Neutrophil Activating Peptides, Fibroblast Derived
% 210.03/210.23  |- skos__hiddenLabel mesh__D016209 Activation Peptide, Neutrophil
% 210.03/210.23  |- skos__hiddenLabel mesh__D016209
% 210.03/210.23       Neutrophil Activating Peptide, Monocyte Derived
% 210.03/210.23  |- skos__altLabel mesh__D016209 IL8
% 210.03/210.23  |- skos__hiddenLabel mesh__D016209
% 210.03/210.23       Neutrophil Activating Peptide, Lymphocyte Derived
% 210.03/210.23  |- mesh__recordAuthorizer mesh__D016209 sjn
% 210.03/210.23  |- skos__hiddenLabel mesh__D016209
% 210.03/210.23       Fibroblast-Derived Neutrophil-Activating Peptides
% 210.03/210.23  |- skos__hiddenLabel mesh__D016209 Peptide, Anionic Neutrophil-Activating
% 210.03/210.23  |- skos__altLabel mesh__D016209
% 210.03/210.23       Neutrophil-Activating Peptide, Lymphocyte-Derived
% 210.03/210.23  |- skos__altLabel mesh__D016209
% 210.03/210.23       Granulocyte Chemotactic Peptide-Interleukin-8
% 210.03/210.23  |- skos__altLabel mesh__D016209 IL-8
% 210.03/210.23  |- skos__prefLabel mesh__D016209 Interleukin-8
% 210.03/210.23  |- skos__hiddenLabel mesh__D016209 Adhesion Inhibitor, Leukocyte
% 210.03/210.23  |- skos__broader mesh__D006621Q000293smesh__D006621
% 210.03/210.23  |- mesh__preferredCombination mesh__D006621Q000293smesh__D025981
% 210.03/210.23  |- rdf__type mesh__D006621Q000293smesh__CompoundConcept
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D004983 2005
% 210.03/210.23  |- mesh__dateRevised mesh__D004983 2001-07-25
% 210.03/210.23  |- mesh__recordMaintainer mesh__D004983 mdb
% 210.03/210.23  |- skos__annotation mesh__D004983 ETHANOLAMINE is also available   
% 210.03/210.23  |- skos__prefLabel mesh__D004983 Ethanolamines
% 210.03/210.23  |- rdf__type mesh__D004983sskos__Concept
% 210.03/210.23  |- mesh__historyNote mesh__D004983 73   
% 210.03/210.23  |- skos__scopeNote mesh__D004983
% 210.03/210.23       AMINO ALCOHOLS containing the ETHANOLAMINE; %28%-NH2CH2CHOH%29% group and its derivatives.%A%    
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D004983 2004
% 210.03/210.23  |- mesh__publicMeSHNote mesh__D004983 73   
% 210.03/210.23  |- mesh__recordAuthorizer mesh__D004983 sjn
% 210.03/210.23  |- skos__broader mesh__D004983smesh__D000605
% 210.03/210.23  |- mesh__recordOriginator mesh__D004983 NLM
% 210.03/210.23  |- skos__broader mesh__D004983smesh__D000431
% 210.03/210.23  |- mesh__dateEstablished mesh__D004983 1973-01-01
% 210.03/210.23  |- mesh__dateCreated mesh__D004983 1999-01-01
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D004983 2003
% 210.03/210.23  |- skos__historyNote mesh__D004983 Amino Alcohols %28%1966-1972%29%
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D004983 2006
% 210.03/210.23  |- skos__altLabel mesh__D004983 Aminoethanols
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D004983 2002
% 210.03/210.23  |- skos__related mesh__D004185smesh__D014729
% 210.03/210.23  |- skos__prefLabel mesh__D004185 Disability Evaluation
% 210.03/210.23  |- rdf__type mesh__D004185sskos__Concept
% 210.03/210.23  |- mesh__dateRevised mesh__D004185 1997-06-20
% 210.03/210.23  |- mesh__recordMaintainer mesh__D004185 PXP
% 210.03/210.23  |- skos__annotation mesh__D004185 no qualif   
% 210.03/210.23  |- skos__hiddenLabel mesh__D004185 Evaluation, Disability
% 210.03/210.23  |- skos__hiddenLabel mesh__D004185 Disability Evaluations
% 210.03/210.23  |- skos__scopeNote mesh__D004185
% 210.03/210.23       Determination of the degree of a physical, mental, or emotional handicap. The diagnosis is applied to legal qualification for benefits and income under disability insurance and to eligibility for Social Security and workmen%27%s compensation benefits.%A%    
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D004185 2006
% 210.03/210.23  |- mesh__recordAuthorizer mesh__D004185 SJN
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D004185 2002
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D004185 1999
% 210.03/210.23  |- mesh__recordOriginator mesh__D004185 NLM
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D004185 2005
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D004185 2001
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D004185 1998
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D004185 2004
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D004185 2000
% 210.03/210.23  |- skos__hiddenLabel mesh__D004185 Evaluations, Disability
% 210.03/210.23  |- skos__broader mesh__D004185smesh__D019937
% 210.03/210.23  |- mesh__dateCreated mesh__D004185 1999-01-01
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D004185 2003
% 210.03/210.23  |- mesh__recordAuthorizer mesh__D012617 sjn
% 210.03/210.23  |- skos__altLabel mesh__D012617 Clypeasteroida
% 210.03/210.23  |- mesh__publicMeSHNote mesh__D012617 72   
% 210.03/210.23  |- mesh__recordMaintainer mesh__D012617 ags
% 210.03/210.23  |- skos__historyNote mesh__D012617 Echinodermata %28%1966-1971%29%
% 210.03/210.23  |- skos__altLabel mesh__D012617 Sand Dollars
% 210.03/210.23  |- skos__annotation mesh__D012617
% 210.03/210.23       general; prefer specifics; sea urchin eggs = OVUM %28%IM%29% + SEA URCHINS %28%NIM%29% if merely test organism%A%  
% 210.03/210.23  |- skos__altLabel mesh__D012617 Echinoidea
% 210.03/210.23  |- mesh__dateCreated mesh__D012617 1999-01-01
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D012617 2005
% 210.03/210.23  |- mesh__dateRevised mesh__D012617 2004-07-07
% 210.03/210.23  |- mesh__dateEstablished mesh__D012617 1972-01-01
% 210.03/210.23  |- skos__prefLabel mesh__D012617 Sea Urchins
% 210.03/210.23  |- skos__broader mesh__D012617smesh__D004447
% 210.03/210.23  |- mesh__recordOriginator mesh__D012617 NLM
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D012617 2006
% 210.03/210.23  |- rdf__type mesh__D012617sskos__Concept
% 210.03/210.23  |- mesh__historyNote mesh__D012617 72   
% 210.03/210.23  |- skos__scopeNote mesh__D012617
% 210.03/210.23       Somewhat flattened, globular echinoderms, having thin, brittle shells of calcareous plates. They are useful models for studying FERTILIZATION and EMBRYO DEVELOPMENT.%A%    
% 210.03/210.23  |- skos__broader mesh__D017302smesh__D002135
% 210.03/210.23  |- mesh__recordOriginator mesh__D017302 AGS
% 210.03/210.23  |- skos__altLabel mesh__D017302 Calpactin
% 210.03/210.23  |- skos__prefLabel mesh__D017302 Annexins
% 210.03/210.23  |- mesh__publicMeSHNote mesh__D017302
% 210.03/210.23       1993; ANNEXIN XI was indexed under CALCIUM-BINDING PROTEINS 1992; ANNEXIN IX %26% ANNEXIN X were indexed under CALCIUM-BINDING PROTEINS 1990-1992; VASCULAR ANTICOAGULANT %28%ENDOGENOUS%29% was indexed under PEPTIDES 1988-1992; PLACENTAL ANTICOAGULANT PROTEINS was indexed under PREGNANCY PROTEINS 1987-1992; LIPOCORTINS was indexed under CALCIUM-BINDING PROTEINS 1985-1992; CALPACTIN %26% CALCIMEDINS were indexed under CALCIUM-BINDING PROTEINS 1984-1992; CALELECTRIN was indexed under CALCIUM-BINDING PROTEINS 1982-1992; CHROMOBINDINS was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1986-2004%A%  
% 210.03/210.23  |- mesh__dateEstablished mesh__D017302 1993-01-01
% 210.03/210.23  |- skos__altLabel mesh__D017302 Lipocortins
% 210.03/210.23  |- skos__historyNote mesh__D017302
% 210.03/210.23       Calcium-Binding Proteins %28%1984-1992%29%
% 210.03/210.23  |- skos__altLabel mesh__D017302 Calcimedins
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D017302 2006
% 210.03/210.23  |- mesh__recordAuthorizer mesh__D017302 sjn
% 210.03/210.23  |- skos__altLabel mesh__D017302 Annexin X
% 210.03/210.23  |- skos__altLabel mesh__D017302 Annexin VIII
% 210.03/210.23  |- skos__altLabel mesh__D017302 Annexin IX
% 210.03/210.23  |- mesh__dateCreated mesh__D017302 1992-05-07
% 210.03/210.23  |- mesh__historyNote mesh__D017302 1993   
% 210.03/210.23  |- skos__altLabel mesh__D017302 Annexin XI
% 210.03/210.23  |- skos__scopeNote mesh__D017302
% 210.03/210.23       Family of calcium- and phospholipid-binding proteins which are structurally related and exhibit immunological cross-reactivity. Each member contains four homologous 70-kDa repeats. The annexins are differentially distributed in vertebrate tissues %28%and lower eukaryotes%29% and appear to be involved in MEMBRANE FUSION and SIGNAL TRANSDUCTION.%A%    
% 210.03/210.23  |- skos__altLabel mesh__D017302 Lipocortin
% 210.03/210.23  |- mesh__recordMaintainer mesh__D017302 SYSTEM
% 210.03/210.23  |- rdf__type mesh__D017302sskos__Concept
% 210.03/210.23  |- mesh__dateRevised mesh__D017302 2005-06-30
% 210.03/210.23  |- skos__altLabel mesh__D017302 Calelectrin
% 210.03/210.23  |- skos__altLabel mesh__D050736 crk Oncogene Protein
% 210.03/210.23  |- skos__hiddenLabel mesh__D050736 Oncogene Protein, v-crk
% 210.03/210.23  |- mesh__historyNote mesh__D050736 2006%28%1989%29%   
% 210.03/210.23  |- skos__hiddenLabel mesh__D050736 Oncogene Protein v crk
% 210.03/210.23  |- mesh__dateEstablished mesh__D050736 2006-01-01
% 210.03/210.23  |- skos__prefLabel mesh__D050736 Oncogene Protein v-crk
% 210.03/210.23  |- skos__altLabel mesh__D050736 v-crk Protein
% 210.03/210.23  |- mesh__recordMaintainer mesh__D050736 DRC
% 210.03/210.23  |- mesh__recordAuthorizer mesh__D050736 sjn
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D050736 2006
% 210.03/210.23  |- rdf__type mesh__D050736sskos__Concept
% 210.03/210.23  |- mesh__publicMeSHNote mesh__D050736
% 210.03/210.23       2006; ONCOGENE PROTEIN V-CRK was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1989-2005%A%  
% 210.03/210.23  |- skos__altLabel mesh__D050736 Oncogene Protein crk
% 210.03/210.23  |- skos__broader mesh__D050736smesh__D015682
% 210.03/210.23  |- skos__altLabel mesh__D050736 CT10 Regulator of Kinase Oncogene Protein
% 210.03/210.23  |- mesh__dateCreated mesh__D050736 2005-06-30
% 210.03/210.23  |- skos__hiddenLabel mesh__D050736 v-crk, Oncogene Protein
% 210.03/210.23  |- skos__hiddenLabel mesh__D050736 crk, Oncogene Protein
% 210.03/210.23  |- skos__scopeNote mesh__D050736
% 210.03/210.23       A signal transducing adaptor protein that is encoded by the crk ONCOGENE from TYPE C AVIAN RETROVIRUSES.  It contains SRC HOMOLOGY DOMAINS and is closely related to its cellular homolog, PROTO-ONCOGENE PROTEIN C-CRK.%A%    
% 210.03/210.23  |- skos__altLabel mesh__D050736 v-crk Oncogene Protein
% 210.03/210.23  |- skos__hiddenLabel mesh__D050736 v crk Oncogene Protein
% 210.03/210.23  |- skos__hiddenLabel mesh__D050736 Oncogene Protein, crk
% 210.03/210.23  |- mesh__recordOriginator mesh__D050736 DRC
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D008576 1995
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D008576 2001
% 210.03/210.23  |- skos__broader mesh__D008576smesh__D001158
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D008576 2003
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D008576 1994
% 210.03/210.23  |- mesh__dateCreated mesh__D008576 1999-01-01
% 210.03/210.23  |- mesh__recordOriginator mesh__D008576 NLM
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D008576 2000
% 210.03/210.23  |- skos__hiddenLabel mesh__D008576 Arteries, Meningeal
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D008576 1999
% 210.03/210.23  |- skos__hiddenLabel mesh__D008576 Artery, Meningeal
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D008576 1993
% 210.03/210.23  |- skos__scopeNote mesh__D008576 Arteries which supply the dura mater.     
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D008576 1998
% 210.03/210.23  |- mesh__dateRevised mesh__D008576 1992-05-15
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D008576 2006
% 210.03/210.23  |- skos__prefLabel mesh__D008576 Meningeal Arteries
% 210.03/210.23  |- mesh__recordAuthorizer mesh__D008576 PLS
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D008576 2005
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D008576 1997
% 210.03/210.23  |- mesh__recordMaintainer mesh__D008576 TAP
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D008576 2002
% 210.03/210.23  |- skos__hiddenLabel mesh__D008576 Meningeal Artery
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D008576 1996
% 210.03/210.23  |- rdf__type mesh__D008576sskos__Concept
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D008576 2004
% 210.03/210.23  |- skos__altLabel mesh__D000593 Naphthylamidases
% 210.03/210.23  |- rdf__type mesh__D000593sskos__Concept
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D000593 2006
% 210.03/210.23  |- skos__altLabel mesh__D000593 Arylamidases
% 210.03/210.23  |- mesh__dateEstablished mesh__D000593 1974-01-01
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D000593 2005
% 210.03/210.23  |- mesh__historyNote mesh__D000593 74   
% 210.03/210.23  |- mesh__recordOriginator mesh__D000593 NLM
% 210.03/210.23  |- mesh__recordAuthorizer mesh__D000593 sjn
% 210.03/210.23  |- skos__broader mesh__D000593smesh__D000626
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D000593 2004
% 210.03/210.23  |- skos__prefLabel mesh__D000593 Amino Acid Naphthylamidases
% 210.03/210.23  |- mesh__publicMeSHNote mesh__D000593 74   
% 210.03/210.23  |- mesh__dateRevised mesh__D000593 2003-07-09
% 210.03/210.23  |- mesh__recordMaintainer mesh__D000593 ssb
% 210.03/210.23  |- mesh__dateCreated mesh__D000593 1999-01-01
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D041401 2006
% 210.03/210.23  |- mesh__historyNote mesh__D041401 2003   
% 210.03/210.23  |- mesh__recordOriginator mesh__D041401 ags
% 210.03/210.23  |- mesh__publicMeSHNote mesh__D041401 2003   
% 210.03/210.23  |- mesh__recordAuthorizer mesh__D041401 sjn
% 210.03/210.23  |- mesh__recordMaintainer mesh__D041401 SYSTEM
% 210.03/210.23  |- mesh__dateRevised mesh__D041401 2005-06-30
% 210.03/210.23  |- skos__prefLabel mesh__D041401 Leptospira interrogans serovar pomona
% 210.03/210.23  |- skos__broader mesh__D041401smesh__D007921
% 210.03/210.23  |- mesh__dateCreated mesh__D041401 2002-07-03
% 210.03/210.23  |- skos__historyNote mesh__D041401 Leptospira interrogans %28%1976-2002%29%
% 210.03/210.23  |- rdf__type mesh__D041401sskos__Concept
% 210.03/210.23  |- skos__scopeNote mesh__D041401
% 210.03/210.23       A serovar of the bacterial species LEPTOSPIRA INTERROGANS, whose primary hosts include CATTLE and SWINE.%A%    
% 210.03/210.23  |- mesh__dateEstablished mesh__D041401 2003-01-01
% 210.03/210.23  |- skos__annotation mesh__D041401
% 210.03/210.23       do not confuse with the seroGROUP pomona, sometimes termed Leptospira pomona %28%index LEPTOSPIRA INTERROGANS%29%; infection: coord IM with probably LEPTOSPIROSIS %28%IM%29%%A%  
% 210.03/210.23  |- skos__scopeNote mesh__D013710
% 210.03/210.23       Fibrous bands or cords of CONNECTIVE TISSUE at the ends of MUSCLE FIBERS that serve to attach the MUSCLES to bones and other structures.%A%    
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D013710 2002
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D013710 2005
% 210.03/210.23  |- mesh__dateCreated mesh__D013710 1999-01-01
% 210.03/210.23  |- skos__prefLabel mesh__D013710 Tendons
% 210.03/210.23  |- mesh__historyNote mesh__D013710
% 210.03/210.23       /transplantation was TENDON TRANSPLANTATION 1963-65   
% 210.03/210.23  |- mesh__recordAuthorizer mesh__D013710 sjn
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D013710 2006
% 210.03/210.23  |- mesh__recordMaintainer mesh__D013710 nns
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D013710 2003
% 210.03/210.23  |- rdf__type mesh__D013710sskos__Concept
% 210.03/210.23  |- mesh__dateRevised mesh__D013710 2001-07-25
% 210.03/210.23  |- skos__annotation mesh__D013710
% 210.03/210.23       tendon rupt = TENDON INJURIES %28%IM%29% + RUPTURE %28%NIM%29%; /surg: consider TENDON TRANSFER; /transpl permitted: do not confuse with TENDON TRANSFER; for specifically located tendons coord IM with general area of tendon, not a bone term, as metacarpal tendon: TENDONS %28%IM%29% + HAND or FINGERS %28%IM%29%, not METACARPUS; %22%false tendons%22% of heart = PURKINJE FIBERS %28%see note there%29%; tendon reflex = REFLEX, TENDON see REFLEX, STRETCH%A%  
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D013710 2004
% 210.03/210.23  |- skos__broader mesh__D013710smesh__D009141
% 210.03/210.23  |- skos__related mesh__D013710smesh__D013709
% 210.03/210.23  |- skos__hiddenLabel mesh__D013710 Tendon
% 210.03/210.23  |- mesh__publicMeSHNote mesh__D013710
% 210.03/210.23       /transplantation was TENDON TRANSPLANTATION 1963-65   
% 210.03/210.23  |- mesh__recordOriginator mesh__D013710 NLM
% 210.03/210.23  |- skos__scopeNote mesh__D004984
% 210.03/210.23       A sedative and hypnotic that has been used in the short-term management of INSOMNIA. Its use has been superseded by other drugs.%A%    
% 210.03/210.23  |- rdf__type mesh__D004984sskos__Concept
% 210.03/210.23  |- skos__altLabel mesh__D004984 Ethchlorvinol
% 210.03/210.23  |- skos__broader mesh__D004984smesh__D002728
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D004984 2004
% 210.03/210.23  |- mesh__publicMeSHNote mesh__D004984 66   
% 210.03/210.23  |- mesh__dateCreated mesh__D004984 1999-01-01
% 210.03/210.23  |- mesh__dateEstablished mesh__D004984 1966-01-01
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D004984 2006
% 210.03/210.23  |- mesh__historyNote mesh__D004984 66%28%63%29%   
% 210.03/210.23  |- skos__prefLabel mesh__D004984 Ethchlorvynol
% 210.03/210.23  |- mesh__recordAuthorizer mesh__D004984 sjn
% 210.03/210.23  |- mesh__recordOriginator mesh__D004984 NLM
% 210.03/210.23  |- mesh__recordMaintainer mesh__D004984 ssb
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D004984 2005
% 210.03/210.23  |- skos__altLabel mesh__D004984 Ethchlorovynol
% 210.03/210.23  |- mesh__dateRevised mesh__D004984 2003-07-09
% 210.03/210.23  |- mesh__dateEstablished mesh__D004186 1974-01-01
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D004186 2006
% 210.03/210.23  |- mesh__dateRevised mesh__D004186 2003-07-09
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D004186 2005
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D004186 2004
% 210.03/210.23  |- mesh__historyNote mesh__D004186 74   
% 210.03/210.23  |- mesh__publicMeSHNote mesh__D004186 74   
% 210.03/210.23  |- mesh__dateCreated mesh__D004186 1999-01-01
% 210.03/210.23  |- skos__broader mesh__D004186smesh__D006026
% 210.03/210.23  |- mesh__recordMaintainer mesh__D004186 ssb
% 210.03/210.23  |- mesh__recordOriginator mesh__D004186 NLM
% 210.03/210.23  |- skos__prefLabel mesh__D004186 Disaccharidases
% 210.03/210.23  |- mesh__recordAuthorizer mesh__D004186 sjn
% 210.03/210.23  |- rdf__type mesh__D004186sskos__Concept
% 210.03/210.23  |- mesh__activeMeSHYear mesh__D012618 2005
% 210.03/210.23  |- skos__broader mesh__D012618smesh__D013106
% 210.03/210.23  |- skos__related mesh__D012618smesh__D009542
% 210.03/210.24  |- skos__hiddenLabel mesh__D012618 Histiocytoses, Sea Blue
% 210.03/210.24  |- mesh__dateCreated mesh__D012618 1983-05-31
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D012618 2003
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D012618 2006
% 210.03/210.24  |- skos__broader mesh__D012618smesh__D015616
% 210.03/210.24  |- skos__hiddenLabel mesh__D012618 Histiocytoses, Sea-Blue
% 210.03/210.24  |- skos__altLabel mesh__D012618 Histiocyte Syndromes, Sea Blue
% 210.03/210.24  |- skos__hiddenLabel mesh__D012618 Sea Blue Histiocyte Syndrome
% 210.03/210.24  |- skos__historyNote mesh__D012618 Histiocytes %28%1966-1983%29%
% 210.03/210.24  |- mesh__dateRevised mesh__D012618 2001-07-25
% 210.03/210.24  |- skos__hiddenLabel mesh__D012618 Sea-Blue Histiocytosis
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D012618 2004
% 210.03/210.24  |- rdf__type mesh__D012618sskos__Concept
% 210.03/210.24  |- skos__hiddenLabel mesh__D012618 Histiocyte Syndrome, Sea-Blue
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D012618 2002
% 210.03/210.24  |- mesh__recordMaintainer mesh__D012618 nns
% 210.03/210.24  |- mesh__publicMeSHNote mesh__D012618 84   
% 210.03/210.24  |- mesh__recordAuthorizer mesh__D012618 sjn
% 210.03/210.24  |- skos__altLabel mesh__D012618 Sea Blue Histiocytosis
% 210.03/210.24  |- skos__hiddenLabel mesh__D012618 Sea-Blue Histiocytoses
% 210.03/210.24  |- mesh__historyNote mesh__D012618 84   
% 210.03/210.24  |- skos__altLabel mesh__D012618 Histiocytosis, Sea-Blue
% 210.03/210.24  |- mesh__dateEstablished mesh__D012618 1984-01-01
% 210.03/210.24  |- mesh__recordOriginator mesh__D012618 VDK
% 210.03/210.24  |- skos__hiddenLabel mesh__D012618 Syndromes, Sea-Blue Histiocyte
% 210.03/210.24  |- skos__hiddenLabel mesh__D012618 Syndrome, Sea-Blue Histiocyte
% 210.03/210.24  |- skos__scopeNote mesh__D012618
% 210.03/210.24       Rare disorder consisting of splenomegaly, mild purpura secondary to thrombocytopenia, and occasionally, hepatic cirrhosis associated with the appearance of numerous histiocytes in the spleen and bone marrow which stain a sea-blue color.%A%    
% 210.03/210.24  |- skos__hiddenLabel mesh__D012618 Histiocyte Syndromes, Sea-Blue
% 210.03/210.24  |- skos__hiddenLabel mesh__D012618 Sea-Blue Histiocyte Syndromes
% 210.03/210.24  |- skos__hiddenLabel mesh__D012618 Histiocytosis, Sea Blue
% 210.03/210.24  |- skos__altLabel mesh__D012618 Histiocyte Syndrome, Sea Blue
% 210.03/210.24  |- skos__prefLabel mesh__D012618 Sea-Blue Histiocyte Syndrome
% 210.03/210.24  |- skos__hiddenLabel mesh__D012618 Sea Blue Histiocytoses
% 210.03/210.24  |- skos__altLabel mesh__D050737 c-crk Protein
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 c-crk, Proto-Oncogene Proteins
% 210.03/210.24  |- skos__altLabel mesh__D050737 CT10 Regulator of Kinase Protein
% 210.03/210.24  |- mesh__recordAuthorizer mesh__D050737 sjn
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 Crk 2 Protein
% 210.03/210.24  |- skos__altLabel mesh__D050737 CRKI Protein
% 210.03/210.24  |- mesh__dateCreated mesh__D050737 2005-06-30
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 Proto-Oncogene Proteins, crk
% 210.03/210.24  |- skos__scopeNote mesh__D050737
% 210.03/210.24       Signal transducing adaptor proteins that contain SRC HOMOLOGY DOMAINS and play a role in CYTOSKELETON reorganization. c-crk protein is closely related to ONCOGENE PROTEIN V-CRK and includes several alternatively spliced isoforms.%A%    
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 Proto Oncogene Protein c crk 3
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 Proto Oncogene Protein c crk
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 Proteins c-crk, Proto-Oncogene
% 210.03/210.24  |- mesh__historyNote mesh__D050737 2006%28%1990%29%   
% 210.03/210.24  |- skos__broader mesh__D050737smesh__D048868
% 210.03/210.24  |- skos__altLabel mesh__D050737 c-crkI Protein
% 210.03/210.24  |- skos__altLabel mesh__D050737 Proto-Oncogene Protein c-crk
% 210.03/210.24  |- skos__altLabel mesh__D050737 Crk-2 Protein
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 crk Proto Oncogene Proteins
% 210.03/210.24  |- skos__altLabel mesh__D050737 CrkII Adapter Protein
% 210.03/210.24  |- skos__prefLabel mesh__D050737 Proto-Oncogene Proteins c-crk
% 210.03/210.24  |- skos__altLabel mesh__D050737 CRKII Protein
% 210.03/210.24  |- skos__altLabel mesh__D050737 crk Proto-Oncogene Proteins
% 210.03/210.24  |- skos__altLabel mesh__D050737 c-crk-3 Proto-Oncogene Protein
% 210.03/210.24  |- skos__broader mesh__D050737smesh__D011518
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 Proto Oncogene Protein c crk 2
% 210.03/210.24  |- mesh__dateEstablished mesh__D050737 2006-01-01
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 c-crk-1, Proto-Oncogene Protein
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 c-crk-2, Proto-Oncogene Protein
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 Proto-Oncogene Protein, c-crk-3
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 Proto-Oncogene Proteins, c-crk
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 c-crk-3, Proto-Oncogene Protein
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D050737 2006
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 c CrkIII Protein
% 210.03/210.24  |- skos__altLabel mesh__D050737 c-crk Proto-Oncogene Proteins
% 210.03/210.24  |- skos__altLabel mesh__D050737 CrkIII Protein
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 c-crk, Proto-Oncogene Protein
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 c crk 3 Proto Oncogene Protein
% 210.03/210.24  |- mesh__recordMaintainer mesh__D050737 DRC
% 210.03/210.24  |- mesh__recordOriginator mesh__D050737 DRC
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 Proto Oncogene Proteins c crk
% 210.03/210.24  |- skos__altLabel mesh__D050737 c-CrkII Protein
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 Adapter Protein, CrkII
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 Crk 1 Protein
% 210.03/210.24  |- skos__altLabel mesh__D050737 c-CrkIII Protein
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 Proto-Oncogene Protein, c-crk-I
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 c CrkII Protein
% 210.03/210.24  |- skos__altLabel mesh__D050737 c-crk-I Proto-Oncogene Protein
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 Proto Oncogene Protein c crk 1
% 210.03/210.24  |- skos__altLabel mesh__D050737 c-crk-2 Proto-Oncogene Protein
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 c crk 2 Proto Oncogene Protein
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 c crk I Proto Oncogene Protein
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 Proto-Oncogene Protein, c-crk-2
% 210.03/210.24  |- rdf__type mesh__D050737sskos__Concept
% 210.03/210.24  |- skos__hiddenLabel mesh__D050737 c crk Proto Oncogene Proteins
% 210.03/210.24  |- skos__altLabel mesh__D050737 Crk-1 Protein
% 210.03/210.24  |- skos__altLabel mesh__D050737 Crk3 Protein
% 210.03/210.24  |- mesh__publicMeSHNote mesh__D050737
% 210.03/210.24       2006; PROTO-ONCOGENE PROTEIN C-CRK was indexed under PROTO-ONCOGENE PROTEINS 1990-2005%A%  
% 210.03/210.24  |- skos__broader mesh__D008577smesh__D016543
% 210.03/210.24  |- mesh__recordOriginator mesh__D008577 VDK
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Meningeal Neoplasm, Malignant
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D008577 2003
% 210.03/210.24  |- mesh__dateRevised mesh__D008577 2001-07-25
% 210.03/210.24  |- mesh__dateEstablished mesh__D008577 1978-01-01
% 210.03/210.24  |- skos__historyNote mesh__D008577 Brain Neoplasms %28%1966-1977%29%
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Leptomeningeal Neoplasm
% 210.03/210.24  |- mesh__recordMaintainer mesh__D008577 nns
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Cancers, Meningeal
% 210.03/210.24  |- skos__scopeNote mesh__D008577
% 210.03/210.24       Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.%A%    
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Meningeal Neoplasm, Intracranial
% 210.03/210.24  |- skos__altLabel mesh__D008577 Meningeal Neoplasms, Intracranial
% 210.03/210.24  |- skos__altLabel mesh__D008577 Neoplasms, Leptomeningeal
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Neoplasm, Leptomeningeal
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Neoplasms, Intracranial Meningeal
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Neoplasm, Benign Meningeal
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D008577 2004
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Neoplasm, Malignant Meningeal
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Neoplasms, Spinal Meningeal
% 210.03/210.24  |- skos__altLabel mesh__D008577 Meningeal Tumors
% 210.03/210.24  |- rdf__type mesh__D008577sskos__Concept
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Tumor, Meningeal
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D008577 2005
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Meningeal Cancers
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Meningeal Neoplasm, Benign
% 210.03/210.24  |- skos__annotation mesh__D008577
% 210.03/210.24       coord IM with histol type of neopl %28%IM%29%; for intracranial or spinal meningioma, see note on MENINGIOMA; intradural extramedullary neopl do not go here: index under SPINAL CORD NEOPLASMS %26% do not try to locate %22%intradural%22% or %22%extramedullary%22%; meningeal leukemia does not go here: index under MENINGES /pathol %28%IM%29% + LEUKEMIC INFILTRATION %28%IM%29% %28%see note there%29% + specific type of leukemia %28%IM%29% if relevant%A%  
% 210.03/210.24  |- skos__historyNote mesh__D008577 Neoplasms %28%1966-1977%29%
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Tumors, Meningeal
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Meningeal Neoplasms, Spinal
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Intracranial Meningeal Neoplasm
% 210.03/210.24  |- mesh__publicMeSHNote mesh__D008577 78   
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Cancer, Meningeal
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Neoplasm, Spinal Meningeal
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D008577 2006
% 210.03/210.24  |- mesh__dateCreated mesh__D008577 1977-04-27
% 210.03/210.24  |- skos__altLabel mesh__D008577 Neoplasms, Meningeal
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Meningeal Neoplasm
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Neoplasms, Malignant Meningeal
% 210.03/210.24  |- skos__altLabel mesh__D008577 Meningeal Cancer
% 210.03/210.24  |- mesh__historyNote mesh__D008577 78   
% 210.03/210.24  |- skos__prefLabel mesh__D008577 Meningeal Neoplasms
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Meningeal Tumor
% 210.03/210.24  |- skos__altLabel mesh__D008577 Meningeal Neoplasms, Malignant
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Neoplasm, Intracranial Meningeal
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Meningeal Neoplasm, Spinal
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Neoplasms, Benign Meningeal
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Spinal Meningeal Neoplasm
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Malignant Meningeal Neoplasm
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Benign Meningeal Neoplasm
% 210.03/210.24  |- skos__altLabel mesh__D008577 Meningeal Neoplasms, Benign
% 210.03/210.24  |- skos__historyNote mesh__D008577 Meninges %28%1966-1977%29%
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D008577 2002
% 210.03/210.24  |- mesh__recordAuthorizer mesh__D008577 sjn
% 210.03/210.24  |- skos__hiddenLabel mesh__D008577 Neoplasm, Meningeal
% 210.03/210.24  |- skos__hiddenLabel mesh__D000594 Oxidoreductases, Amino Acid
% 210.03/210.24  |- mesh__dateRevised mesh__D000594 2005-06-30
% 210.03/210.24  |- mesh__publicMeSHNote mesh__D000594
% 210.03/210.24       74; was AMINOACID OXIDOREDUCTASES 1964-73   
% 210.03/210.24  |- mesh__historyNote mesh__D000594
% 210.03/210.24       74; was AMINOACID OXIDOREDUCTASES 1964-73   
% 210.03/210.24  |- mesh__recordMaintainer mesh__D000594 jmp
% 210.03/210.24  |- skos__prefLabel mesh__D000594 Amino Acid Oxidoreductases
% 210.03/210.24  |- mesh__dateEstablished mesh__D000594 1964-01-01
% 210.03/210.24  |- skos__scopeNote mesh__D000594
% 210.03/210.24       A class of enzymes that catalyze oxidation-reduction reactions of amino acids. EC 1.4.-.%A%    
% 210.03/210.24  |- mesh__onlineNote mesh__D000594
% 210.03/210.24       use AMINO ACID OXIDOREDUCTASES to search AMINOACID OXIDOREDUCTASES 1966-73%A%  
% 210.03/210.24  |- mesh__recordOriginator mesh__D000594 NLM
% 210.03/210.24  |- skos__broader mesh__D000594smesh__D050891
% 210.03/210.24  |- mesh__dateCreated mesh__D000594 1999-01-01
% 210.03/210.24  |- mesh__recordAuthorizer mesh__D000594 sjn
% 210.03/210.24  |- rdf__type mesh__D000594sskos__Concept
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D000594 2006
% 210.03/210.24  |- skos__hiddenLabel mesh__D000594 Acid Oxidoreductases, Amino
% 210.03/210.24  |- skos__hiddenLabel mesh__D013711 Tendon, Paraarticular
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D013711 2006
% 210.03/210.24  |- mesh__dateRevised mesh__D013711 2001-07-25
% 210.03/210.24  |- skos__prefLabel mesh__D013711 Tendons, Para-Articular
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D013711 2003
% 210.03/210.24  |- rdf__type mesh__D013711sskos__Concept
% 210.03/210.24  |- mesh__historyNote mesh__D013711 65   
% 210.03/210.24  |- skos__hiddenLabel mesh__D013711 Tendon, Para-Articular
% 210.03/210.24  |- mesh__recordOriginator mesh__D013711 NLM
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D013711 2004
% 210.03/210.24  |- skos__hiddenLabel mesh__D013711 Paraarticular Tendon
% 210.03/210.24  |- skos__hiddenLabel mesh__D013711 Tendons, Para Articular
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D013711 2002
% 210.03/210.24  |- skos__hiddenLabel mesh__D013711 Paraarticular Tendons
% 210.03/210.24  |- mesh__publicMeSHNote mesh__D013711 65   
% 210.03/210.24  |- mesh__recordMaintainer mesh__D013711 nns
% 210.03/210.24  |- skos__altLabel mesh__D013711 Tendons, Paraarticular
% 210.03/210.24  |- skos__hiddenLabel mesh__D013711 Para-Articular Tendon
% 210.03/210.24  |- mesh__recordAuthorizer mesh__D013711 sjn
% 210.03/210.24  |- skos__hiddenLabel mesh__D013711 Para-Articular Tendons
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D013711 2005
% 210.03/210.24  |- mesh__dateEstablished mesh__D013711 1965-01-01
% 210.03/210.24  |- mesh__dateCreated mesh__D013711 1999-01-01
% 210.03/210.24  |- skos__broader mesh__D013711smesh__D013710
% 210.03/210.24  |- skos__hiddenLabel mesh__D004985 epsilon ATP
% 210.03/210.24  |- skos__prefLabel mesh__D004985 Ethenoadenosine Triphosphate
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D004985 1997
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D004985 2003
% 210.03/210.24  |- mesh__historyNote mesh__D004985
% 210.03/210.24       91%28%75%29%; was see under ADENOSINE TRIPHOSPHATE 1975-90   
% 210.03/210.24  |- mesh__dateEstablished mesh__D004985 1991-01-01
% 210.03/210.24  |- mesh__dateRevised mesh__D004985 1992-05-19
% 210.03/210.24  |- mesh__recordOriginator mesh__D004985 NLM
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D004985 1993
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D004985 2000
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D004985 2006
% 210.03/210.24  |- mesh__publicMeSHNote mesh__D004985
% 210.03/210.24       91; was see under ADENOSINE TRIPHOSPHATE 1975-90   
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D004985 1996
% 210.03/210.24  |- skos__annotation mesh__D004985 %22%a fluorescent analog of ATP%22%   
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D004985 1999
% 210.03/210.24  |- mesh__recordAuthorizer mesh__D004985 PLS
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D004985 2005
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D004985 1995
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D004985 2002
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D004985 1998
% 210.03/210.24  |- rdf__type mesh__D004985sskos__Concept
% 210.03/210.24  |- skos__broader mesh__D004985smesh__D000255
% 210.03/210.24  |- skos__historyNote mesh__D004985 Adenosine Triphosphate %28%1972-1974%29%
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D004985 1994
% 210.03/210.24  |- mesh__recordMaintainer mesh__D004985 TGC
% 210.03/210.24  |- skos__hiddenLabel mesh__D004985 Triphosphate, Ethenoadenosine
% 210.03/210.24  |- skos__scopeNote mesh__D004985
% 210.03/210.24       1,N-6-Ethenoadenosine triphosphate. A fluorescent analog of adenosine triphosphate.%A%    
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D004985 2004
% 210.03/210.24  |- skos__historyNote mesh__D004985 Imidazoles %28%1972-1974%29%
% 210.03/210.24  |- mesh__dateCreated mesh__D004985 1974-11-19
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D004985 2001
% 210.03/210.24  |- skos__prefLabel mesh__D037361 Adenylate Cyclase Toxin
% 210.03/210.24  |- skos__hiddenLabel mesh__D037361 Bordetella Ac-Hly
% 210.03/210.24  |- mesh__publicMeSHNote mesh__D037361
% 210.03/210.24       2003; see PERTUSSIS TOXINS 1986-2002; CYCLOLYSIN was indexed under BACTERIAL PROTEINS and PROTEIN PRECURSORS 1989-2002%A%  
% 210.03/210.24  |- skos__altLabel mesh__D037361 cyaA Toxin
% 210.03/210.24  |- skos__scopeNote mesh__D037361
% 210.03/210.24       One of the virulence factors produced by virulent BORDETELLA organisms. It is a bifunctional protein with both ADENYLATE CYCLASE and hemolysin components.%A%    
% 210.03/210.24  |- skos__altLabel mesh__D037361 Cyclolysin
% 210.03/210.24  |- skos__hiddenLabel mesh__D037361 Ac Hly, Bordetella
% 210.03/210.24  |- skos__altLabel mesh__D037361 cyaA Protein, Bordetella
% 210.03/210.24  |- mesh__recordAuthorizer mesh__D037361 sjn
% 210.03/210.24  |- skos__hiddenLabel mesh__D037361 Toxin, cyaA
% 210.03/210.24  |- skos__hiddenLabel mesh__D037361 Cyclase Toxin, Adenylate
% 210.03/210.24  |- skos__altLabel mesh__D037361 Adenylate Cyclase-Hemolysin
% 210.03/210.24  |- skos__hiddenLabel mesh__D037361 Bordetella AC Toxin
% 210.03/210.24  |- mesh__recordMaintainer mesh__D037361 ssb
% 210.03/210.24  |- skos__altLabel mesh__D037361 Ac-Hly, Bordetella
% 210.03/210.24  |- skos__broader mesh__D037361smesh__D000262
% 210.03/210.24  |- skos__altLabel mesh__D037361 AC Toxin, Bordetella
% 210.03/210.24  |- mesh__dateCreated mesh__D037361 2002-07-02
% 210.03/210.24  |- skos__altLabel mesh__D037361
% 210.03/210.24       Adenylate Cyclase-Haemolysin Bifunctional Protein, B. pertussis
% 210.03/210.24  |- skos__hiddenLabel mesh__D037361 Cyclase-Hemolysin, Adenylate
% 210.03/210.24  |- skos__altLabel mesh__D037361 Bordetella Adenylate Cyclase Toxin
% 210.03/210.24  |- mesh__dateRevised mesh__D037361 2005-06-30
% 210.03/210.24  |- mesh__dateEstablished mesh__D037361 2003-01-01
% 210.03/210.24  |- skos__hiddenLabel mesh__D037361 Adenylate Cyclase Hemolysin
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D037361 2006
% 210.03/210.24  |- mesh__recordOriginator mesh__D037361 nns
% 210.03/210.24  |- skos__hiddenLabel mesh__D037361 Toxin, Adenylate Cyclase
% 210.03/210.24  |- skos__hiddenLabel mesh__D037361
% 210.03/210.24       Pertussis Adenylate Cyclase Haemolysin Bifunctional Protein
% 210.03/210.24  |- skos__hiddenLabel mesh__D037361 Protein, Bordetella cyaA
% 210.03/210.24  |- skos__hiddenLabel mesh__D037361 Toxin, Bordetella AC
% 210.03/210.24  |- skos__broader mesh__D037361smesh__D010566
% 210.03/210.24  |- skos__hiddenLabel mesh__D037361 Bordetella cyaA Protein
% 210.03/210.24  |- skos__hiddenLabel mesh__D037361
% 210.03/210.24       Adenylate Cyclase Haemolysin Bifunctional Protein, B. pertussis
% 210.03/210.24  |- skos__historyNote mesh__D037361
% 210.03/210.24       Virulence Factors, Bordetella %28%1984-2002%29%
% 210.03/210.24  |- skos__altLabel mesh__D037361
% 210.03/210.24       Pertussis Adenylate Cyclase-Haemolysin Bifunctional Protein
% 210.03/210.24  |- rdf__type mesh__D037361sskos__Concept
% 210.03/210.24  |- skos__altLabel mesh__D037361 cyaA Gene Product, Bordetella
% 210.03/210.24  |- mesh__historyNote mesh__D037361
% 210.03/210.24       2003; use VIRULENCE FACTORS, BORDETELLA 1986-2002; for CYCLOLYSIN use ADENYLATE CYCLASE TOXIN %28%NM%29% 1989-2002%A%  
% 210.03/210.24  |- skos__broader mesh__D004187smesh__D009844
% 210.03/210.24  |- rdf__type mesh__D004187sskos__Concept
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D004187 2006
% 210.03/210.24  |- mesh__recordOriginator mesh__D004187 NLM
% 210.03/210.24  |- mesh__recordAuthorizer mesh__D004187 sjn
% 210.03/210.24  |- mesh__dateRevised mesh__D004187 2004-07-07
% 210.03/210.24  |- mesh__dateCreated mesh__D004187 1999-01-01
% 210.03/210.24  |- skos__prefLabel mesh__D004187 Disaccharides
% 210.03/210.24  |- skos__scopeNote mesh__D004187
% 210.03/210.24       Oligosaccharides containing two monosaccharide units linked by a glycosidic bond.%A%    
% 210.03/210.24  |- skos__annotation mesh__D004187 GEN; prefer specifics   
% 210.03/210.24  |- mesh__recordMaintainer mesh__D004187 ssb
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D004187 2005
% 210.03/210.24  |- mesh__recordMaintainer mesh__D009670 ags
% 210.03/210.24  |- mesh__dateEstablished mesh__D009670 1991-01-01
% 210.03/210.24  |- mesh__dateCreated mesh__D009670 1981-05-19
% 210.03/210.24  |- mesh__dateRevised mesh__D009670 2005-06-30
% 210.03/210.24  |- mesh__publicMeSHNote mesh__D009670
% 210.03/210.24       92; was NOSEMA CUNICULI 1982-91 %28%see under SPOROZOA 1982-90%29%; ENCEPHALITOZOON CUNICULI was see NOSEMA CUNICULI 1982-91%A%  
% 210.03/210.24  |- skos__historyNote mesh__D009670 Protozoa %28%1966-1981%29%
% 210.03/210.24  |- skos__prefLabel mesh__D009670 Encephalitozoon cuniculi
% 210.03/210.24  |- skos__scopeNote mesh__D009670
% 210.03/210.24       A species of parasitic FUNGI. This intracellular parasite is found in the BRAIN; HEART; and KIDNEYS of several MAMMALS. Transmission is probably by ingestion of the spores %28%SPORES, FUNGAL%29%.%A%    
% 210.03/210.24  |- skos__historyNote mesh__D009670 Sporozoa %28%1966-1981%29%
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D009670 2006
% 210.03/210.24  |- skos__altLabel mesh__D009670 Nosema cuniculi
% 210.03/210.24  |- mesh__historyNote mesh__D009670
% 210.03/210.24       92; was NOSEMA CUNICULI 1982-91 %28%see under SPOROZOA 1982-90%29%; ENCEPHALITOZOON CUNICULI was see NOSEMA CUNICULI 1982-91%A%  
% 210.03/210.24  |- skos__annotation mesh__D009670
% 210.03/210.24       infection: coordinate IM with ENCEPHALITOZOONOSIS %28%IM%29%; coordinate with specific fungal terms %28%ANTIGENS, FUNGAL, etc%29% if pertinent%A%  
% 210.03/210.24  |- skos__broader mesh__D009670smesh__D016819
% 210.03/210.24  |- mesh__recordAuthorizer mesh__D009670 sjn
% 210.03/210.24  |- rdf__type mesh__D009670sskos__Concept
% 210.03/210.24  |- mesh__recordOriginator mesh__D009670 EC
% 210.03/210.24  |- mesh__onlineNote mesh__D009670
% 210.03/210.24       use ENCEPHALITOZOON CUNICULI to search NOSEMA CUNICULI 1982-91%A%  
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D023341 2003
% 210.03/210.24  |- mesh__publicMeSHNote mesh__D023341 2001; see SHIVERING 1977-2000   
% 210.03/210.24  |- skos__related mesh__D023341smesh__D012768
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D023341 2006
% 210.03/210.24  |- rdf__type mesh__D023341sskos__Concept
% 210.03/210.24  |- skos__scopeNote mesh__D023341
% 210.03/210.24       The sudden sensation of being cold. It may be accompanied by SHIVERING.%A%    
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D023341 2005
% 210.03/210.24  |- skos__broader mesh__D023341smesh__D012816
% 210.03/210.24  |- mesh__dateCreated mesh__D023341 2000-06-22
% 210.03/210.24  |- mesh__dateEstablished mesh__D023341 2001-01-01
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D023341 2002
% 210.03/210.24  |- mesh__historyNote mesh__D023341 2001; use SHIVERING 1977-2000   
% 210.03/210.24  |- skos__prefLabel mesh__D023341 Chills
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D023341 2004
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D023341 2001
% 210.03/210.24  |- skos__historyNote mesh__D023341 Shivering %28%1977-2000%29%
% 210.03/210.24  |- rdf__type mesh__D017304sskos__Concept
% 210.03/210.24  |- mesh__historyNote mesh__D017304 2005%28%1984%29%   
% 210.03/210.24  |- mesh__recordAuthorizer mesh__D017304 sjn
% 210.03/210.24  |- skos__altLabel mesh__D017304 Annexin V
% 210.03/210.24  |- skos__altLabel mesh__D017304 Endonexin II
% 210.03/210.24  |- mesh__recordOriginator mesh__D017304 AGS
% 210.03/210.24  |- skos__altLabel mesh__D017304 Lipocortin-V
% 210.03/210.24  |- skos__altLabel mesh__D017304 Anchorin CII
% 210.03/210.24  |- mesh__publicMeSHNote mesh__D017304
% 210.03/210.24       2005; ANNEXIN V was indexed under CALCIUM-BINDING PROTEINS and PREGNANCY PROTEINS 1984-1992; ANNEXIN A5 was indexed under ANNEXINS 2003-2004 %26% under ANNEXIN V 2004%A%  
% 210.03/210.24  |- skos__prefLabel mesh__D017304 Annexin A5
% 210.03/210.24  |- skos__historyNote mesh__D017304
% 210.03/210.24       Calcium-Binding Proteins %28%1984-1992%29%
% 210.03/210.24  |- mesh__dateRevised mesh__D017304 2004-07-13
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D017304 2006
% 210.03/210.24  |- skos__scopeNote mesh__D017304
% 210.03/210.24       A protein of the annexin family isolated from human PLACENTA and other tissues. It inhibits cytosolic PHOSPHOLIPASE A2, and displays anticoagulant activity.%A%    
% 210.03/210.24  |- mesh__dateCreated mesh__D017304 1992-05-07
% 210.03/210.24  |- skos__altLabel mesh__D017304 Placental Anticoagulant Protein I
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D017304 2005
% 210.03/210.24  |- mesh__recordMaintainer mesh__D017304 sjn
% 210.03/210.24  |- skos__altLabel mesh__D017304 Lipocortin V
% 210.03/210.24  |- skos__altLabel mesh__D017304 Calphobindin I
% 210.03/210.24  |- skos__broader mesh__D017304smesh__D017302
% 210.03/210.24  |- mesh__dateEstablished mesh__D017304 1993-01-01
% 210.03/210.24  |- skos__historyNote mesh__D017304 Pregnancy Proteins %28%1984-1992%29%
% 210.03/210.24  |- mesh__publicMeSHNote mesh__D050738 2006   
% 210.03/210.24  |- skos__hiddenLabel mesh__D050738 Infection, Mesomycetozoea
% 210.03/210.24  |- mesh__dateCreated mesh__D050738 2005-06-30
% 210.03/210.24  |- mesh__recordMaintainer mesh__D050738 ags
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D050738 2006
% 210.03/210.24  |- skos__hiddenLabel mesh__D050738 Mesomycetozoea Infection
% 210.03/210.24  |- rdf__type mesh__D050738sskos__Concept
% 210.03/210.24  |- skos__prefLabel mesh__D050738 Mesomycetozoea Infections
% 210.03/210.24  |- skos__broader mesh__D050738smesh__D010272
% 210.03/210.24  |- mesh__historyNote mesh__D050738 2006   
% 210.03/210.24  |- skos__scopeNote mesh__D050738
% 210.03/210.24       Infections by MESOMYCETOZOEA, general or unspecified.     
% 210.03/210.24  |- skos__hiddenLabel mesh__D050738 Infections, Mesomycetozoea
% 210.03/210.24  |- mesh__recordAuthorizer mesh__D050738 sjn
% 210.03/210.24  |- mesh__recordOriginator mesh__D050738 ags
% 210.03/210.24  |- mesh__dateEstablished mesh__D050738 2006-01-01
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D008578 2005
% 210.03/210.24  |- rdf__type mesh__D008578sskos__Concept
% 210.03/210.24  |- mesh__dateRevised mesh__D008578 2002-07-03
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D008578 2004
% 210.03/210.24  |- skos__broader mesh__D008578smesh__D002490
% 210.03/210.24  |- skos__prefLabel mesh__D008578 Meninges
% 210.03/210.24  |- skos__annotation mesh__D008578
% 210.03/210.24       inflammation = MENINGITIS %26% its specifics   
% 210.03/210.24  |- mesh__recordAuthorizer mesh__D008578 sjn
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D008578 2003
% 210.03/210.24  |- mesh__dateCreated mesh__D008578 1999-01-01
% 210.03/210.24  |- mesh__recordOriginator mesh__D008578 NLM
% 210.03/210.24  |- mesh__recordMaintainer mesh__D008578 mdb
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D008578 2006
% 210.03/210.24  |- mesh__recordOriginator mesh__D000595 NLM
% 210.03/210.24  |- skos__altLabel mesh__D000595 Amino Acid Sequences
% 210.03/210.24  |- skos__altLabel mesh__D000595 Protein Structure, Primary
% 210.03/210.24  |- mesh__recordAuthorizer mesh__D000595 sjn
% 210.03/210.24  |- skos__hiddenLabel mesh__D000595 Protein Structures, Primary
% 210.03/210.24  |- skos__broader mesh__D000595smesh__D015394
% 210.03/210.24  |- mesh__dateEstablished mesh__D000595 1966-01-01
% 210.03/210.24  |- skos__hiddenLabel mesh__D000595 Structure, Primary Protein
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D000595 2003
% 210.03/210.24  |- mesh__dateCreated mesh__D000595 1999-01-01
% 210.03/210.24  |- mesh__dateRevised mesh__D000595 2002-07-02
% 210.03/210.24  |- mesh__historyNote mesh__D000595 66   
% 210.03/210.24  |- mesh__recordMaintainer mesh__D000595 nns
% 210.03/210.24  |- skos__altLabel mesh__D000595 Sequence, Amino Acid
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D000595 2004
% 210.03/210.24  |- skos__scopeNote mesh__D000595
% 210.03/210.24       The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.%A%    
% 210.03/210.24  |- skos__altLabel mesh__D000595 Sequences, Amino Acid
% 210.03/210.24  |- skos__broader mesh__D000595smesh__D008969
% 210.03/210.24  |- skos__hiddenLabel mesh__D000595 Primary Protein Structure
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D000595 2005
% 210.03/210.24  |- skos__hiddenLabel mesh__D000595 Primary Protein Structures
% 210.03/210.24  |- skos__prefLabel mesh__D000595 Amino Acid Sequence
% 210.03/210.24  |- skos__hiddenLabel mesh__D000595 Structures, Primary Protein
% 210.03/210.24  |- rdf__type mesh__D000595sskos__Concept
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D000595 2006
% 210.03/210.24  |- skos__annotation mesh__D000595
% 210.03/210.24       IM general; coord NIM with specific protein or peptide; when to index with MOLECULAR SEQUENCE DATA: see note there; DF: AMINO ACID SEQ or AA SEQ; use this heading when protein structure refers to the sequence of a protein; for covalent bonds to other molecules we have MOLECULAR STRUCTURE; when protein structure refers to protein architecture use PROTEIN CONFORMATION or its specifics%A%  
% 210.03/210.24  |- mesh__publicMeSHNote mesh__D000595 66   
% 210.03/210.24  |- mesh__dateEstablished mesh__D005280 1986-01-01
% 210.03/210.24  |- mesh__recordMaintainer mesh__D005280 exl
% 210.03/210.24  |- skos__scopeNote mesh__D005280
% 210.03/210.24       An adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.%A%    
% 210.03/210.24  |- mesh__recordOriginator mesh__D005280 NLM
% 210.03/210.24  |- skos__historyNote mesh__D005280 Orciprenaline %28%1973-1974%29%
% 210.03/210.24  |- skos__hiddenLabel mesh__D005280 Th1165a
% 210.03/210.24  |- skos__prefLabel mesh__D005280 Fenoterol
% 210.03/210.24  |- skos__hiddenLabel mesh__D005280 Th 1165a
% 210.03/210.24  |- mesh__dateRevised mesh__D005280 2005-06-30
% 210.03/210.24  |- skos__altLabel mesh__D005280 p-Hydroxyphenylorciprenaline
% 210.03/210.24  |- rdf__type mesh__D005280sskos__Concept
% 210.03/210.24  |- skos__altLabel mesh__D005280 Berotec
% 210.03/210.24  |- skos__hiddenLabel mesh__D005280 Hydrochloride, Fenoterol
% 210.03/210.24  |- mesh__dateCreated mesh__D005280 1974-11-19
% 210.03/210.24  |- mesh__publicMeSHNote mesh__D005280
% 210.03/210.24       86; was see under ETHANOLAMINES 1975-85   
% 210.03/210.24  |- mesh__historyNote mesh__D005280
% 210.03/210.24       86%28%75%29%; was see under ETHANOLAMINES 1975-85   
% 210.03/210.24  |- skos__broader mesh__D005280smesh__D009921
% 210.03/210.24  |- skos__altLabel mesh__D005280 p-Hydroxyphenyl-orciprenaline
% 210.03/210.24  |- mesh__activeMeSHYear mesh__D005280 2006
% 210.03/210.24  |- mesh__recordAuthorizer mesh__D005280 sjn
% 210.03/210.24  |- skos__altLabel mesh__D005280 Phenoterol
% 210.03/210.24  |- skos__hiddenLabel mesh__D005280 p Hydroxyphenylorciprenaline
% 210.03/210.24  |- skos__historyNote mesh__D005280 Phenols %28%1973-1974%29%
% 210.03/210.24  |- skos__hiddenLabel mesh__D005280 p Hydroxyphenyl orciprenaline
% 210.03/210.25  |- mesh__recordAuthorizer mesh__D013712 sjn
% 210.03/210.25  |- skos__historyNote mesh__D013712 Beetles %28%1966-1971%29%
% 210.03/210.25  |- skos__prefLabel mesh__D013712 Tenebrio
% 210.03/210.25  |- mesh__publicMeSHNote mesh__D013712 72   
% 210.03/210.25  |- skos__broader mesh__D013712smesh__D001517
% 210.03/210.25  |- mesh__dateEstablished mesh__D013712 1972-01-01
% 210.03/210.25  |- mesh__recordOriginator mesh__D013712 NLM
% 210.03/210.25  |- skos__scopeNote mesh__D013712
% 210.03/210.25       A genus of beetles which infests grain products. Its larva is called mealworm.%A%    
% 210.03/210.25  |- mesh__recordMaintainer mesh__D013712 ags
% 210.03/210.25  |- mesh__historyNote mesh__D013712 72   
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D013712 2005
% 210.03/210.25  |- skos__altLabel mesh__D013712 Mealworm
% 210.03/210.25  |- mesh__dateCreated mesh__D013712 1999-01-01
% 210.03/210.25  |- mesh__dateRevised mesh__D013712 2004-07-07
% 210.03/210.25  |- skos__annotation mesh__D013712
% 210.03/210.25       beetle; /microbiol /parasitol /virol permitted   
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D013712 2006
% 210.03/210.25  |- rdf__type mesh__D013712sskos__Concept
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004986 2006
% 210.03/210.25  |- skos__broader mesh__D004986smesh__D005019
% 210.03/210.25  |- mesh__dateRevised mesh__D004986 2000-06-22
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004986 2001
% 210.03/210.25  |- mesh__publicMeSHNote mesh__D004986
% 210.03/210.25       91,63-64; was see under ETHYL ETHERS 1974-90; was see under ETHYL ETHER 1965-73; was heading 1963-64%A%  
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004986 2005
% 210.03/210.25  |- skos__scopeNote mesh__D004986
% 210.03/210.25       A mobile, very volatile, highly flammable liquid used as an inhalation anesthetic and as a solvent for waxes, fats, oils, perfumes, alkaloids, and gums. It is mildly irritating to skin and mucous membranes.%A%    
% 210.03/210.25  |- skos__altLabel mesh__D004986 Ether
% 210.03/210.25  |- mesh__historyNote mesh__D004986
% 210.03/210.25       91%28%75%29%63-64; was see under ETHYL ETHERS 1974-90; was see under ETHYL ETHER 1965-73; was heading 1963-64%A%  
% 210.03/210.25  |- mesh__recordAuthorizer mesh__D004986 sjn
% 210.03/210.25  |- mesh__recordOriginator mesh__D004986 NLM
% 210.03/210.25  |- rdf__type mesh__D004986sskos__Concept
% 210.03/210.25  |- mesh__onlineNote mesh__D004986
% 210.03/210.25       use ETHYL ETHERS to search ETHER, ETHYL 1966-74   
% 210.03/210.25  |- skos__hiddenLabel mesh__D004986 Ether, Diethyl
% 210.03/210.25  |- skos__altLabel mesh__D004986 Ethyl Ether
% 210.03/210.25  |- skos__prefLabel mesh__D004986 Ether, Ethyl
% 210.03/210.25  |- skos__altLabel mesh__D004986 Diethyl Ether
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004986 2004
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004986 2002
% 210.03/210.25  |- mesh__dateCreated mesh__D004986 1999-01-01
% 210.03/210.25  |- mesh__recordMaintainer mesh__D004986 CCR
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004986 2003
% 210.03/210.25  |- mesh__dateEstablished mesh__D004986 1991-01-01
% 210.03/210.25  |- mesh__dateRevised mesh__D051033 2005-07-27
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D051033 2006C
% 210.03/210.25  |- skos__prefLabel mesh__D051033 Apoptosis Inducing Factor
% 210.03/210.25  |- skos__altLabel mesh__D051033 AIF Apoptosis Regulatory Protein
% 210.03/210.25  |- mesh__recordAuthorizer mesh__D051033 ags
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D051033 2006B
% 210.03/210.25  |- mesh__recordMaintainer mesh__D051033 ags
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D051033 2006D
% 210.03/210.25  |- skos__altLabel mesh__D051033 Mitochondrial Apoptosis-Inducing Factor
% 210.03/210.25  |- skos__broader mesh__D051033smesh__D009247
% 210.03/210.25  |- skos__hiddenLabel mesh__D051033 Apoptosis-Inducing Factor, Mitochondrial
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D051033 2006
% 210.03/210.25  |- skos__hiddenLabel mesh__D051033 Mitochondrial Apoptosis Inducing Factor
% 210.03/210.25  |- mesh__historyNote mesh__D051033 2006%28%1999%29%   
% 210.03/210.25  |- mesh__dateCreated mesh__D051033 2005-06-30
% 210.03/210.25  |- mesh__recordOriginator mesh__D051033 DRC
% 210.03/210.25  |- mesh__publicMeSHNote mesh__D051033
% 210.03/210.25       2006; APOPTOSIS INDUCING FACTOR was indexed under FLAVOPROTEINS %26% MEMBRANE PROTEINS 1999-2005%A%  
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D051033 2006A
% 210.03/210.25  |- skos__annotation mesh__D051033
% 210.03/210.25       INHIBITOR OF APOPTOSIS PROTEINS is also available   
% 210.03/210.25  |- skos__altLabel mesh__D051033 Apoptosis-Inducing Factor
% 210.03/210.25  |- skos__broader mesh__D051033smesh__D005420
% 210.03/210.25  |- rdf__type mesh__D051033sskos__Concept
% 210.03/210.25  |- mesh__dateEstablished mesh__D051033 2006-01-01
% 210.03/210.25  |- skos__broader mesh__D051033smesh__D051017
% 210.03/210.25  |- skos__scopeNote mesh__D051033
% 210.03/210.25       A flavoprotein that functions as a powerful antioxidant in the MITOCHONDRIA and promotes APOPTOSIS when released from the mitochondria. In mammalian cells AIF is released in response to pro-apoptotic protein members of the bcl-2 protein family. It translocates to the CELL NUCLEUS and binds DNA to stimulate CASPASE-independent CHROMATIN condensation.%A%    
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004188 1999
% 210.03/210.25  |- skos__hiddenLabel mesh__D004188 Disarticulations
% 210.03/210.25  |- skos__historyNote mesh__D004188 Amputation %28%1966-1971%29%
% 210.03/210.25  |- mesh__publicMeSHNote mesh__D004188 72   
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004188 2003
% 210.03/210.25  |- mesh__dateCreated mesh__D004188 1999-01-01
% 210.03/210.25  |- skos__prefLabel mesh__D004188 Disarticulation
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004188 2000
% 210.03/210.25  |- skos__scopeNote mesh__D004188
% 210.03/210.25       Amputation or separation at a joint. %28%Dorland, 28th ed%29%%A%    
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004188 2004
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004188 2001
% 210.03/210.25  |- mesh__recordOriginator mesh__D004188 NLM
% 210.03/210.25  |- skos__broader mesh__D004188smesh__D000671
% 210.03/210.25  |- mesh__recordMaintainer mesh__D004188 PXP
% 210.03/210.25  |- mesh__dateEstablished mesh__D004188 1972-01-01
% 210.03/210.25  |- mesh__dateRevised mesh__D004188 1997-06-20
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004188 2005
% 210.03/210.25  |- mesh__historyNote mesh__D004188 72   
% 210.03/210.25  |- rdf__type mesh__D004188sskos__Concept
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004188 1998
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004188 2002
% 210.03/210.25  |- skos__annotation mesh__D004188
% 210.03/210.25       %22%amputation or separation at a joint%22%; do not use /util except by MeSH definition%A%  
% 210.03/210.25  |- mesh__recordAuthorizer mesh__D004188 SJN
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004188 2006
% 210.03/210.25  |- mesh__recordMaintainer mesh__D009671 ssb
% 210.03/210.25  |- mesh__dateCreated mesh__D009671 1999-01-01
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D009671 2006
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D009671 2005
% 210.03/210.25  |- skos__related mesh__D009671smesh__D011781
% 210.03/210.25  |- rdf__type mesh__D009671sskos__Concept
% 210.03/210.25  |- skos__prefLabel mesh__D009671 Nostrums
% 210.03/210.25  |- skos__broader mesh__D009671smesh__D004364
% 210.03/210.25  |- mesh__dateRevised mesh__D009671 2003-07-09
% 210.03/210.25  |- mesh__recordOriginator mesh__D009671 NLM
% 210.03/210.25  |- skos__annotation mesh__D009671
% 210.03/210.25       do not confuse with DRUGS, NON-PRESCRIPTION   
% 210.03/210.25  |- skos__scopeNote mesh__D009671
% 210.03/210.25       Medicines whose effectiveness is unproven and whose ingredients are often secret.%A%    
% 210.03/210.25  |- skos__related mesh__D009671smesh__D008519
% 210.03/210.25  |- mesh__recordAuthorizer mesh__D009671 sjn
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D009671 2004
% 210.03/210.25  |- skos__altLabel mesh__D017305 Lipocortin 1
% 210.03/210.25  |- mesh__dateEstablished mesh__D017305 1993-01-01
% 210.03/210.25  |- mesh__publicMeSHNote mesh__D017305
% 210.03/210.25       2005; see ANNEXIN I 1993-2004; LIPOCORTIN 1 was indexed under CALCIUM-BINDING PROTEINS 1985-1992, ANNEXIN I %26% CALPACTIN II were indexed under CALCIUM-BINDING PROTEINS 1984-1992, ANNEXIN A1 was indexed under ANNEXIN I 2004; RENOCORTIN was indexed under GLYCOPROTEINS 1986-2004 %26% under PROTEINS 1983-1985; CHROMOBINDIN 9 was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1986-2004%A%  
% 210.03/210.25  |- skos__altLabel mesh__D017305 Lipocortin I
% 210.03/210.25  |- mesh__recordAuthorizer mesh__D017305 sjn
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D017305 2006
% 210.03/210.25  |- skos__altLabel mesh__D017305 Annexin I
% 210.03/210.25  |- skos__altLabel mesh__D017305 Renocortin
% 210.03/210.25  |- skos__prefLabel mesh__D017305 Annexin A1
% 210.03/210.25  |- mesh__recordOriginator mesh__D017305 AGS
% 210.03/210.25  |- mesh__dateCreated mesh__D017305 1992-05-07
% 210.03/210.25  |- skos__altLabel mesh__D017305 Calpactin II
% 210.03/210.25  |- mesh__recordMaintainer mesh__D017305 jmp
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D017305 2005
% 210.03/210.25  |- skos__broader mesh__D017305smesh__D017302
% 210.03/210.25  |- skos__scopeNote mesh__D017305
% 210.03/210.25       Protein of the annexin family exhibiting lipid interaction and steroid-inducibility.%A%    
% 210.03/210.25  |- skos__historyNote mesh__D017305
% 210.03/210.25       Calcium-Binding Proteins %28%1984-1992%29%
% 210.03/210.25  |- rdf__type mesh__D017305sskos__Concept
% 210.03/210.25  |- mesh__historyNote mesh__D017305
% 210.03/210.25       2005%28%1993%29%; for LIPOCORTIN I use ANNEXINS %28%NM%29% 1985-1992, for ANNEXIN I %26% CALPACTIN II use ANNEXINS %28%NM%29% 1984-1992%A%  
% 210.03/210.25  |- mesh__dateRevised mesh__D017305 2004-07-07
% 210.03/210.25  |- skos__altLabel mesh__D017305 Chromobindin 9
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Meningotheliomatous
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Transitional Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Intraventricular Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Hemangiopericytic
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Spinal
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Microcystic Meningiomas
% 210.03/210.25  |- rdf__type mesh__D008579sskos__Concept
% 210.03/210.25  |- mesh__recordMaintainer mesh__D008579 ags
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Hemangiopericytic Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Olfactory Groove
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Benign
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Intraorbital Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Spinal
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Intracranial Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Spinal Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningotheliomatous Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Fibrous Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Convexity Meningiomas, Cerebral
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Intraorbital
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Olfactory Groove
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Posterior Fossa
% 210.03/210.25  |- skos__prefLabel mesh__D008579 Meningioma
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Hemangioblastic
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Multiple
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Benign
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Multiple Meningioma
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Parasagittal
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomatoses
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Xanthomatous
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Clear Cell
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Cerebral Convexity
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Fibrous
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Angioblastic
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Angiomatous Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Angiomatous
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Meningotheliomatous
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Cerebral Convexity
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Microcystic
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Malignant Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Fibrous
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D008579 2006
% 210.03/210.25  |- mesh__recordOriginator mesh__D008579 NLM
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Psammomatous
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Microcystic
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Sphenoid Wing Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Papillary
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Transitional
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Papillary
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Wing Meningioma, Sphenoid
% 210.03/210.25  |- skos__altLabel mesh__D008579 Meningiomatosis
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Sphenoid Wing
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Psammomatous
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Secretory
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Benign Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Posterior Fossa Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Parasagittal
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Angiomatous
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Malignant
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Multiple Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Intraventricular
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Xanthomatous Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Secretory Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Clear Cell Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Papillary Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Groove Meningiomas, Olfactory
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Intracranial
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Angioblastic Meningiomas
% 210.03/210.25  |- skos__broader mesh__D008579smesh__D008577
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Olfactory Groove Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Parasagittal Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Xanthomatous
% 210.03/210.25  |- skos__scopeNote mesh__D008579
% 210.03/210.25       A relatively common neoplasm of the CENTRAL NERVOUS SYSTEM that arises from arachnoidal cells. The majority are well differentiated vascular tumors which grow slowly and have a low potential to be invasive, although malignant subtypes occur. Meningiomas have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and SPINAL CANAL. %28%From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2056-7%29%%A%    
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Malignant
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Convexity Meningioma, Cerebral
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Hemangioblastic
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Intraventricular
% 210.03/210.25  |- mesh__dateCreated mesh__D008579 1999-01-01
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Intraorbital
% 210.03/210.25  |- skos__broader mesh__D008579smesh__D009380
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Wing Meningiomas, Sphenoid
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Hemangiopericytic
% 210.03/210.25  |- mesh__recordAuthorizer mesh__D008579 sjn
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Psammomatous Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Posterior Fossa
% 210.03/210.25  |- skos__annotation mesh__D008579
% 210.03/210.25       benign or malignant; coord IM with MENINGEAL NEOPLASMS %28%IM%29% but not with BRAIN NEOPLASMS nor SPINAL CORD NEOPLASMS for intracranial or spinal meningioma unless site is particularly discussed%A%  
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Secretory
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Angioblastic
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Cerebral Convexity Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Transitional
% 210.03/210.25  |- skos__broader mesh__D008579smesh__D009383
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Clear Cell
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Hemangioblastic Meningiomas
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningioma, Intracranial
% 210.03/210.25  |- mesh__dateRevised mesh__D008579 2005-06-30
% 210.03/210.25  |- skos__hiddenLabel mesh__D008579 Meningiomas, Sphenoid Wing
% 210.03/210.25  |- mesh__historyNote mesh__D000596
% 210.03/210.25       /metabolism was AMINO ACID METABOLISM 1965; /metabolism was AMINO ACID METABOLISM see under PROTEIN METABOLISM 1963-64%A%  
% 210.03/210.25  |- skos__broader mesh__D000596smesh__D000602
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D000596 2003
% 210.03/210.25  |- mesh__dateCreated mesh__D000596 1999-01-01
% 210.03/210.25  |- skos__related mesh__D000596smesh__D017459
% 210.03/210.25  |- mesh__recordOriginator mesh__D000596 NLM
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D000596 2004
% 210.03/210.25  |- mesh__dateRevised mesh__D000596 1997-06-20
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D000596 2000
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D000596 2005
% 210.03/210.25  |- skos__scopeNote mesh__D000596
% 210.03/210.25       Organic compounds that generally contain an amino %28%-NH2%29% and a carboxyl %28%-COOH%29% group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins.%A%    
% 210.03/210.25  |- mesh__recordAuthorizer mesh__D000596 SJN
% 210.03/210.25  |- mesh__onlineNote mesh__D000596 pre-explosion = AMINO ACIDS %28%PX%29%   
% 210.03/210.25  |- rdf__type mesh__D000596sskos__Concept
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D000596 2001
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D000596 2006
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D000596 1998
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D000596 2002
% 210.03/210.25  |- mesh__recordMaintainer mesh__D000596 TGC
% 210.03/210.25  |- skos__annotation mesh__D000596
% 210.03/210.25       /urine permitted but consider also AMINOACIDURIA, RENAL   
% 210.03/210.25  |- skos__prefLabel mesh__D000596 Amino Acids
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D000596 1999
% 210.03/210.25  |- mesh__publicMeSHNote mesh__D000596
% 210.03/210.25       /metabolism was AMINO ACID METABOLISM 1965; /metabolism was AMINO ACID METABOLISM see under PROTEIN METABOLISM 1963-64%A%  
% 210.03/210.25  |- skos__hiddenLabel mesh__D000596 Acids, Amino
% 210.03/210.25  |- skos__broader mesh__D005753Q000557smesh__D005753
% 210.03/210.25  |- rdf__type mesh__D005753Q000557smesh__CompoundConcept
% 210.03/210.25  |- skos__hiddenLabel mesh__D013713 Bristol Myers Squibb Brand of Teniposide
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D013713 2006
% 210.03/210.25  |- skos__broader mesh__D013713smesh__D005960
% 210.03/210.25  |- skos__hiddenLabel mesh__D013713 VM26
% 210.03/210.25  |- rdf__type mesh__D013713sskos__Concept
% 210.03/210.25  |- mesh__recordOriginator mesh__D013713 SH
% 210.03/210.25  |- skos__hiddenLabel mesh__D013713 NSC 122819
% 210.03/210.25  |- skos__historyNote mesh__D013713 Podophyllotoxin %28%1973-1974%29%
% 210.03/210.25  |- skos__altLabel mesh__D013713
% 210.03/210.25       Demethyl Epipodophyllotoxin Thenylidine Glucoside
% 210.03/210.25  |- mesh__recordAuthorizer mesh__D013713 sjn
% 210.03/210.25  |- mesh__recordMaintainer mesh__D013713 CCR
% 210.03/210.25  |- skos__hiddenLabel mesh__D013713 Bristol Myers Brand of Teniposide
% 210.03/210.25  |- mesh__dateEstablished mesh__D013713 1991-01-01
% 210.03/210.25  |- mesh__historyNote mesh__D013713
% 210.03/210.25       91%28%81%29%; was see under PODOPHYLLOTOXIN 1981-90; was VM 26 see under PODOPHYLLOTOXIN 1976-80%A%  
% 210.03/210.25  |- skos__historyNote mesh__D013713 Glycosides %28%1973-1974%29%
% 210.03/210.25  |- skos__altLabel mesh__D013713 Bristol-Myers Brand of Teniposide
% 210.03/210.25  |- mesh__dateCreated mesh__D013713 1975-07-25
% 210.03/210.25  |- skos__scopeNote mesh__D013713
% 210.03/210.25       A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Teniposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent cells from entering into the mitotic phase of the cell cycle, and lead to cell death. Teniposide acts primarily in the G2 and S phases of the cycle.%A%    
% 210.03/210.25  |- skos__hiddenLabel mesh__D013713 NSC122819
% 210.03/210.25  |- skos__altLabel mesh__D013713 Bristol-Myers Squibb Brand of Teniposide
% 210.03/210.25  |- mesh__onlineNote mesh__D013713 use TENIPOSIDE to search VM 26 1976-80   
% 210.03/210.25  |- skos__historyNote mesh__D013713 Glucosides %28%1975%29%
% 210.03/210.25  |- skos__prefLabel mesh__D013713 Teniposide
% 210.03/210.25  |- mesh__publicMeSHNote mesh__D013713
% 210.03/210.25       91; was see under PODOPHYLLOTOXIN 1981-90; was VM 26 see under PODOPHYLLOTOXIN 1976-80%A%  
% 210.03/210.25  |- skos__hiddenLabel mesh__D013713 VM 26
% 210.03/210.25  |- mesh__dateRevised mesh__D013713 2005-06-30
% 210.03/210.25  |- mesh__recordAuthorizer mesh__D004987 SJN
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004987 2001
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004987 1999
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004987 2006
% 210.03/210.25  |- mesh__recordOriginator mesh__D004987 NLM
% 210.03/210.25  |- mesh__dateRevised mesh__D004987 1997-06-20
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004987 2000
% 210.03/210.25  |- skos__annotation mesh__D004987
% 210.03/210.25       do not confuse with ETHER see ETHER, ETHYL   
% 210.03/210.25  |- mesh__publicMeSHNote mesh__D004987
% 210.03/210.25       ETHOGLUCID was see under ALKYLATING AGENTS 1967-74   
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004987 1998
% 210.03/210.25  |- rdf__type mesh__D004987sskos__Concept
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004987 2005
% 210.03/210.25  |- skos__broader mesh__D004987smesh__D009930
% 210.03/210.25  |- skos__prefLabel mesh__D004987 Ethers
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004987 2002
% 210.03/210.25  |- mesh__dateCreated mesh__D004987 1999-01-01
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004987 2004
% 210.03/210.25  |- mesh__recordMaintainer mesh__D004987 TGC
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004987 2003
% 210.03/210.25  |- skos__altLabel mesh__D051034 IAP2 Protein
% 210.03/210.25  |- skos__altLabel mesh__D051034 IAP1 Protein
% 210.03/210.25  |- skos__altLabel mesh__D051034
% 210.03/210.25       Baculoviral Inhibitor Of Apoptosis Repeat Proteins
% 210.03/210.25  |- skos__altLabel mesh__D051034 cIAP1 Protein
% 210.03/210.25  |- mesh__recordOriginator mesh__D051034 DRC
% 210.03/210.25  |- skos__prefLabel mesh__D051034 Inhibitor of Apoptosis Proteins
% 210.03/210.25  |- skos__altLabel mesh__D051034 c-IAP2 Protein
% 210.03/210.25  |- skos__altLabel mesh__D051034 IAP Protein %28%Apoptosis%29%
% 210.03/210.25  |- mesh__dateEstablished mesh__D051034 2006-01-01
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D051034 2006
% 210.03/210.25  |- mesh__publicMeSHNote mesh__D051034
% 210.03/210.25       2006; INHIBITOR OF APOPTOSIS PROTEINS was indexed under PROTEINS 1997-2005%A%  
% 210.03/210.25  |- skos__annotation mesh__D051034
% 210.03/210.25       APOPTOSIS REGULATORY PROTEINS is also available   
% 210.03/210.25  |- skos__hiddenLabel mesh__D051034 Apoptosis Proteins Inhibitor
% 210.03/210.25  |- skos__altLabel mesh__D051034 Inhibitor-Of-Apoptosis Protein
% 210.03/210.25  |- mesh__recordAuthorizer mesh__D051034 ags
% 210.03/210.25  |- mesh__dateRevised mesh__D051034 2005-07-11
% 210.03/210.25  |- rdf__type mesh__D051034sskos__Concept
% 210.03/210.25  |- mesh__historyNote mesh__D051034 2006%28%1997%29%   
% 210.03/210.25  |- skos__altLabel mesh__D051034 c-IAP1 Protein
% 210.03/210.25  |- skos__broader mesh__D051034smesh__D051017
% 210.03/210.25  |- mesh__dateCreated mesh__D051034 2005-06-30
% 210.03/210.25  |- skos__hiddenLabel mesh__D051034 Inhibitor Of Apoptosis Protein
% 210.03/210.25  |- skos__scopeNote mesh__D051034
% 210.03/210.25       A conserved class of proteins that control APOPTOSIS in both VERTEBRATES and INVERTEBRATES. IAP proteins interact with and inhibit CASPASES, and they function as ANTI-APOPTOTIC PROTEINS. The protein class is defined by an approximately 80-amino acid motif called the baculoviral inhibitor of apoptosis repeat.%A%    
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D051034 2006A
% 210.03/210.25  |- mesh__recordMaintainer mesh__D051034 ags
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004189 2004
% 210.03/210.25  |- mesh__recordMaintainer mesh__D004189 kle
% 210.03/210.25  |- skos__prefLabel mesh__D004189 Disaster Planning
% 210.03/210.25  |- mesh__historyNote mesh__D004189 78   
% 210.03/210.25  |- skos__hiddenLabel mesh__D004189 Planning, Disaster
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004189 2002
% 210.03/210.25  |- mesh__recordOriginator mesh__D004189 EC
% 210.03/210.25  |- mesh__dateEstablished mesh__D004189 1978-01-01
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004189 2005
% 210.03/210.25  |- rdf__type mesh__D004189sskos__Concept
% 210.03/210.25  |- skos__annotation mesh__D004189
% 210.03/210.25       specify disaster %28%IM%29% if pertinent; specify geog if pertinent%A%  
% 210.03/210.25  |- skos__hiddenLabel mesh__D004189 Plannings, Disaster
% 210.03/210.25  |- mesh__dateRevised mesh__D004189 1999-11-03
% 210.03/210.25  |- skos__broader mesh__D004189smesh__D004190
% 210.03/210.25  |- mesh__dateCreated mesh__D004189 1977-05-05
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004189 2006
% 210.03/210.25  |- skos__scopeNote mesh__D004189
% 210.03/210.25       Procedures outlined for the care of casualties and the maintenance of services in disasters.%A%    
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004189 2000
% 210.03/210.25  |- skos__historyNote mesh__D004189 Disasters %28%1966-1977%29%
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004189 2003
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D004189 2001
% 210.03/210.25  |- skos__hiddenLabel mesh__D004189 Disaster Plannings
% 210.03/210.25  |- mesh__publicMeSHNote mesh__D004189 78   
% 210.03/210.25  |- skos__related mesh__D004189smesh__D002959
% 210.03/210.25  |- mesh__recordAuthorizer mesh__D004189 sjn
% 210.03/210.25  |- skos__hiddenLabel mesh__D009672 Notochords
% 210.03/210.25  |- skos__annotation mesh__D009672 read MeSH definition   
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D009672 2002
% 210.03/210.25  |- mesh__recordMaintainer mesh__D009672 NLM
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D009672 1996
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D009672 2005
% 210.03/210.25  |- skos__prefLabel mesh__D009672 Notochord
% 210.03/210.25  |- mesh__dateCreated mesh__D009672 1977-12-05
% 210.03/210.25  |- skos__historyNote mesh__D009672 Chick Embryo %28%1966-1978%29%
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D009672 2006
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D009672 1997
% 210.03/210.25  |- mesh__historyNote mesh__D009672
% 210.03/210.25       91%28%79%29%; was see under EMBRYO 1979-90   
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D009672 1992
% 210.03/210.25  |- mesh__dateEstablished mesh__D009672 1991-01-01
% 210.03/210.25  |- skos__broader mesh__D009672smesh__D004622
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D009672 1993
% 210.03/210.25  |- mesh__publicMeSHNote mesh__D009672 91; was see under EMBRYO 1979-90   
% 210.03/210.25  |- rdf__type mesh__D009672sskos__Concept
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D009672 1998
% 210.03/210.25  |- mesh__dateRevised mesh__D009672 1990-04-13
% 210.03/210.25  |- skos__historyNote mesh__D009672 Embryo %28%1966-1978%29%
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D009672 2000
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D009672 1991
% 210.03/210.25  |- skos__scopeNote mesh__D009672
% 210.03/210.25       The rod-shaped body, composed of cells derived from the mesoblast and defining the primitive axis of the embryo. In lower vertebrates, it persists throughout life as the main axial support of the body, but in higher vertebrates it is replaced by the vertebral column.%A%    
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D009672 1994
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D009672 2003
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D009672 1999
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D009672 2004
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D009672 1995
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D009672 2001
% 210.03/210.25  |- mesh__recordOriginator mesh__D009672 AEP
% 210.03/210.25  |- mesh__recordAuthorizer mesh__D009672 PLS
% 210.03/210.25  |- mesh__dateCreated mesh__D017306 1992-05-07
% 210.03/210.25  |- skos__historyNote mesh__D017306
% 210.03/210.25       Calcium-Binding Proteins %28%1984-1992%29%
% 210.03/210.25  |- skos__altLabel mesh__D017306 Capactin I Heavy Chain
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D017306 2005
% 210.03/210.25  |- skos__altLabel mesh__D017306 Annexin II, P90 Complex
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D017306 2006B
% 210.03/210.25  |- mesh__recordAuthorizer mesh__D017306 ags
% 210.03/210.25  |- skos__broader mesh__D017306smesh__D017302
% 210.03/210.25  |- mesh__dateEstablished mesh__D017306 1993-01-01
% 210.03/210.25  |- rdf__type mesh__D017306sskos__Concept
% 210.03/210.25  |- mesh__historyNote mesh__D017306
% 210.03/210.25       2005%28%1993%29% for ANNEXIN II %26% CALPACTIN I use ANNEXINS 1984-1992%A%  
% 210.03/210.25  |- mesh__dateRevised mesh__D017306 2005-07-22
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D017306 2006A
% 210.03/210.25  |- skos__hiddenLabel mesh__D017306 P36 Annexin II
% 210.03/210.25  |- skos__altLabel mesh__D017306 Annexin II, P36
% 210.03/210.25  |- skos__altLabel mesh__D017306 Annexin II
% 210.03/210.25  |- mesh__recordMaintainer mesh__D017306 ags
% 210.03/210.25  |- skos__altLabel mesh__D017306 Lipocortin II
% 210.03/210.25  |- skos__scopeNote mesh__D017306
% 210.03/210.25       A member of the annexin family that is a substrate for a tyrosine kinase, ONCOGENE PROTEIN PP60%28%V-SRC%29%. Annexin A2 occurs as a 36-KDa monomer and in a 90-KDa complex containing two subunits of annexin A2 and two subunits of S100 FAMILY PROTEIN P11. The monomeric form of annexin A2 was formerly referred to as calpactin I heavy chain.%A%    
% 210.03/210.25  |- mesh__recordOriginator mesh__D017306 AGS
% 210.03/210.25  |- mesh__publicMeSHNote mesh__D017306
% 210.03/210.25       2005; use ANNEXIN II 1993-2004; ANNEXIN II %26% CALPACTIN I were indexed under CALCIUM-BINDING PROTEINS 1984-1992, ANNEXIN A2 was indexed under ANNEXIN II 2004%A%  
% 210.03/210.25  |- skos__altLabel mesh__D017306 Calpactin I
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D017306 2006
% 210.03/210.25  |- skos__prefLabel mesh__D017306 Annexin A2
% 210.03/210.25  |- skos__scopeNote mesh__D000597
% 210.03/210.25       Amino acids which have a branched carbon chain.     
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D000597 2005
% 210.03/210.25  |- mesh__activeMeSHYear mesh__D000597 1997
% 210.03/210.25  |- mesh__historyNote mesh__D000597 79   
% 210.03/210.26  |- mesh__dateRevised mesh__D000597 1992-05-07
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000597 2002
% 210.03/210.26  |- mesh__recordOriginator mesh__D000597 RLS
% 210.03/210.26  |- rdf__type mesh__D000597sskos__Concept
% 210.03/210.26  |- mesh__publicMeSHNote mesh__D000597 79   
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000597 2006
% 210.03/210.26  |- mesh__dateEstablished mesh__D000597 1979-01-01
% 210.03/210.26  |- mesh__recordAuthorizer mesh__D000597 PLS
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000597 1998
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000597 1993
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000597 1994
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000597 1999
% 210.03/210.26  |- skos__broader mesh__D000597smesh__D000596
% 210.03/210.26  |- mesh__recordMaintainer mesh__D000597 TAP
% 210.03/210.26  |- mesh__dateCreated mesh__D000597 1978-05-16
% 210.03/210.26  |- skos__prefLabel mesh__D000597 Amino Acids, Branched-Chain
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000597 1995
% 210.03/210.26  |- skos__historyNote mesh__D000597 Amino Acids %28%1966-1978%29%
% 210.03/210.26  |- skos__hiddenLabel mesh__D000597 Acids, Branched-Chain Amino
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000597 2003
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000597 2000
% 210.03/210.26  |- skos__altLabel mesh__D000597 Amino Acids, Branched Chain
% 210.03/210.26  |- skos__hiddenLabel mesh__D000597 Branched-Chain Amino Acids
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000597 2004
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000597 1996
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000597 2001
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013714 2005
% 210.03/210.26  |- mesh__recordMaintainer mesh__D013714 PXP
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013714 2001
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013714 2003
% 210.03/210.26  |- mesh__recordOriginator mesh__D013714 NLM
% 210.03/210.26  |- mesh__dateRevised mesh__D013714 1997-06-20
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013714 2000
% 210.03/210.26  |- mesh__recordAuthorizer mesh__D013714 SJN
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013714 2002
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013714 1999
% 210.03/210.26  |- skos__prefLabel mesh__D013714 Tennessee
% 210.03/210.26  |- mesh__dateCreated mesh__D013714 1999-01-01
% 210.03/210.26  |- skos__broader mesh__D013714smesh__D001061
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013714 2006
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013714 1998
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013714 2004
% 210.03/210.26  |- rdf__type mesh__D013714sskos__Concept
% 210.03/210.26  |- skos__broader mesh__D004988smesh__D004987
% 210.03/210.26  |- skos__scopeNote mesh__D004988
% 210.03/210.26       Compounds of the general formula R-O-R arranged in a ring or crown formation.%A%    
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D004988 2006
% 210.03/210.26  |- mesh__recordMaintainer mesh__D004988 ssb
% 210.03/210.26  |- rdf__type mesh__D004988sskos__Concept
% 210.03/210.26  |- mesh__dateCreated mesh__D004988 1999-01-01
% 210.03/210.26  |- skos__hiddenLabel mesh__D004988 Cyclic Ethers
% 210.03/210.26  |- skos__broader mesh__D004988smesh__D047028
% 210.03/210.26  |- skos__prefLabel mesh__D004988 Ethers, Cyclic
% 210.03/210.26  |- mesh__recordOriginator mesh__D004988 NLM
% 210.03/210.26  |- mesh__recordAuthorizer mesh__D004988 sjn
% 210.03/210.26  |- mesh__dateRevised mesh__D004988 2004-07-07
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D004988 2005
% 210.03/210.26  |- mesh__publicMeSHNote mesh__D009673
% 210.03/210.26       91; was see under SALAMANDRIDAE 1981-90   
% 210.03/210.26  |- skos__scopeNote mesh__D009673
% 210.03/210.26       A species of newt in the Salamandridae family in which the larvae transform into terrestrial eft stage and later into an aquatic adult. They occur from Canada to southern United States. Viridescens refers to the greenish color often found in this species.%A%    
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D009673 2006
% 210.03/210.26  |- skos__hiddenLabel mesh__D009673 viridescens, Triturus
% 210.03/210.26  |- skos__hiddenLabel mesh__D009673 viridescens, Diemictylus
% 210.03/210.26  |- mesh__dateEstablished mesh__D009673 1991-01-01
% 210.03/210.26  |- skos__altLabel mesh__D009673 Triturus viridescens
% 210.03/210.26  |- skos__altLabel mesh__D009673 Diemictylus viridescens
% 210.03/210.26  |- mesh__dateCreated mesh__D009673 1980-05-12
% 210.03/210.26  |- skos__hiddenLabel mesh__D009673 viridescens, Notophthalmus
% 210.03/210.26  |- rdf__type mesh__D009673sskos__Concept
% 210.03/210.26  |- skos__historyNote mesh__D009673 Salamandridae %28%1975-1980%29%
% 210.03/210.26  |- mesh__recordAuthorizer mesh__D009673 sjn
% 210.03/210.26  |- skos__hiddenLabel mesh__D009673 Newts, Red-Spotted
% 210.03/210.26  |- mesh__dateRevised mesh__D009673 2003-07-09
% 210.03/210.26  |- mesh__recordMaintainer mesh__D009673 ags
% 210.03/210.26  |- mesh__historyNote mesh__D009673
% 210.03/210.26       91%28%81%29%; was see under SALAMANDRIDAE 1981-90   
% 210.03/210.26  |- skos__historyNote mesh__D009673 Urodela %28%1966-1974%29%
% 210.03/210.26  |- mesh__recordOriginator mesh__D009673 EC
% 210.03/210.26  |- skos__prefLabel mesh__D009673 Notophthalmus viridescens
% 210.03/210.26  |- skos__hiddenLabel mesh__D009673 Red-Spotted Newts
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D009673 2004
% 210.03/210.26  |- skos__annotation mesh__D009673
% 210.03/210.26       a species of newt; NIM as exper animal: no qualif; when IM, qualif permitted%A%  
% 210.03/210.26  |- skos__broader mesh__D009673smesh__D019185
% 210.03/210.26  |- skos__hiddenLabel mesh__D009673 Red-Spotted Newt
% 210.03/210.26  |- skos__hiddenLabel mesh__D009673 Newt, Red Spotted
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D009673 2005
% 210.03/210.26  |- skos__hiddenLabel mesh__D001690 Life Science
% 210.03/210.26  |- mesh__recordAuthorizer mesh__D001690 sjn
% 210.03/210.26  |- mesh__recordMaintainer mesh__D001690 jls
% 210.03/210.26  |- skos__altLabel mesh__D001690 Sciences, Biological
% 210.03/210.26  |- mesh__publicMeSHNote mesh__D001690
% 210.03/210.26       91; BIOLOGICAL SCIENCES was see BIOLOGY 1990   
% 210.03/210.26  |- mesh__runningHead mesh__D001690 G1 - BIOLOGICAL SCIENCES   
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D001690 2003
% 210.03/210.26  |- mesh__onlineNote mesh__D001690
% 210.03/210.26       use BIOLOGY to search BIOLOGICAL SCIENCES 1975-90   
% 210.03/210.26  |- skos__prefLabel mesh__D001690 Biological Sciences
% 210.03/210.26  |- mesh__historyNote mesh__D001690
% 210.03/210.26       91; was BIOLOGICAL SCIENCES %28%NON MESH%29% 1975-90; BIOLOGICAL SCIENCES was see BIOLOGY 1990%A%  
% 210.03/210.26  |- mesh__recordOriginator mesh__D001690 NLM
% 210.03/210.26  |- skos__hiddenLabel mesh__D001690 Science, Life
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D001690 2005
% 210.03/210.26  |- skos__hiddenLabel mesh__D001690 Science, Biologic
% 210.03/210.26  |- mesh__dateEstablished mesh__D001690 1991-01-01
% 210.03/210.26  |- skos__scopeNote mesh__D001690
% 210.03/210.26       All of the divisions of the natural sciences dealing with the various aspects of the phenomena of life and vital processes. The concept includes anatomy and physiology, biochemistry and biophysics, and the biology of animals, plants, and microorganisms. It should be differentiated from BIOLOGY, one of its subdivisions, concerned specifically with the origin and life processes of living organisms.%A%    
% 210.03/210.26  |- skos__annotation mesh__D001690
% 210.03/210.26       SPEC; SPEC qualif; do not confuse with BIOLOGY; DF: BIOL SCIENCES%A%  
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D001690 2004
% 210.03/210.26  |- skos__altLabel mesh__D001690 Biological Science
% 210.03/210.26  |- skos__hiddenLabel mesh__D001690 Sciences, Biologic
% 210.03/210.26  |- skos__hiddenLabel mesh__D001690 Biologic Science
% 210.03/210.26  |- mesh__dateCreated mesh__D001690 1999-01-01
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D001690 2006
% 210.03/210.26  |- mesh__dateRevised mesh__D001690 2001-07-25
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D001690 2002
% 210.03/210.26  |- skos__altLabel mesh__D001690 Life Sciences
% 210.03/210.26  |- skos__historyNote mesh__D001690 Biology %28%1975-1990%29%
% 210.03/210.26  |- skos__hiddenLabel mesh__D001690 Sciences, Life
% 210.03/210.26  |- skos__altLabel mesh__D001690 Biologic Sciences
% 210.03/210.26  |- rdf__type mesh__D001690sskos__Concept
% 210.03/210.26  |- skos__altLabel mesh__D001690 Science, Biological
% 210.03/210.26  |- skos__scopeNote mesh__D017307
% 210.03/210.26       A selective beta-1-adrenergic partial agonist. Because it is a partial agonist it acts like an agonist when sympathetic activity is low and as an antagonist when sympathetic activity is high. It reduces myocardial ischemia and improves ventricular function in patients with mild to moderate heart failure. In patients with severe heart failure it has been shown to produce benefits in systolic and diastolic function.%A%    
% 210.03/210.26  |- skos__broader mesh__D017307smesh__D011412
% 210.03/210.26  |- mesh__onlineNote mesh__D017307
% 210.03/210.26       use XAMOTEROL %28%NM%29% to search XAMOTEROL 1984-92   
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D017307 2006
% 210.03/210.26  |- skos__prefLabel mesh__D017307 Xamoterol
% 210.03/210.26  |- mesh__dateRevised mesh__D017307 2005-06-30
% 210.03/210.26  |- skos__broader mesh__D017307smesh__D050198
% 210.03/210.26  |- skos__historyNote mesh__D017307 Propanolamines %28%1984-1992%29%
% 210.03/210.26  |- rdf__type mesh__D017307sskos__Concept
% 210.03/210.26  |- skos__hiddenLabel mesh__D017307 Monohydrochloride, Xamoterol
% 210.03/210.26  |- skos__hiddenLabel mesh__D017307 ICI118587
% 210.03/210.26  |- skos__hiddenLabel mesh__D017307 Fumarate, Xamoterol
% 210.03/210.26  |- skos__hiddenLabel mesh__D017307 Monohydrobromide, Xamoterol
% 210.03/210.26  |- mesh__dateEstablished mesh__D017307 1993-01-01
% 210.03/210.26  |- mesh__recordAuthorizer mesh__D017307 sjn
% 210.03/210.26  |- mesh__recordMaintainer mesh__D017307 ssb
% 210.03/210.26  |- skos__hiddenLabel mesh__D017307 ICI 118587
% 210.03/210.26  |- skos__hiddenLabel mesh__D017307 Hemifumarate, Xamoterol
% 210.03/210.26  |- mesh__publicMeSHNote mesh__D017307
% 210.03/210.26       93; XAMOTEROL was indexed under PROPANOLAMINES 1984-92   
% 210.03/210.26  |- mesh__recordOriginator mesh__D017307 TPW
% 210.03/210.26  |- mesh__dateCreated mesh__D017307 1992-05-22
% 210.03/210.26  |- skos__broader mesh__D017307smesh__D009025
% 210.03/210.26  |- mesh__historyNote mesh__D017307 93; was XAMOTEROL %28%NM%29% 1984-92   
% 210.03/210.26  |- mesh__recordMaintainer mesh__D000598 ADP
% 210.03/210.26  |- skos__prefLabel mesh__D000598 Amino Acids, Cyclic
% 210.03/210.26  |- mesh__publicMeSHNote mesh__D000598 98   
% 210.03/210.26  |- rdf__type mesh__D000598sskos__Concept
% 210.03/210.26  |- skos__hiddenLabel mesh__D000598 Acids, Cyclic Amino
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000598 2002
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000598 2005
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000598 1998
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000598 2006
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000598 1999
% 210.03/210.26  |- mesh__recordOriginator mesh__D000598 NLM
% 210.03/210.26  |- skos__annotation mesh__D000598
% 210.03/210.26       GEN; prefer specifics; used for mapping supplementary chemicals%A%  
% 210.03/210.26  |- skos__broader mesh__D000598smesh__D000596
% 210.03/210.26  |- mesh__dateCreated mesh__D000598 1999-01-01
% 210.03/210.26  |- skos__altLabel mesh__D000598 Cyclic Amino Acids
% 210.03/210.26  |- skos__scopeNote mesh__D000598
% 210.03/210.26       A class of amino acids characterized by a closed ring structure.%A%    
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000598 2000
% 210.03/210.26  |- mesh__dateRevised mesh__D000598 1997-06-26
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000598 2003
% 210.03/210.26  |- mesh__recordAuthorizer mesh__D000598 SJN
% 210.03/210.26  |- mesh__dateEstablished mesh__D000598 1998-01-01
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000598 2001
% 210.03/210.26  |- mesh__historyNote mesh__D000598 98; use explode 1967-97   
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000598 2004
% 210.03/210.26  |- mesh__dateEstablished mesh__D005283 1966-01-01
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D005283 2002
% 210.03/210.26  |- mesh__recordMaintainer mesh__D005283 CCR
% 210.03/210.26  |- skos__altLabel mesh__D005283 Phentanyl
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D005283 2003
% 210.03/210.26  |- skos__prefLabel mesh__D005283 Fentanyl
% 210.03/210.26  |- rdf__type mesh__D005283sskos__Concept
% 210.03/210.26  |- mesh__dateCreated mesh__D005283 1999-01-01
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D005283 2004
% 210.03/210.26  |- skos__hiddenLabel mesh__D005283 Citrate, Fentanyl
% 210.03/210.26  |- mesh__recordAuthorizer mesh__D005283 sjn
% 210.03/210.26  |- skos__broader mesh__D005283smesh__D010880
% 210.03/210.26  |- mesh__publicMeSHNote mesh__D005283 66   
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D005283 2005
% 210.03/210.26  |- skos__scopeNote mesh__D005283
% 210.03/210.26       A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1078%29%%A%    
% 210.03/210.26  |- mesh__recordOriginator mesh__D005283 NLM
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D005283 2006
% 210.03/210.26  |- mesh__historyNote mesh__D005283 66   
% 210.03/210.26  |- mesh__dateRevised mesh__D005283 2001-07-25
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013715 2002
% 210.03/210.26  |- skos__prefLabel mesh__D013715 Tennis
% 210.03/210.26  |- mesh__dateEstablished mesh__D013715 1990-01-01
% 210.03/210.26  |- mesh__publicMeSHNote mesh__D013715 90; was see under SPORTS 1976-89   
% 210.03/210.26  |- mesh__recordOriginator mesh__D013715 JW
% 210.03/210.26  |- skos__broader mesh__D013715smesh__D015865
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013715 1999
% 210.03/210.26  |- mesh__recordAuthorizer mesh__D013715 PLS
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013715 1997
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013715 2006
% 210.03/210.26  |- skos__historyNote mesh__D013715 Sports %28%1966-1975%29%
% 210.03/210.26  |- mesh__historyNote mesh__D013715
% 210.03/210.26       90%28%76%29%; was see under SPORTS 1976-89   
% 210.03/210.26  |- skos__annotation mesh__D013715
% 210.03/210.26       /inj: coord IM with specific inj %28%IM%29%; /physiol permitted%A%  
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013715 2001
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013715 1998
% 210.03/210.26  |- mesh__recordMaintainer mesh__D013715 TGC
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013715 2004
% 210.03/210.26  |- rdf__type mesh__D013715sskos__Concept
% 210.03/210.26  |- skos__scopeNote mesh__D013715
% 210.03/210.26       A game played by two or four players with rackets and an elastic ball on a level court divided by a low net.%A%    
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013715 2000
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013715 2005
% 210.03/210.26  |- mesh__dateCreated mesh__D013715 1975-07-21
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013715 2003
% 210.03/210.26  |- mesh__dateRevised mesh__D013715 1996-06-10
% 210.03/210.26  |- skos__hiddenLabel mesh__D004989 Moral Policies
% 210.03/210.26  |- rdf__type mesh__D004989sskos__Concept
% 210.03/210.26  |- skos__hiddenLabel mesh__D004989 Laws, Natural
% 210.03/210.26  |- mesh__dateCreated mesh__D004989 1999-01-01
% 210.03/210.26  |- skos__scopeNote mesh__D004989
% 210.03/210.26       The philosophy or code pertaining to what is ideal in human character and conduct. Also, the field of study dealing with the principles of morality.%A%    
% 210.03/210.26  |- skos__broader mesh__D004989smesh__D017530
% 210.03/210.26  |- skos__broader mesh__D004989smesh__D006809
% 210.03/210.26  |- mesh__recordMaintainer mesh__D004989 sjn
% 210.03/210.26  |- skos__hiddenLabel mesh__D004989 Issue, Ethical
% 210.03/210.26  |- skos__hiddenLabel mesh__D004989 Policy, Moral
% 210.03/210.26  |- skos__hiddenLabel mesh__D004989 Ethics, Situational
% 210.03/210.26  |- mesh__dateRevised mesh__D004989 2004-07-13
% 210.03/210.26  |- skos__prefLabel mesh__D004989 Ethics
% 210.03/210.26  |- skos__broader mesh__D004989smesh__D009014
% 210.03/210.26  |- skos__hiddenLabel mesh__D004989 Policies, Moral
% 210.03/210.26  |- skos__hiddenLabel mesh__D004989 Law, Natural
% 210.03/210.26  |- skos__hiddenLabel mesh__D004989 Natural Laws
% 210.03/210.26  |- skos__hiddenLabel mesh__D004989 Issues, Ethical
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D004989 2005
% 210.03/210.26  |- mesh__recordOriginator mesh__D004989 NLM
% 210.03/210.26  |- skos__broader mesh__D004989smesh__D010684
% 210.03/210.26  |- skos__hiddenLabel mesh__D004989 Ethical Issue
% 210.03/210.26  |- mesh__recordAuthorizer mesh__D004989 sjn
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D004989 2006
% 210.03/210.26  |- mesh__recordAuthorizer mesh__D051036 sjn
% 210.03/210.26  |- skos__scopeNote mesh__D051036
% 210.03/210.26       A major class of calcium activated potassium channels whose members are voltage-dependent. MaxiK channels are activated by either membrane depolarization or an increase in intracellular Ca%28%2+%29%. They are key regulators of calcium and electrical signaling in a variety of tissues.%A%    
% 210.03/210.26  |- rdf__type mesh__D051036sskos__Concept
% 210.03/210.26  |- mesh__publicMeSHNote mesh__D051036
% 210.03/210.26       2006; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS  was indexed under MEMBRANE PROTEINS 1993-1995, under POTASSIUM CHANNELS 1995-2002, %26% under POTASSIUM CHANNELS, CALCIUM-ACTIVATED 2002-2005%A%  
% 210.03/210.26  |- skos__hiddenLabel mesh__D051036 Maxi K Channels
% 210.03/210.26  |- mesh__historyNote mesh__D051036 2006%28%2993%29%   
% 210.03/210.26  |- skos__altLabel mesh__D051036 Maxi-K Channels
% 210.03/210.26  |- skos__broader mesh__D051036smesh__D024681
% 210.03/210.26  |- skos__prefLabel mesh__D051036
% 210.03/210.26       Large-Conductance Calcium-Activated Potassium Channels
% 210.03/210.26  |- mesh__dateCreated mesh__D051036 2005-06-30
% 210.03/210.26  |- mesh__recordOriginator mesh__D051036 DRC
% 210.03/210.26  |- mesh__recordMaintainer mesh__D051036 DRC
% 210.03/210.26  |- skos__altLabel mesh__D051036 BK Channels
% 210.03/210.26  |- skos__hiddenLabel mesh__D051036
% 210.03/210.26       Large Conductance Calcium Activated Potassium Channels
% 210.03/210.26  |- skos__altLabel mesh__D051036 MaxiK Channels
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D051036 2006
% 210.03/210.26  |- mesh__dateEstablished mesh__D051036 2006-01-01
% 210.03/210.26  |- skos__altLabel mesh__D051036 Big K Channels
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D009674 2003
% 210.03/210.26  |- mesh__dateCreated mesh__D009674 1999-01-01
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D009674 2004
% 210.03/210.26  |- skos__annotation mesh__D009674 a province of eastern Canada   
% 210.03/210.26  |- mesh__recordMaintainer mesh__D009674 mdb
% 210.03/210.26  |- mesh__dateRevised mesh__D009674 2001-07-25
% 210.03/210.26  |- skos__broader mesh__D009674smesh__D002170
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D009674 2005
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D009674 2002
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D009674 2006
% 210.03/210.26  |- mesh__recordOriginator mesh__D009674 NLM
% 210.03/210.26  |- mesh__recordAuthorizer mesh__D009674 sjn
% 210.03/210.26  |- skos__scopeNote mesh__D009674
% 210.03/210.26       A province of eastern Canada, one of the Maritime Provinces with NEW BRUNSWICK; PRINCE EDWARD ISLAND; and sometimes NEWFOUNDLAND. Its capital is Halifax. The territory was granted in 1621 by James I to the Scotsman Sir William Alexander and was called Nova Scotia, the Latin for New Scotland. The territory had earlier belonged to the French, under the name of Acadia. %28%From Webster%27%s New Geographical Dictionary, 1988, p871 %26% Room, Brewer%27%s Dictionary of Names, 1992, p384%29%%A%    
% 210.03/210.26  |- skos__prefLabel mesh__D009674 Nova Scotia
% 210.03/210.26  |- rdf__type mesh__D009674sskos__Concept
% 210.03/210.26  |- skos__scopeNote mesh__D001691
% 210.03/210.26       Treatment of diseases with biological materials or biological response modifiers, such as the use of GENES; CELLS; TISSUES; organs; SERUM; VACCINES; and humoral agents.%A%    
% 210.03/210.26  |- skos__altLabel mesh__D001691 Therapy, Biological
% 210.03/210.26  |- mesh__historyNote mesh__D001691 98; use explode 1976-97   
% 210.03/210.26  |- skos__hiddenLabel mesh__D001691 Biological Therapies
% 210.03/210.26  |- skos__altLabel mesh__D001691 Biologic Therapy
% 210.03/210.26  |- mesh__dateCreated mesh__D001691 1999-01-01
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D001691 2006
% 210.03/210.26  |- mesh__dateEstablished mesh__D001691 1998-01-01
% 210.03/210.26  |- mesh__recordAuthorizer mesh__D001691 sjn
% 210.03/210.26  |- mesh__publicMeSHNote mesh__D001691 98   
% 210.03/210.26  |- mesh__recordOriginator mesh__D001691 NLM
% 210.03/210.26  |- skos__hiddenLabel mesh__D001691 Biologic Therapies
% 210.03/210.26  |- skos__hiddenLabel mesh__D001691 Therapy, Biologic
% 210.03/210.26  |- mesh__recordMaintainer mesh__D001691 lkt
% 210.03/210.26  |- rdf__type mesh__D001691sskos__Concept
% 210.03/210.26  |- skos__broader mesh__D001691smesh__D013812
% 210.03/210.26  |- skos__annotation mesh__D001691
% 210.03/210.26       general or unspecified; prefer specifics; DF: BIOL THER   
% 210.03/210.26  |- skos__prefLabel mesh__D001691 Biological Therapy
% 210.03/210.26  |- mesh__dateRevised mesh__D001691 2005-06-30
% 210.03/210.26  |- skos__hiddenLabel mesh__D001691 Therapies, Biologic
% 210.03/210.26  |- skos__hiddenLabel mesh__D001691 Therapies, Biological
% 210.03/210.26  |- skos__hiddenLabel mesh__D017308 Acid, Etodolic
% 210.03/210.26  |- mesh__recordAuthorizer mesh__D017308 ags
% 210.03/210.26  |- skos__hiddenLabel mesh__D017308 AY 24236
% 210.03/210.26  |- mesh__recordOriginator mesh__D017308 TPW
% 210.03/210.26  |- skos__historyNote mesh__D017308 Indoleacetic Acids %28%1976-1992%29%
% 210.03/210.26  |- rdf__type mesh__D017308sskos__Concept
% 210.03/210.26  |- mesh__dateCreated mesh__D017308 1992-05-08
% 210.03/210.26  |- skos__hiddenLabel mesh__D017308 AY 24,236
% 210.03/210.26  |- skos__hiddenLabel mesh__D017308 AY24,236
% 210.03/210.26  |- skos__prefLabel mesh__D017308 Etodolac
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D017308 2006A
% 210.03/210.26  |- mesh__recordMaintainer mesh__D017308 ags
% 210.03/210.26  |- skos__scopeNote mesh__D017308
% 210.03/210.26       A nonsteroidal anti-inflammatory agent with potent analgesic and antiarthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ankylosing SPONDYLITIS; and in the alleviation of postoperative pain %28%PAIN, POSTOPERATIVE%29%.%A%    
% 210.03/210.26  |- skos__altLabel mesh__D017308 AY-24236
% 210.03/210.26  |- mesh__onlineNote mesh__D017308
% 210.03/210.26       use ETODOLAC %28%NM%29% to search ETODOLAC 1980-92   
% 210.03/210.26  |- skos__hiddenLabel mesh__D017308 AY24236
% 210.03/210.26  |- mesh__dateEstablished mesh__D017308 1993-01-01
% 210.03/210.26  |- skos__altLabel mesh__D017308 Etodolic Acid
% 210.03/210.26  |- mesh__historyNote mesh__D017308 93; was ETODOLAC %28%NM%29% 1976-92   
% 210.03/210.26  |- mesh__dateRevised mesh__D017308 2005-07-22
% 210.03/210.26  |- mesh__publicMeSHNote mesh__D017308
% 210.03/210.26       93; ETODOLAC was indexed under INDOLEACETIC ACIDS 1989-92 %26% 1976-79 %26% ACETIC ACIDS 1976-88%A%  
% 210.03/210.26  |- skos__historyNote mesh__D017308 Acetic Acids %28%1976-1988%29%
% 210.03/210.26  |- skos__broader mesh__D017308smesh__D007210
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D017308 2006
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D014010 2002
% 210.03/210.26  |- mesh__dateRevised mesh__D014010 1998-06-11
% 210.03/210.26  |- skos__scopeNote mesh__D014010
% 210.03/210.26       A common chronic, noninflammatory and usually symptomless disorder, characterized by the occurrence of multiple macular patches of all sizes and shapes, and varying in pigmentation from fawn-colored to brown. It is seen most frequently in hot, humid, tropical regions, and is caused by Pityrosporon orbiculare. %28%Dorland, 27th ed%29%%A%    
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D014010 2005
% 210.03/210.26  |- skos__annotation mesh__D014010
% 210.03/210.26       caused by PITYROSPORUM ORBICULARE see MALASSEZIA   
% 210.03/210.26  |- mesh__recordMaintainer mesh__D014010 AGS
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D014010 2003
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D014010 2006
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D014010 2004
% 210.03/210.26  |- mesh__recordOriginator mesh__D014010 NLM
% 210.03/210.26  |- mesh__dateCreated mesh__D014010 1999-01-01
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D014010 1999
% 210.03/210.26  |- mesh__recordAuthorizer mesh__D014010 SJN
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D014010 2000
% 210.03/210.26  |- skos__prefLabel mesh__D014010 Tinea Versicolor
% 210.03/210.26  |- skos__broader mesh__D014010smesh__D003881
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D014010 2001
% 210.03/210.26  |- rdf__type mesh__D014010sskos__Concept
% 210.03/210.26  |- skos__altLabel mesh__D014010 Pityriasis Versicolor
% 210.03/210.26  |- skos__altLabel mesh__D000599 Dibasic Amino Acids
% 210.03/210.26  |- mesh__dateRevised mesh__D000599 1992-05-07
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000599 2001
% 210.03/210.26  |- mesh__dateEstablished mesh__D000599 1974-01-01
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000599 1993
% 210.03/210.26  |- skos__altLabel mesh__D000599 Amino Acids, Dibasic
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000599 2006
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000599 1999
% 210.03/210.26  |- mesh__historyNote mesh__D000599 74   
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000599 2002
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000599 1994
% 210.03/210.26  |- mesh__recordAuthorizer mesh__D000599 PLS
% 210.03/210.26  |- skos__broader mesh__D000599smesh__D000596
% 210.03/210.26  |- mesh__dateCreated mesh__D000599 1999-01-01
% 210.03/210.26  |- skos__hiddenLabel mesh__D000599 Acids, Diamino Amino
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000599 2003
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000599 1996
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000599 1995
% 210.03/210.26  |- skos__prefLabel mesh__D000599 Amino Acids, Diamino
% 210.03/210.26  |- skos__hiddenLabel mesh__D000599 Acids, Dibasic Amino
% 210.03/210.26  |- mesh__recordMaintainer mesh__D000599 TAP
% 210.03/210.26  |- mesh__recordOriginator mesh__D000599 NLM
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000599 2004
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000599 1997
% 210.03/210.26  |- skos__altLabel mesh__D000599 Diamino Amino Acids
% 210.03/210.26  |- rdf__type mesh__D000599sskos__Concept
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000599 2000
% 210.03/210.26  |- mesh__publicMeSHNote mesh__D000599
% 210.03/210.26       74; DIAMINOPIMELIC ACID was see under PIMELIC ACIDS 1975-79%A%  
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000599 2005
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D000599 1998
% 210.03/210.26  |- mesh__recordAuthorizer mesh__D005284 sjn
% 210.03/210.26  |- mesh__publicMeSHNote mesh__D005284 74   
% 210.03/210.26  |- skos__prefLabel mesh__D005284 Fenthion
% 210.03/210.26  |- skos__annotation mesh__D005284 TN 111 for eff on insects   
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D005284 2006
% 210.03/210.26  |- skos__broader mesh__D005284smesh__D009946
% 210.03/210.26  |- skos__historyNote mesh__D005284 Insecticides %28%1966-1971%29%
% 210.03/210.26  |- mesh__recordOriginator mesh__D005284 NLM
% 210.03/210.26  |- skos__scopeNote mesh__D005284
% 210.03/210.26       Potent cholinesterase inhibitor used as an insecticide and acaricide.%A%    
% 210.03/210.26  |- mesh__dateCreated mesh__D005284 1999-01-01
% 210.03/210.26  |- mesh__dateRevised mesh__D005284 2005-06-30
% 210.03/210.26  |- mesh__historyNote mesh__D005284 74%28%72%29%   
% 210.03/210.26  |- mesh__dateEstablished mesh__D005284 1974-01-01
% 210.03/210.26  |- rdf__type mesh__D005284sskos__Concept
% 210.03/210.26  |- mesh__recordMaintainer mesh__D005284 ssb
% 210.03/210.26  |- skos__hiddenLabel mesh__D013716 Humeral Epicondylitides, Lateral
% 210.03/210.26  |- skos__historyNote mesh__D013716 Elbow %28%1966-1981%29%
% 210.03/210.26  |- skos__altLabel mesh__D013716 Epicondylitis, Lateral Humeral
% 210.03/210.26  |- mesh__publicMeSHNote mesh__D013716 82   
% 210.03/210.26  |- mesh__recordAuthorizer mesh__D013716 sjn
% 210.03/210.26  |- skos__broader mesh__D013716smesh__D009140
% 210.03/210.26  |- skos__historyNote mesh__D013716 Sports Medicine %28%1966-1967%29%
% 210.03/210.26  |- mesh__historyNote mesh__D013716 82   
% 210.03/210.26  |- skos__scopeNote mesh__D013716
% 210.03/210.26       A condition characterized by pain in or near the lateral humeral epicondyle or in the forearm extensor muscle mass as a result of unusual strain. It occurs in tennis players as well as housewives, artisans, and violinists.%A%    
% 210.03/210.26  |- skos__hiddenLabel mesh__D013716 Epicondylitides, Lateral Humeral
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013716 2006
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013716 2002
% 210.03/210.26  |- skos__hiddenLabel mesh__D013716 Lateral Humeral Epicondylitides
% 210.03/210.26  |- mesh__dateRevised mesh__D013716 1999-11-03
% 210.03/210.26  |- mesh__dateEstablished mesh__D013716 1982-01-01
% 210.03/210.26  |- skos__annotation mesh__D013716
% 210.03/210.26       in %22%housewives, artisans %26% violinists%22% as well as in tennis players; do not coord with TENNIS %28%NIM%29% unless the sport is particularly discussed; do not coord with ATHLETIC INJURIES %28%IM%29% unless tennis elbow is discussed as an athletic inj%A%  
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013716 2004
% 210.03/210.26  |- rdf__type mesh__D013716sskos__Concept
% 210.03/210.26  |- skos__hiddenLabel mesh__D013716 Tennis Elbows
% 210.03/210.26  |- mesh__recordMaintainer mesh__D013716 jls
% 210.03/210.26  |- skos__historyNote mesh__D013716 Tendinitis %28%1966-1981%29%
% 210.03/210.26  |- mesh__dateCreated mesh__D013716 1981-03-02
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013716 2005
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013716 2003
% 210.03/210.26  |- skos__broader mesh__D013716smesh__D001134
% 210.03/210.26  |- skos__historyNote mesh__D013716 Elbow Joint %28%1966-1981%29%
% 210.03/210.26  |- skos__prefLabel mesh__D013716 Tennis Elbow
% 210.03/210.26  |- skos__historyNote mesh__D013716 Sports %28%1966-1975%29%
% 210.03/210.26  |- skos__historyNote mesh__D013716 Tennis %28%1976-1981%29%
% 210.03/210.26  |- mesh__recordOriginator mesh__D013716 RC
% 210.03/210.26  |- mesh__activeMeSHYear mesh__D013716 2001
% 210.03/210.27  |- skos__historyNote mesh__D013716 Athletic Injuries %28%1968-1981%29%
% 210.03/210.27  |- skos__hiddenLabel mesh__D013716 Elbows, Tennis
% 210.03/210.27  |- skos__hiddenLabel mesh__D013716 Elbow, Tennis
% 210.03/210.27  |- mesh__activeMeSHYear mesh__D013716 2000
% 210.03/210.27  |- skos__hiddenLabel mesh__D013716 Lateral Humeral Epicondylitis
% 210.03/210.27  |- skos__hiddenLabel mesh__D013716 Humeral Epicondylitis, Lateral
% 210.03/210.27  |- skos__hiddenLabel mesh__D018401 Size, Sample
% 210.03/210.27  |- mesh__historyNote mesh__D018401 95   
% 210.03/210.27  |- mesh__dateCreated mesh__D018401 1994-02-28
% 210.03/210.27  |- mesh__activeMeSHYear mesh__D018401 2005
% 210.03/210.27  |- skos__annotation mesh__D018401
% 210.03/210.27       NIM with specific population or circumstances sampled %28%IM%29%; no qualif; not restricted to epidemiology%A%  
% 210.03/210.27  |- skos__broader mesh__D018401smesh__D015340
% 210.03/210.27  |- mesh__activeMeSHYear mesh__D018401 2003
% 210.03/210.27  |- mesh__activeMeSHYear mesh__D018401 2006
% 210.03/210.27  |- skos__broader mesh__D018401smesh__D012107
% 210.03/210.27  |- mesh__recordOriginator mesh__D018401 TGC
% 210.03/210.27  |- skos__hiddenLabel mesh__D018401 Sample Sizes
% 210.03/210.27  |- mesh__activeMeSHYear mesh__D018401 2004
% 210.03/210.27  |- mesh__recordMaintainer mesh__D018401 ags
% 210.03/210.27  |- rdf__type mesh__D018401sskos__Concept
% 210.03/210.27  |- mesh__activeMeSHYear mesh__D018401 2002
% 210.03/210.27  |- mesh__dateRevised mesh__D018401 2001-07-25
% 210.03/210.27  |- mesh__dateEstablished mesh__D018401 1995-01-01
% 210.03/210.27  |- skos__prefLabel mesh__D018401 Sample Size
% 210.03/210.27  |- mesh__publicMeSHNote mesh__D018401 95   
% 210.03/210.27  |- mesh__recordAuthorizer mesh__D018401 sjn
% 210.03/210.27  |- skos__scopeNote mesh__D018401
% 210.03/210.27       The number of units %28%persons, animals, patients, specified circumstances, etc.%29% in a population to be studied. The sample size should be big enough to have a high likelihood of detecting a true difference between two groups. %28%From Wassertheil-Smoller, Biostatistics and Epidemiology, 1990, p95%29%%A%    
% 210.03/210.27  |- skos__hiddenLabel mesh__D018401 Sizes, Sample
% 210.03/210.27  |- rdf__type mesh__D051037sskos__Concept
% 210.03/210.27  |- mesh__dateEstablished mesh__D051037 2006-01-01
% 210.03/210.27  |- skos__broader mesh__D051037smesh__D051036
% 210.03/210.27  |- skos__scopeNote mesh__D051037
% 210.03/210.27       The pore-forming subunits of large-conductance calcium-activated potassium channels. They form tetramers in CELL MEMBRANES.%A%    
% 210.03/210.27  |- mesh__recordAuthorizer mesh__D051037 sjn
% 210.03/210.27  |- skos__prefLabel mesh__D051037
% 210.03/210.27       Large-Conductance Calcium-Activated Potassium Channel alpha Subunits
% 210.03/210.27  |- mesh__publicMeSHNote mesh__D051037
% 210.03/210.27       2006; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNITS was indexed under MEMBRANE PROTEINS 1993-1995, under POTASSIUM CHANNELS 1995-2002, %26% under POTASSIUM CHANNELS, CALCIUM-ACTIVATED 2002-2005%A%  
% 210.03/210.27  |- skos__altLabel mesh__D051037 MaxiK Channel alpha Subunit
% 210.03/210.27  |- mesh__recordOriginator mesh__D051037 DRC
% 210.03/210.27  |- skos__hiddenLabel mesh__D051037
% 210.03/210.27       Large Conductance Calcium Activated Potassium Channel alpha Subunits
% 210.03/210.27  |- mesh__activeMeSHYear mesh__D051037 2006
% 210.03/210.27  |- skos__hiddenLabel mesh__D051037
% 210.03/210.27       Large Conductance Calcium Activated Potassium Channels, alpha Subunit
% 210.03/210.27  |- mesh__dateCreated mesh__D051037 2005-06-30
% 210.03/210.27  |- mesh__historyNote mesh__D051037 2006%28%1993%29%   
% 210.03/210.27  |- skos__altLabel mesh__D051037
% 210.03/210.27       Large-Conductance Calcium-Activated Potassium Channels, alpha Subunit
% 210.03/210.27  |- mesh__recordMaintainer mesh__D051037 DRC
% 210.03/210.27  |- skos__hiddenLabel mesh__D009675 Sodium, Novobiocin
% 210.03/210.27  |- skos__hiddenLabel mesh__D009675 Calcium, Novobiocin
% 210.03/210.27  |- mesh__dateCreated mesh__D009675 1999-01-01
% 210.03/210.27  |- mesh__recordAuthorizer mesh__D009675 sjn
% 210.03/210.27  |- skos__prefLabel mesh__D009675 Novobiocin
% 210.03/210.27  |- skos__altLabel mesh__D009675 Streptonivicin
% 210.03/210.27  |- skos__altLabel mesh__D009675 Crystallinic Acid
% 210.03/210.27  |- skos__altLabel mesh__D009675 Novobiocin, Monosodium Salt
% 210.03/210.27  |- mesh__activeMeSHYear mesh__D009675 2006
% 210.03/210.27  |- skos__hiddenLabel mesh__D009675 Monosodium Salt Novobiocin
% 210.03/210.27  |- skos__scopeNote mesh__D009675
% 210.03/210.27       An antibiotic compound derived from Streptomyces niveus. It has a chemical structure similar to coumarin. Novobiocin binds to DNA gyrase, and blocks adenosine triphosphatase %28%ATPase%29% activity.  %28%From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p189%29%%A%    
% 210.03/210.27  |- mesh__dateRevised mesh__D009675 2005-06-30
% 210.03/210.27  |- rdf__type mesh__D009675sskos__Concept
% 210.03/210.27  |- mesh__recordMaintainer mesh__D009675 ssb
% 210.03/210.27  |- mesh__recordOriginator mesh__D009675 NLM
% 210.03/210.27  |- skos__broader mesh__D009675smesh__D049933
% 210.03/210.27  |- skos__broader mesh__D009675smesh__D006027
% 210.03/210.27  |- skos__related mesh__D001692smesh__D009079
% 210.03/210.27  |- skos__altLabel mesh__D001692 Biologic Transport
% 210.03/210.27  |- skos__altLabel mesh__D001692 Transport, Biological
% 210.03/210.27  |- skos__related mesh__D001692smesh__D026901
% 210.03/210.27  |- mesh__activeMeSHYear mesh__D001692 2004
% 210.03/210.27  |- skos__prefLabel mesh__D001692 Biological Transport
% 210.03/210.27  |- skos__hiddenLabel mesh__D001692 Transport, Biologic
% 210.03/210.27  |- skos__related mesh__D001692smesh__D004058
% 210.03/210.27  |- mesh__activeMeSHYear mesh__D001692 2003
% 210.03/210.27  |- skos__related mesh__D001692smesh__D018892
% 210.03/210.27  |- mesh__historyNote mesh__D001692 66%28%64%29%   
% 210.03/210.27  |- mesh__activeMeSHYear mesh__D001692 2006
% 210.03/210.27  |- skos__broader mesh__D001692smesh__D008660
% 210.03/210.27  |- mesh__activeMeSHYear mesh__D001692 2002
% 210.03/210.27  |- mesh__recordMaintainer mesh__D001692 jmp
% 210.03/210.27  |- mesh__dateCreated mesh__D001692 1999-01-01
% 210.03/210.27  |- mesh__dateEstablished mesh__D001692 1966-01-01
% 210.03/210.27  |- mesh__activeMeSHYear mesh__D001692 2005
% 210.03/210.27  |- mesh__publicMeSHNote mesh__D001692 66   
% 210.03/210.27  |- mesh__recordAuthorizer mesh__D001692 sjn
% 210.03/210.27  |- skos__related mesh__D001692smesh__D008431
% 210.03/210.27  |- mesh__recordOriginator mesh__D001692 NLM
% 210.03/210.27  |- skos__annotation mesh__D001692
% 210.03/210.27       almost never IM; coord NIM with endogenous substance /metab %28%IM%29% or exogenous substance /pharmacokin %28%IM%29%; DF: BIOL TRANSPORT%A%  
% 210.03/210.27  |- mesh__dateRevised mesh__D001692 2001-07-25
% 210.03/210.27  |- rdf__type mesh__D001692sskos__Concept
% 210.03/210.27  |- skos__scopeNote mesh__D001692
% 210.03/210.27       The movement of materials %28%including biochemical substances and drugs%29% through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments.%A%    
% 210.03/210.27  |- skos__related mesh__D001692smesh__D002463
% 210.03/210.27  |- skos__altLabel mesh__D014011 Fasigin
% 210.03/210.27  |- mesh__publicMeSHNote mesh__D014011
% 210.03/210.27       91; was see under NITROIMIDAZOLES 1975-90   
% 210.03/210.27  |- skos__prefLabel mesh__D014011 Tinidazole
% 210.03/210.27  |- skos__scopeNote mesh__D014011
% 210.03/210.27       A nitroimidazole antitrichomonal agent effective against Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia infections.%A%    
% 210.03/210.27  |- mesh__dateEstablished mesh__D014011 1991-01-01
% 210.03/210.27  |- mesh__dateCreated mesh__D014011 1974-11-19
% 210.03/210.27  |- mesh__historyNote mesh__D014011
% 210.03/210.27       91%28%75%29%; was see under NITROIMIDAZOLES 1975-90   
% 210.03/210.27  |- skos__hiddenLabel mesh__D014011 CP12574
% 210.03/210.27  |- skos__altLabel mesh__D014011 Pierre Fabre Brand of Tinidazole
% 210.03/210.27  |- skos__altLabel mesh__D014011 Teofarma Brand of Tinidazole
% 210.13/210.27  |- skos__altLabel mesh__D014011 Farmasierra Brand of Tinidazole
% 210.13/210.27  |- skos__hiddenLabel mesh__D014011 CP12,574
% 210.13/210.27  |- skos__broader mesh__D014011smesh__D009593
% 210.13/210.27  |- rdf__type mesh__D014011sskos__Concept
% 210.13/210.27  |- skos__altLabel mesh__D014011 Simplotan
% 210.13/210.27  |- skos__altLabel mesh__D014011 Pfizer Brand of Tinidazole
% 210.13/210.27  |- mesh__recordAuthorizer mesh__D014011 sjn
% 210.13/210.27  |- skos__historyNote mesh__D014011 Nitroimidazoles %28%1971-1974%29%
% 210.13/210.27  |- skos__historyNote mesh__D014011 Sulfones %28%1971-1974%29%
% 210.13/210.27  |- mesh__dateRevised mesh__D014011 2005-06-30
% 210.13/210.27  |- skos__altLabel mesh__D014011 Fasigyne
% 210.13/210.27  |- skos__altLabel mesh__D014011 Fasygin
% 210.13/210.27  |- mesh__recordMaintainer mesh__D014011 ssb
% 210.13/210.27  |- skos__hiddenLabel mesh__D014011 CP 12,574
% 210.13/210.27  |- skos__altLabel mesh__D014011 CP-12574
% 210.13/210.27  |- skos__hiddenLabel mesh__D014011 CP 12574
% 210.13/210.27  |- mesh__recordOriginator mesh__D014011 NLM
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D014011 2006
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D005285 2006
% 210.13/210.27  |- mesh__dateCreated mesh__D005285 1999-01-01
% 210.13/210.27  |- skos__prefLabel mesh__D005285 Fermentation
% 210.13/210.27  |- mesh__recordAuthorizer mesh__D005285 sjn
% 210.13/210.27  |- skos__broader mesh__D005285smesh__D001669
% 210.13/210.27  |- skos__broader mesh__D005285smesh__D050260
% 210.13/210.27  |- mesh__recordOriginator mesh__D005285 NLM
% 210.13/210.27  |- rdf__type mesh__D005285sskos__Concept
% 210.13/210.27  |- skos__scopeNote mesh__D005285
% 210.13/210.27       Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID.%A%    
% 210.13/210.27  |- mesh__recordMaintainer mesh__D005285 lkt
% 210.13/210.27  |- mesh__dateRevised mesh__D005285 2005-06-30
% 210.13/210.27  |- skos__hiddenLabel mesh__D005285 Fermentations
% 210.13/210.27  |- skos__prefLabel mesh__D013717 Tenosynovitis
% 210.13/210.27  |- mesh__dateRevised mesh__D013717 2005-06-30
% 210.13/210.27  |- mesh__recordOriginator mesh__D013717 NLM
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D013717 2006
% 210.13/210.27  |- skos__annotation mesh__D013717
% 210.13/210.27       inflamm of a tendon sheath: do not confuse with TENDINITIS %28%inflamm of tendon%29% or SYNOVITIS %28%inflamm of synovial membrane%29%; do not confuse X ref DE QUERVAIN DISEASE with de Quervain%27%s dis of thyroid %28% = DE QUERVAIN THYROIDITIS see THYROIDITIS, SUBACUTE%29%%A%  
% 210.13/210.27  |- skos__hiddenLabel mesh__D013717 Disease, De Quervain
% 210.13/210.27  |- rdf__type mesh__D013717sskos__Concept
% 210.13/210.27  |- mesh__recordAuthorizer mesh__D013717 sjn
% 210.13/210.27  |- skos__scopeNote mesh__D013717
% 210.13/210.27       Inflammation of a tendon sheath. Causes include trauma, tendon stress, bacterial disease %28%gonorrhea, tuberculosis%29%, rheumatic disease, and gout. Common sites are the shoulder capsule, hip capsule, hamstring muscles, and Achilles tendon. The tendon sheaths become inflamed and painful, and accumulate fluid. Joint mobility is usually reduced. Friction rubs may be felt or heard %28%with a stethoscope%29% on movement. Calcium deposits may occur in the tendon and its sheath, leading to opacities on radiographs of the affected area. %28%Saunders Dictionary %26% Encyclopedia of Laboratory Medicine and Technology, 1984%29%%A%    
% 210.13/210.27  |- skos__hiddenLabel mesh__D013717 Quervain Disease, De
% 210.13/210.27  |- skos__hiddenLabel mesh__D013717 Tenosynovitides
% 210.13/210.27  |- mesh__dateCreated mesh__D013717 1999-01-01
% 210.13/210.27  |- mesh__recordMaintainer mesh__D013717 ags
% 210.13/210.27  |- skos__broader mesh__D013717smesh__D052256
% 210.13/210.27  |- skos__annotation mesh__D018402
% 210.13/210.27       a genus of moth; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111%A%  
% 210.13/210.27  |- mesh__recordAuthorizer mesh__D018402 sjn
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D018402 2006
% 210.13/210.27  |- skos__historyNote mesh__D018402 Moths %28%1975-1994%29%
% 210.13/210.27  |- skos__broader mesh__D018402smesh__D009036
% 210.13/210.27  |- skos__historyNote mesh__D018402 Lepidoptera %28%1975-1994%29%
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D018402 2004
% 210.13/210.27  |- mesh__recordMaintainer mesh__D018402 ags
% 210.13/210.27  |- rdf__type mesh__D018402sskos__Concept
% 210.13/210.27  |- skos__altLabel mesh__D018402 Manduca sexta
% 210.13/210.27  |- skos__historyNote mesh__D018402 Insects %28%1967-1974%29%
% 210.13/210.27  |- mesh__dateCreated mesh__D018402 1994-01-25
% 210.13/210.27  |- skos__prefLabel mesh__D018402 Manduca
% 210.13/210.27  |- mesh__recordOriginator mesh__D018402 PXP
% 210.13/210.27  |- mesh__historyNote mesh__D018402 95   
% 210.13/210.27  |- mesh__dateEstablished mesh__D018402 1995-01-01
% 210.13/210.27  |- skos__scopeNote mesh__D018402
% 210.13/210.27       A genus of sphinx or hawk moths of the family Sphingidae. These insects are used in molecular biology studies during all stages of their life cycle.%A%    
% 210.13/210.27  |- mesh__dateRevised mesh__D018402 2003-07-09
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D018402 2005
% 210.13/210.27  |- mesh__publicMeSHNote mesh__D018402 95   
% 210.13/210.27  |- skos__altLabel mesh__D051836 COUP-TF Proteins
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D051836 2006
% 210.13/210.27  |- skos__broader mesh__D051836smesh__D004268
% 210.13/210.27  |- skos__broader mesh__D051836smesh__D011987
% 210.13/210.27  |- mesh__recordOriginator mesh__D051836 DRC
% 210.13/210.27  |- rdf__type mesh__D051836sskos__Concept
% 210.13/210.27  |- skos__altLabel mesh__D051836
% 210.13/210.27       Chicken Ovalbumin Upstream Promoter-Transcription Factors
% 210.13/210.27  |- mesh__recordAuthorizer mesh__D051836 sjn
% 210.13/210.27  |- mesh__dateEstablished mesh__D051836 2006-01-01
% 210.13/210.27  |- skos__hiddenLabel mesh__D051836 Transcription Factors, COUP
% 210.13/210.27  |- mesh__recordMaintainer mesh__D051836 DRC
% 210.13/210.27  |- mesh__historyNote mesh__D051836 2006%28%1991%29%   
% 210.13/210.27  |- skos__prefLabel mesh__D051836 COUP Transcription Factors
% 210.13/210.27  |- skos__hiddenLabel mesh__D051836
% 210.13/210.27       Chicken Ovalbumin Upstream Promoter Transcription Factors
% 210.13/210.27  |- mesh__dateCreated mesh__D051836 2005-06-30
% 210.13/210.27  |- skos__scopeNote mesh__D051836
% 210.13/210.27       A sub-family of steroid receptor transcription factors with specificity for a variety of DNA sequences related to AGGTCA. They can heterodimerize with a variety of factors including RETINOIC ACID RECEPTORS; THYROID HORMONE RECEPTORS; and VITAMIN D RECEPTORS.%A%    
% 210.13/210.27  |- skos__hiddenLabel mesh__D051836 COUP TF Proteins
% 210.13/210.27  |- mesh__publicMeSHNote mesh__D051836
% 210.13/210.27       2006; CHICKEN OVALBUMIN UPSTREAM PROMOTER-TRANSCRIPTION FACTORS was indexed under DNA-BINDING PROTEINS %26% RECEPTORS, STEROID %26% TRANSCRIPTION FACTORS 1991-2005, %26% under REPRESSOR PROTEINS 1991-2004%A%  
% 210.13/210.27  |- mesh__recordMaintainer mesh__D051038 DRC
% 210.13/210.27  |- skos__broader mesh__D051038smesh__D051036
% 210.13/210.27  |- rdf__type mesh__D051038sskos__Concept
% 210.13/210.27  |- mesh__recordOriginator mesh__D051038 DRC
% 210.13/210.27  |- skos__altLabel mesh__D051038 MaxiK Channel beta Subunits
% 210.13/210.27  |- skos__hiddenLabel mesh__D051038
% 210.13/210.27       Large Conductance Calcium Activated Potassium Channels, beta Subunits
% 210.13/210.27  |- skos__scopeNote mesh__D051038
% 210.13/210.27       The regulatory subunits of large-conductance calcium-activated potassium channels.%A%    
% 210.13/210.27  |- skos__prefLabel mesh__D051038
% 210.13/210.27       Large-Conductance Calcium-Activated Potassium Channel beta Subunits
% 210.13/210.27  |- mesh__dateEstablished mesh__D051038 2006-01-01
% 210.13/210.27  |- mesh__recordAuthorizer mesh__D051038 sjn
% 210.13/210.27  |- mesh__dateCreated mesh__D051038 2005-06-30
% 210.13/210.27  |- mesh__historyNote mesh__D051038 2006%28%1993%29%   
% 210.13/210.27  |- mesh__publicMeSHNote mesh__D051038
% 210.13/210.27       2006; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL BETA SUBUNITS was indexed under MEMBRANE PROTEINS 1993-1995, under POTASSIUM CHANNELS 1995-2002, %26% under POTASSIUM CHANNELS, CALCIUM ACTIVATED 2002-2005%A%  
% 210.13/210.27  |- skos__altLabel mesh__D051038
% 210.13/210.27       Large-Conductance Calcium-Activated Potassium Channels, beta Subunits
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D051038 2006
% 210.13/210.27  |- skos__hiddenLabel mesh__D051038
% 210.13/210.27       Large Conductance Calcium Activated Potassium Channel beta Subunits
% 210.13/210.27  |- rdf__type mesh__D009676sskos__Concept
% 210.13/210.27  |- mesh__historyNote mesh__D009676 98; use explode 1974-97   
% 210.13/210.27  |- skos__prefLabel mesh__D009676 Noxae
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D009676 2004
% 210.13/210.27  |- skos__scopeNote mesh__D009676
% 210.13/210.27       Agents capable of exerting a harmful effect on the body.%A%    
% 210.13/210.27  |- mesh__dateRevised mesh__D009676 2003-07-09
% 210.13/210.27  |- mesh__recordOriginator mesh__D009676 NLM
% 210.13/210.27  |- mesh__recordAuthorizer mesh__D009676 sjn
% 210.13/210.27  |- mesh__dateEstablished mesh__D009676 1998-01-01
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D009676 2006
% 210.13/210.27  |- skos__annotation mesh__D009676 GEN or unspecified; prefer specifics   
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D009676 2005
% 210.13/210.27  |- skos__broader mesh__D009676smesh__D004786
% 210.13/210.27  |- mesh__publicMeSHNote mesh__D009676 98   
% 210.13/210.27  |- mesh__dateCreated mesh__D009676 1999-01-01
% 210.13/210.27  |- mesh__recordMaintainer mesh__D009676 ssb
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D001693 2004
% 210.13/210.27  |- mesh__recordOriginator mesh__D001693 NLM
% 210.13/210.27  |- skos__hiddenLabel mesh__D001693 Transport, Active
% 210.13/210.27  |- mesh__dateRevised mesh__D001693 2001-07-25
% 210.13/210.27  |- skos__hiddenLabel mesh__D001693 Transport, Active Biologic
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D001693 2003
% 210.13/210.27  |- mesh__historyNote mesh__D001693 66   
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D001693 2006
% 210.13/210.27  |- skos__altLabel mesh__D001693 Biologic Transport, Active
% 210.13/210.27  |- skos__broader mesh__D001693smesh__D001692
% 210.13/210.27  |- mesh__dateCreated mesh__D001693 1999-01-01
% 210.13/210.27  |- mesh__recordMaintainer mesh__D001693 jmp
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D001693 2005
% 210.13/210.27  |- mesh__publicMeSHNote mesh__D001693 66   
% 210.13/210.27  |- skos__annotation mesh__D001693
% 210.13/210.27       almost never IM; coord with endogenous substance /metab %28%IM%29% or exogenous substance /pharmacokin %28%IM%29%; DF: BIOL TRANSPORT ACTIVE%A%  
% 210.13/210.27  |- skos__hiddenLabel mesh__D001693 Transport, Uphill
% 210.13/210.27  |- rdf__type mesh__D001693sskos__Concept
% 210.13/210.27  |- skos__scopeNote mesh__D001693
% 210.13/210.27       The movement of materials across cell membranes and epithelial layers against an electrochemical gradient, requiring the expenditure of metabolic energy.%A%    
% 210.13/210.27  |- skos__altLabel mesh__D001693 Transport, Active Biological
% 210.13/210.27  |- skos__prefLabel mesh__D001693 Biological Transport, Active
% 210.13/210.27  |- skos__hiddenLabel mesh__D001693 Active Biologic Transport
% 210.13/210.27  |- skos__altLabel mesh__D001693 Active Transport
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D001693 2002
% 210.13/210.27  |- mesh__dateEstablished mesh__D001693 1966-01-01
% 210.13/210.27  |- skos__related mesh__D001693smesh__D016623
% 210.13/210.27  |- skos__altLabel mesh__D001693 Uphill Transport
% 210.13/210.27  |- skos__altLabel mesh__D001693 Active Biological Transport
% 210.13/210.27  |- mesh__recordAuthorizer mesh__D001693 sjn
% 210.13/210.27  |- skos__scopeNote mesh__D042501
% 210.13/210.27       Intercellular signaling peptides and proteins that regulate the proliferation of new blood vessels under normal physiological conditions %28%ANGIOGENESIS, PHYSIOLOGICAL%29%. Aberrant expression of angiogenic proteins during disease states such as tumorigenesis can also result in PATHOLOGICAL ANGIOGENESIS.%A%    
% 210.13/210.27  |- skos__prefLabel mesh__D042501 Angiogenic Proteins
% 210.13/210.27  |- skos__broader mesh__D042501smesh__D036341
% 210.13/210.27  |- rdf__type mesh__D042501sskos__Concept
% 210.13/210.27  |- mesh__recordAuthorizer mesh__D042501 sjn
% 210.13/210.27  |- mesh__recordMaintainer mesh__D042501 ssb
% 210.13/210.27  |- mesh__publicMeSHNote mesh__D042501 2004   
% 210.13/210.27  |- mesh__dateCreated mesh__D042501 2003-07-09
% 210.13/210.27  |- mesh__dateEstablished mesh__D042501 2004-01-01
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D042501 2006
% 210.13/210.27  |- mesh__dateRevised mesh__D042501 2005-06-30
% 210.13/210.27  |- skos__historyNote mesh__D042501
% 210.13/210.27       Angiogenesis Modulating Agents %28%1973-2003%29%
% 210.13/210.27  |- mesh__historyNote mesh__D042501 2004   
% 210.13/210.27  |- mesh__recordOriginator mesh__D042501 jmp
% 210.13/210.27  |- rdf__type mesh__D014810sskos__Concept
% 210.13/210.27  |- skos__broader mesh__D014810smesh__D001578
% 210.13/210.27  |- mesh__recordMaintainer mesh__D014810 ssb
% 210.13/210.27  |- skos__scopeNote mesh__D014810
% 210.13/210.27       A generic descriptor for all TOCOPHEROLS and TOCOTRIENOLS that exhibit ALPHA-TOCOPHEROL activity. By virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus, these compounds exhibit varying degree of antioxidant activity, depending on the site and number of methyl groups and the type of ISOPRENOIDS.%A%    
% 210.13/210.27  |- skos__prefLabel mesh__D014810 Vitamin E
% 210.13/210.27  |- skos__annotation mesh__D014810
% 210.13/210.27       /ther use: coordinate disease with /drug ther, not /diet ther%A%  
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D014810 2006
% 210.13/210.27  |- mesh__dateCreated mesh__D014810 1999-01-01
% 210.13/210.27  |- mesh__dateRevised mesh__D014810 2005-06-30
% 210.13/210.27  |- mesh__recordOriginator mesh__D014810 NLM
% 210.13/210.27  |- mesh__recordAuthorizer mesh__D014810 sjn
% 210.13/210.27  |- skos__broader mesh__D014012smesh__D006311
% 210.13/210.27  |- mesh__dateRevised mesh__D014012 2004-07-07
% 210.13/210.27  |- skos__hiddenLabel mesh__D014012
% 210.13/210.27       Spontaneous Oto Acoustic Emission Tinnitus
% 210.13/210.27  |- mesh__recordOriginator mesh__D014012 NLM
% 210.13/210.27  |- rdf__type mesh__D014012sskos__Concept
% 210.13/210.27  |- skos__altLabel mesh__D014012 Tensor Palatini Induced Tinnitus
% 210.13/210.27  |- skos__altLabel mesh__D014012 Tinnitus, Leudet%27%s
% 210.13/210.27  |- skos__hiddenLabel mesh__D014012 Induced Tinnitus, Noise
% 210.13/210.27  |- skos__altLabel mesh__D014012 Ringing-Buzzing-Tinnitus
% 210.13/210.27  |- skos__hiddenLabel mesh__D014012 Subjective Tinnitus
% 210.13/210.27  |- skos__hiddenLabel mesh__D014012 Tinnitus, Vascular Origin
% 210.13/210.27  |- skos__hiddenLabel mesh__D014012 Clicking Tinnitus
% 210.13/210.27  |- skos__altLabel mesh__D014012 Vascular Origin Tinnitus
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D014012 2005
% 210.13/210.27  |- skos__scopeNote mesh__D014012
% 210.13/210.27       A nonspecific symptom of hearing disorder characterized by the sensation of buzzing, ringing, clicking, pulsations, and other noises in the ear. Objective tinnitus refers to noises generated from within the ear or adjacent structures that can be heard by other individuals. The term subjective tinnitus is used when the sound is audible only to the affected individual. Tinnitus may occur as a manifestation of COCHLEAR DISEASES; VESTIBULOCOCHLEAR NERVE DISEASES; INTRACRANIAL HYPERTENSION; CRANIOCEREBRAL TRAUMA; and other conditions.%A%    
% 210.13/210.27  |- skos__hiddenLabel mesh__D014012 Ringing Buzzing Tinnitus
% 210.13/210.27  |- skos__hiddenLabel mesh__D014012 Tinnitus, Pulsatile
% 210.13/210.27  |- skos__hiddenLabel mesh__D014012
% 210.13/210.27       Tinnitus, Spontaneous Oto Acoustic Emission
% 210.13/210.27  |- skos__hiddenLabel mesh__D014012 Tinnitus, Leudets
% 210.13/210.27  |- mesh__recordAuthorizer mesh__D014012 sjn
% 210.13/210.27  |- skos__hiddenLabel mesh__D014012 Leudet Tinnitus
% 210.13/210.27  |- skos__altLabel mesh__D014012 Tensor Tympani Induced Tinnitus
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D014012 2006
% 210.13/210.27  |- skos__altLabel mesh__D014012 Spontaneous Oto-Acoustic Emission Tinnitus
% 210.13/210.27  |- mesh__recordMaintainer mesh__D014012 lkt
% 210.13/210.27  |- skos__hiddenLabel mesh__D014012 Noise Induced Tinnitus
% 210.13/210.27  |- skos__hiddenLabel mesh__D014012 Leudet%27%s Tinnitus
% 210.13/210.27  |- skos__prefLabel mesh__D014012 Tinnitus
% 210.13/210.27  |- skos__hiddenLabel mesh__D014012 Objective Tinnitus
% 210.13/210.27  |- mesh__dateCreated mesh__D014012 1999-01-01
% 210.13/210.27  |- mesh__dateRevised mesh__D005286 2005-06-30
% 210.13/210.27  |- mesh__recordMaintainer mesh__D005286 jmp
% 210.13/210.27  |- skos__scopeNote mesh__D005286
% 210.13/210.27       Fermium. A man-made radioactive actinide with atomic symbol Fm, atomic number 100, and atomic weight 257. Its known isotopes range from 244-254 and 256-258. Its valence can be +2 or +3. Like einsteinium, it was discovered in 1952 in the debris from a thermonuclear explosion.%A%    
% 210.13/210.27  |- rdf__type mesh__D005286sskos__Concept
% 210.13/210.27  |- skos__broader mesh__D005286smesh__D019216
% 210.13/210.27  |- skos__annotation mesh__D005286 man-made radioactive element; IM   
% 210.13/210.27  |- mesh__recordAuthorizer mesh__D005286 sjn
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D005286 2006
% 210.13/210.27  |- skos__prefLabel mesh__D005286 Fermium
% 210.13/210.27  |- mesh__dateCreated mesh__D005286 1999-01-01
% 210.13/210.27  |- mesh__recordOriginator mesh__D005286 NLM
% 210.13/210.27  |- skos__broader mesh__D005286smesh__D008671
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D013718 2006
% 210.13/210.27  |- skos__historyNote mesh__D013718 Elasticity %28%1967-1976%29%
% 210.13/210.27  |- skos__hiddenLabel mesh__D013718 Strength, Tensile
% 210.13/210.27  |- rdf__type mesh__D013718sskos__Concept
% 210.13/210.27  |- skos__historyNote mesh__D013718 Biomechanics %28%1968-1976%29%
% 210.13/210.27  |- mesh__recordOriginator mesh__D013718 VDK
% 210.13/210.27  |- mesh__dateEstablished mesh__D013718 1977-01-01
% 210.13/210.27  |- mesh__recordMaintainer mesh__D013718 lkt
% 210.13/210.27  |- skos__broader mesh__D013718smesh__D019563
% 210.13/210.27  |- skos__broader mesh__D013718smesh__D001696
% 210.13/210.27  |- skos__annotation mesh__D013718
% 210.13/210.27       NIM; do not confuse with COMPRESSIVE STRENGTH   
% 210.13/210.27  |- mesh__historyNote mesh__D013718 77   
% 210.13/210.27  |- skos__scopeNote mesh__D013718
% 210.13/210.27       The maximum stress a material subjected to a stretching load can withstand without tearing. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed, p2001%29%%A%    
% 210.13/210.27  |- mesh__dateCreated mesh__D013718 1976-04-16
% 210.13/210.27  |- mesh__dateRevised mesh__D013718 2004-07-07
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D013718 2005
% 210.13/210.27  |- skos__prefLabel mesh__D013718 Tensile Strength
% 210.13/210.27  |- mesh__recordAuthorizer mesh__D013718 sjn
% 210.13/210.27  |- mesh__publicMeSHNote mesh__D013718 77   
% 210.13/210.27  |- skos__hiddenLabel mesh__D013718 Strengths, Tensile
% 210.13/210.27  |- skos__historyNote mesh__D013718 Stress, Mechanical %28%1973-1976%29%
% 210.13/210.27  |- skos__hiddenLabel mesh__D013718 Tensile Strengths
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D010420 1998
% 210.13/210.27  |- mesh__recordAuthorizer mesh__D010420 SJN
% 210.13/210.27  |- skos__prefLabel mesh__D010420 Pentanes
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D010420 2006
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D010420 1999
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D010420 2002
% 210.13/210.27  |- skos__scopeNote mesh__D010420
% 210.13/210.27       Five-carbon saturated hydrocarbon group of the methane series. Include isomers and derivatives.%A%    
% 210.13/210.27  |- mesh__recordOriginator mesh__D010420 RLS
% 210.13/210.27  |- mesh__dateEstablished mesh__D010420 1978-01-01
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D010420 2003
% 210.13/210.27  |- mesh__recordMaintainer mesh__D010420 TGC
% 210.13/210.27  |- skos__historyNote mesh__D010420 Hydrocarbons %28%1966-1977%29%
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D010420 2004
% 210.13/210.27  |- mesh__dateCreated mesh__D010420 1977-05-20
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D010420 2000
% 210.13/210.27  |- skos__broader mesh__D010420smesh__D000473
% 210.13/210.27  |- rdf__type mesh__D010420sskos__Concept
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D010420 2001
% 210.13/210.27  |- mesh__historyNote mesh__D010420 78   
% 210.13/210.27  |- mesh__dateRevised mesh__D010420 1997-06-20
% 210.13/210.27  |- skos__historyNote mesh__D010420 Alkanes %28%1966-1977%29%
% 210.13/210.27  |- skos__annotation mesh__D010420 CYCLOPENTANES is also available   
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D010420 2005
% 210.13/210.27  |- mesh__publicMeSHNote mesh__D010420 78   
% 210.13/210.27  |- skos__broader mesh__D051837smesh__D051836
% 210.13/210.27  |- mesh__recordMaintainer mesh__D051837 ags
% 210.13/210.27  |- rdf__type mesh__D051837sskos__Concept
% 210.13/210.27  |- skos__prefLabel mesh__D051837 COUP Transcription Factor II
% 210.13/210.27  |- mesh__recordOriginator mesh__D051837 DRC
% 210.13/210.27  |- mesh__recordAuthorizer mesh__D051837 ags
% 210.13/210.27  |- skos__altLabel mesh__D051837 ApoAI Regulatory Protein-1
% 210.13/210.27  |- skos__hiddenLabel mesh__D051837
% 210.13/210.27       Chicken Ovalbumin Upstream Promoter Transcription Factor II
% 210.13/210.27  |- mesh__dateEstablished mesh__D051837 2006-01-01
% 210.13/210.27  |- skos__hiddenLabel mesh__D051837 ApoAI Regulatory Protein 1
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D051837 2006A
% 210.13/210.27  |- skos__broader mesh__D051837smesh__D012097
% 210.13/210.27  |- skos__scopeNote mesh__D051837
% 210.13/210.27       A COUP transcription factor that plays a role as a negative regulator of GENETIC TRANSCRIPTION that competes with other hormone receptors for the common response element AGGTCA. It can also stimulate transcription of genes involved in the METABOLISM of GLUCOSE and CHOLESTEROL.%A%    
% 210.13/210.27  |- mesh__dateRevised mesh__D051837 2005-08-03
% 210.13/210.27  |- mesh__activeMeSHYear mesh__D051837 2006
% 210.13/210.27  |- mesh__historyNote mesh__D051837 2006%28%1991%29%   
% 210.13/210.27  |- mesh__dateCreated mesh__D051837 2005-06-30
% 210.13/210.27  |- mesh__publicMeSHNote mesh__D051837
% 210.13/210.27       2006; CHICKEN OVALBUMIN UPSTREAM PROMOTER-TRANSCRIPTION FACTOR II was indexed under DNA-BINDING PROTEINS %26% RECEPTORS, STEROID %26% TRANSCRIPTION FACTORS 1991-2005, %26% under REPRESSOR PROTEINS 1991-2004%A%  
% 210.13/210.27  |- skos__altLabel mesh__D051837 COUP-TFII Protein
% 210.13/210.27  |- skos__hiddenLabel mesh__D051837 COUP TFII Protein
% 210.13/210.27  |- skos__altLabel mesh__D051837 Apolipoprotein AI Regulatory Protein 1
% 210.13/210.27  |- skos__altLabel mesh__D051837
% 210.13/210.27       Chicken Ovalbumin Upstream Promoter-Transcription Factor II
% 210.13/210.27  |- rdf__type mesh__D051039sskos__Concept
% 210.13/210.27  |- skos__annotation mesh__D051039
% 210.13/210.27       diseases: coordinate IM with MONKEY DISEASES %28%IM%29%   
% 210.13/210.27  |- skos__hiddenLabel mesh__D051039 Golden Tamarin
% 210.13/210.27  |- skos__historyNote mesh__D051039 Callitrichidae %28%1977-2005%29%
% 210.13/210.27  |- skos__altLabel mesh__D051039 Leontideus
% 210.13/210.27  |- skos__prefLabel mesh__D051039 Leontopithecus
% 210.13/210.27  |- mesh__historyNote mesh__D051039 2006; use CALLITRICHIDAE 1990-2005   
% 210.13/210.27  |- mesh__recordOriginator mesh__D051039 ags
% 210.13/210.27  |- skos__hiddenLabel mesh__D051039 Golden Tamarins
% 210.13/210.27  |- skos__hiddenLabel mesh__D051039 Tamarins, Golden
% 210.13/210.27  |- skos__scopeNote mesh__D051039
% 210.13/210.27       The genus of lion tamarins in the family CALLITRICHIDAE. The common name refers to the mane on the shoulders.%A%    
% 210.13/210.28  |- mesh__publicMeSHNote mesh__D051039 2006; see CALLITRICHINAE 1990-2005   
% 210.13/210.28  |- skos__hiddenLabel mesh__D051039 Tamarins, Lion
% 210.13/210.28  |- skos__hiddenLabel mesh__D051039 Lion Tamarins
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D051039 2006
% 210.13/210.28  |- skos__altLabel mesh__D051039 Tamarin, Golden
% 210.13/210.28  |- mesh__recordMaintainer mesh__D051039 ags
% 210.13/210.28  |- skos__broader mesh__D051039smesh__D002143
% 210.13/210.28  |- mesh__dateEstablished mesh__D051039 2006-01-01
% 210.13/210.28  |- mesh__recordAuthorizer mesh__D051039 sjn
% 210.13/210.28  |- mesh__dateCreated mesh__D051039 2005-06-30
% 210.13/210.28  |- skos__hiddenLabel mesh__D051039 Lion Tamarin
% 210.13/210.28  |- skos__altLabel mesh__D051039 Tamarin, Lion
% 210.13/210.28  |- skos__scopeNote mesh__D048090
% 210.13/210.28       A multifactorial disease of CATTLE resulting from complex interactions between environmental factors, host factors, and pathogens. The environmental factors act as stressors adversely affecting the IMMUNE SYSTEM and other host defenses and enhancing transmission of infecting agents.%A%    
% 210.13/210.28  |- mesh__recordMaintainer mesh__D048090 ags
% 210.13/210.28  |- mesh__recordOriginator mesh__D048090 ags
% 210.13/210.28  |- mesh__recordAuthorizer mesh__D048090 sjn
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D048090 2005
% 210.13/210.28  |- mesh__dateEstablished mesh__D048090 2005-01-01
% 210.13/210.28  |- rdf__type mesh__D048090sskos__Concept
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D048090 2006
% 210.13/210.28  |- mesh__dateCreated mesh__D048090 2004-07-19
% 210.13/210.28  |- skos__prefLabel mesh__D048090 Bovine Respiratory Disease Complex
% 210.13/210.28  |- skos__broader mesh__D048090smesh__D002418
% 210.13/210.28  |- mesh__historyNote mesh__D048090 2005   
% 210.13/210.28  |- mesh__publicMeSHNote mesh__D048090 2005   
% 210.13/210.28  |- skos__broader mesh__D048090smesh__D012141
% 210.13/210.28  |- skos__historyNote mesh__D048090
% 210.13/210.28       Respiratory Tract Infections %28%1972-2004%29%
% 210.13/210.28  |- mesh__dateCreated mesh__D009677 1975-07-21
% 210.13/210.28  |- mesh__recordOriginator mesh__D009677 SH
% 210.13/210.28  |- mesh__dateEstablished mesh__D009677 1991-01-01
% 210.13/210.28  |- mesh__dateRevised mesh__D009677 2000-06-22
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D009677 2003
% 210.13/210.28  |- mesh__publicMeSHNote mesh__D009677 91; was see under THIOUREA 1976-90   
% 210.13/210.28  |- skos__broader mesh__D009677smesh__D013890
% 210.13/210.28  |- skos__historyNote mesh__D009677
% 210.13/210.28       Thiourea %28%1974%29% /analogs %26% derivatives %28%1975%29%
% 210.13/210.28  |- skos__altLabel mesh__D009677 Noxytiolin
% 210.13/210.28  |- skos__prefLabel mesh__D009677 Noxythiolin
% 210.13/210.28  |- skos__altLabel mesh__D009677 Noxitiolin
% 210.13/210.28  |- skos__hiddenLabel mesh__D009677 NoxyflexS
% 210.13/210.28  |- skos__hiddenLabel mesh__D009677 Noxyflex S
% 210.13/210.28  |- skos__altLabel mesh__D009677
% 210.13/210.28       N-Methyl-N%27%%27%-%28%hydroxymethyl%29%thiourea
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D009677 2006
% 210.13/210.28  |- skos__scopeNote mesh__D009677
% 210.13/210.28       Local antibacterial that probably acts by releasing formaldehyde in aqueous solutions. It is used for irrigation of infected body cavities - bladder, peritoneum, etc. and as a spray for burns.%A%    
% 210.13/210.28  |- skos__altLabel mesh__D009677 Noxitiolinum
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D009677 2005
% 210.13/210.28  |- mesh__recordAuthorizer mesh__D009677 sjn
% 210.13/210.28  |- skos__historyNote mesh__D009677
% 210.13/210.28       Alcohol, Methyl %28%1974%29% /analogs %26% derivatives %28%1975%29%
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D009677 2002
% 210.13/210.28  |- mesh__historyNote mesh__D009677
% 210.13/210.28       91%28%76%29%; was see under THIOUREA 1976-90   
% 210.13/210.28  |- mesh__recordMaintainer mesh__D009677 CCR
% 210.13/210.28  |- rdf__type mesh__D009677sskos__Concept
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D009677 2004
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D009677 2001
% 210.13/210.28  |- mesh__dateCreated mesh__D001694 1999-01-01
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D001694 2005
% 210.13/210.28  |- skos__broader mesh__D001694smesh__D014857
% 210.13/210.28  |- mesh__recordMaintainer mesh__D001694 ags
% 210.13/210.28  |- skos__annotation mesh__D001694 DF: BIOL WARFARE   
% 210.13/210.28  |- skos__altLabel mesh__D001694 Warfare, Bacterial
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D001694 2002
% 210.13/210.28  |- rdf__type mesh__D001694sskos__Concept
% 210.13/210.28  |- mesh__historyNote mesh__D001694
% 210.13/210.28       BACTERIAL WARFARE was see under BIOLOGICAL WARFARE 1963-78%A%  
% 210.13/210.28  |- mesh__recordAuthorizer mesh__D001694 sjn
% 210.13/210.28  |- skos__altLabel mesh__D001694 Warfare, Biological
% 210.13/210.28  |- skos__hiddenLabel mesh__D001694 Warfare, Biologic
% 210.13/210.28  |- mesh__recordOriginator mesh__D001694 NLM
% 210.13/210.28  |- mesh__onlineNote mesh__D001694
% 210.13/210.28       use BIOLOGICAL WARFARE to search BACTERIAL WARFARE 1966-78%A%  
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D001694 2004
% 210.13/210.28  |- skos__prefLabel mesh__D001694 Biological Warfare
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D001694 2001
% 210.13/210.28  |- skos__scopeNote mesh__D001694
% 210.13/210.28       Warfare involving the use of living organisms or their products as disease etiologic agents against people, animals, or plants.%A%    
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D001694 2003
% 210.13/210.28  |- skos__related mesh__D001694smesh__D014754
% 210.13/210.28  |- skos__altLabel mesh__D001694 Biologic Warfare
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D001694 2006
% 210.13/210.28  |- mesh__dateRevised mesh__D001694 2000-06-22
% 210.13/210.28  |- mesh__publicMeSHNote mesh__D042502 2004   
% 210.13/210.28  |- mesh__dateRevised mesh__D042502 2005-06-30
% 210.13/210.28  |- mesh__dateCreated mesh__D042502 2003-07-09
% 210.13/210.28  |- skos__scopeNote mesh__D042502
% 210.13/210.28       A genus of chemoorganotrophic, gram negative rods, in the family ALCALIGENACEAE. They are pathogenic parasites of HORSES.%A%    
% 210.13/210.28  |- mesh__historyNote mesh__D042502 2004   
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D042502 2006
% 210.13/210.28  |- skos__prefLabel mesh__D042502 Taylorella
% 210.13/210.28  |- mesh__recordMaintainer mesh__D042502 SYSTEM
% 210.13/210.28  |- skos__broader mesh__D042502smesh__D042401
% 210.13/210.28  |- mesh__recordOriginator mesh__D042502 ags
% 210.13/210.28  |- skos__annotation mesh__D042502
% 210.13/210.28       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 210.13/210.28  |- mesh__recordAuthorizer mesh__D042502 sjn
% 210.13/210.28  |- mesh__dateEstablished mesh__D042502 2004-01-01
% 210.13/210.28  |- rdf__type mesh__D042502sskos__Concept
% 210.13/210.28  |- mesh__publicMeSHNote mesh__D020050
% 210.13/210.28       99; for MANTIDS %26% PRAYING MANTIS see ORTHOPTERA 1986-98   
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D020050 2005
% 210.13/210.28  |- skos__altLabel mesh__D020050 Mantids
% 210.13/210.28  |- skos__annotation mesh__D020050
% 210.13/210.28       do not use /drug eff for insecticides: TN 111   
% 210.13/210.28  |- mesh__dateCreated mesh__D020050 1998-06-10
% 210.13/210.28  |- skos__scopeNote mesh__D020050
% 210.13/210.28       An order of insects, comprising a single family %28%Mantidae%29%, restricted almost entirely to the tropics. Only one species, the praying mantis %28%Mantis religiosa%29%, is found in temperate habitats.%A%    
% 210.13/210.28  |- mesh__dateRevised mesh__D020050 2003-07-09
% 210.13/210.28  |- mesh__historyNote mesh__D020050
% 210.13/210.28       99; for MANTIDS %26% PRAYING MANTIS use ORTHOPTERA 1986-98   
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D020050 2004
% 210.13/210.28  |- skos__historyNote mesh__D020050 Orthoptera %28%1981-1998%29%
% 210.13/210.28  |- skos__historyNote mesh__D020050 Insects %28%1966-1998%29%
% 210.13/210.28  |- skos__prefLabel mesh__D020050 Mantodea
% 210.13/210.28  |- rdf__type mesh__D020050sskos__Concept
% 210.13/210.28  |- skos__broader mesh__D020050smesh__D007313
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D020050 2006
% 210.13/210.28  |- mesh__dateEstablished mesh__D020050 1999-01-01
% 210.13/210.28  |- mesh__recordOriginator mesh__D014811 NLM
% 210.13/210.28  |- skos__annotation mesh__D014811 DF: VITAMIN E DEFIC   
% 210.13/210.28  |- mesh__dateRevised mesh__D014811 2003-07-09
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D014811 2005
% 210.13/210.28  |- mesh__recordAuthorizer mesh__D014811 sjn
% 210.13/210.28  |- mesh__recordMaintainer mesh__D014811 lkt
% 210.13/210.28  |- skos__hiddenLabel mesh__D014811 Deficiencies, Vitamin E
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D014811 2006
% 210.13/210.28  |- mesh__dateCreated mesh__D014811 1999-01-01
% 210.13/210.28  |- skos__prefLabel mesh__D014811 Vitamin E Deficiency
% 210.13/210.28  |- skos__hiddenLabel mesh__D014811 Vitamin E Deficiencies
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D014811 2004
% 210.13/210.28  |- skos__broader mesh__D014811smesh__D001361
% 210.13/210.28  |- rdf__type mesh__D014811sskos__Concept
% 210.13/210.28  |- skos__scopeNote mesh__D014811
% 210.13/210.28       A nutritional condition produced by a deficiency of VITAMIN E in the diet, characterized by posterior column and spinocerebellar tract abnormalities, areflexia, ophthalmoplegia, and disturbances of gait, proprioception, and vibration. In premature infants vitamin E deficiency is associated with hemolytic anemia, thrombocytosis, edema, intraventricular hemorrhage, and increasing risk of retrolental fibroplasia and bronchopulmonary dysplasia. An apparent inborn error of vitamin E metabolism, named familial isolated vitamin E deficiency, has recently been identified. %28%Cecil Textbook of Medicine, 19th ed, p1181%29%%A%    
% 210.13/210.28  |- skos__altLabel mesh__D014811 Deficiency, Vitamin E
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D014013 2006
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D014013 2003
% 210.13/210.28  |- mesh__recordAuthorizer mesh__D014013 sjn
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D014013 2005
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D014013 2002
% 210.13/210.28  |- skos__historyNote mesh__D014013 Benzenesulfonates %28%1974%29%
% 210.13/210.28  |- skos__annotation mesh__D014013 D25-26 qualif   
% 210.13/210.28  |- mesh__recordMaintainer mesh__D014013 CCR
% 210.13/210.28  |- mesh__dateEstablished mesh__D014013 1991-01-01
% 210.13/210.28  |- mesh__recordOriginator mesh__D014013 NLM
% 210.13/210.28  |- mesh__historyNote mesh__D014013
% 210.13/210.28       91%28%75%29%; was see under BENZENESULFONATES 1975-90   
% 210.13/210.28  |- rdf__type mesh__D014013sskos__Concept
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D014013 2001
% 210.13/210.28  |- mesh__dateRevised mesh__D014013 2000-06-22
% 210.13/210.28  |- skos__scopeNote mesh__D014013
% 210.13/210.28       A colorimetric reagent for iron, manganese, titanium, molybdenum, and complexes of zirconium. %28%From Merck Index, 11th ed%29%%A%    
% 210.13/210.28  |- mesh__publicMeSHNote mesh__D014013
% 210.13/210.28       91; was see under BENZENESULFONATES 1975-90   
% 210.13/210.28  |- skos__historyNote mesh__D014013 Catechols %28%1974%29%
% 210.13/210.28  |- skos__broader mesh__D014013smesh__D002396
% 210.13/210.28  |- skos__prefLabel mesh__D014013 Tiron
% 210.13/210.28  |- skos__broader mesh__D014013smesh__D001557
% 210.13/210.28  |- mesh__dateCreated mesh__D014013 1974-11-19
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D014013 2004
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D038461 2005
% 210.13/210.28  |- mesh__publicMeSHNote mesh__D038461
% 210.13/210.28       2003; PROTEIN-PROLINE KINASE %28%now PROLINE-DIRECTED PROTEIN KINASES%29% was indexed under PROTEIN-SERINE-THREONINE KINASES 1994-2002 %26% under PROTEIN KINASES 1990-1993%A%  
% 210.13/210.28  |- skos__hiddenLabel mesh__D038461 Proline Directed Protein Kinases
% 210.13/210.28  |- skos__hiddenLabel mesh__D038461 Kinase, Protein-Proline
% 210.13/210.28  |- skos__scopeNote mesh__D038461
% 210.13/210.28       A subclass of protein serine-threonine kinases that phosphorylate proteins on a SERINE or THREONINE residue that is immediately preceding a PROLINE residue.%A%    
% 210.13/210.28  |- skos__hiddenLabel mesh__D038461 Kinases, Proline-Directed Protein
% 210.13/210.28  |- skos__hiddenLabel mesh__D038461 Protein Kinase, Proline-Directed
% 210.13/210.28  |- skos__hiddenLabel mesh__D038461 Protein Proline Kinase
% 210.13/210.28  |- skos__broader mesh__D038461smesh__D017346
% 210.13/210.28  |- skos__prefLabel mesh__D038461 Proline-Directed Protein Kinases
% 210.13/210.28  |- skos__altLabel mesh__D038461 Protein-Proline Kinase
% 210.13/210.28  |- skos__historyNote mesh__D038461 Protein Kinases %28%1990-1993%29%
% 210.13/210.28  |- rdf__type mesh__D038461sskos__Concept
% 210.13/210.28  |- skos__hiddenLabel mesh__D038461 Proline Directed Protein Kinase
% 210.13/210.28  |- skos__hiddenLabel mesh__D038461 Protein Kinases, Proline-Directed
% 210.13/210.28  |- skos__altLabel mesh__D038461 PDPK Enzymes
% 210.13/210.28  |- mesh__dateRevised mesh__D038461 2003-07-09
% 210.13/210.28  |- mesh__dateEstablished mesh__D038461 2003-01-01
% 210.13/210.28  |- skos__hiddenLabel mesh__D038461 Kinase, Proline-Directed Protein
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D038461 2006
% 210.13/210.28  |- mesh__historyNote mesh__D038461
% 210.13/210.28       2003; use PROLINE-DIRECTED PROTEIN KINASES %28%NM%29% 1990-2002%A%  
% 210.13/210.28  |- mesh__dateCreated mesh__D038461 2002-07-03
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D038461 2004
% 210.13/210.28  |- skos__altLabel mesh__D038461 Proline-Directed Protein Kinase
% 210.13/210.28  |- skos__historyNote mesh__D038461
% 210.13/210.28       Protein-Serine-Threonine Kinases %28%1994-2002%29%
% 210.13/210.28  |- skos__broader mesh__D005287smesh__D050862
% 210.13/210.28  |- skos__hiddenLabel mesh__D005287 Iron Sulfur Protein Reductase
% 210.13/210.28  |- rdf__type mesh__D005287sskos__Concept
% 210.13/210.28  |- skos__scopeNote mesh__D005287
% 210.13/210.28       An enzyme that catalyzes the oxidation and reduction of FERREDOXIN or ADRENODOXIN in the presence of NADP. EC 1.18.1.2 was formerly listed as EC 1.6.7.1 and EC 1.6.99.4.%A%    
% 210.13/210.28  |- mesh__recordOriginator mesh__D005287 NLM
% 210.13/210.28  |- skos__hiddenLabel mesh__D005287 Protein Reductase, Iron-Sulfur
% 210.13/210.28  |- mesh__dateCreated mesh__D005287 1974-11-19
% 210.13/210.28  |- mesh__dateRevised mesh__D005287 2005-06-30
% 210.13/210.28  |- skos__historyNote mesh__D005287 NADH, NADPH Oxidoreductases %28%1974%29%
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D005287 2006
% 210.13/210.28  |- mesh__publicMeSHNote mesh__D005287
% 210.13/210.28       91; was see under NADH, NADPH OXIDOREDUCTASES 1975-90   
% 210.13/210.28  |- skos__hiddenLabel mesh__D005287 Reductase, Iron-Sulfur Protein
% 210.13/210.28  |- skos__hiddenLabel mesh__D005287 Reductase, Adrenodoxin
% 210.13/210.28  |- skos__prefLabel mesh__D005287 Ferredoxin-NADP Reductase
% 210.13/210.28  |- mesh__recordMaintainer mesh__D005287 AKE
% 210.13/210.28  |- skos__historyNote mesh__D005287 Ferredoxins %28%1974%29%
% 210.13/210.28  |- mesh__dateEstablished mesh__D005287 1991-01-01
% 210.13/210.28  |- skos__hiddenLabel mesh__D005287 Reductase, NADPH-Ferredoxin
% 210.13/210.28  |- skos__hiddenLabel mesh__D005287 NADPH Ferredoxin Reductase
% 210.13/210.28  |- mesh__historyNote mesh__D005287
% 210.13/210.28       91%28%75%29%; was see under NADH, NADPH OXIDOREDUCTASES 1975-90%A%  
% 210.13/210.28  |- skos__altLabel mesh__D005287 Adrenodoxin Reductase
% 210.13/210.28  |- skos__altLabel mesh__D005287 NADPH-Ferredoxin Reductase
% 210.13/210.28  |- mesh__recordAuthorizer mesh__D005287 sjn
% 210.13/210.28  |- skos__hiddenLabel mesh__D005287 Reductase, Ferredoxin-NADP
% 210.13/210.28  |- skos__altLabel mesh__D005287 Iron-Sulfur Protein Reductase
% 210.13/210.28  |- skos__hiddenLabel mesh__D005287 Ferredoxin NADP Reductase
% 210.13/210.28  |- skos__scopeNote mesh__D013719
% 210.13/210.28       Tensor muscle of the tympanic membrane that draws the handle of the malleus medialward and tenses the tympanic membrane. %28%Stedman, 25th ed%29%%A%    
% 210.13/210.28  |- mesh__recordAuthorizer mesh__D013719 sjn
% 210.13/210.28  |- skos__hiddenLabel mesh__D013719 Tympanus, Tensor
% 210.13/210.28  |- mesh__dateCreated mesh__D013719 1999-01-01
% 210.13/210.28  |- skos__annotation mesh__D013719
% 210.13/210.28       /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 210.13/210.28  |- mesh__recordMaintainer mesh__D013719 nns
% 210.13/210.28  |- skos__broader mesh__D013719smesh__D018482
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D013719 2005
% 210.13/210.28  |- skos__prefLabel mesh__D013719 Tensor Tympani
% 210.13/210.28  |- skos__broader mesh__D013719smesh__D004432
% 210.13/210.28  |- skos__hiddenLabel mesh__D013719 Tensor Tympanus
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D013719 2003
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D013719 2006
% 210.13/210.28  |- mesh__dateRevised mesh__D013719 2001-07-25
% 210.13/210.28  |- skos__hiddenLabel mesh__D013719 Tympani, Tensor
% 210.13/210.28  |- mesh__recordOriginator mesh__D013719 NLM
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D013719 2004
% 210.13/210.28  |- rdf__type mesh__D013719sskos__Concept
% 210.13/210.28  |- mesh__publicMeSHNote mesh__D013719
% 210.13/210.28       91; was see under TYMPANIC MEMBRANE 1963-90   
% 210.13/210.28  |- mesh__historyNote mesh__D013719
% 210.13/210.28       91%28%63%29%; was see under TYMPANIC MEMBRANE 1963-90   
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D013719 2002
% 210.13/210.28  |- mesh__dateEstablished mesh__D013719 1991-01-01
% 210.13/210.28  |- skos__broader mesh__D018404smesh__D002875
% 210.13/210.28  |- mesh__historyNote mesh__D018404 95   
% 210.13/210.28  |- mesh__dateEstablished mesh__D018404 1995-01-01
% 210.13/210.28  |- mesh__recordMaintainer mesh__D018404 nns
% 210.13/210.28  |- skos__historyNote mesh__D018404 Chromosome Aberrations %28%1966-1994%29%
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D018404 2005
% 210.13/210.28  |- mesh__recordOriginator mesh__D018404 PXP
% 210.13/210.28  |- skos__historyNote mesh__D018404 specific chromosome %28%1966-1994%29%
% 210.13/210.28  |- skos__broader mesh__D018404smesh__D002869
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D018404 2006
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D018404 2003
% 210.13/210.28  |- mesh__publicMeSHNote mesh__D018404 95   
% 210.13/210.28  |- mesh__dateRevised mesh__D018404 2002-07-03
% 210.13/210.28  |- mesh__recordAuthorizer mesh__D018404 sjn
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D018404 2004
% 210.13/210.28  |- rdf__type mesh__D018404sskos__Concept
% 210.13/210.28  |- skos__hiddenLabel mesh__D018404 Isochromosome
% 210.13/210.28  |- skos__prefLabel mesh__D018404 Isochromosomes
% 210.13/210.28  |- skos__annotation mesh__D018404 note category   
% 210.13/210.28  |- skos__scopeNote mesh__D018404
% 210.13/210.28       Metacentric chromosomes produced during MEIOSIS or MITOSIS when the CENTROMERE splits transversely instead of longitudinally. The chromosomes produced by this abnormal division are one chromosome having the two long arms of the original chromosome, but no short arms, and the other chromosome consisting of the two short arms and no long arms. Each of these isochromosomes constitutes a simultaneous duplication and deletion.%A%    
% 210.13/210.28  |- mesh__dateCreated mesh__D018404 1994-01-25
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D010421 2005
% 210.13/210.28  |- skos__broader mesh__D010421smesh__D014631
% 210.13/210.28  |- skos__prefLabel mesh__D010421 Pentanoic Acids
% 210.13/210.28  |- mesh__recordAuthorizer mesh__D010421 sjn
% 210.13/210.28  |- mesh__recordOriginator mesh__D010421 NLM
% 210.13/210.28  |- mesh__recordMaintainer mesh__D010421 ssb
% 210.13/210.28  |- mesh__dateRevised mesh__D010421 2003-07-09
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D010421 2006
% 210.13/210.28  |- mesh__dateEstablished mesh__D010421 1991-01-01
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D010421 2004
% 210.13/210.28  |- mesh__historyNote mesh__D010421
% 210.13/210.28       91%28%75%29%; was see under VALERATES 1975-90   
% 210.13/210.28  |- mesh__onlineNote mesh__D010421 search VALERATES 1966-74   
% 210.13/210.28  |- skos__hiddenLabel mesh__D010421 Acids, Pentanoic
% 210.13/210.28  |- rdf__type mesh__D010421sskos__Concept
% 210.13/210.28  |- mesh__dateCreated mesh__D010421 1999-01-01
% 210.13/210.28  |- mesh__publicMeSHNote mesh__D010421
% 210.13/210.28       91; was see under VALERATES 1975-90   
% 210.13/210.28  |- mesh__publicMeSHNote mesh__D051838
% 210.13/210.28       2006; CHICKEN OVALBUMIN UPSTREAM PROMOTER-TRANSCRIPTION FACTOR I was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1989-2005%A%  
% 210.13/210.28  |- skos__broader mesh__D051838smesh__D051836
% 210.13/210.28  |- mesh__recordMaintainer mesh__D051838 DRC
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D051838 2006
% 210.13/210.28  |- skos__scopeNote mesh__D051838
% 210.13/210.28       A COUP transcription factor that was originally identified as a homodimer that binds to a direct repeat regulatory element in the chicken albumin PROMOTOR. It is a transcription factor that plays an important role in EMBRYONIC DEVELOPMENT of the CENTRAL NERVOUS SYSTEM.%A%    
% 210.13/210.28  |- mesh__dateEstablished mesh__D051838 2006-01-01
% 210.13/210.28  |- rdf__type mesh__D051838sskos__Concept
% 210.13/210.28  |- mesh__dateCreated mesh__D051838 2005-06-30
% 210.13/210.28  |- mesh__recordOriginator mesh__D051838 DRC
% 210.13/210.28  |- skos__hiddenLabel mesh__D051838 COUP TFI Protein
% 210.13/210.28  |- skos__altLabel mesh__D051838 COUP-TFI Protein
% 210.13/210.28  |- skos__hiddenLabel mesh__D051838
% 210.13/210.28       Chicken Ovalbumin Upstream Promoter Transcription Factor I
% 210.13/210.28  |- skos__altLabel mesh__D051838
% 210.13/210.28       Chicken Ovalbumin Upstream Promoter-Transcription Factor I
% 210.13/210.28  |- skos__prefLabel mesh__D051838 COUP Transcription Factor I
% 210.13/210.28  |- skos__hiddenLabel mesh__D051838 ErbA Related Protein 3
% 210.13/210.28  |- mesh__recordAuthorizer mesh__D051838 sjn
% 210.13/210.28  |- mesh__historyNote mesh__D051838 2006%28%1989%29%   
% 210.13/210.28  |- skos__altLabel mesh__D051838 ErbA-Related Protein-3
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D048091 2005
% 210.13/210.28  |- skos__altLabel mesh__D048091 Regeneration, Guided Tissue
% 210.13/210.28  |- skos__broader mesh__D048091smesh__D019651
% 210.13/210.28  |- skos__hiddenLabel mesh__D048091 Tissue Regeneration, Guided
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D048091 2006
% 210.13/210.28  |- mesh__dateCreated mesh__D048091 2004-07-07
% 210.13/210.28  |- skos__prefLabel mesh__D048091 Guided Tissue Regeneration
% 210.13/210.28  |- rdf__type mesh__D048091sskos__Concept
% 210.13/210.28  |- mesh__dateEstablished mesh__D048091 2005-01-01
% 210.13/210.28  |- mesh__publicMeSHNote mesh__D048091 2005   
% 210.13/210.28  |- mesh__dateRevised mesh__D048091 2005-07-12
% 210.13/210.28  |- mesh__recordAuthorizer mesh__D048091 ags
% 210.13/210.28  |- skos__related mesh__D048091smesh__D023822
% 210.13/210.28  |- skos__scopeNote mesh__D048091
% 210.13/210.28       Procedures for enhancing and directing tissue repair and renewal processes, such as BONE REGENERATION; NERVE REGENERATION; etc. They involve surgically implanting growth conducive tracks or conduits at the damaged site to stimulate and control of the location of cell repopulation. The tracks or conduits are made from synthetic and/or natural materials and may include support cells and induction factors for CELL GROWTH PROCESSES; or CELL MIGRATION.%A%    
% 210.13/210.28  |- mesh__recordMaintainer mesh__D048091 ags
% 210.13/210.28  |- mesh__recordOriginator mesh__D048091 nns
% 210.13/210.28  |- skos__historyNote mesh__D048091
% 210.13/210.28       Guided Tissue Regeneration, Periodontal %28%1992-2004%29%
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D048091 2006A
% 210.13/210.28  |- mesh__historyNote mesh__D048091 2005   
% 210.13/210.28  |- skos__related mesh__D048091smesh__D012038
% 210.13/210.28  |- skos__related mesh__D009678smesh__D011850
% 210.13/210.28  |- mesh__historyNote mesh__D009678
% 210.13/210.28       82; was ATOMIC ENERGY %28%Cat H heading only%29% 1963-81   
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D009678 2006
% 210.13/210.28  |- mesh__publicMeSHNote mesh__D009678 82; was ATOMIC ENERGY 1963-81   
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D009678 1996
% 210.13/210.28  |- mesh__dateRevised mesh__D009678 1994-05-31
% 210.13/210.28  |- skos__prefLabel mesh__D009678 Nuclear Energy
% 210.13/210.28  |- skos__broader mesh__D009678smesh__D009686
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D009678 2002
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D009678 1995
% 210.13/210.28  |- skos__hiddenLabel mesh__D009678 Energy, Atomic
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D009678 2005
% 210.13/210.28  |- mesh__dateCreated mesh__D009678 1999-01-01
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D009678 2001
% 210.13/210.28  |- skos__scopeNote mesh__D009678
% 210.13/210.28       Energy released by nuclear fission or nuclear fusion.     
% 210.13/210.28  |- mesh__recordAuthorizer mesh__D009678 PLS
% 210.13/210.28  |- rdf__type mesh__D009678sskos__Concept
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D009678 1999
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D009678 2004
% 210.13/210.28  |- skos__altLabel mesh__D009678 Atomic Energy
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D009678 2000
% 210.13/210.28  |- skos__broader mesh__D009678smesh__D004736
% 210.13/210.28  |- mesh__onlineNote mesh__D009678
% 210.13/210.28       use NUCLEAR ENERGY to search ATOMIC ENERGY 1966-81 %28%as Cat H heading%29%%A%  
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D009678 1998
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D009678 2003
% 210.13/210.28  |- skos__annotation mesh__D009678
% 210.13/210.28       nuclear power plants: see note %26% X ref at POWER PLANTS   
% 210.13/210.28  |- skos__hiddenLabel mesh__D009678 Energy, Nuclear
% 210.13/210.28  |- mesh__recordMaintainer mesh__D009678 TGC
% 210.13/210.28  |- skos__related mesh__D009678smesh__D011835
% 210.13/210.28  |- mesh__recordOriginator mesh__D009678 NLM
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D009678 1997
% 210.13/210.28  |- mesh__recordMaintainer mesh__D001695 hjn
% 210.13/210.28  |- rdf__type mesh__D001695sskos__Concept
% 210.13/210.28  |- skos__broader mesh__D001695smesh__D001690
% 210.13/210.28  |- skos__prefLabel mesh__D001695 Biology
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D001695 2004
% 210.13/210.28  |- mesh__dateRevised mesh__D001695 2002-07-02
% 210.13/210.28  |- mesh__recordAuthorizer mesh__D001695 sjn
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D001695 2003
% 210.13/210.28  |- mesh__recordOriginator mesh__D001695 NLM
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D001695 2006
% 210.13/210.28  |- skos__annotation mesh__D001695
% 210.13/210.28       SPEC; do not confuse with BIOLOGICAL SCIENCES which includes all the life sciences; DF: BIOL%A%  
% 210.13/210.28  |- mesh__dateCreated mesh__D001695 1999-01-01
% 210.13/210.28  |- skos__scopeNote mesh__D001695
% 210.13/210.28       One of the biological sciences concerned with the origin, structure, development, growth, function, genetics, and reproduction of animals, plants, and microorganisms.%A%    
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D001695 2005
% 210.13/210.28  |- skos__prefLabel mesh__D006380 Helplessness, Learned
% 210.13/210.28  |- mesh__publicMeSHNote mesh__D006380 83   
% 210.13/210.28  |- skos__altLabel mesh__D006380 Learned Helplessness
% 210.13/210.28  |- mesh__recordMaintainer mesh__D006380 sjn
% 210.13/210.28  |- skos__broader mesh__D006380smesh__D003674
% 210.13/210.28  |- mesh__dateCreated mesh__D006380 1982-04-28
% 210.13/210.28  |- rdf__type mesh__D006380sskos__Concept
% 210.13/210.28  |- mesh__dateEstablished mesh__D006380 1983-01-01
% 210.13/210.28  |- mesh__dateRevised mesh__D006380 2004-07-13
% 210.13/210.28  |- skos__broader mesh__D006380smesh__D007858
% 210.13/210.28  |- skos__annotation mesh__D006380 no qualif   
% 210.13/210.28  |- mesh__historyNote mesh__D006380 83   
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D006380 2006
% 210.13/210.28  |- skos__scopeNote mesh__D006380
% 210.13/210.28       Learned expectation that one%27%s responses are independent of reward and, hence, do not predict or control the occurrence of rewards. Learned helplessness derives from a history, experimentally induced or naturally occurring, of having received punishment/aversive stimulation regardless of responses made. Such circumstances result in an impaired ability to learn. Used for human or animal populations. %28%APA, Thesaurus of Psychological Index Terms, 1994%29%%A%    
% 210.13/210.28  |- mesh__recordAuthorizer mesh__D006380 sjn
% 210.13/210.28  |- mesh__recordOriginator mesh__D006380 EC
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D006380 2005
% 210.13/210.28  |- skos__hiddenLabel mesh__D020051 B, Arylsulfatase
% 210.13/210.28  |- mesh__recordMaintainer mesh__D020051 ssb
% 210.13/210.28  |- mesh__recordAuthorizer mesh__D020051 sjn
% 210.13/210.28  |- skos__altLabel mesh__D020051 N-Acetylgalactosamine 4-Sulfatase
% 210.13/210.28  |- skos__hiddenLabel mesh__D020051
% 210.13/210.28       Sulphatase, N-Acetylgalactosamine-4-sulphate
% 210.13/210.28  |- skos__hiddenLabel mesh__D020051 B2, Arylsulfatase
% 210.13/210.28  |- skos__hiddenLabel mesh__D020051 4-Sulfatase, N-Acetylgalactosamine
% 210.13/210.28  |- mesh__dateEstablished mesh__D020051 1999-01-01
% 210.13/210.28  |- mesh__dateRevised mesh__D020051 2003-07-09
% 210.13/210.28  |- skos__altLabel mesh__D020051 N-Acetylgalactosamine-4-sulfate Sulfatase
% 210.13/210.28  |- mesh__activeMeSHYear mesh__D020051 2004
% 210.13/210.28  |- skos__scopeNote mesh__D020051
% 210.13/210.28       An arylsulfatase that catalyzes the hydrolysis of the 4-sulfate groups of the N-acetyl-D-galactosamine 4-sulfate units of chondroitin sulfate and dermatan sulfate. A deficiency of this enzyme is responsible for the inherited lysosomal disease, Maroteaux-Lamy syndrome %28%MUCOPOLYSACCHARIDOSIS VI%29%. EC 3.1.6.12.%A%    
% 210.13/210.28  |- skos__altLabel mesh__D020051 Arylsulfatase B
% 210.13/210.28  |- skos__hiddenLabel mesh__D020051
% 210.13/210.28       N Acetylgalactosamine 4 sulfate Sulfatase
% 210.13/210.28  |- skos__altLabel mesh__D020051 N-Acetylgalactosamine-4-sulphate Sulphatase
% 210.13/210.28  |- skos__broader mesh__D020051smesh__D001192
% 210.13/210.28  |- skos__hiddenLabel mesh__D020051
% 210.13/210.28       N Acetylgalactosamine 4 sulphate Sulphatase
% 210.13/210.28  |- mesh__historyNote mesh__D020051
% 210.13/210.28       99; for ARYLSULFATASE B use CHONDRO-4-SULFATASE 1975-98; use N-ACETYLGALACTOSAMINE-4-SULFATASE %28%NM%29% 1988-98%A%  
% 210.13/210.28  |- skos__historyNote mesh__D020051 Sulfatases %28%1988-1998%29%
% 210.14/210.28  |- mesh__dateCreated mesh__D020051 1998-06-10
% 210.14/210.28  |- rdf__type mesh__D020051sskos__Concept
% 210.14/210.28  |- mesh__recordOriginator mesh__D020051 ADP
% 210.14/210.28  |- mesh__activeMeSHYear mesh__D020051 2006
% 210.14/210.28  |- skos__broader mesh__D020051smesh__D002811
% 210.14/210.28  |- skos__hiddenLabel mesh__D020051 N Acetylgalactosamine 4 Sulfatase
% 210.14/210.28  |- skos__hiddenLabel mesh__D020051 B1, Arylsulfatase
% 210.14/210.28  |- skos__prefLabel mesh__D020051 N-Acetylgalactosamine-4-Sulfatase
% 210.14/210.28  |- mesh__activeMeSHYear mesh__D020051 2005
% 210.14/210.28  |- skos__hiddenLabel mesh__D020051
% 210.14/210.28       Sulfatase, N-Acetylgalactosamine-4-sulfate
% 210.14/210.28  |- mesh__publicMeSHNote mesh__D020051
% 210.14/210.28       99; for ARYLSULFATASE B see CHONDRO-4-SULFATASE 1975-98; N-ACETYLGALACTOSAMINE-4-SULFATE SULFATASE %28%now N-ACETYLGALACTOSAMINE-4-SULFATASE%29% was indexed under SULFATASES 1988-98%A%  
% 210.14/210.28  |- mesh__dateCreated mesh__D014812 1999-01-01
% 210.14/210.28  |- mesh__dateRevised mesh__D014812 2005-06-30
% 210.14/210.28  |- skos__broader mesh__D014812smesh__D009285
% 210.14/210.28  |- mesh__recordOriginator mesh__D014812 NLM
% 210.14/210.28  |- rdf__type mesh__D014812sskos__Concept
% 210.14/210.28  |- skos__prefLabel mesh__D014812 Vitamin K
% 210.14/210.28  |- mesh__recordAuthorizer mesh__D014812 sjn
% 210.14/210.28  |- skos__broader mesh__D014812smesh__D010836
% 210.14/210.28  |- skos__scopeNote mesh__D014812
% 210.14/210.28       A lipid cofactor that is required for normal blood clotting.  Several forms of vitamin K have been identified: VITAMIN K 1 %28%VITAMIN K 1%29% derived from plants, VITAMIN K 2 %28%menaquinone%29% from bacteria, and synthetic naphthoquinone provitamins, VITAMIN K 3 %28%menadione%29%. Vitamin K 3 provitamins, after being alkylated in vivo, exhibit the antifibrinolytic activity of vitamin K. Green leafy vegetables, liver, cheese, butter, and egg yolk are good sources of vitamin K.%A%    
% 210.14/210.28  |- mesh__recordMaintainer mesh__D014812 ssb
% 210.14/210.28  |- skos__annotation mesh__D014812
% 210.14/210.28       /ther use: coordinate disease with /drug ther, not /diet ther%A%  
% 210.14/210.28  |- mesh__activeMeSHYear mesh__D014812 2006
% 210.14/210.28  |- mesh__historyNote mesh__D014014 65%28%63%29%   
% 210.14/210.29  |- mesh__dateRevised mesh__D014014 2000-06-21
% 210.14/210.29  |- mesh__recordMaintainer mesh__D014014 nns
% 210.14/210.29  |- skos__annotation mesh__D014014
% 210.14/210.29       IM; coord with specific substance used as adhesive if pertinent %28%IM%29%; D25-26 qualif%A%  
% 210.14/210.29  |- skos__hiddenLabel mesh__D014014 Adhesives, Tissue
% 210.14/210.29  |- mesh__recordAuthorizer mesh__D014014 sjn
% 210.14/210.29  |- rdf__type mesh__D014014sskos__Concept
% 210.14/210.29  |- mesh__publicMeSHNote mesh__D014014 65   
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014014 2002
% 210.14/210.29  |- mesh__dateCreated mesh__D014014 1999-01-01
% 210.14/210.29  |- skos__related mesh__D014014smesh__D001843
% 210.14/210.29  |- skos__hiddenLabel mesh__D014014 Adhesive, Tissue
% 210.14/210.29  |- skos__broader mesh__D014014smesh__D001697
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014014 2004
% 210.14/210.29  |- mesh__recordOriginator mesh__D014014 NLM
% 210.14/210.29  |- skos__hiddenLabel mesh__D014014 Tissue Adhesive
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014014 2001
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014014 2006
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014014 2003
% 210.14/210.29  |- mesh__dateEstablished mesh__D014014 1965-01-01
% 210.14/210.29  |- skos__scopeNote mesh__D014014
% 210.14/210.29       Substances used to cause adherence of tissue to tissue or tissue to non-tissue surfaces, as for prostheses.%A%    
% 210.14/210.29  |- skos__prefLabel mesh__D014014 Tissue Adhesives
% 210.14/210.29  |- skos__broader mesh__D014014smesh__D013523
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014014 2005
% 210.14/210.29  |- rdf__type mesh__D005288sskos__Concept
% 210.14/210.29  |- skos__altLabel mesh__D005288 Ferredoxin
% 210.14/210.29  |- mesh__historyNote mesh__D005288 66%28%64%29%   
% 210.14/210.29  |- mesh__dateCreated mesh__D005288 1999-01-01
% 210.14/210.29  |- mesh__recordAuthorizer mesh__D005288 sjn
% 210.14/210.29  |- skos__hiddenLabel mesh__D005288 III, Ferredoxin
% 210.14/210.29  |- skos__scopeNote mesh__D005288
% 210.14/210.29       Iron-containing proteins that transfer electrons, usually at a low potential, to flavoproteins; the iron is not present as in heme. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%    
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D005288 2006
% 210.14/210.29  |- mesh__dateEstablished mesh__D005288 1966-01-01
% 210.14/210.29  |- skos__annotation mesh__D005288
% 210.14/210.29       bact %26% plant proteins; /drug eff /ultrastruct permitted   
% 210.14/210.29  |- skos__broader mesh__D005288smesh__D007506
% 210.14/210.29  |- mesh__recordOriginator mesh__D005288 NLM
% 210.14/210.29  |- mesh__publicMeSHNote mesh__D005288 66   
% 210.14/210.29  |- skos__prefLabel mesh__D005288 Ferredoxins
% 210.14/210.29  |- mesh__dateRevised mesh__D005288 2005-06-30
% 210.14/210.29  |- mesh__recordMaintainer mesh__D005288 SYSTEM
% 210.14/210.29  |- skos__broader mesh__D005288smesh__D010940
% 210.14/210.29  |- skos__broader mesh__D005288smesh__D001426
% 210.14/210.29  |- skos__broader mesh__D004798Q000037smesh__D004798
% 210.14/210.29  |- mesh__preferredCombination mesh__D004798Q000037smesh__D004791
% 210.14/210.29  |- rdf__type mesh__D004798Q000037smesh__CompoundConcept
% 210.14/210.29  |- mesh__dateEstablished mesh__D024442 2002-01-01
% 210.14/210.29  |- mesh__recordMaintainer mesh__D024442 ags
% 210.14/210.29  |- skos__hiddenLabel mesh__D024442 Mitochondrial Aspartate Aminotransferase
% 210.14/210.29  |- skos__prefLabel mesh__D024442 Aspartate Aminotransferase, Mitochondrial
% 210.14/210.29  |- skos__broader mesh__D024442smesh__D001219
% 210.14/210.29  |- skos__annotation mesh__D024442
% 210.14/210.29       ASPARTATE AMINOTRANSFERASE, CYTOPLASMIC is also available%A%  
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D024442 2004
% 210.14/210.29  |- skos__historyNote mesh__D024442
% 210.14/210.29       Aspartate Aminotransferases %28%1968-2001%29%
% 210.14/210.29  |- mesh__recordAuthorizer mesh__D024442 ags
% 210.14/210.29  |- mesh__publicMeSHNote mesh__D024442 2002   
% 210.14/210.29  |- mesh__dateRevised mesh__D024442 2005-07-08
% 210.14/210.29  |- skos__hiddenLabel mesh__D024442 Oxaloacetate Transaminase-2, Glutamate
% 210.14/210.29  |- skos__hiddenLabel mesh__D024442
% 210.14/210.29       Aminotransferase, Mitochondrial Aspartate
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D024442 2006A
% 210.14/210.29  |- mesh__recordOriginator mesh__D024442 jmp
% 210.14/210.29  |- mesh__dateCreated mesh__D024442 2001-07-25
% 210.14/210.29  |- mesh__historyNote mesh__D024442 2002   
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D024442 2006
% 210.14/210.29  |- skos__hiddenLabel mesh__D024442 Transaminase-2, Glutamate Oxaloacetate
% 210.14/210.29  |- skos__scopeNote mesh__D024442
% 210.14/210.29       An aspartate aminotransferase found in MITOCHONDRIA.     
% 210.14/210.29  |- skos__altLabel mesh__D024442 Glutamate Oxaloacetate Transaminase-2
% 210.14/210.29  |- rdf__type mesh__D024442sskos__Concept
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D024442 2005
% 210.14/210.29  |- skos__hiddenLabel mesh__D024442 Glutamate Oxaloacetate Transaminase 2
% 210.14/210.29  |- skos__hiddenLabel mesh__D010422 Ketones, Methyl Propyl
% 210.14/210.29  |- skos__broader mesh__D010422smesh__D007659
% 210.14/210.29  |- skos__hiddenLabel mesh__D010422 Ketones, Diethyl
% 210.14/210.29  |- mesh__historyNote mesh__D010422
% 210.14/210.29       91%28%75%29%; was see under KETONES 1975-90   
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D010422 2001
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D010422 2006
% 210.14/210.29  |- mesh__recordAuthorizer mesh__D010422 sjn
% 210.14/210.29  |- skos__scopeNote mesh__D010422
% 210.14/210.29       5-carbon straight-chain or branched-chain ketones.     
% 210.14/210.29  |- skos__prefLabel mesh__D010422 Pentanones
% 210.14/210.29  |- mesh__recordOriginator mesh__D010422 NLM
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D010422 2004
% 210.14/210.29  |- mesh__dateCreated mesh__D010422 1974-11-11
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D010422 2005
% 210.14/210.29  |- skos__hiddenLabel mesh__D010422 Propyl Ketones, Methyl
% 210.14/210.29  |- mesh__dateEstablished mesh__D010422 1991-01-01
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D010422 2003
% 210.14/210.29  |- mesh__recordMaintainer mesh__D010422 CCR
% 210.14/210.29  |- skos__historyNote mesh__D010422 Ketones %28%1966-1974%29%
% 210.14/210.29  |- rdf__type mesh__D010422sskos__Concept
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D010422 2002
% 210.14/210.29  |- mesh__publicMeSHNote mesh__D010422 91; was see under KETONES 1975-90   
% 210.14/210.29  |- mesh__dateRevised mesh__D010422 2000-06-22
% 210.14/210.29  |- rdf__type mesh__D051839sskos__Concept
% 210.14/210.29  |- skos__hiddenLabel mesh__D051839 Nuclear Factor I X
% 210.14/210.29  |- skos__hiddenLabel mesh__D051839 Nuclear Factor I C
% 210.14/210.29  |- skos__scopeNote mesh__D051839
% 210.14/210.29       Transcription factors that were originally identified as site-specific DNA-binding proteins essential for DNA REPLICATION by ADENOVIRUSES. They play important roles in MAMMARY GLAND function and development.%A%    
% 210.14/210.29  |- skos__hiddenLabel mesh__D051839 Transcription Factors, NFI
% 210.14/210.29  |- skos__hiddenLabel mesh__D051839 Nuclear Factor 1
% 210.14/210.29  |- skos__altLabel mesh__D051839 Nuclear Factor-1
% 210.14/210.29  |- mesh__recordAuthorizer mesh__D051839 sjn
% 210.14/210.29  |- mesh__historyNote mesh__D051839 2006%28%1984%29%   
% 210.14/210.29  |- skos__hiddenLabel mesh__D051839 Nuclear Factor I B
% 210.14/210.29  |- mesh__recordOriginator mesh__D051839 DRC
% 210.14/210.29  |- mesh__recordMaintainer mesh__D051839 DRC
% 210.14/210.29  |- skos__hiddenLabel mesh__D051839 TGGCA Binding Protein
% 210.14/210.29  |- mesh__dateEstablished mesh__D051839 2006-01-01
% 210.14/210.29  |- mesh__publicMeSHNote mesh__D051839
% 210.14/210.29       2006; NFI TRANSCRIPTION FACTORS was indexed under TRANSCRIPTION FACTORS 1984-2005, under CCAAT-ENHANCER-BINDING PROTEINS 2005, %26% under DNA-BINDING PROTEINS 1986-2004%A%  
% 210.14/210.29  |- skos__altLabel mesh__D051839 CAAT Box Transcription Factor
% 210.14/210.29  |- mesh__dateCreated mesh__D051839 2005-06-30
% 210.14/210.29  |- skos__altLabel mesh__D051839 Nuclear Factor I
% 210.14/210.29  |- skos__prefLabel mesh__D051839 NFI Transcription Factors
% 210.14/210.29  |- skos__broader mesh__D051839smesh__D004268
% 210.14/210.29  |- skos__altLabel mesh__D051839 TGGCA-Binding Protein
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D051839 2006
% 210.14/210.29  |- skos__broader mesh__D051839smesh__D014157
% 210.14/210.29  |- skos__hiddenLabel mesh__D051839 Nuclear Factor I A
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D009679 2005
% 210.14/210.29  |- mesh__historyNote mesh__D009679
% 210.14/210.29       91%28%75%29%; was see under FAMILY 1975-90   
% 210.14/210.29  |- mesh__dateCreated mesh__D009679 1974-11-11
% 210.14/210.29  |- mesh__onlineNote mesh__D009679
% 210.14/210.29       use FAMILY to search DAUGHTERS 1991, SIBLINGS 1991, SONS 1980-91%A%  
% 210.14/210.29  |- mesh__recordOriginator mesh__D009679 NLM
% 210.14/210.29  |- rdf__type mesh__D009679sskos__Concept
% 210.14/210.29  |- mesh__recordAuthorizer mesh__D009679 sjn
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D009679 2004
% 210.14/210.29  |- mesh__dateRevised mesh__D009679 2002-07-03
% 210.14/210.29  |- mesh__publicMeSHNote mesh__D009679 91; was see under FAMILY 1975-90   
% 210.14/210.29  |- skos__prefLabel mesh__D009679 Nuclear Family
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D009679 2003
% 210.14/210.29  |- skos__hiddenLabel mesh__D009679 Family, Nuclear
% 210.14/210.29  |- mesh__recordMaintainer mesh__D009679 hjn
% 210.14/210.29  |- skos__hiddenLabel mesh__D009679 Son
% 210.14/210.29  |- mesh__dateEstablished mesh__D009679 1991-01-01
% 210.14/210.29  |- skos__annotation mesh__D009679
% 210.14/210.29       parents %26% children: does not include grandparents   
% 210.14/210.29  |- skos__broader mesh__D009679smesh__D005190
% 210.14/210.29  |- skos__hiddenLabel mesh__D009679 Families, Nuclear
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D009679 2006
% 210.14/210.29  |- skos__hiddenLabel mesh__D009679 Nuclear Families
% 210.14/210.29  |- skos__hiddenLabel mesh__D009679 Daughter
% 210.14/210.29  |- skos__scopeNote mesh__D009679
% 210.14/210.29       A family composed of spouses and their children.     
% 210.14/210.29  |- mesh__recordOriginator mesh__D001696 NLM
% 210.14/210.29  |- rdf__type mesh__D001696sskos__Concept
% 210.14/210.29  |- mesh__dateEstablished mesh__D001696 1968-01-01
% 210.14/210.29  |- mesh__recordMaintainer mesh__D001696 nns
% 210.14/210.29  |- skos__prefLabel mesh__D001696 Biomechanics
% 210.14/210.29  |- mesh__dateRevised mesh__D001696 2003-07-09
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D001696 2004
% 210.14/210.29  |- mesh__dateCreated mesh__D001696 1999-01-01
% 210.14/210.29  |- skos__broader mesh__D001696smesh__D001703
% 210.14/210.29  |- skos__annotation mesh__D001696 usually NIM   
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D001696 2005
% 210.14/210.29  |- skos__scopeNote mesh__D001696
% 210.14/210.29       The study of the application of mechanical laws and the action of forces to living structures.%A%    
% 210.14/210.29  |- skos__historyNote mesh__D001696 Biophysics %28%1966-1967%29%
% 210.14/210.29  |- mesh__publicMeSHNote mesh__D001696 68   
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D001696 2006
% 210.14/210.29  |- mesh__recordAuthorizer mesh__D001696 sjn
% 210.14/210.29  |- mesh__historyNote mesh__D001696 68   
% 210.14/210.29  |- skos__scopeNote mesh__D006381
% 210.14/210.29       An international agreement of the World Medical Association which offers guidelines for conducting experiments using human subjects. It was adopted in 1962 and revised by the 18th World Medical Assembly at Helsinki, Finland in 1964. Subsequent revisions were made in 1975, 1983, 1989, and 1996. %28%From Encyclopedia of Bioethics, rev ed, 1995%29%%A%    
% 210.14/210.29  |- mesh__dateRevised mesh__D006381 2004-07-13
% 210.14/210.29  |- skos__prefLabel mesh__D006381 Helsinki Declaration
% 210.14/210.29  |- rdf__type mesh__D006381sskos__Concept
% 210.14/210.29  |- mesh__recordAuthorizer mesh__D006381 sjn
% 210.14/210.29  |- skos__hiddenLabel mesh__D006381 Declaration, Helsinki
% 210.14/210.29  |- mesh__dateCreated mesh__D006381 1999-01-01
% 210.14/210.29  |- skos__related mesh__D006381smesh__D006805
% 210.14/210.29  |- mesh__onlineNote mesh__D006381 search ETHICS, MEDICAL 1969-74   
% 210.14/210.29  |- skos__altLabel mesh__D006381 Declaration of Helsinki
% 210.14/210.29  |- mesh__recordMaintainer mesh__D006381 sjn
% 210.14/210.29  |- skos__broader mesh__D006381smesh__D032984
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D006381 2005
% 210.14/210.29  |- mesh__recordOriginator mesh__D006381 NLM
% 210.14/210.29  |- skos__hiddenLabel mesh__D006381 Helsinki Declarations
% 210.14/210.29  |- mesh__dateEstablished mesh__D006381 1991-01-01
% 210.14/210.29  |- skos__broader mesh__D006381smesh__D032781
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D006381 2006
% 210.14/210.29  |- mesh__historyNote mesh__D006381
% 210.14/210.29       91%28%75%29%; was see under ETHICS, MEDICAL 1975-90   
% 210.14/210.29  |- mesh__publicMeSHNote mesh__D006381
% 210.14/210.29       91; was see under ETHICS, MEDICAL 1975-90   
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014813 2004
% 210.14/210.29  |- skos__broader mesh__D014813smesh__D001361
% 210.14/210.29  |- rdf__type mesh__D014813sskos__Concept
% 210.14/210.29  |- skos__broader mesh__D014813smesh__D001778
% 210.14/210.29  |- skos__hiddenLabel mesh__D014813 Vitamin K Deficiencies
% 210.14/210.29  |- skos__broader mesh__D014813smesh__D006474
% 210.14/210.29  |- skos__scopeNote mesh__D014813
% 210.14/210.29       A nutritional condition produced by a deficiency of VITAMIN K in the diet, characterized by an increased tendency to hemorrhage %28%HEMORRHAGIC DISORDERS%29%. Such bleeding episodes may be particularly severe in newborn infants. %28%From Cecil Textbook of Medicine, 19th ed, p1182%29%%A%    
% 210.14/210.29  |- skos__annotation mesh__D014813 DF: VITAMIN K DEFIC   
% 210.14/210.29  |- mesh__dateRevised mesh__D014813 2003-07-09
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014813 2005
% 210.14/210.29  |- mesh__recordOriginator mesh__D014813 NLM
% 210.14/210.29  |- skos__altLabel mesh__D014813 Deficiency, Vitamin K
% 210.14/210.29  |- mesh__recordMaintainer mesh__D014813 lkt
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014813 2006
% 210.14/210.29  |- mesh__recordAuthorizer mesh__D014813 sjn
% 210.14/210.29  |- skos__hiddenLabel mesh__D014813 Deficiencies, Vitamin K
% 210.14/210.29  |- mesh__dateCreated mesh__D014813 1999-01-01
% 210.14/210.29  |- skos__prefLabel mesh__D014813 Vitamin K Deficiency
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014015 1994
% 210.14/210.29  |- mesh__recordOriginator mesh__D014015 NLM
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014015 2001
% 210.14/210.29  |- skos__annotation mesh__D014015
% 210.14/210.29       GEN or unspecified for tissues or organs: prefer specifics; coord IM with specific organ or tissue %28%IM%29%%A%  
% 210.14/210.29  |- mesh__dateCreated mesh__D014015 1999-01-01
% 210.14/210.29  |- mesh__recordMaintainer mesh__D014015 PLS
% 210.14/210.29  |- skos__hiddenLabel mesh__D014015 Tissue Bank
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014015 2004
% 210.14/210.29  |- skos__scopeNote mesh__D014015
% 210.14/210.29       Centers for acquiring, characterizing, and storing organs or tissue for future use.%A%    
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014015 2000
% 210.14/210.29  |- skos__hiddenLabel mesh__D014015 Banking, Tissue
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014015 2006
% 210.14/210.29  |- mesh__dateRevised mesh__D014015 1993-11-29
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014015 2003
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014015 2005
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014015 1997
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014015 1999
% 210.14/210.29  |- skos__hiddenLabel mesh__D014015 Banks, Tissue
% 210.14/210.29  |- skos__prefLabel mesh__D014015 Tissue Banks
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014015 1996
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014015 1995
% 210.14/210.29  |- rdf__type mesh__D014015sskos__Concept
% 210.14/210.29  |- mesh__recordAuthorizer mesh__D014015 PLS
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014015 2002
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014015 1998
% 210.14/210.29  |- skos__hiddenLabel mesh__D014015 Bank, Tissue
% 210.14/210.29  |- skos__broader mesh__D014015smesh__D018070
% 210.14/210.29  |- mesh__dateCreated mesh__D005289 1974-12-12
% 210.14/210.29  |- skos__altLabel mesh__D005289 European Polecats
% 210.14/210.29  |- skos__hiddenLabel mesh__D005289 Polecat, Domestic
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D005289 2006
% 210.14/210.29  |- mesh__dateRevised mesh__D005289 2004-07-07
% 210.14/210.29  |- skos__hiddenLabel mesh__D005289 Domestic Polecat
% 210.14/210.29  |- mesh__recordAuthorizer mesh__D005289 sjn
% 210.14/210.29  |- mesh__historyNote mesh__D005289
% 210.14/210.29       91%28%75%29%; was see under CARNIVORA 1975-90   
% 210.14/210.29  |- skos__broader mesh__D005289smesh__D045969
% 210.14/210.29  |- mesh__recordMaintainer mesh__D005289 ags
% 210.14/210.29  |- skos__scopeNote mesh__D005289
% 210.14/210.29       Semidomesticated variety of European polecat much used for hunting RODENTS and/or RABBITS and as a laboratory animal. It is in the subfamily Mustelinae, family MUSTELIDAE.%A%    
% 210.14/210.29  |- skos__hiddenLabel mesh__D005289 Polecats, Domestic
% 210.14/210.29  |- mesh__recordOriginator mesh__D005289 NLM
% 210.14/210.29  |- mesh__dateEstablished mesh__D005289 1991-01-01
% 210.14/210.29  |- skos__hiddenLabel mesh__D005289 Polecats, European
% 210.14/210.29  |- mesh__publicMeSHNote mesh__D005289
% 210.14/210.29       91; was see under CARNIVORA 1975-90   
% 210.14/210.29  |- skos__hiddenLabel mesh__D005289 Ferret
% 210.14/210.29  |- rdf__type mesh__D005289sskos__Concept
% 210.14/210.29  |- skos__altLabel mesh__D005289 Mustela putorius furo
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D005289 2005
% 210.14/210.29  |- skos__prefLabel mesh__D005289 Ferrets
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D024443 2004
% 210.14/210.29  |- mesh__recordAuthorizer mesh__D024443 ags
% 210.14/210.29  |- mesh__publicMeSHNote mesh__D024443 2002   
% 210.14/210.29  |- skos__annotation mesh__D024443
% 210.14/210.29       ASPARTATE AMINOTRANSFERASE, MITOCHONDRIAL is also available%A%  
% 210.14/210.29  |- skos__hiddenLabel mesh__D024443 Oxaloacetate-Transaminase-1, Glutamate
% 210.14/210.29  |- mesh__dateRevised mesh__D024443 2005-07-08
% 210.14/210.29  |- skos__historyNote mesh__D024443
% 210.14/210.29       Aspartate Aminotransferases %28%1972-2001%29%
% 210.14/210.29  |- skos__altLabel mesh__D024443 Glutamate Oxaloacetate-Transaminase-1
% 210.14/210.29  |- skos__scopeNote mesh__D024443
% 210.14/210.29       An aspartate aminotransferase found in the CYTOPLASM.     
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D024443 2006
% 210.14/210.29  |- skos__broader mesh__D024443smesh__D001219
% 210.14/210.29  |- skos__hiddenLabel mesh__D024443 Cytoplasmic Aspartate Aminotransferase
% 210.14/210.29  |- rdf__type mesh__D024443sskos__Concept
% 210.14/210.29  |- skos__prefLabel mesh__D024443 Aspartate Aminotransferase, Cytoplasmic
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D024443 2005
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D024443 2006A
% 210.14/210.29  |- mesh__recordOriginator mesh__D024443 jmp
% 210.14/210.29  |- mesh__dateCreated mesh__D024443 2001-07-25
% 210.14/210.29  |- mesh__historyNote mesh__D024443 2002   
% 210.14/210.29  |- skos__hiddenLabel mesh__D024443 Aminotransferase, Cytoplasmic Aspartate
% 210.14/210.29  |- mesh__dateEstablished mesh__D024443 2002-01-01
% 210.14/210.29  |- mesh__recordMaintainer mesh__D024443 ags
% 210.14/210.29  |- mesh__dateCreated mesh__D018406 1994-01-25
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D018406 1999
% 210.14/210.29  |- skos__altLabel mesh__D018406 Physiology, Viral
% 210.14/210.29  |- mesh__recordMaintainer mesh__D018406 NNS
% 210.14/210.29  |- skos__hiddenLabel mesh__D018406 Viral Physiologies
% 210.14/210.29  |- skos__historyNote mesh__D018406 Viruses/physiology %28%1966-1997%29%
% 210.14/210.29  |- mesh__dateRevised mesh__D018406 1998-06-11
% 210.14/210.29  |- mesh__recordAuthorizer mesh__D018406 SJN
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D018406 2002
% 210.14/210.29  |- skos__annotation mesh__D018406
% 210.14/210.29       GEN or unspecified; prefer specifics; DF: VIRAL PHYSIOL   
% 210.14/210.29  |- mesh__recordOriginator mesh__D018406 PXP
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D018406 2004
% 210.14/210.29  |- mesh__dateEstablished mesh__D018406 1998-01-01
% 210.14/210.29  |- skos__related mesh__D018406smesh__D005827
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D018406 2001
% 210.14/210.29  |- skos__scopeNote mesh__D018406
% 210.14/210.29       Biological processes and activities of viruses.     
% 210.14/210.29  |- skos__related mesh__D018406smesh__D008827
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D018406 2006
% 210.14/210.29  |- mesh__publicMeSHNote mesh__D018406 98   
% 210.14/210.29  |- mesh__historyNote mesh__D018406 98; use explode 1995-97   
% 210.14/210.29  |- skos__prefLabel mesh__D018406 Viral Physiology
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D018406 2003
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D018406 2000
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D018406 2005
% 210.14/210.29  |- skos__broader mesh__D018406smesh__D008827
% 210.14/210.29  |- rdf__type mesh__D018406sskos__Concept
% 210.14/210.29  |- skos__hiddenLabel mesh__D018406 Physiologies, Viral
% 210.14/210.29  |- skos__hiddenLabel mesh__D010423 Hydrochloride, Pentazocine
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D010423 2002
% 210.14/210.29  |- mesh__recordMaintainer mesh__D010423 TWD
% 210.14/210.29  |- skos__prefLabel mesh__D010423 Pentazocine
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D010423 2006
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D010423 2004
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D010423 2005
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D010423 2001
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D010423 2003
% 210.14/210.29  |- skos__broader mesh__D010423smesh__D001575
% 210.14/210.29  |- skos__scopeNote mesh__D010423
% 210.14/210.29       The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. %28%From AMA Drug Evaluations Annual, 1991, p97%29%%A%    
% 210.14/210.29  |- rdf__type mesh__D010423sskos__Concept
% 210.14/210.29  |- mesh__recordAuthorizer mesh__D010423 sjn
% 210.14/210.29  |- mesh__recordOriginator mesh__D010423 NLM
% 210.14/210.29  |- mesh__dateRevised mesh__D010423 2000-06-22
% 210.14/210.29  |- mesh__publicMeSHNote mesh__D010423 66   
% 210.14/210.29  |- mesh__dateEstablished mesh__D010423 1966-01-01
% 210.14/210.29  |- mesh__dateCreated mesh__D010423 1999-01-01
% 210.14/210.29  |- mesh__historyNote mesh__D010423 66%28%64%29%   
% 210.14/210.29  |- skos__hiddenLabel mesh__D010423 Lactate, Pentazocine
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D001697 2003
% 210.14/210.29  |- mesh__recordAuthorizer mesh__D001697 sjn
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D001697 2004
% 210.14/210.29  |- mesh__recordOriginator mesh__D001697 NLM
% 210.14/210.29  |- mesh__dateCreated mesh__D001697 1999-01-01
% 210.14/210.29  |- mesh__publicMeSHNote mesh__D001697 98   
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D001697 2005
% 210.14/210.29  |- skos__scopeNote mesh__D001697
% 210.14/210.29       Substances used in biomedicine or dentistry predominantly for their physical, as opposed to chemical, properties.%A%    
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D001697 2001
% 210.14/210.29  |- skos__prefLabel mesh__D001697 Biomedical and Dental Materials
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D001697 2006
% 210.14/210.29  |- mesh__recordMaintainer mesh__D001697 jls
% 210.14/210.29  |- mesh__dateEstablished mesh__D001697 1998-01-01
% 210.14/210.29  |- skos__annotation mesh__D001697
% 210.14/210.29       GEN; prefer specifics; used for mapping supplementary chemicals%A%  
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D001697 2002
% 210.14/210.29  |- mesh__historyNote mesh__D001697 98; use explode 1974-97   
% 210.14/210.29  |- rdf__type mesh__D001697sskos__Concept
% 210.14/210.29  |- mesh__runningHead mesh__D001697 D25 - BIOMEDICAL AND DENTAL MATERIALS   
% 210.14/210.29  |- mesh__dateRevised mesh__D001697 2000-06-22
% 210.14/210.29  |- skos__historyNote mesh__D006382 Hemagglutination %28%1966-1969%29%
% 210.14/210.29  |- rdf__type mesh__D006382sskos__Concept
% 210.14/210.29  |- skos__hiddenLabel mesh__D006382 Hemadsorptions
% 210.14/210.29  |- skos__scopeNote mesh__D006382
% 210.14/210.29       A phenomenon manifested by an agent or substance adhering to or being adsorbed on the surface of a red blood cell, as tuberculin can be adsorbed on red blood cells under certain conditions. %28%Stedman, 25th ed%29%%A%    
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D006382 1999
% 210.14/210.29  |- mesh__dateCreated mesh__D006382 1999-01-01
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D006382 2004
% 210.14/210.29  |- mesh__dateEstablished mesh__D006382 1972-01-01
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D006382 2000
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D006382 2005
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D006382 2001
% 210.14/210.29  |- skos__annotation mesh__D006382
% 210.14/210.29       do not confuse with HEMOSORPTION see HEMOPERFUSION   
% 210.14/210.29  |- skos__prefLabel mesh__D006382 Hemadsorption
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D006382 2006
% 210.14/210.29  |- mesh__publicMeSHNote mesh__D006382 72   
% 210.14/210.29  |- mesh__historyNote mesh__D006382 72%28%70%29%   
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D006382 2002
% 210.14/210.29  |- skos__broader mesh__D006382smesh__D008827
% 210.14/210.29  |- mesh__recordOriginator mesh__D006382 NLM
% 210.14/210.29  |- mesh__recordMaintainer mesh__D006382 TGC
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D006382 1998
% 210.14/210.29  |- mesh__recordAuthorizer mesh__D006382 SJN
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D006382 2003
% 210.14/210.29  |- mesh__dateRevised mesh__D006382 1997-06-20
% 210.14/210.29  |- mesh__dateCreated mesh__D014814 1976-04-13
% 210.14/210.29  |- mesh__recordMaintainer mesh__D014814 ssb
% 210.14/210.29  |- mesh__recordAuthorizer mesh__D014814 sjn
% 210.14/210.29  |- mesh__historyNote mesh__D014814
% 210.14/210.29       91%28%77%29%; was see under VITAMINS 1977-90   
% 210.14/210.29  |- skos__hiddenLabel mesh__D014814 Chloride, Methylmethioninesulfonium
% 210.14/210.29  |- skos__historyNote mesh__D014814 Vitamins %28%1973-1976%29%
% 210.14/210.29  |- skos__scopeNote mesh__D014814
% 210.14/210.29       A vitamin found in green vegetables. It is used in the treatment of peptic ulcers, colitis, and gastritis and has an effect on secretory, acid-forming, and enzymatic functions of the intestinal tract.%A%    
% 210.14/210.29  |- skos__historyNote mesh__D014814 Methionine %28%1973-1976%29%
% 210.14/210.29  |- skos__hiddenLabel mesh__D014814 Methylsulfonium Chloride, Methionine
% 210.14/210.29  |- skos__altLabel mesh__D014814 Methionine Methylsulfonium Chloride
% 210.14/210.29  |- rdf__type mesh__D014814sskos__Concept
% 210.14/210.29  |- skos__broader mesh__D014814smesh__D008715
% 210.14/210.29  |- skos__hiddenLabel mesh__D014814 Chloride, Methionine Methylsulfonium
% 210.14/210.29  |- skos__annotation mesh__D014814
% 210.14/210.29       /ther use: coordinate disease with /drug ther, not /diet ther%A%  
% 210.14/210.29  |- mesh__publicMeSHNote mesh__D014814 91; was see under VITAMINS 1977-90   
% 210.14/210.29  |- skos__hiddenLabel mesh__D014814 S Methylmethionine
% 210.14/210.29  |- skos__prefLabel mesh__D014814 Vitamin U
% 210.14/210.29  |- mesh__dateEstablished mesh__D014814 1991-01-01
% 210.14/210.29  |- skos__altLabel mesh__D014814 Methylmethioninesulfonium Chloride
% 210.14/210.29  |- mesh__recordOriginator mesh__D014814 RLS
% 210.14/210.29  |- mesh__dateRevised mesh__D014814 2005-06-30
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014814 2006
% 210.14/210.29  |- mesh__historyNote mesh__D014016 72%28%68%29%   
% 210.14/210.29  |- mesh__dateCreated mesh__D014016 1999-01-01
% 210.14/210.29  |- skos__annotation mesh__D014016 DF: TISSUE CONDITIONING   
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014016 2004
% 210.14/210.29  |- mesh__recordAuthorizer mesh__D014016 PLS
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014016 2002
% 210.14/210.29  |- skos__altLabel mesh__D014016 Conditioning, Dental Tissue
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014016 2006
% 210.14/210.29  |- mesh__publicMeSHNote mesh__D014016 72   
% 210.14/210.29  |- skos__altLabel mesh__D014016 Tissue Conditioning, Dental
% 210.14/210.29  |- mesh__recordOriginator mesh__D014016 NLM
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014016 2003
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014016 2001
% 210.14/210.29  |- skos__prefLabel mesh__D014016 Tissue Conditioning %28%Dental%29%
% 210.14/210.29  |- mesh__activeMeSHYear mesh__D014016 2005
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D014016 1997
% 210.14/210.30  |- skos__scopeNote mesh__D014016
% 210.14/210.30       The use of a treatment material %28%tissue conditioner%29% to re-establish tone and health to irritated oral soft tissue, usually applied to the edentulous alveolar ridge.%A%    
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D014016 1999
% 210.14/210.30  |- mesh__recordMaintainer mesh__D014016 TAP
% 210.14/210.30  |- skos__altLabel mesh__D014016 Dental Tissue Conditioning
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D014016 2000
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D014016 1993
% 210.14/210.30  |- skos__historyNote mesh__D014016 Prosthodontics %28%1966-1967%29%
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D014016 1996
% 210.14/210.30  |- mesh__dateEstablished mesh__D014016 1972-01-01
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D014016 1995
% 210.14/210.30  |- rdf__type mesh__D014016sskos__Concept
% 210.14/210.30  |- skos__hiddenLabel mesh__D014016 Conditioning, Tissue %28%Dental%29%
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D014016 1998
% 210.14/210.30  |- skos__hiddenLabel mesh__D014016 Conditionings, Tissue %28%Dental%29%
% 210.14/210.30  |- skos__hiddenLabel mesh__D014016 Tissue Conditionings %28%Dental%29%
% 210.14/210.30  |- mesh__dateRevised mesh__D014016 1992-05-18
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D014016 1994
% 210.14/210.30  |- skos__broader mesh__D014016smesh__D011476
% 210.14/210.30  |- skos__historyNote mesh__D014016 Periodontics %28%1966-1967%29%
% 210.14/210.30  |- mesh__dateCreated mesh__D030481 2001-07-25
% 210.14/210.30  |- skos__prefLabel mesh__D030481 Pyruvate Dehydrogenase %28%Lipoamide%29%
% 210.14/210.30  |- skos__historyNote mesh__D030481
% 210.14/210.30       Pyruvate Dehydrogenase Complex %28%1983-2001%29%
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D030481 2006
% 210.14/210.30  |- skos__broader mesh__D030481smesh__D007658
% 210.14/210.30  |- skos__scopeNote mesh__D030481
% 210.14/210.30       The E1 component of the multienzyme PYRUVATE DEHYDROGENASE COMPLEX. It is composed of 2 alpha subunits %28%pyruvate dehydrogenase E1 alpha subunit%29% and 2 beta subunits %28%pyruvate dehydrogenase E1 beta subunit%29%.%A%    
% 210.14/210.30  |- mesh__dateEstablished mesh__D030481 2002-01-01
% 210.14/210.30  |- mesh__recordAuthorizer mesh__D030481 sjn
% 210.14/210.30  |- mesh__recordOriginator mesh__D030481 nns
% 210.14/210.30  |- mesh__dateRevised mesh__D030481 2005-06-30
% 210.14/210.30  |- mesh__publicMeSHNote mesh__D030481
% 210.14/210.30       2002; PYRUVATE DEHYDROGENASE %28%LIPOAMIDE%29% was indexed under PYRUVATE DEHYDROGENASE COMPLEX 1983-2001%A%  
% 210.14/210.30  |- skos__altLabel mesh__D030481 Pyruvate Dehydrogenase-E1
% 210.14/210.30  |- skos__altLabel mesh__D030481 Pyruvate Decarboxylase %28%Lipoamide%29%
% 210.14/210.30  |- mesh__recordMaintainer mesh__D030481 jmp
% 210.14/210.30  |- skos__broader mesh__D030481smesh__D011768
% 210.14/210.30  |- mesh__historyNote mesh__D030481
% 210.14/210.30       2002; use PYRUVATE DEHYDROGENASE %28%LIPOAMIDE%29% %28%NM%29% 1983-2001%A%  
% 210.14/210.30  |- skos__hiddenLabel mesh__D030481 Pyruvate Dehydrogenase E1
% 210.14/210.30  |- skos__altLabel mesh__D030481 Pyruvate Dehydrogenase Component E1
% 210.14/210.30  |- rdf__type mesh__D030481sskos__Concept
% 210.14/210.30  |- skos__altLabel mesh__D002790 CYP 7A
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D002790 2005
% 210.14/210.30  |- mesh__historyNote mesh__D002790 2003 %28%1975%29%   
% 210.14/210.30  |- skos__prefLabel mesh__D002790 Cholesterol 7-alpha-Hydroxylase
% 210.14/210.30  |- skos__broader mesh__D002790smesh__D013250
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D002790 2006
% 210.14/210.30  |- mesh__dateCreated mesh__D002790 1974-11-19
% 210.14/210.30  |- mesh__recordAuthorizer mesh__D002790 sjn
% 210.14/210.30  |- skos__altLabel mesh__D002790 Cholesterol 7alpha-Hydroxylase
% 210.14/210.30  |- skos__altLabel mesh__D002790 Cytochrome P-450 CYP7
% 210.14/210.30  |- skos__hiddenLabel mesh__D002790 Cholesterol 7alpha Hydroxylase
% 210.14/210.30  |- skos__altLabel mesh__D002790 CYP7
% 210.14/210.30  |- mesh__dateRevised mesh__D002790 2004-07-07
% 210.14/210.30  |- mesh__recordOriginator mesh__D002790 NLM
% 210.14/210.30  |- skos__altLabel mesh__D002790 Cholesterol 7-alpha-Monooxygenase
% 210.14/210.30  |- skos__hiddenLabel mesh__D002790 Cholesterol 7 alpha Hydroxylase
% 210.14/210.30  |- skos__altLabel mesh__D002790 Cytochrome P450 7
% 210.14/210.30  |- skos__scopeNote mesh__D002790
% 210.14/210.30       A membrane-bound cytochrome P450 enzyme that catalyzes the 7-alpha-hydroxylation of CHOLESTEROL in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP7, converts cholesterol to 7-alpha-hydroxycholesterol which is the first and rate-limiting step in the synthesis of BILE ACIDS.%A%    
% 210.14/210.30  |- mesh__publicMeSHNote mesh__D002790
% 210.14/210.30       2003; see CHOLESTEROL 7 ALPHA-MONOOXYGENASE 1997-2002, see CHOLESTEROL-7-HYDROXYLASE 1991-1996, see STEROID HYDROXYLASES 1975-1990%A%  
% 210.14/210.30  |- skos__hiddenLabel mesh__D002790 Cholesterol 7 alpha Monooxygenase
% 210.14/210.30  |- skos__historyNote mesh__D002790 Steroid Hydroxylases %28%1974%29%
% 210.14/210.30  |- mesh__recordMaintainer mesh__D002790 ssb
% 210.14/210.30  |- mesh__dateEstablished mesh__D002790 1991-01-01
% 210.14/210.30  |- skos__altLabel mesh__D002790 CYP 7
% 210.14/210.30  |- skos__altLabel mesh__D002790 CYP7A
% 210.14/210.30  |- skos__historyNote mesh__D002790 Cholesterol %28%1974%29%
% 210.14/210.30  |- skos__hiddenLabel mesh__D002790 Cholesterol 7 Hydroxylase
% 210.14/210.30  |- rdf__type mesh__D002790sskos__Concept
% 210.14/210.30  |- skos__hiddenLabel mesh__D002790 Cytochrome P 450 CYP7
% 210.14/210.30  |- skos__altLabel mesh__D002790 Cholesterol-7-Hydroxylase
% 210.14/210.30  |- skos__hiddenLabel mesh__D018407 Bacterial Physiologies
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D018407 1999
% 210.14/210.30  |- mesh__recordMaintainer mesh__D018407 NNS
% 210.14/210.30  |- skos__annotation mesh__D018407
% 210.14/210.30       GEN or unspecified; prefer specifics; DF: BACT PHYSIOL   
% 210.14/210.30  |- mesh__recordAuthorizer mesh__D018407 SJN
% 210.14/210.30  |- skos__altLabel mesh__D018407 Physiology, Bacterial
% 210.14/210.30  |- mesh__recordOriginator mesh__D018407 PXP
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D018407 2002
% 210.14/210.30  |- mesh__dateEstablished mesh__D018407 1998-01-01
% 210.14/210.30  |- skos__scopeNote mesh__D018407
% 210.14/210.30       Physiological processes and activities of bacteria.     
% 210.14/210.30  |- skos__related mesh__D018407smesh__D005827
% 210.14/210.30  |- mesh__publicMeSHNote mesh__D018407 98   
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D018407 2001
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D018407 2004
% 210.14/210.30  |- skos__related mesh__D018407smesh__D008827
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D018407 2000
% 210.14/210.30  |- skos__prefLabel mesh__D018407 Bacterial Physiology
% 210.14/210.30  |- mesh__historyNote mesh__D018407 98; use explode 1995-97   
% 210.14/210.30  |- rdf__type mesh__D018407sskos__Concept
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D018407 2003
% 210.14/210.30  |- skos__broader mesh__D018407smesh__D008827
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D018407 2006
% 210.14/210.30  |- skos__historyNote mesh__D018407 Bacteria/physiology %28%1966-1997%29%
% 210.14/210.30  |- skos__hiddenLabel mesh__D018407 Physiologies, Bacterial
% 210.14/210.30  |- mesh__dateRevised mesh__D018407 1998-06-10
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D018407 2005
% 210.14/210.30  |- mesh__dateCreated mesh__D018407 1994-01-25
% 210.14/210.30  |- skos__broader mesh__D010424smesh__D001463
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D010424 2005
% 210.14/210.30  |- mesh__recordAuthorizer mesh__D010424 sjn
% 210.14/210.30  |- mesh__recordOriginator mesh__D010424 NLM
% 210.14/210.30  |- skos__altLabel mesh__D010424 Pentobarbital, Monosodium Salt
% 210.14/210.30  |- rdf__type mesh__D010424sskos__Concept
% 210.14/210.30  |- mesh__dateCreated mesh__D010424 1999-01-01
% 210.14/210.30  |- skos__scopeNote mesh__D010424
% 210.14/210.30       A short-acting barbiturate that is effective as a sedative and hypnotic %28%but not as an anti-anxiety%29% agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. %28%From AMA Drug Evaluations Annual, 1994, p236%29%%A%    
% 210.14/210.30  |- skos__altLabel mesh__D010424 Pentobarbitone
% 210.14/210.30  |- mesh__dateRevised mesh__D010424 2003-07-09
% 210.14/210.30  |- mesh__recordMaintainer mesh__D010424 ssb
% 210.14/210.30  |- skos__altLabel mesh__D010424 Mebubarbital
% 210.14/210.30  |- skos__altLabel mesh__D010424 Ethaminal
% 210.14/210.30  |- skos__hiddenLabel mesh__D010424 Monosodium Salt Pentobarbital
% 210.14/210.30  |- skos__prefLabel mesh__D010424 Pentobarbital
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D010424 2006
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D010424 2004
% 210.14/210.30  |- skos__altLabel mesh__D001698 Engineering, Biomedical
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D001698 2003
% 210.14/210.30  |- skos__annotation mesh__D001698
% 210.14/210.30       SPEC: SPEC qualif; DF: BIOMED ENGINEERING   
% 210.14/210.30  |- mesh__recordOriginator mesh__D001698 NLM
% 210.14/210.30  |- mesh__dateEstablished mesh__D001698 1968-01-01
% 210.14/210.30  |- mesh__dateCreated mesh__D001698 1999-01-01
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D001698 2000
% 210.14/210.30  |- skos__related mesh__D001698smesh__D008491
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D001698 2004
% 210.14/210.30  |- mesh__historyNote mesh__D001698 68   
% 210.14/210.30  |- skos__scopeNote mesh__D001698
% 210.14/210.30       Application of principles and practices of engineering science to biomedical research and health care.%A%    
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D001698 2001
% 210.14/210.30  |- mesh__recordMaintainer mesh__D001698 jls
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D001698 2005
% 210.14/210.30  |- mesh__publicMeSHNote mesh__D001698 68   
% 210.14/210.30  |- mesh__dateRevised mesh__D001698 1999-11-03
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D001698 2002
% 210.14/210.30  |- skos__broader mesh__D001698smesh__D004738
% 210.14/210.30  |- skos__altLabel mesh__D001698 Engineering, Clinical
% 210.14/210.30  |- skos__broader mesh__D001698smesh__D006281
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D001698 2006
% 210.14/210.30  |- rdf__type mesh__D001698sskos__Concept
% 210.14/210.30  |- skos__prefLabel mesh__D001698 Biomedical Engineering
% 210.14/210.30  |- skos__related mesh__D001698smesh__D004582
% 210.14/210.30  |- skos__related mesh__D001698smesh__D020811
% 210.14/210.30  |- mesh__recordAuthorizer mesh__D001698 sjn
% 210.14/210.30  |- skos__broader mesh__D020852smesh__D020806
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D020852 2004
% 210.14/210.30  |- mesh__historyNote mesh__D020852 2000   
% 210.14/210.30  |- skos__hiddenLabel mesh__D020852 Encephalopathies, Lyme Disease
% 210.14/210.30  |- skos__altLabel mesh__D020852 Meningoencephalitis, Lyme
% 210.14/210.30  |- mesh__dateRevised mesh__D020852 2005-07-08
% 210.14/210.30  |- skos__scopeNote mesh__D020852
% 210.14/210.30       Nervous system infections caused by tick-borne spirochetes of the BORRELIA BURGDORFERI GROUP. The disease may affect elements of the central or peripheral nervous system in isolation or in combination. Common clinical manifestations include a lymphocytic meningitis, cranial neuropathy %28%most often a facial neuropathy%29%, POLYRADICULOPATHY, and a mild loss of memory and other cognitive functions. Less often more extensive inflammation involving the central nervous system %28%encephalomyelitis%29% may occur. In the peripheral nervous system, B. burgdorferi infection is associated with mononeuritis multiplex and polyradiculoneuritis. %28%From J Neurol Sci 1998 Jan 8;153%28%2%29%:182-91%29%%A%    
% 210.14/210.30  |- skos__altLabel mesh__D020852 Lyme Disease Encephalopathy
% 210.14/210.30  |- skos__historyNote mesh__D020852 Lyme Disease %28%1984-1999%29%
% 210.14/210.30  |- skos__altLabel mesh__D020852 Lyme Disease, Central Nervous System
% 210.14/210.30  |- skos__prefLabel mesh__D020852 Lyme Neuroborreliosis
% 210.14/210.30  |- skos__altLabel mesh__D020852 Lyme Borreliosis, Nervous System
% 210.14/210.30  |- mesh__recordMaintainer mesh__D020852 ags
% 210.14/210.30  |- skos__hiddenLabel mesh__D020852 Lyme Polyradiculopathies
% 210.14/210.30  |- mesh__recordAuthorizer mesh__D020852 ags
% 210.14/210.30  |- skos__hiddenLabel mesh__D020852 Polyradiculopathies, Lyme
% 210.14/210.30  |- skos__annotation mesh__D020852
% 210.14/210.30       coord IM with Borrelia %28%IM%29% + specific site/dis term %28%IM%29% if pertinent%A%  
% 210.14/210.30  |- skos__hiddenLabel mesh__D020852 Polyradiculitis, Lyme
% 210.14/210.30  |- skos__historyNote mesh__D020852
% 210.14/210.30       Encephalitis, Tick-Borne %28%1979-1983%29%
% 210.14/210.30  |- skos__hiddenLabel mesh__D020852 Borrelia burgdorferi Neuroborreliosis
% 210.14/210.30  |- skos__hiddenLabel mesh__D020852 Lyme Polyradiculitides
% 210.14/210.30  |- skos__altLabel mesh__D020852 Lyme Disease, Nervous System
% 210.14/210.30  |- rdf__type mesh__D020852sskos__Concept
% 210.14/210.30  |- skos__altLabel mesh__D020852 Nervous System Lyme Disease
% 210.14/210.30  |- mesh__recordOriginator mesh__D020852 KEV
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D020852 2005
% 210.14/210.30  |- skos__hiddenLabel mesh__D020852 Neuroborreliosis, Lyme
% 210.14/210.30  |- skos__hiddenLabel mesh__D020852 Lyme Disease Encephalopathies
% 210.14/210.30  |- skos__hiddenLabel mesh__D020852 Meningoradiculitis, Lyme
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D020852 2002
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D020852 2006A
% 210.14/210.30  |- skos__hiddenLabel mesh__D020852 Neuroborrelioses, Borrelia burgdorferi
% 210.14/210.30  |- mesh__publicMeSHNote mesh__D020852 2000   
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D020852 2006
% 210.14/210.30  |- mesh__dateEstablished mesh__D020852 2000-01-01
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D020852 2003
% 210.14/210.30  |- skos__altLabel mesh__D020852 Nervous System Lyme Borreliosis
% 210.14/210.30  |- skos__hiddenLabel mesh__D020852 Polyradiculitides, Lyme
% 210.14/210.30  |- mesh__dateCreated mesh__D020852 1999-11-03
% 210.14/210.30  |- skos__altLabel mesh__D020852 Neuroborreliosis, Borrelia burgdorferi
% 210.14/210.30  |- skos__altLabel mesh__D020852 Mononeuritis Multiplex, Lyme Disease
% 210.14/210.30  |- skos__broader mesh__D020852smesh__D008193
% 210.14/210.30  |- skos__hiddenLabel mesh__D020852 Polyradiculopathy, Lyme
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006383 2005
% 210.14/210.30  |- skos__hiddenLabel mesh__D006383 Inhibition Test, Hemadsorption
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006383 2002
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006383 2006
% 210.14/210.30  |- mesh__historyNote mesh__D006383 73%28%63%29%   
% 210.14/210.30  |- mesh__recordOriginator mesh__D006383 NLM
% 210.14/210.30  |- mesh__recordAuthorizer mesh__D006383 SJN
% 210.14/210.30  |- skos__hiddenLabel mesh__D006383 Tests, Hemadsorption Inhibition
% 210.14/210.30  |- mesh__dateRevised mesh__D006383 1997-06-20
% 210.14/210.30  |- skos__hiddenLabel mesh__D006383 Test, Hemadsorption Inhibition
% 210.14/210.30  |- skos__hiddenLabel mesh__D006383 Hemadsorption Inhibition Test
% 210.14/210.30  |- mesh__recordMaintainer mesh__D006383 PXP
% 210.14/210.30  |- skos__annotation mesh__D006383 NIM   
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006383 1998
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006383 2003
% 210.14/210.30  |- skos__prefLabel mesh__D006383 Hemadsorption Inhibition Tests
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006383 2000
% 210.14/210.30  |- rdf__type mesh__D006383sskos__Concept
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006383 1999
% 210.14/210.30  |- mesh__dateCreated mesh__D006383 1999-01-01
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006383 2004
% 210.14/210.30  |- skos__hiddenLabel mesh__D006383 Inhibition Tests, Hemadsorption
% 210.14/210.30  |- mesh__dateEstablished mesh__D006383 1973-01-01
% 210.14/210.30  |- skos__broader mesh__D006383smesh__D012698
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006383 2001
% 210.14/210.30  |- mesh__publicMeSHNote mesh__D006383 73   
% 210.14/210.30  |- skos__annotation mesh__D014815
% 210.14/210.30       deficiency = AVITAMINOSIS but prefer specific precoordinated vitamin deficiency terms %28%avitaminosis A = VITAMIN A DEFICIENCY etc%29%; ther use: coordinate disease term with /drug ther, not /diet ther%A%  
% 210.14/210.30  |- mesh__recordOriginator mesh__D014815 NLM
% 210.14/210.30  |- skos__scopeNote mesh__D014815
% 210.14/210.30       A general term for a number of unrelated organic substances that occur in many foods in small amounts and that are necessary in trace amounts for the normal metabolic functioning of the body. They may be water-soluble or fat-soluble. %28%Dorland, 28th ed%29%%A%    
% 210.14/210.30  |- rdf__type mesh__D014815sskos__Concept
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D014815 2006A
% 210.14/210.30  |- mesh__recordMaintainer mesh__D014815 ags
% 210.14/210.30  |- mesh__recordAuthorizer mesh__D014815 ags
% 210.14/210.30  |- mesh__dateRevised mesh__D014815 2005-07-08
% 210.14/210.30  |- skos__broader mesh__D014815smesh__D018977
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D014815 2006
% 210.14/210.30  |- skos__prefLabel mesh__D014815 Vitamins
% 210.14/210.30  |- mesh__dateCreated mesh__D014815 1999-01-01
% 210.14/210.30  |- mesh__recordAuthorizer mesh__D019500 sjn
% 210.14/210.30  |- skos__scopeNote mesh__D019500
% 210.14/210.30       Works containing informational articles on subjects in every field of knowledge, usually arranged in alphabetical order, or a similar work limited to a special field or subject. %28%From The ALA Glossary of Library and Information Science, 1983%29%%A%    
% 210.14/210.30  |- skos__altLabel mesh__D019500 Encyclopedias %28%PT%29%
% 210.14/210.30  |- skos__broader mesh__D019500smesh__D052180
% 210.14/210.30  |- mesh__dateCreated mesh__D019500 1996-06-21
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D019500 2006
% 210.14/210.30  |- mesh__recordOriginator mesh__D019500 TGC
% 210.14/210.30  |- mesh__dateRevised mesh__D019500 2005-06-30
% 210.14/210.30  |- mesh__historyNote mesh__D019500 1997   
% 210.14/210.30  |- mesh__dateEstablished mesh__D019500 1997-01-01
% 210.14/210.30  |- skos__prefLabel mesh__D019500 Encyclopedias %5B%Publication Type%5D%
% 210.14/210.30  |- mesh__recordMaintainer mesh__D019500 jls
% 210.14/210.30  |- skos__annotation mesh__D019500
% 210.14/210.30       publication type only; for encyclopedias as a subject, index under main heading ENCYCLOPEDIAS%A%  
% 210.14/210.30  |- rdf__type mesh__D019500sskos__Concept
% 210.14/210.30  |- skos__related mesh__D002791smesh__D006938
% 210.14/210.30  |- skos__broader mesh__D002791smesh__D002784
% 210.14/210.30  |- skos__scopeNote mesh__D002791
% 210.14/210.30       Cholesterol present in food, especially in animal products.%A%    
% 210.14/210.30  |- mesh__publicMeSHNote mesh__D002791 73   
% 210.14/210.30  |- mesh__recordMaintainer mesh__D002791 ssb
% 210.14/210.30  |- mesh__historyNote mesh__D002791 73   
% 210.14/210.30  |- skos__related mesh__D002791smesh__D006937
% 210.14/210.30  |- skos__altLabel mesh__D002791 Dietary Cholesterol
% 210.14/210.30  |- skos__historyNote mesh__D002791 Dietary Fats %28%1966-1972%29%
% 210.14/210.30  |- mesh__dateRevised mesh__D002791 2003-07-09
% 210.14/210.30  |- skos__broader mesh__D002791smesh__D004041
% 210.14/210.30  |- skos__prefLabel mesh__D002791 Cholesterol, Dietary
% 210.14/210.30  |- rdf__type mesh__D002791sskos__Concept
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D002791 2005
% 210.14/210.30  |- skos__historyNote mesh__D002791 Cholesterol %28%1966-1972%29%
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D002791 2004
% 210.14/210.30  |- mesh__recordAuthorizer mesh__D002791 sjn
% 210.14/210.30  |- mesh__dateEstablished mesh__D002791 1973-01-01
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D002791 2006
% 210.14/210.30  |- mesh__dateCreated mesh__D002791 1999-01-01
% 210.14/210.30  |- skos__annotation mesh__D002791
% 210.14/210.30       /adv eff: coord with disease /etiol, not /chem ind   
% 210.14/210.30  |- mesh__recordOriginator mesh__D002791 NLM
% 210.14/210.30  |- mesh__recordAuthorizer mesh__D018408 sjn
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D018408 2004
% 210.14/210.30  |- mesh__dateRevised mesh__D018408 2000-06-22
% 210.14/210.30  |- skos__hiddenLabel mesh__D018408 Techniques, Voltage-Clamp
% 210.14/210.30  |- mesh__recordOriginator mesh__D018408 PXP
% 210.14/210.30  |- skos__hiddenLabel mesh__D018408 Technics, Patch-Clamp
% 210.14/210.30  |- skos__hiddenLabel mesh__D018408 Technique, Voltage-Clamp
% 210.14/210.30  |- mesh__publicMeSHNote mesh__D018408 95   
% 210.14/210.30  |- mesh__historyNote mesh__D018408 95   
% 210.14/210.30  |- mesh__dateEstablished mesh__D018408 1995-01-01
% 210.14/210.30  |- skos__hiddenLabel mesh__D018408 Technic, Voltage-Clamp
% 210.14/210.30  |- skos__hiddenLabel mesh__D018408 Voltage Clamp Techniques
% 210.14/210.30  |- skos__historyNote mesh__D018408 Electrophysiology %28%1975-1994%29%
% 210.14/210.30  |- skos__hiddenLabel mesh__D018408 Voltage-Clamp Technic
% 210.14/210.30  |- skos__hiddenLabel mesh__D018408 Voltage Clamp Technics
% 210.14/210.30  |- skos__hiddenLabel mesh__D018408 Whole Cell Recording
% 210.14/210.30  |- mesh__dateCreated mesh__D018408 1994-01-25
% 210.14/210.30  |- skos__hiddenLabel mesh__D018408 Technique, Patch-Clamp
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D018408 2001
% 210.14/210.30  |- skos__hiddenLabel mesh__D018408 Recording, Whole-Cell
% 210.14/210.30  |- rdf__type mesh__D018408sskos__Concept
% 210.14/210.30  |- skos__annotation mesh__D018408
% 210.14/210.30       a cytol technique for removing a tiny patch of plasma membrane; NIM%A%  
% 210.14/210.30  |- skos__prefLabel mesh__D018408 Patch-Clamp Techniques
% 210.14/210.30  |- skos__historyNote mesh__D018408 Ion Channels %28%1978-1994%29%
% 210.14/210.30  |- skos__altLabel mesh__D018408 Patch-Clamp Technics
% 210.14/210.30  |- skos__hiddenLabel mesh__D018408 Technics, Voltage-Clamp
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D018408 2005
% 210.14/210.30  |- skos__broader mesh__D018408smesh__D003584
% 210.14/210.30  |- skos__hiddenLabel mesh__D018408 Recordings, Whole-Cell
% 210.14/210.30  |- skos__hiddenLabel mesh__D018408 Technic, Patch-Clamp
% 210.14/210.30  |- skos__altLabel mesh__D018408 Voltage-Clamp Technics
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D018408 2002
% 210.14/210.30  |- skos__historyNote mesh__D018408 Membrane Potentials %28%1975-1994%29%
% 210.14/210.30  |- skos__hiddenLabel mesh__D018408 Patch Clamp Techniques
% 210.14/210.30  |- skos__hiddenLabel mesh__D018408 Patch-Clamp Technique
% 210.14/210.30  |- skos__hiddenLabel mesh__D018408 Whole-Cell Recordings
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D018408 2006
% 210.14/210.30  |- skos__hiddenLabel mesh__D018408 Patch-Clamp Technic
% 210.14/210.30  |- skos__scopeNote mesh__D018408
% 210.14/210.30       An electrophysiologic technique for studying cells, cell membranes, and occasionally isolated organelles. All patch-clamp methods rely on a very high-resistance seal between a micropipette and a membrane; the seal is usually attained by gentle suction. The four most common variants include on-cell patch, inside-out patch, outside-out patch, and whole-cell clamp. Patch-clamp methods are commonly used to voltage clamp, that is control the voltage across the membrane and measure current flow, but current-clamp methods, in which the current is controlled and the voltage is measured, are also used.%A%    
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D018408 2003
% 210.14/210.30  |- skos__hiddenLabel mesh__D018408 Patch Clamp Technics
% 210.14/210.30  |- mesh__recordMaintainer mesh__D018408 TGC
% 210.14/210.30  |- skos__hiddenLabel mesh__D018408 Voltage-Clamp Technique
% 210.14/210.30  |- skos__hiddenLabel mesh__D018408 Techniques, Patch-Clamp
% 210.14/210.30  |- rdf__type mesh__D010425sskos__Concept
% 210.14/210.30  |- skos__hiddenLabel mesh__D010425 Tartrate, Pentolinium
% 210.14/210.30  |- mesh__dateRevised mesh__D010425 2001-07-25
% 210.14/210.30  |- mesh__recordAuthorizer mesh__D010425 sjn
% 210.14/210.30  |- skos__prefLabel mesh__D010425 Pentolinium Tartrate
% 210.14/210.30  |- mesh__dateCreated mesh__D010425 1999-01-01
% 210.14/210.30  |- mesh__recordMaintainer mesh__D010425 CCR
% 210.14/210.30  |- mesh__recordOriginator mesh__D010425 NLM
% 210.14/210.30  |- skos__altLabel mesh__D010425 Pentolonium Tartrate
% 210.14/210.30  |- skos__broader mesh__D010425smesh__D011759
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D010425 2006
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D010425 2002
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D010425 2004
% 210.14/210.30  |- skos__scopeNote mesh__D010425
% 210.14/210.30       A nicotinic antagonist that has been used as a ganglionic blocking agent in hypertension.%A%    
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D010425 2005
% 210.14/210.30  |- skos__hiddenLabel mesh__D010425 Tartrate, Pentolonium
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D010425 2003
% 210.14/210.30  |- skos__broader mesh__D009666Q000557smesh__D009666
% 210.14/210.30  |- mesh__preferredCombination mesh__D009666Q000557smesh__D009297Q000557
% 210.14/210.30  |- rdf__type mesh__D009666Q000557smesh__CompoundConcept
% 210.14/210.30  |- mesh__publicMeSHNote mesh__D015110
% 210.14/210.30       77; PHENPROCOUMON was see under COUMARINS 1975-76   
% 210.14/210.30  |- mesh__recordMaintainer mesh__D015110 ssb
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D015110 2006
% 210.14/210.30  |- skos__prefLabel mesh__D015110 4-Hydroxycoumarins
% 210.14/210.30  |- mesh__historyNote mesh__D015110 77   
% 210.14/210.30  |- mesh__recordOriginator mesh__D015110 SH
% 210.14/210.30  |- mesh__dateRevised mesh__D015110 2005-06-30
% 210.14/210.30  |- skos__scopeNote mesh__D015110
% 210.14/210.30       Substances found in many plants, containing the 4-hydroxycoumarin radical. They interfere with vitamin K and the blood clotting mechanism, are tightly protein-bound, inhibit mitochondrial and microsomal enzymes, and are used as oral anticoagulants.%A%    
% 210.14/210.30  |- rdf__type mesh__D015110sskos__Concept
% 210.14/210.30  |- mesh__dateCreated mesh__D015110 1976-04-13
% 210.14/210.30  |- skos__hiddenLabel mesh__D015110 4 Hydroxycoumarins
% 210.14/210.30  |- skos__annotation mesh__D015110 /biosyn permitted if by plant   
% 210.14/210.30  |- mesh__recordAuthorizer mesh__D015110 sjn
% 210.14/210.30  |- mesh__dateEstablished mesh__D015110 1977-01-01
% 210.14/210.30  |- skos__historyNote mesh__D015110 Coumarins %28%1972-1976%29%
% 210.14/210.30  |- skos__broader mesh__D015110smesh__D003374
% 210.14/210.30  |- skos__broader mesh__D001699smesh__D013223
% 210.14/210.30  |- mesh__dateRevised mesh__D001699 2005-06-30
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D001699 2006
% 210.14/210.30  |- rdf__type mesh__D001699sskos__Concept
% 210.14/210.30  |- mesh__recordAuthorizer mesh__D001699 sjn
% 210.14/210.30  |- skos__prefLabel mesh__D001699 Biometry
% 210.14/210.30  |- mesh__recordOriginator mesh__D001699 NLM
% 210.14/210.30  |- mesh__recordMaintainer mesh__D001699 nns
% 210.14/210.30  |- skos__scopeNote mesh__D001699
% 210.14/210.30       The use of statistical methods to analyze biological observations and phenomena.%A%    
% 210.14/210.30  |- skos__broader mesh__D001699smesh__D015991
% 210.14/210.30  |- mesh__dateCreated mesh__D001699 1999-01-01
% 210.14/210.30  |- skos__altLabel mesh__D001699 Biostatistics
% 210.14/210.30  |- skos__altLabel mesh__D001699 Biometrics
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006384 1997
% 210.14/210.30  |- mesh__dateRevised mesh__D006384 1992-05-15
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006384 2001
% 210.14/210.30  |- skos__prefLabel mesh__D006384 Hemagglutination
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006384 1993
% 210.14/210.30  |- skos__broader mesh__D006384smesh__D000371
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006384 2002
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006384 1998
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006384 2003
% 210.14/210.30  |- mesh__recordOriginator mesh__D006384 NLM
% 210.14/210.30  |- mesh__recordMaintainer mesh__D006384 TAP
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006384 1994
% 210.14/210.30  |- rdf__type mesh__D006384sskos__Concept
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006384 1999
% 210.14/210.30  |- mesh__dateCreated mesh__D006384 1999-01-01
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006384 2004
% 210.14/210.30  |- mesh__recordAuthorizer mesh__D006384 PLS
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006384 1995
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006384 2005
% 210.14/210.30  |- skos__annotation mesh__D006384
% 210.14/210.30       intravascular hemagglutination = ERYTHROCYTE AGGREGATION, INTRAVASCULAR%A%  
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006384 2000
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006384 1996
% 210.14/210.30  |- skos__hiddenLabel mesh__D006384 Hemagglutinations
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D006384 2006
% 210.14/210.30  |- skos__hiddenLabel mesh__D014816 Duct, Vitelline
% 210.14/210.30  |- skos__hiddenLabel mesh__D014816 Vitelline Ducts
% 210.14/210.30  |- skos__hiddenLabel mesh__D014816 Ducts, Vitelline
% 210.14/210.30  |- mesh__historyNote mesh__D014816 79; was VITELLINE DUCTS 1963-78   
% 210.14/210.30  |- skos__hiddenLabel mesh__D014816 Omphalomesenteric Ducts
% 210.14/210.30  |- skos__altLabel mesh__D014816 Omphalomesenteric Duct
% 210.14/210.30  |- skos__hiddenLabel mesh__D014816 Ducts, Omphalomesenteric
% 210.14/210.30  |- mesh__onlineNote mesh__D014816
% 210.14/210.30       use VITELLINE DUCT to search VITELLINE DUCTS 1966-78   
% 210.14/210.30  |- skos__hiddenLabel mesh__D014816 Duct, Omphalomesenteric
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D014816 2006
% 210.14/210.30  |- mesh__publicMeSHNote mesh__D014816 79; was VITELLINE DUCTS 1963-78   
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D014816 2004
% 210.14/210.30  |- mesh__dateCreated mesh__D014816 1999-01-01
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D014816 2005
% 210.14/210.30  |- mesh__recordOriginator mesh__D014816 NLM
% 210.14/210.30  |- skos__broader mesh__D014816smesh__D004622
% 210.14/210.30  |- mesh__recordMaintainer mesh__D014816 lkt
% 210.14/210.30  |- mesh__recordAuthorizer mesh__D014816 sjn
% 210.14/210.30  |- skos__scopeNote mesh__D014816
% 210.14/210.30       The narrow tube connecting the YOLK SAC with the midgut of the EMBRYO; persistence of all or part of it in post-fetal life produces abnormalities, of which the commonest is MECKEL DIVERTICULUM.%A%    
% 210.14/210.30  |- skos__related mesh__D014816smesh__D008467
% 210.14/210.30  |- rdf__type mesh__D014816sskos__Concept
% 210.14/210.30  |- skos__prefLabel mesh__D014816 Vitelline Duct
% 210.14/210.30  |- mesh__dateRevised mesh__D014816 2003-07-09
% 210.14/210.30  |- skos__annotation mesh__D014018
% 210.14/210.30       distrib of drugs or chem in organs %26% tissues; GEN only: not a substitute for organ /metab or organ /chem; never IM; coord NIM with substance /pharmacokin %28%IM%29% or /metab %28%IM%29%%A%  
% 210.14/210.30  |- skos__scopeNote mesh__D014018
% 210.14/210.30       Accumulation of a drug or chemical substance in various organs %28%including those not relevant to its pharmacologic or therapeutic action%29%. This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios.%A%    
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D014018 2005
% 210.14/210.30  |- mesh__recordAuthorizer mesh__D014018 sjn
% 210.14/210.30  |- mesh__dateRevised mesh__D014018 2004-07-07
% 210.14/210.30  |- skos__broader mesh__D014018smesh__D010599
% 210.14/210.30  |- skos__prefLabel mesh__D014018 Tissue Distribution
% 210.14/210.30  |- mesh__activeMeSHYear mesh__D014018 2006
% 210.14/210.30  |- mesh__dateEstablished mesh__D014018 1978-01-01
% 210.14/210.31  |- mesh__publicMeSHNote mesh__D014018 78   
% 210.14/210.31  |- skos__historyNote mesh__D014018 Organ Specificity %28%1966-1977%29%
% 210.14/210.31  |- mesh__recordMaintainer mesh__D014018 ssb
% 210.14/210.31  |- rdf__type mesh__D014018sskos__Concept
% 210.14/210.31  |- skos__hiddenLabel mesh__D014018 Distributions, Tissue
% 210.14/210.31  |- skos__hiddenLabel mesh__D014018 Distribution, Tissue
% 210.14/210.31  |- skos__hiddenLabel mesh__D014018 Tissue Distributions
% 210.14/210.31  |- skos__broader mesh__D014018smesh__D008660
% 210.14/210.31  |- mesh__historyNote mesh__D014018 78   
% 210.14/210.31  |- mesh__recordOriginator mesh__D014018 VDK
% 210.14/210.31  |- mesh__dateCreated mesh__D014018 1977-04-27
% 210.14/210.31  |- skos__prefLabel mesh__D002792 Cholestyramine
% 210.14/210.31  |- mesh__recordOriginator mesh__D002792 NLM
% 210.14/210.31  |- mesh__historyNote mesh__D002792 66%28%64%29%   
% 210.14/210.31  |- skos__scopeNote mesh__D002792
% 210.14/210.31       A strongly basic anion exchange resin whose main constituent is polystyrene trimethylbenzylammonium as Cl%28%-%29% anion. It exchanges chloride ions with bile salts, thus decreasing their concentration and that of cholesterol. It is used as a hypocholesteremic in diarrhea and biliary obstruction, and as an antipruritic.%A%    
% 210.14/210.31  |- skos__hiddenLabel mesh__D002792 Resin, Cholestyramine
% 210.14/210.31  |- rdf__type mesh__D002792sskos__Concept
% 210.14/210.31  |- skos__broader mesh__D002792smesh__D011137
% 210.14/210.31  |- mesh__publicMeSHNote mesh__D002792 66   
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D002792 2005
% 210.14/210.31  |- mesh__recordMaintainer mesh__D002792 jmp
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D002792 2006
% 210.14/210.31  |- mesh__dateCreated mesh__D002792 1999-01-01
% 210.14/210.31  |- skos__altLabel mesh__D002792 Colestyramin
% 210.14/210.31  |- skos__altLabel mesh__D002792 Cholestyramine Resin
% 210.14/210.31  |- skos__altLabel mesh__D002792 Colestyramine
% 210.14/210.31  |- mesh__dateEstablished mesh__D002792 1966-01-01
% 210.14/210.31  |- mesh__dateRevised mesh__D002792 2004-07-07
% 210.14/210.31  |- mesh__recordAuthorizer mesh__D002792 sjn
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D018409 2001
% 210.14/210.31  |- skos__altLabel mesh__D018409 Injuries, Foot
% 210.14/210.31  |- mesh__dateEstablished mesh__D018409 1995-01-01
% 210.14/210.31  |- rdf__type mesh__D018409sskos__Concept
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D018409 2003
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D018409 2006
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D018409 2000
% 210.14/210.31  |- skos__prefLabel mesh__D018409 Foot Injuries
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D018409 2005
% 210.14/210.31  |- skos__scopeNote mesh__D018409
% 210.14/210.31       General or unspecified injuries involving the foot.     
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D018409 1997
% 210.14/210.31  |- mesh__dateCreated mesh__D018409 1994-06-28
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D018409 1996
% 210.14/210.31  |- mesh__onlineNote mesh__D018409
% 210.14/210.31       use FOOT INJURIES to search FOOT/injuries 1966-94   
% 210.14/210.31  |- mesh__publicMeSHNote mesh__D018409 95; was FOOT/injuries 1966-94   
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D018409 1999
% 210.14/210.31  |- skos__broader mesh__D018409smesh__D007869
% 210.14/210.31  |- skos__annotation mesh__D018409
% 210.14/210.31       GEN or unspecified; consider also /inj with specific sites of foot%A%  
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D018409 1998
% 210.14/210.31  |- mesh__historyNote mesh__D018409 95; was FOOT/injuries 1966-94   
% 210.14/210.31  |- skos__hiddenLabel mesh__D018409 Injury, Foot
% 210.14/210.31  |- skos__historyNote mesh__D018409 Foot/injuries %28%1966-1994%29%
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D018409 1995
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D018409 2002
% 210.14/210.31  |- skos__hiddenLabel mesh__D018409 Foot Injury
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D018409 2004
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 Sulfate, Xylan
% 210.14/210.31  |- skos__altLabel mesh__D010426 HOE-946
% 210.14/210.31  |- skos__prefLabel mesh__D010426 Pentosan Sulfuric Polyester
% 210.14/210.31  |- mesh__recordAuthorizer mesh__D010426 sjn
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 SP 54
% 210.14/210.31  |- skos__altLabel mesh__D010426 BAY-946
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 SP54, Xylan
% 210.14/210.31  |- skos__historyNote mesh__D010426 Polysaccharides %28%1970-1974%29%
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 Sulfuric Polyester, Pentosane
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 Xylan, Polysulfated
% 210.14/210.31  |- skos__historyNote mesh__D010426 Sulfuric Acids %28%1972-1974%29%
% 210.14/210.31  |- mesh__publicMeSHNote mesh__D010426
% 210.14/210.31       1991; see POLYSACCHARIDES 1975-1990   
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 946, HOE-BAY
% 210.14/210.31  |- mesh__dateCreated mesh__D010426 1974-11-19
% 210.14/210.31  |- skos__altLabel mesh__D010426 Pentosan Polysulfate Sodium
% 210.14/210.31  |- skos__altLabel mesh__D010426 Polysulfated Xylan
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 PZ 68
% 210.14/210.31  |- mesh__dateRevised mesh__D010426 2005-06-30
% 210.14/210.31  |- skos__altLabel mesh__D010426 Polypentose Sulfate
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 54, Tavan SP
% 210.14/210.31  |- skos__altLabel mesh__D010426 PZ68
% 210.14/210.31  |- skos__altLabel mesh__D010426 HOE-BAY 946
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 SP 54, Tavan
% 210.14/210.31  |- skos__altLabel mesh__D010426 Xylan Sulfate
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D010426 2006
% 210.14/210.31  |- mesh__recordMaintainer mesh__D010426 ssb
% 210.14/210.31  |- skos__altLabel mesh__D010426 Pentosane Sulfuric Polyester
% 210.14/210.31  |- mesh__dateEstablished mesh__D010426 1991-01-01
% 210.14/210.31  |- mesh__recordOriginator mesh__D010426 NLM
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 Polyester, Pentosane Sulfuric
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 Polyester, Pentosan Sulfuric
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 Sulfuric Polyester, Pentosan
% 210.14/210.31  |- skos__broader mesh__D010426smesh__D011134
% 210.14/210.31  |- skos__scopeNote mesh__D010426
% 210.14/210.31       A sulfated pentosyl polysaccharide with heparin-like properties.%A%    
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 Polysulfate, Pentosan
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 Sulfate, Polypentose
% 210.14/210.31  |- rdf__type mesh__D010426sskos__Concept
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 HOE BAY 946
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 Sodium, Pentosan Polysulphate
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 HOE 946
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 Sodium, Pentosan Polysulfate
% 210.14/210.31  |- mesh__historyNote mesh__D010426 1991%28%1975%29%   
% 210.14/210.31  |- skos__broader mesh__D010426smesh__D013464
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 SP54
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 BAY 946
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 Polysulfate Sodium, Pentosan
% 210.14/210.31  |- skos__hiddenLabel mesh__D010426 Polysulphate Sodium, Pentosan
% 210.14/210.31  |- skos__hiddenLabel mesh__D015111 Dioxygenase, 4-Hydroxyphenylpyruvate
% 210.14/210.31  |- mesh__recordMaintainer mesh__D015111 ags
% 210.14/210.31  |- skos__prefLabel mesh__D015111 4-Hydroxyphenylpyruvate Dioxygenase
% 210.14/210.31  |- skos__scopeNote mesh__D015111
% 210.14/210.31       An enzyme that catalyzes the conversion of 4-hydroxyphenylpyruvate plus oxygen to homogentisic acid and carbon dioxide. EC 1.13.11.27.%A%    
% 210.14/210.31  |- skos__altLabel mesh__D015111 P-Hydroxyphenylpyruvate Oxidase
% 210.14/210.31  |- skos__hiddenLabel mesh__D015111 Hydroxylase, para-Hydroxyphenylpyruvate
% 210.14/210.31  |- mesh__dateCreated mesh__D015111 1974-11-19
% 210.14/210.31  |- skos__historyNote mesh__D015111 Phenylpyruvic Acids %28%1974%29%
% 210.14/210.31  |- skos__hiddenLabel mesh__D015111 P Hydroxyphenylpyruvate Hydroxylase
% 210.14/210.31  |- skos__altLabel mesh__D015111 para-Hydroxyphenylpyruvate Hydroxylase
% 210.14/210.31  |- mesh__recordOriginator mesh__D015111 NLM
% 210.14/210.31  |- rdf__type mesh__D015111sskos__Concept
% 210.14/210.31  |- skos__altLabel mesh__D015111 P-Hydroxyphenylpyruvate Hydroxylase
% 210.14/210.31  |- mesh__dateEstablished mesh__D015111 1991-01-01
% 210.14/210.31  |- mesh__historyNote mesh__D015111
% 210.14/210.31       91%28%75%29%; was see under OXYGENASES 1975-90   
% 210.14/210.31  |- skos__hiddenLabel mesh__D015111 Hydroxylase, P-Hydroxyphenylpyruvate
% 210.14/210.31  |- mesh__dateRevised mesh__D015111 2005-06-30
% 210.14/210.31  |- skos__historyNote mesh__D015111 Oxygenases %28%1974%29%
% 210.14/210.31  |- skos__hiddenLabel mesh__D015111 P Hydroxyphenylpyruvate Oxidase
% 210.14/210.31  |- skos__altLabel mesh__D015111 para-Hydroxyphenylpyruvate Oxidase
% 210.14/210.31  |- mesh__publicMeSHNote mesh__D015111
% 210.14/210.31       91; was see under OXYGENASES 1975-90   
% 210.14/210.31  |- skos__hiddenLabel mesh__D015111 para Hydroxyphenylpyruvate Hydroxylase
% 210.14/210.31  |- skos__broader mesh__D015111smesh__D049308
% 210.14/210.31  |- skos__hiddenLabel mesh__D015111 Oxidase, para-Hydroxyphenylpyruvate
% 210.14/210.31  |- skos__hiddenLabel mesh__D015111 Oxidase, P-Hydroxyphenylpyruvate
% 210.14/210.31  |- skos__hiddenLabel mesh__D015111 para Hydroxyphenylpyruvate Oxidase
% 210.14/210.31  |- skos__annotation mesh__D015111
% 210.14/210.31       /defic: consider also TYROSINE /blood %28%IM%29% + AMINO ACID METABOLISM, INBORN ERRORS %28%IM%29%%A%  
% 210.14/210.31  |- mesh__recordAuthorizer mesh__D015111 sjn
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D015111 2006
% 210.14/210.31  |- skos__annotation mesh__D006385 NIM   
% 210.14/210.31  |- skos__prefLabel mesh__D006385 Hemagglutination Inhibition Tests
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D006385 2002
% 210.14/210.31  |- mesh__recordMaintainer mesh__D006385 PXP
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D006385 2006
% 210.14/210.31  |- skos__broader mesh__D006385smesh__D012698
% 210.14/210.31  |- skos__hiddenLabel mesh__D006385 Tests, Hemagglutination Inhibition
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D006385 2001
% 210.14/210.31  |- mesh__dateCreated mesh__D006385 1999-01-01
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D006385 2000
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D006385 2005
% 210.14/210.31  |- skos__scopeNote mesh__D006385
% 210.14/210.31       Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination.%A%    
% 210.14/210.31  |- mesh__recordAuthorizer mesh__D006385 SJN
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D006385 2004
% 210.14/210.31  |- mesh__dateRevised mesh__D006385 1997-06-20
% 210.14/210.31  |- skos__altLabel mesh__D006385 Hemagglutination Inhibition Test
% 210.14/210.31  |- skos__hiddenLabel mesh__D006385 Test, Hemagglutination Inhibition
% 210.14/210.31  |- skos__hiddenLabel mesh__D006385 Inhibition Test, Hemagglutination
% 210.14/210.31  |- skos__hiddenLabel mesh__D006385 Inhibition Tests, Hemagglutination
% 210.14/210.31  |- rdf__type mesh__D006385sskos__Concept
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D006385 1999
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D006385 2003
% 210.14/210.31  |- mesh__recordOriginator mesh__D006385 NLM
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D006385 1998
% 210.14/210.31  |- mesh__dateEstablished mesh__D014817 1973-01-01
% 210.14/210.31  |- skos__hiddenLabel mesh__D014817 Membranes, Vitelline
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014817 1994
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014817 1997
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014817 1992
% 210.14/210.31  |- mesh__recordAuthorizer mesh__D014817 PLS
% 210.14/210.31  |- mesh__recordMaintainer mesh__D014817 TGC
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014817 2006
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014817 1998
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014817 2002
% 210.14/210.31  |- skos__scopeNote mesh__D014817 The plasma membrane of the egg.     
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014817 2004
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014817 1996
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014817 1990
% 210.14/210.31  |- mesh__dateCreated mesh__D014817 1999-01-01
% 210.14/210.31  |- mesh__historyNote mesh__D014817 73%28%63%29%   
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014817 2005
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014817 2003
% 210.14/210.31  |- skos__broader mesh__D014817smesh__D010063
% 210.14/210.31  |- mesh__dateRevised mesh__D014817 1989-04-06
% 210.14/210.31  |- rdf__type mesh__D014817sskos__Concept
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014817 2001
% 210.14/210.31  |- mesh__publicMeSHNote mesh__D014817 73   
% 210.14/210.31  |- skos__prefLabel mesh__D014817 Vitelline Membrane
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014817 2000
% 210.14/210.31  |- mesh__recordOriginator mesh__D014817 NLM
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014817 1991
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014817 1995
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014817 1993
% 210.14/210.31  |- skos__hiddenLabel mesh__D014817 Membrane, Vitelline
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014817 1999
% 210.14/210.31  |- skos__hiddenLabel mesh__D014817 Vitelline Membranes
% 210.14/210.31  |- skos__broader mesh__D013340Q000193smesh__D013340
% 210.14/210.31  |- mesh__preferredCombination mesh__D013340Q000193smesh__D004516
% 210.14/210.31  |- rdf__type mesh__D013340Q000193smesh__CompoundConcept
% 210.14/210.31  |- skos__hiddenLabel mesh__D014019 Donor, Organ
% 210.14/210.31  |- mesh__recordAuthorizer mesh__D014019 jls
% 210.14/210.31  |- skos__related mesh__D014019smesh__D019520
% 210.14/210.31  |- skos__hiddenLabel mesh__D014019 Donor, Ovum
% 210.14/210.31  |- skos__hiddenLabel mesh__D014019 Tissue Donor
% 210.14/210.31  |- mesh__publicMeSHNote mesh__D014019 67   
% 210.14/210.31  |- skos__hiddenLabel mesh__D014019 Donor
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014019 2006
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014019 2003A
% 210.14/210.31  |- skos__hiddenLabel mesh__D014019 Donors, Tissue
% 210.14/210.31  |- skos__hiddenLabel mesh__D014019 Donors, Ovum
% 210.14/210.31  |- mesh__dateCreated mesh__D014019 1999-01-01
% 210.14/210.31  |- mesh__historyNote mesh__D014019 67%28%64%29%   
% 210.14/210.31  |- rdf__type mesh__D014019sskos__Concept
% 210.14/210.31  |- skos__hiddenLabel mesh__D014019 Semen Donor
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014019 2005A
% 210.14/210.31  |- skos__hiddenLabel mesh__D014019 Donor, Semen
% 210.14/210.31  |- skos__hiddenLabel mesh__D014019 Donors, Semen
% 210.14/210.31  |- skos__hiddenLabel mesh__D014019 Organ Donor
% 210.14/210.31  |- skos__hiddenLabel mesh__D014019 Donors, Organ
% 210.14/210.31  |- skos__scopeNote mesh__D014019
% 210.14/210.31       Individuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients.%A%    
% 210.14/210.31  |- mesh__dateEstablished mesh__D014019 1967-01-01
% 210.14/210.31  |- skos__hiddenLabel mesh__D014019 Donor, Tissue
% 210.14/210.31  |- skos__broader mesh__D014019smesh__D009272
% 210.14/210.31  |- mesh__recordOriginator mesh__D014019 NLM
% 210.14/210.31  |- skos__prefLabel mesh__D014019 Tissue Donors
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014019 2003
% 210.14/210.31  |- skos__annotation mesh__D014019
% 210.14/210.31       semen or sperm donors: coord IM with SEMEN %28%IM%29% or SPERMATOZOA %28%IM%29%; consider also INSEMINATION, ARTIFICIAL, HOMOLOGOUS %28%husband%29% %28%IM%29% or INSEMINATION, ARTIFICIAL, HETEROLOGOUS %28%non-husband%29% %28%IM%29%%A%  
% 210.14/210.31  |- skos__related mesh__D014019smesh__D033001
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014019 2005
% 210.14/210.31  |- mesh__dateRevised mesh__D014019 2004-08-02
% 210.14/210.31  |- mesh__recordMaintainer mesh__D014019 jls
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D014019 2004
% 210.14/210.31  |- skos__hiddenLabel mesh__D014019 Ovum Donor
% 210.14/210.31  |- mesh__recordMaintainer mesh__D019502 jls
% 210.14/210.31  |- mesh__recordOriginator mesh__D019502 TGC
% 210.14/210.31  |- mesh__dateRevised mesh__D019502 2005-06-30
% 210.14/210.31  |- mesh__historyNote mesh__D019502 1997   
% 210.14/210.31  |- skos__altLabel mesh__D019502 Ephemera
% 210.14/210.31  |- skos__altLabel mesh__D019502 Ephemera %28%PT%29%
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D019502 2006
% 210.14/210.31  |- mesh__dateEstablished mesh__D019502 1997-01-01
% 210.14/210.31  |- rdf__type mesh__D019502sskos__Concept
% 210.14/210.31  |- skos__annotation mesh__D019502
% 210.14/210.31       publication type only; for ephemera as a subject, index under main heading for specific type of ephemeron such as ADVERTISING; CORRESPONDENCE; PAMPHLETS; etc.%A%  
% 210.14/210.31  |- mesh__recordAuthorizer mesh__D019502 sjn
% 210.14/210.31  |- mesh__dateCreated mesh__D019502 1996-06-21
% 210.14/210.31  |- skos__scopeNote mesh__D019502
% 210.14/210.31       Works consisting of transient everyday items, usually printed on paper, that are produced for a specific limited use and then often thrown away.  %28%From Genre Terms: A Thesaurus for Use in Rare Book and Special Collections Cataloguing, 2d ed %26% The ALA Glossary of Library and Information Science, 1983%29%%A%    
% 210.14/210.31  |- skos__broader mesh__D019502smesh__D052180
% 210.14/210.31  |- skos__prefLabel mesh__D019502 Ephemera %5B%Publication Type%5D%
% 210.14/210.31  |- mesh__recordAuthorizer mesh__D052138 sjn
% 210.14/210.31  |- skos__hiddenLabel mesh__D052138 Gene, Neoplasm
% 210.14/210.31  |- mesh__historyNote mesh__D052138
% 210.14/210.31       2006; for CANCER GENES use ONCOGENES 1985-2005   
% 210.14/210.31  |- mesh__dateCreated mesh__D052138 2005-06-30
% 210.14/210.31  |- skos__scopeNote mesh__D052138
% 210.14/210.31       Genes whose abnormal expression, or MUTATION are associated with the development, growth, or progression of NEOPLASMS.%A%    
% 210.14/210.31  |- skos__related mesh__D052138smesh__D009363
% 210.14/210.31  |- mesh__recordOriginator mesh__D052138 nns
% 210.14/210.31  |- skos__annotation mesh__D052138
% 210.14/210.31       general; prefer specifics; coordinate with specific neoplasm terms /genet; do not confuse with ONCOGENES%A%  
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D052138 2006
% 210.14/210.31  |- skos__hiddenLabel mesh__D052138 Gene, Cancer
% 210.14/210.31  |- rdf__type mesh__D052138sskos__Concept
% 210.14/210.31  |- skos__hiddenLabel mesh__D052138 Genes, Cancer
% 210.14/210.31  |- skos__prefLabel mesh__D052138 Genes, Neoplasm
% 210.14/210.31  |- skos__altLabel mesh__D052138 Neoplasm Genes
% 210.14/210.31  |- skos__hiddenLabel mesh__D052138 Cancer Gene
% 210.14/210.31  |- mesh__publicMeSHNote mesh__D052138
% 210.14/210.31       2006; for CANCER GENES see ONCOGENES 1985-2005   
% 210.14/210.31  |- mesh__recordMaintainer mesh__D052138 nns
% 210.14/210.31  |- skos__broader mesh__D052138smesh__D005796
% 210.14/210.31  |- skos__hiddenLabel mesh__D052138 Neoplasm Gene
% 210.14/210.31  |- mesh__dateEstablished mesh__D052138 2006-01-01
% 210.14/210.31  |- skos__broader mesh__D002793smesh__D002757
% 210.14/210.31  |- mesh__onlineNote mesh__D002793
% 210.14/210.31       use CHOLIC ACIDS to search CHOLIC ACID 1973-74 %28%as Prov 1973%29%; use BILE ACIDS AND SALTS 1966-72%A%  
% 210.14/210.31  |- mesh__dateCreated mesh__D002793 1999-01-01
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D002793 2005
% 210.14/210.31  |- mesh__dateRevised mesh__D002793 1999-11-03
% 210.14/210.31  |- mesh__recordMaintainer mesh__D002793 adp
% 210.14/210.31  |- skos__scopeNote mesh__D002793
% 210.14/210.31       The 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholanic acid family of bile acids in man, usually conjugated with glycine or taurine. They act as detergents to solubilize fats for intestinal absorption, are reabsorbed by the small intestine, and are used as cholagogues and choleretics.%A%    
% 210.14/210.31  |- skos__altLabel mesh__D002793 Cholalic Acids
% 210.14/210.31  |- mesh__recordAuthorizer mesh__D002793 sjn
% 210.14/210.31  |- skos__historyNote mesh__D002793 Bile Acids and Salts %28%1966-1972%29%
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D002793 2001
% 210.14/210.31  |- skos__annotation mesh__D002793
% 210.14/210.31       cholic acid glycine conjugate = GLYCOCHOLIC ACID; cholic acid taurine conjugate = TAUROCHOLIC ACID; CHOLIC ACID is also available%A%  
% 210.14/210.31  |- skos__hiddenLabel mesh__D002793 Acids, Cholic
% 210.14/210.31  |- mesh__recordOriginator mesh__D002793 NLM
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D002793 2004
% 210.14/210.31  |- rdf__type mesh__D002793sskos__Concept
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D002793 2000
% 210.14/210.31  |- mesh__publicMeSHNote mesh__D002793
% 210.14/210.31       75; was CHOLIC ACID 1974, was CHOLIC ACID see under BILE ACIDS AND SALTS 1963-73%A%  
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D002793 2003
% 210.14/210.31  |- mesh__historyNote mesh__D002793
% 210.14/210.31       75; was CHOLIC ACID 1973-74 %28%Prov 1973%29%, was CHOLIC ACID see under BILE ACIDS AND SALTS 1963-73%A%  
% 210.14/210.31  |- skos__prefLabel mesh__D002793 Cholic Acids
% 210.14/210.31  |- mesh__dateEstablished mesh__D002793 1974-01-01
% 210.14/210.31  |- skos__broader mesh__D002793smesh__D001647
% 210.14/210.31  |- skos__hiddenLabel mesh__D002793 Acids, Cholalic
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D002793 2006
% 210.14/210.31  |- mesh__activeMeSHYear mesh__D002793 2002
% 210.14/210.31  |- mesh__publicMeSHNote mesh__D010427
% 210.14/210.31       2006; see PENTOSEPHOSPHATE PATHWAY 1985-2005   
% 210.14/210.31  |- skos__altLabel mesh__D010427 Pentose Phosphate Shunt
% 210.14/210.31  |- skos__hiddenLabel mesh__D010427 Shunts, Pentosephosphate
% 210.14/210.31  |- mesh__dateCreated mesh__D010427 1984-05-29
% 210.14/210.31  |- skos__altLabel mesh__D010427 Pentose-Phosphate Pathway
% 210.14/210.31  |- skos__hiddenLabel mesh__D010427 Pathways, Pentose-Phosphate
% 210.14/210.31  |- mesh__recordAuthorizer mesh__D010427 sjn
% 210.14/210.31  |- skos__altLabel mesh__D010427 Pentosephosphate Pathway
% 210.14/210.31  |- skos__prefLabel mesh__D010427 Pentose Phosphate Pathway
% 210.14/210.31  |- mesh__dateEstablished mesh__D010427 1985-01-01
% 210.14/210.31  |- skos__hiddenLabel mesh__D010427 Shunts, Hexose Monophosphate
% 210.14/210.31  |- mesh__recordMaintainer mesh__D010427 lkt
% 210.14/210.31  |- skos__scopeNote mesh__D010427
% 210.14/210.31       An oxidative decarboxylation process that converts GLUCOSE-6-PHOSPHATE to D-ribose-5-phosphate via 6-phosphogluconate. The pentose product is used in the biosynthesis of NUCLEIC ACIDS. The generated energy is stored in the form of NADPH. This pathway is prominent in tissues which are active in the synthesis of FATTY ACIDS and STEROIDS.%A%    
% 210.14/210.31  |- skos__hiddenLabel mesh__D010427 Hexose Monophosphate Shunts
% 210.14/210.31  |- skos__altLabel mesh__D010427 Pentose Shunt
% 210.17/210.31  |- skos__hiddenLabel mesh__D010427 Pathway, Pentosephosphate
% 210.17/210.31  |- skos__hiddenLabel mesh__D010427 Pentose Phosphate Shunts
% 210.17/210.31  |- skos__broader mesh__D010427smesh__D050260
% 210.17/210.31  |- skos__historyNote mesh__D010427 Hexosephosphates %28%1966-1984%29%
% 210.17/210.31  |- skos__hiddenLabel mesh__D010427 Pentosephosphate Shunts
% 210.17/210.31  |- mesh__activeMeSHYear mesh__D010427 2006
% 210.17/210.31  |- mesh__dateRevised mesh__D010427 2005-06-30
% 210.17/210.31  |- mesh__recordOriginator mesh__D010427 VDK
% 210.17/210.31  |- skos__hiddenLabel mesh__D010427 Pentosephosphate Pathways
% 210.17/210.31  |- skos__hiddenLabel mesh__D010427 Shunts, Pentose Phosphate
% 210.17/210.31  |- skos__hiddenLabel mesh__D010427 Shunt, Pentose Phosphate
% 210.17/210.31  |- mesh__historyNote mesh__D010427 2006 %28%1985%29%   
% 210.17/210.31  |- skos__hiddenLabel mesh__D010427 Shunt, Pentosephosphate
% 210.17/210.31  |- skos__altLabel mesh__D010427 Pentosephosphate Shunt
% 210.17/210.31  |- skos__hiddenLabel mesh__D010427 Pathways, Pentose Phosphate
% 210.17/210.31  |- skos__hiddenLabel mesh__D010427 Pathway, Pentose Phosphate
% 210.17/210.31  |- skos__hiddenLabel mesh__D010427 Pentose Phosphate Pathways
% 210.17/210.31  |- rdf__type mesh__D010427sskos__Concept
% 210.17/210.31  |- skos__hiddenLabel mesh__D010427 Pathway, Pentose-Phosphate
% 210.17/210.31  |- skos__broader mesh__D010427smesh__D004734
% 210.17/210.31  |- skos__hiddenLabel mesh__D010427 Pentose Shunts
% 210.17/210.31  |- skos__historyNote mesh__D010427 Pentosephosphates %28%1966-1984%29%
% 210.17/210.31  |- skos__hiddenLabel mesh__D010427 Pathways, Pentosephosphate
% 210.17/210.31  |- skos__hiddenLabel mesh__D010427 Shunt, Hexose Monophosphate
% 210.17/210.31  |- skos__hiddenLabel mesh__D010427 Shunts, Pentose
% 210.17/210.31  |- skos__hiddenLabel mesh__D010427 Shunt, Pentose
% 210.17/210.31  |- skos__altLabel mesh__D010427 Hexose Monophosphate Shunt
% 210.17/210.31  |- skos__hiddenLabel mesh__D010427 Pentose-Phosphate Pathways
% 210.17/210.31  |- mesh__publicMeSHNote mesh__D015112
% 210.17/210.31       91; was see under NITROQUINOLINES 1975-90   
% 210.17/210.31  |- skos__historyNote mesh__D015112 Quinolines %28%1970-1974%29%
% 210.17/210.31  |- skos__historyNote mesh__D015112 Nitro Compounds %28%1972-1974%29%
% 210.17/210.31  |- skos__scopeNote mesh__D015112
% 210.17/210.31       A potent mutagen and carcinogen. This compound and its metabolite 4-HYDROXYAMINOQUINOLINE-1-OXIDE bind to nucleic acids. It inactivates bacteria but not bacteriophage.%A%    
% 210.17/210.31  |- mesh__dateCreated mesh__D015112 1974-11-14
% 210.17/210.31  |- mesh__dateRevised mesh__D015112 2000-06-22
% 210.17/210.31  |- mesh__dateEstablished mesh__D015112 1991-01-01
% 210.17/210.31  |- skos__broader mesh__D015112smesh__D003497
% 210.17/210.31  |- skos__hiddenLabel mesh__D015112 4 Nitroquinoline N oxide
% 210.17/210.31  |- mesh__recordAuthorizer mesh__D015112 sjn
% 210.17/210.31  |- mesh__recordMaintainer mesh__D015112 CCR
% 210.17/210.31  |- mesh__activeMeSHYear mesh__D015112 2005
% 210.17/210.31  |- skos__hiddenLabel mesh__D015112 4 Nitroquinoline 1 oxide
% 210.17/210.31  |- skos__broader mesh__D015112smesh__D009600
% 210.17/210.31  |- mesh__activeMeSHYear mesh__D015112 2003
% 210.17/210.31  |- mesh__historyNote mesh__D015112
% 210.17/210.31       91%28%75%29%; was see under NITROQUINOLINES 1975-90   
% 210.17/210.31  |- mesh__activeMeSHYear mesh__D015112 2006
% 210.17/210.31  |- mesh__recordOriginator mesh__D015112 NLM
% 210.17/210.31  |- mesh__activeMeSHYear mesh__D015112 2004
% 210.17/210.31  |- skos__altLabel mesh__D015112 4-Nitroquinoline-N-oxide
% 210.17/210.31  |- skos__prefLabel mesh__D015112 4-Nitroquinoline-1-oxide
% 210.17/210.31  |- mesh__activeMeSHYear mesh__D015112 2001
% 210.17/210.31  |- skos__historyNote mesh__D015112 Cyclic N-Oxides %28%1972-1974%29%
% 210.17/210.31  |- rdf__type mesh__D015112sskos__Concept
% 210.17/210.31  |- mesh__activeMeSHYear mesh__D015112 2002
% 210.17/210.31  |- skos__annotation mesh__D015112 D25-26 qualif   
% 210.17/210.31  |- mesh__activeMeSHYear mesh__D006386 2006
% 210.17/210.31  |- mesh__recordOriginator mesh__D006386 NLM
% 210.17/210.31  |- mesh__historyNote mesh__D006386 66   
% 210.17/210.31  |- skos__scopeNote mesh__D006386
% 210.17/210.31       Sensitive tests to measure certain antigens, antibodies, or viruses, using their ability to agglutinate certain erythrocytes. %28%From Stedman, 26th ed%29%%A%    
% 210.17/210.31  |- mesh__dateCreated mesh__D006386 1999-01-01
% 210.17/210.31  |- mesh__publicMeSHNote mesh__D006386 66   
% 210.17/210.31  |- mesh__activeMeSHYear mesh__D006386 2005
% 210.17/210.31  |- skos__annotation mesh__D006386 NIM   
% 210.17/210.31  |- skos__hiddenLabel mesh__D006386 Hemagglutination Test
% 210.17/210.31  |- mesh__activeMeSHYear mesh__D006386 2002
% 210.17/210.31  |- mesh__activeMeSHYear mesh__D006386 2004
% 210.17/210.31  |- mesh__recordMaintainer mesh__D006386 PXP
% 210.17/210.31  |- mesh__activeMeSHYear mesh__D006386 2001
% 210.17/210.31  |- mesh__dateEstablished mesh__D006386 1966-01-01
% 210.17/210.31  |- rdf__type mesh__D006386sskos__Concept
% 210.17/210.31  |- mesh__activeMeSHYear mesh__D006386 1999
% 210.17/210.31  |- mesh__activeMeSHYear mesh__D006386 2003
% 210.17/210.31  |- skos__hiddenLabel mesh__D006386 Test, Hemagglutination
% 210.17/210.31  |- skos__hiddenLabel mesh__D006386 Tests, Hemagglutination
% 210.17/210.31  |- mesh__activeMeSHYear mesh__D006386 2000
% 210.17/210.31  |- mesh__recordAuthorizer mesh__D006386 SJN
% 210.17/210.31  |- mesh__activeMeSHYear mesh__D006386 1998
% 210.17/210.31  |- mesh__dateRevised mesh__D006386 1997-06-20
% 210.17/210.31  |- skos__broader mesh__D006386smesh__D000372
% 210.17/210.31  |- skos__prefLabel mesh__D006386 Hemagglutination Tests
% 210.17/210.31  |- mesh__activeMeSHYear mesh__D014818 2006
% 210.17/210.31  |- skos__hiddenLabel mesh__D014818 Vitellogeneses
% 210.17/210.31  |- mesh__publicMeSHNote mesh__D014818 84   
% 210.17/210.31  |- mesh__recordAuthorizer mesh__D014818 sjn
% 210.17/210.31  |- skos__scopeNote mesh__D014818
% 210.17/210.31       The active production and accumulation of VITELLINS %28%egg yolk proteins%29% in the non-mammalian OOCYTES from circulating precursors, VITELLOGENINS. Vitellogenesis usually begins after the first MEIOSIS and is regulated by estrogenic hormones.%A%    
% 210.17/210.31  |- mesh__recordMaintainer mesh__D014818 lkt
% 210.17/210.31  |- mesh__dateRevised mesh__D014818 2004-07-07
% 210.17/210.31  |- mesh__historyNote mesh__D014818 84   
% 210.17/210.31  |- mesh__dateEstablished mesh__D014818 1984-01-01
% 210.17/210.31  |- mesh__dateCreated mesh__D014818 1983-06-06
% 210.17/210.31  |- rdf__type mesh__D014818sskos__Concept
% 210.17/210.31  |- mesh__recordOriginator mesh__D014818 EC
% 210.17/210.31  |- skos__broader mesh__D014818smesh__D009866
% 210.17/210.31  |- skos__prefLabel mesh__D014818 Vitellogenesis
% 210.17/210.31  |- mesh__activeMeSHYear mesh__D014818 2005
% 210.17/210.31  |- mesh__activeMeSHYear mesh__D011520 2005
% 210.17/210.31  |- skos__scopeNote mesh__D011520
% 210.17/210.31       An enzyme that catalyzes the oxidation of protocatechuate to 3-carboxy-cis-cis-muconate in the presence of molecular oxygen. It contains ferric ion. EC 1.13.11.3.%A%    
% 210.17/210.31  |- mesh__historyNote mesh__D011520
% 210.17/210.31       91%28%75%29%; was see under OXYGENASES 1975-90   
% 210.17/210.31  |- mesh__dateCreated mesh__D011520 1974-11-19
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D011520 2006
% 210.17/210.32  |- mesh__recordAuthorizer mesh__D011520 sjn
% 210.17/210.32  |- mesh__dateEstablished mesh__D011520 1991-01-01
% 210.17/210.32  |- mesh__recordOriginator mesh__D011520 NLM
% 210.17/210.32  |- mesh__recordMaintainer mesh__D011520 ssb
% 210.17/210.32  |- mesh__publicMeSHNote mesh__D011520
% 210.17/210.32       91; was see under OXYGENASES 1975-90   
% 210.17/210.32  |- skos__historyNote mesh__D011520 Oxygenases %28%1972-1974%29%
% 210.17/210.32  |- rdf__type mesh__D011520sskos__Concept
% 210.17/210.32  |- skos__hiddenLabel mesh__D011520 Protocatechuate 3,4 Dioxygenase
% 210.17/210.32  |- skos__broader mesh__D011520smesh__D008084
% 210.17/210.32  |- skos__historyNote mesh__D011520 Benzoates %28%1972-1974%29%
% 210.17/210.32  |- mesh__dateRevised mesh__D011520 2004-07-07
% 210.17/210.32  |- skos__prefLabel mesh__D011520 Protocatechuate-3,4-Dioxygenase
% 210.17/210.32  |- mesh__dateCreated mesh__D052139 2005-06-30
% 210.17/210.32  |- skos__scopeNote mesh__D052139
% 210.17/210.32       Intracellular signaling peptides and proteins that bind to CALCIUM. They undergo allosteric changes when bound to CALCIUM that affects their interaction with other signal-transducing molecules. They differ from CALCIUM-SENSING RECEPTORS which sense extracellular calcium levels.%A%    
% 210.17/210.32  |- skos__hiddenLabel mesh__D052139 Intracellular Calcium Sensing Proteins
% 210.17/210.32  |- skos__hiddenLabel mesh__D052139 Peptides, Intracellular Calcium-Sensing
% 210.17/210.32  |- skos__hiddenLabel mesh__D052139 Calcium Sensing Peptides, Intracellular
% 210.17/210.32  |- skos__prefLabel mesh__D052139 Intracellular Calcium-Sensing Proteins
% 210.17/210.32  |- mesh__historyNote mesh__D052139 2006   
% 210.17/210.32  |- skos__related mesh__D052139smesh__D044169
% 210.17/210.32  |- skos__hiddenLabel mesh__D052139 Intracellular Calcium Sensing Peptides
% 210.17/210.32  |- mesh__recordOriginator mesh__D052139 jmp
% 210.17/210.32  |- mesh__recordAuthorizer mesh__D052139 sjn
% 210.17/210.32  |- mesh__dateEstablished mesh__D052139 2006-01-01
% 210.17/210.32  |- skos__altLabel mesh__D052139 Calcium-Sensing Proteins, Intracellular
% 210.17/210.32  |- skos__hiddenLabel mesh__D052139 Calcium Sensing Proteins, Intracellular
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D052139 2006
% 210.17/210.32  |- mesh__publicMeSHNote mesh__D052139 2006   
% 210.17/210.32  |- mesh__recordMaintainer mesh__D052139 jmp
% 210.17/210.32  |- skos__broader mesh__D052139smesh__D002135
% 210.17/210.32  |- skos__broader mesh__D052139smesh__D047908
% 210.17/210.32  |- skos__altLabel mesh__D052139 Calcium-Sensing Peptides, Intracellular
% 210.17/210.32  |- rdf__type mesh__D052139sskos__Concept
% 210.17/210.32  |- skos__annotation mesh__D002794 /biosyn /physiol permitted   
% 210.17/210.32  |- skos__hiddenLabel mesh__D002794 O-Sulfate, Choline
% 210.17/210.32  |- skos__hiddenLabel mesh__D002794 Bitartrate, Choline
% 210.17/210.32  |- skos__altLabel mesh__D002794 2-Hydroxy-N,N,N-trimethylethanaminium
% 210.17/210.32  |- skos__broader mesh__D002794smesh__D050337
% 210.17/210.32  |- skos__altLabel mesh__D002794 Vidine
% 210.17/210.32  |- skos__hiddenLabel mesh__D002794 Citrate, Choline
% 210.17/210.32  |- rdf__type mesh__D002794sskos__Concept
% 210.17/210.32  |- skos__prefLabel mesh__D002794 Choline
% 210.17/210.32  |- skos__scopeNote mesh__D002794
% 210.17/210.32       A basic constituent of lecithin that is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism.%A%    
% 210.17/210.32  |- skos__altLabel mesh__D002794 Fagine
% 210.17/210.32  |- mesh__recordAuthorizer mesh__D002794 sjn
% 210.17/210.32  |- mesh__recordMaintainer mesh__D002794 ssb
% 210.17/210.32  |- skos__broader mesh__D002794smesh__D004983
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D002794 2006
% 210.17/210.32  |- skos__hiddenLabel mesh__D002794 Chloride, Choline
% 210.17/210.32  |- skos__broader mesh__D002794smesh__D000644
% 210.17/210.32  |- mesh__dateRevised mesh__D002794 2005-06-30
% 210.17/210.32  |- mesh__recordOriginator mesh__D002794 NLM
% 210.17/210.32  |- mesh__dateCreated mesh__D002794 1999-01-01
% 210.17/210.32  |- skos__hiddenLabel mesh__D002794 Choline O Sulfate
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D010428 2006
% 210.17/210.32  |- mesh__recordAuthorizer mesh__D010428 sjn
% 210.17/210.32  |- mesh__dateCreated mesh__D010428 1999-01-01
% 210.17/210.32  |- mesh__recordOriginator mesh__D010428 NLM
% 210.17/210.32  |- skos__broader mesh__D010428smesh__D013403
% 210.17/210.32  |- rdf__type mesh__D010428sskos__Concept
% 210.17/210.32  |- mesh__dateRevised mesh__D010428 2005-07-01
% 210.17/210.32  |- skos__prefLabel mesh__D010428 Pentosephosphates
% 210.17/210.32  |- mesh__recordMaintainer mesh__D010428 sjn
% 210.17/210.32  |- skos__annotation mesh__D010428
% 210.17/210.32       /metab: consider also PENTOSE PHOSPHATE PATHWAY   
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D015911 1992
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D015911 1999
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D015911 2000
% 210.17/210.32  |- mesh__publicMeSHNote mesh__D015911 90   
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D015911 1996
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D015911 1993
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D015911 2005
% 210.17/210.32  |- mesh__recordAuthorizer mesh__D015911 PLS
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D015911 2001
% 210.17/210.32  |- mesh__recordMaintainer mesh__D015911 TGC
% 210.17/210.32  |- skos__related mesh__D015911smesh__D012597
% 210.17/210.32  |- skos__prefLabel mesh__D015911 Sclerotherapy
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D015911 1997
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D015911 2006
% 210.17/210.32  |- mesh__historyNote mesh__D015911 90   
% 210.17/210.32  |- skos__broader mesh__D015911smesh__D004358
% 210.17/210.32  |- mesh__recordOriginator mesh__D015911 PLS
% 210.17/210.32  |- skos__scopeNote mesh__D015911
% 210.17/210.32       Treatment of varicose veins, hemorrhoids, gastric and esophageal varices, and peptic ulcer hemorrhage by injection or infusion of chemical agents which cause localized thrombosis and eventual fibrosis and obliteration of the vessels.%A%    
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D015911 2003
% 210.17/210.32  |- skos__annotation mesh__D015911
% 210.17/210.32       coord IM with dis /ther %28%IM%29%, not /drug ther   
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D015911 1994
% 210.17/210.32  |- mesh__dateCreated mesh__D015911 1989-05-16
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D015911 2002
% 210.17/210.32  |- skos__historyNote mesh__D015911 Sclerosing Solutions %28%1966-1989%29%
% 210.17/210.32  |- skos__hiddenLabel mesh__D015911 Sclerotherapies
% 210.17/210.32  |- mesh__dateEstablished mesh__D015911 1990-01-01
% 210.17/210.32  |- rdf__type mesh__D015911sskos__Concept
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D015911 2004
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D015911 1998
% 210.17/210.32  |- mesh__dateRevised mesh__D015911 1991-06-20
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D015911 1995
% 210.17/210.32  |- mesh__historyNote mesh__D015113
% 210.17/210.32       98%28%75%29%; was 5-ANDROSTANE-3,17-DIOL 1975-97; see ANDROSTANOLS 1980-90; was ANDROSTANEDIOL see ANDROSTANES 1975-79%A%  
% 210.17/210.32  |- skos__hiddenLabel mesh__D015113 Androstane 3,17 diol
% 210.17/210.32  |- skos__broader mesh__D015113smesh__D045165
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D015113 2005
% 210.17/210.32  |- skos__altLabel mesh__D015113 5alpha-Androstane-3beta,17alpha-diol
% 210.17/210.32  |- skos__broader mesh__D015113smesh__D000732
% 210.17/210.32  |- skos__scopeNote mesh__D015113
% 210.17/210.32       The unspecified form of the steroid, normally a major metabolite of TESTOSTERONE with androgenic activity. It has been implicated as a regulator of gonadotropin secretion.%A%    
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D015113 2006
% 210.17/210.32  |- skos__hiddenLabel mesh__D015113 5alpha Androstane 3beta,17alpha diol
% 210.17/210.32  |- mesh__recordAuthorizer mesh__D015113 sjn
% 210.17/210.32  |- mesh__onlineNote mesh__D015113
% 210.17/210.32       use 5-ANDROSTANE-3,17-DIOL to search ANDROSTANEDIOL 1975-79%A%  
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D015113 2004
% 210.17/210.32  |- skos__hiddenLabel mesh__D015113 5 alpha Androstane 3 beta,17 beta diol
% 210.17/210.32  |- mesh__dateRevised mesh__D015113 2003-07-09
% 210.17/210.32  |- skos__historyNote mesh__D015113 Hydroxysteroids %28%1973-1974%29%
% 210.17/210.32  |- mesh__publicMeSHNote mesh__D015113
% 210.17/210.32       98; was 5-ANDROSTANE-3,17-DIOL 1975-97; 91; see ANDROSTANOLS 1980-90; was ANDROSTANEDIOL see ANDROSTANES 1975-79%A%  
% 210.17/210.32  |- skos__historyNote mesh__D015113 Androstanes %28%1973-1975%29%
% 210.17/210.32  |- skos__prefLabel mesh__D015113 Androstane-3,17-diol
% 210.17/210.32  |- skos__hiddenLabel mesh__D015113 5 alpha Androstane 3alpha,17 beta diol
% 210.17/210.32  |- skos__altLabel mesh__D015113 5 Androstane 3,17 diol
% 210.17/210.32  |- skos__hiddenLabel mesh__D015113 5 alpha Androstane 3 beta,17 alpha diol
% 210.17/210.32  |- rdf__type mesh__D015113sskos__Concept
% 210.17/210.32  |- skos__altLabel mesh__D015113 5-Androstane-3,17-diol
% 210.17/210.32  |- mesh__recordOriginator mesh__D015113 NLM
% 210.17/210.32  |- skos__altLabel mesh__D015113 5 alpha-Androstane-3alpha,17 beta-diol
% 210.17/210.32  |- mesh__dateCreated mesh__D015113 1974-11-11
% 210.17/210.32  |- skos__hiddenLabel mesh__D015113 5 alpha Androstane 3 alpha,17 beta diol
% 210.17/210.32  |- skos__hiddenLabel mesh__D015113 5 beta Androstane 3 alpha,17 beta diol
% 210.17/210.32  |- mesh__recordMaintainer mesh__D015113 lkt
% 210.17/210.32  |- mesh__dateEstablished mesh__D015113 1991-01-01
% 210.17/210.32  |- skos__related mesh__D020856smesh__D001482
% 210.17/210.32  |- mesh__dateRevised mesh__D020856 2002-07-02
% 210.17/210.32  |- skos__historyNote mesh__D020856 Base Sequence %28%1980-1999%29%
% 210.17/210.32  |- skos__hiddenLabel mesh__D020856 Region, AT Rich
% 210.17/210.32  |- skos__broader mesh__D020856smesh__D001483
% 210.17/210.32  |- skos__historyNote mesh__D020856 Adenine %28%1971-1987%29%
% 210.17/210.32  |- skos__related mesh__D020856smesh__D020862
% 210.17/210.32  |- mesh__publicMeSHNote mesh__D020856 2000   
% 210.17/210.32  |- skos__hiddenLabel mesh__D020856 Regions, AT Rich
% 210.17/210.32  |- mesh__recordMaintainer mesh__D020856 nns
% 210.17/210.32  |- skos__hiddenLabel mesh__D020856 Sequences, AT Rich
% 210.17/210.32  |- mesh__dateEstablished mesh__D020856 2000-01-01
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D020856 2003
% 210.17/210.32  |- skos__hiddenLabel mesh__D020856 Sequence, AT Rich
% 210.17/210.32  |- skos__prefLabel mesh__D020856 AT Rich Sequence
% 210.17/210.32  |- mesh__historyNote mesh__D020856 2000   
% 210.17/210.32  |- rdf__type mesh__D020856sskos__Concept
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D020856 2004
% 210.17/210.32  |- skos__altLabel mesh__D020856 AT Rich Region
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D020856 2005
% 210.17/210.32  |- mesh__dateCreated mesh__D020856 1999-11-03
% 210.17/210.32  |- skos__scopeNote mesh__D020856
% 210.17/210.32       A nucleic acid sequence that contains an above average number of ADENINE and THYMINE bases.%A%    
% 210.17/210.32  |- skos__hiddenLabel mesh__D020856 AT Rich Sequences
% 210.17/210.32  |- mesh__recordOriginator mesh__D020856 nns
% 210.17/210.32  |- skos__hiddenLabel mesh__D020856 AT Rich Regions
% 210.17/210.32  |- skos__historyNote mesh__D020856 Thymine %28%1971-1987%29%
% 210.17/210.32  |- mesh__recordAuthorizer mesh__D020856 sjn
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D020856 2006
% 210.17/210.32  |- skos__hiddenLabel mesh__D039561 Initiation Factor-4E, Eukaryotic
% 210.17/210.32  |- mesh__publicMeSHNote mesh__D039561
% 210.17/210.32       2003; EIF-4E %28%now EUKARYOTIC INITIATION FACTOR-4E%29% was indexed under PEPTIDE INITIATION FACTORS 1986-2002%A%  
% 210.17/210.32  |- skos__altLabel mesh__D039561 Peptide Initiation Factor EIF-4E
% 210.17/210.32  |- skos__altLabel mesh__D039561 Eukaryotic Peptide Initiation Factor-4E
% 210.17/210.32  |- skos__scopeNote mesh__D039561
% 210.17/210.32       A peptide initiation factor that binds specifically to the 5%27% MRNA CAP STRUCTURE of MRNA in the CYTOPLASM. It is a component of the trimeric complex EIF4F.%A%    
% 210.17/210.32  |- rdf__type mesh__D039561sskos__Concept
% 210.17/210.32  |- skos__broader mesh__D039561smesh__D039381
% 210.17/210.32  |- skos__prefLabel mesh__D039561 Eukaryotic Initiation Factor-4E
% 210.17/210.32  |- skos__altLabel mesh__D039561 EIF4E
% 210.17/210.32  |- mesh__historyNote mesh__D039561
% 210.17/210.32       2003; use EUKARYOTIC INITIATION FACTOR-4E %28%NM%29% 1986-2002   
% 210.17/210.32  |- skos__broader mesh__D039561smesh__D039562
% 210.17/210.32  |- skos__hiddenLabel mesh__D039561 Factor-4E, Eukaryotic Initiation
% 210.17/210.32  |- skos__hiddenLabel mesh__D039561 EIF 4E
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D039561 2006
% 210.17/210.32  |- mesh__dateCreated mesh__D039561 2002-07-03
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D039561 2004
% 210.17/210.32  |- skos__hiddenLabel mesh__D039561 Eukaryotic Peptide Initiation Factor 4E
% 210.17/210.32  |- mesh__dateEstablished mesh__D039561 2003-01-01
% 210.17/210.32  |- skos__altLabel mesh__D039561 EIF-4E
% 210.17/210.32  |- skos__historyNote mesh__D039561
% 210.17/210.32       Peptide Initiation Factors %28%1986-2002%29%
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D039561 2005
% 210.17/210.32  |- skos__altLabel mesh__D039561 CDC33 Gene Product
% 210.17/210.32  |- skos__hiddenLabel mesh__D039561 Eukaryotic Initiation Factor 4E
% 210.17/210.32  |- skos__hiddenLabel mesh__D039561 Peptide Initiation Factor EIF 4E
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D039561 2003
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D006387 2004
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D006387 2000
% 210.17/210.32  |- skos__broader mesh__D006387smesh__D018406
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D006387 1999
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D006387 2003
% 210.17/210.32  |- rdf__type mesh__D006387sskos__Concept
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D006387 1998
% 210.17/210.32  |- mesh__recordAuthorizer mesh__D006387 PLS
% 210.17/210.32  |- skos__prefLabel mesh__D006387 Hemagglutination, Viral
% 210.17/210.32  |- mesh__historyNote mesh__D006387 70   
% 210.17/210.32  |- skos__hiddenLabel mesh__D006387 Viral Hemagglutination
% 210.17/210.32  |- mesh__recordOriginator mesh__D006387 NLM
% 210.17/210.32  |- skos__hiddenLabel mesh__D006387 Hemagglutinations, Viral
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D006387 1997
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D006387 2006
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D006387 2002
% 210.17/210.32  |- mesh__dateEstablished mesh__D006387 1970-01-01
% 210.17/210.32  |- mesh__dateRevised mesh__D006387 1994-02-08
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D006387 1996
% 210.17/210.32  |- skos__hiddenLabel mesh__D006387 Viral Hemagglutinations
% 210.17/210.32  |- mesh__recordMaintainer mesh__D006387 PXP
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D006387 2005
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D006387 1995
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D006387 2001
% 210.17/210.32  |- skos__historyNote mesh__D006387 Hemagglutination %28%1966-1969%29%
% 210.17/210.32  |- mesh__dateCreated mesh__D006387 1999-01-01
% 210.17/210.32  |- skos__scopeNote mesh__D006387
% 210.17/210.32       Agglutination of erythrocytes by a virus.     
% 210.17/210.32  |- mesh__publicMeSHNote mesh__D006387 70   
% 210.17/210.32  |- mesh__dateEstablished mesh__D020058 1999-01-01
% 210.17/210.32  |- skos__annotation mesh__D020058 STYRENES is also available   
% 210.17/210.32  |- skos__scopeNote mesh__D020058
% 210.17/210.32       A colorless, toxic liquid with a strong aromatic odor. It is used to make rubbers, polymers and copolymers, and polystyrene plastics.%A%    
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D020058 2006
% 210.17/210.32  |- skos__prefLabel mesh__D020058 Styrene
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D020058 2002
% 210.17/210.32  |- skos__altLabel mesh__D020058 Vinylbenzene
% 210.17/210.32  |- skos__historyNote mesh__D020058 Styrenes %28%1981-1998%29%
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D020058 2005
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D020058 2001
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D020058 2004
% 210.17/210.32  |- mesh__historyNote mesh__D020058 99; use STYRENE %28%NM%29% 1981-98   
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D020058 2000
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D020058 2003
% 210.17/210.32  |- skos__broader mesh__D020058smesh__D013343
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D020058 1999
% 210.17/210.32  |- skos__hiddenLabel mesh__D020058 Monomer, Styrene
% 210.17/210.32  |- rdf__type mesh__D020058sskos__Concept
% 210.17/210.32  |- mesh__dateCreated mesh__D020058 1998-06-11
% 210.17/210.32  |- mesh__publicMeSHNote mesh__D020058
% 210.17/210.32       99; STYRENE was indexed under STYRENES 1981-98   
% 210.17/210.32  |- skos__altLabel mesh__D020058 Styrol
% 210.17/210.32  |- skos__altLabel mesh__D020058 Styrene Monomer
% 210.17/210.32  |- skos__historyNote mesh__D014819 Lipoproteins %28%1972-1974%29%
% 210.17/210.32  |- skos__historyNote mesh__D014819 Egg Proteins %28%1973-1974%29%
% 210.17/210.32  |- skos__historyNote mesh__D014819 Phosphoproteins %28%1973-1974%29%
% 210.17/210.32  |- mesh__dateEstablished mesh__D014819 1986-01-01
% 210.17/210.32  |- mesh__recordOriginator mesh__D014819 NLM
% 210.17/210.32  |- skos__broader mesh__D014819smesh__D019476
% 210.17/210.32  |- rdf__type mesh__D014819sskos__Concept
% 210.17/210.32  |- skos__scopeNote mesh__D014819
% 210.17/210.32       Phospholipoglycoproteins produced in the fat body of egg-laying animals such as non-mammalian VERTEBRATES; ARTHROPODS; and others. Vitellogenins are secreted into the HEMOLYMPH, and taken into the OOCYTES by receptor-mediated ENDOCYTOSIS to form the major yolk proteins, VITELLINS. Vitellogenin production is under the regulation of steroid hormones, such as ESTRADIOL and JUVENILE HORMONES in insects.%A%    
% 210.17/210.32  |- skos__broader mesh__D014819smesh__D047048
% 210.17/210.32  |- mesh__recordAuthorizer mesh__D014819 sjn
% 210.17/210.32  |- mesh__historyNote mesh__D014819
% 210.17/210.32       2005 %28%1986%29%; use LIPOPROTEINS 1975-1985; for YOLK PROTEIN 2, DROSOPHILA use EGG PROTEINS 1990-2004%A%  
% 210.17/210.32  |- mesh__recordMaintainer mesh__D014819 sjn
% 210.17/210.32  |- skos__prefLabel mesh__D014819 Vitellogenins
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D014819 2005
% 210.17/210.32  |- mesh__dateCreated mesh__D014819 1974-11-11
% 210.17/210.32  |- mesh__dateRevised mesh__D014819 2004-07-13
% 210.17/210.32  |- skos__broader mesh__D014819smesh__D008074
% 210.17/210.32  |- skos__broader mesh__D014819smesh__D010750
% 210.17/210.32  |- mesh__publicMeSHNote mesh__D014819
% 210.17/210.32       2005; see VITELLOGENIN 1986-2004; see LIPOPROTEINS 1975-1985; for YOLK PROTEIN 2, DROSOPHILA see EGG PROTEINS 1990-2004%A%  
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D014819 2006
% 210.17/210.32  |- skos__altLabel mesh__D014819 Vitellogenin
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D025541 2004
% 210.17/210.32  |- mesh__dateRevised mesh__D025541 2003-07-09
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D025541 2006
% 210.17/210.32  |- rdf__type mesh__D025541sskos__Concept
% 210.17/210.32  |- mesh__dateEstablished mesh__D025541 2002-01-01
% 210.17/210.32  |- mesh__publicMeSHNote mesh__D025541
% 210.17/210.32       2002; see BACTERIOCHLOROPHYLLS 1991-2001; see CHLOROPHYLL 1983-1990%A%  
% 210.17/210.32  |- skos__broader mesh__D025541smesh__D001429
% 210.17/210.32  |- skos__scopeNote mesh__D025541
% 210.17/210.32       A specific bacteriochlorophyll that is similar in structure to CHLOROPHYLL A.%A%    
% 210.17/210.32  |- skos__prefLabel mesh__D025541 Bacteriochlorophyll A
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D025541 2005
% 210.17/210.32  |- skos__historyNote mesh__D025541 Bacteriochlorophylls %28%1982-2001%29%
% 210.17/210.32  |- mesh__dateCreated mesh__D025541 2001-07-25
% 210.17/210.32  |- mesh__historyNote mesh__D025541
% 210.17/210.32       2002; use BACTERIOCHLOROPHYLLS 1983-2001   
% 210.17/210.32  |- skos__prefLabel mesh__D019504 Eulogies %5B%Publication Type%5D%
% 210.17/210.32  |- skos__annotation mesh__D019504
% 210.17/210.32       publication type only; do not confuse with Publication Type FUNERAL SERMONS for eulogies delivered at funeral services%A%  
% 210.17/210.32  |- skos__altLabel mesh__D019504 Eulogies %28%PT%29%
% 210.17/210.32  |- mesh__recordAuthorizer mesh__D019504 sjn
% 210.17/210.32  |- mesh__dateCreated mesh__D019504 1996-06-21
% 210.17/210.32  |- skos__broader mesh__D019504smesh__D052180
% 210.17/210.32  |- skos__scopeNote mesh__D019504
% 210.17/210.32       Works consisting of speeches or writings in praise of a person or thing, especially a set oration in honor of a deceased person. They differ from FUNERAL SERMONS %5B%PUBLICATION TYPE%5D% which are delivered at ceremonies for the deceased prior to their burial or cremation. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 210.17/210.32  |- mesh__recordMaintainer mesh__D019504 jls
% 210.17/210.32  |- skos__altLabel mesh__D019504 Eulogies
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D019504 2006
% 210.17/210.32  |- mesh__recordOriginator mesh__D019504 TGC
% 210.17/210.32  |- mesh__dateRevised mesh__D019504 2005-06-30
% 210.17/210.32  |- mesh__historyNote mesh__D019504 1997   
% 210.17/210.32  |- mesh__dateEstablished mesh__D019504 1997-01-01
% 210.17/210.32  |- rdf__type mesh__D019504sskos__Concept
% 210.17/210.32  |- mesh__publicMeSHNote mesh__D011521
% 210.17/210.32       91; was see under CHLOROPHYLL 1975-90   
% 210.17/210.32  |- mesh__recordAuthorizer mesh__D011521 sjn
% 210.17/210.32  |- mesh__dateCreated mesh__D011521 1974-11-19
% 210.17/210.32  |- skos__altLabel mesh__D011521 Monovinyl Protochlorophyllide
% 210.17/210.32  |- skos__altLabel mesh__D011521 MV-PChlide
% 210.17/210.32  |- mesh__dateRevised mesh__D011521 2005-06-30
% 210.17/210.32  |- mesh__dateEstablished mesh__D011521 1991-01-01
% 210.17/210.32  |- skos__historyNote mesh__D011521 Porphyrins %28%1972-1974%29%
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D011521 2006
% 210.17/210.32  |- mesh__recordOriginator mesh__D011521 NLM
% 210.17/210.32  |- mesh__recordMaintainer mesh__D011521 ssb
% 210.17/210.32  |- skos__hiddenLabel mesh__D011521 MV PChlide
% 210.17/210.32  |- skos__broader mesh__D011521smesh__D002734
% 210.17/210.32  |- rdf__type mesh__D011521sskos__Concept
% 210.17/210.32  |- skos__annotation mesh__D011521 a chlorophyll   
% 210.17/210.32  |- mesh__historyNote mesh__D011521
% 210.17/210.32       91%28%75%29%; was see under CHLOROPHYLL 1975-90   
% 210.17/210.32  |- skos__historyNote mesh__D011521 Chlorophyll %28%1972-1974%29%
% 210.17/210.32  |- skos__scopeNote mesh__D011521
% 210.17/210.32       A photo-active pigment localized in prolamellar bodies occurring within the proplastids of dark-grown bean leaves. In the process of photoconversion, the highly fluorescent protochlorophyllide is converted to chlorophyll.%A%    
% 210.17/210.32  |- skos__prefLabel mesh__D011521 Protochlorophyllide
% 210.17/210.32  |- skos__hiddenLabel mesh__D011521 Protochlorophyllide, Monovinyl
% 210.17/210.32  |- skos__hiddenLabel mesh__D011521 A, Protochlorophyllide
% 210.17/210.32  |- mesh__dateCreated mesh__D002795 1974-11-19
% 210.17/210.32  |- skos__scopeNote mesh__D002795
% 210.17/210.32       An enzyme that catalyzes the formation of acetylcholine from acetyl-CoA and choline. EC 2.3.1.6.%A%    
% 210.17/210.32  |- skos__historyNote mesh__D002795 Choline %28%1966-1974%29%
% 210.17/210.32  |- mesh__recordOriginator mesh__D002795 NLM
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D002795 2006
% 210.17/210.32  |- mesh__dateEstablished mesh__D002795 1978-01-01
% 210.17/210.32  |- skos__prefLabel mesh__D002795 Choline O-Acetyltransferase
% 210.17/210.32  |- skos__altLabel mesh__D002795 Choline Acetyltransferase
% 210.17/210.32  |- skos__hiddenLabel mesh__D002795 O-Acetyltransferase, Choline
% 210.17/210.32  |- skos__hiddenLabel mesh__D002795 Choline O Acetyltransferase
% 210.17/210.32  |- skos__historyNote mesh__D002795 Acetyltransferases %28%1973-1974%29%
% 210.17/210.32  |- mesh__historyNote mesh__D002795 98%28%75%29%   
% 210.17/210.32  |- skos__hiddenLabel mesh__D002795 Acetylase, Choline
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D002795 2005
% 210.17/210.32  |- mesh__publicMeSHNote mesh__D002795
% 210.17/210.32       98; see CHOLINE ACETYLTRANSFERASE 1978-97; see ACETYLTRANSFERASES 1975-77%A%  
% 210.17/210.32  |- mesh__dateRevised mesh__D002795 2003-07-09
% 210.17/210.32  |- skos__historyNote mesh__D002795 Transferases %28%1966-1972%29%
% 210.17/210.32  |- skos__hiddenLabel mesh__D002795 Acetyltransferase, Choline
% 210.17/210.32  |- skos__broader mesh__D002795smesh__D000123
% 210.17/210.32  |- mesh__recordAuthorizer mesh__D002795 sjn
% 210.17/210.32  |- mesh__activeMeSHYear mesh__D002795 2004
% 210.17/210.32  |- rdf__type mesh__D002795sskos__Concept
% 210.17/210.32  |- mesh__recordMaintainer mesh__D002795 ssb
% 210.17/210.32  |- skos__altLabel mesh__D002795 Choline Acetylase
% 210.17/210.32  |- rdf__type mesh__D043603sskos__Concept
% 210.17/210.32  |- skos__broader mesh__D043603smesh__D045643
% 210.17/210.32  |- skos__hiddenLabel mesh__D043603 Endonuclease, Apurine-Apyrimidine
% 210.17/210.32  |- mesh__dateCreated mesh__D043603 2003-07-09
% 210.17/210.32  |- skos__hiddenLabel mesh__D043603 DNA Endonuclease, Apurinic
% 210.17/210.32  |- skos__altLabel mesh__D043603 Apurinic DNA Endonuclease
% 210.17/210.32  |- mesh__publicMeSHNote mesh__D043603
% 210.17/210.32       2004; DNA-%28%APURINIC OR APYRIMIDINIC SITE%29% LYASE was indexed under CARBON-OXYGEN LYASES 1996-2003, DEOXYRIBONUCLEASES 1978-1982, ENDODEOXYRIBONUCLEASES 1983-1995, ENDONUCLEASES 1978-1982 %26% LYASES 1978-1980%A%  
% 210.17/210.32  |- mesh__dateEstablished mesh__D043603 2004-01-01
% 210.17/210.32  |- mesh__recordAuthorizer mesh__D043603 sjn
% 210.17/210.32  |- skos__scopeNote mesh__D043603
% 210.17/210.32       A DNA repair enzyme that catalyses the excision of ribose residues at apurinic and apyrimidinic DNA sites that can result from the action of DNA GLYCOSYLASES. The enzyme catalyzes a beta-elimination reaction in which the C-O-P bond 3%27% to the apurinic or apyrimidinic site in DNA is broken, leaving a 3%27%-terminal unsaturated sugar and a product with a terminal 5%27%-phosphate.  This enzyme was previously listed under EC 3.1.25.2.%A%    
% 210.17/210.32  |- skos__broader mesh__D043603smesh__D019757
% 210.17/210.32  |- mesh__historyNote mesh__D043603
% 210.17/210.32       2004; use DNA-%28%APURINIC OR APYRIMIDINIC SITE%29% LYASE %28%NM%29% 1980-2003%A%  
% 210.17/210.32  |- skos__historyNote mesh__D043603 Carbon-Oxygen Lyases %28%1978-2003%29%
% 210.17/210.32  |- skos__hiddenLabel mesh__D043603 Endonuclease, Apurinic
% 210.17/210.32  |- skos__altLabel mesh__D043603
% 210.17/210.32       Endodeoxyribonuclease %28%Apurinic or Apyrimidinic%29%
% 210.17/210.32  |- skos__hiddenLabel mesh__D043603 Apurine Apyrimidine Endonuclease
% 210.17/210.32  |- skos__altLabel mesh__D043603 AP Lyase
% 210.18/210.32  |- skos__hiddenLabel mesh__D043603 Endonuclease, Apurinic DNA
% 210.18/210.32  |- mesh__recordOriginator mesh__D043603 AKE
% 210.18/210.32  |- mesh__activeMeSHYear mesh__D043603 2004
% 210.18/210.32  |- skos__hiddenLabel mesh__D043603 Endonuclease, AP
% 210.18/210.32  |- mesh__activeMeSHYear mesh__D043603 2005
% 210.18/210.32  |- skos__altLabel mesh__D043603 AP Endonuclease
% 210.18/210.32  |- mesh__recordMaintainer mesh__D043603 jmp
% 210.18/210.32  |- skos__altLabel mesh__D043603 Apurinic Endonuclease
% 210.18/210.32  |- skos__prefLabel mesh__D043603
% 210.18/210.32       DNA-%28%Apurinic or Apyrimidinic Site%29% Lyase
% 210.18/210.32  |- mesh__activeMeSHYear mesh__D043603 2006
% 210.18/210.32  |- skos__altLabel mesh__D043603 DNA Lyase %28%Apurinic or Apyrimidinic%29%
% 210.18/210.32  |- skos__altLabel mesh__D043603 Apurine-Apyrimidine Endonuclease
% 210.18/210.32  |- mesh__dateCreated mesh__D010429 1999-01-01
% 210.18/210.32  |- mesh__dateRevised mesh__D010429 2004-07-07
% 210.18/210.32  |- skos__prefLabel mesh__D010429 Pentoses
% 210.18/210.32  |- rdf__type mesh__D010429sskos__Concept
% 210.18/210.32  |- mesh__recordAuthorizer mesh__D010429 sjn
% 210.18/210.32  |- mesh__recordOriginator mesh__D010429 NLM
% 210.18/210.32  |- mesh__activeMeSHYear mesh__D010429 2005
% 210.18/210.32  |- skos__scopeNote mesh__D010429
% 210.18/210.32       A class of carbohydrates that contains five carbon atoms.%A%    
% 210.18/210.32  |- mesh__recordMaintainer mesh__D010429 ssb
% 210.18/210.32  |- mesh__activeMeSHYear mesh__D010429 2006
% 210.18/210.32  |- skos__broader mesh__D010429smesh__D009005
% 210.18/210.32  |- skos__annotation mesh__D010429 monosaccharides; GEN; prefer specifics   
% 210.18/210.32  |- skos__hiddenLabel mesh__D007480 Acid, Iopanoic
% 210.18/210.32  |- mesh__activeMeSHYear mesh__D007480 2005
% 210.18/210.32  |- skos__hiddenLabel mesh__D007480 Acid, Iodopanoic
% 210.18/210.32  |- mesh__activeMeSHYear mesh__D007480 2002
% 210.18/210.32  |- skos__altLabel mesh__D007480 Iodopanoic Acid
% 210.18/210.32  |- skos__annotation mesh__D007480 D25-26 qualif   
% 210.18/210.32  |- rdf__type mesh__D007480sskos__Concept
% 210.18/210.32  |- mesh__activeMeSHYear mesh__D007480 2004
% 210.18/210.32  |- mesh__recordOriginator mesh__D007480 NLM
% 210.18/210.32  |- mesh__recordAuthorizer mesh__D007480 sjn
% 210.18/210.32  |- skos__scopeNote mesh__D007480
% 210.18/210.32       Radiopaque medium used as diagnostic aid.     
% 210.18/210.32  |- mesh__dateRevised mesh__D007480 2000-06-21
% 210.18/210.32  |- mesh__activeMeSHYear mesh__D007480 2001
% 210.18/210.32  |- mesh__activeMeSHYear mesh__D007480 2003
% 210.18/210.32  |- mesh__dateCreated mesh__D007480 1999-01-01
% 210.18/210.32  |- skos__broader mesh__D007480smesh__D007462
% 210.18/210.32  |- skos__prefLabel mesh__D007480 Iopanoic Acid
% 210.18/210.32  |- mesh__recordMaintainer mesh__D007480 CCR
% 210.18/210.32  |- mesh__activeMeSHYear mesh__D007480 2006
% 210.18/210.32  |- skos__hiddenLabel mesh__D015912 Therapies, Thrombolytic
% 210.18/210.32  |- mesh__activeMeSHYear mesh__D015912 1993
% 210.18/210.32  |- mesh__activeMeSHYear mesh__D015912 1996
% 210.18/210.32  |- skos__historyNote mesh__D015912 Fibrinolysis %28%1966-1989%29%
% 210.18/210.32  |- mesh__activeMeSHYear mesh__D015912 2000
% 210.18/210.32  |- skos__prefLabel mesh__D015912 Thrombolytic Therapy
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015912 2004
% 210.18/210.33  |- skos__historyNote mesh__D015912 Fibrinolytic Agents %28%1966-1989%29%
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015912 1992
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015912 1999
% 210.18/210.33  |- skos__hiddenLabel mesh__D015912 Thrombolyses, Therapeutic
% 210.18/210.33  |- skos__altLabel mesh__D015912 Therapeutic Thrombolysis
% 210.18/210.33  |- mesh__historyNote mesh__D015912 90   
% 210.18/210.33  |- skos__hiddenLabel mesh__D015912 Therapeutic Thrombolyses
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015912 1991
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015912 2003
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015912 1995
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015912 1998
% 210.18/210.33  |- rdf__type mesh__D015912sskos__Concept
% 210.18/210.33  |- skos__altLabel mesh__D015912 Therapy, Thrombolytic
% 210.18/210.33  |- skos__historyNote mesh__D015912
% 210.18/210.33       Thrombosis/drug therapy %28%1966-1989%29%
% 210.18/210.33  |- skos__broader mesh__D015912smesh__D004358
% 210.18/210.33  |- skos__hiddenLabel mesh__D015912 Fibrinolytic Therapies
% 210.18/210.33  |- skos__hiddenLabel mesh__D015912 Thrombolytic Therapies
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015912 2002
% 210.18/210.33  |- mesh__dateCreated mesh__D015912 1989-09-06
% 210.18/210.33  |- mesh__publicMeSHNote mesh__D015912 90   
% 210.18/210.33  |- skos__altLabel mesh__D015912 Thrombolysis, Therapeutic
% 210.18/210.33  |- skos__annotation mesh__D015912
% 210.18/210.33       coord IM with specific thrombolytic agents /ther use %28%IM%29% if specified + dis /drug ther %28%IM%29%%A%  
% 210.18/210.33  |- mesh__dateEstablished mesh__D015912 1990-01-01
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015912 2006
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015912 1994
% 210.18/210.33  |- skos__altLabel mesh__D015912 Fibrinolytic Therapy
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015912 1990
% 210.18/210.33  |- skos__altLabel mesh__D015912 Therapy, Fibrinolytic
% 210.18/210.33  |- skos__historyNote mesh__D015912
% 210.18/210.33       Thromboembolism/drug therapy %28%1966-1989%29%
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015912 2005
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015912 1997
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015912 2001
% 210.18/210.33  |- skos__hiddenLabel mesh__D015912 Therapies, Fibrinolytic
% 210.18/210.33  |- skos__scopeNote mesh__D015912
% 210.18/210.33       Use of infusions of fibrinolytic agents to destroy or dissolve thrombi in blood vessels or bypass grafts.%A%    
% 210.18/210.33  |- rdf__type mesh__D015114sskos__Concept
% 210.18/210.33  |- skos__hiddenLabel mesh__D015114 delta 5 Androstene 3 beta,17 beta Diol
% 210.18/210.33  |- skos__hiddenLabel mesh__D015114 Androst 5 ene 3,17 diol
% 210.18/210.33  |- skos__altLabel mesh__D015114 Delta 5-Androstenediol
% 210.18/210.33  |- skos__hiddenLabel mesh__D015114 Androst 5 ene 3 beta,17 beta Diol
% 210.18/210.33  |- skos__altLabel mesh__D015114 5-Androstene-3,17-diol
% 210.18/210.33  |- skos__altLabel mesh__D015114 5-Androstene-3beta-17beta-Diol
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015114 2006A
% 210.18/210.33  |- mesh__dateRevised mesh__D015114 2005-07-11
% 210.18/210.33  |- mesh__recordMaintainer mesh__D015114 ags
% 210.18/210.33  |- skos__prefLabel mesh__D015114 Androstenediol
% 210.18/210.33  |- mesh__historyNote mesh__D015114
% 210.18/210.33       2004 %28%1976%29%; use 5-ANDROSTENE-3,17-DIOL 1991-1997, use ANDROSTENEDIOLS 1976-1990%A%  
% 210.18/210.33  |- skos__hiddenLabel mesh__D015114 Delta 5 Androstenediol
% 210.18/210.33  |- skos__altLabel mesh__D015114 Parke Davis Brand of Androstenediol
% 210.18/210.33  |- mesh__dateCreated mesh__D015114 1975-07-18
% 210.18/210.33  |- mesh__recordAuthorizer mesh__D015114 ags
% 210.18/210.33  |- mesh__dateEstablished mesh__D015114 1991-01-01
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015114 2004
% 210.18/210.33  |- skos__altLabel mesh__D015114 delta 5-Androstene-3 beta,17 beta-Diol
% 210.18/210.33  |- skos__altLabel mesh__D015114 Hermaphrodiol
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015114 2006
% 210.18/210.33  |- skos__broader mesh__D015114smesh__D000734
% 210.18/210.33  |- mesh__recordOriginator mesh__D015114 RLS
% 210.18/210.33  |- mesh__publicMeSHNote mesh__D015114
% 210.18/210.33       2004; see ANDROST-5-ENE-3 BETA,17 BETA-DIOL 1998-2003, see 5-ANDROSTENE-3,17-DIOL 1991-1997, see ANDROSTENEDIOLS 1976-1990%A%  
% 210.18/210.33  |- skos__scopeNote mesh__D015114
% 210.18/210.33       An intermediate in TESTOSTERONE biosynthesis, found in the TESTIS or the ADRENAL GLANDS. Androstenediol, derived from DEHYDROEPIANDROSTERONE by the reduction of the 17-keto group %28%17-HYDROXYSTEROID DEHYDROGENASES%29%, is converted to TESTOSTERONE by the oxidation of the 3-beta hydroxyl group to a 3-keto group %28%3-HYDROXYSTEROID DEHYDROGENASES%29%.%A%    
% 210.18/210.33  |- skos__historyNote mesh__D015114 Androstenediols %28%1975%29%
% 210.18/210.33  |- skos__hiddenLabel mesh__D015114 5 Androstene 3beta 17beta Diol
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015114 2005
% 210.18/210.33  |- skos__hiddenLabel mesh__D015114 5 Androstene 3,17 diol
% 210.18/210.33  |- skos__altLabel mesh__D015114 Androst-5-ene-3,17-diol
% 210.18/210.33  |- skos__broader mesh__D015114smesh__D045165
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015114 2006B
% 210.18/210.33  |- skos__altLabel mesh__D015114 Androst-5-ene-3 beta,17 beta-Diol
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D020857 2003
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D020857 2002
% 210.18/210.33  |- rdf__type mesh__D020857sskos__Concept
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D020857 2006
% 210.18/210.33  |- mesh__historyNote mesh__D020857 2000   
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D020857 2005
% 210.18/210.33  |- skos__historyNote mesh__D020857
% 210.18/210.33       Foot Deformities, Acquired %28%1979-1996%29%
% 210.18/210.33  |- skos__prefLabel mesh__D020857 Hallux Limitus
% 210.18/210.33  |- mesh__publicMeSHNote mesh__D020857 2000   
% 210.18/210.33  |- skos__broader mesh__D020857smesh__D007592
% 210.18/210.33  |- mesh__dateCreated mesh__D020857 1999-11-03
% 210.18/210.33  |- skos__historyNote mesh__D020857 Foot Diseases %28%1997%29%
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D020857 2001
% 210.18/210.33  |- skos__hiddenLabel mesh__D020857 Limitus, Hallux
% 210.18/210.33  |- mesh__dateEstablished mesh__D020857 2000-01-01
% 210.18/210.33  |- skos__historyNote mesh__D020857 Foot Deformities %28%1998-1999%29%
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D020857 2000
% 210.18/210.33  |- skos__scopeNote mesh__D020857
% 210.18/210.33       A bony proliferation and articular degeneration of the first METATARSOPHALANGEAL JOINT that is characterized by pain and a progressive decrease in the dorsiflexion range of motion.%A%    
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D020857 2004
% 210.18/210.33  |- skos__broader mesh__D020857smesh__D005531
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D039562 2006A
% 210.18/210.33  |- mesh__dateEstablished mesh__D039562 2003-01-01
% 210.18/210.33  |- mesh__recordOriginator mesh__D039562 jmp
% 210.18/210.33  |- skos__altLabel mesh__D039562 EIF-4F
% 210.18/210.33  |- mesh__dateCreated mesh__D039562 2002-07-03
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D039562 2006
% 210.18/210.33  |- mesh__historyNote mesh__D039562
% 210.18/210.33       2003; use EUKARYOTIC INITIATION FACTOR-4F %28%NM%29% 1983-2003   
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D039562 2004
% 210.18/210.33  |- mesh__publicMeSHNote mesh__D039562
% 210.18/210.33       2003; EIF-4F %28%now EUKARYOTIC INITIATION FACTOR-4F%29% was indexed under PEPTIDE INITIATION FACTORS 1983-2003%A%  
% 210.18/210.33  |- mesh__recordAuthorizer mesh__D039562 ags
% 210.18/210.33  |- skos__prefLabel mesh__D039562 Eukaryotic Initiation Factor-4F
% 210.18/210.33  |- mesh__recordMaintainer mesh__D039562 ags
% 210.18/210.33  |- skos__hiddenLabel mesh__D039562 EIF 4F
% 210.18/210.33  |- skos__altLabel mesh__D039562 Peptide Initiation Factor EIF-4F
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D039562 2005
% 210.18/210.33  |- skos__hiddenLabel mesh__D039562 Peptide Initiation Factor EIF 4F
% 210.18/210.33  |- skos__broader mesh__D039562smesh__D039381
% 210.18/210.33  |- skos__altLabel mesh__D039562 EIF4F
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D039562 2003
% 210.18/210.33  |- skos__scopeNote mesh__D039562
% 210.18/210.33       A trimeric peptide initiation factor complex that associates with the 5%27% MRNA CAP STRUCTURE of RNA and plays an essential role in MRNA TRANSLATION.  It is composed of EUKAYROTIC INITIATION FACTOR-4A; EUKARYOTIC INITIATION FACTOR-4E; and EUKAYROTIC INITIATION FACTOR-4G.%A%    
% 210.18/210.33  |- skos__hiddenLabel mesh__D039562 Protein Initiation Factor EIF 4F
% 210.18/210.33  |- skos__historyNote mesh__D039562
% 210.18/210.33       Peptide Initiation Factors %28%1983-2002%29%
% 210.18/210.33  |- skos__altLabel mesh__D039562 Eukaryotic Initiation Factor-%28%iso%29%4F
% 210.18/210.33  |- skos__hiddenLabel mesh__D039562 Initiation Factor-4F, Eukaryotic
% 210.18/210.33  |- skos__hiddenLabel mesh__D039562 Eukaryotic Initiation Factor 4F
% 210.18/210.33  |- mesh__dateRevised mesh__D039562 2005-07-13
% 210.18/210.33  |- skos__broader mesh__D039562smesh__D039642
% 210.18/210.33  |- rdf__type mesh__D039562sskos__Concept
% 210.18/210.33  |- skos__altLabel mesh__D039562 EIF4F Translation Initiation Complex
% 210.18/210.33  |- skos__altLabel mesh__D039562 Protein Initiation Factor EIF-4F
% 210.18/210.33  |- rdf__type mesh__D006388sskos__Concept
% 210.18/210.33  |- mesh__recordMaintainer mesh__D006388 ssb
% 210.18/210.33  |- mesh__dateRevised mesh__D006388 2005-06-30
% 210.18/210.33  |- skos__prefLabel mesh__D006388 Hemagglutinins
% 210.18/210.33  |- mesh__onlineNote mesh__D006388 search ANTIBODIES 1966-74   
% 210.18/210.33  |- skos__historyNote mesh__D006388 Antibodies %28%1966-1974%29%
% 210.18/210.33  |- mesh__historyNote mesh__D006388
% 210.18/210.33       81%28%75%29%; was see under AGGLUTININS 1975-80, was see under ANTIBODIES 1968-74, was see ANTIBODIES 1963-67%A%  
% 210.18/210.33  |- mesh__recordAuthorizer mesh__D006388 sjn
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D006388 2006
% 210.18/210.33  |- mesh__publicMeSHNote mesh__D006388
% 210.18/210.33       81; was see under AGGLUTININS 1975-80, was indexed under ANTIBODIES 1963-74.%A%  
% 210.18/210.33  |- skos__broader mesh__D006388smesh__D000373
% 210.18/210.33  |- mesh__dateCreated mesh__D006388 1999-01-01
% 210.18/210.33  |- mesh__recordOriginator mesh__D006388 NLM
% 210.18/210.33  |- skos__annotation mesh__D006388
% 210.18/210.33       restrict to erythrocytes: leukoagglutinins are indexed under AGGLUTININS %28%IM%29% + LEUKOCYTES or specific with /immunol %28%IM%29%%A%  
% 210.18/210.33  |- skos__scopeNote mesh__D006388
% 210.18/210.33       Agents that cause agglutination of red blood cells. They include antibodies, blood group antigens, lectins, autoimmune factors, bacterial, viral, or parasitic blood agglutinins, etc.%A%    
% 210.18/210.33  |- skos__altLabel mesh__D006388 Hemagglutinin
% 210.18/210.33  |- mesh__dateEstablished mesh__D006388 1981-01-01
% 210.18/210.33  |- skos__scopeNote mesh__D020059
% 210.18/210.33       An aspartic endopeptidase of the hydrolase class that is similar to cathepsin D but has a slightly broader specificity. EC 3.4.23.34.%A%    
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D020059 2004
% 210.18/210.33  |- skos__altLabel mesh__D020059 Slow Moving Proteinase
% 210.18/210.33  |- mesh__recordAuthorizer mesh__D020059 sjn
% 210.18/210.33  |- skos__altLabel mesh__D020059 Erythrocyte Membrane Aspartic Proteinase
% 210.18/210.33  |- skos__broader mesh__D020059smesh__D002403
% 210.18/210.33  |- skos__prefLabel mesh__D020059 Cathepsin E
% 210.18/210.33  |- mesh__dateEstablished mesh__D020059 1999-01-01
% 210.18/210.33  |- mesh__publicMeSHNote mesh__D020059
% 210.18/210.33       99; CATHEPSIN E %26% ERYTHROCYTE MEMBRANE ASPARTIC PROTEINASE were indexed under CATHEPSINS 1980-98%A%  
% 210.18/210.33  |- mesh__recordMaintainer mesh__D020059 ssb
% 210.18/210.33  |- mesh__recordOriginator mesh__D020059 ADP
% 210.18/210.33  |- skos__broader mesh__D020059smesh__D016282
% 210.18/210.33  |- rdf__type mesh__D020059sskos__Concept
% 210.18/210.33  |- skos__historyNote mesh__D020059 Cathepsins %28%1980-1998%29%
% 210.18/210.33  |- skos__hiddenLabel mesh__D020059 E, Cathepsin
% 210.18/210.33  |- skos__hiddenLabel mesh__D020059 Proteinase, Slow Moving
% 210.18/210.33  |- mesh__dateRevised mesh__D020059 2003-07-09
% 210.18/210.33  |- skos__related mesh__D020059smesh__D002402
% 210.18/210.33  |- skos__hiddenLabel mesh__D020059 Moving Proteinase, Slow
% 210.18/210.33  |- mesh__dateCreated mesh__D020059 1998-06-10
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D020059 2006
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D020059 2005
% 210.18/210.33  |- mesh__historyNote mesh__D020059
% 210.18/210.33       99; use CATHEPSIN E %28%NM%29% 1980-98   
% 210.18/210.33  |- mesh__historyNote mesh__D025542 2002   
% 210.18/210.33  |- mesh__dateCreated mesh__D025542 2001-07-25
% 210.18/210.33  |- mesh__publicMeSHNote mesh__D025542 2002   
% 210.18/210.33  |- skos__scopeNote mesh__D025542
% 210.18/210.33       A protein found most abundantly in the nervous system. Defects or deficiencies in this protein are associated with NEUROFIBROMATOSIS 1, Watson syndrome, and LEOPARD syndrome. Mutations in the gene %28%GENE, NEUROFIBROMATOSIS 1%29% affect two known functions: regulation of ras-GTPase and tumor suppression.%A%    
% 210.18/210.33  |- skos__historyNote mesh__D025542 Nerve Tissue Proteins %28%1995-2001%29%
% 210.18/210.33  |- skos__historyNote mesh__D025542 Proteins %28%1990-1999%29%
% 210.18/210.33  |- skos__related mesh__D025542smesh__D016514
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D025542 2006
% 210.18/210.33  |- rdf__type mesh__D025542sskos__Concept
% 210.18/210.33  |- mesh__recordMaintainer mesh__D025542 jls
% 210.18/210.33  |- mesh__dateEstablished mesh__D025542 2002-01-01
% 210.18/210.33  |- skos__prefLabel mesh__D025542 Neurofibromin 1
% 210.18/210.33  |- skos__altLabel mesh__D025542 Neurofibromin
% 210.18/210.33  |- skos__altLabel mesh__D025542 NF-1 Protein
% 210.18/210.33  |- skos__altLabel mesh__D025542 NF1 GRP
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D025542 2005A
% 210.18/210.33  |- mesh__recordAuthorizer mesh__D025542 jls
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D025542 2005
% 210.18/210.33  |- mesh__recordOriginator mesh__D025542 nns
% 210.18/210.33  |- mesh__dateRevised mesh__D025542 2004-07-29
% 210.18/210.33  |- skos__altLabel mesh__D025542 Neurofibromatosis Type 1 Protein
% 210.18/210.33  |- skos__altLabel mesh__D025542 NF1 Protein
% 210.18/210.33  |- skos__altLabel mesh__D025542 NF1-GAP-Related Protein
% 210.18/210.33  |- skos__related mesh__D025542smesh__D009456
% 210.18/210.33  |- skos__altLabel mesh__D025542 Neurofibromatosis Type 1 Gene Product
% 210.18/210.33  |- skos__hiddenLabel mesh__D025542 NF 1 Protein
% 210.18/210.33  |- skos__broader mesh__D025542smesh__D020703
% 210.18/210.33  |- skos__hiddenLabel mesh__D025542 NF1 GAP Related Protein
% 210.18/210.33  |- skos__broader mesh__D025542smesh__D025521
% 210.18/210.33  |- skos__hiddenLabel mesh__D003090 Coliphage
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D003090 2002
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D003090 1993
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D003090 1998
% 210.18/210.33  |- skos__annotation mesh__D003090 GEN or unspecified; prefer specifics   
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D003090 2005
% 210.18/210.33  |- mesh__recordMaintainer mesh__D003090 AGS
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D003090 1994
% 210.18/210.33  |- skos__hiddenLabel mesh__D003090 Phage, Escherichia coli
% 210.18/210.33  |- mesh__recordOriginator mesh__D003090 NLM
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D003090 1999
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D003090 2006
% 210.18/210.33  |- mesh__recordAuthorizer mesh__D003090 PLS
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D003090 1995
% 210.18/210.33  |- skos__scopeNote mesh__D003090
% 210.18/210.33       Viruses whose host is Escherichia coli.     
% 210.18/210.33  |- skos__hiddenLabel mesh__D003090 Phages, Escherichia coli
% 210.18/210.33  |- rdf__type mesh__D003090sskos__Concept
% 210.18/210.33  |- mesh__dateRevised mesh__D003090 1992-05-07
% 210.18/210.33  |- skos__hiddenLabel mesh__D003090 Escherichia coli Phage
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D003090 2000
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D003090 1996
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D003090 2003
% 210.18/210.33  |- skos__broader mesh__D003090smesh__D001435
% 210.18/210.33  |- skos__altLabel mesh__D003090 Escherichia coli Phages
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D003090 2001
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D003090 1997
% 210.18/210.33  |- skos__prefLabel mesh__D003090 Coliphages
% 210.18/210.33  |- mesh__dateCreated mesh__D003090 1999-01-01
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D003090 2004
% 210.18/210.33  |- mesh__dateEstablished mesh__D019505 1997-01-01
% 210.18/210.33  |- skos__broader mesh__D019505smesh__D019504
% 210.18/210.33  |- skos__altLabel mesh__D019505 Funeral Sermons
% 210.18/210.33  |- skos__scopeNote mesh__D019505
% 210.18/210.33       Works consisting of sermons delivered at ceremonies for a dead person prior to burial or cremation. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 210.18/210.33  |- skos__annotation mesh__D019505
% 210.18/210.33       publication type only; for funeral sermons as a subject, index under main heading FUNERAL RITES%A%  
% 210.18/210.33  |- mesh__recordAuthorizer mesh__D019505 sjn
% 210.18/210.33  |- skos__prefLabel mesh__D019505 Funeral Sermons %5B%Publication Type%5D%
% 210.18/210.33  |- mesh__dateCreated mesh__D019505 1996-06-21
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D019505 2006
% 210.18/210.33  |- mesh__recordMaintainer mesh__D019505 jls
% 210.18/210.33  |- rdf__type mesh__D019505sskos__Concept
% 210.18/210.33  |- skos__altLabel mesh__D019505 Funeral Sermons %28%PT%29%
% 210.18/210.33  |- mesh__recordOriginator mesh__D019505 TGC
% 210.18/210.33  |- mesh__dateRevised mesh__D019505 2005-06-30
% 210.18/210.33  |- mesh__historyNote mesh__D019505 1997   
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D011522 2002
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D011522 1994
% 210.18/210.33  |- skos__broader mesh__D011522smesh__D002414
% 210.18/210.33  |- skos__hiddenLabel mesh__D011522 Ion, Hydrogen
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D011522 2006
% 210.18/210.33  |- skos__prefLabel mesh__D011522 Protons
% 210.18/210.33  |- mesh__recordAuthorizer mesh__D011522 PLS
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D011522 1998
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D011522 2003
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D011522 1995
% 210.18/210.33  |- rdf__type mesh__D011522sskos__Concept
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D011522 2000
% 210.18/210.33  |- skos__hiddenLabel mesh__D011522 Ions, Hydrogen
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D011522 1999
% 210.18/210.33  |- mesh__dateCreated mesh__D011522 1999-01-01
% 210.18/210.33  |- mesh__recordMaintainer mesh__D011522 TPW
% 210.18/210.33  |- skos__scopeNote mesh__D011522
% 210.18/210.33       Stable elementary particles having the smallest known positive charge, found in the nuclei of all elements. The proton mass is less than that of a neutron. A proton is the nucleus of the light hydrogen atom, i.e., the hydrogen ion.%A%    
% 210.18/210.33  |- mesh__dateEstablished mesh__D011522 1966-01-01
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D011522 2004
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D011522 1996
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D011522 2001
% 210.18/210.33  |- mesh__recordOriginator mesh__D011522 NLM
% 210.18/210.33  |- mesh__historyNote mesh__D011522 66   
% 210.18/210.33  |- mesh__dateRevised mesh__D011522 1993-06-02
% 210.18/210.33  |- skos__broader mesh__D011522smesh__D006859
% 210.18/210.33  |- skos__annotation mesh__D011522 elementary particles; IM   
% 210.18/210.33  |- skos__broader mesh__D011522smesh__D004601
% 210.18/210.33  |- skos__hiddenLabel mesh__D011522 Hydrogen Ion
% 210.18/210.33  |- mesh__publicMeSHNote mesh__D011522 66   
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D011522 1997
% 210.18/210.33  |- skos__altLabel mesh__D011522 Hydrogen Ions
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D011522 2005
% 210.18/210.33  |- skos__hiddenLabel mesh__D011522 Proton
% 210.18/210.33  |- mesh__recordMaintainer mesh__D049990 ssb
% 210.18/210.33  |- mesh__publicMeSHNote mesh__D049990 2006   
% 210.18/210.33  |- mesh__dateCreated mesh__D049990 2005-06-30
% 210.18/210.33  |- skos__hiddenLabel mesh__D049990 Modulators, Membrane Transport
% 210.18/210.33  |- skos__prefLabel mesh__D049990 Membrane Transport Modulators
% 210.18/210.33  |- mesh__dateEstablished mesh__D049990 2006-01-01
% 210.18/210.33  |- skos__altLabel mesh__D049990 Membrane Transport Protein Modulators
% 210.18/210.33  |- skos__broader mesh__D049990smesh__D045504
% 210.18/210.33  |- skos__historyNote mesh__D049990
% 210.18/210.33       Membrane Transport Proteins %28%2002-2005%29%
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D049990 2006
% 210.18/210.33  |- mesh__recordOriginator mesh__D049990 ssb
% 210.18/210.33  |- skos__annotation mesh__D049990 general; prefer specifics   
% 210.18/210.33  |- skos__hiddenLabel mesh__D049990 Transport Modulators, Membrane
% 210.18/210.33  |- skos__scopeNote mesh__D049990
% 210.18/210.33       Agents that affect ION PUMPS; ION CHANNELS; ABC TRANSPORTERS; and other MEMBRANE TRANSPORT PROTEINS.%A%    
% 210.18/210.33  |- mesh__historyNote mesh__D049990 2006   
% 210.18/210.33  |- mesh__recordAuthorizer mesh__D049990 sjn
% 210.18/210.33  |- rdf__type mesh__D049990sskos__Concept
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D002796 2006
% 210.18/210.33  |- mesh__recordAuthorizer mesh__D002796 sjn
% 210.18/210.33  |- mesh__dateCreated mesh__D002796 1999-01-01
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D002796 2005
% 210.18/210.33  |- skos__hiddenLabel mesh__D002796 Deficiencies, Choline
% 210.18/210.33  |- mesh__recordOriginator mesh__D002796 NLM
% 210.18/210.33  |- skos__scopeNote mesh__D002796
% 210.18/210.33       A condition produced by a deficiency of CHOLINE in animals. Choline is known as a lipotropic agent because it has been shown to promote the transport of excess fat from the liver under certain conditions in laboratory animals. Combined deficiency of choline %28%included in the B vitamin complex%29% and all other methyl group donors causes liver cirrhosis in some animals. Unlike compounds normally considered as vitamins, choline does not serve as a cofactor in enzymatic reactions. %28%From Saunders Dictionary %26% Encyclopedia of Laboratory Medicine and Technology, 1984%29%%A%    
% 210.18/210.33  |- mesh__dateRevised mesh__D002796 2003-07-09
% 210.18/210.33  |- skos__prefLabel mesh__D002796 Choline Deficiency
% 210.18/210.33  |- mesh__dateEstablished mesh__D002796 1967-01-01
% 210.18/210.33  |- mesh__historyNote mesh__D002796 67%28%64%29%   
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D002796 2004
% 210.18/210.33  |- rdf__type mesh__D002796sskos__Concept
% 210.18/210.33  |- skos__hiddenLabel mesh__D002796 Choline Deficiencies
% 210.18/210.33  |- mesh__publicMeSHNote mesh__D002796 67   
% 210.18/210.33  |- skos__broader mesh__D002796smesh__D014804
% 210.18/210.33  |- skos__annotation mesh__D002796
% 210.18/210.33       a vitamin B defic in animals; DF: CHOLINE DEFIC   
% 210.18/210.33  |- mesh__recordMaintainer mesh__D002796 lkt
% 210.18/210.33  |- skos__altLabel mesh__D002796 Deficiency, Choline
% 210.18/210.33  |- skos__historyNote mesh__D043604
% 210.18/210.33       Paraganglioma, Extra-Adrenal %28%1970-2003%29%
% 210.18/210.33  |- mesh__publicMeSHNote mesh__D043604 2004   
% 210.18/210.33  |- skos__prefLabel mesh__D043604 Glomus Tympanicum Tumor
% 210.18/210.33  |- mesh__historyNote mesh__D043604 2004   
% 210.18/210.33  |- mesh__dateEstablished mesh__D043604 2004-01-01
% 210.18/210.33  |- skos__historyNote mesh__D043604 Glomus Tumor %28%1974-2003%29%
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D043604 2004
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D043604 2005
% 210.18/210.33  |- skos__hiddenLabel mesh__D043604 Tumor, Glomus Tympanicum
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D043604 2006
% 210.18/210.33  |- rdf__type mesh__D043604sskos__Concept
% 210.18/210.33  |- skos__hiddenLabel mesh__D043604 Glomus Tympanicum Tumors
% 210.18/210.33  |- skos__scopeNote mesh__D043604
% 210.18/210.33       A rare PARAGANGLIOMA involving the GLOMUS TYMPANICUM, a collection of chemoreceptor tissue adjacent to the TYMPANIC CAVITY. It can cause TINNITUS and conductive hearing loss %28%HEARING LOSS, CONDUCTIVE%29%.%A%    
% 210.18/210.33  |- mesh__dateCreated mesh__D043604 2003-07-09
% 210.18/210.33  |- skos__hiddenLabel mesh__D043604 Tumors, Glomus Tympanicum
% 210.18/210.33  |- skos__annotation mesh__D043604 coord IM with EAR NEOPLASMS %28%IM%29%   
% 210.18/210.33  |- skos__broader mesh__D043604smesh__D010236
% 210.18/210.33  |- mesh__recordMaintainer mesh__D007481 CCR
% 210.18/210.33  |- rdf__type mesh__D007481sskos__Concept
% 210.18/210.33  |- mesh__historyNote mesh__D007481
% 210.18/210.33       91%28%75%29%; was see under IODOBENZENES 1975-90   
% 210.18/210.33  |- mesh__dateCreated mesh__D007481 1974-11-19
% 210.18/210.33  |- skos__scopeNote mesh__D007481
% 210.18/210.33       A mixture of isomers used as contrast medium, mainly for brain and spinal cord visualization.%A%    
% 210.18/210.33  |- skos__altLabel mesh__D007481 Iodophendylate
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D007481 2004
% 210.18/210.33  |- skos__historyNote mesh__D007481 Iodobenzenes %28%1973-1974%29%
% 210.18/210.33  |- skos__historyNote mesh__D007481 Benzene %28%1966-1967%29%
% 210.18/210.33  |- mesh__publicMeSHNote mesh__D007481
% 210.18/210.33       91; was see under IODOBENZENES 1975-90   
% 210.18/210.33  |- skos__altLabel mesh__D007481 Myodil
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D007481 2002
% 210.18/210.33  |- skos__annotation mesh__D007481 D25-26 qualif   
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D007481 2003
% 210.18/210.33  |- mesh__dateEstablished mesh__D007481 1991-01-01
% 210.18/210.33  |- skos__altLabel mesh__D007481 Pantopaque
% 210.18/210.33  |- mesh__dateRevised mesh__D007481 2000-06-22
% 210.18/210.33  |- skos__altLabel mesh__D007481 Isophendylate
% 210.18/210.33  |- mesh__recordOriginator mesh__D007481 NLM
% 210.18/210.33  |- mesh__recordAuthorizer mesh__D007481 sjn
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D007481 2006
% 210.18/210.33  |- skos__prefLabel mesh__D007481 Iophendylate
% 210.18/210.33  |- skos__historyNote mesh__D007481 Benzene Derivatives %28%1968-1972%29%
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D007481 2001
% 210.18/210.33  |- skos__broader mesh__D007481smesh__D007462
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D007481 2005
% 210.18/210.33  |- skos__historyNote mesh__D007481 Fatty Acids %28%1966-1974%29%
% 210.18/210.33  |- skos__altLabel mesh__D007481 Iofendylate
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015913 2003
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015913 1994
% 210.18/210.33  |- rdf__type mesh__D015913sskos__Concept
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015913 2004
% 210.18/210.33  |- mesh__dateRevised mesh__D015913 1990-03-22
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015913 1998
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015913 1995
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015913 2002
% 210.18/210.33  |- mesh__dateCreated mesh__D015913 1989-10-03
% 210.18/210.33  |- mesh__dateEstablished mesh__D015913 1990-01-01
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015913 1992
% 210.18/210.33  |- skos__hiddenLabel mesh__D015913 Therapies, Chelation
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015913 1999
% 210.18/210.33  |- skos__historyNote mesh__D015913
% 210.18/210.33       Chelating Agents/therapeutic use %28%1966-1989%29%
% 210.18/210.33  |- skos__prefLabel mesh__D015913 Chelation Therapy
% 210.18/210.33  |- skos__altLabel mesh__D015913 Therapy, Chelation
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015913 1996
% 210.18/210.33  |- skos__annotation mesh__D015913
% 210.18/210.33       coord IM with specific chelating agent /ther use %28%IM%29% + metal being chelated with no qualif%A%  
% 210.18/210.33  |- skos__hiddenLabel mesh__D015913 Chelation Therapies
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015913 1993
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015913 2005
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015913 2000
% 210.18/210.33  |- mesh__publicMeSHNote mesh__D015913 90   
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015913 1997
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015913 1991
% 210.18/210.33  |- skos__broader mesh__D015913smesh__D004358
% 210.18/210.33  |- skos__scopeNote mesh__D015913
% 210.18/210.33       Therapy of heavy metal poisoning using agents which sequester the metal from organs or tissues and bind it firmly within the ring structure of a new compound which can be eliminated from the body.%A%    
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015913 2006
% 210.18/210.33  |- mesh__recordAuthorizer mesh__D015913 PLS
% 210.18/210.33  |- mesh__recordOriginator mesh__D015913 PLS
% 210.18/210.33  |- mesh__historyNote mesh__D015913 90   
% 210.18/210.33  |- mesh__recordMaintainer mesh__D015913 TGC
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015913 2001
% 210.18/210.33  |- mesh__publicMeSHNote mesh__D015115
% 210.18/210.33       78; was see under TRYPTAMINES 1975-77   
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015115 2002
% 210.18/210.33  |- skos__prefLabel mesh__D015115 5,6-Dihydroxytryptamine
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015115 2004
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015115 2001
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015115 2006
% 210.18/210.33  |- skos__altLabel mesh__D015115 3-%28%2-Aminoethyl%29%indole-5,6-diol
% 210.18/210.33  |- skos__broader mesh__D015115smesh__D004102
% 210.18/210.33  |- mesh__activeMeSHYear mesh__D015115 2003
% 210.18/210.33  |- mesh__recordOriginator mesh__D015115 NLM
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D015115 2005
% 210.18/210.34  |- skos__hiddenLabel mesh__D015115 5,6 Dihydroxytryptamine
% 210.18/210.34  |- mesh__dateEstablished mesh__D015115 1978-01-01
% 210.18/210.34  |- rdf__type mesh__D015115sskos__Concept
% 210.18/210.34  |- skos__historyNote mesh__D015115 Tryptamines %28%1966-1974%29%
% 210.18/210.34  |- skos__scopeNote mesh__D015115
% 210.18/210.34       Tryptamine substituted with two hydroxyl groups in positions 5 and 6. It is a neurotoxic serotonin analog that destroys serotonergic neurons preferentially and is used in neuropharmacologic research.%A%    
% 210.18/210.34  |- mesh__recordMaintainer mesh__D015115 TWD
% 210.18/210.34  |- mesh__historyNote mesh__D015115
% 210.18/210.34       78%28%75%29%; was see under TRYPTAMINES 1975-77   
% 210.18/210.34  |- mesh__dateRevised mesh__D015115 2000-06-22
% 210.18/210.34  |- mesh__dateCreated mesh__D015115 1974-11-27
% 210.18/210.34  |- mesh__recordAuthorizer mesh__D015115 sjn
% 210.18/210.34  |- skos__hiddenLabel mesh__D020858 Retrieval, Organ
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D020858 2005
% 210.18/210.34  |- mesh__recordOriginator mesh__D020858 nns
% 210.18/210.34  |- skos__broader mesh__D020858smesh__D013514
% 210.18/210.34  |- skos__annotation mesh__D020858 sperm collection goes here   
% 210.18/210.34  |- skos__hiddenLabel mesh__D020858 Retrievals, Organ
% 210.18/210.34  |- skos__related mesh__D020858smesh__D009926
% 210.18/210.34  |- skos__related mesh__D020858smesh__D009927
% 210.18/210.34  |- skos__broader mesh__D020858smesh__D013048
% 210.18/210.34  |- mesh__dateRevised mesh__D020858 2004-07-07
% 210.18/210.34  |- mesh__dateEstablished mesh__D020858 2000-01-01
% 210.18/210.34  |- mesh__recordMaintainer mesh__D020858 lkt
% 210.18/210.34  |- mesh__publicMeSHNote mesh__D020858
% 210.18/210.34       2005; see TISSUE HARVESTING 2000-2004   
% 210.18/210.34  |- skos__hiddenLabel mesh__D020858 Organ Retrievals
% 210.18/210.34  |- mesh__historyNote mesh__D020858 2005 %28%2000%29%   
% 210.18/210.34  |- mesh__recordAuthorizer mesh__D020858 sjn
% 210.18/210.34  |- mesh__dateCreated mesh__D020858 1999-11-03
% 210.18/210.34  |- skos__prefLabel mesh__D020858 Tissue and Organ Harvesting
% 210.18/210.34  |- skos__related mesh__D020858smesh__D001793
% 210.18/210.34  |- skos__related mesh__D020858smesh__D012662
% 210.18/210.34  |- skos__hiddenLabel mesh__D020858 Organ Harvestings
% 210.18/210.34  |- skos__scopeNote mesh__D020858
% 210.18/210.34       The procedure of removing TISSUES, organs, or specimens from DONORS for reuse, such as TRANSPLANTATION.%A%    
% 210.18/210.34  |- skos__related mesh__D020858smesh__D014021
% 210.18/210.34  |- rdf__type mesh__D020858sskos__Concept
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D020858 2006
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D039563 2006
% 210.18/210.34  |- mesh__dateEstablished mesh__D039563 2003-01-01
% 210.18/210.34  |- skos__scopeNote mesh__D039563
% 210.18/210.34       A class of non-sedating drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early %28%first generation%29% antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment.%A%    
% 210.18/210.34  |- skos__historyNote mesh__D039563
% 210.18/210.34       Histamine H1 Antagonists %28%1982-2002%29%
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D039563 2005
% 210.18/210.34  |- mesh__dateCreated mesh__D039563 2002-07-02
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D039563 2004
% 210.18/210.34  |- mesh__historyNote mesh__D039563 2003   
% 210.18/210.34  |- skos__hiddenLabel mesh__D039563 Non-Sedating H1 Antihistamines
% 210.18/210.34  |- skos__hiddenLabel mesh__D039563 Histamine H1 Antagonists, Non Sedating
% 210.18/210.34  |- skos__hiddenLabel mesh__D039563 H1 Antihistamines, Non Sedating
% 210.18/210.34  |- skos__altLabel mesh__D039563 H1 Antihistamines, Non-Sedating
% 210.18/210.34  |- skos__hiddenLabel mesh__D039563 Antihistamines, Second Generation
% 210.18/210.34  |- skos__altLabel mesh__D039563 Second Generation H1 Antagonists
% 210.18/210.34  |- skos__altLabel mesh__D039563 Second Generation Antihistamines
% 210.18/210.34  |- skos__prefLabel mesh__D039563 Histamine H1 Antagonists, Non-Sedating
% 210.18/210.34  |- skos__broader mesh__D039563smesh__D006634
% 210.18/210.34  |- skos__historyNote mesh__D039563 Benzhydryl Compounds %28%1982-2002%29%
% 210.18/210.34  |- mesh__dateRevised mesh__D039563 2003-07-09
% 210.18/210.34  |- rdf__type mesh__D039563sskos__Concept
% 210.18/210.34  |- mesh__publicMeSHNote mesh__D039563 2003   
% 210.18/210.34  |- mesh__recordMaintainer mesh__D006389 ssb
% 210.18/210.34  |- mesh__recordOriginator mesh__D006389 NLM
% 210.18/210.34  |- skos__prefLabel mesh__D006389 Hemagglutinins, Viral
% 210.18/210.34  |- skos__broader mesh__D006389smesh__D000956
% 210.18/210.34  |- skos__broader mesh__D006389smesh__D014759
% 210.18/210.34  |- skos__historyNote mesh__D006389 Antigens %28%1966%29%
% 210.18/210.34  |- mesh__dateCreated mesh__D006389 1999-01-01
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D006389 2006
% 210.18/210.34  |- mesh__dateEstablished mesh__D006389 1972-01-01
% 210.18/210.34  |- mesh__dateRevised mesh__D006389 2005-06-30
% 210.18/210.34  |- mesh__recordAuthorizer mesh__D006389 sjn
% 210.18/210.34  |- mesh__publicMeSHNote mesh__D006389 72; was see under ANTIGENS 1968-71   
% 210.18/210.34  |- skos__hiddenLabel mesh__D006389 Viral Hemagglutinins
% 210.18/210.34  |- mesh__historyNote mesh__D006389
% 210.18/210.34       72%28%67%29%; was see under ANTIGENS 1968-71   
% 210.18/210.34  |- rdf__type mesh__D006389sskos__Concept
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D025543 2005
% 210.18/210.34  |- mesh__dateEstablished mesh__D025543 2002-01-01
% 210.18/210.34  |- mesh__publicMeSHNote mesh__D025543 2002; see INOVIRUS 1994-2001   
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D025543 2002
% 210.18/210.34  |- skos__prefLabel mesh__D025543 Bacteriophage IKe
% 210.18/210.34  |- skos__historyNote mesh__D025543 Coliphages %28%1976-1996%29%
% 210.18/210.34  |- skos__broader mesh__D025543smesh__D017912
% 210.18/210.34  |- skos__hiddenLabel mesh__D025543 Phages, IKe
% 210.18/210.34  |- mesh__dateCreated mesh__D025543 2001-07-25
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D025543 2004
% 210.18/210.34  |- mesh__historyNote mesh__D025543 2002; use INOVIRUS 1994-2001   
% 210.18/210.34  |- skos__altLabel mesh__D025543 Enterobacteria phage IKe
% 210.18/210.34  |- skos__annotation mesh__D025543 coord with specific bacterium /virol   
% 210.18/210.34  |- skos__scopeNote mesh__D025543
% 210.18/210.34       A species of filamentous phage in the genus INOVIRUS, family INOVIRIDAE. They are specific for enterobacteria that contain an IncN plasmid.%A%    
% 210.18/210.34  |- skos__historyNote mesh__D025543 Inovirus %28%1993-2001%29%
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D025543 2003
% 210.18/210.34  |- skos__altLabel mesh__D025543 Phage IKe
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D025543 2006
% 210.18/210.34  |- skos__altLabel mesh__D025543 IKe Phage
% 210.18/210.34  |- rdf__type mesh__D025543sskos__Concept
% 210.18/210.34  |- skos__hiddenLabel mesh__D025543 IKe Phages
% 210.18/210.34  |- skos__hiddenLabel mesh__D025543 Phage, IKe
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D003091 2005
% 210.18/210.34  |- skos__hiddenLabel mesh__D003091 Sulfate, Colistin
% 210.18/210.34  |- skos__altLabel mesh__D003091 Colisticin
% 210.18/210.34  |- skos__broader mesh__D003091smesh__D011113
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D003091 2006
% 210.18/210.34  |- skos__scopeNote mesh__D003091
% 210.18/210.34       Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 %28%or Colistins A, B, and C%29% which act as detergents on cell membranes. Colistin is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally.%A%    
% 210.18/210.34  |- mesh__recordMaintainer mesh__D003091 ssb
% 210.18/210.34  |- rdf__type mesh__D003091sskos__Concept
% 210.18/210.34  |- mesh__dateRevised mesh__D003091 2004-07-07
% 210.18/210.34  |- mesh__recordOriginator mesh__D003091 NLM
% 210.18/210.34  |- mesh__recordAuthorizer mesh__D003091 sjn
% 210.18/210.34  |- mesh__dateCreated mesh__D003091 1999-01-01
% 210.18/210.34  |- skos__altLabel mesh__D003091 Polymyxin E
% 210.18/210.34  |- skos__hiddenLabel mesh__D003091 Sulfomethate, Colistin
% 210.18/210.34  |- skos__prefLabel mesh__D003091 Colistin
% 210.18/210.34  |- skos__altLabel mesh__D003091 Colimycin
% 210.18/210.34  |- mesh__historyNote mesh__D011523 66%28%64%29%   
% 210.18/210.34  |- skos__broader mesh__D011523smesh__D002477
% 210.18/210.34  |- skos__prefLabel mesh__D011523 Protoplasts
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D011523 2001
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D011523 2006
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D011523 2000
% 210.18/210.34  |- mesh__dateEstablished mesh__D011523 1966-01-01
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D011523 2004
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D011523 1995
% 210.18/210.34  |- skos__annotation mesh__D011523 A 11 qualif   
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D011523 2005
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D011523 1993
% 210.18/210.34  |- rdf__type mesh__D011523sskos__Concept
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D011523 2003
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D011523 1999
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D011523 1994
% 210.18/210.34  |- mesh__recordAuthorizer mesh__D011523 NLM
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D011523 1992
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D011523 1997
% 210.18/210.34  |- mesh__dateRevised mesh__D011523 1990-05-26
% 210.18/210.34  |- skos__hiddenLabel mesh__D011523 Protoplast
% 210.18/210.34  |- mesh__dateCreated mesh__D011523 1999-01-01
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D011523 1998
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D011523 2002
% 210.18/210.34  |- mesh__recordMaintainer mesh__D011523 PLS
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D011523 1996
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D011523 1991
% 210.18/210.34  |- mesh__publicMeSHNote mesh__D011523 66   
% 210.18/210.34  |- mesh__recordOriginator mesh__D011523 NLM
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D002797 2006
% 210.18/210.34  |- skos__hiddenLabel mesh__D002797 Choline Transphosphatase, ATP
% 210.18/210.34  |- skos__hiddenLabel mesh__D002797 Transphosphatase, ATP Choline
% 210.18/210.34  |- skos__altLabel mesh__D002797 ATP Choline Transphosphatase
% 210.18/210.34  |- mesh__publicMeSHNote mesh__D002797
% 210.18/210.34       91; was see under PHOSPHOTRANSFERASES, ATP 1976-90   
% 210.18/210.34  |- mesh__recordMaintainer mesh__D002797 ssb
% 210.18/210.34  |- skos__altLabel mesh__D002797 Choline Phosphokinase
% 210.18/210.34  |- mesh__historyNote mesh__D002797
% 210.18/210.34       91%28%76%29%; was see under PHOSPHOTRANSFERASES, ATP 1976-90   
% 210.18/210.34  |- mesh__dateRevised mesh__D002797 2003-07-09
% 210.18/210.34  |- mesh__recordAuthorizer mesh__D002797 sjn
% 210.18/210.34  |- skos__hiddenLabel mesh__D002797 Phosphokinase, Choline
% 210.18/210.34  |- mesh__dateEstablished mesh__D002797 1991-01-01
% 210.18/210.34  |- skos__scopeNote mesh__D002797
% 210.18/210.34       An enzyme that is active in the first step of choline phosphoglyceride %28%lecithin%29% biosynthesis by catalyzing the phosphorylation of choline to phosphorylcholine in the presence of ATP. Ethanolamine and its methyl and ethyl derivatives can also act as acceptors. EC 2.7.1.32.%A%    
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D002797 2004
% 210.18/210.34  |- rdf__type mesh__D002797sskos__Concept
% 210.18/210.34  |- skos__historyNote mesh__D002797 Choline %28%1974-1975%29%
% 210.18/210.34  |- mesh__dateCreated mesh__D002797 1975-07-18
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D002797 2005
% 210.18/210.34  |- skos__prefLabel mesh__D002797 Choline Kinase
% 210.18/210.34  |- skos__historyNote mesh__D002797
% 210.18/210.34       Phosphotransferases, ATP %28%1974-1975%29%
% 210.18/210.34  |- skos__hiddenLabel mesh__D002797 Kinase, Choline
% 210.18/210.34  |- skos__broader mesh__D002797smesh__D017853
% 210.18/210.34  |- mesh__recordOriginator mesh__D002797 RLS
% 210.18/210.34  |- mesh__dateRevised mesh__D007482 2004-07-07
% 210.18/210.34  |- rdf__type mesh__D007482sskos__Concept
% 210.18/210.34  |- skos__hiddenLabel mesh__D007482 Iotalamate, Meglumine
% 210.18/210.34  |- mesh__recordOriginator mesh__D007482 NLM
% 210.18/210.34  |- mesh__onlineNote mesh__D007482
% 210.18/210.34       use IOTHALAMATE MEGLUMINE to search MEGLUMINE IOTHALAMATE 1975-81%A%  
% 210.18/210.34  |- skos__hiddenLabel mesh__D007482 Meglumine, Iotalamate
% 210.18/210.34  |- mesh__recordAuthorizer mesh__D007482 sjn
% 210.18/210.34  |- skos__scopeNote mesh__D007482
% 210.18/210.34       A radiopaque medium used for urography, angiography, venography, and myelography. It is highly viscous and binds to plasma proteins.%A%    
% 210.18/210.34  |- skos__prefLabel mesh__D007482 Iothalamate Meglumine
% 210.18/210.34  |- skos__altLabel mesh__D007482 Iotalamate Meglumine
% 210.18/210.34  |- skos__altLabel mesh__D007482 Methylglucamine Iotalamate
% 210.18/210.34  |- skos__hiddenLabel mesh__D007482 Iothalamate, Meglumine
% 210.18/210.34  |- skos__historyNote mesh__D007482 Adipic Acids %28%1966-1977%29%
% 210.18/210.34  |- skos__altLabel mesh__D007482 Iothalamic Acid Methylglucamine
% 210.18/210.34  |- mesh__recordMaintainer mesh__D007482 ssb
% 210.18/210.34  |- skos__historyNote mesh__D007482 Iothalamic Acid %28%1966-1977%29%
% 210.18/210.34  |- skos__altLabel mesh__D007482 Methylglucamine Iothalamate
% 210.18/210.34  |- mesh__dateEstablished mesh__D007482 1978-01-01
% 210.18/210.34  |- skos__altLabel mesh__D007482 Iothalamic Acid Meglumine
% 210.18/210.34  |- skos__hiddenLabel mesh__D007482 Meglumine, Iothalamate
% 210.18/210.34  |- skos__altLabel mesh__D007482 Meglumine Iothalamate
% 210.18/210.34  |- mesh__dateCreated mesh__D007482 1974-11-19
% 210.18/210.34  |- skos__hiddenLabel mesh__D007482 Methylglucamine, Iothalamic Acid
% 210.18/210.34  |- skos__broader mesh__D007482smesh__D008536
% 210.18/210.34  |- mesh__historyNote mesh__D007482
% 210.18/210.34       82; was MEGLUMINE IOTHALAMATE 1978-81, was MEGLUMINE IOTHALAMATE see under IOTHALAMIC ACID 1975-77%A%  
% 210.18/210.34  |- skos__historyNote mesh__D007482 Sorbitol %28%1966-1977%29%
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D007482 2005
% 210.18/210.34  |- skos__hiddenLabel mesh__D007482 Iothalamate, Methylglucamine
% 210.18/210.34  |- skos__broader mesh__D007482smesh__D014283
% 210.18/210.34  |- mesh__publicMeSHNote mesh__D007482
% 210.18/210.34       82; was MEGLUMINE IOTHALAMATE 1978-81, was MEGLUMINE IOTHALAMATE see under IOTHALAMIC ACID 1975-77%A%  
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D007482 2006
% 210.18/210.34  |- skos__hiddenLabel mesh__D007482 Meglumine, Iothalamic Acid
% 210.18/210.34  |- skos__hiddenLabel mesh__D007482 Iotalamate, Methylglucamine
% 210.18/210.34  |- skos__altLabel mesh__D007482 Meglumine Iotalamate
% 210.18/210.34  |- rdf__type mesh__D015914sskos__Concept
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D015914 2004
% 210.18/210.34  |- mesh__dateCreated mesh__D015914 1989-07-19
% 210.18/210.34  |- skos__hiddenLabel mesh__D015914
% 210.18/210.34       Hormone Replacement Therapy, Post Menopausal
% 210.18/210.34  |- mesh__historyNote mesh__D015914 90   
% 210.18/210.34  |- skos__hiddenLabel mesh__D015914 Replacements, Estrogen
% 210.18/210.34  |- mesh__dateEstablished mesh__D015914 1990-01-01
% 210.18/210.34  |- skos__scopeNote mesh__D015914
% 210.18/210.34       The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy.%A%    
% 210.18/210.34  |- mesh__dateRevised mesh__D015914 2002-07-03
% 210.18/210.34  |- skos__historyNote mesh__D015914
% 210.18/210.34       Estrogenic Substances, Conjugated %28%1966-1989%29%
% 210.18/210.34  |- skos__hiddenLabel mesh__D015914 Estrogen Replacement Therapies
% 210.18/210.34  |- skos__historyNote mesh__D015914 Estrogens, Synthetic %28%1975-1989%29%
% 210.18/210.34  |- skos__altLabel mesh__D015914 Replacement, Estrogen
% 210.18/210.34  |- skos__altLabel mesh__D015914 Estrogen Progestin Combination Therapy
% 210.18/210.34  |- skos__altLabel mesh__D015914
% 210.18/210.34       Hormone Replacement Therapy, Post-Menopausal
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D015914 2005
% 210.18/210.34  |- mesh__publicMeSHNote mesh__D015914 90   
% 210.18/210.34  |- skos__prefLabel mesh__D015914 Estrogen Replacement Therapy
% 210.18/210.34  |- skos__historyNote mesh__D015914 Estrogens %28%1966-1989%29%
% 210.18/210.34  |- skos__hiddenLabel mesh__D015914 Replacement Therapies, Estrogen
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D015914 2006
% 210.18/210.34  |- skos__historyNote mesh__D015914 Menopause %28%1966-1989%29%
% 210.18/210.34  |- skos__annotation mesh__D015914
% 210.18/210.34       coord IM with specific estrogen %28%IM or NIM%29% and also specific progestational agent %28%IM or NIM%29% if pertinent; check tag FEMALE; DF: ESTROGEN REPLACE%A%  
% 210.18/210.34  |- mesh__recordOriginator mesh__D015914 PLS
% 210.18/210.34  |- skos__hiddenLabel mesh__D015914 Therapies, Estrogen Replacement
% 210.18/210.34  |- skos__altLabel mesh__D015914 Replacement Therapy, Estrogen
% 210.18/210.34  |- skos__broader mesh__D015914smesh__D020249
% 210.18/210.34  |- skos__altLabel mesh__D015914 Therapy, Estrogen Replacement
% 210.18/210.34  |- mesh__recordMaintainer mesh__D015914 lkt
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D015914 2003
% 210.18/210.34  |- mesh__recordAuthorizer mesh__D015914 sjn
% 210.18/210.34  |- skos__hiddenLabel mesh__D015914 Estrogen Replacements
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D015116 2003
% 210.18/210.34  |- skos__hiddenLabel mesh__D015116 5,7 Dihydroxytryptamine
% 210.18/210.34  |- skos__hiddenLabel mesh__D015116
% 210.18/210.34       Sulfate, 5,7-Dihydroxytryptamine Creatine
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D015116 2005
% 210.18/210.34  |- mesh__dateCreated mesh__D015116 1977-04-27
% 210.18/210.34  |- skos__altLabel mesh__D015116 3-%28%2-Aminoethyl%29%-1H-indole-5,7-diol
% 210.18/210.34  |- mesh__recordOriginator mesh__D015116 SH
% 210.18/210.34  |- skos__hiddenLabel mesh__D015116 5,7 Dihydroxytryptamine Creatine Sulfate
% 210.18/210.34  |- mesh__recordMaintainer mesh__D015116 TWD
% 210.18/210.34  |- skos__prefLabel mesh__D015116 5,7-Dihydroxytryptamine
% 210.18/210.34  |- mesh__recordAuthorizer mesh__D015116 sjn
% 210.18/210.34  |- rdf__type mesh__D015116sskos__Concept
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D015116 2002
% 210.18/210.34  |- skos__historyNote mesh__D015116 Tryptamines %28%1966-1977%29%
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D015116 2001
% 210.18/210.34  |- mesh__dateRevised mesh__D015116 2000-06-22
% 210.18/210.34  |- mesh__publicMeSHNote mesh__D015116
% 210.18/210.34       91; was see under DIHYDROXYTRYPTAMINES 1978-90   
% 210.18/210.34  |- skos__hiddenLabel mesh__D015116
% 210.18/210.34       Creatine Sulfate, 5,7-Dihydroxytryptamine
% 210.18/210.34  |- mesh__historyNote mesh__D015116
% 210.18/210.34       91%28%78%29%; was see under DIHYDROXYTRYPTAMINES 1978-90   
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D015116 2004
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D015116 2006
% 210.18/210.34  |- skos__broader mesh__D015116smesh__D004102
% 210.18/210.34  |- skos__scopeNote mesh__D015116
% 210.18/210.34       Tryptamine substituted with two hydroxyl groups in positions 5 and 7. It is a neurotoxic serotonin analog that destroys serotonergic neurons preferentially and is used in neuropharmacology as a tool.%A%    
% 210.18/210.34  |- mesh__dateEstablished mesh__D015116 1991-01-01
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D039564 2006
% 210.18/210.34  |- mesh__historyNote mesh__D039564
% 210.18/210.34       2003; use INTEGRIN ALPHAV %28%NM%29% 1994-2002   
% 210.18/210.34  |- skos__broader mesh__D039564smesh__D039001
% 210.18/210.34  |- skos__altLabel mesh__D039564 alphav Integrin
% 210.18/210.34  |- skos__broader mesh__D039564smesh__D015703
% 210.18/210.34  |- mesh__recordAuthorizer mesh__D039564 sjn
% 210.18/210.34  |- skos__hiddenLabel mesh__D039564 alphaV, Integrin
% 210.18/210.34  |- mesh__dateEstablished mesh__D039564 2003-01-01
% 210.18/210.34  |- skos__altLabel mesh__D039564 CD51 Antigen
% 210.18/210.34  |- skos__historyNote mesh__D039564 Antigens, CD %28%1994-2002%29%
% 210.18/210.34  |- mesh__recordOriginator mesh__D039564 MDJ
% 210.18/210.34  |- mesh__dateRevised mesh__D039564 2005-06-30
% 210.18/210.34  |- skos__altLabel mesh__D039564 Integrin alpha V
% 210.18/210.34  |- skos__altLabel mesh__D039564 CD51 Antigens
% 210.18/210.34  |- skos__altLabel mesh__D039564 Antigens, CD51
% 210.18/210.34  |- skos__annotation mesh__D039564
% 210.18/210.34       %22%V%22% in alphaV is the letter not the roman numeral   
% 210.18/210.34  |- skos__prefLabel mesh__D039564 Integrin alphaV
% 210.18/210.34  |- mesh__recordMaintainer mesh__D039564 ssb
% 210.18/210.34  |- mesh__publicMeSHNote mesh__D039564
% 210.18/210.34       2003; INTEGRIN ALPHAV was indexed under ANTIGENS, CD 1994-2002%A%  
% 210.18/210.34  |- skos__altLabel mesh__D039564 alpha%28%V%29% Integrin
% 210.18/210.34  |- rdf__type mesh__D039564sskos__Concept
% 210.18/210.34  |- mesh__dateCreated mesh__D039564 2002-07-03
% 210.18/210.34  |- skos__hiddenLabel mesh__D039564 Integrin, alphav
% 210.18/210.34  |- skos__scopeNote mesh__D039564
% 210.18/210.34       An alpha integrin with a molecular weight of 160-kDa that is found in a variety of cell types.  It undergoes posttranslational cleavage into a heavy and a light chain that are connected by disulfide bonds. Integrin alphaV can combine with several different beta subunits to form heterodimers that generally bind to RGD sequence-containing extracellular matrix proteins.%A%    
% 210.18/210.34  |- skos__hiddenLabel mesh__D039564 alpha V, Integrin
% 210.18/210.34  |- skos__hiddenLabel mesh__D039564 Antigen, CD51
% 210.18/210.34  |- mesh__publicMeSHNote mesh__D020859 2000   
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D020859 2001
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D020859 2004
% 210.18/210.34  |- mesh__dateEstablished mesh__D020859 2000-01-01
% 210.18/210.34  |- skos__broader mesh__D020859smesh__D005531
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D020859 2000
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D020859 2003
% 210.18/210.34  |- skos__hiddenLabel mesh__D020859 Rigidus, Hallux
% 210.18/210.34  |- rdf__type mesh__D020859sskos__Concept
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D020859 2006
% 210.18/210.34  |- mesh__historyNote mesh__D020859 2000   
% 210.18/210.34  |- skos__historyNote mesh__D020859
% 210.18/210.34       Metatarsophalangeal Joint %28%1983-1999%29%
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D020859 2002
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D020859 2005
% 210.18/210.34  |- skos__broader mesh__D020859smesh__D007592
% 210.18/210.34  |- skos__prefLabel mesh__D020859 Hallux Rigidus
% 210.18/210.34  |- skos__scopeNote mesh__D020859
% 210.18/210.34       A condition caused by degenerative arthritis %28%see OSTEOARTHRITIS%29% of the METATARSOPHALANGEAL JOINT of the great toe and characterized by pain and limited dorsiflexion, but relatively unrestricted plantar flexion.%A%    
% 210.18/210.34  |- mesh__dateCreated mesh__D020859 1999-11-03
% 210.18/210.34  |- skos__altLabel mesh__D031581 Ayahuasca
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D031581 2005
% 210.18/210.34  |- skos__broader mesh__D031581smesh__D029581
% 210.18/210.34  |- mesh__historyNote mesh__D031581 2003   
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D031581 2006
% 210.18/210.34  |- mesh__dateEstablished mesh__D031581 2003-01-01
% 210.18/210.34  |- mesh__publicMeSHNote mesh__D031581 2003   
% 210.18/210.34  |- mesh__dateCreated mesh__D031581 2002-07-02
% 210.18/210.34  |- skos__prefLabel mesh__D031581 Banisteriopsis
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D031581 2003
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D031581 2004
% 210.18/210.34  |- skos__scopeNote mesh__D031581
% 210.18/210.34       A plant genus of the family MALPIGHIACEAE which includes an Amazonian psychoactive plant that contains the beta-carboline harmine and N,N-dimethyltryptamine.%A%    
% 210.18/210.34  |- rdf__type mesh__D031581sskos__Concept
% 210.18/210.34  |- skos__annotation mesh__D031581
% 210.18/210.34       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D003890 2005
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D003890 2004
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D003890 2002
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D003890 2006
% 210.18/210.34  |- mesh__dateEstablished mesh__D003890 1977-01-01
% 210.18/210.34  |- skos__broader mesh__D003890smesh__D002623
% 210.18/210.34  |- skos__annotation mesh__D003890
% 210.18/210.34       note category; differentiate from DEHYDRATION, a disease state%A%  
% 210.18/210.34  |- skos__prefLabel mesh__D003890 Desiccation
% 210.18/210.34  |- skos__related mesh__D003890smesh__D005612
% 210.18/210.34  |- skos__altLabel mesh__D003890 Dessication
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D003890 1996
% 210.18/210.34  |- skos__broader mesh__D003890smesh__D002627
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D003890 1998
% 210.18/210.34  |- mesh__dateCreated mesh__D003890 1976-05-19
% 210.18/210.34  |- mesh__historyNote mesh__D003890 77   
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D003890 2000
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D003890 1997
% 210.18/210.34  |- skos__scopeNote mesh__D003890
% 210.18/210.34       Removal of moisture from a substance %28%chemical, food, tissue, etc.%29%.%A%    
% 210.18/210.34  |- mesh__recordAuthorizer mesh__D003890 PLS
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D003890 2001
% 210.18/210.34  |- mesh__recordOriginator mesh__D003890 VDK
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D003890 1999
% 210.18/210.34  |- mesh__dateRevised mesh__D003890 1994-05-12
% 210.18/210.34  |- mesh__recordMaintainer mesh__D003890 TGC
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D003890 1995
% 210.18/210.34  |- rdf__type mesh__D003890sskos__Concept
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D003890 2003
% 210.18/210.34  |- mesh__publicMeSHNote mesh__D003890 77   
% 210.18/210.34  |- mesh__recordAuthorizer mesh__D003092 sjn
% 210.18/210.34  |- rdf__type mesh__D003092sskos__Concept
% 210.18/210.34  |- mesh__dateRevised mesh__D003092 2004-07-07
% 210.18/210.34  |- skos__annotation mesh__D003092
% 210.18/210.34       general; note specifics; ENTEROCOLITIS is also available   
% 210.18/210.34  |- skos__broader mesh__D003092smesh__D003108
% 210.18/210.34  |- mesh__dateCreated mesh__D003092 1999-01-01
% 210.18/210.34  |- skos__prefLabel mesh__D003092 Colitis
% 210.18/210.34  |- mesh__recordMaintainer mesh__D003092 lkt
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D003092 2005
% 210.18/210.34  |- skos__broader mesh__D003092smesh__D005759
% 210.18/210.34  |- skos__hiddenLabel mesh__D003092 Colitides
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D003092 2006
% 210.18/210.34  |- skos__scopeNote mesh__D003092
% 210.18/210.34       Inflammation of the COLON section of the large intestine %28%INTESTINE, LARGE%29%, usually with symptoms such as DIARRHEA %28%often with blood and mucus%29%, ABDOMINAL PAIN, and FEVER.%A%    
% 210.18/210.34  |- mesh__recordOriginator mesh__D003092 NLM
% 210.18/210.34  |- skos__historyNote mesh__D011524 Porphyrins %28%1968-1974%29%
% 210.18/210.34  |- mesh__publicMeSHNote mesh__D011524
% 210.18/210.34       91; was see under PORPHYRINS 1975-90   
% 210.18/210.34  |- mesh__dateRevised mesh__D011524 2005-06-30
% 210.18/210.34  |- mesh__historyNote mesh__D011524
% 210.18/210.34       91%28%75%29%; was see under PORPHYRINS 1975-90   
% 210.18/210.34  |- mesh__recordOriginator mesh__D011524 NLM
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D011524 2006
% 210.18/210.34  |- skos__scopeNote mesh__D011524
% 210.18/210.34       Porphyrins with four methyl, two vinyl, and two propionic acid side chains attached to the pyrrole rings. Protoporphyrin IX occurs in hemoglobin, myoglobin, and most of the cytochromes.%A%    
% 210.18/210.34  |- mesh__dateEstablished mesh__D011524 1991-01-01
% 210.18/210.34  |- rdf__type mesh__D011524sskos__Concept
% 210.18/210.34  |- skos__annotation mesh__D011524 porphyrins   
% 210.18/210.34  |- mesh__dateCreated mesh__D011524 1974-11-19
% 210.18/210.34  |- skos__broader mesh__D011524smesh__D011166
% 210.18/210.34  |- mesh__recordMaintainer mesh__D011524 ssb
% 210.18/210.34  |- skos__prefLabel mesh__D011524 Protoporphyrins
% 210.18/210.34  |- mesh__recordAuthorizer mesh__D011524 sjn
% 210.18/210.34  |- skos__annotation mesh__D049992 coordinate with DIURETICS if pertinent   
% 210.18/210.34  |- mesh__publicMeSHNote mesh__D049992 2006   
% 210.18/210.34  |- skos__hiddenLabel mesh__D049992 Chloride Cotransporters, Sodium
% 210.18/210.34  |- skos__hiddenLabel mesh__D049992 Cotransporter, Sodium-Chloride
% 210.18/210.34  |- skos__hiddenLabel mesh__D049992 Sodium Chloride Cotransporter
% 210.18/210.34  |- skos__hiddenLabel mesh__D049992 Symporters, Sodium Chloride
% 210.18/210.34  |- skos__hiddenLabel mesh__D049992 Na Cl Symporters
% 210.18/210.34  |- skos__altLabel mesh__D049992 Sodium Chloride Cotransporters
% 210.18/210.34  |- mesh__dateEstablished mesh__D049992 2006-01-01
% 210.18/210.34  |- skos__hiddenLabel mesh__D049992 Sodium Chloride Transporter
% 210.18/210.34  |- mesh__activeMeSHYear mesh__D049992 2006
% 210.18/210.34  |- skos__altLabel mesh__D049992 Na-Cl-Symporters
% 210.18/210.34  |- skos__scopeNote mesh__D049992
% 210.18/210.34       A subclass of symporters found in KIDNEY TUBULES, DISTAL that are the major pathway for salt resorption. Inhibition of these symporters by BENZOTHIADIAZINES is the basis of action of some DIURETICS.%A%    
% 210.18/210.34  |- mesh__recordAuthorizer mesh__D049992 sjn
% 210.18/210.34  |- skos__hiddenLabel mesh__D049992 Cotransporters, Sodium Chloride
% 210.18/210.34  |- skos__hiddenLabel mesh__D049992 Chloride Symporters, Sodium
% 210.18/210.34  |- skos__prefLabel mesh__D049992 Sodium Chloride Symporters
% 210.18/210.34  |- mesh__recordMaintainer mesh__D049992 ssb
% 210.18/210.34  |- skos__hiddenLabel mesh__D049992 Transporter, Sodium-Chloride
% 210.18/210.34  |- mesh__historyNote mesh__D049992
% 210.18/210.34       2006%28%1984%29%; for SODIUM-CHLORIDE COTRANSPORTER use SYMPORTERS %28%NM%29%%A%  
% 210.18/210.34  |- skos__broader mesh__D049992smesh__D027981
% 210.18/210.34  |- rdf__type mesh__D049992sskos__Concept
% 210.18/210.34  |- skos__altLabel mesh__D049992 Sodium-Chloride Transporter
% 210.18/210.34  |- mesh__recordOriginator mesh__D049992 ssb
% 210.18/210.34  |- mesh__dateCreated mesh__D049992 2005-06-30
% 210.18/210.34  |- skos__altLabel mesh__D049992 Sodium-Chloride Cotransporter
% 210.18/210.34  |- mesh__dateCreated mesh__D002798 1974-11-19
% 210.18/210.34  |- skos__altLabel mesh__D002798 Cholinephosphotransferase
% 210.18/210.34  |- mesh__recordMaintainer mesh__D002798 ssb
% 210.18/210.34  |- skos__hiddenLabel mesh__D002798 Transferase, Phosphorylcholine-Glyceride
% 210.18/210.34  |- skos__altLabel mesh__D002798
% 210.18/210.34       CDP-Choline 1,2-Diglyceride Choline Phosphotransferase
% 210.18/210.34  |- skos__historyNote mesh__D002798 Cytosine Nucleotides %28%1973-1974%29%
% 210.18/210.34  |- skos__altLabel mesh__D002798 CDP-Diacylglycerol Synthase
% 210.18/210.34  |- skos__altLabel mesh__D002798 Phosphocholinetransferase
% 210.18/210.34  |- mesh__publicMeSHNote mesh__D002798
% 210.18/210.34       1994; see CHOLINEPHOSPHOTRANSFERASE 1975-93; 1-ALKYL-2-ACETYLGLYCEROL CHOLINEPHOSPHOTRANSFERASE was indexed under DIACYLGLYCEROL CHOLINEPHOSPHOTRANSFERASE 1994-1999; for PHOSPHORYLCHOLINE-GLYCERIDE TRANSFERASE see PHOSPHORYLCHOLINE GLYCERIDE TRANSFERASE 1976-1993%A%  
% 210.18/210.34  |- skos__hiddenLabel mesh__D002798
% 210.18/210.34       Choline Phosphotransferase, Diacylglycerol-CDP
% 210.18/210.34  |- skos__altLabel mesh__D002798 Phosphorylcholineglyceride Transferase
% 210.18/210.34  |- skos__hiddenLabel mesh__D002798
% 210.18/210.34       CDP Choline 1,2 Diglyceride Choline Phosphotransferase
% 210.18/210.34  |- skos__hiddenLabel mesh__D002798
% 210.18/210.34       Cholinephosphotransferase, Diacylglycerol
% 210.18/210.35  |- skos__hiddenLabel mesh__D002798
% 210.18/210.35       Cholinephosphotransferase, 1-alkyl-2-Acetylglycerol
% 210.18/210.35  |- skos__hiddenLabel mesh__D002798 Cholinephosphotransferase, CDP-Choline
% 210.18/210.35  |- skos__altLabel mesh__D002798 CDP-Choline Cholinephosphotransferase
% 210.18/210.35  |- mesh__historyNote mesh__D002798
% 210.18/210.35       1994%28%1975%29%; use CHOLINEPHOSPHOTRANSFERASE 1975-93; for 1-ALKYL-2-ACETOGLYCEROL CHOLINEPHOSPHOTRANSFERASE use DIACYLGLYCEROL CHOLINEPHOSPHOTRANSFERASE %28%NM%29% 1987-1999; for PHOSPHORYLCHOLINE-GLYCERIDE TRANSFERASE use PHOSPHORYLCHOLINE GLYCERIDE TRANSFERASE 1976-1993%A%  
% 210.18/210.35  |- skos__broader mesh__D002798smesh__D017855
% 210.18/210.35  |- mesh__dateRevised mesh__D002798 2003-07-09
% 210.18/210.35  |- skos__scopeNote mesh__D002798
% 210.18/210.35       An enzyme that catalyzes the synthesis of phosphatidylcholines from CDPcholine and 1,2-diacylglycerols. EC 2.7.8.2.%A%    
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D002798 2006
% 210.18/210.35  |- skos__altLabel mesh__D002798
% 210.18/210.35       Diacylglycerol-CDP Choline Phosphotransferase
% 210.18/210.35  |- skos__prefLabel mesh__D002798 Diacylglycerol Cholinephosphotransferase
% 210.18/210.35  |- skos__hiddenLabel mesh__D002798 Phosphocholinetransferase, PAF
% 210.18/210.35  |- skos__hiddenLabel mesh__D002798 Phosphorylcholine Glyceride Transferase
% 210.18/210.35  |- skos__hiddenLabel mesh__D002798
% 210.18/210.35       Phosphotransferase, Diacylglycerol-CDP Choline
% 210.18/210.35  |- skos__historyNote mesh__D002798 Choline %28%1973-1974%29%
% 210.18/210.35  |- rdf__type mesh__D002798sskos__Concept
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D002798 2005
% 210.18/210.35  |- skos__altLabel mesh__D002798 Phosphorylcholine-Glyceride Transferase
% 210.18/210.35  |- skos__hiddenLabel mesh__D002798 CDP Diacylglycerol Synthase
% 210.18/210.35  |- mesh__recordAuthorizer mesh__D002798 sjn
% 210.18/210.35  |- skos__hiddenLabel mesh__D002798 Transferase, Phosphorylcholineglyceride
% 210.18/210.35  |- mesh__dateEstablished mesh__D002798 1991-01-01
% 210.18/210.35  |- skos__historyNote mesh__D002798 Glycerides %28%1973-1974%29%
% 210.18/210.35  |- skos__hiddenLabel mesh__D002798 CDP Choline Cholinephosphotransferase
% 210.18/210.35  |- mesh__recordOriginator mesh__D002798 NLM
% 210.18/210.35  |- skos__historyNote mesh__D002798 Phosphotransferases %28%1973-1974%29%
% 210.18/210.35  |- skos__hiddenLabel mesh__D002798 Synthase, CDP-Diacylglycerol
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D002798 2004
% 210.18/210.35  |- skos__altLabel mesh__D002798
% 210.18/210.35       1-alkyl-2-Acetylglycerol Cholinephosphotransferase
% 210.18/210.35  |- skos__hiddenLabel mesh__D002798
% 210.18/210.35       Diacylglycerol CDP Choline Phosphotransferase
% 210.18/210.35  |- skos__altLabel mesh__D002798 PAF Phosphocholinetransferase
% 210.18/210.35  |- skos__hiddenLabel mesh__D007483 Acid, Methalamic
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D007483 2004
% 210.18/210.35  |- mesh__historyNote mesh__D007483 66%28%63%29%   
% 210.18/210.35  |- skos__hiddenLabel mesh__D007483 AngioConray
% 210.18/210.35  |- mesh__publicMeSHNote mesh__D007483 66   
% 210.18/210.35  |- skos__hiddenLabel mesh__D007483 Acid, Iotalamic
% 210.18/210.35  |- mesh__recordAuthorizer mesh__D007483 sjn
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D007483 2005
% 210.18/210.35  |- mesh__recordOriginator mesh__D007483 NLM
% 210.18/210.35  |- skos__altLabel mesh__D007483 Iotalamic Acid
% 210.18/210.35  |- skos__prefLabel mesh__D007483 Iothalamic Acid
% 210.18/210.35  |- skos__altLabel mesh__D007483 Methalamic Acid
% 210.18/210.35  |- skos__hiddenLabel mesh__D007483 Acid, Iothalamic
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D007483 2001
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D007483 2006
% 210.18/210.35  |- skos__altLabel mesh__D007483 Iothalamic Acid, Monosodium Salt
% 210.18/210.35  |- skos__scopeNote mesh__D007483
% 210.18/210.35       A contrast medium in diagnostic radiology with properties similar to those of diatrizoic acid. It is used primarily as its sodium and meglumine %28%IOTHALAMATE MEGLUMINE%29% salts.%A%    
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D007483 2002
% 210.18/210.35  |- skos__hiddenLabel mesh__D007483 Iothalamate, Sodium
% 210.18/210.35  |- skos__annotation mesh__D007483 D25-26 qualif   
% 210.18/210.35  |- mesh__dateEstablished mesh__D007483 1966-01-01
% 210.18/210.35  |- skos__hiddenLabel mesh__D007483 Angio Conray
% 210.18/210.35  |- mesh__recordMaintainer mesh__D007483 CCR
% 210.18/210.35  |- skos__broader mesh__D007483smesh__D014283
% 210.18/210.35  |- rdf__type mesh__D007483sskos__Concept
% 210.18/210.35  |- mesh__dateCreated mesh__D007483 1999-01-01
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D007483 2003
% 210.18/210.35  |- mesh__dateRevised mesh__D007483 2000-06-21
% 210.18/210.35  |- skos__hiddenLabel mesh__D015915 CPM Therapies
% 210.18/210.35  |- skos__broader mesh__D015915smesh__D005081
% 210.18/210.35  |- skos__scopeNote mesh__D015915
% 210.18/210.35       Movement of a body part initiated and maintained by a mechanical or electrical device to restore normal range of motion to joints, muscles, or tendons after surgery, prosthesis implantation, contracture flexion, or long immobilization.%A%    
% 210.18/210.35  |- skos__altLabel mesh__D015915 Passive Motion Therapy, Continuous
% 210.18/210.35  |- skos__prefLabel mesh__D015915 Motion Therapy, Continuous Passive
% 210.18/210.35  |- rdf__type mesh__D015915sskos__Concept
% 210.18/210.35  |- mesh__dateEstablished mesh__D015915 1990-01-01
% 210.18/210.35  |- skos__annotation mesh__D015915
% 210.18/210.35       a type of exercise ther; do not use /util except by MeSH definition%A%  
% 210.18/210.35  |- mesh__recordAuthorizer mesh__D015915 sjn
% 210.18/210.35  |- skos__altLabel mesh__D015915 Movement Therapy, Continuous Passive
% 210.18/210.35  |- skos__historyNote mesh__D015915 Physical Therapy %28%1966-1989%29%
% 210.18/210.35  |- skos__historyNote mesh__D015915
% 210.18/210.35       Manipulation, Orthopedic %28%1966-1977%29%
% 210.18/210.35  |- mesh__publicMeSHNote mesh__D015915 90   
% 210.18/210.35  |- mesh__recordMaintainer mesh__D015915 lkt
% 210.18/210.35  |- skos__historyNote mesh__D015915 Movement %28%1966-1989%29%
% 210.18/210.35  |- skos__altLabel mesh__D015915 Continuous Passive Movement Therapy
% 210.18/210.35  |- skos__altLabel mesh__D015915 Continuous Passive Motion Therapy
% 210.18/210.35  |- skos__altLabel mesh__D015915 CPM Therapy
% 210.18/210.35  |- mesh__recordOriginator mesh__D015915 PLS
% 210.18/210.35  |- skos__historyNote mesh__D015915 Exercise Therapy %28%1972-1989%29%
% 210.18/210.35  |- mesh__dateCreated mesh__D015915 1989-05-15
% 210.18/210.35  |- skos__altLabel mesh__D015915 Passive Movement Therapy, Continuous
% 210.18/210.35  |- mesh__dateRevised mesh__D015915 2005-06-30
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D015915 2006
% 210.18/210.35  |- skos__hiddenLabel mesh__D015915 Therapy, CPM
% 210.18/210.35  |- skos__hiddenLabel mesh__D015915 Therapies, CPM
% 210.18/210.35  |- mesh__historyNote mesh__D015915 90   
% 210.18/210.35  |- mesh__recordOriginator mesh__D015117 NLM
% 210.18/210.35  |- skos__altLabel mesh__D015117 5,8,11,14 Eicosatetraynoic Acid
% 210.18/210.35  |- rdf__type mesh__D015117sskos__Concept
% 210.18/210.35  |- mesh__dateRevised mesh__D015117 2003-07-09
% 210.18/210.35  |- skos__historyNote mesh__D015117
% 210.18/210.35       Fatty Acids, Unsaturated %28%1973-1974%29%
% 210.18/210.35  |- skos__broader mesh__D015117smesh__D015777
% 210.18/210.35  |- skos__scopeNote mesh__D015117
% 210.18/210.35       A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E%28%2%29% and F%28%2a%29%.%A%    
% 210.18/210.35  |- mesh__publicMeSHNote mesh__D015117
% 210.18/210.35       91; was see under FATTY ACIDS, UNSATURATED 1975-90   
% 210.18/210.35  |- skos__hiddenLabel mesh__D015117 Ro 3 1428
% 210.18/210.35  |- mesh__recordAuthorizer mesh__D015117 sjn
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D015117 2004
% 210.18/210.35  |- skos__prefLabel mesh__D015117 5,8,11,14-Eicosatetraynoic Acid
% 210.18/210.35  |- mesh__recordMaintainer mesh__D015117 ssb
% 210.18/210.35  |- skos__altLabel mesh__D015117 ETYA
% 210.18/210.35  |- mesh__dateCreated mesh__D015117 1974-11-19
% 210.18/210.35  |- skos__hiddenLabel mesh__D015117 Ro 31428
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D015117 2006
% 210.18/210.35  |- mesh__dateEstablished mesh__D015117 1991-01-01
% 210.18/210.35  |- mesh__historyNote mesh__D015117
% 210.18/210.35       91%28%75%29%; was see under FATTY ACIDS, UNSATURATED 1975-90   
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D015117 2005
% 210.18/210.35  |- mesh__publicMeSHNote mesh__D031582 2003   
% 210.18/210.35  |- skos__scopeNote mesh__D031582
% 210.18/210.35       A plant genus of the family MALPIGHIACEAE. G. glauca is the source of %27%Galphimia glauca extract%27% and contains %27%galphimine B%27% and tetragalloylquinic acid.%A%    
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D031582 2003
% 210.18/210.35  |- skos__prefLabel mesh__D031582 Galphimia
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D031582 2004
% 210.18/210.35  |- skos__broader mesh__D031582smesh__D029581
% 210.18/210.35  |- rdf__type mesh__D031582sskos__Concept
% 210.18/210.35  |- skos__annotation mesh__D031582
% 210.18/210.35       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.18/210.35  |- mesh__dateEstablished mesh__D031582 2003-01-01
% 210.18/210.35  |- mesh__dateCreated mesh__D031582 2002-07-03
% 210.18/210.35  |- mesh__historyNote mesh__D031582 2003   
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D031582 2005
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D031582 2006
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D003891 2006
% 210.18/210.35  |- mesh__recordAuthorizer mesh__D003891 sjn
% 210.18/210.35  |- skos__prefLabel mesh__D003891 Desipramine
% 210.18/210.35  |- mesh__publicMeSHNote mesh__D003891 65   
% 210.18/210.35  |- skos__hiddenLabel mesh__D003891 Hydrochloride, Desipramine
% 210.18/210.35  |- skos__hiddenLabel mesh__D003891
% 210.18/210.35       Rh%C3%%B4%ne Poulenc Rorer Brand of Desipramine Hydrochloride
% 210.18/210.35  |- skos__altLabel mesh__D003891 Temmler Brand of Desipramine Hydrochloride
% 210.18/210.35  |- skos__altLabel mesh__D003891
% 210.18/210.35       Rh%C3%%B4%ne-Poulenc Rorer Brand of Desipramine Hydrochloride
% 210.18/210.35  |- mesh__recordOriginator mesh__D003891 NLM
% 210.18/210.35  |- mesh__historyNote mesh__D003891 65%28%63%29%   
% 210.18/210.35  |- skos__hiddenLabel mesh__D003891
% 210.18/210.35       Nu Pharm Brand of Desipramine Hydrochloride
% 210.18/210.35  |- skos__altLabel mesh__D003891 Pertrofran
% 210.18/210.35  |- skos__altLabel mesh__D003891 Aventis Brand of Desipramine Hydrochloride
% 210.18/210.35  |- rdf__type mesh__D003891sskos__Concept
% 210.18/210.35  |- skos__altLabel mesh__D003891
% 210.18/210.35       Ratiopharm Brand of Desipramine Hydrochloride
% 210.18/210.35  |- mesh__dateEstablished mesh__D003891 1965-01-01
% 210.18/210.35  |- mesh__recordMaintainer mesh__D003891 exl
% 210.18/210.35  |- skos__altLabel mesh__D003891 Pertofran
% 210.18/210.35  |- skos__altLabel mesh__D003891 Novartis Brand of Desipramine Hydrochloride
% 210.18/210.35  |- mesh__dateCreated mesh__D003891 1999-01-01
% 210.18/210.35  |- skos__broader mesh__D003891smesh__D003984
% 210.18/210.35  |- skos__altLabel mesh__D003891 Desmethylimipramine
% 210.18/210.35  |- skos__altLabel mesh__D003891 Demethylimipramine
% 210.18/210.35  |- skos__scopeNote mesh__D003891
% 210.18/210.35       A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.%A%    
% 210.18/210.35  |- skos__altLabel mesh__D003891 Apotex Brand of Desipramine Hydrochloride
% 210.18/210.35  |- skos__altLabel mesh__D003891
% 210.18/210.35       Pharmascience Brand of Desipramine Hydrochloride
% 210.18/210.35  |- skos__altLabel mesh__D003891 Nu-Pharm Brand of Desipramine Hydrochloride
% 210.18/210.35  |- skos__altLabel mesh__D003891
% 210.18/210.35       Aventis Behring Brand of Desipramine Hydrochloride
% 210.18/210.35  |- mesh__dateRevised mesh__D003891 2005-06-30
% 210.18/210.35  |- skos__altLabel mesh__D003891
% 210.18/210.35       Novopharm Brand of Desipramine Hydrochloride
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D003093 2004
% 210.18/210.35  |- mesh__recordOriginator mesh__D003093 NLM
% 210.18/210.35  |- mesh__dateCreated mesh__D003093 1999-01-01
% 210.18/210.35  |- mesh__recordAuthorizer mesh__D003093 sjn
% 210.18/210.35  |- skos__broader mesh__D003093smesh__D003092
% 210.18/210.35  |- skos__scopeNote mesh__D003093
% 210.18/210.35       Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.%A%    
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D003093 2005
% 210.18/210.35  |- mesh__dateRevised mesh__D003093 2003-07-09
% 210.18/210.35  |- skos__broader mesh__D003093smesh__D015212
% 210.18/210.35  |- skos__prefLabel mesh__D003093 Colitis, Ulcerative
% 210.18/210.35  |- skos__annotation mesh__D003093
% 210.18/210.35       usually chronic so do not coord with CHRONIC DISEASE   
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D003093 2006
% 210.18/210.35  |- skos__altLabel mesh__D003093 Ulcerative Colitis
% 210.18/210.35  |- mesh__recordMaintainer mesh__D003093 lkt
% 210.18/210.35  |- rdf__type mesh__D003093sskos__Concept
% 210.18/210.35  |- mesh__recordOriginator mesh__D019508 TGC
% 210.18/210.35  |- mesh__dateEstablished mesh__D019508 1997-01-01
% 210.18/210.35  |- mesh__dateCreated mesh__D019508 1996-06-21
% 210.18/210.35  |- mesh__recordMaintainer mesh__D019508 jls
% 210.18/210.35  |- mesh__dateRevised mesh__D019508 2005-06-30
% 210.18/210.35  |- skos__altLabel mesh__D019508 Guidebooks
% 210.18/210.35  |- skos__annotation mesh__D019508
% 210.18/210.35       publication type only; handbooks for travelers   
% 210.18/210.35  |- skos__broader mesh__D019508smesh__D052180
% 210.18/210.35  |- skos__altLabel mesh__D019508 Guidebooks %28%PT%29%
% 210.18/210.35  |- rdf__type mesh__D019508sskos__Concept
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D019508 2006
% 210.18/210.35  |- skos__prefLabel mesh__D019508 Guidebooks %5B%Publication Type%5D%
% 210.18/210.35  |- mesh__recordAuthorizer mesh__D019508 sjn
% 210.18/210.35  |- mesh__historyNote mesh__D019508 1997   
% 210.18/210.35  |- skos__scopeNote mesh__D019508
% 210.18/210.35       Works consisting of publications for travelers that give information about a city, region, or country, or similar handbooks about buildings, museums, etc. %28%The ALA Glossary of Library and Information Science, 1983%29%%A%    
% 210.18/210.35  |- mesh__recordMaintainer mesh__D011525 SYSTEM
% 210.18/210.35  |- skos__annotation mesh__D011525
% 210.18/210.35       infection: coordinate IM with INFECTION %28%IM%29%   
% 210.18/210.35  |- mesh__publicMeSHNote mesh__D011525 80   
% 210.18/210.35  |- mesh__recordAuthorizer mesh__D011525 sjn
% 210.18/210.35  |- mesh__recordOriginator mesh__D011525 AEP
% 210.18/210.35  |- skos__broader mesh__D011525smesh__D000460
% 210.18/210.35  |- skos__historyNote mesh__D011525 Algae, Green %28%1970-1979%29%
% 210.18/210.35  |- mesh__dateRevised mesh__D011525 2005-06-30
% 210.18/210.35  |- mesh__dateEstablished mesh__D011525 1980-01-01
% 210.18/210.35  |- skos__prefLabel mesh__D011525 Prototheca
% 210.18/210.35  |- skos__historyNote mesh__D011525 Algae %28%1966-1979%29%
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D011525 2006
% 210.18/210.35  |- mesh__dateCreated mesh__D011525 1978-12-21
% 210.18/210.35  |- mesh__historyNote mesh__D011525 80   
% 210.18/210.35  |- skos__scopeNote mesh__D011525
% 210.18/210.35       A genus of achlorophyllic algae in the family Chlorellaceae, and closely related to CHLORELLA. It is found in decayed matter; WATER; SEWAGE; and SOIL; and produces cutaneous and disseminated infections in various VERTEBRATES including humans.%A%    
% 210.18/210.35  |- rdf__type mesh__D011525sskos__Concept
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D049993 2006
% 210.18/210.35  |- skos__hiddenLabel mesh__D049993 Diuretics, Benzothiadiazine
% 210.18/210.35  |- mesh__publicMeSHNote mesh__D049993
% 210.18/210.35       2006; for THIAZIDE DIURETICS use THIAZIDE DIURETICS 1976-2005%A%  
% 210.18/210.35  |- skos__scopeNote mesh__D049993
% 210.18/210.35       Agents that inhibit SODIUM CHLORIDE SYMPORTERS. They act as DIURETICS. Excess use is associated with HYPOKALEMIA.%A%    
% 210.18/210.35  |- skos__broader mesh__D049993smesh__D049990
% 210.18/210.35  |- skos__annotation mesh__D049993 coordinate with DIURETICS if pertinent   
% 210.18/210.35  |- skos__altLabel mesh__D049993 Thiazide Diuretics
% 210.18/210.35  |- skos__prefLabel mesh__D049993 Sodium Chloride Symporter Inhibitors
% 210.18/210.35  |- rdf__type mesh__D049993sskos__Concept
% 210.18/210.35  |- mesh__dateCreated mesh__D049993 2005-06-30
% 210.18/210.35  |- skos__altLabel mesh__D049993 Benzothiadiazine Diuretics
% 210.18/210.35  |- skos__hiddenLabel mesh__D049993 Diuretics, Potassium Depleting
% 210.18/210.35  |- mesh__dateEstablished mesh__D049993 2006-01-01
% 210.18/210.35  |- mesh__recordOriginator mesh__D049993 ssb
% 210.18/210.35  |- mesh__historyNote mesh__D049993 2006   
% 210.18/210.35  |- skos__altLabel mesh__D049993 Sodium Chloride Cotransporter Inhibitors
% 210.18/210.35  |- skos__altLabel mesh__D049993
% 210.18/210.35       Thiazide Sensitive NaCl Cotransporter Inhibitors
% 210.18/210.35  |- mesh__recordAuthorizer mesh__D049993 sjn
% 210.18/210.35  |- mesh__recordMaintainer mesh__D049993 ssb
% 210.18/210.35  |- skos__altLabel mesh__D016210 Methapharma Brand of Methacholine Chloride
% 210.18/210.35  |- skos__hiddenLabel mesh__D016210 Acetyl beta methylcholine
% 210.18/210.35  |- mesh__recordAuthorizer mesh__D016210 sjn
% 210.18/210.35  |- mesh__dateEstablished mesh__D016210 1991-01-01
% 210.18/210.35  |- skos__prefLabel mesh__D016210 Methacholine Chloride
% 210.18/210.35  |- skos__broader mesh__D016210smesh__D008688
% 210.18/210.35  |- mesh__publicMeSHNote mesh__D016210 91   
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D016210 2006
% 210.18/210.35  |- skos__altLabel mesh__D016210
% 210.18/210.35       2-%28%Acetyloxy%29%-N,N,N-trimethyl-1-propanaminium Chloride
% 210.18/210.35  |- skos__altLabel mesh__D016210 Acetyl-2-methylcholine Chloride
% 210.18/210.35  |- mesh__historyNote mesh__D016210 91   
% 210.18/210.35  |- skos__scopeNote mesh__D016210
% 210.18/210.35       A quaternary ammonium parasympathomimetic agent with the muscarinic actions of ACETYLCHOLINE. It is hydrolyzed by ACETYLCHOLINESTERASE at a considerably slower rate than ACETYLCHOLINE and is more resistant to hydrolysis by nonspecific CHOLINESTERASES so that its actions are more prolonged. It is used as a parasympathomimetic bronchoconstrictor agent and as a diagnostic aid for bronchial asthma. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1116%29%%A%    
% 210.18/210.35  |- skos__altLabel mesh__D016210 Roche Brand of Methacholine Chloride
% 210.18/210.35  |- rdf__type mesh__D016210sskos__Concept
% 210.18/210.35  |- skos__hiddenLabel mesh__D016210 Chloride, Methacholine
% 210.18/210.35  |- skos__altLabel mesh__D016210 Mecholine
% 210.18/210.35  |- skos__hiddenLabel mesh__D016210 Acetyl 2 methylcholine Chloride
% 210.18/210.35  |- mesh__dateRevised mesh__D016210 2005-06-30
% 210.18/210.35  |- skos__altLabel mesh__D016210 Lindopharm Brand of Methacholine Chloride
% 210.18/210.35  |- skos__historyNote mesh__D016210 Methacholine Compounds %28%1966-1990%29%
% 210.18/210.35  |- mesh__dateCreated mesh__D016210 1990-04-24
% 210.18/210.35  |- mesh__recordMaintainer mesh__D016210 ssb
% 210.18/210.35  |- mesh__recordOriginator mesh__D016210 RLS
% 210.18/210.35  |- skos__altLabel mesh__D016210 Acetyl-beta-methacholine Chloride
% 210.18/210.35  |- skos__hiddenLabel mesh__D016210 Acetyl beta methacholine Chloride
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D002799 2006
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D002799 1999
% 210.18/210.35  |- mesh__publicMeSHNote mesh__D002799 77   
% 210.18/210.35  |- skos__hiddenLabel mesh__D002799 Fibers, Cholinergic
% 210.18/210.35  |- skos__prefLabel mesh__D002799 Cholinergic Fibers
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D002799 1994
% 210.18/210.35  |- mesh__historyNote mesh__D002799 77   
% 210.18/210.35  |- mesh__recordAuthorizer mesh__D002799 PLS
% 210.18/210.35  |- mesh__recordOriginator mesh__D002799 MM
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D002799 2003
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D002799 1995
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D002799 1996
% 210.18/210.35  |- rdf__type mesh__D002799sskos__Concept
% 210.18/210.35  |- skos__scopeNote mesh__D002799
% 210.18/210.35       Nerve fibers liberating acetylcholine at the synapse after an impulse.%A%    
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D002799 2000
% 210.18/210.35  |- skos__broader mesh__D002799smesh__D009412
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D002799 2004
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D002799 1997
% 210.18/210.35  |- skos__hiddenLabel mesh__D002799 Fiber, Cholinergic
% 210.18/210.35  |- skos__historyNote mesh__D002799
% 210.18/210.35       Parasympathetic Nervous System %28%1966-1976%29%
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D002799 2001
% 210.18/210.35  |- mesh__dateRevised mesh__D002799 1993-06-18
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D002799 2005
% 210.18/210.35  |- mesh__recordMaintainer mesh__D002799 RAZ
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D002799 1998
% 210.18/210.35  |- skos__hiddenLabel mesh__D002799 Cholinergic Fiber
% 210.18/210.35  |- mesh__dateCreated mesh__D002799 1976-04-27
% 210.18/210.35  |- mesh__dateEstablished mesh__D002799 1977-01-01
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D002799 2002
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D043607 2004
% 210.18/210.35  |- mesh__recordOriginator mesh__D043607 lkt
% 210.18/210.35  |- skos__altLabel mesh__D043607
% 210.18/210.35       NADPH-Dependent 20 alpha-Hydroxysteroid Oxidoreductase
% 210.18/210.35  |- skos__altLabel mesh__D043607 20-alpha-HSD
% 210.18/210.35  |- skos__hiddenLabel mesh__D043607
% 210.18/210.35       NADPH Dependent 20 alpha Hydroxysteroid Oxidoreductase
% 210.18/210.35  |- mesh__dateCreated mesh__D043607 2003-07-09
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D043607 2006
% 210.18/210.35  |- skos__scopeNote mesh__D043607
% 210.18/210.35       An enzymes that catalyzes the reversible reduction-oxidation reaction of 20-alpha-hydroxysteroids, such as from PROGESTERONE to 20-ALPHA-DIHYDROPROGESTERONE.%A%    
% 210.18/210.35  |- skos__historyNote mesh__D043607
% 210.18/210.35       Hydroxysteroid Dehydrogenases %28%1965-1977%29%
% 210.18/210.35  |- mesh__recordMaintainer mesh__D043607 lkt
% 210.18/210.35  |- rdf__type mesh__D043607sskos__Concept
% 210.18/210.35  |- mesh__publicMeSHNote mesh__D043607
% 210.18/210.35       2004; 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE was indexed under 20-HYDROXYSTEROID DEHYDROGENASES %28%NM%29% 1982-2003%A%  
% 210.18/210.35  |- mesh__recordAuthorizer mesh__D043607 sjn
% 210.18/210.35  |- skos__hiddenLabel mesh__D043607
% 210.18/210.35       17 beta, 20 alpha Hydroxysteroid Dehydrogenase
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D043607 2005
% 210.18/210.35  |- skos__hiddenLabel mesh__D043607 20 alpha Hydroxysteroid Dehydrogenase
% 210.18/210.35  |- skos__broader mesh__D043607smesh__D015089
% 210.18/210.35  |- skos__altLabel mesh__D043607 20 alpha-Hydroxysteroid Dehydrogenase
% 210.18/210.35  |- mesh__dateEstablished mesh__D043607 2004-01-01
% 210.18/210.35  |- mesh__historyNote mesh__D043607
% 210.18/210.35       2004; use 20-ALPHA-HYDROXYSTEROID DEHYDROGENASES %28%NM%29% 1982-2003%A%  
% 210.18/210.35  |- skos__historyNote mesh__D043607
% 210.18/210.35       20-Hydroxysteroid Dehydrogenases %28%1978-2003%29%
% 210.18/210.35  |- skos__hiddenLabel mesh__D043607 20 alpha HSD
% 210.18/210.35  |- skos__prefLabel mesh__D043607 20-alpha-Hydroxysteroid Dehydrogenase
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D007484 2002
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D007484 2006
% 210.18/210.35  |- mesh__recordAuthorizer mesh__D007484 SJN
% 210.18/210.35  |- skos__prefLabel mesh__D007484 Iowa
% 210.18/210.35  |- mesh__dateRevised mesh__D007484 1997-06-20
% 210.18/210.35  |- rdf__type mesh__D007484sskos__Concept
% 210.18/210.35  |- mesh__dateCreated mesh__D007484 1999-01-01
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D007484 2003
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D007484 2000
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D007484 2004
% 210.18/210.35  |- mesh__recordOriginator mesh__D007484 NLM
% 210.18/210.35  |- skos__broader mesh__D007484smesh__D015146
% 210.18/210.35  |- mesh__recordMaintainer mesh__D007484 PXP
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D007484 1998
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D007484 2001
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D007484 2005
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D007484 1999
% 210.18/210.35  |- skos__broader mesh__D015916smesh__D004322
% 210.18/210.35  |- rdf__type mesh__D015916sskos__Concept
% 210.18/210.35  |- mesh__dateEstablished mesh__D015916 1990-01-01
% 210.18/210.35  |- mesh__dateRevised mesh__D015916 2005-06-30
% 210.18/210.35  |- skos__hiddenLabel mesh__D015916 Postural Respiratory Drainage
% 210.18/210.35  |- skos__hiddenLabel mesh__D015916 Drainage, Postural Respiratory
% 210.18/210.35  |- skos__prefLabel mesh__D015916 Drainage, Postural
% 210.18/210.35  |- skos__altLabel mesh__D015916 Postural Drainage
% 210.18/210.35  |- mesh__historyNote mesh__D015916 90   
% 210.18/210.35  |- mesh__publicMeSHNote mesh__D015916 90   
% 210.18/210.35  |- skos__hiddenLabel mesh__D015916 Drainages, Postural Respiratory
% 210.18/210.35  |- skos__broader mesh__D015916smesh__D012138
% 210.18/210.35  |- skos__altLabel mesh__D015916 Respiratory Drainage, Postural
% 210.18/210.35  |- skos__annotation mesh__D015916
% 210.18/210.35       ther drainage of %22%copious mucus secretion%22% in bronchopulm dis%A%  
% 210.18/210.35  |- skos__broader mesh__D015916smesh__D026241
% 210.18/210.35  |- mesh__recordAuthorizer mesh__D015916 sjn
% 210.18/210.35  |- mesh__recordOriginator mesh__D015916 PLS
% 210.18/210.35  |- skos__hiddenLabel mesh__D015916 Postural Respiratory Drainages
% 210.18/210.35  |- mesh__recordMaintainer mesh__D015916 lkt
% 210.18/210.35  |- mesh__dateCreated mesh__D015916 1989-05-15
% 210.18/210.35  |- skos__hiddenLabel mesh__D015916 Respiratory Drainages, Postural
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D015916 2006
% 210.18/210.35  |- skos__historyNote mesh__D015916 Posture %28%1966-1989%29%
% 210.18/210.35  |- skos__scopeNote mesh__D015916
% 210.18/210.35       Therapeutic drainage in bronchopulmonary diseases in which there is copious mucus secretion, such as chronic bronchitis, bronchiectasis, pulmonary abscess, or cystic fibrosis. The patient is placed with head downward, so that the trachea is inclined downward and below the affected area. It may be done in 15- to 20-minute sessions or by having the patient sleep in a head-down position. The therapy may be used in conjunction with forced expiration, bronchodilator agents, or expectorants.%A%    
% 210.18/210.35  |- skos__historyNote mesh__D015916 Drainage %28%1966-1989%29%
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D015118 2005
% 210.18/210.35  |- rdf__type mesh__D015118sskos__Concept
% 210.18/210.35  |- skos__altLabel mesh__D015118 5,8,11,14,17-Eicosapentaenoic Acid
% 210.18/210.35  |- skos__prefLabel mesh__D015118 Eicosapentaenoic Acid
% 210.18/210.35  |- skos__hiddenLabel mesh__D015118 omega 3 Eicosapentaenoic Acid
% 210.18/210.35  |- mesh__publicMeSHNote mesh__D015118
% 210.18/210.35       1986; see 5,8,11,14,17-EICOSAPENTAENOIC ACID 1986-2003   
% 210.18/210.35  |- mesh__recordOriginator mesh__D015118 RLS
% 210.18/210.35  |- mesh__dateCreated mesh__D015118 1985-06-05
% 210.18/210.35  |- skos__broader mesh__D015118smesh__D015777
% 210.18/210.35  |- mesh__dateRevised mesh__D015118 2003-07-09
% 210.18/210.35  |- skos__broader mesh__D015118smesh__D015525
% 210.18/210.35  |- mesh__recordAuthorizer mesh__D015118 sjn
% 210.18/210.35  |- mesh__recordMaintainer mesh__D015118 jmp
% 210.18/210.35  |- skos__scopeNote mesh__D015118
% 210.18/210.35       Important polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families.%A%    
% 210.18/210.35  |- skos__altLabel mesh__D015118 5,8,11,14,17-Icosapentaenoic Acid
% 210.18/210.35  |- mesh__dateEstablished mesh__D015118 1986-01-01
% 210.18/210.35  |- skos__altLabel mesh__D015118 omega-3-Eicosapentaenoic Acid
% 210.18/210.35  |- mesh__historyNote mesh__D015118 2003%28%1986%29%;   
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D015118 2004
% 210.18/210.35  |- skos__altLabel mesh__D015118 Timnodonic Acid
% 210.18/210.35  |- skos__historyNote mesh__D015118
% 210.18/210.35       Fatty Acids, Unsaturated %28%1973-1985%29%
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D015118 2006
% 210.18/210.35  |- skos__historyNote mesh__D015118 Fatty Acids %28%1966-1972%29%
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D031583 2003
% 210.18/210.35  |- mesh__dateCreated mesh__D031583 2002-07-02
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D031583 2004
% 210.18/210.35  |- skos__prefLabel mesh__D031583 Althaea
% 210.18/210.35  |- rdf__type mesh__D031583sskos__Concept
% 210.18/210.35  |- skos__broader mesh__D031583smesh__D019660
% 210.18/210.35  |- skos__annotation mesh__D031583
% 210.18/210.35       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D031583 2005
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D031583 2006
% 210.18/210.35  |- skos__scopeNote mesh__D031583
% 210.18/210.35       A plant genus of the family MALVACEAE known for mucilaginous roots. The common names of hollyhock and mallow are also used for other genera of MALVACEAE.%A%    
% 210.18/210.35  |- mesh__dateEstablished mesh__D031583 2003-01-01
% 210.18/210.35  |- skos__altLabel mesh__D031583 Marshmallow
% 210.18/210.35  |- mesh__publicMeSHNote mesh__D031583 2003   
% 210.18/210.35  |- mesh__historyNote mesh__D031583 2003   
% 210.18/210.35  |- skos__altLabel mesh__D031583 Mallow, Marsh
% 210.18/210.35  |- mesh__dateCreated mesh__D003892 1974-11-19
% 210.18/210.35  |- skos__hiddenLabel mesh__D003892 C, Desacetyllanatoside
% 210.18/210.35  |- mesh__historyNote mesh__D003892
% 210.18/210.35       91%28%75%29%; was see under LANATOSIDES 1975-90   
% 210.18/210.35  |- skos__prefLabel mesh__D003892 Deslanoside
% 210.18/210.35  |- rdf__type mesh__D003892sskos__Concept
% 210.18/210.35  |- skos__historyNote mesh__D003892 Lanatosides %28%1969-1974%29%
% 210.18/210.35  |- skos__scopeNote mesh__D003892
% 210.18/210.35       Deacetyllanatoside C. A cardiotonic glycoside from the leaves of Digitalis lanata.%A%    
% 210.18/210.35  |- skos__hiddenLabel mesh__D003892 C, Deslanatoside
% 210.18/210.35  |- skos__altLabel mesh__D003892 Deslanatoside C
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D003892 2005
% 210.18/210.35  |- mesh__publicMeSHNote mesh__D003892
% 210.18/210.35       91; was see under LANATOSIDES 1975-90   
% 210.18/210.35  |- mesh__recordAuthorizer mesh__D003892 sjn
% 210.18/210.35  |- skos__hiddenLabel mesh__D003892 C, Desacetyldigilanide
% 210.18/210.35  |- skos__altLabel mesh__D003892 Desacetyldigilanide C
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D003892 2006
% 210.18/210.35  |- mesh__dateRevised mesh__D003892 2004-07-07
% 210.18/210.35  |- skos__hiddenLabel mesh__D003892 Cedilanid D
% 210.18/210.35  |- skos__altLabel mesh__D003892 Desacetyllanatoside C
% 210.18/210.35  |- skos__altLabel mesh__D003892 Desacetyl Lanatoside
% 210.18/210.35  |- skos__hiddenLabel mesh__D003892 CedilanidD
% 210.18/210.35  |- mesh__recordOriginator mesh__D003892 NLM
% 210.18/210.35  |- mesh__dateEstablished mesh__D003892 1991-01-01
% 210.18/210.35  |- mesh__recordMaintainer mesh__D003892 ssb
% 210.18/210.35  |- skos__broader mesh__D003892smesh__D007799
% 210.18/210.35  |- skos__hiddenLabel mesh__D003892 Lanatoside, Desacetyl
% 210.18/210.35  |- mesh__dateCreated mesh__D003094 1999-01-01
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D003094 2005
% 210.18/210.35  |- rdf__type mesh__D003094sskos__Concept
% 210.18/210.35  |- mesh__dateRevised mesh__D003094 2005-07-29
% 210.18/210.35  |- skos__scopeNote mesh__D003094
% 210.18/210.35       A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones %28%BONE AND BONES%29% and teeth %28%TOOTH%29%.%A%    
% 210.18/210.35  |- mesh__recordMaintainer mesh__D003094 ags
% 210.18/210.35  |- mesh__activeMeSHYear mesh__D003094 2006B
% 210.18/210.35  |- mesh__recordAuthorizer mesh__D003094 ags
% 210.18/210.35  |- skos__hiddenLabel mesh__D003094 alpha Collagen
% 210.18/210.35  |- skos__hiddenLabel mesh__D003094 Collagen Hemostat, Microfibril
% 210.18/210.36  |- skos__broader mesh__D003094smesh__D016326
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D003094 2006A
% 210.18/210.36  |- mesh__recordOriginator mesh__D003094 NLM
% 210.18/210.36  |- skos__annotation mesh__D003094
% 210.18/210.36       GEN; prefer specifics; precusor = PROCOLLAGEN; do not confuse X ref MICROFIBRIL COLLAGEN HEMOSTAT with FIBRILLAR COLLAGENS%A%  
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D003094 2006
% 210.18/210.36  |- skos__prefLabel mesh__D003094 Collagen
% 210.18/210.36  |- skos__broader mesh__D003094smesh__D001704
% 210.18/210.36  |- skos__altLabel mesh__D003094 Collagenfleece
% 210.18/210.36  |- rdf__type mesh__D019509sskos__Concept
% 210.18/210.36  |- mesh__recordAuthorizer mesh__D019509 sjn
% 210.18/210.36  |- skos__annotation mesh__D019509
% 210.18/210.36       CATALOG: do not use for current materials   
% 210.18/210.36  |- skos__scopeNote mesh__D019509
% 210.18/210.36       Works such as books on herbs or plants usually describing their medicinal value. %28%Random House Unabridged Dictionary, 2d ed%29%%A%    
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D019509 2006
% 210.18/210.36  |- mesh__historyNote mesh__D019509 1997   
% 210.18/210.36  |- mesh__dateEstablished mesh__D019509 1997-01-01
% 210.18/210.36  |- skos__prefLabel mesh__D019509 Herbals %5B%Publication Type%5D%
% 210.18/210.36  |- skos__altLabel mesh__D019509 Herbals %28%PT%29%
% 210.18/210.36  |- mesh__recordOriginator mesh__D019509 TGC
% 210.18/210.36  |- skos__broader mesh__D019509smesh__D019539
% 210.18/210.36  |- mesh__recordMaintainer mesh__D019509 jls
% 210.18/210.36  |- mesh__dateRevised mesh__D019509 2005-06-30
% 210.18/210.36  |- mesh__dateCreated mesh__D019509 1996-06-21
% 210.18/210.36  |- mesh__historyNote mesh__D011526
% 210.18/210.36       91%28%80%29%; was see under VERATRUM ALKALOIDS 1981-90; PROTOVERATRINE A was see under CEVANES 1975-79, was Prov 1966-74; PROTOVERATRINE A DERIVATIVES was see under CEVANES 1969-77; PROTOVERATRINE was see under VERATRUM 1966-68; CRYPTENAMINE was see under VERATRUM ALKALOIDS 1975-79, was see under VERATRUM 1963-74%A%  
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D011526 2001
% 210.18/210.36  |- skos__altLabel mesh__D011526 Neoprotoveratrin
% 210.18/210.36  |- mesh__onlineNote mesh__D011526
% 210.18/210.36       use PROTOVERATRINES to search PROTOVERATRINE A 1966-75; use PROTOVERATRINES to search PROTOVERATRINE A DERIVATIVES 1978-80, use CEVANES 1969-77; use VERATRUM to search PROTOVERATRINE 1966-68; use PROTOVERATRINES to search CRYPTENAMINE 1975-79, use VERATRUM 1966-74%A%  
% 210.18/210.36  |- skos__altLabel mesh__D011526 Protoveratrine A
% 210.18/210.36  |- skos__prefLabel mesh__D011526 Protoveratrines
% 210.18/210.36  |- mesh__publicMeSHNote mesh__D011526
% 210.18/210.36       91; was see under VERATRUM ALKALOIDS 1981-90; PROTOVERATRINE A was see under CEVANES 1975-79, was Prov 1966-74; PROTOVERATRINE A DERIVATIVES was see under CEVANES 1969-77; PROTOVERATRINE was see under VERATRUM 1966-68; CRYPTENAMINE was see under VERATRUM ALKALOIDS 1975-79, was see under VERATRUM 1963-74%A%  
% 210.18/210.36  |- skos__broader mesh__D011526smesh__D002595
% 210.18/210.36  |- mesh__dateRevised mesh__D011526 2000-06-21
% 210.18/210.36  |- mesh__recordAuthorizer mesh__D011526 sjn
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D011526 2006
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D011526 2002
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D011526 2004
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D011526 2005
% 210.18/210.36  |- rdf__type mesh__D011526sskos__Concept
% 210.18/210.36  |- mesh__recordOriginator mesh__D011526 NLM
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D011526 2003
% 210.18/210.36  |- skos__scopeNote mesh__D011526
% 210.18/210.36       Mixtures of closely related hypotensive alkaloids from Veratrum album %28%Liliaceae%29%. They have been used in the treatment of hypertension but have largely been replaced by drugs with fewer adverse effects.%A%    
% 210.18/210.36  |- mesh__dateEstablished mesh__D011526 1991-01-01
% 210.18/210.36  |- mesh__dateCreated mesh__D011526 1999-01-01
% 210.18/210.36  |- mesh__recordMaintainer mesh__D011526 TWD
% 210.18/210.36  |- skos__hiddenLabel mesh__D049994
% 210.18/210.36       Bumetanide Sensitive Na K Cl Transporter Inhibitors
% 210.18/210.36  |- skos__altLabel mesh__D049994
% 210.18/210.36       Bumetanide Sensitive Na-K-Cl-Transporter Inhibitors
% 210.18/210.36  |- mesh__recordAuthorizer mesh__D049994 sjn
% 210.18/210.36  |- skos__altLabel mesh__D049994
% 210.18/210.36       Sodium Potassium Chloride Cotransporter Inhibitors
% 210.18/210.36  |- mesh__recordMaintainer mesh__D049994 ssb
% 210.18/210.36  |- rdf__type mesh__D049994sskos__Concept
% 210.18/210.36  |- skos__hiddenLabel mesh__D049994 Inhibitors, Na-K-CL Symporter
% 210.18/210.36  |- skos__hiddenLabel mesh__D049994 Symporter Inhibitors, Na-K-CL
% 210.18/210.36  |- skos__hiddenLabel mesh__D049994 Diuretics, High Ceiling
% 210.18/210.36  |- skos__broader mesh__D049994smesh__D049990
% 210.18/210.36  |- skos__scopeNote mesh__D049994
% 210.18/210.36       Agents that inhibit SODIUM-POTASSIUM-CHLORIDE SYMPORTERS which are concentrated in the thick ascending limb at the junction of the LOOP OF HENLE and KIDNEY TUBULES, DISTAL. They act as DIURETICS. Excess use is associated with HYPOKALEMIA and HYPERGLYCEMIA.%A%    
% 210.18/210.36  |- skos__annotation mesh__D049994 coordinate with DIURETICS if pertinent   
% 210.18/210.36  |- skos__prefLabel mesh__D049994
% 210.18/210.36       Sodium Potassium Chloride Symporter Inhibitors
% 210.18/210.36  |- skos__hiddenLabel mesh__D049994 Diuretics, Loop
% 210.18/210.36  |- skos__hiddenLabel mesh__D049994 Na K CL Symporter Inhibitors
% 210.18/210.36  |- mesh__recordOriginator mesh__D049994 ssb
% 210.18/210.36  |- mesh__publicMeSHNote mesh__D049994 2006   
% 210.18/210.36  |- mesh__dateCreated mesh__D049994 2005-06-30
% 210.18/210.36  |- skos__hiddenLabel mesh__D049994 Ceiling Diuretics, High
% 210.18/210.36  |- skos__historyNote mesh__D049994
% 210.18/210.36       Sodium-Potassium-Chloride Symporters %28%2002-2005%29%
% 210.18/210.36  |- mesh__dateEstablished mesh__D049994 2006-01-01
% 210.18/210.36  |- skos__altLabel mesh__D049994 Na-K-CL Symporter Inhibitors
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D049994 2006
% 210.18/210.36  |- mesh__historyNote mesh__D049994 2006   
% 210.18/210.36  |- skos__broader mesh__D052119Q000172smesh__D052119
% 210.18/210.36  |- mesh__preferredCombination mesh__D052119Q000172smesh__D052120
% 210.18/210.36  |- rdf__type mesh__D052119Q000172smesh__CompoundConcept
% 210.18/210.36  |- skos__broader mesh__D016211smesh__D015291
% 210.18/210.36  |- skos__hiddenLabel mesh__D016211
% 210.18/210.36       Epidermal Growth Factor Related Transforming Growth Factor
% 210.18/210.36  |- mesh__dateRevised mesh__D016211 2005-06-30
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D016211 2006
% 210.18/210.36  |- skos__annotation mesh__D016211
% 210.18/210.36       /drug eff permitted; DF: note short X ref   
% 210.18/210.36  |- skos__altLabel mesh__D016211 TGFalpha
% 210.18/210.36  |- skos__altLabel mesh__D016211
% 210.18/210.36       Epidermal Growth Factor-Related Transforming Growth Factor
% 210.18/210.36  |- skos__historyNote mesh__D016211 Peptides %28%1983-1988%29%
% 210.18/210.36  |- skos__historyNote mesh__D016211
% 210.18/210.36       Transforming Growth Factors %28%1989-1990%29%
% 210.18/210.36  |- mesh__dateCreated mesh__D016211 1990-06-29
% 210.18/210.36  |- mesh__recordAuthorizer mesh__D016211 sjn
% 210.18/210.36  |- skos__altLabel mesh__D016211 TGF-alpha
% 210.18/210.36  |- mesh__historyNote mesh__D016211
% 210.18/210.36       91; was see TRANSFORMING GROWTH FACTORS 1989-90; TGF-ALPHA was see TRANSFORMING GROWTH FACTORS 1989-90%A%  
% 210.18/210.36  |- mesh__dateEstablished mesh__D016211 1991-01-01
% 210.18/210.36  |- skos__scopeNote mesh__D016211
% 210.18/210.36       Factor isolated in a variety of tissues including epithelium, and maternal decidua. It is closely related to EPIDERMAL GROWTH FACTOR and binds to the EGF receptor. TGF-alpha acts synergistically with TGF-beta in inducing phenotypic transformation, but its physiological role is unknown.%A%    
% 210.18/210.36  |- rdf__type mesh__D016211sskos__Concept
% 210.18/210.36  |- mesh__publicMeSHNote mesh__D016211
% 210.18/210.36       91; was see TRANSFORMING GROWTH FACTORS 1989-90; TGF-ALPHA was see TRANSFORMING GROWTH FACTORS 1989-90%A%  
% 210.18/210.36  |- mesh__recordOriginator mesh__D016211 AGS
% 210.18/210.36  |- mesh__onlineNote mesh__D016211
% 210.18/210.36       use TRANSFORMING GROWTH FACTORS to search TRANSFORMING GROWTH FACTOR ALPHA %26% TGF-ALPHA 1989-90%A%  
% 210.18/210.36  |- mesh__recordMaintainer mesh__D016211 ssb
% 210.18/210.36  |- skos__prefLabel mesh__D016211 Transforming Growth Factor alpha
% 210.18/210.36  |- mesh__publicMeSHNote mesh__D007485
% 210.18/210.36       87; IOXAGLATE MEGLUMINE was IOXAGLATE, MEGLUMINE 1987-93;  IOXAGLATE SODIUM was IOXAGLATE, SODIUM 1987-93%A%  
% 210.18/210.36  |- mesh__recordMaintainer mesh__D007485 ssb
% 210.18/210.36  |- mesh__dateRevised mesh__D007485 2001-07-25
% 210.18/210.36  |- skos__broader mesh__D007485smesh__D014283
% 210.18/210.36  |- rdf__type mesh__D007485sskos__Concept
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D007485 2002
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D007485 2003
% 210.18/210.36  |- skos__scopeNote mesh__D007485
% 210.18/210.36       A low-osmolar, ionic contrast medium used in various radiographic procedures.%A%    
% 210.18/210.36  |- skos__historyNote mesh__D007485 Triiodobenzoic Acids %28%1972-1986%29%
% 210.18/210.36  |- skos__historyNote mesh__D007485 Benzoates %28%1966-1971%29%
% 210.18/210.36  |- skos__altLabel mesh__D007485 Methylglucamine Ioxaglate
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D007485 2004
% 210.18/210.36  |- mesh__dateEstablished mesh__D007485 1987-01-01
% 210.18/210.36  |- skos__altLabel mesh__D007485 Ioxaglic Acid Monosodium Salt
% 210.18/210.36  |- skos__prefLabel mesh__D007485 Ioxaglic Acid
% 210.18/210.36  |- skos__hiddenLabel mesh__D007485 Meglumine, Ioxaglate
% 210.18/210.36  |- skos__hiddenLabel mesh__D007485 Ioxaglate, Methylglucamine
% 210.18/210.36  |- mesh__recordOriginator mesh__D007485 RLS
% 210.18/210.36  |- skos__altLabel mesh__D007485 P286 %28%Contrast Media%29%
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D007485 2005
% 210.18/210.36  |- mesh__historyNote mesh__D007485
% 210.18/210.36       87; IOXAGLATE MEGLUMINE was IOXAGLATE, MEGLUMINE 1987-93; IOXAGLATE SODIUM was IOXAGLATE, SODIUM 1987-93%A%  
% 210.18/210.36  |- mesh__recordAuthorizer mesh__D007485 sjn
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D007485 2006
% 210.18/210.36  |- mesh__dateCreated mesh__D007485 1986-06-16
% 210.18/210.36  |- skos__historyNote mesh__D015917 Penis/surgery %28%1966-1989%29%
% 210.18/210.36  |- skos__hiddenLabel mesh__D015917 Implants, Penile
% 210.18/210.36  |- skos__hiddenLabel mesh__D015917 Implant, Penile
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015917 1998
% 210.18/210.36  |- mesh__recordOriginator mesh__D015917 PLS
% 210.18/210.36  |- mesh__dateCreated mesh__D015917 1989-05-15
% 210.18/210.36  |- skos__related mesh__D015917smesh__D019935
% 210.18/210.36  |- skos__hiddenLabel mesh__D015917 Prostheses, Penis
% 210.18/210.36  |- skos__historyNote mesh__D015917 Impotence %28%1966-1989%29%
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015917 2006
% 210.18/210.36  |- mesh__onlineNote mesh__D015917
% 210.18/210.36       use PENILE PROSTHESIS to search PROSTHESIS, PENILE 1990   
% 210.18/210.36  |- skos__hiddenLabel mesh__D015917 Penile Prostheses
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015917 2001
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015917 2004
% 210.18/210.36  |- skos__altLabel mesh__D015917 Prosthesis, Penile
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015917 2000
% 210.18/210.36  |- mesh__historyNote mesh__D015917
% 210.18/210.36       90; PROSTHESIS, PENILE was see PENILE PROSTHESIS 1990   
% 210.18/210.36  |- mesh__recordMaintainer mesh__D015917 PXP
% 210.18/210.36  |- mesh__publicMeSHNote mesh__D015917
% 210.18/210.36       90; PROSTHESIS, PENILE was see PENILE PROSTHESIS 1990   
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015917 2005
% 210.18/210.36  |- skos__hiddenLabel mesh__D015917 Prosthesis, Penis
% 210.18/210.36  |- skos__hiddenLabel mesh__D015917 Penis Prostheses
% 210.18/210.36  |- skos__hiddenLabel mesh__D015917 Penile Implants
% 210.18/210.36  |- skos__altLabel mesh__D015917 Penile Implant
% 210.18/210.36  |- rdf__type mesh__D015917sskos__Concept
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015917 2003
% 210.18/210.36  |- mesh__recordAuthorizer mesh__D015917 SJN
% 210.18/210.36  |- skos__altLabel mesh__D015917 Penis, Artificial
% 210.18/210.36  |- skos__broader mesh__D015917smesh__D019736
% 210.18/210.36  |- skos__scopeNote mesh__D015917
% 210.18/210.36       Rigid, semi-rigid, or inflatable cylindric hydraulic devices, with either combined or separate reservoir and pumping systems, implanted for the surgical treatment of organic impotence.%A%    
% 210.18/210.36  |- skos__historyNote mesh__D015917 Prosthesis %28%1966-1989%29%
% 210.18/210.36  |- skos__prefLabel mesh__D015917 Penile Prosthesis
% 210.18/210.36  |- skos__altLabel mesh__D015917 Penis Prosthesis
% 210.18/210.36  |- mesh__dateRevised mesh__D015917 1997-06-20
% 210.18/210.36  |- skos__hiddenLabel mesh__D015917 Prostheses, Penile
% 210.18/210.36  |- mesh__dateEstablished mesh__D015917 1990-01-01
% 210.18/210.36  |- skos__altLabel mesh__D015917 Artificial Penis
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015917 1999
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015917 2002
% 210.18/210.36  |- mesh__dateRevised mesh__D015119 2000-06-21
% 210.18/210.36  |- mesh__dateEstablished mesh__D015119 1991-01-01
% 210.18/210.36  |- rdf__type mesh__D015119sskos__Concept
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015119 2001
% 210.18/210.36  |- skos__historyNote mesh__D015119 Aminocaproic Acids %28%1966-1976%29%
% 210.18/210.36  |- skos__scopeNote mesh__D015119
% 210.18/210.36       An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.%A%    
% 210.18/210.36  |- mesh__publicMeSHNote mesh__D015119
% 210.18/210.36       91; was see under AMINOCAPROIC ACIDS 1977-90; EPSILON-AMINOCAPROIC ACID was see AMINOCAPROIC ACIDS 1975-76, was see AMINOCAPROIC ACID 1964-74%A%  
% 210.18/210.36  |- mesh__historyNote mesh__D015119
% 210.18/210.36       91%28%77%29%; was see under AMINOCAPROIC ACIDS 1977-90; EPSILON-AMINOCAPROIC ACID was see AMINOCAPROIC ACIDS 1975-76, was see AMINOCAPROIC ACID 1964-74%A%  
% 210.18/210.36  |- skos__hiddenLabel mesh__D015119 Acid, 6-Aminocaproic
% 210.18/210.36  |- skos__hiddenLabel mesh__D015119 Acid, 6-Aminohexanoic
% 210.18/210.36  |- mesh__dateCreated mesh__D015119 1976-05-19
% 210.18/210.36  |- skos__broader mesh__D015119smesh__D000614
% 210.18/210.36  |- skos__altLabel mesh__D015119 6-Aminohexanoic Acid
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015119 2003
% 210.18/210.36  |- skos__hiddenLabel mesh__D015119 Acid, epsilon-Aminocaproic
% 210.18/210.36  |- mesh__recordMaintainer mesh__D015119 CCR
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015119 2002
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015119 2005
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015119 2004
% 210.18/210.36  |- skos__hiddenLabel mesh__D015119 6 Aminocaproic Acid
% 210.18/210.36  |- skos__hiddenLabel mesh__D015119 6 Aminohexanoic Acid
% 210.18/210.36  |- skos__hiddenLabel mesh__D015119 CY 116
% 210.18/210.36  |- skos__altLabel mesh__D015119 epsilon-Aminocaproic Acid
% 210.18/210.36  |- mesh__recordAuthorizer mesh__D015119 sjn
% 210.18/210.36  |- mesh__recordOriginator mesh__D015119 RLS
% 210.18/210.36  |- skos__prefLabel mesh__D015119 6-Aminocaproic Acid
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015119 2006
% 210.18/210.36  |- mesh__onlineNote mesh__D015119
% 210.18/210.36       use AMINOCAPROIC ACIDS to search EPSILON-AMINOCAPROIC ACID 1966-76%A%  
% 210.18/210.36  |- skos__hiddenLabel mesh__D015119 epsilon Aminocaproic Acid
% 210.18/210.36  |- skos__hiddenLabel mesh__D015119 CY116
% 210.18/210.36  |- mesh__publicMeSHNote mesh__D031584 2003   
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D031584 2004
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D031584 2005
% 210.18/210.36  |- mesh__dateCreated mesh__D031584 2002-07-03
% 210.18/210.36  |- skos__prefLabel mesh__D031584 Hibiscus
% 210.18/210.36  |- skos__altLabel mesh__D031584 Kenaf
% 210.18/210.36  |- mesh__historyNote mesh__D031584 2003   
% 210.18/210.36  |- skos__broader mesh__D031584smesh__D019660
% 210.18/210.36  |- skos__annotation mesh__D031584
% 210.18/210.36       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D031584 2003
% 210.18/210.36  |- rdf__type mesh__D031584sskos__Concept
% 210.18/210.36  |- skos__scopeNote mesh__D031584
% 210.18/210.36       A plant genus of the family MALVACEAE. Members contain LIGNANS. H. cannabinus is a source of textile fiber %28%TEXTILES%29%.%A%    
% 210.18/210.36  |- mesh__dateEstablished mesh__D031584 2003-01-01
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D031584 2006
% 210.18/210.36  |- mesh__recordMaintainer mesh__D003893 jmp
% 210.18/210.36  |- skos__historyNote mesh__D003893
% 210.18/210.36       Intermediate Filament Proteins %28%1983-1984%29%
% 210.18/210.36  |- rdf__type mesh__D003893sskos__Concept
% 210.18/210.36  |- skos__annotation mesh__D003893
% 210.18/210.36       an intermediate filament protein; /biosyn /physiol permitted%A%  
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D003893 2005
% 210.18/210.36  |- mesh__dateEstablished mesh__D003893 1985-01-01
% 210.18/210.36  |- skos__scopeNote mesh__D003893
% 210.18/210.36       An intermediate filament protein found predominantly in smooth, skeletal, and cardiac muscle cells. Localized at the Z line. MW 50,000 to 55,000 is species dependent.%A%    
% 210.18/210.36  |- skos__altLabel mesh__D003893 Skeletin
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D003893 2006
% 210.18/210.36  |- mesh__dateRevised mesh__D003893 2004-07-07
% 210.18/210.36  |- mesh__dateCreated mesh__D003893 1984-04-06
% 210.18/210.36  |- skos__broader mesh__D003893smesh__D007381
% 210.18/210.36  |- mesh__recordAuthorizer mesh__D003893 sjn
% 210.18/210.36  |- skos__prefLabel mesh__D003893 Desmin
% 210.18/210.36  |- skos__historyNote mesh__D003893 Muscle Proteins %28%1966-1982%29%
% 210.18/210.36  |- mesh__historyNote mesh__D003893 85   
% 210.18/210.36  |- mesh__recordOriginator mesh__D003893 RLS
% 210.18/210.36  |- mesh__publicMeSHNote mesh__D003893 85   
% 210.18/210.36  |- skos__scopeNote mesh__D003095
% 210.18/210.36       Historically, a heterogeneous group of acute and chronic diseases, including rheumatoid arthritis, systemic lupus erythematosus, progressive systemic sclerosis, dermatomyositis, etc. This classification was based on the notion that %22%collagen%22% was equivalent to %22%connective tissue%22%, but with the present recognition of the different types of collagen and the aggregates derived from them as distinct entities, the term %22%collagen diseases%22% now pertains exclusively to those inherited conditions in which the primary defect is at the gene level and affects collagen biosynthesis, post-translational modification, or extracellular processing directly. %28%From Cecil Textbook of Medicine, 19th ed, p1494%29%%A%    
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D003095 2001
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D003095 2003
% 210.18/210.36  |- skos__hiddenLabel mesh__D003095 Collagen Disease
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D003095 2000
% 210.18/210.36  |- skos__hiddenLabel mesh__D003095 Disease, Collagen
% 210.18/210.36  |- mesh__recordMaintainer mesh__D003095 KEV
% 210.18/210.36  |- skos__hiddenLabel mesh__D003095 Diseases, Collagen
% 210.18/210.36  |- skos__broader mesh__D003095smesh__D003240
% 210.18/210.36  |- skos__annotation mesh__D003095 GEN or unspecified; prefer specifics   
% 210.18/210.36  |- mesh__dateRevised mesh__D003095 1999-11-03
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D003095 2006
% 210.18/210.36  |- mesh__recordAuthorizer mesh__D003095 sjn
% 210.18/210.36  |- mesh__dateCreated mesh__D003095 1999-01-01
% 210.18/210.36  |- mesh__recordOriginator mesh__D003095 NLM
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D003095 2005
% 210.18/210.36  |- rdf__type mesh__D003095sskos__Concept
% 210.18/210.36  |- skos__prefLabel mesh__D003095 Collagen Diseases
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D003095 2002
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D003095 2004
% 210.18/210.36  |- skos__annotation mesh__D011527
% 210.18/210.36       GEN; avoid: prefer specifics; infection = PROTOZOAN INFECTIONS; /drug eff: consider also ANTIPROTOZOAL AGENTS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 210.18/210.36  |- mesh__dateRevised mesh__D011527 2003-07-09
% 210.18/210.36  |- mesh__recordOriginator mesh__D011527 NLM
% 210.18/210.36  |- skos__broader mesh__D011527smesh__D007448
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D011527 2005
% 210.18/210.36  |- mesh__recordMaintainer mesh__D011527 ags
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D011527 2006
% 210.18/210.36  |- mesh__dateCreated mesh__D011527 1999-01-01
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D011527 2004
% 210.18/210.36  |- rdf__type mesh__D011527sskos__Concept
% 210.18/210.36  |- skos__prefLabel mesh__D011527 Protozoa
% 210.18/210.36  |- skos__scopeNote mesh__D011527
% 210.18/210.36       A subkingdom consisting of unicellular organisms that are the simplest in the animal kingdom. Most are free living. They range in size from submicroscopic to macroscopic. Protozoa are divided into seven phyla: SARCOMASTIGOPHORA; Labyrinthomorpha, APICOMPLEXA; MICROSPORA; Ascetospora, Myxozoa, and CILIOPHORA.%A%    
% 210.18/210.36  |- mesh__recordAuthorizer mesh__D011527 sjn
% 210.18/210.36  |- skos__altLabel mesh__D011527 Protozoans
% 210.18/210.36  |- skos__related mesh__D011527smesh__D000981
% 210.18/210.36  |- skos__hiddenLabel mesh__D016212 Growth Factor, Milk
% 210.18/210.36  |- skos__altLabel mesh__D016212 Platelet Transforming Growth Factor
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D016212 2006
% 210.18/210.36  |- mesh__recordMaintainer mesh__D016212 ssb
% 210.18/210.36  |- skos__broader mesh__D016212smesh__D015291
% 210.18/210.36  |- skos__altLabel mesh__D016212 TGF-beta
% 210.18/210.36  |- skos__hiddenLabel mesh__D016212 Factor, Milk Growth
% 210.18/210.36  |- skos__altLabel mesh__D016212 Milk Growth Factor
% 210.18/210.36  |- skos__altLabel mesh__D016212 Bone-Derived Transforming Growth Factor
% 210.18/210.36  |- mesh__dateRevised mesh__D016212 2005-06-30
% 210.18/210.36  |- mesh__dateEstablished mesh__D016212 1991-01-01
% 210.18/210.36  |- rdf__type mesh__D016212sskos__Concept
% 210.18/210.36  |- skos__historyNote mesh__D016212 Peptides %28%1983-1988%29%
% 210.18/210.36  |- skos__historyNote mesh__D016212
% 210.18/210.36       Transforming Growth Factors %28%1989-1990%29%
% 210.18/210.36  |- mesh__historyNote mesh__D016212
% 210.18/210.36       91; was see TRANSFORMING GROWTH FACTORS 1989-90; TGF-BETA was see TRANSFORMING GROWTH FACTORS 1989-90%A%  
% 210.18/210.36  |- mesh__onlineNote mesh__D016212
% 210.18/210.36       use TRANSFORMING GROWTH FACTORS to search TRANSFORMING GROWTH FACTOR BETA %26% TGF-BETA 1989-90%A%  
% 210.18/210.36  |- mesh__dateCreated mesh__D016212 1990-06-29
% 210.18/210.36  |- skos__altLabel mesh__D016212 TGFbeta
% 210.18/210.36  |- mesh__recordAuthorizer mesh__D016212 sjn
% 210.18/210.36  |- skos__hiddenLabel mesh__D016212 Bone Derived Transforming Growth Factor
% 210.18/210.36  |- mesh__publicMeSHNote mesh__D016212
% 210.18/210.36       91; was see TRANSFORMING GROWTH FACTORS 1989-90; TGF-BETA was see TRANSFORMING GROWTH FACTORS 1989-90%A%  
% 210.18/210.36  |- skos__broader mesh__D016212smesh__D006133
% 210.18/210.36  |- skos__prefLabel mesh__D016212 Transforming Growth Factor beta
% 210.18/210.36  |- skos__scopeNote mesh__D016212
% 210.18/210.36       A factor synthesized in a wide variety of tissues. It acts synergistically with TGF-alpha in inducing phenotypic transformation and can also act as a negative autocrine growth factor. TGF-beta has a potential role in embryonal development, cellular differentiation, hormone secretion, and immune function. TGF-beta is found mostly as homodimer forms of separate gene products TGF-beta1, TGF-beta2 or TGF-beta3. Heterodimers composed of TGF-beta1 and 2 %28%TGF-beta1.2%29% or of TGF-beta2 and 3 %28%TGF-beta2.3%29% have been isolated. The TGF-beta proteins are synthesized as precursor proteins.%A%    
% 210.18/210.36  |- mesh__recordOriginator mesh__D016212 AGS
% 210.18/210.36  |- skos__scopeNote mesh__D007486
% 210.18/210.36       A syrup made from the dried rhizomes of two different species, CEPHAELIS ipecacuanha and C. acuminata. They contain EMETINE, cephaeline, psychotrine and other ISOQUINOLINES. Ipecac syrup is used widely as an emetic acting both locally on the gastric mucosa and centrally on the chemoreceptor trigger zone.%A%    
% 210.18/210.36  |- mesh__recordMaintainer mesh__D007486 ssb
% 210.18/210.36  |- mesh__dateCreated mesh__D007486 1999-01-01
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D007486 2006
% 210.18/210.36  |- skos__altLabel mesh__D007486 Syrup of Ipecac
% 210.18/210.36  |- skos__altLabel mesh__D007486 Ipecac %28%Syrup%29%
% 210.18/210.36  |- mesh__recordAuthorizer mesh__D007486 sjn
% 210.18/210.36  |- mesh__recordOriginator mesh__D007486 NLM
% 210.18/210.36  |- skos__broader mesh__D007486smesh__D010936
% 210.18/210.36  |- skos__related mesh__D007486smesh__D028503
% 210.18/210.36  |- skos__related mesh__D007486smesh__D004640
% 210.18/210.36  |- mesh__publicMeSHNote mesh__D007486
% 210.18/210.36       99; see IPECAC %28%SYRUP%29% 1995-98; see IPECAC 1963-94   
% 210.18/210.36  |- rdf__type mesh__D007486sskos__Concept
% 210.18/210.36  |- mesh__historyNote mesh__D007486 99%28%63%29%   
% 210.18/210.36  |- mesh__dateRevised mesh__D007486 2005-06-30
% 210.18/210.36  |- skos__hiddenLabel mesh__D007486 Ipecac Syrup
% 210.18/210.36  |- skos__prefLabel mesh__D007486 Ipecac
% 210.18/210.36  |- skos__hiddenLabel mesh__D015918 Pumps, Implantable Infusion
% 210.18/210.36  |- skos__hiddenLabel mesh__D015918 Perfusion Pump, Implantable
% 210.18/210.36  |- skos__scopeNote mesh__D015918
% 210.18/210.36       Implanted fluid propulsion systems with self-contained power source for providing long-term controlled-rate delivery of drugs such as chemotherapeutic agents or analgesics. Delivery rate may be externally controlled or osmotically or peristatically controlled with the aid of transcutaneous monitoring.%A%    
% 210.18/210.36  |- skos__altLabel mesh__D015918
% 210.18/210.36       Implantable Medication Systems, Programmable
% 210.18/210.36  |- skos__hiddenLabel mesh__D015918 Implantable Perfusion Pump
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015918 2004
% 210.18/210.36  |- mesh__historyNote mesh__D015918 90   
% 210.18/210.36  |- skos__altLabel mesh__D015918
% 210.18/210.36       Systems, Programmable Implantable Medication
% 210.18/210.36  |- skos__hiddenLabel mesh__D015918 Pumps, Implantable Perfusion
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015918 2005
% 210.18/210.36  |- mesh__dateEstablished mesh__D015918 1990-01-01
% 210.18/210.36  |- skos__altLabel mesh__D015918 Programmable Implantable Medication Systems
% 210.18/210.36  |- rdf__type mesh__D015918sskos__Concept
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015918 2000
% 210.18/210.36  |- mesh__recordAuthorizer mesh__D015918 jls
% 210.18/210.36  |- mesh__publicMeSHNote mesh__D015918 90   
% 210.18/210.36  |- skos__altLabel mesh__D015918 Drug Delivery Systems, Implantable
% 210.18/210.36  |- skos__hiddenLabel mesh__D015918 Implantable Infusion Pump
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015918 2006
% 210.18/210.36  |- skos__hiddenLabel mesh__D015918 Peristaltic Pump, Implantable
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015918 2001
% 210.18/210.36  |- skos__hiddenLabel mesh__D015918 Implantable Peristaltic Pump
% 210.18/210.36  |- skos__historyNote mesh__D015918 Infusion Pumps %28%1987-1989%29%
% 210.18/210.36  |- mesh__recordMaintainer mesh__D015918 jls
% 210.18/210.36  |- mesh__dateCreated mesh__D015918 1989-05-15
% 210.18/210.36  |- skos__hiddenLabel mesh__D015918 Pump, Implantable Peristaltic
% 210.18/210.36  |- mesh__dateRevised mesh__D015918 2004-07-30
% 210.18/210.36  |- skos__broader mesh__D015918smesh__D007260
% 210.18/210.36  |- skos__hiddenLabel mesh__D015918 Infusion Pump, Implantable
% 210.18/210.36  |- skos__prefLabel mesh__D015918 Infusion Pumps, Implantable
% 210.18/210.36  |- skos__altLabel mesh__D015918 Perfusion Pumps, Implantable
% 210.18/210.36  |- skos__hiddenLabel mesh__D015918 Implantable Perfusion Pumps
% 210.18/210.36  |- skos__hiddenLabel mesh__D015918 Implantable Peristaltic Pumps
% 210.18/210.36  |- skos__historyNote mesh__D015918 Infusions, Parenteral %28%1975-1986%29%
% 210.18/210.36  |- skos__related mesh__D015918smesh__D004343
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015918 2005A
% 210.18/210.36  |- skos__hiddenLabel mesh__D015918 Pump, Implantable Perfusion
% 210.18/210.36  |- skos__historyNote mesh__D015918 Drug Implants %28%1977-1989%29%
% 210.18/210.36  |- mesh__recordOriginator mesh__D015918 PLS
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015918 2002
% 210.18/210.36  |- skos__hiddenLabel mesh__D015918 Pumps, Implantable Peristaltic
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D015918 2003
% 210.18/210.36  |- skos__hiddenLabel mesh__D015918 Pump, Implantable Infusion
% 210.18/210.36  |- skos__altLabel mesh__D015918 Implantable Infusion Pumps
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D031585 2006
% 210.18/210.36  |- skos__prefLabel mesh__D031585 Melia
% 210.18/210.36  |- mesh__publicMeSHNote mesh__D031585 2003   
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D031585 2004
% 210.18/210.36  |- skos__scopeNote mesh__D031585
% 210.18/210.36       A plant genus of the family MELIACEAE. Members contain meliavolkinin, melianin C and limonoids.%A%    
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D031585 2005
% 210.18/210.36  |- mesh__dateCreated mesh__D031585 2002-07-03
% 210.18/210.36  |- skos__annotation mesh__D031585
% 210.18/210.36       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.18/210.36  |- skos__broader mesh__D031585smesh__D029582
% 210.18/210.36  |- mesh__historyNote mesh__D031585 2003   
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D031585 2003
% 210.18/210.36  |- rdf__type mesh__D031585sskos__Concept
% 210.18/210.36  |- mesh__dateEstablished mesh__D031585 2003-01-01
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D003894 2006A
% 210.18/210.36  |- skos__altLabel mesh__D003894 Apo-Desmopressin
% 210.18/210.36  |- skos__altLabel mesh__D003894 1-Deamino-8-D-arginine Vasopressin
% 210.18/210.36  |- skos__hiddenLabel mesh__D003894 Vasopressin, 1-Deamino-8-D-arginine
% 210.18/210.36  |- mesh__dateEstablished mesh__D003894 1986-01-01
% 210.18/210.36  |- mesh__onlineNote mesh__D003894
% 210.18/210.36       use DESMOPRESSIN to search DEAMINO ARGININE VASOPRESSIN 1975-78%A%  
% 210.18/210.36  |- skos__hiddenLabel mesh__D003894 Arginine Vasopressin, Deamino
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D003894 2006
% 210.18/210.36  |- skos__altLabel mesh__D003894 Vasopressin, Deamino Arginine
% 210.18/210.36  |- mesh__dateCreated mesh__D003894 1974-11-19
% 210.18/210.36  |- skos__historyNote mesh__D003894 Arginine %28%1966-1974%29%
% 210.18/210.36  |- skos__altLabel mesh__D003894 1-Desamino-8-arginine Vasopressin
% 210.18/210.36  |- skos__prefLabel mesh__D003894 Deamino Arginine Vasopressin
% 210.18/210.36  |- skos__historyNote mesh__D003894 Vasopressins %28%1966-1974%29%
% 210.18/210.36  |- skos__altLabel mesh__D003894 Desmotabs
% 210.18/210.36  |- skos__altLabel mesh__D003894 Octostim
% 210.18/210.36  |- skos__altLabel mesh__D003894 Desmospray
% 210.18/210.36  |- skos__altLabel mesh__D003894 Octim
% 210.18/210.36  |- skos__scopeNote mesh__D003894
% 210.18/210.36       A synthetic analog of the pituitary hormone, ARGIPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR.%A%    
% 210.18/210.36  |- skos__hiddenLabel mesh__D003894 Monoacetate, Desmopressin
% 210.18/210.36  |- mesh__recordAuthorizer mesh__D003894 ags
% 210.18/210.36  |- skos__broader mesh__D003894smesh__D001127
% 210.18/210.36  |- skos__hiddenLabel mesh__D003894 Ferring, Desmopressine
% 210.18/210.36  |- skos__altLabel mesh__D003894 Desmogalen
% 210.18/210.36  |- skos__altLabel mesh__D003894 Stimate
% 210.18/210.36  |- skos__altLabel mesh__D003894 Nocutil
% 210.18/210.36  |- mesh__recordMaintainer mesh__D003894 ags
% 210.18/210.36  |- skos__hiddenLabel mesh__D003894 Monoacetate, Trihydrate Desmopressin
% 210.18/210.36  |- skos__hiddenLabel mesh__D003894 ApoDesmopressin
% 210.18/210.36  |- mesh__historyNote mesh__D003894
% 210.18/210.36       86%28%79%29%; was see under ARGIPRESSIN 1979-85; was DEAMINO ARGININE VASOPRESSIN see under VASOPRESSIN 1975-78%A%  
% 210.18/210.36  |- mesh__recordOriginator mesh__D003894 NLM
% 210.18/210.36  |- skos__altLabel mesh__D003894 Desmopressine Ferring
% 210.18/210.36  |- rdf__type mesh__D003894sskos__Concept
% 210.18/210.36  |- skos__hiddenLabel mesh__D003894 Vasopressin, 1-Desamino-8-arginine
% 210.18/210.36  |- skos__altLabel mesh__D003894 Desmopressin Monoacetate, Trihydrate
% 210.18/210.36  |- skos__altLabel mesh__D003894 Minurin
% 210.18/210.36  |- mesh__publicMeSHNote mesh__D003894
% 210.18/210.36       86; was see under ARGIPRESSIN 1979-85; was DEAMINO ARGININE VASOPRESSIN see under VASOPRESSIN 1975-78%A%  
% 210.18/210.36  |- skos__hiddenLabel mesh__D003894 Trihydrate Desmopressin Monoacetate
% 210.18/210.36  |- mesh__dateRevised mesh__D003894 2005-08-03
% 210.18/210.36  |- skos__hiddenLabel mesh__D003894 Acetate, Desmopressin
% 210.18/210.36  |- skos__annotation mesh__D003096
% 210.18/210.36       a method of surg ther of tuberc; do not use /util except by MeSH definition%A%  
% 210.18/210.36  |- mesh__recordOriginator mesh__D003096 NLM
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D003096 1999
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D003096 2006
% 210.18/210.36  |- skos__prefLabel mesh__D003096 Collapse Therapy
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D003096 2002
% 210.18/210.36  |- skos__hiddenLabel mesh__D003096 Therapies, Collapse
% 210.18/210.36  |- skos__broader mesh__D003096smesh__D013510
% 210.18/210.36  |- mesh__dateCreated mesh__D003096 1999-01-01
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D003096 1998
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D003096 2005
% 210.18/210.36  |- rdf__type mesh__D003096sskos__Concept
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D003096 2001
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D003096 2004
% 210.18/210.36  |- skos__hiddenLabel mesh__D003096 Collapse Therapies
% 210.18/210.36  |- mesh__activeMeSHYear mesh__D003096 2000
% 210.18/210.36  |- mesh__dateRevised mesh__D003096 1997-06-20
% 210.18/210.37  |- skos__scopeNote mesh__D003096
% 210.18/210.37       Surgical treatment of pulmonary tuberculosis whereby the lung is totally or partially, temporarily or permanently, immobilized. The procedure was based on the popular concept that collapsing the affected portion of a tuberculous lung allowed the infected area to rest and thereby recover. At the beginning of the 20th century artificially induced pneumothorax %28%PNEUMOTHORAX, ARTIFICIAL%29% was popular. Later a variety of other techniques was used to encourage collapse of the infected portion of the lung: unilateral phrenic nerve division, PNEUMONOLYSIS, pneumoperitoneum %28%PNEUMOPERITONEUM, ARTIFICIAL%29%, and THORACOPLASTY. Collapse therapy has declined since the advent of antitubercular chemotherapy. %28%Stedman, 25th ed; from Sabiston Jr, Textbook of Surgery, 14th ed, p1733-4%29%%A%    
% 210.18/210.37  |- mesh__recordMaintainer mesh__D003096 PXP
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D003096 2003
% 210.18/210.37  |- mesh__recordAuthorizer mesh__D003096 SJN
% 210.18/210.37  |- skos__altLabel mesh__D003096 Therapy, Collapse
% 210.18/210.37  |- skos__broader mesh__D044702smesh__D012143
% 210.18/210.37  |- skos__hiddenLabel mesh__D044702 Phenomenon, Respiratory Physiologic
% 210.18/210.37  |- mesh__publicMeSHNote mesh__D044702 2004   
% 210.18/210.37  |- skos__hiddenLabel mesh__D044702 Phenomena, Respiratory Physiological
% 210.18/210.37  |- skos__hiddenLabel mesh__D044702 Physiological Phenomena, Respiratory
% 210.18/210.37  |- skos__altLabel mesh__D044702 Respiratory Physiological Phenomenon
% 210.18/210.37  |- mesh__historyNote mesh__D044702 2004   
% 210.18/210.37  |- skos__hiddenLabel mesh__D044702 Physiological Phenomenon, Respiratory
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D044702 2004
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D044702 2005
% 210.18/210.37  |- skos__annotation mesh__D044702 not used for indexing or cataloging   
% 210.18/210.37  |- skos__prefLabel mesh__D044702 Respiratory Physiologic Phenomena
% 210.18/210.37  |- skos__hiddenLabel mesh__D044702 Physiologic Phenomenon, Respiratory
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D044702 2006
% 210.18/210.37  |- rdf__type mesh__D044702sskos__Concept
% 210.18/210.37  |- skos__altLabel mesh__D044702 Respiratory Physiologic Phenomenon
% 210.18/210.37  |- mesh__dateEstablished mesh__D044702 2004-01-01
% 210.18/210.37  |- skos__hiddenLabel mesh__D044702 Phenomena, Respiratory Physiologic
% 210.18/210.37  |- skos__altLabel mesh__D044702 Respiratory Physiological Phenomena
% 210.18/210.37  |- mesh__dateCreated mesh__D044702 2003-07-09
% 210.18/210.37  |- skos__scopeNote mesh__D044702
% 210.18/210.37       Observable or measurable characteristics of the RESPIRATORY SYSTEM.%A%    
% 210.18/210.37  |- skos__hiddenLabel mesh__D044702 Physiologic Phenomena, Respiratory
% 210.18/210.37  |- skos__hiddenLabel mesh__D044702 Phenomenon, Respiratory Physiological
% 210.18/210.37  |- skos__annotation mesh__D011528
% 210.18/210.37       GEN; prefer specifics; /drug ther: consider also ANTIPROTOZOAL AGENTS%A%  
% 210.18/210.37  |- skos__hiddenLabel mesh__D011528 Histomoniases
% 210.18/210.37  |- skos__hiddenLabel mesh__D011528 Protozoan Infection
% 210.18/210.37  |- skos__hiddenLabel mesh__D011528 Infection, Protozoan
% 210.18/210.37  |- mesh__recordMaintainer mesh__D011528 TGC
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D011528 2005
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D011528 2003
% 210.18/210.37  |- skos__altLabel mesh__D011528 Infections, Protozoan
% 210.18/210.37  |- skos__scopeNote mesh__D011528
% 210.18/210.37       Infections with unicellular organisms of the subkingdom PROTOZOA.%A%    
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D011528 2006
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D011528 2000
% 210.18/210.37  |- mesh__dateCreated mesh__D011528 1999-01-01
% 210.18/210.37  |- mesh__recordOriginator mesh__D011528 NLM
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D011528 2004
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D011528 1998
% 210.18/210.37  |- rdf__type mesh__D011528sskos__Concept
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D011528 1999
% 210.18/210.37  |- mesh__dateRevised mesh__D011528 1997-06-20
% 210.18/210.37  |- skos__prefLabel mesh__D011528 Protozoan Infections
% 210.18/210.37  |- mesh__onlineNote mesh__D011528
% 210.18/210.37       use PROTOZOAN INFECTIONS to search HISTOMONIASIS 1968-85   
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D011528 2001
% 210.18/210.37  |- mesh__publicMeSHNote mesh__D011528 HISTOMONIASIS was heading 1968-85   
% 210.18/210.37  |- mesh__recordAuthorizer mesh__D011528 SJN
% 210.18/210.37  |- skos__related mesh__D011528smesh__D000981
% 210.18/210.37  |- mesh__historyNote mesh__D011528 HISTOMONIASIS was heading 1968-85   
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D011528 2002
% 210.18/210.37  |- skos__broader mesh__D011528smesh__D010272
% 210.18/210.37  |- skos__annotation mesh__D016213
% 210.18/210.37       regulatory proteins; growth substances; do not confuse with the nuclear protein cyclin %28%PCNA or Proliferating Cell Nuclear Antigen%29%; note specifics%A%  
% 210.18/210.37  |- skos__scopeNote mesh__D016213
% 210.18/210.37       Regulatory proteins that function in the cell cycle to activate maturation promoting factor. They complex with p34cdc2 %28%PROTEIN P34CDC2%29%, the catalytic subunit of MATURATION-PROMOTING FACTOR, and modulate its protein kinase activity. Cyclins themselves have no enzymatic activity.%A%    
% 210.18/210.37  |- skos__broader mesh__D016213smesh__D006133
% 210.18/210.37  |- rdf__type mesh__D016213sskos__Concept
% 210.18/210.37  |- skos__historyNote mesh__D016213 Invertebrate Hormones %28%1987-1990%29%
% 210.18/210.37  |- mesh__recordAuthorizer mesh__D016213 sjn
% 210.18/210.37  |- mesh__dateEstablished mesh__D016213 1991-01-01
% 210.18/210.37  |- skos__broader mesh__D016213smesh__D018797
% 210.18/210.37  |- skos__altLabel mesh__D016213 Cyclin
% 210.18/210.37  |- mesh__recordOriginator mesh__D016213 AGS
% 210.18/210.37  |- mesh__recordMaintainer mesh__D016213 ssb
% 210.18/210.37  |- mesh__onlineNote mesh__D016213 use CYCLINS to search CYCLIN 1991-2   
% 210.18/210.37  |- mesh__publicMeSHNote mesh__D016213 93; was CYCLIN 1991-2   
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D016213 2006
% 210.18/210.37  |- mesh__historyNote mesh__D016213 93; was CYCLIN 1991-2   
% 210.18/210.37  |- skos__prefLabel mesh__D016213 Cyclins
% 210.18/210.37  |- skos__related mesh__D016213smesh__D016200
% 210.18/210.37  |- mesh__dateRevised mesh__D016213 2005-06-30
% 210.18/210.37  |- mesh__dateCreated mesh__D016213 1990-06-17
% 210.18/210.37  |- skos__hiddenLabel mesh__D007487 Sodium, Ipodate
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D007487 2005
% 210.18/210.37  |- skos__hiddenLabel mesh__D007487 SoluBiloptin
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D007487 2002
% 210.18/210.37  |- skos__hiddenLabel mesh__D007487 Ipodate, Sodium
% 210.18/210.37  |- skos__altLabel mesh__D007487 Iopodate
% 210.18/210.37  |- skos__broader mesh__D007487smesh__D007462
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D007487 2004
% 210.18/210.37  |- rdf__type mesh__D007487sskos__Concept
% 210.18/210.37  |- skos__altLabel mesh__D007487 Sodium Iopodate
% 210.18/210.37  |- mesh__recordMaintainer mesh__D007487 ssb
% 210.18/210.37  |- skos__hiddenLabel mesh__D007487 Iopodate, Calcium
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D007487 2003
% 210.18/210.37  |- skos__hiddenLabel mesh__D007487 Iopodate, Sodium
% 210.18/210.37  |- skos__prefLabel mesh__D007487 Ipodate
% 210.18/210.37  |- mesh__recordOriginator mesh__D007487 NLM
% 210.18/210.37  |- mesh__recordAuthorizer mesh__D007487 sjn
% 210.18/210.37  |- skos__annotation mesh__D007487 D25-26 qualif   
% 210.18/210.37  |- skos__altLabel mesh__D007487 Calcium Iopodate
% 210.18/210.37  |- mesh__dateRevised mesh__D007487 2001-07-25
% 210.18/210.37  |- skos__scopeNote mesh__D007487
% 210.18/210.37       Ionic monomeric contrast media. Usually the sodium or calcium salts are used for examination of the gall bladder and biliary tract. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p704%29%%A%    
% 210.18/210.37  |- skos__hiddenLabel mesh__D007487 Solu Biloptin
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D007487 2006
% 210.18/210.37  |- skos__altLabel mesh__D007487 Sodium Ipodate
% 210.18/210.37  |- skos__hiddenLabel mesh__D007487 Ipodate, Calcium
% 210.18/210.37  |- mesh__dateCreated mesh__D007487 1999-01-01
% 210.18/210.37  |- skos__prefLabel mesh__D015919 Ventilators, Negative-Pressure
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D015919 2003
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D015919 2002
% 210.18/210.37  |- skos__broader mesh__D015919smesh__D012122
% 210.18/210.37  |- skos__hiddenLabel mesh__D015919 Negative-Pressure Respirators
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D015919 2006
% 210.18/210.37  |- skos__hiddenLabel mesh__D015919 Respirators, Negative Pressure
% 210.18/210.37  |- mesh__dateEstablished mesh__D015919 1990-01-01
% 210.18/210.37  |- skos__altLabel mesh__D015919 Pulmonary Ventilators, Negative-Pressure
% 210.18/210.37  |- skos__hiddenLabel mesh__D015919 Negative Pressure Pulmonary Ventilator
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D015919 1994
% 210.18/210.37  |- skos__hiddenLabel mesh__D015919 Ventilators, Negative Pressure
% 210.18/210.37  |- mesh__publicMeSHNote mesh__D015919 90   
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D015919 2001
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D015919 2005
% 210.18/210.37  |- skos__hiddenLabel mesh__D015919 Pulmonary Ventilator, Negative Pressure
% 210.18/210.37  |- skos__hiddenLabel mesh__D015919 Pulmonary Ventilators, Negative Pressure
% 210.18/210.37  |- skos__altLabel mesh__D015919 Negative-Pressure Pulmonary Ventilators
% 210.18/210.37  |- skos__altLabel mesh__D015919 Respirators, Negative-Pressure
% 210.18/210.37  |- skos__hiddenLabel mesh__D015919 Negative-Pressure Respirator
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D015919 1997
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D015919 2000
% 210.18/210.37  |- skos__hiddenLabel mesh__D015919 Respirator, Negative-Pressure
% 210.18/210.37  |- mesh__recordOriginator mesh__D015919 PLS
% 210.18/210.37  |- skos__altLabel mesh__D015919 Respirators, Pulmonary, Negative-Pressure
% 210.18/210.37  |- skos__hiddenLabel mesh__D015919 Negative-Pressure Ventilator
% 210.18/210.37  |- skos__scopeNote mesh__D015919
% 210.18/210.37       Body ventilators that assist ventilation by applying intermittent subatmospheric pressure around the thorax, abdomen, or airway and periodically expand the chest wall and inflate the lungs. They are relatively simple to operate and do not require tracheostomy. These devices include the tank ventilators %28%%22%iron lung%22%%29%, Portalung, Pneumowrap, and chest cuirass %28%%22%tortoise shell%22%%29%.%A%    
% 210.18/210.37  |- skos__hiddenLabel mesh__D015919 Ventilator, Tank
% 210.18/210.37  |- skos__altLabel mesh__D015919 Negative-Pressure Pulmonary Ventilator
% 210.18/210.37  |- skos__historyNote mesh__D015919
% 210.18/210.37       Respiration, Artificial %28%1966-1989%29%
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D015919 1993
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D015919 1996
% 210.18/210.37  |- skos__hiddenLabel mesh__D015919 Tank Ventilator
% 210.18/210.37  |- skos__historyNote mesh__D015919
% 210.18/210.37       Ventilators, Mechanical %28%1966-1989%29%
% 210.18/210.37  |- skos__hiddenLabel mesh__D015919 Negative Pressure Ventilators
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D015919 1999
% 210.18/210.37  |- skos__altLabel mesh__D015919 Ventilator, Negative-Pressure Pulmonary
% 210.18/210.37  |- skos__hiddenLabel mesh__D015919 Negative Pressure Pulmonary Ventilators
% 210.18/210.37  |- skos__altLabel mesh__D015919 Ventilators, Pulmonary, Negative-Pressure
% 210.18/210.37  |- mesh__recordMaintainer mesh__D015919 PLS
% 210.18/210.37  |- mesh__historyNote mesh__D015919 90   
% 210.18/210.37  |- skos__hiddenLabel mesh__D015919 Ventilators, Negative-Pressure Pulmonary
% 210.18/210.37  |- skos__hiddenLabel mesh__D015919 Ventilator, Negative Pressure Pulmonary
% 210.18/210.37  |- skos__hiddenLabel mesh__D015919 Ventilator, Negative-Pressure
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D015919 2004
% 210.18/210.37  |- skos__altLabel mesh__D015919 Negative-Pressure Ventilators
% 210.18/210.37  |- skos__altLabel mesh__D015919 Pulmonary Ventilator, Negative-Pressure
% 210.18/210.37  |- skos__hiddenLabel mesh__D015919 Ventilators, Tank
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D015919 1995
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D015919 1998
% 210.18/210.37  |- mesh__dateCreated mesh__D015919 1989-05-16
% 210.18/210.37  |- rdf__type mesh__D015919sskos__Concept
% 210.18/210.37  |- mesh__recordAuthorizer mesh__D015919 PLS
% 210.18/210.37  |- mesh__dateRevised mesh__D015919 1992-05-18
% 210.18/210.37  |- skos__hiddenLabel mesh__D012621 Seasonal Variations
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012621 1995
% 210.18/210.37  |- mesh__recordMaintainer mesh__D012621 TGC
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012621 1992
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012621 1999
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012621 2002
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012621 2005
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012621 1996
% 210.18/210.37  |- skos__hiddenLabel mesh__D012621 Variation, Seasonal
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012621 1993
% 210.18/210.37  |- skos__broader mesh__D012621smesh__D004777
% 210.18/210.37  |- skos__hiddenLabel mesh__D012621 Season
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012621 2006
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012621 1997
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012621 2000
% 210.18/210.37  |- mesh__dateCreated mesh__D012621 1999-01-01
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012621 2003
% 210.18/210.37  |- skos__broader mesh__D012621smesh__D010507
% 210.18/210.37  |- mesh__recordAuthorizer mesh__D012621 PLS
% 210.18/210.37  |- rdf__type mesh__D012621sskos__Concept
% 210.18/210.37  |- mesh__recordOriginator mesh__D012621 NLM
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012621 2001
% 210.18/210.37  |- mesh__dateRevised mesh__D012621 1991-01-09
% 210.18/210.37  |- skos__prefLabel mesh__D012621 Seasons
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012621 1994
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012621 2004
% 210.18/210.37  |- skos__hiddenLabel mesh__D012621 Variations, Seasonal
% 210.18/210.37  |- skos__annotation mesh__D012621 no qualif   
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012621 1998
% 210.18/210.37  |- mesh__publicMeSHNote mesh__D031586 2003   
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D031586 2004
% 210.18/210.37  |- skos__altLabel mesh__D031586 Chinaberry Tree
% 210.18/210.37  |- mesh__dateEstablished mesh__D031586 2003-01-01
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D031586 2005
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D031586 2003
% 210.18/210.37  |- rdf__type mesh__D031586sskos__Concept
% 210.18/210.37  |- skos__scopeNote mesh__D031586
% 210.18/210.37       A plant species of the genus MELIA, family MELIACEAE, which is toxic to insects. The name is very similar to Melia azadirachta %28%AZADIRACHTA%29%.%A%    
% 210.18/210.37  |- mesh__recordOriginator mesh__D031586 ssb
% 210.18/210.37  |- mesh__recordAuthorizer mesh__D031586 ags
% 210.18/210.37  |- skos__prefLabel mesh__D031586 Melia azedarach
% 210.18/210.37  |- mesh__dateCreated mesh__D031586 2002-07-03
% 210.18/210.37  |- mesh__recordMaintainer mesh__D031586 ags
% 210.18/210.37  |- mesh__historyNote mesh__D031586 2003   
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D031586 2006A
% 210.18/210.37  |- skos__annotation mesh__D031586
% 210.18/210.37       MELIA AZEDARACH see AZADIRACHTA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.18/210.37  |- skos__broader mesh__D031586smesh__D031585
% 210.18/210.37  |- mesh__dateRevised mesh__D031586 2005-07-18
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D031586 2006
% 210.18/210.37  |- skos__scopeNote mesh__D003895
% 210.18/210.37       4-%28%4-Amino-4-carboxybutyl%29%-1-%28%5-amino-5-carboxypentyl%29%-3,5-bis%28%3-amino-3-carboxypropyl%29%pyridinium. A rare amino acid found in elastin, formed by condensation of four molecules of lysine into a pyridinium ring.%A%    
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D003895 1995
% 210.18/210.37  |- rdf__type mesh__D003895sskos__Concept
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D003895 2004
% 210.18/210.37  |- skos__historyNote mesh__D003895 Pyridinium Compounds %28%1970-1974%29%
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D003895 1998
% 210.18/210.37  |- skos__broader mesh__D003895smesh__D011726
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D003895 1994
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D003895 2003
% 210.18/210.37  |- skos__prefLabel mesh__D003895 Desmosine
% 210.18/210.37  |- skos__historyNote mesh__D003895 Amino Acids %28%1972-1974%29%
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D003895 2001
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D003895 2006
% 210.18/210.37  |- mesh__dateCreated mesh__D003895 1974-11-19
% 210.18/210.37  |- skos__broader mesh__D003895smesh__D000598
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D003895 1997
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D003895 2000
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D003895 2005
% 210.18/210.37  |- mesh__recordOriginator mesh__D003895 NLM
% 210.18/210.37  |- mesh__recordAuthorizer mesh__D003895 PLS
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D003895 1993
% 210.18/210.37  |- mesh__dateRevised mesh__D003895 1992-05-13
% 210.18/210.37  |- mesh__recordMaintainer mesh__D003895 TAP
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D003895 1996
% 210.18/210.37  |- mesh__dateEstablished mesh__D003895 1991-01-01
% 210.18/210.37  |- mesh__publicMeSHNote mesh__D003895
% 210.18/210.37       91; was see under AMINO ACIDS 1975-90   
% 210.18/210.37  |- mesh__historyNote mesh__D003895
% 210.18/210.37       91%28%75%29%; was see under AMINO ACIDS 1975-90   
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D003895 1999
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D003895 2002
% 210.18/210.37  |- mesh__dateEstablished mesh__D044703 2004-01-01
% 210.18/210.37  |- skos__hiddenLabel mesh__D044703 Respiratory Physiological Processes
% 210.18/210.37  |- skos__hiddenLabel mesh__D044703 Process, Respiratory Physiological
% 210.18/210.37  |- skos__hiddenLabel mesh__D044703 Physiologic Processes, Respiratory
% 210.18/210.37  |- skos__hiddenLabel mesh__D044703 Processes, Respiratory Physiological
% 210.18/210.37  |- skos__prefLabel mesh__D044703 Respiratory Physiologic Processes
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D044703 2004
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D044703 2005
% 210.18/210.37  |- skos__hiddenLabel mesh__D044703 Processes, Respiratory Physiologic
% 210.18/210.37  |- skos__scopeNote mesh__D044703
% 210.18/210.37       Biological actions and events that support the functions of the RESPIRATORY SYSTEM.%A%    
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D044703 2006
% 210.18/210.37  |- rdf__type mesh__D044703sskos__Concept
% 210.18/210.37  |- mesh__historyNote mesh__D044703 2004   
% 210.18/210.37  |- mesh__dateCreated mesh__D044703 2003-07-09
% 210.18/210.37  |- skos__annotation mesh__D044703 not used for indexing or cataloging   
% 210.18/210.37  |- skos__hiddenLabel mesh__D044703 Physiological Processes, Respiratory
% 210.18/210.37  |- skos__broader mesh__D044703smesh__D012143
% 210.18/210.37  |- skos__hiddenLabel mesh__D044703 Physiological Process, Respiratory
% 210.18/210.37  |- skos__altLabel mesh__D044703 Respiratory Physiological Process
% 210.18/210.37  |- mesh__publicMeSHNote mesh__D044703 2004   
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D003097 2006
% 210.18/210.37  |- mesh__historyNote mesh__D003097 66%28%64%29%   
% 210.18/210.37  |- skos__annotation mesh__D003097
% 210.18/210.37       a naturally occurring physiol phenomenon: not for restoration of funct by surg; not restricted to coronary vessels; do not confuse with NEOVASCULARIZATION, PHYSIOLOGIC: see MeSH scope notes; DF: COLLATERAL CIRC%A%  
% 210.18/210.37  |- skos__hiddenLabel mesh__D003097 Collateral Circulations, Blood
% 210.18/210.37  |- skos__hiddenLabel mesh__D003097 Collateral Blood Circulations
% 210.18/210.37  |- skos__altLabel mesh__D003097 Collateral Blood Circulation
% 210.18/210.37  |- mesh__dateRevised mesh__D003097 2003-07-09
% 210.18/210.37  |- mesh__dateCreated mesh__D003097 1999-01-01
% 210.18/210.37  |- rdf__type mesh__D003097sskos__Concept
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D003097 2005
% 210.18/210.37  |- skos__hiddenLabel mesh__D003097 Blood Collateral Circulation
% 210.18/210.37  |- skos__hiddenLabel mesh__D003097 Collateral Circulations
% 210.18/210.37  |- skos__scopeNote mesh__D003097
% 210.18/210.37       Maintenance of blood flow to an organ despite obstruction of a principal vessel. Blood flow is maintained through small vessels.%A%    
% 210.18/210.37  |- mesh__recordAuthorizer mesh__D003097 sjn
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D003097 2004
% 210.18/210.37  |- mesh__recordMaintainer mesh__D003097 nns
% 210.18/210.37  |- mesh__recordOriginator mesh__D003097 NLM
% 210.18/210.37  |- skos__hiddenLabel mesh__D003097 Circulation, Blood Collateral
% 210.18/210.37  |- mesh__dateEstablished mesh__D003097 1966-01-01
% 210.18/210.37  |- mesh__publicMeSHNote mesh__D003097 66   
% 210.18/210.37  |- skos__broader mesh__D003097smesh__D001775
% 210.18/210.37  |- skos__altLabel mesh__D003097 Collateral Circulation, Blood
% 210.18/210.37  |- skos__prefLabel mesh__D003097 Collateral Circulation
% 210.18/210.37  |- skos__altLabel mesh__D003097 Circulation, Collateral
% 210.18/210.37  |- skos__related mesh__D003097smesh__D018919
% 210.18/210.37  |- skos__hiddenLabel mesh__D003097 Circulation, Collateral Blood
% 210.18/210.37  |- skos__altLabel mesh__D003097 Blood Circulation, Collateral
% 210.18/210.37  |- skos__prefLabel mesh__D011529 Protozoan Infections, Animal
% 210.18/210.37  |- mesh__dateCreated mesh__D011529 1999-01-01
% 210.18/210.37  |- mesh__recordMaintainer mesh__D011529 ags
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D011529 2004
% 210.18/210.37  |- skos__broader mesh__D011529smesh__D011528
% 210.18/210.37  |- mesh__dateEstablished mesh__D011529 1998-01-01
% 210.18/210.37  |- skos__hiddenLabel mesh__D011529 Animal Protozoan Infections
% 210.18/210.37  |- skos__hiddenLabel mesh__D011529 Animal Protozoan Infection
% 210.18/210.37  |- skos__annotation mesh__D011529
% 210.18/210.37       exper or vet; GEN or unspecified; prefer specific indentions or specific protozoan infect /vet; don%27%t forget to check tag ANIMALS; DF: PROTOZOAN INFECT ANIMAL%A%  
% 210.18/210.37  |- rdf__type mesh__D011529sskos__Concept
% 210.18/210.37  |- skos__broader mesh__D011529smesh__D010273
% 210.18/210.37  |- skos__historyNote mesh__D011529
% 210.18/210.37       Protozoan Infections/veterinary %28%1966-1997%29%
% 210.18/210.37  |- mesh__recordAuthorizer mesh__D011529 sjn
% 210.18/210.37  |- mesh__dateRevised mesh__D011529 2003-07-30
% 210.18/210.37  |- skos__scopeNote mesh__D011529
% 210.18/210.37       Infections with unicellular organisms of the subkingdom PROTOZOA. The infections may be experimental or veterinary.%A%    
% 210.18/210.37  |- skos__hiddenLabel mesh__D011529 Protozoan Infection, Animal
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D011529 2005
% 210.18/210.37  |- skos__hiddenLabel mesh__D011529 Infections, Animal Protozoan
% 210.18/210.37  |- mesh__recordOriginator mesh__D011529 NLM
% 210.18/210.37  |- mesh__historyNote mesh__D011529 98; use explode 1971-97   
% 210.18/210.37  |- mesh__publicMeSHNote mesh__D011529 98   
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D011529 2006
% 210.18/210.37  |- skos__hiddenLabel mesh__D011529 Infection, Animal Protozoan
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D008580 2002
% 210.18/210.37  |- skos__hiddenLabel mesh__D008580 Syndrome, Dupre
% 210.18/210.37  |- mesh__recordAuthorizer mesh__D008580 sjn
% 210.18/210.37  |- skos__hiddenLabel mesh__D008580 Meningisms
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D008580 2004
% 210.18/210.37  |- skos__hiddenLabel mesh__D008580 Meningitis-Like Reactions
% 210.18/210.37  |- skos__altLabel mesh__D008580 Meningismus
% 210.18/210.37  |- skos__hiddenLabel mesh__D008580 Reaction, Meningitis-Like
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D008580 2003
% 210.18/210.37  |- mesh__recordMaintainer mesh__D008580 KEV
% 210.18/210.37  |- skos__altLabel mesh__D008580 Pseudomeningitis
% 210.18/210.37  |- skos__hiddenLabel mesh__D008580 Reactions, Meningitis-Like
% 210.18/210.37  |- mesh__dateRevised mesh__D008580 1999-11-04
% 210.18/210.37  |- skos__altLabel mesh__D008580 Dupre Syndrome
% 210.18/210.37  |- mesh__recordOriginator mesh__D008580 NLM
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D008580 2001
% 210.18/210.37  |- skos__hiddenLabel mesh__D008580 Meningitis Like Reaction
% 210.18/210.37  |- skos__altLabel mesh__D008580 Meningitis-Like Reaction
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D008580 2006
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D008580 2000
% 210.18/210.37  |- skos__altLabel mesh__D008580 Dupre%27%s Syndrome
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D008580 2005
% 210.18/210.37  |- skos__scopeNote mesh__D008580
% 210.18/210.37       A condition characterized by neck stiffness, headache, and other symptoms suggestive of meningeal irritation, but without actual inflammation of the meninges %28%MENINGITIS%29%. Spinal fluid pressure may be elevated but spinal fluid is normal. %28%DeJong, The Neurologic Examination, 4th ed, p673%29%%A%    
% 210.18/210.37  |- skos__hiddenLabel mesh__D008580 Dupres Syndrome
% 210.18/210.37  |- mesh__dateCreated mesh__D008580 1999-01-01
% 210.18/210.37  |- skos__hiddenLabel mesh__D008580 Syndrome, Dupre%27%s
% 210.18/210.37  |- skos__broader mesh__D008580smesh__D009461
% 210.18/210.37  |- rdf__type mesh__D008580sskos__Concept
% 210.18/210.37  |- skos__prefLabel mesh__D008580 Meningism
% 210.18/210.37  |- skos__hiddenLabel mesh__D008580 Pseudomeningitides
% 210.18/210.37  |- skos__broader mesh__D019426Q000037smesh__D019426
% 210.18/210.37  |- mesh__preferredCombination mesh__D019426Q000037smesh__D019429
% 210.18/210.37  |- rdf__type mesh__D019426Q000037smesh__CompoundConcept
% 210.18/210.37  |- mesh__dateRevised mesh__D007488 2004-07-07
% 210.18/210.37  |- skos__broader mesh__D007488smesh__D007211
% 210.18/210.37  |- skos__historyNote mesh__D007488 Antidepressive Agents %28%1966-1971%29%
% 210.18/210.37  |- skos__historyNote mesh__D007488 Indoles %28%1966-1971%29%
% 210.18/210.37  |- mesh__dateEstablished mesh__D007488 1991-01-01
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D007488 2006
% 210.18/210.37  |- skos__scopeNote mesh__D007488
% 210.18/210.37       A tricyclic antidepressant that has actions and uses similar to those of AMITRIPTYLINE, but has only weak antimuscarinic and sedative effects. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p257%29%%A%    
% 210.18/210.37  |- mesh__dateCreated mesh__D007488 1999-01-01
% 210.18/210.37  |- skos__prefLabel mesh__D007488 Iprindole
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D007488 2005
% 210.18/210.37  |- mesh__recordMaintainer mesh__D007488 ssb
% 210.18/210.37  |- mesh__historyNote mesh__D007488
% 210.18/210.37       91%28%72%29%; was see under INDOLES 1972-90   
% 210.18/210.37  |- mesh__publicMeSHNote mesh__D007488 91; was see under INDOLES 1972-90   
% 210.18/210.37  |- mesh__recordOriginator mesh__D007488 NLM
% 210.18/210.37  |- mesh__recordAuthorizer mesh__D007488 sjn
% 210.18/210.37  |- rdf__type mesh__D007488sskos__Concept
% 210.18/210.37  |- skos__broader mesh__D007488smesh__D034242
% 210.18/210.37  |- mesh__recordAuthorizer mesh__D004190 sjn
% 210.18/210.37  |- mesh__recordOriginator mesh__D004190 NLM
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D004190 2006
% 210.18/210.37  |- skos__broader mesh__D004190smesh__D004777
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D004190 2005
% 210.18/210.37  |- skos__hiddenLabel mesh__D004190 Disaster
% 210.18/210.37  |- mesh__dateCreated mesh__D004190 1999-01-01
% 210.18/210.37  |- skos__prefLabel mesh__D004190 Disasters
% 210.18/210.37  |- skos__related mesh__D004190smesh__D012066
% 210.18/210.37  |- mesh__dateRevised mesh__D004190 2004-07-07
% 210.18/210.37  |- skos__related mesh__D004190smesh__D047852
% 210.18/210.37  |- rdf__type mesh__D004190sskos__Concept
% 210.18/210.37  |- mesh__recordMaintainer mesh__D004190 jls
% 210.18/210.37  |- mesh__dateEstablished mesh__D012622 1970-01-01
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012622 2006
% 210.18/210.37  |- mesh__recordOriginator mesh__D012622 NLM
% 210.18/210.37  |- skos__scopeNote mesh__D012622
% 210.18/210.37       Restraining belts fastened to the frame of automobiles, aircraft, or other vehicles, and strapped around the person occupying the seat in the car or plane, intended to prevent the person from being thrown forward or out of the vehicle in case of sudden deceleration.%A%    
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012622 2001
% 210.18/210.37  |- mesh__dateCreated mesh__D012622 1999-01-01
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012622 2003
% 210.18/210.37  |- rdf__type mesh__D012622sskos__Concept
% 210.18/210.37  |- mesh__historyNote mesh__D012622 70   
% 210.18/210.37  |- skos__hiddenLabel mesh__D012622 Belt, Seat
% 210.18/210.37  |- mesh__publicMeSHNote mesh__D012622 70   
% 210.18/210.37  |- mesh__recordAuthorizer mesh__D012622 SJN
% 210.18/210.37  |- skos__historyNote mesh__D012622 Accidents, Traffic %28%1966-1969%29%
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012622 2004
% 210.18/210.37  |- skos__hiddenLabel mesh__D012622 Seat Belt
% 210.18/210.37  |- skos__historyNote mesh__D012622 Accident Prevention %28%1966-1969%29%
% 210.18/210.37  |- skos__broader mesh__D012622smesh__D011482
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012622 1998
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012622 2002
% 210.18/210.37  |- skos__historyNote mesh__D012622 Automobiles %28%1966-1969%29%
% 210.18/210.37  |- skos__hiddenLabel mesh__D012622 Belts, Seat
% 210.18/210.37  |- mesh__dateRevised mesh__D012622 1997-06-20
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012622 1999
% 210.18/210.37  |- skos__prefLabel mesh__D012622 Seat Belts
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012622 2005
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D012622 2000
% 210.18/210.37  |- skos__related mesh__D012622smesh__D017278
% 210.18/210.37  |- mesh__recordMaintainer mesh__D012622 PXP
% 210.18/210.37  |- mesh__historyNote mesh__D031587 2003   
% 210.18/210.37  |- skos__prefLabel mesh__D031587 Cedrela
% 210.18/210.37  |- mesh__dateEstablished mesh__D031587 2003-01-01
% 210.18/210.37  |- skos__scopeNote mesh__D031587
% 210.18/210.37       A plant genus of the family MELIACEAE. Members contain cedrelanolide.%A%    
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D031587 2006
% 210.18/210.37  |- mesh__publicMeSHNote mesh__D031587 2003   
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D031587 2004
% 210.18/210.37  |- skos__annotation mesh__D031587
% 210.18/210.37       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D031587 2005
% 210.18/210.37  |- skos__broader mesh__D031587smesh__D029582
% 210.18/210.37  |- mesh__activeMeSHYear mesh__D031587 2003
% 210.18/210.37  |- rdf__type mesh__D031587sskos__Concept
% 210.18/210.37  |- mesh__dateCreated mesh__D031587 2002-07-03
% 210.18/210.37  |- skos__hiddenLabel mesh__D050741 Common Porpoises
% 210.18/210.37  |- mesh__dateCreated mesh__D050741 2005-06-30
% 210.18/210.37  |- skos__historyNote mesh__D050741 Porpoises %28%1998-2005%29%
% 210.18/210.37  |- skos__hiddenLabel mesh__D050741 Porpoise, Common
% 210.18/210.37  |- skos__hiddenLabel mesh__D050741 Porpoises, Harbour
% 210.18/210.37  |- skos__altLabel mesh__D050741 Harbour Porpoise
% 210.18/210.38  |- skos__hiddenLabel mesh__D050741 Porpoise, Harbor
% 210.18/210.38  |- mesh__recordMaintainer mesh__D050741 ags
% 210.18/210.38  |- mesh__publicMeSHNote mesh__D050741 2006; see PORPOISES 1998-2005   
% 210.18/210.38  |- skos__scopeNote mesh__D050741
% 210.18/210.38       A genus of PORPOISES, in the family Phocoenidae, comprised of several species. They frequent coastal waters, bays, estuaries, and the mouths of large rivers.%A%    
% 210.18/210.38  |- skos__hiddenLabel mesh__D050741 Harbour Porpoises
% 210.18/210.38  |- skos__altLabel mesh__D050741 Common Porpoise
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D050741 2006
% 210.18/210.38  |- rdf__type mesh__D050741sskos__Concept
% 210.18/210.38  |- skos__hiddenLabel mesh__D050741 Porpoise, Harbour
% 210.18/210.38  |- skos__altLabel mesh__D050741 Harbor Porpoise
% 210.18/210.38  |- skos__broader mesh__D050741smesh__D019576
% 210.18/210.38  |- skos__prefLabel mesh__D050741 Phocoena
% 210.18/210.38  |- mesh__recordAuthorizer mesh__D050741 sjn
% 210.18/210.38  |- skos__hiddenLabel mesh__D050741 Porpoises, Harbor
% 210.18/210.38  |- mesh__dateEstablished mesh__D050741 2006-01-01
% 210.18/210.38  |- skos__hiddenLabel mesh__D050741 Porpoises, Common
% 210.18/210.38  |- skos__historyNote mesh__D050741 Dolphins %28%1968-1997%29%
% 210.18/210.38  |- skos__hiddenLabel mesh__D050741 Harbor Porpoises
% 210.18/210.38  |- mesh__historyNote mesh__D050741 2006; use PORPOISES 1998-2005   
% 210.18/210.38  |- mesh__recordOriginator mesh__D050741 ags
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003896 2006
% 210.18/210.38  |- mesh__recordOriginator mesh__D003896 NLM
% 210.18/210.38  |- skos__historyNote mesh__D003896 Cell Membrane %28%1966-1971%29%
% 210.18/210.38  |- skos__hiddenLabel mesh__D003896 Desmosome
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003896 2005
% 210.18/210.38  |- mesh__publicMeSHNote mesh__D003896 72   
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003896 2002
% 210.18/210.38  |- mesh__historyNote mesh__D003896 72   
% 210.18/210.38  |- skos__annotation mesh__D003896
% 210.18/210.38       A 11 qualif except /cytol; /genet permitted   
% 210.18/210.38  |- mesh__dateRevised mesh__D003896 2000-06-22
% 210.18/210.38  |- mesh__recordMaintainer mesh__D003896 TGC
% 210.18/210.38  |- mesh__recordAuthorizer mesh__D003896 sjn
% 210.18/210.38  |- rdf__type mesh__D003896sskos__Concept
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003896 2004
% 210.18/210.38  |- skos__prefLabel mesh__D003896 Desmosomes
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003896 2001
% 210.18/210.38  |- mesh__dateEstablished mesh__D003896 1972-01-01
% 210.18/210.38  |- skos__scopeNote mesh__D003896
% 210.18/210.38       A type of junction that attaches one cell to its neighbor. One of a number of differentiated regions which occur, for example, where the cytoplasmic membranes of adjacent epithelial cells are closely apposed. It consists of a circular region of each membrane together with associated intracellular microfilaments and an intercellular material which may include, for example, mucopolysaccharides. %28%From Glick, Glossary of Biochemistry and Molecular Biology, 1990; Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed%29%%A%    
% 210.18/210.38  |- skos__broader mesh__D003896smesh__D007365
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003896 2003
% 210.18/210.38  |- mesh__dateCreated mesh__D003896 1999-01-01
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003098 2001
% 210.18/210.38  |- skos__prefLabel mesh__D003098 Collective Bargaining
% 210.18/210.38  |- skos__hiddenLabel mesh__D003098 Bargaining, Collective
% 210.18/210.38  |- mesh__dateRevised mesh__D003098 1993-09-16
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003098 1996
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003098 2003
% 210.18/210.38  |- mesh__dateEstablished mesh__D003098 1971-01-01
% 210.18/210.38  |- mesh__historyNote mesh__D003098 71   
% 210.18/210.38  |- skos__broader mesh__D003098smesh__D007750
% 210.18/210.38  |- mesh__recordAuthorizer mesh__D003098 NLM
% 210.18/210.38  |- rdf__type mesh__D003098sskos__Concept
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003098 1997
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003098 2004
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003098 2002
% 210.18/210.38  |- skos__historyNote mesh__D003098 Labor Unions %28%1966-1970%29%
% 210.18/210.38  |- mesh__recordMaintainer mesh__D003098 PLS
% 210.18/210.38  |- mesh__publicMeSHNote mesh__D003098 71   
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003098 1995
% 210.18/210.38  |- skos__scopeNote mesh__D003098
% 210.18/210.38       The process of negotiation between representatives of an employee organization, association or union, and representatives of the employer.%A%    
% 210.18/210.38  |- skos__hiddenLabel mesh__D003098 Collective Bargainings
% 210.18/210.38  |- skos__hiddenLabel mesh__D003098 Bargainings, Collective
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003098 1998
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003098 2005
% 210.18/210.38  |- skos__broader mesh__D003098smesh__D010559
% 210.18/210.38  |- mesh__recordOriginator mesh__D003098 NLM
% 210.18/210.38  |- mesh__dateCreated mesh__D003098 1999-01-01
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003098 2000
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003098 1999
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003098 2006
% 210.18/210.38  |- skos__scopeNote mesh__D044704
% 210.18/210.38       An isoform of DNA that occurs in an environment rich in SODIUM and POTASSIUM ions. It is a right-handed helix with 11 base pairs per turn, a pitch of 0.256 nm per base pair and a helical diameter of 2.3 nm.%A%    
% 210.18/210.38  |- skos__altLabel mesh__D044704 A-DNA
% 210.18/210.38  |- skos__prefLabel mesh__D044704 DNA, A-Form
% 210.18/210.38  |- skos__related mesh__D044704smesh__D043542
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D044704 2006
% 210.18/210.38  |- rdf__type mesh__D044704sskos__Concept
% 210.18/210.38  |- skos__historyNote mesh__D044704 DNA %28%1985-2003%29%
% 210.18/210.38  |- mesh__dateEstablished mesh__D044704 2004-01-01
% 210.18/210.38  |- skos__related mesh__D044704smesh__D009690
% 210.18/210.38  |- mesh__dateCreated mesh__D044704 2003-07-09
% 210.18/210.38  |- skos__hiddenLabel mesh__D044704 DNA, A Form
% 210.18/210.38  |- skos__broader mesh__D044704smesh__D004247
% 210.18/210.38  |- skos__related mesh__D044704smesh__D044705
% 210.18/210.38  |- mesh__publicMeSHNote mesh__D044704 2004; see DNA 1986-2003   
% 210.18/210.38  |- skos__hiddenLabel mesh__D044704 A-Form DNA
% 210.18/210.38  |- mesh__historyNote mesh__D044704 2004; use DNA 1986-2003   
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D044704 2004
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D044704 2005
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D008581 2006
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D008581 2005
% 210.18/210.38  |- mesh__dateRevised mesh__D008581 1999-11-03
% 210.18/210.38  |- mesh__dateCreated mesh__D008581 1999-01-01
% 210.18/210.38  |- rdf__type mesh__D008581sskos__Concept
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D008581 2002
% 210.18/210.38  |- mesh__recordAuthorizer mesh__D008581 sjn
% 210.18/210.38  |- skos__annotation mesh__D008581
% 210.18/210.38       GEN: prefer specifics; for pachymeningitis %28%DURA MATER%29% or leptomeningitis %28%ARACHNOIDITIS or PIA MATER%29% do not specify meninx unless particularly discussed; purulent, suppurative or pyogenic: do not coord with SUPPURATION %28%NIM%29% unless particularly discussed%A%  
% 210.18/210.38  |- skos__broader mesh__D008581smesh__D002494
% 210.18/210.38  |- skos__broader mesh__D008581smesh__D002493
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D008581 2004
% 210.18/210.38  |- mesh__recordOriginator mesh__D008581 NLM
% 210.18/210.38  |- skos__scopeNote mesh__D008581
% 210.18/210.38       Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections %28%viral, bacterial, and fungal%29% are the most common causes of this condition, but subarachnoid hemorrhage %28%HEMORRHAGES, SUBARACHNOID%29%, chemical irritation %28%chemical MENINGITIS%29%, granulomatous conditions, neoplastic conditions %28%e.g., carcinomatous meningitis%29%, and other inflammatory conditions may produce this syndrome. %28%From Joynt, Clinical Neurology, 1994, Ch24, p6%29%%A%    
% 210.18/210.38  |- mesh__recordMaintainer mesh__D008581 KEV
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D008581 2001
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D008581 2003
% 210.18/210.38  |- skos__related mesh__D008581smesh__D013353
% 210.18/210.38  |- skos__hiddenLabel mesh__D008581 Pachymeningitides
% 210.18/210.38  |- skos__hiddenLabel mesh__D008581 Meningitides
% 210.18/210.38  |- skos__prefLabel mesh__D008581 Meningitis
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D008581 2000
% 210.18/210.38  |- skos__hiddenLabel mesh__D016215 Macrophage Activating Factors
% 210.18/210.38  |- skos__prefLabel mesh__D016215 Macrophage-Activating Factors
% 210.18/210.38  |- mesh__dateRevised mesh__D016215 2005-06-30
% 210.18/210.38  |- skos__scopeNote mesh__D016215
% 210.18/210.38       Factors secreted by stimulated lymphocytes that prime macrophages to become nonspecifically cytotoxic to tumors. They also modulate the expression of macrophage cell surface Ia antigens. One MAF is interferon-gamma %28%INTERFERON TYPE II%29%. Other factors antigenically distinct from IFN-gamma have also been identified.%A%    
% 210.18/210.38  |- skos__annotation mesh__D016215
% 210.18/210.38       a lymphokine; /biosyn /drug eff /physiol /ultrastruct permitted; DF: MAF%A%  
% 210.18/210.38  |- skos__hiddenLabel mesh__D016215 Factors, Macrophage-Activating
% 210.18/210.38  |- mesh__recordOriginator mesh__D016215 AGS
% 210.18/210.38  |- mesh__historyNote mesh__D016215 91   
% 210.18/210.38  |- mesh__dateEstablished mesh__D016215 1991-01-01
% 210.18/210.38  |- skos__historyNote mesh__D016215 Lymphokines %28%1976-1990%29%
% 210.18/210.38  |- mesh__dateCreated mesh__D016215 1990-04-24
% 210.18/210.38  |- mesh__publicMeSHNote mesh__D016215 91   
% 210.18/210.38  |- mesh__recordMaintainer mesh__D016215 ssb
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D016215 2006
% 210.18/210.38  |- mesh__recordAuthorizer mesh__D016215 sjn
% 210.18/210.38  |- skos__broader mesh__D016215smesh__D008222
% 210.18/210.38  |- rdf__type mesh__D016215sskos__Concept
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004191 1998
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004191 2006
% 210.18/210.38  |- mesh__dateCreated mesh__D004191 1999-01-01
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004191 1999
% 210.18/210.38  |- mesh__runningHead mesh__D004191
% 210.18/210.38       F4 - BEHAVIORAL DISCIPLINES AND ACTIVITIES   
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004191 2000
% 210.18/210.38  |- mesh__publicMeSHNote mesh__D004191 98   
% 210.18/210.38  |- mesh__recordOriginator mesh__D004191 NLM
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004191 2003
% 210.18/210.38  |- mesh__recordAuthorizer mesh__D004191 SJN
% 210.18/210.38  |- mesh__dateRevised mesh__D004191 1997-06-26
% 210.18/210.38  |- mesh__recordMaintainer mesh__D004191 TGC
% 210.18/210.38  |- skos__scopeNote mesh__D004191
% 210.18/210.38       The specialties in psychiatry and psychology, their diagnostic techniques and tests, their therapeutic methods, and psychiatric and psychological services.%A%    
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004191 2001
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004191 2004
% 210.18/210.38  |- skos__annotation mesh__D004191
% 210.18/210.38       not used for indexing      CATALOG: do not use   
% 210.18/210.38  |- skos__prefLabel mesh__D004191 Behavioral Disciplines and Activities
% 210.18/210.38  |- rdf__type mesh__D004191sskos__Concept
% 210.18/210.38  |- mesh__historyNote mesh__D004191 98; use explode   
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004191 2002
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004191 2005
% 210.18/210.38  |- mesh__dateEstablished mesh__D004191 1998-01-01
% 210.18/210.38  |- skos__related mesh__D012623smesh__D013790
% 210.18/210.38  |- mesh__dateRevised mesh__D012623 2004-07-07
% 210.18/210.38  |- rdf__type mesh__D012623sskos__Concept
% 210.18/210.38  |- mesh__historyNote mesh__D012623 74%28%69%29%   
% 210.18/210.38  |- skos__prefLabel mesh__D012623 Seawater
% 210.18/210.38  |- skos__broader mesh__D012623smesh__D014867
% 210.18/210.38  |- mesh__recordOriginator mesh__D012623 NLM
% 210.18/210.38  |- skos__hiddenLabel mesh__D012623 Water, Sea
% 210.18/210.38  |- skos__altLabel mesh__D012623 Sea Water
% 210.18/210.38  |- skos__historyNote mesh__D012623 Water %28%1966-1968%29%
% 210.18/210.38  |- skos__scopeNote mesh__D012623
% 210.18/210.38       The SALINE water of OCEANS AND SEAS that provides habitat for marine organisms.%A%    
% 210.18/210.38  |- skos__related mesh__D012623smesh__D019015
% 210.18/210.38  |- skos__hiddenLabel mesh__D012623 Sea Waters
% 210.18/210.38  |- mesh__recordMaintainer mesh__D012623 ssb
% 210.18/210.38  |- skos__hiddenLabel mesh__D012623 Seawaters
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D012623 2005
% 210.18/210.38  |- mesh__recordAuthorizer mesh__D012623 sjn
% 210.18/210.38  |- skos__hiddenLabel mesh__D012623 Waters, Sea
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D012623 2006
% 210.18/210.38  |- mesh__dateEstablished mesh__D012623 1974-01-01
% 210.18/210.38  |- mesh__publicMeSHNote mesh__D012623 74   
% 210.18/210.38  |- mesh__dateCreated mesh__D012623 1999-01-01
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003897 2005
% 210.18/210.38  |- skos__historyNote mesh__D003897 Sterols %28%1966-1971%29%
% 210.18/210.38  |- mesh__dateEstablished mesh__D003897 1974-01-01
% 210.18/210.38  |- mesh__historyNote mesh__D003897
% 210.18/210.38       74%28%72%29%; DEHYDROCHOLESTEROL was see under VITAMIN D 3 1963-66%A%  
% 210.18/210.38  |- mesh__recordOriginator mesh__D003897 NLM
% 210.18/210.38  |- skos__altLabel mesh__D003897 Demosterol
% 210.18/210.38  |- rdf__type mesh__D003897sskos__Concept
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003897 2004
% 210.18/210.38  |- skos__broader mesh__D003897smesh__D002775
% 210.18/210.38  |- mesh__onlineNote mesh__D003897
% 210.18/210.38       search DEHYDROCHOLESTEROL under CHOLECALCIFEROLS 1966   
% 210.18/210.38  |- skos__altLabel mesh__D003897 24-Dehydrocholesterol
% 210.18/210.38  |- skos__broader mesh__D003897smesh__D003684
% 210.18/210.38  |- skos__prefLabel mesh__D003897 Desmosterol
% 210.18/210.38  |- mesh__dateCreated mesh__D003897 1999-01-01
% 210.18/210.38  |- mesh__dateRevised mesh__D003897 2003-07-09
% 210.18/210.38  |- skos__hiddenLabel mesh__D003897 24 Dehydrocholesterol
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003897 2006
% 210.18/210.38  |- mesh__recordAuthorizer mesh__D003897 sjn
% 210.18/210.38  |- skos__scopeNote mesh__D003897
% 210.18/210.38       An intermediate in the synthesis of cholesterol.     
% 210.18/210.38  |- mesh__recordMaintainer mesh__D003897 ssb
% 210.18/210.38  |- mesh__publicMeSHNote mesh__D003897
% 210.18/210.38       74; DEHYDROCHOLESTEROL was see under VITAMIN D3 1963-66   
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003099 2003
% 210.18/210.38  |- mesh__recordOriginator mesh__D003099 NLM
% 210.18/210.38  |- skos__scopeNote mesh__D003099
% 210.18/210.38       Test designed to identify students suitable for admission into a graduate or undergraduate curriculum.%A%    
% 210.18/210.38  |- skos__hiddenLabel mesh__D003099 College Admission Tests
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003099 2000
% 210.18/210.38  |- mesh__dateEstablished mesh__D003099 1991-01-01
% 210.18/210.38  |- rdf__type mesh__D003099sskos__Concept
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003099 2004
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003099 1997
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003099 1994
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003099 2001
% 210.18/210.38  |- skos__prefLabel mesh__D003099 College Admission Test
% 210.18/210.38  |- mesh__recordAuthorizer mesh__D003099 PLS
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003099 1995
% 210.18/210.38  |- skos__hiddenLabel mesh__D003099 Test, College Admission
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003099 1998
% 210.18/210.38  |- mesh__dateRevised mesh__D003099 1992-05-07
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003099 2005
% 210.18/210.38  |- mesh__publicMeSHNote mesh__D003099
% 210.18/210.38       91; was see under EDUCATIONAL MEASUREMENT 1975-90   
% 210.18/210.38  |- skos__hiddenLabel mesh__D003099 Admission Tests, College
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003099 2002
% 210.18/210.38  |- mesh__dateCreated mesh__D003099 1999-01-01
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003099 2006
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003099 1999
% 210.18/210.38  |- mesh__historyNote mesh__D003099
% 210.18/210.38       91%28%75%29%; was see under EDUCATIONAL MEASUREMENT 1975-90   
% 210.18/210.38  |- skos__broader mesh__D003099smesh__D004521
% 210.18/210.38  |- mesh__onlineNote mesh__D003099 search EDUCATIONAL MEASUREMENT 1966-74   
% 210.18/210.38  |- mesh__recordMaintainer mesh__D003099 TGC
% 210.18/210.38  |- skos__hiddenLabel mesh__D003099 Tests, College Admission
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003099 1993
% 210.18/210.38  |- skos__hiddenLabel mesh__D003099 Admission Test, College
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003099 1996
% 210.18/210.38  |- rdf__type mesh__D044705sskos__Concept
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D044705 2006A
% 210.18/210.38  |- mesh__dateCreated mesh__D044705 2003-07-09
% 210.18/210.38  |- skos__broader mesh__D044705smesh__D004247
% 210.18/210.38  |- mesh__historyNote mesh__D044705 2004   
% 210.18/210.38  |- mesh__recordAuthorizer mesh__D044705 ags
% 210.18/210.38  |- skos__hiddenLabel mesh__D044705 C-Form DNA
% 210.18/210.38  |- mesh__dateEstablished mesh__D044705 2004-01-01
% 210.18/210.38  |- skos__related mesh__D044705smesh__D043542
% 210.18/210.38  |- skos__hiddenLabel mesh__D044705 DNA, C Form
% 210.18/210.38  |- mesh__recordOriginator mesh__D044705 jmp
% 210.18/210.38  |- mesh__publicMeSHNote mesh__D044705 2004   
% 210.18/210.38  |- skos__related mesh__D044705smesh__D009690
% 210.18/210.38  |- mesh__recordMaintainer mesh__D044705 ags
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D044705 2005
% 210.18/210.38  |- skos__historyNote mesh__D044705 DNA %28%1986-2003%29%
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D044705 2004
% 210.18/210.38  |- mesh__dateRevised mesh__D044705 2005-07-13
% 210.18/210.38  |- skos__scopeNote mesh__D044705
% 210.18/210.38       An isoform of DNA that occurs under experimental conditions. It is a right-handed helix that is less compact than the B-form of DNA.%A%    
% 210.18/210.38  |- skos__related mesh__D044705smesh__D044704
% 210.18/210.38  |- skos__related mesh__D044705smesh__D018076
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D044705 2006
% 210.18/210.38  |- skos__prefLabel mesh__D044705 DNA, C-Form
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D008582 2001
% 210.18/210.38  |- skos__altLabel mesh__D008582 Aseptic Meningitis
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D008582 2005
% 210.18/210.38  |- skos__annotation mesh__D008582
% 210.18/210.38       coord IM with specific cause %28%IM%29% if pertinent   
% 210.18/210.38  |- mesh__recordMaintainer mesh__D008582 ags
% 210.18/210.38  |- mesh__publicMeSHNote mesh__D008582 1991; see MENINGITIS 1977-1990   
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D008582 2000
% 210.18/210.38  |- rdf__type mesh__D008582sskos__Concept
% 210.18/210.38  |- skos__broader mesh__D008582smesh__D008587
% 210.18/210.38  |- mesh__historyNote mesh__D008582 1991%28%1977%29%   
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D008582 2000B
% 210.18/210.38  |- skos__scopeNote mesh__D008582
% 210.18/210.38       A syndrome characterized by headache, neck stiffness, low grade fever, and CSF lymphocytic pleocytosis in the absence of an acute bacterial pathogen. Viral meningitis is the most frequent cause although MYCOPLASMA INFECTIONS; RICKETTSIA INFECTIONS; diagnostic or therapeutic procedures; NEOPLASTIC PROCESSES; septic perimeningeal foci; and other conditions may result in this syndrome. %28%From Adams et al., Principles of Neurology, 6th ed, p745%29%%A%    
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D008582 2004
% 210.18/210.38  |- skos__broader mesh__D008582smesh__D008581
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D008582 2000A
% 210.18/210.38  |- mesh__dateRevised mesh__D008582 1999-12-06
% 210.18/210.38  |- mesh__dateEstablished mesh__D008582 1991-01-01
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D008582 2002
% 210.18/210.38  |- mesh__recordAuthorizer mesh__D008582 ags
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D008582 2003
% 210.18/210.38  |- mesh__recordOriginator mesh__D008582 MM
% 210.18/210.38  |- skos__prefLabel mesh__D008582 Meningitis, Aseptic
% 210.18/210.38  |- skos__historyNote mesh__D008582 Meningitis %28%1966-1976%29%
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D008582 2006
% 210.18/210.38  |- mesh__dateCreated mesh__D008582 1976-04-27
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D016216 2000
% 210.18/210.38  |- skos__altLabel mesh__D016216 Diagnosis, Prenatal Ultrasonic
% 210.18/210.38  |- skos__altLabel mesh__D016216 Diagnosis, Ultrasonic Prenatal
% 210.18/210.38  |- skos__historyNote mesh__D016216
% 210.18/210.38       Ultrasonics/diagnostic use %28%1968-1984%29%
% 210.18/210.38  |- mesh__recordMaintainer mesh__D016216 PXP
% 210.18/210.38  |- mesh__publicMeSHNote mesh__D016216 91   
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D016216 2006
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D016216 2001
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D016216 2003
% 210.18/210.38  |- skos__altLabel mesh__D016216 Ultrasonic Diagnosis, Prenatal
% 210.18/210.38  |- skos__hiddenLabel mesh__D016216 Ultrasonic Prenatal Diagnoses
% 210.18/210.38  |- skos__hiddenLabel mesh__D016216 Prenatal Ultrasonic Diagnoses
% 210.18/210.38  |- skos__historyNote mesh__D016216 Ultrasonography %28%1985-1990%29%
% 210.18/210.38  |- skos__altLabel mesh__D016216 Ultrasonic Prenatal Diagnosis
% 210.18/210.38  |- mesh__dateEstablished mesh__D016216 1991-01-01
% 210.18/210.38  |- skos__hiddenLabel mesh__D016216 Ultrasonic Diagnoses, Prenatal
% 210.18/210.38  |- skos__historyNote mesh__D016216 Prenatal Diagnosis %28%1973-1990%29%
% 210.18/210.38  |- skos__prefLabel mesh__D016216 Ultrasonography, Prenatal
% 210.18/210.38  |- skos__broader mesh__D016216smesh__D014463
% 210.18/210.38  |- mesh__historyNote mesh__D016216 91   
% 210.18/210.38  |- skos__hiddenLabel mesh__D016216 Diagnoses, Prenatal Ultrasonic
% 210.18/210.38  |- skos__altLabel mesh__D016216 Prenatal Diagnosis, Ultrasonic
% 210.18/210.38  |- skos__altLabel mesh__D016216 Prenatal Ultrasonic Diagnosis
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D016216 2002
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D016216 2004
% 210.18/210.38  |- skos__altLabel mesh__D016216 Prenatal Ultrasonography
% 210.18/210.38  |- mesh__recordAuthorizer mesh__D016216 SJN
% 210.18/210.38  |- skos__annotation mesh__D016216
% 210.18/210.38       coord IM with specific fetal anat, physiol or other clin feature %28%IM%29%; if on mother, coord IM with specific maternal aspect %28%IM%29%; check tags FEMALE %26% PREGNANCY; DF: ULTRASONOGR PRENATAL%A%  
% 210.18/210.38  |- skos__hiddenLabel mesh__D016216 Diagnoses, Ultrasonic Prenatal
% 210.18/210.38  |- mesh__recordOriginator mesh__D016216 TGC
% 210.18/210.38  |- rdf__type mesh__D016216sskos__Concept
% 210.18/210.38  |- skos__hiddenLabel mesh__D016216 Prenatal Diagnoses, Ultrasonic
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D016216 1998
% 210.18/210.38  |- skos__broader mesh__D016216smesh__D011296
% 210.18/210.38  |- skos__scopeNote mesh__D016216
% 210.18/210.38       The visualization of tissues during pregnancy through recording of the echoes of ultrasonic waves directed into the body. The procedure may be applied with reference to the mother or the fetus and with reference to organs or the detection of maternal or fetal disease.%A%    
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D016216 1999
% 210.18/210.38  |- skos__altLabel mesh__D016216 Ultrasonography, Fetal
% 210.18/210.38  |- mesh__dateRevised mesh__D016216 1997-06-20
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D016216 2005
% 210.18/210.38  |- mesh__dateCreated mesh__D016216 1990-05-07
% 210.18/210.38  |- rdf__type mesh__D032681sskos__Concept
% 210.18/210.38  |- mesh__publicMeSHNote mesh__D032681 2003   
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D032681 2005
% 210.18/210.38  |- skos__historyNote mesh__D032681 Karyotyping %28%1996-2002%29%
% 210.18/210.38  |- mesh__dateCreated mesh__D032681 2002-07-03
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D032681 2006
% 210.18/210.38  |- mesh__historyNote mesh__D032681 2003   
% 210.18/210.38  |- skos__hiddenLabel mesh__D032681 Spectral Karyotypings
% 210.18/210.38  |- skos__scopeNote mesh__D032681
% 210.18/210.38       The simultaneous identification of all chromosomes from a cell by fluorescence in situ hybridization %28%IN SITU HYBRIDIZATION, FLUORESCENCE%29% with chromosome-specific florescent probes that are discerned by their different emission spectra.%A%    
% 210.18/210.38  |- skos__broader mesh__D032681smesh__D020223
% 210.18/210.38  |- skos__altLabel mesh__D032681 Karyotyping, Spectral
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D032681 2003
% 210.18/210.38  |- mesh__dateEstablished mesh__D032681 2003-01-01
% 210.18/210.38  |- skos__hiddenLabel mesh__D032681 Karyotypings, Spectral
% 210.18/210.38  |- skos__broader mesh__D032681smesh__D007621
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D032681 2004
% 210.18/210.38  |- skos__prefLabel mesh__D032681 Spectral Karyotyping
% 210.18/210.38  |- skos__altLabel mesh__D004990 Dental Ethics
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004990 2001
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004990 2005
% 210.18/210.38  |- skos__annotation mesh__D004990
% 210.18/210.38       specify geog if pertinent; DF: ETHICS DENT   
% 210.18/210.38  |- skos__hiddenLabel mesh__D004990 Dental Ethic
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004990 2000
% 210.18/210.38  |- skos__hiddenLabel mesh__D004990 Ethic, Dental
% 210.18/210.38  |- skos__broader mesh__D004990smesh__D010685
% 210.18/210.38  |- skos__prefLabel mesh__D004990 Ethics, Dental
% 210.18/210.38  |- rdf__type mesh__D004990sskos__Concept
% 210.18/210.38  |- mesh__recordAuthorizer mesh__D004990 sjn
% 210.18/210.38  |- mesh__recordOriginator mesh__D004990 NLM
% 210.18/210.38  |- skos__broader mesh__D004990smesh__D004995
% 210.18/210.38  |- mesh__recordMaintainer mesh__D004990 adp
% 210.18/210.38  |- skos__scopeNote mesh__D004990
% 210.18/210.38       The principles of proper professional conduct concerning the rights and duties of the dentist, relations with patients and fellow practitioners, as well as actions of the dentist in patient care and interpersonal relations with patient families.  %28%From Stedman, 25th ed%29%%A%    
% 210.18/210.38  |- mesh__dateRevised mesh__D004990 1999-11-08
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004990 2004
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004990 2002
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004990 2006
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004990 2003
% 210.18/210.38  |- mesh__dateCreated mesh__D004990 1999-01-01
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004192 2002
% 210.18/210.38  |- skos__hiddenLabel mesh__D004192 Discriminations %28%Psychology%29%
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004192 1999
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004192 2003
% 210.18/210.38  |- mesh__dateEstablished mesh__D004192 1966-01-01
% 210.18/210.38  |- skos__broader mesh__D004192smesh__D010465
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004192 2004
% 210.18/210.38  |- rdf__type mesh__D004192sskos__Concept
% 210.18/210.38  |- mesh__dateRevised mesh__D004192 1998-06-10
% 210.18/210.38  |- mesh__onlineNote mesh__D004192
% 210.18/210.38       use DISCRIMINATION %28%PSYCHOLOGY%29% to search DISCRIMINATION 1966-77%A%  
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004192 2000
% 210.18/210.38  |- mesh__recordOriginator mesh__D004192 NLM
% 210.18/210.38  |- skos__prefLabel mesh__D004192 Discrimination %28%Psychology%29%
% 210.18/210.38  |- skos__annotation mesh__D004192
% 210.18/210.38       not for racial, religious, sex or social discrimination %28% = PREJUDICE%29%; DF: DISCRIMINATION%A%  
% 210.18/210.38  |- skos__altLabel mesh__D004192 Discrimination
% 210.18/210.38  |- mesh__recordAuthorizer mesh__D004192 SJN
% 210.18/210.38  |- mesh__publicMeSHNote mesh__D004192 78; was DISCRIMINATION 1966-77   
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004192 2005
% 210.18/210.38  |- skos__scopeNote mesh__D004192
% 210.18/210.38       Differential response to different stimuli.     
% 210.18/210.38  |- mesh__historyNote mesh__D004192 78; was DISCRIMINATION 1966-77   
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004192 2001
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D004192 2006
% 210.18/210.38  |- mesh__dateCreated mesh__D004192 1999-01-01
% 210.18/210.38  |- mesh__recordMaintainer mesh__D004192 JLS
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D012624 2006
% 210.18/210.38  |- mesh__recordAuthorizer mesh__D012624 sjn
% 210.18/210.38  |- skos__prefLabel mesh__D012624 Seaweed
% 210.18/210.38  |- mesh__dateRevised mesh__D012624 2005-06-30
% 210.18/210.38  |- rdf__type mesh__D012624sskos__Concept
% 210.18/210.38  |- mesh__dateCreated mesh__D012624 1999-01-01
% 210.18/210.38  |- skos__broader mesh__D012624smesh__D000456
% 210.18/210.38  |- mesh__recordOriginator mesh__D012624 NLM
% 210.18/210.38  |- mesh__recordMaintainer mesh__D012624 SYSTEM
% 210.18/210.38  |- skos__scopeNote mesh__D012624
% 210.18/210.38       Marine ALGAE widely distributed in the ocean, occurring from the tide level to considerable depths, free-floating %28%planktonic%29% or anchored to the substratum %28%benthic%29%. They lack a specialized vascular system but take up fluids, nutrients, and gases directly from the water. They contain CHLOROPHYLL and are photosynthetic, but some also contain other light-absorbing pigments. Many are of economic importance as FOOD, fertilizer, AGAR, potash, or source of IODINE.%A%    
% 210.18/210.38  |- skos__hiddenLabel mesh__D012624 Seaweeds
% 210.18/210.38  |- skos__annotation mesh__D012624 coord with specific alga if pertinent   
% 210.18/210.38  |- skos__related mesh__D012624smesh__D002351
% 210.18/210.38  |- skos__altLabel mesh__D050743 Pyruvate Ferredoxin Oxidoreductase
% 210.18/210.38  |- skos__hiddenLabel mesh__D050743 Oxidoreductase, Pyruvate
% 210.18/210.38  |- mesh__publicMeSHNote mesh__D050743
% 210.18/210.38       2006; PYRUVATE SYNTHASE was indexed under KETONE OXIDOREDUCTASES 1975-2005, under FERREDOXINS 1972-1979, under ACETYL COENZYME A 1974-1978, under PYRUVATES 1970-1982, %26% under COENZYME A %26% CARBOXY-LYASES 1970-1974%A%  
% 210.18/210.38  |- skos__hiddenLabel mesh__D050743 Synthase, Pyruvate
% 210.18/210.38  |- skos__hiddenLabel mesh__D050743 Ferredoxin Oxidoreductase, Pyruvate
% 210.18/210.38  |- mesh__historyNote mesh__D050743
% 210.18/210.38       2006%28%1980%29%; use KETONE OXIDOREDUCTASES 1975-1979, FERREDOXINS 1972-1979, ACETYL COENZYME A 1974-1978, PYRUVATES 1970-1979, %26% COENZYME A %26% CARBOXY-LYASES 1970-1974%A%  
% 210.18/210.38  |- mesh__dateEstablished mesh__D050743 2006-01-01
% 210.18/210.38  |- skos__altLabel mesh__D050743 Pyruvate-Ferredoxin Oxidoreductase
% 210.18/210.38  |- mesh__recordAuthorizer mesh__D050743 sjn
% 210.18/210.38  |- skos__scopeNote mesh__D050743
% 210.18/210.38       A ferredoxin-containing enzyme that catalyzes the COENZYME A-dependent oxidative decarboxylation of PYRUVATE to acetyl-COENZYME A and CARBON DIOXIDE.%A%    
% 210.18/210.38  |- skos__altLabel mesh__D050743 Pyruvate Oxidoreductase
% 210.18/210.38  |- mesh__recordMaintainer mesh__D050743 AKE
% 210.18/210.38  |- skos__altLabel mesh__D050743 Pyruvate Synthetase
% 210.18/210.38  |- skos__hiddenLabel mesh__D050743 Synthetase, Pyruvate
% 210.18/210.38  |- mesh__recordOriginator mesh__D050743 AKE
% 210.18/210.38  |- mesh__dateCreated mesh__D050743 2005-06-30
% 210.18/210.38  |- skos__hiddenLabel mesh__D050743 Oxidoreductase, Pyruvate-Ferredoxin
% 210.18/210.38  |- skos__hiddenLabel mesh__D050743 Oxidoreductase, Pyruvate Ferredoxin
% 210.18/210.38  |- skos__prefLabel mesh__D050743 Pyruvate Synthase
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D050743 2006
% 210.18/210.38  |- rdf__type mesh__D050743sskos__Concept
% 210.18/210.38  |- skos__broader mesh__D050743smesh__D007658
% 210.18/210.38  |- mesh__activeMeSHYear mesh__D003898 2006
% 210.18/210.39  |- mesh__recordOriginator mesh__D003898 NLM
% 210.18/210.39  |- skos__altLabel mesh__D003898 Bayer Brand of Desonide
% 210.18/210.39  |- skos__altLabel mesh__D003898 Owen Brand of Desonide
% 210.18/210.39  |- skos__altLabel mesh__D003898 CS Brand of Desonide
% 210.18/210.39  |- mesh__publicMeSHNote mesh__D003898
% 210.18/210.39       91; was see under PREGNADIENETRIOLS 1975-90; PREDNACINOLONE was PREDNACINOLON 1975-94; HYDROXYPREDNISOLONACETONIDE was see DESONIDE 1975-95%A%  
% 210.18/210.39  |- skos__altLabel mesh__D003898 Locatop
% 210.18/210.39  |- skos__historyNote mesh__D003898 Acetals %28%1974%29%
% 210.18/210.39  |- skos__scopeNote mesh__D003898
% 210.18/210.39       A nonfluorinated corticosteroid anti-inflammatory agent used topically for DERMATOSES.%A%    
% 210.18/210.39  |- mesh__dateEstablished mesh__D003898 1991-01-01
% 210.18/210.39  |- skos__prefLabel mesh__D003898 Desonide
% 210.18/210.39  |- skos__altLabel mesh__D003898 Alcon Brand of Desonide
% 210.18/210.39  |- rdf__type mesh__D003898sskos__Concept
% 210.18/210.39  |- mesh__recordMaintainer mesh__D003898 exl
% 210.18/210.39  |- skos__altLabel mesh__D003898 Desocort
% 210.18/210.39  |- skos__hiddenLabel mesh__D003898 Clay Park Brand of Desonide
% 210.18/210.39  |- skos__historyNote mesh__D003898 Pregnadienetriols %28%1974%29%
% 210.18/210.39  |- skos__annotation mesh__D003898 D25-26 qualif   
% 210.18/210.39  |- skos__broader mesh__D003898smesh__D011246
% 210.18/210.39  |- skos__altLabel mesh__D003898 Galderma Brand of Desonide
% 210.18/210.39  |- skos__altLabel mesh__D003898 Clay-Park Brand of Desonide
% 210.18/210.39  |- skos__altLabel mesh__D003898 Prednacinolone
% 210.18/210.39  |- mesh__recordAuthorizer mesh__D003898 sjn
% 210.18/210.39  |- mesh__dateRevised mesh__D003898 2005-06-30
% 210.18/210.39  |- mesh__dateCreated mesh__D003898 1974-11-19
% 210.18/210.39  |- skos__historyNote mesh__D003898 Ketosteroids %28%1974%29%
% 210.18/210.39  |- skos__altLabel mesh__D003898 Pierre Fabre Brand of Desonide
% 210.18/210.39  |- mesh__historyNote mesh__D003898
% 210.18/210.39       91%28%75%29%; was see under PREGNADIENETRIOLS 1975-90; PREDNACINOLONE was PREDNACINOLON 1975-94; HYDROXYPREDNISOLONACETONIDE was see DESONIDE 1975-95%A%  
% 210.18/210.39  |- skos__hiddenLabel mesh__D008583 Hemophilus Meningitis
% 210.18/210.39  |- skos__annotation mesh__D008583
% 210.18/210.39       coord IM with Haemophilus species if available   
% 210.18/210.39  |- rdf__type mesh__D008583sskos__Concept
% 210.18/210.39  |- skos__hiddenLabel mesh__D008583 Haemophilus Meningitides
% 210.18/210.39  |- skos__hiddenLabel mesh__D008583 Meningitides, Haemophilus aphrophilus
% 210.18/210.39  |- skos__hiddenLabel mesh__D008583 Hemophilus Meningitides
% 210.18/210.39  |- mesh__recordAuthorizer mesh__D008583 ags
% 210.18/210.39  |- skos__hiddenLabel mesh__D008583 Haemophilus aphrophilus Meningitides
% 210.18/210.39  |- skos__broader mesh__D008583smesh__D016920
% 210.18/210.39  |- skos__altLabel mesh__D008583 Meningitis, Hemophilus influenzae, Type B
% 210.18/210.39  |- skos__hiddenLabel mesh__D008583 Haemophilus aphrophilus Meningitis
% 210.18/210.39  |- mesh__recordOriginator mesh__D008583 NLM
% 210.18/210.39  |- skos__altLabel mesh__D008583 Meningitis, Hemophilus influenzae Type F
% 210.18/210.39  |- skos__altLabel mesh__D008583 Type B Haemophilus influenzae Meningitis
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D008583 2006A
% 210.18/210.39  |- skos__altLabel mesh__D008583 Meningitis, Hemophilus
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D008583 2004
% 210.18/210.39  |- mesh__dateRevised mesh__D008583 2005-07-29
% 210.18/210.39  |- skos__hiddenLabel mesh__D008583 Meningitides, Haemophilus parainfluenzae
% 210.18/210.39  |- skos__hiddenLabel mesh__D008583 HiB Meninigitis
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D008583 2005
% 210.18/210.39  |- mesh__dateCreated mesh__D008583 1999-01-01
% 210.18/210.39  |- skos__hiddenLabel mesh__D008583 Haemophilus Meningitis
% 210.18/210.39  |- skos__hiddenLabel mesh__D008583 Meningitides, Hemophilus
% 210.18/210.39  |- skos__hiddenLabel mesh__D008583 Haemophilus parainfluenzae Meningitis
% 210.18/210.39  |- skos__altLabel mesh__D008583 Meninigitis, HiB
% 210.18/210.39  |- skos__hiddenLabel mesh__D008583 Haemophilus parainfluenzae Meningitides
% 210.18/210.39  |- skos__hiddenLabel mesh__D008583 Meningitides, Haemophilus
% 210.18/210.39  |- skos__altLabel mesh__D008583 Hemophilus influenzae Meningitis Type B
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D008583 2006
% 210.18/210.39  |- skos__scopeNote mesh__D008583
% 210.18/210.39       BACTERIAL INFECTIONS of the nervous system caused by HAEMOPHILUS organisms, and marked by prominent inflammation of the meninges. HAEMOPHILUS INFLUENZAE TYPE B is the most common causative organism. The condition primarily affects children under 6 years of age but may occur in adults. Clinical manifestations include fever; nuchal rigidity; PHOTOPHOBIA; SEIZURES; HEARING LOSS, SENSORINEURAL; COMA; and cerebrovascular thrombosis. The organism tends to enter the central nervous system following infections of adjacent structures, including the middle ear %28%see also OTITIS MEDIA%29%, sinuses, and pharynx. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp396-7%29%%A%    
% 210.18/210.39  |- skos__altLabel mesh__D008583 Type B Hemophilus influenzae Meningitis
% 210.18/210.39  |- skos__prefLabel mesh__D008583 Meningitis, Haemophilus
% 210.18/210.39  |- skos__broader mesh__D008583smesh__D006192
% 210.18/210.39  |- mesh__recordMaintainer mesh__D008583 ags
% 210.18/210.39  |- skos__altLabel mesh__D016217 Mammography, Ultrasonic
% 210.18/210.39  |- mesh__publicMeSHNote mesh__D016217 91   
% 210.18/210.39  |- skos__broader mesh__D016217smesh__D003944
% 210.18/210.39  |- skos__historyNote mesh__D016217 Breast Neoplasms %28%1966-1990%29%
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D016217 2001
% 210.18/210.39  |- skos__altLabel mesh__D016217 Mammography, Ultrasound
% 210.18/210.39  |- skos__hiddenLabel mesh__D016217 Mammary Ultrasonographies
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D016217 2005
% 210.18/210.39  |- mesh__dateCreated mesh__D016217 1990-05-07
% 210.18/210.39  |- skos__hiddenLabel mesh__D016217 Breast Ultrasonographies
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D016217 2002
% 210.18/210.39  |- skos__historyNote mesh__D016217 Ultrasonography %28%1985-1990%29%
% 210.18/210.39  |- skos__annotation mesh__D016217
% 210.18/210.39       check tag usually FEMALE; DF: ULTRASONOGR MAMMARY   
% 210.18/210.39  |- mesh__dateEstablished mesh__D016217 1991-01-01
% 210.18/210.39  |- mesh__recordAuthorizer mesh__D016217 SJN
% 210.18/210.39  |- skos__hiddenLabel mesh__D016217 Ultrasound Mammographies
% 210.18/210.39  |- skos__hiddenLabel mesh__D016217 Mammographies, Ultrasound
% 210.18/210.39  |- skos__altLabel mesh__D016217 Ultrasonic Mammography
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D016217 2006
% 210.18/210.39  |- mesh__recordOriginator mesh__D016217 TGC
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D016217 2003
% 210.18/210.39  |- skos__broader mesh__D016217smesh__D014463
% 210.18/210.39  |- mesh__historyNote mesh__D016217 91   
% 210.18/210.39  |- skos__hiddenLabel mesh__D016217 Mammographies, Ultrasonic
% 210.18/210.39  |- skos__hiddenLabel mesh__D016217 Ultrasonographies, Mammary
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D016217 2004
% 210.18/210.39  |- skos__hiddenLabel mesh__D016217 Ultrasonographies, Breast
% 210.18/210.39  |- skos__altLabel mesh__D016217 Ultrasonography, Breast
% 210.18/210.39  |- skos__hiddenLabel mesh__D016217 Ultrasonic Mammographies
% 210.18/210.39  |- rdf__type mesh__D016217sskos__Concept
% 210.18/210.39  |- skos__altLabel mesh__D016217 Mammary Ultrasonography
% 210.18/210.39  |- skos__scopeNote mesh__D016217
% 210.18/210.39       Use of ultrasound for imaging the breast. The most frequent application is the diagnosis of neoplasms of the female breast.%A%    
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D016217 1998
% 210.18/210.39  |- mesh__dateRevised mesh__D016217 1997-06-20
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D016217 2000
% 210.18/210.39  |- skos__prefLabel mesh__D016217 Ultrasonography, Mammary
% 210.18/210.39  |- skos__historyNote mesh__D016217
% 210.18/210.39       Ultrasonics/diagnostic use %28%1968-1984%29%
% 210.18/210.39  |- mesh__recordMaintainer mesh__D016217 PXP
% 210.18/210.39  |- skos__altLabel mesh__D016217 Breast Ultrasonography
% 210.18/210.39  |- skos__altLabel mesh__D016217 Ultrasound Mammography
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D016217 1999
% 210.18/210.39  |- mesh__recordMaintainer mesh__D004991 sjn
% 210.18/210.39  |- skos__hiddenLabel mesh__D004991 Facility Ethic, Health
% 210.18/210.39  |- skos__hiddenLabel mesh__D004991 Organizational Ethic
% 210.18/210.39  |- mesh__recordOriginator mesh__D004991 EC
% 210.18/210.39  |- skos__scopeNote mesh__D004991
% 210.18/210.39       The moral and ethical obligations or responsibilities of institutions.%A%    
% 210.18/210.39  |- mesh__dateEstablished mesh__D004991 1991-01-01
% 210.18/210.39  |- mesh__dateRevised mesh__D004991 2003-07-25
% 210.18/210.39  |- skos__hiddenLabel mesh__D004991 Obligation, Institutional
% 210.18/210.39  |- skos__prefLabel mesh__D004991 Ethics, Institutional
% 210.18/210.39  |- skos__hiddenLabel mesh__D004991 Institutional Obligation
% 210.18/210.39  |- rdf__type mesh__D004991sskos__Concept
% 210.18/210.39  |- skos__hiddenLabel mesh__D004991 Institutional Ethic
% 210.18/210.39  |- mesh__dateCreated mesh__D004991 1977-04-22
% 210.18/210.39  |- skos__hiddenLabel mesh__D004991 Obligations, Institutional
% 210.18/210.39  |- skos__hiddenLabel mesh__D004991 Facility Ethics, Health
% 210.18/210.39  |- skos__annotation mesh__D004991
% 210.18/210.39       coord IM with type of institution %28%IM%29%; specify geog if pertinent%A%  
% 210.18/210.39  |- skos__altLabel mesh__D004991 Health Facility Ethics
% 210.18/210.39  |- skos__hiddenLabel mesh__D004991 Ethic, Hospital
% 210.18/210.39  |- skos__hiddenLabel mesh__D004991 Ethic, Organizational
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004991 2005
% 210.18/210.39  |- skos__hiddenLabel mesh__D004991 Ethic, Institutional
% 210.18/210.39  |- skos__related mesh__D004991smesh__D040861
% 210.18/210.39  |- skos__hiddenLabel mesh__D004991 Health Facility Ethic
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004991 2004
% 210.18/210.39  |- skos__altLabel mesh__D004991 Institutional Ethics
% 210.18/210.39  |- skos__altLabel mesh__D004991 Hospital Ethics
% 210.18/210.39  |- mesh__historyNote mesh__D004991
% 210.18/210.39       91%28%Aug 77%29%; was see under ETHICS 1977-90   
% 210.18/210.39  |- skos__broader mesh__D004991smesh__D004989
% 210.18/210.39  |- mesh__recordAuthorizer mesh__D004991 sjn
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004991 2006
% 210.18/210.39  |- mesh__publicMeSHNote mesh__D004991
% 210.18/210.39       91; was see under ETHICS Aug 1977-90   
% 210.18/210.39  |- skos__altLabel mesh__D004991 Organizational Ethics
% 210.18/210.39  |- skos__hiddenLabel mesh__D004991 Hospital Ethic
% 210.18/210.39  |- skos__hiddenLabel mesh__D004991 Ethic, Health Facility
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004193 2000
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004193 1996
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004193 2004
% 210.18/210.39  |- rdf__type mesh__D004193sskos__Concept
% 210.18/210.39  |- skos__scopeNote mesh__D004193
% 210.18/210.39       Learning that is manifested in the ability to respond differentially to various stimuli.%A%    
% 210.18/210.39  |- skos__prefLabel mesh__D004193 Discrimination Learning
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004193 2001
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004193 1997
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004193 2005
% 210.18/210.39  |- mesh__recordMaintainer mesh__D004193 TAP
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004193 1993
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004193 2002
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004193 1998
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004193 2006
% 210.18/210.39  |- mesh__dateCreated mesh__D004193 1999-01-01
% 210.18/210.39  |- skos__broader mesh__D004193smesh__D007858
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004193 1994
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004193 1999
% 210.18/210.39  |- skos__hiddenLabel mesh__D004193 Learnings, Discrimination
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004193 1995
% 210.18/210.39  |- mesh__dateRevised mesh__D004193 1992-05-14
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004193 2003
% 210.18/210.39  |- mesh__recordAuthorizer mesh__D004193 PLS
% 210.18/210.39  |- skos__hiddenLabel mesh__D004193 Learning, Discrimination
% 210.18/210.39  |- skos__hiddenLabel mesh__D004193 Discrimination Learnings
% 210.18/210.39  |- mesh__recordOriginator mesh__D004193 NLM
% 210.18/210.39  |- skos__hiddenLabel mesh__D012625 Gland Diseases, Sebaceous
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D012625 2004
% 210.18/210.39  |- skos__hiddenLabel mesh__D012625 Gland Disease, Sebaceous
% 210.18/210.39  |- mesh__dateCreated mesh__D012625 1999-01-01
% 210.18/210.39  |- rdf__type mesh__D012625sskos__Concept
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D012625 2005
% 210.18/210.39  |- skos__historyNote mesh__D012625 Sebaceous Glands %28%1966-1997%29%
% 210.18/210.39  |- mesh__historyNote mesh__D012625 98; use explode 1976-97   
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D012625 2003
% 210.18/210.39  |- mesh__recordAuthorizer mesh__D012625 sjn
% 210.18/210.39  |- skos__annotation mesh__D012625
% 210.18/210.39       GEN or unspecified; prefer specifics; DF: SEBACEOUS GLAND DIS%A%  
% 210.18/210.39  |- skos__hiddenLabel mesh__D012625 Sebaceous Gland Disease
% 210.18/210.39  |- skos__prefLabel mesh__D012625 Sebaceous Gland Diseases
% 210.18/210.39  |- skos__broader mesh__D012625smesh__D012871
% 210.18/210.39  |- skos__hiddenLabel mesh__D012625 Disease, Sebaceous Gland
% 210.18/210.39  |- mesh__dateEstablished mesh__D012625 1998-01-01
% 210.18/210.39  |- skos__hiddenLabel mesh__D012625 Diseases, Sebaceous Gland
% 210.18/210.39  |- skos__historyNote mesh__D012625
% 210.18/210.39       Skin Appendage Diseases %28%1966-1997%29%
% 210.18/210.39  |- mesh__dateRevised mesh__D012625 2001-07-25
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D012625 2002
% 210.18/210.39  |- mesh__recordMaintainer mesh__D012625 lkt
% 210.18/210.39  |- skos__scopeNote mesh__D012625
% 210.18/210.39       Diseases of the sebaceous glands such as sebaceous hyperplasia and sebaceous cell carcinoma %28%SEBACEOUS GLAND NEOPLASMS%29%.%A%    
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D012625 2006
% 210.18/210.39  |- mesh__recordOriginator mesh__D012625 NLM
% 210.18/210.39  |- mesh__publicMeSHNote mesh__D012625 98   
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D017310 2005
% 210.18/210.39  |- skos__altLabel mesh__D017310 Annexin VII
% 210.18/210.39  |- mesh__recordMaintainer mesh__D017310 jmp
% 210.18/210.39  |- skos__altLabel mesh__D017310 Synexin
% 210.18/210.39  |- rdf__type mesh__D017310sskos__Concept
% 210.18/210.39  |- skos__historyNote mesh__D017310 Proteins %28%1978-1992%29%
% 210.18/210.39  |- skos__prefLabel mesh__D017310 Annexin A7
% 210.18/210.39  |- mesh__dateRevised mesh__D017310 2004-07-07
% 210.18/210.39  |- skos__broader mesh__D017310smesh__D017302
% 210.18/210.39  |- skos__scopeNote mesh__D017310
% 210.18/210.39       An annexin family member that plays a role in MEMBRANE FUSION and signaling via VOLTAGE-DEPENDENT CALCIUM CHANNELS.%A%    
% 210.18/210.39  |- mesh__dateEstablished mesh__D017310 1993-01-01
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D017310 2006
% 210.18/210.39  |- mesh__recordAuthorizer mesh__D017310 sjn
% 210.18/210.39  |- mesh__historyNote mesh__D017310 2005%28%1978%29%   
% 210.18/210.39  |- mesh__dateCreated mesh__D017310 1992-05-07
% 210.18/210.39  |- mesh__publicMeSHNote mesh__D017310
% 210.18/210.39       2005; see ANNEXIN VII 1993-2004; SYNEXIN was indexed under PROTEINS 1978-1992; ANNEXIN A7 was indexed under ANNEXIN VIII 2004%A%  
% 210.18/210.39  |- mesh__recordOriginator mesh__D017310 AGS
% 210.18/210.39  |- skos__scopeNote mesh__D050744
% 210.18/210.39       An enzyme that catalyzes the oxidation of 5,6-dihydrouracil to URACIL using NAD as a cofactor. This enzyme also plays a role in the catabolism of the antimetabolite 5-FLUOROURACIL.%A%    
% 210.18/210.39  |- skos__hiddenLabel mesh__D050744 Dehydrogenase, Dihydrouracil
% 210.18/210.39  |- mesh__recordAuthorizer mesh__D050744 ags
% 210.18/210.39  |- skos__prefLabel mesh__D050744 Dihydrouracil Dehydrogenase %28%NAD+%29%
% 210.18/210.39  |- skos__altLabel mesh__D050744 Dihydrothymine Dehydrogenase %28%NAD%29%
% 210.18/210.39  |- mesh__dateEstablished mesh__D050744 2006-01-01
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D050744 2006A
% 210.18/210.39  |- skos__broader mesh__D050744smesh__D044925
% 210.18/210.39  |- mesh__dateRevised mesh__D050744 2005-07-11
% 210.18/210.39  |- skos__altLabel mesh__D050744 Dihydrouracil Dehydrogenase
% 210.18/210.39  |- mesh__publicMeSHNote mesh__D050744
% 210.18/210.39       2006; DIHYDROURACIL DEHYDROGENASE %28%NAD+%29% was indexed under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 2004-2005, OXIDOREDUCTASES 1983-2003, %26% URACIL 1970-1982%A%  
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D050744 2006
% 210.18/210.39  |- skos__altLabel mesh__D050744 Dihydrouracil Dehydrogenase %28%NAD%29%
% 210.18/210.39  |- mesh__recordMaintainer mesh__D050744 ags
% 210.18/210.39  |- skos__historyNote mesh__D050744
% 210.18/210.39       Oxidoreductases Acting on CH-CH Group Donors %28%2004-2005%29%
% 210.18/210.39  |- rdf__type mesh__D050744sskos__Concept
% 210.18/210.39  |- mesh__historyNote mesh__D050744 2006%28%1970%29%   
% 210.18/210.39  |- mesh__dateCreated mesh__D050744 2005-06-30
% 210.18/210.39  |- skos__historyNote mesh__D050744 Oxidoreductases %28%1983-2003%29%
% 210.18/210.39  |- mesh__recordOriginator mesh__D050744 AKE
% 210.18/210.39  |- skos__broader mesh__D003899smesh__D011244
% 210.18/210.39  |- skos__prefLabel mesh__D003899 Desoximetasone
% 210.18/210.39  |- skos__altLabel mesh__D003899 Medicis Brand of Desoximetasone
% 210.18/210.39  |- mesh__recordAuthorizer mesh__D003899 sjn
% 210.18/210.39  |- mesh__publicMeSHNote mesh__D003899
% 210.18/210.39       91; was see under DEXAMETHASONE 1979-90   
% 210.18/210.39  |- skos__historyNote mesh__D003899 Steroids, Fluorinated %28%1974%29%
% 210.18/210.39  |- mesh__dateRevised mesh__D003899 2005-06-30
% 210.18/210.39  |- skos__altLabel mesh__D003899 Optipharma Brand of Desoximetasone
% 210.18/210.39  |- skos__hiddenLabel mesh__D003899 A41304
% 210.18/210.39  |- skos__scopeNote mesh__D003899
% 210.18/210.39       A topical anti-inflammatory glucocorticoid used in DERMATOSES, skin allergies, PSORIASIS, etc.%A%    
% 210.18/210.39  |- skos__hiddenLabel mesh__D003899 17 Desoxymethasone
% 210.18/210.39  |- rdf__type mesh__D003899sskos__Concept
% 210.18/210.39  |- mesh__recordMaintainer mesh__D003899 exl
% 210.18/210.39  |- skos__historyNote mesh__D003899 Dexamethasone %28%1966-1978%29%
% 210.18/210.39  |- mesh__historyNote mesh__D003899
% 210.18/210.39       91%28%79%29%; was see under DEXAMETHASONE 1979-90   
% 210.18/210.39  |- skos__altLabel mesh__D003899 Stiefel Brand of Desoximetasone
% 210.18/210.39  |- skos__altLabel mesh__D003899 17-Desoxymethasone
% 210.18/210.39  |- skos__altLabel mesh__D003899 Aventis Brand of Desoximetasone
% 210.18/210.39  |- mesh__dateEstablished mesh__D003899 1991-01-01
% 210.18/210.39  |- skos__historyNote mesh__D003899 Pregnadienediols %28%1974%29%
% 210.18/210.39  |- skos__altLabel mesh__D003899 Deoxydexamethasone
% 210.18/210.39  |- mesh__recordOriginator mesh__D003899 SH
% 210.18/210.39  |- skos__altLabel mesh__D003899 Hoechst Brand of Desoximetasone
% 210.18/210.39  |- skos__altLabel mesh__D003899 Flubason
% 210.18/210.39  |- skos__altLabel mesh__D003899 Bipharma Brand of Desoximetasone
% 210.18/210.39  |- mesh__dateCreated mesh__D003899 1977-12-08
% 210.18/210.39  |- skos__hiddenLabel mesh__D003899 A 41304
% 210.18/210.39  |- skos__altLabel mesh__D003899 Abbott Brand of Desoximetasone
% 210.18/210.39  |- skos__broader mesh__D003899smesh__D003907
% 210.18/210.39  |- skos__altLabel mesh__D003899 Desoxymethasone
% 210.18/210.39  |- skos__altLabel mesh__D003899 Dermik Brand of Desoximetasone
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D003899 2006
% 210.18/210.39  |- rdf__type mesh__D044707sskos__Concept
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D044707 2005
% 210.18/210.39  |- skos__hiddenLabel mesh__D044707 Sciences, Forensic
% 210.18/210.39  |- skos__scopeNote mesh__D044707
% 210.18/210.39       Disciplines that apply sciences to law. Forensic sciences include a wide range of disciplines, such as TOXICOLOGY; FORENSIC ANTHROPOLOGY; FORENSIC MEDICINE; FORENSIC DENTISTRY; and others.%A%    
% 210.18/210.39  |- skos__broader mesh__D044707smesh__D003418
% 210.18/210.39  |- mesh__dateEstablished mesh__D044707 2004-01-01
% 210.18/210.39  |- skos__hiddenLabel mesh__D044707 Science, Forensic
% 210.18/210.39  |- mesh__publicMeSHNote mesh__D044707 2004   
% 210.18/210.39  |- skos__historyNote mesh__D044707 Forensic Medicine %28%1965-2003%29%
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D044707 2004
% 210.18/210.39  |- mesh__historyNote mesh__D044707 2004   
% 210.18/210.39  |- skos__hiddenLabel mesh__D044707 Forensic Science
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D044707 2006
% 210.18/210.39  |- mesh__dateCreated mesh__D044707 2003-07-09
% 210.18/210.39  |- skos__prefLabel mesh__D044707 Forensic Sciences
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D008584 2003
% 210.18/210.39  |- skos__broader mesh__D008584smesh__D016920
% 210.18/210.39  |- skos__broader mesh__D008584smesh__D008088
% 210.18/210.39  |- skos__hiddenLabel mesh__D008584 Meningitides, Listeria monocytogenes
% 210.18/210.39  |- skos__hiddenLabel mesh__D008584 Listeria Meningitis
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D008584 2005A
% 210.18/210.39  |- mesh__recordMaintainer mesh__D008584 jls
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D008584 2004
% 210.18/210.39  |- skos__hiddenLabel mesh__D008584 Cerebritis, Listeria
% 210.18/210.39  |- skos__hiddenLabel mesh__D008584 Meningoencephalitides, Listeria
% 210.18/210.39  |- skos__hiddenLabel mesh__D008584 Listeria Meningoencephalitides
% 210.18/210.39  |- skos__hiddenLabel mesh__D008584 Cerebritides, Listeria
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D008584 2000
% 210.18/210.39  |- skos__scopeNote mesh__D008584
% 210.18/210.39       Inflammation of the meninges caused by LISTERIA MONOCYTOGENES infection, usually occurring in individuals under the age of 3 years or over the age of 50 years. It may occur at any age in individuals with IMMUNOLOGIC DEFICIENCY SYNDROMES. Clinical manifestations include FEVER, altered mentation, HEADACHE, meningeal signs, focal neurologic signs, and SEIZURES. %28%From Medicine 1998 Sep;77%28%5%29%:313-36%29%%A%    
% 210.18/210.39  |- skos__hiddenLabel mesh__D008584 Meningitis, Listeria monocytogenes
% 210.18/210.39  |- skos__hiddenLabel mesh__D008584 Meningitides, Listeria
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D008584 2005
% 210.18/210.39  |- mesh__recordOriginator mesh__D008584 NLM
% 210.18/210.39  |- mesh__dateCreated mesh__D008584 1999-01-01
% 210.18/210.39  |- skos__altLabel mesh__D008584 Listeria monocytogenes Meningitis
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D008584 2001
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D008584 2006
% 210.18/210.39  |- skos__prefLabel mesh__D008584 Meningitis, Listeria
% 210.18/210.39  |- skos__hiddenLabel mesh__D008584 Listeria Meningitides
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D008584 2002
% 210.18/210.39  |- skos__annotation mesh__D008584
% 210.18/210.39       do not coord with LISTERIA MONOCYTOGENES unless organism is particularly discussed%A%  
% 210.18/210.39  |- skos__hiddenLabel mesh__D008584 Listeria monocytogenes Meningitides
% 210.18/210.39  |- skos__altLabel mesh__D008584 Listeria Meningoencephalitis
% 210.18/210.39  |- mesh__dateRevised mesh__D008584 2004-07-28
% 210.18/210.39  |- mesh__recordAuthorizer mesh__D008584 jls
% 210.18/210.39  |- rdf__type mesh__D008584sskos__Concept
% 210.18/210.39  |- skos__hiddenLabel mesh__D008584 Listeria Cerebritides
% 210.18/210.39  |- mesh__recordOriginator mesh__D004992 NLM
% 210.18/210.39  |- mesh__recordAuthorizer mesh__D004992 sjn
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004992 2002
% 210.18/210.39  |- skos__related mesh__D004992smesh__D001675
% 210.18/210.39  |- skos__broader mesh__D004992smesh__D010686
% 210.18/210.39  |- skos__prefLabel mesh__D004992 Ethics, Medical
% 210.18/210.39  |- rdf__type mesh__D004992sskos__Concept
% 210.18/210.39  |- skos__altLabel mesh__D004992 Medical Ethics
% 210.18/210.39  |- skos__broader mesh__D004992smesh__D004995
% 210.18/210.39  |- mesh__dateCreated mesh__D004992 1999-01-01
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004992 2003
% 210.18/210.39  |- mesh__recordMaintainer mesh__D004992 tjk
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004992 2005
% 210.18/210.39  |- skos__scopeNote mesh__D004992
% 210.18/210.39       The principles of proper professional conduct concerning the rights and duties of the physician, relations with patients and fellow practitioners, as well as actions of the physician in patient care and interpersonal relations with patient families. %28%From Stedman, 25th ed%29%%A%    
% 210.18/210.39  |- skos__annotation mesh__D004992
% 210.18/210.39       restrict to ethics in relation to the physician; ETHICS, CLINICAL is available for ethics in relation to patient care; BIOETHICS and BIOETHICAL ISSUES are also available; specify geog if pertinent; DF: ETHICS MED%A%  
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004992 2004
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004992 2006
% 210.18/210.39  |- mesh__dateRevised mesh__D004992 2001-07-25
% 210.18/210.39  |- mesh__recordMaintainer mesh__D004194 nns
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004194 2005
% 210.18/210.39  |- mesh__recordAuthorizer mesh__D004194 sjn
% 210.18/210.39  |- mesh__recordOriginator mesh__D004194 NLM
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004194 2006
% 210.18/210.39  |- mesh__dateCreated mesh__D004194 1999-01-01
% 210.18/210.39  |- mesh__dateRevised mesh__D004194 2001-07-25
% 210.18/210.39  |- skos__annotation mesh__D004194
% 210.18/210.39       GEN only as a physiol, pathol, philosophical concept, opposite %22%health%22%; Manual 23.5+; /transm = DISEASE TRANSMISSION but consider COMMUNICABLE DISEASES as probably better or DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL or DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; /vet = VETERINARY MEDICINE or ANIMAL DISEASES; /econ permitted but consider also economic aspects of disease as ECONOMICS, MEDICAL; /psychol permitted but consider also psychogenic origin of disease as PSYCHOPHYSIOLOGIC DISORDERS; use remaining qualif discreetly%A%  
% 210.18/210.39  |- skos__scopeNote mesh__D004194
% 210.18/210.39       A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.%A%    
% 210.18/210.39  |- skos__hiddenLabel mesh__D004194 Diseases
% 210.18/210.39  |- skos__prefLabel mesh__D004194 Disease
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004194 2002
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004194 2003
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D004194 2004
% 210.18/210.39  |- rdf__type mesh__D004194sskos__Concept
% 210.18/210.39  |- skos__broader mesh__D004194smesh__D010335
% 210.18/210.39  |- mesh__dateRevised mesh__D012626 2001-07-25
% 210.18/210.39  |- mesh__recordMaintainer mesh__D012626 lkt
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D012626 2002
% 210.18/210.39  |- mesh__historyNote mesh__D012626 68   
% 210.18/210.39  |- skos__broader mesh__D012626smesh__D012625
% 210.18/210.39  |- mesh__recordOriginator mesh__D012626 NLM
% 210.18/210.39  |- skos__broader mesh__D012626smesh__D012878
% 210.18/210.39  |- skos__altLabel mesh__D012626 Neoplasms, Sebaceous Gland
% 210.18/210.39  |- mesh__publicMeSHNote mesh__D012626 68   
% 210.18/210.39  |- skos__hiddenLabel mesh__D012626 Neoplasm, Sebaceous Gland
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D012626 2006
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D012626 2004
% 210.18/210.39  |- rdf__type mesh__D012626sskos__Concept
% 210.18/210.39  |- skos__annotation mesh__D012626
% 210.18/210.39       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%  
% 210.18/210.39  |- skos__prefLabel mesh__D012626 Sebaceous Gland Neoplasms
% 210.18/210.39  |- mesh__dateCreated mesh__D012626 1999-01-01
% 210.18/210.39  |- skos__historyNote mesh__D012626 Sebaceous Glands %28%1966-1967%29%
% 210.18/210.39  |- mesh__recordAuthorizer mesh__D012626 sjn
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D012626 2005
% 210.18/210.39  |- skos__historyNote mesh__D012626 Skin Neoplasms %28%1966-1967%29%
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D012626 2003
% 210.18/210.39  |- skos__hiddenLabel mesh__D012626 Sebaceous Gland Neoplasm
% 210.18/210.39  |- mesh__dateEstablished mesh__D012626 1968-01-01
% 210.18/210.39  |- skos__hiddenLabel mesh__D045002 3 alpha Hydroxysteroid Oxidoreductase
% 210.18/210.39  |- skos__hiddenLabel mesh__D045002 Oxidoreductase, 3 alpha-Hydroxysteroid
% 210.18/210.39  |- skos__altLabel mesh__D045002 5-DP-3 alpha-HSO
% 210.18/210.39  |- skos__altLabel mesh__D045002
% 210.18/210.39       5 alpha-3 alpha-Hydroxysteroid Dehydrogenase
% 210.18/210.39  |- skos__altLabel mesh__D045002
% 210.18/210.39       3alpha-Hydroxysteroid Dehydrogenase %28%B-specific%29%
% 210.18/210.39  |- skos__altLabel mesh__D045002 3 alpha-Hydroxysteroid Dehydrogenase
% 210.18/210.39  |- mesh__recordAuthorizer mesh__D045002 sjn
% 210.18/210.39  |- mesh__recordOriginator mesh__D045002 AKE
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D045002 2004
% 210.18/210.39  |- skos__broader mesh__D045002smesh__D015096
% 210.18/210.39  |- skos__altLabel mesh__D045002 3 alpha-Hydroxysteroid Oxidoreductase
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D045002 2005
% 210.18/210.39  |- skos__hiddenLabel mesh__D045002
% 210.18/210.39       NADPH 5 alpha Dihydroprogesterone 3 alpha Hydroxysteroid Oxidoreductase
% 210.18/210.39  |- mesh__dateCreated mesh__D045002 2003-07-09
% 210.18/210.39  |- skos__altLabel mesh__D045002
% 210.18/210.39       3 alpha-Hydroxysteroid Dehydrogenase %28%B-Specific%29%
% 210.18/210.39  |- rdf__type mesh__D045002sskos__Concept
% 210.18/210.39  |- mesh__historyNote mesh__D045002
% 210.18/210.39       2004; use 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE %28%B-SPECIFIC%29% %28%NM%29% 1979-2003%A%  
% 210.18/210.39  |- mesh__recordMaintainer mesh__D045002 jmp
% 210.18/210.39  |- mesh__activeMeSHYear mesh__D045002 2006
% 210.18/210.39  |- skos__hiddenLabel mesh__D045002 Dehydrogenase, 3 alpha-Hydroxysteroid
% 210.18/210.39  |- skos__altLabel mesh__D045002
% 210.18/210.39       NADPH-5 alpha-Dihydroprogesterone 3 alpha-Hydroxysteroid Oxidoreductase
% 210.18/210.39  |- skos__hiddenLabel mesh__D045002 3 alpha Hydroxysteroid Dehydrogenase
% 210.18/210.39  |- mesh__dateEstablished mesh__D045002 2004-01-01
% 210.18/210.39  |- skos__historyNote mesh__D045002
% 210.18/210.39       3-Hydroxysteroid Dehydrogenases %28%1979-2003%29%
% 210.18/210.39  |- skos__prefLabel mesh__D045002
% 210.18/210.39       3-alpha-Hydroxysteroid Dehydrogenase %28%B-Specific%29%
% 210.18/210.39  |- skos__scopeNote mesh__D045002
% 210.18/210.39       A 3-hydroxysteroid dehydrogenase which catalyzes the reversible reduction of the active androgen, DIHYDROTESTOSTERONE to 5 ALPHA-ANDROSTANE-3 ALPHA,17 BETA-DIOL. It also has activity towards other 3-alpha-hydroxysteroids and on 9-, 11- and 15- hydroxyprostaglandins. The enzyme is B-specific in reference to the orientation of reduced NAD or NADPH.%A%    
% 210.18/210.39  |- skos__hiddenLabel mesh__D045002
% 210.18/210.39       5 alpha Dihydroprogesterone 3 alpha Hydroxysteroid Oxidoreductase
% 210.18/210.39  |- mesh__publicMeSHNote mesh__D045002
% 210.18/210.39       2004; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE %28%B-SPECIFIC%29% was indexed under 3-HYDROXYSTEROID DEHYDROGENASES 1979-2003; 5 ALPHA-DIHYDROPROGESTERONE 3 ALPHA-HYDROSTEROID OXIDOREDUCTASE was indexed under 3-HYDROXYSTEROID DEHYDROGENASES 1981-2003%A%  
% 210.18/210.39  |- mesh__onlineNote mesh__D017311
% 210.18/210.39       use AMLODIPINE %28%NM%29% to search AMLODIPINE 1986-92   
% 210.18/210.39  |- mesh__recordAuthorizer mesh__D017311 sjn
% 210.18/210.39  |- skos__altLabel mesh__D017311 Mack Brand of Amlodipine Besilate
% 210.18/210.39  |- rdf__type mesh__D017311sskos__Concept
% 210.18/210.39  |- skos__altLabel mesh__D017311 Amlor
% 210.18/210.39  |- mesh__historyNote mesh__D017311 93; was AMLODIPINE %28%NM%29% 1986-92   
% 210.18/210.39  |- skos__altLabel mesh__D017311 Almirall Brand of Amlodipine Besilate
% 210.18/210.39  |- mesh__recordMaintainer mesh__D017311 mdb
% 210.18/210.39  |- skos__hiddenLabel mesh__D017311 Besylate, Amlodipine
% 210.18/210.39  |- skos__scopeNote mesh__D017311
% 210.18/210.39       A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of angina pectoris and hypertension.%A%    
% 210.18/210.39  |- mesh__dateRevised mesh__D017311 2004-07-07
% 210.18/210.39  |- skos__hiddenLabel mesh__D017311 Maleate, Amlodipine
% 210.18/210.39  |- skos__historyNote mesh__D017311
% 210.18/210.39       Nifedipine/analogs %26% derivatives %28%1986-1992%29%
% 210.18/210.39  |- skos__altLabel mesh__D017311 Amlodipine Maleate %28%1:1%29%
% 210.18/210.40  |- mesh__recordOriginator mesh__D017311 TPW
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D017311 2006
% 210.18/210.40  |- mesh__publicMeSHNote mesh__D017311
% 210.18/210.40       93; AMLODIPINE was indexed under NIFEDIPINE/analogs %26% derivatives 1986-92%A%  
% 210.18/210.40  |- mesh__dateCreated mesh__D017311 1992-05-07
% 210.18/210.40  |- skos__prefLabel mesh__D017311 Amlodipine
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D017311 2005
% 210.18/210.40  |- skos__altLabel mesh__D017311 Pfizer Brand of Amlodipine Besilate
% 210.18/210.40  |- skos__altLabel mesh__D017311 Istin
% 210.18/210.40  |- mesh__dateEstablished mesh__D017311 1993-01-01
% 210.18/210.40  |- skos__broader mesh__D017311smesh__D004095
% 210.18/210.40  |- skos__historyNote mesh__D050745 Oxidoreductases %28%1980-2005%29%
% 210.18/210.40  |- mesh__recordAuthorizer mesh__D050745 sjn
% 210.18/210.40  |- mesh__publicMeSHNote mesh__D050745
% 210.18/210.40       2006; ENOYL-%28%ACYL-CARRIER-PROTEIN%29% REDUCTASE %28%NADPH%29% was indexed under OXIDOREDUCTASES 1980-2005%A%  
% 210.18/210.40  |- mesh__dateEstablished mesh__D050745 2006-01-01
% 210.18/210.40  |- skos__altLabel mesh__D050745
% 210.18/210.40       Enoyl-%28%Acyl-Carrier-Protein%29%reductase %28%NADPH%29%
% 210.18/210.40  |- mesh__recordMaintainer mesh__D050745 AKE
% 210.18/210.40  |- skos__altLabel mesh__D050745 Acyl-ACP Dehydrogenase
% 210.18/210.40  |- mesh__dateCreated mesh__D050745 2005-06-30
% 210.18/210.40  |- skos__scopeNote mesh__D050745
% 210.18/210.40       An enzyme that catalyzes the oxidation of acyl-%5B%acyl-carrier protein%5D% to trans-2,3-dehydroacyl-%5B%acyl-carrier protein%5D% in the fatty acid biosynthesis pathway. It has a preference for acyl derivatives with carbon chain length from 4 to 16.%A%    
% 210.18/210.40  |- skos__prefLabel mesh__D050745
% 210.18/210.40       Enoyl-%28%Acyl-Carrier Protein%29% Reductase %28%NADPH, B-Specific%29%
% 210.18/210.40  |- mesh__recordOriginator mesh__D050745 AKE
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D050745 2006
% 210.18/210.40  |- skos__hiddenLabel mesh__D050745 Dehydrogenase, Acyl-ACP
% 210.18/210.40  |- rdf__type mesh__D050745sskos__Concept
% 210.18/210.40  |- skos__hiddenLabel mesh__D050745 Acyl ACP Dehydrogenase
% 210.18/210.40  |- mesh__historyNote mesh__D050745 2006%28%1980%29%   
% 210.18/210.40  |- skos__broader mesh__D050745smesh__D044925
% 210.18/210.40  |- skos__broader mesh__D020001Q000031smesh__D020001
% 210.18/210.40  |- mesh__preferredCombination mesh__D020001Q000031smesh__D000440
% 210.18/210.40  |- rdf__type mesh__D020001Q000031smesh__CompoundConcept
% 210.18/210.40  |- skos__related mesh__D044708smesh__D043864
% 210.18/210.40  |- mesh__recordMaintainer mesh__D044708 ssb
% 210.18/210.40  |- skos__related mesh__D044708smesh__D020080
% 210.18/210.40  |- mesh__publicMeSHNote mesh__D044708 2004   
% 210.18/210.40  |- mesh__dateRevised mesh__D044708 2004-07-07
% 210.18/210.40  |- skos__broader mesh__D044708smesh__D004247
% 210.18/210.40  |- skos__annotation mesh__D044708
% 210.18/210.40       coord with specific DNA source; DNA, CATENATED is also available%A%  
% 210.18/210.40  |- mesh__historyNote mesh__D044708 2004   
% 210.18/210.40  |- mesh__recordOriginator mesh__D044708 ssb
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D044708 2006
% 210.18/210.40  |- mesh__dateCreated mesh__D044708 2003-07-09
% 210.18/210.40  |- skos__altLabel mesh__D044708 DNA, Concatemers
% 210.18/210.40  |- mesh__dateEstablished mesh__D044708 2004-01-01
% 210.18/210.40  |- rdf__type mesh__D044708sskos__Concept
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D044708 2005
% 210.18/210.40  |- skos__prefLabel mesh__D044708 DNA, Concatenated
% 210.18/210.40  |- skos__altLabel mesh__D044708 Concatenated DNA
% 210.18/210.40  |- skos__scopeNote mesh__D044708
% 210.18/210.40       Head to tail array of covalently joined DNA sequences generated by concatenation. Concatenated DNA is attached end to end in contrast to CATENATED DNA which is attached loop to loop.%A%    
% 210.18/210.40  |- mesh__recordAuthorizer mesh__D044708 sjn
% 210.18/210.40  |- skos__altLabel mesh__D008585 Meningococcal Meningitis, Serogroup B
% 210.18/210.40  |- skos__altLabel mesh__D008585 Serogroup W-135, Meningococcal Meningitis
% 210.18/210.40  |- mesh__recordMaintainer mesh__D008585 sjn
% 210.18/210.40  |- skos__prefLabel mesh__D008585 Meningitis, Meningococcal
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D008585 2005
% 210.18/210.40  |- skos__annotation mesh__D008585
% 210.18/210.40       do not coord with NEISSERIA MENINGITIDIS unless organism is particularly discussed but coord with specific serogroup %28%IM%29% if given%A%  
% 210.18/210.40  |- mesh__dateCreated mesh__D008585 1999-01-01
% 210.18/210.40  |- skos__altLabel mesh__D008585 Meningococcal Meningitis, Serogroup C
% 210.18/210.40  |- skos__broader mesh__D008585smesh__D008589
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D008585 2006
% 210.18/210.40  |- skos__altLabel mesh__D008585 Serogroup Y, Meningococcal Meningitis
% 210.18/210.40  |- skos__altLabel mesh__D008585 Meningococcal Meningitis, Serogroup W135
% 210.18/210.40  |- mesh__dateRevised mesh__D008585 2002-10-18
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D008585 2003A
% 210.18/210.40  |- skos__altLabel mesh__D008585 Meningococcal Meningitis, Serogroup W-135
% 210.18/210.40  |- skos__altLabel mesh__D008585 Meningitis, Meningococcal, Serogroup W135
% 210.18/210.40  |- skos__altLabel mesh__D008585 Meningitis, Meningococcic
% 210.18/210.40  |- mesh__publicMeSHNote mesh__D008585
% 210.18/210.40       1978; see MENINGITIS, MENINGOCOCCIC 1963-1977   
% 210.18/210.40  |- skos__hiddenLabel mesh__D008585 Meningococcal Meningitis
% 210.18/210.40  |- skos__scopeNote mesh__D008585
% 210.18/210.40       A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. %28%From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10%28%1%29%:13-8%29%%A%    
% 210.18/210.40  |- skos__hiddenLabel mesh__D008585
% 210.18/210.40       Meningococcal Meningitis, Serogroup W 135
% 210.18/210.40  |- skos__altLabel mesh__D008585 Meningococcal Meningitis, Serogroup A
% 210.18/210.40  |- skos__altLabel mesh__D008585 Serogroup W135, Meningococcal Meningitis
% 210.18/210.40  |- skos__altLabel mesh__D008585 Serogroup A Meningococcal Meningitis
% 210.18/210.40  |- rdf__type mesh__D008585sskos__Concept
% 210.18/210.40  |- skos__altLabel mesh__D008585 Serogroup C Meningococcal Meningitis
% 210.18/210.40  |- mesh__historyNote mesh__D008585 1978%28%1963%29%   
% 210.18/210.40  |- mesh__recordAuthorizer mesh__D008585 sjn
% 210.18/210.40  |- skos__altLabel mesh__D008585 Serogroup B Meningococcal Meningitis
% 210.18/210.40  |- skos__broader mesh__D008585smesh__D016920
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D008585 2003
% 210.18/210.40  |- skos__hiddenLabel mesh__D008585
% 210.18/210.40       Serogroup W 135, Meningococcal Meningitis
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D008585 2004
% 210.18/210.40  |- mesh__recordOriginator mesh__D008585 NLM
% 210.18/210.40  |- skos__altLabel mesh__D008585 Meningococcal Meningitis, Serogroup Y
% 210.18/210.40  |- skos__hiddenLabel mesh__D016219 Adoptive Cellular Immunotherapies
% 210.18/210.40  |- skos__hiddenLabel mesh__D016219 Adoptive Immunotherapies
% 210.18/210.40  |- mesh__recordMaintainer mesh__D016219 TGC
% 210.18/210.40  |- skos__altLabel mesh__D016219 Cellular Immunotherapy, Adoptive
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D016219 2003
% 210.18/210.40  |- rdf__type mesh__D016219sskos__Concept
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D016219 2006
% 210.18/210.40  |- skos__annotation mesh__D016219
% 210.18/210.40       IM; do not use /util except by MeSH definition   
% 210.18/210.40  |- mesh__recordOriginator mesh__D016219 AGS
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D016219 2000
% 210.18/210.40  |- skos__historyNote mesh__D016219 Immunization, Passive %28%1983-1990%29%
% 210.18/210.40  |- skos__scopeNote mesh__D016219
% 210.18/210.40       Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer %28%LAK%29% cells and tumor-infiltrating lymphocytes %28%TIL%29%. This is usually considered a form of passive immunotherapy. %28%From DeVita, et al., Cancer, 1993, pp.305-7, 314%29%%A%    
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D016219 2005
% 210.18/210.40  |- mesh__dateRevised mesh__D016219 1997-06-20
% 210.18/210.40  |- skos__altLabel mesh__D016219 Adoptive Cellular Immunotherapy
% 210.18/210.40  |- skos__altLabel mesh__D016219 Immunotherapy, Adoptive Cellular
% 210.18/210.40  |- mesh__publicMeSHNote mesh__D016219 91   
% 210.18/210.40  |- skos__hiddenLabel mesh__D016219 Cellular Immunotherapies, Adoptive
% 210.18/210.40  |- mesh__dateEstablished mesh__D016219 1991-01-01
% 210.18/210.40  |- skos__hiddenLabel mesh__D016219 Immunotherapies, Adoptive Cellular
% 210.18/210.40  |- mesh__recordAuthorizer mesh__D016219 SJN
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D016219 1999
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D016219 2002
% 210.18/210.40  |- mesh__historyNote mesh__D016219 91   
% 210.18/210.40  |- skos__altLabel mesh__D016219 Adoptive Immunotherapy
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D016219 2004
% 210.18/210.40  |- mesh__dateCreated mesh__D016219 1990-06-06
% 210.18/210.40  |- skos__broader mesh__D016219smesh__D019264
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D016219 1998
% 210.18/210.40  |- skos__hiddenLabel mesh__D016219 Immunotherapies, Adoptive
% 210.18/210.40  |- skos__prefLabel mesh__D016219 Immunotherapy, Adoptive
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D016219 2001
% 210.18/210.40  |- skos__broader mesh__D009206Q000648smesh__D009206
% 210.18/210.40  |- rdf__type mesh__D009206Q000648smesh__CompoundConcept
% 210.18/210.40  |- mesh__dateCreated mesh__D004993 1999-01-01
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004993 2001
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004993 2005
% 210.18/210.40  |- skos__altLabel mesh__D004993 Nursing Ethics
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004993 2004
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004993 2006
% 210.18/210.40  |- skos__hiddenLabel mesh__D004993 Nursing Ethic
% 210.18/210.40  |- skos__scopeNote mesh__D004993
% 210.18/210.40       The principles of proper professional conduct concerning the rights and duties of nurses themselves, their patients, and their fellow practitioners, as well as their actions in the care of patients and in relations with their families.%A%    
% 210.18/210.40  |- skos__broader mesh__D004993smesh__D010687
% 210.18/210.40  |- skos__hiddenLabel mesh__D004993 Ethic, Nursing
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004993 2002
% 210.18/210.40  |- mesh__recordOriginator mesh__D004993 NLM
% 210.18/210.40  |- mesh__recordAuthorizer mesh__D004993 sjn
% 210.18/210.40  |- skos__prefLabel mesh__D004993 Ethics, Nursing
% 210.18/210.40  |- mesh__recordMaintainer mesh__D004993 kle
% 210.18/210.40  |- skos__annotation mesh__D004993
% 210.18/210.40       specify geog if pertinent; DF: ETHICS NURS   
% 210.18/210.40  |- mesh__dateRevised mesh__D004993 1999-11-03
% 210.18/210.40  |- rdf__type mesh__D004993sskos__Concept
% 210.18/210.40  |- skos__broader mesh__D004993smesh__D004995
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004993 2000
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004993 2003
% 210.18/210.40  |- rdf__type mesh__D051040sskos__Concept
% 210.18/210.40  |- skos__hiddenLabel mesh__D051040 3, Synaptobrevin
% 210.18/210.40  |- mesh__dateEstablished mesh__D051040 2006-01-01
% 210.18/210.40  |- mesh__publicMeSHNote mesh__D051040
% 210.18/210.40       2006; CELLUBREVIN %28%now VESICLE-ASSOCIATED MEMBRANE PROTEIN 3%29% was indexed under MEMBRANE PROTEINS 1993-2005%A%  
% 210.18/210.40  |- skos__broader mesh__D051040smesh__D050683
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D051040 2006
% 210.18/210.40  |- mesh__recordOriginator mesh__D051040 nns
% 210.18/210.40  |- skos__altLabel mesh__D051040 Synaptobrevin 3
% 210.18/210.40  |- skos__hiddenLabel mesh__D051040 Vesicle Associated Membrane Protein 3
% 210.18/210.40  |- skos__prefLabel mesh__D051040 Vesicle-Associated Membrane Protein 3
% 210.18/210.40  |- skos__historyNote mesh__D051040 Membrane Proteins %28%1997-2005%29%
% 210.18/210.40  |- skos__altLabel mesh__D051040 VAMP3
% 210.18/210.40  |- mesh__recordAuthorizer mesh__D051040 sjn
% 210.18/210.40  |- mesh__recordMaintainer mesh__D051040 nns
% 210.18/210.40  |- skos__historyNote mesh__D051040
% 210.18/210.40       Vesicular Transport Proteins %28%1997-2005%29%
% 210.18/210.40  |- skos__scopeNote mesh__D051040
% 210.18/210.40       A member of the vesicle associated membrane protein family. It has a broad tissue distribution and is involved in MEMBRANE FUSION events of the endocytic pathways.%A%    
% 210.18/210.40  |- mesh__dateCreated mesh__D051040 2005-06-30
% 210.18/210.40  |- skos__altLabel mesh__D051040 Cellubrevin
% 210.18/210.40  |- mesh__historyNote mesh__D051040 2006 %28%1993%29%   
% 210.18/210.40  |- rdf__type mesh__D004195sskos__Concept
% 210.18/210.40  |- mesh__dateCreated mesh__D004195 1999-01-01
% 210.18/210.40  |- skos__prefLabel mesh__D004195 Disease Models, Animal
% 210.18/210.40  |- mesh__historyNote mesh__D004195 70   
% 210.18/210.40  |- skos__broader mesh__D004195smesh__D023421
% 210.18/210.40  |- skos__related mesh__D004195smesh__D000830
% 210.18/210.40  |- skos__annotation mesh__D004195
% 210.18/210.40       not a routine coordinate with experimental animal diseases: index only when the text indicates a disease model; when the model is the point of the article, coordinate IM with the specific disease %28%IM%29% + specific animal %28%IM%29% if pertinent%A%  
% 210.18/210.40  |- skos__broader mesh__D004195smesh__D000820
% 210.18/210.40  |- skos__scopeNote mesh__D004195
% 210.18/210.40       Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.%A%    
% 210.18/210.40  |- skos__historyNote mesh__D004195 Models, Biological %28%1968-1969%29%
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004195 2006
% 210.18/210.40  |- skos__broader mesh__D004195smesh__D008954
% 210.18/210.40  |- mesh__recordAuthorizer mesh__D004195 sjn
% 210.18/210.40  |- mesh__recordOriginator mesh__D004195 NLM
% 210.18/210.40  |- mesh__recordMaintainer mesh__D004195 sjn
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004195 2005
% 210.18/210.40  |- mesh__publicMeSHNote mesh__D004195 70   
% 210.18/210.40  |- skos__hiddenLabel mesh__D004195 Disease Model, Animal
% 210.18/210.40  |- skos__hiddenLabel mesh__D004195 Animal Disease Model
% 210.18/210.40  |- skos__hiddenLabel mesh__D004195 Animal Disease Models
% 210.18/210.40  |- mesh__dateRevised mesh__D004195 2004-07-13
% 210.18/210.40  |- skos__historyNote mesh__D004195 Animal Diseases %28%1966-1969%29%
% 210.18/210.40  |- mesh__dateEstablished mesh__D004195 1970-01-01
% 210.18/210.40  |- skos__hiddenLabel mesh__D012627 Gland, Sebaceous
% 210.18/210.40  |- skos__prefLabel mesh__D012627 Sebaceous Glands
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D012627 2006
% 210.18/210.40  |- mesh__recordMaintainer mesh__D012627 nns
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D012627 2004
% 210.18/210.40  |- skos__scopeNote mesh__D012627
% 210.18/210.40       Small, sacculated organs found within the DERMIS. Each gland has a single duct that emerges from a cluster of oval alveoli. Each alveolus consists of a transparent BASEMENT MEMBRANE enclosing epithelial cells. The ducts from most sebaceous glands open into a HAIR FOLLICLE, but some open on the general surface of the SKIN. Sebaceous glands secrete SEBUM.%A%    
% 210.18/210.40  |- skos__broader mesh__D012627smesh__D012867
% 210.18/210.40  |- skos__broader mesh__D012627smesh__D005088
% 210.18/210.40  |- rdf__type mesh__D012627sskos__Concept
% 210.18/210.40  |- skos__hiddenLabel mesh__D012627 Sebaceous Gland
% 210.18/210.40  |- mesh__dateCreated mesh__D012627 1999-01-01
% 210.18/210.40  |- mesh__recordOriginator mesh__D012627 NLM
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D012627 2005
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D012627 2003
% 210.18/210.40  |- mesh__dateRevised mesh__D012627 2002-07-03
% 210.18/210.40  |- skos__hiddenLabel mesh__D012627 Glands, Sebaceous
% 210.18/210.40  |- mesh__recordAuthorizer mesh__D012627 sjn
% 210.18/210.40  |- skos__broader mesh__D006932Q000151smesh__D006932
% 210.18/210.40  |- mesh__preferredCombination mesh__D006932Q000151smesh__D006933
% 210.18/210.40  |- rdf__type mesh__D006932Q000151smesh__CompoundConcept
% 210.18/210.40  |- rdf__type mesh__D017312sskos__Concept
% 210.18/210.40  |- skos__prefLabel mesh__D017312 Toremifene
% 210.18/210.40  |- skos__hiddenLabel mesh__D017312 Citrate, Toremifene
% 210.18/210.40  |- mesh__recordOriginator mesh__D017312 TPW
% 210.18/210.40  |- mesh__recordAuthorizer mesh__D017312 sjn
% 210.18/210.40  |- mesh__historyNote mesh__D017312 93; was TOREMIFENE %28%NM%29% 1985-92   
% 210.18/210.40  |- mesh__dateEstablished mesh__D017312 1993-01-01
% 210.18/210.40  |- skos__altLabel mesh__D017312 Toremifene Citrate %28%1:1%29%
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D017312 2006
% 210.18/210.40  |- skos__historyNote mesh__D017312
% 210.18/210.40       Tamoxifen/analogs %26% derivatives %28%1985-1992%29%
% 210.18/210.40  |- skos__broader mesh__D017312smesh__D013629
% 210.18/210.40  |- skos__scopeNote mesh__D017312
% 210.18/210.40       A first generation selective estrogen receptor modulator %28%SERM%29%. Like TAMOXIFEN, it is an estrogen agonist for bone tissue and cholesterol metabolism but is antagonistic on mammary and uterine tissue.%A%    
% 210.18/210.40  |- skos__hiddenLabel mesh__D017312 FC 1157a
% 210.18/210.40  |- mesh__recordMaintainer mesh__D017312 ssb
% 210.18/210.40  |- mesh__publicMeSHNote mesh__D017312
% 210.18/210.40       93; TOREMIFENE was indexed under TAMOXIFEN/analogs %26% derivatives 1985-92%A%  
% 210.18/210.40  |- mesh__dateRevised mesh__D017312 2005-06-30
% 210.18/210.40  |- mesh__dateCreated mesh__D017312 1992-05-20
% 210.18/210.40  |- skos__hiddenLabel mesh__D017312 FC1157a
% 210.18/210.40  |- mesh__onlineNote mesh__D017312
% 210.18/210.40       use TOREMIFENE %28%NM%29% to search TOREMIFENE 1985-92   
% 210.18/210.40  |- mesh__recordMaintainer mesh__D050746 AKE
% 210.18/210.40  |- mesh__publicMeSHNote mesh__D050746
% 210.18/210.40       2006; DIHYDRODIPICOLINATE REDUCTASE was indexed under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 2004-2005, under OXIDOREDUCTASES 1982-2003, and under PICOLINIC ACIDS 1974-1981%A%  
% 210.18/210.40  |- skos__hiddenLabel mesh__D050746 Acid Reductase, Dihydrodipicolinic
% 210.18/210.40  |- mesh__recordAuthorizer mesh__D050746 sjn
% 210.18/210.40  |- mesh__dateEstablished mesh__D050746 2006-01-01
% 210.18/210.40  |- skos__prefLabel mesh__D050746 Dihydrodipicolinate Reductase
% 210.18/210.40  |- skos__historyNote mesh__D050746
% 210.18/210.40       Oxidoreductases Acting on CH-CH Group Donors %28%2004-2005%29%
% 210.18/210.40  |- skos__hiddenLabel mesh__D050746 Reductase, Dihydrodipicolinic Acid
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D050746 2006
% 210.18/210.40  |- skos__hiddenLabel mesh__D050746 Reductase, Dihydrodipicolinate
% 210.18/210.40  |- mesh__dateCreated mesh__D050746 2005-06-30
% 210.18/210.40  |- mesh__historyNote mesh__D050746 2006%28%1974%29%   
% 210.18/210.40  |- rdf__type mesh__D050746sskos__Concept
% 210.18/210.40  |- mesh__recordOriginator mesh__D050746 AKE
% 210.18/210.40  |- skos__broader mesh__D050746smesh__D044925
% 210.18/210.40  |- skos__historyNote mesh__D050746 Picolinic Acids %28%1974-1981%29%
% 210.18/210.40  |- skos__altLabel mesh__D050746 Dihydrodipicolinic Acid Reductase
% 210.18/210.40  |- skos__historyNote mesh__D050746 Oxidoreductases %28%1982-2003%29%
% 210.18/210.40  |- skos__scopeNote mesh__D050746
% 210.18/210.40       An enzyme that catalyzes the oxidation of 2,3,4,5-tetrahydrodipicolinate to 2,3-dihydrodipicolinate using NAD%28%P%29%+ as a cofactor. It is found in BACTERIA and higher plants involved in the biosynthesis of DIAMINOPIMELIC ACID and LYSINE.%A%    
% 210.18/210.40  |- skos__broader mesh__D044709smesh__D044707
% 210.18/210.40  |- mesh__recordAuthorizer mesh__D044709 sjn
% 210.18/210.40  |- mesh__recordOriginator mesh__D044709 lkt
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D044709 2006
% 210.18/210.40  |- skos__related mesh__D044709smesh__D014948
% 210.18/210.40  |- mesh__historyNote mesh__D044709
% 210.18/210.40       2004; for BALLISTICS, WOUND see WOUNDS, GUNSHOT 1987-2003%A%  
% 210.18/210.40  |- skos__hiddenLabel mesh__D044709 Ballistics, Forensic
% 210.18/210.40  |- mesh__dateCreated mesh__D044709 2003-07-09
% 210.18/210.40  |- skos__hiddenLabel mesh__D044709 Ballistic, Forensic
% 210.18/210.40  |- rdf__type mesh__D044709sskos__Concept
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D044709 2005
% 210.18/210.40  |- skos__hiddenLabel mesh__D044709 Wound Ballistics
% 210.18/210.40  |- skos__historyNote mesh__D044709 Wounds, Gunshot %28%1966-2003%29%
% 210.18/210.40  |- mesh__publicMeSHNote mesh__D044709
% 210.18/210.40       2004; for BALLISTICS, WOUND use WOUNDS, GUNSHOT 1987-2003%A%  
% 210.18/210.40  |- skos__hiddenLabel mesh__D044709 Forensic Ballistic
% 210.18/210.40  |- skos__scopeNote mesh__D044709
% 210.18/210.40       The science of studying projectiles in motion, BALLISTICS, being applied to law. Ballistics on firearm projectiles, such as bullets, include the study of what happens inside the weapon, during the flight of the projectile, and when the projectile strikes the target, such as body tissue.%A%    
% 210.18/210.40  |- mesh__recordMaintainer mesh__D044709 lkt
% 210.18/210.40  |- mesh__dateEstablished mesh__D044709 2004-01-01
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D044709 2004
% 210.18/210.40  |- skos__prefLabel mesh__D044709 Forensic Ballistics
% 210.18/210.40  |- skos__altLabel mesh__D008586 Meningitis, Streptococcus pneumoniae
% 210.18/210.40  |- skos__hiddenLabel mesh__D008586 Streptococcus pneumoniae Meningitides
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D008586 2006
% 210.18/210.40  |- skos__hiddenLabel mesh__D008586 Pneumococcal Meningitides
% 210.18/210.40  |- mesh__recordOriginator mesh__D008586 NLM
% 210.18/210.40  |- skos__scopeNote mesh__D008586
% 210.18/210.40       An acute purulent infection of the meninges and subarachnoid space caused by Streptococcus pneumoniae, most prevalent in children and adults over the age of 60. This illness may be associated with OTITIS MEDIA; MASTOIDITIS; SINUSITIS; RESPIRATORY TRACT INFECTIONS; sickle cell disease %28%ANEMIA, SICKLE CELL%29%; skull fractures; and other disorders. Clinical manifestations include FEVER; HEADACHE; neck stiffness; and somnolence followed by SEIZURES; focal neurologic deficits %28%notably DEAFNESS%29%; and COMA. %28%From Miller et al., Merritt%27%s Textbook of Neurology, 9th ed, p111%29%%A%    
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D008586 2001
% 210.18/210.40  |- rdf__type mesh__D008586sskos__Concept
% 210.18/210.40  |- skos__hiddenLabel mesh__D008586 Streptococcus pneumoniae Meningitis
% 210.18/210.40  |- skos__hiddenLabel mesh__D008586 Meningitis, Experimental Pneumococcal
% 210.18/210.40  |- skos__hiddenLabel mesh__D008586 Pneumococcal Meningitis
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D008586 2002
% 210.18/210.40  |- skos__broader mesh__D008586smesh__D016920
% 210.18/210.40  |- skos__hiddenLabel mesh__D008586 Experimental Pneumococcal Meningitides
% 210.18/210.40  |- skos__hiddenLabel mesh__D008586 Pneumococcal Meningitis, Experimental
% 210.18/210.40  |- skos__hiddenLabel mesh__D008586 Pneumococcal Meningitides, Experimental
% 210.18/210.40  |- skos__prefLabel mesh__D008586 Meningitis, Pneumococcal
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D008586 2003
% 210.18/210.40  |- skos__annotation mesh__D008586
% 210.18/210.40       do not coord with STREPTOCOCCUS PNEUMONIAE unless organism is particularly discussed%A%  
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D008586 2004
% 210.18/210.40  |- mesh__dateRevised mesh__D008586 1999-11-03
% 210.18/210.40  |- mesh__recordMaintainer mesh__D008586 KEV
% 210.18/210.40  |- mesh__recordAuthorizer mesh__D008586 sjn
% 210.18/210.40  |- skos__altLabel mesh__D008586 Meningitis, Pneumococcal, Experimental
% 210.18/210.40  |- skos__hiddenLabel mesh__D008586 Meningitides, Streptococcus pneumoniae
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D008586 2005
% 210.18/210.40  |- mesh__dateCreated mesh__D008586 1999-01-01
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D008586 2000
% 210.18/210.40  |- skos__broader mesh__D008586smesh__D011008
% 210.18/210.40  |- mesh__dateRevised mesh__D013720 2005-06-30
% 210.18/210.40  |- mesh__historyNote mesh__D013720
% 210.18/210.40       91%28%75%29%; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90%A%  
% 210.18/210.40  |- mesh__publicMeSHNote mesh__D013720
% 210.18/210.40       91; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90   
% 210.18/210.40  |- rdf__type mesh__D013720sskos__Concept
% 210.18/210.40  |- mesh__recordMaintainer mesh__D013720 ssb
% 210.18/210.40  |- mesh__dateEstablished mesh__D013720 1991-01-01
% 210.18/210.40  |- skos__prefLabel mesh__D013720 Tenuazonic Acid
% 210.18/210.40  |- skos__annotation mesh__D013720 an antineoplastic antibiotic   
% 210.18/210.40  |- mesh__recordOriginator mesh__D013720 NLM
% 210.18/210.40  |- mesh__dateCreated mesh__D013720 1974-11-19
% 210.18/210.40  |- skos__broader mesh__D013720smesh__D009183
% 210.18/210.40  |- skos__historyNote mesh__D013720 Pyrrolidinones %28%1971-1974%29%
% 210.18/210.40  |- skos__scopeNote mesh__D013720
% 210.18/210.40       3-Acetyl-5-sec-butyl-4-hydroxy-3-pyrrolin-2-one. A metabolite found in a strain of the fungus Alternaria tenuis Auct. which functions as an antibiotic with antiviral and antineoplastic properties, and may also act as a mycotoxin.%A%    
% 210.18/210.40  |- mesh__recordAuthorizer mesh__D013720 sjn
% 210.18/210.40  |- skos__hiddenLabel mesh__D013720 Acid, Tenuazonic
% 210.18/210.40  |- skos__broader mesh__D013720smesh__D011760
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D013720 2006
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004994 2006
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004994 2000
% 210.18/210.40  |- mesh__publicMeSHNote mesh__D004994
% 210.18/210.40       68; was ETHICS, PHARMACEUTICAL 1963-67   
% 210.18/210.40  |- skos__annotation mesh__D004994
% 210.18/210.40       specify geog if pertinent; DF: ETHICS PHARM   
% 210.18/210.40  |- skos__hiddenLabel mesh__D004994 Ethic, Pharmaceutic
% 210.18/210.40  |- skos__altLabel mesh__D004994 Ethics, Pharmaceutic
% 210.18/210.40  |- skos__scopeNote mesh__D004994
% 210.18/210.40       The principles of proper professional conduct concerning the rights and duties of the pharmacist, relations with patients and fellow practitioners, as well as actions of the pharmacist in health care and interpersonal relations with patient families. %28%From Stedman, 25th ed%29%%A%    
% 210.18/210.40  |- mesh__dateEstablished mesh__D004994 1968-01-01
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004994 2001
% 210.18/210.40  |- skos__prefLabel mesh__D004994 Ethics, Pharmacy
% 210.18/210.40  |- skos__hiddenLabel mesh__D004994 Pharmaceutic Ethic
% 210.18/210.40  |- mesh__recordMaintainer mesh__D004994 adp
% 210.18/210.40  |- skos__altLabel mesh__D004994 Pharmacy Ethics
% 210.18/210.40  |- mesh__historyNote mesh__D004994
% 210.18/210.40       68; was ETHICS, PHARMACEUTICAL 1963-67   
% 210.18/210.40  |- skos__hiddenLabel mesh__D004994 Pharmaceutical Ethic
% 210.18/210.40  |- skos__altLabel mesh__D004994 Ethics, Pharmaceutical
% 210.18/210.40  |- rdf__type mesh__D004994sskos__Concept
% 210.18/210.40  |- mesh__dateRevised mesh__D004994 1999-11-08
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004994 2002
% 210.18/210.40  |- mesh__recordAuthorizer mesh__D004994 sjn
% 210.18/210.40  |- mesh__recordOriginator mesh__D004994 NLM
% 210.18/210.40  |- skos__broader mesh__D004994smesh__D004995
% 210.18/210.40  |- mesh__dateCreated mesh__D004994 1999-01-01
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004994 2003
% 210.18/210.40  |- skos__hiddenLabel mesh__D004994 Ethic, Pharmacy
% 210.18/210.40  |- skos__hiddenLabel mesh__D004994 Ethic, Pharmaceutical
% 210.18/210.40  |- skos__altLabel mesh__D004994 Pharmaceutical Ethics
% 210.18/210.40  |- skos__altLabel mesh__D004994 Pharmaceutic Ethics
% 210.18/210.40  |- skos__hiddenLabel mesh__D004994 Pharmacy Ethic
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004994 2005
% 210.18/210.40  |- mesh__onlineNote mesh__D004994
% 210.18/210.40       use ETHICS, PHARMACY to search ETHICS, PHARMACEUTICAL 1966-67%A%  
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004994 2004
% 210.18/210.40  |- mesh__dateRevised mesh__D045802 2005-06-30
% 210.18/210.40  |- skos__broader mesh__D045802smesh__D009174
% 210.18/210.40  |- mesh__recordMaintainer mesh__D045802 SYSTEM
% 210.18/210.40  |- mesh__publicMeSHNote mesh__D045802 2004   
% 210.18/210.40  |- skos__scopeNote mesh__D045802
% 210.18/210.40       A species of gram-negative bacteria originally isolated from the LUNGS; TRACHEA; and NASAL CAVITY of SHEEP. It causes chronic interstitial pneumonia %28%PNEUMONIA, MYCOPLASMA%29% in both SHEEP and GOATS.%A%    
% 210.18/210.40  |- skos__annotation mesh__D045802
% 210.18/210.40       infection: coord IM with PNEUMONIA, MYCOPLASMA/vet %28%IM%29%   
% 210.18/210.40  |- mesh__recordAuthorizer mesh__D045802 sjn
% 210.18/210.40  |- rdf__type mesh__D045802sskos__Concept
% 210.18/210.40  |- mesh__historyNote mesh__D045802 2004   
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D045802 2006
% 210.18/210.40  |- mesh__recordOriginator mesh__D045802 ags
% 210.18/210.40  |- mesh__dateEstablished mesh__D045802 2004-01-01
% 210.18/210.40  |- skos__historyNote mesh__D045802 Mycoplasma %28%1975-2003%29%
% 210.18/210.40  |- mesh__dateCreated mesh__D045802 2003-07-09
% 210.18/210.40  |- skos__prefLabel mesh__D045802 Mycoplasma ovipneumoniae
% 210.18/210.40  |- skos__hiddenLabel mesh__D004196 Outbreak, Disease
% 210.18/210.40  |- mesh__historyNote mesh__D004196 68%28%66%29%   
% 210.18/210.40  |- skos__altLabel mesh__D004196 Outbreaks
% 210.18/210.40  |- skos__annotation mesh__D004196
% 210.18/210.40       IM; coord IM with specific dis /epidemiol %28%IM%29% %26% specify geog%A%  
% 210.18/210.40  |- mesh__dateEstablished mesh__D004196 1968-01-01
% 210.18/210.40  |- skos__hiddenLabel mesh__D004196 Disease Outbreak
% 210.18/210.40  |- skos__scopeNote mesh__D004196
% 210.18/210.40       Sudden increase in the incidence of a disease. The concept includes epidemics and pandemics.%A%    
% 210.18/210.40  |- skos__hiddenLabel mesh__D004196 Pandemic
% 210.18/210.40  |- mesh__recordAuthorizer mesh__D004196 ags
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004196 2006
% 210.18/210.40  |- skos__hiddenLabel mesh__D004196 Outbreaks, Disease
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004196 2006A
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004196 2005
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004196 2002
% 210.18/210.40  |- skos__related mesh__D004196smesh__D003141
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004196 2004
% 210.18/210.40  |- mesh__recordMaintainer mesh__D004196 ags
% 210.18/210.40  |- skos__hiddenLabel mesh__D004196 Epidemic
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004196 2001
% 210.18/210.40  |- mesh__recordOriginator mesh__D004196 NLM
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004196 2003
% 210.18/210.40  |- mesh__publicMeSHNote mesh__D004196 68   
% 210.18/210.40  |- mesh__dateRevised mesh__D004196 2005-11-10
% 210.18/210.40  |- rdf__type mesh__D004196sskos__Concept
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D004196 2000
% 210.18/210.40  |- skos__prefLabel mesh__D004196 Disease Outbreaks
% 210.18/210.40  |- mesh__dateCreated mesh__D004196 1999-01-01
% 210.18/210.40  |- skos__broader mesh__D004196smesh__D011634
% 210.18/210.40  |- skos__broader mesh__D013587Q000151smesh__D013587
% 210.18/210.40  |- mesh__preferredCombination mesh__D013587Q000151smesh__D013590
% 210.18/210.40  |- rdf__type mesh__D013587Q000151smesh__CompoundConcept
% 210.18/210.40  |- skos__hiddenLabel mesh__D012628 Seborrheic Dermatitides
% 210.18/210.40  |- mesh__dateCreated mesh__D012628 1999-01-01
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D012628 2005
% 210.18/210.40  |- skos__broader mesh__D012628smesh__D003872
% 210.18/210.40  |- mesh__publicMeSHNote mesh__D012628 93; was SEBORRHEA 1963-92   
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D012628 2003
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D012628 2006
% 210.18/210.40  |- mesh__dateRevised mesh__D012628 2001-07-25
% 210.18/210.40  |- mesh__recordAuthorizer mesh__D012628 sjn
% 210.18/210.40  |- skos__prefLabel mesh__D012628 Dermatitis, Seborrheic
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D012628 2002
% 210.18/210.40  |- mesh__activeMeSHYear mesh__D012628 2004
% 210.18/210.40  |- rdf__type mesh__D012628sskos__Concept
% 210.18/210.40  |- skos__broader mesh__D012628smesh__D017444
% 210.18/210.40  |- skos__broader mesh__D012628smesh__D012625
% 210.18/210.40  |- skos__hiddenLabel mesh__D012628 Seborrheic Dermatitis
% 210.18/210.40  |- skos__scopeNote mesh__D012628
% 210.18/210.40       A chronic inflammatory disease of the skin of unknown etiology. It is characterized by moderate erythema, dry, moist, or greasy scaling, and yellow crusted patches on various areas, especially the scalp. On the scalp, it generally appears first as small patches of scales, progressing to involve the entire scalp with exfoliation of excessive amounts of dry scales %28%dandruff%29%.%A%    
% 210.18/210.41  |- skos__hiddenLabel mesh__D012628 Dermatitides, Seborrheic
% 210.18/210.41  |- mesh__onlineNote mesh__D012628
% 210.18/210.41       use DERMATITIS, SEBORRHEIC to search SEBORRHEA 1966-92   
% 210.18/210.41  |- skos__broader mesh__D012628smesh__D017443
% 210.18/210.41  |- mesh__recordMaintainer mesh__D012628 lkt
% 210.18/210.41  |- mesh__recordOriginator mesh__D012628 NLM
% 210.18/210.41  |- skos__altLabel mesh__D012628 Seborrhea
% 210.18/210.41  |- mesh__historyNote mesh__D012628 93; was SEBORRHEA 1963-92   
% 210.18/210.41  |- mesh__recordMaintainer mesh__D017313 ssb
% 210.18/210.41  |- skos__altLabel mesh__D017313 N-%28%4-Hydroxyphenyl%29%retinamide
% 210.18/210.41  |- skos__altLabel mesh__D017313 4-HPR
% 210.18/210.41  |- mesh__dateRevised mesh__D017313 2005-06-30
% 210.18/210.41  |- skos__scopeNote mesh__D017313
% 210.18/210.41       A synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent.%A%    
% 210.18/210.41  |- skos__historyNote mesh__D017313
% 210.18/210.41       Tretinoin/analogs %26% derivatives %28%1979-1992%29%
% 210.18/210.41  |- mesh__publicMeSHNote mesh__D017313
% 210.18/210.41       93; FENRETINIDE was indexed under TRETINOIN/analogs %26% derivatives 1979-92%A%  
% 210.18/210.41  |- mesh__historyNote mesh__D017313
% 210.18/210.41       93; was FENRETINIDE %28%NM%29% 1979-92   
% 210.18/210.41  |- skos__altLabel mesh__D017313 Fenretinimide
% 210.18/210.41  |- skos__hiddenLabel mesh__D017313 MCNR1967
% 210.18/210.41  |- mesh__recordOriginator mesh__D017313 TPW
% 210.18/210.41  |- mesh__activeMeSHYear mesh__D017313 2006
% 210.18/210.41  |- mesh__dateCreated mesh__D017313 1992-05-19
% 210.18/210.41  |- skos__hiddenLabel mesh__D017313 MCN R 1967
% 210.18/210.41  |- skos__hiddenLabel mesh__D017313 Fenretinide, 13 cis Isomer
% 210.18/210.41  |- skos__hiddenLabel mesh__D017313 13-cis-Isomer Fenretinide
% 210.18/210.41  |- skos__prefLabel mesh__D017313 Fenretinide
% 210.18/210.41  |- mesh__recordAuthorizer mesh__D017313 sjn
% 210.18/210.41  |- skos__broader mesh__D017313smesh__D012176
% 210.18/210.41  |- mesh__dateEstablished mesh__D017313 1993-01-01
% 210.18/210.41  |- skos__hiddenLabel mesh__D017313 4 Hydroxyphenylretinamide
% 210.18/210.41  |- mesh__onlineNote mesh__D017313
% 210.18/210.41       use FENRETINIDE %28%NM%29% to search FENRETINIDE 1979-92   
% 210.18/210.41  |- rdf__type mesh__D017313sskos__Concept
% 210.18/210.41  |- skos__altLabel mesh__D017313 4-Hydroxyphenylretinamide
% 210.18/210.41  |- skos__broader mesh__D008587smesh__D014777
% 210.18/210.41  |- mesh__activeMeSHYear mesh__D008587 2002
% 210.18/210.41  |- mesh__dateRevised mesh__D008587 2001-08-03
% 210.18/210.41  |- mesh__recordMaintainer mesh__D008587 sjn
% 210.18/210.41  |- skos__altLabel mesh__D008587 Viral Meningitis
% 210.18/210.41  |- mesh__activeMeSHYear mesh__D008587 2006
% 210.18/210.41  |- mesh__recordAuthorizer mesh__D008587 sjn
% 210.18/210.41  |- skos__scopeNote mesh__D008587
% 210.18/210.41       Viral infections of the leptomeninges and subarachnoid space. TOGAVIRIDAE INFECTIONS; FLAVIVIRIDAE INFECTIONS; RUBELLA; BUNYAVIRIDAE INFECTIONS; ORBIVIRUS infections; PICORNAVIRIDAE INFECTIONS; ORTHOMYXOVIRIDAE INFECTIONS; RHABDOVIRIDAE INFECTIONS; ARENAVIRIDAE INFECTIONS; HERPESVIRIDAE INFECTIONS; ADENOVIRIDAE INFECTIONS; JC VIRUS infections; and RETROVIRIDAE INFECTIONS may cause this form of meningitis. Clinical manifestations include fever, headache, neck pain, vomiting, PHOTOPHOBIA, and signs of meningeal irritation. %28%From Joynt, Clinical Neurology, 1996, Ch26, pp1-3%29%%A%    
% 210.18/210.41  |- mesh__activeMeSHYear mesh__D008587 2005
% 210.18/210.41  |- skos__hiddenLabel mesh__D008587 Meningitides, Viral
% 210.18/210.41  |- mesh__recordOriginator mesh__D008587 NLM
% 210.18/210.41  |- skos__broader mesh__D008587smesh__D008581
% 210.18/210.41  |- rdf__type mesh__D008587sskos__Concept
% 210.18/210.41  |- mesh__activeMeSHYear mesh__D008587 2004
% 210.18/210.41  |- skos__annotation mesh__D008587
% 210.18/210.41       coord IM with specific virus dis %28%IM%29%   
% 210.18/210.41  |- skos__prefLabel mesh__D008587 Meningitis, Viral
% 210.18/210.41  |- skos__hiddenLabel mesh__D008587 Viral Meningitides
% 210.18/210.41  |- skos__broader mesh__D008587smesh__D020805
% 210.18/210.41  |- mesh__activeMeSHYear mesh__D008587 2003
% 210.18/210.41  |- mesh__dateCreated mesh__D008587 1999-01-01
% 210.18/210.41  |- skos__broader mesh__D027741smesh__D027722
% 210.18/210.41  |- mesh__activeMeSHYear mesh__D027741 2002
% 210.18/210.41  |- mesh__dateCreated mesh__D027741 2001-07-25
% 210.18/210.41  |- skos__annotation mesh__D027741
% 210.18/210.41       for morning glory check whether it is IPOMOEA or CONVOLVULUS; specify Plant Components; for /Chem crd with D tree compound and/or Preparation; for therap. coordinate with Food or Toxicity or Diseases and PHYTOTHERAPY%A%  
% 210.18/210.41  |- rdf__type mesh__D027741sskos__Concept
% 210.18/210.41  |- skos__prefLabel mesh__D027741 Ipomoea
% 210.18/210.41  |- mesh__publicMeSHNote mesh__D027741 2002   
% 210.18/210.41  |- skos__scopeNote mesh__D027741
% 210.18/210.41       A plant genus in the family CONVOLVULACEAE best known for morning glories %28%a common name also used with CONVOLVULUS%29% and sweet potato.%A%    
% 210.18/210.41  |- mesh__activeMeSHYear mesh__D027741 2003
% 210.18/210.41  |- mesh__activeMeSHYear mesh__D027741 2005
% 210.18/210.41  |- mesh__dateEstablished mesh__D027741 2002-01-01
% 210.18/210.41  |- mesh__activeMeSHYear mesh__D027741 2004
% 210.18/210.41  |- skos__related mesh__D027741smesh__D027742
% 210.18/210.41  |- mesh__activeMeSHYear mesh__D027741 2006
% 210.18/210.41  |- mesh__historyNote mesh__D027741 2002   
% 210.18/210.41  |- skos__annotation mesh__D013721
% 210.18/210.41       a chemosterilant %26% alkylating antineoplastic   
% 210.18/210.41  |- skos__historyNote mesh__D013721 Chemosterilants %28%1966-1971%29%
% 210.18/210.41  |- mesh__dateCreated mesh__D013721 1999-01-01
% 210.18/210.41  |- mesh__activeMeSHYear mesh__D013721 2006
% 210.18/210.41  |- rdf__type mesh__D013721sskos__Concept
% 210.18/210.41  |- mesh__dateEstablished mesh__D013721 1991-01-01
% 210.18/210.41  |- mesh__activeMeSHYear mesh__D013721 2003
% 210.18/210.41  |- mesh__recordOriginator mesh__D013721 NLM
% 210.18/210.41  |- mesh__historyNote mesh__D013721
% 210.18/210.41       96; was TEPA 1972-95 %28%see under AZIRINES 1972-90%29%   
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D013721 2002
% 210.27/210.41  |- skos__prefLabel mesh__D013721 Triethylenephosphoramide
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D013721 2004
% 210.27/210.41  |- skos__altLabel mesh__D013721 TEPA
% 210.27/210.41  |- mesh__publicMeSHNote mesh__D013721
% 210.27/210.41       96; was TEPA 1972-95 %28%see under AZIRINES 1972-90%29%   
% 210.27/210.41  |- skos__broader mesh__D013721smesh__D001388
% 210.27/210.41  |- mesh__recordMaintainer mesh__D013721 jmp
% 210.27/210.41  |- skos__scopeNote mesh__D013721
% 210.27/210.41       An insect chemosterilant and an antineoplastic agent.     
% 210.27/210.41  |- mesh__recordAuthorizer mesh__D013721 sjn
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D013721 2000
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D013721 2005
% 210.27/210.41  |- mesh__dateRevised mesh__D013721 1999-11-03
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D013721 2001
% 210.27/210.41  |- skos__historyNote mesh__D013721 Azirines %28%1968-1971%29%
% 210.27/210.41  |- skos__altLabel mesh__D051840
% 210.27/210.41       Nuclease Sensitive Element Binding Protein 1
% 210.27/210.41  |- skos__prefLabel mesh__D051840 Y-Box-Binding Protein 1
% 210.27/210.41  |- mesh__dateEstablished mesh__D051840 2006-01-01
% 210.27/210.41  |- skos__hiddenLabel mesh__D051840 Y Box Binding Protein YB 1
% 210.27/210.41  |- skos__altLabel mesh__D051840 Y-Box Protein-1
% 210.27/210.41  |- skos__hiddenLabel mesh__D051840 Y Box Binding Protein 1
% 210.27/210.41  |- mesh__historyNote mesh__D051840 2006%28%1984%29%   
% 210.27/210.41  |- mesh__recordOriginator mesh__D051840 DRC
% 210.27/210.41  |- mesh__dateCreated mesh__D051840 2005-06-30
% 210.27/210.41  |- skos__altLabel mesh__D051840 NSEP1 Transcription Factor
% 210.27/210.41  |- rdf__type mesh__D051840sskos__Concept
% 210.27/210.41  |- skos__hiddenLabel mesh__D051840 Y Box Protein 1
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D051840 2006
% 210.27/210.41  |- mesh__recordAuthorizer mesh__D051840 sjn
% 210.27/210.41  |- mesh__publicMeSHNote mesh__D051840
% 210.27/210.41       2006; Y-BOX-BINDING PROTEIN 1 was indexed under TRANSCRIPTION FACTORS 1984-2005, under CCAAT-ENHANCER-BINDING PROTEINS 2005, %26% under DNA-BINDING PROTEINS 1986-2004%A%  
% 210.27/210.41  |- mesh__recordMaintainer mesh__D051840 DRC
% 210.27/210.41  |- skos__broader mesh__D051840smesh__D022762
% 210.27/210.41  |- skos__altLabel mesh__D051840 DNA Binding Protein B
% 210.27/210.41  |- skos__hiddenLabel mesh__D051840 Transcription Factor, NSEP1
% 210.27/210.41  |- skos__scopeNote mesh__D051840
% 210.27/210.41       Y-box-binding protein 1 was originally identified as a DNA-binding protein that interacts with Y-box PROMOTER REGIONS of MHC CLASS II GENES. It is a highly conserved transcription factor that regulates expression of a wide variety of GENES.%A%    
% 210.27/210.41  |- skos__altLabel mesh__D051840 Y-Box Binding Protein YB-1
% 210.27/210.41  |- mesh__recordAuthorizer mesh__D004995 sjn
% 210.27/210.41  |- skos__historyNote mesh__D004995 Ethics %28%1966-1967%29%
% 210.27/210.41  |- mesh__historyNote mesh__D004995 68   
% 210.27/210.41  |- mesh__recordOriginator mesh__D004995 NLM
% 210.27/210.41  |- mesh__dateCreated mesh__D004995 1999-01-01
% 210.27/210.41  |- skos__prefLabel mesh__D004995 Ethics, Professional
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D004995 2003
% 210.27/210.41  |- mesh__recordMaintainer mesh__D004995 jrf
% 210.27/210.41  |- skos__scopeNote mesh__D004995
% 210.27/210.41       The principles of proper conduct concerning the rights and duties of the professional, relations with patients or consumers and fellow practitioners, as well as actions of the professional and interpersonal relations with patient or consumer families. %28%From Stedman, 25th ed%29%%A%    
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D004995 2006
% 210.27/210.41  |- skos__annotation mesh__D004995 specify geog if pertinent   
% 210.27/210.41  |- skos__hiddenLabel mesh__D004995 Ethic, Professional
% 210.27/210.41  |- skos__broader mesh__D004995smesh__D004989
% 210.27/210.41  |- skos__related mesh__D004995smesh__D028743
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D004995 2002
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D004995 2005
% 210.27/210.41  |- mesh__dateRevised mesh__D004995 2001-07-25
% 210.27/210.41  |- mesh__publicMeSHNote mesh__D004995 68   
% 210.27/210.41  |- rdf__type mesh__D004995sskos__Concept
% 210.27/210.41  |- mesh__dateEstablished mesh__D004995 1968-01-01
% 210.27/210.41  |- skos__hiddenLabel mesh__D004995 Professional Ethic
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D004995 2004
% 210.27/210.41  |- skos__altLabel mesh__D004995 Professional Ethics
% 210.27/210.41  |- skos__hiddenLabel mesh__D051042
% 210.27/210.41       Formimino L Glutamate Tetrahydrofolate 5 Formiminotransferase
% 210.27/210.41  |- rdf__type mesh__D051042sskos__Concept
% 210.27/210.41  |- mesh__recordMaintainer mesh__D051042 ags
% 210.27/210.41  |- mesh__recordOriginator mesh__D051042 AKE
% 210.27/210.41  |- mesh__publicMeSHNote mesh__D051042
% 210.27/210.41       2006; GLUTAMATE FORMIMIDOYLTRANSFERASE was indexed under HYDROXYMETHYL AND FORMYL TRANSFERASES 1980-2005, FORMIMINOGLUTAMIC ACID 1977-1980, TRANSFERASES 1975-1997, GLUTAMATES 1975-1977, %26% under FORMIC ACIDS %26% IMINES 1975-1976%A%  
% 210.27/210.41  |- skos__scopeNote mesh__D051042
% 210.27/210.41       A PYRIDOXAL PHOSPHATE-containing enzyme that catalyzes the transfer of a formyl group from L-GLUTAMATE to N-formimidoyl-L-glutamate and TETRAHYDROFOLATE. This enzyme may also catalyze formyl transfer from 5-formyltetrahydrofolate to L-GLUTAMATE. This enzyme was formerly categorized as EC 2.1.2.6.%A%    
% 210.27/210.41  |- skos__hiddenLabel mesh__D051042 Transferase, Formimino
% 210.27/210.41  |- mesh__recordAuthorizer mesh__D051042 ags
% 210.27/210.41  |- skos__altLabel mesh__D051042 Formimino Transferase
% 210.27/210.41  |- mesh__dateCreated mesh__D051042 2005-06-30
% 210.27/210.41  |- skos__hiddenLabel mesh__D051042 Formiminotransferase, Glutamate
% 210.27/210.41  |- skos__hiddenLabel mesh__D051042 Formyltransferase, Glutamate
% 210.27/210.41  |- skos__hiddenLabel mesh__D051042 Formimidoyltransferase, Glutamate
% 210.27/210.41  |- skos__altLabel mesh__D051042
% 210.27/210.41       Formimino-L-Glutamate Tetrahydrofolate 5-Formiminotransferase
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D051042 2006
% 210.27/210.41  |- skos__hiddenLabel mesh__D051042
% 210.27/210.41       Tetrahydrofolate 5-Formiminotransferase, Formimino-L-Glutamate
% 210.27/210.41  |- skos__hiddenLabel mesh__D051042
% 210.27/210.41       5-Formiminotransferase, Formimino-L-Glutamate Tetrahydrofolate
% 210.27/210.41  |- skos__prefLabel mesh__D051042 Glutamate Formimidoyltransferase
% 210.27/210.41  |- skos__hiddenLabel mesh__D051042 Transferase, Formiminotetrahydrofolate
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D051042 2006A
% 210.27/210.41  |- mesh__dateRevised mesh__D051042 2005-07-14
% 210.27/210.41  |- skos__altLabel mesh__D051042 Glutamate Formiminotransferase
% 210.27/210.41  |- skos__altLabel mesh__D051042 Glutamate Formyltransferase
% 210.27/210.41  |- mesh__historyNote mesh__D051042
% 210.27/210.41       2006%28%1980%29%; use FORMIMINOGLUTAMIC ACID 1977-1980, TRANSFERASES 1975-1997, GLUTAMATES 1975-1977, FORMIC ACIDS %26% IMINES 1975-1976%A%  
% 210.27/210.41  |- mesh__dateEstablished mesh__D051042 2006-01-01
% 210.27/210.41  |- skos__broader mesh__D051042smesh__D019877
% 210.27/210.41  |- skos__altLabel mesh__D051042 Formiminotetrahydrofolate Transferase
% 210.27/210.41  |- mesh__recordAuthorizer mesh__D045803 sjn
% 210.27/210.41  |- mesh__publicMeSHNote mesh__D045803 2004   
% 210.27/210.41  |- mesh__historyNote mesh__D045803 2004   
% 210.27/210.41  |- skos__scopeNote mesh__D045803
% 210.27/210.41       A species of gram-negative bacteria highly pathogenic to RATS and MICE. It is the primary cause of murine respiratory mycoplasmosis.%A%    
% 210.27/210.41  |- skos__historyNote mesh__D045803 Mycoplasma %28%1965-2003%29%
% 210.27/210.41  |- mesh__recordOriginator mesh__D045803 ags
% 210.27/210.41  |- skos__broader mesh__D045803smesh__D009174
% 210.27/210.41  |- skos__annotation mesh__D045803
% 210.27/210.41       infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29%   
% 210.27/210.41  |- mesh__dateRevised mesh__D045803 2005-06-30
% 210.27/210.41  |- mesh__dateEstablished mesh__D045803 2004-01-01
% 210.27/210.41  |- mesh__recordMaintainer mesh__D045803 SYSTEM
% 210.27/210.41  |- rdf__type mesh__D045803sskos__Concept
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D045803 2006
% 210.27/210.41  |- mesh__dateCreated mesh__D045803 2003-07-09
% 210.27/210.41  |- skos__prefLabel mesh__D045803 Mycoplasma pulmonis
% 210.27/210.41  |- skos__prefLabel mesh__D004197 Disease Reservoirs
% 210.27/210.41  |- skos__annotation mesh__D004197
% 210.27/210.41       IM; note category; differentiate from DISEASE VECTORS %28%B1 %26% B2%29%: reservoirs can be animate or inanimate %28%like swamps, housedust, etc.%29%%A%  
% 210.27/210.41  |- skos__related mesh__D004197smesh__D002353
% 210.27/210.41  |- mesh__recordAuthorizer mesh__D004197 sjn
% 210.27/210.41  |- mesh__dateEstablished mesh__D004197 1967-01-01
% 210.27/210.41  |- mesh__recordOriginator mesh__D004197 NLM
% 210.27/210.41  |- mesh__publicMeSHNote mesh__D004197 67   
% 210.27/210.41  |- skos__hiddenLabel mesh__D004197 Reservoir, Disease
% 210.27/210.41  |- skos__scopeNote mesh__D004197
% 210.27/210.41       Animate or inanimate sources which harbor disease-causing organisms and thus serve as potential sources of disease outbreaks. Reservoirs should be distinguished from vectors and carriers, which are agents of disease transmission rather than continuing sources of potential disease outbreaks.%A%    
% 210.27/210.41  |- skos__broader mesh__D004197smesh__D011634
% 210.27/210.41  |- mesh__recordMaintainer mesh__D004197 ags
% 210.27/210.41  |- mesh__historyNote mesh__D004197 67%28%65%29%   
% 210.27/210.41  |- rdf__type mesh__D004197sskos__Concept
% 210.27/210.41  |- skos__hiddenLabel mesh__D004197 Disease Reservoir
% 210.27/210.41  |- mesh__dateCreated mesh__D004197 1999-01-01
% 210.27/210.41  |- skos__related mesh__D004197smesh__D004199
% 210.27/210.41  |- mesh__dateRevised mesh__D004197 2005-06-30
% 210.27/210.41  |- skos__hiddenLabel mesh__D004197 Reservoirs, Disease
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D004197 2006
% 210.27/210.41  |- mesh__dateCreated mesh__D012629 1999-01-01
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D012629 2003
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D012629 2006
% 210.27/210.41  |- mesh__recordOriginator mesh__D012629 NLM
% 210.27/210.41  |- skos__prefLabel mesh__D012629 Sebum
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D012629 2000
% 210.27/210.41  |- skos__scopeNote mesh__D012629
% 210.27/210.41       The oily substance secreted by SEBACEOUS GLANDS. It is composed of KERATIN, fat, and cellular debris.%A%    
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D012629 2004
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D012629 2001
% 210.27/210.41  |- rdf__type mesh__D012629sskos__Concept
% 210.27/210.41  |- mesh__dateRevised mesh__D012629 1999-11-03
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D012629 2002
% 210.27/210.41  |- mesh__recordAuthorizer mesh__D012629 sjn
% 210.27/210.41  |- skos__hiddenLabel mesh__D012629 Sebums
% 210.27/210.41  |- mesh__recordMaintainer mesh__D012629 KEV
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D012629 2005
% 210.27/210.41  |- skos__broader mesh__D012629smesh__D012634
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D009680 1992
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D009680 1999
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D009680 2001
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D009680 2004
% 210.27/210.41  |- mesh__publicMeSHNote mesh__D009680 74   
% 210.27/210.41  |- skos__prefLabel mesh__D009680 Nuclear Fission
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D009680 1995
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D009680 1998
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D009680 2000
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D009680 2003
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D009680 1991
% 210.27/210.41  |- mesh__dateRevised mesh__D009680 1989-06-14
% 210.27/210.41  |- mesh__recordOriginator mesh__D009680 NLM
% 210.27/210.41  |- mesh__historyNote mesh__D009680
% 210.27/210.41       74%28%71%29%; was in Cat H only 1971-81   
% 210.27/210.41  |- skos__scopeNote mesh__D009680
% 210.27/210.41       Nuclear reaction in which the nucleus of a heavy atom such as uranium or plutonium is split into two approximately equal parts by a neutron, charged particle, or photon.%A%    
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D009680 1994
% 210.27/210.41  |- mesh__recordMaintainer mesh__D009680 TGC
% 210.27/210.41  |- mesh__dateCreated mesh__D009680 1999-01-01
% 210.27/210.41  |- skos__hiddenLabel mesh__D009680 Fission, Nuclear
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D009680 2006
% 210.27/210.41  |- skos__hiddenLabel mesh__D009680 Nuclear Fissions
% 210.27/210.41  |- mesh__recordAuthorizer mesh__D009680 PLS
% 210.27/210.41  |- mesh__dateEstablished mesh__D009680 1974-01-01
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D009680 1997
% 210.27/210.41  |- skos__broader mesh__D009680smesh__D009678
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D009680 2002
% 210.27/210.41  |- skos__hiddenLabel mesh__D009680 Fissions, Nuclear
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D009680 1990
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D009680 2005
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D009680 1993
% 210.27/210.41  |- skos__annotation mesh__D009680
% 210.27/210.41       no qualif; do not confuse with NUCLEAR FUSION   
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D009680 1996
% 210.27/210.41  |- skos__historyNote mesh__D009680 Nuclear Energy %28%1966-1970%29%
% 210.27/210.41  |- rdf__type mesh__D009680sskos__Concept
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D017314 2006
% 210.27/210.41  |- mesh__recordAuthorizer mesh__D017314 sjn
% 210.27/210.41  |- skos__prefLabel mesh__D017314 Annexin A4
% 210.27/210.41  |- mesh__dateCreated mesh__D017314 1992-05-07
% 210.27/210.41  |- mesh__publicMeSHNote mesh__D017314
% 210.27/210.41       1993; ANNEXIN IV were indexed under PREGNANCY PROTEINS 1987-1992; LIPOCORTIN IV was indexed under CALCIUM-BINDING PROTEINS 1982-1992; ANNEXIN A4 was indexed under ANNEXIN IV 2004%A%  
% 210.27/210.41  |- skos__scopeNote mesh__D017314
% 210.27/210.41       Protein of the annexin family originally isolated from the electric organ of the electric ray Torpedo marmorata. It has been found in a wide range of mammalian tissue where it is localized to the apical membrane of polarized EPITHELIAL CELLS.%A%    
% 210.27/210.41  |- skos__historyNote mesh__D017314
% 210.27/210.41       Calcium-Binding Proteins %28%1982-1992%29%
% 210.27/210.41  |- skos__hiddenLabel mesh__D017314 Calelectrin 32 kDa
% 210.27/210.41  |- mesh__dateRevised mesh__D017314 2004-07-07
% 210.27/210.41  |- skos__hiddenLabel mesh__D017314 32-kDa, Calelectrin
% 210.27/210.41  |- mesh__recordMaintainer mesh__D017314 jmp
% 210.27/210.41  |- rdf__type mesh__D017314sskos__Concept
% 210.27/210.41  |- skos__altLabel mesh__D017314 Annexin IV
% 210.27/210.41  |- skos__altLabel mesh__D017314 Calelectrin 32-kDa
% 210.27/210.41  |- mesh__historyNote mesh__D017314
% 210.27/210.41       2005%28%1993%29%; for ANNEXIN IV use ANNEXINS 1987-1992   
% 210.27/210.41  |- skos__altLabel mesh__D017314 Placental Anticoagulant Protein II
% 210.27/210.41  |- skos__altLabel mesh__D017314 Lipocortin IV
% 210.27/210.41  |- mesh__recordOriginator mesh__D017314 AGS
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D017314 2005
% 210.27/210.41  |- skos__broader mesh__D017314smesh__D017302
% 210.27/210.41  |- mesh__dateEstablished mesh__D017314 1993-01-01
% 210.27/210.41  |- skos__altLabel mesh__D008588 Herniation of Meninges
% 210.27/210.41  |- skos__hiddenLabel mesh__D008588 Herniation, Meningeal
% 210.27/210.41  |- mesh__recordMaintainer mesh__D008588 KEV
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D008588 2006
% 210.27/210.41  |- skos__hiddenLabel mesh__D008588 Meningoceles, Acquired
% 210.27/210.41  |- skos__broader mesh__D008588smesh__D009436
% 210.27/210.41  |- skos__hiddenLabel mesh__D008588 Traumatic Meningoceles
% 210.27/210.41  |- skos__hiddenLabel mesh__D008588 Meninges Herniations
% 210.27/210.41  |- skos__prefLabel mesh__D008588 Meningocele
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D008588 2005
% 210.27/210.41  |- skos__hiddenLabel mesh__D008588 Meningoceles, Rudimentary
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D008588 2002
% 210.27/210.41  |- skos__scopeNote mesh__D008588
% 210.27/210.41       A congenital or acquired protrusion of the meninges, unaccompanied by neural tissue, through a bony defect in the skull or vertebral column.%A%    
% 210.27/210.41  |- skos__hiddenLabel mesh__D008588 Rudimentary Meningoceles
% 210.27/210.41  |- mesh__dateRevised mesh__D008588 1999-11-03
% 210.27/210.41  |- mesh__recordAuthorizer mesh__D008588 sjn
% 210.27/210.41  |- rdf__type mesh__D008588sskos__Concept
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D008588 2004
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D008588 2001
% 210.27/210.41  |- skos__hiddenLabel mesh__D008588 Meningocele, Rudimentary
% 210.27/210.41  |- skos__altLabel mesh__D008588 Meningeal Herniation
% 210.27/210.41  |- skos__hiddenLabel mesh__D008588 Acquired Meningoceles
% 210.27/210.41  |- skos__hiddenLabel mesh__D008588 Meningeal Herniations
% 210.27/210.41  |- skos__hiddenLabel mesh__D008588 Meningocele, Acquired
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D008588 2003
% 210.27/210.41  |- skos__annotation mesh__D008588
% 210.27/210.41       meningoencephalocele: coord IM with ENCEPHALOCELE %28%IM%29%   
% 210.27/210.41  |- mesh__dateCreated mesh__D008588 1999-01-01
% 210.27/210.41  |- skos__hiddenLabel mesh__D008588 Herniations, Meningeal
% 210.27/210.41  |- mesh__recordOriginator mesh__D008588 NLM
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D008588 2000
% 210.27/210.41  |- skos__hiddenLabel mesh__D008588 Meninges Herniation
% 210.27/210.41  |- skos__hiddenLabel mesh__D008588 Meningoceles, Traumatic
% 210.27/210.41  |- skos__hiddenLabel mesh__D008588 Traumatic Meningocele
% 210.27/210.41  |- skos__hiddenLabel mesh__D008588 Meningoceles
% 210.27/210.41  |- rdf__type mesh__D027742sskos__Concept
% 210.27/210.41  |- skos__historyNote mesh__D027742 Liliaceae %28%1998-2001%29%
% 210.27/210.41  |- mesh__publicMeSHNote mesh__D027742 2002; see Liliaceae 1998-2001   
% 210.27/210.41  |- skos__broader mesh__D027742smesh__D027743
% 210.27/210.41  |- skos__annotation mesh__D027742
% 210.27/210.41       do not confuse X ref YAM with PSEUDO-YAM see IPOMOEA BATATAS; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.27/210.41  |- mesh__historyNote mesh__D027742 2002; use Liliaceae 1998-2001   
% 210.27/210.41  |- mesh__dateCreated mesh__D027742 2001-07-25
% 210.27/210.41  |- mesh__recordAuthorizer mesh__D027742 ags
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D027742 2006A
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D027742 2005
% 210.27/210.41  |- mesh__recordOriginator mesh__D027742 ssb
% 210.27/210.41  |- mesh__dateEstablished mesh__D027742 2002-01-01
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D027742 2006
% 210.27/210.41  |- skos__scopeNote mesh__D027742
% 210.27/210.41       A plant genus best known for edible underground tubers.  Yam may also refer to a moist variety of sweet potato, IPOMOEA BATATAS.%A%    
% 210.27/210.41  |- skos__related mesh__D027742smesh__D027741
% 210.27/210.41  |- mesh__recordMaintainer mesh__D027742 ags
% 210.27/210.41  |- mesh__dateRevised mesh__D027742 2005-07-27
% 210.27/210.41  |- skos__prefLabel mesh__D027742 Dioscorea
% 210.27/210.41  |- mesh__recordOriginator mesh__D005290 NLM
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D005290 2004
% 210.27/210.41  |- mesh__recordAuthorizer mesh__D005290 SJN
% 210.27/210.41  |- rdf__type mesh__D005290sskos__Concept
% 210.27/210.41  |- skos__broader mesh__D005290smesh__D017614
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D005290 2001
% 210.27/210.41  |- mesh__dateRevised mesh__D005290 1997-06-20
% 210.27/210.41  |- mesh__onlineNote mesh__D005290
% 210.27/210.41       use IRON to search FERRIC AND FERROUS COMPOUNDS 1966-74   
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D005290 2003
% 210.27/210.41  |- skos__scopeNote mesh__D005290
% 210.27/210.41       Inorganic or organic compounds containing trivalent iron.%A%    
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D005290 2000
% 210.27/210.41  |- mesh__publicMeSHNote mesh__D005290
% 210.27/210.41       87; was see under IRON 1975-86; FERRIC AND FERROUS COMPOUNDS was see under IRON 1963-74%A%  
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D005290 2006
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D005290 1999
% 210.27/210.41  |- mesh__recordMaintainer mesh__D005290 ADP
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D005290 2005
% 210.27/210.41  |- skos__prefLabel mesh__D005290 Ferric Compounds
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D005290 1998
% 210.27/210.41  |- skos__historyNote mesh__D005290 Iron %28%1966-1974%29%
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D005290 2002
% 210.27/210.41  |- mesh__historyNote mesh__D005290
% 210.27/210.41       87%28%75%29%; was see under IRON 1975-86; FERRIC AND FERROUS COMPOUNDS was see under IRON 1963-74%A%  
% 210.27/210.41  |- skos__hiddenLabel mesh__D005290 Compounds, Ferric
% 210.27/210.41  |- mesh__dateEstablished mesh__D005290 1987-01-01
% 210.27/210.41  |- skos__broader mesh__D005290smesh__D009942
% 210.27/210.41  |- skos__annotation mesh__D005290
% 210.27/210.41       = iron%28%III%29% or Fe%28%III%29%, as Fe2O3, FeCl3; iron%28%II%29% or Fe%28%II%29% = FERROUS COMPOUNDS; hematinics; DF: FERRIC CPDS%A%  
% 210.27/210.41  |- mesh__dateCreated mesh__D005290 1975-02-04
% 210.27/210.41  |- skos__related mesh__D005290smesh__D007501
% 210.27/210.41  |- skos__historyNote mesh__D013722 Snakes %28%1966-1972%29%
% 210.27/210.41  |- skos__historyNote mesh__D013722 Oligopeptides %28%1973-1974%29%
% 210.27/210.41  |- mesh__dateEstablished mesh__D013722 1991-01-01
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D013722 2003
% 210.27/210.41  |- skos__altLabel mesh__D013722 Nonapeptide-Converting Enzyme Inhibitor
% 210.27/210.41  |- mesh__dateRevised mesh__D013722 2001-07-25
% 210.27/210.41  |- skos__hiddenLabel mesh__D013722 Nonapeptide Converting Enzyme Inhibitor
% 210.27/210.41  |- skos__hiddenLabel mesh__D013722 Enzyme Inhibitor, Nonapeptide-Converting
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D013722 2004
% 210.27/210.41  |- skos__scopeNote mesh__D013722
% 210.27/210.41       A synthetic nonapeptide %28%Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro%29% which is identical to the peptide from the venom of the snake, Bothrops jararaca. It inhibits kininase II and ANGIOTENSIN I and has been proposed as an antihypertensive agent.%A%    
% 210.27/210.41  |- mesh__historyNote mesh__D013722
% 210.27/210.41       91%28%81%29%; was see under OLIGOPEPTIDES 1981-90, was SQ 20881 see under OLIGOPEPTIDES 1975-80;  SQ 20881 was see TEPROTIDE 1981-93; NONAPEPTIDE CONVERTING-ENZYME INHIBITOR was %28%NM%29% 1975-93%A%  
% 210.27/210.41  |- mesh__onlineNote mesh__D013722
% 210.27/210.41       use TEPROTIDE to search SQ 20881 1975-93; use TEPROTIDE %28%NM%29% to search NONAPEPTIDE CONVERTING-ENZYME INHIBITOR 1980-93%A%  
% 210.27/210.41  |- mesh__recordMaintainer mesh__D013722 ssb
% 210.27/210.41  |- skos__altLabel mesh__D013722 BPP-9a
% 210.27/210.41  |- skos__broader mesh__D013722smesh__D009842
% 210.27/210.41  |- skos__hiddenLabel mesh__D013722 Bradykinin Potentiating Peptide 9a
% 210.27/210.41  |- mesh__recordOriginator mesh__D013722 NLM
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D013722 2002
% 210.27/210.41  |- skos__historyNote mesh__D013722 Peptides %28%1966-1972%29%
% 210.27/210.41  |- mesh__dateCreated mesh__D013722 1974-11-19
% 210.27/210.41  |- mesh__publicMeSHNote mesh__D013722
% 210.27/210.41       91; was see under OLIGOPEPTIDES 1981-90, was SQ 20881 see under OLIGOPEPTIDES 1975-80; SQ 20881 was see TEPROTIDE 1981-93; NONAPEPTIDE CONVERTING-ENZYME INHIBITOR was indexed under OLIGOPEPTIDES 1975-93%A%  
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D013722 2005
% 210.27/210.41  |- skos__hiddenLabel mesh__D013722 Peptide 9a, Bradykinin-Potentiating
% 210.27/210.41  |- skos__prefLabel mesh__D013722 Teprotide
% 210.27/210.41  |- mesh__recordAuthorizer mesh__D013722 sjn
% 210.27/210.41  |- rdf__type mesh__D013722sskos__Concept
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D013722 2006
% 210.27/210.41  |- skos__altLabel mesh__D013722 Bradykinin-Potentiating Peptide 9a
% 210.27/210.41  |- mesh__recordMaintainer mesh__D051841 DRC
% 210.27/210.41  |- mesh__recordOriginator mesh__D051841 DRC
% 210.27/210.41  |- skos__scopeNote mesh__D051841
% 210.27/210.41       A transcription factor that takes part in the NF-kappa-B complex by interacting with NF-KAPPA B P50 SUBUNIT or NF-KAPPA B P52 SUBUNIT. It regulates GENETIC TRANSCRIPTION that is involved in immune and inflammatory responses.%A%    
% 210.27/210.41  |- mesh__dateEstablished mesh__D051841 2006-01-01
% 210.27/210.41  |- mesh__historyNote mesh__D051841 2006%28%1992%29%   
% 210.27/210.41  |- skos__hiddenLabel mesh__D051841 Rel Protein, Inhibitory
% 210.27/210.41  |- mesh__activeMeSHYear mesh__D051841 2006
% 210.27/210.41  |- rdf__type mesh__D051841sskos__Concept
% 210.27/210.41  |- skos__prefLabel mesh__D051841 Transcription Factor RelB
% 210.27/210.41  |- skos__altLabel mesh__D051841 Inhibitory Rel Protein
% 210.27/210.41  |- skos__broader mesh__D051841smesh__D016328
% 210.27/210.41  |- skos__altLabel mesh__D051841 Rel-Related Protein
% 210.27/210.41  |- mesh__dateCreated mesh__D051841 2005-06-30
% 210.27/210.42  |- skos__altLabel mesh__D051841
% 210.27/210.42       v-Rel Reticuloendotheliosis Viral Oncogene Homolog B
% 210.27/210.42  |- skos__hiddenLabel mesh__D051841 RelB, Transcription Factor
% 210.27/210.42  |- mesh__publicMeSHNote mesh__D051841
% 210.27/210.42       2006; TRANSCRIPTION FACTOR RELB was indexed under PROTO-ONCOGENE PROTEINS %26% TRANSCRIPTION FACTORS 1992-2005%A%  
% 210.27/210.42  |- skos__hiddenLabel mesh__D051841
% 210.27/210.42       v Rel Reticuloendotheliosis Viral Oncogene Homolog B
% 210.27/210.42  |- mesh__recordAuthorizer mesh__D051841 sjn
% 210.27/210.42  |- skos__hiddenLabel mesh__D051841 Rel Related Protein
% 210.27/210.42  |- mesh__dateRevised mesh__D004996 2000-06-22
% 210.27/210.42  |- skos__hiddenLabel mesh__D004996 Bromide, Homidium
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D004996 2001
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D004996 2006
% 210.27/210.42  |- mesh__historyNote mesh__D004996 74%28%72%29%   
% 210.27/210.42  |- skos__historyNote mesh__D004996 Antiviral Agents %28%1966-1971%29%
% 210.27/210.42  |- mesh__recordAuthorizer mesh__D004996 sjn
% 210.27/210.42  |- mesh__recordOriginator mesh__D004996 NLM
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D004996 2005
% 210.27/210.42  |- skos__prefLabel mesh__D004996 Ethidium
% 210.27/210.42  |- mesh__publicMeSHNote mesh__D004996 74   
% 210.27/210.42  |- rdf__type mesh__D004996sskos__Concept
% 210.27/210.42  |- skos__historyNote mesh__D004996 Antiprotozoal Agents %28%1966-1971%29%
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D004996 2002
% 210.27/210.42  |- skos__hiddenLabel mesh__D004996 Bromide, Ethidium
% 210.27/210.42  |- skos__altLabel mesh__D004996 Homidium Bromide
% 210.27/210.42  |- mesh__recordMaintainer mesh__D004996 TWD
% 210.27/210.42  |- skos__historyNote mesh__D004996 Phenanthridines %28%1969-1971%29%
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D004996 2004
% 210.27/210.42  |- skos__scopeNote mesh__D004996
% 210.27/210.42       A trypanocidal agent and possible antiviral agent that is widely used in experimental cell biology and biochemistry. Ethidium has several experimentally useful properties including binding to nucleic acids, noncompetitive inhibition of nicotinic acetylcholine receptors, and fluorescence among others. It is most commonly used as the bromide.%A%    
% 210.27/210.42  |- skos__broader mesh__D004996smesh__D010617
% 210.27/210.42  |- skos__historyNote mesh__D004996 appropriate enzyme/AI %28%1968-1971%29%
% 210.27/210.42  |- mesh__dateEstablished mesh__D004996 1974-01-01
% 210.27/210.42  |- mesh__dateCreated mesh__D004996 1999-01-01
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D004996 2003
% 210.27/210.42  |- skos__broader mesh__D004198smesh__D001824
% 210.27/210.42  |- mesh__dateRevised mesh__D004198 2004-07-07
% 210.27/210.42  |- skos__hiddenLabel mesh__D004198 Susceptibilities, Disease
% 210.27/210.42  |- skos__hiddenLabel mesh__D004198 Disease Susceptibilities
% 210.27/210.42  |- mesh__historyNote mesh__D004198 81; was DIATHESIS 1963-80   
% 210.27/210.42  |- skos__annotation mesh__D004198 IM GEN only   
% 210.27/210.42  |- mesh__recordMaintainer mesh__D004198 nns
% 210.27/210.42  |- rdf__type mesh__D004198sskos__Concept
% 210.27/210.42  |- mesh__dateCreated mesh__D004198 1999-01-01
% 210.27/210.42  |- mesh__recordAuthorizer mesh__D004198 sjn
% 210.27/210.42  |- mesh__recordOriginator mesh__D004198 NLM
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D004198 2006
% 210.27/210.42  |- mesh__publicMeSHNote mesh__D004198 81; was DIATHESIS 1963-80   
% 210.27/210.42  |- skos__broader mesh__D004198smesh__D020969
% 210.27/210.42  |- mesh__onlineNote mesh__D004198
% 210.27/210.42       use DISEASE SUSCEPTIBILITY to search DIATHESIS 1966-80   
% 210.27/210.42  |- skos__scopeNote mesh__D004198
% 210.27/210.42       A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases.%A%    
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D004198 2005
% 210.27/210.42  |- skos__hiddenLabel mesh__D004198 Diatheses
% 210.27/210.42  |- skos__altLabel mesh__D004198 Diathesis
% 210.27/210.42  |- skos__prefLabel mesh__D004198 Disease Susceptibility
% 210.27/210.42  |- skos__altLabel mesh__D004198 Susceptibility, Disease
% 210.27/210.42  |- skos__annotation mesh__D045804
% 210.27/210.42       infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29%   
% 210.27/210.42  |- mesh__recordAuthorizer mesh__D045804 sjn
% 210.27/210.42  |- mesh__recordMaintainer mesh__D045804 SYSTEM
% 210.27/210.42  |- mesh__historyNote mesh__D045804 2004   
% 210.27/210.42  |- mesh__recordOriginator mesh__D045804 ags
% 210.27/210.42  |- rdf__type mesh__D045804sskos__Concept
% 210.27/210.42  |- skos__scopeNote mesh__D045804
% 210.27/210.42       A species of gram-negative bacteria strongly implicated in oral infection, PERIODONTAL DISEASES, eye and ear disorders, and SEPTIC ARTHRITIS.%A%    
% 210.27/210.42  |- skos__broader mesh__D045804smesh__D009174
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D045804 2006
% 210.27/210.42  |- mesh__dateRevised mesh__D045804 2005-06-30
% 210.27/210.42  |- mesh__dateEstablished mesh__D045804 2004-01-01
% 210.27/210.42  |- mesh__dateCreated mesh__D045804 2003-07-09
% 210.27/210.42  |- mesh__publicMeSHNote mesh__D045804 2004   
% 210.27/210.42  |- skos__prefLabel mesh__D045804 Mycoplasma salivarium
% 210.27/210.42  |- skos__historyNote mesh__D045804 Mycoplasma %28%1962-2003%29%
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009681 2004
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009681 1995
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009681 1998
% 210.27/210.42  |- skos__annotation mesh__D009681
% 210.27/210.42       no qualif; do not confuse with NUCLEAR FISSION   
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009681 2003
% 210.27/210.42  |- mesh__recordMaintainer mesh__D009681 NLM
% 210.27/210.42  |- mesh__publicMeSHNote mesh__D009681
% 210.27/210.42       91; was see under NUCLEAR ENERGY 1982-90; was see under ATOMIC ENERGY 1975-81; was in Cat H only 1971-81%A%  
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009681 1994
% 210.27/210.42  |- mesh__dateCreated mesh__D009681 1999-01-01
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009681 2001
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009681 2006
% 210.27/210.42  |- skos__prefLabel mesh__D009681 Nuclear Fusion
% 210.27/210.42  |- mesh__onlineNote mesh__D009681
% 210.27/210.42       use NUCLEAR ENERGY to search NUCLEAR FUSION 1971-74 %28%as Prov%29%%A%  
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009681 1997
% 210.27/210.42  |- skos__broader mesh__D009681smesh__D009678
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009681 2000
% 210.27/210.42  |- mesh__historyNote mesh__D009681
% 210.27/210.42       91%28%71%29%; was see under NUCLEAR ENERGY 1982-90; was see under ATOMIC ENERGY 1975-81; was Prov 1971-74; was in Cat H only 1971-81%A%  
% 210.27/210.42  |- mesh__recordOriginator mesh__D009681 NLM
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009681 1991
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009681 2005
% 210.27/210.42  |- skos__hiddenLabel mesh__D009681 Nuclear Fusions
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009681 1993
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009681 1996
% 210.27/210.42  |- rdf__type mesh__D009681sskos__Concept
% 210.27/210.42  |- skos__historyNote mesh__D009681 Nuclear Energy %28%1966-1970%29%
% 210.27/210.42  |- skos__scopeNote mesh__D009681
% 210.27/210.42       Thermonuclear reaction in which the nuclei of an element of low atomic weight unite under extremely high temperature and pressure to form a nucleus of a heavier atom.%A%    
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009681 1992
% 210.27/210.42  |- mesh__dateRevised mesh__D009681 1990-06-04
% 210.27/210.42  |- skos__hiddenLabel mesh__D009681 Fusion, Nuclear
% 210.27/210.42  |- mesh__recordAuthorizer mesh__D009681 PLS
% 210.27/210.42  |- skos__hiddenLabel mesh__D009681 Fusions, Nuclear
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009681 1999
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009681 2002
% 210.27/210.42  |- mesh__dateEstablished mesh__D009681 1991-01-01
% 210.27/210.42  |- skos__altLabel mesh__D017315 Ro-31-2848
% 210.27/210.42  |- mesh__historyNote mesh__D017315 93; was CILAZAPRIL %28%NM%29% 1984-92   
% 210.27/210.42  |- mesh__dateEstablished mesh__D017315 1993-01-01
% 210.27/210.42  |- skos__broader mesh__D017315smesh__D011724
% 210.27/210.42  |- mesh__publicMeSHNote mesh__D017315
% 210.27/210.42       93; CILAZAPRIL was indexed under PYRIDAZINES 1984-92   
% 210.27/210.42  |- skos__hiddenLabel mesh__D017315 Hydrate, Cilazapril
% 210.27/210.42  |- mesh__recordAuthorizer mesh__D017315 sjn
% 210.27/210.42  |- rdf__type mesh__D017315sskos__Concept
% 210.27/210.42  |- skos__prefLabel mesh__D017315 Cilazapril
% 210.27/210.42  |- skos__hiddenLabel mesh__D017315 Ro 31 2848
% 210.27/210.42  |- mesh__dateRevised mesh__D017315 2001-07-25
% 210.27/210.42  |- mesh__recordMaintainer mesh__D017315 ssb
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D017315 2005
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D017315 2002
% 210.27/210.42  |- skos__scopeNote mesh__D017315
% 210.27/210.42       One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS %28%ACE inhibitors%29% used for hypertension.  It is a prodrug that is hydrolyzed after absorption to its main metabolite cilazaprilat.%A%    
% 210.27/210.42  |- skos__historyNote mesh__D017315 Pyridazines %28%1984-1992%29%
% 210.27/210.42  |- skos__hiddenLabel mesh__D017315 Ro 312848
% 210.27/210.42  |- mesh__onlineNote mesh__D017315
% 210.27/210.42       use CILAZAPRIL %28%NM%29% to search CILAZAPRIL 1984-92   
% 210.27/210.42  |- skos__hiddenLabel mesh__D017315 Ro312848
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D017315 2006
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D017315 2003
% 210.27/210.42  |- mesh__recordOriginator mesh__D017315 TPW
% 210.27/210.42  |- mesh__dateCreated mesh__D017315 1992-05-07
% 210.27/210.42  |- skos__hiddenLabel mesh__D017315 Monohydrobromide, Cilazapril
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D017315 2004
% 210.27/210.42  |- rdf__type mesh__D008589sskos__Concept
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D008589 2004
% 210.27/210.42  |- mesh__recordOriginator mesh__D008589 NLM
% 210.27/210.42  |- skos__hiddenLabel mesh__D008589 Meningococcal Infection
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D008589 2003
% 210.27/210.42  |- mesh__dateCreated mesh__D008589 1999-01-01
% 210.27/210.42  |- skos__prefLabel mesh__D008589 Meningococcal Infections
% 210.27/210.42  |- skos__altLabel mesh__D008589 Infections, Meningococcal
% 210.27/210.42  |- skos__annotation mesh__D008589
% 210.27/210.42       MENINGITIS, MENINGOCOCCAL is also available; coord IM with specific Neisseria meningitidis serogroup %28%IM%29% if given; DF: MENINGOCOCCAL INFECT%A%  
% 210.27/210.42  |- mesh__recordMaintainer mesh__D008589 ags
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D008589 2006
% 210.27/210.42  |- mesh__dateRevised mesh__D008589 2002-07-03
% 210.27/210.42  |- skos__broader mesh__D008589smesh__D016870
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D008589 2005
% 210.27/210.42  |- mesh__recordAuthorizer mesh__D008589 sjn
% 210.27/210.42  |- skos__scopeNote mesh__D008589
% 210.27/210.42       Infections with bacteria of the species NEISSERIA MENINGITIDIS.%A%    
% 210.27/210.42  |- skos__hiddenLabel mesh__D008589 Infection, Meningococcal
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D027743 2005
% 210.27/210.42  |- skos__broader mesh__D027743smesh__D019684
% 210.27/210.42  |- mesh__dateRevised mesh__D027743 2003-07-09
% 210.27/210.42  |- skos__scopeNote mesh__D027743
% 210.27/210.42       The yam plant family, of the order Liliales, has thick roots or tubers and net-veined, heart-shaped leaves that sometimes are lobed.%A%    
% 210.27/210.42  |- rdf__type mesh__D027743sskos__Concept
% 210.27/210.42  |- mesh__dateCreated mesh__D027743 2001-07-25
% 210.27/210.42  |- mesh__publicMeSHNote mesh__D027743 2002   
% 210.27/210.42  |- mesh__historyNote mesh__D027743 2002   
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D027743 2004
% 210.27/210.42  |- mesh__recordOriginator mesh__D027743 ssb
% 210.27/210.42  |- mesh__recordAuthorizer mesh__D027743 sjn
% 210.27/210.42  |- mesh__recordMaintainer mesh__D027743 ssb
% 210.27/210.42  |- skos__prefLabel mesh__D027743 Dioscoreaceae
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D027743 2006
% 210.27/210.42  |- mesh__dateEstablished mesh__D027743 2002-01-01
% 210.27/210.42  |- skos__annotation mesh__D027743
% 210.27/210.42       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.27/210.42  |- skos__broader mesh__D004364Q000493smesh__D004364
% 210.27/210.42  |- mesh__preferredCombination mesh__D004364Q000493smesh__D010599
% 210.27/210.42  |- rdf__type mesh__D004364Q000493smesh__CompoundConcept
% 210.27/210.42  |- mesh__recordOriginator mesh__D005291 NLM
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D005291 2006
% 210.27/210.42  |- mesh__dateEstablished mesh__D005291 1991-01-01
% 210.27/210.42  |- skos__historyNote mesh__D005291 Peptides, Cyclic %28%1973-1974%29%
% 210.27/210.42  |- mesh__dateRevised mesh__D005291 2005-06-30
% 210.27/210.42  |- mesh__publicMeSHNote mesh__D005291
% 210.27/210.42       91; was see under HYDROXAMIC ACIDS 1975-90   
% 210.27/210.42  |- mesh__recordMaintainer mesh__D005291 ssb
% 210.27/210.42  |- skos__prefLabel mesh__D005291 Ferrichrome
% 210.27/210.42  |- mesh__historyNote mesh__D005291
% 210.27/210.42       91%28%75%29%; was see under HYDROXAMIC ACIDS 1975-90   
% 210.27/210.42  |- skos__historyNote mesh__D005291 Iron Chelates %28%1972-1974%29%
% 210.27/210.42  |- rdf__type mesh__D005291sskos__Concept
% 210.27/210.42  |- skos__broader mesh__D005291smesh__D010456
% 210.27/210.42  |- mesh__recordAuthorizer mesh__D005291 sjn
% 210.27/210.42  |- skos__historyNote mesh__D005291 Hydroxamic Acids %28%1972-1974%29%
% 210.27/210.42  |- skos__broader mesh__D005291smesh__D006877
% 210.27/210.42  |- mesh__dateCreated mesh__D005291 1974-11-19
% 210.27/210.42  |- skos__scopeNote mesh__D005291
% 210.27/210.42       A cyclic peptide consisting of three residues of delta-N-hydroxy-delta-N-acetylornithine. It acts as an iron transport agent in Ustilago sphaerogena.%A%    
% 210.27/210.42  |- skos__broader mesh__D013723smesh__D009676
% 210.27/210.42  |- mesh__dateEstablished mesh__D013723 1975-09-01
% 210.27/210.42  |- skos__altLabel mesh__D013723 Embryotoxins
% 210.27/210.42  |- skos__historyNote mesh__D013723
% 210.27/210.42       Abnormalities, Drug-Induced %28%1966-1974%29%
% 210.27/210.42  |- skos__annotation mesh__D013723
% 210.27/210.42       be careful: %22%teratogenic effect%22% of a drug or chem is probably ABNORMALITIES, DRUG-INDUCED + drug or chem named %28%with required qualif%29% %26% not TERATOGENS%A%  
% 210.27/210.42  |- skos__related mesh__D013723smesh__D000014
% 210.27/210.42  |- mesh__recordAuthorizer mesh__D013723 sjn
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D013723 2005
% 210.27/210.42  |- mesh__historyNote mesh__D013723 75   
% 210.27/210.42  |- mesh__dateCreated mesh__D013723 1999-01-01
% 210.27/210.42  |- rdf__type mesh__D013723sskos__Concept
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D013723 2006
% 210.27/210.42  |- mesh__dateRevised mesh__D013723 2003-07-09
% 210.27/210.42  |- skos__prefLabel mesh__D013723 Teratogens
% 210.27/210.42  |- mesh__recordMaintainer mesh__D013723 ssb
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D013723 2004
% 210.27/210.42  |- skos__scopeNote mesh__D013723
% 210.27/210.42       An agent that causes the production of physical defects in the developing embryo.%A%    
% 210.27/210.42  |- mesh__publicMeSHNote mesh__D013723 75   
% 210.27/210.42  |- mesh__recordOriginator mesh__D013723 NLM
% 210.27/210.42  |- skos__broader mesh__D051842smesh__D047908
% 210.27/210.42  |- mesh__recordAuthorizer mesh__D051842 sjn
% 210.27/210.42  |- mesh__recordMaintainer mesh__D051842 DRC
% 210.27/210.42  |- mesh__dateCreated mesh__D051842 2005-06-30
% 210.27/210.42  |- skos__broader mesh__D051842smesh__D009419
% 210.27/210.42  |- skos__prefLabel mesh__D051842 Olfactory Marker Protein
% 210.27/210.42  |- rdf__type mesh__D051842sskos__Concept
% 210.27/210.42  |- mesh__historyNote mesh__D051842 2006%28%1982%29%   
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D051842 2006
% 210.27/210.42  |- mesh__publicMeSHNote mesh__D051842
% 210.27/210.42       2006; OLFACTORY MARKER PROTEIN was indexed under NERVE TISSUE PROTEINS 1982-2005%A%  
% 210.27/210.42  |- mesh__dateEstablished mesh__D051842 2006-01-01
% 210.27/210.42  |- mesh__recordOriginator mesh__D051842 DRC
% 210.27/210.42  |- skos__scopeNote mesh__D051842
% 210.27/210.42       A ubiquitous, cytoplasmic protein found in mature OLFACTORY RECEPTOR NEURONS of all VERTEBRATES. It is a modulator of the olfactory SIGNAL TRANSDUCTION PATHWAY.%A%    
% 210.27/210.42  |- skos__altLabel mesh__D004997 Jenapharm Brand of Ethinyl Estradiol
% 210.27/210.42  |- skos__altLabel mesh__D004997 Ethinyloestradiol
% 210.27/210.42  |- rdf__type mesh__D004997sskos__Concept
% 210.27/210.42  |- mesh__recordMaintainer mesh__D004997 CCR
% 210.27/210.42  |- skos__altLabel mesh__D004997 Schering-Plough Brand of Ethinyl Estradiol
% 210.27/210.42  |- skos__hiddenLabel mesh__D004997 Jenapharm, Ethinylestradiol
% 210.27/210.42  |- skos__hiddenLabel mesh__D004997 Ethinyl Oestradiol Effik
% 210.27/210.42  |- mesh__dateCreated mesh__D004997 1999-01-01
% 210.27/210.42  |- skos__prefLabel mesh__D004997 Ethinyl Estradiol
% 210.27/210.42  |- skos__broader mesh__D004997smesh__D042782
% 210.27/210.42  |- mesh__recordAuthorizer mesh__D004997 sjn
% 210.27/210.42  |- skos__hiddenLabel mesh__D004997 Estradiol, Ethinyl
% 210.27/210.42  |- skos__hiddenLabel mesh__D004997 Estradiol, Ethynyl
% 210.27/210.42  |- mesh__recordOriginator mesh__D004997 NLM
% 210.27/210.42  |- skos__broader mesh__D004997smesh__D009651
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D004997 2006
% 210.27/210.42  |- skos__altLabel mesh__D004997 Effik Brand of Ethinyl Estradiol
% 210.27/210.42  |- skos__scopeNote mesh__D004997
% 210.27/210.42       A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES.%A%    
% 210.27/210.42  |- skos__altLabel mesh__D004997 Schering Brand of Ethinyl Estradiol
% 210.27/210.42  |- skos__altLabel mesh__D004997 Organon Brand of Ethinyl Estradiol
% 210.27/210.42  |- mesh__dateRevised mesh__D004997 2005-06-30
% 210.27/210.42  |- skos__hiddenLabel mesh__D004997 Hemihydrate, Ethinyl Estradiol
% 210.27/210.42  |- skos__altLabel mesh__D004997 Ethynyl Estradiol
% 210.27/210.42  |- mesh__recordMaintainer mesh__D045805 SYSTEM
% 210.27/210.42  |- mesh__dateRevised mesh__D045805 2005-06-30
% 210.27/210.42  |- rdf__type mesh__D045805sskos__Concept
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D045805 2006
% 210.27/210.42  |- skos__scopeNote mesh__D045805
% 210.27/210.42       A species of gram-negative bacteria pathogenic to CHICKENS; TURKEYS, and guinea fowls. It causes disease in a wide variety of organs and tissues including JOINTS, tendon sheaths and the RESPIRATORY TRACT.%A%    
% 210.27/210.42  |- mesh__dateCreated mesh__D045805 2003-07-09
% 210.27/210.42  |- skos__prefLabel mesh__D045805 Mycoplasma synoviae
% 210.27/210.42  |- mesh__publicMeSHNote mesh__D045805 2004   
% 210.27/210.42  |- skos__broader mesh__D045805smesh__D009174
% 210.27/210.42  |- skos__historyNote mesh__D045805 Mycoplasma %28%1965-2003%29%
% 210.27/210.42  |- mesh__recordAuthorizer mesh__D045805 sjn
% 210.27/210.42  |- skos__annotation mesh__D045805
% 210.27/210.42       infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29%   
% 210.27/210.42  |- mesh__recordOriginator mesh__D045805 ags
% 210.27/210.42  |- mesh__historyNote mesh__D045805 2004   
% 210.27/210.42  |- mesh__dateEstablished mesh__D045805 2004-01-01
% 210.27/210.42  |- mesh__dateCreated mesh__D004199 1999-01-01
% 210.27/210.42  |- skos__scopeNote mesh__D004199
% 210.27/210.42       Invertebrates or non-human vertebrates which transmit infective organisms from one host to another.%A%    
% 210.27/210.42  |- skos__hiddenLabel mesh__D004199 Vector, Disease
% 210.27/210.42  |- skos__hiddenLabel mesh__D004199 Disease Vector
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D004199 2004
% 210.27/210.42  |- mesh__dateRevised mesh__D004199 1998-06-10
% 210.27/210.42  |- mesh__recordAuthorizer mesh__D004199 SJN
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D004199 2002
% 210.27/210.42  |- mesh__recordMaintainer mesh__D004199 JLS
% 210.27/210.42  |- skos__prefLabel mesh__D004199 Disease Vectors
% 210.27/210.42  |- rdf__type mesh__D004199sskos__Concept
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D004199 2005
% 210.27/210.42  |- skos__broader mesh__D004199smesh__D018562
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D004199 2000
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D004199 2006
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D004199 2001
% 210.27/210.42  |- mesh__historyNote mesh__D004199 67%28%65%29%   
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D004199 1999
% 210.27/210.42  |- mesh__recordOriginator mesh__D004199 NLM
% 210.27/210.42  |- skos__hiddenLabel mesh__D004199 Vectors, Disease
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D004199 2003
% 210.27/210.42  |- mesh__dateEstablished mesh__D004199 1967-01-01
% 210.27/210.42  |- mesh__publicMeSHNote mesh__D004199 67   
% 210.27/210.42  |- skos__prefLabel mesh__D009682 Magnetic Resonance Spectroscopy
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009682 2006
% 210.27/210.42  |- mesh__dateRevised mesh__D009682 2000-06-22
% 210.27/210.42  |- mesh__recordAuthorizer mesh__D009682 sjn
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009682 2005
% 210.27/210.42  |- mesh__historyNote mesh__D009682 66%28%65%29%   
% 210.27/210.42  |- mesh__publicMeSHNote mesh__D009682 66   
% 210.27/210.42  |- rdf__type mesh__D009682sskos__Concept
% 210.27/210.42  |- mesh__recordMaintainer mesh__D009682 nns
% 210.27/210.42  |- skos__hiddenLabel mesh__D009682 Spectroscopy, MR
% 210.27/210.42  |- skos__hiddenLabel mesh__D009682 Resonance, Nuclear Magnetic
% 210.27/210.42  |- skos__hiddenLabel mesh__D009682 NMR Spectroscopies
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009682 2002
% 210.27/210.42  |- skos__altLabel mesh__D009682 MR Spectroscopy
% 210.27/210.42  |- mesh__dateEstablished mesh__D009682 1966-01-01
% 210.27/210.42  |- skos__hiddenLabel mesh__D009682 Magnetic Resonance, Nuclear
% 210.27/210.42  |- skos__broader mesh__D009682smesh__D013057
% 210.27/210.42  |- skos__hiddenLabel mesh__D009682 Resonance Spectroscopy, Magnetic
% 210.27/210.42  |- skos__related mesh__D009682smesh__D008279
% 210.27/210.42  |- skos__broader mesh__D009682smesh__D009686
% 210.27/210.42  |- skos__hiddenLabel mesh__D009682 Spectroscopies, NMR
% 210.27/210.42  |- skos__altLabel mesh__D009682 NMR Spectroscopy
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009682 2004
% 210.27/210.42  |- skos__altLabel mesh__D009682 NMR Spectroscopy, In Vivo
% 210.27/210.42  |- skos__hiddenLabel mesh__D009682 Magnetic Resonance Spectroscopies
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009682 2001
% 210.27/210.42  |- skos__altLabel mesh__D009682 Spectroscopy, Magnetic Resonance
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D009682 2003
% 210.27/210.42  |- skos__altLabel mesh__D009682 Spectroscopy, NMR
% 210.27/210.42  |- skos__annotation mesh__D009682
% 210.27/210.42       index under element or isotope used in performing the NMR spectroscopy only if discussed %28%probably NIM%29%; do not confuse with MAGNETIC RESONANCE IMAGING: check text; coord with disease, organ or tissue using pertinent qualifs; for diag use coord with disease /diag %28%not /radiogr nor /radionuclide%29%; DF: NMR%A%  
% 210.27/210.42  |- mesh__dateCreated mesh__D009682 1999-01-01
% 210.27/210.42  |- skos__hiddenLabel mesh__D009682 Resonance, Magnetic
% 210.27/210.42  |- skos__scopeNote mesh__D009682
% 210.27/210.42       Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei,  protons or electrons. It is employed in clinical applications such as NMR Tomography %28%MAGNETIC RESONANCE IMAGING%29%.%A%    
% 210.27/210.42  |- mesh__recordOriginator mesh__D009682 NLM
% 210.27/210.42  |- skos__broader mesh__D007862Q000172smesh__D007862
% 210.27/210.42  |- mesh__preferredCombination mesh__D007862Q000172smesh__D007863
% 210.27/210.42  |- rdf__type mesh__D007862Q000172smesh__CompoundConcept
% 210.27/210.42  |- mesh__dateRevised mesh__D017316 2005-06-30
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D017316 2006
% 210.27/210.42  |- skos__hiddenLabel mesh__D017316 CGS 16949A
% 210.27/210.42  |- mesh__dateCreated mesh__D017316 1992-05-19
% 210.27/210.42  |- mesh__publicMeSHNote mesh__D017316
% 210.27/210.42       93; CGS 16949A was indexed under IMIDAZOLES %26% NITRILES 1988-92%A%  
% 210.27/210.42  |- skos__historyNote mesh__D017316 Imidazoles %28%1988-1992%29%
% 210.27/210.42  |- mesh__historyNote mesh__D017316 93; was CGS 16949A %28%NM%29% 1988-92   
% 210.27/210.42  |- skos__scopeNote mesh__D017316
% 210.27/210.42       A selective aromatase inhibitor effective in the treatment of estrogen-dependent disease including breast cancer.%A%    
% 210.27/210.42  |- skos__broader mesh__D017316smesh__D009570
% 210.27/210.42  |- skos__broader mesh__D017316smesh__D007093
% 210.27/210.42  |- skos__prefLabel mesh__D017316 Fadrozole
% 210.27/210.42  |- mesh__onlineNote mesh__D017316
% 210.27/210.42       use FADROZOLE %28%NM%29% to search CGS 16949A 1988-92   
% 210.27/210.42  |- skos__hiddenLabel mesh__D017316 Hydrochloride, Fadrozole
% 210.27/210.42  |- mesh__dateEstablished mesh__D017316 1993-01-01
% 210.27/210.42  |- skos__altLabel mesh__D017316 Fadrozole Hydrochloride
% 210.27/210.42  |- rdf__type mesh__D017316sskos__Concept
% 210.27/210.42  |- mesh__recordAuthorizer mesh__D017316 sjn
% 210.27/210.42  |- mesh__recordMaintainer mesh__D017316 ssb
% 210.27/210.42  |- skos__hiddenLabel mesh__D017316 CGS16949A
% 210.27/210.42  |- skos__historyNote mesh__D017316 Nitriles %28%1988-1992%29%
% 210.27/210.42  |- mesh__recordOriginator mesh__D017316 TPW
% 210.27/210.42  |- skos__hiddenLabel mesh__D017316 Monohydrochloride, Fadrozole
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D033781 2003
% 210.27/210.42  |- mesh__publicMeSHNote mesh__D033781
% 210.27/210.42       2003; see ADENINE NUCLEOTIDE TRANSLOCASE 1999-2002   
% 210.27/210.42  |- mesh__dateEstablished mesh__D033781 2003-01-01
% 210.27/210.42  |- skos__altLabel mesh__D033781 SLC25A6 Protein
% 210.27/210.42  |- skos__altLabel mesh__D033781 ANT-3 Transport Protein
% 210.27/210.42  |- skos__broader mesh__D033781smesh__D000226
% 210.27/210.42  |- skos__scopeNote mesh__D033781
% 210.27/210.42       A subtype of mitochondrial ADP, ATP translocase found primarily in the LIVER.%A%    
% 210.27/210.42  |- skos__altLabel mesh__D033781
% 210.27/210.42       Solute Carrier Family 25 %28%Mitochondrial Carrier; Adenine Nucleotide Translocator%29%, Member 6
% 210.27/210.42  |- mesh__historyNote mesh__D033781
% 210.27/210.42       2003; use MITOCHONDRIAL ADP, ATP TRANSLOCASES 1999-2002   
% 210.27/210.42  |- skos__historyNote mesh__D033781
% 210.27/210.42       Mitochondrial ADP, ATP Translocases %28%1999-2002%29%
% 210.27/210.42  |- mesh__dateCreated mesh__D033781 2002-07-02
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D033781 2006
% 210.27/210.42  |- skos__hiddenLabel mesh__D033781 Transport Protein, ANT3
% 210.27/210.42  |- skos__prefLabel mesh__D033781 Adenine Nucleotide Translocator 3
% 210.27/210.42  |- skos__hiddenLabel mesh__D033781 Transport Protein, ANT-3
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D033781 2005
% 210.27/210.42  |- skos__altLabel mesh__D033781 ANT3 Transport Protein
% 210.27/210.42  |- skos__altLabel mesh__D033781 ADP,ATP Carrier Protein, Liver Isoform T2
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D033781 2004
% 210.27/210.42  |- skos__hiddenLabel mesh__D033781 ANT 3 Transport Protein
% 210.27/210.42  |- rdf__type mesh__D033781sskos__Concept
% 210.27/210.42  |- rdf__type mesh__D027744sskos__Concept
% 210.27/210.42  |- skos__annotation mesh__D027744
% 210.27/210.42       do not confuse with bryony = BRYONIA; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.27/210.42  |- mesh__publicMeSHNote mesh__D027744 2002   
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D027744 2002
% 210.27/210.42  |- skos__scopeNote mesh__D027744
% 210.27/210.42       A plant genus of the DIOSCOREACEAE plant family.     
% 210.27/210.42  |- skos__historyNote mesh__D027744 Plants, Medicinal %28%1968-2001%29%
% 210.27/210.42  |- skos__altLabel mesh__D027744 Black Bryony
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D027744 2004
% 210.27/210.42  |- mesh__dateCreated mesh__D027744 2001-07-25
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D027744 2003
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D027744 2006
% 210.27/210.42  |- mesh__historyNote mesh__D027744 2002   
% 210.27/210.42  |- mesh__dateEstablished mesh__D027744 2002-01-01
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D027744 2005
% 210.27/210.42  |- skos__broader mesh__D027744smesh__D027743
% 210.27/210.42  |- skos__altLabel mesh__D027744 Bryony, Black
% 210.27/210.42  |- skos__prefLabel mesh__D027744 Tamus
% 210.27/210.42  |- skos__broader mesh__D004364Q000494smesh__D004364
% 210.27/210.42  |- mesh__preferredCombination mesh__D004364Q000494smesh__D010600
% 210.27/210.42  |- rdf__type mesh__D004364Q000494smesh__CompoundConcept
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D005292 2002
% 210.27/210.42  |- mesh__publicMeSHNote mesh__D005292 66   
% 210.27/210.42  |- mesh__dateEstablished mesh__D005292 1966-01-01
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D005292 2005
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D005292 1998
% 210.27/210.42  |- mesh__dateRevised mesh__D005292 1993-06-01
% 210.27/210.42  |- skos__broader mesh__D005292smesh__D003486
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D005292 1994
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D005292 2006
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D005292 1999
% 210.27/210.42  |- skos__broader mesh__D005292smesh__D005290
% 210.27/210.42  |- skos__scopeNote mesh__D005292
% 210.27/210.42       Inorganic salts of the hypothetical acid, H3Fe%28%CN%29%6.     
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D005292 1995
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D005292 2000
% 210.27/210.42  |- mesh__recordOriginator mesh__D005292 NLM
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D005292 2003
% 210.27/210.42  |- mesh__recordMaintainer mesh__D005292 TPW
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D005292 1996
% 210.27/210.42  |- mesh__historyNote mesh__D005292 66   
% 210.27/210.42  |- skos__annotation mesh__D005292 do not confuse with FERROCYANIDES   
% 210.27/210.42  |- skos__prefLabel mesh__D005292 Ferricyanides
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D005292 2001
% 210.27/210.42  |- rdf__type mesh__D005292sskos__Concept
% 210.27/210.42  |- mesh__dateCreated mesh__D005292 1999-01-01
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D005292 2004
% 210.27/210.42  |- mesh__activeMeSHYear mesh__D005292 1997
% 210.27/210.42  |- mesh__recordAuthorizer mesh__D005292 PLS
% 210.27/210.42  |- mesh__publicMeSHNote mesh__D013724
% 210.27/210.42       82; was TERATOID TUMOR 1963-81; TERATOMA, CYSTIC %26% TERATOMA, MATURE were see DERMOID CYST 1985-93; DYSEMBRYOMA was heading 1963-84%A%  
% 210.27/210.42  |- mesh__onlineNote mesh__D013724
% 210.27/210.42       use TERATOMA to search TERATOID TUMOR 1966-81 %26% DYSEMBRYOMA 1966-84; use DERMOID CYST to search TERATOMA, CYSTIC %26% TERATOMA, MATURE 1985-93%A%  
% 210.27/210.42  |- skos__altLabel mesh__D013724 Dysembryoma
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D013724 1998
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D013724 2005
% 210.27/210.43  |- mesh__recordMaintainer mesh__D013724 KEV
% 210.27/210.43  |- mesh__dateRevised mesh__D013724 1995-06-08
% 210.27/210.43  |- mesh__recordOriginator mesh__D013724 NLM
% 210.27/210.43  |- skos__hiddenLabel mesh__D013724 Teratomas, Mature
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D013724 2002
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D013724 1999
% 210.27/210.43  |- mesh__dateCreated mesh__D013724 1999-01-01
% 210.27/210.43  |- rdf__type mesh__D013724sskos__Concept
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D013724 2006
% 210.27/210.43  |- skos__hiddenLabel mesh__D013724 Cystic Teratomas
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D013724 1996
% 210.27/210.43  |- mesh__recordAuthorizer mesh__D013724 PLS
% 210.27/210.43  |- skos__broader mesh__D013724smesh__D009373
% 210.27/210.43  |- skos__hiddenLabel mesh__D013724 Teratoid Tumors
% 210.27/210.43  |- skos__altLabel mesh__D013724 Teratoid Tumor
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D013724 2003
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D013724 2000
% 210.27/210.43  |- skos__hiddenLabel mesh__D013724 Teratomas
% 210.27/210.43  |- skos__altLabel mesh__D013724 Teratoma, Cystic
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D013724 1997
% 210.27/210.43  |- mesh__historyNote mesh__D013724
% 210.27/210.43       82; was TERATOID TUMOR 1963-81; TERATOMA, CYSTIC %26% TERATOMA, MATURE were see DERMOID CYST 1985-93; DYSEMBRYOMA was heading 1963-84%A%  
% 210.27/210.43  |- skos__hiddenLabel mesh__D013724 Mature Teratoma
% 210.27/210.43  |- skos__hiddenLabel mesh__D013724 Dysembryomas
% 210.27/210.43  |- skos__altLabel mesh__D013724 Teratoma, Mature
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D013724 2004
% 210.27/210.43  |- skos__annotation mesh__D013724
% 210.27/210.43       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 210.27/210.43  |- skos__hiddenLabel mesh__D013724 Teratomas, Cystic
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D013724 2001
% 210.27/210.43  |- skos__hiddenLabel mesh__D013724 Tumor, Teratoid
% 210.27/210.43  |- skos__hiddenLabel mesh__D013724 Cystic Teratoma
% 210.27/210.43  |- skos__prefLabel mesh__D013724 Teratoma
% 210.27/210.43  |- skos__scopeNote mesh__D013724
% 210.27/210.43       A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They may be solid or cystic and are classified histologically as mature, immature, and malignant. %28%From Dorland, 27th ed %26% DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1642%29%%A%    
% 210.27/210.43  |- skos__hiddenLabel mesh__D013724 Tumors, Teratoid
% 210.27/210.43  |- skos__hiddenLabel mesh__D013724 Mature Teratomas
% 210.27/210.43  |- mesh__dateEstablished mesh__D051843 2006-01-01
% 210.27/210.43  |- skos__scopeNote mesh__D051843
% 210.27/210.43       A family of homologous proteins of low MOLECULAR WEIGHT that are predominately expressed in the BRAIN and that have been implicated in a variety of human diseases. They were originally isolated from CHOLINERGIC FIBERS of TORPEDO.%A%    
% 210.27/210.43  |- skos__broader mesh__D051843smesh__D009419
% 210.27/210.43  |- rdf__type mesh__D051843sskos__Concept
% 210.27/210.43  |- mesh__recordAuthorizer mesh__D051843 sjn
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D051843 2006
% 210.27/210.43  |- mesh__recordMaintainer mesh__D051843 DRC
% 210.27/210.43  |- mesh__publicMeSHNote mesh__D051843
% 210.27/210.43       2006; SYNUCLEIN was indexed under NERVE TISSUE PROTEINS 1988-2005%A%  
% 210.27/210.43  |- mesh__historyNote mesh__D051843 2006%28%1988%29%   
% 210.27/210.43  |- skos__prefLabel mesh__D051843 Synucleins
% 210.27/210.43  |- mesh__dateCreated mesh__D051843 2005-06-30
% 210.27/210.43  |- mesh__recordOriginator mesh__D051843 DRC
% 210.27/210.43  |- skos__altLabel mesh__D051843 Synuclein
% 210.27/210.43  |- rdf__type mesh__D004998sskos__Concept
% 210.27/210.43  |- skos__altLabel mesh__D004998 Ethiodized Oil %28%Injection%29%
% 210.27/210.43  |- skos__altLabel mesh__D004998 Ethiodized Oils
% 210.27/210.43  |- skos__scopeNote mesh__D004998
% 210.27/210.43       Ethyl ester of iodinated fatty acid of poppyseed oil. It contains 37%25% organically bound iodine and has been used as a diagnostic aid %28%radiopaque medium%29% and as an antineoplastic agent when part of the iodine is 131-I. %28%From Merck Index, 11th ed%29%%A%    
% 210.27/210.43  |- skos__broader mesh__D004998smesh__D007459
% 210.27/210.43  |- skos__hiddenLabel mesh__D004998 Oil, Ethiodized
% 210.27/210.43  |- mesh__dateCreated mesh__D004998 1999-01-01
% 210.27/210.43  |- mesh__recordAuthorizer mesh__D004998 sjn
% 210.27/210.43  |- mesh__recordOriginator mesh__D004998 NLM
% 210.27/210.43  |- mesh__onlineNote mesh__D004998
% 210.27/210.43       use ETHIODIZED OIL to search ETHIODIZED OILS 1978-93 %26% ETHIODOL 1966-93 %28%as Prov 1966-72%29%; use ETHIODIZED OIL %28%NM%29% to search ETHIODIZED POPPY SEED OIL 1991-93%A%  
% 210.27/210.43  |- mesh__recordMaintainer mesh__D004998 ssb
% 210.27/210.43  |- mesh__dateEstablished mesh__D004998 1973-01-01
% 210.27/210.43  |- skos__prefLabel mesh__D004998 Ethiodized Oil
% 210.27/210.43  |- skos__annotation mesh__D004998 contrast media; D25-26 qualif   
% 210.27/210.43  |- mesh__publicMeSHNote mesh__D004998
% 210.27/210.43       94; was ETHIODIZED OILS 1978-93, was ETHIODOL 1973-77; ETHIODOL was see ETHIODIZED OILS 1978-93; ETHIODIZED POPPY SEED OIL was indexed under ETHIODIZED OILS 1991-93%A%  
% 210.27/210.43  |- mesh__historyNote mesh__D004998
% 210.27/210.43       94; was ETHIODIZED OILS 1978-93, was ETHIODOL 1964-77 %28%Prov 1964-72%29%; ETHIODOL was see ETHIODIZED OILS 1978-93; ETHIODIZED POPPY SEED OIL was %28%NM%29% 1991-93%A%  
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D004998 2006
% 210.27/210.43  |- skos__hiddenLabel mesh__D004998 Oils, Ethiodized
% 210.27/210.43  |- mesh__dateRevised mesh__D004998 2005-06-30
% 210.27/210.43  |- skos__related mesh__D009683smesh__D011868
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009683 2005
% 210.27/210.43  |- rdf__type mesh__D009683sskos__Concept
% 210.27/210.43  |- skos__altLabel mesh__D009683 Atomic Medicine
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009683 2000
% 210.27/210.43  |- skos__historyNote mesh__D009683 Radiation Injuries %28%1966%29%
% 210.27/210.43  |- skos__altLabel mesh__D009683 Medicine, Nuclear
% 210.27/210.43  |- skos__prefLabel mesh__D009683 Nuclear Medicine
% 210.27/210.43  |- mesh__recordOriginator mesh__D009683 NLM
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009683 1999
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009683 2004
% 210.27/210.43  |- mesh__dateEstablished mesh__D009683 1967-01-01
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009683 2002
% 210.27/210.43  |- mesh__recordAuthorizer mesh__D009683 SJN
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009683 1998
% 210.27/210.43  |- skos__altLabel mesh__D009683 Medicine, Atomic
% 210.27/210.43  |- skos__altLabel mesh__D009683 Nuclear Radiology
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009683 2003
% 210.27/210.43  |- mesh__recordMaintainer mesh__D009683 PXP
% 210.27/210.43  |- mesh__historyNote mesh__D009683 67   
% 210.27/210.43  |- skos__historyNote mesh__D009683 Radioisotopes %28%1966%29%
% 210.27/210.43  |- skos__historyNote mesh__D009683 Nuclear Energy %28%1966%29%
% 210.27/210.43  |- mesh__dateCreated mesh__D009683 1999-01-01
% 210.27/210.43  |- mesh__dateRevised mesh__D009683 1997-06-20
% 210.27/210.43  |- skos__annotation mesh__D009683 SPEC: SPEC qualif; DF: NUCLEAR MED   
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009683 2006
% 210.27/210.43  |- skos__broader mesh__D009683smesh__D011871
% 210.27/210.43  |- mesh__publicMeSHNote mesh__D009683 67   
% 210.27/210.43  |- skos__historyNote mesh__D009683 Nuclear Warfare %28%1966%29%
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009683 2001
% 210.27/210.43  |- skos__scopeNote mesh__D009683
% 210.27/210.43       A specialty field of radiology concerned with diagnostic, therapeutic, and investigative use of radioactive compounds in a pharmaceutical form.%A%    
% 210.27/210.43  |- skos__altLabel mesh__D017317 Calphobindin II
% 210.27/210.43  |- skos__altLabel mesh__D017317 Calcimedin 67-kDa
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D017317 2005
% 210.27/210.43  |- mesh__recordMaintainer mesh__D017317 jmp
% 210.27/210.43  |- skos__hiddenLabel mesh__D017317
% 210.27/210.43       Calcium and Phospholipid Binding Protein p68
% 210.27/210.43  |- skos__hiddenLabel mesh__D017317 Calelectrin 67 kDa
% 210.27/210.43  |- skos__broader mesh__D017317smesh__D017302
% 210.27/210.43  |- skos__historyNote mesh__D017317
% 210.27/210.43       Calcium-Binding Proteins %28%1984-1992%29%
% 210.27/210.43  |- skos__altLabel mesh__D017317 Annexin VI
% 210.27/210.43  |- rdf__type mesh__D017317sskos__Concept
% 210.27/210.43  |- skos__hiddenLabel mesh__D017317 Calcimedin 67 kDa
% 210.27/210.43  |- mesh__dateRevised mesh__D017317 2004-07-07
% 210.27/210.43  |- mesh__historyNote mesh__D017317 2005%28%1987%29%   
% 210.27/210.43  |- mesh__dateEstablished mesh__D017317 1993-01-01
% 210.27/210.43  |- skos__altLabel mesh__D017317 Lipocortin VI
% 210.27/210.43  |- mesh__recordAuthorizer mesh__D017317 sjn
% 210.27/210.43  |- skos__scopeNote mesh__D017317
% 210.27/210.43       Protein of the annexin family with a probable role in exocytotic and endocytotic membrane events.%A%    
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D017317 2006
% 210.27/210.43  |- skos__prefLabel mesh__D017317 Annexin A6
% 210.27/210.43  |- skos__altLabel mesh__D017317
% 210.27/210.43       Calcium and Phospholipid-Binding Protein p68
% 210.27/210.43  |- mesh__publicMeSHNote mesh__D017317
% 210.27/210.43       2005; ANNEXIN VI was indexed under CALCIUM-BINDING PROTEINS 1990-1992; CALPHOBINDIN II was indexed under PREGNANCY PROTEINS 1987-1992; CALCIUM AND PHOSPHOLIPID-BINDING PROTEIN P68 was indexed under BINDING PROTEINS %26% CALCIUM 1979-1980; CALCIUM-BINDING PROTEINS 1981-2004 %26% ANNEXIN VI 2004%A%  
% 210.27/210.43  |- mesh__recordOriginator mesh__D017317 AGS
% 210.27/210.43  |- skos__altLabel mesh__D017317 Calelectrin 67-kDa
% 210.27/210.43  |- mesh__dateCreated mesh__D017317 1992-05-07
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D005293 2006
% 210.27/210.43  |- skos__scopeNote mesh__D005293
% 210.27/210.43       An iron-containing protein complex that is formed by a combination of ferric iron with the protein APOFERRITIN.%A%    
% 210.27/210.43  |- skos__broader mesh__D005293smesh__D033862
% 210.27/210.43  |- mesh__recordMaintainer mesh__D005293 jmp
% 210.27/210.43  |- mesh__dateRevised mesh__D005293 2002-07-03
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D005293 2003
% 210.27/210.43  |- mesh__recordAuthorizer mesh__D005293 sjn
% 210.27/210.43  |- skos__prefLabel mesh__D005293 Ferritin
% 210.27/210.43  |- mesh__dateCreated mesh__D005293 1999-01-01
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D005293 2004
% 210.27/210.43  |- rdf__type mesh__D005293sskos__Concept
% 210.27/210.43  |- mesh__recordOriginator mesh__D005293 NLM
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D005293 2005
% 210.27/210.43  |- mesh__recordMaintainer mesh__D013725 jmp
% 210.27/210.43  |- skos__scopeNote mesh__D013725
% 210.27/210.43       Terbium. An element of the rare earth family of metals. It has the atomic symbol Tb, atomic number 65, and atomic weight 158.92.%A%    
% 210.27/210.43  |- skos__prefLabel mesh__D013725 Terbium
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D013725 2006
% 210.27/210.43  |- rdf__type mesh__D013725sskos__Concept
% 210.27/210.43  |- mesh__recordOriginator mesh__D013725 NLM
% 210.27/210.43  |- mesh__dateCreated mesh__D013725 1999-01-01
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D013725 2004
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D013725 2005
% 210.27/210.43  |- mesh__dateRevised mesh__D013725 2001-07-25
% 210.27/210.43  |- skos__broader mesh__D013725smesh__D028581
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D013725 2003
% 210.27/210.43  |- mesh__recordAuthorizer mesh__D013725 sjn
% 210.27/210.43  |- skos__annotation mesh__D013725
% 210.27/210.43       a rare earth metal; Tb-159; Tb-147-158, 160-164 = TERBIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D013725 2002
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D018410 2000
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D018410 1998
% 210.27/210.43  |- mesh__historyNote mesh__D018410 95   
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D018410 1997
% 210.27/210.43  |- mesh__dateEstablished mesh__D018410 1995-01-01
% 210.27/210.43  |- skos__broader mesh__D018410smesh__D011014
% 210.27/210.43  |- mesh__publicMeSHNote mesh__D018410 95   
% 210.27/210.43  |- skos__hiddenLabel mesh__D018410 Pneumonias, Bacterial
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D018410 1996
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D018410 2006
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D018410 2002
% 210.27/210.43  |- skos__broader mesh__D018410smesh__D001424
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D018410 2005
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D018410 2004
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D018410 1995
% 210.27/210.43  |- rdf__type mesh__D018410sskos__Concept
% 210.27/210.43  |- skos__altLabel mesh__D018410 Bacterial Pneumonia
% 210.27/210.43  |- skos__scopeNote mesh__D018410
% 210.27/210.43       Pneumonia caused by various species of bacteria. Bacterial pneumonia commonly results from bronchogenic spread of infection following microaspiration of secretions. The largest category of this disease arises from community-acquired pneumonias.%A%    
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D018410 2003
% 210.27/210.43  |- skos__annotation mesh__D018410
% 210.27/210.43       GEN or unspecified; prefer specifics; coord IM with specific bact infect %28%IM%29%; DF: PNEUMONIA BACT%A%  
% 210.27/210.43  |- mesh__dateCreated mesh__D018410 1994-01-25
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D018410 2001
% 210.27/210.43  |- skos__hiddenLabel mesh__D018410 Bacterial Pneumonias
% 210.27/210.43  |- skos__prefLabel mesh__D018410 Pneumonia, Bacterial
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D018410 1999
% 210.27/210.43  |- mesh__historyNote mesh__D051844 2006%28%1988%29%   
% 210.27/210.43  |- skos__prefLabel mesh__D051844 alpha-Synuclein
% 210.27/210.43  |- rdf__type mesh__D051844sskos__Concept
% 210.27/210.43  |- skos__scopeNote mesh__D051844
% 210.27/210.43       A synuclein that is a major component of LEWY BODIES that plays a role in neurodegeneration and neuroprotection.%A%    
% 210.27/210.43  |- mesh__recordOriginator mesh__D051844 DRC
% 210.27/210.43  |- mesh__dateEstablished mesh__D051844 2006-01-01
% 210.27/210.43  |- mesh__publicMeSHNote mesh__D051844
% 210.27/210.43       2006; ALPHA-SYNUCLEIN was indexed under NERVE TISSUE PROTEINS 1988-2005%A%  
% 210.27/210.43  |- skos__hiddenLabel mesh__D051844 Non AB Component of AD Amyloid Protein
% 210.27/210.43  |- mesh__recordMaintainer mesh__D051844 DRC
% 210.27/210.43  |- skos__broader mesh__D051844smesh__D051843
% 210.27/210.43  |- mesh__recordAuthorizer mesh__D051844 sjn
% 210.27/210.43  |- skos__altLabel mesh__D051844 Non-AB Component of AD Amyloid Protein
% 210.27/210.43  |- skos__hiddenLabel mesh__D051844 alpha Synuclein
% 210.27/210.43  |- mesh__dateCreated mesh__D051844 2005-06-30
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D051844 2006
% 210.27/210.43  |- rdf__type mesh__D004999sskos__Concept
% 210.27/210.43  |- skos__hiddenLabel mesh__D004999 Amifostine Lilly Brand
% 210.27/210.43  |- mesh__historyNote mesh__D004999
% 210.27/210.43       94; was ETHIOFOS 1985-93 %28%see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1985-90%29%; was WR 2721 see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1977-84%A%  
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D004999 2006
% 210.27/210.43  |- skos__altLabel mesh__D004999 Schering-Plough Brand of Amifostine
% 210.27/210.43  |- skos__altLabel mesh__D004999 Essex Brand of Amifostine
% 210.27/210.43  |- skos__hiddenLabel mesh__D004999 Disodium Salt, Amifostine
% 210.27/210.43  |- skos__altLabel mesh__D004999 Gammaphos
% 210.27/210.43  |- skos__hiddenLabel mesh__D004999
% 210.27/210.43       Acid, Aminopropylaminoethylthiophosphoric
% 210.27/210.43  |- skos__hiddenLabel mesh__D004999 Amifostine Schering-Plough Brand
% 210.27/210.43  |- skos__historyNote mesh__D004999
% 210.27/210.43       Organothiophosphorus Compounds %28%1972-1976%29%
% 210.27/210.43  |- skos__annotation mesh__D004999 D25-26 qualif   
% 210.27/210.43  |- skos__historyNote mesh__D004999 Diamines %28%1974-1976%29%
% 210.27/210.43  |- mesh__dateEstablished mesh__D004999 1991-01-01
% 210.27/210.43  |- skos__hiddenLabel mesh__D004999 Schering Plough Brand of Amifostine
% 210.27/210.43  |- skos__altLabel mesh__D004999 Ethiofos
% 210.27/210.43  |- skos__hiddenLabel mesh__D004999 WR 2721
% 210.27/210.43  |- skos__hiddenLabel mesh__D004999 NSC296961
% 210.27/210.43  |- skos__altLabel mesh__D004999
% 210.27/210.43       S-%28%N-%28%3-Aminopropyl%29%-2-aminoethyl%29%thiophosphoric Acid
% 210.27/210.43  |- skos__altLabel mesh__D004999 US Bioscience Brand of Amifostine
% 210.27/210.43  |- skos__scopeNote mesh__D004999
% 210.27/210.43       A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.%A%    
% 210.27/210.43  |- mesh__publicMeSHNote mesh__D004999
% 210.27/210.43       94; was ETHIOFOS 1985-93 %28%see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1985-90%29%; was WR 2721 see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1977-84%A%  
% 210.27/210.43  |- skos__hiddenLabel mesh__D004999 Amifostine Essex Brand
% 210.27/210.43  |- skos__hiddenLabel mesh__D004999 YM08310
% 210.27/210.43  |- mesh__dateRevised mesh__D004999 2005-06-30
% 210.27/210.43  |- skos__prefLabel mesh__D004999 Amifostine
% 210.27/210.43  |- skos__hiddenLabel mesh__D004999 Salt, Amifostine Disodium
% 210.27/210.43  |- skos__hiddenLabel mesh__D004999 YM 08310
% 210.27/210.43  |- skos__altLabel mesh__D004999 APAETP
% 210.27/210.43  |- skos__altLabel mesh__D004999 Aminopropylaminoethylthiophosphoric Acid
% 210.27/210.43  |- skos__altLabel mesh__D004999 Alza Brand of Amifostine
% 210.27/210.43  |- mesh__recordMaintainer mesh__D004999 ssb
% 210.27/210.43  |- skos__altLabel mesh__D004999 Lilly Brand of Amifostine
% 210.27/210.43  |- mesh__onlineNote mesh__D004999
% 210.27/210.43       use AMIFOSTINE to search ETHIOFOS 1985-93 %26% WR 2721 1977-84%A%  
% 210.27/210.43  |- skos__hiddenLabel mesh__D004999 Monohydrochloride, Amifostine
% 210.27/210.43  |- skos__hiddenLabel mesh__D004999 Monohydrate, Amifostine
% 210.27/210.43  |- skos__hiddenLabel mesh__D004999 Amifostine Alza Brand
% 210.27/210.43  |- skos__altLabel mesh__D004999 Aminopropyl Aminoethylthiophosphate
% 210.27/210.43  |- mesh__dateCreated mesh__D004999 1976-04-13
% 210.27/210.43  |- mesh__recordOriginator mesh__D004999 SH
% 210.27/210.43  |- skos__hiddenLabel mesh__D004999 NSC 296961
% 210.27/210.43  |- skos__broader mesh__D004999smesh__D009946
% 210.27/210.43  |- mesh__recordAuthorizer mesh__D004999 sjn
% 210.27/210.43  |- skos__hiddenLabel mesh__D004999 WR2721
% 210.27/210.43  |- skos__hiddenLabel mesh__D051046 Acetyl CoA Glutamate N Acetyltransferase
% 210.27/210.43  |- skos__hiddenLabel mesh__D051046 N-Acetyltransferase, Amino-Acid
% 210.27/210.43  |- skos__hiddenLabel mesh__D051046 Amino Acid N Acetyltransferase
% 210.27/210.43  |- skos__altLabel mesh__D051046 Amino-Acid Acetyltransferase
% 210.27/210.43  |- mesh__recordOriginator mesh__D051046 AKE
% 210.27/210.43  |- skos__hiddenLabel mesh__D051046 N Acetylglutamate Synthetase
% 210.27/210.43  |- skos__altLabel mesh__D051046 N-Acetyl-L-Glutamate Synthetase
% 210.27/210.43  |- skos__altLabel mesh__D051046 N-Acetylglutamate Synthetase
% 210.27/210.43  |- skos__hiddenLabel mesh__D051046 Synthetase, N-Acetyl-L-Glutamate
% 210.27/210.43  |- skos__hiddenLabel mesh__D051046 N Acetyl L Glutamate Synthetase
% 210.27/210.43  |- rdf__type mesh__D051046sskos__Concept
% 210.27/210.43  |- skos__altLabel mesh__D051046
% 210.27/210.43       Acetyl Coenzyme A Glutamate N-Acetyltransferase
% 210.27/210.43  |- skos__hiddenLabel mesh__D051046 Acetyltransferase, Amino-Acid
% 210.27/210.43  |- mesh__dateCreated mesh__D051046 2005-06-30
% 210.27/210.43  |- skos__hiddenLabel mesh__D051046
% 210.27/210.43       Acetyl Coenzyme A Glutamate N Acetyltransferase
% 210.27/210.43  |- skos__altLabel mesh__D051046 Acetyl CoA Glutamate N-Acetyltransferase
% 210.27/210.43  |- skos__altLabel mesh__D051046 Amino Acid Acetyltransferase
% 210.27/210.43  |- mesh__historyNote mesh__D051046
% 210.27/210.43       2006%28%1980%29%; use ACETYLTRANSFERASES, ACETYL COENZYME A %26% GLUTAMATES 1973-1979%A%  
% 210.27/210.43  |- skos__prefLabel mesh__D051046 Amino-Acid N-Acetyltransferase
% 210.27/210.43  |- skos__hiddenLabel mesh__D051046 Acetyltransferase, Amino Acid
% 210.27/210.43  |- skos__broader mesh__D051046smesh__D000123
% 210.27/210.43  |- skos__hiddenLabel mesh__D051046 N Acetylglutamate Synthase
% 210.27/210.43  |- skos__scopeNote mesh__D051046
% 210.27/210.43       A mitochondrial matrix enzyme that catalyzes the synthesis of L-GLUTAMATE to N-acetyl-L-glutamate in the presence of ACETYL-COA.%A%    
% 210.27/210.43  |- mesh__recordMaintainer mesh__D051046 AKE
% 210.27/210.43  |- skos__hiddenLabel mesh__D051046 Acid Acetyltransferase, Amino
% 210.27/210.43  |- skos__hiddenLabel mesh__D051046 Synthetase, N-Acetylglutamate
% 210.27/210.43  |- mesh__publicMeSHNote mesh__D051046
% 210.27/210.43       2006; AMINO-ACID N-ACETYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1973-2005, %26% under ACETYL COENZYME A %26% GLUTAMATES 1973-1980%A%  
% 210.27/210.43  |- mesh__dateEstablished mesh__D051046 2006-01-01
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D051046 2006
% 210.27/210.43  |- mesh__recordAuthorizer mesh__D051046 sjn
% 210.27/210.43  |- skos__hiddenLabel mesh__D051046 Synthase, N-Acetylglutamate
% 210.27/210.43  |- skos__altLabel mesh__D051046 N-Acetylglutamate Synthase
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009684 1993
% 210.27/210.43  |- mesh__dateCreated mesh__D009684 1981-05-19
% 210.27/210.43  |- rdf__type mesh__D009684sskos__Concept
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009684 2000
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009684 1998
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009684 2003
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009684 1994
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009684 1999
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009684 2004
% 210.27/210.43  |- skos__prefLabel mesh__D009684 Nuclear Medicine Department, Hospital
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009684 2001
% 210.27/210.43  |- mesh__historyNote mesh__D009684
% 210.27/210.43       91%28%82%29%; was see under HOSPITAL DEPARTMENTS 1982-90   
% 210.27/210.43  |- skos__altLabel mesh__D009684 Hospital Nuclear Medicine Department
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009684 1995
% 210.27/210.43  |- mesh__recordAuthorizer mesh__D009684 PLS
% 210.27/210.43  |- skos__scopeNote mesh__D009684
% 210.27/210.43       Hospital department responsible for the administration and management of nuclear medicine services.%A%    
% 210.27/210.43  |- skos__altLabel mesh__D009684 Nuclear Medicine Departments, Hospital
% 210.27/210.43  |- skos__historyNote mesh__D009684 Nuclear Medicine %28%1967-1981%29%
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009684 2002
% 210.27/210.43  |- skos__annotation mesh__D009684
% 210.27/210.43       restrict to radioisotope diag %26% ther serv: do not confuse with RADIOLOGY DEPARTMENT, HOSPITAL %28%x-ray %26% radiocobalt only%29%; DF: NUCLEAR MED DEP%A%  
% 210.27/210.43  |- skos__historyNote mesh__D009684 Hospital Departments %28%1968-1981%29%
% 210.27/210.43  |- mesh__publicMeSHNote mesh__D009684
% 210.27/210.43       91; was see under HOSPITAL DEPARTMENTS 1982-90   
% 210.27/210.43  |- mesh__recordMaintainer mesh__D009684 TGC
% 210.27/210.43  |- skos__broader mesh__D009684smesh__D006748
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009684 2005
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009684 1996
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009684 2006
% 210.27/210.43  |- mesh__recordOriginator mesh__D009684 EC
% 210.27/210.43  |- skos__altLabel mesh__D009684 Hospital Nuclear Medicine Departments
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D009684 1997
% 210.27/210.43  |- mesh__dateEstablished mesh__D009684 1991-01-01
% 210.27/210.43  |- mesh__dateRevised mesh__D009684 1992-05-15
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D017318 2006
% 210.27/210.43  |- skos__broader mesh__D017318smesh__D017302
% 210.27/210.43  |- skos__scopeNote mesh__D017318
% 210.27/210.43       A protein of the annexin family that catalyzes the conversion of 1-D-inositol 1,2-cyclic phosphate and water to 1-D-myo-inositol 1-phosphate.%A%    
% 210.27/210.43  |- skos__altLabel mesh__D017318 Annexin III
% 210.27/210.43  |- skos__prefLabel mesh__D017318 Annexin A3
% 210.27/210.43  |- mesh__recordMaintainer mesh__D017318 jmp
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D017318 2005
% 210.27/210.43  |- rdf__type mesh__D017318sskos__Concept
% 210.27/210.43  |- skos__altLabel mesh__D017318 Lipocortin III
% 210.27/210.43  |- skos__historyNote mesh__D017318
% 210.27/210.43       Calcium-Binding Proteins %28%1991-1992%29%
% 210.27/210.43  |- mesh__dateRevised mesh__D017318 2004-07-07
% 210.27/210.43  |- mesh__historyNote mesh__D017318 2005%28%1991%29%   
% 210.27/210.43  |- mesh__publicMeSHNote mesh__D017318
% 210.27/210.43       2005; ANNEXIN III was indexed under CALCIUM-BINDING PROTEINS 1991-1992;  ANNEXIN A3 was indexed under ANNEXIN III 2004%A%  
% 210.27/210.43  |- mesh__recordAuthorizer mesh__D017318 sjn
% 210.27/210.43  |- skos__broader mesh__D017318smesh__D010727
% 210.27/210.43  |- mesh__dateEstablished mesh__D017318 1993-01-01
% 210.27/210.43  |- mesh__recordOriginator mesh__D017318 AGS
% 210.27/210.43  |- skos__altLabel mesh__D017318 Placental Anticoagulant Protein III
% 210.27/210.43  |- skos__altLabel mesh__D017318 Calcimedin 35 alpha
% 210.27/210.43  |- mesh__dateCreated mesh__D017318 1992-05-07
% 210.27/210.43  |- mesh__dateRevised mesh__D014020 2005-06-30
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D014020 2006
% 210.27/210.43  |- mesh__recordOriginator mesh__D014020 NLM
% 210.27/210.43  |- mesh__recordMaintainer mesh__D014020 ssb
% 210.27/210.43  |- rdf__type mesh__D014020sskos__Concept
% 210.27/210.43  |- skos__prefLabel mesh__D014020 Tissue Extracts
% 210.27/210.43  |- skos__broader mesh__D014020smesh__D045424
% 210.27/210.43  |- skos__scopeNote mesh__D014020
% 210.27/210.43       Preparations made from animal tissues or organs %28%ANIMAL STRUCTURES%29%. They usually contain many components, any one of which may be pharmacologically or physiologically active. Tissue extracts may contain specific, but uncharacterized factors or proteins with specific actions.%A%    
% 210.27/210.43  |- mesh__dateCreated mesh__D014020 1999-01-01
% 210.27/210.43  |- skos__annotation mesh__D014020
% 210.27/210.43       not for chemical substances %22%extracted%22% from tissues %28%= specific chemical + organ or tissue /chem%29%%A%  
% 210.27/210.43  |- mesh__recordAuthorizer mesh__D014020 sjn
% 210.27/210.43  |- skos__hiddenLabel mesh__D014020 Extracts, Tissue
% 210.27/210.43  |- mesh__historyNote mesh__D005294
% 210.27/210.43       91%28%77%29%; was see under LYASES 1977-90   
% 210.27/210.43  |- skos__altLabel mesh__D005294 Porphyrin-Metal Chelatase
% 210.27/210.43  |- mesh__publicMeSHNote mesh__D005294 91; was see under LYASES 1977-90   
% 210.27/210.43  |- skos__hiddenLabel mesh__D005294 Synthetase, Heme
% 210.27/210.43  |- skos__altLabel mesh__D005294 Heme Synthetase
% 210.27/210.43  |- rdf__type mesh__D005294sskos__Concept
% 210.27/210.43  |- mesh__dateEstablished mesh__D005294 1991-01-01
% 210.27/210.43  |- skos__broader mesh__D005294smesh__D008190
% 210.27/210.43  |- skos__hiddenLabel mesh__D005294 Protoheme Ferro Lyase
% 210.27/210.43  |- skos__historyNote mesh__D005294 Lyases %28%1966-1976%29%
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D005294 2005
% 210.27/210.43  |- mesh__dateCreated mesh__D005294 1976-04-27
% 210.27/210.43  |- skos__hiddenLabel mesh__D005294 Chelatase, Zinc
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D005294 2005A
% 210.27/210.43  |- skos__hiddenLabel mesh__D005294 Porphyrin Metal Chelatase
% 210.27/210.43  |- skos__hiddenLabel mesh__D005294 Chelatase, Porphyrin-Metal
% 210.27/210.43  |- skos__hiddenLabel mesh__D005294 Ferro-Lyase, Protoheme
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D005294 2006
% 210.27/210.43  |- skos__altLabel mesh__D005294 Protoheme Ferro-Lyase
% 210.27/210.43  |- skos__historyNote mesh__D005294 Protoporphyrins %28%1975-1976%29%
% 210.27/210.43  |- skos__scopeNote mesh__D005294
% 210.27/210.43       A mitochondrial enzyme found in a wide variety of cells and tissues. It is the final enzyme in the 8-enzyme biosynthetic pathway of HEME. Ferrochelatase catalyzes ferrous insertion into protoporphyrin IX to form protoheme or heme. Deficiency in this enzyme results in ERYTHROPOIETIC PROTOPORPHYRIA.%A%    
% 210.27/210.43  |- mesh__recordMaintainer mesh__D005294 sjn
% 210.27/210.43  |- skos__historyNote mesh__D005294 Porphyrins %28%1966-1976%29%
% 210.27/210.43  |- mesh__recordOriginator mesh__D005294 RLS
% 210.27/210.43  |- skos__prefLabel mesh__D005294 Ferrochelatase
% 210.27/210.43  |- mesh__recordAuthorizer mesh__D005294 sjn
% 210.27/210.43  |- skos__historyNote mesh__D005294 Iron %28%1966-1976%29%
% 210.27/210.43  |- mesh__dateRevised mesh__D005294 2004-10-20
% 210.27/210.43  |- mesh__recordAuthorizer mesh__D013726 sjn
% 210.27/210.43  |- mesh__recordMaintainer mesh__D013726 CCR
% 210.27/210.43  |- skos__hiddenLabel mesh__D013726 KWD2019
% 210.27/210.43  |- skos__altLabel mesh__D013726 Butalitab
% 210.27/210.43  |- skos__altLabel mesh__D013726 Novartis Brand of Terbutaline Sulfate
% 210.27/210.43  |- skos__altLabel mesh__D013726 Aliud Brand of Terbutaline Sulfate
% 210.27/210.43  |- skos__hiddenLabel mesh__D013726 Terbutalin ratiopharm
% 210.27/210.43  |- skos__altLabel mesh__D013726 Lagap Brand of Terbutaline Sulfate
% 210.27/210.43  |- skos__hiddenLabel mesh__D013726 KWD 2019
% 210.27/210.43  |- skos__altLabel mesh__D013726 Estedi Brand of Terbutaline Sulfate
% 210.27/210.43  |- skos__altLabel mesh__D013726 Terbasmin
% 210.27/210.43  |- skos__altLabel mesh__D013726 Dermapharm Brand of Terbutaline Sulfate
% 210.27/210.43  |- skos__altLabel mesh__D013726 Bricanyl SA
% 210.27/210.43  |- skos__altLabel mesh__D013726 Hexal Brand of Terbutaline Sulfate
% 210.27/210.43  |- skos__altLabel mesh__D013726 Alpharma Brand of Terbutaline Sulfate
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D013726 2006
% 210.27/210.43  |- rdf__type mesh__D013726sskos__Concept
% 210.27/210.43  |- skos__scopeNote mesh__D013726
% 210.27/210.43       A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.%A%    
% 210.27/210.43  |- skos__altLabel mesh__D013726 Lindopharm Brand of Terbutaline Sulfate
% 210.27/210.43  |- skos__altLabel mesh__D013726 Fatol Brand of Terbutaline Sulfate
% 210.27/210.43  |- mesh__dateCreated mesh__D013726 1999-01-01
% 210.27/210.43  |- skos__hiddenLabel mesh__D013726
% 210.27/210.43       ct Arzneimittel Brand of Terbutaline Sulfate
% 210.27/210.43  |- skos__altLabel mesh__D013726 Hoechst Brand of Terbutaline Sulfate
% 210.27/210.43  |- skos__altLabel mesh__D013726
% 210.27/210.43       ct-Arzneimittel Brand of Terbutaline Sulfate
% 210.27/210.43  |- mesh__dateRevised mesh__D013726 2005-06-30
% 210.27/210.43  |- skos__altLabel mesh__D013726 Stadapharm Brand of Terbutaline Sulfate
% 210.27/210.43  |- skos__altLabel mesh__D013726 Kendrick Brand of Terbutaline Sulfate
% 210.27/210.43  |- skos__altLabel mesh__D013726 ratiopharm Brand of Terbutaline Sulfate
% 210.27/210.43  |- skos__prefLabel mesh__D013726 Terbutaline
% 210.27/210.43  |- skos__altLabel mesh__D013726 Azupharma Brand of Terbutaline Sulfate
% 210.27/210.43  |- skos__altLabel mesh__D013726 pharma-stern Brand of Terbutaline Sulfate
% 210.27/210.43  |- mesh__recordOriginator mesh__D013726 NLM
% 210.27/210.43  |- skos__altLabel mesh__D013726 AstraZeneca Brand of Terbutaline Sulfate
% 210.27/210.43  |- mesh__dateEstablished mesh__D013726 1974-01-01
% 210.27/210.43  |- skos__broader mesh__D013726smesh__D004983
% 210.27/210.43  |- mesh__historyNote mesh__D013726 74   
% 210.27/210.43  |- mesh__publicMeSHNote mesh__D013726 74   
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D018411 2006
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D018411 2005
% 210.27/210.43  |- mesh__activeMeSHYear mesh__D018411 2004
% 210.27/210.43  |- skos__annotation mesh__D018411
% 210.27/210.43       a genus of moths; /microbiol /parasitol permitted; do not use /drug eff for insecticides: TN 111%A%  
% 210.27/210.43  |- rdf__type mesh__D018411sskos__Concept
% 210.27/210.43  |- mesh__dateEstablished mesh__D018411 1995-01-01
% 210.27/210.43  |- mesh__dateCreated mesh__D018411 1994-01-25
% 210.27/210.44  |- skos__historyNote mesh__D018411 Moths %28%1975-1994%29%
% 210.27/210.44  |- mesh__publicMeSHNote mesh__D018411 95   
% 210.27/210.44  |- skos__historyNote mesh__D018411 Lepidoptera %28%1975-1990%29%
% 210.27/210.44  |- skos__scopeNote mesh__D018411
% 210.27/210.44       A genus of owlet moths of the family Noctuidae. These insects are used in molecular biology studies during all stages of their life cycle.%A%    
% 210.27/210.44  |- mesh__historyNote mesh__D018411 95   
% 210.27/210.44  |- mesh__dateRevised mesh__D018411 2003-07-09
% 210.27/210.44  |- skos__broader mesh__D018411smesh__D009036
% 210.27/210.44  |- skos__prefLabel mesh__D018411 Spodoptera
% 210.27/210.44  |- skos__historyNote mesh__D018411 Insects %28%1966-1974%29%
% 210.27/210.44  |- mesh__recordOriginator mesh__D051845 DRC
% 210.27/210.44  |- skos__broader mesh__D051845smesh__D051843
% 210.27/210.44  |- mesh__recordAuthorizer mesh__D051845 sjn
% 210.27/210.44  |- skos__altLabel mesh__D051845 Synoretin
% 210.27/210.44  |- mesh__dateCreated mesh__D051845 2005-06-30
% 210.27/210.44  |- mesh__dateEstablished mesh__D051845 2006-01-01
% 210.27/210.44  |- skos__scopeNote mesh__D051845
% 210.27/210.44       A homolog of ALPHA-SYNUCLEIN that plays a role in neurofilament network integrity. It is overexpressed in a variety of human NEOPLASMS and may be involved in modulating AXON architecture during EMBRYONIC DEVELOPMENT and in the adult. Gamma-Synuclein may also activate SIGNAL TRANSDUCTION PATHWAYS associated with ETS-DOMAIN PROTEIN ELK-1.%A%    
% 210.27/210.44  |- mesh__publicMeSHNote mesh__D051845
% 210.27/210.44       2006; GAMMA-SYNUCLEIN was indexed under NERVE TISSUE PROTEINS 1988-2005%A%  
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D051845 2006
% 210.27/210.44  |- skos__hiddenLabel mesh__D051845 gamma Synuclein
% 210.27/210.44  |- rdf__type mesh__D051845sskos__Concept
% 210.27/210.44  |- mesh__historyNote mesh__D051845 2006%28%1988%29%   
% 210.27/210.44  |- skos__prefLabel mesh__D051845 gamma-Synuclein
% 210.27/210.44  |- mesh__recordMaintainer mesh__D051845 DRC
% 210.27/210.44  |- skos__altLabel mesh__D051845 Persyn
% 210.27/210.44  |- skos__hiddenLabel mesh__D051047 Acetyltransferase, Dihydrolipoamide
% 210.27/210.44  |- skos__hiddenLabel mesh__D051047 S-Acetyltransferase, Dihydrolipoamide
% 210.27/210.44  |- skos__altLabel mesh__D051047 Lipoate Acetyltransferase
% 210.27/210.44  |- rdf__type mesh__D051047sskos__Concept
% 210.27/210.44  |- skos__altLabel mesh__D051047 Dihydrolipoyl Transacetylase
% 210.27/210.44  |- skos__altLabel mesh__D051047 Dihydrolipoamide Acetyltransferase
% 210.27/210.44  |- skos__hiddenLabel mesh__D051047 Dihydrolipoamide S Acetyltransferase
% 210.27/210.44  |- mesh__dateEstablished mesh__D051047 2006-01-01
% 210.27/210.44  |- mesh__recordAuthorizer mesh__D051047 sjn
% 210.27/210.44  |- skos__hiddenLabel mesh__D051047
% 210.27/210.44       Dihydrolipoyllysine Residue Acetyltransferase
% 210.27/210.44  |- skos__hiddenLabel mesh__D051047
% 210.27/210.44       Acetyltransferase, Dihydrolipoyllysine-Residue
% 210.27/210.44  |- skos__hiddenLabel mesh__D051047 Acetyltransferase, Dihydrolipoyl
% 210.27/210.44  |- skos__altLabel mesh__D051047 Dihydrolipoyl Acetyltransferase
% 210.27/210.44  |- skos__altLabel mesh__D051047 Dihydrolipoamide S-Acetyltransferase
% 210.27/210.44  |- skos__broader mesh__D051047smesh__D011768
% 210.27/210.44  |- mesh__publicMeSHNote mesh__D051047
% 210.27/210.44       2006; DIHYDROLIPOYLLYSINE-RESIDUE ACETYLTRANSFERASE was indexed under PYRUVATE DEHYDROGENASE COMPLEX 1968-2005, under ACETYLTRANSFERASES 1968-1973, under LIPOIC ACID 1968-1982; PYRUVATE DEHYDROGENASE COMPLEX E2 was indexed under PYRUVATE DEHYDROGENASE COMPLEX 1994-2005%A%  
% 210.27/210.44  |- mesh__historyNote mesh__D051047
% 210.27/210.44       2006%28%1980%29%; use PYRUVATE DEHYDROGENASE COMPLEX, ACETYLTRANSFERASES %26% under LIPOIC ACID 1968-1979%A%  
% 210.27/210.44  |- mesh__recordOriginator mesh__D051047 AKE
% 210.27/210.44  |- skos__hiddenLabel mesh__D051047
% 210.27/210.44       Acetyl CoA Dihydrolipoamide S Acetyltransferase
% 210.27/210.44  |- skos__altLabel mesh__D051047 Pyruvate Dehydrogenase Complex E2
% 210.27/210.44  |- skos__hiddenLabel mesh__D051047
% 210.27/210.44       S-Acetyltransferase, Acetyl-CoA-Dihydrolipoamide
% 210.27/210.44  |- skos__broader mesh__D051047smesh__D000123
% 210.27/210.44  |- skos__hiddenLabel mesh__D051047 Acetyltransferase, Lipoate
% 210.27/210.44  |- skos__scopeNote mesh__D051047
% 210.27/210.44       An enzyme that catalyzes the acetyltransferase reaction using ACETYL CoA as an acetyl donor and dihydrolipoamide as acceptor to produce COENZYME A %28%CoA%29% and S-acetyldihydrolipoamide. It forms the %28%E2%29% subunit of the PYRUVATE DEHYDROGENASE COMPLEX.%A%    
% 210.27/210.44  |- mesh__recordMaintainer mesh__D051047 AKE
% 210.27/210.44  |- mesh__dateCreated mesh__D051047 2005-06-30
% 210.27/210.44  |- skos__altLabel mesh__D051047
% 210.27/210.44       Acetyl-CoA-Dihydrolipoamide S-Acetyltransferase
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D051047 2006
% 210.27/210.44  |- skos__prefLabel mesh__D051047
% 210.27/210.44       Dihydrolipoyllysine-Residue Acetyltransferase
% 210.27/210.44  |- skos__hiddenLabel mesh__D051047 Transacetylase, Dihydrolipoyl
% 210.27/210.44  |- skos__prefLabel mesh__D045808 Refusal to Participate
% 210.27/210.44  |- skos__hiddenLabel mesh__D045808 Participate, Refusal to
% 210.27/210.44  |- mesh__dateEstablished mesh__D045808 2004-01-01
% 210.27/210.44  |- skos__scopeNote mesh__D045808
% 210.27/210.44       Refusal to take part in activities or procedures that are requested or expected of an individual. This may include refusal by HEALTH PERSONNEL to participate in specific medical procedures or refusal by PATIENTS or members of the public to take part in CLINICAL TRIALS or health promotion programs.%A%    
% 210.27/210.44  |- skos__related mesh__D045808smesh__D016312
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D045808 2005
% 210.27/210.44  |- mesh__recordMaintainer mesh__D045808 jls
% 210.27/210.44  |- mesh__recordOriginator mesh__D045808 jls
% 210.27/210.44  |- skos__broader mesh__D045808smesh__D034462
% 210.27/210.44  |- mesh__recordAuthorizer mesh__D045808 sjn
% 210.27/210.44  |- skos__related mesh__D045808smesh__D010358
% 210.27/210.44  |- mesh__historyNote mesh__D045808 2004; use DISSENT AND DISPUTES 2003   
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D045808 2004
% 210.27/210.44  |- mesh__dateCreated mesh__D045808 2003-07-22
% 210.27/210.44  |- skos__related mesh__D045808smesh__D003242
% 210.27/210.44  |- mesh__publicMeSHNote mesh__D045808
% 210.27/210.44       2004; see DISSENT AND DISPUTES 2003   
% 210.27/210.44  |- rdf__type mesh__D045808sskos__Concept
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D045808 2006
% 210.27/210.44  |- skos__related mesh__D045808smesh__D016079
% 210.27/210.44  |- skos__hiddenLabel mesh__D009685 Membrane, Nuclear
% 210.27/210.44  |- mesh__dateCreated mesh__D009685 1976-05-19
% 210.27/210.44  |- mesh__dateRevised mesh__D009685 2003-07-09
% 210.27/210.44  |- skos__hiddenLabel mesh__D009685 Nuclear Membranes
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D009685 2004
% 210.27/210.44  |- skos__hiddenLabel mesh__D009685 Membranes, Nuclear
% 210.27/210.44  |- mesh__historyNote mesh__D009685 2001   
% 210.27/210.44  |- skos__hiddenLabel mesh__D009685 Envelopes, Nuclear
% 210.27/210.44  |- skos__historyNote mesh__D009685 Cell Membrane %28%1966-1976%29%
% 210.27/210.44  |- mesh__recordOriginator mesh__D009685 VDK
% 210.27/210.44  |- skos__hiddenLabel mesh__D009685 Envelope, Nuclear
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D009685 2005
% 210.27/210.44  |- skos__altLabel mesh__D009685 Nuclear Membrane
% 210.27/210.44  |- skos__broader mesh__D009685smesh__D007425
% 210.27/210.44  |- skos__scopeNote mesh__D009685
% 210.27/210.44       The membrane system of the CELL NUCLEUS that surrounds the nucleoplasm.  It consists of two concentric membranes separated by the perinuclear space. The structures of  the envelope where it opens to the cytoplasm are called the nuclear pores %28%NUCLEAR PORE%29%.%A%    
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D009685 2006
% 210.27/210.44  |- skos__historyNote mesh__D009685 Membranes %28%1968-1976%29%
% 210.27/210.44  |- skos__broader mesh__D009685smesh__D021961
% 210.27/210.44  |- mesh__publicMeSHNote mesh__D009685
% 210.27/210.44       2001; for NUCLEAR ENVELOPE see NUCLEAR MEMBRANE 1977-2000%A%  
% 210.27/210.44  |- skos__broader mesh__D009685smesh__D022003
% 210.27/210.44  |- skos__historyNote mesh__D009685 Cell Nucleus %28%1966-1976%29%
% 210.27/210.44  |- skos__hiddenLabel mesh__D009685 Nuclear Envelopes
% 210.27/210.44  |- rdf__type mesh__D009685sskos__Concept
% 210.27/210.44  |- mesh__recordAuthorizer mesh__D009685 sjn
% 210.27/210.44  |- mesh__recordMaintainer mesh__D009685 nns
% 210.27/210.44  |- mesh__dateEstablished mesh__D009685 1977-01-01
% 210.27/210.44  |- skos__prefLabel mesh__D009685 Nuclear Envelope
% 210.27/210.44  |- mesh__recordAuthorizer mesh__D017319 sjn
% 210.27/210.44  |- skos__related mesh__D017319smesh__D010778
% 210.27/210.44  |- skos__broader mesh__D017319smesh__D003879
% 210.27/210.44  |- mesh__recordMaintainer mesh__D017319 ssb
% 210.27/210.44  |- mesh__historyNote mesh__D017319 93   
% 210.27/210.44  |- skos__hiddenLabel mesh__D017319 Agents, Photosensitizing
% 210.27/210.44  |- skos__related mesh__D017319smesh__D011701
% 210.27/210.44  |- skos__annotation mesh__D017319
% 210.27/210.44       GEN or unspecified; prefer specifics; D25-26 qualif   
% 210.27/210.44  |- mesh__recordOriginator mesh__D017319 TPW
% 210.27/210.44  |- mesh__dateCreated mesh__D017319 1992-05-22
% 210.27/210.44  |- skos__altLabel mesh__D017319 Photosensitizers
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D017319 2006
% 210.27/210.44  |- skos__related mesh__D017319smesh__D006414
% 210.27/210.44  |- mesh__dateRevised mesh__D017319 2005-06-30
% 210.27/210.44  |- skos__broader mesh__D017319smesh__D011838
% 210.27/210.44  |- rdf__type mesh__D017319sskos__Concept
% 210.27/210.44  |- mesh__publicMeSHNote mesh__D017319 93   
% 210.27/210.44  |- skos__scopeNote mesh__D017319
% 210.27/210.44       Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.%A%    
% 210.27/210.44  |- skos__prefLabel mesh__D017319 Photosensitizing Agents
% 210.27/210.44  |- mesh__dateEstablished mesh__D017319 1993-01-01
% 210.27/210.44  |- skos__altLabel mesh__D028041 Hydrocotyle asiatica
% 210.27/210.44  |- mesh__dateCreated mesh__D028041 2001-07-25
% 210.27/210.44  |- mesh__recordMaintainer mesh__D028041 ags
% 210.27/210.44  |- skos__historyNote mesh__D028041 Plants, Medicinal %28%1967-2001%29%
% 210.27/210.44  |- skos__altLabel mesh__D028041 Hydrocotyle
% 210.27/210.44  |- skos__annotation mesh__D028041
% 210.27/210.44       for Cola or Kola see COLA, for Bitter Kola check if COLA or GARCINIA; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.27/210.44  |- mesh__dateEstablished mesh__D028041 2002-01-01
% 210.27/210.44  |- skos__scopeNote mesh__D028041
% 210.27/210.44       A plant of the family APIACEAE which is the source of asiatic acid and asiaticoside. Centella asiatica %28%L.%29% Urb. = Hydrocotyle asiatica L. is known for effect on peripheral circulation.%A%    
% 210.27/210.44  |- skos__altLabel mesh__D028041 Gotu kola
% 210.27/210.44  |- skos__broader mesh__D028041smesh__D019661
% 210.27/210.44  |- rdf__type mesh__D028041sskos__Concept
% 210.27/210.44  |- skos__altLabel mesh__D028041 Mandukaparni
% 210.27/210.44  |- mesh__historyNote mesh__D028041 2002   
% 210.27/210.44  |- skos__prefLabel mesh__D028041 Centella
% 210.27/210.44  |- mesh__publicMeSHNote mesh__D028041 2002   
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D028041 2006
% 210.27/210.44  |- mesh__recordOriginator mesh__D028041 ssb
% 210.27/210.44  |- mesh__dateRevised mesh__D028041 2005-06-30
% 210.27/210.44  |- mesh__recordAuthorizer mesh__D028041 sjn
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D014021 2006
% 210.27/210.44  |- skos__scopeNote mesh__D014021
% 210.27/210.44       The process by which a tissue or aggregate of cells is kept alive outside of the organism from which it was derived %28%i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism%29%.%A%    
% 210.27/210.44  |- skos__prefLabel mesh__D014021 Tissue Preservation
% 210.27/210.44  |- mesh__dateCreated mesh__D014021 1999-01-01
% 210.27/210.44  |- skos__annotation mesh__D014021
% 210.27/210.44       GEN: prefer specifics; cryopreservation of tissue: coord specific tissue heading %28%no qualif%29% + CRYOPRESERVATION; ORGAN PRESERVATION is also available%A%  
% 210.27/210.44  |- mesh__recordMaintainer mesh__D014021 NLM
% 210.27/210.44  |- skos__broader mesh__D014021smesh__D011309
% 210.27/210.44  |- mesh__dateRevised mesh__D014021 2004-07-20
% 210.27/210.44  |- mesh__historyNote mesh__D014021 67   
% 210.27/210.44  |- mesh__recordAuthorizer mesh__D014021 NLM
% 210.27/210.44  |- mesh__dateEstablished mesh__D014021 1967-01-01
% 210.27/210.44  |- rdf__type mesh__D014021sskos__Concept
% 210.27/210.44  |- skos__broader mesh__D014021smesh__D016591
% 210.27/210.44  |- skos__related mesh__D014021smesh__D020858
% 210.27/210.44  |- skos__historyNote mesh__D014021 Tissue Banks %28%1966%29%
% 210.27/210.44  |- skos__hiddenLabel mesh__D014021 Preservation, Tissue
% 210.27/210.44  |- mesh__recordOriginator mesh__D014021 NLM
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D014021 2005
% 210.27/210.44  |- skos__hiddenLabel mesh__D014021 Tissue Preservations
% 210.27/210.44  |- skos__hiddenLabel mesh__D014021 Preservations, Tissue
% 210.27/210.44  |- mesh__publicMeSHNote mesh__D014021 67   
% 210.27/210.44  |- mesh__dateRevised mesh__D000001 2003-07-30
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D000001 2004
% 210.27/210.44  |- mesh__dateCreated mesh__D000001 1974-11-19
% 210.27/210.44  |- skos__altLabel mesh__D000001 A23187
% 210.27/210.44  |- mesh__historyNote mesh__D000001
% 210.27/210.44       91%28%75%29%; was A 23187 1975-90 %28%see under ANTIBIOTICS 1975-83%29%%A%  
% 210.27/210.44  |- mesh__recordMaintainer mesh__D000001 SYSTEM
% 210.27/210.44  |- skos__historyNote mesh__D000001 Carboxylic Acids %28%1973-1974%29%
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D000001 2006
% 210.27/210.44  |- mesh__recordOriginator mesh__D000001 NLM
% 210.27/210.44  |- skos__broader mesh__D000001smesh__D001583
% 210.27/210.44  |- skos__scopeNote mesh__D000001
% 210.27/210.44       An ionophorous, polyether antibiotic from Streptomyces chartreusensis. It binds and transports cations across membranes and uncouples oxidative phosphorylation while inhibiting ATPase of rat liver mitochondria. The substance is used mostly as a biochemical tool to study the role of divalent cations in various biological systems.%A%    
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D000001 2005
% 210.27/210.44  |- skos__altLabel mesh__D000001 Antibiotic A23187
% 210.27/210.44  |- mesh__publicMeSHNote mesh__D000001
% 210.27/210.44       91; was A 23187 1975-90 %28%see under ANTIBIOTICS 1975-83%29%   
% 210.27/210.44  |- mesh__recordAuthorizer mesh__D000001 NLM
% 210.27/210.44  |- mesh__onlineNote mesh__D000001
% 210.27/210.44       use CALCIMYCIN to search A 23187 1975-90   
% 210.27/210.44  |- skos__historyNote mesh__D000001 Antibiotics %28%1973-1974%29%
% 210.27/210.44  |- skos__hiddenLabel mesh__D000001 A 23187
% 210.27/210.44  |- rdf__type mesh__D000001sskos__Concept
% 210.27/210.44  |- skos__hiddenLabel mesh__D000001 A23187, Antibiotic
% 210.27/210.44  |- mesh__dateEstablished mesh__D000001 1984-01-01
% 210.27/210.44  |- skos__prefLabel mesh__D000001 Calcimycin
% 210.27/210.44  |- mesh__recordMaintainer mesh__D052140 ags
% 210.27/210.44  |- mesh__recordAuthorizer mesh__D052140 sjn
% 210.27/210.44  |- skos__historyNote mesh__D052140 Papillomavirus, Human %28%1994-2005%29%
% 210.27/210.44  |- mesh__publicMeSHNote mesh__D052140 2006   
% 210.27/210.44  |- mesh__recordOriginator mesh__D052140 ags
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D052140 2006
% 210.27/210.44  |- skos__historyNote mesh__D052140 Papillomavirus %28%1983-1993%29%
% 210.27/210.44  |- skos__altLabel mesh__D052140 Human papillomavirus type 11
% 210.27/210.44  |- skos__hiddenLabel mesh__D052140 HPV 11
% 210.27/210.44  |- skos__altLabel mesh__D052140 HPV-11
% 210.27/210.44  |- skos__prefLabel mesh__D052140 Human papillomavirus 11
% 210.27/210.44  |- skos__hiddenLabel mesh__D052140 papillomavirus 11, Human
% 210.27/210.44  |- mesh__dateEstablished mesh__D052140 2006-01-01
% 210.27/210.44  |- skos__broader mesh__D052140smesh__D018145
% 210.27/210.44  |- mesh__historyNote mesh__D052140 2006   
% 210.27/210.44  |- mesh__dateCreated mesh__D052140 2005-06-30
% 210.27/210.44  |- skos__scopeNote mesh__D052140
% 210.27/210.44       A type of HUMAN PAPILLOMAVIRUS causing recurrent respiratory PAPILLOMATOSIS; GENITAL WARTS; and other neoplasms.%A%    
% 210.27/210.44  |- skos__annotation mesh__D052140
% 210.27/210.44       infection: coordinate IM with GENITAL WARTS %28%IM%29% or PAPILLOMAVIRUS INFECTIONS %28%IM%29% + PAPILLOMATOSIS %28%IM%29% or other neoplasms term %28%IM%29% if pertinent%A%  
% 210.27/210.44  |- rdf__type mesh__D052140sskos__Concept
% 210.27/210.44  |- mesh__dateCreated mesh__D005295 1999-01-01
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D005295 2004
% 210.27/210.44  |- mesh__recordAuthorizer mesh__D005295 SJN
% 210.27/210.44  |- rdf__type mesh__D005295sskos__Concept
% 210.27/210.44  |- mesh__dateRevised mesh__D005295 1997-06-20
% 210.27/210.44  |- skos__scopeNote mesh__D005295
% 210.27/210.44       Inorganic salts of the hypothetical acid ferrocyanic acid %28%H4Fe%28%CN%29%6%29%.%A%    
% 210.27/210.44  |- mesh__publicMeSHNote mesh__D005295 66   
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D005295 2005
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D005295 1998
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D005295 2000
% 210.27/210.44  |- skos__broader mesh__D005295smesh__D003486
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D005295 2006
% 210.27/210.44  |- mesh__recordOriginator mesh__D005295 NLM
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D005295 1999
% 210.27/210.44  |- mesh__historyNote mesh__D005295 66   
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D005295 2001
% 210.27/210.44  |- skos__prefLabel mesh__D005295 Ferrocyanides
% 210.27/210.44  |- skos__broader mesh__D005295smesh__D005296
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D005295 2002
% 210.27/210.44  |- mesh__recordMaintainer mesh__D005295 TGC
% 210.27/210.44  |- skos__annotation mesh__D005295 do not confuse with FERRICYANIDES   
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D005295 2003
% 210.27/210.44  |- skos__scopeNote mesh__D013727
% 210.27/210.44       Medical and nursing care of patients in the terminal stage of an illness.%A%    
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D013727 2004
% 210.27/210.44  |- mesh__dateCreated mesh__D013727 1999-01-01
% 210.27/210.44  |- skos__related mesh__D013727smesh__D032722
% 210.27/210.44  |- skos__prefLabel mesh__D013727 Terminal Care
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D013727 2005
% 210.27/210.44  |- mesh__recordOriginator mesh__D013727 NLM
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D013727 2003
% 210.27/210.44  |- skos__related mesh__D013727smesh__D017051
% 210.27/210.44  |- skos__hiddenLabel mesh__D013727 Care, Terminal
% 210.27/210.44  |- skos__annotation mesh__D013727
% 210.27/210.44       med %26% nurs care for the patient: TERMINALLY ILL refers to the patient; also available is HOSPICE CARE %28%palliative %26% supportive care for the patient %26% family%29%%A%  
% 210.27/210.44  |- mesh__recordMaintainer mesh__D013727 jrf
% 210.27/210.44  |- mesh__recordAuthorizer mesh__D013727 sjn
% 210.27/210.44  |- mesh__historyNote mesh__D013727 68%28%64%29%   
% 210.27/210.44  |- skos__related mesh__D013727smesh__D010166
% 210.27/210.44  |- skos__related mesh__D013727smesh__D008020
% 210.27/210.44  |- mesh__dateEstablished mesh__D013727 1968-01-01
% 210.27/210.44  |- mesh__dateRevised mesh__D013727 2002-07-03
% 210.27/210.44  |- skos__broader mesh__D013727smesh__D005791
% 210.27/210.44  |- rdf__type mesh__D013727sskos__Concept
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D013727 2006
% 210.27/210.44  |- mesh__publicMeSHNote mesh__D013727 68   
% 210.27/210.44  |- skos__broader mesh__D051846smesh__D051843
% 210.27/210.44  |- mesh__publicMeSHNote mesh__D051846
% 210.27/210.44       2006; BETA-SYNUCLEIN was indexed under NERVE TISSUE PROTEINS 1988-2005%A%  
% 210.27/210.44  |- mesh__recordMaintainer mesh__D051846 DRC
% 210.27/210.44  |- mesh__dateEstablished mesh__D051846 2006-01-01
% 210.27/210.44  |- skos__prefLabel mesh__D051846 beta-Synuclein
% 210.27/210.44  |- skos__altLabel mesh__D051846 Phosphoneuroprotein 14
% 210.27/210.44  |- mesh__recordAuthorizer mesh__D051846 sjn
% 210.27/210.44  |- skos__hiddenLabel mesh__D051846 beta Synuclein
% 210.27/210.44  |- mesh__dateCreated mesh__D051846 2005-06-30
% 210.27/210.44  |- mesh__recordOriginator mesh__D051846 DRC
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D051846 2006
% 210.27/210.44  |- rdf__type mesh__D051846sskos__Concept
% 210.27/210.44  |- mesh__historyNote mesh__D051846 2006%28%1988%29%   
% 210.27/210.44  |- skos__scopeNote mesh__D051846
% 210.27/210.44       A synuclein that is closely related to ALPHA-SYNUCLEIN. It may play a neuroprotective role against some of the toxic effects of aggregated ALPHA-SYNUCLEIN.%A%    
% 210.27/210.44  |- skos__altLabel mesh__D051048
% 210.27/210.44       Palmitoyl-CoA-sn-1,2-Diacylglycerol Acyltransferase
% 210.27/210.44  |- mesh__dateCreated mesh__D051048 2005-06-30
% 210.27/210.44  |- skos__hiddenLabel mesh__D051048
% 210.27/210.44       Acyltransferase, Palmitoyl-Coenzyme A-sn-1,2-Diacylglycerol
% 210.27/210.44  |- skos__altLabel mesh__D051048 Diacylglycerol O-Acyltransferase 1
% 210.27/210.44  |- skos__hiddenLabel mesh__D051048 Acyltransferase, Diacylglycerol
% 210.27/210.44  |- skos__altLabel mesh__D051048 DAGAT Enzyme
% 210.27/210.44  |- mesh__historyNote mesh__D051048
% 210.27/210.44       2006%28%1980%29%; use ACETYLTRANSFERASES 1973-1979, %26% GLYCERIDES 1973-1975%A%  
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D051048 2006A
% 210.27/210.44  |- skos__broader mesh__D051048smesh__D000217
% 210.27/210.44  |- skos__hiddenLabel mesh__D051048 Diacylglycerol O Acyltransferase 1
% 210.27/210.44  |- mesh__recordMaintainer mesh__D051048 ags
% 210.27/210.44  |- skos__hiddenLabel mesh__D051048 Acyltransferase 1, Diglyceride
% 210.27/210.44  |- skos__hiddenLabel mesh__D051048 O-Acyltransferase, Diacylglycerol
% 210.27/210.44  |- mesh__dateEstablished mesh__D051048 2006-01-01
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D051048 2006
% 210.27/210.44  |- skos__hiddenLabel mesh__D051048 O-Acyltransferase 1, Diacylglycerol
% 210.27/210.44  |- skos__hiddenLabel mesh__D051048
% 210.27/210.44       A-sn-1,2-Diacylglycerol Acyltransferase, Palmitoyl-Coenzyme
% 210.27/210.44  |- skos__hiddenLabel mesh__D051048
% 210.27/210.44       Palmitoyl CoA sn 1,2 Diacylglycerol Acyltransferase
% 210.27/210.44  |- skos__hiddenLabel mesh__D051048
% 210.27/210.44       Palmitoyl Coenzyme A sn 1,2 Diacylglycerol Acyltransferase
% 210.27/210.44  |- skos__hiddenLabel mesh__D051048
% 210.27/210.44       Acyltransferase, Palmitoyl-CoA-sn-1,2-Diacylglycerol
% 210.27/210.44  |- skos__altLabel mesh__D051048
% 210.27/210.44       Acyl-Coenzyme A Diacyl-glycerol Acyltransferase
% 210.27/210.44  |- skos__hiddenLabel mesh__D051048 Diacylglycerol O Acyltransferase
% 210.27/210.44  |- mesh__dateRevised mesh__D051048 2005-07-13
% 210.27/210.44  |- skos__altLabel mesh__D051048 Diacylglycerol Acyltransferase
% 210.27/210.44  |- mesh__recordOriginator mesh__D051048 AKE
% 210.27/210.44  |- mesh__recordAuthorizer mesh__D051048 ags
% 210.27/210.44  |- rdf__type mesh__D051048sskos__Concept
% 210.27/210.44  |- skos__hiddenLabel mesh__D051048
% 210.27/210.44       Acyl Coenzyme A Diacyl glycerol Acyltransferase
% 210.27/210.44  |- skos__altLabel mesh__D051048
% 210.27/210.44       Palmitoyl-Coenzyme A-sn-1,2-Diacylglycerol Acyltransferase
% 210.27/210.44  |- mesh__publicMeSHNote mesh__D051048
% 210.27/210.44       2006; DIACYLGLYCEROL O-ACYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1973-2005, %26% GLYCERIDES 1973-1975%A%  
% 210.27/210.44  |- skos__hiddenLabel mesh__D051048 Acyltransferase, Diglyceride
% 210.27/210.44  |- skos__altLabel mesh__D051048 Diglyceride Acyltransferase
% 210.27/210.44  |- skos__scopeNote mesh__D051048
% 210.27/210.44       An enzyme that catalyses the last step of the TRIACYLGLYCEROL synthesis reaction in which diacylglycerol is covalently joined to LONG-CHAIN ACYL COA to form triglyceride. It was formerly categorized as EC 2.3.1.124.%A%    
% 210.27/210.44  |- skos__prefLabel mesh__D051048 Diacylglycerol O-Acyltransferase
% 210.27/210.44  |- skos__broader mesh__D045809smesh__D012940
% 210.27/210.44  |- skos__related mesh__D045809smesh__D006806
% 210.27/210.44  |- mesh__dateEstablished mesh__D045809 2004-01-01
% 210.27/210.44  |- skos__hiddenLabel mesh__D045809 Human Rights Abuse
% 210.27/210.44  |- skos__related mesh__D045809smesh__D014858
% 210.27/210.44  |- skos__hiddenLabel mesh__D045809 Abuse, Human Rights
% 210.27/210.44  |- skos__scopeNote mesh__D045809
% 210.27/210.44       Deliberate maltreatment of groups of humans beings including violations of generally-accepted fundamental rights as stated by the Universal Declaration of Human Rights, adopted and proclaimed by the United Nations General Assembly resolution 217 A %28%III%29% of 10 December 1948.%A%    
% 210.27/210.44  |- skos__historyNote mesh__D045809 Human Rights %28%1973-2003%29%
% 210.27/210.44  |- rdf__type mesh__D045809sskos__Concept
% 210.27/210.44  |- mesh__dateCreated mesh__D045809 2003-07-09
% 210.27/210.44  |- skos__prefLabel mesh__D045809 Human Rights Abuses
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D045809 2006
% 210.27/210.44  |- mesh__dateRevised mesh__D045809 2004-07-13
% 210.27/210.44  |- skos__hiddenLabel mesh__D045809 Rights Abuse, Human
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D045809 2005
% 210.27/210.44  |- skos__related mesh__D045809smesh__D014104
% 210.27/210.44  |- mesh__recordMaintainer mesh__D045809 sjn
% 210.27/210.44  |- mesh__recordAuthorizer mesh__D045809 sjn
% 210.27/210.44  |- skos__hiddenLabel mesh__D045809 Rights Abuses, Human
% 210.27/210.44  |- mesh__historyNote mesh__D045809 2004   
% 210.27/210.44  |- mesh__publicMeSHNote mesh__D045809 2004   
% 210.27/210.44  |- mesh__recordOriginator mesh__D045809 jls
% 210.27/210.44  |- mesh__recordAuthorizer mesh__D009686 NLM
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D009686 2005
% 210.27/210.44  |- skos__hiddenLabel mesh__D009686 Nuclear Physic
% 210.27/210.44  |- skos__annotation mesh__D009686 SPEC: SPEC qualif   
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D009686 1996
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D009686 2002
% 210.27/210.44  |- mesh__recordOriginator mesh__D009686 NLM
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D009686 2006
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D009686 1992
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D009686 1997
% 210.27/210.44  |- skos__broader mesh__D009686smesh__D010825
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D009686 1993
% 210.27/210.44  |- mesh__recordMaintainer mesh__D009686 CAB
% 210.27/210.44  |- rdf__type mesh__D009686sskos__Concept
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D009686 1998
% 210.27/210.44  |- skos__prefLabel mesh__D009686 Nuclear Physics
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D009686 1990
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D009686 2003
% 210.27/210.44  |- skos__hiddenLabel mesh__D009686 Physic, Nuclear
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D009686 2000
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D009686 1999
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D009686 1994
% 210.27/210.44  |- mesh__dateRevised mesh__D009686 1976-05-12
% 210.27/210.44  |- mesh__dateCreated mesh__D009686 1999-01-01
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D009686 1991
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D009686 2004
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D009686 1989
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D009686 1995
% 210.27/210.44  |- skos__hiddenLabel mesh__D009686 Physics, Nuclear
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D009686 2001
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D028042 2004
% 210.27/210.44  |- skos__broader mesh__D028042smesh__D019661
% 210.27/210.44  |- skos__historyNote mesh__D028042 Anise %28%2001-2002%29%
% 210.27/210.44  |- skos__prefLabel mesh__D028042 Pimpinella
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D028042 2005
% 210.27/210.44  |- mesh__recordAuthorizer mesh__D028042 sjn
% 210.27/210.44  |- rdf__type mesh__D028042sskos__Concept
% 210.27/210.44  |- mesh__dateEstablished mesh__D028042 2002-01-01
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D028042 2006
% 210.27/210.44  |- skos__annotation mesh__D028042
% 210.27/210.44       distinguish from Star Anise %28%ILLICIUM%29%; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.27/210.44  |- mesh__publicMeSHNote mesh__D028042
% 210.27/210.44       2003; see ANISE 2001-2002, see APIACEAE 1988-2001   
% 210.27/210.44  |- mesh__dateRevised mesh__D028042 2002-07-02
% 210.27/210.44  |- mesh__recordMaintainer mesh__D028042 ssb
% 210.27/210.44  |- mesh__recordOriginator mesh__D028042 ssb
% 210.27/210.44  |- skos__scopeNote mesh__D028042
% 210.27/210.44       A plant genus in the family APIACEAE %28%Umbelliferae%29% that is used in SPICES and is a source of anethole.%A%    
% 210.27/210.44  |- mesh__historyNote mesh__D028042 2003; use APIACEAE 1998-2001   
% 210.27/210.44  |- mesh__dateCreated mesh__D028042 2001-07-25
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D028042 2003
% 210.27/210.44  |- skos__scopeNote mesh__D014820
% 210.27/210.44       A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.%A%    
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D014820 2005
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D014820 1998
% 210.27/210.44  |- mesh__recordOriginator mesh__D014820 NLM
% 210.27/210.44  |- mesh__recordMaintainer mesh__D014820 TGC
% 210.27/210.44  |- mesh__recordAuthorizer mesh__D014820 PLS
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D014820 1997
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D014820 2004
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D014820 2002
% 210.27/210.44  |- skos__broader mesh__D014820smesh__D017496
% 210.27/210.44  |- skos__prefLabel mesh__D014820 Vitiligo
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D014820 2003
% 210.27/210.44  |- skos__annotation mesh__D014820 macular depigmentation   
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D014820 1996
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D014820 1995
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D014820 2001
% 210.27/210.44  |- mesh__dateRevised mesh__D014820 1993-06-03
% 210.27/210.44  |- mesh__dateCreated mesh__D014820 1999-01-01
% 210.27/210.44  |- rdf__type mesh__D014820sskos__Concept
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D014820 1994
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D014820 2000
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D014820 1999
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D014820 2006
% 210.27/210.44  |- skos__hiddenLabel mesh__D014022 Viability, Organ
% 210.27/210.44  |- mesh__recordOriginator mesh__D014022 NLM
% 210.27/210.44  |- mesh__dateCreated mesh__D014022 1999-01-01
% 210.27/210.44  |- mesh__historyNote mesh__D014022
% 210.27/210.44       76%28%71%29%; was see under CYTOLOGY 1975   
% 210.27/210.44  |- mesh__dateRevised mesh__D014022 2004-07-07
% 210.27/210.44  |- skos__hiddenLabel mesh__D014022 Viability, Tissue
% 210.27/210.44  |- skos__historyNote mesh__D014022 Tissue Preservation %28%1966-1970%29%
% 210.27/210.44  |- skos__historyNote mesh__D014022 Tissue Culture %28%1966-1970%29%
% 210.27/210.44  |- mesh__recordMaintainer mesh__D014022 nns
% 210.27/210.44  |- rdf__type mesh__D014022sskos__Concept
% 210.27/210.44  |- skos__historyNote mesh__D014022 specific organ or tissue
% 210.27/210.44  |- skos__hiddenLabel mesh__D014022 Survival, Tissue
% 210.27/210.44  |- skos__historyNote mesh__D014022
% 210.27/210.44       Preservation, Biological %28%1966-1970%29%
% 210.27/210.44  |- skos__broader mesh__D014022smesh__D001686
% 210.27/210.44  |- mesh__recordAuthorizer mesh__D014022 sjn
% 210.27/210.44  |- mesh__activeMeSHYear mesh__D014022 2005
% 210.27/210.44  |- skos__prefLabel mesh__D014022 Tissue Survival
% 210.27/210.44  |- mesh__publicMeSHNote mesh__D014022 76; was see under CYTOLOGY 1975   
% 210.27/210.44  |- skos__scopeNote mesh__D014022
% 210.27/210.44       The span of viability of a tissue or an organ.     
% 210.27/210.44  |- skos__hiddenLabel mesh__D014022 Survival, Organ
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D014022 2006
% 210.27/210.45  |- skos__historyNote mesh__D014022 Transplantation %28%1966-1970%29%
% 210.27/210.45  |- mesh__dateEstablished mesh__D014022 1976-01-01
% 210.27/210.45  |- skos__broader mesh__D000800smesh__D017130
% 210.27/210.45  |- skos__hiddenLabel mesh__D000800 Transluminal Arterial Dilatation
% 210.27/210.45  |- mesh__publicMeSHNote mesh__D000800
% 210.27/210.45       93; was ANGIOPLASTY, TRANSLUMINAL 1982-92; ANGIOPLASTY, BALLOON was see ANGIOPLASTY, TRANSLUMINAL 1982-92%A%  
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000800 1999
% 210.27/210.45  |- mesh__dateRevised mesh__D000800 1997-06-20
% 210.27/210.45  |- skos__annotation mesh__D000800
% 210.27/210.45       coord IM with disease /ther %28%IM%29%, not /surg   
% 210.27/210.45  |- skos__hiddenLabel mesh__D000800 Angioplasty, Percutaneous Transluminal
% 210.27/210.45  |- skos__scopeNote mesh__D000800
% 210.27/210.45       Use of a balloon catheter for dilatation of an occluded artery. It is used in treatment of arterial occlusive diseases, including renal artery stenosis and arterial occlusions in the leg. For the specific technique of balloon dilatation in coronary arteries, ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY is available.%A%    
% 210.27/210.45  |- mesh__dateCreated mesh__D000800 1981-02-23
% 210.27/210.45  |- skos__altLabel mesh__D000800 Dilatation, Transluminal Arterial
% 210.27/210.45  |- mesh__recordMaintainer mesh__D000800 PXP
% 210.27/210.45  |- skos__hiddenLabel mesh__D000800 Transluminal Angioplasty
% 210.27/210.45  |- skos__hiddenLabel mesh__D000800 Dilatations, Transluminal Arterial
% 210.27/210.45  |- skos__altLabel mesh__D000800 Balloon Angioplasty
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000800 2000
% 210.27/210.45  |- skos__historyNote mesh__D000800
% 210.27/210.45       specific arterial occlusive disease %28%1966-1981%29%
% 210.27/210.45  |- mesh__recordOriginator mesh__D000800 SMH
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000800 2005
% 210.27/210.45  |- mesh__dateEstablished mesh__D000800 1982-01-01
% 210.27/210.45  |- skos__altLabel mesh__D000800 Percutaneous Transluminal Angioplasty
% 210.27/210.45  |- skos__altLabel mesh__D000800 Angioplasty, Transluminal
% 210.27/210.45  |- mesh__onlineNote mesh__D000800
% 210.27/210.45       use ANGIOPLASTY, BALLOON to search ANGIOPLASTY, TRANSLUMINAL 1982-92%A%  
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000800 2001
% 210.27/210.45  |- skos__broader mesh__D000800smesh__D001451
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000800 2006
% 210.27/210.45  |- skos__historyNote mesh__D000800
% 210.27/210.45       Arterial Occlusive Diseases %28%1973-1981%29%
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000800 2003
% 210.27/210.45  |- rdf__type mesh__D000800sskos__Concept
% 210.27/210.45  |- skos__hiddenLabel mesh__D000800 Transluminal Angioplasty, Percutaneous
% 210.27/210.45  |- skos__historyNote mesh__D000800 Dilatation %28%1968-1981%29%
% 210.27/210.45  |- skos__hiddenLabel mesh__D000800 Arterial Dilatations, Transluminal
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000800 2002
% 210.27/210.45  |- skos__historyNote mesh__D000800 Catheterization %28%1966-1981%29%
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000800 1998
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000800 2004
% 210.27/210.45  |- skos__prefLabel mesh__D000800 Angioplasty, Balloon
% 210.27/210.45  |- mesh__historyNote mesh__D000800
% 210.27/210.45       93; was ANGIOPLASTY, TRANSLUMINAL 1982-92; ANGIOPLASTY, BALLOON was see ANGIOPLASTY, TRANSLUMINAL 1982-92%A%  
% 210.27/210.45  |- mesh__recordAuthorizer mesh__D000800 SJN
% 210.27/210.45  |- skos__hiddenLabel mesh__D000800 Transluminal Arterial Dilatations
% 210.27/210.45  |- skos__historyNote mesh__D000800 Heart Catheterization %28%1976-1981%29%
% 210.27/210.45  |- skos__hiddenLabel mesh__D000800 Arterial Dilatation, Transluminal
% 210.27/210.45  |- mesh__publicMeSHNote mesh__D000002
% 210.27/210.45       96; was ABATE 1972-95 %28%see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90%29%%A%  
% 210.27/210.45  |- mesh__dateEstablished mesh__D000002 1991-01-01
% 210.27/210.45  |- skos__broader mesh__D000002smesh__D009946
% 210.27/210.45  |- mesh__recordAuthorizer mesh__D000002 sjn
% 210.27/210.45  |- mesh__recordMaintainer mesh__D000002 ssb
% 210.27/210.45  |- mesh__historyNote mesh__D000002
% 210.27/210.45       96; was ABATE 1972-95 %28%see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90%29%%A%  
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000002 2006
% 210.27/210.45  |- skos__annotation mesh__D000002 TN 111 for eff on insects   
% 210.27/210.45  |- skos__historyNote mesh__D000002 Insecticides %28%1966-1971%29%
% 210.27/210.45  |- mesh__dateCreated mesh__D000002 1999-01-01
% 210.27/210.45  |- mesh__recordOriginator mesh__D000002 NLM
% 210.27/210.45  |- mesh__dateRevised mesh__D000002 2005-06-30
% 210.27/210.45  |- rdf__type mesh__D000002sskos__Concept
% 210.27/210.45  |- skos__prefLabel mesh__D000002 Temefos
% 210.27/210.45  |- skos__scopeNote mesh__D000002 An organothiophosphate insecticide.     
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D005296 2004
% 210.27/210.45  |- skos__broader mesh__D005296smesh__D009942
% 210.27/210.45  |- mesh__recordAuthorizer mesh__D005296 SJN
% 210.27/210.45  |- mesh__dateEstablished mesh__D005296 1987-01-01
% 210.27/210.45  |- mesh__dateRevised mesh__D005296 1997-06-20
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D005296 2003
% 210.27/210.45  |- rdf__type mesh__D005296sskos__Concept
% 210.27/210.45  |- mesh__historyNote mesh__D005296
% 210.27/210.45       87%28%75%29%; was see under IRON 1975-86; FERRIC AND FERROUS COMPOUNDS was see under IRON 1963-74%A%  
% 210.27/210.45  |- mesh__recordMaintainer mesh__D005296 ADP
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D005296 2002
% 210.27/210.45  |- skos__historyNote mesh__D005296 Iron %28%1966-1974%29%
% 210.27/210.45  |- skos__scopeNote mesh__D005296
% 210.27/210.45       Inorganic or organic compounds that contain divalent iron.%A%    
% 210.27/210.45  |- skos__related mesh__D005296smesh__D007501
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D005296 2006
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D005296 1999
% 210.27/210.45  |- mesh__onlineNote mesh__D005296
% 210.27/210.45       use IRON to search FERRIC AND FERROUS COMPOUNDS 1966-74   
% 210.27/210.45  |- skos__annotation mesh__D005296
% 210.27/210.45       = iron%28%II%29% or Fe%28%II%29%, as FeO, FeCl2; iron%28%III%29% or Fe%28%III%29% = FERRIC COMPOUNDS; DF: FERROUS CPDS%A%  
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D005296 2001
% 210.27/210.45  |- skos__hiddenLabel mesh__D005296 Compounds, Ferrous
% 210.27/210.45  |- mesh__recordOriginator mesh__D005296 NLM
% 210.27/210.45  |- skos__broader mesh__D005296smesh__D017614
% 210.27/210.45  |- mesh__publicMeSHNote mesh__D005296
% 210.27/210.45       87; was see under IRON 1975-86; FERRIC AND FERROUS COMPOUNDS was see under IRON 1964-74%A%  
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D005296 2000
% 210.27/210.45  |- mesh__dateCreated mesh__D005296 1975-02-04
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D005296 2005
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D005296 1998
% 210.27/210.45  |- skos__prefLabel mesh__D005296 Ferrous Compounds
% 210.27/210.45  |- skos__hiddenLabel mesh__D013728 Regions, Transcriptional Terminator
% 210.27/210.45  |- skos__historyNote mesh__D013728 Genes, Regulator %28%1968-1984%29%
% 210.27/210.45  |- skos__hiddenLabel mesh__D013728 Terminator Regions, Transcriptional
% 210.27/210.45  |- mesh__historyNote mesh__D013728
% 210.27/210.45       91%28%85%29%; was see under GENES, REGULATOR 1985-90   
% 210.27/210.45  |- skos__hiddenLabel mesh__D013728 Transcriptional Terminator Region
% 210.27/210.45  |- mesh__dateRevised mesh__D013728 2005-06-30
% 210.27/210.45  |- skos__hiddenLabel mesh__D013728 Region, Terminator %28%Genetics%29%
% 210.27/210.45  |- skos__hiddenLabel mesh__D013728 Regions, Terminator %28%Genetics%29%
% 210.27/210.45  |- skos__hiddenLabel mesh__D013728 Terminator Region
% 210.27/210.45  |- skos__hiddenLabel mesh__D013728 Region, Transcriptional Terminator
% 210.27/210.45  |- mesh__recordMaintainer mesh__D013728 nns
% 210.27/210.45  |- skos__historyNote mesh__D013728 Genes %28%1966-1967%29%
% 210.27/210.45  |- skos__hiddenLabel mesh__D013728 Regions, Terminator
% 210.27/210.45  |- mesh__dateEstablished mesh__D013728 1991-01-01
% 210.27/210.45  |- skos__hiddenLabel mesh__D013728 Terminator Sequences
% 210.27/210.45  |- skos__hiddenLabel mesh__D013728 Region, Terminator
% 210.27/210.45  |- skos__altLabel mesh__D013728 Terminator Sequence
% 210.27/210.45  |- skos__hiddenLabel mesh__D013728 Terminator Region, Transcriptional
% 210.27/210.45  |- skos__altLabel mesh__D013728 Transcriptional Terminator Regions
% 210.27/210.45  |- skos__altLabel mesh__D013728 Terminator Regions
% 210.27/210.45  |- skos__annotation mesh__D013728 DF: TERMINATOR REGIONS   
% 210.27/210.45  |- skos__scopeNote mesh__D013728
% 210.27/210.45       DNA sequences which signal the termination of transcription.%A%    
% 210.27/210.45  |- skos__hiddenLabel mesh__D013728 Sequence, Terminator
% 210.27/210.45  |- skos__prefLabel mesh__D013728 Terminator Regions %28%Genetics%29%
% 210.27/210.45  |- mesh__recordAuthorizer mesh__D013728 sjn
% 210.27/210.45  |- skos__historyNote mesh__D013728 Transcription, Genetic %28%1973-1984%29%
% 210.27/210.45  |- mesh__recordOriginator mesh__D013728 AEP
% 210.27/210.45  |- rdf__type mesh__D013728sskos__Concept
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D013728 2006
% 210.27/210.45  |- skos__historyNote mesh__D013728
% 210.27/210.45       Gene Expression Regulation %28%1981-1984%29%
% 210.27/210.45  |- skos__hiddenLabel mesh__D013728 Sequences, Terminator
% 210.27/210.45  |- skos__broader mesh__D013728smesh__D012045
% 210.27/210.45  |- mesh__dateCreated mesh__D013728 1984-04-05
% 210.27/210.45  |- mesh__publicMeSHNote mesh__D013728
% 210.27/210.45       91; was see under GENES, REGULATOR 1985-90   
% 210.27/210.45  |- skos__broader mesh__D013728smesh__D050436
% 210.27/210.45  |- skos__hiddenLabel mesh__D013728 Terminator Region %28%Genetics%29%
% 210.27/210.45  |- rdf__type mesh__D018413sskos__Concept
% 210.27/210.45  |- skos__prefLabel mesh__D018413 Bartonella quintana
% 210.27/210.45  |- mesh__publicMeSHNote mesh__D018413 96; was ROCHALIMAEA QUINTANA 1995   
% 210.27/210.45  |- skos__historyNote mesh__D018413 Rickettsia %28%1966-1989%29%
% 210.27/210.45  |- mesh__dateEstablished mesh__D018413 1995-01-01
% 210.27/210.45  |- skos__annotation mesh__D018413 infection = TRENCH FEVER   
% 210.27/210.45  |- skos__altLabel mesh__D018413 Rochalimaea quintana
% 210.27/210.45  |- mesh__dateCreated mesh__D018413 1994-01-25
% 210.27/210.45  |- mesh__historyNote mesh__D018413 96; was ROCHALIMAEA QUINTANA 1995   
% 210.27/210.45  |- skos__scopeNote mesh__D018413
% 210.27/210.45       A species of gram-negative bacteria in which man is the primary host and the human body louse, Pediculus humanus, the principal vector. It is the etiological agent of TRENCH FEVER.%A%    
% 210.27/210.45  |- mesh__recordAuthorizer mesh__D018413 sjn
% 210.27/210.45  |- skos__historyNote mesh__D018413 Rickettsiaceae %28%1990-1994%29%
% 210.27/210.45  |- mesh__recordOriginator mesh__D018413 PXP
% 210.27/210.45  |- skos__altLabel mesh__D018413 Rickettsia quintana
% 210.27/210.45  |- mesh__recordMaintainer mesh__D018413 SYSTEM
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D018413 2006
% 210.27/210.45  |- mesh__dateRevised mesh__D018413 2005-06-30
% 210.27/210.45  |- skos__broader mesh__D018413smesh__D001473
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D010430 2005
% 210.27/210.45  |- mesh__recordMaintainer mesh__D010430 ssb
% 210.27/210.45  |- mesh__dateCreated mesh__D010430 1999-01-01
% 210.27/210.45  |- mesh__historyNote mesh__D010430 72   
% 210.27/210.45  |- mesh__recordAuthorizer mesh__D010430 sjn
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D010430 2006
% 210.27/210.45  |- mesh__dateRevised mesh__D010430 2003-07-09
% 210.27/210.45  |- mesh__recordOriginator mesh__D010430 NLM
% 210.27/210.45  |- skos__prefLabel mesh__D010430 Pentosyltransferases
% 210.27/210.45  |- skos__historyNote mesh__D010430 Transferases %28%1966-1971%29%
% 210.27/210.45  |- mesh__publicMeSHNote mesh__D010430 72   
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D010430 2004
% 210.27/210.45  |- skos__broader mesh__D010430smesh__D016695
% 210.27/210.45  |- rdf__type mesh__D010430sskos__Concept
% 210.27/210.45  |- skos__scopeNote mesh__D010430
% 210.27/210.45       Enzymes of the transferase class that catalyze the transfer of a pentose group from one compound to another. %28%Dorland, 28th ed%29% EC 2.4.2.%A%    
% 210.27/210.45  |- mesh__dateEstablished mesh__D010430 1972-01-01
% 210.27/210.45  |- mesh__publicMeSHNote mesh__D051847
% 210.27/210.45       2006; LITHOSTATHINE was indexed under CALCIUM-BINDING PROTEINS %26% NERVE TISSUE PROTEINS 1982-2005%A%  
% 210.27/210.45  |- skos__altLabel mesh__D051847 Lithostatin
% 210.27/210.45  |- skos__broader mesh__D051847smesh__D011506
% 210.27/210.45  |- mesh__recordMaintainer mesh__D051847 DRC
% 210.27/210.45  |- mesh__dateEstablished mesh__D051847 2006-01-01
% 210.27/210.45  |- skos__hiddenLabel mesh__D051847
% 210.27/210.45       Regenerating Islet Derived 1 alpha Protein
% 210.27/210.45  |- mesh__recordOriginator mesh__D051847 DRC
% 210.27/210.45  |- skos__hiddenLabel mesh__D051847
% 210.27/210.45       Regenerating Islet Derived 1 beta Protein
% 210.27/210.45  |- skos__altLabel mesh__D051847 Pancreatic Thread Protein
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D051847 2006
% 210.27/210.45  |- mesh__historyNote mesh__D051847 2006%28%1982%29%   
% 210.27/210.45  |- rdf__type mesh__D051847sskos__Concept
% 210.27/210.45  |- mesh__recordAuthorizer mesh__D051847 sjn
% 210.27/210.45  |- skos__altLabel mesh__D051847 Pancreatic Stone Protein
% 210.27/210.45  |- mesh__dateCreated mesh__D051847 2005-06-30
% 210.27/210.45  |- skos__scopeNote mesh__D051847
% 210.27/210.45       The proteinaceous component of the pancreatic stone in patients with PANCREATITIS.%A%    
% 210.27/210.45  |- skos__prefLabel mesh__D051847 Lithostathine
% 210.27/210.45  |- skos__hiddenLabel mesh__D051049 Synthetase, Ceramide
% 210.27/210.45  |- mesh__recordMaintainer mesh__D051049 AKE
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D051049 2006
% 210.27/210.45  |- mesh__dateCreated mesh__D051049 2005-06-30
% 210.27/210.45  |- skos__prefLabel mesh__D051049 Sphingosine N-Acyltransferase
% 210.27/210.45  |- skos__hiddenLabel mesh__D051049
% 210.27/210.45       Fatty Acyl CoA   Sphingosine Acyltransferase
% 210.27/210.45  |- skos__broader mesh__D051049smesh__D000217
% 210.27/210.45  |- skos__altLabel mesh__D051049
% 210.27/210.45       Fatty Acyl-CoA - Sphingosine Acyltransferase
% 210.27/210.45  |- rdf__type mesh__D051049sskos__Concept
% 210.27/210.45  |- mesh__dateEstablished mesh__D051049 2006-01-01
% 210.27/210.45  |- skos__hiddenLabel mesh__D051049 Sphingosine N Acyltransferase
% 210.27/210.45  |- mesh__historyNote mesh__D051049 2006%28%1985%29%   
% 210.27/210.45  |- skos__altLabel mesh__D051049 Ceramide Synthetase
% 210.27/210.45  |- mesh__publicMeSHNote mesh__D051049
% 210.27/210.45       2006; SPHINGOSINE N-ACYLTRANSFERASE was indexed under ACYLTRANSFERASES 1985-2005%A%  
% 210.27/210.45  |- skos__hiddenLabel mesh__D051049 N-Acyltransferase, Sphingosine
% 210.27/210.45  |- mesh__recordAuthorizer mesh__D051049 sjn
% 210.27/210.45  |- skos__hiddenLabel mesh__D051049 Acyltransferase, Sphingosine
% 210.27/210.45  |- mesh__recordOriginator mesh__D051049 AKE
% 210.27/210.45  |- skos__scopeNote mesh__D051049
% 210.27/210.45       An enzyme that catalyzes the acyltransferase of SPHINGOSINE to N-acylsphingosine using acyl-COENZYME A as donor and COENZYME A as acceptor. The enzyme is mainly localized in the MITOCHONDRIA.%A%    
% 210.27/210.45  |- skos__altLabel mesh__D051049 Sphingosine Acyltransferase
% 210.27/210.45  |- skos__annotation mesh__D009687
% 210.27/210.45       proteins in the cell nucleus: do not confuse with NUCLEOPROTEINS %28%proteins conjugated with nucleic acids%29%%A%  
% 210.27/210.45  |- mesh__recordMaintainer mesh__D009687 SYSTEM
% 210.27/210.45  |- skos__broader mesh__D009687smesh__D011506
% 210.27/210.45  |- mesh__dateRevised mesh__D009687 2005-06-30
% 210.27/210.45  |- skos__historyNote mesh__D009687 Nucleoproteins %28%1966-1987%29%
% 210.27/210.45  |- skos__hiddenLabel mesh__D009687 Proteins, Nucleolar
% 210.27/210.45  |- rdf__type mesh__D009687sskos__Concept
% 210.27/210.45  |- skos__prefLabel mesh__D009687 Nuclear Proteins
% 210.27/210.45  |- skos__hiddenLabel mesh__D009687 Proteins, Nuclear
% 210.27/210.45  |- mesh__historyNote mesh__D009687 88   
% 210.27/210.45  |- skos__hiddenLabel mesh__D009687 Protein, Nuclear
% 210.27/210.45  |- mesh__recordAuthorizer mesh__D009687 sjn
% 210.27/210.45  |- skos__scopeNote mesh__D009687
% 210.27/210.45       Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus.%A%    
% 210.27/210.45  |- mesh__recordOriginator mesh__D009687 RLS
% 210.27/210.45  |- mesh__publicMeSHNote mesh__D009687 88   
% 210.27/210.45  |- skos__historyNote mesh__D009687 Proteins %28%1966-1987%29%
% 210.27/210.45  |- mesh__dateEstablished mesh__D009687 1988-01-01
% 210.27/210.45  |- mesh__dateCreated mesh__D009687 1987-04-03
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D009687 2006
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D014821 1998
% 210.27/210.45  |- skos__annotation mesh__D014821
% 210.27/210.45       do not use /util except by MeSH definition   
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D014821 2006
% 210.27/210.45  |- mesh__recordOriginator mesh__D014821 RC
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D014821 2005
% 210.27/210.45  |- mesh__dateEstablished mesh__D014821 1984-01-01
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D014821 2002
% 210.27/210.45  |- mesh__dateCreated mesh__D014821 1983-02-09
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D014821 2004
% 210.27/210.45  |- skos__hiddenLabel mesh__D014821 Vitrectomies
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D014821 2001
% 210.27/210.45  |- mesh__publicMeSHNote mesh__D014821 84   
% 210.27/210.45  |- mesh__recordMaintainer mesh__D014821 PXP
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D014821 2003
% 210.27/210.45  |- mesh__recordAuthorizer mesh__D014821 SJN
% 210.27/210.45  |- rdf__type mesh__D014821sskos__Concept
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D014821 2000
% 210.27/210.45  |- skos__prefLabel mesh__D014821 Vitrectomy
% 210.27/210.45  |- skos__historyNote mesh__D014821 Vitreous Body/surgery %28%1966-1983%29%
% 210.27/210.45  |- skos__scopeNote mesh__D014821
% 210.27/210.45       Removal of the whole or part of the vitreous body in treating endophthalmitis, diabetic retinopathy, retinal detachment, intraocular foreign bodies, and some types of glaucoma.%A%    
% 210.27/210.45  |- mesh__dateRevised mesh__D014821 1997-06-20
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D014821 1999
% 210.27/210.45  |- skos__broader mesh__D014821smesh__D013508
% 210.27/210.45  |- mesh__historyNote mesh__D014821 84   
% 210.27/210.45  |- mesh__recordAuthorizer mesh__D014023 sjn
% 210.27/210.45  |- skos__hiddenLabel mesh__D014023 Stimulators, Biogenic
% 210.27/210.45  |- mesh__recordMaintainer mesh__D014023 ssb
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D014023 2005
% 210.27/210.45  |- skos__broader mesh__D014023smesh__D009945
% 210.27/210.45  |- skos__altLabel mesh__D014023 Therapy, Tissue
% 210.27/210.45  |- skos__altLabel mesh__D014023 Therapy, Cell
% 210.27/210.45  |- mesh__recordOriginator mesh__D014023 NLM
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D014023 2003
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D014023 2006
% 210.27/210.45  |- skos__prefLabel mesh__D014023 Tissue Therapy
% 210.27/210.45  |- skos__hiddenLabel mesh__D014023 Biogenic Stimulator
% 210.27/210.45  |- skos__scopeNote mesh__D014023
% 210.27/210.45       Historically, tissue transplantation, especially of refrigerated tissue %28%after Filatov%29%. It was theorized that nonspecific substances, capable of initiating restorative processes, formed in tissues when refrigerated. Cell therapy %28%after Niehans%29% refers to implantation of tissue by injection. Originally this involved fresh cells but later frozen or lyophilized cells.%A%    
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D014023 2004
% 210.27/210.45  |- mesh__dateCreated mesh__D014023 1999-01-01
% 210.27/210.45  |- skos__hiddenLabel mesh__D014023 Stimulator, Biogenic
% 210.27/210.45  |- skos__annotation mesh__D014023
% 210.27/210.45       historical; for contemporary cell or tissue therapy prefer CELL TRANSPLANTATION or TISSUE TRANSPLANTATION%A%  
% 210.27/210.45  |- mesh__dateRevised mesh__D014023 2001-07-25
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D014023 2002
% 210.27/210.45  |- rdf__type mesh__D014023sskos__Concept
% 210.27/210.45  |- mesh__dateRevised mesh__D000801 2003-07-09
% 210.27/210.45  |- mesh__historyNote mesh__D000801
% 210.27/210.45       91%28%81%29%; was see under METASTRONGYLOIDEA 1981-90   
% 210.27/210.45  |- skos__annotation mesh__D000801
% 210.27/210.45       a genus of nematodes; infection: coord IM with STRONGYLIDA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 210.27/210.45  |- rdf__type mesh__D000801sskos__Concept
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000801 2004
% 210.27/210.45  |- mesh__recordOriginator mesh__D000801 AEP
% 210.27/210.45  |- mesh__dateCreated mesh__D000801 1980-03-28
% 210.27/210.45  |- skos__prefLabel mesh__D000801 Angiostrongylus
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000801 2006
% 210.27/210.45  |- skos__scopeNote mesh__D000801
% 210.27/210.45       A genus of parasitic nematodes of the superfamily METASTRONGYLOIDEA. Two species, ANGIOSTRONGYLUS CANTONENSIS and A. vasorum, infest the lungs of rats and dogs, respectively. A. cantonensis is transmissible to man where it causes frequently fatal infection of the central nervous system.%A%    
% 210.27/210.45  |- mesh__publicMeSHNote mesh__D000801
% 210.27/210.45       91; was see under METASTRONGYLOIDEA 1981-90   
% 210.27/210.45  |- mesh__recordMaintainer mesh__D000801 ags
% 210.27/210.45  |- mesh__recordAuthorizer mesh__D000801 sjn
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000801 2005
% 210.27/210.45  |- skos__historyNote mesh__D000801 Metastrongyloidea %28%1966-1980%29%
% 210.27/210.45  |- skos__broader mesh__D000801smesh__D008681
% 210.27/210.45  |- mesh__dateEstablished mesh__D000801 1991-01-01
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000003 2000
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000003 2005
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000003 2001
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000003 2006
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000003 2002
% 210.27/210.45  |- skos__broader mesh__D000003smesh__D008462
% 210.27/210.45  |- skos__prefLabel mesh__D000003 Abattoirs
% 210.27/210.45  |- mesh__dateCreated mesh__D000003 1999-01-01
% 210.27/210.45  |- mesh__recordMaintainer mesh__D000003 JLS
% 210.27/210.45  |- mesh__recordAuthorizer mesh__D000003 SJN
% 210.27/210.45  |- skos__hiddenLabel mesh__D000003 Slaughterhouse
% 210.27/210.45  |- mesh__dateRevised mesh__D000003 1997-06-20
% 210.27/210.45  |- rdf__type mesh__D000003sskos__Concept
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000003 1998
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000003 2003
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000003 1999
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D000003 2004
% 210.27/210.45  |- skos__hiddenLabel mesh__D000003 Abattoir
% 210.27/210.45  |- skos__scopeNote mesh__D000003
% 210.27/210.45       Places where animals are slaughtered and dressed for market.%A%    
% 210.27/210.45  |- mesh__recordOriginator mesh__D000003 NLM
% 210.27/210.45  |- skos__altLabel mesh__D000003 Slaughterhouses
% 210.27/210.45  |- skos__broader mesh__D005297smesh__D014227
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D005297 2003
% 210.27/210.45  |- rdf__type mesh__D005297sskos__Concept
% 210.27/210.45  |- mesh__recordMaintainer mesh__D005297 CCR
% 210.27/210.45  |- mesh__historyNote mesh__D005297
% 210.27/210.45       91%28%76%29%; was see under TRIAZINES 1976-90   
% 210.27/210.45  |- mesh__dateEstablished mesh__D005297 1991-01-01
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D005297 2006
% 210.27/210.45  |- mesh__dateCreated mesh__D005297 1975-07-25
% 210.27/210.45  |- mesh__publicMeSHNote mesh__D005297
% 210.27/210.45       91; was see under TRIAZINES 1976-90   
% 210.27/210.45  |- mesh__recordOriginator mesh__D005297 RLS
% 210.27/210.45  |- mesh__dateRevised mesh__D005297 2000-06-22
% 210.27/210.45  |- skos__scopeNote mesh__D005297
% 210.27/210.45       A ferroin compound that forms a stable magenta-colored solution with the ferrous ion. The complex has an absorption peak at 562 nm and is used as a reagent and indicator for iron.%A%    
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D005297 2005
% 210.27/210.45  |- mesh__recordAuthorizer mesh__D005297 sjn
% 210.27/210.45  |- skos__historyNote mesh__D005297 Benzenesulfonates %28%1974-1975%29%
% 210.27/210.45  |- skos__historyNote mesh__D005297 Pyridines %28%1972-1975%29%
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D005297 2002
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D005297 2004
% 210.27/210.45  |- skos__annotation mesh__D005297 D25-26 qualif   
% 210.27/210.45  |- skos__prefLabel mesh__D005297 Ferrozine
% 210.27/210.45  |- skos__historyNote mesh__D005297 Triazines %28%1972-1975%29%
% 210.27/210.45  |- skos__hiddenLabel mesh__D005297 Monosodium Salt Ferrozine
% 210.27/210.45  |- skos__broader mesh__D005297smesh__D001557
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D005297 2001
% 210.27/210.45  |- mesh__recordAuthorizer mesh__D013729 sjn
% 210.27/210.45  |- skos__scopeNote mesh__D013729
% 210.27/210.45       A class of compounds composed of repeating 5-carbon units of HEMITERPENES.%A%    
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D013729 2005
% 210.27/210.45  |- mesh__dateRevised mesh__D013729 2003-07-09
% 210.27/210.45  |- mesh__dateCreated mesh__D013729 1999-01-01
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D013729 2006
% 210.27/210.45  |- skos__prefLabel mesh__D013729 Terpenes
% 210.27/210.45  |- rdf__type mesh__D013729sskos__Concept
% 210.27/210.45  |- mesh__recordOriginator mesh__D013729 NLM
% 210.27/210.45  |- skos__altLabel mesh__D013729 Terpenoids
% 210.27/210.45  |- mesh__recordMaintainer mesh__D013729 ssb
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D013729 2004
% 210.27/210.45  |- skos__broader mesh__D013729smesh__D006838
% 210.27/210.45  |- skos__altLabel mesh__D018414 T8 Cells
% 210.27/210.45  |- skos__hiddenLabel mesh__D018414 Lymphocytes, CD8-Positive
% 210.27/210.45  |- skos__hiddenLabel mesh__D018414 T8 Lymphocyte
% 210.27/210.45  |- mesh__recordOriginator mesh__D018414 AGS
% 210.27/210.45  |- skos__scopeNote mesh__D018414
% 210.27/210.45       A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes %28%T-LYMPHOCYTES, CYTOTOXIC%29% and suppressor T-lymphocytes %28%T-LYMPHOCYTES, SUPPRESSOR-EFFECTOR%29%.%A%    
% 210.27/210.45  |- skos__hiddenLabel mesh__D018414 CD8-Positive T-Lymphocyte
% 210.27/210.45  |- skos__related mesh__D018414smesh__D016827
% 210.27/210.45  |- skos__historyNote mesh__D018414 T-Lymphocytes %28%1982-1994%29%
% 210.27/210.45  |- skos__altLabel mesh__D018414 CD8-Positive Lymphocytes
% 210.27/210.45  |- skos__hiddenLabel mesh__D018414 T8 Cell
% 210.27/210.45  |- skos__hiddenLabel mesh__D018414 Lymphocyte, T8
% 210.27/210.45  |- skos__historyNote mesh__D018414 T-Lymphocyte Subsets %28%1991-1994%29%
% 210.27/210.45  |- skos__hiddenLabel mesh__D018414 Lymphocytes, T8
% 210.27/210.45  |- skos__hiddenLabel mesh__D018414 CD8 Positive T Lymphocytes
% 210.27/210.45  |- mesh__historyNote mesh__D018414 95   
% 210.27/210.45  |- skos__broader mesh__D018414smesh__D013601
% 210.27/210.45  |- mesh__recordMaintainer mesh__D018414 jmp
% 210.27/210.45  |- mesh__dateEstablished mesh__D018414 1995-01-01
% 210.27/210.45  |- mesh__dateRevised mesh__D018414 2003-07-09
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D018414 2005
% 210.27/210.45  |- skos__altLabel mesh__D018414 T8 Lymphocytes
% 210.27/210.45  |- skos__prefLabel mesh__D018414 CD8-Positive T-Lymphocytes
% 210.27/210.45  |- skos__related mesh__D018414smesh__D016516
% 210.27/210.45  |- mesh__publicMeSHNote mesh__D018414 95   
% 210.27/210.45  |- skos__hiddenLabel mesh__D018414 T-Lymphocyte, CD8-Positive
% 210.27/210.45  |- skos__hiddenLabel mesh__D018414 Lymphocyte, CD8-Positive
% 210.27/210.45  |- mesh__recordAuthorizer mesh__D018414 sjn
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D018414 2006
% 210.27/210.45  |- skos__hiddenLabel mesh__D018414 Cells, T8
% 210.27/210.45  |- skos__hiddenLabel mesh__D018414 T-Lymphocytes, CD8-Positive
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D018414 2004
% 210.27/210.45  |- skos__annotation mesh__D018414
% 210.27/210.45       A 11 qualif; a subpopulation of regulatory T-lymphocytes; subpopulations: coord IM with T-LYMPHOCYTE SUBSETS %28%IM%29%; count: coord IM with LYMPHOCYTE COUNT %28%NIM%29%; DF: note short X ref%A%  
% 210.27/210.45  |- mesh__dateCreated mesh__D018414 1994-05-23
% 210.27/210.45  |- skos__hiddenLabel mesh__D018414 Cell, T8
% 210.27/210.45  |- rdf__type mesh__D018414sskos__Concept
% 210.27/210.45  |- skos__hiddenLabel mesh__D018414 CD8 Positive Lymphocytes
% 210.27/210.45  |- skos__hiddenLabel mesh__D018414 CD8-Positive Lymphocyte
% 210.27/210.45  |- skos__hiddenLabel mesh__D010431 BL191
% 210.27/210.45  |- mesh__dateEstablished mesh__D010431 1991-01-01
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D010431 2004
% 210.27/210.45  |- skos__hiddenLabel mesh__D010431 BL 191
% 210.27/210.45  |- skos__historyNote mesh__D010431 Xanthines %28%1972-1976%29%
% 210.27/210.45  |- skos__broader mesh__D010431smesh__D013805
% 210.27/210.45  |- rdf__type mesh__D010431sskos__Concept
% 210.27/210.45  |- skos__prefLabel mesh__D010431 Pentoxifylline
% 210.27/210.45  |- mesh__recordOriginator mesh__D010431 SH
% 210.27/210.45  |- mesh__historyNote mesh__D010431 91%28%77%29%   
% 210.27/210.45  |- mesh__recordMaintainer mesh__D010431 ssb
% 210.27/210.45  |- mesh__recordAuthorizer mesh__D010431 sjn
% 210.27/210.45  |- mesh__publicMeSHNote mesh__D010431 91; see THEOBROMINE 1977-90   
% 210.27/210.45  |- skos__altLabel mesh__D010431 Oxpentifylline
% 210.27/210.45  |- skos__scopeNote mesh__D010431
% 210.27/210.45       A METHYLXANTHINE derivative that inhibits phosphodiesterase and affects blood rheology. It improves blood flow by increasing erythrocyte and leukocyte flexibility. It also inhibits platelet aggregation. Pentoxifylline modulates immunologic activity by stimulating cytokine production.%A%    
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D010431 2005
% 210.27/210.45  |- mesh__dateCreated mesh__D010431 1976-04-16
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D010431 2006
% 210.27/210.45  |- mesh__dateRevised mesh__D010431 2003-07-09
% 210.27/210.45  |- skos__related mesh__D009688smesh__D047852
% 210.27/210.45  |- mesh__publicMeSHNote mesh__D009688 68   
% 210.27/210.45  |- skos__hiddenLabel mesh__D009688 Reactors, Nuclear
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D009688 2006
% 210.27/210.45  |- mesh__recordMaintainer mesh__D009688 jls
% 210.27/210.45  |- skos__broader mesh__D009688smesh__D011210
% 210.27/210.45  |- skos__broader mesh__D009688smesh__D009686
% 210.27/210.45  |- mesh__activeMeSHYear mesh__D009688 2005
% 210.27/210.45  |- mesh__dateCreated mesh__D009688 1999-01-01
% 210.27/210.45  |- skos__annotation mesh__D009688
% 210.27/210.45       RADIONUCLIDE GENERATORS is also available; nuclear power plants does not go here: see note %26% X ref at POWER PLANTS%A%  
% 210.27/210.45  |- skos__hiddenLabel mesh__D009688 Reactor, Nuclear
% 210.27/210.45  |- mesh__dateEstablished mesh__D009688 1968-01-01
% 210.27/210.45  |- rdf__type mesh__D009688sskos__Concept
% 210.27/210.45  |- mesh__historyNote mesh__D009688 68%28%64%29%   
% 210.27/210.45  |- mesh__dateRevised mesh__D009688 2004-07-07
% 210.27/210.45  |- skos__related mesh__D009688smesh__D018788
% 210.27/210.45  |- skos__hiddenLabel mesh__D009688 Nuclear Reactor
% 210.27/210.45  |- skos__scopeNote mesh__D009688
% 210.27/210.45       Devices containing fissionable material in sufficient quantity and so arranged as to be capable of maintaining a controlled, self-sustaining nuclear fission chain reaction. They are also known as atomic piles, atomic reactors, fission reactors, and nuclear piles, although such names are deprecated. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 210.27/210.45  |- mesh__recordOriginator mesh__D009688 NLM
% 210.27/210.46  |- skos__prefLabel mesh__D009688 Nuclear Reactors
% 210.27/210.46  |- mesh__recordAuthorizer mesh__D009688 sjn
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D034081 2005
% 210.27/210.46  |- skos__broader mesh__D034081smesh__D000820
% 210.27/210.46  |- skos__prefLabel mesh__D034081 Wasting Disease, Chronic
% 210.27/210.46  |- skos__historyNote mesh__D034081 Prion Diseases %28%1993-2002%29%
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D034081 2003
% 210.27/210.46  |- skos__altLabel mesh__D034081 Chronic Wasting Disease
% 210.27/210.46  |- rdf__type mesh__D034081sskos__Concept
% 210.27/210.46  |- skos__scopeNote mesh__D034081
% 210.27/210.46       A transmissible spongiform encephalopathy %28%prion disease%29% of DEER and elk characterized by chronic weight loss leading to death. It is thought to spread by direct contact between animals or through environmental contamination with the prion protein %28%PRIONS%29%.%A%    
% 210.27/210.46  |- mesh__historyNote mesh__D034081 2003   
% 210.27/210.46  |- skos__broader mesh__D034081smesh__D017096
% 210.27/210.46  |- mesh__dateCreated mesh__D034081 2002-07-03
% 210.27/210.46  |- skos__historyNote mesh__D034081 Wasting Syndrome %28%1999-2002%29%
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D034081 2006
% 210.27/210.46  |- mesh__dateEstablished mesh__D034081 2003-01-01
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D034081 2004
% 210.27/210.46  |- mesh__publicMeSHNote mesh__D034081 2003   
% 210.27/210.46  |- mesh__dateCreated mesh__D028044 2001-07-25
% 210.27/210.46  |- skos__annotation mesh__D028044
% 210.27/210.46       do not confuse with PHOSPHATE TRANSPORT PROTEINS   
% 210.27/210.46  |- mesh__dateEstablished mesh__D028044 2002-01-01
% 210.27/210.46  |- skos__scopeNote mesh__D028044
% 210.27/210.46       Proteins that bind to and are involved in the metabolism of phosphate ions.%A%    
% 210.27/210.46  |- rdf__type mesh__D028044sskos__Concept
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D028044 2006
% 210.27/210.46  |- mesh__historyNote mesh__D028044
% 210.27/210.46       2002; use PHOSPHATE-BINDING PROTEINS %28%NM%29% 1980-2001   
% 210.27/210.46  |- skos__prefLabel mesh__D028044 Phosphate-Binding Proteins
% 210.27/210.46  |- skos__historyNote mesh__D028044 Carrier Proteins %28%1980-2001%29%
% 210.27/210.46  |- skos__hiddenLabel mesh__D028044 Phosphate Binding Proteins
% 210.27/210.46  |- skos__broader mesh__D028044smesh__D002352
% 210.27/210.46  |- mesh__dateRevised mesh__D028044 2005-06-30
% 210.27/210.46  |- mesh__recordAuthorizer mesh__D028044 sjn
% 210.27/210.46  |- mesh__publicMeSHNote mesh__D028044
% 210.27/210.46       2002; PHOSPHATE-BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-2001%A%  
% 210.27/210.46  |- mesh__recordMaintainer mesh__D028044 SYSTEM
% 210.27/210.46  |- mesh__recordOriginator mesh__D028044 jmp
% 210.27/210.46  |- skos__annotation mesh__D006390
% 210.27/210.46       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D006390 2005
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D006390 1997
% 210.27/210.46  |- mesh__recordOriginator mesh__D006390 NLM
% 210.27/210.46  |- skos__scopeNote mesh__D006390
% 210.27/210.46       A neoplasm derived from blood vessels, characterized by numerous prominent endothelial cells that occur singly, in aggregates, and as the lining of congeries of vascular tubes or channels. Hemangioendotheliomas are relatively rare and are of intermediate malignancy %28%between benign hemangiomas and conventional angiosarcomas%29%. They affect men and women about equally and rarely develop in childhood. %28%From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1866%29%%A%    
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D006390 1996
% 210.27/210.46  |- skos__prefLabel mesh__D006390 Hemangioendothelioma
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D006390 2002
% 210.27/210.46  |- rdf__type mesh__D006390sskos__Concept
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D006390 2004
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D006390 1999
% 210.27/210.46  |- skos__hiddenLabel mesh__D006390 Hemangioendotheliomas
% 210.27/210.46  |- mesh__recordMaintainer mesh__D006390 KEV
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D006390 2003
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D006390 1998
% 210.27/210.46  |- mesh__recordAuthorizer mesh__D006390 PLS
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D006390 2001
% 210.27/210.46  |- mesh__dateCreated mesh__D006390 1999-01-01
% 210.27/210.46  |- skos__broader mesh__D006390smesh__D006391
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D006390 2006
% 210.27/210.46  |- mesh__dateRevised mesh__D006390 1995-06-08
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D006390 2000
% 210.27/210.46  |- mesh__historyNote mesh__D020061 99   
% 210.27/210.46  |- skos__annotation mesh__D020061
% 210.27/210.46       do not use /drug eff for insecticides: TN 111   
% 210.27/210.46  |- mesh__dateEstablished mesh__D020061 1999-01-01
% 210.27/210.46  |- mesh__dateRevised mesh__D020061 2003-07-09
% 210.27/210.46  |- skos__prefLabel mesh__D020061 Phthirus
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D020061 2004
% 210.27/210.46  |- mesh__dateCreated mesh__D020061 1998-06-10
% 210.27/210.46  |- mesh__publicMeSHNote mesh__D020061 99   
% 210.27/210.46  |- skos__altLabel mesh__D020061 Crab Lice
% 210.27/210.46  |- skos__scopeNote mesh__D020061
% 210.27/210.46       Lice of the genus Phthirus, family Pediculidae. Phthirus pubis, the crab louse, is usually acquired by sexual contact or contact with infected objects. It is found most frequently in the pubic hair, but also on eyebrows, eyelashes, or on the axillary hairs.%A%    
% 210.27/210.46  |- rdf__type mesh__D020061sskos__Concept
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D020061 2006
% 210.27/210.46  |- skos__broader mesh__D020061smesh__D000854
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D020061 2005
% 210.27/210.46  |- skos__historyNote mesh__D020061 Lice %28%1965-1998%29%
% 210.27/210.46  |- skos__hiddenLabel mesh__D014822 Body, Vitreous
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D014822 2006
% 210.27/210.46  |- skos__annotation mesh__D014822
% 210.27/210.46       /surg: consider also VITRECTOMY; VITREOUS DETACHMENT is available; opacities, muscae volitantes %26% other dis are indexed VITREOUS BODY %28%IM%29% and EYE DISEASES %28%IM%29%%A%  
% 210.27/210.46  |- mesh__dateCreated mesh__D014822 1999-01-01
% 210.27/210.46  |- mesh__dateRevised mesh__D014822 1999-11-03
% 210.27/210.46  |- skos__prefLabel mesh__D014822 Vitreous Body
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D014822 2003
% 210.27/210.46  |- skos__related mesh__D014822smesh__D014821
% 210.27/210.46  |- mesh__recordOriginator mesh__D014822 NLM
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D014822 2002
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D014822 2004
% 210.27/210.46  |- mesh__recordAuthorizer mesh__D014822 sjn
% 210.27/210.46  |- skos__hiddenLabel mesh__D014822 Vitreous Bodies
% 210.27/210.46  |- rdf__type mesh__D014822sskos__Concept
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D014822 2000
% 210.27/210.46  |- skos__broader mesh__D014822smesh__D005123
% 210.27/210.46  |- skos__scopeNote mesh__D014822
% 210.27/210.46       The transparent, semigelatinous substance that fills the cavity behind the crystalline lens of the EYE and in front of the RETINA. It is contained in a thin hyoid membrane and forms about four fifths of the optic globe.%A%    
% 210.27/210.46  |- skos__hiddenLabel mesh__D014822 Bodies, Vitreous
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D014822 2005
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D014822 2001
% 210.27/210.46  |- mesh__recordMaintainer mesh__D014822 KEV
% 210.27/210.46  |- mesh__runningHead mesh__D014024 A10 - ANATOMY-TISSUES   
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D014024 2005
% 210.27/210.46  |- skos__scopeNote mesh__D014024
% 210.27/210.46       Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.%A%    
% 210.27/210.46  |- mesh__recordAuthorizer mesh__D014024 sjn
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D014024 2006
% 210.27/210.46  |- mesh__recordMaintainer mesh__D014024 lkt
% 210.27/210.46  |- mesh__dateEstablished mesh__D014024 1998-01-01
% 210.27/210.46  |- mesh__dateCreated mesh__D014024 1999-01-01
% 210.27/210.46  |- mesh__dateRevised mesh__D014024 2004-07-07
% 210.27/210.46  |- mesh__recordOriginator mesh__D014024 NLM
% 210.27/210.46  |- skos__hiddenLabel mesh__D014024 Tissue
% 210.27/210.46  |- skos__annotation mesh__D014024 not used for indexing   
% 210.27/210.46  |- skos__prefLabel mesh__D014024 Tissues
% 210.27/210.46  |- mesh__publicMeSHNote mesh__D014024 98   
% 210.27/210.46  |- rdf__type mesh__D014024sskos__Concept
% 210.27/210.46  |- skos__historyNote mesh__D014024
% 210.27/210.46       specific organ/anatomy %26% histology %28%1967-1997%29%
% 210.27/210.46  |- mesh__historyNote mesh__D014024 98; use explode 1967-97   
% 210.27/210.46  |- skos__historyNote mesh__D014024
% 210.27/210.46       specific tissue/anatomy %26% histology %28%1967-1997%29%
% 210.27/210.46  |- mesh__recordAuthorizer mesh__D000802 sjn
% 210.27/210.46  |- skos__altLabel mesh__D000802 5-Valine-Angiotensin II Amide
% 210.27/210.46  |- skos__altLabel mesh__D000802 1-Asparagine-5-valine Angiotensin II
% 210.27/210.46  |- skos__broader mesh__D000802smesh__D000804
% 210.27/210.46  |- rdf__type mesh__D000802sskos__Concept
% 210.27/210.46  |- mesh__dateCreated mesh__D000802 1999-01-01
% 210.27/210.46  |- skos__prefLabel mesh__D000802 Angiotensin Amide
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D000802 2006
% 210.27/210.46  |- skos__hiddenLabel mesh__D000802 Amide, Angiotensin
% 210.27/210.46  |- mesh__historyNote mesh__D000802
% 210.27/210.46       91%28%75%29%66-73; was see under ANGIOTENSIN II/analogs %26% derivatives 1975-90; was see under ANGIOTENSIN II 1974; was heading 1966-73%A%  
% 210.27/210.46  |- mesh__onlineNote mesh__D000802 search ANGIOTENSIN II 1966-74   
% 210.27/210.46  |- skos__hiddenLabel mesh__D000802 Amide, 5-Valine-Angiotensin II
% 210.27/210.46  |- skos__historyNote mesh__D000802 Angiotensin II %28%1966-1974%29%
% 210.27/210.46  |- skos__hiddenLabel mesh__D000802 5 Valine Angiotensin II Amide
% 210.27/210.46  |- mesh__recordMaintainer mesh__D000802 ssb
% 210.27/210.46  |- mesh__recordOriginator mesh__D000802 NLM
% 210.27/210.46  |- mesh__dateRevised mesh__D000802 2005-06-30
% 210.27/210.46  |- skos__altLabel mesh__D000802 Angiotensinamide
% 210.27/210.46  |- skos__hiddenLabel mesh__D000802 1 Asparagine 5 valine Angiotensin II
% 210.27/210.46  |- mesh__publicMeSHNote mesh__D000802
% 210.27/210.46       91,66-73; was see under ANGIOTENSIN II/analogs %26% derivatives 1975-90; was see under ANGIOTENSIN II 1974; was heading 1966-73%A%  
% 210.27/210.46  |- mesh__dateEstablished mesh__D000802 1966-01-01
% 210.27/210.46  |- skos__scopeNote mesh__D000802
% 210.27/210.46       The octapeptide amide of bovine angiotensin II used to increase blood pressure by vasoconstriction.%A%    
% 210.27/210.46  |- skos__hiddenLabel mesh__D000802 Angiotensin II, 1-Asparagine-5-valine
% 210.27/210.46  |- skos__broader mesh__D005121Q000002smesh__D005121
% 210.27/210.46  |- mesh__preferredCombination mesh__D005121Q000002smesh__D017880
% 210.27/210.46  |- rdf__type mesh__D005121Q000002smesh__CompoundConcept
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D000004 2001
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D000004 2005
% 210.27/210.46  |- mesh__recordAuthorizer mesh__D000004 sjn
% 210.27/210.46  |- skos__broader mesh__D000004smesh__D009275
% 210.27/210.46  |- skos__prefLabel mesh__D000004 Abbreviations
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D000004 2002
% 210.27/210.46  |- mesh__dateRevised mesh__D000004 1999-11-03
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D000004 2006
% 210.27/210.46  |- mesh__dateCreated mesh__D000004 1999-01-01
% 210.27/210.46  |- mesh__recordMaintainer mesh__D000004 kle
% 210.27/210.46  |- skos__hiddenLabel mesh__D000004 Abbreviation
% 210.27/210.46  |- rdf__type mesh__D000004sskos__Concept
% 210.27/210.46  |- skos__annotation mesh__D000004 includes acronyms; IM; no qualif   
% 210.27/210.46  |- skos__scopeNote mesh__D000004
% 210.27/210.46       Shortened forms of written words or phrases used for brevity.%A%    
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D000004 2003
% 210.27/210.46  |- mesh__recordOriginator mesh__D000004 NLM
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D000004 2000
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D000004 2004
% 210.27/210.46  |- skos__hiddenLabel mesh__D005298 Surveys, World Fertility
% 210.27/210.46  |- skos__hiddenLabel mesh__D005298 Fertility, Marital
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D005298 2006
% 210.27/210.46  |- skos__hiddenLabel mesh__D005298 Fertility, Natural
% 210.27/210.46  |- skos__hiddenLabel mesh__D005298 Fertility Surveys, World
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D005298 2002
% 210.27/210.46  |- skos__hiddenLabel mesh__D005298 Determinants, Fertility
% 210.27/210.46  |- mesh__recordAuthorizer mesh__D005298 sjn
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D005298 2005
% 210.27/210.46  |- skos__altLabel mesh__D005298 Fecundity
% 210.27/210.46  |- skos__prefLabel mesh__D005298 Fertility
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D005298 2001
% 210.27/210.46  |- skos__related mesh__D005298smesh__D007246
% 210.27/210.46  |- mesh__dateRevised mesh__D005298 2000-06-22
% 210.27/210.46  |- mesh__dateCreated mesh__D005298 1999-01-01
% 210.27/210.46  |- skos__altLabel mesh__D005298 Below Replacement Fertility
% 210.27/210.46  |- skos__hiddenLabel mesh__D005298 World Fertility Surveys
% 210.27/210.46  |- skos__hiddenLabel mesh__D005298 Preference, Fertility
% 210.27/210.46  |- skos__hiddenLabel mesh__D005298 Fertility Incentive
% 210.27/210.46  |- skos__hiddenLabel mesh__D005298 Preferences, Fertility
% 210.27/210.46  |- mesh__recordOriginator mesh__D005298 NLM
% 210.27/210.46  |- skos__hiddenLabel mesh__D005298 Fertility Survey, World
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D005298 2004
% 210.27/210.46  |- skos__hiddenLabel mesh__D005298 Survey, World Fertility
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D005298 2003
% 210.27/210.46  |- skos__scopeNote mesh__D005298
% 210.27/210.46       The capacity to conceive or to induce conception. It may refer to either the male or female.%A%    
% 210.27/210.46  |- rdf__type mesh__D005298sskos__Concept
% 210.27/210.46  |- mesh__recordMaintainer mesh__D005298 jls
% 210.27/210.46  |- skos__annotation mesh__D005298
% 210.27/210.46       IM for human, other mammals, birds %26% fish, NIM for animals lower than fish, plants %26% micro-organisms; /drug eff: consider also FERTILITY AGENTS%A%  
% 210.27/210.46  |- skos__hiddenLabel mesh__D005298 Fertility Determinant
% 210.27/210.46  |- skos__altLabel mesh__D005298 Fecundability
% 210.27/210.46  |- skos__broader mesh__D005298smesh__D012098
% 210.27/210.46  |- skos__hiddenLabel mesh__D005298 Fertility, Differential
% 210.27/210.46  |- skos__hiddenLabel mesh__D005298 Determinant, Fertility
% 210.27/210.46  |- skos__hiddenLabel mesh__D005298 Fertility Preference
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D010432 1996
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D010432 2003
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D010432 1993
% 210.27/210.46  |- mesh__dateEstablished mesh__D010432 1991-01-01
% 210.27/210.46  |- skos__scopeNote mesh__D010432
% 210.27/210.46       5-Hydroxymethyl-6-methyl- 2,4-%28%1H,3H%29%-pyrimidinedione. Uracil derivative used in combination with toxic antibiotics to lessen their toxicity; also to stimulate leukopoiesis and immunity. Synonyms: pentoksil; hydroxymethylmethyluracil.%A%    
% 210.27/210.46  |- mesh__historyNote mesh__D010432
% 210.27/210.46       91%28%80%29%; was see under URACIL 1980-90   
% 210.27/210.46  |- mesh__recordMaintainer mesh__D010432 TAP
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D010432 1997
% 210.27/210.46  |- rdf__type mesh__D010432sskos__Concept
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D010432 2004
% 210.27/210.46  |- mesh__recordOriginator mesh__D010432 SH
% 210.27/210.46  |- skos__prefLabel mesh__D010432 Pentoxyl
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D010432 2002
% 210.27/210.46  |- mesh__publicMeSHNote mesh__D010432 91; was see under URACIL 1980-90   
% 210.27/210.46  |- mesh__recordAuthorizer mesh__D010432 PLS
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D010432 1994
% 210.27/210.46  |- skos__altLabel mesh__D010432 Pentoxil
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D010432 1998
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D010432 2005
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D010432 2000
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D010432 1995
% 210.27/210.46  |- mesh__dateRevised mesh__D010432 1992-05-19
% 210.27/210.46  |- mesh__dateCreated mesh__D010432 1979-03-02
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D010432 1999
% 210.27/210.46  |- skos__historyNote mesh__D010432
% 210.27/210.46       Uracil %28%1966-1974%29% /AA %28%1975-1979%29%
% 210.27/210.46  |- skos__broader mesh__D010432smesh__D014498
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D010432 2006
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D010432 2001
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D009689 2006
% 210.27/210.46  |- mesh__recordOriginator mesh__D009689 NLM
% 210.27/210.46  |- skos__altLabel mesh__D009689 Atomic Warfare
% 210.27/210.46  |- skos__scopeNote mesh__D009689
% 210.27/210.46       Warfare involving the use of nuclear weapons.     
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D009689 2005
% 210.27/210.46  |- mesh__recordAuthorizer mesh__D009689 sjn
% 210.27/210.46  |- skos__broader mesh__D009689smesh__D014857
% 210.27/210.46  |- mesh__dateCreated mesh__D009689 1999-01-01
% 210.27/210.46  |- skos__hiddenLabel mesh__D009689 Weapon, Nuclear
% 210.27/210.46  |- rdf__type mesh__D009689sskos__Concept
% 210.27/210.46  |- mesh__publicMeSHNote mesh__D009689 82; was ATOMIC WARFARE 1963-81   
% 210.27/210.46  |- skos__prefLabel mesh__D009689 Nuclear Warfare
% 210.27/210.46  |- skos__hiddenLabel mesh__D009689 Testings, Nuclear Weapons
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D009689 2004
% 210.27/210.46  |- skos__hiddenLabel mesh__D009689 Nuclear Weapon
% 210.27/210.46  |- mesh__historyNote mesh__D009689 82; was ATOMIC WARFARE 1963-81   
% 210.27/210.46  |- skos__hiddenLabel mesh__D009689 Warfare, Nuclear
% 210.27/210.46  |- skos__hiddenLabel mesh__D009689 Weapons Testings, Nuclear
% 210.27/210.46  |- mesh__dateRevised mesh__D009689 2003-07-09
% 210.27/210.46  |- skos__hiddenLabel mesh__D009689 Testing, Nuclear Weapons
% 210.27/210.46  |- skos__hiddenLabel mesh__D009689 Nuclear Weapons Testings
% 210.27/210.46  |- skos__hiddenLabel mesh__D009689 Weapons, Nuclear
% 210.27/210.46  |- mesh__onlineNote mesh__D009689
% 210.27/210.46       use NUCLEAR WARFARE to search ATOMIC WARFARE 1966-81   
% 210.27/210.46  |- skos__hiddenLabel mesh__D009689 Warfare, Atomic
% 210.27/210.46  |- mesh__recordMaintainer mesh__D009689 ags
% 210.27/210.46  |- skos__related mesh__D009689smesh__D011847
% 210.27/210.46  |- skos__hiddenLabel mesh__D009689 Weapons Testing, Nuclear
% 210.27/210.46  |- skos__historyNote mesh__D020860 Subtilisins %28%1973-1999%29%
% 210.27/210.46  |- mesh__dateCreated mesh__D020860 1999-11-03
% 210.27/210.46  |- skos__historyNote mesh__D020860 Endopeptidases %28%1966-1972%29%
% 210.27/210.46  |- skos__broader mesh__D020860smesh__D013381
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D020860 2005
% 210.27/210.46  |- mesh__dateRevised mesh__D020860 2003-07-09
% 210.27/210.46  |- rdf__type mesh__D020860sskos__Concept
% 210.27/210.46  |- mesh__publicMeSHNote mesh__D020860 2000   
% 210.27/210.46  |- mesh__dateEstablished mesh__D020860 2000-01-01
% 210.27/210.46  |- skos__prefLabel mesh__D020860 Subtilisin
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D020860 2006
% 210.27/210.46  |- mesh__historyNote mesh__D020860 2000   
% 210.27/210.46  |- skos__scopeNote mesh__D020860
% 210.27/210.46       A serine endopeptidase isolated from Bacillus subtilis. It hydrolyzes proteins with broad specificity for peptide bonds, and a preference for a large uncharged residue in P1. It also hydrolyzes peptide amides. %28%From Enzyme Nomenclature, 1992%29% EC 3.4.21.62.%A%    
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D020860 2004
% 210.27/210.46  |- skos__annotation mesh__D020860 SUBTILISINS is also available   
% 210.27/210.46  |- skos__hiddenLabel mesh__D006391 Histiocytoid Hemangioma
% 210.27/210.46  |- rdf__type mesh__D006391sskos__Concept
% 210.27/210.46  |- skos__related mesh__D006391smesh__D018219
% 210.27/210.46  |- skos__prefLabel mesh__D006391 Hemangioma
% 210.27/210.46  |- mesh__recordAuthorizer mesh__D006391 sjn
% 210.27/210.46  |- skos__hiddenLabel mesh__D006391 Hemangiomas
% 210.27/210.46  |- mesh__recordMaintainer mesh__D006391 ags
% 210.27/210.46  |- skos__altLabel mesh__D006391 Chorangioma
% 210.27/210.46  |- skos__hiddenLabel mesh__D006391 Hemangiomas, Histiocytoid
% 210.27/210.46  |- skos__broader mesh__D006391smesh__D009383
% 210.27/210.46  |- mesh__dateCreated mesh__D006391 1999-01-01
% 210.27/210.46  |- mesh__recordOriginator mesh__D006391 NLM
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D006391 2006
% 210.27/210.46  |- skos__hiddenLabel mesh__D006391 Chorangiomas
% 210.27/210.46  |- skos__annotation mesh__D006391
% 210.27/210.46       coordinate IM with pre-coordinated organ/neopl term %28%IM%29%; CENTRAL NERVOUS SYSTEM VENOUS ANGIOMA; PULMONARY SCLEROSING HEMANGIOMA; and LYMPHANGIOMA is also available%A%  
% 210.27/210.46  |- skos__hiddenLabel mesh__D006391 Histiocytoid Hemangiomas
% 210.27/210.46  |- skos__related mesh__D006391smesh__D047868
% 210.27/210.46  |- skos__hiddenLabel mesh__D006391 Angiomas
% 210.27/210.46  |- skos__hiddenLabel mesh__D006391 Intramuscular Hemangiomas
% 210.27/210.46  |- skos__scopeNote mesh__D006391
% 210.27/210.46       A benign tumor, made up of an overgrowth of BLOOD VESSELS.  It is extremely common, occurring mostly in infancy and childhood. It can occur anywhere in the body but is most frequently noticed in the SKIN and SUBCUTANEOUS TISSUE. About 75%25% are present at birth, and about 60%25% occur in the head and neck area. %28%from Stedman, 25th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1355%29%%A%    
% 210.27/210.46  |- skos__hiddenLabel mesh__D006391 Hemangiomas, Intramuscular
% 210.27/210.46  |- skos__hiddenLabel mesh__D006391 Intramuscular Hemangioma
% 210.27/210.46  |- skos__altLabel mesh__D006391 Angioma
% 210.27/210.46  |- mesh__dateRevised mesh__D006391 2005-06-30
% 210.27/210.46  |- skos__broader mesh__D020062smesh__D006430
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D020062 2004
% 210.27/210.46  |- skos__scopeNote mesh__D020062
% 210.27/210.46       A suborder of HEMIPTERA, called true bugs, characterized by the possession of two pairs of wings. It includes the medically important families CIMICIDAE and REDUVIIDAE. %28%From Dorland, 28th ed%29%%A%    
% 210.27/210.46  |- skos__historyNote mesh__D020062 Hemiptera %28%1973-1998%29%
% 210.27/210.46  |- mesh__publicMeSHNote mesh__D020062 99   
% 210.27/210.46  |- skos__prefLabel mesh__D020062 Heteroptera
% 210.27/210.46  |- rdf__type mesh__D020062sskos__Concept
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D020062 2006
% 210.27/210.46  |- mesh__historyNote mesh__D020062 99   
% 210.27/210.46  |- mesh__dateEstablished mesh__D020062 1999-01-01
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D020062 2005
% 210.27/210.46  |- skos__historyNote mesh__D020062 Insects %28%1965-1974%29%
% 210.27/210.46  |- skos__annotation mesh__D020062
% 210.27/210.46       do not use /drug eff for insecticides: TN 111   
% 210.27/210.46  |- mesh__dateCreated mesh__D020062 1998-06-10
% 210.27/210.46  |- mesh__dateRevised mesh__D020062 2003-07-09
% 210.27/210.46  |- skos__prefLabel mesh__D014823 Vitreous Hemorrhage
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D014823 2001
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D014823 2004
% 210.27/210.46  |- skos__hiddenLabel mesh__D014823 Vitreous Hemorrhages
% 210.27/210.46  |- skos__historyNote mesh__D014823 Vitreous Body %28%1966-1986%29%
% 210.27/210.46  |- mesh__dateRevised mesh__D014823 1999-11-03
% 210.27/210.46  |- rdf__type mesh__D014823sskos__Concept
% 210.27/210.46  |- skos__scopeNote mesh__D014823 Hemorrhage into the VITREOUS BODY.     
% 210.27/210.46  |- skos__broader mesh__D014823smesh__D005130
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D014823 2002
% 210.27/210.46  |- mesh__recordOriginator mesh__D014823 RC
% 210.27/210.46  |- skos__historyNote mesh__D014823 Hemorrhage %28%1966-1986%29%
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D014823 2005
% 210.27/210.46  |- skos__altLabel mesh__D014823 Hemorrhage, Vitreous
% 210.27/210.46  |- mesh__recordAuthorizer mesh__D014823 sjn
% 210.27/210.46  |- mesh__dateCreated mesh__D014823 1986-04-08
% 210.27/210.46  |- mesh__dateEstablished mesh__D014823 1987-01-01
% 210.27/210.46  |- mesh__recordMaintainer mesh__D014823 KEV
% 210.27/210.46  |- mesh__historyNote mesh__D014823 87   
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D014823 2006
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D014823 2000
% 210.27/210.46  |- mesh__publicMeSHNote mesh__D014823 87   
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D014823 2003
% 210.27/210.46  |- rdf__type mesh__D014025sskos__Concept
% 210.27/210.46  |- mesh__recordOriginator mesh__D014025 NLM
% 210.27/210.46  |- mesh__dateCreated mesh__D014025 1999-01-01
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D014025 2004
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D014025 2006
% 210.27/210.46  |- skos__annotation mesh__D014025
% 210.27/210.46       Ti-48; Ti-46, 47, 49, 50 = TITANIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Ti-43-45, 51 = TITANIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 210.27/210.46  |- mesh__recordAuthorizer mesh__D014025 sjn
% 210.27/210.46  |- mesh__dateRevised mesh__D014025 2001-07-25
% 210.27/210.46  |- skos__prefLabel mesh__D014025 Titanium
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D014025 2003
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D014025 2005
% 210.27/210.46  |- skos__broader mesh__D014025smesh__D019565
% 210.27/210.46  |- mesh__recordMaintainer mesh__D014025 jmp
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D014025 2002
% 210.27/210.46  |- skos__broader mesh__D014025smesh__D028561
% 210.27/210.46  |- skos__scopeNote mesh__D014025
% 210.27/210.46       A dark-gray, metallic element of widespread distribution but occurring in small amounts; atomic number, 22; atomic weight, 47.90; symbol, Ti; specific gravity, 4.5; used for fixation of fractures. %28%Dorland, 28th ed%29%%A%    
% 210.27/210.46  |- skos__prefLabel mesh__D000803 Angiotensin I
% 210.27/210.46  |- skos__hiddenLabel mesh__D000803 I, Angiotensin
% 210.27/210.46  |- skos__scopeNote mesh__D000803
% 210.27/210.46       The decapeptide precursor of ANGIOTENSIN II, generated by the action of renin on angiotensinogen. It has limited pharmacologic activity.%A%    
% 210.27/210.46  |- mesh__dateRevised mesh__D000803 2005-06-30
% 210.27/210.46  |- rdf__type mesh__D000803sskos__Concept
% 210.27/210.46  |- mesh__publicMeSHNote mesh__D000803
% 210.27/210.46       87; was see under ANGIOTENSINS 1978-86   
% 210.27/210.46  |- mesh__recordAuthorizer mesh__D000803 sjn
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D000803 2006
% 210.27/210.46  |- skos__historyNote mesh__D000803 Angiotensin II %28%1966-1977%29%
% 210.27/210.46  |- mesh__dateCreated mesh__D000803 1977-06-09
% 210.27/210.46  |- skos__broader mesh__D000803smesh__D000809
% 210.27/210.46  |- mesh__recordMaintainer mesh__D000803 ssb
% 210.27/210.46  |- mesh__historyNote mesh__D000803
% 210.27/210.46       87%28%78%29%; was see under ANGIOTENSINS 1978-86   
% 210.27/210.46  |- skos__annotation mesh__D000803
% 210.27/210.46       a neurotransmitter; /biosyn /physiol permitted   
% 210.27/210.46  |- mesh__dateEstablished mesh__D000803 1987-01-01
% 210.27/210.46  |- mesh__recordOriginator mesh__D000803 SH
% 210.27/210.46  |- skos__broader mesh__D000005smesh__D001829
% 210.27/210.46  |- rdf__type mesh__D000005sskos__Concept
% 210.27/210.46  |- mesh__recordMaintainer mesh__D000005 ags
% 210.27/210.46  |- mesh__recordOriginator mesh__D000005 NLM
% 210.27/210.46  |- mesh__dateRevised mesh__D000005 2002-07-02
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D000005 2003
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D000005 2004
% 210.27/210.46  |- mesh__recordAuthorizer mesh__D000005 sjn
% 210.27/210.46  |- skos__prefLabel mesh__D000005 Abdomen
% 210.27/210.46  |- skos__hiddenLabel mesh__D000005 Abdomens
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D000005 2005
% 210.27/210.46  |- skos__scopeNote mesh__D000005
% 210.27/210.46       That portion of the body that lies between the THORAX and the PELVIS.%A%    
% 210.27/210.46  |- skos__annotation mesh__D000005
% 210.27/210.46       GEN: prefer specifics; abdom muscles = ABDOMINAL MUSCLES but RECTUS ABDOMINIS is available; abdominal pain = ABDOMINAL PAIN; abrupt dis requiring emerg surg = ABDOMEN, ACUTE%A%  
% 210.27/210.46  |- mesh__dateCreated mesh__D000005 1999-01-01
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D000005 2006
% 210.27/210.46  |- mesh__dateCreated mesh__D005299 1999-01-01
% 210.27/210.46  |- skos__historyNote mesh__D005299 Gonadotropins %28%1966-1972%29%
% 210.27/210.46  |- mesh__dateEstablished mesh__D005299 1973-01-01
% 210.27/210.46  |- mesh__recordMaintainer mesh__D005299 ssb
% 210.27/210.46  |- skos__scopeNote mesh__D005299
% 210.27/210.46       Drugs used to increase fertility or to treat infertility.%A%    
% 210.27/210.46  |- skos__hiddenLabel mesh__D005299 Drugs, Fertility
% 210.27/210.46  |- skos__altLabel mesh__D005299 Infertility Drugs
% 210.27/210.46  |- skos__broader mesh__D005299smesh__D012102
% 210.27/210.46  |- skos__historyNote mesh__D005299 Ovulation/drug effects %28%1966-1972%29%
% 210.27/210.46  |- mesh__recordAuthorizer mesh__D005299 sjn
% 210.27/210.46  |- skos__altLabel mesh__D005299 Fertility Drugs
% 210.27/210.46  |- skos__hiddenLabel mesh__D005299 Agents, Infertility
% 210.27/210.46  |- rdf__type mesh__D005299sskos__Concept
% 210.27/210.46  |- mesh__historyNote mesh__D005299 73   
% 210.27/210.46  |- skos__altLabel mesh__D005299 Infertility Agents
% 210.27/210.46  |- skos__prefLabel mesh__D005299 Fertility Agents
% 210.27/210.46  |- mesh__recordOriginator mesh__D005299 NLM
% 210.27/210.46  |- skos__hiddenLabel mesh__D005299 Drugs, Infertility
% 210.27/210.46  |- skos__historyNote mesh__D005299 Fertility/drug effects %28%1966-1972%29%
% 210.27/210.46  |- mesh__dateRevised mesh__D005299 2005-06-30
% 210.27/210.46  |- mesh__activeMeSHYear mesh__D005299 2006
% 210.27/210.46  |- skos__hiddenLabel mesh__D005299 Agents, Fertility
% 210.27/210.46  |- mesh__publicMeSHNote mesh__D005299 73   
% 210.27/210.46  |- skos__annotation mesh__D005299 consider also FERTILITY /drug eff   
% 210.27/210.46  |- mesh__historyNote mesh__D018416 96; was ROCHALIMAEA HENSELAE 1995   
% 210.27/210.46  |- skos__broader mesh__D018416smesh__D001473
% 210.27/210.46  |- skos__altLabel mesh__D018416 Rochalimaea henselae
% 210.27/210.46  |- mesh__recordMaintainer mesh__D018416 SYSTEM
% 210.27/210.46  |- mesh__recordAuthorizer mesh__D018416 sjn
% 210.27/210.46  |- mesh__publicMeSHNote mesh__D018416 96; was ROCHALIMAEA HENSELAE 1995   
% 210.27/210.46  |- skos__historyNote mesh__D018416 Rickettsiaceae %28%1992-1994%29%
% 210.27/210.46  |- rdf__type mesh__D018416sskos__Concept
% 210.27/210.46  |- skos__historyNote mesh__D018416 Rickettsieae %28%1992-1994%29%
% 210.27/210.46  |- mesh__dateCreated mesh__D018416 1994-01-25
% 210.27/210.46  |- skos__prefLabel mesh__D018416 Bartonella henselae
% 210.27/210.46  |- mesh__dateRevised mesh__D018416 2005-06-30
% 210.27/210.46  |- mesh__dateEstablished mesh__D018416 1995-01-01
% 210.27/210.46  |- mesh__recordOriginator mesh__D018416 PXP
% 210.27/210.47  |- skos__scopeNote mesh__D018416
% 210.27/210.47       A species of gram-negative bacteria that is the etiologic agent of bacillary angiomatosis %28%ANGIOMATOSIS, BACILLARY%29%. This organism can also be a cause of CAT-SCRATCH DISEASE in immunocompetent patients.%A%    
% 210.27/210.47  |- skos__annotation mesh__D018416
% 210.27/210.47       infection = ANGIOMATOSIS, BACILLARY or CAT-SCRATCH DISEASE %28%see note there%29%: check text%A%  
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D018416 2006
% 210.27/210.47  |- rdf__type mesh__D010433sskos__Concept
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D010433 2004
% 210.27/210.47  |- skos__altLabel mesh__D010433 Korazol
% 210.27/210.47  |- skos__altLabel mesh__D010433 Corazole
% 210.27/210.47  |- skos__altLabel mesh__D010433 Metrazole
% 210.27/210.47  |- skos__broader mesh__D010433smesh__D001381
% 210.27/210.47  |- skos__altLabel mesh__D010433 Pentylenetetrazol
% 210.27/210.47  |- skos__altLabel mesh__D010433 Corazol
% 210.27/210.47  |- mesh__dateCreated mesh__D010433 1999-01-01
% 210.27/210.47  |- skos__scopeNote mesh__D010433
% 210.27/210.47       A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.%A%    
% 210.27/210.47  |- skos__altLabel mesh__D010433 Korazole
% 210.27/210.47  |- mesh__dateRevised mesh__D010433 2001-08-03
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D010433 2005
% 210.27/210.47  |- skos__altLabel mesh__D010433 Leptazole
% 210.27/210.47  |- mesh__recordAuthorizer mesh__D010433 sjn
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D010433 2002
% 210.27/210.47  |- mesh__recordOriginator mesh__D010433 NLM
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D010433 2006
% 210.27/210.47  |- skos__altLabel mesh__D010433 Pentetrazole
% 210.27/210.47  |- mesh__recordMaintainer mesh__D010433 sjn
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D010433 2003
% 210.27/210.47  |- skos__altLabel mesh__D010433 Pentamethylenetetrazole
% 210.27/210.47  |- skos__prefLabel mesh__D010433 Pentylenetetrazole
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D034881 2006
% 210.27/210.47  |- mesh__historyNote mesh__D034881 2003   
% 210.27/210.47  |- mesh__publicMeSHNote mesh__D034881 2003   
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D034881 2005
% 210.27/210.47  |- skos__broader mesh__D034881smesh__D009685
% 210.27/210.47  |- rdf__type mesh__D034881sskos__Concept
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D034881 2004
% 210.27/210.47  |- mesh__dateRevised mesh__D034881 2003-07-09
% 210.27/210.47  |- skos__prefLabel mesh__D034881 Nuclear Lamina
% 210.27/210.47  |- mesh__dateEstablished mesh__D034881 2003-01-01
% 210.27/210.47  |- skos__hiddenLabel mesh__D034881 Nuclear Laminas
% 210.27/210.47  |- skos__broader mesh__D034881smesh__D015530
% 210.27/210.47  |- skos__scopeNote mesh__D034881
% 210.27/210.47       A lattice of fibrils which covers the entire inner surface of the nuclear envelope and interlinks nuclear pores %28%NUCLEAR PORE%29%.%A%    
% 210.27/210.47  |- skos__hiddenLabel mesh__D034881 Lamina, Nuclear
% 210.27/210.47  |- mesh__dateCreated mesh__D034881 2002-07-03
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D006392 2002
% 210.27/210.47  |- skos__broader mesh__D006392smesh__D020141
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D006392 2003
% 210.27/210.47  |- skos__broader mesh__D006392smesh__D006391
% 210.27/210.47  |- mesh__dateCreated mesh__D006392 1999-01-01
% 210.27/210.47  |- mesh__recordAuthorizer mesh__D006392 SJN
% 210.27/210.47  |- skos__annotation mesh__D006392
% 210.27/210.47       /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 210.27/210.47  |- skos__hiddenLabel mesh__D006392 Cavernous Hemangioma
% 210.27/210.47  |- skos__hiddenLabel mesh__D006392 Angiomas, Cavernous
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D006392 2006
% 210.27/210.47  |- skos__hiddenLabel mesh__D006392 Cavernous Angioma
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D006392 2001
% 210.27/210.47  |- skos__prefLabel mesh__D006392 Hemangioma, Cavernous
% 210.27/210.47  |- skos__scopeNote mesh__D006392
% 210.27/210.47       A vascular tumor preponderantly composed of large dilated blood vessels, often containing large amounts of blood, occurring in the skin, subcutaneously, or both, and also in many viscera, particularly the liver, spleen, pancreas, and sometimes the brain. The typical superficial lesions are bright to dark red in color; deep lesions have a blue color. A cavernous hemangioma in the skin extends more deeply than a capillary hemangioma and is less likely to regress spontaneously. %28%Dorland, 27th ed; from Stedman, 25th ed%29%%A%    
% 210.27/210.47  |- skos__hiddenLabel mesh__D006392 Hemangiomas, Cavernous
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D006392 2005
% 210.27/210.47  |- skos__hiddenLabel mesh__D006392 Cavernous Angiomas
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D006392 2000
% 210.27/210.47  |- mesh__recordOriginator mesh__D006392 NLM
% 210.27/210.47  |- mesh__dateRevised mesh__D006392 1998-06-10
% 210.27/210.47  |- skos__hiddenLabel mesh__D006392 Cavernous Hemangiomas
% 210.27/210.47  |- rdf__type mesh__D006392sskos__Concept
% 210.27/210.47  |- mesh__recordMaintainer mesh__D006392 NNS
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D006392 2004
% 210.27/210.47  |- skos__altLabel mesh__D006392 Angioma, Cavernous
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D006392 1999
% 210.27/210.47  |- mesh__publicMeSHNote mesh__D020063 99   
% 210.27/210.47  |- mesh__dateCreated mesh__D020063 1998-06-10
% 210.27/210.47  |- rdf__type mesh__D020063sskos__Concept
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D020063 2006
% 210.27/210.47  |- skos__broader mesh__D020063smesh__D020062
% 210.27/210.47  |- skos__prefLabel mesh__D020063 Cimicidae
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D020063 2005
% 210.27/210.47  |- skos__scopeNote mesh__D020063
% 210.27/210.47       A family of wingless, blood-sucking insects of the suborder HETEROPTERA, including the bedbugs and related forms. Cimex %28%BEDBUGS%29%, Heamatosiphon, and Oeciacus are medically important genera. %28%From Dorland, 28th ed%29%%A%    
% 210.27/210.47  |- skos__annotation mesh__D020063
% 210.27/210.47       do not use /drug eff for insecticides: TN 111   
% 210.27/210.47  |- skos__historyNote mesh__D020063 Hemiptera %28%1986-1998%29%
% 210.27/210.47  |- mesh__historyNote mesh__D020063 99   
% 210.27/210.47  |- mesh__dateEstablished mesh__D020063 1999-01-01
% 210.27/210.47  |- mesh__dateRevised mesh__D020063 2003-07-09
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D020063 2004
% 210.27/210.47  |- mesh__recordMaintainer mesh__D014824 jrf
% 210.27/210.47  |- mesh__recordAuthorizer mesh__D014824 sjn
% 210.27/210.47  |- skos__broader mesh__D014824smesh__D032761
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014824 2005
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014824 2006
% 210.27/210.47  |- mesh__dateCreated mesh__D014824 1999-01-01
% 210.27/210.47  |- mesh__dateRevised mesh__D014824 2002-07-03
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014824 2003
% 210.27/210.47  |- skos__related mesh__D014824smesh__D000827
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014824 2004
% 210.27/210.47  |- skos__hiddenLabel mesh__D014824 Vivisections
% 210.27/210.47  |- skos__scopeNote mesh__D014824
% 210.27/210.47       The cutting of or surgical operation on a living animal, usually for physiological or pathological investigation. %28%from Merriam-Webster%27%s Collegiate Dict, 10th ed%29%%A%    
% 210.27/210.47  |- mesh__recordOriginator mesh__D014824 NLM
% 210.27/210.47  |- skos__prefLabel mesh__D014824 Vivisection
% 210.27/210.47  |- rdf__type mesh__D014824sskos__Concept
% 210.27/210.47  |- mesh__dateCreated mesh__D014026 1999-01-01
% 210.27/210.47  |- skos__prefLabel mesh__D014026 Tobacco
% 210.27/210.47  |- skos__altLabel mesh__D014026 Nicotiana
% 210.27/210.47  |- skos__related mesh__D014026smesh__D014029
% 210.27/210.47  |- mesh__recordOriginator mesh__D014026 NLM
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014026 2006
% 210.27/210.47  |- skos__related mesh__D014026smesh__D012907
% 210.27/210.47  |- skos__annotation mesh__D014026
% 210.27/210.47       as plant %26% for smoking %28% = SMOKING%29%, sniffing %28% = SNUFF see TOBACCO, SMOKELESS%29% %26% chewing %28% = CHEWING TOBACCO see TOBACCO, SMOKELESS%29%; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.27/210.47  |- skos__scopeNote mesh__D014026
% 210.27/210.47       A plant genus of the family SOLANACEAE. Members contain NICOTINE and other biologically active chemicals; its dried leaves are used for SMOKING.%A%    
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014026 2005
% 210.27/210.47  |- mesh__recordMaintainer mesh__D014026 ssb
% 210.27/210.47  |- skos__broader mesh__D014026smesh__D019657
% 210.27/210.47  |- mesh__dateRevised mesh__D014026 2004-07-07
% 210.27/210.47  |- mesh__recordAuthorizer mesh__D014026 sjn
% 210.27/210.47  |- rdf__type mesh__D014026sskos__Concept
% 210.27/210.47  |- skos__related mesh__D014026smesh__D009538
% 210.27/210.47  |- rdf__type mesh__D000804sskos__Concept
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D000804 2006
% 210.27/210.47  |- mesh__publicMeSHNote mesh__D000804
% 210.27/210.47       1974; see ANGIOTENSIN 1971-1973, see ANGIOTENSIN 1967-1970; ANGIOTENSIN was heading 1964-1978, was HYPERTENSIN 1963 %28%HYPERTENSIN see ANGIOTENSIN 1964-1965, see ANGIOTENSIN AMIDE 1966-1973%29%; ANGIOTENSIN II, ILE%28%5%29%- was indexed under ANGIOTENSIN II 1981-1999, and ISOLEUCINE 1975-1981%A%  
% 210.27/210.47  |- skos__broader mesh__D000804smesh__D000809
% 210.27/210.47  |- mesh__historyNote mesh__D000804
% 210.27/210.47       1974%28%1963%29%; for ANGIOTENSIN II, ILE%28%5%29%- use ANGIOTENSIN II %28%NM%29% 1974-1999%A%  
% 210.27/210.47  |- mesh__recordOriginator mesh__D000804 NLM
% 210.27/210.47  |- skos__hiddenLabel mesh__D000804 5 L Isoleucine Angiotensin II
% 210.27/210.47  |- skos__altLabel mesh__D000804 5-L-Isoleucine Angiotensin II
% 210.27/210.47  |- mesh__dateRevised mesh__D000804 2005-06-30
% 210.27/210.47  |- skos__altLabel mesh__D000804 Isoleucine%28%5%29%-Angiotensin
% 210.27/210.47  |- skos__altLabel mesh__D000804 ANG-%28%1-8%29%Octapeptide
% 210.27/210.47  |- skos__related mesh__D000804smesh__D012084
% 210.27/210.47  |- skos__hiddenLabel mesh__D000804 II, 5-L-Isoleucine Angiotensin
% 210.27/210.47  |- skos__altLabel mesh__D000804 Valyl%28%5%29%-Angiotensin II
% 210.27/210.47  |- mesh__recordAuthorizer mesh__D000804 sjn
% 210.27/210.47  |- skos__prefLabel mesh__D000804 Angiotensin II
% 210.27/210.47  |- mesh__dateCreated mesh__D000804 1999-01-01
% 210.27/210.47  |- skos__altLabel mesh__D000804 Angiotensin II, Isoleucine%28%5%29%-
% 210.27/210.47  |- skos__altLabel mesh__D000804 Isoleucyl%28%5%29%-Angiotensin II
% 210.27/210.47  |- skos__altLabel mesh__D000804 Angiotensin-%28%1-8%29% Octapeptide
% 210.27/210.47  |- skos__hiddenLabel mesh__D000804 Angiotensin II, 5-L-Isoleucine
% 210.27/210.47  |- skos__scopeNote mesh__D000804
% 210.27/210.47       The active form of angiotensin. An octapeptide found in blood, it is synthesized from ANGIOTENSIN I and quickly destroyed. Angiotensin II causes profound vasoconstriction with a resulting increase in blood pressure. It differs among species by the amino acid in position 5. The human form has ISOLEUCINE in this position. The clinically and experimentally used bovine form has VALINE in position 5. Medically useful antagonism is obtained with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS.%A%    
% 210.27/210.47  |- skos__altLabel mesh__D000804 Angiotensin II, Valine%28%5%29%-
% 210.27/210.47  |- mesh__recordMaintainer mesh__D000804 ssb
% 210.27/210.47  |- skos__scopeNote mesh__D000006
% 210.27/210.47       A clinical syndrome with acute abdominal pain that is severe, localized, and rapid onset. Acute abdomen may be caused by a variety of disorders, injuries, or diseases.%A%    
% 210.27/210.47  |- skos__hiddenLabel mesh__D000006 Acute Abdomens
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D000006 2004
% 210.27/210.47  |- mesh__recordOriginator mesh__D000006 NLM
% 210.27/210.47  |- mesh__dateRevised mesh__D000006 2003-07-09
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D000006 2005
% 210.27/210.47  |- skos__broader mesh__D000006smesh__D015746
% 210.27/210.47  |- skos__hiddenLabel mesh__D000006 Abdomens, Acute
% 210.27/210.47  |- skos__prefLabel mesh__D000006 Abdomen, Acute
% 210.27/210.47  |- mesh__dateCreated mesh__D000006 1999-01-01
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D000006 2006
% 210.27/210.47  |- mesh__recordAuthorizer mesh__D000006 sjn
% 210.27/210.47  |- skos__hiddenLabel mesh__D000006 Acute Abdomen
% 210.27/210.47  |- mesh__recordMaintainer mesh__D000006 lkt
% 210.27/210.47  |- rdf__type mesh__D000006sskos__Concept
% 210.27/210.47  |- mesh__historyNote mesh__D046108 2005   
% 210.27/210.47  |- skos__hiddenLabel mesh__D046108 Bird, Kiwi
% 210.27/210.47  |- mesh__recordOriginator mesh__D046108 ags
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D046108 2006
% 210.27/210.47  |- skos__scopeNote mesh__D046108
% 210.27/210.47       A superorder of large, mostly flightless birds, named for their distinctive PALATE morphology. It includes the orders Apterygiformes, Casuriiformes, Dinornithiformes, RHEIFORMES; STRUTHIONIFORMES and Tinamiformes.%A%    
% 210.27/210.47  |- rdf__type mesh__D046108sskos__Concept
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D046108 2005
% 210.27/210.47  |- skos__hiddenLabel mesh__D046108 Ratite
% 210.27/210.47  |- mesh__dateCreated mesh__D046108 2004-07-07
% 210.27/210.47  |- mesh__recordAuthorizer mesh__D046108 sjn
% 210.27/210.47  |- mesh__recordMaintainer mesh__D046108 ags
% 210.27/210.47  |- skos__prefLabel mesh__D046108 Palaeognathae
% 210.27/210.47  |- skos__broader mesh__D046108smesh__D001717
% 210.27/210.47  |- mesh__publicMeSHNote mesh__D046108
% 210.27/210.47       2005; for KIWI BIRD see RATITES 2002-2004; for RATITES see RATITES 1999-2004%A%  
% 210.27/210.47  |- mesh__dateEstablished mesh__D046108 2005-01-01
% 210.27/210.47  |- skos__historyNote mesh__D018417
% 210.27/210.47       T-Lymphocytes, Helper-Inducer %28%1985-1994%29%
% 210.27/210.47  |- skos__annotation mesh__D018417
% 210.27/210.47       helper-inducer T-lymphocytes: h stands for %22%helper%22%; A 11 qualif%A%  
% 210.27/210.47  |- skos__hiddenLabel mesh__D018417 Th1 Cell
% 210.27/210.47  |- skos__scopeNote mesh__D018417
% 210.27/210.47       Subset of helper-inducer T-lymphocytes which synthesize and secrete interleukin-2, gamma-interferon, and interleukin-12. Due to their ability to kill antigen-presenting cells and their lymphokine-mediated effector activity, Th1 cells are associated with vigorous delayed-type hypersensitivity reactions.%A%    
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D018417 2004
% 210.27/210.47  |- skos__hiddenLabel mesh__D018417 Cell, Th1
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D018417 2006
% 210.27/210.47  |- mesh__dateRevised mesh__D018417 2003-07-09
% 210.27/210.47  |- mesh__publicMeSHNote mesh__D018417 95   
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D018417 2005
% 210.27/210.47  |- skos__historyNote mesh__D018417 T-Lymphocyte Subsets %28%1991-1994%29%
% 210.27/210.47  |- mesh__historyNote mesh__D018417 95   
% 210.27/210.47  |- rdf__type mesh__D018417sskos__Concept
% 210.27/210.47  |- mesh__dateCreated mesh__D018417 1994-05-12
% 210.27/210.47  |- skos__prefLabel mesh__D018417 Th1 Cells
% 210.27/210.47  |- skos__broader mesh__D018417smesh__D006377
% 210.27/210.47  |- mesh__dateEstablished mesh__D018417 1995-01-01
% 210.27/210.47  |- skos__hiddenLabel mesh__D018417 Cells, Th1
% 210.27/210.47  |- skos__scopeNote mesh__D010434
% 210.27/210.47       Formed from pig pepsinogen by cleavage of one peptide bond. The enzyme is a single polypeptide chain and is inhibited by methyl 2-diaazoacetamidohexanoate. It cleaves peptides preferentially at the carbonyl linkages of phenylalanine or leucine and acts as the principal digestive enzyme of gastric juice.%A%    
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D010434 2004
% 210.27/210.47  |- mesh__recordOriginator mesh__D010434 NLM
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D010434 2005
% 210.27/210.47  |- rdf__type mesh__D010434sskos__Concept
% 210.27/210.47  |- skos__broader mesh__D010434smesh__D016282
% 210.27/210.47  |- mesh__historyNote mesh__D010434 91; was PEPSIN 1964-90   
% 210.27/210.47  |- mesh__recordMaintainer mesh__D010434 ssb
% 210.27/210.47  |- mesh__onlineNote mesh__D010434 use PEPSIN A to search PEPSIN 1966-90   
% 210.27/210.47  |- skos__prefLabel mesh__D010434 Pepsin A
% 210.27/210.47  |- mesh__publicMeSHNote mesh__D010434 91; was PEPSIN 1964-90   
% 210.27/210.47  |- skos__annotation mesh__D010434 /biosyn /physiol permitted   
% 210.27/210.47  |- mesh__dateCreated mesh__D010434 1999-01-01
% 210.27/210.47  |- mesh__dateRevised mesh__D010434 2003-07-09
% 210.27/210.47  |- skos__altLabel mesh__D010434 Pepsin
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D010434 2006
% 210.27/210.47  |- mesh__recordAuthorizer mesh__D010434 sjn
% 210.27/210.47  |- mesh__publicMeSHNote mesh__D034882
% 210.27/210.47       2003; LAMINS was indexed under Nuclear Proteins 1988-2002, NUCLEOPROTEINS 1980-1987%A%  
% 210.27/210.47  |- mesh__recordMaintainer mesh__D034882 SYSTEM
% 210.27/210.47  |- skos__prefLabel mesh__D034882 Lamins
% 210.27/210.47  |- rdf__type mesh__D034882sskos__Concept
% 210.27/210.47  |- mesh__recordOriginator mesh__D034882 jmp
% 210.27/210.47  |- mesh__recordAuthorizer mesh__D034882 sjn
% 210.27/210.47  |- mesh__dateCreated mesh__D034882 2002-07-03
% 210.27/210.47  |- skos__scopeNote mesh__D034882
% 210.27/210.47       Nuclear matrix proteins that are structural components of the NUCLEAR LAMINA. They are found in most multicellular organisms.%A%    
% 210.27/210.47  |- mesh__dateRevised mesh__D034882 2005-06-30
% 210.27/210.47  |- skos__related mesh__D034882smesh__D034881
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D034882 2006
% 210.27/210.47  |- mesh__dateEstablished mesh__D034882 2003-01-01
% 210.27/210.47  |- skos__broader mesh__D034882smesh__D034521
% 210.27/210.47  |- mesh__historyNote mesh__D034882 2003; use LAMINS %28%NM%29% 1980-2002   
% 210.27/210.47  |- skos__annotation mesh__D034882 see SCR for organism-specific lamins   
% 210.27/210.47  |- skos__scopeNote mesh__D020862
% 210.27/210.47       A nucleic acid sequence that contains an above average number of GUANINE and CYTOSINE bases.%A%    
% 210.27/210.47  |- skos__hiddenLabel mesh__D020862 Region, GC Rich
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D020862 2005
% 210.27/210.47  |- mesh__historyNote mesh__D020862 2000   
% 210.27/210.47  |- mesh__recordOriginator mesh__D020862 nns
% 210.27/210.47  |- skos__related mesh__D020862smesh__D020856
% 210.27/210.47  |- skos__hiddenLabel mesh__D020862 Regions, GC Rich
% 210.27/210.47  |- skos__prefLabel mesh__D020862 GC Rich Sequence
% 210.27/210.47  |- skos__historyNote mesh__D020862
% 210.27/210.47       Dinucleoside Phosphates %28%1989-1999%29%
% 210.27/210.47  |- mesh__publicMeSHNote mesh__D020862 2000   
% 210.27/210.47  |- mesh__dateRevised mesh__D020862 2002-07-03
% 210.27/210.47  |- skos__historyNote mesh__D020862 CpG Islands %28%1996-1999%29%
% 210.27/210.47  |- skos__hiddenLabel mesh__D020862 GC Rich Regions
% 210.27/210.47  |- skos__historyNote mesh__D020862 Base Sequence %28%1989-1999%29%
% 210.27/210.47  |- skos__broader mesh__D020862smesh__D001483
% 210.27/210.47  |- skos__hiddenLabel mesh__D020862 Sequences, GC Rich
% 210.27/210.47  |- mesh__dateEstablished mesh__D020862 2000-01-01
% 210.27/210.47  |- skos__altLabel mesh__D020862 GC Rich Region
% 210.27/210.47  |- mesh__dateCreated mesh__D020862 1999-11-03
% 210.27/210.47  |- mesh__recordAuthorizer mesh__D020862 sjn
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D020862 2004
% 210.27/210.47  |- skos__related mesh__D020862smesh__D032085
% 210.27/210.47  |- skos__hiddenLabel mesh__D020862 GC Rich Sequences
% 210.27/210.47  |- rdf__type mesh__D020862sskos__Concept
% 210.27/210.47  |- mesh__recordMaintainer mesh__D020862 nns
% 210.27/210.47  |- skos__hiddenLabel mesh__D020862 Sequence, GC Rich
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D020862 2003
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D020862 2006
% 210.27/210.47  |- skos__related mesh__D020862smesh__D001482
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D006393 2002
% 210.27/210.47  |- mesh__recordOriginator mesh__D006393 NLM
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D006393 2005
% 210.27/210.47  |- skos__hiddenLabel mesh__D006393 Hemangiopericytomas
% 210.27/210.47  |- skos__prefLabel mesh__D006393 Hemangiopericytoma
% 210.27/210.47  |- skos__broader mesh__D006393smesh__D009383
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D006393 1996
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D006393 2006
% 210.27/210.47  |- mesh__dateRevised mesh__D006393 1995-06-08
% 210.27/210.47  |- mesh__recordAuthorizer mesh__D006393 PLS
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D006393 1997
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D006393 2000
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D006393 2003
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D006393 1998
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D006393 2001
% 210.27/210.47  |- rdf__type mesh__D006393sskos__Concept
% 210.27/210.47  |- skos__annotation mesh__D006393
% 210.27/210.47       benign or malignant; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 210.27/210.47  |- mesh__dateCreated mesh__D006393 1999-01-01
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D006393 2004
% 210.27/210.47  |- skos__scopeNote mesh__D006393
% 210.27/210.47       A tumor composed of spindle cells with a rich vascular network, which apparently arises from pericytes, cells of smooth muscle origin that lie around small vessels. Benign and malignant hemangiopericytomas exist, and the rarity of these lesions has led to considerable confusion in distinguishing between benign and malignant variants. %28%From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1364%29%%A%    
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D006393 1999
% 210.27/210.47  |- mesh__recordMaintainer mesh__D006393 KEV
% 210.27/210.47  |- mesh__historyNote mesh__D020064 99; use TRIATOMINAE 1979-98   
% 210.27/210.47  |- rdf__type mesh__D020064sskos__Concept
% 210.27/210.47  |- mesh__dateCreated mesh__D020064 1998-06-11
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D020064 2006
% 210.27/210.47  |- mesh__dateEstablished mesh__D020064 1999-01-01
% 210.27/210.47  |- skos__broader mesh__D020064smesh__D020062
% 210.27/210.47  |- skos__historyNote mesh__D020064 Triatominae %28%1979-1998%29%
% 210.27/210.47  |- skos__scopeNote mesh__D020064
% 210.27/210.47       A family of winged insects of the suborder HETEROPTERA, called assassin bugs, because most prey on other insects. However one subfamily, TRIATOMINAE, attacks humans and other vertebrates and transmits Chagas disease.%A%    
% 210.27/210.47  |- skos__prefLabel mesh__D020064 Reduviidae
% 210.27/210.47  |- skos__annotation mesh__D020064
% 210.27/210.47       do not use /drug eff for insecticides: TN 111   
% 210.27/210.47  |- mesh__dateRevised mesh__D020064 2003-07-09
% 210.27/210.47  |- skos__altLabel mesh__D020064 Assassin Bugs
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D020064 2004
% 210.27/210.47  |- mesh__publicMeSHNote mesh__D020064 99; see TRIATOMINAE 1979-98   
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D020064 2005
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014825 1999
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014825 2005
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014825 2002
% 210.27/210.47  |- mesh__recordOriginator mesh__D014825 NLM
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014825 1996
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014825 2006
% 210.27/210.47  |- mesh__dateCreated mesh__D014825 1999-01-01
% 210.27/210.47  |- skos__prefLabel mesh__D014825 Vocabulary
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014825 1997
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014825 2003
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014825 2000
% 210.27/210.47  |- skos__scopeNote mesh__D014825
% 210.27/210.47       The sum or the stock of words used by a language, a group, or an individual. %28%From Webster, 3d ed%29%%A%    
% 210.27/210.47  |- mesh__recordMaintainer mesh__D014825 TGC
% 210.27/210.47  |- skos__annotation mesh__D014825
% 210.27/210.47       a person%27%s stock of words; do not use for nomenclature %28% = NOMENCLATURE%29% or for THESAURUS see VOCABULARY, CONTROLLED; no qualif%A%  
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014825 2004
% 210.27/210.47  |- mesh__dateRevised mesh__D014825 1994-12-27
% 210.27/210.47  |- skos__broader mesh__D014825smesh__D008037
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014825 2001
% 210.27/210.47  |- rdf__type mesh__D014825sskos__Concept
% 210.27/210.47  |- mesh__recordAuthorizer mesh__D014825 PLS
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014825 1998
% 210.27/210.47  |- skos__hiddenLabel mesh__D014825 Vocabularies
% 210.27/210.47  |- mesh__dateRevised mesh__D014027 1996-06-10
% 210.27/210.47  |- skos__hiddenLabel mesh__D014027 Mosaic Viruses, Tobacco
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014027 2005
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014027 1997
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014027 1999
% 210.27/210.47  |- skos__hiddenLabel mesh__D014027 Viruses, Tobacco Mosaic
% 210.27/210.47  |- skos__hiddenLabel mesh__D014027 Tobacco Mosaic Viruses
% 210.27/210.47  |- rdf__type mesh__D014027sskos__Concept
% 210.27/210.47  |- mesh__recordAuthorizer mesh__D014027 PLS
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014027 2002
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014027 1998
% 210.27/210.47  |- skos__scopeNote mesh__D014027
% 210.27/210.47       The type species of TOBAMOVIRUS which causes mosaic disease of tobacco. Transmission occurs by mechanical inoculation.%A%    
% 210.27/210.47  |- mesh__recordOriginator mesh__D014027 NLM
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014027 2001
% 210.27/210.47  |- skos__hiddenLabel mesh__D014027 Mosaic Virus, Tobacco
% 210.27/210.47  |- skos__broader mesh__D014027smesh__D017898
% 210.27/210.47  |- skos__annotation mesh__D014027
% 210.27/210.47       a species of plant virus; coord IM with TOBACCO /virol %28%IM or NIM%29%%A%  
% 210.27/210.47  |- mesh__dateCreated mesh__D014027 1999-01-01
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014027 2004
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014027 2000
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014027 2006
% 210.27/210.47  |- skos__prefLabel mesh__D014027 Tobacco Mosaic Virus
% 210.27/210.47  |- mesh__recordMaintainer mesh__D014027 AGS
% 210.27/210.47  |- skos__hiddenLabel mesh__D014027 Virus, Tobacco Mosaic
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D014027 2003
% 210.27/210.47  |- mesh__recordOriginator mesh__D000805 RLS
% 210.27/210.47  |- skos__hiddenLabel mesh__D000805 Angiotensin II, Des-Asp
% 210.27/210.47  |- mesh__publicMeSHNote mesh__D000805
% 210.27/210.47       91; was see under ANGIOTENSIN II 1977-90   
% 210.27/210.47  |- mesh__recordAuthorizer mesh__D000805 sjn
% 210.27/210.47  |- skos__broader mesh__D000805smesh__D000809
% 210.27/210.47  |- skos__annotation mesh__D000805
% 210.27/210.47       a neurotransmitter; comparison with angiotensin II: see MeSH definition; /biosyn /physiol permitted%A%  
% 210.27/210.47  |- skos__altLabel mesh__D000805 Des-Aspartyl-Angiotensin II
% 210.27/210.47  |- skos__scopeNote mesh__D000805
% 210.27/210.47       A heptapeptide formed by the enzymatic hydrolysis of ANGIOTENSIN II. It has greater activity than angiotensin II for stimulating aldosterone synthesis and in the release of prostaglandins but only 20%25% of the pressor activity.%A%    
% 210.27/210.47  |- skos__historyNote mesh__D000805 Angiotensin II %28%1966-1976%29%
% 210.27/210.47  |- skos__hiddenLabel mesh__D000805 Des Asp Angiotensin II
% 210.27/210.47  |- skos__prefLabel mesh__D000805 Angiotensin III
% 210.27/210.47  |- mesh__recordMaintainer mesh__D000805 ssb
% 210.27/210.47  |- mesh__dateCreated mesh__D000805 1976-05-19
% 210.27/210.47  |- mesh__historyNote mesh__D000805
% 210.27/210.47       91%28%77%29%; was see under ANGIOTENSIN II 1977-90   
% 210.27/210.47  |- skos__hiddenLabel mesh__D000805 Des Aspartyl Angiotensin II
% 210.27/210.47  |- rdf__type mesh__D000805sskos__Concept
% 210.27/210.47  |- skos__altLabel mesh__D000805 Des-Asp Angiotensin II
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D000805 2006
% 210.27/210.47  |- mesh__dateRevised mesh__D000805 2005-06-30
% 210.27/210.47  |- mesh__dateEstablished mesh__D000805 1991-01-01
% 210.27/210.47  |- skos__prefLabel mesh__D019510 DNA Fragmentation
% 210.27/210.47  |- skos__broader mesh__D019510smesh__D004249
% 210.27/210.47  |- skos__annotation mesh__D019510
% 210.27/210.47       do not confuse with DNA DAMAGE which includes by drugs or radiation; coord IM with specific DNA %28%IM%29%%A%  
% 210.27/210.47  |- skos__scopeNote mesh__D019510
% 210.27/210.47       Endonucleolytic cleavage %28%cutting both strands%29% of genomic DNA into fragments at internucleosomal sites. DNA fragmentation along with chromatin condensation are considered the hallmarks of APOPTOSIS.%A%    
% 210.27/210.47  |- mesh__dateCreated mesh__D019510 1996-06-13
% 210.27/210.47  |- skos__broader mesh__D019510smesh__D017209
% 210.27/210.47  |- mesh__recordOriginator mesh__D019510 AGS
% 210.27/210.47  |- skos__hiddenLabel mesh__D019510 Fragmentation, Internucleosomal DNA
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D019510 2006
% 210.27/210.47  |- skos__historyNote mesh__D019510 DNA %28%1966-1996%29%
% 210.27/210.47  |- mesh__recordMaintainer mesh__D019510 nns
% 210.27/210.47  |- skos__related mesh__D019510smesh__D020287
% 210.27/210.47  |- skos__hiddenLabel mesh__D019510 DNA Fragmentation, Internucleosomal
% 210.27/210.47  |- skos__hiddenLabel mesh__D019510 Fragmentation, DNA
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D019510 2005
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D019510 2004
% 210.27/210.47  |- mesh__publicMeSHNote mesh__D019510 97   
% 210.27/210.47  |- rdf__type mesh__D019510sskos__Concept
% 210.27/210.47  |- mesh__historyNote mesh__D019510 97   
% 210.27/210.47  |- mesh__dateEstablished mesh__D019510 1997-01-01
% 210.27/210.47  |- mesh__recordAuthorizer mesh__D019510 sjn
% 210.27/210.47  |- skos__historyNote mesh__D019510 DNA Damage %28%1987-1996%29%
% 210.27/210.47  |- mesh__dateRevised mesh__D019510 2003-07-09
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D000007 2000
% 210.27/210.47  |- skos__annotation mesh__D000007
% 210.27/210.47       general term for inj of organs in the abdom cavity; prefer specific organs /inj%A%  
% 210.27/210.47  |- rdf__type mesh__D000007sskos__Concept
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D000007 2005
% 210.27/210.47  |- skos__hiddenLabel mesh__D000007 Injury, Abdominal
% 210.27/210.47  |- skos__scopeNote mesh__D000007
% 210.27/210.47       General or unspecified injuries involving organs in the abdominal cavity.%A%    
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D000007 1995
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D000007 2004
% 210.27/210.47  |- skos__hiddenLabel mesh__D000007 Abdominal Injury
% 210.27/210.47  |- mesh__dateRevised mesh__D000007 1991-06-21
% 210.27/210.47  |- skos__broader mesh__D000007smesh__D014947
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D000007 1999
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D000007 1994
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D000007 2003
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D000007 1998
% 210.27/210.47  |- mesh__dateCreated mesh__D000007 1999-01-01
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D000007 1993
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D000007 2002
% 210.27/210.47  |- mesh__recordAuthorizer mesh__D000007 PLS
% 210.27/210.47  |- mesh__recordMaintainer mesh__D000007 PXP
% 210.27/210.47  |- skos__prefLabel mesh__D000007 Abdominal Injuries
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D000007 1997
% 210.27/210.47  |- mesh__recordOriginator mesh__D000007 NLM
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D000007 1992
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D000007 2001
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D000007 1996
% 210.27/210.47  |- skos__altLabel mesh__D000007 Injuries, Abdominal
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D000007 2006
% 210.27/210.47  |- mesh__activeMeSHYear mesh__D046109 2005
% 210.27/210.47  |- skos__historyNote mesh__D046109 Songbirds %28%1998-2004%29%
% 210.27/210.47  |- mesh__dateEstablished mesh__D046109 2005-01-01
% 210.27/210.47  |- mesh__dateCreated mesh__D046109 2004-07-07
% 210.27/210.47  |- mesh__recordOriginator mesh__D046109 ags
% 210.27/210.48  |- mesh__recordMaintainer mesh__D046109 ags
% 210.27/210.48  |- skos__historyNote mesh__D046109 Birds %28%1968-1997%29%
% 210.27/210.48  |- skos__broader mesh__D046109smesh__D001717
% 210.27/210.48  |- skos__scopeNote mesh__D046109
% 210.27/210.48       A widely distributed order of perching BIRDS, including more than half of all bird species.%A%    
% 210.27/210.48  |- mesh__recordAuthorizer mesh__D046109 sjn
% 210.27/210.48  |- skos__prefLabel mesh__D046109 Passeriformes
% 210.27/210.48  |- mesh__publicMeSHNote mesh__D046109 2005; see SONGBIRDS 1999-2004   
% 210.27/210.48  |- mesh__historyNote mesh__D046109 2005; use SONGBIRDS 1999-2004   
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D046109 2006
% 210.27/210.48  |- rdf__type mesh__D046109sskos__Concept
% 210.27/210.48  |- skos__annotation mesh__D018418
% 210.27/210.48       helper-inducer T-lymphocytes: h stands for %22%helper%22%; A 11 qualif%A%  
% 210.27/210.48  |- skos__historyNote mesh__D018418
% 210.27/210.48       T-Lymphocytes, Helper-Inducer %28%1985-1994%29%
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D018418 2004
% 210.27/210.48  |- mesh__publicMeSHNote mesh__D018418 95   
% 210.27/210.48  |- skos__hiddenLabel mesh__D018418 Th2 Cell
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D018418 2006
% 210.27/210.48  |- rdf__type mesh__D018418sskos__Concept
% 210.27/210.48  |- mesh__historyNote mesh__D018418 95   
% 210.27/210.48  |- mesh__dateRevised mesh__D018418 2003-07-09
% 210.27/210.48  |- mesh__dateCreated mesh__D018418 1994-06-03
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D018418 2005
% 210.27/210.48  |- skos__scopeNote mesh__D018418
% 210.27/210.48       Subset of helper-inducer T-lymphocytes which synthesize and secrete the interleukins IL-4, IL-5, IL-6, and IL-10. These cytokines influence B-cell development and antibody production as well as augmenting humoral responses.%A%    
% 210.27/210.48  |- skos__broader mesh__D018418smesh__D006377
% 210.27/210.48  |- skos__hiddenLabel mesh__D018418 Cells, Th2
% 210.27/210.48  |- skos__hiddenLabel mesh__D018418 Cell, Th2
% 210.27/210.48  |- skos__historyNote mesh__D018418 T-Lymphocytes %28%1980-1981%29%
% 210.27/210.48  |- skos__historyNote mesh__D018418 T-Lymphocyte Subsets %28%1989-1994%29%
% 210.27/210.48  |- mesh__dateEstablished mesh__D018418 1995-01-01
% 210.27/210.48  |- skos__prefLabel mesh__D018418 Th2 Cells
% 210.27/210.48  |- skos__historyNote mesh__D010435 Enzyme Precursors %28%1966-1971%29%
% 210.27/210.48  |- rdf__type mesh__D010435sskos__Concept
% 210.27/210.48  |- mesh__historyNote mesh__D010435 99%28%72%29%   
% 210.27/210.48  |- skos__annotation mesh__D010435
% 210.27/210.48       do not confuse with PEPSINOGEN see PEPSINOGEN A   
% 210.27/210.48  |- mesh__recordAuthorizer mesh__D010435 sjn
% 210.27/210.48  |- skos__historyNote mesh__D010435 Pepsinogen %28%1972-1998%29%
% 210.27/210.48  |- mesh__recordOriginator mesh__D010435 NLM
% 210.27/210.48  |- mesh__publicMeSHNote mesh__D010435 99; see Pepsinogen 1972-98   
% 210.27/210.48  |- skos__broader mesh__D010435smesh__D004792
% 210.27/210.48  |- mesh__dateCreated mesh__D010435 1999-01-01
% 210.27/210.48  |- skos__historyNote mesh__D010435 Pepsin %28%1966-1971%29%
% 210.27/210.48  |- mesh__dateEstablished mesh__D010435 1972-01-01
% 210.27/210.48  |- mesh__dateRevised mesh__D010435 2003-07-09
% 210.27/210.48  |- skos__prefLabel mesh__D010435 Pepsinogens
% 210.27/210.48  |- skos__scopeNote mesh__D010435
% 210.27/210.48       Proenzymes secreted by chief cells, mucous neck cells, and pyloric gland cells, which are converted into pepsin in the presence of gastric acid or pepsin itself. %28%Dorland, 28th ed%29% In humans there are 2 related pepsinogen systems: PEPSINOGEN A %28%formerly pepsinogen I or pepsinogen%29% and PEPSINOGEN C %28%formerly pepsinogen II or progastricsin%29%. Pepsinogen B is the name of a pepsinogen from pigs.%A%    
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D010435 2006
% 210.27/210.48  |- mesh__recordMaintainer mesh__D010435 ssb
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D010435 2004
% 210.27/210.48  |- skos__related mesh__D010435smesh__D005750
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D010435 2005
% 210.27/210.48  |- skos__hiddenLabel mesh__D015120 6 Aminonicotinamide
% 210.27/210.48  |- skos__broader mesh__D015120smesh__D009536
% 210.27/210.48  |- mesh__publicMeSHNote mesh__D015120
% 210.27/210.48       91; was see under NICOTINAMIDE 1976-90   
% 210.27/210.48  |- mesh__dateCreated mesh__D015120 1975-07-21
% 210.27/210.48  |- skos__historyNote mesh__D015120 Amines %28%1972-1975%29%
% 210.27/210.48  |- skos__prefLabel mesh__D015120 6-Aminonicotinamide
% 210.27/210.48  |- mesh__dateRevised mesh__D015120 2005-06-30
% 210.27/210.48  |- rdf__type mesh__D015120sskos__Concept
% 210.27/210.48  |- mesh__recordMaintainer mesh__D015120 ssb
% 210.27/210.48  |- mesh__recordOriginator mesh__D015120 RLS
% 210.27/210.48  |- mesh__historyNote mesh__D015120
% 210.27/210.48       91%28%76%29%; was see under NICOTINAMIDE 1976-90   
% 210.27/210.48  |- mesh__recordAuthorizer mesh__D015120 sjn
% 210.27/210.48  |- skos__historyNote mesh__D015120
% 210.27/210.48       Nicotinamide %28%1968-1974%29% /analogs %26% derivatives %28%1975%29%
% 210.27/210.48  |- mesh__dateEstablished mesh__D015120 1991-01-01
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D015120 2006
% 210.27/210.48  |- skos__scopeNote mesh__D015120
% 210.27/210.48       A vitamin antagonist which has teratogenic effects.     
% 210.27/210.48  |- skos__hiddenLabel mesh__D001100 Inflammations, Arachnoid Membrane
% 210.27/210.48  |- rdf__type mesh__D001100sskos__Concept
% 210.27/210.48  |- skos__historyNote mesh__D001100 Brain Diseases %28%1966%29%
% 210.27/210.48  |- mesh__dateRevised mesh__D001100 1999-11-23
% 210.27/210.48  |- mesh__dateCreated mesh__D001100 1999-01-01
% 210.27/210.48  |- mesh__historyNote mesh__D001100 1967   
% 210.27/210.48  |- skos__hiddenLabel mesh__D001100 Arachnoiditides
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D001100 2002
% 210.27/210.48  |- skos__historyNote mesh__D001100 Meningitis %28%1966%29%
% 210.27/210.48  |- skos__broader mesh__D001100smesh__D008581
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D001100 2004
% 210.27/210.48  |- mesh__dateEstablished mesh__D001100 1967-01-01
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D001100 2000A
% 210.27/210.48  |- mesh__recordMaintainer mesh__D001100 ags
% 210.27/210.48  |- mesh__recordAuthorizer mesh__D001100 ags
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D001100 2003
% 210.27/210.48  |- skos__altLabel mesh__D001100 Inflammation, Arachnoid Membrane
% 210.27/210.48  |- skos__altLabel mesh__D001100 Arachnoid Membrane Inflammation
% 210.27/210.48  |- mesh__recordOriginator mesh__D001100 NLM
% 210.27/210.48  |- skos__prefLabel mesh__D001100 Arachnoiditis
% 210.27/210.48  |- skos__scopeNote mesh__D001100
% 210.27/210.48       Acute or chronic inflammation of the arachnoid membrane of the meninges most often involving the spinal cord or base of the brain. This term generally refers to a persistent inflammatory process characterized by thickening of the ARACHNOID membrane and dural adhesions. Associated conditions include prior surgery, infections, trauma, SUBARACHNOID HEMORRHAGE, and chemical irritation. Clinical features vary with the site of inflammation, but include cranial neuropathies, radiculopathies, and myelopathies. %28%From Joynt, Clinical Neurology, 1997, Ch48, p25%29%%A%    
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D001100 2001
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D001100 2006
% 210.27/210.48  |- skos__hiddenLabel mesh__D001100 Arachnoid Membrane Inflammations
% 210.27/210.48  |- mesh__publicMeSHNote mesh__D001100 1967   
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D001100 2000
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D001100 2005
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D020863 2001
% 210.27/210.48  |- skos__altLabel mesh__D020863 Suprasellar Cyst
% 210.27/210.48  |- skos__hiddenLabel mesh__D020863 Cleft Cysts, Rathke%27%s
% 210.27/210.48  |- skos__altLabel mesh__D020863 Rathke%27%s Cleft Cysts
% 210.27/210.48  |- skos__scopeNote mesh__D020863
% 210.27/210.48       Congenital or acquired cysts of the brain, spinal cord, or meninges which may remain stable in size or undergo progressive enlargement.%A%    
% 210.27/210.48  |- skos__hiddenLabel mesh__D020863 Cysts, Rathke Cleft
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D020863 2000
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D020863 2004
% 210.27/210.48  |- skos__hiddenLabel mesh__D020863 Cysts, Suprasellar
% 210.27/210.48  |- rdf__type mesh__D020863sskos__Concept
% 210.27/210.48  |- skos__broader mesh__D020863smesh__D009421
% 210.27/210.48  |- skos__hiddenLabel mesh__D020863 Cyst, Suprasellar
% 210.27/210.48  |- mesh__dateEstablished mesh__D020863 2000-01-01
% 210.27/210.48  |- skos__broader mesh__D020863smesh__D016543
% 210.27/210.48  |- skos__hiddenLabel mesh__D020863 Rathkes Cleft Cysts
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D020863 2003
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D020863 2006
% 210.27/210.48  |- skos__prefLabel mesh__D020863 Central Nervous System Cysts
% 210.27/210.48  |- skos__altLabel mesh__D020863 Cysts, Central Nervous System
% 210.27/210.48  |- skos__annotation mesh__D020863 coord with organ neopl site   
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D020863 2005
% 210.27/210.48  |- mesh__publicMeSHNote mesh__D020863
% 210.27/210.48       2000; for SUPRASELLAR CYST see CRANIOPHARYNGIOMA 1966-1999%A%  
% 210.27/210.48  |- mesh__historyNote mesh__D020863
% 210.27/210.48       2000; for SUPRASELLAR CYST use CRANIOPHARYNGIOMA 1966-1999%A%  
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D020863 2002
% 210.27/210.48  |- skos__hiddenLabel mesh__D020863 Suprasellar Cysts
% 210.27/210.48  |- mesh__dateCreated mesh__D020863 1999-11-03
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D006394 2001
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D006394 2006
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D006394 1996
% 210.27/210.48  |- mesh__dateRevised mesh__D006394 1995-06-08
% 210.27/210.48  |- mesh__publicMeSHNote mesh__D006394 86; was ANGIOSARCOMA 1963-85   
% 210.27/210.48  |- skos__hiddenLabel mesh__D006394 Angiosarcomas
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D006394 2002
% 210.27/210.48  |- skos__prefLabel mesh__D006394 Hemangiosarcoma
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D006394 1997
% 210.27/210.48  |- mesh__recordOriginator mesh__D006394 NLM
% 210.27/210.48  |- skos__broader mesh__D006394smesh__D009383
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D006394 2003
% 210.27/210.48  |- skos__hiddenLabel mesh__D006394 Hemangiosarcomas
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D006394 1998
% 210.27/210.48  |- mesh__recordAuthorizer mesh__D006394 PLS
% 210.27/210.48  |- rdf__type mesh__D006394sskos__Concept
% 210.27/210.48  |- mesh__dateCreated mesh__D006394 1999-01-01
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D006394 2004
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D006394 1999
% 210.27/210.48  |- skos__altLabel mesh__D006394 Angiosarcoma
% 210.27/210.48  |- skos__broader mesh__D006394smesh__D012509
% 210.27/210.48  |- mesh__recordMaintainer mesh__D006394 KEV
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D006394 2000
% 210.27/210.48  |- skos__scopeNote mesh__D006394
% 210.27/210.48       A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. %28%Stedman, 25th ed%29%%A%    
% 210.27/210.48  |- mesh__historyNote mesh__D006394 86; was ANGIOSARCOMA 1963-85   
% 210.27/210.48  |- mesh__onlineNote mesh__D006394
% 210.27/210.48       use HEMANGIOSARCOMA to search ANGIOSARCOMA 1966-85   
% 210.27/210.48  |- skos__annotation mesh__D006394
% 210.27/210.48       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D006394 2005
% 210.27/210.48  |- mesh__dateRevised mesh__D020065 2004-07-07
% 210.27/210.48  |- mesh__recordAuthorizer mesh__D020065 sjn
% 210.27/210.48  |- mesh__publicMeSHNote mesh__D020065 99   
% 210.27/210.48  |- skos__scopeNote mesh__D020065
% 210.27/210.48       A syndrome characterized by the clinical triad of advanced chronic liver disease, pulmonary vascular dilatations, and reduced arterial oxygenation %28%HYPOXEMIA%29% in the absence of intrinsic cardiopulmonary disease. This syndrome is common in the patients with LIVER CIRRHOSIS or portal hypertension %28%HYPERTENSION, PORTAL%29%.%A%    
% 210.27/210.48  |- mesh__dateEstablished mesh__D020065 1999-01-01
% 210.27/210.48  |- skos__hiddenLabel mesh__D020065 Syndromes, Hepatopulmonary
% 210.27/210.48  |- skos__hiddenLabel mesh__D020065 Syndrome, Hepato-Pulmonary
% 210.27/210.48  |- skos__broader mesh__D020065smesh__D008107
% 210.27/210.48  |- mesh__recordMaintainer mesh__D020065 lkt
% 210.27/210.48  |- skos__hiddenLabel mesh__D020065 Hepato Pulmonary Syndrome
% 210.27/210.48  |- mesh__dateCreated mesh__D020065 1998-06-10
% 210.27/210.48  |- mesh__recordOriginator mesh__D020065 NDW
% 210.27/210.48  |- skos__hiddenLabel mesh__D020065 Syndromes, Hepato-Pulmonary
% 210.27/210.48  |- skos__prefLabel mesh__D020065 Hepatopulmonary Syndrome
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D020065 2005
% 210.27/210.48  |- skos__historyNote mesh__D020065 Liver Diseases %28%1982-1998%29%
% 210.27/210.48  |- skos__hiddenLabel mesh__D020065 Hepato-Pulmonary Syndromes
% 210.27/210.48  |- skos__altLabel mesh__D020065 Hepato-Pulmonary Syndrome
% 210.27/210.48  |- mesh__historyNote mesh__D020065 99   
% 210.27/210.48  |- skos__hiddenLabel mesh__D020065 Syndrome, Hepatopulmonary
% 210.27/210.48  |- rdf__type mesh__D020065sskos__Concept
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D020065 2006
% 210.27/210.48  |- skos__hiddenLabel mesh__D020065 Hepatopulmonary Syndromes
% 210.27/210.48  |- skos__altLabel mesh__D014826 Vocal Cord Paresis
% 210.27/210.48  |- skos__altLabel mesh__D014826 Unilateral Paralysis, Vocal Cord
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D014826 2000
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D014826 2006
% 210.27/210.48  |- skos__broader mesh__D014826smesh__D020421
% 210.27/210.48  |- mesh__recordAuthorizer mesh__D014826 ags
% 210.27/210.48  |- skos__hiddenLabel mesh__D014826 Laryngeal Paralyses
% 210.27/210.48  |- skos__broader mesh__D014826smesh__D010243
% 210.27/210.48  |- skos__scopeNote mesh__D014826
% 210.27/210.48       Paralysis of one or both vocal cords, which produces hoarseness or aphonia. This condition may be caused by diseases of the medulla %28%e.g., LATERAL MEDULLARY SYNDROME;%29%, VAGUS NERVE; or recurrent laryngeal nerve. Neuromuscular junction diseases and local myopathic processes may also affect vocal cord function. %28%Adams et al., Principles of Neurology, 6th ed, p1380%29%%A%    
% 210.27/210.48  |- mesh__dateCreated mesh__D014826 1999-01-01
% 210.27/210.48  |- skos__hiddenLabel mesh__D014826 Paralyses, Laryngeal
% 210.27/210.48  |- rdf__type mesh__D014826sskos__Concept
% 210.27/210.48  |- skos__hiddenLabel mesh__D014826 Paralyses, Vocal Cord
% 210.27/210.48  |- skos__hiddenLabel mesh__D014826 Vocal Fold Palsies
% 210.27/210.48  |- skos__altLabel mesh__D014826 Vocal Cord Palsy
% 210.27/210.48  |- skos__hiddenLabel mesh__D014826 Palsy, Vocal Cord
% 210.27/210.48  |- skos__hiddenLabel mesh__D014826 Vocal Cord Paralyses
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D014826 2001
% 210.27/210.48  |- skos__hiddenLabel mesh__D014826 Paresis, Vocal Cord
% 210.27/210.48  |- skos__hiddenLabel mesh__D014826 Paralysis, Laryngeal
% 210.27/210.48  |- skos__hiddenLabel mesh__D014826 Vocal Cord Pareses
% 210.27/210.48  |- skos__hiddenLabel mesh__D014826 Pareses, Vocal Cord
% 210.27/210.48  |- skos__prefLabel mesh__D014826 Vocal Cord Paralysis
% 210.27/210.48  |- skos__hiddenLabel mesh__D014826 Paralysis, Vocal Cord
% 210.27/210.48  |- skos__altLabel mesh__D014826 Total Vocal Cord Paralysis
% 210.27/210.48  |- skos__broader mesh__D014826smesh__D007818
% 210.27/210.48  |- skos__hiddenLabel mesh__D014826 Palsies, Vocal Fold
% 210.27/210.48  |- mesh__recordMaintainer mesh__D014826 ags
% 210.27/210.48  |- skos__hiddenLabel mesh__D014826 Palsy, Vocal Fold
% 210.27/210.48  |- skos__altLabel mesh__D014826 Recurrent Laryngeal Nerve Palsy
% 210.27/210.48  |- skos__annotation mesh__D014826
% 210.27/210.48       coord with RECURRENT LARYNGEAL NERVE if pertinent   
% 210.27/210.48  |- skos__hiddenLabel mesh__D014826 Vocal Cord Palsies
% 210.27/210.48  |- skos__altLabel mesh__D014826 Vocal Cord Paralysis, Unilateral
% 210.27/210.48  |- skos__altLabel mesh__D014826 Vocal Fold Palsy
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D014826 2003
% 210.27/210.48  |- skos__altLabel mesh__D014826 Unilateral Vocal Cord Paralysis
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D014826 2002
% 210.27/210.48  |- skos__hiddenLabel mesh__D014826 Palsies, Vocal Cord
% 210.27/210.48  |- mesh__recordOriginator mesh__D014826 NLM
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D014826 2006A
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D014826 2004
% 210.27/210.48  |- mesh__dateRevised mesh__D014826 2005-07-18
% 210.27/210.48  |- skos__altLabel mesh__D014826 Paralysis, Vocal Cord, Unilateral
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D014826 2005
% 210.27/210.48  |- skos__broader mesh__D014028smesh__D012906
% 210.27/210.48  |- skos__altLabel mesh__D014028 Air Pollution, Tobacco Smoke
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D014028 2000
% 210.27/210.48  |- skos__scopeNote mesh__D014028
% 210.27/210.48       Contamination of the air by tobacco smoke.     
% 210.27/210.48  |- skos__historyNote mesh__D014028 Air Pollution %28%1972-1981%29%
% 210.27/210.48  |- rdf__type mesh__D014028sskos__Concept
% 210.27/210.48  |- mesh__recordMaintainer mesh__D014028 TGC
% 210.27/210.48  |- mesh__dateCreated mesh__D014028 1981-05-19
% 210.27/210.48  |- skos__historyNote mesh__D014028 Ventilation %28%1972-1981%29%
% 210.27/210.48  |- skos__altLabel mesh__D014028 Environmental Tobacco Smoke Pollution
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D014028 1998
% 210.27/210.48  |- mesh__recordOriginator mesh__D014028 EC
% 210.27/210.48  |- mesh__dateRevised mesh__D014028 1996-06-10
% 210.27/210.48  |- skos__historyNote mesh__D014028 Environmental Exposure %28%1972-1981%29%
% 210.27/210.48  |- mesh__dateEstablished mesh__D014028 1982-01-01
% 210.27/210.48  |- skos__annotation mesh__D014028
% 210.27/210.48       note X ref PASSIVE SMOKING; disease caused by passive smoking = disease /etiol, not /chem ind%A%  
% 210.27/210.48  |- mesh__publicMeSHNote mesh__D014028 82   
% 210.27/210.48  |- mesh__historyNote mesh__D014028 82   
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D014028 2004
% 210.27/210.48  |- mesh__recordAuthorizer mesh__D014028 PLS
% 210.27/210.48  |- skos__hiddenLabel mesh__D014028 Smoke Pollution, Tobacco
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D014028 2002
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D014028 2006
% 210.27/210.48  |- skos__altLabel mesh__D014028 Environmental Pollution, Tobacco Smoke
% 210.27/210.48  |- skos__hiddenLabel mesh__D014028 Pollution, Tobacco Smoke
% 210.27/210.48  |- skos__historyNote mesh__D014028 Smoking %28%1972-1981%29%
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D014028 2003
% 210.27/210.48  |- skos__historyNote mesh__D014028
% 210.27/210.48       Air Pollutants, Environmental %28%1975-1981%29%
% 210.27/210.48  |- skos__historyNote mesh__D014028 Smoke %28%1972-1981%29%
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D014028 2001
% 210.27/210.48  |- skos__altLabel mesh__D014028 Passive Smoking
% 210.27/210.48  |- skos__prefLabel mesh__D014028 Tobacco Smoke Pollution
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D014028 2005
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D014028 1997
% 210.27/210.48  |- skos__historyNote mesh__D014028 Air Pollutants %28%1975-1981%29%
% 210.27/210.48  |- skos__altLabel mesh__D014028 Environmental Smoke Pollution, Tobacco
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D014028 1999
% 210.27/210.48  |- skos__hiddenLabel mesh__D000806
% 210.27/210.48       Enzyme Inhibitors, Angiotensin-Converting
% 210.27/210.48  |- skos__altLabel mesh__D000806 Kininase II Inhibitors
% 210.27/210.48  |- skos__prefLabel mesh__D000806 Angiotensin-Converting Enzyme Inhibitors
% 210.27/210.48  |- mesh__dateEstablished mesh__D000806 1988-01-01
% 210.27/210.48  |- skos__hiddenLabel mesh__D000806
% 210.27/210.48       Angiotensin I Converting Enzyme Inhibitors
% 210.27/210.48  |- skos__broader mesh__D000806smesh__D011480
% 210.27/210.48  |- mesh__publicMeSHNote mesh__D000806
% 210.27/210.48       88; ANGIOTENSIN I-CONVERTING ENZYME INHIBITOR was see TEPROTIDE 1991-93%A%  
% 210.27/210.48  |- skos__hiddenLabel mesh__D000806
% 210.27/210.48       Antagonists, Angiotensin Converting Enzyme
% 210.27/210.48  |- skos__altLabel mesh__D000806 Angiotensin-Converting Enzyme Antagonists
% 210.27/210.48  |- mesh__recordOriginator mesh__D000806 RLS
% 210.27/210.48  |- mesh__recordAuthorizer mesh__D000806 sjn
% 210.27/210.48  |- skos__annotation mesh__D000806
% 210.27/210.48       protease inhib %26% antihypertensives; DF: ACE INHIB   
% 210.27/210.48  |- skos__historyNote mesh__D000806
% 210.27/210.48       Kininase II/antagonists %26% inhibitors %28%1973-1987%29%
% 210.27/210.48  |- skos__hiddenLabel mesh__D000806
% 210.27/210.48       Angiotensin Converting Enzyme Antagonists
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D000806 2005
% 210.27/210.48  |- skos__altLabel mesh__D000806 Kininase II Antagonists
% 210.27/210.48  |- rdf__type mesh__D000806sskos__Concept
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D000806 2004
% 210.27/210.48  |- skos__hiddenLabel mesh__D000806 Angiotensin Converting Enzyme Inhibitors
% 210.27/210.48  |- mesh__onlineNote mesh__D000806
% 210.27/210.48       use TEPROTIDE to search ANGIOTENSIN I-CONVERTING ENZYME INHIBITOR 1991-93%A%  
% 210.27/210.48  |- skos__hiddenLabel mesh__D000806
% 210.27/210.48       Enzyme Antagonists, Angiotensin-Converting
% 210.27/210.48  |- mesh__recordMaintainer mesh__D000806 ssb
% 210.27/210.48  |- mesh__historyNote mesh__D000806
% 210.27/210.48       88; ANGIOTENSIN I-CONVERTING ENZYME INHIBITOR was see TEPROTIDE 1991-93%A%  
% 210.27/210.48  |- skos__hiddenLabel mesh__D000806
% 210.27/210.48       Inhibitors, Angiotensin Converting Enzyme
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D000806 2006
% 210.27/210.48  |- skos__altLabel mesh__D000806 Inhibitors, Kininase II
% 210.27/210.48  |- skos__altLabel mesh__D000806 Antagonists, Kininase II
% 210.27/210.48  |- skos__altLabel mesh__D000806 ACE Inhibitors
% 210.27/210.48  |- skos__altLabel mesh__D000806 Inhibitors, Angiotensin-Converting Enzyme
% 210.27/210.48  |- skos__altLabel mesh__D000806 Antagonists, Angiotensin-Converting Enzyme
% 210.27/210.48  |- skos__historyNote mesh__D000806
% 210.27/210.48       Enzymes/antagonists %26% inhibitors %28%1968-1974%29%
% 210.27/210.48  |- skos__altLabel mesh__D000806 Inhibitors, ACE
% 210.27/210.48  |- skos__historyNote mesh__D000806 Enzyme Inhibitors %28%1975-1987%29%
% 210.27/210.48  |- mesh__dateCreated mesh__D000806 1987-05-04
% 210.27/210.48  |- skos__scopeNote mesh__D000806
% 210.27/210.48       A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.%A%    
% 210.27/210.48  |- skos__altLabel mesh__D000806 Angiotensin I-Converting Enzyme Inhibitors
% 210.27/210.48  |- mesh__dateRevised mesh__D000806 2003-07-09
% 210.27/210.48  |- skos__hiddenLabel mesh__D000008 Neoplasms, Abdominal
% 210.27/210.48  |- mesh__recordOriginator mesh__D000008 NLM
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D000008 2001
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D000008 2004
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D000008 2000
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D000008 1999
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D000008 2003
% 210.27/210.48  |- skos__hiddenLabel mesh__D000008 Neoplasm, Abdominal
% 210.27/210.48  |- mesh__dateCreated mesh__D000008 1999-01-01
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D000008 1998
% 210.27/210.48  |- mesh__dateRevised mesh__D000008 1995-06-08
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D000008 1997
% 210.27/210.48  |- skos__annotation mesh__D000008
% 210.27/210.48       general term for neopl of organs in the abdom cavity; prefer specific organ/neopl terms; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl if given %28%IM%29%%A%  
% 210.27/210.48  |- mesh__recordMaintainer mesh__D000008 KEV
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D000008 1996
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D000008 2006
% 210.27/210.48  |- skos__broader mesh__D000008smesh__D009371
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D000008 2002
% 210.27/210.48  |- skos__hiddenLabel mesh__D000008 Abdominal Neoplasm
% 210.27/210.48  |- mesh__recordAuthorizer mesh__D000008 PLS
% 210.27/210.48  |- skos__prefLabel mesh__D000008 Abdominal Neoplasms
% 210.27/210.48  |- rdf__type mesh__D000008sskos__Concept
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D000008 2005
% 210.27/210.48  |- skos__historyNote mesh__D046908 Peptide Biosynthesis %28%1976-2004%29%
% 210.27/210.48  |- skos__hiddenLabel mesh__D046908
% 210.27/210.48       Peptide Biosynthesis, Nucleic Acid Independent
% 210.27/210.48  |- mesh__recordOriginator mesh__D046908 nns
% 210.27/210.48  |- skos__annotation mesh__D046908
% 210.27/210.48       coordinate with specific peptide /biosyn if pertinent   
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D046908 2005
% 210.27/210.48  |- mesh__publicMeSHNote mesh__D046908 2005   
% 210.27/210.48  |- mesh__historyNote mesh__D046908 2005   
% 210.27/210.48  |- skos__hiddenLabel mesh__D046908 Biosynthesis, Extra-Ribosomal Peptide
% 210.27/210.48  |- skos__hiddenLabel mesh__D046908 Non-Ribosomal Peptide Biosynthesis
% 210.27/210.48  |- skos__broader mesh__D046908smesh__D010452
% 210.27/210.48  |- skos__hiddenLabel mesh__D046908 Peptide Biosynthesis, Extraribosomal
% 210.27/210.48  |- skos__hiddenLabel mesh__D046908
% 210.27/210.48       Nucleic Acid Independent Peptide Biosynthesis
% 210.27/210.48  |- skos__altLabel mesh__D046908 Peptide Biosynthesis, Non-Ribosomal
% 210.27/210.48  |- skos__prefLabel mesh__D046908
% 210.27/210.48       Peptide Biosynthesis, Nucleic Acid-Independent
% 210.27/210.48  |- skos__altLabel mesh__D046908
% 210.27/210.48       Nucleic Acid-Independent Peptide Biosynthesis
% 210.27/210.48  |- skos__hiddenLabel mesh__D046908 Extra-Ribosomal Peptide Biosynthesis
% 210.27/210.48  |- skos__altLabel mesh__D046908 Extraribosomal Peptide Biosynthesis
% 210.27/210.48  |- skos__altLabel mesh__D046908 Peptide Biosynthesis, Extra-Ribosomal
% 210.27/210.48  |- mesh__dateEstablished mesh__D046908 2005-01-01
% 210.27/210.48  |- mesh__dateCreated mesh__D046908 2004-07-07
% 210.27/210.48  |- skos__hiddenLabel mesh__D046908 Peptide Biosynthesis, Non Ribosomal
% 210.27/210.48  |- skos__hiddenLabel mesh__D046908 Peptide Biosynthesis, Extra Ribosomal
% 210.27/210.48  |- skos__historyNote mesh__D046908
% 210.27/210.48       specific peptide/biosynthesis %28%1969-2004%29%
% 210.27/210.48  |- skos__altLabel mesh__D046908 Nonribosomal Peptide Biosynthesis
% 210.27/210.48  |- rdf__type mesh__D046908sskos__Concept
% 210.27/210.48  |- skos__hiddenLabel mesh__D046908 Peptide Biosynthesis, Nonribosomal
% 210.27/210.48  |- mesh__recordMaintainer mesh__D046908 nns
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D046908 2006
% 210.27/210.48  |- skos__scopeNote mesh__D046908
% 210.27/210.48       The enzymatic synthesis of PEPTIDES without an RNA template by processes that do not use the ribosomal apparatus %28%RIBOSOMES%29%.%A%    
% 210.27/210.48  |- mesh__recordAuthorizer mesh__D046908 sjn
% 210.27/210.48  |- skos__annotation mesh__D018419
% 210.27/210.48       animal only, not man; GEN or unspecified; prefer specifics; coord IM with specific dis /vet %28%IM%29%; for abnormalities or injuries, index under specific primate heading /abnorm or /inj; don%27%t forget also PRIMATES %28%NIM%29% if no specific primate is indexed; also check tag ANIMALS; DF: PRIMATE DIS%A%  
% 210.27/210.48  |- mesh__dateEstablished mesh__D018419 1995-01-01
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D018419 2006
% 210.27/210.48  |- rdf__type mesh__D018419sskos__Concept
% 210.27/210.48  |- skos__prefLabel mesh__D018419 Primate Diseases
% 210.27/210.48  |- mesh__historyNote mesh__D018419 95   
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D018419 2005
% 210.27/210.48  |- skos__scopeNote mesh__D018419
% 210.27/210.48       Diseases of animals within the order PRIMATES. This term includes diseases of Haplorhini and Strepsirhini.%A%    
% 210.27/210.48  |- skos__hiddenLabel mesh__D018419 Diseases, Primate
% 210.27/210.48  |- mesh__dateCreated mesh__D018419 1994-01-25
% 210.27/210.48  |- mesh__dateRevised mesh__D018419 2003-07-30
% 210.27/210.48  |- mesh__publicMeSHNote mesh__D018419 95   
% 210.27/210.48  |- mesh__recordAuthorizer mesh__D018419 sjn
% 210.27/210.48  |- skos__broader mesh__D018419smesh__D000820
% 210.27/210.48  |- skos__hiddenLabel mesh__D018419 Primate Disease
% 210.27/210.48  |- skos__hiddenLabel mesh__D018419 Disease, Primate
% 210.27/210.48  |- mesh__recordOriginator mesh__D018419 PXP
% 210.27/210.48  |- mesh__recordMaintainer mesh__D018419 ags
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D018419 2004
% 210.27/210.48  |- mesh__recordAuthorizer mesh__D010436 PLS
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D010436 1999
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D010436 2006
% 210.27/210.48  |- mesh__recordMaintainer mesh__D010436 JRT
% 210.27/210.48  |- skos__historyNote mesh__D010436 Oligopeptides %28%1973-1974%29%
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D010436 1997
% 210.27/210.48  |- mesh__publicMeSHNote mesh__D010436
% 210.27/210.48       91; was see under OLIGOPEPTIDES 1975-90   
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D010436 2001
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D010436 2004
% 210.27/210.48  |- mesh__historyNote mesh__D010436
% 210.27/210.48       91%28%75%29%; was see under OLIGOPEPTIDES 1975-90   
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D010436 1998
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D010436 2000
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D010436 2005
% 210.27/210.48  |- mesh__activeMeSHYear mesh__D010436 1996
% 210.27/210.48  |- rdf__type mesh__D010436sskos__Concept
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D010436 2003
% 210.27/210.49  |- skos__scopeNote mesh__D010436
% 210.27/210.49       N-acylated oligopeptides isolated from culture filtrates of Actinomycetes, which act specifically to inhibit acid proteases such as pepsin and renin.%A%    
% 210.27/210.49  |- mesh__recordOriginator mesh__D010436 NLM
% 210.27/210.49  |- mesh__dateRevised mesh__D010436 1995-06-08
% 210.27/210.49  |- skos__prefLabel mesh__D010436 Pepstatins
% 210.27/210.49  |- mesh__dateEstablished mesh__D010436 1991-01-01
% 210.27/210.49  |- skos__annotation mesh__D010436 protease inhib   
% 210.27/210.49  |- mesh__dateCreated mesh__D010436 1974-11-19
% 210.27/210.49  |- skos__broader mesh__D010436smesh__D009842
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D010436 2002
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D029141 2004
% 210.27/210.49  |- skos__broader mesh__D029141smesh__D012209
% 210.27/210.49  |- skos__altLabel mesh__D029141 Egtved virus
% 210.27/210.49  |- skos__hiddenLabel mesh__D029141 Novirhabdoviruses
% 210.27/210.49  |- skos__annotation mesh__D029141
% 210.27/210.49       infection: coord IM with RHABDOVIRIDAE INFECTIONS %28%IM%29%   
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D029141 2002
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D029141 2005
% 210.27/210.49  |- skos__scopeNote mesh__D029141
% 210.27/210.49       A genus in the family RHABDOVIRIDAE, infecting numerous species of fish with broad geographic distribution. The type species is INFECTIOUS HEMATOPOIETIC NECROSIS VIRUS.%A%    
% 210.27/210.49  |- skos__hiddenLabel mesh__D029141 rhabdovirus, Hirame
% 210.27/210.49  |- mesh__publicMeSHNote mesh__D029141 2002   
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D029141 2006
% 210.27/210.49  |- skos__altLabel mesh__D029141 Hemorrhagic Septicemia Virus, Viral
% 210.27/210.49  |- mesh__dateCreated mesh__D029141 2001-07-25
% 210.27/210.49  |- skos__prefLabel mesh__D029141 Novirhabdovirus
% 210.27/210.49  |- mesh__historyNote mesh__D029141 2002   
% 210.27/210.49  |- rdf__type mesh__D029141sskos__Concept
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D029141 2003
% 210.27/210.49  |- mesh__dateEstablished mesh__D029141 2002-01-01
% 210.27/210.49  |- skos__hiddenLabel mesh__D015121 F1 alpha, 6-Ketoprostaglandin
% 210.27/210.49  |- mesh__historyNote mesh__D015121 82   
% 210.27/210.49  |- rdf__type mesh__D015121sskos__Concept
% 210.27/210.49  |- skos__hiddenLabel mesh__D015121 alpha, 6-Ketoprostaglandin F1
% 210.27/210.49  |- mesh__publicMeSHNote mesh__D015121 82   
% 210.27/210.49  |- skos__broader mesh__D015121smesh__D005229
% 210.27/210.49  |- skos__altLabel mesh__D015121 6-Oxo-PGF1 alpha
% 210.27/210.49  |- skos__historyNote mesh__D015121 Prostaglandins F %28%1975-1981%29%
% 210.27/210.49  |- skos__altLabel mesh__D015121 6 Ketoprostaglandin F1 alpha
% 210.27/210.49  |- skos__hiddenLabel mesh__D015121 alpha, 6-Oxo-PGF1
% 210.27/210.49  |- skos__hiddenLabel mesh__D015121 alpha, 6-Oxoprostaglandin F1
% 210.27/210.49  |- skos__hiddenLabel mesh__D015121 6 Oxoprostaglandin F1 alpha
% 210.27/210.49  |- mesh__dateEstablished mesh__D015121 1982-01-01
% 210.27/210.49  |- skos__broader mesh__D015121smesh__D011460
% 210.27/210.49  |- mesh__dateRevised mesh__D015121 2005-06-30
% 210.27/210.49  |- skos__hiddenLabel mesh__D015121 alpha, 6-Keto-PGF1
% 210.27/210.49  |- skos__hiddenLabel mesh__D015121 6 Keto PGF1 alpha
% 210.27/210.49  |- mesh__recordOriginator mesh__D015121 RLS
% 210.27/210.49  |- skos__prefLabel mesh__D015121 6-Ketoprostaglandin F1 alpha
% 210.27/210.49  |- skos__altLabel mesh__D015121 6-Oxoprostaglandin F1 alpha
% 210.27/210.49  |- skos__altLabel mesh__D015121 6-Keto-PGF1 alpha
% 210.27/210.49  |- mesh__recordMaintainer mesh__D015121 ssb
% 210.27/210.49  |- skos__hiddenLabel mesh__D015121 6 Oxo PGF1 alpha
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D015121 2006
% 210.27/210.49  |- skos__historyNote mesh__D015121 Prostaglandins %28%1966-1974%29%
% 210.27/210.49  |- mesh__recordAuthorizer mesh__D015121 sjn
% 210.27/210.49  |- skos__annotation mesh__D015121
% 210.27/210.49       a prostaglandin F; /biosyn /physiol permitted; DF: note short X ref%A%  
% 210.27/210.49  |- skos__hiddenLabel mesh__D015121 F1 alpha, 6-Oxoprostaglandin
% 210.27/210.49  |- mesh__dateCreated mesh__D015121 1981-05-12
% 210.27/210.49  |- skos__scopeNote mesh__D015121
% 210.27/210.49       The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue.%A%    
% 210.27/210.49  |- mesh__dateEstablished mesh__D001101 1991-01-01
% 210.27/210.49  |- mesh__onlineNote mesh__D001101
% 210.27/210.49       use ARBAPROSTIL to search 15-METHYLPROSTAGLANDIN E2 METHYL ESTER %26% METHYLDINOPROSTONE 1980-93%A%  
% 210.27/210.49  |- mesh__recordAuthorizer mesh__D001101 sjn
% 210.27/210.49  |- skos__hiddenLabel mesh__D001101 15 Methylprostaglandin E2
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D001101 2006
% 210.27/210.49  |- mesh__dateCreated mesh__D001101 1979-05-23
% 210.27/210.49  |- skos__hiddenLabel mesh__D001101 U42842
% 210.27/210.49  |- skos__hiddenLabel mesh__D001101 U 42842
% 210.27/210.49  |- skos__altLabel mesh__D001101 15-Methylprostaglandin E2
% 210.27/210.49  |- mesh__dateRevised mesh__D001101 2005-06-30
% 210.27/210.49  |- skos__historyNote mesh__D001101 Prostaglandins, Synthetic %28%1977%29%
% 210.27/210.49  |- skos__prefLabel mesh__D001101 Arbaprostil
% 210.27/210.49  |- skos__broader mesh__D001101smesh__D011459
% 210.27/210.49  |- skos__historyNote mesh__D001101
% 210.27/210.49       Prostaglandins E, Synthetic %28%1978-1979%29%
% 210.27/210.49  |- mesh__recordMaintainer mesh__D001101 ssb
% 210.27/210.49  |- rdf__type mesh__D001101sskos__Concept
% 210.27/210.49  |- skos__historyNote mesh__D001101 Prostaglandins %28%1966-1974%29%
% 210.27/210.49  |- mesh__publicMeSHNote mesh__D001101
% 210.27/210.49       91; was see under PROSTAGLANDINS E, SYNTHETIC 1980-90; 15-METHYLPROSTAGLANDIN E2 METHYL ESTER %26% METHYLDINOPROSTONE were see ARBAPROSTIL 1980-93%A%  
% 210.27/210.49  |- mesh__historyNote mesh__D001101
% 210.27/210.49       91%28%80%29%; was see under PROSTAGLANDINS E, SYNTHETIC 1980-90; 15-METHYLPROSTAGLANDIN E2 METHYL ESTER %26% METHYLDINOPROSTONE were see ARBAPROSTIL 1980-93%A%  
% 210.27/210.49  |- mesh__recordOriginator mesh__D001101 RLS
% 210.27/210.49  |- skos__historyNote mesh__D001101 Prostaglandins E %28%1975-1977%29%
% 210.27/210.49  |- skos__scopeNote mesh__D001101
% 210.27/210.49       A synthetic prostaglandin E analog that protects the gastric mucosa, prevents ulceration, and promotes healing of peptic ulcers. The protective effect is independent of acid inhibition. It is also a potent inhibitor of pancreatic function and can inhibit the growth of experimental tumors.%A%    
% 210.27/210.49  |- skos__scopeNote mesh__D020864
% 210.27/210.49       CALCIUM CHANNELS that are concentrated in neural tissue. Omega toxins inhibit the actions of these channels by altering their voltage dependence.%A%    
% 210.27/210.49  |- skos__hiddenLabel mesh__D020864 Calcium Channels, Neural-Type
% 210.27/210.49  |- skos__hiddenLabel mesh__D020864 N Type Calcium Channels
% 210.27/210.49  |- mesh__dateCreated mesh__D020864 1999-11-03
% 210.27/210.49  |- rdf__type mesh__D020864sskos__Concept
% 210.27/210.49  |- skos__hiddenLabel mesh__D020864 Channels, N-Type Calcium
% 210.27/210.49  |- skos__altLabel mesh__D020864 N-Type VDCC
% 210.27/210.49  |- mesh__dateEstablished mesh__D020864 2000-01-01
% 210.27/210.49  |- skos__hiddenLabel mesh__D020864 N Type Calcium Channel
% 210.27/210.49  |- skos__altLabel mesh__D020864 N-Type Calcium Channel
% 210.27/210.49  |- mesh__recordAuthorizer mesh__D020864 sjn
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D020864 2006
% 210.27/210.49  |- skos__hiddenLabel mesh__D020864 Neural Type Calcium Channels
% 210.27/210.49  |- mesh__recordOriginator mesh__D020864 adp
% 210.27/210.49  |- skos__hiddenLabel mesh__D020864 VDCC, N-Type
% 210.27/210.49  |- mesh__dateRevised mesh__D020864 2005-06-30
% 210.27/210.49  |- skos__hiddenLabel mesh__D020864 N Type VDCC
% 210.27/210.49  |- mesh__historyNote mesh__D020864 2000   
% 210.27/210.49  |- skos__annotation mesh__D020864 DF: VDCC N   
% 210.27/210.49  |- skos__prefLabel mesh__D020864 Calcium Channels, N-Type
% 210.27/210.49  |- skos__historyNote mesh__D020864 Calcium Channels %28%1990-1999%29%
% 210.27/210.49  |- skos__hiddenLabel mesh__D020864 Channel, N-Type Calcium
% 210.27/210.49  |- skos__altLabel mesh__D020864 N-Type Voltage-Dependent Calcium Channels
% 210.27/210.49  |- skos__broader mesh__D020864smesh__D015220
% 210.27/210.49  |- skos__altLabel mesh__D020864 N-Type Calcium Channels
% 210.27/210.49  |- skos__hiddenLabel mesh__D020864 Channels, Neural-Type Calcium
% 210.27/210.49  |- skos__altLabel mesh__D020864 Neural-Type Calcium Channels
% 210.27/210.49  |- skos__hiddenLabel mesh__D020864 Calcium Channel, N-Type
% 210.27/210.49  |- skos__hiddenLabel mesh__D020864
% 210.27/210.49       N Type Voltage Dependent Calcium Channels
% 210.27/210.49  |- skos__hiddenLabel mesh__D020864 Calcium Channels, N Type
% 210.27/210.49  |- mesh__publicMeSHNote mesh__D020864 2000   
% 210.27/210.49  |- mesh__recordMaintainer mesh__D020864 SYSTEM
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D006395 2003
% 210.27/210.49  |- skos__hiddenLabel mesh__D006395 Hemarthroses
% 210.27/210.49  |- skos__broader mesh__D006395smesh__D007592
% 210.27/210.49  |- skos__broader mesh__D006395smesh__D006470
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D006395 2000
% 210.27/210.49  |- rdf__type mesh__D006395sskos__Concept
% 210.27/210.49  |- mesh__dateCreated mesh__D006395 1999-01-01
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D006395 2004
% 210.27/210.49  |- mesh__publicMeSHNote mesh__D006395 67   
% 210.27/210.49  |- skos__prefLabel mesh__D006395 Hemarthrosis
% 210.27/210.49  |- mesh__recordMaintainer mesh__D006395 KEV
% 210.27/210.49  |- mesh__recordAuthorizer mesh__D006395 sjn
% 210.27/210.49  |- mesh__dateRevised mesh__D006395 1999-11-03
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D006395 2001
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D006395 2005
% 210.27/210.49  |- mesh__historyNote mesh__D006395 67%28%64%29%   
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D006395 2002
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D006395 2006
% 210.27/210.49  |- mesh__dateEstablished mesh__D006395 1967-01-01
% 210.27/210.49  |- mesh__recordOriginator mesh__D006395 NLM
% 210.27/210.49  |- skos__scopeNote mesh__D006395
% 210.27/210.49       Bleeding into the joints. It may arise from trauma or spontaneously in patients with hemophilia.%A%    
% 210.27/210.49  |- mesh__historyNote mesh__D020066
% 210.27/210.49       99; use PLASMODIUM FALCIPARUM MEROZOITE PRECURSOR SURFACE COAT PROTEIN %28%NM%29% 1987-98%A%  
% 210.27/210.49  |- skos__altLabel mesh__D020066 MSA1
% 210.27/210.49  |- skos__prefLabel mesh__D020066 Merozoite Surface Protein 1
% 210.27/210.49  |- mesh__dateCreated mesh__D020066 1998-06-10
% 210.27/210.49  |- skos__scopeNote mesh__D020066
% 210.27/210.49       A surface protein found on Plasmodium species which induces a T-cell response. The antigen is polymorphic, sharing amino acid sequence homology among PLASMODIUM FALCIPARUM; PLASMODIUM CHABAUDI; PLASMODIUM VIVAX; and PLASMODIUM YOELII.%A%    
% 210.27/210.49  |- mesh__recordMaintainer mesh__D020066 ssb
% 210.27/210.49  |- mesh__publicMeSHNote mesh__D020066
% 210.27/210.49       99; PLASMODIUM FALCIPARUM MEROZOITE PRECURSOR SURFACE COAT PROTEIN %28%now MEROZOITE SURFACE PROTEIN 1%29% was indexed under PROTOZOAN PROTEINS 1990-98 and ANTIGENS, PROTOZOAN 1987-89%A%  
% 210.27/210.49  |- skos__altLabel mesh__D020066 MSP1
% 210.27/210.49  |- skos__altLabel mesh__D020066 MSA-1
% 210.27/210.49  |- skos__altLabel mesh__D020066 Merozoite Surface Protein-1
% 210.27/210.49  |- skos__altLabel mesh__D020066 PFM-PSCP
% 210.27/210.49  |- skos__altLabel mesh__D020066 MSA-1 Protein
% 210.27/210.49  |- mesh__dateRevised mesh__D020066 2005-06-30
% 210.27/210.49  |- skos__altLabel mesh__D020066 Major Merozoite Surface Protein Precursor
% 210.27/210.49  |- mesh__recordOriginator mesh__D020066 NDW
% 210.27/210.49  |- mesh__recordAuthorizer mesh__D020066 sjn
% 210.27/210.49  |- rdf__type mesh__D020066sskos__Concept
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D020066 2006
% 210.27/210.49  |- skos__altLabel mesh__D020066 PMMSA
% 210.27/210.49  |- skos__hiddenLabel mesh__D020066 P. vivax MSP1
% 210.27/210.49  |- mesh__dateEstablished mesh__D020066 1999-01-01
% 210.27/210.49  |- skos__broader mesh__D020066smesh__D015800
% 210.27/210.49  |- skos__historyNote mesh__D020066 Antigens, Protozoan %28%1985-1989%29%
% 210.27/210.49  |- skos__hiddenLabel mesh__D020066 MSA 1 Protein
% 210.27/210.49  |- skos__altLabel mesh__D020066
% 210.27/210.49       Plasmodium falciparum Merozoite Precursor Surface Coat Protein
% 210.27/210.49  |- skos__annotation mesh__D020066
% 210.27/210.49       coord IM with specific PLASMODIUM species   
% 210.27/210.49  |- skos__altLabel mesh__D020066 MSP-1
% 210.27/210.49  |- skos__historyNote mesh__D020066 Protozoan Proteins %28%1990-1998%29%
% 210.27/210.49  |- skos__altLabel mesh__D020066 Merozoite Surface Antigen 1
% 210.27/210.49  |- skos__broader mesh__D020066smesh__D000953
% 210.27/210.49  |- skos__hiddenLabel mesh__D020066 Surface Protein-1, Merozoite
% 210.27/210.49  |- skos__hiddenLabel mesh__D020066 Protein, MSA1
% 210.27/210.49  |- skos__hiddenLabel mesh__D020066 Protein, MSA-1
% 210.27/210.49  |- skos__altLabel mesh__D020066 MSA1 Protein
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014827 1999
% 210.27/210.49  |- mesh__recordAuthorizer mesh__D014827 PLS
% 210.27/210.49  |- skos__annotation mesh__D014827 inflammation = LARYNGITIS   
% 210.27/210.49  |- mesh__recordMaintainer mesh__D014827 TGC
% 210.27/210.49  |- skos__hiddenLabel mesh__D014827 Folds, Vocal
% 210.27/210.49  |- skos__hiddenLabel mesh__D014827 Vocal Cord
% 210.27/210.49  |- mesh__dateRevised mesh__D014827 1991-01-08
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014827 2002
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014827 1994
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014827 1997
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014827 1992
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014827 2006
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014827 1998
% 210.27/210.49  |- skos__prefLabel mesh__D014827 Vocal Cords
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014827 2004
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014827 1996
% 210.27/210.49  |- mesh__dateCreated mesh__D014827 1999-01-01
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014827 2005
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014827 2001
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014827 2003
% 210.27/210.49  |- skos__hiddenLabel mesh__D014827 Cords, Vocal
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014827 2000
% 210.27/210.49  |- skos__hiddenLabel mesh__D014827 Cord, Vocal
% 210.27/210.49  |- mesh__recordOriginator mesh__D014827 NLM
% 210.27/210.49  |- rdf__type mesh__D014827sskos__Concept
% 210.27/210.49  |- skos__scopeNote mesh__D014827
% 210.27/210.49       The folds of mucous membrane along either wall of the larynx from the angle between the laminae of the thyroid cartilage to the vocal process of the arytenoid cartilage.%A%    
% 210.27/210.49  |- skos__altLabel mesh__D014827 Vocal Fold
% 210.27/210.49  |- skos__hiddenLabel mesh__D014827 Fold, Vocal
% 210.27/210.49  |- skos__hiddenLabel mesh__D014827 Vocal Folds
% 210.27/210.49  |- skos__broader mesh__D014827smesh__D005931
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014827 1995
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014827 1993
% 210.27/210.49  |- skos__hiddenLabel mesh__D014029 Nicotine Use Disorders
% 210.27/210.49  |- rdf__type mesh__D014029sskos__Concept
% 210.27/210.49  |- skos__annotation mesh__D014029
% 210.27/210.49       includes cigarettes, cigars, chewing tobacco %26% snuff; a psychiatric diag: do not confuse with SMOKING /adv eff; note X ref NICOTINE DEPENDENCE: do not coord with NICOTINE unless nicotine is substantially discussed as a chemical%A%  
% 210.27/210.49  |- skos__hiddenLabel mesh__D014029 Disorder, Nicotine Use
% 210.27/210.49  |- mesh__dateRevised mesh__D014029 1999-11-03
% 210.27/210.49  |- skos__historyNote mesh__D014029 Smoking %28%1966-1980%29%
% 210.27/210.49  |- mesh__publicMeSHNote mesh__D014029 81   
% 210.27/210.49  |- mesh__recordOriginator mesh__D014029 EC
% 210.27/210.49  |- mesh__recordAuthorizer mesh__D014029 sjn
% 210.27/210.49  |- skos__hiddenLabel mesh__D014029 Dependence, Tobacco
% 210.27/210.49  |- skos__hiddenLabel mesh__D014029 Dependence, Nicotine
% 210.27/210.49  |- skos__prefLabel mesh__D014029 Tobacco Use Disorder
% 210.27/210.49  |- skos__hiddenLabel mesh__D014029 Use Disorder, Nicotine
% 210.27/210.49  |- skos__hiddenLabel mesh__D014029 Tobacco Use Disorders
% 210.27/210.49  |- mesh__historyNote mesh__D014029 81   
% 210.27/210.49  |- mesh__recordMaintainer mesh__D014029 adp
% 210.27/210.49  |- skos__broader mesh__D014029smesh__D019966
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014029 2002
% 210.27/210.49  |- mesh__dateCreated mesh__D014029 1980-05-21
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014029 2004
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014029 2001
% 210.27/210.49  |- mesh__dateEstablished mesh__D014029 1981-01-01
% 210.27/210.49  |- skos__hiddenLabel mesh__D014029 Tobacco Dependences
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014029 2003
% 210.27/210.49  |- skos__altLabel mesh__D014029 Tobacco-Use Disorder
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014029 2006
% 210.27/210.49  |- skos__related mesh__D014029smesh__D016540
% 210.27/210.49  |- skos__hiddenLabel mesh__D014029 Disorder, Tobacco-Use
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014029 2000
% 210.27/210.49  |- skos__scopeNote mesh__D014029
% 210.27/210.49       Tobacco used to the detriment of a person%27%s health or social functioning. Tobacco dependence is included.%A%    
% 210.27/210.49  |- skos__hiddenLabel mesh__D014029 Disorder, Tobacco Use
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D014029 2005
% 210.27/210.49  |- skos__broader mesh__D019512smesh__D020751
% 210.27/210.49  |- skos__historyNote mesh__D019512 Alcoholism %28%1966-1996%29%
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D019512 2005
% 210.27/210.49  |- mesh__dateCreated mesh__D019512 1996-06-19
% 210.27/210.49  |- rdf__type mesh__D019512sskos__Concept
% 210.27/210.49  |- skos__annotation mesh__D019512
% 210.27/210.49       usually chronic so do not coord with CHRONIC DISEASE   
% 210.27/210.49  |- mesh__historyNote mesh__D019512 97   
% 210.27/210.49  |- mesh__dateEstablished mesh__D019512 1997-01-01
% 210.27/210.49  |- skos__historyNote mesh__D019512 Pancreatitis %28%1966-1996%29%
% 210.27/210.49  |- mesh__publicMeSHNote mesh__D019512 97   
% 210.27/210.49  |- skos__broader mesh__D019512smesh__D010195
% 210.27/210.49  |- mesh__dateRevised mesh__D019512 2004-07-07
% 210.27/210.49  |- mesh__recordAuthorizer mesh__D019512 sjn
% 210.27/210.49  |- skos__scopeNote mesh__D019512
% 210.27/210.49       Acute or chronic INFLAMMATION of the PANCREAS due to excessive ALCOHOL DRINKING. Alcoholic pancreatitis usually presents as an acute episode but it is a chronic progressive disease in alcoholics.%A%    
% 210.27/210.49  |- skos__altLabel mesh__D019512 Alcoholic Pancreatitis
% 210.27/210.49  |- mesh__recordOriginator mesh__D019512 PXP
% 210.27/210.49  |- skos__prefLabel mesh__D019512 Pancreatitis, Alcoholic
% 210.27/210.49  |- mesh__recordMaintainer mesh__D019512 lkt
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D019512 2006
% 210.27/210.49  |- mesh__onlineNote mesh__D000009
% 210.27/210.49       use ABDOMINAL MUSCLES to search ABDOMINAL WALL 1966-92   
% 210.27/210.49  |- skos__broader mesh__D000009smesh__D018482
% 210.27/210.49  |- mesh__publicMeSHNote mesh__D000009 93; was ABDOMINAL WALL 1963-92   
% 210.27/210.49  |- skos__related mesh__D000009smesh__D034861
% 210.27/210.49  |- mesh__recordMaintainer mesh__D000009 ags
% 210.27/210.49  |- skos__hiddenLabel mesh__D000009 Abdominal Muscle
% 210.27/210.49  |- skos__prefLabel mesh__D000009 Abdominal Muscles
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D000009 2006
% 210.27/210.49  |- skos__hiddenLabel mesh__D000009 Muscle, Abdominal
% 210.27/210.49  |- mesh__recordOriginator mesh__D000009 NLM
% 210.27/210.49  |- rdf__type mesh__D000009sskos__Concept
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D000009 2005
% 210.27/210.49  |- mesh__dateRevised mesh__D000009 2002-07-02
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D000009 2004
% 210.27/210.49  |- skos__scopeNote mesh__D000009
% 210.27/210.49       Muscles forming the ABDOMINAL WALL including RECTUS ABDOMINIS, external and internal oblique muscles, transversus abdominis, and quadratus abdominis. %28%from Stedman, 25th ed%29%%A%    
% 210.27/210.49  |- mesh__recordAuthorizer mesh__D000009 sjn
% 210.27/210.49  |- skos__annotation mesh__D000009
% 210.27/210.49       RECTUS ABDOMINIS is available; hernia = HERNIA, VENTRAL; /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 210.27/210.49  |- mesh__historyNote mesh__D000009 93; was ABDOMINAL WALL 1966-92   
% 210.27/210.49  |- skos__hiddenLabel mesh__D000009 Muscles, Abdominal
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D000009 2003
% 210.27/210.49  |- mesh__dateCreated mesh__D000009 1999-01-01
% 210.27/210.49  |- mesh__dateRevised mesh__D010437 2003-07-09
% 210.27/210.49  |- skos__hiddenLabel mesh__D010437 Ulcers, Gastroduodenal
% 210.27/210.49  |- skos__broader mesh__D010437smesh__D013272
% 210.27/210.49  |- skos__altLabel mesh__D010437 Gastroduodenal Ulcer
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D010437 2006
% 210.27/210.49  |- skos__broader mesh__D010437smesh__D004378
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D010437 2004
% 210.27/210.49  |- mesh__recordMaintainer mesh__D010437 lkt
% 210.27/210.49  |- skos__hiddenLabel mesh__D010437 Ulcer, Marginal
% 210.27/210.49  |- skos__scopeNote mesh__D010437
% 210.27/210.49       Ulcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs %28%NSAIDS%29%.%A%    
% 210.27/210.49  |- skos__hiddenLabel mesh__D010437 Ulcers, Marginal
% 210.27/210.49  |- skos__hiddenLabel mesh__D010437 Peptic Ulcers
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D010437 2005
% 210.27/210.49  |- rdf__type mesh__D010437sskos__Concept
% 210.27/210.49  |- skos__hiddenLabel mesh__D010437 Ulcers, Peptic
% 210.27/210.49  |- mesh__publicMeSHNote mesh__D010437
% 210.27/210.49       MARGINAL ULCER was heading 1964-96 %28%see under PEPTIC ULCER 1964-90%29%%A%  
% 210.27/210.49  |- skos__related mesh__D010437smesh__D015043
% 210.27/210.49  |- skos__related mesh__D010437smesh__D005743
% 210.27/210.49  |- skos__related mesh__D010437smesh__D010438
% 210.27/210.49  |- skos__annotation mesh__D010437
% 210.27/210.49       GEN: prefer STOMACH ULCER or DUODENAL ULCER but note GASTRODUODENAL ULCER = PEPTIC ULCER; stress ulcer: coord with STRESS or STRESS, PSYCHOLOGICAL %28%IM or NIM%29%%A%  
% 210.27/210.49  |- skos__hiddenLabel mesh__D010437 Marginal Ulcers
% 210.27/210.49  |- skos__hiddenLabel mesh__D010437 Gastroduodenal Ulcers
% 210.27/210.49  |- skos__hiddenLabel mesh__D010437 Ulcer, Gastroduodenal
% 210.27/210.49  |- mesh__recordAuthorizer mesh__D010437 sjn
% 210.27/210.49  |- skos__prefLabel mesh__D010437 Peptic Ulcer
% 210.27/210.49  |- mesh__historyNote mesh__D010437
% 210.27/210.49       MARGINAL ULCER was heading 1964-96 %28%see under PEPTIC ULCER 1964-90%29%%A%  
% 210.27/210.49  |- mesh__dateCreated mesh__D010437 1999-01-01
% 210.27/210.49  |- skos__broader mesh__D010437smesh__D005767
% 210.27/210.49  |- mesh__recordOriginator mesh__D010437 NLM
% 210.27/210.49  |- skos__related mesh__D010437smesh__D000897
% 210.27/210.49  |- skos__hiddenLabel mesh__D010437 Ulcer, Peptic
% 210.27/210.49  |- mesh__historyNote mesh__D029142 2002   
% 210.27/210.49  |- skos__prefLabel mesh__D029142 Infectious hematopoietic necrosis virus
% 210.27/210.49  |- skos__scopeNote mesh__D029142
% 210.27/210.49       The type species of NOVIRHABDOVIRUS, in the family RHABDOVIRIDAE. It is a major pathogen of TROUT and SALMON.%A%    
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D029142 2005
% 210.27/210.49  |- skos__broader mesh__D029142smesh__D029141
% 210.27/210.49  |- mesh__publicMeSHNote mesh__D029142 2002   
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D029142 2006
% 210.27/210.49  |- skos__annotation mesh__D029142
% 210.27/210.49       do not confuse with INFECTIOUS HYPODERMAL AND HEMATOPOIETIC NECROSIS VIRUS see DENSOVIRINAE; infection: coord IM with RHABDOVIRIDAE INFECTIONS %28%IM%29%%A%  
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D029142 2002
% 210.27/210.49  |- skos__historyNote mesh__D029142 RNA Viruses %28%1973-1975%29%
% 210.27/210.49  |- skos__altLabel mesh__D029142 IHNV
% 210.27/210.49  |- rdf__type mesh__D029142sskos__Concept
% 210.27/210.49  |- mesh__dateEstablished mesh__D029142 2002-01-01
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D029142 2003
% 210.27/210.49  |- skos__historyNote mesh__D029142 Rhabdoviridae %28%1981-2001%29%
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D029142 2004
% 210.27/210.49  |- mesh__dateCreated mesh__D029142 2001-07-25
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D015920 2006
% 210.27/210.49  |- mesh__recordAuthorizer mesh__D015920 sjn
% 210.27/210.49  |- skos__broader mesh__D015920smesh__D004864
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D015920 2005
% 210.27/210.49  |- mesh__dateCreated mesh__D015920 1989-05-15
% 210.27/210.49  |- skos__historyNote mesh__D015920
% 210.27/210.49       Air Pollutants, Occupational %28%1975-1989%29%
% 210.27/210.49  |- skos__hiddenLabel mesh__D015920 Scavengers, Anesthetic Gas
% 210.27/210.49  |- mesh__publicMeSHNote mesh__D015920 90   
% 210.27/210.49  |- mesh__historyNote mesh__D015920 90   
% 210.27/210.49  |- mesh__recordOriginator mesh__D015920 PLS
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D015920 2004
% 210.27/210.49  |- skos__hiddenLabel mesh__D015920 Scavengers, Gas
% 210.27/210.49  |- skos__hiddenLabel mesh__D015920 Gas Scavenger
% 210.27/210.49  |- skos__hiddenLabel mesh__D015920 Anesthetic Gas Scavenger
% 210.27/210.49  |- skos__hiddenLabel mesh__D015920 Gas Scavenger, Anesthetic
% 210.27/210.49  |- skos__hiddenLabel mesh__D015920 Scavenger, Gas
% 210.27/210.49  |- skos__prefLabel mesh__D015920 Gas Scavengers
% 210.27/210.49  |- skos__hiddenLabel mesh__D015920 Gas Scavengers, Anesthetic
% 210.27/210.49  |- rdf__type mesh__D015920sskos__Concept
% 210.27/210.49  |- skos__scopeNote mesh__D015920
% 210.27/210.49       Apparatus for removing exhaled or leaked anesthetic gases or other volatile agents, thus reducing the exposure of operating room personnel to such agents, as well as preventing the buildup of potentially explosive mixtures in operating rooms or laboratories.%A%    
% 210.27/210.49  |- mesh__recordMaintainer mesh__D015920 lkt
% 210.27/210.49  |- mesh__dateRevised mesh__D015920 2003-07-09
% 210.27/210.49  |- skos__historyNote mesh__D015920 Air Pollutants %28%1972-1983%29%
% 210.27/210.49  |- skos__historyNote mesh__D015920 Anesthesia, Inhalation %28%1972-1989%29%
% 210.27/210.49  |- skos__historyNote mesh__D015920 Operating Rooms %28%1977-1989%29%
% 210.27/210.49  |- mesh__dateEstablished mesh__D015920 1990-01-01
% 210.27/210.49  |- skos__hiddenLabel mesh__D015920 Scavenger, Anesthetic Gas
% 210.27/210.49  |- skos__annotation mesh__D015920
% 210.27/210.49       note category %26% cross refs or read MeSH definition   
% 210.27/210.49  |- skos__altLabel mesh__D015122 GlaxoSmithKline Brand of 6-Mercaptopurine
% 210.27/210.49  |- skos__hiddenLabel mesh__D015122 Puri Nethol
% 210.27/210.49  |- rdf__type mesh__D015122sskos__Concept
% 210.27/210.49  |- mesh__historyNote mesh__D015122
% 210.27/210.49       85; was MERCAPTOPURINE 1963-84; ARABINOSYL-6-MERCAPTOPURINE was heading 1975-91 %28%see under 6-MERCAPTOPURINE 1975-90%29%%A%  
% 210.27/210.49  |- mesh__recordAuthorizer mesh__D015122 sjn
% 210.27/210.49  |- skos__hiddenLabel mesh__D015122 6 Thiohypoxanthine
% 210.27/210.49  |- skos__hiddenLabel mesh__D015122 6 Thiopurine
% 210.27/210.49  |- skos__prefLabel mesh__D015122 6-Mercaptopurine
% 210.27/210.49  |- skos__hiddenLabel mesh__D015122 Wellcome Brand of 6 Mercaptopurine
% 210.27/210.49  |- skos__hiddenLabel mesh__D015122
% 210.27/210.49       GlaxoSmithKline Brand of 6 Mercaptopurine
% 210.27/210.49  |- skos__broader mesh__D015122smesh__D011687
% 210.27/210.49  |- skos__altLabel mesh__D015122 6-Thiopurine
% 210.27/210.49  |- skos__altLabel mesh__D015122 Puri-Nethol
% 210.27/210.49  |- skos__hiddenLabel mesh__D015122 BW 57 323H
% 210.27/210.49  |- skos__hiddenLabel mesh__D015122 6 Mercaptopurine Monohydrate
% 210.27/210.49  |- mesh__recordMaintainer mesh__D015122 CCR
% 210.27/210.49  |- skos__hiddenLabel mesh__D015122 BW 57323H
% 210.27/210.49  |- skos__broader mesh__D015122smesh__D013438
% 210.27/210.49  |- skos__scopeNote mesh__D015122
% 210.27/210.49       An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.%A%    
% 210.27/210.49  |- skos__hiddenLabel mesh__D015122 Glaxo Wellcome Brand of 6 Mercaptopurine
% 210.27/210.49  |- mesh__onlineNote mesh__D015122
% 210.27/210.49       use 6-MERCAPTOPURINE to search MERCAPTOPURINE 1966-84 %26% ARABINOSYL-6-MERCAPTOPURINE 1975-91%A%  
% 210.27/210.49  |- skos__altLabel mesh__D015122 Mercaptopurine
% 210.27/210.49  |- mesh__recordOriginator mesh__D015122 NLM
% 210.27/210.49  |- skos__hiddenLabel mesh__D015122 6 Mercaptopurine
% 210.27/210.49  |- mesh__activeMeSHYear mesh__D015122 2006
% 210.27/210.49  |- skos__altLabel mesh__D015122 1,7-Dihydro-6H-purine-6-thione
% 210.27/210.50  |- skos__altLabel mesh__D015122 Glaxo Wellcome Brand of 6-Mercaptopurine
% 210.27/210.50  |- skos__altLabel mesh__D015122 Wellcome Brand of 6-Mercaptopurine
% 210.27/210.50  |- skos__altLabel mesh__D015122 6-Thiohypoxanthine
% 210.27/210.50  |- mesh__publicMeSHNote mesh__D015122
% 210.27/210.50       85; was MERCAPTOPURINE 1963-84; ARABINOSYL-6-MERCAPTOPURINE was heading 1991, was see under 6-MERCAPTOPURINE 1975-90%A%  
% 210.27/210.50  |- mesh__dateCreated mesh__D015122 1999-01-01
% 210.27/210.50  |- mesh__dateRevised mesh__D015122 2005-06-30
% 210.27/210.50  |- skos__historyNote mesh__D001900 Massachusetts %28%1966-1969%29%
% 210.27/210.50  |- mesh__dateEstablished mesh__D001900 1970-01-01
% 210.27/210.50  |- rdf__type mesh__D001900sskos__Concept
% 210.27/210.50  |- mesh__recordOriginator mesh__D001900 NLM
% 210.27/210.50  |- mesh__activeMeSHYear mesh__D001900 2004
% 210.27/210.50  |- skos__prefLabel mesh__D001900 Boston
% 210.27/210.50  |- mesh__recordMaintainer mesh__D001900 PXP
% 210.27/210.50  |- mesh__historyNote mesh__D001900 70   
% 210.27/210.50  |- mesh__activeMeSHYear mesh__D001900 2006
% 210.27/210.50  |- mesh__activeMeSHYear mesh__D001900 2003
% 210.27/210.50  |- skos__broader mesh__D001900smesh__D008404
% 210.27/210.50  |- mesh__activeMeSHYear mesh__D001900 1999
% 210.27/210.50  |- mesh__dateRevised mesh__D001900 1997-06-20
% 210.27/210.50  |- mesh__activeMeSHYear mesh__D001900 2002
% 210.27/210.50  |- mesh__activeMeSHYear mesh__D001900 2005
% 210.27/210.50  |- skos__broader mesh__D001900smesh__D002947
% 210.27/210.50  |- mesh__activeMeSHYear mesh__D001900 1998
% 210.27/210.50  |- mesh__dateCreated mesh__D001900 1999-01-01
% 210.27/210.50  |- mesh__activeMeSHYear mesh__D001900 2001
% 210.27/210.50  |- mesh__activeMeSHYear mesh__D001900 2000
% 210.27/210.50  |- mesh__recordAuthorizer mesh__D001900 SJN
% 210.27/210.50  |- skos__hiddenLabel mesh__D001102 Infections, Arbovirus
% 210.27/210.50  |- mesh__dateRevised mesh__D001102 2004-07-13
% 210.27/210.50  |- skos__hiddenLabel mesh__D001102 Infection, Arbovirus
% 210.27/210.50  |- mesh__activeMeSHYear mesh__D001102 2006
% 210.27/210.50  |- skos__hiddenLabel mesh__D001102 Arbovirus Infection
% 210.27/210.50  |- mesh__historyNote mesh__D001102 65; was ARBORVIRUS INFECTIONS 1963-64   
% 210.27/210.50  |- mesh__recordOriginator mesh__D001102 NLM
% 210.27/210.50  |- mesh__activeMeSHYear mesh__D001102 2005
% 210.27/210.50  |- mesh__recordAuthorizer mesh__D001102 sjn
% 210.27/210.50  |- rdf__type mesh__D001102sskos__Concept
% 210.27/210.50  |- skos__scopeNote mesh__D001102
% 210.27/210.50       Infections caused by arthropod-borne viruses, general or unspecified.%A%    
% 210.27/210.50  |- skos__broader mesh__D001102smesh__D014777
% 210.27/210.50  |- skos__prefLabel mesh__D001102 Arbovirus Infections
% 210.27/210.50  |- mesh__dateCreated mesh__D001102 1999-01-01
% 210.27/210.50  |- mesh__recordMaintainer mesh__D001102 sjn
% 210.27/210.50  |- mesh__dateEstablished mesh__D001102 1965-01-01
% 210.27/210.50  |- mesh__publicMeSHNote mesh__D001102
% 210.27/210.50       65; was ARBORVIRUS INFECTIONS 1963-64   
% 210.27/210.50  |- skos__annotation mesh__D001102
% 210.27/210.50       GEN; consider also 2 major groups, BUNYAVIRUS INFECTIONS %26% TOGAVIRUS INFECTIONS or specifics%A%  
% 210.27/210.50  |- skos__hiddenLabel mesh__D020865 P Type VDCC
% 210.27/210.50  |- skos__altLabel mesh__D020865 Purkinje-Type Calcium Channels
% 210.27/210.50  |- skos__historyNote mesh__D020865 Calcium Channels %28%1991-1999%29%
% 210.27/210.50  |- skos__hiddenLabel mesh__D020865 Calcium Channels, P Type
% 210.27/210.50  |- rdf__type mesh__D020865sskos__Concept
% 210.27/210.50  |- skos__hiddenLabel mesh__D020865 Channels, Purkinje-Type Calcium
% 210.27/210.50  |- skos__altLabel mesh__D020865 P-Type Calcium Channels
% 210.27/210.50  |- skos__hiddenLabel mesh__D020865 Channel, P-Type Calcium
% 210.27/210.50  |- skos__altLabel mesh__D020865 P-Type Calcium Channel
% 210.27/210.50  |- mesh__activeMeSHYear mesh__D020865 2006
% 210.27/210.50  |- skos__hiddenLabel mesh__D020865 VDCC, P-Type
% 210.27/210.50  |- skos__hiddenLabel mesh__D020865 Calcium Channels, Purkinje-Type
% 210.27/210.50  |- skos__altLabel mesh__D020865 P-Type Voltage-Dependent Calcium Channels
% 210.27/210.50  |- skos__hiddenLabel mesh__D020865 Purkinje Type Calcium Channels
% 210.27/210.50  |- mesh__recordOriginator mesh__D020865 adp
% 210.27/210.50  |- mesh__recordMaintainer mesh__D020865 SYSTEM
% 210.27/210.50  |- mesh__publicMeSHNote mesh__D020865
% 210.27/210.50       2000; P-TYPE VDCC was indexed under CALCIUM CHANNELS 1999%A%  
% 210.27/210.50  |- skos__scopeNote mesh__D020865
% 210.27/210.50       CALCIUM CHANNELS located within the PURKINJE CELLS of the cerebellum. They are involved in stimulation-secretion coupling of neurons.%A%    
% 210.27/210.50  |- skos__hiddenLabel mesh__D020865 Calcium Channel, P-Type
% 210.27/210.50  |- skos__hiddenLabel mesh__D020865
% 210.27/210.50       P Type Voltage Dependent Calcium Channels
% 210.27/210.50  |- mesh__dateCreated mesh__D020865 1999-11-08
% 210.27/210.50  |- mesh__dateEstablished mesh__D020865 2000-01-01
% 210.27/210.50  |- mesh__recordAuthorizer mesh__D020865 sjn
% 210.27/210.50  |- skos__prefLabel mesh__D020865 Calcium Channels, P-Type
% 210.27/210.50  |- skos__hiddenLabel mesh__D020865 P Type Calcium Channels
% 210.27/210.50  |- skos__annotation mesh__D020865 DF: VDCC P   
% 210.35/210.50  |- skos__altLabel mesh__D020865 P-Type VDCC
% 210.35/210.50  |- mesh__dateRevised mesh__D020865 2005-06-30
% 210.35/210.50  |- skos__hiddenLabel mesh__D020865 P Type Calcium Channel
% 210.35/210.50  |- skos__hiddenLabel mesh__D020865 Channels, P-Type Calcium
% 210.35/210.50  |- skos__broader mesh__D020865smesh__D020864
% 210.35/210.50  |- mesh__historyNote mesh__D020865
% 210.35/210.50       2000; for P-TYPE VDCC use VOLTAGE-DEPENDENT CALCIUM CHANNEL %28%P-Q TYPE%29% %28%NM%29% 1999%A%  
% 210.35/210.50  |- skos__broader mesh__D006396smesh__D006471
% 210.35/210.50  |- rdf__type mesh__D006396sskos__Concept
% 210.35/210.50  |- mesh__dateCreated mesh__D006396 1999-01-01
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D006396 2004
% 210.35/210.50  |- skos__broader mesh__D006396smesh__D014839
% 210.35/210.50  |- mesh__recordMaintainer mesh__D006396 lkt
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D006396 2005
% 210.35/210.50  |- mesh__dateRevised mesh__D006396 2003-07-09
% 210.35/210.50  |- skos__scopeNote mesh__D006396
% 210.35/210.50       Vomiting of blood that is either fresh bright red, or older %22%coffee-ground%22% in character. It generally indicates bleeding of the UPPER GASTROINTESTINAL TRACT.%A%    
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D006396 2006
% 210.35/210.50  |- mesh__recordAuthorizer mesh__D006396 sjn
% 210.35/210.50  |- skos__prefLabel mesh__D006396 Hematemesis
% 210.35/210.50  |- skos__hiddenLabel mesh__D006396 Hematemeses
% 210.35/210.50  |- mesh__recordOriginator mesh__D006396 NLM
% 210.35/210.50  |- mesh__dateCreated mesh__D014828 1999-01-01
% 210.35/210.50  |- skos__altLabel mesh__D014828 Animal Vocalization
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D014828 2005
% 210.35/210.50  |- mesh__recordOriginator mesh__D014828 NLM
% 210.35/210.50  |- skos__prefLabel mesh__D014828 Vocalization, Animal
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D014828 2003
% 210.35/210.50  |- skos__hiddenLabel mesh__D014828 Animal Vocalizations
% 210.35/210.50  |- skos__historyNote mesh__D014828 Communication %28%1966-1967%29%
% 210.35/210.50  |- mesh__recordAuthorizer mesh__D014828 sjn
% 210.35/210.50  |- mesh__recordMaintainer mesh__D014828 JLS
% 210.35/210.50  |- skos__scopeNote mesh__D014828
% 210.35/210.50       Vocal sounds used in animal communication.     
% 210.35/210.50  |- rdf__type mesh__D014828sskos__Concept
% 210.35/210.50  |- mesh__dateRevised mesh__D014828 2002-07-02
% 210.35/210.50  |- mesh__historyNote mesh__D014828 68   
% 210.35/210.50  |- skos__historyNote mesh__D014828 Voice %28%1966-1967%29%
% 210.35/210.50  |- mesh__dateEstablished mesh__D014828 1968-01-01
% 210.35/210.50  |- skos__broader mesh__D014828smesh__D000819
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D014828 2006
% 210.35/210.50  |- mesh__publicMeSHNote mesh__D014828 68   
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D014828 2004
% 210.35/210.50  |- skos__hiddenLabel mesh__D014828 Vocalizations, Animal
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D019513 2002
% 210.35/210.50  |- skos__annotation mesh__D019513
% 210.35/210.50       polit, econ %26% social equality of women to men   
% 210.35/210.50  |- skos__hiddenLabel mesh__D019513 Ethics, Feminist
% 210.35/210.50  |- mesh__historyNote mesh__D019513 97; was see WOMEN%27%S RIGHTS 1994-96   
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D019513 2003
% 210.35/210.50  |- skos__prefLabel mesh__D019513 Feminism
% 210.35/210.50  |- mesh__dateCreated mesh__D019513 1996-06-10
% 210.35/210.50  |- mesh__publicMeSHNote mesh__D019513
% 210.35/210.50       97; was see WOMEN%27%S RIGHTS 1994-96   
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D019513 1999
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D019513 2001
% 210.35/210.50  |- skos__hiddenLabel mesh__D019513 Ethic, Feminist
% 210.35/210.50  |- mesh__dateEstablished mesh__D019513 1997-01-01
% 210.35/210.50  |- skos__hiddenLabel mesh__D019513 Feminist Ethic
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D019513 1998
% 210.35/210.50  |- mesh__dateRevised mesh__D019513 1997-06-20
% 210.35/210.50  |- skos__historyNote mesh__D019513 Women%27%s Rights %28%1977-1996%29%
% 210.35/210.50  |- mesh__recordAuthorizer mesh__D019513 SJN
% 210.35/210.50  |- mesh__recordMaintainer mesh__D019513 JLS
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D019513 2000
% 210.35/210.50  |- skos__broader mesh__D019513smesh__D006808
% 210.35/210.50  |- skos__scopeNote mesh__D019513
% 210.35/210.50       The theory of the political, economic, and social equality of the sexes and organized activity on behalf of women%27%s rights and interests. %28%Webster New Collegiate Dictionary, 1981%29%%A%    
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D019513 2006
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D019513 2005
% 210.35/210.50  |- rdf__type mesh__D019513sskos__Concept
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D019513 2004
% 210.35/210.50  |- mesh__recordOriginator mesh__D019513 JLS
% 210.35/210.50  |- mesh__onlineNote mesh__D019513
% 210.35/210.50       use WOMEN%27%S RIGHTS to search FEMINISM 1994-96   
% 210.35/210.50  |- mesh__dateCreated mesh__D000808 1974-11-19
% 210.35/210.50  |- mesh__recordMaintainer mesh__D000808 JRT
% 210.35/210.50  |- skos__historyNote mesh__D000808 Protein Precursors %28%1971-1974%29%
% 210.35/210.50  |- skos__altLabel mesh__D000808 Renin-Substrate
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D000808 2004
% 210.35/210.50  |- skos__scopeNote mesh__D000808
% 210.35/210.50       An alpha-globulin of which a fragment of 14 amino acids is converted by renin to angiotensin I, the inactive precursor of angiotensin II. It is a member of the serpin superfamily.%A%    
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D000808 2001
% 210.35/210.50  |- skos__hiddenLabel mesh__D000808 Renin Substrate
% 210.35/210.50  |- skos__hiddenLabel mesh__D000808 Tetradecapeptide, Renin Substrate
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D000808 2003
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D000808 1997
% 210.35/210.50  |- mesh__publicMeSHNote mesh__D000808
% 210.35/210.50       87; was see under ANGIOTENSINS 1975-86   
% 210.35/210.50  |- rdf__type mesh__D000808sskos__Concept
% 210.35/210.50  |- skos__annotation mesh__D000808
% 210.35/210.50       a serpin %26% angiotensin II precursor; /biosyn /drug eff /physiol /ultrastruct permitted%A%  
% 210.35/210.50  |- skos__historyNote mesh__D000808 Alpha Globulins %28%1968-1974%29%
% 210.35/210.50  |- mesh__dateEstablished mesh__D000808 1987-01-01
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D000808 2000
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D000808 2006
% 210.35/210.50  |- skos__broader mesh__D000808smesh__D015843
% 210.35/210.50  |- mesh__recordOriginator mesh__D000808 NLM
% 210.35/210.50  |- skos__historyNote mesh__D000808 Angiotensin II %28%1968-1974%29%
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D000808 1996
% 210.35/210.50  |- mesh__dateRevised mesh__D000808 1995-06-08
% 210.35/210.50  |- skos__broader mesh__D000808smesh__D011498
% 210.35/210.50  |- skos__broader mesh__D000808smesh__D000809
% 210.35/210.50  |- skos__prefLabel mesh__D000808 Angiotensinogen
% 210.35/210.50  |- skos__altLabel mesh__D000808 Hypertensinogen
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D000808 2005
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D000808 1999
% 210.35/210.50  |- mesh__historyNote mesh__D000808
% 210.35/210.50       87%28%75%29%; was see under ANGIOTENSINS 1975-86   
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D000808 2002
% 210.35/210.50  |- skos__altLabel mesh__D000808 Proangiotensin
% 210.35/210.50  |- mesh__recordAuthorizer mesh__D000808 PLS
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D000808 1998
% 210.35/210.50  |- mesh__recordMaintainer mesh__D011530 lkw
% 210.35/210.50  |- skos__broader mesh__D011530smesh__D003986
% 210.35/210.50  |- mesh__recordAuthorizer mesh__D011530 sjn
% 210.35/210.50  |- mesh__dateRevised mesh__D011530 2005-06-30
% 210.35/210.50  |- skos__historyNote mesh__D011530 Propylamines %28%1969-1974%29%
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D011530 2006
% 210.35/210.50  |- mesh__dateCreated mesh__D011530 1974-11-19
% 210.35/210.50  |- mesh__publicMeSHNote mesh__D011530
% 210.35/210.50       91; was see under DIBENZOCYCLOHEPTENES 1975-90   
% 210.35/210.50  |- mesh__dateEstablished mesh__D011530 1991-01-01
% 210.35/210.50  |- skos__altLabel mesh__D011530
% 210.35/210.50       Odyssey Brand of Protriptyline Hydrochloride
% 210.35/210.50  |- mesh__recordOriginator mesh__D011530 NLM
% 210.35/210.50  |- skos__historyNote mesh__D011530 Dibenzocycloheptenes %28%1969-1974%29%
% 210.35/210.50  |- skos__scopeNote mesh__D011530
% 210.35/210.50       Tricyclic antidepressant similar in action and side effects to IMIPRAMINE. It may produce excitation.%A%    
% 210.35/210.50  |- skos__hiddenLabel mesh__D011530 Hydrochloride, Protriptyline
% 210.35/210.50  |- skos__prefLabel mesh__D011530 Protriptyline
% 210.35/210.50  |- rdf__type mesh__D011530sskos__Concept
% 210.35/210.50  |- mesh__historyNote mesh__D011530
% 210.35/210.50       91%28%75%29%; was see under DIBENZOCYCLOHEPTENES 1975-90   
% 210.35/210.50  |- skos__prefLabel mesh__D029941 Fish Proteins
% 210.35/210.50  |- mesh__dateRevised mesh__D029941 2005-06-30
% 210.35/210.50  |- mesh__dateEstablished mesh__D029941 2002-01-01
% 210.35/210.50  |- mesh__historyNote mesh__D029941 2002   
% 210.35/210.50  |- mesh__dateCreated mesh__D029941 2001-07-25
% 210.35/210.50  |- mesh__recordOriginator mesh__D029941 jmp
% 210.35/210.50  |- skos__related mesh__D029941smesh__D005399
% 210.35/210.50  |- mesh__recordMaintainer mesh__D029941 DRC
% 210.35/210.50  |- skos__broader mesh__D029941smesh__D011506
% 210.35/210.50  |- skos__annotation mesh__D029941
% 210.35/210.50       coorrd IM with specific protein %28%IM%29% + specific fish %28%IM%29%%A%  
% 210.35/210.50  |- mesh__publicMeSHNote mesh__D029941 2002   
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D029941 2006
% 210.35/210.50  |- skos__scopeNote mesh__D029941
% 210.35/210.50       Proteins obtained from species of fish %28%FISHES%29%.     
% 210.35/210.50  |- rdf__type mesh__D029941sskos__Concept
% 210.35/210.50  |- mesh__recordAuthorizer mesh__D029941 sjn
% 210.35/210.50  |- mesh__dateRevised mesh__D010438 2003-07-09
% 210.35/210.50  |- skos__annotation mesh__D010438
% 210.35/210.50       coord IM with STOMACH ULCER %28%IM%29% or DUODENAL ULCER %28%IM%29% if appropriate%A%  
% 210.35/210.50  |- skos__prefLabel mesh__D010438 Peptic Ulcer Hemorrhage
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D010438 2006
% 210.35/210.50  |- mesh__recordAuthorizer mesh__D010438 sjn
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D010438 2004
% 210.35/210.50  |- mesh__recordOriginator mesh__D010438 NLM
% 210.35/210.50  |- rdf__type mesh__D010438sskos__Concept
% 210.35/210.50  |- skos__scopeNote mesh__D010438
% 210.35/210.50       Bleeding from a PEPTIC ULCER that can be located in any segment of the GASTROINTESTINAL TRACT.%A%    
% 210.35/210.50  |- mesh__dateCreated mesh__D010438 1999-01-01
% 210.35/210.50  |- skos__hiddenLabel mesh__D010438 Peptic Ulcer Hemorrhages
% 210.35/210.50  |- skos__hiddenLabel mesh__D010438 Ulcer Hemorrhage, Peptic
% 210.35/210.50  |- skos__related mesh__D010438smesh__D010437
% 210.35/210.50  |- skos__broader mesh__D010438smesh__D006471
% 210.35/210.50  |- mesh__recordMaintainer mesh__D010438 lkt
% 210.35/210.50  |- skos__altLabel mesh__D010438 Hemorrhage, Peptic Ulcer
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D010438 2005
% 210.35/210.50  |- mesh__dateCreated mesh__D015921 1989-05-26
% 210.35/210.50  |- mesh__recordAuthorizer mesh__D015921 sjn
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D015921 2002
% 210.35/210.50  |- mesh__publicMeSHNote mesh__D015921
% 210.35/210.50       90; DENTAL PROSTHESIS, SURGICAL was see DENTAL IMPLANTATION 1975-89%A%  
% 210.35/210.50  |- skos__related mesh__D015921smesh__D003757
% 210.35/210.50  |- skos__related mesh__D015921smesh__D014093
% 210.35/210.50  |- skos__altLabel mesh__D015921 Prosthesis, Surgical Dental
% 210.35/210.50  |- skos__prefLabel mesh__D015921 Dental Implants
% 210.35/210.50  |- mesh__historyNote mesh__D015921
% 210.35/210.50       90; DENTAL PROSTHESIS, SURGICAL was see DENTAL IMPLANTATION 1975-89%A%  
% 210.35/210.50  |- skos__altLabel mesh__D015921 Dental Implant
% 210.35/210.50  |- skos__altLabel mesh__D015921 Implant, Dental
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D015921 2006
% 210.35/210.50  |- skos__altLabel mesh__D015921 Prostheses, Surgical Dental
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D015921 2001
% 210.35/210.50  |- mesh__dateRevised mesh__D015921 1999-11-03
% 210.35/210.50  |- mesh__recordOriginator mesh__D015921 PLS
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D015921 2005
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D015921 2000
% 210.35/210.50  |- skos__annotation mesh__D015921 DF: DENT IMPLANTS   
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D015921 2004
% 210.35/210.50  |- skos__broader mesh__D015921smesh__D017266
% 210.35/210.50  |- rdf__type mesh__D015921sskos__Concept
% 210.35/210.50  |- skos__altLabel mesh__D015921 Implants, Dental
% 210.35/210.50  |- mesh__recordMaintainer mesh__D015921 jls
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D015921 2003
% 210.35/210.50  |- skos__scopeNote mesh__D015921
% 210.35/210.50       Biocompatible materials placed into %28%endosseous%29% or onto %28%subperiosteal%29% the jawbone to support a crown, bridge, or artificial tooth, or to stabilize a diseased tooth.%A%    
% 210.35/210.50  |- mesh__onlineNote mesh__D015921
% 210.35/210.50       use DENTAL IMPLANTATION to search DENTAL PROSTHESIS, SURGICAL 1975-89%A%  
% 210.35/210.50  |- mesh__dateEstablished mesh__D015921 1990-01-01
% 210.35/210.50  |- skos__altLabel mesh__D015921 Dental Prosthesis, Surgical
% 210.35/210.50  |- skos__altLabel mesh__D015921 Surgical Dental Prostheses
% 210.35/210.50  |- skos__broader mesh__D015921smesh__D003764
% 210.35/210.50  |- skos__historyNote mesh__D015921 Dental Implantation %28%1966-1989%29%
% 210.35/210.50  |- skos__broader mesh__D015921smesh__D019736
% 210.35/210.50  |- skos__altLabel mesh__D015921 Surgical Dental Prosthesis
% 210.35/210.50  |- skos__altLabel mesh__D015123 Anti-BaPDE
% 210.35/210.50  |- skos__historyNote mesh__D015123 Benzopyrenes %28%1966-1986%29%
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D015123 2002
% 210.35/210.50  |- skos__altLabel mesh__D015123
% 210.35/210.50       7,8-Dihydroxy-9,10-Epoxy-7,8,9,10-Tetrahydrobenzo%28%a%29%pyrene
% 210.35/210.50  |- mesh__dateRevised mesh__D015123 1995-06-16
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D015123 1998
% 210.35/210.50  |- mesh__recordMaintainer mesh__D015123 JRT
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D015123 2005
% 210.35/210.50  |- mesh__historyNote mesh__D015123
% 210.35/210.50       91%28%87%29%; was see under DIHYDROXYDIHYDROBENZOPYRENES 1987-90%A%  
% 210.35/210.50  |- skos__altLabel mesh__D015123
% 210.35/210.50       Benzo%28%a%29%pyrene 7,8-Dihydrodiol 9,10-Epoxide
% 210.35/210.50  |- mesh__recordOriginator mesh__D015123 RLS
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D015123 1996
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D015123 2003
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D015123 1999
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D015123 2006
% 210.35/210.50  |- mesh__dateCreated mesh__D015123 1986-04-09
% 210.35/210.50  |- skos__altLabel mesh__D015123 7,8-BaP-9,10-Diol Epoxide
% 210.35/210.50  |- mesh__publicMeSHNote mesh__D015123
% 210.35/210.50       91; was see under DIHYDROXYDIHYDROBENZOPYRENES 1987-90   
% 210.35/210.50  |- skos__altLabel mesh__D015123 Benzo%28%a%29%pyrene-7,8-diol 9,10-Epoxide
% 210.35/210.50  |- mesh__recordAuthorizer mesh__D015123 PLS
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D015123 1997
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D015123 2004
% 210.35/210.50  |- skos__altLabel mesh__D015123 BPDE
% 210.35/210.50  |- skos__broader mesh__D015123smesh__D004101
% 210.35/210.50  |- skos__prefLabel mesh__D015123
% 210.35/210.50       7,8-Dihydro-7,8-dihydroxybenzo%28%a%29%pyrene 9,10-oxide
% 210.35/210.50  |- skos__annotation mesh__D015123
% 210.35/210.50       a carcinogen %26% mutagen; D25-26 qualif; DF: 7 8 DDBP   
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D015123 2000
% 210.35/210.50  |- skos__hiddenLabel mesh__D015123 Anti BaPDE
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D015123 2001
% 210.35/210.50  |- rdf__type mesh__D015123sskos__Concept
% 210.35/210.50  |- mesh__dateEstablished mesh__D015123 1991-01-01
% 210.35/210.50  |- skos__scopeNote mesh__D015123
% 210.35/210.50       7,8,8a,9a-Tetrahydrobenzo%28%10,11%29%chryseno %28%3,4-b%29%oxirene-7,8-diol. A benzopyrene derivative with carcinogenic and mutagenic activity.%A%    
% 210.35/210.50  |- skos__broader mesh__D001901smesh__D001695
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D001901 2006
% 210.35/210.50  |- mesh__recordMaintainer mesh__D001901 jls
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D001901 2003
% 210.35/210.50  |- skos__annotation mesh__D001901 SPEC: SPEC qualif   
% 210.35/210.50  |- skos__hiddenLabel mesh__D001901 Botanies
% 210.35/210.50  |- skos__related mesh__D001901smesh__D010944
% 210.35/210.50  |- mesh__recordAuthorizer mesh__D001901 sjn
% 210.35/210.50  |- mesh__recordOriginator mesh__D001901 NLM
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D001901 2005
% 210.35/210.50  |- mesh__dateCreated mesh__D001901 1999-01-01
% 210.35/210.50  |- skos__prefLabel mesh__D001901 Botany
% 210.35/210.50  |- skos__related mesh__D001901smesh__D019448
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D001901 2002
% 210.35/210.50  |- rdf__type mesh__D001901sskos__Concept
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D001901 2004
% 210.35/210.50  |- mesh__dateRevised mesh__D001901 2001-07-25
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D001103 2005
% 210.35/210.50  |- skos__hiddenLabel mesh__D001103 Arthropod Borne Viruses
% 210.35/210.50  |- skos__hiddenLabel mesh__D001103 Virus, Arthropod-Borne
% 210.35/210.50  |- skos__related mesh__D001103smesh__D001116
% 210.35/210.50  |- skos__hiddenLabel mesh__D001103 Arbovirus
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D001103 2006
% 210.35/210.50  |- skos__related mesh__D001103smesh__D014035
% 210.35/210.50  |- skos__hiddenLabel mesh__D001103 Arthropod-Borne Virus
% 210.35/210.50  |- mesh__dateCreated mesh__D001103 1999-01-01
% 210.35/210.50  |- mesh__dateEstablished mesh__D001103 1965-01-01
% 210.35/210.50  |- skos__scopeNote mesh__D001103
% 210.35/210.50       Arthropod-borne viruses. A non-taxonomic designation for viruses that can replicate in both vertebrate hosts and arthropod vectors. Included are some members of the following families: ARENAVIRIDAE; BUNYAVIRIDAE; REOVIRIDAE; TOGAVIRIDAE; and FLAVIVIRIDAE. %28%From Dictionary of Microbiology and Molecular Biology, 2nd ed%29%%A%    
% 210.35/210.50  |- skos__broader mesh__D001103smesh__D014780
% 210.35/210.50  |- skos__related mesh__D001103smesh__D012087
% 210.35/210.50  |- skos__annotation mesh__D001103
% 210.35/210.50       GEN; from ARthropod-BOrne; infection = ARBOVIRUS INFECTIONS%A%  
% 210.35/210.50  |- rdf__type mesh__D001103sskos__Concept
% 210.35/210.50  |- mesh__dateRevised mesh__D001103 2001-07-25
% 210.35/210.50  |- skos__prefLabel mesh__D001103 Arboviruses
% 210.35/210.50  |- skos__related mesh__D001103smesh__D018067
% 210.35/210.50  |- skos__altLabel mesh__D001103 Arthropod-Borne Viruses
% 210.35/210.50  |- mesh__recordOriginator mesh__D001103 NLM
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D001103 2003
% 210.35/210.50  |- mesh__publicMeSHNote mesh__D001103
% 210.35/210.50       75; was ARBOVIRUS 1965-74, was ARBORVIRUSES 1963-64; CAPIM GROUP VIRUSES was see under ARBOVIRUSES 1975-80%A%  
% 210.35/210.50  |- mesh__recordAuthorizer mesh__D001103 sjn
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D001103 2004
% 210.35/210.50  |- mesh__historyNote mesh__D001103
% 210.35/210.50       75; was ARBOVIRUS 1965-74, was ARBORVIRUSES 1963-64; CAPIM GROUP VIRUSES was see under ARBOVIRUSES 1975-80%A%  
% 210.35/210.50  |- skos__related mesh__D001103smesh__D002043
% 210.35/210.50  |- mesh__recordMaintainer mesh__D001103 mdb
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D001103 2002
% 210.35/210.50  |- mesh__onlineNote mesh__D001103
% 210.35/210.50       use ARBOVIRUSES to search ARBOVIRUS 1966-74   
% 210.35/210.50  |- skos__hiddenLabel mesh__D001103 Viruses, Arthropod-Borne
% 210.35/210.50  |- mesh__dateRevised mesh__D020866 2005-06-30
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D020866 2006
% 210.35/210.50  |- skos__altLabel mesh__D020866 Conus geographus Toxin
% 210.35/210.50  |- skos__scopeNote mesh__D020866
% 210.35/210.50       A neurotoxic peptide, which is a cleavage product %28%VIa%29% of the omega-Conotoxin precursor protein contained in venom from the marine snail, CONUS geographus. It is an antagonist of CALCIUM CHANNELS, N-TYPE.%A%    
% 210.35/210.50  |- mesh__historyNote mesh__D020866
% 210.35/210.50       2000; use OMEGA-CONOTOXIN GVIA %28%NM%29% 1984-1999   
% 210.35/210.50  |- skos__hiddenLabel mesh__D020866 geographus Toxin, Conus
% 210.35/210.50  |- skos__altLabel mesh__D020866 Conus geographus Toxin GVIA
% 210.35/210.50  |- skos__hiddenLabel mesh__D020866 toxin, omega-Conus geographus
% 210.35/210.50  |- skos__altLabel mesh__D020866 omega-Conus geographus toxin
% 210.35/210.50  |- skos__altLabel mesh__D020866 omega-CgTX GVIA
% 210.35/210.50  |- skos__hiddenLabel mesh__D020866 Toxin, Conus geographus
% 210.35/210.50  |- mesh__recordMaintainer mesh__D020866 ssb
% 210.35/210.50  |- mesh__dateEstablished mesh__D020866 2000-01-01
% 210.35/210.50  |- skos__altLabel mesh__D020866 omega-CgTX
% 210.35/210.50  |- skos__historyNote mesh__D020866 Peptides %28%1994-1999%29%
% 210.35/210.50  |- skos__hiddenLabel mesh__D020866 omega CgTX
% 210.35/210.50  |- skos__historyNote mesh__D020866 Mollusk Venoms %28%1984-1993%29%
% 210.35/210.50  |- mesh__recordOriginator mesh__D020866 adp
% 210.35/210.50  |- skos__broader mesh__D020866smesh__D020960
% 210.35/210.50  |- skos__hiddenLabel mesh__D020866 geographus toxin, omega-Conus
% 210.35/210.50  |- skos__hiddenLabel mesh__D020866 omega Conus geographus toxin
% 210.35/210.50  |- skos__hiddenLabel mesh__D020866 omega Conotoxin GVIA
% 210.35/210.50  |- skos__prefLabel mesh__D020866 omega-Conotoxin GVIA
% 210.35/210.50  |- mesh__recordAuthorizer mesh__D020866 sjn
% 210.35/210.50  |- skos__hiddenLabel mesh__D020866 omega CgTX GVIA
% 210.35/210.50  |- mesh__dateCreated mesh__D020866 1999-11-03
% 210.35/210.50  |- rdf__type mesh__D020866sskos__Concept
% 210.35/210.50  |- mesh__publicMeSHNote mesh__D020866
% 210.35/210.50       2000; CONUS GEOGRAPHUS TOXIN %28%now OMEGA-CONOTOXIN GVIA%29% was indexed under PEPTIDES 1994-1999 %26% MOLLUSK VENOMS 1984-1993%A%  
% 210.35/210.50  |- skos__hiddenLabel mesh__D020866 GVIA, omega-CgTX
% 210.35/210.50  |- skos__hiddenLabel mesh__D020866 GVIA, omega-Conotoxin
% 210.35/210.50  |- skos__scopeNote mesh__D006397
% 210.35/210.50       Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias.%A%    
% 210.35/210.50  |- skos__hiddenLabel mesh__D006397 Agents, Hematopoietic
% 210.35/210.50  |- rdf__type mesh__D006397sskos__Concept
% 210.35/210.50  |- skos__broader mesh__D006397smesh__D006401
% 210.35/210.50  |- mesh__recordOriginator mesh__D006397 NLM
% 210.35/210.50  |- mesh__publicMeSHNote mesh__D006397 75   
% 210.35/210.50  |- skos__historyNote mesh__D006397 Anemia/drug therapy %28%1966-1974%29%
% 210.35/210.50  |- mesh__historyNote mesh__D006397 75   
% 210.35/210.50  |- mesh__recordMaintainer mesh__D006397 ssb
% 210.35/210.50  |- mesh__dateEstablished mesh__D006397 1975-09-01
% 210.35/210.50  |- mesh__activeMeSHYear mesh__D006397 2006
% 210.35/210.50  |- skos__altLabel mesh__D006397 Hematopoietic Agents
% 210.35/210.50  |- mesh__dateRevised mesh__D006397 2005-06-30
% 210.35/210.50  |- mesh__dateCreated mesh__D006397 1999-01-01
% 210.35/210.50  |- skos__prefLabel mesh__D006397 Hematinics
% 210.35/210.50  |- mesh__recordAuthorizer mesh__D006397 sjn
% 210.35/210.50  |- mesh__recordMaintainer mesh__D020068 SYSTEM
% 210.35/210.50  |- skos__prefLabel mesh__D020068 Zygosaccharomyces
% 210.35/210.51  |- rdf__type mesh__D020068sskos__Concept
% 210.35/210.51  |- mesh__dateCreated mesh__D020068 1998-06-11
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D020068 2006
% 210.35/210.51  |- mesh__recordAuthorizer mesh__D020068 sjn
% 210.35/210.51  |- mesh__dateRevised mesh__D020068 2005-06-30
% 210.35/210.51  |- mesh__historyNote mesh__D020068 99   
% 210.35/210.51  |- mesh__recordOriginator mesh__D020068 AGS
% 210.35/210.51  |- mesh__dateEstablished mesh__D020068 1999-01-01
% 210.35/210.51  |- skos__scopeNote mesh__D020068
% 210.35/210.51       A genus of ascomycetous fungi of the family Saccharomycetaceae, order SACCHAROMYCETALES.%A%    
% 210.35/210.51  |- skos__historyNote mesh__D020068 Saccharomyces %28%1973-1985%29%
% 210.35/210.51  |- skos__historyNote mesh__D020068 Saccharomycetales %28%1986-1998%29%
% 210.35/210.51  |- skos__broader mesh__D020068smesh__D004718
% 210.35/210.51  |- mesh__publicMeSHNote mesh__D020068 99   
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D014829 2001
% 210.35/210.51  |- skos__altLabel mesh__D014829 Education, Vocational
% 210.35/210.51  |- skos__hiddenLabel mesh__D014829 Vocational Educations
% 210.35/210.51  |- rdf__type mesh__D014829sskos__Concept
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D014829 1995
% 210.35/210.51  |- mesh__dateRevised mesh__D014829 1992-05-18
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D014829 2000
% 210.35/210.51  |- mesh__recordOriginator mesh__D014829 NLM
% 210.35/210.51  |- skos__prefLabel mesh__D014829 Vocational Education
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D014829 1999
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D014829 1994
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D014829 1993
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D014829 1998
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D014829 1997
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D014829 2006
% 210.35/210.51  |- mesh__recordMaintainer mesh__D014829 TGC
% 210.35/210.51  |- skos__broader mesh__D014829smesh__D004505
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D014829 2002
% 210.35/210.51  |- mesh__recordAuthorizer mesh__D014829 PLS
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D014829 1996
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D014829 2005
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D014829 2004
% 210.35/210.51  |- skos__hiddenLabel mesh__D014829 Educations, Vocational
% 210.35/210.51  |- skos__scopeNote mesh__D014829
% 210.35/210.51       Education for specific trades or occupations.     
% 210.35/210.51  |- mesh__dateCreated mesh__D014829 1999-01-01
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D014829 2003
% 210.35/210.51  |- mesh__dateEstablished mesh__D019514 1997-01-01
% 210.35/210.51  |- mesh__recordAuthorizer mesh__D019514 sjn
% 210.35/210.51  |- mesh__dateCreated mesh__D019514 1996-06-21
% 210.35/210.51  |- skos__prefLabel mesh__D019514 Instruction %5B%Publication Type%5D%
% 210.35/210.51  |- skos__broader mesh__D019514smesh__D052180
% 210.35/210.51  |- skos__altLabel mesh__D019514 Instruction %28%Pub Type%29%
% 210.35/210.51  |- skos__scopeNote mesh__D019514
% 210.35/210.51       Works consisting of nonfiction films and video designed to teach, instruct, or train. %28%From Moving Image Materials: Genre Terms, 1988%29%%A%    
% 210.35/210.51  |- skos__altLabel mesh__D019514 Instruction
% 210.35/210.51  |- mesh__dateRevised mesh__D019514 2005-06-30
% 210.35/210.51  |- skos__annotation mesh__D019514
% 210.35/210.51       publication type only; restrict to instruction by motion pictures %26% video, not by lectures, classroom or printed matter; used for historical materials only  CATALOG: do not use for current materials%A%  
% 210.35/210.51  |- mesh__recordMaintainer mesh__D019514 jls
% 210.35/210.51  |- mesh__recordOriginator mesh__D019514 TGC
% 210.35/210.51  |- mesh__historyNote mesh__D019514 1997   
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D019514 2006
% 210.35/210.51  |- rdf__type mesh__D019514sskos__Concept
% 210.35/210.51  |- skos__altLabel mesh__D019514 Instruction %28%PT%29%
% 210.35/210.51  |- rdf__type mesh__D000809sskos__Concept
% 210.35/210.51  |- mesh__recordMaintainer mesh__D000809 ssb
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D000809 2006
% 210.35/210.51  |- skos__historyNote mesh__D000809 Angiotensin II %28%1966-1977%29%
% 210.35/210.51  |- mesh__recordAuthorizer mesh__D000809 sjn
% 210.35/210.51  |- skos__broader mesh__D000809smesh__D009479
% 210.35/210.51  |- mesh__dateEstablished mesh__D000809 1964-01-01
% 210.35/210.51  |- skos__scopeNote mesh__D000809
% 210.35/210.51       Oligopeptides ranging in size from angiotensin precursors with 14 amino acids to the active vasoconstrictor angiotensin II with 8 amino acids, or their analogs or derivatives. The amino acid content varies with the species and changes in that content produce antagonistic or inactive compounds.%A%    
% 210.35/210.51  |- skos__related mesh__D000809smesh__D011945
% 210.35/210.51  |- skos__broader mesh__D000809smesh__D009842
% 210.35/210.51  |- skos__prefLabel mesh__D000809 Angiotensins
% 210.35/210.51  |- skos__altLabel mesh__D000809 Angiotensin
% 210.35/210.51  |- skos__related mesh__D000809smesh__D012084
% 210.35/210.51  |- skos__historyNote mesh__D000809 Angiotensin III %28%1977%29%
% 210.35/210.51  |- mesh__dateCreated mesh__D000809 1999-01-01
% 210.35/210.51  |- mesh__publicMeSHNote mesh__D000809
% 210.35/210.51       1978; for ANGIOTENSIN see ANGIOTENSIN II 1978-1999   
% 210.35/210.51  |- skos__broader mesh__D000809smesh__D012898
% 210.35/210.51  |- mesh__historyNote mesh__D000809
% 210.35/210.51       1978; for ANGIOTENSIN use ANGIOTENSIN II 1978-1999   
% 210.35/210.51  |- mesh__dateRevised mesh__D000809 2005-06-30
% 210.35/210.51  |- mesh__recordOriginator mesh__D000809 NLM
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D011531 2006
% 210.35/210.51  |- skos__prefLabel mesh__D011531 Proventriculus
% 210.35/210.51  |- mesh__publicMeSHNote mesh__D011531 68   
% 210.35/210.51  |- skos__historyNote mesh__D011531 Poultry %28%1966-1967%29%
% 210.35/210.51  |- mesh__recordAuthorizer mesh__D011531 sjn
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D011531 2003
% 210.35/210.51  |- mesh__dateEstablished mesh__D011531 1968-01-01
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D011531 2000
% 210.35/210.51  |- skos__historyNote mesh__D011531 Birds %28%1966-1967%29%
% 210.35/210.51  |- mesh__historyNote mesh__D011531 68   
% 210.35/210.51  |- skos__annotation mesh__D011531
% 210.35/210.51       avian only; non-avian: use DIGESTIVE SYSTEM; dis: coord IM with STOMACH DISEASES /vet %28%IM%29%; neopl: coord IM with STOMACH NEOPLASMS /vet %28%IM%29% + histol type %28%IM%29%%A%  
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D011531 2004
% 210.35/210.51  |- mesh__recordMaintainer mesh__D011531 KEV
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D011531 2001
% 210.35/210.51  |- skos__historyNote mesh__D011531 Stomach %28%1966-1967%29%
% 210.35/210.51  |- mesh__dateRevised mesh__D011531 1999-11-03
% 210.35/210.51  |- rdf__type mesh__D011531sskos__Concept
% 210.35/210.51  |- mesh__dateCreated mesh__D011531 1999-01-01
% 210.35/210.51  |- skos__scopeNote mesh__D011531
% 210.35/210.51       A thin-walled, glandular stomach found in birds. It precedes the gizzard.%A%    
% 210.35/210.51  |- mesh__recordOriginator mesh__D011531 NLM
% 210.35/210.51  |- skos__broader mesh__D011531smesh__D013278
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D011531 2005
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D011531 2002
% 210.35/210.51  |- skos__hiddenLabel mesh__D035181 TATA Box Binding Protein
% 210.35/210.51  |- skos__altLabel mesh__D035181 TATA-Binding Protein
% 210.35/210.51  |- mesh__dateEstablished mesh__D035181 2003-01-01
% 210.35/210.51  |- skos__hiddenLabel mesh__D035181 RNA Polymerase II TATA Binding Protein
% 210.35/210.51  |- skos__hiddenLabel mesh__D035181 TATA Binding Protein
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D035181 2006
% 210.35/210.51  |- skos__altLabel mesh__D035181 TATA-Box-Binding Protein
% 210.35/210.51  |- skos__prefLabel mesh__D035181 TATA-Box Binding Protein
% 210.35/210.51  |- skos__historyNote mesh__D035181 DNA-Binding Proteins %28%1992-2002%29%
% 210.35/210.51  |- skos__scopeNote mesh__D035181
% 210.35/210.51       A general transcription factor that plays a major role in the activation of eukaryotic genes transcribed by RNA POLYMERASES. It binds specifically to the TATA BOX promoter element, which lies close to the position of transcription initiation in RNA transcribed by RNA POLYMERASE II. Although considered a principal component of TRANSCRIPTION FACTOR TFIID it also takes part in general transcription factor complexes involved in RNA POLYMERASE I and RNA POLYMERASE III transcription.%A%    
% 210.35/210.51  |- skos__broader mesh__D035181smesh__D035362
% 210.35/210.51  |- mesh__publicMeSHNote mesh__D035181
% 210.35/210.51       2003; TATA-BOX BINDING PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1992-2002%A%  
% 210.35/210.51  |- mesh__historyNote mesh__D035181
% 210.35/210.51       2003; use TATA-BOX BINDING PROTEIN %28%NM%29% 1992-2002   
% 210.35/210.51  |- mesh__recordMaintainer mesh__D035181 ags
% 210.35/210.51  |- skos__altLabel mesh__D035181 Transcription Factor TBP
% 210.35/210.51  |- mesh__dateRevised mesh__D035181 2005-06-30
% 210.35/210.51  |- skos__altLabel mesh__D035181 RNA Polymerase II TATA-Binding Protein
% 210.35/210.51  |- mesh__recordAuthorizer mesh__D035181 sjn
% 210.35/210.51  |- skos__historyNote mesh__D035181 Transcription Factors %28%1992-2002%29%
% 210.35/210.51  |- mesh__recordOriginator mesh__D035181 jmp
% 210.35/210.51  |- mesh__dateCreated mesh__D035181 2002-07-03
% 210.35/210.51  |- skos__broader mesh__D035181smesh__D035165
% 210.35/210.51  |- rdf__type mesh__D035181sskos__Concept
% 210.35/210.51  |- mesh__recordMaintainer mesh__D010439 lkt
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D010439 2004
% 210.35/210.51  |- skos__hiddenLabel mesh__D010439 Peptic Ulcer Perforations
% 210.35/210.51  |- skos__hiddenLabel mesh__D010439 Ulcer Perforation, Peptic
% 210.35/210.51  |- rdf__type mesh__D010439sskos__Concept
% 210.35/210.51  |- mesh__dateCreated mesh__D010439 1999-01-01
% 210.35/210.51  |- mesh__recordAuthorizer mesh__D010439 sjn
% 210.35/210.51  |- skos__annotation mesh__D010439
% 210.35/210.51       coord IM with STOMACH ULCER /compl %28%IM%29% or DUODENAL ULCER /compl %28%IM%29% if pertinent%A%  
% 210.35/210.51  |- skos__hiddenLabel mesh__D010439 Perforations, Peptic Ulcer
% 210.35/210.51  |- skos__hiddenLabel mesh__D010439 Ulcer Perforations, Peptic
% 210.35/210.51  |- mesh__recordOriginator mesh__D010439 NLM
% 210.35/210.51  |- skos__hiddenLabel mesh__D010439 Perforation, Peptic Ulcer
% 210.35/210.51  |- skos__scopeNote mesh__D010439
% 210.35/210.51       Penetration of a PEPTIC ULCER through the wall of DUODENUM or STOMACH allowing the leakage of luminal contents into the PERITONEAL CAVITY.%A%    
% 210.35/210.51  |- skos__broader mesh__D010439smesh__D010437
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D010439 2005
% 210.35/210.51  |- mesh__dateRevised mesh__D010439 2003-07-09
% 210.35/210.51  |- skos__prefLabel mesh__D010439 Peptic Ulcer Perforation
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D010439 2006
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D007490 2002
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D007490 2005
% 210.35/210.51  |- skos__prefLabel mesh__D007490 Iproniazid
% 210.35/210.51  |- rdf__type mesh__D007490sskos__Concept
% 210.35/210.51  |- mesh__recordAuthorizer mesh__D007490 sjn
% 210.35/210.51  |- mesh__recordOriginator mesh__D007490 NLM
% 210.35/210.51  |- skos__scopeNote mesh__D007490
% 210.35/210.51       An irreversible inhibitor of monoamine oxidase types A and B that is used as an antidepressive agent. It has also been used as an antitubercular agent, but its use is limited by its toxicity.%A%    
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D007490 2001
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D007490 2004
% 210.35/210.51  |- skos__broader mesh__D007490smesh__D006834
% 210.35/210.51  |- mesh__dateRevised mesh__D007490 2000-06-22
% 210.35/210.51  |- mesh__dateCreated mesh__D007490 1999-01-01
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D007490 2003
% 210.35/210.51  |- skos__broader mesh__D007490smesh__D007539
% 210.35/210.51  |- mesh__recordMaintainer mesh__D007490 CCR
% 210.35/210.51  |- skos__altLabel mesh__D007490 Iprazid
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D007490 2006
% 210.35/210.51  |- rdf__type mesh__D021161sskos__Concept
% 210.35/210.51  |- skos__broader mesh__D021161smesh__D021141
% 210.35/210.51  |- skos__altLabel mesh__D021161 Nucleic Acid Sequence-Based Amplification
% 210.35/210.51  |- skos__scopeNote mesh__D021161
% 210.35/210.51       An isothermal in-vitro nucleotide amplification process. The process involves the concomitant action of a RNA-DIRECTED DNA POLYMERASE, a ribonuclease %28%RIBONUCLEASES%29%, and DNA-DIRECTED RNA POLYMERASES to synthesize large quantities of sequence-specific RNA and DNA molecules.%A%    
% 210.35/210.51  |- skos__hiddenLabel mesh__D021161
% 210.35/210.51       Nucleic Acid Sequence Based Amplification
% 210.35/210.51  |- skos__hiddenLabel mesh__D021161 Self-Sustained Sequence Replications
% 210.35/210.51  |- mesh__recordAuthorizer mesh__D021161 sjn
% 210.35/210.51  |- mesh__dateEstablished mesh__D021161 2001-01-01
% 210.35/210.51  |- skos__hiddenLabel mesh__D021161 Replications, Self-Sustained Sequence
% 210.35/210.51  |- mesh__publicMeSHNote mesh__D021161 2001   
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D021161 2004
% 210.35/210.51  |- mesh__dateRevised mesh__D021161 2002-07-03
% 210.35/210.51  |- skos__annotation mesh__D021161 DF:NASBA   
% 210.35/210.51  |- skos__hiddenLabel mesh__D021161 Replication, Self-Sustained Sequence
% 210.35/210.51  |- mesh__dateCreated mesh__D021161 2000-06-21
% 210.35/210.51  |- mesh__recordOriginator mesh__D021161 jmp
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D021161 2003
% 210.35/210.51  |- skos__altLabel mesh__D021161 NASBA Analysis
% 210.35/210.51  |- skos__hiddenLabel mesh__D021161 NASBA Analyses
% 210.35/210.51  |- skos__hiddenLabel mesh__D021161 Analysis, NASBA
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D021161 2006
% 210.35/210.51  |- skos__hiddenLabel mesh__D021161 Self Sustained Sequence Replication
% 210.35/210.51  |- skos__hiddenLabel mesh__D021161 Sequence Replications, Self-Sustained
% 210.35/210.51  |- mesh__recordMaintainer mesh__D021161 sjn
% 210.35/210.51  |- skos__hiddenLabel mesh__D021161 Sequence Replication, Self-Sustained
% 210.35/210.51  |- skos__hiddenLabel mesh__D021161 Analyses, NASBA
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D021161 2005
% 210.35/210.51  |- skos__prefLabel mesh__D021161 Self-Sustained Sequence Replication
% 210.35/210.51  |- mesh__historyNote mesh__D021161 2001   
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D015922 2006
% 210.35/210.51  |- skos__broader mesh__D015922smesh__D003172
% 210.35/210.51  |- mesh__publicMeSHNote mesh__D015922 2006; see COMPLEMENT 1Q 1990-2005   
% 210.35/210.51  |- skos__altLabel mesh__D015922 C1q Complement
% 210.35/210.51  |- mesh__recordMaintainer mesh__D015922 lkt
% 210.35/210.51  |- skos__historyNote mesh__D015922 Complement 1 %28%1980-1989%29%
% 210.35/210.51  |- skos__prefLabel mesh__D015922 Complement C1q
% 210.35/210.51  |- skos__hiddenLabel mesh__D015922 C1q, Complement
% 210.35/210.51  |- mesh__recordAuthorizer mesh__D015922 sjn
% 210.35/210.51  |- rdf__type mesh__D015922sskos__Concept
% 210.35/210.51  |- mesh__recordOriginator mesh__D015922 AGS
% 210.35/210.51  |- mesh__historyNote mesh__D015922 2006 %28%1990%29%   
% 210.35/210.51  |- mesh__dateEstablished mesh__D015922 1990-01-01
% 210.35/210.51  |- skos__hiddenLabel mesh__D015922 Complement, C1q
% 210.35/210.51  |- skos__altLabel mesh__D015922 Complement Component 1q
% 210.35/210.51  |- skos__scopeNote mesh__D015922
% 210.35/210.51       A subcomponent of complement C1, composed of six copies of three polypeptide chains %28%A, B, and C%29%, each encoded by a separate gene %28%C1QA; C1QB; C1QC%29%. This complex is arranged in nine subunits %28%six disulfide-linked dimers of A and B, and three disulfide-linked homodimers of C%29%. C1q has binding sites for antibodies %28%the heavy chain of IMMUNOGLOBULIN G or IMMUNOGLOBULIN M%29%. The interaction of C1q and immunoglobulin activates the two proenzymes COMPLEMENT C1R and COMPLEMENT C1S, thus initiating the cascade of COMPLEMENT ACTIVATION via the CLASSICAL COMPLEMENT PATHWAY.%A%    
% 210.35/210.51  |- skos__altLabel mesh__D015922 Complement 1q
% 210.35/210.51  |- mesh__dateCreated mesh__D015922 1989-05-25
% 210.35/210.51  |- mesh__dateRevised mesh__D015922 2005-06-30
% 210.35/210.51  |- skos__hiddenLabel mesh__D015922 Component 1q, Complement
% 210.35/210.51  |- skos__historyNote mesh__D015922
% 210.35/210.51       Complement Activating Enzymes %28%1979-1989%29%
% 210.35/210.51  |- skos__hiddenLabel mesh__D015124
% 210.35/210.51       8 Bromo Cyclic Adenosine Monophosphate, Monosodium Salt
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D015124 2006
% 210.35/210.51  |- skos__prefLabel mesh__D015124 8-Bromo Cyclic Adenosine Monophosphate
% 210.35/210.51  |- skos__hiddenLabel mesh__D015124 8 Bromo cAMP
% 210.35/210.51  |- skos__historyNote mesh__D015124 Adenine Nucleotides %28%1966-1968%29%
% 210.35/210.51  |- skos__hiddenLabel mesh__D015124 Cyclic AMP, 8-Br
% 210.35/210.51  |- mesh__recordMaintainer mesh__D015124 ssb
% 210.35/210.51  |- skos__hiddenLabel mesh__D015124 8 Bromo Cyclic AMP
% 210.35/210.51  |- skos__hiddenLabel mesh__D015124 8 Br Cyclic AMP
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D015124 2004
% 210.35/210.51  |- mesh__dateRevised mesh__D015124 2001-07-25
% 210.35/210.51  |- skos__hiddenLabel mesh__D015124
% 210.35/210.51       8 Bromo Cyclic Adenosine Monophosphate, Sodium Salt
% 210.35/210.51  |- rdf__type mesh__D015124sskos__Concept
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D015124 2002
% 210.35/210.51  |- mesh__recordOriginator mesh__D015124 RLS
% 210.35/210.51  |- mesh__dateEstablished mesh__D015124 1984-01-01
% 210.35/210.51  |- skos__broader mesh__D015124smesh__D000242
% 210.35/210.51  |- skos__altLabel mesh__D015124 8-Bromo Cyclic AMP
% 210.35/210.51  |- mesh__dateCreated mesh__D015124 1983-05-31
% 210.35/210.51  |- skos__hiddenLabel mesh__D015124 8 Bromo Cyclic Adenosine Monophosphate
% 210.35/210.51  |- skos__altLabel mesh__D015124
% 210.35/210.51       8-Bromoadenosine 3%27%,5%27%-Cyclic Monophosphate
% 210.35/210.51  |- skos__annotation mesh__D015124 DF: BR CAMP   
% 210.35/210.51  |- skos__altLabel mesh__D015124 8-Bromo-cAMP
% 210.35/210.51  |- mesh__historyNote mesh__D015124 84   
% 210.35/210.51  |- skos__hiddenLabel mesh__D015124 Cyclic AMP, 8-Bromo
% 210.35/210.51  |- mesh__recordAuthorizer mesh__D015124 sjn
% 210.35/210.51  |- skos__hiddenLabel mesh__D015124 AMP, Br Cycl
% 210.35/210.51  |- mesh__publicMeSHNote mesh__D015124 84   
% 210.35/210.51  |- skos__altLabel mesh__D015124 Br Cycl AMP
% 210.35/210.51  |- skos__altLabel mesh__D015124 8-Br Cyclic AMP
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D015124 2005
% 210.35/210.51  |- skos__historyNote mesh__D015124
% 210.35/210.51       Adenosine Cyclic Monophosphate %28%1968-1983%29%
% 210.35/210.51  |- skos__scopeNote mesh__D015124
% 210.35/210.51       A long-acting derivative of cyclic AMP. It is an activator of cyclic AMP-dependent protein kinase, but resistant to degradation by cyclic AMP phosphodiesterase.%A%    
% 210.35/210.51  |- skos__hiddenLabel mesh__D015124
% 210.35/210.51       8 Bromoadenosine 3%27%,5%27% Cyclic Monophosphate
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D015124 2003
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D001902 2005
% 210.35/210.51  |- mesh__dateRevised mesh__D001902 1997-06-20
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D001902 1998
% 210.35/210.51  |- mesh__dateCreated mesh__D001902 1999-01-01
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D001902 2002
% 210.35/210.51  |- skos__annotation mesh__D001902
% 210.35/210.51       a republic in southern Africa; X ref BECHUANALAND was its former name; X ref KALAHARI refers to the desert %26% region%A%  
% 210.35/210.51  |- skos__altLabel mesh__D001902 Bechuanaland
% 210.35/210.51  |- skos__broader mesh__D001902smesh__D000353
% 210.35/210.51  |- skos__scopeNote mesh__D001902
% 210.35/210.51       A republic in southern Africa, between NAMIBIA and ZAMBIA. It was formerly called Bechuanaland. Its capital is Gaborone. The Kalahari Desert is in the west and southwest. Botswana was organized as a British protectorate in 1885 and became independent in 1966. The name comes from bo, the prefix for abstract nouns + Tswana, the people themselves. Bechuana in its earlier name is the English corruption of Botswana. %28%From Webster%27%s New Geographical Dictionary, 1988, p185 %26% Room, Brewer%27%s Dictionary of Names, 1992, p74%29%%A%    
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D001902 2001
% 210.35/210.51  |- mesh__recordMaintainer mesh__D001902 TGC
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D001902 2000
% 210.35/210.51  |- mesh__recordAuthorizer mesh__D001902 SJN
% 210.35/210.51  |- rdf__type mesh__D001902sskos__Concept
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D001902 2004
% 210.35/210.51  |- mesh__recordOriginator mesh__D001902 NLM
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D001902 2006
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D001902 2003
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D001902 1999
% 210.35/210.51  |- skos__prefLabel mesh__D001902 Botswana
% 210.35/210.51  |- mesh__dateCreated mesh__D001104 1999-01-01
% 210.35/210.51  |- mesh__historyNote mesh__D001104
% 210.35/210.51       91%28%75%29%; was see under GLYCOSIDES 1976-90; was see under UVA URSI 1963-75%A%  
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D001104 2005
% 210.35/210.51  |- mesh__dateEstablished mesh__D001104 1991-01-01
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D001104 2006
% 210.35/210.51  |- rdf__type mesh__D001104sskos__Concept
% 210.35/210.51  |- mesh__recordOriginator mesh__D001104 NLM
% 210.35/210.51  |- mesh__onlineNote mesh__D001104 search PLANTS, MEDICINAL 1966-74   
% 210.35/210.51  |- mesh__recordAuthorizer mesh__D001104 sjn
% 210.35/210.51  |- mesh__publicMeSHNote mesh__D001104
% 210.35/210.51       91; was see under GLYCOSIDES 1976-90; was see under UVA URSI 1963-75%A%  
% 210.35/210.51  |- mesh__recordMaintainer mesh__D001104 ssb
% 210.35/210.51  |- mesh__dateRevised mesh__D001104 2004-07-07
% 210.35/210.51  |- skos__prefLabel mesh__D001104 Arbutin
% 210.35/210.51  |- skos__broader mesh__D001104smesh__D005960
% 210.35/210.51  |- mesh__dateCreated mesh__D020867 1999-11-08
% 210.35/210.51  |- skos__prefLabel mesh__D020867 omega-Agatoxin IVA
% 210.35/210.51  |- mesh__dateEstablished mesh__D020867 2000-01-01
% 210.35/210.51  |- skos__broader mesh__D020867smesh__D013111
% 210.35/210.51  |- mesh__recordAuthorizer mesh__D020867 sjn
% 210.35/210.51  |- mesh__historyNote mesh__D020867
% 210.35/210.51       2000; use OMEGA-AGATOXIN IVA %28%NM%29% 1992-1999   
% 210.35/210.51  |- skos__historyNote mesh__D020867 Spider Venoms %28%1992-1999%29%
% 210.35/210.51  |- mesh__dateRevised mesh__D020867 2005-06-30
% 210.35/210.51  |- rdf__type mesh__D020867sskos__Concept
% 210.35/210.51  |- mesh__publicMeSHNote mesh__D020867
% 210.35/210.51       2000; OMEGA-AGATOXIN IVA was indexed under SPIDER VENOMS 1992-1999%A%  
% 210.35/210.51  |- skos__hiddenLabel mesh__D020867 omega Agatoxin IVA
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D020867 2006
% 210.35/210.51  |- skos__hiddenLabel mesh__D020867 omega Aga IVA
% 210.35/210.51  |- skos__altLabel mesh__D020867 omega-Aga-IVA
% 210.35/210.51  |- mesh__recordMaintainer mesh__D020867 ssb
% 210.35/210.51  |- skos__broader mesh__D020867smesh__D019476
% 210.35/210.51  |- skos__scopeNote mesh__D020867
% 210.35/210.51       A neuropeptide toxin from the venom of the funnel web spider, Agelenopsis aperta. It inhibits CALCIUM CHANNELS, P-TYPE by altering the voltage-dependent gating so that very large depolarizations are needed for channel opening. It also inhibits CALCIUM CHANNELS, Q-TYPE.%A%    
% 210.35/210.51  |- skos__hiddenLabel mesh__D020867 IVA, omega-Agatoxin
% 210.35/210.51  |- mesh__recordOriginator mesh__D020867 adp
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D006398 2003
% 210.35/210.51  |- rdf__type mesh__D006398sskos__Concept
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D006398 2000
% 210.35/210.51  |- mesh__recordAuthorizer mesh__D006398 sjn
% 210.35/210.51  |- skos__broader mesh__D006398smesh__D005832
% 210.35/210.51  |- skos__scopeNote mesh__D006398
% 210.35/210.51       Hemorrhage into a canal or cavity of the body, especially into the tunica vaginalis testis.%A%    
% 210.35/210.51  |- mesh__dateRevised mesh__D006398 1999-11-03
% 210.35/210.51  |- mesh__recordMaintainer mesh__D006398 KEV
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D006398 2006
% 210.35/210.51  |- mesh__recordOriginator mesh__D006398 NLM
% 210.35/210.51  |- skos__hiddenLabel mesh__D006398 Hematoceles
% 210.35/210.51  |- skos__broader mesh__D006398smesh__D006470
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D006398 2005
% 210.35/210.51  |- skos__prefLabel mesh__D006398 Hematocele
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D006398 2002
% 210.35/210.51  |- mesh__dateCreated mesh__D006398 1999-01-01
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D006398 2004
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D006398 2001
% 210.35/210.51  |- skos__scopeNote mesh__D020069
% 210.35/210.51       Unilateral or bilateral pain of the shoulder. It is often caused by physical activities such as work or sports participation, but may also be pathologic in origin.%A%    
% 210.35/210.51  |- mesh__recordMaintainer mesh__D020069 KEV
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D020069 2004
% 210.35/210.51  |- skos__broader mesh__D020069smesh__D010146
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D020069 2003
% 210.35/210.51  |- skos__hiddenLabel mesh__D020069 Pain, Shoulder
% 210.35/210.51  |- mesh__dateEstablished mesh__D020069 1999-01-01
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D020069 2002
% 210.35/210.51  |- rdf__type mesh__D020069sskos__Concept
% 210.35/210.51  |- mesh__dateCreated mesh__D020069 1998-06-11
% 210.35/210.51  |- mesh__dateRevised mesh__D020069 1999-11-08
% 210.35/210.51  |- mesh__publicMeSHNote mesh__D020069 99   
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D020069 2001
% 210.35/210.51  |- mesh__recordOriginator mesh__D020069 NDW
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D020069 2006
% 210.35/210.51  |- skos__prefLabel mesh__D020069 Shoulder Pain
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D020069 2000
% 210.35/210.51  |- skos__hiddenLabel mesh__D020069 Shoulder Pains
% 210.35/210.51  |- skos__hiddenLabel mesh__D020069 Pains, Shoulder
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D020069 2005
% 210.35/210.51  |- skos__historyNote mesh__D020069 Pain %28%1966-1998%29%
% 210.35/210.51  |- mesh__historyNote mesh__D020069 99   
% 210.35/210.51  |- skos__broader mesh__D020069smesh__D018771
% 210.35/210.51  |- mesh__recordAuthorizer mesh__D020069 sjn
% 210.35/210.51  |- mesh__dateEstablished mesh__D011532 1991-01-01
% 210.35/210.51  |- mesh__recordAuthorizer mesh__D011532 sjn
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D011532 2006
% 210.35/210.51  |- mesh__dateRevised mesh__D011532 2005-06-30
% 210.35/210.51  |- rdf__type mesh__D011532sskos__Concept
% 210.35/210.51  |- skos__scopeNote mesh__D011532
% 210.35/210.51       Gram-negative rods isolated from human urine and feces.%A%    
% 210.35/210.51  |- mesh__historyNote mesh__D011532
% 210.35/210.51       91%28%75%29%; was see under ENTEROBACTERIACEAE 1975-90; was see under PROTEUS 1975-89; PROTEUS INCONSTANS was see PROVIDENCIA 1978-91%A%  
% 210.35/210.51  |- mesh__dateCreated mesh__D011532 1999-01-01
% 210.35/210.51  |- mesh__recordOriginator mesh__D011532 NLM
% 210.35/210.51  |- skos__prefLabel mesh__D011532 Providencia
% 210.35/210.51  |- skos__broader mesh__D011532smesh__D004755
% 210.35/210.51  |- skos__annotation mesh__D011532
% 210.35/210.51       infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 210.35/210.51  |- mesh__recordMaintainer mesh__D011532 SYSTEM
% 210.35/210.51  |- mesh__publicMeSHNote mesh__D011532
% 210.35/210.51       91; was see under ENTEROBACTERIACEAE 1975-90; was see under PROTEUS 1975-89; PROTEUS INCONSTANS was see PROVIDENCIA 1978-91%A%  
% 210.35/210.51  |- mesh__onlineNote mesh__D011532
% 210.35/210.51       use PROVIDENCIA to search PROTEUS INCONSTANS 1978-91; use PROTEUS to search PROVIDENCIA 1974%A%  
% 210.35/210.51  |- skos__altLabel mesh__D035182 TBP-Related Factor
% 210.35/210.51  |- skos__altLabel mesh__D035182 TBP-Like Protein %28%TLP%29%
% 210.35/210.51  |- mesh__dateRevised mesh__D035182 2005-06-30
% 210.35/210.51  |- skos__scopeNote mesh__D035182
% 210.35/210.51       A class of proteins related in structure and function to TATA-BOX BINDING PROTEIN that can take the place of TATA-BOX BINDING PROTEIN in the transcription initiation complex. They are found in most multicellular organisms and may be involved in tissue-specific promoter regulation. They bind to DNA and interact with TATA-BINDING PROTEIN ASSOCIATED FACTORS, however they may lack specificity for the TATA-BOX.%A%    
% 210.35/210.51  |- mesh__recordAuthorizer mesh__D035182 sjn
% 210.35/210.51  |- mesh__recordOriginator mesh__D035182 jmp
% 210.35/210.51  |- mesh__publicMeSHNote mesh__D035182
% 210.35/210.51       2003; TBP-RELATED FACTOR %28%now TATA-BOX BINDING PROTEIN-LIKE PROTEINS%29% was indexed under TRANSCRIPTION FACTORS %26% DNA-BINDING PROTEINS 1993-2002%A%  
% 210.35/210.51  |- mesh__dateCreated mesh__D035182 2002-07-03
% 210.35/210.51  |- skos__historyNote mesh__D035182 DNA-Binding Proteins %28%1993-2002%29%
% 210.35/210.51  |- mesh__dateEstablished mesh__D035182 2003-01-01
% 210.35/210.51  |- skos__hiddenLabel mesh__D035182 TLP, TBP-Like
% 210.35/210.51  |- skos__hiddenLabel mesh__D035182 TBP Like TLP
% 210.35/210.51  |- mesh__recordMaintainer mesh__D035182 ags
% 210.35/210.51  |- skos__hiddenLabel mesh__D035182 TATA Binding Protein Related Factor
% 210.35/210.51  |- skos__broader mesh__D035182smesh__D035165
% 210.35/210.51  |- rdf__type mesh__D035182sskos__Concept
% 210.35/210.51  |- skos__hiddenLabel mesh__D035182 TATA Box Binding Protein Like Proteins
% 210.35/210.51  |- skos__altLabel mesh__D035182 TATA-Binding Protein-Related Factors
% 210.35/210.51  |- skos__prefLabel mesh__D035182 TATA Box Binding Protein-Like Proteins
% 210.35/210.51  |- skos__historyNote mesh__D035182 Transcription Factors %28%1993-2002%29%
% 210.35/210.51  |- skos__altLabel mesh__D035182 TBP-Like TLP
% 210.35/210.51  |- mesh__historyNote mesh__D035182
% 210.35/210.51       2003; use TATA-BOX BINDING PROTEIN-LIKE PROTEINS %28%NM%29% 1993-2002%A%  
% 210.35/210.51  |- skos__hiddenLabel mesh__D035182 TBP Related Factor
% 210.35/210.51  |- skos__hiddenLabel mesh__D035182 TATA Binding Protein Related Factors
% 210.35/210.51  |- skos__altLabel mesh__D035182 TATA-Binding Protein-Related Factor
% 210.35/210.51  |- skos__annotation mesh__D035182
% 210.35/210.51       X ref TBP-RELATED FACTOR: see SCR for organism-specific TBP-related factors%A%  
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D035182 2006
% 210.35/210.51  |- mesh__dateRevised mesh__D007491 2005-06-30
% 210.35/210.51  |- rdf__type mesh__D007491sskos__Concept
% 210.35/210.51  |- mesh__recordMaintainer mesh__D007491 ssb
% 210.35/210.51  |- skos__scopeNote mesh__D007491
% 210.35/210.51       An antihistomonal agent with low toxicity. It also promotes growth and feed utilization in poultry.%A%    
% 210.35/210.51  |- mesh__dateCreated mesh__D007491 1974-11-19
% 210.35/210.51  |- mesh__dateEstablished mesh__D007491 1991-01-01
% 210.35/210.51  |- skos__historyNote mesh__D007491 Imidazoles %28%1966-1973%29%
% 210.35/210.51  |- mesh__historyNote mesh__D007491
% 210.35/210.51       91%28%75%29%; was see under NITROIMIDAZOLES 1975-90   
% 210.35/210.51  |- mesh__publicMeSHNote mesh__D007491
% 210.35/210.51       91; was see under NITROIMIDAZOLES 1975-90   
% 210.35/210.51  |- skos__prefLabel mesh__D007491 Ipronidazole
% 210.35/210.51  |- mesh__recordAuthorizer mesh__D007491 sjn
% 210.35/210.51  |- mesh__recordOriginator mesh__D007491 NLM
% 210.35/210.51  |- skos__broader mesh__D007491smesh__D009593
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D007491 2006
% 210.35/210.51  |- skos__historyNote mesh__D007491 Nitroimidazoles %28%1974%29%
% 210.35/210.51  |- mesh__activeMeSHYear mesh__D015923 2006
% 210.35/210.51  |- skos__altLabel mesh__D015923 C1r Complement
% 210.35/210.51  |- mesh__historyNote mesh__D015923 2006 %28%1990%29%   
% 210.35/210.51  |- mesh__dateRevised mesh__D015923 2005-06-30
% 210.35/210.51  |- skos__broader mesh__D015923smesh__D003172
% 210.35/210.51  |- rdf__type mesh__D015923sskos__Concept
% 210.35/210.51  |- mesh__dateEstablished mesh__D015923 1990-01-01
% 210.35/210.51  |- skos__scopeNote mesh__D015923
% 210.35/210.51       A 80-kDa subcomponent of complement C1, existing as a SERINE PROTEASE proenzyme in the intact complement C1 complex. When COMPLEMENT C1Q is bound to antibodies, the changed tertiary structure causes autolytic activation of complement C1r which is cleaved into two chains, A %28%heavy%29% and B %28%light, the serine protease%29%, connected by disulfide bonds. The activated C1r serine protease, in turn, activates COMPLEMENT C1S proenzyme by cleaving the Arg426-Ile427 bond. No fragment is released when either C1r or C1s is cleaved.%A%    
% 210.35/210.51  |- mesh__dateCreated mesh__D015923 1989-05-25
% 210.35/210.51  |- skos__altLabel mesh__D015923 Complement Component 1r
% 210.35/210.51  |- mesh__recordOriginator mesh__D015923 AGS
% 210.35/210.51  |- skos__historyNote mesh__D015923
% 210.35/210.51       Complement Activating Enzymes %28%1979-1989%29%
% 210.35/210.51  |- skos__historyNote mesh__D015923 Complement 1 %28%1979-1989%29%
% 210.35/210.52  |- skos__altLabel mesh__D015923 Complement 1r
% 210.35/210.52  |- mesh__recordAuthorizer mesh__D015923 sjn
% 210.35/210.52  |- mesh__recordMaintainer mesh__D015923 lkt
% 210.35/210.52  |- skos__hiddenLabel mesh__D015923 Complement, C1r
% 210.35/210.52  |- mesh__publicMeSHNote mesh__D015923 2006; see COMPLEMENT 1R 1990-2005   
% 210.35/210.52  |- skos__hiddenLabel mesh__D015923 Component 1r, Complement
% 210.35/210.52  |- skos__hiddenLabel mesh__D015923 C1r, Complement
% 210.35/210.52  |- skos__prefLabel mesh__D015923 Complement C1r
% 210.35/210.52  |- skos__broader mesh__D015923smesh__D003166
% 210.35/210.52  |- skos__historyNote mesh__D015923 Enzyme Precursors %28%1979-1982%29%
% 210.35/210.52  |- skos__altLabel mesh__D015125 Riemser Brand of Oxyquinoline Sulfate
% 210.35/210.52  |- skos__hiddenLabel mesh__D015125 8 Hydroxyquinoline
% 210.35/210.52  |- skos__scopeNote mesh__D015125
% 210.35/210.52       An antiseptic with mild fungistatic, bacteriostatic, anthelmintic, and amebicidal action. It is also used as a reagent and metal chelator, as a carrier for radio-indium for diagnostic purposes, and its halogenated derivatives are used in addition as topical anti-infective agents and oral antiamebics.%A%    
% 210.35/210.52  |- skos__hiddenLabel mesh__D015125 Sulfate, 8-Hydroxyquinoline
% 210.35/210.52  |- skos__broader mesh__D015125smesh__D006912
% 210.35/210.52  |- skos__hiddenLabel mesh__D015125 8 Hydroxyquinoline Sulfate
% 210.35/210.52  |- mesh__dateCreated mesh__D015125 1974-11-19
% 210.35/210.52  |- mesh__historyNote mesh__D015125
% 210.35/210.52       92; was 8-HYDROXYQUINOLINE 1975-91 %28%see under HYDROXYQUINOLINES 1975-90%29%; OXYQUINOLINE was see 8-HYDROXYQUINOLINE 1975-91%A%  
% 210.35/210.52  |- skos__altLabel mesh__D015125 8-Oxyquinoline
% 210.35/210.52  |- rdf__type mesh__D015125sskos__Concept
% 210.35/210.52  |- skos__annotation mesh__D015125 DF: note short X ref   
% 210.35/210.52  |- skos__hiddenLabel mesh__D015125 8 Oxyquinoline
% 210.35/210.52  |- skos__altLabel mesh__D015125
% 210.35/210.52       Chinosol Brand of Oxyquinoline Potassium Sulfate %28%2:1%29%
% 210.35/210.52  |- skos__prefLabel mesh__D015125 Oxyquinoline
% 210.35/210.52  |- skos__altLabel mesh__D015125 8-Hydroxyquinoline
% 210.35/210.52  |- mesh__recordOriginator mesh__D015125 NLM
% 210.35/210.52  |- skos__altLabel mesh__D015125 Oxyquinol
% 210.35/210.52  |- mesh__dateEstablished mesh__D015125 1991-01-01
% 210.35/210.52  |- skos__altLabel mesh__D015125 8-Hydroxyquinoline Sulfate
% 210.35/210.52  |- mesh__recordMaintainer mesh__D015125 lkw
% 210.35/210.52  |- skos__historyNote mesh__D015125 Quinolines %28%1971-1974%29%
% 210.35/210.52  |- mesh__dateRevised mesh__D015125 2005-06-30
% 210.35/210.52  |- skos__hiddenLabel mesh__D015125 8 Quinolinol
% 210.35/210.52  |- skos__hiddenLabel mesh__D015125 Sulfate, Oxyquinoline
% 210.35/210.52  |- mesh__publicMeSHNote mesh__D015125
% 210.35/210.52       92; was 8-HYDROXYQUINOLINE 1975-91 %28%see under HYDROXYQUINOLINES 1975-90%29%; OXYQUINOLINE was see 8-HYDROXYQUINOLINE 1975-91%A%  
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D015125 2006
% 210.35/210.52  |- skos__altLabel mesh__D015125 Tendem Brand of Oxyquinoline Sulfate
% 210.35/210.52  |- skos__altLabel mesh__D015125 Oxine
% 210.35/210.52  |- mesh__recordAuthorizer mesh__D015125 sjn
% 210.35/210.52  |- skos__altLabel mesh__D015125 8-Quinolinol
% 210.35/210.52  |- mesh__onlineNote mesh__D015125
% 210.35/210.52       use OXYQUINOLINE to search 8-HYDROXYQUINOLINE 1975-91   
% 210.35/210.52  |- skos__historyNote mesh__D001903 Infant Nutrition %28%1966-1974%29%
% 210.35/210.52  |- skos__hiddenLabel mesh__D001903 Bottlefeedings
% 210.35/210.52  |- skos__scopeNote mesh__D001903
% 210.35/210.52       Use of nursing bottles for feeding. Applies to humans and animals.%A%    
% 210.35/210.52  |- skos__broader mesh__D001903smesh__D007227
% 210.35/210.52  |- rdf__type mesh__D001903sskos__Concept
% 210.35/210.52  |- mesh__dateCreated mesh__D001903 1974-11-19
% 210.35/210.52  |- mesh__recordMaintainer mesh__D001903 TAP
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D001903 2004
% 210.35/210.52  |- skos__broader mesh__D001903smesh__D005248
% 210.35/210.52  |- skos__altLabel mesh__D001903 Bottlefeeding
% 210.35/210.52  |- mesh__dateEstablished mesh__D001903 1975-09-01
% 210.35/210.52  |- mesh__historyNote mesh__D001903 75   
% 210.35/210.52  |- skos__hiddenLabel mesh__D001903 Bottle Feedings
% 210.35/210.52  |- skos__hiddenLabel mesh__D001903 Feeding, Bottle
% 210.35/210.52  |- skos__annotation mesh__D001903 human %26% animal   
% 210.35/210.52  |- skos__prefLabel mesh__D001903 Bottle Feeding
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D001903 2006
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D001903 2003
% 210.35/210.52  |- mesh__dateRevised mesh__D001903 2002-07-02
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D001903 2005
% 210.35/210.52  |- mesh__recordAuthorizer mesh__D001903 sjn
% 210.35/210.52  |- mesh__recordOriginator mesh__D001903 NLM
% 210.35/210.52  |- mesh__publicMeSHNote mesh__D001903 75   
% 210.35/210.52  |- skos__hiddenLabel mesh__D001903 Feedings, Bottle
% 210.35/210.52  |- mesh__publicMeSHNote mesh__D001105
% 210.35/210.52       98; see ARCHAEOBACTERIA 1992-97, see ARCHAEBACTERIA 1991, see BACTERIA 1981-90; ARCHAEA was see ARCHAEOBACTERIA 1995-97%A%  
% 210.35/210.52  |- skos__prefLabel mesh__D001105 Archaea
% 210.35/210.52  |- skos__scopeNote mesh__D001105
% 210.35/210.52       One of the three domains of life %28%the others being BACTERIA and Eukarya%29%, formerly called Archaebacteria under the taxon Bacteria, but now considered separate and distinct. They are characterized by: %28%1%29% the presence of characteristic tRNAs and ribosomal RNAs; %28%2%29% the absence of peptidoglycan cell walls; %28%3%29% the presence of ether-linked lipids built from branched-chain subunits; and %28%4%29% their occurrence in unusual habitats. While archaea resemble bacteria in morphology and genomic organization, they resemble eukarya in their method of genomic replication. The domain contains at least four kingdoms: CRENARCHAEOTA; EURYARCHAEOTA; NANOARCHAEOTA; and KORARCHAEOTA.%A%    
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D001105 2006
% 210.35/210.52  |- rdf__type mesh__D001105sskos__Concept
% 210.35/210.52  |- skos__altLabel mesh__D001105 Archaeobacteria
% 210.35/210.52  |- skos__historyNote mesh__D001105 Bacteria %28%1966-1980%29%
% 210.35/210.52  |- mesh__dateRevised mesh__D001105 2005-06-30
% 210.35/210.52  |- mesh__runningHead mesh__D001105 B7 - ORGANISMS-ARCHAEA   
% 210.35/210.52  |- mesh__dateCreated mesh__D001105 1980-04-02
% 210.35/210.52  |- skos__altLabel mesh__D001105 Archaebacteria
% 210.35/210.52  |- skos__altLabel mesh__D001105 Archaeon
% 210.35/210.52  |- mesh__historyNote mesh__D001105
% 210.35/210.52       98%28%81%29%; ARCHAEA was see ARCHAEOBACTERIA 1995-97   
% 210.35/210.52  |- mesh__recordMaintainer mesh__D001105 ags
% 210.35/210.52  |- skos__annotation mesh__D001105
% 210.35/210.52       in taxonomy, one of the 3 domains of life along with BACTERIA %26% Eucarya%A%  
% 210.35/210.52  |- mesh__recordAuthorizer mesh__D001105 sjn
% 210.35/210.52  |- skos__altLabel mesh__D001105 Archebacteria
% 210.35/210.52  |- mesh__recordOriginator mesh__D001105 AEP
% 210.35/210.52  |- mesh__dateEstablished mesh__D001105 1991-01-01
% 210.35/210.52  |- skos__related mesh__D020868smesh__D019175
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D020868 2005
% 210.35/210.52  |- skos__scopeNote mesh__D020868
% 210.35/210.52       Interruption or suppression of the expression of a gene at transcriptional or translational levels.%A%    
% 210.35/210.52  |- skos__historyNote mesh__D020868
% 210.35/210.52       Gene Expression Regulation %28%1981-1999%29%
% 210.35/210.52  |- mesh__dateCreated mesh__D020868 1999-11-03
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D020868 2004
% 210.35/210.52  |- mesh__historyNote mesh__D020868 2000   
% 210.35/210.52  |- rdf__type mesh__D020868sskos__Concept
% 210.35/210.52  |- mesh__recordOriginator mesh__D020868 nns
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D020868 2006
% 210.35/210.52  |- skos__altLabel mesh__D020868 Gene Inactivation
% 210.35/210.52  |- mesh__recordAuthorizer mesh__D020868 sjn
% 210.35/210.52  |- skos__hiddenLabel mesh__D020868 Silencing, Gene
% 210.35/210.52  |- skos__broader mesh__D020868smesh__D005786
% 210.35/210.52  |- mesh__dateRevised mesh__D020868 2003-07-09
% 210.35/210.52  |- skos__related mesh__D020868smesh__D044127
% 210.35/210.52  |- skos__prefLabel mesh__D020868 Gene Silencing
% 210.35/210.52  |- skos__hiddenLabel mesh__D020868 Inactivation, Gene
% 210.35/210.52  |- mesh__publicMeSHNote mesh__D020868 2000   
% 210.35/210.52  |- mesh__recordMaintainer mesh__D020868 nns
% 210.35/210.52  |- mesh__dateEstablished mesh__D020868 2000-01-01
% 210.35/210.52  |- mesh__dateCreated mesh__D006399 1977-11-25
% 210.35/210.52  |- skos__prefLabel mesh__D006399 Hematocolpos
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D006399 2006
% 210.35/210.52  |- mesh__publicMeSHNote mesh__D006399 79   
% 210.35/210.52  |- skos__broader mesh__D006399smesh__D014623
% 210.35/210.52  |- mesh__recordMaintainer mesh__D006399 lkt
% 210.35/210.52  |- skos__historyNote mesh__D006399 Vagina/abnormalities %28%1966-1978%29%
% 210.35/210.52  |- skos__scopeNote mesh__D006399
% 210.35/210.52       A blood-filled VAGINA that is obstructed.     
% 210.35/210.52  |- mesh__dateRevised mesh__D006399 2005-06-30
% 210.35/210.52  |- skos__historyNote mesh__D006399 Vaginal Diseases %28%1966-1978%29%
% 210.35/210.52  |- mesh__historyNote mesh__D006399 79   
% 210.35/210.52  |- mesh__recordAuthorizer mesh__D006399 sjn
% 210.35/210.52  |- mesh__recordOriginator mesh__D006399 SMH
% 210.35/210.52  |- rdf__type mesh__D006399sskos__Concept
% 210.35/210.52  |- mesh__dateEstablished mesh__D006399 1979-01-01
% 210.35/210.52  |- skos__hiddenLabel mesh__D019516 Closure, Orthodontic Space
% 210.35/210.52  |- skos__hiddenLabel mesh__D019516 Orthodontic Space Closures
% 210.35/210.52  |- skos__hiddenLabel mesh__D019516 Space Closures, Orthodontic
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D019516 2006
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D019516 2003
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D019516 2000
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D019516 2004
% 210.35/210.52  |- rdf__type mesh__D019516sskos__Concept
% 210.35/210.52  |- skos__scopeNote mesh__D019516
% 210.35/210.52       Therapeutic closure of spaces caused by the extraction of teeth, the congenital absence of teeth, or the excessive space between teeth.%A%    
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D019516 2001
% 210.35/210.52  |- mesh__historyNote mesh__D019516 97   
% 210.35/210.52  |- skos__prefLabel mesh__D019516 Orthodontic Space Closure
% 210.35/210.52  |- mesh__dateEstablished mesh__D019516 1997-01-01
% 210.35/210.52  |- mesh__publicMeSHNote mesh__D019516 97   
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D019516 1998
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D019516 2002
% 210.35/210.52  |- mesh__dateCreated mesh__D019516 1996-06-24
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D019516 1999
% 210.35/210.52  |- skos__altLabel mesh__D019516 Space Closure, Orthodontic
% 210.35/210.52  |- skos__broader mesh__D019516smesh__D009971
% 210.35/210.52  |- skos__hiddenLabel mesh__D019516 Closures, Orthodontic Space
% 210.35/210.52  |- skos__historyNote mesh__D019516 Tooth Movement %28%1993-1996%29%
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D019516 1997
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D019516 2005
% 210.35/210.52  |- skos__related mesh__D011533smesh__D016254
% 210.35/210.52  |- skos__scopeNote mesh__D011533
% 210.35/210.52       Duplex DNA sequences in eukaryotic chromosomes, corresponding to the genome of a virus, that are transmitted from one cell generation to the next without causing lysis of the host. Proviruses are often associated with neoplastic cell transformation and are key features of retrovirus biology.%A%    
% 210.35/210.52  |- skos__related mesh__D011533smesh__D020077
% 210.35/210.52  |- rdf__type mesh__D011533sskos__Concept
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D011533 2004
% 210.35/210.52  |- skos__related mesh__D011533smesh__D016662
% 210.35/210.52  |- mesh__dateCreated mesh__D011533 1987-05-09
% 210.35/210.52  |- skos__historyNote mesh__D011533
% 210.35/210.52       Oncogenic Viruses or specific %28%1971-1976%29%
% 210.35/210.52  |- skos__annotation mesh__D011533
% 210.35/210.52       coord IM with specific virus %28%IM%29%   
% 210.35/210.52  |- mesh__historyNote mesh__D011533 88   
% 210.35/210.52  |- skos__related mesh__D011533smesh__D039002
% 210.35/210.52  |- mesh__dateRevised mesh__D011533 2002-07-03
% 210.35/210.52  |- mesh__recordAuthorizer mesh__D011533 sjn
% 210.35/210.52  |- skos__altLabel mesh__D011533 Provirus
% 210.35/210.52  |- skos__broader mesh__D011533smesh__D014780
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D011533 2005
% 210.35/210.52  |- mesh__recordOriginator mesh__D011533 SCD
% 210.35/210.52  |- mesh__dateEstablished mesh__D011533 1988-01-01
% 210.35/210.52  |- skos__historyNote mesh__D011533
% 210.35/210.52       Retroviridae or specific %28%1977-1987%29%
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D011533 2006
% 210.35/210.52  |- mesh__publicMeSHNote mesh__D011533 88   
% 210.35/210.52  |- mesh__recordMaintainer mesh__D011533 ags
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D011533 2003
% 210.35/210.52  |- skos__prefLabel mesh__D011533 Proviruses
% 210.35/210.52  |- rdf__type mesh__D035981sskos__Concept
% 210.35/210.52  |- skos__altLabel mesh__D035981 Ivy, English
% 210.35/210.52  |- mesh__dateEstablished mesh__D035981 2003-01-01
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D035981 2006
% 210.35/210.52  |- skos__scopeNote mesh__D035981
% 210.35/210.52       A plant genus of the family ARALIACEAE. Members contain hederin %28%olean-12-ene%29% type TRITERPENES.%A%    
% 210.35/210.52  |- skos__annotation mesh__D035981
% 210.35/210.52       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.35/210.52  |- skos__prefLabel mesh__D035981 Hedera
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D035981 2005
% 210.35/210.52  |- mesh__publicMeSHNote mesh__D035981 2003   
% 210.35/210.52  |- mesh__historyNote mesh__D035981 2003   
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D035981 2004
% 210.35/210.52  |- mesh__dateCreated mesh__D035981 2002-07-03
% 210.35/210.52  |- skos__broader mesh__D035981smesh__D027481
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D035981 2003
% 210.35/210.52  |- skos__hiddenLabel mesh__D021961 Structures, Cell Membrane
% 210.35/210.52  |- mesh__recordAuthorizer mesh__D021961 ags
% 210.35/210.52  |- mesh__publicMeSHNote mesh__D021961 2001   
% 210.35/210.52  |- mesh__dateCreated mesh__D021961 2000-07-05
% 210.35/210.52  |- skos__prefLabel mesh__D021961 Cell Membrane Structures
% 210.35/210.52  |- mesh__recordMaintainer mesh__D021961 nns
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D021961 2001
% 210.35/210.52  |- skos__hiddenLabel mesh__D021961 Structure, Cell Membrane
% 210.35/210.52  |- skos__hiddenLabel mesh__D021961 Membrane Structure, Cell
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D021961 2002
% 210.35/210.52  |- skos__hiddenLabel mesh__D021961 Cell Membrane Structure
% 210.35/210.52  |- skos__hiddenLabel mesh__D021961 Membrane Structures, Cell
% 210.35/210.52  |- mesh__historyNote mesh__D021961 2001   
% 210.35/210.52  |- rdf__type mesh__D021961sskos__Concept
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D021961 2005
% 210.35/210.52  |- skos__annotation mesh__D021961 GEN: avoid; prefer specifics   
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D021961 2003
% 210.35/210.52  |- mesh__recordOriginator mesh__D021961 nns
% 210.35/210.52  |- skos__scopeNote mesh__D021961
% 210.35/210.52       Structures which are part of the CELL MEMBRANE or have cell membrane as a major part of their structure.%A%    
% 210.35/210.52  |- skos__broader mesh__D021961smesh__D002462
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D021961 2006
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D021961 2004
% 210.35/210.52  |- mesh__dateEstablished mesh__D021961 2001-01-01
% 210.35/210.52  |- skos__prefLabel mesh__D007492 Iran
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D007492 1996
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D007492 1993
% 210.35/210.52  |- mesh__dateRevised mesh__D007492 1992-05-20
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D007492 2001
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D007492 2003
% 210.35/210.52  |- mesh__dateCreated mesh__D007492 1999-01-01
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D007492 2000
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D007492 1999
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D007492 2006
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D007492 1995
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D007492 1998
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D007492 2005
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D007492 1994
% 210.35/210.52  |- mesh__recordAuthorizer mesh__D007492 PLS
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D007492 2002
% 210.35/210.52  |- skos__broader mesh__D007492smesh__D008877
% 210.35/210.52  |- rdf__type mesh__D007492sskos__Concept
% 210.35/210.52  |- mesh__recordMaintainer mesh__D007492 PLS
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D007492 1997
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D007492 2004
% 210.35/210.52  |- mesh__recordOriginator mesh__D007492 NLM
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D015924 2001
% 210.35/210.52  |- skos__annotation mesh__D015924
% 210.35/210.52       measurement must be continuous; often in telemetric monitoring; do not use as a substitute for use of a sphygmomanometer for the usual blood pressure reading %28% = BLOOD PRESSURE DETERMINATION /instrum%29%%A%  
% 210.35/210.52  |- skos__altLabel mesh__D015924 Monitors, Blood Pressure
% 210.35/210.52  |- rdf__type mesh__D015924sskos__Concept
% 210.35/210.52  |- mesh__dateRevised mesh__D015924 1997-06-20
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D015924 2004
% 210.35/210.52  |- mesh__dateEstablished mesh__D015924 1990-01-01
% 210.35/210.52  |- skos__hiddenLabel mesh__D015924 Continuous Sphygmomanometers
% 210.35/210.52  |- mesh__historyNote mesh__D015924 90   
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D015924 1998
% 210.35/210.52  |- skos__hiddenLabel mesh__D015924 Blood Pressure Monitor
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D015924 1999
% 210.35/210.52  |- skos__hiddenLabel mesh__D015924 Pressure Monitor, Blood
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D015924 2002
% 210.35/210.52  |- mesh__publicMeSHNote mesh__D015924 90   
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D015924 2005
% 210.35/210.52  |- mesh__dateCreated mesh__D015924 1989-05-26
% 210.35/210.52  |- skos__historyNote mesh__D015924
% 210.35/210.52       Blood Pressure Determination/instrumentation %28%1970-1989%29%
% 210.35/210.52  |- skos__hiddenLabel mesh__D015924 Sphygmomanometer, Continuous
% 210.35/210.52  |- skos__scopeNote mesh__D015924
% 210.35/210.52       Devices for continuously measuring and displaying the arterial blood pressure.%A%    
% 210.35/210.52  |- skos__broader mesh__D015924smesh__D019722
% 210.35/210.52  |- skos__altLabel mesh__D015924 Sphygmomanometers, Continuous
% 210.35/210.52  |- skos__prefLabel mesh__D015924 Blood Pressure Monitors
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D015924 2006
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D015924 2000
% 210.35/210.52  |- mesh__recordOriginator mesh__D015924 PLS
% 210.35/210.52  |- skos__hiddenLabel mesh__D015924 Continuous Sphygmomanometer
% 210.35/210.52  |- skos__historyNote mesh__D015924
% 210.35/210.52       Monitoring, Physiologic/instrumentation %28%1970-1989%29%
% 210.35/210.52  |- mesh__recordMaintainer mesh__D015924 PXP
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D015924 2003
% 210.35/210.52  |- skos__hiddenLabel mesh__D015924 Monitor, Blood Pressure
% 210.35/210.52  |- skos__hiddenLabel mesh__D015924 Pressure Monitors, Blood
% 210.35/210.52  |- mesh__recordAuthorizer mesh__D015924 SJN
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D015126 2006
% 210.35/210.52  |- skos__historyNote mesh__D015126
% 210.35/210.52       Fatty Acids, Unsaturated %28%1973-1974%29%
% 210.35/210.52  |- skos__hiddenLabel mesh__D015126 Linolenic Acid, Homo-gamma
% 210.35/210.52  |- skos__hiddenLabel mesh__D015126 Acid, Dihomo-gamma-Linolenic
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D015126 2005
% 210.35/210.52  |- mesh__publicMeSHNote mesh__D015126
% 210.35/210.52       91; was see under FATTY ACIDS, UNSATURATED 1975-90   
% 210.35/210.52  |- mesh__recordAuthorizer mesh__D015126 sjn
% 210.35/210.52  |- mesh__historyNote mesh__D015126
% 210.35/210.52       91%28%75%29%; was see under FATTY ACIDS, UNSATURATED 1975-90   
% 210.35/210.52  |- skos__hiddenLabel mesh__D015126 Dihomo gamma Linolenic Acid
% 210.35/210.52  |- skos__altLabel mesh__D015126 8,11,14 Eicosatrienoic Acid
% 210.35/210.52  |- mesh__recordMaintainer mesh__D015126 ssb
% 210.35/210.52  |- skos__prefLabel mesh__D015126 8,11,14-Eicosatrienoic Acid
% 210.35/210.52  |- skos__hiddenLabel mesh__D015126 Acid, Homo-gamma Linolenic
% 210.35/210.52  |- skos__hiddenLabel mesh__D015126 Acid, Dihomogammalinolenic
% 210.35/210.52  |- skos__hiddenLabel mesh__D015126 Ro 121989
% 210.35/210.52  |- skos__hiddenLabel mesh__D015126 Homo gamma Linolenic Acid
% 210.35/210.52  |- rdf__type mesh__D015126sskos__Concept
% 210.35/210.52  |- skos__altLabel mesh__D015126 Dihomogammalinolenic Acid
% 210.35/210.52  |- mesh__dateRevised mesh__D015126 2003-07-09
% 210.35/210.52  |- mesh__dateCreated mesh__D015126 1974-11-19
% 210.35/210.52  |- skos__scopeNote mesh__D015126
% 210.35/210.52       A 20-carbon-chain fatty acid, unsaturated at positions 8, 11, and 14. It differs from arachidonic acid, 5,8,11,14-eicosatetraenoic acid, only at position 5.%A%    
% 210.35/210.52  |- skos__broader mesh__D015126smesh__D015777
% 210.35/210.52  |- mesh__recordOriginator mesh__D015126 NLM
% 210.35/210.52  |- skos__hiddenLabel mesh__D015126 Ro 12 1989
% 210.35/210.52  |- skos__altLabel mesh__D015126 DHLA
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D015126 2004
% 210.35/210.52  |- mesh__dateEstablished mesh__D015126 1991-01-01
% 210.35/210.52  |- skos__altLabel mesh__D015126 Dihomo-gamma-Linolenic Acid
% 210.35/210.52  |- skos__scopeNote mesh__D001904
% 210.35/210.52       Antiserum given therapeutically in BOTULISM.     
% 210.35/210.52  |- mesh__dateRevised mesh__D001904 2005-06-30
% 210.35/210.52  |- skos__historyNote mesh__D001904 Antitoxins %28%1966-1971%29%
% 210.35/210.52  |- mesh__publicMeSHNote mesh__D001904 73   
% 210.35/210.52  |- mesh__recordAuthorizer mesh__D001904 sjn
% 210.35/210.52  |- mesh__recordOriginator mesh__D001904 NLM
% 210.35/210.52  |- skos__broader mesh__D001904smesh__D000992
% 210.35/210.52  |- rdf__type mesh__D001904sskos__Concept
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D001904 2006
% 210.35/210.52  |- mesh__dateCreated mesh__D001904 1999-01-01
% 210.35/210.52  |- mesh__recordMaintainer mesh__D001904 ssb
% 210.35/210.52  |- skos__prefLabel mesh__D001904 Botulinum Antitoxin
% 210.35/210.52  |- skos__hiddenLabel mesh__D001904 Antitoxin, Botulinum
% 210.35/210.52  |- mesh__historyNote mesh__D001904 73%28%72%29%   
% 210.35/210.52  |- mesh__dateEstablished mesh__D001904 1973-01-01
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D001106 2000
% 210.35/210.52  |- mesh__recordOriginator mesh__D001106 NLM
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D001106 2003
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D001106 1997
% 210.35/210.52  |- skos__related mesh__D001106smesh__D010162
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D001106 2001
% 210.35/210.52  |- skos__annotation mesh__D001106
% 210.35/210.52       IM; SPEC; SPEC qualif; pre-Columbian: nothing later; DF: ARCHAEOL%A%  
% 210.35/210.52  |- skos__broader mesh__D001106smesh__D000884
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D001106 2004
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D001106 1998
% 210.35/210.52  |- mesh__recordMaintainer mesh__D001106 JLS
% 210.35/210.52  |- mesh__dateRevised mesh__D001106 1993-06-04
% 210.35/210.52  |- mesh__recordAuthorizer mesh__D001106 PLS
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D001106 2002
% 210.35/210.52  |- mesh__dateCreated mesh__D001106 1999-01-01
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D001106 2005
% 210.35/210.52  |- skos__altLabel mesh__D001106 Archeology
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D001106 1999
% 210.35/210.52  |- skos__prefLabel mesh__D001106 Archaeology
% 210.35/210.52  |- rdf__type mesh__D001106sskos__Concept
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D001106 1994
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D001106 2006
% 210.35/210.52  |- skos__scopeNote mesh__D001106
% 210.35/210.52       The scientific study of past societies through artifacts, fossils, etc.%A%    
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D001106 1995
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D001106 1996
% 210.35/210.52  |- skos__annotation mesh__D020869
% 210.35/210.52       do not confuse with DNA PROFILING see DNA FINGERPRINTING %28%determining the uniqueness of the DNA sequence of an individual%29%%A%  
% 210.35/210.52  |- skos__scopeNote mesh__D020869
% 210.35/210.52       The determination of the pattern of genes expressed at the level of GENETIC TRANSCRIPTION, under specific circumstances or in a specific cell.%A%    
% 210.35/210.52  |- skos__hiddenLabel mesh__D020869 Profilings, Gene Expression
% 210.35/210.52  |- skos__hiddenLabel mesh__D020869 Transcript Expression Analyses
% 210.35/210.52  |- skos__hiddenLabel mesh__D020869 Differential Displays, mRNA
% 210.35/210.52  |- skos__hiddenLabel mesh__D020869 Analyses, Transcript Expression
% 210.35/210.52  |- mesh__recordMaintainer mesh__D020869 nns
% 210.35/210.52  |- mesh__dateEstablished mesh__D020869 2000-01-01
% 210.35/210.52  |- skos__prefLabel mesh__D020869 Gene Expression Profiling
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D020869 2004
% 210.35/210.52  |- skos__altLabel mesh__D020869 Transcript Expression Analysis
% 210.35/210.52  |- skos__hiddenLabel mesh__D020869 mRNA Differential Displays
% 210.35/210.52  |- skos__hiddenLabel mesh__D020869 Gene Expression Profilings
% 210.35/210.52  |- mesh__dateRevised mesh__D020869 2003-07-09
% 210.35/210.52  |- skos__hiddenLabel mesh__D020869 Analysis, Transcript Expression
% 210.35/210.52  |- rdf__type mesh__D020869sskos__Concept
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D020869 2006
% 210.35/210.52  |- skos__hiddenLabel mesh__D020869 Monitoring, Gene Expression
% 210.35/210.52  |- skos__related mesh__D020869smesh__D015870
% 210.35/210.52  |- skos__hiddenLabel mesh__D020869 Profiling, Gene Expression
% 210.35/210.52  |- mesh__historyNote mesh__D020869 2000   
% 210.35/210.52  |- skos__altLabel mesh__D020869 Gene Expression Pattern Analysis
% 210.35/210.52  |- skos__related mesh__D020869smesh__D020411
% 210.35/210.52  |- skos__altLabel mesh__D020869 Gene Expression Monitoring
% 210.35/210.52  |- mesh__recordOriginator mesh__D020869 nns
% 210.35/210.52  |- skos__hiddenLabel mesh__D020869 Gene Expression Monitorings
% 210.35/210.52  |- skos__hiddenLabel mesh__D020869 Differential Display, mRNA
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D020869 2005
% 210.35/210.52  |- skos__broader mesh__D020869smesh__D005821
% 210.35/210.52  |- skos__hiddenLabel mesh__D020869 Monitorings, Gene Expression
% 210.35/210.52  |- mesh__publicMeSHNote mesh__D020869 2000   
% 210.35/210.52  |- mesh__dateCreated mesh__D020869 1999-11-03
% 210.35/210.52  |- mesh__recordAuthorizer mesh__D020869 sjn
% 210.35/210.52  |- skos__hiddenLabel mesh__D020869 Displays, mRNA Differential
% 210.35/210.52  |- skos__hiddenLabel mesh__D020869 Display, mRNA Differential
% 210.35/210.52  |- mesh__recordMaintainer mesh__D047208 ags
% 210.35/210.52  |- mesh__recordAuthorizer mesh__D047208 ags
% 210.35/210.52  |- skos__hiddenLabel mesh__D047208 Neurotoxin, RNS2
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D047208 2006A
% 210.35/210.52  |- skos__broader mesh__D047208smesh__D047091
% 210.35/210.52  |- skos__hiddenLabel mesh__D047208 Eosinophil Derived Neurotoxin
% 210.35/210.52  |- skos__hiddenLabel mesh__D047208 Neurotoxin, Eosinophil-Derived
% 210.35/210.52  |- skos__altLabel mesh__D047208 Eosinophil Protein X
% 210.35/210.52  |- skos__altLabel mesh__D047208 Serum Eosinophil Protein X
% 210.35/210.52  |- mesh__historyNote mesh__D047208 2005%28%1989%29%   
% 210.35/210.52  |- mesh__dateCreated mesh__D047208 2004-07-07
% 210.35/210.52  |- mesh__dateRevised mesh__D047208 2005-07-08
% 210.35/210.52  |- skos__historyNote mesh__D047208 Ribonucleases %28%1989-2004%29%
% 210.35/210.52  |- skos__broader mesh__D047208smesh__D004722
% 210.35/210.52  |- skos__altLabel mesh__D047208 RNS2 Neurotoxin
% 210.35/210.52  |- mesh__publicMeSHNote mesh__D047208
% 210.35/210.52       2005; EOSINOPHIL-DERIVED NEUROTOXIN was indexed under RIBONUCLEASES 1989-2004%A%  
% 210.35/210.52  |- skos__scopeNote mesh__D047208
% 210.35/210.52       A 19-kDa cationic peptide found in EOSINOPHIL granules. Eosinophil-derived neurotoxin is a RIBONUCLEASE and may play a role as an endogenous antiviral agent.%A%    
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D047208 2006
% 210.35/210.52  |- rdf__type mesh__D047208sskos__Concept
% 210.35/210.52  |- mesh__recordOriginator mesh__D047208 jmp
% 210.35/210.52  |- skos__prefLabel mesh__D047208 Eosinophil-Derived Neurotoxin
% 210.35/210.52  |- mesh__dateEstablished mesh__D047208 2005-01-01
% 210.35/210.52  |- skos__altLabel mesh__D047208 s-EPX
% 210.35/210.52  |- mesh__dateCreated mesh__D019517 1996-06-21
% 210.35/210.52  |- skos__scopeNote mesh__D019517
% 210.35/210.52       Work consisting of untitled raw motion picture and video footage which has not been edited or assembled into a finished work. %28%From: Moving Image Materials: Genre Terms, 1988%29%%A%    
% 210.35/210.52  |- rdf__type mesh__D019517sskos__Concept
% 210.35/210.52  |- mesh__recordMaintainer mesh__D019517 jls
% 210.35/210.52  |- mesh__dateRevised mesh__D019517 2005-06-30
% 210.35/210.52  |- mesh__recordOriginator mesh__D019517 TGC
% 210.35/210.52  |- mesh__historyNote mesh__D019517 1997   
% 210.35/210.52  |- skos__annotation mesh__D019517
% 210.35/210.52       publication type only; unedited raw motion picture or video footage;  used for historical materials only; CATALOG: do not use for current materials%A%  
% 210.35/210.52  |- skos__broader mesh__D019517smesh__D052180
% 210.35/210.52  |- skos__prefLabel mesh__D019517 Unedited Footage %5B%Publication Type%5D%
% 210.35/210.52  |- mesh__dateEstablished mesh__D019517 1997-01-01
% 210.35/210.52  |- skos__altLabel mesh__D019517 Unedited Footage %28%PT%29%
% 210.35/210.52  |- skos__altLabel mesh__D019517 Unedited Footage
% 210.35/210.52  |- mesh__recordAuthorizer mesh__D019517 sjn
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D019517 2006
% 210.35/210.52  |- skos__altLabel mesh__D019517 Outtakes
% 210.35/210.52  |- skos__broader mesh__D021962smesh__D021961
% 210.35/210.52  |- skos__scopeNote mesh__D021962
% 210.35/210.52       Detergent-insoluble CELL MEMBRANE components. They are enriched in SPHINGOLIPIDS and CHOLESTEROL and clustered with glycosyl-phosphatidylinositol %28%GPI%29%-anchored proteins.%A%    
% 210.35/210.52  |- mesh__recordOriginator mesh__D021962 nns
% 210.35/210.52  |- mesh__activeMeSHYear mesh__D021962 2006
% 210.35/210.53  |- skos__historyNote mesh__D021962 Cell Membrane %28%1981-2000%29%
% 210.35/210.53  |- mesh__publicMeSHNote mesh__D021962 2001   
% 210.35/210.53  |- skos__hiddenLabel mesh__D021962 Sphingolipid Microdomain
% 210.35/210.53  |- skos__hiddenLabel mesh__D021962 Microdomain, Membrane
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D021962 2005
% 210.35/210.53  |- mesh__recordAuthorizer mesh__D021962 sjn
% 210.35/210.53  |- skos__prefLabel mesh__D021962 Membrane Microdomains
% 210.35/210.53  |- skos__altLabel mesh__D021962 Lipid Rafts, Cell Membrane
% 210.35/210.53  |- mesh__dateCreated mesh__D021962 2000-06-22
% 210.35/210.53  |- skos__hiddenLabel mesh__D021962 Sphingolipid-Cholesterol Raft
% 210.35/210.53  |- skos__altLabel mesh__D021962 Sphingolipid Microdomains
% 210.35/210.53  |- mesh__recordMaintainer mesh__D021962 jmp
% 210.35/210.53  |- mesh__dateRevised mesh__D021962 2004-07-07
% 210.35/210.53  |- mesh__historyNote mesh__D021962 2001   
% 210.35/210.53  |- skos__hiddenLabel mesh__D021962 Microdomains, Sphingolipid
% 210.35/210.53  |- mesh__dateEstablished mesh__D021962 2001-01-01
% 210.35/210.53  |- skos__hiddenLabel mesh__D021962 Microdomains, Membrane
% 210.35/210.53  |- skos__hiddenLabel mesh__D021962 Sphingolipid Cholesterol Rafts
% 210.35/210.53  |- skos__hiddenLabel mesh__D021962 Membrane Microdomain
% 210.35/210.53  |- skos__hiddenLabel mesh__D021962 Microdomain, Sphingolipid
% 210.35/210.53  |- rdf__type mesh__D021962sskos__Concept
% 210.35/210.53  |- skos__altLabel mesh__D021962 Sphingolipid-Cholesterol Rafts
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007493 1999
% 210.35/210.53  |- mesh__recordOriginator mesh__D007493 NLM
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007493 2006
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007493 1995
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007493 1998
% 210.35/210.53  |- mesh__dateRevised mesh__D007493 1992-05-20
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007493 2001
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007493 2005
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007493 1994
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007493 2000
% 210.35/210.53  |- skos__broader mesh__D007493smesh__D008877
% 210.35/210.53  |- rdf__type mesh__D007493sskos__Concept
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007493 1997
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007493 2004
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007493 1996
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007493 1993
% 210.35/210.53  |- mesh__recordAuthorizer mesh__D007493 PLS
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007493 2003
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007493 2002
% 210.35/210.53  |- mesh__dateCreated mesh__D007493 1999-01-01
% 210.35/210.53  |- skos__prefLabel mesh__D007493 Iraq
% 210.35/210.53  |- mesh__recordMaintainer mesh__D007493 PLS
% 210.35/210.53  |- skos__annotation mesh__D015925
% 210.35/210.53       %22%preservation of cells, tissue, organs or embryos by freezing%22%; cryopreserv of organs or tissue: coord IM with specific organ or tissue heading %28%IM with no qualif%29%%A%  
% 210.35/210.53  |- mesh__dateCreated mesh__D015925 1989-05-26
% 210.35/210.53  |- mesh__recordAuthorizer mesh__D015925 sjn
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D015925 2005
% 210.35/210.53  |- mesh__publicMeSHNote mesh__D015925 90   
% 210.35/210.53  |- skos__broader mesh__D015925smesh__D011309
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D015925 2006
% 210.35/210.53  |- mesh__historyNote mesh__D015925 90   
% 210.35/210.53  |- mesh__recordOriginator mesh__D015925 PLS
% 210.35/210.53  |- skos__prefLabel mesh__D015925 Cryopreservation
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D015925 2003
% 210.35/210.53  |- mesh__dateRevised mesh__D015925 2001-07-25
% 210.35/210.53  |- skos__hiddenLabel mesh__D015925 Suspension, Cryonic
% 210.35/210.53  |- skos__hiddenLabel mesh__D015925 Suspensions, Cryonic
% 210.35/210.53  |- skos__hiddenLabel mesh__D015925 Cryonic Suspensions
% 210.35/210.53  |- skos__historyNote mesh__D015925
% 210.35/210.53       Preservation, Biological %28%1975-1989%29%
% 210.35/210.53  |- mesh__recordMaintainer mesh__D015925 nns
% 210.35/210.53  |- skos__historyNote mesh__D015925 Freezing %28%1966-1989%29%
% 210.35/210.53  |- skos__altLabel mesh__D015925 Cryofixation
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D015925 2004
% 210.35/210.53  |- rdf__type mesh__D015925sskos__Concept
% 210.35/210.53  |- skos__scopeNote mesh__D015925
% 210.35/210.53       Preservation of cells, tissues, organs, or embryos by freezing. In histological preparations, cryopreservation or cryofixation is used to maintain the existing form, structure, and chemical composition of all the constituent elements of the specimens.%A%    
% 210.35/210.53  |- skos__broader mesh__D015925smesh__D014021
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D015925 2002
% 210.35/210.53  |- mesh__dateEstablished mesh__D015925 1990-01-01
% 210.35/210.53  |- mesh__publicMeSHNote mesh__D015127
% 210.35/210.53       85; was see under BENZANTHRACENES 1975-84   
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D015127 2005
% 210.35/210.53  |- skos__altLabel mesh__D015127 7,12-Dimethylbenzanthracene
% 210.35/210.53  |- skos__broader mesh__D015127smesh__D001551
% 210.35/210.53  |- skos__altLabel mesh__D015127 DMBA
% 210.35/210.53  |- mesh__recordOriginator mesh__D015127 RLS
% 210.35/210.53  |- rdf__type mesh__D015127sskos__Concept
% 210.35/210.53  |- mesh__historyNote mesh__D015127
% 210.35/210.53       85%28%75%29%; was see under BENZANTHRACENES 1975-84   
% 210.35/210.53  |- mesh__recordAuthorizer mesh__D015127 sjn
% 210.35/210.53  |- skos__hiddenLabel mesh__D015127 7,12 Dimethylbenzanthracene
% 210.35/210.53  |- mesh__dateEstablished mesh__D015127 1985-01-01
% 210.35/210.53  |- mesh__recordMaintainer mesh__D015127 ssb
% 210.35/210.53  |- skos__annotation mesh__D015127
% 210.35/210.53       a carcinogen; D25-26 qualif; DF: note short X ref   
% 210.35/210.53  |- skos__historyNote mesh__D015127 Benzanthracenes %28%1966-1974%29%
% 210.35/210.53  |- mesh__dateCreated mesh__D015127 1974-10-24
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D015127 2006
% 210.35/210.53  |- skos__prefLabel mesh__D015127 9,10-Dimethyl-1,2-benzanthracene
% 210.35/210.53  |- skos__scopeNote mesh__D015127
% 210.35/210.53       7,12-Dimethylbenzanthracene. Polycyclic aromatic hydrocarbon found in tobacco smoke that is a potent carcinogen.%A%    
% 210.35/210.53  |- mesh__dateRevised mesh__D015127 2004-07-07
% 210.35/210.53  |- skos__historyNote mesh__D001905 Clostridium Botulinum %28%1966-1968%29%
% 210.35/210.53  |- mesh__publicMeSHNote mesh__D001905 78; was BOTULINUM TOXIN 1972-77   
% 210.35/210.53  |- skos__related mesh__D001905smesh__D001906
% 210.35/210.53  |- rdf__type mesh__D001905sskos__Concept
% 210.35/210.53  |- mesh__dateRevised mesh__D001905 2005-06-30
% 210.35/210.53  |- skos__hiddenLabel mesh__D001905 Toxins, Clostridium botulinum
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001905 2006
% 210.35/210.53  |- mesh__dateCreated mesh__D001905 1999-01-01
% 210.35/210.53  |- mesh__historyNote mesh__D001905
% 210.35/210.53       78; was BOTULINUM TOXIN 1969-77 %28%Prov 1969-71%29%   
% 210.35/210.53  |- mesh__onlineNote mesh__D001905
% 210.35/210.53       use BOTULINUM TOXINS to search BOTULINUM TOXIN 1969-77 %28%as Prov 1969-71%29%%A%  
% 210.35/210.53  |- mesh__recordAuthorizer mesh__D001905 sjn
% 210.35/210.53  |- mesh__recordOriginator mesh__D001905 NLM
% 210.35/210.53  |- skos__hiddenLabel mesh__D001905 botulinum Toxins, Clostridium
% 210.35/210.53  |- skos__altLabel mesh__D001905 Botulin
% 210.35/210.53  |- skos__altLabel mesh__D001905 Botulinum Toxin
% 210.35/210.53  |- skos__scopeNote mesh__D001905
% 210.35/210.53       Proteins synthesized as a single chain of %7E%150 kDa with 35%25% sequence identity to TETANUS TOXIN that is cleaved to a light and a heavy chain that are linked by a single disulfide bond. They have neuro-, entero-, and hemotoxic properties, are immunogenic, and include the most potent poisons known. The most commonly used apparently blocks release of ACETYLCHOLINE at cholinergic SYNAPSES.%A%    
% 210.35/210.53  |- skos__hiddenLabel mesh__D001905 Toxins, Botulinum
% 210.35/210.53  |- skos__historyNote mesh__D001905 Toxins %28%1966-1968%29%
% 210.35/210.53  |- mesh__dateEstablished mesh__D001905 1972-01-01
% 210.35/210.53  |- skos__altLabel mesh__D001905 Clostridium botulinum Toxins
% 210.35/210.53  |- skos__broader mesh__D001905smesh__D001426
% 210.35/210.53  |- mesh__recordMaintainer mesh__D001905 ssb
% 210.35/210.53  |- skos__annotation mesh__D001905
% 210.35/210.53       /antag permitted but consider also BOTULINUM ANTITOXIN   
% 210.35/210.53  |- skos__prefLabel mesh__D001905 Botulinum Toxins
% 210.35/210.53  |- skos__hiddenLabel mesh__D001905 Toxin, Botulinum
% 210.35/210.53  |- skos__broader mesh__D001905smesh__D001427
% 210.35/210.53  |- skos__broader mesh__D019800Q000031smesh__D019800
% 210.35/210.53  |- mesh__preferredCombination mesh__D019800Q000031smesh__D010636
% 210.35/210.53  |- rdf__type mesh__D019800Q000031smesh__CompoundConcept
% 210.35/210.53  |- skos__hiddenLabel mesh__D001107 Ramp
% 210.35/210.53  |- skos__scopeNote mesh__D001107
% 210.35/210.53       Designs for approaching areas inside or outside facilities.%A%    
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001107 2004
% 210.35/210.53  |- skos__hiddenLabel mesh__D001107 Architectural Barriers
% 210.35/210.53  |- mesh__recordMaintainer mesh__D001107 TPW
% 210.35/210.53  |- skos__hiddenLabel mesh__D001107 Accesses, Facility
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001107 1998
% 210.35/210.53  |- skos__hiddenLabel mesh__D001107 Architectural Barrier
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001107 2000
% 210.35/210.53  |- mesh__historyNote mesh__D001107
% 210.35/210.53       91%28%Aug 77%29%; was see under FACILITY DESIGN AND CONSTRUCTION 1977-90%A%  
% 210.35/210.53  |- skos__hiddenLabel mesh__D001107 Barrier, Architectural
% 210.35/210.53  |- skos__hiddenLabel mesh__D001107 Access, Facility
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001107 2005
% 210.35/210.53  |- skos__altLabel mesh__D001107 Accessibility, Architectural
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001107 1999
% 210.35/210.53  |- skos__hiddenLabel mesh__D001107 Facility Accesses
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001107 2001
% 210.35/210.53  |- skos__annotation mesh__D001107
% 210.35/210.53       for approaching inside or outside areas; DF: note short X ref%A%  
% 210.35/210.53  |- rdf__type mesh__D001107sskos__Concept
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001107 2006
% 210.35/210.53  |- mesh__dateRevised mesh__D001107 1997-06-20
% 210.35/210.53  |- skos__historyNote mesh__D001107 Architecture %28%1966-Jul 1977%29%
% 210.35/210.53  |- mesh__dateEstablished mesh__D001107 1991-01-01
% 210.35/210.53  |- mesh__recordOriginator mesh__D001107 EC
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001107 2002
% 210.35/210.53  |- mesh__dateCreated mesh__D001107 1977-05-05
% 210.35/210.53  |- mesh__recordAuthorizer mesh__D001107 SJN
% 210.35/210.53  |- skos__broader mesh__D001107smesh__D005160
% 210.35/210.53  |- skos__prefLabel mesh__D001107 Architectural Accessibility
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001107 2003
% 210.35/210.53  |- mesh__publicMeSHNote mesh__D001107
% 210.35/210.53       91; was see under FACILITY DESIGN AND CONSTRUCTION 1977-90%A%  
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D047209 2006
% 210.35/210.53  |- skos__historyNote mesh__D047209 Peroxides %28%1997-2004%29%
% 210.35/210.53  |- rdf__type mesh__D047209sskos__Concept
% 210.35/210.53  |- mesh__dateEstablished mesh__D047209 2005-01-01
% 210.35/210.53  |- mesh__recordAuthorizer mesh__D047209 sjn
% 210.35/210.53  |- skos__scopeNote mesh__D047209
% 210.35/210.53       A 66-kDa peroxidase found in EOSINOPHIL granules. Eosinophil peroxidase is a cationic protein with a pI of 10.8 and is comprised of a heavy chain subunit and a light chain subunit. It possesses cytotoxic activity towards BACTERIA and other organisms, which is attributed to its peroxidase activity.%A%    
% 210.35/210.53  |- mesh__dateCreated mesh__D047209 2004-07-07
% 210.35/210.53  |- mesh__historyNote mesh__D047209 2005%28%1997%29%   
% 210.35/210.53  |- skos__broader mesh__D047209smesh__D047091
% 210.35/210.53  |- mesh__dateRevised mesh__D047209 2005-06-30
% 210.35/210.53  |- skos__hiddenLabel mesh__D047209 Peroxidase, Eosinophil
% 210.35/210.53  |- mesh__recordMaintainer mesh__D047209 ssb
% 210.35/210.53  |- skos__prefLabel mesh__D047209 Eosinophil Peroxidase
% 210.35/210.53  |- mesh__recordOriginator mesh__D047209 jmp
% 210.35/210.53  |- mesh__publicMeSHNote mesh__D047209
% 210.35/210.53       2005; EOSINOPHIL PEROXIDASE was indexed under PEROXIDES 1997-2004%A%  
% 210.35/210.53  |- skos__broader mesh__D047209smesh__D010544
% 210.35/210.53  |- skos__hiddenLabel mesh__D019518 Period, Postcibal
% 210.35/210.53  |- rdf__type mesh__D019518sskos__Concept
% 210.35/210.53  |- mesh__historyNote mesh__D019518 97   
% 210.35/210.53  |- skos__prefLabel mesh__D019518 Postprandial Period
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D019518 2006
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D019518 2004
% 210.35/210.53  |- skos__hiddenLabel mesh__D019518 Postcibal Periods
% 210.35/210.53  |- mesh__recordMaintainer mesh__D019518 lkt
% 210.35/210.53  |- mesh__recordOriginator mesh__D019518 JLS
% 210.35/210.53  |- skos__hiddenLabel mesh__D019518 Periods, Postprandial
% 210.35/210.53  |- mesh__dateRevised mesh__D019518 2003-07-09
% 210.35/210.53  |- skos__broader mesh__D019518smesh__D004068
% 210.35/210.53  |- skos__historyNote mesh__D019518 Eating %28%1966-1996%29%
% 210.35/210.53  |- skos__scopeNote mesh__D019518
% 210.35/210.53       The time frame after a meal or FOOD INTAKE.     
% 210.35/210.53  |- mesh__publicMeSHNote mesh__D019518 97   
% 210.35/210.53  |- mesh__dateEstablished mesh__D019518 1997-01-01
% 210.35/210.53  |- skos__historyNote mesh__D019518 Food %28%1966-1996%29%
% 210.35/210.53  |- skos__hiddenLabel mesh__D019518 Postprandial Periods
% 210.35/210.53  |- mesh__recordAuthorizer mesh__D019518 sjn
% 210.35/210.53  |- skos__altLabel mesh__D019518 Postcibal Period
% 210.35/210.53  |- skos__hiddenLabel mesh__D019518 Period, Postprandial
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D019518 2005
% 210.35/210.53  |- skos__hiddenLabel mesh__D019518 Periods, Postcibal
% 210.35/210.53  |- mesh__dateCreated mesh__D019518 1996-06-13
% 210.35/210.53  |- skos__hiddenLabel mesh__D011535 Belly Syndrome, Prune
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D011535 2005
% 210.35/210.53  |- skos__hiddenLabel mesh__D011535 Belly Syndromes, Prune
% 210.35/210.53  |- skos__annotation mesh__D011535
% 210.35/210.53       a syndrome of multiple abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 210.35/210.53  |- rdf__type mesh__D011535sskos__Concept
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D011535 2003
% 210.35/210.53  |- skos__historyNote mesh__D011535 Cryptorchism %28%1966-1981%29%
% 210.35/210.53  |- mesh__recordAuthorizer mesh__D011535 sjn
% 210.35/210.53  |- mesh__publicMeSHNote mesh__D011535 82   
% 210.35/210.53  |- skos__hiddenLabel mesh__D011535 Prune-Belly Syndromes
% 210.35/210.53  |- mesh__recordOriginator mesh__D011535 AEP
% 210.35/210.53  |- skos__historyNote mesh__D011535
% 210.35/210.53       Abnormalities, Multiple %28%1968-1981%29%
% 210.35/210.53  |- skos__hiddenLabel mesh__D011535 Syndromes, Prune Belly
% 210.35/210.53  |- skos__broader mesh__D011535smesh__D000015
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D011535 2002
% 210.35/210.53  |- mesh__recordMaintainer mesh__D011535 kle
% 210.35/210.53  |- skos__prefLabel mesh__D011535 Prune Belly Syndrome
% 210.35/210.53  |- skos__hiddenLabel mesh__D011535 Syndrome, Prune-Belly
% 210.35/210.53  |- mesh__historyNote mesh__D011535 82   
% 210.35/210.53  |- skos__hiddenLabel mesh__D011535 Syndromes, Prune-Belly
% 210.35/210.53  |- skos__historyNote mesh__D011535 Abdominal Wall/AB %28%1966-1981%29%
% 210.35/210.53  |- skos__hiddenLabel mesh__D011535 Prune Belly Syndromes
% 210.35/210.53  |- skos__altLabel mesh__D011535 Prune-Belly Syndrome
% 210.35/210.53  |- skos__hiddenLabel mesh__D011535 Syndrome, Prune Belly
% 210.35/210.53  |- skos__scopeNote mesh__D011535
% 210.35/210.53       A syndrome characterized by abdominal wall musculature deficiency, cryptorchism, and urinary tract abnormalities. The syndrome derives its name from its characteristic distended abdomen with wrinkled skin.%A%    
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D011535 2001
% 210.35/210.53  |- mesh__dateRevised mesh__D011535 1999-11-03
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D011535 2006
% 210.35/210.53  |- mesh__dateEstablished mesh__D011535 1982-01-01
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D011535 2000
% 210.35/210.53  |- skos__historyNote mesh__D011535 Urogenital System/AB %28%1966-1981%29%
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D011535 2004
% 210.35/210.53  |- mesh__dateCreated mesh__D011535 1981-02-23
% 210.35/210.53  |- skos__prefLabel mesh__D016220 Fibroblast Growth Factor 1
% 210.35/210.53  |- mesh__dateEstablished mesh__D016220 1991-01-01
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D016220 2006A
% 210.35/210.53  |- skos__altLabel mesh__D016220
% 210.35/210.53       Heparin-Binding Fibroblast Growth Factor Class I
% 210.35/210.53  |- skos__altLabel mesh__D016220 Fibroblast Growth Factor, Acidic
% 210.35/210.53  |- skos__altLabel mesh__D016220 Heparin-Binding Growth Factor, Class I
% 210.35/210.53  |- skos__scopeNote mesh__D016220
% 210.35/210.53       A 17-kDa single-chain polypeptide growth factor that plays a significant role in the process of WOUND HEALING and is a potent inducer of PHYSIOLOGIC ANGIOGENESIS. It binds to HEPARIN, which potentiates its biological activity and protects it from proteolysis. The growth factor is an extremely potent inducer of DNA synthesis in a variety of cell types from mesoderm and neuroectoderm lineages, and also has chemotactic and mitogenic activities. It was originally named acidic fibroblast growth factor based upon its chemical properties and to distinguish it from basic fibroblast growth factor %28%FIBROBLAST GROWTH FACTOR 2%29%.%A%    
% 210.35/210.53  |- skos__altLabel mesh__D016220 Class I Heparin-Binding Growth Factor
% 210.35/210.53  |- mesh__dateRevised mesh__D016220 2005-07-07
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D016220 2006
% 210.35/210.53  |- skos__altLabel mesh__D016220 HBGF-1
% 210.35/210.53  |- mesh__recordAuthorizer mesh__D016220 ags
% 210.35/210.53  |- mesh__recordMaintainer mesh__D016220 ags
% 210.35/210.53  |- skos__broader mesh__D016220smesh__D042501
% 210.35/210.53  |- rdf__type mesh__D016220sskos__Concept
% 210.35/210.53  |- skos__historyNote mesh__D016220
% 210.35/210.53       Fibroblast Growth Factor %28%1984-1990%29%
% 210.35/210.53  |- skos__annotation mesh__D016220 DF: FGF1   
% 210.35/210.53  |- skos__altLabel mesh__D016220 Fibroblast Growth Factor-1
% 210.35/210.53  |- mesh__publicMeSHNote mesh__D016220
% 210.35/210.53       2002; FIBROBLAST GROWTH FACTOR-1 was indexed under FIBROBLAST GROWTH FACTOR ACIDIC 2001, FIBROBLAST GROWTH FACTOR 2000-2001 %26% under FIBROBLAST GROWTH FACTOR, BASIC 1998-2000%A%  
% 210.35/210.53  |- skos__altLabel mesh__D016220 Acidic Fibroblast Growth Factor
% 210.35/210.53  |- skos__hiddenLabel mesh__D016220 Heparin Binding Growth Factor, Class I
% 210.35/210.53  |- skos__historyNote mesh__D016220 Growth Substances %28%1974-1983%29%
% 210.35/210.53  |- skos__altLabel mesh__D016220 FGF-1
% 210.35/210.53  |- mesh__dateCreated mesh__D016220 1990-07-05
% 210.35/210.53  |- mesh__recordOriginator mesh__D016220 RLS
% 210.35/210.53  |- skos__altLabel mesh__D016220 FGF1
% 210.35/210.53  |- skos__broader mesh__D016220smesh__D005346
% 210.35/210.53  |- mesh__historyNote mesh__D016220
% 210.35/210.53       2002%28%1991%29%; for FIBROBLAST GROWTH FACTOR-1 use FIBROBLAST GROWTH FACTOR 1%28%NM%29% 1998-2001%A%  
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D002200 2006
% 210.35/210.53  |- skos__scopeNote mesh__D002200
% 210.35/210.53       The vascular resistance to the flow of BLOOD through the CAPILLARIES portions of the peripheral vascular bed.%A%    
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D002200 2005
% 210.35/210.53  |- mesh__recordMaintainer mesh__D002200 nns
% 210.35/210.53  |- mesh__publicMeSHNote mesh__D002200
% 210.35/210.53       91,63-85; was see under VASCULAR RESISTANCE 1986-90; was heading 1963-85%A%  
% 210.35/210.53  |- rdf__type mesh__D002200sskos__Concept
% 210.35/210.53  |- skos__hiddenLabel mesh__D002200 Resistances, Capillary
% 210.35/210.53  |- mesh__dateEstablished mesh__D002200 1991-01-01
% 210.35/210.53  |- skos__prefLabel mesh__D002200 Capillary Resistance
% 210.35/210.53  |- mesh__recordAuthorizer mesh__D002200 sjn
% 210.35/210.53  |- mesh__recordOriginator mesh__D002200 NLM
% 210.35/210.53  |- mesh__dateCreated mesh__D002200 1999-01-01
% 210.35/210.53  |- skos__hiddenLabel mesh__D002200 Resistance, Capillary
% 210.35/210.53  |- skos__hiddenLabel mesh__D002200 Capillary Resistances
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D002200 2004
% 210.35/210.53  |- skos__broader mesh__D002200smesh__D014655
% 210.35/210.53  |- mesh__historyNote mesh__D002200
% 210.35/210.53       91%28%86%29%63; was see under VASCULAR RESISTANCE 1986-90; was heading 1963-85%A%  
% 210.35/210.53  |- mesh__dateRevised mesh__D002200 2003-07-09
% 210.35/210.53  |- skos__altLabel mesh__D007494 Irish Free State
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007494 1994
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007494 1999
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007494 2006
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007494 1995
% 210.35/210.53  |- skos__prefLabel mesh__D007494 Ireland
% 210.35/210.53  |- skos__altLabel mesh__D007494 Ireland, Republic of
% 210.35/210.53  |- skos__altLabel mesh__D007494 Eire
% 210.35/210.53  |- mesh__dateRevised mesh__D007494 1993-06-02
% 210.35/210.53  |- mesh__recordMaintainer mesh__D007494 TGC
% 210.35/210.53  |- skos__annotation mesh__D007494
% 210.35/210.53       capital, Dublin; differentiate from NORTHERN IRELAND   
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007494 2000
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007494 1996
% 210.35/210.53  |- mesh__dateCreated mesh__D007494 1999-01-01
% 210.35/210.53  |- skos__broader mesh__D007494smesh__D005060
% 210.35/210.53  |- rdf__type mesh__D007494sskos__Concept
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007494 2003
% 210.35/210.53  |- mesh__recordOriginator mesh__D007494 NLM
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007494 1997
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007494 2004
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007494 2001
% 210.35/210.53  |- mesh__recordAuthorizer mesh__D007494 PLS
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007494 2002
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007494 1998
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D007494 2005
% 210.35/210.53  |- skos__broader mesh__D015926smesh__D000706
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D015926 2006
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D015926 2006A
% 210.35/210.53  |- skos__historyNote mesh__D015926 Anaphylatoxins %28%1977-1989%29%
% 210.35/210.53  |- skos__altLabel mesh__D015926 Complement 3a
% 210.35/210.53  |- mesh__recordMaintainer mesh__D015926 ags
% 210.35/210.53  |- skos__historyNote mesh__D015926 Complement 3 %28%1975-1989%29%
% 210.35/210.53  |- mesh__historyNote mesh__D015926 2006 %28%1990%29%   
% 210.35/210.53  |- mesh__recordOriginator mesh__D015926 AGS
% 210.35/210.53  |- skos__hiddenLabel mesh__D015926 Complement, C3a
% 210.35/210.53  |- skos__broader mesh__D015926smesh__D003176
% 210.35/210.53  |- skos__hiddenLabel mesh__D015926 C3a, Complement
% 210.35/210.53  |- rdf__type mesh__D015926sskos__Concept
% 210.35/210.53  |- skos__altLabel mesh__D015926 Complement Component 3a
% 210.35/210.53  |- skos__hiddenLabel mesh__D015926 Component 3a, Complement
% 210.35/210.53  |- mesh__dateRevised mesh__D015926 2005-07-11
% 210.35/210.53  |- skos__scopeNote mesh__D015926
% 210.35/210.53       The smaller fragment generated from the cleavage of complement C3 by C3 CONVERTASE. C3a, a 77-amino acid peptide, is a mediator of local inflammatory process.  It induces smooth MUSCLE CONTRACTION, and HISTAMINE RELEASE from MAST CELLS and LEUKOCYTES. C3a is considered an anaphylatoxin along with COMPLEMENT C4A; COMPLEMENT C5A; and COMPLEMENT C5A, DES-ARGININE.%A%    
% 210.35/210.53  |- skos__historyNote mesh__D015926 Complement %28%1967-1976%29%
% 210.35/210.53  |- mesh__dateEstablished mesh__D015926 1990-01-01
% 210.35/210.53  |- mesh__recordAuthorizer mesh__D015926 ags
% 210.35/210.53  |- mesh__dateCreated mesh__D015926 1989-07-14
% 210.35/210.53  |- mesh__publicMeSHNote mesh__D015926 2006; see COMPLEMENT 3A 1990-2005   
% 210.35/210.53  |- skos__altLabel mesh__D015926 C3a Complement
% 210.35/210.53  |- skos__prefLabel mesh__D015926 Complement C3a
% 210.35/210.53  |- skos__scopeNote mesh__D001906
% 210.35/210.53       A disease caused by potent protein NEUROTOXINS produced by CLOSTRIDIUM BOTULINUM which interfere with the presynaptic release of ACETYLCHOLINE at the NEUROMUSCULAR JUNCTION. Clinical features include abdominal pain, vomiting, acute PARALYSIS %28%including respiratory paralysis%29%, blurred vision, and DIPLOPIA. Botulism may be classified into several subtypes %28%e.g., food-borne, infant, wound, and others%29%. %28%From Adams et al., Principles of Neurology, 6th ed, p1208%29%%A%    
% 210.35/210.53  |- skos__broader mesh__D001906smesh__D020511
% 210.35/210.53  |- skos__altLabel mesh__D001906 Toxico-Infectious Botulism
% 210.35/210.53  |- mesh__recordMaintainer mesh__D001906 ags
% 210.35/210.53  |- skos__broader mesh__D001906smesh__D005517
% 210.35/210.53  |- skos__broader mesh__D001906smesh__D020258
% 210.35/210.53  |- skos__related mesh__D001906smesh__D001905
% 210.35/210.53  |- skos__prefLabel mesh__D001906 Botulism
% 210.35/210.53  |- skos__broader mesh__D001906smesh__D003015
% 210.35/210.53  |- mesh__dateRevised mesh__D001906 2004-07-07
% 210.35/210.53  |- skos__hiddenLabel mesh__D001906 Infantile Botulism
% 210.35/210.53  |- skos__altLabel mesh__D001906 Botulism, Toxico-Infectious
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001906 2005
% 210.35/210.53  |- skos__annotation mesh__D001906
% 210.35/210.53       coordinate IM with specific Clostridium botulinum type %28%IM%29% if pertinent%A%  
% 210.35/210.53  |- rdf__type mesh__D001906sskos__Concept
% 210.35/210.53  |- skos__hiddenLabel mesh__D001906 Botulism, Toxico Infectious
% 210.35/210.53  |- skos__hiddenLabel mesh__D001906 Toxico Infectious Botulism
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001906 2006
% 210.35/210.53  |- mesh__recordOriginator mesh__D001906 NLM
% 210.35/210.53  |- mesh__recordAuthorizer mesh__D001906 sjn
% 210.35/210.53  |- mesh__dateCreated mesh__D001906 1999-01-01
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001108 2004
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001108 1991
% 210.35/210.53  |- mesh__dateCreated mesh__D001108 1999-01-01
% 210.35/210.53  |- skos__annotation mesh__D001108 SPEC: SPEC qualif   
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001108 1996
% 210.35/210.53  |- skos__related mesh__D001108smesh__D006275
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001108 2003
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001108 1990
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001108 2002
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001108 1995
% 210.35/210.53  |- mesh__recordMaintainer mesh__D001108 TGC
% 210.35/210.53  |- skos__broader mesh__D001108smesh__D013676
% 210.35/210.53  |- skos__prefLabel mesh__D001108 Architecture
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001108 1999
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001108 2001
% 210.35/210.53  |- mesh__recordAuthorizer mesh__D001108 PLS
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001108 1994
% 210.35/210.53  |- rdf__type mesh__D001108sskos__Concept
% 210.35/210.53  |- mesh__recordOriginator mesh__D001108 NLM
% 210.35/210.53  |- skos__hiddenLabel mesh__D001108 Architectures
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001108 2006
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001108 2000
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001108 1993
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001108 1998
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001108 1997
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001108 2005
% 210.35/210.53  |- mesh__dateRevised mesh__D001108 1989-06-13
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D001108 1992
% 210.35/210.53  |- mesh__recordAuthorizer mesh__D019519 sjn
% 210.35/210.53  |- skos__broader mesh__D019519smesh__D019502
% 210.35/210.53  |- skos__scopeNote mesh__D019519
% 210.35/210.53       Works consisting of single or multi-sheet notices made to attract attention to events, activities, causes, goods, or services. They are for posting, usually in a public place and are chiefly pictorial. They are intended to make an immediate impression from a distance. Posters do not include poster presentations at conferences and meetings. %28%From Thesaurus for Graphic Materials II: Genre and Physical Characteristic Headings, 1995%29%%A%    
% 210.35/210.53  |- mesh__historyNote mesh__D019519 1997   
% 210.35/210.53  |- skos__annotation mesh__D019519
% 210.35/210.53       publication type only; not for poster presentations at meetings; Publication Types ADVERTISEMENTS %26% BROADSIDES are also available%A%  
% 210.35/210.53  |- rdf__type mesh__D019519sskos__Concept
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D019519 2006
% 210.35/210.53  |- mesh__dateEstablished mesh__D019519 1997-01-01
% 210.35/210.53  |- mesh__recordOriginator mesh__D019519 TGC
% 210.35/210.53  |- skos__prefLabel mesh__D019519 Posters %5B%Publication Type%5D%
% 210.35/210.53  |- skos__altLabel mesh__D019519 Posters
% 210.35/210.53  |- skos__altLabel mesh__D019519 Posters %28%PT%29%
% 210.35/210.53  |- mesh__dateCreated mesh__D019519 1996-06-21
% 210.35/210.53  |- mesh__recordMaintainer mesh__D019519 jls
% 210.35/210.53  |- mesh__dateRevised mesh__D019519 2005-06-30
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D011536 2000
% 210.35/210.53  |- mesh__dateCreated mesh__D011536 1999-01-01
% 210.35/210.53  |- mesh__dateRevised mesh__D011536 1993-06-02
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D011536 1998
% 210.35/210.53  |- mesh__recordMaintainer mesh__D011536 TAP
% 210.35/210.53  |- skos__prefLabel mesh__D011536 Prurigo
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D011536 1996
% 210.35/210.53  |- skos__annotation mesh__D011536 itchy skin eruptions   
% 210.35/210.53  |- skos__scopeNote mesh__D011536
% 210.35/210.53       A name applied to several itchy skin eruptions of unknown cause. The characteristic course is the formation of a dome-shaped papule with a small transient vesicle on top, followed by crusting over or lichenification. %28%From Dorland, 27th ed%29%%A%    
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D011536 2002
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D011536 2006
% 210.35/210.53  |- skos__broader mesh__D011536smesh__D012871
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D011536 2004
% 210.35/210.53  |- mesh__recordOriginator mesh__D011536 NLM
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D011536 1995
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D011536 2005
% 210.35/210.53  |- mesh__recordAuthorizer mesh__D011536 PLS
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D011536 1999
% 210.35/210.53  |- rdf__type mesh__D011536sskos__Concept
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D011536 2001
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D011536 2003
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D011536 1994
% 210.35/210.53  |- mesh__activeMeSHYear mesh__D011536 1997
% 210.35/210.53  |- skos__altLabel mesh__D016221 Festschrift
% 210.35/210.54  |- skos__altLabel mesh__D016221 Festschrift %28%PT%29%
% 210.35/210.54  |- skos__altLabel mesh__D016221 Festschriften
% 210.35/210.54  |- skos__altLabel mesh__D016221 Festschriften %28%PT%29%
% 210.35/210.54  |- mesh__dateEstablished mesh__D016221 1996-01-01
% 210.35/210.54  |- skos__broader mesh__D016221smesh__D016456
% 210.35/210.54  |- rdf__type mesh__D016221sskos__Concept
% 210.35/210.54  |- skos__historyNote mesh__D016221 Historical Biography %28%1966-1990%29%
% 210.35/210.54  |- mesh__historyNote mesh__D016221 1991   
% 210.35/210.54  |- mesh__recordAuthorizer mesh__D016221 sjn
% 210.35/210.54  |- mesh__recordOriginator mesh__D016221 TGC
% 210.35/210.54  |- skos__broader mesh__D016221smesh__D016424
% 210.35/210.54  |- skos__prefLabel mesh__D016221 Festschrift %5B%Publication Type%5D%
% 210.35/210.54  |- mesh__recordMaintainer mesh__D016221 jls
% 210.35/210.54  |- skos__annotation mesh__D016221
% 210.35/210.54       publication type only; check appropriate century tags; Manual 32.18.8%A%  
% 210.35/210.54  |- skos__scopeNote mesh__D016221
% 210.35/210.54       Work consisting of a collection of essays or other writings contributed by students, teachers, colleagues, and admirers to honor a scholar, physician, or other scientist on a special occasion noting an event of importance in his or her life.%A%    
% 210.35/210.54  |- skos__broader mesh__D016221smesh__D020470
% 210.35/210.54  |- skos__historyNote mesh__D016221 Current Biog-Obit %28%1966-1990%29%
% 210.35/210.54  |- mesh__dateRevised mesh__D016221 2005-06-30
% 210.35/210.54  |- mesh__dateCreated mesh__D016221 1995-06-23
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D016221 2006
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002201 2000
% 210.35/210.54  |- mesh__recordMaintainer mesh__D002201 PLS
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002201 2005
% 210.35/210.54  |- skos__broader mesh__D002201smesh__D005102
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002201 1997
% 210.35/210.54  |- skos__hiddenLabel mesh__D002201 Expenditure, Capital
% 210.35/210.54  |- mesh__historyNote mesh__D002201
% 210.35/210.54       91%28%Aug 77%29%; was see under ECONOMICS 1977-90   
% 210.35/210.54  |- rdf__type mesh__D002201sskos__Concept
% 210.35/210.54  |- mesh__dateEstablished mesh__D002201 1991-01-01
% 210.35/210.54  |- skos__prefLabel mesh__D002201 Capital Expenditures
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002201 2002
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002201 1996
% 210.35/210.54  |- mesh__recordOriginator mesh__D002201 EC
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002201 2004
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002201 1999
% 210.35/210.54  |- skos__hiddenLabel mesh__D002201 Capital Expenditure
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002201 1995
% 210.35/210.54  |- mesh__dateCreated mesh__D002201 1977-05-12
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002201 2003
% 210.35/210.54  |- mesh__dateRevised mesh__D002201 1993-09-16
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002201 1998
% 210.35/210.54  |- mesh__publicMeSHNote mesh__D002201
% 210.35/210.54       91; was see under ECONOMICS Aug 1977-90   
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002201 2001
% 210.35/210.54  |- skos__annotation mesh__D002201 not restricted to health care; NIM   
% 210.35/210.54  |- skos__scopeNote mesh__D002201
% 210.35/210.54       Those funds disbursed for facilities and equipment, particularly those related to the delivery of health care.%A%    
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002201 2006
% 210.35/210.54  |- mesh__recordAuthorizer mesh__D002201 NLM
% 210.35/210.54  |- skos__hiddenLabel mesh__D002201 Expenditures, Capital
% 210.35/210.54  |- skos__broader mesh__D007495smesh__D019216
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D007495 2002
% 210.35/210.54  |- mesh__dateCreated mesh__D007495 1999-01-01
% 210.35/210.54  |- skos__broader mesh__D007495smesh__D028561
% 210.35/210.54  |- rdf__type mesh__D007495sskos__Concept
% 210.35/210.54  |- skos__prefLabel mesh__D007495 Iridium
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D007495 2003
% 210.35/210.54  |- skos__related mesh__D007495smesh__D007496
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D007495 2004
% 210.35/210.54  |- skos__annotation mesh__D007495
% 210.35/210.54       Ir-193; Ir-191 = IRIDIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Ir-182-190, 192, 194-198 = IRIDIUM RADIOISOTOPES %28%IM%29%%A%  
% 210.35/210.54  |- mesh__recordAuthorizer mesh__D007495 sjn
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D007495 2005
% 210.35/210.54  |- mesh__recordOriginator mesh__D007495 NLM
% 210.35/210.54  |- mesh__recordMaintainer mesh__D007495 jmp
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D007495 2006
% 210.35/210.54  |- skos__scopeNote mesh__D007495
% 210.35/210.54       A metallic element with the atomic symbol Ir, atomic number 77, and atomic weight 192.22.%A%    
% 210.35/210.54  |- mesh__dateRevised mesh__D007495 2001-07-25
% 210.35/210.54  |- mesh__historyNote mesh__D015927
% 210.35/210.54       91%28%90%29%; was see under SKIN TESTS 1990   
% 210.35/210.54  |- skos__broader mesh__D015927smesh__D007428
% 210.35/210.54  |- mesh__publicMeSHNote mesh__D015927 91; was see under SKIN TESTS 1990   
% 210.35/210.54  |- skos__altLabel mesh__D015927 Skin Test Endpoint Titration
% 210.35/210.54  |- mesh__dateRevised mesh__D015927 2002-07-03
% 210.35/210.54  |- mesh__recordOriginator mesh__D015927 PLS
% 210.35/210.54  |- skos__prefLabel mesh__D015927 Skin Test End-Point Titration
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D015927 2006
% 210.35/210.54  |- skos__annotation mesh__D015927
% 210.35/210.54       a type of intradermal allergy test; DF: STEPT   
% 210.35/210.54  |- mesh__dateCreated mesh__D015927 1989-05-16
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D015927 2004
% 210.35/210.54  |- skos__altLabel mesh__D015927 Serial Dilution Endpoint Titration
% 210.35/210.54  |- skos__broader mesh__D015927smesh__D017186
% 210.35/210.54  |- skos__scopeNote mesh__D015927
% 210.35/210.54       A quantitative form of intradermal testing for the relative allergenicity of a substance. It is used to determine the amount of an allergen that will be tolerated in immunotherapy.%A%    
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D015927 2005
% 210.35/210.54  |- skos__historyNote mesh__D015927 Skin Tests %28%1975-1989%29%
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D015927 2003
% 210.35/210.54  |- rdf__type mesh__D015927sskos__Concept
% 210.35/210.54  |- skos__hiddenLabel mesh__D015927 Serial Dilution End Point Titration
% 210.35/210.54  |- skos__hiddenLabel mesh__D015927 Skin Test End Point Titration
% 210.35/210.54  |- skos__altLabel mesh__D015927 Serial Dilution End-Point Titration
% 210.35/210.54  |- mesh__recordAuthorizer mesh__D015927 sjn
% 210.35/210.54  |- mesh__dateEstablished mesh__D015927 1991-01-01
% 210.35/210.54  |- skos__broader mesh__D015927smesh__D009500
% 210.35/210.54  |- skos__hiddenLabel mesh__D015927 Titration Skin Test, End Point
% 210.35/210.54  |- mesh__recordMaintainer mesh__D015927 lkt
% 210.35/210.54  |- skos__altLabel mesh__D015927 Titration Skin Test, End-Point
% 210.35/210.54  |- skos__altLabel mesh__D015927 Titration Skin Test, Endpoint
% 210.35/210.54  |- mesh__recordMaintainer mesh__D001907 ags
% 210.35/210.54  |- skos__hiddenLabel mesh__D001907 Fever, Mediterranean Spotted
% 210.35/210.54  |- skos__annotation mesh__D001907 caused by RICKETTSIA CONORII   
% 210.35/210.54  |- mesh__publicMeSHNote mesh__D001907
% 210.35/210.54       87; was see under RICKETTSIACEAE INFECTIONS 1977-86; was see under RICKETTSIAL DISEASES 1965-76; was see under ROCKY MOUNTAIN SPOTTED FEVER 1963-64%A%  
% 210.35/210.54  |- mesh__recordOriginator mesh__D001907 NLM
% 210.35/210.54  |- mesh__recordAuthorizer mesh__D001907 sjn
% 210.35/210.54  |- mesh__historyNote mesh__D001907
% 210.35/210.54       87%28%75%29%; was see under RICKETTSIACEAE INFECTIONS 1977-86; was see under RICKETTSIAL DISEASES 1965-76; was see under ROCKY MOUNTAIN SPOTTED FEVER 1963-64%A%  
% 210.35/210.54  |- skos__hiddenLabel mesh__D001907 Boutonneuse Fevers
% 210.35/210.54  |- skos__scopeNote mesh__D001907
% 210.35/210.54       A febrile disease of the Mediterranean area, the Crimea, Africa, and India, caused by infection with RICKETTSIA CONORII.%A%    
% 210.35/210.54  |- skos__hiddenLabel mesh__D001907 Spotted Fever, Mediterranean
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D001907 2005
% 210.35/210.54  |- skos__altLabel mesh__D001907 Mediterranean Spotted Fever
% 210.35/210.54  |- mesh__dateEstablished mesh__D001907 1987-01-01
% 210.35/210.54  |- rdf__type mesh__D001907sskos__Concept
% 210.35/210.54  |- skos__broader mesh__D001907smesh__D017282
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D001907 2004
% 210.35/210.54  |- skos__hiddenLabel mesh__D001907 Fever, Boutonneuse
% 210.35/210.54  |- skos__broader mesh__D001907smesh__D012282
% 210.35/210.54  |- skos__hiddenLabel mesh__D001907 Fevers, Boutonneuse
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D001907 2006
% 210.35/210.54  |- mesh__dateCreated mesh__D001907 1999-01-01
% 210.35/210.54  |- mesh__onlineNote mesh__D001907 search RICKETTSIAL INFECTIONS 1966-74   
% 210.35/210.54  |- mesh__dateRevised mesh__D001907 2003-07-09
% 210.35/210.54  |- skos__prefLabel mesh__D001907 Boutonneuse Fever
% 210.35/210.54  |- mesh__recordAuthorizer mesh__D001109 sjn
% 210.35/210.54  |- skos__hiddenLabel mesh__D001109 Archive
% 210.35/210.54  |- skos__broader mesh__D001109smesh__D007253
% 210.35/210.54  |- skos__prefLabel mesh__D001109 Archives
% 210.35/210.54  |- skos__broader mesh__D001109smesh__D006664
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D001109 2006
% 210.35/210.54  |- rdf__type mesh__D001109sskos__Concept
% 210.35/210.54  |- mesh__dateRevised mesh__D001109 2005-06-30
% 210.35/210.54  |- skos__annotation mesh__D001109
% 210.35/210.54       restricted use;  note category;  archives of clinical or other biological specimens = BIOLOGICAL SPECIMEN BANKS or specifics;  for %22%medical archives%22% do not coordinate with MEDICINE; note PICTURE ARCHIVING, RADIOLOGIC see RADIOLOGY INFORMATION SYSTEMS is available%A%  
% 210.35/210.54  |- mesh__recordMaintainer mesh__D001109 ags
% 210.35/210.54  |- mesh__dateCreated mesh__D001109 1999-01-01
% 210.35/210.54  |- mesh__recordOriginator mesh__D001109 NLM
% 210.35/210.54  |- skos__broader mesh__D003920Q000150smesh__D003920
% 210.35/210.54  |- mesh__preferredCombination mesh__D003920Q000150smesh__D048909
% 210.35/210.54  |- rdf__type mesh__D003920Q000150smesh__CompoundConcept
% 210.35/210.54  |- mesh__recordOriginator mesh__D011537 NLM
% 210.35/210.54  |- mesh__dateRevised mesh__D011537 1999-11-03
% 210.35/210.54  |- skos__altLabel mesh__D011537 Itching
% 210.35/210.54  |- skos__scopeNote mesh__D011537
% 210.35/210.54       An intense itching sensation that produces the urge to rub or scratch the skin to obtain relief.%A%    
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D011537 2006
% 210.35/210.54  |- skos__prefLabel mesh__D011537 Pruritus
% 210.35/210.54  |- mesh__recordMaintainer mesh__D011537 KEV
% 210.35/210.54  |- skos__broader mesh__D011537smesh__D012871
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D011537 2001
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D011537 2004
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D011537 2000
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D011537 2005
% 210.35/210.54  |- skos__broader mesh__D011537smesh__D012877
% 210.35/210.54  |- rdf__type mesh__D011537sskos__Concept
% 210.35/210.54  |- skos__altLabel mesh__D011537 Pruritis
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D011537 2003
% 210.35/210.54  |- mesh__dateCreated mesh__D011537 1999-01-01
% 210.35/210.54  |- skos__annotation mesh__D011537
% 210.35/210.54       /drug ther: consider also ANTIPRURITICS   
% 210.35/210.54  |- mesh__recordAuthorizer mesh__D011537 sjn
% 210.35/210.54  |- skos__related mesh__D011537smesh__D000982
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D011537 2002
% 210.35/210.54  |- skos__altLabel mesh__D016222 Fibroblast Growth Factor-2
% 210.35/210.54  |- rdf__type mesh__D016222sskos__Concept
% 210.35/210.54  |- mesh__recordMaintainer mesh__D016222 ags
% 210.35/210.54  |- skos__historyNote mesh__D016222 Growth Substances %28%1974-1983%29%
% 210.35/210.54  |- skos__broader mesh__D016222smesh__D042501
% 210.35/210.54  |- skos__altLabel mesh__D016222 FGF2
% 210.35/210.54  |- mesh__recordOriginator mesh__D016222 RLS
% 210.35/210.54  |- mesh__publicMeSHNote mesh__D016222
% 210.35/210.54       2001; FIBROBLAST GROWTH FACTOR-2 was indexed under FIBROBLAST GROWTH FACTOR, BASIC 1996-2001 %26% under FIBROBLAST GROWTH FACTOR 1995; PROSTATROPIN was indexed under NERVE TISSUE PROTEINS 1986-2001%A%  
% 210.35/210.54  |- skos__broader mesh__D016222smesh__D005346
% 210.35/210.54  |- skos__altLabel mesh__D016222 FGF-2
% 210.35/210.54  |- skos__altLabel mesh__D016222 Prostate Epithelial Cell Growth Factor
% 210.35/210.54  |- skos__altLabel mesh__D016222 Basic Fibroblast Growth Factor
% 210.35/210.54  |- mesh__historyNote mesh__D016222
% 210.35/210.54       2001%28%1991%29%; for FIBROBLAST GROWTH FACTOR-2 use FIBROBLAST GROWTH FACTOR 2 %28%NM%29% 1995; for PROSTATROPIN use FIBROBLAST GROWTH FACTOR 2 %28%NM%29% 1986-2001%A%  
% 210.35/210.54  |- mesh__dateRevised mesh__D016222 2005-07-07
% 210.35/210.54  |- mesh__dateCreated mesh__D016222 1990-06-28
% 210.35/210.54  |- skos__altLabel mesh__D016222 Prostatropin
% 210.35/210.54  |- skos__hiddenLabel mesh__D016222 FGF 2
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D016222 2006A
% 210.35/210.54  |- mesh__dateEstablished mesh__D016222 1991-01-01
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D016222 2006
% 210.35/210.54  |- skos__altLabel mesh__D016222 HBGF-2
% 210.35/210.54  |- skos__prefLabel mesh__D016222 Fibroblast Growth Factor 2
% 210.35/210.54  |- mesh__recordAuthorizer mesh__D016222 ags
% 210.35/210.54  |- skos__scopeNote mesh__D016222
% 210.35/210.54       A single-chain polypeptide growth factor that plays a significant role in the process of WOUND HEALING and is a potent inducer of PHYSIOLOGIC ANGIOGENESIS. Several different forms of the human protein exist ranging from 18-24 kDa in size due to the use of alternative start sites within the fgf-2 gene.  It has a 55 percent amino acid residue identity to FIBROBLAST GROWTH FACTOR 1 and has potent heparin-binding activity. The growth factor is an extremely potent inducer of DNA synthesis in a variety of cell types from mesoderm and neuroectoderm lineages. It was originally named basic fibroblast growth factor based upon its chemical properties and to distinguish it from acidic fibroblast growth factor %28%FIBROBLAST GROWTH FACTOR 1%29%.%A%    
% 210.35/210.54  |- skos__altLabel mesh__D016222 Class II Heparin-Binding Growth Factor
% 210.35/210.54  |- skos__altLabel mesh__D016222 Heparin-Binding Growth Factor Class II
% 210.35/210.54  |- skos__annotation mesh__D016222 DF: FGFB   
% 210.35/210.54  |- skos__altLabel mesh__D016222 Fibroblast Growth Factor, Basic
% 210.35/210.54  |- skos__historyNote mesh__D016222
% 210.35/210.54       Fibroblast Growth Factor %28%1984-1990%29%
% 210.35/210.54  |- mesh__dateCreated mesh__D002202 1979-05-29
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002202 2004
% 210.35/210.54  |- mesh__publicMeSHNote mesh__D002202
% 210.35/210.54       91; was see under FINANCIAL MANAGEMENT 1980-90   
% 210.35/210.54  |- skos__historyNote mesh__D002202 Financial Management %28%1978-1979%29%
% 210.35/210.54  |- mesh__dateEstablished mesh__D002202 1991-01-01
% 210.35/210.54  |- skos__hiddenLabel mesh__D002202 Capital Funding
% 210.35/210.54  |- mesh__recordAuthorizer mesh__D002202 sjn
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002202 2001
% 210.35/210.54  |- skos__prefLabel mesh__D002202 Capital Financing
% 210.35/210.54  |- mesh__dateRevised mesh__D002202 1999-11-03
% 210.35/210.54  |- mesh__recordMaintainer mesh__D002202 ags
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002202 2003
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002202 2000
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002202 2006
% 210.35/210.54  |- skos__hiddenLabel mesh__D002202 Capital Financings
% 210.35/210.54  |- skos__altLabel mesh__D002202 Financing, Capital
% 210.35/210.54  |- mesh__recordOriginator mesh__D002202 EC
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002202 2005
% 210.35/210.54  |- mesh__historyNote mesh__D002202
% 210.35/210.54       91%28%80%29%; was see under FINANCIAL MANAGEMENT 1980-90   
% 210.35/210.54  |- skos__broader mesh__D002202smesh__D005376
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002202 2002
% 210.35/210.54  |- skos__scopeNote mesh__D002202
% 210.35/210.54       Institutional funding for facilities and for equipment which becomes a part of the assets of the institution.%A%    
% 210.35/210.54  |- skos__hiddenLabel mesh__D002202 Capital Fundings
% 210.35/210.54  |- skos__altLabel mesh__D002202 Funding, Capital
% 210.35/210.54  |- rdf__type mesh__D002202sskos__Concept
% 210.35/210.54  |- mesh__recordOriginator mesh__D007496 RLS
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D007496 1997
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D007496 2000
% 210.35/210.54  |- mesh__dateCreated mesh__D007496 1987-04-08
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D007496 2004
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D007496 1998
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D007496 2001
% 210.35/210.54  |- skos__annotation mesh__D007496
% 210.35/210.54       Ir-182-190, 192, 194-198; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D007496 2005
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D007496 1994
% 210.35/210.54  |- mesh__recordAuthorizer mesh__D007496 PLS
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D007496 1999
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D007496 2002
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D007496 2006
% 210.35/210.54  |- skos__hiddenLabel mesh__D007496 Radioisotopes, Iridium
% 210.35/210.54  |- skos__broader mesh__D007496smesh__D011868
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D007496 1995
% 210.35/210.54  |- mesh__publicMeSHNote mesh__D007496 88   
% 210.35/210.54  |- skos__prefLabel mesh__D007496 Iridium Radioisotopes
% 210.35/210.54  |- skos__historyNote mesh__D007496 Iridium %28%1966-1987%29%
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D007496 1996
% 210.35/210.54  |- mesh__recordMaintainer mesh__D007496 TPW
% 210.35/210.54  |- rdf__type mesh__D007496sskos__Concept
% 210.35/210.54  |- skos__historyNote mesh__D007496 Radioisotopes %28%1966-1987%29%
% 210.35/210.54  |- mesh__historyNote mesh__D007496 88   
% 210.35/210.54  |- mesh__dateEstablished mesh__D007496 1988-01-01
% 210.35/210.54  |- skos__scopeNote mesh__D007496
% 210.35/210.54       Unstable isotopes of iridium that decay or disintegrate emitting radiation. Ir atoms with atomic weights 182-190, 192, and 194-198 are radioactive iridium isotopes.%A%    
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D007496 2003
% 210.35/210.54  |- mesh__dateRevised mesh__D007496 1993-06-02
% 210.35/210.54  |- skos__broader mesh__D015928smesh__D001521
% 210.35/210.54  |- mesh__recordOriginator mesh__D015928 PLS
% 210.35/210.54  |- skos__altLabel mesh__D015928 Therapy, Cognition
% 210.35/210.54  |- skos__historyNote mesh__D015928 Behavior Therapy %28%1967-1989%29%
% 210.35/210.54  |- skos__prefLabel mesh__D015928 Cognitive Therapy
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D015928 2001
% 210.35/210.54  |- skos__altLabel mesh__D015928 Behavior Therapy, Cognitive
% 210.35/210.54  |- mesh__recordMaintainer mesh__D015928 TGC
% 210.35/210.54  |- mesh__publicMeSHNote mesh__D015928 90   
% 210.35/210.54  |- skos__altLabel mesh__D015928 Psychotherapy, Cognitive
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D015928 1996
% 210.35/210.54  |- skos__hiddenLabel mesh__D015928 Therapies, Cognitive Behavior
% 210.35/210.54  |- skos__hiddenLabel mesh__D015928 Therapies, Cognitive
% 210.35/210.54  |- rdf__type mesh__D015928sskos__Concept
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D015928 2003
% 210.35/210.54  |- mesh__recordAuthorizer mesh__D015928 PLS
% 210.35/210.54  |- skos__hiddenLabel mesh__D015928 Psychotherapies, Cognitive
% 210.35/210.54  |- skos__annotation mesh__D015928
% 210.35/210.54       a psychother technique; DF: COGNITIVE THER   
% 210.35/210.54  |- mesh__dateEstablished mesh__D015928 1990-01-01
% 210.35/210.54  |- skos__hiddenLabel mesh__D015928 Therapies, Cognition
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D015928 2002
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D015928 1997
% 210.35/210.54  |- skos__hiddenLabel mesh__D015928 Cognitive Psychotherapies
% 210.35/210.54  |- skos__altLabel mesh__D015928 Therapy, Cognitive
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D015928 2004
% 210.35/210.54  |- mesh__historyNote mesh__D015928 90   
% 210.35/210.54  |- mesh__dateCreated mesh__D015928 1989-05-15
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D015928 1998
% 210.35/210.54  |- skos__altLabel mesh__D015928 Cognitive Psychotherapy
% 210.35/210.54  |- skos__historyNote mesh__D015928 Cognition %28%1967-1989%29%
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D015928 2005
% 210.35/210.54  |- skos__hiddenLabel mesh__D015928 Behavior Therapies, Cognitive
% 210.35/210.54  |- skos__altLabel mesh__D015928 Cognitive Behavior Therapy
% 210.35/210.54  |- skos__hiddenLabel mesh__D015928 Cognition Therapies
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D015928 1999
% 210.35/210.54  |- skos__scopeNote mesh__D015928
% 210.35/210.54       A direct form of psychotherapy based on the interpretation of situations %28%cognitive structure of experiences%29% that determine how an individual feels and behaves. It is based on the premise that cognition, the process of acquiring knowledge and forming beliefs, is a primary determinant of mood and behavior. The therapy uses behavioral and verbal techniques to identify and correct negative thinking that is at the root of the aberrant behavior.%A%    
% 210.35/210.54  |- skos__altLabel mesh__D015928 Therapy, Cognitive Behavior
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D015928 2006
% 210.35/210.54  |- skos__hiddenLabel mesh__D015928 Cognitive Behavior Therapies
% 210.35/210.54  |- skos__hiddenLabel mesh__D015928 Cognitive Therapies
% 210.35/210.54  |- skos__altLabel mesh__D015928 Cognition Therapy
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D015928 2000
% 210.35/210.54  |- mesh__dateRevised mesh__D015928 1995-05-31
% 210.35/210.54  |- skos__historyNote mesh__D040321
% 210.35/210.54       Receptors, Growth Factor %28%1995-2002%29%
% 210.35/210.54  |- rdf__type mesh__D040321sskos__Concept
% 210.35/210.54  |- mesh__recordOriginator mesh__D040321 MDJ
% 210.35/210.54  |- skos__altLabel mesh__D040321 VEGFR-3
% 210.35/210.54  |- skos__historyNote mesh__D040321
% 210.35/210.54       Receptors, Cell Surface %28%1994-2000%29%
% 210.35/210.54  |- mesh__dateRevised mesh__D040321 2005-06-30
% 210.35/210.54  |- mesh__dateEstablished mesh__D040321 2003-01-01
% 210.35/210.54  |- mesh__recordMaintainer mesh__D040321 jmp
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D040321 2006
% 210.35/210.54  |- skos__historyNote mesh__D040321
% 210.35/210.54       Receptor Protein-Tyrosine Kinases %28%1994-2002%29%
% 210.35/210.54  |- skos__prefLabel mesh__D040321
% 210.35/210.54       Vascular Endothelial Growth Factor Receptor-3
% 210.35/210.54  |- mesh__publicMeSHNote mesh__D040321
% 210.35/210.54       2003; FLT4 PROTEIN %28%now VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3%29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASE 1994-2002, RECEPTORS, CELL SURFACE 1994-2000 %26% RECEPTORS, GROWTH FACTOR 1995-2002%A%  
% 210.35/210.54  |- skos__altLabel mesh__D040321 FLT4 Protein
% 210.35/210.54  |- mesh__historyNote mesh__D040321
% 210.35/210.54       2003; use VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3 %28%NM%29% 1994-2002%A%  
% 210.35/210.54  |- skos__hiddenLabel mesh__D040321 Flt 4
% 210.35/210.54  |- skos__hiddenLabel mesh__D040321
% 210.35/210.54       Vascular Endothelial Growth Factor Receptor 3
% 210.35/210.54  |- mesh__recordAuthorizer mesh__D040321 sjn
% 210.35/210.54  |- skos__altLabel mesh__D040321 Flt-4
% 210.35/210.54  |- skos__broader mesh__D040321smesh__D040262
% 210.35/210.54  |- skos__scopeNote mesh__D040321
% 210.35/210.54       A vascular endothelial cell growth factor receptor whose expression is restricted primarily to adult lymphatic endothelium.  VEGFR-3 preferentially binds the vascular endothelial growth factor C and vascular endothelial growth factor D and may be involved in the control of lymphangiogenesis.%A%    
% 210.35/210.54  |- mesh__dateCreated mesh__D040321 2002-07-03
% 210.35/210.54  |- skos__hiddenLabel mesh__D001908 Bovine Pestiviruses
% 210.35/210.54  |- mesh__dateEstablished mesh__D001908 1991-01-01
% 210.35/210.54  |- mesh__recordMaintainer mesh__D001908 ags
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D001908 2006A
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D001908 2005
% 210.35/210.54  |- skos__altLabel mesh__D001908 Diarrhea Virus, Bovine Viral
% 210.35/210.54  |- skos__scopeNote mesh__D001908
% 210.35/210.54       A group of viruses in the genus PESTIVIRUS, causing diarrhea, fever, oral ulcerations, hemorrhagic syndrome, and various necrotic lesions among cattle and other domestic animals. The two species %28%genotypes%29%, BVDV-1 and BVDV-2 , exhibit antigenic and pathological differences. The historical designation, BVDV, consisted of both %28%then unrecognized%29% genotypes.%A%    
% 210.35/210.54  |- mesh__historyNote mesh__D001908 2002 %28%1975%29%   
% 210.35/210.54  |- mesh__publicMeSHNote mesh__D001908
% 210.35/210.54       2002; see DIARRHEA VIRUS, BOVINE VIRAL 1994-2001, see BOVINE DIARRHEA VIRUS 1991-1993, see PESTIVIRUSES 1981-1990, see RNA VIRUSES 1975-1980%A%  
% 210.35/210.54  |- skos__hiddenLabel mesh__D001908 Diarrhea Viruses, Bovine
% 210.35/210.54  |- mesh__dateRevised mesh__D001908 2005-07-08
% 210.35/210.54  |- skos__altLabel mesh__D001908 Bovine Viral Diarrhea Viruses
% 210.35/210.54  |- skos__annotation mesh__D001908
% 210.35/210.54       historical only: prefer specifics; infection = BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE or HEMORRHAGIC SYNDROME, BOVINE%A%  
% 210.35/210.54  |- mesh__recordOriginator mesh__D001908 NLM
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D001908 2004
% 210.35/210.54  |- mesh__recordAuthorizer mesh__D001908 ags
% 210.35/210.54  |- skos__altLabel mesh__D001908 Bovine Diarrhea Virus
% 210.35/210.54  |- rdf__type mesh__D001908sskos__Concept
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D001908 2003
% 210.35/210.54  |- skos__prefLabel mesh__D001908 Diarrhea Viruses, Bovine Viral
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D001908 2002
% 210.35/210.54  |- skos__hiddenLabel mesh__D001908 Diarrhea Virus, Bovine
% 210.35/210.54  |- skos__hiddenLabel mesh__D001908 Viruses, Bovine Diarrhea
% 210.35/210.54  |- skos__hiddenLabel mesh__D001908 Pestiviruses, Bovine
% 210.35/210.54  |- skos__altLabel mesh__D001908 Bovine Pestivirus
% 210.35/210.54  |- skos__hiddenLabel mesh__D001908 Bovine Diarrhea Viruses
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D001908 2006
% 210.35/210.54  |- mesh__dateCreated mesh__D001908 1974-12-12
% 210.35/210.54  |- skos__hiddenLabel mesh__D001908 Virus, Bovine Diarrhea
% 210.35/210.54  |- skos__broader mesh__D001908smesh__D010576
% 210.35/210.54  |- skos__broader mesh__D005333Q000254smesh__D005333
% 210.35/210.54  |- mesh__preferredCombination mesh__D005333Q000254smesh__D047109
% 210.35/210.54  |- rdf__type mesh__D005333Q000254smesh__CompoundConcept
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D011538 2006
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D011538 2002
% 210.35/210.54  |- skos__prefLabel mesh__D011538 Pruritus Ani
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D011538 2004
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D011538 2005
% 210.35/210.54  |- rdf__type mesh__D011538sskos__Concept
% 210.35/210.54  |- mesh__recordOriginator mesh__D011538 NLM
% 210.35/210.54  |- skos__annotation mesh__D011538 note spelling: -itus, not -itis   
% 210.35/210.54  |- mesh__dateRevised mesh__D011538 1999-11-03
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D011538 2003
% 210.35/210.54  |- mesh__recordMaintainer mesh__D011538 TPW
% 210.35/210.54  |- mesh__dateCreated mesh__D011538 1999-01-01
% 210.35/210.54  |- skos__broader mesh__D011538smesh__D001004
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D011538 2001
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D011538 2000
% 210.35/210.54  |- skos__scopeNote mesh__D011538
% 210.35/210.54       Intense chronic itching in the anal area.     
% 210.35/210.54  |- skos__broader mesh__D011538smesh__D011537
% 210.35/210.54  |- mesh__recordAuthorizer mesh__D011538 sjn
% 210.35/210.54  |- skos__hiddenLabel mesh__D016223 Psychiatric Will
% 210.35/210.54  |- skos__prefLabel mesh__D016223 Advance Directives
% 210.35/210.54  |- skos__broader mesh__D016223smesh__D032722
% 210.35/210.54  |- skos__hiddenLabel mesh__D016223 Directive, Advance
% 210.35/210.54  |- mesh__recordAuthorizer mesh__D016223 sjn
% 210.35/210.54  |- rdf__type mesh__D016223sskos__Concept
% 210.35/210.54  |- skos__hiddenLabel mesh__D016223 Directives, Advance
% 210.35/210.54  |- skos__hiddenLabel mesh__D016223 Wills, Psychiatric
% 210.35/210.54  |- mesh__publicMeSHNote mesh__D016223 1991   
% 210.35/210.54  |- mesh__recordOriginator mesh__D016223 TGC
% 210.35/210.54  |- mesh__dateCreated mesh__D016223 1990-06-01
% 210.35/210.54  |- mesh__dateEstablished mesh__D016223 1991-01-01
% 210.35/210.54  |- skos__related mesh__D016223smesh__D016414
% 210.35/210.54  |- skos__hiddenLabel mesh__D016223 Contracts, Ulysses
% 210.35/210.54  |- skos__altLabel mesh__D016223 Ulysses Contracts
% 210.35/210.54  |- skos__altLabel mesh__D016223 Healthcare Power of Attorney
% 210.35/210.54  |- mesh__dateRevised mesh__D016223 2002-07-02
% 210.35/210.54  |- skos__broader mesh__D016223smesh__D007603
% 210.35/210.54  |- skos__hiddenLabel mesh__D016223 Contract, Ulysses
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D016223 2005
% 210.35/210.54  |- skos__hiddenLabel mesh__D016223 Ulysses Contract
% 210.35/210.54  |- mesh__recordMaintainer mesh__D016223 jrf
% 210.35/210.54  |- skos__historyNote mesh__D016223 Wills %28%1966-1990%29%
% 210.35/210.54  |- skos__related mesh__D016223smesh__D024362
% 210.35/210.54  |- skos__related mesh__D016223smesh__D012297
% 210.35/210.54  |- skos__hiddenLabel mesh__D016223 Will, Psychiatric
% 210.35/210.54  |- skos__hiddenLabel mesh__D016223 Attorney Medical Power
% 210.35/210.54  |- skos__hiddenLabel mesh__D016223 Advance Directive
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D016223 2003
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D016223 2006
% 210.35/210.54  |- skos__scopeNote mesh__D016223
% 210.35/210.54       Declarations by patients, made in advance of a situation in which they may be incompetent to decide about their own care, stating their treatment preferences or authorizing a third party to make decisions for them. %28%Bioethics Thesaurus%29%%A%    
% 210.35/210.54  |- skos__hiddenLabel mesh__D016223 Attorney Healthcare Power
% 210.35/210.54  |- skos__historyNote mesh__D016223 Right to Die %28%1987-1990%29%
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D016223 2004
% 210.35/210.54  |- mesh__historyNote mesh__D016223 1991   
% 210.35/210.54  |- skos__hiddenLabel mesh__D002203 Punishment, Capital
% 210.35/210.54  |- skos__hiddenLabel mesh__D002203 Penalty, Death
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002203 2003
% 210.35/210.54  |- skos__prefLabel mesh__D002203 Capital Punishment
% 210.35/210.54  |- skos__hiddenLabel mesh__D002203 Electrocutions, Judicial
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002203 1998
% 210.35/210.54  |- mesh__dateRevised mesh__D002203 1997-06-20
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002203 2006
% 210.35/210.54  |- skos__annotation mesh__D002203
% 210.35/210.54       X ref ELECTROCUTION, JUDICIAL: do not index also under the electricity aspect unless particularly discussed%A%  
% 210.35/210.54  |- skos__broader mesh__D002203smesh__D012926
% 210.35/210.54  |- skos__hiddenLabel mesh__D002203 Penalties, Death
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002203 2001
% 210.35/210.54  |- mesh__recordOriginator mesh__D002203 NLM
% 210.35/210.54  |- mesh__recordMaintainer mesh__D002203 TGC
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002203 2005
% 210.35/210.54  |- skos__altLabel mesh__D002203 Death Penalty
% 210.35/210.54  |- skos__hiddenLabel mesh__D002203 Punishments, Capital
% 210.35/210.54  |- mesh__activeMeSHYear mesh__D002203 2000
% 210.35/210.54  |- rdf__type mesh__D002203sskos__Concept
% 210.35/210.54  |- skos__hiddenLabel mesh__D002203 Capital Punishments
% 210.35/210.55  |- skos__scopeNote mesh__D002203
% 210.35/210.55       The use of the death penalty for certain crimes.     
% 210.35/210.55  |- skos__hiddenLabel mesh__D002203 Death Penalties
% 210.35/210.55  |- mesh__dateCreated mesh__D002203 1999-01-01
% 210.35/210.55  |- skos__hiddenLabel mesh__D002203 Judicial Electrocutions
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002203 2004
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002203 2002
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002203 1999
% 210.35/210.55  |- mesh__recordAuthorizer mesh__D002203 SJN
% 210.35/210.55  |- skos__hiddenLabel mesh__D002203 Judicial Electrocution
% 210.35/210.55  |- skos__annotation mesh__D007497
% 210.35/210.55       infection in insects: coord IM with specific insect /virol %28%IM%29%; infection in vertebrates: coord IM with DNA VIRUS INFECTIONS %28%IM%29%%A%  
% 210.35/210.55  |- mesh__dateEstablished mesh__D007497 1978-01-01
% 210.35/210.55  |- skos__historyNote mesh__D007497 DNA Viruses %28%1966-1977%29%
% 210.35/210.55  |- mesh__dateCreated mesh__D007497 1977-05-04
% 210.35/210.55  |- mesh__historyNote mesh__D007497 1981 %28%1978%29%   
% 210.35/210.55  |- skos__hiddenLabel mesh__D007497
% 210.35/210.55       Deoxyriboviruses, Icosahedral Cytoplasmic
% 210.35/210.55  |- skos__hiddenLabel mesh__D007497
% 210.35/210.55       Cytoplasmic Deoxyriboviruses, Icosahedral
% 210.35/210.55  |- mesh__publicMeSHNote mesh__D007497
% 210.35/210.55       1981; see IRIDOVIRUSES 1978-80; for GOLDFISH VIRUSES see GOLDFISH VIRUS 1-LIKE VIRUSES 1997-2001, see IRIDOVIRIDAE 1994-96, see IRIDOVIRUSES 1978-80%A%  
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007497 2005
% 210.35/210.55  |- skos__prefLabel mesh__D007497 Iridoviridae
% 210.35/210.55  |- mesh__recordAuthorizer mesh__D007497 sjn
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007497 2006
% 210.35/210.55  |- skos__hiddenLabel mesh__D007497 Chloriridoviruses
% 210.35/210.55  |- skos__scopeNote mesh__D007497
% 210.35/210.55       A family of large icosahedral DNA viruses infecting insects and poikilothermic vertebrates. Genera include IRIDOVIRUS; RANAVIRUS; Chloriridovirus, and  Lymphocystivirus.%A%    
% 210.35/210.55  |- mesh__recordOriginator mesh__D007497 AEP
% 210.35/210.55  |- skos__hiddenLabel mesh__D007497 Viruses, Goldfish
% 210.35/210.55  |- skos__broader mesh__D007497smesh__D004267
% 210.35/210.55  |- mesh__dateRevised mesh__D007497 2001-07-25
% 210.35/210.55  |- mesh__recordMaintainer mesh__D007497 ags
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007497 2002
% 210.35/210.55  |- rdf__type mesh__D007497sskos__Concept
% 210.35/210.55  |- skos__historyNote mesh__D007497 Insect Viruses %28%1966-1977%29%
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007497 2003
% 210.35/210.55  |- skos__hiddenLabel mesh__D007497 Lymphocystiviruses
% 210.35/210.55  |- skos__hiddenLabel mesh__D007497 Goldfish Virus
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007497 2004
% 210.35/210.55  |- skos__altLabel mesh__D007497 Icosahedral Cytoplasmic Deoxyriboviruses
% 210.35/210.55  |- skos__prefLabel mesh__D001909 Leukemia Virus, Bovine
% 210.35/210.55  |- mesh__historyNote mesh__D001909
% 210.35/210.55       94; was BOVINE LEUKEMIA VIRUS 1977-93 %28%see under RETROVIRIDAE 1981-90, see under LEUKOVIRUSES 1978-80, see under LEUKEMOGENIC VIRUSES 1977%29%; was CATTLE LEUKEMIA VIRUS see under LEUKEMOGENIC VIRUSES 1975-76%A%  
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D001909 2002
% 210.35/210.55  |- skos__broader mesh__D001909smesh__D017977
% 210.35/210.55  |- skos__hiddenLabel mesh__D001909 Leukemia Virus, Cattle
% 210.35/210.55  |- skos__hiddenLabel mesh__D001909 Virus, Cattle Leukemia
% 210.35/210.55  |- skos__altLabel mesh__D001909 Bovine Leukemia Virus
% 210.35/210.55  |- skos__scopeNote mesh__D001909
% 210.35/210.55       The type species of DELTARETROVIRUS that causes a form of bovine lymphosarcoma %28%ENZOOTIC BOVINE LEUKOSIS%29% or persistent lymphocytosis.%A%    
% 210.35/210.55  |- mesh__publicMeSHNote mesh__D001909
% 210.35/210.55       94; was BOVINE LEUKEMIA VIRUS 1977-93 %28%see under RETROVIRIDAE 1981-90, see under LEUKOVIRUSES 1978-80, see under LEUKEMOGENIC VIRUSES 1977%29%; was CATTLE LEUKEMIA VIRUS see under LEUKEMOGENIC VIRUSES 1975-76%A%  
% 210.35/210.55  |- mesh__dateRevised mesh__D001909 2001-08-03
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D001909 2004
% 210.35/210.55  |- skos__altLabel mesh__D001909 Cattle Leukemia Virus
% 210.35/210.55  |- skos__annotation mesh__D001909
% 210.35/210.55       a species of the genus DELTARETROVIRUS; infection = ENZOOTIC BOVINE LEUKOSIS%A%  
% 210.35/210.55  |- rdf__type mesh__D001909sskos__Concept
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D001909 2003
% 210.35/210.55  |- mesh__recordMaintainer mesh__D001909 sjn
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D001909 2006
% 210.35/210.55  |- mesh__dateCreated mesh__D001909 1974-12-12
% 210.35/210.55  |- mesh__recordAuthorizer mesh__D001909 sjn
% 210.35/210.55  |- mesh__recordOriginator mesh__D001909 NLM
% 210.35/210.55  |- mesh__dateEstablished mesh__D001909 1991-01-01
% 210.35/210.55  |- mesh__onlineNote mesh__D001909
% 210.35/210.55       use LEUKEMIA VIRUS, BOVINE to search BOVINE LEUKEMIA VIRUS 1977-93 %26% CATTLE LEUKEMIA VIRUS 1975-76%A%  
% 210.35/210.55  |- skos__altLabel mesh__D001909 BLV
% 210.35/210.55  |- skos__hiddenLabel mesh__D001909 Virus, Bovine Leukemia
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D001909 2005
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D012631 2006
% 210.35/210.55  |- skos__scopeNote mesh__D012631
% 210.35/210.55       A barbiturate that is used as a sedative. Secobarbital is reported to have no anti-anxiety activity.%A%    
% 210.35/210.55  |- mesh__recordOriginator mesh__D012631 NLM
% 210.35/210.55  |- skos__altLabel mesh__D012631 Flynn Brand of Secobarbital Sodium
% 210.35/210.55  |- mesh__dateCreated mesh__D012631 1999-01-01
% 210.35/210.55  |- mesh__recordMaintainer mesh__D012631 CCR
% 210.35/210.55  |- mesh__dateRevised mesh__D012631 2005-06-30
% 210.35/210.55  |- skos__altLabel mesh__D012631 Meballymal
% 210.35/210.55  |- rdf__type mesh__D012631sskos__Concept
% 210.35/210.55  |- skos__altLabel mesh__D012631 Quinalbarbitone
% 210.35/210.55  |- mesh__recordAuthorizer mesh__D012631 sjn
% 210.35/210.55  |- skos__broader mesh__D012631smesh__D001463
% 210.35/210.55  |- skos__altLabel mesh__D012631 Vangard Brand of Secobarbital Sodium
% 210.35/210.55  |- skos__hiddenLabel mesh__D012631 Sodium, Secobarbital
% 210.35/210.55  |- skos__prefLabel mesh__D012631 Secobarbital
% 210.35/210.55  |- skos__altLabel mesh__D012631 Ranbaxy Brand of Secobarbital Sodium
% 210.35/210.55  |- mesh__recordMaintainer mesh__D036281 jls
% 210.35/210.55  |- mesh__historyNote mesh__D036281 2003   
% 210.35/210.55  |- skos__scopeNote mesh__D036281
% 210.35/210.55       Research into the cause, transmission, amelioration, elimination, or enhancement of inherited disorders and traits.%A%    
% 210.35/210.55  |- skos__broader mesh__D036281smesh__D005823
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D036281 2006
% 210.35/210.55  |- mesh__dateEstablished mesh__D036281 2003-01-01
% 210.35/210.55  |- mesh__dateCreated mesh__D036281 2002-07-03
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D036281 2004
% 210.35/210.55  |- mesh__recordAuthorizer mesh__D036281 jls
% 210.35/210.55  |- mesh__dateRevised mesh__D036281 2002-10-31
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D036281 2005
% 210.35/210.55  |- skos__annotation mesh__D036281
% 210.35/210.55       genetic research as a field or the progress or status of genetic research; do not add routinely for specific research studies in genetics%A%  
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D036281 2003
% 210.35/210.55  |- skos__altLabel mesh__D036281 Research, Genetic
% 210.35/210.55  |- mesh__recordOriginator mesh__D036281 hjn
% 210.35/210.55  |- skos__prefLabel mesh__D036281 Genetic Research
% 210.35/210.55  |- skos__broader mesh__D036281smesh__D035843
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D036281 2003A
% 210.35/210.55  |- rdf__type mesh__D036281sskos__Concept
% 210.35/210.55  |- mesh__publicMeSHNote mesh__D036281 2003   
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D011539 2006
% 210.35/210.55  |- mesh__dateCreated mesh__D011539 1999-01-01
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D011539 2002
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D011539 2004
% 210.35/210.55  |- skos__broader mesh__D011539smesh__D011537
% 210.35/210.55  |- skos__scopeNote mesh__D011539
% 210.35/210.55       Intense itching of the external female genitals.     
% 210.35/210.55  |- rdf__type mesh__D011539sskos__Concept
% 210.35/210.55  |- mesh__recordAuthorizer mesh__D011539 sjn
% 210.35/210.55  |- skos__prefLabel mesh__D011539 Pruritus Vulvae
% 210.35/210.55  |- mesh__recordMaintainer mesh__D011539 PLS
% 210.35/210.55  |- skos__broader mesh__D011539smesh__D014845
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D011539 2000
% 210.35/210.55  |- mesh__recordOriginator mesh__D011539 NLM
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D011539 2005
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D011539 2001
% 210.35/210.55  |- mesh__dateRevised mesh__D011539 1999-11-03
% 210.35/210.55  |- skos__annotation mesh__D011539 note spelling: -itus, not -itis   
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D011539 2003
% 210.35/210.55  |- skos__broader mesh__D008590smesh__D004660
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D008590 2001
% 210.35/210.55  |- skos__annotation mesh__D008590
% 210.35/210.55       coord IM with precoord or specific infection term %28%IM%29% or other cause %28%IM%29%; DF: MENINGOENCEPH%A%  
% 210.35/210.55  |- skos__scopeNote mesh__D008590
% 210.35/210.55       An inflammatory process involving the brain %28%ENCEPHALITIS%29% and meninges %28%MENINGITIS%29%, most often produced by pathogenic organisms which invade the central nervous system, and occasionally by toxins, autoimmune disorders, and other conditions.%A%    
% 210.35/210.55  |- rdf__type mesh__D008590sskos__Concept
% 210.35/210.55  |- mesh__recordOriginator mesh__D008590 NLM
% 210.35/210.55  |- skos__broader mesh__D008590smesh__D008581
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D008590 2002
% 210.35/210.55  |- skos__altLabel mesh__D008590 Cerebromeningitis
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D008590 2003
% 210.35/210.55  |- skos__hiddenLabel mesh__D008590 Cerebromeningitides
% 210.35/210.55  |- mesh__recordMaintainer mesh__D008590 KEV
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D008590 2005
% 210.35/210.55  |- mesh__dateRevised mesh__D008590 1999-11-03
% 210.35/210.55  |- skos__prefLabel mesh__D008590 Meningoencephalitis
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D008590 2004
% 210.35/210.55  |- skos__hiddenLabel mesh__D008590 Meningoencephalitides
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D008590 2000
% 210.35/210.55  |- skos__broader mesh__D008590smesh__D002494
% 210.35/210.55  |- skos__hiddenLabel mesh__D008590 Encephalomeningitides
% 210.35/210.55  |- mesh__dateCreated mesh__D008590 1999-01-01
% 210.35/210.55  |- mesh__recordAuthorizer mesh__D008590 sjn
% 210.35/210.55  |- skos__altLabel mesh__D008590 Encephalomeningitis
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D008590 2006
% 210.35/210.55  |- mesh__recordMaintainer mesh__D022261 ssb
% 210.35/210.55  |- mesh__dateEstablished mesh__D022261 2001-01-01
% 210.35/210.55  |- mesh__recordOriginator mesh__D022261 ags
% 210.35/210.55  |- mesh__recordAuthorizer mesh__D022261 sjn
% 210.35/210.55  |- skos__prefLabel mesh__D022261 Respiratory Syncytial Virus Vaccines
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D022261 2006
% 210.35/210.55  |- skos__scopeNote mesh__D022261
% 210.35/210.55       Vaccines or candidate vaccines used to prevent infection with RESPIRATORY SYNCYTIAL VIRUSES.%A%    
% 210.35/210.55  |- skos__hiddenLabel mesh__D022261 Vaccines, RSV
% 210.35/210.55  |- mesh__dateCreated mesh__D022261 2000-06-22
% 210.35/210.55  |- skos__altLabel mesh__D022261 RSV Vaccines
% 210.35/210.55  |- skos__broader mesh__D022261smesh__D014765
% 210.35/210.55  |- mesh__publicMeSHNote mesh__D022261 2001   
% 210.35/210.55  |- mesh__historyNote mesh__D022261 2001   
% 210.35/210.55  |- mesh__dateRevised mesh__D022261 2005-06-30
% 210.35/210.55  |- rdf__type mesh__D022261sskos__Concept
% 210.35/210.55  |- skos__historyNote mesh__D022261 Viral Vaccines %28%1966-2000%29%
% 210.35/210.55  |- mesh__historyNote mesh__D016224
% 210.35/210.55       91; was see RIGHT TO DIE 1987-90; was see WILLS 1977-86   
% 210.35/210.55  |- mesh__recordMaintainer mesh__D016224 jls
% 210.35/210.55  |- mesh__recordAuthorizer mesh__D016224 sjn
% 210.35/210.55  |- skos__broader mesh__D016224smesh__D016223
% 210.35/210.55  |- mesh__recordOriginator mesh__D016224 TGC
% 210.35/210.55  |- skos__hiddenLabel mesh__D016224 Living Will
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D016224 2005
% 210.35/210.55  |- mesh__publicMeSHNote mesh__D016224
% 210.35/210.55       91; was see RIGHT TO DIE 1987-90; was see WILLS 1977-86   
% 210.35/210.55  |- skos__broader mesh__D016224smesh__D014918
% 210.35/210.55  |- skos__related mesh__D016224smesh__D012297
% 210.35/210.55  |- skos__prefLabel mesh__D016224 Living Wills
% 210.35/210.55  |- skos__historyNote mesh__D016224 Wills %28%1977-1986%29%
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D016224 2006
% 210.35/210.55  |- mesh__dateRevised mesh__D016224 2003-07-09
% 210.35/210.55  |- skos__hiddenLabel mesh__D016224 Will, Living
% 210.35/210.55  |- skos__scopeNote mesh__D016224
% 210.35/210.55       Written, witnessed declarations in which persons request that if they become disabled beyond reasonable expectation of recovery, they be allowed to die rather than be kept alive by extraordinary means. %28%Bioethics Thesaurus%29%%A%    
% 210.35/210.55  |- skos__hiddenLabel mesh__D016224 Wills, Living
% 210.35/210.55  |- mesh__dateCreated mesh__D016224 1990-08-03
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D016224 2004
% 210.35/210.55  |- skos__historyNote mesh__D016224 Right to Die %28%1987-1990%29%
% 210.35/210.55  |- rdf__type mesh__D016224sskos__Concept
% 210.35/210.55  |- mesh__onlineNote mesh__D016224
% 210.35/210.55       use RIGHT TO DIE to search LIVING WILLS 1987-90; use WILLS to search LIVING WILLS 1977-86%A%  
% 210.35/210.55  |- mesh__dateEstablished mesh__D016224 1991-01-01
% 210.35/210.55  |- mesh__publicMeSHNote mesh__D002204
% 210.35/210.55       91; was see under FEES AND CHARGES Aug 1977-90   
% 210.35/210.55  |- mesh__dateRevised mesh__D002204 1997-06-20
% 210.35/210.55  |- skos__hiddenLabel mesh__D002204 Fees, Capitation
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002204 1998
% 210.35/210.55  |- skos__altLabel mesh__D002204 Fee, Capitation
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002204 2003
% 210.35/210.55  |- mesh__recordMaintainer mesh__D002204 JLS
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002204 2001
% 210.35/210.55  |- mesh__historyNote mesh__D002204
% 210.35/210.55       91%28%Aug 77%29%; was see under FEES AND CHARGES 1977-90   
% 210.35/210.55  |- skos__scopeNote mesh__D002204
% 210.35/210.55       A method of payment for health services in which an individual or institutional provider is paid a fixed, per capita amount without regard to the actual number or nature of services provided to each patient.%A%    
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002204 2006
% 210.35/210.55  |- skos__hiddenLabel mesh__D002204 Capitation Fees
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002204 2000
% 210.35/210.55  |- rdf__type mesh__D002204sskos__Concept
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002204 2005
% 210.35/210.55  |- mesh__dateCreated mesh__D002204 1977-05-05
% 210.35/210.55  |- skos__prefLabel mesh__D002204 Capitation Fee
% 210.35/210.55  |- skos__broader mesh__D002204smesh__D005249
% 210.35/210.55  |- skos__annotation mesh__D002204
% 210.35/210.55       %22%capitation%22% refers to %22%a fixed per capita amt without regard to no. or nature of serv provided%22%%A%  
% 210.35/210.55  |- mesh__dateEstablished mesh__D002204 1991-01-01
% 210.35/210.55  |- mesh__recordOriginator mesh__D002204 EC
% 210.35/210.55  |- mesh__recordAuthorizer mesh__D002204 SJN
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002204 2002
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002204 1999
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002204 2004
% 210.35/210.55  |- skos__scopeNote mesh__D007498
% 210.35/210.55       The most anterior portion of the uveal layer, separating the anterior chamber from the posterior. It consists of two layers - the stroma and the pigmented epithelium. Color of the iris depends on the amount of melanin in the stroma on reflection from the pigmented epithelium.%A%    
% 210.35/210.55  |- rdf__type mesh__D007498sskos__Concept
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007498 2003
% 210.35/210.55  |- mesh__recordMaintainer mesh__D007498 ags
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007498 2002
% 210.35/210.55  |- skos__prefLabel mesh__D007498 Iris
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007498 2006
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007498 2001
% 210.35/210.55  |- skos__broader mesh__D007498smesh__D014602
% 210.35/210.55  |- mesh__dateCreated mesh__D007498 1999-01-01
% 210.35/210.55  |- skos__annotation mesh__D007498
% 210.35/210.55       inflammation = IRITIS but note IRIDOCYCLITIS is also available; color = EYE COLOR; /blood supply consider also CILIARY ARTERIES; pigmented epithelium of iris: coord IRIS with PIGMENT EPITHELIUM OF EYE%A%  
% 210.35/210.55  |- mesh__dateRevised mesh__D007498 1999-11-03
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007498 2005
% 210.35/210.55  |- mesh__recordAuthorizer mesh__D007498 sjn
% 210.35/210.55  |- mesh__recordOriginator mesh__D007498 NLM
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007498 2000
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007498 2004
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D012632 2005
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D012632 2001
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D012632 1996
% 210.35/210.55  |- mesh__publicMeSHNote mesh__D012632 68   
% 210.35/210.55  |- mesh__historyNote mesh__D012632 68   
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D012632 2006
% 210.35/210.55  |- mesh__dateEstablished mesh__D012632 1968-01-01
% 210.35/210.55  |- mesh__dateCreated mesh__D012632 1999-01-01
% 210.35/210.55  |- skos__scopeNote mesh__D012632
% 210.35/210.55       Steroids in which fission of one or more ring structures and concomitant addition of a hydrogen atom at each terminal group has occurred.%A%    
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D012632 1997
% 210.35/210.55  |- skos__broader mesh__D012632smesh__D013256
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D012632 2003
% 210.35/210.55  |- skos__prefLabel mesh__D012632 Secosteroids
% 210.35/210.55  |- rdf__type mesh__D012632sskos__Concept
% 210.35/210.55  |- mesh__dateRevised mesh__D012632 1993-06-03
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D012632 2002
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D012632 2004
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D012632 1994
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D012632 1998
% 210.35/210.55  |- mesh__recordMaintainer mesh__D012632 PLS
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D012632 1995
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D012632 2000
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D012632 1999
% 210.35/210.55  |- mesh__recordAuthorizer mesh__D012632 PLS
% 210.35/210.55  |- mesh__recordOriginator mesh__D012632 NLM
% 210.35/210.55  |- mesh__publicMeSHNote mesh__D008591
% 210.35/210.55       78; was see under SPINA BIFIDA 1963-77; MYELOCELE was see under SPINA BIFIDA 1963-77%A%  
% 210.35/210.55  |- skos__scopeNote mesh__D008591
% 210.35/210.55       Congenital, or rarely acquired, herniation of meningeal and spinal cord tissue through a bony defect in the vertebral column. The majority of these defects occur in the lumbosacral region. Clinical features include PARAPLEGIA, loss of sensation in the lower body, and incontinence. This condition may be associated with the ARNOLD-CHIARI MALFORMATION and HYDROCEPHALUS. %28%From Joynt, Clinical Neurology, 1992, Ch55, pp35-6%29%%A%    
% 210.35/210.55  |- skos__hiddenLabel mesh__D008591 Myeloceles
% 210.35/210.55  |- skos__hiddenLabel mesh__D008591 Meningomyeloceles
% 210.35/210.55  |- skos__altLabel mesh__D008591 Myelomeningocele
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D008591 2006
% 210.35/210.55  |- skos__hiddenLabel mesh__D008591 Acquired Myelomeningocele
% 210.35/210.55  |- skos__hiddenLabel mesh__D008591 Myelomeningoceles
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D008591 2002
% 210.35/210.55  |- mesh__dateCreated mesh__D008591 1999-01-01
% 210.35/210.55  |- mesh__dateRevised mesh__D008591 1999-11-03
% 210.35/210.55  |- mesh__recordAuthorizer mesh__D008591 sjn
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D008591 2005
% 210.35/210.55  |- mesh__dateEstablished mesh__D008591 1978-01-01
% 210.35/210.55  |- mesh__onlineNote mesh__D008591
% 210.35/210.55       search SPINA BIFIDA 1966-74; use SPINA BIFIDA to search MYELOCELE 1966-77%A%  
% 210.35/210.55  |- rdf__type mesh__D008591sskos__Concept
% 210.35/210.55  |- skos__prefLabel mesh__D008591 Meningomyelocele
% 210.35/210.55  |- skos__hiddenLabel mesh__D008591 Myelomeningoceles, Acquired
% 210.35/210.55  |- skos__hiddenLabel mesh__D008591 Acquired Meningomyeloceles
% 210.35/210.55  |- mesh__recordMaintainer mesh__D008591 KEV
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D008591 2001
% 210.35/210.55  |- mesh__recordOriginator mesh__D008591 NLM
% 210.35/210.55  |- skos__altLabel mesh__D008591 Myelomeningocele, Acquired
% 210.35/210.55  |- mesh__historyNote mesh__D008591
% 210.35/210.55       78%28%75%29%; was see under SPINA BIFIDA 1963-77; MYELOCELE was see under SPINA BIFIDA 1963-77%A%  
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D008591 2004
% 210.35/210.55  |- skos__hiddenLabel mesh__D008591 Meningomyelocele, Acquired
% 210.35/210.55  |- skos__historyNote mesh__D008591 Spina Bifida %28%1966-1974%29%
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D008591 2000
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D008591 2003
% 210.35/210.55  |- skos__hiddenLabel mesh__D008591 Meningomyeloceles, Acquired
% 210.35/210.55  |- skos__hiddenLabel mesh__D008591 Acquired Myelomeningoceles
% 210.35/210.55  |- skos__broader mesh__D008591smesh__D009436
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002205 1994
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002205 2005
% 210.35/210.55  |- mesh__dateEstablished mesh__D002205 1991-01-01
% 210.35/210.55  |- mesh__recordAuthorizer mesh__D002205 PLS
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002205 1995
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002205 1996
% 210.35/210.55  |- skos__hiddenLabel mesh__D002205 Syndrome, Caplan%27%s
% 210.35/210.55  |- mesh__publicMeSHNote mesh__D002205
% 210.35/210.55       91,63-83; was see under PNEUMOCONIOSIS 1984-90; was heading 1963-83%A%  
% 210.35/210.55  |- skos__annotation mesh__D002205
% 210.35/210.55       %22%pneumoconiosis assoc with rheum arthritis%22%; do not coord with OCCUPATIONAL DISEASES%A%  
% 210.35/210.55  |- mesh__dateCreated mesh__D002205 1999-01-01
% 210.35/210.55  |- skos__prefLabel mesh__D002205 Caplan%27%s Syndrome
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002205 2006
% 210.35/210.55  |- mesh__recordMaintainer mesh__D002205 TGC
% 210.35/210.55  |- skos__scopeNote mesh__D002205
% 210.35/210.55       Pneumoconiosis associated with rheumatoid arthritis.     
% 210.35/210.55  |- mesh__historyNote mesh__D002205
% 210.35/210.55       91%28%84%29%63; was see under PNEUMOCONIOSIS 1984-90; was heading 1963-83%A%  
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002205 1997
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002205 2000
% 210.35/210.55  |- rdf__type mesh__D002205sskos__Concept
% 210.35/210.55  |- mesh__recordOriginator mesh__D002205 NLM
% 210.35/210.55  |- skos__broader mesh__D002205smesh__D011009
% 210.35/210.55  |- skos__broader mesh__D002205smesh__D001172
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002205 1998
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002205 2001
% 210.35/210.55  |- mesh__dateRevised mesh__D002205 1993-03-03
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002205 2003
% 210.35/210.55  |- skos__hiddenLabel mesh__D002205 Caplans Syndrome
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002205 1999
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002205 2002
% 210.35/210.55  |- skos__hiddenLabel mesh__D002205 Caplan Syndrome
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D002205 2004
% 210.35/210.55  |- mesh__dateCreated mesh__D007499 1980-04-07
% 210.35/210.55  |- mesh__dateEstablished mesh__D007499 1981-01-01
% 210.35/210.55  |- skos__broader mesh__D007499smesh__D014603
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007499 2000
% 210.35/210.55  |- skos__prefLabel mesh__D007499 Iris Diseases
% 210.35/210.55  |- mesh__dateRevised mesh__D007499 1993-06-03
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007499 1994
% 210.35/210.55  |- skos__scopeNote mesh__D007499
% 210.35/210.55       Diseases, dysfunctions, or disorders of or located in the iris.%A%    
% 210.35/210.55  |- mesh__recordMaintainer mesh__D007499 PLS
% 210.35/210.55  |- skos__historyNote mesh__D007499 Uveal Diseases %28%1966-1980%29%
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007499 1999
% 210.35/210.55  |- skos__hiddenLabel mesh__D007499 Disease, Iris
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007499 2006
% 210.35/210.55  |- mesh__historyNote mesh__D007499 81   
% 210.35/210.55  |- skos__historyNote mesh__D007499 Iris %28%1966-1980%29%
% 210.35/210.55  |- skos__hiddenLabel mesh__D007499 Iris Disease
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007499 1998
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007499 2005
% 210.35/210.55  |- mesh__publicMeSHNote mesh__D007499 81   
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007499 2002
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007499 1997
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007499 2004
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007499 2001
% 210.35/210.55  |- rdf__type mesh__D007499sskos__Concept
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007499 1996
% 210.35/210.55  |- mesh__recordOriginator mesh__D007499 RC
% 210.35/210.55  |- skos__hiddenLabel mesh__D007499 Diseases, Iris
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007499 1995
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D007499 2003
% 210.35/210.55  |- mesh__recordAuthorizer mesh__D007499 PLS
% 210.35/210.55  |- skos__broader mesh__D005947Q000652smesh__D005947
% 210.35/210.55  |- mesh__preferredCombination mesh__D005947Q000652smesh__D006029
% 210.35/210.55  |- rdf__type mesh__D005947Q000652smesh__CompoundConcept
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D012633 2006
% 210.35/210.55  |- skos__broader mesh__D012633smesh__D036361
% 210.35/210.55  |- mesh__dateCreated mesh__D012633 1999-01-01
% 210.35/210.55  |- skos__hiddenLabel mesh__D012633 Pig Secretin Maleate
% 210.35/210.55  |- mesh__recordOriginator mesh__D012633 NLM
% 210.35/210.55  |- rdf__type mesh__D012633sskos__Concept
% 210.35/210.55  |- skos__broader mesh__D012633smesh__D005768
% 210.35/210.55  |- skos__hiddenLabel mesh__D012633 Pig Secretin
% 210.35/210.55  |- skos__prefLabel mesh__D012633 Secretin
% 210.35/210.55  |- mesh__recordMaintainer mesh__D012633 ssb
% 210.35/210.55  |- mesh__recordAuthorizer mesh__D012633 sjn
% 210.35/210.55  |- skos__hiddenLabel mesh__D012633 Pig Secretin Citrate
% 210.35/210.55  |- mesh__dateRevised mesh__D012633 2005-06-30
% 210.35/210.55  |- skos__broader mesh__D012633smesh__D009479
% 210.35/210.55  |- skos__hiddenLabel mesh__D012633 Pig Secretin Sulfate
% 210.35/210.55  |- skos__scopeNote mesh__D012633
% 210.35/210.55       A peptide hormone of about 27 amino acids from the duodenal mucosa that activates pancreatic secretion and lowers the blood sugar level. %28%USAN and the USP Dictionary of Drug Names, 1994, p597%29%%A%    
% 210.35/210.55  |- skos__hiddenLabel mesh__D012633 Pig Secretin Pentacetate
% 210.35/210.55  |- skos__broader mesh__D008592smesh__D007719
% 210.35/210.55  |- skos__altLabel mesh__D008592 Lateral Menisci
% 210.35/210.55  |- mesh__dateCreated mesh__D008592 1999-01-01
% 210.35/210.55  |- mesh__dateRevised mesh__D008592 2005-06-30
% 210.35/210.55  |- skos__hiddenLabel mesh__D008592 Lateral Meniscus
% 210.35/210.55  |- mesh__historyNote mesh__D008592 87; was SEMILUNAR CARTILAGES 1963-86   
% 210.35/210.55  |- rdf__type mesh__D008592sskos__Concept
% 210.35/210.55  |- mesh__recordMaintainer mesh__D008592 ags
% 210.35/210.55  |- skos__hiddenLabel mesh__D008592 Medial Meniscus
% 210.35/210.55  |- skos__hiddenLabel mesh__D008592 Meniscus, Lateral
% 210.35/210.55  |- skos__hiddenLabel mesh__D008592 Meniscus, Medial
% 210.35/210.55  |- skos__hiddenLabel mesh__D008592 Meniscus, Tibial
% 210.35/210.55  |- mesh__publicMeSHNote mesh__D008592
% 210.35/210.55       87; was SEMILUNAR CARTILAGES 1963-86   
% 210.35/210.55  |- skos__altLabel mesh__D008592 Menisci, Medial
% 210.35/210.55  |- mesh__recordAuthorizer mesh__D008592 sjn
% 210.35/210.55  |- skos__hiddenLabel mesh__D008592 Cartilages, Semilunar
% 210.35/210.55  |- skos__scopeNote mesh__D008592
% 210.35/210.55       The interarticular fibrocartilages of the superior surface of the tibia.%A%    
% 210.35/210.55  |- mesh__onlineNote mesh__D008592
% 210.35/210.55       use MENISCI, TIBIAL to search SEMILUNAR CARTILAGES 1966-86%A%  
% 210.35/210.55  |- skos__hiddenLabel mesh__D008592 Semilunar Cartilage
% 210.35/210.55  |- skos__altLabel mesh__D008592 Tibial Menisci
% 210.35/210.55  |- skos__altLabel mesh__D008592 Semilunar Cartilages
% 210.35/210.55  |- skos__broader mesh__D008592smesh__D051445
% 210.35/210.55  |- skos__hiddenLabel mesh__D008592 Cartilage, Semilunar
% 210.35/210.55  |- skos__prefLabel mesh__D008592 Menisci, Tibial
% 210.35/210.55  |- skos__hiddenLabel mesh__D008592 Tibial Meniscus
% 210.35/210.55  |- mesh__recordOriginator mesh__D008592 NLM
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D008592 2006
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D016226 1997
% 210.35/210.55  |- skos__historyNote mesh__D016226 Phosphorus %28%1966-1990%29%
% 210.35/210.55  |- skos__prefLabel mesh__D016226 Phosphorus, Dietary
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D016226 2004
% 210.35/210.55  |- mesh__historyNote mesh__D016226 91   
% 210.35/210.55  |- rdf__type mesh__D016226sskos__Concept
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D016226 1994
% 210.35/210.55  |- mesh__dateCreated mesh__D016226 1990-05-07
% 210.35/210.55  |- skos__broader mesh__D016226smesh__D017553
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D016226 2000
% 210.35/210.55  |- mesh__recordOriginator mesh__D016226 RLS
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D016226 1995
% 210.35/210.55  |- mesh__dateEstablished mesh__D016226 1991-01-01
% 210.35/210.55  |- skos__annotation mesh__D016226
% 210.35/210.55       /adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with disease /diet ther%A%  
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D016226 2001
% 210.35/210.55  |- skos__altLabel mesh__D016226 Dietary Phosphorus
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D016226 1998
% 210.35/210.55  |- mesh__dateRevised mesh__D016226 1993-06-02
% 210.35/210.55  |- mesh__activeMeSHYear mesh__D016226 2005
% 210.35/210.56  |- mesh__recordMaintainer mesh__D016226 TPW
% 210.35/210.56  |- mesh__publicMeSHNote mesh__D016226 91   
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D016226 2002
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D016226 1999
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D016226 1996
% 210.35/210.56  |- skos__scopeNote mesh__D016226
% 210.35/210.56       Phosphorus used in foods or obtained from food. This element is a major intracellular component which plays an important role in many biochemical pathways relating to normal physiological functions. High concentrations of dietary phosphorus can cause nephrocalcinosis which is associated with impaired kidney function. Low concentrations of dietary phosphorus cause an increase in calcitriol in the blood and osteoporosis.%A%    
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D016226 2006
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D016226 2003
% 210.35/210.56  |- mesh__recordAuthorizer mesh__D016226 PLS
% 210.35/210.56  |- mesh__dateCreated mesh__D002206 1981-05-20
% 210.35/210.56  |- skos__prefLabel mesh__D002206 Capnocytophaga
% 210.35/210.56  |- skos__historyNote mesh__D002206 Bacteroides %28%1975-1981%29%
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D002206 2006
% 210.35/210.56  |- skos__scopeNote mesh__D002206
% 210.35/210.56       A gram-negative gliding bacterium isolated from the oral cavity. It is a pathogen often causing PERIODONTITIS.%A%    
% 210.35/210.56  |- skos__broader mesh__D002206smesh__D041965
% 210.35/210.56  |- mesh__dateRevised mesh__D002206 2005-06-30
% 210.35/210.56  |- rdf__type mesh__D002206sskos__Concept
% 210.35/210.56  |- mesh__historyNote mesh__D002206
% 210.35/210.56       91%28%82%29%; was see under CYTOPHAGACEAE 1982-90   
% 210.35/210.56  |- mesh__recordMaintainer mesh__D002206 SYSTEM
% 210.35/210.56  |- skos__annotation mesh__D002206
% 210.35/210.56       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 210.35/210.56  |- mesh__recordOriginator mesh__D002206 RC
% 210.35/210.56  |- mesh__publicMeSHNote mesh__D002206
% 210.35/210.56       91; was see under CYTOPHAGACEAE 1982-90   
% 210.35/210.56  |- mesh__recordAuthorizer mesh__D002206 sjn
% 210.35/210.56  |- skos__broader mesh__D002206smesh__D006092
% 210.35/210.56  |- skos__historyNote mesh__D002206 Cytophagaceae %28%1975-1981%29%
% 210.35/210.56  |- mesh__dateEstablished mesh__D002206 1991-01-01
% 210.35/210.56  |- skos__hiddenLabel mesh__D048308
% 210.35/210.56       Cytokine Suppressive Anti inflammatory Drug Binding Protein
% 210.35/210.56  |- skos__altLabel mesh__D048308 SAPK2a
% 210.35/210.56  |- skos__altLabel mesh__D048308 MAPK14
% 210.35/210.56  |- skos__altLabel mesh__D048308 Kinase CSBP
% 210.35/210.56  |- skos__hiddenLabel mesh__D048308 MAP Kinase, p38alpha
% 210.35/210.56  |- skos__hiddenLabel mesh__D048308 MAX Interacting Protein 2
% 210.35/210.56  |- skos__altLabel mesh__D048308 p38alpha MAP Kinase
% 210.35/210.56  |- skos__altLabel mesh__D048308 Mxi2 Protein
% 210.35/210.56  |- skos__altLabel mesh__D048308 CSAID-Binding Protein
% 210.35/210.56  |- skos__hiddenLabel mesh__D048308 Stress activated protein kinase 2a
% 210.35/210.56  |- skos__hiddenLabel mesh__D048308 Mitogen Activated Protein Kinase 14
% 210.35/210.56  |- skos__altLabel mesh__D048308 p38alpha Mitogen-Activated Protein Kinase
% 210.35/210.56  |- skos__hiddenLabel mesh__D048308 MAPK14 Mitogen Activated Protein Kinase
% 210.35/210.56  |- skos__historyNote mesh__D048308
% 210.35/210.56       Ca%28%2+%29%-Calmodulin Dependent Protein Kinase %28%1995-1999%29%
% 210.35/210.56  |- mesh__historyNote mesh__D048308 2005%28%1994%29%   
% 210.35/210.56  |- skos__scopeNote mesh__D048308
% 210.35/210.56       A 38-kDa mitogen-activated protein kinase that is abundantly expressed in a broad variety of cell types. It is involved in the regulation of cellular stress responses as well as the control of proliferation and survival of many cell types. The kinase activity of the enzyme is inhibited by the pyridinyl-imidazole compound SB 203580.%A%    
% 210.35/210.56  |- skos__hiddenLabel mesh__D048308
% 210.35/210.56       p38alpha Mitogen Activated Protein Kinase
% 210.35/210.56  |- skos__prefLabel mesh__D048308 Mitogen-Activated Protein Kinase 14
% 210.35/210.56  |- mesh__dateEstablished mesh__D048308 2005-01-01
% 210.35/210.56  |- skos__hiddenLabel mesh__D048308 CSBP, Kinase
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D048308 2005
% 210.35/210.56  |- mesh__recordOriginator mesh__D048308 jmp
% 210.35/210.56  |- skos__altLabel mesh__D048308
% 210.35/210.56       Cytokine Suppressive Anti-inflammatory Drug Binding Protein
% 210.35/210.56  |- rdf__type mesh__D048308sskos__Concept
% 210.35/210.56  |- skos__historyNote mesh__D048308
% 210.35/210.56       Mitogen-Activated Protein Kinases %28%2000-2004%29%
% 210.35/210.56  |- mesh__publicMeSHNote mesh__D048308
% 210.35/210.56       2005; MITOGEN-ACTIVATED PROTEIN KINASE 14 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2002-2004; CSAID-BINDING PROTEIN %26% KINASE CSBP were indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004; MXI2 PROTEIN was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004, under CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1994-2000%A%  
% 210.35/210.56  |- mesh__recordAuthorizer mesh__D048308 sjn
% 210.35/210.56  |- skos__broader mesh__D048308smesh__D048051
% 210.35/210.56  |- skos__altLabel mesh__D048308 p38alphaMAPK
% 210.35/210.56  |- skos__hiddenLabel mesh__D048308 CSAID Binding Protein
% 210.35/210.56  |- mesh__dateCreated mesh__D048308 2004-07-07
% 210.35/210.56  |- skos__altLabel mesh__D048308 Stress-activated protein kinase 2a
% 210.35/210.56  |- skos__altLabel mesh__D048308 MAX-Interacting Protein 2
% 210.35/210.56  |- skos__altLabel mesh__D048308 MAPK14 Mitogen-Activated Protein Kinase
% 210.35/210.56  |- mesh__recordMaintainer mesh__D048308 jmp
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D048308 2006
% 210.35/210.56  |- skos__historyNote mesh__D012634 specific secretions %28%1966-1997%29%
% 210.35/210.56  |- skos__prefLabel mesh__D012634 Bodily Secretions
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012634 2002
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012634 1998
% 210.35/210.56  |- skos__hiddenLabel mesh__D012634 Bodily Secretion
% 210.35/210.56  |- mesh__dateRevised mesh__D012634 1997-06-20
% 210.35/210.56  |- skos__altLabel mesh__D012634 Secretions
% 210.35/210.56  |- skos__hiddenLabel mesh__D012634 Secretion
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012634 1999
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012634 2005
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012634 2000
% 210.35/210.56  |- mesh__recordMaintainer mesh__D012634 TGC
% 210.35/210.56  |- mesh__dateEstablished mesh__D012634 1998-01-01
% 210.35/210.56  |- skos__scopeNote mesh__D012634
% 210.35/210.56       Endogenous substances produced through the activity of intact cells of glands, tissues, or organs. They do not include hormones or enzymes.%A%    
% 210.35/210.56  |- skos__historyNote mesh__D012634
% 210.35/210.56       specific organ/secretion %28%1966-1997%29%
% 210.35/210.56  |- mesh__recordOriginator mesh__D012634 NLM
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012634 2006
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012634 2001
% 210.35/210.56  |- mesh__dateCreated mesh__D012634 1999-01-01
% 210.35/210.56  |- mesh__historyNote mesh__D012634 98; use explode 1967-97   
% 210.35/210.56  |- mesh__publicMeSHNote mesh__D012634 98   
% 210.35/210.56  |- skos__hiddenLabel mesh__D012634 Secretion, Bodily
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012634 2003
% 210.35/210.56  |- skos__annotation mesh__D012634
% 210.35/210.56       avoid: too general; prefer specific secretion or Cat A %26% D terms with /secret%A%  
% 210.35/210.56  |- skos__hiddenLabel mesh__D012634 Secretions, Bodily
% 210.35/210.56  |- skos__broader mesh__D012634smesh__D005441
% 210.35/210.56  |- rdf__type mesh__D012634sskos__Concept
% 210.35/210.56  |- skos__historyNote mesh__D012634
% 210.35/210.56       specific substance/secretion %28%1966-1997%29%
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012634 2004
% 210.35/210.56  |- mesh__recordAuthorizer mesh__D012634 SJN
% 210.35/210.56  |- rdf__type mesh__D050753sskos__Concept
% 210.35/210.56  |- skos__hiddenLabel mesh__D050753 Enoyl-ACP Reductase, NADH-Dependent
% 210.35/210.56  |- skos__hiddenLabel mesh__D050753 Reductase, NADH-Enoyl ACP
% 210.35/210.56  |- skos__prefLabel mesh__D050753
% 210.35/210.56       Enoyl-%28%Acyl-Carrier-Protein%29% Reductase %28%NADH%29%
% 210.35/210.56  |- skos__altLabel mesh__D050753 NADH-Enoyl ACP Reductase
% 210.35/210.56  |- skos__historyNote mesh__D050753 Acyl Carrier Protein %28%1978-1983%29%
% 210.35/210.56  |- mesh__recordAuthorizer mesh__D050753 sjn
% 210.35/210.56  |- skos__hiddenLabel mesh__D050753 Reductase, NADH-Dependent Enoyl-ACP
% 210.35/210.56  |- skos__altLabel mesh__D050753
% 210.35/210.56       Enoyl%28%Acyl-Carrier-Protein%29% Reductase %28%NADH%29%
% 210.35/210.56  |- mesh__dateEstablished mesh__D050753 2006-01-01
% 210.35/210.56  |- skos__altLabel mesh__D050753 NADH-Dependent Enoyl-ACP Reductase
% 210.35/210.56  |- mesh__publicMeSHNote mesh__D050753
% 210.35/210.56       2006; ENOYL-%5B%ACYL-CARRIER-PROTEIN%5D% REDUCTASE %28%NADH%29% was indexed under OXIDOREDUCTASES 1984-2005, under ACYL CARRIER PROTEIN 1978-1983, under CARRIER PROTEINS 1972-1979, and under PROTEINS 1970-1972%A%  
% 210.35/210.56  |- skos__historyNote mesh__D050753 Proteins %28%1970-1972%29%
% 210.35/210.56  |- skos__historyNote mesh__D050753 Carrier Proteins %28%1972-1979%29%
% 210.35/210.56  |- skos__hiddenLabel mesh__D050753 NADH Enoyl ACP Reductase
% 210.35/210.56  |- mesh__recordMaintainer mesh__D050753 AKE
% 210.35/210.56  |- skos__scopeNote mesh__D050753
% 210.35/210.56       An NAD-dependent enzyme that catalyzes the oxidation of acyl-%5B%acyl-carrier protein%5D% to trans-2,3-dehydroacyl-%5B%acyl-carrier protein%5D%. It has a preference for acyl groups with a carbon chain length between 4 to 16.%A%    
% 210.35/210.56  |- mesh__dateCreated mesh__D050753 2005-06-30
% 210.35/210.56  |- mesh__historyNote mesh__D050753 2006%28%1970%29%   
% 210.35/210.56  |- skos__broader mesh__D050753smesh__D044925
% 210.35/210.56  |- mesh__recordOriginator mesh__D050753 AKE
% 210.35/210.56  |- skos__historyNote mesh__D050753 Oxidoreductases %28%1984-2005%29%
% 210.35/210.56  |- skos__hiddenLabel mesh__D050753 ACP Reductase, NADH-Enoyl
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D050753 2006
% 210.35/210.56  |- skos__hiddenLabel mesh__D050753 NADH Dependent Enoyl ACP Reductase
% 210.35/210.56  |- skos__altLabel mesh__D008593 Change of Life, Female
% 210.35/210.56  |- skos__related mesh__D008593smesh__D017698
% 210.35/210.56  |- skos__broader mesh__D008593smesh__D002979
% 210.35/210.56  |- mesh__recordOriginator mesh__D008593 NLM
% 210.35/210.56  |- skos__annotation mesh__D008593
% 210.35/210.56       PERIMENOPAUSE; PREMENOPAUSE; and POSTMENOPAUSE are available%A%  
% 210.35/210.56  |- mesh__dateRevised mesh__D008593 2004-07-07
% 210.35/210.56  |- mesh__recordMaintainer mesh__D008593 lkt
% 210.35/210.56  |- skos__related mesh__D008593smesh__D015663
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D008593 2006
% 210.35/210.56  |- skos__prefLabel mesh__D008593 Menopause
% 210.35/210.56  |- mesh__dateCreated mesh__D008593 1999-01-01
% 210.35/210.56  |- skos__related mesh__D008593smesh__D015914
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D008593 2005
% 210.35/210.56  |- skos__scopeNote mesh__D008593
% 210.35/210.56       The last menstrual period. Permanent cessation of menses %28%MENSTRUATION%29% is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.%A%    
% 210.35/210.56  |- rdf__type mesh__D008593sskos__Concept
% 210.35/210.56  |- skos__related mesh__D008593smesh__D019584
% 210.35/210.56  |- mesh__recordAuthorizer mesh__D008593 sjn
% 210.35/210.56  |- skos__related mesh__D008593smesh__D017697
% 210.35/210.56  |- mesh__historyNote mesh__D016227 91   
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D016227 2004
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D016227 2006
% 210.35/210.56  |- mesh__recordMaintainer mesh__D016227 ssb
% 210.35/210.56  |- mesh__publicMeSHNote mesh__D016227 91   
% 210.35/210.56  |- mesh__recordAuthorizer mesh__D016227 sjn
% 210.35/210.56  |- skos__altLabel mesh__D016227 o-Benzoquinones
% 210.35/210.56  |- skos__altLabel mesh__D016227 p-Benzoquinones
% 210.35/210.56  |- skos__historyNote mesh__D016227 Quinones %28%1966-1990%29%
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D016227 2005
% 210.35/210.56  |- mesh__dateRevised mesh__D016227 2003-07-09
% 210.35/210.56  |- rdf__type mesh__D016227sskos__Concept
% 210.35/210.56  |- skos__prefLabel mesh__D016227 Benzoquinones
% 210.35/210.56  |- skos__altLabel mesh__D016227 Benzodiones
% 210.35/210.56  |- mesh__recordOriginator mesh__D016227 RLS
% 210.35/210.56  |- mesh__dateCreated mesh__D016227 1990-05-07
% 210.35/210.56  |- skos__broader mesh__D016227smesh__D011809
% 210.35/210.56  |- skos__scopeNote mesh__D016227
% 210.35/210.56       Benzene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.%A%    
% 210.35/210.56  |- mesh__dateEstablished mesh__D016227 1991-01-01
% 210.35/210.56  |- skos__broader mesh__D002207smesh__D010456
% 210.35/210.56  |- skos__hiddenLabel mesh__D002207 Sulfate, Capreomycin
% 210.35/210.56  |- skos__altLabel mesh__D002207 Elan Brand of Capreomycin Disulfate
% 210.35/210.56  |- mesh__dateRevised mesh__D002207 2004-07-07
% 210.35/210.56  |- skos__scopeNote mesh__D002207
% 210.35/210.56       Cyclic peptide antibiotic similar to VIOMYCIN. It is produced by Streptomyces capreolus.%A%    
% 210.35/210.56  |- skos__altLabel mesh__D002207 Capastat
% 210.35/210.56  |- mesh__recordOriginator mesh__D002207 NLM
% 210.35/210.56  |- mesh__recordAuthorizer mesh__D002207 sjn
% 210.35/210.56  |- mesh__historyNote mesh__D002207
% 210.35/210.56       96; was CAPREOMYCIN 1972-95 %28%Prov 1972-73%29%; CAPROMYCIN was see CAPREOMYCIN 1978-93%A%  
% 210.35/210.56  |- skos__prefLabel mesh__D002207 Capreomycin Sulfate
% 210.35/210.56  |- mesh__dateEstablished mesh__D002207 1974-01-01
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D002207 2005
% 210.35/210.56  |- mesh__onlineNote mesh__D002207
% 210.35/210.56       use CAPREOMYCIN SULFATE to search CAPROMYCIN 1978-93   
% 210.35/210.56  |- mesh__recordMaintainer mesh__D002207 ssb
% 210.35/210.56  |- mesh__publicMeSHNote mesh__D002207
% 210.35/210.56       96; was CAPREOMYCIN 1974-95; CAPROMYCIN was see CAPREOMYCIN 1978-93%A%  
% 210.35/210.56  |- mesh__dateCreated mesh__D002207 1999-01-01
% 210.35/210.56  |- skos__historyNote mesh__D002207 Antitubercular Agents %28%1966-1971%29%
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D002207 2006
% 210.35/210.56  |- skos__altLabel mesh__D002207 Dista Brand of Capreomycin Disulfate
% 210.35/210.56  |- skos__altLabel mesh__D002207 Capromycin
% 210.35/210.56  |- rdf__type mesh__D002207sskos__Concept
% 210.35/210.56  |- skos__altLabel mesh__D002207 Lilly Brand of Capreomycin Disulfate
% 210.35/210.56  |- skos__hiddenLabel mesh__D048309 Short-Tailed Opossums
% 210.35/210.56  |- skos__scopeNote mesh__D048309
% 210.35/210.56       A genus of short-tailed OPOSSUMS in the family Didelphidae found in South American, chiefly Brazil. They are opossums least well-adapted to arboreal life.%A%    
% 210.35/210.56  |- skos__hiddenLabel mesh__D048309 Short-Tailed Opossum
% 210.35/210.56  |- mesh__recordMaintainer mesh__D048309 jls
% 210.35/210.56  |- skos__historyNote mesh__D048309 Opossums %28%1969-2004%29%
% 210.35/210.56  |- mesh__historyNote mesh__D048309 2005; use OPOSSUMS 1995-2004   
% 210.35/210.56  |- skos__broader mesh__D048309smesh__D009893
% 210.35/210.56  |- skos__prefLabel mesh__D048309 Monodelphis
% 210.35/210.56  |- skos__hiddenLabel mesh__D048309 Opossum, Short-Tailed
% 210.35/210.56  |- mesh__recordAuthorizer mesh__D048309 jls
% 210.35/210.56  |- skos__hiddenLabel mesh__D048309 Opossums, Short Tailed
% 210.35/210.56  |- mesh__publicMeSHNote mesh__D048309 2005; see OPOSSUMS 1995-2004   
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D048309 2005A
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D048309 2005
% 210.35/210.56  |- rdf__type mesh__D048309sskos__Concept
% 210.35/210.56  |- skos__altLabel mesh__D048309 Opossums, Short-Tailed
% 210.35/210.56  |- mesh__dateCreated mesh__D048309 2004-07-07
% 210.35/210.56  |- mesh__dateRevised mesh__D048309 2004-07-28
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D048309 2006
% 210.35/210.56  |- mesh__dateEstablished mesh__D048309 2005-01-01
% 210.35/210.56  |- mesh__recordOriginator mesh__D048309 ags
% 210.35/210.56  |- mesh__recordMaintainer mesh__D012635 nns
% 210.35/210.56  |- mesh__dateCreated mesh__D012635 1975-07-25
% 210.35/210.56  |- mesh__recordAuthorizer mesh__D012635 sjn
% 210.35/210.56  |- mesh__recordOriginator mesh__D012635 SH
% 210.35/210.56  |- mesh__historyNote mesh__D012635
% 210.35/210.56       91%28%76%29%; was see under IMMUNOGLOBULIN FRAGMENTS 1976-90   
% 210.35/210.56  |- skos__historyNote mesh__D012635 Colostrum %28%1973-1975%29%
% 210.35/210.56  |- mesh__dateRevised mesh__D012635 2005-06-30
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012635 2006
% 210.35/210.56  |- skos__historyNote mesh__D012635
% 210.35/210.56       Immunoglobulin Fragments %28%1973-1975%29%
% 210.35/210.56  |- skos__prefLabel mesh__D012635 Secretory Component
% 210.35/210.56  |- rdf__type mesh__D012635sskos__Concept
% 210.35/210.56  |- skos__altLabel mesh__D012635 Secretory Piece
% 210.35/210.56  |- skos__scopeNote mesh__D012635
% 210.35/210.56       The extracellular moiety of the POLYMERIC IMMUNOGLOBULIN RECEPTOR found alone or complexed with IGA or IGM, in a variety of external secretions %28%tears, bile, colostrum.%29% Secretory component is derived by proteolytic cleavage of the receptor during transcytosis. When immunoglobulins IgA and IgM are bound to the receptor, during their transcytosis secretory component becomes covalently attached to them generating SECRETORY IMMUNOGLOBULIN A or secretory IMMUNOGLOBULIN M.%A%    
% 210.35/210.56  |- skos__historyNote mesh__D012635 IgA %28%1973-1975%29%
% 210.35/210.56  |- mesh__publicMeSHNote mesh__D012635
% 210.35/210.56       91; was see under IMMUNOGLOBULIN FRAGMENTS 1976-90   
% 210.35/210.56  |- mesh__dateEstablished mesh__D012635 1991-01-01
% 210.35/210.56  |- skos__broader mesh__D012635smesh__D050440
% 210.35/210.56  |- skos__broader mesh__D012635smesh__D007071
% 210.35/210.56  |- skos__broader mesh__D017320smesh__D011480
% 210.35/210.56  |- mesh__historyNote mesh__D017320 93   
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D017320 2004
% 210.35/210.56  |- mesh__dateRevised mesh__D017320 2003-07-09
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D017320 2005
% 210.35/210.56  |- skos__annotation mesh__D017320 DF: HIV PROTEASE INHIB   
% 210.35/210.56  |- skos__scopeNote mesh__D017320
% 210.35/210.56       Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly.%A%    
% 210.35/210.56  |- mesh__dateCreated mesh__D017320 1992-05-20
% 210.35/210.56  |- mesh__publicMeSHNote mesh__D017320 93   
% 210.35/210.56  |- rdf__type mesh__D017320sskos__Concept
% 210.35/210.56  |- skos__hiddenLabel mesh__D017320 Inhibitors, HIV Protease
% 210.35/210.56  |- skos__broader mesh__D017320smesh__D019380
% 210.35/210.56  |- mesh__recordMaintainer mesh__D017320 ssb
% 210.35/210.56  |- skos__historyNote mesh__D017320 Antiviral Agents %28%1990-1992%29%
% 210.35/210.56  |- skos__historyNote mesh__D017320
% 210.35/210.56       HIV Protease/antagonists %26% inhibitors %28%1990-1992%29%
% 210.35/210.56  |- skos__prefLabel mesh__D017320 HIV Protease Inhibitors
% 210.35/210.56  |- mesh__recordAuthorizer mesh__D017320 sjn
% 210.35/210.56  |- skos__hiddenLabel mesh__D017320 Protease Inhibitors, HIV
% 210.35/210.56  |- mesh__dateEstablished mesh__D017320 1993-01-01
% 210.35/210.56  |- mesh__recordOriginator mesh__D017320 AGS
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D017320 2006
% 210.35/210.56  |- skos__related mesh__D003300smesh__D002570
% 210.35/210.56  |- skos__related mesh__D003300smesh__D003301
% 210.35/210.56  |- skos__annotation mesh__D003300
% 210.35/210.56       Cu-63; Cu-65 = COPPER %28%IM%29% + ISOTOPES %28%NIM%29%; Cu-58-62, 64, 66-68 = COPPER RADIOISOTOPES %28%IM%29%%A%  
% 210.35/210.56  |- mesh__dateRevised mesh__D003300 2005-06-30
% 210.35/210.56  |- rdf__type mesh__D003300sskos__Concept
% 210.35/210.56  |- mesh__recordOriginator mesh__D003300 NLM
% 210.35/210.56  |- skos__broader mesh__D003300smesh__D019216
% 210.35/210.56  |- mesh__recordAuthorizer mesh__D003300 sjn
% 210.35/210.56  |- skos__hiddenLabel mesh__D003300 Copper Level, Serum
% 210.35/210.56  |- mesh__recordMaintainer mesh__D003300 ssb
% 210.35/210.56  |- skos__hiddenLabel mesh__D003300 Level, Serum Copper
% 210.35/210.56  |- mesh__dateCreated mesh__D003300 1999-01-01
% 210.35/210.56  |- skos__broader mesh__D003300smesh__D028561
% 210.35/210.56  |- skos__prefLabel mesh__D003300 Copper
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D003300 2006
% 210.35/210.56  |- skos__scopeNote mesh__D003300
% 210.35/210.56       A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55.%A%    
% 210.35/210.56  |- skos__related mesh__D008594smesh__D016649
% 210.35/210.56  |- mesh__recordAuthorizer mesh__D008594 sjn
% 210.35/210.56  |- skos__scopeNote mesh__D008594
% 210.35/210.56       The premature cessation of menses %28%MENSTRUATION%29% when the last menstrual period occurs in a woman under the age of 40. It is due to the depletion of OVARIAN FOLLICLES. Premature MENOPAUSE can be caused by diseases; OVARIECTOMY; RADIATION; chemicals; and chromosomal abnormalities.%A%    
% 210.35/210.56  |- skos__broader mesh__D008594smesh__D010049
% 210.35/210.56  |- mesh__dateRevised mesh__D008594 2004-07-07
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D008594 2006
% 210.35/210.56  |- mesh__publicMeSHNote mesh__D008594
% 210.35/210.56       91; was see under MENOPAUSE 1975-90   
% 210.35/210.56  |- mesh__recordOriginator mesh__D008594 NLM
% 210.35/210.56  |- skos__hiddenLabel mesh__D008594 Premature Menopause
% 210.35/210.56  |- rdf__type mesh__D008594sskos__Concept
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D008594 2005
% 210.35/210.56  |- skos__prefLabel mesh__D008594 Menopause, Premature
% 210.35/210.56  |- mesh__recordMaintainer mesh__D008594 lkt
% 210.35/210.56  |- skos__broader mesh__D008594smesh__D008593
% 210.35/210.56  |- mesh__dateEstablished mesh__D008594 1991-01-01
% 210.35/210.56  |- mesh__dateCreated mesh__D008594 1974-11-11
% 210.35/210.56  |- mesh__historyNote mesh__D008594
% 210.35/210.56       91%28%75%29%; was see under MENOPAUSE 1975-90   
% 210.35/210.56  |- skos__altLabel mesh__D016228 ECDGF
% 210.35/210.56  |- mesh__recordOriginator mesh__D016228 RLS
% 210.35/210.56  |- skos__altLabel mesh__D016228 Endothelial Growth Factor
% 210.35/210.56  |- skos__broader mesh__D016228smesh__D036341
% 210.35/210.56  |- mesh__dateRevised mesh__D016228 2005-07-13
% 210.35/210.56  |- skos__hiddenLabel mesh__D016228 Endothelial Cell Derived Growth Factors
% 210.35/210.56  |- skos__hiddenLabel mesh__D016228 alpha Endothelial Growth Factor
% 210.35/210.56  |- rdf__type mesh__D016228sskos__Concept
% 210.35/210.56  |- skos__historyNote mesh__D016228 Growth Substances %28%1966-1983%29%
% 210.35/210.56  |- skos__annotation mesh__D016228
% 210.35/210.56       do not confuse with EGF; %28%EPIDERMAL GROWTH FACTOR%29%   
% 210.35/210.56  |- skos__related mesh__D016228smesh__D042461
% 210.35/210.56  |- skos__hiddenLabel mesh__D016228 Growth Factor, alpha-Endothelial
% 210.35/210.56  |- mesh__publicMeSHNote mesh__D016228 91   
% 210.35/210.56  |- skos__altLabel mesh__D016228 Endo-GF
% 210.35/210.56  |- skos__altLabel mesh__D016228 Endothelial Growth Factor Polypeptides
% 210.35/210.56  |- skos__historyNote mesh__D016228
% 210.35/210.56       Fibroblast Growth Factor %28%1984-1990%29%
% 210.35/210.56  |- skos__hiddenLabel mesh__D016228 Growth Factors, Endothelial
% 210.35/210.56  |- skos__hiddenLabel mesh__D016228 beta Endothelial Growth Factor
% 210.35/210.56  |- mesh__recordAuthorizer mesh__D016228 ags
% 210.35/210.56  |- mesh__dateCreated mesh__D016228 1990-05-30
% 210.35/210.56  |- skos__prefLabel mesh__D016228 Endothelial Growth Factors
% 210.35/210.56  |- mesh__recordMaintainer mesh__D016228 ags
% 210.35/210.56  |- mesh__dateEstablished mesh__D016228 1991-01-01
% 210.35/210.56  |- mesh__historyNote mesh__D016228 91   
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D016228 2006A
% 210.35/210.56  |- skos__scopeNote mesh__D016228
% 210.35/210.56       These growth factors are soluble mitogens secreted by a variety of organs. The factors are a mixture of two single chain polypeptides which have affinity to heparin. Their molecular weight are organ and species dependent. They have mitogenic and chemotactic effects and can stimulate endothelial cells to grow and synthesize DNA. The factors are related to both the basic and acidic FIBROBLAST GROWTH FACTORS but have different amino acid sequences.%A%    
% 210.35/210.56  |- skos__hiddenLabel mesh__D016228 Growth Factor, beta-Endothelial
% 210.35/210.56  |- skos__hiddenLabel mesh__D016228 Growth Factor, Endothelial
% 210.35/210.56  |- skos__altLabel mesh__D016228 Endothelial Cell-Derived Growth Factors
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D016228 2006
% 210.35/210.56  |- skos__prefLabel mesh__D002208 Caproates
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D002208 2004
% 210.35/210.56  |- skos__broader mesh__D002208smesh__D005232
% 210.35/210.56  |- mesh__recordAuthorizer mesh__D002208 sjn
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D002208 2005
% 210.35/210.56  |- mesh__recordOriginator mesh__D002208 NLM
% 210.35/210.56  |- mesh__dateRevised mesh__D002208 2003-07-09
% 210.35/210.56  |- mesh__dateCreated mesh__D002208 1999-01-01
% 210.35/210.56  |- skos__broader mesh__D002208smesh__D000144
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D002208 2006
% 210.35/210.56  |- skos__altLabel mesh__D002208 Hexanoates
% 210.35/210.56  |- rdf__type mesh__D002208sskos__Concept
% 210.35/210.56  |- mesh__recordMaintainer mesh__D002208 ssb
% 210.35/210.56  |- mesh__dateEstablished mesh__D012636 1968-01-01
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012636 2002
% 210.35/210.56  |- mesh__recordOriginator mesh__D012636 NLM
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012636 1995
% 210.35/210.56  |- mesh__recordMaintainer mesh__D012636 TAP
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012636 1993
% 210.35/210.56  |- skos__broader mesh__D012636smesh__D008660
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012636 1999
% 210.35/210.56  |- skos__prefLabel mesh__D012636 Secretory Rate
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012636 1994
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012636 1997
% 210.35/210.56  |- mesh__publicMeSHNote mesh__D012636 68   
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012636 2001
% 210.35/210.56  |- skos__annotation mesh__D012636
% 210.35/210.56       NIM; restrict to secretion of endogenous substances %28%see MeSH definition%29%%A%  
% 210.35/210.56  |- skos__hiddenLabel mesh__D012636 Secretory Rates
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012636 1998
% 210.35/210.56  |- skos__hiddenLabel mesh__D012636 Rates, Secretory
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012636 2006
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012636 2000
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012636 1996
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012636 2004
% 210.35/210.56  |- mesh__dateRevised mesh__D012636 1992-05-18
% 210.35/210.56  |- skos__scopeNote mesh__D012636
% 210.35/210.56       The amount of a substance secreted by cells or by a specific organ or organism over a given period of time; usually applies to those substances which are formed by glandular tissues and are released by them into biological fluids, e.g., secretory rate of corticosteroids by the adrenal cortex, secretory rate of gastric acid by the gastric mucosa.%A%    
% 210.35/210.56  |- mesh__historyNote mesh__D012636 68%28%66%29%   
% 210.35/210.56  |- mesh__recordAuthorizer mesh__D012636 PLS
% 210.35/210.56  |- mesh__dateCreated mesh__D012636 1999-01-01
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012636 2005
% 210.35/210.56  |- rdf__type mesh__D012636sskos__Concept
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D012636 2003
% 210.35/210.56  |- skos__hiddenLabel mesh__D012636 Rate, Secretory
% 210.35/210.56  |- mesh__dateEstablished mesh__D017321 1993-01-01
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D017321 2003
% 210.35/210.56  |- skos__historyNote mesh__D017321 Drug Evaluation %28%1980-1992%29%
% 210.35/210.56  |- skos__altLabel mesh__D017321 Evaluation Studies, FDA Phase 1
% 210.35/210.56  |- skos__prefLabel mesh__D017321 Clinical Trials, Phase I
% 210.35/210.56  |- rdf__type mesh__D017321sskos__Concept
% 210.35/210.56  |- skos__altLabel mesh__D017321 Clinical Trials, Phase 1
% 210.35/210.56  |- skos__altLabel mesh__D017321 Drug Evaluation, FDA Phase 1
% 210.35/210.56  |- mesh__recordMaintainer mesh__D017321 tjk
% 210.35/210.56  |- mesh__dateCreated mesh__D017321 1992-05-13
% 210.35/210.56  |- skos__broader mesh__D017321smesh__D002986
% 210.35/210.56  |- skos__scopeNote mesh__D017321
% 210.35/210.56       Studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range %28%if appropriate%29%. These tests also are used to determine pharmacologic and pharmacokinetic properties %28%toxicity, metabolism, absorption, elimination, and preferred route of administration%29%. They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the U.S. and in other countries.%A%    
% 210.35/210.56  |- mesh__publicMeSHNote mesh__D017321
% 210.35/210.56       93; DRUG EVALUATION, FDA PHASE I was see DRUG EVALUATION 1980-92; EVALUATION STUDIES, FDA PHASE I was EVALUATION STUDIES, DRUG, FDA PHASE I see DRUG EVALUATION 1982-92%A%  
% 210.35/210.56  |- skos__annotation mesh__D017321
% 210.35/210.56       trial lasts about a year; for U.S. %26% foreign studies; for I/II clin trials, index under CLINICAL TRIALS, PHASE I + CLINICAL TRIALS, PHASE II; IM for articles %26% books about phase I clin trials as a method in med research; do not confuse with Publication Type CLINICAL TRIAL, PHASE I; DF: CLIN TRIALS PHASE I%A%  
% 210.35/210.56  |- skos__historyNote mesh__D017321 Clinical Trials %28%1980-1992%29%
% 210.35/210.56  |- mesh__recordOriginator mesh__D017321 TPW
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D017321 2006
% 210.35/210.56  |- skos__related mesh__D017321smesh__D033281
% 210.35/210.56  |- skos__altLabel mesh__D017321 Phase I Clinical Trials
% 210.35/210.56  |- mesh__dateRevised mesh__D017321 2002-07-03
% 210.35/210.56  |- mesh__onlineNote mesh__D017321
% 210.35/210.56       use DRUG EVALUATION to search DRUG EVALUATION, FDA PHASE I 1980-92 %26% EVALUATION STUDIES, DRUG, FDA PHASE I 1982-92%A%  
% 210.35/210.56  |- skos__altLabel mesh__D017321 Phase 1 Clinical Trials
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D017321 2005
% 210.35/210.56  |- mesh__historyNote mesh__D017321
% 210.35/210.56       93; DRUG EVALUATION, FDA PHASE I was see DRUG EVALUATION 1980-92; EVALUATION STUDIES, FDA PHASE I was EVALUATION STUDIES, DRUG, FDA PHASE I see DRUG EVALUATION 1982-92%A%  
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D017321 2004
% 210.35/210.56  |- mesh__recordAuthorizer mesh__D017321 sjn
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D003301 2003
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D003301 1997
% 210.35/210.56  |- mesh__dateEstablished mesh__D003301 1988-01-01
% 210.35/210.56  |- mesh__dateCreated mesh__D003301 1987-04-06
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D003301 2006
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D003301 1996
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D003301 2002
% 210.35/210.56  |- mesh__historyNote mesh__D003301 88   
% 210.35/210.56  |- skos__scopeNote mesh__D003301
% 210.35/210.56       Unstable isotopes of copper that decay or disintegrate emitting radiation. Cu atoms with atomic weights 58-62, 64, and 66-68 are radioactive copper isotopes.%A%    
% 210.35/210.56  |- skos__annotation mesh__D003301
% 210.35/210.56       Cu-58-62, 64, 66-68; /blood-csf-urine /metab permitted but not for tracer studies  %28% = /diag use%29%%A%  
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D003301 1999
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D003301 2005
% 210.35/210.56  |- skos__historyNote mesh__D003301 Copper %28%1966-1987%29%
% 210.35/210.56  |- skos__historyNote mesh__D003301 Radioisotopes %28%1966-1987%29%
% 210.35/210.56  |- skos__prefLabel mesh__D003301 Copper Radioisotopes
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D003301 1995
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D003301 1998
% 210.35/210.56  |- mesh__dateRevised mesh__D003301 1993-06-01
% 210.35/210.56  |- rdf__type mesh__D003301sskos__Concept
% 210.35/210.56  |- skos__broader mesh__D003301smesh__D011868
% 210.35/210.56  |- mesh__recordAuthorizer mesh__D003301 PLS
% 210.35/210.56  |- mesh__publicMeSHNote mesh__D003301 88   
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D003301 1994
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D003301 2001
% 210.35/210.56  |- mesh__recordMaintainer mesh__D003301 TPW
% 210.35/210.56  |- mesh__recordOriginator mesh__D003301 RLS
% 210.35/210.56  |- skos__hiddenLabel mesh__D003301 Radioisotopes, Copper
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D003301 2004
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D003301 2000
% 210.35/210.56  |- mesh__dateRevised mesh__D008595 2005-06-30
% 210.35/210.56  |- mesh__dateCreated mesh__D008595 1999-01-01
% 210.35/210.56  |- skos__prefLabel mesh__D008595 Menorrhagia
% 210.35/210.56  |- skos__scopeNote mesh__D008595
% 210.35/210.56       Excessive uterine bleeding during MENSTRUATION.     
% 210.35/210.56  |- mesh__recordMaintainer mesh__D008595 lkt
% 210.35/210.56  |- mesh__activeMeSHYear mesh__D008595 2006
% 210.35/210.56  |- skos__broader mesh__D008595smesh__D008599
% 210.35/210.56  |- mesh__recordAuthorizer mesh__D008595 sjn
% 210.35/210.56  |- skos__annotation mesh__D008595 do not confuse with METRORRHAGIA   
% 210.35/210.57  |- rdf__type mesh__D008595sskos__Concept
% 210.35/210.57  |- skos__broader mesh__D008595smesh__D014592
% 210.35/210.57  |- skos__altLabel mesh__D008595 Hypermenorrhea
% 210.35/210.57  |- mesh__recordOriginator mesh__D008595 NLM
% 210.35/210.57  |- mesh__dateRevised mesh__D016229 2004-07-07
% 210.35/210.57  |- skos__hiddenLabel mesh__D016229 AD-AP, Amyloid
% 210.35/210.57  |- skos__hiddenLabel mesh__D016229 Alzheimer beta Protein
% 210.35/210.57  |- skos__altLabel mesh__D016229 beta-Amyloid Protein
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D016229 2006
% 210.35/210.57  |- skos__annotation mesh__D016229
% 210.35/210.57       /biosyn /drug eff /physiol /ultrastruct permitted   
% 210.35/210.57  |- mesh__recordOriginator mesh__D016229 RLS
% 210.35/210.57  |- rdf__type mesh__D016229sskos__Concept
% 210.35/210.57  |- mesh__recordMaintainer mesh__D016229 nns
% 210.35/210.57  |- skos__hiddenLabel mesh__D016229 Amyloid beta Protein
% 210.35/210.57  |- skos__altLabel mesh__D016229
% 210.35/210.57       Amyloid Fibril Protein %28%Alzheimer%27%s%29%
% 210.35/210.57  |- mesh__recordAuthorizer mesh__D016229 sjn
% 210.35/210.57  |- skos__prefLabel mesh__D016229 Amyloid beta-Protein
% 210.35/210.57  |- mesh__dateCreated mesh__D016229 1990-06-17
% 210.35/210.57  |- skos__hiddenLabel mesh__D016229 Amyloid AD AP
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D016229 2005
% 210.35/210.57  |- skos__hiddenLabel mesh__D016229 beta-Protein, Alzheimer
% 210.35/210.57  |- skos__altLabel mesh__D016229 ABP %28%Alzheimer%27%s%29%
% 210.35/210.57  |- skos__related mesh__D016229smesh__D016657
% 210.35/210.57  |- skos__hiddenLabel mesh__D016229 beta-Protein, Amyloid
% 210.35/210.57  |- skos__broader mesh__D016229smesh__D000682
% 210.35/210.57  |- skos__altLabel mesh__D016229 Amyloid AD-AP
% 210.35/210.57  |- mesh__publicMeSHNote mesh__D016229 91   
% 210.35/210.57  |- skos__altLabel mesh__D016229 Alzheimer beta-Protein
% 210.35/210.57  |- mesh__dateEstablished mesh__D016229 1991-01-01
% 210.35/210.57  |- skos__scopeNote mesh__D016229
% 210.35/210.57       A 4-kDa protein, 39-43 amino acids long, expressed by a gene located on chromosome 21. It is the major protein subunit of the vascular and plaque amyloid filaments in individuals with Alzheimer%27%s disease and in aged individuals with trisomy 21 %28%DOWN SYNDROME%29%. The protein is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue.%A%    
% 210.35/210.57  |- skos__hiddenLabel mesh__D016229 Protein A4, Amyloid
% 210.35/210.57  |- skos__altLabel mesh__D016229 Amyloid Protein A4
% 210.35/210.57  |- skos__hiddenLabel mesh__D016229 Protein, beta-Amyloid
% 210.35/210.57  |- skos__historyNote mesh__D016229 Amyloid %28%1966-1990%29%
% 210.35/210.57  |- mesh__historyNote mesh__D016229 91   
% 210.35/210.57  |- skos__hiddenLabel mesh__D016229 beta Amyloid Protein
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D002209 2005
% 210.35/210.57  |- mesh__historyNote mesh__D002209
% 210.35/210.57       91%28%75%29%; was see under AZEPINES 1975-90   
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D002209 2004
% 210.35/210.57  |- mesh__publicMeSHNote mesh__D002209 91; was see under AZEPINES 1975-90   
% 210.35/210.57  |- skos__broader mesh__D002209smesh__D007769
% 210.35/210.57  |- mesh__recordMaintainer mesh__D002209 CCR
% 210.35/210.57  |- skos__hiddenLabel mesh__D002209 Lactam, Aminocaproic
% 210.35/210.57  |- skos__broader mesh__D002209smesh__D001381
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D002209 2003
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D002209 2002
% 210.35/210.57  |- skos__altLabel mesh__D002209 Aminocaproic Lactam
% 210.35/210.57  |- mesh__dateCreated mesh__D002209 1974-11-19
% 210.35/210.57  |- skos__altLabel mesh__D002209 Hexahydro-2H-Azepin-2-One
% 210.35/210.57  |- skos__scopeNote mesh__D002209
% 210.35/210.57       Cyclic amide of caproic acid used in manufacture of synthetic fibers of the polyamide type. Can cause local irritation.%A%    
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D002209 2001
% 210.35/210.57  |- mesh__recordAuthorizer mesh__D002209 sjn
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D002209 2006
% 210.35/210.57  |- mesh__recordOriginator mesh__D002209 NLM
% 210.35/210.57  |- skos__hiddenLabel mesh__D002209 Hexahydro 2H Azepin 2 One
% 210.35/210.57  |- mesh__dateRevised mesh__D002209 2000-06-21
% 210.35/210.57  |- skos__historyNote mesh__D002209 Azepines %28%1968-1974%29%
% 210.35/210.57  |- skos__prefLabel mesh__D002209 Caprolactam
% 210.35/210.57  |- mesh__dateEstablished mesh__D002209 1991-01-01
% 210.35/210.57  |- rdf__type mesh__D002209sskos__Concept
% 210.35/210.57  |- rdf__type mesh__D051050sskos__Concept
% 210.35/210.57  |- mesh__dateEstablished mesh__D051050 2006-01-01
% 210.35/210.57  |- skos__hiddenLabel mesh__D051050 Acetyltransferase, Serine
% 210.35/210.57  |- skos__altLabel mesh__D051050 L-Serine O-Acetyltransferase
% 210.35/210.57  |- mesh__dateCreated mesh__D051050 2005-06-30
% 210.35/210.57  |- mesh__historyNote mesh__D051050
% 210.35/210.57       2006%28%1980%29%; use ACETYLTRANSFERASES %26% ACETYL COENZYME A 1973-1979, SERINE 1970-1979, %26% ACYLTRANSFERASES 1970-1973%A%  
% 210.35/210.57  |- skos__hiddenLabel mesh__D051050 O-Acetyltransferase, L-Serine
% 210.35/210.57  |- mesh__recordAuthorizer mesh__D051050 sjn
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D051050 2006
% 210.35/210.57  |- skos__hiddenLabel mesh__D051050 O-Acetyltransferase, Serine
% 210.35/210.57  |- skos__altLabel mesh__D051050 Serine Transacetylase
% 210.35/210.57  |- skos__altLabel mesh__D051050 Serine Acetyltransferase
% 210.35/210.57  |- skos__broader mesh__D051050smesh__D000123
% 210.35/210.57  |- skos__hiddenLabel mesh__D051050 Transacetylase, Serine
% 210.35/210.57  |- skos__hiddenLabel mesh__D051050 L Serine O Acetyltransferase
% 210.35/210.57  |- mesh__recordMaintainer mesh__D051050 AKE
% 210.35/210.57  |- mesh__recordOriginator mesh__D051050 AKE
% 210.35/210.57  |- skos__scopeNote mesh__D051050
% 210.35/210.57       An enzyme that catalyzes the conversion of L-SERINE to COENZYME A and O-acetyl-L-serine, using ACETYL-COA as a donor.%A%    
% 210.35/210.57  |- skos__hiddenLabel mesh__D051050 Serine O Acetyltransferase
% 210.35/210.57  |- mesh__publicMeSHNote mesh__D051050
% 210.35/210.57       2006; SERINE O-ACETYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1973-2005, under ACETYL COENZYME A 1973-1980, under SERINE 1970-1980, %26% under ACYLTRANSFERASES 1970-1973%A%  
% 210.35/210.57  |- skos__prefLabel mesh__D051050 Serine O-Acetyltransferase
% 210.35/210.57  |- skos__broader mesh__D012637smesh__D009934
% 210.35/210.57  |- mesh__historyNote mesh__D012637 78   
% 210.35/210.57  |- skos__annotation mesh__D012637 med or non-med contexts   
% 210.35/210.57  |- mesh__recordOriginator mesh__D012637 EC
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D012637 2006
% 210.35/210.57  |- skos__hiddenLabel mesh__D012637 Security Measure
% 210.35/210.57  |- skos__scopeNote mesh__D012637
% 210.35/210.57       Regulations to assure protection of property and equipment.%A%    
% 210.35/210.57  |- mesh__publicMeSHNote mesh__D012637 78   
% 210.35/210.57  |- skos__hiddenLabel mesh__D012637 Security, National
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D012637 2004
% 210.35/210.57  |- mesh__recordMaintainer mesh__D012637 tjk
% 210.35/210.57  |- rdf__type mesh__D012637sskos__Concept
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D012637 2005
% 210.35/210.57  |- mesh__dateRevised mesh__D012637 2002-07-03
% 210.35/210.57  |- skos__hiddenLabel mesh__D012637 Measures, Security
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D012637 2003
% 210.35/210.57  |- skos__prefLabel mesh__D012637 Security Measures
% 210.35/210.57  |- mesh__recordAuthorizer mesh__D012637 sjn
% 210.35/210.57  |- mesh__dateEstablished mesh__D012637 1978-01-01
% 210.35/210.57  |- skos__hiddenLabel mesh__D012637 Measure, Security
% 210.35/210.57  |- mesh__dateCreated mesh__D012637 1977-05-12
% 210.35/210.57  |- mesh__dateRevised mesh__D017322 2001-07-25
% 210.35/210.57  |- skos__prefLabel mesh__D017322 Clinical Trials, Phase II
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D017322 2002
% 210.35/210.57  |- mesh__dateEstablished mesh__D017322 1993-01-01
% 210.35/210.57  |- skos__scopeNote mesh__D017322
% 210.35/210.57       Studies that are usually controlled to assess the effectiveness and dosage %28%if appropriate%29% of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.%A%    
% 210.35/210.57  |- skos__altLabel mesh__D017322 Phase 2 Clinical Trials
% 210.35/210.57  |- skos__historyNote mesh__D017322 Clinical Trials %28%1980-1992%29%
% 210.35/210.57  |- mesh__onlineNote mesh__D017322
% 210.35/210.57       use DRUG EVALUATION to search DRUG EVALUATION, FDA PHASE II 1980-92 %26% EVALUATION STUDIES, DRUG, FDA PHASE II 1982-92%A%  
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D017322 2006
% 210.35/210.57  |- mesh__recordAuthorizer mesh__D017322 sjn
% 210.35/210.57  |- skos__altLabel mesh__D017322 Evaluation Studies, FDA Phase 2
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D017322 2005
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D017322 2004
% 210.35/210.57  |- mesh__recordMaintainer mesh__D017322 ags
% 210.35/210.57  |- skos__altLabel mesh__D017322 Drug Evaluation, FDA Phase 2
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D017322 2003
% 210.35/210.57  |- skos__altLabel mesh__D017322 Clinical Trials, Phase 2
% 210.35/210.57  |- mesh__historyNote mesh__D017322
% 210.35/210.57       93; DRUG EVALUATION, FDA PHASE II was see DRUG EVALUATION 1980-92; EVALUATION STUDIES, FDA PHASE II was EVALUATION STUDIES, DRUG, FDA PHASE II see DRUG EVALUATION 1982-92%A%  
% 210.35/210.57  |- rdf__type mesh__D017322sskos__Concept
% 210.35/210.57  |- mesh__publicMeSHNote mesh__D017322
% 210.35/210.57       93; DRUG EVALUATION, FDA PHASE II was see DRUG EVALUATION 1980-92; EVALUATION STUDIES, FDA PHASE II was EVALUATION STUDIES, DRUG, FDA PHASE II see DRUG EVALUATION 1982-92%A%  
% 210.35/210.57  |- mesh__dateCreated mesh__D017322 1992-05-13
% 210.35/210.57  |- skos__historyNote mesh__D017322 Drug Evaluation %28%1980-1992%29%
% 210.35/210.57  |- mesh__recordOriginator mesh__D017322 TPW
% 210.35/210.57  |- skos__broader mesh__D017322smesh__D002986
% 210.35/210.57  |- skos__altLabel mesh__D017322 Phase II Clinical Trials
% 210.35/210.57  |- skos__annotation mesh__D017322
% 210.35/210.57       trial lasts about 2 years; for U.S. %26% foreign studies; for I/II clin trials, index under CLINICAL TRIALS, PHASE I + CLINICAL TRIALS, PHASE II, for II/III clin trials, index under CLINICAL TRIALS, PHASE II + CLINICAL TRIALS, PHASE III; IM for articles %26% books about phase II clin trials as a method in med research; do not confuse with Publication Type CLINICAL TRIAL, PHASE II; DF: CLIN TRIALS PHASE II%A%  
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D050756 2006A
% 210.35/210.57  |- skos__hiddenLabel mesh__D050756 CIP KIP CDKI Proteins
% 210.35/210.57  |- skos__altLabel mesh__D050756 INK4 CKI Proteins
% 210.35/210.57  |- skos__hiddenLabel mesh__D050756 CDKI Proteins, CIP-KIP
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D050756 2006
% 210.35/210.57  |- mesh__recordOriginator mesh__D050756 DRC
% 210.35/210.57  |- skos__broader mesh__D050756smesh__D025521
% 210.35/210.57  |- skos__hiddenLabel mesh__D050756 Inhibitor Proteins, Cyclin-Kinase
% 210.35/210.57  |- skos__altLabel mesh__D050756 CIP-KIP CDKI Proteins
% 210.35/210.57  |- mesh__recordMaintainer mesh__D050756 ags
% 210.35/210.57  |- skos__altLabel mesh__D050756 CIP-KIP CKI Proteins
% 210.35/210.57  |- rdf__type mesh__D050756sskos__Concept
% 210.35/210.57  |- skos__hiddenLabel mesh__D050756 CKI Proteins, INK4
% 210.35/210.57  |- skos__hiddenLabel mesh__D050756 CIP KIP CKI Proteins
% 210.35/210.57  |- skos__hiddenLabel mesh__D050756
% 210.35/210.57       Inhibitors of Cyclin Dependent Kinase 4 Proteins
% 210.35/210.57  |- mesh__dateCreated mesh__D050756 2005-06-30
% 210.35/210.57  |- skos__altLabel mesh__D050756 CKI Proteins
% 210.35/210.57  |- skos__prefLabel mesh__D050756 Cyclin-Dependent Kinase Inhibitor Proteins
% 210.35/210.57  |- skos__hiddenLabel mesh__D050756 CKI Proteins, CIP-KIP
% 210.35/210.57  |- skos__hiddenLabel mesh__D050756
% 210.35/210.57       CIP KIP Cyclin Dependent Kinase Inhibitors
% 210.35/210.57  |- skos__altLabel mesh__D050756
% 210.35/210.57       Inhibitors of Cyclin-Dependent Kinase 4 Proteins
% 210.35/210.57  |- skos__hiddenLabel mesh__D050756
% 210.35/210.57       Cyclin Dependent Kinase Inhibitor Proteins
% 210.35/210.57  |- skos__scopeNote mesh__D050756
% 210.35/210.57       A group of cell cycle proteins that negatively regulate the activity of CYCLIN/CYCLIN-DEPENDENT KINASE complexes. They inhibit CELL CYCLE progression and help control CELL PROLIFERATION following GENOTOXIC STRESS as well as during CELL DIFFERENTIATION.%A%    
% 210.35/210.57  |- skos__altLabel mesh__D050756 Cyclin-Kinase Inhibitor Proteins
% 210.35/210.57  |- skos__hiddenLabel mesh__D050756 INK4 Cyclin Dependent Kinase Inhibitors
% 210.35/210.57  |- skos__hiddenLabel mesh__D050756 Cyclin Kinase Inhibitor Proteins
% 210.35/210.57  |- mesh__recordAuthorizer mesh__D050756 ags
% 210.35/210.57  |- mesh__dateRevised mesh__D050756 2005-07-07
% 210.35/210.57  |- skos__altLabel mesh__D050756 INK4 CDKI Proteins
% 210.35/210.57  |- mesh__historyNote mesh__D050756 2006   
% 210.35/210.57  |- mesh__publicMeSHNote mesh__D050756 2006   
% 210.35/210.57  |- skos__hiddenLabel mesh__D050756 CDKI Proteins, INK4
% 210.35/210.57  |- skos__altLabel mesh__D050756 CDKI Proteins
% 210.35/210.57  |- skos__broader mesh__D050756smesh__D018797
% 210.35/210.57  |- mesh__dateEstablished mesh__D050756 2006-01-01
% 210.35/210.57  |- mesh__dateRevised mesh__D003302 2005-06-30
% 210.35/210.57  |- skos__scopeNote mesh__D003302
% 210.35/210.57       A genus of black-spored basidiomycetous fungi of the family Coprinaceae, order Agaricales; some species are edible.%A%    
% 210.35/210.57  |- mesh__recordOriginator mesh__D003302 NLM
% 210.35/210.57  |- mesh__publicMeSHNote mesh__D003302
% 210.35/210.57       91; was see under AGARICALES 1986-90; was see under AGARICACEAE 1975-85%A%  
% 210.35/210.57  |- mesh__recordAuthorizer mesh__D003302 sjn
% 210.35/210.57  |- mesh__historyNote mesh__D003302
% 210.35/210.57       91%28%75%29%; was see under AGARICALES 1986-90; was see under AGARICACEAE 1975-85%A%  
% 210.35/210.57  |- rdf__type mesh__D003302sskos__Concept
% 210.35/210.57  |- skos__prefLabel mesh__D003302 Coprinus
% 210.35/210.57  |- mesh__dateEstablished mesh__D003302 1991-01-01
% 210.35/210.57  |- mesh__recordMaintainer mesh__D003302 SYSTEM
% 210.35/210.57  |- skos__broader mesh__D003302smesh__D000363
% 210.35/210.57  |- mesh__dateCreated mesh__D003302 1974-12-12
% 210.35/210.57  |- skos__annotation mesh__D003302 a basidiomycete   
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D003302 2006
% 210.35/210.57  |- skos__hiddenLabel mesh__D008596 CP90033
% 210.35/210.57  |- skos__altLabel mesh__D008596 Menopur
% 210.35/210.57  |- skos__altLabel mesh__D008596 Gonadotropins, Human Menopausal
% 210.35/210.57  |- mesh__historyNote mesh__D008596 73   
% 210.35/210.57  |- skos__historyNote mesh__D008596
% 210.35/210.57       Gonadotropins, Pituitary %28%1966-1972%29%
% 210.35/210.57  |- mesh__dateEstablished mesh__D008596 1973-01-01
% 210.35/210.57  |- skos__hiddenLabel mesh__D008596 Menotropins Lepori Brand
% 210.35/210.57  |- mesh__dateCreated mesh__D008596 1999-01-01
% 210.35/210.57  |- skos__hiddenLabel mesh__D008596 CP 89044
% 210.35/210.57  |- skos__altLabel mesh__D008596 Organon Brand of Menotropins
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D008596 2006
% 210.35/210.57  |- skos__broader mesh__D008596smesh__D001688
% 210.35/210.57  |- skos__hiddenLabel mesh__D008596 Menotropins Serono Brand
% 210.35/210.57  |- skos__altLabel mesh__D008596 Organon Teknika Brand of Menotropins
% 210.35/210.57  |- skos__hiddenLabel mesh__D008596 Human Menopausal Gonadotropins
% 210.35/210.57  |- skos__altLabel mesh__D008596 Fustery Brand of Menotropins
% 210.35/210.57  |- skos__altLabel mesh__D008596 Lepori Brand of Menotropins
% 210.35/210.57  |- skos__related mesh__D008596smesh__D011967
% 210.35/210.57  |- skos__altLabel mesh__D008596 Ferring Brand of Menotropins
% 210.35/210.57  |- rdf__type mesh__D008596sskos__Concept
% 210.35/210.57  |- skos__hiddenLabel mesh__D008596 Lepori, HMG
% 210.35/210.57  |- skos__altLabel mesh__D008596 HMG Ferring
% 210.35/210.57  |- skos__hiddenLabel mesh__D008596 Pergonal 500
% 210.35/210.57  |- skos__scopeNote mesh__D008596
% 210.35/210.57       Extracts of urine from menopausal women that contain high concentrations of pituitary gonadotropins, FOLLICLE STIMULATING HORMONE and LUTEINIZING HORMONE. Menotropins are used to treat infertility. The FSH:LH ratio and degree of purity vary in different preparations.%A%    
% 210.35/210.57  |- skos__hiddenLabel mesh__D008596 CP89044
% 210.35/210.57  |- skos__altLabel mesh__D008596 Menotrophin
% 210.35/210.57  |- mesh__publicMeSHNote mesh__D008596 73   
% 210.35/210.57  |- mesh__recordAuthorizer mesh__D008596 sjn
% 210.35/210.57  |- skos__prefLabel mesh__D008596 Menotropins
% 210.35/210.57  |- skos__hiddenLabel mesh__D008596 Menotropins Organon Brand
% 210.35/210.57  |- mesh__dateRevised mesh__D008596 2005-06-30
% 210.35/210.57  |- skos__broader mesh__D008596smesh__D006065
% 210.35/210.57  |- skos__altLabel mesh__D008596 Serono Brand of Menotropins
% 210.35/210.57  |- skos__hiddenLabel mesh__D008596 CP 90033
% 210.35/210.57  |- mesh__recordOriginator mesh__D008596 NLM
% 210.35/210.57  |- skos__hiddenLabel mesh__D008596 Menotropins Fustery Brand
% 210.35/210.57  |- skos__hiddenLabel mesh__D008596 Menotropins Ferring Brand
% 210.35/210.57  |- skos__hiddenLabel mesh__D008596 ORG31338
% 210.35/210.57  |- skos__hiddenLabel mesh__D008596 Pergonal500
% 210.35/210.57  |- skos__hiddenLabel mesh__D008596 ORG 31338
% 210.35/210.57  |- mesh__recordMaintainer mesh__D008596 lkt
% 210.35/210.57  |- skos__broader mesh__D007239Q000517smesh__D007239
% 210.35/210.57  |- mesh__preferredCombination mesh__D007239Q000517smesh__D017053
% 210.35/210.57  |- rdf__type mesh__D007239Q000517smesh__CompoundConcept
% 210.35/210.57  |- mesh__recordAuthorizer mesh__D013730 PLS
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D013730 1998
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D013730 2004
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D013730 2000
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D013730 1997
% 210.35/210.57  |- skos__hiddenLabel mesh__D013730 Compounds, Triphenyl
% 210.35/210.57  |- skos__prefLabel mesh__D013730 Terphenyl Compounds
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D013730 2003
% 210.35/210.57  |- skos__historyNote mesh__D013730 Benzene Derivatives %28%1973-1974%29%
% 210.35/210.57  |- mesh__publicMeSHNote mesh__D013730 75   
% 210.35/210.57  |- mesh__dateCreated mesh__D013730 1974-11-11
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D013730 1996
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D013730 1995
% 210.35/210.57  |- mesh__dateRevised mesh__D013730 1992-05-20
% 210.35/210.57  |- mesh__recordOriginator mesh__D013730 NLM
% 210.35/210.57  |- skos__broader mesh__D013730smesh__D001555
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D013730 2006
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D013730 1994
% 210.35/210.57  |- skos__annotation mesh__D013730 DF: TERPHENYL CPDS   
% 210.35/210.57  |- skos__hiddenLabel mesh__D013730 Compounds, Terphenyl
% 210.35/210.57  |- mesh__dateEstablished mesh__D013730 1975-09-01
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D013730 2002
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D013730 1999
% 210.35/210.57  |- mesh__historyNote mesh__D013730 75   
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D013730 2005
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D013730 1993
% 210.35/210.57  |- mesh__recordMaintainer mesh__D013730 TGC
% 210.35/210.57  |- skos__scopeNote mesh__D013730
% 210.35/210.57       Compounds consisting of benzene rings linked to each other in either ortho, meta or para positions. Permitted are any substitutions, but ring fusion to any of the benzene rings is not allowed.%A%    
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D013730 2001
% 210.35/210.57  |- rdf__type mesh__D013730sskos__Concept
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D051051 2006
% 210.35/210.57  |- skos__hiddenLabel mesh__D051051 CoA-ACP Transacylase, Acetyl
% 210.35/210.57  |- skos__altLabel mesh__D051051
% 210.35/210.57       Acetyl Coenzyme A-Acyl Carrier Protein Transacylase
% 210.35/210.57  |- mesh__historyNote mesh__D051051
% 210.35/210.57       2006%28%1980%29%; use ACETYLTRANSFERASES 1970-1979, CARRIER PROTEINS 1973-1978, ACYL CARRIER PROTEIN 1978-1979, ACYLTRANSFERASES 1970-1973, ACETYL COENZYME A 1978-1979, %26% ACYLTRANSFERASES %26% PROTEINS 1970-1973%A%  
% 210.35/210.57  |- skos__hiddenLabel mesh__D051051 Acetyl CoA ACP Transacylase
% 210.35/210.57  |- skos__hiddenLabel mesh__D051051 Acyl Carrier Protein S Acetyltransferase
% 210.35/210.57  |- skos__hiddenLabel mesh__D051051
% 210.35/210.57       S-Acetyltransferase, Acyl-Carrier Protein
% 210.35/210.57  |- mesh__recordMaintainer mesh__D051051 ags
% 210.35/210.57  |- skos__broader mesh__D051051smesh__D000123
% 210.35/210.57  |- skos__hiddenLabel mesh__D051051 Acetyl CoA Transacylase
% 210.35/210.57  |- skos__hiddenLabel mesh__D051051
% 210.35/210.57       Acetyl Coenzyme A Acyl Carrier Protein Transacylase
% 210.35/210.57  |- skos__altLabel mesh__D051051 Acetyl CoA-ACP Transacylase
% 210.35/210.57  |- mesh__dateEstablished mesh__D051051 2006-01-01
% 210.35/210.57  |- skos__altLabel mesh__D051051
% 210.35/210.57       %28%Acyl-Carrier-Protein%29% S-Acetyltransferase
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D051051 2006A
% 210.35/210.57  |- skos__scopeNote mesh__D051051
% 210.35/210.57       A enzyme that catalyzes the transfer of acetyl groups from ACETYL CoA to acyl-carrier protein to form COENZYME A and acetyl-acyl-carrier protein.%A%    
% 210.35/210.57  |- rdf__type mesh__D051051sskos__Concept
% 210.35/210.57  |- mesh__dateCreated mesh__D051051 2005-06-30
% 210.35/210.57  |- skos__hiddenLabel mesh__D051051 Transacylase, Acetyl CoA-ACP
% 210.35/210.57  |- skos__prefLabel mesh__D051051 Acyl-Carrier Protein S-Acetyltransferase
% 210.35/210.57  |- skos__altLabel mesh__D051051
% 210.35/210.57       %28%Acyl-Carrier-Protein%29% Acetyltransferase
% 210.35/210.57  |- skos__hiddenLabel mesh__D051051
% 210.35/210.57       Protein S-Acetyltransferase, Acyl-Carrier
% 210.35/210.57  |- mesh__recordAuthorizer mesh__D051051 ags
% 210.35/210.57  |- mesh__dateRevised mesh__D051051 2005-07-07
% 210.35/210.57  |- skos__altLabel mesh__D051051 Acetyl-CoA Transacylase
% 210.35/210.57  |- mesh__recordOriginator mesh__D051051 AKE
% 210.35/210.57  |- mesh__publicMeSHNote mesh__D051051
% 210.35/210.57       2006; %28%ACYL-CARRIER-PROTEIN%29% S-ACETYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1970-2005, under CARRIER PROTEINS 1973-1978, ACYL CARRIER PROTEIN 1978-1982, ACYLTRANSFERASES 1970-1973, ACETYL COENZYME A 1978-1982, %26% under ACYLTRANSFERASES %26% PROTEINS 1970-1973%A%  
% 210.35/210.57  |- skos__hiddenLabel mesh__D051051 Transacylase, Acetyl-CoA
% 210.35/210.57  |- mesh__dateRevised mesh__D017323 2005-06-30
% 210.35/210.57  |- mesh__dateCreated mesh__D017323 1992-05-20
% 210.35/210.57  |- mesh__recordOriginator mesh__D017323 TPW
% 210.35/210.57  |- skos__scopeNote mesh__D017323
% 210.35/210.57       The purified component of HEMATOPORPHYRIN DERIVATIVE, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy %28%HEMATOPORPHYRIN PHOTORADIATION%29%; to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of photodynamic therapy in the United States.%A%    
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D017323 2006
% 210.35/210.57  |- skos__related mesh__D017323smesh__D006414
% 210.35/210.57  |- skos__altLabel mesh__D017323 DHP Ether
% 210.35/210.57  |- skos__historyNote mesh__D017323 Hematoporphyrins %28%1985-1992%29%
% 210.35/210.57  |- mesh__recordMaintainer mesh__D017323 ssb
% 210.35/210.57  |- mesh__dateEstablished mesh__D017323 1993-01-01
% 210.35/210.57  |- skos__broader mesh__D017323smesh__D017324
% 210.35/210.57  |- skos__altLabel mesh__D017323 Dihematoporphyrin Ester
% 210.35/210.57  |- mesh__recordAuthorizer mesh__D017323 sjn
% 210.35/210.57  |- mesh__onlineNote mesh__D017323
% 210.35/210.57       use DIHEMATOPORPHYRIN ETHER %28%NM%29% to search DIHEMATOPORPHYRIN ETHER 1985-92%A%  
% 210.35/210.57  |- rdf__type mesh__D017323sskos__Concept
% 210.35/210.57  |- skos__hiddenLabel mesh__D017323 Ether, Dihematoporphyrin
% 210.35/210.57  |- mesh__historyNote mesh__D017323
% 210.35/210.57       93; was DIHEMATOPORPHYRIN ETHER %28%NM%29% 1985-92   
% 210.35/210.57  |- skos__prefLabel mesh__D017323 Dihematoporphyrin Ether
% 210.35/210.57  |- skos__altLabel mesh__D017323 Porfimer
% 210.35/210.57  |- mesh__publicMeSHNote mesh__D017323
% 210.35/210.57       93; DIHEMATOPORPHYRIN ETHER was indexed under HEMATOPORPHYRINS 1985-92%A%  
% 210.35/210.57  |- skos__broader mesh__D003303smesh__D001526
% 210.35/210.57  |- rdf__type mesh__D003303sskos__Concept
% 210.35/210.57  |- mesh__dateRevised mesh__D003303 2002-07-03
% 210.35/210.57  |- skos__historyNote mesh__D003303 Feces %28%1966-1969%29%
% 210.35/210.57  |- mesh__dateEstablished mesh__D003303 1970-01-01
% 210.35/210.57  |- mesh__recordMaintainer mesh__D003303 KEV
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D003303 2004
% 210.35/210.57  |- mesh__recordOriginator mesh__D003303 NLM
% 210.35/210.57  |- skos__broader mesh__D003303smesh__D012817
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D003303 2003
% 210.35/210.57  |- skos__scopeNote mesh__D003303 Eating of excrement.     
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D003303 2006
% 210.35/210.57  |- mesh__dateCreated mesh__D003303 1999-01-01
% 210.35/210.57  |- mesh__recordAuthorizer mesh__D003303 sjn
% 210.35/210.57  |- mesh__historyNote mesh__D003303 70   
% 210.35/210.57  |- skos__prefLabel mesh__D003303 Coprophagia
% 210.35/210.57  |- skos__broader mesh__D003303smesh__D001068
% 210.35/210.57  |- mesh__publicMeSHNote mesh__D003303 70   
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D003303 2005
% 210.35/210.57  |- skos__annotation mesh__D003303 human %26% animal   
% 210.35/210.57  |- mesh__dateRevised mesh__D008597 2005-07-27
% 210.35/210.57  |- skos__hiddenLabel mesh__D008597 Ovarian Cycles
% 210.35/210.57  |- skos__hiddenLabel mesh__D008597 Endometrial Cycles
% 210.35/210.57  |- mesh__historyNote mesh__D008597 85   
% 210.35/210.57  |- mesh__recordMaintainer mesh__D008597 ags
% 210.35/210.57  |- skos__hiddenLabel mesh__D008597 Cycle, Ovarian
% 210.35/210.57  |- mesh__recordAuthorizer mesh__D008597 ags
% 210.35/210.57  |- mesh__recordOriginator mesh__D008597 EC
% 210.35/210.57  |- skos__hiddenLabel mesh__D008597 Cycle, Endometrial
% 210.35/210.57  |- skos__annotation mesh__D008597
% 210.35/210.57       human %26% other primates only; for non-primates use ESTROUS CYCLE; do not confuse with MENSTRUATION%A%  
% 210.35/210.57  |- mesh__dateEstablished mesh__D008597 1985-01-01
% 210.35/210.57  |- skos__hiddenLabel mesh__D008597 Cycles, Endometrial
% 210.35/210.57  |- skos__historyNote mesh__D008597 Menstruation %28%1966-1984%29%
% 210.35/210.57  |- skos__broader mesh__D008597smesh__D012098
% 210.35/210.57  |- skos__hiddenLabel mesh__D008597 Cycles, Menstrual
% 210.35/210.57  |- skos__scopeNote mesh__D008597
% 210.35/210.57       The period from onset of one menstrual bleeding %28%MENSTRUATION%29% to the next in an ovulating woman or female primate. The menstrual cycle is regulated by endocrine interactions of the HYPOTHALAMUS; the PITUITARY GLAND; the ovaries; and the genital tract. The menstrual cycle is divided by OVULATION into two phases. Based on the endocrine status of the OVARY, there is a FOLLICULAR PHASE and a LUTEAL PHASE. Based on the response in the ENDOMETRIUM, the menstrual cycle is divided into a proliferative and a secretory phase.%A%    
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D008597 2005
% 210.35/210.57  |- skos__hiddenLabel mesh__D008597 Cycle, Menstrual
% 210.35/210.57  |- skos__related mesh__D008597smesh__D030762
% 210.35/210.57  |- skos__hiddenLabel mesh__D008597 Menstrual Cycles
% 210.35/210.57  |- skos__hiddenLabel mesh__D008597 Cycles, Ovarian
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D008597 2006
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D008597 2006A
% 210.35/210.57  |- mesh__dateCreated mesh__D008597 1984-05-31
% 210.35/210.57  |- mesh__publicMeSHNote mesh__D008597 85   
% 210.35/210.57  |- skos__prefLabel mesh__D008597 Menstrual Cycle
% 210.35/210.57  |- rdf__type mesh__D008597sskos__Concept
% 210.35/210.57  |- mesh__dateCreated mesh__D013731 1999-01-01
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D013731 2003
% 210.35/210.57  |- mesh__dateEstablished mesh__D013731 1968-01-01
% 210.35/210.57  |- skos__broader mesh__D013731smesh__D013037
% 210.35/210.57  |- skos__hiddenLabel mesh__D013731 Territorialities
% 210.35/210.57  |- skos__prefLabel mesh__D013731 Territoriality
% 210.35/210.57  |- skos__scopeNote mesh__D013731
% 210.35/210.57       Behavior in defense of an area against another individual or individuals primarily of the same species.%A%    
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D013731 2006
% 210.35/210.57  |- skos__annotation mesh__D013731 no qualif   
% 210.35/210.57  |- mesh__publicMeSHNote mesh__D013731 68   
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D013731 2005
% 210.35/210.57  |- mesh__recordOriginator mesh__D013731 NLM
% 210.35/210.57  |- mesh__recordMaintainer mesh__D013731 TGC
% 210.35/210.57  |- skos__historyNote mesh__D013731 Behavior, Animal %28%1966-1967%29%
% 210.35/210.57  |- rdf__type mesh__D013731sskos__Concept
% 210.35/210.57  |- mesh__dateRevised mesh__D013731 2002-07-03
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D013731 2004
% 210.35/210.57  |- mesh__recordAuthorizer mesh__D013731 sjn
% 210.35/210.57  |- mesh__historyNote mesh__D013731 68   
% 210.35/210.57  |- mesh__dateCreated mesh__D012639 1999-01-01
% 210.35/210.57  |- rdf__type mesh__D012639sskos__Concept
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D012639 2005
% 210.35/210.57  |- skos__altLabel mesh__D012639 Plant Zygotes
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D012639 2003
% 210.35/210.57  |- skos__broader mesh__D012639smesh__D005638
% 210.35/210.57  |- skos__related mesh__D012639smesh__D009754
% 210.35/210.57  |- skos__hiddenLabel mesh__D012639 Plant Zygote
% 210.35/210.57  |- mesh__onlineNote mesh__D012639
% 210.35/210.57       use EMBRYO, PLANT to search EMBRYOS, PLANT 1986-94   
% 210.35/210.57  |- mesh__dateRevised mesh__D012639 2002-07-03
% 210.35/210.57  |- skos__annotation mesh__D012639
% 210.35/210.57       IM GEN or unspecified; for seed of specific plants, coord IM with plant %28%IM%29%, as sunflower seeds = SEEDS %28%IM%29% + HELIANTHUS %28%IM%29%; coord probably IM in genetics %26% space physiol, NIM in pharmacognosy, with specific plant %28%IM or NIM%29%%A%  
% 210.35/210.57  |- mesh__historyNote mesh__D012639
% 210.35/210.57       63; EMBRYO, PLANT was EMBRYOS, PLANT see SEEDS 1986-94   
% 210.35/210.57  |- skos__hiddenLabel mesh__D012639 Embryo, Plant
% 210.35/210.57  |- mesh__publicMeSHNote mesh__D012639
% 210.35/210.57       63; EMBRYO, PLANT was EMBRYOS, PLANT see SEEDS 1986-94   
% 210.35/210.57  |- mesh__recordAuthorizer mesh__D012639 sjn
% 210.35/210.57  |- skos__prefLabel mesh__D012639 Seeds
% 210.35/210.57  |- skos__altLabel mesh__D012639 Zygotes, Plant
% 210.35/210.57  |- skos__hiddenLabel mesh__D012639 Plant Embryo
% 210.35/210.57  |- skos__scopeNote mesh__D012639
% 210.35/210.57       The encapsulated embryos of flowering plants. They are used as is or for animal feed because of the high content of concentrated nutrients like starches, proteins, and fats. Rapeseed, cottonseed, and sunflower seed are also produced for the oils %28%fats%29% they yield.%A%    
% 210.35/210.57  |- skos__altLabel mesh__D012639 Plant Embryos
% 210.35/210.57  |- skos__hiddenLabel mesh__D012639 Seed
% 210.35/210.57  |- skos__altLabel mesh__D012639 Embryos, Plant
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D012639 2006
% 210.35/210.57  |- skos__hiddenLabel mesh__D012639 Zygote, Plant
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D012639 2004
% 210.35/210.57  |- skos__broader mesh__D012639smesh__D005502
% 210.35/210.57  |- mesh__recordMaintainer mesh__D012639 JLS
% 210.35/210.57  |- mesh__recordOriginator mesh__D012639 NLM
% 210.35/210.57  |- mesh__dateEstablished mesh__D009690 1972-01-01
% 210.35/210.57  |- mesh__historyNote mesh__D009690 72   
% 210.35/210.57  |- mesh__activeMeSHYear mesh__D009690 2006
% 210.35/210.57  |- skos__hiddenLabel mesh__D009690 Conformation, Nucleic Acid
% 210.35/210.57  |- mesh__recordOriginator mesh__D009690 NLM
% 210.35/210.57  |- rdf__type mesh__D009690sskos__Concept
% 210.35/210.57  |- mesh__recordAuthorizer mesh__D009690 sjn
% 210.35/210.57  |- skos__historyNote mesh__D009690 Nucleic Acids %28%1966-1971%29%
% 210.35/210.58  |- mesh__dateRevised mesh__D009690 2004-07-07
% 210.35/210.58  |- mesh__publicMeSHNote mesh__D009690 72   
% 210.35/210.58  |- skos__related mesh__D009690smesh__D018807
% 210.35/210.58  |- skos__prefLabel mesh__D009690 Nucleic Acid Conformation
% 210.35/210.58  |- skos__broader mesh__D009690smesh__D008968
% 210.35/210.58  |- mesh__dateCreated mesh__D009690 1999-01-01
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D009690 2005
% 210.35/210.58  |- skos__annotation mesh__D009690 coord with DNA or RNA or specific   
% 210.35/210.58  |- skos__hiddenLabel mesh__D009690 Conformations, Nucleic Acid
% 210.35/210.58  |- skos__hiddenLabel mesh__D009690 Nucleic Acid Conformations
% 210.35/210.58  |- skos__scopeNote mesh__D009690
% 210.35/210.58       The spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape.%A%    
% 210.35/210.58  |- mesh__recordMaintainer mesh__D009690 nns
% 210.35/210.58  |- mesh__recordOriginator mesh__D023361 jls
% 210.35/210.58  |- skos__related mesh__D023361smesh__D016430
% 210.35/210.58  |- mesh__recordMaintainer mesh__D023361 ags
% 210.35/210.58  |- skos__altLabel mesh__D023361 Validation Studies %5B%PT%5D%
% 210.35/210.58  |- mesh__historyNote mesh__D023361 2001   
% 210.35/210.58  |- skos__scopeNote mesh__D023361
% 210.35/210.58       Works consisting of research using processes by which the reliability and relevance of a procedure for a specific purpose are established.%A%    
% 210.35/210.58  |- skos__prefLabel mesh__D023361
% 210.35/210.58       Validation Studies %5B%Publication Type%5D%
% 210.35/210.58  |- mesh__dateRevised mesh__D023361 2005-08-03
% 210.35/210.58  |- skos__altLabel mesh__D023361 Validation Studies %28%Pub Type%29%
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D023361 2006A
% 210.35/210.58  |- skos__broader mesh__D023361smesh__D052182
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D023361 2006
% 210.35/210.58  |- skos__annotation mesh__D023361
% 210.35/210.58       publication type only; CATALOG: do not use   
% 210.35/210.58  |- mesh__dateCreated mesh__D023361 2000-06-22
% 210.35/210.58  |- rdf__type mesh__D023361sskos__Concept
% 210.35/210.58  |- mesh__recordAuthorizer mesh__D023361 ags
% 210.35/210.58  |- mesh__dateEstablished mesh__D023361 2001-01-01
% 210.35/210.58  |- mesh__dateEstablished mesh__D017324 1993-01-01
% 210.35/210.58  |- skos__prefLabel mesh__D017324 Hematoporphyrin Derivative
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D017324 2006
% 210.35/210.58  |- skos__broader mesh__D017324smesh__D006415
% 210.35/210.58  |- skos__related mesh__D017324smesh__D006414
% 210.35/210.58  |- skos__altLabel mesh__D017324 Hematoporphyrin D
% 210.35/210.58  |- skos__altLabel mesh__D017324 Hematoporphyrin YHPD
% 210.35/210.58  |- mesh__recordMaintainer mesh__D017324 ssb
% 210.35/210.58  |- mesh__historyNote mesh__D017324
% 210.35/210.58       93; was HEMATOPORPHYRIN D %28%NM%29% 1981-92   
% 210.35/210.58  |- mesh__dateRevised mesh__D017324 2005-06-30
% 210.35/210.58  |- mesh__dateCreated mesh__D017324 1992-05-20
% 210.35/210.58  |- skos__historyNote mesh__D017324 Hematoporphyrins %28%1980-1992%29%
% 210.35/210.58  |- skos__hiddenLabel mesh__D017324 YHPD, Hematoporphyrin
% 210.35/210.58  |- skos__annotation mesh__D017324 DF: note short X ref   
% 210.35/210.58  |- mesh__onlineNote mesh__D017324
% 210.35/210.58       use HEMATOPORPHYRIN DERIVATIVE %28%NM%29% to search HEMATOPORPHYRIN D 1981-92%A%  
% 210.35/210.58  |- rdf__type mesh__D017324sskos__Concept
% 210.35/210.58  |- mesh__publicMeSHNote mesh__D017324
% 210.35/210.58       93; HEMATOPORPHYRIN D was indexed under HEMATOPORPHYRINS 1981-92%A%  
% 210.35/210.58  |- mesh__recordOriginator mesh__D017324 TPW
% 210.35/210.58  |- skos__scopeNote mesh__D017324
% 210.35/210.58       A complex mixture of monomeric and aggregated porphyrins used in the photodynamic therapy of tumors %28%HEMATOPORPHYRIN PHOTORADIATION%29%. A purified component of this mixture is known as DIHEMATOPORPHYRIN ETHER.%A%    
% 210.35/210.58  |- mesh__recordAuthorizer mesh__D017324 sjn
% 210.35/210.58  |- skos__historyNote mesh__D003304 Carboxy-Lyases %28%1972-1974%29%
% 210.35/210.58  |- mesh__recordMaintainer mesh__D003304 jmp
% 210.35/210.58  |- skos__broader mesh__D003304smesh__D044925
% 210.35/210.58  |- skos__historyNote mesh__D003304 Coproporphyrins %28%1975%29%
% 210.35/210.58  |- skos__altLabel mesh__D003304 Coproporphyrinogenase
% 210.35/210.58  |- skos__altLabel mesh__D003304 Coproporphyrinogen III Oxidases
% 210.35/210.58  |- mesh__dateEstablished mesh__D003304 1991-01-01
% 210.35/210.58  |- skos__historyNote mesh__D003304 Oxidoreductases %28%1975%29%
% 210.35/210.58  |- mesh__dateCreated mesh__D003304 1975-07-25
% 210.35/210.58  |- skos__hiddenLabel mesh__D003304 Oxidases, Coproporphyrinogen III
% 210.35/210.58  |- mesh__recordOriginator mesh__D003304 RLS
% 210.35/210.58  |- mesh__historyNote mesh__D003304
% 210.35/210.58       91%28%76%29%; was see under OXIDOREDUCTASES 1976-90   
% 210.35/210.58  |- mesh__dateRevised mesh__D003304 2005-06-30
% 210.35/210.58  |- mesh__recordAuthorizer mesh__D003304 sjn
% 210.35/210.58  |- skos__scopeNote mesh__D003304
% 210.35/210.58       An enzyme that catalyzes the oxidative decarboxylation of coproporphyrinogen III to protoporphyrinogen IX by the conversion of two propionate groups to two vinyl groups. It is the sixth enzyme in the 8-enzyme biosynthetic pathway of HEME, and is encoded by CPO gene. Mutations of CPO gene result in HEREDITARY COPROPORPHYRIA.%A%    
% 210.35/210.58  |- skos__historyNote mesh__D003304 Porphyrins %28%1972-1974%29%
% 210.35/210.58  |- mesh__publicMeSHNote mesh__D003304
% 210.35/210.58       91; was see under OXIDOREDUCTASES 1976-90   
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D003304 2006
% 210.35/210.58  |- skos__hiddenLabel mesh__D003304 Oxidase, Coproporphyrinogen
% 210.35/210.58  |- skos__prefLabel mesh__D003304 Coproporphyrinogen Oxidase
% 210.35/210.58  |- rdf__type mesh__D003304sskos__Concept
% 210.35/210.58  |- skos__hiddenLabel mesh__D003304 III Oxidases, Coproporphyrinogen
% 210.35/210.58  |- skos__prefLabel mesh__D008598 Menstruation
% 210.35/210.58  |- mesh__dateRevised mesh__D008598 2004-07-07
% 210.35/210.58  |- skos__broader mesh__D008598smesh__D008597
% 210.35/210.58  |- skos__related mesh__D008598smesh__D008600
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D008598 2005
% 210.35/210.58  |- skos__hiddenLabel mesh__D008598 Menstruations
% 210.35/210.58  |- mesh__dateCreated mesh__D008598 1999-01-01
% 210.35/210.58  |- mesh__recordAuthorizer mesh__D008598 sjn
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D008598 2006
% 210.35/210.58  |- skos__annotation mesh__D008598
% 210.35/210.58       human %26% other primates only; non-primates = ESTRUS; do not confuse with MENSTRUAL CYCLE%A%  
% 210.35/210.58  |- skos__related mesh__D008598smesh__D011293
% 210.35/210.58  |- mesh__recordOriginator mesh__D008598 NLM
% 210.35/210.58  |- rdf__type mesh__D008598sskos__Concept
% 210.35/210.58  |- skos__scopeNote mesh__D008598
% 210.35/210.58       The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.%A%    
% 210.35/210.58  |- mesh__recordMaintainer mesh__D008598 lkt
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D013732 2001
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D013732 1996
% 210.35/210.58  |- mesh__recordAuthorizer mesh__D013732 PLS
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D013732 2003
% 210.35/210.58  |- skos__hiddenLabel mesh__D013732 Questionnaires, Test Anxiety
% 210.35/210.58  |- mesh__publicMeSHNote mesh__D013732
% 210.35/210.58       91; was see under PERSONALITY INVENTORY 1975-90   
% 210.35/210.58  |- skos__hiddenLabel mesh__D013732 Test Anxiety Scales
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D013732 2000
% 210.35/210.58  |- skos__broader mesh__D013732smesh__D010555
% 210.35/210.58  |- skos__hiddenLabel mesh__D013732 Scale, Test Anxiety
% 210.35/210.58  |- mesh__dateEstablished mesh__D013732 1991-01-01
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D013732 1995
% 210.35/210.58  |- skos__hiddenLabel mesh__D013732 Test Anxiety Questionnaires
% 210.35/210.58  |- skos__hiddenLabel mesh__D013732 Scales, Test Anxiety
% 210.35/210.58  |- mesh__recordOriginator mesh__D013732 NLM
% 210.35/210.58  |- mesh__historyNote mesh__D013732
% 210.35/210.58       91%28%75%29%; was see under PERSONALITY INVENTORY 1975-90   
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D013732 1999
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D013732 1994
% 210.35/210.58  |- mesh__dateRevised mesh__D013732 1992-05-18
% 210.35/210.58  |- skos__scopeNote mesh__D013732
% 210.35/210.58       A self-reporting test consisting of items concerning fear and worry about taking tests and physiological activity, such as heart rate, sweating, etc., before, during, and after tests.%A%    
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D013732 2006
% 210.35/210.58  |- skos__altLabel mesh__D013732 Test Anxiety Questionnaire
% 210.35/210.58  |- rdf__type mesh__D013732sskos__Concept
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D013732 1998
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D013732 1993
% 210.35/210.58  |- mesh__recordMaintainer mesh__D013732 TAP
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D013732 2005
% 210.35/210.58  |- skos__hiddenLabel mesh__D013732 Questionnaire, Test Anxiety
% 210.35/210.58  |- skos__prefLabel mesh__D013732 Test Anxiety Scale
% 210.35/210.58  |- mesh__onlineNote mesh__D013732 search PERSONALITY INVENTORY 1968-74   
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D013732 1997
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D013732 2002
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D013732 2004
% 210.35/210.58  |- mesh__dateCreated mesh__D013732 1999-01-01
% 210.35/210.58  |- skos__hiddenLabel mesh__D009691 Denaturations, Nucleic Acid
% 210.35/210.58  |- skos__hiddenLabel mesh__D009691 Denaturation, Nucleic Acid
% 210.35/210.58  |- skos__related mesh__D009691smesh__D020871
% 210.35/210.58  |- mesh__dateEstablished mesh__D009691 1970-01-01
% 210.35/210.58  |- mesh__recordMaintainer mesh__D009691 nns
% 210.35/210.58  |- rdf__type mesh__D009691sskos__Concept
% 210.35/210.58  |- skos__broader mesh__D009691smesh__D001669
% 210.35/210.58  |- skos__hiddenLabel mesh__D009691 Acid Denaturation, Nucleic
% 210.35/210.58  |- mesh__publicMeSHNote mesh__D009691 70   
% 210.35/210.58  |- skos__annotation mesh__D009691
% 210.35/210.58       IM general only; coord NIM with DNA or RNA or specific %28%IM%29%%A%  
% 210.35/210.58  |- mesh__historyNote mesh__D009691 70%28%67%29%   
% 210.35/210.58  |- mesh__dateRevised mesh__D009691 2003-07-09
% 210.35/210.58  |- mesh__recordOriginator mesh__D009691 NLM
% 210.35/210.58  |- skos__hiddenLabel mesh__D009691 Acid Denaturations, Nucleic
% 210.35/210.58  |- mesh__dateCreated mesh__D009691 1999-01-01
% 210.35/210.58  |- mesh__recordAuthorizer mesh__D009691 sjn
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D009691 2005
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D009691 2004
% 210.35/210.58  |- skos__hiddenLabel mesh__D009691 Nucleic Acid Denaturations
% 210.35/210.58  |- skos__prefLabel mesh__D009691 Nucleic Acid Denaturation
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D009691 2006
% 210.35/210.58  |- skos__scopeNote mesh__D009691
% 210.35/210.58       Disorganization of secondary structures of nucleic acids through cleavage of hydrogen bonds and hydrophobic linkages. Denatured DNA appears to be a single-stranded flexible structure. The effects of denaturation on RNA are similar though less pronounced and largely reversible.%A%    
% 210.35/210.58  |- skos__altLabel mesh__D023362 Evaluation Studies %28%Pub Type%29%
% 210.35/210.58  |- mesh__historyNote mesh__D023362 2001   
% 210.35/210.58  |- skos__scopeNote mesh__D023362
% 210.35/210.58       Works consisting of studies determining the effectiveness or utility of processes, personnel, and equipment.%A%    
% 210.35/210.58  |- skos__prefLabel mesh__D023362
% 210.35/210.58       Evaluation Studies %5B%Publication Type%5D%
% 210.35/210.58  |- mesh__recordMaintainer mesh__D023362 jls
% 210.35/210.58  |- skos__broader mesh__D023362smesh__D052182
% 210.35/210.58  |- skos__related mesh__D023362smesh__D023361
% 210.35/210.58  |- mesh__recordAuthorizer mesh__D023362 sjn
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D023362 2006
% 210.35/210.58  |- rdf__type mesh__D023362sskos__Concept
% 210.35/210.58  |- skos__altLabel mesh__D023362 Evaluation Studies %5B%PT%5D%
% 210.35/210.58  |- mesh__dateCreated mesh__D023362 2000-06-22
% 210.35/210.58  |- skos__annotation mesh__D023362
% 210.35/210.58       publication type only; evaluation studies as a subject are indexed under the main heading EVALUATION STUDIES%A%  
% 210.35/210.58  |- mesh__dateRevised mesh__D023362 2005-06-30
% 210.35/210.58  |- mesh__dateEstablished mesh__D023362 2001-01-01
% 210.35/210.58  |- mesh__recordOriginator mesh__D023362 jls
% 210.35/210.58  |- skos__related mesh__D023362smesh__D016430
% 210.35/210.58  |- skos__scopeNote mesh__D017325
% 210.35/210.58       Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced.%A%    
% 210.35/210.58  |- skos__hiddenLabel mesh__D017325 Vaccine, Hepatitis B
% 210.35/210.58  |- mesh__recordAuthorizer mesh__D017325 sjn
% 210.35/210.58  |- skos__hiddenLabel mesh__D017325 Vaccines, Hepatitis B
% 210.35/210.58  |- mesh__dateEstablished mesh__D017325 1993-01-01
% 210.35/210.58  |- mesh__publicMeSHNote mesh__D017325
% 210.35/210.58       93; HEPATITIS B VACCINE was indexed under VIRAL HEPATITIS VACCINES 1985-92 %26% VIRAL VACCINES 1982-84%A%  
% 210.35/210.58  |- rdf__type mesh__D017325sskos__Concept
% 210.35/210.58  |- mesh__onlineNote mesh__D017325
% 210.35/210.58       use HEPATITIS B VACCINES %28%NM%29% to search HEPATITIS B VACCINE 1982-92%A%  
% 210.35/210.58  |- mesh__recordMaintainer mesh__D017325 ssb
% 210.35/210.58  |- mesh__dateRevised mesh__D017325 2005-06-30
% 210.35/210.58  |- mesh__dateCreated mesh__D017325 1992-05-20
% 210.35/210.58  |- skos__altLabel mesh__D017325 Hepatitis B Vaccine
% 210.35/210.58  |- mesh__historyNote mesh__D017325
% 210.35/210.58       93; was HEPATITIS B VACCINE %28%NM%29% 1982-92   
% 210.35/210.58  |- skos__historyNote mesh__D017325 Viral Vaccines %28%1982-1984%29%
% 210.35/210.58  |- skos__historyNote mesh__D017325
% 210.35/210.58       Viral Hepatitis Vaccines %28%1985-1992%29%
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D017325 2006
% 210.35/210.58  |- mesh__recordOriginator mesh__D017325 AGS
% 210.35/210.58  |- skos__prefLabel mesh__D017325 Hepatitis B Vaccines
% 210.35/210.58  |- skos__broader mesh__D017325smesh__D014761
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D050759 2006A
% 210.35/210.58  |- skos__broader mesh__D050759smesh__D050756
% 210.35/210.58  |- skos__hiddenLabel mesh__D050759 Cyclin Dependent Kinase Inhibitor p21
% 210.35/210.58  |- skos__altLabel mesh__D050759 Cdk2 Inhibitor Protein
% 210.35/210.58  |- skos__hiddenLabel mesh__D050759 CDK2 Associated Protein 20 kDa
% 210.35/210.58  |- skos__altLabel mesh__D050759 CDKN1 Protein
% 210.35/210.58  |- skos__altLabel mesh__D050759 Cell Cycle Regulator p21
% 210.35/210.58  |- mesh__recordOriginator mesh__D050759 DRC
% 210.35/210.58  |- skos__hiddenLabel mesh__D050759
% 210.35/210.58       Cyclin Dependent Kinase Inhibitor 1A Protein
% 210.35/210.58  |- skos__altLabel mesh__D050759
% 210.35/210.58       Cyclin-Dependent Kinase Inhibitor 1A Protein
% 210.35/210.58  |- skos__altLabel mesh__D050759 Cyclin Kinase Inhibitor p21
% 210.35/210.58  |- mesh__dateCreated mesh__D050759 2005-06-30
% 210.35/210.58  |- skos__altLabel mesh__D050759 p21 Cyclin Kinase Inhibitor
% 210.35/210.58  |- skos__altLabel mesh__D050759 CDKN1A Protein
% 210.35/210.58  |- mesh__dateRevised mesh__D050759 2005-07-12
% 210.35/210.58  |- mesh__historyNote mesh__D050759 2006%28%1993%29%   
% 210.35/210.58  |- skos__altLabel mesh__D050759 p21 Cell Cycle Regulator
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D050759 2006
% 210.35/210.58  |- skos__hiddenLabel mesh__D050759
% 210.35/210.58       Senescent Cell Derived Inhibitor Protein 1
% 210.35/210.58  |- skos__altLabel mesh__D050759 CDK2-Associated Protein 20 kDa
% 210.35/210.58  |- skos__prefLabel mesh__D050759 Cyclin-Dependent Kinase Inhibitor p21
% 210.35/210.58  |- mesh__recordMaintainer mesh__D050759 ags
% 210.35/210.58  |- rdf__type mesh__D050759sskos__Concept
% 210.35/210.58  |- skos__hiddenLabel mesh__D050759 Cdk Interacting Protein 1
% 210.35/210.58  |- skos__scopeNote mesh__D050759
% 210.35/210.58       A cyclin-dependent kinase inhibitor that mediates TUMOR SUPRESSOR PROTEIN P53-dependent CELL CYCLE arrest. p21 interacts with a range of CYCLIN-DEPENDENT KINASES and associates with PROLIFERATING CELL NUCLEAR ANTIGEN and CASPASE 3.%A%    
% 210.35/210.58  |- mesh__recordAuthorizer mesh__D050759 ags
% 210.35/210.58  |- mesh__publicMeSHNote mesh__D050759
% 210.35/210.58       2006; CYCLIN-DEPENDENT KINASE INHIBITOR P21 was indexed under CYCLINS 1993-2005, %26% under CELL CYCLE PROTEINS 2005%A%  
% 210.35/210.58  |- skos__altLabel mesh__D050759 Senescent Cell-Derived Inhibitor Protein 1
% 210.35/210.58  |- mesh__dateEstablished mesh__D050759 2006-01-01
% 210.35/210.58  |- skos__altLabel mesh__D050759 Cdk-Interacting Protein 1
% 210.35/210.58  |- mesh__dateEstablished mesh__D003305 1991-01-01
% 210.35/210.58  |- mesh__dateCreated mesh__D003305 1975-07-25
% 210.35/210.58  |- mesh__historyNote mesh__D003305
% 210.35/210.58       91%28%76%29%; was see under PORPHYRINOGENS 1976-90   
% 210.35/210.58  |- skos__scopeNote mesh__D003305
% 210.35/210.58       Porphyrinogens which are intermediates in the heme biosynthesis. They have four methyl and four propionic acid side chains attached to the pyrrole rings. Coproporphyrinogens I and III are formed in the presence of uroporphyrinogen decarboxylase from the corresponding uroporphyrinogen. They can yield coproporphyrins by autooxidation or protoporphyrin by oxidative decarboxylation.%A%    
% 210.35/210.58  |- skos__historyNote mesh__D003305 Porphyrins %28%1971-1974%29%
% 210.35/210.58  |- mesh__recordMaintainer mesh__D003305 ssb
% 210.35/210.58  |- skos__prefLabel mesh__D003305 Coproporphyrinogens
% 210.35/210.58  |- mesh__recordOriginator mesh__D003305 RLS
% 210.35/210.58  |- skos__annotation mesh__D003305 intermediates in heme biosyn   
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D003305 2006
% 210.35/210.58  |- mesh__publicMeSHNote mesh__D003305
% 210.35/210.58       91; was see under PORPHYRINOGENS 1976-90   
% 210.35/210.58  |- mesh__dateRevised mesh__D003305 2005-06-30
% 210.35/210.58  |- mesh__recordAuthorizer mesh__D003305 sjn
% 210.35/210.58  |- rdf__type mesh__D003305sskos__Concept
% 210.35/210.58  |- skos__broader mesh__D003305smesh__D011165
% 210.35/210.58  |- skos__historyNote mesh__D003305 Porphyrinogens %28%1975%29%
% 210.35/210.58  |- rdf__type mesh__D008599sskos__Concept
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D008599 2000
% 210.35/210.58  |- skos__annotation mesh__D008599
% 210.35/210.58       human only; GEN or unspecified: prefer specifics; note X refs%A%  
% 210.35/210.58  |- skos__hiddenLabel mesh__D008599 Disorder, Menstruation
% 210.35/210.58  |- skos__hiddenLabel mesh__D008599 Retrograde Menstruation
% 210.35/210.58  |- skos__prefLabel mesh__D008599 Menstruation Disturbances
% 210.35/210.58  |- mesh__recordOriginator mesh__D008599 NLM
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D008599 2004
% 210.35/210.58  |- skos__hiddenLabel mesh__D008599 Disturbances, Menstruation
% 210.35/210.58  |- mesh__dateCreated mesh__D008599 1999-01-01
% 210.35/210.58  |- mesh__recordAuthorizer mesh__D008599 ags
% 210.35/210.58  |- skos__hiddenLabel mesh__D008599 Retrograde Menstruations
% 210.35/210.58  |- mesh__publicMeSHNote mesh__D008599
% 210.35/210.58       2000; see MENSTRUATION DISORDERS 1963-1999; for HYPOMENORRHEA, POLYMENORRHEA %26% MENSTRUATION, RETROGRADE see MENSTRUATION DISORDERS 1975-1985%A%  
% 210.35/210.58  |- skos__hiddenLabel mesh__D008599 Menstruations, Retrograde
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D008599 2003
% 210.35/210.58  |- skos__scopeNote mesh__D008599
% 210.35/210.58       Variations of menstruation which may be indicative of disease.%A%    
% 210.35/210.58  |- skos__hiddenLabel mesh__D008599 Disorders, Menstruation
% 210.35/210.58  |- skos__hiddenLabel mesh__D008599 Polymenorrheas
% 210.35/210.58  |- mesh__historyNote mesh__D008599 2000%28%1963%29%   
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D008599 2002
% 210.35/210.58  |- mesh__recordMaintainer mesh__D008599 ags
% 210.35/210.58  |- skos__hiddenLabel mesh__D008599 Disturbance, Menstruation
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D008599 2000A
% 210.35/210.58  |- skos__broader mesh__D008599smesh__D010335
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D008599 2006
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D008599 2001
% 210.35/210.58  |- skos__hiddenLabel mesh__D008599 Menstruation Disorder
% 210.35/210.58  |- mesh__dateRevised mesh__D008599 1999-12-06
% 210.35/210.58  |- skos__altLabel mesh__D008599 Menstruation Disorders
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D008599 2005
% 210.35/210.58  |- skos__hiddenLabel mesh__D008599 Hypomenorrheas
% 210.35/210.58  |- skos__hiddenLabel mesh__D008599 Menstruation Disturbance
% 210.35/210.58  |- skos__hiddenLabel mesh__D013733 Disease, Testicular
% 210.35/210.58  |- mesh__dateEstablished mesh__D013733 1966-01-01
% 210.35/210.58  |- mesh__publicMeSHNote mesh__D013733 66   
% 210.35/210.58  |- mesh__recordAuthorizer mesh__D013733 sjn
% 210.35/210.58  |- skos__broader mesh__D013733smesh__D005832
% 210.35/210.58  |- skos__prefLabel mesh__D013733 Testicular Diseases
% 210.35/210.58  |- mesh__dateCreated mesh__D013733 1999-01-01
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D013733 2006
% 210.35/210.58  |- skos__hiddenLabel mesh__D013733 Diseases, Testicular
% 210.35/210.58  |- rdf__type mesh__D013733sskos__Concept
% 210.35/210.58  |- mesh__dateRevised mesh__D013733 2005-06-30
% 210.35/210.58  |- skos__broader mesh__D013733smesh__D006058
% 210.35/210.58  |- skos__annotation mesh__D013733 inflammatory disease  = ORCHITIS   
% 210.35/210.58  |- mesh__historyNote mesh__D013733 66   
% 210.35/210.58  |- skos__scopeNote mesh__D013733 Pathological processes of the TESTIS.     
% 210.35/210.58  |- skos__hiddenLabel mesh__D013733 Testicular Disease
% 210.35/210.58  |- mesh__recordOriginator mesh__D013733 NLM
% 210.35/210.58  |- mesh__recordMaintainer mesh__D013733 lkt
% 210.35/210.58  |- skos__historyNote mesh__D009692 specific DNA %28%1966-1979%29%
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D009692 2006
% 210.35/210.58  |- skos__historyNote mesh__D009692 Recombination, Genetic %28%1968-1979%29%
% 210.35/210.58  |- skos__historyNote mesh__D009692 specific RNA %28%1966-1979%29%
% 210.35/210.58  |- skos__altLabel mesh__D009692 Heteroduplexes, Nucleic Acid
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D009692 2002
% 210.35/210.58  |- skos__historyNote mesh__D009692 RNA %28%1966-1979%29%
% 210.35/210.58  |- mesh__recordAuthorizer mesh__D009692 SJN
% 210.35/210.58  |- skos__hiddenLabel mesh__D009692 DNA, Heteroduplex
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D009692 2005
% 210.35/210.58  |- skos__annotation mesh__D009692
% 210.35/210.58       coord with specific DNA or RNA or both %28%IM%29%   
% 210.35/210.58  |- mesh__recordMaintainer mesh__D009692 NDW
% 210.35/210.58  |- mesh__recordOriginator mesh__D009692 RLS
% 210.35/210.58  |- rdf__type mesh__D009692sskos__Concept
% 210.35/210.58  |- skos__scopeNote mesh__D009692
% 210.35/210.58       Double-stranded nucleic acid molecules %28%DNA-DNA or DNA-RNA%29% which contain regions of nucleotide mismatches %28%non-complementary%29%. In vivo, these heteroduplexes can result from mutation or genetic recombination; in vitro, they are formed by nucleic acid hybridization. Electron microscopic analysis of the resulting heteroduplexes facilitates the mapping of regions of base sequence homology of nucleic acids.%A%    
% 210.35/210.58  |- skos__related mesh__D009692smesh__D020180
% 210.35/210.58  |- skos__historyNote mesh__D009692 Base Sequence %28%1971-1979%29%
% 210.35/210.58  |- skos__related mesh__D009692smesh__D020137
% 210.35/210.58  |- mesh__dateEstablished mesh__D009692 1980-01-01
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D009692 1999
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D009692 2001
% 210.35/210.58  |- mesh__historyNote mesh__D009692 80   
% 210.35/210.58  |- skos__historyNote mesh__D009692
% 210.35/210.58       Nucleic Acid Hybridization %28%1971-1979%29%
% 210.35/210.58  |- skos__prefLabel mesh__D009692 Nucleic Acid Heteroduplexes
% 210.35/210.58  |- skos__hiddenLabel mesh__D009692 Acid Heteroduplexes, Nucleic
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D009692 2004
% 210.35/210.58  |- mesh__dateCreated mesh__D009692 1979-05-23
% 210.35/210.58  |- skos__historyNote mesh__D009692 DNA %28%1966-1979%29%
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D009692 2000
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D009692 2003
% 210.35/210.58  |- mesh__publicMeSHNote mesh__D009692 80   
% 210.35/210.58  |- mesh__dateRevised mesh__D009692 1998-06-10
% 210.35/210.58  |- skos__broader mesh__D009692smesh__D009696
% 210.35/210.58  |- skos__historyNote mesh__D009692 Mutation %28%1966-1979%29%
% 210.35/210.58  |- skos__altLabel mesh__D017326 Evaluation Studies, FDA Phase 3
% 210.35/210.58  |- mesh__recordOriginator mesh__D017326 TPW
% 210.35/210.58  |- skos__broader mesh__D017326smesh__D002986
% 210.35/210.58  |- skos__altLabel mesh__D017326 Phase III Clinical Trials
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D017326 2005
% 210.35/210.58  |- skos__altLabel mesh__D017326 Clinical Trials, Phase 3
% 210.35/210.58  |- skos__altLabel mesh__D017326 Drug Evaluation, FDA Phase 3
% 210.35/210.58  |- mesh__dateEstablished mesh__D017326 1993-01-01
% 210.35/210.58  |- skos__historyNote mesh__D017326 Clinical Trials %28%1980-1992%29%
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D017326 2006
% 210.35/210.58  |- mesh__recordAuthorizer mesh__D017326 sjn
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D017326 2003
% 210.35/210.58  |- skos__annotation mesh__D017326
% 210.35/210.58       trial lasts about 3 years; for U.S. %26% foreign studies; for II/III clin trials, index under CLINICAL TRIALS, PHASE II + CLINICAL TRIALS, PHASE III; IM for articles %26% books about phase III clin trials as a method in med research; do not confuse with Publication Type CLINICAL TRIAL, PHASE III; DF: CLIN TRIALS PAHSE III%A%  
% 210.35/210.58  |- mesh__onlineNote mesh__D017326
% 210.35/210.58       use CLINICAL TRIALS to search DRUG EVALUATION, FDA PHASE III 1980-92 %26% EVALUATION STUDIES, FDA PHASE III 1982-92%A%  
% 210.35/210.58  |- mesh__dateCreated mesh__D017326 1992-05-13
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D017326 2004
% 210.35/210.58  |- skos__scopeNote mesh__D017326
% 210.35/210.58       Comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.%A%    
% 210.35/210.58  |- skos__altLabel mesh__D017326 Phase 3 Clinical Trials
% 210.35/210.58  |- mesh__publicMeSHNote mesh__D017326
% 210.35/210.58       93; DRUG EVALUATION, FDA PHASE III was see CLINICAL TRIALS 1980-92; EVALUATION STUDIES, FDA PHASE III was see CLINICAL TRIALS 1982-92%A%  
% 210.35/210.58  |- mesh__recordMaintainer mesh__D017326 ags
% 210.35/210.58  |- mesh__historyNote mesh__D017326
% 210.35/210.58       93; DRUG EVALUATION, FDA PHASE III was see CLINICAL TRIALS 1980-92; EVALUATION STUDIES, FDA PHASE III was see CLINICAL TRIALS 1982-92%A%  
% 210.35/210.58  |- skos__altLabel mesh__D017326 Drug Evaluation, FDA Phase III
% 210.35/210.58  |- mesh__dateRevised mesh__D017326 2001-07-25
% 210.35/210.58  |- skos__prefLabel mesh__D017326 Clinical Trials, Phase III
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D017326 2002
% 210.35/210.58  |- rdf__type mesh__D017326sskos__Concept
% 210.35/210.58  |- mesh__dateRevised mesh__D003306 2005-06-30
% 210.35/210.58  |- mesh__recordAuthorizer mesh__D003306 sjn
% 210.35/210.58  |- mesh__historyNote mesh__D003306
% 210.35/210.58       91%28%75%29%; was see under PORPHYRINS 1975-90   
% 210.35/210.58  |- skos__broader mesh__D003306smesh__D011166
% 210.35/210.58  |- skos__scopeNote mesh__D003306
% 210.35/210.58       Porphyrins with four methyl and four propionic acid side chains attached to the pyrrole rings. Elevated levels of Coproporphyrin III in the urine and feces are major findings in patients with HEREDITARY COPROPORPHYRIA.%A%    
% 210.35/210.58  |- mesh__recordMaintainer mesh__D003306 ssb
% 210.35/210.58  |- mesh__dateEstablished mesh__D003306 1991-01-01
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D003306 2006
% 210.35/210.58  |- skos__prefLabel mesh__D003306 Coproporphyrins
% 210.35/210.58  |- rdf__type mesh__D003306sskos__Concept
% 210.35/210.58  |- skos__historyNote mesh__D003306 Porphyrins %28%1969-1974%29%
% 210.35/210.58  |- mesh__publicMeSHNote mesh__D003306
% 210.35/210.58       91; was see under PORPHYRINS 1975-90   
% 210.35/210.58  |- mesh__recordOriginator mesh__D003306 NLM
% 210.35/210.58  |- mesh__dateCreated mesh__D003306 1974-11-19
% 210.35/210.58  |- skos__broader mesh__D003080Q000627smesh__D003080
% 210.35/210.58  |- mesh__preferredCombination mesh__D003080Q000627smesh__D017679
% 210.35/210.58  |- rdf__type mesh__D003080Q000627smesh__CompoundConcept
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D049408 2006
% 210.35/210.58  |- mesh__recordAuthorizer mesh__D049408 sjn
% 210.35/210.58  |- mesh__publicMeSHNote mesh__D049408 2005   
% 210.35/210.58  |- skos__broader mesh__D049408smesh__D007202
% 210.35/210.58  |- skos__historyNote mesh__D049408
% 210.35/210.58       Luminescent Measurements %28%1964-2004%29%
% 210.35/210.58  |- mesh__historyNote mesh__D049408 2005   
% 210.35/210.58  |- skos__scopeNote mesh__D049408
% 210.35/210.58       Compound such as LUMINESCENT PROTEINS that cause or emit light %28%PHYSICAL LUMINESCENCE%29%.%A%    
% 210.35/210.58  |- skos__prefLabel mesh__D049408 Luminescent Agents
% 210.35/210.58  |- skos__related mesh__D049408smesh__D005456
% 210.35/210.58  |- mesh__recordMaintainer mesh__D049408 ssb
% 210.35/210.58  |- skos__related mesh__D049408smesh__D002863
% 210.35/210.58  |- mesh__dateEstablished mesh__D049408 2005-01-01
% 210.35/210.58  |- mesh__recordOriginator mesh__D049408 ssb
% 210.35/210.58  |- mesh__dateCreated mesh__D049408 2004-07-07
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D049408 2005
% 210.35/210.58  |- skos__hiddenLabel mesh__D049408 Agents, Phosphorescent
% 210.35/210.58  |- rdf__type mesh__D049408sskos__Concept
% 210.35/210.58  |- skos__hiddenLabel mesh__D049408 Agents, Luminescent
% 210.35/210.58  |- skos__altLabel mesh__D013734 Androgen-Insensitivity Syndrome, Complete
% 210.35/210.58  |- mesh__historyNote mesh__D013734 2002%28%1968%29%   
% 210.35/210.58  |- skos__hiddenLabel mesh__D013734 Androgen Insensitivity Syndrome
% 210.35/210.58  |- mesh__recordOriginator mesh__D013734 NLM
% 210.35/210.58  |- mesh__recordMaintainer mesh__D013734 lkt
% 210.35/210.58  |- skos__broader mesh__D013734smesh__D011545
% 210.35/210.58  |- skos__hiddenLabel mesh__D013734
% 210.35/210.58       Androgen Insensitivity Syndrome, Complete
% 210.35/210.58  |- skos__hiddenLabel mesh__D013734
% 210.35/210.58       Androgen-Insensitivity Syndromes, Partial
% 210.35/210.58  |- mesh__publicMeSHNote mesh__D013734
% 210.35/210.58       2002; see TESTICULAR FEMINIZATION %28%1970-2001%29%   
% 210.35/210.58  |- mesh__dateCreated mesh__D013734 1999-01-01
% 210.35/210.58  |- mesh__recordAuthorizer mesh__D013734 sjn
% 210.35/210.58  |- skos__scopeNote mesh__D013734
% 210.35/210.58       A familial form of PSEUDOHERMAPHRODITISM transmitted as an X-linked recessive trait. These patients have a karyotype of 46,XY with end-organ resistance to androgen due to mutations in the androgen receptor %28%RECEPTORS, ANDROGEN%29% gene. Severity of the defect in receptor quantity or quality correlates with their phenotypes. In these genetic males, the phenotypic spectrum ranges from those with normal female external genitalia, through those with genital ambiguity as in Reifenstein Syndrome, to that of a normal male with INFERTILITY.%A%    
% 210.35/210.58  |- mesh__activeMeSHYear mesh__D013734 2006
% 210.35/210.58  |- rdf__type mesh__D013734sskos__Concept
% 210.35/210.58  |- skos__annotation mesh__D013734 check the tag MALE   
% 210.35/210.58  |- skos__hiddenLabel mesh__D013734 Androgen Insensitivity Syndrome, Partial
% 210.35/210.58  |- skos__prefLabel mesh__D013734 Androgen-Insensitivity Syndrome
% 210.35/210.58  |- mesh__dateEstablished mesh__D013734 1970-01-01
% 210.35/210.58  |- skos__hiddenLabel mesh__D013734 Reifensteins Syndrome
% 210.35/210.58  |- skos__altLabel mesh__D013734 Reifenstein%27%s Syndrome
% 210.35/210.58  |- skos__broader mesh__D013734smesh__D040181
% 210.35/210.58  |- skos__altLabel mesh__D013734 Androgen-Insensitivity Syndrome, Partial
% 210.35/210.58  |- skos__historyNote mesh__D013734
% 210.35/210.58       Sex Differentiation Disorders %28%1966-1967%29%
% 210.35/210.58  |- mesh__dateRevised mesh__D013734 2005-06-30
% 210.35/210.58  |- rdf__type mesh__D046110sskos__Concept
% 210.35/210.58  |- skos__hiddenLabel mesh__D046110 Hypertension, Pregnancy Transient
% 210.35/210.58  |- skos__hiddenLabel mesh__D046110 Pregnancy Transient Hypertension
% 210.35/210.58  |- mesh__publicMeSHNote mesh__D046110 2005   
% 210.35/210.58  |- skos__broader mesh__D046110smesh__D011248
% 210.35/210.58  |- skos__hiddenLabel mesh__D046110 Hypertension, Gestational
% 210.35/210.58  |- skos__historyNote mesh__D046110 Hypertension %28%1970-2004%29%
% 210.35/210.58  |- skos__hiddenLabel mesh__D046110 Pregnancy-Induced Hypertension
% 210.35/210.58  |- skos__hiddenLabel mesh__D046110 Hypertension, Pregnancy Induced
% 210.35/210.58  |- mesh__historyNote mesh__D046110 2005   
% 210.35/210.58  |- skos__historyNote mesh__D046110
% 210.35/210.58       Pregnancy Complications, Cardiovascular %28%1970-2004%29%
% 210.35/210.59  |- skos__scopeNote mesh__D046110
% 210.35/210.59       A condition in pregnant women with elevated systolic %28%%3E%140 mm Hg%29% and diastolic %28%%3E%90 mm Hg%29% blood pressure on at least two occasions 6 h apart. HYPERTENSION complicates 8-10%25% of all pregnancies, generally after 20 weeks of gestation. Gestational hypertension can be divided into several broad categories according to the complexity and associated symptoms, such as EDEMA; PROTEINURIA; SEIZURES; abnormalities in BLOOD COAGULATION and liver functions.%A%    
% 210.35/210.59  |- mesh__recordOriginator mesh__D046110 lkt
% 210.35/210.59  |- skos__altLabel mesh__D046110 Gestational Hypertension
% 210.35/210.59  |- mesh__recordAuthorizer mesh__D046110 sjn
% 210.35/210.59  |- mesh__recordMaintainer mesh__D046110 lkt
% 210.35/210.59  |- skos__annotation mesh__D046110 check tags FEMALE %26% PREGNANCY   
% 210.35/210.59  |- mesh__dateRevised mesh__D046110 2005-06-30
% 210.35/210.59  |- mesh__dateCreated mesh__D046110 2004-07-07
% 210.35/210.59  |- mesh__dateEstablished mesh__D046110 2005-01-01
% 210.35/210.59  |- mesh__activeMeSHYear mesh__D046110 2006
% 210.35/210.59  |- skos__broader mesh__D046110smesh__D006973
% 210.35/210.59  |- skos__prefLabel mesh__D046110 Hypertension, Pregnancy-Induced
% 210.35/210.59  |- skos__prefLabel mesh__D009693 Nucleic Acid Hybridization
% 210.35/210.59  |- mesh__activeMeSHYear mesh__D009693 2000
% 210.35/210.59  |- skos__hiddenLabel mesh__D009693 Acid Hybridization, Nucleic
% 210.35/210.59  |- mesh__activeMeSHYear mesh__D009693 2005
% 210.35/210.59  |- mesh__recordOriginator mesh__D009693 NLM
% 210.35/210.59  |- mesh__recordAuthorizer mesh__D009693 jls
% 210.35/210.59  |- skos__hiddenLabel mesh__D009693 Hybridizations, Genomic
% 210.35/210.59  |- mesh__activeMeSHYear mesh__D009693 2005A
% 210.35/210.59  |- rdf__type mesh__D009693sskos__Concept
% 210.35/210.59  |- skos__hiddenLabel mesh__D009693 Hybridization, Genomic
% 210.35/210.59  |- skos__hiddenLabel mesh__D009693 Acid Hybridizations, Nucleic
% 210.35/210.59  |- skos__annotation mesh__D009693
% 210.35/210.59       IM general only; coord NIM with DNA or RNA or specific %28%IM%29%; IN SITU HYBRIDIZATION %26% IN SITU HYBRIDIZATION, FLUORESCENCE are available%A%  
% 210.35/210.59  |- skos__historyNote mesh__D009693 RNA %28%1966-1970%29%
% 210.35/210.59  |- skos__historyNote mesh__D009693 DNA %28%1966-1970%29%
% 210.35/210.59  |- mesh__activeMeSHYear mesh__D009693 1999
% 210.35/210.59  |- mesh__dateEstablished mesh__D009693 1972-01-01
% 210.35/210.59  |- mesh__activeMeSHYear mesh__D009693 2002
% 210.45/210.59  |- mesh__historyNote mesh__D009693 72%28%71%29%   
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D009693 2004
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D009693 1998
% 210.45/210.59  |- mesh__publicMeSHNote mesh__D009693 72   
% 210.45/210.59  |- skos__hiddenLabel mesh__D009693 Hybridizations, Nucleic Acid
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D009693 2003
% 210.45/210.59  |- skos__hiddenLabel mesh__D009693 Genomic Hybridizations
% 210.45/210.59  |- skos__hiddenLabel mesh__D009693 Nucleic Acid Hybridizations
% 210.45/210.59  |- mesh__recordMaintainer mesh__D009693 jls
% 210.45/210.59  |- mesh__dateCreated mesh__D009693 1999-01-01
% 210.45/210.59  |- skos__broader mesh__D009693smesh__D001669
% 210.45/210.59  |- skos__hiddenLabel mesh__D009693 Hybridization, Nucleic Acid
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D009693 2001
% 210.45/210.59  |- skos__scopeNote mesh__D009693
% 210.45/210.59       Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. %28%Kendrew, Encyclopedia of Molecular Biology, 1994, p503%29%%A%    
% 210.45/210.59  |- skos__broader mesh__D009693smesh__D005821
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D009693 2006
% 210.45/210.59  |- skos__related mesh__D009693smesh__D015139
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D009693 1997
% 210.45/210.59  |- mesh__dateRevised mesh__D009693 2004-07-29
% 210.45/210.59  |- skos__altLabel mesh__D017327 Evaluation Studies, FDA Phase 4
% 210.45/210.59  |- skos__altLabel mesh__D017327 Clinical Trials, Phase 4
% 210.45/210.59  |- skos__altLabel mesh__D017327 Phase IV Clinical Trials
% 210.45/210.59  |- mesh__recordMaintainer mesh__D017327 ssb
% 210.45/210.59  |- mesh__dateRevised mesh__D017327 2005-06-30
% 210.45/210.59  |- skos__historyNote mesh__D017327 Clinical Trials %28%1980-1992%29%
% 210.45/210.59  |- mesh__recordOriginator mesh__D017327 TPW
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D017327 2006
% 210.45/210.59  |- skos__broader mesh__D017327smesh__D002986
% 210.45/210.59  |- mesh__publicMeSHNote mesh__D017327
% 210.45/210.59       93; DRUG EVALUATION, FDA PHASE IV was see CLINICAL TRIALS 1981-92; EVALUATION STUDIES, FDA PHASE IV was see CLINICAL TRIALS 1982-92%A%  
% 210.45/210.59  |- mesh__historyNote mesh__D017327
% 210.45/210.59       93; DRUG EVALUATION, FDA PHASE IV was see CLINICAL TRIALS 1981-92; EVALUATION STUDIES, FDA PHASE IV was see CLINICAL TRIALS 1982-92%A%  
% 210.45/210.59  |- skos__prefLabel mesh__D017327 Clinical Trials, Phase IV
% 210.45/210.59  |- mesh__onlineNote mesh__D017327
% 210.45/210.59       use CLINICAL TRIALS to search DRUG EVALUATION, FDA PHASE IV 1980-92 %26% EVALUATION STUDIES, FDA PHASE IV 1981-92%A%  
% 210.45/210.59  |- mesh__dateEstablished mesh__D017327 1993-01-01
% 210.45/210.59  |- skos__annotation mesh__D017327
% 210.45/210.59       for U.S. %26% foreign studies; IM for articles %26% books about phase IV clin trials as a method in med research; do not confuse with Publication Type CLINICAL TRIAL, PHASE IV; DF: CLIN TRIALS PHASE IV%A%  
% 210.45/210.59  |- skos__scopeNote mesh__D017327
% 210.45/210.59       Planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale. These studies are often conducted to obtain additional data about the safety and efficacy of a product. This concept includes phase IV studies conducted in both the U.S. and in other countries.%A%    
% 210.45/210.59  |- mesh__recordAuthorizer mesh__D017327 sjn
% 210.45/210.59  |- skos__related mesh__D017327smesh__D004362
% 210.45/210.59  |- rdf__type mesh__D017327sskos__Concept
% 210.45/210.59  |- mesh__dateCreated mesh__D017327 1992-05-13
% 210.45/210.59  |- skos__altLabel mesh__D017327 Drug Evaluation, FDA Phase IV
% 210.45/210.59  |- skos__broader mesh__D017327smesh__D011358
% 210.45/210.59  |- skos__altLabel mesh__D017327 Drug Evaluation, FDA Phase 4
% 210.45/210.59  |- skos__altLabel mesh__D017327 Phase 4 Clinical Trials
% 210.45/210.59  |- skos__prefLabel mesh__D003307 Copulation
% 210.45/210.59  |- mesh__recordOriginator mesh__D003307 NLM
% 210.45/210.59  |- mesh__recordMaintainer mesh__D003307 lkt
% 210.45/210.59  |- skos__scopeNote mesh__D003307
% 210.45/210.59       Sexual union of a male and a female in non-human species.%A%    
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D003307 2005
% 210.45/210.59  |- mesh__recordAuthorizer mesh__D003307 sjn
% 210.45/210.59  |- skos__annotation mesh__D003307 animal only: for human, use COITUS   
% 210.45/210.59  |- mesh__publicMeSHNote mesh__D003307 75   
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D003307 2006
% 210.45/210.59  |- mesh__dateRevised mesh__D003307 2004-07-07
% 210.45/210.59  |- mesh__dateCreated mesh__D003307 1974-11-11
% 210.45/210.59  |- rdf__type mesh__D003307sskos__Concept
% 210.45/210.59  |- skos__hiddenLabel mesh__D003307 Copulations
% 210.45/210.59  |- skos__historyNote mesh__D003307 Coitus %28%1966-1974%29%
% 210.45/210.59  |- mesh__historyNote mesh__D003307 75   
% 210.45/210.59  |- mesh__dateEstablished mesh__D003307 1975-09-01
% 210.45/210.59  |- skos__broader mesh__D003307smesh__D012726
% 210.45/210.59  |- mesh__recordMaintainer mesh__D049409 ags
% 210.45/210.59  |- skos__scopeNote mesh__D049409
% 210.45/210.59       Luciferases from FIREFLIES, usually Photinus, that oxidizes FIREFLY LUCIFERIN to cause emission of PHOTONS.%A%    
% 210.45/210.59  |- skos__broader mesh__D049409smesh__D008156
% 210.45/210.59  |- mesh__recordAuthorizer mesh__D049409 ags
% 210.45/210.59  |- skos__hiddenLabel mesh__D049409 Firefly Luciferases
% 210.45/210.59  |- mesh__dateCreated mesh__D049409 2004-07-07
% 210.45/210.59  |- rdf__type mesh__D049409sskos__Concept
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D049409 2005
% 210.45/210.59  |- mesh__recordOriginator mesh__D049409 ssb
% 210.45/210.59  |- mesh__dateRevised mesh__D049409 2005-07-14
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D049409 2006A
% 210.45/210.59  |- skos__prefLabel mesh__D049409 Luciferases, Firefly
% 210.45/210.59  |- mesh__historyNote mesh__D049409 2005   
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D049409 2006
% 210.45/210.59  |- skos__historyNote mesh__D049409 Luciferases %28%1965-2004%29%
% 210.45/210.59  |- mesh__publicMeSHNote mesh__D049409 2005   
% 210.45/210.59  |- mesh__dateEstablished mesh__D049409 2005-01-01
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D013735 2006
% 210.45/210.59  |- rdf__type mesh__D013735sskos__Concept
% 210.45/210.59  |- mesh__dateRevised mesh__D013735 2003-07-09
% 210.45/210.59  |- skos__broader mesh__D013735smesh__D042341
% 210.45/210.59  |- mesh__dateCreated mesh__D013735 1974-11-11
% 210.45/210.59  |- skos__prefLabel mesh__D013735 Testicular Hormones
% 210.45/210.59  |- mesh__recordMaintainer mesh__D013735 lkt
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D013735 2004
% 210.45/210.59  |- skos__annotation mesh__D013735 /biosyn /physiol permitted   
% 210.45/210.59  |- mesh__publicMeSHNote mesh__D013735 75   
% 210.45/210.59  |- mesh__recordOriginator mesh__D013735 NLM
% 210.45/210.59  |- mesh__dateEstablished mesh__D013735 1975-09-01
% 210.45/210.59  |- skos__hiddenLabel mesh__D013735 Hormones, Testicular
% 210.45/210.59  |- skos__scopeNote mesh__D013735 Hormones produced in the testis.     
% 210.45/210.59  |- mesh__recordAuthorizer mesh__D013735 sjn
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D013735 2005
% 210.45/210.59  |- skos__historyNote mesh__D013735 Sex Hormones %28%1966-1974%29%
% 210.45/210.59  |- mesh__historyNote mesh__D013735 75   
% 210.45/210.59  |- mesh__dateCreated mesh__D018420 1994-06-03
% 210.45/210.59  |- skos__hiddenLabel mesh__D018420 Diseases, Pongidae
% 210.45/210.59  |- mesh__recordMaintainer mesh__D018420 jls
% 210.45/210.59  |- rdf__type mesh__D018420sskos__Concept
% 210.45/210.59  |- skos__broader mesh__D018420smesh__D018419
% 210.45/210.59  |- skos__hiddenLabel mesh__D018420 Diseases, Ape
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D018420 2005A
% 210.45/210.59  |- mesh__dateRevised mesh__D018420 2004-08-03
% 210.45/210.59  |- mesh__publicMeSHNote mesh__D018420 95   
% 210.45/210.59  |- mesh__recordAuthorizer mesh__D018420 jls
% 210.45/210.59  |- skos__altLabel mesh__D018420 Pongidae Diseases
% 210.45/210.59  |- skos__hiddenLabel mesh__D018420 Disease, Pongidae
% 210.45/210.59  |- skos__scopeNote mesh__D018420
% 210.45/210.59       Diseases of chimpanzees, gorillas, and orangutans.     
% 210.45/210.59  |- skos__hiddenLabel mesh__D018420 Disease, Ape
% 210.45/210.59  |- skos__hiddenLabel mesh__D018420 Ape Disease
% 210.45/210.59  |- mesh__historyNote mesh__D018420 95   
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D018420 2005
% 210.45/210.59  |- skos__hiddenLabel mesh__D018420 Pongidae Disease
% 210.45/210.59  |- mesh__dateEstablished mesh__D018420 1995-01-01
% 210.45/210.59  |- skos__annotation mesh__D018420
% 210.45/210.59       coordinate IM with specific ape %28%IM%29% or with HOMINIDAE %28%NIM%29% if ape is not specified + specific disease /vet; DF: APE DIS%A%  
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D018420 2006
% 210.45/210.59  |- mesh__recordOriginator mesh__D018420 PXP
% 210.45/210.59  |- skos__prefLabel mesh__D018420 Ape Diseases
% 210.45/210.59  |- mesh__dateRevised mesh__D004400 2005-06-30
% 210.45/210.59  |- mesh__historyNote mesh__D004400
% 210.45/210.59       91%28%80%29%; was see under THEOPHYLLINE 1980-90   
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D004400 2006
% 210.45/210.59  |- mesh__recordMaintainer mesh__D004400 exl
% 210.45/210.59  |- skos__scopeNote mesh__D004400
% 210.45/210.59       A THEOPHYLLINE derivative with broncho- and vasodilator properties. It is used in the treatment of asthma, cardiac dyspnea, and bronchitis.%A%    
% 210.45/210.59  |- skos__broader mesh__D004400smesh__D013806
% 210.45/210.59  |- mesh__dateEstablished mesh__D004400 1991-01-01
% 210.45/210.59  |- skos__prefLabel mesh__D004400 Dyphylline
% 210.45/210.59  |- skos__altLabel mesh__D004400 Major Brand of Dyphylline
% 210.45/210.59  |- mesh__publicMeSHNote mesh__D004400
% 210.45/210.59       91; was see under THEOPHYLLINE 1980-90   
% 210.45/210.59  |- skos__altLabel mesh__D004400 Diphylline
% 210.45/210.59  |- rdf__type mesh__D004400sskos__Concept
% 210.45/210.59  |- mesh__dateCreated mesh__D004400 1979-05-30
% 210.45/210.59  |- skos__altLabel mesh__D004400 Wallace Brand of Dyphylline
% 210.45/210.59  |- skos__altLabel mesh__D004400 Savage Brand of Dyphylline
% 210.45/210.59  |- mesh__recordAuthorizer mesh__D004400 sjn
% 210.45/210.59  |- skos__historyNote mesh__D004400
% 210.45/210.59       Theophylline %28%1966-1974%29% /analogs %26% derivatives %28%1975-1979%29%
% 210.45/210.59  |- skos__altLabel mesh__D004400 Lunsco Brand of Dyphylline
% 210.45/210.59  |- skos__altLabel mesh__D004400 Dihydroxypropyltheophylline
% 210.45/210.59  |- mesh__recordOriginator mesh__D004400 SH
% 210.45/210.59  |- skos__altLabel mesh__D004400 Hauck Brand of Dyphylline
% 210.45/210.59  |- skos__altLabel mesh__D004400 Diprophylline
% 210.45/210.59  |- skos__hiddenLabel mesh__D051056 Inactivating Agents, Complement
% 210.45/210.59  |- skos__annotation mesh__D051056
% 210.45/210.59       do not confuse with COMPLEMENT INACTIVATOR PROTEINS   
% 210.45/210.59  |- mesh__dateCreated mesh__D051056 2005-06-30
% 210.45/210.59  |- skos__scopeNote mesh__D051056
% 210.45/210.59       Compounds that negatively regulate the cascade process of COMPLEMENT ACTIVATION. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host.%A%    
% 210.45/210.59  |- skos__prefLabel mesh__D051056 Complement Inactivating Agents
% 210.45/210.59  |- mesh__historyNote mesh__D051056 2006   
% 210.45/210.59  |- skos__hiddenLabel mesh__D051056 Inhibiting Agents, Complement
% 210.45/210.59  |- skos__hiddenLabel mesh__D051056 Agents, Complement Inhibiting
% 210.45/210.59  |- skos__hiddenLabel mesh__D051056 Agents, Complement Inactivating
% 210.45/210.59  |- skos__broader mesh__D051056smesh__D007166
% 210.45/210.59  |- skos__historyNote mesh__D051056
% 210.45/210.59       Complement System Proteins %28%1975-2005%29%
% 210.45/210.59  |- skos__altLabel mesh__D051056 Complement Inhibiting Agents
% 210.45/210.59  |- mesh__recordOriginator mesh__D051056 lkt
% 210.45/210.59  |- mesh__dateEstablished mesh__D051056 2006-01-01
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D051056 2006
% 210.45/210.59  |- mesh__publicMeSHNote mesh__D051056 2006   
% 210.45/210.59  |- mesh__recordMaintainer mesh__D051056 lkt
% 210.45/210.59  |- mesh__recordAuthorizer mesh__D051056 sjn
% 210.45/210.59  |- rdf__type mesh__D051056sskos__Concept
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D009694 2004
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D009694 1995
% 210.45/210.59  |- skos__hiddenLabel mesh__D009694 Acid Precursors, Nucleic
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D009694 1998
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D009694 2001
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D009694 2003
% 210.45/210.59  |- skos__hiddenLabel mesh__D009694 Precursors, Nucleic Acid
% 210.45/210.59  |- mesh__dateRevised mesh__D009694 1992-05-19
% 210.45/210.59  |- mesh__publicMeSHNote mesh__D009694 75   
% 210.45/210.59  |- mesh__dateEstablished mesh__D009694 1975-09-01
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D009694 1994
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D009694 2000
% 210.45/210.59  |- skos__annotation mesh__D009694
% 210.45/210.59       IM; coord with DNA or RNA or specific %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D009694 2006
% 210.45/210.59  |- mesh__recordMaintainer mesh__D009694 TGC
% 210.45/210.59  |- skos__broader mesh__D009694smesh__D009706
% 210.45/210.59  |- mesh__recordOriginator mesh__D009694 NLM
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D009694 1997
% 210.45/210.59  |- skos__historyNote mesh__D009694 Nucleic Acids %28%1968-1974%29%
% 210.45/210.59  |- mesh__dateCreated mesh__D009694 1974-11-11
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D009694 2005
% 210.45/210.59  |- mesh__historyNote mesh__D009694 75   
% 210.45/210.59  |- mesh__recordAuthorizer mesh__D009694 PLS
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D009694 1993
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D009694 1996
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D009694 2002
% 210.45/210.59  |- rdf__type mesh__D009694sskos__Concept
% 210.45/210.59  |- skos__prefLabel mesh__D009694 Nucleic Acid Precursors
% 210.45/210.59  |- skos__scopeNote mesh__D009694
% 210.45/210.59       Use for nucleic acid precursors in general or for which there is no specific heading.%A%    
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D009694 1999
% 210.45/210.59  |- skos__hiddenLabel mesh__D017328
% 210.45/210.59       Bristol Myers Squibb Brand of Fosinopril Sodium
% 210.45/210.59  |- mesh__recordAuthorizer mesh__D017328 sjn
% 210.45/210.59  |- skos__broader mesh__D017328smesh__D011392
% 210.45/210.59  |- skos__altLabel mesh__D017328
% 210.45/210.59       Merck Lipha Sant%C3%%A9% Brand of Fosinopril
% 210.45/210.59  |- mesh__publicMeSHNote mesh__D017328
% 210.45/210.59       93; FOSENOPRIL was indexed under PROLINE/analogs %26% derivatives 1985-92%A%  
% 210.45/210.59  |- skos__altLabel mesh__D017328 Fosenopril
% 210.45/210.59  |- skos__altLabel mesh__D017328 Esteve Brand of Fosinopril Sodium
% 210.45/210.59  |- mesh__dateEstablished mesh__D017328 1993-01-01
% 210.45/210.59  |- skos__altLabel mesh__D017328 Tensocardil
% 210.45/210.59  |- skos__hiddenLabel mesh__D017328 Sodium, Fosinopril
% 210.45/210.59  |- mesh__recordOriginator mesh__D017328 TPW
% 210.45/210.59  |- skos__hiddenLabel mesh__D017328 SQ28555
% 210.45/210.59  |- skos__altLabel mesh__D017328 Newace
% 210.45/210.59  |- mesh__onlineNote mesh__D017328
% 210.45/210.59       use FOSINOPRIL %28%NM%29% to search FOSENOPRIL 1985-92   
% 210.45/210.59  |- skos__hiddenLabel mesh__D017328 SQ 28,555
% 210.45/210.59  |- skos__altLabel mesh__D017328
% 210.45/210.59       Fosinopril, %28%1%28%S*%28%R*%29%%29%,2 alpha,4 beta%29%-Isomer
% 210.45/210.59  |- skos__altLabel mesh__D017328 Squibb Brand of Fosinopril Sodium
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D017328 2006
% 210.45/210.59  |- skos__prefLabel mesh__D017328 Fosinopril
% 210.45/210.59  |- skos__hiddenLabel mesh__D017328 SQ 28555
% 210.45/210.59  |- skos__altLabel mesh__D017328 Fositens
% 210.45/210.59  |- skos__altLabel mesh__D017328 Staril
% 210.45/210.59  |- mesh__recordMaintainer mesh__D017328 CCR
% 210.45/210.59  |- skos__broader mesh__D017328smesh__D009943
% 210.45/210.59  |- skos__altLabel mesh__D017328 SQ-28555
% 210.45/210.59  |- mesh__dateRevised mesh__D017328 2005-06-30
% 210.45/210.59  |- mesh__dateCreated mesh__D017328 1992-05-20
% 210.45/210.59  |- skos__historyNote mesh__D017328
% 210.45/210.59       Proline/analogs %26% derivatives %28%1985-1992%29%
% 210.45/210.59  |- skos__scopeNote mesh__D017328
% 210.45/210.59       A phosphinic acid-containing angiotensin-converting enzyme inhibitor that is effective in the treatment of hypertension. It is a prodrug that is converted to its active metabolite fosinoprilat.%A%    
% 210.45/210.59  |- skos__altLabel mesh__D017328 Fosinorm
% 210.45/210.59  |- rdf__type mesh__D017328sskos__Concept
% 210.45/210.59  |- skos__altLabel mesh__D017328
% 210.45/210.59       Bristol-Myers Squibb Brand of Fosinopril Sodium
% 210.45/210.59  |- skos__hiddenLabel mesh__D017328 SQ28,555
% 210.45/210.59  |- mesh__historyNote mesh__D017328 93; was FOSENOPRIL %28%NM%29% 1985-92   
% 210.45/210.59  |- skos__altLabel mesh__D017328 Ferrer Brand of Fosinopril Sodium
% 210.45/210.59  |- skos__altLabel mesh__D017328 Schwarz Brand of Fosinopril Sodium
% 210.45/210.59  |- skos__altLabel mesh__D017328 Sanol Brand of Fosinopril Sodium
% 210.45/210.59  |- skos__hiddenLabel mesh__D003308 Processes, Duplicating
% 210.45/210.59  |- skos__broader mesh__D003308smesh__D007254
% 210.45/210.59  |- rdf__type mesh__D003308sskos__Concept
% 210.45/210.59  |- skos__hiddenLabel mesh__D003308 Processes, Copying
% 210.45/210.59  |- mesh__recordMaintainer mesh__D003308 PXP
% 210.45/210.59  |- skos__altLabel mesh__D003308 Copying Process
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D003308 2000
% 210.45/210.59  |- mesh__dateCreated mesh__D003308 1999-01-01
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D003308 2003
% 210.45/210.59  |- mesh__recordAuthorizer mesh__D003308 SJN
% 210.45/210.59  |- skos__hiddenLabel mesh__D003308 Process, Copying
% 210.45/210.59  |- skos__scopeNote mesh__D003308
% 210.45/210.59       Reproduction of data in a new location or other destination, leaving the source data unchanged, although the physical form of the result may differ from that of the source.%A%    
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D003308 2001
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D003308 2004
% 210.45/210.59  |- mesh__recordOriginator mesh__D003308 NLM
% 210.45/210.59  |- skos__altLabel mesh__D003308 Duplicating Process
% 210.45/210.59  |- mesh__dateRevised mesh__D003308 1997-06-20
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D003308 2002
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D003308 2005
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D003308 1998
% 210.45/210.59  |- skos__altLabel mesh__D003308 Duplicating Processes
% 210.45/210.59  |- skos__prefLabel mesh__D003308 Copying Processes
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D003308 2006
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D003308 1999
% 210.45/210.59  |- skos__hiddenLabel mesh__D003308 Process, Duplicating
% 210.45/210.59  |- skos__broader mesh__D014030smesh__D014026
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D014030 2006
% 210.45/210.59  |- mesh__dateRevised mesh__D014030 2001-07-25
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D014030 2002
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D014030 2004
% 210.45/210.59  |- skos__altLabel mesh__D014030 Chewing Tobacco
% 210.45/210.59  |- mesh__recordOriginator mesh__D014030 NLM
% 210.45/210.59  |- mesh__recordMaintainer mesh__D014030 ssb
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D014030 2005
% 210.45/210.59  |- skos__scopeNote mesh__D014030
% 210.45/210.59       The powdered leaves of Nicotiana tabacum which are either inhaled through the nose, chewed, or stored in cheek pouches. It includes any product of tobacco that is not smoked.%A%    
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D014030 2003
% 210.45/210.59  |- skos__prefLabel mesh__D014030 Tobacco, Smokeless
% 210.45/210.59  |- mesh__dateEstablished mesh__D014030 1991-01-01
% 210.45/210.59  |- mesh__historyNote mesh__D014030
% 210.45/210.59       91%28%86%29%; was see under TOBACCO 1986-90; was SNUFF see under TOBACCO 1963-85%A%  
% 210.45/210.59  |- skos__altLabel mesh__D014030 Smokeless Tobacco
% 210.45/210.59  |- rdf__type mesh__D014030sskos__Concept
% 210.45/210.59  |- mesh__dateCreated mesh__D014030 1999-01-01
% 210.45/210.59  |- skos__annotation mesh__D014030 D25-26 qualif   
% 210.45/210.59  |- mesh__recordAuthorizer mesh__D014030 sjn
% 210.45/210.59  |- mesh__publicMeSHNote mesh__D014030
% 210.45/210.59       91; was see under TOBACCO 1986-90; was SNUFF see under TOBACCO 1963-85%A%  
% 210.45/210.59  |- mesh__onlineNote mesh__D014030
% 210.45/210.59       to search SNUFF use TOBACCO, SMOKELESS 1975-85 %26% TOBACCO 1966-74%A%  
% 210.45/210.59  |- skos__annotation mesh__D000010
% 210.45/210.59       neopl = ABDUCENS NERVE DISEASES %28%IM%29% + CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 210.45/210.59  |- skos__hiddenLabel mesh__D000010 Nerve, Abducens
% 210.45/210.59  |- skos__altLabel mesh__D000010 Sixth Cranial Nerve
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D000010 2000
% 210.45/210.59  |- mesh__onlineNote mesh__D000010
% 210.45/210.59       use ABDUCENS NERVE to search ABDUCENT NERVE 1966-76   
% 210.45/210.59  |- skos__hiddenLabel mesh__D000010 Sixth Cranial Nerves
% 210.45/210.59  |- skos__hiddenLabel mesh__D000010 Nerve VI, Cranial
% 210.45/210.59  |- skos__hiddenLabel mesh__D000010 Cranial Nerves, Sixth
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D000010 2003
% 210.45/210.59  |- skos__hiddenLabel mesh__D000010 VI, Cranial Nerve
% 210.45/210.59  |- skos__hiddenLabel mesh__D000010 Nerve, Abducent
% 210.45/210.59  |- mesh__dateCreated mesh__D000010 1999-01-01
% 210.45/210.59  |- skos__hiddenLabel mesh__D000010 Abducens Nerves
% 210.45/210.59  |- skos__prefLabel mesh__D000010 Abducens Nerve
% 210.45/210.59  |- mesh__publicMeSHNote mesh__D000010 77; was ABDUCENT NERVE 1963-76   
% 210.45/210.59  |- skos__hiddenLabel mesh__D000010 Cranial Nerve, Sixth
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D000010 2006
% 210.45/210.59  |- skos__hiddenLabel mesh__D000010 Nerves, Sixth Cranial
% 210.45/210.59  |- mesh__historyNote mesh__D000010 77; was ABDUCENT NERVE 1963-76   
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D000010 2002
% 210.45/210.59  |- skos__hiddenLabel mesh__D000010 Nerve, Sixth Cranial
% 210.45/210.59  |- skos__hiddenLabel mesh__D000010 Cranial Nerve VIs
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D000010 2005
% 210.45/210.59  |- skos__hiddenLabel mesh__D000010 Nerves, Abducens
% 210.45/210.59  |- mesh__dateRevised mesh__D000010 1999-11-03
% 210.45/210.59  |- mesh__recordAuthorizer mesh__D000010 sjn
% 210.45/210.59  |- rdf__type mesh__D000010sskos__Concept
% 210.45/210.59  |- skos__hiddenLabel mesh__D000010 Nerves, Abducent
% 210.45/210.59  |- skos__broader mesh__D000010smesh__D003391
% 210.45/210.59  |- mesh__recordOriginator mesh__D000010 NLM
% 210.45/210.59  |- skos__hiddenLabel mesh__D000010 Nerve VIs, Cranial
% 210.45/210.59  |- skos__altLabel mesh__D000010 Abducent Nerve
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D000010 2001
% 210.45/210.59  |- skos__altLabel mesh__D000010 Cranial Nerve VI
% 210.45/210.59  |- skos__hiddenLabel mesh__D000010 VIs, Cranial Nerve
% 210.45/210.59  |- mesh__recordMaintainer mesh__D000010 KEV
% 210.45/210.59  |- skos__scopeNote mesh__D000010
% 210.45/210.59       The 6th cranial nerve. The abducens nerve originates in the abducens nucleus of the pons and sends motor fibers to the lateral rectus muscles of the eye. Damage to the nerve or its nucleus disrupts horizontal eye movement control.%A%    
% 210.45/210.59  |- skos__hiddenLabel mesh__D000010 Abducent Nerves
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D000010 2004
% 210.45/210.59  |- mesh__dateEstablished mesh__D046910 2005-01-01
% 210.45/210.59  |- skos__scopeNote mesh__D046910
% 210.45/210.59       The period in the MENSTRUAL CYCLE that is optimal for FERTILIZATION of the OVUM and yielding PREGNANCY. The duration of fertile period depends on the life span of male GAMETES within the female reproductive tract and the time of OVULATION. It usually begins a few days before ovulation and ends on the day of ovulation.%A%    
% 210.45/210.59  |- skos__historyNote mesh__D046910 Menstruation %28%1980-2004%29%
% 210.45/210.59  |- mesh__dateCreated mesh__D046910 2004-07-07
% 210.45/210.59  |- skos__prefLabel mesh__D046910 Fertile Period
% 210.45/210.59  |- mesh__historyNote mesh__D046910 2005; use MENSTRUATION 1980-2004   
% 210.45/210.59  |- mesh__recordOriginator mesh__D046910 lkt
% 210.45/210.59  |- skos__historyNote mesh__D046910 Fertility %28%1971-2004%29%
% 210.45/210.59  |- mesh__recordAuthorizer mesh__D046910 sjn
% 210.45/210.59  |- mesh__publicMeSHNote mesh__D046910 2005; see MENSTRUATION 1980-2004   
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D046910 2005
% 210.45/210.59  |- rdf__type mesh__D046910sskos__Concept
% 210.45/210.59  |- skos__related mesh__D046910smesh__D012252
% 210.45/210.59  |- mesh__recordMaintainer mesh__D046910 lkt
% 210.45/210.59  |- skos__broader mesh__D046910smesh__D008597
% 210.45/210.59  |- mesh__activeMeSHYear mesh__D046910 2006
% 210.45/210.59  |- skos__broader mesh__D013736smesh__D005834
% 210.45/210.59  |- mesh__onlineNote mesh__D013736
% 210.45/210.59       use TESTICULAR NEOPLASMS to search RETE CELL TUMOR 1966-83%A%  
% 210.45/210.59  |- skos__hiddenLabel mesh__D013736 Cancers, Testis
% 210.45/210.59  |- skos__altLabel mesh__D013736 Testis Cancer
% 210.45/210.59  |- mesh__historyNote mesh__D013736 RETE CELL TUMOR was heading 1963-83   
% 210.45/210.59  |- skos__hiddenLabel mesh__D013736 Tumors, Rete Cell
% 210.45/210.59  |- skos__altLabel mesh__D013736 Cancer of the Testis
% 210.45/210.59  |- skos__hiddenLabel mesh__D013736 Rete Cell Tumors
% 210.45/210.59  |- skos__hiddenLabel mesh__D013736 Tumor, Rete Cell
% 210.45/210.59  |- skos__prefLabel mesh__D013736 Testicular Neoplasms
% 210.45/210.59  |- skos__related mesh__D013736smesh__D018237
% 210.45/210.59  |- skos__hiddenLabel mesh__D013736 Testis Cancers
% 210.45/210.59  |- skos__hiddenLabel mesh__D013736 Cancer, Testicular
% 210.45/210.59  |- mesh__dateRevised mesh__D013736 2005-06-30
% 210.45/210.59  |- skos__altLabel mesh__D013736 Testis Neoplasms
% 210.45/210.59  |- skos__hiddenLabel mesh__D013736 Testicular Neoplasm
% 210.45/210.59  |- skos__hiddenLabel mesh__D013736 Testicular Cancers
% 210.45/210.59  |- mesh__recordMaintainer mesh__D013736 lkt
% 210.45/210.59  |- skos__broader mesh__D013736smesh__D013733
% 210.45/210.59  |- skos__hiddenLabel mesh__D013736 Neoplasm, Testicular
% 210.45/210.59  |- skos__hiddenLabel mesh__D013736 Cancers, Testicular
% 210.45/210.59  |- skos__altLabel mesh__D013736 Neoplasms, Testis
% 210.45/210.59  |- skos__scopeNote mesh__D013736
% 210.45/210.59       Tumors or cancer of the TESTIS. Germ cell tumors %28%GERMINOMA%29% of the testis constitute 95%25% of all testicular neoplasms.%A%    
% 210.45/210.59  |- skos__hiddenLabel mesh__D013736 Testis Neoplasm
% 210.45/210.60  |- mesh__recordOriginator mesh__D013736 NLM
% 210.45/210.60  |- mesh__dateCreated mesh__D013736 1999-01-01
% 210.45/210.60  |- skos__hiddenLabel mesh__D013736 Neoplasm, Testis
% 210.45/210.60  |- skos__altLabel mesh__D013736 Neoplasms, Testicular
% 210.45/210.60  |- skos__annotation mesh__D013736
% 210.45/210.60       coord IM with histol type of neopl %28%IM%29%   
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D013736 2006
% 210.45/210.60  |- mesh__publicMeSHNote mesh__D013736
% 210.45/210.60       RETE CELL TUMOR was heading 1963-83   
% 210.45/210.60  |- rdf__type mesh__D013736sskos__Concept
% 210.45/210.60  |- skos__hiddenLabel mesh__D013736 Cancer, Testis
% 210.45/210.60  |- skos__altLabel mesh__D013736 Testicular Cancer
% 210.45/210.60  |- skos__broader mesh__D013736smesh__D004701
% 210.45/210.60  |- mesh__recordAuthorizer mesh__D013736 sjn
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D018421 2006
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D018421 2001
% 210.45/210.60  |- skos__broader mesh__D018421smesh__D006348
% 210.45/210.60  |- skos__related mesh__D018421smesh__D019739
% 210.45/210.60  |- mesh__recordOriginator mesh__D018421 PXP
% 210.45/210.60  |- skos__scopeNote mesh__D018421
% 210.45/210.60       An operation that uses stimulated latissimus dorsi muscle %28%SKELETAL MUSCLE VENTRICLE%29% to assist cardiac function. The latissimus dorsi muscle is mobilized from the chest wall and moved into the thorax through the bed of the resected 2nd or 3rd rib. The muscle is then wrapped around the left and right ventricles and stimulated to contract during cardiac systole by means of an implanted burst-stimulator. %28%Stedman, 26th ed%29%%A%    
% 210.45/210.60  |- skos__altLabel mesh__D018421 Dynamic Cardiomyoplasty
% 210.45/210.60  |- skos__prefLabel mesh__D018421 Cardiomyoplasty
% 210.45/210.60  |- skos__altLabel mesh__D018421 Cardiomyoplasty, Dynamic
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D018421 2005
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D018421 2004
% 210.45/210.60  |- mesh__recordMaintainer mesh__D018421 PXP
% 210.45/210.60  |- mesh__dateRevised mesh__D018421 1997-06-20
% 210.45/210.60  |- skos__annotation mesh__D018421
% 210.45/210.60       a technique in heart surg using autol skeletal muscle   
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D018421 2000
% 210.45/210.60  |- rdf__type mesh__D018421sskos__Concept
% 210.45/210.60  |- mesh__recordAuthorizer mesh__D018421 SJN
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D018421 2003
% 210.45/210.60  |- mesh__dateEstablished mesh__D018421 1995-01-01
% 210.45/210.60  |- mesh__publicMeSHNote mesh__D018421 95   
% 210.45/210.60  |- skos__hiddenLabel mesh__D018421 Dynamic Cardiomyoplasties
% 210.45/210.60  |- skos__hiddenLabel mesh__D018421 Cardiomyoplasties, Dynamic
% 210.45/210.60  |- skos__historyNote mesh__D018421 Heart Surgery %28%1987-1994%29%
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D018421 2002
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D018421 1999
% 210.45/210.60  |- mesh__dateCreated mesh__D018421 1994-06-03
% 210.45/210.60  |- skos__hiddenLabel mesh__D018421 Cardiomyoplasties
% 210.45/210.60  |- mesh__historyNote mesh__D018421 95   
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D018421 1998
% 210.45/210.60  |- skos__hiddenLabel mesh__D004401 Spastic Dysarthrias
% 210.45/210.60  |- skos__hiddenLabel mesh__D004401 Mixed Dysarthrias
% 210.45/210.60  |- skos__hiddenLabel mesh__D004401 Dysarthrias
% 210.45/210.60  |- mesh__publicMeSHNote mesh__D004401
% 210.45/210.60       91; was see under SPEECH DISORDERS 1963-90   
% 210.45/210.60  |- mesh__recordOriginator mesh__D004401 RC
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D004401 2001
% 210.45/210.60  |- skos__historyNote mesh__D004401 Speech Disorders %28%1966-1978%29%
% 210.45/210.60  |- skos__hiddenLabel mesh__D004401 Flaccid Dysarthrias
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D004401 2006A
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D004401 2006
% 210.45/210.60  |- skos__hiddenLabel mesh__D004401 Guttural Dysarthria
% 210.45/210.60  |- skos__scopeNote mesh__D004401
% 210.45/210.60       Disorders of speech articulation caused by imperfect coordination of pharynx, larynx, tongue, or face muscles. This may result from CRANIAL NERVE DISEASES; NEUROMUSCULAR DISEASES; CEREBELLAR DISEASES; BASAL GANGLIA DISEASES; BRAIN STEM diseases; or diseases of the corticobulbar tracts %28%see PYRAMIDAL TRACTS%29%. The cortical language centers are intact in this condition. %28%From Adams et al., Principles of Neurology, 6th ed, p489%29%%A%    
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D004401 2000
% 210.45/210.60  |- skos__hiddenLabel mesh__D004401 Dysarthrias, Guttural
% 210.45/210.60  |- mesh__recordAuthorizer mesh__D004401 jls
% 210.45/210.60  |- skos__hiddenLabel mesh__D004401 Mixed Dysarthria
% 210.45/210.60  |- skos__prefLabel mesh__D004401 Dysarthria
% 210.45/210.60  |- mesh__historyNote mesh__D004401
% 210.45/210.60       91%28%75%29%; was see under SPEECH DISORDERS 1963-90   
% 210.45/210.60  |- mesh__dateEstablished mesh__D004401 1991-01-01
% 210.45/210.60  |- mesh__dateRevised mesh__D004401 2005-07-30
% 210.45/210.60  |- skos__altLabel mesh__D004401 Dysarthosis
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D004401 2005
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D004401 2004
% 210.45/210.60  |- skos__hiddenLabel mesh__D004401 Dysarthrias, Flaccid
% 210.45/210.60  |- skos__hiddenLabel mesh__D004401 Scanning Dysarthria
% 210.45/210.60  |- skos__hiddenLabel mesh__D004401 Spastic Dysarthria
% 210.45/210.60  |- rdf__type mesh__D004401sskos__Concept
% 210.45/210.60  |- skos__hiddenLabel mesh__D004401 Dysarthrias, Mixed
% 210.45/210.60  |- mesh__dateCreated mesh__D004401 1978-05-17
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D004401 2002
% 210.45/210.60  |- mesh__recordMaintainer mesh__D004401 jls
% 210.45/210.60  |- skos__hiddenLabel mesh__D004401 Scanning Dysarthrias
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D004401 2003
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D004401 2003A
% 210.45/210.60  |- skos__hiddenLabel mesh__D004401 Dysarthrias, Scanning
% 210.45/210.60  |- mesh__onlineNote mesh__D004401
% 210.45/210.60       use SPEECH DISORDERS to search DYSARTHRIA 1966-74   
% 210.45/210.60  |- skos__hiddenLabel mesh__D004401 Dysarthoses
% 210.45/210.60  |- skos__broader mesh__D004401smesh__D001184
% 210.45/210.60  |- skos__hiddenLabel mesh__D004401 Guttural Dysarthrias
% 210.45/210.60  |- skos__hiddenLabel mesh__D004401 Flaccid Dysarthria
% 210.45/210.60  |- skos__hiddenLabel mesh__D004401 Dysarthrias, Spastic
% 210.45/210.60  |- skos__altLabel mesh__D051057 RAC-PK Protein
% 210.45/210.60  |- skos__broader mesh__D051057smesh__D017346
% 210.45/210.60  |- skos__altLabel mesh__D051057 Proto-Oncogene Protein Akt
% 210.45/210.60  |- skos__scopeNote mesh__D051057
% 210.45/210.60       A protein-serine-threonine kinase that is activated by PHOSPHORYLATION in response to GROWTH FACTORS or INSULIN. It plays a major role in cell metabolism, growth, and survival as a core component of SIGNAL TRANSDUCTION. Three isoforms have been described in mammalian cells.%A%    
% 210.45/210.60  |- mesh__dateCreated mesh__D051057 2005-06-30
% 210.45/210.60  |- skos__altLabel mesh__D051057 Protein Kinase B alpha
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 Proteins c-akt1, Proto-Oncogene
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D051057 2006
% 210.45/210.60  |- mesh__recordAuthorizer mesh__D051057 sjn
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 Related to A and C Protein
% 210.45/210.60  |- skos__altLabel mesh__D051057 Akt-beta Protein
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 Rac PK alpha Protein
% 210.45/210.60  |- skos__broader mesh__D051057smesh__D047908
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 c-akt, Proto-Oncogene Proteins
% 210.45/210.60  |- skos__altLabel mesh__D051057 Akt-gamma Protein
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 Proto Oncogene Proteins c akt3
% 210.45/210.60  |- skos__altLabel mesh__D051057 Rac Protein Kinase
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 RAC PK Protein
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 Proto Oncogene Proteins c akt2
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 Protein, akt Proto-Oncogene
% 210.45/210.60  |- mesh__recordOriginator mesh__D051057 DRC
% 210.45/210.60  |- rdf__type mesh__D051057sskos__Concept
% 210.45/210.60  |- skos__altLabel mesh__D051057 Protein Kinase B gamma
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 Akt, Proto-Oncogene Protein
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 Protein, c-akt Proto-Oncogene
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 Proteins c-akt2, Proto-Oncogene
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 Proteins c-akt3, Proto-Oncogene
% 210.45/210.60  |- mesh__historyNote mesh__D051057 2006%28%1987%29%   
% 210.45/210.60  |- skos__prefLabel mesh__D051057 Proto-Oncogene Proteins c-akt
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 Akt beta Protein
% 210.45/210.60  |- skos__altLabel mesh__D051057 AKT3 Protein Kinase
% 210.45/210.60  |- skos__altLabel mesh__D051057 Rac-PK beta Protein
% 210.45/210.60  |- skos__altLabel mesh__D051057 Rac-PK alpha Protein
% 210.45/210.60  |- skos__altLabel mesh__D051057 Protein Kinase B
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 akt Proto Oncogene Protein
% 210.45/210.60  |- skos__broader mesh__D051057smesh__D011518
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 Proto Oncogene Proteins c akt1
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 Proto Oncogene Protein RAC
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 Proto Oncogene Protein Akt
% 210.45/210.60  |- skos__altLabel mesh__D051057 Proto-Oncogene Protein RAC
% 210.45/210.60  |- skos__altLabel mesh__D051057 Protein-Serine-Threonine Kinase %28%Rac%29%
% 210.45/210.60  |- skos__altLabel mesh__D051057 AKT1 Protein Kinase
% 210.45/210.60  |- skos__altLabel mesh__D051057 akt Proto-Oncogene Protein
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 alpha Protein, Rac-PK
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 Proto-Oncogene Protein, akt
% 210.45/210.60  |- mesh__publicMeSHNote mesh__D051057
% 210.45/210.60       2006; PROTO-ONCOGENE PROTEINS C-AKT was indexed under PROTEIN-SERINE-THREONINE KINASES %26% PROTO-ONCOGENE PROTEINS 1987-2005%A%  
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 Proto Oncogene Proteins c akt
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 c akt Proto Oncogene Protein
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 c-akt3, Proto-Oncogene Proteins
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 RAC, Proto-Oncogene Protein
% 210.45/210.60  |- skos__altLabel mesh__D051057 Protein Kinase B beta
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 c-akt2, Proto-Oncogene Proteins
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 Proto-Oncogene Protein, c-akt
% 210.45/210.60  |- skos__altLabel mesh__D051057 c-akt Protein
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 Akt gamma Protein
% 210.45/210.60  |- skos__altLabel mesh__D051057 Related to A and C-Protein
% 210.45/210.60  |- mesh__dateEstablished mesh__D051057 2006-01-01
% 210.45/210.60  |- skos__altLabel mesh__D051057 Akt-alpha Protein
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 Akt alpha Protein
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 c-akt1, Proto-Oncogene Proteins
% 210.45/210.60  |- mesh__recordMaintainer mesh__D051057 DRC
% 210.45/210.60  |- skos__altLabel mesh__D051057 AKT2 Protein Kinase
% 210.45/210.60  |- skos__altLabel mesh__D051057 c-akt Proto-Oncogene Protein
% 210.45/210.60  |- skos__hiddenLabel mesh__D051057 Rac PK beta Protein
% 210.45/210.60  |- mesh__publicMeSHNote mesh__D009695
% 210.45/210.60       78; was see under NUCLEIC ACIDS 1975-77   
% 210.45/210.60  |- skos__hiddenLabel mesh__D009695 Renaturations, Nucleic Acid
% 210.45/210.60  |- skos__hiddenLabel mesh__D009695 Acid Renaturation, Nucleic
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D009695 2003
% 210.45/210.60  |- skos__hiddenLabel mesh__D009695 Nucleic Acid Renaturations
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D009695 1994
% 210.45/210.60  |- mesh__dateCreated mesh__D009695 1999-01-01
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D009695 2006
% 210.45/210.60  |- mesh__recordMaintainer mesh__D009695 TGC
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D009695 1997
% 210.45/210.60  |- skos__broader mesh__D009695smesh__D001669
% 210.45/210.60  |- skos__historyNote mesh__D009695 Nucleic Acids %28%1966-1970%29%
% 210.45/210.60  |- mesh__dateRevised mesh__D009695 1992-05-15
% 210.45/210.60  |- skos__hiddenLabel mesh__D009695 Renaturation, Nucleic Acid
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D009695 2001
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D009695 2005
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D009695 1993
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D009695 2000
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D009695 1996
% 210.45/210.60  |- mesh__dateEstablished mesh__D009695 1978-01-01
% 210.45/210.60  |- rdf__type mesh__D009695sskos__Concept
% 210.45/210.60  |- mesh__recordOriginator mesh__D009695 NLM
% 210.45/210.60  |- skos__historyNote mesh__D009695 RNA %28%1966-1970%29%
% 210.45/210.60  |- skos__historyNote mesh__D009695 DNA %28%1966-1970%29%
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D009695 1999
% 210.45/210.60  |- skos__hiddenLabel mesh__D009695 Acid Renaturations, Nucleic
% 210.45/210.60  |- skos__scopeNote mesh__D009695
% 210.45/210.60       The reformation of all, or part of, the native conformation of a nucleic acid molecule after the molecule has undergone denaturation.%A%    
% 210.45/210.60  |- skos__prefLabel mesh__D009695 Nucleic Acid Renaturation
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D009695 2004
% 210.45/210.60  |- mesh__recordAuthorizer mesh__D009695 PLS
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D009695 1995
% 210.45/210.60  |- skos__annotation mesh__D009695
% 210.45/210.60       IM general only; coord NIM with DNA or RNA or specific %28%IM%29%%A%  
% 210.45/210.60  |- mesh__historyNote mesh__D009695
% 210.45/210.60       78%28%71%29%; was see under NUCLEIC ACIDS 1975-77   
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D009695 2002
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D009695 1998
% 210.45/210.60  |- skos__altLabel mesh__D017329 LHRH, Tryptophyl%28%6%29%-
% 210.45/210.60  |- skos__hiddenLabel mesh__D017329 CL118532
% 210.45/210.60  |- mesh__publicMeSHNote mesh__D017329
% 210.45/210.60       1993; TRIPTORELIN was indexed under GONADORELIN/analogs %26% derivatives 1978-1992%A%  
% 210.45/210.60  |- skos__altLabel mesh__D017329 LHRH, Trp%28%6%29%-
% 210.45/210.60  |- skos__historyNote mesh__D017329
% 210.45/210.60       Gonadorelin/analogs %26% derivatives %28%1978-1992%29%
% 210.45/210.60  |- mesh__dateEstablished mesh__D017329 1993-01-01
% 210.45/210.60  |- skos__hiddenLabel mesh__D017329 AY 25650
% 210.45/210.60  |- mesh__recordOriginator mesh__D017329 TPW
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D017329 2004
% 210.45/210.60  |- skos__altLabel mesh__D017329 GnRH, Trp%28%6%29%-
% 210.45/210.60  |- mesh__dateCreated mesh__D017329 1992-05-22
% 210.45/210.60  |- skos__broader mesh__D017329smesh__D007987
% 210.45/210.60  |- skos__hiddenLabel mesh__D017329 AY25650
% 210.45/210.60  |- skos__altLabel mesh__D017329
% 210.45/210.60       6-D-Tryptophan-Luteinizing Hormone-Releasing Factor %28%Pig%29%
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D017329 2003
% 210.45/210.60  |- skos__prefLabel mesh__D017329 Triptorelin
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D017329 2006
% 210.45/210.60  |- rdf__type mesh__D017329sskos__Concept
% 210.45/210.60  |- skos__hiddenLabel mesh__D017329 CL 118532
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D017329 2002
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D017329 2005
% 210.45/210.60  |- mesh__recordAuthorizer mesh__D017329 sjn
% 210.45/210.60  |- skos__scopeNote mesh__D017329
% 210.45/210.60       A long-acting GONADORELIN analog agonist. It has been used in the treatment of prostatic cancer, ovarian cancer, precocious puberty, endometriosis, and to induce ovulation for in vitro fertilization.%A%    
% 210.45/210.60  |- mesh__historyNote mesh__D017329
% 210.45/210.60       1993; use TRIPTORELIN %28%NM%29% 1980-1992; for LHRH, TRP%28%6%29%- use TRIPTORELIN %28%NM%29% 1995-1999%A%  
% 210.45/210.60  |- skos__altLabel mesh__D017329 D-Trp-6-LH-RH
% 210.45/210.60  |- mesh__dateRevised mesh__D017329 2001-07-25
% 210.45/210.60  |- mesh__recordMaintainer mesh__D017329 ssb
% 210.45/210.60  |- mesh__dateCreated mesh__D003309 1999-01-01
% 210.45/210.60  |- mesh__dateRevised mesh__D003309 1999-11-03
% 210.45/210.60  |- skos__hiddenLabel mesh__D003309 Copyrights
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D003309 2003
% 210.45/210.60  |- skos__broader mesh__D003309smesh__D018973
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D003309 2004
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D003309 2000
% 210.45/210.60  |- skos__broader mesh__D003309smesh__D011643
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D003309 2005
% 210.45/210.60  |- skos__annotation mesh__D003309 specify geog   
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D003309 2001
% 210.45/210.60  |- mesh__recordOriginator mesh__D003309 NLM
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D003309 2006
% 210.45/210.60  |- skos__prefLabel mesh__D003309 Copyright
% 210.45/210.60  |- mesh__recordAuthorizer mesh__D003309 sjn
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D003309 2002
% 210.45/210.60  |- rdf__type mesh__D003309sskos__Concept
% 210.45/210.60  |- mesh__recordMaintainer mesh__D003309 kle
% 210.45/210.60  |- skos__scopeNote mesh__D003309
% 210.45/210.60       The exclusive right, granted by law for a certain number of years, to make and dispose of copies of a literary, musical or artistic work. In the United States the copyright is granted for the life of the author plus 50 years. In the case of a joint work, it is for the life of the last joint author to die, plus 50 years. In either case the copyright runs until the end of the calendar year 50 years after the author%27%s death. %28%Random House College Dictionary, rev ed; Strong, W.S.: The Copyright Book: a Practical Guide, 1981%29%%A%    
% 210.45/210.60  |- skos__historyNote mesh__D014031 Glycosides %28%1966-1973%29%
% 210.45/210.60  |- skos__historyNote mesh__D014031 Aminoglycosides %28%1974%29%
% 210.45/210.60  |- skos__hiddenLabel mesh__D014031 Sulfate, Tobramycin
% 210.45/210.60  |- mesh__dateCreated mesh__D014031 1974-11-11
% 210.45/210.60  |- mesh__historyNote mesh__D014031
% 210.45/210.60       84%28%75%29%; was see under ANTIBIOTICS 1975-83   
% 210.45/210.60  |- rdf__type mesh__D014031sskos__Concept
% 210.45/210.60  |- mesh__recordAuthorizer mesh__D014031 sjn
% 210.45/210.60  |- mesh__dateEstablished mesh__D014031 1984-01-01
% 210.45/210.60  |- skos__historyNote mesh__D014031 Antibiotics %28%1966-1974%29%
% 210.45/210.60  |- skos__altLabel mesh__D014031 Nebramycin Factor 6
% 210.45/210.60  |- mesh__dateRevised mesh__D014031 2004-07-07
% 210.45/210.60  |- skos__prefLabel mesh__D014031 Tobramycin
% 210.45/210.60  |- mesh__recordOriginator mesh__D014031 NLM
% 210.45/210.60  |- skos__scopeNote mesh__D014031
% 210.45/210.60       An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the PSEUDOMONAS species. It is a 10%25% component of the antibiotic complex, NEBRAMYCIN, produced by the same species.%A%    
% 210.45/210.60  |- mesh__recordMaintainer mesh__D014031 ssb
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D014031 2006
% 210.45/210.60  |- skos__broader mesh__D014031smesh__D009328
% 210.45/210.60  |- skos__altLabel mesh__D014031 Nebicin
% 210.45/210.60  |- mesh__publicMeSHNote mesh__D014031
% 210.45/210.60       84; was see under ANTIBIOTICS 1975-83   
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D014031 2005
% 210.45/210.60  |- skos__annotation mesh__D000011
% 210.45/210.60       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% + LEUKEMIA, EXPERIMENTAL %28%IM%29%%A%  
% 210.45/210.60  |- skos__hiddenLabel mesh__D000011 Virus, Abelson Leukemia
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D000011 2006
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D000011 2006B
% 210.45/210.60  |- mesh__publicMeSHNote mesh__D000011
% 210.45/210.60       2002; see ABELSON LEUKEMIA VIRUS 1991-2001, see MOUSE LEUKEMIA VIRUSES 1980-1990%A%  
% 210.45/210.60  |- mesh__recordAuthorizer mesh__D000011 ags
% 210.45/210.60  |- skos__hiddenLabel mesh__D000011 Leukemia Virus, Abelson
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D000011 2005
% 210.45/210.60  |- mesh__dateEstablished mesh__D000011 1991-01-01
% 210.45/210.60  |- skos__altLabel mesh__D000011 Abelson Leukemia Virus
% 210.45/210.60  |- rdf__type mesh__D000011sskos__Concept
% 210.45/210.60  |- skos__broader mesh__D000011smesh__D009052
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D000011 2006A
% 210.45/210.60  |- skos__prefLabel mesh__D000011 Abelson murine leukemia virus
% 210.45/210.60  |- mesh__dateRevised mesh__D000011 2005-07-28
% 210.45/210.60  |- mesh__dateCreated mesh__D000011 1979-04-16
% 210.45/210.60  |- mesh__historyNote mesh__D000011 2002 %28%1980%29%   
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D000011 2004
% 210.45/210.60  |- mesh__recordMaintainer mesh__D000011 ags
% 210.45/210.60  |- skos__scopeNote mesh__D000011
% 210.45/210.60       A replication-defective strain of Murine leukemia virus %28%LEUKEMIA VIRUS, MURINE%29% capable of transforming lymphoid cells and producing a rapidly progressing lymphoid leukemia after superinfection with FRIEND MURINE LEUKEMIA VIRUS; MOLONEY MURINE LEUKEMIA VIRUS; or RAUSCHER VIRUS.%A%    
% 210.45/210.60  |- mesh__recordOriginator mesh__D000011 AEP
% 210.45/210.60  |- skos__historyNote mesh__D000011 Mouse Leukemia Viruses %28%1966-1979%29%
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D000011 2003
% 210.45/210.60  |- mesh__recordOriginator mesh__D046911 jmp
% 210.45/210.60  |- mesh__dateEstablished mesh__D046911 2005-01-01
% 210.45/210.60  |- mesh__historyNote mesh__D046911 2005   
% 210.45/210.60  |- skos__hiddenLabel mesh__D046911 Compounds, Macromolecular
% 210.45/210.60  |- skos__altLabel mesh__D046911 Macromolecular Compounds and Complexes
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D046911 2005
% 210.45/210.60  |- rdf__type mesh__D046911sskos__Concept
% 210.45/210.60  |- mesh__publicMeSHNote mesh__D046911
% 210.45/210.60       2005; see MACROMOLECULAR SYSTEMS 1966-2004   
% 210.45/210.60  |- skos__hiddenLabel mesh__D046911 Complexes, Macromolecular
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D046911 2006
% 210.45/210.60  |- skos__annotation mesh__D046911
% 210.45/210.60       general only; do not use as a routine coordinate with specific macromolecular substances%A%  
% 210.45/210.60  |- mesh__recordAuthorizer mesh__D046911 sjn
% 210.45/210.60  |- mesh__recordMaintainer mesh__D046911 jmp
% 210.45/210.60  |- mesh__runningHead mesh__D046911 D5 - MACROMOLECULAR SUBSTANCES   
% 210.45/210.60  |- skos__prefLabel mesh__D046911 Macromolecular Substances
% 210.45/210.60  |- skos__hiddenLabel mesh__D046911 Substances, Macromolecular
% 210.45/210.60  |- skos__scopeNote mesh__D046911
% 210.45/210.60       Compounds and molecular complexes that consist of very large numbers of atoms and are generally over 500 kD in size. In biological systems macromolecular substances usually can be visualized using ELECTRON MICROSCOPY and are distinguished from ORGANELLES by the lack of a membrane structure.%A%    
% 210.45/210.60  |- mesh__dateCreated mesh__D046911 2004-07-07
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D013737 2006
% 210.45/210.60  |- rdf__type mesh__D013737sskos__Concept
% 210.45/210.60  |- mesh__dateCreated mesh__D013737 1999-01-01
% 210.45/210.60  |- mesh__recordOriginator mesh__D013737 NLM
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D013737 2004
% 210.45/210.60  |- skos__related mesh__D013737smesh__D009919
% 210.45/210.60  |- mesh__recordMaintainer mesh__D013737 lkt
% 210.45/210.60  |- mesh__activeMeSHYear mesh__D013737 2005
% 210.46/210.60  |- mesh__recordAuthorizer mesh__D013737 sjn
% 210.46/210.60  |- skos__prefLabel mesh__D013737 Testis
% 210.46/210.60  |- mesh__activeMeSHYear mesh__D013737 2003
% 210.46/210.60  |- skos__altLabel mesh__D013737 Testicles
% 210.46/210.60  |- skos__annotation mesh__D013737
% 210.46/210.60       torsion = SPERMATIC CORD TORSION; inflammation = ORCHITIS; /abnorm: agenesis or dysgenesis: coord TESTIS /abnorm %28%IM%29% with GONADAL DYSGENESIS %28%IM%29%; /cytol: consider also LEYDIG CELLS; /surg is probably ORCHIECTOMY; excision = ORCHIECTOMY%A%  
% 210.46/210.60  |- skos__broader mesh__D013737smesh__D005837
% 210.46/210.60  |- mesh__dateRevised mesh__D013737 2002-07-03
% 210.46/210.60  |- mesh__considerAlso mesh__D013737 consider also terms at ORCHI-   
% 210.46/210.60  |- skos__scopeNote mesh__D013737
% 210.46/210.60       The male gonad containing two functional parts: the SEMINIFEROUS TUBULES for the production and transport of male germ cells %28%SPERMATOGENESIS%29% and the interstitial compartment containing LEYDIG CELLS that produce ANDROGENS.%A%    
% 210.46/210.60  |- skos__broader mesh__D013737smesh__D006066
% 210.46/210.60  |- skos__hiddenLabel mesh__D013737 Testicle
% 210.46/210.60  |- skos__altLabel mesh__D013737 Testes
% 210.46/210.60  |- skos__altLabel mesh__D051856 FANC Proteins
% 210.46/210.60  |- mesh__recordMaintainer mesh__D051856 DRC
% 210.46/210.60  |- skos__broader mesh__D051856smesh__D011506
% 210.46/210.60  |- skos__scopeNote mesh__D051856
% 210.46/210.60       A diverse group of proteins whose genetic MUTATIONS have been associated with the chromosomal instability syndrome FANCONI ANEMIA. Many of these proteins play important roles in protecting CELLS against OXIDATIVE STRESS.%A%    
% 210.46/210.60  |- mesh__recordAuthorizer mesh__D051856 sjn
% 210.46/210.60  |- mesh__activeMeSHYear mesh__D051856 2006
% 210.46/210.60  |- mesh__dateCreated mesh__D051856 2005-06-30
% 210.46/210.60  |- skos__prefLabel mesh__D051856
% 210.46/210.60       Fanconi Anemia Complementation Group Proteins
% 210.46/210.60  |- rdf__type mesh__D051856sskos__Concept
% 210.46/210.60  |- skos__annotation mesh__D051856 general; prefer specifics   
% 210.46/210.60  |- mesh__recordOriginator mesh__D051856 DRC
% 210.46/210.60  |- mesh__dateEstablished mesh__D051856 2006-01-01
% 210.46/210.60  |- mesh__historyNote mesh__D051856 2006%28%1993%29%   
% 210.46/210.60  |- skos__altLabel mesh__D051856 Fanconi Anemia Proteins
% 210.46/210.60  |- mesh__publicMeSHNote mesh__D051856
% 210.46/210.60       2006; FANCONI ANEMIA PROTEINS was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% CELL CYCLE PROTEINS 1993-2005%A%  
% 210.46/210.60  |- skos__broader mesh__D004402smesh__D001342
% 210.46/210.60  |- mesh__activeMeSHYear mesh__D004402 2003
% 210.46/210.60  |- skos__altLabel mesh__D004402 Riley-Day Syndrome
% 210.46/210.60  |- mesh__recordOriginator mesh__D004402 NLM
% 210.46/210.60  |- skos__broader mesh__D004402smesh__D009477
% 210.46/210.60  |- mesh__dateRevised mesh__D004402 2001-07-25
% 210.46/210.60  |- mesh__activeMeSHYear mesh__D004402 2006
% 210.46/210.60  |- mesh__recordAuthorizer mesh__D004402 sjn
% 210.46/210.60  |- skos__altLabel mesh__D004402
% 210.46/210.60       Type 3 Hereditary Sensory Neuropathy, Dominant
% 210.46/210.60  |- skos__altLabel mesh__D004402
% 210.46/210.60       HSAN %28%Hereditary Sensory and Autonomic Neuropathy%29% Type III
% 210.46/210.60  |- mesh__activeMeSHYear mesh__D004402 2002
% 210.46/210.60  |- mesh__historyNote mesh__D004402 81; was AUTONOMIC DYSFUNCTION 1963-80   
% 210.46/210.60  |- skos__altLabel mesh__D004402
% 210.46/210.60       Hereditary-Sensory and Autonomic Neuropathy Type III
% 210.46/210.60  |- skos__altLabel mesh__D004402
% 210.46/210.60       Hereditary Sensory Neuropathy, Dominant, Type III
% 210.46/210.60  |- mesh__activeMeSHYear mesh__D004402 2005
% 210.46/210.60  |- skos__annotation mesh__D004402
% 210.46/210.60       do not confuse with DYSAUTONOMIA see AUTONOMIC NERVOUS SYSTEM DISEASES%A%  
% 210.46/210.60  |- skos__hiddenLabel mesh__D004402 Syndrome, Riley-Day
% 210.46/210.60  |- rdf__type mesh__D004402sskos__Concept
% 210.46/210.60  |- mesh__onlineNote mesh__D004402
% 210.46/210.60       use DYSAUTONOMIA, FAMILIAL to search AUTONOMIC DYSFUNCTION 1966-80%A%  
% 210.46/210.60  |- skos__altLabel mesh__D004402
% 210.46/210.60       Type III Hereditary Sensory Neuropathy, Dominant
% 210.46/210.60  |- skos__altLabel mesh__D004402 HSAN Type III
% 210.46/210.60  |- skos__altLabel mesh__D004402
% 210.46/210.60       Neuropathy, Hereditary and Autonomic, Type III
% 210.46/210.60  |- skos__scopeNote mesh__D004402
% 210.46/210.60       An autosomal disorder of the peripheral and autonomic nervous systems limited to individuals of Ashkenazic Jewish descent. Clinical manifestations are present at birth and include diminished lacrimation, defective thermoregulation, orthostatic hypotension %28%HYPOTENSION, ORTHOSTATIC%29%, fixed pupils, excessive SWEATING, loss of pain and temperature sensation, and absent reflexes. Pathologic features include reduced numbers of small diameter peripheral nerve fibers and autonomic ganglion neurons. %28%From Adams et al., Principles of Neurology, 6th ed, p1348; Nat Genet 1993;4%28%2%29%:160-4%29%%A%    
% 210.46/210.60  |- skos__altLabel mesh__D004402
% 210.46/210.60       Dominant Hereditary Sensory Neuropathy, Type III
% 210.46/210.60  |- skos__hiddenLabel mesh__D004402 Familial Dysautonomia
% 210.46/210.60  |- mesh__activeMeSHYear mesh__D004402 2004
% 210.46/210.60  |- skos__altLabel mesh__D004402
% 210.46/210.60       Hereditary Sensory Neuropathy, Type 3, Dominant
% 210.46/210.60  |- mesh__recordMaintainer mesh__D004402 nns
% 210.46/210.60  |- mesh__dateCreated mesh__D004402 1999-01-01
% 210.46/210.60  |- mesh__publicMeSHNote mesh__D004402
% 210.46/210.60       81; was AUTONOMIC DYSFUNCTION 1963-80   
% 210.46/210.60  |- skos__altLabel mesh__D004402
% 210.46/210.60       Hereditary Sensory Neuropathy, Dominant, Type 3
% 210.46/210.60  |- skos__hiddenLabel mesh__D004402 Riley Day Syndrome
% 210.46/210.60  |- skos__prefLabel mesh__D004402 Dysautonomia, Familial
% 210.46/210.60  |- mesh__recordOriginator mesh__D051058 DRC
% 210.46/210.60  |- skos__broader mesh__D051058smesh__D017346
% 210.46/210.60  |- skos__altLabel mesh__D051058 akt-Oncogene Protein
% 210.46/210.60  |- skos__hiddenLabel mesh__D051058 Oncogene Protein v akt
% 210.46/210.60  |- skos__hiddenLabel mesh__D051058 v-akt, Oncogene Protein
% 210.46/210.60  |- skos__altLabel mesh__D051058 v-akt Kinase Transforming Protein
% 210.46/210.60  |- skos__hiddenLabel mesh__D051058 v akt Kinase Transforming Protein
% 210.46/210.60  |- mesh__dateEstablished mesh__D051058 2006-01-01
% 210.46/210.60  |- mesh__activeMeSHYear mesh__D051058 2006
% 210.46/210.60  |- mesh__recordAuthorizer mesh__D051058 sjn
% 210.46/210.60  |- skos__altLabel mesh__D051058 Oncogene Protein akt
% 210.46/210.60  |- skos__hiddenLabel mesh__D051058 akt, Oncogene Protein
% 210.46/210.60  |- skos__hiddenLabel mesh__D051058 akt Oncogene Protein
% 210.46/210.60  |- skos__altLabel mesh__D051058 v-akt Protein
% 210.46/210.60  |- mesh__publicMeSHNote mesh__D051058
% 210.46/210.60       2006; ONCOGENE PROTEIN V-AKT was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-2005, %26% under RETROVIRIDAE PROTEINS 1987-1989%A%  
% 210.46/210.60  |- mesh__dateCreated mesh__D051058 2005-06-30
% 210.46/210.60  |- skos__broader mesh__D051058smesh__D015682
% 210.46/210.60  |- rdf__type mesh__D051058sskos__Concept
% 210.46/210.60  |- mesh__historyNote mesh__D051058 2006%28%1987%29%   
% 210.46/210.60  |- skos__scopeNote mesh__D051058
% 210.46/210.60       A viral oncoprotein originally isolated from a murine T CELL LYMPHOMA infected with the acutely transforming retrovirus AKT8. v-akt protein is the viral homologue of PROTO-ONCOGENE PROTEINS C-AKT.%A%    
% 210.46/210.60  |- skos__prefLabel mesh__D051058 Oncogene Protein v-akt
% 210.46/210.60  |- mesh__recordMaintainer mesh__D051058 DRC
% 210.46/210.60  |- mesh__activeMeSHYear mesh__D009696 2002
% 210.46/210.60  |- skos__broader mesh__D009696smesh__D009706
% 210.46/210.60  |- mesh__recordOriginator mesh__D009696 NLM
% 210.46/210.60  |- skos__hiddenLabel mesh__D009696 Acids, Nucleic
% 210.46/210.60  |- mesh__activeMeSHYear mesh__D009696 2005
% 210.46/210.60  |- mesh__recordAuthorizer mesh__D009696 sjn
% 210.46/210.61  |- skos__annotation mesh__D009696
% 210.46/210.61       GEN: prefer RNA %26% DNA whether Priority 1, 2 or 3 article;%A%  
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D009696 2006
% 210.46/210.61  |- skos__scopeNote mesh__D009696
% 210.46/210.61       High molecular weight polymers containing a mixture of purine and pyrimidine nucleotides chained together by ribose or deoxyribose linkages.%A%    
% 210.46/210.61  |- rdf__type mesh__D009696sskos__Concept
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D009696 2000
% 210.46/210.61  |- skos__prefLabel mesh__D009696 Nucleic Acids
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D009696 2003
% 210.46/210.61  |- mesh__recordMaintainer mesh__D009696 jmp
% 210.46/210.61  |- mesh__dateCreated mesh__D009696 1999-01-01
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D009696 2004
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D009696 2001
% 210.46/210.61  |- mesh__dateRevised mesh__D009696 1999-11-03
% 210.46/210.61  |- mesh__recordOriginator mesh__D042521 ags
% 210.46/210.61  |- mesh__recordAuthorizer mesh__D042521 sjn
% 210.46/210.61  |- rdf__type mesh__D042521sskos__Concept
% 210.46/210.61  |- mesh__dateCreated mesh__D042521 2003-07-09
% 210.46/210.61  |- mesh__publicMeSHNote mesh__D042521 2004   
% 210.46/210.61  |- skos__broader mesh__D042521smesh__D016946
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D042521 2006
% 210.46/210.61  |- mesh__dateEstablished mesh__D042521 2004-01-01
% 210.46/210.61  |- mesh__dateRevised mesh__D042521 2005-06-30
% 210.46/210.61  |- skos__broader mesh__D042521smesh__D020562
% 210.46/210.61  |- skos__prefLabel mesh__D042521 Burkholderiaceae
% 210.46/210.61  |- mesh__historyNote mesh__D042521 2004   
% 210.46/210.61  |- mesh__recordMaintainer mesh__D042521 SYSTEM
% 210.46/210.61  |- skos__scopeNote mesh__D042521
% 210.46/210.61       A family of gram negative, aerobic, non-sporeforming, rod-shaped bacteria.%A%    
% 210.46/210.61  |- mesh__recordOriginator mesh__D014830 NLM
% 210.46/210.61  |- skos__annotation mesh__D014830
% 210.46/210.61       consider also APTITUDE or APTITUDE TESTS   
% 210.46/210.61  |- skos__broader mesh__D014830smesh__D011588
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D014830 1997
% 210.46/210.61  |- skos__scopeNote mesh__D014830
% 210.46/210.61       Systematic efforts to assist individuals in selecting an occupation or suitable employment on the basis of aptitude, education, etc.%A%    
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D014830 2005
% 210.46/210.61  |- skos__prefLabel mesh__D014830 Vocational Guidance
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D014830 2002
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D014830 2004
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D014830 2001
% 210.46/210.61  |- skos__hiddenLabel mesh__D014830 Counseling, Career
% 210.46/210.61  |- mesh__dateCreated mesh__D014830 1999-01-01
% 210.46/210.61  |- mesh__recordMaintainer mesh__D014830 JLS
% 210.46/210.61  |- mesh__dateRevised mesh__D014830 1996-06-10
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D014830 2003
% 210.46/210.61  |- rdf__type mesh__D014830sskos__Concept
% 210.46/210.61  |- skos__hiddenLabel mesh__D014830 Guidance, Vocational
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D014830 2000
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D014830 1999
% 210.46/210.61  |- skos__broader mesh__D014830smesh__D011590
% 210.46/210.61  |- skos__altLabel mesh__D014830 Career Counseling
% 210.46/210.61  |- mesh__recordAuthorizer mesh__D014830 PLS
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D014830 1998
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D014830 2006
% 210.46/210.61  |- skos__altLabel mesh__D014032 Ecarazine
% 210.46/210.61  |- rdf__type mesh__D014032sskos__Concept
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D014032 2001
% 210.46/210.61  |- mesh__onlineNote mesh__D014032
% 210.46/210.61       use TODRALAZINE to search BINAZINE 1975-79   
% 210.46/210.61  |- mesh__dateEstablished mesh__D014032 1991-01-01
% 210.46/210.61  |- mesh__recordMaintainer mesh__D014032 CCR
% 210.46/210.61  |- skos__altLabel mesh__D014032 Binazin
% 210.46/210.61  |- skos__historyNote mesh__D014032 Heterocyclic Compounds %28%1971-1974%29%
% 210.46/210.61  |- mesh__dateRevised mesh__D014032 2000-06-21
% 210.46/210.61  |- mesh__historyNote mesh__D014032
% 210.46/210.61       91%28%80%29%; was see under HYDRAZINES 1980-90; was BINAZINE see under HYDRAZINES 1975-79%A%  
% 210.46/210.61  |- skos__prefLabel mesh__D014032 Todralazine
% 210.46/210.61  |- mesh__recordAuthorizer mesh__D014032 sjn
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D014032 2006
% 210.46/210.61  |- skos__broader mesh__D014032smesh__D010793
% 210.46/210.61  |- skos__scopeNote mesh__D014032
% 210.46/210.61       An antihypertensive agent with both central and peripheral action; it has some central nervous system depressant effects.%A%    
% 210.46/210.61  |- mesh__dateCreated mesh__D014032 1974-11-19
% 210.46/210.61  |- mesh__publicMeSHNote mesh__D014032
% 210.46/210.61       91; was see under HYDRAZINES 1980-90; was BINAZINE see under HYDRAZINES 1975-79%A%  
% 210.46/210.61  |- skos__altLabel mesh__D014032 Todrazoline
% 210.46/210.61  |- skos__historyNote mesh__D014032 Hydrazines %28%1971-1974%29%
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D014032 2005
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D014032 2004
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D014032 2002
% 210.46/210.61  |- skos__broader mesh__D014032smesh__D006834
% 210.46/210.61  |- skos__historyNote mesh__D014032 Carboxylic Acids %28%1972-1974%29%
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D014032 2003
% 210.46/210.61  |- mesh__recordOriginator mesh__D014032 NLM
% 210.46/210.61  |- mesh__recordOriginator mesh__D000810 NLM
% 210.46/210.61  |- mesh__recordMaintainer mesh__D000810 AGS
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D000810 2002
% 210.46/210.61  |- rdf__type mesh__D000810sskos__Concept
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D000810 2005
% 210.46/210.61  |- skos__prefLabel mesh__D000810 Angola
% 210.46/210.61  |- skos__annotation mesh__D000810 a republic in southern Africa   
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D000810 2003
% 210.46/210.61  |- skos__broader mesh__D000810smesh__D000353
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D000810 2006
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D000810 1998
% 210.46/210.61  |- skos__scopeNote mesh__D000810
% 210.46/210.61       A republic in southern Africa, southwest of DEMOCRATIC REPUBLIC OF THE CONGO and west of ZAMBIA. Its capital is Luanda. It was formerly a Portuguese overseas province called Portuguese West Africa, having been reached by Portuguese sailors in 1483, with Portuguese rule established in 1575. Its status was changed from colony to overseas province in 1951 and it received its independence in 1975. Angola is named for N%27%gola, a native ruler there in the 16th century. %28%From Webster%27%s New Geographical Dictionary, 1988, p51 %26% Room, Brewer%27%s Dictionary of Names, 1992, p23%29%%A%    
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D000810 2004
% 210.46/210.61  |- mesh__recordAuthorizer mesh__D000810 SJN
% 210.46/210.61  |- mesh__dateCreated mesh__D000810 1999-01-01
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D000810 1999
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D000810 2000
% 210.46/210.61  |- mesh__dateRevised mesh__D000810 1997-06-20
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D000810 2001
% 210.46/210.61  |- mesh__recordMaintainer mesh__D000012 lkt
% 210.46/210.61  |- skos__prefLabel mesh__D000012 Abetalipoproteinemia
% 210.46/210.61  |- rdf__type mesh__D000012sskos__Concept
% 210.46/210.61  |- mesh__historyNote mesh__D000012 1966%28%1964%29%   
% 210.46/210.61  |- skos__hiddenLabel mesh__D000012 Diseases, Betalipoprotein Deficiency
% 210.46/210.61  |- skos__hiddenLabel mesh__D000012 Disease, Betalipoprotein Deficiency
% 210.46/210.61  |- skos__broader mesh__D000012smesh__D020739
% 210.46/210.61  |- skos__altLabel mesh__D000012
% 210.46/210.61       Deficiency Disease, Microsomal Triglyceride Transfer Protein
% 210.46/210.61  |- skos__altLabel mesh__D000012 Apolipoprotein B Deficiency Disease
% 210.46/210.61  |- mesh__recordAuthorizer mesh__D000012 sjn
% 210.46/210.61  |- mesh__dateRevised mesh__D000012 2005-06-30
% 210.46/210.61  |- mesh__publicMeSHNote mesh__D000012 1966   
% 210.46/210.61  |- skos__altLabel mesh__D000012 Bassen-Kornzweig Disease
% 210.46/210.61  |- skos__hiddenLabel mesh__D000012 Bassen Kornzweig Syndrome
% 210.46/210.61  |- skos__broader mesh__D000012smesh__D007009
% 210.46/210.61  |- skos__hiddenLabel mesh__D000012 Diseases, Bassen-Kornzweig
% 210.46/210.61  |- skos__hiddenLabel mesh__D000012 Bassen-Kornzweig Diseases
% 210.46/210.61  |- mesh__recordOriginator mesh__D000012 NLM
% 210.46/210.61  |- skos__broader mesh__D000012smesh__D001796
% 210.46/210.61  |- skos__hiddenLabel mesh__D000012 Bassen Kornzweig Disease
% 210.46/210.61  |- skos__hiddenLabel mesh__D000012 Betalipoprotein Deficiency Diseases
% 210.46/210.61  |- skos__annotation mesh__D000012
% 210.46/210.61       do not confuse with HYPOBETALIPOPROTEINEMIA   
% 210.46/210.61  |- skos__altLabel mesh__D000012 Deficiency Disease, Betalipoprotein
% 210.46/210.61  |- skos__scopeNote mesh__D000012
% 210.46/210.61       A disorder of lipid metabolism inherited as an autosomal recessive trait characterized by the near absence of APOLIPOPROTEINS B and apoB-containing lipoproteins in plasma. Microsomal triglyceride transfer protein is deficient or absent in enterocytes. Clinical and laboratory findings include acanthocytosis, hypocholesterolemia, peripheral neuropathy, posterior column degeneration, ataxia, and steatorrhea. Intellectual abilities may also be impaired. %28%Menkes, Textbook of Child Neurology, 5th ed, p118; Curr Opin Lipidol 1994 Apr;5%28%2%29%:81-6%29%%A%    
% 210.46/210.61  |- mesh__dateCreated mesh__D000012 1999-01-01
% 210.46/210.61  |- mesh__dateEstablished mesh__D000012 1966-01-01
% 210.46/210.61  |- skos__hiddenLabel mesh__D000012 Deficiency Diseases, Betalipoprotein
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D000012 2006
% 210.46/210.61  |- skos__altLabel mesh__D000012
% 210.46/210.61       Microsomal Triglyceride Transfer Protein Deficiency Disease
% 210.46/210.61  |- skos__altLabel mesh__D000012 Betalipoprotein Deficiency Disease
% 210.46/210.61  |- skos__altLabel mesh__D000012 Bassen-Kornzweig Syndrome
% 210.46/210.61  |- skos__altLabel mesh__D000012 Deficiency Disease, Apolipoprotein B
% 210.46/210.61  |- skos__hiddenLabel mesh__D000012 Abetalipoproteinemias
% 210.46/210.61  |- skos__related mesh__D000012smesh__D001055
% 210.46/210.61  |- mesh__recordAuthorizer mesh__D046912 sjn
% 210.46/210.61  |- mesh__dateRevised mesh__D046912 2005-06-30
% 210.46/210.61  |- skos__altLabel mesh__D046912 Macromolecular Protein Complexes
% 210.46/210.61  |- skos__annotation mesh__D046912
% 210.46/210.61       general only; do not use as a routine coordinate with specific multiprotein complexes; MULTIENZYME COMPLEXES is also available%A%  
% 210.46/210.61  |- mesh__dateEstablished mesh__D046912 2005-01-01
% 210.46/210.61  |- mesh__publicMeSHNote mesh__D046912
% 210.46/210.61       2005; see MACROMOLECULAR SYSTEMS 1966-2004   
% 210.46/210.61  |- skos__historyNote mesh__D046912
% 210.46/210.61       Macromolecular Substances %28%1966-2004%29%
% 210.46/210.61  |- mesh__recordMaintainer mesh__D046912 SYSTEM
% 210.46/210.61  |- skos__scopeNote mesh__D046912
% 210.46/210.61       Macromolecular complexes formed from the association of defined protein subunits.%A%    
% 210.46/210.61  |- mesh__historyNote mesh__D046912
% 210.46/210.61       2005; use MACROMOLECULAR SUBSTANCES 1966-2004   
% 210.46/210.61  |- skos__broader mesh__D046912smesh__D046911
% 210.46/210.61  |- rdf__type mesh__D046912sskos__Concept
% 210.46/210.61  |- mesh__dateCreated mesh__D046912 2004-07-07
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D046912 2006
% 210.46/210.61  |- skos__hiddenLabel mesh__D046912 Complexes, Macromolecular Protein
% 210.46/210.61  |- skos__prefLabel mesh__D046912 Multiprotein Complexes
% 210.46/210.61  |- skos__hiddenLabel mesh__D046912 Protein Complexes, Macromolecular
% 210.46/210.61  |- skos__hiddenLabel mesh__D046912 Complexes, Multiprotein
% 210.46/210.61  |- mesh__recordOriginator mesh__D046912 jmp
% 210.46/210.61  |- mesh__historyNote mesh__D013738 73%28%64%29%   
% 210.46/210.61  |- mesh__publicMeSHNote mesh__D013738 73   
% 210.46/210.61  |- mesh__dateRevised mesh__D013738 2005-06-30
% 210.46/210.61  |- mesh__dateEstablished mesh__D013738 1973-01-01
% 210.46/210.61  |- skos__altLabel mesh__D013738 1-Dehydrotestolactone
% 210.46/210.61  |- mesh__recordOriginator mesh__D013738 NLM
% 210.46/210.61  |- skos__broader mesh__D013738smesh__D000730
% 210.46/210.61  |- skos__broader mesh__D013738smesh__D006718
% 210.46/210.61  |- skos__altLabel mesh__D013738 delta%28%1%29%-Testolactone
% 210.46/210.61  |- skos__scopeNote mesh__D013738
% 210.46/210.61       An antineoplastic agent that is a derivative of progesterone and used to treat advanced breast cancer.%A%    
% 210.46/210.61  |- skos__altLabel mesh__D013738 Bristol-Myers Squibb Brand of Testolactone
% 210.46/210.61  |- mesh__recordAuthorizer mesh__D013738 sjn
% 210.46/210.61  |- mesh__recordMaintainer mesh__D013738 CCR
% 210.46/210.61  |- skos__hiddenLabel mesh__D013738 1 Dehydrotestolactone
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D013738 2006
% 210.46/210.61  |- rdf__type mesh__D013738sskos__Concept
% 210.46/210.61  |- mesh__dateCreated mesh__D013738 1999-01-01
% 210.46/210.61  |- skos__prefLabel mesh__D013738 Testolactone
% 210.46/210.61  |- skos__hiddenLabel mesh__D013738
% 210.46/210.61       Bristol Myers Squibb Brand of Testolactone
% 210.46/210.61  |- mesh__dateRevised mesh__D010440 2000-06-22
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D010440 2005
% 210.46/210.61  |- mesh__recordMaintainer mesh__D010440 CCR
% 210.46/210.61  |- mesh__recordOriginator mesh__D010440 NLM
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D010440 2004
% 210.46/210.61  |- mesh__dateCreated mesh__D010440 1974-11-19
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D010440 2002
% 210.46/210.61  |- skos__historyNote mesh__D010440 Peptides %28%1974%29%
% 210.46/210.61  |- rdf__type mesh__D010440sskos__Concept
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D010440 2003
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D010440 2001
% 210.46/210.61  |- mesh__historyNote mesh__D010440
% 210.46/210.61       91%28%75%29%; was see under MELPHALAN 1981-90; was see under NITROGEN MUSTARD COMPOUNDS 1975-80%A%  
% 210.46/210.61  |- skos__broader mesh__D010440smesh__D008558
% 210.46/210.61  |- mesh__dateEstablished mesh__D010440 1991-01-01
% 210.46/210.61  |- skos__scopeNote mesh__D010440
% 210.46/210.61       A mixture of six synthetic oligopeptides, each containing MELPHALAN. It is used as a broad-spectrum antineoplastic due to its alkylating and antimetabolic actions but, is toxic to bone marrow, gastrointestinal system and vasculature.%A%    
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D010440 2006
% 210.46/210.61  |- skos__broader mesh__D010440smesh__D009842
% 210.46/210.61  |- skos__prefLabel mesh__D010440 Peptichemio
% 210.46/210.61  |- mesh__publicMeSHNote mesh__D010440
% 210.46/210.61       91; was see under MELPHALAN 1981-90; was see under NITROGEN MUSTARD COMPOUNDS 1975-80%A%  
% 210.46/210.61  |- skos__historyNote mesh__D010440 Nitrogen Mustard Compounds %28%1974%29%
% 210.46/210.61  |- mesh__recordAuthorizer mesh__D010440 sjn
% 210.46/210.61  |- skos__hiddenLabel mesh__D051857 Transcription Factor, Otx1
% 210.46/210.61  |- skos__broader mesh__D051857smesh__D014157
% 210.46/210.61  |- skos__hiddenLabel mesh__D051857 Transcription Factor, Otx2
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D051857 2006
% 210.46/210.61  |- mesh__recordMaintainer mesh__D051857 DRC
% 210.46/210.61  |- rdf__type mesh__D051857sskos__Concept
% 210.46/210.61  |- skos__hiddenLabel mesh__D051857 Transcription Factors, Otx
% 210.46/210.61  |- mesh__recordOriginator mesh__D051857 DRC
% 210.46/210.61  |- mesh__recordAuthorizer mesh__D051857 sjn
% 210.46/210.61  |- skos__altLabel mesh__D051857 Homeobox Protein OTX2
% 210.46/210.61  |- skos__hiddenLabel mesh__D051857 Homeodomain Proteins, Otx
% 210.46/210.61  |- skos__altLabel mesh__D051857 Otx Homeodomain Proteins
% 210.46/210.61  |- skos__altLabel mesh__D051857 Orthodenticle Homolog Homeodomain Proteins
% 210.46/210.61  |- mesh__dateCreated mesh__D051857 2005-06-30
% 210.46/210.61  |- skos__prefLabel mesh__D051857 Otx Transcription Factors
% 210.46/210.61  |- skos__hiddenLabel mesh__D051857 OTX1, Homeobox Protein
% 210.46/210.61  |- mesh__publicMeSHNote mesh__D051857
% 210.46/210.61       2006; OTX TRANSCRIPTION FACTORS was indexed under HOMEODOMAIN PROTEINS 2000-2005%A%  
% 210.46/210.61  |- skos__altLabel mesh__D051857 Homeobox Protein OTX1
% 210.46/210.61  |- mesh__historyNote mesh__D051857 2006%28%2000%29%   
% 210.46/210.61  |- skos__scopeNote mesh__D051857
% 210.46/210.61       A family of VERTEBRATE homeodomain proteins that share homology with orthodenticle protein, Drosophila. They regulate GENETIC TRANSCRIPTION and play an important role in EMBRYONIC DEVELOPMENT of the BRAIN.%A%    
% 210.46/210.61  |- skos__hiddenLabel mesh__D051857 OTX2, Homeobox Protein
% 210.46/210.61  |- skos__broader mesh__D051857smesh__D018398
% 210.46/210.61  |- mesh__dateEstablished mesh__D051857 2006-01-01
% 210.46/210.61  |- mesh__recordMaintainer mesh__D004403 ags
% 210.46/210.61  |- skos__prefLabel mesh__D004403 Dysentery
% 210.46/210.61  |- skos__hiddenLabel mesh__D004403 Diarrheal Disease, Infectious
% 210.46/210.61  |- mesh__recordOriginator mesh__D004403 NLM
% 210.46/210.61  |- rdf__type mesh__D004403sskos__Concept
% 210.46/210.61  |- skos__scopeNote mesh__D004403
% 210.46/210.61       Acute inflammation of the intestine associated with infectious DIARRHEA of various etiologies, generally acquired by eating contaminated food containing TOXINS, BIOLOGICAL derived from BACTERIA; PROTOZOA; or other microorganisms. Dysentery is characterized initially by watery FECES then by bloody mucoid stools. It is often associated with ABDOMINAL PAIN; FEVER; and DEHYDRATION.%A%    
% 210.46/210.61  |- mesh__dateRevised mesh__D004403 2005-07-08
% 210.46/210.61  |- skos__broader mesh__D004403smesh__D005759
% 210.46/210.61  |- skos__hiddenLabel mesh__D004403 Infectious Diarrheal Diseases
% 210.46/210.61  |- mesh__recordAuthorizer mesh__D004403 ags
% 210.46/210.61  |- mesh__dateCreated mesh__D004403 1999-01-01
% 210.46/210.61  |- skos__altLabel mesh__D004403 Infectious Diarrheal Disease
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D004403 2006
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D004403 2006A
% 210.46/210.61  |- skos__broader mesh__D004403smesh__D007410
% 210.46/210.61  |- mesh__recordMaintainer mesh__D051059 DRC
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D051059 2006
% 210.46/210.61  |- skos__prefLabel mesh__D051059 PTEN Phosphohydrolase
% 210.46/210.61  |- mesh__publicMeSHNote mesh__D051059
% 210.46/210.61       2006; PTEN PROTEIN was indexed under PROTEIN-TYROSINE-PHOSPHATASES 1997-1998, under TUMOR SUPPRESSOR PROTEINS 1997-2005, %26% under PHOSPHORIC MONOESTER HYDROLASES 1999-2005%A%  
% 210.46/210.61  |- skos__scopeNote mesh__D051059
% 210.46/210.61       A lipid phosphatase that acts on phosphatidylinositol-3,4,5-trisphosphate to regulate various SIGNAL TRANSDUCTION PATHWAYS. It modulates CELL GROWTH PROCESSES; CELL MIGRATION; and APOPTOSIS. Mutations in PTEN are associated with COWDEN DISEASE and PROTEUS SYNDROME as well as NEOPLASTIC CELL TRANSFORMATION.%A%    
% 210.46/210.61  |- skos__altLabel mesh__D051059
% 210.46/210.61       Phosphatase and Tensin Homologue on Chromosome Ten Protein
% 210.46/210.61  |- rdf__type mesh__D051059sskos__Concept
% 210.46/210.61  |- skos__broader mesh__D051059smesh__D010744
% 210.46/210.61  |- mesh__dateEstablished mesh__D051059 2006-01-01
% 210.46/210.61  |- mesh__recordAuthorizer mesh__D051059 sjn
% 210.46/210.61  |- skos__altLabel mesh__D051059 PTEN Protein
% 210.46/210.61  |- skos__hiddenLabel mesh__D051059 Phosphatase, PTEN
% 210.46/210.61  |- skos__altLabel mesh__D051059
% 210.46/210.61       Mutated In Multiple Advanced Cancers 1 Protein
% 210.46/210.61  |- skos__altLabel mesh__D051059 PTEN Phosphatase
% 210.46/210.61  |- mesh__historyNote mesh__D051059 2006%28%1997%29%   
% 210.46/210.61  |- skos__hiddenLabel mesh__D051059 Phosphohydrolase, PTEN
% 210.46/210.61  |- skos__broader mesh__D051059smesh__D047908
% 210.46/210.61  |- mesh__dateCreated mesh__D051059 2005-06-30
% 210.46/210.61  |- mesh__recordOriginator mesh__D051059 DRC
% 210.46/210.61  |- skos__altLabel mesh__D051059 MMAC1 Protein
% 210.46/210.61  |- skos__broader mesh__D051059smesh__D025521
% 210.46/210.61  |- skos__altLabel mesh__D009697 Nucleolar Organizer
% 210.46/210.61  |- skos__prefLabel mesh__D009697 Nucleolus Organizer Region
% 210.46/210.61  |- skos__historyNote mesh__D009697 Chromosomes %28%1966-1979%29%
% 210.46/210.61  |- mesh__dateRevised mesh__D009697 2005-06-30
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D009697 2006
% 210.46/210.61  |- skos__hiddenLabel mesh__D009697 Nucleolus Organizer Regions
% 210.46/210.61  |- mesh__historyNote mesh__D009697 80   
% 210.46/210.61  |- skos__hiddenLabel mesh__D009697 Organizer Region, Nucleolus
% 210.46/210.61  |- skos__hiddenLabel mesh__D009697 Nucleolar Organizers
% 210.46/210.61  |- rdf__type mesh__D009697sskos__Concept
% 210.46/210.61  |- skos__hiddenLabel mesh__D009697 Region, Nucleolus Organizer
% 210.46/210.61  |- skos__hiddenLabel mesh__D009697 Organizers, Nucleolar
% 210.46/210.61  |- mesh__recordAuthorizer mesh__D009697 sjn
% 210.46/210.61  |- mesh__recordMaintainer mesh__D009697 nns
% 210.46/210.61  |- skos__scopeNote mesh__D009697
% 210.46/210.61       The chromosome region which is active in nucleolus formation and which functions in the synthesis of ribosomal RNA.%A%    
% 210.46/210.61  |- skos__hiddenLabel mesh__D009697 Organizer, Nucleolar
% 210.46/210.61  |- mesh__dateEstablished mesh__D009697 1980-01-01
% 210.46/210.61  |- mesh__dateCreated mesh__D009697 1979-05-25
% 210.46/210.61  |- skos__hiddenLabel mesh__D009697 Organizer Regions, Nucleolus
% 210.46/210.61  |- skos__historyNote mesh__D009697 Cell Nucleolus %28%1966-1979%29%
% 210.46/210.61  |- skos__historyNote mesh__D009697 Chromosomes, Human %28%1978-1979%29%
% 210.46/210.61  |- mesh__publicMeSHNote mesh__D009697 80   
% 210.46/210.61  |- mesh__recordOriginator mesh__D009697 VDK
% 210.46/210.61  |- skos__broader mesh__D009697smesh__D040481
% 210.46/210.61  |- skos__broader mesh__D009697smesh__D022004
% 210.46/210.61  |- skos__hiddenLabel mesh__D009697 Regions, Nucleolus Organizer
% 210.46/210.61  |- skos__historyNote mesh__D009697
% 210.46/210.61       specific human chromosome %28%1968-1979%29%
% 210.46/210.61  |- skos__altLabel mesh__D042522 Gene Replication Timing
% 210.46/210.61  |- skos__broader mesh__D042522smesh__D004261
% 210.46/210.61  |- mesh__historyNote mesh__D042522 2004   
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D042522 2006
% 210.46/210.61  |- skos__hiddenLabel mesh__D042522 Timings, Chromosome Replication
% 210.46/210.61  |- skos__hiddenLabel mesh__D042522 DNA Replication Timings
% 210.46/210.61  |- skos__hiddenLabel mesh__D042522 Timing, DNA Replication
% 210.46/210.61  |- mesh__activeMeSHYear mesh__D042522 2005
% 210.46/210.61  |- skos__altLabel mesh__D042522 DNA Replication Pattern, Temporal
% 210.46/210.61  |- skos__hiddenLabel mesh__D042522 Replication Timing, DNA
% 210.46/210.61  |- skos__historyNote mesh__D042522 DNA Replication %28%1968-2003%29%
% 210.46/210.61  |- skos__hiddenLabel mesh__D042522 Replication Timing, Chromosome
% 210.46/210.61  |- skos__hiddenLabel mesh__D042522 Replication Timings, DNA
% 210.46/210.61  |- skos__hiddenLabel mesh__D042522 Replication Timings, Chromosome
% 210.46/210.61  |- skos__related mesh__D042522smesh__D016196
% 210.46/210.61  |- skos__hiddenLabel mesh__D042522 Timing, Chromosome Replication
% 210.46/210.61  |- skos__scopeNote mesh__D042522
% 210.46/210.61       The temporal order in which the DNA of the GENOME is replicated.%A%    
% 210.46/210.61  |- skos__hiddenLabel mesh__D042522 Replication Timing, Gene
% 210.46/210.61  |- skos__hiddenLabel mesh__D042522 Timing, Gene Replication
% 210.46/210.61  |- skos__altLabel mesh__D042522 DNA Replication Order, Temporal
% 210.47/210.61  |- mesh__dateEstablished mesh__D042522 2004-01-01
% 210.47/210.61  |- skos__altLabel mesh__D042522 Chromosome Replication Pattern, Temporal
% 210.47/210.61  |- skos__hiddenLabel mesh__D042522 Chromosome Replication Timings
% 210.47/210.61  |- skos__hiddenLabel mesh__D042522 Timings, DNA Replication
% 210.47/210.61  |- rdf__type mesh__D042522sskos__Concept
% 210.47/210.61  |- skos__hiddenLabel mesh__D042522 Timings, Gene Replication
% 210.47/210.61  |- skos__altLabel mesh__D042522 Chromosome Replication Timing
% 210.47/210.61  |- skos__altLabel mesh__D042522 Gene Replication Pattern, Temporal
% 210.47/210.61  |- skos__hiddenLabel mesh__D042522 Replication Timings, Gene
% 210.47/210.61  |- mesh__activeMeSHYear mesh__D042522 2004
% 210.47/210.61  |- skos__hiddenLabel mesh__D042522 Gene Replication Timings
% 210.47/210.61  |- mesh__dateCreated mesh__D042522 2003-07-09
% 210.47/210.61  |- skos__prefLabel mesh__D042522 DNA Replication Timing
% 210.47/210.61  |- mesh__publicMeSHNote mesh__D042522 2004   
% 210.47/210.61  |- skos__prefLabel mesh__D020070 Cervical Ripening
% 210.47/210.61  |- mesh__dateCreated mesh__D020070 1998-06-10
% 210.47/210.61  |- skos__hiddenLabel mesh__D020070 Cervical Ripenings
% 210.47/210.61  |- skos__broader mesh__D020070smesh__D007743
% 210.47/210.61  |- mesh__activeMeSHYear mesh__D020070 2005
% 210.47/210.61  |- skos__historyNote mesh__D020070 Cervix Uteri %28%1976-1998%29%
% 210.47/210.61  |- rdf__type mesh__D020070sskos__Concept
% 210.47/210.61  |- skos__hiddenLabel mesh__D020070 Ripenings, Cervical
% 210.47/210.61  |- skos__scopeNote mesh__D020070
% 210.47/210.61       A change in the CERVIX UTERI with respect to its readiness to relax. The cervix normally becomes softer, more flexible, more distensible, and shorter in the final weeks of PREGNANCY. These cervical changes can also be chemically induced %28%LABOR, INDUCED%29%.%A%    
% 210.47/210.61  |- mesh__historyNote mesh__D020070 99   
% 210.47/210.61  |- mesh__activeMeSHYear mesh__D020070 2006
% 210.47/210.61  |- mesh__recordAuthorizer mesh__D020070 sjn
% 210.47/210.61  |- mesh__recordOriginator mesh__D020070 NDW
% 210.47/210.61  |- mesh__dateRevised mesh__D020070 2004-07-07
% 210.47/210.61  |- mesh__dateEstablished mesh__D020070 1999-01-01
% 210.47/210.61  |- mesh__recordMaintainer mesh__D020070 lkt
% 210.47/210.61  |- skos__hiddenLabel mesh__D020070 Ripening, Cervical
% 210.47/210.61  |- mesh__publicMeSHNote mesh__D020070 99   
% 210.47/210.61  |- mesh__activeMeSHYear mesh__D014831 2004
% 210.47/210.61  |- skos__annotation mesh__D014831
% 210.47/210.61       human only: for animal use VOCALIZATION, ANIMAL   
% 210.47/210.61  |- skos__prefLabel mesh__D014831 Voice
% 210.47/210.61  |- mesh__recordMaintainer mesh__D014831 nns
% 210.47/210.61  |- mesh__dateCreated mesh__D014831 1999-01-01
% 210.47/210.61  |- skos__related mesh__D014831smesh__D013060
% 210.47/210.61  |- rdf__type mesh__D014831sskos__Concept
% 210.47/210.61  |- mesh__dateRevised mesh__D014831 2003-07-09
% 210.47/210.61  |- skos__broader mesh__D014831smesh__D044702
% 210.47/210.61  |- mesh__recordOriginator mesh__D014831 NLM
% 210.47/210.61  |- mesh__recordAuthorizer mesh__D014831 sjn
% 210.47/210.61  |- mesh__activeMeSHYear mesh__D014831 2006
% 210.47/210.61  |- skos__hiddenLabel mesh__D014831 Voices
% 210.47/210.61  |- mesh__activeMeSHYear mesh__D014831 2005
% 210.47/210.61  |- skos__related mesh__D014831smesh__D010699
% 210.47/210.61  |- skos__scopeNote mesh__D014831
% 210.47/210.61       The sounds produced by humans by the passage of air through the LARYNX and over the VOCAL CORDS, and then modified by the resonance organs, the NASOPHARYNX, and the MOUTH.%A%    
% 210.47/210.61  |- mesh__dateRevised mesh__D014033 2005-06-30
% 210.47/210.61  |- skos__hiddenLabel mesh__D014033 Toe Interphalangeal Joints
% 210.47/210.61  |- skos__hiddenLabel mesh__D014033 Toe Interphalangeal Joint
% 210.47/210.61  |- mesh__recordMaintainer mesh__D014033 ags
% 210.47/210.61  |- rdf__type mesh__D014033sskos__Concept
% 210.47/210.61  |- skos__prefLabel mesh__D014033 Toe Joint
% 210.47/210.61  |- skos__scopeNote mesh__D014033
% 210.47/210.61       The articulation between the head of one phalanx and the base of the one distal to it, in each toe.%A%    
% 210.47/210.61  |- skos__hiddenLabel mesh__D014033 Foot Interphalangeal Joint
% 210.47/210.61  |- mesh__publicMeSHNote mesh__D014033 65   
% 210.47/210.61  |- skos__broader mesh__D014033smesh__D033023
% 210.47/210.61  |- mesh__recordOriginator mesh__D014033 NLM
% 210.47/210.61  |- skos__hiddenLabel mesh__D014033 Foot Interphalangeal Joints
% 210.47/210.61  |- skos__hiddenLabel mesh__D014033 Joint, Toe
% 210.47/210.61  |- skos__hiddenLabel mesh__D014033 Joints, Toe
% 210.47/210.61  |- mesh__activeMeSHYear mesh__D014033 2006
% 210.47/210.61  |- mesh__historyNote mesh__D014033 65   
% 210.47/210.61  |- mesh__dateCreated mesh__D014033 1999-01-01
% 210.47/210.61  |- skos__altLabel mesh__D014033 Interphalangeal Joint of Foot
% 210.47/210.61  |- mesh__recordAuthorizer mesh__D014033 sjn
% 210.47/210.61  |- skos__annotation mesh__D014033
% 210.47/210.61       restrict to humans and other vertebrates; differentiate from TOES%A%  
% 210.47/210.61  |- skos__altLabel mesh__D014033 Interphalangeal Joint of Toe
% 210.47/210.61  |- mesh__dateEstablished mesh__D014033 1965-01-01
% 210.47/210.61  |- skos__hiddenLabel mesh__D014033 Toe Joints
% 210.47/210.61  |- mesh__dateRevised mesh__D000811 2003-07-09
% 210.47/210.61  |- mesh__historyNote mesh__D000811 72   
% 210.47/210.61  |- mesh__dateEstablished mesh__D000811 1972-01-01
% 210.47/210.61  |- mesh__dateCreated mesh__D000811 1999-01-01
% 210.47/210.61  |- mesh__recordOriginator mesh__D000811 NLM
% 210.47/210.61  |- mesh__activeMeSHYear mesh__D000811 2004
% 210.47/210.61  |- rdf__type mesh__D000811sskos__Concept
% 210.47/210.61  |- mesh__activeMeSHYear mesh__D000811 2006
% 210.47/210.61  |- mesh__recordAuthorizer mesh__D000811 sjn
% 210.47/210.61  |- mesh__recordMaintainer mesh__D000811 ags
% 210.47/210.61  |- skos__prefLabel mesh__D000811 Anguilla
% 210.47/210.61  |- skos__broader mesh__D000811smesh__D004524
% 210.47/210.61  |- skos__historyNote mesh__D000811 Eels %28%1966-1971%29%
% 210.47/210.61  |- mesh__publicMeSHNote mesh__D000811 72   
% 210.47/210.61  |- skos__hiddenLabel mesh__D000811 Anguillas
% 210.47/210.61  |- mesh__activeMeSHYear mesh__D000811 2005
% 210.47/210.62  |- skos__annotation mesh__D000811
% 210.47/210.62       eel; NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 210.47/210.62  |- mesh__onlineNote mesh__D000013
% 210.47/210.62       pre-explosion = ABNORMALITIES %28%PX%29%   
% 210.47/210.62  |- skos__altLabel mesh__D000013 Birth Defects
% 210.47/210.62  |- skos__hiddenLabel mesh__D000013 Abnormality
% 210.47/210.62  |- skos__altLabel mesh__D000013 Deformities
% 210.47/210.62  |- skos__altLabel mesh__D000013 Defects, Congenital
% 210.47/210.62  |- skos__altLabel mesh__D000013 Abnormalities, Congenital
% 210.47/210.62  |- skos__hiddenLabel mesh__D000013 Deformity
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D000013 2004
% 210.47/210.62  |- skos__broader mesh__D000013smesh__D009358
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D000013 2002
% 210.47/210.62  |- skos__altLabel mesh__D000013 Congenital Defects
% 210.47/210.62  |- mesh__dateRevised mesh__D000013 2000-06-22
% 210.47/210.62  |- skos__hiddenLabel mesh__D000013 Abnormality, Congenital
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D000013 2003
% 210.47/210.62  |- mesh__dateCreated mesh__D000013 1999-01-01
% 210.47/210.62  |- mesh__recordAuthorizer mesh__D000013 sjn
% 210.47/210.62  |- skos__hiddenLabel mesh__D000013 Defect, Birth
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D000013 2006
% 210.47/210.62  |- skos__prefLabel mesh__D000013 Abnormalities
% 210.47/210.62  |- mesh__recordOriginator mesh__D000013 NLM
% 210.47/210.62  |- skos__hiddenLabel mesh__D000013 Defects, Birth
% 210.47/210.62  |- skos__hiddenLabel mesh__D000013 Birth Defect
% 210.47/210.62  |- skos__hiddenLabel mesh__D000013 Congenital Abnormality
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D000013 2001
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D000013 2005
% 210.47/210.62  |- rdf__type mesh__D000013sskos__Concept
% 210.47/210.62  |- skos__hiddenLabel mesh__D000013 Defect, Congenital
% 210.47/210.62  |- skos__hiddenLabel mesh__D000013 Congenital Defect
% 210.47/210.62  |- mesh__recordMaintainer mesh__D000013 jls
% 210.47/210.62  |- skos__annotation mesh__D000013
% 210.47/210.62       GEN only: prefer /abnorm: Manual 19.7+, 19.8.1; do not use /compl /congen %26% do not coord with INFANT, NEWBORN, DISEASES; policy: Manual 23.20+; TN 109: relation to /congen %26% INFANT, NEWBORN, DISEASES%A%  
% 210.47/210.62  |- skos__altLabel mesh__D000013 Congenital Abnormalities
% 210.47/210.62  |- skos__scopeNote mesh__D000013
% 210.47/210.62       Congenital malformations of organs or parts.     
% 210.47/210.62  |- mesh__dateRevised mesh__D038481 2005-07-12
% 210.47/210.62  |- mesh__recordOriginator mesh__D038481 lkt
% 210.47/210.62  |- mesh__historyNote mesh__D038481 2003   
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D038481 2005
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D038481 2006A
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D038481 2006
% 210.47/210.62  |- skos__prefLabel mesh__D038481 Anterior Temporal Lobectomy
% 210.47/210.62  |- skos__hiddenLabel mesh__D038481 Lobectomy, Anterior Temporal
% 210.47/210.62  |- mesh__recordMaintainer mesh__D038481 ags
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D038481 2003
% 210.47/210.62  |- skos__broader mesh__D038481smesh__D019635
% 210.47/210.62  |- mesh__publicMeSHNote mesh__D038481 2003   
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D038481 2004
% 210.47/210.62  |- mesh__dateCreated mesh__D038481 2002-07-02
% 210.47/210.62  |- skos__scopeNote mesh__D038481
% 210.47/210.62       A neurosurgical procedure that removes the anterior TEMPORAL LOBE including the medial temporal structures of CEREBRAL CORTEX; AMYGDALA; HIPPOCAMPUS; and the adjacent PARAHIPPOCAMPAL GYRUS. This procedure is generally used for the treatment of intractable temporal epilepsy %28%EPILEPSY, TEMPORAL LOBE%29%.%A%    
% 210.47/210.62  |- skos__related mesh__D038481smesh__D004833
% 210.47/210.62  |- skos__historyNote mesh__D038481
% 210.47/210.62       Epilepsy, Temporal Lobe %28%1965-2002%29%
% 210.47/210.62  |- rdf__type mesh__D038481sskos__Concept
% 210.47/210.62  |- mesh__dateEstablished mesh__D038481 2003-01-01
% 210.47/210.62  |- mesh__recordAuthorizer mesh__D038481 ags
% 210.47/210.62  |- mesh__recordMaintainer mesh__D046913 ssb
% 210.47/210.62  |- skos__annotation mesh__D046913
% 210.47/210.62       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.47/210.62  |- mesh__recordAuthorizer mesh__D046913 sjn
% 210.47/210.62  |- mesh__historyNote mesh__D046913 2005   
% 210.47/210.62  |- rdf__type mesh__D046913sskos__Concept
% 210.47/210.62  |- skos__scopeNote mesh__D046913
% 210.47/210.62       A plant species of the family FABACEAE used to study GENETICS because it is DIPLOID, self fertile, has a small genome, and short generation time.%A%    
% 210.47/210.62  |- skos__prefLabel mesh__D046913 Medicago truncatula
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D046913 2006
% 210.47/210.62  |- mesh__dateEstablished mesh__D046913 2005-01-01
% 210.47/210.62  |- mesh__dateCreated mesh__D046913 2004-07-07
% 210.47/210.62  |- mesh__recordOriginator mesh__D046913 ssb
% 210.47/210.62  |- mesh__publicMeSHNote mesh__D046913 2005   
% 210.47/210.62  |- skos__historyNote mesh__D046913 Medicago %28%1992-2004%29%
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D046913 2005
% 210.47/210.62  |- skos__broader mesh__D046913smesh__D029902
% 210.47/210.62  |- skos__altLabel mesh__D013739 Ortho Brand of Testosterone
% 210.47/210.62  |- skos__prefLabel mesh__D013739 Testosterone
% 210.47/210.62  |- skos__altLabel mesh__D013739 Dr. Kade Brand of Testosterone
% 210.47/210.62  |- skos__altLabel mesh__D013739 CEPA Brand of Testosterone
% 210.47/210.62  |- skos__altLabel mesh__D013739 Solvay Brand of Testosterone
% 210.47/210.62  |- skos__altLabel mesh__D013739 17-beta-Hydroxy-8 alpha-4-Androsten-3-one
% 210.47/210.62  |- skos__annotation mesh__D013739
% 210.47/210.62       TESTOSTERONE PROPIONATE is also available   
% 210.47/210.62  |- mesh__recordMaintainer mesh__D013739 ags
% 210.47/210.62  |- skos__altLabel mesh__D013739 Ulmer Brand of Testosterone
% 210.47/210.62  |- skos__hiddenLabel mesh__D013739 8 Isotestosterone
% 210.47/210.62  |- skos__altLabel mesh__D013739 Paladin Brand of Testosterone
% 210.47/210.62  |- skos__altLabel mesh__D013739
% 210.47/210.62       Auxilium Pharmaceuticals Inc. Brand of Testosterone
% 210.47/210.62  |- skos__broader mesh__D013739smesh__D000737
% 210.47/210.62  |- mesh__historyNote mesh__D013739
% 210.47/210.62       1963; for SUSTANON use TESTOSTERONE %28%NM%29% 1976-2003; /therapeutic use was TESTOSTERONE, THERAPEUTIC 1965%A%  
% 210.47/210.62  |- skos__altLabel mesh__D013739 Unimed Brand of Testosterone
% 210.47/210.62  |- skos__altLabel mesh__D013739 SmithKline Beecham Brand of Testosterone
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D013739 2006
% 210.47/210.62  |- rdf__type mesh__D013739sskos__Concept
% 210.47/210.62  |- mesh__publicMeSHNote mesh__D013739
% 210.47/210.62       1963; SUSTANON was indexed under TESTOSTERONE/AA 1976-2003; /therapeutic use was TESTOSTERONE, THERAPEUTIC 1965%A%  
% 210.47/210.62  |- mesh__dateCreated mesh__D013739 1999-01-01
% 210.47/210.62  |- skos__scopeNote mesh__D013739
% 210.47/210.62       A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.%A%    
% 210.47/210.62  |- skos__altLabel mesh__D013739 Bartor Brand of Testosterone
% 210.47/210.62  |- skos__altLabel mesh__D013739 Watson Brand of Testosterone
% 210.47/210.62  |- skos__altLabel mesh__D013739 Ferring Brand of Testosterone
% 210.47/210.62  |- mesh__recordOriginator mesh__D013739 NLM
% 210.47/210.62  |- mesh__dateRevised mesh__D013739 2005-07-27
% 210.47/210.62  |- skos__hiddenLabel mesh__D013739
% 210.47/210.62       17 beta Hydroxy 8 alpha 4 Androsten 3 one
% 210.47/210.62  |- skos__altLabel mesh__D013739 AstraZeneca Brand of Testosterone
% 210.47/210.62  |- skos__altLabel mesh__D013739 17-beta-Hydroxy-4-Androsten-3-one
% 210.47/210.62  |- skos__broader mesh__D013739smesh__D045165
% 210.47/210.62  |- skos__altLabel mesh__D013739 Schering Brand of Testosterone
% 210.47/210.62  |- skos__hiddenLabel mesh__D013739 17 beta Hydroxy 4 Androsten 3 one
% 210.47/210.62  |- mesh__recordAuthorizer mesh__D013739 ags
% 210.47/210.62  |- skos__altLabel mesh__D013739 Faulding Brand of Testosterone
% 210.47/210.62  |- skos__altLabel mesh__D013739 Pasadena Brand of Testosterone
% 210.47/210.62  |- skos__altLabel mesh__D013739 GlaxoSmithKline Brand of Testosterone
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D013739 2006A
% 210.47/210.62  |- skos__altLabel mesh__D013739 Hauck Brand of Testosterone
% 210.47/210.62  |- mesh__recordAuthorizer mesh__D024461 sjn
% 210.47/210.62  |- skos__altLabel mesh__D024461 Myosin I
% 210.47/210.62  |- mesh__dateRevised mesh__D024461 2005-06-30
% 210.47/210.62  |- mesh__publicMeSHNote mesh__D024461
% 210.47/210.62       2002; for MYOSIN IA %26% MYOSIN IB see MYOSIN 1988-2001   
% 210.47/210.62  |- skos__prefLabel mesh__D024461 Myosin Type I
% 210.47/210.62  |- mesh__recordMaintainer mesh__D024461 DRC
% 210.47/210.62  |- skos__scopeNote mesh__D024461
% 210.47/210.62       A subclass of myosins found generally associated with actin-rich membrane structures such as filopodia. Members of the myosin type I family are ubiquitously expressed in eukaryotes. The heavy chains of myosin type I lack coiled-coil forming sequences in their tails and therefore do not dimerize.%A%    
% 210.47/210.62  |- mesh__dateCreated mesh__D024461 2001-07-25
% 210.47/210.62  |- mesh__dateEstablished mesh__D024461 2002-01-01
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D024461 2006
% 210.47/210.62  |- skos__broader mesh__D024461smesh__D009218
% 210.47/210.62  |- rdf__type mesh__D024461sskos__Concept
% 210.47/210.62  |- mesh__historyNote mesh__D024461
% 210.47/210.62       2002; for MYOSIN IA %26% MYOSIN IB use MYOSINS 1988-2001   
% 210.47/210.62  |- skos__historyNote mesh__D024461 Myosins %28%1987-2001%29%
% 210.47/210.62  |- mesh__recordOriginator mesh__D024461 jmp
% 210.47/210.62  |- skos__altLabel mesh__D018424 Middle Ear Cholesteatoma
% 210.47/210.62  |- mesh__historyNote mesh__D018424 95   
% 210.47/210.62  |- skos__prefLabel mesh__D018424 Cholesteatoma, Middle Ear
% 210.47/210.62  |- mesh__dateEstablished mesh__D018424 1995-01-01
% 210.47/210.62  |- skos__broader mesh__D018424smesh__D002781
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D018424 2000
% 210.47/210.62  |- skos__historyNote mesh__D018424 Ear, Middle %28%1966-1994%29%
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D018424 2006
% 210.47/210.62  |- skos__hiddenLabel mesh__D018424 Middle Ear Cholesteatomas
% 210.47/210.62  |- mesh__publicMeSHNote mesh__D018424 95   
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D018424 2005
% 210.47/210.62  |- mesh__recordAuthorizer mesh__D018424 sjn
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D018424 2004
% 210.47/210.62  |- skos__broader mesh__D018424smesh__D004427
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D018424 2002
% 210.47/210.62  |- mesh__recordOriginator mesh__D018424 PXP
% 210.47/210.62  |- rdf__type mesh__D018424sskos__Concept
% 210.47/210.62  |- skos__scopeNote mesh__D018424
% 210.47/210.62       Cholesteatoma of the middle ear, usually associated with chronic infection, and commonly affecting the tympanum, epitympanum, and antrum.%A%    
% 210.47/210.62  |- mesh__recordMaintainer mesh__D018424 KEV
% 210.47/210.62  |- mesh__dateRevised mesh__D018424 1999-11-03
% 210.47/210.62  |- mesh__dateCreated mesh__D018424 1994-06-03
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D018424 2003
% 210.47/210.62  |- skos__historyNote mesh__D018424 Ear Diseases %28%1966-1994%29%
% 210.47/210.62  |- skos__hiddenLabel mesh__D018424 Cholesteatomas, Middle Ear
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D018424 2001
% 210.47/210.62  |- skos__historyNote mesh__D018424 Cholesteatoma %28%1966-1994%29%
% 210.47/210.62  |- mesh__dateRevised mesh__D010441 2004-07-30
% 210.47/210.62  |- mesh__publicMeSHNote mesh__D010441
% 210.47/210.62       2005; see PEPTIDE CHAIN ELONGATION 1973-2004   
% 210.47/210.62  |- mesh__recordMaintainer mesh__D010441 jls
% 210.47/210.62  |- skos__prefLabel mesh__D010441 Peptide Chain Elongation, Translational
% 210.47/210.62  |- skos__related mesh__D010441smesh__D010458
% 210.47/210.62  |- skos__altLabel mesh__D010441 Chain Elongation, Peptide, Translational
% 210.47/210.62  |- rdf__type mesh__D010441sskos__Concept
% 210.47/210.62  |- mesh__recordOriginator mesh__D010441 NLM
% 210.47/210.62  |- skos__related mesh__D010441smesh__D010445
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D010441 2005
% 210.47/210.62  |- mesh__historyNote mesh__D010441 2005%28%1971%29%   
% 210.47/210.62  |- skos__historyNote mesh__D010441 Peptides/biosynthesis %28%1966-1970%29%
% 210.47/210.62  |- mesh__dateEstablished mesh__D010441 1973-01-01
% 210.47/210.62  |- mesh__dateCreated mesh__D010441 1999-01-01
% 210.47/210.62  |- skos__related mesh__D010441smesh__D011500
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D010441 2006
% 210.47/210.62  |- mesh__recordAuthorizer mesh__D010441 jls
% 210.47/210.62  |- skos__altLabel mesh__D010441 Translational Peptide Chain Elongation
% 210.47/210.62  |- skos__broader mesh__D010441smesh__D014176
% 210.47/210.62  |- skos__altLabel mesh__D010441 Protein Chain Elongation, Translational
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D010441 2005A
% 210.47/210.62  |- skos__annotation mesh__D010441
% 210.47/210.62       coordinate with specific peptide; for protein biosynthesis on the ribosome only; for non-ribosomal biosynthesis use PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT%A%  
% 210.47/210.62  |- skos__scopeNote mesh__D010441
% 210.47/210.62       A process of GENETIC TRANSLATION, when an amino acid is transferred from its cognate TRANSFER RNA to the lengthening chain of PEPTIDES.%A%    
% 210.47/210.62  |- mesh__dateCreated mesh__D051858 2005-06-30
% 210.47/210.62  |- skos__scopeNote mesh__D051858
% 210.47/210.62       A subclass of winged helix DNA-binding proteins that share homology with their founding member fork head protein, Drosophila.%A%    
% 210.47/210.62  |- mesh__recordOriginator mesh__D051858 DRC
% 210.47/210.62  |- skos__altLabel mesh__D051858 Fox Transcription Factors
% 210.47/210.62  |- skos__altLabel mesh__D051858 Forkhead Box Transcription Factors
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D051858 2006
% 210.47/210.62  |- skos__hiddenLabel mesh__D051858 Transcription Factors, Fox
% 210.47/210.62  |- mesh__historyNote mesh__D051858 2006%28%1989%29%   
% 210.47/210.62  |- rdf__type mesh__D051858sskos__Concept
% 210.47/210.62  |- skos__hiddenLabel mesh__D051858 Transcription Factors, Forkhead
% 210.47/210.62  |- mesh__recordMaintainer mesh__D051858 DRC
% 210.47/210.62  |- mesh__dateEstablished mesh__D051858 2006-01-01
% 210.47/210.62  |- skos__altLabel mesh__D051858 Forkhead Proteins
% 210.47/210.62  |- mesh__publicMeSHNote mesh__D051858
% 210.47/210.62       2006; FORKHEAD TRANSCRIPTION FACTORS was indexed under NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1989-2005%A%  
% 210.47/210.62  |- skos__altLabel mesh__D051858 Forkhead Box Proteins
% 210.47/210.62  |- skos__broader mesh__D051858smesh__D051540
% 210.47/210.62  |- skos__prefLabel mesh__D051858 Forkhead Transcription Factors
% 210.47/210.62  |- mesh__recordAuthorizer mesh__D051858 sjn
% 210.47/210.62  |- skos__hiddenLabel mesh__D004404 Intestinal Entamoebiasis
% 210.47/210.62  |- skos__hiddenLabel mesh__D004404 Amoebic Dysenteries
% 210.47/210.62  |- skos__hiddenLabel mesh__D004404 Amebic Dysenteries
% 210.47/210.62  |- skos__broader mesh__D004404smesh__D000562
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D004404 2006
% 210.47/210.62  |- mesh__recordOriginator mesh__D004404 NLM
% 210.47/210.62  |- skos__broader mesh__D004404smesh__D007411
% 210.47/210.62  |- rdf__type mesh__D004404sskos__Concept
% 210.47/210.62  |- skos__hiddenLabel mesh__D004404 Dysenteries, Amebic
% 210.47/210.62  |- skos__scopeNote mesh__D004404
% 210.47/210.62       DYSENTERY caused by intestinal PROTOZOA infection, chiefly with ENTAMOEBA HISTOLYTICA. This condition may be associated with amebic infection of the LIVER and other distant sites.%A%    
% 210.47/210.62  |- skos__hiddenLabel mesh__D004404 Intestinal Amebiases
% 210.47/210.62  |- mesh__recordMaintainer mesh__D004404 lkt
% 210.47/210.62  |- mesh__recordAuthorizer mesh__D004404 sjn
% 210.47/210.62  |- skos__hiddenLabel mesh__D004404 Entamoebiases, Intestinal
% 210.47/210.62  |- skos__hiddenLabel mesh__D004404 Dysenteries, Amoebic
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D004404 2005
% 210.47/210.62  |- skos__hiddenLabel mesh__D004404 Amebic Colitis
% 210.47/210.62  |- skos__broader mesh__D004404smesh__D004403
% 210.47/210.62  |- skos__hiddenLabel mesh__D004404 Colitides, Amoebic
% 210.47/210.62  |- skos__altLabel mesh__D004404 Intestinal Amebiasis
% 210.47/210.62  |- skos__altLabel mesh__D004404 Colitis, Amebic
% 210.47/210.62  |- skos__hiddenLabel mesh__D004404 Amebic Colitides
% 210.47/210.62  |- skos__altLabel mesh__D004404 Intestinal Amoebiasis
% 210.47/210.62  |- skos__hiddenLabel mesh__D004404 Colitides, Amebic
% 210.47/210.62  |- mesh__dateCreated mesh__D004404 1999-01-01
% 210.47/210.62  |- skos__hiddenLabel mesh__D004404 Colitis, Amoebic
% 210.47/210.62  |- skos__altLabel mesh__D004404 Amoebic Colitis
% 210.47/210.62  |- skos__hiddenLabel mesh__D004404 Dysentery, Amoebic
% 210.47/210.62  |- mesh__dateRevised mesh__D004404 2004-07-07
% 210.47/210.62  |- skos__hiddenLabel mesh__D004404 Intestinal Entamoebiases
% 210.47/210.62  |- skos__hiddenLabel mesh__D004404 Intestinal Amoebiases
% 210.47/210.62  |- skos__prefLabel mesh__D004404 Dysentery, Amebic
% 210.47/210.62  |- skos__hiddenLabel mesh__D004404 Amoebic Colitides
% 210.47/210.62  |- skos__hiddenLabel mesh__D004404 Amoebiases, Intestinal
% 210.47/210.62  |- skos__altLabel mesh__D004404 Amebic Dysentery
% 210.47/210.62  |- skos__hiddenLabel mesh__D004404 Amebiases, Intestinal
% 210.47/210.62  |- skos__altLabel mesh__D004404 Amoebic Dysentery
% 210.47/210.62  |- skos__altLabel mesh__D004404 Amoebiasis, Intestinal
% 210.47/210.62  |- skos__altLabel mesh__D004404 Amebiasis, Intestinal
% 210.47/210.62  |- rdf__type mesh__D009698sskos__Concept
% 210.47/210.62  |- mesh__dateCreated mesh__D009698 1999-01-01
% 210.47/210.62  |- skos__scopeNote mesh__D009698
% 210.47/210.62       Proteins conjugated with nucleic acids.     
% 210.47/210.62  |- skos__prefLabel mesh__D009698 Nucleoproteins
% 210.47/210.62  |- skos__altLabel mesh__D009698 Nucleoprotein
% 210.47/210.62  |- skos__broader mesh__D009698smesh__D011506
% 210.47/210.62  |- mesh__dateRevised mesh__D009698 2005-06-30
% 210.47/210.62  |- skos__annotation mesh__D009698
% 210.47/210.62       proteins conjugated with nucleic acids: do not confuse with NUCLEAR PROTEINS %28%proteins in the cell nucleus%29%%A%  
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D009698 2006
% 210.47/210.62  |- mesh__recordOriginator mesh__D009698 NLM
% 210.47/210.62  |- mesh__recordMaintainer mesh__D009698 SYSTEM
% 210.47/210.62  |- mesh__recordAuthorizer mesh__D009698 sjn
% 210.47/210.62  |- rdf__type mesh__D020071sskos__Concept
% 210.47/210.62  |- mesh__recordMaintainer mesh__D020071 nns
% 210.47/210.62  |- skos__prefLabel mesh__D020071 Interspersed Repetitive Sequences
% 210.47/210.62  |- skos__altLabel mesh__D020071 Elements, Mobile Genetic
% 210.47/210.62  |- skos__hiddenLabel mesh__D020071 Gene, Jumping
% 210.47/210.62  |- skos__hiddenLabel mesh__D020071 Repetitive Sequence, Dispersed
% 210.47/210.62  |- mesh__recordOriginator mesh__D020071 NNS
% 210.47/210.62  |- skos__hiddenLabel mesh__D020071 Element, Mobile Genetic
% 210.47/210.62  |- skos__annotation mesh__D020071
% 210.47/210.62       GEN: prefer specifics - DNA TRANSPOSABLE ELEMENTS or RETROELEMENTS or its indentions%A%  
% 210.47/210.62  |- skos__historyNote mesh__D020071
% 210.47/210.62       DNA Transposable Elements %28%1980-1998%29%
% 210.47/210.62  |- skos__broader mesh__D020071smesh__D012091
% 210.47/210.62  |- mesh__recordAuthorizer mesh__D020071 sjn
% 210.47/210.62  |- skos__altLabel mesh__D020071 Interspersed Repetitive Elements
% 210.47/210.62  |- skos__related mesh__D020071smesh__D016254
% 210.47/210.62  |- mesh__dateCreated mesh__D020071 1998-06-10
% 210.47/210.62  |- skos__hiddenLabel mesh__D020071 Repetitive Elements, Interspersed
% 210.47/210.62  |- skos__hiddenLabel mesh__D020071 Sequence, Dispersed Repetitive
% 210.47/210.62  |- skos__altLabel mesh__D020071 Dispersed Repetitive Sequences
% 210.47/210.62  |- skos__hiddenLabel mesh__D020071 Element, Interspersed Repetitive
% 210.47/210.62  |- skos__hiddenLabel mesh__D020071 Sequences, Interspersed Repetitive
% 210.47/210.62  |- skos__altLabel mesh__D020071 Repetitive Sequences, Interspersed
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D020071 2006
% 210.47/210.62  |- mesh__dateEstablished mesh__D020071 1999-01-01
% 210.47/210.62  |- skos__scopeNote mesh__D020071
% 210.47/210.62       Copies of transposable elements interspersed throughout the genome, some of which are still active and often referred to as %22%jumping genes%22%. There are two classes of interspersed repetitive elements. Class I elements %28%or RETROELEMENTS - such as retrotransposons, retroviruses, LONG INTERSPERSED NUCLEOTIDE ELEMENTS and SHORT INTERSPERSED NUCLEOTIDE ELEMENTS%29% transpose via reverse transcription of an RNA intermediate. Class II elements %28%or DNA TRANSPOSABLE ELEMENTS - such as transposons, Tn elements, insertion sequence elements and mobile gene cassettes of bacterial integrons%29% transpose directly from one site in the DNA to another.%A%    
% 210.47/210.62  |- skos__hiddenLabel mesh__D020071 Sequence, Interspersed Repetitive
% 210.47/210.62  |- skos__altLabel mesh__D020071 Jumping Genes
% 210.47/210.62  |- skos__historyNote mesh__D020071
% 210.47/210.62       Repetitive Sequences, Nucleic Acid %28%1981-1998%29%
% 210.47/210.62  |- skos__altLabel mesh__D020071 Repetitive Sequences, Dispersed
% 210.47/210.62  |- skos__hiddenLabel mesh__D020071 Repetitive Sequence, Interspersed
% 210.47/210.62  |- skos__hiddenLabel mesh__D020071 Sequences, Dispersed Repetitive
% 210.47/210.62  |- skos__hiddenLabel mesh__D020071 Interspersed Repetitive Element
% 210.47/210.62  |- skos__hiddenLabel mesh__D020071 Jumping Gene
% 210.47/210.62  |- mesh__publicMeSHNote mesh__D020071
% 210.47/210.62       99; for MOBILE GENETIC ELEMENTS see DNA INSERTION ELEMENTS 1986-98; for SELFISH DNA see DNA %28%1983-2003%29%%A%  
% 210.47/210.62  |- skos__hiddenLabel mesh__D020071 Dispersed Repetitive Sequence
% 210.47/210.62  |- mesh__dateRevised mesh__D020071 2005-06-30
% 210.47/210.62  |- skos__hiddenLabel mesh__D020071 Genetic Element, Mobile
% 210.47/210.62  |- skos__hiddenLabel mesh__D020071 Elements, Interspersed Repetitive
% 210.47/210.62  |- skos__hiddenLabel mesh__D020071 Interspersed Repetitive Sequence
% 210.47/210.62  |- skos__altLabel mesh__D020071 Genetic Elements, Mobile
% 210.47/210.62  |- skos__hiddenLabel mesh__D020071 Mobile Genetic Element
% 210.47/210.62  |- skos__broader mesh__D020071smesh__D040481
% 210.47/210.62  |- mesh__historyNote mesh__D020071
% 210.47/210.62       99; for MOBILE GENETIC ELEMENTS use DNA TRANSPOSABLE ELEMENTS 1986-98; for SELFISH DNA use DNA %28%1983-2003%29%%A%  
% 210.47/210.62  |- skos__hiddenLabel mesh__D020071 Repetitive Element, Interspersed
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Dysphonias, Flaccid
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Flaccid Dysphonias
% 210.47/210.62  |- mesh__dateRevised mesh__D014832 2001-07-25
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Dysphonia, Flaccid
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Fatigues, Voice
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Pseudobulbar Dysphonia, Spastic
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D014832 2004
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Dysphonias, Spastic
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Dysphonias, Hyperkinetic
% 210.47/210.62  |- skos__annotation mesh__D014832 available also is HOARSENESS   
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Neurologic Voice Disorders
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Voice Disorders, Neurologic
% 210.47/210.62  |- skos__scopeNote mesh__D014832
% 210.47/210.62       Disorders of voice pitch, loudness, or quality. Dysphonia refers to impaired utterance of sounds by the vocal folds.%A%    
% 210.47/210.62  |- mesh__dateEstablished mesh__D014832 1979-01-01
% 210.47/210.62  |- mesh__publicMeSHNote mesh__D014832 1979   
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Dysphonia, Spastic
% 210.47/210.62  |- mesh__recordMaintainer mesh__D014832 nns
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Dysphonia, Hyperkinetic
% 210.47/210.62  |- skos__prefLabel mesh__D014832 Voice Disorders
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D014832 2005
% 210.47/210.62  |- skos__altLabel mesh__D014832 Neurologic Adducter Spastic Dysphonia
% 210.47/210.62  |- mesh__dateCreated mesh__D014832 1978-05-22
% 210.47/210.62  |- skos__broader mesh__D014832smesh__D007818
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Voice Disorder
% 210.47/210.62  |- mesh__recordOriginator mesh__D014832 RC
% 210.47/210.62  |- mesh__recordAuthorizer mesh__D014832 sjn
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Dysphonia, Organic Tremor
% 210.47/210.62  |- skos__altLabel mesh__D014832 Neurologic Voice Disorder
% 210.47/210.62  |- mesh__historyNote mesh__D014832 1979   
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D014832 2006
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Tremor Dysphonia, Organic
% 210.47/210.62  |- skos__altLabel mesh__D014832 Phonation Disorders
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Disturbance, Voice
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Dysphonias, Spastic Pseudobulbar
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Tremor Dysphonias, Organic
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Spastic Dysphonias
% 210.47/210.62  |- rdf__type mesh__D014832sskos__Concept
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Organic Tremor Dysphonias
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D014832 2002
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Hyperkinetic Dysphonias
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Dysphonias, Organic Tremor
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Phonation Disorder
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Dysphonia, Spastic Pseudobulbar
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Spastic Pseudobulbar Dysphonias
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D014832 2003
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Voice Fatigues
% 210.47/210.62  |- skos__broader mesh__D014832smesh__D009461
% 210.47/210.62  |- skos__historyNote mesh__D014832 Voice %28%1966-1978%29%
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Pseudobulbar Dysphonias, Spastic
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Fatigue, Voice
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Disturbances, Voice
% 210.47/210.62  |- skos__hiddenLabel mesh__D014832 Voice Disturbances
% 210.47/210.62  |- mesh__recordAuthorizer mesh__D014034 sjn
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D014034 2005
% 210.47/210.62  |- skos__broader mesh__D014034smesh__D005545
% 210.47/210.62  |- skos__annotation mesh__D014034
% 210.47/210.62       TN 117: use for human %26% other vertebrates; TN 238: differentiation from TOE JOINT %26% indexing instructions; NIM when merely locational as in FOOT DERMATOSES %28%IM%29%%A%  
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D014034 2006
% 210.47/210.62  |- mesh__dateRevised mesh__D014034 2004-07-13
% 210.47/210.62  |- skos__prefLabel mesh__D014034 Toes
% 210.47/210.62  |- mesh__recordOriginator mesh__D014034 NLM
% 210.47/210.62  |- mesh__dateCreated mesh__D014034 1999-01-01
% 210.47/210.62  |- mesh__recordMaintainer mesh__D014034 sjn
% 210.47/210.62  |- skos__hiddenLabel mesh__D014034 Toe
% 210.47/210.62  |- rdf__type mesh__D014034sskos__Concept
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D000812 2002
% 210.47/210.62  |- mesh__recordMaintainer mesh__D000812 adp
% 210.47/210.62  |- skos__broader mesh__D000812smesh__D009930
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D000812 2001
% 210.47/210.62  |- mesh__dateCreated mesh__D000812 1999-01-01
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D000812 2004
% 210.47/210.62  |- rdf__type mesh__D000812sskos__Concept
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D000812 2006
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D000812 2003
% 210.47/210.62  |- skos__scopeNote mesh__D000812
% 210.47/210.62       Chemical compounds derived from acids by the elimination of a molecule of water.%A%    
% 210.47/210.62  |- mesh__recordOriginator mesh__D000812 NLM
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D000812 2005
% 210.47/210.62  |- mesh__dateRevised mesh__D000812 2000-06-21
% 210.47/210.62  |- mesh__historyNote mesh__D000812 66   
% 210.47/210.62  |- mesh__recordAuthorizer mesh__D000812 sjn
% 210.47/210.62  |- skos__prefLabel mesh__D000812 Anhydrides
% 210.47/210.62  |- mesh__publicMeSHNote mesh__D000812 66   
% 210.47/210.62  |- mesh__dateEstablished mesh__D000812 1966-01-01
% 210.47/210.62  |- mesh__dateCreated mesh__D000014 1999-01-01
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D000014 2001
% 210.47/210.62  |- skos__related mesh__D000014smesh__D013723
% 210.47/210.62  |- skos__scopeNote mesh__D000014
% 210.47/210.62       Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.%A%    
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D000014 2004
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D000014 2002
% 210.47/210.62  |- skos__hiddenLabel mesh__D000014 Drug-Induced Abnormality
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D000014 2005
% 210.47/210.62  |- skos__hiddenLabel mesh__D000014 Abnormality, Drug-Induced
% 210.47/210.62  |- mesh__historyNote mesh__D000014 64   
% 210.47/210.62  |- skos__broader mesh__D000014smesh__D000013
% 210.47/210.62  |- skos__hiddenLabel mesh__D000014 Abnormalities, Drug Induced
% 210.47/210.62  |- skos__altLabel mesh__D000014 Drug-Induced Abnormalities
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D000014 2006
% 210.47/210.62  |- skos__hiddenLabel mesh__D000014 Drug Induced Abnormalities
% 210.47/210.62  |- mesh__publicMeSHNote mesh__D000014 64   
% 210.47/210.62  |- skos__annotation mesh__D000014
% 210.47/210.62       IM; do not use /chem ind /compl /congen %26% do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific chem /adv eff-pois-tox %28%IM%29% + specific organ /abnorm or specific abnorm /chem ind %28%IM%29%; Manual 23.20.3%A%  
% 210.47/210.62  |- skos__prefLabel mesh__D000014 Abnormalities, Drug-Induced
% 210.47/210.62  |- mesh__recordMaintainer mesh__D000014 kle
% 210.47/210.62  |- mesh__dateRevised mesh__D000014 1999-11-03
% 210.47/210.62  |- mesh__recordAuthorizer mesh__D000014 sjn
% 210.47/210.62  |- rdf__type mesh__D000014sskos__Concept
% 210.47/210.62  |- mesh__activeMeSHYear mesh__D000014 2000
% 210.47/210.63  |- mesh__dateEstablished mesh__D000014 1964-01-01
% 210.47/210.63  |- mesh__recordOriginator mesh__D000014 NLM
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000014 2003
% 210.47/210.63  |- rdf__type mesh__D046914sskos__Concept
% 210.47/210.63  |- skos__altLabel mesh__D046914 Coumarouna odorata
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D046914 2006
% 210.47/210.63  |- skos__prefLabel mesh__D046914 Dipteryx
% 210.47/210.63  |- mesh__dateCreated mesh__D046914 2004-07-07
% 210.47/210.63  |- mesh__publicMeSHNote mesh__D046914 2005   
% 210.47/210.63  |- skos__broader mesh__D046914smesh__D007887
% 210.47/210.63  |- mesh__recordOriginator mesh__D046914 ssb
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D046914 2005
% 210.47/210.63  |- mesh__recordMaintainer mesh__D046914 ssb
% 210.47/210.63  |- skos__historyNote mesh__D046914 Fabaceae %28%1995-2004%29%
% 210.47/210.63  |- skos__altLabel mesh__D046914 Tonka Bean
% 210.47/210.63  |- mesh__recordAuthorizer mesh__D046914 sjn
% 210.47/210.63  |- skos__scopeNote mesh__D046914
% 210.47/210.63       A plant genus of the family FABACEAE. Members contain COUMARINS.%A%    
% 210.47/210.63  |- skos__annotation mesh__D046914
% 210.47/210.63       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.47/210.63  |- mesh__historyNote mesh__D046914 2005   
% 210.47/210.63  |- mesh__dateEstablished mesh__D046914 2005-01-01
% 210.47/210.63  |- skos__historyNote mesh__D024462 Myosins %28%1973-2001%29%
% 210.47/210.63  |- skos__historyNote mesh__D024462 Muscle Proteins %28%1965-1972%29%
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D024462 2006
% 210.47/210.63  |- mesh__recordOriginator mesh__D024462 jmp
% 210.47/210.63  |- skos__broader mesh__D024462smesh__D009218
% 210.47/210.63  |- rdf__type mesh__D024462sskos__Concept
% 210.47/210.63  |- mesh__dateEstablished mesh__D024462 2002-01-01
% 210.47/210.63  |- mesh__recordAuthorizer mesh__D024462 sjn
% 210.47/210.63  |- mesh__publicMeSHNote mesh__D024462
% 210.47/210.63       2002; for MYOSIN II see MYOSIN 1983-2001   
% 210.47/210.63  |- mesh__historyNote mesh__D024462
% 210.47/210.63       2002; for MYOSIN II use MYOSINS 1983-2001   
% 210.47/210.63  |- mesh__recordMaintainer mesh__D024462 DRC
% 210.47/210.63  |- skos__scopeNote mesh__D024462
% 210.47/210.63       The subfamily of myosin proteins that are commonly found in muscle fibers. Myosin II is also involved a diverse array of cellular functions including cell division, transport within the GOLGI APPARATUS, and maintaining MICROVILLI structure.%A%    
% 210.47/210.63  |- mesh__dateRevised mesh__D024462 2005-06-30
% 210.47/210.63  |- skos__altLabel mesh__D024462 Myosin II
% 210.47/210.63  |- skos__prefLabel mesh__D024462 Myosin Type II
% 210.47/210.63  |- mesh__dateCreated mesh__D024462 2001-07-25
% 210.47/210.63  |- skos__annotation mesh__D024462 GEN or unspecified; prefer specifics   
% 210.47/210.63  |- skos__related mesh__D010442smesh__D010448
% 210.47/210.63  |- mesh__recordAuthorizer mesh__D010442 jls
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D010442 2005A
% 210.47/210.63  |- rdf__type mesh__D010442sskos__Concept
% 210.47/210.63  |- skos__altLabel mesh__D010442 Protein Chain Initiation, Translational
% 210.47/210.63  |- mesh__publicMeSHNote mesh__D010442
% 210.47/210.63       2005; see PEPTIDE CHAIN INITIATION 1973-2004   
% 210.47/210.63  |- mesh__recordMaintainer mesh__D010442 jls
% 210.47/210.63  |- skos__scopeNote mesh__D010442
% 210.47/210.63       A process of GENETIC TRANSLATION whereby the formation of a peptide chain is started. It includes assembly of the RIBOSOME components, the MESSENGER RNA coding for the polypeptide to be made, INITIATOR TRNA, and PEPTIDE INITIATION FACTORS; and placement of the first amino acid in the peptide chain. The details and components of this process are unique for prokaryotic protein biosynthesis and eukaryotic protein biosynthesis.%A%    
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D010442 2005
% 210.47/210.63  |- skos__prefLabel mesh__D010442 Peptide Chain Initiation, Translational
% 210.47/210.63  |- mesh__dateCreated mesh__D010442 1999-01-01
% 210.47/210.63  |- skos__related mesh__D010442smesh__D018387
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D010442 2006
% 210.47/210.63  |- skos__altLabel mesh__D010442 Translational Peptide Chain Initiation
% 210.47/210.63  |- skos__broader mesh__D010442smesh__D014176
% 210.47/210.63  |- skos__annotation mesh__D010442
% 210.47/210.63       coordinate with specific peptide; for protein biosynthesis on the ribosome only; for non-ribosomal biosynthesis use PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT%A%  
% 210.47/210.63  |- mesh__dateRevised mesh__D010442 2004-07-30
% 210.47/210.63  |- mesh__recordOriginator mesh__D010442 NLM
% 210.47/210.63  |- mesh__historyNote mesh__D010442 73%28%71%29%   
% 210.47/210.63  |- skos__historyNote mesh__D010442 Peptides/biosynthesis %28%1966-1970%29%
% 210.47/210.63  |- mesh__dateEstablished mesh__D010442 1973-01-01
% 210.47/210.63  |- skos__related mesh__D010442smesh__D011500
% 210.47/210.63  |- skos__altLabel mesh__D010442 Chain Initiation, Peptide, Translational
% 210.47/210.63  |- mesh__recordAuthorizer mesh__D051859 sjn
% 210.47/210.63  |- mesh__historyNote mesh__D051859 2006%28%1985%29%   
% 210.47/210.63  |- rdf__type mesh__D051859sskos__Concept
% 210.47/210.63  |- mesh__dateCreated mesh__D051859 2005-06-30
% 210.47/210.63  |- skos__altLabel mesh__D051859 Neuroendocrine Peptide 7B2
% 210.47/210.63  |- skos__prefLabel mesh__D051859 Neuroendocrine Secretory Protein 7B2
% 210.47/210.63  |- skos__hiddenLabel mesh__D051859 7B2, Pituitary Protein
% 210.47/210.63  |- skos__altLabel mesh__D051859 Neuroendocrine Protein 7B2
% 210.47/210.63  |- skos__altLabel mesh__D051859 Secretory Granule Endocrine Protein I
% 210.47/210.63  |- skos__hiddenLabel mesh__D051859 7B2, Neuroendocrine Protein
% 210.47/210.63  |- skos__broader mesh__D051859smesh__D009419
% 210.47/210.63  |- skos__hiddenLabel mesh__D051859 7B2, Neuroendocrine Peptide
% 210.47/210.63  |- skos__hiddenLabel mesh__D051859 7B2, Neuroendocrine Chaperone
% 210.47/210.63  |- skos__altLabel mesh__D051859 Pituitary Protein 7B2
% 210.47/210.63  |- mesh__publicMeSHNote mesh__D051859
% 210.47/210.63       2006; NEUROENDOCRINE SECRETORY PROTEIN 7B2 was indexed under NERVE TISSUE PROTEINS %26% PITUITARY HORMONES 1985-2005%A%  
% 210.47/210.63  |- mesh__dateEstablished mesh__D051859 2006-01-01
% 210.47/210.63  |- skos__altLabel mesh__D051859 Secretogranin V
% 210.47/210.63  |- mesh__recordMaintainer mesh__D051859 DRC
% 210.47/210.63  |- skos__scopeNote mesh__D051859
% 210.47/210.63       An acidic protein found in the NEUROENDOCRINE SYSTEM that functions as a molecular chaperone for PROPROTEIN CONVERTASE 2.%A%    
% 210.47/210.63  |- skos__altLabel mesh__D051859 Secretory Granule Protein 7B2
% 210.47/210.63  |- skos__altLabel mesh__D051859 Neuroendocrine Chaperone 7B2
% 210.47/210.63  |- skos__broader mesh__D051859smesh__D018832
% 210.47/210.63  |- mesh__recordOriginator mesh__D051859 DRC
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D051859 2006
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D004405 2006
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 Dysenteries, Shigella dysenteriae
% 210.47/210.63  |- mesh__recordOriginator mesh__D004405 NLM
% 210.47/210.63  |- skos__broader mesh__D004405smesh__D004403
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 Dysenteries, Shigella
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 Shiga bacillus Dysentery
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 dysenteriae Dysentery, Shigella
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 Dysenteries, Shigella sonnei
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 flexneri Dysenteries, Shigella
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 Dysenteries, Shigella flexneri
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 Shigella boydii Dysentery
% 210.47/210.63  |- skos__broader mesh__D004405smesh__D004756
% 210.47/210.63  |- mesh__recordAuthorizer mesh__D004405 sjn
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 Shigella flexneri Dysentery
% 210.47/210.63  |- rdf__type mesh__D004405sskos__Concept
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 Shigella Dysenteries
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 Shigella flexneri Dysenteries
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 Dysentery, Shigella
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D004405 2004
% 210.47/210.63  |- skos__scopeNote mesh__D004405
% 210.47/210.63       DYSENTERY caused by gram-negative rod-shaped enteric bacteria %28%ENTEROBACTERIACEAE%29%, most often by the genus SHIGELLA. Shigella dysentery, Shigellosis, is classified into subgroups according to syndrome severity and the infectious species. Group A: SHIGELLA DYSENTERIAE %28%severest%29%; Group B: SHIGELLA FLEXNERI; Group C: SHIGELLA BOYDII; and Group D: SHIGELLA SONNEI %28%mildest%29%.%A%    
% 210.47/210.63  |- skos__altLabel mesh__D004405 Dysentery, Shiga bacillus
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 boydii Dysentery, Shigella
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 flexneri Dysentery, Shigella
% 210.47/210.63  |- mesh__dateRevised mesh__D004405 2003-07-09
% 210.47/210.63  |- skos__altLabel mesh__D004405 Dysentery, Shigella dysenteriae type 1
% 210.47/210.63  |- mesh__recordMaintainer mesh__D004405 lkt
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 Shigella dysenteriae Dysentery
% 210.47/210.63  |- mesh__dateCreated mesh__D004405 1999-01-01
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 Shigella dysenteriae Dysenteries
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 Shigella sonnei Dysentery
% 210.47/210.63  |- skos__altLabel mesh__D004405 Shigella Dysentery
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 dysenteriae Dysenteries, Shigella
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 Dysenteries, Shigella boydii
% 210.47/210.63  |- skos__annotation mesh__D004405
% 210.47/210.63       coord IM with specific organism %28%IM%29% if pertinent   
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 sonnei Dysentery, Shigella
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 Shigella boydii Dysenteries
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D004405 2005
% 210.47/210.63  |- skos__prefLabel mesh__D004405 Dysentery, Bacillary
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 boydii Dysenteries, Shigella
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 Shigella sonnei Dysenteries
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 sonnei Dysenteries, Shigella
% 210.47/210.63  |- skos__hiddenLabel mesh__D004405 Bacillary Dysentery
% 210.47/210.63  |- skos__hiddenLabel mesh__D009699 Hydrolases, Nucleoside
% 210.47/210.63  |- skos__hiddenLabel mesh__D009699 Hydrolases, Nitrogen-linked Glycoside
% 210.47/210.63  |- skos__altLabel mesh__D009699 Hydrolases, N-Glycosyl
% 210.47/210.63  |- mesh__dateCreated mesh__D009699 1999-01-01
% 210.47/210.63  |- mesh__recordAuthorizer mesh__D009699 sjn
% 210.47/210.63  |- skos__altLabel mesh__D009699 Nitrogen-linked Glycoside Hydrolases
% 210.47/210.63  |- mesh__recordMaintainer mesh__D009699 ags
% 210.47/210.63  |- skos__prefLabel mesh__D009699 N-Glycosyl Hydrolases
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D009699 2004
% 210.47/210.63  |- skos__scopeNote mesh__D009699
% 210.47/210.63       A class of enzymes involved in the hydrolysis of the N-glycosidic bond of nitrogen-linked sugars.%A%    
% 210.47/210.63  |- skos__broader mesh__D009699smesh__D006026
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D009699 2005
% 210.47/210.63  |- skos__altLabel mesh__D009699 Nucleoside Hydrolases
% 210.47/210.63  |- skos__hiddenLabel mesh__D009699 N Glycosyl Hydrolases
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D009699 2006
% 210.47/210.63  |- skos__altLabel mesh__D009699 Glycoside Hydrolases, Nitrogen-linked
% 210.47/210.63  |- mesh__historyNote mesh__D009699 2003%28%1966%29%   
% 210.47/210.63  |- skos__hiddenLabel mesh__D009699 Nitrogen linked Glycoside Hydrolases
% 210.47/210.63  |- skos__hiddenLabel mesh__D009699 Hydrolases, N Glycosyl
% 210.47/210.63  |- mesh__dateRevised mesh__D009699 2003-07-09
% 210.47/210.63  |- rdf__type mesh__D009699sskos__Concept
% 210.47/210.63  |- skos__hiddenLabel mesh__D009699 Glycoside Hydrolases, Nitrogen linked
% 210.47/210.63  |- mesh__recordOriginator mesh__D009699 NLM
% 210.47/210.63  |- mesh__publicMeSHNote mesh__D009699 2003; see NUCLEOSIDASES 1966-2002   
% 210.47/210.63  |- skos__broader mesh__D020072smesh__D001487
% 210.47/210.63  |- skos__prefLabel mesh__D020072 Polyporales
% 210.47/210.63  |- mesh__dateRevised mesh__D020072 2005-06-30
% 210.47/210.63  |- mesh__publicMeSHNote mesh__D020072 2005; see APHYLLPHORALES 1999-2004   
% 210.47/210.63  |- mesh__recordAuthorizer mesh__D020072 sjn
% 210.47/210.63  |- mesh__historyNote mesh__D020072 2005 %28%1999%29%   
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D020072 2006
% 210.47/210.63  |- rdf__type mesh__D020072sskos__Concept
% 210.47/210.63  |- skos__altLabel mesh__D020072 Aphyllophorales
% 210.47/210.63  |- mesh__dateEstablished mesh__D020072 1999-01-01
% 210.47/210.63  |- mesh__recordOriginator mesh__D020072 AGS
% 210.47/210.63  |- mesh__dateCreated mesh__D020072 1998-06-10
% 210.47/210.63  |- skos__scopeNote mesh__D020072
% 210.47/210.63       An order of fungi in the phylum BASIDIOMYCOTA having macroscopic basidiocarps. The members are characterized by their saprophytic activities as decomposers, particularly in the degradation of CELLULOSE and LIGNIN. A large number of species in the order have been used medicinally. %28%From Alexopoulos, Introductory Mycology, 4th ed, pp504-68%29%%A%    
% 210.47/210.63  |- mesh__recordMaintainer mesh__D020072 ags
% 210.47/210.63  |- mesh__publicMeSHNote mesh__D014833 91; was see under VOICE 1979-90   
% 210.47/210.63  |- skos__historyNote mesh__D014833 Voice %28%1966-1978%29%
% 210.47/210.63  |- skos__related mesh__D014833smesh__D010699
% 210.47/210.63  |- mesh__historyNote mesh__D014833
% 210.47/210.63       91%28%79%29%; was see under VOICE 1979-90   
% 210.47/210.63  |- skos__hiddenLabel mesh__D014833 Quality, Voice
% 210.47/210.63  |- mesh__recordMaintainer mesh__D014833 nns
% 210.47/210.63  |- mesh__dateEstablished mesh__D014833 1991-01-01
% 210.47/210.63  |- mesh__dateRevised mesh__D014833 2003-07-09
% 210.47/210.63  |- skos__hiddenLabel mesh__D014833 Voice Qualities
% 210.47/210.63  |- mesh__dateCreated mesh__D014833 1978-05-22
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D014833 2006
% 210.47/210.63  |- mesh__recordAuthorizer mesh__D014833 sjn
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D014833 2005
% 210.47/210.63  |- skos__scopeNote mesh__D014833
% 210.47/210.63       That component of SPEECH which gives the primary distinction to a given speaker%27%s VOICE when pitch and loudness are excluded. It involves both phonatory and resonatory characteristics. Some of the descriptions of voice quality are harshness, breathiness and nasality.%A%    
% 210.47/210.63  |- mesh__recordOriginator mesh__D014833 RC
% 210.47/210.63  |- skos__hiddenLabel mesh__D014833 Qualities, Voice
% 210.47/210.63  |- skos__related mesh__D014833smesh__D006685
% 210.47/210.63  |- skos__broader mesh__D014833smesh__D014831
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D014833 2004
% 210.47/210.63  |- rdf__type mesh__D014833sskos__Concept
% 210.47/210.63  |- skos__prefLabel mesh__D014833 Voice Quality
% 210.47/210.63  |- skos__altLabel mesh__D014035 Togaviruses
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D014035 2000
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D014035 1998
% 210.47/210.63  |- mesh__recordAuthorizer mesh__D014035 PLS
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D014035 2004
% 210.47/210.63  |- mesh__recordMaintainer mesh__D014035 AGS
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D014035 2001
% 210.47/210.63  |- skos__hiddenLabel mesh__D014035 Togavirus
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D014035 1996
% 210.47/210.63  |- mesh__publicMeSHNote mesh__D014035
% 210.47/210.63       81; was TOGAVIRUSES see ARBOVIRUSES 1978-80   
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D014035 1999
% 210.47/210.63  |- skos__broader mesh__D014035smesh__D012328
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D014035 2002
% 210.47/210.63  |- skos__prefLabel mesh__D014035 Togaviridae
% 210.47/210.63  |- skos__historyNote mesh__D014035 Arboviruses %28%1966-1980%29%
% 210.47/210.63  |- mesh__onlineNote mesh__D014035
% 210.47/210.63       use ARBOVIRUSES to search TOGAVIRUSES 1978-80   
% 210.47/210.63  |- skos__annotation mesh__D014035
% 210.47/210.63       %22%a family of RNA viruses, mainly arboviruses%22%; infection = TOGAVIRIDAE INFECTIONS%A%  
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D014035 1997
% 210.47/210.63  |- rdf__type mesh__D014035sskos__Concept
% 210.47/210.63  |- mesh__dateCreated mesh__D014035 1980-05-22
% 210.47/210.63  |- mesh__recordOriginator mesh__D014035 RC
% 210.47/210.63  |- skos__scopeNote mesh__D014035
% 210.47/210.63       A family of RNA viruses, mainly arboviruses, consisting of two genera: ALPHAVIRUS %28%group A arboviruses%29%, and RUBIVIRUS. Virions are spherical, 60-70 nm in diameter, with a lipoprotein envelope tightly applied to the icosahedral nucleocapsid.%A%    
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D014035 2005
% 210.47/210.63  |- mesh__dateRevised mesh__D014035 1993-06-04
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D014035 1994
% 210.47/210.63  |- mesh__dateEstablished mesh__D014035 1981-01-01
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D014035 2003
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D014035 1995
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D014035 2006
% 210.47/210.63  |- mesh__historyNote mesh__D014035
% 210.47/210.63       81; was TOGAVIRUSES see ARBOVIRUSES 1978-80   
% 210.47/210.63  |- mesh__recordMaintainer mesh__D000813 TGC
% 210.47/210.63  |- mesh__recordOriginator mesh__D000813 NLM
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000813 2006
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000813 2003
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000813 1997
% 210.47/210.63  |- mesh__recordAuthorizer mesh__D000813 PLS
% 210.47/210.63  |- skos__prefLabel mesh__D000813 Anilides
% 210.47/210.63  |- skos__broader mesh__D000813smesh__D000577
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000813 2005
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000813 1999
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000813 1996
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000813 2002
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000813 1993
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000813 1998
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000813 2001
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000813 1995
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000813 2000
% 210.47/210.63  |- mesh__dateRevised mesh__D000813 1992-05-07
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000813 1994
% 210.47/210.63  |- mesh__dateCreated mesh__D000813 1999-01-01
% 210.47/210.63  |- rdf__type mesh__D000813sskos__Concept
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000813 2004
% 210.47/210.63  |- skos__altLabel mesh__D000015 Multiple Abnormalities
% 210.47/210.63  |- mesh__dateEstablished mesh__D000015 1968-01-01
% 210.47/210.63  |- mesh__recordMaintainer mesh__D000015 KEV
% 210.47/210.63  |- skos__prefLabel mesh__D000015 Abnormalities, Multiple
% 210.47/210.63  |- skos__historyNote mesh__D000015 Abnormalities %28%1966-1967%29%
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000015 2002
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000015 2004
% 210.47/210.63  |- mesh__dateRevised mesh__D000015 1999-11-08
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000015 2005
% 210.47/210.63  |- skos__broader mesh__D000015smesh__D000013
% 210.47/210.63  |- skos__annotation mesh__D000015
% 210.47/210.63       IM; do not use /compl /congen %26% do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific abnorm %28%IM%29%; Manual 23.20.2%A%  
% 210.47/210.63  |- skos__related mesh__D000015smesh__D008607
% 210.47/210.63  |- mesh__historyNote mesh__D000015 68   
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000015 2006
% 210.47/210.63  |- mesh__recordAuthorizer mesh__D000015 sjn
% 210.47/210.63  |- rdf__type mesh__D000015sskos__Concept
% 210.47/210.63  |- mesh__publicMeSHNote mesh__D000015 68   
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000015 2000
% 210.47/210.63  |- mesh__recordOriginator mesh__D000015 NLM
% 210.47/210.63  |- mesh__dateCreated mesh__D000015 1999-01-01
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000015 2001
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D000015 2003
% 210.47/210.63  |- rdf__type mesh__D046915sskos__Concept
% 210.47/210.63  |- skos__altLabel mesh__D046915 Penicillin-Binding Protein
% 210.47/210.63  |- skos__broader mesh__D046915smesh__D001426
% 210.47/210.63  |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 2b
% 210.47/210.63  |- skos__related mesh__D046915smesh__D006602
% 210.47/210.63  |- skos__hiddenLabel mesh__D046915 Protein 1b, Penicillin-Binding
% 210.47/210.63  |- skos__historyNote mesh__D046915 Bacterial Proteins %28%1978-2004%29%
% 210.47/210.63  |- skos__hiddenLabel mesh__D046915 Synthetase, Peptidoglycan
% 210.47/210.63  |- skos__related mesh__D046915smesh__D002267
% 210.47/210.63  |- mesh__dateRevised mesh__D046915 2005-06-30
% 210.47/210.63  |- mesh__historyNote mesh__D046915 2005 %28%1978%29%;   
% 210.47/210.63  |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 4
% 210.47/210.63  |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 1b
% 210.47/210.63  |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 7
% 210.47/210.63  |- mesh__recordOriginator mesh__D046915 jmp
% 210.47/210.63  |- skos__historyNote mesh__D046915 Peptidyltransferase %28%1978-2004%29%
% 210.47/210.63  |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 3
% 210.47/210.63  |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 6
% 210.47/210.63  |- mesh__publicMeSHNote mesh__D046915
% 210.47/210.63       2005; PENICILLIN-BINDING PROTEINS was indexed under HEXOSYLTRANSFERASES 1999-2004, under BACTERIAL PROTEINS, MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE; CARRIER PROTEINS,  %26% PEPTIDYLTRANSFERASE 1978-2004%A%  
% 210.47/210.63  |- skos__hiddenLabel mesh__D046915 Penicillin Binding Proteins
% 210.47/210.63  |- skos__hiddenLabel mesh__D046915 Proteins, Penicillin-Binding
% 210.47/210.63  |- mesh__recordMaintainer mesh__D046915 SYSTEM
% 210.47/210.63  |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein
% 210.47/210.63  |- mesh__dateCreated mesh__D046915 2004-07-08
% 210.47/210.63  |- skos__prefLabel mesh__D046915 Penicillin-Binding Proteins
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D046915 2006
% 210.47/210.63  |- skos__related mesh__D046915smesh__D010458
% 210.47/210.63  |- mesh__dateEstablished mesh__D046915 2005-01-01
% 210.47/210.63  |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 2
% 210.47/210.63  |- skos__altLabel mesh__D046915 Penicillin-Binding Protein-2a
% 210.47/210.63  |- skos__hiddenLabel mesh__D046915 Protein 1A, Penicillin-Binding
% 210.47/210.63  |- skos__historyNote mesh__D046915
% 210.47/210.63       Muramoylpentapeptide Carboxypeptidase %28%1978-2004%29%
% 210.47/210.63  |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 5
% 210.47/210.63  |- mesh__recordAuthorizer mesh__D046915 sjn
% 210.47/210.63  |- skos__scopeNote mesh__D046915
% 210.47/210.63       Bacterial proteins that share the property of binding irreversibly to PENICILLINS and other ANTIBACTERIAL AGENTS derived from LACTAMS. The penicillin-binding proteins are primarily enzymes involved in CELL WALL biosynthesis including MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE; PEPTIDE SYNTHASES; TRANSPEPTIDASES; and HEXOSYLTRANSFERASES.%A%    
% 210.47/210.63  |- skos__historyNote mesh__D046915 Carrier Proteins %28%1978-2004%29%
% 210.47/210.63  |- skos__broader mesh__D046915smesh__D004798
% 210.47/210.63  |- skos__historyNote mesh__D046915 Hexosyltransferases %28%1999-2004%29%
% 210.47/210.63  |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 1
% 210.47/210.63  |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 2a
% 210.47/210.63  |- skos__hiddenLabel mesh__D046915 Penicillin Binding Protein 1A
% 210.47/210.63  |- mesh__recordAuthorizer mesh__D018426 sjn
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D018426 2006
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D018426 2003
% 210.47/210.63  |- skos__prefLabel mesh__D018426 SEER Program
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D018426 2004
% 210.47/210.63  |- skos__hiddenLabel mesh__D018426 Program, SEER
% 210.47/210.63  |- mesh__recordMaintainer mesh__D018426 jls
% 210.47/210.63  |- rdf__type mesh__D018426sskos__Concept
% 210.47/210.63  |- skos__altLabel mesh__D018426
% 210.47/210.63       SEER Program %28%National Cancer Institute %28%U.S.%29%%29%
% 210.47/210.63  |- mesh__recordOriginator mesh__D018426 TGC
% 210.47/210.63  |- skos__broader mesh__D018426smesh__D012042
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D018426 2002
% 210.47/210.63  |- skos__annotation mesh__D018426
% 210.47/210.63       a cancer surveillance program of Nat Cancer Inst; X ref explains acronym; IM      CATALOG: use NAF entry%A%  
% 210.47/210.63  |- mesh__dateRevised mesh__D018426 2001-07-25
% 210.47/210.63  |- mesh__historyNote mesh__D018426 95   
% 210.47/210.63  |- skos__scopeNote mesh__D018426
% 210.47/210.63       A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results %28%SEER%29% Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. %28%From National Cancer Institute, NIH Publication No. 91-3074, October 1990%29%%A%    
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D018426 2005
% 210.47/210.63  |- mesh__dateEstablished mesh__D018426 1995-01-01
% 210.47/210.63  |- mesh__dateCreated mesh__D018426 1994-02-28
% 210.47/210.63  |- mesh__publicMeSHNote mesh__D018426 95   
% 210.47/210.63  |- skos__altLabel mesh__D018426
% 210.47/210.63       Surveillance, Epidemiology, and End Results Program
% 210.47/210.63  |- mesh__dateEstablished mesh__D010443 1973-01-01
% 210.47/210.63  |- rdf__type mesh__D010443sskos__Concept
% 210.47/210.63  |- skos__altLabel mesh__D010443 Translational Peptide Chain Termination
% 210.47/210.63  |- mesh__dateRevised mesh__D010443 2004-07-07
% 210.47/210.63  |- skos__altLabel mesh__D010443 Chain Termination, Peptide, Translational
% 210.47/210.63  |- mesh__dateCreated mesh__D010443 1999-01-01
% 210.47/210.63  |- mesh__recordAuthorizer mesh__D010443 sjn
% 210.47/210.63  |- skos__scopeNote mesh__D010443
% 210.47/210.63       A process of GENETIC TRANSLATION whereby the last amino acid is added to a lengthening polypeptide. This termination is signaled from the MESSENGER RNA, by one of three termination codons %28%CODON, TERMINATOR%29% that immediately follows the last amino acid-specifying CODON.%A%    
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D010443 2005
% 210.47/210.63  |- mesh__recordOriginator mesh__D010443 NLM
% 210.47/210.63  |- mesh__publicMeSHNote mesh__D010443
% 210.47/210.63       2005; see PEPTIDE CHAIN TERMINATION 1973-2004   
% 210.47/210.63  |- skos__broader mesh__D010443smesh__D014176
% 210.47/210.63  |- skos__prefLabel mesh__D010443 Peptide Chain Termination, Translational
% 210.47/210.63  |- skos__related mesh__D010443smesh__D010454
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D010443 2006
% 210.47/210.63  |- skos__annotation mesh__D010443
% 210.47/210.63       coordinate with specific peptide; for protein biosynthesis on the ribosome only; for non-ribosomal biosynthesis use PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT%A%  
% 210.47/210.63  |- skos__altLabel mesh__D010443 Protein Chain Termination, Translational
% 210.47/210.63  |- mesh__recordMaintainer mesh__D010443 nns
% 210.47/210.63  |- skos__historyNote mesh__D010443 Peptides/biosynthesis %28%1966-1970%29%
% 210.47/210.63  |- mesh__historyNote mesh__D010443 2005%28%1971%29%   
% 210.47/210.63  |- skos__related mesh__D010443smesh__D018388
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D004406 2004
% 210.47/210.63  |- skos__broader mesh__D004406smesh__D007153
% 210.47/210.63  |- skos__historyNote mesh__D004406 Immunity %28%1966-1970%29%
% 210.47/210.63  |- skos__scopeNote mesh__D004406
% 210.47/210.63       An immunologic deficiency state characterized by selective deficiencies of one or more, but not all, classes of immunoglobulins.%A%    
% 210.47/210.63  |- mesh__publicMeSHNote mesh__D004406
% 210.47/210.63       78; was see under IMMUNOLOGIC DEFICIENCY SYNDROMES 1970-77%A%  
% 210.47/210.63  |- skos__broader mesh__D004406smesh__D001796
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D004406 2006
% 210.47/210.63  |- skos__prefLabel mesh__D004406 Dysgammaglobulinemia
% 210.47/210.63  |- skos__hiddenLabel mesh__D004406 Dysgammaglobulinemias
% 210.47/210.63  |- mesh__recordMaintainer mesh__D004406 lkt
% 210.47/210.63  |- rdf__type mesh__D004406sskos__Concept
% 210.47/210.63  |- mesh__dateRevised mesh__D004406 2003-07-09
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D004406 2005
% 210.47/210.63  |- mesh__recordOriginator mesh__D004406 NLM
% 210.47/210.63  |- mesh__historyNote mesh__D004406
% 210.47/210.63       78%28%75%29%; was see under IMMUNOLOGIC DEFICIENCY SYNDROMES 1970-77%A%  
% 210.47/210.63  |- mesh__dateEstablished mesh__D004406 1978-01-01
% 210.47/210.63  |- skos__historyNote mesh__D004406
% 210.47/210.63       Immunologic Deficiency Syndromes %28%1968-1974%29%
% 210.47/210.63  |- mesh__recordAuthorizer mesh__D004406 sjn
% 210.47/210.63  |- mesh__onlineNote mesh__D004406
% 210.47/210.63       search IMMUNOLOGIC DEFICIENCY SYNDROMES 1970-74   
% 210.47/210.63  |- skos__annotation mesh__D004406
% 210.47/210.63       coord IM with specific immunoglobulin /defic %28%IM%29% but note IGA DEFICIENCY and IGG DEFICIENCY are available; AGAMMAGLOBULINEMIA is also available%A%  
% 210.47/210.63  |- mesh__dateCreated mesh__D004406 1999-01-01
% 210.47/210.63  |- skos__hiddenLabel mesh__D020871 Degradation, mRNA
% 210.47/210.63  |- skos__related mesh__D020871smesh__D009691
% 210.47/210.63  |- skos__hiddenLabel mesh__D020871 Degradation, RNA
% 210.47/210.63  |- mesh__dateRevised mesh__D020871 2005-07-29
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D020871 2005
% 210.47/210.63  |- mesh__dateEstablished mesh__D020871 2000-01-01
% 210.47/210.63  |- skos__hiddenLabel mesh__D020871 Decay, mRNA
% 210.47/210.63  |- skos__prefLabel mesh__D020871 RNA Stability
% 210.47/210.63  |- rdf__type mesh__D020871sskos__Concept
% 210.47/210.63  |- skos__hiddenLabel mesh__D020871 Transcript Degradation, mRNA
% 210.47/210.63  |- skos__annotation mesh__D020871 coord with specific RNA if pertinent   
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D020871 2006A
% 210.47/210.63  |- skos__hiddenLabel mesh__D020871 Stability, mRNA
% 210.47/210.63  |- skos__hiddenLabel mesh__D020871 Instability, mRNA
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D020871 2006
% 210.47/210.63  |- skos__altLabel mesh__D020871 mRNA Transcript Degradation
% 210.47/210.63  |- skos__broader mesh__D020871smesh__D001669
% 210.47/210.63  |- skos__scopeNote mesh__D020871
% 210.47/210.63       The extent to which an RNA molecule retains its structural integrity and resists degradation by RNASE, and base-catalyzed HYDROLYSIS, under changing in vivo or in vitro conditions.%A%    
% 210.47/210.63  |- skos__hiddenLabel mesh__D020871 Stability, RNA
% 210.47/210.63  |- mesh__activeMeSHYear mesh__D020871 2004
% 210.47/210.63  |- skos__hiddenLabel mesh__D020871 Decay, RNA
% 210.47/210.63  |- mesh__historyNote mesh__D020871 2000   
% 210.47/210.63  |- mesh__recordAuthorizer mesh__D020871 ags
% 210.47/210.63  |- mesh__dateCreated mesh__D020871 1999-11-03
% 210.47/210.63  |- skos__hiddenLabel mesh__D020871 Instability, RNA
% 210.47/210.63  |- mesh__recordOriginator mesh__D020871 nns
% 210.47/210.63  |- mesh__recordMaintainer mesh__D020871 ags
% 210.47/210.63  |- skos__hiddenLabel mesh__D020871 Degradation, mRNA Transcript
% 210.47/210.63  |- mesh__publicMeSHNote mesh__D020871 2000   
% 210.47/210.63  |- skos__broader mesh__D020073smesh__D011247
% 210.47/210.64  |- mesh__publicMeSHNote mesh__D020073 99   
% 210.47/210.64  |- skos__hiddenLabel mesh__D020073 Nulligravidities
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D020073 2006
% 210.47/210.64  |- rdf__type mesh__D020073sskos__Concept
% 210.47/210.64  |- skos__hiddenLabel mesh__D020073 Multigravidities
% 210.47/210.64  |- mesh__recordOriginator mesh__D020073 NDW
% 210.47/210.64  |- mesh__recordAuthorizer mesh__D020073 sjn
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D020073 2005
% 210.47/210.64  |- skos__broader mesh__D020073smesh__D017584
% 210.47/210.64  |- skos__historyNote mesh__D020073 Pregnancy %28%1966-1998%29%
% 210.47/210.64  |- skos__related mesh__D020073smesh__D010298
% 210.47/210.64  |- skos__prefLabel mesh__D020073 Gravidity
% 210.47/210.64  |- mesh__historyNote mesh__D020073 99   
% 210.47/210.64  |- skos__hiddenLabel mesh__D020073 Gravidities
% 210.47/210.64  |- skos__hiddenLabel mesh__D020073 Primigravidities
% 210.47/210.64  |- mesh__dateRevised mesh__D020073 2004-07-07
% 210.47/210.64  |- mesh__recordMaintainer mesh__D020073 lkt
% 210.47/210.64  |- mesh__dateEstablished mesh__D020073 1999-01-01
% 210.47/210.64  |- skos__annotation mesh__D020073
% 210.47/210.64       human %26% animal; do not confuse with PARITY   
% 210.47/210.64  |- skos__scopeNote mesh__D020073
% 210.47/210.64       The number of pregnancies, complete or incomplete, experienced by a female. It is different from PARITY, which is the number of offspring borne. %28%From Stedman, 26th ed%29%%A%    
% 210.47/210.64  |- mesh__dateCreated mesh__D020073 1998-06-10
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014834 1992
% 210.47/210.64  |- skos__hiddenLabel mesh__D014834 Training, Voice
% 210.47/210.64  |- skos__hiddenLabel mesh__D014834 Trainings, Voice
% 210.47/210.64  |- skos__hiddenLabel mesh__D014834 Voice Trainings
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014834 1999
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014834 2000
% 210.47/210.64  |- skos__broader mesh__D014834smesh__D012049
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014834 1996
% 210.47/210.64  |- skos__annotation mesh__D014834 no qualif   
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014834 1991
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014834 1993
% 210.47/210.64  |- skos__prefLabel mesh__D014834 Voice Training
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014834 2005
% 210.47/210.64  |- mesh__recordAuthorizer mesh__D014834 PLS
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014834 2001
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014834 1997
% 210.47/210.64  |- mesh__dateCreated mesh__D014834 1999-01-01
% 210.47/210.64  |- mesh__recordMaintainer mesh__D014834 TGC
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014834 2006
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014834 2003
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014834 1994
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014834 1990
% 210.47/210.64  |- mesh__dateRevised mesh__D014834 1989-05-16
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014834 2002
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014834 2004
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014834 1998
% 210.47/210.64  |- mesh__recordOriginator mesh__D014834 NLM
% 210.47/210.64  |- rdf__type mesh__D014834sskos__Concept
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014834 1995
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014036 1999
% 210.47/210.64  |- mesh__dateCreated mesh__D014036 1980-05-13
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014036 1996
% 210.47/210.64  |- mesh__historyNote mesh__D014036 94; was TOGAVIRUS INFECTIONS 1981-93   
% 210.47/210.64  |- mesh__onlineNote mesh__D014036
% 210.47/210.64       use TOGAVIRIDAE INFECTIONS to search TOGAVIRUS INFECTIONS 1981-93%A%  
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014036 2000
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014036 1997
% 210.47/210.64  |- mesh__recordAuthorizer mesh__D014036 PLS
% 210.47/210.64  |- rdf__type mesh__D014036sskos__Concept
% 210.47/210.64  |- skos__hiddenLabel mesh__D014036 Togavirus Infection
% 210.47/210.64  |- skos__altLabel mesh__D014036 Togavirus Infections
% 210.47/210.64  |- mesh__publicMeSHNote mesh__D014036
% 210.47/210.64       94; was TOGAVIRUS INFECTIONS 1981-93   
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014036 2001
% 210.47/210.64  |- skos__hiddenLabel mesh__D014036 Infection, Togaviridae
% 210.47/210.64  |- mesh__recordOriginator mesh__D014036 RC
% 210.47/210.64  |- skos__hiddenLabel mesh__D014036 Infection, Togavirus
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014036 1994
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014036 2005
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014036 2002
% 210.47/210.64  |- skos__prefLabel mesh__D014036 Togaviridae Infections
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014036 1995
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014036 2006
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014036 2003
% 210.47/210.64  |- skos__broader mesh__D014036smesh__D012327
% 210.47/210.64  |- skos__historyNote mesh__D014036 Arbovirus Infections %28%1966-1980%29%
% 210.47/210.64  |- skos__hiddenLabel mesh__D014036 Togaviridae Infection
% 210.47/210.64  |- skos__altLabel mesh__D014036 Infections, Togavirus
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014036 1998
% 210.47/210.64  |- skos__scopeNote mesh__D014036
% 210.47/210.64       Virus diseases caused by the TOGAVIRIDAE.     
% 210.47/210.64  |- mesh__dateRevised mesh__D014036 1993-06-04
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014036 2004
% 210.47/210.64  |- skos__annotation mesh__D014036 GEN or unspecified; prefer specifics   
% 210.47/210.64  |- mesh__dateEstablished mesh__D014036 1981-01-01
% 210.47/210.64  |- skos__altLabel mesh__D014036 Infections, Togaviridae
% 210.47/210.64  |- mesh__recordMaintainer mesh__D014036 AGS
% 210.47/210.64  |- skos__annotation mesh__D000814 DF: ANILINE CPDS   
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000814 2005
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000814 1999
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000814 1996
% 210.47/210.64  |- skos__prefLabel mesh__D000814 Aniline Compounds
% 210.47/210.64  |- mesh__recordOriginator mesh__D000814 NLM
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000814 1993
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000814 1998
% 210.47/210.64  |- mesh__recordAuthorizer mesh__D000814 PLS
% 210.47/210.64  |- skos__broader mesh__D000814smesh__D000588
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000814 1995
% 210.47/210.64  |- skos__altLabel mesh__D000814 Phenylamines
% 210.47/210.64  |- mesh__dateRevised mesh__D000814 1992-05-07
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000814 2002
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000814 1994
% 210.47/210.64  |- mesh__dateCreated mesh__D000814 1999-01-01
% 210.47/210.64  |- rdf__type mesh__D000814sskos__Concept
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000814 2004
% 210.47/210.64  |- mesh__recordMaintainer mesh__D000814 TGC
% 210.47/210.64  |- skos__hiddenLabel mesh__D000814 Compounds, Aniline
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000814 2001
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000814 2006
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000814 2003
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000814 1997
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000814 2000
% 210.47/210.64  |- mesh__recordMaintainer mesh__D000016 kle
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000016 2004
% 210.47/210.64  |- skos__hiddenLabel mesh__D000016 Abnormality, Radiation-Induced
% 210.47/210.64  |- mesh__dateRevised mesh__D000016 1999-11-03
% 210.47/210.64  |- skos__hiddenLabel mesh__D000016 Abnormalities, Radiation Induced
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000016 2001
% 210.47/210.64  |- mesh__recordOriginator mesh__D000016 AEP
% 210.47/210.64  |- skos__prefLabel mesh__D000016 Abnormalities, Radiation-Induced
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000016 2005
% 210.47/210.64  |- mesh__dateEstablished mesh__D000016 1979-01-01
% 210.47/210.64  |- skos__broader mesh__D000016smesh__D000013
% 210.47/210.64  |- skos__historyNote mesh__D000016 Radiation Injuries %28%1966-1978%29%
% 210.47/210.64  |- skos__hiddenLabel mesh__D000016 Radiation-Induced Abnormality
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000016 2002
% 210.47/210.64  |- skos__historyNote mesh__D000016 Abnormalities %28%1966-1978%29%
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000016 2006
% 210.47/210.64  |- mesh__publicMeSHNote mesh__D000016 79   
% 210.47/210.64  |- rdf__type mesh__D000016sskos__Concept
% 210.47/210.64  |- skos__annotation mesh__D000016
% 210.47/210.64       IM; do not use /compl /congen %26% do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific abnorm %28%IM%29%%A%  
% 210.47/210.64  |- skos__hiddenLabel mesh__D000016 Radiation Induced Abnormalities
% 210.47/210.64  |- skos__scopeNote mesh__D000016
% 210.47/210.64       Congenital changes in the morphology of organs produced by exposure to ionizing or non-ionizing radiation.%A%    
% 210.47/210.64  |- skos__broader mesh__D000016smesh__D011832
% 210.47/210.64  |- mesh__dateCreated mesh__D000016 1978-03-20
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000016 2003
% 210.47/210.64  |- mesh__historyNote mesh__D000016 79   
% 210.47/210.64  |- mesh__recordAuthorizer mesh__D000016 sjn
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000016 2000
% 210.47/210.64  |- skos__altLabel mesh__D000016 Radiation-Induced Abnormalities
% 210.47/210.64  |- skos__altLabel mesh__D018427 Breast Prosthesis, Internal
% 210.47/210.64  |- mesh__recordOriginator mesh__D018427 TGC
% 210.47/210.64  |- skos__hiddenLabel mesh__D018427 Internal Breast Prosthesis
% 210.47/210.64  |- mesh__dateEstablished mesh__D018427 1995-01-01
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D018427 2002
% 210.47/210.64  |- skos__hiddenLabel mesh__D018427 Breast Implant
% 210.47/210.64  |- skos__hiddenLabel mesh__D018427 Prostheses, Internal Breast
% 210.47/210.64  |- skos__historyNote mesh__D018427 Implants, Artificial %28%1971-1994%29%
% 210.47/210.64  |- mesh__dateCreated mesh__D018427 1994-04-21
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D018427 1999
% 210.47/210.64  |- mesh__publicMeSHNote mesh__D018427 95   
% 210.47/210.64  |- skos__historyNote mesh__D018427 Silicones %28%1967-1994%29%
% 210.47/210.64  |- skos__prefLabel mesh__D018427 Breast Implants
% 210.47/210.64  |- mesh__recordMaintainer mesh__D018427 ADP
% 210.47/210.64  |- mesh__historyNote mesh__D018427 95   
% 210.47/210.64  |- skos__hiddenLabel mesh__D018427 Implant, Breast
% 210.47/210.64  |- skos__hiddenLabel mesh__D018427 Internal Breast Prostheses
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D018427 2005
% 210.47/210.64  |- skos__altLabel mesh__D018427 Implants, Breast
% 210.47/210.64  |- mesh__dateRevised mesh__D018427 1998-06-10
% 210.47/210.64  |- skos__related mesh__D018427smesh__D019928
% 210.47/210.64  |- skos__scopeNote mesh__D018427
% 210.47/210.64       Implants used to reconstruct and/or cosmetically enhance the female breast. They have an outer shell or envelope of silicone elastomer and are filled with either saline or silicone gel. The outer shell may be either smooth or textured.%A%    
% 210.47/210.64  |- skos__hiddenLabel mesh__D018427 Breast Prostheses, Internal
% 210.47/210.64  |- skos__related mesh__D018427smesh__D012826
% 210.47/210.64  |- skos__hiddenLabel mesh__D018427 Prosthesis, Internal Breast
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D018427 2006
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D018427 2003
% 210.47/210.64  |- skos__broader mesh__D018427smesh__D019736
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D018427 2000
% 210.47/210.64  |- skos__related mesh__D018427smesh__D020034
% 210.47/210.64  |- mesh__recordAuthorizer mesh__D018427 SJN
% 210.47/210.64  |- skos__annotation mesh__D018427
% 210.47/210.64       IM; coord with implant material %28%IM or NIM%29%   
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D018427 2004
% 210.47/210.64  |- skos__historyNote mesh__D018427 Prosthesis %28%1967-1994%29%
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D018427 2001
% 210.47/210.64  |- rdf__type mesh__D018427sskos__Concept
% 210.47/210.64  |- skos__altLabel mesh__D010444 Elongation Factor Tu
% 210.47/210.64  |- mesh__recordOriginator mesh__D010444 RLS
% 210.47/210.64  |- skos__hiddenLabel mesh__D010444 EF Tu
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D010444 2005
% 210.47/210.64  |- skos__historyNote mesh__D010444 Bacterial Proteins %28%1966-1972%29%
% 210.47/210.64  |- skos__hiddenLabel mesh__D010444 Factor Tu, Elongation
% 210.47/210.64  |- mesh__publicMeSHNote mesh__D010444 86   
% 210.47/210.64  |- skos__historyNote mesh__D010444
% 210.47/210.64       Peptide Elongation Factors %28%1973-1985%29%
% 210.47/210.64  |- skos__hiddenLabel mesh__D010444 eEF Tu
% 210.47/210.64  |- skos__altLabel mesh__D010444 EF-Tu
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D010444 2006
% 210.47/210.64  |- skos__prefLabel mesh__D010444 Peptide Elongation Factor Tu
% 210.47/210.64  |- mesh__dateRevised mesh__D010444 2003-07-09
% 210.47/210.64  |- mesh__dateCreated mesh__D010444 1985-06-06
% 210.47/210.64  |- mesh__historyNote mesh__D010444 86   
% 210.47/210.64  |- skos__historyNote mesh__D010444 Peptides %28%1966-1972%29%
% 210.47/210.64  |- skos__altLabel mesh__D010444 Protein Synthesis Elongation Factor Tu
% 210.47/210.64  |- skos__broader mesh__D010444smesh__D020963
% 210.47/210.64  |- skos__scopeNote mesh__D010444
% 210.47/210.64       A protein found in bacteria and eukaryotic mitochondria which delivers aminoacyl-tRNA%27%s to the A site of the ribosome. The aminoacyl-tRNA is first bound to a complex of elongation factor Tu containing a molecule of bound GTP. The resulting complex is then bound to the 70S initiation complex. Simultaneously the GTP is hydrolyzed and a Tu-GDP complex is released from the 70S ribosome. The Tu-GTP complex is regenerated from the Tu-GDP complex by the Ts elongation factor and GTP. EC 3.6.1.-.%A%    
% 210.47/210.64  |- skos__annotation mesh__D010444 DF: EFTU   
% 210.47/210.64  |- rdf__type mesh__D010444sskos__Concept
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D010444 2004
% 210.47/210.64  |- mesh__recordAuthorizer mesh__D010444 sjn
% 210.47/210.64  |- skos__historyNote mesh__D010444 Proteins %28%1966-1972%29%
% 210.47/210.64  |- mesh__recordMaintainer mesh__D010444 ssb
% 210.47/210.64  |- mesh__dateEstablished mesh__D010444 1986-01-01
% 210.47/210.64  |- mesh__recordMaintainer mesh__D004407 mdb
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D004407 2004
% 210.47/210.64  |- mesh__recordOriginator mesh__D004407 NLM
% 210.47/210.64  |- skos__scopeNote mesh__D004407
% 210.47/210.64       A malignant ovarian neoplasm, thought to be derived from primordial germ cells of the sexually undifferentiated embryonic gonad. It is the counterpart of the classical seminoma of the testis, to which it is both grossly and histologically identical. Dysgerminomas comprise 16%25% of all germ cell tumors but are rare before the age of 10, although nearly 50%25% occur before the age of 20. They are generally considered of low-grade malignancy but may spread if the tumor extends through its capsule and involves lymph nodes or blood vessels. %28%Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1646%29%%A%    
% 210.47/210.64  |- mesh__onlineNote mesh__D004407
% 210.47/210.64       use DYSGERMINOMA to search DISGERMINOMA 1966-78   
% 210.47/210.64  |- mesh__recordAuthorizer mesh__D004407 sjn
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D004407 2005
% 210.47/210.64  |- mesh__publicMeSHNote mesh__D004407 79; was DISGERMINOMA 1963-78   
% 210.47/210.64  |- skos__hiddenLabel mesh__D004407 Dysgerminomas
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D004407 2006
% 210.47/210.64  |- mesh__dateCreated mesh__D004407 1999-01-01
% 210.47/210.64  |- skos__altLabel mesh__D004407 Disgerminoma
% 210.47/210.64  |- rdf__type mesh__D004407sskos__Concept
% 210.47/210.64  |- mesh__historyNote mesh__D004407 79; was DISGERMINOMA 1963-78   
% 210.47/210.64  |- mesh__dateRevised mesh__D004407 2003-07-09
% 210.47/210.64  |- skos__hiddenLabel mesh__D004407 Disgerminomas
% 210.47/210.64  |- skos__prefLabel mesh__D004407 Dysgerminoma
% 210.47/210.64  |- skos__broader mesh__D004407smesh__D018237
% 210.47/210.64  |- skos__annotation mesh__D004407
% 210.47/210.64       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with probably OVARIAN NEOPLASMS %28%IM%29%%A%  
% 210.47/210.64  |- mesh__dateEstablished mesh__D020074 1999-01-01
% 210.47/210.64  |- skos__historyNote mesh__D020074 Agaricales %28%1978-1998%29%
% 210.47/210.64  |- skos__historyNote mesh__D020074 Basidiomycota %28%1966-1993%29%
% 210.47/210.64  |- mesh__recordOriginator mesh__D020074 AGS
% 210.47/210.64  |- skos__prefLabel mesh__D020074 Lentinula
% 210.47/210.64  |- mesh__dateCreated mesh__D020074 1998-06-10
% 210.47/210.64  |- skos__broader mesh__D020074smesh__D011124
% 210.47/210.64  |- skos__historyNote mesh__D020074 Polyporaceae %28%1985-1998%29%
% 210.47/210.64  |- mesh__publicMeSHNote mesh__D020074
% 210.47/210.64       2005; see LENTINUS 1999-2004, see POLYPORACEAE 1986-98   
% 210.47/210.64  |- mesh__dateRevised mesh__D020074 2005-06-30
% 210.47/210.64  |- skos__scopeNote mesh__D020074
% 210.47/210.64       A genus of fungi of the family Tricholomataceae, order AGARICALES. The commonly known SHIITAKE MUSHROOMS are Lentinula edodes %28%also seen as Lentinus edodes%29%.%A%    
% 210.47/210.64  |- mesh__recordMaintainer mesh__D020074 SYSTEM
% 210.47/210.64  |- mesh__recordAuthorizer mesh__D020074 sjn
% 210.47/210.64  |- skos__altLabel mesh__D020074 Lentinus
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D020074 2006
% 210.47/210.64  |- rdf__type mesh__D020074sskos__Concept
% 210.47/210.64  |- mesh__historyNote mesh__D020074
% 210.47/210.64       2005 %28%1999%29%; use POLYPORACEAE 1986-98   
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014835 1996
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014835 2002
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014835 1993
% 210.47/210.64  |- mesh__recordOriginator mesh__D014835 NLM
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014835 2005
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014835 1997
% 210.47/210.64  |- mesh__dateCreated mesh__D014835 1999-01-01
% 210.47/210.64  |- skos__historyNote mesh__D014835 Gases %28%1966-1970%29%
% 210.47/210.64  |- skos__historyNote mesh__D014835 Chemistry, Physical %28%1966-1970%29%
% 210.47/210.64  |- skos__prefLabel mesh__D014835 Volatilization
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014835 2006
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014835 2000
% 210.47/210.64  |- skos__hiddenLabel mesh__D014835 Volatilizations
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014835 2003
% 210.47/210.64  |- mesh__dateEstablished mesh__D014835 1974-01-01
% 210.47/210.64  |- mesh__publicMeSHNote mesh__D014835 74   
% 210.47/210.64  |- skos__hiddenLabel mesh__D014835 Vaporizations
% 210.47/210.64  |- mesh__recordMaintainer mesh__D014835 TAP
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014835 1994
% 210.47/210.64  |- mesh__recordAuthorizer mesh__D014835 PLS
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014835 2001
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014835 2004
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014835 1998
% 210.47/210.64  |- skos__historyNote mesh__D014835 appropriate chemical heading
% 210.47/210.64  |- skos__annotation mesh__D014835 NIM   
% 210.47/210.64  |- rdf__type mesh__D014835sskos__Concept
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014835 1995
% 210.47/210.64  |- skos__broader mesh__D014835smesh__D002627
% 210.47/210.64  |- mesh__dateRevised mesh__D014835 1992-05-18
% 210.47/210.64  |- mesh__historyNote mesh__D014835 74%28%71%29%   
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014835 1999
% 210.47/210.64  |- mesh__recordOriginator mesh__D014037 NLM
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014037 2001
% 210.47/210.64  |- mesh__recordAuthorizer mesh__D014037 PLS
% 210.47/210.64  |- mesh__dateRevised mesh__D014037 1995-02-21
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014037 2000
% 210.47/210.64  |- skos__prefLabel mesh__D014037 Togo
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014037 2004
% 210.47/210.64  |- skos__broader mesh__D014037smesh__D000354
% 210.47/210.64  |- skos__scopeNote mesh__D014037
% 210.47/210.64       A republic in western Africa, lying between GHANA on its west and BENIN on its east. Its capital is Lome. Togo was the eastern part of the German protectorate of Togoland from 1884 until it was captured by Anglo-French forces in 1914. It became an autonomous republic within the French Union in 1956, achieving independence in 1960. The country probably derives its name from Lake Togo, to %28%water%29% + go %28%edge or shore%29%. %28%From Webster%27%s New Geographical Dictionary, 1988, p1216 %26% Room, Brewer%27%s Dictionary of Names, 1992, p548%29%%A%    
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014037 2006
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014037 1997
% 210.47/210.64  |- mesh__dateCreated mesh__D014037 1999-01-01
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014037 1999
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014037 2003
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014037 2005
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014037 1996
% 210.47/210.64  |- mesh__recordMaintainer mesh__D014037 TGC
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014037 1998
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D014037 2002
% 210.47/210.64  |- skos__annotation mesh__D014037 a republic in western Africa   
% 210.47/210.64  |- rdf__type mesh__D014037sskos__Concept
% 210.47/210.64  |- skos__scopeNote mesh__D000815
% 210.47/210.64       A drug-metabolizing, cytochrome P-450 enzyme which catalyzes the hydroxylation of aniline to hydroxyaniline in the presence of reduced flavoprotein and molecular oxygen. EC 1.14.14.-.%A%    
% 210.47/210.64  |- skos__historyNote mesh__D000815 Hydroxylases %28%1973-1974%29%
% 210.47/210.64  |- mesh__recordMaintainer mesh__D000815 ssb
% 210.47/210.64  |- skos__historyNote mesh__D000815 Aniline Compounds %28%1973-1974%29%
% 210.47/210.64  |- skos__hiddenLabel mesh__D000815 Hydroxylase, Aniline
% 210.47/210.64  |- mesh__dateRevised mesh__D000815 2004-07-07
% 210.47/210.64  |- mesh__dateCreated mesh__D000815 1974-11-11
% 210.47/210.64  |- skos__prefLabel mesh__D000815 Aniline Hydroxylase
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000815 2005
% 210.47/210.64  |- skos__broader mesh__D000815smesh__D001189
% 210.47/210.64  |- mesh__recordOriginator mesh__D000815 NLM
% 210.47/210.64  |- mesh__dateEstablished mesh__D000815 1991-01-01
% 210.47/210.64  |- skos__annotation mesh__D000815 a cytochrome P-450 enzyme   
% 210.47/210.64  |- rdf__type mesh__D000815sskos__Concept
% 210.47/210.64  |- mesh__historyNote mesh__D000815
% 210.47/210.64       91%28%75%29%; was see under ARYL HYDROCARBON HYDROXYLASES 1977-90; was see under HYDROXYLASES 1975-76%A%  
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000815 2006
% 210.47/210.64  |- mesh__publicMeSHNote mesh__D000815
% 210.47/210.64       91; was see under ARYL HYDROCARBON HYDROXYLASES 1977-90; was see under HYDROXYLASES 1975-76%A%  
% 210.47/210.64  |- mesh__recordAuthorizer mesh__D000815 sjn
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D019520 2006
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D019520 2000
% 210.47/210.64  |- mesh__dateCreated mesh__D019520 1996-06-10
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D019520 2003A
% 210.47/210.64  |- skos__prefLabel mesh__D019520 Living Donors
% 210.47/210.64  |- rdf__type mesh__D019520sskos__Concept
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D019520 2003
% 210.47/210.64  |- mesh__historyNote mesh__D019520 97   
% 210.47/210.64  |- skos__hiddenLabel mesh__D019520 Living Donor
% 210.47/210.64  |- mesh__recordOriginator mesh__D019520 JLS
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D019520 2001
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D019520 2004
% 210.47/210.64  |- mesh__dateEstablished mesh__D019520 1997-01-01
% 210.47/210.64  |- skos__annotation mesh__D019520
% 210.47/210.64       coord IM with precoord organ/transpl heading %28%IM%29% or specific organ or tissue /transpl %28%IM%29% if precoord transpl heading is not in MeSH%A%  
% 210.47/210.64  |- skos__historyNote mesh__D019520 Tissue Donors %28%1990-1996%29%
% 210.47/210.64  |- skos__hiddenLabel mesh__D019520 Donor, Living
% 210.47/210.64  |- mesh__dateRevised mesh__D019520 2002-10-31
% 210.47/210.64  |- skos__broader mesh__D019520smesh__D014019
% 210.47/210.64  |- mesh__publicMeSHNote mesh__D019520 97   
% 210.47/210.64  |- skos__scopeNote mesh__D019520
% 210.47/210.64       Non-cadaveric providers of organs for transplant to related or non-related recipients.%A%    
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D019520 1999
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D019520 2002
% 210.47/210.64  |- mesh__recordMaintainer mesh__D019520 jls
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D019520 2005
% 210.47/210.64  |- mesh__recordAuthorizer mesh__D019520 jls
% 210.47/210.64  |- skos__altLabel mesh__D019520 Donors, Living
% 210.47/210.64  |- skos__prefLabel mesh__D000017 ABO Blood-Group System
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D000017 2006
% 210.47/210.64  |- skos__altLabel mesh__D000017 ABH Blood Group
% 210.47/210.64  |- rdf__type mesh__D000017sskos__Concept
% 210.47/210.64  |- skos__hiddenLabel mesh__D000017 ABO Factor
% 210.47/210.64  |- skos__hiddenLabel mesh__D000017 ABO Blood-Group Systems
% 210.47/210.64  |- skos__hiddenLabel mesh__D000017 Factor, ABO
% 210.47/210.64  |- skos__hiddenLabel mesh__D000017 H Blood Groups
% 210.47/210.64  |- mesh__recordAuthorizer mesh__D000017 sjn
% 210.47/210.64  |- mesh__publicMeSHNote mesh__D000017 76; was ABO FACTORS 1963-75   
% 210.47/210.64  |- skos__hiddenLabel mesh__D000017 Factors, ABO
% 210.47/210.64  |- skos__hiddenLabel mesh__D000017 Blood-Group Systems, ABO
% 210.47/210.64  |- skos__scopeNote mesh__D000017
% 210.47/210.64       The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane.%A%    
% 210.47/210.64  |- mesh__dateRevised mesh__D000017 2005-06-30
% 210.47/210.64  |- mesh__recordMaintainer mesh__D000017 ssb
% 210.47/210.64  |- skos__altLabel mesh__D000017 H Blood Group
% 210.47/210.64  |- skos__hiddenLabel mesh__D000017 Blood Groups, ABH
% 210.47/210.64  |- skos__annotation mesh__D000017
% 210.47/210.64       IM; coord with disease /blood %28%IM%29%, not /immunol nor /genet; TN 230%A%  
% 210.47/210.64  |- skos__hiddenLabel mesh__D000017 Blood Group, ABH
% 210.47/210.64  |- skos__hiddenLabel mesh__D000017 Blood-Group System, ABO
% 210.47/210.64  |- skos__hiddenLabel mesh__D000017 Blood Group, H
% 210.47/210.64  |- mesh__historyNote mesh__D000017 76; was ABO FACTORS 1963-75   
% 210.47/210.64  |- mesh__recordOriginator mesh__D000017 SH
% 210.47/210.64  |- mesh__onlineNote mesh__D000017
% 210.47/210.64       use ABO BLOOD-GROUP SYSTEM to search ABO FACTORS 1966-75   
% 210.47/210.64  |- mesh__dateEstablished mesh__D000017 1976-01-01
% 210.47/210.64  |- skos__hiddenLabel mesh__D000017 Blood Groups, H
% 210.47/210.64  |- skos__hiddenLabel mesh__D000017 ABH Blood Groups
% 210.47/210.64  |- skos__broader mesh__D000017smesh__D001789
% 210.47/210.64  |- skos__hiddenLabel mesh__D000017 Systems, ABO Blood-Group
% 210.47/210.64  |- skos__hiddenLabel mesh__D000017 System, ABO Blood-Group
% 210.47/210.64  |- skos__altLabel mesh__D000017 H Blood Group System
% 210.47/210.64  |- mesh__dateCreated mesh__D000017 1975-07-25
% 210.47/210.64  |- skos__hiddenLabel mesh__D000017 ABO Blood Group System
% 210.47/210.64  |- mesh__historyNote mesh__D005500 67%28%65%29%   
% 210.47/210.64  |- skos__broader mesh__D005500smesh__D008137
% 210.47/210.64  |- mesh__recordOriginator mesh__D005500 NLM
% 210.47/210.64  |- rdf__type mesh__D005500sskos__Concept
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D005500 2005
% 210.47/210.64  |- mesh__dateEstablished mesh__D005500 1967-01-01
% 210.47/210.64  |- skos__hiddenLabel mesh__D005500 Study, Follow-Up
% 210.47/210.64  |- mesh__dateCreated mesh__D005500 1999-01-01
% 210.47/210.64  |- skos__hiddenLabel mesh__D005500 Studies, Followup
% 210.47/210.64  |- mesh__activeMeSHYear mesh__D005500 2006
% 210.47/210.64  |- skos__hiddenLabel mesh__D005500 Followup Study
% 210.47/210.64  |- mesh__recordMaintainer mesh__D005500 jls
% 210.47/210.64  |- skos__altLabel mesh__D005500 Followup Studies
% 210.47/210.64  |- skos__hiddenLabel mesh__D005500 Studies, Follow-Up
% 210.47/210.64  |- skos__scopeNote mesh__D005500
% 210.47/210.64       Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.%A%    
% 210.47/210.64  |- skos__annotation mesh__D005500
% 210.47/210.64       IM General only; coord NIM with specific disease %28%IM%29%; specify geography if pertinent; usually epidemiologic in concept; relation to age tag: Manual 18.5.13%A%  
% 210.47/210.64  |- skos__prefLabel mesh__D005500 Follow-Up Studies
% 210.47/210.64  |- skos__hiddenLabel mesh__D005500 Follow-Up Study
% 210.47/210.64  |- mesh__dateRevised mesh__D005500 2004-07-07
% 210.47/210.64  |- mesh__publicMeSHNote mesh__D005500 67   
% 210.47/210.64  |- skos__hiddenLabel mesh__D005500 Study, Followup
% 210.47/210.64  |- skos__broader mesh__D005500smesh__D015331
% 210.47/210.64  |- mesh__recordAuthorizer mesh__D005500 sjn
% 210.47/210.64  |- skos__hiddenLabel mesh__D005500 Follow Up Studies
% 210.47/210.64  |- skos__prefLabel mesh__D052156 SELEX Aptamer Technique
% 210.47/210.64  |- mesh__recordMaintainer mesh__D052156 ssb
% 210.47/210.64  |- skos__hiddenLabel mesh__D052156 Aptamer Technique, SELEX
% 210.47/210.64  |- mesh__historyNote mesh__D052156 2006   
% 210.47/210.64  |- skos__hiddenLabel mesh__D052156 Technique, SELEX Aptamer
% 210.47/210.64  |- rdf__type mesh__D052156sskos__Concept
% 210.47/210.65  |- mesh__recordAuthorizer mesh__D052156 sjn
% 210.47/210.65  |- skos__hiddenLabel mesh__D052156 Techniques, SELEX Aptamer
% 210.47/210.65  |- mesh__dateEstablished mesh__D052156 2006-01-01
% 210.47/210.65  |- skos__scopeNote mesh__D052156
% 210.47/210.65       A method of generating a large library of randomized nucleotides and selecting NUCLEOTIDE APTAMERS by iterative rounds of in vitro selection. A modified procedure substitutes AMINO ACIDS in place of NUCLEOTIDES to make PEPTIDE APTAMERS.%A%    
% 210.47/210.65  |- skos__hiddenLabel mesh__D052156 Aptamer Techniques, SELEX
% 210.47/210.65  |- mesh__dateCreated mesh__D052156 2005-06-30
% 210.47/210.65  |- mesh__publicMeSHNote mesh__D052156 2006   
% 210.47/210.65  |- mesh__recordOriginator mesh__D052156 ssb
% 210.47/210.65  |- skos__hiddenLabel mesh__D052156 SELEX Aptamer Techniques
% 210.47/210.65  |- skos__altLabel mesh__D052156
% 210.47/210.65       Systematic Evolution of Ligands by Eponential Enrichment
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D052156 2006
% 210.47/210.65  |- skos__broader mesh__D052156smesh__D020650
% 210.47/210.65  |- skos__broader mesh__D006225Q000293smesh__D006225
% 210.47/210.65  |- mesh__preferredCombination mesh__D006225Q000293smesh__D006230
% 210.47/210.65  |- rdf__type mesh__D006225Q000293smesh__CompoundConcept
% 210.47/210.65  |- mesh__historyNote mesh__D018428 95   
% 210.47/210.65  |- mesh__dateEstablished mesh__D018428 1995-01-01
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D018428 2005
% 210.47/210.65  |- mesh__recordOriginator mesh__D018428 PXP
% 210.47/210.65  |- mesh__dateRevised mesh__D018428 2003-07-09
% 210.47/210.65  |- mesh__dateCreated mesh__D018428 1994-06-03
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D018428 2006
% 210.47/210.65  |- mesh__publicMeSHNote mesh__D018428 95   
% 210.47/210.65  |- skos__prefLabel mesh__D018428 Drosophilidae
% 210.47/210.65  |- skos__annotation mesh__D018428
% 210.47/210.65       a family of Diptera; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111%A%  
% 210.47/210.65  |- mesh__recordAuthorizer mesh__D018428 sjn
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D018428 2004
% 210.47/210.65  |- skos__broader mesh__D018428smesh__D004175
% 210.47/210.65  |- rdf__type mesh__D018428sskos__Concept
% 210.47/210.65  |- skos__scopeNote mesh__D018428
% 210.47/210.65       A family of the order DIPTERA. These flies are generally found around decaying vegetation and fruit. Several species, because of their short life span, giant salivary gland chromosomes, and ease of culturing, have been used extensively in studies of heredity.%A%    
% 210.47/210.65  |- mesh__recordMaintainer mesh__D018428 ags
% 210.47/210.65  |- skos__prefLabel mesh__D010445 Peptide Elongation Factors
% 210.47/210.65  |- mesh__recordAuthorizer mesh__D010445 sjn
% 210.47/210.65  |- skos__annotation mesh__D010445
% 210.47/210.65       /drug eff /biosyn /physiol /ultrastruct permitted   
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D010445 2006
% 210.47/210.65  |- mesh__recordOriginator mesh__D010445 NLM
% 210.47/210.65  |- skos__hiddenLabel mesh__D010445 Elongation Factors, Peptide
% 210.47/210.65  |- mesh__publicMeSHNote mesh__D010445 73   
% 210.47/210.65  |- mesh__dateEstablished mesh__D010445 1973-01-01
% 210.47/210.65  |- skos__historyNote mesh__D010445 Peptides %28%1966-1972%29%
% 210.47/210.65  |- skos__hiddenLabel mesh__D010445 Factor, Elongation
% 210.47/210.65  |- skos__historyNote mesh__D010445 Bacterial Proteins %28%1966-1972%29%
% 210.47/210.65  |- rdf__type mesh__D010445sskos__Concept
% 210.47/210.65  |- skos__hiddenLabel mesh__D010445 Factors, Peptide Elongation
% 210.47/210.65  |- mesh__recordMaintainer mesh__D010445 SYSTEM
% 210.47/210.65  |- skos__historyNote mesh__D010445 Proteins %28%1966-1972%29%
% 210.47/210.65  |- skos__scopeNote mesh__D010445
% 210.47/210.65       Protein factors uniquely required during the elongation phase of protein synthesis.%A%    
% 210.47/210.65  |- mesh__dateRevised mesh__D010445 2005-06-30
% 210.47/210.65  |- mesh__dateCreated mesh__D010445 1999-01-01
% 210.47/210.65  |- mesh__historyNote mesh__D010445 73   
% 210.47/210.65  |- skos__broader mesh__D010445smesh__D012269
% 210.47/210.65  |- mesh__dateEstablished mesh__D004408 1991-01-01
% 210.47/210.65  |- skos__scopeNote mesh__D004408
% 210.47/210.65       A condition characterized by alterations of the sense of taste which may range from mild to severe, including gross distortions of taste quality.%A%    
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D004408 2001
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D004408 2000A
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D004408 2005
% 210.47/210.65  |- skos__hiddenLabel mesh__D004408 Dysgeusias
% 210.47/210.65  |- mesh__historyNote mesh__D004408 1991%28%1975%29%   
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D004408 2002
% 210.47/210.65  |- mesh__dateRevised mesh__D004408 1999-12-02
% 210.47/210.65  |- mesh__recordMaintainer mesh__D004408 ags
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D004408 2006
% 210.47/210.65  |- skos__broader mesh__D004408smesh__D013651
% 210.47/210.65  |- mesh__recordOriginator mesh__D004408 NLM
% 210.47/210.65  |- mesh__dateCreated mesh__D004408 1999-01-01
% 210.47/210.65  |- rdf__type mesh__D004408sskos__Concept
% 210.47/210.65  |- skos__altLabel mesh__D004408 Parageusia
% 210.47/210.65  |- mesh__recordAuthorizer mesh__D004408 ags
% 210.47/210.65  |- skos__annotation mesh__D004408
% 210.47/210.65       do not confuse with AGEUSIA, loss of sense of taste   
% 210.47/210.65  |- skos__hiddenLabel mesh__D004408 Distorted Taste
% 210.47/210.65  |- skos__hiddenLabel mesh__D004408 Parageusias
% 210.47/210.65  |- skos__altLabel mesh__D004408 Taste, Distorted
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D004408 2003
% 210.47/210.65  |- mesh__publicMeSHNote mesh__D004408
% 210.47/210.65       1991; see TASTE DISORDERS 1975-1990   
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D004408 2000
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D004408 2004
% 210.47/210.65  |- skos__prefLabel mesh__D004408 Dysgeusia
% 210.47/210.65  |- skos__hiddenLabel mesh__D004408 Altered Taste
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001110 1996
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001110 2005
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001110 1998
% 210.47/210.65  |- skos__scopeNote mesh__D001110
% 210.47/210.65       The Arctic Ocean and the lands in it and adjacent to it. It includes Point Barrow, Alaska, most of the Franklin District in Canada, two thirds of Greenland, Svalbard, Franz Josef Land, Lapland, Novaya Zemlya, and Northern Siberia. %28%Webster%27%s New Geographical Dictionary, 1988, p66%29%%A%    
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001110 2004
% 210.47/210.65  |- mesh__dateRevised mesh__D001110 1995-02-17
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001110 1997
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001110 2006
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001110 2000
% 210.47/210.65  |- skos__broader mesh__D001110smesh__D005842
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001110 1999
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001110 2001
% 210.47/210.65  |- mesh__dateCreated mesh__D001110 1999-01-01
% 210.47/210.65  |- mesh__recordOriginator mesh__D001110 NLM
% 210.47/210.65  |- rdf__type mesh__D001110sskos__Concept
% 210.47/210.65  |- mesh__recordAuthorizer mesh__D001110 PLS
% 210.47/210.65  |- mesh__recordMaintainer mesh__D001110 TGC
% 210.47/210.65  |- skos__prefLabel mesh__D001110 Arctic Regions
% 210.47/210.65  |- skos__annotation mesh__D001110
% 210.47/210.65       note spelling: ARCTIC: neither spelled nor pronounced %22%artic%22%%A%  
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001110 2002
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001110 2003
% 210.47/210.65  |- mesh__historyNote mesh__D020075 99   
% 210.47/210.65  |- skos__historyNote mesh__D020075 Basidiomycota %28%1978-1998%29%
% 210.47/210.65  |- mesh__dateEstablished mesh__D020075 1999-01-01
% 210.47/210.65  |- skos__broader mesh__D020075smesh__D011124
% 210.47/210.65  |- mesh__recordMaintainer mesh__D020075 SYSTEM
% 210.47/210.65  |- mesh__publicMeSHNote mesh__D020075 99   
% 210.47/210.65  |- mesh__recordOriginator mesh__D020075 AGS
% 210.47/210.65  |- mesh__dateCreated mesh__D020075 1998-06-10
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D020075 2006
% 210.47/210.65  |- rdf__type mesh__D020075sskos__Concept
% 210.47/210.65  |- mesh__dateRevised mesh__D020075 2005-06-30
% 210.47/210.65  |- skos__prefLabel mesh__D020075 Phanerochaete
% 210.47/210.65  |- skos__scopeNote mesh__D020075
% 210.47/210.65       A genus of fungi in the family Corticiaceae, order Stereales, that degrades lignin. The white-rot fungus Phanerochaete chrysosporium is a frequently used species in research.%A%    
% 210.47/210.65  |- mesh__recordAuthorizer mesh__D020075 sjn
% 210.47/210.65  |- skos__broader mesh__D014836smesh__D008606
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014836 2003
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014836 2004
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014836 1998
% 210.47/210.65  |- rdf__type mesh__D014836sskos__Concept
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014836 2002
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014836 1999
% 210.47/210.65  |- mesh__dateRevised mesh__D014836 1995-05-23
% 210.47/210.65  |- mesh__recordOriginator mesh__D014836 NLM
% 210.47/210.65  |- mesh__recordMaintainer mesh__D014836 KEV
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014836 1996
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014836 2000
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014836 2005
% 210.47/210.65  |- mesh__dateCreated mesh__D014836 1999-01-01
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014836 1997
% 210.47/210.65  |- skos__prefLabel mesh__D014836 Volition
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014836 2006
% 210.47/210.65  |- mesh__recordAuthorizer mesh__D014836 PLS
% 210.47/210.65  |- skos__scopeNote mesh__D014836
% 210.47/210.65       Voluntary activity without external compulsion.     
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014836 2001
% 210.47/210.65  |- skos__altLabel mesh__D014836 Will
% 210.47/210.65  |- skos__annotation mesh__D014038
% 210.47/210.65       includes bed pans, urinals, commodes, etc.   
% 210.47/210.65  |- mesh__dateEstablished mesh__D014038 1977-01-01
% 210.47/210.65  |- skos__hiddenLabel mesh__D014038 Facility, Toilet
% 210.47/210.65  |- skos__broader mesh__D014038smesh__D012498
% 210.47/210.65  |- skos__scopeNote mesh__D014038
% 210.47/210.65       Facilities provided for human excretion, often with accompanying handwashing facilities.%A%    
% 210.47/210.65  |- mesh__recordOriginator mesh__D014038 NLM
% 210.47/210.65  |- mesh__recordAuthorizer mesh__D014038 sjn
% 210.47/210.65  |- mesh__onlineNote mesh__D014038
% 210.47/210.65       use TOILET FACILITIES to search LATRINES 1966-76   
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014038 2006
% 210.47/210.65  |- mesh__dateCreated mesh__D014038 1999-01-01
% 210.47/210.65  |- skos__broader mesh__D014038smesh__D011633
% 210.47/210.65  |- mesh__dateRevised mesh__D014038 2004-07-13
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014038 2005
% 210.47/210.65  |- skos__prefLabel mesh__D014038 Toilet Facilities
% 210.47/210.65  |- mesh__recordMaintainer mesh__D014038 sjn
% 210.47/210.65  |- skos__hiddenLabel mesh__D014038 Latrine
% 210.47/210.65  |- rdf__type mesh__D014038sskos__Concept
% 210.47/210.65  |- skos__hiddenLabel mesh__D014038 Facilities, Toilet
% 210.47/210.65  |- skos__hiddenLabel mesh__D014038 Toilet Facility
% 210.47/210.65  |- mesh__historyNote mesh__D014038 77; was LATRINES 1963-76   
% 210.47/210.65  |- mesh__publicMeSHNote mesh__D014038 77; was LATRINES 1963-76   
% 210.47/210.65  |- mesh__recordOriginator mesh__D000816 SH
% 210.47/210.65  |- mesh__dateCreated mesh__D000816 1975-07-21
% 210.47/210.65  |- mesh__recordAuthorizer mesh__D000816 sjn
% 210.47/210.65  |- skos__broader mesh__D000816smesh__D009588
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D000816 2003
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D000816 2001
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D000816 2005
% 210.47/210.65  |- skos__altLabel mesh__D000816 N,N-Di%28%2-Chloroethyl%29%aniline
% 210.47/210.65  |- skos__altLabel mesh__D000816 N,N-bis%28%2-chloroethyl%29%aniline
% 210.47/210.65  |- mesh__historyNote mesh__D000816
% 210.47/210.65       91%28%76%29%; was see under NITROGEN MUSTARD COMPOUNDS 1976-90; LYMPHOCHIN %26% LYMPHOQUIN were see ANILINE MUSTARD 1976-95%A%  
% 210.47/210.65  |- mesh__dateEstablished mesh__D000816 1991-01-01
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D000816 2004
% 210.47/210.65  |- rdf__type mesh__D000816sskos__Concept
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D000816 2006
% 210.47/210.65  |- mesh__publicMeSHNote mesh__D000816
% 210.47/210.65       91; was see under NITROGEN MUSTARD COMPOUNDS 1976-90; LYMPHOCHIN %26% LYMPHOQUIN were see ANILINE MUSTARD 1976-95%A%  
% 210.47/210.65  |- skos__historyNote mesh__D000816
% 210.47/210.65       Nitrogen Mustard Compounds %28%1970-1975%29%
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D000816 2002
% 210.47/210.65  |- mesh__recordMaintainer mesh__D000816 jmp
% 210.47/210.65  |- skos__prefLabel mesh__D000816 Aniline Mustard
% 210.47/210.65  |- mesh__dateRevised mesh__D000816 2000-06-21
% 210.47/210.65  |- skos__scopeNote mesh__D000816 Alkylating anti-neoplastic agent.     
% 210.47/210.65  |- skos__historyNote mesh__D000816 Aniline Compounds %28%1970-1975%29%
% 210.47/210.65  |- skos__hiddenLabel mesh__D000816 Mustard, Aniline
% 210.47/210.65  |- mesh__recordOriginator mesh__D019521 JLS
% 210.47/210.65  |- rdf__type mesh__D019521sskos__Concept
% 210.47/210.65  |- mesh__historyNote mesh__D019521 97   
% 210.47/210.65  |- skos__prefLabel mesh__D019521 Body Patterning
% 210.47/210.65  |- skos__scopeNote mesh__D019521
% 210.47/210.65       The processes occurring in early development that direct morphogenesis. They specify the body plan ensuring that cells will proceed to differentiate, grow, and diversify in size and shape at the correct relative positions. Included are axial patterning, segmentation, compartment specification, limb position, organ boundary patterning, blood vessel patterning, etc.%A%    
% 210.47/210.65  |- skos__altLabel mesh__D019521 Body Pattern Specification
% 210.47/210.65  |- mesh__dateRevised mesh__D019521 2004-07-07
% 210.47/210.65  |- skos__hiddenLabel mesh__D019521 Formation, Embryonic Pattern
% 210.47/210.65  |- skos__hiddenLabel mesh__D019521 Specification, Body Pattern
% 210.47/210.65  |- skos__hiddenLabel mesh__D019521 Development Polarity
% 210.47/210.65  |- mesh__recordMaintainer mesh__D019521 lkt
% 210.47/210.65  |- skos__hiddenLabel mesh__D019521 Pattern Formation, Body
% 210.47/210.65  |- skos__historyNote mesh__D019521 Morphogenesis %28%1986-1996%29%
% 210.47/210.65  |- skos__hiddenLabel mesh__D019521 Embryonic Pattern Formations
% 210.47/210.65  |- skos__altLabel mesh__D019521 Body Pattern Formation
% 210.47/210.65  |- skos__hiddenLabel mesh__D019521 Pattern Formation, Embryonic
% 210.47/210.65  |- skos__hiddenLabel mesh__D019521 Pattern Specification, Body
% 210.47/210.65  |- mesh__dateEstablished mesh__D019521 1997-01-01
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D019521 2005
% 210.47/210.65  |- skos__hiddenLabel mesh__D019521 Specification, Embryonic Pattern
% 210.47/210.65  |- skos__altLabel mesh__D019521 Embryonic Pattern Specification
% 210.47/210.65  |- skos__hiddenLabel mesh__D019521 Patterning, Body
% 210.47/210.65  |- skos__broader mesh__D019521smesh__D009024
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D019521 2006
% 210.47/210.65  |- mesh__publicMeSHNote mesh__D019521 97   
% 210.47/210.65  |- mesh__dateCreated mesh__D019521 1996-06-13
% 210.47/210.65  |- skos__hiddenLabel mesh__D019521 Patterning, Axial %28%Embryology%29%
% 210.47/210.65  |- skos__hiddenLabel mesh__D019521 Pattern Specification, Embryonic
% 210.47/210.65  |- mesh__recordAuthorizer mesh__D019521 sjn
% 210.47/210.65  |- mesh__recordAuthorizer mesh__D000018 PLS
% 210.47/210.65  |- mesh__dateCreated mesh__D000018 1999-01-01
% 210.47/210.65  |- skos__broader mesh__D000018smesh__D013279
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D000018 2003
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D000018 1996
% 210.47/210.65  |- mesh__dateEstablished mesh__D000018 1968-01-01
% 210.47/210.65  |- skos__annotation mesh__D000018
% 210.47/210.65       a ruminant%27%s 4th stomach; dis: coord IM with STOMACH DISEASES /vet %28%IM%29%; neopl: coord IM with STOMACH NEOPLASMS /vet %28%IM%29% + histol type /vet %28%IM%29%; ulcer: coord IM with STOMACH ULCER /vet %28%IM%29%%A%  
% 210.47/210.65  |- mesh__recordMaintainer mesh__D000018 TGC
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D000018 2004
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D000018 1997
% 210.47/210.65  |- mesh__historyNote mesh__D000018 68   
% 210.47/210.65  |- skos__scopeNote mesh__D000018
% 210.47/210.65       The fourth stomach of ruminating animals. It is also called the %22%true%22% stomach. It is an elongated pear-shaped sac lying on the floor of the abdomen, on the right-hand side, and roughly between the seventh and twelfth ribs. It leads to the beginning of the small intestine. %28%From Black%27%s Veterinary Dictionary, 17th ed%29%%A%    
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D000018 2000
% 210.47/210.65  |- mesh__recordOriginator mesh__D000018 NLM
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D000018 2005
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D000018 1998
% 210.47/210.65  |- skos__historyNote mesh__D000018 Stomach %28%1966-1967%29%
% 210.47/210.65  |- skos__prefLabel mesh__D000018 Abomasum
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D000018 2001
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D000018 2006
% 210.47/210.65  |- mesh__dateRevised mesh__D000018 1995-05-18
% 210.47/210.65  |- skos__hiddenLabel mesh__D000018 Abomasums
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D000018 1999
% 210.47/210.65  |- rdf__type mesh__D000018sskos__Concept
% 210.47/210.65  |- mesh__publicMeSHNote mesh__D000018 68   
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D000018 2002
% 210.47/210.65  |- skos__prefLabel mesh__D052157 Aptamers, Nucleotide
% 210.47/210.65  |- mesh__publicMeSHNote mesh__D052157 2006   
% 210.47/210.65  |- skos__altLabel mesh__D052157 Nucleotide Aptamers
% 210.47/210.65  |- skos__scopeNote mesh__D052157
% 210.47/210.65       Nucleotide sequences, generated by iterative rounds of SELEX APTAMER TECHNIQUE, that bind to a target molecule specifically and with high affinity.%A%    
% 210.47/210.65  |- mesh__recordMaintainer mesh__D052157 ssb
% 210.47/210.65  |- mesh__recordOriginator mesh__D052157 ssb
% 210.47/210.65  |- skos__hiddenLabel mesh__D052157 Ligands, RNA Oligonucleotide
% 210.47/210.65  |- mesh__historyNote mesh__D052157 2006   
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D052157 2006
% 210.47/210.65  |- mesh__dateEstablished mesh__D052157 2006-01-01
% 210.47/210.65  |- skos__hiddenLabel mesh__D052157 RNA Oligonucleotide Ligands
% 210.47/210.65  |- skos__hiddenLabel mesh__D052157 DNA Oligonucleotide Ligands
% 210.47/210.65  |- mesh__recordAuthorizer mesh__D052157 sjn
% 210.47/210.65  |- skos__broader mesh__D052157smesh__D009841
% 210.47/210.65  |- skos__hiddenLabel mesh__D052157 Ligands, DNA Oligonucleotide
% 210.47/210.65  |- rdf__type mesh__D052157sskos__Concept
% 210.47/210.65  |- mesh__dateCreated mesh__D052157 2005-06-30
% 210.47/210.65  |- mesh__recordMaintainer mesh__D018429 ags
% 210.47/210.65  |- skos__prefLabel mesh__D018429 Glossinidae
% 210.47/210.65  |- mesh__historyNote mesh__D018429 95   
% 210.47/210.65  |- skos__annotation mesh__D018429
% 210.47/210.65       a family of Diptera occurring only in Africa; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111%A%  
% 210.47/210.65  |- mesh__recordOriginator mesh__D018429 PXP
% 210.47/210.65  |- mesh__dateCreated mesh__D018429 1994-06-03
% 210.47/210.65  |- mesh__dateEstablished mesh__D018429 1995-01-01
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D018429 2005
% 210.47/210.65  |- skos__scopeNote mesh__D018429
% 210.47/210.65       A family of the order DIPTERA that includes the TSETSE FLIES. These flies occur only in Africa.%A%    
% 210.47/210.65  |- mesh__publicMeSHNote mesh__D018429 95   
% 210.47/210.65  |- mesh__dateRevised mesh__D018429 2003-07-09
% 210.47/210.65  |- mesh__recordAuthorizer mesh__D018429 sjn
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D018429 2006
% 210.47/210.65  |- rdf__type mesh__D018429sskos__Concept
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D018429 2004
% 210.47/210.65  |- skos__broader mesh__D018429smesh__D004175
% 210.47/210.65  |- mesh__dateRevised mesh__D010446 1998-06-10
% 210.47/210.65  |- mesh__historyNote mesh__D010446 74   
% 210.47/210.65  |- mesh__dateCreated mesh__D010446 1999-01-01
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D010446 2001
% 210.47/210.65  |- skos__hiddenLabel mesh__D010446 Fragments, Peptide
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D010446 1999
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D010446 2006
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D010446 2000
% 210.47/210.65  |- skos__prefLabel mesh__D010446 Peptide Fragments
% 210.47/210.65  |- skos__scopeNote mesh__D010446
% 210.47/210.65       Partial proteins formed by partial hydrolysis of complete proteins.%A%    
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D010446 2004
% 210.47/210.65  |- skos__broader mesh__D010446smesh__D010455
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D010446 2005
% 210.47/210.65  |- mesh__recordOriginator mesh__D010446 NLM
% 210.47/210.65  |- mesh__publicMeSHNote mesh__D010446 74   
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D010446 2003
% 210.47/210.65  |- mesh__dateEstablished mesh__D010446 1974-01-01
% 210.47/210.65  |- rdf__type mesh__D010446sskos__Concept
% 210.47/210.65  |- mesh__recordAuthorizer mesh__D010446 SJN
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D010446 2002
% 210.47/210.65  |- mesh__recordMaintainer mesh__D010446 ADP
% 210.47/210.65  |- skos__broader mesh__D014566Q000530smesh__D014566
% 210.47/210.65  |- mesh__preferredCombination mesh__D014566Q000530smesh__D014567
% 210.47/210.65  |- rdf__type mesh__D014566Q000530smesh__CompoundConcept
% 210.47/210.65  |- rdf__type mesh__D004409sskos__Concept
% 210.47/210.65  |- mesh__recordMaintainer mesh__D004409 nns
% 210.47/210.65  |- mesh__dateCreated mesh__D004409 1976-05-19
% 210.47/210.65  |- mesh__recordOriginator mesh__D004409 MM
% 210.47/210.65  |- mesh__dateEstablished mesh__D004409 1977-01-01
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D004409 2003
% 210.47/210.65  |- skos__hiddenLabel mesh__D004409 Dyskinesias, Lingual-Facial-Buccal
% 210.47/210.65  |- skos__hiddenLabel mesh__D004409 Dyskinesia, Drug Induced
% 210.47/210.65  |- skos__altLabel mesh__D004409 Medication-Induced Dyskinesia
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D004409 2004
% 210.47/210.65  |- skos__historyNote mesh__D004409 Movement Disorders %28%1966-1976%29%
% 210.47/210.65  |- skos__related mesh__D004409smesh__D017109
% 210.47/210.65  |- skos__hiddenLabel mesh__D004409 Orofacial Dyskinesias
% 210.47/210.65  |- skos__hiddenLabel mesh__D004409 Dyskinesias, Medication-Induced
% 210.47/210.65  |- skos__scopeNote mesh__D004409
% 210.47/210.65       Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents %28%see ANTIPSYCHOTIC AGENTS%29%. %28%Adams et al., Principles of Neurology, 6th ed, p1199%29%%A%    
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D004409 2002
% 210.47/210.65  |- skos__altLabel mesh__D004409 Orofacial Dyskinesia
% 210.47/210.65  |- skos__prefLabel mesh__D004409 Dyskinesia, Drug-Induced
% 210.47/210.65  |- mesh__dateRevised mesh__D004409 2001-07-25
% 210.47/210.65  |- skos__hiddenLabel mesh__D004409 Drug-Induced Dyskinesia
% 210.47/210.65  |- skos__hiddenLabel mesh__D004409 Medication Induced Dyskinesia
% 210.47/210.65  |- skos__hiddenLabel mesh__D004409 Dyskinesia, Orofacial
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D004409 2005
% 210.47/210.65  |- skos__hiddenLabel mesh__D004409 Dyskinesia, Medication Induced
% 210.47/210.65  |- mesh__historyNote mesh__D004409 77   
% 210.47/210.65  |- mesh__publicMeSHNote mesh__D004409 77   
% 210.47/210.65  |- mesh__recordAuthorizer mesh__D004409 sjn
% 210.47/210.65  |- skos__hiddenLabel mesh__D004409 Dyskinesia, Lingual-Facial-Buccal
% 210.47/210.65  |- skos__broader mesh__D004409smesh__D020258
% 210.47/210.65  |- skos__hiddenLabel mesh__D004409 Lingual-Facial-Buccal Dyskinesias
% 210.47/210.65  |- skos__hiddenLabel mesh__D004409 Dyskinesias, Drug-Induced
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D004409 2006
% 210.47/210.65  |- skos__annotation mesh__D004409
% 210.47/210.65       do not confuse with AKATHISIA, DRUG-INDUCED which shows %22%anxiety, restlessness %26% agitation%22%%A%  
% 210.47/210.65  |- skos__hiddenLabel mesh__D004409 Lingual Facial Buccal Dyskinesia
% 210.47/210.65  |- skos__hiddenLabel mesh__D004409 Medication-Induced Dyskinesias
% 210.47/210.65  |- skos__hiddenLabel mesh__D004409 Drug-Induced Dyskinesias
% 210.47/210.65  |- skos__hiddenLabel mesh__D001111 Nucleus, Arcuate
% 210.47/210.65  |- mesh__dateEstablished mesh__D001111 1983-01-01
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001111 2001
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001111 2004
% 210.47/210.65  |- skos__altLabel mesh__D001111 Infundibular Nucleus
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001111 1997
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001111 2000
% 210.47/210.65  |- skos__hiddenLabel mesh__D001111 Nucleus, Infundibular
% 210.47/210.65  |- skos__historyNote mesh__D001111 Hypothalamus %28%1966-1982%29%
% 210.47/210.65  |- mesh__recordMaintainer mesh__D001111 TAP
% 210.47/210.65  |- mesh__dateRevised mesh__D001111 1992-03-25
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001111 2003
% 210.47/210.65  |- skos__broader mesh__D001111smesh__D007033
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001111 1993
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001111 1996
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001111 2006
% 210.47/210.65  |- skos__prefLabel mesh__D001111 Arcuate Nucleus
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001111 1999
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001111 2002
% 210.47/210.65  |- mesh__historyNote mesh__D001111 83   
% 210.47/210.65  |- mesh__dateCreated mesh__D001111 1982-04-23
% 210.47/210.65  |- mesh__recordOriginator mesh__D001111 RC
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001111 1995
% 210.47/210.65  |- mesh__recordAuthorizer mesh__D001111 PLS
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001111 2005
% 210.47/210.65  |- skos__scopeNote mesh__D001111
% 210.47/210.65       A nucleus located in the middle hypothalamus in the most ventral part of the third ventricle near the entrance of the infundibular recess. Its small cells are in close contact with the ependyma.%A%    
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001111 1998
% 210.47/210.65  |- skos__annotation mesh__D001111 in the HYPOTHALAMUS, MIDDLE   
% 210.47/210.65  |- rdf__type mesh__D001111sskos__Concept
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D001111 1994
% 210.47/210.65  |- mesh__publicMeSHNote mesh__D001111 83   
% 210.47/210.65  |- mesh__publicMeSHNote mesh__D020076 99   
% 210.47/210.65  |- mesh__recordMaintainer mesh__D020076 ags
% 210.47/210.65  |- mesh__historyNote mesh__D020076 99   
% 210.47/210.65  |- skos__broader mesh__D020076smesh__D000363
% 210.47/210.65  |- skos__altLabel mesh__D020076 Pleurotus ostreatus
% 210.47/210.65  |- mesh__dateRevised mesh__D020076 2005-06-30
% 210.47/210.65  |- skos__prefLabel mesh__D020076 Pleurotus
% 210.47/210.65  |- mesh__recordAuthorizer mesh__D020076 sjn
% 210.47/210.65  |- skos__historyNote mesh__D020076 Basidiomycota %28%1966-1998%29%
% 210.47/210.65  |- mesh__recordOriginator mesh__D020076 AGS
% 210.47/210.65  |- skos__historyNote mesh__D020076 Polyporaceae %28%1988-1998%29%
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D020076 2006
% 210.47/210.65  |- rdf__type mesh__D020076sskos__Concept
% 210.47/210.65  |- skos__scopeNote mesh__D020076
% 210.47/210.65       A genus of basidiomycetous fungi, family POLYPORACEAE, order POLYPORALES, that grows on logs or tree stumps in shelflike layers. The species P. ostreatus, the oyster mushroom, is a choice edible species and is the most frequently encountered member of the genus in eastern North America. %28%Alexopoulos et al., Introductory Mycology, 4th ed, p531%29%%A%    
% 210.47/210.65  |- mesh__dateEstablished mesh__D020076 1999-01-01
% 210.47/210.65  |- mesh__dateCreated mesh__D020076 1998-06-10
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014837 2004
% 210.47/210.65  |- rdf__type mesh__D014837sskos__Concept
% 210.47/210.65  |- skos__hiddenLabel mesh__D014837 Agency, Voluntary Health
% 210.47/210.65  |- skos__prefLabel mesh__D014837 Voluntary Health Agencies
% 210.47/210.65  |- skos__hiddenLabel mesh__D014837 Voluntary Health Agency
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014837 2001
% 210.47/210.65  |- mesh__dateRevised mesh__D014837 1999-11-03
% 210.47/210.65  |- skos__hiddenLabel mesh__D014837 Agencies, Voluntary Health
% 210.47/210.65  |- skos__annotation mesh__D014837
% 210.47/210.65       IM; coord with specific pertinent med specialty %28%IM%29%; TN 174: definition %26% use%A%  
% 210.47/210.65  |- skos__hiddenLabel mesh__D014837 Health Agencies, Voluntary
% 210.47/210.65  |- mesh__recordMaintainer mesh__D014837 kle
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014837 2005
% 210.47/210.65  |- skos__scopeNote mesh__D014837
% 210.47/210.65       Non-profit organizations concerned with various aspects of health, e.g., education, promotion, treatment, services, etc.%A%    
% 210.47/210.65  |- mesh__dateCreated mesh__D014837 1999-01-01
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014837 2002
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014837 2006
% 210.47/210.65  |- mesh__recordAuthorizer mesh__D014837 sjn
% 210.47/210.65  |- skos__hiddenLabel mesh__D014837 Health Agency, Voluntary
% 210.47/210.65  |- mesh__recordOriginator mesh__D014837 NLM
% 210.47/210.65  |- skos__broader mesh__D014837smesh__D009939
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014837 2003
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014837 2000
% 210.47/210.65  |- skos__altLabel mesh__D014837 PPFA
% 210.47/210.65  |- mesh__dateCreated mesh__D014039 1999-01-01
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014039 1999
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014039 2003
% 210.47/210.65  |- mesh__activeMeSHYear mesh__D014039 1993
% 210.47/210.66  |- skos__hiddenLabel mesh__D014039 Toilet Trainings
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D014039 2005
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D014039 1996
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D014039 1995
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D014039 1998
% 210.47/210.66  |- mesh__dateRevised mesh__D014039 1989-05-16
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D014039 1992
% 210.47/210.66  |- mesh__dateEstablished mesh__D014039 1968-01-01
% 210.47/210.66  |- mesh__recordMaintainer mesh__D014039 TGC
% 210.47/210.66  |- rdf__type mesh__D014039sskos__Concept
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D014039 1994
% 210.47/210.66  |- mesh__publicMeSHNote mesh__D014039 68   
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D014039 2002
% 210.47/210.66  |- skos__scopeNote mesh__D014039
% 210.47/210.66       Conditioning to defecate and urinate in culturally acceptable places.%A%    
% 210.47/210.66  |- skos__historyNote mesh__D014039 Child Care %28%1966-1967%29%
% 210.47/210.66  |- skos__broader mesh__D014039smesh__D002668
% 210.47/210.66  |- mesh__recordOriginator mesh__D014039 NLM
% 210.47/210.66  |- skos__hiddenLabel mesh__D014039 Training, Toilet
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D014039 2001
% 210.47/210.66  |- mesh__recordAuthorizer mesh__D014039 PLS
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D014039 1991
% 210.47/210.66  |- mesh__historyNote mesh__D014039 68   
% 210.47/210.66  |- skos__hiddenLabel mesh__D014039 Trainings, Toilet
% 210.47/210.66  |- skos__annotation mesh__D014039 no qualif   
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D014039 2004
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D014039 2006
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D014039 2000
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D014039 1997
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D014039 1990
% 210.47/210.66  |- skos__prefLabel mesh__D014039 Toilet Training
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D000817 2005
% 210.47/210.66  |- mesh__recordAuthorizer mesh__D000817 PLS
% 210.47/210.66  |- skos__broader mesh__D000817smesh__D009282
% 210.47/210.66  |- rdf__type mesh__D000817sskos__Concept
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D000817 2004
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D000817 1996
% 210.47/210.66  |- skos__scopeNote mesh__D000817
% 210.47/210.66       A class of organic compounds which contain an anilino %28%phenylamino%29% group linked to a salt or ester of naphthalenesulfonic acid. They are frequently used as fluorescent dyes and sulfhydryl reagents.%A%    
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D000817 2002
% 210.47/210.66  |- skos__prefLabel mesh__D000817 Anilino Naphthalenesulfonates
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D000817 2006
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D000817 1998
% 210.47/210.66  |- mesh__recordOriginator mesh__D000817 NLM
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D000817 1997
% 210.47/210.66  |- skos__hiddenLabel mesh__D000817 Naphthalenesulfonates, Anilino
% 210.47/210.66  |- mesh__historyNote mesh__D000817 74   
% 210.47/210.66  |- mesh__publicMeSHNote mesh__D000817 74   
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D000817 1999
% 210.47/210.66  |- mesh__recordMaintainer mesh__D000817 TPW
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D000817 1994
% 210.47/210.66  |- skos__broader mesh__D000817smesh__D000814
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D000817 2000
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D000817 2001
% 210.47/210.66  |- mesh__dateCreated mesh__D000817 1999-01-01
% 210.47/210.66  |- mesh__dateEstablished mesh__D000817 1974-01-01
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D000817 1995
% 210.47/210.66  |- mesh__dateRevised mesh__D000817 1993-06-04
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D000817 2003
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D019522 2006
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D019522 2001
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D019522 2005
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D019522 2004
% 210.47/210.66  |- mesh__publicMeSHNote mesh__D019522 97   
% 210.47/210.66  |- skos__hiddenLabel mesh__D019522 Vaginal Discharges
% 210.47/210.66  |- skos__broader mesh__D019522smesh__D014623
% 210.47/210.66  |- rdf__type mesh__D019522sskos__Concept
% 210.47/210.66  |- mesh__historyNote mesh__D019522 97   
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D019522 2000
% 210.47/210.66  |- skos__scopeNote mesh__D019522
% 210.47/210.66       A common gynecologic disorder characterized by an abnormal, nonbloody discharge from the genital tract.%A%    
% 210.47/210.66  |- skos__hiddenLabel mesh__D019522 Discharge, Vaginal
% 210.47/210.66  |- mesh__dateEstablished mesh__D019522 1997-01-01
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D019522 2003
% 210.47/210.66  |- skos__historyNote mesh__D019522 Vagina/secretion %28%1966-1996%29%
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D019522 1999
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D019522 2002
% 210.47/210.66  |- skos__hiddenLabel mesh__D019522 Discharges, Vaginal
% 210.47/210.66  |- skos__prefLabel mesh__D019522 Vaginal Discharge
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D019522 1998
% 210.47/210.66  |- skos__annotation mesh__D019522
% 210.47/210.66       note category; nonbloody; IM; coord with cause of discharge %28%IM%29%%A%  
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D019522 1997
% 210.47/210.66  |- skos__historyNote mesh__D019522 Vaginal Diseases %28%1966-1996%29%
% 210.47/210.66  |- mesh__dateCreated mesh__D019522 1996-06-13
% 210.47/210.66  |- skos__related mesh__D000019smesh__D010120
% 210.47/210.66  |- mesh__recordOriginator mesh__D000019 NLM
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D000019 2006
% 210.47/210.66  |- mesh__dateRevised mesh__D000019 2005-06-30
% 210.47/210.66  |- skos__historyNote mesh__D000019 Abortion, Induced %28%1970-1974%29%
% 210.47/210.66  |- rdf__type mesh__D000019sskos__Concept
% 210.47/210.66  |- skos__altLabel mesh__D000019 Contraceptive Agents, Postconception
% 210.47/210.66  |- mesh__publicMeSHNote mesh__D000019 75   
% 210.47/210.66  |- skos__prefLabel mesh__D000019 Abortifacient Agents
% 210.47/210.66  |- skos__hiddenLabel mesh__D000019 Agents, Postconception Contraceptive
% 210.47/210.66  |- skos__altLabel mesh__D000019 Abortifacients
% 210.47/210.66  |- skos__scopeNote mesh__D000019
% 210.47/210.66       Chemical substances that interrupt pregnancy after implantation.%A%    
% 210.47/210.66  |- skos__broader mesh__D000019smesh__D012102
% 210.47/210.66  |- mesh__recordMaintainer mesh__D000019 ssb
% 210.47/210.66  |- mesh__historyNote mesh__D000019 75   
% 210.47/210.66  |- mesh__recordAuthorizer mesh__D000019 sjn
% 210.47/210.66  |- skos__hiddenLabel mesh__D000019 Postconception Contraceptive Agents
% 210.47/210.66  |- mesh__dateCreated mesh__D000019 1999-01-01
% 210.47/210.66  |- mesh__dateEstablished mesh__D000019 1975-01-01
% 210.47/210.66  |- skos__annotation mesh__D000019
% 210.47/210.66       do not use /ther use for use of abortifacients as abortifacients%A%  
% 210.47/210.66  |- skos__hiddenLabel mesh__D000019 Agents, Abortifacient
% 210.47/210.66  |- mesh__dateRevised mesh__D005502 2002-06-26
% 210.47/210.66  |- skos__broader mesh__D005502smesh__D019602
% 210.47/210.66  |- mesh__recordMaintainer mesh__D005502 ssb
% 210.47/210.66  |- skos__scopeNote mesh__D005502
% 210.47/210.66       Anything which, when taken into the body, serves to nourish or build up the tissues or to supply body heat. %28%Dorland, 27th ed%29%%A%    
% 210.47/210.66  |- skos__related mesh__D005502smesh__D004032
% 210.47/210.66  |- skos__hiddenLabel mesh__D005502 Foods
% 210.47/210.66  |- mesh__recordAuthorizer mesh__D005502 sjn
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D005502 2003
% 210.47/210.66  |- rdf__type mesh__D005502sskos__Concept
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D005502 2005
% 210.47/210.66  |- skos__related mesh__D005502smesh__D010945
% 210.47/210.66  |- mesh__dateCreated mesh__D005502 1999-01-01
% 210.47/210.66  |- mesh__recordOriginator mesh__D005502 NLM
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D005502 2004
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D005502 2006
% 210.47/210.66  |- skos__annotation mesh__D005502
% 210.47/210.66       /adv eff = probably FOOD HYPERSENSITIVITY or FOOD POISONING; /rad eff = probably FOOD IRRADIATION or FOOD CONTAMINATION, RADIOACTIVE; Manual 31.5-31.12; food consumption = FOOD or EATING or FOOD SUPPLY; food for animals = ANIMAL FEED; refeeding after starvation goes here; microbes found in food: consider FOOD MICROBIOLOGY %28%IM%29% + specific microbe %28%IM%29%; parasites found in food: consider FOOD PARASITOLOGY %28%IM%29% + specific parasite %28%IM%29%; differentiation from DIET %26% NUTRITION: see note under NUTRITION %26% Manual 31.5%A%  
% 210.47/210.66  |- skos__prefLabel mesh__D005502 Food
% 210.47/210.66  |- mesh__dateCreated mesh__D052158 2005-06-30
% 210.47/210.66  |- mesh__recordOriginator mesh__D052158 ssb
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D052158 2006
% 210.47/210.66  |- skos__prefLabel mesh__D052158 Aptamers, Peptide
% 210.47/210.66  |- skos__altLabel mesh__D052158 Peptide Aptamers
% 210.47/210.66  |- skos__scopeNote mesh__D052158
% 210.47/210.66       Peptide sequences, generated by iterative rounds of SELEX APTAMER TECHNIQUE, that bind to a target molecule specifically and with high affinity.%A%    
% 210.47/210.66  |- rdf__type mesh__D052158sskos__Concept
% 210.47/210.66  |- mesh__recordMaintainer mesh__D052158 ssb
% 210.47/210.66  |- skos__broader mesh__D052158smesh__D010455
% 210.47/210.66  |- mesh__historyNote mesh__D052158 2006   
% 210.47/210.66  |- mesh__dateEstablished mesh__D052158 2006-01-01
% 210.47/210.66  |- mesh__recordAuthorizer mesh__D052158 sjn
% 210.47/210.66  |- mesh__publicMeSHNote mesh__D052158 2006   
% 210.47/210.66  |- skos__prefLabel mesh__D010447 Peptide Hydrolases
% 210.47/210.66  |- skos__broader mesh__D010447smesh__D006867
% 210.47/210.66  |- skos__altLabel mesh__D010447 Esteroproteases
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D010447 2006
% 210.47/210.66  |- mesh__historyNote mesh__D010447
% 210.47/210.66       1966; for PROTEINASES use ENDOPEPTIDASES 1979-2000; for PROTEASES use ENDOPEPTIDASES 1987-2004%A%  
% 210.47/210.66  |- skos__altLabel mesh__D010447 Peptidases
% 210.47/210.66  |- skos__altLabel mesh__D010447 Proteinases
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D010447 2005
% 210.47/210.66  |- mesh__recordMaintainer mesh__D010447 jmp
% 210.47/210.66  |- mesh__publicMeSHNote mesh__D010447
% 210.47/210.66       1966; for PROTEINASES see ENDOPEPTIDASES 1979-2004; for PROTEASES see ENDOPEPTIDASES 1987-2004%A%  
% 210.47/210.66  |- rdf__type mesh__D010447sskos__Concept
% 210.47/210.66  |- skos__scopeNote mesh__D010447
% 210.47/210.66       Hydrolases that specifically cleave the peptide bonds found in PROTEINS and PEPTIDES. Examples of sub-subclasses for this group include EXOPEPTIDASES and ENDOPEPTIDASES.%A%    
% 210.47/210.66  |- mesh__recordAuthorizer mesh__D010447 sjn
% 210.47/210.66  |- mesh__dateRevised mesh__D010447 2004-07-07
% 210.47/210.66  |- skos__altLabel mesh__D010447 Proteases
% 210.47/210.66  |- mesh__recordOriginator mesh__D010447 NLM
% 210.47/210.66  |- skos__altLabel mesh__D010447 Proteolytic Enzymes
% 210.47/210.66  |- mesh__dateCreated mesh__D010447 1999-01-01
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D015930 1993
% 210.47/210.66  |- skos__hiddenLabel mesh__D015930 Dietary Record
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D015930 2006
% 210.47/210.66  |- skos__hiddenLabel mesh__D015930 Food Diary
% 210.47/210.66  |- skos__hiddenLabel mesh__D015930 Records, Diet
% 210.47/210.66  |- skos__altLabel mesh__D015930 Food Diaries
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D015930 1998
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D015930 2001
% 210.47/210.66  |- mesh__publicMeSHNote mesh__D015930 90   
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D015930 1992
% 210.47/210.66  |- skos__altLabel mesh__D015930 Dietary Records
% 210.47/210.66  |- skos__scopeNote mesh__D015930
% 210.47/210.66       Records of nutrient intake over a specific period of time, usually kept by the patient.%A%    
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D015930 2005
% 210.47/210.66  |- skos__broader mesh__D015930smesh__D011996
% 210.47/210.66  |- skos__annotation mesh__D015930
% 210.47/210.66       record of food intake usually kept by patient; no qualif   
% 210.47/210.66  |- mesh__dateCreated mesh__D015930 1989-05-15
% 210.47/210.66  |- skos__historyNote mesh__D015930 Diet %28%1966-1989%29%
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D015930 1997
% 210.47/210.66  |- skos__hiddenLabel mesh__D015930 Record, Diet
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D015930 2000
% 210.47/210.66  |- skos__hiddenLabel mesh__D015930 Diary, Food
% 210.47/210.66  |- mesh__historyNote mesh__D015930 90   
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D015930 1991
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D015930 2004
% 210.47/210.66  |- skos__prefLabel mesh__D015930 Diet Records
% 210.47/210.66  |- skos__hiddenLabel mesh__D015930 Diet Record
% 210.47/210.66  |- skos__hiddenLabel mesh__D015930 Diaries, Food
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D015930 1996
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D015930 1995
% 210.47/210.66  |- skos__hiddenLabel mesh__D015930 Record, Dietary
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D015930 1990
% 210.47/210.66  |- skos__historyNote mesh__D015930 Nutrition Surveys %28%1971-1989%29%
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D015930 2003
% 210.47/210.66  |- rdf__type mesh__D015930sskos__Concept
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D015930 1994
% 210.47/210.66  |- mesh__dateEstablished mesh__D015930 1990-01-01
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D015930 1999
% 210.47/210.66  |- skos__hiddenLabel mesh__D015930 Records, Dietary
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D015930 2002
% 210.47/210.66  |- mesh__publicMeSHNote mesh__D001910
% 210.47/210.66       94; was BOVINE PAPILLOMATOSIS VIRUS 1975-93 %28%see under PAPILLOMAVIRUSES 1978-90, see under PAPILLOMA VIRUSES 1975-77%29%%A%  
% 210.47/210.66  |- mesh__recordOriginator mesh__D001910 NLM
% 210.47/210.66  |- mesh__recordAuthorizer mesh__D001910 sjn
% 210.47/210.66  |- skos__hiddenLabel mesh__D001910 Papillomaviruses, Bovine
% 210.47/210.66  |- skos__hiddenLabel mesh__D001910 papillomatosis viruses, Bovine
% 210.47/210.66  |- skos__altLabel mesh__D001910 Bovine Wart Virus
% 210.47/210.66  |- skos__altLabel mesh__D001910 Papilloma Virus, Bovine
% 210.47/210.66  |- skos__altLabel mesh__D001910 Bovine Papular Dermatitis Virus
% 210.47/210.66  |- mesh__historyNote mesh__D001910
% 210.47/210.66       94; was BOVINE PAPILLOMATOSIS VIRUS 1975-93 %28%see under PAPILLOMAVIRUSES 1978-90, see under PAPILLOMA VIRUSES 1975-77%29%%A%  
% 210.47/210.66  |- skos__scopeNote mesh__D001910
% 210.47/210.66       A species of PAPILLOMAVIRUS producing large numbers of WARTS on calves. Connective tissue proliferation is an important component of the warts.%A%    
% 210.47/210.66  |- skos__hiddenLabel mesh__D001910 Bovine papillomatosis viruses
% 210.47/210.66  |- skos__hiddenLabel mesh__D001910 Wart Viruses, Bovine
% 210.47/210.66  |- skos__altLabel mesh__D001910 Bovine papillomatosis virus
% 210.47/210.66  |- mesh__recordMaintainer mesh__D001910 ags
% 210.47/210.66  |- rdf__type mesh__D001910sskos__Concept
% 210.47/210.66  |- skos__prefLabel mesh__D001910 Papillomavirus, Bovine
% 210.47/210.66  |- skos__hiddenLabel mesh__D001910 Bovine Papilloma Virus
% 210.47/210.66  |- skos__broader mesh__D001910smesh__D010213
% 210.47/210.66  |- skos__hiddenLabel mesh__D001910 Bovine Papillomavirus
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D001910 2005
% 210.47/210.66  |- skos__hiddenLabel mesh__D001910 Bovine Wart Viruses
% 210.47/210.66  |- mesh__dateEstablished mesh__D001910 1991-01-01
% 210.47/210.66  |- skos__hiddenLabel mesh__D001910 Bovine Papillomaviruses
% 210.47/210.66  |- mesh__dateRevised mesh__D001910 2003-07-09
% 210.47/210.66  |- skos__hiddenLabel mesh__D001910 Wart Virus, Bovine
% 210.47/210.66  |- skos__hiddenLabel mesh__D001910 Papilloma Viruses, Bovine
% 210.47/210.66  |- mesh__dateCreated mesh__D001910 1974-12-12
% 210.47/210.66  |- skos__hiddenLabel mesh__D001910 Bovine Papilloma Viruses
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D001910 2006
% 210.47/210.66  |- skos__annotation mesh__D001910
% 210.47/210.66       infection: coord IM with PAPILLOMAVIRUS INFECTIONS %28%IM%29%   
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D001910 2004
% 210.47/210.66  |- mesh__onlineNote mesh__D001910
% 210.47/210.66       use PAPILLOMAVIRUS, BOVINE to search BOVINE PAPILLOMATOSIS VIRUS 1975-93%A%  
% 210.47/210.66  |- skos__prefLabel mesh__D001112 Arcus Senilis
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D001112 2003
% 210.47/210.66  |- skos__annotation mesh__D001112
% 210.47/210.66       cholesterol or hyalin deposits in cornea causing opacity; frequent in those over 50%A%  
% 210.47/210.66  |- mesh__recordMaintainer mesh__D001112 TPW
% 210.47/210.66  |- skos__scopeNote mesh__D001112
% 210.47/210.66       A corneal disease in which there is a deposition of phospholipid and cholesterol in the corneal stroma and anterior sclera.%A%    
% 210.47/210.66  |- mesh__recordOriginator mesh__D001112 NLM
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D001112 2001
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D001112 2006
% 210.47/210.66  |- skos__hiddenLabel mesh__D001112 Arcus, Corneal
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D001112 1999
% 210.47/210.66  |- mesh__historyNote mesh__D001112
% 210.47/210.66       91%28%64%29%; was see under CORNEAL OPACITY 1990; was see under EYE DISEASES 1964-89%A%  
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D001112 2000
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D001112 2005
% 210.47/210.66  |- mesh__publicMeSHNote mesh__D001112
% 210.47/210.66       91; was see under CORNEAL OPACITY 1990; was see under EYE DISEASES 1964-89%A%  
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D001112 1998
% 210.47/210.66  |- skos__altLabel mesh__D001112 Corneal Arcus
% 210.47/210.66  |- rdf__type mesh__D001112sskos__Concept
% 210.47/210.66  |- mesh__dateCreated mesh__D001112 1999-01-01
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D001112 2002
% 210.47/210.66  |- mesh__dateEstablished mesh__D001112 1991-01-01
% 210.47/210.66  |- mesh__dateRevised mesh__D001112 1997-06-20
% 210.47/210.66  |- skos__broader mesh__D001112smesh__D003318
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D001112 2004
% 210.47/210.66  |- mesh__recordAuthorizer mesh__D001112 SJN
% 210.47/210.66  |- skos__altLabel mesh__D020875 D-Ala2-NMe-Phe4-Gly-ol Enkephalin
% 210.47/210.66  |- skos__altLabel mesh__D020875 DAMGE
% 210.47/210.66  |- skos__altLabel mesh__D020875
% 210.47/210.66       Ala%28%2%29%-MePhe%28%4%29%-Gly-ol%28%5%29% Enkephalin
% 210.47/210.66  |- skos__hiddenLabel mesh__D020875 RX 783006
% 210.47/210.66  |- skos__altLabel mesh__D020875 DAMGO
% 210.47/210.66  |- skos__hiddenLabel mesh__D020875 2 Ala 4 MePhe 5 Gly Enkephalin
% 210.47/210.66  |- skos__hiddenLabel mesh__D020875 Enkephalin, D-Ala2-NMe-Phe4-Gly-ol
% 210.47/210.66  |- mesh__publicMeSHNote mesh__D020875
% 210.47/210.66       2000; ENKEPHALIN, ALA%28%2%29%-MEPHE%28%4%29%-GLY%28%5%29%- was indexed under ENKEPHALINS 1981-1999%A%  
% 210.47/210.66  |- skos__hiddenLabel mesh__D020875 D Ala2 NMe Phe4 Gly ol Enkephalin
% 210.47/210.66  |- skos__broader mesh__D020875smesh__D004745
% 210.47/210.66  |- mesh__recordAuthorizer mesh__D020875 sjn
% 210.47/210.66  |- mesh__recordMaintainer mesh__D020875 ssb
% 210.47/210.66  |- skos__altLabel mesh__D020875
% 210.47/210.66       Enkephalin, alanyl%28%2%29%-methylphenylalanyl%28%4%29%-glycine%28%5%29%-
% 210.47/210.66  |- skos__altLabel mesh__D020875 DAGOL
% 210.47/210.66  |- mesh__recordOriginator mesh__D020875 adp
% 210.47/210.66  |- mesh__dateCreated mesh__D020875 1999-11-08
% 210.47/210.66  |- mesh__dateRevised mesh__D020875 2005-06-30
% 210.47/210.66  |- skos__altLabel mesh__D020875
% 210.47/210.66       D-Ala%28%2%29%-MePhe%28%4%29%-Gly-ol%28%5%29% Enkephalin
% 210.47/210.66  |- skos__altLabel mesh__D020875 2-Ala-4-MePhe-5-Gly-Enkephalin
% 210.47/210.66  |- mesh__historyNote mesh__D020875
% 210.47/210.66       2000; use ENKEPHALIN, ALA%28%2%29%-MEPHE%28%4%29%-GLY%28%5%29%- %28%NM%29% 1981-1999%A%  
% 210.47/210.66  |- rdf__type mesh__D020875sskos__Concept
% 210.47/210.66  |- skos__scopeNote mesh__D020875
% 210.47/210.66       An enkephalin analog that selectively binds to the MU OPIOID RECEPTOR. It is used as a model for drug permeability experiments.%A%    
% 210.47/210.66  |- skos__altLabel mesh__D020875 Tyr-Ala-Gly-%28%NMe%29%Phe-Gly-ol
% 210.47/210.66  |- skos__altLabel mesh__D020875 DAGO
% 210.47/210.66  |- mesh__dateEstablished mesh__D020875 2000-01-01
% 210.47/210.66  |- skos__prefLabel mesh__D020875
% 210.47/210.66       Enkephalin, Ala%28%2%29%-MePhe%28%4%29%-Gly%28%5%29%-
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D020875 2006
% 210.47/210.66  |- skos__historyNote mesh__D020875 Enkephalins %28%1981-1999%29%
% 210.47/210.66  |- mesh__dateEstablished mesh__D020077 1999-01-01
% 210.47/210.66  |- skos__related mesh__D020077smesh__D011533
% 210.47/210.66  |- skos__hiddenLabel mesh__D020077 Retrovirus, Endogenous
% 210.47/210.66  |- skos__hiddenLabel mesh__D020077 Endogenous Retrovirus, Human
% 210.47/210.66  |- mesh__dateCreated mesh__D020077 1998-06-10
% 210.47/210.66  |- skos__hiddenLabel mesh__D020077 Retrovirus, Human Endogenous
% 210.47/210.66  |- skos__prefLabel mesh__D020077 Endogenous Retroviruses
% 210.47/210.66  |- skos__hiddenLabel mesh__D020077 Retroviruses, Human Endogenous
% 210.47/210.66  |- skos__altLabel mesh__D020077 ERVs
% 210.47/210.66  |- mesh__historyNote mesh__D020077 99   
% 210.47/210.66  |- rdf__type mesh__D020077sskos__Concept
% 210.47/210.66  |- skos__historyNote mesh__D020077 Retroelements %28%1995-1998%29%
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D020077 2006
% 210.47/210.66  |- skos__hiddenLabel mesh__D020077 Endogenous Retroviruses, Human
% 210.47/210.66  |- mesh__dateRevised mesh__D020077 2005-06-30
% 210.47/210.66  |- skos__scopeNote mesh__D020077
% 210.47/210.66       Retroviruses that have integrated into the germline %28%PROVIRUSES%29% that have lost infectious capability but retained the capability to transpose.%A%    
% 210.47/210.66  |- mesh__recordAuthorizer mesh__D020077 sjn
% 210.47/210.66  |- skos__hiddenLabel mesh__D020077 Human Endogenous Retrovirus
% 210.47/210.66  |- skos__hiddenLabel mesh__D020077 Endogenous Retrovirus
% 210.47/210.66  |- skos__altLabel mesh__D020077 Retroviruses, Endogenous
% 210.47/210.66  |- mesh__recordOriginator mesh__D020077 NNS
% 210.47/210.66  |- mesh__recordMaintainer mesh__D020077 nns
% 210.47/210.66  |- skos__altLabel mesh__D020077 HERVs
% 210.47/210.66  |- mesh__publicMeSHNote mesh__D020077 99   
% 210.47/210.66  |- skos__broader mesh__D020077smesh__D018626
% 210.47/210.66  |- skos__broader mesh__D020077smesh__D012190
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D014838 2004
% 210.47/210.66  |- skos__prefLabel mesh__D014838 Voluntary Workers
% 210.47/210.66  |- mesh__recordOriginator mesh__D014838 NLM
% 210.47/210.66  |- mesh__recordAuthorizer mesh__D014838 sjn
% 210.47/210.66  |- mesh__publicMeSHNote mesh__D014838 68   
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D014838 2005
% 210.47/210.66  |- skos__scopeNote mesh__D014838 Persons who donate their services.     
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D014838 2003
% 210.47/210.66  |- skos__broader mesh__D014838smesh__D009272
% 210.47/210.66  |- rdf__type mesh__D014838sskos__Concept
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D014838 2002
% 210.47/210.66  |- mesh__historyNote mesh__D014838 68   
% 210.47/210.66  |- mesh__recordMaintainer mesh__D014838 hjn
% 210.47/210.66  |- skos__hiddenLabel mesh__D014838 Voluntary Worker
% 210.47/210.66  |- mesh__dateEstablished mesh__D014838 1968-01-01
% 210.47/210.66  |- skos__historyNote mesh__D014838 specific service %28%1966-1967%29%
% 210.47/210.66  |- skos__hiddenLabel mesh__D014838 Personnel, Untrained
% 210.47/210.66  |- skos__hiddenLabel mesh__D014838 Workers, Voluntary
% 210.47/210.66  |- skos__altLabel mesh__D014838 Volunteer Workers
% 210.47/210.66  |- skos__hiddenLabel mesh__D014838 Worker, Voluntary
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D014838 2006
% 210.47/210.66  |- mesh__dateRevised mesh__D014838 2001-07-25
% 210.47/210.66  |- mesh__dateCreated mesh__D014838 1999-01-01
% 210.47/210.66  |- mesh__dateRevised mesh__D019523 2005-06-30
% 210.47/210.66  |- rdf__type mesh__D019523sskos__Concept
% 210.47/210.66  |- mesh__dateCreated mesh__D019523 1996-06-21
% 210.47/210.66  |- mesh__recordOriginator mesh__D019523 TGC
% 210.47/210.66  |- mesh__historyNote mesh__D019523 1997   
% 210.47/210.66  |- skos__scopeNote mesh__D019523
% 210.47/210.66       Works consisting of discourses for the purpose of religious instruction or exhortation, especially one based on a text of Scripture and delivered by a member of the clergy, as part of a religious service. %28%From: Random House Unabridged Dictionary, 2d ed%29%%A%    
% 210.47/210.66  |- mesh__recordMaintainer mesh__D019523 jls
% 210.47/210.66  |- skos__annotation mesh__D019523
% 210.47/210.66       publication type only; do not confuse with Publication Type FUNERAL SERMONS which is restricted to funeral ceremonies%A%  
% 210.47/210.66  |- skos__prefLabel mesh__D019523 Sermons %5B%Publication Type%5D%
% 210.47/210.66  |- skos__altLabel mesh__D019523 Sermons
% 210.47/210.66  |- mesh__recordAuthorizer mesh__D019523 sjn
% 210.47/210.66  |- mesh__dateEstablished mesh__D019523 1997-01-01
% 210.47/210.66  |- skos__broader mesh__D019523smesh__D019484
% 210.47/210.66  |- skos__altLabel mesh__D019523 Sermons %28%PT%29%
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D019523 2006
% 210.47/210.66  |- skos__annotation mesh__D000818
% 210.47/210.66       NIM as check tag; Manual 18.7+, 22.33; relation to /vet: Manual 19.8.81%A%  
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D000818 2006
% 210.47/210.66  |- skos__prefLabel mesh__D000818 Animals
% 210.47/210.66  |- mesh__recordOriginator mesh__D000818 CAB
% 210.47/210.66  |- mesh__recordMaintainer mesh__D000818 ags
% 210.47/210.66  |- mesh__historyNote mesh__D000818
% 210.47/210.66       2004 %28%1974%29%; was check tag only %28%not a descriptor%29% 1974-2003%A%  
% 210.47/210.66  |- mesh__dateCreated mesh__D000818 1975-07-25
% 210.47/210.66  |- mesh__dateRevised mesh__D000818 2003-07-09
% 210.47/210.66  |- mesh__dateEstablished mesh__D000818 1976-01-01
% 210.47/210.66  |- mesh__runningHead mesh__D000818 B1 - ORGANISMS-ANIMALS   
% 210.47/210.66  |- skos__scopeNote mesh__D000818
% 210.47/210.66       Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain Eukarya.%A%    
% 210.47/210.66  |- skos__altLabel mesh__D000818 Animalia
% 210.47/210.66  |- mesh__recordAuthorizer mesh__D000818 sjn
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D000818 2005
% 210.47/210.66  |- skos__altLabel mesh__D000818 Animal
% 210.47/210.66  |- rdf__type mesh__D000818sskos__Concept
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D000818 2004
% 210.47/210.66  |- mesh__publicMeSHNote mesh__D000818 2004   
% 210.47/210.66  |- rdf__type mesh__D011540sskos__Concept
% 210.47/210.66  |- skos__scopeNote mesh__D011540
% 210.47/210.66       The reaction of potassium ferrocyanide with ferric iron to yield a dark blue precipitate at the sites of the ferric iron. Used to determine ferric iron in tissues, particularly in the diagnosis of disorders of iron metabolism.%A%    
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D011540 2003
% 210.47/210.66  |- mesh__recordMaintainer mesh__D011540 MXR
% 210.47/210.66  |- mesh__recordOriginator mesh__D011540 SMH
% 210.47/210.66  |- skos__historyNote mesh__D011540 Dyes %28%1966-1978%29%
% 210.47/210.66  |- skos__broader mesh__D011540smesh__D013194
% 210.47/210.66  |- skos__hiddenLabel mesh__D011540 Reactions, Ferrocyanide
% 210.47/210.66  |- skos__hiddenLabel mesh__D011540 Prussian Blue Reactions
% 210.47/210.66  |- mesh__dateEstablished mesh__D011540 1991-01-01
% 210.47/210.66  |- skos__hiddenLabel mesh__D011540 Reaction, Ferrocyanide
% 210.47/210.66  |- mesh__publicMeSHNote mesh__D011540
% 210.47/210.66       91; was see under HISTOCYTOCHEMISTRY 1979-90   
% 210.47/210.66  |- skos__altLabel mesh__D011540 Ferrocyanide Reaction
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D011540 2006
% 210.47/210.66  |- mesh__historyNote mesh__D011540
% 210.47/210.66       91%28%79%29%; was see under HISTOCYTOCHEMISTRY 1979-90   
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D011540 2002
% 210.47/210.66  |- skos__hiddenLabel mesh__D011540 Blue Reactions, Prussian
% 210.47/210.66  |- mesh__dateRevised mesh__D011540 2000-06-22
% 210.47/210.66  |- mesh__dateCreated mesh__D011540 1978-04-28
% 210.47/210.66  |- skos__annotation mesh__D011540 NIM; no qualif   
% 210.47/210.66  |- skos__broader mesh__D011540smesh__D006651
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D011540 2005
% 210.47/210.66  |- skos__hiddenLabel mesh__D011540 Reactions, Prussian Blue
% 210.47/210.66  |- skos__prefLabel mesh__D011540 Prussian Blue Reaction
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D011540 2001
% 210.47/210.66  |- skos__historyNote mesh__D011540 Ferrocyanides %28%1966-1978%29%
% 210.47/210.66  |- skos__hiddenLabel mesh__D011540 Ferrocyanide Reactions
% 210.47/210.66  |- skos__hiddenLabel mesh__D011540 Reaction, Prussian Blue
% 210.47/210.66  |- skos__hiddenLabel mesh__D011540 Blue Reaction, Prussian
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D011540 2004
% 210.47/210.66  |- mesh__recordAuthorizer mesh__D011540 sjn
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D005503 2006
% 210.47/210.66  |- mesh__dateRevised mesh__D005503 2003-07-09
% 210.47/210.66  |- mesh__dateCreated mesh__D005503 1999-01-01
% 210.47/210.66  |- mesh__recordMaintainer mesh__D005503 ssb
% 210.47/210.66  |- mesh__recordOriginator mesh__D005503 NLM
% 210.47/210.66  |- skos__scopeNote mesh__D005503
% 210.47/210.66       Substances which are of little or no nutritive value, but are used in the processing or storage of foods or animal feed, especially in the developed countries; includes ANTIOXIDANTS; FOOD PRESERVATIVES; FOOD COLORING AGENTS; FLAVORING AGENTS; ANTI-INFECTIVE AGENTS %28%both plain and LOCAL%29%; VEHICLES; EXCIPIENTS and other similarly used substances. Many of the same substances are PHARMACEUTIC AIDS when added to pharmaceuticals rather than to foods.%A%    
% 210.47/210.66  |- skos__related mesh__D005503smesh__D010592
% 210.47/210.66  |- skos__hiddenLabel mesh__D005503 Additives, Food
% 210.47/210.66  |- skos__prefLabel mesh__D005503 Food Additives
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D005503 2005
% 210.47/210.66  |- skos__hiddenLabel mesh__D005503 Food Additive
% 210.47/210.66  |- skos__broader mesh__D005503smesh__D005502
% 210.47/210.66  |- skos__hiddenLabel mesh__D005503 Additive, Food
% 210.47/210.66  |- skos__broader mesh__D005503smesh__D020313
% 210.47/210.66  |- mesh__activeMeSHYear mesh__D005503 2004
% 210.47/210.66  |- rdf__type mesh__D005503sskos__Concept
% 210.47/210.66  |- skos__annotation mesh__D005503 D25-26 qualif   
% 210.47/210.66  |- mesh__recordAuthorizer mesh__D005503 sjn
% 210.47/210.66  |- skos__prefLabel mesh__D052159 Frasier Syndrome
% 210.47/210.66  |- skos__broader mesh__D052159smesh__D014564
% 210.47/210.66  |- mesh__publicMeSHNote mesh__D052159
% 210.47/210.66       2006; see DENYS-DRASH SYNDROME 2002-2005   
% 210.47/210.66  |- mesh__historyNote mesh__D052159
% 210.47/210.66       2006; use DENYS-DRASH SYNDROME 2002-2005   
% 210.47/210.67  |- mesh__recordMaintainer mesh__D052159 lkt
% 210.47/210.67  |- mesh__recordAuthorizer mesh__D052159 sjn
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D052159 2006
% 210.47/210.67  |- mesh__dateEstablished mesh__D052159 2006-01-01
% 210.47/210.67  |- mesh__dateCreated mesh__D052159 2005-06-30
% 210.47/210.67  |- skos__scopeNote mesh__D052159
% 210.47/210.67       A syndrome characterized by CHRONIC KIDNEY FAILURE and GONADAL DYSGENESIS in phenotypic females with karyotype of 46,XY or 46,XX. It is caused by donor splice-site mutations of Wilms tumor suppressor gene %28%GENES, WILMS TUMOR%29% on chromosome 11.%A%    
% 210.47/210.67  |- rdf__type mesh__D052159sskos__Concept
% 210.47/210.67  |- skos__hiddenLabel mesh__D052159 Syndrome, Frasier
% 210.47/210.67  |- mesh__recordOriginator mesh__D052159 lkt
% 210.47/210.67  |- skos__prefLabel mesh__D010448 Peptide Initiation Factors
% 210.47/210.67  |- mesh__recordAuthorizer mesh__D010448 sjn
% 210.47/210.67  |- skos__hiddenLabel mesh__D010448 Initiation Factors, Peptide
% 210.47/210.67  |- skos__altLabel mesh__D010448 Initiation Factor
% 210.47/210.67  |- rdf__type mesh__D010448sskos__Concept
% 210.47/210.67  |- skos__related mesh__D010448smesh__D010442
% 210.47/210.67  |- skos__altLabel mesh__D010448 Initiation Factors
% 210.47/210.67  |- mesh__historyNote mesh__D010448 73   
% 210.47/210.67  |- mesh__recordOriginator mesh__D010448 NLM
% 210.47/210.67  |- skos__broader mesh__D010448smesh__D012269
% 210.47/210.67  |- skos__historyNote mesh__D010448 Proteins %28%1966-1972%29%
% 210.47/210.67  |- skos__historyNote mesh__D010448 Peptides %28%1966-1972%29%
% 210.47/210.67  |- skos__annotation mesh__D010448 GEN or unspecified; prefer specifics   
% 210.47/210.67  |- mesh__publicMeSHNote mesh__D010448 73   
% 210.47/210.67  |- mesh__dateCreated mesh__D010448 1999-01-01
% 210.47/210.67  |- mesh__dateEstablished mesh__D010448 1973-01-01
% 210.47/210.67  |- mesh__recordMaintainer mesh__D010448 SYSTEM
% 210.47/210.67  |- skos__scopeNote mesh__D010448
% 210.47/210.67       Protein factors uniquely required during the initiation phase of protein synthesis in GENETIC TRANSLATION.%A%    
% 210.47/210.67  |- skos__hiddenLabel mesh__D010448 Factors, Peptide Initiation
% 210.47/210.67  |- mesh__dateRevised mesh__D010448 2005-06-30
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D010448 2006
% 210.47/210.67  |- skos__historyNote mesh__D010448 Bacterial Proteins %28%1966-1972%29%
% 210.47/210.67  |- mesh__publicMeSHNote mesh__D015931 90   
% 210.47/210.67  |- skos__altLabel mesh__D015931 Infant, Newborn, Intensive Care
% 210.47/210.67  |- skos__hiddenLabel mesh__D015931 Care, Neonatal Intensive
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D015931 2005
% 210.47/210.67  |- mesh__dateCreated mesh__D015931 1989-05-15
% 210.47/210.67  |- mesh__recordAuthorizer mesh__D015931 sjn
% 210.47/210.67  |- skos__broader mesh__D015931smesh__D007224
% 210.47/210.67  |- mesh__recordOriginator mesh__D015931 PLS
% 210.47/210.67  |- skos__historyNote mesh__D015931 Infant Care %28%1966-1989%29%
% 210.47/210.67  |- skos__prefLabel mesh__D015931 Intensive Care, Neonatal
% 210.47/210.67  |- mesh__recordMaintainer mesh__D015931 sjn
% 210.47/210.67  |- mesh__dateRevised mesh__D015931 2004-07-13
% 210.47/210.67  |- skos__broader mesh__D015931smesh__D017055
% 210.47/210.67  |- rdf__type mesh__D015931sskos__Concept
% 210.47/210.67  |- mesh__dateEstablished mesh__D015931 1990-01-01
% 210.47/210.67  |- mesh__historyNote mesh__D015931 90   
% 210.47/210.67  |- skos__historyNote mesh__D015931 Intensive Care Units %28%1966-1981%29%
% 210.47/210.67  |- skos__altLabel mesh__D015931 Neonatal Intensive Care
% 210.47/210.67  |- skos__historyNote mesh__D015931 Infant, Newborn %28%1966-1989%29%
% 210.47/210.67  |- skos__annotation mesh__D015931
% 210.47/210.67        check also tags  HUMANS %26% INFANT, NEWBORN   
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D015931 2006
% 210.47/210.67  |- skos__scopeNote mesh__D015931
% 210.47/210.67       Continuous care and monitoring of newborn infants with life-threatening conditions, in any setting.%A%    
% 210.47/210.67  |- skos__historyNote mesh__D015931
% 210.47/210.67       Intensive Care Units, Neonatal %28%1982-1989%29%
% 210.47/210.67  |- skos__hiddenLabel mesh__D001911 mamillitis viruses, Bovine
% 210.47/210.67  |- skos__altLabel mesh__D001911 Bovine Ulcerative Mammillitis Virus
% 210.47/210.67  |- skos__altLabel mesh__D001911 Bovine mamillitis virus
% 210.47/210.67  |- skos__altLabel mesh__D001911 Bovine herpesvirus 2
% 210.47/210.67  |- skos__broader mesh__D001911smesh__D018139
% 210.47/210.67  |- mesh__recordAuthorizer mesh__D001911 sjn
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001911 2002
% 210.47/210.67  |- mesh__recordOriginator mesh__D001911 NLM
% 210.47/210.67  |- skos__altLabel mesh__D001911 Herpes Mammillitis Virus, Bovine
% 210.47/210.67  |- mesh__onlineNote mesh__D001911
% 210.47/210.67       use HERPESVIRUS 2, BOVINE to search BOVINE ULCERATIVE MAMMILLITIS VIRUS 1975-93; search ALLERTON VIRUS INFECTIONS under LUMPY SKIN DISEASE 1970-76%A%  
% 210.47/210.67  |- skos__hiddenLabel mesh__D001911 mamillitis virus, Bovine
% 210.47/210.67  |- rdf__type mesh__D001911sskos__Concept
% 210.47/210.67  |- mesh__recordMaintainer mesh__D001911 ags
% 210.47/210.67  |- skos__altLabel mesh__D001911 Bovine Herpes Mammillitis Virus
% 210.47/210.67  |- mesh__dateEstablished mesh__D001911 1991-01-01
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001911 2005
% 210.47/210.67  |- skos__scopeNote mesh__D001911
% 210.47/210.67       A species of SIMPLEXVIRUS causing mammillitis in cattle in Great Britain and South Africa.%A%    
% 210.47/210.67  |- skos__prefLabel mesh__D001911 Herpesvirus 2, Bovine
% 210.47/210.67  |- skos__altLabel mesh__D001911 Ulcerative Mammillitis Virus, Bovine
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001911 2003
% 210.47/210.67  |- skos__altLabel mesh__D001911 BHM Virus
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001911 2006
% 210.47/210.67  |- mesh__dateCreated mesh__D001911 1974-12-12
% 210.47/210.67  |- skos__altLabel mesh__D001911 Herpesvirus 2 %28%alpha%29%, Bovine
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001911 2004
% 210.47/210.67  |- mesh__dateRevised mesh__D001911 2001-07-25
% 210.47/210.67  |- skos__altLabel mesh__D001911 Allerton Virus
% 210.47/210.67  |- mesh__publicMeSHNote mesh__D001911
% 210.47/210.67       94; was BOVINE ULCERATIVE MAMMILLITIS VIRUS 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%; ALLERTON VIRUS INFECTIONS was indexed under LUMPY SKIN DISEASE 1970-76%A%  
% 210.47/210.67  |- skos__hiddenLabel mesh__D001911 Bovine mamillitis viruses
% 210.47/210.67  |- skos__annotation mesh__D001911
% 210.47/210.67       do not confuse with HERPESVIRUS 1, BOVINE; infection: coord IM with HERPES SIMPLEX %28%IM%29%%A%  
% 210.47/210.67  |- mesh__historyNote mesh__D001911
% 210.47/210.67       94; was BOVINE ULCERATIVE MAMMILLITIS VIRUS 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%; ALLERTON VIRUS INFECTIONS was indexed under LUMPY SKIN DISEASE 1970-76%A%  
% 210.47/210.67  |- mesh__recordMaintainer mesh__D001113 kle
% 210.47/210.67  |- skos__altLabel mesh__D001113 Area Health Education Center
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001113 2005
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001113 2002
% 210.47/210.67  |- rdf__type mesh__D001113sskos__Concept
% 210.47/210.67  |- skos__broader mesh__D001113smesh__D012576
% 210.47/210.67  |- mesh__historyNote mesh__D001113
% 210.47/210.67       91%28%75%29%; was see under SCHOOLS, HEALTH OCCUPATIONS 1975-90%A%  
% 210.47/210.67  |- mesh__dateRevised mesh__D001113 1999-11-03
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001113 2004
% 210.47/210.67  |- mesh__dateEstablished mesh__D001113 1991-01-01
% 210.47/210.67  |- mesh__recordOriginator mesh__D001113 NLM
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001113 2001
% 210.47/210.67  |- mesh__dateCreated mesh__D001113 1974-11-11
% 210.47/210.67  |- mesh__recordAuthorizer mesh__D001113 sjn
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001113 2003
% 210.47/210.67  |- mesh__publicMeSHNote mesh__D001113
% 210.47/210.67       91; was see under SCHOOLS, HEALTH OCCUPATIONS 1975-90   
% 210.47/210.67  |- skos__prefLabel mesh__D001113 Area Health Education Centers
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001113 2000
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001113 2006
% 210.47/210.67  |- skos__annotation mesh__D001113 specify geog if pertinent; DF: AHEC   
% 210.47/210.67  |- skos__scopeNote mesh__D001113
% 210.47/210.67       Education centers authorized by the Comprehensive Health Manpower Training Act, 1971, for the training of health personnel in areas where health needs are the greatest. May be used for centers other than those established by the United States act.%A%    
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D020078 2006
% 210.47/210.67  |- rdf__type mesh__D020078sskos__Concept
% 210.47/210.67  |- skos__hiddenLabel mesh__D020078 Neurogenic Inflammations
% 210.47/210.67  |- mesh__dateEstablished mesh__D020078 1999-01-01
% 210.47/210.67  |- skos__broader mesh__D020078smesh__D007249
% 210.47/210.67  |- mesh__recordMaintainer mesh__D020078 KEV
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D020078 2003
% 210.47/210.67  |- mesh__dateCreated mesh__D020078 1998-06-10
% 210.47/210.67  |- mesh__publicMeSHNote mesh__D020078 99   
% 210.47/210.67  |- skos__prefLabel mesh__D020078 Neurogenic Inflammation
% 210.47/210.67  |- skos__broader mesh__D020078smesh__D009461
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D020078 2000
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D020078 2004
% 210.47/210.67  |- mesh__dateRevised mesh__D020078 1999-11-03
% 210.47/210.67  |- skos__scopeNote mesh__D020078
% 210.47/210.67       Inflammation caused by an injurious stimulus of peripheral neurons and resulting in release of neuropeptides which affect vascular permeability and help initiate proinflammatory and immune reactions at the site of injury.%A%    
% 210.47/210.67  |- skos__hiddenLabel mesh__D020078 Inflammations, Neurogenic
% 210.47/210.67  |- skos__hiddenLabel mesh__D020078 Inflammation, Neurogenic
% 210.47/210.67  |- skos__historyNote mesh__D020078 Inflammation %28%1967-1998%29%
% 210.47/210.67  |- mesh__historyNote mesh__D020078 99   
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D020078 2001
% 210.47/210.67  |- skos__related mesh__D020078smesh__D015213
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D020078 2005
% 210.47/210.67  |- mesh__recordOriginator mesh__D020078 NDW
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D020078 2002
% 210.47/210.67  |- mesh__recordAuthorizer mesh__D020078 sjn
% 210.47/210.67  |- skos__altLabel mesh__D014839 Emesis
% 210.47/210.67  |- rdf__type mesh__D014839sskos__Concept
% 210.47/210.67  |- skos__annotation mesh__D014839
% 210.47/210.67       /chem ind: EMETICS is also available; /drug ther: ANTIEMETICS is also available%A%  
% 210.47/210.67  |- mesh__recordMaintainer mesh__D014839 lkt
% 210.47/210.67  |- skos__related mesh__D014839smesh__D004639
% 210.47/210.67  |- skos__prefLabel mesh__D014839 Vomiting
% 210.47/210.67  |- mesh__recordOriginator mesh__D014839 NLM
% 210.47/210.67  |- mesh__recordAuthorizer mesh__D014839 sjn
% 210.47/210.67  |- mesh__dateRevised mesh__D014839 2003-07-09
% 210.47/210.67  |- skos__related mesh__D014839smesh__D000932
% 210.47/210.67  |- skos__broader mesh__D014839smesh__D012817
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D014839 2006
% 210.47/210.67  |- mesh__dateCreated mesh__D014839 1999-01-01
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D014839 2004
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D014839 2005
% 210.47/210.67  |- skos__scopeNote mesh__D014839
% 210.47/210.67       The forcible expulsion of the contents of the STOMACH through the MOUTH.%A%    
% 210.47/210.67  |- skos__altLabel mesh__D025561 Pf1 Phage
% 210.47/210.67  |- skos__broader mesh__D025561smesh__D017912
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D025561 2003
% 210.47/210.67  |- skos__broader mesh__D025561smesh__D017105
% 210.47/210.67  |- skos__historyNote mesh__D025561 Inovirus %28%1993-2001%29%
% 210.47/210.67  |- skos__hiddenLabel mesh__D025561 Pf1 Phages
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D025561 2005
% 210.47/210.67  |- skos__hiddenLabel mesh__D025561 Phage, Pf1
% 210.47/210.67  |- skos__altLabel mesh__D025561 Phage Pf1
% 210.47/210.67  |- mesh__recordMaintainer mesh__D025561 ags
% 210.47/210.67  |- skos__hiddenLabel mesh__D025561 Phages, Pf1
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D025561 2004
% 210.47/210.67  |- rdf__type mesh__D025561sskos__Concept
% 210.47/210.67  |- mesh__recordAuthorizer mesh__D025561 sjn
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D025561 2006
% 210.47/210.67  |- skos__annotation mesh__D025561 coord with specific Pseudomonas /virol   
% 210.47/210.67  |- skos__historyNote mesh__D025561 Bacteriophages %28%1980-1993%29%
% 210.47/210.67  |- mesh__dateCreated mesh__D025561 2001-07-25
% 210.47/210.67  |- mesh__dateEstablished mesh__D025561 2002-01-01
% 210.47/210.67  |- mesh__historyNote mesh__D025561 2002; use INOVIRUS 1994-2001   
% 210.47/210.67  |- skos__prefLabel mesh__D025561 Bacteriophage Pf1
% 210.47/210.67  |- mesh__dateRevised mesh__D025561 2002-07-02
% 210.47/210.67  |- mesh__publicMeSHNote mesh__D025561 2002; see INOVIRUS 1994-2001   
% 210.47/210.67  |- skos__scopeNote mesh__D025561
% 210.47/210.67       A species of filamentous Pseudomonas phage in the genus INOVIRUS, family INOVIRIDAE.%A%    
% 210.47/210.67  |- mesh__recordOriginator mesh__D025561 ags
% 210.47/210.67  |- skos__altLabel mesh__D025561 Pseudomonas phage Pf1
% 210.47/210.67  |- mesh__dateRevised mesh__D000819 2003-07-30
% 210.47/210.67  |- mesh__recordAuthorizer mesh__D000819 sjn
% 210.47/210.67  |- skos__prefLabel mesh__D000819 Animal Communication
% 210.47/210.67  |- rdf__type mesh__D000819sskos__Concept
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D000819 2006
% 210.47/210.67  |- skos__related mesh__D000819smesh__D010675
% 210.47/210.67  |- mesh__recordMaintainer mesh__D000819 ags
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D000819 2005
% 210.47/210.67  |- skos__related mesh__D000819smesh__D014828
% 210.47/210.67  |- mesh__historyNote mesh__D000819 68   
% 210.47/210.67  |- skos__broader mesh__D000819smesh__D001522
% 210.47/210.67  |- skos__hiddenLabel mesh__D000819 Communication, Animal
% 210.47/210.67  |- mesh__publicMeSHNote mesh__D000819 68   
% 210.47/210.67  |- skos__historyNote mesh__D000819 Communication %28%1966-1967%29%
% 210.47/210.67  |- mesh__dateEstablished mesh__D000819 1968-01-01
% 210.47/210.67  |- skos__scopeNote mesh__D000819
% 210.47/210.67       Communication between animals involving the giving off by one individual of some chemical or physical signal, that, on being received by another, influences its behavior.%A%    
% 210.47/210.67  |- skos__hiddenLabel mesh__D000819 Animal Communications
% 210.47/210.67  |- skos__hiddenLabel mesh__D000819 Communications, Animal
% 210.47/210.67  |- mesh__dateCreated mesh__D000819 1999-01-01
% 210.47/210.67  |- mesh__recordOriginator mesh__D000819 NLM
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D000819 2004
% 210.47/210.67  |- skos__annotation mesh__D000819
% 210.47/210.67       no qualif; do not forget also to check tag ANIMALS   
% 210.47/210.67  |- skos__altLabel mesh__D011541 Allescheria
% 210.47/210.67  |- mesh__historyNote mesh__D011541
% 210.47/210.67       91%28%86%29%; was see under ASCOMYCETES 1986-90; MONOSPORIUM was heading 1963-85%A%  
% 210.47/210.67  |- skos__altLabel mesh__D011541 Petriellidium
% 210.47/210.67  |- mesh__dateEstablished mesh__D011541 1991-01-01
% 210.47/210.67  |- mesh__recordAuthorizer mesh__D011541 sjn
% 210.47/210.67  |- mesh__dateCreated mesh__D011541 1985-02-07
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D011541 2006
% 210.47/210.67  |- skos__annotation mesh__D011541
% 210.47/210.67       infection: coord IM with probably MADUROMYCOSIS or other mycosis %28%IM%29%%A%  
% 210.47/210.67  |- mesh__publicMeSHNote mesh__D011541
% 210.47/210.67       91; was see under ASCOMYCETES 1986-90; MONOSPORIUM was heading 1963-85%A%  
% 210.47/210.67  |- mesh__recordMaintainer mesh__D011541 SYSTEM
% 210.47/210.67  |- skos__historyNote mesh__D011541 Ascomycetes %28%1966-1985%29%
% 210.47/210.67  |- mesh__recordOriginator mesh__D011541 RC
% 210.47/210.67  |- skos__historyNote mesh__D011541 Maduromycosis %28%1966-1985%29%
% 210.47/210.67  |- skos__scopeNote mesh__D011541
% 210.47/210.67       Ascomycetous fungi, family Microascaceae, order Microascales, commonly found in the soil. They are causative agents of mycetoma, maduromycosis, and other infections in humans.%A%    
% 210.47/210.67  |- mesh__dateRevised mesh__D011541 2005-06-30
% 210.47/210.67  |- skos__prefLabel mesh__D011541 Pseudallescheria
% 210.47/210.67  |- rdf__type mesh__D011541sskos__Concept
% 210.47/210.67  |- mesh__onlineNote mesh__D011541
% 210.47/210.67       use PSEUDALLESCHERIA to search MONOSPORIUM 1966-85   
% 210.47/210.67  |- skos__historyNote mesh__D011541 Mycoses %28%1966-1985%29%
% 210.47/210.67  |- skos__broader mesh__D011541smesh__D001203
% 210.47/210.67  |- skos__hiddenLabel mesh__D005504 Food Analyses
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D005504 2002
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D005504 2006
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D005504 1999
% 210.47/210.67  |- mesh__dateRevised mesh__D005504 1997-06-20
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D005504 2005
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D005504 1998
% 210.47/210.67  |- skos__broader mesh__D005504smesh__D008919
% 210.47/210.67  |- skos__broader mesh__D005504smesh__D005524
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D005504 2001
% 210.47/210.67  |- mesh__recordMaintainer mesh__D005504 JLS
% 210.47/210.67  |- skos__prefLabel mesh__D005504 Food Analysis
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D005504 2000
% 210.47/210.67  |- mesh__recordAuthorizer mesh__D005504 SJN
% 210.47/210.67  |- skos__altLabel mesh__D005504 Analysis, Food
% 210.47/210.67  |- rdf__type mesh__D005504sskos__Concept
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D005504 2004
% 210.47/210.67  |- skos__hiddenLabel mesh__D005504 Analyses, Food
% 210.47/210.67  |- skos__annotation mesh__D005504
% 210.47/210.67       GEN only; prefer /anal with specific food item in Cat J2   
% 210.47/210.67  |- mesh__dateCreated mesh__D005504 1999-01-01
% 210.47/210.67  |- mesh__recordOriginator mesh__D005504 NLM
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D005504 2003
% 210.47/210.67  |- mesh__historyNote mesh__D010449 87   
% 210.47/210.67  |- skos__hiddenLabel mesh__D010449 Fingerprint, Protein
% 210.47/210.67  |- mesh__recordMaintainer mesh__D010449 nns
% 210.47/210.67  |- skos__broader mesh__D010449smesh__D004590
% 210.47/210.67  |- skos__broader mesh__D010449smesh__D002854
% 210.47/210.67  |- skos__hiddenLabel mesh__D010449 Fingerprint, Peptide
% 210.47/210.67  |- mesh__recordAuthorizer mesh__D010449 sjn
% 210.47/210.67  |- mesh__recordOriginator mesh__D010449 VDK
% 210.47/210.67  |- mesh__dateRevised mesh__D010449 2004-07-07
% 210.47/210.67  |- skos__altLabel mesh__D010449 Peptide Fingerprinting
% 210.47/210.67  |- skos__related mesh__D010449smesh__D010446
% 210.47/210.67  |- skos__hiddenLabel mesh__D010449 Mapping, Peptide
% 210.47/210.67  |- skos__altLabel mesh__D010449 Fingerprints, Protein
% 210.47/210.67  |- skos__broader mesh__D010449smesh__D002623
% 210.47/210.67  |- skos__hiddenLabel mesh__D010449 Peptide Fingerprint
% 210.47/210.67  |- skos__historyNote mesh__D010449 Chromatography, Paper %28%1966-1986%29%
% 210.47/210.67  |- skos__hiddenLabel mesh__D010449 Peptide Fingerprints
% 210.47/210.67  |- skos__hiddenLabel mesh__D010449 Protein Fingerprints
% 210.47/210.67  |- skos__hiddenLabel mesh__D010449 Fingerprinting, Peptide
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D010449 2006
% 210.47/210.67  |- skos__scopeNote mesh__D010449
% 210.47/210.67       Analysis of PEPTIDES that are generated from the digestion or fragmentation of a protein or mixture of PROTEINS, by ELECTROPHORESIS; CHROMATOGRAPHY; or MASS SPECTROMETRY. The resulting peptide fingerprints are analyzed for a variety of purposes including the identification of the proteins in a sample, GENETIC POLYMORPHISMS, patterns of gene expression, and patterns diagnostic for diseases.%A%    
% 210.47/210.67  |- skos__hiddenLabel mesh__D010449 Protein Fingerprint
% 210.47/210.67  |- skos__hiddenLabel mesh__D010449 Fingerprinting, Protein
% 210.47/210.67  |- skos__altLabel mesh__D010449 Protein Fingerprinting
% 210.47/210.67  |- skos__prefLabel mesh__D010449 Peptide Mapping
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D010449 2005
% 210.47/210.67  |- mesh__dateCreated mesh__D010449 1986-06-24
% 210.47/210.67  |- mesh__publicMeSHNote mesh__D010449 87   
% 210.47/210.67  |- rdf__type mesh__D010449sskos__Concept
% 210.47/210.67  |- skos__historyNote mesh__D010449 Electrophoresis, Paper %28%1973-1986%29%
% 210.47/210.67  |- skos__broader mesh__D010449smesh__D020539
% 210.47/210.67  |- mesh__dateEstablished mesh__D010449 1987-01-01
% 210.47/210.67  |- skos__hiddenLabel mesh__D015932 C3c Fragment, Complement
% 210.47/210.67  |- skos__altLabel mesh__D015932 Complement Component 3c
% 210.47/210.67  |- mesh__publicMeSHNote mesh__D015932 2006; see COMPLEMENT 3C 1990-2005   
% 210.47/210.67  |- skos__hiddenLabel mesh__D015932 Component 3c, Complement
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D015932 2006
% 210.47/210.67  |- mesh__recordAuthorizer mesh__D015932 sjn
% 210.47/210.67  |- skos__historyNote mesh__D015932 Complement 3 %28%1974-1989%29%
% 210.47/210.67  |- skos__prefLabel mesh__D015932 Complement C3c
% 210.47/210.67  |- mesh__recordMaintainer mesh__D015932 lkt
% 210.47/210.67  |- skos__hiddenLabel mesh__D015932 Complement, C3c
% 210.47/210.67  |- skos__broader mesh__D015932smesh__D003179
% 210.47/210.67  |- skos__scopeNote mesh__D015932
% 210.47/210.67       A 206-amino-acid fragment in the alpha chain %28%672-1663%29% of C3b. It is generated when C3b is inactivated %28%iC3b%29% and its alpha chain is cleaved by COMPLEMENT FACTOR I into C3c %28%749-954%29%, and C3dg %28%955-1303%29% in the presence COMPLEMENT FACTOR H.%A%    
% 210.47/210.67  |- skos__altLabel mesh__D015932 Complement C3c Fragment
% 210.47/210.67  |- mesh__recordOriginator mesh__D015932 AGS
% 210.47/210.67  |- mesh__dateEstablished mesh__D015932 1990-01-01
% 210.47/210.67  |- rdf__type mesh__D015932sskos__Concept
% 210.47/210.67  |- skos__hiddenLabel mesh__D015932 C3c, Complement
% 210.47/210.67  |- mesh__historyNote mesh__D015932 2006 %28%1990%29%   
% 210.47/210.67  |- skos__altLabel mesh__D015932 C3c Complement
% 210.47/210.67  |- mesh__dateRevised mesh__D015932 2005-06-30
% 210.47/210.67  |- skos__hiddenLabel mesh__D015932 Fragment, Complement C3c
% 210.47/210.67  |- skos__altLabel mesh__D015932 Complement 3c
% 210.47/210.67  |- mesh__dateCreated mesh__D015932 1989-05-25
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001912 2002
% 210.47/210.67  |- skos__scopeNote mesh__D001912
% 210.47/210.67       Acute disease of cattle caused by the bovine viral diarrhea viruses %28%DIARRHEA VIRUSES, BOVINE VIRAL%29%. Often mouth ulcerations are the only sign but fever, diarrhea, drop in milk yield, and loss of appetite are also seen. Severity of clinical disease varies and is strain dependent. Outbreaks are characterized by low morbidity and high mortality.%A%    
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001912 2005
% 210.47/210.67  |- skos__prefLabel mesh__D001912 Bovine Virus Diarrhea-Mucosal Disease
% 210.47/210.67  |- mesh__historyNote mesh__D001912
% 210.47/210.67       91%28%72%29%; was see under CATTLE DISEASES 1972-90   
% 210.47/210.67  |- skos__altLabel mesh__D001912 Mucosal Disease, Bovine Viral Diarrhea
% 210.47/210.67  |- mesh__dateRevised mesh__D001912 2001-07-25
% 210.47/210.67  |- mesh__dateCreated mesh__D001912 1999-01-01
% 210.47/210.67  |- skos__altLabel mesh__D001912 Bovine Virus Diarrhea Mucosal Disease
% 210.47/210.67  |- mesh__publicMeSHNote mesh__D001912
% 210.47/210.67       91; was see under CATTLE DISEASES 1972-90   
% 210.47/210.67  |- rdf__type mesh__D001912sskos__Concept
% 210.47/210.67  |- mesh__recordAuthorizer mesh__D001912 sjn
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001912 2004
% 210.47/210.67  |- skos__broader mesh__D001912smesh__D018182
% 210.47/210.67  |- skos__historyNote mesh__D001912 Cattle Diseases %28%1966-1971%29%
% 210.47/210.67  |- skos__historyNote mesh__D001912
% 210.47/210.67       Virus Diseases/veterinary %28%1966-1971%29%
% 210.47/210.67  |- skos__annotation mesh__D001912 DF: BVD DIS   
% 210.47/210.67  |- mesh__recordOriginator mesh__D001912 NLM
% 210.47/210.67  |- mesh__recordMaintainer mesh__D001912 ags
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001912 2006
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001912 2003
% 210.47/210.67  |- mesh__dateEstablished mesh__D001912 1991-01-01
% 210.47/210.67  |- skos__broader mesh__D001912smesh__D002418
% 210.47/210.67  |- rdf__type mesh__D001114sskos__Concept
% 210.47/210.67  |- mesh__dateRevised mesh__D001114 2005-07-27
% 210.47/210.67  |- mesh__dateCreated mesh__D001114 1999-01-01
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001114 2006A
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001114 2004
% 210.47/210.67  |- mesh__dateEstablished mesh__D001114 1991-01-01
% 210.47/210.67  |- skos__prefLabel mesh__D001114 Areca
% 210.47/210.67  |- skos__annotation mesh__D001114
% 210.47/210.67       Betel may go here or under PIPER BETLE; %27%catechu%27% may go here or under ACACIA CATECHU see ACACIA; check text; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001114 2003
% 210.47/210.67  |- mesh__recordAuthorizer mesh__D001114 ags
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001114 2006
% 210.47/210.67  |- mesh__recordMaintainer mesh__D001114 ags
% 210.47/210.67  |- mesh__historyNote mesh__D001114
% 210.47/210.67       91%28%86%29%63; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85%A%  
% 210.47/210.67  |- skos__broader mesh__D001114smesh__D028023
% 210.47/210.67  |- mesh__recordOriginator mesh__D001114 NLM
% 210.47/210.67  |- skos__scopeNote mesh__D001114
% 210.47/210.67       A plant genus of the family ARECACEAE. Members contain ARECOLINE and CATECHIN. The leaves and nuts have been used as masticatories, stimulants, and astringents in traditional medicine. The common name of betel is also used for PIPER BETLE. The common name of catechu is sometimes used for ACACIA CATECHU.%A%    
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D001114 2005
% 210.47/210.67  |- mesh__publicMeSHNote mesh__D001114
% 210.47/210.67       91,63-85; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85%A%  
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Long Terminal Repeats
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Sequence, R Repetitive
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Repeat Sequences, Terminal
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Repeats, Terminal
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Sequence, Terminal Repeat
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D020079 2005
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Sequences, Flanking Repeat
% 210.47/210.67  |- skos__altLabel mesh__D020079 Flanking Repeat Sequences
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Sequences, Terminal Repeat
% 210.47/210.67  |- skos__altLabel mesh__D020079 Terminal Repeat
% 210.47/210.67  |- mesh__dateRevised mesh__D020079 2002-07-03
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 R Repetitive Sequences
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Terminal Repeat, Long
% 210.47/210.67  |- skos__prefLabel mesh__D020079 Terminal Repeat Sequences
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Repeat, Terminal
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Repeat, Long Terminal
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D020079 2004
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Repeats, Long Terminal
% 210.47/210.67  |- rdf__type mesh__D020079sskos__Concept
% 210.47/210.67  |- mesh__publicMeSHNote mesh__D020079
% 210.47/210.67       99; for DELTA ELEMENTS see DNA INSERTION ELEMENTS 1988-98; for INVERTED TERMINAL REPEAT see REPETITIVE SEQUENCE, NUCLEIC ACID 1988-98; for LONG TERMINAL REPEAT, TERMINAL REPEAT %26% R REPETITIVE SEQUENCE see REPETITIVE SEQUENCE, NUCLEIC ACID 1990-98%A%  
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Repeat Sequence, Terminal
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Terminal Repeats, Long
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Terminal Repeats
% 210.47/210.67  |- skos__broader mesh__D020079smesh__D012091
% 210.47/210.67  |- skos__scopeNote mesh__D020079
% 210.47/210.67       Nucleotide sequences repeated on both the 5%27% and 3%27% ends of a sequence under consideration. For example, the hallmarks of a transposon are that it is flanked by inverted repeats on each end and the inverted repeats are flanked by direct repeats. The Delta element of Ty retrotransposons and LTRs %28%long terminal repeats%29% are examples of this concept.%A%    
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D020079 2003
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Sequence, Flanking Repeat
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Repetitive Sequences, R
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Delta Element
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Repetitive Sequence, R
% 210.47/210.67  |- mesh__historyNote mesh__D020079
% 210.47/210.67       99; for DELTA ELEMENTS use DNA TRANSPOSABLE ELEMENTS 1988-98; for INVERTED TERMINAL REPEAT use REPETITIVE SEQUENCE, NUCLEIC ACID 1988-98; for LONG TERMINAL REPEAT, TERMINAL REPEAT %26% R REPETITIVE SEQUENCE use REPETITIVE SEQUENCE, NUCLEIC ACID 1990-98%A%  
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Terminal Repeat Sequence
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Element, Delta
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Repeat Sequences, Flanking
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Sequences, R Repetitive
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Flanking Repeat Sequence
% 210.47/210.67  |- skos__historyNote mesh__D020079
% 210.47/210.67       Repetitive Sequences, Nucleic Acid %28%1981-1998%29%
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Repeat Sequence, Flanking
% 210.47/210.67  |- skos__annotation mesh__D020079 DF: TERMINAL REPEAT SEQ   
% 210.47/210.67  |- skos__hiddenLabel mesh__D020079 Elements, Delta
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D020079 2006
% 210.47/210.67  |- mesh__dateCreated mesh__D020079 1998-06-11
% 210.47/210.67  |- mesh__dateEstablished mesh__D020079 1999-01-01
% 210.47/210.67  |- skos__prefLabel mesh__D019525 Price Lists %5B%Publication Type%5D%
% 210.47/210.67  |- mesh__recordAuthorizer mesh__D019525 sjn
% 210.47/210.67  |- skos__altLabel mesh__D019525 Price Lists
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D019525 2006
% 210.47/210.67  |- skos__annotation mesh__D019525 publication type only   
% 210.47/210.67  |- rdf__type mesh__D019525sskos__Concept
% 210.47/210.67  |- skos__altLabel mesh__D019525 Price Lists %28%PT%29%
% 210.47/210.67  |- mesh__dateRevised mesh__D019525 2005-06-30
% 210.47/210.67  |- mesh__dateCreated mesh__D019525 1996-06-21
% 210.47/210.67  |- skos__broader mesh__D019525smesh__D019494
% 210.47/210.67  |- skos__scopeNote mesh__D019525
% 210.47/210.67       Works consisting of lists giving the prices of items for sale, including drugs, equipment, books, etc. Price lists are less detailed than catalogs and not as long.%A%    
% 210.47/210.67  |- mesh__recordOriginator mesh__D019525 TGC
% 210.47/210.67  |- mesh__historyNote mesh__D019525 1997   
% 210.47/210.67  |- mesh__recordMaintainer mesh__D019525 jls
% 210.47/210.67  |- mesh__dateEstablished mesh__D019525 1997-01-01
% 210.47/210.67  |- mesh__dateCreated mesh__D011542 1999-01-01
% 210.47/210.67  |- mesh__dateRevised mesh__D011542 2005-06-30
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D011542 2006
% 210.47/210.67  |- skos__hiddenLabel mesh__D011542 Pseudarthroses
% 210.47/210.67  |- mesh__recordOriginator mesh__D011542 NLM
% 210.47/210.67  |- mesh__recordMaintainer mesh__D011542 ssb
% 210.47/210.67  |- skos__scopeNote mesh__D011542
% 210.47/210.67       A pathologic entity characterized by deossification of a weight-bearing long bone, followed by bending and pathologic fracture, with inability to form normal BONY CALLUS leading to existence of the %22%false joint%22% that gives the condition its name. %28%Dorland, 27th ed%29%%A%    
% 210.47/210.67  |- skos__prefLabel mesh__D011542 Pseudarthrosis
% 210.47/210.67  |- mesh__recordAuthorizer mesh__D011542 sjn
% 210.47/210.67  |- skos__altLabel mesh__D011542 Pseudoarthrosis
% 210.47/210.67  |- skos__broader mesh__D011542smesh__D005599
% 210.47/210.67  |- skos__annotation mesh__D011542
% 210.47/210.67       a type of ununited fract; do not index under FRACTURES, UNUNITED unless particularly discussed%A%  
% 210.47/210.67  |- rdf__type mesh__D011542sskos__Concept
% 210.47/210.67  |- skos__hiddenLabel mesh__D011542 Pseudoarthroses
% 210.47/210.67  |- mesh__activeMeSHYear mesh__D005505 2006
% 210.47/210.68  |- mesh__recordAuthorizer mesh__D005505 sjn
% 210.47/210.68  |- skos__annotation mesh__D005505 D25-26 qualif   
% 210.47/210.68  |- mesh__recordOriginator mesh__D005505 NLM
% 210.47/210.68  |- mesh__recordMaintainer mesh__D005505 ssb
% 210.47/210.68  |- mesh__dateCreated mesh__D005505 1974-11-19
% 210.47/210.68  |- mesh__historyNote mesh__D005505 75   
% 210.47/210.68  |- skos__hiddenLabel mesh__D005505 Agents, Food Coloring
% 210.47/210.68  |- skos__altLabel mesh__D005505 Food Colorants
% 210.47/210.68  |- skos__altLabel mesh__D005505 Coloring Agents, Food
% 210.47/210.68  |- skos__scopeNote mesh__D005505
% 210.47/210.68       Natural or synthetic dyes used as coloring agents in processed foods.%A%    
% 210.47/210.68  |- rdf__type mesh__D005505sskos__Concept
% 210.47/210.68  |- skos__historyNote mesh__D005505 Food Additives %28%1966-1974%29%
% 210.47/210.68  |- skos__broader mesh__D005505smesh__D004396
% 210.47/210.68  |- skos__hiddenLabel mesh__D005505 Colorants, Food
% 210.47/210.68  |- mesh__publicMeSHNote mesh__D005505 75   
% 210.47/210.68  |- skos__broader mesh__D005505smesh__D005503
% 210.47/210.68  |- skos__prefLabel mesh__D005505 Food Coloring Agents
% 210.47/210.68  |- mesh__dateRevised mesh__D005505 2005-06-30
% 210.47/210.68  |- mesh__dateEstablished mesh__D005505 1975-09-01
% 210.47/210.68  |- rdf__type mesh__D015933sskos__Concept
% 210.47/210.68  |- skos__historyNote mesh__D015933 Complement 3 %28%1975-1989%29%
% 210.47/210.68  |- mesh__dateRevised mesh__D015933 2005-06-30
% 210.47/210.68  |- mesh__historyNote mesh__D015933 2006 %28%1990%29%   
% 210.47/210.68  |- skos__historyNote mesh__D015933 Complement %28%1973-1976%29%
% 210.47/210.68  |- skos__hiddenLabel mesh__D015933 Complement, C3d
% 210.47/210.68  |- skos__hiddenLabel mesh__D015933 C3d, Complement
% 210.47/210.68  |- mesh__dateEstablished mesh__D015933 1990-01-01
% 210.47/210.68  |- mesh__publicMeSHNote mesh__D015933 2006; see COMPLEMENT 3D 1990-2005   
% 210.47/210.68  |- skos__altLabel mesh__D015933 Complement C3d Fragment
% 210.47/210.68  |- mesh__recordMaintainer mesh__D015933 lkt
% 210.47/210.68  |- skos__hiddenLabel mesh__D015933 Component 3d, Complement
% 210.47/210.68  |- mesh__recordAuthorizer mesh__D015933 sjn
% 210.47/210.68  |- skos__altLabel mesh__D015933 Complement 3d
% 210.47/210.68  |- mesh__dateCreated mesh__D015933 1989-05-25
% 210.47/210.68  |- skos__hiddenLabel mesh__D015933 C3d Fragment, Complement
% 210.47/210.68  |- skos__prefLabel mesh__D015933 Complement C3d
% 210.47/210.68  |- skos__altLabel mesh__D015933 Complement Component 3d
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D015933 2006
% 210.47/210.68  |- skos__hiddenLabel mesh__D015933 Fragment, Complement C3d
% 210.47/210.68  |- skos__related mesh__D015933smesh__D017464
% 210.47/210.68  |- mesh__recordOriginator mesh__D015933 AGS
% 210.47/210.68  |- skos__scopeNote mesh__D015933
% 210.47/210.68       A 302-amino-acid fragment in the alpha chain %28%672-1663%29% of C3b. It is generated when C3b is inactivated %28%iC3b%29% and its alpha chain is cleaved by COMPLEMENT FACTOR I into C3c, and C3dg %28%955-1303%29% in the presence COMPLEMENT FACTOR H. Serum proteases further degrade C3dg into C3d %28%1002-1303%29% and C3g %28%955-1001%29%.%A%    
% 210.47/210.68  |- skos__altLabel mesh__D015933 C3d Complement
% 210.47/210.68  |- skos__broader mesh__D015933smesh__D003179
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001913 1998
% 210.47/210.68  |- mesh__dateCreated mesh__D001913 1999-01-01
% 210.47/210.68  |- skos__scopeNote mesh__D001913
% 210.47/210.68       A persistent progressive non-elevated red scaly or crusted plaque which is due to an intradermal carcinoma and is potentially malignant. Atypical squamous cells proliferate through the whole thickness of the epidermis. The lesions may occur anywhere on the skin surface or on mucosal surfaces. The cause most frequently found is trivalent arsenic compounds. Freezing, cauterization or diathermy coagulation is often effective. %28%From Rook et al., Textbook of Dermatology, 4th ed, pp2428-9%29%%A%    
% 210.47/210.68  |- mesh__recordMaintainer mesh__D001913 KEV
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001913 2002
% 210.47/210.68  |- mesh__historyNote mesh__D001913
% 210.47/210.68       91%28%75%29%; was see under CARCINOMA, SQUAMOUS CELL 1981-90; was see under CARCINOMA, EPIDERMOID 1969-80%A%  
% 210.47/210.68  |- rdf__type mesh__D001913sskos__Concept
% 210.47/210.68  |- skos__prefLabel mesh__D001913 Bowen%27%s Disease
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001913 2001
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001913 2004
% 210.47/210.68  |- skos__broader mesh__D001913smesh__D002294
% 210.47/210.68  |- skos__annotation mesh__D001913
% 210.47/210.68       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with SKIN NEOPLASMS %28%IM%29%%A%  
% 210.47/210.68  |- mesh__publicMeSHNote mesh__D001913
% 210.47/210.68       91; was see under CARCINOMA, SQUAMOUS CELL 1981-90; was see under CARCINOMA, EPIDERMOID 1969-80%A%  
% 210.47/210.68  |- skos__hiddenLabel mesh__D001913 Bowens Disease
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001913 2000
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001913 1997
% 210.47/210.68  |- mesh__recordAuthorizer mesh__D001913 PLS
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001913 2006
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001913 2003
% 210.47/210.68  |- skos__hiddenLabel mesh__D001913 Disease, Bowen%27%s
% 210.47/210.68  |- mesh__dateEstablished mesh__D001913 1991-01-01
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001913 1999
% 210.47/210.68  |- mesh__onlineNote mesh__D001913
% 210.47/210.68       search CARCINOMA, SQUAMOUS CELL 1969-74   
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001913 1996
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001913 2005
% 210.47/210.68  |- skos__altLabel mesh__D001913 Bowen Disease
% 210.47/210.68  |- skos__hiddenLabel mesh__D001913 Disease, Bowen
% 210.47/210.68  |- mesh__recordOriginator mesh__D001913 NLM
% 210.47/210.68  |- mesh__dateRevised mesh__D001913 1995-06-08
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001115 2005
% 210.47/210.68  |- skos__historyNote mesh__D001115 Nicotinic Acids %28%1969-1972%29%
% 210.47/210.68  |- skos__broader mesh__D001115smesh__D009539
% 210.47/210.68  |- skos__scopeNote mesh__D001115
% 210.47/210.68       An alkaloid obtained from the betel nut %28%Areca catechu%29%, fruit of a palm tree. It is an agonist at both muscarinic and nicotinic acetylcholine receptors. It is used in the form of various salts as a ganglionic stimulant, a parasympathomimetic, and a vermifuge, especially in veterinary practice. It has been used as a euphoriant in the Pacific Islands.%A%    
% 210.47/210.68  |- skos__prefLabel mesh__D001115 Arecoline
% 210.47/210.68  |- mesh__publicMeSHNote mesh__D001115
% 210.47/210.68       73; was see under NICOTINIC ACID 1969-72, was see under PARASYMPATHOMIMETICS 1963-68; ARECHOLIN was see ARECOLINE 1981-95%A%  
% 210.47/210.68  |- mesh__historyNote mesh__D001115
% 210.47/210.68       73%28%72%29%; was see under NICOTINIC ACID 1969-72, was see under PARASYMPATHOMIMETICS 1963-68; ARECHOLIN was see ARECOLINE 1981-95%A%  
% 210.47/210.68  |- skos__historyNote mesh__D001115 Parasympatholytics %28%1966-1968%29%
% 210.47/210.68  |- skos__altLabel mesh__D001115 Arecolin
% 210.47/210.68  |- mesh__recordMaintainer mesh__D001115 jls
% 210.47/210.68  |- skos__altLabel mesh__D001115 Arecaline
% 210.47/210.68  |- mesh__dateEstablished mesh__D001115 1973-01-01
% 210.47/210.68  |- mesh__recordOriginator mesh__D001115 NLM
% 210.47/210.68  |- skos__altLabel mesh__D001115 Methylarecaidin
% 210.47/210.68  |- mesh__dateRevised mesh__D001115 2004-07-19
% 210.47/210.68  |- mesh__onlineNote mesh__D001115
% 210.47/210.68       search NICOTINIC ACID 1969-71 %26% PARASYMPATHOMIMETICS 1966-68%A%  
% 210.47/210.68  |- skos__altLabel mesh__D001115 Arecholin
% 210.47/210.68  |- mesh__recordAuthorizer mesh__D001115 sjn
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001115 2006
% 210.47/210.68  |- rdf__type mesh__D001115sskos__Concept
% 210.47/210.68  |- skos__altLabel mesh__D001115 Arecholine
% 210.47/210.68  |- skos__broader mesh__D001115smesh__D000470
% 210.47/210.68  |- mesh__dateCreated mesh__D001115 1999-01-01
% 210.47/210.68  |- mesh__dateRevised mesh__D020878 2002-07-03
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D020878 2003
% 210.47/210.68  |- skos__broader mesh__D020878smesh__D013514
% 210.47/210.68  |- skos__hiddenLabel mesh__D020878 Device Removals
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D020878 2004
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D020878 2005
% 210.47/210.68  |- mesh__historyNote mesh__D020878 2000   
% 210.47/210.68  |- mesh__dateCreated mesh__D020878 1999-11-03
% 210.47/210.68  |- rdf__type mesh__D020878sskos__Concept
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D020878 2006
% 210.47/210.68  |- skos__hiddenLabel mesh__D020878 Removals, Device
% 210.47/210.68  |- skos__hiddenLabel mesh__D020878 Removal, Device
% 210.47/210.68  |- skos__scopeNote mesh__D020878
% 210.47/210.68       Removal of an implanted therapeutic or prosthetic device.%A%    
% 210.47/210.68  |- mesh__publicMeSHNote mesh__D020878 2000   
% 210.47/210.68  |- mesh__dateEstablished mesh__D020878 2000-01-01
% 210.47/210.68  |- skos__prefLabel mesh__D020878 Device Removal
% 210.47/210.68  |- mesh__dateCreated mesh__D011543 1999-01-01
% 210.47/210.68  |- skos__scopeNote mesh__D011543 An aspect of cholinesterases.     
% 210.47/210.68  |- skos__prefLabel mesh__D011543 Pseudocholinesterase
% 210.47/210.68  |- skos__altLabel mesh__D011543 Benzoylcholinesterase
% 210.47/210.68  |- skos__annotation mesh__D011543
% 210.47/210.68       /antag = CHOLINESTERASE INHIBITORS %28%IM%29% + PSEUDOCHOLINESTERASE %28%NIM with no qualif%29%%A%  
% 210.47/210.68  |- mesh__recordOriginator mesh__D011543 NLM
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D011543 2005
% 210.47/210.68  |- mesh__historyNote mesh__D011543
% 210.47/210.68       91%28%75%29%; was see under CHOLINESTERASES 1975-90; was see under CHOLINESTERASE 1963-74%A%  
% 210.47/210.68  |- mesh__recordMaintainer mesh__D011543 ssb
% 210.47/210.68  |- mesh__recordAuthorizer mesh__D011543 sjn
% 210.47/210.68  |- mesh__dateEstablished mesh__D011543 1991-01-01
% 210.47/210.68  |- skos__broader mesh__D011543smesh__D002802
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D011543 2006
% 210.47/210.68  |- rdf__type mesh__D011543sskos__Concept
% 210.47/210.68  |- mesh__dateRevised mesh__D011543 2003-07-09
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D011543 2004
% 210.47/210.68  |- mesh__publicMeSHNote mesh__D011543
% 210.47/210.68       91; was see under CHOLINESTERASES 1975-90; was see under CHOLINESTERASE 1963-74%A%  
% 210.47/210.68  |- mesh__onlineNote mesh__D011543 search CHOLINESTERASES 1966-74   
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005506 1995
% 210.47/210.68  |- skos__hiddenLabel mesh__D005506 Food Adulterations
% 210.47/210.68  |- rdf__type mesh__D005506sskos__Concept
% 210.47/210.68  |- skos__hiddenLabel mesh__D005506 Contamination, Food
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005506 2001
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005506 1994
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005506 2004
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005506 1997
% 210.47/210.68  |- skos__scopeNote mesh__D005506
% 210.47/210.68       The presence in food of harmful, unpalatable, or otherwise objectionable foreign substances, e.g. chemicals, microorganisms or diluents, before, during, or after processing or storage.%A%    
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005506 2000
% 210.47/210.68  |- mesh__recordMaintainer mesh__D005506 TAP
% 210.47/210.68  |- skos__hiddenLabel mesh__D005506 Food Contaminations
% 210.47/210.68  |- mesh__dateCreated mesh__D005506 1999-01-01
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005506 2003
% 210.47/210.68  |- skos__prefLabel mesh__D005506 Food Contamination
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005506 1996
% 210.47/210.68  |- mesh__dateRevised mesh__D005506 1992-05-15
% 210.47/210.68  |- skos__broader mesh__D005506smesh__D004787
% 210.47/210.68  |- mesh__recordOriginator mesh__D005506 NLM
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005506 1993
% 210.47/210.68  |- skos__hiddenLabel mesh__D005506 Adulteration, Food
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005506 2006
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005506 1999
% 210.47/210.68  |- mesh__recordAuthorizer mesh__D005506 PLS
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005506 2002
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005506 2005
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005506 1998
% 210.47/210.68  |- skos__hiddenLabel mesh__D005506 Adulterations, Food
% 210.47/210.68  |- skos__hiddenLabel mesh__D005506 Contaminations, Food
% 210.47/210.68  |- skos__annotation mesh__D005506
% 210.47/210.68       coord IM with specific food item probably NIM; contamination by dirt, dust, chemicals %26% toxic substances, organisms; contamination by microbes: consider FOOD MICROBIOLOGY %28%IM%29% + specific microbe %28%IM%29% + specific food item %28%IM or NIM%29%; contamination by parasites: consider FOOD PARASITOLOGY %28%IM%29% + specific parasite %28%IM%29% + specific food item %28%IM or NIM%29%%A%  
% 210.47/210.68  |- mesh__historyNote mesh__D015934 2006 %28%1990%29%   
% 210.47/210.68  |- mesh__recordMaintainer mesh__D015934 ssb
% 210.47/210.68  |- mesh__dateEstablished mesh__D015934 1990-01-01
% 210.47/210.68  |- skos__altLabel mesh__D015934 Complement Component 4a
% 210.47/210.68  |- skos__altLabel mesh__D015934 C4a Complement
% 210.47/210.68  |- skos__hiddenLabel mesh__D015934 Complement, C4a
% 210.47/210.68  |- mesh__dateCreated mesh__D015934 1989-05-25
% 210.47/210.68  |- mesh__dateRevised mesh__D015934 2005-06-30
% 210.47/210.68  |- skos__broader mesh__D015934smesh__D000706
% 210.47/210.68  |- skos__hiddenLabel mesh__D015934 Component 4a, Complement
% 210.47/210.68  |- skos__hiddenLabel mesh__D015934 C4a, Complement
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D015934 2006
% 210.47/210.68  |- mesh__recordAuthorizer mesh__D015934 sjn
% 210.47/210.68  |- skos__historyNote mesh__D015934 Complement 4 %28%1978-1989%29%
% 210.47/210.68  |- skos__prefLabel mesh__D015934 Complement C4a
% 210.47/210.68  |- skos__scopeNote mesh__D015934
% 210.47/210.68       The smaller fragment formed when complement C4 is cleaved by COMPLEMENT C1S. It is an anaphylatoxin that causes symptoms of immediate hypersensitivity %28%HYPERSENSITIVITY, IMMEDIATE%29% but its activity is weaker than that of COMPLEMENT C3A or COMPLEMENT C5A.%A%    
% 210.47/210.68  |- skos__altLabel mesh__D015934 Complement 4a
% 210.47/210.68  |- skos__broader mesh__D015934smesh__D003181
% 210.47/210.68  |- skos__historyNote mesh__D015934 Anaphylatoxins %28%1980-1982%29%
% 210.47/210.68  |- rdf__type mesh__D015934sskos__Concept
% 210.47/210.68  |- mesh__publicMeSHNote mesh__D015934 2006; see COMPLEMENT 4A 1990-2005   
% 210.47/210.68  |- mesh__recordOriginator mesh__D015934 AGS
% 210.47/210.68  |- mesh__recordAuthorizer mesh__D001914 PLS
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001914 2004
% 210.47/210.68  |- skos__broader mesh__D001914smesh__D013177
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001914 1997
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001914 2006
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001914 2003
% 210.47/210.68  |- mesh__recordOriginator mesh__D001914 NLM
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001914 1999
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001914 2005
% 210.47/210.68  |- skos__hiddenLabel mesh__D001914 Boxings
% 210.47/210.68  |- skos__annotation mesh__D001914
% 210.47/210.68       /inj: coord IM with specific inj %28%IM%29%; /physiol permitted; Manual 30.15.1%A%  
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001914 2002
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001914 1998
% 210.47/210.68  |- skos__prefLabel mesh__D001914 Boxing
% 210.47/210.68  |- mesh__dateRevised mesh__D001914 1996-06-10
% 210.47/210.68  |- mesh__recordMaintainer mesh__D001914 TAP
% 210.47/210.68  |- mesh__dateCreated mesh__D001914 1999-01-01
% 210.47/210.68  |- skos__scopeNote mesh__D001914
% 210.47/210.68       A two-person sport in which the fists are skillfully used to attack and defend.%A%    
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001914 2001
% 210.47/210.68  |- rdf__type mesh__D001914sskos__Concept
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001914 2000
% 210.47/210.68  |- mesh__dateRevised mesh__D001116 2001-07-25
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001116 2003
% 210.47/210.68  |- mesh__dateCreated mesh__D001116 1977-05-04
% 210.47/210.68  |- mesh__recordAuthorizer mesh__D001116 sjn
% 210.47/210.68  |- mesh__recordOriginator mesh__D001116 AEP
% 210.47/210.68  |- skos__historyNote mesh__D001116 RNA Viruses %28%1966-1977%29%
% 210.47/210.68  |- skos__prefLabel mesh__D001116 Arenaviridae
% 210.47/210.68  |- mesh__dateEstablished mesh__D001116 1978-01-01
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001116 2002
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001116 2004
% 210.47/210.68  |- mesh__onlineNote mesh__D001116
% 210.47/210.68       use ARENAVIRIDAE to search ARENAVIRUSES 1978-80   
% 210.47/210.68  |- mesh__historyNote mesh__D001116 81; was ARENAVIRUSES 1978-80   
% 210.47/210.68  |- mesh__recordMaintainer mesh__D001116 ags
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001116 2005
% 210.47/210.68  |- skos__scopeNote mesh__D001116
% 210.47/210.68       A family of RNA viruses naturally infecting rodents and consisting of one genus %28%ARENAVIRUS%29% with two groups: Old World Arenaviruses %28%ARENAVIRUSES, OLD WORLD%29% and New World Arenaviruses %28%ARENAVIRUSES, NEW WORLD%29%. Infection in rodents is persistent and silent. Vertical transmission is through milk-, saliva-, or urine-borne routes. Horizontal transmission to humans, monkeys, and other animals is important.%A%    
% 210.47/210.68  |- mesh__publicMeSHNote mesh__D001116 81; was ARENAVIRUSES 1978-80   
% 210.47/210.68  |- skos__broader mesh__D001116smesh__D012328
% 210.47/210.68  |- skos__annotation mesh__D001116 infection = ARENAVIRIDAE INFECTIONS   
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001116 2006
% 210.47/210.68  |- rdf__type mesh__D001116sskos__Concept
% 210.47/210.68  |- skos__hiddenLabel mesh__D020879 Muscle Disease Manifestation
% 210.47/210.68  |- skos__hiddenLabel mesh__D020879 Manifestation, Muscle Disease
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D020879 2004
% 210.47/210.68  |- mesh__historyNote mesh__D020879 2000   
% 210.47/210.68  |- skos__altLabel mesh__D020879 Neuromuscular Signs and Symptoms
% 210.47/210.68  |- skos__hiddenLabel mesh__D020879 Manifestation, Neuromuscular
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D020879 2006
% 210.47/210.68  |- rdf__type mesh__D020879sskos__Concept
% 210.47/210.68  |- mesh__publicMeSHNote mesh__D020879 2000   
% 210.47/210.68  |- skos__annotation mesh__D020879 not used for indexing   
% 210.47/210.68  |- skos__broader mesh__D020879smesh__D009461
% 210.47/210.68  |- mesh__recordMaintainer mesh__D020879 sjn
% 210.47/210.68  |- mesh__dateRevised mesh__D020879 2003-07-22
% 210.47/210.68  |- mesh__recordOriginator mesh__D020879 KEV
% 210.47/210.68  |- skos__hiddenLabel mesh__D020879 Disease Manifestation, Muscle
% 210.47/210.68  |- mesh__dateCreated mesh__D020879 1999-11-03
% 210.47/210.68  |- skos__hiddenLabel mesh__D020879 Manifestations, Neuromuscular
% 210.47/210.68  |- skos__prefLabel mesh__D020879 Neuromuscular Manifestations
% 210.47/210.68  |- mesh__dateEstablished mesh__D020879 2000-01-01
% 210.47/210.68  |- skos__altLabel mesh__D020879 Manifestations, Muscle Disease
% 210.47/210.68  |- mesh__recordAuthorizer mesh__D020879 sjn
% 210.47/210.68  |- skos__scopeNote mesh__D020879
% 210.47/210.68       Signs and symptoms associated with diseases of the muscle, neuromuscular junction, or peripheral nerves.%A%    
% 210.47/210.68  |- skos__altLabel mesh__D020879 Signs and Symptoms, Neuromuscular
% 210.47/210.68  |- skos__hiddenLabel mesh__D020879 Disease Manifestations, Muscle
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D020879 2005
% 210.47/210.68  |- skos__hiddenLabel mesh__D020879 Neuromuscular Manifestation
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D019527 2006
% 210.47/210.68  |- skos__altLabel mesh__D019527 Prospectuses %28%PT%29%
% 210.47/210.68  |- skos__prefLabel mesh__D019527 Prospectuses %5B%Publication Type%5D%
% 210.47/210.68  |- mesh__dateRevised mesh__D019527 2005-06-30
% 210.47/210.68  |- rdf__type mesh__D019527sskos__Concept
% 210.47/210.68  |- mesh__recordMaintainer mesh__D019527 jls
% 210.47/210.68  |- mesh__recordOriginator mesh__D019527 TGC
% 210.47/210.68  |- mesh__historyNote mesh__D019527 1997   
% 210.47/210.68  |- skos__broader mesh__D019527smesh__D019502
% 210.47/210.68  |- skos__scopeNote mesh__D019527
% 210.47/210.68       Works consisting of advertisements separately printed and distributed by a publisher to describe and solicit orders for a recent or forthcoming publication. In the case of books, they may include sample pages. %28%From: ALA Glossary of Library and Information Science, 1983%29%%A%    
% 210.47/210.68  |- skos__altLabel mesh__D019527 Prospectuses
% 210.47/210.68  |- mesh__dateEstablished mesh__D019527 1997-01-01
% 210.47/210.68  |- mesh__recordAuthorizer mesh__D019527 sjn
% 210.47/210.68  |- mesh__dateCreated mesh__D019527 1996-06-21
% 210.47/210.68  |- skos__annotation mesh__D019527
% 210.47/210.68       publication type only; for prospectuses as a subject, index under main heading ADVERTISING; not used for indexing; CATALOG: do not use for current materials%A%  
% 210.47/210.68  |- skos__hiddenLabel mesh__D011544 Gene, Processed
% 210.47/210.68  |- mesh__recordMaintainer mesh__D011544 nns
% 210.47/210.68  |- mesh__historyNote mesh__D011544 88   
% 210.47/210.68  |- skos__hiddenLabel mesh__D011544 beta-Tubulin Pseudogenes
% 210.47/210.68  |- mesh__dateEstablished mesh__D011544 1988-01-01
% 210.47/210.68  |- mesh__recordOriginator mesh__D011544 SCD
% 210.47/210.68  |- skos__historyNote mesh__D011544 Genes, Structural %28%1975-1987%29%
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D011544 2006
% 210.47/210.68  |- mesh__dateRevised mesh__D011544 2005-06-30
% 210.47/210.68  |- rdf__type mesh__D011544sskos__Concept
% 210.47/210.68  |- skos__hiddenLabel mesh__D011544 Pseudogene
% 210.47/210.68  |- skos__prefLabel mesh__D011544 Pseudogenes
% 210.47/210.68  |- mesh__dateCreated mesh__D011544 1987-05-09
% 210.47/210.68  |- skos__hiddenLabel mesh__D011544 Pseudogenes, beta-Tubulin
% 210.47/210.68  |- skos__hiddenLabel mesh__D011544 Pseudogene, beta-Tubulin
% 210.47/210.68  |- skos__hiddenLabel mesh__D011544 Processed Gene
% 210.47/210.68  |- mesh__recordAuthorizer mesh__D011544 sjn
% 210.47/210.68  |- skos__hiddenLabel mesh__D011544 Processed Genes
% 210.47/210.68  |- skos__hiddenLabel mesh__D011544 beta Tubulin Pseudogene
% 210.47/210.68  |- mesh__publicMeSHNote mesh__D011544 88   
% 210.47/210.68  |- skos__broader mesh__D011544smesh__D005796
% 210.47/210.68  |- skos__historyNote mesh__D011544 Genes %28%1975-1987%29%
% 210.47/210.68  |- skos__scopeNote mesh__D011544
% 210.47/210.68       Genes bearing close resemblance to known genes at different loci, but rendered non-functional by additions or deletions in structure that prevent normal transcription or translation. When lacking introns and containing a poly-A segment near the downstream end %28%as a result of reverse copying from processed nuclear RNA into double-stranded DNA%29%, they are called processed genes.%A%    
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005507 2004
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005507 1997
% 210.47/210.68  |- skos__hiddenLabel mesh__D005507 Radioactive Food Contaminations
% 210.47/210.68  |- mesh__dateCreated mesh__D005507 1999-01-01
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005507 2003
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005507 1996
% 210.47/210.68  |- skos__prefLabel mesh__D005507 Food Contamination, Radioactive
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005507 2001
% 210.47/210.68  |- skos__hiddenLabel mesh__D005507 Radioactive Food Contamination
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005507 1993
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005507 2006
% 210.47/210.68  |- skos__hiddenLabel mesh__D005507 Food Contaminations, Radioactive
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005507 1999
% 210.47/210.68  |- skos__broader mesh__D005507smesh__D005506
% 210.47/210.68  |- skos__hiddenLabel mesh__D005507 Contaminations, Radioactive Food
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005507 2000
% 210.47/210.68  |- mesh__recordMaintainer mesh__D005507 TAP
% 210.47/210.68  |- skos__broader mesh__D005507smesh__D011870
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005507 2005
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005507 1998
% 210.47/210.68  |- mesh__dateRevised mesh__D005507 1992-05-15
% 210.47/210.68  |- mesh__recordOriginator mesh__D005507 NLM
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005507 1995
% 210.47/210.68  |- skos__annotation mesh__D005507
% 210.47/210.68       do not confuse with FOOD IRRADIATION: food preservation by irradiation%A%  
% 210.47/210.68  |- skos__hiddenLabel mesh__D005507 Contamination, Radioactive Food
% 210.47/210.68  |- mesh__recordAuthorizer mesh__D005507 PLS
% 210.47/210.68  |- rdf__type mesh__D005507sskos__Concept
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005507 2002
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D005507 1994
% 210.47/210.68  |- skos__altLabel mesh__D015935 Complement 4b
% 210.47/210.68  |- skos__hiddenLabel mesh__D015935 C4b, Complement
% 210.47/210.68  |- mesh__recordAuthorizer mesh__D015935 sjn
% 210.47/210.68  |- mesh__recordMaintainer mesh__D015935 lkt
% 210.47/210.68  |- mesh__publicMeSHNote mesh__D015935 2006; see COMPLEMENT 4B 1990-2005   
% 210.47/210.68  |- skos__broader mesh__D015935smesh__D003181
% 210.47/210.68  |- skos__hiddenLabel mesh__D015935 Component 4b, Complement
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D015935 2006
% 210.47/210.68  |- skos__altLabel mesh__D015935 C4b Complement
% 210.47/210.68  |- skos__hiddenLabel mesh__D015935 Complement, C4b
% 210.47/210.68  |- skos__scopeNote mesh__D015935
% 210.47/210.68       The large fragment formed when COMPLEMENT C4 is cleaved by COMPLEMENT C1S. The membrane-bound C4b binds COMPLEMENT C2A, a SERINE PROTEASE, to form C4b2a %28%CLASSICAL PATHWAY C3 CONVERTASE%29% and subsequent C4b2a3b %28%CLASSICAL PATHWAY C5 CONVERTASE%29%.%A%    
% 210.47/210.68  |- mesh__historyNote mesh__D015935 2006 %28%1990%29%   
% 210.47/210.68  |- skos__prefLabel mesh__D015935 Complement C4b
% 210.47/210.68  |- mesh__dateRevised mesh__D015935 2005-06-30
% 210.47/210.68  |- skos__altLabel mesh__D015935 Complement Component 4b
% 210.47/210.68  |- rdf__type mesh__D015935sskos__Concept
% 210.47/210.68  |- mesh__dateEstablished mesh__D015935 1990-01-01
% 210.47/210.68  |- skos__historyNote mesh__D015935 Complement 4 %28%1975-1989%29%
% 210.47/210.68  |- mesh__dateCreated mesh__D015935 1989-05-25
% 210.47/210.68  |- mesh__recordOriginator mesh__D015935 AGS
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001915 2006
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001915 2003
% 210.47/210.68  |- mesh__recordAuthorizer mesh__D001915 SJN
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001915 2005
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001915 1999
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001915 2000
% 210.47/210.68  |- skos__prefLabel mesh__D001915 Braces
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001915 1998
% 210.47/210.68  |- mesh__recordMaintainer mesh__D001915 PXP
% 210.47/210.68  |- skos__broader mesh__D001915smesh__D009989
% 210.47/210.68  |- mesh__recordOriginator mesh__D001915 NLM
% 210.47/210.68  |- mesh__dateCreated mesh__D001915 1999-01-01
% 210.47/210.68  |- skos__hiddenLabel mesh__D001915 Brace
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001915 2002
% 210.47/210.68  |- rdf__type mesh__D001915sskos__Concept
% 210.47/210.68  |- skos__scopeNote mesh__D001915
% 210.47/210.68       Orthopedic appliances used to support, align, or hold parts of the body in correct position. %28%Dorland, 28th ed%29%%A%    
% 210.47/210.68  |- mesh__dateRevised mesh__D001915 1997-06-20
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001915 2004
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001915 2001
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001117 1997
% 210.47/210.68  |- skos__hiddenLabel mesh__D001117 Arenavirus Infection
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001117 2000
% 210.47/210.68  |- skos__historyNote mesh__D001117 Arenaviridae %28%1978-1980%29%
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001117 2004
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001117 1998
% 210.47/210.68  |- skos__hiddenLabel mesh__D001117 Infection, Arenaviridae
% 210.47/210.68  |- mesh__dateEstablished mesh__D001117 1981-01-01
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001117 2001
% 210.47/210.68  |- mesh__recordOriginator mesh__D001117 RC
% 210.47/210.68  |- mesh__onlineNote mesh__D001117
% 210.47/210.68       use ARENAVIRIDAE INFECTIONS to search ARENAVIRUS INFECTIONS 1981-93%A%  
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001117 2005
% 210.47/210.68  |- skos__prefLabel mesh__D001117 Arenaviridae Infections
% 210.47/210.68  |- mesh__dateCreated mesh__D001117 1980-05-13
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001117 1999
% 210.47/210.68  |- mesh__historyNote mesh__D001117 94; was ARENAVIRUS INFECTIONS 1981-93   
% 210.47/210.68  |- mesh__dateRevised mesh__D001117 1993-06-04
% 210.47/210.68  |- mesh__recordAuthorizer mesh__D001117 PLS
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001117 2002
% 210.47/210.68  |- skos__altLabel mesh__D001117 Arenavirus Infections
% 210.47/210.68  |- skos__hiddenLabel mesh__D001117 Infection, Arenavirus
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001117 1994
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001117 2006
% 210.47/210.68  |- rdf__type mesh__D001117sskos__Concept
% 210.47/210.68  |- mesh__publicMeSHNote mesh__D001117
% 210.47/210.68       94; was ARENAVIRUS INFECTIONS 1981-93   
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001117 1995
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001117 1996
% 210.47/210.68  |- skos__broader mesh__D001117smesh__D012327
% 210.47/210.68  |- skos__historyNote mesh__D001117 Virus Diseases %28%1966-1980%29%
% 210.47/210.68  |- skos__hiddenLabel mesh__D001117 Arenaviridae Infection
% 210.47/210.68  |- skos__altLabel mesh__D001117 Infections, Arenaviridae
% 210.47/210.68  |- skos__scopeNote mesh__D001117
% 210.47/210.68       Virus diseases caused by the ARENAVIRIDAE.     
% 210.47/210.68  |- mesh__recordMaintainer mesh__D001117 AGS
% 210.47/210.68  |- skos__annotation mesh__D001117 GEN or unspecified; prefer specifics   
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D001117 2003
% 210.47/210.68  |- mesh__recordOriginator mesh__D006600 NLM
% 210.47/210.68  |- rdf__type mesh__D006600sskos__Concept
% 210.47/210.68  |- mesh__recordMaintainer mesh__D006600 ssb
% 210.47/210.68  |- skos__prefLabel mesh__D006600 Hexosephosphates
% 210.47/210.68  |- mesh__recordAuthorizer mesh__D006600 sjn
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D006600 2005
% 210.47/210.68  |- mesh__dateCreated mesh__D006600 1999-01-01
% 210.47/210.68  |- mesh__dateRevised mesh__D006600 2004-07-07
% 210.47/210.68  |- mesh__activeMeSHYear mesh__D006600 2006
% 210.47/210.68  |- skos__broader mesh__D006600smesh__D013403
% 210.47/210.68  |- mesh__recordAuthorizer mesh__D019528 sjn
% 210.47/210.68  |- skos__broader mesh__D019528smesh__D019514
% 210.47/210.68  |- mesh__dateCreated mesh__D019528 1996-06-21
% 210.47/210.68  |- skos__prefLabel mesh__D019528 Lecture Notes %5B%Publication Type%5D%
% 210.47/210.68  |- skos__annotation mesh__D019528
% 210.47/210.68       publication type only; for notes %28%usually instructive%29% taken at a lecture or class%A%  
% 210.47/210.69  |- mesh__recordMaintainer mesh__D019528 jls
% 210.47/210.69  |- skos__altLabel mesh__D019528 Lecture Notes %28%PT%29%
% 210.47/210.69  |- mesh__dateRevised mesh__D019528 2005-06-30
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D019528 2006
% 210.47/210.69  |- skos__scopeNote mesh__D019528
% 210.47/210.69       Works consisting of notes taken at the delivery or reading of a speech before an audience or class, usually given to instruct. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 210.47/210.69  |- mesh__recordOriginator mesh__D019528 TGC
% 210.47/210.69  |- mesh__historyNote mesh__D019528 1997   
% 210.47/210.69  |- skos__altLabel mesh__D019528 Lecture Notes
% 210.47/210.69  |- rdf__type mesh__D019528sskos__Concept
% 210.47/210.69  |- mesh__dateEstablished mesh__D019528 1997-01-01
% 210.47/210.69  |- rdf__type mesh__D011545sskos__Concept
% 210.47/210.69  |- skos__historyNote mesh__D011545 Hermaphroditism %28%1966-1972%29%
% 210.47/210.69  |- mesh__recordAuthorizer mesh__D011545 sjn
% 210.47/210.69  |- mesh__publicMeSHNote mesh__D011545
% 210.47/210.69       73; was see under HERMAPHRODITISM 1963-72   
% 210.47/210.69  |- skos__broader mesh__D011545smesh__D006546
% 210.47/210.69  |- skos__hiddenLabel mesh__D011545 Pseudohermaphroditism, Male
% 210.47/210.69  |- mesh__historyNote mesh__D011545
% 210.47/210.69       73; was see under HERMAPHRODITISM 1963-72   
% 210.47/210.69  |- skos__prefLabel mesh__D011545 Pseudohermaphroditism
% 210.47/210.69  |- mesh__dateCreated mesh__D011545 1999-01-01
% 210.47/210.69  |- mesh__onlineNote mesh__D011545 search HERMAPHRODITISM 1966-72   
% 210.47/210.69  |- mesh__recordMaintainer mesh__D011545 lkt
% 210.47/210.69  |- mesh__dateRevised mesh__D011545 2005-06-30
% 210.47/210.69  |- skos__scopeNote mesh__D011545
% 210.47/210.69       A condition of sexual ambiguity in which the individual %28%pseudohermaphrodite%29% possesses gonadal tissue of one SEX but exhibits external PHENOTYPE of the opposite sex. Female pseudohermaphroditism is an individual with XX karyotype, normal development of OVARIES and internal reproductive tract, but with ambiguous or virilized external GENITALIA. Male pseudohermaphroditism is characterized by the presence of a Y CHROMOSOME and TESTES, but the genital tract and external genitalia are ambiguous or completely female.%A%    
% 210.47/210.69  |- mesh__recordOriginator mesh__D011545 NLM
% 210.47/210.69  |- skos__annotation mesh__D011545 use check tag for genetic sex   
% 210.47/210.69  |- mesh__dateEstablished mesh__D011545 1973-01-01
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D011545 2006
% 210.47/210.69  |- skos__hiddenLabel mesh__D011545 Pseudohermaphroditism, Female
% 210.47/210.69  |- skos__hiddenLabel mesh__D005508 Deprivations, Food
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005508 1992
% 210.47/210.69  |- mesh__recordOriginator mesh__D005508 NLM
% 210.47/210.69  |- skos__broader mesh__D005508smesh__D009042
% 210.47/210.69  |- skos__scopeNote mesh__D005508
% 210.47/210.69       The withholding of food in a structured experimental situation.%A%    
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005508 2005
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005508 1998
% 210.47/210.69  |- skos__annotation mesh__D005508
% 210.47/210.69       human %26% animal; /physiol permitted for physiol %26% metab eff%A%  
% 210.47/210.69  |- mesh__dateEstablished mesh__D005508 1969-01-01
% 210.47/210.69  |- mesh__dateRevised mesh__D005508 1991-06-20
% 210.47/210.69  |- mesh__publicMeSHNote mesh__D005508 69   
% 210.47/210.69  |- mesh__historyNote mesh__D005508 69   
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005508 1993
% 210.47/210.69  |- skos__prefLabel mesh__D005508 Food Deprivation
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005508 2006
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005508 1999
% 210.47/210.69  |- skos__historyNote mesh__D005508 Motivation %28%1966-1968%29%
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005508 2000
% 210.47/210.69  |- skos__hiddenLabel mesh__D005508 Food Deprivations
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005508 1994
% 210.47/210.69  |- mesh__dateCreated mesh__D005508 1999-01-01
% 210.47/210.69  |- skos__related mesh__D005508smesh__D013217
% 210.47/210.69  |- skos__historyNote mesh__D005508 Hunger %28%1966-1968%29%
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005508 2001
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005508 1995
% 210.47/210.69  |- skos__hiddenLabel mesh__D005508 Deprivation, Food
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005508 2003
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005508 1996
% 210.47/210.69  |- mesh__recordAuthorizer mesh__D005508 PLS
% 210.47/210.69  |- rdf__type mesh__D005508sskos__Concept
% 210.47/210.69  |- mesh__recordMaintainer mesh__D005508 TGC
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005508 2002
% 210.47/210.69  |- skos__related mesh__D005508smesh__D006815
% 210.47/210.69  |- skos__related mesh__D005508smesh__D005215
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005508 2004
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005508 1997
% 210.47/210.69  |- rdf__type mesh__D002210sskos__Concept
% 210.47/210.69  |- skos__prefLabel mesh__D002210 Caprylates
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D002210 2005
% 210.47/210.69  |- skos__altLabel mesh__D002210 Octanoates
% 210.47/210.69  |- mesh__recordOriginator mesh__D002210 NLM
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D002210 2004
% 210.47/210.69  |- mesh__recordAuthorizer mesh__D002210 sjn
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D002210 2006
% 210.47/210.69  |- mesh__recordMaintainer mesh__D002210 ssb
% 210.47/210.69  |- mesh__dateRevised mesh__D002210 2003-07-09
% 210.47/210.69  |- skos__broader mesh__D002210smesh__D000144
% 210.47/210.69  |- skos__broader mesh__D002210smesh__D005227
% 210.47/210.69  |- mesh__dateCreated mesh__D002210 1999-01-01
% 210.47/210.69  |- skos__historyNote mesh__D015936 Complement 5 %28%1975-1989%29%
% 210.47/210.69  |- skos__broader mesh__D015936smesh__D000706
% 210.47/210.69  |- skos__historyNote mesh__D015936 Anaphylatoxins %28%1977-1989%29%
% 210.47/210.69  |- mesh__recordOriginator mesh__D015936 AGS
% 210.47/210.69  |- skos__prefLabel mesh__D015936 Complement C5a
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D015936 2006
% 210.47/210.69  |- mesh__recordMaintainer mesh__D015936 ssb
% 210.47/210.69  |- mesh__recordAuthorizer mesh__D015936 sjn
% 210.47/210.69  |- skos__altLabel mesh__D015936 Complement Component 5a
% 210.47/210.69  |- skos__hiddenLabel mesh__D015936 Complement, C5a
% 210.47/210.69  |- mesh__historyNote mesh__D015936 2006 %28%1990%29%   
% 210.47/210.69  |- skos__scopeNote mesh__D015936
% 210.47/210.69       The minor fragment formed when C5 convertase cleaves C5 into C5a and COMPLEMENT C5B. C5a is a 74-amino-acid glycopeptide with a carboxy-terminal ARGININE that is crucial for its spasmogenic activity. Of all the complement-derived anaphylatoxins, C5a is the most potent in mediating immediate hypersensitivity %28%HYPERSENSITIVITY, IMMEDIATE%29%, smooth MUSCLE CONTRACTION; HISTAMINE RELEASE; and migration of LEUKOCYTES to site of INFLAMMATION.%A%    
% 210.47/210.69  |- skos__hiddenLabel mesh__D015936 5a, Complement Component
% 210.47/210.69  |- skos__hiddenLabel mesh__D015936 C5a, Complement
% 210.47/210.69  |- skos__broader mesh__D015936smesh__D003182
% 210.47/210.69  |- skos__altLabel mesh__D015936 C5a Complement
% 210.47/210.69  |- rdf__type mesh__D015936sskos__Concept
% 210.47/210.69  |- mesh__dateEstablished mesh__D015936 1990-01-01
% 210.47/210.69  |- mesh__publicMeSHNote mesh__D015936 2006; see COMPLEMENT 5A 1990-2005   
% 210.47/210.69  |- skos__hiddenLabel mesh__D015936 Component 5a, Complement
% 210.47/210.69  |- mesh__dateCreated mesh__D015936 1989-07-14
% 210.47/210.69  |- skos__historyNote mesh__D015936 Complement %28%1972-1975%29%
% 210.47/210.69  |- mesh__dateRevised mesh__D015936 2005-06-30
% 210.47/210.69  |- skos__altLabel mesh__D015936 Complement 5a
% 210.47/210.69  |- skos__historyNote mesh__D015138 RNA %28%1966-1988%29%
% 210.47/210.69  |- rdf__type mesh__D015138sskos__Concept
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D015138 2001
% 210.47/210.69  |- skos__altLabel mesh__D015138 Chromosomal RNA
% 210.47/210.69  |- mesh__dateCreated mesh__D015138 1988-03-18
% 210.47/210.69  |- skos__scopeNote mesh__D015138
% 210.47/210.69       RNA molecules found in the nucleus either associated with chromosomes or in the nucleoplasm.%A%    
% 210.47/210.69  |- skos__historyNote mesh__D015138 Chromosomes %28%1966-1988%29%
% 210.47/210.69  |- mesh__dateRevised mesh__D015138 1995-06-08
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D015138 2000
% 210.47/210.69  |- mesh__historyNote mesh__D015138 89   
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D015138 2004
% 210.47/210.69  |- mesh__recordMaintainer mesh__D015138 AGS
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D015138 1997
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D015138 2006
% 210.47/210.69  |- mesh__dateEstablished mesh__D015138 1989-01-01
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D015138 1999
% 210.47/210.69  |- skos__annotation mesh__D015138 IM; /drug eff /ultrastruct permitted   
% 210.47/210.69  |- skos__broader mesh__D015138smesh__D012313
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D015138 2003
% 210.47/210.69  |- mesh__recordAuthorizer mesh__D015138 PLS
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D015138 1996
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D015138 2005
% 210.47/210.69  |- skos__prefLabel mesh__D015138 RNA, Nuclear
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D015138 1998
% 210.47/210.69  |- mesh__recordOriginator mesh__D015138 SCD
% 210.47/210.69  |- skos__historyNote mesh__D015138 Cell Nucleus %28%1966-1988%29%
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D015138 2002
% 210.47/210.69  |- skos__altLabel mesh__D015138 Nuclear RNA
% 210.47/210.69  |- mesh__publicMeSHNote mesh__D015138 89   
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001916 2006
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001916 1997
% 210.47/210.69  |- skos__hiddenLabel mesh__D001916 Artery, Brachial
% 210.47/210.69  |- skos__hiddenLabel mesh__D001916 Arteries, Brachial
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001916 1999
% 210.47/210.69  |- skos__prefLabel mesh__D001916 Brachial Artery
% 210.47/210.69  |- mesh__recordMaintainer mesh__D001916 TAP
% 210.47/210.69  |- mesh__dateCreated mesh__D001916 1999-01-01
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001916 2000
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001916 1994
% 210.47/210.69  |- mesh__recordAuthorizer mesh__D001916 PLS
% 210.47/210.69  |- mesh__dateRevised mesh__D001916 1992-03-25
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001916 2001
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001916 1993
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001916 1995
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001916 2003
% 210.47/210.69  |- rdf__type mesh__D001916sskos__Concept
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001916 2002
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001916 2005
% 210.47/210.69  |- skos__broader mesh__D001916smesh__D001158
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001916 1996
% 210.47/210.69  |- skos__scopeNote mesh__D001916
% 210.47/210.69       The continuation of the axillary artery; it branches into the radial and ulnar arteries.%A%    
% 210.47/210.69  |- skos__hiddenLabel mesh__D001916 Brachial Arteries
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001916 2004
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001916 1998
% 210.47/210.69  |- mesh__recordOriginator mesh__D001916 NLM
% 210.47/210.69  |- mesh__dateCreated mesh__D001118 1999-01-01
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001118 2005
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001118 1993
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001118 1999
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001118 1991
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001118 1994
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001118 2006
% 210.47/210.69  |- rdf__type mesh__D001118sskos__Concept
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001118 1989
% 210.47/210.69  |- mesh__recordMaintainer mesh__D001118 PLS
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001118 1995
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001118 1996
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001118 2000
% 210.47/210.69  |- mesh__dateRevised mesh__D001118 1991-11-02
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001118 2003
% 210.47/210.69  |- mesh__recordOriginator mesh__D001118 NLM
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001118 1997
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001118 2001
% 210.47/210.69  |- skos__broader mesh__D001118smesh__D013020
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001118 2004
% 210.47/210.69  |- skos__prefLabel mesh__D001118 Argentina
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001118 1992
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001118 1998
% 210.47/210.69  |- mesh__recordAuthorizer mesh__D001118 PLS
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001118 2002
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001118 1990
% 210.47/210.69  |- rdf__type mesh__D006601sskos__Concept
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D006601 2005
% 210.47/210.69  |- mesh__dateCreated mesh__D006601 1999-01-01
% 210.47/210.69  |- mesh__dateRevised mesh__D006601 2004-07-07
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D006601 2006
% 210.47/210.69  |- mesh__recordOriginator mesh__D006601 NLM
% 210.47/210.69  |- mesh__recordMaintainer mesh__D006601 ssb
% 210.47/210.69  |- skos__annotation mesh__D006601
% 210.47/210.69       monosaccharides; GEN only; prefer specifics   
% 210.47/210.69  |- mesh__recordAuthorizer mesh__D006601 sjn
% 210.47/210.69  |- skos__prefLabel mesh__D006601 Hexoses
% 210.47/210.69  |- skos__broader mesh__D006601smesh__D009005
% 210.47/210.69  |- mesh__recordOriginator mesh__D019529 JLS
% 210.47/210.69  |- mesh__recordAuthorizer mesh__D019529 sjn
% 210.47/210.69  |- skos__scopeNote mesh__D019529
% 210.47/210.69       The sexual functions, activities, attitudes, and orientations of an individual. Sexuality, male or female, becomes evident at PUBERTY under the influence of gonadal steroids %28%TESTOSTERONE or ESTRADIOL%29%, and social effects.%A%    
% 210.47/210.69  |- skos__related mesh__D019529smesh__D011606
% 210.47/210.69  |- skos__broader mesh__D019529smesh__D012725
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D019529 2005
% 210.47/210.69  |- skos__annotation mesh__D019529 human only   
% 210.47/210.69  |- skos__historyNote mesh__D019529 Sex Behavior %28%1974-1996%29%
% 210.47/210.69  |- mesh__recordMaintainer mesh__D019529 lkt
% 210.47/210.69  |- mesh__dateCreated mesh__D019529 1996-06-13
% 210.47/210.69  |- mesh__historyNote mesh__D019529 1997; use SEX BEHAVIOR 1978-1996   
% 210.47/210.69  |- mesh__publicMeSHNote mesh__D019529 1997; see SEX BEHAVIOR 1978-1996   
% 210.47/210.69  |- rdf__type mesh__D019529sskos__Concept
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D019529 2006
% 210.47/210.69  |- mesh__dateRevised mesh__D019529 2004-07-07
% 210.47/210.69  |- mesh__dateEstablished mesh__D019529 1997-01-01
% 210.47/210.69  |- skos__prefLabel mesh__D019529 Sexuality
% 210.47/210.69  |- skos__prefLabel mesh__D011546 Pseudohypoaldosteronism
% 210.47/210.69  |- skos__broader mesh__D011546smesh__D015499
% 210.47/210.69  |- skos__historyNote mesh__D011546 Hyperaldosteronism %28%1975-1980%29%
% 210.47/210.69  |- mesh__recordAuthorizer mesh__D011546 sjn
% 210.47/210.69  |- skos__scopeNote mesh__D011546
% 210.47/210.69       A heterogeneous group of disorders with common symptoms of apparent HYPOALDOSTERONISM despite the elevated levels of ALDOSTERONE and RENIN. Other clinical symptoms include HYPERKALEMIA with %28%Type I%29% or without %28%Type II%29% sodium wasting. Pseudohypoaldosteronism can be the result of defective MINERALOCORTICOID RECEPTORS or defects in the epithelial SODIUM CHANNEL. It can also be acquired after KIDNEY TRANSPLANTATION.%A%    
% 210.47/210.69  |- skos__hiddenLabel mesh__D011546 Pseudohypoaldosteronisms, Type II
% 210.47/210.69  |- skos__hiddenLabel mesh__D011546 Type II Pseudohypoaldosteronisms
% 210.47/210.69  |- mesh__dateRevised mesh__D011546 2004-07-07
% 210.47/210.69  |- skos__historyNote mesh__D011546
% 210.47/210.69       Renal Tubular Transport, Inborn Errors %28%1971-1987%29%
% 210.47/210.69  |- mesh__historyNote mesh__D011546
% 210.47/210.69       91%28%88%29%; was see under RENAL TUBULAR TRANSPORT, INBORN ERRORS 1988-90%A%  
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D011546 2005
% 210.47/210.69  |- skos__historyNote mesh__D011546 Aldosterone %28%1971-1987%29%
% 210.47/210.69  |- skos__hiddenLabel mesh__D011546 Type II Pseudohypoaldosteronism
% 210.47/210.69  |- mesh__dateCreated mesh__D011546 1987-03-13
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D011546 2006
% 210.47/210.69  |- skos__hiddenLabel mesh__D011546 Pseudohypoaldosteronisms
% 210.47/210.69  |- mesh__recordOriginator mesh__D011546 SD
% 210.47/210.69  |- rdf__type mesh__D011546sskos__Concept
% 210.47/210.69  |- mesh__dateEstablished mesh__D011546 1991-01-01
% 210.47/210.69  |- mesh__recordMaintainer mesh__D011546 lkt
% 210.47/210.69  |- mesh__publicMeSHNote mesh__D011546
% 210.47/210.69       91; was see under RENAL TUBULAR TRANSPORT, INBORN ERRORS 1988-90%A%  
% 210.47/210.69  |- skos__hiddenLabel mesh__D005509 Food Vending Machine
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005509 2005
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005509 1998
% 210.47/210.69  |- skos__hiddenLabel mesh__D005509 Automatic Food Dispenser
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005509 2002
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005509 2006
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005509 1999
% 210.47/210.69  |- skos__hiddenLabel mesh__D005509 Automatic Food Dispensers
% 210.47/210.69  |- skos__hiddenLabel mesh__D005509 Food Dispenser, Automatic
% 210.47/210.69  |- mesh__dateEstablished mesh__D005509 1991-01-01
% 210.47/210.69  |- mesh__dateRevised mesh__D005509 1997-06-20
% 210.47/210.69  |- skos__prefLabel mesh__D005509 Food Dispensers, Automatic
% 210.47/210.69  |- skos__hiddenLabel mesh__D005509 Dispenser, Automatic Food
% 210.47/210.69  |- mesh__historyNote mesh__D005509
% 210.47/210.69       91%28%Aug 77%29%; was see under FOOD SERVICES 1977-90   
% 210.47/210.69  |- skos__hiddenLabel mesh__D005509 Dispensers, Automatic Food
% 210.47/210.69  |- skos__hiddenLabel mesh__D005509 Vending Machine, Food
% 210.47/210.69  |- skos__hiddenLabel mesh__D005509 Machine, Food Vending
% 210.47/210.69  |- mesh__dateCreated mesh__D005509 1977-05-05
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005509 2003
% 210.47/210.69  |- skos__hiddenLabel mesh__D005509 Food Vending Machines
% 210.47/210.69  |- skos__scopeNote mesh__D005509 Mechanical food dispensing machines.     
% 210.47/210.69  |- rdf__type mesh__D005509sskos__Concept
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005509 2000
% 210.47/210.69  |- mesh__recordAuthorizer mesh__D005509 SJN
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005509 2004
% 210.47/210.69  |- skos__broader mesh__D005509smesh__D005511
% 210.47/210.69  |- mesh__recordOriginator mesh__D005509 EC
% 210.47/210.69  |- mesh__publicMeSHNote mesh__D005509
% 210.47/210.69       91; was see under FOOD SERVICES 1977-90   
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D005509 2001
% 210.47/210.69  |- skos__hiddenLabel mesh__D005509 Machines, Food Vending
% 210.47/210.69  |- mesh__recordMaintainer mesh__D005509 JLS
% 210.47/210.69  |- mesh__onlineNote mesh__D016231
% 210.47/210.69       use FLUOROIMMUNOASSAY to search POLARIZATION FLUOROIMMUNOASSAY 1989-91%A%  
% 210.47/210.69  |- skos__hiddenLabel mesh__D016231 Polarization Immunoassay, Fluorescence
% 210.47/210.69  |- skos__historyNote mesh__D016231
% 210.47/210.69       Fluorescent Antibody Technique %28%1978-1988%29%
% 210.47/210.69  |- mesh__recordOriginator mesh__D016231 AGS
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D016231 2006
% 210.47/210.69  |- mesh__publicMeSHNote mesh__D016231
% 210.47/210.69       91; POLARIZATION FLUOROIMMUNOASSAY was see FLUOROIMMUNOASSAY 1989-91%A%  
% 210.47/210.69  |- skos__hiddenLabel mesh__D016231 Immunoassays, Fluorescence Polarization
% 210.47/210.69  |- skos__hiddenLabel mesh__D016231 Fluorescence Polarization Immunoassays
% 210.47/210.69  |- skos__hiddenLabel mesh__D016231 Polarization Fluoroimmunoassays
% 210.47/210.69  |- skos__altLabel mesh__D016231 Polarization Fluoroimmunoassay
% 210.47/210.69  |- mesh__dateRevised mesh__D016231 2004-07-07
% 210.47/210.69  |- mesh__recordAuthorizer mesh__D016231 sjn
% 210.47/210.69  |- skos__annotation mesh__D016231
% 210.47/210.69       NIM; application of fluorescence polarization to hapten-antibody reaction: do not confuse with FLUORESCENCE POLARIZATION, determ of polarization of fluorescent light; DF: FPIA%A%  
% 210.47/210.69  |- skos__hiddenLabel mesh__D016231 Polarization Immunoassays, Fluorescence
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D016231 2005
% 210.47/210.69  |- rdf__type mesh__D016231sskos__Concept
% 210.47/210.69  |- skos__broader mesh__D016231smesh__D015200
% 210.47/210.69  |- skos__scopeNote mesh__D016231
% 210.47/210.69       Fluoroimmunoassay where detection of the hapten-antibody reaction is based on measurement of the increased polarization of fluorescence-labeled hapten when it is combined with antibody. The assay is very useful for the measurement of small haptenic antigens such as drugs at low concentrations.%A%    
% 210.47/210.69  |- mesh__dateCreated mesh__D016231 1990-05-07
% 210.47/210.69  |- skos__hiddenLabel mesh__D016231 Fluoroimmunoassays, Polarization
% 210.47/210.69  |- skos__hiddenLabel mesh__D016231 Fluoroimmunoassay, Polarization
% 210.47/210.69  |- skos__historyNote mesh__D016231 Fluoroimmunoassay %28%1989-1990%29%
% 210.47/210.69  |- skos__altLabel mesh__D016231 Immunoassay, Fluorescence Polarization
% 210.47/210.69  |- mesh__historyNote mesh__D016231
% 210.47/210.69       91; POLARIZATION FLUOROIMMUNOASSAY was see FLUOROIMMUNOASSAY 1989-91%A%  
% 210.47/210.69  |- skos__historyNote mesh__D016231
% 210.47/210.69       Fluorescence Polarization %28%1978-1990%29%
% 210.47/210.69  |- mesh__dateEstablished mesh__D016231 1991-01-01
% 210.47/210.69  |- skos__prefLabel mesh__D016231 Fluorescence Polarization Immunoassay
% 210.47/210.69  |- skos__broader mesh__D016231smesh__D005454
% 210.47/210.69  |- mesh__recordMaintainer mesh__D016231 ssb
% 210.47/210.69  |- mesh__dateRevised mesh__D002211 2005-06-30
% 210.47/210.69  |- skos__altLabel mesh__D002211 Centrum Brand of Capsaicin
% 210.47/210.69  |- skos__hiddenLabel mesh__D002211 Capsaicin Elan Brand
% 210.47/210.69  |- skos__hiddenLabel mesh__D002211 Capsaicin Vinas Brand
% 210.47/210.69  |- skos__historyNote mesh__D002211 Amides %28%1966-1974%29%
% 210.47/210.69  |- skos__altLabel mesh__D002211 Carter Horner Brand of Capsaicin
% 210.47/210.69  |- skos__hiddenLabel mesh__D002211 Farmaya, Capsicum
% 210.47/210.69  |- skos__broader mesh__D002211smesh__D012991
% 210.47/210.69  |- skos__altLabel mesh__D002211 Link Brand of Capsaicin
% 210.47/210.69  |- skos__altLabel mesh__D002211 Zacin
% 210.47/210.69  |- skos__altLabel mesh__D002211 Thompson Brand of Capsaicin
% 210.47/210.69  |- mesh__historyNote mesh__D002211 84%28%75%29%   
% 210.47/210.69  |- skos__hiddenLabel mesh__D002211 Capsaicin Flemming Brand
% 210.47/210.69  |- skos__hiddenLabel mesh__D002211 Capsaicin Thompson Brand
% 210.47/210.69  |- mesh__dateEstablished mesh__D002211 1984-01-01
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D002211 2006
% 210.47/210.69  |- skos__prefLabel mesh__D002211 Capsaicin
% 210.47/210.69  |- skos__hiddenLabel mesh__D002211 Antiphlogistine Rub A535 Capsaicin
% 210.47/210.69  |- skos__altLabel mesh__D002211 Medicis Brand of Capsaicin
% 210.47/210.69  |- skos__hiddenLabel mesh__D002211 Capsaicin Centrum Brand
% 210.47/210.69  |- skos__historyNote mesh__D002211
% 210.47/210.69       Fatty Acids, Unsaturated %28%1973-1974%29%
% 210.47/210.69  |- skos__altLabel mesh__D002211 Flemming Brand of Capsaicin
% 210.47/210.69  |- skos__historyNote mesh__D002211 Capsicum %28%1966-1974%29%
% 210.47/210.69  |- mesh__dateCreated mesh__D002211 1974-11-27
% 210.47/210.69  |- skos__altLabel mesh__D002211 Capsaicine
% 210.47/210.69  |- skos__hiddenLabel mesh__D002211 Capsaicin Link Brand
% 210.47/210.69  |- skos__hiddenLabel mesh__D002211 Capsaicin Alacan Brand
% 210.47/210.69  |- skos__hiddenLabel mesh__D002211 Capsaicin Medicis Brand
% 210.47/210.69  |- skos__scopeNote mesh__D002211
% 210.47/210.69       Cytotoxic alkaloid from various species of Capsicum %28%pepper, paprika%29%, of the Solanaceae.%A%    
% 210.47/210.69  |- skos__altLabel mesh__D002211 Smaller Brand of Capsaicin
% 210.47/210.69  |- skos__altLabel mesh__D002211 Vinas Brand of Capsaicin
% 210.47/210.69  |- mesh__publicMeSHNote mesh__D002211
% 210.47/210.69       84; see FATTY ACIDS, UNSATURATED 1975-83   
% 210.47/210.69  |- skos__altLabel mesh__D002211 Elan Brand of Capsaicin
% 210.47/210.69  |- skos__altLabel mesh__D002211 Alacan Brand of Capsaicin
% 210.47/210.69  |- mesh__recordMaintainer mesh__D002211 lkw
% 210.47/210.69  |- skos__broader mesh__D002211smesh__D005229
% 210.47/210.69  |- skos__altLabel mesh__D002211 8-Methyl-N-Vanillyl-6-Nonenamide
% 210.47/210.69  |- skos__historyNote mesh__D002211 Catechols %28%1966-1974%29%
% 210.47/210.69  |- skos__hiddenLabel mesh__D002211 8 Methyl N Vanillyl 6 Nonenamide
% 210.47/210.69  |- skos__hiddenLabel mesh__D002211 Capsaicin Smaller Brand
% 210.47/210.69  |- skos__historyNote mesh__D002211 Alkaloids %28%1966-1974%29%
% 210.47/210.69  |- mesh__recordAuthorizer mesh__D002211 sjn
% 210.47/210.69  |- mesh__recordOriginator mesh__D002211 NLM
% 210.47/210.69  |- rdf__type mesh__D002211sskos__Concept
% 210.47/210.69  |- skos__hiddenLabel mesh__D002211 Antiphlogistine Rub A 535 Capsaicin
% 210.47/210.69  |- skos__hiddenLabel mesh__D015937 des-Arginine C5 a
% 210.47/210.69  |- skos__altLabel mesh__D015937 C5 a, des-Arg
% 210.47/210.69  |- skos__altLabel mesh__D015937 Complement 5a, des-Arginine
% 210.47/210.69  |- skos__hiddenLabel mesh__D015937 C5a, des Arg
% 210.47/210.69  |- skos__hiddenLabel mesh__D015937 Complement C5a, des Arginine
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D015937 2006
% 210.47/210.69  |- skos__hiddenLabel mesh__D015937 C5a des Arginine
% 210.47/210.69  |- mesh__dateEstablished mesh__D015937 1990-01-01
% 210.47/210.69  |- skos__broader mesh__D015937smesh__D015936
% 210.47/210.69  |- mesh__publicMeSHNote mesh__D015937
% 210.47/210.69       2006; see COMPLEMENT 5A, DES-ARGININE 1990-2005   
% 210.47/210.69  |- rdf__type mesh__D015937sskos__Concept
% 210.47/210.69  |- skos__altLabel mesh__D015937 C5a des-Arginine
% 210.47/210.69  |- skos__hiddenLabel mesh__D015937 des-Arginine Complement 5a
% 210.47/210.69  |- mesh__recordMaintainer mesh__D015937 ssb
% 210.47/210.69  |- skos__historyNote mesh__D015937 Complement 5 %28%1979-1989%29%
% 210.47/210.69  |- skos__hiddenLabel mesh__D015937 C5a, des-Arginine Complement
% 210.47/210.69  |- skos__hiddenLabel mesh__D015937 C5a, des Arginine
% 210.47/210.69  |- skos__hiddenLabel mesh__D015937 de-Arginine Complement 5a
% 210.47/210.69  |- skos__hiddenLabel mesh__D015937 des-Arginine, C5a
% 210.47/210.69  |- skos__hiddenLabel mesh__D015937 C5 a, des Arg
% 210.47/210.69  |- skos__hiddenLabel mesh__D015937 des-Arg C5 a
% 210.47/210.69  |- skos__altLabel mesh__D015937 C5a, des-Arg
% 210.47/210.69  |- skos__altLabel mesh__D015937 Complement 5a, de-Arginine
% 210.47/210.69  |- skos__prefLabel mesh__D015937 Complement C5a, des-Arginine
% 210.47/210.69  |- mesh__recordAuthorizer mesh__D015937 sjn
% 210.47/210.69  |- skos__altLabel mesh__D015937 C5a des-Arg
% 210.47/210.69  |- skos__hiddenLabel mesh__D015937 des-Arginine Complement C5a
% 210.47/210.69  |- skos__altLabel mesh__D015937 C5a, des-Arginine
% 210.47/210.69  |- mesh__dateRevised mesh__D015937 2005-06-30
% 210.47/210.69  |- skos__hiddenLabel mesh__D015937 des-Arg C5a
% 210.47/210.69  |- skos__hiddenLabel mesh__D015937 C5 a, des Arginine
% 210.47/210.69  |- mesh__historyNote mesh__D015937 2006 %28%1990%29%   
% 210.47/210.69  |- mesh__dateCreated mesh__D015937 1989-07-14
% 210.47/210.69  |- skos__altLabel mesh__D015937 C5 a, des-Arginine
% 210.47/210.69  |- skos__hiddenLabel mesh__D015937 Complement 5a, de Arginine
% 210.47/210.69  |- skos__hiddenLabel mesh__D015937 des-Arg, C5a
% 210.47/210.69  |- skos__hiddenLabel mesh__D015937 Complement 5a, des Arginine
% 210.47/210.69  |- skos__hiddenLabel mesh__D015937 des-Arginine C5a
% 210.47/210.69  |- mesh__recordOriginator mesh__D015937 AGS
% 210.47/210.69  |- skos__scopeNote mesh__D015937
% 210.47/210.69       A derivative of complement C5a, generated when the carboxy-terminal ARGININE is removed by CARBOXYPEPTIDASE B present in normal human serum. C5a des-Arg shows complete loss of spasmogenic activity though it retains some chemotactic ability %28%CHEMOATTRACTANTS%29%.%A%    
% 210.47/210.69  |- skos__historyNote mesh__D015139
% 210.47/210.69       Nucleic Acid Hybridization %28%1980-1988%29%
% 210.47/210.69  |- skos__altLabel mesh__D015139 Southern Blotting
% 210.47/210.69  |- skos__altLabel mesh__D015139 Southern Blot
% 210.47/210.69  |- skos__annotation mesh__D015139
% 210.47/210.69       %22%Southern%22% %28%developed by E.M. Southern%29% is capitalized in titles %26% translations; DF: SOUTHERN BLOT%A%  
% 210.47/210.69  |- skos__historyNote mesh__D015139
% 210.47/210.69       Electrophoresis, Agar Gel %28%1979-1988%29%
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D015139 2004
% 210.47/210.69  |- skos__prefLabel mesh__D015139 Blotting, Southern
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D015139 2006
% 210.47/210.69  |- mesh__dateEstablished mesh__D015139 1989-01-01
% 210.47/210.69  |- mesh__dateCreated mesh__D015139 1988-03-18
% 210.47/210.69  |- skos__historyNote mesh__D015139 DNA or specific %28%1975-1988%29%
% 210.47/210.69  |- skos__scopeNote mesh__D015139
% 210.47/210.69       A method %28%first developed by E.M. Southern%29% for detection of DNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES.%A%    
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D015139 2003
% 210.47/210.69  |- mesh__dateRevised mesh__D015139 2002-07-02
% 210.47/210.69  |- mesh__historyNote mesh__D015139 89   
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D015139 2005
% 210.47/210.69  |- mesh__recordOriginator mesh__D015139 SCD
% 210.47/210.69  |- skos__broader mesh__D015139smesh__D015336
% 210.47/210.69  |- mesh__recordMaintainer mesh__D015139 lkt
% 210.47/210.69  |- mesh__publicMeSHNote mesh__D015139 89   
% 210.47/210.69  |- rdf__type mesh__D015139sskos__Concept
% 210.47/210.69  |- skos__historyNote mesh__D015139
% 210.47/210.69       Electrophoresis, Polyacrylamide Gel %28%1980-1988%29%
% 210.47/210.69  |- mesh__recordAuthorizer mesh__D015139 sjn
% 210.47/210.69  |- skos__broader mesh__D015139smesh__D009710
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001917 2002
% 210.47/210.69  |- mesh__dateCreated mesh__D001917 1999-01-01
% 210.47/210.69  |- mesh__recordAuthorizer mesh__D001917 sjn
% 210.47/210.69  |- mesh__recordOriginator mesh__D001917 NLM
% 210.47/210.69  |- mesh__dateRevised mesh__D001917 2001-07-25
% 210.47/210.69  |- skos__hiddenLabel mesh__D001917 Plexus, Brachial
% 210.47/210.69  |- skos__related mesh__D001917smesh__D020516
% 210.47/210.69  |- skos__prefLabel mesh__D001917 Brachial Plexus
% 210.47/210.69  |- mesh__activeMeSHYear mesh__D001917 2003
% 210.47/210.70  |- skos__scopeNote mesh__D001917
% 210.47/210.70       The large network of nerve fibers which distributes the innervation of the upper extremity. The brachial plexus extends from the neck into the axilla. In humans, the nerves of the plexus usually originate from the lower cervical and the first thoracic spinal cord segments %28%C5-C8 and T1%29%, but variations are not uncommon.%A%    
% 210.47/210.70  |- rdf__type mesh__D001917sskos__Concept
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D001917 2005
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D001917 2004
% 210.47/210.70  |- skos__broader mesh__D001917smesh__D013127
% 210.47/210.70  |- mesh__recordMaintainer mesh__D001917 ags
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D001917 2006
% 210.47/210.70  |- skos__related mesh__D001917smesh__D013901
% 210.47/210.70  |- skos__annotation mesh__D001917
% 210.47/210.70       dis = BRACHIAL PLEXUS NEUROPATHIES; inflammation = BRACHIAL PLEXUS NEURITIS%A%  
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D001119 2006
% 210.47/210.70  |- skos__scopeNote mesh__D001119
% 210.47/210.70       A ureahydrolase that catalyzes the hydrolysis of arginine or canavanine to yield L-ORNITHINE and urea. Deficiency of this enzyme causes HYPERARGININEMIA. EC 3.5.3.1.%A%    
% 210.47/210.70  |- rdf__type mesh__D001119sskos__Concept
% 210.47/210.70  |- mesh__recordMaintainer mesh__D001119 ssb
% 210.47/210.70  |- skos__hiddenLabel mesh__D001119 Proliferation Inhibitor, Hepatic
% 210.47/210.70  |- skos__annotation mesh__D001119 /defic: consider also HYPERARGININEMIA   
% 210.47/210.70  |- mesh__dateRevised mesh__D001119 2003-07-09
% 210.47/210.70  |- skos__broader mesh__D001119smesh__D014512
% 210.47/210.70  |- skos__hiddenLabel mesh__D001119 Immunoregulatory Protein, Liver
% 210.47/210.70  |- skos__hiddenLabel mesh__D001119 Protein, Liver-Derived Inhibitory
% 210.47/210.70  |- skos__hiddenLabel mesh__D001119
% 210.47/210.70       Liver Derived Lymphocyte Proliferation Inhibiting Protein
% 210.47/210.70  |- skos__hiddenLabel mesh__D001119 Inhibitory Protein, Liver-Derived
% 210.47/210.70  |- skos__altLabel mesh__D001119 Hepatic Proliferation Inhibitor
% 210.47/210.70  |- skos__altLabel mesh__D001119 Liver-Derived Inhibitory Protein
% 210.47/210.70  |- skos__prefLabel mesh__D001119 Arginase
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D001119 2004
% 210.47/210.70  |- mesh__dateCreated mesh__D001119 1999-01-01
% 210.47/210.70  |- skos__hiddenLabel mesh__D001119 Liver Derived Inhibitory Protein
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D001119 2005
% 210.47/210.70  |- mesh__recordOriginator mesh__D001119 NLM
% 210.47/210.70  |- skos__related mesh__D001119smesh__D020162
% 210.47/210.70  |- skos__hiddenLabel mesh__D001119 Inhibitor, Hepatic Proliferation
% 210.47/210.70  |- skos__hiddenLabel mesh__D001119 Protein, Liver Immunoregulatory
% 210.47/210.70  |- skos__altLabel mesh__D001119 Liver Immunoregulatory Protein
% 210.47/210.70  |- mesh__recordAuthorizer mesh__D001119 sjn
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D006602 2006
% 210.47/210.70  |- mesh__recordAuthorizer mesh__D006602 sjn
% 210.47/210.70  |- mesh__dateRevised mesh__D006602 2003-07-09
% 210.47/210.70  |- mesh__historyNote mesh__D006602 72   
% 210.47/210.70  |- skos__broader mesh__D006602smesh__D016695
% 210.47/210.70  |- mesh__dateEstablished mesh__D006602 1972-01-01
% 210.47/210.70  |- skos__historyNote mesh__D006602 Transferases %28%1966-1971%29%
% 210.47/210.70  |- mesh__publicMeSHNote mesh__D006602 72   
% 210.47/210.70  |- rdf__type mesh__D006602sskos__Concept
% 210.47/210.70  |- skos__scopeNote mesh__D006602
% 210.47/210.70       Enzymes that catalyze the transfer of hexose groups. EC 2.4.1.-.%A%    
% 210.47/210.70  |- skos__prefLabel mesh__D006602 Hexosyltransferases
% 210.47/210.70  |- mesh__recordOriginator mesh__D006602 NLM
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D006602 2005
% 210.47/210.70  |- mesh__recordMaintainer mesh__D006602 ssb
% 210.47/210.70  |- mesh__dateCreated mesh__D006602 1999-01-01
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D006602 2004
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D011547 2004
% 210.47/210.70  |- rdf__type mesh__D011547sskos__Concept
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D011547 2005
% 210.47/210.70  |- skos__annotation mesh__D011547
% 210.47/210.70       a metab bone dis; do not confuse with PSEUDOPSEUDOHYPOPARATHYROIDISM%A%  
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D011547 2003
% 210.47/210.70  |- skos__scopeNote mesh__D011547
% 210.47/210.70       A hereditary condition clinically resembling HYPOPARATHYROIDISM, but caused by failure of response to rather than deficiency of parathyroid hormones. It is characterized by hypocalcemia and hyperphosphatemia, and is commonly associated with short stature, obesity, short metacarpals, and ectopic calcification. %28%Dorland, 27th ed%29%%A%    
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D011547 2002
% 210.47/210.70  |- skos__broader mesh__D011547smesh__D001851
% 210.47/210.70  |- skos__hiddenLabel mesh__D011547 Pseudohypoparathyroidisms
% 210.47/210.70  |- skos__broader mesh__D011547smesh__D008664
% 210.47/210.70  |- skos__broader mesh__D011547smesh__D002128
% 210.47/210.70  |- mesh__recordOriginator mesh__D011547 NLM
% 210.47/210.70  |- skos__prefLabel mesh__D011547 Pseudohypoparathyroidism
% 210.47/210.70  |- mesh__dateCreated mesh__D011547 1999-01-01
% 210.47/210.70  |- mesh__recordAuthorizer mesh__D011547 sjn
% 210.47/210.70  |- mesh__recordMaintainer mesh__D011547 nns
% 210.47/210.70  |- mesh__publicMeSHNote mesh__D011547 65   
% 210.47/210.70  |- mesh__historyNote mesh__D011547 65%28%63%29%   
% 210.47/210.70  |- mesh__dateEstablished mesh__D011547 1965-01-01
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D011547 2006
% 210.47/210.70  |- mesh__dateRevised mesh__D011547 2001-07-25
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D030701 2004
% 210.47/210.70  |- skos__broader mesh__D030701smesh__D019684
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D030701 2002
% 210.47/210.70  |- skos__prefLabel mesh__D030701 Nyssaceae
% 210.47/210.70  |- mesh__dateEstablished mesh__D030701 2002-01-01
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D030701 2005
% 210.47/210.70  |- mesh__historyNote mesh__D030701 2002   
% 210.47/210.70  |- mesh__publicMeSHNote mesh__D030701 2002   
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D030701 2006
% 210.47/210.70  |- rdf__type mesh__D030701sskos__Concept
% 210.47/210.70  |- skos__annotation mesh__D030701
% 210.47/210.70       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D030701 2003
% 210.47/210.70  |- skos__scopeNote mesh__D030701
% 210.47/210.70       A plant family of the order Cornales, subclass Rosidae, class Magnoliopsida.  Some botanical classifications do not recognize this family and place the members in CORNACEAE.%A%    
% 210.47/210.70  |- mesh__dateCreated mesh__D030701 2001-07-25
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D016232 2005
% 210.47/210.70  |- skos__scopeNote mesh__D016232
% 210.47/210.70       21-Amino-acid peptides produced by vascular endothelial cells and functioning as potent vasoconstrictors. The endothelin family consists of three members, ENDOTHELIN-1; ENDOTHELIN-2; and ENDOTHELIN-3. All three peptides contain 21 amino acids, but vary in amino acid composition. The three peptides produce vasoconstrictor and pressor responses in various parts of the body. However, the quantitative profiles of the pharmacological activities are considerably different among the three isopeptides.%A%    
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D016232 2004
% 210.47/210.70  |- skos__altLabel mesh__D016232 Endothelium-Derived Vasoconstrictor Factors
% 210.47/210.70  |- mesh__recordMaintainer mesh__D016232 jmp
% 210.47/210.70  |- mesh__historyNote mesh__D016232 91   
% 210.47/210.70  |- rdf__type mesh__D016232sskos__Concept
% 210.47/210.70  |- skos__historyNote mesh__D016232 Peptides %28%1966-1990%29%
% 210.47/210.70  |- skos__altLabel mesh__D016232 Endothelin
% 210.47/210.70  |- mesh__recordOriginator mesh__D016232 RLS
% 210.47/210.70  |- mesh__publicMeSHNote mesh__D016232 91   
% 210.47/210.70  |- mesh__recordAuthorizer mesh__D016232 sjn
% 210.47/210.70  |- mesh__dateCreated mesh__D016232 1990-06-28
% 210.47/210.70  |- skos__annotation mesh__D016232
% 210.47/210.70       GEN or unspecified; prefer specifics; /drug eff permitted%A%  
% 210.47/210.70  |- skos__hiddenLabel mesh__D016232
% 210.47/210.70       Vasoconstrictor Factors, Endothelium-Derived
% 210.47/210.70  |- mesh__dateEstablished mesh__D016232 1991-01-01
% 210.47/210.70  |- skos__related mesh__D016232smesh__D017466
% 210.47/210.70  |- skos__prefLabel mesh__D016232 Endothelins
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D016232 2006
% 210.47/210.70  |- mesh__dateRevised mesh__D016232 2003-07-09
% 210.47/210.70  |- skos__broader mesh__D016232smesh__D036341
% 210.47/210.70  |- skos__hiddenLabel mesh__D002212 Peppers, Chili
% 210.47/210.70  |- mesh__historyNote mesh__D002212
% 210.47/210.70       91%28%86%29%63; was see under PLANTS, EDIBLE 1986-90; was heading 1963-85%A%  
% 210.47/210.70  |- skos__hiddenLabel mesh__D002212 Pepper, Chili
% 210.47/210.70  |- skos__hiddenLabel mesh__D002212 Bell Peppers
% 210.47/210.70  |- skos__altLabel mesh__D002212 Green Pepper
% 210.47/210.70  |- skos__hiddenLabel mesh__D002212 Chili Peppers
% 210.47/210.70  |- skos__hiddenLabel mesh__D002212 Pepper, Jalapeno
% 210.47/210.70  |- skos__hiddenLabel mesh__D002212 Peppers, Bell
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D002212 2003
% 210.47/210.70  |- skos__prefLabel mesh__D002212 Capsicum
% 210.47/210.70  |- mesh__dateRevised mesh__D002212 2002-07-02
% 210.47/210.70  |- skos__hiddenLabel mesh__D002212 Pepper, Bell
% 210.47/210.70  |- skos__hiddenLabel mesh__D002212 Peppers, Red
% 210.47/210.70  |- skos__hiddenLabel mesh__D002212 Cayenne Peppers
% 210.47/210.70  |- skos__altLabel mesh__D002212 Chili Pepper
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D002212 2004
% 210.47/210.70  |- skos__hiddenLabel mesh__D002212 Pepper, Red
% 210.47/210.70  |- skos__hiddenLabel mesh__D002212 Green Peppers
% 210.47/210.70  |- skos__broader mesh__D002212smesh__D019657
% 210.47/210.70  |- skos__hiddenLabel mesh__D002212 Peppers, Jalapeno
% 210.47/210.70  |- skos__hiddenLabel mesh__D002212 Peppers, Chilli
% 210.47/210.70  |- skos__scopeNote mesh__D002212
% 210.47/210.70       A plant genus of the family SOLANACEAE.  The hot peppers yield CAPSAICIN, which activates vanilloid receptors. Several varieties have sweet or pungent edible fruits that are used as vegetables when fresh and spices when the pods are dried.%A%    
% 210.47/210.70  |- mesh__publicMeSHNote mesh__D002212
% 210.47/210.70       91,63-85; was see under PLANTS, EDIBLE 1986-90; was heading 1963-85%A%  
% 210.47/210.70  |- skos__hiddenLabel mesh__D002212 Chilli Peppers
% 210.47/210.70  |- mesh__dateEstablished mesh__D002212 1991-01-01
% 210.47/210.70  |- rdf__type mesh__D002212sskos__Concept
% 210.47/210.70  |- mesh__recordMaintainer mesh__D002212 ssb
% 210.47/210.70  |- skos__hiddenLabel mesh__D002212 Peppers, Cayenne
% 210.47/210.70  |- mesh__dateCreated mesh__D002212 1999-01-01
% 210.47/210.70  |- skos__hiddenLabel mesh__D002212 Pepper, Chilli
% 210.47/210.70  |- skos__hiddenLabel mesh__D002212 Peppers, Green
% 210.47/210.70  |- skos__hiddenLabel mesh__D002212 Pepper, Cayenne
% 210.47/210.70  |- skos__hiddenLabel mesh__D002212 Jalapeno Peppers
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D002212 2005
% 210.47/210.70  |- mesh__recordAuthorizer mesh__D002212 sjn
% 210.47/210.70  |- skos__hiddenLabel mesh__D002212 Red Peppers
% 210.47/210.70  |- mesh__recordOriginator mesh__D002212 NLM
% 210.47/210.70  |- skos__broader mesh__D002212smesh__D014675
% 210.47/210.70  |- skos__altLabel mesh__D002212 Red Pepper
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D002212 2006
% 210.47/210.70  |- skos__hiddenLabel mesh__D002212 Pepper, Green
% 210.47/210.70  |- skos__annotation mesh__D002212
% 210.47/210.70       Tabasco goes here; BLACK PEPPER is available as a spice; black pepper as a plant use PIPER NIGRUM;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.47/210.70  |- skos__hiddenLabel mesh__D015938 Complement Complex, Terminal
% 210.47/210.70  |- rdf__type mesh__D015938sskos__Concept
% 210.47/210.70  |- skos__altLabel mesh__D015938 C 5b-9
% 210.47/210.70  |- mesh__historyNote mesh__D015938 90   
% 210.47/210.70  |- mesh__dateCreated mesh__D015938 1989-05-25
% 210.47/210.70  |- skos__altLabel mesh__D015938 Cytolytic Terminal Complement Complex
% 210.47/210.70  |- skos__historyNote mesh__D015938 Complement %28%1973-1989%29%
% 210.47/210.70  |- skos__hiddenLabel mesh__D015938 Complex, Terminal Complement
% 210.47/210.70  |- skos__annotation mesh__D015938 DF: COMPLEMENT MAC   
% 210.47/210.70  |- skos__hiddenLabel mesh__D015938 C5b 8 poly C9
% 210.47/210.70  |- mesh__dateEstablished mesh__D015938 1990-01-01
% 210.47/210.70  |- skos__altLabel mesh__D015938 Membrane Attack Complex
% 210.47/210.70  |- skos__altLabel mesh__D015938 Terminal Complement Complex
% 210.47/210.70  |- skos__prefLabel mesh__D015938 Complement Membrane Attack Complex
% 210.47/210.70  |- mesh__dateRevised mesh__D015938 2005-06-30
% 210.47/210.70  |- skos__scopeNote mesh__D015938
% 210.47/210.70       A product of COMPLEMENT ACTIVATION cascade, regardless of the pathways, that forms transmembrane channels causing disruption of the target CELL MEMBRANE and cell lysis. It is formed by the sequential assembly of terminal complement components %28%COMPLEMENT C5B; COMPLEMENT C6; COMPLEMENT C7; COMPLEMENT C8; and COMPLEMENT C9%29% into the target membrane. The resultant C5b-8-poly-C9 is the %22%membrane attack complex%22% or MAC.%A%    
% 210.47/210.70  |- mesh__publicMeSHNote mesh__D015938 90   
% 210.47/210.70  |- skos__altLabel mesh__D015938 C5b-8-poly-C9
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D015938 2006
% 210.47/210.70  |- skos__altLabel mesh__D015938 C5b-9
% 210.47/210.70  |- mesh__recordMaintainer mesh__D015938 lkt
% 210.47/210.70  |- mesh__recordOriginator mesh__D015938 AGS
% 210.47/210.70  |- skos__hiddenLabel mesh__D015938 Complement Complex C5b 9
% 210.47/210.70  |- mesh__recordAuthorizer mesh__D015938 sjn
% 210.47/210.70  |- skos__broader mesh__D015938smesh__D003165
% 210.47/210.70  |- skos__altLabel mesh__D015938 Complement Complex C5b-9
% 210.47/210.70  |- skos__altLabel mesh__D001918 Radiotherapy, Surface
% 210.47/210.70  |- mesh__dateRevised mesh__D001918 2005-06-30
% 210.47/210.70  |- skos__altLabel mesh__D001918 Brachytherapy, Radioisotope
% 210.47/210.70  |- skos__annotation mesh__D001918 a type of radiother   
% 210.47/210.70  |- rdf__type mesh__D001918sskos__Concept
% 210.47/210.70  |- skos__historyNote mesh__D001918
% 210.47/210.70       specific radioisotope/administration %26% dosage/therapeutic use %28%1966-1979%29%
% 210.47/210.70  |- skos__altLabel mesh__D001918 Curietherapy
% 210.47/210.70  |- skos__scopeNote mesh__D001918
% 210.47/210.70       A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues.%A%    
% 210.47/210.70  |- skos__altLabel mesh__D001918 Intracavity Radiotherapy
% 210.47/210.70  |- mesh__recordOriginator mesh__D001918 SMH
% 210.47/210.70  |- skos__altLabel mesh__D001918 Implant Radiotherapy
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D001918 2006
% 210.47/210.70  |- skos__prefLabel mesh__D001918 Brachytherapy
% 210.47/210.70  |- skos__historyNote mesh__D001918 Neoplasms/radiotherapy %28%1966-1979%29%
% 210.47/210.70  |- mesh__recordAuthorizer mesh__D001918 sjn
% 210.47/210.70  |- skos__historyNote mesh__D001918
% 210.47/210.70       specific neoplasm/radiotherapy %28%1966-1979%29%
% 210.47/210.70  |- skos__historyNote mesh__D001918
% 210.47/210.70       Radioisotopes/administration %26% dosage/therapeutic use %28%1966-1979%29%
% 210.47/210.70  |- skos__altLabel mesh__D001918 Radioisotope Plaque Therapy
% 210.47/210.70  |- skos__altLabel mesh__D001918 Radioisotope Brachytherapy
% 210.47/210.70  |- mesh__historyNote mesh__D001918 80   
% 210.47/210.70  |- mesh__dateEstablished mesh__D001918 1980-01-01
% 210.47/210.70  |- skos__broader mesh__D001918smesh__D011878
% 210.47/210.70  |- skos__hiddenLabel mesh__D001918 Therapy, Radioisotope Plaque
% 210.47/210.70  |- mesh__recordMaintainer mesh__D001918 lkt
% 210.47/210.70  |- skos__altLabel mesh__D001918 Radiotherapy, Implant
% 210.47/210.70  |- skos__altLabel mesh__D001918 Interstitial Radiotherapy
% 210.47/210.70  |- mesh__publicMeSHNote mesh__D001918 80   
% 210.47/210.70  |- skos__historyNote mesh__D001918 Radiotherapy %28%1966-1979%29%
% 210.47/210.70  |- mesh__dateCreated mesh__D001918 1979-03-07
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D012640 2006
% 210.47/210.70  |- skos__historyNote mesh__D012640 Convulsions %28%1966-1978%29%
% 210.47/210.70  |- skos__broader mesh__D012640smesh__D004827
% 210.47/210.70  |- skos__altLabel mesh__D012640 Seizures, Convulsive
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Seizure, Clonic
% 210.47/210.70  |- mesh__dateEstablished mesh__D012640 1979-01-01
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Motor Seizure
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Gustatory Seizure
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Vestibular Seizure
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Convulsion
% 210.47/210.70  |- skos__related mesh__D012640smesh__D003292
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Seizure, Tonic-Clonic
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Vertiginous Seizure
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Seizure, Visual
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Seizure, Tonic
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Sensory Seizures
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Generalized Seizure
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Seizure, Somatosensory
% 210.47/210.70  |- mesh__recordAuthorizer mesh__D012640 sjn
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Vestibular Seizures
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Visual Seizures
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Clonic Seizure
% 210.47/210.70  |- skos__related mesh__D012640smesh__D000927
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Non-Epileptic Convulsions
% 210.47/210.70  |- rdf__type mesh__D012640sskos__Concept
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Seizure, Sensory
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Sensory Seizure
% 210.47/210.70  |- skos__historyNote mesh__D012640 Epilepsy %28%1966-1978%29%
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Visual Seizure
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Motor Seizures
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Seizure, Olfactory
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Tonic Seizure
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Seizure, Jacksonian
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Generalized Seizures
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Clonic Seizures
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Seizure, Vestibular
% 210.47/210.70  |- mesh__publicMeSHNote mesh__D012640
% 210.47/210.70       1979; for CONVULSIVE SEIZURES %26% SEIZURES, CONVULSIVE see CONVULSIONS 1998-1999; for JACKSONIAN SEIZURE see EPILEPSY, PARTIAL 1992-1999; for CONVULSIONS see CONVULSIONS 1963-2004; for CONVULSION, NON-EPILEPTIC see CONVULSIONS 2000-2004%A%  
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Auditory Seizures
% 210.47/210.70  |- skos__annotation mesh__D012640
% 210.47/210.70       note other specific seizure terms in MeSH; audiogenic or acoustic seizures = REFLEX EPILEPSY, AUDIOGENIC%A%  
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Convulsion, Non Epileptic
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Tonic Seizures
% 210.47/210.70  |- skos__related mesh__D012640smesh__D004461
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Seizure, Convulsive
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Tonic-Clonic Seizure
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Seizures, Tonic Clonic
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Auditory Seizure
% 210.47/210.70  |- mesh__historyNote mesh__D012640
% 210.47/210.70       1979; for CONVULSIVE SEIZURES %26% SEIZURES, CONVULSIVE use CONVULSIONS 1998-1999; for JACKSONIAN SEIZURE use EPILEPSY, PARTIAL 1992-1999%A%  
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Focal Seizure
% 210.47/210.70  |- skos__related mesh__D012640smesh__D004827
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Seizure
% 210.47/210.70  |- mesh__recordMaintainer mesh__D012640 lkt
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Somatosensory Seizures
% 210.47/210.70  |- mesh__recordOriginator mesh__D012640 RC
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Seizure, Gustatory
% 210.47/210.70  |- skos__broader mesh__D012640smesh__D009461
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Somatosensory Seizure
% 210.47/210.70  |- skos__altLabel mesh__D012640 Seizures, Motor
% 210.47/210.70  |- skos__altLabel mesh__D012640 Seizures, Vestibular
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Tonic-Clonic Seizures
% 210.47/210.70  |- skos__historyNote mesh__D012640
% 210.47/210.70       specific epilepsy heading %28%1966-1978%29%
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Non-Epileptic Convulsion
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Seizure, Vertiginous
% 210.47/210.70  |- mesh__dateRevised mesh__D012640 2004-07-07
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Olfactory Seizures
% 210.47/210.70  |- mesh__dateCreated mesh__D012640 1978-05-17
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Convulsions, Non-Epileptic
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Olfactory Seizure
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D012640 2005
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Vertiginous Seizures
% 210.47/210.70  |- skos__scopeNote mesh__D012640
% 210.47/210.70       Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or %22%seizure disorder.%22%%A%    
% 210.47/210.70  |- skos__prefLabel mesh__D012640 Seizures
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Seizure, Auditory
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Seizure, Motor
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Convulsive Seizure
% 210.47/210.70  |- skos__related mesh__D012640smesh__D007696
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Focal Seizures
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Gustatory Seizures
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Seizure, Generalized
% 210.47/210.70  |- skos__hiddenLabel mesh__D012640 Seizure, Focal
% 210.47/210.70  |- mesh__recordOriginator mesh__D006603 NLM
% 210.47/210.70  |- skos__hiddenLabel mesh__D006603 Acids, Hexouronic
% 210.47/210.70  |- mesh__recordMaintainer mesh__D006603 ssb
% 210.47/210.70  |- skos__altLabel mesh__D006603 Hexouronic Acids
% 210.47/210.70  |- mesh__historyNote mesh__D006603
% 210.47/210.70       91%28%75%29%; was see under URONIC ACIDS 1975-90   
% 210.47/210.70  |- skos__scopeNote mesh__D006603
% 210.47/210.70       Term used to designate tetrahydroxy aldehydic acids obtained by oxidation of hexose sugars, i.e. glucuronic acid, galacturonic acid, etc. Historically, the name hexuronic acid was originally given to ascorbic acid.%A%    
% 210.47/210.70  |- mesh__dateCreated mesh__D006603 1974-11-19
% 210.47/210.70  |- skos__historyNote mesh__D006603 Uronic Acids %28%1971-1974%29%
% 210.47/210.70  |- mesh__recordAuthorizer mesh__D006603 sjn
% 210.47/210.70  |- skos__broader mesh__D006603smesh__D014574
% 210.47/210.70  |- skos__prefLabel mesh__D006603 Hexuronic Acids
% 210.47/210.70  |- mesh__dateEstablished mesh__D006603 1991-01-01
% 210.47/210.70  |- rdf__type mesh__D006603sskos__Concept
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D006603 2005
% 210.47/210.70  |- skos__hiddenLabel mesh__D006603 Acids, Hexuronic
% 210.47/210.70  |- mesh__dateRevised mesh__D006603 2004-07-07
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D006603 2006
% 210.47/210.70  |- mesh__publicMeSHNote mesh__D006603
% 210.47/210.70       91; was see under URONIC ACIDS 1975-90   
% 210.47/210.70  |- mesh__recordOriginator mesh__D044722 ags
% 210.47/210.70  |- mesh__dateRevised mesh__D044722 2005-06-30
% 210.47/210.70  |- mesh__historyNote mesh__D044722 2004   
% 210.47/210.70  |- rdf__type mesh__D044722sskos__Concept
% 210.47/210.70  |- skos__historyNote mesh__D044722 Algae, Red %28%1973-2003%29%
% 210.47/210.70  |- skos__prefLabel mesh__D044722 Laurencia
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D044722 2006
% 210.47/210.70  |- skos__scopeNote mesh__D044722
% 210.47/210.70       A genus of RED ALGAE in the family Rhodomelaceae. Some species are a rich source of chlorine-and bromine-containing metabolites which show significant antibacterial activity.%A%    
% 210.47/210.70  |- mesh__dateCreated mesh__D044722 2003-07-09
% 210.47/210.70  |- mesh__recordMaintainer mesh__D044722 SYSTEM
% 210.47/210.70  |- mesh__dateEstablished mesh__D044722 2004-01-01
% 210.47/210.70  |- skos__broader mesh__D044722smesh__D000461
% 210.47/210.70  |- mesh__publicMeSHNote mesh__D044722 2004   
% 210.47/210.70  |- mesh__recordAuthorizer mesh__D044722 sjn
% 210.47/210.70  |- mesh__dateEstablished mesh__D011548 1975-01-01
% 210.47/210.70  |- skos__broader mesh__D011548smesh__D020563
% 210.47/210.70  |- skos__historyNote mesh__D011548 Bacteria %28%1966-1974%29%
% 210.47/210.70  |- mesh__dateCreated mesh__D011548 1999-01-01
% 210.47/210.70  |- skos__prefLabel mesh__D011548 Pseudomonadaceae
% 210.47/210.70  |- mesh__dateRevised mesh__D011548 2005-06-30
% 210.47/210.70  |- mesh__recordOriginator mesh__D011548 NLM
% 210.47/210.70  |- mesh__recordMaintainer mesh__D011548 SYSTEM
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D011548 2006
% 210.47/210.70  |- mesh__recordAuthorizer mesh__D011548 sjn
% 210.47/210.70  |- mesh__publicMeSHNote mesh__D011548 75   
% 210.47/210.70  |- skos__broader mesh__D011548smesh__D016946
% 210.47/210.70  |- rdf__type mesh__D011548sskos__Concept
% 210.47/210.70  |- skos__scopeNote mesh__D011548
% 210.47/210.70       A family of gram-negative bacteria usually found in soil or water and including many plant pathogens and a few animal pathogens.%A%    
% 210.47/210.70  |- mesh__historyNote mesh__D011548 75   
% 210.47/210.70  |- mesh__recordAuthorizer mesh__D030702 sjn
% 210.47/210.70  |- mesh__dateRevised mesh__D030702 2002-07-03
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D030702 2005
% 210.47/210.70  |- mesh__dateCreated mesh__D030702 2001-07-25
% 210.47/210.70  |- mesh__dateEstablished mesh__D030702 2002-01-01
% 210.47/210.70  |- mesh__publicMeSHNote mesh__D030702 2002   
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D030702 2006
% 210.47/210.70  |- skos__broader mesh__D030702smesh__D019684
% 210.47/210.70  |- skos__scopeNote mesh__D030702
% 210.47/210.70       The sour gum plant family of the order Nymphaeales, subclass Magnoliidae, class Magnoliopsida. All have horizontal or hanging branches and broad alternate leaves, and they are dioecious %28%male and female flowers on different plants%29%.%A%    
% 210.47/210.70  |- rdf__type mesh__D030702sskos__Concept
% 210.47/210.70  |- skos__prefLabel mesh__D030702 Nymphaeaceae
% 210.47/210.70  |- mesh__recordOriginator mesh__D030702 ssb
% 210.47/210.70  |- mesh__historyNote mesh__D030702 2002   
% 210.47/210.70  |- skos__annotation mesh__D030702
% 210.47/210.70       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D030702 2003
% 210.47/210.70  |- mesh__recordMaintainer mesh__D030702 ssb
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D030702 2004
% 210.47/210.70  |- skos__hiddenLabel mesh__D016233 Active Immunotherapies
% 210.47/210.70  |- skos__altLabel mesh__D016233 Active Immunotherapy
% 210.47/210.70  |- skos__prefLabel mesh__D016233 Immunotherapy, Active
% 210.47/210.70  |- skos__broader mesh__D016233smesh__D007114
% 210.47/210.70  |- mesh__onlineNote mesh__D016233
% 210.47/210.70       use IMMUNIZATION, PASSIVE to search IMMUNE RNA MANIPULATION 1983-96; use IMMUNOTHERAPY to search VACCINE THERAPY 1990%A%  
% 210.47/210.70  |- skos__hiddenLabel mesh__D016233 Vaccine Therapies
% 210.47/210.70  |- skos__hiddenLabel mesh__D016233 RNA Manipulation, Immune
% 210.47/210.70  |- skos__hiddenLabel mesh__D016233 Immune RNA Manipulations
% 210.47/210.70  |- skos__hiddenLabel mesh__D016233 Manipulation, Immune RNA
% 210.47/210.70  |- skos__altLabel mesh__D016233 Therapy, Vaccine
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D016233 2002
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D016233 1999
% 210.47/210.70  |- mesh__dateRevised mesh__D016233 1996-06-10
% 210.47/210.70  |- skos__scopeNote mesh__D016233
% 210.47/210.70       Active immunization where vaccine is administered for therapeutic or preventive purposes. This can include administration of immunopotentiating agents such as BCG vaccine and Corynebacterium parvum as well as biological response modifiers such as interferons, interleukins, and colony-stimulating factors in order to directly stimulate the immune system.%A%    
% 210.47/210.70  |- mesh__dateEstablished mesh__D016233 1991-01-01
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D016233 2006
% 210.47/210.70  |- mesh__recordAuthorizer mesh__D016233 PLS
% 210.47/210.70  |- skos__historyNote mesh__D016233 Immunotherapy %28%1967-1990%29%
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D016233 1998
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D016233 1997
% 210.47/210.70  |- mesh__recordOriginator mesh__D016233 AGS
% 210.47/210.70  |- skos__hiddenLabel mesh__D016233 Manipulations, Immune RNA
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D016233 2005
% 210.47/210.70  |- skos__hiddenLabel mesh__D016233 Immunotherapies, Active
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D016233 2004
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D016233 2001
% 210.47/210.70  |- rdf__type mesh__D016233sskos__Concept
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D016233 2003
% 210.47/210.70  |- skos__annotation mesh__D016233
% 210.47/210.70       IM; do not use /util except by MeSH definition   
% 210.47/210.70  |- mesh__publicMeSHNote mesh__D016233
% 210.47/210.70       91; IMMUNE RNA MANIPULATION was see IMMUNIZATION, PASSIVE 1983-96; VACCINE THERAPY was see IMMUNOTHERAPY 1990, was heading 1963-82%A%  
% 210.47/210.70  |- mesh__dateCreated mesh__D016233 1990-05-07
% 210.47/210.70  |- skos__hiddenLabel mesh__D016233 Therapies, Vaccine
% 210.47/210.70  |- mesh__historyNote mesh__D016233
% 210.47/210.70       91; IMMUNE RNA MANIPULATION was see IMMUNIZATION, PASSIVE 1983-96; VACCINE THERAPY was see IMMUNOTHERAPY 1990, was heading 1963-82%A%  
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D016233 2000
% 210.47/210.70  |- skos__hiddenLabel mesh__D016233 RNA Manipulations, Immune
% 210.47/210.70  |- mesh__recordMaintainer mesh__D016233 AGS
% 210.47/210.70  |- skos__annotation mesh__D002213 CAPSID PROTEINS is also available   
% 210.47/210.70  |- mesh__recordMaintainer mesh__D002213 jmp
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D002213 2003
% 210.47/210.70  |- mesh__recordAuthorizer mesh__D002213 sjn
% 210.47/210.70  |- mesh__recordOriginator mesh__D002213 NLM
% 210.47/210.70  |- mesh__dateEstablished mesh__D002213 1984-01-01
% 210.47/210.70  |- mesh__dateRevised mesh__D002213 2002-07-03
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D002213 2006
% 210.47/210.70  |- skos__hiddenLabel mesh__D002213 Capsids
% 210.47/210.70  |- skos__prefLabel mesh__D002213 Capsid
% 210.47/210.70  |- mesh__historyNote mesh__D002213
% 210.47/210.70       84%28%75%29%; was see under VIRAL PROTEINS 1975-83   
% 210.47/210.70  |- mesh__publicMeSHNote mesh__D002213
% 210.47/210.70       84; was see under VIRAL PROTEINS 1975-83   
% 210.47/210.70  |- skos__historyNote mesh__D002213 Viral Proteins %28%1968-1974%29%
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D002213 2005
% 210.47/210.70  |- skos__scopeNote mesh__D002213
% 210.47/210.70       The outer protein protective shell of a virus, which protects the viral nucleic acid.%A%    
% 210.47/210.70  |- mesh__dateCreated mesh__D002213 1974-11-11
% 210.47/210.70  |- rdf__type mesh__D002213sskos__Concept
% 210.47/210.70  |- skos__broader mesh__D002213smesh__D019251
% 210.47/210.70  |- mesh__activeMeSHYear mesh__D002213 2004
% 210.47/210.70  |- mesh__recordOriginator mesh__D015939 RLS
% 210.47/210.71  |- skos__historyNote mesh__D015939 Leucomycins %28%1981-1989%29%
% 210.47/210.71  |- skos__scopeNote mesh__D015939
% 210.47/210.71       A macrolide antibiotic produced by Streptomyces kitasatoensis. The drug has antimicrobial activity against a wide spectrum of pathogens.%A%    
% 210.47/210.71  |- mesh__historyNote mesh__D015939
% 210.47/210.71       90; was KITASAMYCINS see under ANTIBIOTICS 1976-80; was see LEUCOMYCINS 1981-89%A%  
% 210.47/210.71  |- mesh__activeMeSHYear mesh__D015939 2005
% 210.47/210.71  |- skos__broader mesh__D015939smesh__D007933
% 210.47/210.71  |- rdf__type mesh__D015939sskos__Concept
% 210.47/210.71  |- mesh__recordAuthorizer mesh__D015939 sjn
% 210.47/210.71  |- mesh__dateEstablished mesh__D015939 1990-01-01
% 210.47/210.71  |- mesh__publicMeSHNote mesh__D015939
% 210.47/210.71       90; was KITASAMYCINS see under ANTIBIOTICS 1976-80; was see LEUCOMYCINS 1981-89%A%  
% 210.47/210.71  |- mesh__onlineNote mesh__D015939
% 210.47/210.71       use KITASAMYCINS to search KITASAMICIN 1976-80; use  LEUCOMYCINS 1981-89%A%  
% 210.47/210.71  |- mesh__dateCreated mesh__D015939 1989-05-25
% 210.47/210.71  |- skos__historyNote mesh__D015939 Antibiotics %28%1970-1975%29%
% 210.47/210.71  |- skos__annotation mesh__D015939
% 210.47/210.71       do not use /biosyn unless by living matter; do not confuse X ref LEUCOMYCIN see KITASAMYCIN with LEUCOMYCINS%A%  
% 210.47/210.71  |- mesh__recordMaintainer mesh__D015939 ssb
% 210.47/210.71  |- skos__altLabel mesh__D015939 Leucomycin
% 210.47/210.71  |- mesh__activeMeSHYear mesh__D015939 2006
% 210.47/210.71  |- skos__prefLabel mesh__D015939 Kitasamycin
% 210.47/210.71  |- skos__historyNote mesh__D015939 Kitasamycins %28%1976-1980%29%
% 210.47/210.71  |- mesh__dateRevised mesh__D015939 2004-07-07
% 210.47/210.71  |- skos__hiddenLabel mesh__D026661 Safety Monitoring Board
% 210.47/210.71  |- skos__scopeNote mesh__D026661
% 210.47/210.71       Committees established to review interim data and efficacy outcomes in CLINICAL TRIALS. The findings of these committees are used in deciding whether a trial should be continued as designed, changed, or terminated. Government regulations regarding federally-funded research involving human subjects %28%the %22%Common Rule%22%%29% require %28%45 CFR 46.111%29% that research ethics committees reviewing large-scale clinical trials monitor the data collected using a mechanism such as a data monitoring committee. FDA regulations %28%21 CFR 50.24%29% require that such committees be established to monitor studies conducted in emergency settings.%A%    
% 210.47/210.71  |- skos__related mesh__D026661smesh__D012107
% 210.47/210.71  |- skos__historyNote mesh__D026661
% 210.47/210.71       Professional Staff Committees %28%1991-2001%29%
% 210.47/210.71  |- mesh__publicMeSHNote mesh__D026661 2002   
% 210.47/210.71  |- skos__hiddenLabel mesh__D026661 Committee, Data Monitoring
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D026661 2006
% 210.56/210.71  |- mesh__dateEstablished mesh__D026661 2002-01-01
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D026661 2005
% 210.56/210.71  |- skos__hiddenLabel mesh__D026661 Monitoring Committee, Data
% 210.56/210.71  |- mesh__recordOriginator mesh__D026661 hjn
% 210.56/210.71  |- mesh__dateRevised mesh__D026661 2004-07-13
% 210.56/210.71  |- skos__broader mesh__D026661smesh__D011367
% 210.56/210.71  |- skos__altLabel mesh__D026661 Safety Monitoring Boards
% 210.56/210.71  |- mesh__dateCreated mesh__D026661 2001-07-25
% 210.56/210.71  |- mesh__recordMaintainer mesh__D026661 sjn
% 210.56/210.71  |- skos__hiddenLabel mesh__D026661 Monitoring Committees, Data
% 210.56/210.71  |- skos__hiddenLabel mesh__D026661 Monitoring Boards, Safety
% 210.56/210.71  |- skos__hiddenLabel mesh__D026661 Monitoring Board, Safety
% 210.56/210.71  |- skos__hiddenLabel mesh__D026661 Data Monitoring Committee
% 210.56/210.71  |- mesh__recordAuthorizer mesh__D026661 sjn
% 210.56/210.71  |- skos__altLabel mesh__D026661 Data and Safety Monitoring Boards
% 210.56/210.71  |- skos__altLabel mesh__D026661 Data Monitoring Committees
% 210.56/210.71  |- skos__historyNote mesh__D026661 Clinical Trials %28%1991-2001%29%
% 210.56/210.71  |- skos__hiddenLabel mesh__D026661 Boards, Safety Monitoring
% 210.56/210.71  |- skos__hiddenLabel mesh__D026661 Board, Safety Monitoring
% 210.56/210.71  |- rdf__type mesh__D026661sskos__Concept
% 210.56/210.71  |- skos__related mesh__D026661smesh__D002986
% 210.56/210.71  |- mesh__historyNote mesh__D026661 2002   
% 210.56/210.71  |- skos__prefLabel mesh__D026661 Clinical Trials Data Monitoring Committees
% 210.56/210.71  |- skos__related mesh__D026661smesh__D028744
% 210.56/210.71  |- skos__hiddenLabel mesh__D026661 Committees, Data Monitoring
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D001919 2005
% 210.56/210.71  |- skos__prefLabel mesh__D001919 Bradycardia
% 210.56/210.71  |- skos__hiddenLabel mesh__D001919 Bradyarrhythmias
% 210.56/210.71  |- skos__scopeNote mesh__D001919
% 210.56/210.71       Excessive slowness in the action of the heart, usually with a heart rate below 60 beats per minute.%A%    
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D001919 2004
% 210.56/210.71  |- skos__broader mesh__D001919smesh__D001145
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D001919 2001
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D001919 2006
% 210.56/210.71  |- skos__hiddenLabel mesh__D001919 Bradycardias
% 210.56/210.71  |- mesh__dateCreated mesh__D001919 1999-01-01
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D001919 2002
% 210.56/210.71  |- mesh__dateRevised mesh__D001919 1999-11-08
% 210.56/210.71  |- mesh__recordAuthorizer mesh__D001919 sjn
% 210.56/210.71  |- mesh__recordMaintainer mesh__D001919 adp
% 210.56/210.71  |- skos__annotation mesh__D001919 TN 99: BRADYCARDIA vs HEART RATE   
% 210.56/210.71  |- mesh__recordOriginator mesh__D001919 NLM
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D001919 2003
% 210.56/210.71  |- rdf__type mesh__D001919sskos__Concept
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D001919 2000
% 210.56/210.71  |- skos__scopeNote mesh__D012641
% 210.56/210.71       Differential and non-random reproduction of different genotypes, operating to alter the gene frequencies within a population.%A%    
% 210.56/210.71  |- mesh__dateRevised mesh__D012641 2002-07-03
% 210.56/210.71  |- mesh__onlineNote mesh__D012641
% 210.56/210.71       use EVOLUTION %26% SELECTION %28%GENETICS%29% to search NATURAL SELECTION 1978%A%  
% 210.56/210.71  |- mesh__recordOriginator mesh__D012641 NLM
% 210.56/210.71  |- skos__historyNote mesh__D012641 Genetics %28%1966-1967%29%
% 210.56/210.71  |- skos__broader mesh__D012641smesh__D039361
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D012641 2004
% 210.56/210.71  |- mesh__dateEstablished mesh__D012641 1968-01-01
% 210.56/210.71  |- skos__prefLabel mesh__D012641 Selection %28%Genetics%29%
% 210.56/210.71  |- rdf__type mesh__D012641sskos__Concept
% 210.56/210.71  |- skos__hiddenLabel mesh__D012641 Selections %28%Genetics%29%
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D012641 2003
% 210.56/210.71  |- mesh__publicMeSHNote mesh__D012641
% 210.56/210.71       68; NATURAL SELECTION was indexed under EVOLUTION 1978   
% 210.56/210.71  |- mesh__dateCreated mesh__D012641 1999-01-01
% 210.56/210.71  |- mesh__recordAuthorizer mesh__D012641 sjn
% 210.56/210.71  |- skos__hiddenLabel mesh__D012641 Selections, Natural
% 210.56/210.71  |- mesh__historyNote mesh__D012641
% 210.56/210.71       68; NATURAL SELECTION was indexed under EVOLUTION 1978   
% 210.56/210.71  |- skos__annotation mesh__D012641 DF: SELECTION   
% 210.56/210.71  |- skos__hiddenLabel mesh__D012641 Natural Selections
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D012641 2006
% 210.56/210.71  |- skos__hiddenLabel mesh__D012641 Selection, Natural
% 210.56/210.71  |- mesh__recordMaintainer mesh__D012641 KEV
% 210.56/210.71  |- skos__historyNote mesh__D012641 Genetics, Population %28%1966-1967%29%
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D012641 2005
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D006604 2006
% 210.56/210.71  |- mesh__recordAuthorizer mesh__D006604 sjn
% 210.56/210.71  |- skos__prefLabel mesh__D006604 Hexylresorcinol
% 210.56/210.71  |- mesh__dateRevised mesh__D006604 2000-06-22
% 210.56/210.71  |- rdf__type mesh__D006604sskos__Concept
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D006604 2002
% 210.56/210.71  |- skos__scopeNote mesh__D006604
% 210.56/210.71       A substituted dihydroxybenzene that is used topically as an antiseptic for the treatment of minor skin infections.%A%    
% 210.56/210.71  |- mesh__dateCreated mesh__D006604 1999-01-01
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D006604 2003
% 210.56/210.71  |- mesh__recordMaintainer mesh__D006604 CCR
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D006604 2005
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D006604 2004
% 210.56/210.71  |- mesh__recordOriginator mesh__D006604 NLM
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D006604 2001
% 210.56/210.71  |- skos__broader mesh__D006604smesh__D012118
% 210.56/210.71  |- mesh__dateEstablished mesh__D050760 2006-01-01
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D050760 2006
% 210.56/210.71  |- skos__altLabel mesh__D050760 p27Kip1 Protein
% 210.56/210.71  |- skos__altLabel mesh__D050760 CDK Inhibitor p27
% 210.56/210.71  |- mesh__dateCreated mesh__D050760 2005-06-30
% 210.56/210.71  |- skos__altLabel mesh__D050760 p27 CDK Inhibitor
% 210.56/210.71  |- rdf__type mesh__D050760sskos__Concept
% 210.56/210.71  |- skos__altLabel mesh__D050760 Cyclin-Dependent Kinase Inhibitor 1B
% 210.56/210.71  |- skos__hiddenLabel mesh__D050760 CDK Inhibitor, p27
% 210.56/210.71  |- mesh__recordAuthorizer mesh__D050760 ags
% 210.56/210.71  |- mesh__dateRevised mesh__D050760 2005-07-12
% 210.56/210.71  |- skos__scopeNote mesh__D050760
% 210.56/210.71       A cyclin-dependent kinase inhibitor that coordinates the activation of CYCLIN and CYCLIN-DEPENDENT KINASES during the CELL CYCLE.  It interacts with active CYCLIN D complexed to CYCLIN-DEPENDENT KINASE 4 in proliferating cells, while in arrested cells it binds and inhibits CYCLIN E complexed to CYCLIN-DEPENDENT KINASE 2.%A%    
% 210.56/210.71  |- skos__hiddenLabel mesh__D050760 Kip1 Protein, p27
% 210.56/210.71  |- mesh__recordMaintainer mesh__D050760 ags
% 210.56/210.71  |- skos__altLabel mesh__D050760 CDKN1B Protein
% 210.56/210.71  |- skos__altLabel mesh__D050760 CDKN4 Protein
% 210.56/210.71  |- mesh__historyNote mesh__D050760 2006%28%1992%29%   
% 210.56/210.71  |- skos__hiddenLabel mesh__D050760 p27, CDK Inhibitor
% 210.56/210.71  |- skos__hiddenLabel mesh__D050760 Cyclin Dependent Kinase Inhibitor 1B
% 210.56/210.71  |- skos__altLabel mesh__D050760 p27 Kip1 Protein
% 210.56/210.71  |- skos__prefLabel mesh__D050760 Cyclin-Dependent Kinase Inhibitor p27
% 210.56/210.71  |- skos__hiddenLabel mesh__D050760 Cyclin Dependent Kinase Inhibitor p27
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D050760 2006A
% 210.56/210.71  |- mesh__publicMeSHNote mesh__D050760
% 210.56/210.71       2006; CYCLIN-DEPENDENT KINASE INHIBITOR P27 was indexed under CELL CYCLE PROTEINS %26% TUMOR SUPPRESSOR PROTEINS 1992-2005%A%  
% 210.56/210.71  |- mesh__recordOriginator mesh__D050760 DRC
% 210.56/210.71  |- skos__broader mesh__D050760smesh__D050756
% 210.56/210.71  |- skos__related mesh__D044723smesh__D002351
% 210.56/210.71  |- mesh__recordAuthorizer mesh__D044723 sjn
% 210.56/210.71  |- rdf__type mesh__D044723sskos__Concept
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D044723 2006
% 210.56/210.71  |- skos__prefLabel mesh__D044723 Chondrus
% 210.56/210.71  |- skos__scopeNote mesh__D044723
% 210.56/210.71       A genus of RED ALGAE, in the family Gigartinaceae. The species Chondrus crispus is a source of CARRAGEENAN.%A%    
% 210.56/210.71  |- mesh__dateCreated mesh__D044723 2003-07-09
% 210.56/210.71  |- mesh__recordOriginator mesh__D044723 ags
% 210.56/210.71  |- mesh__recordMaintainer mesh__D044723 SYSTEM
% 210.56/210.71  |- mesh__dateRevised mesh__D044723 2005-06-30
% 210.56/210.71  |- skos__altLabel mesh__D044723 Carrageen
% 210.56/210.71  |- mesh__historyNote mesh__D044723 2004   
% 210.56/210.71  |- skos__broader mesh__D044723smesh__D000461
% 210.56/210.71  |- mesh__publicMeSHNote mesh__D044723 2004   
% 210.56/210.71  |- skos__historyNote mesh__D044723 Algae, Red %28%1973-2003%29%
% 210.56/210.71  |- mesh__dateEstablished mesh__D044723 2004-01-01
% 210.56/210.71  |- skos__altLabel mesh__D044723 Moss, Irish
% 210.56/210.71  |- mesh__dateRevised mesh__D011549 2005-06-30
% 210.56/210.71  |- mesh__recordOriginator mesh__D011549 NLM
% 210.56/210.71  |- skos__broader mesh__D011549smesh__D011548
% 210.56/210.71  |- skos__prefLabel mesh__D011549 Pseudomonas
% 210.56/210.71  |- mesh__recordAuthorizer mesh__D011549 sjn
% 210.56/210.71  |- skos__altLabel mesh__D011549 Flavimonas
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D011549 2006
% 210.56/210.71  |- rdf__type mesh__D011549sskos__Concept
% 210.56/210.71  |- mesh__recordMaintainer mesh__D011549 SYSTEM
% 210.56/210.71  |- skos__altLabel mesh__D011549 Chrysemonas
% 210.56/210.71  |- skos__scopeNote mesh__D011549
% 210.56/210.71       A genus of gram-negative, aerobic, rod-shaped bacteria widely distributed in nature. Some species are pathogenic for humans, animals, and plants.%A%    
% 210.56/210.71  |- skos__annotation mesh__D011549 infection = PSEUDOMONAS INFECTIONS   
% 210.56/210.71  |- mesh__dateCreated mesh__D011549 1999-01-01
% 210.56/210.71  |- skos__scopeNote mesh__D016234
% 210.56/210.71       A system of metabolic interactions by products produced in the distal nephron of the KIDNEY. These products include KALLIKREIN; KININS; KININASE I; KININASE II; and ENKEPHALINASE. This system participates in the control of renal functions. It interacts with the RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM to regulate BLOOD PRESSURE, generation of PROSTAGLANDINS, release of VASOPRESSINS, and WATER-ELECTROLYTE BALANCE.%A%    
% 210.56/210.71  |- mesh__publicMeSHNote mesh__D016234 91   
% 210.56/210.71  |- mesh__recordAuthorizer mesh__D016234 sjn
% 210.56/210.71  |- skos__hiddenLabel mesh__D016234 Kallikrein-Kinin Systems
% 210.56/210.71  |- mesh__dateEstablished mesh__D016234 1991-01-01
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D016234 2006
% 210.56/210.71  |- skos__broader mesh__D016234smesh__D008660
% 210.56/210.71  |- mesh__dateRevised mesh__D016234 2004-07-09
% 210.56/210.71  |- skos__historyNote mesh__D016234 Kinins %28%1966-1990%29%
% 210.56/210.71  |- skos__broader mesh__D016234smesh__D006439
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D016234 2005
% 210.56/210.71  |- skos__prefLabel mesh__D016234 Kallikrein-Kinin System
% 210.56/210.71  |- skos__hiddenLabel mesh__D016234 Systems, Kallikrein-Kinin
% 210.56/210.71  |- skos__related mesh__D016234smesh__D012084
% 210.56/210.71  |- skos__hiddenLabel mesh__D016234 Kallikrein Kinin System
% 210.56/210.71  |- rdf__type mesh__D016234sskos__Concept
% 210.56/210.71  |- mesh__historyNote mesh__D016234 91   
% 210.56/210.71  |- mesh__dateCreated mesh__D016234 1990-05-07
% 210.56/210.71  |- skos__annotation mesh__D016234 DF: KK SYSTEM   
% 210.56/210.71  |- mesh__recordMaintainer mesh__D016234 jmp
% 210.56/210.71  |- skos__broader mesh__D016234smesh__D014882
% 210.56/210.71  |- mesh__recordOriginator mesh__D016234 RLS
% 210.56/210.71  |- skos__historyNote mesh__D016234 Kallikrein %28%1966-1990%29%
% 210.56/210.71  |- skos__broader mesh__D002214smesh__D004304
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D002214 2005
% 210.56/210.71  |- skos__scopeNote mesh__D002214
% 210.56/210.71       Hard or soft soluble containers used for the oral administration of medicine.%A%    
% 210.56/210.71  |- rdf__type mesh__D002214sskos__Concept
% 210.56/210.71  |- mesh__recordMaintainer mesh__D002214 ssb
% 210.56/210.71  |- mesh__dateCreated mesh__D002214 1999-01-01
% 210.56/210.71  |- skos__prefLabel mesh__D002214 Capsules
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D002214 2004
% 210.56/210.71  |- mesh__recordAuthorizer mesh__D002214 sjn
% 210.56/210.71  |- mesh__recordOriginator mesh__D002214 NLM
% 210.56/210.71  |- skos__annotation mesh__D002214
% 210.56/210.71       IM for general only; NIM %28%no qualif%29% with specific drug IM %28%with qualif%29%; /adv eff permitted but be careful: it may be the adv eff of the drug in capsule form, not the capsule; note X ref MICROCAPSULES: do not confuse with MICROENCAPSULATION see DRUG COMPOUNDING%A%  
% 210.56/210.71  |- mesh__dateRevised mesh__D002214 2003-07-09
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D002214 2006
% 210.56/210.71  |- mesh__recordOriginator mesh__D012642 RLS
% 210.56/210.71  |- mesh__recordMaintainer mesh__D012642 sjn
% 210.56/210.71  |- rdf__type mesh__D012642sskos__Concept
% 210.56/210.71  |- skos__altLabel mesh__D012642 Selegiline, %28%R%29%-Isomer
% 210.56/210.71  |- skos__hiddenLabel mesh__D012642 E250
% 210.56/210.71  |- skos__broader mesh__D012642smesh__D010627
% 210.56/210.71  |- mesh__onlineNote mesh__D012642
% 210.56/210.71       use SELEGILINE to search DEPRENYL 1979-83   
% 210.56/210.71  |- skos__altLabel mesh__D012642 L-Deprenyl
% 210.56/210.71  |- skos__hiddenLabel mesh__D012642 Hydrochloride, Selegiline
% 210.56/210.71  |- skos__altLabel mesh__D012642 Humex
% 210.56/210.71  |- skos__hiddenLabel mesh__D012642 L Deprenyl
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D012642 2006
% 210.56/210.71  |- skos__altLabel mesh__D012642 Deprenalin
% 210.56/210.71  |- mesh__publicMeSHNote mesh__D012642
% 210.56/210.71       91; was see under PHENETHYLAMINES 1984-90; was DEPRENYL see under PHENETHYLAMINES 1979-83%A%  
% 210.56/210.71  |- mesh__historyNote mesh__D012642
% 210.56/210.71       91%28%84%29%; was see under PHENETHYLAMINES 1984-90; was DEPRENYL see under PHENETHYLAMINES 1979-83%A%  
% 210.56/210.71  |- mesh__dateEstablished mesh__D012642 1991-01-01
% 210.56/210.71  |- skos__altLabel mesh__D012642 Selegyline
% 210.56/210.71  |- mesh__recordAuthorizer mesh__D012642 sjn
% 210.56/210.71  |- skos__prefLabel mesh__D012642 Selegiline
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D012642 2005
% 210.56/210.71  |- skos__historyNote mesh__D012642 Phenethylamines %28%1966-1978%29%
% 210.56/210.71  |- skos__scopeNote mesh__D012642
% 210.56/210.71       A selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson%27%s disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. %28%From AMA Drug Evaluations Annual, 1994, p385%29% The compound without isomeric designation is Deprenyl.%A%    
% 210.56/210.71  |- skos__historyNote mesh__D012642
% 210.56/210.71       Monoamine Oxidase Inhibitors %28%1966-1978%29%
% 210.56/210.71  |- mesh__dateCreated mesh__D012642 1977-12-09
% 210.56/210.71  |- skos__altLabel mesh__D012642 Jumex
% 210.56/210.71  |- skos__altLabel mesh__D012642 Selegiline Hydrochloride
% 210.56/210.71  |- skos__altLabel mesh__D012642 Deprenil
% 210.56/210.71  |- mesh__dateRevised mesh__D012642 2003-07-25
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D012642 2004
% 210.56/210.71  |- skos__hiddenLabel mesh__D012642 E 250
% 210.56/210.71  |- mesh__dateRevised mesh__D006605 2003-07-09
% 210.56/210.71  |- skos__hiddenLabel mesh__D006605 Hibernations
% 210.56/210.71  |- skos__broader mesh__D006605smesh__D001833
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D006605 2006
% 210.56/210.71  |- mesh__recordOriginator mesh__D006605 NLM
% 210.56/210.71  |- skos__prefLabel mesh__D006605 Hibernation
% 210.56/210.71  |- skos__annotation mesh__D006605
% 210.56/210.71       animal only; a natural physiol process; summer dormancy corresponding to this winter dormancy = ESTIVATION%A%  
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D006605 2005
% 210.56/210.71  |- skos__scopeNote mesh__D006605
% 210.56/210.71       The dormant state in which some animal species pass the winter. It is characterized by narcosis and by sharp reduction in body temperature and metabolic activity and by a depression of vital signs. It is a natural physiological process in many warm-blooded animals.%A%    
% 210.56/210.71  |- mesh__recordAuthorizer mesh__D006605 sjn
% 210.56/210.71  |- rdf__type mesh__D006605sskos__Concept
% 210.56/210.71  |- skos__broader mesh__D006605smesh__D000222
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D006605 2004
% 210.56/210.71  |- mesh__dateCreated mesh__D006605 1999-01-01
% 210.56/210.71  |- mesh__recordMaintainer mesh__D006605 lkt
% 210.56/210.71  |- skos__altLabel mesh__D050761 CDKN1C Protein
% 210.56/210.71  |- skos__hiddenLabel mesh__D050761 KIP2 Protein, p57
% 210.56/210.71  |- skos__altLabel mesh__D050761 Cyclin Kinase Inhibitor Protein 2
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D050761 2006
% 210.56/210.71  |- skos__altLabel mesh__D050761 p57KIP2 Protein
% 210.56/210.71  |- skos__scopeNote mesh__D050761
% 210.56/210.71       A potent inhibitor of CYCLIN-DEPENDENT KINASES in G1 PHASE and S PHASE. In humans, aberrant expression of p57 is associated with various NEOPLASMS as well as with BECKWITH-WIEDEMANN SYNDROME.%A%    
% 210.56/210.71  |- rdf__type mesh__D050761sskos__Concept
% 210.56/210.71  |- skos__prefLabel mesh__D050761 Cyclin-Dependent Kinase Inhibitor p57
% 210.56/210.71  |- mesh__publicMeSHNote mesh__D050761
% 210.56/210.71       2006; CYCLIN-DEPENDENT KINASE INHIBITOR P57 was indexed under NUCLEAR PROTEINS 1995-2005%A%  
% 210.56/210.71  |- skos__broader mesh__D050761smesh__D050756
% 210.56/210.71  |- mesh__dateCreated mesh__D050761 2005-06-30
% 210.56/210.71  |- mesh__recordOriginator mesh__D050761 DRC
% 210.56/210.71  |- mesh__recordAuthorizer mesh__D050761 sjn
% 210.56/210.71  |- mesh__recordMaintainer mesh__D050761 DRC
% 210.56/210.71  |- mesh__historyNote mesh__D050761 2006%28%1995%29%   
% 210.56/210.71  |- mesh__dateEstablished mesh__D050761 2006-01-01
% 210.56/210.71  |- skos__hiddenLabel mesh__D050761 Cyclin Dependent Kinase Inhibitor 1C
% 210.56/210.71  |- skos__hiddenLabel mesh__D050761 Cyclin Dependent Kinase Inhibitor p57
% 210.56/210.71  |- skos__altLabel mesh__D050761 Cyclin-Dependent Kinase Inhibitor 1C
% 210.56/210.71  |- skos__altLabel mesh__D050761 p57 KIP2 Protein
% 210.56/210.71  |- mesh__dateCreated mesh__D044724 2003-07-09
% 210.56/210.71  |- mesh__dateEstablished mesh__D044724 2004-01-01
% 210.56/210.71  |- skos__historyNote mesh__D044724 Algae, Red %28%1976-2003%29%
% 210.56/210.71  |- skos__broader mesh__D044724smesh__D000461
% 210.56/210.71  |- skos__scopeNote mesh__D044724
% 210.56/210.71       A genus of RED ALGAE in the family Gracilariaceae. It is a highly commercial SEAWEED and a source of AGAR.%A%    
% 210.56/210.71  |- skos__prefLabel mesh__D044724 Gracilaria
% 210.56/210.71  |- mesh__recordMaintainer mesh__D044724 SYSTEM
% 210.56/210.71  |- mesh__publicMeSHNote mesh__D044724 2004   
% 210.56/210.71  |- mesh__recordAuthorizer mesh__D044724 sjn
% 210.56/210.71  |- rdf__type mesh__D044724sskos__Concept
% 210.56/210.71  |- mesh__recordOriginator mesh__D044724 ags
% 210.56/210.71  |- mesh__dateRevised mesh__D044724 2005-06-30
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D044724 2006
% 210.56/210.71  |- mesh__historyNote mesh__D044724 2004   
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D016235 1993
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D016235 2005
% 210.56/210.71  |- mesh__dateCreated mesh__D016235 1990-06-06
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D016235 1996
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D016235 1999
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D016235 2000
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D016235 2003
% 210.56/210.71  |- skos__annotation mesh__D016235
% 210.56/210.71       add UNITED STATES %28%NIM%29%; DF: ASHA       CATALOG: use NAF entry%A%  
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D016235 2006
% 210.56/210.71  |- skos__hiddenLabel mesh__D016235
% 210.56/210.71       Association, American Speech-Language-Hearing
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D016235 2001
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D016235 1997
% 210.56/210.71  |- skos__historyNote mesh__D016235
% 210.56/210.71       Speech-Language Pathology %28%1980-1990%29%
% 210.56/210.71  |- skos__hiddenLabel mesh__D016235
% 210.56/210.71       American Speech Language Hearing Association
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D016235 2004
% 210.56/210.71  |- skos__historyNote mesh__D016235 Audiology %28%1978-1990%29%
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D016235 2002
% 210.56/210.71  |- mesh__publicMeSHNote mesh__D016235 91   
% 210.56/210.71  |- skos__historyNote mesh__D016235 Speech Therapy %28%1966-1979%29%
% 210.56/210.71  |- rdf__type mesh__D016235sskos__Concept
% 210.56/210.71  |- mesh__historyNote mesh__D016235 91   
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D016235 1994
% 210.56/210.71  |- skos__hiddenLabel mesh__D016235
% 210.56/210.71       Speech-Language-Hearing Association, American
% 210.56/210.71  |- skos__historyNote mesh__D016235 Hearing %28%1966-1974%29%
% 210.56/210.71  |- mesh__recordOriginator mesh__D016235 TGC
% 210.56/210.71  |- mesh__dateEstablished mesh__D016235 1991-01-01
% 210.56/210.71  |- skos__broader mesh__D016235smesh__D012952
% 210.56/210.71  |- mesh__recordAuthorizer mesh__D016235 PLS
% 210.56/210.71  |- mesh__dateRevised mesh__D016235 1992-03-25
% 210.56/210.71  |- skos__scopeNote mesh__D016235
% 210.56/210.71       A professional society concerned with the diagnosis, prevention, treatment, and remediation of speech, language, and hearing disorders.%A%    
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D016235 1995
% 210.56/210.71  |- skos__historyNote mesh__D016235 Societies %28%1966-1990%29%
% 210.56/210.71  |- skos__prefLabel mesh__D016235
% 210.56/210.71       American Speech-Language-Hearing Association
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D016235 1998
% 210.56/210.71  |- mesh__recordMaintainer mesh__D016235 TAP
% 210.56/210.71  |- skos__broader mesh__D002215smesh__D007211
% 210.56/210.71  |- skos__historyNote mesh__D002215 Pesticides %28%1966-1971%29%
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D002215 2006
% 210.56/210.71  |- mesh__recordMaintainer mesh__D002215 nns
% 210.56/210.71  |- skos__hiddenLabel mesh__D002215
% 210.56/210.71       N Trichloromethylthio 4 cyclohexane 1,2 dicarboximide
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D002215 2002
% 210.56/210.71  |- mesh__dateEstablished mesh__D002215 1974-01-01
% 210.56/210.71  |- mesh__dateRevised mesh__D002215 2001-07-25
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D002215 2005
% 210.56/210.71  |- skos__historyNote mesh__D002215 Indoles %28%1966-1971%29%
% 210.56/210.71  |- rdf__type mesh__D002215sskos__Concept
% 210.56/210.71  |- skos__scopeNote mesh__D002215 One of the phthalimide fungicides.     
% 210.56/210.71  |- mesh__dateCreated mesh__D002215 1999-01-01
% 210.56/210.71  |- mesh__recordOriginator mesh__D002215 NLM
% 210.56/210.71  |- mesh__recordAuthorizer mesh__D002215 sjn
% 210.56/210.71  |- skos__historyNote mesh__D002215 Antifungal Agents %28%1966-1971%29%
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D002215 2004
% 210.56/210.71  |- mesh__publicMeSHNote mesh__D002215 74   
% 210.56/210.71  |- skos__prefLabel mesh__D002215 Captan
% 210.56/210.71  |- mesh__historyNote mesh__D002215 74%28%72%29%   
% 210.56/210.71  |- skos__altLabel mesh__D002215
% 210.56/210.71       N-Trichloromethylthio-4-cyclohexane-1,2-dicarboximide
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D002215 2003
% 210.56/210.71  |- skos__prefLabel mesh__D012643 Selenium
% 210.56/210.71  |- mesh__recordOriginator mesh__D012643 NLM
% 210.56/210.71  |- mesh__dateCreated mesh__D012643 1999-01-01
% 210.56/210.71  |- skos__annotation mesh__D012643
% 210.56/210.71       Se-80; Se-74, 76-78, 82 = SELENIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Se-70-73, 75, 79, 81, 83-85 = SELENIUM RADIOISOTOPES %28%IM%29%%A%  
% 210.56/210.71  |- skos__broader mesh__D012643smesh__D008903
% 210.56/210.71  |- skos__scopeNote mesh__D012643
% 210.56/210.71       An element with the atomic symbol Se, atomic number 34, and atomic weight 78.96. It is an essential micronutrient for mammals and other animals but is toxic in large amounts. Selenium protects intracellular structures against oxidative damage. It is an essential component of GLUTATHIONE PEROXIDASE.%A%    
% 210.56/210.71  |- mesh__recordAuthorizer mesh__D012643 sjn
% 210.56/210.71  |- mesh__dateRevised mesh__D012643 2005-06-30
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D012643 2006
% 210.56/210.71  |- skos__related mesh__D012643smesh__D012644
% 210.56/210.71  |- skos__broader mesh__D012643smesh__D018011
% 210.56/210.71  |- mesh__recordMaintainer mesh__D012643 ssb
% 210.56/210.71  |- rdf__type mesh__D012643sskos__Concept
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D006606 2006
% 210.56/210.71  |- skos__broader mesh__D006606smesh__D012817
% 210.56/210.71  |- skos__hiddenLabel mesh__D006606 Hiccups
% 210.56/210.71  |- mesh__dateRevised mesh__D006606 1999-11-03
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D006606 2005
% 210.56/210.71  |- skos__prefLabel mesh__D006606 Hiccup
% 210.56/210.71  |- rdf__type mesh__D006606sskos__Concept
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D006606 2002
% 210.56/210.71  |- mesh__recordMaintainer mesh__D006606 KEV
% 210.56/210.71  |- mesh__recordOriginator mesh__D006606 NLM
% 210.56/210.71  |- skos__scopeNote mesh__D006606
% 210.56/210.71       A spasm of the diaphragm that causes a sudden inhalation followed by rapid closure of the glottis which produces a sound.%A%    
% 210.56/210.71  |- skos__hiddenLabel mesh__D006606 Hiccoughs
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D006606 2004
% 210.56/210.71  |- mesh__recordAuthorizer mesh__D006606 sjn
% 210.56/210.71  |- mesh__dateCreated mesh__D006606 1999-01-01
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D006606 2001
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D006606 2003
% 210.56/210.71  |- skos__altLabel mesh__D006606 Hiccough
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D006606 2000
% 210.56/210.71  |- skos__altLabel mesh__D050762 Cyclin-Dependent Kinase Inhibitor 2B
% 210.56/210.71  |- skos__hiddenLabel mesh__D050762 Cyclin Dependent Kinase Inhibitor p15
% 210.56/210.71  |- skos__altLabel mesh__D050762 INK4B Protein
% 210.56/210.71  |- skos__altLabel mesh__D050762 CDKN2B Protein
% 210.56/210.71  |- mesh__historyNote mesh__D050762 2006%28%1994%29%   
% 210.56/210.71  |- mesh__publicMeSHNote mesh__D050762
% 210.56/210.71       2006; CYCLIN-DEPENDENT KINASE INHIBITOR P15 was indexed under TUMOR SUPPRESSOR PROTEINS %26% CELL CYCLE PROTEINS 2004-2005, under PROTEIN P16 2002-2004, %26% under CARRIER PROTEINS 1994-2001%A%  
% 210.56/210.71  |- skos__prefLabel mesh__D050762 Cyclin-Dependent Kinase Inhibitor p15
% 210.56/210.71  |- skos__broader mesh__D050762smesh__D050756
% 210.56/210.71  |- skos__hiddenLabel mesh__D050762 CDK4 Inhibitor, p15
% 210.56/210.71  |- skos__altLabel mesh__D050762 p15 CDK4 Inhibitor
% 210.56/210.71  |- mesh__recordOriginator mesh__D050762 DRC
% 210.56/210.71  |- skos__hiddenLabel mesh__D050762 Cyclin Dependent Kinase Inhibitor 2B
% 210.56/210.71  |- skos__altLabel mesh__D050762 INK4b Cyclin-Dependent Kinase Inhibitor
% 210.56/210.71  |- skos__hiddenLabel mesh__D050762 INK4b Cyclin Dependent Kinase Inhibitor
% 210.56/210.71  |- mesh__dateCreated mesh__D050762 2005-06-30
% 210.56/210.71  |- skos__scopeNote mesh__D050762
% 210.56/210.71       An INK4 cyclin-dependent kinase inhibitor containing four ANKYRIN-LIKE REPEATS. INK4B is often inactivated by deletions, mutations, or hypermethylation in HEMATOLOGIC NEOPLASMS.%A%    
% 210.56/210.71  |- mesh__recordAuthorizer mesh__D050762 sjn
% 210.56/210.71  |- mesh__dateEstablished mesh__D050762 2006-01-01
% 210.56/210.71  |- mesh__activeMeSHYear mesh__D050762 2006
% 210.56/210.72  |- mesh__recordMaintainer mesh__D050762 DRC
% 210.56/210.72  |- skos__altLabel mesh__D050762 p15INK4B Protein
% 210.56/210.72  |- rdf__type mesh__D050762sskos__Concept
% 210.56/210.72  |- mesh__recordOriginator mesh__D044725 ags
% 210.56/210.72  |- mesh__recordMaintainer mesh__D044725 SYSTEM
% 210.56/210.72  |- mesh__dateRevised mesh__D044725 2005-06-30
% 210.56/210.72  |- mesh__publicMeSHNote mesh__D044725 2004   
% 210.56/210.72  |- mesh__historyNote mesh__D044725 2004   
% 210.56/210.72  |- skos__prefLabel mesh__D044725 Plocamium
% 210.56/210.72  |- mesh__dateEstablished mesh__D044725 2004-01-01
% 210.56/210.72  |- skos__scopeNote mesh__D044725
% 210.56/210.72       A genus of RED ALGAE, in the family Plocamiaceae, found in temperate marine environments worldwide. Polyhalogenated monoterpenes of potential medicinal use have been isolated from its species.%A%    
% 210.56/210.72  |- rdf__type mesh__D044725sskos__Concept
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D044725 2006
% 210.56/210.72  |- mesh__recordAuthorizer mesh__D044725 sjn
% 210.56/210.72  |- mesh__dateCreated mesh__D044725 2003-07-09
% 210.56/210.72  |- skos__historyNote mesh__D044725 Algae, Red %28%1977-2003%29%
% 210.56/210.72  |- skos__broader mesh__D044725smesh__D000461
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D049410 2006
% 210.56/210.72  |- skos__altLabel mesh__D049410 Renilla Luciferases
% 210.56/210.72  |- skos__broader mesh__D049410smesh__D008156
% 210.56/210.72  |- mesh__dateCreated mesh__D049410 2004-07-07
% 210.56/210.72  |- mesh__historyNote mesh__D049410 2005   
% 210.56/210.72  |- rdf__type mesh__D049410sskos__Concept
% 210.56/210.72  |- mesh__recordAuthorizer mesh__D049410 sjn
% 210.56/210.72  |- mesh__publicMeSHNote mesh__D049410 2005   
% 210.56/210.72  |- mesh__recordMaintainer mesh__D049410 ssb
% 210.56/210.72  |- mesh__dateEstablished mesh__D049410 2005-01-01
% 210.56/210.72  |- skos__altLabel mesh__D049410 Luciferases, Sea Pansy
% 210.56/210.72  |- skos__scopeNote mesh__D049410
% 210.56/210.72       Luciferases from RENILLA that oxidizes certain LUMINESCENT AGENTS to cause emission of PHOTONS.%A%    
% 210.56/210.72  |- skos__historyNote mesh__D049410 Luciferases %28%1966-2004%29%
% 210.56/210.72  |- skos__hiddenLabel mesh__D049410 Sea Pansy Luciferases
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D049410 2005
% 210.56/210.72  |- mesh__recordOriginator mesh__D049410 ssb
% 210.56/210.72  |- skos__prefLabel mesh__D049410 Luciferases, Renilla
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D016236 2006
% 210.56/210.72  |- mesh__recordOriginator mesh__D016236 AGS
% 210.56/210.72  |- skos__hiddenLabel mesh__D016236 v-fms Gene
% 210.56/210.72  |- skos__hiddenLabel mesh__D016236 c fms Proto Oncogenes
% 210.56/210.72  |- mesh__dateRevised mesh__D016236 2005-07-22
% 210.56/210.72  |- skos__hiddenLabel mesh__D016236 c-fms Proto-Oncogene
% 210.56/210.72  |- skos__altLabel mesh__D016236 fms Genes
% 210.56/210.72  |- skos__hiddenLabel mesh__D016236 c-fms Gene
% 210.56/210.72  |- mesh__recordMaintainer mesh__D016236 ags
% 210.56/210.72  |- skos__hiddenLabel mesh__D016236 v fms Oncogenes
% 210.56/210.72  |- skos__altLabel mesh__D016236 v-fms Oncogenes
% 210.56/210.72  |- mesh__historyNote mesh__D016236 91   
% 210.56/210.72  |- rdf__type mesh__D016236sskos__Concept
% 210.56/210.72  |- skos__hiddenLabel mesh__D016236 c fms Genes
% 210.56/210.72  |- mesh__dateEstablished mesh__D016236 1991-01-01
% 210.56/210.72  |- skos__prefLabel mesh__D016236 Genes, fms
% 210.56/210.72  |- skos__related mesh__D016236smesh__D016186
% 210.56/210.72  |- skos__related mesh__D016236smesh__D016281
% 210.56/210.72  |- skos__hiddenLabel mesh__D016236 Oncogenes, v-fms
% 210.56/210.72  |- skos__hiddenLabel mesh__D016236 Gene, c-fms
% 210.56/210.72  |- skos__hiddenLabel mesh__D016236 v-fms Oncogene
% 210.56/210.72  |- skos__scopeNote mesh__D016236
% 210.56/210.72       Family of genes originally isolated from the Susan McDonough strain of feline sarcoma virus %28%SARCOMA VIRUSES, FELINE%29%. The proto-oncogene fms %28%c-fms%29% codes for the MCSF receptor %28%RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR%29%. The oncogene fms %28%v-fms%29% codes for ONCOGENE PROTEIN GP140%28%V-FMS%29% which is a mutated form of the MCSF. The human c-fms gene is located between 5q33.2 and 5q33.3.%A%    
% 210.56/210.72  |- skos__hiddenLabel mesh__D016236 fms Gene
% 210.56/210.72  |- skos__hiddenLabel mesh__D016236 Oncogene, v-fms
% 210.56/210.72  |- skos__historyNote mesh__D016236 Oncogenes %28%1983-1990%29%
% 210.56/210.72  |- mesh__publicMeSHNote mesh__D016236 91   
% 210.56/210.72  |- skos__hiddenLabel mesh__D016236 v fms Genes
% 210.56/210.72  |- skos__hiddenLabel mesh__D016236 Proto-Oncogenes, c-fms
% 210.56/210.72  |- mesh__recordAuthorizer mesh__D016236 ags
% 210.56/210.72  |- mesh__dateCreated mesh__D016236 1990-06-28
% 210.56/210.72  |- skos__hiddenLabel mesh__D016236 Gene, fms
% 210.56/210.72  |- skos__hiddenLabel mesh__D016236 Genes, v-fms
% 210.56/210.72  |- skos__broader mesh__D016236smesh__D011519
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D016236 2006A
% 210.56/210.72  |- skos__hiddenLabel mesh__D016236 Proto-Oncogene, c-fms
% 210.56/210.72  |- skos__historyNote mesh__D016236 Proto-Oncogenes %28%1986-1990%29%
% 210.56/210.72  |- skos__hiddenLabel mesh__D016236 Gene, v-fms
% 210.56/210.72  |- skos__hiddenLabel mesh__D016236 Genes, c-fms
% 210.56/210.72  |- skos__altLabel mesh__D016236 c-fms Proto-Oncogenes
% 210.56/210.72  |- skos__scopeNote mesh__D002216
% 210.56/210.72       A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin.%A%    
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D002216 2005
% 210.56/210.72  |- skos__hiddenLabel mesh__D002216 SQ14225
% 210.56/210.72  |- rdf__type mesh__D002216sskos__Concept
% 210.56/210.72  |- skos__hiddenLabel mesh__D002216 SQ 14534
% 210.56/210.72  |- mesh__recordAuthorizer mesh__D002216 ags
% 210.56/210.72  |- skos__broader mesh__D002216smesh__D011392
% 210.56/210.72  |- skos__hiddenLabel mesh__D002216 SQ14,225
% 210.56/210.72  |- mesh__onlineNote mesh__D002216
% 210.56/210.72       use CAPTOPRIL to search SQ 14225 1980-93   
% 210.56/210.72  |- skos__hiddenLabel mesh__D002216 SQ14534
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D002216 2000B
% 210.56/210.72  |- skos__prefLabel mesh__D002216 Captopril
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D002216 2002
% 210.56/210.72  |- skos__altLabel mesh__D002216 SQ-14225
% 210.56/210.72  |- mesh__dateEstablished mesh__D002216 1986-01-01
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D002216 2004
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D002216 2000A
% 210.56/210.72  |- skos__hiddenLabel mesh__D002216 SQ 14,225
% 210.56/210.72  |- skos__historyNote mesh__D002216
% 210.56/210.72       Peptide Peptidohydrolases %28%1966-1967%29% /antagonists %26% inhibitors %28%1968-1972%29%
% 210.56/210.72  |- mesh__publicMeSHNote mesh__D002216
% 210.56/210.72       86; was see under PROLINE 1980-85; SQ 14225 was see CAPTOPRIL 1980-93%A%  
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D002216 2003
% 210.56/210.72  |- skos__historyNote mesh__D002216
% 210.56/210.72       Kininase II/antagonists %26% inhibitors %28%1973-1979%29%
% 210.56/210.72  |- mesh__recordMaintainer mesh__D002216 ags
% 210.56/210.72  |- mesh__dateRevised mesh__D002216 2000-01-19
% 210.56/210.72  |- skos__altLabel mesh__D002216
% 210.56/210.72       %28%S%29%-1-%28%3-Mercapto-2-methyl-1-oxopropyl%29%-L-proline
% 210.56/210.72  |- skos__altLabel mesh__D002216 SQ-14534
% 210.56/210.72  |- skos__hiddenLabel mesh__D002216 SQ14,534
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D002216 2001
% 210.56/210.72  |- mesh__historyNote mesh__D002216
% 210.56/210.72       86%28%80%29%; was see under PROLINE 1980-85; SQ 14225 was see CAPTOPRIL 1980-93%A%  
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D002216 2006
% 210.56/210.72  |- skos__hiddenLabel mesh__D002216 SQ 14,534
% 210.56/210.72  |- skos__historyNote mesh__D002216
% 210.56/210.72       Proline %28%1966-1974%29% /antagonists %26% inhibitors %28%1975-1979%29%
% 210.56/210.72  |- mesh__dateCreated mesh__D002216 1979-05-23
% 210.56/210.72  |- skos__hiddenLabel mesh__D002216 SQ 14225
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D002216 2000
% 210.56/210.72  |- mesh__recordOriginator mesh__D002216 RLS
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D012644 2004
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D012644 1994
% 210.56/210.72  |- skos__hiddenLabel mesh__D012644 Radioisotopes, Selenium
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D012644 1998
% 210.56/210.72  |- mesh__recordMaintainer mesh__D012644 TPW
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D012644 1995
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D012644 2000
% 210.56/210.72  |- mesh__historyNote mesh__D012644 88   
% 210.56/210.72  |- skos__scopeNote mesh__D012644
% 210.56/210.72       Unstable isotopes of selenium that decay or disintegrate emitting radiation. Se atoms with atomic weights 70-73, 75, 79, 81, and 83-85 are radioactive selenium isotopes.%A%    
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D012644 1999
% 210.56/210.72  |- mesh__recordAuthorizer mesh__D012644 PLS
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D012644 2005
% 210.56/210.72  |- skos__historyNote mesh__D012644 Radioisotopes %28%1966-1987%29%
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D012644 2001
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D012644 1996
% 210.56/210.72  |- skos__prefLabel mesh__D012644 Selenium Radioisotopes
% 210.56/210.72  |- skos__broader mesh__D012644smesh__D011868
% 210.56/210.72  |- mesh__publicMeSHNote mesh__D012644 88   
% 210.56/210.72  |- skos__annotation mesh__D012644
% 210.56/210.72       Se-70-73, 75, 79, 81, 83-85; /blood-csf-urine /metab  permitted but not for tracer studies %28% = /diag use%29%%A%  
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D012644 2006
% 210.56/210.72  |- mesh__recordOriginator mesh__D012644 RLS
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D012644 1997
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D012644 2003
% 210.56/210.72  |- mesh__dateEstablished mesh__D012644 1988-01-01
% 210.56/210.72  |- skos__historyNote mesh__D012644 Selenium %28%1966-1987%29%
% 210.56/210.72  |- mesh__dateCreated mesh__D012644 1987-04-08
% 210.56/210.72  |- rdf__type mesh__D012644sskos__Concept
% 210.56/210.72  |- mesh__dateRevised mesh__D012644 1993-06-03
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D012644 2002
% 210.56/210.72  |- skos__scopeNote mesh__D006607
% 210.56/210.72       A benign neoplasm derived from epithelial cells of sweat glands. %28%Stedman, 25th ed%29%%A%    
% 210.56/210.72  |- skos__hiddenLabel mesh__D006607 Sweat Gland Adenomas
% 210.56/210.72  |- mesh__recordMaintainer mesh__D006607 KEV
% 210.56/210.72  |- skos__broader mesh__D006607smesh__D018294
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D006607 1997
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D006607 2001
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D006607 2004
% 210.56/210.72  |- skos__hiddenLabel mesh__D006607 Sweat Gland Adenoma
% 210.56/210.72  |- skos__altLabel mesh__D006607 Hidradenoma
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D006607 1996
% 210.56/210.72  |- skos__hiddenLabel mesh__D006607 Adenomas, Sweat Gland
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D006607 2000
% 210.56/210.72  |- mesh__dateCreated mesh__D006607 1999-01-01
% 210.56/210.72  |- skos__hiddenLabel mesh__D006607 Hidradenomas
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D006607 2003
% 210.56/210.72  |- mesh__publicMeSHNote mesh__D006607 94; was HIDRADENOMA 1963-93   
% 210.56/210.72  |- mesh__recordAuthorizer mesh__D006607 PLS
% 210.56/210.72  |- skos__hiddenLabel mesh__D006607 Syringadenomas
% 210.56/210.72  |- mesh__historyNote mesh__D006607 94; was HIDRADENOMA 1963-93   
% 210.56/210.72  |- skos__altLabel mesh__D006607 Syringadenoma
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D006607 1999
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D006607 2006
% 210.56/210.72  |- skos__annotation mesh__D006607
% 210.56/210.72       /blood supply /chem /secret /ultrastruct permitted; coord IM with SWEAT GLAND NEOPLASMS %28%IM%29%%A%  
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D006607 1998
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D006607 2002
% 210.56/210.72  |- skos__broader mesh__D006607smesh__D000236
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D006607 2005
% 210.56/210.72  |- mesh__recordOriginator mesh__D006607 NLM
% 210.56/210.72  |- mesh__dateRevised mesh__D006607 1995-06-08
% 210.56/210.72  |- rdf__type mesh__D006607sskos__Concept
% 210.56/210.72  |- mesh__onlineNote mesh__D006607
% 210.56/210.72       use ADENOMA, SWEAT GLAND to search HIDRADENOMA 1966-93   
% 210.56/210.72  |- skos__prefLabel mesh__D006607 Adenoma, Sweat Gland
% 210.56/210.72  |- mesh__dateEstablished mesh__D050763 2006-01-01
% 210.56/210.72  |- mesh__recordMaintainer mesh__D050763 DRC
% 210.56/210.72  |- mesh__dateCreated mesh__D050763 2005-06-30
% 210.56/210.72  |- skos__altLabel mesh__D050763 p18INK4c Protein
% 210.56/210.72  |- mesh__recordAuthorizer mesh__D050763 sjn
% 210.56/210.72  |- skos__hiddenLabel mesh__D050763 p18, CDK6-Associated Protein
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D050763 2006
% 210.56/210.72  |- skos__altLabel mesh__D050763 CDKN2C Protein
% 210.56/210.72  |- skos__hiddenLabel mesh__D050763 Cyclin Dependent Kinase Inhibitor 2C
% 210.56/210.72  |- skos__altLabel mesh__D050763 p18 CDK6 Inhibitor
% 210.56/210.72  |- mesh__historyNote mesh__D050763 2006%28%1994%29%   
% 210.56/210.72  |- skos__hiddenLabel mesh__D050763 CDK6 Inhibitor, p18
% 210.56/210.72  |- rdf__type mesh__D050763sskos__Concept
% 210.56/210.72  |- skos__altLabel mesh__D050763 INK4C Protein
% 210.56/210.72  |- mesh__publicMeSHNote mesh__D050763
% 210.56/210.72       2006; CYCLIN-DEPENDENT KINASE INHIBITOR P 18 was indexed under TUMOR SUPPRESSOR PROTEINS %26% CELL CYCLE PROTEINS 2002-2005, %26% under CARRIER PROTEINS 1994-2001%A%  
% 210.56/210.72  |- skos__hiddenLabel mesh__D050763 Cyclin Dependent Kinase Inhibitor p18
% 210.56/210.72  |- skos__altLabel mesh__D050763 Cyclin-Dependent Kinase Inhibitor 2C
% 210.56/210.72  |- skos__prefLabel mesh__D050763 Cyclin-Dependent Kinase Inhibitor p18
% 210.56/210.72  |- skos__hiddenLabel mesh__D050763 CDK6 Associated Protein p18
% 210.56/210.72  |- skos__scopeNote mesh__D050763
% 210.56/210.72       An INK4 cyclin-dependent kinase inhibitor containing five ANKYRIN-LIKE REPEATS. Aberrant expression of this protein has been associated with deregulated EPITHELIAL CELL growth, organ enlargement, and a variety of NEOPLASMS.%A%    
% 210.56/210.72  |- mesh__recordOriginator mesh__D050763 DRC
% 210.56/210.72  |- skos__altLabel mesh__D050763 CDK6-Associated Protein p18
% 210.56/210.72  |- skos__broader mesh__D050763smesh__D050756
% 210.56/210.72  |- skos__broader mesh__D044726smesh__D009868
% 210.56/210.72  |- mesh__publicMeSHNote mesh__D044726 2004   
% 210.56/210.72  |- mesh__recordAuthorizer mesh__D044726 sjn
% 210.56/210.72  |- skos__prefLabel mesh__D044726 Lagenidium
% 210.56/210.72  |- skos__annotation mesh__D044726
% 210.56/210.72       infection: coord IM with INFECTION %28%IM%29%   
% 210.56/210.72  |- skos__historyNote mesh__D044726 Oomycetes %28%1983-2003%29%
% 210.56/210.72  |- mesh__recordOriginator mesh__D044726 ags
% 210.56/210.72  |- mesh__dateRevised mesh__D044726 2005-06-30
% 210.56/210.72  |- mesh__recordMaintainer mesh__D044726 SYSTEM
% 210.56/210.72  |- mesh__historyNote mesh__D044726 2004   
% 210.56/210.72  |- rdf__type mesh__D044726sskos__Concept
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D044726 2006
% 210.56/210.72  |- skos__scopeNote mesh__D044726
% 210.56/210.72       A genus of ALGAE in the family Lagenidiaceae. One species %28%L. giganteum%29% parasitizes the larval stage of MOSQUITOES and is used in its biological control %28%PEST CONTROL, BIOLOGICAL%29%; it also causes disease in freshwater FISHES.%A%    
% 210.56/210.72  |- mesh__dateCreated mesh__D044726 2003-07-09
% 210.56/210.72  |- mesh__dateEstablished mesh__D044726 2004-01-01
% 210.56/210.72  |- skos__historyNote mesh__D044726 Fungi %28%1972-1982%29%
% 210.56/210.72  |- skos__broader mesh__D005971Q000819smesh__D005971
% 210.56/210.72  |- mesh__preferredCombination mesh__D005971Q000819smesh__D018690
% 210.56/210.72  |- rdf__type mesh__D005971Q000819smesh__CompoundConcept
% 210.56/210.72  |- rdf__type mesh__D049411sskos__Concept
% 210.56/210.72  |- skos__prefLabel mesh__D049411 Utrophin
% 210.56/210.72  |- skos__broader mesh__D049411smesh__D003598
% 210.56/210.72  |- skos__historyNote mesh__D049411 Membrane Proteins %28%1991-2004%29%
% 210.56/210.72  |- skos__hiddenLabel mesh__D049411 Dystrophin Related Protein
% 210.56/210.72  |- mesh__recordOriginator mesh__D049411 jmp
% 210.56/210.72  |- skos__historyNote mesh__D049411 Cytoskeletal Proteins %28%1991-2004%29%
% 210.56/210.72  |- skos__broader mesh__D049411smesh__D008565
% 210.56/210.72  |- mesh__dateRevised mesh__D049411 2004-08-03
% 210.56/210.72  |- skos__related mesh__D049411smesh__D049028
% 210.56/210.72  |- skos__scopeNote mesh__D049411
% 210.56/210.72       An autosomally-encoded 376-kDa cytoskeletal protein that is similar in structure and function to DYSTROPHIN. It is a ubiquitously-expressed protein that plays a role in anchoring the CYTOSKELETON to the PLASMA MEMBRANE.%A%    
% 210.56/210.72  |- mesh__publicMeSHNote mesh__D049411
% 210.56/210.72       2005; UTROPHIN was indexed under CYTOSKELETAL PROTEINS %26% MEMBRANE PROTEINS 1991-2004%A%  
% 210.56/210.72  |- skos__altLabel mesh__D049411 Dystrophin-Related Protein
% 210.56/210.72  |- mesh__dateEstablished mesh__D049411 2005-01-01
% 210.56/210.72  |- mesh__recordMaintainer mesh__D049411 jls
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D049411 2005
% 210.56/210.72  |- skos__hiddenLabel mesh__D049411 Dystrophin Related Protein 1
% 210.56/210.72  |- mesh__recordAuthorizer mesh__D049411 jls
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D049411 2006
% 210.56/210.72  |- mesh__dateCreated mesh__D049411 2004-07-07
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D049411 2005A
% 210.56/210.72  |- skos__altLabel mesh__D049411 UTRN Protein
% 210.56/210.72  |- skos__altLabel mesh__D049411 Dystrophin-Related Protein 1
% 210.56/210.72  |- mesh__historyNote mesh__D049411 2005%28%1991%29%   
% 210.56/210.72  |- skos__altLabel mesh__D002217 Carbacholine
% 210.56/210.72  |- skos__altLabel mesh__D002217 Bioniche Brand of Carbachol
% 210.56/210.72  |- mesh__recordOriginator mesh__D002217 NLM
% 210.56/210.72  |- rdf__type mesh__D002217sskos__Concept
% 210.56/210.72  |- skos__hiddenLabel mesh__D002217 Carbachol NutraMax Brand
% 210.56/210.72  |- mesh__recordAuthorizer mesh__D002217 sjn
% 210.56/210.72  |- skos__altLabel mesh__D002217 Optopics Brand of Carbachol
% 210.56/210.72  |- skos__prefLabel mesh__D002217 Carbachol
% 210.56/210.72  |- skos__hiddenLabel mesh__D002217 Carbachol Alcon Brand
% 210.56/210.72  |- skos__hiddenLabel mesh__D002217 Carbachol Optopics Brand
% 210.56/210.72  |- skos__altLabel mesh__D002217 Miostat
% 210.56/210.72  |- skos__hiddenLabel mesh__D002217 Carbachol Mann Brand
% 210.56/210.72  |- skos__altLabel mesh__D002217 Carbocholine
% 210.56/210.72  |- skos__altLabel mesh__D002217 Allphar Brand of Carbachol
% 210.56/210.72  |- skos__altLabel mesh__D002217 Carbamoylcholine
% 210.56/210.72  |- skos__hiddenLabel mesh__D002217 Carbachol Allphar Brand
% 210.56/210.72  |- skos__broader mesh__D002217smesh__D002794
% 210.56/210.72  |- mesh__recordMaintainer mesh__D002217 ssb
% 210.56/210.72  |- skos__altLabel mesh__D002217 Bipharma Brand of Carbachol
% 210.56/210.72  |- skos__altLabel mesh__D002217 NutraMax Brand of Carbachol
% 210.56/210.72  |- skos__altLabel mesh__D002217 Novartis Brand of Carbachol
% 210.56/210.72  |- skos__hiddenLabel mesh__D002217 Carbachol Novartis Brand
% 210.56/210.72  |- mesh__dateRevised mesh__D002217 2005-06-30
% 210.56/210.72  |- skos__hiddenLabel mesh__D002217 Carbachol, Isopto
% 210.56/210.72  |- skos__altLabel mesh__D002217 Alcon Brand of Carbachol
% 210.56/210.72  |- skos__hiddenLabel mesh__D002217 Carbachol Merck Brand
% 210.56/210.72  |- skos__altLabel mesh__D002217 Mann Brand of Carbachol
% 210.56/210.72  |- skos__altLabel mesh__D002217 Merck Brand of Carbachol
% 210.56/210.72  |- skos__hiddenLabel mesh__D002217 Carbachol Chauvin Brand
% 210.56/210.72  |- mesh__dateCreated mesh__D002217 1999-01-01
% 210.56/210.72  |- skos__scopeNote mesh__D002217
% 210.56/210.72       A slowly hydrolyzed cholinergic agonist that acts at both muscarinic and nicotinic receptors.%A%    
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D002217 2006
% 210.56/210.72  |- skos__altLabel mesh__D002217 Chauvin Brand of Carbachol
% 210.56/210.72  |- skos__hiddenLabel mesh__D002217 Carbachol Bipharma Brand
% 210.56/210.72  |- skos__hiddenLabel mesh__D002217 Carbachol Bioniche Brand
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D007700 2005
% 210.56/210.72  |- skos__broader mesh__D007700smesh__D002620
% 210.56/210.72  |- mesh__recordOriginator mesh__D007700 NLM
% 210.56/210.72  |- skos__broader mesh__D007700smesh__D019563
% 210.56/210.72  |- skos__hiddenLabel mesh__D007700 Kinetic
% 210.56/210.72  |- mesh__dateRevised mesh__D007700 2003-07-09
% 210.56/210.72  |- skos__prefLabel mesh__D007700 Kinetics
% 210.56/210.72  |- rdf__type mesh__D007700sskos__Concept
% 210.56/210.72  |- skos__annotation mesh__D007700
% 210.56/210.72       almost never IM; do not confuse with KINESICS %28%%22%use of posture or gesture for communication%22%%29% or KINESIS %28%a form of movement%29%; pharmacokinetics of chemicals and drugs is PHARMACOKINETICS or better, specific drug term /pharmacokin%A%  
% 210.56/210.72  |- skos__broader mesh__D007700smesh__D001696
% 210.56/210.72  |- mesh__recordAuthorizer mesh__D007700 sjn
% 210.56/210.72  |- mesh__dateEstablished mesh__D007700 1966-01-01
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D007700 2004
% 210.56/210.72  |- mesh__dateCreated mesh__D007700 1999-01-01
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D007700 2006
% 210.56/210.72  |- mesh__publicMeSHNote mesh__D007700 66   
% 210.56/210.72  |- mesh__historyNote mesh__D007700 66%28%64%29%   
% 210.56/210.72  |- mesh__recordMaintainer mesh__D007700 nns
% 210.56/210.72  |- skos__scopeNote mesh__D007700
% 210.56/210.72       The study of rate dynamics in chemical or physical systems.%A%    
% 210.56/210.72  |- skos__broader mesh__D000486Q000379smesh__D000486
% 210.56/210.72  |- mesh__preferredCombination mesh__D000486Q000379smesh__D007158
% 210.56/210.72  |- rdf__type mesh__D000486Q000379smesh__CompoundConcept
% 210.56/210.72  |- mesh__recordMaintainer mesh__D012645 ssb
% 210.56/210.72  |- mesh__recordAuthorizer mesh__D012645 sjn
% 210.56/210.72  |- skos__hiddenLabel mesh__D012645 Se 75, Selenomethionine
% 210.56/210.72  |- skos__altLabel mesh__D012645 Radioselenomethionine
% 210.56/210.72  |- mesh__dateRevised mesh__D012645 2005-06-30
% 210.56/210.72  |- mesh__dateCreated mesh__D012645 1974-11-19
% 210.56/210.72  |- skos__historyNote mesh__D012645 Selenium %28%1969-1974%29%
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D012645 2006
% 210.56/210.72  |- skos__broader mesh__D012645smesh__D016566
% 210.56/210.72  |- skos__annotation mesh__D012645
% 210.56/210.72       for radiolabeled x-refs, coord IM with SELENIUM RADIOISOTOPES %28%NIM%29%%A%  
% 210.56/210.72  |- skos__prefLabel mesh__D012645 Selenomethionine
% 210.56/210.72  |- mesh__recordOriginator mesh__D012645 NLM
% 210.56/210.72  |- skos__broader mesh__D012645smesh__D008715
% 210.56/210.72  |- rdf__type mesh__D012645sskos__Concept
% 210.56/210.72  |- mesh__dateEstablished mesh__D012645 1991-01-01
% 210.56/210.72  |- mesh__publicMeSHNote mesh__D012645 91; was see under SELENIUM 1975-90   
% 210.56/210.72  |- skos__scopeNote mesh__D012645
% 210.56/210.72       Diagnostic aid in pancreas function determination.     
% 210.56/210.72  |- skos__historyNote mesh__D012645 Methionine %28%1971-1974%29%
% 210.56/210.72  |- mesh__historyNote mesh__D012645
% 210.56/210.72       91%28%75%29%; was see under SELENIUM 1975-90   
% 210.56/210.72  |- mesh__onlineNote mesh__D006608 search SOCIAL DOMINANCE 1968-74   
% 210.56/210.72  |- mesh__dateEstablished mesh__D006608 1991-01-01
% 210.56/210.72  |- skos__hiddenLabel mesh__D006608 Social Hierarchy
% 210.56/210.72  |- mesh__recordOriginator mesh__D006608 NLM
% 210.56/210.72  |- mesh__dateCreated mesh__D006608 1999-01-01
% 210.56/210.72  |- mesh__dateRevised mesh__D006608 1997-06-20
% 210.56/210.72  |- mesh__publicMeSHNote mesh__D006608
% 210.56/210.72       91; was see under SOCIAL DOMINANCE 1969-90; was see under DOMINANCE, SOCIAL 1968%A%  
% 210.56/210.72  |- skos__hiddenLabel mesh__D006608 Hierarchies, Social
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D006608 2003
% 210.56/210.72  |- skos__broader mesh__D006608smesh__D012961
% 210.56/210.72  |- skos__prefLabel mesh__D006608 Hierarchy, Social
% 210.56/210.72  |- skos__scopeNote mesh__D006608
% 210.56/210.72       Social rank-order established by certain behavioral patterns.%A%    
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D006608 1999
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D006608 2001
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D006608 2006
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D006608 2000
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D006608 1998
% 210.56/210.72  |- mesh__historyNote mesh__D006608
% 210.56/210.72       91%28%75%29%; was see under SOCIAL DOMINANCE 1969-90; was see under DOMINANCE, SOCIAL 1968%A%  
% 210.56/210.72  |- mesh__recordMaintainer mesh__D006608 JLS
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D006608 2005
% 210.56/210.72  |- mesh__recordAuthorizer mesh__D006608 SJN
% 210.56/210.72  |- rdf__type mesh__D006608sskos__Concept
% 210.56/210.72  |- skos__hiddenLabel mesh__D006608 Social Hierarchies
% 210.56/210.72  |- skos__annotation mesh__D006608 human %26% animal; no qualif   
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D006608 2002
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D006608 2004
% 210.56/210.72  |- skos__hiddenLabel mesh__D017330 Hydrochloride, Remoxipride
% 210.56/210.72  |- skos__hiddenLabel mesh__D017330 FLA731
% 210.56/210.72  |- skos__prefLabel mesh__D017330 Remoxipride
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D017330 2002
% 210.56/210.72  |- mesh__onlineNote mesh__D017330
% 210.56/210.72       use REMOXIPRIDE %28%NM%29% to search REMOXIPRIDE 1984-92   
% 210.56/210.72  |- mesh__recordOriginator mesh__D017330 TPW
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D017330 2005
% 210.56/210.72  |- mesh__publicMeSHNote mesh__D017330
% 210.56/210.72       93; REMOXIPRIDE was indexed under BENZAMIDES 1984-92   
% 210.56/210.72  |- skos__hiddenLabel mesh__D017330 Monohydrochloride, Remoxipride
% 210.56/210.72  |- mesh__dateCreated mesh__D017330 1992-05-20
% 210.56/210.72  |- skos__historyNote mesh__D017330 Benzamides %28%1984-1992%29%
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D017330 2006
% 210.56/210.72  |- mesh__dateRevised mesh__D017330 2000-06-22
% 210.56/210.72  |- mesh__recordMaintainer mesh__D017330 CCR
% 210.56/210.72  |- skos__scopeNote mesh__D017330
% 210.56/210.72       An antipsychotic agent that is specific for dopamine D2 receptors. It has been shown to be effective in the treatment of schizophrenia.%A%    
% 210.56/210.72  |- mesh__recordAuthorizer mesh__D017330 sjn
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D017330 2003
% 210.56/210.72  |- mesh__dateEstablished mesh__D017330 1993-01-01
% 210.56/210.72  |- rdf__type mesh__D017330sskos__Concept
% 210.56/210.72  |- skos__altLabel mesh__D017330
% 210.56/210.72       %28%S%29%-3-Bromo-N-%28%%28%1-ethyl-2-pyrrolidinyl%29%methyl%29%-2,6-dimethoxybenzamide
% 210.56/210.72  |- mesh__historyNote mesh__D017330
% 210.56/210.72       93; was REMOXIPRIDE %28%NM%29% 1984-92   
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D017330 2001
% 210.56/210.72  |- skos__broader mesh__D017330smesh__D001549
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D017330 2004
% 210.56/210.72  |- skos__hiddenLabel mesh__D017330
% 210.56/210.72       Monohydrochloride Monohydrate, Remoxipride
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D031001 2006
% 210.56/210.72  |- skos__scopeNote mesh__D031001
% 210.56/210.72       A plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida. Leaves are opposite and usually toothed or lobed. The fruit, a samara %28%a winged nutlet%29%, splits into two %28%rarely three%29% winged, one-seeded parts.  This family is widely distributed in the Northern Hemisphere.%A%    
% 210.56/210.72  |- mesh__historyNote mesh__D031001 2003   
% 210.56/210.72  |- skos__prefLabel mesh__D031001 Aceraceae
% 210.56/210.72  |- mesh__publicMeSHNote mesh__D031001 2003   
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D031001 2003
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D031001 2004
% 210.56/210.72  |- skos__annotation mesh__D031001
% 210.56/210.72       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.56/210.72  |- mesh__dateEstablished mesh__D031001 2003-01-01
% 210.56/210.72  |- rdf__type mesh__D031001sskos__Concept
% 210.56/210.72  |- skos__broader mesh__D031001smesh__D019684
% 210.56/210.72  |- mesh__dateCreated mesh__D031001 2002-07-02
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D031001 2005
% 210.56/210.72  |- skos__altLabel mesh__D050764 Cyclin-Dependent Kinase Inhibitor 2D
% 210.56/210.72  |- mesh__publicMeSHNote mesh__D050764
% 210.56/210.72       2006; CYCLIN-DEPENDENT KINASE INHIBITOR P19 was indexed under CARRIER PROTEINS 1995-2001, under PROTEIN P16 2002-2004, %26% under CELL CYCLE PROTEINS 2005%A%  
% 210.56/210.72  |- mesh__recordMaintainer mesh__D050764 DRC
% 210.56/210.72  |- mesh__dateEstablished mesh__D050764 2006-01-01
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D050764 2006
% 210.56/210.72  |- mesh__dateCreated mesh__D050764 2005-06-30
% 210.56/210.72  |- rdf__type mesh__D050764sskos__Concept
% 210.56/210.72  |- skos__scopeNote mesh__D050764
% 210.56/210.72       An INK4 cyclin-dependent kinase inhibitor containing five ANKYRIN REPEATS. Aberrant expression of this protein has been associated with TESTICULAR CANCER.%A%    
% 210.56/210.72  |- mesh__recordAuthorizer mesh__D050764 sjn
% 210.56/210.72  |- skos__prefLabel mesh__D050764 Cyclin-Dependent Kinase Inhibitor p19
% 210.56/210.72  |- skos__altLabel mesh__D050764 INK4D Protein
% 210.56/210.72  |- mesh__historyNote mesh__D050764 2006%28%1995%29%   
% 210.56/210.72  |- skos__hiddenLabel mesh__D050764 Cyclin Dependent Kinase Inhibitor 2D
% 210.56/210.72  |- skos__altLabel mesh__D050764 p19INK4D Protein
% 210.56/210.72  |- mesh__recordOriginator mesh__D050764 DRC
% 210.56/210.72  |- skos__altLabel mesh__D050764 CDKN2D Protein
% 210.56/210.72  |- skos__broader mesh__D050764smesh__D050756
% 210.56/210.72  |- skos__hiddenLabel mesh__D050764 Cyclin Dependent Kinase Inhibitor p19
% 210.56/210.72  |- mesh__activeMeSHYear mesh__D003310 2001
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D003310 2006
% 210.56/210.73  |- skos__scopeNote mesh__D003310
% 210.56/210.73       A congenital anomaly characterized by the presence in the atrium of a perforated muscular membrane which separates the atrium into upper and lower chambers.%A%    
% 210.56/210.73  |- mesh__dateEstablished mesh__D003310 1987-01-01
% 210.56/210.73  |- skos__hiddenLabel mesh__D003310 Triatrial Hearts
% 210.56/210.73  |- skos__hiddenLabel mesh__D003310 Heart, Triatrial
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D003310 2002
% 210.56/210.73  |- mesh__recordMaintainer mesh__D003310 kle
% 210.56/210.73  |- rdf__type mesh__D003310sskos__Concept
% 210.56/210.73  |- skos__prefLabel mesh__D003310 Cor Triatriatum
% 210.56/210.73  |- mesh__recordAuthorizer mesh__D003310 sjn
% 210.56/210.73  |- skos__historyNote mesh__D003310 Heart Atrium %28%1966-1986%29%
% 210.56/210.73  |- mesh__publicMeSHNote mesh__D003310 87   
% 210.56/210.73  |- mesh__historyNote mesh__D003310 87   
% 210.56/210.73  |- mesh__dateRevised mesh__D003310 1999-11-03
% 210.56/210.73  |- skos__hiddenLabel mesh__D003310 Hearts, Triatrial
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D003310 2003
% 210.56/210.73  |- mesh__recordOriginator mesh__D003310 VDK
% 210.56/210.73  |- skos__historyNote mesh__D003310
% 210.56/210.73       Heart Defects, Congenital %28%1966-1986%29%
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D003310 2005
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D003310 2000
% 210.56/210.73  |- skos__broader mesh__D003310smesh__D006330
% 210.56/210.73  |- mesh__dateCreated mesh__D003310 1986-06-23
% 210.56/210.73  |- skos__altLabel mesh__D003310 Triatrial Heart
% 210.56/210.73  |- skos__annotation mesh__D003310
% 210.56/210.73       a heart with 3 atrial chambers; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D003310 2004
% 210.56/210.73  |- mesh__dateEstablished mesh__D016238 1991-01-01
% 210.56/210.73  |- skos__annotation mesh__D016238
% 210.56/210.73       do not use /util except by MeSH definition   
% 210.56/210.73  |- mesh__recordMaintainer mesh__D016238 lkt
% 210.56/210.73  |- skos__hiddenLabel mesh__D016238 Cytaphereses
% 210.56/210.73  |- mesh__publicMeSHNote mesh__D016238 91   
% 210.56/210.73  |- mesh__recordAuthorizer mesh__D016238 sjn
% 210.56/210.73  |- skos__broader mesh__D016238smesh__D002469
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D016238 2006
% 210.56/210.73  |- skos__broader mesh__D016238smesh__D001691
% 210.56/210.73  |- skos__prefLabel mesh__D016238 Cytapheresis
% 210.56/210.73  |- mesh__recordOriginator mesh__D016238 AGS
% 210.56/210.73  |- skos__related mesh__D016238smesh__D019264
% 210.56/210.73  |- skos__historyNote mesh__D016238
% 210.56/210.73       Blood Component Removal %28%1986-1990%29%
% 210.56/210.73  |- skos__scopeNote mesh__D016238
% 210.56/210.73       Separation of one or more kinds of cells from whole blood with the return of other blood cell constituents to the patient or donor. This is accomplished with an instrument that uses centrifugation to separate the cells into different layers based on the differences in cell density %28%displacement%29% or drag coefficients in a current %28%elutriation%29%. The procedure is commonly used in adoptive transfer to isolate NK cells, lymphocytes, or monocytes.%A%    
% 210.56/210.73  |- rdf__type mesh__D016238sskos__Concept
% 210.56/210.73  |- mesh__historyNote mesh__D016238 91   
% 210.56/210.73  |- mesh__dateRevised mesh__D016238 2005-06-30
% 210.56/210.73  |- skos__historyNote mesh__D016238 Cell Separation %28%1978-1990%29%
% 210.56/210.73  |- mesh__dateCreated mesh__D016238 1990-06-06
% 210.56/210.73  |- skos__broader mesh__D016238smesh__D001781
% 210.56/210.73  |- skos__related mesh__D016238smesh__D016219
% 210.56/210.73  |- skos__broader mesh__D002218smesh__D011810
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D002218 2003
% 210.56/210.73  |- skos__scopeNote mesh__D002218
% 210.56/210.73       An antibacterial agent that has been used in veterinary practice for treating swine dysentery and enteritis and for promoting growth. However, its use has been prohibited in the UK following reports of carcinogenicity and mutagenicity. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p125%29%%A%    
% 210.56/210.73  |- skos__prefLabel mesh__D002218 Carbadox
% 210.56/210.73  |- skos__historyNote mesh__D002218 Carbamates %28%1969-1974%29%
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D002218 2004
% 210.56/210.73  |- mesh__recordMaintainer mesh__D002218 CCR
% 210.56/210.73  |- mesh__dateCreated mesh__D002218 1974-11-19
% 210.56/210.73  |- mesh__recordOriginator mesh__D002218 NLM
% 210.56/210.73  |- mesh__historyNote mesh__D002218
% 210.56/210.73       91%28%75%29%; was see under QUINOXALINES 1975-90   
% 210.56/210.73  |- mesh__recordAuthorizer mesh__D002218 sjn
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D002218 2001
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D002218 2005
% 210.56/210.73  |- skos__broader mesh__D002218smesh__D002219
% 210.56/210.73  |- mesh__dateEstablished mesh__D002218 1991-01-01
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D002218 2002
% 210.56/210.73  |- skos__historyNote mesh__D002218 Quinoxalines %28%1973-1974%29%
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D002218 2006
% 210.56/210.73  |- mesh__dateRevised mesh__D002218 2000-06-22
% 210.56/210.73  |- rdf__type mesh__D002218sskos__Concept
% 210.56/210.73  |- mesh__publicMeSHNote mesh__D002218
% 210.56/210.73       91; was see under QUINOXALINES 1975-90   
% 210.56/210.73  |- mesh__historyNote mesh__D007701
% 210.56/210.73       2006%28%1975%29%; for KINETIN use KINETINS %28%NM%29% 1974-2005; use PLANT GROWTH REGULATORS 1975-1990%A%  
% 210.56/210.73  |- skos__altLabel mesh__D007701 6-Furfuryladenine
% 210.56/210.73  |- mesh__publicMeSHNote mesh__D007701
% 210.56/210.73       2006; see KINETINS 1991-2005, see PLANT GROWTH REGULATORS 1975-1990%A%  
% 210.56/210.73  |- mesh__dateCreated mesh__D007701 1999-01-01
% 210.56/210.73  |- rdf__type mesh__D007701sskos__Concept
% 210.56/210.73  |- skos__broader mesh__D007701smesh__D003583
% 210.56/210.73  |- skos__hiddenLabel mesh__D007701 6 Furfuryladenine
% 210.56/210.73  |- skos__altLabel mesh__D007701 6-Furfurylaminopurine
% 210.56/210.73  |- mesh__dateEstablished mesh__D007701 1991-01-01
% 210.56/210.73  |- mesh__recordOriginator mesh__D007701 NLM
% 210.56/210.73  |- skos__hiddenLabel mesh__D007701 6 Furfurylaminopurine
% 210.56/210.73  |- skos__scopeNote mesh__D007701
% 210.56/210.73       A furanyl adenine found in PLANTS and FUNGI. It has plant growth regulation effects.%A%    
% 210.56/210.73  |- skos__annotation mesh__D007701 do not confuse with KINECTIN   
% 210.56/210.73  |- mesh__recordMaintainer mesh__D007701 ssb
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D007701 2006
% 210.56/210.73  |- skos__prefLabel mesh__D007701 Kinetin
% 210.56/210.73  |- mesh__dateRevised mesh__D007701 2005-06-30
% 210.56/210.73  |- mesh__recordAuthorizer mesh__D007701 sjn
% 210.56/210.73  |- skos__broader mesh__D012646smesh__D012648
% 210.56/210.73  |- mesh__dateCreated mesh__D012646 1976-04-16
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D012646 2006
% 210.56/210.73  |- mesh__dateEstablished mesh__D012646 1977-01-01
% 210.56/210.73  |- skos__hiddenLabel mesh__D012646 Administrations, Self
% 210.56/210.73  |- mesh__recordOriginator mesh__D012646 SMH
% 210.56/210.73  |- rdf__type mesh__D012646sskos__Concept
% 210.56/210.73  |- skos__prefLabel mesh__D012646 Self Administration
% 210.56/210.73  |- mesh__dateRevised mesh__D012646 2004-07-13
% 210.56/210.73  |- skos__historyNote mesh__D012646 Self Medication %28%1966-1976%29%
% 210.56/210.73  |- skos__broader mesh__D012646smesh__D004358
% 210.56/210.73  |- mesh__recordAuthorizer mesh__D012646 sjn
% 210.56/210.73  |- skos__hiddenLabel mesh__D012646 Self Administrations
% 210.56/210.73  |- skos__altLabel mesh__D012646 Administration, Self
% 210.56/210.73  |- skos__annotation mesh__D012646
% 210.56/210.73       NIM; differentiate from SELF MEDICATION %26% SELF CARE %28%see note there%29%%A%  
% 210.56/210.73  |- mesh__recordMaintainer mesh__D012646 sjn
% 210.56/210.73  |- skos__historyNote mesh__D012646
% 210.56/210.73       specific heading/administration %26% dosage %28%1966-1976%29%
% 210.56/210.73  |- skos__scopeNote mesh__D012646
% 210.56/210.73       Administration of a drug or chemical by the individual under the direction of a physician. It includes administration clinically or experimentally, by human or animal.%A%    
% 210.56/210.73  |- mesh__historyNote mesh__D012646 77   
% 210.56/210.73  |- mesh__publicMeSHNote mesh__D012646 77   
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D012646 2005
% 210.56/210.73  |- skos__historyNote mesh__D045022
% 210.56/210.73       L-Lactate Dehydrogenase %28%1974-2003%29%
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D045022 2004
% 210.56/210.73  |- skos__prefLabel mesh__D045022 Lactate Dehydrogenases
% 210.56/210.73  |- mesh__historyNote mesh__D045022 2004   
% 210.56/210.73  |- mesh__dateCreated mesh__D045022 2003-07-09
% 210.56/210.73  |- skos__annotation mesh__D045022
% 210.56/210.73       L-LACTATE DEHYDROGENASE and L-LACTATE DEHYDROGENASE %28%CYTOCHROME%29% are also available%A%  
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D045022 2006
% 210.56/210.73  |- rdf__type mesh__D045022sskos__Concept
% 210.56/210.73  |- skos__broader mesh__D045022smesh__D000429
% 210.56/210.73  |- mesh__publicMeSHNote mesh__D045022 2004   
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D045022 2005
% 210.56/210.73  |- mesh__dateEstablished mesh__D045022 2004-01-01
% 210.56/210.73  |- skos__scopeNote mesh__D045022
% 210.56/210.73       Alcohol oxidoreductases with substrate specificity for LACTIC ACID.%A%    
% 210.56/210.73  |- skos__hiddenLabel mesh__D045022 Dehydrogenases, Lactate
% 210.56/210.73  |- skos__historyNote mesh__D006609
% 210.56/210.73       Chromosomal Proteins, Non-Histone %28%1977-1984%29%
% 210.56/210.73  |- skos__broader mesh__D006609smesh__D002868
% 210.56/210.73  |- mesh__historyNote mesh__D006609 85   
% 210.56/210.73  |- mesh__dateEstablished mesh__D006609 1985-01-01
% 210.56/210.73  |- skos__historyNote mesh__D006609 Nucleoproteins %28%1966-1981%29%
% 210.56/210.73  |- skos__altLabel mesh__D006609 HMG Proteins
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D006609 2006
% 210.56/210.73  |- skos__annotation mesh__D006609
% 210.56/210.73       GEN or unspecified; HMG-BOX DOMAINS is also available   
% 210.56/210.73  |- mesh__recordMaintainer mesh__D006609 SYSTEM
% 210.56/210.73  |- mesh__recordOriginator mesh__D006609 RLS
% 210.56/210.73  |- mesh__dateRevised mesh__D006609 2005-06-30
% 210.56/210.73  |- mesh__recordAuthorizer mesh__D006609 sjn
% 210.56/210.73  |- rdf__type mesh__D006609sskos__Concept
% 210.56/210.73  |- mesh__dateCreated mesh__D006609 1984-05-30
% 210.56/210.73  |- skos__scopeNote mesh__D006609
% 210.56/210.73       A family of low-molecular weight, non-histone proteins found in chromatin.%A%    
% 210.56/210.73  |- skos__altLabel mesh__D006609 High Mobility Group Chromosomal Proteins
% 210.56/210.73  |- mesh__publicMeSHNote mesh__D006609 85   
% 210.56/210.73  |- skos__prefLabel mesh__D006609 High Mobility Group Proteins
% 210.56/210.73  |- skos__altLabel mesh__D031002 Maple
% 210.56/210.73  |- skos__altLabel mesh__D031002 Elder, Box
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D031002 2006
% 210.56/210.73  |- skos__prefLabel mesh__D031002 Acer
% 210.56/210.73  |- mesh__historyNote mesh__D031002 2003   
% 210.56/210.73  |- skos__scopeNote mesh__D031002
% 210.56/210.73       A plant genus of the family ACERACEAE, best known for trees with palmately lobed leaves.%A%    
% 210.56/210.73  |- skos__annotation mesh__D031002
% 210.56/210.73       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.56/210.73  |- mesh__dateRevised mesh__D031002 2003-07-25
% 210.56/210.73  |- mesh__recordAuthorizer mesh__D031002 sjn
% 210.56/210.73  |- skos__altLabel mesh__D031002 Sugar Maple
% 210.56/210.73  |- mesh__publicMeSHNote mesh__D031002 2003   
% 210.56/210.73  |- rdf__type mesh__D031002sskos__Concept
% 210.56/210.73  |- skos__altLabel mesh__D031002 Box Elder
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D031002 2004
% 210.56/210.73  |- mesh__dateEstablished mesh__D031002 2003-01-01
% 210.56/210.73  |- skos__broader mesh__D031002smesh__D031001
% 210.56/210.73  |- mesh__dateCreated mesh__D031002 2002-07-02
% 210.56/210.73  |- mesh__recordMaintainer mesh__D031002 sjn
% 210.56/210.73  |- mesh__recordOriginator mesh__D031002 ssb
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D031002 2005
% 210.56/210.73  |- skos__altLabel mesh__D050765 Syntaxin Protein
% 210.56/210.73  |- skos__altLabel mesh__D050765 Syntaxin 3B Protein
% 210.56/210.73  |- skos__altLabel mesh__D050765 Syntaxin 7 Protein
% 210.56/210.73  |- skos__altLabel mesh__D050765 Syntaxin 3A Protein
% 210.56/210.73  |- skos__altLabel mesh__D050765 Syntaxins
% 210.56/210.73  |- skos__altLabel mesh__D050765 Syntaxin 17 Protein
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D050765 2006
% 210.56/210.73  |- skos__altLabel mesh__D050765 Syntaxin 6 Protein
% 210.56/210.73  |- skos__altLabel mesh__D050765 Syntaxin 11 Protein
% 210.56/210.73  |- skos__scopeNote mesh__D050765
% 210.56/210.73       A subfamily of Q-SNARE PROTEINS which occupy the same position as syntaxin 1A in the SNARE complex and which also are most similar to syntaxin 1A in their AMINO ACID SEQUENCE. This subfamily is also known as the syntaxins, although a few so called syntaxins are Qc-SNARES.%A%    
% 210.56/210.73  |- skos__broader mesh__D050765smesh__D050682
% 210.56/210.73  |- skos__altLabel mesh__D050765 Syntaxin Proteins
% 210.56/210.73  |- mesh__recordOriginator mesh__D050765 nns
% 210.56/210.73  |- mesh__recordMaintainer mesh__D050765 ags
% 210.56/210.73  |- skos__altLabel mesh__D050765 Syntaxin 18 Protein
% 210.56/210.73  |- mesh__publicMeSHNote mesh__D050765
% 210.56/210.73       2006; SYNTAXIN %28%now QA-SNARE PROTEINS%29% was indexed under MEMBRANE PROTEINS 1995-2005 and PROTEINS 1994%A%  
% 210.56/210.73  |- skos__altLabel mesh__D050765 Syntaxin
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D050765 2006A
% 210.56/210.73  |- rdf__type mesh__D050765sskos__Concept
% 210.56/210.73  |- mesh__historyNote mesh__D050765 2006 %28%1994%29%   
% 210.56/210.73  |- mesh__dateCreated mesh__D050765 2005-06-30
% 210.56/210.73  |- skos__altLabel mesh__D050765 Syntaxin 4 Protein
% 210.56/210.73  |- mesh__recordAuthorizer mesh__D050765 ags
% 210.56/210.73  |- skos__hiddenLabel mesh__D050765 Qa SNAREs
% 210.56/210.73  |- skos__altLabel mesh__D050765 Syntaxin 13 Protein
% 210.56/210.73  |- skos__altLabel mesh__D050765 Syntaxin 3D Protein
% 210.56/210.73  |- skos__prefLabel mesh__D050765 Qa-SNARE Proteins
% 210.56/210.73  |- skos__hiddenLabel mesh__D050765 11 Protein, Syntaxin
% 210.56/210.73  |- skos__altLabel mesh__D050765 Syntaxin 5 Protein
% 210.56/210.73  |- skos__hiddenLabel mesh__D050765 Protein, Syntaxin
% 210.56/210.73  |- skos__hiddenLabel mesh__D050765 Protein, Syntaxin 11
% 210.56/210.73  |- skos__hiddenLabel mesh__D050765 Qa SNARE Proteins
% 210.56/210.73  |- mesh__dateEstablished mesh__D050765 2006-01-01
% 210.56/210.73  |- skos__altLabel mesh__D050765 Syntaxin 8 Protein
% 210.56/210.73  |- skos__altLabel mesh__D050765 Qa-SNAREs
% 210.56/210.73  |- skos__altLabel mesh__D050765 Syntaxin 10 Protein
% 210.56/210.73  |- mesh__dateRevised mesh__D050765 2005-07-27
% 210.56/210.73  |- skos__altLabel mesh__D050765 Syntaxin 1A Homologs
% 210.56/210.73  |- skos__hiddenLabel mesh__D050765 Proteins, Syntaxin
% 210.56/210.73  |- skos__altLabel mesh__D050765 Syntaxin 3 Protein
% 210.56/210.73  |- skos__altLabel mesh__D050765 Syntaxin 3C Protein
% 210.56/210.73  |- mesh__dateEstablished mesh__D003311 1991-01-01
% 210.56/210.73  |- skos__altLabel mesh__D003311 Cord Factor
% 210.56/210.73  |- mesh__recordMaintainer mesh__D003311 ssb
% 210.56/210.73  |- skos__hiddenLabel mesh__D003311 Factors, Cord
% 210.56/210.73  |- skos__broader mesh__D003311smesh__D001427
% 210.56/210.73  |- rdf__type mesh__D003311sskos__Concept
% 210.56/210.73  |- mesh__dateCreated mesh__D003311 1974-11-11
% 210.56/210.73  |- skos__historyNote mesh__D003311 Trehalose %28%1973-1974%29%
% 210.56/210.73  |- skos__hiddenLabel mesh__D003311 Trehalose 6,6%27% Dimycolate
% 210.56/210.73  |- skos__altLabel mesh__D003311 Trehalose Dimycolates
% 210.56/210.73  |- mesh__historyNote mesh__D003311
% 210.56/210.73       91%28%80%29%; was see under GLYCOLIPIDS 1980-90; was CORD FACTOR see under GLYCOLIPIDS 1975-79%A%  
% 210.56/210.73  |- skos__scopeNote mesh__D003311
% 210.56/210.73       Toxic glycolipids composed of trehalose dimycolate derivatives. They are produced by MYCOBACTERIUM TUBERCULOSIS and other species of MYCOBACTERIUM. They induce cellular dysfunction in animals.%A%    
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D003311 2006
% 210.56/210.73  |- skos__hiddenLabel mesh__D003311 Factor, Cord
% 210.56/210.73  |- skos__broader mesh__D003311smesh__D006017
% 210.56/210.73  |- skos__hiddenLabel mesh__D003311 Dimycolates, Trehalose
% 210.56/210.73  |- mesh__dateRevised mesh__D003311 2005-06-30
% 210.56/210.73  |- skos__historyNote mesh__D003311 Glycolipids %28%1971-1974%29%
% 210.56/210.73  |- mesh__recordOriginator mesh__D003311 NLM
% 210.56/210.73  |- mesh__publicMeSHNote mesh__D003311
% 210.56/210.73       91; was see under GLYCOLIPIDS 1980-90; was CORD FACTOR see under GLYCOLIPIDS 1975-79%A%  
% 210.56/210.73  |- skos__prefLabel mesh__D003311 Cord Factors
% 210.56/210.73  |- mesh__recordAuthorizer mesh__D003311 sjn
% 210.56/210.73  |- skos__historyNote mesh__D003311 Mycobacterium Tuberculosis %28%1974%29%
% 210.56/210.73  |- mesh__onlineNote mesh__D003311
% 210.56/210.73       use CORD FACTORS to search CORD FACTOR 1975-79   
% 210.56/210.73  |- rdf__type mesh__D016239sskos__Concept
% 210.56/210.73  |- skos__historyNote mesh__D016239 MEDLARS %28%1978-1990%29%
% 210.56/210.73  |- skos__historyNote mesh__D016239
% 210.56/210.73       National Library of Medicine %28%U.S.%29% %28%1966-1977%29%
% 210.56/210.73  |- skos__related mesh__D016239smesh__D046650
% 210.56/210.73  |- mesh__dateCreated mesh__D016239 1990-06-06
% 210.56/210.73  |- mesh__recordMaintainer mesh__D016239 ags
% 210.56/210.73  |- mesh__historyNote mesh__D016239
% 210.56/210.73       1991; use MEDLARS 1978-1990; for INDEX MEDICUS use MEDLINE 1979-2004%A%  
% 210.56/210.73  |- skos__annotation mesh__D016239 CATALOG: use NAF entry   
% 210.56/210.73  |- skos__scopeNote mesh__D016239
% 210.56/210.73       The premier bibliographic database of the NATIONAL LIBRARY OF MEDICINE. MEDLINE%C2%%AE% %28%MEDLARS Online%29% is the primary subset of PUBMED and can be searched on NLM%27%s Web site in PubMed or the NLM Gateway. MEDLINE references are indexed with MEDICAL SUBJECT HEADINGS %28%MeSH%29%.%A%    
% 210.56/210.73  |- mesh__dateEstablished mesh__D016239 1991-01-01
% 210.56/210.73  |- mesh__recordOriginator mesh__D016239 TGC
% 210.56/210.73  |- mesh__publicMeSHNote mesh__D016239
% 210.56/210.73       1991; see MEDLARS-MEDLINE INFORMATION SYSTEM 1978-1990; for INDEX MEDICUS see MEDLINE 1979-2004%A%  
% 210.56/210.73  |- mesh__recordAuthorizer mesh__D016239 sjn
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D016239 2006
% 210.56/210.73  |- mesh__dateRevised mesh__D016239 2004-07-07
% 210.56/210.73  |- skos__broader mesh__D016239smesh__D008523
% 210.56/210.73  |- skos__prefLabel mesh__D016239 MEDLINE
% 210.56/210.73  |- skos__historyNote mesh__D016239 Information Systems %28%1966-1977%29%
% 210.56/210.73  |- skos__related mesh__D016239smesh__D039781
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D016239 2005
% 210.56/210.73  |- skos__broader mesh__D016239smesh__D039781
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D002219 2005
% 210.56/210.73  |- mesh__recordMaintainer mesh__D002219 ssb
% 210.56/210.73  |- mesh__dateCreated mesh__D002219 1999-01-01
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D002219 2006
% 210.56/210.73  |- skos__broader mesh__D002219smesh__D000144
% 210.56/210.73  |- rdf__type mesh__D002219sskos__Concept
% 210.56/210.73  |- mesh__onlineNote mesh__D002219
% 210.56/210.73       use CARBAMATES to search TYBAMATE 1966-84 %28%as Prov 1966-72%29%%A%  
% 210.56/210.73  |- mesh__publicMeSHNote mesh__D002219 TYBAMATE was heading 1973-84   
% 210.56/210.73  |- skos__scopeNote mesh__D002219
% 210.56/210.73       Salts or esters of carbamic acid, H2NC%28%=O%29%OH, or of N-substituted carbamic acids: R2NC%28%=O%29%OR%27%, %28%R%27% = hydrocarbyl or a cation%29%. The esters are often called URETHANE or urethan, a usage that is strictly correct only for the ethyl esters. %28%From IUPAC %5B%Internet%5D%. International Union Of Pure And Applied Chemistry; c1995 %5B%updated 2004 Jan 9; cited 2004 May 3%5D%. Available from http://www.chem.qmul.ac.uk/iupac/class/oneN.html%23%35/%29%.%A%    
% 210.56/210.73  |- mesh__dateRevised mesh__D002219 2004-07-07
% 210.56/210.73  |- skos__prefLabel mesh__D002219 Carbamates
% 210.56/210.73  |- mesh__recordAuthorizer mesh__D002219 sjn
% 210.56/210.73  |- mesh__recordOriginator mesh__D002219 NLM
% 210.56/210.73  |- mesh__historyNote mesh__D002219
% 210.56/210.73       TYBAMATE was heading 1965-84 %28%Prov 1965-72%29%   
% 210.56/210.73  |- skos__prefLabel mesh__D007702 Kinetocardiography
% 210.56/210.73  |- skos__hiddenLabel mesh__D007702 Accelographies
% 210.56/210.73  |- skos__scopeNote mesh__D007702
% 210.56/210.73       The graphic recording of chest wall movement due to cardiac impulses.%A%    
% 210.56/210.73  |- mesh__dateCreated mesh__D007702 1999-01-01
% 210.56/210.73  |- mesh__recordAuthorizer mesh__D007702 sjn
% 210.56/210.73  |- rdf__type mesh__D007702sskos__Concept
% 210.56/210.73  |- skos__hiddenLabel mesh__D007702 Vibrocardiographies
% 210.56/210.73  |- mesh__dateEstablished mesh__D007702 1967-01-01
% 210.56/210.73  |- mesh__dateRevised mesh__D007702 1999-11-03
% 210.56/210.73  |- mesh__publicMeSHNote mesh__D007702 67   
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D007702 2003
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D007702 2000
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D007702 2005
% 210.56/210.73  |- mesh__recordMaintainer mesh__D007702 KEV
% 210.56/210.73  |- skos__broader mesh__D007702smesh__D006334
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D007702 2004
% 210.56/210.73  |- skos__annotation mesh__D007702 DF: KINETOCARDIOGR   
% 210.56/210.73  |- skos__hiddenLabel mesh__D007702 Apex Cardiographies
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D007702 2001
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D007702 2006
% 210.56/210.73  |- skos__hiddenLabel mesh__D007702 Kinetocardiographies
% 210.56/210.73  |- mesh__recordOriginator mesh__D007702 NLM
% 210.56/210.73  |- skos__hiddenLabel mesh__D007702 Cardiographies, Apex
% 210.56/210.73  |- skos__altLabel mesh__D007702 Cardiography, Apex
% 210.56/210.73  |- mesh__historyNote mesh__D007702 67%28%64%29%   
% 210.56/210.73  |- skos__altLabel mesh__D007702 Vibrocardiography
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D007702 2002
% 210.56/210.73  |- skos__broader mesh__D005740Q000506smesh__D005740
% 210.56/210.73  |- mesh__preferredCombination mesh__D005740Q000506smesh__D005739
% 210.56/210.73  |- rdf__type mesh__D005740Q000506smesh__CompoundConcept
% 210.56/210.73  |- skos__broader mesh__D012647smesh__D012649
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D012647 2003
% 210.56/210.73  |- mesh__dateEstablished mesh__D012647 1979-01-01
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D012647 2000
% 210.56/210.73  |- skos__hiddenLabel mesh__D012647 Self Assessments %28%Psychology%29%
% 210.56/210.73  |- rdf__type mesh__D012647sskos__Concept
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D012647 2004
% 210.56/210.73  |- skos__historyNote mesh__D012647 Self Concept %28%1969-1974%29%
% 210.56/210.73  |- skos__annotation mesh__D012647 no qualif; DF: SELF ASSESS   
% 210.56/210.73  |- mesh__recordAuthorizer mesh__D012647 PLS
% 210.56/210.73  |- skos__altLabel mesh__D012647 Assessment, Self
% 210.56/210.73  |- mesh__recordOriginator mesh__D012647 NLM
% 210.56/210.73  |- mesh__dateRevised mesh__D012647 1994-02-08
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D012647 2001
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D012647 1998
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D012647 1995
% 210.56/210.73  |- skos__hiddenLabel mesh__D012647 Assessment, Self %28%Psychology%29%
% 210.56/210.73  |- skos__hiddenLabel mesh__D012647 Assessments, Self %28%Psychology%29%
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D012647 1999
% 210.56/210.73  |- mesh__publicMeSHNote mesh__D012647
% 210.56/210.73       79; was SELF ASSESSMENT see under SELF CONCEPT 1969-78   
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D012647 2005
% 210.56/210.73  |- skos__altLabel mesh__D012647 Self Assessment
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D012647 2002
% 210.56/210.73  |- mesh__recordMaintainer mesh__D012647 TGC
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D012647 1996
% 210.56/210.73  |- skos__hiddenLabel mesh__D012647 Assessments, Self
% 210.56/210.73  |- skos__prefLabel mesh__D012647 Self Assessment %28%Psychology%29%
% 210.56/210.73  |- skos__hiddenLabel mesh__D012647 Self Assessments
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D012647 2006
% 210.56/210.73  |- skos__scopeNote mesh__D012647
% 210.56/210.73       Appraisal of one%27%s own personal qualities or traits.     
% 210.56/210.73  |- mesh__onlineNote mesh__D012647
% 210.56/210.73       use SELF ASSESSMENT %28%PSYCHOLOGY%29% to search SELF ASSESSMENT 1975-78; use SELF CONCEPT 1969-74%A%  
% 210.56/210.73  |- mesh__historyNote mesh__D012647
% 210.56/210.73       79; was SELF ASSESSMENT see under SELF CONCEPT 1969-78   
% 210.56/210.73  |- mesh__dateCreated mesh__D012647 1999-01-01
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D012647 1997
% 210.56/210.73  |- skos__broader mesh__D031801smesh__D029608
% 210.56/210.73  |- skos__annotation mesh__D031801
% 210.56/210.73       other snakeroots are available such as ASARUM; SANICULA; ARISTOLOCHIA; AGERATINA;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D031801 2005
% 210.56/210.73  |- mesh__publicMeSHNote mesh__D031801 2003   
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D031801 2006
% 210.56/210.73  |- mesh__historyNote mesh__D031801 2003   
% 210.56/210.73  |- skos__altLabel mesh__D031801 Snakeroot, Seneca
% 210.56/210.73  |- rdf__type mesh__D031801sskos__Concept
% 210.56/210.73  |- skos__scopeNote mesh__D031801
% 210.56/210.73       A plant genus of the family POLYGALACEAE that contains onjisaponins, xanthones, pyrones, and benzophenones. The name is similar to other snakeroots such as ASARUM; SANICULA; ARISTOLOCHIA; AGERATINA; and others.%A%    
% 210.56/210.73  |- mesh__dateEstablished mesh__D031801 2003-01-01
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D031801 2003
% 210.56/210.73  |- skos__prefLabel mesh__D031801 Polygala
% 210.56/210.73  |- mesh__dateCreated mesh__D031801 2002-07-03
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D031801 2004
% 210.56/210.73  |- skos__historyNote mesh__D017332
% 210.56/210.73       Hydroxyzine/analogs %26% derivatives %28%1987-1992%29%
% 210.56/210.73  |- skos__scopeNote mesh__D017332
% 210.56/210.73       A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.%A%    
% 210.56/210.73  |- skos__altLabel mesh__D017332 Krewel Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- skos__altLabel mesh__D017332
% 210.56/210.73       Azupharma Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- mesh__dateRevised mesh__D017332 2005-06-30
% 210.56/210.73  |- skos__altLabel mesh__D017332
% 210.56/210.73       Sanofi Synthelabo Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- skos__altLabel mesh__D017332 Rodleben Brand of Cetirizine
% 210.56/210.73  |- skos__prefLabel mesh__D017332 Cetirizine
% 210.56/210.73  |- skos__altLabel mesh__D017332 UCB Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- skos__altLabel mesh__D017332
% 210.56/210.73       UCB Pharma Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- skos__altLabel mesh__D017332
% 210.56/210.73       AWD.pharma Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- mesh__recordMaintainer mesh__D017332 lkw
% 210.56/210.73  |- skos__altLabel mesh__D017332
% 210.56/210.73       ct-Arzneimittel Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- skos__altLabel mesh__D017332
% 210.56/210.73       Merck dura Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- skos__altLabel mesh__D017332
% 210.56/210.73       Dermapharm Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D017332 2006
% 210.56/210.73  |- skos__altLabel mesh__D017332 Aliud Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- rdf__type mesh__D017332sskos__Concept
% 210.56/210.73  |- skos__altLabel mesh__D017332
% 210.56/210.73       Menarini Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- skos__altLabel mesh__D017332
% 210.56/210.73       W%C3%%B6%rwag Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- skos__altLabel mesh__D017332
% 210.56/210.73       Pfizer Consumer Healthcare Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- skos__broader mesh__D017332smesh__D006919
% 210.56/210.73  |- skos__hiddenLabel mesh__D017332 P 071
% 210.56/210.73  |- skos__altLabel mesh__D017332
% 210.56/210.73       United Drug Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- skos__altLabel mesh__D017332 Zirtek
% 210.56/210.73  |- skos__altLabel mesh__D017332
% 210.56/210.73       Alpharma Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- skos__altLabel mesh__D017332 TAD Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- mesh__dateCreated mesh__D017332 1992-05-07
% 210.56/210.73  |- skos__altLabel mesh__D017332
% 210.56/210.73       %28%2-%28%4-%28%%28%4-Chlorophenyl%29%phenylmethyl%29%-1-piperazinyl%29%ethoxy%29%acetic Acid
% 210.56/210.73  |- skos__altLabel mesh__D017332 Reactine
% 210.56/210.73  |- mesh__historyNote mesh__D017332 93; was CETIRIZINE %28%NM%29% 1987-92   
% 210.56/210.73  |- mesh__publicMeSHNote mesh__D017332
% 210.56/210.73       93; CETIRIZINE was indexed under HYDROXYZINE/analogs %26% derivatives 1987-92%A%  
% 210.56/210.73  |- skos__hiddenLabel mesh__D017332 Dihydrochloride, Cetirizine
% 210.56/210.73  |- mesh__dateEstablished mesh__D017332 1993-01-01
% 210.56/210.73  |- skos__altLabel mesh__D017332 Wolff Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- mesh__onlineNote mesh__D017332
% 210.56/210.73       use CETIRIZINE %28%NM%29% to search CETIRIZINE 1987-92   
% 210.56/210.73  |- skos__hiddenLabel mesh__D017332 P071
% 210.56/210.73  |- skos__altLabel mesh__D017332
% 210.56/210.73       Glaxo Wellcome Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- skos__altLabel mesh__D017332
% 210.56/210.73       Lichtenstein Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- skos__altLabel mesh__D017332 Pfizer Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- mesh__recordOriginator mesh__D017332 TPW
% 210.56/210.73  |- mesh__recordAuthorizer mesh__D017332 sjn
% 210.56/210.73  |- skos__altLabel mesh__D017332 Basics Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- skos__altLabel mesh__D017332 Lacer Brand of Cetirizine Dihydrochloride
% 210.56/210.73  |- skos__altLabel mesh__D017332 Voltric
% 210.56/210.73  |- mesh__dateCreated mesh__D031003 2002-07-02
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D031003 2003
% 210.56/210.73  |- skos__annotation mesh__D031003
% 210.56/210.73       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.56/210.73  |- mesh__publicMeSHNote mesh__D031003 2003   
% 210.56/210.73  |- rdf__type mesh__D031003sskos__Concept
% 210.56/210.73  |- skos__prefLabel mesh__D031003 Adoxaceae
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D031003 2004
% 210.56/210.73  |- mesh__historyNote mesh__D031003 2003   
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D031003 2005
% 210.56/210.73  |- mesh__dateEstablished mesh__D031003 2003-01-01
% 210.56/210.73  |- skos__altLabel mesh__D031003 Muskroot
% 210.56/210.73  |- skos__broader mesh__D031003smesh__D019684
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D031003 2006
% 210.56/210.73  |- skos__scopeNote mesh__D031003
% 210.56/210.73       A plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida. Members of this family are sometimes classified in CAPRIFOLIACEAE.%A%    
% 210.56/210.73  |- skos__scopeNote mesh__D050766
% 210.56/210.73       A subfamily of Q-SNARE PROTEINS which occupy the same position in the SNARE complex as the N-terminal SNARE domain of SNAP-25 and which also are most similar to the N-terminal region of SNAP-25 in their AMINO ACID SEQUENCE.%A%    
% 210.56/210.73  |- mesh__dateEstablished mesh__D050766 2006-01-01
% 210.56/210.73  |- mesh__recordMaintainer mesh__D050766 ags
% 210.56/210.73  |- skos__hiddenLabel mesh__D050766 Qb SNAREs
% 210.56/210.73  |- mesh__activeMeSHYear mesh__D050766 2006
% 210.56/210.73  |- skos__altLabel mesh__D050766 Qb-SNAREs
% 210.56/210.73  |- mesh__dateCreated mesh__D050766 2005-06-30
% 210.56/210.73  |- skos__prefLabel mesh__D050766 Qb-SNARE Proteins
% 210.56/210.73  |- rdf__type mesh__D050766sskos__Concept
% 210.56/210.74  |- mesh__dateRevised mesh__D050766 2005-07-27
% 210.56/210.74  |- skos__broader mesh__D050766smesh__D050682
% 210.56/210.74  |- mesh__historyNote mesh__D050766 2006   
% 210.56/210.74  |- mesh__recordOriginator mesh__D050766 nns
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D050766 2006A
% 210.56/210.74  |- mesh__recordAuthorizer mesh__D050766 ags
% 210.56/210.74  |- skos__hiddenLabel mesh__D050766 Qb SNARE Proteins
% 210.56/210.74  |- mesh__publicMeSHNote mesh__D050766 2006   
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D003312 2002
% 210.56/210.74  |- mesh__recordOriginator mesh__D003312 NLM
% 210.56/210.74  |- mesh__dateEstablished mesh__D003312 1970-01-01
% 210.56/210.74  |- mesh__recordAuthorizer mesh__D003312 PLS
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D003312 2003
% 210.56/210.74  |- mesh__dateRevised mesh__D003312 1995-05-18
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D003312 2005
% 210.56/210.74  |- mesh__dateCreated mesh__D003312 1999-01-01
% 210.56/210.74  |- skos__broader mesh__D003312smesh__D009038
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D003312 2004
% 210.56/210.74  |- skos__prefLabel mesh__D003312 Coriolis Force
% 210.56/210.74  |- skos__hiddenLabel mesh__D003312 Acceleration, Coriolis
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D003312 1996
% 210.56/210.74  |- mesh__onlineNote mesh__D003312
% 210.56/210.74       use CORIOLIS FORCE to search CORIOLIS EFFECT 1966-69 %28%as Prov%29%%A%  
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D003312 2006
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D003312 2000
% 210.56/210.74  |- skos__scopeNote mesh__D003312
% 210.56/210.74       The apparent deflection %28%Coriolis acceleration%29% of a body in motion with respect to the earth, as seen by an observer on the earth, attributed to a fictitious force %28%Coriolis force%29% but actually caused by the rotation of the earth. In a medical context it refers to the physiological effects %28%nausea, vertigo, dizziness, etc.%29% felt by a person moving radially in a rotating system, as a rotating space station. %28%From Random House Unabridged Dictionary, 2d ed %26% McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D003312 1998
% 210.56/210.74  |- skos__hiddenLabel mesh__D003312 Stimulation, Coriolis
% 210.56/210.74  |- mesh__recordMaintainer mesh__D003312 TGC
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D003312 1997
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D003312 2001
% 210.56/210.74  |- skos__annotation mesh__D003312
% 210.56/210.74       a principle of motion; named for Gaspard Coriolis %28%d. 1843%29%, a French civil engineer; no qualif%A%  
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D003312 1999
% 210.56/210.74  |- skos__hiddenLabel mesh__D003312 Effect, Coriolis
% 210.56/210.74  |- skos__hiddenLabel mesh__D003312 Force, Coriolis
% 210.56/210.74  |- rdf__type mesh__D003312sskos__Concept
% 210.56/210.74  |- mesh__historyNote mesh__D003312
% 210.56/210.74       70; was CORIOLIS EFFECT 1964-69 %28%Prov%29%   
% 210.56/210.74  |- mesh__publicMeSHNote mesh__D003312 70   
% 210.56/210.74  |- skos__scopeNote mesh__D007703
% 210.56/210.74       A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, -Xaa-*-Xbb-Xcc, when neither Xaa nor Xbb is Pro. It is a Cl%28%-%29%-dependent, zinc glycoprotein that is generally membrane-bound and active at neutral pH. It may also have endopeptidase activity on some substrates. %28%From Enzyme Nomenclature, 1992%29% EC 3.4.15.1.%A%    
% 210.56/210.74  |- mesh__recordOriginator mesh__D007703 NLM
% 210.56/210.74  |- skos__broader mesh__D007703smesh__D015703
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D007703 2006
% 210.56/210.74  |- skos__altLabel mesh__D007703 Carboxycathepsin
% 210.56/210.74  |- mesh__recordMaintainer mesh__D007703 ssb
% 210.56/210.74  |- skos__hiddenLabel mesh__D007703 Angiotensin I Converting Enzyme
% 210.56/210.74  |- mesh__historyNote mesh__D007703
% 210.56/210.74       94; was KININASE II 1973-93 %28%Prov 1973%29%; TONIN was see KININASE II 1984-93%A%  
% 210.56/210.74  |- skos__altLabel mesh__D007703 Dipeptidyl Peptidase A
% 210.56/210.74  |- skos__altLabel mesh__D007703 CD143 Antigens
% 210.56/210.74  |- mesh__dateRevised mesh__D007703 2005-06-30
% 210.56/210.74  |- mesh__publicMeSHNote mesh__D007703
% 210.56/210.74       94; was KININASE II 1974-93; TONIN was see KININASE II 1984-93%A%  
% 210.56/210.74  |- mesh__recordAuthorizer mesh__D007703 sjn
% 210.56/210.74  |- skos__altLabel mesh__D007703 Antigens, CD143
% 210.56/210.74  |- skos__annotation mesh__D007703
% 210.56/210.74       /antag = ANGIOTENSIN-CONVERTING ENZYME INHIBITORS   
% 210.56/210.74  |- skos__hiddenLabel mesh__D007703 Peptidyl Dipeptidase A
% 210.56/210.74  |- skos__broader mesh__D007703smesh__D020689
% 210.56/210.74  |- skos__historyNote mesh__D007703
% 210.56/210.74       Peptide Peptidohydrolases %28%1966-1972%29%
% 210.56/210.74  |- skos__altLabel mesh__D007703 Kininase A
% 210.56/210.74  |- mesh__onlineNote mesh__D007703
% 210.56/210.74       use PEPTIDYL-DIPEPTIDASE A to search KININASE II 1973-93 %28%as Prov 1973%29% %26% TONIN 1984-93%A%  
% 210.56/210.74  |- mesh__dateCreated mesh__D007703 1999-01-01
% 210.56/210.74  |- rdf__type mesh__D007703sskos__Concept
% 210.56/210.74  |- mesh__dateEstablished mesh__D007703 1974-01-01
% 210.56/210.74  |- skos__altLabel mesh__D007703 Angiotensin I-Converting Enzyme
% 210.56/210.74  |- skos__altLabel mesh__D007703 Angiotensin Converting Enzyme
% 210.56/210.74  |- skos__altLabel mesh__D007703 Kininase II
% 210.56/210.74  |- skos__prefLabel mesh__D007703 Peptidyl-Dipeptidase A
% 210.56/210.74  |- skos__broader mesh__D002343Q000293smesh__D002343
% 210.56/210.74  |- mesh__preferredCombination mesh__D002343Q000293smesh__D020212
% 210.56/210.74  |- rdf__type mesh__D002343Q000293smesh__CompoundConcept
% 210.56/210.74  |- mesh__historyNote mesh__D045822
% 210.56/210.74       2004; use INTESTINAL OBSTRUCTION 1975-2003   
% 210.56/210.74  |- skos__prefLabel mesh__D045822 Intestinal Volvulus
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D045822 2005
% 210.56/210.74  |- skos__altLabel mesh__D045822 Volvulus
% 210.56/210.74  |- mesh__publicMeSHNote mesh__D045822
% 210.56/210.74       2004; see INTESTINAL OBSTRUCTION 1975-2003   
% 210.56/210.74  |- skos__historyNote mesh__D045822 Intestinal Obstruction %28%1965-2003%29%
% 210.56/210.74  |- rdf__type mesh__D045822sskos__Concept
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D045822 2006
% 210.56/210.74  |- mesh__dateEstablished mesh__D045822 2004-01-01
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D045822 2004
% 210.56/210.74  |- skos__altLabel mesh__D045822 Volvulus, Intestine
% 210.56/210.74  |- skos__broader mesh__D045822smesh__D007415
% 210.56/210.74  |- skos__scopeNote mesh__D045822
% 210.56/210.74       A twisting in the intestine %28%INTESTINES%29% that can cause INTESTINAL OBSTRUCTION.%A%    
% 210.56/210.74  |- mesh__dateCreated mesh__D045822 2003-07-09
% 210.56/210.74  |- skos__broader mesh__D045822smesh__D014102
% 210.56/210.74  |- skos__hiddenLabel mesh__D045822 Volvulus, Intestinal
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D012648 1998
% 210.56/210.74  |- skos__historyNote mesh__D012648 Health Education %28%1966-1980%29%
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D012648 2006
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D012648 2000
% 210.56/210.74  |- mesh__dateCreated mesh__D012648 1980-05-19
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D012648 1996
% 210.56/210.74  |- mesh__dateEstablished mesh__D012648 1981-01-01
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D012648 2004
% 210.56/210.74  |- skos__hiddenLabel mesh__D012648 Care, Self
% 210.56/210.74  |- mesh__recordAuthorizer mesh__D012648 PLS
% 210.56/210.74  |- skos__annotation mesh__D012648
% 210.56/210.74       = care prescribed by MD or generated by person himself %26% includes care for self, family or friends; differentiate from SELF MEDICATION %28%medication not prescribed by MD%29% and SELF ADMINISTRATION %28%admin of medication prescribed by MD or self admin of substances by exper animals%29%%A%  
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D012648 2005
% 210.56/210.74  |- rdf__type mesh__D012648sskos__Concept
% 210.56/210.74  |- mesh__historyNote mesh__D012648
% 210.56/210.74       81; was see ACTIVITIES OF DAILY LIVING 1979-80   
% 210.56/210.74  |- skos__altLabel mesh__D012648 Self-Care
% 210.56/210.74  |- skos__historyNote mesh__D012648 Patient Participation %28%1978%29%
% 210.56/210.74  |- skos__historyNote mesh__D012648 Consumer Participation %28%1974-1978%29%
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D012648 2003
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D012648 2002
% 210.56/210.74  |- skos__historyNote mesh__D012648 Patient Education %28%1966-1980%29%
% 210.56/210.74  |- mesh__publicMeSHNote mesh__D012648
% 210.56/210.74       81; was see ACTIVITIES OF DAILY LIVING 1979-80   
% 210.56/210.74  |- skos__hiddenLabel mesh__D012648 Self Management
% 210.56/210.74  |- mesh__onlineNote mesh__D012648
% 210.56/210.74       search ACTIVITIES OF DAILY LIVING 1979-80   
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D012648 1999
% 210.56/210.74  |- mesh__recordMaintainer mesh__D012648 KEV
% 210.56/210.74  |- skos__broader mesh__D012648smesh__D013812
% 210.56/210.74  |- skos__broader mesh__D012648smesh__D012046
% 210.56/210.74  |- mesh__recordOriginator mesh__D012648 SMH
% 210.56/210.74  |- skos__prefLabel mesh__D012648 Self Care
% 210.56/210.74  |- skos__scopeNote mesh__D012648
% 210.56/210.74       Performance of activities or tasks traditionally performed by professional health care providers. The concept includes care of oneself or one%27%s family and friends.%A%    
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D012648 1997
% 210.56/210.74  |- skos__historyNote mesh__D012648
% 210.56/210.74       Activities of Daily Living %28%1978-1980%29%
% 210.56/210.74  |- mesh__dateRevised mesh__D012648 1995-05-23
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D012648 2001
% 210.56/210.74  |- skos__prefLabel mesh__D031802 Securidaca
% 210.56/210.74  |- mesh__dateCreated mesh__D031802 2002-07-03
% 210.56/210.74  |- skos__scopeNote mesh__D031802
% 210.56/210.74       A plant genus of the family POLYGALACEAE that contains securiosides and indole alkaloids.%A%    
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D031802 2003
% 210.56/210.74  |- skos__broader mesh__D031802smesh__D029608
% 210.56/210.74  |- rdf__type mesh__D031802sskos__Concept
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D031802 2004
% 210.56/210.74  |- skos__annotation mesh__D031802
% 210.56/210.74       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D031802 2005
% 210.56/210.74  |- mesh__historyNote mesh__D031802 2003   
% 210.56/210.74  |- mesh__publicMeSHNote mesh__D031802 2003   
% 210.56/210.74  |- mesh__dateEstablished mesh__D031802 2003-01-01
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D031802 2006
% 210.56/210.74  |- rdf__type mesh__D050767sskos__Concept
% 210.56/210.74  |- skos__scopeNote mesh__D050767
% 210.56/210.74       A subfamily of Q-SNARE PROTEINS which occupy the same position in the SNARE complex as the C-terminal SNARE domain of SNAP-25 and which also are most similar to the C-terminal region of SNAP-25 in their AMINO ACID SEQUENCE.%A%    
% 210.56/210.74  |- skos__broader mesh__D050767smesh__D050682
% 210.56/210.74  |- mesh__dateRevised mesh__D050767 2005-07-27
% 210.56/210.74  |- mesh__historyNote mesh__D050767 2006   
% 210.56/210.74  |- mesh__dateEstablished mesh__D050767 2006-01-01
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D050767 2006A
% 210.56/210.74  |- skos__prefLabel mesh__D050767 Qc-SNARE Proteins
% 210.56/210.74  |- skos__hiddenLabel mesh__D050767 Qc SNARE Proteins
% 210.56/210.74  |- mesh__recordOriginator mesh__D050767 nns
% 210.56/210.74  |- skos__hiddenLabel mesh__D050767 Qc SNAREs
% 210.56/210.74  |- skos__altLabel mesh__D050767 Qc-SNAREs
% 210.56/210.74  |- mesh__recordAuthorizer mesh__D050767 ags
% 210.56/210.74  |- mesh__publicMeSHNote mesh__D050767 2006   
% 210.56/210.74  |- mesh__dateCreated mesh__D050767 2005-06-30
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D050767 2006
% 210.56/210.74  |- mesh__recordMaintainer mesh__D050767 ags
% 210.56/210.74  |- mesh__dateRevised mesh__D003313 2002-07-03
% 210.56/210.74  |- skos__broader mesh__D003313smesh__D002523
% 210.56/210.74  |- skos__hiddenLabel mesh__D003313 Corn, Indian
% 210.56/210.74  |- rdf__type mesh__D003313sskos__Concept
% 210.56/210.74  |- skos__broader mesh__D003313smesh__D000821
% 210.56/210.74  |- mesh__publicMeSHNote mesh__D003313
% 210.56/210.74       2003; see CORN 1966-2002, see GRAIN 1963-1965   
% 210.56/210.74  |- mesh__recordMaintainer mesh__D003313 ssb
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D003313 2004
% 210.56/210.74  |- mesh__recordOriginator mesh__D003313 NLM
% 210.56/210.74  |- skos__altLabel mesh__D003313 Maize
% 210.56/210.74  |- mesh__recordAuthorizer mesh__D003313 sjn
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D003313 2003
% 210.56/210.74  |- skos__prefLabel mesh__D003313 Zea mays
% 210.56/210.74  |- skos__altLabel mesh__D003313 Indian Corn
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D003313 2006
% 210.56/210.74  |- mesh__dateCreated mesh__D003313 1999-01-01
% 210.56/210.74  |- skos__broader mesh__D003313smesh__D006109
% 210.56/210.74  |- skos__annotation mesh__D003313
% 210.56/210.74       restrict to American corn, Zea mays: for ancient %26% non-American use of the word %22%corn%22% index under CEREALS; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.56/210.74  |- mesh__historyNote mesh__D003313 2003%28%1963%29%   
% 210.56/210.74  |- skos__scopeNote mesh__D003313
% 210.56/210.74       A plant species of the family POACEAE. It is a tall grass grown for its seed, corn, used as food and animal fodder.%A%    
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D003313 2005
% 210.56/210.74  |- mesh__dateEstablished mesh__D003313 1966-01-01
% 210.56/210.74  |- rdf__type mesh__D027761sskos__Concept
% 210.56/210.74  |- mesh__publicMeSHNote mesh__D027761 2002; see Liliaceae 1998-2001   
% 210.56/210.74  |- skos__broader mesh__D027761smesh__D019668
% 210.56/210.74  |- mesh__dateCreated mesh__D027761 2001-07-25
% 210.56/210.74  |- mesh__historyNote mesh__D027761 2002; use Liliaceae 1998-2001   
% 210.56/210.74  |- skos__prefLabel mesh__D027761 Asparagus Plant
% 210.56/210.74  |- skos__historyNote mesh__D027761 Liliaceae %28%1998-2001%29%
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D027761 2004
% 210.56/210.74  |- mesh__dateRevised mesh__D027761 2002-07-02
% 210.56/210.74  |- skos__scopeNote mesh__D027761
% 210.56/210.74       A plant genus in the family LILIACEAE %28%sometimes placed in Asparagaceae%29% that contains ECDYSTEROIDS and is an ingredient of Siotone. The shoots are used as a vegetable and the roots are used in FOLK MEDICINE.%A%    
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D027761 2006
% 210.56/210.74  |- mesh__recordMaintainer mesh__D027761 ssb
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D027761 2003
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D027761 2005
% 210.56/210.74  |- skos__annotation mesh__D027761
% 210.56/210.74       coord with specific PLANT COMPONENTS and FOOD term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.56/210.74  |- mesh__recordOriginator mesh__D027761 ssb
% 210.56/210.74  |- mesh__recordAuthorizer mesh__D027761 sjn
% 210.56/210.74  |- mesh__dateEstablished mesh__D027761 2002-01-01
% 210.56/210.74  |- skos__hiddenLabel mesh__D013741 Reductase, Steroid delta-4-5-alpha
% 210.56/210.74  |- skos__prefLabel mesh__D013741 Testosterone 5-alpha-Reductase
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D013741 2006
% 210.56/210.74  |- skos__hiddenLabel mesh__D013741 5Alpha Reductase, Steroid
% 210.56/210.74  |- skos__altLabel mesh__D013741 4-Ene-5-alpha-Reductase
% 210.56/210.74  |- skos__historyNote mesh__D013741 Oxidoreductases %28%1972-1974%29%
% 210.56/210.74  |- skos__altLabel mesh__D013741 4-Ene-3-Oxosteroid-5alpha-Reductase
% 210.56/210.74  |- skos__altLabel mesh__D013741 Steroid delta-4-5-alpha Reductase
% 210.56/210.74  |- skos__hiddenLabel mesh__D013741 NADH 5 alpha Reductase
% 210.56/210.74  |- skos__hiddenLabel mesh__D013741 delta-4-5-alpha Reductase, Steroid
% 210.56/210.74  |- mesh__recordMaintainer mesh__D013741 jmp
% 210.56/210.74  |- skos__hiddenLabel mesh__D013741 Reductase, Steroid 5Alpha
% 210.56/210.74  |- mesh__publicMeSHNote mesh__D013741
% 210.56/210.74       86; was see under OXIDOREDUCTASES 1975-85   
% 210.56/210.74  |- skos__hiddenLabel mesh__D013741 4 Ene 5 alpha Reductase
% 210.56/210.74  |- skos__historyNote mesh__D013741 Testosterone %28%1972-1974%29%
% 210.56/210.74  |- skos__altLabel mesh__D013741 NADH-5-alpha-Reductase
% 210.56/210.74  |- skos__hiddenLabel mesh__D013741 delta 4 Reductase
% 210.56/210.74  |- skos__hiddenLabel mesh__D013741
% 210.56/210.74       3 Keto 5 alpha Steroid delta 4 Dehydrogenase
% 210.56/210.74  |- mesh__recordAuthorizer mesh__D013741 sjn
% 210.56/210.74  |- mesh__historyNote mesh__D013741
% 210.56/210.74       86%28%75%29%; was see under OXIDOREDUCTASES 1975-85   
% 210.56/210.74  |- mesh__dateCreated mesh__D013741 1974-11-19
% 210.56/210.74  |- skos__altLabel mesh__D013741 5-alpha-Reductase, Testosterone
% 210.56/210.74  |- skos__altLabel mesh__D013741
% 210.56/210.74       3-Keto-5-alpha-Steroid delta-4-Dehydrogenase
% 210.56/210.74  |- skos__hiddenLabel mesh__D013741 5 alpha Reductase, Testosterone
% 210.56/210.74  |- skos__altLabel mesh__D013741
% 210.56/210.74       delta%28%4%29%-3-Ketosteroid-5alpha-Reductase
% 210.56/210.74  |- mesh__dateRevised mesh__D013741 2005-06-30
% 210.56/210.74  |- skos__hiddenLabel mesh__D013741 4 Ene 3 Oxosteroid 5alpha Reductase
% 210.56/210.74  |- skos__hiddenLabel mesh__D013741 Steroid delta 4 5 alpha Reductase
% 210.56/210.74  |- skos__altLabel mesh__D013741 Testosterone delta-4-5-alpha-Reductase
% 210.56/210.74  |- skos__hiddenLabel mesh__D013741 delta-4-5-alpha-Reductase, Testosterone
% 210.56/210.74  |- skos__hiddenLabel mesh__D013741
% 210.56/210.74       delta-4-Dehydrogenase, 3-Keto-5-alpha-Steroid
% 210.56/210.74  |- skos__hiddenLabel mesh__D013741 4-Reductase, delta
% 210.56/210.74  |- rdf__type mesh__D013741sskos__Concept
% 210.56/210.74  |- skos__altLabel mesh__D013741 Steroid 5Alpha Reductase
% 210.56/210.74  |- skos__altLabel mesh__D013741 SRD5A2
% 210.56/210.74  |- mesh__dateEstablished mesh__D013741 1986-01-01
% 210.56/210.74  |- skos__broader mesh__D013741smesh__D044925
% 210.56/210.74  |- skos__hiddenLabel mesh__D013741 Testosterone delta 4 5 alpha Reductase
% 210.56/210.74  |- skos__hiddenLabel mesh__D013741 Testosterone 5 alpha Reductase
% 210.56/210.74  |- skos__altLabel mesh__D013741
% 210.56/210.74       NADPH delta%28%4%29%-3-Ketosteroid 5 alpha-Oxidoreductase
% 210.56/210.74  |- mesh__recordOriginator mesh__D013741 NLM
% 210.56/210.74  |- skos__altLabel mesh__D013741 delta 4-Reductase
% 210.56/210.74  |- skos__scopeNote mesh__D007704
% 210.56/210.74       Endogenous peptides present in most body fluids. Certain enzymes convert them to active KININS which are involved in inflammation, blood clotting, complement reactions, etc. Kininogens belong to the cystatin superfamily. They are cysteine proteinase inhibitors. HIGH-MOLECULAR-WEIGHT KININOGEN; %28%HMWK%29%; is split by plasma kallikrein to produce BRADYKININ. LOW-MOLECULAR-WEIGHT KININOGEN; %28%LMWK%29%; is split by tissue kallikrein to produce KALLIDIN.%A%    
% 210.56/210.74  |- mesh__recordMaintainer mesh__D007704 ssb
% 210.56/210.74  |- mesh__historyNote mesh__D007704 74%28%72%29%   
% 210.56/210.74  |- skos__hiddenLabel mesh__D007704 T Kininogen
% 210.56/210.74  |- skos__annotation mesh__D007704
% 210.56/210.74       cysteine proteinase inhib; /drug eff /physiol permitted   
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D007704 2006
% 210.56/210.74  |- mesh__recordAuthorizer mesh__D007704 sjn
% 210.56/210.74  |- skos__altLabel mesh__D007704 Prokinins
% 210.56/210.74  |- mesh__dateRevised mesh__D007704 2005-06-30
% 210.56/210.74  |- skos__broader mesh__D007704smesh__D011498
% 210.56/210.74  |- skos__prefLabel mesh__D007704 Kininogens
% 210.56/210.74  |- mesh__dateCreated mesh__D007704 1999-01-01
% 210.56/210.74  |- skos__broader mesh__D007704smesh__D007705
% 210.56/210.74  |- mesh__publicMeSHNote mesh__D007704 74   
% 210.56/210.74  |- rdf__type mesh__D007704sskos__Concept
% 210.56/210.74  |- mesh__dateEstablished mesh__D007704 1974-01-01
% 210.56/210.74  |- skos__altLabel mesh__D007704 Cystatins, Kininogen
% 210.56/210.74  |- skos__historyNote mesh__D007704 Proteins %28%1966-1971%29%
% 210.56/210.74  |- skos__altLabel mesh__D007704 Prekinins
% 210.56/210.74  |- skos__hiddenLabel mesh__D007704 Kininogen Cystatins
% 210.56/210.74  |- mesh__recordOriginator mesh__D007704 NLM
% 210.56/210.74  |- skos__historyNote mesh__D007704 Kinins %28%1966-1971%29%
% 210.56/210.74  |- skos__broader mesh__D007704smesh__D001779
% 210.56/210.74  |- skos__altLabel mesh__D051860 FMRP Protein
% 210.56/210.74  |- mesh__dateCreated mesh__D051860 2005-06-30
% 210.56/210.74  |- skos__scopeNote mesh__D051860
% 210.56/210.74       A RNA-binding protein that is found predominately in the CYTOPLASM. It helps regulate GENETIC TRANSLATION in NEURONS and is absent or under-expressed in FRAGILE X SYNDROME.%A%    
% 210.56/210.74  |- mesh__historyNote mesh__D051860 2006%28%1991%29%   
% 210.56/210.74  |- skos__prefLabel mesh__D051860 Fragile X Mental Retardation Protein
% 210.56/210.74  |- mesh__dateRevised mesh__D051860 2005-08-02
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D051860 2006
% 210.56/210.74  |- rdf__type mesh__D051860sskos__Concept
% 210.56/210.74  |- mesh__publicMeSHNote mesh__D051860
% 210.56/210.74       2006; FRAGILE X MENTAL RETARDATION PROTEIN was indexed under NERVE TISSUE PROTEINS %26% RNA-BINDING PROTEINS 1991-2005%A%  
% 210.56/210.74  |- mesh__recordOriginator mesh__D051860 DRC
% 210.56/210.74  |- skos__hiddenLabel mesh__D051860 Fragile X Mental Retardation 1 Protein
% 210.56/210.74  |- mesh__recordMaintainer mesh__D051860 ags
% 210.56/210.74  |- skos__broader mesh__D051860smesh__D016601
% 210.56/210.74  |- skos__altLabel mesh__D051860 Fragile X Mental Retardation-1 Protein
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D051860 2006A
% 210.56/210.74  |- mesh__dateEstablished mesh__D051860 2006-01-01
% 210.56/210.74  |- mesh__recordAuthorizer mesh__D051860 ags
% 210.56/210.74  |- skos__broader mesh__D051860smesh__D009419
% 210.56/210.74  |- skos__annotation mesh__D045823
% 210.56/210.74       coord IM with specific precoord intestinal dis %28%IM%29%; PARALYTIC ILEUS see INTESTINAL PSEUDO-OBSTRUCTION is also available%A%  
% 210.56/210.74  |- skos__prefLabel mesh__D045823 Ileus
% 210.56/210.74  |- mesh__dateCreated mesh__D045823 2003-07-09
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D045823 2004
% 210.56/210.74  |- mesh__dateEstablished mesh__D045823 2004-01-01
% 210.56/210.74  |- rdf__type mesh__D045823sskos__Concept
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D045823 2006
% 210.56/210.74  |- skos__historyNote mesh__D045823 Intestinal Obstruction %28%1968-2003%29%
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D045823 2005
% 210.56/210.74  |- mesh__publicMeSHNote mesh__D045823
% 210.56/210.74       2004; see INTESTINAL OBSTRUCTION 1975-2003   
% 210.56/210.74  |- skos__broader mesh__D045823smesh__D007415
% 210.56/210.74  |- skos__scopeNote mesh__D045823
% 210.56/210.74       A condition caused by the lack of intestinal PERISTALSIS or INTESTINAL MOTILITY without any mechanical obstruction. This interference of the flow of INTESTINAL CONTENTS often leads to INTESTINAL OBSTRUCTION. Ileus may be classified into postoperative, inflammatory, metabolic, neurogenic, and drug-induced.%A%    
% 210.56/210.74  |- mesh__historyNote mesh__D045823
% 210.56/210.74       2004; use INTESTINAL OBSTRUCTION 1975-2003   
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D012649 2004
% 210.56/210.74  |- mesh__recordMaintainer mesh__D012649 tjk
% 210.56/210.74  |- skos__hiddenLabel mesh__D012649 Concepts, Self
% 210.56/210.74  |- mesh__dateCreated mesh__D012649 1999-01-01
% 210.56/210.74  |- mesh__onlineNote mesh__D012649
% 210.56/210.74       use SELF CONCEPT to search SELF PERCEPTION 1969-78   
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D012649 2005
% 210.56/210.74  |- rdf__type mesh__D012649sskos__Concept
% 210.56/210.74  |- skos__scopeNote mesh__D012649 A person%27%s view of himself.     
% 210.56/210.74  |- skos__hiddenLabel mesh__D012649 Self Esteems
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D012649 2003
% 210.56/210.74  |- skos__hiddenLabel mesh__D012649 Self-Perceptions
% 210.56/210.74  |- skos__related mesh__D012649smesh__D026684
% 210.56/210.74  |- skos__prefLabel mesh__D012649 Self Concept
% 210.56/210.74  |- mesh__recordAuthorizer mesh__D012649 sjn
% 210.56/210.74  |- skos__hiddenLabel mesh__D012649 Concept, Self
% 210.56/210.74  |- skos__hiddenLabel mesh__D012649 Perceptions, Self
% 210.56/210.74  |- skos__hiddenLabel mesh__D012649 Perception, Self
% 210.56/210.74  |- mesh__publicMeSHNote mesh__D012649 69   
% 210.56/210.74  |- skos__hiddenLabel mesh__D012649 Esteems, Self
% 210.56/210.74  |- skos__related mesh__D012649smesh__D001828
% 210.56/210.74  |- skos__altLabel mesh__D012649 Self Perception
% 210.56/210.74  |- mesh__historyNote mesh__D012649
% 210.56/210.74       69; SELF PERCEPTION was see under SELF CONCEPT 1969-78   
% 210.56/210.74  |- skos__hiddenLabel mesh__D012649 Self Concepts
% 210.56/210.74  |- mesh__dateRevised mesh__D012649 2001-07-25
% 210.56/210.74  |- skos__hiddenLabel mesh__D012649 Esteem, Self
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D012649 2002
% 210.56/210.74  |- skos__hiddenLabel mesh__D012649 Self Perceptions
% 210.56/210.74  |- skos__annotation mesh__D012649
% 210.56/210.74       do not confuse with SELF PSYCHOLOGY: see MeSH definition; no qualif%A%  
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D012649 2006
% 210.56/210.74  |- mesh__recordOriginator mesh__D012649 NLM
% 210.56/210.74  |- mesh__dateEstablished mesh__D012649 1969-01-01
% 210.56/210.74  |- skos__broader mesh__D012649smesh__D010553
% 210.56/210.74  |- mesh__historyNote mesh__D031803 2003   
% 210.56/210.74  |- mesh__dateEstablished mesh__D031803 2003-01-01
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D031803 2003
% 210.56/210.74  |- rdf__type mesh__D031803sskos__Concept
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D031803 2004
% 210.56/210.74  |- skos__scopeNote mesh__D031803
% 210.56/210.74       A plant genus of the family POLYGONACEAE.     
% 210.56/210.74  |- skos__broader mesh__D031803smesh__D019664
% 210.56/210.74  |- skos__annotation mesh__D031803
% 210.56/210.74       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D031803 2005
% 210.56/210.74  |- skos__altLabel mesh__D031803 Buckwheat, Red
% 210.56/210.74  |- mesh__publicMeSHNote mesh__D031803 2003   
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D031803 2006
% 210.56/210.74  |- skos__prefLabel mesh__D031803 Eriogonum
% 210.56/210.74  |- skos__altLabel mesh__D031803 Buckwheat, Wild
% 210.56/210.74  |- mesh__dateCreated mesh__D031803 2002-07-02
% 210.56/210.74  |- mesh__dateEstablished mesh__D017334 1993-01-01
% 210.56/210.74  |- skos__altLabel mesh__D017334 Teichomycin
% 210.56/210.74  |- rdf__type mesh__D017334sskos__Concept
% 210.56/210.74  |- skos__altLabel mesh__D017334 Hoechst Brand of Teicoplanin
% 210.56/210.74  |- skos__altLabel mesh__D017334 Aventis Pharma Brand of Teicoplanin
% 210.56/210.74  |- mesh__dateRevised mesh__D017334 2005-06-30
% 210.56/210.74  |- skos__prefLabel mesh__D017334 Teicoplanin
% 210.56/210.74  |- skos__scopeNote mesh__D017334
% 210.56/210.74       Glycopeptide antibiotic complex from Actinoplanes teichomyceticus active against gram-positive bacteria. It consists of five major components each with a different fatty acid moiety.%A%    
% 210.56/210.74  |- skos__altLabel mesh__D017334 Aventis Brand of Teicoplanin
% 210.56/210.74  |- mesh__recordOriginator mesh__D017334 AGS
% 210.56/210.74  |- mesh__recordMaintainer mesh__D017334 CCR
% 210.56/210.74  |- skos__broader mesh__D017334smesh__D006020
% 210.56/210.74  |- mesh__onlineNote mesh__D017334
% 210.56/210.74       use TEICOPLANIN %28%NM%29% to search TEICHOMYCINS 1980-92   
% 210.56/210.74  |- mesh__publicMeSHNote mesh__D017334
% 210.56/210.74       93; TEICOMYCINS was indexed under GLYCOPEPTIDES 1978-92   
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D017334 2006
% 210.56/210.74  |- mesh__recordAuthorizer mesh__D017334 sjn
% 210.56/210.74  |- mesh__historyNote mesh__D017334
% 210.56/210.74       93; was TEICHOMYCINS %28%NM%29% 1978-92   
% 210.56/210.74  |- skos__historyNote mesh__D017334 Glycopeptides %28%1978-1992%29%
% 210.56/210.74  |- mesh__dateCreated mesh__D017334 1992-05-22
% 210.56/210.74  |- skos__historyNote mesh__D050768 Protoporphyrins %28%1975-1982%29%
% 210.56/210.74  |- skos__altLabel mesh__D050768 Protox
% 210.56/210.74  |- skos__altLabel mesh__D050768 Protoporphyrinogenase
% 210.56/210.74  |- skos__broader mesh__D050768smesh__D008565
% 210.56/210.74  |- mesh__recordMaintainer mesh__D050768 AKE
% 210.56/210.74  |- skos__historyNote mesh__D050768 Porphyrins %28%1975-1976%29%
% 210.56/210.74  |- skos__historyNote mesh__D050768 Oxidoreductases %28%1993-2003%29%
% 210.56/210.74  |- skos__scopeNote mesh__D050768
% 210.56/210.74       A membrane-bound flavoenzyme that catalyzes the oxygen-dependent aromatization of PROTOPORPHYRINOGEN IX %28%Protogen%29% to protoporphyrin IX %28%Proto IX%29%. It is the last enzyme of the common branch of the HEME and CHLOROPHYLL pathways in plants, and is the molecular target of diphenyl ether-type herbicides. VARIEGATE PORPHYRIA is an autosomal dominant disorder associated with deficiency of protoporphyrinogen oxidase.%A%    
% 210.56/210.74  |- skos__altLabel mesh__D050768 Protoporphyrinogen IX Oxidase
% 210.56/210.74  |- mesh__dateEstablished mesh__D050768 2006-01-01
% 210.56/210.74  |- skos__broader mesh__D050768smesh__D044925
% 210.56/210.74  |- mesh__publicMeSHNote mesh__D050768
% 210.56/210.74       2006; PROTOPORPHYRINOGEN OXIDASE was indexed under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 2004-2005, under OXIDOREDUCTASES 1993-2003, under PORPHYRINS 1975-1976, and under PROTOPORPHYRINS 1975-1982%A%  
% 210.56/210.74  |- mesh__recordAuthorizer mesh__D050768 sjn
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D050768 2006
% 210.56/210.74  |- skos__prefLabel mesh__D050768 Protoporphyrinogen Oxidase
% 210.56/210.74  |- skos__hiddenLabel mesh__D050768 Oxidase, Protoporphyrinogen
% 210.56/210.74  |- skos__hiddenLabel mesh__D050768 Dehydrogenase, Protoporphyrinogen
% 210.56/210.74  |- rdf__type mesh__D050768sskos__Concept
% 210.56/210.74  |- skos__hiddenLabel mesh__D050768 Oxidase, Protoporphyrinogen IX
% 210.56/210.74  |- mesh__historyNote mesh__D050768 2006%28%1975%29%   
% 210.56/210.74  |- skos__historyNote mesh__D050768
% 210.56/210.74       Oxidoreductases Acting on CH-CH Group Donors %28%2004-2005%29%
% 210.56/210.74  |- mesh__recordOriginator mesh__D050768 AKE
% 210.56/210.74  |- skos__altLabel mesh__D050768 Protoporphyrinogen Dehydrogenase
% 210.56/210.74  |- mesh__dateCreated mesh__D050768 2005-06-30
% 210.56/210.74  |- mesh__dateEstablished mesh__D003314 1991-01-01
% 210.56/210.74  |- skos__broader mesh__D003314smesh__D010938
% 210.56/210.74  |- skos__historyNote mesh__D003314 Oils %28%1966-1986%29%
% 210.56/210.74  |- skos__hiddenLabel mesh__D003314 Lipomuls
% 210.56/210.74  |- skos__hiddenLabel mesh__D003314 Oil, Maize
% 210.56/210.74  |- skos__hiddenLabel mesh__D003314 Oils, Maize
% 210.56/210.74  |- skos__broader mesh__D003314smesh__D005224
% 210.56/210.74  |- mesh__recordMaintainer mesh__D003314 ssb
% 210.56/210.74  |- skos__scopeNote mesh__D003314 Oil from ZEA MAYS or corn plant.     
% 210.56/210.74  |- mesh__activeMeSHYear mesh__D003314 2006
% 210.56/210.74  |- mesh__recordOriginator mesh__D003314 RLS
% 210.56/210.74  |- mesh__dateRevised mesh__D003314 2005-06-30
% 210.56/210.74  |- mesh__dateCreated mesh__D003314 1986-06-03
% 210.56/210.74  |- skos__prefLabel mesh__D003314 Corn Oil
% 210.56/210.74  |- skos__hiddenLabel mesh__D003314 Corn Oils
% 210.56/210.74  |- mesh__publicMeSHNote mesh__D003314
% 210.56/210.74       91; was see under PLANT OILS 1987-90   
% 210.56/210.74  |- mesh__recordAuthorizer mesh__D003314 sjn
% 210.56/210.74  |- skos__altLabel mesh__D003314 Maize Oil
% 210.56/210.74  |- skos__hiddenLabel mesh__D003314 Maize Oils
% 210.56/210.74  |- skos__broader mesh__D003314smesh__D004042
% 210.56/210.74  |- mesh__historyNote mesh__D003314
% 210.56/210.74       91%28%87%29%; was see under PLANT OILS 1987-90   
% 210.56/210.74  |- skos__hiddenLabel mesh__D003314 Oil, Corn
% 210.56/210.74  |- skos__hiddenLabel mesh__D003314 Oils, Corn
% 210.56/210.74  |- rdf__type mesh__D003314sskos__Concept
% 210.56/210.74  |- skos__prefLabel mesh__D027762 Lilium
% 210.56/210.74  |- mesh__dateRevised mesh__D027762 2003-07-09
% 210.56/210.74  |- mesh__recordAuthorizer mesh__D027762 sjn
% 210.56/210.75  |- skos__historyNote mesh__D027762 Liliaceae %28%1998-2001%29%
% 210.56/210.75  |- skos__scopeNote mesh__D027762
% 210.56/210.75       A plant genus in the family LILIACEAE generally growing in temperate areas. The word lily is also used in the common names of many plants of other genera that resemble true lilies. True lilies are erect perennial plants with leafy stems, scaly bulbs, usually narrow leaves, and solitary or clustered flowers.%A%    
% 210.56/210.75  |- skos__annotation mesh__D027762
% 210.56/210.75       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D027762 2004
% 210.56/210.75  |- mesh__dateCreated mesh__D027762 2001-07-25
% 210.56/210.75  |- mesh__historyNote mesh__D027762 2002; use Liliaceae 1998-2001   
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D027762 2006
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D027762 2005
% 210.56/210.75  |- skos__altLabel mesh__D027762 Lily
% 210.56/210.75  |- mesh__recordOriginator mesh__D027762 ssb
% 210.56/210.75  |- mesh__dateEstablished mesh__D027762 2002-01-01
% 210.56/210.75  |- mesh__recordMaintainer mesh__D027762 ssb
% 210.56/210.75  |- rdf__type mesh__D027762sskos__Concept
% 210.56/210.75  |- skos__broader mesh__D027762smesh__D019668
% 210.56/210.75  |- mesh__publicMeSHNote mesh__D027762 2002; see Liliaceae 1998-2001   
% 210.56/210.75  |- mesh__recordMaintainer mesh__D013742 ags
% 210.56/210.75  |- skos__prefLabel mesh__D013742 Tetanus
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D013742 2006
% 210.56/210.75  |- mesh__recordAuthorizer mesh__D013742 sjn
% 210.56/210.75  |- mesh__dateRevised mesh__D013742 2003-07-09
% 210.56/210.75  |- skos__related mesh__D013742smesh__D014313
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D013742 2005
% 210.56/210.75  |- skos__annotation mesh__D013742
% 210.56/210.75       caused by Clostridium tetani; do not confuse with TETANY; do not use for tonic spasm of muscle %28% = SPASM%29% or for tetanic contraction %28% = MUSCLE CONTRACTION%29%%A%  
% 210.56/210.75  |- skos__scopeNote mesh__D013742
% 210.56/210.75       A disease caused by tetanospasmin, a powerful protein toxin produced by CLOSTRIDIUM TETANI. Tetanus usually occurs after an acute injury, such as a puncture wound or laceration. Generalized tetanus, the most common form, is characterized by tetanic muscular contractions and hyperreflexia. Localized tetanus presents itself as a mild condition with manifestations restricted to muscles near the wound. It may progress to the generalized form.%A%    
% 210.56/210.75  |- rdf__type mesh__D013742sskos__Concept
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D013742 2004
% 210.56/210.75  |- skos__broader mesh__D013742smesh__D003015
% 210.56/210.75  |- mesh__dateCreated mesh__D013742 1999-01-01
% 210.56/210.75  |- mesh__recordOriginator mesh__D013742 NLM
% 210.56/210.75  |- mesh__historyNote mesh__D007705 66%28%64%29%   
% 210.56/210.75  |- mesh__recordOriginator mesh__D007705 NLM
% 210.56/210.75  |- mesh__publicMeSHNote mesh__D007705 66   
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D007705 2006
% 210.56/210.75  |- skos__broader mesh__D007705smesh__D012898
% 210.56/210.75  |- skos__prefLabel mesh__D007705 Kinins
% 210.56/210.75  |- skos__broader mesh__D007705smesh__D036341
% 210.56/210.75  |- mesh__dateEstablished mesh__D007705 1966-01-01
% 210.56/210.75  |- mesh__recordMaintainer mesh__D007705 ssb
% 210.56/210.75  |- mesh__dateCreated mesh__D007705 1999-01-01
% 210.56/210.75  |- skos__scopeNote mesh__D007705
% 210.56/210.75       A generic term used to describe a group of polypeptides with related chemical structures and pharmacological properties that are widely distributed in nature. These peptides are AUTACOIDS that act locally to produce pain, vasodilatation, increased vascular permeability, and the synthesis of prostaglandins. Thus, they comprise a subset of the large number of mediators that contribute to the inflammatory response. %28%From Goodman and Gilman%27%s The Pharmacologic Basis of Therapeutics, 8th ed, p588%29%%A%    
% 210.56/210.75  |- rdf__type mesh__D007705sskos__Concept
% 210.56/210.75  |- skos__annotation mesh__D007705 a group of polypeptide autacoids   
% 210.56/210.75  |- mesh__recordAuthorizer mesh__D007705 sjn
% 210.56/210.75  |- mesh__dateRevised mesh__D007705 2005-06-30
% 210.56/210.75  |- mesh__dateEstablished mesh__D051861 2006-01-01
% 210.56/210.75  |- skos__altLabel mesh__D051861 KAI1 Protein
% 210.56/210.75  |- skos__broader mesh__D051861smesh__D015703
% 210.56/210.75  |- skos__hiddenLabel mesh__D051861 Antigen, CD82
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D051861 2006
% 210.56/210.75  |- rdf__type mesh__D051861sskos__Concept
% 210.56/210.75  |- mesh__recordOriginator mesh__D051861 DRC
% 210.56/210.75  |- mesh__recordMaintainer mesh__D051861 DRC
% 210.56/210.75  |- mesh__dateCreated mesh__D051861 2005-06-30
% 210.56/210.75  |- skos__prefLabel mesh__D051861 Kangai-1 Protein
% 210.56/210.75  |- mesh__publicMeSHNote mesh__D051861
% 210.56/210.75       2006; KANGAI-1 PROTEIN was indexed under MEMBRANE GLYCOPROTEINS %26% PROTO-ONCOGENE PROTEINS 1993-2005, %26% under ANTIGENS, CD 2005, %26% under SURFACE ANTIGENS 1993-2004%A%  
% 210.56/210.75  |- mesh__historyNote mesh__D051861 2006%28%1993%29%   
% 210.56/210.75  |- skos__hiddenLabel mesh__D051861 Kangai 1 Protein
% 210.56/210.75  |- mesh__recordAuthorizer mesh__D051861 sjn
% 210.56/210.75  |- skos__altLabel mesh__D051861 CD82 Antigen
% 210.56/210.75  |- skos__hiddenLabel mesh__D051861 CD82 Antigens
% 210.56/210.75  |- skos__broader mesh__D051861smesh__D008562
% 210.56/210.75  |- skos__broader mesh__D051861smesh__D025521
% 210.56/210.75  |- skos__scopeNote mesh__D051861
% 210.56/210.75       A widely expressed transmembrane glycoprotein that functions as a METASTASIS suppressor protein. It is under-expressed in a variety of human NEOPLASMS.%A%    
% 210.56/210.75  |- skos__altLabel mesh__D051861 Antigens, CD82
% 210.56/210.75  |- skos__hiddenLabel mesh__D045824 Lawsonia Infection
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D045824 2004
% 210.56/210.75  |- skos__hiddenLabel mesh__D045824 Infection, Desulfovibrionaceae
% 210.56/210.75  |- skos__hiddenLabel mesh__D045824 Desulfovibrio Infection
% 210.56/210.75  |- skos__prefLabel mesh__D045824 Desulfovibrionaceae Infections
% 210.56/210.75  |- rdf__type mesh__D045824sskos__Concept
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D045824 2006
% 210.56/210.75  |- skos__hiddenLabel mesh__D045824 Infections, Bilophila
% 210.56/210.75  |- skos__hiddenLabel mesh__D045824 Infection, Bilophila
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D045824 2005
% 210.56/210.75  |- skos__scopeNote mesh__D045824
% 210.56/210.75       Infections with bacteria of the family Desulfovibrionaceae.%A%    
% 210.56/210.75  |- skos__hiddenLabel mesh__D045824 Infection, Lawsonia
% 210.56/210.75  |- mesh__dateEstablished mesh__D045824 2004-01-01
% 210.56/210.75  |- skos__broader mesh__D045824smesh__D016905
% 210.56/210.75  |- skos__hiddenLabel mesh__D045824 Infections, Lawsonia
% 210.56/210.75  |- skos__hiddenLabel mesh__D045824 Infections, Desulfovibrionaceae
% 210.56/210.75  |- mesh__historyNote mesh__D045824 2004   
% 210.56/210.75  |- skos__hiddenLabel mesh__D045824 Infection, Desulfovibrio
% 210.56/210.75  |- skos__hiddenLabel mesh__D045824 Desulfovibrionaceae Infection
% 210.56/210.75  |- mesh__publicMeSHNote mesh__D045824 2004   
% 210.56/210.75  |- skos__hiddenLabel mesh__D045824 Bilophila Infection
% 210.56/210.75  |- skos__hiddenLabel mesh__D045824 Infections, Desulfovibrio
% 210.56/210.75  |- mesh__dateCreated mesh__D045824 2003-07-09
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D031804 2006
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D031804 2005
% 210.56/210.75  |- skos__scopeNote mesh__D031804
% 210.56/210.75       A plant genus of the family POLYGONACEAE that contains patientosides and other naphthalene glycosides.%A%    
% 210.56/210.75  |- skos__altLabel mesh__D031804 Canaigre
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D031804 2004
% 210.56/210.75  |- skos__altLabel mesh__D031804 Yellow Dock
% 210.56/210.75  |- mesh__dateCreated mesh__D031804 2002-07-03
% 210.56/210.75  |- rdf__type mesh__D031804sskos__Concept
% 210.56/210.75  |- mesh__dateEstablished mesh__D031804 2003-01-01
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D031804 2003
% 210.56/210.75  |- skos__prefLabel mesh__D031804 Rumex
% 210.56/210.75  |- skos__broader mesh__D031804smesh__D019664
% 210.56/210.75  |- skos__altLabel mesh__D031804 Sorrel
% 210.56/210.75  |- mesh__historyNote mesh__D031804 2003   
% 210.56/210.75  |- mesh__publicMeSHNote mesh__D031804 2003   
% 210.56/210.75  |- skos__altLabel mesh__D031804 Dock, Yellow
% 210.56/210.75  |- skos__annotation mesh__D031804
% 210.56/210.75       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.56/210.75  |- mesh__recordAuthorizer mesh__D017335 sjn
% 210.56/210.75  |- mesh__historyNote mesh__D017335 93; was MDL 17043 %28%NM%29% 1982-92   
% 210.56/210.75  |- skos__hiddenLabel mesh__D017335 MDL 19,438
% 210.56/210.75  |- skos__prefLabel mesh__D017335 Enoximone
% 210.56/210.75  |- skos__hiddenLabel mesh__D017335 19438, MDL
% 210.56/210.75  |- mesh__dateEstablished mesh__D017335 1993-01-01
% 210.56/210.75  |- skos__altLabel mesh__D017335 MDL-17043
% 210.56/210.75  |- mesh__publicMeSHNote mesh__D017335
% 210.56/210.75       93; MDL 17043 was indexed under IMIDAZOLES 1982-92   
% 210.56/210.75  |- skos__altLabel mesh__D017335 Fenoximone
% 210.56/210.75  |- skos__hiddenLabel mesh__D017335 MDL 17043
% 210.56/210.75  |- skos__hiddenLabel mesh__D017335 MDL17,043
% 210.56/210.75  |- mesh__recordOriginator mesh__D017335 TPW
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D017335 2006
% 210.56/210.75  |- skos__altLabel mesh__D017335 MDL-19,438
% 210.56/210.75  |- skos__historyNote mesh__D017335 Imidazoles %28%1982-1992%29%
% 210.56/210.75  |- mesh__dateRevised mesh__D017335 2005-06-30
% 210.56/210.75  |- skos__scopeNote mesh__D017335
% 210.56/210.75       1,3-Dihydro-4-methyl-5-%28%4-%28%methylthio%29%benzoyl%29%-2H-imidazol-2-one. A selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure.%A%    
% 210.56/210.75  |- mesh__onlineNote mesh__D017335
% 210.56/210.75       use ENOXIMONE %28%NM%29% to search MDL 17043 1982-92   
% 210.56/210.75  |- mesh__recordMaintainer mesh__D017335 ssb
% 210.56/210.75  |- mesh__dateCreated mesh__D017335 1992-05-08
% 210.56/210.75  |- skos__hiddenLabel mesh__D017335 MDL17043
% 210.56/210.75  |- skos__hiddenLabel mesh__D017335 MDL 17,043
% 210.56/210.75  |- skos__hiddenLabel mesh__D017335 MDL19,438
% 210.56/210.75  |- skos__broader mesh__D017335smesh__D007093
% 210.56/210.75  |- rdf__type mesh__D017335sskos__Concept
% 210.56/210.75  |- mesh__recordAuthorizer mesh__D050769 sjn
% 210.56/210.75  |- skos__hiddenLabel mesh__D050769 A Dehydrogenase, Isovaleryl-Coenzyme
% 210.56/210.75  |- mesh__dateEstablished mesh__D050769 2006-01-01
% 210.56/210.75  |- skos__altLabel mesh__D050769 Isovaleryl CoA Dehydrogenase
% 210.56/210.75  |- mesh__recordMaintainer mesh__D050769 AKE
% 210.56/210.75  |- skos__historyNote mesh__D050769
% 210.56/210.75       Oxidoreductases Acting on CH-CH Group Donors %28%2004-2005%29%
% 210.56/210.75  |- mesh__publicMeSHNote mesh__D050769
% 210.56/210.75       2006; ISOVALERYL-COA DEHYDROGENASE was indexed under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 2004-2005, under OXIDOREDUCTASES 1983-2003, under ACYL COENZYME A 1980-1982, COENZYME A 1973-1980, and under VALERATES 1973-1982%A%  
% 210.56/210.75  |- mesh__dateCreated mesh__D050769 2005-06-30
% 210.56/210.75  |- skos__scopeNote mesh__D050769
% 210.56/210.75       A mitochondrial flavoprotein, this enzyme catalyzes the oxidation of 3-methylbutanoyl-CoA to 3-methylbut-2-enoyl-CoA using FAD as a cofactor. Defects in the enzyme, is associated with isovaleric acidemia %28%IVA%29%.%A%    
% 210.56/210.75  |- skos__hiddenLabel mesh__D050769 Dehydrogenase, Isovaleryl-CoA
% 210.56/210.75  |- mesh__recordOriginator mesh__D050769 AKE
% 210.56/210.75  |- skos__hiddenLabel mesh__D050769 Dehydrogenase, Isovaleryl CoA
% 210.56/210.75  |- skos__altLabel mesh__D050769 Isovaleryl-Coenzyme A Dehydrogenase
% 210.56/210.75  |- skos__hiddenLabel mesh__D050769 Dehydrogenase, Isovaleryl-Coenzyme A
% 210.56/210.75  |- skos__historyNote mesh__D050769 Oxidoreductases %28%1983-2003%29%
% 210.56/210.75  |- skos__prefLabel mesh__D050769 Isovaleryl-CoA Dehydrogenase
% 210.56/210.75  |- skos__hiddenLabel mesh__D050769 CoA Dehydrogenase, Isovaleryl
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D050769 2006
% 210.56/210.75  |- skos__historyNote mesh__D050769 Valerates %28%1973-1982%29%
% 210.56/210.75  |- skos__historyNote mesh__D050769 Acyl Coenzyme A %28%1980-1982%29%
% 210.56/210.75  |- rdf__type mesh__D050769sskos__Concept
% 210.56/210.75  |- skos__historyNote mesh__D050769 Coenzyme A %28%1973-1980%29%
% 210.56/210.75  |- skos__hiddenLabel mesh__D050769 Isovaleryl Coenzyme A Dehydrogenase
% 210.56/210.75  |- mesh__historyNote mesh__D050769 2006%28%1973%29%   
% 210.56/210.75  |- skos__broader mesh__D050769smesh__D044925
% 210.56/210.75  |- mesh__considerAlso mesh__D003315 consider also terms at KERAT-   
% 210.56/210.75  |- skos__broader mesh__D003315smesh__D000869
% 210.56/210.75  |- skos__hiddenLabel mesh__D003315 Corneas
% 210.56/210.75  |- skos__annotation mesh__D003315
% 210.56/210.75       inflammation = KERATITIS; neoplasms = CORNEAL DISEASES %28%IM%29% + EYE NEOPLASMS %28%IM%29% + histological type of neoplasm %28%IM%29%; /anat: consider CORNEAL TOPOGRAPHY; KERATOPLASTY, PENETRATING is also available%A%  
% 210.56/210.75  |- mesh__historyNote mesh__D003315
% 210.56/210.75       /transplantation was CORNEAL TRANSPLANTATION 1963-65; was CORNEA/transplantation 1966-89%A%  
% 210.56/210.75  |- mesh__dateCreated mesh__D003315 1999-01-01
% 210.56/210.75  |- skos__prefLabel mesh__D003315 Cornea
% 210.56/210.75  |- skos__related mesh__D003315smesh__D018903
% 210.56/210.75  |- mesh__recordMaintainer mesh__D003315 lkt
% 210.56/210.75  |- mesh__recordOriginator mesh__D003315 NLM
% 210.56/210.75  |- mesh__publicMeSHNote mesh__D003315
% 210.56/210.75       /transplantation was CORNEAL TRANSPLANTATION 1963-65; was CORNEA/transplantation 1966-89%A%  
% 210.56/210.75  |- mesh__recordAuthorizer mesh__D003315 sjn
% 210.56/210.75  |- mesh__dateRevised mesh__D003315 2005-06-30
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D003315 2006
% 210.56/210.75  |- rdf__type mesh__D003315sskos__Concept
% 210.56/210.75  |- skos__related mesh__D003315smesh__D007646
% 210.56/210.75  |- skos__scopeNote mesh__D003315
% 210.56/210.75       The transparent anterior portion of the fibrous coat of the eye consisting of five layers: stratified squamous CORNEAL EPITHELIUM; BOWMAN MEMBRANE; CORNEAL STROMA; DESCEMET MEMBRANE; and mesenchymal CORNEAL ENDOTHELIUM. It serves as the first refracting medium of the eye. It is structurally continuous with the SCLERA, avascular, receiving its nourishment by permeation through spaces between the lamellae, and is innervated by the ophthalmic division of the TRIGEMINAL NERVE via the ciliary nerves and those of the surrounding conjunctiva which together form plexuses. %28%Cline et al., Dictionary of Visual Science, 4th ed%29%%A%    
% 210.56/210.75  |- skos__related mesh__D003315smesh__D004728
% 210.56/210.75  |- mesh__dateCreated mesh__D008000 1999-01-01
% 210.56/210.75  |- skos__scopeNote mesh__D008000
% 210.56/210.75       Collection and analysis of data pertaining to operations of a particular library, library system, or group of independent libraries, with recommendations for improvement and/or ordered plans for further development.%A%    
% 210.56/210.75  |- mesh__recordOriginator mesh__D008000 NLM
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D008000 2006
% 210.56/210.75  |- skos__hiddenLabel mesh__D008000 Surveys, Library
% 210.56/210.75  |- skos__hiddenLabel mesh__D008000 Library Survey
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D008000 2005
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D008000 2002
% 210.56/210.75  |- mesh__dateRevised mesh__D008000 1999-11-03
% 210.56/210.75  |- skos__prefLabel mesh__D008000 Library Surveys
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D008000 2004
% 210.56/210.75  |- mesh__recordMaintainer mesh__D008000 kle
% 210.56/210.75  |- skos__hiddenLabel mesh__D008000 Survey, Library
% 210.56/210.75  |- skos__broader mesh__D008000smesh__D007998
% 210.56/210.75  |- rdf__type mesh__D008000sskos__Concept
% 210.56/210.75  |- mesh__recordAuthorizer mesh__D008000 sjn
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D008000 2001
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D008000 2003
% 210.56/210.75  |- skos__annotation mesh__D008000 IM   
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D008000 2000
% 210.56/210.75  |- mesh__recordAuthorizer mesh__D013743 sjn
% 210.56/210.75  |- skos__annotation mesh__D013743
% 210.56/210.75       for therapy: for prevention index under TETANUS TOXOID   
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D013743 2006
% 210.56/210.75  |- rdf__type mesh__D013743sskos__Concept
% 210.56/210.75  |- skos__scopeNote mesh__D013743
% 210.56/210.75       An antitoxin used for the treatment of TETANUS.     
% 210.56/210.75  |- skos__broader mesh__D013743smesh__D000992
% 210.56/210.75  |- mesh__dateRevised mesh__D013743 2005-06-30
% 210.56/210.75  |- mesh__dateCreated mesh__D013743 1999-01-01
% 210.56/210.75  |- mesh__recordOriginator mesh__D013743 NLM
% 210.56/210.75  |- skos__related mesh__D013743smesh__D013745
% 210.56/210.75  |- skos__prefLabel mesh__D013743 Tetanus Antitoxin
% 210.56/210.75  |- skos__hiddenLabel mesh__D013743 Antitoxin, Tetanus
% 210.56/210.75  |- mesh__recordMaintainer mesh__D013743 ssb
% 210.56/210.75  |- skos__altLabel mesh__D007706 Kinky Hair Syndrome
% 210.56/210.75  |- skos__related mesh__D007706smesh__D002570
% 210.56/210.75  |- skos__hiddenLabel mesh__D007706 Congenital Hypocupremias
% 210.56/210.75  |- skos__related mesh__D007706smesh__D013482
% 210.56/210.75  |- skos__hiddenLabel mesh__D007706 Disease, Steely Hair
% 210.56/210.75  |- skos__broader mesh__D007706smesh__D008664
% 210.56/210.75  |- mesh__dateCreated mesh__D007706 1976-05-05
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D007706 2005
% 210.56/210.75  |- skos__hiddenLabel mesh__D007706 Diseases, Steely Hair
% 210.56/210.75  |- skos__prefLabel mesh__D007706 Menkes Kinky Hair Syndrome
% 210.56/210.75  |- mesh__recordAuthorizer mesh__D007706 sjn
% 210.56/210.75  |- skos__historyNote mesh__D007706 Brain Diseases %28%1966-1976%29%
% 210.56/210.75  |- mesh__dateEstablished mesh__D007706 1991-01-01
% 210.56/210.75  |- skos__hiddenLabel mesh__D007706 Hypocupremias, Congenital
% 210.56/210.75  |- skos__altLabel mesh__D007706 Kinky Hair Disease
% 210.56/210.75  |- skos__altLabel mesh__D007706 Hypocupremia, Congenital
% 210.56/210.75  |- mesh__publicMeSHNote mesh__D007706
% 210.56/210.75       2000; see KINKY HAIR SYNDROME 1991-1999; see BRAIN DISEASES, METABOLIC 1977-1990%A%  
% 210.56/210.75  |- skos__altLabel mesh__D007706 Menkes%27% Disease
% 210.56/210.75  |- skos__altLabel mesh__D007706 Steely Hair Syndrome
% 210.56/210.75  |- skos__altLabel mesh__D007706 Congenital Hypocupremia
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D007706 2006
% 210.56/210.75  |- skos__scopeNote mesh__D007706
% 210.56/210.75       An inherited disorder of copper metabolism transmitted as an X-linked trait and characterized by the infantile onset of HYPOTHERMIA, feeding difficulties, hypotonia, SEIZURES, bony deformities, pili torti %28%twisted hair%29%, and severely impaired intellectual development. Defective copper transport across plasma and endoplasmic reticulum membranes results in copper being unavailable for the synthesis of several copper containing enzymes, including PROTEIN-LYSINE 6-OXIDASE; CERULOPLASMIN; and SUPEROXIDE DISMUTASE. Pathologic changes include defects in arterial elastin, neuronal loss, and gliosis. %28%From Menkes, Textbook of Child Neurology, 5th ed, p125%29%%A%    
% 210.56/210.75  |- skos__hiddenLabel mesh__D007706 Hair Diseases, Steely
% 210.56/210.75  |- skos__hiddenLabel mesh__D007706 Steely Hair Syndromes
% 210.56/210.75  |- mesh__historyNote mesh__D007706 2000%28%1977%29%   
% 210.56/210.75  |- skos__hiddenLabel mesh__D007706 Diseases, Menkes%27%
% 210.56/210.75  |- mesh__dateRevised mesh__D007706 2002-07-03
% 210.56/210.75  |- rdf__type mesh__D007706sskos__Concept
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D007706 2003
% 210.56/210.75  |- skos__broader mesh__D007706smesh__D020271
% 210.56/210.75  |- skos__altLabel mesh__D007706 Menkes Disease
% 210.56/210.75  |- skos__altLabel mesh__D007706 Steely Hair Disease
% 210.56/210.75  |- skos__hiddenLabel mesh__D007706 Hair Diseases, Kinky
% 210.56/210.75  |- skos__hiddenLabel mesh__D007706 Kinky Hair Diseases
% 210.56/210.75  |- skos__hiddenLabel mesh__D007706 Syndrome, Steely Hair
% 210.56/210.75  |- skos__hiddenLabel mesh__D007706 Syndromes, Steely Hair
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D007706 2004
% 210.56/210.75  |- mesh__recordOriginator mesh__D007706 MM
% 210.56/210.75  |- skos__broader mesh__D007706smesh__D006201
% 210.56/210.75  |- skos__related mesh__D007706smesh__D008249
% 210.56/210.75  |- skos__broader mesh__D007706smesh__D020739
% 210.56/210.75  |- skos__altLabel mesh__D007706 Menkes Syndrome
% 210.56/210.75  |- skos__hiddenLabel mesh__D007706 Diseases, Kinky Hair
% 210.56/210.75  |- skos__broader mesh__D007706smesh__D038901
% 210.56/210.75  |- skos__hiddenLabel mesh__D007706 Menkes%27% Diseases
% 210.56/210.75  |- skos__hiddenLabel mesh__D007706 Steely Hair Diseases
% 210.56/210.75  |- mesh__recordMaintainer mesh__D007706 lkt
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D045825 2005
% 210.56/210.75  |- mesh__historyNote mesh__D045825 2004   
% 210.56/210.75  |- skos__prefLabel mesh__D045825 Fusobacteriaceae Infections
% 210.56/210.75  |- skos__hiddenLabel mesh__D045825 Fusobacteriaceae Infection
% 210.56/210.75  |- skos__hiddenLabel mesh__D045825 Infection, Fusobacteriaceae
% 210.56/210.75  |- mesh__publicMeSHNote mesh__D045825 2004   
% 210.56/210.75  |- mesh__dateCreated mesh__D045825 2003-07-09
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D045825 2004
% 210.56/210.75  |- skos__scopeNote mesh__D045825
% 210.56/210.75       Infections with bacteria of the family Fusobacteriaceae, in the order Fusobacterales, phylum FUSOBACTERIA.%A%    
% 210.56/210.75  |- mesh__dateEstablished mesh__D045825 2004-01-01
% 210.56/210.75  |- rdf__type mesh__D045825sskos__Concept
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D045825 2006
% 210.56/210.75  |- skos__hiddenLabel mesh__D045825 Infections, Fusobacteriaceae
% 210.56/210.75  |- skos__broader mesh__D045825smesh__D016905
% 210.56/210.75  |- mesh__historyNote mesh__D031805 2003   
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D031805 2004
% 210.56/210.75  |- rdf__type mesh__D031805sskos__Concept
% 210.56/210.75  |- skos__scopeNote mesh__D031805
% 210.56/210.75       A plant family of the order Liliales, subclass Liliidae, class Liliopsida %28%monocotyledons%29%. Most species are perennials, native primarily to tropical America. They have creeping rootstocks, fibrous roots, and leaves in clusters at the base of the plant or borne on branched stems. The fruit is a capsule containing many seeds, or a one-seeded winged structure.%A%    
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D031805 2003
% 210.56/210.75  |- skos__broader mesh__D031805smesh__D019684
% 210.56/210.75  |- mesh__dateCreated mesh__D031805 2002-07-03
% 210.56/210.75  |- mesh__publicMeSHNote mesh__D031805 2003   
% 210.56/210.75  |- mesh__dateEstablished mesh__D031805 2003-01-01
% 210.56/210.75  |- skos__prefLabel mesh__D031805 Pontederiaceae
% 210.56/210.75  |- skos__annotation mesh__D031805
% 210.56/210.75       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D031805 2006
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D031805 2005
% 210.56/210.75  |- skos__broader mesh__D013435Q000097smesh__D013435
% 210.56/210.75  |- mesh__preferredCombination mesh__D013435Q000097smesh__D013436
% 210.56/210.75  |- rdf__type mesh__D013435Q000097smesh__CompoundConcept
% 210.56/210.75  |- mesh__recordOriginator mesh__D017336 TPW
% 210.56/210.75  |- skos__hiddenLabel mesh__D017336 Sch29851
% 210.56/210.75  |- mesh__recordAuthorizer mesh__D017336 sjn
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D017336 2005
% 210.56/210.75  |- skos__hiddenLabel mesh__D017336 Sch 29851
% 210.56/210.75  |- skos__historyNote mesh__D017336
% 210.56/210.75       Cyproheptadine/analogs %26% derivatives %28%1987-1992%29%
% 210.56/210.75  |- mesh__publicMeSHNote mesh__D017336
% 210.56/210.75       93; LORATADINE was indexed under CYPROHEPTADINE/analogs %26% derivatives 1976-92 %26% PIPERIDINES 1984-86%A%  
% 210.56/210.75  |- skos__historyNote mesh__D017336 Piperidines %28%1984-1986%29%
% 210.56/210.75  |- mesh__onlineNote mesh__D017336
% 210.56/210.75       use LORATADINE %28%NM%29% to search LORATADINE 1984-92   
% 210.56/210.75  |- mesh__dateCreated mesh__D017336 1992-05-22
% 210.56/210.75  |- skos__broader mesh__D017336smesh__D003533
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D017336 2006
% 210.56/210.75  |- skos__prefLabel mesh__D017336 Loratadine
% 210.56/210.75  |- skos__scopeNote mesh__D017336
% 210.56/210.75       A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines %28%HISTAMINE H1 ANTAGONISTS%29% it lacks central nervous system depressing effects such as drowsiness.%A%    
% 210.56/210.75  |- mesh__dateRevised mesh__D017336 2003-07-09
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D017336 2004
% 210.56/210.75  |- mesh__dateEstablished mesh__D017336 1993-01-01
% 210.56/210.75  |- mesh__recordMaintainer mesh__D017336 ssb
% 210.56/210.75  |- skos__altLabel mesh__D017336 Wyeth Brand of Loratadine
% 210.56/210.75  |- skos__hiddenLabel mesh__D017336 Loratadine Wyeth Brand
% 210.56/210.75  |- skos__altLabel mesh__D017336
% 210.56/210.75       4-%28%8-Chloro-5,6-dihydro-11H-benzo%28%5,6%29%cyclohepta%28%1,2-b%29%pyridin-11-ylidene%29%-1-piperidinecarboxylic Acid Ethyl Ester
% 210.56/210.75  |- mesh__historyNote mesh__D017336 93; was LORATADINE %28%NM%29% 1984-92   
% 210.56/210.75  |- rdf__type mesh__D017336sskos__Concept
% 210.56/210.75  |- mesh__dateEstablished mesh__D003316 1976-01-01
% 210.56/210.75  |- mesh__recordMaintainer mesh__D003316 PLS
% 210.56/210.75  |- skos__hiddenLabel mesh__D003316 Diseases, Corneal
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D003316 1993
% 210.56/210.75  |- skos__annotation mesh__D003316 inflamm dis = KERATITIS %26% specific   
% 210.56/210.75  |- skos__hiddenLabel mesh__D003316 Corneal Disease
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D003316 2006
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D003316 1999
% 210.56/210.75  |- skos__prefLabel mesh__D003316 Corneal Diseases
% 210.56/210.75  |- skos__historyNote mesh__D003316 Cornea %28%1966-1975%29%
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D003316 2002
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D003316 1992
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D003316 2005
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D003316 1998
% 210.56/210.75  |- rdf__type mesh__D003316sskos__Concept
% 210.56/210.75  |- skos__historyNote mesh__D003316 specific corneal disease heading
% 210.56/210.75  |- mesh__recordAuthorizer mesh__D003316 NLM
% 210.56/210.75  |- mesh__recordOriginator mesh__D003316 SMH
% 210.56/210.75  |- skos__scopeNote mesh__D003316 Diseases of the cornea.     
% 210.56/210.75  |- skos__broader mesh__D003316smesh__D005128
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D003316 1995
% 210.56/210.75  |- skos__hiddenLabel mesh__D003316 Disease, Corneal
% 210.56/210.75  |- mesh__historyNote mesh__D003316 76; was NON MESH before 1976   
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D003316 1991
% 210.56/210.75  |- mesh__publicMeSHNote mesh__D003316 76   
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D003316 2001
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D003316 1994
% 210.56/210.75  |- mesh__dateCreated mesh__D003316 1975-07-25
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D003316 2004
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D003316 1997
% 210.56/210.75  |- mesh__dateRevised mesh__D003316 1990-05-29
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D003316 2000
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D003316 2003
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D003316 1996
% 210.56/210.75  |- skos__altLabel mesh__D008001 Technical Services Library
% 210.56/210.75  |- mesh__recordAuthorizer mesh__D008001 sjn
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D008001 2001
% 210.56/210.75  |- mesh__dateEstablished mesh__D008001 1976-01-01
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D008001 2005
% 210.56/210.75  |- skos__hiddenLabel mesh__D008001 Services Technical, Library
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D008001 2000
% 210.56/210.75  |- skos__hiddenLabel mesh__D008001 Technical Services Libraries
% 210.56/210.75  |- skos__hiddenLabel mesh__D008001 Library Technical Service
% 210.56/210.75  |- skos__hiddenLabel mesh__D008001 Libraries, Technical Services
% 210.56/210.75  |- skos__altLabel mesh__D008001 Library Services Technical
% 210.56/210.75  |- skos__hiddenLabel mesh__D008001 Library, Technical Services
% 210.56/210.75  |- skos__prefLabel mesh__D008001 Library Technical Services
% 210.56/210.75  |- mesh__historyNote mesh__D008001
% 210.56/210.75       76; was LIBRARY TECHNICAL PROCESSES %28%NON MESH%29% before 1976%A%  
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D008001 2004
% 210.56/210.75  |- mesh__dateCreated mesh__D008001 1975-07-25
% 210.56/210.75  |- skos__historyNote mesh__D008001
% 210.56/210.75       specific library or library science heading%28%1966-1975%29%
% 210.56/210.75  |- skos__broader mesh__D008001smesh__D007998
% 210.56/210.75  |- mesh__publicMeSHNote mesh__D008001 76   
% 210.56/210.75  |- skos__broader mesh__D008001smesh__D007255
% 210.56/210.75  |- rdf__type mesh__D008001sskos__Concept
% 210.56/210.75  |- skos__altLabel mesh__D008001 Services, Library Technical
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D008001 2002
% 210.56/210.75  |- skos__hiddenLabel mesh__D008001 Library Services, Technical
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D008001 2003
% 210.56/210.75  |- mesh__dateRevised mesh__D008001 1999-11-03
% 210.56/210.75  |- skos__annotation mesh__D008001 IM; DF: LIBRARY TECHNICAL SERV   
% 210.56/210.75  |- skos__scopeNote mesh__D008001
% 210.56/210.75       Acquisition, organization, and preparation of library materials for use, including selection, weeding, cataloging, classification, and preservation.%A%    
% 210.56/210.75  |- skos__altLabel mesh__D008001 Technical Library Services
% 210.56/210.75  |- skos__altLabel mesh__D008001 Services, Technical Library
% 210.56/210.75  |- skos__hiddenLabel mesh__D008001 Library Service, Technical
% 210.56/210.75  |- mesh__recordMaintainer mesh__D008001 kle
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D008001 2006
% 210.56/210.75  |- skos__hiddenLabel mesh__D008001 Technical Library Service
% 210.56/210.75  |- mesh__recordOriginator mesh__D008001 SMH
% 210.56/210.75  |- skos__annotation mesh__D013744
% 210.56/210.75       /antag permitted but consider also TETANUS ANTITOXIN   
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D013744 2006
% 210.56/210.75  |- mesh__recordMaintainer mesh__D013744 ssb
% 210.56/210.75  |- skos__altLabel mesh__D013744 Tetanus Toxins
% 210.56/210.75  |- rdf__type mesh__D013744sskos__Concept
% 210.56/210.75  |- skos__hiddenLabel mesh__D013744 Toxin, Tetanus
% 210.56/210.75  |- mesh__recordAuthorizer mesh__D013744 sjn
% 210.56/210.75  |- mesh__dateCreated mesh__D013744 1999-01-01
% 210.56/210.75  |- skos__broader mesh__D013744smesh__D001426
% 210.56/210.75  |- mesh__dateEstablished mesh__D013744 1965-01-01
% 210.56/210.75  |- skos__hiddenLabel mesh__D013744 Toxins, Tetanus
% 210.56/210.75  |- skos__prefLabel mesh__D013744 Tetanus Toxin
% 210.56/210.75  |- skos__related mesh__D013744smesh__D013743
% 210.56/210.75  |- mesh__historyNote mesh__D013744 65   
% 210.56/210.75  |- mesh__publicMeSHNote mesh__D013744 65   
% 210.56/210.75  |- skos__hiddenLabel mesh__D013744 Toxin, Clostridium tetani
% 210.56/210.75  |- skos__hiddenLabel mesh__D013744 Neurotoxin, Clostridial
% 210.56/210.75  |- mesh__dateRevised mesh__D013744 2005-06-30
% 210.56/210.75  |- skos__altLabel mesh__D013744 Clostridium tetani Toxin
% 210.56/210.75  |- skos__broader mesh__D013744smesh__D001427
% 210.56/210.75  |- skos__scopeNote mesh__D013744
% 210.56/210.75       Protein synthesized by CLOSTRIDIUM TETANI as a single chain of %7E%150 kDa with 35%25% sequence identity to BOTULINUM TOXIN that is cleaved to a light and a heavy chain that are linked by a single disulfide bond. Tetanolysin is the hemolytic and tetanospasmin is the neurotoxic principle. The toxin causes disruption of the inhibitory mechanisms of the CNS, thus permitting uncontrolled nervous activity, leading to fatal CONVULSIONS.%A%    
% 210.56/210.75  |- mesh__recordOriginator mesh__D013744 NLM
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D007707 1998
% 210.56/210.75  |- skos__prefLabel mesh__D007707 Kyrgyzstan
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D007707 2000
% 210.56/210.75  |- mesh__activeMeSHYear mesh__D007707 2006
% 210.56/210.75  |- skos__altLabel mesh__D007707 Kirghizia
% 210.56/210.76  |- skos__annotation mesh__D007707 use this spelling in translations   
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D007707 1995
% 210.56/210.76  |- skos__broader mesh__D007707smesh__D014586
% 210.56/210.76  |- skos__altLabel mesh__D007707 Kirgizstan
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D007707 2005
% 210.56/210.76  |- rdf__type mesh__D007707sskos__Concept
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D007707 1997
% 210.56/210.76  |- mesh__recordAuthorizer mesh__D007707 PLS
% 210.56/210.76  |- skos__altLabel mesh__D007707 Kirghiz SSR
% 210.56/210.76  |- skos__altLabel mesh__D007707 Kirghiz S.S.R.
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D007707 2002
% 210.56/210.76  |- mesh__recordMaintainer mesh__D007707 PLS
% 210.56/210.76  |- skos__altLabel mesh__D007707 Kyrgyz Republic
% 210.56/210.76  |- mesh__dateCreated mesh__D007707 1999-01-01
% 210.56/210.76  |- skos__broader mesh__D007707smesh__D001209
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D007707 1996
% 210.56/210.76  |- mesh__onlineNote mesh__D007707
% 210.56/210.76       use KYRGYZSTAN to search KIRGHIZ S.S.R. 1982-92 %26% KIRGHIZIA 1966-81%A%  
% 210.56/210.76  |- mesh__dateRevised mesh__D007707 1994-05-31
% 210.56/210.76  |- mesh__recordOriginator mesh__D007707 NLM
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D007707 2004
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D007707 1999
% 210.56/210.76  |- skos__broader mesh__D007707smesh__D017517
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D007707 2001
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D007707 2003
% 210.56/210.76  |- mesh__historyNote mesh__D007707
% 210.56/210.76       93; was KIRGHIZ S.S.R. 1982-92; was KIRGHIZIA 1963-81   
% 210.56/210.76  |- mesh__recordAuthorizer mesh__D051863 ags
% 210.56/210.76  |- mesh__historyNote mesh__D051863 2006%28%1995%29%   
% 210.56/210.76  |- skos__scopeNote mesh__D051863
% 210.56/210.76       A cellular transcriptional coactivator that was originally identified by its requirement for the stable assembly IMMEDIATE-EARLY PROTEINS of the HERPES SIMPLEX VIRUS. It is a nuclear protein that is a transcriptional coactivator for a number of transcription factors including VP16 PROTEIN; GA-BINDING PROTEIN; EARLY GROWTH RESPONSE PROTEIN 2; and E2F4 TRANSCRIPTION FACTOR. It also interacts with and stabilizes HERPES SIMPLEX VIRUS PROTEIN VMW65 and helps regulate GENETIC TRANSCRIPTION of IMMEDIATE-EARLY GENES in HERPES SIMPLEX VIRUS.%A%    
% 210.56/210.76  |- skos__altLabel mesh__D051863 Cell Proliferation Factor HCF
% 210.56/210.76  |- mesh__dateRevised mesh__D051863 2005-07-18
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D051863 2006A
% 210.56/210.76  |- mesh__publicMeSHNote mesh__D051863
% 210.56/210.76       2006; HOST CELL FACTOR C1 was indexed under TRANSCRIPTION FACTORS 1995-2005%A%  
% 210.56/210.76  |- mesh__recordOriginator mesh__D051863 DRC
% 210.56/210.76  |- skos__prefLabel mesh__D051863 Host Cell Factor C1
% 210.56/210.76  |- mesh__dateEstablished mesh__D051863 2006-01-01
% 210.56/210.76  |- skos__altLabel mesh__D051863 C1 Host Cell Factor
% 210.56/210.76  |- skos__broader mesh__D051863smesh__D014157
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D051863 2006
% 210.56/210.76  |- mesh__dateCreated mesh__D051863 2005-06-30
% 210.56/210.76  |- mesh__recordMaintainer mesh__D051863 ags
% 210.56/210.76  |- rdf__type mesh__D051863sskos__Concept
% 210.56/210.76  |- skos__broader mesh__D045826smesh__D016905
% 210.56/210.76  |- mesh__publicMeSHNote mesh__D045826 2004   
% 210.56/210.76  |- skos__hiddenLabel mesh__D045826 Flavobacteriaceae Infection
% 210.56/210.76  |- mesh__historyNote mesh__D045826 2004   
% 210.56/210.76  |- mesh__dateCreated mesh__D045826 2003-07-09
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D045826 2004
% 210.56/210.76  |- rdf__type mesh__D045826sskos__Concept
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D045826 2006
% 210.56/210.76  |- skos__prefLabel mesh__D045826 Flavobacteriaceae Infections
% 210.56/210.76  |- skos__hiddenLabel mesh__D045826 Infections, Flavobacteriaceae
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D045826 2005
% 210.56/210.76  |- skos__hiddenLabel mesh__D045826 Infection, Flavobacteriaceae
% 210.56/210.76  |- mesh__dateEstablished mesh__D045826 2004-01-01
% 210.56/210.76  |- skos__scopeNote mesh__D045826
% 210.56/210.76       Infections with bacteria of the family FLAVOBACTERIACEAE.%A%    
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D031806 2003
% 210.56/210.76  |- mesh__dateCreated mesh__D031806 2002-07-03
% 210.56/210.76  |- skos__annotation mesh__D031806
% 210.56/210.76       X ref WATER HYACINTH: HYACINTH see HYACINTHUS is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.56/210.76  |- skos__prefLabel mesh__D031806 Eichhornia
% 210.56/210.76  |- mesh__publicMeSHNote mesh__D031806 2003   
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D031806 2006
% 210.56/210.76  |- skos__altLabel mesh__D031806 Water Hyacinth
% 210.56/210.76  |- mesh__historyNote mesh__D031806 2003   
% 210.56/210.76  |- skos__scopeNote mesh__D031806
% 210.56/210.76       A plant genus of the family PONTEDERIACEAE that is used as a biological filter for treating wastewater.%A%    
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D031806 2005
% 210.56/210.76  |- skos__broader mesh__D031806smesh__D031805
% 210.56/210.76  |- skos__altLabel mesh__D031806 Hyacinth, Water
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D031806 2004
% 210.56/210.76  |- rdf__type mesh__D031806sskos__Concept
% 210.56/210.76  |- mesh__dateEstablished mesh__D031806 2003-01-01
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D017337 2002
% 210.56/210.76  |- mesh__onlineNote mesh__D017337
% 210.56/210.76       use SERMORELIN %28%NM%29% to search SOMATOTROPIN RELEASING HORMONE%28%1-29%29%AMIDE 1984-92%A%  
% 210.56/210.76  |- skos__altLabel mesh__D017337 GRF%28%1-29%29%NH2
% 210.56/210.76  |- skos__altLabel mesh__D017337 hGHRH%28%1-29%29%NH2
% 210.56/210.76  |- skos__historyNote mesh__D017337
% 210.56/210.76       Somatotropin-Releasing Hormone/analogs %26% derivatives %28%1984-1992%29%
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D017337 2005
% 210.56/210.76  |- mesh__dateRevised mesh__D017337 2001-07-25
% 210.56/210.76  |- skos__scopeNote mesh__D017337
% 210.56/210.76       Human growth hormone-releasing factor %28%1-29%29%amide. The biologically active fragment of SOMATOTROPIN-RELEASING HORMONE. It is used to stimulate growth in children with a growth hormone deficiency or insufficiency.%A%    
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D017337 2006
% 210.56/210.76  |- mesh__recordOriginator mesh__D017337 TPW
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D017337 2003
% 210.56/210.76  |- mesh__historyNote mesh__D017337
% 210.56/210.76       93; was SOMATOTROPIN RELEASING HORMONE%28%1-29%29%AMIDE %28%NM%29% 1984-92%A%  
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D017337 2004
% 210.56/210.76  |- mesh__recordAuthorizer mesh__D017337 sjn
% 210.56/210.76  |- skos__historyNote mesh__D017337 Peptide Fragments %28%1984-1992%29%
% 210.56/210.76  |- mesh__dateCreated mesh__D017337 1992-05-22
% 210.56/210.76  |- rdf__type mesh__D017337sskos__Concept
% 210.56/210.76  |- skos__altLabel mesh__D017337
% 210.56/210.76       Somatotropin-Releasing-Hormone%28%1-29%29%Amide
% 210.56/210.76  |- skos__altLabel mesh__D017337 GHRH%28%1-29%29%NH2
% 210.56/210.76  |- mesh__publicMeSHNote mesh__D017337
% 210.56/210.76       93; SOMATOTROPIN RELEASING HORMONE%28%1-29%29%AMIDE was indexed under SOMATOTROPIN-RELEASING HORMONE/analogs %26% derivatives %26% PEPTIDE FRAGMENTS 1984-92%A%  
% 210.56/210.76  |- skos__prefLabel mesh__D017337 Sermorelin
% 210.56/210.76  |- skos__altLabel mesh__D017337
% 210.56/210.76       Growth Hormone-Releasing Factor%28%1-29%29%Amide
% 210.56/210.76  |- skos__broader mesh__D017337smesh__D013007
% 210.56/210.76  |- mesh__dateEstablished mesh__D017337 1993-01-01
% 210.56/210.76  |- mesh__recordMaintainer mesh__D017337 ssb
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Corneal Stromal Dystrophy
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D003317 2002
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Corneal Granular Dystrophies
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Corneal Granular Dystrophy
% 210.56/210.76  |- mesh__dateCreated mesh__D003317 1999-01-01
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D003317 2003
% 210.56/210.76  |- mesh__publicMeSHNote mesh__D003317
% 210.56/210.76       90; was CORNEAL DYSTROPHIES 1963-89   
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Dystrophy, Corneal Stromal
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Groenouws Dystrophies
% 210.56/210.76  |- mesh__onlineNote mesh__D003317
% 210.56/210.76       use CORNEAL DYSTROPHIES, HEREDITARY to search CORNEAL DYSTROPHIES 1966-89%A%  
% 210.56/210.76  |- mesh__historyNote mesh__D003317 90; was CORNEAL DYSTROPHIES 1963-89   
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D003317 2004
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Dystrophy, Corneal Macular
% 210.56/210.76  |- skos__scopeNote mesh__D003317
% 210.56/210.76       Bilateral hereditary disorders of the cornea, usually autosomal dominant, which may be present at birth but more frequently develop during adolescence and progress slowly throughout life. Central macular dystrophy is transmitted as an autosomal recessive defect.%A%    
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Groenouw Dystrophies
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Dystrophy, Hereditary Corneal
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Dystrophies, Corneal Granular
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Corneal Macular Dystrophies
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Dystrophies, Groenouw%27%s
% 210.56/210.76  |- mesh__recordAuthorizer mesh__D003317 sjn
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Corneal Macular Dystrophy
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Macular Dystrophies, Corneal
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Dystrophies, Hereditary Corneal
% 210.56/210.76  |- mesh__recordMaintainer mesh__D003317 nns
% 210.56/210.76  |- skos__prefLabel mesh__D003317 Corneal Dystrophies, Hereditary
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Dystrophies, Corneal Stromal
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D003317 2005
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Corneal Stromal Dystrophies
% 210.56/210.76  |- skos__broader mesh__D003317smesh__D015785
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Dystrophies, Corneal Macular
% 210.56/210.76  |- skos__broader mesh__D003317smesh__D003316
% 210.56/210.76  |- rdf__type mesh__D003317sskos__Concept
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Dystrophy, Corneal Granular
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Granular Dystrophies, Corneal
% 210.56/210.76  |- mesh__dateRevised mesh__D003317 2001-07-25
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D003317 2006
% 210.56/210.76  |- mesh__recordOriginator mesh__D003317 NLM
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Corneal Dystrophy, Hereditary
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Hereditary Corneal Dystrophy
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Hereditary Corneal Dystrophies
% 210.56/210.76  |- skos__hiddenLabel mesh__D003317 Stromal Dystrophy, Corneal
% 210.56/210.76  |- skos__broader mesh__D008800smesh__D009656
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008800 1997
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008800 2003
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008800 1999
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008800 2005
% 210.56/210.76  |- mesh__dateRevised mesh__D008800 1993-04-21
% 210.56/210.76  |- mesh__recordMaintainer mesh__D008800 PLS
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008800 1996
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008800 1995
% 210.56/210.76  |- mesh__recordOriginator mesh__D008800 NLM
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008800 1998
% 210.56/210.76  |- mesh__recordAuthorizer mesh__D008800 PLS
% 210.56/210.76  |- rdf__type mesh__D008800sskos__Concept
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008800 2002
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008800 1994
% 210.56/210.76  |- mesh__dateCreated mesh__D008800 1999-01-01
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008800 2001
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008800 2004
% 210.56/210.76  |- skos__annotation mesh__D008800
% 210.56/210.76       part of No. Amer., not So. Amer. nor Cent. Amer.; Indians of Mexico are indexed under MEXICO + INDIANS, NORTH AMERICAN: do not confuse with INDIANS, CENTRAL AMERICAN%A%  
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008800 2000
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008800 2006
% 210.56/210.76  |- skos__prefLabel mesh__D008800 Mexico
% 210.56/210.76  |- mesh__recordAuthorizer mesh__D008002 SJN
% 210.56/210.76  |- mesh__dateRevised mesh__D008002 1998-06-10
% 210.56/210.76  |- skos__prefLabel mesh__D008002 Libya
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008002 2000
% 210.56/210.76  |- mesh__recordMaintainer mesh__D008002 JLS
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008002 2003
% 210.56/210.76  |- mesh__dateCreated mesh__D008002 1999-01-01
% 210.56/210.76  |- skos__broader mesh__D008002smesh__D008877
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008002 2004
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008002 2001
% 210.56/210.76  |- rdf__type mesh__D008002sskos__Concept
% 210.56/210.76  |- mesh__recordOriginator mesh__D008002 NLM
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008002 2002
% 210.56/210.76  |- skos__scopeNote mesh__D008002
% 210.56/210.76       A country in northern Africa. Its capital is Tripoli. The general geographical area has been known since ancient times to the Phoenicians, Greeks, and Romans. Although the name is ancient and appeared in Egyptian hieroglyphics as early as 2000 B.C., the meaning is not known. %28%From Webster%27%s New Geographical Dictionary, 1988, p668%29%%A%    
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008002 2005
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008002 1999
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008002 2006
% 210.56/210.76  |- skos__broader mesh__D008002smesh__D000352
% 210.56/210.76  |- mesh__dateCreated mesh__D013745 1999-01-01
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D013745 2006
% 210.56/210.76  |- mesh__recordMaintainer mesh__D013745 ssb
% 210.56/210.76  |- rdf__type mesh__D013745sskos__Concept
% 210.56/210.76  |- skos__hiddenLabel mesh__D013745 Toxoid, Tetanus
% 210.56/210.76  |- mesh__dateRevised mesh__D013745 2005-06-30
% 210.56/210.76  |- skos__prefLabel mesh__D013745 Tetanus Toxoid
% 210.56/210.76  |- mesh__recordOriginator mesh__D013745 NLM
% 210.56/210.76  |- skos__broader mesh__D013745smesh__D014121
% 210.56/210.76  |- skos__hiddenLabel mesh__D013745 Vaccine, Tetanus
% 210.56/210.76  |- mesh__recordAuthorizer mesh__D013745 sjn
% 210.56/210.76  |- skos__related mesh__D013745smesh__D013743
% 210.56/210.76  |- skos__annotation mesh__D013745 note specific indentions   
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D007708 2005
% 210.56/210.76  |- skos__prefLabel mesh__D007708 Kirsten murine sarcoma virus
% 210.56/210.76  |- rdf__type mesh__D007708sskos__Concept
% 210.56/210.76  |- skos__broader mesh__D007708smesh__D009053
% 210.56/210.76  |- skos__historyNote mesh__D007708 Mouse Tumor Viruses %28%1966-1974%29%
% 210.56/210.76  |- skos__historyNote mesh__D007708 Mouse Sarcoma Viruses %28%1975-1979%29%
% 210.56/210.76  |- skos__altLabel mesh__D007708 Kirsten Sarcoma Virus
% 210.56/210.76  |- skos__hiddenLabel mesh__D007708 Virus, Kirsten Sarcoma
% 210.56/210.76  |- mesh__dateCreated mesh__D007708 1979-04-18
% 210.56/210.76  |- mesh__recordAuthorizer mesh__D007708 sjn
% 210.56/210.76  |- skos__scopeNote mesh__D007708
% 210.56/210.76       A replication-defective murine sarcoma virus %28%SARCOMA VIRUSES, MURINE%29% capable of transforming mouse lymphoid cells and producing erythroid leukemia after superinfection with murine leukemia viruses %28%LEUKEMIA VIRUS, MURINE%29%. It has also been found to transform cultured human fibroblasts, rat liver epithelial cells, and rat adrenocortical cells.%A%    
% 210.56/210.76  |- skos__hiddenLabel mesh__D007708 Sarcoma Virus, Kirsten
% 210.56/210.76  |- mesh__dateRevised mesh__D007708 2004-07-13
% 210.56/210.76  |- mesh__dateEstablished mesh__D007708 1991-01-01
% 210.56/210.76  |- mesh__historyNote mesh__D007708 2002 %28%1980%29%   
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D007708 2006
% 210.56/210.76  |- mesh__recordOriginator mesh__D007708 AEP
% 210.56/210.76  |- mesh__publicMeSHNote mesh__D007708
% 210.56/210.76       2002; see KIRSTEN SARCOMA VIRUS 1991-2001, see MOUSE SARCOMA VIRUSES 1980-1990%A%  
% 210.56/210.76  |- skos__annotation mesh__D007708
% 210.56/210.76       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% + SARCOMA, EXPERIMENTAL %28%IM%29%%A%  
% 210.56/210.76  |- mesh__recordMaintainer mesh__D007708 sjn
% 210.56/210.76  |- skos__broader mesh__D032101smesh__D027821
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D032101 2005
% 210.56/210.76  |- mesh__publicMeSHNote mesh__D032101 2003   
% 210.56/210.76  |- mesh__historyNote mesh__D032101 2003   
% 210.56/210.76  |- skos__scopeNote mesh__D032101
% 210.56/210.76       A plant genus of the family RUTACEAE. Members contain murrayanine, koenine, isomahanine, kwangsine, siamenol, murrayafoline A, murrayaquinone A and other cytotoxic carbazolequinones.%A%    
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D032101 2006
% 210.56/210.76  |- mesh__dateEstablished mesh__D032101 2003-01-01
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D032101 2003
% 210.56/210.76  |- skos__prefLabel mesh__D032101 Murraya
% 210.56/210.76  |- rdf__type mesh__D032101sskos__Concept
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D032101 2004
% 210.56/210.76  |- skos__annotation mesh__D032101
% 210.56/210.76       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.56/210.76  |- mesh__dateCreated mesh__D032101 2002-07-03
% 210.56/210.76  |- skos__hiddenLabel mesh__D004410 Reading Disabilities, Developmental
% 210.56/210.76  |- skos__altLabel mesh__D004410 Reading Disorder
% 210.56/210.76  |- skos__prefLabel mesh__D004410 Dyslexia
% 210.56/210.76  |- mesh__recordOriginator mesh__D004410 NLM
% 210.56/210.76  |- mesh__dateRevised mesh__D004410 2001-07-25
% 210.56/210.76  |- mesh__publicMeSHNote mesh__D004410
% 210.56/210.76       1966; see READING 1963-1965; for ALEXIA see DYSLEXIA, ACQUIRED 1977-1999%A%  
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D004410 2005
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D004410 2004
% 210.56/210.76  |- mesh__historyNote mesh__D004410
% 210.56/210.76       1966%28%1963%29%; for ALEXIA use DYSLEXIA, ACQUIRED 1977-1999   
% 210.56/210.76  |- skos__hiddenLabel mesh__D004410 Developmental Reading Disorders
% 210.56/210.76  |- skos__hiddenLabel mesh__D004410 Disability, Developmental Reading
% 210.56/210.76  |- skos__related mesh__D004410smesh__D007859
% 210.56/210.76  |- skos__scopeNote mesh__D004410
% 210.56/210.76       A cognitive disorder characterized by an impaired ability to comprehend written and printed words or phrases despite intact vision. This condition may be developmental or acquired. Developmental dyslexia is marked by reading achievement that falls substantially below that expected given the individual%27%s chronological age, measured intelligence, and age-appropriate education. The disturbance in reading significantly interferes with academic achievement or with activities of daily living that require reading skills. %28%From DSM-IV%29%%A%    
% 210.56/210.76  |- skos__hiddenLabel mesh__D004410 Disorder, Reading
% 210.56/210.76  |- rdf__type mesh__D004410sskos__Concept
% 210.56/210.76  |- skos__altLabel mesh__D004410 Word Blindness
% 210.56/210.76  |- mesh__recordAuthorizer mesh__D004410 sjn
% 210.56/210.76  |- skos__hiddenLabel mesh__D004410 Alexias
% 210.56/210.76  |- skos__hiddenLabel mesh__D004410 Developmental Dyslexia
% 210.56/210.76  |- skos__broader mesh__D004410smesh__D007806
% 210.56/210.76  |- skos__hiddenLabel mesh__D004410 Blindnesses, Word
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D004410 2003
% 210.56/210.76  |- skos__altLabel mesh__D004410 Dyslexia, Developmental
% 210.56/210.76  |- skos__hiddenLabel mesh__D004410 Dyslexias
% 210.56/210.76  |- mesh__dateCreated mesh__D004410 1999-01-01
% 210.56/210.76  |- skos__altLabel mesh__D004410 Developmental Reading Disorder
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D004410 2002
% 210.56/210.76  |- skos__annotation mesh__D004410
% 210.56/210.76       dyslexia caused by a brain lesion is DYSLEXIA, ACQUIRED; note x-ref: ALEXIA, PURE is also available%A%  
% 210.56/210.76  |- skos__hiddenLabel mesh__D004410 Developmental Reading Disabilities
% 210.56/210.76  |- skos__hiddenLabel mesh__D004410 Blindness, Word
% 210.56/210.76  |- skos__altLabel mesh__D004410 Reading Disability, Developmental
% 210.56/210.76  |- skos__hiddenLabel mesh__D004410 Developmental Dyslexias
% 210.56/210.76  |- mesh__dateEstablished mesh__D004410 1966-01-01
% 210.56/210.76  |- skos__hiddenLabel mesh__D004410 Disorder, Developmental Reading
% 210.56/210.76  |- skos__hiddenLabel mesh__D004410 Reading Disorders
% 210.56/210.76  |- skos__hiddenLabel mesh__D004410 Word Blindnesses
% 210.56/210.76  |- mesh__recordMaintainer mesh__D004410 nns
% 210.56/210.76  |- skos__broader mesh__D004410smesh__D007859
% 210.56/210.76  |- skos__hiddenLabel mesh__D004410 Disorders, Reading
% 210.56/210.76  |- skos__hiddenLabel mesh__D004410 Reading Disorders, Developmental
% 210.56/210.76  |- skos__hiddenLabel mesh__D004410 Dyslexias, Developmental
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D004410 2006
% 210.56/210.76  |- skos__hiddenLabel mesh__D004410 Disorders, Developmental Reading
% 210.56/210.76  |- skos__hiddenLabel mesh__D004410 Developmental Reading Disability
% 210.56/210.76  |- skos__hiddenLabel mesh__D004410 Disabilities, Developmental Reading
% 210.56/210.76  |- skos__hiddenLabel mesh__D045827 Infection, Flexibacteraceae
% 210.56/210.76  |- skos__prefLabel mesh__D045827 Flexibacteraceae Infections
% 210.56/210.76  |- mesh__publicMeSHNote mesh__D045827 2004   
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D045827 2005
% 210.56/210.76  |- mesh__dateCreated mesh__D045827 2003-07-09
% 210.56/210.76  |- mesh__dateEstablished mesh__D045827 2004-01-01
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D045827 2004
% 210.56/210.76  |- skos__broader mesh__D045827smesh__D016905
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D045827 2006
% 210.56/210.76  |- rdf__type mesh__D045827sskos__Concept
% 210.56/210.76  |- skos__hiddenLabel mesh__D045827 Flexibacteraceae Infection
% 210.56/210.76  |- mesh__historyNote mesh__D045827 2004   
% 210.56/210.76  |- skos__scopeNote mesh__D045827
% 210.56/210.76       Infections with bacteria of the family FLEXIBACTERACEAE.%A%    
% 210.56/210.76  |- skos__hiddenLabel mesh__D045827 Infections, Flexibacteraceae
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D017338 2003
% 210.56/210.76  |- mesh__dateCreated mesh__D017338 1992-05-22
% 210.56/210.76  |- skos__prefLabel mesh__D017338 Cladribine
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D017338 2004
% 210.56/210.76  |- mesh__dateEstablished mesh__D017338 1993-01-01
% 210.56/210.76  |- skos__broader mesh__D017338smesh__D015762
% 210.56/210.76  |- skos__altLabel mesh__D017338 2-Chloro-2%27%-deoxyadenosine
% 210.56/210.76  |- rdf__type mesh__D017338sskos__Concept
% 210.56/210.76  |- skos__altLabel mesh__D017338 2-Chlorodeoxyadenosine
% 210.56/210.76  |- mesh__recordMaintainer mesh__D017338 ssb
% 210.56/210.76  |- skos__historyNote mesh__D017338 Deoxyadenosines %28%1986-1992%29%
% 210.56/210.76  |- mesh__onlineNote mesh__D017338
% 210.56/210.76       use CLADRIBINE to search 2-CHLORODEOXYADENOSINE 1993-94; use CLADRIBINE %28%NM%29% to search 2-CHLORO-2%27%-DEOXYADENOSINE 1986-92%A%  
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D017338 2002
% 210.56/210.76  |- skos__broader mesh__D017338smesh__D003839
% 210.56/210.76  |- mesh__recordOriginator mesh__D017338 TPW
% 210.56/210.76  |- skos__altLabel mesh__D017338 2%27%-Deoxy-2-chloroadenosine
% 210.56/210.76  |- mesh__dateRevised mesh__D017338 2001-07-25
% 210.56/210.76  |- mesh__publicMeSHNote mesh__D017338
% 210.56/210.76       95; was 2-CHLORODEOXYADENOSINE 1993-94; 2-CHLORO-2%27%-DEOXYADENOSINE was indexed under 2-CHLOROADENOSINE/analogs %26% derivatives %26% DEOXYADENOSINES 1986-92%A%  
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D017338 2005
% 210.56/210.76  |- skos__scopeNote mesh__D017338
% 210.56/210.76       An antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia.%A%    
% 210.56/210.76  |- skos__historyNote mesh__D017338
% 210.56/210.76       2-Chloroadenosine/analogs %26% derivatives %28%1986-1992%29%
% 210.56/210.76  |- mesh__historyNote mesh__D017338
% 210.56/210.76       95; was 2-CHLORODEOXYADENOSINE 1993-94; was 2-CHLORO-2%27%-DEOXYADENOSINE %28%NM%29% 1986-92%A%  
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D017338 2006
% 210.56/210.76  |- mesh__recordAuthorizer mesh__D017338 sjn
% 210.56/210.76  |- skos__hiddenLabel mesh__D003318 Opacities, Corneal
% 210.56/210.76  |- skos__hiddenLabel mesh__D003318 Corneal Opacities
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D003318 2006
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D003318 1999
% 210.56/210.76  |- skos__hiddenLabel mesh__D003318 Leukomas
% 210.56/210.76  |- skos__scopeNote mesh__D003318
% 210.56/210.76       Disorder occurring in the central or peripheral area of the cornea. The usual degree of transparency becomes relatively opaque.%A%    
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D003318 2000
% 210.56/210.76  |- mesh__dateRevised mesh__D003318 1994-03-14
% 210.56/210.76  |- rdf__type mesh__D003318sskos__Concept
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D003318 2003
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D003318 2001
% 210.56/210.76  |- mesh__dateCreated mesh__D003318 1999-01-01
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D003318 1996
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D003318 1995
% 210.56/210.76  |- mesh__recordOriginator mesh__D003318 NLM
% 210.56/210.76  |- mesh__historyNote mesh__D003318
% 210.56/210.76       ARCUS SENILIS was see under EYE DISEASES 1964-89   
% 210.56/210.76  |- skos__hiddenLabel mesh__D003318 Opacity, Corneal
% 210.56/210.76  |- skos__prefLabel mesh__D003318 Corneal Opacity
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D003318 2002
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D003318 2004
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D003318 1997
% 210.56/210.76  |- skos__broader mesh__D003318smesh__D003316
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D003318 2005
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D003318 1998
% 210.56/210.76  |- mesh__recordAuthorizer mesh__D003318 PLS
% 210.56/210.76  |- mesh__recordMaintainer mesh__D003318 PLS
% 210.56/210.76  |- mesh__publicMeSHNote mesh__D003318
% 210.56/210.76       ARCUS SENILIS was see under EYE DISEASES 1964-89   
% 210.56/210.76  |- skos__altLabel mesh__D003318 Leukoma
% 210.56/210.76  |- skos__hiddenLabel mesh__D014040 Token Economies
% 210.56/210.76  |- mesh__dateCreated mesh__D014040 1974-12-12
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D014040 2005
% 210.56/210.76  |- skos__altLabel mesh__D014040 Token Reinforcement
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D014040 1992
% 210.56/210.76  |- skos__hiddenLabel mesh__D014040 Token Reinforcements
% 210.56/210.76  |- skos__annotation mesh__D014040 no qualif   
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D014040 1998
% 210.56/210.76  |- mesh__dateEstablished mesh__D014040 1979-01-01
% 210.56/210.76  |- mesh__historyNote mesh__D014040
% 210.56/210.76       79%28%75%29%; was see under REWARD 1975-78   
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D014040 2006
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D014040 1993
% 210.56/210.76  |- skos__historyNote mesh__D014040 Reward %28%1966-1974%29%
% 210.56/210.76  |- mesh__recordMaintainer mesh__D014040 PLS
% 210.56/210.76  |- skos__hiddenLabel mesh__D014040 Economies, Token
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D014040 2002
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D014040 1999
% 210.56/210.76  |- skos__altLabel mesh__D014040 Economy, Token
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D014040 2003
% 210.56/210.76  |- skos__broader mesh__D014040smesh__D012201
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D014040 1996
% 210.56/210.76  |- skos__scopeNote mesh__D014040
% 210.56/210.76       A practice whereby tokens representing money, toys, candy, etc., are given as secondary reinforcers contingent upon certain desired behaviors or performances.%A%    
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D014040 2004
% 210.56/210.76  |- rdf__type mesh__D014040sskos__Concept
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D014040 2000
% 210.56/210.76  |- mesh__publicMeSHNote mesh__D014040 79; was see under REWARD 1975-78   
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D014040 1997
% 210.56/210.76  |- mesh__recordOriginator mesh__D014040 NLM
% 210.56/210.76  |- skos__hiddenLabel mesh__D014040 Reinforcement, Token
% 210.56/210.76  |- skos__hiddenLabel mesh__D014040 Reinforcements, Token
% 210.56/210.76  |- mesh__dateRevised mesh__D014040 1991-06-11
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D014040 1994
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D014040 2001
% 210.56/210.76  |- mesh__recordAuthorizer mesh__D014040 PLS
% 210.56/210.76  |- skos__prefLabel mesh__D014040 Token Economy
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D014040 1995
% 210.56/210.76  |- skos__hiddenLabel mesh__D008801 KO 1173
% 210.56/210.76  |- skos__altLabel mesh__D008801
% 210.56/210.76       Boehringer Ingelheim Brand of Mexiletine Hydrochloride
% 210.56/210.76  |- skos__altLabel mesh__D008801 KO1173
% 210.56/210.76  |- mesh__dateEstablished mesh__D008801 1987-01-01
% 210.56/210.76  |- mesh__dateRevised mesh__D008801 2005-06-30
% 210.56/210.76  |- mesh__recordMaintainer mesh__D008801 CCR
% 210.56/210.76  |- skos__historyNote mesh__D008801 Phenyl Ethers %28%1974%29%
% 210.56/210.76  |- rdf__type mesh__D008801sskos__Concept
% 210.56/210.76  |- skos__altLabel mesh__D008801 Mexityl
% 210.56/210.76  |- skos__broader mesh__D008801smesh__D011437
% 210.56/210.76  |- skos__hiddenLabel mesh__D008801 KOE1173
% 210.56/210.76  |- mesh__dateCreated mesh__D008801 1974-11-19
% 210.56/210.76  |- skos__historyNote mesh__D008801 Propylamines %28%1972-1974%29%
% 210.56/210.76  |- skos__prefLabel mesh__D008801 Mexiletine
% 210.56/210.76  |- skos__hiddenLabel mesh__D008801 Novo Mexiletine
% 210.56/210.76  |- mesh__recordOriginator mesh__D008801 NLM
% 210.56/210.76  |- skos__hiddenLabel mesh__D008801 KOE 1173
% 210.56/210.76  |- skos__altLabel mesh__D008801 Mexitil PL
% 210.56/210.76  |- skos__altLabel mesh__D008801 KOE-1173
% 210.56/210.76  |- skos__altLabel mesh__D008801 Novopharm Brand of Mexiletine Hydrochloride
% 210.56/210.76  |- mesh__publicMeSHNote mesh__D008801
% 210.56/210.76       87; was see under PROPYLAMINES 1975-86   
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008801 2006
% 210.56/210.76  |- mesh__recordAuthorizer mesh__D008801 sjn
% 210.56/210.76  |- mesh__historyNote mesh__D008801
% 210.56/210.76       87%28%75%29%; was see under PROPYLAMINES 1975-86   
% 210.56/210.76  |- skos__scopeNote mesh__D008801
% 210.56/210.76       Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.%A%    
% 210.56/210.76  |- mesh__recordMaintainer mesh__D008003 ags
% 210.56/210.76  |- mesh__publicMeSHNote mesh__D008003 PHTHIRAPTERA was heading 1975-79   
% 210.56/210.76  |- mesh__dateCreated mesh__D008003 1999-01-01
% 210.56/210.76  |- mesh__activeMeSHYear mesh__D008003 2004
% 210.56/210.77  |- skos__annotation mesh__D008003
% 210.56/210.77       do not use /drug eff for insecticides: TN 111   
% 210.56/210.77  |- rdf__type mesh__D008003sskos__Concept
% 210.56/210.77  |- mesh__historyNote mesh__D008003 PHTHIRAPTERA was heading 1975-79   
% 210.56/210.77  |- mesh__onlineNote mesh__D008003
% 210.56/210.77       use LICE to search PHTHIRAPTERA 1975-79   
% 210.56/210.77  |- skos__scopeNote mesh__D008003
% 210.56/210.77       A general name for small, wingless, parasitic insects, previously of the order Phthiraptera. Though exact taxonomy is still controversial, they can be grouped in the orders ANOPLURA %28%sucking lice%29%, MALLOPHAGA %28%biting lice%29%, and Rhynchophthirina %28%elephant-lice%29%.%A%    
% 210.56/210.77  |- mesh__dateRevised mesh__D008003 2003-07-09
% 210.56/210.77  |- skos__related mesh__D008003smesh__D010373
% 210.56/210.77  |- skos__altLabel mesh__D008003 Louse
% 210.56/210.77  |- skos__prefLabel mesh__D008003 Lice
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D008003 2005
% 210.56/210.77  |- mesh__recordAuthorizer mesh__D008003 sjn
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D008003 2006
% 210.56/210.77  |- skos__altLabel mesh__D008003 Phthiraptera
% 210.56/210.77  |- mesh__recordOriginator mesh__D008003 NLM
% 210.56/210.77  |- skos__broader mesh__D008003smesh__D007313
% 210.56/210.77  |- skos__altLabel mesh__D000020 Abortifacient Agents, Non-Steroidal
% 210.56/210.77  |- rdf__type mesh__D000020sskos__Concept
% 210.56/210.77  |- skos__prefLabel mesh__D000020 Abortifacient Agents, Nonsteroidal
% 210.56/210.77  |- skos__hiddenLabel mesh__D000020 Abortifacient Agents, Non Steroidal
% 210.56/210.77  |- skos__historyNote mesh__D000020 specific chemical %28%1971-1974%29%
% 210.56/210.77  |- skos__historyNote mesh__D000020 Abortion, Induced %28%1970-1974%29%
% 210.56/210.77  |- skos__broader mesh__D000020smesh__D000019
% 210.56/210.77  |- skos__hiddenLabel mesh__D000020 Non-Steroidal Abortifacient Agents
% 210.56/210.77  |- mesh__recordAuthorizer mesh__D000020 sjn
% 210.56/210.77  |- skos__annotation mesh__D000020
% 210.56/210.77       do not use /ther use for use of the abortifacients as abortifacients%A%  
% 210.56/210.77  |- skos__hiddenLabel mesh__D000020 Agents, Nonsteroidal Abortifacient
% 210.56/210.77  |- skos__hiddenLabel mesh__D000020 Agents, Non-Steroidal Abortifacient
% 210.56/210.77  |- mesh__dateRevised mesh__D000020 2005-06-30
% 210.56/210.77  |- mesh__recordMaintainer mesh__D000020 ssb
% 210.56/210.77  |- mesh__recordOriginator mesh__D000020 NLM
% 210.56/210.77  |- skos__scopeNote mesh__D000020
% 210.56/210.77       Non-steroidal chemical compounds with abortifacient activity.%A%    
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D000020 2006
% 210.56/210.77  |- mesh__dateEstablished mesh__D000020 1991-01-01
% 210.56/210.77  |- mesh__publicMeSHNote mesh__D000020
% 210.56/210.77       91; was see under ABORTIFACIENT AGENTS 1975-90   
% 210.56/210.77  |- skos__hiddenLabel mesh__D000020 Nonsteroidal Abortifacient Agents
% 210.56/210.77  |- mesh__dateCreated mesh__D000020 1974-11-11
% 210.56/210.77  |- mesh__historyNote mesh__D000020
% 210.56/210.77       91%28%75%29%; was see under ABORTIFACIENT AGENTS 1975-90   
% 210.56/210.77  |- mesh__publicMeSHNote mesh__D013746 SPASMOPHILIA was heading 1963-76   
% 210.56/210.77  |- mesh__historyNote mesh__D013746 SPASMOPHILIA was heading 1963-76   
% 210.56/210.77  |- skos__scopeNote mesh__D013746
% 210.56/210.77       A disorder characterized by muscle twitches, cramps, and carpopedal spasm, and when severe, laryngospasm and seizures. This condition is associated with unstable depolarization of axonal membranes, primarily in the peripheral nervous system. Tetany usually results from HYPOCALCEMIA or reduced serum levels of MAGNESIUM that may be associated with HYPERVENTILATION; HYPOPARATHYROIDISM; RICKETS; UREMIA; or other conditions. %28%From Adams et al., Principles of Neurology, 6th ed, p1490%29%%A%    
% 210.56/210.77  |- skos__hiddenLabel mesh__D013746 Neonatal Tetanies
% 210.56/210.77  |- skos__broader mesh__D013746smesh__D006996
% 210.56/210.77  |- skos__hiddenLabel mesh__D013746 Tetanies
% 210.56/210.77  |- skos__hiddenLabel mesh__D013746 Spasmophilias
% 210.56/210.77  |- skos__broader mesh__D013746smesh__D020879
% 210.56/210.77  |- mesh__dateRevised mesh__D013746 2005-06-30
% 210.56/210.77  |- skos__annotation mesh__D013746
% 210.56/210.77       do not confuse with TETANUS, a Clostridium tetani infection; tetanic spasm of muscle = SPASM; tetanic contraction = MUSCLE CONTRACTION; coordinate with cause if given%A%  
% 210.56/210.77  |- mesh__recordOriginator mesh__D013746 NLM
% 210.56/210.77  |- skos__hiddenLabel mesh__D013746 Tetanillas
% 210.56/210.77  |- mesh__recordMaintainer mesh__D013746 lkt
% 210.56/210.77  |- skos__prefLabel mesh__D013746 Tetany
% 210.56/210.77  |- skos__hiddenLabel mesh__D013746 Tetanies, Neonatal
% 210.56/210.77  |- mesh__onlineNote mesh__D013746
% 210.56/210.77       use TETANY to search SPASMOPHILIA 1966-76   
% 210.56/210.77  |- skos__hiddenLabel mesh__D013746 Neonatal Tetany
% 210.56/210.77  |- mesh__dateCreated mesh__D013746 1999-01-01
% 210.56/210.77  |- mesh__recordAuthorizer mesh__D013746 sjn
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D013746 2006
% 210.56/210.77  |- rdf__type mesh__D013746sskos__Concept
% 210.56/210.77  |- skos__annotation mesh__D007709
% 210.56/210.77       KLEBSIELLA AEROGENES and KLEBSIELLA MOBILIS see ENTEROBACTER AEROGENES are also available%A%  
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D007709 2006A
% 210.56/210.77  |- mesh__dateRevised mesh__D007709 2005-07-18
% 210.56/210.77  |- skos__scopeNote mesh__D007709
% 210.56/210.77       A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms arrange singly, in pairs, or short chains. This genus is commonly found in the intestinal tract and is an opportunistic pathogen that can give rise to bacteremia, pneumonia, urinary tract and several other types of human infection.%A%    
% 210.56/210.77  |- skos__prefLabel mesh__D007709 Klebsiella
% 210.56/210.77  |- mesh__recordAuthorizer mesh__D007709 ags
% 210.56/210.77  |- mesh__recordMaintainer mesh__D007709 ags
% 210.56/210.77  |- mesh__recordOriginator mesh__D007709 NLM
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D007709 2006
% 210.56/210.77  |- skos__broader mesh__D007709smesh__D004755
% 210.56/210.77  |- rdf__type mesh__D007709sskos__Concept
% 210.56/210.77  |- mesh__dateCreated mesh__D007709 1999-01-01
% 210.56/210.77  |- skos__prefLabel mesh__D018431 Newspaper Article %5B%Publication Type%5D%
% 210.56/210.77  |- mesh__dateRevised mesh__D018431 2005-06-30
% 210.56/210.77  |- skos__annotation mesh__D018431
% 210.56/210.77       publication type only; for items indexed from newspapers or newsletters: do not confuse with the Publication Type NEWS used for news items indexed from journals%A%  
% 210.56/210.77  |- mesh__dateEstablished mesh__D018431 1996-01-01
% 210.56/210.77  |- skos__altLabel mesh__D018431 Newspaper Article %28%PT%29%
% 210.56/210.77  |- mesh__historyNote mesh__D018431 1995   
% 210.56/210.77  |- skos__broader mesh__D018431smesh__D052180
% 210.56/210.77  |- mesh__recordMaintainer mesh__D018431 jls
% 210.56/210.77  |- mesh__recordAuthorizer mesh__D018431 sjn
% 210.56/210.77  |- skos__altLabel mesh__D018431 Newspaper Article
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D018431 2006
% 210.56/210.77  |- skos__scopeNote mesh__D018431
% 210.56/210.77       Work consisting of a news item appearing in a general-interest newspaper or other general news periodical, containing information of current and timely interest in the field of medicine or science. This publication type should not be confused with NEWS %5B%PUBLICATION TYPE%5D%,  reserved for news reports published in various medical or other scientific journals, such as %22%Nature%22%.%A%    
% 210.56/210.77  |- rdf__type mesh__D018431sskos__Concept
% 210.56/210.77  |- mesh__recordOriginator mesh__D018431 TGC
% 210.56/210.77  |- mesh__dateCreated mesh__D018431 1995-06-23
% 210.56/210.77  |- mesh__dateCreated mesh__D032102 2002-07-03
% 210.56/210.77  |- skos__scopeNote mesh__D032102
% 210.56/210.77       A plant genus of the family RUTACEAE. Members contain BERBERINE, indolopyridoquinazoline and other ALKALOIDS and limonoids.%A%    
% 210.56/210.77  |- skos__broader mesh__D032102smesh__D027821
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D032102 2005
% 210.56/210.77  |- mesh__publicMeSHNote mesh__D032102 2003   
% 210.56/210.77  |- mesh__historyNote mesh__D032102 2003   
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D032102 2006
% 210.56/210.77  |- mesh__dateEstablished mesh__D032102 2003-01-01
% 210.56/210.77  |- skos__altLabel mesh__D032102 Corktree
% 210.56/210.77  |- rdf__type mesh__D032102sskos__Concept
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D032102 2003
% 210.56/210.77  |- skos__prefLabel mesh__D032102 Phellodendron
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D032102 2004
% 210.56/210.77  |- skos__annotation mesh__D032102
% 210.56/210.77       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.56/210.77  |- mesh__publicMeSHNote mesh__D004411 1977; see ALEXIA 1963-1976   
% 210.56/210.77  |- skos__hiddenLabel mesh__D004411 Spelling Dyslexia, Acquired
% 210.56/210.77  |- skos__broader mesh__D004411smesh__D004410
% 210.56/210.77  |- skos__altLabel mesh__D004411 Word Blindness, Acquired
% 210.56/210.77  |- skos__hiddenLabel mesh__D004411 Blindnesses, Acquired Word
% 210.56/210.77  |- mesh__recordMaintainer mesh__D004411 KEV
% 210.56/210.77  |- skos__hiddenLabel mesh__D004411 Disability, Acquired Reading
% 210.56/210.77  |- rdf__type mesh__D004411sskos__Concept
% 210.56/210.77  |- skos__hiddenLabel mesh__D004411 Dyslexia, Acquired Spelling
% 210.56/210.77  |- skos__hiddenLabel mesh__D004411 Global Dyslexia, Acquired
% 210.56/210.77  |- skos__scopeNote mesh__D004411
% 210.56/210.77       A receptive visual aphasia characterized by the loss of a previously possessed ability to comprehend the meaning or significance of handwritten words, despite intact vision. This condition may be associated with posterior cerebral artery infarction %28%INFARCTION, POSTERIOR CEREBRAL ARTERY%29% and other BRAIN DISEASES.%A%    
% 210.56/210.77  |- skos__broader mesh__D004411smesh__D019965
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D004411 2002
% 210.56/210.77  |- skos__hiddenLabel mesh__D004411 Acquired Reading Disability
% 210.56/210.77  |- mesh__dateRevised mesh__D004411 1999-11-04
% 210.56/210.77  |- skos__hiddenLabel mesh__D004411 Disabilities, Acquired Reading
% 210.56/210.77  |- skos__altLabel mesh__D004411 Reading Disability, Acquired
% 210.56/210.77  |- skos__hiddenLabel mesh__D004411 Reading Disabilities, Acquired
% 210.56/210.77  |- skos__hiddenLabel mesh__D004411 Acquired Word Blindness
% 210.56/210.77  |- skos__hiddenLabel mesh__D004411 Dyslexia, Acquired Global
% 210.56/210.77  |- skos__hiddenLabel mesh__D004411 Acquired Word Blindnesses
% 210.56/210.77  |- mesh__recordAuthorizer mesh__D004411 sjn
% 210.56/210.77  |- mesh__historyNote mesh__D004411 1977%28%1963%29%   
% 210.56/210.77  |- skos__hiddenLabel mesh__D004411 Blindness, Acquired Word
% 210.56/210.77  |- skos__hiddenLabel mesh__D004411 Acquired Alexia
% 210.56/210.77  |- mesh__recordOriginator mesh__D004411 NLM
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D004411 2003
% 210.56/210.77  |- mesh__dateCreated mesh__D004411 1999-01-01
% 210.56/210.77  |- skos__hiddenLabel mesh__D004411 Word Blindnesses, Acquired
% 210.56/210.77  |- skos__hiddenLabel mesh__D004411 Acquired Reading Disabilities
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D004411 2000
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D004411 2005
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D004411 2004
% 210.56/210.77  |- skos__hiddenLabel mesh__D004411 Acquired Dyslexia
% 210.56/210.77  |- skos__prefLabel mesh__D004411 Dyslexia, Acquired
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D004411 2001
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D004411 2006
% 210.56/210.77  |- skos__hiddenLabel mesh__D045828 Infection, Moraxella
% 210.56/210.77  |- skos__hiddenLabel mesh__D045828 Psychobacter Infection
% 210.56/210.77  |- skos__hiddenLabel mesh__D045828 Moraxella Infection
% 210.56/210.77  |- mesh__publicMeSHNote mesh__D045828 2004   
% 210.56/210.77  |- skos__hiddenLabel mesh__D045828 Infections, Moraxellaceae
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D045828 2005
% 210.56/210.77  |- mesh__dateCreated mesh__D045828 2003-07-09
% 210.56/210.77  |- skos__hiddenLabel mesh__D045828 Infection, Moraxellaceae
% 210.56/210.77  |- skos__hiddenLabel mesh__D045828 Infections, Psychobacter
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D045828 2004
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D045828 2006
% 210.56/210.77  |- rdf__type mesh__D045828sskos__Concept
% 210.56/210.77  |- skos__prefLabel mesh__D045828 Moraxellaceae Infections
% 210.56/210.77  |- skos__scopeNote mesh__D045828
% 210.56/210.77       Infections with bacteria of the family MORAXELLACEAE.     
% 210.56/210.77  |- skos__hiddenLabel mesh__D045828 Infections, Moraxella
% 210.56/210.77  |- mesh__dateEstablished mesh__D045828 2004-01-01
% 210.56/210.77  |- skos__broader mesh__D045828smesh__D016905
% 210.56/210.77  |- skos__hiddenLabel mesh__D045828 Infection, Psychobacter
% 210.56/210.77  |- skos__hiddenLabel mesh__D045828 Moraxellaceae Infection
% 210.56/210.77  |- mesh__historyNote mesh__D045828 2004   
% 210.56/210.77  |- mesh__recordOriginator mesh__D028061 jmp
% 210.56/210.77  |- mesh__recordMaintainer mesh__D028061 SYSTEM
% 210.56/210.77  |- rdf__type mesh__D028061sskos__Concept
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D028061 2006
% 210.56/210.77  |- skos__broader mesh__D028061smesh__D027321
% 210.56/210.77  |- skos__altLabel mesh__D028061 Inorganic Phosphate Transporter
% 210.56/210.77  |- mesh__dateRevised mesh__D028061 2005-06-30
% 210.56/210.77  |- skos__prefLabel mesh__D028061 Phosphate Transport Proteins
% 210.56/210.77  |- mesh__dateCreated mesh__D028061 2001-07-25
% 210.56/210.77  |- skos__hiddenLabel mesh__D028061 Transporters, Inorganic Phosphate
% 210.56/210.77  |- skos__scopeNote mesh__D028061
% 210.56/210.77       Membrane proteins that are involved in the active transport of phosphate.%A%    
% 210.56/210.77  |- mesh__recordAuthorizer mesh__D028061 sjn
% 210.56/210.77  |- skos__hiddenLabel mesh__D028061 Carriers, Phosphate
% 210.56/210.77  |- skos__historyNote mesh__D028061 Carrier Proteins %28%1991-2001%29%
% 210.56/210.77  |- skos__altLabel mesh__D028061 Inorganic Phosphate Transporters
% 210.56/210.77  |- skos__hiddenLabel mesh__D028061 Phosphate Transporters, Inorganic
% 210.56/210.77  |- skos__hiddenLabel mesh__D028061 Transporters, Phosphate
% 210.56/210.77  |- skos__hiddenLabel mesh__D028061 Transporter, Phosphate
% 210.56/210.77  |- skos__altLabel mesh__D028061 Phosphate Transporter
% 210.56/210.77  |- skos__broader mesh__D028061smesh__D028044
% 210.56/210.77  |- skos__annotation mesh__D028061
% 210.56/210.77       do not confuse with PHOSPHATE-BINDING PROTEINS   
% 210.56/210.77  |- mesh__publicMeSHNote mesh__D028061
% 210.56/210.77       2002; PHOSPHATE TRANSPORT PROTEINS %26% PHOSPHATE TRANSPORTER  were indexed under CARRIER PROTEINS 1991-2001; INORGANIC PHOSPHATE TRANSPORTER was indexed under CARRIER PROTEINS 1999-2001%A%  
% 210.56/210.77  |- mesh__historyNote mesh__D028061
% 210.56/210.77       2002; for PHOSPHATE TRANSPORT PROTEINS %26% PHOSPHATE TRANSPORTER use PHOSPHATE BINDING PROTEINS %28%NM%29% 1991-2001; for INORGANIC PHOSPHATE TRANSPORTER use PHOSPHATE BINDING PROTEINS %28%NM%29% 1999-2001%A%  
% 210.56/210.77  |- skos__altLabel mesh__D028061 Phosphate Transporters
% 210.56/210.77  |- mesh__dateEstablished mesh__D028061 2002-01-01
% 210.56/210.77  |- rdf__type mesh__D003319sskos__Concept
% 210.56/210.77  |- mesh__recordAuthorizer mesh__D003319 PLS
% 210.56/210.77  |- mesh__publicMeSHNote mesh__D003319 91; was see under CORNEA 1983-90   
% 210.56/210.77  |- skos__hiddenLabel mesh__D003319 Stroma, Corneal
% 210.56/210.77  |- skos__broader mesh__D003319smesh__D003315
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D003319 1991
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D003319 1995
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D003319 2003
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D003319 1996
% 210.56/210.77  |- skos__historyNote mesh__D003319 Cornea %28%1966-1982%29%
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D003319 2000
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D003319 2004
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D003319 1997
% 210.56/210.77  |- skos__prefLabel mesh__D003319 Corneal Stroma
% 210.56/210.77  |- mesh__recordOriginator mesh__D003319 RC
% 210.56/210.77  |- skos__hiddenLabel mesh__D003319 Stromas, Corneal
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D003319 2001
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D003319 1992
% 210.56/210.77  |- mesh__historyNote mesh__D003319
% 210.56/210.77       91%28%83%29%; was see under CORNEA 1983-90   
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D003319 2005
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D003319 1998
% 210.56/210.77  |- mesh__dateEstablished mesh__D003319 1991-01-01
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D003319 2002
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D003319 1993
% 210.56/210.77  |- skos__scopeNote mesh__D003319
% 210.56/210.77       The lamellated connective tissue constituting the thickest layer of the cornea between the Bowman and Descemet membranes.%A%    
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D003319 2006
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D003319 1999
% 210.56/210.77  |- mesh__recordMaintainer mesh__D003319 NLM
% 210.56/210.77  |- mesh__dateRevised mesh__D003319 1990-04-13
% 210.56/210.77  |- skos__hiddenLabel mesh__D003319 Corneal Stromas
% 210.56/210.77  |- mesh__dateCreated mesh__D003319 1982-04-28
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D003319 1994
% 210.56/210.77  |- skos__broader mesh__D014041smesh__D007564
% 210.56/210.77  |- mesh__historyNote mesh__D014041 BONIN ISLANDS was see JAPAN 1975-83   
% 210.56/210.77  |- mesh__onlineNote mesh__D014041
% 210.56/210.77       use JAPAN to search BONIN ISLANDS 1975-83   
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D014041 2002
% 210.56/210.77  |- mesh__recordOriginator mesh__D014041 NLM
% 210.56/210.77  |- mesh__dateCreated mesh__D014041 1999-01-01
% 210.56/210.77  |- mesh__dateRevised mesh__D014041 1991-06-11
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D014041 1995
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D014041 1993
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D014041 1994
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D014041 2006
% 210.56/210.77  |- skos__prefLabel mesh__D014041 Tokyo
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D014041 1992
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D014041 2004
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D014041 2001
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D014041 1999
% 210.56/210.77  |- skos__broader mesh__D014041smesh__D002947
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D014041 1997
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D014041 2000
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D014041 2005
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D014041 2003
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D014041 1998
% 210.56/210.77  |- rdf__type mesh__D014041sskos__Concept
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D014041 1996
% 210.56/210.77  |- mesh__recordAuthorizer mesh__D014041 PLS
% 210.56/210.77  |- mesh__recordMaintainer mesh__D014041 TGC
% 210.56/210.77  |- skos__hiddenLabel mesh__D008802 Bay f 1353
% 210.56/210.77  |- mesh__publicMeSHNote mesh__D008802 84   
% 210.56/210.77  |- skos__altLabel mesh__D008802
% 210.56/210.77       curasan Brand of Mezlocillin Sodium %28%Sterile%29%
% 210.56/210.77  |- skos__altLabel mesh__D008802
% 210.56/210.77       Bayer Brand of Mezlocillin Sodium %28%Sterile%29%
% 210.56/210.77  |- mesh__recordAuthorizer mesh__D008802 sjn
% 210.56/210.77  |- skos__prefLabel mesh__D008802 Mezlocillin
% 210.56/210.77  |- mesh__dateCreated mesh__D008802 1983-04-04
% 210.56/210.77  |- rdf__type mesh__D008802sskos__Concept
% 210.56/210.77  |- mesh__recordOriginator mesh__D008802 SH
% 210.56/210.77  |- skos__scopeNote mesh__D008802
% 210.56/210.77       Semisynthetic ampicillin-derived acylureido penicillin. It has been proposed for infections with certain anaerobes and may be useful in inner ear, bile, and CNS infections.%A%    
% 210.56/210.77  |- skos__altLabel mesh__D008802 Meslocillin
% 210.56/210.77  |- mesh__dateRevised mesh__D008802 2005-06-30
% 210.56/210.77  |- skos__broader mesh__D008802smesh__D000667
% 210.56/210.77  |- skos__hiddenLabel mesh__D008802 Bayf 1353
% 210.56/210.77  |- mesh__historyNote mesh__D008802 84   
% 210.56/210.77  |- mesh__dateEstablished mesh__D008802 1984-01-01
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D008802 2006
% 210.56/210.77  |- skos__altLabel mesh__D008802 Baypen
% 210.56/210.77  |- mesh__recordMaintainer mesh__D008802 CCR
% 210.56/210.77  |- skos__historyNote mesh__D008802 Penicillins %28%1966-1983%29%
% 210.56/210.77  |- skos__altLabel mesh__D008802 Mezlocilline
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D008004 2005
% 210.56/210.77  |- rdf__type mesh__D008004sskos__Concept
% 210.56/210.77  |- mesh__recordAuthorizer mesh__D008004 sjn
% 210.56/210.77  |- skos__hiddenLabel mesh__D008004 Permit
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D008004 2002
% 210.56/210.77  |- skos__related mesh__D008004smesh__D002568
% 210.56/210.77  |- skos__hiddenLabel mesh__D008004 Licensures
% 210.56/210.77  |- mesh__recordOriginator mesh__D008004 NLM
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D008004 2006
% 210.56/210.77  |- skos__scopeNote mesh__D008004
% 210.56/210.77       The legal authority or formal permission from authorities to carry on certain activities which by law or regulation require such permission. It may be applied to licensure of institutions as well as individuals.%A%    
% 210.56/210.77  |- skos__altLabel mesh__D008004 Institutional Personnel Licensure
% 210.56/210.77  |- skos__hiddenLabel mesh__D008004 Institutional Personnel Licensures
% 210.56/210.77  |- skos__hiddenLabel mesh__D008004 Personnel Licensure, Institutional
% 210.56/210.77  |- skos__prefLabel mesh__D008004 Licensure
% 210.56/210.77  |- skos__broader mesh__D008004smesh__D003406
% 210.56/210.77  |- skos__annotation mesh__D008004
% 210.56/210.77       by the state; differentiate from ACCREDITATION %28%by the profession%29%; IM; various boards can go here; specify geog%A%  
% 210.56/210.77  |- skos__hiddenLabel mesh__D008004 License
% 210.56/210.77  |- skos__altLabel mesh__D008004 Licenses
% 210.56/210.77  |- skos__hiddenLabel mesh__D008004 Licensures, Institutional Personnel
% 210.56/210.77  |- mesh__dateRevised mesh__D008004 1999-11-03
% 210.56/210.77  |- skos__hiddenLabel mesh__D008004 Personnel Licensures, Institutional
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D008004 2003
% 210.56/210.77  |- skos__hiddenLabel mesh__D008004 Licensure, Institutional Personnel
% 210.56/210.77  |- mesh__recordMaintainer mesh__D008004 kle
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D008004 2000
% 210.56/210.77  |- mesh__dateCreated mesh__D008004 1999-01-01
% 210.56/210.77  |- skos__related mesh__D008004smesh__D000068
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D008004 2004
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D008004 2001
% 210.56/210.77  |- skos__hiddenLabel mesh__D000021 Abortifacients, Steroid
% 210.56/210.77  |- mesh__historyNote mesh__D000021
% 210.56/210.77       91%28%75%29%; was see under ABORTIFACIENT AGENTS 1975-90   
% 210.56/210.77  |- skos__historyNote mesh__D000021 Abortion, Induced %28%1970-1974%29%
% 210.56/210.77  |- skos__annotation mesh__D000021
% 210.56/210.77       do not use /ther use for use of the abortifacients as abortifacients%A%  
% 210.56/210.77  |- skos__hiddenLabel mesh__D000021 Steroidal Abortifacient Agents
% 210.56/210.77  |- skos__prefLabel mesh__D000021 Abortifacient Agents, Steroidal
% 210.56/210.77  |- skos__altLabel mesh__D000021 Steroid Abortifacients
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D000021 2006
% 210.56/210.77  |- skos__broader mesh__D000021smesh__D000019
% 210.56/210.77  |- skos__historyNote mesh__D000021 specific chemical %28%1970-1974%29%
% 210.56/210.77  |- mesh__dateEstablished mesh__D000021 1991-01-01
% 210.56/210.77  |- skos__hiddenLabel mesh__D000021 Agents, Steroidal Abortifacient
% 210.56/210.77  |- mesh__publicMeSHNote mesh__D000021
% 210.56/210.77       91; was see under ABORTIFACIENT AGENTS 1975-90   
% 210.56/210.77  |- mesh__dateCreated mesh__D000021 1974-11-11
% 210.56/210.77  |- mesh__recordAuthorizer mesh__D000021 sjn
% 210.56/210.77  |- skos__scopeNote mesh__D000021
% 210.56/210.77       Steroidal compounds with abortifacient activity.     
% 210.56/210.77  |- mesh__dateRevised mesh__D000021 2005-06-30
% 210.56/210.77  |- mesh__recordMaintainer mesh__D000021 ssb
% 210.56/210.77  |- mesh__recordOriginator mesh__D000021 NLM
% 210.56/210.77  |- rdf__type mesh__D000021sskos__Concept
% 210.56/210.77  |- skos__broader mesh__D052160smesh__D006574
% 210.56/210.77  |- skos__scopeNote mesh__D052160
% 210.56/210.77       Compounds with a benzene ring fused to a thiazole ring.%A%    
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D052160 2006
% 210.56/210.77  |- mesh__recordMaintainer mesh__D052160 ssb
% 210.56/210.77  |- skos__prefLabel mesh__D052160 Benzothiazoles
% 210.56/210.77  |- mesh__recordOriginator mesh__D052160 ssb
% 210.56/210.77  |- skos__broader mesh__D052160smesh__D013844
% 210.56/210.77  |- mesh__dateEstablished mesh__D052160 2006-01-01
% 210.56/210.77  |- rdf__type mesh__D052160sskos__Concept
% 210.56/210.77  |- mesh__dateCreated mesh__D052160 2005-06-30
% 210.56/210.77  |- mesh__historyNote mesh__D052160 2006   
% 210.56/210.77  |- skos__historyNote mesh__D052160 Thiazoles %28%1965-2005%29%
% 210.56/210.77  |- mesh__recordAuthorizer mesh__D052160 sjn
% 210.56/210.77  |- mesh__publicMeSHNote mesh__D052160 2006   
% 210.56/210.77  |- mesh__recordMaintainer mesh__D013747 CCR
% 210.56/210.77  |- mesh__recordAuthorizer mesh__D013747 sjn
% 210.56/210.77  |- skos__scopeNote mesh__D013747
% 210.56/210.77       A drug formerly used as an antipsychotic but now used primarily in the treatment of various movement disorders including tardive dyskinesia. Tetrabenazine blocks uptake into adrenergic storage vesicles and has been used as a high affinity label for the vesicle transport system.%A%    
% 210.56/210.77  |- skos__altLabel mesh__D013747
% 210.56/210.77       Cambridge Laboratories Brand of Tetrabenazine
% 210.56/210.77  |- mesh__dateCreated mesh__D013747 1999-01-01
% 210.56/210.77  |- skos__altLabel mesh__D013747 Roche Brand of Tetrabenazine
% 210.56/210.77  |- skos__annotation mesh__D013747
% 210.56/210.77       do not confuse with TETRACYCLINES, the group   
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D013747 2006
% 210.56/210.77  |- skos__altLabel mesh__D013747 Shire Brand of Tetrabenazine
% 210.56/210.77  |- rdf__type mesh__D013747sskos__Concept
% 210.56/210.77  |- skos__prefLabel mesh__D013747 Tetrabenazine
% 210.56/210.77  |- skos__broader mesh__D013747smesh__D011807
% 210.56/210.77  |- mesh__dateRevised mesh__D013747 2005-06-30
% 210.56/210.77  |- mesh__recordOriginator mesh__D013747 NLM
% 210.56/210.77  |- skos__scopeNote mesh__D032901
% 210.56/210.77       A fungal genus in the family Trichocomaceae, order EUROTIALES, characterized by loose hyphal fruiting bodies containing spherical asci. Anamorphs include PENICILLIUM and PAECILOMYCES.%A%    
% 210.56/210.77  |- mesh__dateRevised mesh__D032901 2005-06-30
% 210.56/210.77  |- mesh__recordAuthorizer mesh__D032901 sjn
% 210.56/210.77  |- mesh__dateCreated mesh__D032901 2002-07-03
% 210.56/210.77  |- mesh__dateEstablished mesh__D032901 2003-01-01
% 210.56/210.77  |- skos__broader mesh__D032901smesh__D032641
% 210.56/210.77  |- mesh__publicMeSHNote mesh__D032901 2003   
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D032901 2006
% 210.56/210.77  |- skos__prefLabel mesh__D032901 Talaromyces
% 210.56/210.77  |- mesh__recordMaintainer mesh__D032901 SYSTEM
% 210.56/210.77  |- mesh__historyNote mesh__D032901 2003   
% 210.56/210.77  |- rdf__type mesh__D032901sskos__Concept
% 210.56/210.77  |- mesh__recordOriginator mesh__D032901 ags
% 210.56/210.77  |- skos__historyNote mesh__D032901 Ascomycota %28%1965-2002%29%
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D018432 2005
% 210.56/210.77  |- mesh__historyNote mesh__D018432 95   
% 210.56/210.77  |- skos__annotation mesh__D018432
% 210.56/210.77       DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, VIRAL; and DRUG RESISTANCE, MULTIPLE, FUNGAL are also available%A%  
% 210.56/210.77  |- skos__related mesh__D018432smesh__D019450
% 210.56/210.77  |- skos__hiddenLabel mesh__D018432 Resistance, Multiple Drug
% 210.56/210.77  |- skos__related mesh__D018432smesh__D018435
% 210.56/210.77  |- skos__related mesh__D018432smesh__D018088
% 210.56/210.77  |- skos__broader mesh__D018432smesh__D008827
% 210.56/210.77  |- mesh__activeMeSHYear mesh__D018432 2006
% 210.75/210.89  |- skos__scopeNote mesh__D018432
% 210.75/210.89       Simultaneous resistance to several structurally and functionally distinct drugs.%A%    
% 210.75/210.89  |- mesh__recordOriginator mesh__D018432 AGS
% 210.75/210.89  |- skos__hiddenLabel mesh__D018432 Multiple Drug Resistance
% 210.75/210.89  |- mesh__dateRevised mesh__D018432 2003-07-09
% 210.75/210.89  |- mesh__dateEstablished mesh__D018432 1995-01-01
% 210.75/210.89  |- skos__historyNote mesh__D018432
% 210.75/210.89       Drug Resistance, Microbial %28%1966-1994%29%
% 210.75/210.89  |- skos__historyNote mesh__D018432 Drug Resistance %28%1981-1994%29%
% 210.75/210.89  |- mesh__publicMeSHNote mesh__D018432 95   
% 210.75/210.89  |- skos__altLabel mesh__D018432 Multidrug Resistance
% 210.75/210.89  |- rdf__type mesh__D018432sskos__Concept
% 210.75/210.89  |- mesh__recordAuthorizer mesh__D018432 sjn
% 210.75/210.89  |- mesh__dateCreated mesh__D018432 1994-01-25
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D018432 2004
% 210.75/210.89  |- skos__related mesh__D018432smesh__D027425
% 210.75/210.89  |- mesh__recordMaintainer mesh__D018432 ssb
% 210.75/210.89  |- skos__altLabel mesh__D018432 Multi-Drug Resistance
% 210.75/210.89  |- skos__prefLabel mesh__D018432 Drug Resistance, Multiple
% 210.75/210.89  |- skos__broader mesh__D018432smesh__D004351
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D032103 2006
% 210.75/210.89  |- rdf__type mesh__D032103sskos__Concept
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D032103 2003
% 210.75/210.89  |- mesh__dateCreated mesh__D032103 2002-07-03
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D032103 2004
% 210.75/210.89  |- skos__scopeNote mesh__D032103
% 210.75/210.89       A plant genus of the family RUTACEAE that is the natural source of PILOCARPINE.%A%    
% 210.75/210.89  |- skos__annotation mesh__D032103
% 210.75/210.89       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.75/210.89  |- skos__broader mesh__D032103smesh__D027821
% 210.75/210.89  |- mesh__dateEstablished mesh__D032103 2003-01-01
% 210.75/210.89  |- mesh__historyNote mesh__D032103 2003   
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D032103 2005
% 210.75/210.89  |- mesh__publicMeSHNote mesh__D032103 2003   
% 210.75/210.89  |- skos__prefLabel mesh__D032103 Pilocarpus
% 210.75/210.89  |- mesh__recordAuthorizer mesh__D004412 sjn
% 210.75/210.89  |- mesh__recordOriginator mesh__D004412 NLM
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D004412 2000
% 210.75/210.89  |- skos__altLabel mesh__D004412 Menstruation, Painful
% 210.75/210.89  |- skos__hiddenLabel mesh__D004412 Menstrual Pain
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D004412 2003
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D004412 2001
% 210.75/210.89  |- mesh__dateCreated mesh__D004412 1999-01-01
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D004412 2005
% 210.75/210.89  |- skos__hiddenLabel mesh__D004412 Menstrual Pains
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D004412 2004
% 210.75/210.89  |- skos__altLabel mesh__D004412 Pain, Menstrual
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D004412 2006
% 210.75/210.89  |- mesh__dateRevised mesh__D004412 1999-11-04
% 210.75/210.89  |- skos__hiddenLabel mesh__D004412 Painful Menstruation
% 210.75/210.89  |- skos__broader mesh__D004412smesh__D008599
% 210.75/210.89  |- skos__hiddenLabel mesh__D004412 Pains, Menstrual
% 210.75/210.89  |- skos__hiddenLabel mesh__D004412 Painful Menstruations
% 210.75/210.89  |- skos__scopeNote mesh__D004412 Painful menstruation.     
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D004412 2002
% 210.75/210.89  |- skos__prefLabel mesh__D004412 Dysmenorrhea
% 210.75/210.89  |- skos__hiddenLabel mesh__D004412 Menstruations, Painful
% 210.75/210.89  |- mesh__recordMaintainer mesh__D004412 KEV
% 210.75/210.89  |- skos__hiddenLabel mesh__D004412 Dysmenorrheas
% 210.75/210.89  |- rdf__type mesh__D004412sskos__Concept
% 210.75/210.89  |- skos__broader mesh__D004412smesh__D017699
% 210.75/210.89  |- mesh__recordMaintainer mesh__D014840 KEV
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D014840 2004
% 210.75/210.89  |- mesh__dateRevised mesh__D014840 1999-11-03
% 210.75/210.89  |- mesh__historyNote mesh__D014840 88   
% 210.75/210.89  |- rdf__type mesh__D014840sskos__Concept
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D014840 2005
% 210.75/210.89  |- skos__broader mesh__D014840smesh__D014839
% 210.75/210.89  |- skos__scopeNote mesh__D014840
% 210.75/210.89       Vomiting caused by expectation of discomfort or unpleasantness.%A%    
% 210.75/210.89  |- mesh__dateEstablished mesh__D014840 1988-01-01
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D014840 2006
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D014840 2000
% 210.75/210.89  |- skos__annotation mesh__D014840
% 210.75/210.89       do not use /chem ind in cancer chemother: prefer /etiol, /psychol, etc.%A%  
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D014840 2001
% 210.75/210.89  |- skos__prefLabel mesh__D014840 Vomiting, Anticipatory
% 210.75/210.89  |- mesh__dateCreated mesh__D014840 1987-05-01
% 210.75/210.89  |- skos__historyNote mesh__D014840 Vomiting %28%1966-1987%29%
% 210.75/210.89  |- mesh__publicMeSHNote mesh__D014840 88   
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D014840 2002
% 210.75/210.89  |- skos__altLabel mesh__D014840 Anticipatory Vomiting
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D014840 2003
% 210.75/210.89  |- mesh__recordOriginator mesh__D014840 EC
% 210.75/210.89  |- mesh__recordAuthorizer mesh__D014840 sjn
% 210.75/210.89  |- skos__broader mesh__D014042smesh__D013453
% 210.75/210.89  |- mesh__dateRevised mesh__D014042 2005-06-30
% 210.75/210.89  |- mesh__historyNote mesh__D014042 73%28%64%29%   
% 210.75/210.89  |- mesh__dateEstablished mesh__D014042 1973-01-01
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D014042 2006
% 210.75/210.89  |- mesh__recordOriginator mesh__D014042 NLM
% 210.75/210.89  |- skos__scopeNote mesh__D014042
% 210.75/210.89       A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE.%A%    
% 210.75/210.89  |- mesh__recordAuthorizer mesh__D014042 sjn
% 210.75/210.89  |- skos__prefLabel mesh__D014042 Tolazamide
% 210.75/210.89  |- skos__altLabel mesh__D014042 Pharmacia Brand of Tolazamide
% 210.75/210.89  |- mesh__publicMeSHNote mesh__D014042 73   
% 210.75/210.89  |- rdf__type mesh__D014042sskos__Concept
% 210.75/210.89  |- mesh__recordMaintainer mesh__D014042 CCR
% 210.75/210.89  |- mesh__dateCreated mesh__D014042 1999-01-01
% 210.75/210.89  |- skos__altLabel mesh__D008803 Mianserin Monohydrochloride
% 210.75/210.89  |- rdf__type mesh__D008803sskos__Concept
% 210.75/210.89  |- mesh__recordOriginator mesh__D008803 NLM
% 210.75/210.89  |- skos__prefLabel mesh__D008803 Mianserin
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D008803 2003
% 210.75/210.89  |- skos__historyNote mesh__D008803 Dibenzazepines %28%1972-1974%29%
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D008803 2005
% 210.75/210.89  |- mesh__recordAuthorizer mesh__D008803 sjn
% 210.75/210.89  |- mesh__dateRevised mesh__D008803 2000-06-21
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D008803 2004
% 210.75/210.89  |- skos__hiddenLabel mesh__D008803 Hydrochloride, Mianserin
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D008803 2001
% 210.75/210.89  |- skos__scopeNote mesh__D008803
% 210.75/210.89       A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.%A%    
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D008803 2006
% 210.75/210.89  |- skos__broader mesh__D008803smesh__D003984
% 210.75/210.89  |- mesh__recordMaintainer mesh__D008803 TWD
% 210.75/210.89  |- skos__historyNote mesh__D008803 Pyrazines %28%1972-1974%29%
% 210.75/210.89  |- mesh__publicMeSHNote mesh__D008803
% 210.75/210.89       87; was see under DIBENZAZEPINES 1975-86   
% 210.75/210.89  |- skos__hiddenLabel mesh__D008803 Monohydrochloride, Mianserin
% 210.75/210.89  |- mesh__historyNote mesh__D008803
% 210.75/210.89       87%28%75%29%; was see under DIBENZAZEPINES 1975-86   
% 210.75/210.89  |- mesh__dateCreated mesh__D008803 1974-11-19
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D008803 2002
% 210.75/210.89  |- mesh__dateEstablished mesh__D008803 1987-01-01
% 210.75/210.89  |- mesh__recordMaintainer mesh__D000820 ags
% 210.75/210.89  |- mesh__historyNote mesh__D000820
% 210.75/210.89       66; was see under VETERINARY MEDICINE %26% ZOONOSES 1963-65   
% 210.75/210.89  |- mesh__recordAuthorizer mesh__D000820 sjn
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D000820 2005
% 210.75/210.89  |- rdf__type mesh__D000820sskos__Concept
% 210.75/210.89  |- skos__altLabel mesh__D000820 Diseases, Animal
% 210.75/210.89  |- mesh__dateEstablished mesh__D000820 1966-01-01
% 210.75/210.89  |- mesh__publicMeSHNote mesh__D000820
% 210.75/210.89       66; was see under VETERINARY MEDICINE %26% ZOONOSES 1963-65   
% 210.75/210.89  |- mesh__runningHead mesh__D000820 C22 - DISEASES-ANIMAL   
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D000820 2006
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D000820 2004
% 210.75/210.89  |- skos__prefLabel mesh__D000820 Animal Diseases
% 210.75/210.89  |- skos__annotation mesh__D000820
% 210.75/210.89       avoid: too general; IM general only for unspecified animal %26% unspecified disease; NIM with specific animal %28%IM%29% for which no precoord animal/diseases term exists; do not use at all when a specific dis /vet is used; do not forget also to check tag ANIMALS; policy: Manual 23.33+; animal neopl: Manual 24.6+; TN 136; TN 193%A%  
% 210.75/210.89  |- mesh__dateCreated mesh__D000820 1999-01-01
% 210.75/210.89  |- mesh__dateRevised mesh__D000820 2003-07-30
% 210.75/210.89  |- mesh__recordOriginator mesh__D000820 NLM
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D008005 2006
% 210.75/210.89  |- mesh__recordMaintainer mesh__D008005 kle
% 210.75/210.89  |- skos__scopeNote mesh__D008005
% 210.75/210.89       The granting of a license to practice dentistry.     
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D008005 2000
% 210.75/210.89  |- skos__broader mesh__D008005smesh__D008004
% 210.75/210.89  |- skos__prefLabel mesh__D008005 Licensure, Dental
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D008005 2001
% 210.75/210.89  |- mesh__recordAuthorizer mesh__D008005 sjn
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D008005 2002
% 210.75/210.89  |- mesh__recordOriginator mesh__D008005 NLM
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D008005 2003
% 210.75/210.89  |- skos__hiddenLabel mesh__D008005 Licensures, Dental
% 210.75/210.89  |- mesh__dateCreated mesh__D008005 1999-01-01
% 210.75/210.89  |- skos__hiddenLabel mesh__D008005 Dental Licensures
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D008005 2004
% 210.75/210.89  |- skos__annotation mesh__D008005
% 210.75/210.89       by the state; differentiate from ACCREDITATION %28%by the profession%29%; IM; various boards can go here; specify geog; DF: LICENSURE DENT%A%  
% 210.75/210.89  |- skos__altLabel mesh__D008005 Dental Licensure
% 210.75/210.89  |- mesh__dateRevised mesh__D008005 1999-11-03
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D008005 2005
% 210.75/210.89  |- rdf__type mesh__D008005sskos__Concept
% 210.75/210.89  |- mesh__recordMaintainer mesh__D000022 lkt
% 210.75/210.89  |- mesh__recordAuthorizer mesh__D000022 sjn
% 210.75/210.89  |- skos__scopeNote mesh__D000022
% 210.75/210.89       Expulsion of the product of FERTILIZATION before completing the term of GESTATION and without deliberate interference.%A%    
% 210.75/210.89  |- rdf__type mesh__D000022sskos__Concept
% 210.75/210.89  |- mesh__publicMeSHNote mesh__D000022
% 210.75/210.89       99; see ABORTION 1966-98; for ABORTION, SPONTANEOUS see ABORTION 1992-98%A%  
% 210.75/210.89  |- skos__hiddenLabel mesh__D000022 Abortions, Spontaneous
% 210.75/210.89  |- mesh__dateRevised mesh__D000022 2005-06-30
% 210.75/210.89  |- mesh__historyNote mesh__D000022 99%28%63%29%   
% 210.75/210.89  |- skos__related mesh__D000022smesh__D037881
% 210.75/210.89  |- skos__hiddenLabel mesh__D000022 Spontaneous Abortions
% 210.75/210.89  |- mesh__recordOriginator mesh__D000022 NLM
% 210.75/210.89  |- skos__prefLabel mesh__D000022 Abortion, Spontaneous
% 210.75/210.89  |- skos__hiddenLabel mesh__D000022 Tubal Abortion
% 210.75/210.89  |- skos__altLabel mesh__D000022 Spontaneous Abortion
% 210.75/210.89  |- skos__altLabel mesh__D000022 Miscarriage
% 210.75/210.89  |- mesh__dateCreated mesh__D000022 1999-01-01
% 210.75/210.89  |- skos__hiddenLabel mesh__D000022 Abortions, Tubal
% 210.75/210.89  |- skos__related mesh__D000022smesh__D000019
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D000022 2006
% 210.75/210.89  |- skos__hiddenLabel mesh__D000022 Tubal Abortions
% 210.75/210.89  |- skos__annotation mesh__D000022
% 210.75/210.89       /chem ind permitted but do not confuse with ABORTION, INDUCED; check the tags HUMANS %26% FEMALE %26% PREGNANCY%A%  
% 210.75/210.89  |- skos__hiddenLabel mesh__D000022 Miscarriages
% 210.75/210.89  |- skos__broader mesh__D000022smesh__D011248
% 210.75/210.89  |- mesh__dateCreated mesh__D052161 2005-06-30
% 210.75/210.89  |- mesh__historyNote mesh__D052161 2006   
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D052161 2006
% 210.75/210.89  |- skos__hiddenLabel mesh__D052161 papillomavirus 18, Human
% 210.75/210.89  |- mesh__recordAuthorizer mesh__D052161 sjn
% 210.75/210.89  |- skos__scopeNote mesh__D052161
% 210.75/210.89       A type of HUMAN PAPILLOMAVIRUS especially associated with malignant tumors of the genital and RESPIRATORY MUCOSA.%A%    
% 210.75/210.89  |- skos__altLabel mesh__D052161 HPV-18
% 210.75/210.89  |- skos__broader mesh__D052161smesh__D018145
% 210.75/210.89  |- mesh__recordOriginator mesh__D052161 ags
% 210.75/210.89  |- skos__altLabel mesh__D052161 Human papillomavirus type 18
% 210.75/210.89  |- rdf__type mesh__D052161sskos__Concept
% 210.75/210.89  |- mesh__recordMaintainer mesh__D052161 ags
% 210.75/210.89  |- mesh__publicMeSHNote mesh__D052161 2006   
% 210.75/210.89  |- skos__historyNote mesh__D052161 Papillomavirus %28%1985-1993%29%
% 210.75/210.89  |- skos__hiddenLabel mesh__D052161 HPV 18
% 210.75/210.89  |- mesh__dateEstablished mesh__D052161 2006-01-01
% 210.75/210.89  |- skos__prefLabel mesh__D052161 Human papillomavirus 18
% 210.75/210.89  |- skos__historyNote mesh__D052161 Papillomavirus, Human %28%1994-2005%29%
% 210.75/210.89  |- mesh__recordMaintainer mesh__D013748 jmp
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D013748 2005
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D013748 2002
% 210.75/210.89  |- mesh__recordOriginator mesh__D013748 NLM
% 210.75/210.89  |- mesh__dateCreated mesh__D013748 1999-01-01
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D013748 2006
% 210.75/210.89  |- rdf__type mesh__D013748sskos__Concept
% 210.75/210.89  |- mesh__recordAuthorizer mesh__D013748 sjn
% 210.75/210.89  |- skos__scopeNote mesh__D013748
% 210.75/210.89       A potent local anesthetic of the ester type used for surface and spinal anesthesia.%A%    
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D013748 2003
% 210.75/210.89  |- skos__altLabel mesh__D013748 Amethocaine
% 210.75/210.89  |- skos__altLabel mesh__D013748 Tetrakain
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D013748 2004
% 210.75/210.89  |- skos__prefLabel mesh__D013748 Tetracaine
% 210.75/210.89  |- mesh__dateRevised mesh__D013748 2001-07-25
% 210.75/210.89  |- skos__broader mesh__D013748smesh__D010129
% 210.75/210.89  |- mesh__publicMeSHNote mesh__D032902 2003   
% 210.75/210.89  |- mesh__recordOriginator mesh__D032902 ags
% 210.75/210.89  |- mesh__dateEstablished mesh__D032902 2003-01-01
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D032902 2006
% 210.75/210.89  |- mesh__dateRevised mesh__D032902 2005-06-30
% 210.75/210.89  |- mesh__recordAuthorizer mesh__D032902 sjn
% 210.75/210.89  |- mesh__dateCreated mesh__D032902 2002-07-03
% 210.75/210.89  |- skos__broader mesh__D032902smesh__D020072
% 210.75/210.89  |- skos__historyNote mesh__D032902 Basidiomycota %28%1971-2002%29%
% 210.75/210.89  |- mesh__recordMaintainer mesh__D032902 ags
% 210.75/210.89  |- skos__prefLabel mesh__D032902 Ganoderma
% 210.75/210.89  |- skos__scopeNote mesh__D032902
% 210.75/210.89       A genus of fungi in the family Ganodermataceae, order POLYPORALES, containing a dimitic hyphal system. It causes a white rot, and is a wood decomposer. Ganoderma lucidum %28%REISHI%29% is used in traditional Chinese medicine %28%MEDICINE, CHINESE TRADITIONAL%29%.%A%    
% 210.75/210.89  |- rdf__type mesh__D032902sskos__Concept
% 210.75/210.89  |- mesh__historyNote mesh__D032902 2003   
% 210.75/210.89  |- skos__historyNote mesh__D032902 Aphyllophorales %28%1979-2002%29%
% 210.75/210.89  |- mesh__dateEstablished mesh__D018433 1995-01-01
% 210.75/210.89  |- mesh__recordMaintainer mesh__D018433 sjn
% 210.75/210.89  |- mesh__publicMeSHNote mesh__D018433 95   
% 210.75/210.89  |- skos__hiddenLabel mesh__D018433 Twin Study
% 210.75/210.89  |- mesh__dateCreated mesh__D018433 1994-05-27
% 210.75/210.89  |- mesh__recordAuthorizer mesh__D018433 sjn
% 210.75/210.89  |- mesh__dateRevised mesh__D018433 2004-07-13
% 210.75/210.89  |- skos__annotation mesh__D018433
% 210.75/210.89       an epidemiol technique for study of twins: do not confuse with articles on TWINS as persons or on specific or general DISEASES IN TWINS; IM GEN only; coord NIM with specific subject %28%IM%29% + TWINS %28%IM%29% or with specific dis %28%IM%29% + DISEASES IN TWINS %28%IM%29%; do not confuse with Publication Type TWIN STUDY%A%  
% 210.75/210.89  |- mesh__historyNote mesh__D018433 95   
% 210.75/210.89  |- skos__historyNote mesh__D018433 Diseases in Twins %28%1966-1994%29%
% 210.75/210.89  |- skos__historyNote mesh__D018433 Twins %28%1966-1994%29%
% 210.75/210.89  |- skos__scopeNote mesh__D018433
% 210.75/210.89       Methods of detecting genetic etiology in human traits. The basic premise of twin studies is that monozygotic twins, being formed by the division of a single fertilized ovum, carry identical genes, while dizygotic twins, being formed by the fertilization of two ova by two different spermatozoa, are genetically no more similar than two siblings born after separate pregnancies. %28%Last, J.M., A Dictionary of Epidemiology, 2d ed%29%%A%    
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D018433 2006
% 210.75/210.89  |- skos__broader mesh__D018433smesh__D016020
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D018433 2005
% 210.75/210.89  |- mesh__recordOriginator mesh__D018433 TGC
% 210.75/210.89  |- skos__hiddenLabel mesh__D018433 Studies, Twin
% 210.75/210.89  |- rdf__type mesh__D018433sskos__Concept
% 210.75/210.89  |- skos__prefLabel mesh__D018433 Twin Studies
% 210.75/210.89  |- mesh__recordOriginator mesh__D010450 NLM
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D010450 2005
% 210.75/210.89  |- skos__prefLabel mesh__D010450 Endopeptidases
% 210.75/210.89  |- mesh__recordMaintainer mesh__D010450 jmp
% 210.75/210.89  |- mesh__dateCreated mesh__D010450 1999-01-01
% 210.75/210.89  |- skos__scopeNote mesh__D010450
% 210.75/210.89       A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS.%A%    
% 210.75/210.89  |- mesh__historyNote mesh__D010450 2000%28%1963%29%   
% 210.75/210.89  |- rdf__type mesh__D010450sskos__Concept
% 210.75/210.89  |- mesh__publicMeSHNote mesh__D010450
% 210.75/210.89       2000; see PEPTIDE PEPTIDOHYDROLASES 1963-1999; for ENDOPEPTIDASES see PEPTIDE PEPTIDOHYDROLASES 1980-1999%A%  
% 210.75/210.89  |- skos__broader mesh__D010450smesh__D010447
% 210.75/210.89  |- mesh__recordAuthorizer mesh__D010450 sjn
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D010450 2006
% 210.75/210.89  |- mesh__dateRevised mesh__D010450 2004-07-07
% 210.75/210.89  |- skos__altLabel mesh__D010450 Peptide Peptidohydrolases
% 210.75/210.89  |- mesh__historyNote mesh__D032104 2003   
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D032104 2003
% 210.75/210.89  |- skos__scopeNote mesh__D032104
% 210.75/210.89       A plant genus of the family RUTACEAE. Members contain ponfolin, a coumarin %28%COUMARINS%29%.%A%    
% 210.75/210.89  |- skos__altLabel mesh__D032104 Orange, Trifoliate
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D032104 2004
% 210.75/210.89  |- skos__annotation mesh__D032104
% 210.75/210.89       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.75/210.89  |- skos__prefLabel mesh__D032104 Poncirus
% 210.75/210.89  |- skos__broader mesh__D032104smesh__D027821
% 210.75/210.89  |- mesh__dateCreated mesh__D032104 2002-07-03
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D032104 2005
% 210.75/210.89  |- mesh__publicMeSHNote mesh__D032104 2003   
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D032104 2006
% 210.75/210.89  |- rdf__type mesh__D032104sskos__Concept
% 210.75/210.89  |- mesh__dateEstablished mesh__D032104 2003-01-01
% 210.75/210.89  |- mesh__dateRevised mesh__D004413 1993-05-27
% 210.75/210.89  |- skos__altLabel mesh__D004413 Dysostosis
% 210.75/210.89  |- skos__historyNote mesh__D004413
% 210.75/210.89       Bone Diseases, Developmental %28%1970-1984%29%
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D004413 2003
% 210.75/210.89  |- mesh__dateEstablished mesh__D004413 1985-01-01
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D004413 2005
% 210.75/210.89  |- skos__annotation mesh__D004413 defective bone formation   
% 210.75/210.89  |- mesh__recordOriginator mesh__D004413 RC
% 210.75/210.89  |- mesh__recordAuthorizer mesh__D004413 PLS
% 210.75/210.89  |- mesh__publicMeSHNote mesh__D004413 85   
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D004413 2004
% 210.75/210.89  |- skos__scopeNote mesh__D004413
% 210.75/210.89       Defective bone formation involving individual bones, singly or in combination.%A%    
% 210.75/210.89  |- skos__prefLabel mesh__D004413 Dysostoses
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D004413 2006
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D004413 2000
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D004413 1996
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D004413 2001
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D004413 1998
% 210.75/210.89  |- mesh__historyNote mesh__D004413 85   
% 210.75/210.89  |- skos__broader mesh__D004413smesh__D001848
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D004413 1997
% 210.75/210.89  |- rdf__type mesh__D004413sskos__Concept
% 210.75/210.89  |- mesh__activeMeSHYear mesh__D004413 1994
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D004413 1999
% 210.75/210.90  |- mesh__recordMaintainer mesh__D004413 PLS
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D004413 1995
% 210.75/210.90  |- mesh__dateCreated mesh__D004413 1984-04-05
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D004413 2002
% 210.75/210.90  |- skos__historyNote mesh__D004413 Bone Diseases %28%1966-1969%29%
% 210.75/210.90  |- skos__historyNote mesh__D028861 Nuclear Proteins %28%1991-2001%29%
% 210.75/210.90  |- mesh__recordAuthorizer mesh__D028861 sjn
% 210.75/210.90  |- skos__scopeNote mesh__D028861
% 210.75/210.90       Proteins that form the structure of the NUCLEAR PORE. They are involved in active, facilitated and passive transport of molecules in and out of the CELL NUCLEUS.%A%    
% 210.75/210.90  |- mesh__recordMaintainer mesh__D028861 SYSTEM
% 210.75/210.90  |- mesh__dateCreated mesh__D028861 2001-07-25
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D028861 2006
% 210.75/210.90  |- mesh__historyNote mesh__D028861 2002   
% 210.75/210.90  |- skos__broader mesh__D028861smesh__D029543
% 210.75/210.90  |- skos__prefLabel mesh__D028861 Nuclear Pore Complex Proteins
% 210.75/210.90  |- mesh__publicMeSHNote mesh__D028861 2002   
% 210.75/210.90  |- mesh__recordOriginator mesh__D028861 jmp
% 210.75/210.90  |- mesh__dateRevised mesh__D028861 2005-06-30
% 210.75/210.90  |- rdf__type mesh__D028861sskos__Concept
% 210.75/210.90  |- mesh__dateEstablished mesh__D028861 2002-01-01
% 210.75/210.90  |- skos__altLabel mesh__D028861 Nucleoporins
% 210.75/210.90  |- skos__altLabel mesh__D028861 Nucleoporin
% 210.75/210.90  |- skos__broader mesh__D020080smesh__D040481
% 210.75/210.90  |- skos__hiddenLabel mesh__D020080 Repeat Sequences, Tandem
% 210.75/210.90  |- mesh__publicMeSHNote mesh__D020080
% 210.75/210.90       99; for TANDEM REPEAT see REPETITIVE SEQUENCE, NUCLEIC ACID 1990-98%A%  
% 210.75/210.90  |- skos__altLabel mesh__D020080 Tandem Repeats
% 210.75/210.90  |- mesh__dateRevised mesh__D020080 2005-06-30
% 210.75/210.90  |- skos__hiddenLabel mesh__D020080 Sequences, Tandem Repeat
% 210.75/210.90  |- mesh__recordAuthorizer mesh__D020080 sjn
% 210.75/210.90  |- skos__broader mesh__D020080smesh__D012091
% 210.75/210.90  |- skos__hiddenLabel mesh__D020080 Repeats, Tandem
% 210.75/210.90  |- skos__hiddenLabel mesh__D020080 Repeat, Tandem
% 210.75/210.90  |- rdf__type mesh__D020080sskos__Concept
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D020080 2006
% 210.75/210.90  |- skos__altLabel mesh__D020080 Tandem Repeat
% 210.75/210.90  |- mesh__recordMaintainer mesh__D020080 nns
% 210.75/210.90  |- skos__prefLabel mesh__D020080 Tandem Repeat Sequences
% 210.75/210.90  |- skos__historyNote mesh__D020080
% 210.75/210.90       Repetitive Sequences, Nucleic Acid %28%1981-1998%29%
% 210.75/210.90  |- skos__hiddenLabel mesh__D020080 Tandem Repeat Sequence
% 210.75/210.90  |- mesh__dateCreated mesh__D020080 1998-06-11
% 210.75/210.90  |- skos__hiddenLabel mesh__D020080 Repeat Sequence, Tandem
% 210.75/210.90  |- mesh__recordOriginator mesh__D020080 NNS
% 210.75/210.90  |- mesh__dateEstablished mesh__D020080 1999-01-01
% 210.75/210.90  |- skos__scopeNote mesh__D020080
% 210.75/210.90       Copies of DNA sequences which lie adjacent to each other in the same orientation %28%direct tandem repeats%29% or in the opposite direction to each other %28%inverted tandem repeats%29%.%A%    
% 210.75/210.90  |- skos__hiddenLabel mesh__D020080 Sequence, Tandem Repeat
% 210.75/210.90  |- mesh__historyNote mesh__D020080
% 210.75/210.90       99; for TANDEM REPEAT use REPETITIVE SEQUENCE, NUCLEIC ACID 1990-98%A%  
% 210.75/210.90  |- skos__hiddenLabel mesh__D014841 Factor VIIIR Ag
% 210.75/210.90  |- skos__hiddenLabel mesh__D014841 F VIII vWf
% 210.75/210.90  |- skos__altLabel mesh__D014841 vWF Ag
% 210.75/210.90  |- mesh__recordMaintainer mesh__D014841 ssb
% 210.75/210.90  |- skos__hiddenLabel mesh__D014841 Ag, vWF
% 210.75/210.90  |- skos__historyNote mesh__D014841
% 210.75/210.90       Blood Coagulation Factors %28%1966-1974%29%
% 210.75/210.90  |- skos__related mesh__D014841smesh__D020302
% 210.75/210.90  |- skos__scopeNote mesh__D014841
% 210.75/210.90       A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in von Willebrand%27%s disease is due to the deficiency of this factor.%A%    
% 210.75/210.90  |- mesh__dateRevised mesh__D014841 2005-06-30
% 210.75/210.90  |- skos__hiddenLabel mesh__D014841 Factor VIII Related Antigen
% 210.75/210.90  |- skos__hiddenLabel mesh__D014841 Protein, von Willebrand
% 210.75/210.90  |- skos__altLabel mesh__D014841 Ristocetin-Willebrand Factor
% 210.75/210.90  |- skos__annotation mesh__D014841 DF: VWF   
% 210.75/210.90  |- mesh__dateCreated mesh__D014841 1975-07-25
% 210.75/210.90  |- mesh__recordAuthorizer mesh__D014841 sjn
% 210.75/210.90  |- rdf__type mesh__D014841sskos__Concept
% 210.75/210.90  |- skos__hiddenLabel mesh__D014841 Cofactor, Ristocetin
% 210.75/210.90  |- skos__altLabel mesh__D014841 Ristocetin Cofactor
% 210.75/210.90  |- skos__hiddenLabel mesh__D014841 Factor VIIIR RCo
% 210.75/210.90  |- mesh__publicMeSHNote mesh__D014841
% 210.75/210.90       86; was see under BLOOD COAGULATION FACTORS 1976-85   
% 210.75/210.90  |- mesh__dateEstablished mesh__D014841 1986-01-01
% 210.75/210.90  |- mesh__onlineNote mesh__D014841
% 210.75/210.90       use FACTOR VIII %26% ANTIGENS to search FACTOR VIII RELATED ANTIGEN 1977-89%A%  
% 210.75/210.90  |- skos__prefLabel mesh__D014841 von Willebrand Factor
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D014841 2006
% 210.75/210.90  |- skos__hiddenLabel mesh__D014841 Ristocetin Willebrand Factor
% 210.75/210.90  |- mesh__historyNote mesh__D014841
% 210.75/210.90       86%28%76%29%; was see under BLOOD COAGULATION FACTORS 1976-85; FACTOR VIII RELATED ANTIGEN, previously in the Supplementary Chemical File, was mapped to both FACTOR VIII %26% ANTIGENS 1977-89%A%  
% 210.75/210.90  |- skos__altLabel mesh__D014841 von Willebrand Protein
% 210.75/210.90  |- mesh__recordOriginator mesh__D014841 RLS
% 210.75/210.90  |- skos__hiddenLabel mesh__D014841 Antigen, Factor VIII-Related
% 210.75/210.90  |- skos__related mesh__D014841smesh__D003029
% 210.75/210.90  |- skos__broader mesh__D014841smesh__D001779
% 210.75/210.90  |- skos__historyNote mesh__D014841
% 210.75/210.90       von Willebrand%27%s Disease %28%1966-1975%29%
% 210.75/210.90  |- skos__historyNote mesh__D014841 Blood Platelets %28%1966-1974%29%
% 210.75/210.90  |- skos__scopeNote mesh__D014043
% 210.75/210.90       A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn.%A%    
% 210.75/210.90  |- rdf__type mesh__D014043sskos__Concept
% 210.75/210.90  |- skos__prefLabel mesh__D014043 Tolazoline
% 210.75/210.90  |- skos__altLabel mesh__D014043
% 210.75/210.90       Ciba Vision Brand of Tolazoline Hydrochloride
% 210.75/210.90  |- mesh__dateRevised mesh__D014043 2005-06-30
% 210.75/210.90  |- skos__altLabel mesh__D014043 Benzalolin
% 210.75/210.90  |- skos__altLabel mesh__D014043 Novartis Brand of Tolazoline Hydrochloride
% 210.75/210.90  |- skos__altLabel mesh__D014043 Tolazoline Monohydrochloride
% 210.75/210.90  |- mesh__dateCreated mesh__D014043 1999-01-01
% 210.75/210.90  |- mesh__recordOriginator mesh__D014043 NLM
% 210.75/210.90  |- mesh__recordAuthorizer mesh__D014043 sjn
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D014043 2006
% 210.75/210.90  |- mesh__recordMaintainer mesh__D014043 ssb
% 210.75/210.90  |- skos__broader mesh__D014043smesh__D048288
% 210.75/210.90  |- mesh__historyNote mesh__D000821 68%28%66%29%   
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D000821 2003
% 210.75/210.90  |- mesh__publicMeSHNote mesh__D000821 68   
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D000821 2006
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D000821 1998
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D000821 2001
% 210.75/210.90  |- mesh__dateRevised mesh__D000821 1997-06-20
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D000821 2004
% 210.75/210.90  |- mesh__dateEstablished mesh__D000821 1968-01-01
% 210.75/210.90  |- mesh__dateCreated mesh__D000821 1999-01-01
% 210.75/210.90  |- mesh__recordOriginator mesh__D000821 NLM
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D000821 1999
% 210.75/210.90  |- skos__broader mesh__D000821smesh__D018556
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D000821 2002
% 210.75/210.90  |- skos__hiddenLabel mesh__D000821 Animal Feeds
% 210.75/210.90  |- skos__hiddenLabel mesh__D000821 Feeds, Animal
% 210.75/210.90  |- skos__hiddenLabel mesh__D000821 Feed, Animal
% 210.75/210.90  |- skos__prefLabel mesh__D000821 Animal Feed
% 210.75/210.90  |- skos__annotation mesh__D000821
% 210.75/210.90       TN 50: differentiate from ANIMAL NUTRITION %26% DIET   
% 210.75/210.90  |- mesh__recordAuthorizer mesh__D000821 SJN
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D000821 2005
% 210.75/210.90  |- mesh__recordMaintainer mesh__D000821 JLS
% 210.75/210.90  |- rdf__type mesh__D000821sskos__Concept
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D000821 2000
% 210.75/210.90  |- mesh__dateEstablished mesh__D008006 1991-01-01
% 210.75/210.90  |- rdf__type mesh__D008006sskos__Concept
% 210.75/210.90  |- skos__altLabel mesh__D008006 Hospital Licensure
% 210.75/210.90  |- mesh__recordOriginator mesh__D008006 EC
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D008006 2002
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D008006 2006
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D008006 2001
% 210.75/210.90  |- skos__hiddenLabel mesh__D008006 Hospital Licensures
% 210.75/210.90  |- skos__prefLabel mesh__D008006 Licensure, Hospital
% 210.75/210.90  |- mesh__dateRevised mesh__D008006 1999-11-03
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D008006 2005
% 210.75/210.90  |- mesh__historyNote mesh__D008006
% 210.75/210.90       91%28%Aug 77%29%; was see under LICENSURE 1977-90   
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D008006 2000
% 210.75/210.90  |- mesh__dateCreated mesh__D008006 1977-05-11
% 210.75/210.90  |- skos__scopeNote mesh__D008006
% 210.75/210.90       The granting of a license to a hospital.     
% 210.75/210.90  |- skos__hiddenLabel mesh__D008006 Licensures, Hospital
% 210.75/210.90  |- mesh__recordAuthorizer mesh__D008006 sjn
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D008006 2004
% 210.75/210.90  |- skos__broader mesh__D008006smesh__D008004
% 210.75/210.90  |- skos__annotation mesh__D008006
% 210.75/210.90       by the state; differentiate from ACCREDITATION %28%by the profession%29%; IM; specify geog%A%  
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D008006 2003
% 210.75/210.90  |- mesh__recordMaintainer mesh__D008006 kle
% 210.75/210.90  |- mesh__publicMeSHNote mesh__D008006
% 210.75/210.90       91; was see under LICENSURE Aug 1977-90   
% 210.75/210.90  |- skos__hiddenLabel mesh__D000023 Refused Abortion Seeker
% 210.75/210.90  |- skos__hiddenLabel mesh__D000023 Applicant, Abortion
% 210.75/210.90  |- skos__altLabel mesh__D000023 Abortion Seekers
% 210.75/210.90  |- skos__prefLabel mesh__D000023 Abortion Applicants
% 210.75/210.90  |- skos__hiddenLabel mesh__D000023 Abortion Seeker, Repeated
% 210.75/210.90  |- skos__hiddenLabel mesh__D000023 Seeker, Abortion
% 210.75/210.90  |- skos__hiddenLabel mesh__D000023 Applicants, Abortion
% 210.75/210.90  |- mesh__publicMeSHNote mesh__D000023 76; was see under ABORTION 1975   
% 210.75/210.90  |- mesh__recordAuthorizer mesh__D000023 sjn
% 210.75/210.90  |- skos__hiddenLabel mesh__D000023 Abortion Seeker, Refused
% 210.75/210.90  |- skos__hiddenLabel mesh__D000023 Seeker, Refused Abortion
% 210.75/210.90  |- skos__hiddenLabel mesh__D000023 Abortion Applicant
% 210.75/210.90  |- skos__hiddenLabel mesh__D000023 Seekers, Refused Abortion
% 210.75/210.90  |- mesh__recordMaintainer mesh__D000023 sjn
% 210.75/210.90  |- skos__historyNote mesh__D000023 Abortion, Induced %28%1970-1974%29%
% 210.75/210.90  |- mesh__dateEstablished mesh__D000023 1976-01-01
% 210.75/210.90  |- skos__scopeNote mesh__D000023
% 210.75/210.90       Individuals requesting induced abortions.     
% 210.75/210.90  |- skos__hiddenLabel mesh__D000023 Repeated Abortion Seeker
% 210.75/210.90  |- mesh__recordOriginator mesh__D000023 NLM
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D000023 2006
% 210.75/210.90  |- mesh__dateCreated mesh__D000023 1974-11-19
% 210.75/210.90  |- skos__hiddenLabel mesh__D000023 Abortion Seeker
% 210.75/210.90  |- skos__broader mesh__D000023smesh__D009272
% 210.75/210.90  |- skos__historyNote mesh__D000023 Abortion, Therapeutic %28%1966-1974%29%
% 210.75/210.90  |- skos__annotation mesh__D000023
% 210.75/210.90        don%27%t forget also check tags  HUMANS %26% FEMALE %26% PREGNANCY%A%  
% 210.75/210.90  |- skos__hiddenLabel mesh__D000023 Seekers, Repeated Abortion
% 210.75/210.90  |- mesh__dateRevised mesh__D000023 2004-07-13
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D000023 2005
% 210.75/210.90  |- mesh__historyNote mesh__D000023
% 210.75/210.90       76%28%75%29%; was see under ABORTION 1975   
% 210.75/210.90  |- rdf__type mesh__D000023sskos__Concept
% 210.75/210.90  |- skos__hiddenLabel mesh__D000023 Seekers, Abortion
% 210.75/210.90  |- skos__hiddenLabel mesh__D000023 Refused Abortion Seekers
% 210.75/210.90  |- skos__hiddenLabel mesh__D000023 Seeker, Repeated Abortion
% 210.75/210.90  |- skos__hiddenLabel mesh__D000023 Repeated Abortion Seekers
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D052162 2006
% 210.75/210.90  |- skos__annotation mesh__D052162
% 210.75/210.90       infection: coordinate IM with PAPILLOMAVIRUS INFECTIONS %28%IM%29% + UTERINE CERVICAL NEOPLASMS %28%IM%29%, RESPIRATORY TRACT NEOPLASMS %28%IM%29% or other neoplasm term %28%IM%29% if pertinent%A%  
% 210.75/210.90  |- skos__historyNote mesh__D052162 Papillomavirus %28%1983-1993%29%
% 210.75/210.90  |- mesh__historyNote mesh__D052162 2006   
% 210.75/210.90  |- mesh__dateEstablished mesh__D052162 2006-01-01
% 210.75/210.90  |- mesh__recordMaintainer mesh__D052162 ags
% 210.75/210.90  |- mesh__dateCreated mesh__D052162 2005-06-30
% 210.75/210.90  |- skos__hiddenLabel mesh__D052162 papillomavirus 16, Human
% 210.75/210.90  |- skos__prefLabel mesh__D052162 Human papillomavirus 16
% 210.75/210.90  |- mesh__recordAuthorizer mesh__D052162 sjn
% 210.75/210.90  |- rdf__type mesh__D052162sskos__Concept
% 210.75/210.90  |- skos__broader mesh__D052162smesh__D018145
% 210.75/210.90  |- skos__hiddenLabel mesh__D052162 HPV 16
% 210.75/210.90  |- mesh__publicMeSHNote mesh__D052162 2006   
% 210.75/210.90  |- mesh__recordOriginator mesh__D052162 ags
% 210.75/210.90  |- skos__historyNote mesh__D052162 Papillomavirus, Human %28%1994-2005%29%
% 210.75/210.90  |- skos__altLabel mesh__D052162 HPV-16
% 210.75/210.90  |- skos__scopeNote mesh__D052162
% 210.75/210.90       A type of HUMAN PAPILLOMAVIRUS especially associated with malignant tumors of the CERVIX and the RESPIRATORY MUCOSA.%A%    
% 210.75/210.90  |- skos__historyNote mesh__D013749 Dioxins %28%1972-1974%29%
% 210.75/210.90  |- mesh__dateEstablished mesh__D013749 1991-01-01
% 210.75/210.90  |- mesh__dateCreated mesh__D013749 1974-11-19
% 210.75/210.90  |- mesh__dateRevised mesh__D013749 1999-11-03
% 210.75/210.90  |- mesh__historyNote mesh__D013749
% 210.75/210.90       91%28%75%29%; was see under DIOXINS 1975-90   
% 210.75/210.90  |- skos__altLabel mesh__D013749 TCDD
% 210.75/210.90  |- mesh__publicMeSHNote mesh__D013749 91; was see under DIOXINS 1975-90   
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D013749 2001
% 210.75/210.90  |- skos__historyNote mesh__D013749 Chlorobenzenes %28%1974%29%
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D013749 2006
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D013749 2000
% 210.75/210.90  |- mesh__recordOriginator mesh__D013749 NLM
% 210.75/210.90  |- rdf__type mesh__D013749sskos__Concept
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D013749 2004
% 210.75/210.90  |- skos__altLabel mesh__D013749 2,3,7,8-Tetrachlorodibenzo-p-dioxin
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D013749 2005
% 210.75/210.90  |- skos__broader mesh__D013749smesh__D004147
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D013749 2003
% 210.75/210.90  |- mesh__recordAuthorizer mesh__D013749 sjn
% 210.75/210.90  |- skos__prefLabel mesh__D013749 Tetrachlorodibenzodioxin
% 210.75/210.90  |- mesh__recordMaintainer mesh__D013749 adp
% 210.75/210.90  |- skos__scopeNote mesh__D013749
% 210.75/210.90       A chemical by-product that results from burning or incinerating chlorinated industrial chemicals and other hydrocarbons. This compound is considered an environmental toxin, and may pose reproductive, as well as, other health risks for animals and humans.%A%    
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D013749 2002
% 210.75/210.90  |- mesh__publicMeSHNote mesh__D032903
% 210.75/210.90       2003; see RELIGIOUS PHILOSOPHIES 2002   
% 210.75/210.90  |- skos__prefLabel mesh__D032903 Confucianism
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D032903 2003
% 210.75/210.90  |- rdf__type mesh__D032903sskos__Concept
% 210.75/210.90  |- skos__scopeNote mesh__D032903
% 210.75/210.90       A school of thought and set of moral, ethical, and political teachings usually considered to be founded by Confucius in 6th-5th century B.C. China. %28%from Cambridge Dictionary of Philosophy, 1995%29%%A%    
% 210.75/210.90  |- mesh__dateEstablished mesh__D032903 2003-01-01
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D032903 2004
% 210.75/210.90  |- mesh__historyNote mesh__D032903 2003; use RELIGIOUS PHILOSOPHIES 2002   
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D032903 2005
% 210.75/210.90  |- mesh__dateCreated mesh__D032903 2002-07-03
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D032903 2006
% 210.75/210.90  |- skos__broader mesh__D032903smesh__D012072
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D018434 1999
% 210.75/210.90  |- skos__historyNote mesh__D018434 Attitude to Health %28%1976-1994%29%
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D018434 2000
% 210.75/210.90  |- skos__annotation mesh__D018434 a health status indicator   
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D018434 1998
% 210.75/210.90  |- mesh__historyNote mesh__D018434 95   
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D018434 1997
% 210.75/210.90  |- skos__scopeNote mesh__D018434
% 210.75/210.90       A quality-of-life scale developed in the United States in 1972 as a measure of health status or dysfunction generated by a disease. It is a behaviorally based questionnaire for patients and addresses activities such as sleep and rest, mobility, recreation, home management, emotional behavior, social interaction, and the like. It measures the patient%27%s perceived health status and is sensitive enough to detect changes or differences in health status occurring over time or between groups. %28%From Medical Care, vol.xix, no.8, August 1981, p.787-805%29%%A%    
% 210.75/210.90  |- mesh__dateEstablished mesh__D018434 1995-01-01
% 210.75/210.90  |- skos__hiddenLabel mesh__D018434 Profiles, Sickness Impact
% 210.75/210.90  |- mesh__publicMeSHNote mesh__D018434 95   
% 210.75/210.90  |- skos__hiddenLabel mesh__D018434 Profile, Sickness Impact
% 210.75/210.90  |- skos__historyNote mesh__D018434 Quality of Life %28%1976-1994%29%
% 210.75/210.90  |- skos__hiddenLabel mesh__D018434 Impact Profiles, Sickness
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D018434 1996
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D018434 2006
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D018434 2002
% 210.75/210.90  |- skos__prefLabel mesh__D018434 Sickness Impact Profile
% 210.75/210.90  |- skos__hiddenLabel mesh__D018434 Sickness Impact Profiles
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D018434 2005
% 210.75/210.90  |- skos__hiddenLabel mesh__D018434 Impact Profile, Sickness
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D018434 2004
% 210.75/210.90  |- mesh__dateCreated mesh__D018434 1994-02-28
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D018434 1995
% 210.75/210.90  |- rdf__type mesh__D018434sskos__Concept
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D018434 2003
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D018434 2001
% 210.75/210.90  |- skos__historyNote mesh__D018434
% 210.75/210.90       Health Status Indicators %28%1976-1994%29%
% 210.75/210.90  |- skos__broader mesh__D018434smesh__D006305
% 210.75/210.90  |- skos__historyNote mesh__D018434
% 210.75/210.90       Activities of Daily Living %28%1975-1994%29%
% 210.75/210.90  |- skos__hiddenLabel mesh__D010451 Peptide Histidine Isoleucine
% 210.75/210.90  |- skos__historyNote mesh__D010451
% 210.75/210.90       Gastrointestinal Hormones %28%1966-1986%29%
% 210.75/210.90  |- skos__hiddenLabel mesh__D010451 Peptide, PHI
% 210.75/210.90  |- mesh__recordMaintainer mesh__D010451 ssb
% 210.75/210.90  |- skos__altLabel mesh__D010451 Neuropeptide PHI 27
% 210.75/210.90  |- skos__hiddenLabel mesh__D010451 Peptide, Pro-Vasoactive Intestinal
% 210.75/210.90  |- skos__hiddenLabel mesh__D010451 Histidine Methionine, Peptide
% 210.75/210.90  |- skos__hiddenLabel mesh__D010451 Heptacosapeptide, Porcine Intestinal
% 210.75/210.90  |- skos__hiddenLabel mesh__D010451 Peptide PHI 27
% 210.75/210.90  |- skos__altLabel mesh__D010451 Peptide PHI-27
% 210.75/210.90  |- mesh__dateEstablished mesh__D010451 1987-01-01
% 210.75/210.90  |- skos__altLabel mesh__D010451 Peptide PHM
% 210.75/210.90  |- mesh__dateRevised mesh__D010451 2005-06-30
% 210.75/210.90  |- mesh__dateCreated mesh__D010451 1986-04-14
% 210.75/210.90  |- skos__hiddenLabel mesh__D010451 PHM, Peptide
% 210.75/210.90  |- skos__altLabel mesh__D010451 PHM Neuropeptide
% 210.75/210.90  |- skos__altLabel mesh__D010451 Pro-Vasoactive Intestinal Peptide
% 210.75/210.90  |- skos__hiddenLabel mesh__D010451 Intestinal Heptacosapeptide, Porcine
% 210.75/210.90  |- skos__historyNote mesh__D010451 Peptides %28%1966-1986%29%
% 210.75/210.90  |- mesh__activeMeSHYear mesh__D010451 2006
% 210.76/210.90  |- skos__prefLabel mesh__D010451 Peptide PHI
% 210.76/210.90  |- skos__altLabel mesh__D010451 PHM-27
% 210.76/210.90  |- skos__altLabel mesh__D010451 Peptide Histidine Methionine
% 210.76/210.90  |- skos__altLabel mesh__D010451 Peptide-Histidine-Isoleucinamide
% 210.76/210.90  |- skos__hiddenLabel mesh__D010451 Methionine, Peptide Histidine
% 210.76/210.90  |- skos__annotation mesh__D010451
% 210.76/210.90       a neurotransmitter; X ref explains PHI; /biosyn /physiol permitted%A%  
% 210.76/210.90  |- skos__hiddenLabel mesh__D010451 Pro Vasoactive Intestinal Peptide
% 210.76/210.90  |- skos__scopeNote mesh__D010451
% 210.76/210.90       A 27-amino acid peptide with histidine at the N-terminal and isoleucine amide at the C-terminal. The exact amino acid composition of the peptide is species dependent. The peptide is secreted in the intestine, but is found in the nervous system, many organs, and in the majority of peripheral tissues. It has a wide range of biological actions, affecting the cardiovascular, gastrointestinal, respiratory, and central nervous systems.%A%    
% 210.76/210.90  |- skos__altLabel mesh__D010451 Peptide HI
% 210.76/210.90  |- skos__altLabel mesh__D010451 Peptide Histidine-Isoleucine
% 210.76/210.90  |- skos__hiddenLabel mesh__D010451 PHI, Human
% 210.76/210.90  |- mesh__recordAuthorizer mesh__D010451 sjn
% 210.76/210.90  |- skos__hiddenLabel mesh__D010451 Peptide Histidine Isoleucinamide
% 210.76/210.90  |- mesh__historyNote mesh__D010451 87   
% 210.76/210.90  |- mesh__recordOriginator mesh__D010451 RLS
% 210.76/210.90  |- skos__broader mesh__D010451smesh__D009479
% 210.76/210.90  |- skos__broader mesh__D010451smesh__D036361
% 210.76/210.90  |- skos__hiddenLabel mesh__D010451 Neuropeptide, PHM
% 210.76/210.90  |- skos__hiddenLabel mesh__D010451 Histidine-Isoleucine, Peptide
% 210.76/210.90  |- skos__hiddenLabel mesh__D010451 Intestinal Peptide, Pro-Vasoactive
% 210.76/210.90  |- mesh__publicMeSHNote mesh__D010451 87   
% 210.76/210.90  |- rdf__type mesh__D010451sskos__Concept
% 210.76/210.90  |- skos__altLabel mesh__D010451 PHI Peptide
% 210.76/210.90  |- skos__scopeNote mesh__D032105
% 210.76/210.90       A plant genus of the family RUTACEAE. Members contain quinoline alkaloids.%A%    
% 210.76/210.90  |- mesh__dateCreated mesh__D032105 2002-07-03
% 210.76/210.90  |- skos__altLabel mesh__D032105 Rue
% 210.76/210.90  |- mesh__activeMeSHYear mesh__D032105 2006
% 210.76/210.90  |- rdf__type mesh__D032105sskos__Concept
% 210.76/210.90  |- mesh__activeMeSHYear mesh__D032105 2004
% 210.76/210.90  |- skos__annotation mesh__D032105
% 210.76/210.90       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.76/210.90  |- mesh__activeMeSHYear mesh__D032105 2005
% 210.76/210.90  |- mesh__activeMeSHYear mesh__D032105 2003
% 210.76/210.90  |- mesh__historyNote mesh__D032105 2003   
% 210.76/210.90  |- skos__broader mesh__D032105smesh__D027821
% 210.76/210.90  |- mesh__dateEstablished mesh__D032105 2003-01-01
% 210.76/210.90  |- skos__prefLabel mesh__D032105 Ruta
% 210.76/210.90  |- mesh__publicMeSHNote mesh__D032105 2003   
% 210.76/210.90  |- skos__prefLabel mesh__D004414 Dyspareunia
% 210.76/210.90  |- skos__broader mesh__D004414smesh__D020018
% 210.76/210.90  |- skos__scopeNote mesh__D004414
% 210.76/210.90       Recurrent genital pain occurring during, before, or after SEXUAL INTERCOURSE in either the male or the female.%A%    
% 210.76/210.90  |- skos__broader mesh__D004414smesh__D012735
% 210.76/210.90  |- mesh__historyNote mesh__D004414 67%28%63%29%   
% 210.76/210.90  |- mesh__dateCreated mesh__D004414 1999-01-01
% 210.76/210.90  |- mesh__recordMaintainer mesh__D004414 lkt
% 210.76/210.90  |- mesh__activeMeSHYear mesh__D004414 2006
% 210.76/210.90  |- mesh__recordAuthorizer mesh__D004414 sjn
% 210.76/210.90  |- mesh__recordOriginator mesh__D004414 NLM
% 210.76/210.90  |- skos__broader mesh__D004414smesh__D014623
% 210.76/210.90  |- mesh__dateEstablished mesh__D004414 1967-01-01
% 210.76/210.90  |- mesh__publicMeSHNote mesh__D004414 67   
% 210.76/210.90  |- rdf__type mesh__D004414sskos__Concept
% 210.76/210.90  |- mesh__dateRevised mesh__D004414 2005-06-30
% 210.76/210.90  |- mesh__dateEstablished mesh__D020081 1999-01-01
% 210.76/210.90  |- skos__related mesh__D020081smesh__D020231
% 210.76/210.90  |- mesh__dateCreated mesh__D020081 1998-06-10
% 210.76/210.90  |- rdf__type mesh__D020081sskos__Concept
% 210.76/210.90  |- mesh__activeMeSHYear mesh__D020081 2006
% 210.76/210.90  |- mesh__historyNote mesh__D020081 99   
% 210.76/210.90  |- mesh__dateRevised mesh__D020081 2005-06-30
% 210.76/210.90  |- skos__prefLabel mesh__D020081 Phyllachorales
% 210.76/210.90  |- mesh__recordAuthorizer mesh__D020081 sjn
% 210.76/210.90  |- skos__scopeNote mesh__D020081
% 210.76/210.90       An order of fungi in the phylum ASCOMYCOTA characterized by stromatic perithecial forms in most species. Notable genera are Magnaporthe and Glomerella, the latter having the anamorph %28%mitosporic form%29% COLLETOTRICHUM.%A%    
% 210.76/210.90  |- mesh__recordMaintainer mesh__D020081 SYSTEM
% 210.76/210.90  |- skos__broader mesh__D020081smesh__D001203
% 210.76/210.90  |- mesh__publicMeSHNote mesh__D020081 99   
% 210.76/210.90  |- mesh__recordOriginator mesh__D020081 AGS
% 210.76/210.90  |- mesh__dateCreated mesh__D014842 1999-01-01
% 210.76/210.90  |- skos__hiddenLabel mesh__D014842 Vascular Hemophilias
% 210.76/210.90  |- mesh__historyNote mesh__D014842 99%28%63%29%   
% 210.76/210.90  |- mesh__activeMeSHYear mesh__D014842 2003
% 210.76/210.90  |- skos__hiddenLabel mesh__D014842 Disease, von Willebrand%27%s
% 210.76/210.90  |- skos__prefLabel mesh__D014842 von Willebrand Disease
% 210.76/210.90  |- mesh__dateEstablished mesh__D014842 1968-01-01
% 210.76/210.90  |- rdf__type mesh__D014842sskos__Concept
% 210.76/210.90  |- skos__scopeNote mesh__D014842
% 210.76/210.90       Group of hemorrhagic disorders in which the von Willebrand factor %28%Factor VIII-related antigen%29% is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion.%A%    
% 210.76/210.90  |- skos__hiddenLabel mesh__D014842 Disease, von Willebrand
% 210.76/210.90  |- skos__hiddenLabel mesh__D014842 Vascular Hemophilia
% 210.76/210.90  |- skos__annotation mesh__D014842
% 210.76/210.90       do not coord with INFANT, NEWBORN, DISEASES   
% 210.76/210.90  |- mesh__recordMaintainer mesh__D014842 nns
% 210.76/210.90  |- skos__broader mesh__D014842smesh__D025861
% 210.76/210.90  |- mesh__activeMeSHYear mesh__D014842 2006
% 210.76/210.90  |- skos__broader mesh__D014842smesh__D006474
% 210.76/210.90  |- skos__hiddenLabel mesh__D014842 von Willebrands Disease
% 210.76/210.90  |- mesh__recordAuthorizer mesh__D014842 sjn
% 210.76/210.90  |- skos__altLabel mesh__D014842 von Willebrand%27%s Disease
% 210.76/210.90  |- mesh__recordOriginator mesh__D014842 NLM
% 210.76/210.90  |- skos__altLabel mesh__D014842 Angiohemophilia
% 210.76/210.90  |- skos__altLabel mesh__D014842 Hemophilia, Vascular
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D014842 2005
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D014842 2002
% 210.76/210.91  |- mesh__publicMeSHNote mesh__D014842
% 210.76/210.91       99; see von Willebrand%27%s Disease 1968-98, see HEMORRHAGIC DIATHESIS 1967, see THROMBOCYTOPATHY 1963-66%A%  
% 210.76/210.91  |- skos__broader mesh__D014842smesh__D020147
% 210.76/210.91  |- mesh__dateRevised mesh__D014842 2001-07-25
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D014842 2004
% 210.76/210.91  |- skos__hiddenLabel mesh__D014842 Hemophilias, Vascular
% 210.76/210.91  |- skos__hiddenLabel mesh__D014842 Angiohemophilias
% 210.76/210.91  |- skos__broader mesh__D014842smesh__D001791
% 210.76/210.91  |- rdf__type mesh__D014044sskos__Concept
% 210.76/210.91  |- skos__altLabel mesh__D014044 Hoechst Brand of Tolbutamide
% 210.76/210.91  |- skos__altLabel mesh__D014044 Apotex Brand of Tolbutamide
% 210.76/210.91  |- skos__hiddenLabel mesh__D014044 Berlin Chemie Brand of Tolbutamide
% 210.76/210.91  |- skos__altLabel mesh__D014044 Valdecasas Brand of Tolbutamide
% 210.76/210.91  |- skos__altLabel mesh__D014044 Rastinon
% 210.76/210.91  |- skos__altLabel mesh__D014044 Pharmacia Brand of Tolbutamide
% 210.76/210.91  |- mesh__recordMaintainer mesh__D014044 CCR
% 210.76/210.91  |- skos__prefLabel mesh__D014044 Tolbutamide
% 210.76/210.91  |- skos__broader mesh__D014044smesh__D013453
% 210.76/210.91  |- mesh__dateCreated mesh__D014044 1999-01-01
% 210.76/210.91  |- skos__altLabel mesh__D014044 R.A.N. Brand of Tolbutamide
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D014044 2006
% 210.76/210.91  |- skos__altLabel mesh__D014044 Berlin-Chemie Brand of Tolbutamide
% 210.76/210.91  |- mesh__dateRevised mesh__D014044 2005-06-30
% 210.76/210.91  |- skos__scopeNote mesh__D014044
% 210.76/210.91       A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p290%29%%A%    
% 210.76/210.91  |- skos__altLabel mesh__D014044 Aventis Brand of Tolbutamide
% 210.76/210.91  |- skos__altLabel mesh__D014044 Yamanouchi Brand of Tolbutamide
% 210.76/210.91  |- skos__hiddenLabel mesh__D014044 Apo Tolbutamide
% 210.76/210.91  |- mesh__recordOriginator mesh__D014044 NLM
% 210.76/210.91  |- mesh__recordAuthorizer mesh__D014044 sjn
% 210.76/210.91  |- skos__broader mesh__D008805smesh__D008815
% 210.76/210.91  |- skos__hiddenLabel mesh__D008805 Inbred A Mice
% 210.76/210.91  |- skos__annotation mesh__D008805
% 210.76/210.91       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%  
% 210.76/210.91  |- mesh__dateCreated mesh__D008805 1999-01-01
% 210.76/210.91  |- mesh__dateRevised mesh__D008805 2005-06-30
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D008805 2006
% 210.76/210.91  |- skos__altLabel mesh__D008805 Mouse, Inbred A
% 210.76/210.91  |- mesh__recordOriginator mesh__D008805 NLM
% 210.76/210.91  |- mesh__dateEstablished mesh__D008805 1974-01-01
% 210.76/210.91  |- skos__hiddenLabel mesh__D008805 Inbred A Mouse
% 210.76/210.91  |- skos__historyNote mesh__D008805 Mice %28%1966-1971%29%
% 210.76/210.91  |- rdf__type mesh__D008805sskos__Concept
% 210.76/210.91  |- mesh__recordMaintainer mesh__D008805 ags
% 210.76/210.91  |- mesh__recordAuthorizer mesh__D008805 sjn
% 210.76/210.91  |- mesh__publicMeSHNote mesh__D008805 74   
% 210.76/210.91  |- skos__prefLabel mesh__D008805 Mice, Inbred A
% 210.76/210.91  |- mesh__historyNote mesh__D008805 74%28%72%29%   
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D000822 1995
% 210.76/210.91  |- mesh__recordAuthorizer mesh__D000822 PLS
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D000822 1996
% 210.76/210.91  |- mesh__dateEstablished mesh__D000822 1976-01-01
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D000822 1993
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D000822 2000
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D000822 1999
% 210.76/210.91  |- mesh__recordMaintainer mesh__D000822 TGC
% 210.76/210.91  |- skos__hiddenLabel mesh__D000822 Husbandry, Animal
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D000822 1997
% 210.76/210.91  |- mesh__publicMeSHNote mesh__D000822 76   
% 210.76/210.91  |- skos__related mesh__D000822smesh__D014730
% 210.76/210.91  |- skos__hiddenLabel mesh__D000822 Animal Husbandries
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D000822 2001
% 210.76/210.91  |- skos__historyNote mesh__D000822 Agriculture %28%1966-1975%29%
% 210.76/210.91  |- mesh__dateCreated mesh__D000822 1975-07-23
% 210.76/210.91  |- skos__annotation mesh__D000822
% 210.76/210.91       includes animal %22%breeding, feeding %26% care ... housing %26% nutrition%22%; do not confuse with VETERINARY MEDICINE; SPEC: SPEC qualif%A%  
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D000822 1990
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D000822 2002
% 210.76/210.91  |- mesh__recordOriginator mesh__D000822 FPG
% 210.76/210.91  |- skos__prefLabel mesh__D000822 Animal Husbandry
% 210.76/210.91  |- skos__hiddenLabel mesh__D000822 Husbandries, Animal
% 210.76/210.91  |- mesh__historyNote mesh__D000822 76   
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D000822 1991
% 210.76/210.91  |- skos__broader mesh__D000822smesh__D000383
% 210.76/210.91  |- mesh__dateRevised mesh__D000822 1989-06-13
% 210.76/210.91  |- rdf__type mesh__D000822sskos__Concept
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D000822 2005
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D000822 1994
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D000822 2003
% 210.76/210.91  |- skos__scopeNote mesh__D000822
% 210.76/210.91       The science of breeding, feeding and care of domestic animals; includes housing and nutrition.%A%    
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D000822 2006
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D000822 1992
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D000822 1998
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D000822 2004
% 210.76/210.91  |- mesh__recordOriginator mesh__D008007 NLM
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D008007 2006
% 210.76/210.91  |- mesh__recordMaintainer mesh__D008007 kle
% 210.76/210.91  |- skos__prefLabel mesh__D008007 Licensure, Medical
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D008007 2005
% 210.76/210.91  |- mesh__dateCreated mesh__D008007 1999-01-01
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D008007 2002
% 210.76/210.91  |- skos__scopeNote mesh__D008007
% 210.76/210.91       The granting of a license to practice medicine.     
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D008007 2004
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D008007 2001
% 210.76/210.91  |- skos__broader mesh__D008007smesh__D008004
% 210.76/210.91  |- mesh__dateRevised mesh__D008007 1999-11-03
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D008007 2003
% 210.76/210.91  |- skos__annotation mesh__D008007
% 210.76/210.91       by the state; differentiate from ACCREDITATION %28%by the profession%29%; IM; various boards can go here; specify geog; DF: LICENSURE MED%A%  
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D008007 2000
% 210.76/210.91  |- rdf__type mesh__D008007sskos__Concept
% 210.76/210.91  |- mesh__recordAuthorizer mesh__D008007 sjn
% 210.76/210.91  |- skos__altLabel mesh__D008007 Medical Licensure
% 210.76/210.91  |- skos__hiddenLabel mesh__D000024 Abortions, Criminal
% 210.76/210.91  |- skos__hiddenLabel mesh__D000024 Criminal Abortion
% 210.76/210.91  |- mesh__dateCreated mesh__D000024 1999-01-01
% 210.76/210.91  |- skos__hiddenLabel mesh__D000024 Criminal Abortions
% 210.76/210.91  |- mesh__dateRevised mesh__D000024 2004-07-13
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D000024 2006
% 210.76/210.91  |- skos__broader mesh__D000024smesh__D003415
% 210.76/210.91  |- skos__altLabel mesh__D000024 Illegal Abortion
% 210.76/210.91  |- skos__annotation mesh__D000024
% 210.76/210.91        don%27%t forget also check tags  HUMANS %26% FEMALE %26% PREGNANCY; for abortifacients in crim abort see note on ABORTION, INDUCED%A%  
% 210.76/210.91  |- skos__prefLabel mesh__D000024 Abortion, Criminal
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D000024 2005
% 210.76/210.91  |- skos__hiddenLabel mesh__D000024 Illegal Abortions
% 210.76/210.91  |- rdf__type mesh__D000024sskos__Concept
% 210.76/210.91  |- mesh__recordMaintainer mesh__D000024 sjn
% 210.76/210.91  |- skos__altLabel mesh__D000024 Abortion, Illegal
% 210.76/210.91  |- mesh__recordAuthorizer mesh__D000024 sjn
% 210.76/210.91  |- skos__scopeNote mesh__D000024 Illegal termination of pregnancy.     
% 210.76/210.91  |- mesh__recordOriginator mesh__D000024 NLM
% 210.76/210.91  |- skos__hiddenLabel mesh__D000024 Abortions, Illegal
% 210.76/210.91  |- skos__annotation mesh__D052163
% 210.76/210.91       infection: coordinate IM with probably GENITAL WARTS %28%IM%29% or PAPILLOMAVIRUS INFECTIONS %28%IM%29%; coordinate with LARYNGEAL NEOPLASMS if pertinent%A%  
% 210.76/210.91  |- mesh__recordMaintainer mesh__D052163 ags
% 210.76/210.91  |- skos__altLabel mesh__D052163 Human papillomavirus type 6
% 210.76/210.91  |- rdf__type mesh__D052163sskos__Concept
% 210.76/210.91  |- mesh__publicMeSHNote mesh__D052163 2006   
% 210.76/210.91  |- skos__historyNote mesh__D052163 Papillomavirus, Human %28%1994-2005%29%
% 210.76/210.91  |- skos__altLabel mesh__D052163 HPV-6
% 210.76/210.91  |- skos__hiddenLabel mesh__D052163 papillomavirus 6, Human
% 210.76/210.91  |- skos__hiddenLabel mesh__D052163 HPV 6
% 210.76/210.91  |- mesh__dateCreated mesh__D052163 2005-06-30
% 210.76/210.91  |- mesh__dateEstablished mesh__D052163 2006-01-01
% 210.76/210.91  |- mesh__historyNote mesh__D052163 2006   
% 210.76/210.91  |- mesh__recordAuthorizer mesh__D052163 sjn
% 210.76/210.91  |- skos__broader mesh__D052163smesh__D018145
% 210.76/210.91  |- skos__scopeNote mesh__D052163
% 210.76/210.91       A type of HUMAN PAPILLOMAVIRUS usually associated with GENITAL WARTS; and LARYNGEAL NEOPLASMS.%A%    
% 210.76/210.91  |- skos__prefLabel mesh__D052163 Human papillomavirus 6
% 210.76/210.91  |- skos__historyNote mesh__D052163 Papillomavirus %28%1982-1993%29%
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D052163 2006
% 210.76/210.91  |- mesh__recordOriginator mesh__D052163 ags
% 210.76/210.91  |- skos__annotation mesh__D032904
% 210.76/210.91       note X refs: do not confuse with CASSIA SENNA or CASSIA ANGUSTIFOLIA see SENNA PLANT; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.76/210.91  |- mesh__dateCreated mesh__D032904 2002-07-03
% 210.76/210.91  |- skos__broader mesh__D032904smesh__D027424
% 210.76/210.91  |- skos__altLabel mesh__D032904 Cassia Tree
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D032904 2003
% 210.76/210.91  |- rdf__type mesh__D032904sskos__Concept
% 210.76/210.91  |- skos__scopeNote mesh__D032904
% 210.76/210.91       A plant species of the genus CINNAMOMUM that contains CINNAMATES and has been used in traditional Chinese medicine %28%DRUGS, CHINESE HERBAL%29%.%A%    
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D032904 2004
% 210.76/210.91  |- mesh__historyNote mesh__D032904 2003   
% 210.76/210.91  |- mesh__publicMeSHNote mesh__D032904 2003   
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D032904 2005
% 210.76/210.91  |- skos__altLabel mesh__D032904 Cassia, Chinese
% 210.76/210.91  |- skos__altLabel mesh__D032904 Cinnamomum cassia
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D032904 2006
% 210.76/210.91  |- mesh__dateEstablished mesh__D032904 2003-01-01
% 210.76/210.91  |- skos__prefLabel mesh__D032904 Cinnamomum aromaticum
% 210.76/210.91  |- skos__historyNote mesh__D018435 Membrane Proteins %28%1980-1988%29%
% 210.76/210.91  |- skos__historyNote mesh__D018435 Glycoproteins %28%1980-1987%29%
% 210.76/210.91  |- mesh__dateRevised mesh__D018435 2005-06-30
% 210.76/210.91  |- rdf__type mesh__D018435sskos__Concept
% 210.76/210.91  |- mesh__historyNote mesh__D018435 99; use P-GLYCOPROTEIN 1995-98   
% 210.76/210.91  |- skos__related mesh__D018435smesh__D018432
% 210.76/210.91  |- skos__hiddenLabel mesh__D018435 P Glycoproteins
% 210.76/210.91  |- mesh__publicMeSHNote mesh__D018435
% 210.76/210.91       99; see P-GLYCOPROTEIN 1995-98; P-GLYCOPROTEIN was indexed under CARRIER PROTEINS %26% MEMBRANE GLYCOPROTEINS 1980-94, GLYCOPROTEINS 1980-87, and MEMBRANE PROTEINS 1980-82%A%  
% 210.76/210.91  |- mesh__dateCreated mesh__D018435 1994-01-25
% 210.76/210.91  |- mesh__dateEstablished mesh__D018435 1995-01-01
% 210.76/210.91  |- skos__altLabel mesh__D018435 ATP-Binding Cassette, Sub-Family B Proteins
% 210.76/210.91  |- skos__related mesh__D018435smesh__D027425
% 210.76/210.91  |- skos__related mesh__D018435smesh__D020112
% 210.76/210.91  |- skos__related mesh__D018435smesh__D019450
% 210.76/210.91  |- skos__historyNote mesh__D018435 Membrane Glycoproteins %28%1989-1994%29%
% 210.76/210.91  |- skos__broader mesh__D018435smesh__D029365
% 210.76/210.91  |- skos__annotation mesh__D018435
% 210.76/210.91       P-GLYCOPROTEIN is also available; P stands for %22%permeability%22%%A%  
% 210.76/210.91  |- mesh__recordOriginator mesh__D018435 AGS
% 210.76/210.91  |- mesh__recordAuthorizer mesh__D018435 sjn
% 210.76/210.91  |- skos__scopeNote mesh__D018435
% 210.76/210.91       A subfamily of transmembrane proteins from the superfamily of ATP-BINDING CASSETTE TRANSPORTERS that are closely related in sequence to P-GLYCOPROTEIN.   When overexpressed, they function as ATP-dependent efflux pumps able to extrude lipophilic drugs, especially ANTINEOPLASTIC AGENTS, from cells causing multidrug resistance %28%DRUG RESISTANCE, MULTIPLE%29%. Although P-Glycoproteins share functional similarities to MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS they are two distinct subclasses of ATP-BINDING CASSETTE TRANSPORTERS, and have little sequence homology.%A%    
% 210.76/210.91  |- mesh__recordMaintainer mesh__D018435 jmp
% 210.76/210.91  |- skos__prefLabel mesh__D018435 P-Glycoproteins
% 210.76/210.91  |- skos__hiddenLabel mesh__D018435
% 210.76/210.91       ATP Binding Cassette, Sub Family B Proteins
% 210.76/210.91  |- skos__altLabel mesh__D018435 Multidrug Resistance Proteins
% 210.76/210.91  |- skos__broader mesh__D018435smesh__D018528
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D018435 2006
% 210.76/210.91  |- skos__prefLabel mesh__D010452 Peptide Biosynthesis
% 210.76/210.91  |- mesh__recordMaintainer mesh__D010452 nns
% 210.76/210.91  |- mesh__historyNote mesh__D010452 2005 %28%1998%29%   
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D010452 2006
% 210.76/210.91  |- mesh__dateRevised mesh__D010452 2004-07-07
% 210.76/210.91  |- mesh__recordAuthorizer mesh__D010452 sjn
% 210.76/210.91  |- skos__annotation mesh__D010452
% 210.76/210.91       general or unspecified; prefer specific peptide/biosyn; PROTEIN BIOSYNTHESIS and PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT are also available%A%  
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D010452 2005
% 210.76/210.91  |- mesh__dateCreated mesh__D010452 1999-01-01
% 210.76/210.91  |- mesh__recordOriginator mesh__D010452 NLM
% 210.76/210.91  |- mesh__dateEstablished mesh__D010452 1998-01-01
% 210.76/210.91  |- skos__hiddenLabel mesh__D010452 Biosynthesis, Peptide
% 210.76/210.91  |- skos__historyNote mesh__D010452 Peptides/biosynthesis %28%1966-1997%29%
% 210.76/210.91  |- skos__related mesh__D010452smesh__D014176
% 210.76/210.91  |- mesh__publicMeSHNote mesh__D010452
% 210.76/210.91       2005; see PEPTIDE SYNTHESIS 1998-2004   
% 210.76/210.91  |- skos__scopeNote mesh__D010452
% 210.76/210.91       The production of PEPTIDES or PROTEINS by the constituents of a living organism. The biosynthesis of proteins on RIBOSOMES following an RNA template is termed translation %28%TRANSLATION, GENETIC%29%. There are other, non-ribosomal peptide biosynthesis %28%PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT%29% mechanisms carried out by PEPTIDE SYNTHASES and PEPTIDYLTRANSFERASES. Further modifications of peptide chains yield functional peptide and protein molecules.%A%    
% 210.76/210.91  |- skos__broader mesh__D010452smesh__D008660
% 210.76/210.91  |- rdf__type mesh__D010452sskos__Concept
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D032106 2004
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D032106 2005
% 210.76/210.91  |- skos__scopeNote mesh__D032106
% 210.76/210.91       A plant genus of the family RUTACEAE. Most plants that are called Fagara are actually Zanthoxylum. Some members of Zanthoxylum are reclassified from ELEUTHEROCOCCUS, Melicope, and EVODIA. The twigs are used as dental brushing sticks %28%TOOTHBRUSHING%29%.%A%    
% 210.76/210.91  |- mesh__dateEstablished mesh__D032106 2003-01-01
% 210.76/210.91  |- mesh__dateCreated mesh__D032106 2002-07-03
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D032106 2003
% 210.76/210.91  |- skos__altLabel mesh__D032106 Fagara rhetza
% 210.76/210.91  |- skos__altLabel mesh__D032106 Fagara boninensis
% 210.76/210.91  |- skos__altLabel mesh__D032106 Xanthoxylum
% 210.76/210.91  |- skos__altLabel mesh__D032106 Fagara xanthoxyloides
% 210.76/210.91  |- mesh__historyNote mesh__D032106 2003   
% 210.76/210.91  |- skos__altLabel mesh__D032106 Fagara zanthoxyloides
% 210.76/210.91  |- skos__broader mesh__D032106smesh__D027821
% 210.76/210.91  |- mesh__publicMeSHNote mesh__D032106 2003   
% 210.76/210.91  |- skos__prefLabel mesh__D032106 Zanthoxylum
% 210.76/210.91  |- skos__annotation mesh__D032106
% 210.76/210.91       note FAGARA X refs: FAGARA see RUTACEAE and FAGARA HORRIDA see GLEDITSIA are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D032106 2006
% 210.76/210.91  |- rdf__type mesh__D032106sskos__Concept
% 210.76/210.91  |- skos__hiddenLabel mesh__D004415 Indigestions
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D004415 2001
% 210.76/210.91  |- skos__broader mesh__D004415smesh__D012817
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D004415 2000
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D004415 2004
% 210.76/210.91  |- mesh__dateCreated mesh__D004415 1999-01-01
% 210.76/210.91  |- mesh__recordAuthorizer mesh__D004415 sjn
% 210.76/210.91  |- mesh__recordOriginator mesh__D004415 NLM
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D004415 2003
% 210.76/210.91  |- skos__altLabel mesh__D004415 Indigestion
% 210.76/210.91  |- mesh__recordMaintainer mesh__D004415 KEV
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D004415 2002
% 210.76/210.91  |- skos__hiddenLabel mesh__D004415 Dyspepsias
% 210.76/210.91  |- skos__prefLabel mesh__D004415 Dyspepsia
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D004415 2006
% 210.76/210.91  |- rdf__type mesh__D004415sskos__Concept
% 210.76/210.91  |- skos__scopeNote mesh__D004415
% 210.76/210.91       Impaired digestion, especially after eating.     
% 210.76/210.91  |- mesh__dateRevised mesh__D004415 1999-11-04
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D004415 2005
% 210.76/210.91  |- skos__broader mesh__D009100smesh__D002239
% 210.76/210.91  |- skos__hiddenLabel mesh__D009100 Multiple Carboxylase Deficiencies
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D009100 2006
% 210.76/210.91  |- skos__hiddenLabel mesh__D009100 Carboxylase Deficiencies, Multiple
% 210.76/210.91  |- mesh__dateRevised mesh__D009100 2001-07-25
% 210.76/210.91  |- mesh__publicMeSHNote mesh__D009100 87   
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D009100 2005
% 210.76/210.91  |- skos__historyNote mesh__D009100
% 210.76/210.91       specific enzyme/deficiency %28%1975-1986%29%
% 210.76/210.91  |- skos__altLabel mesh__D009100 Combined Carboxylase Deficiency
% 210.76/210.91  |- skos__historyNote mesh__D009100 specific enzyme %28%1966-1974%29%
% 210.76/210.91  |- mesh__dateEstablished mesh__D009100 1987-01-01
% 210.76/210.91  |- mesh__recordMaintainer mesh__D009100 nns
% 210.76/210.91  |- skos__hiddenLabel mesh__D009100 Deficiencies, Multiple Carboxylase
% 210.76/210.91  |- rdf__type mesh__D009100sskos__Concept
% 210.76/210.91  |- skos__hiddenLabel mesh__D009100 Deficiencies, Combined Carboxylase
% 210.76/210.91  |- skos__scopeNote mesh__D009100
% 210.76/210.91       A deficiency in the activities of biotin-dependent enzymes %28%propionyl-CoA carboxylase, methylcrotonyl-CoA carboxylase, and PYRUVATE CARBOXYLASE%29% due to one of two defects in BIOTIN metabolism. The neonatal form is due to HOLOCARBOXYLASE SYNTHETASE DEFICIENCY. The late-onset form is due to BIOTINIDASE DEFICIENCY.%A%    
% 210.76/210.91  |- mesh__dateCreated mesh__D009100 1986-04-18
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D009100 2002
% 210.76/210.91  |- mesh__recordOriginator mesh__D009100 VDK
% 210.76/210.91  |- skos__related mesh__D009100smesh__D001710
% 210.76/210.91  |- mesh__recordAuthorizer mesh__D009100 sjn
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D009100 2004
% 210.76/210.91  |- skos__hiddenLabel mesh__D009100 Combined Carboxylase Deficiencies
% 210.76/210.91  |- skos__altLabel mesh__D009100 Carboxylase Deficiency, Combined
% 210.76/210.91  |- skos__hiddenLabel mesh__D009100 Carboxylase Deficiencies, Combined
% 210.76/210.91  |- skos__altLabel mesh__D009100 Deficiency, Multiple Carboxylase
% 210.76/210.91  |- mesh__historyNote mesh__D009100 87   
% 210.76/210.91  |- skos__prefLabel mesh__D009100 Multiple Carboxylase Deficiency
% 210.76/210.91  |- skos__altLabel mesh__D009100 Carboxylase Deficiency, Multiple
% 210.76/210.91  |- mesh__activeMeSHYear mesh__D009100 2003
% 210.76/210.91  |- skos__broader mesh__D009100smesh__D000592
% 210.76/210.91  |- skos__altLabel mesh__D009100 Deficiency, Combined Carboxylase
% 210.76/210.91  |- skos__broader mesh__D020880smesh__D009414
% 210.76/210.91  |- skos__scopeNote mesh__D020880
% 210.76/210.91       A family of peptides originally found as factors that stimulate the phosphorylation of the erbB-2 receptor %28%RECEPTORS, ERBB-2%29%. Multiple variant forms of NEUREGULINS occur due to alternative splicing of their mRNAs. The NEUREGULINS include products from the three known genes %28%NGR1; NGR2 and NGR3%29%.%A%    
% 210.76/210.91  |- skos__annotation mesh__D020880 GEN: prefer specifics   
% 210.76/210.91  |- mesh__publicMeSHNote mesh__D020880
% 210.76/210.91       2000; NEURONAL DIFFERENTIATION FACTOR, CHOLINERGIC %28%now NEUREGULINS%29% was indexed under GLYCOPROTEINS 1986-1999%A%  
% 210.76/210.91  |- mesh__recordOriginator mesh__D020880 jmp
% 210.77/210.91  |- skos__prefLabel mesh__D020880 Neuregulins
% 210.77/210.91  |- skos__broader mesh__D020880smesh__D036341
% 210.77/210.91  |- mesh__dateEstablished mesh__D020880 2000-01-01
% 210.77/210.91  |- mesh__historyNote mesh__D020880
% 210.77/210.91       2000; use NEUREGULINS %28%NM%29% 1986-1999   
% 210.77/210.91  |- mesh__dateRevised mesh__D020880 2005-06-30
% 210.77/210.91  |- mesh__recordAuthorizer mesh__D020880 sjn
% 210.77/210.91  |- mesh__activeMeSHYear mesh__D020880 2006
% 210.77/210.91  |- skos__historyNote mesh__D020880 Glycoproteins %28%1986-1999%29%
% 210.77/210.91  |- mesh__dateCreated mesh__D020880 1999-11-04
% 210.77/210.91  |- rdf__type mesh__D020880sskos__Concept
% 210.77/210.91  |- skos__related mesh__D020880smesh__D018719
% 210.77/210.91  |- mesh__recordMaintainer mesh__D020880 ssb
% 210.77/210.91  |- skos__broader mesh__D020880smesh__D006133
% 210.77/210.91  |- skos__altLabel mesh__D020880 NRG Proteins
% 210.77/210.91  |- mesh__dateRevised mesh__D020082 2005-06-30
% 210.77/210.91  |- mesh__recordAuthorizer mesh__D020082 sjn
% 210.77/210.91  |- skos__broader mesh__D020082smesh__D001203
% 210.77/210.91  |- mesh__recordOriginator mesh__D020082 AGS
% 210.77/210.91  |- skos__prefLabel mesh__D020082 Magnaporthe
% 210.77/210.91  |- mesh__dateEstablished mesh__D020082 1999-01-01
% 210.77/210.91  |- mesh__publicMeSHNote mesh__D020082 99   
% 210.77/210.91  |- skos__scopeNote mesh__D020082
% 210.77/210.91       A genus of FUNGI, in the family Magnaporthaceae of uncertain position %28%incertae sedis%29%. It is best known for its species, M. grisea, which is one of the most popular experimental organisms of all fungal plant pathogens.%A%    
% 210.77/210.91  |- mesh__recordMaintainer mesh__D020082 ags
% 210.77/210.91  |- mesh__dateCreated mesh__D020082 1998-06-10
% 210.77/210.91  |- mesh__historyNote mesh__D020082 99   
% 210.77/210.91  |- mesh__activeMeSHYear mesh__D020082 2006
% 210.77/210.91  |- skos__historyNote mesh__D020082 Ascomycota %28%1990-1998%29%
% 210.77/210.91  |- rdf__type mesh__D020082sskos__Concept
% 210.77/210.91  |- mesh__activeMeSHYear mesh__D014843 2000
% 210.77/210.91  |- rdf__type mesh__D014843sskos__Concept
% 210.77/210.91  |- mesh__activeMeSHYear mesh__D014843 2003
% 210.77/210.91  |- mesh__dateEstablished mesh__D014843 1991-01-01
% 210.77/210.91  |- mesh__recordAuthorizer mesh__D014843 SJN
% 210.77/210.91  |- mesh__activeMeSHYear mesh__D014843 1999
% 210.77/210.91  |- skos__broader mesh__D014843smesh__D010262
% 210.77/210.91  |- mesh__recordOriginator mesh__D014843 NLM
% 210.77/210.91  |- skos__scopeNote mesh__D014843
% 210.77/210.91       A paraphilia characterized by repetitive looking at unsuspecting people, usually strangers, who are either naked, in the act of disrobing, or engaging in sexual activity, as the method for achieving sexual excitement.%A%    
% 210.77/210.91  |- skos__prefLabel mesh__D014843 Voyeurism
% 210.77/210.91  |- mesh__historyNote mesh__D014843
% 210.77/210.91       91%28%75%29%; was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1968-80%A%  
% 210.77/210.91  |- mesh__activeMeSHYear mesh__D014843 2006
% 210.77/210.91  |- skos__hiddenLabel mesh__D014843 Voyeurisms
% 210.77/210.91  |- mesh__activeMeSHYear mesh__D014843 2002
% 210.77/210.91  |- mesh__activeMeSHYear mesh__D014843 2005
% 210.77/210.91  |- mesh__activeMeSHYear mesh__D014843 2001
% 210.77/210.91  |- mesh__dateCreated mesh__D014843 1999-01-01
% 210.77/210.91  |- mesh__activeMeSHYear mesh__D014843 2004
% 210.77/210.91  |- mesh__recordMaintainer mesh__D014843 JLS
% 210.77/210.91  |- mesh__onlineNote mesh__D014843 search PARAPHILIAS 1968-74   
% 210.77/210.91  |- mesh__dateRevised mesh__D014843 1998-06-11
% 210.77/210.91  |- mesh__publicMeSHNote mesh__D014843
% 210.77/210.91       91; was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1968-80%A%  
% 210.77/210.91  |- skos__hiddenLabel mesh__D008806 AKR Mouse, Inbred
% 210.77/210.91  |- skos__hiddenLabel mesh__D008806 AKR Mouse
% 210.77/210.91  |- skos__hiddenLabel mesh__D008806 AKR Mice, Inbred
% 210.77/210.91  |- mesh__activeMeSHYear mesh__D008806 2006
% 210.77/210.91  |- skos__prefLabel mesh__D008806 Mice, Inbred AKR
% 210.77/210.91  |- mesh__historyNote mesh__D008806 74%28%72%29%   
% 210.77/210.91  |- skos__hiddenLabel mesh__D008806 Inbred AKR Mouse
% 210.77/210.91  |- skos__broader mesh__D008806smesh__D008815
% 210.77/210.91  |- skos__hiddenLabel mesh__D008806 Inbred AKR Mice
% 210.77/210.91  |- rdf__type mesh__D008806sskos__Concept
% 210.77/210.91  |- mesh__recordMaintainer mesh__D008806 ags
% 210.77/210.91  |- skos__annotation mesh__D008806
% 210.77/210.91       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%  
% 210.77/210.91  |- mesh__dateRevised mesh__D008806 2005-06-30
% 210.77/210.91  |- skos__hiddenLabel mesh__D008806 AKR Mice
% 210.77/210.91  |- skos__altLabel mesh__D008806 Mice, AKR
% 210.77/210.91  |- mesh__recordOriginator mesh__D008806 NLM
% 210.77/210.91  |- mesh__dateEstablished mesh__D008806 1974-01-01
% 210.77/210.91  |- skos__historyNote mesh__D008806 Mice %28%1966-1971%29%
% 210.77/210.91  |- mesh__recordAuthorizer mesh__D008806 sjn
% 210.77/210.91  |- skos__altLabel mesh__D008806 Mouse, AKR
% 210.77/210.91  |- skos__altLabel mesh__D008806 Mouse, Inbred AKR
% 210.77/210.91  |- mesh__publicMeSHNote mesh__D008806 74   
% 210.77/210.91  |- mesh__dateCreated mesh__D008806 1999-01-01
% 210.77/210.91  |- mesh__activeMeSHYear mesh__D000823 1994
% 210.77/210.91  |- rdf__type mesh__D000823sskos__Concept
% 210.77/210.91  |- mesh__recordAuthorizer mesh__D000823 PLS
% 210.77/210.91  |- mesh__dateRevised mesh__D000823 1992-05-26
% 210.77/210.91  |- mesh__historyNote mesh__D000823 78   
% 210.77/210.91  |- mesh__activeMeSHYear mesh__D000823 2006
% 210.77/210.91  |- mesh__activeMeSHYear mesh__D000823 2003
% 210.77/210.91  |- skos__hiddenLabel mesh__D000823 Systems, Animal Identification
% 210.77/210.91  |- skos__hiddenLabel mesh__D000823 Animal Identification System
% 210.77/210.91  |- mesh__activeMeSHYear mesh__D000823 1997
% 210.77/210.91  |- mesh__publicMeSHNote mesh__D000823 78   
% 210.77/210.92  |- mesh__dateEstablished mesh__D000823 1978-01-01
% 210.77/210.92  |- skos__scopeNote mesh__D000823
% 210.77/210.92       Procedures for recognizing individual animals and certain identifiable characteristics pertaining to them; includes computerized methods, ear tags, etc.%A%    
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000823 2002
% 210.77/210.92  |- mesh__dateCreated mesh__D000823 1977-05-12
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000823 2005
% 210.77/210.92  |- skos__prefLabel mesh__D000823 Animal Identification Systems
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000823 1999
% 210.77/210.92  |- mesh__recordMaintainer mesh__D000823 TAP
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000823 1996
% 210.77/210.92  |- skos__hiddenLabel mesh__D000823 Identification System, Animal
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000823 2001
% 210.77/210.92  |- skos__broader mesh__D000823smesh__D008919
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000823 1993
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000823 2000
% 210.77/210.92  |- skos__hiddenLabel mesh__D000823 Identification Systems, Animal
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000823 1998
% 210.77/210.92  |- mesh__recordOriginator mesh__D000823 EC
% 210.77/210.92  |- skos__annotation mesh__D000823
% 210.77/210.92       does not include classif or taxonomy: for individual animals only%A%  
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000823 1995
% 210.77/210.92  |- skos__hiddenLabel mesh__D000823 System, Animal Identification
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000823 2004
% 210.77/210.92  |- skos__altLabel mesh__D008008 Nursing Licensures
% 210.77/210.92  |- skos__annotation mesh__D008008
% 210.77/210.92       by the state; differentiate from ACCREDITATION %28%by the profession%29%; IM; various boards can go here; specify geog; DF: LICENSURE NURS%A%  
% 210.77/210.92  |- skos__prefLabel mesh__D008008 Licensure, Nursing
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D008008 2004
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D008008 2000
% 210.77/210.92  |- skos__broader mesh__D008008smesh__D008004
% 210.77/210.92  |- mesh__dateEstablished mesh__D008008 1966-01-01
% 210.77/210.92  |- mesh__recordAuthorizer mesh__D008008 sjn
% 210.77/210.92  |- mesh__publicMeSHNote mesh__D008008 66   
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D008008 2003
% 210.77/210.92  |- skos__scopeNote mesh__D008008
% 210.77/210.92       The granting of a license to practice the profession of nursing.%A%    
% 210.77/210.92  |- mesh__recordOriginator mesh__D008008 NLM
% 210.77/210.92  |- rdf__type mesh__D008008sskos__Concept
% 210.77/210.92  |- mesh__recordMaintainer mesh__D008008 kle
% 210.77/210.92  |- skos__altLabel mesh__D008008 Nursing Licensure
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D008008 2006
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D008008 2002
% 210.77/210.92  |- mesh__dateRevised mesh__D008008 1999-11-03
% 210.77/210.92  |- skos__altLabel mesh__D008008 Licensures, Nursing
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D008008 2005
% 210.77/210.92  |- mesh__dateCreated mesh__D008008 1999-01-01
% 210.77/210.92  |- mesh__historyNote mesh__D008008 66   
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D008008 2001
% 210.77/210.92  |- mesh__dateCreated mesh__D000025 1974-11-19
% 210.77/210.92  |- mesh__recordOriginator mesh__D000025 NLM
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000025 2005
% 210.77/210.92  |- skos__altLabel mesh__D000025 Eugenic Abortion
% 210.77/210.92  |- skos__hiddenLabel mesh__D000025 Selective Abortions
% 210.77/210.92  |- skos__hiddenLabel mesh__D000025 Abortions, Eugenic
% 210.77/210.92  |- mesh__dateRevised mesh__D000025 2004-07-13
% 210.77/210.92  |- rdf__type mesh__D000025sskos__Concept
% 210.77/210.92  |- mesh__dateEstablished mesh__D000025 1991-01-01
% 210.77/210.92  |- skos__hiddenLabel mesh__D000025 Abortions, Selective
% 210.77/210.92  |- skos__altLabel mesh__D000025 Selective Abortion
% 210.77/210.92  |- skos__broader mesh__D000025smesh__D000028
% 210.77/210.92  |- mesh__recordMaintainer mesh__D000025 sjn
% 210.77/210.92  |- skos__prefLabel mesh__D000025 Abortion, Eugenic
% 210.77/210.92  |- mesh__historyNote mesh__D000025
% 210.77/210.92       91%28%75%29%; was see under ABORTION, INDUCED 1975-90   
% 210.77/210.92  |- mesh__publicMeSHNote mesh__D000025
% 210.77/210.92       91; was see under ABORTION, INDUCED 1975-90   
% 210.77/210.92  |- skos__annotation mesh__D000025
% 210.77/210.92        do not use /util except by MeSH definition; don%27%t forget also check tags  HUMANS or ANIMALS %26% FEMALE %26% PREGNANCY%A%  
% 210.77/210.92  |- mesh__recordAuthorizer mesh__D000025 sjn
% 210.77/210.92  |- skos__scopeNote mesh__D000025
% 210.77/210.92       Abortion performed because of possible fetal defects.     
% 210.77/210.92  |- skos__hiddenLabel mesh__D000025 Eugenic Abortions
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000025 2006
% 210.77/210.92  |- rdf__type mesh__D018436sskos__Concept
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D018436 2003
% 210.77/210.92  |- mesh__recordMaintainer mesh__D018436 TGC
% 210.77/210.92  |- skos__prefLabel mesh__D018436 Ancient Lands
% 210.77/210.92  |- mesh__historyNote mesh__D018436 98; use explode 1995-97   
% 210.77/210.92  |- skos__scopeNote mesh__D018436
% 210.77/210.92       Geographical sites known to be extant in a remote period in the history of civilization, familiar as the names of ancient countries and empires.%A%    
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D018436 1999
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D018436 2001
% 210.77/210.92  |- skos__broader mesh__D018436smesh__D017516
% 210.77/210.92  |- skos__annotation mesh__D018436
% 210.77/210.92       %22%ancient%22% refers to a far-past date or period; GEN or unspecified ancient countries or empires; prefer specifics; use historical tags%A%  
% 210.77/210.92  |- mesh__recordOriginator mesh__D018436 TGC
% 210.77/210.92  |- mesh__dateRevised mesh__D018436 1997-06-20
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D018436 1998
% 210.77/210.92  |- skos__historyNote mesh__D018436
% 210.77/210.92       specific geographic location %28%1966-1997%29%
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D018436 2000
% 210.77/210.92  |- mesh__dateEstablished mesh__D018436 1998-01-01
% 210.77/210.92  |- mesh__recordAuthorizer mesh__D018436 SJN
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D018436 2006
% 210.77/210.92  |- mesh__dateCreated mesh__D018436 1994-04-19
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D018436 2004
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D018436 2005
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D018436 2002
% 210.77/210.92  |- mesh__recordOriginator mesh__D010453 NLM
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D010453 2005
% 210.77/210.92  |- mesh__historyNote mesh__D010453 98%28%73%29%   
% 210.77/210.92  |- mesh__recordMaintainer mesh__D010453 nns
% 210.77/210.92  |- mesh__dateCreated mesh__D010453 1999-01-01
% 210.77/210.92  |- skos__prefLabel mesh__D010453 Peptide Synthases
% 210.77/210.92  |- skos__scopeNote mesh__D010453
% 210.77/210.92       Ligases that catalyze the joining of adjacent AMINO ACIDS by the formation of carbon-nitrogen bonds between their carboxylic acid groups and amine groups.%A%    
% 210.77/210.92  |- skos__altLabel mesh__D010453 Acid-Amino-Acid Ligases
% 210.77/210.92  |- mesh__dateEstablished mesh__D010453 1973-01-01
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D010453 2006
% 210.77/210.92  |- skos__hiddenLabel mesh__D010453 Synthases, Peptide
% 210.77/210.92  |- skos__altLabel mesh__D010453 Peptide Synthetases
% 210.77/210.92  |- skos__hiddenLabel mesh__D010453 Ligases, Acid-Amino-Acid
% 210.77/210.92  |- skos__broader mesh__D010453smesh__D019731
% 210.77/210.92  |- skos__hiddenLabel mesh__D010453 Acid Amino Acid Ligases
% 210.77/210.92  |- skos__historyNote mesh__D010453 Ligases %28%1966-1972%29%
% 210.77/210.92  |- skos__hiddenLabel mesh__D010453 Synthetases, Peptide
% 210.77/210.92  |- mesh__recordAuthorizer mesh__D010453 sjn
% 210.77/210.92  |- mesh__publicMeSHNote mesh__D010453
% 210.77/210.92       98%28%73%29%; see PEPTIDE SYNTHETASES 1973-97   
% 210.77/210.92  |- mesh__dateRevised mesh__D010453 2004-07-07
% 210.77/210.92  |- rdf__type mesh__D010453sskos__Concept
% 210.77/210.92  |- mesh__historyNote mesh__D032107 2003   
% 210.77/210.92  |- skos__prefLabel mesh__D032107 Populus
% 210.77/210.92  |- skos__altLabel mesh__D032107 Poplar, Black
% 210.77/210.92  |- skos__scopeNote mesh__D032107
% 210.77/210.92       A plant genus of the family SALICACEAE. Balm of Gilead is a common name used for P. candicans, or P. gileadensis, or P. jackii, and sometimes also used for ABIES BALSAMEA or for COMMIPHORA.%A%    
% 210.77/210.92  |- mesh__publicMeSHNote mesh__D032107 2003   
% 210.77/210.92  |- mesh__dateEstablished mesh__D032107 2003-01-01
% 210.77/210.92  |- skos__altLabel mesh__D032107 Cottonwood
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D032107 2006
% 210.77/210.92  |- rdf__type mesh__D032107sskos__Concept
% 210.77/210.92  |- mesh__dateCreated mesh__D032107 2002-07-03
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D032107 2004
% 210.77/210.92  |- skos__annotation mesh__D032107
% 210.77/210.92       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.77/210.92  |- skos__altLabel mesh__D032107 Poplar, True
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D032107 2005
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D032107 2003
% 210.77/210.92  |- skos__broader mesh__D032107smesh__D029629
% 210.77/210.92  |- skos__altLabel mesh__D032107 Poplar, Balsam
% 210.77/210.92  |- skos__altLabel mesh__D004416 B-K Mole Syndrome
% 210.77/210.92  |- mesh__dateEstablished mesh__D004416 1987-01-01
% 210.77/210.92  |- mesh__recordOriginator mesh__D004416 VDK
% 210.77/210.92  |- skos__broader mesh__D004416smesh__D009506
% 210.77/210.92  |- skos__altLabel mesh__D004416 Nevus, Dysplastic
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D004416 2004
% 210.77/210.92  |- mesh__publicMeSHNote mesh__D004416 87   
% 210.77/210.92  |- skos__historyNote mesh__D004416 Nevus %28%1966-1986%29%
% 210.77/210.92  |- skos__hiddenLabel mesh__D004416 B K Mole Syndrome
% 210.77/210.92  |- skos__prefLabel mesh__D004416 Dysplastic Nevus Syndrome
% 210.77/210.92  |- skos__scopeNote mesh__D004416
% 210.77/210.92       Clinically atypical nevi %28%usually exceeding 5 mm in diameter and having variable pigmentation and ill defined borders%29% with an increased risk for development of non-familial cutaneous malignant melanoma. Biopsies show melanocytic dysplasia. Nevi are clinically and histologically identical to the precursor lesions for melanoma in the B-K mole syndrome. %28%Stedman, 25th ed%29%%A%    
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D004416 2003
% 210.77/210.92  |- mesh__historyNote mesh__D004416 87   
% 210.77/210.92  |- skos__altLabel mesh__D004416 Nevus Syndrome, Dysplastic
% 210.77/210.92  |- skos__historyNote mesh__D004416 Melanoma %28%1966-1986%29%
% 210.77/210.92  |- skos__hiddenLabel mesh__D004416 Familial Atypical Multiple Mole Melanoma
% 210.77/210.92  |- mesh__recordMaintainer mesh__D004416 nns
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D004416 2006
% 210.77/210.92  |- mesh__dateCreated mesh__D004416 1986-04-18
% 210.77/210.92  |- rdf__type mesh__D004416sskos__Concept
% 210.77/210.92  |- skos__broader mesh__D004416smesh__D009386
% 210.77/210.92  |- skos__hiddenLabel mesh__D004416 Syndrome, Dysplastic Nevus
% 210.77/210.92  |- mesh__recordAuthorizer mesh__D004416 sjn
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D004416 2005
% 210.77/210.92  |- skos__hiddenLabel mesh__D004416 Nevi, Dysplastic
% 210.77/210.92  |- mesh__dateRevised mesh__D004416 2001-07-25
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D004416 2002
% 210.77/210.92  |- skos__hiddenLabel mesh__D004416 Syndrome, B-K Mole
% 210.77/210.92  |- skos__hiddenLabel mesh__D004416 Dysplastic Nevus
% 210.77/210.92  |- skos__annotation mesh__D004416
% 210.77/210.92       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 210.77/210.92  |- skos__historyNote mesh__D004416 Nevus, Pigmented %28%1966-1986%29%
% 210.77/210.92  |- mesh__recordAuthorizer mesh__D009101 sjn
% 210.77/210.92  |- skos__annotation mesh__D009101
% 210.77/210.92       myeloma unspecified is probably MULTIPLE MYELOMA; solitary myeloma = PLASMACYTOMA%A%  
% 210.77/210.92  |- mesh__recordMaintainer mesh__D009101 jmp
% 210.77/210.92  |- skos__hiddenLabel mesh__D009101 Myeloma, Plasma Cell
% 210.77/210.92  |- skos__hiddenLabel mesh__D009101 Myelomas, Plasma-Cell
% 210.77/210.92  |- rdf__type mesh__D009101sskos__Concept
% 210.77/210.92  |- skos__broader mesh__D009101smesh__D010265
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D009101 2004
% 210.77/210.92  |- skos__related mesh__D009101smesh__D009194
% 210.77/210.92  |- skos__hiddenLabel mesh__D009101 Plasma-Cell Myeloma
% 210.77/210.92  |- skos__broader mesh__D009101smesh__D010954
% 210.77/210.92  |- skos__hiddenLabel mesh__D009101 Myelomas, Multiple
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D009101 2001
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D009101 2003
% 210.77/210.92  |- skos__broader mesh__D009101smesh__D020141
% 210.77/210.92  |- mesh__dateCreated mesh__D009101 1999-01-01
% 210.77/210.92  |- skos__altLabel mesh__D009101 Myeloma, Plasma-Cell
% 210.77/210.92  |- skos__hiddenLabel mesh__D009101 Myeloma, Multiple
% 210.77/210.92  |- skos__scopeNote mesh__D009101
% 210.77/210.92       A malignant tumor of plasma cells usually arising in the bone marrow; characterized by diffuse involvement of the skeletal system, hyperglobulinemia, Bence-Jones proteinuria, and anemia.%A%    
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D009101 2006
% 210.77/210.92  |- skos__hiddenLabel mesh__D009101 Plasma-Cell Myelomas
% 210.77/210.92  |- mesh__recordOriginator mesh__D009101 NLM
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D009101 2005
% 210.77/210.92  |- skos__hiddenLabel mesh__D009101 Multiple Myelomas
% 210.77/210.92  |- skos__prefLabel mesh__D009101 Multiple Myeloma
% 210.77/210.92  |- mesh__dateRevised mesh__D009101 2000-06-22
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D009101 2002
% 210.77/210.92  |- skos__hiddenLabel mesh__D020881 Bis Pen Enkephalin
% 210.77/210.92  |- skos__hiddenLabel mesh__D020881 D Pen2, L Pen5 Enkephalin
% 210.77/210.92  |- mesh__dateEstablished mesh__D020881 2000-01-01
% 210.77/210.92  |- mesh__publicMeSHNote mesh__D020881
% 210.77/210.92       2000; ENKEPHALIN, PEN%28%2,5%29%- %28%now ENKEPHALIN, D-PENICILLAMINE %28%2,5%29%-%29% was indexed under ENKEPHALINS 1983-1999%A%  
% 210.77/210.92  |- skos__altLabel mesh__D020881 Bis-Pen-Enkephalin
% 210.77/210.92  |- skos__scopeNote mesh__D020881
% 210.77/210.92       A disulfide opioid pentapeptide that selectively binds to the DELTA OPIOID RECEPTOR. It possesses antinociceptive activity.%A%    
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D020881 2006
% 210.77/210.92  |- skos__hiddenLabel mesh__D020881 D Pen2, D Pen5 Enkephalin
% 210.77/210.92  |- mesh__historyNote mesh__D020881
% 210.77/210.92       2000; use ENKEPHALIN, D-PENICILLAMINE %28%2,5%29%- %28%NM%29% 1983-1999%A%  
% 210.77/210.92  |- skos__historyNote mesh__D020881 Enkephalins %28%1983-1999%29%
% 210.77/210.92  |- skos__altLabel mesh__D020881 DPLPE
% 210.77/210.92  |- rdf__type mesh__D020881sskos__Concept
% 210.77/210.92  |- mesh__recordOriginator mesh__D020881 adp
% 210.77/210.92  |- skos__hiddenLabel mesh__D020881 L-Pen5-Enkephalin D-Pen2
% 210.77/210.92  |- skos__altLabel mesh__D020881 DPDPE%28%SH%29%2
% 210.77/210.92  |- skos__altLabel mesh__D020881 Enkephalin, Penicillamine %28%2,5%29%-
% 210.77/210.92  |- skos__altLabel mesh__D020881 D-Penicillamine %28%2,5%29%-Enkephalin
% 210.77/210.92  |- mesh__dateCreated mesh__D020881 1999-11-08
% 210.77/210.92  |- mesh__dateRevised mesh__D020881 2005-06-30
% 210.77/210.92  |- mesh__recordAuthorizer mesh__D020881 sjn
% 210.77/210.92  |- skos__altLabel mesh__D020881 Enkephalin, Pen%28%2,5%29%-
% 210.77/210.92  |- skos__hiddenLabel mesh__D020881 D-Pen5-Enkephalin D-Pen2
% 210.77/210.92  |- skos__hiddenLabel mesh__D020881 Bis Penicillamine Enkephalin
% 210.77/210.92  |- skos__prefLabel mesh__D020881 Enkephalin, D-Penicillamine %28%2,5%29%-
% 210.77/210.92  |- skos__altLabel mesh__D020881 DPDPE
% 210.77/210.92  |- skos__broader mesh__D020881smesh__D004745
% 210.77/210.92  |- mesh__recordMaintainer mesh__D020881 ssb
% 210.77/210.92  |- skos__altLabel mesh__D020881 D-Pen2, D-Pen5-Enkephalin
% 210.77/210.92  |- skos__altLabel mesh__D020083 SAPHO Syndrome
% 210.77/210.92  |- mesh__historyNote mesh__D020083 99   
% 210.77/210.92  |- mesh__publicMeSHNote mesh__D020083 99   
% 210.77/210.92  |- skos__hiddenLabel mesh__D020083 Syndrome, SAPHO
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D020083 2002
% 210.77/210.92  |- skos__hiddenLabel mesh__D020083 Hyperostosis Syndromes, Acquired
% 210.77/210.92  |- skos__hiddenLabel mesh__D020083 Syndrome, Acquired Hyperostosis
% 210.77/210.92  |- skos__hiddenLabel mesh__D020083 Syndromes, SAPHO
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D020083 2003
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D020083 2005
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D020083 1999
% 210.77/210.92  |- mesh__dateEstablished mesh__D020083 1999-01-01
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D020083 2004
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D020083 2006
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D020083 2000
% 210.77/210.92  |- skos__hiddenLabel mesh__D020083 Acquired Hyperostosis Syndromes
% 210.77/210.92  |- skos__broader mesh__D020083smesh__D010009
% 210.77/210.92  |- skos__hiddenLabel mesh__D020083 Syndromes, Acquired Hyperostosis
% 210.77/210.92  |- rdf__type mesh__D020083sskos__Concept
% 210.77/210.92  |- skos__scopeNote mesh__D020083
% 210.77/210.92       Syndrome consisting of synovitis, acne, palmoplantar pustulosis, hyperostosis, and osteitis %28%SAPHO%29%. The most common site of the disease is the upper anterior chest wall, characterized by predominantly osteosclerotic lesions, hyperostosis, and arthritis of the adjacent joints. The association of sterile inflammatory bone lesions and neutrophilic skin eruptions is indicative of this syndrome.%A%    
% 210.77/210.92  |- skos__prefLabel mesh__D020083 Acquired Hyperostosis Syndrome
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D020083 2001
% 210.77/210.92  |- mesh__dateCreated mesh__D020083 1998-06-10
% 210.77/210.92  |- skos__hiddenLabel mesh__D020083 SAPHO Syndromes
% 210.77/210.92  |- skos__hiddenLabel mesh__D020083 Hyperostosis Syndrome, Acquired
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D014844 2006
% 210.77/210.92  |- skos__prefLabel mesh__D014844 Vulva
% 210.77/210.92  |- skos__annotation mesh__D014844 inflammation = VULVITIS   
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D014844 2005
% 210.77/210.92  |- mesh__dateRevised mesh__D014844 2004-07-07
% 210.77/210.92  |- mesh__dateCreated mesh__D014844 1999-01-01
% 210.77/210.92  |- skos__broader mesh__D014844smesh__D005836
% 210.77/210.92  |- mesh__recordMaintainer mesh__D014844 lkt
% 210.77/210.92  |- rdf__type mesh__D014844sskos__Concept
% 210.77/210.92  |- skos__scopeNote mesh__D014844
% 210.77/210.92       The external genitalia of the female. It includes the CLITORIS, the labia, the vestibule, and its glands.%A%    
% 210.77/210.92  |- skos__hiddenLabel mesh__D014844 Vulvas
% 210.77/210.92  |- mesh__recordAuthorizer mesh__D014844 sjn
% 210.77/210.92  |- mesh__recordOriginator mesh__D014844 NLM
% 210.77/210.92  |- skos__altLabel mesh__D014046 Tolmetin Sodium, Dihydrate
% 210.77/210.92  |- mesh__dateRevised mesh__D014046 2005-06-30
% 210.77/210.92  |- mesh__recordMaintainer mesh__D014046 ssb
% 210.77/210.92  |- skos__scopeNote mesh__D014046
% 210.77/210.92       A non-steroidal anti-inflammatory agent %28%ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL%29% similar in mode of action to INDOMETHACIN.%A%    
% 210.77/210.92  |- skos__hiddenLabel mesh__D014046 McN2559
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D014046 2006
% 210.77/210.92  |- mesh__publicMeSHNote mesh__D014046 90; was see under PYRROLES 1976-89   
% 210.77/210.92  |- skos__historyNote mesh__D014046 Pyrroles %28%1973-1975%29%
% 210.77/210.92  |- skos__hiddenLabel mesh__D014046 McN 2559
% 210.77/210.92  |- skos__hiddenLabel mesh__D014046 Dihydrate Tolmetin Sodium
% 210.77/210.92  |- mesh__recordAuthorizer mesh__D014046 sjn
% 210.77/210.92  |- mesh__historyNote mesh__D014046
% 210.77/210.92       90%28%76%29%; was see under PYRROLES 1976-89   
% 210.77/210.92  |- skos__historyNote mesh__D014046 Benzoates %28%1973-1975%29%
% 210.77/210.92  |- mesh__dateEstablished mesh__D014046 1990-01-01
% 210.77/210.92  |- mesh__dateCreated mesh__D014046 1975-07-25
% 210.77/210.92  |- skos__broader mesh__D014046smesh__D011758
% 210.77/210.92  |- skos__hiddenLabel mesh__D014046 Anhydrous Tolmetin Sodium
% 210.77/210.92  |- rdf__type mesh__D014046sskos__Concept
% 210.77/210.92  |- mesh__recordOriginator mesh__D014046 SH
% 210.77/210.92  |- skos__prefLabel mesh__D014046 Tolmetin
% 210.77/210.92  |- skos__altLabel mesh__D008807 Inbred BALB C Mice
% 210.77/210.92  |- mesh__historyNote mesh__D008807 74%28%72%29%   
% 210.77/210.92  |- skos__altLabel mesh__D008807 BALB C Mouse, Inbred
% 210.77/210.92  |- skos__hiddenLabel mesh__D008807 BALB C Mouse
% 210.77/210.92  |- mesh__recordAuthorizer mesh__D008807 sjn
% 210.77/210.92  |- skos__altLabel mesh__D008807 Mouse, BALB C
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D008807 2006
% 210.77/210.92  |- mesh__dateCreated mesh__D008807 1999-01-01
% 210.77/210.92  |- mesh__recordMaintainer mesh__D008807 ags
% 210.77/210.92  |- skos__altLabel mesh__D008807 Inbred BALB C Mouse
% 210.77/210.92  |- skos__altLabel mesh__D008807 Mouse, Inbred BALB C
% 210.77/210.92  |- rdf__type mesh__D008807sskos__Concept
% 210.77/210.92  |- mesh__publicMeSHNote mesh__D008807 74   
% 210.77/210.92  |- skos__broader mesh__D008807smesh__D008815
% 210.77/210.92  |- skos__altLabel mesh__D008807 Mice, BALB C
% 210.77/210.92  |- mesh__dateEstablished mesh__D008807 1974-01-01
% 210.77/210.92  |- mesh__dateRevised mesh__D008807 2005-06-30
% 210.77/210.92  |- skos__prefLabel mesh__D008807 Mice, Inbred BALB C
% 210.77/210.92  |- skos__hiddenLabel mesh__D008807 BALB C Mice
% 210.77/210.92  |- mesh__recordOriginator mesh__D008807 NLM
% 210.77/210.92  |- skos__historyNote mesh__D008807 Mice %28%1966-1971%29%
% 210.77/210.92  |- skos__altLabel mesh__D008807 BALB C Mice, Inbred
% 210.77/210.92  |- skos__annotation mesh__D008807
% 210.77/210.92       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%  
% 210.77/210.92  |- skos__hiddenLabel mesh__D000824 Nutritions, Animal
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000824 1997
% 210.77/210.92  |- skos__broader mesh__D000824smesh__D009747
% 210.77/210.92  |- mesh__recordOriginator mesh__D000824 NLM
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000824 1991
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000824 2005
% 210.77/210.92  |- mesh__recordAuthorizer mesh__D000824 PLS
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000824 1999
% 210.77/210.92  |- skos__hiddenLabel mesh__D000824 Animal Nutritions
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000824 1996
% 210.77/210.92  |- mesh__publicMeSHNote mesh__D000824 68   
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000824 1990
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000824 1993
% 210.77/210.92  |- mesh__dateRevised mesh__D000824 1989-06-13
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000824 1998
% 210.77/210.92  |- mesh__dateEstablished mesh__D000824 1968-01-01
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000824 2002
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000824 1995
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000824 1992
% 210.77/210.92  |- skos__prefLabel mesh__D000824 Animal Nutrition
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000824 2004
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000824 2001
% 210.77/210.92  |- mesh__dateCreated mesh__D000824 1999-01-01
% 210.77/210.92  |- skos__historyNote mesh__D000824 Nutrition %28%1966-1967%29%
% 210.77/210.92  |- mesh__recordMaintainer mesh__D000824 TGC
% 210.77/210.92  |- rdf__type mesh__D000824sskos__Concept
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000824 1994
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000824 2000
% 210.77/210.92  |- skos__hiddenLabel mesh__D000824 Nutrition, Animal
% 210.77/210.92  |- mesh__historyNote mesh__D000824 68   
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000824 2006
% 210.77/210.92  |- skos__annotation mesh__D000824
% 210.77/210.92       no qualif; TN 50: differentiate from ANIMAL FEED %26% DIET   
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000824 2003
% 210.77/210.92  |- skos__broader mesh__D008009smesh__D008004
% 210.77/210.92  |- skos__hiddenLabel mesh__D008009 Licensures, Pharmacy
% 210.77/210.92  |- mesh__dateRevised mesh__D008009 1999-11-03
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D008009 2003
% 210.77/210.92  |- mesh__dateEstablished mesh__D008009 1968-01-01
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D008009 2001
% 210.77/210.92  |- skos__prefLabel mesh__D008009 Licensure, Pharmacy
% 210.77/210.92  |- skos__scopeNote mesh__D008009
% 210.77/210.92       The granting of a license to practice pharmacy.     
% 210.77/210.92  |- rdf__type mesh__D008009sskos__Concept
% 210.77/210.92  |- skos__altLabel mesh__D008009 Pharmacy Licensure
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D008009 2000
% 210.77/210.92  |- mesh__historyNote mesh__D008009 68   
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D008009 2006
% 210.77/210.92  |- mesh__recordAuthorizer mesh__D008009 sjn
% 210.77/210.92  |- mesh__publicMeSHNote mesh__D008009 68   
% 210.77/210.92  |- mesh__recordOriginator mesh__D008009 NLM
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D008009 2005
% 210.77/210.92  |- mesh__recordMaintainer mesh__D008009 kle
% 210.77/210.92  |- mesh__dateCreated mesh__D008009 1999-01-01
% 210.77/210.92  |- skos__hiddenLabel mesh__D008009 Pharmacy Licensures
% 210.77/210.92  |- skos__annotation mesh__D008009
% 210.77/210.92       by the state; differentiate from ACCREDITATION %28%by the profession%29%; IM; various boards can go here; specify geog; DF: LICENSURE PHARM%A%  
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D008009 2004
% 210.77/210.92  |- skos__historyNote mesh__D008009 Pharmacy %28%1966-1967%29%
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D008009 2002
% 210.77/210.92  |- mesh__dateRevised mesh__D000026 2005-06-30
% 210.77/210.92  |- skos__hiddenLabel mesh__D000026 Miscarriages, Recurrent
% 210.77/210.92  |- mesh__activeMeSHYear mesh__D000026 2006
% 210.77/210.92  |- skos__prefLabel mesh__D000026 Abortion, Habitual
% 210.77/210.92  |- skos__scopeNote mesh__D000026
% 210.77/210.92       Three or more consecutive spontaneous abortions.     
% 210.77/210.92  |- rdf__type mesh__D000026sskos__Concept
% 210.77/210.92  |- skos__hiddenLabel mesh__D000026 Habitual Abortions
% 210.77/210.92  |- skos__hiddenLabel mesh__D000026 Recurrent Miscarriages
% 210.77/210.92  |- skos__hiddenLabel mesh__D000026 Habitual Abortion
% 210.77/210.92  |- skos__related mesh__D000026smesh__D020964
% 210.77/210.92  |- skos__related mesh__D000026smesh__D005313
% 210.77/210.92  |- skos__broader mesh__D000026smesh__D000022
% 210.77/210.92  |- skos__altLabel mesh__D000026 Abortion, Recurrent
% 210.77/210.92  |- skos__hiddenLabel mesh__D000026 Recurrent Miscarriage
% 210.77/210.92  |- skos__hiddenLabel mesh__D000026 Abortions, Recurrent
% 210.77/210.92  |- skos__hiddenLabel mesh__D000026 Recurrent Abortions
% 210.77/210.92  |- mesh__recordMaintainer mesh__D000026 lkt
% 210.77/210.92  |- skos__hiddenLabel mesh__D000026 Abortions, Habitual
% 210.77/210.92  |- mesh__dateCreated mesh__D000026 1999-01-01
% 210.77/210.92  |- mesh__recordAuthorizer mesh__D000026 sjn
% 210.77/210.92  |- skos__altLabel mesh__D000026 Miscarriage, Recurrent
% 210.77/210.92  |- skos__hiddenLabel mesh__D000026 Recurrent Abortion
% 210.77/210.92  |- mesh__recordOriginator mesh__D000026 NLM
% 210.77/210.92  |- mesh__dateEstablished mesh__D046128 2005-01-01
% 210.77/210.92  |- mesh__recordOriginator mesh__D046128 lkt
% 210.77/210.92  |- skos__scopeNote mesh__D046128
% 210.77/210.92       Prenatal interventions to correct fetal anomalies or treat FETAL DISEASES in utero. Fetal therapies include several major areas, such as open surgery; FETOSCOPY; pharmacological therapy; INTRAUTERINE TRANSFUSION; STEM CELL TRANSPLANTATION; and GENE THERAPY.%A%    
% 210.77/210.93  |- mesh__historyNote mesh__D046128
% 210.77/210.93       2005; use FETAL DISEASES 1993-2004, use FETUS 1986-1992   
% 210.77/210.93  |- skos__hiddenLabel mesh__D046128 Therapies, Fetal
% 210.77/210.93  |- skos__historyNote mesh__D046128 Fetal Diseases %28%1982-2004%29%
% 210.77/210.93  |- mesh__recordAuthorizer mesh__D046128 sjn
% 210.77/210.93  |- mesh__dateCreated mesh__D046128 2004-07-07
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D046128 2005
% 210.77/210.93  |- skos__altLabel mesh__D046128 Fetal Therapy
% 210.77/210.93  |- skos__annotation mesh__D046128 General only; prefer specifics   
% 210.77/210.93  |- skos__prefLabel mesh__D046128 Fetal Therapies
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D046128 2006
% 210.77/210.93  |- mesh__recordMaintainer mesh__D046128 lkt
% 210.77/210.93  |- rdf__type mesh__D046128sskos__Concept
% 210.77/210.93  |- skos__altLabel mesh__D046128 Therapy, Fetal
% 210.77/210.93  |- mesh__publicMeSHNote mesh__D046128
% 210.77/210.93       2005; see FETAL DISEASES 1993-2004, see FETUS 1986-1992   
% 210.77/210.93  |- skos__broader mesh__D046128smesh__D013812
% 210.77/210.93  |- mesh__dateRevised mesh__D018437 2001-08-13
% 210.77/210.93  |- skos__historyNote mesh__D018437 Spinal Cord Injuries %28%1970-1994%29%
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D018437 2003
% 210.77/210.93  |- mesh__recordAuthorizer mesh__D018437 sjn
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D018437 2006
% 210.77/210.93  |- skos__hiddenLabel mesh__D018437 Brown Sequard%27%s Syndrome
% 210.77/210.93  |- skos__hiddenLabel mesh__D018437 Syndrome, Hemispinal Cord
% 210.77/210.93  |- skos__hiddenLabel mesh__D018437 Brown Sequard%27%s Disease
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D018437 2002
% 210.77/210.93  |- skos__hiddenLabel mesh__D018437 Brown-Sequards Syndrome
% 210.77/210.93  |- skos__hiddenLabel mesh__D018437 Paralysis, Brown-Sequard%27%s
% 210.77/210.93  |- rdf__type mesh__D018437sskos__Concept
% 210.77/210.93  |- skos__hiddenLabel mesh__D018437 Brown Sequard Syndrome
% 210.77/210.93  |- skos__scopeNote mesh__D018437
% 210.77/210.93       A syndrome associated with injury to the lateral half of the spinal cord. The condition is characterized by the following clinical features %28%which are found below the level of the lesion%29%: contralateral hemisensory anesthesia to pain and temperature, ipsilateral loss of propioception, and ipsilateral motor paralysis. Tactile sensation is generally spared. %28%From Adams et al., Principles of Neurology, 6th ed, p162%29%.%A%    
% 210.77/210.93  |- skos__hiddenLabel mesh__D018437 Brown-Sequards Paralysis
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D018437 2005
% 210.77/210.93  |- skos__altLabel mesh__D018437 Brown-Sequard%27%s Disease
% 210.77/210.93  |- skos__hiddenLabel mesh__D018437 Brown-Sequards Disease
% 210.77/210.93  |- mesh__recordOriginator mesh__D018437 TGC
% 210.77/210.93  |- skos__hiddenLabel mesh__D018437 Hemicord Syndromes
% 210.77/210.93  |- mesh__historyNote mesh__D018437 1995   
% 210.77/210.93  |- skos__hiddenLabel mesh__D018437 Brown Sequard%27%s Paralysis
% 210.77/210.93  |- skos__annotation mesh__D018437
% 210.77/210.93       do not confuse with flaccid paralysis of the bladder, also called Brown S%C3%%A9%quard paralysis; in titles %26% translations use diacrit: Brown-Sequard%A%  
% 210.77/210.93  |- skos__historyNote mesh__D018437 Spinal Cord Diseases %28%1975-1991%29%
% 210.77/210.93  |- mesh__dateCreated mesh__D018437 1994-07-06
% 210.77/210.93  |- skos__altLabel mesh__D018437 Hemispinal Cord Syndrome
% 210.77/210.93  |- mesh__publicMeSHNote mesh__D018437 1995   
% 210.77/210.93  |- skos__altLabel mesh__D018437 Brown-Sequard%27%s Syndrome
% 210.77/210.93  |- skos__hiddenLabel mesh__D018437 Syndrome, Brown-Sequard%27%s
% 210.77/210.93  |- skos__historyNote mesh__D018437 Paralysis %28%1968-1994%29%
% 210.77/210.93  |- skos__hiddenLabel mesh__D018437 Hemispinal Cord Syndromes
% 210.77/210.93  |- skos__hiddenLabel mesh__D018437 Syndromes, Hemiparaplegic
% 210.77/210.93  |- skos__hiddenLabel mesh__D018437 Brown Sequard Disease
% 210.77/210.93  |- skos__historyNote mesh__D018437 Hemiplegia %28%1970-1994%29%
% 210.77/210.93  |- skos__altLabel mesh__D018437 Hemicord Syndrome
% 210.77/210.93  |- mesh__recordMaintainer mesh__D018437 jls
% 210.77/210.93  |- skos__hiddenLabel mesh__D018437 Brown-Sequard Paralysis
% 210.77/210.93  |- skos__altLabel mesh__D018437 Brown-Sequard Disease
% 210.77/210.93  |- skos__altLabel mesh__D018437 Hemiparaplegic Syndrome
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D018437 2004
% 210.77/210.93  |- skos__hiddenLabel mesh__D018437 Syndrome, Hemicord
% 210.77/210.93  |- skos__prefLabel mesh__D018437 Brown-Sequard Syndrome
% 210.77/210.93  |- skos__broader mesh__D018437smesh__D010264
% 210.77/210.93  |- skos__hiddenLabel mesh__D018437 Syndrome, Hemiparaplegic
% 210.77/210.93  |- skos__hiddenLabel mesh__D018437 Syndromes, Hemispinal Cord
% 210.77/210.93  |- mesh__dateEstablished mesh__D018437 1995-01-01
% 210.77/210.93  |- skos__hiddenLabel mesh__D018437 Hemiparaplegic Syndromes
% 210.77/210.93  |- skos__hiddenLabel mesh__D018437 Syndromes, Hemicord
% 210.77/210.93  |- skos__hiddenLabel mesh__D018437 Syndrome, Brown-Sequard
% 210.77/210.93  |- mesh__dateCreated mesh__D010454 1999-01-01
% 210.77/210.93  |- mesh__historyNote mesh__D010454 73   
% 210.77/210.93  |- skos__hiddenLabel mesh__D010454 Release Factor, Termination
% 210.77/210.93  |- skos__prefLabel mesh__D010454 Peptide Termination Factors
% 210.77/210.93  |- mesh__dateEstablished mesh__D010454 1973-01-01
% 210.77/210.93  |- skos__hiddenLabel mesh__D010454 Termination Factors, Peptide
% 210.77/210.93  |- skos__historyNote mesh__D010454 Bacterial Proteins %28%1966-1972%29%
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D010454 2006
% 210.77/210.93  |- mesh__dateRevised mesh__D010454 2005-06-30
% 210.77/210.93  |- skos__historyNote mesh__D010454 Peptides %28%1966-1972%29%
% 210.77/210.93  |- skos__hiddenLabel mesh__D010454 Factor, Termination Release
% 210.77/210.93  |- skos__broader mesh__D010454smesh__D012269
% 210.77/210.93  |- mesh__recordAuthorizer mesh__D010454 sjn
% 210.77/210.93  |- mesh__recordMaintainer mesh__D010454 SYSTEM
% 210.77/210.93  |- skos__historyNote mesh__D010454 Proteins %28%1966-1972%29%
% 210.77/210.93  |- rdf__type mesh__D010454sskos__Concept
% 210.77/210.93  |- skos__scopeNote mesh__D010454
% 210.77/210.93       Proteins that are involved in the peptide chain termination reaction %28%PEPTIDE CHAIN TERMINATION, TRANSLATIONAL%29% on RIBOSOMES. They include codon-specific class-I release factors, which recognize stop signals %28%TERMINATOR CODON%29% in the MESSENGER RNA; and codon-nonspecific class-II release factors.%A%    
% 210.77/210.93  |- skos__hiddenLabel mesh__D010454 Factors, Peptide Termination
% 210.77/210.93  |- mesh__recordOriginator mesh__D010454 NLM
% 210.77/210.93  |- skos__related mesh__D010454smesh__D010443
% 210.77/210.93  |- mesh__publicMeSHNote mesh__D010454 73   
% 210.77/210.93  |- skos__broader mesh__D032108smesh__D029629
% 210.77/210.93  |- mesh__publicMeSHNote mesh__D032108 2003   
% 210.77/210.93  |- mesh__historyNote mesh__D032108 2003   
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D032108 2006
% 210.77/210.93  |- skos__prefLabel mesh__D032108 Salix
% 210.77/210.93  |- rdf__type mesh__D032108sskos__Concept
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D032108 2004
% 210.77/210.93  |- skos__annotation mesh__D032108
% 210.77/210.93       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D032108 2005
% 210.77/210.93  |- mesh__dateEstablished mesh__D032108 2003-01-01
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D032108 2003
% 210.77/210.93  |- skos__scopeNote mesh__D032108
% 210.77/210.93       A plant genus of the family SALICACEAE. Members contain salicin, which yields SALICYLIC ACID.%A%    
% 210.77/210.93  |- skos__altLabel mesh__D032108 Willow
% 210.77/210.93  |- mesh__dateCreated mesh__D032108 2002-07-03
% 210.77/210.93  |- mesh__recordOriginator mesh__D004417 NLM
% 210.77/210.93  |- mesh__recordAuthorizer mesh__D004417 sjn
% 210.77/210.93  |- mesh__dateRevised mesh__D004417 1999-11-03
% 210.77/210.93  |- skos__prefLabel mesh__D004417 Dyspnea
% 210.77/210.93  |- rdf__type mesh__D004417sskos__Concept
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D004417 2006
% 210.77/210.93  |- skos__broader mesh__D004417smesh__D012818
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D004417 2002
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D004417 2005
% 210.77/210.93  |- skos__annotation mesh__D004417
% 210.77/210.93       do not confuse with APNEA or other resp disord; use only when text uses DYSPNEA%A%  
% 210.77/210.93  |- skos__broader mesh__D004417smesh__D012120
% 210.77/210.93  |- skos__hiddenLabel mesh__D004417 Dyspneas
% 210.77/210.93  |- skos__scopeNote mesh__D004417 Difficult or labored breathing.     
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D004417 2001
% 210.77/210.93  |- skos__hiddenLabel mesh__D004417 Breath Shortness
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D004417 2004
% 210.77/210.93  |- skos__hiddenLabel mesh__D004417 Breath Shortnesses
% 210.77/210.93  |- mesh__dateCreated mesh__D004417 1999-01-01
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D004417 2000
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D004417 2003
% 210.77/210.93  |- mesh__recordMaintainer mesh__D004417 KEV
% 210.77/210.93  |- skos__hiddenLabel mesh__D009900 Nerve II, Cranial
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D009900 2002
% 210.77/210.93  |- skos__annotation mesh__D009900
% 210.77/210.93       2d cranial nerve; neopl = OPTIC NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%; atrophy = OPTIC ATROPHY; neuritis = OPTIC NEURITIS; optic nerve head = OPTIC DISK%A%  
% 210.77/210.93  |- skos__hiddenLabel mesh__D009900 IIs, Cranial Nerve
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D009900 2004
% 210.77/210.93  |- mesh__recordOriginator mesh__D009900 NLM
% 210.77/210.93  |- skos__hiddenLabel mesh__D009900 Nerve IIs, Cranial
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D009900 2001
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D009900 2006
% 210.77/210.93  |- skos__broader mesh__D009900smesh__D003391
% 210.77/210.93  |- skos__scopeNote mesh__D009900
% 210.77/210.93       The 2nd cranial nerve. The optic nerve conveys visual information from the retina to the brain. The nerve carries the axons of the retinal ganglion cells which sort at the optic chiasm and continue via the optic tracts to the brain. The largest projection is to the lateral geniculate nuclei; other important targets include the superior colliculi and the suprachiasmatic nuclei. Though known as the second cranial nerve, it is considered part of the central nervous system.%A%    
% 210.77/210.93  |- skos__hiddenLabel mesh__D009900 Nerve, Optic
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D009900 2003
% 210.77/210.93  |- skos__hiddenLabel mesh__D009900 Nerves, Second Cranial
% 210.77/210.93  |- skos__hiddenLabel mesh__D009900 Nerve, Second Cranial
% 210.77/210.93  |- mesh__recordMaintainer mesh__D009900 KEV
% 210.77/210.93  |- mesh__dateCreated mesh__D009900 1999-01-01
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D009900 2000
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D009900 2005
% 210.77/210.93  |- mesh__dateRevised mesh__D009900 1999-11-03
% 210.77/210.93  |- skos__hiddenLabel mesh__D009900 Cranial Nerves, Second
% 210.77/210.93  |- skos__altLabel mesh__D009900 Cranial Nerve II
% 210.77/210.93  |- rdf__type mesh__D009900sskos__Concept
% 210.77/210.93  |- skos__hiddenLabel mesh__D009900 Cranial Nerve, Second
% 210.77/210.93  |- skos__hiddenLabel mesh__D009900 Optic Nerves
% 210.77/210.93  |- skos__hiddenLabel mesh__D009900 Cranial Nerve IIs
% 210.77/210.93  |- skos__hiddenLabel mesh__D009900 Second Cranial Nerves
% 210.77/210.93  |- skos__altLabel mesh__D009900 Second Cranial Nerve
% 210.77/210.93  |- skos__prefLabel mesh__D009900 Optic Nerve
% 210.77/210.93  |- mesh__recordAuthorizer mesh__D009900 sjn
% 210.77/210.93  |- skos__hiddenLabel mesh__D009900 Nerves, Optic
% 210.77/210.93  |- skos__hiddenLabel mesh__D009900 II, Cranial Nerve
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D009102 2004
% 210.77/210.93  |- mesh__dateCreated mesh__D009102 1982-04-26
% 210.77/210.93  |- skos__hiddenLabel mesh__D009102 Failure, Multiple Organ
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D009102 2002
% 210.77/210.93  |- mesh__recordAuthorizer mesh__D009102 sjn
% 210.77/210.93  |- skos__altLabel mesh__D009102 Multiple Organ Dysfunction Syndrome
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D009102 2003
% 210.77/210.93  |- skos__altLabel mesh__D009102 MODS
% 210.77/210.93  |- skos__prefLabel mesh__D009102 Multiple Organ Failure
% 210.77/210.93  |- mesh__recordOriginator mesh__D009102 CAB
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D009102 2006
% 210.77/210.93  |- skos__altLabel mesh__D009102 Organ Failure, Multiple
% 210.77/210.93  |- mesh__historyNote mesh__D009102 83   
% 210.77/210.93  |- skos__scopeNote mesh__D009102
% 210.77/210.93       A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative.%A%    
% 210.77/210.93  |- skos__hiddenLabel mesh__D009102 Multiple Organ Failures
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D009102 2005
% 210.77/210.93  |- mesh__recordMaintainer mesh__D009102 ags
% 210.77/210.93  |- mesh__dateRevised mesh__D009102 2001-07-25
% 210.77/210.93  |- mesh__dateEstablished mesh__D009102 1983-01-01
% 210.77/210.93  |- skos__altLabel mesh__D009102 Organ Dysfunction Syndrome, Multiple
% 210.77/210.93  |- mesh__publicMeSHNote mesh__D009102 83   
% 210.77/210.93  |- skos__broader mesh__D009102smesh__D010335
% 210.77/210.93  |- rdf__type mesh__D009102sskos__Concept
% 210.77/210.93  |- rdf__type mesh__D020084sskos__Concept
% 210.77/210.93  |- skos__altLabel mesh__D020084 Long Interspersed DNA Sequence Elements
% 210.77/210.93  |- mesh__dateEstablished mesh__D020084 1999-01-01
% 210.77/210.93  |- skos__hiddenLabel mesh__D020084 Repeat Sequence, LINE
% 210.77/210.93  |- skos__historyNote mesh__D020084
% 210.77/210.93       Repetitive Sequences, Nucleic Acid %28%1981-1998%29%
% 210.77/210.93  |- mesh__dateCreated mesh__D020084 1998-06-10
% 210.77/210.93  |- skos__hiddenLabel mesh__D020084 Sequence, LINE Repeat
% 210.77/210.93  |- mesh__recordMaintainer mesh__D020084 nns
% 210.77/210.93  |- mesh__recordOriginator mesh__D020084 NNS
% 210.77/210.93  |- skos__hiddenLabel mesh__D020084 L1 Element
% 210.77/210.93  |- skos__altLabel mesh__D020084 L1 Elements
% 210.77/210.93  |- skos__hiddenLabel mesh__D020084 Elements, L1
% 210.77/210.93  |- skos__hiddenLabel mesh__D020084 Elements, Jockey
% 210.77/210.93  |- mesh__dateRevised mesh__D020084 2005-06-30
% 210.77/210.93  |- skos__prefLabel mesh__D020084 Long Interspersed Nucleotide Elements
% 210.77/210.93  |- skos__hiddenLabel mesh__D020084 Elements, LINE-1
% 210.77/210.93  |- mesh__recordAuthorizer mesh__D020084 sjn
% 210.77/210.93  |- skos__hiddenLabel mesh__D020084 LINE-1 Element
% 210.77/210.93  |- skos__hiddenLabel mesh__D020084 Repeat Sequences, LINE
% 210.77/210.93  |- skos__hiddenLabel mesh__D020084 Jockey Element
% 210.77/210.93  |- skos__scopeNote mesh__D020084
% 210.77/210.93       Highly repeated sequences, 6K-8K base pairs in length, which contain RNA polymerase II promoters. They also have an open reading frame that is related to the reverse transcriptase of retroviruses but they do not contain LTRs %28%long terminal repeats%29%. Copies of the LINE 1 %28%L1%29% family form about 15%25% of the human genome. The jockey elements of Drosophila are LINEs.%A%    
% 210.77/210.93  |- skos__hiddenLabel mesh__D020084 Element, L1
% 210.77/210.93  |- skos__hiddenLabel mesh__D020084 Element, Jockey
% 210.77/210.93  |- skos__hiddenLabel mesh__D020084 LINE Repeat Sequence
% 210.77/210.93  |- mesh__publicMeSHNote mesh__D020084 99   
% 210.77/210.93  |- skos__broader mesh__D020084smesh__D018626
% 210.77/210.93  |- skos__hiddenLabel mesh__D020084 Sequences, LINE Repeat
% 210.77/210.93  |- mesh__historyNote mesh__D020084 99   
% 210.77/210.93  |- skos__altLabel mesh__D020084 LINE Repeat Sequences
% 210.77/210.93  |- skos__hiddenLabel mesh__D020084 LINE 1 Elements
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D020084 2006
% 210.77/210.93  |- skos__hiddenLabel mesh__D020084 Element, LINE-1
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D014845 2006
% 210.77/210.93  |- mesh__recordAuthorizer mesh__D014845 sjn
% 210.77/210.93  |- mesh__dateRevised mesh__D014845 2005-06-30
% 210.77/210.93  |- skos__historyNote mesh__D014845 Vulva %28%1966-1975%29%
% 210.77/210.93  |- mesh__publicMeSHNote mesh__D014845 76   
% 210.77/210.93  |- skos__historyNote mesh__D014845 specific vulvar disease
% 210.77/210.93  |- skos__broader mesh__D014845smesh__D005831
% 210.77/210.93  |- mesh__historyNote mesh__D014845 76; was NON MESH before 1976   
% 210.77/210.93  |- skos__scopeNote mesh__D014845 Pathological processes of the VULVA.     
% 210.77/210.93  |- mesh__recordOriginator mesh__D014845 SMH
% 210.77/210.93  |- rdf__type mesh__D014845sskos__Concept
% 210.77/210.93  |- skos__annotation mesh__D014845 inflammatory disease = VULVITIS   
% 210.77/210.93  |- skos__hiddenLabel mesh__D014845 Disease, Vulvar
% 210.77/210.93  |- skos__hiddenLabel mesh__D014845 Diseases, Vulvar
% 210.77/210.93  |- mesh__dateCreated mesh__D014845 1975-07-25
% 210.77/210.93  |- mesh__recordMaintainer mesh__D014845 lkt
% 210.77/210.93  |- mesh__dateEstablished mesh__D014845 1976-01-01
% 210.77/210.93  |- skos__prefLabel mesh__D014845 Vulvar Diseases
% 210.77/210.93  |- skos__hiddenLabel mesh__D014845 Vulvar Disease
% 210.77/210.93  |- skos__scopeNote mesh__D014047 A synthetic antifungal agent.     
% 210.77/210.93  |- mesh__publicMeSHNote mesh__D014047 73   
% 210.77/210.93  |- skos__altLabel mesh__D014047 Stiefel Brand of Tolnaftate
% 210.77/210.93  |- mesh__historyNote mesh__D014047 73%28%72%29%   
% 210.77/210.93  |- skos__historyNote mesh__D014047 Thiocarbamates %28%1966-1971%29%
% 210.77/210.93  |- skos__altLabel mesh__D014047 Tinaderm
% 210.77/210.93  |- skos__altLabel mesh__D014047 Insight Brand of Tolnaftate
% 210.77/210.93  |- skos__altLabel mesh__D014047 Schering-Plough Brand 1 of Tolnaftate
% 210.77/210.93  |- skos__altLabel mesh__D014047 Carter Wallace Brand of Tolnaftate
% 210.77/210.93  |- skos__altLabel mesh__D014047 Pedinol Brand 2 of Tolnaftate
% 210.77/210.93  |- skos__hiddenLabel mesh__D014047 NP27
% 210.77/210.93  |- skos__altLabel mesh__D014047 Schering Brand of Tolnaftate
% 210.77/210.93  |- skos__altLabel mesh__D014047 Sporiline
% 210.77/210.93  |- mesh__recordMaintainer mesh__D014047 CCR
% 210.77/210.93  |- skos__prefLabel mesh__D014047 Tolnaftate
% 210.77/210.93  |- rdf__type mesh__D014047sskos__Concept
% 210.77/210.93  |- skos__altLabel mesh__D014047 Zenith Brand of Tolnaftate
% 210.77/210.93  |- skos__altLabel mesh__D014047 Wernigerode Brand of Tolnaftate
% 210.77/210.93  |- mesh__dateCreated mesh__D014047 1999-01-01
% 210.77/210.93  |- skos__broader mesh__D014047smesh__D009281
% 210.77/210.93  |- skos__hiddenLabel mesh__D014047 Purder N, Tolnaftat
% 210.77/210.93  |- mesh__dateEstablished mesh__D014047 1973-01-01
% 210.77/210.93  |- skos__historyNote mesh__D014047 Antifungal Agents %28%1966-1971%29%
% 210.77/210.93  |- skos__altLabel mesh__D014047 Schering-Plough Brand 2 of Tolnaftate
% 210.77/210.93  |- skos__altLabel mesh__D014047 Essex Brand of Tolnaftate
% 210.77/210.93  |- skos__altLabel mesh__D014047 Chinosol Brand of Tolnaftate
% 210.77/210.93  |- skos__altLabel mesh__D014047 Bioglan Brand of Tolnaftate
% 210.77/210.93  |- mesh__dateRevised mesh__D014047 2005-06-30
% 210.77/210.93  |- skos__altLabel mesh__D014047 Pedinol Brand 1 of Tolnaftate
% 210.77/210.93  |- skos__hiddenLabel mesh__D014047 Ony Clear
% 210.77/210.93  |- skos__altLabel mesh__D014047 Thompson Brand of Tolnaftate
% 210.77/210.93  |- skos__altLabel mesh__D014047 Isdin Brand of Tolnaftate
% 210.77/210.93  |- mesh__recordOriginator mesh__D014047 NLM
% 210.77/210.93  |- mesh__recordAuthorizer mesh__D014047 sjn
% 210.77/210.93  |- skos__broader mesh__D014047smesh__D013859
% 210.77/210.93  |- skos__hiddenLabel mesh__D014047 NP 27
% 210.77/210.93  |- skos__altLabel mesh__D014047 Douglas Brand of Tolnaftate
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D014047 2006
% 210.77/210.93  |- mesh__dateEstablished mesh__D008808 1974-01-01
% 210.77/210.93  |- skos__prefLabel mesh__D008808 Mice, Inbred CBA
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D008808 2006
% 210.77/210.93  |- mesh__dateCreated mesh__D008808 1999-01-01
% 210.77/210.93  |- skos__historyNote mesh__D008808 Mice %28%1966-1971%29%
% 210.77/210.93  |- skos__annotation mesh__D008808
% 210.77/210.93       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%  
% 210.77/210.93  |- mesh__recordOriginator mesh__D008808 NLM
% 210.77/210.93  |- skos__hiddenLabel mesh__D008808 Inbred CBA Mice
% 210.77/210.93  |- skos__hiddenLabel mesh__D008808 Inbred CBA Mouse
% 210.77/210.93  |- skos__altLabel mesh__D008808 Mice, CBA
% 210.77/210.93  |- mesh__recordMaintainer mesh__D008808 ags
% 210.77/210.93  |- skos__altLabel mesh__D008808 Mouse, CBA
% 210.77/210.93  |- rdf__type mesh__D008808sskos__Concept
% 210.77/210.93  |- mesh__historyNote mesh__D008808 74%28%72%29%   
% 210.77/210.93  |- mesh__recordAuthorizer mesh__D008808 sjn
% 210.77/210.93  |- skos__hiddenLabel mesh__D008808 CBA Mice, Inbred
% 210.77/210.93  |- skos__hiddenLabel mesh__D008808 CBA Mouse, Inbred
% 210.77/210.93  |- skos__altLabel mesh__D008808 Mouse, Inbred CBA
% 210.77/210.93  |- skos__broader mesh__D008808smesh__D008815
% 210.77/210.93  |- mesh__publicMeSHNote mesh__D008808 74   
% 210.77/210.93  |- skos__hiddenLabel mesh__D008808 CBA Mouse
% 210.77/210.93  |- skos__hiddenLabel mesh__D008808 CBA Mice
% 210.77/210.93  |- mesh__dateRevised mesh__D008808 2005-06-30
% 210.77/210.93  |- skos__hiddenLabel mesh__D000825 Animal Structure
% 210.77/210.93  |- mesh__dateRevised mesh__D000825 2003-07-09
% 210.77/210.93  |- skos__hiddenLabel mesh__D000825 Animal Organ
% 210.77/210.93  |- mesh__historyNote mesh__D000825
% 210.77/210.93       1998 %28%1967%29%; for ANIMAL ORGANS use ANIMALS 1986-2003   
% 210.77/210.93  |- mesh__dateEstablished mesh__D000825 1998-01-01
% 210.77/210.93  |- mesh__dateCreated mesh__D000825 1999-01-01
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D000825 2004
% 210.77/210.93  |- rdf__type mesh__D000825sskos__Concept
% 210.77/210.93  |- skos__hiddenLabel mesh__D000825 Structure, Animal
% 210.77/210.93  |- skos__prefLabel mesh__D000825 Animal Structures
% 210.77/210.93  |- mesh__recordOriginator mesh__D000825 NLM
% 210.77/210.93  |- skos__scopeNote mesh__D000825
% 210.77/210.93       Organs and other anatomical structures of non-human vertebrate and invertebrate animals.%A%    
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D000825 2006
% 210.77/210.93  |- skos__historyNote mesh__D000825
% 210.77/210.93       Animals/anatomy %26% histology %28%1966-1997%29%
% 210.77/210.93  |- mesh__recordAuthorizer mesh__D000825 sjn
% 210.77/210.93  |- mesh__recordMaintainer mesh__D000825 ags
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D000825 2005
% 210.77/210.93  |- skos__annotation mesh__D000825 avoid: too general; prefer specifics   
% 210.77/210.93  |- mesh__runningHead mesh__D000825 A13 - ANATOMY-ANIMAL STRUCTURES   
% 210.77/210.93  |- skos__hiddenLabel mesh__D000825 Structures, Animal
% 210.77/210.93  |- skos__hiddenLabel mesh__D000825 Organ, Animal
% 210.77/210.93  |- skos__historyNote mesh__D000825
% 210.77/210.93       specific animal/anatomy %26% histology %28%1966-1997%29%
% 210.77/210.93  |- mesh__publicMeSHNote mesh__D000825
% 210.77/210.93       1998; for ANIMAL ORGANS see ANIMAL 1986-2003   
% 210.77/210.93  |- skos__hiddenLabel mesh__D000825 Organs, Animal
% 210.77/210.93  |- rdf__type mesh__D033201sskos__Concept
% 210.77/210.93  |- mesh__publicMeSHNote mesh__D033201
% 210.77/210.93       2003; see CRUSTACEA 1990-2002; for EUPHAUSIA %26% NYCTIPHANES see CRUSTACEA 1986-2002%A%  
% 210.77/210.93  |- skos__annotation mesh__D033201
% 210.77/210.93       as animal %26% food; IM; as food, coord IM with SHELLFISH %28%IM%29%%A%  
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D033201 2004
% 210.77/210.93  |- mesh__historyNote mesh__D033201
% 210.77/210.93       2003; use CRUSTACEA 1990-2002; for EUPHAUSIA %26% NYCTIPHANES use CRUSTACEA 1986-2002%A%  
% 210.77/210.93  |- skos__historyNote mesh__D033201 Plankton %28%1986-1989%29%
% 210.77/210.93  |- skos__altLabel mesh__D033201 Krill
% 210.77/210.93  |- skos__scopeNote mesh__D033201
% 210.77/210.93       An order of pelagic, shrimplike CRUSTACEA. Many consume ZOOPLANKTON and a few are predacious. Many antarctic species, such as Euphuasia superba, constitute the chief food of other animals.%A%    
% 210.77/210.93  |- mesh__dateCreated mesh__D033201 2002-07-03
% 210.77/210.93  |- skos__broader mesh__D033201smesh__D003445
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D033201 2005
% 210.77/210.93  |- mesh__dateRevised mesh__D033201 2003-07-09
% 210.77/210.93  |- skos__historyNote mesh__D033201 Zooplankton %28%1983-1985%29%
% 210.77/210.93  |- mesh__dateEstablished mesh__D033201 2003-01-01
% 210.77/210.93  |- skos__historyNote mesh__D033201 Crustacea %28%1970-2002%29%
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D033201 2006
% 210.77/210.93  |- skos__prefLabel mesh__D033201 Euphausiacea
% 210.77/210.93  |- skos__scopeNote mesh__D000027
% 210.77/210.93       Premature loss of PREGNANCY in which not all the products of CONCEPTION have been expelled.%A%    
% 210.77/210.93  |- skos__hiddenLabel mesh__D000027 Incomplete Abortion
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D000027 2006
% 210.77/210.93  |- mesh__historyNote mesh__D000027 75   
% 210.77/210.93  |- mesh__recordAuthorizer mesh__D000027 sjn
% 210.77/210.93  |- skos__historyNote mesh__D000027 Abortion, Spontaneous %28%1966-1974%29%
% 210.77/210.93  |- rdf__type mesh__D000027sskos__Concept
% 210.77/210.93  |- skos__hiddenLabel mesh__D000027 Abortions, Incomplete
% 210.77/210.93  |- mesh__recordMaintainer mesh__D000027 lkt
% 210.77/210.93  |- skos__annotation mesh__D000027
% 210.77/210.93       restrict to spontaneous, not induced abortions; check the tags FEMALE %26% PREGNANCY%A%  
% 210.77/210.93  |- mesh__recordOriginator mesh__D000027 NLM
% 210.77/210.93  |- mesh__dateRevised mesh__D000027 2005-06-30
% 210.77/210.93  |- skos__broader mesh__D000027smesh__D000022
% 210.77/210.93  |- mesh__dateEstablished mesh__D000027 1975-09-01
% 210.77/210.93  |- mesh__publicMeSHNote mesh__D000027 75   
% 210.77/210.93  |- mesh__dateCreated mesh__D000027 1974-11-11
% 210.77/210.93  |- skos__hiddenLabel mesh__D000027 Incomplete Abortions
% 210.77/210.93  |- skos__prefLabel mesh__D000027 Abortion, Incomplete
% 210.77/210.93  |- skos__hiddenLabel mesh__D005510 Habits, Food
% 210.77/210.93  |- skos__annotation mesh__D005510 IM   
% 210.77/210.93  |- skos__hiddenLabel mesh__D005510 Habit, Dietary
% 210.77/210.93  |- skos__hiddenLabel mesh__D005510 Dietary Modifications
% 210.77/210.93  |- skos__hiddenLabel mesh__D005510 Modification, Diet
% 210.77/210.93  |- skos__hiddenLabel mesh__D005510 Habits, Diet
% 210.77/210.93  |- mesh__onlineNote mesh__D005510
% 210.77/210.93       use FOOD HABITS to search DIETARY HABITS 1969-78   
% 210.77/210.93  |- skos__hiddenLabel mesh__D005510 Habits, Dietary
% 210.77/210.93  |- skos__altLabel mesh__D005510 Diet Habits
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D005510 2006
% 210.77/210.93  |- mesh__dateRevised mesh__D005510 2002-07-03
% 210.77/210.93  |- mesh__recordAuthorizer mesh__D005510 sjn
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D005510 2003
% 210.77/210.93  |- mesh__dateCreated mesh__D005510 1999-01-01
% 210.77/210.93  |- skos__hiddenLabel mesh__D005510 Modification, Dietary
% 210.77/210.93  |- mesh__dateEstablished mesh__D005510 1969-01-01
% 210.77/210.93  |- rdf__type mesh__D005510sskos__Concept
% 210.77/210.93  |- mesh__publicMeSHNote mesh__D005510 69   
% 210.77/210.93  |- mesh__activeMeSHYear mesh__D005510 2004
% 210.77/210.93  |- skos__hiddenLabel mesh__D005510 Diet Habit
% 210.77/210.93  |- mesh__historyNote mesh__D005510
% 210.77/210.93       69; DIETARY HABITS was see under FOOD HABITS 1969-78   
% 210.77/210.93  |- skos__hiddenLabel mesh__D005510 Modifications, Diet
% 210.77/210.93  |- skos__scopeNote mesh__D005510 Acquired or learned food preferences.     
% 210.77/210.93  |- skos__hiddenLabel mesh__D005510 Modifications, Dietary
% 210.77/210.93  |- skos__hiddenLabel mesh__D005510 Diet Modifications
% 210.77/210.93  |- skos__historyNote mesh__D005510 Food %28%1966-1968%29%
% 210.77/210.93  |- skos__broader mesh__D005510smesh__D005247
% 210.77/210.93  |- skos__hiddenLabel mesh__D005510 Dietary Habit
% 210.77/210.93  |- skos__prefLabel mesh__D005510 Food Habits
% 210.77/210.93  |- skos__broader mesh__D005510smesh__D006184
% 210.77/210.93  |- skos__altLabel mesh__D005510 Diet Modification
% 210.77/210.93  |- skos__hiddenLabel mesh__D005510 Food Habit
% 210.77/210.93  |- skos__historyNote mesh__D005510 Nutrition Surveys %28%1966-1968%29%
% 210.77/210.93  |- skos__hiddenLabel mesh__D005510 Habit, Diet
% 210.77/210.93  |- skos__historyNote mesh__D005510 Diet %28%1966-1968%29%
% 210.77/210.93  |- mesh__recordOriginator mesh__D005510 NLM
% 210.77/210.93  |- skos__historyNote mesh__D005510 Ethnology %28%1966-1968%29%
% 210.77/210.94  |- mesh__recordMaintainer mesh__D005510 kle
% 210.77/210.94  |- skos__hiddenLabel mesh__D005510 Habit, Food
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D005510 2005
% 210.77/210.94  |- skos__broader mesh__D046129smesh__D014765
% 210.77/210.94  |- mesh__recordOriginator mesh__D046129 ags
% 210.77/210.94  |- skos__hiddenLabel mesh__D046129 Vaccines, Ebola Virus
% 210.77/210.94  |- mesh__dateCreated mesh__D046129 2004-07-07
% 210.77/210.94  |- mesh__dateEstablished mesh__D046129 2005-01-01
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D046129 2006
% 210.77/210.94  |- mesh__recordAuthorizer mesh__D046129 sjn
% 210.77/210.94  |- skos__prefLabel mesh__D046129 Ebola Vaccines
% 210.77/210.94  |- mesh__historyNote mesh__D046129 2005   
% 210.77/210.94  |- skos__hiddenLabel mesh__D046129 Vaccines, Ebola
% 210.77/210.94  |- rdf__type mesh__D046129sskos__Concept
% 210.77/210.94  |- skos__scopeNote mesh__D046129
% 210.77/210.94       Vaccines or candidate vaccines used to prevent EBOLA HEMORRHAGIC FEVER.%A%    
% 210.77/210.94  |- mesh__recordMaintainer mesh__D046129 ssb
% 210.77/210.94  |- mesh__publicMeSHNote mesh__D046129 2005   
% 210.77/210.94  |- skos__altLabel mesh__D046129 Ebola Virus Vaccines
% 210.77/210.94  |- mesh__dateRevised mesh__D046129 2005-06-30
% 210.77/210.94  |- skos__historyNote mesh__D046129 Viral Vaccines %28%1980-2004%29%
% 210.77/210.94  |- skos__historyNote mesh__D018438 Toes/blood supply %28%1976-1994%29%
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D018438 1998
% 210.77/210.94  |- mesh__dateCreated mesh__D018438 1994-01-25
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D018438 2001
% 210.77/210.94  |- skos__scopeNote mesh__D018438
% 210.77/210.94       Atherothrombotic microembolism of the lower extremities due to recurrent cholesterol embolic %27%showers%27% with painful cyanotic discoloration of the toes and embolism to other sites that completely resolve between attacks. Despite the gangrene-like appearance, blue toes may respond to conservative therapy without amputation. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D018438 1999
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D018438 2002
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D018438 1996
% 210.77/210.94  |- skos__annotation mesh__D018438
% 210.77/210.94       caused by recur cholesterol embolism of the toes; do not confuse with black toe disease %28% = AINHUM%29%%A%  
% 210.77/210.94  |- skos__broader mesh__D018438smesh__D017700
% 210.77/210.94  |- mesh__historyNote mesh__D018438 95   
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D018438 1997
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D018438 2005
% 210.77/210.94  |- mesh__dateEstablished mesh__D018438 1995-01-01
% 210.77/210.94  |- skos__prefLabel mesh__D018438 Blue Toe Syndrome
% 210.77/210.94  |- mesh__publicMeSHNote mesh__D018438 95   
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D018438 2006
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D018438 2003
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D018438 2004
% 210.77/210.94  |- skos__historyNote mesh__D018438 Embolism %28%1976-1994%29%
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D018438 1995
% 210.77/210.94  |- skos__hiddenLabel mesh__D018438 Syndrome, Blue Toe
% 210.77/210.94  |- rdf__type mesh__D018438sskos__Concept
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D018438 2000
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D010455 2005
% 210.77/210.94  |- mesh__recordOriginator mesh__D010455 NLM
% 210.77/210.94  |- skos__annotation mesh__D010455
% 210.77/210.94       general; prefer specifics; fewer than 13 amino acids = oligopeptides; %22%primary structure%22% = PROTEIN STRUCTURE, PRIMARY see AMINO ACID SEQUENCE; peptide structure other than primary: coordinate IM with PROTEIN CONFORMATION or its specifics%A%  
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D010455 2006
% 210.77/210.94  |- mesh__recordMaintainer mesh__D010455 nns
% 210.77/210.94  |- skos__related mesh__D010455smesh__D000595
% 210.77/210.94  |- skos__scopeNote mesh__D010455
% 210.77/210.94       Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are linear polypeptides that are normally synthesized on RIBOSOMES.%A%    
% 210.77/210.94  |- skos__prefLabel mesh__D010455 Peptides
% 210.77/210.94  |- rdf__type mesh__D010455sskos__Concept
% 210.77/210.94  |- mesh__dateRevised mesh__D010455 2004-07-07
% 210.77/210.94  |- mesh__dateCreated mesh__D010455 1999-01-01
% 210.77/210.94  |- skos__broader mesh__D010455smesh__D000602
% 210.77/210.94  |- mesh__recordAuthorizer mesh__D010455 sjn
% 210.77/210.94  |- rdf__type mesh__D004418sskos__Concept
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D004418 2006
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D004418 2000
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D004418 2005
% 210.77/210.94  |- skos__hiddenLabel mesh__D004418 Paroxysmal Dyspneas
% 210.77/210.94  |- skos__broader mesh__D004418smesh__D004417
% 210.77/210.94  |- skos__hiddenLabel mesh__D004418 Nocturnal Dyspneas, Paroxysmal
% 210.77/210.94  |- skos__altLabel mesh__D004418 Asthma, Cardiac
% 210.77/210.94  |- mesh__recordOriginator mesh__D004418 NLM
% 210.77/210.94  |- skos__scopeNote mesh__D004418
% 210.77/210.94       A disorder characterized by episodes of respiratory distress, usually occurring after several hours of sleep in a reclining position. It is most commonly caused by pulmonary edema resulting from congestive heart failure. The episodes may be accompanied by coughing, a feeling of suffocation, a cold sweat, and tachycardia.%A%    
% 210.77/210.94  |- mesh__recordAuthorizer mesh__D004418 sjn
% 210.77/210.94  |- skos__hiddenLabel mesh__D004418 Cardiac Asthma
% 210.77/210.94  |- skos__altLabel mesh__D004418 Dyspnea, Paroxysmal Nocturnal
% 210.77/210.94  |- skos__broader mesh__D004418smesh__D006333
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D004418 2002
% 210.77/210.94  |- mesh__dateRevised mesh__D004418 1999-11-04
% 210.77/210.94  |- skos__hiddenLabel mesh__D004418 Nocturnal Dyspnea, Paroxysmal
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D004418 2004
% 210.77/210.94  |- mesh__dateCreated mesh__D004418 1999-01-01
% 210.77/210.94  |- skos__hiddenLabel mesh__D004418 Dyspneas, Paroxysmal
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D004418 2003
% 210.77/210.94  |- mesh__recordMaintainer mesh__D004418 KEV
% 210.77/210.94  |- skos__hiddenLabel mesh__D004418 Paroxysmal Dyspnea
% 210.77/210.94  |- skos__hiddenLabel mesh__D004418 Dyspneas, Paroxysmal Nocturnal
% 210.77/210.94  |- skos__prefLabel mesh__D004418 Dyspnea, Paroxysmal
% 210.77/210.94  |- skos__hiddenLabel mesh__D004418 Paroxysmal Nocturnal Dyspnea
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D004418 2001
% 210.77/210.94  |- skos__hiddenLabel mesh__D004418 Paroxysmal Nocturnal Dyspneas
% 210.77/210.94  |- skos__broader mesh__D015140smesh__D002537
% 210.77/210.94  |- skos__historyNote mesh__D015140
% 210.77/210.94       Cerebrovascular Disorders %28%1966-1988%29%
% 210.77/210.94  |- skos__altLabel mesh__D015140 Binswanger Encephalopathy
% 210.77/210.94  |- skos__hiddenLabel mesh__D015140 Vascular Dementias, Subcortical
% 210.77/210.94  |- skos__historyNote mesh__D015140
% 210.77/210.94       Cerebral Arteriosclerosis %28%1966-1988%29%
% 210.77/210.94  |- mesh__historyNote mesh__D015140 1989   
% 210.77/210.94  |- skos__altLabel mesh__D015140
% 210.77/210.94       Subcortical Encephalopathy, Chronic Progressive
% 210.77/210.94  |- skos__altLabel mesh__D015140
% 210.77/210.94       Arteriosclerotic Encephalopathy, Subcortical
% 210.77/210.94  |- skos__prefLabel mesh__D015140 Dementia, Vascular
% 210.77/210.94  |- skos__hiddenLabel mesh__D015140 Binswanger%27%s Encephalopathy
% 210.77/210.94  |- mesh__dateRevised mesh__D015140 2004-07-19
% 210.77/210.94  |- skos__hiddenLabel mesh__D015140 Subcortical Leukoencephalopathies
% 210.77/210.94  |- skos__altLabel mesh__D015140
% 210.77/210.94       Encephalopathy, Subcortical Arteriosclerotic
% 210.77/210.94  |- skos__hiddenLabel mesh__D015140
% 210.77/210.94       Arteriosclerotic Encephalopathies, Subcortical
% 210.77/210.94  |- skos__hiddenLabel mesh__D015140 Subcortical Vascular Dementias
% 210.77/210.94  |- skos__hiddenLabel mesh__D015140 Dementias, Arteriosclerotic
% 210.77/210.94  |- skos__altLabel mesh__D015140 Encephalopathy, Binswanger
% 210.77/210.94  |- skos__hiddenLabel mesh__D015140 Vascular Dementia, Subcortical
% 210.77/210.94  |- skos__hiddenLabel mesh__D015140 Disease, Binswanger
% 210.77/210.94  |- skos__altLabel mesh__D015140 Encephalopathy, Binswanger%27%s
% 210.77/210.94  |- skos__hiddenLabel mesh__D015140
% 210.77/210.94       Subcortical Arteriosclerotic Encephalopathies
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D015140 2006
% 210.77/210.94  |- skos__altLabel mesh__D015140
% 210.77/210.94       Encephalopathy, Subcortical, Chronic Progressive
% 210.77/210.94  |- skos__altLabel mesh__D015140
% 210.77/210.94       Encephalopathy, Chronic Progressive Subcortical
% 210.77/210.94  |- skos__hiddenLabel mesh__D015140 Vascular Dementias
% 210.77/210.94  |- mesh__dateCreated mesh__D015140 1988-03-18
% 210.77/210.94  |- mesh__recordAuthorizer mesh__D015140 sjn
% 210.77/210.94  |- skos__hiddenLabel mesh__D015140 Arteriosclerotic Dementias
% 210.77/210.94  |- mesh__recordMaintainer mesh__D015140 jls
% 210.77/210.94  |- mesh__recordOriginator mesh__D015140 EC
% 210.77/210.94  |- skos__altLabel mesh__D015140 Leukoencephalopathy, Subcortical
% 210.77/210.94  |- skos__altLabel mesh__D015140
% 210.77/210.94       Chronic Progressive Subcortical Encephalopathy
% 210.77/210.94  |- skos__hiddenLabel mesh__D015140 Dementias, Vascular
% 210.77/210.94  |- skos__hiddenLabel mesh__D015140
% 210.77/210.94       Encephalopathies, Subcortical Arteriosclerotic
% 210.77/210.94  |- skos__broader mesh__D015140smesh__D003704
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D015140 2005
% 210.77/210.94  |- skos__scopeNote mesh__D015140
% 210.77/210.94       An imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION %28%single or multiple%29%, and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described. %28%From Gerontol Geriatr 1998 Feb;31%28%1%29%:36-44%29%%A%    
% 210.77/210.94  |- rdf__type mesh__D015140sskos__Concept
% 210.77/210.94  |- skos__hiddenLabel mesh__D015140 Dementia, Arteriosclerotic
% 210.77/210.94  |- mesh__publicMeSHNote mesh__D015140 1989   
% 210.77/210.94  |- skos__hiddenLabel mesh__D015140 Dementias, Subcortical Vascular
% 210.77/210.94  |- skos__altLabel mesh__D015140 Acute Onset Vascular Dementia
% 210.77/210.94  |- skos__hiddenLabel mesh__D015140 Leukoencephalopathies, Subcortical
% 210.77/210.94  |- skos__hiddenLabel mesh__D015140 Encephalopathy, Binswangers
% 210.77/210.94  |- skos__historyNote mesh__D015140 Dementia %28%1981-1988%29%
% 210.77/210.94  |- skos__hiddenLabel mesh__D015140 Dementia, Subcortical Vascular
% 210.77/210.94  |- skos__altLabel mesh__D015140 Subcortical Leukoencephalopathy
% 210.77/210.94  |- mesh__dateEstablished mesh__D015140 1989-01-01
% 210.77/210.94  |- skos__altLabel mesh__D015140 Vascular Dementia
% 210.77/210.94  |- skos__broader mesh__D015140smesh__D002561
% 210.77/210.94  |- skos__altLabel mesh__D015140 Subcortical Arteriosclerotic Encephalopathy
% 210.77/210.94  |- skos__scopeNote mesh__D009901
% 210.77/210.94       Conditions which produce injury or dysfunction of the second cranial or optic nerve, which is generally considered a component of the central nervous system. Damage to optic nerve fibers may occur at or near their origin in the retina, at the optic disk, or in the nerve, optic chiasm, optic tract, or lateral geniculate nuclei. Clinical manifestations may include decreased visual acuity and contrast sensitivity, impaired color vision, and an afferent pupillary defect.%A%    
% 210.77/210.94  |- skos__prefLabel mesh__D009901 Optic Nerve Diseases
% 210.77/210.94  |- skos__altLabel mesh__D009901 Second Cranial Nerve Diseases
% 210.77/210.94  |- mesh__dateCreated mesh__D009901 1975-07-25
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D009901 2004
% 210.77/210.94  |- skos__broader mesh__D009901smesh__D003389
% 210.77/210.94  |- skos__hiddenLabel mesh__D009901 Lesion, Neural-Optical
% 210.77/210.94  |- mesh__recordMaintainer mesh__D009901 KEV
% 210.77/210.94  |- skos__hiddenLabel mesh__D009901 Neuropathy, Optic
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D009901 2000
% 210.77/210.94  |- skos__altLabel mesh__D009901 Optic Neuropathy
% 210.77/210.94  |- skos__hiddenLabel mesh__D009901 Neural-Optical Lesions
% 210.77/210.94  |- skos__hiddenLabel mesh__D009901 Optic Nerve Disease
% 210.77/210.94  |- skos__historyNote mesh__D009901 Optic Nerve %28%1966-1975%29%
% 210.77/210.94  |- skos__broader mesh__D009901smesh__D005128
% 210.77/210.94  |- skos__altLabel mesh__D009901 Cranial Nerve II Diseases
% 210.77/210.94  |- mesh__dateRevised mesh__D009901 1999-11-04
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D009901 2001
% 210.77/210.94  |- rdf__type mesh__D009901sskos__Concept
% 210.77/210.94  |- skos__altLabel mesh__D009901 Neural-Optical Lesion
% 210.77/210.94  |- skos__hiddenLabel mesh__D009901 Optic Disk Disorder
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D009901 2005
% 210.77/210.94  |- skos__altLabel mesh__D009901 Cranial Nerve II Disorder
% 210.77/210.94  |- mesh__recordOriginator mesh__D009901 SMH
% 210.77/210.94  |- skos__annotation mesh__D009901
% 210.77/210.94       SMON: see note on OPTIC NEURITIS; inflamm dis = OPTIC NEURITIS%A%  
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D009901 2002
% 210.77/210.94  |- skos__hiddenLabel mesh__D009901 Foster Kennedy Syndrome
% 210.77/210.94  |- skos__hiddenLabel mesh__D009901 Syndrome, Foster-Kennedy
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D009901 2006
% 210.77/210.94  |- mesh__historyNote mesh__D009901 76; was NON MESH before 1976   
% 210.77/210.94  |- mesh__recordAuthorizer mesh__D009901 sjn
% 210.77/210.94  |- mesh__dateEstablished mesh__D009901 1976-01-01
% 210.77/210.94  |- skos__hiddenLabel mesh__D009901 Disk Disorders, Optic
% 210.77/210.94  |- skos__hiddenLabel mesh__D009901 Neural Optical Lesion
% 210.77/210.94  |- skos__hiddenLabel mesh__D009901 Disk Disorder, Optic
% 210.77/210.94  |- skos__hiddenLabel mesh__D009901 Optic Neuropathies
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D009901 2003
% 210.77/210.94  |- mesh__publicMeSHNote mesh__D009901 76   
% 210.77/210.94  |- skos__hiddenLabel mesh__D009901 Neuropathies, Optic
% 210.77/210.94  |- skos__hiddenLabel mesh__D009901 Lesions, Neural-Optical
% 210.77/210.94  |- mesh__dateRevised mesh__D009103 2004-07-29
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D009103 2004
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D009103 2005A
% 210.77/210.94  |- skos__prefLabel mesh__D009103 Multiple Sclerosis
% 210.77/210.94  |- skos__altLabel mesh__D009103 Sclerosis, Disseminated
% 210.77/210.94  |- skos__hiddenLabel mesh__D009103 Disseminated Sclerosis
% 210.77/210.94  |- skos__hiddenLabel mesh__D009103 Sclerosis, Multiple
% 210.77/210.94  |- skos__broader mesh__D009103smesh__D020278
% 210.77/210.94  |- mesh__recordMaintainer mesh__D009103 jls
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D009103 2005
% 210.77/210.94  |- mesh__recordOriginator mesh__D009103 NLM
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D009103 2006
% 210.77/210.94  |- skos__scopeNote mesh__D009103
% 210.77/210.94       An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery %28%see MULTIPLE SCLEROSIS, RELAPSING-REMITTING%29%, but acute fulminating and chronic progressive forms %28%see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE%29% also occur. %28%Adams et al., Principles of Neurology, 6th ed, p903%29%%A%    
% 210.77/210.94  |- skos__related mesh__D009103smesh__D009188
% 210.77/210.94  |- mesh__recordAuthorizer mesh__D009103 jls
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D009103 2003
% 210.77/210.94  |- rdf__type mesh__D009103sskos__Concept
% 210.77/210.94  |- skos__altLabel mesh__D009103 MS %28%Multiple Sclerosis%29%
% 210.77/210.94  |- mesh__dateCreated mesh__D009103 1999-01-01
% 210.77/210.94  |- skos__annotation mesh__D001120 /biosyn /defic /physiol permitted   
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D001120 2003
% 210.77/210.94  |- skos__broader mesh__D001120smesh__D024361
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D001120 2005
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D001120 2004
% 210.77/210.94  |- skos__prefLabel mesh__D001120 Arginine
% 210.77/210.94  |- skos__broader mesh__D001120smesh__D000599
% 210.77/210.94  |- skos__hiddenLabel mesh__D001120 Monohydrate DL-Arginine Acetate
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D001120 2006
% 210.77/210.94  |- skos__altLabel mesh__D001120 L-Arginine
% 210.77/210.94  |- skos__broader mesh__D001120smesh__D000601
% 210.77/210.94  |- rdf__type mesh__D001120sskos__Concept
% 210.77/210.94  |- mesh__recordOriginator mesh__D001120 NLM
% 210.77/210.94  |- mesh__recordAuthorizer mesh__D001120 sjn
% 210.77/210.94  |- skos__hiddenLabel mesh__D001120 DL Arginine Acetate, Monohydrate
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D001120 2002
% 210.77/210.94  |- mesh__dateCreated mesh__D001120 1999-01-01
% 210.77/210.94  |- skos__hiddenLabel mesh__D001120 L-Isomer Arginine
% 210.77/210.94  |- mesh__recordMaintainer mesh__D001120 nns
% 210.77/210.94  |- skos__scopeNote mesh__D001120
% 210.77/210.94       An essential amino acid that is physiologically active in the L-form.%A%    
% 210.77/210.94  |- skos__hiddenLabel mesh__D001120 Arginine, L Isomer
% 210.77/210.94  |- skos__altLabel mesh__D001120 Arginine, L-Isomer
% 210.77/210.94  |- mesh__dateRevised mesh__D001120 2001-07-25
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D020883 2006
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D020883 2001
% 210.77/210.94  |- skos__scopeNote mesh__D020883
% 210.77/210.94       An incision in the uterus, performed through either the abdomen or the vagina.%A%    
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D020883 2004
% 210.77/210.94  |- mesh__historyNote mesh__D020883 2000   
% 210.77/210.94  |- mesh__dateRevised mesh__D020883 1999-12-28
% 210.77/210.94  |- mesh__recordAuthorizer mesh__D020883 ags
% 210.77/210.94  |- mesh__dateCreated mesh__D020883 1999-11-03
% 210.77/210.94  |- skos__prefLabel mesh__D020883 Hysterotomy
% 210.77/210.94  |- mesh__recordOriginator mesh__D020883 nns
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D020883 2002
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D020883 2000A
% 210.77/210.94  |- mesh__recordMaintainer mesh__D020883 ags
% 210.77/210.94  |- mesh__publicMeSHNote mesh__D020883 2000   
% 210.77/210.94  |- skos__hiddenLabel mesh__D020883 Hysterotomies
% 210.77/210.94  |- skos__broader mesh__D020883smesh__D013513
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D020883 2005
% 210.77/210.94  |- skos__historyNote mesh__D020883 Uterus/surgery %28%1966-1999%29%
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D020883 2000
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D020883 2003
% 210.77/210.94  |- mesh__dateEstablished mesh__D020883 2000-01-01
% 210.77/210.94  |- rdf__type mesh__D020883sskos__Concept
% 210.77/210.94  |- skos__prefLabel mesh__D020085 Neocallimasticales
% 210.77/210.94  |- mesh__historyNote mesh__D020085 99   
% 210.77/210.94  |- skos__scopeNote mesh__D020085
% 210.77/210.94       An order of fungi in the phylum CHYTRIDIOMYCOTA comprising anaerobic chytrids that inhabit the RUMEN; and CECUM of herbivorous animals. Genera %28%all in the lone family Neocallimasticaceae%29% include NEOCALLIMASTIX, Orpinomyces, PIROMYCES, and Caecomyces.%A%    
% 210.77/210.94  |- mesh__dateEstablished mesh__D020085 1999-01-01
% 210.77/210.94  |- mesh__recordOriginator mesh__D020085 AGS
% 210.77/210.94  |- mesh__recordMaintainer mesh__D020085 SYSTEM
% 210.77/210.94  |- mesh__dateCreated mesh__D020085 1998-06-10
% 210.77/210.94  |- mesh__publicMeSHNote mesh__D020085 99   
% 210.77/210.94  |- skos__broader mesh__D020085smesh__D008411
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D020085 2006
% 210.77/210.94  |- skos__altLabel mesh__D020085 Sphaeromonas
% 210.77/210.94  |- rdf__type mesh__D020085sskos__Concept
% 210.77/210.94  |- mesh__dateRevised mesh__D020085 2005-06-30
% 210.77/210.94  |- mesh__recordAuthorizer mesh__D020085 sjn
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D014846 2006
% 210.77/210.94  |- skos__scopeNote mesh__D014846 Tumors or cancer of the VULVA.     
% 210.77/210.94  |- skos__altLabel mesh__D014846 Vulva Cancer
% 210.77/210.94  |- skos__broader mesh__D014846smesh__D014845
% 210.77/210.94  |- skos__broader mesh__D014846smesh__D005833
% 210.77/210.94  |- skos__altLabel mesh__D014846 Cancer of the Vulva
% 210.77/210.94  |- skos__hiddenLabel mesh__D014846 Neoplasm, Vulvar
% 210.77/210.94  |- mesh__recordMaintainer mesh__D014846 lkt
% 210.77/210.94  |- skos__hiddenLabel mesh__D014846 Vulvar Cancers
% 210.77/210.94  |- skos__hiddenLabel mesh__D014846 Cancer, Vulvar
% 210.77/210.94  |- mesh__recordOriginator mesh__D014846 NLM
% 210.77/210.94  |- mesh__recordAuthorizer mesh__D014846 sjn
% 210.77/210.94  |- rdf__type mesh__D014846sskos__Concept
% 210.77/210.94  |- mesh__dateRevised mesh__D014846 2005-06-30
% 210.77/210.94  |- skos__hiddenLabel mesh__D014846 Vulva Neoplasm
% 210.77/210.94  |- skos__prefLabel mesh__D014846 Vulvar Neoplasms
% 210.77/210.94  |- skos__annotation mesh__D014846
% 210.77/210.94       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%  
% 210.77/210.94  |- skos__hiddenLabel mesh__D014846 Cancer, Vulva
% 210.77/210.94  |- skos__hiddenLabel mesh__D014846 Vulva Cancers
% 210.77/210.94  |- skos__hiddenLabel mesh__D014846 Cancers, Vulva
% 210.77/210.94  |- skos__hiddenLabel mesh__D014846 Cancers, Vulvar
% 210.77/210.94  |- skos__hiddenLabel mesh__D014846 Vulvar Neoplasm
% 210.77/210.94  |- skos__hiddenLabel mesh__D014846 Neoplasm, Vulva
% 210.77/210.94  |- skos__hiddenLabel mesh__D014846 Neoplasms, Vulva
% 210.77/210.94  |- skos__altLabel mesh__D014846 Neoplasms, Vulvar
% 210.77/210.94  |- mesh__dateCreated mesh__D014846 1999-01-01
% 210.77/210.94  |- skos__altLabel mesh__D014846 Vulvar Cancer
% 210.77/210.94  |- skos__altLabel mesh__D014846 Vulva Neoplasms
% 210.77/210.94  |- skos__hiddenLabel mesh__D014048 CI52040
% 210.77/210.94  |- mesh__recordOriginator mesh__D014048 NLM
% 210.77/210.94  |- skos__annotation mesh__D014048 D25-26 qualif   
% 210.77/210.94  |- mesh__recordAuthorizer mesh__D014048 sjn
% 210.77/210.94  |- rdf__type mesh__D014048sskos__Concept
% 210.77/210.94  |- skos__hiddenLabel mesh__D014048 CI 52040
% 210.77/210.94  |- skos__hiddenLabel mesh__D014048 Blue, Toluidine
% 210.77/210.94  |- skos__hiddenLabel mesh__D014048 Blue O, Toluidine
% 210.77/210.94  |- mesh__dateCreated mesh__D014048 1999-01-01
% 210.77/210.94  |- skos__altLabel mesh__D014048 Toluidine Blue
% 210.77/210.94  |- skos__hiddenLabel mesh__D014048 O, Toluidine Blue
% 210.77/210.94  |- skos__hiddenLabel mesh__D014048 Chloride, Tolonium
% 210.77/210.94  |- skos__altLabel mesh__D014048 Toluidine Blue O
% 210.77/210.94  |- mesh__publicMeSHNote mesh__D014048
% 210.77/210.94       74; was see under HEMOSTATICS 1963-73   
% 210.77/210.94  |- mesh__onlineNote mesh__D014048
% 210.77/210.94       use TOLONIUM CHLORIDE to search TOLUIDINE BLUE O 1972-73 %28%as Prov 1972-73%29%; search HEMOSTATICS 1966-71%A%  
% 210.77/210.94  |- skos__broader mesh__D014048smesh__D010640
% 210.77/210.94  |- skos__scopeNote mesh__D014048
% 210.77/210.94       A phenothiazine that has been used as a hemostatic, a biological stain, and a dye for wool and silk. Tolonium chloride has also been used as a diagnostic aid for oral and gastric neoplasms and in the identification of the parathyroid gland in thyroid surgery.%A%    
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D014048 2006
% 210.77/210.94  |- skos__prefLabel mesh__D014048 Tolonium Chloride
% 210.77/210.94  |- mesh__dateRevised mesh__D014048 2005-06-30
% 210.77/210.94  |- mesh__historyNote mesh__D014048
% 210.77/210.94       74; was see under HEMOSTATICS 1963-73, was TOLUIDINE BLUE O 1972-73 %28%Prov%29%%A%  
% 210.77/210.94  |- mesh__recordMaintainer mesh__D014048 ssb
% 210.77/210.94  |- mesh__recordMaintainer mesh__D008809 ags
% 210.77/210.94  |- skos__hiddenLabel mesh__D008809 C3H Mice
% 210.77/210.94  |- skos__broader mesh__D008809smesh__D008815
% 210.77/210.94  |- mesh__publicMeSHNote mesh__D008809 74   
% 210.77/210.94  |- mesh__dateEstablished mesh__D008809 1974-01-01
% 210.77/210.94  |- skos__annotation mesh__D008809
% 210.77/210.94       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%  
% 210.77/210.94  |- skos__historyNote mesh__D008809 Mice %28%1966-1971%29%
% 210.77/210.94  |- skos__altLabel mesh__D008809 Mouse, Inbred C3H
% 210.77/210.94  |- mesh__dateRevised mesh__D008809 2005-06-30
% 210.77/210.94  |- skos__altLabel mesh__D008809 Mouse, C3H
% 210.77/210.94  |- skos__hiddenLabel mesh__D008809 Inbred C3H Mice
% 210.77/210.94  |- skos__hiddenLabel mesh__D008809 C3H Mouse
% 210.77/210.94  |- skos__hiddenLabel mesh__D008809 C3H Mice, Inbred
% 210.77/210.94  |- skos__prefLabel mesh__D008809 Mice, Inbred C3H
% 210.77/210.94  |- skos__altLabel mesh__D008809 Mice, C3H
% 210.77/210.94  |- mesh__recordOriginator mesh__D008809 NLM
% 210.77/210.94  |- skos__hiddenLabel mesh__D008809 Inbred C3H Mouse
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D008809 2006
% 210.77/210.94  |- mesh__dateCreated mesh__D008809 1999-01-01
% 210.77/210.94  |- mesh__historyNote mesh__D008809 74%28%72%29%   
% 210.77/210.94  |- mesh__recordAuthorizer mesh__D008809 sjn
% 210.77/210.94  |- rdf__type mesh__D008809sskos__Concept
% 210.77/210.94  |- skos__hiddenLabel mesh__D008809 C3H Mouse, Inbred
% 210.77/210.94  |- skos__annotation mesh__D000826 SPEC qualif   
% 210.77/210.94  |- mesh__publicMeSHNote mesh__D000826 85   
% 210.77/210.94  |- skos__hiddenLabel mesh__D000826 Alternative, Animal Testing
% 210.77/210.94  |- mesh__dateRevised mesh__D000826 2005-08-02
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D000826 2004
% 210.77/210.94  |- skos__altLabel mesh__D000826 Alternatives to Animal Testing
% 210.77/210.94  |- mesh__recordAuthorizer mesh__D000826 ags
% 210.77/210.94  |- rdf__type mesh__D000826sskos__Concept
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D000826 2006A
% 210.77/210.94  |- skos__prefLabel mesh__D000826 Animal Testing Alternatives
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D000826 2006
% 210.77/210.94  |- skos__hiddenLabel mesh__D000826 Animal Testing Alternative
% 210.77/210.94  |- mesh__dateEstablished mesh__D000826 1985-01-01
% 210.77/210.94  |- mesh__dateCreated mesh__D000826 1984-06-11
% 210.77/210.94  |- mesh__historyNote mesh__D000826 85   
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D000826 2003
% 210.77/210.94  |- skos__hiddenLabel mesh__D000826 Testing Alternative, Animal
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D000826 2005
% 210.77/210.94  |- skos__hiddenLabel mesh__D000826 Testing Alternatives, Animal
% 210.77/210.94  |- skos__broader mesh__D000826smesh__D023401
% 210.77/210.94  |- mesh__recordMaintainer mesh__D000826 ags
% 210.77/210.94  |- mesh__recordOriginator mesh__D000826 CAB
% 210.77/210.94  |- skos__scopeNote mesh__D000826
% 210.77/210.94       Procedures, such as TISSUE CULTURE TECHNIQUES; mathematical models; etc., when used or advocated for use in place of the use of animals in research or diagnostic laboratories.%A%    
% 210.77/210.94  |- skos__hiddenLabel mesh__D000826 Alternatives, Animal Testing
% 210.77/210.94  |- mesh__recordMaintainer mesh__D019531 jls
% 210.77/210.94  |- rdf__type mesh__D019531sskos__Concept
% 210.77/210.94  |- mesh__dateCreated mesh__D019531 1996-06-21
% 210.77/210.94  |- mesh__recordOriginator mesh__D019531 TGC
% 210.77/210.94  |- skos__altLabel mesh__D019531 Lectures %28%PT%29%
% 210.77/210.94  |- mesh__dateRevised mesh__D019531 2005-06-30
% 210.77/210.94  |- skos__prefLabel mesh__D019531 Lectures %5B%Publication Type%5D%
% 210.77/210.94  |- skos__broader mesh__D019531smesh__D019484
% 210.77/210.94  |- skos__altLabel mesh__D019531 Lectures
% 210.77/210.94  |- mesh__historyNote mesh__D019531 1997   
% 210.77/210.94  |- skos__scopeNote mesh__D019531
% 210.77/210.94       Works consisting of speeches read or delivered before an audience or class, especially for instruction or to set forth some subject. They are differentiated from ADDRESSES %5B%PUBLICATION TYPE%5D% which are less didactic and more informational, entertaining, inspirational, or polemic. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 210.77/210.94  |- mesh__dateEstablished mesh__D019531 1997-01-01
% 210.77/210.94  |- mesh__recordAuthorizer mesh__D019531 sjn
% 210.77/210.94  |- skos__annotation mesh__D019531
% 210.77/210.94       publication type only; usually for instruction; do not confuse with the publication type ADDRESSES; CATALOG:  publication type LECTURE NOTES is also available%A%  
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D019531 2006
% 210.77/210.94  |- skos__historyNote mesh__D033202 Crustacea %28%1968-2002%29%
% 210.77/210.94  |- skos__altLabel mesh__D033202 Fairy Shrimp
% 210.77/210.94  |- skos__prefLabel mesh__D033202 Anostraca
% 210.77/210.94  |- skos__annotation mesh__D033202
% 210.77/210.94       note X ref FAIRY SHRIMP: several other shrimp terms are available; check text and MeSH; as animal %26% food; as food, coord IM with SHELLFISH %28%IM%29%; unspecified shrimp as food is probably PENAEIDAE%A%  
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D033202 2004
% 210.77/210.94  |- mesh__historyNote mesh__D033202 2003   
% 210.77/210.94  |- mesh__publicMeSHNote mesh__D033202 2003   
% 210.77/210.94  |- skos__broader mesh__D033202smesh__D003445
% 210.77/210.94  |- mesh__dateCreated mesh__D033202 2002-07-02
% 210.77/210.94  |- skos__altLabel mesh__D033202 Shrimp, Fairy
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D033202 2005
% 210.77/210.94  |- mesh__dateRevised mesh__D033202 2003-07-09
% 210.77/210.94  |- mesh__dateEstablished mesh__D033202 2003-01-01
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D033202 2006
% 210.77/210.94  |- rdf__type mesh__D033202sskos__Concept
% 210.77/210.94  |- skos__scopeNote mesh__D033202
% 210.77/210.94       An order of CRUSTACEA comprised of shrimp-like organisms containing body trunks with at least 20 segments. The are commonly used as aquarium food.%A%    
% 210.77/210.94  |- skos__hiddenLabel mesh__D000028 Abortions, Previous
% 210.77/210.94  |- mesh__dateCreated mesh__D000028 1999-01-01
% 210.77/210.94  |- skos__hiddenLabel mesh__D000028 Abortions, Drug-Induced
% 210.77/210.94  |- skos__annotation mesh__D000028
% 210.77/210.94       do not use /util except by MeSH definition; for use of an abortifacient here or in ABORTION, CRIMINAL, coord IM with abortifacient agent %28%IM with no qualif, not /adv eff unless text specifically discusses adverse eff%29%; don%27%t forget also check tags FEMALE %26% PREGNANCY%A%  
% 210.77/210.94  |- skos__hiddenLabel mesh__D000028 Anti-Abortion Group
% 210.77/210.94  |- skos__hiddenLabel mesh__D000028 Embryotomies
% 210.77/210.94  |- mesh__activeMeSHYear mesh__D000028 2005
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Soap-Solution Abortion
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Histories, Abortion
% 210.77/210.95  |- mesh__dateEstablished mesh__D000028 1971-01-01
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Rivanol Abortion
% 210.77/210.95  |- skos__altLabel mesh__D000028 Abortion %28%Induced%29%
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Postconception Fertility Control
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D000028 2004
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Abortion Rates
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Abortions %28%Induced%29%
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Anti Abortion Groups
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Abortion, Drug Induced
% 210.77/210.95  |- mesh__dateRevised mesh__D000028 2002-07-02
% 210.77/210.95  |- mesh__recordOriginator mesh__D000028 NLM
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Failures, Abortion
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Induced Abortions
% 210.77/210.95  |- skos__related mesh__D000028smesh__D037881
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Abortion, Previous
% 210.77/210.95  |- skos__altLabel mesh__D000028 Induced Abortion
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Rate, Abortion
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Abortion, Soap Solution
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Previous Abortions
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Abortions, Rivanol
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Drug-Induced Abortion
% 210.77/210.95  |- skos__altLabel mesh__D000028 Abortion History
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Technic, Abortion
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Saline-Solution Abortions
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Abortion Technic
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D000028 2003
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Abortion Failures
% 210.77/210.95  |- rdf__type mesh__D000028sskos__Concept
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Techniques, Abortion
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Group, Anti-Abortion
% 210.77/210.95  |- skos__scopeNote mesh__D000028
% 210.77/210.95       Intentional removal of a fetus from the uterus by any of a number of techniques. %28%POPLINE, 1978%29%%A%    
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Abortions, Induced
% 210.77/210.95  |- mesh__onlineNote mesh__D000028
% 210.77/210.95       use ABORTION, INDUCED to search EMBRYOTOMY 1966-85; search ABORTION, CRIMINAL %26% ABORTION, LEGAL %26% ABORTION, THERAPEUTIC 1966-70%A%  
% 210.77/210.95  |- mesh__historyNote mesh__D000028
% 210.77/210.95       71; was see under ABORTION, CRIMINAL %26% ABORTION, THERAPEUTIC 1963-70, was see under ABORTION, LEGAL 1964-70; EMBRYOTOMY was heading 1963-85%A%  
% 210.77/210.95  |- skos__historyNote mesh__D000028 Abortion, Therapeutic %28%1966-1970%29%
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Abortions, Saline-Solution
% 210.77/210.95  |- skos__historyNote mesh__D000028 Abortion, Legal %28%1966-1970%29%
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Abortion Histories
% 210.77/210.95  |- skos__altLabel mesh__D000028 Abortion Technics
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Abortion, Saline Solution
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Saline-Solution Abortion
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Abortion Technique
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Technics, Abortion
% 210.77/210.95  |- skos__historyNote mesh__D000028 Abortion, Criminal %28%1966-1970%29%
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Failure, Abortion
% 210.77/210.95  |- mesh__recordAuthorizer mesh__D000028 sjn
% 210.77/210.95  |- mesh__recordMaintainer mesh__D000028 hjn
% 210.77/210.95  |- skos__prefLabel mesh__D000028 Abortion, Induced
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Technique, Abortion
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Groups, Anti-Abortion
% 210.77/210.95  |- skos__broader mesh__D000028smesh__D013513
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Abortions, Soap-Solution
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Drug-Induced Abortions
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D000028 2006
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Rivanol Abortions
% 210.77/210.95  |- mesh__publicMeSHNote mesh__D000028
% 210.77/210.95       71; was see under ABORTION, CRIMINAL %26% ABORTION, THERAPEUTIC 1963-70, was see under ABORTION, LEGAL 1964-70; EMBRYOTOMY was heading 1963-85%A%  
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 History, Abortion
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Rates, Abortion
% 210.77/210.95  |- skos__hiddenLabel mesh__D000028 Soap-Solution Abortions
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D005511 2004
% 210.77/210.95  |- skos__related mesh__D005511smesh__D015416
% 210.77/210.95  |- skos__hiddenLabel mesh__D005511 Handling, Food
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D005511 2002
% 210.77/210.95  |- mesh__recordMaintainer mesh__D005511 JLS
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D005511 2006
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D005511 1998
% 210.77/210.95  |- mesh__dateRevised mesh__D005511 1997-06-20
% 210.77/210.95  |- skos__broader mesh__D005511smesh__D019649
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D005511 1999
% 210.77/210.95  |- skos__prefLabel mesh__D005511 Food Handling
% 210.77/210.95  |- skos__scopeNote mesh__D005511
% 210.77/210.95       Any aspect of the operations in the preparation, transport, storage, packaging, wrapping, exposure for sale, service, or delivery of food.%A%    
% 210.77/210.95  |- mesh__recordOriginator mesh__D005511 NLM
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D005511 2000
% 210.77/210.95  |- mesh__recordAuthorizer mesh__D005511 SJN
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D005511 2001
% 210.77/210.95  |- skos__hiddenLabel mesh__D005511 Processing, Food
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D005511 2003
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D005511 2005
% 210.77/210.95  |- rdf__type mesh__D005511sskos__Concept
% 210.77/210.95  |- mesh__dateCreated mesh__D005511 1999-01-01
% 210.77/210.95  |- skos__annotation mesh__D005511
% 210.77/210.95       includes prep, processing, handling, transport, serving, delivering, etc.%A%  
% 210.77/210.95  |- skos__altLabel mesh__D046928 Peptidoglycan TGase
% 210.77/210.95  |- mesh__publicMeSHNote mesh__D046928
% 210.77/210.95       2005; PEPTIDOGLYCAN GLYCOSYLTRANSFERASE was indexed under HEXOSYLTRANSFERASES 1981-2004%A%  
% 210.77/210.95  |- mesh__dateCreated mesh__D046928 2004-07-07
% 210.77/210.95  |- skos__prefLabel mesh__D046928 Peptidoglycan Glycosyltransferase
% 210.77/210.95  |- skos__hiddenLabel mesh__D046928 Transglycosylase, Peptidoglycan
% 210.77/210.95  |- skos__hiddenLabel mesh__D046928 Glycosyltransferase, Peptidoglycan
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D046928 2005
% 210.77/210.95  |- skos__altLabel mesh__D046928 Peptidoglycan Transglycosylase
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D046928 2006
% 210.77/210.95  |- rdf__type mesh__D046928sskos__Concept
% 210.77/210.95  |- skos__scopeNote mesh__D046928
% 210.77/210.95       A hexosyltransferase involved in the transfer of disaccharide molecules to the peptidoglycan structure of the CELL WALL SKELETON. It plays an important role in the genesis of the bacterial CELL WALL.%A%    
% 210.77/210.95  |- mesh__recordMaintainer mesh__D046928 jmp
% 210.77/210.95  |- mesh__recordOriginator mesh__D046928 jmp
% 210.77/210.95  |- mesh__recordAuthorizer mesh__D046928 sjn
% 210.77/210.95  |- mesh__dateEstablished mesh__D046928 2005-01-01
% 210.77/210.95  |- skos__historyNote mesh__D046928 Hexosyltransferases %28%1981-2004%29%
% 210.77/210.95  |- skos__broader mesh__D046928smesh__D006602
% 210.77/210.95  |- mesh__historyNote mesh__D046928
% 210.77/210.95       2005; use PEPTIDOGLYCAN GLYCOSYLTRANSFERASE %28%NM%29% 1981-2004%A%  
% 210.77/210.95  |- skos__broader mesh__D014867Q000382smesh__D014867
% 210.77/210.95  |- mesh__preferredCombination mesh__D014867Q000382smesh__D014871
% 210.77/210.95  |- rdf__type mesh__D014867Q000382smesh__CompoundConcept
% 210.77/210.95  |- skos__broader mesh__D010456smesh__D010455
% 210.77/210.95  |- skos__historyNote mesh__D010456 Peptides %28%1966-1970%29%
% 210.77/210.95  |- rdf__type mesh__D010456sskos__Concept
% 210.77/210.95  |- mesh__recordMaintainer mesh__D010456 ssb
% 210.77/210.95  |- mesh__recordAuthorizer mesh__D010456 sjn
% 210.77/210.95  |- mesh__dateRevised mesh__D010456 2004-07-07
% 210.77/210.95  |- mesh__recordOriginator mesh__D010456 NLM
% 210.77/210.95  |- mesh__dateCreated mesh__D010456 1999-01-01
% 210.77/210.95  |- mesh__publicMeSHNote mesh__D010456 73   
% 210.77/210.95  |- skos__prefLabel mesh__D010456 Peptides, Cyclic
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D010456 2005
% 210.77/210.95  |- mesh__historyNote mesh__D010456 73%28%71%29%   
% 210.77/210.95  |- mesh__dateEstablished mesh__D010456 1973-01-01
% 210.77/210.95  |- skos__broader mesh__D010456smesh__D047028
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D010456 2006
% 210.77/210.95  |- skos__hiddenLabel mesh__D010456 Cyclic Peptides
% 210.77/210.95  |- skos__hiddenLabel mesh__D029161 Oleaviruses
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D029161 2003
% 210.77/210.95  |- mesh__dateEstablished mesh__D029161 2002-01-01
% 210.77/210.95  |- skos__historyNote mesh__D029161 Bromoviridae %28%1997-2001%29%
% 210.77/210.95  |- mesh__publicMeSHNote mesh__D029161 2002   
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D029161 2006
% 210.77/210.95  |- skos__broader mesh__D029161smesh__D019177
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D029161 2002
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D029161 2005
% 210.77/210.95  |- skos__prefLabel mesh__D029161 Oleavirus
% 210.77/210.95  |- skos__annotation mesh__D029161 coord IM with speciic plant /virol   
% 210.77/210.95  |- mesh__historyNote mesh__D029161 2002   
% 210.77/210.95  |- skos__scopeNote mesh__D029161
% 210.77/210.95       A genus in the family BROMOVIRIDAE containing one species: Olive latent virus 2.%A%    
% 210.77/210.95  |- rdf__type mesh__D029161sskos__Concept
% 210.77/210.95  |- mesh__dateCreated mesh__D029161 2001-07-25
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D029161 2004
% 210.77/210.95  |- mesh__dateCreated mesh__D004419 1999-01-01
% 210.77/210.95  |- mesh__recordMaintainer mesh__D004419 jmp
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D004419 2003
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D004419 2002
% 210.77/210.95  |- skos__scopeNote mesh__D004419
% 210.77/210.95       Dysprosium. An element of the rare earth family that has the atomic symbol Dy, atomic number 66, and atomic weight 162.50. Dysprosium is a silvery metal used primarily in the form of various salts.%A%    
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D004419 2004
% 210.77/210.95  |- mesh__dateRevised mesh__D004419 2001-07-25
% 210.77/210.95  |- skos__prefLabel mesh__D004419 Dysprosium
% 210.77/210.95  |- mesh__recordAuthorizer mesh__D004419 sjn
% 210.77/210.95  |- skos__broader mesh__D004419smesh__D028581
% 210.77/210.95  |- skos__annotation mesh__D004419
% 210.77/210.95       a rare earth metal; Dy-164; Dy-156, 158, 160-163 = DYSPROSIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Dy-149-155, 157, 159, 165-167 = DYSPROSIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 210.77/210.95  |- mesh__recordOriginator mesh__D004419 NLM
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D004419 2005
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D004419 2006
% 210.77/210.95  |- rdf__type mesh__D004419sskos__Concept
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D015141 2005
% 210.77/210.95  |- mesh__recordMaintainer mesh__D015141 PXP
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D015141 1998
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D015141 2006
% 210.77/210.95  |- mesh__recordOriginator mesh__D015141 EC
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D015141 1999
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D015141 2002
% 210.77/210.95  |- mesh__recordAuthorizer mesh__D015141 SJN
% 210.77/210.95  |- skos__broader mesh__D015141smesh__D002947
% 210.77/210.95  |- skos__broader mesh__D015141smesh__D002140
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D015141 2003
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D015141 2004
% 210.77/210.95  |- mesh__dateRevised mesh__D015141 1997-06-20
% 210.77/210.95  |- mesh__historyNote mesh__D015141 89   
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D015141 2000
% 210.77/210.95  |- rdf__type mesh__D015141sskos__Concept
% 210.77/210.95  |- skos__prefLabel mesh__D015141 Los Angeles
% 210.77/210.95  |- mesh__dateEstablished mesh__D015141 1989-01-01
% 210.77/210.95  |- mesh__dateCreated mesh__D015141 1988-03-18
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D015141 2001
% 210.77/210.95  |- skos__broader mesh__D009902smesh__D009901
% 210.77/210.95  |- rdf__type mesh__D009902sskos__Concept
% 210.77/210.95  |- skos__hiddenLabel mesh__D009902 Anterior Optic Neuritides
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009902 2000
% 210.77/210.95  |- skos__hiddenLabel mesh__D009902 Neuritis, Optic
% 210.77/210.95  |- skos__hiddenLabel mesh__D009902 Posterior Optic Neuritides
% 210.77/210.95  |- skos__annotation mesh__D009902
% 210.77/210.95       SMON %28%Subacute Myelo-Optico-Neuropathy%29% is indexed here + MYELITIS + SYNDROME%A%  
% 210.77/210.95  |- skos__hiddenLabel mesh__D009902 Neuritis, Posterior Optic
% 210.77/210.95  |- skos__hiddenLabel mesh__D009902 Optic Neuritides, Anterior
% 210.77/210.95  |- skos__hiddenLabel mesh__D009902 Optic Neuritides, Posterior
% 210.77/210.95  |- skos__hiddenLabel mesh__D009902 Neuritides, Optic
% 210.77/210.95  |- mesh__recordAuthorizer mesh__D009902 sjn
% 210.77/210.95  |- skos__hiddenLabel mesh__D009902 Retrobulbar Neuritides
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009902 2004
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009902 2002
% 210.77/210.95  |- skos__hiddenLabel mesh__D009902 Neuritis, Anterior Optic
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009902 2006
% 210.77/210.95  |- skos__related mesh__D009902smesh__D009443
% 210.77/210.95  |- skos__hiddenLabel mesh__D009902 Neuritides, Posterior Optic
% 210.77/210.95  |- skos__hiddenLabel mesh__D009902 Optic Neuritis, Anterior
% 210.77/210.95  |- skos__hiddenLabel mesh__D009902 Neuropapillitides
% 210.77/210.95  |- skos__hiddenLabel mesh__D009902 Neuritides, Anterior Optic
% 210.77/210.95  |- skos__altLabel mesh__D009902 Posterior Optic Neuritis
% 210.77/210.95  |- mesh__recordOriginator mesh__D009902 NLM
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009902 2003
% 210.77/210.95  |- mesh__recordMaintainer mesh__D009902 KEV
% 210.77/210.95  |- skos__prefLabel mesh__D009902 Optic Neuritis
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009902 2001
% 210.77/210.95  |- mesh__dateCreated mesh__D009902 1999-01-01
% 210.77/210.95  |- skos__hiddenLabel mesh__D009902 Optic Neuritis, Posterior
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009902 2005
% 210.77/210.95  |- skos__hiddenLabel mesh__D009902 Neuritides, Retrobulbar
% 210.77/210.95  |- skos__hiddenLabel mesh__D009902 Neuritis, Retrobulbar
% 210.77/210.95  |- skos__altLabel mesh__D009902 Anterior Optic Neuritis
% 210.77/210.95  |- mesh__dateRevised mesh__D009902 1999-11-03
% 210.77/210.95  |- skos__scopeNote mesh__D009902
% 210.77/210.95       Inflammation of the optic nerve. Commonly associated conditions include autoimmune disorders such as MULTIPLE SCLEROSIS, infections, and granulomatous diseases. Clinical features include retro-orbital pain that is aggravated by eye movement, loss of color vision, and contrast sensitivity that may progress to severe visual loss, an afferent pupillary defect %28%Marcus-Gunn pupil%29%, and in some instances optic disc hyperemia and swelling. Inflammation may occur in the portion of the nerve within the globe %28%neuropapillitis or anterior optic neuritis%29% or the portion behind the globe %28%retrobulbar neuritis or posterior optic neuritis%29%.%A%    
% 210.77/210.95  |- skos__hiddenLabel mesh__D009902 Optic Neuritides
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009104 2004
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009104 1995
% 210.77/210.95  |- mesh__recordOriginator mesh__D009104 EC
% 210.77/210.95  |- mesh__dateEstablished mesh__D009104 1988-01-01
% 210.77/210.95  |- skos__hiddenLabel mesh__D009104 Injury, Multiple
% 210.77/210.95  |- mesh__recordAuthorizer mesh__D009104 PLS
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009104 1993
% 210.77/210.95  |- mesh__publicMeSHNote mesh__D009104 88   
% 210.77/210.95  |- skos__hiddenLabel mesh__D009104 Multiple Wound
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009104 2003
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009104 1999
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009104 1994
% 210.77/210.95  |- mesh__recordMaintainer mesh__D009104 TGC
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009104 1992
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009104 2002
% 210.77/210.95  |- skos__broader mesh__D009104smesh__D014947
% 210.77/210.95  |- skos__altLabel mesh__D009104 Multiple Injuries
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009104 1998
% 210.77/210.95  |- skos__prefLabel mesh__D009104 Multiple Trauma
% 210.77/210.95  |- rdf__type mesh__D009104sskos__Concept
% 210.77/210.95  |- mesh__dateRevised mesh__D009104 1991-06-18
% 210.77/210.95  |- skos__annotation mesh__D009104
% 210.77/210.95       coord IM with specific inj term or organ/inj IM or NIM if pertinent%A%  
% 210.77/210.95  |- skos__altLabel mesh__D009104 Injuries, Multiple
% 210.77/210.95  |- skos__hiddenLabel mesh__D009104 Wound, Multiple
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009104 2006
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009104 2001
% 210.77/210.95  |- skos__scopeNote mesh__D009104
% 210.77/210.95       Physical insults or injuries occurring simultaneously in several parts of the body.%A%    
% 210.77/210.95  |- skos__historyNote mesh__D009104 Wounds and Injuries %28%1966-1987%29%
% 210.77/210.95  |- skos__hiddenLabel mesh__D009104 Traumas, Multiple
% 210.77/210.95  |- skos__altLabel mesh__D009104 Wounds, Multiple
% 210.77/210.95  |- skos__hiddenLabel mesh__D009104 Multiple Traumas
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009104 1997
% 210.77/210.95  |- skos__hiddenLabel mesh__D009104 Multiple Wounds
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009104 2005
% 210.77/210.95  |- skos__hiddenLabel mesh__D009104 Multiple Injury
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009104 2000
% 210.77/210.95  |- skos__altLabel mesh__D009104 Trauma, Multiple
% 210.77/210.95  |- mesh__historyNote mesh__D009104 88   
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D009104 1996
% 210.77/210.95  |- mesh__dateCreated mesh__D009104 1987-04-30
% 210.77/210.95  |- skos__altLabel mesh__D001121 Kininase I
% 210.77/210.95  |- mesh__recordAuthorizer mesh__D001121 sjn
% 210.77/210.95  |- rdf__type mesh__D001121sskos__Concept
% 210.77/210.95  |- skos__prefLabel mesh__D001121 Lysine Carboxypeptidase
% 210.77/210.95  |- skos__broader mesh__D001121smesh__D045727
% 210.77/210.95  |- skos__hiddenLabel mesh__D001121 Carboxypeptidase, Lysine
% 210.77/210.95  |- skos__historyNote mesh__D001121 Arginine %28%1972-1974%29%
% 210.77/210.95  |- skos__hiddenLabel mesh__D001121 Inactivator, Anaphylatoxin
% 210.77/210.95  |- skos__broader mesh__D001121smesh__D002268
% 210.77/210.95  |- mesh__dateRevised mesh__D001121 2003-07-09
% 210.77/210.95  |- skos__scopeNote mesh__D001121
% 210.77/210.95       A metallocarboxypeptidase that removes C-terminal basic amino acid from peptides and proteins, with preference shown for lysine over arginine. It is a plasma zinc enzyme that inactivates bradykinin and anaphylatoxins.%A%    
% 210.77/210.95  |- mesh__dateEstablished mesh__D001121 1991-01-01
% 210.77/210.95  |- mesh__publicMeSHNote mesh__D001121
% 210.77/210.95       1997; see ARGININE CARBOXYPEPTIDASE 1991-1996, see CARBOXYPEPTIDASES 1975-1990; for KININASE I see CARBOXYPEPTIDASES 1975-1981%A%  
% 210.77/210.95  |- skos__altLabel mesh__D001121 Carboxypeptidase N
% 210.77/210.95  |- skos__historyNote mesh__D001121 Peptides %28%1972-1974%29%
% 210.77/210.95  |- skos__altLabel mesh__D001121 Anaphylatoxin Inactivator
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D001121 2005
% 210.77/210.95  |- mesh__historyNote mesh__D001121 1997 %28%1975%29%   
% 210.77/210.95  |- skos__historyNote mesh__D001121 Carboxypeptidases %28%1972-1974%29%
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D001121 2004
% 210.77/210.95  |- mesh__recordMaintainer mesh__D001121 jmp
% 210.77/210.95  |- skos__altLabel mesh__D001121 Bradykininase
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D001121 2006
% 210.77/210.95  |- mesh__dateCreated mesh__D001121 1974-11-19
% 210.77/210.95  |- mesh__recordOriginator mesh__D001121 NLM
% 210.77/210.95  |- skos__hiddenLabel mesh__D020884 Vaginotomies
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D020884 2000
% 210.77/210.95  |- skos__altLabel mesh__D020884 Vaginotomy
% 210.77/210.95  |- skos__scopeNote mesh__D020884 An incision in the vagina.     
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D020884 2001
% 210.77/210.95  |- skos__hiddenLabel mesh__D020884 Colpotomies
% 210.77/210.95  |- skos__historyNote mesh__D020884 Vagina/surgery %28%1978-1999%29%
% 210.77/210.95  |- skos__broader mesh__D020884smesh__D013509
% 210.77/210.95  |- mesh__dateCreated mesh__D020884 1999-11-03
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D020884 2002
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D020884 2005
% 210.77/210.95  |- mesh__publicMeSHNote mesh__D020884 2000   
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D020884 2003
% 210.77/210.95  |- mesh__dateEstablished mesh__D020884 2000-01-01
% 210.77/210.95  |- rdf__type mesh__D020884sskos__Concept
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D020884 2006
% 210.77/210.95  |- skos__prefLabel mesh__D020884 Colpotomy
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D020884 2004
% 210.77/210.95  |- mesh__historyNote mesh__D020884 2000   
% 210.77/210.95  |- skos__broader mesh__D020884smesh__D013513
% 210.77/210.95  |- mesh__dateRevised mesh__D020086 2005-06-30
% 210.77/210.95  |- mesh__publicMeSHNote mesh__D020086 99   
% 210.77/210.95  |- skos__scopeNote mesh__D020086
% 210.77/210.95       Highly repeated sequences, 100-300 bases long, which contain RNA polymerase III promoters. The primate Alu %28%ALU ELEMENTS%29% and the rodent B1 SINEs are derived from 7SL RNA, the RNA component of the signal recognition particle. Most other SINEs are derived from tRNAs including the MIRs %28%mammalian-wide interspersed repeats%29%.%A%    
% 210.77/210.95  |- mesh__recordAuthorizer mesh__D020086 sjn
% 210.77/210.95  |- skos__broader mesh__D020086smesh__D018626
% 210.77/210.95  |- skos__prefLabel mesh__D020086 Short Interspersed Nucleotide Elements
% 210.77/210.95  |- mesh__dateCreated mesh__D020086 1998-06-11
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D020086 2006
% 210.77/210.95  |- rdf__type mesh__D020086sskos__Concept
% 210.77/210.95  |- mesh__historyNote mesh__D020086 99   
% 210.77/210.95  |- skos__altLabel mesh__D020086 SINEs
% 210.77/210.95  |- mesh__dateEstablished mesh__D020086 1999-01-01
% 210.77/210.95  |- skos__altLabel mesh__D020086 Short Interspersed DNA Sequence Elements
% 210.77/210.95  |- mesh__recordMaintainer mesh__D020086 nns
% 210.77/210.95  |- mesh__recordOriginator mesh__D020086 NNS
% 210.77/210.95  |- skos__historyNote mesh__D020086
% 210.77/210.95       Repetitive Sequences, Nucleic Acid %28%1981-1998%29%
% 210.77/210.95  |- skos__hiddenLabel mesh__D014847 Vulvitides
% 210.77/210.95  |- rdf__type mesh__D014847sskos__Concept
% 210.77/210.95  |- skos__broader mesh__D014847smesh__D014845
% 210.77/210.95  |- skos__prefLabel mesh__D014847 Vulvitis
% 210.77/210.95  |- mesh__recordMaintainer mesh__D014847 lkt
% 210.77/210.95  |- mesh__recordAuthorizer mesh__D014847 sjn
% 210.77/210.95  |- mesh__dateRevised mesh__D014847 2005-06-30
% 210.77/210.95  |- mesh__recordOriginator mesh__D014847 NLM
% 210.77/210.95  |- mesh__dateCreated mesh__D014847 1999-01-01
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D014847 2006
% 210.77/210.95  |- skos__scopeNote mesh__D014847
% 210.77/210.95       Inflammation of the VULVA. It is characterized by PRURITUS and painful urination.%A%    
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D014049 2006
% 210.77/210.95  |- skos__historyNote mesh__D014049 Piperidines %28%1966-1978%29%
% 210.77/210.95  |- mesh__historyNote mesh__D014049
% 210.77/210.95       91%28%79%29%; was see under PROPIOPHENONES 1979-90   
% 210.77/210.95  |- mesh__publicMeSHNote mesh__D014049
% 210.77/210.95       91; was see under PROPIOPHENONES 1979-90   
% 210.77/210.95  |- mesh__dateRevised mesh__D014049 2005-06-30
% 210.77/210.95  |- mesh__dateCreated mesh__D014049 1978-03-20
% 210.77/210.95  |- skos__altLabel mesh__D014049
% 210.77/210.95       Strathmann Brand of Tolperisone Hydrochloride
% 210.77/210.95  |- skos__hiddenLabel mesh__D014049 Hydrochloride, Tolperisone
% 210.77/210.95  |- skos__historyNote mesh__D014049 Propiophenones %28%1966-1978%29%
% 210.77/210.95  |- skos__altLabel mesh__D014049 Midocalm
% 210.77/210.95  |- rdf__type mesh__D014049sskos__Concept
% 210.77/210.95  |- mesh__recordAuthorizer mesh__D014049 sjn
% 210.77/210.95  |- mesh__recordOriginator mesh__D014049 SH
% 210.77/210.95  |- mesh__recordMaintainer mesh__D014049 CCR
% 210.77/210.95  |- mesh__dateEstablished mesh__D014049 1991-01-01
% 210.77/210.95  |- skos__broader mesh__D014049smesh__D011427
% 210.77/210.95  |- skos__scopeNote mesh__D014049
% 210.77/210.95       A centrally acting muscle relaxant that has been used for the symptomatic treatment of spasticity and muscle spasm. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1211%29%%A%    
% 210.77/210.95  |- skos__prefLabel mesh__D014049 Tolperisone
% 210.77/210.95  |- skos__broader mesh__D014049smesh__D011725
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D000827 2005
% 210.77/210.95  |- mesh__historyNote mesh__D000827 1986   
% 210.77/210.95  |- skos__broader mesh__D000827smesh__D012926
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D000827 2004
% 210.77/210.95  |- skos__related mesh__D000827smesh__D023401
% 210.77/210.95  |- rdf__type mesh__D000827sskos__Concept
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D000827 2006
% 210.77/210.95  |- mesh__dateRevised mesh__D000827 2003-07-24
% 210.77/210.95  |- mesh__dateCreated mesh__D000827 1985-02-25
% 210.77/210.95  |- mesh__recordAuthorizer mesh__D000827 sjn
% 210.77/210.95  |- mesh__recordOriginator mesh__D000827 EC
% 210.77/210.95  |- skos__scopeNote mesh__D000827
% 210.77/210.95       The protection of animals in laboratories or other specific environments by promoting their health through better nutrition, housing, and care.%A%    
% 210.77/210.95  |- skos__hiddenLabel mesh__D000827 Welfare, Animal
% 210.77/210.95  |- mesh__publicMeSHNote mesh__D000827 1986   
% 210.77/210.95  |- mesh__dateEstablished mesh__D000827 1986-01-01
% 210.77/210.95  |- skos__prefLabel mesh__D000827 Animal Welfare
% 210.77/210.95  |- mesh__recordMaintainer mesh__D000827 sjn
% 210.77/210.95  |- skos__hiddenLabel mesh__D000827 Cruelty, Animal
% 210.77/210.95  |- skos__related mesh__D000827smesh__D037901
% 210.77/210.95  |- skos__scopeNote mesh__D019532
% 210.77/210.95       Works consisting of representations, normally to scale and on a flat medium, of a selection of material or abstract features on the surface of the earth. They may be used also in delineating the heavens and celestial bodies. %28%From Anglo-American Cataloguing Rules, 2d ed, p619%29%%A%    
% 210.77/210.95  |- skos__broader mesh__D019532smesh__D019489
% 210.77/210.95  |- skos__annotation mesh__D019532
% 210.77/210.95       publication type only; Use for geographic atlases.  Do not also use the publication type ATLASES; maps as a subject are indexed under the main heading MAPS%A%  
% 210.77/210.95  |- skos__altLabel mesh__D019532 Maps %28%PT%29%
% 210.77/210.95  |- mesh__recordAuthorizer mesh__D019532 sjn
% 210.77/210.95  |- mesh__recordMaintainer mesh__D019532 jls
% 210.77/210.95  |- skos__broader mesh__D019532smesh__D020495
% 210.77/210.95  |- mesh__dateCreated mesh__D019532 1996-06-21
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D019532 2006
% 210.77/210.95  |- mesh__recordOriginator mesh__D019532 TGC
% 210.77/210.95  |- mesh__dateRevised mesh__D019532 2005-06-30
% 210.77/210.95  |- mesh__dateEstablished mesh__D019532 1997-01-01
% 210.77/210.95  |- rdf__type mesh__D019532sskos__Concept
% 210.77/210.95  |- skos__prefLabel mesh__D019532 Maps %5B%Publication Type%5D%
% 210.77/210.95  |- mesh__historyNote mesh__D019532 1997   
% 210.77/210.95  |- skos__hiddenLabel mesh__D000029 Legal Abortion
% 210.77/210.95  |- mesh__historyNote mesh__D000029 64   
% 210.77/210.95  |- mesh__dateRevised mesh__D000029 2004-07-13
% 210.77/210.95  |- skos__broader mesh__D000029smesh__D000028
% 210.77/210.95  |- skos__annotation mesh__D000029
% 210.77/210.95        /adv eff permitted; do not use /util %28%except by MeSH definition%29% /vet; don%27%t forget also  HUMANS %26% FEMALE %26% PREGNANCY%A%  
% 210.77/210.95  |- skos__hiddenLabel mesh__D000029 Abortions, Legal
% 210.77/210.95  |- skos__hiddenLabel mesh__D000029 Legal Abortions
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D000029 2005
% 210.77/210.95  |- skos__prefLabel mesh__D000029 Abortion, Legal
% 210.77/210.95  |- mesh__publicMeSHNote mesh__D000029 64   
% 210.77/210.95  |- mesh__recordMaintainer mesh__D000029 sjn
% 210.77/210.95  |- mesh__activeMeSHYear mesh__D000029 2006
% 210.77/210.95  |- rdf__type mesh__D000029sskos__Concept
% 210.77/210.95  |- mesh__dateCreated mesh__D000029 1999-01-01
% 210.77/210.95  |- mesh__dateEstablished mesh__D000029 1964-01-01
% 210.77/210.95  |- mesh__recordAuthorizer mesh__D000029 sjn
% 210.77/210.95  |- skos__scopeNote mesh__D000029
% 210.77/210.95       Termination of pregnancy under conditions allowed under local laws. %28%POPLINE Thesaurus, 1991%29%%A%    
% 210.77/210.96  |- mesh__recordOriginator mesh__D000029 NLM
% 210.77/210.96  |- skos__scopeNote mesh__D005512
% 210.77/210.96       Gastrointestinal disturbances, skin eruptions, or shock due to allergic reactions to allergens in food.%A%    
% 210.77/210.96  |- skos__altLabel mesh__D005512 Food Allergy
% 210.77/210.96  |- skos__hiddenLabel mesh__D005512 Food Hypersensitivities
% 210.77/210.96  |- mesh__recordMaintainer mesh__D005512 tpw
% 210.77/210.96  |- skos__related mesh__D005512smesh__D005517
% 210.77/210.96  |- mesh__historyNote mesh__D005512 66; was FOOD ALLERGY 1963-65   
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D005512 2002
% 210.77/210.96  |- mesh__dateRevised mesh__D005512 2001-07-25
% 210.77/210.96  |- mesh__recordAuthorizer mesh__D005512 sjn
% 210.77/210.96  |- skos__prefLabel mesh__D005512 Food Hypersensitivity
% 210.77/210.96  |- skos__annotation mesh__D005512
% 210.77/210.96       GEN:  Prefer specific precoord; coord IM with specific food /adv eff %28%IM%29%:  Manual 31.12%A%  
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D005512 2003
% 210.77/210.96  |- mesh__recordOriginator mesh__D005512 NLM
% 210.77/210.96  |- skos__broader mesh__D005512smesh__D006969
% 210.77/210.96  |- rdf__type mesh__D005512sskos__Concept
% 210.77/210.96  |- skos__hiddenLabel mesh__D005512 Hypersensitivities, Food
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D005512 2005
% 210.77/210.96  |- mesh__publicMeSHNote mesh__D005512 66; was FOOD ALLERGY 1963-65   
% 210.77/210.96  |- skos__hiddenLabel mesh__D005512 Allergies, Food
% 210.77/210.96  |- mesh__dateCreated mesh__D005512 1999-01-01
% 210.77/210.96  |- mesh__dateEstablished mesh__D005512 1966-01-01
% 210.77/210.96  |- skos__altLabel mesh__D005512 Allergy, Food
% 210.77/210.96  |- skos__hiddenLabel mesh__D005512 Food Allergies
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D005512 2004
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D005512 2006
% 210.77/210.96  |- skos__altLabel mesh__D005512 Hypersensitivity, Food
% 210.77/210.96  |- skos__hiddenLabel mesh__D046929 Ala Ala Carboxypeptidase, Serine Type
% 210.77/210.96  |- skos__hiddenLabel mesh__D046929
% 210.77/210.96       D-Ala-D-Ala Carboxypeptidases, Serine-Type
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D046929 2005
% 210.77/210.96  |- skos__altLabel mesh__D046929 Serine-Type D-Ala-D-Ala Carboxypeptidases
% 210.77/210.96  |- skos__prefLabel mesh__D046929 Serine-Type D-Ala-D-Ala Carboxypeptidase
% 210.77/210.96  |- skos__altLabel mesh__D046929 D-D Carboxypeptidase
% 210.77/210.96  |- skos__hiddenLabel mesh__D046929 Carboxypeptidase, Serine-Type Ala-Ala
% 210.77/210.96  |- skos__scopeNote mesh__D046929
% 210.77/210.96       A carboxypeptidase that is specific for proteins that contain two ALANINE residues on their C-terminal. Enzymes in this class play an important role in bacterial CELL WALL biosynthesis.%A%    
% 210.77/210.96  |- rdf__type mesh__D046929sskos__Concept
% 210.77/210.96  |- skos__hiddenLabel mesh__D046929 D D Carboxypeptidase
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D046929 2006
% 210.77/210.96  |- skos__hiddenLabel mesh__D046929
% 210.77/210.96       Transpeptidase, D-Alanyl-D-Alanine-Cleaving
% 210.77/210.96  |- skos__hiddenLabel mesh__D046929
% 210.77/210.96       Serine Type D Ala D Ala Carboxypeptidases
% 210.77/210.96  |- mesh__recordMaintainer mesh__D046929 jmp
% 210.77/210.96  |- mesh__historyNote mesh__D046929
% 210.77/210.96       2005%28%1993%29%; for D-ALANYL-D-ALANINE-CLEAVING TRANSPEPTIDASE use MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE 1984-2004; for D-D CARBOXYPEPTIDASE use MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE 1974-2004%A%  
% 210.77/210.96  |- skos__broader mesh__D046929smesh__D002268
% 210.77/210.96  |- skos__hiddenLabel mesh__D046929
% 210.77/210.96       D Alanyl D Alanine Cleaving Transpeptidase
% 210.77/210.96  |- skos__hiddenLabel mesh__D046929 Serine-Type Ala-Ala Carboxypeptidase
% 210.77/210.96  |- skos__hiddenLabel mesh__D046929
% 210.77/210.96       Carboxypeptidase, Serine-Type D-Ala-D-Ala
% 210.77/210.96  |- skos__altLabel mesh__D046929 Ala-Ala Carboxypeptidase, Serine-Type
% 210.77/210.96  |- skos__hiddenLabel mesh__D046929
% 210.77/210.96       D-Ala-D-Ala Carboxypeptidase, Serine-Type
% 210.77/210.96  |- skos__hiddenLabel mesh__D046929 Serine Type D Ala D Ala Carboxypeptidase
% 210.77/210.96  |- skos__altLabel mesh__D046929 DD-Peptidase
% 210.77/210.96  |- skos__hiddenLabel mesh__D046929
% 210.77/210.96       Carboxypeptidases, Serine-Type D-Ala-D-Ala
% 210.77/210.96  |- skos__hiddenLabel mesh__D046929 D Alanyl D Alanine Carboxypeptidase
% 210.77/210.96  |- mesh__recordOriginator mesh__D046929 jmp
% 210.77/210.96  |- skos__hiddenLabel mesh__D046929 DD Peptidase
% 210.77/210.96  |- mesh__publicMeSHNote mesh__D046929
% 210.77/210.96       2005; SERINE-TYPE D-ALA-D-ALA CARBOXYPEPTIDASE was indexed under CARBOXYPEPTIDASES 1993-2003; for D-ALANYL-D-ALANINE-CLEAVING TRANSPEPTIDASE see MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE 1984-2004; for D-D CARBOXYPEPTIDASE see MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE 1974-2004%A%  
% 210.77/210.96  |- skos__altLabel mesh__D046929 D-Alanyl-D-Alanine-Carboxypeptidase
% 210.77/210.96  |- skos__altLabel mesh__D046929 D-Alanyl-D-Alanine-Cleaving Transpeptidase
% 210.77/210.96  |- mesh__dateCreated mesh__D046929 2004-07-07
% 210.77/210.96  |- skos__historyNote mesh__D046929 Carboxypeptidases %28%1993-2004%29%
% 210.77/210.96  |- mesh__recordAuthorizer mesh__D046929 sjn
% 210.77/210.96  |- mesh__dateEstablished mesh__D046929 2005-01-01
% 210.77/210.96  |- skos__hiddenLabel mesh__D046929 Carboxypeptidase, D-D
% 210.77/210.96  |- rdf__type mesh__D010457sskos__Concept
% 210.77/210.96  |- skos__broader mesh__D010457smesh__D006020
% 210.77/210.96  |- skos__historyNote mesh__D010457 Mucopolysaccharides %28%1966-1970%29%
% 210.77/210.96  |- mesh__dateCreated mesh__D010457 1999-01-01
% 210.77/210.96  |- skos__broader mesh__D010457smesh__D011135
% 210.77/210.96  |- mesh__dateRevised mesh__D010457 2005-06-30
% 210.77/210.96  |- skos__altLabel mesh__D010457 Murein
% 210.77/210.96  |- skos__prefLabel mesh__D010457 Peptidoglycan
% 210.77/210.96  |- mesh__recordMaintainer mesh__D010457 ssb
% 210.77/210.96  |- mesh__recordAuthorizer mesh__D010457 sjn
% 210.77/210.96  |- skos__broader mesh__D010457smesh__D009088
% 210.77/210.96  |- mesh__recordOriginator mesh__D010457 NLM
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D010457 2006
% 210.77/210.96  |- skos__annotation mesh__D010457
% 210.77/210.96       coord IM with specific bacterium %28%IM%29% %26% do not coord with POLYSACCHARIDES, BACTERIAL%A%  
% 210.77/210.96  |- mesh__publicMeSHNote mesh__D010457 73   
% 210.77/210.96  |- mesh__historyNote mesh__D010457 73%28%71%29%   
% 210.77/210.96  |- skos__historyNote mesh__D010457
% 210.77/210.96       Polysaccharides, Bacterial %28%1966-1970%29%
% 210.77/210.96  |- mesh__dateEstablished mesh__D010457 1973-01-01
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D015142 2002
% 210.77/210.96  |- mesh__recordMaintainer mesh__D015142 PXP
% 210.77/210.96  |- skos__prefLabel mesh__D015142 Baltimore
% 210.77/210.96  |- mesh__historyNote mesh__D015142 89   
% 210.77/210.96  |- mesh__recordOriginator mesh__D015142 EC
% 210.77/210.96  |- skos__annotation mesh__D015142 DF: BALT   
% 210.77/210.96  |- mesh__recordAuthorizer mesh__D015142 SJN
% 210.77/210.96  |- skos__broader mesh__D015142smesh__D002947
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D015142 2006
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D015142 1999
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D015142 2004
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D015142 2001
% 210.77/210.96  |- mesh__dateRevised mesh__D015142 1997-06-20
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D015142 2000
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D015142 2005
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D015142 1998
% 210.77/210.96  |- mesh__dateEstablished mesh__D015142 1989-01-01
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D015142 2003
% 210.77/210.96  |- rdf__type mesh__D015142sskos__Concept
% 210.77/210.96  |- skos__broader mesh__D015142smesh__D008396
% 210.77/210.96  |- mesh__dateCreated mesh__D015142 1988-03-18
% 210.77/210.96  |- rdf__type mesh__D009903sskos__Concept
% 210.77/210.96  |- skos__broader mesh__D009903smesh__D007088
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009903 2000
% 210.77/210.96  |- mesh__recordOriginator mesh__D009903 NLM
% 210.77/210.96  |- skos__scopeNote mesh__D009903
% 210.77/210.96       An illusion of vision usually affecting spatial relations.%A%    
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009903 2001
% 210.77/210.96  |- mesh__dateEstablished mesh__D009903 1991-01-01
% 210.77/210.96  |- mesh__onlineNote mesh__D009903 search ILLUSIONS 1966-74   
% 210.77/210.96  |- mesh__recordMaintainer mesh__D009903 TAP
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009903 2003
% 210.77/210.96  |- skos__hiddenLabel mesh__D009903 Illusions, Optical
% 210.77/210.96  |- mesh__dateCreated mesh__D009903 1999-01-01
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009903 1996
% 210.77/210.96  |- mesh__publicMeSHNote mesh__D009903
% 210.77/210.96       91; was see under ILLUSIONS 1975-90   
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009903 2005
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009903 1998
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009903 2004
% 210.77/210.96  |- mesh__historyNote mesh__D009903
% 210.77/210.96       91%28%75%29%; was see under ILLUSIONS 1975-90   
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009903 2002
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009903 1997
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009903 2006
% 210.77/210.96  |- skos__hiddenLabel mesh__D009903 Optical Illusion
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009903 1994
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009903 1999
% 210.77/210.96  |- skos__hiddenLabel mesh__D009903 Illusion, Optical
% 210.77/210.96  |- skos__prefLabel mesh__D009903 Optical Illusions
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009903 1993
% 210.77/210.96  |- mesh__dateRevised mesh__D009903 1992-05-15
% 210.77/210.96  |- mesh__recordAuthorizer mesh__D009903 PLS
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009903 1995
% 210.77/210.96  |- mesh__recordOriginator mesh__D001920 NLM
% 210.77/210.96  |- skos__broader mesh__D001920smesh__D009842
% 210.77/210.96  |- skos__hiddenLabel mesh__D001920 Arg Pro Pro Gly Phe Ser Pro Phe Arg
% 210.77/210.96  |- skos__broader mesh__D001920smesh__D007705
% 210.77/210.96  |- skos__scopeNote mesh__D001920
% 210.77/210.96       A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter.%A%    
% 210.77/210.96  |- mesh__dateRevised mesh__D001920 2005-06-30
% 210.77/210.96  |- rdf__type mesh__D001920sskos__Concept
% 210.77/210.96  |- skos__related mesh__D001920smesh__D018002
% 210.77/210.96  |- skos__altLabel mesh__D001920 Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg
% 210.77/210.96  |- skos__prefLabel mesh__D001920 Bradykinin
% 210.77/210.96  |- mesh__dateCreated mesh__D001920 1999-01-01
% 210.77/210.96  |- skos__broader mesh__D001920smesh__D009479
% 210.77/210.96  |- mesh__recordMaintainer mesh__D001920 ssb
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D001920 2006
% 210.77/210.96  |- mesh__recordAuthorizer mesh__D001920 sjn
% 210.77/210.96  |- mesh__dateEstablished mesh__D009105 1979-01-01
% 210.77/210.96  |- mesh__recordOriginator mesh__D009105 NLM
% 210.77/210.96  |- skos__hiddenLabel mesh__D009105 Disorder, Multiple Personality
% 210.77/210.96  |- skos__altLabel mesh__D009105 Dissociative Identity Disorder
% 210.77/210.96  |- mesh__recordMaintainer mesh__D009105 JLS
% 210.77/210.96  |- skos__hiddenLabel mesh__D009105 Multiple Personality
% 210.77/210.96  |- skos__hiddenLabel mesh__D009105 Personalities, Multiple
% 210.77/210.96  |- skos__hiddenLabel mesh__D009105 Personality Disorder, Multiple
% 210.77/210.96  |- mesh__historyNote mesh__D009105 98%28%68%29%   
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009105 2003
% 210.77/210.96  |- skos__hiddenLabel mesh__D009105 Disorder, Multiple Identity
% 210.77/210.96  |- skos__hiddenLabel mesh__D009105 Disorder, Dissociative Identity
% 210.77/210.96  |- skos__hiddenLabel mesh__D009105 Identity Disorder, Multiple
% 210.77/210.96  |- skos__prefLabel mesh__D009105 Multiple Personality Disorder
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009105 1998
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009105 2000
% 210.77/210.96  |- skos__hiddenLabel mesh__D009105 Personality Disorders, Multiple
% 210.77/210.96  |- mesh__dateCreated mesh__D009105 1999-01-01
% 210.77/210.96  |- rdf__type mesh__D009105sskos__Concept
% 210.77/210.96  |- skos__altLabel mesh__D009105 Multiple Personalities
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009105 2004
% 210.77/210.96  |- skos__broader mesh__D009105smesh__D004213
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009105 2001
% 210.77/210.96  |- skos__hiddenLabel mesh__D009105 Multiple Personality Disorders
% 210.77/210.96  |- mesh__publicMeSHNote mesh__D009105
% 210.77/210.96       98; see MULTIPLE-PERSONALITY DISORDER 1979-97; for MULTIPLE PERSONALITIES see DUAL PERSONALITY 1968-78; DUAL PERSONALITY was heading 1968-78%A%  
% 210.77/210.96  |- skos__altLabel mesh__D009105 Multiple Identity Disorder
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009105 1999
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009105 2005
% 210.77/210.96  |- skos__hiddenLabel mesh__D009105 Personality, Dual
% 210.77/210.96  |- skos__hiddenLabel mesh__D009105 Multiple Identity Disorders
% 210.77/210.96  |- mesh__dateRevised mesh__D009105 1997-06-20
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009105 2002
% 210.77/210.96  |- skos__hiddenLabel mesh__D009105 Personalities, Dual
% 210.77/210.96  |- skos__scopeNote mesh__D009105
% 210.77/210.96       A dissociative disorder in which the individual adopts two or more distinct personalities. Each personality is a fully integrated and complex unit with memories, behavior patterns and social friendships. Transition from one personality to another is sudden.%A%    
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D009105 2006
% 210.77/210.96  |- mesh__recordAuthorizer mesh__D009105 SJN
% 210.77/210.96  |- skos__hiddenLabel mesh__D009105 Identity Disorder, Dissociative
% 210.77/210.96  |- skos__hiddenLabel mesh__D009105 Personality, Multiple
% 210.77/210.96  |- mesh__dateCreated mesh__D001122 1977-12-08
% 210.77/210.96  |- mesh__recordMaintainer mesh__D001122 ssb
% 210.77/210.96  |- mesh__dateEstablished mesh__D001122 1991-01-01
% 210.77/210.96  |- mesh__dateRevised mesh__D001122 2003-07-09
% 210.77/210.96  |- mesh__publicMeSHNote mesh__D001122
% 210.77/210.96       91; was see under PHOSPHOTRANSFERASES, ATP 1979-90   
% 210.77/210.96  |- mesh__recordAuthorizer mesh__D001122 sjn
% 210.77/210.96  |- skos__hiddenLabel mesh__D001122 Kinase, Arginine
% 210.77/210.96  |- skos__historyNote mesh__D001122 Phosphotransferases %28%1966-1973%29%
% 210.77/210.96  |- skos__historyNote mesh__D001122
% 210.77/210.96       Phosphotransferases, ATP %28%1974-1978%29%
% 210.77/210.96  |- skos__prefLabel mesh__D001122 Arginine Kinase
% 210.77/210.96  |- mesh__historyNote mesh__D001122
% 210.77/210.96       91%28%79%29%; was see under PHOSPHOTRANSFERASES, ATP 1979-90   
% 210.77/210.96  |- skos__broader mesh__D001122smesh__D017852
% 210.77/210.96  |- skos__scopeNote mesh__D001122
% 210.77/210.96       An enzyme that catalyzes the phosphorylation of the guanidine nitrogen of arginine in the presence of ATP and a divalent cation with formation of phosphorylarginine and ADP. EC 2.7.3.3.%A%    
% 210.77/210.96  |- mesh__recordOriginator mesh__D001122 RLS
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D001122 2005
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D001122 2004
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D001122 2006
% 210.77/210.96  |- rdf__type mesh__D001122sskos__Concept
% 210.77/210.96  |- skos__historyNote mesh__D001122 Arginine %28%1966-1978%29%
% 210.77/210.96  |- mesh__historyNote mesh__D020885
% 210.77/210.96       2000; for U7 SNRNP, U7 SMALL NUCLEAR RIBONUCLEARPROTEINS and SMALL NUCLEAR RIBONUCLEARPROTEINS, U7 use RIBONUCLEOPROTEINS, SMALL NUCLEAR %28%1993-1999%29%%A%  
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D020885 2006
% 210.77/210.96  |- mesh__dateCreated mesh__D020885 1999-11-05
% 210.77/210.96  |- skos__scopeNote mesh__D020885
% 210.77/210.96       This ribonucleoprotein particle, composed of U7 snRNA, Sm core protein, and U7 snRNP-specific proteins, is involved in the 3%27%end processing of histone premessenger RNAs.%A%    
% 210.77/210.96  |- skos__broader mesh__D020885smesh__D017411
% 210.77/210.96  |- skos__altLabel mesh__D020885 Small Nuclear Ribonucleoproteins, U7
% 210.77/210.96  |- mesh__publicMeSHNote mesh__D020885
% 210.77/210.96       2000; for U7 SNRNP, U7 SMALL NUCLEAR RIBONUCLEARPROTEINS and SMALL NUCLEAR RIBONUCLEARPROTEINS, U7 see RIBONUCLEOPROTEINS, SMALL NUCLEAR %28%1993-1999%29%%A%  
% 210.77/210.96  |- skos__historyNote mesh__D020885 Ribonucleoproteins %28%1986-1999%29%
% 210.77/210.96  |- mesh__recordOriginator mesh__D020885 nns
% 210.77/210.96  |- mesh__recordAuthorizer mesh__D020885 sjn
% 210.77/210.96  |- skos__hiddenLabel mesh__D020885 snRNP, U7
% 210.77/210.96  |- mesh__dateRevised mesh__D020885 2005-06-30
% 210.77/210.96  |- skos__historyNote mesh__D020885
% 210.77/210.96       Ribonucleoproteins, Small Nuclear %28%1993-1999%29%
% 210.77/210.96  |- skos__prefLabel mesh__D020885 Ribonucleoprotein, U7 Small Nuclear
% 210.77/210.96  |- mesh__recordMaintainer mesh__D020885 SYSTEM
% 210.77/210.96  |- skos__altLabel mesh__D020885 U7 snRNP
% 210.77/210.96  |- rdf__type mesh__D020885sskos__Concept
% 210.77/210.96  |- skos__altLabel mesh__D020885 U7 Small Nuclear Ribonucleoproteins
% 210.77/210.96  |- mesh__dateEstablished mesh__D020885 2000-01-01
% 210.77/210.96  |- skos__hiddenLabel mesh__D020087 Repetitive Sequences, Alu
% 210.77/210.96  |- mesh__dateCreated mesh__D020087 1998-06-10
% 210.77/210.96  |- mesh__publicMeSHNote mesh__D020087
% 210.77/210.96       99; see REPETITIVE SEQUENCES, NUCLEIC ACID 1988-98; for ALU REPETITIVE SEQUENCE, ALU FAMILY, and ALU-LIKE REPETITIVE SEQUENCE see REPETITIVE SEQUENCES, NUCLEIC ACID 1988-98%A%  
% 210.77/210.96  |- skos__hiddenLabel mesh__D020087 Repetitive Sequence, Alu
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D020087 2006
% 210.77/210.96  |- skos__hiddenLabel mesh__D020087 Families, Alu
% 210.77/210.96  |- skos__hiddenLabel mesh__D020087 Alu Element
% 210.77/210.96  |- rdf__type mesh__D020087sskos__Concept
% 210.77/210.96  |- skos__hiddenLabel mesh__D020087 Elements, Alu
% 210.77/210.96  |- skos__hiddenLabel mesh__D020087 Alu Families
% 210.77/210.96  |- skos__prefLabel mesh__D020087 Alu Elements
% 210.77/210.96  |- mesh__historyNote mesh__D020087
% 210.77/210.96       99; use REPETITIVE SEQUENCES, NUCLEIC ACID 1988-98; for ALU REPETITIVE SEQUENCE, ALU FAMILY, and ALU-LIKE REPETITIVE SEQUENCE use REPETITIVE SEQUENCES, NUCLEIC ACID 1988-98%A%  
% 210.77/210.96  |- skos__broader mesh__D020087smesh__D020086
% 210.77/210.96  |- mesh__dateRevised mesh__D020087 2005-06-30
% 210.77/210.96  |- mesh__recordAuthorizer mesh__D020087 sjn
% 210.77/210.96  |- mesh__recordOriginator mesh__D020087 NNS
% 210.77/210.96  |- skos__hiddenLabel mesh__D020087 Alu Repetitive Sequence
% 210.77/210.96  |- skos__scopeNote mesh__D020087
% 210.77/210.96       The Alu sequence family %28%named for the restriction endonuclease cleavage enzyme Alu I%29% is the most highly repeated interspersed repeat element in humans %28%over a million copies%29%. It is derived from the 7SL RNA component of the SIGNAL RECOGNITION PARTICLE and contains an RNA polymerase III promoter. Transposition of this element into coding and regulatory regions of genes is responsible for many heritable diseases.%A%    
% 210.77/210.96  |- skos__altLabel mesh__D020087 Alu Family
% 210.77/210.96  |- skos__hiddenLabel mesh__D020087 Element, Alu
% 210.77/210.96  |- mesh__dateEstablished mesh__D020087 1999-01-01
% 210.77/210.96  |- skos__hiddenLabel mesh__D020087 Family, Alu
% 210.77/210.96  |- skos__hiddenLabel mesh__D020087 Sequence, Alu Repetitive
% 210.77/210.96  |- skos__hiddenLabel mesh__D020087 Sequences, Alu Repetitive
% 210.77/210.96  |- skos__related mesh__D020087smesh__D016254
% 210.77/210.96  |- skos__altLabel mesh__D020087 Alu Repetitive Sequences
% 210.77/210.96  |- mesh__recordMaintainer mesh__D020087 nns
% 210.77/210.96  |- skos__historyNote mesh__D020087
% 210.77/210.96       Repetitive Sequences, Nucleic Acid %28%1981-1998%29%
% 210.77/210.96  |- skos__prefLabel mesh__D014848 Vulvovaginitis
% 210.77/210.96  |- mesh__dateRevised mesh__D014848 2005-06-30
% 210.77/210.96  |- mesh__recordOriginator mesh__D014848 NLM
% 210.77/210.96  |- mesh__dateCreated mesh__D014848 1999-01-01
% 210.77/210.96  |- skos__hiddenLabel mesh__D014848 Vulvovaginitides
% 210.77/210.96  |- skos__broader mesh__D014848smesh__D014847
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D014848 2006
% 210.77/210.96  |- skos__broader mesh__D014848smesh__D014627
% 210.77/210.96  |- skos__scopeNote mesh__D014848
% 210.77/210.96       Inflammation of the VULVA and the VAGINA, characterized by discharge, burning, and PRURITUS.%A%    
% 210.77/210.96  |- mesh__recordMaintainer mesh__D014848 lkt
% 210.77/210.96  |- rdf__type mesh__D014848sskos__Concept
% 210.77/210.96  |- mesh__recordAuthorizer mesh__D014848 sjn
% 210.77/210.96  |- mesh__dateEstablished mesh__D019533 1997-01-01
% 210.77/210.96  |- skos__prefLabel mesh__D019533 Streptococcus oralis
% 210.77/210.96  |- mesh__recordOriginator mesh__D019533 PXP
% 210.77/210.96  |- mesh__recordMaintainer mesh__D019533 SYSTEM
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D019533 2006
% 210.77/210.96  |- mesh__publicMeSHNote mesh__D019533 97   
% 210.77/210.96  |- mesh__recordAuthorizer mesh__D019533 sjn
% 210.77/210.96  |- mesh__historyNote mesh__D019533 97   
% 210.77/210.96  |- rdf__type mesh__D019533sskos__Concept
% 210.77/210.96  |- skos__annotation mesh__D019533
% 210.77/210.96       infection: coord IM with STREPTOCOCCAL INFECTIONS %28%IM%29%; DF: STREP ORALIS%A%  
% 210.77/210.96  |- skos__scopeNote mesh__D019533
% 210.77/210.96       A species of gram-positive, coccoid bacteria that is numerous in the mouth and throat. It is a common cause of endocarditis and is also implicated in dental plaque formation.%A%    
% 210.77/210.96  |- mesh__dateCreated mesh__D019533 1996-06-10
% 210.77/210.96  |- skos__broader mesh__D019533smesh__D034363
% 210.77/210.96  |- skos__historyNote mesh__D019533 Streptococcus %28%1983-1996%29%
% 210.77/210.96  |- mesh__dateRevised mesh__D019533 2005-06-30
% 210.77/210.96  |- skos__scopeNote mesh__D000828
% 210.77/210.96       Animals grouped according to ecological, morphological or genetic populations.%A%    
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D000828 2004
% 210.77/210.96  |- rdf__type mesh__D000828sskos__Concept
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D000828 2006
% 210.77/210.96  |- skos__hiddenLabel mesh__D000828 Animal Population Group
% 210.77/210.96  |- mesh__recordMaintainer mesh__D000828 ags
% 210.77/210.96  |- mesh__publicMeSHNote mesh__D000828 2004; see ANIMALS 1963-2003   
% 210.77/210.96  |- mesh__recordOriginator mesh__D000828 NLM
% 210.77/210.96  |- skos__annotation mesh__D000828
% 210.77/210.96       GEN; prefer specifics; /surg: consider also SURGERY, VETERINARY%A%  
% 210.77/210.96  |- skos__hiddenLabel mesh__D000828 Population Group, Animal
% 210.77/210.96  |- skos__prefLabel mesh__D000828 Animal Population Groups
% 210.77/210.96  |- mesh__dateRevised mesh__D000828 2003-07-09
% 210.77/210.96  |- mesh__dateCreated mesh__D000828 1999-01-01
% 210.77/210.96  |- mesh__recordAuthorizer mesh__D000828 sjn
% 210.77/210.96  |- skos__broader mesh__D000828smesh__D000818
% 210.77/210.96  |- mesh__historyNote mesh__D000828 2004 %28%1963%29%   
% 210.77/210.96  |- skos__hiddenLabel mesh__D000828 Population Groups, Animal
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D000828 2005
% 210.77/210.96  |- rdf__type mesh__D011550sskos__Concept
% 210.77/210.96  |- skos__prefLabel mesh__D011550 Pseudomonas aeruginosa
% 210.77/210.96  |- skos__altLabel mesh__D011550 Pseudomonas pyocyanea
% 210.77/210.96  |- mesh__dateRevised mesh__D011550 2005-06-30
% 210.77/210.96  |- skos__scopeNote mesh__D011550
% 210.77/210.96       A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens %28%wound, burn, and urinary tract infections%29%. It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection.%A%    
% 210.77/210.96  |- mesh__recordMaintainer mesh__D011550 SYSTEM
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D011550 2006
% 210.77/210.96  |- skos__broader mesh__D011550smesh__D011549
% 210.77/210.96  |- mesh__recordOriginator mesh__D011550 NLM
% 210.77/210.96  |- mesh__dateCreated mesh__D011550 1999-01-01
% 210.77/210.96  |- mesh__recordAuthorizer mesh__D011550 sjn
% 210.77/210.96  |- skos__annotation mesh__D011550
% 210.77/210.96       infection = PSEUDOMONAS INFECTIONS %26% do not bother to coord with Ps. aerug. unless pertinent%A%  
% 210.77/210.96  |- mesh__recordOriginator mesh__D005513 NLM
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D005513 2000
% 210.77/210.96  |- skos__hiddenLabel mesh__D005513 Food Inspections
% 210.77/210.96  |- skos__hiddenLabel mesh__D005513 Inspections, Food
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D005513 2003
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D005513 2001
% 210.77/210.96  |- rdf__type mesh__D005513sskos__Concept
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D005513 2005
% 210.77/210.96  |- mesh__dateCreated mesh__D005513 1999-01-01
% 210.77/210.96  |- skos__hiddenLabel mesh__D005513 Inspection, Food
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D005513 2004
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D005513 2006
% 210.77/210.96  |- skos__annotation mesh__D005513
% 210.77/210.96       IM; coord with milieu %28%IM%29% or specific food %28%IM%29% if pertinent%A%  
% 210.77/210.96  |- skos__prefLabel mesh__D005513 Food Inspection
% 210.77/210.96  |- skos__broader mesh__D005513smesh__D012499
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D005513 2002
% 210.77/210.96  |- skos__scopeNote mesh__D005513
% 210.77/210.96       Examination of foods to assure wholesome and clean products free from unsafe microbes or chemical contamination, natural or added deleterious substances, and decomposition during production, processing, packaging, etc.%A%    
% 210.77/210.96  |- skos__broader mesh__D005513smesh__D005524
% 210.77/210.96  |- mesh__recordAuthorizer mesh__D005513 sjn
% 210.77/210.96  |- mesh__recordMaintainer mesh__D005513 kle
% 210.77/210.96  |- mesh__dateRevised mesh__D005513 1999-11-03
% 210.77/210.96  |- skos__prefLabel mesh__D029961 Zebrafish Proteins
% 210.77/210.96  |- mesh__recordOriginator mesh__D029961 jmp
% 210.77/210.96  |- skos__scopeNote mesh__D029961
% 210.77/210.96       Proteins obtained from the ZEBRAFISH. Many of the proteins in this species have been the subject of studies involving basic embryological development %28%EMBRYOLOGY%29%.%A%    
% 210.77/210.96  |- mesh__dateEstablished mesh__D029961 2002-01-01
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D029961 2006
% 210.77/210.96  |- mesh__dateCreated mesh__D029961 2001-07-25
% 210.77/210.96  |- rdf__type mesh__D029961sskos__Concept
% 210.77/210.96  |- mesh__publicMeSHNote mesh__D029961 2002   
% 210.77/210.96  |- skos__altLabel mesh__D029961 Danio rerio Proteins
% 210.77/210.96  |- skos__related mesh__D029961smesh__D015027
% 210.77/210.96  |- mesh__recordAuthorizer mesh__D029961 sjn
% 210.77/210.96  |- mesh__dateRevised mesh__D029961 2005-06-30
% 210.77/210.96  |- skos__altLabel mesh__D029961 Brachydanio rerio Proteins
% 210.77/210.96  |- skos__altLabel mesh__D029961 Zebra Fish Proteins
% 210.77/210.96  |- mesh__historyNote mesh__D029961 2002   
% 210.77/210.96  |- skos__annotation mesh__D029961
% 210.77/210.96       coord IM with specific protein %28%IM%29%   
% 210.77/210.96  |- skos__broader mesh__D029961smesh__D029941
% 210.77/210.96  |- mesh__recordMaintainer mesh__D029961 SYSTEM
% 210.77/210.96  |- skos__altLabel mesh__D029961 Zebra Danio Proteins
% 210.77/210.96  |- mesh__recordMaintainer mesh__D010458 nns
% 210.77/210.96  |- skos__related mesh__D010458smesh__D010441
% 210.77/210.96  |- skos__scopeNote mesh__D010458
% 210.77/210.96       Acyltransferases that use AMINO ACYL TRNA as the amino acid donor in formation of a peptide bond. There are ribosomal and non-ribosomal peptidyltransferases.%A%    
% 210.77/210.96  |- skos__hiddenLabel mesh__D010458 Transferases, Peptidyl
% 210.77/210.96  |- mesh__recordOriginator mesh__D010458 NLM
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D010458 2005
% 210.77/210.96  |- skos__hiddenLabel mesh__D010458 Translocases, Peptidyl
% 210.77/210.96  |- skos__broader mesh__D010458smesh__D019881
% 210.77/210.96  |- rdf__type mesh__D010458sskos__Concept
% 210.77/210.96  |- mesh__dateEstablished mesh__D010458 1991-01-01
% 210.77/210.96  |- skos__prefLabel mesh__D010458 Peptidyl Transferases
% 210.77/210.96  |- skos__historyNote mesh__D010458
% 210.77/210.96       Peptide Elongation Factors %28%1973-1974%29%
% 210.77/210.96  |- skos__related mesh__D010458smesh__D012269
% 210.77/210.96  |- skos__altLabel mesh__D010458 Peptidyltransferase
% 210.77/210.96  |- skos__altLabel mesh__D010458 Peptidyl Translocases
% 210.77/210.96  |- mesh__publicMeSHNote mesh__D010458
% 210.77/210.96       2005; see PEPTIDYLTRANSFERASE 1998-2004, see PEPTIDYL TRANSFERASES 1991-1997, see ACYLTRANSFERASES 1975-1990%A%  
% 210.77/210.96  |- mesh__dateCreated mesh__D010458 1974-11-19
% 210.77/210.96  |- skos__historyNote mesh__D010458 Acyltransferases %28%1972-1974%29%
% 210.77/210.96  |- mesh__dateRevised mesh__D010458 2004-07-07
% 210.77/210.96  |- skos__historyNote mesh__D010458 Peptides %28%1972-1974%29%
% 210.77/210.96  |- skos__altLabel mesh__D010458 Peptidyltransferases
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D010458 2006
% 210.77/210.96  |- mesh__recordAuthorizer mesh__D010458 sjn
% 210.77/210.96  |- skos__altLabel mesh__D010458 Transpeptidases
% 210.77/210.96  |- mesh__historyNote mesh__D010458 2005%28%1975%29%   
% 210.77/210.96  |- skos__broader mesh__D015941smesh__D017186
% 210.77/210.96  |- skos__altLabel mesh__D015941 Hemolytic Titration Assay
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D015941 2006A
% 210.77/210.96  |- skos__hiddenLabel mesh__D015941 CH50 Assays
% 210.77/210.96  |- skos__hiddenLabel mesh__D015941 Titer, Serum Complement
% 210.77/210.96  |- skos__hiddenLabel mesh__D015941 Titration Assay, Hemolytic
% 210.77/210.96  |- mesh__publicMeSHNote mesh__D015941 90   
% 210.77/210.96  |- mesh__activeMeSHYear mesh__D015941 2006
% 210.77/210.96  |- skos__broader mesh__D015941smesh__D003601
% 210.77/210.96  |- skos__hiddenLabel mesh__D015941 Assay, CH50
% 210.77/210.96  |- skos__prefLabel mesh__D015941 Complement Hemolytic Activity Assay
% 210.77/210.96  |- skos__hiddenLabel mesh__D015941 Hemolytic Complement, Total
% 210.77/210.96  |- mesh__recordOriginator mesh__D015941 AGS
% 210.77/210.96  |- skos__historyNote mesh__D015941 Complement/analysis %28%1969-1989%29%
% 210.77/210.96  |- mesh__recordMaintainer mesh__D015941 ags
% 210.77/210.96  |- skos__altLabel mesh__D015941 CH%28%50%29%
% 210.77/210.96  |- mesh__dateEstablished mesh__D015941 1990-01-01
% 210.77/210.96  |- skos__hiddenLabel mesh__D015941 Hemolytic Titration Assays
% 210.77/210.97  |- rdf__type mesh__D015941sskos__Concept
% 210.77/210.97  |- skos__hiddenLabel mesh__D015941 Assays, CH50
% 210.77/210.97  |- skos__hiddenLabel mesh__D015941 Hemolytic Complements, Total
% 210.77/210.97  |- mesh__dateCreated mesh__D015941 1989-05-25
% 210.77/210.97  |- skos__hiddenLabel mesh__D015941 Complement H50s
% 210.77/210.97  |- skos__broader mesh__D015941smesh__D012698
% 210.77/210.97  |- skos__hiddenLabel mesh__D015941 Complements, Total Hemolytic
% 210.77/210.97  |- skos__hiddenLabel mesh__D015941 Titers, Serum Complement
% 210.77/210.97  |- mesh__recordAuthorizer mesh__D015941 ags
% 210.77/210.97  |- skos__hiddenLabel mesh__D015941 Titration Assays, Hemolytic
% 210.77/210.97  |- skos__scopeNote mesh__D015941
% 210.77/210.97       A screening assay for circulating COMPLEMENT PROTEINS. Diluted SERUM samples are added to antibody-coated ERYTHROCYTES and the percentage of cell lysis is measured. The values are expressed by the so called CH50, in HEMOLYTIC COMPLEMENT units per milliliter, which is the dilution of serum required to lyse 50 percent of the erythrocytes in the assay.%A%    
% 210.77/210.97  |- mesh__historyNote mesh__D015941 90   
% 210.77/210.97  |- skos__hiddenLabel mesh__D015941 Total Hemolytic Complements
% 210.77/210.97  |- skos__hiddenLabel mesh__D015941 Whole Complement Titers
% 210.77/210.97  |- skos__hiddenLabel mesh__D015941 Titers, Whole Complement
% 210.77/210.97  |- skos__hiddenLabel mesh__D015941 Titer, Whole Complement
% 210.77/210.97  |- skos__altLabel mesh__D015941 CH50 Assay
% 210.77/210.97  |- skos__hiddenLabel mesh__D015941 Complement, Total Hemolytic
% 210.77/210.97  |- skos__hiddenLabel mesh__D015941 Serum Complement Titers
% 210.77/210.97  |- mesh__dateRevised mesh__D015941 2005-07-12
% 210.77/210.97  |- skos__hiddenLabel mesh__D015941 Assay, Hemolytic Titration
% 210.77/210.97  |- skos__hiddenLabel mesh__D015941 Assays, Hemolytic Titration
% 210.77/210.97  |- skos__broader mesh__D015143smesh__D010414
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D015143 2006
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D015143 2002
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D015143 1999
% 210.77/210.97  |- mesh__dateCreated mesh__D015143 1988-03-18
% 210.77/210.97  |- mesh__recordMaintainer mesh__D015143 PXP
% 210.77/210.97  |- mesh__historyNote mesh__D015143 89   
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D015143 2005
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D015143 2004
% 210.77/210.97  |- mesh__recordOriginator mesh__D015143 EC
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D015143 1998
% 210.77/210.97  |- mesh__dateEstablished mesh__D015143 1989-01-01
% 210.77/210.97  |- skos__prefLabel mesh__D015143 Philadelphia
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D015143 2003
% 210.77/210.97  |- mesh__recordAuthorizer mesh__D015143 SJN
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D015143 2001
% 210.77/210.97  |- skos__broader mesh__D015143smesh__D002947
% 210.77/210.97  |- rdf__type mesh__D015143sskos__Concept
% 210.77/210.97  |- skos__annotation mesh__D015143 DF: PHILA   
% 210.77/210.97  |- mesh__dateRevised mesh__D015143 1997-06-20
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D015143 2000
% 210.77/210.97  |- mesh__recordOriginator mesh__D009904 NLM
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009904 1995
% 210.77/210.97  |- skos__hiddenLabel mesh__D009904 Optical Rotations
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009904 2001
% 210.77/210.97  |- skos__prefLabel mesh__D009904 Optical Rotation
% 210.77/210.97  |- skos__hiddenLabel mesh__D009904 Rotations, Optical
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009904 1996
% 210.77/210.97  |- mesh__historyNote mesh__D009904 74%28%71%29%   
% 210.77/210.97  |- mesh__dateCreated mesh__D009904 1999-01-01
% 210.77/210.97  |- mesh__dateRevised mesh__D009904 1989-06-14
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009904 1990
% 210.77/210.97  |- skos__hiddenLabel mesh__D009904 Rotation, Optical
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009904 2003
% 210.77/210.97  |- mesh__recordMaintainer mesh__D009904 TGC
% 210.77/210.97  |- skos__broader mesh__D009904smesh__D009906
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009904 1998
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009904 1997
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009904 2002
% 210.77/210.97  |- mesh__publicMeSHNote mesh__D009904 74   
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009904 2005
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009904 1992
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009904 2004
% 210.77/210.97  |- mesh__recordAuthorizer mesh__D009904 PLS
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009904 1999
% 210.77/210.97  |- skos__historyNote mesh__D009904 Chemistry, Physical %28%1966-1970%29%
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009904 1991
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009904 1994
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009904 2006
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009904 1993
% 210.77/210.97  |- mesh__dateEstablished mesh__D009904 1974-01-01
% 210.77/210.97  |- rdf__type mesh__D009904sskos__Concept
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009904 2000
% 210.77/210.97  |- skos__annotation mesh__D009904 NIM; no qualif   
% 210.77/210.97  |- skos__prefLabel mesh__D001921 Brain
% 210.77/210.97  |- skos__annotation mesh__D001921
% 210.77/210.97       GEN; /blood supply: consider also CEREBROVASCULAR CIRCULATION; CEREBRAL ARTERIES; CEREBRAL VEINS; CRANIAL SINUSES; /cytol: do not routinely convert to NEURONS; /drug eff: consider terms in D14 %26% D15; /surg: consider also CEREBRAL DECORTICATION %26% PSYCHOSURGERY; inflammation = ENCEPHALITIS %26% its specifics; infarct = CEREBRAL INFARCTION; malacia = ENCEPHALOMALACIA; brain-isolated, enc%C3%%A9%phale isol%C3%%A9%, cerveau isol%C3%%A9%: index DECEREBRATE STATE%A%  
% 210.77/210.97  |- skos__related mesh__D001921smesh__D011612
% 210.77/210.97  |- mesh__recordAuthorizer mesh__D001921 sjn
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D001921 2002
% 210.77/210.97  |- skos__hiddenLabel mesh__D001921 Brains
% 210.77/210.97  |- mesh__recordOriginator mesh__D001921 NLM
% 210.77/210.97  |- skos__altLabel mesh__D001921 Encephalon
% 210.77/210.97  |- rdf__type mesh__D001921sskos__Concept
% 210.77/210.97  |- mesh__publicMeSHNote mesh__D001921
% 210.77/210.97       /enzymology was BRAIN ENZYMOLOGY 1964-65; /physiology was BRAIN PHYSIOLOGY 1965; BRAIN ELECTROPHYSIOLOGY was heading 1964-65%A%  
% 210.77/210.97  |- mesh__dateRevised mesh__D001921 2001-08-13
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D001921 2005
% 210.77/210.97  |- mesh__dateCreated mesh__D001921 1999-01-01
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D001921 2003
% 210.77/210.97  |- skos__scopeNote mesh__D001921
% 210.77/210.97       The part of the central nervous system contained within the cranium, comprising the prosencephalon, mesencephalon, and rhombencephalon. It is derived from the anterior part of the embryonic neural tube.%A%    
% 210.77/210.97  |- mesh__historyNote mesh__D001921
% 210.77/210.97       /enzymology was BRAIN ENZYMOLOGY 1964-65; /physiology was BRAIN PHYSIOLOGY 1965; BRAIN ELECTROPHYSIOLOGY was heading 1964-65%A%  
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D001921 2006
% 210.77/210.97  |- mesh__recordMaintainer mesh__D001921 jls
% 210.77/210.97  |- skos__related mesh__D001921smesh__D002541
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D001921 2004
% 210.77/210.97  |- mesh__onlineNote mesh__D001921 pre-explosion = BRAIN %28%PX%29%   
% 210.77/210.97  |- mesh__considerAlso mesh__D001921
% 210.77/210.97       consider also terms at CEREBR- and ENCEPHAL-   
% 210.77/210.97  |- skos__broader mesh__D001921smesh__D002490
% 210.77/210.97  |- skos__hiddenLabel mesh__D001921 Encephalons
% 210.77/210.97  |- skos__broader mesh__D011095Q000031smesh__D011095
% 210.77/210.97  |- mesh__preferredCombination mesh__D011095Q000031smesh__D020959
% 210.77/210.97  |- rdf__type mesh__D011095Q000031smesh__CompoundConcept
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009106 2003
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009106 1997
% 210.77/210.97  |- mesh__dateRevised mesh__D009106 1996-06-10
% 210.77/210.97  |- mesh__recordOriginator mesh__D009106 NLM
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009106 1998
% 210.77/210.97  |- rdf__type mesh__D009106sskos__Concept
% 210.77/210.97  |- mesh__dateCreated mesh__D009106 1999-01-01
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009106 2004
% 210.77/210.97  |- skos__hiddenLabel mesh__D009106 Mummy
% 210.77/210.97  |- skos__broader mesh__D009106smesh__D010163
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009106 1999
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009106 2005
% 210.77/210.97  |- mesh__recordAuthorizer mesh__D009106 PLS
% 210.77/210.97  |- skos__annotation mesh__D009106
% 210.77/210.97       do not routinely check tags HISTORICAL ARTICLE + ANCIENT: check only when the hist %26% ancient med aspects are particularly discussed; /pathol: do not bother to coord with PALEOPATHOLOGY%A%  
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009106 2006
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009106 2000
% 210.77/210.97  |- skos__scopeNote mesh__D009106
% 210.77/210.97       Bodies preserved either by the ancient Egyptian technique or due to chance under favorable climatic conditions.%A%    
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009106 2001
% 210.77/210.97  |- mesh__recordMaintainer mesh__D009106 TGC
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D009106 2002
% 210.77/210.97  |- skos__prefLabel mesh__D009106 Mummies
% 210.77/210.97  |- mesh__publicMeSHNote mesh__D001123 91; was see under LYASES 1975-90   
% 210.77/210.97  |- mesh__recordMaintainer mesh__D001123 ssb
% 210.77/210.97  |- mesh__dateCreated mesh__D001123 1974-11-19
% 210.77/210.97  |- mesh__dateRevised mesh__D001123 2003-07-09
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D001123 2005
% 210.77/210.97  |- rdf__type mesh__D001123sskos__Concept
% 210.77/210.97  |- skos__hiddenLabel mesh__D001123 Lyase, Argininosuccinate
% 210.77/210.97  |- skos__historyNote mesh__D001123 Succinates %28%1973-1974%29%
% 210.77/210.97  |- skos__historyNote mesh__D001123 Arginine %28%1973-1974%29%
% 210.77/210.97  |- skos__scopeNote mesh__D001123
% 210.77/210.97       An enzyme of the urea cycle which splits argininosuccinate to fumarate plus arginine. Its absence leads to the metabolic disease argininosuccinic acidemia in man. EC 4.3.2.1.%A%    
% 210.77/210.97  |- mesh__dateEstablished mesh__D001123 1991-01-01
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D001123 2004
% 210.77/210.97  |- skos__prefLabel mesh__D001123 Argininosuccinate Lyase
% 210.77/210.97  |- mesh__recordAuthorizer mesh__D001123 sjn
% 210.77/210.97  |- mesh__recordOriginator mesh__D001123 NLM
% 210.77/210.97  |- skos__broader mesh__D001123smesh__D019760
% 210.77/210.97  |- skos__annotation mesh__D001123
% 210.77/210.97       /defic: consider also ARGININOSUCCINIC ACID /urine %28%IM%29% + AMINO ACID METABOLISM, INBORN ERRORS %28%IM%29%%A%  
% 210.77/210.97  |- skos__altLabel mesh__D001123 Argininosuccinase
% 210.77/210.97  |- skos__historyNote mesh__D001123 Lyases %28%1973-1974%29%
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D001123 2006
% 210.77/210.97  |- mesh__historyNote mesh__D001123
% 210.77/210.97       91%28%75%29%; was see under LYASES 1975-90   
% 210.77/210.97  |- skos__hiddenLabel mesh__D020886 Sensation Disorder, Somatic
% 210.77/210.97  |- skos__altLabel mesh__D020886 Somatic Sensation Disorders
% 210.77/210.97  |- skos__hiddenLabel mesh__D020886 Thermal Sensation Disorder
% 210.77/210.97  |- skos__hiddenLabel mesh__D020886 Diminished, Pinprick Sensation
% 210.77/210.97  |- skos__hiddenLabel mesh__D020886 Somatic Sensation Disorder
% 210.77/210.97  |- skos__hiddenLabel mesh__D020886 Diminisheds, Pinprick Sensation
% 210.77/210.97  |- skos__hiddenLabel mesh__D020886 Somatosensory Disorder
% 210.77/210.97  |- skos__hiddenLabel mesh__D020886 Sensation Diminished, Pinprick
% 210.77/210.97  |- skos__prefLabel mesh__D020886 Somatosensory Disorders
% 210.77/210.97  |- skos__annotation mesh__D020886 GEN: prefer specifics   
% 210.77/210.97  |- skos__hiddenLabel mesh__D020886 Pinprick Sensation Diminisheds
% 210.77/210.97  |- skos__hiddenLabel mesh__D020886 Sensation Diminisheds, Pain
% 210.77/210.97  |- skos__broader mesh__D020886smesh__D012678
% 210.77/210.97  |- skos__hiddenLabel mesh__D020886 Diminished, Pain Sensation
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D020886 2000
% 210.77/210.97  |- skos__hiddenLabel mesh__D020886 Sense Disorders, Position
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D020886 2005
% 210.77/210.97  |- skos__altLabel mesh__D020886 Light Touch Sensation Impairment
% 210.77/210.97  |- mesh__publicMeSHNote mesh__D020886 2000   
% 210.77/210.97  |- skos__hiddenLabel mesh__D020886 Sensation Diminisheds, Pinprick
% 210.77/210.97  |- skos__hiddenLabel mesh__D020886 Pain Sensation Diminisheds
% 210.77/210.97  |- skos__hiddenLabel mesh__D020886 Sensation Diminished, Pain
% 210.77/210.97  |- skos__hiddenLabel mesh__D020886 Position Sense Disorder
% 210.77/210.97  |- skos__hiddenLabel mesh__D020886 Sensation Disorders, Somatic
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D020886 2001
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D020886 2006
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D020886 2003
% 210.77/210.97  |- skos__hiddenLabel mesh__D020886 Diminisheds, Pain Sensation
% 210.77/210.97  |- skos__hiddenLabel mesh__D020886 Sensation Disorder, Thermal
% 210.77/210.97  |- skos__historyNote mesh__D020886 Sensation Disorders %28%1966-1999%29%
% 210.77/210.97  |- rdf__type mesh__D020886sskos__Concept
% 210.77/210.97  |- mesh__dateCreated mesh__D020886 1999-11-03
% 210.77/210.97  |- skos__scopeNote mesh__D020886
% 210.77/210.97       Disorders of sensory information received from superficial and deep regions of the body. The somatosensory system conveys neural impulses which pertain to proprioception, tactile sensation, thermal sensation, pressure sensation, and pain. PERIPHERAL NERVOUS SYSTEM DISEASES; SPINAL CORD DISEASES; and BRAIN DISEASES may be associated with impaired or abnormal somatic sensation.%A%    
% 210.77/210.97  |- skos__hiddenLabel mesh__D020886 Sense Disorder, Position
% 210.77/210.97  |- skos__hiddenLabel mesh__D020886 Sensation Disorders, Thermal
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D020886 2002
% 210.77/210.97  |- mesh__dateEstablished mesh__D020886 2000-01-01
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D020886 2004
% 210.77/210.97  |- mesh__historyNote mesh__D020886 2000   
% 210.77/210.97  |- skos__hiddenLabel mesh__D020886 Proprioceptive Disorder
% 210.77/210.97  |- mesh__recordOriginator mesh__D020088 AGS
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D020088 2006
% 210.77/210.97  |- skos__historyNote mesh__D020088 Chytridiomycota %28%1989-1995%29%
% 210.77/210.97  |- rdf__type mesh__D020088sskos__Concept
% 210.77/210.97  |- skos__scopeNote mesh__D020088
% 210.77/210.97       A genus of fungi in the family Neocallimasticaceae, order NEOCALLIMASTICALES. They contain polyflagellate zoospores and grow on a range of simple and complex carbohydrates in the rumen of sheep and cattle.%A%    
% 210.77/210.97  |- mesh__dateEstablished mesh__D020088 1999-01-01
% 210.77/210.97  |- skos__historyNote mesh__D020088 Fungi %28%1975-1998%29%
% 210.77/210.97  |- mesh__dateCreated mesh__D020088 1998-06-10
% 210.77/210.97  |- mesh__recordMaintainer mesh__D020088 SYSTEM
% 210.77/210.97  |- skos__prefLabel mesh__D020088 Neocallimastix
% 210.77/210.97  |- mesh__publicMeSHNote mesh__D020088 99   
% 210.77/210.97  |- mesh__historyNote mesh__D020088 99   
% 210.77/210.97  |- skos__broader mesh__D020088smesh__D020085
% 210.77/210.97  |- mesh__dateRevised mesh__D020088 2005-06-30
% 210.77/210.97  |- mesh__recordAuthorizer mesh__D020088 sjn
% 210.77/210.97  |- skos__hiddenLabel mesh__D014849 Klein Syndrome
% 210.77/210.97  |- skos__hiddenLabel mesh__D014849 Syndrome, Klein%27%s
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D014849 2005
% 210.77/210.97  |- skos__altLabel mesh__D014849 Waardenburg-Klein Syndrome
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D014849 2002
% 210.77/210.97  |- mesh__dateCreated mesh__D014849 1999-01-01
% 210.77/210.97  |- skos__hiddenLabel mesh__D014849 Waardenburg Klein Syndrome
% 210.77/210.97  |- skos__hiddenLabel mesh__D014849 Syndrome, Waardenburg%27%s
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D014849 2006
% 210.77/210.97  |- mesh__recordAuthorizer mesh__D014849 sjn
% 210.77/210.97  |- mesh__recordOriginator mesh__D014849 NLM
% 210.77/210.97  |- skos__scopeNote mesh__D014849
% 210.77/210.97       Rare, autosomal dominant disease with variable penetrance and several known clinical types. Characteristics may include depigmentation of the hair and skin, congenital deafness, heterochromia iridis, medial eyebrow hyperplasia, hypertrophy of the nasal root, and especially dystopia canthorum. The underlying cause may be defective development of the neural crest %28%neurocristopathy%29%. Waardenburg%27%s syndrome may be closely related to piebaldism. Klein-Waardenburg Syndrome refers to a disorder that also includes upper limb abnormalities.%A%    
% 210.77/210.97  |- skos__hiddenLabel mesh__D014849 Syndrome, Klein-Waardenburg
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D014849 2003
% 210.77/210.97  |- skos__annotation mesh__D014849
% 210.77/210.97       a syndrome of multiple abnorm; check syndrome book for other Waardenburg skull deform syndromes; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D014849 2000
% 210.77/210.97  |- skos__hiddenLabel mesh__D014849 Kleins Syndrome
% 210.77/210.97  |- mesh__historyNote mesh__D014849
% 210.77/210.97       91%28%66%29%; was see under ABNORMALITIES, MULTIPLE 1975-90   
% 210.77/210.97  |- skos__altLabel mesh__D014849 Klein-Waardenburg Syndrome
% 210.77/210.97  |- skos__hiddenLabel mesh__D014849 Syndrome, Waardenburg-Klein
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D014849 2004
% 210.77/210.97  |- mesh__publicMeSHNote mesh__D014849
% 210.77/210.97       91; was see under ABNORMALITIES, MULTIPLE 1975-90   
% 210.77/210.97  |- mesh__dateEstablished mesh__D014849 1991-01-01
% 210.77/210.97  |- skos__prefLabel mesh__D014849 Waardenburg%27%s Syndrome
% 210.77/210.97  |- rdf__type mesh__D014849sskos__Concept
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D014849 2001
% 210.77/210.97  |- skos__broader mesh__D014849smesh__D000015
% 210.77/210.97  |- mesh__dateRevised mesh__D014849 1999-11-03
% 210.77/210.97  |- skos__hiddenLabel mesh__D014849 Waardenburgs Syndrome
% 210.77/210.97  |- mesh__recordMaintainer mesh__D014849 kle
% 210.77/210.97  |- skos__hiddenLabel mesh__D014849 Klein Waardenburg Syndrome
% 210.77/210.97  |- skos__hiddenLabel mesh__D014849 Waardenburg Syndrome
% 210.77/210.97  |- skos__hiddenLabel mesh__D019534 Syndromes, Subacromial Impingement
% 210.77/210.97  |- skos__hiddenLabel mesh__D019534 Syndrome, Shoulder Impingement
% 210.77/210.97  |- skos__hiddenLabel mesh__D019534 Impingement Syndromes, Shoulder
% 210.77/210.97  |- skos__hiddenLabel mesh__D019534 Impingement Syndrome, Shoulder
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D019534 2002
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D019534 1999
% 210.77/210.97  |- skos__hiddenLabel mesh__D019534 Impingement Syndrome, Subacromial
% 210.77/210.97  |- skos__hiddenLabel mesh__D019534 Subacromial Impingement Syndromes
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D019534 1998
% 210.77/210.97  |- skos__hiddenLabel mesh__D019534 Syndrome, Subacromial Impingement
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D019534 1997
% 210.77/210.97  |- mesh__dateCreated mesh__D019534 1996-06-10
% 210.77/210.97  |- skos__hiddenLabel mesh__D019534 Syndromes, Shoulder Impingement
% 210.77/210.97  |- skos__hiddenLabel mesh__D019534 Shoulder Impingement Syndromes
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D019534 2006
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D019534 2001
% 210.77/210.97  |- skos__broader mesh__D019534smesh__D007592
% 210.77/210.97  |- skos__altLabel mesh__D019534 Subacromial Impingement Syndrome
% 210.77/210.97  |- skos__historyNote mesh__D019534 Joint Diseases %28%1982-1996%29%
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D019534 2005
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D019534 2004
% 210.77/210.97  |- rdf__type mesh__D019534sskos__Concept
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D019534 2000
% 210.77/210.97  |- mesh__historyNote mesh__D019534 97   
% 210.77/210.97  |- mesh__publicMeSHNote mesh__D019534 97   
% 210.77/210.97  |- mesh__dateEstablished mesh__D019534 1997-01-01
% 210.77/210.97  |- skos__scopeNote mesh__D019534
% 210.77/210.97       Compression of the rotator cuff tendons and subacromial bursa between the humeral head and structures that make up the coracoacromial arch and the humeral tuberosities. This condition is associated with subacromial bursitis and rotator cuff %28%largely supraspinatus%29% and bicipital tendon inflammation, with or without degenerative changes in the tendon. Pain that is most severe when the arm is abducted in an arc between 40 and 120 degrees, sometimes associated with tears in the rotator cuff, is the chief symptom. %28%From Jablonski%27%s Dictionary of Syndromes and Eponymic Diseases, 2d ed%29%%A%    
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D019534 2003
% 210.77/210.97  |- skos__prefLabel mesh__D019534 Shoulder Impingement Syndrome
% 210.77/210.97  |- skos__hiddenLabel mesh__D019534 Impingement Syndromes, Subacromial
% 210.77/210.97  |- mesh__recordAuthorizer mesh__D000829 sjn
% 210.77/210.97  |- skos__hiddenLabel mesh__D000829 Animals, Farm
% 210.77/210.97  |- skos__broader mesh__D000829smesh__D000828
% 210.77/210.97  |- skos__hiddenLabel mesh__D000829 Animal, Farm
% 210.77/210.97  |- skos__hiddenLabel mesh__D000829 Domestic Animal
% 210.77/210.97  |- mesh__dateCreated mesh__D000829 1999-01-01
% 210.77/210.97  |- skos__annotation mesh__D000829
% 210.77/210.97       GEN or unspecified; prefer specific domestic animals like CATTLE; SHEEP; HORSES; DOGS; CATS; etc.; IM; qualif permitted; PETS: TN 146; domestication goes here; do not forget also to check tag ANIMALS%A%  
% 210.77/210.97  |- skos__hiddenLabel mesh__D000829 Farm Animal
% 210.77/210.97  |- skos__hiddenLabel mesh__D000829 Pet
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D000829 2005
% 210.77/210.97  |- skos__altLabel mesh__D000829 Livestock
% 210.77/210.97  |- skos__hiddenLabel mesh__D000829 Domestic Animals
% 210.77/210.97  |- skos__hiddenLabel mesh__D000829 Livestocks
% 210.77/210.97  |- mesh__dateRevised mesh__D000829 2003-07-30
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D000829 2004
% 210.77/210.97  |- skos__hiddenLabel mesh__D000829 Animal, Domestic
% 210.77/210.97  |- rdf__type mesh__D000829sskos__Concept
% 210.77/210.97  |- mesh__recordOriginator mesh__D000829 NLM
% 210.77/210.97  |- skos__scopeNote mesh__D000829
% 210.77/210.97       Animals which have become adapted through breeding in captivity to a life intimately associated with man. They include animals domesticated by man to live and breed in a tame condition on farms or ranches %28%e.g., horses, cattle, sheep%29% and those raised or kept for pleasure and companionship %28%e.g., dogs, cats, horses%29%.%A%    
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D000829 2006
% 210.77/210.97  |- skos__prefLabel mesh__D000829 Animals, Domestic
% 210.77/210.97  |- mesh__recordMaintainer mesh__D000829 ags
% 210.77/210.97  |- mesh__recordOriginator mesh__D011551 NLM
% 210.77/210.97  |- mesh__recordAuthorizer mesh__D011551 sjn
% 210.77/210.97  |- skos__prefLabel mesh__D011551 Pseudomonas fluorescens
% 210.77/210.97  |- mesh__recordMaintainer mesh__D011551 SYSTEM
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D011551 2006
% 210.77/210.97  |- mesh__publicMeSHNote mesh__D011551 74   
% 210.77/210.97  |- skos__historyNote mesh__D011551 Pseudomonas %28%1966-1971%29%
% 210.77/210.97  |- mesh__dateCreated mesh__D011551 1999-01-01
% 210.77/210.97  |- mesh__dateRevised mesh__D011551 2005-06-30
% 210.77/210.97  |- mesh__dateEstablished mesh__D011551 1974-01-01
% 210.77/210.97  |- skos__scopeNote mesh__D011551
% 210.77/210.97       A species of nonpathogenic fluorescent bacteria found in feces, sewage, soil, and water, and which liquefy gelatin.%A%    
% 210.77/210.97  |- skos__broader mesh__D011551smesh__D011549
% 210.77/210.97  |- rdf__type mesh__D011551sskos__Concept
% 210.77/210.97  |- mesh__historyNote mesh__D011551 74%28%72%29%   
% 210.77/210.97  |- skos__hiddenLabel mesh__D005514 Irradiations, Food
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D005514 2003
% 210.77/210.97  |- skos__hiddenLabel mesh__D005514 Irradiated Food
% 210.77/210.97  |- rdf__type mesh__D005514sskos__Concept
% 210.77/210.97  |- skos__hiddenLabel mesh__D005514 Irradiation, Food
% 210.77/210.97  |- skos__hiddenLabel mesh__D005514 Irradiated Foods
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D005514 2005
% 210.77/210.97  |- mesh__dateCreated mesh__D005514 1999-01-01
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D005514 2004
% 210.77/210.97  |- mesh__recordOriginator mesh__D005514 NLM
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D005514 2006
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D005514 2000
% 210.77/210.97  |- mesh__recordAuthorizer mesh__D005514 SJN
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D005514 1998
% 210.77/210.97  |- skos__broader mesh__D005514smesh__D005519
% 210.77/210.97  |- skos__annotation mesh__D005514
% 210.77/210.97       food preservation by irradiation: do not confuse with FOOD CONTAMINATION, RADIOACTIVE; DF: FOOD IRRAD%A%  
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D005514 2001
% 210.77/210.97  |- skos__hiddenLabel mesh__D005514 Foods, Irradiated
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D005514 1999
% 210.77/210.97  |- skos__prefLabel mesh__D005514 Food Irradiation
% 210.77/210.97  |- mesh__recordMaintainer mesh__D005514 JLS
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D005514 2002
% 210.77/210.97  |- skos__hiddenLabel mesh__D005514 Food Irradiations
% 210.77/210.97  |- mesh__dateRevised mesh__D005514 1997-06-20
% 210.77/210.97  |- skos__scopeNote mesh__D029962
% 210.77/210.97       A plant family of the order Fagales subclass Hamamelidae, class Magnoliopsida.%A%    
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D029962 2002
% 210.77/210.97  |- mesh__historyNote mesh__D029962 2002   
% 210.77/210.97  |- mesh__dateEstablished mesh__D029962 2002-01-01
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D029962 2004
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D029962 2006
% 210.77/210.97  |- rdf__type mesh__D029962sskos__Concept
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D029962 2003
% 210.77/210.97  |- skos__prefLabel mesh__D029962 Fagaceae
% 210.77/210.97  |- mesh__publicMeSHNote mesh__D029962 2002   
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D029962 2005
% 210.77/210.97  |- skos__broader mesh__D029962smesh__D019684
% 210.77/210.97  |- mesh__dateCreated mesh__D029962 2001-07-25
% 210.77/210.97  |- skos__annotation mesh__D029962
% 210.77/210.97       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.77/210.97  |- skos__historyNote mesh__D010459 Lactobacillaceae %28%1975%29%
% 210.77/210.97  |- rdf__type mesh__D010459sskos__Concept
% 210.77/210.97  |- mesh__dateCreated mesh__D010459 1975-07-21
% 210.77/210.97  |- mesh__recordAuthorizer mesh__D010459 sjn
% 210.77/210.97  |- skos__historyNote mesh__D010459 Micrococcaceae %28%1975%29%
% 210.77/210.97  |- skos__prefLabel mesh__D010459 Peptococcaceae
% 210.77/210.97  |- skos__annotation mesh__D010459 in man, animals, soil   
% 210.77/210.97  |- skos__scopeNote mesh__D010459
% 210.77/210.97       A family of bacteria found in the mouth and intestinal and respiratory tracts of man and other animals as well as in the human female urogenital tract. Its organisms are also found in soil and on cereal grains.%A%    
% 210.77/210.97  |- mesh__historyNote mesh__D010459 76   
% 210.77/210.97  |- skos__historyNote mesh__D010459 Bacteria %28%1966-1977%29%
% 210.77/210.97  |- mesh__recordMaintainer mesh__D010459 SYSTEM
% 210.77/210.97  |- mesh__dateEstablished mesh__D010459 1976-01-01
% 210.77/210.97  |- mesh__recordOriginator mesh__D010459 JW
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D010459 2006
% 210.77/210.97  |- mesh__publicMeSHNote mesh__D010459 76   
% 210.77/210.97  |- skos__broader mesh__D010459smesh__D006095
% 210.77/210.97  |- mesh__dateRevised mesh__D010459 2005-06-30
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D021181 2004
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D021181 2005
% 210.77/210.97  |- skos__altLabel mesh__D021181 Allergy, Egg
% 210.77/210.97  |- skos__altLabel mesh__D021181 Egg Allergy
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D021181 2002
% 210.77/210.97  |- skos__scopeNote mesh__D021181
% 210.77/210.97       Allergic reaction to eggs that is triggered by the immune system.%A%    
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D021181 2006
% 210.77/210.97  |- mesh__publicMeSHNote mesh__D021181 2002   
% 210.77/210.97  |- mesh__dateEstablished mesh__D021181 2002-01-01
% 210.77/210.97  |- skos__historyNote mesh__D021181 Food Hypersensitivity %28%1965-2001%29%
% 210.77/210.97  |- skos__hiddenLabel mesh__D021181 Egg Allergies
% 210.77/210.97  |- skos__annotation mesh__D021181
% 210.77/210.97       coord IM with specific egg component /adv eff %28%IM%29% if pertinent%A%  
% 210.77/210.97  |- skos__broader mesh__D021181smesh__D005512
% 210.77/210.97  |- skos__altLabel mesh__D021181 Hypersensitivity, Egg
% 210.77/210.97  |- mesh__dateCreated mesh__D021181 2001-07-25
% 210.77/210.97  |- rdf__type mesh__D021181sskos__Concept
% 210.77/210.97  |- mesh__historyNote mesh__D021181 2002   
% 210.77/210.97  |- skos__hiddenLabel mesh__D021181 Hypersensitivities, Egg
% 210.77/210.97  |- skos__historyNote mesh__D021181 Eggs %28%1965-2001%29%
% 210.77/210.97  |- skos__prefLabel mesh__D021181 Egg Hypersensitivity
% 210.77/210.97  |- skos__hiddenLabel mesh__D021181 Egg Hypersensitivities
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D021181 2003
% 210.77/210.97  |- skos__hiddenLabel mesh__D021181 Allergies, Egg
% 210.77/210.97  |- skos__related mesh__D015942smesh__D003029
% 210.77/210.97  |- mesh__historyNote mesh__D015942 90   
% 210.77/210.97  |- skos__hiddenLabel mesh__D015942 Activated Factor VII
% 210.77/210.97  |- skos__historyNote mesh__D015942 Factor VII %28%1975-1989%29%
% 210.77/210.97  |- rdf__type mesh__D015942sskos__Concept
% 210.77/210.97  |- skos__scopeNote mesh__D015942
% 210.77/210.97       Activated form of factor VII. Factor VIIa activates factor X in the extrinsic pathway of blood coagulation.%A%    
% 210.77/210.97  |- mesh__dateEstablished mesh__D015942 1990-01-01
% 210.77/210.97  |- skos__broader mesh__D015942smesh__D012697
% 210.77/210.97  |- skos__altLabel mesh__D015942 Blood Coagulation Factor VII, Activated
% 210.77/210.97  |- skos__altLabel mesh__D015942 Factor VII, Activated
% 210.77/210.97  |- mesh__recordAuthorizer mesh__D015942 sjn
% 210.77/210.97  |- skos__annotation mesh__D015942
% 210.77/210.97       a blood coag factor; a serine proteinase; /defic = FACTOR VII DEFICIENCY%A%  
% 210.77/210.97  |- mesh__activeMeSHYear mesh__D015942 2006
% 210.77/210.97  |- mesh__publicMeSHNote mesh__D015942 90   
% 210.77/210.97  |- skos__altLabel mesh__D015942 Coagulation Factor VIIa
% 210.77/210.97  |- skos__broader mesh__D015942smesh__D005167
% 210.77/210.97  |- skos__prefLabel mesh__D015942 Factor VIIa
% 210.77/210.97  |- mesh__recordOriginator mesh__D015942 AGS
% 210.77/210.98  |- mesh__recordMaintainer mesh__D015942 ssb
% 210.77/210.98  |- mesh__dateCreated mesh__D015942 1989-05-25
% 210.77/210.98  |- mesh__dateRevised mesh__D015942 2005-06-30
% 210.77/210.98  |- skos__hiddenLabel mesh__D015942 VIIa, Coagulation Factor
% 210.77/210.98  |- skos__hiddenLabel mesh__D015942 Factor VIIa, Coagulation
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D015144 2001
% 210.77/210.98  |- mesh__dateEstablished mesh__D015144 1989-01-01
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D015144 2003
% 210.77/210.98  |- mesh__dateRevised mesh__D015144 1997-06-20
% 210.77/210.98  |- skos__prefLabel mesh__D015144 Southeastern United States
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D015144 2000
% 210.77/210.98  |- rdf__type mesh__D015144sskos__Concept
% 210.77/210.98  |- skos__altLabel mesh__D015144 Southeast US
% 210.77/210.98  |- mesh__dateCreated mesh__D015144 1988-03-18
% 210.77/210.98  |- mesh__recordOriginator mesh__D015144 EC
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D015144 2002
% 210.77/210.98  |- mesh__recordMaintainer mesh__D015144 PXP
% 210.77/210.98  |- skos__broader mesh__D015144smesh__D014481
% 210.77/210.98  |- skos__annotation mesh__D015144
% 210.77/210.98       includes Ala, Ark, Fla, Ga, La, Miss, N Carolina, S Carolina, W Virginia, Virginia; specify as needed but use SOUTHEASTERN UNITED STATES when text uses the term; DF: note short X ref      CATALOG: use for 4 or more states%A%  
% 210.77/210.98  |- mesh__historyNote mesh__D015144 89   
% 210.77/210.98  |- skos__altLabel mesh__D015144 Southeast U.S.
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D015144 2006
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D015144 1999
% 210.77/210.98  |- skos__scopeNote mesh__D015144
% 210.77/210.98       The geographic area of the southeastern region of the United States in general or when the specific state or states are not included. The states usually included in this region are Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, South Carolina, West Virginia, and Virginia.%A%    
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D015144 2005
% 210.77/210.98  |- mesh__recordAuthorizer mesh__D015144 SJN
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D015144 2004
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D015144 1998
% 210.77/210.98  |- skos__annotation mesh__D009905 a type of spectrum anal; NIM   
% 210.77/210.98  |- skos__prefLabel mesh__D009905 Optical Rotatory Dispersion
% 210.77/210.98  |- mesh__dateCreated mesh__D009905 1999-01-01
% 210.77/210.98  |- mesh__publicMeSHNote mesh__D009905 70   
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009905 2003
% 210.77/210.98  |- mesh__recordOriginator mesh__D009905 NLM
% 210.77/210.98  |- mesh__dateEstablished mesh__D009905 1970-01-01
% 210.77/210.98  |- mesh__dateRevised mesh__D009905 2002-07-03
% 210.77/210.98  |- skos__broader mesh__D009905smesh__D013057
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009905 2005
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009905 2004
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009905 2006
% 210.77/210.98  |- skos__historyNote mesh__D009905 Spectrum Analysis %28%1966-1967%29%
% 210.77/210.98  |- rdf__type mesh__D009905sskos__Concept
% 210.77/210.98  |- skos__hiddenLabel mesh__D009905 Rotatory Dispersion, Optical
% 210.77/210.98  |- mesh__historyNote mesh__D009905 70%28%68%29%   
% 210.77/210.98  |- skos__scopeNote mesh__D009905
% 210.77/210.98       The method of measuring the dispersion of an optically active molecule to determine the relative magnitude of right- or left-handed components and sometimes structural features of the molecule.%A%    
% 210.77/210.98  |- mesh__recordMaintainer mesh__D009905 lkt
% 210.77/210.98  |- mesh__recordAuthorizer mesh__D009905 sjn
% 210.77/210.98  |- skos__hiddenLabel mesh__D009905 Dispersion, Optical Rotatory
% 210.77/210.98  |- skos__prefLabel mesh__D001922 Brain Abscess
% 210.77/210.98  |- skos__hiddenLabel mesh__D001922 Abscess, Child Brain
% 210.77/210.98  |- skos__hiddenLabel mesh__D001922 Child Brain Abscess
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D001922 2005
% 210.77/210.98  |- mesh__recordAuthorizer mesh__D001922 ags
% 210.77/210.98  |- mesh__dateCreated mesh__D001922 1999-01-01
% 210.77/210.98  |- skos__hiddenLabel mesh__D001922 Brain Abscesses, Multiple
% 210.77/210.98  |- skos__broader mesh__D001922smesh__D001423
% 210.77/210.98  |- skos__broader mesh__D001922smesh__D000038
% 210.77/210.98  |- skos__hiddenLabel mesh__D001922 Multiple Brain Abscess
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D001922 2006
% 210.77/210.98  |- skos__hiddenLabel mesh__D001922 Sterile Brain Abscesses
% 210.77/210.98  |- skos__annotation mesh__D001922
% 210.77/210.98       coord IM with specific infection %28%IM%29% + specific CNS infect term %28%IM%29% + site/dis term %28%IM%29% if pertinent%A%  
% 210.77/210.98  |- skos__hiddenLabel mesh__D001922 Pyogenic Brain Abscess
% 210.77/210.98  |- skos__hiddenLabel mesh__D001922 Abscesses, Cerebral
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D001922 2004
% 210.77/210.98  |- skos__hiddenLabel mesh__D001922 Brain Abscesses
% 210.77/210.98  |- skos__hiddenLabel mesh__D001922 Multiple Brain Abscesses
% 210.77/210.98  |- skos__hiddenLabel mesh__D001922 Abscesses, Multiple Brain
% 210.77/210.98  |- skos__hiddenLabel mesh__D001922 Sterile Brain Abscess
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D001922 2006A
% 210.77/210.98  |- skos__scopeNote mesh__D001922
% 210.77/210.98       A circumscribed collection of purulent exudate in the brain, due to bacterial and other infections. The majority are caused by spread of infected material from a focus of suppuration elsewhere in the body, notably the PARANASAL SINUSES, middle ear %28%see EAR, MIDDLE%29%; HEART %28%see also ENDOCARDITIS, BACTERIAL%29%, and LUNG. Penetrating CRANIOCEREBRAL TRAUMA and NEUROSURGICAL PROCEDURES may also be associated with this condition. Clinical manifestations include HEADACHE; SEIZURES; focal neurologic deficits; and alterations of consciousness. %28%Adams et al., Principles of Neurology, 6th ed, pp712-6%29%%A%    
% 210.77/210.98  |- skos__broader mesh__D001922smesh__D002494
% 210.77/210.98  |- skos__hiddenLabel mesh__D001922 Brain Abscesses, Sterile
% 210.77/210.98  |- skos__hiddenLabel mesh__D001922 Brain Abscesses, Pyogenic
% 210.77/210.98  |- mesh__recordOriginator mesh__D001922 NLM
% 210.77/210.98  |- skos__hiddenLabel mesh__D001922 Abscess, Pyogenic Brain
% 210.77/210.98  |- skos__hiddenLabel mesh__D001922 Pyogenic Brain Abscesses
% 210.77/210.98  |- mesh__dateRevised mesh__D001922 2005-07-15
% 210.77/210.98  |- skos__hiddenLabel mesh__D001922 Abscess, Brain
% 210.77/210.98  |- skos__related mesh__D001922smesh__D013354
% 210.77/210.98  |- skos__hiddenLabel mesh__D001922 Cerebral Abscesses
% 210.77/210.98  |- skos__hiddenLabel mesh__D001922 Abscess, Cerebral
% 210.77/210.98  |- skos__broader mesh__D001922smesh__D001927
% 210.77/210.98  |- rdf__type mesh__D001922sskos__Concept
% 210.77/210.98  |- skos__hiddenLabel mesh__D001922 Abscess, Multiple Brain
% 210.77/210.98  |- mesh__recordMaintainer mesh__D001922 ags
% 210.77/210.98  |- skos__broader mesh__D001922smesh__D020806
% 210.77/210.98  |- skos__broader mesh__D009107smesh__D010309
% 210.77/210.98  |- skos__hiddenLabel mesh__D009107 Parotitides, Epidemic
% 210.77/210.98  |- mesh__dateRevised mesh__D009107 2001-08-03
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009107 2005
% 210.77/210.98  |- mesh__dateCreated mesh__D009107 1999-01-01
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009107 2004
% 210.77/210.98  |- skos__annotation mesh__D009107
% 210.77/210.98       caused by the MUMPS VIRUS, a rubulavirus   
% 210.77/210.98  |- skos__hiddenLabel mesh__D009107 Epidemic Parotitides
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009107 2003
% 210.77/210.98  |- rdf__type mesh__D009107sskos__Concept
% 210.77/210.98  |- skos__hiddenLabel mesh__D009107 Epidemic Parotitis
% 210.77/210.98  |- skos__prefLabel mesh__D009107 Mumps
% 210.77/210.98  |- mesh__recordOriginator mesh__D009107 NLM
% 210.77/210.98  |- skos__broader mesh__D009107smesh__D019351
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009107 2002
% 210.77/210.98  |- skos__scopeNote mesh__D009107
% 210.77/210.98       An acute infectious disease caused by RUBULAVIRUS, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected. %28%From Dorland, 28th ed%29%%A%    
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009107 2006
% 210.77/210.98  |- mesh__recordAuthorizer mesh__D009107 sjn
% 210.77/210.98  |- mesh__recordMaintainer mesh__D009107 sjn
% 210.77/210.98  |- skos__altLabel mesh__D009107 Parotitis, Epidemic
% 210.77/210.98  |- skos__prefLabel mesh__D001124 Argininosuccinate Synthase
% 210.77/210.98  |- skos__hiddenLabel mesh__D001124 Synthetase, Argininosuccinate
% 210.77/210.98  |- skos__historyNote mesh__D001124 Succinates %28%1973-1974%29%
% 210.77/210.98  |- mesh__recordMaintainer mesh__D001124 ssb
% 210.77/210.98  |- mesh__dateCreated mesh__D001124 1974-11-19
% 210.77/210.98  |- mesh__dateEstablished mesh__D001124 1991-01-01
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D001124 2004
% 210.77/210.98  |- mesh__publicMeSHNote mesh__D001124
% 210.77/210.98       98; see ARGININOSUCCINATE SYNTHETASE 1991-97; see LIGASES 1975-90%A%  
% 210.77/210.98  |- skos__historyNote mesh__D001124 Arginine %28%1973-1974%29%
% 210.77/210.98  |- skos__scopeNote mesh__D001124
% 210.77/210.98       An enzyme of the urea cycle that catalyzes the formation of argininosuccinic acid from citrulline and aspartic acid in the presence of ATP. Absence or deficiency of this enzyme causes the metabolic disease CITRULLINEMIA in humans. EC 6.3.4.5.%A%    
% 210.77/210.98  |- skos__broader mesh__D001124smesh__D019731
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D001124 2006
% 210.77/210.98  |- skos__annotation mesh__D001124 /defic: consider also CITRULLINEMIA   
% 210.77/210.98  |- mesh__historyNote mesh__D001124 98%28%75%29%   
% 210.77/210.98  |- mesh__recordOriginator mesh__D001124 NLM
% 210.77/210.98  |- mesh__recordAuthorizer mesh__D001124 sjn
% 210.77/210.98  |- rdf__type mesh__D001124sskos__Concept
% 210.77/210.98  |- skos__historyNote mesh__D001124 Ligases %28%1973-1974%29%
% 210.77/210.98  |- skos__hiddenLabel mesh__D001124 Synthase, Argininosuccinate
% 210.77/210.98  |- skos__altLabel mesh__D001124 Argininosuccinate Synthetase
% 210.77/210.98  |- skos__related mesh__D001124smesh__D020159
% 210.77/210.98  |- mesh__dateRevised mesh__D001124 2003-07-09
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D001124 2005
% 210.77/210.98  |- skos__historyNote mesh__D020887 Oxides %28%1974-1979%29%
% 210.77/210.98  |- mesh__recordOriginator mesh__D020887 adp
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D020887 2000
% 210.77/210.98  |- skos__historyNote mesh__D020887 Selenium %28%1974-1993%29%
% 210.77/210.98  |- rdf__type mesh__D020887sskos__Concept
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D020887 2004
% 210.77/210.98  |- mesh__recordMaintainer mesh__D020887 ags
% 210.77/210.98  |- skos__broader mesh__D020887smesh__D018036
% 210.77/210.98  |- mesh__publicMeSHNote mesh__D020887
% 210.77/210.98       2000; SELENIOUS ACID was indexed under SELENIUM COMPOUNDS 1994-1999, SELENIUM 1974-1993, %26% OXIDES 1974-1979%A%  
% 210.77/210.98  |- mesh__dateCreated mesh__D020887 1999-11-08
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D020887 2006
% 210.77/210.98  |- mesh__recordAuthorizer mesh__D020887 ags
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D020887 2003
% 210.77/210.98  |- skos__scopeNote mesh__D020887
% 210.77/210.98       A selenium compound used as a source of SELENIUM, especially for patients that develop selenium deficiency following prolonged PARENTERAL NUTRITION.%A%    
% 210.77/210.98  |- mesh__dateEstablished mesh__D020887 2000-01-01
% 210.77/210.98  |- mesh__dateRevised mesh__D020887 2000-01-19
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D020887 2000B
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D020887 2005
% 210.77/210.98  |- mesh__historyNote mesh__D020887
% 210.77/210.98       2000; use SELENIOUS ACID %28%NM%29% 1974-1999   
% 210.77/210.98  |- skos__prefLabel mesh__D020887 Selenious Acid
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D020887 2002
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D020887 2000A
% 210.77/210.98  |- skos__hiddenLabel mesh__D020887 Acid, Selenious
% 210.77/210.98  |- skos__historyNote mesh__D020887 Selenium Compounds %28%1994-1999%29%
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D020887 2001
% 210.77/210.98  |- mesh__recordAuthorizer mesh__D020089 sjn
% 210.77/210.98  |- skos__altLabel mesh__D020089 Piromonas
% 210.77/210.98  |- mesh__recordMaintainer mesh__D020089 SYSTEM
% 210.77/210.98  |- mesh__recordOriginator mesh__D020089 AGS
% 210.77/210.98  |- mesh__historyNote mesh__D020089
% 210.77/210.98       1999; for PIROMONAS use NEOCALLIMASTICALES 1999-2004   
% 210.77/210.98  |- skos__broader mesh__D020089smesh__D020085
% 210.77/210.98  |- mesh__dateEstablished mesh__D020089 1999-01-01
% 210.77/210.98  |- mesh__dateCreated mesh__D020089 1998-06-10
% 210.77/210.98  |- skos__scopeNote mesh__D020089
% 210.77/210.98       A genus of fungi in the family Neocallimasticaceae, order NEOCALLIMASTICALES, containing uniflagellate zoospores.%A%    
% 210.77/210.98  |- skos__historyNote mesh__D020089 Fungi %28%1992-1998%29%
% 210.77/210.98  |- skos__prefLabel mesh__D020089 Piromyces
% 210.77/210.98  |- mesh__publicMeSHNote mesh__D020089
% 210.77/210.98       1999; for PIROMONAS see NEOCALLIMASTICALES 1999-2004   
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D020089 2006
% 210.77/210.98  |- skos__historyNote mesh__D020089 Chytridiomycota %28%1991-1996%29%
% 210.77/210.98  |- rdf__type mesh__D020089sskos__Concept
% 210.77/210.98  |- mesh__dateRevised mesh__D020089 2005-06-30
% 210.77/210.98  |- mesh__recordOriginator mesh__D019535 PXP
% 210.77/210.98  |- mesh__publicMeSHNote mesh__D019535 97   
% 210.77/210.98  |- mesh__dateEstablished mesh__D019535 1997-01-01
% 210.77/210.98  |- mesh__recordAuthorizer mesh__D019535 sjn
% 210.77/210.98  |- skos__annotation mesh__D019535
% 210.77/210.98       infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29%   
% 210.77/210.98  |- skos__prefLabel mesh__D019535 Mycoplasma hominis
% 210.77/210.98  |- mesh__dateCreated mesh__D019535 1996-06-13
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D019535 2006
% 210.77/210.98  |- skos__scopeNote mesh__D019535
% 210.77/210.98       A common inhabitant of the vagina and cervix and a potential human pathogen, causing infections of the male and female reproductive tracts. It has also been associated with respiratory disease and pharyngitis. %28%From Dorland, 28th ed%29%%A%    
% 210.77/210.98  |- mesh__recordMaintainer mesh__D019535 SYSTEM
% 210.77/210.98  |- skos__historyNote mesh__D019535 Mycoplasma %28%1966-1996%29%
% 210.77/210.98  |- mesh__dateRevised mesh__D019535 2005-06-30
% 210.77/210.98  |- rdf__type mesh__D019535sskos__Concept
% 210.77/210.98  |- mesh__historyNote mesh__D019535 97   
% 210.77/210.98  |- skos__broader mesh__D019535smesh__D009174
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D011552 2006
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D011552 2002
% 210.77/210.98  |- skos__altLabel mesh__D011552 Infections, Pseudomonas
% 210.77/210.98  |- mesh__dateCreated mesh__D011552 1999-01-01
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D011552 2005
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D011552 1999
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D011552 2001
% 210.77/210.98  |- mesh__recordMaintainer mesh__D011552 PLS
% 210.77/210.98  |- mesh__recordOriginator mesh__D011552 NLM
% 210.77/210.98  |- rdf__type mesh__D011552sskos__Concept
% 210.77/210.98  |- skos__hiddenLabel mesh__D011552 Infection, Pseudomonas
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D011552 2004
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D011552 1998
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D011552 2000
% 210.77/210.98  |- mesh__dateRevised mesh__D011552 1995-05-31
% 210.77/210.98  |- skos__prefLabel mesh__D011552 Pseudomonas Infections
% 210.77/210.98  |- skos__scopeNote mesh__D011552
% 210.77/210.98       Infections with bacteria of the genus PSEUDOMONAS.     
% 210.77/210.98  |- skos__broader mesh__D011552smesh__D016905
% 210.77/210.98  |- mesh__recordAuthorizer mesh__D011552 PLS
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D011552 2003
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D011552 1997
% 210.77/210.98  |- skos__hiddenLabel mesh__D011552 Pseudomonas Infection
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D011552 1996
% 210.77/210.98  |- skos__annotation mesh__D011552
% 210.77/210.98       gram-neg bact infect; see note under PSEUDOMONAS AERUGINOSA%A%  
% 210.77/210.98  |- rdf__type mesh__D005515sskos__Concept
% 210.77/210.98  |- mesh__dateCreated mesh__D005515 1999-01-01
% 210.77/210.98  |- skos__broader mesh__D005515smesh__D018857
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D005515 2003
% 210.77/210.98  |- mesh__recordOriginator mesh__D005515 NLM
% 210.77/210.98  |- mesh__dateEstablished mesh__D005515 1974-01-01
% 210.77/210.98  |- skos__altLabel mesh__D005515 Product Labeling, Food
% 210.77/210.98  |- skos__hiddenLabel mesh__D005515 Labeling, Food Product
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D005515 2000
% 210.77/210.98  |- mesh__recordAuthorizer mesh__D005515 SJN
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D005515 2005
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D005515 2004
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D005515 1998
% 210.77/210.98  |- mesh__historyNote mesh__D005515 74   
% 210.77/210.98  |- mesh__publicMeSHNote mesh__D005515 74   
% 210.77/210.98  |- skos__altLabel mesh__D005515 Food Labelling
% 210.77/210.98  |- skos__prefLabel mesh__D005515 Food Labeling
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D005515 2001
% 210.77/210.98  |- skos__scopeNote mesh__D005515
% 210.77/210.98       Use of written, printed, or graphic materials upon or accompanying a food or its container or wrapper. The concept includes ingredients, nutritional value, directions, warnings, and other relevant information.%A%    
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D005515 2006
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D005515 1999
% 210.77/210.98  |- mesh__recordMaintainer mesh__D005515 JLS
% 210.77/210.98  |- skos__hiddenLabel mesh__D005515 Labeling, Nutrition
% 210.77/210.98  |- skos__altLabel mesh__D005515 Labeling, Food
% 210.77/210.98  |- mesh__dateRevised mesh__D005515 1997-06-20
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D005515 2002
% 210.77/210.98  |- skos__hiddenLabel mesh__D005515 Food Product Labeling
% 210.77/210.98  |- skos__hiddenLabel mesh__D005515 Labelling, Food
% 210.77/210.98  |- rdf__type mesh__D029963sskos__Concept
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D029963 2003
% 210.77/210.98  |- mesh__dateEstablished mesh__D029963 2002-01-01
% 210.77/210.98  |- mesh__publicMeSHNote mesh__D029963 2002   
% 210.77/210.98  |- skos__annotation mesh__D029963
% 210.77/210.98       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D029963 2005
% 210.77/210.98  |- skos__broader mesh__D029963smesh__D029962
% 210.77/210.98  |- mesh__dateCreated mesh__D029963 2001-07-25
% 210.77/210.98  |- mesh__dateRevised mesh__D029963 2002-07-03
% 210.77/210.98  |- mesh__recordAuthorizer mesh__D029963 sjn
% 210.77/210.98  |- mesh__historyNote mesh__D029963 2002   
% 210.77/210.98  |- skos__scopeNote mesh__D029963
% 210.77/210.98       A plant genus of the family FAGACEAE that is a source of TANNINS.  Do not confuse with Holly %28%ILEX%29%.%A%    
% 210.77/210.98  |- skos__prefLabel mesh__D029963 Quercus
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D029963 2004
% 210.77/210.98  |- mesh__recordOriginator mesh__D029963 ssb
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D029963 2006
% 210.77/210.98  |- mesh__recordMaintainer mesh__D029963 ssb
% 210.77/210.98  |- skos__scopeNote mesh__D021182
% 210.77/210.98       Allergic reaction to wheat that is triggered by the immune system.%A%    
% 210.77/210.98  |- skos__broader mesh__D021182smesh__D005512
% 210.77/210.98  |- mesh__dateEstablished mesh__D021182 2002-01-01
% 210.77/210.98  |- skos__historyNote mesh__D021182 Food Allergy %28%1967-2001%29%
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D021182 2002
% 210.77/210.98  |- skos__historyNote mesh__D021182 Wheat %28%1967-2001%29%
% 210.77/210.98  |- rdf__type mesh__D021182sskos__Concept
% 210.77/210.98  |- skos__altLabel mesh__D021182 Wheat Allergy
% 210.77/210.98  |- skos__annotation mesh__D021182 differentiate from CELIAC DISEASE   
% 210.77/210.98  |- skos__hiddenLabel mesh__D021182 Wheat Hypersensitivities
% 210.77/210.98  |- skos__hiddenLabel mesh__D021182 Hypersensitivities, Wheat
% 210.77/210.98  |- skos__prefLabel mesh__D021182 Wheat Hypersensitivity
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D021182 2003
% 210.77/210.98  |- skos__hiddenLabel mesh__D021182 Allergies, Wheat
% 210.77/210.98  |- mesh__historyNote mesh__D021182 2002   
% 210.77/210.98  |- mesh__dateCreated mesh__D021182 2001-07-25
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D021182 2005
% 210.77/210.98  |- skos__altLabel mesh__D021182 Allergy, Wheat
% 210.77/210.98  |- skos__hiddenLabel mesh__D021182 Wheat Allergies
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D021182 2004
% 210.77/210.98  |- skos__altLabel mesh__D021182 Hypersensitivity, Wheat
% 210.77/210.98  |- skos__related mesh__D021182smesh__D002446
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D021182 2006
% 210.77/210.98  |- mesh__publicMeSHNote mesh__D021182 2002   
% 210.77/210.98  |- mesh__dateEstablished mesh__D015943 1990-01-01
% 210.77/210.98  |- rdf__type mesh__D015943sskos__Concept
% 210.77/210.98  |- skos__hiddenLabel mesh__D015943 Va, Coagulation Factor
% 210.77/210.98  |- skos__related mesh__D015943smesh__D003029
% 210.77/210.98  |- skos__broader mesh__D015943smesh__D005165
% 210.77/210.98  |- skos__altLabel mesh__D015943 Blood Coagulation Factor V, Activated
% 210.77/210.98  |- mesh__recordAuthorizer mesh__D015943 sjn
% 210.77/210.98  |- skos__altLabel mesh__D015943 Coagulation Factor Va
% 210.77/210.98  |- mesh__publicMeSHNote mesh__D015943 90   
% 210.77/210.98  |- skos__hiddenLabel mesh__D015943 Factor Va, Coagulation
% 210.77/210.98  |- skos__altLabel mesh__D015943 Factor V, Activated
% 210.77/210.98  |- skos__historyNote mesh__D015943 Factor V %28%1974-1989%29%
% 210.77/210.98  |- mesh__dateCreated mesh__D015943 1989-05-25
% 210.77/210.98  |- mesh__recordMaintainer mesh__D015943 ssb
% 210.77/210.98  |- mesh__recordOriginator mesh__D015943 AGS
% 210.77/210.98  |- skos__annotation mesh__D015943
% 210.77/210.98       a blood coag factor; /defic = FACTOR V DEFICIENCY   
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D015943 2006
% 210.77/210.98  |- skos__scopeNote mesh__D015943
% 210.77/210.98       Activated form of factor V. It is an essential cofactor for the activation of prothrombin catalyzed by factor Xa.%A%    
% 210.77/210.98  |- mesh__historyNote mesh__D015943 90   
% 210.77/210.98  |- mesh__dateRevised mesh__D015943 2005-06-30
% 210.77/210.98  |- skos__prefLabel mesh__D015943 Factor Va
% 210.77/210.98  |- skos__hiddenLabel mesh__D015943 Activated Factor V
% 210.77/210.98  |- skos__altLabel mesh__D015145 Therapy, Tocolytic
% 210.77/210.98  |- skos__hiddenLabel mesh__D015145 Treatments, Tocolytic
% 210.77/210.98  |- skos__historyNote mesh__D015145 Labor, Premature %28%1973-1988%29%
% 210.77/210.98  |- skos__historyNote mesh__D015145 Uterine Contraction %28%1975-1988%29%
% 210.77/210.98  |- rdf__type mesh__D015145sskos__Concept
% 210.77/210.98  |- mesh__recordOriginator mesh__D015145 SCD
% 210.77/210.98  |- mesh__recordMaintainer mesh__D015145 lkt
% 210.77/210.98  |- skos__scopeNote mesh__D015145
% 210.77/210.98       Any drug treatment modality designed to inhibit UTERINE CONTRACTION. It is used in pregnant women to arrest PREMATURE LABOR.%A%    
% 210.77/210.98  |- skos__annotation mesh__D015145
% 210.77/210.98       check tags FEMALE %26% PREGNANCY; %22%tokolysis%22%: translate as %22%tocolysis%22%; TOCOLYTIC AGENTS is available%A%  
% 210.77/210.98  |- skos__historyNote mesh__D015145 Uterus %28%1966-1974%29%
% 210.77/210.98  |- skos__hiddenLabel mesh__D015145 Tocolyses
% 210.77/210.98  |- mesh__dateRevised mesh__D015145 2005-06-30
% 210.77/210.98  |- skos__historyNote mesh__D015145 Muscle Contraction %28%1966-1974%29%
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D015145 2006
% 210.77/210.98  |- skos__hiddenLabel mesh__D015145 Treatment, Tocolytic
% 210.77/210.98  |- skos__altLabel mesh__D015145 Tocolytic Therapy
% 210.77/210.98  |- mesh__recordAuthorizer mesh__D015145 sjn
% 210.77/210.98  |- skos__prefLabel mesh__D015145 Tocolysis
% 210.77/210.98  |- mesh__publicMeSHNote mesh__D015145 89   
% 210.77/210.98  |- skos__hiddenLabel mesh__D015145 Therapies, Tocolytic
% 210.77/210.98  |- mesh__dateEstablished mesh__D015145 1989-01-01
% 210.77/210.98  |- skos__hiddenLabel mesh__D015145 Tocolytic Treatments
% 210.77/210.98  |- mesh__dateCreated mesh__D015145 1988-03-21
% 210.77/210.98  |- skos__broader mesh__D015145smesh__D012099
% 210.77/210.98  |- mesh__historyNote mesh__D015145 89   
% 210.77/210.98  |- skos__altLabel mesh__D015145 Tocolytic Treatment
% 210.77/210.98  |- skos__hiddenLabel mesh__D015145 Tocolytic Therapies
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009906 2005
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009906 2004
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009906 1999
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009906 2002
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009906 1994
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009906 2006
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009906 1993
% 210.77/210.98  |- mesh__recordAuthorizer mesh__D009906 PLS
% 210.77/210.98  |- skos__hiddenLabel mesh__D009906 Optic
% 210.77/210.98  |- rdf__type mesh__D009906sskos__Concept
% 210.77/210.98  |- mesh__dateRevised mesh__D009906 1992-05-15
% 210.77/210.98  |- skos__prefLabel mesh__D009906 Optics
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009906 1995
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009906 2000
% 210.77/210.98  |- skos__broader mesh__D009906smesh__D010825
% 210.77/210.98  |- mesh__recordOriginator mesh__D009906 NLM
% 210.77/210.98  |- skos__related mesh__D009906smesh__D007909
% 210.77/210.98  |- skos__related mesh__D009906smesh__D014785
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009906 1996
% 210.77/210.98  |- mesh__dateCreated mesh__D009906 1999-01-01
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009906 2001
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009906 2003
% 210.77/210.98  |- mesh__recordMaintainer mesh__D009906 TAP
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009906 1998
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D009906 1997
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D001923 2003
% 210.77/210.98  |- mesh__historyNote mesh__D001923 65   
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D001923 1998
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D001923 2006
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D001923 1995
% 210.77/210.98  |- skos__hiddenLabel mesh__D001923 Chemistries, Brain
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D001923 1993
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D001923 1996
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D001923 2004
% 210.77/210.98  |- mesh__recordMaintainer mesh__D001923 TAP
% 210.77/210.98  |- skos__annotation mesh__D001923
% 210.77/210.98       TN 29: differentiate from BRAIN /metab; consider also /chem with specific parts of the brain but probably as NIM with BRAIN CHEMISTRY %28%IM%29% if site is merely locational %26% illustrative%A%  
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D001923 1999
% 210.77/210.98  |- skos__prefLabel mesh__D001923 Brain Chemistry
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D001923 2000
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D001923 1997
% 210.77/210.98  |- mesh__dateRevised mesh__D001923 1992-05-26
% 210.77/210.98  |- mesh__dateEstablished mesh__D001923 1965-01-01
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D001923 2001
% 210.77/210.98  |- skos__broader mesh__D001923smesh__D001669
% 210.77/210.98  |- skos__altLabel mesh__D001923 Chemistry, Brain
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D001923 2002
% 210.77/210.98  |- rdf__type mesh__D001923sskos__Concept
% 210.77/210.98  |- mesh__publicMeSHNote mesh__D001923 65   
% 210.77/210.98  |- mesh__recordAuthorizer mesh__D001923 PLS
% 210.77/210.98  |- mesh__recordOriginator mesh__D001923 NLM
% 210.77/210.98  |- skos__hiddenLabel mesh__D001923 Brain Chemistries
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D001923 2005
% 210.77/210.98  |- mesh__activeMeSHYear mesh__D001923 1994
% 210.77/210.98  |- mesh__dateCreated mesh__D001923 1999-01-01
% 210.77/210.98  |- skos__historyNote mesh__D009108 Mumps Virus %28%1966-1968%29%
% 210.77/210.98  |- mesh__recordAuthorizer mesh__D009108 sjn
% 210.77/210.98  |- mesh__dateRevised mesh__D009108 2005-06-30
% 210.77/210.98  |- skos__scopeNote mesh__D009108
% 210.77/210.98       A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine.%A%    
% 210.77/210.99  |- rdf__type mesh__D009108sskos__Concept
% 210.77/210.99  |- mesh__historyNote mesh__D009108 72%28%69%29%   
% 210.77/210.99  |- mesh__recordMaintainer mesh__D009108 ssb
% 210.77/210.99  |- mesh__dateEstablished mesh__D009108 1972-01-01
% 210.77/210.99  |- skos__hiddenLabel mesh__D009108 Vaccine, Mumps
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009108 2006
% 210.77/210.99  |- skos__historyNote mesh__D009108 Viral Vaccines %28%1966-1968%29%
% 210.77/210.99  |- skos__prefLabel mesh__D009108 Mumps Vaccine
% 210.77/210.99  |- mesh__publicMeSHNote mesh__D009108 72   
% 210.77/210.99  |- skos__broader mesh__D009108smesh__D014765
% 210.77/210.99  |- mesh__recordOriginator mesh__D009108 NLM
% 210.77/210.99  |- mesh__dateCreated mesh__D009108 1999-01-01
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D001125 2004
% 210.77/210.99  |- skos__hiddenLabel mesh__D001125 Acid, Argininosuccinic
% 210.77/210.99  |- skos__scopeNote mesh__D001125
% 210.77/210.99       This amino acid is formed during the urea cycle from citrulline, aspartate and ATP. This reaction is catalyzed by argininosuccinic acid synthetase.%A%    
% 210.77/210.99  |- mesh__dateEstablished mesh__D001125 1991-01-01
% 210.77/210.99  |- mesh__dateRevised mesh__D001125 2001-07-25
% 210.77/210.99  |- mesh__recordAuthorizer mesh__D001125 sjn
% 210.77/210.99  |- mesh__dateCreated mesh__D001125 1975-07-21
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D001125 2003
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D001125 2006
% 210.77/210.99  |- skos__altLabel mesh__D001125
% 210.77/210.99       N-%28%4-Amino-4-carboxybutyl%29%amidino-L-aspartic Acid
% 210.77/210.99  |- rdf__type mesh__D001125sskos__Concept
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D001125 2005
% 210.77/210.99  |- skos__historyNote mesh__D001125 Succinates %28%1971-1975%29%
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D001125 2002
% 210.77/210.99  |- mesh__historyNote mesh__D001125
% 210.77/210.99       91%28%76%29%; was see under ARGININE 1976-90   
% 210.77/210.99  |- skos__historyNote mesh__D001125
% 210.77/210.99       Arginine %28%1971-1974%29% /analogs %26% derivatives %28%1975%29%
% 210.77/210.99  |- mesh__recordOriginator mesh__D001125 RLS
% 210.77/210.99  |- mesh__publicMeSHNote mesh__D001125 91; was see under ARGININE 1976-90   
% 210.77/210.99  |- skos__broader mesh__D001125smesh__D019822
% 210.77/210.99  |- skos__broader mesh__D001125smesh__D001120
% 210.77/210.99  |- skos__prefLabel mesh__D001125 Argininosuccinic Acid
% 210.77/210.99  |- mesh__recordMaintainer mesh__D001125 nns
% 210.77/210.99  |- rdf__type mesh__D020888sskos__Concept
% 210.77/210.99  |- mesh__historyNote mesh__D020888 2000; use VIGABATRIN 1977-1999   
% 210.77/210.99  |- mesh__recordMaintainer mesh__D020888 ssb
% 210.77/210.99  |- skos__historyNote mesh__D020888
% 210.77/210.99       GABA/analogs %26% derivatives %28%1979-1980%29%
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D020888 2006
% 210.77/210.99  |- mesh__recordAuthorizer mesh__D020888 sjn
% 210.77/210.99  |- mesh__recordOriginator mesh__D020888 adp
% 210.77/210.99  |- mesh__publicMeSHNote mesh__D020888
% 210.77/210.99       2000; VIGABATRIN was indexed under GABA/analogs %26% derivatives 1994-1999, AMINOCAPROIC ACIDS 1981-1994, %26% GABA/analogs 1979-1980%A%  
% 210.77/210.99  |- skos__altLabel mesh__D020888 gamma-Vinyl-GABA
% 210.77/210.99  |- mesh__dateRevised mesh__D020888 2005-06-30
% 210.77/210.99  |- mesh__dateEstablished mesh__D020888 2000-01-01
% 210.77/210.99  |- skos__hiddenLabel mesh__D020888 gamma Vinyl GABA
% 210.77/210.99  |- skos__broader mesh__D020888smesh__D005680
% 210.77/210.99  |- mesh__dateCreated mesh__D020888 1999-11-04
% 210.77/210.99  |- skos__hiddenLabel mesh__D020888 gamma Vinyl gamma Aminobutyric Acid
% 210.77/210.99  |- skos__hiddenLabel mesh__D020888 Acid, gamma-Vinyl-gamma-Aminobutyric
% 210.77/210.99  |- skos__scopeNote mesh__D020888
% 210.77/210.99       An analogue of GAMMA-AMINOBUTYRIC ACID. It is an irreversible inhibitor of 4-AMINOBUTYRATE TRANSAMINASE, the enzyme responsible for the catabolism of GAMMA-AMINOBUTYRIC ACID. %28%From Martindale The Extra Pharmacopoeia, 31st ed%29%%A%    
% 210.77/210.99  |- skos__prefLabel mesh__D020888 Vigabatrin
% 210.77/210.99  |- skos__altLabel mesh__D020888 gamma-Vinyl-gamma-Aminobutyric Acid
% 210.77/210.99  |- skos__historyNote mesh__D020888
% 210.77/210.99       GABA/analogs %26% derivatives %28%1994-1999%29%
% 210.77/210.99  |- skos__historyNote mesh__D020888 Aminocaproic Acids %28%1981-1994%29%
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D011553 2005
% 210.77/210.99  |- mesh__dateCreated mesh__D011553 1986-04-18
% 210.77/210.99  |- mesh__recordMaintainer mesh__D011553 KEV
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D011553 1999
% 210.77/210.99  |- mesh__historyNote mesh__D011553 87   
% 210.77/210.99  |- skos__annotation mesh__D011553
% 210.77/210.99       neoplastic; accumulation of mucoid matter in peritoneal cavity: see MeSH definition; coord IM with PERITONEAL NEOPLASMS %28%IM%29%%A%  
% 210.77/210.99  |- skos__prefLabel mesh__D011553 Pseudomyxoma Peritonei
% 210.77/210.99  |- skos__scopeNote mesh__D011553
% 210.77/210.99       A condition characterized by poorly-circumscribed gelatinous masses filled with malignant mucin-secreting cells. Forty-five percent of pseudomyxomas arise from the ovary, usually in a mucinous cystadenocarcinoma %28%CYSTADENOCARCINOMA, MUCINOUS%29%, which has prognostic significance. Pseudomyxoma peritonei must be differentiated from mucinous spillage into the peritoneum by a benign mucocele of the appendix. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D011553 2004
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D011553 1998
% 210.77/210.99  |- rdf__type mesh__D011553sskos__Concept
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D011553 2002
% 210.77/210.99  |- skos__altLabel mesh__D011553 Ascites, Gelatinous
% 210.77/210.99  |- mesh__dateEstablished mesh__D011553 1987-01-01
% 210.77/210.99  |- skos__broader mesh__D011553smesh__D018297
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D011553 2003
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D011553 1997
% 210.77/210.99  |- mesh__dateRevised mesh__D011553 1995-06-08
% 210.77/210.99  |- skos__altLabel mesh__D011553 Gelatinous Ascites
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D011553 2001
% 210.77/210.99  |- mesh__publicMeSHNote mesh__D011553 87   
% 210.77/210.99  |- skos__historyNote mesh__D011553 Ascitic Fluid %28%1968-1986%29%
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D011553 1996
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D011553 2000
% 210.77/210.99  |- mesh__recordAuthorizer mesh__D011553 PLS
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D011553 2006
% 210.77/210.99  |- mesh__recordOriginator mesh__D011553 VDK
% 210.77/210.99  |- skos__historyNote mesh__D011553 Peritoneal Neoplasms %28%1966-1986%29%
% 210.77/210.99  |- mesh__dateEstablished mesh__D005516 1966-01-01
% 210.77/210.99  |- skos__broader mesh__D005516smesh__D005524
% 210.77/210.99  |- mesh__dateRevised mesh__D005516 2001-07-25
% 210.77/210.99  |- skos__scopeNote mesh__D005516
% 210.77/210.99       The presence of bacteria, viruses, and fungi in food and food products. This term is not restricted to pathogenic organisms: the presence of various non-pathogenic bacteria and fungi in cheeses and wines, for example, is included in this concept.%A%    
% 210.77/210.99  |- skos__broader mesh__D005516smesh__D005506
% 210.77/210.99  |- rdf__type mesh__D005516sskos__Concept
% 210.77/210.99  |- skos__broader mesh__D005516smesh__D004783
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D005516 2004
% 210.77/210.99  |- mesh__recordAuthorizer mesh__D005516 sjn
% 210.77/210.99  |- mesh__historyNote mesh__D005516 66   
% 210.77/210.99  |- mesh__dateCreated mesh__D005516 1999-01-01
% 210.77/210.99  |- mesh__recordMaintainer mesh__D005516 jls
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D005516 2003
% 210.77/210.99  |- mesh__recordOriginator mesh__D005516 NLM
% 210.77/210.99  |- skos__annotation mesh__D005516
% 210.77/210.99       coord with specific food /microbiol or /virol and specific microbe; FOOD PARASITOLOGY is also available; DF: FOOD MICROBIOL%A%  
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D005516 2002
% 210.77/210.99  |- skos__altLabel mesh__D005516 Microbiology, Food
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D005516 2006
% 210.77/210.99  |- mesh__publicMeSHNote mesh__D005516 66   
% 210.77/210.99  |- skos__prefLabel mesh__D005516 Food Microbiology
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D005516 2005
% 210.77/210.99  |- mesh__dateCreated mesh__D029964 2001-07-25
% 210.77/210.99  |- skos__prefLabel mesh__D029964 Fagus
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D029964 2004
% 210.77/210.99  |- skos__scopeNote mesh__D029964 A plant genus of the family FAGACEAE.     
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D029964 2002
% 210.77/210.99  |- mesh__historyNote mesh__D029964 2002   
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D029964 2006
% 210.77/210.99  |- mesh__dateEstablished mesh__D029964 2002-01-01
% 210.77/210.99  |- rdf__type mesh__D029964sskos__Concept
% 210.77/210.99  |- mesh__publicMeSHNote mesh__D029964 2002   
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D029964 2003
% 210.77/210.99  |- skos__annotation mesh__D029964
% 210.77/210.99       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D029964 2005
% 210.77/210.99  |- skos__broader mesh__D029964smesh__D029962
% 210.77/210.99  |- skos__altLabel mesh__D021183 Allergy, Peanut
% 210.77/210.99  |- rdf__type mesh__D021183sskos__Concept
% 210.77/210.99  |- mesh__historyNote mesh__D021183 2002   
% 210.77/210.99  |- mesh__dateCreated mesh__D021183 2001-07-25
% 210.77/210.99  |- skos__altLabel mesh__D021183 Peanut Allergy
% 210.77/210.99  |- skos__altLabel mesh__D021183 Hypersensitivity, Peanut
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D021183 2003
% 210.77/210.99  |- skos__hiddenLabel mesh__D021183 Allergies, Peanut
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D021183 2005
% 210.77/210.99  |- skos__hiddenLabel mesh__D021183 Hypersensitivity, Groundnut
% 210.77/210.99  |- skos__annotation mesh__D021183 NUT HYPERSENSITIVITY is also available   
% 210.77/210.99  |- skos__hiddenLabel mesh__D021183 Peanut Allergies
% 210.77/210.99  |- skos__historyNote mesh__D021183 Food Hypersensitivity %28%1966-2001%29%
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D021183 2004
% 210.77/210.99  |- skos__altLabel mesh__D021183 Groundnut Hypersensitivity
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D021183 2006
% 210.77/210.99  |- mesh__publicMeSHNote mesh__D021183 2002   
% 210.77/210.99  |- skos__prefLabel mesh__D021183 Peanut Hypersensitivity
% 210.77/210.99  |- skos__broader mesh__D021183smesh__D005512
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D021183 2002
% 210.77/210.99  |- skos__historyNote mesh__D021183 Arachis hypogaea %28%1966-2001%29%
% 210.77/210.99  |- skos__scopeNote mesh__D021183
% 210.77/210.99       Allergic reaction to peanuts that is triggered by the immune system.%A%    
% 210.77/210.99  |- mesh__dateEstablished mesh__D021183 2002-01-01
% 210.77/210.99  |- skos__hiddenLabel mesh__D015944 Activated Factor VIII
% 210.77/210.99  |- skos__altLabel mesh__D015944 Blood Coagulation Factor VIII, Activated
% 210.77/210.99  |- mesh__historyNote mesh__D015944 90   
% 210.77/210.99  |- mesh__dateRevised mesh__D015944 2005-06-30
% 210.77/210.99  |- mesh__publicMeSHNote mesh__D015944 90   
% 210.77/210.99  |- skos__hiddenLabel mesh__D015944 Thrombin-Activated Factor VIII
% 210.77/210.99  |- skos__related mesh__D015944smesh__D003029
% 210.77/210.99  |- skos__prefLabel mesh__D015944 Factor VIIIa
% 210.77/210.99  |- skos__annotation mesh__D015944
% 210.77/210.99       a blood coag factor; /defic = HEMOPHILIA   
% 210.77/210.99  |- skos__scopeNote mesh__D015944
% 210.77/210.99       Activated form of factor VIII. The B-domain of factor VIII is proteolytically cleaved by thrombin to form factor VIIIa. Factor VIIIa exists as a non-covalent dimer in a metal-linked %28%probably calcium%29% complex and functions as a cofactor in the enzymatic activation of factor X by factor IXa. Factor VIIIa is similar in structure and generation to factor Va.%A%    
% 210.77/210.99  |- mesh__dateCreated mesh__D015944 1989-05-25
% 210.77/210.99  |- skos__altLabel mesh__D015944 Factor VIII, Thrombin-Activated
% 210.77/210.99  |- skos__altLabel mesh__D015944 Factor VIII, Activated
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D015944 2006
% 210.77/210.99  |- mesh__recordAuthorizer mesh__D015944 sjn
% 210.77/210.99  |- skos__hiddenLabel mesh__D015944 Factor VIIIa, Coagulation
% 210.77/210.99  |- skos__altLabel mesh__D015944 Coagulation Factor VIIIa
% 210.77/210.99  |- skos__broader mesh__D015944smesh__D005169
% 210.77/210.99  |- mesh__dateEstablished mesh__D015944 1990-01-01
% 210.77/210.99  |- rdf__type mesh__D015944sskos__Concept
% 210.77/210.99  |- skos__hiddenLabel mesh__D015944 Factor VIII, Thrombin Activated
% 210.77/210.99  |- mesh__recordMaintainer mesh__D015944 ssb
% 210.77/210.99  |- skos__hiddenLabel mesh__D015944 VIIIa, Coagulation Factor
% 210.77/210.99  |- mesh__recordOriginator mesh__D015944 AGS
% 210.77/210.99  |- skos__historyNote mesh__D015944 Factor VIII %28%1981-1989%29%
% 210.77/210.99  |- rdf__type mesh__D015146sskos__Concept
% 210.77/210.99  |- mesh__recordAuthorizer mesh__D015146 SJN
% 210.77/210.99  |- skos__prefLabel mesh__D015146 Midwestern United States
% 210.77/210.99  |- skos__altLabel mesh__D015146 Middle West U.S.
% 210.77/210.99  |- mesh__historyNote mesh__D015146 89   
% 210.77/210.99  |- skos__annotation mesh__D015146
% 210.77/210.99       includes Ill, Ind, Iowa, Kans, Ky, Mich, Minn, Missouri, Nebr, Ohio, Okla, N Dakota, S Dakota, Wisc; specify as needed but use MIDWESTERN UNITED STATES when text uses the term; DF: note short X ref      CATALOG: use for 4 or more states%A%  
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D015146 2005
% 210.77/210.99  |- skos__scopeNote mesh__D015146
% 210.77/210.99       The geographic area of the midwestern region of the United States in general or when the specific state or states are not indicated. The states usually included in this region are Illinois, Indiana, Iowa, Kansas, Kentucky, Michigan, Minnesota, Missouri, Nebraska, Ohio, Oklahoma, North Dakota, South Dakota and Wisconsin.%A%    
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D015146 1998
% 210.77/210.99  |- skos__broader mesh__D015146smesh__D014481
% 210.77/210.99  |- mesh__dateRevised mesh__D015146 1997-06-20
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D015146 2000
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D015146 2003
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D015146 2006
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D015146 2001
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D015146 1999
% 210.77/210.99  |- skos__altLabel mesh__D015146 Midwest U.S.
% 210.77/210.99  |- skos__altLabel mesh__D015146 Midwest US
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D015146 2004
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D015146 2002
% 210.77/210.99  |- mesh__dateEstablished mesh__D015146 1989-01-01
% 210.77/210.99  |- mesh__recordMaintainer mesh__D015146 PXP
% 210.77/210.99  |- mesh__dateCreated mesh__D015146 1988-03-21
% 210.77/210.99  |- mesh__recordOriginator mesh__D015146 EC
% 210.77/210.99  |- skos__hiddenLabel mesh__D009907 Optometries
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009907 1994
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009907 2006
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009907 1993
% 210.77/210.99  |- rdf__type mesh__D009907sskos__Concept
% 210.77/210.99  |- skos__annotation mesh__D009907 SPEC: SPEC qualif   
% 210.77/210.99  |- skos__broader mesh__D009907smesh__D006281
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009907 1995
% 210.77/210.99  |- skos__prefLabel mesh__D009907 Optometry
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009907 2002
% 210.77/210.99  |- mesh__recordAuthorizer mesh__D009907 PLS
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009907 1996
% 210.77/210.99  |- mesh__dateCreated mesh__D009907 1999-01-01
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009907 1991
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009907 2003
% 210.77/210.99  |- skos__scopeNote mesh__D009907
% 210.77/210.99       The professional practice of primary eye and vision care that includes the measurement of visual refractive power and the correction of visual defects with lenses or glasses.%A%    
% 210.77/210.99  |- mesh__recordMaintainer mesh__D009907 AGS
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009907 1998
% 210.77/210.99  |- mesh__dateRevised mesh__D009907 1990-05-29
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009907 1997
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009907 2000
% 210.77/210.99  |- mesh__recordOriginator mesh__D009907 NLM
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009907 2005
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009907 1992
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009907 2004
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009907 1999
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009907 2001
% 210.77/210.99  |- rdf__type mesh__D001924sskos__Concept
% 210.77/210.99  |- skos__broader mesh__D001924smesh__D014949
% 210.77/210.99  |- skos__broader mesh__D001924smesh__D016489
% 210.77/210.99  |- mesh__recordAuthorizer mesh__D001924 sjn
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D001924 2004
% 210.77/210.99  |- skos__hiddenLabel mesh__D001924 Cerebral Concussions
% 210.77/210.99  |- skos__broader mesh__D001924smesh__D001930
% 210.77/210.99  |- skos__hiddenLabel mesh__D001924 Mild Concussions
% 210.77/210.99  |- mesh__recordOriginator mesh__D001924 NLM
% 210.77/210.99  |- skos__prefLabel mesh__D001924 Brain Concussion
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D001924 2006
% 210.77/210.99  |- skos__scopeNote mesh__D001924
% 210.77/210.99       A nonspecific term used to describe transient alterations or loss of consciousness following closed head injuries. The duration of UNCONSCIOUSNESS generally lasts a few seconds, but may persist for several hours. Concussions may be classified as mild, intermediate, and severe. Prolonged periods of unconsciousness %28%often defined as greater than 6 hours in duration%29% may be referred to as post-traumatic coma %28%COMA, POST-HEAD INJURY%29%. %28%From Rowland, Merritt%27%s Textbook of Neurology, 9th ed, p418%29%%A%    
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D001924 2003
% 210.77/210.99  |- skos__hiddenLabel mesh__D001924 Intermediate Concussions
% 210.77/210.99  |- skos__hiddenLabel mesh__D001924 Intermediate Concussion
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D001924 2002
% 210.77/210.99  |- mesh__dateEstablished mesh__D001924 1965-01-01
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D001924 2005
% 210.77/210.99  |- mesh__historyNote mesh__D001924 65%28%63%29%   
% 210.77/210.99  |- skos__hiddenLabel mesh__D001924 Severe Concussions
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D001924 2001
% 210.77/210.99  |- skos__altLabel mesh__D001924 Cerebral Concussion
% 210.77/210.99  |- skos__hiddenLabel mesh__D001924 Brain Concussions
% 210.77/210.99  |- mesh__dateCreated mesh__D001924 1999-01-01
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D001924 2000
% 210.77/210.99  |- skos__hiddenLabel mesh__D001924 Concussion, Brain
% 210.77/210.99  |- mesh__publicMeSHNote mesh__D001924 65   
% 210.77/210.99  |- mesh__recordMaintainer mesh__D001924 KEV
% 210.77/210.99  |- skos__hiddenLabel mesh__D001924 Severe Concussion
% 210.77/210.99  |- skos__hiddenLabel mesh__D001924 Concussion, Cerebral
% 210.77/210.99  |- skos__altLabel mesh__D001924 Commotio Cerebri
% 210.77/210.99  |- skos__hiddenLabel mesh__D001924 Mild Concussion
% 210.77/210.99  |- mesh__dateRevised mesh__D001924 1999-11-03
% 210.77/210.99  |- skos__hiddenLabel mesh__D009109 Mumps viruses
% 210.77/210.99  |- mesh__recordMaintainer mesh__D009109 ags
% 210.77/210.99  |- skos__scopeNote mesh__D009109
% 210.77/210.99       The type species of RUBULAVIRUS that causes an acute infectious disease in humans, affecting mainly children. Transmission occurs by droplet infection.%A%    
% 210.77/210.99  |- mesh__recordOriginator mesh__D009109 NLM
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009109 2006
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009109 2002
% 210.77/210.99  |- skos__altLabel mesh__D009109 Myxovirus parotitidis
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009109 2005
% 210.77/210.99  |- mesh__recordAuthorizer mesh__D009109 sjn
% 210.77/210.99  |- skos__annotation mesh__D009109 infection = MUMPS   
% 210.77/210.99  |- mesh__dateCreated mesh__D009109 1999-01-01
% 210.77/210.99  |- skos__altLabel mesh__D009109 Epidemic Parotitis Virus
% 210.77/210.99  |- mesh__dateRevised mesh__D009109 2001-07-25
% 210.77/210.99  |- skos__prefLabel mesh__D009109 Mumps virus
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009109 2004
% 210.77/210.99  |- skos__broader mesh__D009109smesh__D019213
% 210.77/210.99  |- rdf__type mesh__D009109sskos__Concept
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D009109 2003
% 210.77/210.99  |- skos__hiddenLabel mesh__D009109 Epidemic Parotitis Viruses
% 210.77/210.99  |- mesh__dateEstablished mesh__D001126 1991-01-01
% 210.77/210.99  |- mesh__recordOriginator mesh__D001126 NLM
% 210.77/210.99  |- skos__altLabel mesh__D001126 Arginyl-tRNA Synthetase
% 210.77/210.99  |- mesh__recordAuthorizer mesh__D001126 sjn
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D001126 2004
% 210.77/210.99  |- skos__hiddenLabel mesh__D001126 Arginyl tRNA Synthetase
% 210.77/210.99  |- mesh__publicMeSHNote mesh__D001126
% 210.77/210.99       98; see ARGINYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A%  
% 210.77/210.99  |- skos__hiddenLabel mesh__D001126 Arginine tRNA Ligase
% 210.77/210.99  |- skos__altLabel mesh__D001126 Arg-tRNA Ligase
% 210.77/210.99  |- mesh__historyNote mesh__D001126 98%28%75%29%   
% 210.77/210.99  |- skos__historyNote mesh__D001126
% 210.77/210.99       Amino Acyl T RNA Synthetases %28%1973-1974%29%
% 210.77/210.99  |- skos__prefLabel mesh__D001126 Arginine-tRNA Ligase
% 210.77/210.99  |- skos__altLabel mesh__D001126 Arginyl T RNA Synthetase
% 210.77/210.99  |- skos__hiddenLabel mesh__D001126 Ligase, Arg-tRNA
% 210.77/210.99  |- rdf__type mesh__D001126sskos__Concept
% 210.77/210.99  |- mesh__dateCreated mesh__D001126 1974-11-19
% 210.77/210.99  |- skos__hiddenLabel mesh__D001126 Arg tRNA Ligase
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D001126 2006
% 210.77/210.99  |- mesh__recordMaintainer mesh__D001126 ssb
% 210.77/210.99  |- skos__hiddenLabel mesh__D001126 Ligase, Arginine-tRNA
% 210.77/210.99  |- mesh__dateRevised mesh__D001126 2003-07-09
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D001126 2005
% 210.77/210.99  |- skos__historyNote mesh__D001126 Arginine %28%1973-1974%29%
% 210.77/210.99  |- skos__broader mesh__D001126smesh__D000604
% 210.77/210.99  |- skos__scopeNote mesh__D001126
% 210.77/210.99       An enzyme that activates arginine with its specific transfer RNA. EC 6.1.1.19.%A%    
% 210.77/210.99  |- skos__hiddenLabel mesh__D001126 Synthetase, Arginyl-tRNA
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D020889 2002
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D020889 2004
% 210.77/210.99  |- skos__broader mesh__D020889smesh__D011760
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D020889 2005
% 210.77/210.99  |- skos__hiddenLabel mesh__D020889 ZK62711
% 210.77/210.99  |- skos__historyNote mesh__D020889 Cyclopentanes %28%1979-1982%29%
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D020889 2006
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D020889 2000A
% 210.77/210.99  |- mesh__recordOriginator mesh__D020889 adp
% 210.77/210.99  |- skos__hiddenLabel mesh__D020889 ZK 62711
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D020889 2000
% 210.77/210.99  |- skos__scopeNote mesh__D020889
% 210.77/210.99       A phosphodiesterase inhibitor with antidepressant properties.%A%    
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D020889 2000B
% 210.77/210.99  |- skos__prefLabel mesh__D020889 Rolipram
% 210.77/210.99  |- skos__historyNote mesh__D020889 Pyrrolidinones %28%1983-1999%29%
% 210.77/210.99  |- mesh__publicMeSHNote mesh__D020889
% 210.77/210.99       2000; ROLIPRAM was indexed under PYRROLIDINONES 1983-1999 %26% CYCLOPENTANES 1979-1982%A%  
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D020889 2001
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D020889 2000C
% 210.77/210.99  |- mesh__dateEstablished mesh__D020889 2000-01-01
% 210.77/210.99  |- mesh__dateCreated mesh__D020889 1999-11-03
% 210.77/210.99  |- mesh__recordMaintainer mesh__D020889 ags
% 210.77/210.99  |- mesh__recordAuthorizer mesh__D020889 ags
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D020889 2003
% 210.77/210.99  |- mesh__dateRevised mesh__D020889 2000-01-19
% 210.77/210.99  |- mesh__historyNote mesh__D020889
% 210.77/210.99       2000; use ROLIPRAM %28%NM%29% 1979-1999   
% 210.77/210.99  |- rdf__type mesh__D020889sskos__Concept
% 210.77/210.99  |- skos__prefLabel mesh__D047228 Angiotensin II Type 1 Receptor Blockers
% 210.77/210.99  |- skos__altLabel mesh__D047228 Angiotensin II Type 1 Receptor Antagonists
% 210.77/210.99  |- mesh__dateEstablished mesh__D047228 2005-01-01
% 210.77/210.99  |- mesh__publicMeSHNote mesh__D047228 2005   
% 210.77/210.99  |- skos__broader mesh__D047228smesh__D045504
% 210.77/210.99  |- skos__altLabel mesh__D047228 Sartans
% 210.77/210.99  |- skos__historyNote mesh__D047228 Angiotensin II %28%1975-2004%29%
% 210.77/210.99  |- skos__altLabel mesh__D047228 Type 1 Angiotensin Receptor Blockers
% 210.77/210.99  |- rdf__type mesh__D047228sskos__Concept
% 210.77/210.99  |- mesh__recordAuthorizer mesh__D047228 sjn
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D047228 2006
% 210.77/210.99  |- mesh__dateCreated mesh__D047228 2004-07-07
% 210.77/210.99  |- skos__historyNote mesh__D047228
% 210.77/210.99       Angiotensin Receptors/antagonists %26% inhibitors %28%1984-2004%29%
% 210.77/210.99  |- skos__scopeNote mesh__D047228
% 210.77/210.99       Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS.%A%    
% 210.77/210.99  |- skos__related mesh__D047228smesh__D000806
% 210.77/210.99  |- mesh__historyNote mesh__D047228 2005   
% 210.77/210.99  |- skos__altLabel mesh__D047228 Type 1 Angiotensin Receptor Antagonists
% 210.77/210.99  |- mesh__recordOriginator mesh__D047228 ssb
% 210.77/210.99  |- mesh__recordMaintainer mesh__D047228 ssb
% 210.77/210.99  |- mesh__dateRevised mesh__D047228 2005-06-30
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D011554 2006
% 210.77/210.99  |- mesh__publicMeSHNote mesh__D011554 72   
% 210.77/210.99  |- mesh__recordMaintainer mesh__D011554 nns
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D011554 2005
% 210.77/210.99  |- rdf__type mesh__D011554sskos__Concept
% 210.77/210.99  |- skos__hiddenLabel mesh__D011554 Lamellipodias
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D011554 2002
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D011554 2004
% 210.77/210.99  |- mesh__historyNote mesh__D011554 72%28%70%29%   
% 210.77/210.99  |- mesh__recordOriginator mesh__D011554 NLM
% 210.77/210.99  |- skos__hiddenLabel mesh__D011554 Cell Surface Microspike
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D011554 2001
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D011554 2003
% 210.77/210.99  |- skos__broader mesh__D011554smesh__D022081
% 210.77/210.99  |- mesh__recordAuthorizer mesh__D011554 sjn
% 210.77/210.99  |- skos__hiddenLabel mesh__D011554 Microspike, Cell Surface
% 210.77/210.99  |- skos__hiddenLabel mesh__D011554 Surface Microspike, Cell
% 210.77/210.99  |- skos__prefLabel mesh__D011554 Pseudopodia
% 210.77/210.99  |- skos__scopeNote mesh__D011554
% 210.77/210.99       A dynamic actin-rich extension of the surface of an animal cell used for locomotion or prehension of food.%A%    
% 210.77/210.99  |- skos__historyNote mesh__D011554 Organoids %28%1966-1969%29%
% 210.77/210.99  |- mesh__dateRevised mesh__D011554 2000-06-21
% 210.77/210.99  |- skos__hiddenLabel mesh__D011554 Surface Microspikes, Cell
% 210.77/210.99  |- skos__hiddenLabel mesh__D011554 Cell Surface Microspikes
% 210.77/210.99  |- mesh__dateEstablished mesh__D011554 1972-01-01
% 210.77/210.99  |- skos__altLabel mesh__D011554 Pseudopodium
% 210.77/210.99  |- mesh__dateCreated mesh__D011554 1999-01-01
% 210.77/210.99  |- rdf__type mesh__D005517sskos__Concept
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D005517 2004
% 210.77/210.99  |- skos__prefLabel mesh__D005517 Food Poisoning
% 210.77/210.99  |- mesh__dateCreated mesh__D005517 1999-01-01
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D005517 2003
% 210.77/210.99  |- mesh__dateRevised mesh__D005517 2001-07-25
% 210.77/210.99  |- skos__broader mesh__D005517smesh__D011041
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D005517 2006
% 210.77/210.99  |- mesh__recordAuthorizer mesh__D005517 sjn
% 210.77/210.99  |- skos__altLabel mesh__D005517 Poisoning, Food
% 210.77/210.99  |- skos__hiddenLabel mesh__D005517 Food Poisonings
% 210.77/210.99  |- mesh__recordOriginator mesh__D005517 NLM
% 210.77/210.99  |- mesh__recordMaintainer mesh__D005517 tpw
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D005517 2005
% 210.77/210.99  |- skos__hiddenLabel mesh__D005517 Poisonings, Food
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D005517 2002
% 210.77/210.99  |- skos__related mesh__D005517smesh__D005512
% 210.77/210.99  |- skos__annotation mesh__D005517
% 210.77/210.99       GEN only; prefer /pois with specific food items in Cat J2: Manual 31.11; MUSHROOM POISONING; PLANT POISONING; SALMONELLA FOOD POISONING %26% STAPHYLOCOCCAL FOOD POISONING are also available%A%  
% 210.77/210.99  |- mesh__dateRevised mesh__D029965 2005-06-30
% 210.77/210.99  |- skos__annotation mesh__D029965
% 210.77/210.99       GEN or unspecified; prefer specifics; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.77/210.99  |- mesh__historyNote mesh__D029965 2002   
% 210.77/210.99  |- mesh__recordOriginator mesh__D029965 ssb
% 210.77/210.99  |- mesh__recordMaintainer mesh__D029965 ssb
% 210.77/210.99  |- mesh__dateEstablished mesh__D029965 2002-01-01
% 210.77/210.99  |- skos__broader mesh__D029965smesh__D019684
% 210.77/210.99  |- skos__prefLabel mesh__D029965 Gentianaceae
% 210.77/210.99  |- mesh__dateCreated mesh__D029965 2001-07-25
% 210.77/210.99  |- mesh__activeMeSHYear mesh__D029965 2006
% 210.77/211.00  |- rdf__type mesh__D029965sskos__Concept
% 210.77/211.00  |- skos__scopeNote mesh__D029965
% 210.77/211.00       A plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida.%A%    
% 210.77/211.00  |- mesh__publicMeSHNote mesh__D029965 2002   
% 210.77/211.00  |- mesh__recordAuthorizer mesh__D029965 sjn
% 210.77/211.00  |- skos__hiddenLabel mesh__D021982 Adhesions, Cell-Matrix
% 210.77/211.00  |- skos__prefLabel mesh__D021982 Cell-Matrix Junctions
% 210.77/211.00  |- skos__related mesh__D021982smesh__D002448
% 210.77/211.00  |- skos__hiddenLabel mesh__D021982 Cell-Matrix Junction
% 210.77/211.00  |- skos__altLabel mesh__D021982 Cell-Matrix Adhesions
% 210.77/211.00  |- mesh__publicMeSHNote mesh__D021982 2001   
% 210.77/211.00  |- skos__hiddenLabel mesh__D021982 Cell Matrix Adhesions
% 210.77/211.00  |- skos__hiddenLabel mesh__D021982 Junctions, Cell-Matrix
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D021982 2005
% 210.77/211.00  |- mesh__dateCreated mesh__D021982 2000-06-21
% 210.77/211.00  |- mesh__historyNote mesh__D021982 2001   
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D021982 2001
% 210.77/211.00  |- rdf__type mesh__D021982sskos__Concept
% 210.77/211.00  |- skos__scopeNote mesh__D021982
% 210.77/211.00       Specialized areas at the CELL MEMBRANE where a cell attaches to the EXTRACELLULAR MATRIX or other substratum.%A%    
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D021982 2003
% 210.77/211.00  |- mesh__dateEstablished mesh__D021982 2001-01-01
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D021982 2006
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D021982 2002
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D021982 2004
% 210.77/211.00  |- skos__broader mesh__D021982smesh__D021961
% 210.77/211.00  |- skos__hiddenLabel mesh__D021982 Junction, Cell-Matrix
% 210.77/211.00  |- skos__hiddenLabel mesh__D021982 Cell Matrix Junctions
% 210.77/211.00  |- skos__historyNote mesh__D021982 Cell Adhesion %28%1991-2000%29%
% 210.77/211.00  |- skos__historyNote mesh__D021982 Extracellular Matrix %28%1991-2000%29%
% 210.77/211.00  |- skos__hiddenLabel mesh__D021184 Tree Nut Allergies
% 210.77/211.00  |- skos__hiddenLabel mesh__D021184 Allergy, Tree Nut
% 210.77/211.00  |- skos__hiddenLabel mesh__D021184 Hypersensitivity, Tree Nut
% 210.77/211.00  |- skos__altLabel mesh__D021184 Tree Nut Allergy
% 210.77/211.00  |- skos__annotation mesh__D021184
% 210.77/211.00       PEANUT HYPERSENSITIVITY is also available   
% 210.77/211.00  |- skos__altLabel mesh__D021184 Nut Allergy
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D021184 2003
% 210.77/211.00  |- skos__hiddenLabel mesh__D021184 Hypersensitivities, Tree Nut
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D021184 2005
% 210.77/211.00  |- skos__prefLabel mesh__D021184 Nut Hypersensitivity
% 210.77/211.00  |- skos__hiddenLabel mesh__D021184 Nut Hypersensitivity, Tree
% 210.77/211.00  |- skos__hiddenLabel mesh__D021184 Nut Hypersensitivities
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D021184 2004
% 210.77/211.00  |- skos__hiddenLabel mesh__D021184 Nut Hypersensitivities, Tree
% 210.77/211.00  |- skos__hiddenLabel mesh__D021184 Hypersensitivities, Nut
% 210.77/211.00  |- mesh__historyNote mesh__D021184 2002   
% 210.77/211.00  |- mesh__dateCreated mesh__D021184 2001-07-25
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D021184 2006
% 210.77/211.00  |- mesh__publicMeSHNote mesh__D021184 2002   
% 210.77/211.00  |- skos__hiddenLabel mesh__D021184 Allergies, Nut
% 210.77/211.00  |- skos__broader mesh__D021184smesh__D005512
% 210.77/211.00  |- skos__historyNote mesh__D021184 Nuts %28%1968-2001%29%
% 210.77/211.00  |- skos__hiddenLabel mesh__D021184 Nut Allergies
% 210.77/211.00  |- skos__altLabel mesh__D021184 Tree Nut Hypersensitivity
% 210.77/211.00  |- skos__scopeNote mesh__D021184
% 210.77/211.00       Allergic reaction to tree nuts that is triggered by the immune system.%A%    
% 210.77/211.00  |- skos__hiddenLabel mesh__D021184 Tree Nut Hypersensitivities
% 210.77/211.00  |- skos__altLabel mesh__D021184 Allergy, Nut
% 210.77/211.00  |- mesh__dateEstablished mesh__D021184 2002-01-01
% 210.77/211.00  |- skos__altLabel mesh__D021184 Hypersensitivity, Nut
% 210.77/211.00  |- rdf__type mesh__D021184sskos__Concept
% 210.77/211.00  |- skos__hiddenLabel mesh__D021184 Allergies, Tree Nut
% 210.77/211.00  |- skos__historyNote mesh__D021184 Food Hypersensitivity %28%1968-2001%29%
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D021184 2002
% 210.77/211.00  |- skos__hiddenLabel mesh__D015945 Factor XIa, Coagulation
% 210.77/211.00  |- mesh__publicMeSHNote mesh__D015945 90   
% 210.77/211.00  |- skos__historyNote mesh__D015945 Factor XI %28%1972-1989%29%
% 210.77/211.00  |- skos__altLabel mesh__D015945 Contact Activation Product
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D015945 2006
% 210.77/211.00  |- mesh__recordMaintainer mesh__D015945 ssb
% 210.77/211.00  |- mesh__recordOriginator mesh__D015945 AGS
% 210.77/211.00  |- mesh__historyNote mesh__D015945 90   
% 210.77/211.00  |- skos__annotation mesh__D015945 /defic = FACTOR XI DEFICIENCY   
% 210.77/211.00  |- skos__prefLabel mesh__D015945 Factor XIa
% 210.77/211.00  |- rdf__type mesh__D015945sskos__Concept
% 210.77/211.00  |- skos__scopeNote mesh__D015945
% 210.77/211.00       Activated form of factor XI. In the intrinsic pathway, Factor XI is activated to XIa by factor XIIa in the presence of cofactor HMWK; %28%HIGH MOLECULAR WEIGHT KININOGEN%29%. Factor XIa then activates factor IX to factor IXa in the presence of calcium.%A%    
% 210.77/211.00  |- mesh__dateRevised mesh__D015945 2005-06-30
% 210.77/211.00  |- skos__altLabel mesh__D015945 Activated Factor XI
% 210.77/211.00  |- mesh__dateEstablished mesh__D015945 1990-01-01
% 210.77/211.00  |- skos__broader mesh__D015945smesh__D012697
% 210.77/211.00  |- skos__broader mesh__D015945smesh__D005172
% 210.77/211.00  |- skos__related mesh__D015945smesh__D003029
% 210.77/211.00  |- skos__historyNote mesh__D015945 Serine Proteinases %28%1988-1989%29%
% 210.77/211.00  |- skos__altLabel mesh__D015945 Blood Coagulation Factor XI, Activated
% 210.77/211.00  |- skos__hiddenLabel mesh__D015945 XIa, Coagulation Factor
% 210.77/211.00  |- skos__altLabel mesh__D015945 Coagulation Factor XIa
% 210.77/211.00  |- skos__altLabel mesh__D015945 Factor XI, Activated
% 210.77/211.00  |- mesh__dateCreated mesh__D015945 1989-09-06
% 210.77/211.00  |- mesh__recordAuthorizer mesh__D015945 sjn
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D001925 2000
% 210.77/211.00  |- skos__scopeNote mesh__D001925
% 210.77/211.00       A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders %28%see BRAIN DISEASES, METABOLIC%29%; and other conditions.%A%    
% 210.77/211.00  |- mesh__recordMaintainer mesh__D001925 ags
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D001925 2006
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D001925 2003
% 210.77/211.00  |- skos__altLabel mesh__D001925 Encephalopathy, Chronic
% 210.77/211.00  |- mesh__dateRevised mesh__D001925 2005-07-21
% 210.77/211.00  |- skos__altLabel mesh__D001925 Chronic Encephalopathy
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D001925 2005
% 210.77/211.00  |- skos__annotation mesh__D001925
% 210.77/211.00       coord with specific condition causing damage if pertinent%A%  
% 210.77/211.00  |- mesh__recordOriginator mesh__D001925 NLM
% 210.77/211.00  |- mesh__dateCreated mesh__D001925 1999-01-01
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D001925 2006A
% 210.77/211.00  |- skos__hiddenLabel mesh__D001925 Chronic Brain Damage
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D001925 2002
% 210.77/211.00  |- rdf__type mesh__D001925sskos__Concept
% 210.77/211.00  |- mesh__recordAuthorizer mesh__D001925 ags
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D001925 2001
% 210.77/211.00  |- skos__broader mesh__D001925smesh__D001927
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D001925 2004
% 210.77/211.00  |- skos__prefLabel mesh__D001925 Brain Damage, Chronic
% 210.77/211.00  |- skos__prefLabel mesh__D034301 Deinococcus
% 210.77/211.00  |- skos__broader mesh__D034301smesh__D006095
% 210.77/211.00  |- mesh__dateCreated mesh__D034301 2002-07-03
% 210.77/211.00  |- mesh__recordAuthorizer mesh__D034301 sjn
% 210.77/211.00  |- mesh__recordMaintainer mesh__D034301 SYSTEM
% 210.77/211.00  |- rdf__type mesh__D034301sskos__Concept
% 210.77/211.00  |- mesh__historyNote mesh__D034301 2003   
% 210.77/211.00  |- mesh__recordOriginator mesh__D034301 ags
% 210.77/211.00  |- mesh__publicMeSHNote mesh__D034301 2003   
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D034301 2006
% 210.77/211.00  |- mesh__dateRevised mesh__D034301 2005-06-30
% 210.77/211.00  |- mesh__dateEstablished mesh__D034301 2003-01-01
% 210.77/211.00  |- skos__scopeNote mesh__D034301
% 210.77/211.00       A genus of gram-positive aerobic cocci found in the soil, that is highly resistant to radiation, especially ionizing radiation %28%RADIATION, IONIZING%29%. Deinococcus radiodurans is the type species.%A%    
% 210.77/211.00  |- skos__historyNote mesh__D034301 Gram-Positive Cocci %28%1983-2002%29%
% 210.77/211.00  |- skos__historyNote mesh__D034301 Micrococcus %28%1983-1999%29%
% 210.77/211.00  |- skos__historyNote mesh__D001127 Vasopressins %28%1966-1974%29%
% 210.77/211.00  |- mesh__historyNote mesh__D001127
% 210.77/211.00       1979; for PITRESSIN use VASOPRESSINS %28%1981-2001%29%   
% 210.77/211.00  |- skos__prefLabel mesh__D001127 Argipressin
% 210.77/211.00  |- skos__hiddenLabel mesh__D001127 Tannate, Argipressin
% 210.77/211.00  |- mesh__dateEstablished mesh__D001127 1979-01-01
% 210.77/211.00  |- mesh__recordOriginator mesh__D001127 NLM
% 210.77/211.00  |- rdf__type mesh__D001127sskos__Concept
% 210.77/211.00  |- skos__altLabel mesh__D001127 Arginine Vasopressin
% 210.77/211.00  |- mesh__recordAuthorizer mesh__D001127 sjn
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D001127 2006
% 210.77/211.00  |- skos__scopeNote mesh__D001127
% 210.77/211.00       Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2, cyclic 1-6 disulfide. The usual mammalian antidiuretic hormone, it is a cyclic nonapeptide with arginine in position 8 of the chain. Argipressin is used to treat DIABETES INSIPIDUS and as a hemostatic because of its vasoconstrictor action.%A%    
% 210.77/211.00  |- mesh__publicMeSHNote mesh__D001127
% 210.77/211.00       1979;  for PITRESSIN see VASOPRESSINS %28%1981-2001%29%   
% 210.77/211.00  |- skos__altLabel mesh__D001127 Vasopressin, Arginine
% 210.77/211.00  |- mesh__recordMaintainer mesh__D001127 ssb
% 210.77/211.00  |- mesh__dateRevised mesh__D001127 2005-06-30
% 210.77/211.00  |- skos__historyNote mesh__D001127 Arginine %28%1966-1974%29%
% 210.77/211.00  |- skos__broader mesh__D001127smesh__D014667
% 210.77/211.00  |- mesh__dateCreated mesh__D001127 1974-11-11
% 210.77/211.00  |- rdf__type mesh__D006610sskos__Concept
% 210.77/211.00  |- skos__related mesh__D006610smesh__D003665
% 210.77/211.00  |- mesh__recordOriginator mesh__D006610 RC
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D006610 2001
% 210.77/211.00  |- skos__annotation mesh__D006610
% 210.77/211.00       in divers; do not confuse with INERT GAS NARCOSIS   
% 210.77/211.00  |- skos__broader mesh__D006610smesh__D002493
% 210.77/211.00  |- skos__historyNote mesh__D006610 Syndrome %28%1972-1985%29%
% 210.77/211.00  |- mesh__publicMeSHNote mesh__D006610
% 210.77/211.00       2000; see HIGH PRESSURE NERVOUS SYNDROME 1991-1999; see CENTRAL NERVOUS SYSTEM DISEASES 1986-1990%A%  
% 210.77/211.00  |- skos__altLabel mesh__D006610 High Pressure Nervous Syndrome
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D006610 2004
% 210.77/211.00  |- mesh__recordMaintainer mesh__D006610 KEV
% 210.77/211.00  |- skos__altLabel mesh__D006610 High Pressure Neural Syndrome
% 210.77/211.00  |- skos__altLabel mesh__D006610 HPNS
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D006610 2000
% 210.77/211.00  |- mesh__dateEstablished mesh__D006610 1991-01-01
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D006610 2006
% 210.77/211.00  |- mesh__recordAuthorizer mesh__D006610 sjn
% 210.77/211.00  |- skos__historyNote mesh__D006610 Diving %28%1966-1985%29%
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D006610 2003
% 210.77/211.00  |- skos__altLabel mesh__D006610
% 210.77/211.00       High Pressure Neurological Syndrome, Experimental
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D006610 2005
% 210.77/211.00  |- skos__hiddenLabel mesh__D006610 HPNSs
% 210.77/211.00  |- mesh__dateRevised mesh__D006610 1999-11-05
% 210.77/211.00  |- skos__scopeNote mesh__D006610
% 210.77/211.00       A syndrome related to increased atmospheric pressure and characterized by tremors, nausea, dizziness, decreased motor and mental performance, and SEIZURES. This condition may occur in those who dive deeply %28%c. 1000 ft%29% usually while breathing a mixture of oxygen and helium. The condition is associated with a neuroexcitatory effect of helium.%A%    
% 210.77/211.00  |- skos__historyNote mesh__D006610 Atmospheric Pressure %28%1966-1985%29%
% 210.77/211.00  |- skos__historyNote mesh__D006610 Pressure %28%1966-1985%29%
% 210.77/211.00  |- skos__historyNote mesh__D006610
% 210.77/211.00       Central Nervous System Diseases %28%1966-1985%29%
% 210.77/211.00  |- mesh__historyNote mesh__D006610 2000%28%1986%29%   
% 210.77/211.00  |- skos__broader mesh__D006610smesh__D009784
% 210.77/211.00  |- skos__related mesh__D006610smesh__D001469
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D006610 2002
% 210.77/211.00  |- mesh__dateCreated mesh__D006610 1985-05-09
% 210.77/211.00  |- skos__related mesh__D006610smesh__D004242
% 210.77/211.00  |- skos__prefLabel mesh__D006610 High Pressure Neurological Syndrome
% 210.77/211.00  |- mesh__recordAuthorizer mesh__D047229 sjn
% 210.77/211.00  |- skos__historyNote mesh__D047229 Porifera %28%1990-2004%29%
% 210.77/211.00  |- mesh__recordOriginator mesh__D047229 ags
% 210.77/211.00  |- mesh__historyNote mesh__D047229 2005   
% 210.77/211.00  |- skos__scopeNote mesh__D047229
% 210.77/211.00       A genus of SPONGES in the family Plakinidae, with the skeleton formed by small diactine %28%and some triactine%29% needle-like terminations.%A%    
% 210.77/211.00  |- mesh__publicMeSHNote mesh__D047229 2005   
% 210.77/211.00  |- mesh__dateCreated mesh__D047229 2004-07-07
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D047229 2005
% 210.77/211.00  |- skos__prefLabel mesh__D047229 Plakortis
% 210.77/211.00  |- skos__broader mesh__D047229smesh__D011161
% 210.77/211.00  |- mesh__dateEstablished mesh__D047229 2005-01-01
% 210.77/211.00  |- mesh__recordMaintainer mesh__D047229 ags
% 210.77/211.00  |- rdf__type mesh__D047229sskos__Concept
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D047229 2006
% 210.77/211.00  |- mesh__dateEstablished mesh__D019538 1997-01-01
% 210.77/211.00  |- mesh__recordAuthorizer mesh__D019538 sjn
% 210.77/211.00  |- skos__annotation mesh__D019538
% 210.77/211.00       do not confuse with HEALTH SURVEYS: health care surveys are on health services provided, health surveys are on health statist; specify geog if pertinent%A%  
% 210.77/211.00  |- skos__broader mesh__D019538smesh__D003625
% 210.77/211.00  |- skos__scopeNote mesh__D019538
% 210.77/211.00       Statistical measures of utilization and other aspects of the provision of health care services including hospitalization and ambulatory care.%A%    
% 210.77/211.00  |- mesh__dateRevised mesh__D019538 1999-11-03
% 210.77/211.00  |- skos__hiddenLabel mesh__D019538 Survey, Health Care
% 210.77/211.00  |- skos__hiddenLabel mesh__D019538 Survey, Healthcare
% 210.77/211.00  |- skos__broader mesh__D019538smesh__D006302
% 210.77/211.00  |- skos__hiddenLabel mesh__D019538 Healthcare Survey
% 210.77/211.00  |- skos__hiddenLabel mesh__D019538 Care Surveys, Health
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D019538 2005
% 210.77/211.00  |- skos__hiddenLabel mesh__D019538 Care Survey, Health
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D019538 2000
% 210.77/211.00  |- mesh__dateCreated mesh__D019538 1996-06-13
% 210.77/211.00  |- skos__prefLabel mesh__D019538 Health Care Surveys
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D019538 2006
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D019538 2003
% 210.77/211.00  |- skos__hiddenLabel mesh__D019538 Surveys, Health Care
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D019538 2001
% 210.77/211.00  |- skos__hiddenLabel mesh__D019538 Health Care Survey
% 210.77/211.00  |- skos__hiddenLabel mesh__D019538 Surveys, Healthcare
% 210.77/211.00  |- skos__altLabel mesh__D019538 Healthcare Surveys
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D019538 2004
% 210.77/211.00  |- mesh__recordMaintainer mesh__D019538 kle
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D019538 2002
% 210.77/211.00  |- mesh__recordOriginator mesh__D019538 JLS
% 210.77/211.00  |- rdf__type mesh__D019538sskos__Concept
% 210.77/211.00  |- mesh__publicMeSHNote mesh__D019538 97   
% 210.77/211.00  |- mesh__historyNote mesh__D019538 97   
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D011555 2006
% 210.77/211.00  |- skos__annotation mesh__D011555 do NOT check tag PREGNANCY   
% 210.77/211.00  |- skos__broader mesh__D011555smesh__D011247
% 210.77/211.00  |- rdf__type mesh__D011555sskos__Concept
% 210.77/211.00  |- skos__hiddenLabel mesh__D011555 Pseudopregnancies
% 210.77/211.00  |- mesh__dateCreated mesh__D011555 1999-01-01
% 210.77/211.00  |- skos__scopeNote mesh__D011555
% 210.77/211.00       An acyclic state that resembles PREGNANCY in that there is no ovarian cycle, ESTROUS CYCLE, or MENSTRUAL CYCLE. Unlike pregnancy, there is no EMBRYO IMPLANTATION. Pseudopregnancy can be experimentally induced to form DECIDUOMA in the UTERUS.%A%    
% 210.77/211.00  |- skos__prefLabel mesh__D011555 Pseudopregnancy
% 210.77/211.00  |- mesh__dateRevised mesh__D011555 2004-07-07
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D011555 2005
% 210.77/211.00  |- mesh__recordOriginator mesh__D011555 NLM
% 210.77/211.00  |- skos__altLabel mesh__D011555 Pseudocyesis
% 210.77/211.00  |- mesh__recordMaintainer mesh__D011555 lkt
% 210.77/211.00  |- mesh__historyNote mesh__D011555
% 210.77/211.00       was in Cat G only 1968-78, was in Cat F only 1963-67   
% 210.77/211.00  |- mesh__recordAuthorizer mesh__D011555 sjn
% 210.77/211.00  |- mesh__recordOriginator mesh__D005518 NLM
% 210.77/211.00  |- skos__hiddenLabel mesh__D005518 Selections, Food
% 210.77/211.00  |- skos__hiddenLabel mesh__D005518 Preferences, Food
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D005518 2006
% 210.77/211.00  |- mesh__historyNote mesh__D005518 69   
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D005518 2005
% 210.77/211.00  |- skos__historyNote mesh__D005518 Food %28%1966-1968%29%
% 210.77/211.00  |- skos__hiddenLabel mesh__D005518 Preference, Food
% 210.77/211.00  |- skos__historyNote mesh__D005518 Diet %28%1966-1968%29%
% 210.77/211.00  |- skos__hiddenLabel mesh__D005518 Selection, Food
% 210.77/211.00  |- skos__hiddenLabel mesh__D005518 Food Selections
% 210.77/211.00  |- skos__historyNote mesh__D005518 Behavior, Animal %28%1966-1968%29%
% 210.77/211.00  |- skos__prefLabel mesh__D005518 Food Preferences
% 210.77/211.00  |- rdf__type mesh__D005518sskos__Concept
% 210.77/211.00  |- skos__hiddenLabel mesh__D005518 Food Preference
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D005518 2004
% 210.77/211.00  |- skos__scopeNote mesh__D005518
% 210.77/211.00       The selection of one food over another.     
% 210.77/211.00  |- skos__historyNote mesh__D005518 Behavior %28%1966-1968%29%
% 210.77/211.00  |- mesh__dateCreated mesh__D005518 1999-01-01
% 210.77/211.00  |- mesh__recordMaintainer mesh__D005518 TAP
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D005518 2003
% 210.77/211.00  |- mesh__recordAuthorizer mesh__D005518 sjn
% 210.77/211.00  |- skos__broader mesh__D005518smesh__D005247
% 210.77/211.00  |- skos__annotation mesh__D005518 human %26% animal   
% 210.77/211.00  |- mesh__dateRevised mesh__D005518 2002-07-03
% 210.77/211.00  |- mesh__dateEstablished mesh__D005518 1969-01-01
% 210.77/211.00  |- mesh__publicMeSHNote mesh__D005518 69   
% 210.77/211.00  |- rdf__type mesh__D016240sskos__Concept
% 210.77/211.00  |- mesh__historyNote mesh__D016240 91   
% 210.77/211.00  |- mesh__dateEstablished mesh__D016240 1991-01-01
% 210.77/211.00  |- mesh__dateCreated mesh__D016240 1990-06-06
% 210.77/211.00  |- skos__broader mesh__D016240smesh__D012984
% 210.77/211.00  |- skos__prefLabel mesh__D016240 Grateful Med
% 210.77/211.00  |- mesh__recordMaintainer mesh__D016240 jls
% 210.77/211.00  |- skos__historyNote mesh__D016240 MEDLARS %28%1986-1990%29%
% 210.77/211.00  |- mesh__recordOriginator mesh__D016240 TGC
% 210.77/211.00  |- skos__scopeNote mesh__D016240
% 210.77/211.00       A microcomputer-based software package providing a user-friendly interface to the MEDLARS system of the National Library of Medicine.%A%    
% 210.77/211.00  |- mesh__recordAuthorizer mesh__D016240 sjn
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D016240 2005
% 210.77/211.00  |- mesh__publicMeSHNote mesh__D016240 91   
% 210.77/211.00  |- skos__broader mesh__D016240smesh__D016247
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D016240 2006
% 210.77/211.00  |- mesh__dateRevised mesh__D016240 2004-07-07
% 210.77/211.00  |- skos__annotation mesh__D016240 IM      CATALOG: use NAF entry   
% 210.77/211.00  |- mesh__dateEstablished mesh__D029966 2002-01-01
% 210.77/211.00  |- mesh__recordAuthorizer mesh__D029966 sjn
% 210.77/211.00  |- skos__prefLabel mesh__D029966 Centaurium
% 210.77/211.00  |- skos__scopeNote mesh__D029966
% 210.77/211.00       A plant genus of the family GENTIANACEAE. Triterpene lactones and other compounds have been isolated from species of this genus.  The common name of  century plant has also been used for the AGAVE genus.%A%    
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D029966 2003
% 210.77/211.00  |- mesh__historyNote mesh__D029966 2002   
% 210.77/211.00  |- mesh__dateCreated mesh__D029966 2001-08-03
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D029966 2005
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D029966 2004
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D029966 2006
% 210.77/211.00  |- rdf__type mesh__D029966sskos__Concept
% 210.77/211.00  |- mesh__recordMaintainer mesh__D029966 jls
% 210.77/211.00  |- mesh__publicMeSHNote mesh__D029966 2002   
% 210.77/211.00  |- skos__broader mesh__D029966smesh__D029965
% 210.77/211.00  |- skos__annotation mesh__D029966
% 210.77/211.00       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D029966 2002
% 210.77/211.00  |- mesh__recordOriginator mesh__D029966 ssb
% 210.77/211.00  |- skos__prefLabel mesh__D002220 Carbamazepine
% 210.77/211.00  |- mesh__dateEstablished mesh__D002220 1972-01-01
% 210.77/211.00  |- mesh__dateCreated mesh__D002220 1999-01-01
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D002220 2001
% 210.77/211.00  |- rdf__type mesh__D002220sskos__Concept
% 210.77/211.00  |- skos__hiddenLabel mesh__D002220 Hydrochloride, Carbamazepine
% 210.77/211.00  |- skos__historyNote mesh__D002220 Anticonvulsants %28%1966-1967%29%
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D002220 2003
% 210.77/211.00  |- mesh__recordOriginator mesh__D002220 NLM
% 210.77/211.00  |- mesh__recordAuthorizer mesh__D002220 sjn
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D002220 2005
% 210.77/211.00  |- mesh__recordMaintainer mesh__D002220 jmp
% 210.77/211.00  |- mesh__dateRevised mesh__D002220 2000-06-21
% 210.77/211.00  |- skos__scopeNote mesh__D002220
% 210.77/211.00       An anticonvulsant used to control grand mal and psychomotor or focal seizures. Its mode of action is not fully understood, but some of its actions resemble those of PHENYTOIN; although there is little chemical resemblance between the two compounds, their three-dimensional structure is similar.%A%    
% 210.77/211.00  |- skos__historyNote mesh__D002220 Azepines %28%1966-1967%29%
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D002220 2004
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D002220 2002
% 210.77/211.00  |- mesh__publicMeSHNote mesh__D002220 72   
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D002220 2006
% 210.77/211.00  |- skos__hiddenLabel mesh__D002220 Phosphate, Carbamazepine
% 210.77/211.00  |- skos__hiddenLabel mesh__D002220 Dihydrate, Carbamazepine
% 210.77/211.00  |- skos__broader mesh__D002220smesh__D003984
% 210.77/211.00  |- skos__hiddenLabel mesh__D002220 Acetate, Carbamazepine
% 210.77/211.00  |- mesh__historyNote mesh__D002220 72%28%68%29%   
% 210.77/211.00  |- skos__prefLabel mesh__D021983 Cyclophilins
% 210.77/211.00  |- skos__altLabel mesh__D021983 Cyclosporin-Binding Proteins
% 210.77/211.00  |- skos__scopeNote mesh__D021983
% 210.77/211.00       A family of peptidyl-prolyl cis-trans isomerases that bind to CYCLOSPORINS and regulate the IMMUNE SYSTEM. EC 5.2.1.-%A%    
% 210.77/211.00  |- mesh__recordOriginator mesh__D021983 jmp
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D021983 2005
% 210.77/211.00  |- skos__broader mesh__D021983smesh__D020104
% 210.77/211.00  |- mesh__publicMeSHNote mesh__D021983
% 210.77/211.00       2001; see PEPTIDYLPROLYL ISOMERASE 1998-2000, was indexed under CARRIER PROTEINS %26% AMINO ACID ISOMERASES 1984-1997%A%  
% 210.77/211.00  |- mesh__recordAuthorizer mesh__D021983 sjn
% 210.77/211.00  |- rdf__type mesh__D021983sskos__Concept
% 210.77/211.00  |- mesh__historyNote mesh__D021983
% 210.77/211.00       2001; use PEPTIDYLPROLYL ISOMERASE 1998-2000 %26% PEPTIDYLPROLYL ISOMERASE %28%NM%29% 1984-1997%A%  
% 210.77/211.00  |- mesh__dateEstablished mesh__D021983 2001-01-01
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D021983 2006
% 210.77/211.00  |- skos__hiddenLabel mesh__D021983 Cyclosporin Binding Proteins
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D021983 2004
% 210.77/211.00  |- skos__historyNote mesh__D021983 Amino Acid Isomerases %28%1984-1997%29%
% 210.77/211.00  |- skos__hiddenLabel mesh__D021983 Cyclosporin Binding Protein
% 210.77/211.00  |- mesh__dateCreated mesh__D021983 2000-07-05
% 210.77/211.00  |- mesh__recordMaintainer mesh__D021983 jmp
% 210.77/211.00  |- skos__altLabel mesh__D021983 Cyclophilin
% 210.77/211.00  |- skos__hiddenLabel mesh__D021983 Protein, Cyclosporin-Binding
% 210.77/211.00  |- skos__historyNote mesh__D021983
% 210.77/211.00       Peptidylprolyl Isomerase %28%1998-2000%29%
% 210.77/211.00  |- mesh__dateRevised mesh__D021983 2003-07-09
% 210.77/211.00  |- skos__hiddenLabel mesh__D021983 Proteins, Cyclosporin-Binding
% 210.77/211.00  |- skos__altLabel mesh__D021983 Cyclosporin-Binding Protein
% 210.77/211.00  |- skos__hiddenLabel mesh__D015946 Dibromides, Ethylene
% 210.77/211.00  |- skos__historyNote mesh__D015946 Ethylene Dibromides %28%1977-1989%29%
% 210.77/211.00  |- skos__hiddenLabel mesh__D015946 sym Dibromoethane
% 210.77/211.00  |- mesh__historyNote mesh__D015946
% 210.77/211.00       90; was ETHYLENE DIBROMIDES see under HYDROCARBONS, BROMINATED 1977-89; was ETHYLENE DIBROMIDE see under HYDROCARBONS, BROMINATED 1975-76; ETHYLENE DIBROMIDES was see under HYDROCARBONS, BROMINATED 1977-90%A%  
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D015946 2005
% 210.77/211.00  |- skos__hiddenLabel mesh__D015946 Dibromide, Ethylene
% 210.77/211.00  |- mesh__recordAuthorizer mesh__D015946 sjn
% 210.77/211.00  |- skos__altLabel mesh__D015946 Dowfume W85
% 210.77/211.00  |- rdf__type mesh__D015946sskos__Concept
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D015946 2002
% 210.77/211.00  |- mesh__onlineNote mesh__D015946
% 210.77/211.00       use ETHYLENE DIBROMIDE to search ETHYLENE DIBROMIDES 1975-90%A%  
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D015946 2004
% 210.77/211.00  |- mesh__recordOriginator mesh__D015946 RLS
% 210.77/211.00  |- skos__altLabel mesh__D015946 1,2-Dibromoethane
% 210.77/211.00  |- skos__hiddenLabel mesh__D015946 Bromide, Ethylene
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D015946 2001
% 210.77/211.00  |- mesh__dateEstablished mesh__D015946 1990-01-01
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D015946 2003
% 210.77/211.00  |- skos__broader mesh__D015946smesh__D006842
% 210.77/211.00  |- mesh__publicMeSHNote mesh__D015946
% 210.77/211.00       90; was ETHYLENE DIBROMIDES see under HYDROCARBONS, BROMINATED 1977-89; was ETHYLENE DIBROMIDE see under HYDROCARBONS, BROMINATED 1975-76; ETHYLENE DIBROMIDES was see under HYDROCARBONS, BROMINATED 1977-90%A%  
% 210.77/211.00  |- skos__historyNote mesh__D015946 Hydrocarbons, Brominated %28%1974%29%
% 210.77/211.00  |- skos__altLabel mesh__D015946 sym-Dibromoethane
% 210.77/211.00  |- skos__prefLabel mesh__D015946 Ethylene Dibromide
% 210.77/211.00  |- skos__scopeNote mesh__D015946
% 210.77/211.00       An effective soil fumigant, insecticide, and nematocide. In humans, it causes severe burning of skin and irritation of the eyes and respiratory tract. Prolonged inhalation may cause liver necrosis. It is also used in gasoline. Members of this group have caused liver and lung cancers in rodents. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%, 1,2-dibromoethane may reasonably be anticipated to be a carcinogen.%A%    
% 210.77/211.00  |- skos__hiddenLabel mesh__D015946 1,2 Dibromoethane
% 210.77/211.00  |- mesh__recordMaintainer mesh__D015946 CCR
% 210.77/211.00  |- mesh__dateCreated mesh__D015946 1989-05-25
% 210.77/211.00  |- mesh__dateRevised mesh__D015946 2000-06-22
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D015946 2006
% 210.77/211.00  |- mesh__dateRevised mesh__D015148 1997-06-20
% 210.77/211.00  |- skos__historyNote mesh__D015148 Fetal Monitoring %28%1978-1988%29%
% 210.77/211.00  |- skos__hiddenLabel mesh__D015148 Cardiotocograms
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D015148 2000
% 210.77/211.00  |- skos__broader mesh__D015148smesh__D005323
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D015148 2004
% 210.77/211.00  |- mesh__publicMeSHNote mesh__D015148 89   
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D015148 2001
% 210.77/211.00  |- mesh__dateCreated mesh__D015148 1988-03-21
% 210.77/211.00  |- mesh__dateEstablished mesh__D015148 1989-01-01
% 210.77/211.00  |- skos__hiddenLabel mesh__D015148 Antepartum CTG
% 210.77/211.00  |- skos__altLabel mesh__D015148 CTG, Antepartum
% 210.77/211.00  |- skos__prefLabel mesh__D015148 Cardiotocography
% 210.77/211.00  |- mesh__activeMeSHYear mesh__D015148 2002
% 210.77/211.00  |- mesh__recordMaintainer mesh__D015148 PXP
% 210.77/211.00  |- rdf__type mesh__D015148sskos__Concept
% 210.77/211.00  |- mesh__recordOriginator mesh__D015148 SCD
% 210.77/211.01  |- skos__historyNote mesh__D015148 Fetal Heart %28%1969-1988%29%
% 210.77/211.01  |- skos__historyNote mesh__D015148 Labor, Premature %28%1977-1988%29%
% 210.77/211.01  |- skos__annotation mesh__D015148
% 210.77/211.01       monitors fetal heart rate; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: CARDIOTOCOGR%A%  
% 210.77/211.01  |- skos__historyNote mesh__D015148 Uterine Contraction %28%1974-1988%29%
% 210.77/211.01  |- mesh__recordAuthorizer mesh__D015148 SJN
% 210.77/211.01  |- skos__broader mesh__D015148smesh__D006334
% 210.77/211.01  |- mesh__activeMeSHYear mesh__D015148 2005
% 210.77/211.01  |- mesh__activeMeSHYear mesh__D015148 1998
% 210.77/211.01  |- skos__scopeNote mesh__D015148
% 210.77/211.01       Monitoring of fetal heart frequency before birth in order to assess impending prematurity in relation to the pattern or intensity of antepartum UTERINE CONTRACTION.%A%    
% 210.77/211.01  |- mesh__historyNote mesh__D015148 89   
% 210.77/211.01  |- mesh__activeMeSHYear mesh__D015148 2006
% 210.77/211.01  |- mesh__activeMeSHYear mesh__D015148 2003
% 210.77/211.01  |- mesh__activeMeSHYear mesh__D015148 1999
% 210.77/211.01  |- skos__related mesh__D009909smesh__D003753
% 210.77/211.01  |- mesh__recordMaintainer mesh__D009909 PXP
% 210.77/211.01  |- mesh__activeMeSHYear mesh__D009909 2006
% 210.77/211.01  |- skos__hiddenLabel mesh__D009909 Health, Oral
% 210.77/211.01  |- skos__related mesh__D009909smesh__D009065
% 210.77/211.01  |- mesh__activeMeSHYear mesh__D009909 1998
% 210.77/211.01  |- rdf__type mesh__D009909sskos__Concept
% 210.77/211.01  |- mesh__activeMeSHYear mesh__D009909 2005
% 210.86/211.01  |- skos__prefLabel mesh__D009909 Oral Health
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D009909 2002
% 210.86/211.01  |- mesh__historyNote mesh__D009909
% 210.86/211.01       65; DENTAL HYGIENE was heading 1963-64   
% 210.86/211.01  |- mesh__recordOriginator mesh__D009909 NLM
% 210.86/211.01  |- skos__related mesh__D009909smesh__D003945
% 210.86/211.01  |- skos__related mesh__D009909smesh__D003740
% 210.86/211.01  |- mesh__dateRevised mesh__D009909 1997-06-20
% 210.86/211.01  |- mesh__dateEstablished mesh__D009909 1965-01-01
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D009909 2004
% 210.86/211.01  |- mesh__dateCreated mesh__D009909 1999-01-01
% 210.86/211.01  |- mesh__publicMeSHNote mesh__D009909
% 210.86/211.01       65; DENTAL HYGIENE was heading 1963-64   
% 210.86/211.01  |- skos__broader mesh__D009909smesh__D006262
% 210.86/211.01  |- skos__annotation mesh__D009909
% 210.86/211.01       differentiate from ORAL HYGIENE; oral health is the state of health of the mouth%A%  
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D009909 2001
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D009909 2003
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D009909 1999
% 210.86/211.01  |- mesh__recordAuthorizer mesh__D009909 SJN
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D009909 2000
% 210.86/211.01  |- skos__related mesh__D009909smesh__D009059
% 210.86/211.01  |- skos__scopeNote mesh__D009909
% 210.86/211.01       The optimal state of the mouth and normal functioning of the organs of the mouth without evidence of disease.%A%    
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001926 2002
% 210.86/211.01  |- skos__hiddenLabel mesh__D001926 Death, Brain
% 210.86/211.01  |- skos__broader mesh__D001926smesh__D003643
% 210.86/211.01  |- mesh__dateEstablished mesh__D001926 1972-01-01
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001926 2001
% 210.86/211.01  |- mesh__historyNote mesh__D001926 1972%28%1969%29%   
% 210.86/211.01  |- mesh__dateCreated mesh__D001926 1999-01-01
% 210.86/211.01  |- skos__historyNote mesh__D001926 Death %28%1966-1968%29%
% 210.86/211.01  |- mesh__recordMaintainer mesh__D001926 jls
% 210.86/211.01  |- skos__altLabel mesh__D001926 Brain Dead
% 210.86/211.01  |- rdf__type mesh__D001926sskos__Concept
% 210.86/211.01  |- skos__hiddenLabel mesh__D001926 Brain Deads
% 210.86/211.01  |- mesh__dateRevised mesh__D001926 2000-06-22
% 210.86/211.01  |- mesh__publicMeSHNote mesh__D001926 1972   
% 210.86/211.01  |- skos__hiddenLabel mesh__D001926 Coma, Irreversible
% 210.86/211.01  |- skos__broader mesh__D001926smesh__D003128
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001926 2004
% 210.86/211.01  |- skos__altLabel mesh__D001926 Coma Depasse
% 210.86/211.01  |- skos__broader mesh__D001926smesh__D001927
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001926 2006
% 210.86/211.01  |- skos__scopeNote mesh__D001926
% 210.86/211.01       A state of prolonged irreversible cessation of all brain activity, including lower brain stem function with the complete absence of voluntary movements, responses to stimuli, brain stem reflexes, and spontaneous respirations. Reversible conditions which mimic this clinical state %28%e.g., sedative overdose, hypothermia, etc.%29% are excluded prior to making the determination of brain death. %28%From Adams et al., Principles of Neurology, 6th ed, pp348-9%29%%A%    
% 210.86/211.01  |- skos__prefLabel mesh__D001926 Brain Death
% 210.86/211.01  |- mesh__recordAuthorizer mesh__D001926 sjn
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001926 2003
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001926 2005
% 210.86/211.01  |- mesh__recordOriginator mesh__D001926 NLM
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001128 1998
% 210.86/211.01  |- mesh__recordMaintainer mesh__D001128 TPW
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001128 2005
% 210.86/211.01  |- skos__scopeNote mesh__D001128
% 210.86/211.01       Argon. A noble gas with the atomic symbol Ar, atomic number 18, and atomic weight 39.948. It is used in fluorescent tubes and wherever an inert atmosphere is desired and nitrogen cannot be used.%A%    
% 210.86/211.01  |- rdf__type mesh__D001128sskos__Concept
% 210.86/211.01  |- mesh__dateCreated mesh__D001128 1999-01-01
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001128 1999
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001128 2006
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001128 1994
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001128 2000
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001128 1995
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001128 1996
% 210.86/211.01  |- mesh__recordOriginator mesh__D001128 NLM
% 210.86/211.01  |- skos__prefLabel mesh__D001128 Argon
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001128 2001
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001128 2003
% 210.86/211.01  |- mesh__dateRevised mesh__D001128 1993-06-04
% 210.86/211.01  |- skos__broader mesh__D001128smesh__D005741
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001128 1997
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001128 2002
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001128 2004
% 210.86/211.01  |- skos__annotation mesh__D001128
% 210.86/211.01       a rare gas; Ar-40; Ar-36, 38 = ARGON %28%IM%29% + ISOTOPES %28%NIM%29%; Ar-35, 37, 39, 41, 42 = ARGON %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 210.86/211.01  |- mesh__recordAuthorizer mesh__D001128 PLS
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D006611 2004
% 210.86/211.01  |- skos__hiddenLabel mesh__D006611 Ventilations, High-Frequency Jet
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D006611 2002
% 210.86/211.01  |- skos__hiddenLabel mesh__D006611 Ventilation, High-Frequency Jet
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D006611 2006
% 210.86/211.01  |- skos__broader mesh__D006611smesh__D006612
% 210.86/211.01  |- skos__scopeNote mesh__D006611
% 210.86/211.01       Respiratory support system used primarily with rates of about 100 to 200/min with volumes of from about one to three times predicted anatomic dead space. Used to treat respiratory failure and maintain ventilation under severe circumstances.%A%    
% 210.86/211.01  |- mesh__dateEstablished mesh__D006611 1988-01-01
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D006611 1997
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D006611 2003
% 210.86/211.01  |- skos__hiddenLabel mesh__D006611 Jet Ventilation, High-Frequency
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D006611 2001
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D006611 1999
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D006611 2005
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D006611 1993
% 210.86/211.01  |- skos__annotation mesh__D006611
% 210.86/211.01       a type of artif resp; do not use /util except by MeSH definition; DF: HFJV%A%  
% 210.86/211.01  |- skos__historyNote mesh__D006611
% 210.86/211.01       Respiration, Artificial %28%1966-1987%29%
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D006611 1996
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D006611 1995
% 210.86/211.01  |- mesh__recordOriginator mesh__D006611 EC
% 210.86/211.01  |- skos__hiddenLabel mesh__D006611 Jet Ventilations, High-Frequency
% 210.86/211.01  |- mesh__recordMaintainer mesh__D006611 TGC
% 210.86/211.01  |- mesh__historyNote mesh__D006611 88   
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D006611 2000
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D006611 1998
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D006611 1992
% 210.86/211.01  |- mesh__recordAuthorizer mesh__D006611 PLS
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D006611 1994
% 210.86/211.01  |- mesh__publicMeSHNote mesh__D006611 88   
% 210.86/211.01  |- rdf__type mesh__D006611sskos__Concept
% 210.86/211.01  |- mesh__dateCreated mesh__D006611 1987-04-30
% 210.86/211.01  |- skos__prefLabel mesh__D006611 High-Frequency Jet Ventilation
% 210.86/211.01  |- skos__altLabel mesh__D006611 High Frequency Jet Ventilation
% 210.86/211.01  |- skos__hiddenLabel mesh__D006611 High-Frequency Jet Ventilations
% 210.86/211.01  |- mesh__dateRevised mesh__D006611 1991-06-27
% 210.86/211.01  |- skos__altLabel mesh__D006611 Ventilation, High Frequency Jet
% 210.86/211.01  |- skos__annotation mesh__D019539
% 210.86/211.01       publication type only; for pharmacopoeias as a subject, index under main heading PHARMACOPOEIAS%A%  
% 210.86/211.01  |- skos__broader mesh__D019539smesh__D052180
% 210.86/211.01  |- mesh__dateEstablished mesh__D019539 1997-01-01
% 210.86/211.01  |- mesh__recordAuthorizer mesh__D019539 sjn
% 210.86/211.01  |- mesh__dateCreated mesh__D019539 1996-06-21
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D019539 2006
% 210.86/211.01  |- skos__prefLabel mesh__D019539 Pharmacopoeias %5B%Publication Type%5D%
% 210.86/211.01  |- skos__altLabel mesh__D019539 Pharmacopoeias %28%PT%29%
% 210.86/211.01  |- mesh__dateRevised mesh__D019539 2005-06-30
% 210.86/211.01  |- mesh__recordMaintainer mesh__D019539 jls
% 210.86/211.01  |- rdf__type mesh__D019539sskos__Concept
% 210.86/211.01  |- skos__scopeNote mesh__D019539
% 210.86/211.01       Authoritative works containing lists of drugs and preparations, their description, formulation, analytic composition, main chemical properties, standards for strength, purity, and dosage, chemical tests for determining identity, etc. They have the status of a standard.%A%    
% 210.86/211.01  |- mesh__recordOriginator mesh__D019539 TGC
% 210.86/211.01  |- mesh__historyNote mesh__D019539 1997   
% 210.86/211.01  |- mesh__recordOriginator mesh__D011556 NLM
% 210.86/211.01  |- skos__annotation mesh__D011556
% 210.86/211.01       do not confuse with PSEUDOHYPOPARATHYROIDISM of which it is an incomplete form%A%  
% 210.86/211.01  |- skos__scopeNote mesh__D011556
% 210.86/211.01       A genetically related form of PSEUDOHYPOPARATHYROIDISM characterized by the same features except for the abnormal response to parathyroid hormone.%A%    
% 210.86/211.01  |- skos__prefLabel mesh__D011556 Pseudopseudohypoparathyroidism
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D011556 2004
% 210.86/211.01  |- mesh__recordAuthorizer mesh__D011556 sjn
% 210.86/211.01  |- skos__hiddenLabel mesh__D011556 Pseudopseudo Hypoparathyroidism
% 210.86/211.01  |- skos__hiddenLabel mesh__D011556 Pseudo-Pseudohypoparathyroidisms
% 210.86/211.01  |- mesh__dateCreated mesh__D011556 1999-01-01
% 210.86/211.01  |- mesh__dateEstablished mesh__D011556 1965-01-01
% 210.86/211.01  |- skos__altLabel mesh__D011556 Pseudo-Pseudohypoparathyroidism
% 210.86/211.01  |- skos__hiddenLabel mesh__D011556 Pseudopseudo-Hypoparathyroidisms
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D011556 2002
% 210.86/211.01  |- skos__hiddenLabel mesh__D011556 Pseudo Pseudohypoparathyroidism
% 210.86/211.01  |- mesh__recordMaintainer mesh__D011556 nns
% 210.86/211.01  |- skos__altLabel mesh__D011556 Pseudopseudo-Hypoparathyroidism
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D011556 2005
% 210.86/211.01  |- mesh__publicMeSHNote mesh__D011556 65   
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D011556 2006
% 210.86/211.01  |- skos__broader mesh__D011556smesh__D011547
% 210.86/211.01  |- mesh__dateRevised mesh__D011556 2001-07-25
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D011556 2003
% 210.86/211.01  |- skos__hiddenLabel mesh__D011556 Pseudopseudohypoparathyroidisms
% 210.86/211.01  |- mesh__historyNote mesh__D011556 65%28%63%29%   
% 210.86/211.01  |- rdf__type mesh__D011556sskos__Concept
% 210.86/211.01  |- mesh__recordAuthorizer mesh__D005519 SJN
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D005519 2005
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D005519 1998
% 210.86/211.01  |- skos__hiddenLabel mesh__D005519 Canned Foods
% 210.86/211.01  |- skos__broader mesh__D005519smesh__D005524
% 210.86/211.01  |- mesh__recordOriginator mesh__D005519 NLM
% 210.86/211.01  |- skos__hiddenLabel mesh__D005519 Dried Foods
% 210.86/211.01  |- skos__related mesh__D005519smesh__D015416
% 210.86/211.01  |- skos__prefLabel mesh__D005519 Food Preservation
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D005519 2002
% 210.86/211.01  |- rdf__type mesh__D005519sskos__Concept
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D005519 2004
% 210.86/211.01  |- skos__hiddenLabel mesh__D005519 Foods, Dried
% 210.86/211.01  |- skos__hiddenLabel mesh__D005519 Foods, Canned
% 210.86/211.01  |- mesh__dateCreated mesh__D005519 1999-01-01
% 210.86/211.01  |- skos__hiddenLabel mesh__D005519 Preserved Foods
% 210.86/211.01  |- skos__altLabel mesh__D005519 Preservation, Food
% 210.86/211.01  |- mesh__dateRevised mesh__D005519 1997-06-20
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D005519 2003
% 210.86/211.01  |- skos__hiddenLabel mesh__D005519 Preserved Food
% 210.86/211.01  |- mesh__recordMaintainer mesh__D005519 JLS
% 210.86/211.01  |- skos__hiddenLabel mesh__D005519 Canned Food
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D005519 2001
% 210.86/211.01  |- skos__hiddenLabel mesh__D005519 Dried Food
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D005519 2006
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D005519 1999
% 210.86/211.01  |- skos__hiddenLabel mesh__D005519 Foods, Preserved
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D005519 2000
% 210.86/211.01  |- mesh__recordMaintainer mesh__D016241 PXP
% 210.86/211.01  |- mesh__recordOriginator mesh__D016241 TGC
% 210.86/211.01  |- skos__broader mesh__D016241smesh__D009272
% 210.86/211.01  |- mesh__dateEstablished mesh__D016241 1991-01-01
% 210.86/211.01  |- skos__scopeNote mesh__D016241
% 210.86/211.01       Child with one or more parents afflicted by a physical or mental disorder.%A%    
% 210.86/211.01  |- mesh__recordAuthorizer mesh__D016241 sjn
% 210.86/211.01  |- skos__hiddenLabel mesh__D016241 Parents Offspring, Impaired
% 210.86/211.01  |- skos__annotation mesh__D016241
% 210.86/211.01       coord IM with parental dis %28%IM with no qualif%29%; restrict to impaired parents: for child with impaired siblings; index CHILD %28%IM%29% + disease of sibling %28%IM%29% + SIBLINGS %28%IM%29%; interpret %22%child%22% as %22%offspring%22% %26% check appropriate age check tags%A%  
% 210.86/211.01  |- skos__hiddenLabel mesh__D016241 Parents Offsprings, Impaired
% 210.86/211.01  |- skos__hiddenLabel mesh__D016241 Children, Impaired Parents%27%
% 210.86/211.01  |- mesh__publicMeSHNote mesh__D016241 91   
% 210.86/211.01  |- mesh__dateRevised mesh__D016241 2002-07-03
% 210.86/211.01  |- skos__hiddenLabel mesh__D016241 Impaired Parents Offsprings
% 210.86/211.01  |- skos__altLabel mesh__D016241 Impaired Parents%27% Children
% 210.86/211.01  |- skos__altLabel mesh__D016241 Offspring of Impaired Parents
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D016241 2005
% 210.86/211.01  |- skos__prefLabel mesh__D016241 Child of Impaired Parents
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D016241 2006
% 210.86/211.01  |- skos__altLabel mesh__D016241 Children of Impaired Parents
% 210.86/211.01  |- skos__hiddenLabel mesh__D016241 Impaired Parents Offspring
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D016241 2003
% 210.86/211.01  |- rdf__type mesh__D016241sskos__Concept
% 210.86/211.01  |- mesh__dateCreated mesh__D016241 1990-06-06
% 210.86/211.01  |- mesh__historyNote mesh__D016241 91   
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D016241 2004
% 210.86/211.01  |- mesh__dateCreated mesh__D029967 2001-07-25
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D029967 2004
% 210.86/211.01  |- skos__scopeNote mesh__D029967
% 210.86/211.01       A plant genus of the family GENTIANACEAE.  It is a source of swertiapuniside and iridoid glycosides.%A%    
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D029967 2006
% 210.86/211.01  |- rdf__type mesh__D029967sskos__Concept
% 210.86/211.01  |- mesh__publicMeSHNote mesh__D029967 2002   
% 210.86/211.01  |- skos__broader mesh__D029967smesh__D029965
% 210.86/211.01  |- skos__annotation mesh__D029967
% 210.86/211.01       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D029967 2002
% 210.86/211.01  |- skos__prefLabel mesh__D029967 Swertia
% 210.86/211.01  |- mesh__historyNote mesh__D029967 2002   
% 210.86/211.01  |- mesh__dateEstablished mesh__D029967 2002-01-01
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D029967 2003
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D029967 2005
% 210.86/211.01  |- skos__broader mesh__D002221smesh__D009943
% 210.86/211.01  |- skos__hiddenLabel mesh__D002221 Phosphate, Carbamyl
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D002221 2003
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D002221 1997
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D002221 1994
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D002221 2005
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D002221 1999
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D002221 2000
% 210.86/211.01  |- skos__scopeNote mesh__D002221 Phosphate salt of carbamic acid.     
% 210.86/211.01  |- skos__broader mesh__D002221smesh__D002219
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D002221 1993
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D002221 2004
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D002221 2001
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D002221 1995
% 210.86/211.01  |- skos__historyNote mesh__D002221 Carbamates %28%1973-1974%29%
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D002221 2006
% 210.86/211.01  |- skos__hiddenLabel mesh__D002221 Phosphate, Dilithium Carbamyl
% 210.86/211.01  |- mesh__dateCreated mesh__D002221 1974-11-19
% 210.86/211.01  |- skos__prefLabel mesh__D002221 Carbamyl Phosphate
% 210.86/211.01  |- skos__altLabel mesh__D002221 Carbamoyl Phosphate
% 210.86/211.01  |- mesh__recordOriginator mesh__D002221 NLM
% 210.86/211.01  |- mesh__dateEstablished mesh__D002221 1991-01-01
% 210.86/211.01  |- mesh__recordMaintainer mesh__D002221 TGC
% 210.86/211.01  |- mesh__historyNote mesh__D002221
% 210.86/211.01       91%28%75%29%; was see under CARBAMATES 1975-90   
% 210.86/211.01  |- skos__historyNote mesh__D002221
% 210.86/211.01       Organophosphorus Compounds %28%1973-1974%29%
% 210.86/211.01  |- skos__hiddenLabel mesh__D002221 Phosphate, Carbamoyl
% 210.86/211.01  |- skos__hiddenLabel mesh__D002221 Carbamyl Phosphate, Dilithium
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D002221 2002
% 210.86/211.01  |- mesh__dateRevised mesh__D002221 1992-05-11
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D002221 1996
% 210.86/211.01  |- rdf__type mesh__D002221sskos__Concept
% 210.86/211.01  |- mesh__recordAuthorizer mesh__D002221 PLS
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D002221 1998
% 210.86/211.01  |- mesh__publicMeSHNote mesh__D002221
% 210.86/211.01       91; was see under CARBAMATES 1975-90   
% 210.86/211.01  |- skos__historyNote mesh__D021984
% 210.86/211.01       Peptidylprolyl Isomerase %28%1998-2000%29%
% 210.86/211.01  |- mesh__historyNote mesh__D021984
% 210.86/211.01       2001; use PEPTIDYLPROLYL ISOMERASE 1998-2000 %26% PEPTIDYLPROLYL ISOMERASE %28%NM%29% 1984-1997%A%  
% 210.86/211.01  |- mesh__dateEstablished mesh__D021984 2001-01-01
% 210.86/211.01  |- mesh__dateRevised mesh__D021984 2004-07-07
% 210.86/211.01  |- skos__prefLabel mesh__D021984 Cyclophilin A
% 210.86/211.01  |- skos__hiddenLabel mesh__D021984 A, Cyclophilin
% 210.86/211.01  |- skos__scopeNote mesh__D021984
% 210.86/211.01       A 17-KDa cytoplasmic PEPTIDYLPROLYL ISOMERASE involved in immunoregulation. It is a member of the cyclophilin family of proteins that binds to CYCLOSPORINE.%A%    
% 210.86/211.01  |- mesh__recordMaintainer mesh__D021984 jmp
% 210.86/211.01  |- skos__altLabel mesh__D021984 Peptidyl-Prolyl cis-trans Isomerase A
% 210.86/211.01  |- mesh__recordOriginator mesh__D021984 jmp
% 210.86/211.01  |- skos__broader mesh__D021984smesh__D021983
% 210.86/211.01  |- skos__historyNote mesh__D021984 Carrier Proteins %28%1984-1997%29%
% 210.86/211.01  |- mesh__recordAuthorizer mesh__D021984 sjn
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D021984 2005
% 210.86/211.01  |- mesh__publicMeSHNote mesh__D021984
% 210.86/211.01       2001; see PEPTIDYLPROLYL ISOMERASE 1998-2000, was indexed under CARRIER PROTEINS %26% AMINO ACID ISOMERASES 1984-1997%A%  
% 210.86/211.01  |- rdf__type mesh__D021984sskos__Concept
% 210.86/211.01  |- skos__historyNote mesh__D021984 Amino Acid Isomerases %28%1984-1997%29%
% 210.86/211.01  |- mesh__dateCreated mesh__D021984 2000-07-05
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D021984 2006
% 210.86/211.01  |- skos__broader mesh__D003391Q000293smesh__D003391
% 210.86/211.01  |- mesh__preferredCombination mesh__D003391Q000293smesh__D020209
% 210.86/211.01  |- rdf__type mesh__D003391Q000293smesh__CompoundConcept
% 210.86/211.01  |- skos__broader mesh__D011976Q000819smesh__D011976
% 210.86/211.01  |- mesh__preferredCombination mesh__D011976Q000819smesh__D018721
% 210.86/211.01  |- rdf__type mesh__D011976Q000819smesh__CompoundConcept
% 210.86/211.01  |- mesh__dateCreated mesh__D015149 1988-03-21
% 210.86/211.01  |- mesh__dateEstablished mesh__D015149 1989-01-01
% 210.86/211.01  |- mesh__historyNote mesh__D015149 89   
% 210.86/211.01  |- skos__broader mesh__D015149smesh__D012102
% 210.86/211.01  |- skos__scopeNote mesh__D015149
% 210.86/211.01       Drugs that prevent preterm labor and immature birth by suppressing uterine contractions. Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete.%A%    
% 210.86/211.01  |- rdf__type mesh__D015149sskos__Concept
% 210.86/211.01  |- skos__hiddenLabel mesh__D015149 Agents, Tocolytic
% 210.86/211.01  |- mesh__recordMaintainer mesh__D015149 ssb
% 210.86/211.01  |- mesh__recordOriginator mesh__D015149 SCD
% 210.86/211.01  |- skos__historyNote mesh__D015149 Muscle Contraction %28%1966-1974%29%
% 210.86/211.01  |- skos__historyNote mesh__D015149 Uterus %28%1966-1974%29%
% 210.86/211.01  |- mesh__dateRevised mesh__D015149 2005-06-30
% 210.86/211.01  |- skos__altLabel mesh__D015149 Tocolytics
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D015149 2006
% 210.86/211.01  |- skos__prefLabel mesh__D015149 Tocolytic Agents
% 210.86/211.01  |- skos__annotation mesh__D015149
% 210.86/211.01       suppress uterine contractions to prevent preterm labor %26% premature birth%A%  
% 210.86/211.01  |- skos__historyNote mesh__D015149 Labor, Premature %28%1973-1988%29%
% 210.86/211.01  |- mesh__recordAuthorizer mesh__D015149 sjn
% 210.86/211.01  |- skos__historyNote mesh__D015149 Uterine Contraction %28%1975-1988%29%
% 210.86/211.01  |- mesh__publicMeSHNote mesh__D015149 89   
% 210.86/211.01  |- skos__altLabel mesh__D001927 Encephalon Diseases
% 210.86/211.01  |- mesh__dateCreated mesh__D001927 1999-01-01
% 210.86/211.01  |- mesh__recordOriginator mesh__D001927 NLM
% 210.86/211.01  |- skos__altLabel mesh__D001927
% 210.86/211.01       Central Nervous System Disorders, Intracranial
% 210.86/211.01  |- skos__hiddenLabel mesh__D001927 Brain Disease
% 210.86/211.01  |- skos__hiddenLabel mesh__D001927 Brain Disorder
% 210.86/211.01  |- rdf__type mesh__D001927sskos__Concept
% 210.86/211.01  |- skos__scopeNote mesh__D001927
% 210.86/211.01       Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes %28%but is not limited to%29% the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.%A%    
% 210.86/211.01  |- skos__altLabel mesh__D001927 Brain Disorders
% 210.86/211.01  |- skos__altLabel mesh__D001927 Brain Pathology
% 210.86/211.01  |- skos__prefLabel mesh__D001927 Brain Diseases
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001927 2004
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001927 2006
% 210.86/211.01  |- skos__hiddenLabel mesh__D001927 CNS Disorder, Intracranial
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001927 2003
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001927 2005
% 210.86/211.01  |- skos__broader mesh__D001927smesh__D002493
% 210.86/211.01  |- mesh__dateRevised mesh__D001927 2002-07-02
% 210.86/211.01  |- skos__altLabel mesh__D001927 Intracranial CNS Disorders
% 210.86/211.01  |- skos__altLabel mesh__D001927 CNS Disorders, Intracranial
% 210.86/211.01  |- skos__altLabel mesh__D001927
% 210.86/211.01       Intracranial Central Nervous System Disorders
% 210.86/211.01  |- skos__hiddenLabel mesh__D001927 Encephalon Disease
% 210.86/211.01  |- skos__altLabel mesh__D001927
% 210.86/211.01       Central Nervous System Intracranial Disorders
% 210.86/211.01  |- skos__hiddenLabel mesh__D001927 Intracranial CNS Disorder
% 210.86/211.01  |- mesh__recordAuthorizer mesh__D001927 sjn
% 210.86/211.01  |- mesh__recordMaintainer mesh__D001927 hjn
% 210.86/211.01  |- mesh__dateRevised mesh__D001129 1997-06-20
% 210.86/211.01  |- mesh__dateCreated mesh__D001129 1999-01-01
% 210.86/211.01  |- skos__prefLabel mesh__D001129 Argyria
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001129 2002
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001129 1999
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001129 2006
% 210.86/211.01  |- skos__scopeNote mesh__D001129
% 210.86/211.01       A permanent ashen-gray discoloration of the skin, conjunctiva, and internal organs resulting from long-continued use of silver salts. %28%Dorland, 27th ed%29%%A%    
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001129 2003
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001129 2000
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001129 2004
% 210.86/211.01  |- skos__broader mesh__D001129smesh__D011041
% 210.86/211.01  |- skos__hiddenLabel mesh__D001129 Argyrias
% 210.86/211.01  |- skos__annotation mesh__D001129
% 210.86/211.01       caused by prolonged use of silver salts   
% 210.86/211.01  |- mesh__recordOriginator mesh__D001129 NLM
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001129 2001
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001129 1998
% 210.86/211.01  |- skos__broader mesh__D001129smesh__D010859
% 210.86/211.01  |- mesh__recordMaintainer mesh__D001129 TPW
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D001129 2005
% 210.86/211.01  |- rdf__type mesh__D001129sskos__Concept
% 210.86/211.01  |- mesh__recordAuthorizer mesh__D001129 SJN
% 210.86/211.01  |- skos__historyNote mesh__D006612
% 210.86/211.01       Respiration, Artificial %28%1966-1987%29%
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D006612 2004
% 210.86/211.01  |- skos__altLabel mesh__D006612 High Frequency Oscillation
% 210.86/211.01  |- skos__altLabel mesh__D006612 Ventilation, High-Frequency
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D006612 2002
% 210.86/211.01  |- mesh__activeMeSHYear mesh__D006612 2006
% 210.86/211.02  |- mesh__dateRevised mesh__D006612 2001-07-25
% 210.86/211.02  |- skos__hiddenLabel mesh__D006612 Oscillations, High Frequency
% 210.86/211.02  |- skos__altLabel mesh__D006612 High Frequency Ventilation
% 210.86/211.02  |- skos__hiddenLabel mesh__D006612 Ventilations, High Frequency
% 210.86/211.02  |- skos__hiddenLabel mesh__D006612 High Frequency Oscillations
% 210.86/211.02  |- skos__hiddenLabel mesh__D006612 Ventilations, High-Frequency
% 210.86/211.02  |- skos__broader mesh__D006612smesh__D012121
% 210.86/211.02  |- skos__scopeNote mesh__D006612
% 210.86/211.02       Ventilatory support system using frequencies from 60-900 cycles/min or more. Three types of systems have been distinguished on the basis of rates, volumes, and the system used. They are high frequency positive-pressure ventilation %28%HFPPV%29%; HIGH-FREQUENCY JET VENTILATION; %28%HFJV%29%; and high-frequency oscillation %28%HFO%29%.%A%    
% 210.86/211.02  |- skos__hiddenLabel mesh__D006612 Oscillation, High-Frequency
% 210.86/211.02  |- mesh__dateEstablished mesh__D006612 1988-01-01
% 210.86/211.02  |- skos__hiddenLabel mesh__D006612 High Frequency Ventilations
% 210.86/211.02  |- skos__hiddenLabel mesh__D006612 High-Frequency Ventilations
% 210.86/211.02  |- skos__prefLabel mesh__D006612 High-Frequency Ventilation
% 210.86/211.02  |- skos__altLabel mesh__D006612 Ventilation, High Frequency
% 210.86/211.02  |- mesh__recordOriginator mesh__D006612 EC
% 210.86/211.02  |- skos__hiddenLabel mesh__D006612 High-Frequency Oscillations
% 210.86/211.02  |- mesh__publicMeSHNote mesh__D006612 88   
% 210.86/211.02  |- rdf__type mesh__D006612sskos__Concept
% 210.86/211.02  |- skos__altLabel mesh__D006612
% 210.86/211.02       High Frequency Positive Pressure Ventilation
% 210.86/211.02  |- skos__hiddenLabel mesh__D006612 Oscillations, High-Frequency
% 210.86/211.02  |- mesh__dateCreated mesh__D006612 1987-04-30
% 210.86/211.02  |- skos__hiddenLabel mesh__D006612 Oscillation, High Frequency
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D006612 2003
% 210.86/211.02  |- mesh__recordMaintainer mesh__D006612 mdb
% 210.86/211.02  |- mesh__historyNote mesh__D006612 88   
% 210.86/211.02  |- mesh__recordAuthorizer mesh__D006612 sjn
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D006612 2005
% 210.86/211.02  |- skos__annotation mesh__D006612
% 210.86/211.02       a type of artif resp; do not use /util except by MeSH definition; DF: HFV%A%  
% 210.86/211.02  |- skos__altLabel mesh__D011557 Aujeszky%27%s Disease
% 210.86/211.02  |- mesh__recordMaintainer mesh__D011557 ags
% 210.86/211.02  |- skos__altLabel mesh__D011557 Aujeszky Disease
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D011557 2005
% 210.86/211.02  |- mesh__dateRevised mesh__D011557 2001-07-25
% 210.86/211.02  |- skos__prefLabel mesh__D011557 Pseudorabies
% 210.86/211.02  |- mesh__recordOriginator mesh__D011557 NLM
% 210.86/211.02  |- skos__broader mesh__D011557smesh__D000820
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D011557 2006
% 210.86/211.02  |- skos__broader mesh__D011557smesh__D020805
% 210.86/211.02  |- skos__scopeNote mesh__D011557
% 210.86/211.02       A highly contagious herpesvirus infection affecting the central nervous system of swine, cattle, dogs, cats, rats, and other animals.%A%    
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D011557 2003
% 210.86/211.02  |- mesh__recordAuthorizer mesh__D011557 sjn
% 210.86/211.02  |- rdf__type mesh__D011557sskos__Concept
% 210.86/211.02  |- skos__broader mesh__D011557smesh__D006566
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D011557 2004
% 210.86/211.02  |- skos__hiddenLabel mesh__D011557 Aujeszkys Disease
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D011557 2002
% 210.86/211.02  |- mesh__dateCreated mesh__D011557 1999-01-01
% 210.86/211.02  |- mesh__recordMaintainer mesh__D016242 TAP
% 210.86/211.02  |- skos__scopeNote mesh__D016242
% 210.86/211.02       The use of automatic machines or processing devices in libraries. The automation may be applied to library administrative activities, office procedures, and delivery of library services to users.%A%    
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016242 2001
% 210.86/211.02  |- mesh__dateRevised mesh__D016242 1992-03-25
% 210.86/211.02  |- mesh__dateCreated mesh__D016242 1990-05-07
% 210.86/211.02  |- skos__hiddenLabel mesh__D016242 Automation, Library
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016242 1998
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016242 2005
% 210.86/211.02  |- skos__prefLabel mesh__D016242 Library Automation
% 210.86/211.02  |- mesh__recordAuthorizer mesh__D016242 PLS
% 210.86/211.02  |- mesh__recordOriginator mesh__D016242 TGC
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016242 1993
% 210.86/211.02  |- skos__historyNote mesh__D016242 Automation %28%1966-1990%29%
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016242 1999
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016242 2006
% 210.86/211.02  |- skos__historyNote mesh__D016242 Libraries %28%1966-1990%29%
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016242 2002
% 210.86/211.02  |- skos__historyNote mesh__D016242
% 210.86/211.02       Automatic Data Processing %28%1966-1990%29%
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016242 1996
% 210.86/211.02  |- mesh__publicMeSHNote mesh__D016242 91   
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016242 2003
% 210.86/211.02  |- skos__broader mesh__D016242smesh__D007998
% 210.86/211.02  |- rdf__type mesh__D016242sskos__Concept
% 210.86/211.02  |- mesh__historyNote mesh__D016242 91   
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016242 1997
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016242 2004
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016242 2000
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016242 1994
% 210.86/211.02  |- mesh__dateEstablished mesh__D016242 1991-01-01
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016242 1995
% 210.86/211.02  |- skos__broader mesh__D000388Q000382smesh__D000388
% 210.86/211.02  |- mesh__preferredCombination mesh__D000388Q000382smesh__D000391
% 210.86/211.02  |- rdf__type mesh__D000388Q000382smesh__CompoundConcept
% 210.86/211.02  |- skos__altLabel mesh__D002222 Carbamoylphosphate Synthetase I
% 210.86/211.02  |- skos__broader mesh__D002222smesh__D019731
% 210.86/211.02  |- mesh__recordAuthorizer mesh__D002222 ags
% 210.86/211.02  |- skos__related mesh__D002222smesh__D020165
% 210.86/211.02  |- skos__altLabel mesh__D002222 CP Synthase I
% 210.86/211.02  |- skos__altLabel mesh__D002222 Carbamoyl-Phosphate Synthetase I
% 210.86/211.02  |- skos__historyNote mesh__D002222 Ammonia %28%1974%29%
% 210.86/211.02  |- skos__scopeNote mesh__D002222
% 210.86/211.02       An enzyme that catalyzes the formation of carbamoyl phosphate from ATP, carbon dioxide, and ammonia. This enzyme is specific for arginine biosynthesis or the urea cycle. Absence or lack of this enzyme may cause CARBAMOYL-PHOSPHATE SYNTHASE I DEFICIENCY DISEASE. EC 6.3.4.16.%A%    
% 210.86/211.02  |- skos__annotation mesh__D002222
% 210.86/211.02       /defic: consider CARBAMOYL-PHOSPHATE SYNTHETASE I DEFICIENCY DISEASE; DF: AMMONIA CP SYNTHASE or CP SYNTHASE I%A%  
% 210.86/211.02  |- skos__hiddenLabel mesh__D002222 Synthase I, CP
% 210.86/211.02  |- skos__hiddenLabel mesh__D002222 Synthetase I, Carbamoyl-Phosphate
% 210.86/211.02  |- mesh__historyNote mesh__D002222 98%28%75%29%   
% 210.86/211.02  |- rdf__type mesh__D002222sskos__Concept
% 210.86/211.02  |- mesh__dateEstablished mesh__D002222 1989-01-01
% 210.86/211.02  |- skos__hiddenLabel mesh__D002222 I, Carbamoyl-Phosphate Synthetase
% 210.86/211.02  |- skos__historyNote mesh__D002222 Phosphotransferases, ATP %28%1974%29%
% 210.86/211.02  |- mesh__dateCreated mesh__D002222 1974-11-19
% 210.86/211.02  |- skos__hiddenLabel mesh__D002222 Synthetase I, Carbamoylphosphate
% 210.86/211.02  |- mesh__publicMeSHNote mesh__D002222
% 210.86/211.02       98; see CARBAMYL PHOSPHATE SYNTHASE %28%AMMONIA%29% 1989-97; see LIGASES 1981-88; see PHOSPHOTRANSFERASES, ATP 1975-80%A%  
% 210.86/211.02  |- skos__altLabel mesh__D002222
% 210.86/211.02       Carbamoyl-Phosphate Synthetase %28%Ammonia%29%
% 210.86/211.02  |- skos__altLabel mesh__D002222 Carbamyl Phosphate Synthase %28%Ammonia%29%
% 210.86/211.02  |- skos__altLabel mesh__D002222 Carbamyl-Phosphate Synthase %28%Ammonia%29%
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D002222 2006A
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D002222 2005
% 210.86/211.02  |- skos__historyNote mesh__D002222 Carbamates %28%1974%29%
% 210.86/211.02  |- skos__prefLabel mesh__D002222
% 210.86/211.02       Carbamoyl-Phosphate Synthase %28%Ammonia%29%
% 210.86/211.02  |- skos__altLabel mesh__D002222 Carbamoyl Phosphate Synthetase I
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D002222 2004
% 210.86/211.02  |- mesh__dateRevised mesh__D002222 2005-07-11
% 210.86/211.02  |- mesh__recordMaintainer mesh__D002222 ags
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D002222 2006
% 210.86/211.02  |- mesh__recordOriginator mesh__D002222 NLM
% 210.86/211.02  |- mesh__dateCreated mesh__D029968 2001-07-25
% 210.86/211.02  |- skos__related mesh__D029968smesh__D004926
% 210.86/211.02  |- rdf__type mesh__D029968sskos__Concept
% 210.86/211.02  |- skos__altLabel mesh__D029968 E coli Proteins
% 210.86/211.02  |- skos__scopeNote mesh__D029968
% 210.86/211.02       Proteins obtained from ESCHERICHIA COLI.     
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D029968 2006
% 210.86/211.02  |- skos__prefLabel mesh__D029968 Escherichia coli Proteins
% 210.86/211.02  |- mesh__recordAuthorizer mesh__D029968 sjn
% 210.86/211.02  |- mesh__publicMeSHNote mesh__D029968 2002   
% 210.86/211.02  |- skos__broader mesh__D029968smesh__D001426
% 210.86/211.02  |- mesh__recordMaintainer mesh__D029968 SYSTEM
% 210.86/211.02  |- mesh__dateEstablished mesh__D029968 2002-01-01
% 210.86/211.02  |- mesh__dateRevised mesh__D029968 2005-06-30
% 210.86/211.02  |- mesh__recordOriginator mesh__D029968 jmp
% 210.86/211.02  |- mesh__historyNote mesh__D029968 2002   
% 210.86/211.02  |- skos__historyNote mesh__D029968 Bacterial Proteins %28%1994-2001%29%
% 210.86/211.02  |- rdf__type mesh__D015948sskos__Concept
% 210.86/211.02  |- mesh__recordMaintainer mesh__D015948 lkt
% 210.86/211.02  |- mesh__dateEstablished mesh__D015948 1990-01-01
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D015948 2004
% 210.86/211.02  |- skos__hiddenLabel mesh__D015948 Penetrating Keratoplasty
% 210.86/211.02  |- skos__scopeNote mesh__D015948
% 210.86/211.02       Partial or total replacement of all layers of a central portion of the cornea.%A%    
% 210.86/211.02  |- mesh__dateRevised mesh__D015948 2002-07-03
% 210.86/211.02  |- mesh__dateCreated mesh__D015948 1989-05-25
% 210.86/211.02  |- mesh__historyNote mesh__D015948 90   
% 210.86/211.02  |- skos__hiddenLabel mesh__D015948 Penetrating Keratoplasties
% 210.86/211.02  |- mesh__publicMeSHNote mesh__D015948 90   
% 210.86/211.02  |- skos__historyNote mesh__D015948 Cornea/transplantation %28%1966-1989%29%
% 210.86/211.02  |- mesh__recordOriginator mesh__D015948 EGC
% 210.86/211.02  |- skos__broader mesh__D015948smesh__D016039
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D015948 2005
% 210.86/211.02  |- skos__hiddenLabel mesh__D015948 Keratoplasties, Penetrating
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D015948 2006
% 210.86/211.02  |- skos__prefLabel mesh__D015948 Keratoplasty, Penetrating
% 210.86/211.02  |- mesh__recordAuthorizer mesh__D015948 sjn
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D015948 2003
% 210.86/211.02  |- skos__annotation mesh__D015948
% 210.86/211.02       do not use /util except by MeSH definition   
% 210.86/211.02  |- skos__altLabel mesh__D040341 Genetic Phenomenon
% 210.86/211.02  |- mesh__publicMeSHNote mesh__D040341 2003   
% 210.86/211.02  |- mesh__dateEstablished mesh__D040341 2003-01-01
% 210.86/211.02  |- skos__hiddenLabel mesh__D040341 Phenomena, Genetic
% 210.86/211.02  |- mesh__dateCreated mesh__D040341 2002-07-03
% 210.86/211.02  |- mesh__recordOriginator mesh__D040341 nns
% 210.86/211.02  |- mesh__recordAuthorizer mesh__D040341 sjn
% 210.86/211.02  |- skos__related mesh__D040341smesh__D039361
% 210.86/211.02  |- skos__hiddenLabel mesh__D040341 Phenomenon, Genetic
% 210.86/211.02  |- skos__prefLabel mesh__D040341 Genetic Phenomena
% 210.86/211.02  |- mesh__recordMaintainer mesh__D040341 nns
% 210.86/211.02  |- mesh__historyNote mesh__D040341 2003   
% 210.86/211.02  |- mesh__dateRevised mesh__D040341 2003-07-09
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D040341 2005
% 210.86/211.02  |- skos__scopeNote mesh__D040341
% 210.86/211.02       Temporal, spatial, qualitative, and quantitative concepts related to GENETIC PROCESSES and GENETIC STRUCTURES.%A%    
% 210.86/211.02  |- rdf__type mesh__D040341sskos__Concept
% 210.86/211.02  |- skos__related mesh__D040341smesh__D040342
% 210.86/211.02  |- skos__annotation mesh__D040341 GEN only: avoid: prefer specifics   
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D040341 2006
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D040341 2004
% 210.86/211.02  |- mesh__runningHead mesh__D040341 G13 - GENETIC PHENOMENA   
% 210.86/211.02  |- skos__related mesh__D040341smesh__D005823
% 210.86/211.02  |- mesh__dateCreated mesh__D001928 1999-01-01
% 210.86/211.02  |- skos__altLabel mesh__D001928 Encephalopathies, Metabolic
% 210.86/211.02  |- skos__hiddenLabel mesh__D001928 Brain Metabolic Disorder
% 210.86/211.02  |- skos__altLabel mesh__D001928 Metabolic Disorders, Brain
% 210.86/211.02  |- mesh__dateEstablished mesh__D001928 1977-01-01
% 210.86/211.02  |- skos__hiddenLabel mesh__D001928 Metabolic Brain Disease
% 210.86/211.02  |- skos__annotation mesh__D001928
% 210.86/211.02       GEN; avoid: prefer specifics; DF: BRAIN DIS METAB   
% 210.86/211.02  |- mesh__historyNote mesh__D001928 1977; was NON MESH before 1977   
% 210.86/211.02  |- skos__altLabel mesh__D001928 Metabolic Brain Syndromes
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D001928 2003
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D001928 2002
% 210.86/211.02  |- skos__broader mesh__D001928smesh__D001927
% 210.86/211.02  |- skos__altLabel mesh__D001928 Metabolic Encephalopathies
% 210.86/211.02  |- skos__historyNote mesh__D001928 Brain Diseases %28%1966-1976%29%
% 210.86/211.02  |- skos__hiddenLabel mesh__D001928 Brain Metabolic Disorders
% 210.86/211.02  |- skos__hiddenLabel mesh__D001928 Metabolic Brain Disorders
% 210.86/211.02  |- skos__altLabel mesh__D001928 Metabolic Brain Diseases
% 210.86/211.02  |- skos__prefLabel mesh__D001928 Brain Diseases, Metabolic
% 210.86/211.02  |- skos__altLabel mesh__D001928 Metabolic Disorders, CNS, Acquired
% 210.86/211.02  |- skos__hiddenLabel mesh__D001928 Metabolic Disorder, CNS
% 210.86/211.02  |- skos__altLabel mesh__D001928 Encephalopathy, Metabolic, Acquired
% 210.86/211.02  |- skos__scopeNote mesh__D001928
% 210.86/211.02       Acquired or inborn metabolic diseases that produce brain dysfunction or damage. These include primary %28%i.e., disorders intrinsic to the brain%29% and secondary %28%i.e., extracranial%29% metabolic conditions that adversely affect cerebral function.%A%    
% 210.86/211.02  |- skos__altLabel mesh__D001928 Metabolic Disorders, CNS
% 210.86/211.02  |- skos__hiddenLabel mesh__D001928 Metabolic Brain Disorder
% 210.86/211.02  |- skos__hiddenLabel mesh__D001928 Encephalopathy, Metabolic
% 210.86/211.02  |- skos__hiddenLabel mesh__D001928 Metabolic Disorder, Brain
% 210.86/211.02  |- skos__altLabel mesh__D001928 CNS Metabolic Disorders, Acquired
% 210.86/211.02  |- skos__hiddenLabel mesh__D001928 Encephalopathy, Acquired Metabolic
% 210.86/211.02  |- skos__altLabel mesh__D001928 Metabolic Brain Syndrome, Acquired
% 210.86/211.02  |- skos__hiddenLabel mesh__D001928 Brain Disorder, Metabolic
% 210.86/211.02  |- mesh__recordMaintainer mesh__D001928 nns
% 210.86/211.02  |- skos__hiddenLabel mesh__D001928 Encephalopathies, Acquired Metabolic
% 210.86/211.02  |- skos__altLabel mesh__D001928 Metabolic Brain Syndrome
% 210.86/211.02  |- rdf__type mesh__D001928sskos__Concept
% 210.86/211.02  |- skos__altLabel mesh__D001928 CNS Metabolic Disorders
% 210.86/211.02  |- skos__altLabel mesh__D001928 Brain Syndrome, Metabolic, Acquired
% 210.86/211.02  |- skos__altLabel mesh__D001928 Brain Disorders, Metabolic, Acquired
% 210.86/211.02  |- skos__hiddenLabel mesh__D001928 Brain Disease, Metabolic
% 210.86/211.02  |- skos__broader mesh__D001928smesh__D008659
% 210.86/211.02  |- skos__altLabel mesh__D001928
% 210.86/211.02       Metabolic Diseases, Acquired, Nervous System
% 210.86/211.02  |- skos__altLabel mesh__D001928 Brain Disorders, Metabolic
% 210.86/211.02  |- mesh__dateRevised mesh__D001928 2001-07-25
% 210.86/211.02  |- skos__altLabel mesh__D001928 Nervous System Acquired Metabolic Diseases
% 210.86/211.02  |- skos__hiddenLabel mesh__D001928 Metabolic Encephalopathy
% 210.86/211.02  |- skos__altLabel mesh__D001928 Acquired Metabolic Encephalopathies
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D001928 2006
% 210.86/211.02  |- skos__altLabel mesh__D001928 Metabolic Disorders, Central Nervous System
% 210.86/211.02  |- skos__hiddenLabel mesh__D001928 Acquired Metabolic Encephalopathy
% 210.86/211.02  |- skos__altLabel mesh__D001928 Metabolic Brain Syndromes, Acquired
% 210.86/211.02  |- skos__hiddenLabel mesh__D001928 CNS Metabolic Disorder
% 210.86/211.02  |- mesh__recordOriginator mesh__D001928 NLM
% 210.86/211.02  |- mesh__publicMeSHNote mesh__D001928 1977   
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D001928 2005
% 210.86/211.02  |- skos__altLabel mesh__D001928 Brain Syndrome, Metabolic
% 210.86/211.02  |- skos__hiddenLabel mesh__D001928 Metabolic Encephalopathy, Acquired
% 210.86/211.02  |- skos__hiddenLabel mesh__D001928 Metabolic Encephalopathies, Acquired
% 210.86/211.02  |- skos__altLabel mesh__D001928 Acquired Metabolic Diseases, Brain
% 210.86/211.02  |- mesh__recordAuthorizer mesh__D001928 sjn
% 210.86/211.02  |- skos__altLabel mesh__D001928 Metabolic Brain Diseases, Acquired
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D001928 2004
% 210.86/211.02  |- skos__broader mesh__D002645Q000196smesh__D002645
% 210.86/211.02  |- mesh__preferredCombination mesh__D002645Q000196smesh__D002642
% 210.86/211.02  |- rdf__type mesh__D002645Q000196smesh__CompoundConcept
% 210.86/211.02  |- skos__hiddenLabel mesh__D012650 Disclosure, Self
% 210.86/211.02  |- rdf__type mesh__D012650sskos__Concept
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D012650 1991
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D012650 2003
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D012650 1996
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D012650 2004
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D012650 1992
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D012650 1997
% 210.86/211.02  |- skos__scopeNote mesh__D012650
% 210.86/211.02       A willingness to reveal information about oneself to others.%A%    
% 210.86/211.02  |- mesh__publicMeSHNote mesh__D012650
% 210.86/211.02       79; was see under SELF CONCEPT 1969-78   
% 210.86/211.02  |- mesh__dateRevised mesh__D012650 1989-05-16
% 210.86/211.02  |- skos__hiddenLabel mesh__D012650 Disclosures, Self
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D012650 2005
% 210.86/211.02  |- mesh__recordAuthorizer mesh__D012650 PLS
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D012650 1993
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D012650 1998
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D012650 2006
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D012650 2000
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D012650 1994
% 210.86/211.02  |- skos__hiddenLabel mesh__D012650 Self Disclosures
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D012650 1999
% 210.86/211.02  |- mesh__recordMaintainer mesh__D012650 TGC
% 210.86/211.02  |- mesh__recordOriginator mesh__D012650 NLM
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D012650 2001
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D012650 1995
% 210.86/211.02  |- skos__broader mesh__D012650smesh__D012649
% 210.86/211.02  |- skos__historyNote mesh__D012650 Self Concept %28%1969-1974%29%
% 210.86/211.02  |- skos__annotation mesh__D012650
% 210.86/211.02       %22%a willingness to reveal information about oneself to others%22%; no qualif%A%  
% 210.86/211.02  |- mesh__dateCreated mesh__D012650 1999-01-01
% 210.86/211.02  |- mesh__historyNote mesh__D012650
% 210.86/211.02       79%28%75%29%; was see under SELF CONCEPT 1969-78   
% 210.86/211.02  |- skos__prefLabel mesh__D012650 Self Disclosure
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D012650 2002
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D012650 1990
% 210.86/211.02  |- mesh__onlineNote mesh__D012650 search SELF CONCEPT 1969-74   
% 210.86/211.02  |- mesh__dateEstablished mesh__D012650 1979-01-01
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D006613 1997
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D006613 1994
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D006613 1999
% 210.86/211.02  |- mesh__publicMeSHNote mesh__D006613 65   
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D006613 1993
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D006613 1995
% 210.86/211.02  |- skos__hiddenLabel mesh__D006613 Activity, Higher Nervous
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D006613 2002
% 210.86/211.02  |- mesh__historyNote mesh__D006613 65%28%64%29%   
% 210.86/211.02  |- skos__annotation mesh__D006613
% 210.86/211.02       this expression is found intact as %22%vysshaia nervnaia deiatel%27%nost%22% in Russian neurophysiol lit%A%  
% 210.86/211.02  |- mesh__recordMaintainer mesh__D006613 TAP
% 210.86/211.02  |- rdf__type mesh__D006613sskos__Concept
% 210.86/211.02  |- skos__hiddenLabel mesh__D006613 Nervous Activity, Higher
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D006613 2003
% 210.86/211.02  |- mesh__dateEstablished mesh__D006613 1965-01-01
% 210.86/211.02  |- skos__hiddenLabel mesh__D006613 Nervous Activities, Higher
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D006613 2000
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D006613 2005
% 210.86/211.02  |- skos__hiddenLabel mesh__D006613 Higher Nervous Activities
% 210.86/211.02  |- mesh__dateCreated mesh__D006613 1999-01-01
% 210.86/211.02  |- skos__hiddenLabel mesh__D006613 Activities, Higher Nervous
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D006613 2004
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D006613 1996
% 210.86/211.02  |- mesh__dateRevised mesh__D006613 1992-05-15
% 210.86/211.02  |- mesh__recordAuthorizer mesh__D006613 PLS
% 210.86/211.02  |- mesh__recordOriginator mesh__D006613 NLM
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D006613 2001
% 210.86/211.02  |- skos__prefLabel mesh__D006613 Higher Nervous Activity
% 210.86/211.02  |- skos__broader mesh__D006613smesh__D009424
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D006613 2006
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D006613 1998
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D011558 2005
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D011558 2002
% 210.86/211.02  |- skos__hiddenLabel mesh__D011558 Herpesvirus 1, Swine
% 210.86/211.02  |- skos__historyNote mesh__D011558 Herpesviridae %28%1966-1974%29%
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D011558 2006
% 210.86/211.02  |- skos__altLabel mesh__D011558 Herpesvirus 1 %28%alpha%29%, Suid
% 210.86/211.02  |- skos__prefLabel mesh__D011558 Herpesvirus 1, Suid
% 210.86/211.02  |- mesh__dateEstablished mesh__D011558 1980-01-01
% 210.86/211.02  |- skos__altLabel mesh__D011558 Pseudorabies virus
% 210.86/211.02  |- skos__altLabel mesh__D011558 Aujeszky Disease Virus
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D011558 2003
% 210.86/211.02  |- skos__annotation mesh__D011558 infection = PSEUDORABIES   
% 210.86/211.02  |- rdf__type mesh__D011558sskos__Concept
% 210.86/211.02  |- skos__hiddenLabel mesh__D011558 Pseudorabies viruses
% 210.86/211.02  |- mesh__dateRevised mesh__D011558 2001-07-25
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D011558 2004
% 210.86/211.02  |- mesh__onlineNote mesh__D011558
% 210.86/211.02       use HERPESVIRUS 1, SUID to search HERPESVIRUS SUIS 1975-93 %26% PSEUDORABIES VIRUS 1966-93%A%  
% 210.86/211.02  |- skos__altLabel mesh__D011558 Swine Herpesvirus 1
% 210.86/211.02  |- skos__altLabel mesh__D011558 Herpesvirus Suis
% 210.86/211.02  |- skos__hiddenLabel mesh__D011558 Aujeszkys Disease Virus
% 210.86/211.02  |- skos__altLabel mesh__D011558 Suid herpesvirus 1
% 210.86/211.02  |- mesh__recordOriginator mesh__D011558 NLM
% 210.86/211.02  |- mesh__publicMeSHNote mesh__D011558
% 210.86/211.02       94; was PSEUDORABIES VIRUS 1963-93 %28%see under HERPESVIRUSES 1975-79, see under HERPESVIRUS 1963-74%29%; HERPESVIRUS SUIS was see PSEUDORABIES VIRUS 1975-93%A%  
% 210.86/211.02  |- mesh__dateCreated mesh__D011558 1999-01-01
% 210.86/211.02  |- mesh__recordAuthorizer mesh__D011558 sjn
% 210.86/211.02  |- skos__scopeNote mesh__D011558
% 210.86/211.02       A species of VARICELLOVIRUS producing a respiratory infection %28%PSEUDORABIES%29% in swine, its natural host. It also produces an usually fatal ENCEPHALOMYELITIS in cattle, sheep, dogs, cats, foxes, and mink.%A%    
% 210.86/211.02  |- skos__broader mesh__D011558smesh__D018140
% 210.86/211.02  |- mesh__historyNote mesh__D011558
% 210.86/211.02       94; was PSEUDORABIES VIRUS 1963-93 %28%see under HERPESVIRUSES 1975-79, see under HERPESVIRUS 1963-74%29%; HERPESVIRUS SUIS was see PSEUDORABIES VIRUS 1975-93%A%  
% 210.86/211.02  |- mesh__recordMaintainer mesh__D011558 ags
% 210.86/211.02  |- skos__altLabel mesh__D011558 Aujeszky%27%s Disease Virus
% 210.86/211.02  |- mesh__recordOriginator mesh__D016243 TGC
% 210.86/211.02  |- mesh__dateRevised mesh__D016243 1992-03-25
% 210.86/211.02  |- skos__broader mesh__D016243smesh__D007998
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016243 2002
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016243 1995
% 210.86/211.02  |- skos__scopeNote mesh__D016243
% 210.86/211.02       Development of a library collection, including the determination and coordination of selection policy, assessment of needs of users and potential users, collection use studies, collection evaluation, identification of collection needs, selection of materials, planning for resource sharing, collection maintenance and weeding, and budgeting.%A%    
% 210.86/211.02  |- skos__hiddenLabel mesh__D016243
% 210.86/211.02       Developments, Collection %28%Libraries%29%
% 210.86/211.02  |- skos__altLabel mesh__D016243 Collection Development %28%Libraries%29%
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016243 1994
% 210.86/211.02  |- mesh__recordMaintainer mesh__D016243 TAP
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016243 1993
% 210.86/211.02  |- mesh__recordAuthorizer mesh__D016243 PLS
% 210.86/211.02  |- skos__historyNote mesh__D016243 Book Selection %28%1966-1990%29%
% 210.86/211.02  |- mesh__dateEstablished mesh__D016243 1991-01-01
% 210.86/211.02  |- skos__hiddenLabel mesh__D016243 Development, Library Collection
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016243 1999
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016243 2006
% 210.86/211.02  |- skos__hiddenLabel mesh__D016243 Collection Development, Library
% 210.86/211.02  |- skos__prefLabel mesh__D016243 Library Collection Development
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016243 2001
% 210.86/211.02  |- skos__hiddenLabel mesh__D016243
% 210.86/211.02       Development, Collection %28%Libraries%29%
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016243 1998
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016243 2005
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016243 1997
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016243 2004
% 210.86/211.02  |- skos__hiddenLabel mesh__D016243
% 210.86/211.02       Collection Developments %28%Libraries%29%
% 210.86/211.02  |- mesh__historyNote mesh__D016243 91   
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016243 2000
% 210.86/211.02  |- mesh__publicMeSHNote mesh__D016243 91   
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016243 1996
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D016243 2003
% 210.86/211.02  |- skos__annotation mesh__D016243 DF: COLLECTION DEVELOPMENT   
% 210.86/211.02  |- rdf__type mesh__D016243sskos__Concept
% 210.86/211.02  |- mesh__dateCreated mesh__D016243 1990-05-07
% 210.86/211.02  |- skos__historyNote mesh__D002223 Carbamates %28%1974%29%
% 210.86/211.02  |- skos__annotation mesh__D002223 DF: GLUTAMINE CP SYNTHASE   
% 210.86/211.02  |- skos__hiddenLabel mesh__D002223 Synthetase II, Carbamoylphosphate
% 210.86/211.02  |- mesh__recordAuthorizer mesh__D002223 sjn
% 210.86/211.02  |- mesh__recordOriginator mesh__D002223 NLM
% 210.86/211.02  |- skos__prefLabel mesh__D002223
% 210.86/211.02       Carbamoyl-Phosphate Synthase %28%Glutamine-Hydrolyzing%29%
% 210.86/211.02  |- rdf__type mesh__D002223sskos__Concept
% 210.86/211.02  |- skos__altLabel mesh__D002223
% 210.86/211.02       Carbamoyl-Phosphate Synthase %28%Glutamine%29%
% 210.86/211.02  |- mesh__recordMaintainer mesh__D002223 ssb
% 210.86/211.02  |- mesh__dateEstablished mesh__D002223 1989-01-01
% 210.86/211.02  |- skos__historyNote mesh__D002223 Phosphotransferases, ATP %28%1974%29%
% 210.86/211.02  |- skos__historyNote mesh__D002223 Glutamine %28%1974%29%
% 210.86/211.02  |- skos__altLabel mesh__D002223 Carbamoylphosphate Synthetase II
% 210.86/211.02  |- mesh__publicMeSHNote mesh__D002223
% 210.86/211.02       98; see CARBAMYL PHOSPHATE SYNTHASE %28%GLUTAMINE%29% 1989-97; see LIGASES 1981-88; see PHOSPHOTRANSFERASES, ATP 1975-80%A%  
% 210.86/211.02  |- skos__altLabel mesh__D002223
% 210.86/211.02       Carbamyl-Phosphate Synthase %28%Glutamine%29%
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D002223 2005
% 210.86/211.02  |- mesh__historyNote mesh__D002223 98%28%75%29%   
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D002223 2004
% 210.86/211.02  |- mesh__activeMeSHYear mesh__D002223 2006
% 210.86/211.02  |- skos__broader mesh__D002223smesh__D019733
% 210.86/211.02  |- mesh__dateCreated mesh__D002223 1974-11-19
% 210.86/211.02  |- skos__altLabel mesh__D002223
% 210.86/211.02       Carbamyl Phosphate Synthase %28%Glutamine%29%
% 210.86/211.02  |- skos__scopeNote mesh__D002223
% 210.86/211.02       An enzyme that catalyzes the formation of carbamoyl phosphate from ATP, carbon dioxide, and glutamine. This enzyme is important in the de novo biosynthesis of pyrimidines. EC 6.3.5.5.%A%    
% 210.86/211.02  |- mesh__dateRevised mesh__D002223 2003-07-09
% 210.86/211.03  |- skos__prefLabel mesh__D029969 Angelica
% 210.86/211.03  |- mesh__historyNote mesh__D029969 2002   
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D029969 2006
% 210.86/211.03  |- mesh__publicMeSHNote mesh__D029969 2002   
% 210.86/211.03  |- mesh__dateCreated mesh__D029969 2001-07-25
% 210.86/211.03  |- skos__scopeNote mesh__D029969 A plant genus of the family Apiaceae.     
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D029969 2002
% 210.86/211.03  |- mesh__dateEstablished mesh__D029969 2002-01-01
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D029969 2003
% 210.86/211.03  |- skos__broader mesh__D029969smesh__D019661
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D029969 2005
% 210.86/211.03  |- rdf__type mesh__D029969sskos__Concept
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D029969 2004
% 210.86/211.03  |- skos__annotation mesh__D029969
% 210.86/211.03       GEN or unspecified; prefer specifics; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.86/211.03  |- skos__annotation mesh__D015949 /defic = CHRISTMAS DISEASE   
% 210.86/211.03  |- mesh__recordMaintainer mesh__D015949 ssb
% 210.86/211.03  |- skos__altLabel mesh__D015949 Blood Coagulation Factor IX, Activated
% 210.86/211.03  |- mesh__recordAuthorizer mesh__D015949 sjn
% 210.86/211.03  |- mesh__recordOriginator mesh__D015949 AGS
% 210.86/211.03  |- skos__broader mesh__D015949smesh__D005164
% 210.86/211.03  |- mesh__publicMeSHNote mesh__D015949 90   
% 210.86/211.03  |- skos__altLabel mesh__D015949 Coagulation Factor IXa
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D015949 2006
% 210.86/211.03  |- skos__altLabel mesh__D015949 Factor IX, Activated
% 210.86/211.03  |- mesh__historyNote mesh__D015949 90   
% 210.86/211.03  |- skos__scopeNote mesh__D015949
% 210.86/211.03       Activated form of factor IX. This activation can take place via the intrinsic pathway by the action of factor XIa and calcium, or via the extrinsic pathway by the action of factor VIIa, thromboplastin, and calcium. Factor IXa serves to activate factor X to Xa by cleaving the arginyl-leucine peptide bond in factor X.%A%    
% 210.86/211.03  |- rdf__type mesh__D015949sskos__Concept
% 210.86/211.03  |- mesh__dateRevised mesh__D015949 2005-06-30
% 210.86/211.03  |- skos__hiddenLabel mesh__D015949 Activated Factor IX
% 210.86/211.03  |- skos__hiddenLabel mesh__D015949 Factor IXa, Coagulation
% 210.86/211.03  |- skos__broader mesh__D015949smesh__D012697
% 210.86/211.03  |- skos__related mesh__D015949smesh__D003029
% 210.86/211.03  |- mesh__dateEstablished mesh__D015949 1990-01-01
% 210.86/211.03  |- skos__hiddenLabel mesh__D015949 IXa, Coagulation Factor
% 210.86/211.03  |- skos__historyNote mesh__D015949 Factor IX %28%1975-1989%29%
% 210.86/211.03  |- mesh__dateCreated mesh__D015949 1989-07-14
% 210.86/211.03  |- skos__historyNote mesh__D015949 Serine Proteinases %28%1988-1989%29%
% 210.86/211.03  |- skos__prefLabel mesh__D015949 Factor IXa
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D040342 2006
% 210.86/211.03  |- mesh__dateRevised mesh__D040342 2003-07-09
% 210.86/211.03  |- skos__hiddenLabel mesh__D040342 Structures, Genetic
% 210.86/211.03  |- mesh__dateCreated mesh__D040342 2002-07-03
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D040342 2005
% 210.86/211.03  |- mesh__recordMaintainer mesh__D040342 nns
% 210.86/211.03  |- skos__hiddenLabel mesh__D040342 Genetic Structure
% 210.86/211.03  |- skos__related mesh__D040342smesh__D005823
% 210.86/211.03  |- mesh__publicMeSHNote mesh__D040342 2003   
% 210.86/211.03  |- mesh__historyNote mesh__D040342 2003   
% 210.86/211.03  |- skos__annotation mesh__D040342 GEN only; avoid: prefer specifics   
% 210.86/211.03  |- skos__related mesh__D040342smesh__D039361
% 210.86/211.03  |- mesh__dateEstablished mesh__D040342 2003-01-01
% 210.86/211.03  |- mesh__recordOriginator mesh__D040342 nns
% 210.86/211.03  |- skos__prefLabel mesh__D040342 Genetic Structures
% 210.86/211.03  |- mesh__recordAuthorizer mesh__D040342 sjn
% 210.86/211.03  |- skos__scopeNote mesh__D040342
% 210.86/211.03       The biological objects that contain genetic information and that are involved in transmitting genetically encoded traits from one organism to another.%A%    
% 210.86/211.03  |- mesh__runningHead mesh__D040342 G14 - GENETIC STRUCTURES   
% 210.86/211.03  |- skos__related mesh__D040342smesh__D040341
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D040342 2004
% 210.86/211.03  |- skos__hiddenLabel mesh__D040342 Structure, Genetic
% 210.86/211.03  |- rdf__type mesh__D040342sskos__Concept
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D001929 2003
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D001929 2001
% 210.86/211.03  |- rdf__type mesh__D001929sskos__Concept
% 210.86/211.03  |- skos__hiddenLabel mesh__D001929 Brain Edema, Vasogenic
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D001929 2005
% 210.86/211.03  |- mesh__dateRevised mesh__D001929 1999-11-04
% 210.86/211.03  |- skos__hiddenLabel mesh__D001929 Edema, Cerebral
% 210.86/211.03  |- skos__hiddenLabel mesh__D001929 Edema, Brain
% 210.86/211.03  |- skos__altLabel mesh__D001929 Intracranial Edema
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D001929 2004
% 210.86/211.03  |- skos__hiddenLabel mesh__D001929 Edema, Vasogenic Cerebral
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D001929 2006
% 210.86/211.03  |- skos__hiddenLabel mesh__D001929 Brain Swellings
% 210.86/211.03  |- skos__hiddenLabel mesh__D001929 Edema, Cytotoxic Brain
% 210.86/211.03  |- skos__hiddenLabel mesh__D001929 Edema, Intracranial
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D001929 2002
% 210.86/211.03  |- mesh__dateCreated mesh__D001929 1999-01-01
% 210.86/211.03  |- mesh__recordAuthorizer mesh__D001929 sjn
% 210.86/211.03  |- skos__broader mesh__D001929smesh__D001927
% 210.86/211.03  |- skos__related mesh__D001929smesh__D019586
% 210.86/211.03  |- skos__hiddenLabel mesh__D001929 Edema, Cytotoxic Cerebral
% 210.86/211.03  |- skos__altLabel mesh__D001929 Cerebral Edema, Cytotoxic
% 210.86/211.03  |- mesh__recordOriginator mesh__D001929 NLM
% 210.86/211.03  |- skos__hiddenLabel mesh__D001929 Brain Edema, Cytotoxic
% 210.86/211.03  |- skos__prefLabel mesh__D001929 Brain Edema
% 210.86/211.03  |- skos__scopeNote mesh__D001929
% 210.86/211.03       Increased intracellular or extracellular fluid in brain tissue. Cytotoxic brain edema %28%swelling due to increased intracellular fluid%29% is indicative of a disturbance in cell metabolism, and is commonly associated with hypoxic or ischemic injuries %28%see HYPOXIA, BRAIN%29%. An increase in extracellular fluid may be caused by increased brain capillary permeability %28%vasogenic edema%29%, an osmotic gradient, local blockages in interstitial fluid pathways, or by obstruction of CSF flow %28%e.g., obstructive HYDROCEPHALUS%29%. %28%From Childs Nerv Syst 1992 Sep; 8%28%6%29%:301-6%29%%A%    
% 210.86/211.03  |- mesh__historyNote mesh__D001929 1965%28%1964%29%   
% 210.86/211.03  |- mesh__recordMaintainer mesh__D001929 KEV
% 210.86/211.03  |- skos__hiddenLabel mesh__D001929 Edema, Vasogenic Brain
% 210.86/211.03  |- skos__altLabel mesh__D001929 Cerebral Edema, Vasogenic
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D001929 2000
% 210.86/211.03  |- mesh__publicMeSHNote mesh__D001929 1965   
% 210.86/211.03  |- skos__hiddenLabel mesh__D001929 Cerebral Edemas, Vasogenic
% 210.86/211.03  |- mesh__dateEstablished mesh__D001929 1965-01-01
% 210.86/211.03  |- skos__hiddenLabel mesh__D001929 Swelling, Brain
% 210.86/211.03  |- skos__altLabel mesh__D001929 Brain Swelling
% 210.86/211.03  |- skos__hiddenLabel mesh__D012651 Medication, Self
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D012651 2005
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D012651 1998
% 210.86/211.03  |- mesh__recordMaintainer mesh__D012651 KEV
% 210.86/211.03  |- mesh__recordOriginator mesh__D012651 NLM
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D012651 2000
% 210.86/211.03  |- mesh__dateRevised mesh__D012651 1995-05-23
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D012651 2004
% 210.86/211.03  |- rdf__type mesh__D012651sskos__Concept
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D012651 1997
% 210.86/211.03  |- skos__hiddenLabel mesh__D012651 Medications, Self
% 210.86/211.03  |- mesh__dateEstablished mesh__D012651 1968-01-01
% 210.86/211.03  |- mesh__recordAuthorizer mesh__D012651 PLS
% 210.86/211.03  |- mesh__historyNote mesh__D012651 68%28%65%29%   
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D012651 2003
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D012651 1996
% 210.86/211.03  |- skos__prefLabel mesh__D012651 Self Medication
% 210.86/211.03  |- skos__scopeNote mesh__D012651
% 210.86/211.03       The self administration of medication not prescribed by a physician or in a manner not directed by a physician.%A%    
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D012651 2002
% 210.86/211.03  |- mesh__dateCreated mesh__D012651 1999-01-01
% 210.86/211.03  |- skos__broader mesh__D012651smesh__D004358
% 210.86/211.03  |- skos__broader mesh__D012651smesh__D012648
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D012651 2006
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D012651 1999
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D012651 2001
% 210.86/211.03  |- mesh__publicMeSHNote mesh__D012651 68   
% 210.86/211.03  |- skos__hiddenLabel mesh__D012651 Self Medications
% 210.86/211.03  |- skos__annotation mesh__D012651
% 210.86/211.03       differentiate from SELF ADMINISTRATION %26% SELF CARE %28%see note there%29%%A%  
% 210.86/211.03  |- mesh__publicMeSHNote mesh__D006614 1968   
% 210.86/211.03  |- rdf__type mesh__D006614sskos__Concept
% 210.86/211.03  |- mesh__recordAuthorizer mesh__D006614 ags
% 210.86/211.03  |- mesh__historyNote mesh__D006614 1968   
% 210.86/211.03  |- skos__annotation mesh__D006614
% 210.86/211.03       non-primate vertebrates only; for primates use LEG   
% 210.86/211.03  |- mesh__recordOriginator mesh__D006614 NLM
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D006614 2003
% 210.86/211.03  |- skos__scopeNote mesh__D006614
% 210.86/211.03       Either of two extremities of four-footed non-primate land animals. It usually consists of a FEMUR; TIBIA; and FIBULA; tarsals; METATARSALS; and TOES. %28%From Storer et al., General Zoology, 6th ed, p73%29%%A%    
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D006614 2006A
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D006614 2005
% 210.86/211.03  |- mesh__dateCreated mesh__D006614 1999-01-01
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D006614 2004
% 210.86/211.03  |- mesh__recordMaintainer mesh__D006614 ags
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D006614 2006
% 210.86/211.03  |- skos__hiddenLabel mesh__D006614 Hindlimbs
% 210.86/211.03  |- skos__prefLabel mesh__D006614 Hindlimb
% 210.86/211.03  |- mesh__dateRevised mesh__D006614 2005-07-13
% 210.86/211.03  |- skos__historyNote mesh__D006614 Extremities %28%1966-1967%29%
% 210.86/211.03  |- skos__broader mesh__D006614smesh__D000825
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D006614 2002
% 210.86/211.03  |- mesh__dateEstablished mesh__D006614 1968-01-01
% 210.86/211.03  |- skos__historyNote mesh__D006614 Leg %28%1966-1967%29%
% 210.86/211.03  |- skos__hiddenLabel mesh__D050770 Dehydrogenase, Glutaryl-Coenzyme A
% 210.86/211.03  |- skos__hiddenLabel mesh__D050770 Dehydrogenase, Glutaryl CoA
% 210.86/211.03  |- skos__altLabel mesh__D050770 Glutaryl CoA Dehydrogenase
% 210.86/211.03  |- mesh__dateEstablished mesh__D050770 2006-01-01
% 210.86/211.03  |- mesh__publicMeSHNote mesh__D050770
% 210.86/211.03       2006; GLUTARYL-COA DEHYDROGENASE was indexed under ACYL COENZYME A 1973-1979; under GLUTARATES 1973-1982; and under COENZYME A 1973-1979; under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 2004-2005%A%  
% 210.86/211.03  |- skos__hiddenLabel mesh__D050770 Dehydrogenase, Glutaryl-CoA
% 210.86/211.03  |- mesh__dateCreated mesh__D050770 2005-06-30
% 210.86/211.03  |- skos__hiddenLabel mesh__D050770 Glutaryl Coenzyme A Dehydrogenase
% 210.86/211.03  |- skos__historyNote mesh__D050770 Glutarates %28%1973-1980%29%
% 210.86/211.03  |- skos__historyNote mesh__D050770 Coenzymes %28%1973-1979%29%
% 210.86/211.03  |- skos__historyNote mesh__D050770 Oxidoreductases %28%1983-2003%29%
% 210.86/211.03  |- skos__scopeNote mesh__D050770
% 210.86/211.03       A flavoprotein enzyme that is responsible for the catabolism of LYSINE; HYDROXYLYSINE; and TRYPTOPHAN. It catalyzes the oxidation of GLUTARYL-CoA to crotonoyl-CoA using FAD as a cofactor. Glutaric aciduria type I is an inborn error of metabolism due to the deficiency of glutaryl-CoA dehydrogenase.%A%    
% 210.86/211.03  |- mesh__recordOriginator mesh__D050770 AKE
% 210.86/211.03  |- skos__hiddenLabel mesh__D050770 CoA Dehydrogenase, Glutaryl
% 210.86/211.03  |- skos__broader mesh__D050770smesh__D044925
% 210.86/211.03  |- skos__historyNote mesh__D050770
% 210.86/211.03       Oxidoreductases Acting on CH-CH Group Donors %28%2004-2005%29%
% 210.86/211.03  |- skos__prefLabel mesh__D050770 Glutaryl-CoA Dehydrogenase
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D050770 2006
% 210.86/211.03  |- skos__historyNote mesh__D050770 Acyl Coenzyme A %28%1973-1979%29%
% 210.86/211.03  |- mesh__recordMaintainer mesh__D050770 AKE
% 210.86/211.03  |- mesh__recordAuthorizer mesh__D050770 sjn
% 210.86/211.03  |- rdf__type mesh__D050770sskos__Concept
% 210.86/211.03  |- mesh__historyNote mesh__D050770 2006%28%1973%29%   
% 210.86/211.03  |- skos__altLabel mesh__D050770 Glutaryl-Coenzyme A Dehydrogenase
% 210.86/211.03  |- mesh__recordAuthorizer mesh__D011559 ags
% 210.86/211.03  |- mesh__recordOriginator mesh__D011559 NLM
% 210.86/211.03  |- mesh__dateCreated mesh__D011559 1999-01-01
% 210.86/211.03  |- skos__hiddenLabel mesh__D011559 Hypertension, Benign Intracranial
% 210.86/211.03  |- skos__altLabel mesh__D011559 Idiopathic Intracranial Hypertension
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D011559 2000A
% 210.86/211.03  |- mesh__dateRevised mesh__D011559 1999-12-08
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D011559 2001
% 210.86/211.03  |- mesh__publicMeSHNote mesh__D011559 1973   
% 210.86/211.03  |- mesh__dateEstablished mesh__D011559 1973-01-01
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D011559 2006
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D011559 2000
% 210.86/211.03  |- mesh__historyNote mesh__D011559 1973%28%1964%29%   
% 210.86/211.03  |- skos__altLabel mesh__D011559 Benign Intracranial Hypertension
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D011559 2004
% 210.86/211.03  |- skos__altLabel mesh__D011559 Intracranial Hypertension, Benign
% 210.86/211.03  |- rdf__type mesh__D011559sskos__Concept
% 210.86/211.03  |- skos__hiddenLabel mesh__D011559 Hypertension, Idiopathic Intracranial
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D011559 2005
% 210.86/211.03  |- skos__hiddenLabel mesh__D011559 Intracranial Hypertension, Idiopathic
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D011559 2003
% 210.86/211.03  |- skos__broader mesh__D011559smesh__D019586
% 210.86/211.03  |- skos__scopeNote mesh__D011559
% 210.86/211.03       A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury %28%see OPTIC NERVE DISEASES%29% and visual loss %28%see BLINDNESS%29%.%A%    
% 210.86/211.03  |- skos__prefLabel mesh__D011559 Pseudotumor Cerebri
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D011559 2002
% 210.86/211.03  |- skos__annotation mesh__D011559 note category: non-neopl   
% 210.86/211.03  |- mesh__recordMaintainer mesh__D011559 ags
% 210.86/211.03  |- skos__hiddenLabel mesh__D022281 Vaccines, Shigella
% 210.86/211.03  |- mesh__recordMaintainer mesh__D022281 ssb
% 210.86/211.03  |- mesh__recordOriginator mesh__D022281 ags
% 210.86/211.03  |- mesh__dateCreated mesh__D022281 2000-06-22
% 210.86/211.03  |- skos__broader mesh__D022281smesh__D001428
% 210.86/211.03  |- skos__scopeNote mesh__D022281
% 210.86/211.03       Vaccines or candidate vaccines used to prevent bacillary dysentery %28%DYSENTERY, BACILLARY%29% caused by species of SHIGELLA.%A%    
% 210.86/211.03  |- skos__historyNote mesh__D022281 Bacterial Vaccines %28%1967-2000%29%
% 210.86/211.03  |- mesh__historyNote mesh__D022281 2001   
% 210.86/211.03  |- skos__related mesh__D022281smesh__D012762
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D022281 2006
% 210.86/211.03  |- rdf__type mesh__D022281sskos__Concept
% 210.86/211.03  |- mesh__dateEstablished mesh__D022281 2001-01-01
% 210.86/211.03  |- mesh__dateRevised mesh__D022281 2005-06-30
% 210.86/211.03  |- skos__annotation mesh__D022281
% 210.86/211.03       coord IM with specific Shigella species /immunol %28%IM%29%   
% 210.86/211.03  |- mesh__publicMeSHNote mesh__D022281 2001   
% 210.86/211.03  |- skos__prefLabel mesh__D022281 Shigella Vaccines
% 210.86/211.03  |- mesh__recordAuthorizer mesh__D022281 sjn
% 210.86/211.03  |- skos__annotation mesh__D016244 /biosyn /physiol permitted   
% 210.86/211.03  |- mesh__recordAuthorizer mesh__D016244 sjn
% 210.86/211.03  |- mesh__publicMeSHNote mesh__D016244 91   
% 210.86/211.03  |- mesh__dateEstablished mesh__D016244 1991-01-01
% 210.86/211.03  |- skos__scopeNote mesh__D016244
% 210.86/211.03       Guanosine 5%27%-%28%trihydrogen diphosphate%29%, monoanhydride with phosphorothioic acid. A stable GTP analog which enjoys a variety of physiological actions such as stimulation of guanine nucleotide-binding proteins, phosphoinositide hydrolysis, cyclic AMP accumulation, and activation of specific proto-oncogenes.%A%    
% 210.86/211.03  |- skos__broader mesh__D016244smesh__D013873
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D016244 2006
% 210.86/211.03  |- skos__altLabel mesh__D016244 GTPgammaS
% 210.86/211.03  |- skos__historyNote mesh__D016244 Thionucleotides %28%1977-1990%29%
% 210.86/211.03  |- skos__broader mesh__D016244smesh__D006160
% 210.86/211.03  |- mesh__dateRevised mesh__D016244 2005-06-30
% 210.86/211.03  |- skos__historyNote mesh__D016244 Guanosine Triphosphate %28%1972-1990%29%
% 210.86/211.03  |- skos__altLabel mesh__D016244 Guanosine 5%27%-%28%gamma-S%29%Triphosphate
% 210.86/211.03  |- mesh__historyNote mesh__D016244 91   
% 210.86/211.03  |- mesh__recordMaintainer mesh__D016244 ssb
% 210.86/211.03  |- rdf__type mesh__D016244sskos__Concept
% 210.86/211.03  |- skos__hiddenLabel mesh__D016244 gamma Thio GTP
% 210.86/211.03  |- mesh__dateCreated mesh__D016244 1990-05-07
% 210.86/211.03  |- skos__altLabel mesh__D016244 gamma-Thio-GTP
% 210.86/211.03  |- skos__altLabel mesh__D016244
% 210.86/211.03       Guanosine 5%27%-%28%3-O-Thio%29%Triphosphate
% 210.86/211.03  |- skos__prefLabel mesh__D016244
% 210.86/211.03       Guanosine 5%27%-O-%28%3-Thiotriphosphate%29%
% 210.86/211.03  |- mesh__recordOriginator mesh__D016244 RLS
% 210.86/211.03  |- skos__altLabel mesh__D016244 GTP gamma S
% 210.86/211.03  |- skos__hiddenLabel mesh__D016244 gamma S, GTP
% 210.86/211.03  |- mesh__recordMaintainer mesh__D002224 TGC
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D002224 2002
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D002224 1994
% 210.86/211.03  |- skos__altLabel mesh__D002224 Diphenylurea Compounds
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D002224 2005
% 210.86/211.03  |- skos__broader mesh__D002224smesh__D000813
% 210.86/211.03  |- mesh__dateRevised mesh__D002224 1992-05-11
% 210.86/211.03  |- mesh__dateEstablished mesh__D002224 1974-01-01
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D002224 1997
% 210.86/211.03  |- skos__prefLabel mesh__D002224 Carbanilides
% 210.86/211.03  |- skos__hiddenLabel mesh__D002224 Compounds, Diphenylurea
% 210.86/211.03  |- mesh__recordAuthorizer mesh__D002224 PLS
% 210.86/211.03  |- rdf__type mesh__D002224sskos__Concept
% 210.86/211.03  |- mesh__recordOriginator mesh__D002224 NLM
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D002224 2001
% 210.86/211.03  |- mesh__dateCreated mesh__D002224 1999-01-01
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D002224 1993
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D002224 2004
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D002224 1996
% 210.86/211.03  |- mesh__publicMeSHNote mesh__D002224 74   
% 210.86/211.03  |- mesh__historyNote mesh__D002224 74%28%72%29%   
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D002224 2000
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D002224 1999
% 210.86/211.03  |- skos__historyNote mesh__D002224 Urea %28%1970-1971%29%
% 210.86/211.03  |- skos__broader mesh__D002224smesh__D010671
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D002224 2003
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D002224 1995
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D002224 2006
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D002224 1998
% 210.86/211.03  |- skos__broader mesh__D006653Q000379smesh__D006653
% 210.86/211.03  |- mesh__preferredCombination mesh__D006653Q000379smesh__D006652
% 210.86/211.03  |- rdf__type mesh__D006653Q000379smesh__CompoundConcept
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D040343 2005
% 210.86/211.03  |- skos__historyNote mesh__D040343 Health Surveys %28%1985-2002%29%
% 210.86/211.03  |- skos__scopeNote mesh__D040343
% 210.86/211.03       Telephone surveys are conducted to monitor prevalence of the major behavioral risks among adults associated with premature MORBIDITY and MORTALITY. The data collected is in regard to actual behaviors, rather than on attitudes or knowledge. The Centers for Disease Control and Prevention %28%CDC%29% established the Behavioral Risk Factor Surveillance System %28%BRFSS%29% in 1984.%A%    
% 210.86/211.03  |- skos__annotation mesh__D040343 CATALOG: Use NAF entry   
% 210.86/211.03  |- mesh__publicMeSHNote mesh__D040343 2003   
% 210.86/211.03  |- skos__prefLabel mesh__D040343 Behavioral Risk Factor Surveillance System
% 210.86/211.03  |- skos__altLabel mesh__D040343 Behavior Risk Factor Surveillance System
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D040343 2004
% 210.86/211.03  |- mesh__historyNote mesh__D040343 2003   
% 210.86/211.03  |- rdf__type mesh__D040343sskos__Concept
% 210.86/211.03  |- skos__broader mesh__D040343smesh__D006306
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D040343 2003
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D040343 2006
% 210.86/211.03  |- mesh__dateCreated mesh__D040343 2002-07-02
% 210.86/211.03  |- mesh__dateEstablished mesh__D040343 2003-01-01
% 210.86/211.03  |- skos__altLabel mesh__D040343 BRFSS
% 210.86/211.03  |- skos__scopeNote mesh__D012652
% 210.86/211.03       The act of injuring one%27%s own body to the extent of cutting off or permanently destroying a limb or other essential part of a body.%A%    
% 210.86/211.03  |- skos__prefLabel mesh__D012652 Self Mutilation
% 210.86/211.03  |- rdf__type mesh__D012652sskos__Concept
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D012652 2004
% 210.86/211.03  |- mesh__dateRevised mesh__D012652 2002-07-03
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D012652 2003
% 210.86/211.03  |- mesh__recordOriginator mesh__D012652 NLM
% 210.86/211.03  |- mesh__recordMaintainer mesh__D012652 JLS
% 210.86/211.03  |- skos__broader mesh__D012652smesh__D016728
% 210.86/211.03  |- mesh__dateCreated mesh__D012652 1999-01-01
% 210.86/211.03  |- mesh__recordAuthorizer mesh__D012652 sjn
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D012652 2006
% 210.86/211.03  |- skos__hiddenLabel mesh__D012652 Mutilation, Self
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D012652 2005
% 210.86/211.03  |- skos__broader mesh__D012652smesh__D014947
% 210.86/211.03  |- skos__annotation mesh__D012652
% 210.86/211.03       SELF-INJURIOUS BEHAVIOR is also available   
% 210.86/211.03  |- rdf__type mesh__D006615sskos__Concept
% 210.86/211.03  |- skos__hiddenLabel mesh__D006615 Coxas
% 210.86/211.03  |- mesh__considerAlso mesh__D006615 consider also terms at COX-   
% 210.86/211.03  |- mesh__recordOriginator mesh__D006615 NLM
% 210.86/211.03  |- mesh__dateRevised mesh__D006615 2002-07-03
% 210.86/211.03  |- mesh__dateCreated mesh__D006615 1999-01-01
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D006615 2003
% 210.86/211.03  |- mesh__recordAuthorizer mesh__D006615 sjn
% 210.86/211.03  |- skos__prefLabel mesh__D006615 Hip
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D006615 2005
% 210.86/211.03  |- skos__altLabel mesh__D006615 Coxa
% 210.86/211.03  |- skos__annotation mesh__D006615
% 210.86/211.03       do not confuse with HIP JOINT or PELVIC BONES %28%os coxae%29%; aseptic or avascular necrosis = FEMUR HEAD NECROSIS; differentiate from HIP JOINT%A%  
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D006615 2004
% 210.86/211.03  |- mesh__recordMaintainer mesh__D006615 lkt
% 210.86/211.03  |- skos__hiddenLabel mesh__D006615 Hips
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D006615 2006
% 210.86/211.03  |- skos__scopeNote mesh__D006615
% 210.86/211.03       The projecting part on each side of the body, formed by the side of the pelvis and the top portion of the femur.%A%    
% 210.86/211.03  |- skos__broader mesh__D006615smesh__D035002
% 210.86/211.03  |- skos__broader mesh__D003585Q000379smesh__D003585
% 210.86/211.03  |- mesh__preferredCombination mesh__D003585Q000379smesh__D003584
% 210.86/211.03  |- rdf__type mesh__D003585Q000379smesh__CompoundConcept
% 210.86/211.03  |- skos__annotation mesh__D022282
% 210.86/211.03       IM general only; coord NIM with specific vaccine %28%IM%29%   
% 210.86/211.03  |- skos__prefLabel mesh__D022282 Vaccines, Acellular
% 210.86/211.03  |- skos__broader mesh__D022282smesh__D022223
% 210.86/211.03  |- mesh__recordMaintainer mesh__D022282 ssb
% 210.86/211.03  |- mesh__dateRevised mesh__D022282 2005-06-30
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D022282 2006
% 210.86/211.03  |- mesh__recordAuthorizer mesh__D022282 sjn
% 210.86/211.03  |- mesh__recordOriginator mesh__D022282 ags
% 210.86/211.03  |- skos__hiddenLabel mesh__D022282 Acellular Vaccines
% 210.86/211.03  |- rdf__type mesh__D022282sskos__Concept
% 210.86/211.03  |- skos__scopeNote mesh__D022282
% 210.86/211.03       Vaccines that are produced by using only the antigenic part of the disease causing organism. They often require a %22%booster%22% every few years to maintain their effectiveness.%A%    
% 210.86/211.03  |- mesh__dateEstablished mesh__D022282 2001-01-01
% 210.86/211.03  |- mesh__dateCreated mesh__D022282 2000-06-21
% 210.86/211.03  |- mesh__historyNote mesh__D022282 2001   
% 210.86/211.03  |- mesh__publicMeSHNote mesh__D022282 2001   
% 210.86/211.03  |- mesh__dateEstablished mesh__D016245 1991-01-01
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D016245 2005
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D016245 2004
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D016245 2001
% 210.86/211.03  |- skos__annotation mesh__D016245
% 210.86/211.03       IM; coord with area of specialism of the librarian %28%IM%29%   
% 210.86/211.03  |- mesh__historyNote mesh__D016245 91   
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D016245 2003
% 210.86/211.03  |- mesh__dateRevised mesh__D016245 1999-11-03
% 210.86/211.03  |- rdf__type mesh__D016245sskos__Concept
% 210.86/211.03  |- mesh__dateCreated mesh__D016245 1990-05-07
% 210.86/211.03  |- skos__scopeNote mesh__D016245
% 210.86/211.03       Specialists in the management of a library or the services rendered by a library, bringing professional skills to administration, organization of material and personnel, interpretation of bibliothecal rules, the development and maintenance of the library%27%s collection, and the provision of information services.%A%    
% 210.86/211.03  |- mesh__recordAuthorizer mesh__D016245 sjn
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D016245 2000
% 210.86/211.03  |- mesh__publicMeSHNote mesh__D016245 91   
% 210.86/211.03  |- mesh__recordMaintainer mesh__D016245 kle
% 210.86/211.03  |- mesh__recordOriginator mesh__D016245 TGC
% 210.86/211.03  |- skos__hiddenLabel mesh__D016245 Librarian
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D016245 2002
% 210.86/211.03  |- skos__historyNote mesh__D016245 Libraries %28%1966-1990%29%
% 210.86/211.03  |- skos__broader mesh__D016245smesh__D009274
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D016245 2006
% 210.86/211.03  |- skos__prefLabel mesh__D016245 Librarians
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D002225 2005
% 210.86/211.03  |- skos__altLabel mesh__D002225 Carboquinone
% 210.86/211.03  |- skos__historyNote mesh__D002225 Azirines %28%1971-1974%29%
% 210.86/211.03  |- skos__historyNote mesh__D002225 Carbamates %28%1972-1974%29%
% 210.86/211.03  |- skos__broader mesh__D002225smesh__D016227
% 210.86/211.03  |- rdf__type mesh__D002225sskos__Concept
% 210.86/211.03  |- mesh__dateEstablished mesh__D002225 1991-01-01
% 210.86/211.03  |- skos__broader mesh__D002225smesh__D001388
% 210.86/211.03  |- mesh__recordMaintainer mesh__D002225 sjn
% 210.86/211.03  |- skos__historyNote mesh__D002225 Quinones %28%1972-1974%29%
% 210.86/211.03  |- mesh__publicMeSHNote mesh__D002225 91; was see under AZIRINES 1975-90   
% 210.86/211.03  |- mesh__dateRevised mesh__D002225 2004-07-13
% 210.86/211.03  |- mesh__recordAuthorizer mesh__D002225 sjn
% 210.86/211.03  |- skos__altLabel mesh__D002225 Carboquone
% 210.86/211.03  |- mesh__recordOriginator mesh__D002225 NLM
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D002225 2006
% 210.86/211.03  |- mesh__historyNote mesh__D002225
% 210.86/211.03       91%28%75%29%; was see under AZIRINES 1975-90   
% 210.86/211.03  |- skos__prefLabel mesh__D002225 Carbazilquinone
% 210.86/211.03  |- skos__scopeNote mesh__D002225
% 210.86/211.03       An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.%A%    
% 210.86/211.03  |- mesh__dateCreated mesh__D002225 1974-11-19
% 210.86/211.03  |- mesh__dateCreated mesh__D012653 1999-01-01
% 210.86/211.03  |- skos__broader mesh__D012653smesh__D001519
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D012653 2006
% 210.86/211.03  |- mesh__publicMeSHNote mesh__D012653 65   
% 210.86/211.03  |- skos__hiddenLabel mesh__D012653 Stimulations, Self
% 210.86/211.03  |- skos__annotation mesh__D012653 human %26% animal   
% 210.86/211.03  |- skos__hiddenLabel mesh__D012653 Stimulation, Self
% 210.86/211.03  |- skos__scopeNote mesh__D012653
% 210.86/211.03       Stimulation of the brain, which is self-administered. The stimulation may result in negative or positive reinforcement.%A%    
% 210.86/211.03  |- mesh__activeMeSHYear mesh__D012653 2005
% 210.86/211.03  |- mesh__recordMaintainer mesh__D012653 JLS
% 210.86/211.03  |- skos__broader mesh__D012653smesh__D011603
% 210.86/211.03  |- skos__hiddenLabel mesh__D012653 Self Stimulations
% 210.86/211.03  |- mesh__dateRevised mesh__D012653 2002-07-03
% 210.86/211.03  |- rdf__type mesh__D012653sskos__Concept
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012653 2004
% 210.86/211.04  |- mesh__recordOriginator mesh__D012653 NLM
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012653 2003
% 210.86/211.04  |- mesh__dateEstablished mesh__D012653 1965-01-01
% 210.86/211.04  |- mesh__historyNote mesh__D012653 65%28%64%29%   
% 210.86/211.04  |- skos__prefLabel mesh__D012653 Self Stimulation
% 210.86/211.04  |- mesh__recordAuthorizer mesh__D012653 sjn
% 210.86/211.04  |- skos__scopeNote mesh__D006616
% 210.86/211.04       Permanent fixation of the hip in primary positions, with limited passive or active motion at the hip joint. Locomotion is difficult and pain is sometimes present when the hip is in motion. It may be caused by trauma, infection, or poliomyelitis. %28%From Current Medical Information %26% Technology, 5th ed%29%%A%    
% 210.86/211.04  |- mesh__dateCreated mesh__D006616 1999-01-01
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006616 1996
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006616 2003
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006616 2000
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006616 1998
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006616 2005
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006616 1997
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006616 2004
% 210.86/211.04  |- mesh__recordOriginator mesh__D006616 NLM
% 210.86/211.04  |- mesh__recordAuthorizer mesh__D006616 PLS
% 210.86/211.04  |- skos__broader mesh__D006616smesh__D003286
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006616 2001
% 210.86/211.04  |- skos__hiddenLabel mesh__D006616 Hip Contractures
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006616 1999
% 210.86/211.04  |- skos__hiddenLabel mesh__D006616 Contractures, Hip
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006616 2006
% 210.86/211.04  |- skos__prefLabel mesh__D006616 Hip Contracture
% 210.86/211.04  |- mesh__dateRevised mesh__D006616 1994-05-24
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006616 1995
% 210.86/211.04  |- rdf__type mesh__D006616sskos__Concept
% 210.86/211.04  |- skos__hiddenLabel mesh__D006616 Contracture, Hip
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006616 2002
% 210.86/211.04  |- mesh__recordMaintainer mesh__D006616 TGC
% 210.86/211.04  |- skos__prefLabel mesh__D022283 Herpesvirus Vaccines
% 210.86/211.04  |- mesh__publicMeSHNote mesh__D022283 2001   
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D022283 2006
% 210.86/211.04  |- skos__scopeNote mesh__D022283
% 210.86/211.04       Vaccines or candidate vaccines used to prevent infection by any virus from the family HERPESVIRIDAE.%A%    
% 210.86/211.04  |- skos__hiddenLabel mesh__D022283 Vaccines, Herpesvirus
% 210.86/211.04  |- skos__broader mesh__D022283smesh__D014765
% 210.86/211.04  |- skos__historyNote mesh__D022283 Viral Vaccines %28%1965-2000%29%
% 210.86/211.04  |- rdf__type mesh__D022283sskos__Concept
% 210.86/211.04  |- mesh__dateEstablished mesh__D022283 2001-01-01
% 210.86/211.04  |- mesh__dateCreated mesh__D022283 2000-06-22
% 210.86/211.04  |- mesh__recordMaintainer mesh__D022283 ssb
% 210.86/211.04  |- mesh__dateRevised mesh__D022283 2005-06-30
% 210.86/211.04  |- skos__annotation mesh__D022283
% 210.86/211.04       coord IM with specific herpesvirus /immunol %28%IM%29% but note specifics%A%  
% 210.86/211.04  |- mesh__recordAuthorizer mesh__D022283 sjn
% 210.86/211.04  |- mesh__recordOriginator mesh__D022283 ags
% 210.86/211.04  |- mesh__historyNote mesh__D022283 2001   
% 210.86/211.04  |- skos__hiddenLabel mesh__D016246 Tumor Derived Activated Cells
% 210.86/211.04  |- mesh__historyNote mesh__D016246 91   
% 210.86/211.04  |- skos__hiddenLabel mesh__D016246 Tumor Infiltrating Lymphocytes
% 210.86/211.04  |- rdf__type mesh__D016246sskos__Concept
% 210.86/211.04  |- skos__hiddenLabel mesh__D016246 Tumor-Infiltrating Lymphocyte
% 210.86/211.04  |- skos__hiddenLabel mesh__D016246 Tumor-Derived Activated Cell
% 210.86/211.04  |- skos__annotation mesh__D016246
% 210.86/211.04       A 11 qualif; subpopulations: coord IM with LYMPHOCYTE SUBSETS %28%IM%29%; DF: TIL%A%  
% 210.86/211.04  |- mesh__recordMaintainer mesh__D016246 jmp
% 210.86/211.04  |- mesh__dateCreated mesh__D016246 1990-06-06
% 210.86/211.04  |- skos__historyNote mesh__D016246
% 210.86/211.04       T-Lymphocytes, Cytotoxic %28%1984-1990%29%
% 210.86/211.04  |- skos__broader mesh__D016246smesh__D008214
% 210.86/211.04  |- mesh__recordOriginator mesh__D016246 AGS
% 210.86/211.04  |- skos__historyNote mesh__D016246 Lymphocytes %28%1976-1990%29%
% 210.86/211.04  |- skos__historyNote mesh__D016246 T-Lymphocytes %28%1977-1990%29%
% 210.86/211.04  |- skos__hiddenLabel mesh__D016246 Activated Cells, Tumor-Derived
% 210.86/211.04  |- skos__scopeNote mesh__D016246
% 210.86/211.04       Lymphocytes that show specificity for autologous tumor cells. Ex vivo isolation and culturing of TIL with interleukin-2, followed by reinfusion into the patient, is one form of adoptive immunotherapy of cancer.%A%    
% 210.86/211.04  |- mesh__recordAuthorizer mesh__D016246 sjn
% 210.86/211.04  |- skos__related mesh__D016246smesh__D016219
% 210.86/211.04  |- skos__hiddenLabel mesh__D016246 Lymphocytes, Tumor Infiltrating
% 210.86/211.04  |- mesh__publicMeSHNote mesh__D016246 91   
% 210.86/211.04  |- skos__hiddenLabel mesh__D016246 Lymphocyte, Tumor-Infiltrating
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D016246 2006
% 210.86/211.04  |- mesh__dateEstablished mesh__D016246 1991-01-01
% 210.86/211.04  |- mesh__dateRevised mesh__D016246 2003-07-09
% 210.86/211.04  |- skos__altLabel mesh__D016246 Tumor-Infiltrating Lymphocytes
% 210.86/211.04  |- skos__hiddenLabel mesh__D016246 Activated Cell, Tumor-Derived
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D016246 2005
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D016246 2004
% 210.86/211.04  |- skos__prefLabel mesh__D016246 Lymphocytes, Tumor-Infiltrating
% 210.86/211.04  |- skos__broader mesh__D019789Q000031smesh__D019789
% 210.86/211.04  |- mesh__preferredCombination mesh__D019789Q000031smesh__D013757
% 210.86/211.04  |- rdf__type mesh__D019789Q000031smesh__CompoundConcept
% 210.86/211.04  |- mesh__publicMeSHNote mesh__D048328 2005; see KANGAROOS 2001-2004   
% 210.86/211.04  |- skos__hiddenLabel mesh__D048328 Rat Kangaroos, Long-Nosed
% 210.86/211.04  |- skos__hiddenLabel mesh__D048328 Kangaroo, Rat
% 210.86/211.04  |- skos__historyNote mesh__D048328 Marsupialia %28%1967-1996%29%
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D048328 2005B
% 210.86/211.04  |- skos__hiddenLabel mesh__D048328 Potoroos
% 210.86/211.04  |- mesh__recordAuthorizer mesh__D048328 jls
% 210.86/211.04  |- skos__hiddenLabel mesh__D048328 Rat Kangaroo, Long-Nosed
% 210.86/211.04  |- mesh__dateEstablished mesh__D048328 2005-01-01
% 210.86/211.04  |- skos__hiddenLabel mesh__D048328 Potoroo, Long-Nosed
% 210.86/211.04  |- skos__hiddenLabel mesh__D048328 Long-Nosed Potoroos
% 210.86/211.04  |- mesh__dateRevised mesh__D048328 2004-07-30
% 210.86/211.04  |- skos__scopeNote mesh__D048328
% 210.86/211.04       A family of rat kangaroos found in and around Australia. Genera include Potorous and Bettongia.%A%    
% 210.86/211.04  |- skos__hiddenLabel mesh__D048328 Long Nosed Potoroo
% 210.86/211.04  |- skos__annotation mesh__D048328
% 210.86/211.04       do not confuse rat kangaroo with KANGAROO RATS see DIPODOMYS%A%  
% 210.86/211.04  |- skos__hiddenLabel mesh__D048328 Potoroos, Long-Nosed
% 210.86/211.04  |- skos__hiddenLabel mesh__D048328 Long Nosed Rat Kangaroo
% 210.86/211.04  |- skos__broader mesh__D048328smesh__D008394
% 210.86/211.04  |- skos__hiddenLabel mesh__D048328 Rat Kangaroos
% 210.86/211.04  |- mesh__dateCreated mesh__D048328 2004-07-07
% 210.86/211.04  |- rdf__type mesh__D048328sskos__Concept
% 210.86/211.04  |- skos__hiddenLabel mesh__D048328 Kangaroos, Rat
% 210.86/211.04  |- skos__altLabel mesh__D048328 Rat Kangaroo
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D048328 2006
% 210.86/211.04  |- skos__prefLabel mesh__D048328 Potoroidae
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D048328 2005A
% 210.86/211.04  |- skos__altLabel mesh__D048328 Potorous tridactylus
% 210.86/211.04  |- mesh__recordMaintainer mesh__D048328 jls
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D048328 2005
% 210.86/211.04  |- mesh__historyNote mesh__D048328 2005; use MACROPODIDAE 2001-2004   
% 210.86/211.04  |- skos__hiddenLabel mesh__D048328 Long-Nosed Rat Kangaroos
% 210.86/211.04  |- mesh__recordOriginator mesh__D048328 ags
% 210.86/211.04  |- skos__altLabel mesh__D048328 Long-Nosed Rat Kangaroo
% 210.86/211.04  |- skos__historyNote mesh__D048328 Macropodidae %28%1997-2004%29%
% 210.86/211.04  |- skos__hiddenLabel mesh__D012654 Unit, Self-Care
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012654 1995
% 210.86/211.04  |- mesh__recordOriginator mesh__D012654 EC
% 210.86/211.04  |- skos__scopeNote mesh__D012654
% 210.86/211.04       Rooms in health care facilities for patients who require a minimal level of care.%A%    
% 210.86/211.04  |- skos__hiddenLabel mesh__D012654 Units, Self-Care
% 210.86/211.04  |- mesh__dateCreated mesh__D012654 1977-05-19
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012654 1999
% 210.86/211.04  |- mesh__recordMaintainer mesh__D012654 TGC
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012654 1994
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012654 2002
% 210.86/211.04  |- mesh__historyNote mesh__D012654
% 210.86/211.04       91%28%Aug 77%29%; was see under HOSPITAL UNITS 1977-90   
% 210.86/211.04  |- mesh__dateEstablished mesh__D012654 1991-01-01
% 210.86/211.04  |- skos__hiddenLabel mesh__D012654 Units, Minimal Care
% 210.86/211.04  |- skos__hiddenLabel mesh__D012654 Self-Care Unit
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012654 1998
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012654 1993
% 210.86/211.04  |- mesh__publicMeSHNote mesh__D012654
% 210.86/211.04       91; was see under HOSPITAL UNITS Aug 1977-90   
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012654 2006
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012654 2001
% 210.86/211.04  |- skos__broader mesh__D012654smesh__D006757
% 210.86/211.04  |- rdf__type mesh__D012654sskos__Concept
% 210.86/211.04  |- skos__hiddenLabel mesh__D012654 Self Care Units
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012654 1997
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012654 2005
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012654 2000
% 210.86/211.04  |- skos__prefLabel mesh__D012654 Self-Care Units
% 210.86/211.04  |- mesh__dateRevised mesh__D012654 1992-05-18
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012654 1996
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012654 2004
% 210.86/211.04  |- skos__hiddenLabel mesh__D012654 Unit, Minimal Care
% 210.86/211.04  |- skos__hiddenLabel mesh__D012654 Minimal Care Unit
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012654 2003
% 210.86/211.04  |- mesh__recordAuthorizer mesh__D012654 PLS
% 210.86/211.04  |- mesh__recordAuthorizer mesh__D006617 sjn
% 210.86/211.04  |- rdf__type mesh__D006617sskos__Concept
% 210.86/211.04  |- mesh__dateRevised mesh__D006617 2001-07-25
% 210.86/211.04  |- skos__broader mesh__D006617smesh__D004204
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006617 2004
% 210.86/211.04  |- mesh__recordMaintainer mesh__D006617 lkt
% 210.86/211.04  |- mesh__dateCreated mesh__D006617 1999-01-01
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006617 2003
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006617 2002
% 210.86/211.04  |- mesh__recordOriginator mesh__D006617 NLM
% 210.86/211.04  |- skos__broader mesh__D006617smesh__D025981
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006617 2006
% 210.86/211.04  |- skos__scopeNote mesh__D006617
% 210.86/211.04       Displacement of the femur bone from its normal position at the HIP JOINT.%A%    
% 210.86/211.04  |- skos__prefLabel mesh__D006617 Hip Dislocation
% 210.86/211.04  |- skos__related mesh__D006617smesh__D006618
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006617 2005
% 210.86/211.04  |- mesh__recordMaintainer mesh__D016247 jls
% 210.86/211.04  |- rdf__type mesh__D016247sskos__Concept
% 210.86/211.04  |- skos__altLabel mesh__D016247 Information Retrieval
% 210.86/211.04  |- skos__altLabel mesh__D016247 Information Storage
% 210.86/211.04  |- mesh__recordOriginator mesh__D016247 TGC
% 210.86/211.04  |- skos__hiddenLabel mesh__D016247 Storage, Data
% 210.86/211.04  |- mesh__dateEstablished mesh__D016247 1991-01-01
% 210.86/211.04  |- mesh__dateCreated mesh__D016247 1990-05-07
% 210.86/211.04  |- skos__annotation mesh__D016247 DF: INFORMATION STORAGE   
% 210.86/211.04  |- skos__hiddenLabel mesh__D016247 Retrieval, Data
% 210.86/211.04  |- mesh__onlineNote mesh__D016247
% 210.86/211.04       use INFORMATION SYSTEMS to search INFORMATION STORAGE AND RETRIEVAL 1982-90%A%  
% 210.86/211.04  |- skos__historyNote mesh__D016247 Information Systems %28%1966-1990%29%
% 210.86/211.04  |- skos__broader mesh__D016247smesh__D008491
% 210.86/211.04  |- skos__scopeNote mesh__D016247
% 210.86/211.04       A branch of computer or library science relating to the storage, locating, searching, and selecting, upon demand, relevant data on a given subject.%A%    
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D016247 2005
% 210.86/211.04  |- mesh__dateRevised mesh__D016247 2004-07-07
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D016247 2006
% 210.86/211.04  |- mesh__publicMeSHNote mesh__D016247
% 210.86/211.04       91; was see INFORMATION SYSTEMS 1982-90   
% 210.86/211.04  |- skos__prefLabel mesh__D016247 Information Storage and Retrieval
% 210.86/211.04  |- mesh__historyNote mesh__D016247
% 210.86/211.04       91; was see INFORMATION SYSTEMS 1982-90   
% 210.86/211.04  |- skos__broader mesh__D016247smesh__D007254
% 210.86/211.04  |- mesh__recordAuthorizer mesh__D016247 sjn
% 210.86/211.04  |- skos__prefLabel mesh__D035401 Conyza
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D035401 2005
% 210.86/211.04  |- mesh__dateEstablished mesh__D035401 2003-01-01
% 210.86/211.04  |- mesh__dateCreated mesh__D035401 2002-07-02
% 210.86/211.04  |- mesh__historyNote mesh__D035401 2003   
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D035401 2004
% 210.86/211.04  |- skos__scopeNote mesh__D035401
% 210.86/211.04       A plant genus of the family ASTERACEAE. Members contain alkenynes, daucosterol, friedelinol, conyzasaponins and other TRITERPENES.%A%    
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D035401 2003
% 210.86/211.04  |- rdf__type mesh__D035401sskos__Concept
% 210.86/211.04  |- skos__altLabel mesh__D035401 Horseweed
% 210.86/211.04  |- skos__annotation mesh__D035401
% 210.86/211.04       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.86/211.04  |- mesh__publicMeSHNote mesh__D035401 2003   
% 210.86/211.04  |- skos__broader mesh__D035401smesh__D019659
% 210.86/211.04  |- skos__altLabel mesh__D035401 Asthmaweed
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D035401 2006
% 210.86/211.04  |- skos__scopeNote mesh__D002227
% 210.86/211.04       Benzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.%A%    
% 210.86/211.04  |- skos__broader mesh__D002227smesh__D006575
% 210.86/211.04  |- skos__prefLabel mesh__D002227 Carbazoles
% 210.86/211.04  |- mesh__dateEstablished mesh__D002227 1969-01-01
% 210.86/211.04  |- mesh__dateRevised mesh__D002227 2004-07-07
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D002227 2006
% 210.86/211.04  |- mesh__publicMeSHNote mesh__D002227 69; was see under AZOLES 1963-68   
% 210.86/211.04  |- skos__historyNote mesh__D002227 Azoles %28%1966-1968%29%
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D002227 2005
% 210.86/211.04  |- mesh__historyNote mesh__D002227 69; was see under AZOLES 1963-68   
% 210.86/211.04  |- mesh__onlineNote mesh__D002227 search AZOLES 1966-68   
% 210.86/211.04  |- rdf__type mesh__D002227sskos__Concept
% 210.86/211.04  |- mesh__recordMaintainer mesh__D002227 ssb
% 210.86/211.04  |- mesh__dateCreated mesh__D002227 1999-01-01
% 210.86/211.04  |- mesh__recordAuthorizer mesh__D002227 sjn
% 210.86/211.04  |- mesh__recordOriginator mesh__D002227 NLM
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D007710 2003
% 210.86/211.04  |- mesh__recordOriginator mesh__D007710 NLM
% 210.86/211.04  |- skos__hiddenLabel mesh__D007710 Klebsiella Infection
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D007710 2005
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D007710 2000
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D007710 1994
% 210.86/211.04  |- mesh__dateRevised mesh__D007710 1993-06-02
% 210.86/211.04  |- mesh__historyNote mesh__D007710 68   
% 210.86/211.04  |- mesh__publicMeSHNote mesh__D007710 68   
% 210.86/211.04  |- mesh__recordAuthorizer mesh__D007710 PLS
% 210.86/211.04  |- skos__altLabel mesh__D007710 Infections, Klebsiella
% 210.86/211.04  |- rdf__type mesh__D007710sskos__Concept
% 210.86/211.04  |- mesh__recordMaintainer mesh__D007710 TAP
% 210.86/211.04  |- skos__prefLabel mesh__D007710 Klebsiella Infections
% 210.86/211.04  |- mesh__dateEstablished mesh__D007710 1968-01-01
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D007710 2002
% 210.86/211.04  |- skos__historyNote mesh__D007710 Klebsiella %28%1966-1967%29%
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D007710 1997
% 210.86/211.04  |- skos__broader mesh__D007710smesh__D004756
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D007710 2004
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D007710 1999
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D007710 2001
% 210.86/211.04  |- mesh__dateCreated mesh__D007710 1999-01-01
% 210.86/211.04  |- skos__annotation mesh__D007710
% 210.86/211.04       gram-neg bact infect; coord IM with various species %28%IM%29%   
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D007710 1996
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D007710 2006
% 210.86/211.04  |- skos__scopeNote mesh__D007710
% 210.86/211.04       Infections with bacteria of the genus KLEBSIELLA.     
% 210.86/211.04  |- skos__hiddenLabel mesh__D007710 Infection, Klebsiella
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D007710 1995
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D007710 1998
% 210.86/211.04  |- mesh__recordOriginator mesh__D048329 ags
% 210.86/211.04  |- skos__annotation mesh__D048329
% 210.86/211.04       possums unspecified go here; OPOSSUMS is also available   
% 210.86/211.04  |- mesh__recordMaintainer mesh__D048329 ags
% 210.86/211.04  |- skos__hiddenLabel mesh__D048329 Phalangers
% 210.86/211.04  |- mesh__recordAuthorizer mesh__D048329 sjn
% 210.86/211.04  |- mesh__dateCreated mesh__D048329 2004-07-07
% 210.86/211.04  |- rdf__type mesh__D048329sskos__Concept
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D048329 2006
% 210.86/211.04  |- mesh__dateEstablished mesh__D048329 2005-01-01
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D048329 2005
% 210.86/211.04  |- mesh__historyNote mesh__D048329 2005   
% 210.86/211.04  |- skos__broader mesh__D048329smesh__D008394
% 210.86/211.04  |- skos__scopeNote mesh__D048329
% 210.86/211.04       A family of possums and cuscuses found in Australia, Tasmania, New Guinea and other islands.%A%    
% 210.86/211.04  |- skos__historyNote mesh__D048329 Marsupialia %28%1967-2004%29%
% 210.86/211.04  |- skos__prefLabel mesh__D048329 Phalangeridae
% 210.86/211.04  |- mesh__publicMeSHNote mesh__D048329 2005   
% 210.86/211.04  |- mesh__recordMaintainer mesh__D012655 TGC
% 210.86/211.04  |- skos__prefLabel mesh__D012655 Self-Evaluation Programs
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012655 1994
% 210.86/211.04  |- mesh__dateEstablished mesh__D012655 1991-01-01
% 210.86/211.04  |- mesh__recordAuthorizer mesh__D012655 PLS
% 210.86/211.04  |- skos__hiddenLabel mesh__D012655 Self-Evaluation Program
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012655 2006
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012655 1993
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012655 1998
% 210.86/211.04  |- mesh__publicMeSHNote mesh__D012655
% 210.86/211.04       91; was see under EDUCATIONAL MEASUREMENT 1979-90   
% 210.86/211.04  |- skos__hiddenLabel mesh__D012655 Self Evaluation Programs
% 210.86/211.04  |- mesh__historyNote mesh__D012655
% 210.86/211.04       91%28%79%29%; was see under EDUCATIONAL MEASUREMENT 1979-90   
% 210.86/211.04  |- skos__hiddenLabel mesh__D012655 Programs, Self-Evaluation
% 210.86/211.04  |- rdf__type mesh__D012655sskos__Concept
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012655 1997
% 210.86/211.04  |- mesh__recordOriginator mesh__D012655 EC
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012655 2005
% 210.86/211.04  |- skos__broader mesh__D012655smesh__D004521
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012655 2002
% 210.86/211.04  |- mesh__dateRevised mesh__D012655 1992-05-18
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012655 1996
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012655 2004
% 210.86/211.04  |- mesh__dateCreated mesh__D012655 1978-05-10
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012655 2001
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012655 2003
% 210.86/211.04  |- skos__hiddenLabel mesh__D012655 Program, Self-Evaluation
% 210.86/211.04  |- skos__historyNote mesh__D012655
% 210.86/211.04       Educational Measurement %28%1974-1978%29%
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012655 2000
% 210.86/211.04  |- skos__scopeNote mesh__D012655
% 210.86/211.04       Educational programs structured in such a manner that the participating professionals, physicians, or students develop an increased awareness of their performance, usually on the basis of self-evaluation questionnaires.%A%    
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012655 1995
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D012655 1999
% 210.86/211.04  |- skos__broader mesh__D005502Q000506smesh__D005502
% 210.86/211.04  |- mesh__preferredCombination mesh__D005502Q000506smesh__D005517
% 210.86/211.04  |- rdf__type mesh__D005502Q000506smesh__CompoundConcept
% 210.86/211.04  |- skos__scopeNote mesh__D006618
% 210.86/211.04       Congenital dislocation of the hip generally includes subluxation of the femoral head, acetabular dysplasia, and complete dislocation of the femoral head from the true acetabulum. This condition occurs in approximately 1 in 1000 live births and is more common in females than in males.%A%    
% 210.86/211.04  |- skos__hiddenLabel mesh__D006618 Dislocations, Congenital Hip
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006618 2004
% 210.86/211.04  |- skos__annotation mesh__D006618
% 210.86/211.04       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; /vet permitted but congen hip disloc in dogs = HIP DYSPLASIA, CANINE: see note there%A%  
% 210.86/211.04  |- skos__altLabel mesh__D006618 Dysplasia, Congenital Hip
% 210.86/211.04  |- mesh__recordAuthorizer mesh__D006618 sjn
% 210.86/211.04  |- mesh__dateCreated mesh__D006618 1999-01-01
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006618 2001
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006618 2003
% 210.86/211.04  |- skos__broader mesh__D006618smesh__D009139
% 210.86/211.04  |- skos__altLabel mesh__D006618 Congenital Hip Dysplasia
% 210.86/211.04  |- skos__hiddenLabel mesh__D006618 Congenital Hip Dysplasias
% 210.86/211.04  |- skos__hiddenLabel mesh__D006618 Hip Dysplasias, Congenital
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006618 2000
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006618 2006
% 210.86/211.04  |- skos__altLabel mesh__D006618 Congenital Hip Dislocation
% 210.86/211.04  |- skos__hiddenLabel mesh__D006618 Congenital Hip Dislocations
% 210.86/211.04  |- skos__altLabel mesh__D006618 Hip Dysplasia, Congenital
% 210.86/211.04  |- mesh__dateRevised mesh__D006618 1999-11-03
% 210.86/211.04  |- skos__hiddenLabel mesh__D006618 Hip Dislocations, Congenital
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006618 2005
% 210.86/211.04  |- mesh__recordMaintainer mesh__D006618 kle
% 210.86/211.04  |- skos__hiddenLabel mesh__D006618 Dysplasias, Congenital Hip
% 210.86/211.04  |- skos__prefLabel mesh__D006618 Hip Dislocation, Congenital
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D006618 2002
% 210.86/211.04  |- skos__broader mesh__D006618smesh__D007592
% 210.86/211.04  |- rdf__type mesh__D006618sskos__Concept
% 210.86/211.04  |- mesh__recordOriginator mesh__D006618 NLM
% 210.86/211.04  |- skos__altLabel mesh__D006618 Dislocation, Congenital Hip
% 210.86/211.04  |- skos__broader mesh__D011506Q000096smesh__D011506
% 210.86/211.04  |- mesh__preferredCombination mesh__D011506Q000096smesh__D014176
% 210.86/211.04  |- rdf__type mesh__D011506Q000096smesh__CompoundConcept
% 210.86/211.04  |- skos__broader mesh__D003320smesh__D007634
% 210.86/211.04  |- mesh__dateCreated mesh__D003320 1999-01-01
% 210.86/211.04  |- skos__broader mesh__D003320smesh__D015817
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D003320 1999
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D003320 1996
% 210.86/211.04  |- mesh__publicMeSHNote mesh__D003320 65   
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D003320 2000
% 210.86/211.04  |- skos__hiddenLabel mesh__D003320 Ulcerative Keratitides
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D003320 1995
% 210.86/211.04  |- mesh__dateRevised mesh__D003320 1993-06-02
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D003320 1998
% 210.86/211.04  |- mesh__recordOriginator mesh__D003320 NLM
% 210.86/211.04  |- rdf__type mesh__D003320sskos__Concept
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D003320 1994
% 210.86/211.04  |- skos__prefLabel mesh__D003320 Corneal Ulcer
% 210.86/211.04  |- skos__hiddenLabel mesh__D003320 Ulcerative Keratitis
% 210.86/211.04  |- mesh__historyNote mesh__D003320 65%28%64%29%   
% 210.86/211.04  |- skos__altLabel mesh__D003320 Keratitis, Ulcerative
% 210.86/211.04  |- mesh__dateEstablished mesh__D003320 1965-01-01
% 210.86/211.04  |- skos__scopeNote mesh__D003320
% 210.86/211.04       Loss of epithelial tissue from the surface of the cornea due to progressive erosion and necrosis of the tissue; usually caused by bacterial, fungal, or viral infection.%A%    
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D003320 2004
% 210.86/211.04  |- skos__annotation mesh__D003320 a form of keratitis   
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D003320 2002
% 210.86/211.04  |- skos__hiddenLabel mesh__D003320 Ulcer, Corneal
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D003320 2006
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D003320 2003
% 210.86/211.04  |- mesh__recordAuthorizer mesh__D003320 PLS
% 210.86/211.04  |- skos__hiddenLabel mesh__D003320 Keratitides, Ulcerative
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D003320 2001
% 210.86/211.04  |- mesh__recordMaintainer mesh__D003320 TAP
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D003320 2005
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D003320 1997
% 210.86/211.04  |- mesh__dateCreated mesh__D016248 1990-05-07
% 210.86/211.04  |- skos__hiddenLabel mesh__D016248 Memory Systems, Computer
% 210.86/211.04  |- skos__historyNote mesh__D016248 Computers %28%1966-1990%29%
% 210.86/211.04  |- skos__hiddenLabel mesh__D016248 Devices, Mass Storage
% 210.86/211.04  |- skos__hiddenLabel mesh__D016248 System, Computer Memory
% 210.86/211.04  |- mesh__recordAuthorizer mesh__D016248 sjn
% 210.86/211.04  |- skos__altLabel mesh__D016248 Computer Memory Systems
% 210.86/211.04  |- mesh__recordMaintainer mesh__D016248 jls
% 210.86/211.04  |- mesh__publicMeSHNote mesh__D016248 91   
% 210.86/211.04  |- skos__scopeNote mesh__D016248
% 210.86/211.04       Devices capable of receiving data, retaining data for an indefinite or finite period of time, and supplying data upon demand.%A%    
% 210.86/211.04  |- skos__hiddenLabel mesh__D016248 Device, Computer Storage
% 210.86/211.04  |- skos__annotation mesh__D016248
% 210.86/211.04       do not use /util except by MeSH definition   
% 210.86/211.04  |- skos__hiddenLabel mesh__D016248 Mass Storage Device
% 210.86/211.04  |- skos__hiddenLabel mesh__D016248 Devices, Computer Storage
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D016248 2005
% 210.86/211.04  |- mesh__recordOriginator mesh__D016248 TGC
% 210.86/211.04  |- mesh__dateRevised mesh__D016248 2004-07-07
% 210.86/211.04  |- mesh__activeMeSHYear mesh__D016248 2006
% 210.86/211.04  |- skos__altLabel mesh__D016248 Mass Storage Devices
% 210.86/211.04  |- skos__hiddenLabel mesh__D016248 Memory System, Computer
% 210.86/211.04  |- skos__hiddenLabel mesh__D016248 Device, Mass Storage
% 210.86/211.04  |- mesh__historyNote mesh__D016248 91   
% 210.86/211.04  |- skos__hiddenLabel mesh__D016248 Systems, Computer Memory
% 210.86/211.04  |- skos__hiddenLabel mesh__D016248 Computer Storage Device
% 210.86/211.04  |- skos__prefLabel mesh__D016248 Computer Storage Devices
% 210.86/211.04  |- skos__hiddenLabel mesh__D016248 Computer Memory System
% 210.86/211.04  |- rdf__type mesh__D016248sskos__Concept
% 210.86/211.04  |- skos__broader mesh__D016248smesh__D016287
% 210.86/211.04  |- mesh__dateEstablished mesh__D016248 1991-01-01
% 210.86/211.04  |- mesh__recordMaintainer mesh__D002228 ssb
% 210.86/211.04  |- skos__altLabel mesh__D002228 Sanfer Brand of Carbenicillin Disodium Salt
% 210.86/211.04  |- skos__scopeNote mesh__D002228
% 210.86/211.04       Broad-spectrum semisynthetic penicillin derivative used parenterally. It is susceptible to gastric juice and penicillinase and may damage platelet function.%A%    
% 210.86/211.04  |- mesh__recordOriginator mesh__D002228 NLM
% 210.86/211.04  |- skos__historyNote mesh__D002228 Penicillins %28%1966-1970%29%
% 210.86/211.04  |- mesh__dateRevised mesh__D002228 2004-07-07
% 210.86/211.05  |- mesh__recordAuthorizer mesh__D002228 sjn
% 210.86/211.05  |- skos__altLabel mesh__D002228 Carboxybenzyl Penicillin
% 210.86/211.05  |- skos__altLabel mesh__D002228 CSL Brand of Carbenicillin Disodium Salt
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D002228 2006
% 210.86/211.05  |- mesh__dateEstablished mesh__D002228 1973-01-01
% 210.86/211.05  |- mesh__historyNote mesh__D002228 73%28%71%29%   
% 210.86/211.05  |- skos__broader mesh__D002228smesh__D010400
% 210.86/211.05  |- mesh__publicMeSHNote mesh__D002228 73   
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D002228 2005
% 210.86/211.05  |- rdf__type mesh__D002228sskos__Concept
% 210.86/211.05  |- skos__prefLabel mesh__D002228 Carbenicillin
% 210.86/211.05  |- skos__hiddenLabel mesh__D002228 Penicillin, Carboxybenzyl
% 210.86/211.05  |- mesh__dateCreated mesh__D002228 1999-01-01
% 210.86/211.05  |- skos__hiddenLabel mesh__D002228 Disodium, Carbenicillin
% 210.86/211.05  |- mesh__historyNote mesh__D007711 1974%28%1972%29%   
% 210.86/211.05  |- rdf__type mesh__D007711sskos__Concept
% 210.86/211.05  |- skos__prefLabel mesh__D007711 Klebsiella pneumoniae
% 210.86/211.05  |- skos__historyNote mesh__D007711 Klebsiella %28%1966-1971%29%
% 210.86/211.05  |- mesh__dateCreated mesh__D007711 1999-01-01
% 210.86/211.05  |- mesh__recordOriginator mesh__D007711 NLM
% 210.86/211.05  |- mesh__dateEstablished mesh__D007711 1974-01-01
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D007711 2006
% 210.86/211.05  |- skos__broader mesh__D007711smesh__D007709
% 210.86/211.05  |- skos__scopeNote mesh__D007711
% 210.86/211.05       Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans.%A%    
% 210.86/211.05  |- skos__annotation mesh__D007711
% 210.86/211.05       infection: coord IM with KLEBSIELLA INFECTIONS %28%IM%29%   
% 210.86/211.05  |- mesh__publicMeSHNote mesh__D007711
% 210.86/211.05       1974; for KLEBSIELLA RHINOSCLEROMATIS see KLEBSIELLA RHINOSCLEROMATIS 1972-2003%A%  
% 210.86/211.05  |- mesh__dateRevised mesh__D007711 2005-06-30
% 210.86/211.05  |- mesh__recordAuthorizer mesh__D007711 sjn
% 210.86/211.05  |- mesh__recordMaintainer mesh__D007711 SYSTEM
% 210.86/211.05  |- skos__related mesh__D007711smesh__D021902
% 210.86/211.05  |- skos__hiddenLabel mesh__D012656 Devices, Self-Help
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012656 1999
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012656 2001
% 210.86/211.05  |- skos__hiddenLabel mesh__D012656 Self-Help Device
% 210.86/211.05  |- mesh__dateRevised mesh__D012656 1998-06-11
% 210.86/211.05  |- mesh__recordOriginator mesh__D012656 NLM
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012656 2006
% 210.86/211.05  |- skos__hiddenLabel mesh__D012656 Assistive Device
% 210.86/211.05  |- mesh__recordAuthorizer mesh__D012656 SJN
% 210.86/211.05  |- mesh__recordMaintainer mesh__D012656 NNS
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012656 2003
% 210.86/211.05  |- rdf__type mesh__D012656sskos__Concept
% 210.86/211.05  |- skos__prefLabel mesh__D012656 Self-Help Devices
% 210.86/211.05  |- mesh__dateCreated mesh__D012656 1999-01-01
% 210.86/211.05  |- skos__altLabel mesh__D012656 Assistive Technology
% 210.86/211.05  |- skos__altLabel mesh__D012656 Assistive Devices
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012656 2002
% 210.86/211.05  |- skos__hiddenLabel mesh__D012656 Devices, Assistive
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012656 2004
% 210.86/211.05  |- skos__hiddenLabel mesh__D012656 Device, Assistive
% 210.86/211.05  |- skos__scopeNote mesh__D012656
% 210.86/211.05       Devices, not affixed to the body, designed to help persons having musculoskeletal or neuromuscular disabilities to perform activities involving movement.%A%    
% 210.86/211.05  |- skos__hiddenLabel mesh__D012656 Assistive Technologies
% 210.86/211.05  |- skos__hiddenLabel mesh__D012656 Technologies, Assistive
% 210.86/211.05  |- skos__broader mesh__D012656smesh__D004864
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012656 2000
% 210.86/211.05  |- skos__hiddenLabel mesh__D012656 Device, Self-Help
% 210.86/211.05  |- skos__hiddenLabel mesh__D012656 Self Help Devices
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012656 2005
% 210.86/211.05  |- skos__hiddenLabel mesh__D012656 Technology, Assistive
% 210.86/211.05  |- skos__historyNote mesh__D006619
% 210.86/211.05       Hip Dislocation, Congenital/veterinary %28%1966-1975%29%
% 210.86/211.05  |- skos__scopeNote mesh__D006619
% 210.86/211.05       A hereditary disease of the hip joints in dogs. Signs of the disease may be evident any time after 4 weeks of age.%A%    
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D006619 2006
% 210.86/211.05  |- skos__prefLabel mesh__D006619 Hip Dysplasia, Canine
% 210.86/211.05  |- mesh__publicMeSHNote mesh__D006619
% 210.86/211.05       91; was see under HIP DISLOCATION, CONGENITAL 1976-90   
% 210.86/211.05  |- mesh__dateCreated mesh__D006619 1975-07-25
% 210.86/211.05  |- skos__altLabel mesh__D006619 Canine Hip Dysplasia
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D006619 2005
% 210.86/211.05  |- skos__broader mesh__D006619smesh__D004283
% 210.86/211.05  |- rdf__type mesh__D006619sskos__Concept
% 210.86/211.05  |- mesh__historyNote mesh__D006619
% 210.86/211.05       91%28%76%29%; was see under HIP DISLOCATION, CONGENITAL 1976-90%A%  
% 210.86/211.05  |- mesh__recordAuthorizer mesh__D006619 sjn
% 210.86/211.05  |- skos__annotation mesh__D006619
% 210.86/211.05       congen hip disloc in dogs; don%27%t forget check tags ANIMALS %26% DOGS %28%NIM%29%%A%  
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D006619 2004
% 210.86/211.05  |- mesh__recordOriginator mesh__D006619 FPG
% 210.86/211.05  |- mesh__dateEstablished mesh__D006619 1991-01-01
% 210.86/211.05  |- skos__hiddenLabel mesh__D006619 Dysplasia, Canine Hip
% 210.86/211.05  |- mesh__recordMaintainer mesh__D006619 ags
% 210.86/211.05  |- mesh__dateRevised mesh__D006619 2003-07-30
% 210.86/211.05  |- skos__prefLabel mesh__D017341 Etanidazole
% 210.86/211.05  |- skos__hiddenLabel mesh__D017341 NSC301467
% 210.86/211.05  |- mesh__dateCreated mesh__D017341 1992-05-08
% 210.86/211.05  |- skos__scopeNote mesh__D017341
% 210.86/211.05       A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy.%A%    
% 210.86/211.05  |- mesh__onlineNote mesh__D017341
% 210.86/211.05       use ETANIDAZOLE %28%NM%29% to search ETANIDAZOLE 1981-92   
% 210.86/211.05  |- mesh__historyNote mesh__D017341
% 210.86/211.05       93; was ETANIDAZOLE %28%NM%29% 1981-92   
% 210.86/211.05  |- skos__hiddenLabel mesh__D017341 SR2508
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D017341 2006
% 210.86/211.05  |- mesh__publicMeSHNote mesh__D017341
% 210.86/211.05       93; ETANIDAZOLE was indexed under NITROIMIDAZOLES 1981-92%A%  
% 210.86/211.05  |- skos__broader mesh__D017341smesh__D009593
% 210.86/211.05  |- mesh__dateRevised mesh__D017341 2005-06-30
% 210.86/211.05  |- skos__hiddenLabel mesh__D017341 SR 2508
% 210.86/211.05  |- mesh__recordOriginator mesh__D017341 TPW
% 210.86/211.05  |- rdf__type mesh__D017341sskos__Concept
% 210.86/211.05  |- skos__hiddenLabel mesh__D017341 NSC 301467
% 210.86/211.05  |- mesh__recordAuthorizer mesh__D017341 sjn
% 210.86/211.05  |- mesh__recordMaintainer mesh__D017341 ssb
% 210.86/211.05  |- skos__historyNote mesh__D017341 Nitroimidazoles %28%1981-1992%29%
% 210.86/211.05  |- mesh__dateEstablished mesh__D017341 1993-01-01
% 210.86/211.05  |- skos__broader mesh__D011506Q000097smesh__D011506
% 210.86/211.05  |- mesh__preferredCombination mesh__D011506Q000097smesh__D001798
% 210.86/211.05  |- rdf__type mesh__D011506Q000097smesh__CompoundConcept
% 210.86/211.05  |- mesh__dateEstablished mesh__D003321 1991-01-01
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D003321 1999
% 210.86/211.05  |- mesh__publicMeSHNote mesh__D003321
% 210.86/211.05       91; was see under MEDICAL HISTORY TAKING 1975-90   
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D003321 2000
% 210.86/211.05  |- skos__scopeNote mesh__D003321
% 210.86/211.05       Self-administered health questionnaire developed to obtain details of the medical history as an adjunct to the medical interview. It consists of 195 questions divided into eighteen sections; the first twelve deal with somatic complaints and the last six with mood and feeling patterns. The Index is used also as a personality inventory or in epidemiologic studies.%A%    
% 210.86/211.05  |- rdf__type mesh__D003321sskos__Concept
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D003321 2001
% 210.86/211.05  |- mesh__recordAuthorizer mesh__D003321 SJN
% 210.86/211.05  |- mesh__historyNote mesh__D003321
% 210.86/211.05       91%28%75%29%; was see under MEDICAL HISTORY TAKING 1975-90   
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D003321 2003
% 210.86/211.05  |- skos__broader mesh__D003321smesh__D008487
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D003321 2005
% 210.86/211.05  |- mesh__dateRevised mesh__D003321 1997-06-20
% 210.86/211.05  |- mesh__recordOriginator mesh__D003321 NLM
% 210.86/211.05  |- skos__annotation mesh__D003321 no qualif; DF: CORNELL MED INDEX   
% 210.86/211.05  |- mesh__dateCreated mesh__D003321 1975-02-04
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D003321 2004
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D003321 2002
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D003321 2006
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D003321 1998
% 210.86/211.05  |- mesh__recordMaintainer mesh__D003321 PXP
% 210.86/211.05  |- skos__prefLabel mesh__D003321 Cornell Medical Index
% 210.86/211.05  |- skos__scopeNote mesh__D016249
% 210.86/211.05       A computer disk read by a laser beam, containing data prerecorded by a vendor. The buyer cannot enter or modify data in any way but the advantages lie in the speed of accessibility, relative immunity to damage, and relatively low cost of purchase.%A%    
% 210.86/211.05  |- mesh__dateRevised mesh__D016249 2004-07-07
% 210.86/211.05  |- skos__hiddenLabel mesh__D016249 Disks, WORM
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D016249 2006
% 210.86/211.05  |- skos__hiddenLabel mesh__D016249 Devices, Optical Storage
% 210.86/211.05  |- mesh__historyNote mesh__D016249 91   
% 210.86/211.05  |- mesh__recordMaintainer mesh__D016249 jls
% 210.86/211.05  |- skos__hiddenLabel mesh__D016249 Optical Storage Device
% 210.86/211.05  |- rdf__type mesh__D016249sskos__Concept
% 210.86/211.05  |- mesh__recordAuthorizer mesh__D016249 sjn
% 210.86/211.05  |- mesh__dateCreated mesh__D016249 1990-05-07
% 210.86/211.05  |- mesh__publicMeSHNote mesh__D016249 91   
% 210.86/211.05  |- skos__broader mesh__D016249smesh__D016248
% 210.86/211.05  |- skos__hiddenLabel mesh__D016249 WORM Disk
% 210.86/211.05  |- mesh__recordOriginator mesh__D016249 TGC
% 210.86/211.05  |- skos__hiddenLabel mesh__D016249 Storage Device, Optical
% 210.86/211.05  |- mesh__dateEstablished mesh__D016249 1991-01-01
% 210.86/211.05  |- skos__hiddenLabel mesh__D016249 Device, Optical Storage
% 210.86/211.05  |- skos__broader mesh__D016249smesh__D001296
% 210.86/211.05  |- skos__annotation mesh__D016249
% 210.86/211.05       do not use /util except by MeSH definition   
% 210.86/211.05  |- skos__hiddenLabel mesh__D016249 Disk, WORM
% 210.86/211.05  |- skos__prefLabel mesh__D016249 Optical Storage Devices
% 210.86/211.05  |- skos__hiddenLabel mesh__D016249 Storage Devices, Optical
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D016249 2005
% 210.86/211.05  |- skos__historyNote mesh__D002229 Triterpenes %28%1974%29%
% 210.86/211.05  |- skos__hiddenLabel mesh__D002229 Acid 3-O-hemisuccinate, Glycyrrhetinic
% 210.86/211.05  |- skos__historyNote mesh__D002229 Glycyrrhiza %28%1966-1974%29%
% 210.86/211.05  |- skos__broader mesh__D002229smesh__D006034
% 210.86/211.05  |- skos__altLabel mesh__D002229 Glycyrrhetinic Acid 3-O-hemisuccinate
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D002229 2005
% 210.86/211.05  |- skos__altLabel mesh__D002229 Rowa Brand of Carbenoxolone Disodium Salt
% 210.86/211.05  |- skos__hiddenLabel mesh__D002229
% 210.86/211.05       3beta-O-Hemisuccinate, 18alpha-Glycyrrhetinic Acid
% 210.86/211.05  |- skos__hiddenLabel mesh__D002229
% 210.86/211.05       18alpha Glycyrrhetinic Acid 3beta O Hemisuccinate
% 210.86/211.05  |- mesh__dateCreated mesh__D002229 1974-11-11
% 210.86/211.05  |- skos__prefLabel mesh__D002229 Carbenoxolone
% 210.86/211.05  |- mesh__dateEstablished mesh__D002229 1991-01-01
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D002229 2006
% 210.86/211.05  |- skos__altLabel mesh__D002229
% 210.86/211.05       18alpha-Glycyrrhetinic Acid 3beta-O-Hemisuccinate
% 210.86/211.05  |- skos__altLabel mesh__D002229 Carbeneoxolone
% 210.86/211.05  |- skos__hiddenLabel mesh__D002229
% 210.86/211.05       Acid 3beta-O-Hemisuccinate, 18alpha-Glycyrrhetinic
% 210.86/211.05  |- skos__historyNote mesh__D002229 Succinates %28%1974%29%
% 210.86/211.05  |- mesh__recordAuthorizer mesh__D002229 sjn
% 210.86/211.05  |- mesh__recordOriginator mesh__D002229 NLM
% 210.86/211.05  |- rdf__type mesh__D002229sskos__Concept
% 210.86/211.05  |- mesh__publicMeSHNote mesh__D002229
% 210.86/211.05       1991; see GLYCYRRHETINIC ACID 1979-1990, see TRITERPENES 1975-1978; for 18ALPHA-CARBENOXOLONE was indexed under CARBENOXOLONE %28%NM%29% 1995-2002%A%  
% 210.86/211.05  |- mesh__recordMaintainer mesh__D002229 mdb
% 210.86/211.05  |- skos__altLabel mesh__D002229 Carbenoxalone
% 210.86/211.05  |- skos__annotation mesh__D002229 /biosyn permitted if by plant   
% 210.86/211.05  |- mesh__historyNote mesh__D002229
% 210.86/211.05       1991%28%1975%29%; for 18ALPHA-CARBENOXOLONE use CARBENOXOLONE %28%NM%29% 1995-2002%A%  
% 210.86/211.05  |- skos__altLabel mesh__D002229 Carbenoxolone Disodium Salt
% 210.86/211.05  |- mesh__dateRevised mesh__D002229 2004-07-07
% 210.86/211.05  |- skos__hiddenLabel mesh__D002229 3-O-hemisuccinate, Glycyrrhetinic Acid
% 210.86/211.05  |- skos__altLabel mesh__D002229 Byk Brand of Carbenoxolone Disodium Salt
% 210.86/211.05  |- skos__hiddenLabel mesh__D002229 18alpha Carbenoxolone
% 210.86/211.05  |- skos__scopeNote mesh__D002229
% 210.86/211.05       An agent derived from licorice root. It is used for the treatment of digestive tract ulcers, especially in the stomach. Antidiuretic side effects are frequent, but otherwise the drug is low in toxicity.%A%    
% 210.86/211.05  |- skos__hiddenLabel mesh__D002229 Glycyrrhetinic Acid 3 O hemisuccinate
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012657 2000
% 210.86/211.05  |- skos__prefLabel mesh__D012657 Self-Help Groups
% 210.86/211.05  |- skos__hiddenLabel mesh__D012657 Self Help Groups
% 210.86/211.05  |- mesh__onlineNote mesh__D012657
% 210.86/211.05       use SELF-HELP GROUPS to search SOCIAL CLUBS %28%now SOCIAL CLUBS, THERAPEUTIC see SELF-HELP GROUPS%29% 1973-78 %28%as Prov 1973-74%29%%A%  
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012657 2003
% 210.86/211.05  |- rdf__type mesh__D012657sskos__Concept
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012657 1997
% 210.86/211.05  |- mesh__dateEstablished mesh__D012657 1979-01-01
% 210.86/211.05  |- skos__scopeNote mesh__D012657
% 210.86/211.05       Organizations which provide an environment encouraging social interactions through group activities or individual relationships especially for the purpose of rehabilitating or supporting patients, individuals with common health problems, or the elderly. They include therapeutic social clubs.%A%    
% 210.86/211.05  |- skos__hiddenLabel mesh__D012657 Support Group
% 210.86/211.05  |- mesh__dateCreated mesh__D012657 1999-01-01
% 210.86/211.05  |- skos__altLabel mesh__D012657 Social Clubs, Therapeutic
% 210.86/211.05  |- skos__altLabel mesh__D012657 Support Groups
% 210.86/211.05  |- skos__hiddenLabel mesh__D012657 Self-Help Group
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012657 2001
% 210.86/211.05  |- skos__hiddenLabel mesh__D012657 Groups, Self-Help
% 210.86/211.05  |- mesh__dateRevised mesh__D012657 1994-05-23
% 210.86/211.05  |- skos__hiddenLabel mesh__D012657 Group, Support
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012657 2004
% 210.86/211.05  |- mesh__recordOriginator mesh__D012657 NLM
% 210.86/211.05  |- mesh__recordAuthorizer mesh__D012657 PLS
% 210.86/211.05  |- mesh__recordMaintainer mesh__D012657 JLS
% 210.86/211.05  |- skos__hiddenLabel mesh__D012657 Club, Therapeutic Social
% 210.86/211.05  |- skos__hiddenLabel mesh__D012657 Group, Self-Help
% 210.86/211.05  |- skos__altLabel mesh__D012657 Therapeutic Social Clubs
% 210.86/211.05  |- skos__hiddenLabel mesh__D012657 Therapeutic Social Club
% 210.86/211.05  |- mesh__publicMeSHNote mesh__D012657
% 210.86/211.05       79; was SOCIAL CLUBS see under ORGANIZATIONS 1975-78   
% 210.86/211.05  |- skos__historyNote mesh__D012657 Organizations %28%1968-1972%29%
% 210.86/211.05  |- skos__hiddenLabel mesh__D012657 Social Club, Therapeutic
% 210.86/211.05  |- skos__broader mesh__D012657smesh__D009938
% 210.86/211.05  |- skos__hiddenLabel mesh__D012657 Groups, Support
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012657 1998
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012657 1995
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012657 2002
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012657 2005
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012657 1999
% 210.86/211.05  |- mesh__historyNote mesh__D012657
% 210.86/211.05       79; was SOCIAL CLUBS see under ORGANIZATIONS 1975-78, was SOCIAL CLUBS 1973-74 %28%Prov%29%%A%  
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012657 1996
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012657 2006
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D050776 2006A
% 210.86/211.05  |- skos__hiddenLabel mesh__D050776 Complement, C5b
% 210.86/211.05  |- mesh__dateCreated mesh__D050776 2005-06-30
% 210.86/211.05  |- skos__broader mesh__D050776smesh__D003182
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D050776 2006
% 210.86/211.05  |- rdf__type mesh__D050776sskos__Concept
% 210.86/211.05  |- skos__altLabel mesh__D050776 C5b Complement
% 210.86/211.05  |- mesh__historyNote mesh__D050776 2006 %28%1982%29%   
% 210.86/211.05  |- skos__scopeNote mesh__D050776
% 210.86/211.05       The larger fragment generated from the cleavage of C5 by C5 CONVERTASE  that yields COMPLEMENT C5A and C5b %28%beta chain + alpha%27% chain, the residual alpha chain, bound by disulfide bond%29%. C5b remains bound to the membrane and initiates the spontaneous assembly of the late complement components to form C5b-8-poly-C9, the MEMBRANE ATTACK COMPLEX.%A%    
% 210.86/211.05  |- skos__hiddenLabel mesh__D050776 C5b, Complement
% 210.86/211.05  |- skos__altLabel mesh__D050776 Complement 5b
% 210.86/211.05  |- mesh__recordMaintainer mesh__D050776 ags
% 210.86/211.05  |- skos__prefLabel mesh__D050776 Complement C5b
% 210.86/211.05  |- mesh__recordAuthorizer mesh__D050776 ags
% 210.86/211.05  |- skos__hiddenLabel mesh__D050776 Component 5b, Complement
% 210.86/211.05  |- mesh__dateEstablished mesh__D050776 2006-01-01
% 210.86/211.05  |- mesh__dateRevised mesh__D050776 2005-07-11
% 210.86/211.05  |- mesh__recordOriginator mesh__D050776 lkt
% 210.86/211.05  |- mesh__publicMeSHNote mesh__D050776
% 210.86/211.05       2006; COMPLEMENT C5B was indexed under COMPLEMENT 5 1982-2005%A%  
% 210.86/211.05  |- skos__altLabel mesh__D050776 Complement Component 5b
% 210.86/211.05  |- skos__hiddenLabel mesh__D041441 X-Linked Retinoschises
% 210.86/211.05  |- skos__hiddenLabel mesh__D041441 Retinoschises, Juvenile
% 210.86/211.05  |- skos__broader mesh__D041441smesh__D012162
% 210.86/211.05  |- rdf__type mesh__D041441sskos__Concept
% 210.86/211.05  |- skos__hiddenLabel mesh__D041441 Retinoschises, Degenerative
% 210.86/211.05  |- skos__hiddenLabel mesh__D041441 Juvenile Retinoschises
% 210.86/211.05  |- mesh__historyNote mesh__D041441 2003   
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D041441 2005
% 210.86/211.05  |- skos__hiddenLabel mesh__D041441 Degenerative Retinoschisis
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D041441 2003
% 210.86/211.05  |- skos__hiddenLabel mesh__D041441 X Linked Retinoschisis
% 210.86/211.05  |- skos__historyNote mesh__D041441 Retinal Diseases %28%1970-2002%29%
% 210.86/211.05  |- skos__hiddenLabel mesh__D041441 Retinoschises, X-Linked
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D041441 2006
% 210.86/211.05  |- skos__historyNote mesh__D041441 Retinal Degeneration %28%1969-2002%29%
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D041441 2004
% 210.86/211.05  |- skos__hiddenLabel mesh__D041441 Juvenile Retinoschisis
% 210.86/211.05  |- skos__prefLabel mesh__D041441 Retinoschisis
% 210.86/211.05  |- skos__altLabel mesh__D041441
% 210.86/211.05       Retinoschisis, Juvenile, X Chromosome-Linked
% 210.86/211.05  |- skos__related mesh__D041441smesh__D012163
% 210.86/211.05  |- skos__hiddenLabel mesh__D041441 Degenerative Retinoschises
% 210.86/211.05  |- mesh__publicMeSHNote mesh__D041441 2003   
% 210.86/211.05  |- skos__hiddenLabel mesh__D041441 Retinoschisis, X Linked
% 210.86/211.05  |- mesh__dateEstablished mesh__D041441 2003-01-01
% 210.86/211.05  |- mesh__dateCreated mesh__D041441 2002-07-18
% 210.86/211.05  |- skos__scopeNote mesh__D041441
% 210.86/211.05       A vitreoretinal dystrophy characterized by splitting of the neuroretinal layers. It occurs in two forms: degenerative retinoschisis and X chromosome-linked juvenile retinoschisis.%A%    
% 210.86/211.05  |- skos__hiddenLabel mesh__D041441 Retinoschises
% 210.86/211.05  |- skos__altLabel mesh__D041441 X-Linked Retinoschisis
% 210.86/211.05  |- skos__altLabel mesh__D041441 Retinoschisis, X-Linked
% 210.86/211.05  |- skos__altLabel mesh__D041441 Retinoschisis, Juvenile
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D013750 2005
% 210.86/211.05  |- skos__altLabel mesh__D013750 Tetrachlorethylene
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D013750 2002
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D013750 2006
% 210.86/211.05  |- mesh__dateCreated mesh__D013750 1999-01-01
% 210.86/211.05  |- mesh__recordOriginator mesh__D013750 NLM
% 210.86/211.05  |- skos__altLabel mesh__D013750 Tetrachloroethene
% 210.86/211.05  |- skos__scopeNote mesh__D013750
% 210.86/211.05       A chlorinated hydrocarbon used as an industrial solvent and cooling liquid in electrical transformers. It is a potential carcinogen.%A%    
% 210.86/211.05  |- mesh__recordAuthorizer mesh__D013750 sjn
% 210.86/211.05  |- skos__altLabel mesh__D013750 Perchlorethylene
% 210.86/211.05  |- rdf__type mesh__D013750sskos__Concept
% 210.86/211.05  |- skos__broader mesh__D013750smesh__D006843
% 210.86/211.05  |- skos__altLabel mesh__D013750 Perchloroethylene
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D013750 2003
% 210.86/211.05  |- mesh__dateRevised mesh__D013750 2001-07-25
% 210.86/211.05  |- mesh__recordMaintainer mesh__D013750 ssb
% 210.86/211.05  |- skos__prefLabel mesh__D013750 Tetrachloroethylene
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D013750 2004
% 210.86/211.05  |- mesh__recordOriginator mesh__D007713 NLM
% 210.86/211.05  |- skos__prefLabel mesh__D007713 Klinefelter Syndrome
% 210.86/211.05  |- skos__hiddenLabel mesh__D007713 Klinefelters Syndrome
% 210.86/211.05  |- skos__hiddenLabel mesh__D007713 Klinefelter Syndromes
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D007713 2006
% 210.86/211.05  |- skos__altLabel mesh__D007713 Klinefelter%27%s Syndrome
% 210.86/211.05  |- mesh__dateRevised mesh__D007713 2005-06-30
% 210.86/211.05  |- mesh__recordMaintainer mesh__D007713 lkt
% 210.86/211.05  |- mesh__recordAuthorizer mesh__D007713 sjn
% 210.86/211.05  |- skos__annotation mesh__D007713
% 210.86/211.05       index here karyotypes XXXY, XXXXY, XXYY, XXXYY, XX/XXY, XX/YY, XY/XXY, XXY/XXXY, XXY/XXYY, XY/XXY/XXXY if called KLINEFELTER SYNDROME by author but if not so named by author, index under SEX CHROMOSOME DISORDERS%A%  
% 210.86/211.05  |- skos__broader mesh__D007713smesh__D025064
% 210.86/211.05  |- skos__broader mesh__D007713smesh__D012734
% 210.86/211.05  |- skos__hiddenLabel mesh__D007713 Syndrome, Klinefelter%27%s
% 210.86/211.05  |- skos__hiddenLabel mesh__D007713 Syndromes, Klinefelter
% 210.86/211.05  |- skos__hiddenLabel mesh__D007713 Syndrome, Klinefelter
% 210.86/211.05  |- mesh__dateCreated mesh__D007713 1999-01-01
% 210.86/211.05  |- rdf__type mesh__D007713sskos__Concept
% 210.86/211.05  |- skos__broader mesh__D007713smesh__D007006
% 210.86/211.05  |- skos__scopeNote mesh__D007713
% 210.86/211.05       A form of male HYPOGONADISM, characterized by the presence of an extra X CHROMOSOME, small TESTES, seminiferous tubule dysgenesis, elevated levels of GONADOTROPINS, low serum TESTOSTERONE, underdeveloped secondary sex characteristics, and male infertility %28%INFERTILITY, MALE%29%. Patients tend to have long legs and a slim, tall stature. GYNECOMASTIA is present in many of the patients. The classic form has the karyotype 47,XXY. Several karyotype variants include 48,XXYY; 48,XXXY; 49,XXXXY, and mosaic patterns %28% 46,XY/47,XXY; 47,XXY/48,XXXY, etc.%29%.%A%    
% 210.86/211.05  |- mesh__recordAuthorizer mesh__D012658 sjn
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012658 2002
% 210.86/211.05  |- skos__prefLabel mesh__D012658 Sella Turcica
% 210.86/211.05  |- skos__scopeNote mesh__D012658
% 210.86/211.05       A bony prominence situated on the upper surface of the body of the sphenoid bone. It houses the PITUITARY GLAND.%A%    
% 210.86/211.05  |- skos__hiddenLabel mesh__D012658 Sella Turcicas
% 210.86/211.05  |- skos__hiddenLabel mesh__D012658 Turcicas, Sella
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012658 2000
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012658 2005
% 210.86/211.05  |- skos__broader mesh__D012658smesh__D013100
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012658 2006
% 210.86/211.05  |- skos__hiddenLabel mesh__D012658 Turcica, Sella
% 210.86/211.05  |- mesh__recordMaintainer mesh__D012658 KEV
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012658 2001
% 210.86/211.05  |- rdf__type mesh__D012658sskos__Concept
% 210.86/211.05  |- skos__related mesh__D012658smesh__D004652
% 210.86/211.05  |- mesh__recordOriginator mesh__D012658 NLM
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012658 2003
% 210.86/211.05  |- mesh__dateCreated mesh__D012658 1999-01-01
% 210.86/211.05  |- mesh__dateRevised mesh__D012658 1999-11-03
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D012658 2004
% 210.86/211.05  |- mesh__dateCreated mesh__D017343 1992-05-20
% 210.86/211.05  |- skos__annotation mesh__D017343
% 210.86/211.05       coordinate IM with specific plant term /genet %28%IM%29%   
% 210.86/211.05  |- rdf__type mesh__D017343sskos__Concept
% 210.86/211.05  |- skos__broader mesh__D017343smesh__D005796
% 210.86/211.05  |- skos__historyNote mesh__D017343 Genes %28%1966-1992%29%
% 210.86/211.05  |- skos__hiddenLabel mesh__D017343 Gene, Plant
% 210.86/211.05  |- mesh__dateEstablished mesh__D017343 1993-01-01
% 210.86/211.05  |- skos__historyNote mesh__D017343 specific plant %28%1966-1992%29%
% 210.86/211.05  |- mesh__recordAuthorizer mesh__D017343 sjn
% 210.86/211.05  |- skos__hiddenLabel mesh__D017343 Plant Gene
% 210.86/211.05  |- skos__altLabel mesh__D017343 Plant Genes
% 210.86/211.05  |- mesh__recordMaintainer mesh__D017343 nns
% 210.86/211.05  |- skos__scopeNote mesh__D017343
% 210.86/211.05       The functional hereditary units of PLANTS.     
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D017343 2006
% 210.86/211.05  |- skos__prefLabel mesh__D017343 Genes, Plant
% 210.86/211.05  |- skos__related mesh__D017343smesh__D018745
% 210.86/211.05  |- mesh__publicMeSHNote mesh__D017343 93   
% 210.86/211.05  |- mesh__historyNote mesh__D017343 93   
% 210.86/211.05  |- skos__broader mesh__D017343smesh__D018745
% 210.86/211.05  |- mesh__recordOriginator mesh__D017343 PXP
% 210.86/211.05  |- mesh__dateRevised mesh__D017343 2005-06-30
% 210.86/211.05  |- skos__broader mesh__D050777smesh__D010750
% 210.86/211.05  |- skos__altLabel mesh__D050777 Oncoprotein 18
% 210.86/211.05  |- skos__scopeNote mesh__D050777
% 210.86/211.05       A ubiquitous phosphoprotein that serves as an intracellular substrate for a variety of SIGNAL TRANSDUCTION PATHWAYS. PHOSPHORYLATION of stathmin occurs during CELL CYCLE progression, and stathmin functions as a microtubule-destabilizing protein that promotes MICROTUBULE depolymerization during INTERPHASE and late MITOSIS. Stathmin is expressed at very high levels in a variety of human CANCERS.%A%    
% 210.86/211.05  |- skos__prefLabel mesh__D050777 Stathmin
% 210.86/211.05  |- mesh__recordAuthorizer mesh__D050777 sjn
% 210.86/211.05  |- skos__altLabel mesh__D050777 Metablastin
% 210.86/211.05  |- skos__altLabel mesh__D050777 Lap18 Protein
% 210.86/211.05  |- mesh__historyNote mesh__D050777 2006%28%1987%29%   
% 210.86/211.05  |- skos__hiddenLabel mesh__D050777 p19, Phosphoprotein
% 210.86/211.05  |- skos__broader mesh__D050777smesh__D008869
% 210.86/211.05  |- mesh__publicMeSHNote mesh__D050777
% 210.86/211.05       2006; STATHMIN was indexed under MICROTUBULE PROTEINS %26% PHOSPHOPROTEINS 1987-2005%A%  
% 210.86/211.05  |- skos__hiddenLabel mesh__D050777 p18, Leukemia-Associated Phosphoprotein
% 210.86/211.05  |- skos__altLabel mesh__D050777 Op18b Protein
% 210.86/211.05  |- skos__altLabel mesh__D050777 Op18 Phosphoprotein
% 210.86/211.05  |- mesh__dateEstablished mesh__D050777 2006-01-01
% 210.86/211.05  |- skos__altLabel mesh__D050777 Phosphoprotein p19
% 210.86/211.05  |- mesh__recordMaintainer mesh__D050777 DRC
% 210.86/211.05  |- skos__altLabel mesh__D050777 Leukemia-Associated Phosphoprotein p18
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D050777 2006
% 210.86/211.05  |- skos__altLabel mesh__D050777 Phosphoprotein p18
% 210.86/211.05  |- skos__hiddenLabel mesh__D050777 Phosphoprotein, Op18
% 210.86/211.05  |- skos__altLabel mesh__D050777 Prosolin
% 210.86/211.05  |- skos__hiddenLabel mesh__D050777 Alpha Stathmin
% 210.86/211.05  |- skos__broader mesh__D050777smesh__D011518
% 210.86/211.05  |- rdf__type mesh__D050777sskos__Concept
% 210.86/211.05  |- mesh__recordOriginator mesh__D050777 DRC
% 210.86/211.05  |- skos__hiddenLabel mesh__D050777 Leukemia Associated Phosphoprotein p18
% 210.86/211.05  |- skos__hiddenLabel mesh__D050777 Beta Stathmin
% 210.86/211.05  |- skos__altLabel mesh__D050777 Op18a Protein
% 210.86/211.05  |- skos__hiddenLabel mesh__D050777 p18, Phosphoprotein
% 210.86/211.05  |- mesh__dateCreated mesh__D050777 2005-06-30
% 210.86/211.05  |- mesh__dateEstablished mesh__D003323 1987-01-01
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D003323 2004
% 210.86/211.05  |- skos__related mesh__D003323smesh__D006322
% 210.86/211.05  |- skos__hiddenLabel mesh__D003323 Coronary Aneurysms
% 210.86/211.05  |- mesh__dateRevised mesh__D003323 1997-06-20
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D003323 2006
% 210.86/211.05  |- skos__hiddenLabel mesh__D003323 Aneurysms, Coronary
% 210.86/211.05  |- skos__scopeNote mesh__D003323
% 210.86/211.05       Aneurysm of a coronary vessel. A coronary artery aneurysm is rarely congenital; it is usually due to atherosclerosis, inflammatory processes, or a coronary fistula. %28%From Stedman, 26th ed%29%%A%    
% 210.86/211.05  |- mesh__activeMeSHYear mesh__D003323 1998
% 210.86/211.06  |- mesh__recordMaintainer mesh__D003323 TGC
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003323 2002
% 210.86/211.06  |- skos__prefLabel mesh__D003323 Coronary Aneurysm
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003323 1999
% 210.86/211.06  |- skos__altLabel mesh__D003323 Aneurysm, Coronary
% 210.86/211.06  |- skos__broader mesh__D003323smesh__D000783
% 210.86/211.06  |- mesh__recordOriginator mesh__D003323 VDK
% 210.86/211.06  |- mesh__dateCreated mesh__D003323 1986-03-27
% 210.86/211.06  |- mesh__publicMeSHNote mesh__D003323 87   
% 210.86/211.06  |- rdf__type mesh__D003323sskos__Concept
% 210.86/211.06  |- skos__broader mesh__D003323smesh__D003327
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003323 2000
% 210.86/211.06  |- mesh__historyNote mesh__D003323 87   
% 210.86/211.06  |- skos__historyNote mesh__D003323 Coronary Disease %28%1966-1986%29%
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003323 2003
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003323 2001
% 210.86/211.06  |- skos__historyNote mesh__D003323 Aneurysm %28%1966-1986%29%
% 210.86/211.06  |- mesh__recordAuthorizer mesh__D003323 SJN
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003323 2005
% 210.86/211.06  |- mesh__dateCreated mesh__D013751 1999-01-01
% 210.86/211.06  |- mesh__dateRevised mesh__D013751 2004-07-07
% 210.86/211.06  |- skos__historyNote mesh__D013751 Organophosphorus Compounds %28%1971%29%
% 210.86/211.06  |- mesh__onlineNote mesh__D013751
% 210.86/211.06       use TETRACHLORVINPHOS to search GARDONA 1972-78 %28%as Prov 1972-73%29%%A%  
% 210.86/211.06  |- skos__prefLabel mesh__D013751 Tetrachlorvinphos
% 210.86/211.06  |- rdf__type mesh__D013751sskos__Concept
% 210.86/211.06  |- skos__scopeNote mesh__D013751
% 210.86/211.06       An organophosphate cholinesterase inhibitor that is used as an insecticide. It has low mammalian toxicity. %28%From Merck Index, 11th ed%29%%A%    
% 210.86/211.06  |- mesh__recordOriginator mesh__D013751 NLM
% 210.86/211.06  |- mesh__publicMeSHNote mesh__D013751 79; was GARDONA 1974-78   
% 210.86/211.06  |- mesh__recordAuthorizer mesh__D013751 sjn
% 210.86/211.06  |- mesh__historyNote mesh__D013751
% 210.86/211.06       79; was GARDONA 1972-78 %28%Prov 1972-73%29%   
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D013751 2005
% 210.86/211.06  |- mesh__dateEstablished mesh__D013751 1974-01-01
% 210.86/211.06  |- skos__broader mesh__D013751smesh__D009943
% 210.86/211.06  |- skos__altLabel mesh__D013751 Stirofos
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D013751 2006
% 210.86/211.06  |- skos__annotation mesh__D013751 TN 111 for eff on insects   
% 210.86/211.06  |- mesh__recordMaintainer mesh__D013751 ssb
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D007714 2004
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D007714 2001
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D007714 2006
% 210.86/211.06  |- skos__prefLabel mesh__D007714 Klippel-Feil Syndrome
% 210.86/211.06  |- skos__hiddenLabel mesh__D007714 Syndrome, Klippel-Feil
% 210.86/211.06  |- skos__hiddenLabel mesh__D007714 Klippel Feil Syndrome
% 210.86/211.06  |- mesh__recordOriginator mesh__D007714 NLM
% 210.86/211.06  |- skos__annotation mesh__D007714
% 210.86/211.06       short neck as result of vertebral abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 210.86/211.06  |- mesh__recordMaintainer mesh__D007714 kle
% 210.86/211.06  |- skos__hiddenLabel mesh__D007714 Dystrophia Brevicollis Congenitas
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D007714 2002
% 210.86/211.06  |- skos__broader mesh__D007714smesh__D004413
% 210.86/211.06  |- skos__broader mesh__D007714smesh__D009139
% 210.86/211.06  |- mesh__dateCreated mesh__D007714 1999-01-01
% 210.86/211.06  |- mesh__recordAuthorizer mesh__D007714 sjn
% 210.86/211.06  |- rdf__type mesh__D007714sskos__Concept
% 210.86/211.06  |- skos__altLabel mesh__D007714 Dystrophia Brevicollis Congenita
% 210.86/211.06  |- mesh__dateRevised mesh__D007714 1999-11-03
% 210.86/211.06  |- skos__scopeNote mesh__D007714
% 210.86/211.06       A condition characterized by shortness of the neck resulting from reduction in the number of vertebrae or the fusion of multiple hemivertebrae into one osseous mass. The hairline is low and the motion of the neck is limited. %28%Dorland, 27th ed%29%%A%    
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D007714 2003
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D007714 2000
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D007714 2005
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D012659 1998
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D012659 1995
% 210.86/211.06  |- skos__historyNote mesh__D012659 Semantics %28%1966-1967%29%
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D012659 1999
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D012659 2005
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D012659 2002
% 210.86/211.06  |- skos__scopeNote mesh__D012659
% 210.86/211.06       Analysis of word concepts by the association of polar adjectives, e.g., good-bad, with the concept, father. The adjectives are usually scaled in 7 steps. The subject%27%s placement of the concept on the adjectival scale indicates the connotative meaning of the concept.%A%    
% 210.86/211.06  |- mesh__dateRevised mesh__D012659 1992-05-18
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D012659 1993
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D012659 1996
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D012659 2006
% 210.86/211.06  |- mesh__publicMeSHNote mesh__D012659 68   
% 210.86/211.06  |- skos__prefLabel mesh__D012659 Semantic Differential
% 210.86/211.06  |- rdf__type mesh__D012659sskos__Concept
% 210.86/211.06  |- skos__historyNote mesh__D012659 Psychological Tests %28%1966-1967%29%
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D012659 2003
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D012659 1997
% 210.86/211.06  |- mesh__dateEstablished mesh__D012659 1968-01-01
% 210.86/211.06  |- mesh__dateCreated mesh__D012659 1999-01-01
% 210.86/211.06  |- skos__altLabel mesh__D012659 Differential, Semantic
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D012659 2000
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D012659 2004
% 210.86/211.06  |- skos__hiddenLabel mesh__D012659 Semantic Differentials
% 210.86/211.06  |- mesh__historyNote mesh__D012659 68   
% 210.86/211.06  |- skos__broader mesh__D012659smesh__D011578
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D012659 2001
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D012659 1994
% 210.86/211.06  |- mesh__recordAuthorizer mesh__D012659 PLS
% 210.86/211.06  |- mesh__recordMaintainer mesh__D012659 TAP
% 210.86/211.06  |- skos__annotation mesh__D012659
% 210.86/211.06       a type of psychol test: do not confuse with SEMANTICS; DF: SEMANTIC DIFFER%A%  
% 210.86/211.06  |- mesh__recordOriginator mesh__D012659 NLM
% 210.86/211.06  |- skos__broader mesh__D012659smesh__D010556
% 210.86/211.06  |- skos__hiddenLabel mesh__D012659 Differentials, Semantic
% 210.86/211.06  |- skos__hiddenLabel mesh__D023381 Assays, End Point
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D023381 2002
% 210.86/211.06  |- skos__hiddenLabel mesh__D023381 Point Assays, End
% 210.86/211.06  |- skos__hiddenLabel mesh__D023381 Determinations, End Point
% 210.86/211.06  |- skos__prefLabel mesh__D023381 Endpoint Determination
% 210.86/211.06  |- skos__broader mesh__D023381smesh__D001681
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D023381 2001
% 210.86/211.06  |- skos__hiddenLabel mesh__D023381 Determination, Endpoint
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D023381 2004
% 210.86/211.06  |- skos__hiddenLabel mesh__D023381 Endpoint Assays
% 210.86/211.06  |- mesh__historyNote mesh__D023381 2001   
% 210.86/211.06  |- skos__hiddenLabel mesh__D023381 Determinations, Endpoint
% 210.86/211.06  |- rdf__type mesh__D023381sskos__Concept
% 210.86/211.06  |- skos__hiddenLabel mesh__D023381 End Point Determinations
% 210.86/211.06  |- mesh__publicMeSHNote mesh__D023381 2001   
% 210.86/211.06  |- skos__hiddenLabel mesh__D023381 Assay, End Point
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D023381 2006
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D023381 2003
% 210.86/211.06  |- skos__scopeNote mesh__D023381
% 210.86/211.06       Establishment of the level of a quantifiable effect indicative of a biologic process. The evaluation is frequently to detect the degree of toxic or therapeutic effect.%A%    
% 210.86/211.06  |- skos__historyNote mesh__D023381 Biological Assay %28%1980-2000%29%
% 210.86/211.06  |- skos__hiddenLabel mesh__D023381 Point Determinations, End
% 210.86/211.06  |- skos__altLabel mesh__D023381 End Point Determination
% 210.86/211.06  |- skos__hiddenLabel mesh__D023381 Endpoint Determinations
% 210.86/211.06  |- skos__hiddenLabel mesh__D023381 Assays, Endpoint
% 210.86/211.06  |- skos__altLabel mesh__D023381 End Point Assay
% 210.86/211.06  |- mesh__dateCreated mesh__D023381 2000-06-21
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D023381 2005
% 210.86/211.06  |- mesh__dateEstablished mesh__D023381 2001-01-01
% 210.86/211.06  |- skos__hiddenLabel mesh__D023381 Assay, Endpoint
% 210.86/211.06  |- skos__hiddenLabel mesh__D023381 End Point Assays
% 210.86/211.06  |- skos__hiddenLabel mesh__D023381 Point Assay, End
% 210.86/211.06  |- skos__historyNote mesh__D017344 specific insect %28%1966-1992%29%
% 210.86/211.06  |- mesh__dateEstablished mesh__D017344 1993-01-01
% 210.86/211.06  |- mesh__historyNote mesh__D017344 93   
% 210.86/211.06  |- skos__annotation mesh__D017344
% 210.86/211.06       coordinate IM with specific insect /genet %28%IM%29%   
% 210.86/211.06  |- mesh__recordOriginator mesh__D017344 PXP
% 210.86/211.06  |- mesh__publicMeSHNote mesh__D017344 93   
% 210.86/211.06  |- rdf__type mesh__D017344sskos__Concept
% 210.86/211.06  |- skos__hiddenLabel mesh__D017344 Gene, Insect
% 210.86/211.06  |- mesh__dateRevised mesh__D017344 2005-06-30
% 210.86/211.06  |- mesh__dateCreated mesh__D017344 1992-05-20
% 210.86/211.06  |- skos__related mesh__D017344smesh__D049750
% 210.86/211.06  |- skos__scopeNote mesh__D017344
% 210.86/211.06       The functional hereditary units of INSECTS.     
% 210.86/211.06  |- skos__historyNote mesh__D017344 Genes %28%1966-1992%29%
% 210.86/211.06  |- skos__altLabel mesh__D017344 Insect Genes
% 210.86/211.06  |- mesh__recordMaintainer mesh__D017344 nns
% 210.86/211.06  |- skos__prefLabel mesh__D017344 Genes, Insect
% 210.86/211.06  |- mesh__recordAuthorizer mesh__D017344 sjn
% 210.86/211.06  |- skos__broader mesh__D017344smesh__D049750
% 210.86/211.06  |- skos__broader mesh__D017344smesh__D005796
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D017344 2006
% 210.86/211.06  |- skos__hiddenLabel mesh__D017344 Insect Gene
% 210.86/211.06  |- skos__altLabel mesh__D050778 NFATC3 Protein
% 210.86/211.06  |- skos__altLabel mesh__D050778
% 210.86/211.06       Nuclear Factor of Activated T-Cells, Cytoplasmic 3 Protein
% 210.86/211.06  |- skos__altLabel mesh__D050778 TonEBP Protein
% 210.86/211.06  |- skos__altLabel mesh__D050778 NFAT3 Protein
% 210.86/211.06  |- skos__altLabel mesh__D050778 Osmotic Response Element Binding Protein
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778 Nuclear Factors of Activated T Cells
% 210.86/211.06  |- skos__altLabel mesh__D050778 NFAT-2 Protein
% 210.86/211.06  |- skos__prefLabel mesh__D050778 NFATC Transcription Factors
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778 NFAT 2 Protein
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778 Factor, NFATC2 Transcription
% 210.86/211.06  |- skos__altLabel mesh__D050778 NFAT5 Protein
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778 Factor, NFATC3 Transcription
% 210.86/211.06  |- skos__altLabel mesh__D050778
% 210.86/211.06       Nuclear Factor of Activated T-Cells, Cytoplasmic 2 Protein
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778
% 210.86/211.06       Tonicity Responsive Enhancer Binding Protein
% 210.86/211.06  |- skos__altLabel mesh__D050778
% 210.86/211.06       Nuclear Factor of Activated T-Cells, Cytoplasmic 4 Protein
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778
% 210.86/211.06       Nuclear Factor of Activated T Cells, Cytoplasmic 4 Protein
% 210.86/211.06  |- skos__altLabel mesh__D050778 NFAT Proteins
% 210.86/211.06  |- skos__altLabel mesh__D050778 NFATC4 Transcription Factor
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778
% 210.86/211.06       Nuclear Factor of Activated T Cells, Cytoplasmic 3 Protein
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778
% 210.86/211.06       Nuclear Factor of Activated T Cells, Cytoplasmic
% 210.86/211.06  |- skos__altLabel mesh__D050778 NFATC2 Protein
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778 NFAT 1 Protein
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778 Transcription Factor, NFATC4
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778
% 210.86/211.06       Nuclear Factor of Activated T Cells, Cytoplasmic 1 Protein
% 210.86/211.06  |- mesh__recordMaintainer mesh__D050778 ags
% 210.86/211.06  |- skos__altLabel mesh__D050778 NFATz Protein
% 210.86/211.06  |- skos__altLabel mesh__D050778 NFATL1 Protein
% 210.86/211.06  |- skos__altLabel mesh__D050778 NF-AT3 Protein
% 210.86/211.06  |- skos__altLabel mesh__D050778 NFATC Proteins
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778 Transcription Factor NF AT
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D050778 2006
% 210.86/211.06  |- skos__altLabel mesh__D050778 NFAT-1 Protein
% 210.86/211.06  |- skos__altLabel mesh__D050778 NF-AT Proteins
% 210.86/211.06  |- skos__altLabel mesh__D050778 Transcription Factor NF-AT
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778 NF AT4 Protein
% 210.86/211.06  |- skos__altLabel mesh__D050778 NFATx Protein
% 210.86/211.06  |- skos__altLabel mesh__D050778
% 210.86/211.06       Nuclear Factor of Activated T-Cells, Cytoplasmic
% 210.86/211.06  |- mesh__dateCreated mesh__D050778 2005-06-30
% 210.86/211.06  |- skos__altLabel mesh__D050778 NFATC4 Protein
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778 Transcription Factor, NFATC3
% 210.86/211.06  |- mesh__recordOriginator mesh__D050778 DRC
% 210.86/211.06  |- skos__altLabel mesh__D050778 NFATC3 Transcription Factor
% 210.86/211.06  |- skos__altLabel mesh__D050778 NF-ATc1 Protein
% 210.86/211.06  |- skos__altLabel mesh__D050778
% 210.86/211.06       Tonicity-Responsive Enhancer-Binding Protein
% 210.86/211.06  |- mesh__recordAuthorizer mesh__D050778 ags
% 210.86/211.06  |- skos__altLabel mesh__D050778 NFAT4 Protein
% 210.86/211.06  |- skos__altLabel mesh__D050778 NF-AT4 Protein
% 210.86/211.06  |- mesh__historyNote mesh__D050778 2006%28%1993%29%   
% 210.86/211.06  |- skos__altLabel mesh__D050778
% 210.86/211.06       Nuclear Factor of Activated T-Cells, Cytoplasmic 1 Protein
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778
% 210.86/211.06       Nuclear Factor of Activated T Cells 5 Protein
% 210.86/211.06  |- skos__altLabel mesh__D050778 NFATC1 Protein
% 210.86/211.06  |- skos__altLabel mesh__D050778 OREBP Protein
% 210.86/211.06  |- mesh__publicMeSHNote mesh__D050778
% 210.86/211.06       2006; NFATC TRANSCRIPTION FACTORS was indexed under DNA-BINDING PROTEIN, NUCLEAR PROTEINS, %26% TRANSCRIPTION FACTORS 1993-2005%A%  
% 210.86/211.06  |- rdf__type mesh__D050778sskos__Concept
% 210.86/211.06  |- skos__scopeNote mesh__D050778
% 210.86/211.06       A family of transcription factors characterized by the presence of highly conserved calcineurin- and DNA-binding domains. NFAT proteins are activated in the CYTOPLASM by the calcium-dependent phosphatase CALCINEURIN. They transduce calcium signals to the nucleus where they can interact with TRANSCRIPTION FACTOR AP-1 or NF-KAPPA B and initiate GENETIC TRANSCRIPTION of GENES involved in CELL DIFFERENTIATION and development.  NFAT proteins stimulate T-CELL activation through the induction of IMMEDIATE-EARLY GENES such as INTERLEUKIN-2.%A%    
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778 Transcription Factor, NFATC2
% 210.86/211.06  |- skos__altLabel mesh__D050778 NFAT2 Protein
% 210.86/211.06  |- skos__altLabel mesh__D050778 Nuclear Factors of Activated T-Cells
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778 NF-AT, Transcription Factor
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778 NF AT3 Protein
% 210.86/211.06  |- skos__altLabel mesh__D050778 NFAT1 Protein
% 210.86/211.06  |- mesh__dateEstablished mesh__D050778 2006-01-01
% 210.86/211.06  |- skos__altLabel mesh__D050778 NFATC1 Transcription Factor
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778 Transcription Factors, NFATC
% 210.86/211.06  |- mesh__dateRevised mesh__D050778 2005-07-21
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778
% 210.86/211.06       Nuclear Factor of Activated T Cells, Cytoplasmic 2 Protein
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778 NF ATc1 Protein
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D050778 2006A
% 210.86/211.06  |- skos__broader mesh__D050778smesh__D014157
% 210.86/211.06  |- skos__altLabel mesh__D050778
% 210.86/211.06       Nuclear Factor of Activated T-Cells 5 Protein
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778 Transcription Factor, NFATC1
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778 Factor, NFATC1 Transcription
% 210.86/211.06  |- skos__hiddenLabel mesh__D050778 NF AT Proteins
% 210.86/211.06  |- skos__altLabel mesh__D050778 NFATC2 Transcription Factor
% 210.86/211.06  |- skos__hiddenLabel mesh__D003324 Coronary Artery Diseases
% 210.86/211.06  |- skos__altLabel mesh__D003324 Coronary Artery Disease
% 210.86/211.06  |- skos__hiddenLabel mesh__D003324 Atheroscleroses, Coronary
% 210.86/211.06  |- skos__altLabel mesh__D003324 Arteriosclerosis, Coronary
% 210.86/211.06  |- skos__hiddenLabel mesh__D003324 Disease, Coronary Artery
% 210.86/211.06  |- skos__altLabel mesh__D003324 Atherosclerosis, Coronary
% 210.86/211.06  |- skos__hiddenLabel mesh__D003324 Coronary Atheroscleroses
% 210.86/211.06  |- mesh__dateEstablished mesh__D003324 1987-01-01
% 210.86/211.06  |- skos__prefLabel mesh__D003324 Coronary Arteriosclerosis
% 210.86/211.06  |- skos__hiddenLabel mesh__D003324 Arterioscleroses, Coronary
% 210.86/211.06  |- skos__hiddenLabel mesh__D003324 Artery Disease, Coronary
% 210.86/211.06  |- mesh__historyNote mesh__D003324
% 210.86/211.06       1987; use CORONARY DISEASE 1974-1987; for CORONARY ARTERY DISEASE use CORONARY DISEASE 1986-2001%A%  
% 210.86/211.06  |- skos__hiddenLabel mesh__D003324 Artery Diseases, Coronary
% 210.86/211.06  |- skos__altLabel mesh__D003324 Coronary Atherosclerosis
% 210.86/211.06  |- mesh__recordMaintainer mesh__D003324 nns
% 210.86/211.06  |- mesh__dateRevised mesh__D003324 2004-07-07
% 210.86/211.06  |- skos__related mesh__D003324smesh__D017225
% 210.86/211.06  |- mesh__dateCreated mesh__D003324 1986-03-27
% 210.86/211.06  |- rdf__type mesh__D003324sskos__Concept
% 210.86/211.06  |- mesh__publicMeSHNote mesh__D003324
% 210.86/211.06       1987; see CORONARY DISEASE 1974-1987; for CORONARY ARTERY DISEASE see CORONARY DISEASE 1986-2001%A%  
% 210.86/211.06  |- mesh__recordAuthorizer mesh__D003324 sjn
% 210.86/211.06  |- skos__scopeNote mesh__D003324
% 210.86/211.06       Thickening and loss of elasticity of the coronary arteries, leading to progressive insufficiency of the arteries %28%CORONARY DISEASE%29%.%A%    
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003324 2005
% 210.86/211.06  |- mesh__recordOriginator mesh__D003324 VDK
% 210.86/211.06  |- skos__hiddenLabel mesh__D003324 Diseases, Coronary Artery
% 210.86/211.06  |- skos__broader mesh__D003324smesh__D001161
% 210.86/211.06  |- skos__broader mesh__D003324smesh__D003327
% 210.86/211.06  |- skos__hiddenLabel mesh__D003324 Coronary Arterioscleroses
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003324 2006
% 210.86/211.06  |- skos__historyNote mesh__D003324 Coronary Disease %28%1966-1986%29%
% 210.86/211.06  |- skos__hiddenLabel mesh__D013752 4 Epitetracycline
% 210.86/211.06  |- mesh__recordAuthorizer mesh__D013752 sjn
% 210.86/211.06  |- skos__broader mesh__D013752smesh__D013754
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D013752 2006
% 210.86/211.06  |- skos__scopeNote mesh__D013752
% 210.86/211.06       A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis.%A%    
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D013752 2005
% 210.86/211.06  |- mesh__dateRevised mesh__D013752 2004-07-07
% 210.86/211.06  |- rdf__type mesh__D013752sskos__Concept
% 210.86/211.06  |- mesh__recordOriginator mesh__D013752 NLM
% 210.86/211.06  |- skos__altLabel mesh__D013752 Tetracycline Monohydrochloride
% 210.86/211.06  |- mesh__dateCreated mesh__D013752 1999-01-01
% 210.86/211.06  |- skos__prefLabel mesh__D013752 Tetracycline
% 210.86/211.06  |- mesh__recordMaintainer mesh__D013752 ssb
% 210.86/211.06  |- mesh__recordMaintainer mesh__D007715 TGC
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D007715 2005
% 210.86/211.06  |- skos__altLabel mesh__D007715 Klippel-Trenaunay Disease
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D007715 2004
% 210.86/211.06  |- mesh__recordOriginator mesh__D007715 NLM
% 210.86/211.06  |- skos__hiddenLabel mesh__D007715 Syndrome, Klippel-Trenaunay-Weber
% 210.86/211.06  |- mesh__recordAuthorizer mesh__D007715 PLS
% 210.86/211.06  |- skos__hiddenLabel mesh__D007715 Disease, Klippel-Trenaunay
% 210.86/211.06  |- skos__annotation mesh__D007715 a form of angiomatosis   
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D007715 2006
% 210.86/211.06  |- skos__prefLabel mesh__D007715 Klippel-Trenaunay-Weber Syndrome
% 210.86/211.06  |- skos__hiddenLabel mesh__D007715 Klippel Trenaunay Disease
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D007715 1995
% 210.86/211.06  |- skos__broader mesh__D007715smesh__D000798
% 210.86/211.06  |- mesh__onlineNote mesh__D007715
% 210.86/211.06       use KLIPPEL-TRENAUNAY-WEBER SYNDROME to search KLIPPEL-TRENAUNAY DISEASE 1975-93; search ANGIOMATOSIS 1966-74%A%  
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D007715 2002
% 210.86/211.06  |- mesh__dateCreated mesh__D007715 1999-01-01
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D007715 1996
% 210.86/211.06  |- mesh__dateRevised mesh__D007715 1994-05-24
% 210.86/211.06  |- rdf__type mesh__D007715sskos__Concept
% 210.86/211.06  |- mesh__dateEstablished mesh__D007715 1991-01-01
% 210.86/211.06  |- mesh__historyNote mesh__D007715
% 210.86/211.06       94; was KLIPPEL-TRENAUNAY DISEASE 1975-93 %28%see under ANGIOMATOSIS 1975-90%29%%A%  
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D007715 1998
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D007715 2000
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D007715 1997
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D007715 2003
% 210.86/211.06  |- mesh__publicMeSHNote mesh__D007715
% 210.86/211.06       94; was KLIPPEL-TRENAUNAY DISEASE 1975-93 %28%see under ANGIOMATOSIS 1975-90%29%%A%  
% 210.86/211.06  |- skos__hiddenLabel mesh__D007715 Klippel Trenaunay Weber Syndrome
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D007715 1999
% 210.86/211.06  |- skos__scopeNote mesh__D007715
% 210.86/211.06       A rare condition usually affecting one extremity, characterized by hypertrophy of the bone and related soft tissues, large cutaneous hemangiomas, persistent nevus flammeus, and skin varices. %28%Dorland, 27th ed%29%%A%    
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D007715 2001
% 210.86/211.06  |- skos__historyNote mesh__D023382 Toxicity Tests %28%1995-2000%29%
% 210.86/211.06  |- mesh__historyNote mesh__D023382 2001   
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D023382 2004
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D023382 2002
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D023382 2006
% 210.86/211.06  |- skos__hiddenLabel mesh__D023382 Test, Acute Toxicity
% 210.86/211.06  |- skos__prefLabel mesh__D023382 Acute Toxicity Tests
% 210.86/211.06  |- skos__hiddenLabel mesh__D023382 Tests, Acute Toxicity
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D023382 2003
% 210.86/211.06  |- rdf__type mesh__D023382sskos__Concept
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D023382 2001
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D023382 2005
% 210.86/211.06  |- skos__altLabel mesh__D023382 Toxicity Tests, Acute
% 210.86/211.06  |- mesh__dateCreated mesh__D023382 2000-06-21
% 210.86/211.06  |- mesh__dateEstablished mesh__D023382 2001-01-01
% 210.86/211.06  |- skos__scopeNote mesh__D023382
% 210.86/211.06       Experiments designed to determine the potential toxic effects of one-time, short-term exposure to a chemical or chemicals.%A%    
% 210.86/211.06  |- skos__broader mesh__D023382smesh__D018675
% 210.86/211.06  |- mesh__publicMeSHNote mesh__D023382 2001   
% 210.86/211.06  |- skos__hiddenLabel mesh__D023382 Toxicity Test, Acute
% 210.86/211.06  |- skos__hiddenLabel mesh__D023382 Acute Toxicity Test
% 210.86/211.06  |- skos__historyNote mesh__D023382
% 210.86/211.06       specific substance/toxicity %28%1966-1994%29%
% 210.86/211.06  |- skos__hiddenLabel mesh__D050779
% 210.86/211.06       NF90 Double Stranded RNA Binding Proteins
% 210.86/211.06  |- mesh__historyNote mesh__D050779 2006%28%1993%29%   
% 210.86/211.06  |- rdf__type mesh__D050779sskos__Concept
% 210.86/211.06  |- skos__altLabel mesh__D050779 Interleukin Enhancer Binding Factor 3
% 210.86/211.06  |- mesh__publicMeSHNote mesh__D050779
% 210.86/211.06       2006; NUCLEAR FACTOR 90 PROTEINS were indexed under DNA-BINDING PROTEINS, NUCLEAR PROTEINS, %26% TRANSCRIPTION FACTORS 1993-2005%A%  
% 210.86/211.06  |- skos__altLabel mesh__D050779 NF90 Protein
% 210.86/211.06  |- mesh__recordOriginator mesh__D050779 DRC
% 210.86/211.06  |- skos__altLabel mesh__D050779 M Phase Phosphoprotein 4
% 210.86/211.06  |- skos__altLabel mesh__D050779 ILF3 Protein
% 210.86/211.06  |- skos__scopeNote mesh__D050779
% 210.86/211.06       A family of double-stranded RNA-binding proteins that are related to NFATC TRANSCRIPTION FACTORS. In addition to binding to RNA, nuclear factor 90 proteins form heterodimeric complexes that regulate GENETIC TRANSCRIPTION and may play a role in T-CELL activation.%A%    
% 210.86/211.06  |- mesh__dateCreated mesh__D050779 2005-06-30
% 210.86/211.06  |- skos__prefLabel mesh__D050779 Nuclear Factor 90 Proteins
% 210.86/211.06  |- mesh__recordAuthorizer mesh__D050779 sjn
% 210.86/211.06  |- skos__broader mesh__D050779smesh__D014157
% 210.86/211.06  |- mesh__dateEstablished mesh__D050779 2006-01-01
% 210.86/211.06  |- skos__broader mesh__D050779smesh__D016601
% 210.86/211.06  |- mesh__recordMaintainer mesh__D050779 DRC
% 210.86/211.06  |- skos__altLabel mesh__D050779 Nuclear Factor 90
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D050779 2006
% 210.86/211.06  |- skos__altLabel mesh__D050779 NF90 Double-Stranded RNA-Binding Proteins
% 210.86/211.06  |- skos__hiddenLabel mesh__D003325 Units, Coronary Care
% 210.86/211.06  |- mesh__publicMeSHNote mesh__D003325 72   
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003325 2003
% 210.86/211.06  |- skos__hiddenLabel mesh__D003325 Care Units, Coronary
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003325 1997
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003325 2006
% 210.86/211.06  |- mesh__dateCreated mesh__D003325 1999-01-01
% 210.86/211.06  |- skos__historyNote mesh__D003325 Coronary Disease %28%1966-1969%29%
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003325 1993
% 210.86/211.06  |- skos__prefLabel mesh__D003325 Coronary Care Units
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003325 2002
% 210.86/211.06  |- mesh__dateEstablished mesh__D003325 1972-01-01
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003325 1996
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003325 2005
% 210.86/211.06  |- skos__hiddenLabel mesh__D003325 Unit, Coronary Care
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003325 1999
% 210.86/211.06  |- skos__historyNote mesh__D003325 Intensive Care Units %28%1966-1969%29%
% 210.86/211.06  |- skos__scopeNote mesh__D003325
% 210.86/211.06       The hospital unit in which patients with acute cardiac disorders receive intensive care.%A%    
% 210.86/211.06  |- skos__broader mesh__D003325smesh__D007362
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003325 1995
% 210.86/211.06  |- mesh__recordAuthorizer mesh__D003325 PLS
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003325 1998
% 210.86/211.06  |- rdf__type mesh__D003325sskos__Concept
% 210.86/211.06  |- mesh__historyNote mesh__D003325 72%28%70%29%   
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003325 2001
% 210.86/211.06  |- skos__hiddenLabel mesh__D003325 Coronary Care Unit
% 210.86/211.06  |- mesh__dateRevised mesh__D003325 1992-05-14
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003325 1994
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003325 2004
% 210.86/211.06  |- mesh__recordOriginator mesh__D003325 NLM
% 210.86/211.06  |- mesh__recordMaintainer mesh__D003325 TGC
% 210.86/211.06  |- skos__hiddenLabel mesh__D003325 Care Unit, Coronary
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D003325 2000
% 210.86/211.06  |- skos__scopeNote mesh__D008010
% 210.86/211.06       An inflammatory, pruritic disease of the skin and mucous membranes, which can be either generalized or localized. It is characterized by distinctive purplish, flat-topped papules having a predilection for the trunk and flexor surfaces. The lesions may be discrete or coalesce to form plaques. Histologically, there is a %22%saw-tooth%22% pattern of epidermal hyperplasia and vacuolar alteration of the basal layer of the epidermis along with an intense upper dermal inflammatory infiltrate composed predominantly of T-cells. Etiology is unknown.%A%    
% 210.86/211.06  |- mesh__dateCreated mesh__D008010 1999-01-01
% 210.86/211.06  |- skos__altLabel mesh__D008010 Lichen Ruber Planus
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D008010 2006
% 210.86/211.06  |- mesh__dateRevised mesh__D008010 1994-04-11
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D008010 1999
% 210.86/211.06  |- skos__prefLabel mesh__D008010 Lichen Planus
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D008010 2002
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D008010 1995
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D008010 1998
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D008010 2005
% 210.86/211.06  |- mesh__recordAuthorizer mesh__D008010 PLS
% 210.86/211.06  |- mesh__recordMaintainer mesh__D008010 TGC
% 210.86/211.06  |- skos__altLabel mesh__D008010 Lichen Rubra Planus
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D008010 2001
% 210.86/211.06  |- skos__annotation mesh__D008010
% 210.86/211.06       a skin dis; sometimes called simply %22%lichen%22%: check text %26% its bibliog; lichen planus atrophicus: index here %26% do not confuse with LICHEN SCLEROSUS ET ATROPHICUS%A%  
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D008010 1997
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D008010 2004
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D008010 2000
% 210.86/211.06  |- mesh__recordOriginator mesh__D008010 NLM
% 210.86/211.06  |- rdf__type mesh__D008010sskos__Concept
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D008010 1996
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D008010 2003
% 210.86/211.06  |- skos__broader mesh__D008010smesh__D017512
% 210.86/211.06  |- mesh__activeMeSHYear mesh__D013753 2006
% 210.86/211.06  |- skos__broader mesh__D013753smesh__D024881
% 210.86/211.06  |- skos__historyNote mesh__D013753 Tetracycline %28%1966-1987%29%
% 210.86/211.07  |- mesh__dateRevised mesh__D013753 2003-07-09
% 210.86/211.07  |- mesh__recordMaintainer mesh__D013753 ssb
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D013753 2005
% 210.86/211.07  |- mesh__recordAuthorizer mesh__D013753 sjn
% 210.86/211.07  |- mesh__recordOriginator mesh__D013753 SCD
% 210.86/211.07  |- mesh__publicMeSHNote mesh__D013753 88   
% 210.86/211.07  |- rdf__type mesh__D013753sskos__Concept
% 210.86/211.07  |- skos__scopeNote mesh__D013753
% 210.86/211.07       Nonsusceptibility of bacteria to the action of TETRACYCLINE which inhibits aminoacyl-tRNA binding to the 30S ribosomal subunit during protein synthesis.%A%    
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D013753 2004
% 210.86/211.07  |- skos__historyNote mesh__D013753
% 210.86/211.07       Drug Resistance, Microbial %28%1966-1987%29%
% 210.86/211.07  |- mesh__dateEstablished mesh__D013753 1988-01-01
% 210.86/211.07  |- mesh__dateCreated mesh__D013753 1987-05-08
% 210.86/211.07  |- mesh__historyNote mesh__D013753 88   
% 210.86/211.07  |- skos__prefLabel mesh__D013753 Tetracycline Resistance
% 210.86/211.07  |- mesh__publicMeSHNote mesh__D007716 91; see ENDOMYCETALES 1986-90   
% 210.86/211.07  |- skos__prefLabel mesh__D007716 Kluyveromyces
% 210.86/211.07  |- mesh__dateRevised mesh__D007716 2005-06-30
% 210.86/211.07  |- skos__historyNote mesh__D007716 Ascomycetes %28%1966-1985%29%
% 210.86/211.07  |- rdf__type mesh__D007716sskos__Concept
% 210.86/211.07  |- mesh__dateEstablished mesh__D007716 1991-01-01
% 210.86/211.07  |- skos__broader mesh__D007716smesh__D004718
% 210.86/211.07  |- mesh__recordOriginator mesh__D007716 RC
% 210.86/211.07  |- skos__broader mesh__D007716smesh__D015003
% 210.86/211.07  |- skos__scopeNote mesh__D007716
% 210.86/211.07       An ascomycetous yeast of the fungal family Saccharomycetaceae, order SACCHAROMYCETALES.%A%    
% 210.86/211.07  |- mesh__historyNote mesh__D007716 91%28%86%29%   
% 210.86/211.07  |- mesh__dateCreated mesh__D007716 1985-02-07
% 210.86/211.07  |- mesh__recordMaintainer mesh__D007716 SYSTEM
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D007716 2006
% 210.86/211.07  |- mesh__recordAuthorizer mesh__D007716 sjn
% 210.86/211.07  |- skos__historyNote mesh__D007716 Endomycetales %28%1975-1985%29%
% 210.86/211.07  |- skos__scopeNote mesh__D017346
% 210.86/211.07       A group of enzymes that catalyzes the phosphorylation of serine or threonine residues in proteins, with ATP or other nucleotides as phosphate donors.%A%    
% 210.86/211.07  |- skos__hiddenLabel mesh__D017346 Kinase, Serine
% 210.86/211.07  |- mesh__dateRevised mesh__D017346 2003-07-09
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D017346 2006
% 210.86/211.07  |- skos__hiddenLabel mesh__D017346 Kinase, Threonine
% 210.86/211.07  |- skos__hiddenLabel mesh__D017346 Serine Threonine Kinases
% 210.86/211.07  |- mesh__dateCreated mesh__D017346 1992-05-22
% 210.86/211.07  |- skos__hiddenLabel mesh__D017346 Kinases, Serine-Threonine Protein
% 210.86/211.07  |- skos__hiddenLabel mesh__D017346 Kinase, Serine-Threonine
% 210.86/211.07  |- skos__hiddenLabel mesh__D017346 Protein Threonine Kinase
% 210.86/211.07  |- skos__hiddenLabel mesh__D017346 Protein Kinases, Serine-Threonine
% 210.86/211.07  |- mesh__publicMeSHNote mesh__D017346
% 210.86/211.07       93; SERINE KINASE was indexed under PROTEIN KINASES 1985-92; PROTEIN-THREONINE KINASE was indexed under PROTEIN KINASES 1983-92%A%  
% 210.86/211.07  |- skos__hiddenLabel mesh__D017346 Protein Serine Threonine Kinases
% 210.86/211.07  |- mesh__recordMaintainer mesh__D017346 ssb
% 210.86/211.07  |- skos__altLabel mesh__D017346 Protein-Serine-Threonine Kinase
% 210.86/211.07  |- skos__hiddenLabel mesh__D017346 Protein Serine Threonine Kinase
% 210.86/211.07  |- mesh__dateEstablished mesh__D017346 1993-01-01
% 210.86/211.07  |- mesh__recordAuthorizer mesh__D017346 sjn
% 210.86/211.07  |- mesh__onlineNote mesh__D017346
% 210.86/211.07       use PROTEIN-SERINE-THREONINE KINASES %28%NM%29% to search SERINE KINASE 1985-92 %26% PROTEIN-THREONINE KINASE 1983-92%A%  
% 210.86/211.07  |- skos__altLabel mesh__D017346 Protein-Serine Kinase
% 210.86/211.07  |- skos__prefLabel mesh__D017346 Protein-Serine-Threonine Kinases
% 210.86/211.07  |- skos__altLabel mesh__D017346 Serine-Threonine Kinases
% 210.86/211.07  |- skos__altLabel mesh__D017346 Serine Kinase
% 210.86/211.07  |- skos__hiddenLabel mesh__D017346 Kinase, Protein-Serine-Threonine
% 210.86/211.07  |- skos__historyNote mesh__D017346 Protein Kinases %28%1983-1992%29%
% 210.86/211.07  |- mesh__recordOriginator mesh__D017346 TPW
% 210.86/211.07  |- skos__hiddenLabel mesh__D017346 Protein Serine Kinase
% 210.86/211.07  |- skos__hiddenLabel mesh__D017346 Kinase, Protein-Threonine
% 210.86/211.07  |- skos__hiddenLabel mesh__D017346 Kinases, Protein-Serine-Threonine
% 210.86/211.07  |- skos__altLabel mesh__D017346 Serine-Threonine Protein Kinases
% 210.86/211.07  |- skos__hiddenLabel mesh__D017346 Serine Threonine Kinase
% 210.86/211.07  |- skos__hiddenLabel mesh__D017346 Kinase, Protein-Serine
% 210.86/211.07  |- skos__broader mesh__D017346smesh__D011494
% 210.86/211.07  |- skos__altLabel mesh__D017346 Protein-Threonine Kinase
% 210.86/211.07  |- skos__altLabel mesh__D017346 Serine-Threonine Kinase
% 210.86/211.07  |- rdf__type mesh__D017346sskos__Concept
% 210.86/211.07  |- mesh__historyNote mesh__D017346
% 210.86/211.07       93; was SERINE KINASE %28%NM%29% 1985-92 %26% PROTEIN-THREONINE KINASE %28%NM%29% 1983-92%A%  
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D017346 2004
% 210.86/211.07  |- skos__hiddenLabel mesh__D017346 Kinases, Serine-Threonine
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D017346 2005
% 210.86/211.07  |- skos__hiddenLabel mesh__D017346 Serine Threonine Protein Kinases
% 210.86/211.07  |- skos__altLabel mesh__D017346 Threonine Kinase
% 210.86/211.07  |- mesh__dateCreated mesh__D003326 1999-01-01
% 210.86/211.07  |- mesh__publicMeSHNote mesh__D003326 72   
% 210.86/211.07  |- skos__historyNote mesh__D003326 Coronary Vessels %28%1966-1971%29%
% 210.86/211.07  |- skos__prefLabel mesh__D003326 Coronary Circulation
% 210.86/211.07  |- mesh__historyNote mesh__D003326 72   
% 210.86/211.07  |- mesh__dateEstablished mesh__D003326 1972-01-01
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D003326 2006
% 210.86/211.07  |- skos__annotation mesh__D003326 DF: CORONARY CIRC   
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D003326 2005
% 210.86/211.07  |- mesh__recordMaintainer mesh__D003326 nns
% 210.86/211.07  |- rdf__type mesh__D003326sskos__Concept
% 210.86/211.07  |- skos__altLabel mesh__D003326 Circulation, Coronary
% 210.86/211.07  |- mesh__dateRevised mesh__D003326 2003-07-09
% 210.86/211.07  |- mesh__recordOriginator mesh__D003326 NLM
% 210.86/211.07  |- skos__scopeNote mesh__D003326
% 210.86/211.07       The circulation of blood through the CORONARY VESSELS of the HEART.%A%    
% 210.86/211.07  |- skos__broader mesh__D003326smesh__D001775
% 210.86/211.07  |- mesh__recordAuthorizer mesh__D003326 sjn
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D003326 2004
% 210.86/211.07  |- skos__scopeNote mesh__D008011
% 210.86/211.07       Any of a group of plants formed by a mutual combination of an alga and a fungus.%A%    
% 210.86/211.07  |- skos__prefLabel mesh__D008011 Lichens
% 210.86/211.07  |- mesh__recordOriginator mesh__D008011 NLM
% 210.86/211.07  |- skos__hiddenLabel mesh__D008011 Lichen
% 210.86/211.07  |- mesh__recordMaintainer mesh__D008011 SYSTEM
% 210.86/211.07  |- skos__broader mesh__D008011smesh__D005658
% 210.86/211.07  |- skos__broader mesh__D008011smesh__D000456
% 210.86/211.07  |- rdf__type mesh__D008011sskos__Concept
% 210.86/211.07  |- skos__annotation mesh__D008011 plant, not skin disease   
% 210.86/211.07  |- mesh__dateRevised mesh__D008011 2005-06-30
% 210.86/211.07  |- mesh__dateCreated mesh__D008011 1999-01-01
% 210.86/211.07  |- mesh__recordAuthorizer mesh__D008011 sjn
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D008011 2006
% 210.86/211.07  |- skos__hiddenLabel mesh__D049428 Barrier, Blood-Nerve
% 210.86/211.07  |- skos__historyNote mesh__D049428 Endothelium, Vascular %28%1970-2004%29%
% 210.86/211.07  |- mesh__historyNote mesh__D049428 2005   
% 210.86/211.07  |- mesh__publicMeSHNote mesh__D049428 2005   
% 210.86/211.07  |- mesh__recordMaintainer mesh__D049428 ags
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D049428 2005
% 210.86/211.07  |- skos__hiddenLabel mesh__D049428 Barriers, Blood-Nerve
% 210.86/211.07  |- mesh__dateCreated mesh__D049428 2004-07-07
% 210.86/211.07  |- skos__hiddenLabel mesh__D049428 Blood-Nerve Barriers
% 210.86/211.07  |- mesh__recordOriginator mesh__D049428 ags
% 210.86/211.07  |- skos__related mesh__D049428smesh__D002199
% 210.86/211.07  |- skos__broader mesh__D049428smesh__D002319
% 210.86/211.07  |- skos__prefLabel mesh__D049428 Blood-Nerve Barrier
% 210.86/211.07  |- skos__hiddenLabel mesh__D049428 Blood Nerve Barrier
% 210.86/211.07  |- rdf__type mesh__D049428sskos__Concept
% 210.86/211.07  |- skos__broader mesh__D049428smesh__D010525
% 210.86/211.07  |- mesh__dateEstablished mesh__D049428 2005-01-01
% 210.86/211.07  |- skos__scopeNote mesh__D049428
% 210.86/211.07       The barrier between the perineurium of PERIPHERAL NERVES and the endothelium %28%ENDOTHELIUM, VASCULAR%29% of endoneurial CAPILLARIES. The perineurium acts as a diffusion barrier, but ion permeability at the blood-nerve barrier is still higher than at the BLOOD-BRAIN BARRIER.%A%    
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D049428 2006
% 210.86/211.07  |- mesh__recordAuthorizer mesh__D049428 sjn
% 210.86/211.07  |- mesh__recordMaintainer mesh__D013754 ssb
% 210.86/211.07  |- mesh__recordAuthorizer mesh__D013754 sjn
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D013754 2006
% 210.86/211.07  |- mesh__dateCreated mesh__D013754 1975-07-23
% 210.86/211.07  |- skos__prefLabel mesh__D013754 Tetracyclines
% 210.86/211.07  |- rdf__type mesh__D013754sskos__Concept
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D013754 2005
% 210.86/211.07  |- mesh__historyNote mesh__D013754 76; was NON MESH before 1976   
% 210.86/211.07  |- mesh__dateRevised mesh__D013754 2004-07-07
% 210.86/211.07  |- mesh__dateEstablished mesh__D013754 1976-01-01
% 210.86/211.07  |- mesh__recordOriginator mesh__D013754 SH
% 210.86/211.07  |- mesh__publicMeSHNote mesh__D013754 76   
% 210.86/211.07  |- skos__broader mesh__D013754smesh__D009279
% 210.86/211.07  |- skos__scopeNote mesh__D013754
% 210.86/211.07       Closely congeneric derivatives of the polycyclic naphthacenecarboxamide. %28%Gilman et al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 8th ed, p1117%29%%A%    
% 210.86/211.07  |- skos__annotation mesh__D013754 TETRACYCLINE is also available   
% 210.86/211.07  |- skos__prefLabel mesh__D007717 Knee
% 210.86/211.07  |- mesh__recordMaintainer mesh__D007717 TPW
% 210.86/211.07  |- skos__annotation mesh__D007717
% 210.86/211.07       primates only; /inj = KNEE INJURIES but PATELLA /inj is also available; TN 238: differentiation from KNEE JOINT %26% indexing instructions%A%  
% 210.86/211.07  |- mesh__recordAuthorizer mesh__D007717 sjn
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D007717 2003
% 210.86/211.07  |- mesh__dateRevised mesh__D007717 2002-07-03
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D007717 2005
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D007717 2004
% 210.86/211.07  |- mesh__recordOriginator mesh__D007717 NLM
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D007717 2006
% 210.86/211.07  |- skos__broader mesh__D007717smesh__D035002
% 210.86/211.07  |- skos__hiddenLabel mesh__D007717 Knees
% 210.86/211.07  |- mesh__dateCreated mesh__D007717 1999-01-01
% 210.86/211.07  |- rdf__type mesh__D007717sskos__Concept
% 210.86/211.07  |- mesh__publicMeSHNote mesh__D017347 93   
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D017347 2006
% 210.86/211.07  |- skos__broader mesh__D017347smesh__D002002
% 210.86/211.07  |- mesh__dateRevised mesh__D017347 2005-06-30
% 210.86/211.07  |- mesh__dateCreated mesh__D017347 1992-05-07
% 210.86/211.07  |- skos__scopeNote mesh__D017347
% 210.86/211.07       A species of the genus BRUCELLA whose natural hosts are sheep and goats. Other mammals, including humans, may be infected. In general, these organisms tend to be more virulent for laboratory animals than BRUCELLA ABORTUS and may cause fatal infections.%A%    
% 210.86/211.07  |- mesh__historyNote mesh__D017347 93   
% 210.86/211.07  |- rdf__type mesh__D017347sskos__Concept
% 210.86/211.07  |- mesh__recordAuthorizer mesh__D017347 sjn
% 210.86/211.07  |- mesh__recordOriginator mesh__D017347 PXP
% 210.86/211.07  |- mesh__dateEstablished mesh__D017347 1993-01-01
% 210.86/211.07  |- skos__prefLabel mesh__D017347 Brucella melitensis
% 210.86/211.07  |- skos__historyNote mesh__D017347 Brucella %28%1966-1992%29%
% 210.86/211.07  |- skos__annotation mesh__D017347
% 210.86/211.07       note specific biovars are X refs to other species; infection: coord IM with BRUCELLOSIS %28%IM%29%%A%  
% 210.86/211.07  |- mesh__recordMaintainer mesh__D017347 SYSTEM
% 210.86/211.07  |- skos__annotation mesh__D036501
% 210.86/211.07       do not confuse X ref SPACER INHALERS with INHALATION SPACERS%A%  
% 210.86/211.07  |- skos__hiddenLabel mesh__D036501 Inhaler, Metered Dose
% 210.86/211.07  |- skos__historyNote mesh__D036501
% 210.86/211.07       Nebulizers and Vaporizers %28%1986-2002%29%
% 210.86/211.07  |- skos__altLabel mesh__D036501 Spacer-Inhalers
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D036501 2006
% 210.86/211.07  |- skos__hiddenLabel mesh__D036501 Spacer Inhaler
% 210.86/211.07  |- skos__altLabel mesh__D036501 Spinhaler
% 210.86/211.07  |- mesh__dateEstablished mesh__D036501 2003-01-01
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D036501 2005
% 210.86/211.07  |- skos__broader mesh__D036501smesh__D009330
% 210.86/211.07  |- skos__altLabel mesh__D036501 Inhalers, Metered Dose
% 210.86/211.07  |- skos__historyNote mesh__D036501 Aerosols %28%1976-2002%29%
% 210.86/211.07  |- skos__scopeNote mesh__D036501
% 210.86/211.07       A medical device used to ensure the proper amount of medication is delivered for inhalation. Usually, it is a small aerosol canister placed in a plastic holder. When the canister is pressed, a calibrated amount of drug is released.%A%    
% 210.86/211.07  |- mesh__publicMeSHNote mesh__D036501 2003   
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D036501 2004
% 210.86/211.07  |- rdf__type mesh__D036501sskos__Concept
% 210.86/211.07  |- skos__hiddenLabel mesh__D036501 Spacer-Inhaler
% 210.86/211.07  |- skos__historyNote mesh__D036501 Respiratory Therapy %28%1980-2002%29%
% 210.86/211.07  |- skos__altLabel mesh__D036501 MDI %28%Inhalers%29%
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D036501 2003
% 210.86/211.07  |- mesh__historyNote mesh__D036501 2003   
% 210.86/211.07  |- mesh__dateCreated mesh__D036501 2002-07-03
% 210.86/211.07  |- skos__prefLabel mesh__D036501 Metered Dose Inhalers
% 210.86/211.07  |- skos__hiddenLabel mesh__D036501 Spinhalers
% 210.86/211.07  |- skos__hiddenLabel mesh__D036501 Metered Dose Inhaler
% 210.86/211.07  |- mesh__recordAuthorizer mesh__D003327 sjn
% 210.86/211.07  |- skos__hiddenLabel mesh__D003327 Diseases, Coronary Heart
% 210.86/211.07  |- skos__hiddenLabel mesh__D003327 Heart Disease, Coronary
% 210.86/211.07  |- mesh__dateRevised mesh__D003327 2001-07-25
% 210.86/211.07  |- skos__hiddenLabel mesh__D003327 Coronary Heart Diseases
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D003327 2006
% 210.86/211.07  |- skos__hiddenLabel mesh__D003327 Disease, Coronary Heart
% 210.86/211.07  |- skos__annotation mesh__D003327
% 210.86/211.07       GEN or unspecified; prefer specific; /surg: coord with specific surgical procedure if pertinent%A%  
% 210.86/211.07  |- skos__broader mesh__D003327smesh__D017202
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D003327 2005
% 210.86/211.07  |- skos__prefLabel mesh__D003327 Coronary Disease
% 210.86/211.07  |- skos__hiddenLabel mesh__D003327 Diseases, Coronary
% 210.86/211.07  |- rdf__type mesh__D003327sskos__Concept
% 210.86/211.07  |- skos__scopeNote mesh__D003327
% 210.86/211.07       An imbalance between myocardial functional requirements and the capacity of the coronary vessels to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA %28%insufficient blood supply to the heart muscle%29% caused by a decreased capacity of the coronary vessels.%A%    
% 210.86/211.07  |- skos__hiddenLabel mesh__D003327 Coronary Diseases
% 210.86/211.07  |- skos__hiddenLabel mesh__D003327 Occlusions, Coronary
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D003327 2002
% 210.86/211.07  |- skos__related mesh__D003327smesh__D009204
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D003327 2004
% 210.86/211.07  |- skos__hiddenLabel mesh__D003327 Coronary Occlusions
% 210.86/211.07  |- mesh__recordMaintainer mesh__D003327 nns
% 210.86/211.07  |- mesh__dateCreated mesh__D003327 1999-01-01
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D003327 2003
% 210.86/211.07  |- mesh__recordOriginator mesh__D003327 NLM
% 210.86/211.07  |- skos__related mesh__D003327smesh__D015906
% 210.86/211.07  |- skos__hiddenLabel mesh__D003327 Heart Diseases, Coronary
% 210.86/211.07  |- skos__related mesh__D003327smesh__D001026
% 210.86/211.07  |- skos__hiddenLabel mesh__D003327 Disease, Coronary
% 210.86/211.07  |- skos__hiddenLabel mesh__D003327 Occlusion, Coronary
% 210.86/211.07  |- skos__altLabel mesh__D003327 Coronary Heart Disease
% 210.86/211.07  |- skos__annotation mesh__D008810
% 210.86/211.07       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%  
% 210.86/211.07  |- skos__altLabel mesh__D008810 Mouse, Inbred C57BL
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D008810 2006
% 210.86/211.07  |- mesh__dateRevised mesh__D008810 2005-06-30
% 210.86/211.07  |- mesh__historyNote mesh__D008810 74%28%72%29%   
% 210.86/211.07  |- skos__prefLabel mesh__D008810 Mice, Inbred C57BL
% 210.86/211.07  |- skos__hiddenLabel mesh__D008810 C57BL Mouse, Inbred
% 210.86/211.07  |- skos__altLabel mesh__D008810 Mice, C57BL
% 210.86/211.07  |- skos__hiddenLabel mesh__D008810 C57BL Mouse
% 210.86/211.07  |- mesh__recordOriginator mesh__D008810 NLM
% 210.86/211.07  |- mesh__recordMaintainer mesh__D008810 ags
% 210.86/211.07  |- mesh__dateCreated mesh__D008810 1999-01-01
% 210.86/211.07  |- rdf__type mesh__D008810sskos__Concept
% 210.86/211.07  |- mesh__recordAuthorizer mesh__D008810 sjn
% 210.86/211.07  |- skos__historyNote mesh__D008810 Mice %28%1966-1971%29%
% 210.86/211.07  |- mesh__publicMeSHNote mesh__D008810 74   
% 210.86/211.07  |- skos__hiddenLabel mesh__D008810 Inbred C57BL Mouse
% 210.86/211.07  |- skos__related mesh__D008810smesh__D018827
% 210.86/211.07  |- skos__hiddenLabel mesh__D008810 Inbred C57BL Mice
% 210.86/211.07  |- skos__altLabel mesh__D008810 Mouse, C57BL
% 210.86/211.07  |- skos__hiddenLabel mesh__D008810 C57BL Mice
% 210.86/211.07  |- skos__broader mesh__D008810smesh__D008815
% 210.86/211.07  |- mesh__dateEstablished mesh__D008810 1974-01-01
% 210.86/211.07  |- skos__hiddenLabel mesh__D008810 C57BL Mice, Inbred
% 210.86/211.07  |- mesh__recordMaintainer mesh__D008012 ssb
% 210.86/211.07  |- skos__hiddenLabel mesh__D008012 Carbonate, Lidocaine
% 210.86/211.07  |- mesh__dateRevised mesh__D008012 2005-06-30
% 210.86/211.07  |- skos__altLabel mesh__D008012 2-2EtN-2MePhAcN
% 210.86/211.07  |- rdf__type mesh__D008012sskos__Concept
% 210.86/211.07  |- mesh__recordAuthorizer mesh__D008012 sjn
% 210.86/211.07  |- skos__prefLabel mesh__D008012 Lidocaine
% 210.86/211.07  |- skos__hiddenLabel mesh__D008012 Hydrochloride, Lidocaine
% 210.86/211.07  |- skos__altLabel mesh__D008012 Lidocaine Carbonate
% 210.86/211.07  |- skos__hiddenLabel mesh__D008012 Monohydrochloride, Lidocaine
% 210.86/211.07  |- mesh__dateCreated mesh__D008012 1999-01-01
% 210.86/211.07  |- skos__hiddenLabel mesh__D008012 Monohydrate Lidocaine Monohydrochloride
% 210.86/211.07  |- skos__altLabel mesh__D008012
% 210.86/211.07       2-%28%Diethylamino%29%-N-%28%2,6-Dimethylphenyl%29%Acetamide
% 210.86/211.07  |- skos__scopeNote mesh__D008012
% 210.86/211.07       A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of procaine but its duration of action is shorter than that of bupivacaine or prilocaine.%A%    
% 210.86/211.07  |- mesh__recordOriginator mesh__D008012 NLM
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D008012 2006
% 210.86/211.07  |- skos__broader mesh__D008012smesh__D000083
% 210.86/211.07  |- skos__hiddenLabel mesh__D008012 Hydrocarbonate, Lidocaine
% 210.86/211.07  |- skos__hiddenLabel mesh__D008012 2 2EtN 2MePhAcN
% 210.86/211.07  |- skos__altLabel mesh__D008012 Lignocaine
% 210.86/211.07  |- skos__altLabel mesh__D008012 Lidocaine Monohydrochloride
% 210.86/211.07  |- skos__hiddenLabel mesh__D008012 Monoacetate, Lidocaine
% 210.86/211.07  |- skos__prefLabel mesh__D049429 Forensic Pathology
% 210.86/211.07  |- skos__annotation mesh__D049429
% 210.86/211.07       specialty; may also be used for forensic aspects in pathology%A%  
% 210.86/211.07  |- mesh__dateEstablished mesh__D049429 2005-01-01
% 210.86/211.07  |- skos__historyNote mesh__D049429 Forensic Medicine %28%1966-2004%29%
% 210.86/211.07  |- mesh__recordAuthorizer mesh__D049429 sjn
% 210.86/211.07  |- rdf__type mesh__D049429sskos__Concept
% 210.86/211.07  |- skos__broader mesh__D049429smesh__D010336
% 210.86/211.07  |- mesh__historyNote mesh__D049429 2005   
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D049429 2006
% 210.86/211.07  |- skos__broader mesh__D049429smesh__D005554
% 210.86/211.07  |- mesh__publicMeSHNote mesh__D049429 2005   
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D049429 2005
% 210.86/211.07  |- mesh__dateCreated mesh__D049429 2004-07-07
% 210.86/211.07  |- skos__scopeNote mesh__D049429
% 210.86/211.07       The application of pathology to questions of law.     
% 210.86/211.07  |- mesh__recordMaintainer mesh__D049429 ags
% 210.86/211.07  |- mesh__recordOriginator mesh__D049429 ags
% 210.86/211.07  |- skos__altLabel mesh__D049429 Pathology, Forensic
% 210.86/211.07  |- skos__historyNote mesh__D013755 Fatty Acids %28%1966-1974%29%
% 210.86/211.07  |- skos__prefLabel mesh__D013755 Tetradecanoylphorbol Acetate
% 210.86/211.07  |- skos__historyNote mesh__D013755 Diterpenes %28%1974%29%
% 210.86/211.07  |- mesh__dateRevised mesh__D013755 2000-06-21
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D013755 2004
% 210.86/211.07  |- skos__hiddenLabel mesh__D013755 Acetate, Tetradecanoylphorbol
% 210.86/211.07  |- skos__historyNote mesh__D013755 Croton Oil %28%1966-1974%29%
% 210.86/211.07  |- mesh__recordOriginator mesh__D013755 NLM
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D013755 2003
% 210.86/211.07  |- skos__hiddenLabel mesh__D013755
% 210.86/211.07       Tetradecanoylphorbol Acetate, 4a alpha Isomer
% 210.86/211.07  |- skos__hiddenLabel mesh__D013755 12 O Tetradecanoyl Phorbol 13 Acetate
% 210.86/211.07  |- skos__altLabel mesh__D013755 Phorbol Myristate Acetate
% 210.86/211.07  |- skos__hiddenLabel mesh__D013755 Myristate Acetate, Phorbol
% 210.86/211.07  |- mesh__dateEstablished mesh__D013755 1987-01-01
% 210.86/211.07  |- mesh__recordMaintainer mesh__D013755 jmp
% 210.86/211.07  |- mesh__recordAuthorizer mesh__D013755 sjn
% 210.86/211.07  |- skos__hiddenLabel mesh__D013755 Acetate, Phorbol Myristate
% 210.86/211.07  |- skos__scopeNote mesh__D013755
% 210.86/211.07       A phorbol ester found in CROTON OIL with very effective tumor promoting activity. It stimulates the synthesis of both DNA and RNA.%A%    
% 210.86/211.07  |- skos__historyNote mesh__D013755 Alcohols %28%1966-1974%29%
% 210.86/211.07  |- mesh__historyNote mesh__D013755
% 210.86/211.07       87%28%75%29%; was see under PHORBOLS 1975-86   
% 210.86/211.07  |- skos__annotation mesh__D013755 D25-26 qualif   
% 210.86/211.07  |- skos__hiddenLabel mesh__D013755 Phorbol 13-Acetate, 12-O-Tetradecanoyl
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D013755 2002
% 210.86/211.07  |- skos__altLabel mesh__D013755 12-Myristoyl-13-acetylphorbol
% 210.86/211.07  |- skos__hiddenLabel mesh__D013755 12 Myristoyl 13 acetylphorbol
% 210.86/211.07  |- mesh__publicMeSHNote mesh__D013755 87; was see under PHORBOLS 1975-86   
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D013755 2006
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D013755 2001
% 210.86/211.07  |- skos__altLabel mesh__D013755 12-O-Tetradecanoyl Phorbol 13-Acetate
% 210.86/211.07  |- skos__broader mesh__D013755smesh__D010703
% 210.86/211.07  |- mesh__dateCreated mesh__D013755 1974-11-14
% 210.86/211.07  |- skos__historyNote mesh__D013755 Terpenes %28%1966-1973%29%
% 210.86/211.07  |- skos__hiddenLabel mesh__D013755 13-Acetate, 12-O-Tetradecanoyl Phorbol
% 210.86/211.07  |- rdf__type mesh__D013755sskos__Concept
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D013755 2005
% 210.86/211.07  |- mesh__recordOriginator mesh__D007718 NLM
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D007718 2005
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D007718 1994
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D007718 1997
% 210.86/211.07  |- skos__scopeNote mesh__D007718
% 210.86/211.07       Injuries to the knee or the knee joint.     
% 210.86/211.07  |- rdf__type mesh__D007718sskos__Concept
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D007718 2001
% 210.86/211.07  |- mesh__dateRevised mesh__D007718 1990-11-10
% 210.86/211.07  |- mesh__dateCreated mesh__D007718 1999-01-01
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D007718 1996
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D007718 2000
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D007718 2004
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D007718 1993
% 210.86/211.07  |- skos__hiddenLabel mesh__D007718 Knee Injury
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D007718 1999
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D007718 2003
% 210.86/211.07  |- skos__annotation mesh__D007718 consider also PATELLA /inj   
% 210.86/211.07  |- skos__broader mesh__D007718smesh__D007869
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D007718 1992
% 210.86/211.07  |- mesh__recordMaintainer mesh__D007718 PXP
% 210.86/211.07  |- skos__hiddenLabel mesh__D007718 Injury, Knee
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D007718 1998
% 210.86/211.07  |- skos__altLabel mesh__D007718 Injuries, Knee
% 210.86/211.07  |- mesh__recordAuthorizer mesh__D007718 PLS
% 210.86/211.07  |- skos__prefLabel mesh__D007718 Knee Injuries
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D007718 2002
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D007718 2006
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D007718 1995
% 210.86/211.07  |- mesh__recordMaintainer mesh__D018440 ags
% 210.86/211.07  |- mesh__dateRevised mesh__D018440 2005-07-07
% 210.86/211.07  |- mesh__recordOriginator mesh__D018440 AGS
% 210.86/211.07  |- skos__hiddenLabel mesh__D018440 beta Lactam Resistance
% 210.86/211.07  |- mesh__dateCreated mesh__D018440 1994-01-25
% 210.86/211.07  |- skos__annotation mesh__D018440 GEN or unspecified; prefer specifics   
% 210.86/211.07  |- skos__prefLabel mesh__D018440 beta-Lactam Resistance
% 210.86/211.07  |- mesh__publicMeSHNote mesh__D018440 1995   
% 210.86/211.07  |- skos__broader mesh__D018440smesh__D024881
% 210.86/211.07  |- skos__historyNote mesh__D018440
% 210.86/211.07       Drug Resistance, Microbial %28%1974-1994%29%
% 210.86/211.07  |- mesh__recordAuthorizer mesh__D018440 ags
% 210.86/211.07  |- mesh__dateEstablished mesh__D018440 1995-01-01
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D018440 2006A
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D018440 2006
% 210.86/211.07  |- rdf__type mesh__D018440sskos__Concept
% 210.86/211.07  |- mesh__historyNote mesh__D018440 1995   
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D018440 2005
% 210.86/211.07  |- skos__hiddenLabel mesh__D018440 beta-Lactam Resistances
% 210.86/211.07  |- skos__scopeNote mesh__D018440
% 210.86/211.07       Nonsusceptibility of bacteria to the action of the beta-lactam antibiotics. Mechanisms responsible for beta-lactam resistance may be degradation of antibiotics by BETA-LACTAMASES, failure of antibiotics to penetrate, or low-affinity binding of antibiotics to targets.%A%    
% 210.86/211.07  |- skos__historyNote mesh__D018440 Lactams/pharmacology %28%1974-1994%29%
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D018440 2004
% 210.86/211.07  |- skos__scopeNote mesh__D004420
% 210.86/211.07       Slow or difficult OBSTETRIC LABOR or CHILDBIRTH.     
% 210.86/211.07  |- mesh__dateCreated mesh__D004420 1999-01-01
% 210.86/211.07  |- mesh__recordMaintainer mesh__D004420 lkt
% 210.86/211.07  |- rdf__type mesh__D004420sskos__Concept
% 210.86/211.07  |- skos__broader mesh__D004420smesh__D007744
% 210.86/211.07  |- mesh__recordAuthorizer mesh__D004420 sjn
% 210.86/211.07  |- mesh__recordOriginator mesh__D004420 NLM
% 210.86/211.07  |- mesh__dateRevised mesh__D004420 2005-06-30
% 210.86/211.07  |- skos__hiddenLabel mesh__D004420 Dystocias
% 210.86/211.07  |- mesh__activeMeSHYear mesh__D004420 2006
% 210.86/211.07  |- skos__prefLabel mesh__D004420 Dystocia
% 210.86/211.07  |- skos__altLabel mesh__D051076 Proto-Oncogene Protein c-syn
% 210.86/211.07  |- skos__altLabel mesh__D051076 p72%28%fyn%29% Protein
% 210.86/211.07  |- skos__broader mesh__D051076smesh__D019061
% 210.86/211.07  |- skos__hiddenLabel mesh__D051076 p59 c fyn Protein
% 210.86/211.07  |- skos__broader mesh__D051076smesh__D047908
% 210.86/211.07  |- skos__altLabel mesh__D051076 fyn Proto-Oncogene Proteins
% 210.86/211.07  |- skos__altLabel mesh__D051076 Fyn Tyrosine Kinase
% 210.86/211.07  |- skos__scopeNote mesh__D051076
% 210.86/211.07       Src-family kinases that associate with T-CELL ANTIGEN RECEPTOR and phosphorylate a wide variety of intracellular signaling molecules.%A%    
% 210.86/211.07  |- skos__altLabel mesh__D051076 c-fyn Protein
% 210.86/211.08  |- skos__hiddenLabel mesh__D051076 c fyn Proto Oncogene Proteins
% 210.86/211.08  |- skos__altLabel mesh__D051076 p72 c-fyn Protein
% 210.86/211.08  |- mesh__historyNote mesh__D051076 2006%28%1989%29%   
% 210.86/211.08  |- skos__prefLabel mesh__D051076 Proto-Oncogene Proteins c-fyn
% 210.86/211.08  |- skos__hiddenLabel mesh__D051076 p60 c fyn Protein
% 210.86/211.08  |- skos__hiddenLabel mesh__D051076 Proto Oncogene Protein c syn
% 210.86/211.08  |- skos__hiddenLabel mesh__D051076 c-fyn, Proto-Oncogene Protein
% 210.86/211.08  |- skos__hiddenLabel mesh__D051076 c-fyn Protein, p60
% 210.86/211.08  |- mesh__recordMaintainer mesh__D051076 DRC
% 210.86/211.08  |- skos__altLabel mesh__D051076 p59 c-fyn Protein
% 210.86/211.08  |- rdf__type mesh__D051076sskos__Concept
% 210.86/211.08  |- mesh__dateEstablished mesh__D051076 2006-01-01
% 210.86/211.08  |- skos__hiddenLabel mesh__D051076 c-fyn Protein, p59
% 210.86/211.08  |- skos__hiddenLabel mesh__D051076 p72 c fyn Protein
% 210.86/211.08  |- skos__altLabel mesh__D051076 Protein-Tyrosine Kinase p59%28%fyn%29%
% 210.86/211.08  |- skos__hiddenLabel mesh__D051076 Proto-Oncogene Proteins, fyn
% 210.86/211.08  |- skos__hiddenLabel mesh__D051076 Proteins c-fyn, Proto-Oncogene
% 210.86/211.08  |- mesh__recordOriginator mesh__D051076 DRC
% 210.86/211.08  |- skos__broader mesh__D051076smesh__D011518
% 210.86/211.08  |- skos__hiddenLabel mesh__D051076 Proto Oncogene Protein c fyn
% 210.86/211.08  |- mesh__recordAuthorizer mesh__D051076 sjn
% 210.86/211.08  |- skos__hiddenLabel mesh__D051076 c-fyn, Proto-Oncogene Proteins
% 210.86/211.08  |- skos__altLabel mesh__D051076 c-fyn Proto-Oncogene Proteins
% 210.86/211.08  |- skos__hiddenLabel mesh__D051076 fyn Proto Oncogene Proteins
% 210.86/211.08  |- skos__altLabel mesh__D051076 p59%28%fyn%29% Protein
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D051076 2006
% 210.86/211.08  |- skos__hiddenLabel mesh__D051076 c-syn, Proto-Oncogene Protein
% 210.86/211.08  |- mesh__publicMeSHNote mesh__D051076
% 210.86/211.08       2006; PROTO-ONCOGENE PROTEIN C-FYN was indexed under SRC-FAMILY KINASES %26% PROTO-ONCOGENE PROTEINS 1989-2005%A%  
% 210.86/211.08  |- skos__altLabel mesh__D051076 Proto-Oncogene Protein c-fyn
% 210.86/211.08  |- skos__hiddenLabel mesh__D051076 Proto Oncogene Proteins c fyn
% 210.86/211.08  |- skos__hiddenLabel mesh__D051076 Proto-Oncogene Proteins, c-fyn
% 210.86/211.08  |- skos__altLabel mesh__D051076 p60%28%fyn%29% Protein
% 210.86/211.08  |- mesh__dateCreated mesh__D051076 2005-06-30
% 210.86/211.08  |- skos__hiddenLabel mesh__D051076 Tyrosine Kinase, Fyn
% 210.86/211.08  |- skos__altLabel mesh__D051076 p60 c-fyn Protein
% 210.86/211.08  |- skos__scopeNote mesh__D017348
% 210.86/211.08       A type of TRANSMISSION ELECTRON MICROSCOPY in which the object is examined directly by an extremely narrow electron beam scanning the specimen point-by-point and using the reactions of the electrons that are transmitted through the specimen to create the image. It should not be confused with SCANNING ELECTRON MICROSCOPY.%A%    
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D017348 2006
% 210.86/211.08  |- skos__broader mesh__D017348smesh__D046529
% 210.86/211.08  |- mesh__dateEstablished mesh__D017348 1993-01-01
% 210.86/211.08  |- skos__altLabel mesh__D017348 STEM
% 210.86/211.08  |- mesh__historyNote mesh__D017348 93   
% 210.86/211.08  |- mesh__recordOriginator mesh__D017348 TGC
% 210.86/211.08  |- skos__prefLabel mesh__D017348
% 210.86/211.08       Microscopy, Electron, Scanning Transmission
% 210.86/211.08  |- mesh__recordMaintainer mesh__D017348 ags
% 210.86/211.08  |- skos__altLabel mesh__D017348 Scanning Transmission Electron Microscopy
% 210.86/211.08  |- mesh__publicMeSHNote mesh__D017348 93   
% 210.86/211.08  |- rdf__type mesh__D017348sskos__Concept
% 210.86/211.08  |- skos__altLabel mesh__D017348 Electron Microscopy, Scanning Transmission
% 210.86/211.08  |- mesh__dateRevised mesh__D017348 2005-06-30
% 210.86/211.08  |- skos__historyNote mesh__D017348
% 210.86/211.08       Microscopy, Electron, Scanning %28%1969-1992%29%
% 210.86/211.08  |- mesh__dateCreated mesh__D017348 1992-05-18
% 210.86/211.08  |- skos__annotation mesh__D017348
% 210.86/211.08       do not confuse with MICROSCOPY, ELECTRON, SCANNING nor with MICROSCOPY, ELECTRON, TRANSMISSION; since the techniques have different applications, do not interpret: if in doubt, use words of author%A%  
% 210.86/211.08  |- mesh__recordAuthorizer mesh__D017348 sjn
% 210.86/211.08  |- skos__hiddenLabel mesh__D036502 Infusion, Intralesional
% 210.86/211.08  |- skos__hiddenLabel mesh__D036502 Intralesional Infusions
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D036502 2006
% 210.86/211.08  |- skos__prefLabel mesh__D036502 Infusions, Intralesional
% 210.86/211.08  |- skos__annotation mesh__D036502
% 210.86/211.08       do not confuse with INJECTIONS, INTRALESIONAL   
% 210.86/211.08  |- mesh__dateEstablished mesh__D036502 2003-01-01
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D036502 2005
% 210.86/211.08  |- rdf__type mesh__D036502sskos__Concept
% 210.86/211.08  |- skos__hiddenLabel mesh__D036502 Intralesional Infusion
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D036502 2004
% 210.86/211.08  |- mesh__publicMeSHNote mesh__D036502 2003   
% 210.86/211.08  |- skos__scopeNote mesh__D036502
% 210.86/211.08       The administration of medication or fluid directly into localized lesions, by means of gravity flow or INFUSION PUMPS.%A%    
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D036502 2003
% 210.86/211.08  |- mesh__dateCreated mesh__D036502 2002-07-03
% 210.86/211.08  |- mesh__historyNote mesh__D036502 2003   
% 210.86/211.08  |- skos__broader mesh__D036502smesh__D007263
% 210.86/211.08  |- mesh__onlineNote mesh__D003328
% 210.86/211.08       use CORONARY THROMBOSIS to search THROMBOSIS, CORONARY 1987-91; use CORONARY DISEASE 1974-86%A%  
% 210.86/211.08  |- skos__altLabel mesh__D003328 Thrombosis, Coronary
% 210.86/211.08  |- skos__prefLabel mesh__D003328 Coronary Thrombosis
% 210.86/211.08  |- skos__broader mesh__D003328smesh__D003327
% 210.86/211.08  |- skos__historyNote mesh__D003328 Coronary Disease %28%1966-1986%29%
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003328 2001
% 210.86/211.08  |- mesh__dateEstablished mesh__D003328 1991-01-01
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003328 2004
% 210.86/211.08  |- mesh__historyNote mesh__D003328
% 210.86/211.08       91%28%87%29%; was see under CORONARY DISEASE 1987-90; was THROMBOSIS, CORONARY see CORONARY DISEASE 1974-86%A%  
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003328 2000
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003328 2003
% 210.86/211.08  |- mesh__recordMaintainer mesh__D003328 MSR
% 210.86/211.08  |- skos__hiddenLabel mesh__D003328 Coronary Thromboses
% 210.86/211.08  |- mesh__recordAuthorizer mesh__D003328 SJN
% 210.86/211.08  |- skos__broader mesh__D003328smesh__D013927
% 210.86/211.08  |- skos__annotation mesh__D003328
% 210.86/211.08       do not confuse %22%mural thrombus%22% with %22%coronary thrombosis%22%: index under HEART DISEASES + THROMBOSIS%A%  
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003328 2006
% 210.86/211.08  |- skos__hiddenLabel mesh__D003328 Thromboses, Coronary
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003328 1999
% 210.86/211.08  |- skos__scopeNote mesh__D003328
% 210.86/211.08       Presence of a thrombus in a coronary artery, often causing a myocardial infarction.%A%    
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003328 2002
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003328 2005
% 210.86/211.08  |- mesh__dateRevised mesh__D003328 1998-06-10
% 210.86/211.08  |- mesh__dateCreated mesh__D003328 1986-03-27
% 210.86/211.08  |- mesh__recordOriginator mesh__D003328 VDK
% 210.86/211.08  |- rdf__type mesh__D003328sskos__Concept
% 210.86/211.08  |- mesh__publicMeSHNote mesh__D003328
% 210.86/211.08       91; was see under CORONARY DISEASE 1987-90; was THROMBOSIS, CORONARY see CORONARY DISEASE 1974-86%A%  
% 210.86/211.08  |- skos__broader mesh__D014050smesh__D001555
% 210.86/211.08  |- mesh__dateRevised mesh__D014050 2001-07-25
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D014050 2005
% 210.86/211.08  |- mesh__recordMaintainer mesh__D014050 ssb
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D014050 2002
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D014050 2006
% 210.86/211.08  |- skos__scopeNote mesh__D014050 A widely used industrial solvent.     
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D014050 2003
% 210.86/211.08  |- mesh__recordAuthorizer mesh__D014050 sjn
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D014050 2004
% 210.86/211.08  |- mesh__recordOriginator mesh__D014050 NLM
% 210.86/211.08  |- rdf__type mesh__D014050sskos__Concept
% 210.86/211.08  |- skos__prefLabel mesh__D014050 Toluene
% 210.86/211.08  |- mesh__dateCreated mesh__D014050 1999-01-01
% 210.86/211.08  |- skos__hiddenLabel mesh__D008811 DBA Mouse, Inbred
% 210.86/211.08  |- skos__hiddenLabel mesh__D008811 Inbred DBA Mice
% 210.86/211.08  |- skos__altLabel mesh__D008811 Mouse, Inbred DBA
% 210.86/211.08  |- skos__hiddenLabel mesh__D008811 DBA Mice
% 210.86/211.08  |- skos__broader mesh__D008811smesh__D008815
% 210.86/211.08  |- skos__hiddenLabel mesh__D008811 DBA Mouse
% 210.86/211.08  |- mesh__recordMaintainer mesh__D008811 ags
% 210.86/211.08  |- mesh__dateEstablished mesh__D008811 1974-01-01
% 210.86/211.08  |- mesh__dateRevised mesh__D008811 2005-06-30
% 210.86/211.08  |- mesh__dateCreated mesh__D008811 1999-01-01
% 210.86/211.08  |- skos__annotation mesh__D008811
% 210.86/211.08       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%  
% 210.86/211.08  |- rdf__type mesh__D008811sskos__Concept
% 210.86/211.08  |- mesh__historyNote mesh__D008811 74%28%72%29%   
% 210.86/211.08  |- skos__altLabel mesh__D008811 Mouse, DBA
% 210.86/211.08  |- mesh__recordOriginator mesh__D008811 NLM
% 210.86/211.08  |- skos__hiddenLabel mesh__D008811 DBA Mice, Inbred
% 210.86/211.08  |- skos__hiddenLabel mesh__D008811 Inbred DBA Mouse
% 210.86/211.08  |- mesh__recordAuthorizer mesh__D008811 sjn
% 210.86/211.08  |- skos__altLabel mesh__D008811 Mice, DBA
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D008811 2006
% 210.86/211.08  |- skos__prefLabel mesh__D008811 Mice, Inbred DBA
% 210.86/211.08  |- skos__historyNote mesh__D008811 Mice %28%1966-1971%29%
% 210.86/211.08  |- mesh__publicMeSHNote mesh__D008811 74   
% 210.86/211.08  |- skos__historyNote mesh__D008013 Acetic Acids %28%1966-1972%29%
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D008013 2002
% 210.86/211.08  |- rdf__type mesh__D008013sskos__Concept
% 210.86/211.08  |- skos__historyNote mesh__D008013 Amides %28%1966-1972%29%
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D008013 2003
% 210.86/211.08  |- skos__prefLabel mesh__D008013 Lidoflazine
% 210.86/211.08  |- mesh__recordMaintainer mesh__D008013 TWD
% 210.86/211.08  |- mesh__dateEstablished mesh__D008013 1991-01-01
% 210.86/211.08  |- skos__historyNote mesh__D008013 Piperazines %28%1966-1972%29%
% 210.86/211.08  |- mesh__dateCreated mesh__D008013 1999-01-01
% 210.86/211.08  |- skos__scopeNote mesh__D008013
% 210.86/211.08       Coronary vasodilator with some antiarrhythmic action.     
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D008013 2006
% 210.86/211.08  |- mesh__publicMeSHNote mesh__D008013
% 210.86/211.08       91; was see under PIPERAZINES 1973-90   
% 210.86/211.08  |- mesh__recordAuthorizer mesh__D008013 sjn
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D008013 2001
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D008013 2005
% 210.86/211.08  |- mesh__dateRevised mesh__D008013 2000-06-22
% 210.86/211.08  |- mesh__recordOriginator mesh__D008013 NLM
% 210.86/211.08  |- skos__historyNote mesh__D008013 Xylenes %28%1966-1972%29%
% 210.86/211.08  |- mesh__historyNote mesh__D008013
% 210.86/211.08       91%28%73%29%; was see under PIPERAZINES 1973-90   
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D008013 2004
% 210.86/211.08  |- skos__broader mesh__D008013smesh__D010879
% 210.86/211.08  |- skos__prefLabel mesh__D000030 Abortion, Missed
% 210.86/211.08  |- rdf__type mesh__D000030sskos__Concept
% 210.86/211.08  |- skos__hiddenLabel mesh__D000030 Missed Abortion
% 210.86/211.08  |- mesh__recordMaintainer mesh__D000030 lkt
% 210.86/211.08  |- skos__hiddenLabel mesh__D000030 Missed Abortions
% 210.86/211.08  |- mesh__recordAuthorizer mesh__D000030 sjn
% 210.86/211.08  |- skos__hiddenLabel mesh__D000030 Abortions, Missed
% 210.86/211.08  |- mesh__dateRevised mesh__D000030 2005-06-30
% 210.86/211.08  |- mesh__recordOriginator mesh__D000030 NLM
% 210.86/211.08  |- skos__broader mesh__D000030smesh__D000022
% 210.86/211.08  |- skos__scopeNote mesh__D000030
% 210.86/211.08       The retention in the UTERUS of a dead FETUS two months or more after its DEATH.%A%    
% 210.86/211.08  |- skos__annotation mesh__D000030 check the tags FEMALE %26% PREGNANCY   
% 210.86/211.08  |- mesh__dateCreated mesh__D000030 1999-01-01
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D000030 2006
% 210.86/211.08  |- skos__historyNote mesh__D046930 Thyme %28%1998-2004%29%
% 210.86/211.08  |- mesh__dateEstablished mesh__D046930 2005-01-01
% 210.86/211.08  |- skos__scopeNote mesh__D046930
% 210.86/211.08       A plant genus of the family LAMIACEAE best known for the thyme spice added to foods.%A%    
% 210.86/211.08  |- mesh__recordAuthorizer mesh__D046930 sjn
% 210.86/211.08  |- mesh__dateCreated mesh__D046930 2004-07-07
% 210.86/211.08  |- rdf__type mesh__D046930sskos__Concept
% 210.86/211.08  |- mesh__recordOriginator mesh__D046930 ssb
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D046930 2006
% 210.86/211.08  |- mesh__publicMeSHNote mesh__D046930
% 210.86/211.08       2005; for THYME, see THYME 2002-2004, see LAMIACEAE 1998-2001, see HERBS 1983-1997, see THYME 1963-1982%A%  
% 210.86/211.08  |- skos__broader mesh__D046930smesh__D019686
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D046930 2005
% 210.86/211.08  |- skos__prefLabel mesh__D046930 Thymus Plant
% 210.86/211.08  |- mesh__historyNote mesh__D046930 2005   
% 210.86/211.08  |- mesh__recordMaintainer mesh__D046930 ssb
% 210.86/211.08  |- skos__annotation mesh__D046930
% 210.86/211.08       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.86/211.08  |- skos__scopeNote mesh__D013756
% 210.86/211.08       A highly toxic compound used as a gasoline additive. It causes acute toxic psychosis or chronic poisoning if inhaled or absorbed through the skin.%A%    
% 210.86/211.08  |- skos__historyNote mesh__D013756
% 210.86/211.08       Organometallic Compounds %28%1969-1975%29%
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D013756 2001
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D013756 2003
% 210.86/211.08  |- mesh__dateRevised mesh__D013756 2000-06-22
% 210.86/211.08  |- mesh__publicMeSHNote mesh__D013756
% 210.86/211.08       91; was see under ORGANOMETALLIC COMPOUNDS 1976-90   
% 210.86/211.08  |- mesh__dateEstablished mesh__D013756 1991-01-01
% 210.86/211.08  |- skos__hiddenLabel mesh__D013756 Lead, Tetraethyl
% 210.86/211.08  |- mesh__dateCreated mesh__D013756 1975-07-25
% 210.86/211.08  |- mesh__recordMaintainer mesh__D013756 CCR
% 210.86/211.08  |- skos__altLabel mesh__D013756 Tetraethyllead
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D013756 2006
% 210.86/211.08  |- mesh__historyNote mesh__D013756
% 210.86/211.08       91%28%76%29%; was see under ORGANOMETALLIC COMPOUNDS 1976-90   
% 210.86/211.08  |- rdf__type mesh__D013756sskos__Concept
% 210.86/211.08  |- skos__broader mesh__D013756smesh__D009942
% 210.86/211.08  |- mesh__recordAuthorizer mesh__D013756 sjn
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D013756 2005
% 210.86/211.08  |- skos__prefLabel mesh__D013756 Tetraethyl Lead
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D013756 2002
% 210.86/211.08  |- skos__historyNote mesh__D013756 Lead %28%1969-1975%29%
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D013756 2004
% 210.86/211.08  |- mesh__recordOriginator mesh__D013756 RLS
% 210.86/211.08  |- mesh__dateEstablished mesh__D007719 1965-01-01
% 210.86/211.08  |- mesh__dateCreated mesh__D007719 1999-01-01
% 210.86/211.08  |- skos__prefLabel mesh__D007719 Knee Joint
% 210.86/211.08  |- mesh__dateRevised mesh__D007719 1992-05-14
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D007719 1996
% 210.86/211.08  |- mesh__historyNote mesh__D007719 65   
% 210.86/211.08  |- skos__annotation mesh__D007719
% 210.86/211.08       primates only; TN 238: differentiation from KNEE %26% indexing instructions%A%  
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D007719 2004
% 210.86/211.08  |- mesh__recordOriginator mesh__D007719 NLM
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D007719 1993
% 210.86/211.08  |- skos__hiddenLabel mesh__D007719 Knee Joints
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D007719 1999
% 210.86/211.08  |- skos__broader mesh__D007719smesh__D007596
% 210.86/211.08  |- skos__hiddenLabel mesh__D007719 Joint, Knee
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D007719 2003
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D007719 2001
% 210.86/211.08  |- mesh__publicMeSHNote mesh__D007719 65   
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D007719 2000
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D007719 1998
% 210.86/211.08  |- skos__hiddenLabel mesh__D007719 Joints, Knee
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D007719 2006
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D007719 1995
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D007719 2005
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D007719 1997
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D007719 1994
% 210.86/211.08  |- mesh__recordMaintainer mesh__D007719 TAP
% 210.86/211.08  |- mesh__recordAuthorizer mesh__D007719 PLS
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D007719 2002
% 210.86/211.08  |- rdf__type mesh__D007719sskos__Concept
% 210.86/211.08  |- skos__related mesh__D018441smesh__D016459
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D018441 1995
% 210.86/211.08  |- mesh__dateEstablished mesh__D018441 1995-01-01
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D018441 2002
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D018441 1998
% 210.86/211.08  |- skos__historyNote mesh__D018441 Bacteria %28%1981-1994%29%
% 210.86/211.08  |- mesh__publicMeSHNote mesh__D018441 95   
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D018441 1999
% 210.86/211.08  |- skos__related mesh__D018441smesh__D001422
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D018441 2000
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D018441 2005
% 210.86/211.08  |- mesh__historyNote mesh__D018441 95   
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D018441 1996
% 210.86/211.08  |- skos__scopeNote mesh__D018441
% 210.86/211.08       Films of bacteria or other microbial organisms, usually embedded in extracellular polymers such as implanted medical devices, which adhere to surfaces submerged in, or subjected to, aquatic environments %28%From Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed%29%. Biofilms consist of multilayers of microbial cells glued together to form microbial communities which are highly resistant to both phagocytes and antibiotics.%A%    
% 210.86/211.08  |- skos__annotation mesh__D018441
% 210.86/211.08       films of multilayers of bacteria or other micro-organism on polymers, usually implanted med devices; bacteria-named biofilms: coord IM with specific bacterium %28%IM%29% with no qualif, as Pseudomonas biofilm = PSEUDOMONAS %28%IM%29% + BIOFILMS %28%IM%29%; biofilm formation, production, generation, deposition: coord BIOFILMS /growth %28%IM%29% + specific micro-organism /physiol %28%IM%29%; occurrence of biofilms on prostheses or other devices: coord IM with specific device %28%IM%29%; infection of prostheses by biofilms: coord BIOFILMS %28%IM%29% with specific prosthesis %28%IM%29% + PROSTHESIS-RELATED INFECTIONS %28%IM%29% + specific infection %28%IM%29%%A%  
% 210.86/211.08  |- skos__prefLabel mesh__D018441 Biofilms
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D018441 2006
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D018441 1997
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D018441 2001
% 210.86/211.08  |- skos__altLabel mesh__D018441 Biofilm
% 210.86/211.08  |- rdf__type mesh__D018441sskos__Concept
% 210.86/211.08  |- mesh__dateCreated mesh__D018441 1994-04-16
% 210.86/211.08  |- skos__broader mesh__D018441smesh__D001419
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D018441 2003
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D018441 2004
% 210.86/211.08  |- mesh__historyNote mesh__D004421 1982   
% 210.86/211.08  |- mesh__publicMeSHNote mesh__D004421
% 210.86/211.08       1982; see MUSCLE DYSTONIA 1979-1981   
% 210.86/211.08  |- rdf__type mesh__D004421sskos__Concept
% 210.86/211.08  |- skos__related mesh__D004421smesh__D004422
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D004421 2000
% 210.86/211.08  |- skos__hiddenLabel mesh__D004421 Dystonia, Muscle
% 210.86/211.08  |- mesh__dateRevised mesh__D004421 1999-12-02
% 210.86/211.08  |- skos__annotation mesh__D004421
% 210.86/211.08       do not confuse with MUSCLE HYPERTONIA or MUSCLE HYPOTONIA; DYSTONIC DISORDERS is available%A%  
% 210.86/211.08  |- skos__hiddenLabel mesh__D004421 Paroxysmal Dystonia
% 210.86/211.08  |- skos__prefLabel mesh__D004421 Dystonia
% 210.86/211.08  |- skos__historyNote mesh__D004421 Movement Disorders %28%1966-1978%29%
% 210.86/211.08  |- skos__hiddenLabel mesh__D004421 Diurnal Dystonia
% 210.86/211.08  |- mesh__recordAuthorizer mesh__D004421 ags
% 210.86/211.08  |- mesh__dateEstablished mesh__D004421 1979-01-01
% 210.86/211.08  |- skos__altLabel mesh__D004421 Muscle Dystonia
% 210.86/211.08  |- skos__historyNote mesh__D004421 Muscle Tonus %28%1970-1978%29%
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D004421 2004
% 210.86/211.08  |- skos__hiddenLabel mesh__D004421 Limb Dystonia
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D004421 2002
% 210.86/211.08  |- skos__related mesh__D004421smesh__D020821
% 210.86/211.08  |- mesh__dateCreated mesh__D004421 1978-05-17
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D004421 2006
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D004421 2003
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D004421 2001
% 210.86/211.08  |- mesh__recordMaintainer mesh__D004421 ags
% 210.86/211.08  |- skos__broader mesh__D004421smesh__D020820
% 210.86/211.08  |- skos__scopeNote mesh__D004421
% 210.86/211.08       A persistent attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. %28%Adams et al., Principles of Neurology, 6th ed, p77%29%%A%    
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D004421 2005
% 210.86/211.08  |- mesh__recordOriginator mesh__D004421 RC
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D004421 2000A
% 210.86/211.08  |- mesh__dateCreated mesh__D051077 2005-06-30
% 210.86/211.08  |- mesh__publicMeSHNote mesh__D051077 2006   
% 210.86/211.08  |- mesh__historyNote mesh__D051077 2006   
% 210.86/211.08  |- skos__historyNote mesh__D051077 Cebidae %28%1992-2005%29%
% 210.86/211.08  |- rdf__type mesh__D051077sskos__Concept
% 210.86/211.08  |- skos__broader mesh__D051077smesh__D051078
% 210.86/211.08  |- mesh__recordOriginator mesh__D051077 ags
% 210.86/211.08  |- skos__annotation mesh__D051077
% 210.86/211.08       diseases: coordinate IM with MONKEY DISEASES %28%IM%29%   
% 210.86/211.08  |- mesh__dateEstablished mesh__D051077 2006-01-01
% 210.86/211.08  |- mesh__recordAuthorizer mesh__D051077 sjn
% 210.86/211.08  |- skos__scopeNote mesh__D051077
% 210.86/211.08       A family of new world monkeys in the infraorder PLATYRRHINI, comprising the HOWLER MONKEYS, spider monkeys, and wooley monkeys.%A%    
% 210.86/211.08  |- skos__prefLabel mesh__D051077 Atelidae
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D051077 2006
% 210.86/211.08  |- mesh__recordMaintainer mesh__D051077 ags
% 210.86/211.08  |- mesh__dateRevised mesh__D017349 2003-07-09
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D017349 2004
% 210.86/211.08  |- skos__broader mesh__D017349smesh__D016695
% 210.86/211.08  |- mesh__recordAuthorizer mesh__D017349 sjn
% 210.86/211.08  |- mesh__historyNote mesh__D017349 93   
% 210.86/211.08  |- skos__hiddenLabel mesh__D017349 N Acetylhexosaminyltransferases
% 210.86/211.08  |- mesh__dateCreated mesh__D017349 1992-05-22
% 210.86/211.08  |- rdf__type mesh__D017349sskos__Concept
% 210.86/211.08  |- skos__historyNote mesh__D017349 Hexosyltransferases %28%1972-1992%29%
% 210.86/211.08  |- skos__hiddenLabel mesh__D017349 Transferases, N-Acetylhexosamine
% 210.86/211.08  |- skos__altLabel mesh__D017349 N-Acetylhexosamine Transferases
% 210.86/211.08  |- skos__hiddenLabel mesh__D017349 N Acetylhexosamine Transferases
% 210.86/211.08  |- mesh__dateEstablished mesh__D017349 1993-01-01
% 210.86/211.08  |- skos__scopeNote mesh__D017349
% 210.86/211.08       Enzymes that catalyze the transfer of N-acetylhexosaminyl groups to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.%A%    
% 210.86/211.08  |- mesh__recordMaintainer mesh__D017349 ssb
% 210.86/211.08  |- mesh__publicMeSHNote mesh__D017349 93   
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D017349 2005
% 210.86/211.08  |- skos__prefLabel mesh__D017349 N-Acetylhexosaminyltransferases
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D017349 2006
% 210.86/211.08  |- mesh__recordOriginator mesh__D017349 TPW
% 210.86/211.08  |- skos__prefLabel mesh__D036503 Inhalation Spacers
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D036503 2005
% 210.86/211.08  |- rdf__type mesh__D036503sskos__Concept
% 210.86/211.08  |- skos__annotation mesh__D036503
% 210.86/211.08       do not confuse with spacer inhalers see METERED DOSE INHALERS%A%  
% 210.86/211.08  |- skos__hiddenLabel mesh__D036503 Spacers, Tube
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D036503 2004
% 210.86/211.08  |- mesh__publicMeSHNote mesh__D036503 2003   
% 210.86/211.08  |- mesh__dateCreated mesh__D036503 2002-07-03
% 210.86/211.08  |- mesh__historyNote mesh__D036503 2003   
% 210.86/211.08  |- skos__hiddenLabel mesh__D036503 Spacer, Inhalation
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D036503 2003
% 210.86/211.08  |- skos__hiddenLabel mesh__D036503 Spacers, Inhalation
% 210.86/211.08  |- skos__hiddenLabel mesh__D036503 Spacer, Tube
% 210.86/211.08  |- mesh__recordAuthorizer mesh__D036503 sjn
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D036503 2003A
% 210.86/211.08  |- mesh__recordOriginator mesh__D036503 lkt
% 210.86/211.08  |- skos__broader mesh__D036503smesh__D036501
% 210.86/211.08  |- skos__historyNote mesh__D036503
% 210.86/211.08       Nebulizers and Vaporizers %28%1986-2002%29%
% 210.86/211.08  |- mesh__dateEstablished mesh__D036503 2003-01-01
% 210.86/211.08  |- mesh__dateRevised mesh__D036503 2002-10-28
% 210.86/211.08  |- skos__scopeNote mesh__D036503
% 210.86/211.08       A variety of devices used in conjunction with METERED DOSE INHALERS. Their purpose is to hold the released medication for inhalation and make it easy for the patients to inhale the metered dose of medication into their lungs.%A%    
% 210.86/211.08  |- skos__hiddenLabel mesh__D036503 Tube Spacer
% 210.86/211.08  |- skos__historyNote mesh__D036503 Aerosols %28%1979-2002%29%
% 210.86/211.08  |- skos__hiddenLabel mesh__D036503 Inhalation Spacer
% 210.86/211.08  |- skos__historyNote mesh__D036503 Respiratory Therapy %28%1979-2002%29%
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D036503 2006
% 210.86/211.08  |- mesh__recordMaintainer mesh__D036503 sjn
% 210.86/211.08  |- mesh__publicMeSHNote mesh__D003329 82   
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003329 2002
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003329 2004
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003329 1994
% 210.86/211.08  |- mesh__recordOriginator mesh__D003329 VDK
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003329 1997
% 210.86/211.08  |- skos__hiddenLabel mesh__D003329 Artery Vasospasm, Coronary
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003329 2003
% 210.86/211.08  |- mesh__dateRevised mesh__D003329 1992-05-13
% 210.86/211.08  |- mesh__historyNote mesh__D003329 82   
% 210.86/211.08  |- skos__hiddenLabel mesh__D003329 Coronary Vasospasms
% 210.86/211.08  |- mesh__recordAuthorizer mesh__D003329 PLS
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003329 1996
% 210.86/211.08  |- skos__broader mesh__D003329smesh__D003327
% 210.86/211.08  |- skos__hiddenLabel mesh__D003329 Vasospasm, Coronary Artery
% 210.86/211.08  |- skos__altLabel mesh__D003329 Coronary Artery Vasospasm
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003329 2001
% 210.86/211.08  |- mesh__dateEstablished mesh__D003329 1982-01-01
% 210.86/211.08  |- skos__hiddenLabel mesh__D003329 Vasospasms, Coronary Artery
% 210.86/211.08  |- skos__hiddenLabel mesh__D003329 Artery Vasospasms, Coronary
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003329 1993
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003329 2006
% 210.86/211.08  |- skos__hiddenLabel mesh__D003329 Vasospasm, Coronary
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003329 2000
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003329 1999
% 210.86/211.08  |- skos__hiddenLabel mesh__D003329 Vasospasms, Coronary
% 210.86/211.08  |- skos__hiddenLabel mesh__D003329 Coronary Artery Vasospasms
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003329 2005
% 210.86/211.08  |- skos__prefLabel mesh__D003329 Coronary Vasospasm
% 210.86/211.08  |- rdf__type mesh__D003329sskos__Concept
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003329 1998
% 210.86/211.08  |- mesh__recordMaintainer mesh__D003329 PLS
% 210.86/211.08  |- mesh__dateCreated mesh__D003329 1981-05-19
% 210.86/211.08  |- skos__scopeNote mesh__D003329
% 210.86/211.08       Spasm of the large- or medium-sized coronary arteries.     
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D003329 1995
% 210.86/211.08  |- skos__broader mesh__D014051smesh__D014050
% 210.86/211.08  |- mesh__recordOriginator mesh__D014051 NLM
% 210.86/211.08  |- mesh__activeMeSHYear mesh__D014051 2003
% 210.86/211.09  |- skos__hiddenLabel mesh__D014051 Diisocyanate, Toluene
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014051 2001
% 210.86/211.09  |- skos__hiddenLabel mesh__D014051 Diisocyanate, Tolylene
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014051 2004
% 210.86/211.09  |- mesh__dateEstablished mesh__D014051 1991-01-01
% 210.86/211.09  |- rdf__type mesh__D014051sskos__Concept
% 210.86/211.09  |- skos__historyNote mesh__D014051 Toluene %28%1973-1974%29%
% 210.86/211.09  |- mesh__publicMeSHNote mesh__D014051
% 210.86/211.09       94; was TOLUENE DIISOCYANATE 1975-93 %28%see under CYANATES 1975-90%29%%A%  
% 210.86/211.09  |- skos__hiddenLabel mesh__D014051 2,4 Toluenediisocyanate
% 210.86/211.09  |- mesh__onlineNote mesh__D014051
% 210.86/211.09       use TOLUENE 2,4-DIISOCYANATE to search TOLUENE DIISOCYANATE 1975-93%A%  
% 210.86/211.09  |- skos__hiddenLabel mesh__D014051 2,4-Diisocyanate, Toluene
% 210.86/211.09  |- mesh__recordMaintainer mesh__D014051 CCR
% 210.86/211.09  |- skos__historyNote mesh__D014051 Cyanates %28%1970-1974%29%
% 210.86/211.09  |- skos__scopeNote mesh__D014051
% 210.86/211.09       Skin irritant and allergen used in the manufacture of polyurethane foams and other elastomers.%A%    
% 210.86/211.09  |- skos__altLabel mesh__D014051 Toluene Diisocyanate
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014051 2002
% 210.86/211.09  |- mesh__dateRevised mesh__D014051 2000-06-22
% 210.86/211.09  |- mesh__historyNote mesh__D014051
% 210.86/211.09       94; was TOLUENE DIISOCYANATE 1975-93 %28%see under CYANATES 1975-90%29%%A%  
% 210.86/211.09  |- mesh__dateCreated mesh__D014051 1974-11-19
% 210.86/211.09  |- skos__broader mesh__D014051smesh__D017953
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014051 2005
% 210.86/211.09  |- skos__hiddenLabel mesh__D014051 Toluene 2,4 Diisocyanate
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014051 2006
% 210.86/211.09  |- skos__altLabel mesh__D014051 2,4-Toluenediisocyanate
% 210.86/211.09  |- skos__prefLabel mesh__D014051 Toluene 2,4-Diisocyanate
% 210.86/211.09  |- mesh__recordAuthorizer mesh__D014051 sjn
% 210.86/211.09  |- mesh__recordMaintainer mesh__D008812 ags
% 210.86/211.09  |- skos__hiddenLabel mesh__D008812 Mouse, Hairless
% 210.86/211.09  |- mesh__recordAuthorizer mesh__D008812 sjn
% 210.86/211.09  |- skos__altLabel mesh__D008812 Mice, HRS
% 210.86/211.09  |- skos__prefLabel mesh__D008812 Mice, Inbred HRS
% 210.86/211.09  |- skos__altLabel mesh__D008812 Mouse, Inbred HRS
% 210.86/211.09  |- skos__altLabel mesh__D008812 Mouse, HRS
% 210.86/211.09  |- mesh__dateCreated mesh__D008812 1981-05-14
% 210.86/211.09  |- skos__hiddenLabel mesh__D008812 Inbred HRS Mice
% 210.86/211.09  |- skos__altLabel mesh__D008812 Hairless Mice
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D008812 2006
% 210.86/211.09  |- mesh__publicMeSHNote mesh__D008812
% 210.86/211.09       82; HAIRLESS MICE was see MICE, NUDE 1975-81   
% 210.86/211.09  |- skos__scopeNote mesh__D008812
% 210.86/211.09       Homozygous, permanently near-hairless mice which lose their hair at about 10 days of age.%A%    
% 210.86/211.09  |- skos__broader mesh__D008812smesh__D008815
% 210.86/211.09  |- skos__annotation mesh__D008812
% 210.86/211.09       NIM when exper animal: no qualif; when IM, qualif permitted; do not confuse X ref MICE, HAIRLESS with MICE, NUDE; do not forget also to check tag MICE%A%  
% 210.86/211.09  |- mesh__dateRevised mesh__D008812 2005-06-30
% 210.86/211.09  |- mesh__historyNote mesh__D008812
% 210.86/211.09       82; HAIRLESS MICE was see MICE, NUDE 1975-81   
% 210.86/211.09  |- skos__hiddenLabel mesh__D008812 HRS Mice
% 210.86/211.09  |- skos__hiddenLabel mesh__D008812 HRS Mouse, Inbred
% 210.86/211.09  |- skos__hiddenLabel mesh__D008812 HRS Mice, Inbred
% 210.86/211.09  |- skos__hiddenLabel mesh__D008812 Inbred HRS Mouse
% 210.86/211.09  |- mesh__dateEstablished mesh__D008812 1982-01-01
% 210.86/211.09  |- skos__hiddenLabel mesh__D008812 HRS Mouse
% 210.86/211.09  |- mesh__recordOriginator mesh__D008812 EC
% 210.86/211.09  |- rdf__type mesh__D008812sskos__Concept
% 210.86/211.09  |- skos__altLabel mesh__D008812 Mice, Hairless
% 210.86/211.09  |- skos__altLabel mesh__D008812 Hairless Mouse
% 210.86/211.09  |- mesh__onlineNote mesh__D008812
% 210.86/211.09       use MICE, NUDE to search HAIRLESS MICE 1975-81   
% 210.86/211.09  |- skos__hiddenLabel mesh__D008014 Detections, Lie
% 210.86/211.09  |- rdf__type mesh__D008014sskos__Concept
% 210.86/211.09  |- mesh__recordOriginator mesh__D008014 NLM
% 210.86/211.09  |- mesh__dateRevised mesh__D008014 2003-07-09
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D008014 2005
% 210.86/211.09  |- skos__broader mesh__D008014smesh__D003417
% 210.86/211.09  |- skos__broader mesh__D008014smesh__D005554
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D008014 2006
% 210.86/211.09  |- skos__scopeNote mesh__D008014
% 210.86/211.09       Ascertaining of deception through detection of emotional disturbance as manifested by changes in physiologic processes usually using a polygraph.%A%    
% 210.86/211.09  |- skos__broader mesh__D008014smesh__D011603
% 210.86/211.09  |- skos__hiddenLabel mesh__D008014 Detection, Lie
% 210.86/211.09  |- skos__prefLabel mesh__D008014 Lie Detection
% 210.86/211.09  |- skos__hiddenLabel mesh__D008014 Lie Detections
% 210.86/211.09  |- mesh__recordMaintainer mesh__D008014 lkt
% 210.86/211.09  |- mesh__dateCreated mesh__D008014 1999-01-01
% 210.86/211.09  |- mesh__recordAuthorizer mesh__D008014 sjn
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D008014 2004
% 210.86/211.09  |- rdf__type mesh__D000031sskos__Concept
% 210.86/211.09  |- skos__prefLabel mesh__D000031 Abortion, Septic
% 210.86/211.09  |- skos__altLabel mesh__D000031 Septic Abortion
% 210.86/211.09  |- skos__broader mesh__D000031smesh__D000022
% 210.86/211.09  |- skos__scopeNote mesh__D000031
% 210.86/211.09       Any type of abortion, induced or spontaneous, that is associated with infection of the UTERUS and its appendages. It is characterized by FEVER, uterine tenderness, and foul discharge.%A%    
% 210.86/211.09  |- mesh__dateCreated mesh__D000031 1999-01-01
% 210.86/211.09  |- skos__broader mesh__D000031smesh__D011251
% 210.86/211.09  |- skos__annotation mesh__D000031
% 210.86/211.09       /vet permitted only if discussed as %22%septic%22% abortion: do not use automatically for animal abortion in brucellosis, vibriosis, trichomoniasis, etc; check the tags FEMALE %26% PREGNANCY%A%  
% 210.86/211.09  |- mesh__recordMaintainer mesh__D000031 lkt
% 210.86/211.09  |- mesh__recordAuthorizer mesh__D000031 sjn
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D000031 2006
% 210.86/211.09  |- mesh__recordOriginator mesh__D000031 NLM
% 210.86/211.09  |- mesh__dateRevised mesh__D000031 2005-06-30
% 210.86/211.09  |- skos__hiddenLabel mesh__D000031 Abortions, Septic
% 210.86/211.09  |- skos__hiddenLabel mesh__D000031 Septic Abortions
% 210.86/211.09  |- mesh__historyNote mesh__D046931 2005   
% 210.86/211.09  |- skos__scopeNote mesh__D046931
% 210.86/211.09       A form-genus of CYANOBACTERIA in the order Chroococcales. Many species are planktonic and possess gas vacuoles.%A%    
% 210.86/211.09  |- mesh__dateCreated mesh__D046931 2004-07-07
% 210.86/211.09  |- skos__historyNote mesh__D046931 Cyanobacteria %28%1969-2004%29%
% 210.86/211.09  |- mesh__recordOriginator mesh__D046931 ags
% 210.86/211.09  |- rdf__type mesh__D046931sskos__Concept
% 210.86/211.09  |- skos__broader mesh__D046931smesh__D000458
% 210.86/211.09  |- mesh__dateEstablished mesh__D046931 2005-01-01
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D046931 2006
% 210.86/211.09  |- skos__prefLabel mesh__D046931 Microcystis
% 210.86/211.09  |- mesh__recordAuthorizer mesh__D046931 sjn
% 210.86/211.09  |- mesh__publicMeSHNote mesh__D046931 2005   
% 210.86/211.09  |- mesh__dateRevised mesh__D046931 2005-06-30
% 210.86/211.09  |- mesh__recordMaintainer mesh__D046931 SYSTEM
% 210.86/211.09  |- mesh__recordAuthorizer mesh__D013757 sjn
% 210.86/211.09  |- skos__broader mesh__D013757smesh__D000644
% 210.86/211.09  |- skos__hiddenLabel mesh__D013757 Compounds, Tetraethylammonium
% 210.86/211.09  |- skos__annotation mesh__D013757 DF: TETRAETHYLAMMONIUM CPDS   
% 210.86/211.09  |- skos__prefLabel mesh__D013757 Tetraethylammonium Compounds
% 210.86/211.09  |- mesh__dateCreated mesh__D013757 1999-01-01
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D013757 2006
% 210.86/211.09  |- mesh__recordMaintainer mesh__D013757 ssb
% 210.86/211.09  |- rdf__type mesh__D013757sskos__Concept
% 210.86/211.09  |- mesh__dateRevised mesh__D013757 2005-06-30
% 210.86/211.09  |- skos__altLabel mesh__D013757 Tetrylammonium
% 210.86/211.09  |- mesh__recordOriginator mesh__D013757 NLM
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D018442 1998
% 210.86/211.09  |- skos__broader mesh__D018442smesh__D016393
% 210.86/211.09  |- skos__scopeNote mesh__D018442
% 210.86/211.09       Extranodal lymphoma of lymphoid tissue associated with mucosa that is in contact with exogenous antigens. Many of the sites of these lymphomas, such as the stomach, salivary gland, and thyroid, are normally devoid of lymphoid tissue. They acquire MALT tissue as a result of an immunologically mediated disorder.%A%    
% 210.86/211.09  |- skos__historyNote mesh__D018442 Lymphoma, B-Cell %28%1990-1994%29%
% 210.86/211.09  |- skos__hiddenLabel mesh__D018442
% 210.86/211.09       Lymphoma, Mucosa Associated Lymphoid Tissue
% 210.86/211.09  |- skos__altLabel mesh__D018442 MALT Lymphoma
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D018442 1999
% 210.86/211.09  |- skos__historyNote mesh__D018442 Lymphoma %28%1989-1994%29%
% 210.86/211.09  |- skos__hiddenLabel mesh__D018442 Lymphomas, MALT
% 210.86/211.09  |- skos__historyNote mesh__D018442 Lymphoid Tissue %28%1989-1994%29%
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D018442 2005
% 210.86/211.09  |- mesh__historyNote mesh__D018442 95   
% 210.86/211.09  |- skos__altLabel mesh__D018442
% 210.86/211.09       Lymphoma of Mucosa-Associated Lymphoid Tissue
% 210.86/211.09  |- mesh__dateEstablished mesh__D018442 1995-01-01
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D018442 2002
% 210.86/211.09  |- mesh__dateCreated mesh__D018442 1994-06-03
% 210.86/211.09  |- mesh__recordOriginator mesh__D018442 AGS
% 210.86/211.09  |- skos__historyNote mesh__D018442
% 210.86/211.09       Lymphoma, Non-Hodgkin%27%s %28%1991-1994%29%
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D018442 2006
% 210.86/211.09  |- skos__prefLabel mesh__D018442
% 210.86/211.09       Lymphoma, Mucosa-Associated Lymphoid Tissue
% 210.86/211.09  |- mesh__publicMeSHNote mesh__D018442 95   
% 210.86/211.09  |- rdf__type mesh__D018442sskos__Concept
% 210.86/211.09  |- mesh__recordMaintainer mesh__D018442 PXP
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D018442 2003
% 210.86/211.09  |- mesh__recordAuthorizer mesh__D018442 SJN
% 210.86/211.09  |- mesh__dateRevised mesh__D018442 1997-06-20
% 210.86/211.09  |- skos__broader mesh__D018442smesh__D016397
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D018442 2000
% 210.86/211.09  |- skos__hiddenLabel mesh__D018442
% 210.86/211.09       Lymphoma of Mucosa Associated Lymphoid Tissue
% 210.86/211.09  |- skos__hiddenLabel mesh__D018442
% 210.86/211.09       Mucosa Associated Lymphoid Tissue Lymphoma
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D018442 2004
% 210.86/211.09  |- skos__altLabel mesh__D018442 Mucosa-Associated Lymphoid Tissue Lymphoma
% 210.86/211.09  |- skos__hiddenLabel mesh__D018442 Lymphoma, MALT
% 210.86/211.09  |- skos__hiddenLabel mesh__D018442 MALT Lymphomas
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D018442 2001
% 210.86/211.09  |- skos__annotation mesh__D018442
% 210.86/211.09       a low-grade B-cell lymphoma; DF: LYMPHOMA MALT   
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D051876 2006
% 210.86/211.09  |- mesh__recordAuthorizer mesh__D051876 sjn
% 210.86/211.09  |- rdf__type mesh__D051876sskos__Concept
% 210.86/211.09  |- skos__prefLabel mesh__D051876 Sex-Determining Region Y Protein
% 210.86/211.09  |- skos__broader mesh__D051876smesh__D004268
% 210.86/211.09  |- mesh__recordMaintainer mesh__D051876 DRC
% 210.86/211.09  |- mesh__dateEstablished mesh__D051876 2006-01-01
% 210.86/211.09  |- skos__related mesh__D051876smesh__D024282
% 210.86/211.09  |- mesh__historyNote mesh__D051876 2006%28%1990%29%   
% 210.86/211.09  |- mesh__recordOriginator mesh__D051876 DRC
% 210.86/211.09  |- skos__hiddenLabel mesh__D051876 Sex Determining Region Y Protein
% 210.86/211.09  |- skos__altLabel mesh__D051876 Testis-Determining Factor
% 210.86/211.09  |- skos__scopeNote mesh__D051876
% 210.86/211.09       A high mobility group protein encoded by the Y CHROMOSOME. It functions as a transcription factor and is essential for development of the TESTES.%A%    
% 210.86/211.09  |- skos__hiddenLabel mesh__D051876 SRY Sex Determining Region Protein
% 210.86/211.09  |- mesh__dateCreated mesh__D051876 2005-06-30
% 210.86/211.09  |- skos__altLabel mesh__D051876 SRY Sex-Determining Region Protein
% 210.86/211.09  |- skos__broader mesh__D051876smesh__D014157
% 210.86/211.09  |- mesh__publicMeSHNote mesh__D051876
% 210.86/211.09       2006; SEX-DETERMINING REGION Y PROTEIN was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005%A%  
% 210.86/211.09  |- skos__broader mesh__D051876smesh__D006609
% 210.86/211.09  |- skos__hiddenLabel mesh__D004422 Dystonias, Idiopathic Torsion
% 210.86/211.09  |- rdf__type mesh__D004422sskos__Concept
% 210.86/211.09  |- mesh__recordOriginator mesh__D004422 NLM
% 210.86/211.09  |- skos__altLabel mesh__D004422 Idiopathic Torsion Dystonia
% 210.86/211.09  |- skos__scopeNote mesh__D004422
% 210.86/211.09       A condition characterized by focal DYSTONIA that progresses to involuntary spasmodic contractions of the muscles of the legs, trunk, arms, and face. The hands are often spared, however, sustained axial and limb contractions may lead to a state where the body is grossly contorted. Onset is usually in the first or second decade. Familial patterns of inheritance, primarily autosomal dominant with incomplete penetrance, have been identified. %28%Adams et al., Principles of Neurology, 6th ed, p1078%29%%A%    
% 210.86/211.09  |- skos__hiddenLabel mesh__D004422 Torsion Dystonia, Idiopathic
% 210.86/211.09  |- skos__altLabel mesh__D004422 Progressive Torsion Spasm
% 210.86/211.09  |- skos__hiddenLabel mesh__D004422 Torsion Disease, Childhood
% 210.86/211.09  |- skos__altLabel mesh__D004422 Dystonia Deformans Musculorum
% 210.86/211.09  |- mesh__dateRevised mesh__D004422 2004-07-19
% 210.86/211.09  |- skos__altLabel mesh__D004422 Childhood Torsion Disease
% 210.86/211.09  |- skos__altLabel mesh__D004422 Oppenheim-Ziehen Disease
% 210.86/211.09  |- skos__hiddenLabel mesh__D004422 Idiopathic Torsion Dystonias
% 210.86/211.09  |- skos__hiddenLabel mesh__D004422 Torsion Spasm, Progressive
% 210.86/211.09  |- skos__altLabel mesh__D004422 Torsion Disease of Childhood
% 210.86/211.09  |- skos__broader mesh__D004422smesh__D020271
% 210.86/211.09  |- mesh__dateCreated mesh__D004422 1999-01-01
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D004422 2005
% 210.86/211.09  |- skos__hiddenLabel mesh__D004422 Dystonias, Torsion
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D004422 2006
% 210.86/211.09  |- mesh__recordMaintainer mesh__D004422 jls
% 210.86/211.09  |- skos__hiddenLabel mesh__D004422 Spasm, Progressive Torsion
% 210.86/211.09  |- skos__hiddenLabel mesh__D004422 Oppenheim Ziehen Disease
% 210.86/211.09  |- skos__hiddenLabel mesh__D004422 Dystonia, Idiopathic Torsion
% 210.86/211.09  |- skos__related mesh__D004422smesh__D004421
% 210.86/211.09  |- skos__altLabel mesh__D004422 Dystonia Deformans Progressiva
% 210.86/211.09  |- skos__prefLabel mesh__D004422 Dystonia Musculorum Deformans
% 210.86/211.09  |- mesh__recordAuthorizer mesh__D004422 sjn
% 210.86/211.09  |- skos__broader mesh__D004422smesh__D020821
% 210.86/211.09  |- skos__broader mesh__D004422smesh__D001480
% 210.86/211.09  |- skos__altLabel mesh__D004422 Torsion Dystonia
% 210.86/211.09  |- mesh__recordMaintainer mesh__D051078 ags
% 210.86/211.09  |- mesh__historyNote mesh__D051078
% 210.86/211.09       2006; for MONKEYS, NEW WORLD use CEBIDAE 1981-2005   
% 210.86/211.09  |- mesh__publicMeSHNote mesh__D051078
% 210.86/211.09       2006; for MONKEYS, NEW WORLD see CEBIDAE 1981-2005   
% 210.86/211.09  |- skos__broader mesh__D051078smesh__D000882
% 210.86/211.09  |- skos__scopeNote mesh__D051078
% 210.86/211.09       An infraorder of new world monkeys, comprised of the families ATELIDAE; CALLITRICHIDAE; and CEBIDAE. They are found exclusively in the Americas.%A%    
% 210.86/211.09  |- skos__hiddenLabel mesh__D051078 New World Monkeys
% 210.86/211.09  |- skos__hiddenLabel mesh__D051078 New World Monkey
% 210.86/211.09  |- mesh__dateEstablished mesh__D051078 2006-01-01
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D051078 2006
% 210.86/211.09  |- mesh__recordAuthorizer mesh__D051078 sjn
% 210.86/211.09  |- skos__hiddenLabel mesh__D051078 Monkey, New World
% 210.86/211.09  |- skos__hiddenLabel mesh__D051078 World Monkey, New
% 210.86/211.09  |- mesh__dateCreated mesh__D051078 2005-06-30
% 210.86/211.09  |- rdf__type mesh__D051078sskos__Concept
% 210.86/211.09  |- skos__hiddenLabel mesh__D051078 World Monkeys, New
% 210.86/211.09  |- skos__altLabel mesh__D051078 Monkeys, New World
% 210.86/211.09  |- mesh__recordOriginator mesh__D051078 ags
% 210.86/211.09  |- skos__prefLabel mesh__D051078 Platyrrhini
% 210.86/211.09  |- skos__annotation mesh__D051078
% 210.86/211.09       diseases: coordinate IM with MONKEY DISEASES %28%IM%29%   
% 210.86/211.09  |- mesh__recordAuthorizer mesh__D042541 sjn
% 210.86/211.09  |- skos__hiddenLabel mesh__D042541 Space, Subcellular
% 210.86/211.09  |- skos__hiddenLabel mesh__D042541 Space, Intracellular
% 210.86/211.09  |- mesh__dateCreated mesh__D042541 2003-07-09
% 210.86/211.09  |- skos__broader mesh__D042541smesh__D022082
% 210.86/211.09  |- mesh__dateEstablished mesh__D042541 2004-01-01
% 210.86/211.09  |- skos__related mesh__D042541smesh__D007424
% 210.86/211.09  |- skos__prefLabel mesh__D042541 Intracellular Space
% 210.86/211.09  |- mesh__historyNote mesh__D042541 2004   
% 210.86/211.09  |- mesh__recordMaintainer mesh__D042541 nns
% 210.86/211.09  |- skos__related mesh__D042541smesh__D005110
% 210.86/211.09  |- skos__scopeNote mesh__D042541 The area within CELLS.     
% 210.86/211.09  |- mesh__recordOriginator mesh__D042541 nns
% 210.86/211.09  |- mesh__publicMeSHNote mesh__D042541 2004   
% 210.86/211.09  |- skos__hiddenLabel mesh__D042541 Subcellular Spaces
% 210.86/211.09  |- rdf__type mesh__D042541sskos__Concept
% 210.86/211.09  |- skos__hiddenLabel mesh__D042541 Intracellular Spaces
% 210.86/211.09  |- skos__hiddenLabel mesh__D042541 Spaces, Subcellular
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D042541 2005
% 210.86/211.09  |- mesh__dateRevised mesh__D042541 2004-07-07
% 210.86/211.09  |- skos__hiddenLabel mesh__D042541 Spaces, Intracellular
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D042541 2006
% 210.86/211.09  |- mesh__recordAuthorizer mesh__D014850 PLS
% 210.86/211.09  |- mesh__dateEstablished mesh__D014850 1991-01-01
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014850 1993
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014850 2004
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014850 1998
% 210.86/211.09  |- mesh__dateRevised mesh__D014850 1990-04-13
% 210.86/211.09  |- rdf__type mesh__D014850sskos__Concept
% 210.86/211.09  |- skos__hiddenLabel mesh__D014850 Lists, Waiting
% 210.86/211.09  |- skos__hiddenLabel mesh__D014850 List, Waiting
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014850 2000
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014850 1994
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014850 2005
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014850 1999
% 210.86/211.09  |- mesh__onlineNote mesh__D014850
% 210.86/211.09       search APPOINTMENTS AND SCHEDULES 1968-74   
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014850 2001
% 210.86/211.09  |- skos__annotation mesh__D014850 no qualif   
% 210.86/211.09  |- mesh__dateCreated mesh__D014850 1999-01-01
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014850 1995
% 210.86/211.09  |- skos__prefLabel mesh__D014850 Waiting Lists
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014850 2006
% 210.86/211.09  |- skos__hiddenLabel mesh__D014850 Waiting List
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014850 1991
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014850 2002
% 210.86/211.09  |- skos__scopeNote mesh__D014850
% 210.86/211.09       Prospective patient listings for appointments.     
% 210.86/211.09  |- mesh__recordMaintainer mesh__D014850 NLM
% 210.86/211.09  |- mesh__historyNote mesh__D014850
% 210.86/211.09       91%28%75%29%; was see under APPOINTMENTS AND SCHEDULES 1975-90   
% 210.86/211.09  |- mesh__publicMeSHNote mesh__D014850
% 210.86/211.09       91; was see under APPOINTMENTS AND SCHEDULES 1975-90   
% 210.86/211.09  |- skos__broader mesh__D014850smesh__D001071
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014850 1996
% 210.86/211.09  |- mesh__recordOriginator mesh__D014850 NLM
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014850 1992
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014850 2003
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014850 1997
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014052 2004
% 210.86/211.09  |- rdf__type mesh__D014052sskos__Concept
% 210.86/211.09  |- mesh__historyNote mesh__D014052 73%28%72%29%   
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014052 2000
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014052 1997
% 210.86/211.09  |- skos__prefLabel mesh__D014052 Toluidines
% 210.86/211.09  |- skos__broader mesh__D014052smesh__D014050
% 210.86/211.09  |- mesh__publicMeSHNote mesh__D014052 73   
% 210.86/211.09  |- skos__historyNote mesh__D014052 Toluene %28%1966-1971%29%
% 210.86/211.09  |- mesh__recordOriginator mesh__D014052 NLM
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014052 1994
% 210.86/211.09  |- mesh__dateCreated mesh__D014052 1999-01-01
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014052 2001
% 210.86/211.09  |- mesh__recordAuthorizer mesh__D014052 PLS
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014052 1995
% 210.86/211.09  |- mesh__dateEstablished mesh__D014052 1973-01-01
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014052 2005
% 210.86/211.09  |- mesh__recordMaintainer mesh__D014052 TGC
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014052 1998
% 210.86/211.09  |- skos__broader mesh__D014052smesh__D000814
% 210.86/211.09  |- mesh__dateRevised mesh__D014052 1992-05-20
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014052 2006
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014052 2002
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014052 1993
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014052 1999
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014052 2003
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D014052 1996
% 210.86/211.09  |- skos__hiddenLabel mesh__D008813 ICR Mouse, Inbred
% 210.86/211.09  |- skos__hiddenLabel mesh__D008813 ICRC Mice, Inbred
% 210.86/211.09  |- skos__hiddenLabel mesh__D008813 ICR Mouse
% 210.86/211.09  |- skos__hiddenLabel mesh__D008813 Inbred ICRC Mouse
% 210.86/211.09  |- skos__hiddenLabel mesh__D008813 Inbred ICRC Mice
% 210.86/211.09  |- mesh__recordOriginator mesh__D008813 NLM
% 210.86/211.09  |- skos__hiddenLabel mesh__D008813 ICR Mice, Inbred
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D008813 2006
% 210.86/211.09  |- mesh__recordAuthorizer mesh__D008813 sjn
% 210.86/211.09  |- skos__altLabel mesh__D008813 Mouse, Inbred ICR
% 210.86/211.09  |- skos__historyNote mesh__D008813 Mice %28%1966-1971%29%
% 210.86/211.09  |- skos__prefLabel mesh__D008813 Mice, Inbred ICR
% 210.86/211.09  |- skos__altLabel mesh__D008813 Mice, Inbred ICRC
% 210.86/211.09  |- mesh__publicMeSHNote mesh__D008813 74   
% 210.86/211.09  |- mesh__dateEstablished mesh__D008813 1974-01-01
% 210.86/211.09  |- skos__annotation mesh__D008813
% 210.86/211.09       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%  
% 210.86/211.09  |- mesh__dateCreated mesh__D008813 1999-01-01
% 210.86/211.09  |- rdf__type mesh__D008813sskos__Concept
% 210.86/211.09  |- skos__broader mesh__D008813smesh__D008815
% 210.86/211.09  |- skos__hiddenLabel mesh__D008813 Inbred ICR Mice
% 210.86/211.09  |- skos__hiddenLabel mesh__D008813 ICR Mice
% 210.86/211.09  |- skos__altLabel mesh__D008813 Mice, ICR
% 210.86/211.09  |- mesh__recordMaintainer mesh__D008813 ags
% 210.86/211.09  |- mesh__dateRevised mesh__D008813 2005-06-30
% 210.86/211.09  |- skos__hiddenLabel mesh__D008813 Inbred ICR Mouse
% 210.86/211.09  |- skos__hiddenLabel mesh__D008813 ICRC Mouse, Inbred
% 210.86/211.09  |- mesh__historyNote mesh__D008813 74%28%72%29%   
% 210.86/211.09  |- skos__altLabel mesh__D008813 Mouse, ICR
% 210.86/211.09  |- skos__related mesh__D000830smesh__D000826
% 210.86/211.09  |- mesh__recordMaintainer mesh__D000830 lkt
% 210.86/211.09  |- rdf__type mesh__D000830sskos__Concept
% 210.86/211.09  |- mesh__recordAuthorizer mesh__D000830 sjn
% 210.86/211.09  |- skos__broader mesh__D000830smesh__D000828
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D000830 2006
% 210.86/211.09  |- skos__related mesh__D000830smesh__D004195
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D000830 2005
% 210.86/211.09  |- skos__altLabel mesh__D000830 Laboratory Animals
% 210.86/211.09  |- mesh__dateRevised mesh__D000830 2004-07-07
% 210.86/211.09  |- skos__prefLabel mesh__D000830 Animals, Laboratory
% 210.86/211.09  |- skos__annotation mesh__D000830
% 210.86/211.09       GEN or unspecified; prefer specifics; IM; qualif permitted; do not forget also to check tag ANIMALS%A%  
% 210.86/211.09  |- mesh__dateCreated mesh__D000830 1999-01-01
% 210.86/211.09  |- mesh__recordOriginator mesh__D000830 NLM
% 210.86/211.09  |- skos__related mesh__D000830smesh__D007756
% 210.86/211.09  |- rdf__type mesh__D008015sskos__Concept
% 210.86/211.09  |- mesh__dateRevised mesh__D008015 1991-11-26
% 210.86/211.09  |- mesh__recordMaintainer mesh__D008015 PLS
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D008015 1994
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D008015 2001
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D008015 1999
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D008015 2006
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D008015 1995
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D008015 2002
% 210.86/211.09  |- mesh__recordOriginator mesh__D008015 NLM
% 210.86/211.09  |- mesh__recordAuthorizer mesh__D008015 PLS
% 210.86/211.09  |- skos__altLabel mesh__D008015 Leichtenstein
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D008015 1996
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D008015 2003
% 210.86/211.09  |- mesh__dateCreated mesh__D008015 1999-01-01
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D008015 1992
% 210.86/211.09  |- mesh__activeMeSHYear mesh__D008015 1997
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D008015 2004
% 210.86/211.10  |- skos__broader mesh__D008015smesh__D005060
% 210.86/211.10  |- skos__prefLabel mesh__D008015 Liechtenstein
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D008015 1998
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D008015 2005
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D008015 2000
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D008015 1993
% 210.86/211.10  |- mesh__dateCreated mesh__D000032 1999-01-01
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D000032 2005
% 210.86/211.10  |- mesh__recordOriginator mesh__D000032 NLM
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D000032 2004
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D000032 2006
% 210.86/211.10  |- skos__scopeNote mesh__D000032
% 210.86/211.10       Abortion induced to save the life or health of a pregnant woman. %28%From Dorland, 28th ed%29%%A%    
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D000032 1998
% 210.86/211.10  |- skos__hiddenLabel mesh__D000032 Therapeutic Abortions
% 210.86/211.10  |- mesh__dateRevised mesh__D000032 1997-06-20
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D000032 2002
% 210.86/211.10  |- skos__annotation mesh__D000032
% 210.86/211.10       do not use /util except by MeSH definition; don%27%t forget also check tags FEMALE %26% PREGNANCY%A%  
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D000032 1999
% 210.86/211.10  |- skos__broader mesh__D000032smesh__D000028
% 210.86/211.10  |- skos__altLabel mesh__D000032 Therapeutic Abortion
% 210.86/211.10  |- skos__prefLabel mesh__D000032 Abortion, Therapeutic
% 210.86/211.10  |- rdf__type mesh__D000032sskos__Concept
% 210.86/211.10  |- skos__hiddenLabel mesh__D000032 Abortions, Therapeutic
% 210.86/211.10  |- mesh__recordAuthorizer mesh__D000032 SJN
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D000032 2000
% 210.86/211.10  |- mesh__recordMaintainer mesh__D000032 PXP
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D000032 2003
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D000032 2001
% 210.86/211.10  |- mesh__dateRevised mesh__D046932 2005-06-30
% 210.86/211.10  |- skos__scopeNote mesh__D046932
% 210.86/211.10       A form-genus of filamentous CYANOBACTERIA in the order Nostocales. Its members can be planktonic or benthic and the trichomes are composed of disc-shaped vegetative cells.%A%    
% 210.86/211.10  |- mesh__recordMaintainer mesh__D046932 SYSTEM
% 210.86/211.10  |- skos__historyNote mesh__D046932 Cyanobacteria %28%1977-2004%29%
% 210.86/211.10  |- rdf__type mesh__D046932sskos__Concept
% 210.86/211.10  |- skos__broader mesh__D046932smesh__D000458
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D046932 2006
% 210.86/211.10  |- mesh__historyNote mesh__D046932 2005   
% 210.86/211.10  |- mesh__publicMeSHNote mesh__D046932 2005   
% 210.86/211.10  |- mesh__dateEstablished mesh__D046932 2005-01-01
% 210.86/211.10  |- mesh__recordOriginator mesh__D046932 ags
% 210.86/211.10  |- mesh__dateCreated mesh__D046932 2004-07-07
% 210.86/211.10  |- mesh__recordAuthorizer mesh__D046932 sjn
% 210.86/211.10  |- skos__prefLabel mesh__D046932 Nodularia
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D013758 2000
% 210.86/211.10  |- skos__altLabel mesh__D013758 Cholecystokinin-Tetrapeptide
% 210.86/211.10  |- mesh__dateCreated mesh__D013758 1978-03-16
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D013758 2004
% 210.86/211.10  |- skos__altLabel mesh__D013758 Cholecystokinin %28%30-33%29%
% 210.86/211.10  |- skos__historyNote mesh__D013758 Oligopeptides %28%1973-1978%29%
% 210.86/211.10  |- skos__altLabel mesh__D013758 CCK %28%30-33%29%
% 210.86/211.10  |- skos__prefLabel mesh__D013758 Tetragastrin
% 210.86/211.10  |- mesh__recordMaintainer mesh__D013758 TGC
% 210.86/211.10  |- skos__historyNote mesh__D013758 Peptides %28%1966-1972%29%
% 210.86/211.10  |- skos__related mesh__D013758smesh__D005765
% 210.86/211.10  |- mesh__historyNote mesh__D013758
% 210.86/211.10       91%28%79%29%; was see under GASTRINS 1979-90   
% 210.86/211.10  |- skos__broader mesh__D013758smesh__D005755
% 210.86/211.10  |- skos__scopeNote mesh__D013758
% 210.86/211.10       L-Tryptophyl-L-methionyl-L-aspartyl-L-phenylalaninamide. The C-terminal tetrapeptide of gastrin. It is the smallest peptide fragment of gastrin which has the same physiological and pharmacological activity as gastrin.%A%    
% 210.86/211.10  |- mesh__recordOriginator mesh__D013758 RLS
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D013758 2003
% 210.86/211.10  |- mesh__dateEstablished mesh__D013758 1991-01-01
% 210.86/211.10  |- skos__hiddenLabel mesh__D013758 Tetrapeptide, Gastrin
% 210.86/211.10  |- skos__altLabel mesh__D013758 Gastrin Tetrapeptide
% 210.86/211.10  |- skos__hiddenLabel mesh__D013758 AOC Tetrapeptide
% 210.86/211.10  |- skos__hiddenLabel mesh__D013758 Cholecystokinin Tetrapeptide
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D013758 2002
% 210.86/211.10  |- mesh__publicMeSHNote mesh__D013758 91; was see under GASTRINS 1979-90   
% 210.86/211.10  |- skos__altLabel mesh__D013758 Cholecystokinin 4
% 210.86/211.10  |- skos__altLabel mesh__D013758 AOC-Tetrapeptide
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D013758 2006
% 210.86/211.10  |- skos__broader mesh__D013758smesh__D009842
% 210.86/211.10  |- skos__altLabel mesh__D013758 CKK-4
% 210.86/211.10  |- skos__altLabel mesh__D013758 AOC-Tetragastrin
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D013758 1999
% 210.86/211.10  |- mesh__recordAuthorizer mesh__D013758 SJN
% 210.86/211.10  |- skos__historyNote mesh__D013758 Gastrins %28%1966-1978%29%
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D013758 2005
% 210.86/211.10  |- skos__hiddenLabel mesh__D013758 4, Cholecystokinin
% 210.86/211.10  |- mesh__dateRevised mesh__D013758 1997-06-20
% 210.86/211.10  |- skos__hiddenLabel mesh__D013758 AOC Tetragastrin
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D013758 1998
% 210.86/211.10  |- skos__annotation mesh__D013758
% 210.86/211.10       %22%smallest peptide fragment of gastrin%22%   
% 210.86/211.10  |- rdf__type mesh__D013758sskos__Concept
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D013758 2001
% 210.86/211.10  |- skos__altLabel mesh__D013758 CCK-4
% 210.86/211.10  |- mesh__dateCreated mesh__D010460 1999-01-01
% 210.86/211.10  |- rdf__type mesh__D010460sskos__Concept
% 210.86/211.10  |- mesh__recordMaintainer mesh__D010460 SYSTEM
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D010460 2006
% 210.86/211.10  |- skos__prefLabel mesh__D010460 Peptococcus
% 210.86/211.10  |- skos__scopeNote mesh__D010460
% 210.86/211.10       A genus of gram-positive, anaerobic, coccoid bacteria that is part of the normal flora of the mouth, upper respiratory tract, and large intestine in humans. Its organisms cause infections of soft tissues and bacteremias.%A%    
% 210.86/211.10  |- mesh__dateRevised mesh__D010460 2005-06-30
% 210.86/211.10  |- skos__annotation mesh__D010460
% 210.86/211.10       infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 210.86/211.10  |- skos__broader mesh__D010460smesh__D010459
% 210.86/211.10  |- mesh__recordAuthorizer mesh__D010460 sjn
% 210.86/211.10  |- mesh__recordOriginator mesh__D010460 NLM
% 210.86/211.10  |- mesh__dateCreated mesh__D051877 2005-06-30
% 210.86/211.10  |- skos__prefLabel mesh__D051877 RNA Polymerase Sigma 54
% 210.86/211.10  |- mesh__recordMaintainer mesh__D051877 ags
% 210.86/211.10  |- mesh__dateRevised mesh__D051877 2005-08-03
% 210.86/211.10  |- skos__broader mesh__D051877smesh__D012321
% 210.86/211.10  |- skos__broader mesh__D051877smesh__D001426
% 210.86/211.10  |- mesh__historyNote mesh__D051877 2006%28%1991%29%   
% 210.86/211.10  |- skos__hiddenLabel mesh__D051877 54, Sigma Factor
% 210.86/211.10  |- skos__altLabel mesh__D051877 Sigma54 Protein
% 210.86/211.10  |- mesh__recordOriginator mesh__D051877 DRC
% 210.86/211.10  |- skos__altLabel mesh__D051877 Transcription Factor Sigma-54
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D051877 2006A
% 210.86/211.10  |- skos__altLabel mesh__D051877 RNA Polymerase SigmaN
% 210.86/211.10  |- mesh__dateEstablished mesh__D051877 2006-01-01
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D051877 2006
% 210.86/211.10  |- skos__hiddenLabel mesh__D051877 SigmaN, RNA Polymerase
% 210.86/211.10  |- skos__scopeNote mesh__D051877
% 210.86/211.10       A DNA-directed RNA polymerase found in BACTERIA. It is a holoenzyme that consists of multiple subunits including sigma factor 54.%A%    
% 210.86/211.10  |- skos__hiddenLabel mesh__D051877 Factor 54, Sigma
% 210.86/211.10  |- mesh__publicMeSHNote mesh__D051877
% 210.86/211.10       2006; RNA POLYMERASE SIGMA 54 was indexed under DNA-BINDING PROTEINS %26% DNA-DIRECTED RNA POLYMERASES 1991-2005, %26% under SIGMA FACTOR 2005, %26% under BACTERIAL PROTEINS %26% TRANSCRIPTION FACTORS 1991-2004%A%  
% 210.86/211.10  |- mesh__recordAuthorizer mesh__D051877 ags
% 210.86/211.10  |- skos__hiddenLabel mesh__D051877 Transcription Factor Sigma 54
% 210.86/211.10  |- rdf__type mesh__D051877sskos__Concept
% 210.86/211.10  |- skos__prefLabel mesh__D004423 Ear
% 210.86/211.10  |- mesh__publicMeSHNote mesh__D004423
% 210.86/211.10       EAR, EXTERNAL, DEFORMITY was heading 1966-70   
% 210.86/211.10  |- mesh__recordMaintainer mesh__D004423 lkt
% 210.86/211.10  |- mesh__recordAuthorizer mesh__D004423 sjn
% 210.86/211.10  |- mesh__considerAlso mesh__D004423 consider also terms at OTI- and OTO-   
% 210.86/211.10  |- mesh__recordOriginator mesh__D004423 NLM
% 210.86/211.10  |- mesh__dateCreated mesh__D004423 1999-01-01
% 210.86/211.10  |- skos__scopeNote mesh__D004423
% 210.86/211.10       The hearing and equilibrium system of the body. It consists of three parts: the EXTERNAL EAR, the MIDDLE EAR, and the INNER EAR. Sound waves are transmitted through this organ where vibration is transduced to nerve signals that pass through the ACOUSTIC NERVE to the CENTRAL NERVOUS SYSTEM. The inner ear also contains the vestibular organ that maintains equilibrium by transducing signals to the VESTIBULAR NERVE.%A%    
% 210.86/211.10  |- skos__altLabel mesh__D004423 Vestibulocochlear Apparatus
% 210.86/211.10  |- skos__broader mesh__D004423smesh__D012679
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D004423 2006
% 210.86/211.10  |- skos__hiddenLabel mesh__D004423 Ears
% 210.86/211.10  |- mesh__onlineNote mesh__D004423
% 210.86/211.10       use EAR /AB %26% EAR, EXTERNAL /AB %26% EAR DEFORMITIES, ACQUIRED to search EAR, EXTERNAL, DEFORMITY 1966-70; in searching non-acquired ear abnormalities consider EAR DEFORMITIES, ACQUIRED 1966-74%A%  
% 210.86/211.10  |- mesh__dateRevised mesh__D004423 2005-06-30
% 210.86/211.10  |- mesh__historyNote mesh__D004423
% 210.86/211.10       EAR, EXTERNAL, DEFORMITY was heading 1966-70   
% 210.86/211.10  |- skos__annotation mesh__D004423
% 210.86/211.10       general only or unspecified; prefer EAR, EXTERNAL or EAR, MIDDLE or EAR, INNER; /abnorm permitted but note EAR DEFORMITIES, ACQUIRED; /surg: consider also OTOLOGIC SURGICAL PROCEDURES; ear acupuncture or otopuncture or auriculoacupuncture %28%acupunct ther with ear as pressure point%29%: index under ACUPUNCTURE THERAPY %28%IM%29% + EAR, EXTERNAL %28%IM%29%%A%  
% 210.86/211.10  |- rdf__type mesh__D004423sskos__Concept
% 210.86/211.10  |- skos__broader mesh__D004423smesh__D006257
% 210.86/211.10  |- skos__hiddenLabel mesh__D004423 System, Vestibulocochlear
% 210.86/211.10  |- skos__hiddenLabel mesh__D004423 Apparatus, Vestibulocochlear
% 210.86/211.10  |- skos__altLabel mesh__D004423 Vestibulocochlear System
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D051079 2006
% 210.86/211.10  |- mesh__recordOriginator mesh__D051079 ags
% 210.86/211.10  |- mesh__publicMeSHNote mesh__D051079 2006   
% 210.86/211.10  |- skos__scopeNote mesh__D051079
% 210.86/211.10       An infraorder of PRIMATES comprised of the families CERCOPITHECIDAE %28%old world monkeys%29%; HYLOBATIDAE %28%siamangs and GIBBONS%29%; and HOMINIDAE %28%great apes and HUMANS%29%. With the exception of humans, they all live exclusively in Africa and Asia.%A%    
% 210.86/211.10  |- rdf__type mesh__D051079sskos__Concept
% 210.86/211.10  |- mesh__dateEstablished mesh__D051079 2006-01-01
% 210.86/211.10  |- mesh__recordAuthorizer mesh__D051079 sjn
% 210.86/211.10  |- skos__prefLabel mesh__D051079 Catarrhini
% 210.86/211.10  |- mesh__dateCreated mesh__D051079 2005-06-30
% 210.86/211.10  |- mesh__recordMaintainer mesh__D051079 ags
% 210.86/211.10  |- skos__broader mesh__D051079smesh__D000882
% 210.86/211.10  |- mesh__historyNote mesh__D051079 2006   
% 210.86/211.10  |- skos__historyNote mesh__D051079 Cercopithecidae %28%1980-2005%29%
% 210.86/211.10  |- rdf__type mesh__D020090sskos__Concept
% 210.86/211.10  |- mesh__publicMeSHNote mesh__D020090 99   
% 210.86/211.10  |- skos__scopeNote mesh__D020090
% 210.86/211.10       The orderly segregation of CHROMOSOMES during MEIOSIS or MITOSIS.%A%    
% 210.86/211.10  |- skos__hiddenLabel mesh__D020090 Segregations, Chromosome
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D020090 2006
% 210.86/211.10  |- mesh__recordAuthorizer mesh__D020090 sjn
% 210.86/211.10  |- skos__hiddenLabel mesh__D020090 Segregation, Chromosome
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D020090 2005
% 210.86/211.10  |- mesh__historyNote mesh__D020090 99   
% 210.86/211.10  |- mesh__dateEstablished mesh__D020090 1999-01-01
% 210.86/211.10  |- skos__prefLabel mesh__D020090 Chromosome Segregation
% 210.86/211.10  |- skos__broader mesh__D020090smesh__D048750
% 210.86/211.10  |- mesh__recordMaintainer mesh__D020090 lkt
% 210.86/211.10  |- mesh__recordOriginator mesh__D020090 NDW
% 210.86/211.10  |- skos__hiddenLabel mesh__D020090 Chromosome Segregations
% 210.86/211.10  |- mesh__dateRevised mesh__D020090 2004-07-07
% 210.86/211.10  |- mesh__dateCreated mesh__D020090 1998-06-10
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D014851 2002
% 210.86/211.10  |- mesh__publicMeSHNote mesh__D014851 69   
% 210.86/211.10  |- mesh__dateCreated mesh__D014851 1999-01-01
% 210.86/211.10  |- skos__scopeNote mesh__D014851
% 210.86/211.10       A state in which there is an enhanced potential for sensitivity and an efficient responsiveness to external stimuli.%A%    
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D014851 2006
% 210.86/211.10  |- skos__prefLabel mesh__D014851 Wakefulness
% 210.86/211.10  |- mesh__historyNote mesh__D014851 69%28%67%29%   
% 210.86/211.10  |- mesh__recordAuthorizer mesh__D014851 sjn
% 210.86/211.10  |- mesh__recordOriginator mesh__D014851 NLM
% 210.86/211.10  |- skos__hiddenLabel mesh__D014851 Wakefulnesses
% 210.86/211.10  |- skos__related mesh__D014851smesh__D007319
% 210.86/211.10  |- mesh__dateRevised mesh__D014851 1999-11-03
% 210.86/211.10  |- skos__broader mesh__D014851smesh__D001143
% 210.86/211.10  |- skos__historyNote mesh__D014851 Consciousness %28%1966%29%
% 210.86/211.10  |- mesh__dateEstablished mesh__D014851 1969-01-01
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D014851 2003
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D014851 2000
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D014851 2004
% 210.86/211.10  |- mesh__recordMaintainer mesh__D014851 KEV
% 210.86/211.10  |- skos__historyNote mesh__D014851 Cerebral Cortex/physiology %28%1966%29%
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D014851 2001
% 210.86/211.10  |- rdf__type mesh__D014851sskos__Concept
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D014851 2005
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D014053 2005
% 210.86/211.10  |- skos__prefLabel mesh__D014053 Tomatine
% 210.86/211.10  |- rdf__type mesh__D014053sskos__Concept
% 210.86/211.10  |- skos__broader mesh__D014053smesh__D006027
% 210.86/211.10  |- mesh__dateEstablished mesh__D014053 1991-01-01
% 210.86/211.10  |- mesh__dateRevised mesh__D014053 2004-07-07
% 210.86/211.10  |- mesh__recordAuthorizer mesh__D014053 sjn
% 210.86/211.10  |- mesh__recordOriginator mesh__D014053 NLM
% 210.86/211.10  |- mesh__dateCreated mesh__D014053 1999-01-01
% 210.86/211.10  |- skos__scopeNote mesh__D014053
% 210.86/211.10       An alkaloid that occurs in the extract of leaves of wild tomato plants. It has been found to inhibit the growth of various fungi and bacteria. It is used as a precipitating agent for steroids. %28%From The Merck Index, 11th ed%29%%A%    
% 210.86/211.10  |- mesh__recordMaintainer mesh__D014053 ssb
% 210.86/211.10  |- mesh__publicMeSHNote mesh__D014053
% 210.86/211.10       91; was see under ALKALOIDS 1964-90   
% 210.86/211.10  |- mesh__historyNote mesh__D014053
% 210.86/211.10       91%28%64%29%; was see under ALKALOIDS 1964-90   
% 210.86/211.10  |- skos__broader mesh__D014053smesh__D012991
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D014053 2006
% 210.86/211.10  |- skos__hiddenLabel mesh__D008814 Inbred NZB Mouse
% 210.86/211.10  |- skos__prefLabel mesh__D008814 Mice, Inbred NZB
% 210.86/211.10  |- skos__broader mesh__D008814smesh__D008815
% 210.86/211.10  |- skos__hiddenLabel mesh__D008814 NZB Mice
% 210.86/211.10  |- skos__hiddenLabel mesh__D008814 NZB Mice, Inbred
% 210.86/211.10  |- skos__annotation mesh__D008814
% 210.86/211.10       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%  
% 210.86/211.10  |- skos__hiddenLabel mesh__D008814 NZB Mouse
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D008814 2006
% 210.86/211.10  |- mesh__dateRevised mesh__D008814 2005-06-30
% 210.86/211.10  |- mesh__dateCreated mesh__D008814 1999-01-01
% 210.86/211.10  |- skos__altLabel mesh__D008814 Mouse, Inbred NZB
% 210.86/211.10  |- mesh__recordOriginator mesh__D008814 NLM
% 210.86/211.10  |- skos__historyNote mesh__D008814 Mice %28%1966-1971%29%
% 210.86/211.10  |- mesh__recordMaintainer mesh__D008814 ags
% 210.86/211.10  |- rdf__type mesh__D008814sskos__Concept
% 210.86/211.10  |- skos__hiddenLabel mesh__D008814 NZB Mouse, Inbred
% 210.86/211.10  |- skos__altLabel mesh__D008814 Mice, NZB
% 210.86/211.10  |- mesh__recordAuthorizer mesh__D008814 sjn
% 210.86/211.10  |- mesh__dateEstablished mesh__D008814 1974-01-01
% 210.86/211.10  |- skos__hiddenLabel mesh__D008814 Inbred NZB Mice
% 210.86/211.10  |- skos__altLabel mesh__D008814 Mouse, NZB
% 210.86/211.10  |- mesh__historyNote mesh__D008814 74%28%72%29%   
% 210.86/211.10  |- mesh__publicMeSHNote mesh__D008814 74   
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D000831 2005
% 210.86/211.10  |- rdf__type mesh__D000831sskos__Concept
% 210.86/211.10  |- skos__hiddenLabel mesh__D000831 Newborn Animal
% 210.86/211.10  |- mesh__recordOriginator mesh__D000831 NLM
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D000831 2006
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D000831 2004
% 210.86/211.10  |- skos__hiddenLabel mesh__D000831 Animal, Newborn
% 210.86/211.10  |- skos__annotation mesh__D000831
% 210.86/211.10       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag ANIMALS%A%  
% 210.86/211.10  |- mesh__dateCreated mesh__D000831 1999-01-01
% 210.86/211.10  |- mesh__dateRevised mesh__D000831 2003-07-30
% 210.86/211.10  |- mesh__recordAuthorizer mesh__D000831 sjn
% 210.86/211.10  |- skos__broader mesh__D000831smesh__D000828
% 210.86/211.10  |- skos__hiddenLabel mesh__D000831 Newborn Animals
% 210.86/211.10  |- skos__prefLabel mesh__D000831 Animals, Newborn
% 210.86/211.10  |- mesh__recordMaintainer mesh__D000831 ags
% 210.86/211.10  |- mesh__publicMeSHNote mesh__D008016 77   
% 210.86/211.10  |- mesh__recordOriginator mesh__D008016 EC
% 210.86/211.10  |- skos__hiddenLabel mesh__D008016 Event, Stressful
% 210.86/211.10  |- skos__scopeNote mesh__D008016
% 210.86/211.10       Those occurrences, including social, psychological, and environmental, which require an adjustment or effect a change in an individual%27%s pattern of living.%A%    
% 210.86/211.10  |- skos__hiddenLabel mesh__D008016 Event History Analyses
% 210.86/211.10  |- mesh__recordAuthorizer mesh__D008016 SJN
% 210.86/211.10  |- skos__broader mesh__D008016smesh__D008019
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D008016 2003
% 210.86/211.10  |- mesh__recordMaintainer mesh__D008016 TGC
% 210.86/211.10  |- skos__hiddenLabel mesh__D008016 Stressful Event
% 210.86/211.10  |- skos__hiddenLabel mesh__D008016 Event, Life Change
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D008016 2000
% 210.86/211.10  |- skos__hiddenLabel mesh__D008016 Events, Stressful
% 210.86/211.10  |- skos__hiddenLabel mesh__D008016 Analyses, Event History
% 210.86/211.10  |- skos__hiddenLabel mesh__D008016 Experience, Life
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D008016 2004
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D008016 2001
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D008016 2005
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D008016 1998
% 210.86/211.10  |- mesh__dateCreated mesh__D008016 1976-04-16
% 210.86/211.10  |- rdf__type mesh__D008016sskos__Concept
% 210.86/211.10  |- skos__annotation mesh__D008016
% 210.86/211.10       human only: do not confuse with life cycles %26% life stages of animals %26% lower organisms; no qualif; FAMILY LIFE CYCLES see FAMILY is also available for %22%transitional stages through which the family evolves...e.g., marriage, childbearing %26% death%22%%A%  
% 210.86/211.10  |- skos__historyNote mesh__D008016 Stress, Psychological %28%1969-1976%29%
% 210.86/211.10  |- skos__prefLabel mesh__D008016 Life Change Events
% 210.86/211.10  |- skos__historyNote mesh__D008016 Life Style %28%1972-1976%29%
% 210.86/211.10  |- skos__hiddenLabel mesh__D008016 Events, Life Change
% 210.86/211.10  |- skos__altLabel mesh__D008016 Event History Analysis
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D008016 2002
% 210.86/211.10  |- mesh__dateEstablished mesh__D008016 1977-01-01
% 210.86/211.10  |- mesh__historyNote mesh__D008016 77   
% 210.86/211.10  |- skos__hiddenLabel mesh__D008016 Life Experience
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D008016 1999
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D008016 2006
% 210.86/211.10  |- mesh__dateRevised mesh__D008016 1997-06-20
% 210.86/211.10  |- skos__hiddenLabel mesh__D008016 Experiences, Life
% 210.86/211.10  |- skos__hiddenLabel mesh__D008016 Life Change Event
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D000033 2006
% 210.86/211.10  |- mesh__recordMaintainer mesh__D000033 ags
% 210.86/211.10  |- mesh__dateRevised mesh__D000033 2005-07-12
% 210.86/211.10  |- mesh__recordOriginator mesh__D000033 NLM
% 210.86/211.10  |- rdf__type mesh__D000033sskos__Concept
% 210.86/211.10  |- skos__hiddenLabel mesh__D000033 Threatened Abortions
% 210.86/211.10  |- skos__hiddenLabel mesh__D000033 Abortions, Threatened
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D000033 2006A
% 210.86/211.10  |- skos__broader mesh__D000033smesh__D000022
% 210.86/211.10  |- skos__hiddenLabel mesh__D000033 Threatened Abortion
% 210.86/211.10  |- mesh__recordAuthorizer mesh__D000033 ags
% 210.86/211.10  |- skos__scopeNote mesh__D000033
% 210.86/211.10       UTERINE BLEEDING from a GESTATION of less than 20 weeks without any CERVICAL DILATATION. It is characterized by vaginal bleeding, lower back discomfort, or midline pelvic cramping and a risk factor for MISCARRIAGE.%A%    
% 210.86/211.10  |- mesh__dateCreated mesh__D000033 1999-01-01
% 210.86/211.10  |- skos__annotation mesh__D000033 check the tags FEMALE %26% PREGNANCY   
% 210.86/211.10  |- skos__prefLabel mesh__D000033 Abortion, Threatened
% 210.86/211.10  |- skos__broader mesh__D013759smesh__D002186
% 210.86/211.10  |- skos__altLabel mesh__D013759 THC
% 210.86/211.10  |- rdf__type mesh__D013759sskos__Concept
% 210.86/211.10  |- skos__scopeNote mesh__D013759
% 210.86/211.10       A psychoactive compound extracted from the resin of Cannabis sativa %28%marihuana, hashish%29%. The isomer delta-9-tetrahydrocannabinol %28%THC%29% is considered the most active form, producing characteristic mood and perceptual changes associated with this compound. Dronabinol is a synthetic form of delta-9-THC.%A%    
% 210.86/211.10  |- skos__altLabel mesh__D013759 delta%28%9%29%-THC
% 210.86/211.10  |- skos__altLabel mesh__D013759 delta%28%1%29%-Tetrahydrocannabinol
% 210.86/211.10  |- mesh__publicMeSHNote mesh__D013759 77; was see under CANNABIS 1975-76   
% 210.86/211.10  |- skos__prefLabel mesh__D013759 Tetrahydrocannabinol
% 210.86/211.10  |- mesh__dateRevised mesh__D013759 2005-06-30
% 210.86/211.10  |- skos__altLabel mesh__D013759 Dronabinol
% 210.86/211.10  |- skos__altLabel mesh__D013759 9-ene-Tetrahydrocannabinol
% 210.86/211.10  |- mesh__recordOriginator mesh__D013759 NLM
% 210.86/211.10  |- skos__altLabel mesh__D013759 delta%28%1%29%-THC
% 210.86/211.10  |- mesh__recordAuthorizer mesh__D013759 sjn
% 210.86/211.10  |- skos__hiddenLabel mesh__D013759 9 ene Tetrahydrocannabinol
% 210.86/211.10  |- skos__hiddenLabel mesh__D013759 Tetrahydrocannabinol, Trans Isomer
% 210.86/211.10  |- skos__altLabel mesh__D013759 delta%28%9%29%-Tetrahydrocannabinol
% 210.86/211.10  |- mesh__historyNote mesh__D013759
% 210.86/211.10       77%28%71%29%; was see under CANNABIS 1975-76   
% 210.86/211.10  |- mesh__recordMaintainer mesh__D013759 exl
% 210.86/211.10  |- mesh__dateCreated mesh__D013759 1999-01-01
% 210.86/211.10  |- skos__altLabel mesh__D013759 Solvay Brand of Tetrahydrocannabinol
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D013759 2006
% 210.86/211.10  |- mesh__dateEstablished mesh__D013759 1977-01-01
% 210.86/211.10  |- skos__historyNote mesh__D013759 Cannabis %28%1966-1970%29%
% 210.86/211.10  |- skos__altLabel mesh__D010461 Peptone
% 210.86/211.10  |- skos__scopeNote mesh__D010461
% 210.86/211.10       Derived proteins or mixtures of cleavage products produced by the partial hydrolysis of a native protein either by an acid or by an enzyme. Peptones are readily soluble in water, and are not precipitable by heat, by alkalis, or by saturation with ammonium sulfate. %28%Dorland, 28th ed%29%%A%    
% 210.86/211.10  |- skos__prefLabel mesh__D010461 Peptones
% 210.86/211.10  |- mesh__recordAuthorizer mesh__D010461 sjn
% 210.86/211.10  |- mesh__recordMaintainer mesh__D010461 SYSTEM
% 210.86/211.10  |- rdf__type mesh__D010461sskos__Concept
% 210.86/211.10  |- skos__annotation mesh__D010461 proteins   
% 210.86/211.10  |- mesh__recordOriginator mesh__D010461 NLM
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D010461 2006
% 210.86/211.10  |- skos__broader mesh__D010461smesh__D011506
% 210.86/211.10  |- mesh__dateRevised mesh__D010461 2005-06-30
% 210.86/211.10  |- mesh__dateCreated mesh__D010461 1999-01-01
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D004424 2004
% 210.86/211.10  |- skos__hiddenLabel mesh__D004424 External Auditory Canals
% 210.86/211.10  |- skos__prefLabel mesh__D004424 Ear Canal
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D004424 2006
% 210.86/211.10  |- mesh__recordMaintainer mesh__D004424 PLS
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D004424 1996
% 210.86/211.10  |- skos__hiddenLabel mesh__D004424 Canal, Ear
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D004424 2002
% 210.86/211.10  |- skos__hiddenLabel mesh__D004424 External Auditory Canal
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D004424 1998
% 210.86/211.10  |- rdf__type mesh__D004424sskos__Concept
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D004424 1997
% 210.86/211.10  |- skos__altLabel mesh__D004424 Auditory Canal, External
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D004424 1992
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D004424 1990
% 210.86/211.10  |- skos__hiddenLabel mesh__D004424 Canal, External Auditory
% 210.86/211.10  |- skos__related mesh__D004424smesh__D002571
% 210.86/211.10  |- mesh__activeMeSHYear mesh__D004424 1994
% 210.86/211.11  |- skos__hiddenLabel mesh__D004424 Canals, Ear
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D004424 1999
% 210.86/211.11  |- mesh__recordAuthorizer mesh__D004424 PLS
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D004424 1993
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D004424 1995
% 210.86/211.11  |- mesh__recordOriginator mesh__D004424 NLM
% 210.86/211.11  |- skos__hiddenLabel mesh__D004424 Auditory Canals, External
% 210.86/211.11  |- skos__broader mesh__D004424smesh__D004431
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D004424 2000
% 210.86/211.11  |- mesh__dateRevised mesh__D004424 1989-10-06
% 210.86/211.11  |- skos__hiddenLabel mesh__D004424 Canals, External Auditory
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D004424 1991
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D004424 2003
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D004424 2001
% 210.86/211.11  |- mesh__dateCreated mesh__D004424 1999-01-01
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D004424 2005
% 210.86/211.11  |- skos__hiddenLabel mesh__D004424 Ear Canals
% 210.86/211.11  |- mesh__publicMeSHNote mesh__D020091 99   
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D020091 2006
% 210.86/211.11  |- mesh__recordMaintainer mesh__D020091 SYSTEM
% 210.86/211.11  |- mesh__dateCreated mesh__D020091 1998-06-10
% 210.86/211.11  |- skos__broader mesh__D020091smesh__D015052
% 210.86/211.11  |- skos__prefLabel mesh__D020091 Entomophthorales
% 210.86/211.11  |- mesh__recordOriginator mesh__D020091 AGS
% 210.86/211.11  |- skos__annotation mesh__D020091
% 210.86/211.11       infection: coord IM with ZYGOMYCOSIS %28%IM%29%   
% 210.86/211.11  |- mesh__dateRevised mesh__D020091 2005-06-30
% 210.86/211.11  |- skos__historyNote mesh__D020091 Zygomycota %28%1976-1998%29%
% 210.86/211.11  |- skos__scopeNote mesh__D020091
% 210.86/211.11       An order of fungi comprising mostly insect pathogens, though some infect mammals including humans. Strict host specificity make these fungi a focus of many biological control studies.%A%    
% 210.86/211.11  |- mesh__recordAuthorizer mesh__D020091 sjn
% 210.86/211.11  |- mesh__historyNote mesh__D020091 99   
% 210.86/211.11  |- mesh__dateEstablished mesh__D020091 1999-01-01
% 210.86/211.11  |- rdf__type mesh__D020091sskos__Concept
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D014852 2001
% 210.86/211.11  |- skos__broader mesh__D014852smesh__D006113
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D014852 2002
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D014852 1996
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D014852 2003
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D014852 1997
% 210.86/211.11  |- mesh__recordOriginator mesh__D014852 NLM
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D014852 2004
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D014852 1998
% 210.86/211.11  |- mesh__recordMaintainer mesh__D014852 KEV
% 210.86/211.11  |- mesh__recordAuthorizer mesh__D014852 PLS
% 210.86/211.11  |- rdf__type mesh__D014852sskos__Concept
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D014852 2005
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D014852 1999
% 210.86/211.11  |- skos__prefLabel mesh__D014852 Wales
% 210.86/211.11  |- mesh__dateCreated mesh__D014852 1999-01-01
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D014852 2006
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D014852 2000
% 210.86/211.11  |- mesh__dateRevised mesh__D014852 1995-05-23
% 210.86/211.11  |- mesh__recordAuthorizer mesh__D014054 SJN
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D014054 2003
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D014054 2001
% 210.86/211.11  |- rdf__type mesh__D014054sskos__Concept
% 210.86/211.11  |- skos__broader mesh__D014054smesh__D003952
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D014054 2000
% 210.86/211.11  |- mesh__dateRevised mesh__D014054 1997-06-20
% 210.86/211.11  |- mesh__recordMaintainer mesh__D014054 PXP
% 210.86/211.11  |- skos__related mesh__D014054smesh__D019412
% 210.86/211.11  |- skos__prefLabel mesh__D014054 Tomography
% 210.86/211.11  |- mesh__dateCreated mesh__D014054 1999-01-01
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D014054 2006
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D014054 2002
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D014054 1999
% 210.86/211.11  |- skos__scopeNote mesh__D014054
% 210.86/211.11       Imaging methods that result in sharp images of objects located on a chosen plane and blurred images located above or below the plane.%A%    
% 210.86/211.11  |- mesh__recordOriginator mesh__D014054 NLM
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D014054 2005
% 210.86/211.11  |- skos__hiddenLabel mesh__D014054 Tomographies
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D014054 2004
% 210.86/211.11  |- skos__annotation mesh__D014054
% 210.86/211.11       do not use /util except by MeSH definition; used for non-x-ray %26% non-radionuclide tomographies; echotomography seen in foreign lit is probably ULTRASONOGRAPHY %26% if so use %22%ultrasonics%22% or %22%ultrasonic diagnosis%22% or %22%ultrasonography%22% in translations %26% not %22%echotomography%22%; DF: TOMOGR%A%  
% 210.86/211.11  |- mesh__activeMeSHYear mesh__D014054 1998
% 210.86/211.11  |- mesh__historyNote mesh__D008815 72   
% 210.86/211.11  |- skos__hiddenLabel mesh__D008815 Strain, Inbred Mouse
% 210.86/211.11  |- mesh__dateCreated mesh__D008815 1999-01-01
% 210.86/211.11  |- skos__altLabel mesh__D008815 Mouse, Inbred Strain
% 210.86/211.11  |- skos__broader mesh__D008815smesh__D051379
% 210.96/211.11  |- skos__hiddenLabel mesh__D008815 Strains, Inbred Mouse
% 210.96/211.11  |- skos__scopeNote mesh__D008815
% 210.96/211.11       Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation.%A%    
% 210.96/211.11  |- mesh__dateRevised mesh__D008815 2005-06-30
% 210.96/211.11  |- skos__hiddenLabel mesh__D008815 Inbred Mouse Strain
% 210.96/211.11  |- mesh__publicMeSHNote mesh__D008815 72   
% 210.96/211.11  |- mesh__recordOriginator mesh__D008815 NLM
% 210.96/211.11  |- skos__broader mesh__D008815smesh__D017849
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D008815 2006
% 210.96/211.11  |- skos__historyNote mesh__D008815 Mice %28%1966-1971%29%
% 210.96/211.11  |- skos__altLabel mesh__D008815 Inbred Strain of Mice
% 210.96/211.11  |- mesh__recordAuthorizer mesh__D008815 sjn
% 210.96/211.11  |- rdf__type mesh__D008815sskos__Concept
% 210.96/211.11  |- skos__prefLabel mesh__D008815 Mice, Inbred Strains
% 210.96/211.11  |- skos__altLabel mesh__D008815 Inbred Strain of Mouse
% 210.96/211.11  |- mesh__recordMaintainer mesh__D008815 ags
% 210.96/211.11  |- skos__hiddenLabel mesh__D008815 Mouse Inbred Strain
% 210.96/211.11  |- skos__altLabel mesh__D008815 Inbred Strains of Mice
% 210.96/211.11  |- skos__hiddenLabel mesh__D008815 Mouse Inbred Strains
% 210.96/211.11  |- skos__annotation mesh__D008815
% 210.96/211.11       GEN or unspecified; prefer specifics; NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE; Manual 22.36%A%  
% 210.96/211.11  |- skos__hiddenLabel mesh__D008815 Mouse Strains, Inbred
% 210.96/211.11  |- mesh__dateEstablished mesh__D008815 1972-01-01
% 210.96/211.11  |- skos__altLabel mesh__D008815 Inbred Mouse Strains
% 210.96/211.11  |- skos__hiddenLabel mesh__D008815 Mouse Strain, Inbred
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D000832 2006
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D000832 2004
% 210.96/211.11  |- mesh__dateEstablished mesh__D000832 1968-01-01
% 210.96/211.11  |- mesh__dateCreated mesh__D000832 1999-01-01
% 210.96/211.11  |- mesh__historyNote mesh__D000832 68   
% 210.96/211.11  |- mesh__dateRevised mesh__D000832 2003-07-30
% 210.96/211.11  |- skos__annotation mesh__D000832
% 210.96/211.11       IM; qualif permitted; coord IM with specific poisonous animal %28%IM%29%; do not forget also to check tag ANIMALS%A%  
% 210.96/211.11  |- skos__broader mesh__D000832smesh__D000828
% 210.96/211.11  |- mesh__recordOriginator mesh__D000832 NLM
% 210.96/211.11  |- skos__prefLabel mesh__D000832 Animals, Poisonous
% 210.96/211.11  |- mesh__recordMaintainer mesh__D000832 ags
% 210.96/211.11  |- skos__hiddenLabel mesh__D000832 Poisonous Animal
% 210.96/211.11  |- skos__altLabel mesh__D000832 Poisonous Animals
% 210.96/211.11  |- mesh__recordAuthorizer mesh__D000832 sjn
% 210.96/211.11  |- skos__historyNote mesh__D000832 Animals %28%1966-1967%29%
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D000832 2005
% 210.96/211.11  |- rdf__type mesh__D000832sskos__Concept
% 210.96/211.11  |- skos__hiddenLabel mesh__D000832 Animal, Poisonous
% 210.96/211.11  |- mesh__publicMeSHNote mesh__D000832 68   
% 210.96/211.11  |- mesh__historyNote mesh__D008017
% 210.96/211.11       was in Cat H %26% N 1979-81; was in Cat N only 1968-78; was in Cat G only 1967; was in Cat G %26% I 1963-66%A%  
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D008017 2003
% 210.96/211.11  |- skos__hiddenLabel mesh__D008017 Expectancies, Life
% 210.96/211.11  |- mesh__dateCreated mesh__D008017 1999-01-01
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D008017 2004
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D008017 2005
% 210.96/211.11  |- mesh__dateRevised mesh__D008017 1999-11-03
% 210.96/211.11  |- rdf__type mesh__D008017sskos__Concept
% 210.96/211.11  |- skos__related mesh__D008017smesh__D008136
% 210.96/211.11  |- mesh__recordMaintainer mesh__D008017 kle
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D008017 2006
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D008017 2000
% 210.96/211.11  |- skos__hiddenLabel mesh__D008017 Expectancy, Life
% 210.96/211.11  |- skos__broader mesh__D008017smesh__D014798
% 210.96/211.11  |- skos__prefLabel mesh__D008017 Life Expectancy
% 210.96/211.11  |- skos__annotation mesh__D008017
% 210.96/211.11       IM for human, NIM for animal; consider also LONGEVITY   
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D008017 2001
% 210.96/211.11  |- skos__scopeNote mesh__D008017
% 210.96/211.11       A figure representing the number of years, based on known statistics, to which any person of a given age may reasonably expect to live.%A%    
% 210.96/211.11  |- skos__hiddenLabel mesh__D008017 Life Expectancies
% 210.96/211.11  |- mesh__recordAuthorizer mesh__D008017 sjn
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D008017 2002
% 210.96/211.11  |- mesh__recordOriginator mesh__D008017 NLM
% 210.96/211.11  |- mesh__dateCreated mesh__D000034 1999-01-01
% 210.96/211.11  |- skos__prefLabel mesh__D000034 Abortion, Veterinary
% 210.96/211.11  |- skos__annotation mesh__D000034
% 210.96/211.11       coordinate IM with specific type of abortion /vet %28%IM%29%; check the tags ANIMALS %26% FEMALE %26% PREGNANCY%A%  
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D000034 2006
% 210.96/211.11  |- skos__altLabel mesh__D000034 Veterinary Abortion
% 210.96/211.11  |- mesh__recordMaintainer mesh__D000034 lkt
% 210.96/211.11  |- mesh__recordAuthorizer mesh__D000034 sjn
% 210.96/211.11  |- skos__scopeNote mesh__D000034
% 210.96/211.11       Premature expulsion of the FETUS in animals.     
% 210.96/211.11  |- rdf__type mesh__D000034sskos__Concept
% 210.96/211.11  |- mesh__dateRevised mesh__D000034 2005-06-30
% 210.96/211.11  |- skos__broader mesh__D000034smesh__D000022
% 210.96/211.11  |- mesh__recordOriginator mesh__D000034 NLM
% 210.96/211.11  |- skos__broader mesh__D000034smesh__D000820
% 210.96/211.11  |- skos__hiddenLabel mesh__D000034 Abortions, Veterinary
% 210.96/211.11  |- skos__hiddenLabel mesh__D000034 Veterinary Abortions
% 210.96/211.11  |- mesh__dateEstablished mesh__D046934 2005-01-01
% 210.96/211.11  |- mesh__historyNote mesh__D046934 2005   
% 210.96/211.11  |- skos__scopeNote mesh__D046934
% 210.96/211.11       DITERPENES with three LACTONES and a unique tert-butyl group, which are found in GINKGO plants along with BILOBALIDES.%A%    
% 210.96/211.11  |- mesh__dateCreated mesh__D046934 2004-07-07
% 210.96/211.11  |- skos__broader mesh__D046934smesh__D004224
% 210.96/211.11  |- skos__prefLabel mesh__D046934 Ginkgolides
% 210.96/211.11  |- mesh__recordOriginator mesh__D046934 ssb
% 210.96/211.11  |- mesh__recordAuthorizer mesh__D046934 sjn
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D046934 2005
% 210.96/211.11  |- rdf__type mesh__D046934sskos__Concept
% 210.96/211.11  |- mesh__recordMaintainer mesh__D046934 ssb
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D046934 2006
% 210.96/211.11  |- mesh__publicMeSHNote mesh__D046934 2005   
% 210.96/211.11  |- mesh__dateCreated mesh__D024482 2001-07-25
% 210.96/211.11  |- skos__altLabel mesh__D024482 Vitamin K2
% 210.96/211.11  |- rdf__type mesh__D024482sskos__Concept
% 210.96/211.11  |- skos__scopeNote mesh__D024482
% 210.96/211.11       A group of substances similar to VITAMIN K 1 which contains a ring of 2-methyl-1,4-naphthoquinione and an isoprenoid side chain of varying number of isoprene units. In vitamin K 2, each isoprene unit contains a double bond. They are produced by bacteria including the normal intestinal flora.%A%    
% 210.96/211.11  |- mesh__recordAuthorizer mesh__D024482 sjn
% 210.96/211.11  |- skos__prefLabel mesh__D024482 Vitamin K 2
% 210.96/211.11  |- skos__altLabel mesh__D024482 Menaquinones
% 210.96/211.11  |- skos__historyNote mesh__D024482 Vitamin K %28%1965-2001%29%
% 210.96/211.11  |- mesh__historyNote mesh__D024482 2002; use VITAMIN K 1965-2001   
% 210.96/211.11  |- skos__broader mesh__D024482smesh__D009285
% 210.96/211.11  |- skos__altLabel mesh__D024482 Vitamin K Quinone
% 210.96/211.11  |- skos__annotation mesh__D024482
% 210.96/211.11       deficiency: coordinate VITAMIN K 2 %28%IM%29% with VITAMIN K DEFICIENCY %28%IM%29%%A%  
% 210.96/211.11  |- mesh__recordMaintainer mesh__D024482 ssb
% 210.96/211.11  |- mesh__dateRevised mesh__D024482 2005-06-30
% 210.96/211.11  |- mesh__dateEstablished mesh__D024482 2002-01-01
% 210.96/211.11  |- skos__altLabel mesh__D024482 Menaquinone
% 210.96/211.11  |- mesh__recordOriginator mesh__D024482 lkt
% 210.96/211.11  |- skos__broader mesh__D024482smesh__D014812
% 210.96/211.11  |- mesh__publicMeSHNote mesh__D024482 2002; see VITAMIN K 1965-2001   
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D024482 2006
% 210.96/211.11  |- skos__scopeNote mesh__D018445
% 210.96/211.11       The transmission of infectious disease or pathogens from one generation to another. It includes transmission in utero or intrapartum by exposure to blood and secretions, and postpartum exposure via breastfeeding.%A%    
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D018445 2006
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D018445 2001
% 210.96/211.11  |- skos__hiddenLabel mesh__D018445 Transmission, Maternal Fetal
% 210.96/211.11  |- mesh__recordAuthorizer mesh__D018445 PLS
% 210.96/211.11  |- skos__hiddenLabel mesh__D018445 Transmission, Vertical Disease
% 210.96/211.11  |- mesh__recordMaintainer mesh__D018445 TGC
% 210.96/211.11  |- skos__altLabel mesh__D018445 Vertical Disease Transmission
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D018445 2005
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D018445 2004
% 210.96/211.11  |- rdf__type mesh__D018445sskos__Concept
% 210.96/211.11  |- skos__altLabel mesh__D018445 Fetomaternal Transmission
% 210.96/211.11  |- skos__altLabel mesh__D018445 Vertical Transmission
% 210.96/211.11  |- skos__altLabel mesh__D018445 Transmission, Fetomaternal
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D018445 2000
% 210.96/211.11  |- mesh__dateEstablished mesh__D018445 1995-01-01
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D018445 2003
% 210.96/211.11  |- skos__prefLabel mesh__D018445 Disease Transmission, Vertical
% 210.96/211.11  |- mesh__publicMeSHNote mesh__D018445 95   
% 210.96/211.11  |- skos__annotation mesh__D018445
% 210.96/211.11       vertical refers to transm from one generation to another; coord IM with specific dis /transm %28%IM%29%; DISEASE TRANSMISSION, HORIZONTAL %28%transm in same generation%29% is also available; DF: DIS TRANSM VERTICAL%A%  
% 210.96/211.11  |- skos__hiddenLabel mesh__D018445 Maternal Fetal Transmission
% 210.96/211.11  |- skos__historyNote mesh__D018445
% 210.96/211.11       specific diseases/transmission %28%1975-1994%29%
% 210.96/211.11  |- mesh__dateCreated mesh__D018445 1994-01-25
% 210.96/211.11  |- mesh__recordOriginator mesh__D018445 AGS
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D018445 2002
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D018445 1999
% 210.96/211.11  |- skos__altLabel mesh__D018445 Transmission, Maternal-Fetal
% 210.96/211.11  |- skos__broader mesh__D018445smesh__D018562
% 210.96/211.11  |- skos__altLabel mesh__D018445 Vertical Transmission of Disease
% 210.96/211.11  |- mesh__historyNote mesh__D018445 95   
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D018445 1998
% 210.96/211.11  |- skos__altLabel mesh__D018445 Transmission, Vertical
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D018445 1997
% 210.96/211.11  |- mesh__dateRevised mesh__D018445 1996-06-10
% 210.96/211.11  |- mesh__dateRevised mesh__D010462 2005-06-30
% 210.96/211.11  |- mesh__recordMaintainer mesh__D010462 SYSTEM
% 210.96/211.11  |- skos__broader mesh__D010462smesh__D006095
% 210.96/211.11  |- rdf__type mesh__D010462sskos__Concept
% 210.96/211.11  |- skos__scopeNote mesh__D010462
% 210.96/211.11       A genus of gram-positive, anaerobic, coccoid bacteria that is part of the normal flora of humans. Its organisms are opportunistic pathogens causing bacteremias and soft tissue infections.%A%    
% 210.96/211.11  |- mesh__recordAuthorizer mesh__D010462 sjn
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D010462 2006
% 210.96/211.11  |- mesh__recordOriginator mesh__D010462 NLM
% 210.96/211.11  |- skos__prefLabel mesh__D010462 Peptostreptococcus
% 210.96/211.11  |- mesh__historyNote mesh__D010462
% 210.96/211.11       GAFFKYA ANAEROBIA was see MICROCOCCUS 1979-91   
% 210.96/211.11  |- mesh__dateCreated mesh__D010462 1999-01-01
% 210.96/211.11  |- mesh__onlineNote mesh__D010462
% 210.96/211.11       use MICROCOCCUS to search GAFFKYA ANAEROBIA 1979-91   
% 210.96/211.11  |- mesh__publicMeSHNote mesh__D010462
% 210.96/211.11       GAFFKYA ANAEROBIA was see MICROCOCCUS 1979-91   
% 210.96/211.11  |- skos__annotation mesh__D010462
% 210.96/211.11       opportunistic; infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 210.96/211.11  |- rdf__type mesh__D051879sskos__Concept
% 210.96/211.11  |- mesh__historyNote mesh__D051879 2006%28%1990%29%   
% 210.96/211.11  |- skos__prefLabel mesh__D051879 Twist Transcription Factor
% 210.96/211.11  |- skos__hiddenLabel mesh__D051879 Transcription Factor, Twist
% 210.96/211.11  |- mesh__dateCreated mesh__D051879 2005-06-30
% 210.96/211.11  |- mesh__recordOriginator mesh__D051879 DRC
% 210.96/211.11  |- skos__scopeNote mesh__D051879
% 210.96/211.11       A basic helix-loop-helix transcription factor that was originally identified in DROSOPHILA as essential for proper gastrulation and MESODERM formation. It plays an important role in EMBRYONIC DEVELOPMENT and CELL DIFFERENTIATION of MUSCLE CELLS, and is found in a wide variety of organisms.%A%    
% 210.96/211.11  |- mesh__dateEstablished mesh__D051879 2006-01-01
% 210.96/211.11  |- skos__altLabel mesh__D051879 Twist Protein
% 210.96/211.11  |- mesh__publicMeSHNote mesh__D051879
% 210.96/211.11       2006; TWIST TRANSCRIPTION FACTOR was indexed under NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005%A%  
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D051879 2006
% 210.96/211.11  |- mesh__recordAuthorizer mesh__D051879 sjn
% 210.96/211.11  |- mesh__recordMaintainer mesh__D051879 DRC
% 210.96/211.11  |- skos__broader mesh__D051879smesh__D051792
% 210.96/211.11  |- mesh__recordMaintainer mesh__D004425 ags
% 210.96/211.11  |- mesh__dateRevised mesh__D004425 2005-06-30
% 210.96/211.11  |- skos__hiddenLabel mesh__D004425 Cartilages, Ear
% 210.96/211.11  |- mesh__dateEstablished mesh__D004425 1991-01-01
% 210.96/211.11  |- rdf__type mesh__D004425sskos__Concept
% 210.96/211.11  |- skos__historyNote mesh__D004425 Ear, External %28%1966-1978%29%
% 210.96/211.11  |- skos__prefLabel mesh__D004425 Ear Cartilages
% 210.96/211.11  |- skos__broader mesh__D004425smesh__D004431
% 210.96/211.11  |- skos__hiddenLabel mesh__D004425 Cartilage, Ear
% 210.96/211.11  |- mesh__dateCreated mesh__D004425 1978-05-19
% 210.96/211.11  |- skos__historyNote mesh__D004425 Cartilage %28%1966-1978%29%
% 210.96/211.11  |- skos__annotation mesh__D004425
% 210.96/211.11       /abnorm permitted for congen deform but acquired deform = EAR DEFORMITIES, ACQUIRED %28%IM%29% + EAR CARTILAGES %28%NIM%29%%A%  
% 210.96/211.11  |- skos__scopeNote mesh__D004425
% 210.96/211.11       Cartilages of the auricle %28%pinna%29% and the external acoustic meatus.%A%    
% 210.96/211.11  |- skos__hiddenLabel mesh__D004425 Ear Cartilage
% 210.96/211.11  |- mesh__historyNote mesh__D004425
% 210.96/211.11       91%28%79%29%; was see under EAR, EXTERNAL 1979-90   
% 210.96/211.11  |- mesh__recordOriginator mesh__D004425 RC
% 210.96/211.11  |- mesh__recordAuthorizer mesh__D004425 sjn
% 210.96/211.11  |- skos__broader mesh__D004425smesh__D051472
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D004425 2006
% 210.96/211.11  |- mesh__publicMeSHNote mesh__D004425
% 210.96/211.11       91; was see under EAR, EXTERNAL 1979-90   
% 210.96/211.11  |- skos__broader mesh__D009887Q000295smesh__D009887
% 210.96/211.11  |- mesh__preferredCombination mesh__D009887Q000295smesh__D019721
% 210.96/211.11  |- rdf__type mesh__D009887Q000295smesh__CompoundConcept
% 210.96/211.11  |- rdf__type mesh__D009110sskos__Concept
% 210.96/211.11  |- skos__hiddenLabel mesh__D009110 Syndrome, Hospital Addiction
% 210.96/211.11  |- skos__annotation mesh__D009110
% 210.96/211.11       dis symptoms fabricated by a person seeking hospitalization repeatedly; MUNCHAUSEN SYNDROME BY PROXY is available%A%  
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D009110 2002
% 210.96/211.11  |- skos__hiddenLabel mesh__D009110 Syndromes, Hospital-Addiction
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D009110 2003
% 210.96/211.11  |- skos__hiddenLabel mesh__D009110 Syndrome, Munchausen
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D009110 1998
% 210.96/211.11  |- skos__hiddenLabel mesh__D009110 Hospital Addiction Syndrome
% 210.96/211.11  |- mesh__recordOriginator mesh__D009110 NLM
% 210.96/211.11  |- skos__hiddenLabel mesh__D009110 Hospital-Addiction Syndromes
% 210.96/211.11  |- mesh__recordMaintainer mesh__D009110 JLS
% 210.96/211.11  |- mesh__dateCreated mesh__D009110 1999-01-01
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D009110 2005
% 210.96/211.11  |- skos__altLabel mesh__D009110 Hospital-Addiction Syndrome
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D009110 2004
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D009110 1999
% 210.96/211.11  |- skos__scopeNote mesh__D009110
% 210.96/211.11       A factitious disorder characterized by habitual presentation for hospital treatment of an apparent acute illness, the patient giving a plausible and dramatic history, all of which is false.%A%    
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D009110 2000
% 210.96/211.11  |- mesh__historyNote mesh__D009110 68%28%64%29%   
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D009110 2006
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D009110 2001
% 210.96/211.11  |- mesh__dateRevised mesh__D009110 1997-06-20
% 210.96/211.11  |- mesh__dateEstablished mesh__D009110 1968-01-01
% 210.96/211.11  |- skos__altLabel mesh__D009110 Syndrome, Hospital-Addiction
% 210.96/211.11  |- skos__hiddenLabel mesh__D009110 Syndrome, Munchhausen
% 210.96/211.11  |- mesh__recordAuthorizer mesh__D009110 SJN
% 210.96/211.11  |- skos__broader mesh__D009110smesh__D005162
% 210.96/211.11  |- skos__prefLabel mesh__D009110 Munchausen Syndrome
% 210.96/211.11  |- mesh__publicMeSHNote mesh__D009110 68   
% 210.96/211.11  |- skos__altLabel mesh__D009110 Munchhausen Syndrome
% 210.96/211.11  |- skos__hiddenLabel mesh__D020890 Differentiation Factor, neu
% 210.96/211.11  |- mesh__historyNote mesh__D020890
% 210.96/211.11       2000; use NEUREGULIN-1 %28%NM%29% 1993-1999; for GLIAL GROWTH FACTOR use GLIA MATURATION FACTOR %28%NM%29% 1980-1999%A%  
% 210.96/211.11  |- skos__altLabel mesh__D020890 NRG1 Protein
% 210.96/211.11  |- mesh__recordOriginator mesh__D020890 jmp
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D020890 2006
% 210.96/211.11  |- skos__historyNote mesh__D020890 Nerve Tissue Proteins %28%1980-1999%29%
% 210.96/211.11  |- mesh__dateRevised mesh__D020890 2005-06-30
% 210.96/211.11  |- rdf__type mesh__D020890sskos__Concept
% 210.96/211.11  |- mesh__recordAuthorizer mesh__D020890 sjn
% 210.96/211.11  |- skos__altLabel mesh__D020890 NDF Protein
% 210.96/211.11  |- skos__historyNote mesh__D020890 Glycoproteins %28%1986-1999%29%
% 210.96/211.11  |- skos__scopeNote mesh__D020890
% 210.96/211.11       A peptide factor originally identified by its ability to stimulate the phosphorylation the erbB-2 receptor %28%RECEPTOR, ERBB-2%29%. It is a ligand for the erbB-3 receptor %28%RECEPTOR, ERBB-3%29% and the erbB-4 receptor. Variant forms of NEUREGULIN-1 occur through alternative splicing of its mRNA.%A%    
% 210.96/211.11  |- skos__broader mesh__D020890smesh__D020880
% 210.96/211.11  |- skos__prefLabel mesh__D020890 Neuregulin-1
% 210.96/211.11  |- skos__hiddenLabel mesh__D020890 Neuregulin 1
% 210.96/211.11  |- mesh__dateEstablished mesh__D020890 2000-01-01
% 210.96/211.11  |- skos__annotation mesh__D020890
% 210.96/211.11       do not confuse X ref GLIAL GROWTH FACTOR with GLIA MATURATION FACTOR%A%  
% 210.96/211.11  |- skos__altLabel mesh__D020890 GGF Protein
% 210.96/211.11  |- mesh__dateCreated mesh__D020890 1999-11-04
% 210.96/211.11  |- mesh__publicMeSHNote mesh__D020890
% 210.96/211.11       2000; NEUREGULIN-1 was indexed under GLYCOPROTEINS 1993-1999; GLIAL GROWTH FACTOR was indexed under NERVE TISSUE PROTEINS 1980-1999%A%  
% 210.96/211.11  |- mesh__recordMaintainer mesh__D020890 ssb
% 210.96/211.11  |- skos__broader mesh__D020168Q000031smesh__D020168
% 210.96/211.11  |- mesh__preferredCombination mesh__D020168Q000031smesh__D018435
% 210.96/211.11  |- rdf__type mesh__D020168Q000031smesh__CompoundConcept
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D020092 2006
% 210.96/211.11  |- skos__scopeNote mesh__D020092
% 210.96/211.11       A genus of fungi in the family Ancylistaceae, order ENTOMOPHTHORALES, characterized by the presence of small nuclei with a prominent central nucleolus in interphase. They are commonly found in the soil but also infect termites, aphids, and sometimes, though rarely, mammals including humans. %28%Alexopoulos et al, Introductory Mycology, 4th ed, pp159-60%29%%A%    
% 210.96/211.11  |- mesh__recordOriginator mesh__D020092 AGS
% 210.96/211.11  |- skos__annotation mesh__D020092
% 210.96/211.11       infection: coord IM with ZYGOMYCOSIS %28%IM%29%   
% 210.96/211.11  |- skos__historyNote mesh__D020092 Zygomycota %28%1976-1998%29%
% 210.96/211.11  |- skos__broader mesh__D020092smesh__D020091
% 210.96/211.11  |- mesh__dateEstablished mesh__D020092 1999-01-01
% 210.96/211.11  |- mesh__dateCreated mesh__D020092 1998-06-10
% 210.96/211.11  |- mesh__recordMaintainer mesh__D020092 SYSTEM
% 210.96/211.11  |- mesh__publicMeSHNote mesh__D020092 99   
% 210.96/211.11  |- mesh__dateRevised mesh__D020092 2005-06-30
% 210.96/211.11  |- skos__prefLabel mesh__D020092 Conidiobolus
% 210.96/211.11  |- mesh__historyNote mesh__D020092 99   
% 210.96/211.11  |- rdf__type mesh__D020092sskos__Concept
% 210.96/211.11  |- mesh__recordAuthorizer mesh__D020092 sjn
% 210.96/211.11  |- skos__hiddenLabel mesh__D014853 Walker
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D014853 1993
% 210.96/211.11  |- mesh__dateEstablished mesh__D014853 1991-01-01
% 210.96/211.11  |- mesh__dateRevised mesh__D014853 1992-05-18
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D014853 2006
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D014853 1998
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D014853 2001
% 210.96/211.11  |- mesh__recordMaintainer mesh__D014853 TAP
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D014853 2005
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D014853 1997
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D014853 2000
% 210.96/211.11  |- mesh__historyNote mesh__D014853
% 210.96/211.11       91%28%75%29%; was see under ORTHOPEDIC EQUIPMENT 1975-90   
% 210.96/211.11  |- mesh__dateCreated mesh__D014853 1974-12-12
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D014853 2004
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D014853 1996
% 210.96/211.11  |- mesh__activeMeSHYear mesh__D014853 1995
% 210.96/211.11  |- mesh__recordAuthorizer mesh__D014853 PLS
% 210.96/211.11  |- mesh__publicMeSHNote mesh__D014853
% 210.96/211.11       91; was see under ORTHOPEDIC EQUIPMENT 1975-90   
% 210.96/211.11  |- skos__broader mesh__D014853smesh__D009983
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D014853 2003
% 210.96/211.12  |- skos__scopeNote mesh__D014853
% 210.96/211.12       Walking aids generally having two handgrips and four legs.%A%    
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D014853 1994
% 210.96/211.12  |- mesh__recordOriginator mesh__D014853 NLM
% 210.96/211.12  |- rdf__type mesh__D014853sskos__Concept
% 210.96/211.12  |- skos__prefLabel mesh__D014853 Walkers
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D014853 1999
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D014853 2002
% 210.96/211.12  |- skos__broader mesh__D014055smesh__D011877
% 210.96/211.12  |- skos__altLabel mesh__D014055 CAT Scan, Radionuclide
% 210.96/211.12  |- mesh__recordOriginator mesh__D014055 SMH
% 210.96/211.12  |- mesh__dateEstablished mesh__D014055 1980-01-01
% 210.96/211.12  |- skos__hiddenLabel mesh__D014055 Radionuclide Computed Tomography
% 210.96/211.12  |- skos__altLabel mesh__D014055 Tomography, Computerized Emission
% 210.96/211.12  |- skos__hiddenLabel mesh__D014055 Radionuclide CAT Scan
% 210.96/211.12  |- skos__hiddenLabel mesh__D014055 Emission Tomography, Computerized
% 210.96/211.12  |- skos__historyNote mesh__D014055
% 210.96/211.12       Tomography, X-Ray Computed %28%1977-1979%29%
% 210.96/211.12  |- skos__altLabel mesh__D014055 Tomography, Radionuclide-Computed
% 210.96/211.12  |- skos__hiddenLabel mesh__D014055 Tomography, Emission Computed
% 210.96/211.12  |- skos__altLabel mesh__D014055 Radionuclide Tomography, Computed
% 210.96/211.12  |- mesh__dateCreated mesh__D014055 1979-05-29
% 210.96/211.12  |- mesh__historyNote mesh__D014055
% 210.96/211.12       90; was TOMOGRAPHY, EMISSION COMPUTED 1980-89   
% 210.96/211.12  |- skos__altLabel mesh__D014055 Emission-Computed Tomography
% 210.96/211.12  |- skos__altLabel mesh__D014055 Computerized Emission Tomography
% 210.96/211.12  |- skos__annotation mesh__D014055
% 210.96/211.12       uses radionuclides %26% computer: do not confuse with TOMOGRAPHY, X-RAY COMPUTED using x-rays %26% computer; %22%computed tomography%22% unspecified is probably TOMOGRAPHY, X-RAY COMPUTED;%A%  
% 210.96/211.12  |- skos__altLabel mesh__D014055 Computed Tomographic Scintigraphy
% 210.96/211.12  |- skos__hiddenLabel mesh__D014055 Scan, Radionuclide CAT
% 210.96/211.12  |- skos__hiddenLabel mesh__D014055 Computed Radionuclide Tomography
% 210.96/211.12  |- skos__hiddenLabel mesh__D014055 Tomographic Scintigraphy, Computed
% 210.96/211.12  |- skos__historyNote mesh__D014055 Tomography %28%1966-1979%29%
% 210.96/211.12  |- skos__hiddenLabel mesh__D014055 Radionuclide CAT Scans
% 210.96/211.12  |- skos__broader mesh__D014055smesh__D007089
% 210.96/211.12  |- skos__broader mesh__D014055smesh__D007090
% 210.96/211.12  |- skos__broader mesh__D014055smesh__D014054
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D014055 2005
% 210.96/211.12  |- skos__hiddenLabel mesh__D014055 Emission Computed Tomography
% 210.96/211.12  |- mesh__onlineNote mesh__D014055
% 210.96/211.12       use TOMOGRAPHY, EMISSION-COMPUTED to search TOMOGRAPHY, EMISSION COMPUTED 1980-89%A%  
% 210.96/211.12  |- skos__hiddenLabel mesh__D014055 Scans, Radionuclide CAT
% 210.96/211.12  |- skos__scopeNote mesh__D014055
% 210.96/211.12       Tomography using emissions from radionuclides and a computer algorithm to reconstruct the image.%A%    
% 210.96/211.12  |- skos__hiddenLabel mesh__D014055 Tomography, Computed Radionuclide
% 210.96/211.12  |- mesh__recordMaintainer mesh__D014055 ssb
% 210.96/211.12  |- mesh__publicMeSHNote mesh__D014055
% 210.96/211.12       90; was TOMOGRAPHY, EMISSION COMPUTED 1980-89   
% 210.96/211.12  |- skos__hiddenLabel mesh__D014055 CAT Scans, Radionuclide
% 210.96/211.12  |- skos__altLabel mesh__D014055 Scintigraphy, Computed Tomographic
% 210.96/211.12  |- skos__prefLabel mesh__D014055 Tomography, Emission-Computed
% 210.96/211.12  |- mesh__dateRevised mesh__D014055 2004-07-07
% 210.96/211.12  |- rdf__type mesh__D014055sskos__Concept
% 210.96/211.12  |- skos__hiddenLabel mesh__D014055 Tomography, Radionuclide Computed
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D014055 2006
% 210.96/211.12  |- mesh__recordAuthorizer mesh__D014055 sjn
% 210.96/211.12  |- skos__related mesh__D014055smesh__D015902
% 210.96/211.12  |- mesh__dateCreated mesh__D008816 1978-03-20
% 210.96/211.12  |- skos__prefLabel mesh__D008816 Mice, Jimpy
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D008816 2006
% 210.96/211.12  |- mesh__historyNote mesh__D008816
% 210.96/211.12       91%28%79%29%; was see under MICE, NEUROLOGIC MUTANTS 1979-90   
% 210.96/211.12  |- mesh__dateEstablished mesh__D008816 1991-01-01
% 210.96/211.12  |- rdf__type mesh__D008816sskos__Concept
% 210.96/211.12  |- mesh__recordOriginator mesh__D008816 EC
% 210.96/211.12  |- mesh__recordMaintainer mesh__D008816 ags
% 210.96/211.12  |- skos__hiddenLabel mesh__D008816 Jimpy Mice
% 210.96/211.12  |- mesh__dateRevised mesh__D008816 2005-06-30
% 210.96/211.12  |- skos__scopeNote mesh__D008816
% 210.96/211.12       Myelin-deficient mutants which are from the inbred Tabby-Jimpy strain.%A%    
% 210.96/211.12  |- mesh__publicMeSHNote mesh__D008816
% 210.96/211.12       91; was see under MICE, NEUROLOGIC MUTANTS 1979-90   
% 210.96/211.12  |- skos__historyNote mesh__D008816 Mice, Inbred Strains %28%1972-1978%29%
% 210.96/211.12  |- skos__annotation mesh__D008816
% 210.96/211.12       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%  
% 210.96/211.12  |- skos__broader mesh__D008816smesh__D008817
% 210.96/211.12  |- mesh__recordAuthorizer mesh__D008816 sjn
% 210.96/211.12  |- mesh__historyNote mesh__D000833
% 210.96/211.12       87%28%79%29%; was see under ANIMALS 1979-86   
% 210.96/211.12  |- mesh__recordAuthorizer mesh__D000833 sjn
% 210.96/211.12  |- mesh__dateRevised mesh__D000833 2003-07-30
% 210.96/211.12  |- mesh__dateEstablished mesh__D000833 1987-01-01
% 210.96/211.12  |- skos__broader mesh__D000833smesh__D000828
% 210.96/211.12  |- skos__prefLabel mesh__D000833 Animals, Suckling
% 210.96/211.12  |- skos__hiddenLabel mesh__D000833 Animal, Suckling
% 210.96/211.12  |- mesh__recordMaintainer mesh__D000833 ags
% 210.96/211.12  |- skos__scopeNote mesh__D000833
% 210.96/211.12       Young, unweaned mammals. Refers to nursing animals whether nourished by their biological mother, foster mother, or bottle fed.%A%    
% 210.96/211.12  |- mesh__dateCreated mesh__D000833 1978-05-04
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D000833 2005
% 210.96/211.12  |- rdf__type mesh__D000833sskos__Concept
% 210.96/211.12  |- skos__hiddenLabel mesh__D000833 Suckling Animals
% 210.96/211.12  |- skos__hiddenLabel mesh__D000833 Suckling Animal
% 210.96/211.12  |- mesh__recordOriginator mesh__D000833 EC
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D000833 2006
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D000833 2004
% 210.96/211.12  |- mesh__publicMeSHNote mesh__D000833 87; was see under ANIMALS 1979-86   
% 210.96/211.12  |- skos__annotation mesh__D000833
% 210.96/211.12       suckled by mother or by bottle; coord with specific suckling; NIM when exper animal: no qualif; when IM, qualif permitted; suckling of animals %28%the act, as in the eff of suckling on animal physiol%29% goes under LACTATION; do not forget also to check tag ANIMALS%A%  
% 210.96/211.12  |- mesh__dateCreated mesh__D008018 1999-01-01
% 210.96/211.12  |- skos__hiddenLabel mesh__D008018 Cycle, Life
% 210.96/211.12  |- mesh__dateEstablished mesh__D008018 1998-01-01
% 210.96/211.12  |- skos__historyNote mesh__D008018
% 210.96/211.12       specific organism/growth %26% development %28%1967-1997%29%
% 210.96/211.12  |- skos__hiddenLabel mesh__D008018 Stage, Life Cycle
% 210.96/211.12  |- mesh__recordAuthorizer mesh__D008018 sjn
% 210.96/211.12  |- skos__annotation mesh__D008018
% 210.96/211.12       GEN or unspecified; prefer specifics; coord IM with name of organism with /growth %28%IM%29%%A%  
% 210.96/211.12  |- mesh__recordOriginator mesh__D008018 NLM
% 210.96/211.12  |- skos__hiddenLabel mesh__D008018 Stages, Life Cycle
% 210.96/211.12  |- mesh__publicMeSHNote mesh__D008018 98   
% 210.96/211.12  |- skos__prefLabel mesh__D008018 Life Cycle Stages
% 210.96/211.12  |- skos__hiddenLabel mesh__D008018 Life Cycle Stage
% 210.96/211.12  |- rdf__type mesh__D008018sskos__Concept
% 210.96/211.12  |- skos__scopeNote mesh__D008018
% 210.96/211.12       The continuous sequence of changes undergone by metamorphosing insects and other animals during the post-embryonic development process.%A%    
% 210.96/211.12  |- mesh__historyNote mesh__D008018 98; use explode 1975-97   
% 210.96/211.12  |- skos__broader mesh__D008018smesh__D008675
% 210.96/211.12  |- mesh__dateRevised mesh__D008018 2004-07-07
% 210.96/211.12  |- skos__altLabel mesh__D008018 Life Cycle
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D008018 2006
% 210.96/211.12  |- skos__historyNote mesh__D008018
% 210.96/211.12       Metamorphosis, Biological %28%1967-1997%29%
% 210.96/211.12  |- skos__hiddenLabel mesh__D008018 Life Cycles
% 210.96/211.12  |- skos__hiddenLabel mesh__D008018 Cycles, Life
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D008018 2005
% 210.96/211.12  |- mesh__recordMaintainer mesh__D008018 lkt
% 210.96/211.12  |- skos__scopeNote mesh__D000035
% 210.96/211.12       A process in psychotherapy in which the patient is %22%desensitized%22% to emotionally painful, often forgotten %28%repressed%29% memories by recalling and reacting to them in the %22%safety%22% of the treatment setting.%A%    
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D000035 2001
% 210.96/211.12  |- skos__hiddenLabel mesh__D000035 Abreactions
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D000035 2006
% 210.96/211.12  |- mesh__recordAuthorizer mesh__D000035 SJN
% 210.96/211.12  |- mesh__publicMeSHNote mesh__D000035 68   
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D000035 2000
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D000035 2005
% 210.96/211.12  |- mesh__recordMaintainer mesh__D000035 PXP
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D000035 1999
% 210.96/211.12  |- skos__prefLabel mesh__D000035 Abreaction
% 210.96/211.12  |- rdf__type mesh__D000035sskos__Concept
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D000035 1998
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D000035 2002
% 210.96/211.12  |- mesh__historyNote mesh__D000035 68   
% 210.96/211.12  |- skos__broader mesh__D000035smesh__D013811
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D000035 2004
% 210.96/211.12  |- mesh__dateRevised mesh__D000035 1997-06-20
% 210.96/211.12  |- mesh__dateEstablished mesh__D000035 1968-01-01
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D000035 2003
% 210.96/211.12  |- mesh__recordOriginator mesh__D000035 NLM
% 210.96/211.12  |- mesh__dateCreated mesh__D000035 1999-01-01
% 210.96/211.12  |- skos__annotation mesh__D000035 no qualif   
% 210.96/211.12  |- mesh__recordOriginator mesh__D046935 ssb
% 210.96/211.12  |- mesh__dateEstablished mesh__D046935 2005-01-01
% 210.96/211.12  |- mesh__historyNote mesh__D046935 2005   
% 210.96/211.12  |- skos__scopeNote mesh__D046935
% 210.96/211.12       A degraded form of GINKGOLIDES that have three LACTONES and a unique tert-butyl group which are found in GINKGO plants.%A%    
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D046935 2005
% 210.96/211.12  |- rdf__type mesh__D046935sskos__Concept
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D046935 2006
% 210.96/211.12  |- skos__broader mesh__D046935smesh__D046934
% 210.96/211.12  |- mesh__recordAuthorizer mesh__D046935 sjn
% 210.96/211.12  |- mesh__publicMeSHNote mesh__D046935 2005   
% 210.96/211.12  |- mesh__recordMaintainer mesh__D046935 ssb
% 210.96/211.12  |- skos__prefLabel mesh__D046935 Bilobalides
% 210.96/211.12  |- mesh__dateCreated mesh__D046935 2004-07-07
% 210.96/211.12  |- skos__broader mesh__D024483smesh__D014812
% 210.96/211.12  |- skos__historyNote mesh__D024483 Vitamin K %28%1965-2001%29%
% 210.96/211.12  |- skos__altLabel mesh__D024483 Vitamin K3
% 210.96/211.12  |- mesh__dateCreated mesh__D024483 2001-07-25
% 210.96/211.12  |- skos__prefLabel mesh__D024483 Vitamin K 3
% 210.96/211.12  |- mesh__dateEstablished mesh__D024483 2002-01-01
% 210.96/211.12  |- skos__annotation mesh__D024483
% 210.96/211.12       deficiency: coordinate VITAMIN K 3 %28%IM%29% with VITAMIN K DEFICIENCY %28%IM%29%%A%  
% 210.96/211.12  |- skos__altLabel mesh__D024483 Menadione
% 210.96/211.12  |- mesh__recordAuthorizer mesh__D024483 sjn
% 210.96/211.12  |- mesh__recordOriginator mesh__D024483 lkt
% 210.96/211.12  |- skos__altLabel mesh__D024483 Menadione sodium bisulfite
% 210.96/211.12  |- skos__scopeNote mesh__D024483
% 210.96/211.12       A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.%A%    
% 210.96/211.12  |- mesh__historyNote mesh__D024483 2002; use VITAMIN K 1965-2001   
% 210.96/211.12  |- skos__broader mesh__D024483smesh__D009285
% 210.96/211.12  |- mesh__publicMeSHNote mesh__D024483 2002; see VITAMIN K 1965-2001   
% 210.96/211.12  |- mesh__dateRevised mesh__D024483 2005-06-30
% 210.96/211.12  |- mesh__recordMaintainer mesh__D024483 ssb
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D024483 2006
% 210.96/211.12  |- skos__altLabel mesh__D024483 2-Methyl-1,4-naphthalenedione
% 210.96/211.12  |- skos__altLabel mesh__D024483 2-Methylnaphthoquinone
% 210.96/211.12  |- skos__altLabel mesh__D024483 2-Methyl-1,4-naphthoquinone
% 210.96/211.12  |- rdf__type mesh__D024483sskos__Concept
% 210.96/211.12  |- skos__scopeNote mesh__D018446
% 210.96/211.12       The transmission of infectious disease or pathogens from one individual to another in the same generation.%A%    
% 210.96/211.12  |- skos__altLabel mesh__D018446 Horizontal Disease Transmission
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D018446 2005
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D018446 2004
% 210.96/211.12  |- rdf__type mesh__D018446sskos__Concept
% 210.96/211.12  |- skos__hiddenLabel mesh__D018446 Transmissions, Horizontal
% 210.96/211.12  |- skos__hiddenLabel mesh__D018446 Disease Transmissions, Horizontal
% 210.96/211.12  |- mesh__dateRevised mesh__D018446 1996-06-10
% 210.96/211.12  |- skos__annotation mesh__D018446
% 210.96/211.12       horizontal refers to transm in same generation; coord IM with specific dis /transm %28%IM%29%; DISEASE TRANSMISSION, VERTICAL %28%transm from one generation to another%29% is also available; DF: DIS TRANSM HORIZONTAL%A%  
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D018446 2003
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D018446 2001
% 210.96/211.12  |- skos__hiddenLabel mesh__D018446 Transmissions, Horizontal Disease
% 210.96/211.12  |- mesh__recordAuthorizer mesh__D018446 PLS
% 210.96/211.12  |- mesh__dateCreated mesh__D018446 1994-01-25
% 210.96/211.12  |- skos__prefLabel mesh__D018446 Disease Transmission, Horizontal
% 210.96/211.12  |- skos__altLabel mesh__D018446 Transmission, Horizontal
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D018446 2000
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D018446 1999
% 210.96/211.12  |- mesh__dateEstablished mesh__D018446 1995-01-01
% 210.96/211.12  |- skos__hiddenLabel mesh__D018446 Horizontal Transmissions
% 210.96/211.12  |- skos__altLabel mesh__D018446 Horizontal Transmission of Disease
% 210.96/211.12  |- mesh__historyNote mesh__D018446 95   
% 210.96/211.12  |- mesh__publicMeSHNote mesh__D018446 95   
% 210.96/211.12  |- skos__hiddenLabel mesh__D018446 Horizontal Disease Transmissions
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D018446 1998
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D018446 1997
% 210.96/211.12  |- skos__historyNote mesh__D018446
% 210.96/211.12       specific diseases/transmission %28%1975-1994%29%
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D018446 2006
% 210.96/211.12  |- mesh__recordOriginator mesh__D018446 AGS
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D018446 2002
% 210.96/211.12  |- skos__hiddenLabel mesh__D018446 Transmission, Horizontal Disease
% 210.96/211.12  |- skos__broader mesh__D018446smesh__D018562
% 210.96/211.12  |- skos__altLabel mesh__D018446 Horizontal Transmission
% 210.96/211.12  |- mesh__recordMaintainer mesh__D018446 TGC
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D010463 2006
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D010463 2002
% 210.96/211.12  |- skos__hiddenLabel mesh__D010463 Desoxone1
% 210.96/211.12  |- mesh__dateRevised mesh__D010463 2000-06-21
% 210.96/211.12  |- mesh__dateCreated mesh__D010463 1974-11-19
% 210.96/211.12  |- skos__broader mesh__D010463smesh__D000088
% 210.96/211.12  |- skos__altLabel mesh__D010463 Acetyl Hydroperoxide
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D010463 2005
% 210.96/211.12  |- mesh__publicMeSHNote mesh__D010463
% 210.96/211.12       91; was see under ACETIC ACIDS 1975-90   
% 210.96/211.12  |- skos__historyNote mesh__D010463 Peroxides %28%1969-1974%29%
% 210.96/211.12  |- skos__hiddenLabel mesh__D010463 Peracetate, Zinc
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D010463 2001
% 210.96/211.12  |- skos__historyNote mesh__D010463 Acetic Acids %28%1969-1974%29%
% 210.96/211.12  |- skos__scopeNote mesh__D010463
% 210.96/211.12       A liquid that functions as a strong oxidizing agent. It has an acrid odor and is used as a disinfectant.%A%    
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D010463 2004
% 210.96/211.12  |- skos__hiddenLabel mesh__D010463 Acid, Peracetic
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D010463 2003
% 210.96/211.12  |- rdf__type mesh__D010463sskos__Concept
% 210.96/211.12  |- skos__altLabel mesh__D010463 Peroxyethanoic Acid
% 210.96/211.12  |- skos__prefLabel mesh__D010463 Peracetic Acid
% 210.96/211.12  |- mesh__recordAuthorizer mesh__D010463 sjn
% 210.96/211.12  |- skos__hiddenLabel mesh__D010463 Acid, Peroxyethanoic
% 210.96/211.12  |- mesh__recordMaintainer mesh__D010463 CCR
% 210.96/211.12  |- skos__altLabel mesh__D010463 Sodium Peracetate
% 210.96/211.12  |- skos__hiddenLabel mesh__D010463 Peracetate, Sodium
% 210.96/211.12  |- mesh__dateEstablished mesh__D010463 1991-01-01
% 210.96/211.12  |- mesh__historyNote mesh__D010463
% 210.96/211.12       91%28%75%29%; was see under ACETIC ACIDS 1975-90   
% 210.96/211.12  |- skos__hiddenLabel mesh__D010463 Desoxone 1
% 210.96/211.12  |- skos__altLabel mesh__D010463 Peroxyacetic Acid
% 210.96/211.12  |- mesh__recordOriginator mesh__D010463 NLM
% 210.96/211.12  |- skos__hiddenLabel mesh__D010463 Acid, Peroxyacetic
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D004426 1998
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D004426 1997
% 210.96/211.12  |- mesh__dateEstablished mesh__D004426 1971-01-01
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D004426 2006
% 210.96/211.12  |- skos__broader mesh__D004426smesh__D004427
% 210.96/211.12  |- rdf__type mesh__D004426sskos__Concept
% 210.96/211.12  |- mesh__historyNote mesh__D004426
% 210.96/211.12       71; was EAR, EXTERNAL, DEFORMITY 1963-70   
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D004426 1992
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D004426 1999
% 210.96/211.12  |- mesh__recordMaintainer mesh__D004426 TAP
% 210.96/211.12  |- mesh__dateRevised mesh__D004426 1990-06-04
% 210.96/211.12  |- skos__hiddenLabel mesh__D004426 Deformity, Acquired Ear
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D004426 1994
% 210.96/211.12  |- skos__scopeNote mesh__D004426
% 210.96/211.12       Distortion or disfigurement of the ear caused by disease or injury after birth.%A%    
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D004426 1993
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D004426 2002
% 210.96/211.12  |- skos__hiddenLabel mesh__D004426 Ear Deformity, Acquired
% 210.96/211.12  |- skos__hiddenLabel mesh__D004426 Acquired Ear Deformity
% 210.96/211.12  |- mesh__dateCreated mesh__D004426 1999-01-01
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D004426 1995
% 210.96/211.12  |- mesh__recordAuthorizer mesh__D004426 PLS
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D004426 2003
% 210.96/211.12  |- mesh__recordOriginator mesh__D004426 NLM
% 210.96/211.12  |- skos__annotation mesh__D004426
% 210.96/211.12       acquired through inj or dis; do not use /congen : = EAR, EXTERNAL /abnorm %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D004426 2000
% 210.96/211.12  |- skos__hiddenLabel mesh__D004426 Deformities, Acquired Ear
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D004426 1996
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D004426 2005
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D004426 2004
% 210.96/211.12  |- mesh__publicMeSHNote mesh__D004426
% 210.96/211.12       71; was EAR, EXTERNAL, DEFORMITY 1963-70   
% 210.96/211.12  |- mesh__onlineNote mesh__D004426
% 210.96/211.12       use EAR /AB %26% EAR, EXTERNAL /AB %26% EAR DEFORMITIES, ACQUIRED to search EAR, EXTERNAL, DEFORMITY 1966-70%A%  
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D004426 2001
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D004426 1991
% 210.96/211.12  |- skos__prefLabel mesh__D004426 Ear Deformities, Acquired
% 210.96/211.12  |- skos__hiddenLabel mesh__D004426 Acquired Ear Deformities
% 210.96/211.12  |- mesh__dateRevised mesh__D009111 1999-11-03
% 210.96/211.12  |- rdf__type mesh__D009111sskos__Concept
% 210.96/211.12  |- skos__scopeNote mesh__D009111
% 210.96/211.12       Smallest political subdivisions within a country at which general governmental functions are carried-out.%A%    
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D009111 2004
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D009111 2001
% 210.96/211.12  |- skos__altLabel mesh__D009111 Government, Local
% 210.96/211.12  |- skos__annotation mesh__D009111 specify geog   
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D009111 2000
% 210.96/211.12  |- mesh__publicMeSHNote mesh__D009111
% 210.96/211.12       99; was MUNICIPAL GOVERNMENT 1966-98   
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D009111 2003
% 210.96/211.12  |- mesh__historyNote mesh__D009111 99; was MUNICIPAL GOVERNMENT 1966-98   
% 210.96/211.12  |- skos__hiddenLabel mesh__D009111 Government, City
% 210.96/211.12  |- mesh__recordOriginator mesh__D009111 NLM
% 210.96/211.12  |- mesh__dateCreated mesh__D009111 1999-01-01
% 210.96/211.12  |- skos__prefLabel mesh__D009111 Local Government
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D009111 2006
% 210.96/211.12  |- skos__broader mesh__D009111smesh__D006076
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D009111 2002
% 210.96/211.12  |- skos__hiddenLabel mesh__D009111 Government, County
% 210.96/211.12  |- mesh__recordAuthorizer mesh__D009111 sjn
% 210.96/211.12  |- skos__hiddenLabel mesh__D009111 Government, Municipal
% 210.96/211.12  |- skos__hiddenLabel mesh__D009111 Government, Metropolitan
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D009111 2005
% 210.96/211.12  |- mesh__recordMaintainer mesh__D009111 kle
% 210.96/211.12  |- rdf__type mesh__D020891sskos__Concept
% 210.96/211.12  |- skos__scopeNote mesh__D020891
% 210.96/211.12       A substituted benzamide that has antipsychotic properties. It is a dopamine D2 receptor %28%see RECEPTORS, DOPAMINE D2%29% antagonist.%A%    
% 210.96/211.12  |- skos__hiddenLabel mesh__D020891 FLA870
% 210.96/211.12  |- skos__historyNote mesh__D020891 Benzamides %28%1985-1986%29%
% 210.96/211.12  |- skos__hiddenLabel mesh__D020891 FLB472
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D020891 2004
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D020891 2005
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D020891 2002
% 210.96/211.12  |- mesh__recordMaintainer mesh__D020891 ssb
% 210.96/211.12  |- mesh__dateRevised mesh__D020891 2001-07-25
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D020891 2003
% 210.96/211.12  |- mesh__publicMeSHNote mesh__D020891
% 210.96/211.12       2000; RACLOPRIDE was indexed under SALICYLAMIDES 1987-1999 %26% BENZAMIDES 1985-1986%A%  
% 210.96/211.12  |- skos__prefLabel mesh__D020891 Raclopride
% 210.96/211.12  |- mesh__recordAuthorizer mesh__D020891 sjn
% 210.96/211.12  |- mesh__dateEstablished mesh__D020891 2000-01-01
% 210.96/211.12  |- skos__historyNote mesh__D020891 Salicylamides %28%1987-1999%29%
% 210.96/211.12  |- mesh__recordOriginator mesh__D020891 adp
% 210.96/211.12  |- skos__hiddenLabel mesh__D020891 FLB 472
% 210.96/211.12  |- mesh__dateCreated mesh__D020891 1999-11-03
% 210.96/211.12  |- skos__hiddenLabel mesh__D020891 FLA 870
% 210.96/211.12  |- skos__broader mesh__D020891smesh__D001549
% 210.96/211.12  |- skos__hiddenLabel mesh__D020891 C11, Raclopride
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D020891 2006
% 210.96/211.12  |- mesh__historyNote mesh__D020891 2000; use RACLOPRIDE 1985-1999   
% 210.96/211.12  |- mesh__recordAuthorizer mesh__D020093 sjn
% 210.96/211.12  |- mesh__recordMaintainer mesh__D020093 SYSTEM
% 210.96/211.12  |- mesh__publicMeSHNote mesh__D020093 99   
% 210.96/211.12  |- skos__scopeNote mesh__D020093
% 210.96/211.12       A genus of zygomycetous fungi of the family Cunninghamellaceae, order MUCORALES. Some species cause systemic infections in humans.%A%    
% 210.96/211.12  |- mesh__recordOriginator mesh__D020093 AGS
% 210.96/211.12  |- skos__prefLabel mesh__D020093 Cunninghamella
% 210.96/211.12  |- skos__broader mesh__D020093smesh__D009090
% 210.96/211.12  |- mesh__dateEstablished mesh__D020093 1999-01-01
% 210.96/211.12  |- rdf__type mesh__D020093sskos__Concept
% 210.96/211.12  |- mesh__dateCreated mesh__D020093 1998-06-10
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D020093 2006
% 210.96/211.12  |- mesh__historyNote mesh__D020093 99   
% 210.96/211.12  |- skos__annotation mesh__D020093
% 210.96/211.12       infection: coord IM with MUCORMYCOSIS %28%IM%29%   
% 210.96/211.12  |- mesh__dateRevised mesh__D020093 2005-06-30
% 210.96/211.12  |- skos__altLabel mesh__D014854 Wallenberg%27%s Syndrome
% 210.96/211.12  |- skos__hiddenLabel mesh__D014854 Vieseaux Wallenberg Syndrome
% 210.96/211.12  |- skos__hiddenLabel mesh__D014854 Lateral Medullary Syndromes
% 210.96/211.12  |- skos__scopeNote mesh__D014854
% 210.96/211.12       Infarction of the dorsolateral aspect of the medulla due to occlusion of the vertebral artery and/or the posterior inferior cerebellar artery. Clinical manifestations vary with the size of infarction, but may include loss of pain and temperature sensation in the ipsilateral face and contralateral body below the chin; ipsilateral HORNER SYNDROME; ipsilateral ATAXIA; DYSARTHRIA; VERTIGO; nausea, hiccup; dysphagia; and VOCAL CORD PARALYSIS. %28%From Adams et al., Principles of Neurology, 6th ed, p801%29%%A%    
% 210.96/211.12  |- skos__altLabel mesh__D014854 Vieseaux-Wallenberg Syndrome
% 210.96/211.12  |- skos__hiddenLabel mesh__D014854 Medullary Syndrome, Dorsolateral
% 210.96/211.12  |- skos__hiddenLabel mesh__D014854 Wallenbergs Syndrome
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D014854 2006
% 210.96/211.12  |- skos__hiddenLabel mesh__D014854 Syndromes, Lateral Medullary
% 210.96/211.12  |- mesh__historyNote mesh__D014854 f f   
% 210.96/211.12  |- mesh__recordMaintainer mesh__D014854 ssb
% 210.96/211.12  |- skos__hiddenLabel mesh__D014854 Syndrome, Vieseaux-Wallenberg
% 210.96/211.12  |- mesh__publicMeSHNote mesh__D014854
% 210.96/211.12       2000 %28%1991%29%; see WALLENBERG%27%S SYNDROME 1991-1999, see CEREBRAL EMBOLISM AND THROMBOSIS 1964-1990%A%  
% 210.96/211.12  |- skos__altLabel mesh__D014854 Lateral Bulbar Syndrome
% 210.96/211.12  |- skos__altLabel mesh__D014854 Dorsolateral Medullary Syndrome
% 210.96/211.12  |- skos__prefLabel mesh__D014854 Lateral Medullary Syndrome
% 210.96/211.12  |- mesh__dateCreated mesh__D014854 1999-01-01
% 210.96/211.12  |- skos__hiddenLabel mesh__D014854 Syndrome, Wallenberg
% 210.96/211.12  |- skos__altLabel mesh__D014854
% 210.96/211.12       Posterior Inferior Cerebellar Artery Syndrome
% 210.96/211.12  |- mesh__recordOriginator mesh__D014854 NLM
% 210.96/211.12  |- skos__altLabel mesh__D014854 Wallenberg Syndrome
% 210.96/211.12  |- mesh__recordAuthorizer mesh__D014854 sjn
% 210.96/211.12  |- skos__broader mesh__D014854smesh__D020526
% 210.96/211.12  |- mesh__dateRevised mesh__D014854 2005-06-30
% 210.96/211.12  |- rdf__type mesh__D014854sskos__Concept
% 210.96/211.12  |- mesh__dateEstablished mesh__D014854 1991-01-01
% 210.96/211.12  |- skos__broader mesh__D047230smesh__D011161
% 210.96/211.12  |- skos__scopeNote mesh__D047230
% 210.96/211.12       A genus of large, brightly colored SPONGES in the family Agelasidae, possessing a skeleton of spongin fibers with a core of large spicules %28%megascleres%29%.%A%    
% 210.96/211.12  |- mesh__publicMeSHNote mesh__D047230 2005   
% 210.96/211.12  |- skos__historyNote mesh__D047230 Porifera %28%1989-2004%29%
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D047230 2006
% 210.96/211.12  |- mesh__recordAuthorizer mesh__D047230 sjn
% 210.96/211.12  |- mesh__historyNote mesh__D047230 2005   
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D047230 2005
% 210.96/211.12  |- mesh__recordMaintainer mesh__D047230 ags
% 210.96/211.12  |- mesh__dateEstablished mesh__D047230 2005-01-01
% 210.96/211.12  |- mesh__recordOriginator mesh__D047230 ags
% 210.96/211.12  |- rdf__type mesh__D047230sskos__Concept
% 210.96/211.12  |- mesh__dateCreated mesh__D047230 2004-07-07
% 210.96/211.12  |- skos__prefLabel mesh__D047230 Agelas
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D014056 2000
% 210.96/211.12  |- mesh__dateRevised mesh__D014056 1997-06-20
% 210.96/211.12  |- mesh__dateEstablished mesh__D014056 1973-01-01
% 210.96/211.12  |- mesh__recordMaintainer mesh__D014056 PXP
% 210.96/211.12  |- skos__altLabel mesh__D014056 Tomography, Transmission
% 210.96/211.12  |- skos__annotation mesh__D014056
% 210.96/211.12       do not use /util except by MeSH definition; DF: TOMOGR X RAY%A%  
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D014056 2006
% 210.96/211.12  |- skos__broader mesh__D014056smesh__D011859
% 210.96/211.12  |- skos__altLabel mesh__D014056 Radiographic Tomography
% 210.96/211.12  |- skos__historyNote mesh__D014056 Tomography %28%1966-1972%29%
% 210.96/211.12  |- mesh__activeMeSHYear mesh__D014056 1999
% 210.96/211.12  |- mesh__onlineNote mesh__D014056
% 210.96/211.12       use TOMOGRAPHY, X-RAY to search TOMOGRAPHY, RADIOGRAPHIC 1973-79; LAMINAGRAPHY X-RAY, PLANIGRAPHY, X-RAY %26% STRATIGRAPHY, X-RAY 1980-96; RADIOGRAPHY, BODY-SECTION 1973-96; LAMINAGRAPHY, RADIOGRAPHIC 1975-79; PLANIGRAPHY, RADIOGRAPHIC %26% STRATIGRAPHY, RADIOGRAPHIC 1973-79%A%  
% 210.96/211.12  |- skos__altLabel mesh__D014056 Tomography, Radiographic
% 210.96/211.12  |- skos__altLabel mesh__D014056 X-Ray Tomography
% 210.96/211.13  |- skos__altLabel mesh__D014056 Transmission Tomography
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D014056 2005
% 210.96/211.13  |- skos__altLabel mesh__D014056 Tomography, Xray
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D014056 2004
% 210.96/211.13  |- mesh__historyNote mesh__D014056
% 210.96/211.13       80; was TOMOGRAPHY, RADIOGRAPHIC 1973-79; LAMINAGRAPHY, X-RAY was see TOMOGRAPHY, X-RAY 1980-96, was LAMINAGRAPHY, RADIOGRAPHIC see TOMOGRAPHY, RADIOGRAPHIC 1975-79; PLANIGRAPHY, X-RAY %26% STRATIGRAPHY, X-RAY were see TOMOGRAPHY, X-RAY 1980-96, were PLANIGRAPHY, RADIOGRAPHIC %26% STRATIGRAPHY, RADIOGRAPHIC see TOMOGRAPHY, RADIOGRAPHIC 1973-79; RADIOGRAPHY, BODY-SECTION was see TOMOGRAPHY, X-RAY 1973-96%A%  
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D014056 2002
% 210.96/211.13  |- skos__broader mesh__D014056smesh__D014054
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D014056 1998
% 210.96/211.13  |- skos__altLabel mesh__D014056 X Ray Tomography
% 210.96/211.13  |- mesh__recordOriginator mesh__D014056 NLM
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D014056 2003
% 210.96/211.13  |- skos__scopeNote mesh__D014056 Tomography using x-ray transmission.     
% 210.96/211.13  |- rdf__type mesh__D014056sskos__Concept
% 210.96/211.13  |- mesh__recordAuthorizer mesh__D014056 SJN
% 210.96/211.13  |- skos__altLabel mesh__D014056 Xray Tomography
% 210.96/211.13  |- mesh__publicMeSHNote mesh__D014056
% 210.96/211.13       80; was TOMOGRAPHY, RADIOGRAPHIC 1973-79; LAMINAGRAPHY, X-RAY was see TOMOGRAPHY, X-RAY 1980-96, was LAMINAGRAPHY, RADIOGRAPHIC see TOMOGRAPHY, RADIOGRAPHIC 1975-96; PLANIGRAPHY, X-RAY %26% STRATIGRAPHY, X-RAY were see TOMOGRAPHY, X-RAY 1980-96, were PLANIGRAPHY, RADIOGRAPHIC %26% STRATIGRAPHY, RADIOGRAPHIC see TOMOGRAPHY, RADIOGRAPHIC 1973-79; RADIOGRAPHY, BODY-SECTION was see TOMOGRAPHY, X-RAY 1973-96%A%  
% 210.96/211.13  |- skos__prefLabel mesh__D014056 Tomography, X-Ray
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D014056 2001
% 210.96/211.13  |- skos__altLabel mesh__D014056 Tomography, X Ray
% 210.96/211.13  |- mesh__dateCreated mesh__D014056 1999-01-01
% 210.96/211.13  |- skos__altLabel mesh__D014056 Zonography
% 210.96/211.13  |- skos__hiddenLabel mesh__D008817 Mouse Strains, Mutant
% 210.96/211.13  |- skos__hiddenLabel mesh__D008817 Mutant Strain Mouse
% 210.96/211.13  |- mesh__recordAuthorizer mesh__D008817 sjn
% 210.96/211.13  |- skos__annotation mesh__D008817
% 210.96/211.13       GEN or unspecified; prefer specifics; NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%  
% 210.96/211.13  |- mesh__recordMaintainer mesh__D008817 ags
% 210.96/211.13  |- skos__hiddenLabel mesh__D008817 Mice Mutant Strain
% 210.96/211.13  |- skos__hiddenLabel mesh__D008817 Mutant Mouse Strains
% 210.96/211.13  |- skos__hiddenLabel mesh__D008817 Strain, Mutant Mouse
% 210.96/211.13  |- skos__hiddenLabel mesh__D008817 Strains Mice, Mutant
% 210.96/211.13  |- skos__altLabel mesh__D008817 Mutant Strains of Mice
% 210.96/211.13  |- skos__prefLabel mesh__D008817 Mice, Mutant Strains
% 210.96/211.13  |- skos__hiddenLabel mesh__D008817 Mouse Mutant Strain
% 210.96/211.13  |- mesh__historyNote mesh__D008817 79   
% 210.96/211.13  |- skos__altLabel mesh__D008817 Mutant Mouse Strain
% 210.96/211.13  |- mesh__dateEstablished mesh__D008817 1979-01-01
% 210.96/211.13  |- mesh__recordOriginator mesh__D008817 EC
% 210.96/211.13  |- skos__hiddenLabel mesh__D008817 Mouse Strain, Mutant
% 210.96/211.13  |- skos__altLabel mesh__D008817 Mutant Strain of Mouse
% 210.96/211.13  |- skos__hiddenLabel mesh__D008817 Mutant Strains Mice
% 210.96/211.13  |- skos__hiddenLabel mesh__D008817 Strain Mouse, Mutant
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D008817 2006
% 210.96/211.13  |- skos__broader mesh__D008817smesh__D051379
% 210.96/211.13  |- mesh__dateCreated mesh__D008817 1978-04-26
% 210.96/211.13  |- skos__hiddenLabel mesh__D008817 Mouse Mutant Strains
% 210.96/211.13  |- rdf__type mesh__D008817sskos__Concept
% 210.96/211.13  |- skos__hiddenLabel mesh__D008817 Mice Mutant Strains
% 210.96/211.13  |- mesh__dateRevised mesh__D008817 2005-06-30
% 210.96/211.13  |- skos__scopeNote mesh__D008817
% 210.96/211.13       Mice bearing mutant genes which are phenotypically expressed in the animals.%A%    
% 210.96/211.13  |- skos__altLabel mesh__D008817 Mouse, Mutant Strain
% 210.96/211.13  |- skos__hiddenLabel mesh__D008817 Strains, Mutant Mouse
% 210.96/211.13  |- mesh__publicMeSHNote mesh__D008817 79   
% 210.96/211.13  |- skos__scopeNote mesh__D008019
% 210.96/211.13       Typical way of life or manner of living characteristic of an individual or group. %28%From APA, Thesaurus of Psychological Index Terms, 8th ed%29%%A%    
% 210.96/211.13  |- skos__hiddenLabel mesh__D008019 Styles, Life
% 210.96/211.13  |- mesh__recordAuthorizer mesh__D008019 jls
% 210.96/211.13  |- skos__hiddenLabel mesh__D008019 Induced Illness, Self
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D008019 2001
% 210.96/211.13  |- mesh__publicMeSHNote mesh__D008019 72   
% 210.96/211.13  |- mesh__historyNote mesh__D008019 72%28%70%29%   
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D008019 2003
% 210.96/211.13  |- skos__hiddenLabel mesh__D008019 Style, Life
% 210.96/211.13  |- skos__hiddenLabel mesh__D008019 Illnesses, Self Induced
% 210.96/211.13  |- skos__hiddenLabel mesh__D008019 Illness, Self Induced
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D008019 2000
% 210.96/211.13  |- skos__hiddenLabel mesh__D008019 Induced Illnesses, Self
% 210.96/211.13  |- mesh__recordMaintainer mesh__D008019 jls
% 210.96/211.13  |- skos__broader mesh__D008019smesh__D011593
% 210.96/211.13  |- skos__related mesh__D008019smesh__D011788
% 210.96/211.13  |- rdf__type mesh__D008019sskos__Concept
% 210.96/211.13  |- skos__hiddenLabel mesh__D008019 Self Induced Illnesses
% 210.96/211.13  |- skos__altLabel mesh__D008019 Lifestyle
% 210.96/211.13  |- skos__prefLabel mesh__D008019 Life Style
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D008019 2006
% 210.96/211.13  |- mesh__dateRevised mesh__D008019 2004-07-28
% 210.96/211.13  |- mesh__recordOriginator mesh__D008019 NLM
% 210.96/211.13  |- mesh__dateEstablished mesh__D008019 1972-01-01
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D008019 2005A
% 210.96/211.13  |- skos__hiddenLabel mesh__D008019 Lifestyles
% 210.96/211.13  |- skos__related mesh__D008019smesh__D015438
% 210.96/211.13  |- skos__hiddenLabel mesh__D008019 Life Styles
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D008019 2005
% 210.96/211.13  |- mesh__dateCreated mesh__D008019 1999-01-01
% 210.96/211.13  |- skos__historyNote mesh__D008019
% 210.96/211.13       Personality Development %28%1968-1969%29%
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D008019 2002
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D008019 2004
% 210.96/211.13  |- rdf__type mesh__D000036sskos__Concept
% 210.96/211.13  |- skos__broader mesh__D000036smesh__D037121
% 210.96/211.13  |- mesh__dateEstablished mesh__D000036 1991-01-01
% 210.96/211.13  |- skos__historyNote mesh__D000036 Plant Proteins %28%1971-1975%29%
% 210.96/211.13  |- mesh__recordOriginator mesh__D000036 NLM
% 210.96/211.13  |- mesh__dateCreated mesh__D000036 1974-11-19
% 210.96/211.13  |- mesh__publicMeSHNote mesh__D000036
% 210.96/211.13       91; was see under PLANT PROTEINS 1975-90   
% 210.96/211.13  |- mesh__dateRevised mesh__D000036 2005-07-29
% 210.96/211.13  |- mesh__recordMaintainer mesh__D000036 jls
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D000036 2006
% 210.96/211.13  |- mesh__recordAuthorizer mesh__D000036 jls
% 210.96/211.13  |- skos__prefLabel mesh__D000036 Abrin
% 210.96/211.13  |- skos__scopeNote mesh__D000036
% 210.96/211.13       A toxic lectin from the seeds of jequirity, Abrus precatorius L. Very active poison. Five different proteins have so far been isolated: Abrus agglutinin, the component responsible for: hemagglutinating activity, %26% abrins a-d, the toxic principals each consisting of two peptide chains are held together by disulfide bonds.%A%    
% 210.96/211.13  |- skos__historyNote mesh__D000036 Disulfides %28%1973-1974%29%
% 210.96/211.13  |- mesh__historyNote mesh__D000036
% 210.96/211.13       91%28%75%29%; was see under PLANT PROTEINS 1975-90   
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D000036 2006A
% 210.96/211.13  |- skos__altLabel mesh__D046936 Black Chokecherry Tree
% 210.96/211.13  |- mesh__dateRevised mesh__D046936 2005-06-30
% 210.96/211.13  |- skos__annotation mesh__D046936
% 210.96/211.13       X ref BLACK CHOKECHERRY TREE: CHOKECHERRY TREE see PRUNUS is also available; coordinate with specific PLANT COMPONENTS term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.96/211.13  |- skos__prefLabel mesh__D046936 Photinia
% 210.96/211.13  |- mesh__historyNote mesh__D046936 2005   
% 210.96/211.13  |- skos__altLabel mesh__D046936 Black Chokeberry Tree
% 210.96/211.13  |- skos__broader mesh__D046936smesh__D027824
% 210.96/211.13  |- mesh__dateEstablished mesh__D046936 2005-01-01
% 210.96/211.13  |- rdf__type mesh__D046936sskos__Concept
% 210.96/211.13  |- skos__altLabel mesh__D046936 Aronia melanocarpa
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D046936 2006
% 210.96/211.13  |- mesh__recordMaintainer mesh__D046936 ssb
% 210.96/211.13  |- mesh__dateCreated mesh__D046936 2004-07-07
% 210.96/211.13  |- mesh__publicMeSHNote mesh__D046936 2005   
% 210.96/211.13  |- mesh__recordOriginator mesh__D046936 ssb
% 210.96/211.13  |- mesh__recordAuthorizer mesh__D046936 sjn
% 210.96/211.13  |- skos__scopeNote mesh__D046936
% 210.96/211.13       A plant genus of the family ROSACEAE. The common names of chokeberry or chokecherry are also used for some species of PRUNUS.%A%    
% 210.96/211.13  |- mesh__publicMeSHNote mesh__D018447 95   
% 210.96/211.13  |- skos__hiddenLabel mesh__D018447 Futile Treatments
% 210.96/211.13  |- mesh__recordAuthorizer mesh__D018447 sjn
% 210.96/211.13  |- skos__historyNote mesh__D018447 Ethics, Medical %28%1990-1994%29%
% 210.96/211.13  |- mesh__historyNote mesh__D018447 95   
% 210.96/211.13  |- skos__hiddenLabel mesh__D018447 Treatments, Futile
% 210.96/211.13  |- mesh__dateRevised mesh__D018447 2003-07-09
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D018447 2006
% 210.96/211.13  |- skos__annotation mesh__D018447 DF: MED FUTILITY   
% 210.96/211.13  |- skos__related mesh__D018447smesh__D016414
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D018447 2004
% 210.96/211.13  |- skos__hiddenLabel mesh__D018447 Treatment, Futile
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D018447 2005
% 210.96/211.13  |- rdf__type mesh__D018447sskos__Concept
% 210.96/211.13  |- mesh__recordMaintainer mesh__D018447 jls
% 210.96/211.13  |- skos__historyNote mesh__D018447 Decision Making %28%1985-1994%29%
% 210.96/211.13  |- mesh__dateEstablished mesh__D018447 1995-01-01
% 210.96/211.13  |- skos__historyNote mesh__D018447 Resuscitation %28%1989%29%
% 210.96/211.13  |- skos__scopeNote mesh__D018447
% 210.96/211.13       The absence of a useful purpose or useful result in a diagnostic procedure or therapeutic intervention. The situation of a patient whose condition will not be improved by treatment or instances in which treatment preserves permanent unconsciousness or cannot end dependence on intensive medical care. %28%From Ann Intern Med 1990 Jun 15;112%28%12%29%:949%29%%A%    
% 210.96/211.13  |- skos__prefLabel mesh__D018447 Medical Futility
% 210.96/211.13  |- skos__altLabel mesh__D018447 Futility, Medical
% 210.96/211.13  |- mesh__recordOriginator mesh__D018447 JLS
% 210.96/211.13  |- mesh__dateCreated mesh__D018447 1994-06-01
% 210.96/211.13  |- skos__broader mesh__D018447smesh__D011379
% 210.96/211.13  |- skos__hiddenLabel mesh__D018447 Futility, Treatment
% 210.96/211.13  |- mesh__historyNote mesh__D010464
% 210.96/211.13       91%28%76%29%; was see under PHENOTHIAZINE TRANQUILIZERS 1976-90%A%  
% 210.96/211.13  |- skos__historyNote mesh__D010464
% 210.96/211.13       Phenothiazine Tranquilizers %28%1973-1975%29%
% 210.96/211.13  |- skos__prefLabel mesh__D010464 Perazine
% 210.96/211.13  |- skos__historyNote mesh__D010464 Piperazines %28%1972-1975%29%
% 210.96/211.13  |- mesh__recordMaintainer mesh__D010464 ssb
% 210.96/211.13  |- mesh__recordOriginator mesh__D010464 SH
% 210.96/211.13  |- skos__altLabel mesh__D010464 Pernazine
% 210.96/211.13  |- mesh__publicMeSHNote mesh__D010464
% 210.96/211.13       91; was see under PHENOTHIAZINE TRANQUILIZERS 1976-90   
% 210.96/211.13  |- rdf__type mesh__D010464sskos__Concept
% 210.96/211.13  |- mesh__dateCreated mesh__D010464 1975-07-25
% 210.96/211.13  |- skos__hiddenLabel mesh__D010464 Maleate, Perazine
% 210.96/211.13  |- mesh__dateRevised mesh__D010464 2005-06-30
% 210.96/211.13  |- mesh__dateEstablished mesh__D010464 1991-01-01
% 210.96/211.13  |- skos__broader mesh__D010464smesh__D010640
% 210.96/211.13  |- skos__scopeNote mesh__D010464
% 210.96/211.13       A phenothiazine antipsychotic with actions and uses similar to those of CHLORPROMAZINE. Extrapyramidal symptoms may be more common than other side effects.%A%    
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D010464 2006
% 210.96/211.13  |- skos__hiddenLabel mesh__D010464 Dihydrochloride, Perazine
% 210.96/211.13  |- mesh__recordAuthorizer mesh__D010464 sjn
% 210.96/211.13  |- skos__hiddenLabel mesh__D037601 Mannan Binding Lectin
% 210.96/211.13  |- mesh__dateCreated mesh__D037601 2002-07-03
% 210.96/211.13  |- skos__prefLabel mesh__D037601 Mannose-Binding Lectin
% 210.96/211.13  |- skos__hiddenLabel mesh__D037601 Mannan Binding Protein
% 210.96/211.13  |- skos__altLabel mesh__D037601 Mannose-Binding Protein
% 210.96/211.13  |- skos__historyNote mesh__D037601 Carrier Proteins %28%1990-2002%29%
% 210.96/211.13  |- skos__altLabel mesh__D037601 Mannan-Binding Protein
% 210.96/211.13  |- mesh__dateRevised mesh__D037601 2005-06-30
% 210.96/211.13  |- skos__altLabel mesh__D037601 Mannan-Binding Lectin
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D037601 2006
% 210.96/211.13  |- skos__scopeNote mesh__D037601
% 210.96/211.13       A specific mannose-binding member of the collectin family of lectins. It binds to carbohydrate groups on invading pathogens and plays a key role in the MANNOSE-BINDING LECTIN COMPLEMENT PATHWAY.%A%    
% 210.96/211.13  |- skos__broader mesh__D037601smesh__D037222
% 210.96/211.13  |- skos__hiddenLabel mesh__D037601 Lectin, Mannan-Binding
% 210.96/211.13  |- mesh__recordOriginator mesh__D037601 jmp
% 210.96/211.13  |- skos__hiddenLabel mesh__D037601 Mannose Binding Lectin
% 210.96/211.13  |- mesh__historyNote mesh__D037601
% 210.96/211.13       2003; for MANNOSE-BINDING LECTIN, MANNAN-BINDING PROTEIN %26% MANNAN-BINDING LECTIN use COLLECTINS 1990-2002%A%  
% 210.96/211.13  |- skos__hiddenLabel mesh__D037601 Mannose Binding Protein
% 210.96/211.13  |- skos__annotation mesh__D037601
% 210.96/211.13       MANNOSE-BINDING LECTINS is also available; see SCR for species specific terms; analogs %26% homologs are not MANNOSE-BINDING LECTINS%A%  
% 210.96/211.13  |- mesh__recordAuthorizer mesh__D037601 sjn
% 210.96/211.13  |- rdf__type mesh__D037601sskos__Concept
% 210.96/211.13  |- mesh__recordMaintainer mesh__D037601 ssb
% 210.96/211.13  |- skos__broader mesh__D037601smesh__D037241
% 210.96/211.13  |- skos__hiddenLabel mesh__D037601 Lectin, Mannose-Binding
% 210.96/211.13  |- mesh__dateEstablished mesh__D037601 2003-01-01
% 210.96/211.13  |- mesh__publicMeSHNote mesh__D037601
% 210.96/211.13       2003; MANNOSE-BINDING LECTIN, MANNAN-BINDING PROTEIN %26% MANNAN-BINDING LECTIN were indexed under CARRIER PROTEINS 1990-2002%A%  
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D004427 2003
% 210.96/211.13  |- mesh__recordOriginator mesh__D004427 NLM
% 210.96/211.13  |- mesh__dateEstablished mesh__D004427 1966-01-01
% 210.96/211.13  |- skos__prefLabel mesh__D004427 Ear Diseases
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D004427 2002
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D004427 2006
% 210.96/211.13  |- mesh__dateRevised mesh__D004427 1997-06-20
% 210.96/211.13  |- rdf__type mesh__D004427sskos__Concept
% 210.96/211.13  |- mesh__publicMeSHNote mesh__D004427 66   
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D004427 2005
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D004427 1999
% 210.96/211.13  |- skos__hiddenLabel mesh__D004427 Ear Disease
% 210.96/211.13  |- skos__annotation mesh__D004427
% 210.96/211.13       GEN only; NIM with coord for diseases of specific parts; /diag: consider also DIAGNOSTIC TECHNIQUES, OTOLOGICAL; inflamm dis = OTITIS and its specifics%A%  
% 210.96/211.13  |- skos__broader mesh__D004427smesh__D010038
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D004427 2001
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D004427 1998
% 210.96/211.13  |- skos__hiddenLabel mesh__D004427 Disease, Ear
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D004427 2000
% 210.96/211.13  |- skos__scopeNote mesh__D004427
% 210.96/211.13       Diseases of the ear, general or unspecified.     
% 210.96/211.13  |- mesh__recordMaintainer mesh__D004427 TGC
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D004427 2004
% 210.96/211.13  |- mesh__historyNote mesh__D004427 66   
% 210.96/211.13  |- skos__hiddenLabel mesh__D004427 Diseases, Ear
% 210.96/211.13  |- mesh__dateCreated mesh__D004427 1999-01-01
% 210.96/211.13  |- mesh__recordAuthorizer mesh__D004427 SJN
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D009910 1997
% 210.96/211.13  |- skos__scopeNote mesh__D009910
% 210.96/211.13       The practice of personal hygiene of the mouth. It includes the maintenance of oral cleanliness, tissue tone, and general preservation of oral health.%A%    
% 210.96/211.13  |- skos__broader mesh__D009910smesh__D011313
% 210.96/211.13  |- mesh__historyNote mesh__D009910
% 210.96/211.13       73; DENTAL HYGIENE was heading 1963-64, was see DENTAL PROPHYLAXIS 1991%A%  
% 210.96/211.13  |- mesh__recordOriginator mesh__D009910 NLM
% 210.96/211.13  |- rdf__type mesh__D009910sskos__Concept
% 210.96/211.13  |- mesh__onlineNote mesh__D009910
% 210.96/211.13       use DENTAL PROPHYLAXIS to search DENTAL HYGIENE 1991   
% 210.96/211.13  |- skos__related mesh__D009910smesh__D003742
% 210.96/211.13  |- skos__altLabel mesh__D009910 Hygiene, Dental
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D009910 1994
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D009910 2000
% 210.96/211.13  |- mesh__dateCreated mesh__D009910 1999-01-01
% 210.96/211.13  |- skos__prefLabel mesh__D009910 Oral Hygiene
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D009910 2001
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D009910 1995
% 210.96/211.13  |- mesh__recordAuthorizer mesh__D009910 PLS
% 210.96/211.13  |- mesh__dateRevised mesh__D009910 1992-12-28
% 210.96/211.13  |- skos__hiddenLabel mesh__D009910 Hygiene, Oral
% 210.96/211.13  |- skos__altLabel mesh__D009910 Dental Hygiene
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D009910 2005
% 210.96/211.13  |- skos__broader mesh__D009910smesh__D006920
% 210.96/211.13  |- mesh__publicMeSHNote mesh__D009910
% 210.96/211.13       73; DENTAL HYGIENE was heading 1963-64, was see DENTAL PROPHYLAXIS 1991%A%  
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D009910 2002
% 210.96/211.13  |- mesh__dateEstablished mesh__D009910 1973-01-01
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D009910 1998
% 210.96/211.13  |- mesh__recordMaintainer mesh__D009910 PLS
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D009910 2003
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D009910 2006
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D009910 1996
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D009910 1999
% 210.96/211.13  |- skos__historyNote mesh__D009910 Oral Health %28%1966-1972%29%
% 210.96/211.13  |- skos__related mesh__D009910smesh__D014099
% 210.96/211.13  |- skos__annotation mesh__D009910
% 210.96/211.13       differentiate from ORAL HEALTH; oral hyg is care toward maintaining good oral health performed by the person himself or a caregiver in the case of invalid or disabled persons; differentiate also from DENTAL CARE, care by professionals; for oral hyg using dental floss, water picks, etc. use DENTAL DEVICES, HOME CARE or TOOTHBRUSHING%A%  
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D009910 2004
% 210.96/211.13  |- mesh__publicMeSHNote mesh__D009112
% 210.96/211.13       91; was see under SUGAR ACIDS 1975-90; was MURAMIC ACID 1973-74 %28%Prov%29%%A%  
% 210.96/211.13  |- mesh__recordMaintainer mesh__D009112 ssb
% 210.96/211.13  |- mesh__recordAuthorizer mesh__D009112 sjn
% 210.96/211.13  |- rdf__type mesh__D009112sskos__Concept
% 210.96/211.13  |- mesh__dateEstablished mesh__D009112 1991-01-01
% 210.96/211.13  |- mesh__onlineNote mesh__D009112
% 210.96/211.13       use MURAMIC ACIDS to search MURAMIC ACID 1973-74 %28%as Prov%29%%A%  
% 210.96/211.13  |- skos__broader mesh__D009112smesh__D000606
% 210.96/211.13  |- mesh__dateCreated mesh__D009112 1999-01-01
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D009112 2006
% 210.96/211.13  |- skos__historyNote mesh__D009112 Hexosamines %28%1966-1972%29%
% 210.96/211.13  |- skos__broader mesh__D009112smesh__D013400
% 210.96/211.13  |- skos__historyNote mesh__D009112 Glucosamine %28%1966-1972%29%
% 210.96/211.13  |- skos__hiddenLabel mesh__D009112 Acids, Muramic
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D009112 2005
% 210.96/211.13  |- mesh__dateRevised mesh__D009112 2004-07-07
% 210.96/211.13  |- mesh__recordOriginator mesh__D009112 NLM
% 210.96/211.13  |- skos__scopeNote mesh__D009112
% 210.96/211.13       Compounds consisting of glucosamine and lactate joined by an ether linkage. They occur naturally as N-acetyl derivatives in peptidoglycan, the characteristic polysaccharide composing bacterial cell walls. %28%From Dorland, 28th ed%29%%A%    
% 210.96/211.13  |- mesh__historyNote mesh__D009112
% 210.96/211.13       91%28%75%29%; was see under SUGAR ACIDS 1975-90; was MURAMIC ACID 1973-74 %28%Prov%29%%A%  
% 210.96/211.13  |- skos__historyNote mesh__D009112 Amino Sugars %28%1966-1970%29%
% 210.96/211.13  |- skos__historyNote mesh__D009112 Disaccharides %28%1971-1972%29%
% 210.96/211.13  |- skos__prefLabel mesh__D009112 Muramic Acids
% 210.96/211.13  |- skos__hiddenLabel mesh__D009112 Acid, Muramic
% 210.96/211.13  |- mesh__recordMaintainer mesh__D020094 SYSTEM
% 210.96/211.13  |- mesh__dateCreated mesh__D020094 1998-06-10
% 210.96/211.13  |- skos__historyNote mesh__D020094 Fungi %28%1965-1981%29%
% 210.96/211.13  |- skos__annotation mesh__D020094
% 210.96/211.13       infection: coord IM with MUCORMYCOSIS %28%IM%29%   
% 210.96/211.13  |- skos__broader mesh__D020094smesh__D009090
% 210.96/211.13  |- rdf__type mesh__D020094sskos__Concept
% 210.96/211.13  |- mesh__historyNote mesh__D020094 99   
% 210.96/211.13  |- mesh__dateRevised mesh__D020094 2005-06-30
% 210.96/211.13  |- skos__prefLabel mesh__D020094 Mortierella
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D020094 2006
% 210.96/211.13  |- skos__scopeNote mesh__D020094
% 210.96/211.13       A genus of zygomycetous fungi of the family Mortierellaceae, order MUCORALES. Its species are abundant in soil and can cause rare infections in humans and animals. Mortierella alpinais is used for production of arachidonic acid.%A%    
% 210.96/211.13  |- mesh__recordAuthorizer mesh__D020094 sjn
% 210.96/211.13  |- mesh__recordOriginator mesh__D020094 AGS
% 210.96/211.13  |- skos__historyNote mesh__D020094 Mucorales %28%1973-1998%29%
% 210.96/211.13  |- mesh__dateEstablished mesh__D020094 1999-01-01
% 210.96/211.13  |- mesh__publicMeSHNote mesh__D020094 99   
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D014855 2006
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D014855 2002
% 210.96/211.13  |- mesh__onlineNote mesh__D014855 search NERVE DEGENERATION 1967-74   
% 210.96/211.13  |- mesh__publicMeSHNote mesh__D014855
% 210.96/211.13       91; was see under NERVE DEGENERATION 1975-90   
% 210.96/211.13  |- skos__hiddenLabel mesh__D014855 Degeneration, Wallerian
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D014855 2005
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D014855 2001
% 210.96/211.13  |- mesh__dateCreated mesh__D014855 1999-01-01
% 210.96/211.13  |- skos__prefLabel mesh__D014855 Wallerian Degeneration
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D014855 2004
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D014855 2000
% 210.96/211.13  |- mesh__historyNote mesh__D014855
% 210.96/211.13       91%28%75%29%; was see under NERVE DEGENERATION 1975-90   
% 210.96/211.13  |- mesh__dateRevised mesh__D014855 1999-11-03
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D014855 2003
% 210.96/211.13  |- rdf__type mesh__D014855sskos__Concept
% 210.96/211.13  |- skos__broader mesh__D014855smesh__D009410
% 210.96/211.13  |- mesh__dateEstablished mesh__D014855 1991-01-01
% 210.96/211.13  |- mesh__recordMaintainer mesh__D014855 KEV
% 210.96/211.13  |- mesh__recordOriginator mesh__D014855 NLM
% 210.96/211.13  |- mesh__recordAuthorizer mesh__D014855 sjn
% 210.96/211.13  |- skos__scopeNote mesh__D014855
% 210.96/211.13       Degeneration of distal aspects of a nerve axon following injury to the cell body or proximal portion of the axon. The process is characterized by fragmentation of the axon and its MYELIN SHEATH.%A%    
% 210.96/211.13  |- mesh__dateEstablished mesh__D047231 2005-01-01
% 210.96/211.13  |- mesh__recordOriginator mesh__D047231 ags
% 210.96/211.13  |- mesh__publicMeSHNote mesh__D047231 2005   
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D047231 2006
% 210.96/211.13  |- skos__scopeNote mesh__D047231
% 210.96/211.13       A genus of massive or globular SPONGES in the family Geodiidae, with large spicules at or near the surface.%A%    
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D047231 2005
% 210.96/211.13  |- skos__historyNote mesh__D047231 Porifera %28%1974-2004%29%
% 210.96/211.13  |- mesh__recordMaintainer mesh__D047231 ags
% 210.96/211.13  |- rdf__type mesh__D047231sskos__Concept
% 210.96/211.13  |- mesh__dateCreated mesh__D047231 2004-07-07
% 210.96/211.13  |- skos__prefLabel mesh__D047231 Geodia
% 210.96/211.13  |- skos__broader mesh__D047231smesh__D011161
% 210.96/211.13  |- mesh__recordAuthorizer mesh__D047231 sjn
% 210.96/211.13  |- mesh__historyNote mesh__D047231 2005   
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Scans, X-Ray CAT
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Computed X-Ray Tomographies
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Tomographies, Xray Computed
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Scan, X-Ray CAT
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Computed Tomographies, Transmission
% 210.96/211.13  |- skos__altLabel mesh__D014057 CAT Scan, X Ray
% 210.96/211.13  |- skos__altLabel mesh__D014057 Electron Beam Tomography
% 210.96/211.13  |- mesh__onlineNote mesh__D014057
% 210.96/211.13       use TOMOGRAPHY, X-RAY COMPUTED to search TOMOGRAPHY, COMPUTERIZED AXIAL 1977-79%A%  
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 X Ray, CT
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Electron Beam Tomographies
% 210.96/211.13  |- skos__altLabel mesh__D014057 CAT Scan, X-Ray
% 210.96/211.13  |- skos__altLabel mesh__D014057 Computerized Tomography, X-Ray
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Xray Computed Tomography
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D014057 2000
% 210.96/211.13  |- skos__scopeNote mesh__D014057
% 210.96/211.13       Tomography using x-ray transmission and a computer algorithm to reconstruct the image.%A%    
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Tomographies, X-Ray Computed
% 210.96/211.13  |- mesh__recordAuthorizer mesh__D014057 SJN
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 X-Ray Tomographies, Computed
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 X-Ray Computed Tomography
% 210.96/211.13  |- skos__altLabel mesh__D014057 CT X Ray
% 210.96/211.13  |- skos__broader mesh__D014057smesh__D014056
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Tomographies, X-Ray Computerized
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Tomographies, Transmission Computed
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Xray Computed Tomographies
% 210.96/211.13  |- skos__historyNote mesh__D014057 Tomography, X-Ray %28%1973-1976%29%
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Computed Tomographies, X-Ray
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Tomographies, Computed X-Ray
% 210.96/211.13  |- mesh__dateRevised mesh__D014057 1998-06-11
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 X Rays, CT
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Computed Tomographies, Xray
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 X-Ray CAT Scan
% 210.96/211.13  |- mesh__recordMaintainer mesh__D014057 NDW
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D014057 2004
% 210.96/211.13  |- skos__altLabel mesh__D014057 Tomography, Xray Computed
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Computed Tomography, Transmission
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Computed X-Ray Tomography
% 210.96/211.13  |- mesh__dateCreated mesh__D014057 1976-04-13
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Tomographies, Electron Beam
% 210.96/211.13  |- skos__broader mesh__D014057smesh__D007090
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 X-Ray CAT Scans
% 210.96/211.13  |- skos__altLabel mesh__D014057 Tomodensitometry
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D014057 2003
% 210.96/211.13  |- rdf__type mesh__D014057sskos__Concept
% 210.96/211.13  |- skos__broader mesh__D014057smesh__D011856
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D014057 2006
% 210.96/211.13  |- skos__altLabel mesh__D014057 X-Ray Tomography, Computed
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D014057 2002
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Tomography, X-Ray Computerized
% 210.96/211.13  |- skos__altLabel mesh__D014057 X Ray Tomography, Computed
% 210.96/211.13  |- skos__altLabel mesh__D014057 Computerized Tomography, X Ray
% 210.96/211.13  |- mesh__publicMeSHNote mesh__D014057
% 210.96/211.13       80; was TOMOGRAPHY, COMPUTERIZED AXIAL 1977-79   
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Tomography, Electron Beam
% 210.96/211.13  |- mesh__dateEstablished mesh__D014057 1977-01-01
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 X-Ray Computerized Tomographies
% 210.96/211.13  |- mesh__historyNote mesh__D014057
% 210.96/211.13       80; was TOMOGRAPHY, COMPUTERIZED AXIAL 1977-79   
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Beam Tomography, Electron
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D014057 2005
% 210.96/211.13  |- skos__annotation mesh__D014057
% 210.96/211.13       uses x-rays %26% computer: do not confuse with TOMOGRAPHY, EMISSION-COMPUTED using radionuclides %26% computer; %22%computed tomography%22% unspecified probably goes here; /instrum: consider also TOMOGRAPHY SCANNERS, X-RAY COMPUTED; DF: CT XRAY%A%  
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Computed Tomography, X-Ray
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 CAT Scans, X-Ray
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Cine CT
% 210.96/211.13  |- mesh__activeMeSHYear mesh__D014057 2001
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Computed Tomography, Xray
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 X-Ray Computed Tomographies
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 CT X Rays
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Tomodensitometries
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Beam Tomographies, Electron
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 X-Ray Computerized Tomography
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Transmission Computed Tomography
% 210.96/211.13  |- mesh__recordOriginator mesh__D014057 SMH
% 210.96/211.13  |- skos__hiddenLabel mesh__D014057 Computerized Tomographies, X-Ray
% 210.96/211.14  |- skos__prefLabel mesh__D014057 Tomography, X-Ray Computed
% 210.96/211.14  |- skos__altLabel mesh__D014057 Tomography, X Ray Computed
% 210.96/211.14  |- skos__hiddenLabel mesh__D014057 Transmission Computed Tomographies
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D014057 1999
% 210.96/211.14  |- skos__hiddenLabel mesh__D014057 Tomography, Computed X-Ray
% 210.96/211.14  |- mesh__recordMaintainer mesh__D008818 ags
% 210.96/211.14  |- skos__altLabel mesh__D008818 Lurcher Mouse
% 210.96/211.14  |- skos__altLabel mesh__D008818 Mouse, Neurologic Mutant
% 210.96/211.14  |- skos__altLabel mesh__D008818 Nervous Mouse
% 210.96/211.14  |- mesh__dateRevised mesh__D008818 2005-06-30
% 210.96/211.14  |- skos__hiddenLabel mesh__D008818 Mice, Weaver
% 210.96/211.14  |- skos__altLabel mesh__D008818 Neurologic Mutant Mice
% 210.96/211.14  |- skos__hiddenLabel mesh__D008818 Mouse, Reeler
% 210.96/211.14  |- mesh__dateCreated mesh__D008818 1978-05-17
% 210.96/211.14  |- skos__broader mesh__D008818smesh__D008817
% 210.96/211.14  |- mesh__recordAuthorizer mesh__D008818 sjn
% 210.96/211.14  |- skos__hiddenLabel mesh__D008818 Mouse, Nervous
% 210.96/211.14  |- mesh__dateEstablished mesh__D008818 1979-01-01
% 210.96/211.14  |- skos__hiddenLabel mesh__D008818 Mouse, Weaver
% 210.96/211.14  |- skos__hiddenLabel mesh__D008818 Mice, Neurologic Mutant
% 210.96/211.14  |- skos__hiddenLabel mesh__D008818 Mouse, Staggerer
% 210.96/211.14  |- skos__hiddenLabel mesh__D008818 Mice, Nervous
% 210.96/211.14  |- skos__hiddenLabel mesh__D008818 Mice, Staggerer
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D008818 2006
% 210.96/211.14  |- skos__hiddenLabel mesh__D008818 Mice, Reeler
% 210.96/211.14  |- mesh__historyNote mesh__D008818 79   
% 210.96/211.14  |- skos__altLabel mesh__D008818 Weaver Mice
% 210.96/211.14  |- skos__annotation mesh__D008818
% 210.96/211.14       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE; MICE, JIMPY %26% MICE, QUAKING, both neurol mutants, are available; DF: MICE NEUROL MUTANTS%A%  
% 210.96/211.14  |- rdf__type mesh__D008818sskos__Concept
% 210.96/211.14  |- skos__hiddenLabel mesh__D008818 Mutant Mice, Neurologic
% 210.96/211.14  |- skos__altLabel mesh__D008818 Neurological Mutant Mouse
% 210.96/211.14  |- skos__hiddenLabel mesh__D008818 Mutant Mouse, Neurologic
% 210.96/211.14  |- mesh__publicMeSHNote mesh__D008818 79   
% 210.96/211.14  |- skos__altLabel mesh__D008818 Reeler Mouse
% 210.96/211.14  |- mesh__recordOriginator mesh__D008818 EC
% 210.96/211.14  |- skos__hiddenLabel mesh__D008818 Neurologic Mutant Mouse
% 210.96/211.14  |- skos__altLabel mesh__D008818 Mice, Neurological Mutants
% 210.96/211.14  |- skos__scopeNote mesh__D008818
% 210.96/211.14       Mice which carry mutant genes for neurologic defects or abnormalities.%A%    
% 210.96/211.14  |- skos__altLabel mesh__D008818 Mouse, Neurological Mutant
% 210.96/211.14  |- skos__historyNote mesh__D008818 Mice, Inbred Strains %28%1972-1978%29%
% 210.96/211.14  |- skos__hiddenLabel mesh__D008818 Mouse, Lurcher
% 210.96/211.14  |- skos__hiddenLabel mesh__D008818 Mice, Lurcher
% 210.96/211.14  |- skos__altLabel mesh__D008818 Staggerer Mouse
% 210.96/211.14  |- skos__prefLabel mesh__D008818 Mice, Neurologic Mutants
% 210.96/211.14  |- skos__scopeNote mesh__D000835
% 210.96/211.14       Animals considered to be wild or feral or not adapted for domestic use. It does not include wild animals in zoos for which ANIMALS, ZOO is available.%A%    
% 210.96/211.14  |- skos__broader mesh__D000835smesh__D000828
% 210.96/211.14  |- skos__annotation mesh__D000835
% 210.96/211.14       GEN or unspecified; do not index as coord with animals ordinarily considered wild, as LIONS; BEARS; etc.; coord IM with animal not usually wild %28%IM%29% as wild dogs; IM; qualif permitted; do not forget also to check tag ANIMALS%A%  
% 210.96/211.14  |- skos__historyNote mesh__D000835 Animals %28%1966-1977%29%
% 210.96/211.14  |- mesh__dateEstablished mesh__D000835 1987-01-01
% 210.96/211.14  |- skos__hiddenLabel mesh__D000835 Animal, Nondomestic
% 210.96/211.14  |- mesh__recordOriginator mesh__D000835 EC
% 210.96/211.14  |- skos__prefLabel mesh__D000835 Animals, Wild
% 210.96/211.14  |- skos__hiddenLabel mesh__D000835 Wild Animal
% 210.96/211.14  |- skos__hiddenLabel mesh__D000835 Animal, Wild
% 210.96/211.14  |- mesh__dateRevised mesh__D000835 2003-07-30
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D000835 2004
% 210.96/211.14  |- rdf__type mesh__D000835sskos__Concept
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D000835 2006
% 210.96/211.14  |- mesh__recordAuthorizer mesh__D000835 sjn
% 210.96/211.14  |- mesh__recordMaintainer mesh__D000835 ags
% 210.96/211.14  |- skos__hiddenLabel mesh__D000835 Wild Animals
% 210.96/211.14  |- skos__hiddenLabel mesh__D000835 Nondomestic Animals
% 210.96/211.14  |- mesh__dateCreated mesh__D000835 1977-05-12
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D000835 2005
% 210.96/211.14  |- mesh__publicMeSHNote mesh__D000835 87; was see under ANIMALS 1978-86   
% 210.96/211.14  |- mesh__historyNote mesh__D000835
% 210.96/211.14       87%28%78%29%; was see under ANIMALS 1978-86   
% 210.96/211.14  |- skos__hiddenLabel mesh__D000835 Nondomestic Animal
% 210.96/211.14  |- skos__altLabel mesh__D019540 AUC
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D019540 2005
% 210.96/211.14  |- mesh__dateCreated mesh__D019540 1996-06-13
% 210.96/211.14  |- rdf__type mesh__D019540sskos__Concept
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D019540 2001
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D019540 2004
% 210.96/211.14  |- mesh__dateEstablished mesh__D019540 1997-01-01
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D019540 2000
% 210.96/211.14  |- skos__hiddenLabel mesh__D019540 Under Curves, Area
% 210.96/211.14  |- skos__broader mesh__D019540smesh__D010599
% 210.96/211.14  |- skos__hiddenLabel mesh__D019540 Under Curve, Area
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D019540 2003
% 210.96/211.14  |- skos__prefLabel mesh__D019540 Area Under Curve
% 210.96/211.14  |- mesh__publicMeSHNote mesh__D019540 97   
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D019540 1999
% 210.96/211.14  |- skos__broader mesh__D019540smesh__D013223
% 210.96/211.14  |- skos__hiddenLabel mesh__D019540 Area Under Curves
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D019540 1998
% 210.96/211.14  |- skos__scopeNote mesh__D019540
% 210.96/211.14       A statistical means of summarizing information from a series of measurements on one individual. It is frequently used in clinical pharmacology where the AUC from serum levels can be interpreted as the total uptake of whatever has been administered. As a plot of the concentration of a drug against time, after a single dose of medicine, producing a standard shape curve, it is a means of comparing the bioavailability of the same drug made by different companies. %28%From Winslade, Dictionary of Clinical Research, 1992%29%%A%    
% 210.96/211.14  |- skos__hiddenLabel mesh__D019540 Curve, Area Under
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D019540 1997
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D019540 2006
% 210.96/211.14  |- skos__hiddenLabel mesh__D019540 Curves, Area Under
% 210.96/211.14  |- skos__annotation mesh__D019540
% 210.96/211.14       a measure of drug bioavailability after a single dose; DF: note short X ref%A%  
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D019540 2002
% 210.96/211.14  |- mesh__historyNote mesh__D019540 97   
% 210.96/211.14  |- mesh__recordMaintainer mesh__D000037 lkt
% 210.96/211.14  |- mesh__recordAuthorizer mesh__D000037 sjn
% 210.96/211.14  |- skos__hiddenLabel mesh__D000037 Abruption, Placental
% 210.96/211.14  |- mesh__recordOriginator mesh__D000037 NLM
% 210.96/211.14  |- mesh__dateRevised mesh__D000037 2005-06-30
% 210.96/211.14  |- skos__prefLabel mesh__D000037 Abruptio Placentae
% 210.96/211.14  |- mesh__dateCreated mesh__D000037 1999-01-01
% 210.96/211.14  |- skos__altLabel mesh__D000037 Placental Abruption
% 210.96/211.14  |- skos__scopeNote mesh__D000037
% 210.96/211.14       Premature separation of the normally implanted PLACENTA from the UTERUS. Signs of varying degree of severity include UTERINE BLEEDING, uterine MUSCLE HYPERTONIA, and FETAL DISTRESS or FETAL DEATH.%A%    
% 210.96/211.14  |- skos__hiddenLabel mesh__D000037 Placental Abruptions
% 210.96/211.14  |- skos__hiddenLabel mesh__D000037 Abruptions, Placental
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D000037 2006
% 210.96/211.14  |- skos__broader mesh__D000037smesh__D007744
% 210.96/211.14  |- rdf__type mesh__D000037sskos__Concept
% 210.96/211.14  |- skos__broader mesh__D000037smesh__D010922
% 210.96/211.14  |- skos__scopeNote mesh__D005520
% 210.96/211.14       Substances capable of inhibiting, retarding or arresting the process of fermentation, acidification or other deterioration of foods.%A%    
% 210.96/211.14  |- skos__annotation mesh__D005520 D25-26 qualif   
% 210.96/211.14  |- mesh__recordMaintainer mesh__D005520 ssb
% 210.96/211.14  |- mesh__publicMeSHNote mesh__D005520 75   
% 210.96/211.14  |- skos__related mesh__D005520smesh__D000975
% 210.96/211.14  |- mesh__recordOriginator mesh__D005520 NLM
% 210.96/211.14  |- mesh__dateRevised mesh__D005520 2003-07-09
% 210.96/211.14  |- rdf__type mesh__D005520sskos__Concept
% 210.96/211.14  |- skos__prefLabel mesh__D005520 Food Preservatives
% 210.96/211.14  |- skos__historyNote mesh__D005520 Food Additives %28%1966-1974%29%
% 210.96/211.14  |- mesh__dateCreated mesh__D005520 1974-11-19
% 210.96/211.14  |- mesh__historyNote mesh__D005520 75   
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D005520 2004
% 210.96/211.14  |- mesh__recordAuthorizer mesh__D005520 sjn
% 210.96/211.14  |- skos__broader mesh__D005520smesh__D005503
% 210.96/211.14  |- skos__hiddenLabel mesh__D005520 Preservatives, Food
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D005520 2006
% 210.96/211.14  |- mesh__dateEstablished mesh__D005520 1975-09-01
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D005520 2005
% 210.96/211.14  |- skos__scopeNote mesh__D052176
% 210.96/211.14       Compounds based on a seven-membered ring fused to a five-membered ring. Heat can rearrange them to NAPHTHALENES which have two fused six-membered rings. They are similar to guaiazulenes which are SESQUITERPENES with a six-membered ring fused to a five-membered ring.%A%    
% 210.96/211.14  |- skos__broader mesh__D052176smesh__D011084
% 210.96/211.14  |- mesh__dateEstablished mesh__D052176 2006-01-01
% 210.96/211.14  |- rdf__type mesh__D052176sskos__Concept
% 210.96/211.14  |- mesh__dateCreated mesh__D052176 2005-06-30
% 210.96/211.14  |- mesh__historyNote mesh__D052176 2006   
% 210.96/211.14  |- mesh__recordAuthorizer mesh__D052176 sjn
% 210.96/211.14  |- skos__broader mesh__D052176smesh__D003508
% 210.96/211.14  |- mesh__publicMeSHNote mesh__D052176 2006   
% 210.96/211.14  |- skos__altLabel mesh__D052176 Cyclopentacycloheptenes
% 210.96/211.14  |- mesh__recordMaintainer mesh__D052176 ssb
% 210.96/211.14  |- skos__historyNote mesh__D052176 Cycloheptanes %28%1968-2005%29%
% 210.96/211.14  |- mesh__recordOriginator mesh__D052176 ssb
% 210.96/211.14  |- skos__prefLabel mesh__D052176 Azulenes
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D052176 2006
% 210.96/211.14  |- mesh__recordOriginator mesh__D046937 ags
% 210.96/211.14  |- mesh__recordAuthorizer mesh__D046937 sjn
% 210.96/211.14  |- mesh__recordMaintainer mesh__D046937 ags
% 210.96/211.14  |- mesh__dateRevised mesh__D046937 2005-06-30
% 210.96/211.14  |- skos__broader mesh__D046937smesh__D000458
% 210.96/211.14  |- rdf__type mesh__D046937sskos__Concept
% 210.96/211.14  |- skos__prefLabel mesh__D046937 Nostoc
% 210.96/211.14  |- mesh__historyNote mesh__D046937 2005   
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D046937 2006
% 210.96/211.14  |- skos__historyNote mesh__D046937 Cyanobacteria %28%1971-2004%29%
% 210.96/211.14  |- mesh__dateCreated mesh__D046937 2004-07-07
% 210.96/211.14  |- mesh__publicMeSHNote mesh__D046937 2005   
% 210.96/211.14  |- mesh__dateEstablished mesh__D046937 2005-01-01
% 210.96/211.14  |- skos__scopeNote mesh__D046937
% 210.96/211.14       A form-genus of CYANOBACTERIA in the order Nostocales. Trichomes composed of spherical or ovoid vegetative cells along with heterocysts and akinetes. The species form symbiotic associations with a wide range of eukaryotes.%A%    
% 210.96/211.14  |- skos__hiddenLabel mesh__D018448 Model, Immunological
% 210.96/211.14  |- skos__prefLabel mesh__D018448 Models, Immunological
% 210.96/211.14  |- mesh__historyNote mesh__D018448 95   
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D018448 2000
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D018448 1997
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D018448 1998
% 210.96/211.14  |- skos__altLabel mesh__D018448 Immunological Models
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D018448 2006
% 210.96/211.14  |- mesh__publicMeSHNote mesh__D018448 95   
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D018448 1996
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D018448 2004
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D018448 2005
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D018448 2002
% 210.96/211.14  |- rdf__type mesh__D018448sskos__Concept
% 210.96/211.14  |- skos__altLabel mesh__D018448 Model, Immunologic
% 210.96/211.14  |- skos__annotation mesh__D018448
% 210.96/211.14       no qualif; TN 128: definition of MODELS, BIOLOGICAL; DF: MODELS IMMUNOL%A%  
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D018448 1995
% 210.96/211.14  |- skos__hiddenLabel mesh__D018448 Immunological Model
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D018448 2003
% 210.96/211.14  |- skos__altLabel mesh__D018448 Immunologic Model
% 210.96/211.14  |- skos__historyNote mesh__D018448 Models, Biological %28%1967-1994%29%
% 210.96/211.14  |- skos__broader mesh__D018448smesh__D008954
% 210.96/211.14  |- skos__hiddenLabel mesh__D018448 Models, Immunologic
% 210.96/211.14  |- skos__hiddenLabel mesh__D018448 Immunologic Models
% 210.96/211.14  |- mesh__dateCreated mesh__D018448 1994-01-25
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D018448 2001
% 210.96/211.14  |- skos__scopeNote mesh__D018448
% 210.96/211.14       Theoretical representations that simulate the behavior or activity of immune system, processes, or phenomena. They include the use of mathematical equations, computers, and other electrical equipment.%A%    
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D018448 1999
% 210.96/211.14  |- mesh__dateEstablished mesh__D018448 1995-01-01
% 210.96/211.14  |- mesh__recordOriginator mesh__D010465 NLM
% 210.96/211.14  |- skos__scopeNote mesh__D010465
% 210.96/211.14       The process by which the nature and meaning of sensory stimuli are recognized and interpreted.%A%    
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D010465 2005
% 210.96/211.14  |- mesh__recordMaintainer mesh__D010465 lkt
% 210.96/211.14  |- skos__annotation mesh__D010465 general; prefer specifics   
% 210.96/211.14  |- rdf__type mesh__D010465sskos__Concept
% 210.96/211.14  |- skos__prefLabel mesh__D010465 Perception
% 210.96/211.14  |- mesh__recordAuthorizer mesh__D010465 sjn
% 210.96/211.14  |- skos__broader mesh__D010465smesh__D008606
% 210.96/211.14  |- skos__hiddenLabel mesh__D010465 Perceptions
% 210.96/211.14  |- skos__related mesh__D010465smesh__D012677
% 210.96/211.14  |- mesh__dateRevised mesh__D010465 2004-07-07
% 210.96/211.14  |- mesh__dateCreated mesh__D010465 1999-01-01
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D010465 2006
% 210.96/211.14  |- mesh__dateEstablished mesh__D037602 2003-01-01
% 210.96/211.14  |- mesh__dateCreated mesh__D037602 2002-07-03
% 210.96/211.14  |- mesh__historyNote mesh__D037602 2003   
% 210.96/211.14  |- mesh__publicMeSHNote mesh__D037602 2003   
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D037602 2006
% 210.96/211.14  |- skos__annotation mesh__D037602
% 210.96/211.14       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.96/211.14  |- skos__prefLabel mesh__D037602 Isodon
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D037602 2005
% 210.96/211.14  |- rdf__type mesh__D037602sskos__Concept
% 210.96/211.14  |- skos__broader mesh__D037602smesh__D019686
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D037602 2004
% 210.96/211.14  |- skos__scopeNote mesh__D037602
% 210.96/211.14       A plant genus of the family LAMIACEAE. Members contain ent-kaurene type DITERPENES.%A%    
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D037602 2003
% 210.96/211.14  |- mesh__historyNote mesh__D004428 66   
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D004428 2006
% 210.96/211.14  |- rdf__type mesh__D004428sskos__Concept
% 210.96/211.14  |- skos__altLabel mesh__D004428 Cancer of Ear
% 210.96/211.14  |- skos__hiddenLabel mesh__D004428 Neoplasm, Auricular
% 210.96/211.14  |- skos__hiddenLabel mesh__D004428 Cancer, Ear
% 210.96/211.14  |- skos__altLabel mesh__D004428 Neoplasms, Auricular
% 210.96/211.14  |- mesh__publicMeSHNote mesh__D004428 66   
% 210.96/211.14  |- mesh__recordAuthorizer mesh__D004428 sjn
% 210.96/211.14  |- mesh__recordOriginator mesh__D004428 NLM
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D004428 2005
% 210.96/211.14  |- mesh__dateEstablished mesh__D004428 1966-01-01
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D004428 2002
% 210.96/211.14  |- skos__hiddenLabel mesh__D004428 Cancer, Auricular
% 210.96/211.14  |- skos__altLabel mesh__D004428 Cancer of the Ear
% 210.96/211.14  |- skos__hiddenLabel mesh__D004428 Cancers, Ear
% 210.96/211.14  |- skos__altLabel mesh__D004428 Neoplasms, Ear
% 210.96/211.14  |- skos__broader mesh__D004428smesh__D004427
% 210.96/211.14  |- skos__hiddenLabel mesh__D004428 Neoplasm, Ear
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D004428 2004
% 210.96/211.14  |- skos__prefLabel mesh__D004428 Ear Neoplasms
% 210.96/211.14  |- mesh__dateRevised mesh__D004428 1999-11-04
% 210.96/211.14  |- mesh__dateCreated mesh__D004428 1999-01-01
% 210.96/211.14  |- skos__hiddenLabel mesh__D004428 Ear Cancers
% 210.96/211.14  |- skos__scopeNote mesh__D004428
% 210.96/211.14       Tumors or cancer of the internal, external, or middle ear.%A%    
% 210.96/211.14  |- skos__hiddenLabel mesh__D004428 Ear Neoplasm
% 210.96/211.14  |- skos__hiddenLabel mesh__D004428 Cancers, Auricular
% 210.96/211.14  |- skos__altLabel mesh__D004428 Auricular Neoplasms
% 210.96/211.14  |- skos__altLabel mesh__D004428 Ear Cancer
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D004428 2001
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D004428 2003
% 210.96/211.14  |- skos__hiddenLabel mesh__D004428 Auricular Neoplasm
% 210.96/211.14  |- mesh__recordMaintainer mesh__D004428 KEV
% 210.96/211.14  |- skos__broader mesh__D004428smesh__D010039
% 210.96/211.14  |- skos__annotation mesh__D004428
% 210.96/211.14       coord IM with specific ear term %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 210.96/211.14  |- skos__hiddenLabel mesh__D004428 Auricular Cancers
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D004428 2000
% 210.96/211.14  |- mesh__dateRevised mesh__D015150 2001-07-25
% 210.96/211.14  |- skos__hiddenLabel mesh__D015150 Doppler Echocardiography, 2 D
% 210.96/211.14  |- skos__altLabel mesh__D015150 Continuous Doppler Echocardiography
% 210.96/211.14  |- skos__altLabel mesh__D015150 Doppler Echocardiography
% 210.96/211.14  |- mesh__dateCreated mesh__D015150 1988-03-21
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D015150 2005
% 210.96/211.14  |- skos__scopeNote mesh__D015150
% 210.96/211.14       Measurement of intracardiac blood flow using an M-mode and/or two-dimensional %28%2-D%29% echocardiogram while simultaneously recording the spectrum of the audible Doppler signal %28%e.g., velocity, direction, amplitude, intensity, timing%29% reflected from the moving column of red blood cells.%A%    
% 210.96/211.14  |- mesh__recordAuthorizer mesh__D015150 sjn
% 210.96/211.14  |- skos__broader mesh__D015150smesh__D004452
% 210.96/211.14  |- rdf__type mesh__D015150sskos__Concept
% 210.96/211.14  |- skos__altLabel mesh__D015150 Two-Dimensional Doppler Echocardiography
% 210.96/211.14  |- skos__altLabel mesh__D015150 Doppler Echocardiography, Two-Dimensional
% 210.96/211.14  |- mesh__recordOriginator mesh__D015150 SCD
% 210.96/211.14  |- skos__altLabel mesh__D015150 Doppler Echocardiography, Continuous
% 210.96/211.14  |- skos__hiddenLabel mesh__D015150 2 D Doppler Echocardiography
% 210.96/211.14  |- mesh__publicMeSHNote mesh__D015150
% 210.96/211.14       89; was DOPPLER ECHOCARDIOGRAPHY see ECHOCARDIOGRAPHY 1985-88%A%  
% 210.96/211.14  |- skos__altLabel mesh__D015150 Echocardiography, 2D Doppler
% 210.96/211.14  |- skos__altLabel mesh__D015150 Doppler Echocardiography, 2D
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D015150 2004
% 210.96/211.14  |- mesh__recordMaintainer mesh__D015150 nns
% 210.96/211.14  |- skos__hiddenLabel mesh__D015150 Echocardiography, 2 D Doppler
% 210.96/211.14  |- skos__annotation mesh__D015150
% 210.96/211.14       GEN or unspecified; prefer specifics; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ECHOCARDIOGR DOPPLER%A%  
% 210.96/211.14  |- skos__historyNote mesh__D015150 Ultrasonic Diagnosis %28%1985-1988%29%
% 210.96/211.14  |- mesh__historyNote mesh__D015150
% 210.96/211.14       89; was DOPPLER ECHOCARDIOGRAPHY see ECHOCARDIOGRAPHY 1985-88%A%  
% 210.96/211.14  |- skos__altLabel mesh__D015150 Doppler Echocardiography, 2-D
% 210.96/211.14  |- skos__hiddenLabel mesh__D015150 Two Dimensional Doppler Echocardiography
% 210.96/211.14  |- skos__altLabel mesh__D015150 Echocardiography, 2-D Doppler
% 210.96/211.14  |- skos__altLabel mesh__D015150 Echocardiography, Two-Dimensional Doppler
% 210.96/211.14  |- skos__hiddenLabel mesh__D015150
% 210.96/211.14       Doppler Echocardiography, Two Dimensional
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D015150 2003
% 210.96/211.14  |- skos__historyNote mesh__D015150 Echocardiography %28%1966-1988%29%
% 210.96/211.14  |- skos__historyNote mesh__D015150 Ultrasonics %28%1966-1988%29%
% 210.96/211.14  |- skos__altLabel mesh__D015150 2-D Doppler Echocardiography
% 210.96/211.14  |- skos__broader mesh__D015150smesh__D018608
% 210.96/211.14  |- skos__prefLabel mesh__D015150 Echocardiography, Doppler
% 210.96/211.14  |- mesh__dateEstablished mesh__D015150 1989-01-01
% 210.96/211.14  |- skos__hiddenLabel mesh__D015150
% 210.96/211.14       Echocardiography, Two Dimensional Doppler
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D015150 2002
% 210.96/211.14  |- mesh__onlineNote mesh__D015150
% 210.96/211.14       use ECHOCARDIOGRAPHY to search DOPPLER ECHOCARDIOGRAPHY 1985-88%A%  
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D015150 2006
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D009911 1999
% 210.96/211.14  |- skos__hiddenLabel mesh__D009911 Hygiene Indexe, Oral
% 210.96/211.14  |- skos__broader mesh__D009911smesh__D003753
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D009911 2003
% 210.96/211.14  |- skos__hiddenLabel mesh__D009911 Oral Hygiene Indices
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D009911 1993
% 210.96/211.14  |- skos__prefLabel mesh__D009911 Oral Hygiene Index
% 210.96/211.14  |- mesh__dateCreated mesh__D009911 1999-01-01
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D009911 1996
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D009911 1995
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D009911 2005
% 210.96/211.14  |- skos__annotation mesh__D009911 no qualif   
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D009911 1998
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D009911 2002
% 210.96/211.14  |- mesh__dateRevised mesh__D009911 1992-05-22
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D009911 1994
% 210.96/211.14  |- mesh__publicMeSHNote mesh__D009911
% 210.96/211.14       91; was see under DENTAL HEALTH SURVEYS 1975-90   
% 210.96/211.14  |- rdf__type mesh__D009911sskos__Concept
% 210.96/211.14  |- skos__hiddenLabel mesh__D009911 Indexes, Oral Hygiene
% 210.96/211.14  |- mesh__recordAuthorizer mesh__D009911 PLS
% 210.96/211.14  |- skos__scopeNote mesh__D009911
% 210.96/211.14       A combination of the debris index and the dental calculus index to determine the status of oral hygiene.%A%    
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D009911 2001
% 210.96/211.14  |- mesh__recordOriginator mesh__D009911 NLM
% 210.96/211.14  |- mesh__recordMaintainer mesh__D009911 PLS
% 210.96/211.14  |- skos__hiddenLabel mesh__D009911 Index, Oral Hygiene
% 210.96/211.14  |- skos__hiddenLabel mesh__D009911 Oral Hygiene Indexe
% 210.96/211.14  |- mesh__onlineNote mesh__D009911
% 210.96/211.14       use DENTAL HEALTH SURVEYS to search ORAL HYGIENE INDEX 1973-74%A%  
% 210.96/211.14  |- skos__hiddenLabel mesh__D009911 Indices, Oral Hygiene
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D009911 2000
% 210.96/211.14  |- skos__hiddenLabel mesh__D009911 Hygiene Indexes, Oral
% 210.96/211.14  |- skos__altLabel mesh__D009911 Oral Hygiene Indexes
% 210.96/211.14  |- skos__hiddenLabel mesh__D009911 Indexe, Oral Hygiene
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D009911 2004
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D009911 1997
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D009911 2006
% 210.96/211.14  |- mesh__dateEstablished mesh__D009911 1991-01-01
% 210.96/211.14  |- mesh__historyNote mesh__D009911
% 210.96/211.14       91%28%75%29%; was see under DENTAL HEALTH SURVEYS 1975-90   
% 210.96/211.14  |- mesh__dateCreated mesh__D009113 1999-01-01
% 210.96/211.14  |- skos__hiddenLabel mesh__D009113 Glycanhydrolase, N-Acetylmuramide
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D009113 2006
% 210.96/211.14  |- mesh__recordOriginator mesh__D009113 NLM
% 210.96/211.14  |- skos__altLabel mesh__D009113 Lysozyme
% 210.96/211.14  |- skos__altLabel mesh__D009113 N-Acetylmuramide Glycanhydrolase
% 210.96/211.14  |- mesh__dateRevised mesh__D009113 2003-07-09
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D009113 2005
% 210.96/211.14  |- skos__broader mesh__D009113smesh__D006026
% 210.96/211.14  |- mesh__recordMaintainer mesh__D009113 ssb
% 210.96/211.14  |- mesh__recordAuthorizer mesh__D009113 sjn
% 210.96/211.14  |- skos__hiddenLabel mesh__D009113 N Acetylmuramide Glycanhydrolase
% 210.96/211.14  |- skos__annotation mesh__D009113 an anti-infective glycoside hydrolase   
% 210.96/211.14  |- skos__scopeNote mesh__D009113
% 210.96/211.14       A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17.%A%    
% 210.96/211.14  |- rdf__type mesh__D009113sskos__Concept
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D009113 2004
% 210.96/211.14  |- skos__prefLabel mesh__D009113 Muramidase
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D001130 2006
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D001130 2003
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D001130 2001
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D001130 1999
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D001130 2005
% 210.96/211.14  |- rdf__type mesh__D001130sskos__Concept
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D001130 1998
% 210.96/211.14  |- mesh__recordMaintainer mesh__D001130 PXP
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D001130 2000
% 210.96/211.14  |- skos__prefLabel mesh__D001130 Arizona
% 210.96/211.14  |- mesh__recordOriginator mesh__D001130 NLM
% 210.96/211.14  |- skos__broader mesh__D001130smesh__D015206
% 210.96/211.14  |- mesh__recordAuthorizer mesh__D001130 SJN
% 210.96/211.14  |- mesh__dateRevised mesh__D001130 1997-06-20
% 210.96/211.14  |- mesh__dateCreated mesh__D001130 1999-01-01
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D001130 2004
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D001130 2002
% 210.96/211.14  |- skos__hiddenLabel mesh__D020893 Proto Oncogene Protein c erbB 3
% 210.96/211.14  |- skos__hiddenLabel mesh__D020893 HER 3 Proto Oncogene Protein
% 210.96/211.14  |- mesh__activeMeSHYear mesh__D020893 2006
% 210.96/211.14  |- skos__historyNote mesh__D020893
% 210.96/211.14       Proto-Oncogene Proteins %28%1993-1999%29%
% 210.96/211.14  |- skos__hiddenLabel mesh__D020893 Receptor, erbB 3
% 210.96/211.14  |- skos__broader mesh__D020893smesh__D014408
% 210.96/211.14  |- skos__historyNote mesh__D020893
% 210.96/211.14       Receptor, Epidermal Growth Factor %28%1990-1999%29%
% 210.96/211.14  |- mesh__publicMeSHNote mesh__D020893
% 210.96/211.14       2000; PROTO-ONCOGENE PROTEIN ERBB-3 %28%now RECEPTOR, ERBB-3%29% was indexed under EPIDERMAL GROWTH FACTOR RECEPTOR PROTEIN-TYROSINE KINASE 1993-1999 %26% PROTO-ONCOGENE PROTEINS 1990-1999%A%  
% 210.96/211.14  |- skos__hiddenLabel mesh__D020893 erbB-3, Proto-Oncogene Protein
% 210.96/211.14  |- skos__scopeNote mesh__D020893
% 210.96/211.14       A cell surface protein-tyrosine kinase receptor that is specific for NEUREGULINS. It has extensive homology to and can heterodimerize with the EGF Receptor %28%RECEPTOR, EPIDERMAL GROWTH FACTOR%29% and the erbB-2 receptor %28%RECEPTOR, ERBB-2%29%. Overexpression of the erbB-3 receptor is associated with tumorigenesis.%A%    
% 210.96/211.14  |- skos__broader mesh__D020893smesh__D020794
% 210.96/211.14  |- skos__hiddenLabel mesh__D020893 erbB-3 Receptor
% 210.96/211.14  |- skos__altLabel mesh__D020893 HER-3 Proto-Oncogene Protein
% 210.96/211.14  |- mesh__dateCreated mesh__D020893 1999-11-03
% 210.96/211.14  |- mesh__recordMaintainer mesh__D020893 jmp
% 210.96/211.14  |- skos__altLabel mesh__D020893 Proto-Oncogene Protein c-erbB-3
% 210.96/211.14  |- skos__hiddenLabel mesh__D020893 Proto Oncogene Proteins erbB 3
% 210.96/211.14  |- skos__hiddenLabel mesh__D020893 Proto-Oncogene Protein, HER-3
% 210.96/211.14  |- skos__hiddenLabel mesh__D020893 c-erbB-3, Proto-Oncogene Protein
% 210.96/211.14  |- skos__altLabel mesh__D020893 c-erbB-3 Protein
% 210.96/211.14  |- skos__broader mesh__D020893smesh__D011518
% 210.96/211.14  |- skos__hiddenLabel mesh__D020893 erbB-3, Proto-Oncogene Proteins
% 210.96/211.14  |- skos__altLabel mesh__D020893 Proto-Oncogene Proteins erbB-3
% 210.96/211.14  |- mesh__recordOriginator mesh__D020893 jmp
% 210.96/211.14  |- skos__altLabel mesh__D020893 erbB-3 Protein
% 210.96/211.14  |- mesh__recordAuthorizer mesh__D020893 sjn
% 210.96/211.14  |- skos__hiddenLabel mesh__D020893 erbB 3 Protein
% 210.96/211.14  |- skos__hiddenLabel mesh__D020893 c erbB 3 Protein
% 210.96/211.14  |- skos__prefLabel mesh__D020893 Receptor, erbB-3
% 210.96/211.14  |- rdf__type mesh__D020893sskos__Concept
% 210.96/211.14  |- mesh__dateRevised mesh__D020893 2005-06-30
% 210.96/211.15  |- mesh__historyNote mesh__D020893
% 210.96/211.15       2000; use RECEPTOR, ERBB-3 %28%NM%29% 1990-1999   
% 210.96/211.15  |- skos__hiddenLabel mesh__D020893 Proto Oncogene Protein erbB 3
% 210.96/211.15  |- mesh__dateEstablished mesh__D020893 2000-01-01
% 210.96/211.15  |- skos__broader mesh__D020893smesh__D017978
% 210.96/211.15  |- skos__altLabel mesh__D020893 Proto-Oncogene Protein erbB-3
% 210.96/211.15  |- skos__scopeNote mesh__D020095
% 210.96/211.15       A genus of zygomycetous fungi, family Mucoraceae, order MUCORALES, which sometimes causes infection in humans.%A%    
% 210.96/211.15  |- mesh__dateEstablished mesh__D020095 1999-01-01
% 210.96/211.15  |- skos__broader mesh__D020095smesh__D009090
% 210.96/211.15  |- rdf__type mesh__D020095sskos__Concept
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D020095 2006
% 210.96/211.15  |- mesh__dateCreated mesh__D020095 1998-06-10
% 210.96/211.15  |- skos__annotation mesh__D020095
% 210.96/211.15       infection: coord IM with MUCORMYCOSIS %28%IM%29%   
% 210.96/211.15  |- mesh__historyNote mesh__D020095 99   
% 210.96/211.15  |- mesh__dateRevised mesh__D020095 2005-06-30
% 210.96/211.15  |- skos__prefLabel mesh__D020095 Absidia
% 210.96/211.15  |- mesh__recordAuthorizer mesh__D020095 sjn
% 210.96/211.15  |- mesh__publicMeSHNote mesh__D020095 99   
% 210.96/211.15  |- skos__historyNote mesh__D020095 Mucorales %28%1975-1998%29%
% 210.96/211.15  |- mesh__recordMaintainer mesh__D020095 SYSTEM
% 210.96/211.15  |- skos__historyNote mesh__D020095 Fungi %28%1966-1977%29%
% 210.96/211.15  |- mesh__recordOriginator mesh__D020095 AGS
% 210.96/211.15  |- mesh__recordMaintainer mesh__D014856 jls
% 210.96/211.15  |- skos__altLabel mesh__D014856 Walrus
% 210.96/211.15  |- mesh__dateRevised mesh__D014856 2004-08-03
% 210.96/211.15  |- rdf__type mesh__D014856sskos__Concept
% 210.96/211.15  |- mesh__recordOriginator mesh__D014856 NLM
% 210.96/211.15  |- skos__prefLabel mesh__D014856 Walruses
% 210.96/211.15  |- skos__broader mesh__D014856smesh__D010872
% 210.96/211.15  |- mesh__dateEstablished mesh__D014856 1991-01-01
% 210.96/211.15  |- mesh__historyNote mesh__D014856 2005 %28%1975%29%   
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D014856 2005A
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D014856 2006
% 210.96/211.15  |- skos__altLabel mesh__D014856 Odobenidae
% 210.96/211.15  |- mesh__publicMeSHNote mesh__D014856
% 210.96/211.15       2005; see WALRUS 1991-2004, see PINNIPEDIA 1975-1990   
% 210.96/211.15  |- mesh__recordAuthorizer mesh__D014856 jls
% 210.96/211.15  |- skos__scopeNote mesh__D014856
% 210.96/211.15       The family Odobenidae, suborder PINNIPEDIA, order CARNIVORA. It is represented by a single species of large, nearly hairless mammal found on Arctic shorelines, whose upper canines are modified into tusks.%A%    
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D014856 2005
% 210.96/211.15  |- mesh__dateCreated mesh__D014856 1999-01-01
% 210.96/211.15  |- skos__historyNote mesh__D047232 Porifera %28%1987-2004%29%
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D047232 2005
% 210.96/211.15  |- mesh__publicMeSHNote mesh__D047232 2005   
% 210.96/211.15  |- skos__scopeNote mesh__D047232
% 210.96/211.15       A genus of shallow-cupped SPONGES with a broad base in the family Theonellidae. They are characterized by ectosomal spicules dominated by phyllotriaenes.%A%    
% 210.96/211.15  |- mesh__dateEstablished mesh__D047232 2005-01-01
% 210.96/211.15  |- mesh__recordAuthorizer mesh__D047232 sjn
% 210.96/211.15  |- mesh__historyNote mesh__D047232 2005   
% 210.96/211.15  |- skos__prefLabel mesh__D047232 Theonella
% 210.96/211.15  |- mesh__dateCreated mesh__D047232 2004-07-07
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D047232 2006
% 210.96/211.15  |- mesh__recordMaintainer mesh__D047232 ags
% 210.96/211.15  |- skos__broader mesh__D047232smesh__D011161
% 210.96/211.15  |- mesh__recordOriginator mesh__D047232 ags
% 210.96/211.15  |- rdf__type mesh__D047232sskos__Concept
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D014058 2004
% 210.96/211.15  |- mesh__dateCreated mesh__D014058 1974-11-11
% 210.96/211.15  |- mesh__recordOriginator mesh__D014058 NLM
% 210.96/211.15  |- skos__prefLabel mesh__D014058 Tonga
% 210.96/211.15  |- skos__scopeNote mesh__D014058
% 210.96/211.15       An archipelago in Polynesia in the southwest Pacific Ocean, comprising about 150 islands. It is a kingdom whose capital is Nukualofa. It was discovered by the Dutch in 1616, visited by Tasman in 1643, and by Captain Cook in 1773 and 1777. The modern kingdom was established during the reign of King George Tupou I, 1845-93. It became a British protectorate in 1900 and gained independence in 1970. The name Tonga may be of local origin, meaning either island or holy. Its other name, Friendly Islands, was given by Captain Cook from the welcome given him by the natives. %28%From Webster%27%s New Geographical Dictionary, 1988, p1219 %26% Room, Brewer%27%s Dictionary of Names, 1992, p549%29%%A%    
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D014058 1997
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D014058 2000
% 210.96/211.15  |- skos__annotation mesh__D014058 an island group in Polynesia   
% 210.96/211.15  |- skos__broader mesh__D014058smesh__D011114
% 210.96/211.15  |- rdf__type mesh__D014058sskos__Concept
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D014058 2001
% 210.96/211.15  |- mesh__dateEstablished mesh__D014058 1975-01-01
% 210.96/211.15  |- mesh__recordAuthorizer mesh__D014058 PLS
% 210.96/211.15  |- mesh__recordMaintainer mesh__D014058 KEV
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D014058 2002
% 210.96/211.15  |- mesh__dateRevised mesh__D014058 1995-05-23
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D014058 2005
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D014058 1998
% 210.96/211.15  |- mesh__historyNote mesh__D014058 75   
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D014058 2006
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D014058 2003
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D014058 1999
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D014058 1996
% 210.96/211.15  |- mesh__dateEstablished mesh__D008819 1975-09-01
% 210.96/211.15  |- skos__hiddenLabel mesh__D008819 Nude Mouse
% 210.96/211.15  |- skos__altLabel mesh__D008819 Mouse, Nude
% 210.96/211.15  |- mesh__recordMaintainer mesh__D008819 ags
% 210.96/211.15  |- mesh__dateCreated mesh__D008819 1974-11-11
% 210.96/211.15  |- skos__altLabel mesh__D008819 Athymic Mice
% 210.96/211.15  |- skos__historyNote mesh__D008819 Mice %28%1966-1974%29%
% 210.96/211.15  |- skos__altLabel mesh__D008819 Mice, Athymic
% 210.96/211.15  |- mesh__dateRevised mesh__D008819 2005-06-30
% 210.96/211.15  |- mesh__recordOriginator mesh__D008819 NLM
% 210.96/211.15  |- mesh__recordAuthorizer mesh__D008819 sjn
% 210.96/211.15  |- mesh__historyNote mesh__D008819 75   
% 210.96/211.15  |- mesh__publicMeSHNote mesh__D008819 75   
% 210.96/211.15  |- skos__scopeNote mesh__D008819
% 210.96/211.15       Mutant mice homozygous for the recessive gene %22%nude%22% which fail to develop a thymus. They are useful in tumor studies and studies on immune responses.%A%    
% 210.96/211.15  |- skos__hiddenLabel mesh__D008819 Athymic Mouse
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D008819 2006
% 210.96/211.15  |- skos__broader mesh__D008819smesh__D008817
% 210.96/211.15  |- skos__altLabel mesh__D008819 Mouse, Athymic
% 210.96/211.15  |- skos__prefLabel mesh__D008819 Mice, Nude
% 210.96/211.15  |- rdf__type mesh__D008819sskos__Concept
% 210.96/211.15  |- skos__altLabel mesh__D008819 Nude Mice
% 210.96/211.15  |- skos__annotation mesh__D008819
% 210.96/211.15       NIM when exper animal: no qualif; when IM, qualif permitted; do not confuse with MICE, HAIRLESS see MICE, INBRED HRS; do not forget also to check tag MICE%A%  
% 210.96/211.15  |- mesh__recordMaintainer mesh__D000836 meshuser
% 210.96/211.15  |- skos__hiddenLabel mesh__D000836 Animal, Zoo
% 210.96/211.15  |- skos__hiddenLabel mesh__D000836 Zoo Animals
% 210.96/211.15  |- mesh__dateRevised mesh__D000836 2003-07-30
% 210.96/211.15  |- mesh__dateCreated mesh__D000836 1999-01-01
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D000836 2004
% 210.96/211.15  |- skos__historyNote mesh__D000836 Animals %28%1966-1967%29%
% 210.96/211.15  |- rdf__type mesh__D000836sskos__Concept
% 210.96/211.15  |- mesh__historyNote mesh__D000836 68   
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D000836 2006
% 210.96/211.15  |- skos__prefLabel mesh__D000836 Animals, Zoo
% 210.96/211.15  |- mesh__recordOriginator mesh__D000836 NLM
% 210.96/211.15  |- skos__hiddenLabel mesh__D000836 Zoo Animal
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D000836 2005
% 210.96/211.15  |- mesh__recordAuthorizer mesh__D000836 meshuser
% 210.96/211.15  |- mesh__publicMeSHNote mesh__D000836 68   
% 210.96/211.15  |- skos__broader mesh__D000836smesh__D000828
% 210.96/211.15  |- skos__annotation mesh__D000836
% 210.96/211.15       IM; qualif permitted; coord IM with specific zoo animal %28%IM%29%; do not forget also to check tag ANIMALS%A%  
% 210.96/211.15  |- mesh__dateEstablished mesh__D000836 1968-01-01
% 210.96/211.15  |- mesh__dateRevised mesh__D000038 2005-08-01
% 210.96/211.15  |- skos__broader mesh__D000038smesh__D013492
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D000038 2002
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D000038 2004
% 210.96/211.15  |- mesh__dateCreated mesh__D000038 1999-01-01
% 210.96/211.15  |- skos__related mesh__D000038smesh__D004653
% 210.96/211.15  |- skos__hiddenLabel mesh__D000038 Abscesses
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D000038 2003
% 210.96/211.15  |- mesh__recordOriginator mesh__D000038 NLM
% 210.96/211.15  |- mesh__recordMaintainer mesh__D000038 ags
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D000038 2001
% 210.96/211.15  |- mesh__recordAuthorizer mesh__D000038 ags
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D000038 2006
% 210.96/211.15  |- skos__annotation mesh__D000038
% 210.96/211.15       IM; coord IM with site %28%organ/dis term%29% %28%IM%29% + precoord organism/infect term %28%IM%29%; if unspecified bacterial abscess do not coord with BACTERIAL INFECTIONS %28%since most abscesses are bact%29% but coord with specific bact infect term if given %28%as ABSCESS + STAPHYLOCOCCAL INFECTIONS%29%%A%  
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D000038 2000
% 210.96/211.15  |- rdf__type mesh__D000038sskos__Concept
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D000038 2005
% 210.96/211.15  |- skos__prefLabel mesh__D000038 Abscess
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D000038 2006A
% 210.96/211.15  |- skos__scopeNote mesh__D000038
% 210.96/211.15       Accumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection.%A%    
% 210.96/211.15  |- skos__hiddenLabel mesh__D005521 Food Services, Hospital
% 210.96/211.15  |- skos__broader mesh__D005521smesh__D006748
% 210.96/211.15  |- skos__broader mesh__D005521smesh__D005522
% 210.96/211.15  |- rdf__type mesh__D005521sskos__Concept
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D005521 2001
% 210.96/211.15  |- mesh__recordAuthorizer mesh__D005521 sjn
% 210.96/211.15  |- skos__altLabel mesh__D005521 Service, Hospital Food
% 210.96/211.15  |- skos__annotation mesh__D005521 DF: FOOD SERV HOSP   
% 210.96/211.15  |- skos__scopeNote mesh__D005521
% 210.96/211.15       Hospital department that manages and supervises the dietary program in accordance with the patients%27% requirements.%A%    
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D005521 2004
% 210.96/211.15  |- mesh__historyNote mesh__D005521 78; was HOSPITAL FOOD SERVICE 1963-77   
% 210.96/211.15  |- skos__hiddenLabel mesh__D005521 Services, Hospital Food
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D005521 2000
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D005521 2006
% 210.96/211.15  |- mesh__onlineNote mesh__D005521
% 210.96/211.15       use FOOD SERVICE, HOSPITAL to search HOSPITAL FOOD SERVICE 1966-77%A%  
% 210.96/211.15  |- mesh__publicMeSHNote mesh__D005521
% 210.96/211.15       78; was HOSPITAL FOOD SERVICE 1963-77   
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D005521 2003
% 210.96/211.15  |- skos__broader mesh__D005521smesh__D004045
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D005521 2005
% 210.96/211.15  |- skos__altLabel mesh__D005521 Hospital Food Service
% 210.96/211.15  |- skos__hiddenLabel mesh__D005521 Hospital Food Services
% 210.96/211.15  |- mesh__recordMaintainer mesh__D005521 kle
% 210.96/211.15  |- skos__prefLabel mesh__D005521 Food Service, Hospital
% 210.96/211.15  |- mesh__recordOriginator mesh__D005521 NLM
% 210.96/211.15  |- mesh__dateRevised mesh__D005521 1999-11-03
% 210.96/211.15  |- mesh__dateCreated mesh__D005521 1999-01-01
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D005521 2002
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D052177 2006
% 210.96/211.15  |- skos__hiddenLabel mesh__D052177 Renal Disease, Cystic
% 210.96/211.15  |- skos__hiddenLabel mesh__D052177 Cystic Kidneys
% 210.96/211.15  |- skos__historyNote mesh__D052177
% 210.96/211.15       Polycystic Kidney Diseases %28%1976-2005%29%
% 210.96/211.15  |- skos__prefLabel mesh__D052177 Kidney Diseases, Cystic
% 210.96/211.15  |- skos__hiddenLabel mesh__D052177 Kidney Disease, Cystic
% 210.96/211.15  |- rdf__type mesh__D052177sskos__Concept
% 210.96/211.15  |- mesh__recordMaintainer mesh__D052177 lkt
% 210.96/211.15  |- skos__hiddenLabel mesh__D052177 Diseases, Cystic Kidney
% 210.96/211.15  |- mesh__recordOriginator mesh__D052177 lkt
% 210.96/211.15  |- mesh__dateEstablished mesh__D052177 2006-01-01
% 210.96/211.15  |- mesh__recordAuthorizer mesh__D052177 sjn
% 210.96/211.15  |- skos__historyNote mesh__D052177 Kidney, Cystic %28%1975-2005%29%
% 210.96/211.15  |- skos__hiddenLabel mesh__D052177 Kidneys, Cystic
% 210.96/211.15  |- skos__hiddenLabel mesh__D052177 Cystic Renal Disease
% 210.96/211.15  |- skos__hiddenLabel mesh__D052177 Cystic Kidney
% 210.96/211.15  |- mesh__historyNote mesh__D052177 2006   
% 210.96/211.15  |- skos__broader mesh__D052177smesh__D016146
% 210.96/211.15  |- skos__scopeNote mesh__D052177
% 210.96/211.15       A heterogeneous group of hereditary and acquired disorders in which the KIDNEY contains one or more CYSTS unilaterally or bilaterally %28%KIDNEY, CYSTIC%29%.%A%    
% 210.96/211.15  |- skos__broader mesh__D052177smesh__D007674
% 210.96/211.15  |- skos__hiddenLabel mesh__D052177 Disease, Cystic Renal
% 210.96/211.15  |- mesh__publicMeSHNote mesh__D052177 2006   
% 210.96/211.15  |- skos__altLabel mesh__D052177 Cystic Kidney Diseases
% 210.96/211.15  |- skos__hiddenLabel mesh__D052177 Diseases, Cystic Renal
% 210.96/211.15  |- skos__hiddenLabel mesh__D052177 Disease, Cystic Kidney
% 210.96/211.15  |- mesh__dateCreated mesh__D052177 2005-06-30
% 210.96/211.15  |- skos__altLabel mesh__D052177 Cystic Renal Diseases
% 210.96/211.15  |- skos__hiddenLabel mesh__D052177 Renal Diseases, Cystic
% 210.96/211.15  |- skos__annotation mesh__D052177 note specifics   
% 210.96/211.15  |- skos__hiddenLabel mesh__D052177 Cystic Kidney Disease
% 210.96/211.15  |- rdf__type mesh__D046938sskos__Concept
% 210.96/211.15  |- skos__scopeNote mesh__D046938
% 210.96/211.15       A form-genus of CYANOBACTERIA in the order Oscillatoriales. They are non-heterocystous but may carry out NITROGEN FIXATION under microaerobic conditions. Some smaller members have undergone transfer to the form-genus Leptolyngbya.%A%    
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D046938 2006
% 210.96/211.15  |- mesh__recordMaintainer mesh__D046938 SYSTEM
% 210.96/211.15  |- mesh__dateCreated mesh__D046938 2004-07-07
% 210.96/211.15  |- mesh__publicMeSHNote mesh__D046938 2005   
% 210.96/211.15  |- mesh__recordOriginator mesh__D046938 ags
% 210.96/211.15  |- skos__prefLabel mesh__D046938 Plectonema
% 210.96/211.15  |- mesh__recordAuthorizer mesh__D046938 sjn
% 210.96/211.15  |- mesh__dateRevised mesh__D046938 2005-06-30
% 210.96/211.15  |- skos__historyNote mesh__D046938 Cyanobacteria %28%1970-2004%29%
% 210.96/211.15  |- skos__broader mesh__D046938smesh__D000458
% 210.96/211.15  |- mesh__historyNote mesh__D046938 2005   
% 210.96/211.15  |- mesh__dateEstablished mesh__D046938 2005-01-01
% 210.96/211.15  |- mesh__dateCreated mesh__D018449 1994-05-23
% 210.96/211.15  |- skos__hiddenLabel mesh__D018449 Vaccines, SIV
% 210.96/211.15  |- mesh__historyNote mesh__D018449 95   
% 210.96/211.15  |- skos__hiddenLabel mesh__D018449 AIDS Vaccines, Simian
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D018449 2006
% 210.96/211.15  |- mesh__recordMaintainer mesh__D018449 sjn
% 210.96/211.15  |- skos__hiddenLabel mesh__D018449 Vaccines, SAIDS
% 210.96/211.15  |- skos__annotation mesh__D018449
% 210.96/211.15       coord IM with specific SAIDS virus %28%IM or NIM%29% if pertinent%A%  
% 210.96/211.15  |- skos__hiddenLabel mesh__D018449 Vaccines, Simian AIDS
% 210.96/211.15  |- rdf__type mesh__D018449sskos__Concept
% 210.96/211.15  |- skos__hiddenLabel mesh__D018449 Vaccine, SIV
% 210.96/211.15  |- skos__historyNote mesh__D018449
% 210.96/211.15       Simian Acquired Immunodeficiency Syndrome/prevention %26% control %28%1990-1994%29%
% 210.96/211.15  |- mesh__recordOriginator mesh__D018449 AGS
% 210.96/211.15  |- mesh__dateEstablished mesh__D018449 1995-01-01
% 210.96/211.15  |- skos__broader mesh__D018449smesh__D014765
% 210.96/211.15  |- skos__altLabel mesh__D018449 SIV Vaccines
% 210.96/211.15  |- skos__prefLabel mesh__D018449 SAIDS Vaccines
% 210.96/211.15  |- mesh__publicMeSHNote mesh__D018449 95   
% 210.96/211.15  |- mesh__recordAuthorizer mesh__D018449 sjn
% 210.96/211.15  |- skos__scopeNote mesh__D018449
% 210.96/211.15       Vaccines or candidate vaccines designed to prevent SAIDS; %28%SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME%29%; and containing inactivated SIMIAN IMMUNODEFICIENCY VIRUS or type D retroviruses or some of their component antigens.%A%    
% 210.96/211.15  |- mesh__dateRevised mesh__D018449 2005-07-01
% 210.96/211.15  |- skos__altLabel mesh__D018449 Simian AIDS Vaccines
% 210.96/211.15  |- skos__historyNote mesh__D018449
% 210.96/211.15       Viral Vaccines/immunology %28%1991-1994%29%
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D010466 1999
% 210.96/211.15  |- skos__altLabel mesh__D010466 Perceptual Completion Phenomena
% 210.96/211.15  |- skos__broader mesh__D010466smesh__D014796
% 210.96/211.15  |- skos__historyNote mesh__D010466 Visual Perception %28%1966-1968%29%
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D010466 2003A
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D010466 2003
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D010466 1996
% 210.96/211.15  |- skos__prefLabel mesh__D010466 Perceptual Closure
% 210.96/211.15  |- skos__hiddenLabel mesh__D010466 Perceptual Closures
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D010466 1993
% 210.96/211.15  |- skos__historyNote mesh__D010466 Form Perception %28%1966-1968%29%
% 210.96/211.15  |- mesh__recordAuthorizer mesh__D010466 sjn
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D010466 2002
% 210.96/211.15  |- skos__hiddenLabel mesh__D010466 Closure, Perceptual
% 210.96/211.15  |- skos__hiddenLabel mesh__D010466 Completion Phenomena, Perceptual
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D010466 2004
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D010466 1997
% 210.96/211.15  |- rdf__type mesh__D010466sskos__Concept
% 210.96/211.15  |- mesh__dateRevised mesh__D010466 2002-10-24
% 210.96/211.15  |- mesh__recordOriginator mesh__D010466 NLM
% 210.96/211.15  |- mesh__historyNote mesh__D010466
% 210.96/211.15       69; GESTALT LAW OF CLOSURE was see under PERCEPTUAL CLOSURE 1969-78%A%  
% 210.96/211.15  |- mesh__onlineNote mesh__D010466
% 210.96/211.15       use PERCEPTUAL CLOSURE to search GESTALT LAW OF CLOSURE 1969-78%A%  
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D010466 2000
% 210.96/211.15  |- mesh__dateCreated mesh__D010466 1999-01-01
% 210.96/211.15  |- skos__scopeNote mesh__D010466
% 210.96/211.15       The tendency to perceive an incomplete pattern or object as complete or whole. This includes the Gestalt Law of Closure.%A%    
% 210.96/211.15  |- mesh__publicMeSHNote mesh__D010466 69   
% 210.96/211.15  |- mesh__dateEstablished mesh__D010466 1969-01-01
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D010466 1994
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D010466 2005
% 210.96/211.15  |- mesh__recordMaintainer mesh__D010466 sjn
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D010466 1998
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D010466 2001
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D010466 1995
% 210.96/211.15  |- skos__hiddenLabel mesh__D010466 Phenomena, Perceptual Completion
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D010466 2006
% 210.96/211.15  |- skos__hiddenLabel mesh__D010466 Closures, Perceptual
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D004429 1998
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D004429 2001
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D004429 1995
% 210.96/211.15  |- mesh__recordAuthorizer mesh__D004429 PLS
% 210.96/211.15  |- skos__hiddenLabel mesh__D004429 Ossicles, Ear
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D004429 2004
% 210.96/211.15  |- skos__hiddenLabel mesh__D004429 Auditory Ossicle
% 210.96/211.15  |- mesh__dateCreated mesh__D004429 1999-01-01
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D004429 1991
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D004429 2000
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D004429 1994
% 210.96/211.15  |- skos__altLabel mesh__D004429 Auditory Ossicles
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D004429 2003
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D004429 1997
% 210.96/211.15  |- skos__broader mesh__D004429smesh__D004432
% 210.96/211.15  |- skos__related mesh__D004429smesh__D013201
% 210.96/211.15  |- skos__hiddenLabel mesh__D004429 Ear Ossicle
% 210.96/211.15  |- mesh__dateRevised mesh__D004429 1989-10-06
% 210.96/211.15  |- skos__prefLabel mesh__D004429 Ear Ossicles
% 210.96/211.15  |- skos__hiddenLabel mesh__D004429 Ossicle, Auditory
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D004429 1996
% 210.96/211.15  |- skos__hiddenLabel mesh__D004429 Ossicles, Auditory
% 210.96/211.15  |- mesh__recordOriginator mesh__D004429 NLM
% 210.96/211.15  |- mesh__recordMaintainer mesh__D004429 PLS
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D004429 2006
% 210.96/211.15  |- rdf__type mesh__D004429sskos__Concept
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D004429 1990
% 210.96/211.15  |- skos__hiddenLabel mesh__D004429 Ossicle, Ear
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D004429 2002
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D004429 1993
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D004429 2005
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D004429 1999
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D004429 1992
% 210.96/211.15  |- skos__annotation mesh__D015151
% 210.96/211.15       GEN or unspecified: prefer specifics; DF: IMMUNOBLOT   
% 210.96/211.15  |- skos__hiddenLabel mesh__D015151 Reverse Immunoblottings
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D015151 2005
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D015151 2002
% 210.96/211.15  |- skos__historyNote mesh__D015151
% 210.96/211.15       Electrophoresis, Polyacrylamide Gel %28%1982-1988%29%
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D015151 2006
% 210.96/211.15  |- skos__broader mesh__D015151smesh__D007118
% 210.96/211.15  |- mesh__dateCreated mesh__D015151 1988-03-22
% 210.96/211.15  |- mesh__recordAuthorizer mesh__D015151 sjn
% 210.96/211.15  |- skos__hiddenLabel mesh__D015151 Immunoblottings, Reverse
% 210.96/211.15  |- mesh__historyNote mesh__D015151 89   
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D015151 2003
% 210.96/211.15  |- skos__historyNote mesh__D015151
% 210.96/211.15       Immunoenzyme Techniques %28%1983-1988%29%
% 210.96/211.15  |- skos__altLabel mesh__D015151 Reverse Immunoblotting
% 210.96/211.15  |- skos__historyNote mesh__D015151 Isoelectric Focusing %28%1984-1988%29%
% 210.96/211.15  |- skos__hiddenLabel mesh__D015151 Immunoblottings, Dot
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D015151 2004
% 210.96/211.15  |- rdf__type mesh__D015151sskos__Concept
% 210.96/211.15  |- skos__hiddenLabel mesh__D015151 Electroimmunoblottings
% 210.96/211.15  |- skos__hiddenLabel mesh__D015151 Immunoelectroblottings
% 210.96/211.15  |- skos__altLabel mesh__D015151 Electroimmunoblotting
% 210.96/211.15  |- skos__hiddenLabel mesh__D015151 Dot Immunoblottings
% 210.96/211.15  |- skos__altLabel mesh__D015151 Immunoblotting, Dot
% 210.96/211.15  |- mesh__dateRevised mesh__D015151 2001-07-25
% 210.96/211.15  |- mesh__publicMeSHNote mesh__D015151 89   
% 210.96/211.15  |- skos__scopeNote mesh__D015151
% 210.96/211.15       Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies.%A%    
% 210.96/211.15  |- mesh__recordMaintainer mesh__D015151 nns
% 210.96/211.15  |- skos__hiddenLabel mesh__D015151 Immunoblottings
% 210.96/211.15  |- mesh__dateEstablished mesh__D015151 1989-01-01
% 210.96/211.15  |- skos__prefLabel mesh__D015151 Immunoblotting
% 210.96/211.15  |- skos__historyNote mesh__D015151 Immunoelectrophoresis %28%1984-1988%29%
% 210.96/211.15  |- skos__historyNote mesh__D015151 Immunochemistry %28%1983-1988%29%
% 210.96/211.15  |- mesh__recordOriginator mesh__D015151 SCD
% 210.96/211.15  |- skos__related mesh__D015151smesh__D007120
% 210.96/211.15  |- skos__broader mesh__D009912smesh__D009059
% 210.96/211.15  |- rdf__type mesh__D009912sskos__Concept
% 210.96/211.15  |- skos__hiddenLabel mesh__D009912 Manifestations, Oral
% 210.96/211.15  |- mesh__recordMaintainer mesh__D009912 ags
% 210.96/211.15  |- mesh__recordAuthorizer mesh__D009912 sjn
% 210.96/211.15  |- skos__hiddenLabel mesh__D009912 Oral Manifestation
% 210.96/211.15  |- mesh__historyNote mesh__D009912 65   
% 210.96/211.15  |- mesh__dateRevised mesh__D009912 2004-07-07
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D009912 2006
% 210.96/211.15  |- mesh__recordOriginator mesh__D009912 NLM
% 210.96/211.15  |- mesh__dateEstablished mesh__D009912 1965-01-01
% 210.96/211.15  |- mesh__publicMeSHNote mesh__D009912 65   
% 210.96/211.15  |- skos__prefLabel mesh__D009912 Oral Manifestations
% 210.96/211.15  |- skos__broader mesh__D009912smesh__D012816
% 210.96/211.15  |- skos__hiddenLabel mesh__D009912 Manifestation, Oral
% 210.96/211.15  |- skos__annotation mesh__D009912
% 210.96/211.15       not used for indexing since 1989; prior to 1989 used for oral manifest of non-oral diseases%A%  
% 210.96/211.15  |- mesh__dateCreated mesh__D009912 1999-01-01
% 210.96/211.15  |- skos__scopeNote mesh__D009912
% 210.96/211.15       Disorders of the mouth attendant upon non-oral disease or injury.%A%    
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D009912 2005
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D009114 1998
% 210.96/211.15  |- mesh__recordAuthorizer mesh__D009114 PLS
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D009114 2001
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D009114 2005
% 210.96/211.15  |- mesh__recordMaintainer mesh__D009114 JRT
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D009114 2000
% 210.96/211.15  |- skos__altLabel mesh__D009114 Acid Ammonium Purpurate
% 210.96/211.15  |- skos__prefLabel mesh__D009114 Murexide
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D009114 1997
% 210.96/211.15  |- skos__scopeNote mesh__D009114
% 210.96/211.15       5,5%27%-Nitrilodibarbituric acid ammonium derivative. Used as an indicator for complexometric titrations.%A%    
% 210.96/211.15  |- skos__hiddenLabel mesh__D009114 Ammonium Purpurate, Acid
% 210.96/211.15  |- mesh__recordOriginator mesh__D009114 NLM
% 210.96/211.15  |- rdf__type mesh__D009114sskos__Concept
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D009114 2004
% 210.96/211.15  |- skos__hiddenLabel mesh__D009114 Purpurate, Ammonium
% 210.96/211.15  |- skos__altLabel mesh__D009114 Ammonium Purpurate
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D009114 1996
% 210.96/211.15  |- mesh__historyNote mesh__D009114
% 210.96/211.15       91%28%75%29%; was see under BARBITURATES 1975-90   
% 210.96/211.15  |- mesh__dateRevised mesh__D009114 1995-06-08
% 210.96/211.15  |- skos__annotation mesh__D009114 an indicator; D25-26 qualif   
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D009114 2002
% 210.96/211.15  |- skos__broader mesh__D009114smesh__D001463
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D009114 2003
% 210.96/211.15  |- mesh__publicMeSHNote mesh__D009114
% 210.96/211.15       91; was see under BARBITURATES 1975-90   
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D009114 1999
% 210.96/211.15  |- mesh__dateEstablished mesh__D009114 1991-01-01
% 210.96/211.15  |- skos__hiddenLabel mesh__D009114 Purpurate, Acid Ammonium
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D009114 2006
% 210.96/211.15  |- mesh__dateCreated mesh__D009114 1974-11-19
% 210.96/211.15  |- skos__historyNote mesh__D009114 Barbiturates %28%1969-1974%29%
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D001131 2002
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D001131 2006
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D001131 1999
% 210.96/211.15  |- skos__broader mesh__D001131smesh__D015144
% 210.96/211.15  |- rdf__type mesh__D001131sskos__Concept
% 210.96/211.15  |- mesh__recordMaintainer mesh__D001131 PXP
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D001131 2000
% 210.96/211.15  |- mesh__dateCreated mesh__D001131 1999-01-01
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D001131 2001
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D001131 2003
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D001131 2005
% 210.96/211.15  |- mesh__dateRevised mesh__D001131 1997-06-20
% 210.96/211.15  |- mesh__recordAuthorizer mesh__D001131 SJN
% 210.96/211.15  |- mesh__recordOriginator mesh__D001131 NLM
% 210.96/211.15  |- mesh__activeMeSHYear mesh__D001131 2004
% 210.96/211.16  |- skos__prefLabel mesh__D001131 Arkansas
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D001131 1998
% 210.96/211.16  |- skos__broader mesh__D020894smesh__D005109
% 210.96/211.16  |- skos__scopeNote mesh__D020894
% 210.96/211.16       Components of the extracellular matrix consisting primarily of fibrillin. They are essential for the integrity of elastic fibers.%A%    
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D020894 2001
% 210.96/211.16  |- skos__prefLabel mesh__D020894 Microfibrils
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D020894 2002
% 210.96/211.16  |- mesh__dateCreated mesh__D020894 1999-11-03
% 210.96/211.16  |- rdf__type mesh__D020894sskos__Concept
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D020894 2005
% 210.96/211.16  |- mesh__dateRevised mesh__D020894 2000-06-22
% 210.96/211.16  |- mesh__dateEstablished mesh__D020894 2000-01-01
% 210.96/211.16  |- mesh__publicMeSHNote mesh__D020894 2000   
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D020894 2003
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D020894 2006
% 210.96/211.16  |- skos__hiddenLabel mesh__D020894 Microfibril
% 210.96/211.16  |- mesh__historyNote mesh__D020894 2000   
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D020894 2004
% 210.96/211.16  |- skos__historyNote mesh__D020096 Mucormycosis %28%1975-1998%29%
% 210.96/211.16  |- skos__hiddenLabel mesh__D020096 Phycomycoses
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D020096 2004
% 210.96/211.16  |- mesh__recordAuthorizer mesh__D020096 sjn
% 210.96/211.16  |- mesh__publicMeSHNote mesh__D020096 99; see MUCORMYCOSIS 1989-98   
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D020096 2003
% 210.96/211.16  |- mesh__dateRevised mesh__D020096 2000-06-22
% 210.96/211.16  |- skos__hiddenLabel mesh__D020096 Zygomycoses
% 210.96/211.16  |- rdf__type mesh__D020096sskos__Concept
% 210.96/211.16  |- mesh__dateCreated mesh__D020096 1998-06-11
% 210.96/211.16  |- mesh__historyNote mesh__D020096 99; use MUCORMYCOSIS 1989-98   
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D020096 2006
% 210.96/211.16  |- skos__prefLabel mesh__D020096 Zygomycosis
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D020096 2002
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D020096 2005
% 210.96/211.16  |- skos__historyNote mesh__D020096 Mycoses %28%1976-1991%29%
% 210.96/211.16  |- skos__scopeNote mesh__D020096
% 210.96/211.16       Infection in humans and animals caused by fungi in the class Zygomycetes. It includes MUCORMYCOSIS and entomophthoramycosis. The latter is a tropical infection of subcutaneous tissue or paranasal sinuses caused by fungi in the order Entomophthorales. Phycomycosis, closely related to zygomycosis, describes infection with members of Phycomycetes, an obsolete classification.%A%    
% 210.96/211.16  |- mesh__dateEstablished mesh__D020096 1999-01-01
% 210.96/211.16  |- mesh__recordOriginator mesh__D020096 AGS
% 210.96/211.16  |- skos__hiddenLabel mesh__D020096 Entomophthoramycoses
% 210.96/211.16  |- mesh__recordMaintainer mesh__D020096 ags
% 210.96/211.16  |- skos__annotation mesh__D020096
% 210.96/211.16       fungus dis caused by various Zygomycetes; for dis caused by Mucorales, MUCORMYCOSIS is available%A%  
% 210.96/211.16  |- skos__broader mesh__D020096smesh__D009181
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D020096 2001
% 210.96/211.16  |- skos__scopeNote mesh__D014857
% 210.96/211.16       Hostile conflict between organized groups of people.     
% 210.96/211.16  |- skos__related mesh__D014857smesh__D014754
% 210.96/211.16  |- skos__hiddenLabel mesh__D014857 Wars
% 210.96/211.16  |- mesh__recordMaintainer mesh__D014857 jls
% 210.96/211.16  |- skos__broader mesh__D014857smesh__D012940
% 210.96/211.16  |- skos__annotation mesh__D014857
% 210.96/211.16       war wounds: index under WOUNDS AND INJURIES or specific inj %28%IM%29% + WAR %28%IM or NIM%29%; note specific wars indented under HISTORY; other wars: index WAR + geographical term%A%  
% 210.96/211.16  |- mesh__recordOriginator mesh__D014857 NLM
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D014857 2006
% 210.96/211.16  |- mesh__recordAuthorizer mesh__D014857 sjn
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D014857 2005
% 210.96/211.16  |- mesh__dateRevised mesh__D014857 2004-07-07
% 210.96/211.16  |- mesh__dateCreated mesh__D014857 1999-01-01
% 210.96/211.16  |- skos__prefLabel mesh__D014857 War
% 210.96/211.16  |- skos__related mesh__D014857smesh__D003130
% 210.96/211.16  |- rdf__type mesh__D014857sskos__Concept
% 210.96/211.16  |- mesh__dateCreated mesh__D047233 2004-07-07
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D047233 2006
% 210.96/211.16  |- mesh__recordMaintainer mesh__D047233 ags
% 210.96/211.16  |- skos__broader mesh__D047233smesh__D011161
% 210.96/211.16  |- rdf__type mesh__D047233sskos__Concept
% 210.96/211.16  |- mesh__dateEstablished mesh__D047233 2005-01-01
% 210.96/211.16  |- skos__scopeNote mesh__D047233
% 210.96/211.16       A genus of velvety smooth SPONGES in the family Suberitidae, characterized by the ectosomal and choanosomal skeletons dominated by tylostyles %28%pin-like spicules with a pinched bulbous end%29%.%A%    
% 210.96/211.16  |- mesh__recordAuthorizer mesh__D047233 sjn
% 210.96/211.16  |- mesh__historyNote mesh__D047233 2005   
% 210.96/211.16  |- mesh__recordOriginator mesh__D047233 ags
% 210.96/211.16  |- skos__prefLabel mesh__D047233 Suberites
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D047233 2005
% 210.96/211.16  |- mesh__publicMeSHNote mesh__D047233 2005   
% 210.96/211.16  |- skos__historyNote mesh__D047233 Porifera %28%1971-2004%29%
% 210.96/211.16  |- skos__related mesh__D014059smesh__D005927
% 210.96/211.16  |- skos__hiddenLabel mesh__D014059 Microglossias
% 210.96/211.16  |- mesh__dateRevised mesh__D014059 2003-07-09
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D014059 2005
% 210.96/211.16  |- mesh__recordAuthorizer mesh__D014059 sjn
% 210.96/211.16  |- mesh__recordMaintainer mesh__D014059 lkt
% 210.96/211.16  |- mesh__recordOriginator mesh__D014059 NLM
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D014059 2006
% 210.96/211.16  |- mesh__considerAlso mesh__D014059
% 210.96/211.16       consider also terms at GLOSS- and LINGUAL   
% 210.96/211.16  |- mesh__historyNote mesh__D014059
% 210.96/211.16       /abnormalities was TONGUE ABNORMALITIES 1965   
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D014059 2004
% 210.96/211.16  |- skos__prefLabel mesh__D014059 Tongue
% 210.96/211.16  |- skos__hiddenLabel mesh__D014059 Tongues
% 210.96/211.16  |- mesh__publicMeSHNote mesh__D014059
% 210.96/211.16       /abnormalities was TONGUE ABNORMALITIES 1965   
% 210.96/211.16  |- skos__annotation mesh__D014059
% 210.96/211.16       /surg: consider GLOSSECTOMY; /transpl permitted for tongue grafts as in palate surg; inflammation = GLOSSITIS; tongue thrust: index under TONGUE HABITS; painful or sore tongue = GLOSSALGIA; scrotal tongue = TONGUE, FISSURED%A%  
% 210.96/211.16  |- mesh__dateCreated mesh__D014059 1999-01-01
% 210.96/211.16  |- skos__broader mesh__D014059smesh__D009055
% 210.96/211.16  |- rdf__type mesh__D014059sskos__Concept
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D000837 2006
% 210.96/211.16  |- mesh__recordMaintainer mesh__D000837 ssb
% 210.96/211.16  |- rdf__type mesh__D000837sskos__Concept
% 210.96/211.16  |- mesh__recordOriginator mesh__D000837 NLM
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D000837 2005
% 210.96/211.16  |- skos__broader mesh__D000837smesh__D007475
% 210.96/211.16  |- mesh__recordAuthorizer mesh__D000837 sjn
% 210.96/211.16  |- skos__prefLabel mesh__D000837 Anion Exchange Resins
% 210.96/211.16  |- skos__scopeNote mesh__D000837
% 210.96/211.16       High-molecular-weight insoluble polymers that contain functional cationic groups capable of undergoing exchange reactions with anions.%A%    
% 210.96/211.16  |- mesh__historyNote mesh__D000837
% 210.96/211.16       91%28%75%29%; was see under ION EXCHANGE RESINS 1975-90   
% 210.96/211.16  |- mesh__dateRevised mesh__D000837 2003-07-09
% 210.96/211.16  |- mesh__publicMeSHNote mesh__D000837
% 210.96/211.16       91; was see under ION EXCHANGE RESINS 1975-90   
% 210.96/211.16  |- mesh__dateEstablished mesh__D000837 1991-01-01
% 210.96/211.16  |- skos__hiddenLabel mesh__D000837 Resins, Anion Exchange
% 210.96/211.16  |- mesh__onlineNote mesh__D000837 search ION EXCHANGE RESINS 1966-74   
% 210.96/211.16  |- mesh__dateCreated mesh__D000837 1999-01-01
% 210.96/211.16  |- skos__altLabel mesh__D000837 Anion Exchangers %28%Resins%29%
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D000837 2004
% 210.96/211.16  |- skos__hiddenLabel mesh__D000837 Exchange Resins, Anion
% 210.96/211.16  |- mesh__recordAuthorizer mesh__D019542 sjn
% 210.96/211.16  |- skos__broader mesh__D019542smesh__D019502
% 210.96/211.16  |- skos__scopeNote mesh__D019542
% 210.96/211.16       Works consisting of lists of the events, pieces, performers, speakers, etc., of an entertainment, ceremony, or the like. %28%From: Genre Terms: A Thesaurus for Use in Rare Book and Special Collections Cataloging, 2d ed%29%%A%    
% 210.96/211.16  |- mesh__recordMaintainer mesh__D019542 jls
% 210.96/211.16  |- mesh__dateCreated mesh__D019542 1996-06-21
% 210.96/211.16  |- skos__prefLabel mesh__D019542 Programs %5B%Publication Type%5D%
% 210.96/211.16  |- mesh__recordOriginator mesh__D019542 TGC
% 210.96/211.16  |- skos__altLabel mesh__D019542 Programs %28%PT%29%
% 210.96/211.16  |- skos__annotation mesh__D019542 publication type only   
% 210.96/211.16  |- skos__altLabel mesh__D019542 Programs
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D019542 2006
% 210.96/211.16  |- mesh__dateRevised mesh__D019542 2005-06-30
% 210.96/211.16  |- mesh__historyNote mesh__D019542 1997   
% 210.96/211.16  |- rdf__type mesh__D019542sskos__Concept
% 210.96/211.16  |- mesh__dateEstablished mesh__D019542 1997-01-01
% 210.96/211.16  |- mesh__publicMeSHNote mesh__D000039
% 210.96/211.16       89; was ABSCESS, PERITONSILLAR 1963-88   
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D000039 1995
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D000039 1996
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D000039 2002
% 210.96/211.16  |- mesh__recordAuthorizer mesh__D000039 PLS
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D000039 2004
% 210.96/211.16  |- skos__hiddenLabel mesh__D000039 Peritonsillar Abscesses
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D000039 1997
% 210.96/211.16  |- skos__scopeNote mesh__D000039
% 210.96/211.16       An abscess in the peritonsillar tissue extending into the tonsil capsule, resulting from suppuration of the tonsil. %28%Dorland, 27th ed%29%%A%    
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D000039 2005
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D000039 1998
% 210.96/211.16  |- skos__broader mesh__D000039smesh__D014069
% 210.96/211.16  |- skos__prefLabel mesh__D000039 Peritonsillar Abscess
% 210.96/211.16  |- mesh__recordMaintainer mesh__D000039 PLS
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D000039 2006
% 210.96/211.16  |- mesh__historyNote mesh__D000039
% 210.96/211.16       89; was ABSCESS, PERITONSILLAR 1963-88   
% 210.96/211.16  |- skos__altLabel mesh__D000039 Abscess, Peritonsillar
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D000039 1999
% 210.96/211.16  |- mesh__onlineNote mesh__D000039
% 210.96/211.16       use PERITONSILLAR ABSCESS to search ABSCESS, PERITONSILLAR 1966-88%A%  
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D000039 2000
% 210.96/211.16  |- skos__broader mesh__D000039smesh__D010608
% 210.96/211.16  |- rdf__type mesh__D000039sskos__Concept
% 210.96/211.16  |- mesh__recordOriginator mesh__D000039 NLM
% 210.96/211.16  |- skos__hiddenLabel mesh__D000039 Abscesses, Peritonsillar
% 210.96/211.16  |- skos__broader mesh__D000039smesh__D000038
% 210.96/211.16  |- mesh__dateCreated mesh__D000039 1999-01-01
% 210.96/211.16  |- skos__annotation mesh__D000039 for coord read note on ABSCESS   
% 210.96/211.16  |- mesh__dateRevised mesh__D000039 1994-05-27
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D000039 2001
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D000039 2003
% 210.96/211.16  |- mesh__dateRevised mesh__D005522 1999-11-03
% 210.96/211.16  |- skos__broader mesh__D005522smesh__D019649
% 210.96/211.16  |- skos__annotation mesh__D005522
% 210.96/211.16       includes food distribution programs, food stamp plans, school lunches, child feeding programs; do not confuse with DIETARY SERVICES where nutrition is emphasized; DF: FOOD SER%A%  
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D005522 2004
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D005522 2002
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D005522 2006
% 210.96/211.16  |- mesh__recordOriginator mesh__D005522 JW
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D005522 2003
% 210.96/211.16  |- mesh__recordAuthorizer mesh__D005522 sjn
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D005522 2001
% 210.96/211.16  |- skos__altLabel mesh__D005522 Services, Food
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D005522 2005
% 210.96/211.16  |- mesh__publicMeSHNote mesh__D005522 76   
% 210.96/211.16  |- skos__prefLabel mesh__D005522 Food Services
% 210.96/211.16  |- skos__hiddenLabel mesh__D005522 Food Service
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D005522 2000
% 210.96/211.16  |- mesh__historyNote mesh__D005522
% 210.96/211.16       76; was FOOD SERVICE %28%NON MESH%29% before 1976   
% 210.96/211.16  |- skos__hiddenLabel mesh__D005522 Service, Food
% 210.96/211.16  |- mesh__dateEstablished mesh__D005522 1976-01-01
% 210.96/211.16  |- skos__altLabel mesh__D005522 Meals on Wheels
% 210.96/211.16  |- mesh__recordMaintainer mesh__D005522 kle
% 210.96/211.16  |- mesh__dateCreated mesh__D005522 1975-07-25
% 210.96/211.16  |- rdf__type mesh__D005522sskos__Concept
% 210.96/211.16  |- skos__scopeNote mesh__D005522
% 210.96/211.16       Functions, equipment, and facilities concerned with the preparation and distribution of ready-to-eat food.%A%    
% 210.96/211.16  |- rdf__type mesh__D052178sskos__Concept
% 210.96/211.16  |- mesh__recordOriginator mesh__D052178 lkt
% 210.96/211.16  |- skos__scopeNote mesh__D052178
% 210.96/211.16       A condition in which the HEAD of the FETUS is larger than the mother%27%s PELVIS through which the fetal head must pass during a vaginal delivery.%A%    
% 210.96/211.16  |- skos__hiddenLabel mesh__D052178 Disproportion, Cephalopelvic
% 210.96/211.16  |- skos__prefLabel mesh__D052178 Cephalopelvic Disproportion
% 210.96/211.16  |- mesh__recordMaintainer mesh__D052178 lkt
% 210.96/211.16  |- mesh__dateEstablished mesh__D052178 2006-01-01
% 210.96/211.16  |- skos__broader mesh__D052178smesh__D007744
% 210.96/211.16  |- mesh__recordAuthorizer mesh__D052178 sjn
% 210.96/211.16  |- mesh__historyNote mesh__D052178
% 210.96/211.16       2006; use LABOR COOMPLICATIONS 1992-2005   
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D052178 2006
% 210.96/211.16  |- mesh__dateCreated mesh__D052178 2005-06-30
% 210.96/211.16  |- mesh__publicMeSHNote mesh__D052178
% 210.96/211.16       2006; see LABOR COOMPLICATIONS 1992-2005   
% 210.96/211.16  |- skos__historyNote mesh__D046939 Cyanobacteria %28%1971-2004%29%
% 210.96/211.16  |- mesh__dateCreated mesh__D046939 2004-07-07
% 210.96/211.16  |- mesh__historyNote mesh__D046939 2005   
% 210.96/211.16  |- mesh__publicMeSHNote mesh__D046939 2005   
% 210.96/211.16  |- mesh__dateEstablished mesh__D046939 2005-01-01
% 210.96/211.16  |- skos__prefLabel mesh__D046939 Synechocystis
% 210.96/211.16  |- mesh__recordOriginator mesh__D046939 ags
% 210.96/211.16  |- skos__scopeNote mesh__D046939
% 210.96/211.16       A form-genus of unicellular CYANOBACTERIA in the order Chroococcales. None of the strains fix NITROGEN, there are no gas vacuoles, and sheath layers are never produced.%A%    
% 210.96/211.16  |- mesh__recordAuthorizer mesh__D046939 sjn
% 210.96/211.16  |- rdf__type mesh__D046939sskos__Concept
% 210.96/211.16  |- mesh__dateRevised mesh__D046939 2005-06-30
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D046939 2006
% 210.96/211.16  |- mesh__recordMaintainer mesh__D046939 SYSTEM
% 210.96/211.16  |- skos__broader mesh__D046939smesh__D000458
% 210.96/211.16  |- mesh__publicMeSHNote mesh__D029970 2002   
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D029970 2002
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D029970 2005
% 210.96/211.16  |- skos__prefLabel mesh__D029970 Angelica archangelica
% 210.96/211.16  |- mesh__dateEstablished mesh__D029970 2002-01-01
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D029970 2003
% 210.96/211.16  |- rdf__type mesh__D029970sskos__Concept
% 210.96/211.16  |- mesh__dateCreated mesh__D029970 2001-07-25
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D029970 2006
% 210.96/211.16  |- mesh__historyNote mesh__D029970 2002   
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D029970 2004
% 210.96/211.16  |- skos__scopeNote mesh__D029970
% 210.96/211.16       A plant species of the family Apiaceae that contains COUMARINS.%A%    
% 210.96/211.16  |- skos__annotation mesh__D029970
% 210.96/211.16       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.96/211.16  |- skos__broader mesh__D029970smesh__D029969
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D010467 2001
% 210.96/211.16  |- mesh__publicMeSHNote mesh__D010467 70   
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D010467 2004
% 210.96/211.16  |- mesh__dateRevised mesh__D010467 1997-06-20
% 210.96/211.16  |- rdf__type mesh__D010467sskos__Concept
% 210.96/211.16  |- mesh__historyNote mesh__D010467 70%28%65%29%   
% 210.96/211.16  |- mesh__recordAuthorizer mesh__D010467 SJN
% 210.96/211.16  |- skos__annotation mesh__D010467 no qualif   
% 210.96/211.16  |- skos__broader mesh__D010467smesh__D003674
% 210.96/211.16  |- skos__scopeNote mesh__D010467
% 210.96/211.16       Selective perceiving such that the individual protects himself from becoming aware of something unpleasant or threatening, e.g., obscene words are not heard correctly, or violent acts are not seen accurately.%A%    
% 210.96/211.16  |- mesh__dateCreated mesh__D010467 1999-01-01
% 210.96/211.16  |- mesh__recordMaintainer mesh__D010467 JLS
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D010467 2002
% 210.96/211.16  |- skos__hiddenLabel mesh__D010467 Defense, Perceptual
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D010467 2005
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D010467 1998
% 210.96/211.16  |- mesh__recordOriginator mesh__D010467 NLM
% 210.96/211.16  |- skos__prefLabel mesh__D010467 Perceptual Defense
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D010467 2006
% 210.96/211.16  |- mesh__dateEstablished mesh__D010467 1970-01-01
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D010467 2000
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D010467 1999
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D010467 2003
% 210.96/211.16  |- skos__hiddenLabel mesh__D010467 Defenses, Perceptual
% 210.96/211.16  |- skos__historyNote mesh__D015152 RNA or specific %28%1979-1988%29%
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D015152 2003
% 210.96/211.16  |- mesh__dateRevised mesh__D015152 2002-07-02
% 210.96/211.16  |- skos__broader mesh__D015152smesh__D009710
% 210.96/211.16  |- mesh__historyNote mesh__D015152
% 210.96/211.16       91%28%89%29%; was see under MOLECULAR PROBE TECHNIQUES 1989-90   
% 210.96/211.16  |- rdf__type mesh__D015152sskos__Concept
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D015152 2004
% 210.96/211.16  |- skos__hiddenLabel mesh__D015152 Blots, Northern
% 210.96/211.16  |- mesh__publicMeSHNote mesh__D015152
% 210.96/211.16       91; was see under MOLECULAR PROBE TECHNIQUES 1989-90   
% 210.96/211.16  |- skos__hiddenLabel mesh__D015152 Northern Blots
% 210.96/211.16  |- skos__hiddenLabel mesh__D015152 Northern Blottings
% 210.96/211.16  |- skos__altLabel mesh__D015152 Northern Blotting
% 210.96/211.16  |- mesh__recordMaintainer mesh__D015152 lkt
% 210.96/211.16  |- skos__annotation mesh__D015152
% 210.96/211.16       %22%northern%22% is not capitalized in titles or translations; DF: NORTHERN BLOT%A%  
% 210.96/211.16  |- mesh__recordOriginator mesh__D015152 SCD
% 210.96/211.16  |- mesh__dateEstablished mesh__D015152 1991-01-01
% 210.96/211.16  |- skos__prefLabel mesh__D015152 Blotting, Northern
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D015152 2005
% 210.96/211.16  |- skos__broader mesh__D015152smesh__D015336
% 210.96/211.16  |- mesh__recordAuthorizer mesh__D015152 sjn
% 210.96/211.16  |- skos__historyNote mesh__D015152
% 210.96/211.16       Nucleic Acid Hybridization %28%1979-1988%29%
% 210.96/211.16  |- skos__hiddenLabel mesh__D015152 Blottings, Northern
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D015152 2006
% 210.96/211.16  |- skos__scopeNote mesh__D015152
% 210.96/211.16       Detection of RNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES.%A%    
% 210.96/211.16  |- mesh__dateCreated mesh__D015152 1988-03-22
% 210.96/211.16  |- skos__historyNote mesh__D015152
% 210.96/211.16       Electrophoresis, Polyacrylamide Gel %28%1984-1988%29%
% 210.96/211.16  |- skos__altLabel mesh__D015152 Northern Blot
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D009913 2000
% 210.96/211.16  |- mesh__dateCreated mesh__D009913 1999-01-01
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D009913 1997
% 210.96/211.16  |- skos__hiddenLabel mesh__D009913 Stages, Oral Sadistic
% 210.96/211.16  |- skos__prefLabel mesh__D009913 Oral Stage
% 210.96/211.16  |- mesh__historyNote mesh__D009913
% 210.96/211.16       91%28%75%29%; was see under PSYCHOSEXUAL DEVELOPMENT 1975-90   
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D009913 2001
% 210.96/211.16  |- mesh__dateRevised mesh__D009913 1991-06-11
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D009913 2005
% 210.96/211.16  |- skos__hiddenLabel mesh__D009913 Stages, Oral
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D009913 1992
% 210.96/211.16  |- skos__broader mesh__D009913smesh__D011606
% 210.96/211.16  |- skos__hiddenLabel mesh__D009913 Oral Sadistic Stages
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D009913 1994
% 210.96/211.16  |- skos__hiddenLabel mesh__D009913 Stage, Oral
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D009913 2002
% 210.96/211.16  |- mesh__recordMaintainer mesh__D009913 TGC
% 210.96/211.16  |- skos__scopeNote mesh__D009913
% 210.96/211.16       The earliest of the stages of infantile psychosexual development, lasting from birth to 12 months or longer.%A%    
% 210.96/211.16  |- mesh__publicMeSHNote mesh__D009913
% 210.96/211.16       91; was see under PSYCHOSEXUAL DEVELOPMENT 1975-90   
% 210.96/211.16  |- skos__hiddenLabel mesh__D009913 Stage, Oral Sadistic
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D009913 2006
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D009913 1993
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D009913 2003
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D009913 1998
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D009913 1995
% 210.96/211.16  |- skos__hiddenLabel mesh__D009913 Erotic Stage, Oral
% 210.96/211.16  |- skos__hiddenLabel mesh__D009913 Oral Erotic Stages
% 210.96/211.16  |- skos__hiddenLabel mesh__D009913 Erotic Stages, Oral
% 210.96/211.16  |- skos__hiddenLabel mesh__D009913 Oral Stages
% 210.96/211.16  |- skos__hiddenLabel mesh__D009913 Stage, Oral Erotic
% 210.96/211.16  |- mesh__recordAuthorizer mesh__D009913 PLS
% 210.96/211.16  |- skos__hiddenLabel mesh__D009913 Sadistic Stages, Oral
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D009913 2004
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D009913 1999
% 210.96/211.16  |- mesh__recordOriginator mesh__D009913 NLM
% 210.96/211.16  |- mesh__onlineNote mesh__D009913
% 210.96/211.16       search PSYCHOSEXUAL DEVELOPMENT 1968-74   
% 210.96/211.16  |- skos__annotation mesh__D009913 no qualif   
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D009913 1996
% 210.96/211.16  |- skos__hiddenLabel mesh__D009913 Sadistic Stage, Oral
% 210.96/211.16  |- rdf__type mesh__D009913sskos__Concept
% 210.96/211.16  |- mesh__dateEstablished mesh__D009913 1991-01-01
% 210.96/211.16  |- skos__hiddenLabel mesh__D009913 Stages, Oral Erotic
% 210.96/211.16  |- skos__altLabel mesh__D001930 Encephalopathy, Traumatic
% 210.96/211.16  |- skos__altLabel mesh__D001930 Injuries, Brain
% 210.96/211.16  |- skos__altLabel mesh__D001930 Traumatic Brain Injury
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Contusions, Brain
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Injuries, Traumatic Brain
% 210.96/211.16  |- mesh__publicMeSHNote mesh__D001930
% 210.96/211.16       1981; see BRAIN INJURIES 1981-1999, see BRAIN INJURIES, ACUTE 1973-1980, see BRAIN INJURY, ACUTE 1963-1972; for BRAIN CONTUSION see BRAIN CONCUSSION 1998-1999%A%  
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Injuries, Diffuse Brain
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Encephalopathies, Post-Traumatic
% 210.96/211.16  |- skos__altLabel mesh__D001930 Acute Brain Injuries
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Contusions, Cortical
% 210.96/211.16  |- rdf__type mesh__D001930sskos__Concept
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Brain Injury
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Encephalopathy, Post Traumatic
% 210.96/211.16  |- skos__altLabel mesh__D001930 Injury, Brain, Traumatic
% 210.96/211.16  |- mesh__historyNote mesh__D001930
% 210.96/211.16       1981%28%1963%29%; for BRAIN CONTUSION use BRAIN CONCUSSION 1998-1999%A%  
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Brain Injury, Focal
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 TBIs %28%Traumatic Brain Injury%29%
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Injury, Brain
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Post Concussive Encephalopathy
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Contusion, Brain
% 210.96/211.16  |- skos__broader mesh__D001930smesh__D001927
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Brain Laceration
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Encephalopathy, Post Concussive
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Traumatic Encephalopathies
% 210.96/211.16  |- mesh__dateCreated mesh__D001930 1999-01-01
% 210.96/211.16  |- mesh__activeMeSHYear mesh__D001930 2006
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Post Traumatic Encephalopathy
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Laceration, Brain
% 210.96/211.16  |- skos__scopeNote mesh__D001930
% 210.96/211.16       Acute and chronic %28%see also BRAIN INJURIES, CHRONIC%29% injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.%A%    
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Brain Injury, Acute
% 210.96/211.16  |- skos__prefLabel mesh__D001930 Brain Injuries
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Diffuse Brain Injury
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Contusion, Cortical
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Injuries, Focal Brain
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Brain Injury, Diffuse
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Injury, Focal Brain
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Injury, Diffuse Brain
% 210.96/211.16  |- skos__altLabel mesh__D001930 Post-Traumatic Encephalopathy
% 210.96/211.16  |- mesh__dateRevised mesh__D001930 2005-06-30
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Acute Brain Injury
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Brain Trauma
% 210.96/211.16  |- skos__altLabel mesh__D001930 Focal Brain Injuries
% 210.96/211.16  |- skos__altLabel mesh__D001930 Trauma, Brain
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Post-Traumatic Encephalopathies
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Traumas, Brain
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Lacerations, Brain
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Cortical Contusions
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Post-Concussive Encephalopathies
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Encephalopathies, Post-Concussive
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Focal Brain Injury
% 210.96/211.16  |- skos__altLabel mesh__D001930 Brain Injuries, Acute
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Encephalopathies, Traumatic
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Injury, Traumatic Brain
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Brain Contusions
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Traumatic Brain Injuries
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Brain Traumas
% 210.96/211.16  |- skos__annotation mesh__D001930
% 210.96/211.16       general or unspecified; consider also /inj with specific parts of the brain; X ref BRAIN CONTUSION: do not coordinate with CONTUSIONS; do not confuse with CRANIOCEREBRAL TRAUMA%A%  
% 210.96/211.16  |- mesh__recordOriginator mesh__D001930 NLM
% 210.96/211.16  |- skos__altLabel mesh__D001930 Traumatic Encephalopathy
% 210.96/211.16  |- mesh__recordAuthorizer mesh__D001930 sjn
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Diffuse Brain Injuries
% 210.96/211.16  |- mesh__recordMaintainer mesh__D001930 lkt
% 210.96/211.16  |- skos__altLabel mesh__D001930 Post-Concussive Encephalopathy
% 210.96/211.16  |- skos__altLabel mesh__D001930 TBI %28%Traumatic Brain Injury%29%
% 210.96/211.16  |- skos__broader mesh__D001930smesh__D006259
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Injury, Acute Brain
% 210.96/211.16  |- mesh__dateEstablished mesh__D001930 1973-01-01
% 210.96/211.16  |- skos__hiddenLabel mesh__D001930 Brain Injury, Traumatic
% 210.96/211.16  |- mesh__recordMaintainer mesh__D009115 ags
% 210.96/211.16  |- skos__broader mesh__D009115smesh__D012377
% 210.96/211.16  |- mesh__publicMeSHNote mesh__D009115 82   
% 210.96/211.16  |- skos__historyNote mesh__D009115 Mice %28%1966-1981%29%
% 210.96/211.16  |- mesh__recordAuthorizer mesh__D009115 sjn
% 210.96/211.16  |- mesh__historyNote mesh__D009115 82   
% 210.96/211.16  |- skos__historyNote mesh__D009115 Rats %28%1966-1981%29%
% 210.96/211.16  |- mesh__dateRevised mesh__D009115 2005-06-30
% 210.96/211.16  |- skos__prefLabel mesh__D009115 Muridae
% 210.96/211.16  |- mesh__dateEstablished mesh__D009115 1982-01-01
% 210.96/211.17  |- rdf__type mesh__D009115sskos__Concept
% 210.96/211.17  |- skos__hiddenLabel mesh__D009115 Murid
% 210.96/211.17  |- mesh__dateCreated mesh__D009115 1981-05-14
% 210.96/211.17  |- skos__historyNote mesh__D009115 Rodentia %28%1966-1981%29%
% 210.96/211.17  |- skos__annotation mesh__D009115 do not check tags MICE or RATS   
% 210.96/211.17  |- mesh__recordOriginator mesh__D009115 EC
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D009115 2006
% 210.96/211.17  |- skos__altLabel mesh__D009115 Murids
% 210.96/211.17  |- skos__scopeNote mesh__D009115
% 210.96/211.17       A family of the order Rodentia containing 250 genera including the two genera Mus %28%MICE%29% and Rattus %28%RATS%29%, from which the laboratory inbred strains are developed. The fifteen subfamilies are SIGMODONTINAE %28%New World mice and rats%29%, CRICETINAE, Spalacinae, Myospalacinae, Lophiomyinae, ARVICOLINAE, Platacanthomyinae, Nesomyinae, Otomyinae, Rhizomyinae, GERBILLINAE, Dendromurinae, Cricetomyinae, MURINAE %28%Old World mice and rats%29%, and Hydromyinae.%A%    
% 210.96/211.17  |- rdf__type mesh__D001132sskos__Concept
% 210.96/211.17  |- mesh__recordOriginator mesh__D001132 NLM
% 210.96/211.17  |- mesh__recordAuthorizer mesh__D001132 sjn
% 210.96/211.17  |- mesh__dateRevised mesh__D001132 2002-07-02
% 210.96/211.17  |- mesh__dateCreated mesh__D001132 1999-01-01
% 210.96/211.17  |- skos__broader mesh__D001132smesh__D034941
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D001132 2003
% 210.96/211.17  |- mesh__recordMaintainer mesh__D001132 ags
% 210.96/211.17  |- skos__prefLabel mesh__D001132 Arm
% 210.96/211.17  |- skos__scopeNote mesh__D001132
% 210.96/211.17       The superior part of the upper extremity between the SHOULDER and the ELBOW.%A%    
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D001132 2005
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D001132 2004
% 210.96/211.17  |- skos__annotation mesh__D001132
% 210.96/211.17       primates only; for whole arm or upper arm; FOREARM is also available; Manual 21.58: extremities of humans %26% animals; NIM when merely locational as in skin dis %28%IM%29%%A%  
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D001132 2006
% 210.96/211.17  |- skos__related mesh__D001132smesh__D005552
% 210.96/211.17  |- skos__hiddenLabel mesh__D001132 Arms
% 210.96/211.17  |- mesh__publicMeSHNote mesh__D020895 2000   
% 210.96/211.17  |- skos__hiddenLabel mesh__D020895 Enterocyte
% 210.96/211.17  |- mesh__recordMaintainer mesh__D020895 lkt
% 210.96/211.17  |- rdf__type mesh__D020895sskos__Concept
% 210.96/211.17  |- skos__scopeNote mesh__D020895
% 210.96/211.17       Absorptive cells in the lining of the INTESTINAL MUCOSA. They are differentiated EPITHELIAL CELLS with apical MICROVILLI facing the intestinal lumen. Enterocytes are more abundant in the SMALL INTESTINE than in the LARGE INTESTINE. Their microvilli greatly increase the luminal surface area of the cell by 14- to 40 fold.%A%    
% 210.96/211.17  |- mesh__recordAuthorizer mesh__D020895 sjn
% 210.96/211.17  |- skos__broader mesh__D020895smesh__D007413
% 210.96/211.17  |- mesh__dateRevised mesh__D020895 2005-06-30
% 210.96/211.17  |- mesh__dateEstablished mesh__D020895 2000-01-01
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D020895 2006
% 210.96/211.17  |- mesh__recordOriginator mesh__D020895 ndw
% 210.96/211.17  |- mesh__historyNote mesh__D020895 2000   
% 210.96/211.17  |- skos__prefLabel mesh__D020895 Enterocytes
% 210.96/211.17  |- mesh__dateCreated mesh__D020895 1999-11-03
% 210.96/211.17  |- skos__broader mesh__D020895smesh__D004847
% 210.96/211.17  |- skos__historyNote mesh__D020895 Intestinal Mucosa %28%1968-1999%29%
% 210.96/211.17  |- skos__altLabel mesh__D020097 BNP-32
% 210.96/211.17  |- skos__altLabel mesh__D020097 Brain Natriuretic Peptide-32
% 210.96/211.17  |- skos__hiddenLabel mesh__D020097 Natriuretic Peptide-32, Brain
% 210.96/211.17  |- mesh__dateRevised mesh__D020097 2005-06-30
% 210.96/211.17  |- rdf__type mesh__D020097sskos__Concept
% 210.96/211.17  |- skos__hiddenLabel mesh__D020097 Peptide-32, Brain Natriuretic
% 210.96/211.17  |- skos__hiddenLabel mesh__D020097 Peptide, Brain Natriuretic
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D020097 2006
% 210.96/211.17  |- skos__hiddenLabel mesh__D020097 Ventricular Natriuretic Peptide, B type
% 210.96/211.17  |- skos__hiddenLabel mesh__D020097 Natriuretic Peptide, Type-B
% 210.96/211.17  |- skos__prefLabel mesh__D020097 Natriuretic Peptide, Brain
% 210.96/211.17  |- mesh__recordMaintainer mesh__D020097 ssb
% 210.96/211.17  |- mesh__recordAuthorizer mesh__D020097 sjn
% 210.96/211.17  |- skos__altLabel mesh__D020097 Natriuretic Peptide Type-B
% 210.96/211.17  |- mesh__historyNote mesh__D020097
% 210.96/211.17       1999, use BRAIN NATRIURETIC PEPTIDE %28%NM%29% 1988-1998; use NATRIURETIC PEPTIDE, BRAIN %28%NM%29% for NATRIURETIC PEPTIDE TYPE-B 1994-2003; use NATRIURETIC PEPTIDE, BRAIN %28%NM%29% for NESIRITIDE 2003; for VENTRICULAR NATRIURETIC PEPTIDE, B-TYPE use NATRIURETIC PEPTIDE, BRAIN %28%NM%29% 1994-2003.%A%  
% 210.96/211.17  |- skos__altLabel mesh__D020097 Nesiritide
% 210.96/211.17  |- skos__altLabel mesh__D020097 Natriuretic Factor-32
% 210.96/211.17  |- skos__historyNote mesh__D020097 Nerve Tissue Proteins %28%1988-1998%29%
% 210.96/211.17  |- skos__broader mesh__D020097smesh__D009419
% 210.96/211.17  |- skos__scopeNote mesh__D020097
% 210.96/211.17       A PEPTIDE that is secreted by the BRAIN and the HEART ATRIA, stored mainly in cardiac ventricular MYOCARDIUM. It can cause NATRIURESIS; DIURESIS; VASODILATION; and inhibits secretion of RENIN and ALDOSTERONE. It improves heart function. It contains 32 AMINO ACIDS.%A%    
% 210.96/211.17  |- skos__hiddenLabel mesh__D020097 Natriuretic Peptide, B-Type
% 210.96/211.17  |- skos__altLabel mesh__D020097 BNP Gene Product
% 210.96/211.17  |- skos__altLabel mesh__D020097 Type-B Natriuretic Peptide
% 210.96/211.17  |- skos__broader mesh__D020097smesh__D001685
% 210.96/211.17  |- skos__hiddenLabel mesh__D020097 Type B Natriuretic Peptide
% 210.96/211.17  |- skos__hiddenLabel mesh__D020097 Brain Natriuretic Peptide 32
% 210.96/211.17  |- skos__hiddenLabel mesh__D020097 BNP 32
% 210.96/211.17  |- skos__altLabel mesh__D020097 Brain Natriuretic Peptide
% 210.96/211.17  |- mesh__recordOriginator mesh__D020097 TPW
% 210.96/211.17  |- mesh__dateEstablished mesh__D020097 1999-01-01
% 210.96/211.17  |- skos__broader mesh__D020097smesh__D045265
% 210.96/211.17  |- mesh__publicMeSHNote mesh__D020097
% 210.96/211.17       1999; BRAIN NATRIURETIC PEPTIDE was indexed under NERVE TISSUE PROTEINS 1988-1998; NATRIURETIC PEPTIDE TYPE-B was indexed under ATRIAL NATRIURETIC FACTOR 1994-2003; NESIRITIDE was indexed under NATRIURETIC HORMONE 2003; VENTRICULAR NATRIURETIC PEPTIDE, B-TYPE was indexed under ATRIAL NATRIURETIC FACTOR 1994-2003.%A%  
% 210.96/211.17  |- skos__altLabel mesh__D020097 B-Type Natriuretic Peptide
% 210.96/211.17  |- skos__hiddenLabel mesh__D020097 Natriuretic Factor 32
% 210.96/211.17  |- mesh__dateCreated mesh__D020097 1998-06-10
% 210.96/211.17  |- skos__hiddenLabel mesh__D020097 Natriuretic Peptide Type B
% 210.96/211.17  |- skos__related mesh__D014858smesh__D045809
% 210.96/211.17  |- skos__prefLabel mesh__D014858 War Crimes
% 210.96/211.17  |- skos__hiddenLabel mesh__D014858 Crimes, War
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D014858 2005
% 210.96/211.17  |- mesh__dateCreated mesh__D014858 1999-01-01
% 210.96/211.17  |- skos__broader mesh__D014858smesh__D003415
% 210.96/211.17  |- mesh__dateRevised mesh__D014858 2003-07-09
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D014858 2006
% 210.96/211.17  |- mesh__recordMaintainer mesh__D014858 jls
% 210.96/211.17  |- skos__broader mesh__D014858smesh__D014857
% 210.96/211.17  |- skos__hiddenLabel mesh__D014858 Crime, War
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D014858 2004
% 210.96/211.17  |- skos__scopeNote mesh__D014858
% 210.96/211.17       Criminal acts committed during, or in connection with, war, e.g., maltreatment of prisoners, willful killing of civilians, etc.%A%    
% 210.96/211.17  |- mesh__recordAuthorizer mesh__D014858 sjn
% 210.96/211.17  |- mesh__recordOriginator mesh__D014858 NLM
% 210.96/211.17  |- skos__hiddenLabel mesh__D014858 War Crime
% 210.96/211.17  |- rdf__type mesh__D014858sskos__Concept
% 210.96/211.17  |- mesh__historyNote mesh__D000838 74   
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D000838 1999
% 210.96/211.17  |- mesh__dateEstablished mesh__D000838 1974-01-01
% 210.96/211.17  |- mesh__recordOriginator mesh__D000838 NLM
% 210.96/211.17  |- mesh__publicMeSHNote mesh__D000838 74   
% 210.96/211.17  |- mesh__recordMaintainer mesh__D000838 ADP
% 210.96/211.17  |- mesh__dateRevised mesh__D000838 1998-06-10
% 210.96/211.17  |- skos__broader mesh__D000838smesh__D007477
% 210.96/211.17  |- mesh__recordAuthorizer mesh__D000838 SJN
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D000838 2002
% 210.96/211.17  |- mesh__dateCreated mesh__D000838 1999-01-01
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D000838 2004
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D000838 2001
% 210.96/211.17  |- skos__scopeNote mesh__D000838
% 210.96/211.17       Negatively charged atoms, radicals or groups of atoms which travel to the anode or positive pole during electrolysis.%A%    
% 210.96/211.17  |- skos__prefLabel mesh__D000838 Anions
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D000838 2006
% 210.96/211.17  |- rdf__type mesh__D000838sskos__Concept
% 210.96/211.17  |- skos__annotation mesh__D000838 GEN or unspecified; prefer specifics   
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D000838 2003
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D000838 2005
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D000838 2000
% 210.96/211.17  |- skos__annotation mesh__D011560 /biosyn permitted for micro-organisms   
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D011560 2002
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D011560 1997
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D011560 2006
% 210.96/211.17  |- skos__prefLabel mesh__D011560 Pseudouridine
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D011560 1998
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D011560 1993
% 210.96/211.17  |- mesh__recordAuthorizer mesh__D011560 PLS
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D011560 1994
% 210.96/211.17  |- mesh__dateRevised mesh__D011560 1992-05-20
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D011560 1999
% 210.96/211.17  |- mesh__publicMeSHNote mesh__D011560 91; was see under URIDINE 1972-90   
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D011560 2003
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D011560 1995
% 210.96/211.17  |- mesh__recordMaintainer mesh__D011560 TGC
% 210.96/211.17  |- skos__historyNote mesh__D011560 Uridine %28%1966-1971%29%
% 210.96/211.17  |- mesh__recordOriginator mesh__D011560 NLM
% 210.96/211.17  |- rdf__type mesh__D011560sskos__Concept
% 210.96/211.17  |- mesh__dateEstablished mesh__D011560 1991-01-01
% 210.96/211.17  |- mesh__dateCreated mesh__D011560 1999-01-01
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D011560 2000
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D011560 2004
% 210.96/211.17  |- skos__broader mesh__D011560smesh__D014529
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D011560 2001
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D011560 1996
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D011560 2005
% 210.96/211.17  |- mesh__historyNote mesh__D011560
% 210.96/211.17       91%28%72%29%; was see under URIDINE 1972-90   
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D005523 2005
% 210.96/211.17  |- skos__broader mesh__D005523smesh__D019649
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D005523 2004
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D005523 2002
% 210.96/211.17  |- skos__annotation mesh__D005523 specify geog if pertinent   
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D005523 2006
% 210.96/211.17  |- mesh__recordMaintainer mesh__D005523 kle
% 210.96/211.17  |- mesh__dateCreated mesh__D005523 1999-01-01
% 210.96/211.17  |- mesh__recordOriginator mesh__D005523 NLM
% 210.96/211.17  |- skos__hiddenLabel mesh__D005523 Supplies, Food
% 210.96/211.17  |- skos__prefLabel mesh__D005523 Food Supply
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D005523 2000
% 210.96/211.17  |- mesh__dateRevised mesh__D005523 1999-11-03
% 210.96/211.17  |- mesh__recordAuthorizer mesh__D005523 sjn
% 210.96/211.17  |- skos__hiddenLabel mesh__D005523 Food Supplies
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D005523 2001
% 210.96/211.17  |- skos__hiddenLabel mesh__D005523 Supply, Food
% 210.96/211.17  |- rdf__type mesh__D005523sskos__Concept
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D005523 2003
% 210.96/211.17  |- mesh__historyNote mesh__D052179 2006   
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D052179 2006
% 210.96/211.17  |- mesh__dateEstablished mesh__D052179 2006-01-01
% 210.96/211.17  |- rdf__type mesh__D052179sskos__Concept
% 210.96/211.17  |- mesh__dateCreated mesh__D052179 2005-06-30
% 210.96/211.17  |- skos__prefLabel mesh__D052179 Antigens, Plant
% 210.96/211.17  |- skos__annotation mesh__D052179
% 210.96/211.17       if allergen is LATEX consider LATEX HYPERSENSITIVITY   
% 210.96/211.17  |- skos__scopeNote mesh__D052179
% 210.96/211.17       Substances from PLANTS that have antigenic activity.     
% 210.96/211.17  |- mesh__publicMeSHNote mesh__D052179 2006   
% 210.96/211.17  |- skos__hiddenLabel mesh__D052179 Plant Allergens
% 210.96/211.17  |- skos__broader mesh__D052179smesh__D000941
% 210.96/211.17  |- mesh__recordMaintainer mesh__D052179 ssb
% 210.96/211.17  |- skos__altLabel mesh__D052179 Plant Antigens
% 210.96/211.17  |- mesh__recordOriginator mesh__D052179 ssb
% 210.96/211.17  |- mesh__recordAuthorizer mesh__D052179 sjn
% 210.96/211.17  |- skos__annotation mesh__D029971
% 210.96/211.17       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.96/211.17  |- rdf__type mesh__D029971sskos__Concept
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D029971 2004
% 210.96/211.17  |- skos__scopeNote mesh__D029971
% 210.96/211.17       A plant species of the family APIACEAE that is the source of dong quai.%A%    
% 210.96/211.17  |- mesh__dateEstablished mesh__D029971 2002-01-01
% 210.96/211.17  |- skos__prefLabel mesh__D029971 Angelica sinensis
% 210.96/211.17  |- skos__broader mesh__D029971smesh__D029969
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D029971 2002
% 210.96/211.17  |- mesh__publicMeSHNote mesh__D029971 2002   
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D029971 2005
% 210.96/211.17  |- mesh__dateCreated mesh__D029971 2001-07-25
% 210.96/211.17  |- mesh__historyNote mesh__D029971 2002   
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D029971 2003
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D029971 2006
% 210.96/211.17  |- skos__hiddenLabel mesh__D043642 Receptor, M5 Muscarinic
% 210.96/211.17  |- skos__hiddenLabel mesh__D043642 Muscarinic Receptor, M5
% 210.96/211.17  |- mesh__dateCreated mesh__D043642 2003-07-09
% 210.96/211.17  |- skos__hiddenLabel mesh__D043642 M5 Receptors, Muscarinic
% 210.96/211.17  |- skos__hiddenLabel mesh__D043642 Muscarinic M5 Receptor
% 210.96/211.17  |- skos__altLabel mesh__D043642 Muscarinic Receptor M5
% 210.96/211.17  |- mesh__historyNote mesh__D043642
% 210.96/211.17       2004; use RECEPTOR, MUSCARINIC M5 %28%NM%29% 1996-2003   
% 210.96/211.17  |- skos__hiddenLabel mesh__D043642 Receptor M5, Muscarinic
% 210.96/211.17  |- mesh__recordOriginator mesh__D043642 jmp
% 210.96/211.17  |- mesh__recordMaintainer mesh__D043642 jmp
% 210.96/211.17  |- skos__hiddenLabel mesh__D043642 Receptors M5, Muscarinic
% 210.96/211.17  |- mesh__dateEstablished mesh__D043642 2004-01-01
% 210.96/211.17  |- mesh__recordAuthorizer mesh__D043642 sjn
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D043642 2005
% 210.96/211.17  |- skos__broader mesh__D043642smesh__D011976
% 210.96/211.17  |- skos__scopeNote mesh__D043642
% 210.96/211.17       A specific subtype of muscarinic receptor found in a variety of locations including the SALIVARY GLANDS and the SUBSTANTIA NIGRA and VENTRAL TEGMENTAL AREA of the BRAIN.%A%    
% 210.96/211.17  |- skos__hiddenLabel mesh__D043642 M5, Muscarinic Receptors
% 210.96/211.17  |- mesh__publicMeSHNote mesh__D043642
% 210.96/211.17       2004; M5 MUSCARINIC RECEPTOR was indexed under RECEPTORS, MUSCARINIC 1996-2003%A%  
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D043642 2006
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D043642 2004
% 210.96/211.17  |- skos__altLabel mesh__D043642 M5 Muscarinic Receptor
% 210.96/211.17  |- rdf__type mesh__D043642sskos__Concept
% 210.96/211.17  |- skos__hiddenLabel mesh__D043642 M5, Muscarinic Receptor
% 210.96/211.17  |- skos__historyNote mesh__D043642 Receptors, Muscarinic %28%1996-2003%29%
% 210.96/211.17  |- skos__hiddenLabel mesh__D043642 M5 Receptor, Muscarinic
% 210.96/211.17  |- skos__altLabel mesh__D043642 Receptors, Muscarinic M5
% 210.96/211.17  |- skos__prefLabel mesh__D043642 Receptor, Muscarinic M5
% 210.96/211.17  |- skos__hiddenLabel mesh__D043642 Muscarinic M5 Receptors
% 210.96/211.17  |- skos__altLabel mesh__D043642 Muscarinic Receptors M5
% 210.96/211.17  |- mesh__dateCreated mesh__D010468 1999-01-01
% 210.96/211.17  |- skos__hiddenLabel mesh__D010468 Neglects, Hemisensory
% 210.96/211.17  |- skos__hiddenLabel mesh__D010468 Discrimination Disorders, Somatosensory
% 210.96/211.17  |- mesh__dateEstablished mesh__D010468 1969-01-01
% 210.96/211.17  |- skos__hiddenLabel mesh__D010468 Discrimination Disorder, Somatosensory
% 210.96/211.17  |- skos__historyNote mesh__D010468 Illusions %28%1966-1968%29%
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D010468 2005
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D010468 2000
% 210.96/211.17  |- skos__hiddenLabel mesh__D010468 Neglect, Hemispatial
% 210.96/211.17  |- mesh__dateRevised mesh__D010468 1999-11-03
% 210.96/211.17  |- skos__scopeNote mesh__D010468
% 210.96/211.17       Cognitive disorders characterized by an impaired ability to perceive the nature of objects or concepts through use of the sense organs. These include spatial neglect syndromes, where an individual does not attend to visual, auditory, or sensory stimuli presented from one side of the body.%A%    
% 210.96/211.17  |- skos__prefLabel mesh__D010468 Perceptual Disorders
% 210.96/211.17  |- skos__hiddenLabel mesh__D010468 Perceptual Disorder
% 210.96/211.17  |- skos__hiddenLabel mesh__D010468 Hemispatial Neglects
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D010468 2006
% 210.96/211.17  |- skos__historyNote mesh__D010468 Perception %28%1966-1968%29%
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D010468 2001
% 210.96/211.17  |- skos__hiddenLabel mesh__D010468 Neglect, Sensory
% 210.96/211.17  |- mesh__recordMaintainer mesh__D010468 KEV
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D010468 2003
% 210.96/211.17  |- skos__broader mesh__D010468smesh__D019954
% 210.96/211.17  |- skos__hiddenLabel mesh__D010468 Hemisensory Neglects
% 210.96/211.17  |- mesh__historyNote mesh__D010468 1969   
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D010468 2004
% 210.96/211.17  |- rdf__type mesh__D010468sskos__Concept
% 210.96/211.17  |- mesh__publicMeSHNote mesh__D010468 1969   
% 210.96/211.17  |- skos__historyNote mesh__D010468 Hallucinations %28%1966-1968%29%
% 210.96/211.17  |- skos__hiddenLabel mesh__D010468 Somatosensory Discrimination Disorders
% 210.96/211.17  |- skos__hiddenLabel mesh__D010468 Sensory Neglects
% 210.96/211.17  |- mesh__recordAuthorizer mesh__D010468 sjn
% 210.96/211.17  |- skos__hiddenLabel mesh__D010468 Neglect, Hemisensory
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D010468 2002
% 210.96/211.17  |- skos__historyNote mesh__D010468 Phantom Limb %28%1966-1968%29%
% 210.96/211.17  |- skos__historyNote mesh__D010468 Agnosia %28%1966-1968%29%
% 210.96/211.17  |- mesh__recordOriginator mesh__D010468 NLM
% 210.96/211.17  |- mesh__recordAuthorizer mesh__D015951 sjn
% 210.96/211.17  |- rdf__type mesh__D015951sskos__Concept
% 210.96/211.17  |- skos__hiddenLabel mesh__D015951 Factor Xa, Coagulation
% 210.96/211.17  |- mesh__dateEstablished mesh__D015951 1990-01-01
% 210.96/211.17  |- mesh__dateCreated mesh__D015951 1989-05-25
% 210.96/211.17  |- skos__altLabel mesh__D015951 Factor X, Activated
% 210.96/211.17  |- skos__historyNote mesh__D015951 Serine Proteinases %28%1988-1989%29%
% 210.96/211.17  |- skos__hiddenLabel mesh__D015951 Xa, Coagulation Factor
% 210.96/211.17  |- skos__altLabel mesh__D015951 Activated Factor X
% 210.96/211.17  |- mesh__publicMeSHNote mesh__D015951 90   
% 210.96/211.17  |- skos__related mesh__D015951smesh__D003029
% 210.96/211.17  |- mesh__historyNote mesh__D015951 90   
% 210.96/211.17  |- mesh__dateRevised mesh__D015951 2005-06-30
% 210.96/211.17  |- skos__prefLabel mesh__D015951 Factor Xa
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D015951 2006
% 210.96/211.17  |- skos__altLabel mesh__D015951 Coagulation Factor Xa
% 210.96/211.17  |- skos__altLabel mesh__D015951 Blood Coagulation Factor X, Activated
% 210.96/211.17  |- skos__broader mesh__D015951smesh__D012697
% 210.96/211.17  |- skos__altLabel mesh__D015951 Thrombokinase
% 210.96/211.17  |- skos__historyNote mesh__D015951 Factor X %28%1970-1989%29%
% 210.96/211.17  |- mesh__recordMaintainer mesh__D015951 ssb
% 210.96/211.17  |- skos__annotation mesh__D015951 /defic = FACTOR X DEFICIENCY   
% 210.96/211.17  |- skos__scopeNote mesh__D015951
% 210.96/211.17       Activated form of factor X that participates in both the intrinsic and extrinsic pathways of blood coagulation. It catalyzes the conversion of prothrombin to thrombin in conjunction with other cofactors.%A%    
% 210.96/211.17  |- skos__altLabel mesh__D015951 Autoprothrombin C
% 210.96/211.17  |- skos__broader mesh__D015951smesh__D005170
% 210.96/211.17  |- mesh__recordOriginator mesh__D015951 AGS
% 210.96/211.17  |- mesh__historyNote mesh__D015153 89   
% 210.96/211.17  |- skos__broader mesh__D015153smesh__D015151
% 210.96/211.17  |- skos__prefLabel mesh__D015153 Blotting, Western
% 210.96/211.17  |- skos__altLabel mesh__D015153 Immunoblot, Western
% 210.96/211.17  |- skos__altLabel mesh__D015153 Western Blotting
% 210.96/211.17  |- skos__annotation mesh__D015153
% 210.96/211.17       %22%western%22% is not capitalized in titles or translations; DF: WESTERN BLOT%A%  
% 210.96/211.17  |- skos__historyNote mesh__D015153 Immunologic Techniques %28%1981-1988%29%
% 210.96/211.17  |- mesh__publicMeSHNote mesh__D015153 89   
% 210.96/211.17  |- skos__hiddenLabel mesh__D015153 Western Blottings
% 210.96/211.17  |- mesh__recordMaintainer mesh__D015153 nns
% 210.96/211.17  |- skos__altLabel mesh__D015153 Western Immunoblotting
% 210.96/211.17  |- skos__altLabel mesh__D015153 Western Blot
% 210.96/211.17  |- mesh__dateEstablished mesh__D015153 1989-01-01
% 210.96/211.17  |- mesh__dateRevised mesh__D015153 2001-07-25
% 210.96/211.17  |- mesh__recordOriginator mesh__D015153 SCD
% 210.96/211.17  |- skos__hiddenLabel mesh__D015153 Immunoblottings, Western
% 210.96/211.17  |- skos__hiddenLabel mesh__D015153 Western Blots
% 210.96/211.17  |- skos__altLabel mesh__D015153 Immunoblotting, Western
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D015153 2005
% 210.96/211.17  |- skos__broader mesh__D015153smesh__D015336
% 210.96/211.17  |- skos__hiddenLabel mesh__D015153 Blottings, Western
% 210.96/211.17  |- skos__historyNote mesh__D015153
% 210.96/211.17       Electrophoresis, Polyacrylamide Gel %28%1982-1988%29%
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D015153 2006
% 210.96/211.17  |- skos__hiddenLabel mesh__D015153 Western Immunoblots
% 210.96/211.17  |- mesh__dateCreated mesh__D015153 1988-03-22
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D015153 2002
% 210.96/211.17  |- skos__hiddenLabel mesh__D015153 Blots, Western
% 210.96/211.17  |- skos__hiddenLabel mesh__D015153 Immunoblots, Western
% 210.96/211.17  |- skos__historyNote mesh__D015153
% 210.96/211.17       Immunoenzyme Techniques %28%1981-1988%29%
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D015153 2003
% 210.96/211.17  |- skos__scopeNote mesh__D015153
% 210.96/211.17       Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.%A%    
% 210.96/211.17  |- skos__historyNote mesh__D015153
% 210.96/211.17       Enzyme-Linked Immunosorbent Assay %28%1983-1988%29%
% 210.96/211.17  |- skos__hiddenLabel mesh__D015153 Western Immunoblottings
% 210.96/211.17  |- mesh__recordAuthorizer mesh__D015153 sjn
% 210.96/211.17  |- skos__altLabel mesh__D015153 Western Immunoblot
% 210.96/211.17  |- rdf__type mesh__D015153sskos__Concept
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D015153 2004
% 210.96/211.17  |- mesh__historyNote mesh__D009914
% 210.96/211.17       91%28%68%29%; was see under MOUTH DISEASES 1968-90   
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D009914 2004
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D009914 2002
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D009914 1997
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D009914 2006
% 210.96/211.17  |- mesh__publicMeSHNote mesh__D009914
% 210.96/211.17       91; was see under MOUTH DISEASES 1968-90   
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D009914 1999
% 210.96/211.17  |- skos__hiddenLabel mesh__D009914 Fibroses, Oral Submucous
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D009914 2003
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D009914 2001
% 210.96/211.17  |- mesh__recordAuthorizer mesh__D009914 PLS
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D009914 1996
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D009914 1993
% 210.96/211.17  |- mesh__recordOriginator mesh__D009914 NLM
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D009914 1995
% 210.96/211.17  |- mesh__dateCreated mesh__D009914 1999-01-01
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D009914 1991
% 210.96/211.17  |- mesh__dateEstablished mesh__D009914 1991-01-01
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D009914 2005
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D009914 1998
% 210.96/211.17  |- skos__hiddenLabel mesh__D009914 Submucous Fibrosis, Oral
% 210.96/211.17  |- skos__broader mesh__D009914smesh__D009059
% 210.96/211.17  |- skos__hiddenLabel mesh__D009914 Submucous Fibroses, Oral
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D009914 1992
% 210.96/211.17  |- mesh__recordMaintainer mesh__D009914 NLM
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D009914 2000
% 210.96/211.17  |- rdf__type mesh__D009914sskos__Concept
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D009914 1994
% 210.96/211.17  |- mesh__dateRevised mesh__D009914 1990-04-13
% 210.96/211.17  |- skos__hiddenLabel mesh__D009914 Oral Submucous Fibroses
% 210.96/211.17  |- skos__historyNote mesh__D009914 Mouth Diseases %28%1966-1967%29%
% 210.96/211.17  |- skos__hiddenLabel mesh__D009914 Fibrosis, Oral Submucous
% 210.96/211.17  |- skos__prefLabel mesh__D009914 Oral Submucous Fibrosis
% 210.96/211.17  |- mesh__dateEstablished mesh__D001931 1968-01-01
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D001931 2000
% 210.96/211.17  |- rdf__type mesh__D001931sskos__Concept
% 210.96/211.17  |- skos__hiddenLabel mesh__D001931 Brain Mappings
% 210.96/211.17  |- mesh__recordOriginator mesh__D001931 NLM
% 210.96/211.17  |- mesh__historyNote mesh__D001931 68%28%64%29%   
% 210.96/211.17  |- mesh__publicMeSHNote mesh__D001931 68   
% 210.96/211.17  |- skos__broader mesh__D001931smesh__D008919
% 210.96/211.17  |- skos__hiddenLabel mesh__D001931 Brain Mappings, Topographic
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D001931 2006
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D001931 1995
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D001931 2002
% 210.96/211.17  |- mesh__recordMaintainer mesh__D001931 TAP
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D001931 2004
% 210.96/211.17  |- mesh__dateRevised mesh__D001931 1992-05-18
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D001931 1993
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D001931 1999
% 210.96/211.17  |- mesh__recordAuthorizer mesh__D001931 PLS
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D001931 2005
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D001931 1994
% 210.96/211.17  |- skos__hiddenLabel mesh__D001931 Brain Mapping, Topographic
% 210.96/211.17  |- mesh__dateCreated mesh__D001931 1999-01-01
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D001931 1997
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D001931 2003
% 210.96/211.17  |- skos__hiddenLabel mesh__D001931 Mappings, Topographic Brain
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D001931 1998
% 210.96/211.17  |- skos__hiddenLabel mesh__D001931 Mapping, Topographic Brain
% 210.96/211.17  |- skos__hiddenLabel mesh__D001931 Mappings, Brain
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D001931 1996
% 210.96/211.17  |- skos__hiddenLabel mesh__D001931 Topographic Brain Mappings
% 210.96/211.17  |- mesh__activeMeSHYear mesh__D001931 2001
% 210.96/211.17  |- skos__prefLabel mesh__D001931 Brain Mapping
% 210.96/211.17  |- skos__annotation mesh__D001931
% 210.96/211.17       coord IM with specific part of brain /physiol %28%IM%29%   
% 210.96/211.17  |- skos__hiddenLabel mesh__D001931 Mapping, Brain
% 210.96/211.17  |- skos__broader mesh__D009116smesh__D000644
% 210.96/211.17  |- skos__broader mesh__D009116smesh__D000470
% 210.96/211.17  |- mesh__dateCreated mesh__D009116 1976-05-19
% 210.96/211.17  |- skos__historyNote mesh__D009116 Ammonium Compounds %28%1970-1976%29%
% 210.96/211.18  |- mesh__recordOriginator mesh__D009116 SH
% 210.96/211.18  |- skos__historyNote mesh__D009116 Mycotoxins %28%1975-1976%29%
% 210.96/211.18  |- skos__historyNote mesh__D009116 Parasympathomimetics %28%1966-1976%29%
% 210.96/211.18  |- skos__historyNote mesh__D009116 Furans %28%1972-1976%29%
% 210.96/211.18  |- skos__historyNote mesh__D009116 Alkaloids %28%1968-1976%29%
% 210.96/211.18  |- skos__prefLabel mesh__D009116 Muscarine
% 210.96/211.18  |- mesh__historyNote mesh__D009116
% 210.96/211.18       77; was see under PARASYMPATHOMIMETICS 1963-68   
% 210.96/211.18  |- mesh__recordAuthorizer mesh__D009116 sjn
% 210.96/211.18  |- rdf__type mesh__D009116sskos__Concept
% 210.96/211.18  |- mesh__dateRevised mesh__D009116 2005-06-30
% 210.96/211.18  |- skos__broader mesh__D009116smesh__D050337
% 210.96/211.18  |- skos__scopeNote mesh__D009116
% 210.96/211.18       A toxic alkaloid found in Amanita muscaria %28%fly fungus%29% and other fungi of the Inocybe species. It is the first parasympathomimetic substance ever studied and causes profound parasympathetic activation that may end in convulsions and death. The specific antidote is atropine.%A%    
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D009116 2006
% 210.96/211.18  |- mesh__dateEstablished mesh__D009116 1977-01-01
% 210.96/211.18  |- mesh__onlineNote mesh__D009116 search PARASYMPATHOMIMETICS 1966-68   
% 210.96/211.18  |- skos__annotation mesh__D009116
% 210.96/211.18       /biosyn if permitted by plant; do not confuse with the dye muscarine%A%  
% 210.96/211.18  |- mesh__recordMaintainer mesh__D009116 ssb
% 210.96/211.18  |- mesh__publicMeSHNote mesh__D001133 98   
% 210.96/211.18  |- mesh__dateEstablished mesh__D001133 1998-01-01
% 210.96/211.18  |- skos__hiddenLabel mesh__D001133 Upper Extremity Bones
% 210.96/211.18  |- skos__annotation mesh__D001133
% 210.96/211.18       avoid: too general; prefer specifics; permitted with all vertebrates; Manual 21.58%A%  
% 210.96/211.18  |- mesh__recordMaintainer mesh__D001133 ags
% 210.96/211.18  |- mesh__historyNote mesh__D001133 98; use explode 1975-97   
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D001133 2006
% 210.96/211.18  |- skos__broader mesh__D001133smesh__D001842
% 210.96/211.18  |- mesh__recordAuthorizer mesh__D001133 sjn
% 210.96/211.18  |- skos__hiddenLabel mesh__D001133 Upper Extremity Bone
% 210.96/211.18  |- mesh__recordOriginator mesh__D001133 NLM
% 210.96/211.18  |- rdf__type mesh__D001133sskos__Concept
% 210.96/211.18  |- mesh__dateRevised mesh__D001133 2005-06-30
% 210.96/211.18  |- skos__prefLabel mesh__D001133 Bones of Upper Extremity
% 210.96/211.18  |- skos__scopeNote mesh__D001133
% 210.96/211.18       The bones of the upper and lower ARM. They include the CLAVICLE and SCAPULA.%A%    
% 210.96/211.18  |- mesh__dateCreated mesh__D001133 1999-01-01
% 210.96/211.18  |- skos__historyNote mesh__D001133 specific bones of arm %28%1966-1997%29%
% 210.96/211.18  |- skos__historyNote mesh__D001133 Forearm %28%1969-1997%29%
% 210.96/211.18  |- skos__historyNote mesh__D001133 Arm %28%1966-1997%29%
% 210.96/211.18  |- mesh__dateCreated mesh__D020896 1999-11-03
% 210.96/211.18  |- rdf__type mesh__D020896sskos__Concept
% 210.96/211.18  |- skos__scopeNote mesh__D020896
% 210.96/211.18       An abnormally low volume of blood circulating through the body. It may result in hypovolemic shock %28%see SHOCK%29%.%A%    
% 210.96/211.18  |- skos__prefLabel mesh__D020896 Hypovolemia
% 210.96/211.18  |- skos__historyNote mesh__D020896 Blood Volume %28%1966-1999%29%
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D020896 2005
% 210.96/211.18  |- skos__hiddenLabel mesh__D020896 Hypovolemias
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D020896 2003
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D020896 2006
% 210.96/211.18  |- mesh__dateEstablished mesh__D020896 2000-01-01
% 210.96/211.18  |- mesh__publicMeSHNote mesh__D020896 2000   
% 210.96/211.18  |- mesh__historyNote mesh__D020896 2000   
% 210.96/211.18  |- skos__related mesh__D020896smesh__D001810
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D020896 2004
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D020896 2000
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D020896 2001
% 210.96/211.18  |- skos__hiddenLabel mesh__D020896 Hypovolemics
% 210.96/211.18  |- skos__broader mesh__D020896smesh__D010335
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D020896 2002
% 210.96/211.18  |- skos__related mesh__D020896smesh__D012769
% 210.96/211.18  |- mesh__dateEstablished mesh__D020098 1999-01-01
% 210.96/211.18  |- skos__prefLabel mesh__D020098 Natriuretic Peptide, C-Type
% 210.96/211.18  |- skos__broader mesh__D020098smesh__D036361
% 210.96/211.18  |- mesh__publicMeSHNote mesh__D020098
% 210.96/211.18       99; C-TYPE NATRIURETIC PEPTIDE was indexed under PROTEINS 1995-98 %26% NERVE TISSUE PROTEINS 1990-94%A%  
% 210.96/211.18  |- skos__altLabel mesh__D020098 C-Type Natriuretic Peptide
% 210.96/211.18  |- skos__broader mesh__D020098smesh__D001685
% 210.96/211.18  |- mesh__dateCreated mesh__D020098 1998-06-10
% 210.96/211.18  |- mesh__recordMaintainer mesh__D020098 ags
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D020098 2006A
% 210.96/211.18  |- mesh__historyNote mesh__D020098
% 210.96/211.18       99; use C-TYPE NATRIURETIC PEPTIDE %28%NM%29% 1990-98   
% 210.96/211.18  |- skos__broader mesh__D020098smesh__D045265
% 210.96/211.18  |- skos__scopeNote mesh__D020098
% 210.96/211.18       A PEPTIDE of 22 amino acids, derived mainly from cells of VASCULAR ENDOTHELIUM. It is also found in the BRAIN, major endocrine glands, and other tissues. It shares structural homology with ATRIAL NATRIURETIC FACTOR. It has vasorelaxant activity thus is important in the regulation of vascular tone and blood flow. Several high molecular weight forms containing the 22 amino acids have been identified.%A%    
% 210.96/211.18  |- mesh__recordAuthorizer mesh__D020098 ags
% 210.96/211.18  |- mesh__dateRevised mesh__D020098 2005-07-08
% 210.96/211.18  |- skos__altLabel mesh__D020098 CNP-22
% 210.96/211.18  |- skos__hiddenLabel mesh__D020098 Natriuretic Peptide, C Type
% 210.96/211.18  |- skos__historyNote mesh__D020098 Nerve Tissue Proteins %28%1990-1994%29%
% 210.96/211.18  |- rdf__type mesh__D020098sskos__Concept
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D020098 2006
% 210.96/211.18  |- skos__hiddenLabel mesh__D020098 Peptide, C-Type Natriuretic
% 210.96/211.18  |- skos__historyNote mesh__D020098 Proteins %28%1995-1998%29%
% 210.96/211.18  |- skos__hiddenLabel mesh__D020098 C Type Natriuretic Peptide
% 210.96/211.18  |- mesh__recordOriginator mesh__D020098 TPW
% 210.96/211.18  |- skos__hiddenLabel mesh__D014859 Sodium, Warfarin
% 210.96/211.18  |- skos__altLabel mesh__D014859 Boots Brand of Warfarin Sodium
% 210.96/211.18  |- skos__altLabel mesh__D014859 Bailly Brand of Warfarin Sodium
% 210.96/211.18  |- mesh__recordAuthorizer mesh__D014859 sjn
% 210.96/211.18  |- mesh__recordOriginator mesh__D014859 NLM
% 210.96/211.18  |- skos__prefLabel mesh__D014859 Warfarin
% 210.96/211.18  |- mesh__dateRevised mesh__D014859 2005-06-30
% 210.96/211.18  |- mesh__dateCreated mesh__D014859 1999-01-01
% 210.96/211.18  |- skos__altLabel mesh__D014859 Genpharm Brand of Warfarin Sodium
% 210.96/211.18  |- skos__altLabel mesh__D014859 Goldshield Brand of Warfarin Sodium
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D014859 2006
% 210.96/211.18  |- mesh__recordMaintainer mesh__D014859 lkw
% 210.96/211.18  |- skos__altLabel mesh__D014859 Apotex Brand of Warfarin Sodium
% 210.96/211.18  |- skos__broader mesh__D014859smesh__D015110
% 210.96/211.18  |- skos__altLabel mesh__D014859 Antigen Brand of Warfarin Sodium
% 210.96/211.18  |- skos__altLabel mesh__D014859 Marevan
% 210.96/211.18  |- skos__altLabel mesh__D014859 Aldo Brand of Warfarin Sodium
% 210.96/211.18  |- skos__altLabel mesh__D014859
% 210.96/211.18       Bristol-Myers Squibb Brand of Warfarin Sodium
% 210.96/211.18  |- skos__altLabel mesh__D014859 Estedi Brand of Warfarin Sodium
% 210.96/211.18  |- skos__altLabel mesh__D014859
% 210.96/211.18       4-Hydroxy-3-%28%3-oxo-1-phenylbutyl%29%-2H-1-benzopyran-2-one
% 210.96/211.18  |- rdf__type mesh__D014859sskos__Concept
% 210.96/211.18  |- skos__hiddenLabel mesh__D014859 Potassium, Warfarin
% 210.96/211.18  |- skos__annotation mesh__D014859 an anticoagulant %26% rodenticide   
% 210.96/211.18  |- skos__scopeNote mesh__D014859
% 210.96/211.18       An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide.%A%    
% 210.96/211.18  |- skos__related mesh__D025581smesh__D016515
% 210.96/211.18  |- skos__scopeNote mesh__D025581
% 210.96/211.18       A membrane protein homologous to the ERM %28%Ezrin-Radixin-Moesin%29% family of cytoskeleton-associated proteins which regulate physical properties of membranes. Alterations in neurofibromin 2 are the cause of NEUROFIBROMATOSIS 2.%A%    
% 210.96/211.18  |- skos__historyNote mesh__D025581 Neoplasm Proteins %28%1993-2001%29%
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D025581 2004
% 210.96/211.18  |- rdf__type mesh__D025581sskos__Concept
% 210.96/211.18  |- skos__altLabel mesh__D025581 Moesin-Ezrin-Radixin-Like Protein
% 210.96/211.18  |- skos__prefLabel mesh__D025581 Neurofibromin 2
% 210.96/211.18  |- skos__altLabel mesh__D025581 NF2 Gene Product
% 210.96/211.18  |- skos__altLabel mesh__D025581 Neurofibromatosis Type 2 Protein
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D025581 2006
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D025581 2003
% 210.96/211.18  |- skos__hiddenLabel mesh__D025581 Protein, Schwannomin
% 210.96/211.18  |- skos__historyNote mesh__D025581 Membrane Proteins %28%1993-2001%29%
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D025581 2005
% 210.96/211.18  |- skos__related mesh__D025581smesh__D016518
% 210.96/211.18  |- skos__altLabel mesh__D025581 Schwannomin Protein
% 210.96/211.18  |- skos__hiddenLabel mesh__D025581 Moesin Ezrin Radixin Like Protein
% 210.96/211.18  |- skos__broader mesh__D025581smesh__D008565
% 210.96/211.18  |- skos__altLabel mesh__D025581 Neurofibromatosis 2 Gene Product
% 210.96/211.18  |- skos__hiddenLabel mesh__D025581 Gene Product, NF2
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D025581 2002
% 210.96/211.18  |- mesh__historyNote mesh__D025581
% 210.96/211.18       2002; for SCHWANNOMIN PROTEIN use NEUROFIBROMIN 2 %28%NM%29% 1993-2001%A%  
% 210.96/211.18  |- skos__altLabel mesh__D025581 Merlin
% 210.96/211.18  |- skos__broader mesh__D025581smesh__D025521
% 210.96/211.18  |- skos__altLabel mesh__D025581 Schwannomin
% 210.96/211.18  |- mesh__dateCreated mesh__D025581 2001-07-25
% 210.96/211.18  |- mesh__publicMeSHNote mesh__D025581
% 210.96/211.18       2002; SCHWANNOMIN PROTEIN was indexed under MEMBRANE PROTEINS 1993-2001%A%  
% 210.96/211.18  |- mesh__dateEstablished mesh__D025581 2002-01-01
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D019544 1997
% 210.96/211.18  |- skos__hiddenLabel mesh__D019544 Materials Failure Analyses
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D019544 2000
% 210.96/211.18  |- skos__altLabel mesh__D019544 Analysis, Equipment Failure
% 210.96/211.18  |- skos__altLabel mesh__D019544 Analysis, Materials Failure
% 210.96/211.18  |- mesh__dateCreated mesh__D019544 1996-06-13
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D019544 2003
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D019544 2001
% 210.96/211.18  |- skos__hiddenLabel mesh__D019544 Equipment Failure Analyses
% 210.96/211.18  |- skos__hiddenLabel mesh__D019544 Failure Analyses, Equipment
% 210.96/211.18  |- skos__hiddenLabel mesh__D019544 Analyses, Equipment Failure
% 210.96/211.18  |- mesh__historyNote mesh__D019544 97   
% 210.96/211.18  |- mesh__dateEstablished mesh__D019544 1997-01-01
% 210.96/211.18  |- rdf__type mesh__D019544sskos__Concept
% 210.96/211.18  |- skos__broader mesh__D019544smesh__D008919
% 210.96/211.18  |- skos__hiddenLabel mesh__D019544 Failure Analyses, Prosthesis
% 210.96/211.18  |- skos__hiddenLabel mesh__D019544 Prosthesis Failure Analyses
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D019544 2004
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D019544 1998
% 210.96/211.18  |- skos__hiddenLabel mesh__D019544 Analyses, Materials Failure
% 210.96/211.18  |- skos__historyNote mesh__D019544 Equipment and Supplies %28%1993-1996%29%
% 210.96/211.18  |- skos__hiddenLabel mesh__D019544 Analyses, Prosthesis Failure
% 210.96/211.18  |- skos__hiddenLabel mesh__D019544 Failure Analysis, Equipment
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D019544 1999
% 210.96/211.18  |- skos__annotation mesh__D019544
% 210.96/211.18       NIM; coord with specific equip %28%IM%29% or specific techn /instrum %28%IM%29%%A%  
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D019544 2002
% 210.96/211.18  |- mesh__publicMeSHNote mesh__D019544 97   
% 210.96/211.18  |- skos__scopeNote mesh__D019544
% 210.96/211.18       Determination of reliability and maintainability of equipment.%A%    
% 210.96/211.18  |- skos__hiddenLabel mesh__D019544 Failure Analyses, Materials
% 210.96/211.18  |- skos__prefLabel mesh__D019544 Equipment Failure Analysis
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D019544 2005
% 210.96/211.18  |- skos__hiddenLabel mesh__D019544 Failure Analysis, Prosthesis
% 210.96/211.18  |- skos__hiddenLabel mesh__D019544 Failure Analysis, Materials
% 210.96/211.18  |- skos__altLabel mesh__D019544 Analysis, Prosthesis Failure
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D019544 2006
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D000839 1997
% 210.96/211.18  |- mesh__dateRevised mesh__D000839 1993-08-06
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D000839 1999
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D000839 2001
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D000839 1994
% 210.96/211.18  |- skos__prefLabel mesh__D000839 Aniseikonia
% 210.96/211.18  |- mesh__dateCreated mesh__D000839 1999-01-01
% 210.96/211.18  |- mesh__publicMeSHNote mesh__D000839 66   
% 210.96/211.18  |- mesh__recordAuthorizer mesh__D000839 PLS
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D000839 1995
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D000839 2003
% 210.96/211.18  |- skos__annotation mesh__D000839
% 210.96/211.18       refractive error in which each eye sees a different size %26% shape of an object%A%  
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D000839 2002
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D000839 2005
% 210.96/211.18  |- mesh__historyNote mesh__D000839 66%28%64%29%   
% 210.96/211.18  |- mesh__recordOriginator mesh__D000839 NLM
% 210.96/211.18  |- skos__broader mesh__D000839smesh__D012030
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D000839 2004
% 210.96/211.18  |- mesh__dateEstablished mesh__D000839 1966-01-01
% 210.96/211.18  |- rdf__type mesh__D000839sskos__Concept
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D000839 1996
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D000839 2006
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D000839 1998
% 210.96/211.18  |- skos__scopeNote mesh__D000839
% 210.96/211.18       A condition in which the ocular image of an object as seen by one eye differs in size and shape from that seen by the other.%A%    
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D000839 2000
% 210.96/211.18  |- mesh__recordMaintainer mesh__D000839 PLS
% 210.96/211.18  |- skos__broader mesh__D011561smesh__D020141
% 210.96/211.18  |- mesh__dateRevised mesh__D011561 2001-08-13
% 210.96/211.18  |- skos__broader mesh__D011561smesh__D003240
% 210.96/211.18  |- skos__annotation mesh__D011561
% 210.96/211.18       skin %26% other abnorm; in titles %26% translations use diacrit: Gr%C3%%B6%nblad%A%  
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D011561 2002
% 210.96/211.18  |- skos__broader mesh__D011561smesh__D012868
% 210.96/211.18  |- mesh__recordMaintainer mesh__D011561 nns
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D011561 2003
% 210.96/211.18  |- rdf__type mesh__D011561sskos__Concept
% 210.96/211.18  |- mesh__dateCreated mesh__D011561 1999-01-01
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D011561 2004
% 210.96/211.18  |- skos__prefLabel mesh__D011561 Pseudoxanthoma Elasticum
% 210.96/211.18  |- skos__broader mesh__D011561smesh__D012873
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D011561 2005
% 210.96/211.18  |- skos__hiddenLabel mesh__D011561 Gronblad Strandberg Syndrome
% 210.96/211.18  |- mesh__recordOriginator mesh__D011561 NLM
% 210.96/211.18  |- skos__scopeNote mesh__D011561
% 210.96/211.18       A rare, progressive inherited disorder resulting from extensive basophilic degeneration of elastic tissue, usually presenting after puberty and involving the skin, eye, and cardiovascular system. Characteristic manifestations are small, circumscribed yellowish patches at sites of considerable movement of the skin, ANGIOID STREAKS in the retina, and a tendency towards hemorrhage and arterial insufficiency.%A%    
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D011561 2006
% 210.96/211.18  |- skos__hiddenLabel mesh__D011561 Syndrome, Gronblad-Strandberg
% 210.96/211.18  |- mesh__recordAuthorizer mesh__D011561 sjn
% 210.96/211.18  |- mesh__dateEstablished mesh__D005524 1976-01-01
% 210.96/211.18  |- mesh__publicMeSHNote mesh__D005524 76   
% 210.96/211.18  |- skos__scopeNote mesh__D005524
% 210.96/211.18       The application of knowledge to the food industry.     
% 210.96/211.18  |- mesh__dateCreated mesh__D005524 1975-07-25
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D005524 2002
% 210.96/211.18  |- mesh__recordMaintainer mesh__D005524 kle
% 210.96/211.18  |- skos__altLabel mesh__D005524 Technology, Food
% 210.96/211.18  |- mesh__historyNote mesh__D005524 76; was NON MESH before 1976   
% 210.96/211.18  |- rdf__type mesh__D005524sskos__Concept
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D005524 2003
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D005524 2000
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D005524 2005
% 210.96/211.18  |- mesh__dateRevised mesh__D005524 1999-11-03
% 210.96/211.18  |- skos__broader mesh__D005524smesh__D019649
% 210.96/211.18  |- skos__prefLabel mesh__D005524 Food Technology
% 210.96/211.18  |- mesh__recordOriginator mesh__D005524 JW
% 210.96/211.18  |- skos__annotation mesh__D005524
% 210.96/211.18       IM; usually in ref to the food industry %26% food manufacture or prep on a large scale; covers aroma, flavor, color, texture, temperature, preparability, cookability, packaging, etc.; SPEC: SPEC qualif; DF: FOOD TECHNOL%A%  
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D005524 2004
% 210.96/211.18  |- mesh__recordAuthorizer mesh__D005524 sjn
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D005524 2001
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D005524 2006
% 210.96/211.18  |- mesh__dateEstablished mesh__D029972 2002-01-01
% 210.96/211.18  |- mesh__dateCreated mesh__D029972 2001-07-25
% 210.96/211.18  |- mesh__historyNote mesh__D029972 2002   
% 210.96/211.18  |- skos__prefLabel mesh__D029972 Bupleurum
% 210.96/211.18  |- skos__scopeNote mesh__D029972
% 210.96/211.18       A plant genus of the family APIACEAE that is the source of bupleurum root and of bupleurotoxin and is an ingredient of sho-saiko-to.%A%    
% 210.96/211.18  |- mesh__recordOriginator mesh__D029972 ssb
% 210.96/211.18  |- mesh__dateRevised mesh__D029972 2002-07-02
% 210.96/211.18  |- skos__broader mesh__D029972smesh__D019661
% 210.96/211.18  |- mesh__publicMeSHNote mesh__D029972 2002   
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D029972 2005
% 210.96/211.18  |- skos__annotation mesh__D029972
% 210.96/211.18       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D029972 2003
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D029972 2006
% 210.96/211.18  |- mesh__recordAuthorizer mesh__D029972 sjn
% 210.96/211.18  |- mesh__recordMaintainer mesh__D029972 ssb
% 210.96/211.18  |- rdf__type mesh__D029972sskos__Concept
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D029972 2004
% 210.96/211.18  |- skos__hiddenLabel mesh__D043643 Receptor M1, Muscarinic
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D043643 2005
% 210.96/211.18  |- skos__altLabel mesh__D043643 Muscarinic Receptor M1
% 210.96/211.18  |- skos__prefLabel mesh__D043643 Receptor, Muscarinic M1
% 210.96/211.18  |- skos__scopeNote mesh__D043643
% 210.96/211.18       A specific subtype of muscarinic receptor that has a high affinity for the drug PIRENZEPINE. It is found in the peripheral GANGLIA where it signals a variety of physiological functions such as GASTRIC ACID secretion and BRONCHOCONSTRICTION. This subtype of muscarinic receptor is also found in neuronal tissues including the CEREBRAL CORTEX and HIPPOCAMPUS where it mediates the process of MEMORY and LEARNING.%A%    
% 210.96/211.18  |- skos__hiddenLabel mesh__D043643 Receptors M1, Muscarinic
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D043643 2006
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D043643 2004
% 210.96/211.18  |- rdf__type mesh__D043643sskos__Concept
% 210.96/211.18  |- skos__hiddenLabel mesh__D043643 M1, Muscarinic Receptor
% 210.96/211.18  |- mesh__historyNote mesh__D043643
% 210.96/211.18       2004; use RECEPTOR, MUSCARINIC M1%28%NM%29% 1996-2003   
% 210.96/211.18  |- skos__altLabel mesh__D043643 Muscarinic Receptors M1
% 210.96/211.18  |- mesh__dateEstablished mesh__D043643 2004-01-01
% 210.96/211.18  |- skos__hiddenLabel mesh__D043643 M1 Receptors, Muscarinic
% 210.96/211.18  |- skos__historyNote mesh__D043643 Receptors, Muscarinic %28%1996-2003%29%
% 210.96/211.18  |- skos__altLabel mesh__D043643 Receptors, Muscarinic M1
% 210.96/211.18  |- mesh__dateCreated mesh__D043643 2003-07-09
% 210.96/211.18  |- mesh__publicMeSHNote mesh__D043643
% 210.96/211.18       2004; MUSCARINIC RECEPTOR M1 was indexed under RECEPTORS, MUSCARINIC 1996-2003%A%  
% 210.96/211.18  |- skos__hiddenLabel mesh__D043643 M1 Receptor, Muscarinic
% 210.96/211.18  |- skos__hiddenLabel mesh__D043643 Muscarinic M1 Receptor
% 210.96/211.18  |- skos__hiddenLabel mesh__D043643 Muscarinic M1 Receptors
% 210.96/211.18  |- skos__broader mesh__D043643smesh__D011976
% 210.96/211.18  |- skos__hiddenLabel mesh__D043643 M1, Muscarinic Receptors
% 210.96/211.18  |- skos__scopeNote mesh__D010469
% 210.96/211.18       Lack of correspondence between the way a stimulus is commonly perceived and the way an individual perceives it under given conditions.%A%    
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D010469 1998
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D010469 2002
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D010469 1995
% 210.96/211.18  |- mesh__recordAuthorizer mesh__D010469 PLS
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D010469 2006
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D010469 1999
% 210.96/211.18  |- mesh__recordOriginator mesh__D010469 NLM
% 210.96/211.18  |- mesh__dateRevised mesh__D010469 1992-05-15
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D010469 2003
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D010469 1996
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D010469 2000
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D010469 1993
% 210.96/211.18  |- skos__hiddenLabel mesh__D010469 Distortions, Perceptual
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D010469 2004
% 210.96/211.18  |- skos__broader mesh__D010469smesh__D010465
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D010469 1997
% 210.96/211.18  |- rdf__type mesh__D010469sskos__Concept
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D010469 2001
% 210.96/211.18  |- skos__historyNote mesh__D010469 Perception %28%1966%29%
% 210.96/211.18  |- skos__prefLabel mesh__D010469 Perceptual Distortion
% 210.96/211.18  |- skos__related mesh__D010469smesh__D010468
% 210.96/211.18  |- skos__hiddenLabel mesh__D010469 Distortion, Perceptual
% 210.96/211.18  |- mesh__dateCreated mesh__D010469 1999-01-01
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D010469 1994
% 210.96/211.18  |- mesh__publicMeSHNote mesh__D010469 69   
% 210.96/211.18  |- mesh__dateEstablished mesh__D010469 1969-01-01
% 210.96/211.18  |- mesh__historyNote mesh__D010469 69%28%67%29%   
% 210.96/211.18  |- skos__hiddenLabel mesh__D010469 Perceptual Distortions
% 210.96/211.18  |- mesh__recordMaintainer mesh__D010469 TAP
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D010469 2005
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D015154 2005
% 210.96/211.18  |- skos__prefLabel mesh__D015154 Esophageal Motility Disorders
% 210.96/211.18  |- skos__hiddenLabel mesh__D015154 Disorder, Esophageal Motility
% 210.96/211.18  |- skos__historyNote mesh__D015154
% 210.96/211.18       Gastrointestinal Motility %28%1966-1988%29%
% 210.96/211.18  |- mesh__dateEstablished mesh__D015154 1989-01-01
% 210.96/211.18  |- mesh__dateRevised mesh__D015154 2004-07-07
% 210.96/211.18  |- skos__historyNote mesh__D015154 Peristalsis %28%1975-1988%29%
% 210.96/211.18  |- mesh__dateCreated mesh__D015154 1988-03-22
% 210.96/211.18  |- mesh__recordMaintainer mesh__D015154 lkt
% 210.96/211.18  |- skos__altLabel mesh__D015154 Esophageal Dysmotility
% 210.96/211.18  |- skos__historyNote mesh__D015154 Esophageal Diseases %28%1966-1988%29%
% 210.96/211.18  |- rdf__type mesh__D015154sskos__Concept
% 210.96/211.18  |- skos__scopeNote mesh__D015154
% 210.96/211.18       Disorders affecting the motor function of the UPPER ESOPHAGEAL SPHINCTER; LOWER ESOPHAGEAL SPHINCTER; the ESOPHAGUS body, or a combination of these parts. The failure of the sphincters to maintain a tonic pressure may result in gastric reflux of food and acid into the esophagus %28%GASTROESOPHAGEAL REFLUX%29%. Other disorders include hypermotility %28%spastic disorders%29% and markedly increased amplitude in contraction %28%nutcracker esophagus%29%.%A%    
% 210.96/211.18  |- skos__broader mesh__D015154smesh__D003680
% 210.96/211.18  |- mesh__recordAuthorizer mesh__D015154 sjn
% 210.96/211.18  |- skos__hiddenLabel mesh__D015154 Motility Disorder, Esophageal
% 210.96/211.18  |- skos__hiddenLabel mesh__D015154 Dysmotilities, Esophageal
% 210.96/211.18  |- mesh__publicMeSHNote mesh__D015154 1989   
% 210.96/211.18  |- skos__hiddenLabel mesh__D015154 Esophagus, Nutcracker
% 210.96/211.18  |- skos__hiddenLabel mesh__D015154 Dysmotility, Esophageal
% 210.96/211.18  |- mesh__recordOriginator mesh__D015154 EC
% 210.96/211.18  |- skos__hiddenLabel mesh__D015154 Motility Disorders, Esophageal
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D015154 2006
% 210.96/211.18  |- mesh__historyNote mesh__D015154 1989   
% 210.96/211.18  |- skos__hiddenLabel mesh__D015154 Esophageal Motility Disorder
% 210.96/211.18  |- skos__hiddenLabel mesh__D015154 Esophageal Dysmotilities
% 210.96/211.18  |- skos__hiddenLabel mesh__D015154 Disorders, Esophageal Motility
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D009915 2002
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D009915 2004
% 210.96/211.18  |- mesh__recordMaintainer mesh__D009915 TGC
% 210.96/211.18  |- mesh__recordAuthorizer mesh__D009915 PLS
% 210.96/211.18  |- mesh__recordOriginator mesh__D009915 NLM
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D009915 1996
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D009915 1999
% 210.96/211.18  |- mesh__dateCreated mesh__D009915 1999-01-01
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D009915 2001
% 210.96/211.18  |- skos__broader mesh__D009915smesh__D005147
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D009915 2003
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D009915 1991
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D009915 2006
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D009915 1998
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D009915 1993
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D009915 2000
% 210.96/211.18  |- rdf__type mesh__D009915sskos__Concept
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D009915 1990
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D009915 2005
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D009915 1995
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D009915 1992
% 210.96/211.18  |- skos__prefLabel mesh__D009915 Orbit
% 210.96/211.18  |- skos__annotation mesh__D009915
% 210.96/211.18       bony cavity %26% its contents as a unit; not a synonym for EYE%A%  
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D009915 1994
% 210.96/211.18  |- skos__hiddenLabel mesh__D009915 Orbits
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D009915 1997
% 210.96/211.18  |- mesh__dateRevised mesh__D009915 1989-05-26
% 210.96/211.18  |- skos__annotation mesh__D001932
% 210.96/211.18       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with specific site in brain %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 210.96/211.18  |- skos__hiddenLabel mesh__D001932 Recurrent Brain Tumor
% 210.96/211.18  |- skos__hiddenLabel mesh__D001932 Brain Cancers
% 210.96/211.18  |- mesh__recordMaintainer mesh__D001932 nns
% 210.96/211.18  |- skos__hiddenLabel mesh__D001932 Cancers, Brain
% 210.96/211.18  |- skos__altLabel mesh__D001932 Cancer of the Brain
% 210.96/211.18  |- skos__hiddenLabel mesh__D001932 Primary Brain Tumors
% 210.96/211.18  |- skos__hiddenLabel mesh__D001932 Brain Neoplasms, Primary
% 210.96/211.18  |- skos__hiddenLabel mesh__D001932 Brain Neoplasm, Malignant
% 210.96/211.18  |- skos__hiddenLabel mesh__D001932 Cancer, Brain
% 210.96/211.18  |- skos__hiddenLabel mesh__D001932 Benign Brain Neoplasms
% 210.96/211.18  |- skos__hiddenLabel mesh__D001932 Neoplasm, Brain
% 210.96/211.18  |- skos__hiddenLabel mesh__D001932 Tumors, Brain
% 210.96/211.18  |- mesh__activeMeSHYear mesh__D001932 2005
% 210.96/211.18  |- skos__altLabel mesh__D001932 Primary Malignant Brain Tumors
% 210.96/211.18  |- skos__hiddenLabel mesh__D001932 Primary Brain Tumor
% 210.96/211.18  |- mesh__dateRevised mesh__D001932 2001-07-25
% 210.96/211.18  |- skos__hiddenLabel mesh__D001932 Brain Malignant Neoplasm
% 210.96/211.18  |- skos__hiddenLabel mesh__D001932 Brain Tumors, Recurrent
% 210.96/211.18  |- skos__hiddenLabel mesh__D001932 Recurrent Brain Tumors
% 210.96/211.18  |- skos__altLabel mesh__D001932 Neoplasms, Brain, Benign
% 210.96/211.18  |- skos__altLabel mesh__D001932 Primary Malignant Brain Neoplasms
% 210.96/211.18  |- skos__altLabel mesh__D001932 Primary Brain Neoplasms
% 210.96/211.18  |- skos__hiddenLabel mesh__D001932 Brain Neoplasm, Benign
% 210.96/211.18  |- skos__altLabel mesh__D001932 Brain Neoplasms, Benign
% 210.96/211.18  |- skos__altLabel mesh__D001932 Neoplasms, Brain, Malignant
% 210.96/211.19  |- skos__prefLabel mesh__D001932 Brain Neoplasms
% 210.96/211.19  |- mesh__dateCreated mesh__D001932 1999-01-01
% 210.96/211.19  |- skos__hiddenLabel mesh__D001932 Brain Tumors, Primary
% 210.96/211.19  |- skos__altLabel mesh__D001932 Brain Neoplasms, Malignant, Primary
% 210.96/211.19  |- skos__hiddenLabel mesh__D001932 Brain Tumor
% 210.96/211.19  |- skos__broader mesh__D001932smesh__D001927
% 210.96/211.19  |- skos__altLabel mesh__D001932 Brain Tumors
% 210.96/211.19  |- skos__hiddenLabel mesh__D001932 Brain Benign Neoplasm
% 210.96/211.19  |- skos__hiddenLabel mesh__D001932 Brain Benign Neoplasms
% 210.96/211.19  |- skos__altLabel mesh__D001932 Brain Neoplasms, Primary Malignant
% 210.96/211.19  |- skos__hiddenLabel mesh__D001932 Malignant Neoplasm, Brain
% 210.96/211.19  |- skos__altLabel mesh__D001932 Intracranial Neoplasms
% 210.96/211.19  |- skos__altLabel mesh__D001932 Cancer of Brain
% 210.96/211.19  |- skos__hiddenLabel mesh__D001932 Malignant Brain Neoplasm
% 210.96/211.19  |- skos__altLabel mesh__D001932 Brain Neoplasm, Primary
% 210.96/211.19  |- mesh__recordOriginator mesh__D001932 NLM
% 210.96/211.19  |- mesh__recordAuthorizer mesh__D001932 sjn
% 210.96/211.19  |- skos__hiddenLabel mesh__D001932 Benign Brain Neoplasm
% 210.96/211.19  |- skos__broader mesh__D001932smesh__D016543
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D001932 2004
% 210.96/211.19  |- skos__hiddenLabel mesh__D001932 Malignant Brain Neoplasms
% 210.96/211.19  |- skos__hiddenLabel mesh__D001932 Benign Neoplasm, Brain
% 210.96/211.19  |- rdf__type mesh__D001932sskos__Concept
% 210.96/211.19  |- skos__hiddenLabel mesh__D001932 Primary Brain Neoplasm
% 210.96/211.19  |- skos__altLabel mesh__D001932 Malignant Neoplasms, Brain
% 210.96/211.19  |- skos__altLabel mesh__D001932 Neoplasms, Brain, Primary
% 210.96/211.19  |- skos__scopeNote mesh__D001932
% 210.96/211.19       Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary %28%originating from brain tissue%29% and secondary %28%i.e., metastatic%29% forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.%A%    
% 210.96/211.19  |- skos__hiddenLabel mesh__D001932 Tumor, Brain
% 210.96/211.19  |- skos__hiddenLabel mesh__D001932 Brain Neoplasm
% 210.96/211.19  |- skos__hiddenLabel mesh__D001932 Intracranial Neoplasm
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D001932 2003
% 210.96/211.19  |- skos__altLabel mesh__D001932 Brain Neoplasms, Malignant
% 210.96/211.19  |- skos__hiddenLabel mesh__D001932 Brain Malignant Neoplasms
% 210.96/211.19  |- skos__altLabel mesh__D001932 Neoplasms, Brain
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D001932 2002
% 210.96/211.19  |- skos__hiddenLabel mesh__D001932 Neoplasm, Intracranial
% 210.96/211.19  |- skos__altLabel mesh__D001932 Malignant Primary Brain Neoplasms
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D001932 2006
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D009117 2004
% 210.96/211.19  |- skos__broader mesh__D009117smesh__D004175
% 210.96/211.19  |- skos__scopeNote mesh__D009117
% 210.96/211.19       A family of the order DIPTERA with over 700 species. Important species that may be mechanical vectors of disease include Musca domesticus %28%HOUSEFLIES%29%, Musca autumnalis %28%face fly%29%, Stomoxys calcitrans %28%stable fly%29%, Haematobia irritans %28%horn fly%29% and Fannia spp.%A%    
% 210.96/211.19  |- skos__altLabel mesh__D009117 Face Fly
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D009117 2005
% 210.96/211.19  |- skos__prefLabel mesh__D009117 Muscidae
% 210.96/211.19  |- mesh__dateCreated mesh__D009117 1987-05-02
% 210.96/211.19  |- mesh__recordOriginator mesh__D009117 EC
% 210.96/211.19  |- mesh__historyNote mesh__D009117 88   
% 210.96/211.19  |- skos__historyNote mesh__D009117 Houseflies %28%1966-1987%29%
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D009117 2006
% 210.96/211.19  |- mesh__publicMeSHNote mesh__D009117 88   
% 210.96/211.19  |- skos__annotation mesh__D009117
% 210.96/211.19       do not use /drug eff for insecticides: TN 111; note MUSCA DOMESTICA see HOUSEFLIES%A%  
% 210.96/211.19  |- mesh__dateRevised mesh__D009117 2003-07-09
% 210.96/211.19  |- skos__historyNote mesh__D009117 Diptera %28%1966-1987%29%
% 210.96/211.19  |- mesh__recordMaintainer mesh__D009117 ags
% 210.96/211.19  |- skos__altLabel mesh__D009117 Stomoxys calcitrans
% 210.96/211.19  |- skos__altLabel mesh__D009117 Haematobia irritans
% 210.96/211.19  |- mesh__recordAuthorizer mesh__D009117 sjn
% 210.96/211.19  |- mesh__dateEstablished mesh__D009117 1988-01-01
% 210.96/211.19  |- rdf__type mesh__D009117sskos__Concept
% 210.96/211.19  |- skos__scopeNote mesh__D001134
% 210.96/211.19       General or unspecified injuries involving the arm.     
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D001134 2005
% 210.96/211.19  |- mesh__dateRevised mesh__D001134 2001-07-25
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D001134 2004
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D001134 2006
% 210.96/211.19  |- mesh__recordMaintainer mesh__D001134 mdb
% 210.96/211.19  |- skos__hiddenLabel mesh__D001134 Arm Injury
% 210.96/211.19  |- skos__annotation mesh__D001134
% 210.96/211.19       GEN or unspecified; consider also /inj with specific bones of arm; also available are FOREARM INJURIES; HAND INJURIES; FINGER INJURIES; WRIST INJURIES %26% many specific organ/fract precoords%A%  
% 210.96/211.19  |- rdf__type mesh__D001134sskos__Concept
% 210.96/211.19  |- skos__altLabel mesh__D001134 Injuries, Arm
% 210.96/211.19  |- mesh__dateCreated mesh__D001134 1999-01-01
% 210.96/211.19  |- mesh__recordAuthorizer mesh__D001134 sjn
% 210.96/211.19  |- skos__broader mesh__D001134smesh__D014947
% 210.96/211.19  |- mesh__recordOriginator mesh__D001134 NLM
% 210.96/211.19  |- skos__hiddenLabel mesh__D001134 Injury, Arm
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D001134 2002
% 210.96/211.19  |- skos__prefLabel mesh__D001134 Arm Injuries
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D001134 2003
% 210.96/211.19  |- skos__related mesh__D020897smesh__D004627
% 210.96/211.19  |- skos__prefLabel mesh__D020897 Organizers, Embryonic
% 210.96/211.19  |- skos__altLabel mesh__D020897 Hensen%27%s Node
% 210.96/211.19  |- skos__scopeNote mesh__D020897
% 210.96/211.19       The regions within an embryo that control development and differentiation. In AMPHIBIA, the organizer forms at the dorsal-most lip of the blastopore during gastrulation and is named after its discoverer, Hans Spemann.%A%    
% 210.96/211.19  |- mesh__dateCreated mesh__D020897 1999-11-03
% 210.96/211.19  |- skos__hiddenLabel mesh__D020897 Spemanns Organizer
% 210.96/211.19  |- skos__hiddenLabel mesh__D020897 Embryonic Organizer
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D020897 2004
% 210.96/211.19  |- rdf__type mesh__D020897sskos__Concept
% 210.96/211.19  |- skos__hiddenLabel mesh__D020897 Organizers, Embryo
% 210.96/211.19  |- skos__hiddenLabel mesh__D020897 Embryo Organizer
% 210.96/211.19  |- mesh__dateEstablished mesh__D020897 2000-01-01
% 210.96/211.19  |- skos__hiddenLabel mesh__D020897 Node, Hensen%27%s
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D020897 2006
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D020897 2003
% 210.96/211.19  |- skos__hiddenLabel mesh__D020897 Organizer, Embryonic
% 210.96/211.19  |- skos__hiddenLabel mesh__D020897 Organizer, Embryo
% 210.96/211.19  |- skos__altLabel mesh__D020897 Spemann%27%s Organizer
% 210.96/211.19  |- mesh__historyNote mesh__D020897 2000   
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D020897 2002
% 210.96/211.19  |- skos__hiddenLabel mesh__D020897 Hensens Node
% 210.96/211.19  |- skos__historyNote mesh__D020897 Embryonic Induction %28%1990-1999%29%
% 210.96/211.19  |- skos__altLabel mesh__D020897 Embryo Organizers
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D020897 2005
% 210.96/211.19  |- skos__hiddenLabel mesh__D020897 Organizer, Spemann%27%s
% 210.96/211.19  |- skos__hiddenLabel mesh__D020897 Organizer, Spemann
% 210.96/211.19  |- mesh__publicMeSHNote mesh__D020897 2000   
% 210.96/211.19  |- skos__broader mesh__D020897smesh__D004622
% 210.96/211.19  |- skos__hiddenLabel mesh__D020897 Node, Hensen
% 210.96/211.19  |- skos__altLabel mesh__D020897 Embryonic Organizers
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D020897 2001
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D020897 2000
% 210.96/211.19  |- skos__historyNote mesh__D020099
% 210.96/211.19       Biocompatible Materials %28%1967-1998%29%
% 210.96/211.19  |- mesh__historyNote mesh__D020099 99   
% 210.96/211.19  |- mesh__dateEstablished mesh__D020099 1999-01-01
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D020099 2004
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D020099 2002
% 210.96/211.19  |- skos__hiddenLabel mesh__D020099 Materials, Surface-Coated
% 210.96/211.19  |- skos__hiddenLabel mesh__D020099 Surface Coated Materials
% 210.96/211.19  |- skos__hiddenLabel mesh__D020099 Biocompatible Coated Materials
% 210.96/211.19  |- skos__prefLabel mesh__D020099 Coated Materials, Biocompatible
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D020099 2003
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D020099 1999
% 210.96/211.19  |- mesh__dateCreated mesh__D020099 1998-06-10
% 210.96/211.19  |- rdf__type mesh__D020099sskos__Concept
% 210.96/211.19  |- mesh__publicMeSHNote mesh__D020099 99   
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D020099 2006
% 210.96/211.19  |- skos__altLabel mesh__D020099 Surface-Coated Materials
% 210.96/211.19  |- skos__broader mesh__D020099smesh__D001672
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D020099 2001
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D020099 2005
% 210.96/211.19  |- skos__annotation mesh__D020099 coord with specific coating material   
% 210.96/211.19  |- skos__hiddenLabel mesh__D020099 Materials, Biocompatible Coated
% 210.96/211.19  |- skos__scopeNote mesh__D020099
% 210.96/211.19       Biocompatible materials usually used in dental and bone implants that enhance biologic fixation, thereby increasing the bond strength between the coated material and bone, and minimize possible biological effects that may result from the implant itself.%A%    
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D020099 2000
% 210.96/211.19  |- skos__broader mesh__D006321Q000254smesh__D006321
% 210.96/211.19  |- rdf__type mesh__D006321Q000254smesh__CompoundConcept
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D019545 2003
% 210.96/211.19  |- mesh__historyNote mesh__D019545 97   
% 210.96/211.19  |- skos__prefLabel mesh__D019545 Intuition
% 210.96/211.19  |- rdf__type mesh__D019545sskos__Concept
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D019545 2004
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D019545 1998
% 210.96/211.19  |- skos__historyNote mesh__D019545 Consciousness %28%1966-1996%29%
% 210.96/211.19  |- mesh__dateRevised mesh__D019545 1997-06-20
% 210.96/211.19  |- mesh__dateCreated mesh__D019545 1996-06-10
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D019545 2000
% 210.96/211.19  |- skos__scopeNote mesh__D019545
% 210.96/211.19       Knowing or understanding without conscious use of reasoning. %28%Thesaurus of ERIC Descriptors, 1994%29%%A%    
% 210.96/211.19  |- mesh__recordAuthorizer mesh__D019545 SJN
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D019545 2001
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D019545 1999
% 210.96/211.19  |- skos__broader mesh__D019545smesh__D003071
% 210.96/211.19  |- mesh__dateEstablished mesh__D019545 1997-01-01
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D019545 2005
% 210.96/211.19  |- skos__annotation mesh__D019545 knowing without conscious reasoning   
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D019545 2006
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D019545 2002
% 210.96/211.19  |- mesh__publicMeSHNote mesh__D019545 97   
% 210.96/211.19  |- mesh__recordMaintainer mesh__D019545 JLS
% 210.96/211.19  |- mesh__recordOriginator mesh__D019545 JLS
% 210.96/211.19  |- skos__broader mesh__D011562smesh__D026121
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D011562 2006
% 210.96/211.19  |- mesh__publicMeSHNote mesh__D011562 66   
% 210.96/211.19  |- skos__altLabel mesh__D011562 Psilocibin
% 210.96/211.19  |- mesh__recordOriginator mesh__D011562 NLM
% 210.96/211.19  |- mesh__historyNote mesh__D011562 66%28%63%29%   
% 210.96/211.19  |- mesh__dateCreated mesh__D011562 1999-01-01
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D011562 2005
% 210.96/211.19  |- mesh__dateRevised mesh__D011562 2004-07-07
% 210.96/211.19  |- mesh__recordAuthorizer mesh__D011562 sjn
% 210.96/211.19  |- skos__prefLabel mesh__D011562 Psilocybine
% 210.96/211.19  |- rdf__type mesh__D011562sskos__Concept
% 210.96/211.19  |- mesh__recordMaintainer mesh__D011562 ssb
% 210.96/211.19  |- mesh__dateEstablished mesh__D011562 1966-01-01
% 210.96/211.19  |- skos__broader mesh__D011562smesh__D014363
% 210.96/211.19  |- skos__scopeNote mesh__D011562
% 210.96/211.19       The major of two hallucinogenic components of Teonanacatl, the sacred mushroom of Mexico, the other component being psilocin. %28%From Merck Index, 11th ed%29%%A%    
% 210.96/211.19  |- mesh__recordOriginator mesh__D005525 NLM
% 210.96/211.19  |- skos__annotation mesh__D005525
% 210.96/211.19       SPEC: SPEC qualifs; DF: FOOD PROCESSING INDUST   
% 210.96/211.19  |- skos__altLabel mesh__D005525 Industry, Food-Processing
% 210.96/211.19  |- skos__broader mesh__D005525smesh__D005511
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D005525 2000
% 210.96/211.19  |- mesh__recordMaintainer mesh__D005525 JLS
% 210.96/211.19  |- skos__hiddenLabel mesh__D005525 Food-Processing Industries
% 210.96/211.19  |- rdf__type mesh__D005525sskos__Concept
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D005525 2003
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D005525 2001
% 210.96/211.19  |- skos__hiddenLabel mesh__D005525 Industries, Food-Processing
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D005525 2005
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D005525 1998
% 210.96/211.19  |- skos__hiddenLabel mesh__D005525 Food Processing Industry
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D005525 2004
% 210.96/211.19  |- skos__hiddenLabel mesh__D005525 Industry, Food Processing
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D005525 2006
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D005525 1999
% 210.96/211.19  |- mesh__dateRevised mesh__D005525 1997-06-20
% 210.96/211.19  |- mesh__dateCreated mesh__D005525 1999-01-01
% 210.96/211.19  |- skos__prefLabel mesh__D005525 Food-Processing Industry
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D005525 2002
% 210.96/211.19  |- skos__scopeNote mesh__D005525
% 210.96/211.19       The productive enterprises concerned with food processing.%A%    
% 210.96/211.19  |- mesh__recordAuthorizer mesh__D005525 SJN
% 210.96/211.19  |- mesh__dateCreated mesh__D015155 1988-03-22
% 210.96/211.19  |- skos__historyNote mesh__D015155 Esophageal Diseases %28%1966-1988%29%
% 210.96/211.19  |- rdf__type mesh__D015155sskos__Concept
% 210.96/211.19  |- skos__annotation mesh__D015155
% 210.96/211.19       %22%diffuse%22% need not be used by author: note X ref   
% 210.96/211.19  |- skos__historyNote mesh__D015155 Spasm %28%1966-1988%29%
% 210.96/211.19  |- skos__hiddenLabel mesh__D015155 Esophageal Spasms
% 210.96/211.19  |- skos__scopeNote mesh__D015155
% 210.96/211.19       A hypermotility disorder of the ESOPHAGUS that is characterized by spastic non-peristaltic responses to SWALLOWING; CHEST PAIN; and DYSPHAGIA.%A%    
% 210.96/211.19  |- skos__hiddenLabel mesh__D015155 Diffuse Esophageal Spasms
% 210.96/211.19  |- mesh__recordMaintainer mesh__D015155 lkt
% 210.96/211.19  |- skos__prefLabel mesh__D015155 Esophageal Spasm, Diffuse
% 210.96/211.19  |- mesh__recordAuthorizer mesh__D015155 sjn
% 210.96/211.19  |- skos__broader mesh__D015155smesh__D015154
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D015155 2006
% 210.96/211.19  |- skos__altLabel mesh__D015155 Spasm, Esophageal
% 210.96/211.19  |- skos__hiddenLabel mesh__D015155 Diffuse Esophageal Spasm
% 210.96/211.19  |- skos__hiddenLabel mesh__D015155 Spasms, Esophageal
% 210.96/211.19  |- mesh__historyNote mesh__D015155 89   
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D015155 2005
% 210.96/211.19  |- skos__hiddenLabel mesh__D015155 Spasm, Diffuse Esophageal
% 210.96/211.19  |- skos__hiddenLabel mesh__D015155 Esophageal Spasms, Diffuse
% 210.96/211.19  |- skos__altLabel mesh__D015155 Esophageal Spasm
% 210.96/211.19  |- mesh__publicMeSHNote mesh__D015155 89   
% 210.96/211.19  |- skos__hiddenLabel mesh__D015155 Spasms, Diffuse Esophageal
% 210.96/211.19  |- mesh__dateEstablished mesh__D015155 1989-01-01
% 210.96/211.19  |- mesh__recordOriginator mesh__D015155 EC
% 210.96/211.19  |- mesh__dateRevised mesh__D015155 2004-07-07
% 210.96/211.19  |- mesh__dateRevised mesh__D009916 1990-05-29
% 210.96/211.19  |- skos__hiddenLabel mesh__D009916 Disease, Orbital
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D009916 2002
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D009916 2005
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D009916 2004
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D009916 1992
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D009916 1999
% 210.96/211.19  |- mesh__publicMeSHNote mesh__D009916 81   
% 210.96/211.19  |- skos__historyNote mesh__D009916 Orbit %28%1966-1980%29%
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D009916 1994
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D009916 2006
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D009916 1991
% 210.96/211.19  |- skos__annotation mesh__D009916
% 210.96/211.19       dis of bony cavity %26% its contents except eyeball %28% = EYE DISEASES or specifics%29%%A%  
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D009916 1993
% 210.96/211.19  |- skos__scopeNote mesh__D009916
% 210.96/211.19       Diseases of the bony orbit and contents except the eyeball.%A%    
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D009916 2000
% 210.96/211.19  |- skos__hiddenLabel mesh__D009916 Orbital Disease
% 210.96/211.19  |- rdf__type mesh__D009916sskos__Concept
% 210.96/211.19  |- skos__hiddenLabel mesh__D009916 Diseases, Orbital
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D009916 1995
% 210.96/211.19  |- skos__prefLabel mesh__D009916 Orbital Diseases
% 210.96/211.19  |- mesh__dateCreated mesh__D009916 1980-04-09
% 210.96/211.19  |- mesh__recordOriginator mesh__D009916 RC
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D009916 2001
% 210.96/211.19  |- mesh__historyNote mesh__D009916 81   
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D009916 1996
% 210.96/211.19  |- mesh__recordMaintainer mesh__D009916 PLS
% 210.96/211.19  |- mesh__recordAuthorizer mesh__D009916 NLM
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D009916 2003
% 210.96/211.19  |- mesh__dateEstablished mesh__D009916 1981-01-01
% 210.96/211.19  |- skos__broader mesh__D009916smesh__D005128
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D009916 1998
% 210.96/211.19  |- skos__historyNote mesh__D009916 Eye Diseases %28%1966-1980%29%
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D009916 1997
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D001933 2005
% 210.96/211.19  |- mesh__dateCreated mesh__D001933 1999-01-01
% 210.96/211.19  |- mesh__recordAuthorizer mesh__D001933 ags
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D001933 2003
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D001933 2006
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D001933 2000
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D001933 2004
% 210.96/211.19  |- skos__broader mesh__D001933smesh__D001921
% 210.96/211.19  |- skos__hiddenLabel mesh__D001933 Brain Stems
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D001933 2001
% 210.96/211.19  |- skos__scopeNote mesh__D001933
% 210.96/211.19       The part of the brain that connects the cerebral hemispheres with the spinal cord. It consists of the MESENCEPHALON; PONS; and MEDULLA OBLONGATA.%A%    
% 210.96/211.19  |- mesh__dateRevised mesh__D001933 2005-07-20
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D001933 2002
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D001933 2006A
% 210.96/211.19  |- mesh__recordMaintainer mesh__D001933 ags
% 210.96/211.19  |- skos__altLabel mesh__D001933 Brainstem
% 210.96/211.19  |- mesh__recordOriginator mesh__D001933 NLM
% 210.96/211.19  |- skos__hiddenLabel mesh__D001933 Brainstems
% 210.96/211.19  |- rdf__type mesh__D001933sskos__Concept
% 210.96/211.19  |- skos__prefLabel mesh__D001933 Brain Stem
% 210.96/211.19  |- mesh__publicMeSHNote mesh__D009118 86; was see under OXAZOLES 1979-85   
% 210.96/211.19  |- mesh__dateRevised mesh__D009118 2005-06-30
% 210.96/211.19  |- skos__altLabel mesh__D009118 Agarin
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D009118 2006
% 210.96/211.19  |- skos__altLabel mesh__D009118 Pantherine
% 210.96/211.19  |- skos__scopeNote mesh__D009118
% 210.96/211.19       Neurotoxic isoxazole isolated from Amanita muscaria and A. phalloides and also obtained by decarboxylation of IBOTENIC ACID. It is a potent agonist at GABA-A receptors and is used mainly as an experimental tool in animal and tissue studies.%A%    
% 210.96/211.19  |- skos__historyNote mesh__D009118 Oxazoles %28%1966-1978%29%
% 210.96/211.19  |- skos__prefLabel mesh__D009118 Muscimol
% 210.96/211.19  |- mesh__historyNote mesh__D009118
% 210.96/211.19       86%28%79%29%; was see under OXAZOLES 1979-85   
% 210.96/211.19  |- mesh__recordOriginator mesh__D009118 SH
% 210.96/211.19  |- mesh__recordMaintainer mesh__D009118 ssb
% 210.96/211.19  |- skos__broader mesh__D009118smesh__D010080
% 210.96/211.19  |- skos__related mesh__D009118smesh__D011963
% 210.96/211.19  |- skos__historyNote mesh__D009118 Mycotoxins %28%1967-1978%29%
% 210.96/211.19  |- rdf__type mesh__D009118sskos__Concept
% 210.96/211.19  |- mesh__dateEstablished mesh__D009118 1986-01-01
% 210.96/211.19  |- skos__broader mesh__D009118smesh__D009183
% 210.96/211.19  |- mesh__dateCreated mesh__D009118 1978-05-03
% 210.96/211.19  |- skos__historyNote mesh__D009118 Toxins %28%1966%29%
% 210.96/211.19  |- mesh__recordAuthorizer mesh__D009118 sjn
% 210.96/211.19  |- mesh__dateEstablished mesh__D001135 1991-01-01
% 210.96/211.19  |- skos__annotation mesh__D001135 IM; qualif permitted   
% 210.96/211.19  |- mesh__recordAuthorizer mesh__D001135 sjn
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D001135 2004
% 210.96/211.19  |- mesh__recordOriginator mesh__D001135 NLM
% 210.96/211.19  |- mesh__recordMaintainer mesh__D001135 ags
% 210.96/211.19  |- mesh__publicMeSHNote mesh__D001135 91; was see under EDENTATA 1975-90   
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D001135 2006
% 210.96/211.19  |- skos__prefLabel mesh__D001135 Armadillos
% 210.96/211.19  |- mesh__historyNote mesh__D001135
% 210.96/211.19       91%28%75%29%; was see under EDENTATA 1975-90   
% 210.96/211.19  |- skos__broader mesh__D001135smesh__D004490
% 210.96/211.19  |- mesh__dateRevised mesh__D001135 2003-07-09
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D001135 2005
% 210.96/211.19  |- mesh__dateCreated mesh__D001135 1974-11-19
% 210.96/211.19  |- rdf__type mesh__D001135sskos__Concept
% 210.96/211.19  |- skos__scopeNote mesh__D001135
% 210.96/211.19       Burrowing, chiefly nocturnal mammals of the family Dasypodidae having bodies and heads encased in small bony plates. They are widely distributed in the warmer parts of the Americas.%A%    
% 210.96/211.19  |- skos__hiddenLabel mesh__D001135 Armadillo
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D019546 2006
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D019546 2001
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D019546 2005
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D019546 2004
% 210.96/211.19  |- skos__related mesh__D019546smesh__D008388
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D019546 2000
% 210.96/211.19  |- mesh__historyNote mesh__D019546 97   
% 210.96/211.19  |- mesh__publicMeSHNote mesh__D019546 97   
% 210.96/211.19  |- skos__altLabel mesh__D019546 Couple Therapy
% 210.96/211.19  |- rdf__type mesh__D019546sskos__Concept
% 210.96/211.19  |- mesh__dateEstablished mesh__D019546 1997-01-01
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D019546 2003
% 210.96/211.19  |- skos__hiddenLabel mesh__D019546 Couples Therapies
% 210.96/211.19  |- skos__hiddenLabel mesh__D019546 Therapy, Couples
% 210.96/211.19  |- skos__hiddenLabel mesh__D019546 Therapy, Couple
% 210.96/211.19  |- skos__scopeNote mesh__D019546
% 210.96/211.19       Psychotherapy used specifically for unmarried couples, of mixed or same sex. %28%From APA, Thesaurus of Psychological Index Terms, 1994%29%%A%    
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D019546 2002
% 210.96/211.19  |- skos__hiddenLabel mesh__D019546 Couple Therapies
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D019546 1999
% 210.96/211.19  |- skos__historyNote mesh__D019546 Psychotherapy %28%1990-1996%29%
% 210.96/211.19  |- skos__broader mesh__D019546smesh__D011615
% 210.96/211.19  |- skos__hiddenLabel mesh__D019546 Therapies, Couple
% 210.96/211.19  |- skos__hiddenLabel mesh__D019546 Therapies, Couples
% 210.96/211.19  |- skos__annotation mesh__D019546
% 210.96/211.19       a psychother technique for unmarried couples: for married couples index under MARITAL THERAPY; DF: COUPLES THER%A%  
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D019546 1998
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D019546 1997
% 210.96/211.19  |- mesh__dateCreated mesh__D019546 1996-06-13
% 210.96/211.19  |- skos__prefLabel mesh__D019546 Couples Therapy
% 210.96/211.19  |- skos__scopeNote mesh__D011563
% 210.96/211.19       An order of BIRDS comprised of several families and more than 300 species. It includes COCKATOOS; PARROTS; PARAKEETS; macaws; and BUDGERIGARS.%A%    
% 210.96/211.19  |- mesh__dateCreated mesh__D011563 1999-01-01
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D011563 2005
% 210.96/211.19  |- mesh__dateRevised mesh__D011563 2004-07-07
% 210.96/211.19  |- mesh__publicMeSHNote mesh__D011563 2005; see PSITTACINES 1968-2004   
% 210.96/211.19  |- rdf__type mesh__D011563sskos__Concept
% 210.96/211.19  |- mesh__dateEstablished mesh__D011563 1968-01-01
% 210.96/211.19  |- mesh__recordOriginator mesh__D011563 NLM
% 210.96/211.19  |- skos__altLabel mesh__D011563 Psittacines
% 210.96/211.19  |- mesh__historyNote mesh__D011563 2005 %28%1968%29%   
% 210.96/211.19  |- skos__prefLabel mesh__D011563 Psittaciformes
% 210.96/211.19  |- mesh__recordAuthorizer mesh__D011563 sjn
% 210.96/211.19  |- mesh__recordMaintainer mesh__D011563 ags
% 210.96/211.19  |- skos__historyNote mesh__D011563 Birds %28%1966-1967%29%
% 210.96/211.19  |- skos__broader mesh__D011563smesh__D001717
% 210.96/211.19  |- skos__annotation mesh__D011563
% 210.96/211.19       General or unspecified; prefer specifics   
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D011563 2006
% 210.96/211.19  |- mesh__historyNote mesh__D005526
% 210.96/211.19       80; was FOOD, ARTIFICIAL 1979; was FOOD, ARTIFICIAL see under FOOD 1973-78 %28%Prov 1973-74%29%; was FOODS, ARTIFICIAL 1972 %28%Prov%29%%A%  
% 210.96/211.19  |- skos__altLabel mesh__D005526 Diet, Synthetic
% 210.96/211.19  |- skos__hiddenLabel mesh__D005526 Diets, Formula
% 210.96/211.19  |- skos__historyNote mesh__D005526 Food %28%1966-1971%29%
% 210.96/211.19  |- skos__hiddenLabel mesh__D005526 Elemental Diets
% 210.96/211.19  |- skos__historyNote mesh__D005526 specific food %28%1966-1971%29%
% 210.96/211.19  |- mesh__recordAuthorizer mesh__D005526 sjn
% 210.96/211.19  |- rdf__type mesh__D005526sskos__Concept
% 210.96/211.19  |- mesh__publicMeSHNote mesh__D005526
% 210.96/211.19       80; was FOOD, ARTIFICIAL 1979; was FOOD, ARTIFICIAL see under FOOD 1975-78%A%  
% 210.96/211.19  |- skos__hiddenLabel mesh__D005526 Formulations, Dietary
% 210.96/211.19  |- skos__hiddenLabel mesh__D005526 Dietary Formulation
% 210.96/211.19  |- mesh__recordMaintainer mesh__D005526 ssb
% 210.96/211.19  |- mesh__dateRevised mesh__D005526 2003-07-09
% 210.96/211.19  |- skos__hiddenLabel mesh__D005526 Formulated Foods
% 210.96/211.19  |- mesh__dateEstablished mesh__D005526 1979-01-01
% 210.96/211.19  |- skos__hiddenLabel mesh__D005526 Diets, Synthetic
% 210.96/211.19  |- mesh__onlineNote mesh__D005526
% 210.96/211.19       use FOOD, FORMULATED to search FOOD, ARTIFICIAL %26% FOODS, ARTIFICIAL 1972-79 %28%as Prov 1972-74%29%%A%  
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D005526 2005
% 210.96/211.19  |- mesh__dateCreated mesh__D005526 1999-01-01
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D005526 2004
% 210.96/211.19  |- skos__annotation mesh__D005526
% 210.96/211.19       includes imitation eggs, meat, dairy prod, space diets, weight reduction formulas, tube-feeding diets; does not include infant formulas and baby foods %28% = INFANT FORMULA or INFANT FOOD%29%; do not confuse with FOOD, FORTIFIED which emphasizes addition of essential nutrients%A%  
% 210.96/211.19  |- skos__hiddenLabel mesh__D005526 Elemental Diet
% 210.96/211.19  |- skos__hiddenLabel mesh__D005526 Diets, Elemental
% 210.96/211.19  |- skos__hiddenLabel mesh__D005526 Diets, Chemically Defined
% 210.96/211.19  |- skos__altLabel mesh__D005526 Chemically Defined Diet
% 210.96/211.19  |- mesh__activeMeSHYear mesh__D005526 2006
% 210.96/211.19  |- skos__hiddenLabel mesh__D005526 Chemically Defined Diets
% 210.96/211.19  |- skos__prefLabel mesh__D005526 Food, Formulated
% 210.96/211.19  |- skos__hiddenLabel mesh__D005526 Formulation, Dietary
% 210.96/211.19  |- skos__hiddenLabel mesh__D005526 Formulated Food
% 210.96/211.19  |- skos__scopeNote mesh__D005526
% 210.96/211.19       Food and dietary formulations including elemental %28%chemically defined formula%29% diets, synthetic and semisynthetic diets, space diets, weight-reduction formulas, tube-feeding diets, complete liquid diets, and supplemental liquid and solid diets.%A%    
% 210.96/211.20  |- mesh__recordOriginator mesh__D005526 NLM
% 210.96/211.20  |- skos__hiddenLabel mesh__D005526 Foods, Formulated
% 210.96/211.20  |- skos__broader mesh__D005526smesh__D019648
% 210.96/211.20  |- skos__prefLabel mesh__D029974 Carum
% 210.96/211.20  |- skos__scopeNote mesh__D029974
% 210.96/211.20       A plant genus of the family Apiaceae.  The seeds are used as flavoring.%A%    
% 210.96/211.20  |- skos__altLabel mesh__D029974 Caraway
% 210.96/211.20  |- mesh__dateCreated mesh__D029974 2001-07-25
% 210.96/211.20  |- skos__broader mesh__D029974smesh__D019661
% 210.96/211.20  |- skos__altLabel mesh__D029974 Ajowan
% 210.96/211.20  |- mesh__historyNote mesh__D029974 2002   
% 210.96/211.20  |- skos__annotation mesh__D029974
% 210.96/211.20       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 210.96/211.20  |- mesh__activeMeSHYear mesh__D029974 2004
% 210.96/211.20  |- mesh__dateEstablished mesh__D029974 2002-01-01
% 210.96/211.20  |- mesh__activeMeSHYear mesh__D029974 2006
% 210.96/211.20  |- mesh__activeMeSHYear mesh__D029974 2003
% 210.96/211.20  |- rdf__type mesh__D029974sskos__Concept
% 210.96/211.20  |- mesh__dateRevised mesh__D029974 2002-07-02
% 210.96/211.20  |- mesh__activeMeSHYear mesh__D029974 2005
% 210.96/211.20  |- mesh__publicMeSHNote mesh__D029974 2002   
% 210.96/211.20  |- rdf__type mesh__D048330sskos__Concept
% 210.96/211.20  |- mesh__historyNote mesh__D048330 2005   
% 210.96/211.20  |- skos__prefLabel mesh__D048330 Trichosurus
% 210.96/211.20  |- skos__hiddenLabel mesh__D048330 Brush-Tailed Possums
% 210.96/211.20  |- mesh__publicMeSHNote mesh__D048330 2005   
% 210.96/211.20  |- mesh__recordMaintainer mesh__D048330 ags
% 210.96/211.20  |- skos__broader mesh__D048330smesh__D048329
% 210.96/211.20  |- skos__hiddenLabel mesh__D048330 Brush-Tailed Possum
% 210.96/211.20  |- skos__historyNote mesh__D048330 Marsupialia %28%1965-2004%29%
% 210.96/211.20  |- mesh__recordOriginator mesh__D048330 ags
% 210.96/211.20  |- mesh__activeMeSHYear mesh__D048330 2006
% 210.96/211.20  |- skos__altLabel mesh__D048330 Possums, Brush-Tailed
% 210.96/211.20  |- skos__scopeNote mesh__D048330
% 210.96/211.20       A genus of brush-tailed possums found chiefly in Australia and New Zealand. Secretions from their ANAL GLAND function both in defense and demarcating territory.%A%    
% 210.96/211.20  |- skos__hiddenLabel mesh__D048330 Possum, Brush-Tailed
% 210.96/211.20  |- skos__hiddenLabel mesh__D048330 Possums, Brush Tailed
% 210.96/211.20  |- mesh__dateEstablished mesh__D048330 2005-01-01
% 210.96/211.20  |- mesh__activeMeSHYear mesh__D048330 2005
% 210.96/211.20  |- mesh__dateCreated mesh__D048330 2004-07-07
% 210.96/211.20  |- mesh__recordAuthorizer mesh__D048330 sjn
% 210.96/211.20  |- mesh__recordMaintainer mesh__D009917 ssb
% 210.96/211.20  |- skos__broader mesh__D009917smesh__D012887
% 210.96/211.20  |- mesh__activeMeSHYear mesh__D009917 2006
% 210.96/211.20  |- skos__historyNote mesh__D009917 Fractures %28%1966-1982%29%
% 210.96/211.20  |- mesh__dateCreated mesh__D009917 1982-04-27
% 210.96/211.20  |- rdf__type mesh__D009917sskos__Concept
% 210.96/211.20  |- skos__broader mesh__D009917smesh__D008446
% 210.96/211.20  |- skos__hiddenLabel mesh__D009917 Orbital Fracture
% 210.96/211.20  |- mesh__dateRevised mesh__D009917 2005-06-30
% 210.96/211.20  |- skos__scopeNote mesh__D009917
% 210.96/211.20       Fractures of the bones in the orbit, which include parts of the frontal, ethmoidal, lacrimal, and sphenoid bones and the maxilla and zygoma.%A%    
% 210.96/211.20  |- skos__hiddenLabel mesh__D009917 Blow-Out Fracture
% 210.96/211.20  |- mesh__recordOriginator mesh__D009917 RC
% 210.96/211.20  |- mesh__recordAuthorizer mesh__D009917 sjn
% 210.96/211.20  |- mesh__dateEstablished mesh__D009917 1991-01-01
% 210.96/211.20  |- mesh__publicMeSHNote mesh__D009917
% 210.96/211.20       91; was see under SKULL FRACTURES 1983-90   
% 210.96/211.20  |- skos__hiddenLabel mesh__D009917 Blow Out Fractures
% 210.96/211.20  |- skos__hiddenLabel mesh__D009917 Fracture, Orbital
% 210.96/211.20  |- mesh__historyNote mesh__D009917
% 210.96/211.20       91%28%83%29%; was see under SKULL FRACTURES 1983-90   
% 210.96/211.20  |- skos__hiddenLabel mesh__D009917 Fractures, Blow Out
% 210.96/211.20  |- skos__hiddenLabel mesh__D009917 Fracture, Blow-Out
% 210.96/211.20  |- skos__prefLabel mesh__D009917 Orbital Fractures
% 210.96/211.20  |- skos__annotation mesh__D009917
% 210.96/211.20       ZYGOMATIC FRACTURES %26% MAXILLARY FRACTURES are also available%A%  
% 210.96/211.20  |- skos__historyNote mesh__D009917 Orbit %28%1966-1982%29%
% 210.96/211.20  |- skos__altLabel mesh__D009917 Fractures, Blow-Out
% 210.96/211.20  |- skos__historyNote mesh__D009917 Skull Fractures %28%1966-1982%29%
% 210.96/211.20  |- skos__hiddenLabel mesh__D009917 Fractures, Orbital
% 210.96/211.20  |- skos__hiddenLabel mesh__D001934 Branchial Cleft
% 210.96/211.20  |- mesh__activeMeSHYear mesh__D001934 2003
% 210.96/211.20  |- mesh__activeMeSHYear mesh__D001934 1992
% 210.96/211.20  |- skos__altLabel mesh__D001934 Visceral Arches
% 210.96/211.20  |- mesh__activeMeSHYear mesh__D001934 2001
% 210.96/211.20  |- mesh__activeMeSHYear mesh__D001934 2006
% 210.96/211.20  |- mesh__activeMeSHYear mesh__D001934 1995
% 210.96/211.20  |- mesh__activeMeSHYear mesh__D001934 1998
% 210.96/211.20  |- skos__hiddenLabel mesh__D001934 Arch, Pharyngeal
% 210.96/211.20  |- skos__annotation mesh__D001934
% 210.96/211.20       includes branchial arch %26% branchial cleft; branchial arch syndrome: index under BRANCHIAL REGION %28%IM%29% + SYNDROME %28%NIM%29%%A%  
% 210.96/211.20  |- skos__hiddenLabel mesh__D001934 Arches, Pharyngeal
% 210.96/211.20  |- skos__prefLabel mesh__D001934 Branchial Region
% 210.96/211.20  |- skos__hiddenLabel mesh__D001934 Region, Branchial
% 210.96/211.20  |- mesh__activeMeSHYear mesh__D001934 2000
% 210.96/211.20  |- skos__hiddenLabel mesh__D001934 Arches, Branchial
% 210.96/211.20  |- skos__hiddenLabel mesh__D001934 Pharyngeal Archs
% 210.96/211.20  |- mesh__activeMeSHYear mesh__D001934 2005
% 210.96/211.20  |- skos__hiddenLabel mesh__D001934 Clefts, Branchial
% 210.96/211.20  |- skos__altLabel mesh__D001934 Branchial Arches
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001934 1994
% 211.05/211.20  |- skos__scopeNote mesh__D001934
% 211.05/211.20       Region containing paired arched columns that bear gills in lower aquatic vertebrates and appear in the embryos of higher vertebrates in comparable form. In higher vertebrates the arches are subsequently modified into structures of the neck and ear.%A%    
% 211.05/211.20  |- skos__hiddenLabel mesh__D001934 Arch, Visceral
% 211.05/211.20  |- skos__hiddenLabel mesh__D001934 Branchial Regions
% 211.05/211.20  |- mesh__dateRevised mesh__D001934 2005-07-30
% 211.05/211.20  |- skos__hiddenLabel mesh__D001934 Archs, Pharyngeal
% 211.05/211.20  |- skos__hiddenLabel mesh__D001934 Arch, Branchial
% 211.05/211.20  |- mesh__dateCreated mesh__D001934 1999-01-01
% 211.05/211.20  |- mesh__recordAuthorizer mesh__D001934 jls
% 211.05/211.20  |- mesh__recordOriginator mesh__D001934 NLM
% 211.05/211.20  |- skos__altLabel mesh__D001934 Visceral Arch
% 211.05/211.20  |- skos__hiddenLabel mesh__D001934 Arches, Visceral
% 211.05/211.20  |- skos__broader mesh__D001934smesh__D004622
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001934 1997
% 211.05/211.20  |- skos__hiddenLabel mesh__D001934 Cleft, Branchial
% 211.05/211.20  |- skos__altLabel mesh__D001934 Pharyngeal Arches
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001934 2006A
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001934 2004
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001934 1993
% 211.05/211.20  |- skos__hiddenLabel mesh__D001934 Regions, Branchial
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001934 1996
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001934 2002
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001934 1991
% 211.05/211.20  |- rdf__type mesh__D001934sskos__Concept
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001934 1999
% 211.05/211.20  |- mesh__recordMaintainer mesh__D001934 jls
% 211.05/211.20  |- skos__altLabel mesh__D001934 Pharyngeal Arch
% 211.05/211.20  |- mesh__recordOriginator mesh__D009119 NLM
% 211.05/211.20  |- skos__hiddenLabel mesh__D009119 Contractions, Muscle
% 211.05/211.20  |- skos__annotation mesh__D009119
% 211.05/211.20       do not use for HEART or MYOCARDIUM %28% = MYOCARDIAL CONTRACTION%29% or UTERUS %28% = UTERINE CONTRACTION%29%%A%  
% 211.05/211.20  |- skos__hiddenLabel mesh__D009119 Contraction, Muscular
% 211.05/211.20  |- skos__altLabel mesh__D009119 Muscular Contraction
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D009119 2006
% 211.05/211.20  |- mesh__recordAuthorizer mesh__D009119 sjn
% 211.05/211.20  |- skos__prefLabel mesh__D009119 Muscle Contraction
% 211.05/211.20  |- skos__altLabel mesh__D009119 Muscular Tension
% 211.05/211.20  |- skos__broader mesh__D009119smesh__D043702
% 211.05/211.20  |- skos__hiddenLabel mesh__D009119 Tension, Muscular
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D009119 2005
% 211.05/211.20  |- mesh__dateCreated mesh__D009119 1999-01-01
% 211.05/211.20  |- skos__hiddenLabel mesh__D009119 Contractions, Muscular
% 211.05/211.20  |- skos__scopeNote mesh__D009119
% 211.05/211.20       A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.%A%    
% 211.05/211.20  |- skos__related mesh__D009119smesh__D018763
% 211.05/211.20  |- skos__hiddenLabel mesh__D009119 Tension, Muscle
% 211.05/211.20  |- mesh__dateRevised mesh__D009119 2003-07-09
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D009119 2004
% 211.05/211.20  |- mesh__historyNote mesh__D009119 65%28%64%29%   
% 211.05/211.20  |- mesh__recordMaintainer mesh__D009119 nns
% 211.05/211.20  |- mesh__dateEstablished mesh__D009119 1965-01-01
% 211.05/211.20  |- skos__hiddenLabel mesh__D009119 Contraction, Muscle
% 211.05/211.20  |- skos__hiddenLabel mesh__D009119 Muscular Contractions
% 211.05/211.20  |- mesh__publicMeSHNote mesh__D009119 65   
% 211.05/211.20  |- skos__hiddenLabel mesh__D009119 Muscle Contractions
% 211.05/211.20  |- rdf__type mesh__D009119sskos__Concept
% 211.05/211.20  |- skos__related mesh__D009119smesh__D009126
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001136 1997
% 211.05/211.20  |- skos__annotation mesh__D001136
% 211.05/211.20       includes present and historical contexts   
% 211.05/211.20  |- skos__broader mesh__D001136smesh__D017517
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001136 2003
% 211.05/211.20  |- skos__broader mesh__D001136smesh__D018436
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001136 2001
% 211.05/211.20  |- skos__broader mesh__D001136smesh__D014586
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001136 2006
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001136 1996
% 211.05/211.20  |- skos__scopeNote mesh__D001136
% 211.05/211.20       An ancient country in western Asia, by the twentieth century divided among the former USSR, Turkey, and Iran. It was attacked at various times from before the 7th century B.C. to 69 B.C. by Assyrians, Medes, Persians, the Greeks under Alexander, and the Romans. It changed hands frequently in wars between Neo-Persian and Roman Empires from the 3d to 7th centuries and later under Arabs, Seljuks, Byzantines, and Mongols. In the 19th century Armenian nationalism arose but suffered during Russo-Turkish hostilities. It became part of the Soviet Republic in 1921, with part remaining under Turkey. %28%Webster%27%s New Geographical Dictionary, 1988%29%%A%    
% 211.05/211.20  |- mesh__recordOriginator mesh__D001136 NLM
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001136 1999
% 211.05/211.20  |- mesh__dateRevised mesh__D001136 1994-04-19
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001136 2000
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001136 2005
% 211.05/211.20  |- skos__altLabel mesh__D001136 Armenian SSR
% 211.05/211.20  |- rdf__type mesh__D001136sskos__Concept
% 211.05/211.20  |- mesh__onlineNote mesh__D001136
% 211.05/211.20       use ARMENIA to search ARMENIAN S.S.R 1982-92 %26% ARMENIAN SSR 1975-81%A%  
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001136 1995
% 211.05/211.20  |- skos__altLabel mesh__D001136 Armenian S.S.R.
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001136 1998
% 211.05/211.20  |- skos__prefLabel mesh__D001136 Armenia
% 211.05/211.20  |- mesh__historyNote mesh__D001136
% 211.05/211.20       ARMENIAN S.S.R. was heading 1982-92; was ARMENIAN SSR 1975-81%A%  
% 211.05/211.20  |- skos__broader mesh__D001136smesh__D014154
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001136 2002
% 211.05/211.20  |- mesh__dateCreated mesh__D001136 1999-01-01
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001136 2004
% 211.05/211.20  |- mesh__recordMaintainer mesh__D001136 PLS
% 211.05/211.20  |- mesh__recordAuthorizer mesh__D001136 PLS
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Cervical Pain, Anterior
% 211.05/211.20  |- skos__scopeNote mesh__D019547
% 211.05/211.20       Discomfort or more intense forms of pain that are localized to the cervical region. This term generally refers to pain in the posterior or lateral regions of the neck.%A%    
% 211.05/211.20  |- mesh__recordMaintainer mesh__D019547 ags
% 211.05/211.20  |- mesh__recordAuthorizer mesh__D019547 ags
% 211.05/211.20  |- skos__prefLabel mesh__D019547 Neck Pain
% 211.05/211.20  |- mesh__dateEstablished mesh__D019547 1997-01-01
% 211.05/211.20  |- mesh__recordOriginator mesh__D019547 PXP
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Pain, Anterior Neck
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Posterior Neck Pains
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Cervical Pains
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Pain, Neck
% 211.05/211.20  |- skos__altLabel mesh__D019547 Cervicalgia
% 211.05/211.20  |- mesh__publicMeSHNote mesh__D019547 1997   
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D019547 2003
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Ache, Neck
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Posterior Cervical Pains
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Pain, Posterior Neck
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Cervical Pains, Posterior
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D019547 2002
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D019547 2000A
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Pains, Anterior Neck
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D019547 2004
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Pains, Posterior Cervical
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Pain, Anterior Cervical
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D019547 2005
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Cervicodynias
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Cervicalgias
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Neck Aches
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Cervical Pain, Posterior
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Pains, Anterior Cervical
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Anterior Neck Pains
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Aches, Neck
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Anterior Cervical Pains
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D019547 2006
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Pain, Cervical
% 211.05/211.20  |- mesh__dateRevised mesh__D019547 1999-12-13
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Pains, Posterior Neck
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Neck Pains, Anterior
% 211.05/211.20  |- rdf__type mesh__D019547sskos__Concept
% 211.05/211.20  |- skos__altLabel mesh__D019547 Neck Ache
% 211.05/211.20  |- skos__altLabel mesh__D019547 Cervical Pain
% 211.05/211.20  |- skos__historyNote mesh__D019547 Pain %28%1966-1996%29%
% 211.05/211.20  |- skos__altLabel mesh__D019547 Anterior Neck Pain
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Neck Pain, Posterior
% 211.05/211.20  |- mesh__historyNote mesh__D019547 1997   
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Pain, Posterior Cervical
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Cervical Pains, Anterior
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D019547 2000
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Pains, Cervical
% 211.05/211.20  |- skos__altLabel mesh__D019547 Cervicodynia
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Neckaches
% 211.05/211.20  |- skos__altLabel mesh__D019547 Neckache
% 211.05/211.20  |- skos__broader mesh__D019547smesh__D010146
% 211.05/211.20  |- skos__historyNote mesh__D019547 Neck %28%1966-1996%29%
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Pains, Neck
% 211.05/211.20  |- mesh__dateCreated mesh__D019547 1996-06-10
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Neck Pain, Anterior
% 211.05/211.20  |- skos__altLabel mesh__D019547 Posterior Neck Pain
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Neck Pains, Posterior
% 211.05/211.20  |- skos__hiddenLabel mesh__D019547 Neck Pains
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D019547 2001
% 211.05/211.20  |- mesh__dateCreated mesh__D011564 1978-03-13
% 211.05/211.20  |- rdf__type mesh__D011564sskos__Concept
% 211.05/211.20  |- skos__broader mesh__D011564smesh__D006575
% 211.05/211.20  |- skos__scopeNote mesh__D011564
% 211.05/211.20       Linear furanocoumarins which are found in many PLANTS, especially UMBELLIFERAE and RUTACEAE, as well as PSORALEA from which they were originally discovered.  They can intercalate DNA and, in an UV-initiated reaction of the furan portion, alkylate PYRIMIDINES, resulting in PHOTOSENSITIVITY DISORDERS.%A%    
% 211.05/211.20  |- skos__related mesh__D011564smesh__D003374
% 211.05/211.20  |- skos__historyNote mesh__D011564 Furans %28%1966-1978%29%
% 211.05/211.20  |- mesh__recordMaintainer mesh__D011564 ssb
% 211.05/211.20  |- mesh__publicMeSHNote mesh__D011564
% 211.05/211.20       79; FICUSIN %26% TRIOXSALEN were see under COUMARINS 1975-78%A%  
% 211.05/211.20  |- skos__prefLabel mesh__D011564 Psoralens
% 211.05/211.20  |- mesh__recordOriginator mesh__D011564 SH
% 211.05/211.20  |- mesh__dateEstablished mesh__D011564 1979-01-01
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D011564 2006
% 211.05/211.20  |- skos__historyNote mesh__D011564 Coumarins %28%1966-1978%29%
% 211.05/211.20  |- mesh__historyNote mesh__D011564 79   
% 211.05/211.20  |- skos__altLabel mesh__D011564 Furanocoumarins
% 211.05/211.20  |- mesh__dateRevised mesh__D011564 2005-06-30
% 211.05/211.20  |- skos__broader mesh__D011564smesh__D005663
% 211.05/211.20  |- skos__broader mesh__D011564smesh__D003374
% 211.05/211.20  |- skos__annotation mesh__D011564
% 211.05/211.20       dermatol agents; do not confuse with the specific drug PSORALEN see FICUSIN; do not index here for psoralens in PUVA THERAPY unless particularly discussed%A%  
% 211.05/211.20  |- mesh__recordAuthorizer mesh__D011564 sjn
% 211.05/211.20  |- mesh__onlineNote mesh__D005527
% 211.05/211.20       use FOOD, FORTIFIED to search FOODS, FORTIFIED 1970-72 %28%as Prov%29%%A%  
% 211.05/211.20  |- mesh__recordOriginator mesh__D005527 NLM
% 211.05/211.20  |- skos__hiddenLabel mesh__D005527 Fortified Food
% 211.05/211.20  |- skos__altLabel mesh__D005527 Enriched Food
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D005527 1998
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D005527 2003
% 211.05/211.20  |- mesh__historyNote mesh__D005527
% 211.05/211.20       73; was FOODS, FORTIFIED 1970-72 %28%Prov%29%   
% 211.05/211.20  |- skos__annotation mesh__D005527
% 211.05/211.20       coord IM with added nutrient if relevant %28%IM%29%; do not confuse with FOOD, FORMULATED or DIETARY SUPPLEMENTS: read MeSH definitions%A%  
% 211.05/211.20  |- skos__hiddenLabel mesh__D005527 Enriched Foods
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D005527 2000
% 211.05/211.20  |- mesh__recordMaintainer mesh__D005527 JLS
% 211.05/211.20  |- mesh__dateEstablished mesh__D005527 1973-01-01
% 211.05/211.20  |- skos__prefLabel mesh__D005527 Food, Fortified
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D005527 2005
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D005527 1999
% 211.05/211.20  |- mesh__dateCreated mesh__D005527 1999-01-01
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D005527 2004
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D005527 2001
% 211.05/211.20  |- skos__hiddenLabel mesh__D005527 Fortified Foods
% 211.05/211.20  |- skos__hiddenLabel mesh__D005527 Foods, Enriched
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D005527 2006
% 211.05/211.20  |- skos__hiddenLabel mesh__D005527 Food, Enriched
% 211.05/211.20  |- skos__scopeNote mesh__D005527
% 211.05/211.20       Any food that has been supplemented with essential nutrients either in quantities that are greater than those present normally, or which are not present in the fortified food. The supplementation of cereals with iron and vitamins is an example of fortified food. Fortified food includes also enriched food to which various nutrients have been added to compensate for those essential nutrients removed by refinement or processing. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 211.05/211.20  |- skos__historyNote mesh__D005527 Food %28%1966-1969%29%
% 211.05/211.20  |- skos__broader mesh__D005527smesh__D019648
% 211.05/211.20  |- mesh__dateRevised mesh__D005527 1997-06-20
% 211.05/211.20  |- mesh__publicMeSHNote mesh__D005527 73   
% 211.05/211.20  |- skos__hiddenLabel mesh__D005527 Foods, Fortified
% 211.05/211.20  |- mesh__recordAuthorizer mesh__D005527 SJN
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D005527 2002
% 211.05/211.20  |- rdf__type mesh__D005527sskos__Concept
% 211.05/211.20  |- skos__broader mesh__D009918smesh__D012888
% 211.05/211.20  |- skos__related mesh__D009918smesh__D005134
% 211.05/211.20  |- mesh__recordOriginator mesh__D009918 NLM
% 211.05/211.20  |- skos__broader mesh__D009918smesh__D009916
% 211.05/211.20  |- skos__hiddenLabel mesh__D009918 Neoplasm, Orbital
% 211.05/211.20  |- skos__hiddenLabel mesh__D009918 Neoplasms, Orbital
% 211.05/211.20  |- mesh__dateCreated mesh__D009918 1999-01-01
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D009918 2001
% 211.05/211.20  |- skos__scopeNote mesh__D009918
% 211.05/211.20       Neoplasms of the bony orbit and contents except the eyeball.%A%    
% 211.05/211.20  |- skos__prefLabel mesh__D009918 Orbital Neoplasms
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D009918 2003
% 211.05/211.20  |- mesh__dateRevised mesh__D009918 2000-06-22
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D009918 2005
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D009918 2004
% 211.05/211.20  |- skos__hiddenLabel mesh__D009918 Orbital Neoplasm
% 211.05/211.20  |- mesh__recordMaintainer mesh__D009918 KEV
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D009918 2002
% 211.05/211.20  |- skos__broader mesh__D009918smesh__D005134
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D009918 2006
% 211.05/211.20  |- rdf__type mesh__D009918sskos__Concept
% 211.05/211.20  |- mesh__recordAuthorizer mesh__D009918 sjn
% 211.05/211.20  |- skos__annotation mesh__D009918
% 211.05/211.20       neopl of bony cavity %26% its contents except eyeball %28% = EYE NEOPLASMS or specifics%29%; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%  
% 211.05/211.20  |- skos__prefLabel mesh__D001935 Branchioma
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001935 2001
% 211.05/211.20  |- skos__altLabel mesh__D001935 Branchial Cleft Cyst
% 211.05/211.20  |- mesh__dateRevised mesh__D001935 1995-06-08
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001935 2002
% 211.05/211.20  |- rdf__type mesh__D001935sskos__Concept
% 211.05/211.20  |- skos__hiddenLabel mesh__D001935 Cleft Cysts, Branchial
% 211.05/211.20  |- skos__broader mesh__D001935smesh__D003560
% 211.05/211.20  |- skos__hiddenLabel mesh__D001935 Cyst, Branchial
% 211.05/211.20  |- mesh__recordAuthorizer mesh__D001935 PLS
% 211.05/211.20  |- mesh__recordOriginator mesh__D001935 NLM
% 211.05/211.20  |- skos__hiddenLabel mesh__D001935 Cleft Cyst, Branchial
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001935 2005
% 211.05/211.20  |- mesh__dateCreated mesh__D001935 1999-01-01
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001935 2003
% 211.05/211.20  |- skos__annotation mesh__D001935
% 211.05/211.20       neoplastic; includes branchial inclusion cyst, branchial chondroma, branchial fistula; /blood supply /chem /secret /ultrastruct permitted; coord IM with HEAD AND NECK NEOPLASMS %28%IM%29%%A%  
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001935 1998
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001935 2006
% 211.05/211.20  |- skos__hiddenLabel mesh__D001935 Branchiomas
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001935 1996
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001935 2004
% 211.05/211.20  |- skos__hiddenLabel mesh__D001935 Branchial Cleft Cysts
% 211.05/211.20  |- skos__scopeNote mesh__D001935
% 211.05/211.20       A tumor derived from branchial epithelium or branchial rests. %28%Dorland, 27th ed%29%%A%    
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001935 1999
% 211.05/211.20  |- skos__hiddenLabel mesh__D001935 Cysts, Branchial
% 211.05/211.20  |- skos__hiddenLabel mesh__D001935 Branchial Cysts
% 211.05/211.20  |- skos__hiddenLabel mesh__D001935 Cyst, Branchial Cleft
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001935 2000
% 211.05/211.20  |- mesh__activeMeSHYear mesh__D001935 1997
% 211.05/211.20  |- skos__hiddenLabel mesh__D001935 Cysts, Branchial Cleft
% 211.05/211.20  |- mesh__recordMaintainer mesh__D001935 KEV
% 211.05/211.20  |- skos__altLabel mesh__D001935 Branchial Cyst
% 211.05/211.20  |- skos__historyNote mesh__D006620 Femoral Fractures %28%1966-1977%29%
% 211.05/211.20  |- skos__hiddenLabel mesh__D006620 Fractures, Intertrochanteric
% 211.05/211.20  |- mesh__dateEstablished mesh__D006620 1978-01-01
% 211.05/211.20  |- mesh__dateRevised mesh__D006620 2005-07-14
% 211.05/211.20  |- rdf__type mesh__D006620sskos__Concept
% 211.07/211.20  |- mesh__recordMaintainer mesh__D006620 ags
% 211.07/211.20  |- skos__broader mesh__D006620smesh__D005264
% 211.07/211.20  |- skos__hiddenLabel mesh__D006620 Fractures, Subtrochanteric
% 211.07/211.20  |- mesh__recordOriginator mesh__D006620 AEP
% 211.07/211.20  |- mesh__publicMeSHNote mesh__D006620 78   
% 211.07/211.20  |- mesh__activeMeSHYear mesh__D006620 2006
% 211.07/211.20  |- mesh__dateCreated mesh__D006620 1977-05-04
% 211.07/211.20  |- skos__hiddenLabel mesh__D006620 Fractures, Trochanteric
% 211.07/211.20  |- skos__scopeNote mesh__D006620
% 211.07/211.20       Fractures of the FEMUR HEAD; the FEMUR NECK; %28%FEMORAL NECK FRACTURES%29%; the trochanters; or the inter- or subtrochanteric region. Excludes fractures of the acetabulum and fractures of the femoral shaft below the subtrochanteric region %28%FEMORAL FRACTURES%29%.%A%    
% 211.07/211.20  |- mesh__recordAuthorizer mesh__D006620 ags
% 211.07/211.20  |- mesh__historyNote mesh__D006620 78   
% 211.07/211.20  |- skos__hiddenLabel mesh__D006620 Fractures, Hip
% 211.07/211.20  |- skos__broader mesh__D006620smesh__D050723
% 211.07/211.20  |- skos__prefLabel mesh__D006620 Hip Fractures
% 211.07/211.20  |- skos__annotation mesh__D006620
% 211.07/211.20       GEN or unspecified; note X refs: fract below subtrochant = FEMORAL FRACTURES; FEMORAL NECK FRACTURES is available; femur head fract = FEMUR HEAD /inj %28%IM%29% + HIP FRACTURES %28%IM%29%; acetabular fract = ACETABULUM /inj %28%IM%29% + FRACTURES, BONE %28%IM%29%%A%  
% 211.07/211.20  |- mesh__activeMeSHYear mesh__D006620 2006B
% 211.07/211.20  |- skos__historyNote mesh__D006620 Fractures %28%1966-1977%29%
% 211.07/211.20  |- skos__broader mesh__D006620smesh__D025981
% 211.07/211.20  |- mesh__activeMeSHYear mesh__D006620 2006A
% 211.07/211.20  |- mesh__activeMeSHYear mesh__D019548 1999
% 211.07/211.20  |- mesh__activeMeSHYear mesh__D019548 2002
% 211.07/211.20  |- mesh__activeMeSHYear mesh__D019548 1998
% 211.07/211.20  |- skos__hiddenLabel mesh__D019548 Victims, Crime
% 211.07/211.20  |- mesh__activeMeSHYear mesh__D019548 2006
% 211.07/211.20  |- mesh__dateCreated mesh__D019548 1996-06-13
% 211.07/211.20  |- skos__annotation mesh__D019548
% 211.07/211.20       coord IM with specific crime if pertinent %28%IM%29%   
% 211.07/211.20  |- skos__broader mesh__D019548smesh__D009272
% 211.07/211.20  |- skos__scopeNote mesh__D019548
% 211.07/211.20       Individuals subjected to and adversely affected by criminal activity. %28%APA, Thesaurus of Psychological Index Terms, 1994%29%%A%    
% 211.07/211.20  |- skos__historyNote mesh__D019548 Crime %28%1986-1996%29%
% 211.07/211.20  |- mesh__activeMeSHYear mesh__D019548 2004
% 211.07/211.20  |- mesh__activeMeSHYear mesh__D019548 2005
% 211.07/211.20  |- skos__hiddenLabel mesh__D019548 Crime Victim
% 211.07/211.21  |- skos__prefLabel mesh__D019548 Crime Victims
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D019548 2001
% 211.07/211.21  |- mesh__recordOriginator mesh__D019548 JLS
% 211.07/211.21  |- mesh__historyNote mesh__D019548 97   
% 211.07/211.21  |- mesh__dateEstablished mesh__D019548 1997-01-01
% 211.07/211.21  |- rdf__type mesh__D019548sskos__Concept
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D019548 2003
% 211.07/211.21  |- skos__hiddenLabel mesh__D019548 Victim, Crime
% 211.07/211.21  |- mesh__dateRevised mesh__D019548 1997-06-20
% 211.07/211.21  |- mesh__publicMeSHNote mesh__D019548 97   
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D019548 2000
% 211.07/211.21  |- skos__related mesh__D019548smesh__D014754
% 211.07/211.21  |- mesh__recordAuthorizer mesh__D019548 SJN
% 211.07/211.21  |- mesh__recordMaintainer mesh__D019548 JLS
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D011565 2004
% 211.07/211.21  |- mesh__dateRevised mesh__D011565 1997-06-20
% 211.07/211.21  |- skos__altLabel mesh__D011565 Palmoplantaris Pustulosis
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D011565 2003
% 211.07/211.21  |- skos__hiddenLabel mesh__D011565 Psoriases
% 211.07/211.21  |- skos__altLabel mesh__D011565 Pustulosis Palmaris et Plantaris
% 211.07/211.21  |- skos__prefLabel mesh__D011565 Psoriasis
% 211.07/211.21  |- skos__scopeNote mesh__D011565
% 211.07/211.21       A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.%A%    
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D011565 2002
% 211.07/211.21  |- mesh__dateCreated mesh__D011565 1999-01-01
% 211.07/211.21  |- mesh__recordOriginator mesh__D011565 NLM
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D011565 2006
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D011565 2001
% 211.07/211.21  |- skos__annotation mesh__D011565
% 211.07/211.21       a papulosquamous skin dis; ARTHRITIS, PSORIATIC is also available%A%  
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D011565 1999
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D011565 2005
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D011565 2000
% 211.07/211.21  |- mesh__recordAuthorizer mesh__D011565 SJN
% 211.07/211.21  |- skos__altLabel mesh__D011565 Pustular Psoriasis of Palms and Soles
% 211.07/211.21  |- rdf__type mesh__D011565sskos__Concept
% 211.07/211.21  |- mesh__recordMaintainer mesh__D011565 TGC
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D011565 1998
% 211.07/211.21  |- skos__broader mesh__D011565smesh__D017444
% 211.07/211.21  |- skos__historyNote mesh__D038702 Glycoproteins %28%2001-2002%29%
% 211.07/211.21  |- mesh__recordAuthorizer mesh__D038702 sjn
% 211.07/211.21  |- skos__altLabel mesh__D038702 Follistatin-Related Protein 1
% 211.07/211.21  |- skos__altLabel mesh__D038702 FSTL3 Gene Product
% 211.07/211.21  |- mesh__publicMeSHNote mesh__D038702 2003   
% 211.07/211.21  |- mesh__dateCreated mesh__D038702 2002-07-03
% 211.07/211.21  |- skos__hiddenLabel mesh__D038702 Follistatin Related Protein 1
% 211.07/211.21  |- skos__hiddenLabel mesh__D038702 Follistatin Like Secreted Glycoprotein
% 211.07/211.21  |- rdf__type mesh__D038702sskos__Concept
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D038702 2006
% 211.07/211.21  |- skos__scopeNote mesh__D038702
% 211.07/211.21       Broadly distributed glycoproteins that are homologous to the activin-binding protein, FOLLISTATIN. These follistatin-related proteins are encoded by a number of genes.%A%    
% 211.07/211.21  |- mesh__historyNote mesh__D038702 2003   
% 211.07/211.21  |- mesh__dateEstablished mesh__D038702 2003-01-01
% 211.07/211.21  |- skos__hiddenLabel mesh__D038702 Follistatin Like Protein 3
% 211.07/211.21  |- mesh__dateRevised mesh__D038702 2005-06-30
% 211.07/211.21  |- skos__broader mesh__D038702smesh__D002352
% 211.07/211.21  |- skos__hiddenLabel mesh__D038702 Follistatin Related Proteins
% 211.07/211.21  |- skos__altLabel mesh__D038702 FLRG Protein
% 211.07/211.21  |- skos__prefLabel mesh__D038702 Follistatin-Related Proteins
% 211.07/211.21  |- skos__historyNote mesh__D038702 Activins %28%1994-2002%29%
% 211.07/211.21  |- skos__altLabel mesh__D038702 Follistatin Secreted Related Protein
% 211.07/211.21  |- skos__hiddenLabel mesh__D038702 Follistatin Like Protein 1
% 211.07/211.21  |- mesh__recordOriginator mesh__D038702 lkt
% 211.07/211.21  |- skos__altLabel mesh__D038702 FSTL1 Gene Product
% 211.07/211.21  |- skos__altLabel mesh__D038702 Follistatin-Like Secreted Glycoprotein
% 211.07/211.21  |- skos__annotation mesh__D038702 note species-specific terms in SCR   
% 211.07/211.21  |- mesh__recordMaintainer mesh__D038702 SYSTEM
% 211.07/211.21  |- skos__annotation mesh__D005528
% 211.07/211.21       vertebrates only: for invertebrates use EXTREMITIES: dis of foot = FOOT DISEASES; skin dis on foot = FOOT DERMATOSES: see note there; neopl of foot: use neopl coords %28%IM%29% + FOOT DISEASES %28%IM%29%; foot prints %28%like finger prints%29% = PLANTAR PRINTS see DERMATOGLYPHICS%A%  
% 211.07/211.21  |- rdf__type mesh__D005528sskos__Concept
% 211.07/211.21  |- mesh__recordMaintainer mesh__D005528 ags
% 211.07/211.21  |- mesh__dateRevised mesh__D005528 2002-07-03
% 211.07/211.21  |- skos__prefLabel mesh__D005528 Foot
% 211.07/211.21  |- skos__scopeNote mesh__D005528
% 211.07/211.21       The distal extremity of the leg in vertebrates, consisting of the tarsus %28%ANKLE%29%, METATARSUS, phalanges, and the soft tissues surrounding these bones.%A%    
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D005528 2004
% 211.07/211.21  |- mesh__recordOriginator mesh__D005528 NLM
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D005528 2003
% 211.07/211.21  |- skos__altLabel mesh__D005528 Feet
% 211.07/211.21  |- mesh__dateCreated mesh__D005528 1999-01-01
% 211.07/211.21  |- skos__related mesh__D005528smesh__D005529
% 211.07/211.21  |- mesh__recordAuthorizer mesh__D005528 sjn
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D005528 2006
% 211.07/211.21  |- skos__broader mesh__D005528smesh__D035002
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D005528 2005
% 211.07/211.21  |- skos__broader mesh__D001854Q000637smesh__D001854
% 211.07/211.21  |- mesh__preferredCombination mesh__D001854Q000637smesh__D016026
% 211.07/211.21  |- rdf__type mesh__D001854Q000637smesh__CompoundConcept
% 211.07/211.21  |- skos__scopeNote mesh__D016250
% 211.07/211.21       Computer disks storing data with a maximum reduction of space and bandwidth. The compact size reduces cost of transmission and storage.%A%    
% 211.07/211.21  |- mesh__dateRevised mesh__D016250 2004-07-07
% 211.07/211.21  |- skos__hiddenLabel mesh__D016250 Compact Disc
% 211.07/211.21  |- skos__hiddenLabel mesh__D016250 Disks, Compact
% 211.07/211.21  |- skos__hiddenLabel mesh__D016250 Discs, Compact
% 211.07/211.21  |- skos__hiddenLabel mesh__D016250 Disc, Compact
% 211.07/211.21  |- mesh__dateCreated mesh__D016250 1990-05-07
% 211.07/211.21  |- skos__hiddenLabel mesh__D016250 Disk, Compact
% 211.07/211.21  |- skos__hiddenLabel mesh__D016250 Compact Disk
% 211.07/211.21  |- mesh__dateEstablished mesh__D016250 1991-01-01
% 211.07/211.21  |- skos__broader mesh__D016250smesh__D014742
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D016250 2006
% 211.07/211.21  |- mesh__recordOriginator mesh__D016250 TGC
% 211.07/211.21  |- skos__annotation mesh__D016250
% 211.07/211.21       do not use /util except by MeSH definition   
% 211.07/211.21  |- mesh__recordAuthorizer mesh__D016250 sjn
% 211.07/211.21  |- skos__altLabel mesh__D016250 Compact Discs
% 211.07/211.21  |- mesh__recordMaintainer mesh__D016250 jls
% 211.07/211.21  |- mesh__publicMeSHNote mesh__D016250 91   
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D016250 2005
% 211.07/211.21  |- skos__prefLabel mesh__D016250 Compact Disks
% 211.07/211.21  |- skos__broader mesh__D016250smesh__D016249
% 211.07/211.21  |- rdf__type mesh__D016250sskos__Concept
% 211.07/211.21  |- mesh__historyNote mesh__D016250 91   
% 211.07/211.21  |- skos__prefLabel mesh__D002230 Carbidopa
% 211.07/211.21  |- mesh__recordMaintainer mesh__D002230 jmp
% 211.07/211.21  |- skos__historyNote mesh__D002230 Methyldopa %28%1972-1974%29%
% 211.07/211.21  |- skos__hiddenLabel mesh__D002230 MK485
% 211.07/211.21  |- mesh__onlineNote mesh__D002230
% 211.07/211.21       use CARBIDOPA to search METHYLDOPAHYDRAZINE 1973-79 %28%as Prov 1973-74%29%%A%  
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D002230 2004
% 211.07/211.21  |- skos__altLabel mesh__D002230 Lodosyn
% 211.07/211.21  |- mesh__recordAuthorizer mesh__D002230 sjn
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D002230 2006
% 211.07/211.21  |- mesh__publicMeSHNote mesh__D002230
% 211.07/211.21       80; was METHYLDOPAHYDRAZINE see under HYDRAZINES 1975-79   
% 211.07/211.21  |- skos__broader mesh__D002230smesh__D008750
% 211.07/211.21  |- skos__hiddenLabel mesh__D002230 MK486
% 211.07/211.21  |- skos__altLabel mesh__D002230 Methyldopahydrazine
% 211.07/211.21  |- skos__hiddenLabel mesh__D002230 MK 485
% 211.07/211.21  |- mesh__recordOriginator mesh__D002230 NLM
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D002230 2003
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D002230 2005
% 211.07/211.21  |- skos__hiddenLabel mesh__D002230 MK 486
% 211.07/211.21  |- skos__broader mesh__D002230smesh__D006834
% 211.07/211.21  |- skos__historyNote mesh__D002230 Hydrazines %28%1972-1974%29%
% 211.07/211.21  |- mesh__dateEstablished mesh__D002230 1980-01-01
% 211.07/211.21  |- mesh__historyNote mesh__D002230
% 211.07/211.21       80; was METHYLDOPAHYDRAZINE see under HYDRAZINES 1975-79; was METHYLDOPAHYDRAZINE 1973-74 %28%Prov%29%%A%  
% 211.07/211.21  |- mesh__dateRevised mesh__D002230 2001-07-25
% 211.07/211.21  |- rdf__type mesh__D002230sskos__Concept
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D002230 2002
% 211.07/211.21  |- skos__scopeNote mesh__D002230
% 211.07/211.21       An inhibitor of DOPA DECARBOXYLASE, preventing conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no antiparkinson actions by itself.%A%    
% 211.07/211.21  |- mesh__dateCreated mesh__D002230 1999-01-01
% 211.07/211.21  |- skos__historyNote mesh__D002230 Dopa %28%1972-1974%29%
% 211.07/211.21  |- skos__historyNote mesh__D015956 Serine Proteinases %28%1988-1989%29%
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D015956 2006
% 211.07/211.21  |- mesh__recordAuthorizer mesh__D015956 sjn
% 211.07/211.21  |- skos__historyNote mesh__D015956 Peptide Fragments %28%1979-1987%29%
% 211.07/211.21  |- skos__altLabel mesh__D015956 Activated Factor XII
% 211.07/211.21  |- rdf__type mesh__D015956sskos__Concept
% 211.07/211.21  |- skos__altLabel mesh__D015956 Factor XII, Activated
% 211.07/211.21  |- mesh__dateEstablished mesh__D015956 1990-01-01
% 211.07/211.21  |- skos__historyNote mesh__D015956 Factor XII %28%1966-1989%29%
% 211.07/211.21  |- skos__hiddenLabel mesh__D015956 Fragments, Hageman-Factor
% 211.07/211.21  |- skos__annotation mesh__D015956 /defic = FACTOR XII DEFICIENCY   
% 211.07/211.21  |- mesh__recordOriginator mesh__D015956 AGS
% 211.07/211.21  |- mesh__recordMaintainer mesh__D015956 ssb
% 211.07/211.21  |- skos__scopeNote mesh__D015956
% 211.07/211.21       Activated form of factor XII. In the initial event in the intrinsic pathway of blood coagulation, kallikrein %28%with cofactor HIGH MOLECULAR WEIGHT KININOGEN%29% cleaves factor XII to XIIa. Factor XIIa is then further cleaved by kallikrein, plasmin, and trypsin to yield smaller factor XII fragments %28%Hageman-Factor fragments%29%. These fragments increase the activity of prekallikrein to kallikrein but decrease the procoagulant activity of factor XII.%A%    
% 211.07/211.21  |- skos__broader mesh__D015956smesh__D005174
% 211.07/211.21  |- skos__hiddenLabel mesh__D015956 XIIa, Coagulation Factor
% 211.07/211.21  |- skos__altLabel mesh__D015956 Coagulation Factor XIIa
% 211.07/211.21  |- skos__prefLabel mesh__D015956 Factor XIIa
% 211.07/211.21  |- skos__broader mesh__D015956smesh__D012697
% 211.07/211.21  |- mesh__historyNote mesh__D015956 90   
% 211.07/211.21  |- skos__altLabel mesh__D015956 Prekallikrein Activator
% 211.07/211.21  |- mesh__dateRevised mesh__D015956 2005-06-30
% 211.07/211.21  |- skos__hiddenLabel mesh__D015956 Hageman Factor Fragments
% 211.07/211.21  |- mesh__publicMeSHNote mesh__D015956 90   
% 211.07/211.21  |- skos__hiddenLabel mesh__D015956 Activator, Prekallikrein
% 211.07/211.21  |- skos__related mesh__D015956smesh__D003029
% 211.07/211.21  |- skos__altLabel mesh__D015956 Blood Coagulation Factor XII, Activated
% 211.07/211.21  |- skos__hiddenLabel mesh__D015956 Factor XIIa, Coagulation
% 211.07/211.21  |- mesh__dateCreated mesh__D015956 1989-05-25
% 211.07/211.21  |- mesh__dateEstablished mesh__D009919 1986-01-01
% 211.07/211.21  |- skos__hiddenLabel mesh__D009919 Male Castrations
% 211.07/211.21  |- skos__hiddenLabel mesh__D009919 Orchidectomies
% 211.07/211.21  |- skos__hiddenLabel mesh__D009919 Male Castration
% 211.07/211.21  |- skos__broader mesh__D009919smesh__D013521
% 211.07/211.21  |- skos__hiddenLabel mesh__D009919 Castrations, Male
% 211.07/211.21  |- skos__historyNote mesh__D009919 Castration %28%1966-1985%29%
% 211.07/211.21  |- mesh__recordMaintainer mesh__D009919 sjn
% 211.07/211.21  |- skos__prefLabel mesh__D009919 Orchiectomy
% 211.07/211.21  |- skos__altLabel mesh__D009919 Orchidectomy
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D009919 2004
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D009919 2005
% 211.07/211.21  |- skos__scopeNote mesh__D009919
% 211.07/211.21       The surgical removal of one or both testicles.     
% 211.07/211.21  |- skos__annotation mesh__D009919
% 211.07/211.21       do not use /util except by MeSH definition; check tags MALE %26% ANIMALS or HUMAN%A%  
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D009919 2006
% 211.07/211.21  |- mesh__recordOriginator mesh__D009919 SH
% 211.07/211.21  |- mesh__publicMeSHNote mesh__D009919 86   
% 211.07/211.21  |- mesh__dateRevised mesh__D009919 2003-07-30
% 211.07/211.21  |- mesh__historyNote mesh__D009919 86   
% 211.07/211.21  |- rdf__type mesh__D009919sskos__Concept
% 211.07/211.21  |- mesh__dateCreated mesh__D009919 1985-06-06
% 211.07/211.21  |- skos__broader mesh__D009919smesh__D002369
% 211.07/211.21  |- skos__hiddenLabel mesh__D009919 Orchiectomies
% 211.07/211.21  |- mesh__recordAuthorizer mesh__D009919 sjn
% 211.07/211.21  |- skos__historyNote mesh__D001936 Neisseria %28%1975-1987%29%
% 211.07/211.21  |- mesh__dateCreated mesh__D001936 1987-05-07
% 211.07/211.21  |- skos__broader mesh__D001936smesh__D009016
% 211.07/211.21  |- skos__historyNote mesh__D001936 Moraxella %28%1983-1987%29%
% 211.07/211.21  |- skos__historyNote mesh__D001936 Neisseriaceae %28%1975-1987%29%
% 211.07/211.21  |- mesh__dateRevised mesh__D001936 2005-07-19
% 211.07/211.21  |- mesh__historyNote mesh__D001936
% 211.07/211.21       92; was BRANHAMELLA CATARRHALIS 1988-91; MORAXELLA %28%BRANHAMELLA%29% CATARRHALIS was see BRANHAMELLA CATARRHALIS 1988-91%A%  
% 211.07/211.21  |- mesh__onlineNote mesh__D001936
% 211.07/211.21       use MORAXELLA %28%BRANHAMELLA%29% CATARRHALIS to search BRANHAMELLA CATARRHALIS 1988-91%A%  
% 211.07/211.21  |- skos__altLabel mesh__D001936 Branhamella catarrhalis
% 211.07/211.21  |- skos__altLabel mesh__D001936 Moraxella catarrhalis
% 211.07/211.21  |- mesh__recordAuthorizer mesh__D001936 ags
% 211.07/211.21  |- rdf__type mesh__D001936sskos__Concept
% 211.07/211.21  |- mesh__recordOriginator mesh__D001936 SCD
% 211.07/211.21  |- mesh__publicMeSHNote mesh__D001936
% 211.07/211.21       92; was BRANHAMELLA CATARRHALIS 1988-91; MORAXELLA %28%BRANHAMELLA%29% CATARRHALIS was see BRANHAMELLA CATARRHALIS 1988-91%A%  
% 211.07/211.21  |- skos__scopeNote mesh__D001936
% 211.07/211.21       Gram-negative aerobic cocci of low virulence that colonize the nasopharynx and occasionally cause MENINGITIS; BACTEREMIA; EMPYEMA; PERICARDITIS; and PNEUMONIA.%A%    
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D001936 2006
% 211.07/211.21  |- skos__annotation mesh__D001936
% 211.07/211.21       infection: coord IM with MORAXELLACEAE INFECTIONS %28%IM%29%   
% 211.07/211.21  |- mesh__recordMaintainer mesh__D001936 ags
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D001936 2006A
% 211.07/211.21  |- mesh__dateEstablished mesh__D001936 1988-01-01
% 211.07/211.21  |- skos__prefLabel mesh__D001936 Moraxella %28%Branhamella%29% catarrhalis
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D001138 2006
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D001138 2002
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D001138 2005
% 211.07/211.21  |- mesh__recordMaintainer mesh__D001138 CCR
% 211.07/211.21  |- mesh__dateCreated mesh__D001138 1978-05-17
% 211.07/211.21  |- skos__altLabel mesh__D001138 Ethyl-p-Nitrophenyl Ethylphosphonate
% 211.07/211.21  |- skos__broader mesh__D001138smesh__D009943
% 211.07/211.21  |- skos__historyNote mesh__D001138
% 211.07/211.21       Cholinesterase Inhibitors %28%1966-1978%29%
% 211.07/211.21  |- skos__altLabel mesh__D001138 Armine
% 211.07/211.21  |- mesh__historyNote mesh__D001138
% 211.07/211.21       91%28%79%29%; was see under ORGANOPHOSPHORUS COMPOUNDS 1979-90   
% 211.07/211.21  |- skos__scopeNote mesh__D001138
% 211.07/211.21       A reversible organophosphorus cholinesterase inhibitor. It also affects the presynaptic membrane and inhibits membrane postsynaptic cholinergic receptors. The compound had former use as a miotic.%A%    
% 211.07/211.21  |- mesh__recordOriginator mesh__D001138 RLS
% 211.07/211.21  |- skos__prefLabel mesh__D001138 Armin
% 211.07/211.21  |- mesh__dateEstablished mesh__D001138 1991-01-01
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D001138 2001
% 211.07/211.21  |- mesh__publicMeSHNote mesh__D001138
% 211.07/211.21       91; was see under ORGANOPHOSPHORUS COMPOUNDS 1979-90   
% 211.07/211.21  |- mesh__recordAuthorizer mesh__D001138 sjn
% 211.07/211.21  |- skos__historyNote mesh__D001138
% 211.07/211.21       Organophosphorus Compounds %28%1971-1978%29%
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D001138 2004
% 211.07/211.21  |- mesh__dateRevised mesh__D001138 2000-06-21
% 211.07/211.21  |- skos__historyNote mesh__D001138 Nitrobenzenes %28%1966-1978%29%
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D001138 2003
% 211.07/211.21  |- rdf__type mesh__D001138sskos__Concept
% 211.07/211.21  |- mesh__dateRevised mesh__D006621 2002-07-03
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D006621 2004
% 211.07/211.21  |- mesh__historyNote mesh__D006621 65   
% 211.07/211.21  |- mesh__recordOriginator mesh__D006621 NLM
% 211.07/211.21  |- skos__hiddenLabel mesh__D006621 Joint, Hip
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D006621 2006
% 211.07/211.21  |- skos__broader mesh__D006621smesh__D007596
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D006621 2003
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D006621 2005
% 211.07/211.21  |- mesh__recordAuthorizer mesh__D006621 sjn
% 211.07/211.21  |- mesh__dateCreated mesh__D006621 1999-01-01
% 211.07/211.21  |- skos__prefLabel mesh__D006621 Hip Joint
% 211.07/211.21  |- mesh__recordMaintainer mesh__D006621 ssb
% 211.07/211.21  |- skos__hiddenLabel mesh__D006621 Joints, Hip
% 211.07/211.21  |- mesh__publicMeSHNote mesh__D006621 65   
% 211.07/211.21  |- rdf__type mesh__D006621sskos__Concept
% 211.07/211.21  |- mesh__dateEstablished mesh__D006621 1965-01-01
% 211.07/211.21  |- skos__hiddenLabel mesh__D006621 Hip Joints
% 211.07/211.21  |- skos__annotation mesh__D006621
% 211.07/211.21       /inj is probably HIP DISLOCATION or HIP FRACTURES, otherwise coord IM with HIP INJURIES %28%IM%29%; differentiate from HIP%A%  
% 211.07/211.21  |- skos__hiddenLabel mesh__D011566 Attendant, Psychiatric Ward
% 211.07/211.21  |- mesh__dateEstablished mesh__D011566 1971-01-01
% 211.07/211.21  |- skos__hiddenLabel mesh__D011566 Psychiatric Aide
% 211.07/211.21  |- skos__hiddenLabel mesh__D011566 Orderlies, Psychiatric Hospital
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D011566 2000
% 211.07/211.21  |- mesh__recordAuthorizer mesh__D011566 SJN
% 211.07/211.21  |- mesh__historyNote mesh__D011566 71   
% 211.07/211.21  |- skos__historyNote mesh__D011566 Health Manpower %28%1968-1970%29%
% 211.07/211.21  |- skos__prefLabel mesh__D011566 Psychiatric Aides
% 211.07/211.21  |- skos__annotation mesh__D011566
% 211.07/211.21       coord IM with HOSPITALS, PSYCHIATRIC or PSYCHIATRIC DEPARTMENT, HOSPITAL %28%IM or NIM%29% if pertinent%A%  
% 211.07/211.21  |- mesh__publicMeSHNote mesh__D011566 71   
% 211.07/211.21  |- mesh__dateRevised mesh__D011566 1997-06-20
% 211.07/211.21  |- skos__hiddenLabel mesh__D011566 Ward Attendant, Psychiatric
% 211.07/211.21  |- skos__hiddenLabel mesh__D011566 Hospital Orderlies, Psychiatric
% 211.07/211.21  |- mesh__dateCreated mesh__D011566 1999-01-01
% 211.07/211.21  |- skos__hiddenLabel mesh__D011566 Orderly, Psychiatric Hospital
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D011566 2006
% 211.07/211.21  |- skos__hiddenLabel mesh__D011566 Psychiatric Hospital Orderly
% 211.07/211.21  |- skos__hiddenLabel mesh__D011566 Psychiatric Ward Attendant
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D011566 1999
% 211.07/211.21  |- skos__broader mesh__D011566smesh__D009728
% 211.07/211.21  |- skos__hiddenLabel mesh__D011566 Aides, Psychiatric
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D011566 2005
% 211.07/211.21  |- skos__hiddenLabel mesh__D011566 Attendants, Psychiatric Ward
% 211.07/211.21  |- rdf__type mesh__D011566sskos__Concept
% 211.07/211.21  |- skos__scopeNote mesh__D011566
% 211.07/211.21       Persons who assist in the routine care of psychiatric persons, usually under the supervision of the nursing department.%A%    
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D011566 2002
% 211.07/211.21  |- mesh__recordMaintainer mesh__D011566 TGC
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D011566 1998
% 211.07/211.21  |- skos__hiddenLabel mesh__D011566 Aide, Psychiatric
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D011566 2004
% 211.07/211.21  |- skos__historyNote mesh__D011566 Psychiatry %28%1968-1970%29%
% 211.07/211.21  |- mesh__recordOriginator mesh__D011566 NLM
% 211.07/211.21  |- skos__hiddenLabel mesh__D011566 Ward Attendants, Psychiatric
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D011566 2001
% 211.07/211.21  |- skos__hiddenLabel mesh__D011566 Hospital Orderly, Psychiatric
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D011566 2003
% 211.07/211.21  |- rdf__type mesh__D005529sskos__Concept
% 211.07/211.21  |- skos__hiddenLabel mesh__D005529 Feet Bone
% 211.07/211.21  |- skos__hiddenLabel mesh__D005529 Foot Bone
% 211.07/211.21  |- mesh__recordMaintainer mesh__D005529 ags
% 211.07/211.21  |- skos__scopeNote mesh__D005529
% 211.07/211.21       The TARSAL BONES; METATARSAL BONES; and PHALANGES OF TOES. The tarsal bones consists of seven bones: CALCANEUS; TALUS; cuboid; navicular; internal; middle; and external cuneiform bones. The five metatarsal bones are numbered one through five, running medial to lateral. There are 14 phalanges in each foot, the great toe has two while the other toes have three each.%A%    
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D005529 2006A
% 211.07/211.21  |- mesh__recordOriginator mesh__D005529 EC
% 211.07/211.21  |- skos__hiddenLabel mesh__D005529 Feet Bones
% 211.07/211.21  |- skos__broader mesh__D005529smesh__D050281
% 211.07/211.21  |- skos__prefLabel mesh__D005529 Foot Bones
% 211.07/211.21  |- mesh__recordAuthorizer mesh__D005529 ags
% 211.07/211.21  |- skos__historyNote mesh__D005529 specific bones of foot %28%1966-1997%29%
% 211.07/211.21  |- skos__hiddenLabel mesh__D005529 Bone, Foot
% 211.07/211.21  |- skos__hiddenLabel mesh__D005529 Bones, Foot
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D005529 2006
% 211.07/211.21  |- mesh__dateRevised mesh__D005529 2005-08-02
% 211.07/211.21  |- mesh__dateCreated mesh__D005529 1987-04-02
% 211.07/211.21  |- skos__historyNote mesh__D005529 Foot %28%1966-1997%29%
% 211.07/211.21  |- skos__altLabel mesh__D005529 Bones of Foot
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D005529 2006B
% 211.07/211.21  |- mesh__dateEstablished mesh__D005529 1998-01-01
% 211.07/211.21  |- skos__related mesh__D005529smesh__D005528
% 211.07/211.21  |- skos__annotation mesh__D005529
% 211.07/211.21       general or unspecified; prefer specifics; permitted with all vertebrates; Manual 21.58%A%  
% 211.07/211.21  |- mesh__publicMeSHNote mesh__D005529 98   
% 211.07/211.21  |- mesh__historyNote mesh__D005529 98; use explode 1988-97   
% 211.07/211.21  |- skos__altLabel mesh__D005529 Bones of Feet
% 211.07/211.21  |- mesh__dateEstablished mesh__D016251 1991-01-01
% 211.07/211.21  |- mesh__recordOriginator mesh__D016251 TGC
% 211.07/211.21  |- mesh__recordAuthorizer mesh__D016251 sjn
% 211.07/211.21  |- skos__altLabel mesh__D016251 Compact Disk Read-Only Memory
% 211.07/211.21  |- mesh__publicMeSHNote mesh__D016251 91   
% 211.07/211.21  |- skos__hiddenLabel mesh__D016251 Compact Disk Read Only Memory
% 211.07/211.21  |- skos__broader mesh__D016251smesh__D016250
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D016251 2005
% 211.07/211.21  |- skos__prefLabel mesh__D016251 CD-ROM
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D016251 2006
% 211.07/211.21  |- skos__annotation mesh__D016251
% 211.07/211.21       a type of compact disk; X ref explains acronym; do not use /util except by MeSH definition%A%  
% 211.07/211.21  |- mesh__dateRevised mesh__D016251 2004-07-07
% 211.07/211.21  |- skos__scopeNote mesh__D016251
% 211.07/211.21       An optical disk storage system for computers on which data can be read or from which data can be retrieved but not entered or modified. A CD-ROM unit is almost identical to the compact disk playback device for home use.%A%    
% 211.07/211.21  |- mesh__recordMaintainer mesh__D016251 jls
% 211.07/211.21  |- rdf__type mesh__D016251sskos__Concept
% 211.07/211.21  |- mesh__dateCreated mesh__D016251 1990-06-11
% 211.07/211.21  |- mesh__historyNote mesh__D016251 91   
% 211.07/211.21  |- skos__altLabel mesh__D016251 CDROM
% 211.07/211.21  |- skos__broader mesh__D006632Q000557smesh__D006632
% 211.07/211.21  |- mesh__preferredCombination mesh__D006632Q000557smesh__D006636
% 211.07/211.21  |- rdf__type mesh__D006632Q000557smesh__CompoundConcept
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D002231 2006
% 211.07/211.21  |- skos__altLabel mesh__D002231 Sanofi Synthelabo Brand of Carbimazole
% 211.07/211.21  |- skos__prefLabel mesh__D002231 Carbimazole
% 211.07/211.21  |- mesh__historyNote mesh__D002231 73%28%68%29%   
% 211.07/211.21  |- mesh__recordMaintainer mesh__D002231 lkw
% 211.07/211.21  |- skos__scopeNote mesh__D002231
% 211.07/211.21       An imidazole antithyroid agent. Carbimazole is metabolized to METHIMAZOLE, which is responsible for the antithyroid activity.%A%    
% 211.07/211.21  |- skos__historyNote mesh__D002231 Thyroid Antagonists %28%1966-1967%29%
% 211.07/211.21  |- mesh__publicMeSHNote mesh__D002231 73   
% 211.07/211.21  |- mesh__dateEstablished mesh__D002231 1973-01-01
% 211.07/211.21  |- mesh__recordAuthorizer mesh__D002231 sjn
% 211.07/211.21  |- skos__broader mesh__D002231smesh__D007093
% 211.07/211.21  |- rdf__type mesh__D002231sskos__Concept
% 211.07/211.21  |- mesh__recordOriginator mesh__D002231 NLM
% 211.07/211.21  |- skos__altLabel mesh__D002231 Neo-Mercazole
% 211.07/211.21  |- skos__altLabel mesh__D002231 Roche Brand of Carbimazole
% 211.07/211.21  |- skos__altLabel mesh__D002231 Tarbis Brand of Carbimazole
% 211.07/211.21  |- skos__altLabel mesh__D002231 Herbrand Brand of Carbimazole
% 211.07/211.21  |- mesh__dateCreated mesh__D002231 1999-01-01
% 211.07/211.21  |- skos__historyNote mesh__D002231 Imidazoles %28%1966-1967%29%
% 211.07/211.21  |- skos__altLabel mesh__D002231 Henning Berlin Brand of Carbimazole
% 211.07/211.21  |- mesh__dateRevised mesh__D002231 2005-06-30
% 211.07/211.21  |- skos__historyNote mesh__D001937 Plants %28%1966-1977%29%
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D001937 2006A
% 211.07/211.21  |- mesh__recordAuthorizer mesh__D001937 ags
% 211.07/211.21  |- skos__hiddenLabel mesh__D001937 Cabbages
% 211.07/211.21  |- rdf__type mesh__D001937sskos__Concept
% 211.07/211.21  |- mesh__publicMeSHNote mesh__D001937 78   
% 211.07/211.21  |- skos__broader mesh__D001937smesh__D019607
% 211.07/211.21  |- mesh__dateEstablished mesh__D001937 1978-01-01
% 211.07/211.21  |- skos__historyNote mesh__D001937 Plants, Edible %28%1966-1977%29%
% 211.07/211.21  |- skos__annotation mesh__D001937
% 211.07/211.21       GEN or unspecified; prefer specifics; note common names as X refs; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D001937 2006
% 211.07/211.21  |- mesh__dateCreated mesh__D001937 1977-04-27
% 211.07/211.21  |- mesh__historyNote mesh__D001937 78   
% 211.07/211.21  |- mesh__dateRevised mesh__D001937 2005-07-20
% 211.07/211.21  |- mesh__recordMaintainer mesh__D001937 ags
% 211.07/211.21  |- skos__scopeNote mesh__D001937
% 211.07/211.21       A plant genus of the family Cruciferae.  It contains many species and cultivars used as food including cabbage, cauliflower, broccoli, Brussel sprouts, kale, collard greens, MUSTARD PLANT; %28%B. alba, B. junica, and B. nigra%29%, turnips %28%BRASSICA NAPUS%29% and rapeseed %28%BRASSICA RAPA%29%.%A%    
% 211.07/211.21  |- skos__hiddenLabel mesh__D001937 Collard Greens
% 211.07/211.21  |- skos__broader mesh__D001937smesh__D014675
% 211.07/211.21  |- mesh__activeMeSHYear mesh__D001937 2005
% 211.07/211.22  |- mesh__recordOriginator mesh__D001937 VDK
% 211.07/211.22  |- skos__prefLabel mesh__D001937 Brassica
% 211.07/211.22  |- skos__hiddenLabel mesh__D001139 Syndrome, Arnold-Chiari
% 211.07/211.22  |- skos__altLabel mesh__D001139 Type IV Arnold-Chiari Malformation
% 211.07/211.22  |- skos__scopeNote mesh__D001139
% 211.07/211.22       A group of congenital malformations involving the brainstem, cerebellum, upper spinal cord, and surrounding bony structures. Type II is the most common, and features compression of the medulla and cerebellar tonsils into the upper cervical spinal canal and an associated MENINGOMYELOCELE. Type I features similar, but less severe malformations and is without an associated meningomyelocele. Type III has the features of type II with an additional herniation of the entire cerebellum through the bony defect involving the foramen magnum, forming an ENCEPHALOCELE. Type IV is a form a cerebellar hypoplasia. Clinical manifestations of types I-III include TORTICOLLIS; opisthotonus; HEADACHE; VERTIGO; VOCAL CORD PARALYSIS; APNEA; NYSTAGMUS, CONGENITAL; swallowing difficulties; and ATAXIA. %28%From Menkes, Textbook of Child Neurology, 5th ed, p261; Davis, Textbook of Neuropathology, 2nd ed, pp236-46%29%%A%    
% 211.07/211.22  |- mesh__recordMaintainer mesh__D001139 ags
% 211.07/211.22  |- skos__annotation mesh__D001139
% 211.07/211.22       do not confuse with CHIARI%27%S SYNDROME see HEPATIC VEIN THROMBOSIS%A%  
% 211.07/211.22  |- mesh__dateRevised mesh__D001139 2005-07-21
% 211.07/211.22  |- skos__hiddenLabel mesh__D001139 Type IV Arnold Chiari Malformation
% 211.07/211.22  |- mesh__recordAuthorizer mesh__D001139 ags
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001139 2004
% 211.07/211.22  |- skos__hiddenLabel mesh__D001139 Type II Arnold Chiari Malformation
% 211.07/211.22  |- skos__broader mesh__D001139smesh__D009436
% 211.07/211.22  |- skos__hiddenLabel mesh__D001139 Type III Arnold Chiari Malformation
% 211.07/211.22  |- skos__hiddenLabel mesh__D001139 Arnold Chiari Malformation, Type I
% 211.07/211.22  |- mesh__historyNote mesh__D001139 2000%28%1963%29%   
% 211.07/211.22  |- skos__hiddenLabel mesh__D001139 Deformity, Arnold-Chiari
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001139 2000
% 211.07/211.22  |- skos__altLabel mesh__D001139 Arnold-Chiari Syndrome
% 211.07/211.22  |- skos__hiddenLabel mesh__D001139 Arnold Chiari Malformation
% 211.07/211.22  |- skos__altLabel mesh__D001139 Malformation, Arnold-Chiari
% 211.07/211.22  |- skos__altLabel mesh__D001139 Arnold-Chiari Deformity
% 211.07/211.22  |- mesh__dateCreated mesh__D001139 1999-01-01
% 211.07/211.22  |- rdf__type mesh__D001139sskos__Concept
% 211.07/211.22  |- skos__altLabel mesh__D001139 Type II Arnold-Chiari Malformation
% 211.07/211.22  |- mesh__publicMeSHNote mesh__D001139
% 211.07/211.22       2000; see ARNOLD-CHIARI DEFORMITY 1963-1999; for ARNOLD-CHIARI MALFORMATION see ARNOLD-CHIARI DEFORMITY 1963-1999%A%  
% 211.07/211.22  |- skos__altLabel mesh__D001139 Type I Arnold-Chiari Malformation
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001139 2001
% 211.07/211.22  |- skos__hiddenLabel mesh__D001139 Arnold Chiari Syndrome
% 211.07/211.22  |- skos__hiddenLabel mesh__D001139 Arnold Chiari Malformation, Type II
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001139 2005
% 211.07/211.22  |- skos__hiddenLabel mesh__D001139 Arnold Chiari Malformation, Type IV
% 211.07/211.22  |- mesh__recordOriginator mesh__D001139 NLM
% 211.07/211.22  |- skos__hiddenLabel mesh__D001139 Arnold Chiari Deformity
% 211.07/211.22  |- skos__altLabel mesh__D001139 Type III Arnold-Chiari Malformation
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001139 2006
% 211.07/211.22  |- skos__prefLabel mesh__D001139 Arnold-Chiari Malformation
% 211.07/211.22  |- skos__hiddenLabel mesh__D001139 Type I Arnold Chiari Malformation
% 211.07/211.22  |- skos__hiddenLabel mesh__D001139 Arnold Chiari Malformation, Type III
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001139 2002
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001139 2006A
% 211.07/211.22  |- skos__hiddenLabel mesh__D001139 Malformation, Arnold Chiari
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001139 2003
% 211.07/211.22  |- skos__hiddenLabel mesh__D006622 Prosthesis, Femoral Head
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D006622 2005
% 211.07/211.22  |- mesh__historyNote mesh__D006622 80   
% 211.07/211.22  |- mesh__recordAuthorizer mesh__D006622 SJN
% 211.07/211.22  |- skos__historyNote mesh__D006622 Hip Joint %28%1966-1979%29%
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D006622 1998
% 211.07/211.22  |- skos__broader mesh__D006622smesh__D007595
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D006622 2002
% 211.07/211.22  |- skos__historyNote mesh__D006622 Arthroplasty %28%1966-1979%29%
% 211.07/211.22  |- rdf__type mesh__D006622sskos__Concept
% 211.07/211.22  |- mesh__recordOriginator mesh__D006622 SMH
% 211.07/211.22  |- skos__prefLabel mesh__D006622 Hip Prosthesis
% 211.07/211.22  |- mesh__dateRevised mesh__D006622 1997-06-20
% 211.07/211.22  |- skos__historyNote mesh__D006622 Hip %28%1966-1979%29%
% 211.07/211.22  |- skos__hiddenLabel mesh__D006622 Hip Prostheses
% 211.07/211.22  |- mesh__dateEstablished mesh__D006622 1980-01-01
% 211.07/211.22  |- skos__historyNote mesh__D006622 Prosthesis %28%1966-1970%29%
% 211.07/211.22  |- skos__hiddenLabel mesh__D006622 Prostheses, Hip
% 211.07/211.22  |- skos__hiddenLabel mesh__D006622 Prostheses, Femoral Head
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D006622 2001
% 211.07/211.22  |- skos__related mesh__D006622smesh__D019644
% 211.07/211.22  |- mesh__dateCreated mesh__D006622 1978-12-19
% 211.07/211.22  |- skos__historyNote mesh__D006622 Joint Prosthesis %28%1971-1979%29%
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D006622 2004
% 211.07/211.22  |- skos__hiddenLabel mesh__D006622 Prosthesis, Hip
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D006622 2000
% 211.07/211.22  |- skos__scopeNote mesh__D006622 Replacement for a hip joint.     
% 211.07/211.22  |- skos__hiddenLabel mesh__D006622 Femoral Head Prostheses
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D006622 2006
% 211.07/211.22  |- mesh__recordMaintainer mesh__D006622 PXP
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D006622 2003
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D006622 1999
% 211.07/211.22  |- mesh__publicMeSHNote mesh__D006622 80   
% 211.07/211.22  |- mesh__dateCreated mesh__D011567 1999-01-01
% 211.07/211.22  |- skos__annotation mesh__D011567
% 211.07/211.22       orderlies %26% ward attendants go under PSYCHIATRIC AIDES; DF: PSYCHIATR DEP%A%  
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D011567 2000
% 211.07/211.22  |- mesh__historyNote mesh__D011567
% 211.07/211.22       78; was HOSPITAL PSYCHIATRIC DEPARTMENTS 1966-77   
% 211.07/211.22  |- mesh__recordAuthorizer mesh__D011567 PLS
% 211.07/211.22  |- mesh__recordOriginator mesh__D011567 NLM
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D011567 1994
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D011567 2005
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D011567 2001
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D011567 1998
% 211.07/211.22  |- mesh__dateEstablished mesh__D011567 1966-01-01
% 211.07/211.22  |- skos__hiddenLabel mesh__D011567 Department, Hospital Psychiatric
% 211.07/211.22  |- skos__altLabel mesh__D011567 Psychiatric Departments, Hospital
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D011567 1995
% 211.07/211.22  |- skos__hiddenLabel mesh__D011567 Hospital Psychiatric Departments
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D011567 2006
% 211.07/211.22  |- mesh__recordMaintainer mesh__D011567 TGC
% 211.07/211.22  |- skos__altLabel mesh__D011567 Hospital Psychiatric Department
% 211.07/211.22  |- skos__hiddenLabel mesh__D011567 Departments, Hospital Psychiatric
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D011567 1999
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D011567 2003
% 211.07/211.22  |- rdf__type mesh__D011567sskos__Concept
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D011567 1996
% 211.07/211.22  |- skos__broader mesh__D011567smesh__D006748
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D011567 2002
% 211.07/211.22  |- mesh__dateRevised mesh__D011567 1993-06-02
% 211.07/211.22  |- mesh__onlineNote mesh__D011567
% 211.07/211.22       use PSYCHIATRIC DEPARTMENT, HOSPITAL to search HOSPITAL PSYCHIATRIC DEPARTMENTS 1966-77%A%  
% 211.07/211.22  |- skos__scopeNote mesh__D011567
% 211.07/211.22       Hospital department responsible for the organization and administration of psychiatric services.%A%    
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D011567 2004
% 211.07/211.22  |- skos__prefLabel mesh__D011567 Psychiatric Department, Hospital
% 211.07/211.22  |- mesh__publicMeSHNote mesh__D011567
% 211.07/211.22       78; was HOSPITAL PSYCHIATRIC DEPARTMENTS 1966-77   
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D011567 1997
% 211.07/211.22  |- skos__broader mesh__D017674Q000151smesh__D017674
% 211.07/211.22  |- mesh__preferredCombination mesh__D017674Q000151smesh__D007015
% 211.07/211.22  |- rdf__type mesh__D017674Q000151smesh__CompoundConcept
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D030721 2003
% 211.07/211.22  |- mesh__dateCreated mesh__D030721 2001-07-25
% 211.07/211.22  |- skos__altLabel mesh__D030721 Waterlily
% 211.07/211.22  |- skos__scopeNote mesh__D030721
% 211.07/211.22       A plant genus of the family NYMPHAEACEAE. The common name of lotus is also used for LOTUS and NELUMBO.%A%    
% 211.07/211.22  |- mesh__publicMeSHNote mesh__D030721 2002   
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D030721 2006
% 211.07/211.22  |- mesh__historyNote mesh__D030721 2002   
% 211.07/211.22  |- rdf__type mesh__D030721sskos__Concept
% 211.07/211.22  |- skos__altLabel mesh__D030721 Water Lily
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D030721 2005
% 211.07/211.22  |- skos__broader mesh__D030721smesh__D030702
% 211.07/211.22  |- mesh__recordAuthorizer mesh__D030721 sjn
% 211.07/211.22  |- mesh__dateEstablished mesh__D030721 2002-01-01
% 211.07/211.22  |- skos__altLabel mesh__D030721 Lily, Water
% 211.07/211.22  |- mesh__dateRevised mesh__D030721 2002-07-03
% 211.07/211.22  |- mesh__recordMaintainer mesh__D030721 ssb
% 211.07/211.22  |- skos__annotation mesh__D030721
% 211.07/211.22       X ref NYMPHAEA LOTUS: LOTUS is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D030721 2004
% 211.07/211.22  |- skos__prefLabel mesh__D030721 Nymphaea
% 211.07/211.22  |- mesh__recordOriginator mesh__D030721 ssb
% 211.07/211.22  |- skos__hiddenLabel mesh__D016252 Tunnelling Microscopies, Scanning
% 211.07/211.22  |- mesh__recordOriginator mesh__D016252 PXP
% 211.07/211.22  |- skos__hiddenLabel mesh__D016252 Scanning Tunneling Microscopies
% 211.07/211.22  |- mesh__dateCreated mesh__D016252 1990-05-07
% 211.07/211.22  |- skos__hiddenLabel mesh__D016252 Tunneling Microscopy, Scanning
% 211.07/211.22  |- mesh__recordAuthorizer mesh__D016252 sjn
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D016252 2005
% 211.07/211.22  |- skos__hiddenLabel mesh__D016252 Microscopy, Scanning Tunnelling
% 211.07/211.22  |- skos__hiddenLabel mesh__D016252 Tunnelling Microscopy, Scanning
% 211.07/211.22  |- skos__hiddenLabel mesh__D016252 Microscopies, Scanning Tunnelling
% 211.07/211.22  |- skos__altLabel mesh__D016252 Scanning Tunnelling Microscopy
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D016252 2006
% 211.07/211.22  |- mesh__publicMeSHNote mesh__D016252 91   
% 211.07/211.22  |- skos__altLabel mesh__D016252 Scanning Tunneling Microscopy
% 211.07/211.22  |- skos__related mesh__D016252smesh__D018625
% 211.07/211.22  |- mesh__dateRevised mesh__D016252 2004-07-07
% 211.07/211.22  |- skos__broader mesh__D016252smesh__D020527
% 211.07/211.22  |- skos__historyNote mesh__D016252
% 211.07/211.22       Microscopy, Electron, Scanning %28%1987-1990%29%
% 211.07/211.22  |- rdf__type mesh__D016252sskos__Concept
% 211.07/211.22  |- skos__hiddenLabel mesh__D016252 Microscopies, Scanning Tunneling
% 211.07/211.22  |- mesh__historyNote mesh__D016252 91   
% 211.07/211.22  |- mesh__dateEstablished mesh__D016252 1991-01-01
% 211.07/211.22  |- skos__prefLabel mesh__D016252 Microscopy, Scanning Tunneling
% 211.07/211.22  |- skos__hiddenLabel mesh__D016252 Scanning Tunnelling Microscopies
% 211.07/211.22  |- skos__scopeNote mesh__D016252
% 211.07/211.22       A type of scanning probe microscopy in which a very sharp conducting needle is swept just a few angstroms above the surface of a sample. The tiny tunneling current that flows between the sample and the needle tip is measured, and from this are produced three-dimensional topographs. Due to the poor electron conductivity of most biological samples, thin metal coatings are deposited on the sample.%A%    
% 211.07/211.22  |- mesh__recordMaintainer mesh__D016252 nns
% 211.07/211.22  |- skos__hiddenLabel mesh__D016252 Tunneling Microscopies, Scanning
% 211.07/211.22  |- mesh__dateEstablished mesh__D002232 1991-01-01
% 211.07/211.22  |- mesh__recordOriginator mesh__D002232 SH
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D002232 2006
% 211.07/211.22  |- mesh__recordAuthorizer mesh__D002232 NLM
% 211.07/211.22  |- skos__historyNote mesh__D002232 Quinolines %28%1972-1975%29%
% 211.07/211.22  |- mesh__publicMeSHNote mesh__D002232
% 211.07/211.22       91; was see under QUINOLINES 1976-90   
% 211.07/211.22  |- skos__historyNote mesh__D002232 Alkenes %28%1972-1975%29%
% 211.07/211.22  |- rdf__type mesh__D002232sskos__Concept
% 211.07/211.22  |- skos__annotation mesh__D002232 D25-26 qualif   
% 211.07/211.22  |- mesh__dateRevised mesh__D002232 2005-07-06
% 211.07/211.22  |- skos__prefLabel mesh__D002232 Carbocyanines
% 211.07/211.22  |- skos__scopeNote mesh__D002232
% 211.07/211.22       Compounds that contain three methine groups. They are frequently used as cationic dyes used for differential staining of biological materials.%A%    
% 211.07/211.22  |- skos__broader mesh__D002232smesh__D000480
% 211.07/211.22  |- mesh__historyNote mesh__D002232
% 211.07/211.22       91%28%76%29%; was see under QUINOLINES 1976-90   
% 211.07/211.22  |- mesh__recordMaintainer mesh__D002232 NLM
% 211.07/211.22  |- mesh__dateCreated mesh__D002232 1975-07-18
% 211.07/211.22  |- rdf__type mesh__D001938sskos__Concept
% 211.07/211.22  |- mesh__recordAuthorizer mesh__D001938 PLS
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001938 2004
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001938 1991
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001938 2006
% 211.07/211.22  |- skos__broader mesh__D001938smesh__D013020
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001938 2003
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001938 1990
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001938 1997
% 211.07/211.22  |- mesh__recordMaintainer mesh__D001938 PLS
% 211.07/211.22  |- skos__prefLabel mesh__D001938 Brazil
% 211.07/211.22  |- mesh__recordOriginator mesh__D001938 NLM
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001938 2005
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001938 1999
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001938 1996
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001938 2002
% 211.07/211.22  |- mesh__dateRevised mesh__D001938 1991-11-02
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001938 1998
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001938 1993
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001938 2001
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001938 1995
% 211.07/211.22  |- mesh__dateCreated mesh__D001938 1999-01-01
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001938 1992
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001938 1989
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001938 1994
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001938 2000
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D012660 1991
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D012660 2003
% 211.07/211.22  |- rdf__type mesh__D012660sskos__Concept
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D012660 1996
% 211.07/211.22  |- skos__broader mesh__D012660smesh__D008037
% 211.07/211.22  |- skos__annotation mesh__D012660
% 211.07/211.22       hist or psychol study of changes in language %26% meaning; do not confuse with LINGUISTICS %28%overall study of LANGUAGE %26% SPEECH%29% or NOMENCLATURE %28%names of things %26% etymology%29%; no qualif%A%  
% 211.07/211.22  |- mesh__recordAuthorizer mesh__D012660 PLS
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D012660 1992
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D012660 2004
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D012660 1997
% 211.07/211.22  |- mesh__dateRevised mesh__D012660 1989-05-16
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D012660 2005
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D012660 2000
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D012660 1998
% 211.07/211.22  |- skos__hiddenLabel mesh__D012660 Semantic
% 211.07/211.22  |- mesh__recordMaintainer mesh__D012660 TGC
% 211.07/211.22  |- skos__prefLabel mesh__D012660 Semantics
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D012660 1993
% 211.07/211.22  |- mesh__recordOriginator mesh__D012660 NLM
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D012660 2001
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D012660 1994
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D012660 2006
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D012660 1999
% 211.07/211.22  |- skos__scopeNote mesh__D012660
% 211.07/211.22       The relationships between symbols and their meanings.     
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D012660 1990
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D012660 2002
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D012660 1995
% 211.07/211.22  |- mesh__dateCreated mesh__D012660 1999-01-01
% 211.07/211.22  |- skos__broader mesh__D006623smesh__D020752
% 211.07/211.22  |- skos__hiddenLabel mesh__D006623 Hippel Lindau Disease
% 211.07/211.22  |- skos__hiddenLabel mesh__D006623 Cerebelloretinal Angiomatoses, Familial
% 211.07/211.22  |- skos__altLabel mesh__D006623 Familial Cerebello-Retinal Angiomatosis
% 211.07/211.22  |- skos__hiddenLabel mesh__D006623 Angiomatoses, Familial Cerebelloretinal
% 211.07/211.22  |- skos__prefLabel mesh__D006623 Hippel-Lindau Disease
% 211.07/211.22  |- mesh__recordAuthorizer mesh__D006623 sjn
% 211.07/211.22  |- skos__scopeNote mesh__D006623
% 211.07/211.22       An autosomal dominant disorder associated with various neoplasms including central nervous system %28%most often cerebellar%29% and retinal HEMANGIOBLASTOMA, endolymphatic sac tumors, renal cell carcinoma %28%see CARCINOMA, RENAL CELL%29%, renal and pancreatic cysts, HEMANGIOMA of the spinal cord, and PHEOCHROMOCYTOMA. The most common presenting manifestations are neurologic deficits associated with intracranial hemangioblastomas which may HEMORRHAGE, causing ataxia, INTRACRANIAL HYPERTENSION, and other signs of neurologic dysfunction. %28%From Neurochirurgie 1998 Nov;44%28%4%29%:258-66%29%%A%    
% 211.07/211.22  |- mesh__historyNote mesh__D006623
% 211.07/211.22       91%28%75%29%; was see under ANGIOMATOSIS 1975-90   
% 211.07/211.22  |- skos__hiddenLabel mesh__D006623 Lindau%27%s Diseases
% 211.07/211.22  |- mesh__recordOriginator mesh__D006623 NLM
% 211.07/211.22  |- skos__altLabel mesh__D006623 Lindau%27%s Disease
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D006623 2005
% 211.07/211.22  |- skos__hiddenLabel mesh__D006623 Lindaus Disease
% 211.07/211.22  |- mesh__dateRevised mesh__D006623 2003-07-09
% 211.07/211.22  |- mesh__onlineNote mesh__D006623 search ANGIOMATOSIS 1966-74   
% 211.07/211.22  |- skos__altLabel mesh__D006623 Lindau Disease
% 211.07/211.22  |- skos__hiddenLabel mesh__D006623 Familial Cerebello Retinal Angiomatosis
% 211.07/211.22  |- skos__hiddenLabel mesh__D006623 Diseases, Lindau%27%s
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D006623 2006
% 211.07/211.22  |- skos__altLabel mesh__D006623 von Hippel-Lindau Syndrome
% 211.07/211.22  |- skos__hiddenLabel mesh__D006623 Angiomatosis, Familial Cerebelloretinal
% 211.07/211.22  |- mesh__dateEstablished mesh__D006623 1991-01-01
% 211.07/211.22  |- skos__hiddenLabel mesh__D006623 Familial Cerebelloretinal Angiomatosis
% 211.07/211.22  |- skos__hiddenLabel mesh__D006623 Cerebello-Retinal Angiomatoses, Familial
% 211.07/211.22  |- skos__hiddenLabel mesh__D006623 Familial Cerebelloretinal Angiomatoses
% 211.07/211.22  |- skos__altLabel mesh__D006623 Cerebelloretinal Angiomatosis, Familial
% 211.07/211.22  |- mesh__dateCreated mesh__D006623 1999-01-01
% 211.07/211.22  |- skos__hiddenLabel mesh__D006623 Angiomatosis, Familial Cerebello-Retinal
% 211.07/211.22  |- skos__hiddenLabel mesh__D006623 Cerebello-Retinal Angiomatosis, Familial
% 211.07/211.22  |- skos__hiddenLabel mesh__D006623 Syndrome, von Hippel-Lindau
% 211.07/211.22  |- mesh__publicMeSHNote mesh__D006623
% 211.07/211.22       91; was see under ANGIOMATOSIS 1975-90   
% 211.07/211.22  |- skos__altLabel mesh__D006623 von Hippel-Lindau Disease
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D006623 2004
% 211.07/211.22  |- rdf__type mesh__D006623sskos__Concept
% 211.07/211.22  |- skos__broader mesh__D006623smesh__D000798
% 211.07/211.22  |- skos__hiddenLabel mesh__D006623 von Hippel Lindau Syndrome
% 211.07/211.22  |- skos__hiddenLabel mesh__D006623 Familial Cerebello-Retinal Angiomatoses
% 211.07/211.22  |- mesh__recordMaintainer mesh__D006623 lkt
% 211.07/211.22  |- skos__hiddenLabel mesh__D006623 Angiomatoses, Familial Cerebello-Retinal
% 211.07/211.22  |- skos__hiddenLabel mesh__D006623 von Hippel Lindau Disease
% 211.07/211.22  |- mesh__publicMeSHNote mesh__D044742 2004   
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D044742 2006
% 211.07/211.22  |- rdf__type mesh__D044742sskos__Concept
% 211.07/211.22  |- mesh__recordOriginator mesh__D044742 ags
% 211.07/211.22  |- mesh__dateRevised mesh__D044742 2005-06-30
% 211.07/211.22  |- mesh__historyNote mesh__D044742 2004   
% 211.07/211.22  |- skos__historyNote mesh__D044742 Oomycetes %28%1978-2003%29%
% 211.07/211.22  |- mesh__dateEstablished mesh__D044742 2004-01-01
% 211.07/211.22  |- mesh__recordMaintainer mesh__D044742 SYSTEM
% 211.07/211.22  |- skos__broader mesh__D044742smesh__D009868
% 211.07/211.22  |- skos__historyNote mesh__D044742 Fungi %28%1968-1977%29%
% 211.07/211.22  |- mesh__dateCreated mesh__D044742 2003-07-09
% 211.07/211.22  |- skos__prefLabel mesh__D044742 Peronospora
% 211.07/211.22  |- skos__scopeNote mesh__D044742
% 211.07/211.22       A genus of ALGAE in the family Peronosporaceae. Most species are obligatory parasites and many are plant pathogens.%A%    
% 211.07/211.22  |- mesh__recordAuthorizer mesh__D044742 sjn
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D011568 2005
% 211.07/211.22  |- skos__broader mesh__D011568smesh__D009732
% 211.07/211.22  |- mesh__recordMaintainer mesh__D011568 jls
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D011568 2006
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D011568 2003
% 211.07/211.22  |- mesh__recordOriginator mesh__D011568 NLM
% 211.07/211.22  |- rdf__type mesh__D011568sskos__Concept
% 211.07/211.22  |- skos__prefLabel mesh__D011568 Psychiatric Nursing
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D011568 2001
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D011568 2004
% 211.07/211.22  |- mesh__recordAuthorizer mesh__D011568 sjn
% 211.07/211.22  |- mesh__dateRevised mesh__D011568 2000-06-22
% 211.07/211.22  |- mesh__dateCreated mesh__D011568 1999-01-01
% 211.07/211.22  |- skos__scopeNote mesh__D011568
% 211.07/211.22       A specialty concerned with the application of psychiatric principles in caring for the mentally ill. It also includes the nursing care provided the mentally ill patient.%A%    
% 211.07/211.22  |- skos__broader mesh__D011568smesh__D013041
% 211.07/211.22  |- skos__altLabel mesh__D011568 Nursing, Psychiatric
% 211.07/211.22  |- skos__annotation mesh__D011568 SPEC: SPEC qualif   
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D011568 2002
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D016253 2006
% 211.07/211.22  |- mesh__recordMaintainer mesh__D016253 nns
% 211.07/211.22  |- skos__hiddenLabel mesh__D016253 Microscopies, Immuno-Electron
% 211.07/211.22  |- skos__hiddenLabel mesh__D016253 Immuno-Electron Microscopy
% 211.07/211.22  |- mesh__dateRevised mesh__D016253 2004-07-07
% 211.07/211.22  |- skos__annotation mesh__D016253 NIM   
% 211.07/211.22  |- skos__altLabel mesh__D016253 Microscopy, Immuno-Electron
% 211.07/211.22  |- skos__hiddenLabel mesh__D016253 Immuno-Electron Microscopies
% 211.07/211.22  |- rdf__type mesh__D016253sskos__Concept
% 211.07/211.22  |- skos__prefLabel mesh__D016253 Microscopy, Immunoelectron
% 211.07/211.22  |- mesh__historyNote mesh__D016253 91   
% 211.07/211.22  |- skos__hiddenLabel mesh__D016253 Microscopy, Immuno Electron
% 211.07/211.22  |- skos__altLabel mesh__D016253 Immunoelectron Microscopy
% 211.07/211.22  |- skos__historyNote mesh__D016253 Microscopy, Electron %28%1973-1990%29%
% 211.07/211.22  |- skos__hiddenLabel mesh__D016253 Microscopies, Immunoelectron
% 211.07/211.22  |- mesh__dateEstablished mesh__D016253 1991-01-01
% 211.07/211.22  |- mesh__recordAuthorizer mesh__D016253 sjn
% 211.07/211.22  |- skos__scopeNote mesh__D016253
% 211.07/211.22       Microscopy in which the samples are first stained immunocytochemically and then examined using an electron microscope. Immunoelectron microscopy is used extensively in diagnostic virology as part of very sensitive immunoassays.%A%    
% 211.07/211.22  |- skos__broader mesh__D016253smesh__D008854
% 211.07/211.22  |- mesh__dateCreated mesh__D016253 1990-05-07
% 211.07/211.22  |- mesh__publicMeSHNote mesh__D016253 91   
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D016253 2005
% 211.07/211.22  |- skos__hiddenLabel mesh__D016253 Immunoelectron Microscopies
% 211.07/211.22  |- mesh__recordOriginator mesh__D016253 PXP
% 211.07/211.22  |- skos__altLabel mesh__D002233 3-%28%Carboxymethylthio%29%alanine
% 211.07/211.22  |- skos__prefLabel mesh__D002233 Carbocysteine
% 211.07/211.22  |- mesh__recordOriginator mesh__D002233 NLM
% 211.07/211.22  |- mesh__recordMaintainer mesh__D002233 ssb
% 211.07/211.22  |- rdf__type mesh__D002233sskos__Concept
% 211.07/211.22  |- skos__altLabel mesh__D002233 S-Carboxymethylcysteine
% 211.07/211.22  |- skos__scopeNote mesh__D002233
% 211.07/211.22       A compound formed when iodoacetic acid reacts with sulfhydryl groups in proteins. It has been used as an anti-infective nasal spray with mucolytic and expectorant action.%A%    
% 211.07/211.22  |- mesh__dateRevised mesh__D002233 2005-06-30
% 211.07/211.22  |- mesh__historyNote mesh__D002233
% 211.07/211.22       91%28%80%29%; was see under CYSTEINE 1980-90; was CARBOXYMETHYLCYSTEINE see under CYSTEINE 1975-79%A%  
% 211.07/211.22  |- skos__altLabel mesh__D002233 Mucodyne
% 211.07/211.22  |- mesh__dateCreated mesh__D002233 1974-11-19
% 211.07/211.22  |- skos__hiddenLabel mesh__D002233 L-Isomer Carbocysteine
% 211.07/211.22  |- skos__broader mesh__D002233smesh__D003545
% 211.07/211.22  |- skos__broader mesh__D002233smesh__D000600
% 211.07/211.22  |- mesh__onlineNote mesh__D002233
% 211.07/211.22       use CARBOCYSTEINE to search CARBOXYMETHYLCYSTEINE 1975-79%A%  
% 211.07/211.22  |- skos__historyNote mesh__D002233 Amino Acids, Sulfur %28%1974%29%
% 211.07/211.22  |- skos__altLabel mesh__D002233 S-%28%Carboxymethyl%29%-L-cysteine
% 211.07/211.22  |- mesh__publicMeSHNote mesh__D002233
% 211.07/211.22       91; was see under CYSTEINE 1980-90; was CARBOXYMETHYLCYSTEINE see under CYSTEINE 1975-79%A%  
% 211.07/211.22  |- mesh__dateEstablished mesh__D002233 1991-01-01
% 211.07/211.22  |- skos__historyNote mesh__D002233 Amino Acids, Dicarboxylic %28%1974%29%
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D002233 2006
% 211.07/211.22  |- skos__altLabel mesh__D002233 Mucodine
% 211.07/211.22  |- skos__hiddenLabel mesh__D002233 Carbocysteine, L Isomer
% 211.07/211.22  |- skos__hiddenLabel mesh__D002233 S Carboxymethylcysteine
% 211.07/211.22  |- mesh__recordAuthorizer mesh__D002233 sjn
% 211.07/211.22  |- mesh__dateEstablished mesh__D026681 2002-01-01
% 211.07/211.22  |- skos__scopeNote mesh__D026681
% 211.07/211.22       A nutritional condition produced by a deficiency of VITAMIN B 6 in the diet, characterized by dermatitis, glossitis, cheilosis, and stomatitis. Marked deficiency causes irritability, weakness, depression, dizziness, peripheral neuropathy, and seizures. In infants and children typical manifestations are diarrhea, anemia, and seizures. Deficiency can be caused by certain medications, such as isoniazid.%A%    
% 211.07/211.22  |- skos__altLabel mesh__D026681 Deficiency, Pyridoxine
% 211.07/211.22  |- rdf__type mesh__D026681sskos__Concept
% 211.07/211.22  |- mesh__publicMeSHNote mesh__D026681
% 211.07/211.22       2000; for PYRIDOXINE DEFICIENCY see PYRIDOXINE DEFICIENCY 1963-2001%A%  
% 211.07/211.22  |- skos__altLabel mesh__D026681 Deficiency, Vitamin B6
% 211.07/211.22  |- mesh__recordAuthorizer mesh__D026681 sjn
% 211.07/211.22  |- skos__hiddenLabel mesh__D026681 Deficiencies, Vitamin B6
% 211.07/211.22  |- mesh__recordOriginator mesh__D026681 ssb
% 211.07/211.22  |- skos__hiddenLabel mesh__D026681 B6 Deficiencies, Vitamin
% 211.07/211.22  |- skos__hiddenLabel mesh__D026681 Vitamin B6 Deficiencies
% 211.07/211.22  |- skos__prefLabel mesh__D026681 Vitamin B 6 Deficiency
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D026681 2005
% 211.07/211.22  |- mesh__recordMaintainer mesh__D026681 lkt
% 211.07/211.22  |- skos__hiddenLabel mesh__D026681 B6 Deficiency, Vitamin
% 211.07/211.22  |- skos__historyNote mesh__D026681 Pyridoxine Deficiency %28%1963-2001%29%
% 211.07/211.22  |- skos__altLabel mesh__D026681 Vitamin B6 Deficiency
% 211.07/211.22  |- skos__altLabel mesh__D026681 Deficiency, Vitamin B 6
% 211.07/211.22  |- mesh__dateCreated mesh__D026681 2001-07-25
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D026681 2006
% 211.07/211.22  |- mesh__historyNote mesh__D026681 2000   
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D026681 2004
% 211.07/211.22  |- skos__broader mesh__D026681smesh__D014804
% 211.07/211.22  |- mesh__dateRevised mesh__D026681 2003-07-09
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001939 2006
% 211.07/211.22  |- mesh__activeMeSHYear mesh__D001939 2003
% 211.07/211.22  |- skos__hiddenLabel mesh__D001939 Breads
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D001939 2005
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D001939 2000
% 211.07/211.23  |- mesh__recordAuthorizer mesh__D001939 SJN
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D001939 1999
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D001939 1998
% 211.07/211.23  |- mesh__recordOriginator mesh__D001939 NLM
% 211.07/211.23  |- skos__broader mesh__D001939smesh__D005502
% 211.07/211.23  |- mesh__dateCreated mesh__D001939 1999-01-01
% 211.07/211.23  |- skos__scopeNote mesh__D001939
% 211.07/211.23       Baked food product made of flour or meal that is moistened, kneaded, and sometimes fermented. A major food since prehistoric times, it has been made in various forms using a variety of ingredients and methods.%A%    
% 211.07/211.23  |- mesh__recordMaintainer mesh__D001939 JLS
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D001939 2002
% 211.07/211.23  |- rdf__type mesh__D001939sskos__Concept
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D001939 2004
% 211.07/211.23  |- mesh__dateRevised mesh__D001939 1997-06-20
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D001939 2001
% 211.07/211.23  |- skos__prefLabel mesh__D001939 Bread
% 211.07/211.23  |- skos__related mesh__D012661smesh__D013094
% 211.07/211.23  |- mesh__recordOriginator mesh__D012661 NLM
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012661 2001
% 211.07/211.23  |- skos__scopeNote mesh__D012661
% 211.07/211.23       The thick, yellowish-white, viscid fluid secretion of male reproductive organs discharged upon ejaculation. In addition to reproductive organ secretions, it contains SPERMATOZOA and their nutrient plasma.%A%    
% 211.07/211.23  |- skos__related mesh__D012661smesh__D013074
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012661 2005
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012661 2002
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012661 2006
% 211.07/211.23  |- mesh__recordAuthorizer mesh__D012661 sjn
% 211.07/211.23  |- skos__hiddenLabel mesh__D012661 Plasma, Seminal
% 211.07/211.23  |- mesh__recordMaintainer mesh__D012661 KEV
% 211.07/211.23  |- mesh__dateCreated mesh__D012661 1999-01-01
% 211.07/211.23  |- skos__prefLabel mesh__D012661 Semen
% 211.07/211.23  |- skos__broader mesh__D012661smesh__D012634
% 211.07/211.23  |- rdf__type mesh__D012661sskos__Concept
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012661 2003
% 211.07/211.23  |- skos__annotation mesh__D012661
% 211.07/211.23       semen donors: coord SEMEN %28%IM%29% + TISSUE DONORS %28%IM%29%; consider also INSEMINATION, ARTIFICIAL, HOMOLOGOUS %28%husband%29% %28%IM%29% or INSEMINATION, ARTIFICIAL, HETEROLOGOUS %28%non-husband%29% %28%IM%29% if pertinent; hemospermia: index under SEMEN %28%IM%29% + BLOOD %28%IM%29%%A%  
% 211.07/211.23  |- mesh__dateRevised mesh__D012661 1999-11-03
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012661 2000
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012661 2004
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D006624 2000
% 211.07/211.23  |- skos__broader mesh__D006624smesh__D008032
% 211.07/211.23  |- skos__prefLabel mesh__D006624 Hippocampus
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D006624 2001
% 211.07/211.23  |- mesh__recordOriginator mesh__D006624 NLM
% 211.07/211.23  |- rdf__type mesh__D006624sskos__Concept
% 211.07/211.23  |- skos__hiddenLabel mesh__D006624 Hippocampal Formations
% 211.07/211.23  |- skos__hiddenLabel mesh__D006624 Formations, Hippocampal
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D006624 2003
% 211.07/211.23  |- mesh__recordMaintainer mesh__D006624 ags
% 211.07/211.23  |- skos__hiddenLabel mesh__D006624 Horn, Ammon%27%s
% 211.07/211.23  |- mesh__recordAuthorizer mesh__D006624 sjn
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D006624 2005
% 211.07/211.23  |- skos__hiddenLabel mesh__D006624 Ammons Horn
% 211.07/211.23  |- mesh__dateCreated mesh__D006624 1999-01-01
% 211.07/211.23  |- skos__altLabel mesh__D006624 Cornu Ammonis
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D006624 2004
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D006624 2002
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D006624 2006
% 211.07/211.23  |- mesh__dateRevised mesh__D006624 1999-11-03
% 211.07/211.23  |- skos__altLabel mesh__D006624 Ammon Horn
% 211.07/211.23  |- skos__hiddenLabel mesh__D006624 Formation, Hippocampal
% 211.07/211.23  |- skos__related mesh__D006624smesh__D019580
% 211.07/211.23  |- skos__scopeNote mesh__D006624
% 211.07/211.23       A curved elevation of gray matter extending the entire length of the floor of the temporal horn of the lateral ventricle %28%Dorland, 28th ed%29%. The hippocampus, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation.%A%    
% 211.07/211.23  |- skos__hiddenLabel mesh__D006624 Subiculums
% 211.07/211.23  |- skos__altLabel mesh__D006624 Ammon%27%s Horn
% 211.07/211.23  |- skos__related mesh__D006624smesh__D018728
% 211.07/211.23  |- skos__hiddenLabel mesh__D006624 Horn, Ammon
% 211.07/211.23  |- skos__scopeNote mesh__D044743
% 211.07/211.23       A genus of ALGAE in the family Saprolegniaceae. They are pathogens of FISHES and INSECTS.%A%    
% 211.07/211.23  |- skos__historyNote mesh__D044743 Fungi %28%1967-2003%29%
% 211.07/211.23  |- mesh__recordMaintainer mesh__D044743 SYSTEM
% 211.07/211.23  |- skos__broader mesh__D044743smesh__D009868
% 211.07/211.23  |- mesh__dateCreated mesh__D044743 2003-07-09
% 211.07/211.23  |- mesh__recordOriginator mesh__D044743 ags
% 211.07/211.23  |- mesh__dateRevised mesh__D044743 2005-06-30
% 211.07/211.23  |- mesh__historyNote mesh__D044743 2004   
% 211.07/211.23  |- mesh__dateEstablished mesh__D044743 2004-01-01
% 211.07/211.23  |- skos__annotation mesh__D044743
% 211.07/211.23       infection: coord IM with INFECTION %28%IM%29%   
% 211.07/211.23  |- skos__historyNote mesh__D044743 Oomycetes %28%1975-2003%29%
% 211.07/211.23  |- skos__prefLabel mesh__D044743 Achlya
% 211.07/211.23  |- rdf__type mesh__D044743sskos__Concept
% 211.07/211.23  |- mesh__publicMeSHNote mesh__D044743 2004   
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D044743 2006
% 211.07/211.23  |- mesh__recordAuthorizer mesh__D044743 sjn
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D011569 2003
% 211.07/211.23  |- skos__broader mesh__D011569smesh__D004191
% 211.07/211.23  |- rdf__type mesh__D011569sskos__Concept
% 211.07/211.23  |- mesh__onlineNote mesh__D011569
% 211.07/211.23       use PSYCHIATRIC STATUS RATING SCALES to search KATZ ADJUSTMENT SCALES 1975-96, LORR%27%S INPATIENT MULTIDIMENSIONAL PSYCHIATRIC RATING SCALE 1975-91, WITTENBORN SCALES 1979-91, WITTENBORN SCALE 1969-78, %26% FACTOR CONSTRUCT RATING SCALES 1973-78%A%  
% 211.07/211.23  |- skos__hiddenLabel mesh__D011569 Adjustment Scales, Katz
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D011569 2004
% 211.07/211.23  |- skos__scopeNote mesh__D011569
% 211.07/211.23       Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness.%A%    
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D011569 1997
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D011569 2002
% 211.07/211.23  |- mesh__dateCreated mesh__D011569 1999-01-01
% 211.07/211.23  |- mesh__publicMeSHNote mesh__D011569
% 211.07/211.23       69; KATZ ADJUSTMENT SCALES was heading 1975-96 %28%see under PSYCHIATRIC STATUS RATING SCALES 1975-90%29%; WITTENBORN SCALES was heading 1991, was see under PSYCHIATRIC STATUS RATING SCALES 1979-90, was WITTENBORN SCALE see under PSYCHIATRIC STATUS RATING SCALES 1969-78; LORR%27%S INPATIENT MULTIDIMENSIONAL PSYCHIATRIC RATING SCALE was heading 1991, see under PSYCHIATRIC STATUS RATING SCALES 1975-90%A%  
% 211.07/211.23  |- skos__hiddenLabel mesh__D011569 Scales, Katz Adjustment
% 211.07/211.23  |- mesh__dateRevised mesh__D011569 1996-06-10
% 211.07/211.23  |- mesh__historyNote mesh__D011569
% 211.07/211.23       69; KATZ ADJUSTMENT SCALES was heading 1975-96 %28%see under PSYCHIATRIC STATUS RATING SCALES 1975-90%29%; WITTENBORN SCALES was heading 1979-91 %28%see under PSYCHIATRIC STATUS RATING SCALES 1979-90%29%, was WITTENBORN SCALE see under PSYCHIATRIC STATUS RATING SCALES 1969-78; LORR%27%S INPATIENT MULTIDIMENSIONAL PSYCHIATRIC RATING SCALE was heading 1975-91 %28%see under PSYCHIATRIC STATUS RATING SCALES 1975-90%29%; FACTOR CONSTRUCT RATING SCALES was see under PSYCHIATRIC STATUS RATING SCALES 1973-78%A%  
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D011569 2000
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D011569 2005
% 211.07/211.23  |- mesh__recordAuthorizer mesh__D011569 PLS
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D011569 1998
% 211.07/211.23  |- mesh__recordMaintainer mesh__D011569 PXP
% 211.07/211.23  |- skos__historyNote mesh__D011569 Psychological Tests %28%1966-1968%29%
% 211.07/211.23  |- mesh__dateEstablished mesh__D011569 1969-01-01
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D011569 2006
% 211.07/211.23  |- mesh__recordOriginator mesh__D011569 NLM
% 211.07/211.23  |- skos__annotation mesh__D011569 DF: PSR SCALES   
% 211.07/211.23  |- skos__hiddenLabel mesh__D011569 Scales, Wittenborn
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D011569 2001
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D011569 1999
% 211.07/211.23  |- skos__prefLabel mesh__D011569 Psychiatric Status Rating Scales
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D016254 2003
% 211.07/211.23  |- skos__hiddenLabel mesh__D016254 Mutageneses, Insertional
% 211.07/211.23  |- mesh__historyNote mesh__D016254 91   
% 211.07/211.23  |- skos__hiddenLabel mesh__D016254 Activations, Insertional
% 211.07/211.23  |- mesh__dateRevised mesh__D016254 2002-07-02
% 211.07/211.23  |- skos__scopeNote mesh__D016254
% 211.07/211.23       Mutagenesis where the mutation is caused by the introduction of foreign DNA sequences into a gene. This may occur spontaneously in vivo or be experimentally induced in vivo or in vitro. Proviral DNA can be inserted into or adjacent to a cellular proto-oncogene. Insertion of the provirus can cause mutations by interrupting coding sequences or regulatory elements, or cause unregulated expression of the proto-oncogene resulting in tumor formation.%A%    
% 211.07/211.23  |- rdf__type mesh__D016254sskos__Concept
% 211.07/211.23  |- skos__hiddenLabel mesh__D016254 Mutagenesis, Linker-Insertion
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D016254 2004
% 211.07/211.23  |- skos__hiddenLabel mesh__D016254 Mutageneses, Viral Insertional
% 211.07/211.23  |- skos__hiddenLabel mesh__D016254 Cassette Mutagenesis
% 211.07/211.23  |- mesh__recordOriginator mesh__D016254 AGS
% 211.07/211.23  |- skos__hiddenLabel mesh__D016254 Viral Insertional Mutageneses
% 211.07/211.23  |- skos__broader mesh__D016254smesh__D015202
% 211.07/211.23  |- skos__hiddenLabel mesh__D016254 Insertional Mutagenesis, Viral
% 211.07/211.23  |- skos__hiddenLabel mesh__D016254 Mutageneses, Cassette
% 211.07/211.23  |- mesh__dateEstablished mesh__D016254 1991-01-01
% 211.07/211.23  |- skos__hiddenLabel mesh__D016254 Cassette Mutageneses
% 211.07/211.23  |- skos__altLabel mesh__D016254 Insertional Mutagenesis
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D016254 2005
% 211.07/211.23  |- skos__hiddenLabel mesh__D016254 Insertional Mutageneses, Viral
% 211.07/211.23  |- mesh__recordMaintainer mesh__D016254 NDW
% 211.07/211.23  |- skos__hiddenLabel mesh__D016254 Mutageneses, Linker-Insertion
% 211.07/211.23  |- skos__hiddenLabel mesh__D016254 Linker Insertion Mutagenesis
% 211.07/211.23  |- skos__broader mesh__D016254smesh__D016296
% 211.07/211.23  |- skos__prefLabel mesh__D016254 Mutagenesis, Insertional
% 211.07/211.23  |- skos__hiddenLabel mesh__D016254 Activation, Insertional
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D016254 2006
% 211.07/211.23  |- skos__historyNote mesh__D016254 Mutation %28%1982-1990%29%
% 211.07/211.23  |- skos__historyNote mesh__D016254 DNA Insertion Elements %28%1983-1990%29%
% 211.07/211.23  |- skos__hiddenLabel mesh__D016254 Mutagenesis, Viral Insertional
% 211.07/211.23  |- mesh__recordAuthorizer mesh__D016254 sjn
% 211.07/211.23  |- skos__annotation mesh__D016254 selected qualif from Cat G %26% Cat E   
% 211.07/211.23  |- skos__hiddenLabel mesh__D016254 Linker-Insertion Mutageneses
% 211.07/211.23  |- skos__hiddenLabel mesh__D016254 Insertional Mutageneses
% 211.07/211.23  |- mesh__dateCreated mesh__D016254 1990-05-29
% 211.07/211.23  |- skos__hiddenLabel mesh__D016254 Insertional Activations
% 211.07/211.23  |- mesh__publicMeSHNote mesh__D016254 91   
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D002234 2000
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D002234 1993
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D002234 1995
% 211.07/211.23  |- skos__historyNote mesh__D002234 Imines %28%1966-1972%29%
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D002234 2003
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D002234 2001
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D002234 2005
% 211.07/211.23  |- mesh__publicMeSHNote mesh__D002234 73   
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D002234 2004
% 211.07/211.23  |- mesh__dateEstablished mesh__D002234 1973-01-01
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D002234 2006
% 211.07/211.23  |- mesh__recordOriginator mesh__D002234 NLM
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D002234 2002
% 211.07/211.23  |- mesh__dateRevised mesh__D002234 1992-05-11
% 211.07/211.23  |- mesh__recordAuthorizer mesh__D002234 PLS
% 211.07/211.23  |- skos__prefLabel mesh__D002234 Carbodiimides
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D002234 1996
% 211.07/211.23  |- mesh__dateCreated mesh__D002234 1999-01-01
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D002234 1998
% 211.07/211.23  |- mesh__historyNote mesh__D002234 73   
% 211.07/211.23  |- mesh__recordMaintainer mesh__D002234 TGC
% 211.07/211.23  |- rdf__type mesh__D002234sskos__Concept
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D002234 1997
% 211.07/211.23  |- skos__broader mesh__D002234smesh__D007097
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D002234 1994
% 211.07/211.23  |- skos__annotation mesh__D002234
% 211.07/211.23       do not confuse CARBODIIMIDES %28%a group term%29% with %22%carbodiimide%22% %28%a specific chemical%29%%A%  
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D002234 1999
% 211.07/211.23  |- skos__broader mesh__D019271Q000031smesh__D019271
% 211.07/211.23  |- mesh__preferredCombination mesh__D019271Q000031smesh__D007042
% 211.07/211.23  |- rdf__type mesh__D019271Q000031smesh__CompoundConcept
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012662 2006
% 211.07/211.23  |- mesh__recordMaintainer mesh__D012662 NLM
% 211.07/211.23  |- mesh__dateEstablished mesh__D012662 1978-01-01
% 211.07/211.23  |- skos__related mesh__D012662smesh__D013074
% 211.07/211.23  |- skos__annotation mesh__D012662
% 211.07/211.23       cryopreservation of semen: coord IM with CRYOPRESERVATION %28%IM%29%%A%  
% 211.07/211.23  |- skos__related mesh__D012662smesh__D020858
% 211.07/211.23  |- mesh__dateCreated mesh__D012662 1977-04-22
% 211.07/211.23  |- mesh__recordAuthorizer mesh__D012662 NLM
% 211.07/211.23  |- rdf__type mesh__D012662sskos__Concept
% 211.07/211.23  |- mesh__historyNote mesh__D012662 78   
% 211.07/211.23  |- skos__scopeNote mesh__D012662
% 211.07/211.23       The process by which semen is kept viable outside of the organism from which it was derived %28%i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism%29%.%A%    
% 211.07/211.23  |- skos__historyNote mesh__D012662 Freezing %28%1966-1977%29%
% 211.07/211.23  |- skos__hiddenLabel mesh__D012662 Semen, Frozen
% 211.07/211.23  |- mesh__dateRevised mesh__D012662 2004-07-20
% 211.07/211.23  |- skos__broader mesh__D012662smesh__D014021
% 211.07/211.23  |- skos__hiddenLabel mesh__D012662 Preservation, Semen
% 211.07/211.23  |- skos__prefLabel mesh__D012662 Semen Preservation
% 211.07/211.23  |- skos__hiddenLabel mesh__D012662 Preservation, Sperm
% 211.07/211.23  |- mesh__recordOriginator mesh__D012662 EC
% 211.07/211.23  |- mesh__publicMeSHNote mesh__D012662 78   
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012662 2005
% 211.07/211.23  |- skos__historyNote mesh__D012662 Semen %28%1966-1977%29%
% 211.07/211.23  |- mesh__recordMaintainer mesh__D006625 jrf
% 211.07/211.23  |- rdf__type mesh__D006625sskos__Concept
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D006625 2003
% 211.07/211.23  |- mesh__dateRevised mesh__D006625 2002-07-03
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D006625 2005
% 211.07/211.23  |- skos__prefLabel mesh__D006625 Hippocratic Oath
% 211.07/211.23  |- skos__scopeNote mesh__D006625
% 211.07/211.23       An oath, attributed to Hippocrates, that serves as an ethical guide for the medical profession.%A%    
% 211.07/211.23  |- mesh__dateCreated mesh__D006625 1999-01-01
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D006625 2004
% 211.07/211.23  |- mesh__recordOriginator mesh__D006625 NLM
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D006625 2006
% 211.07/211.23  |- skos__broader mesh__D006625smesh__D004992
% 211.07/211.23  |- skos__annotation mesh__D006625
% 211.07/211.23       capitalize Hippocratic in titles %26% translations   
% 211.07/211.23  |- mesh__recordAuthorizer mesh__D006625 sjn
% 211.07/211.23  |- skos__broader mesh__D006625smesh__D032781
% 211.07/211.23  |- skos__hiddenLabel mesh__D006625 Oath, Hippocratic
% 211.07/211.23  |- mesh__historyNote mesh__D039001 2003   
% 211.07/211.23  |- mesh__recordOriginator mesh__D039001 MDJ
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D039001 2006A
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D039001 2005
% 211.07/211.23  |- skos__altLabel mesh__D039001 alpha Integrins
% 211.07/211.23  |- skos__hiddenLabel mesh__D039001 alpha Chains, Integrin
% 211.07/211.23  |- skos__altLabel mesh__D039001 Integrin alpha Subunits
% 211.07/211.23  |- mesh__dateCreated mesh__D039001 2002-07-02
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D039001 2006
% 211.07/211.23  |- skos__scopeNote mesh__D039001
% 211.07/211.23       The alpha subunits of integrin heterodimers %28%INTEGRINS%29%, which mediate ligand specificity.  There are approximately 18 different alpha chains, exhibiting great sequence diversity; several chains are also spliced into alternative isoforms.  They possess a long extracellular portion %28%1200 amino acids%29% containing a MIDAS %28%metal ion-dependent adhesion site%29% motif, and seven 60-amino acid tandem repeats, the last 4 of which form EF HAND MOTIFS.  The intracellular portion is short %28%%3E%50 AA%29% with the exception of INTEGRIN ALPHA4.%A%    
% 211.07/211.23  |- mesh__recordAuthorizer mesh__D039001 ags
% 211.07/211.23  |- skos__prefLabel mesh__D039001 Integrin alpha Chains
% 211.07/211.23  |- skos__broader mesh__D039001smesh__D016023
% 211.07/211.23  |- mesh__dateRevised mesh__D039001 2005-07-13
% 211.07/211.23  |- skos__historyNote mesh__D039001 Integrins %28%1966-2002%29%
% 211.07/211.23  |- skos__hiddenLabel mesh__D039001 Integrins, alpha
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D039001 2004
% 211.07/211.23  |- mesh__publicMeSHNote mesh__D039001 2003   
% 211.07/211.23  |- rdf__type mesh__D039001sskos__Concept
% 211.07/211.23  |- mesh__dateEstablished mesh__D039001 2003-01-01
% 211.07/211.23  |- mesh__recordMaintainer mesh__D039001 ags
% 211.07/211.23  |- skos__hiddenLabel mesh__D050781 Stimulations, Transcranial Magnetic
% 211.07/211.23  |- mesh__publicMeSHNote mesh__D050781 2006   
% 211.07/211.23  |- mesh__recordAuthorizer mesh__D050781 sjn
% 211.07/211.23  |- skos__historyNote mesh__D050781 Magnetics %28%1988-2005%29%
% 211.07/211.23  |- skos__hiddenLabel mesh__D050781 Stimulation, Transcranial Magnetic
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D050781 2006
% 211.07/211.23  |- mesh__recordOriginator mesh__D050781 ssb
% 211.07/211.23  |- mesh__dateEstablished mesh__D050781 2006-01-01
% 211.07/211.23  |- skos__hiddenLabel mesh__D050781 Transcranial Magnetic Stimulations
% 211.07/211.23  |- rdf__type mesh__D050781sskos__Concept
% 211.07/211.23  |- skos__related mesh__D050781smesh__D015225
% 211.07/211.23  |- skos__prefLabel mesh__D050781 Transcranial Magnetic Stimulation
% 211.07/211.23  |- skos__broader mesh__D050781smesh__D003943
% 211.07/211.23  |- skos__hiddenLabel mesh__D050781 Magnetic Stimulations, Transcranial
% 211.07/211.23  |- mesh__dateCreated mesh__D050781 2005-06-30
% 211.07/211.23  |- skos__hiddenLabel mesh__D050781 Magnetic Stimulation, Transcranial
% 211.07/211.23  |- mesh__historyNote mesh__D050781 2006   
% 211.07/211.23  |- mesh__recordMaintainer mesh__D050781 ssb
% 211.07/211.23  |- skos__scopeNote mesh__D050781
% 211.07/211.23       A technique that involves the use of electrical coils on the head to generate a brief magnetic field which reaches the CEREBRAL CORTEX.  It is coupled with ELECTROMYOGRAPHY response detection to assess cortical excitability by the threshold required to induce MOTOR EVOKED POTENTIALS. This method is also used for BRAIN MAPPING, to study NEUROPHYSIOLOGY, and as a substitute for ELECTROCONVULSIVE THERAPY for treating DEPRESSION. Induction of SEIZURES limits its clinical usage.%A%    
% 211.07/211.23  |- skos__annotation mesh__D044744
% 211.07/211.23       infection: coord IM with INFECTION %28%IM%29%   
% 211.07/211.23  |- mesh__recordAuthorizer mesh__D044744 sjn
% 211.07/211.23  |- skos__historyNote mesh__D044744 Fungi %28%1966-1977%29%
% 211.07/211.23  |- rdf__type mesh__D044744sskos__Concept
% 211.07/211.23  |- mesh__publicMeSHNote mesh__D044744 2004   
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D044744 2006
% 211.07/211.23  |- mesh__dateEstablished mesh__D044744 2004-01-01
% 211.07/211.23  |- mesh__recordOriginator mesh__D044744 ags
% 211.07/211.23  |- skos__scopeNote mesh__D044744
% 211.07/211.23       A genus of ALGAE in the family Saprolegniaceae. It causes root rot in plants and is also a pathogen of FISHES.%A%    
% 211.07/211.23  |- mesh__dateRevised mesh__D044744 2005-06-30
% 211.07/211.23  |- skos__broader mesh__D044744smesh__D009868
% 211.07/211.23  |- mesh__historyNote mesh__D044744 2004   
% 211.07/211.23  |- skos__historyNote mesh__D044744 Oomycetes %28%1978-2003%29%
% 211.07/211.23  |- skos__prefLabel mesh__D044744 Aphanomyces
% 211.07/211.23  |- mesh__dateCreated mesh__D044744 2003-07-09
% 211.07/211.23  |- mesh__recordMaintainer mesh__D044744 SYSTEM
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D016255 2006
% 211.07/211.23  |- mesh__recordMaintainer mesh__D016255 ssb
% 211.07/211.23  |- skos__altLabel mesh__D016255
% 211.07/211.23       Anisoylated Plasminogen-Streptokinase Activator Complex
% 211.07/211.23  |- skos__altLabel mesh__D016255 Reusch Brand of Anistreplase
% 211.07/211.23  |- skos__altLabel mesh__D016255 Madaus Brand of Anistreplase
% 211.07/211.23  |- skos__historyNote mesh__D016255 Fibrinolytic Agents %28%1966-1990%29%
% 211.07/211.23  |- mesh__recordOriginator mesh__D016255 RLS
% 211.07/211.23  |- skos__historyNote mesh__D016255 Streptokinase %28%1966-1990%29%
% 211.07/211.23  |- skos__altLabel mesh__D016255 APSAC
% 211.07/211.23  |- skos__prefLabel mesh__D016255 Anistreplase
% 211.07/211.23  |- mesh__recordAuthorizer mesh__D016255 sjn
% 211.07/211.23  |- mesh__historyNote mesh__D016255 91   
% 211.07/211.23  |- skos__altLabel mesh__D016255 Monmouth Brand Anistreplase
% 211.07/211.23  |- mesh__publicMeSHNote mesh__D016255 91   
% 211.07/211.23  |- rdf__type mesh__D016255sskos__Concept
% 211.07/211.23  |- skos__hiddenLabel mesh__D016255 Anistreplase Reusch Brand
% 211.07/211.23  |- mesh__dateCreated mesh__D016255 1990-05-07
% 211.07/211.23  |- skos__broader mesh__D016255smesh__D010960
% 211.07/211.23  |- skos__hiddenLabel mesh__D016255 Anistreplase Roberts Brand
% 211.07/211.23  |- skos__altLabel mesh__D016255 Roberts Brand of Anistreplase
% 211.07/211.23  |- skos__altLabel mesh__D016255 SmithKline Beecham Brand of Anistreplase
% 211.07/211.23  |- skos__hiddenLabel mesh__D016255 Brand Anistreplase, Monmouth
% 211.07/211.23  |- skos__hiddenLabel mesh__D016255 BRL26921
% 211.07/211.23  |- skos__broader mesh__D016255smesh__D013300
% 211.07/211.23  |- skos__hiddenLabel mesh__D016255 Anistreplase Madaus Brand
% 211.07/211.23  |- skos__hiddenLabel mesh__D016255 BRL 26921
% 211.07/211.23  |- skos__historyNote mesh__D016255 Plasminogen %28%1966-1990%29%
% 211.07/211.23  |- skos__hiddenLabel mesh__D016255 Anistreplase, Monmouth Brand
% 211.07/211.23  |- skos__scopeNote mesh__D016255
% 211.07/211.23       An acylated inactive complex of streptokinase and human lysine-plasminogen. After injection, the acyl group is slowly hydrolyzed, producing an activator that converts plasminogen to plasmin, thereby initiating fibrinolysis. Its half-life is about 90 minutes compared to 5 minutes for TPA; %28%TISSUE PLASMINOGEN ACTIVATOR%29%; 16 minutes for URINARY PLASMINOGEN ACTIVATOR and 23 minutes for STREPTOKINASE. If treatment is initiated within 3 hours of onset of symptoms for acute myocardial infarction, the drug preserves myocardial tissue and left ventricular function and increases coronary artery patency. Bleeding complications are similar to other thrombolytic agents.%A%    
% 211.07/211.23  |- mesh__dateEstablished mesh__D016255 1991-01-01
% 211.07/211.23  |- mesh__dateRevised mesh__D016255 2005-06-30
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D002235 2005
% 211.07/211.23  |- skos__hiddenLabel mesh__D002235 70143, Bayer
% 211.07/211.23  |- mesh__dateRevised mesh__D002235 2004-07-07
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D002235 2006
% 211.07/211.23  |- skos__historyNote mesh__D002235 Carbamates %28%1966-1971%29%
% 211.07/211.23  |- skos__hiddenLabel mesh__D002235 NIA 10242
% 211.07/211.23  |- mesh__dateEstablished mesh__D002235 1991-01-01
% 211.07/211.23  |- skos__annotation mesh__D002235 TN 111 for eff on insects   
% 211.07/211.23  |- mesh__dateCreated mesh__D002235 1999-01-01
% 211.07/211.23  |- mesh__recordAuthorizer mesh__D002235 sjn
% 211.07/211.23  |- mesh__historyNote mesh__D002235
% 211.07/211.23       91%28%72%29%; was see under INSECTICIDES, CARBAMATE 1972-90   
% 211.07/211.23  |- skos__broader mesh__D002235smesh__D048448
% 211.07/211.23  |- rdf__type mesh__D002235sskos__Concept
% 211.07/211.23  |- mesh__recordOriginator mesh__D002235 NLM
% 211.07/211.23  |- mesh__recordMaintainer mesh__D002235 ssb
% 211.07/211.23  |- skos__historyNote mesh__D002235 Insecticides %28%1966-1971%29%
% 211.07/211.23  |- skos__hiddenLabel mesh__D002235 NIA10242
% 211.07/211.23  |- skos__prefLabel mesh__D002235 Carbofuran
% 211.07/211.23  |- skos__scopeNote mesh__D002235
% 211.07/211.23       A cholinesterase inhibitor that is used as a systemic insecticide, an acaricide, and nematocide. %28%From Merck Index, 11th ed%29%%A%    
% 211.07/211.23  |- mesh__publicMeSHNote mesh__D002235
% 211.07/211.23       91; was see under INSECTICIDES, CARBAMATE 1972-90   
% 211.07/211.23  |- mesh__dateCreated mesh__D026683 2001-07-25
% 211.07/211.23  |- mesh__historyNote mesh__D026683 2002   
% 211.07/211.23  |- skos__hiddenLabel mesh__D026683 Committees, Advisory
% 211.07/211.23  |- skos__scopeNote mesh__D026683
% 211.07/211.23       Groups set up to advise governmental bodies, societies, or other institutions on policy. %28%Bioethics Thesaurus%29%%A%    
% 211.07/211.23  |- skos__hiddenLabel mesh__D026683 Commissions, Governmental
% 211.07/211.23  |- skos__hiddenLabel mesh__D026683 Review Committee
% 211.07/211.23  |- rdf__type mesh__D026683sskos__Concept
% 211.07/211.23  |- skos__broader mesh__D026683smesh__D011050
% 211.07/211.23  |- skos__historyNote mesh__D026683 Public Policy %28%1981-2001%29%
% 211.07/211.23  |- skos__prefLabel mesh__D026683 Advisory Committees
% 211.07/211.23  |- skos__hiddenLabel mesh__D026683 Governmental Commission
% 211.07/211.23  |- skos__hiddenLabel mesh__D026683 Committee, Review
% 211.07/211.23  |- skos__annotation mesh__D026683
% 211.07/211.23       coord IM with specific activity or agency %28%IM%29% + geog if pertinent%A%  
% 211.07/211.23  |- skos__altLabel mesh__D026683 Task Forces
% 211.07/211.23  |- skos__related mesh__D026683smesh__D017041
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D026683 2002
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D026683 2004
% 211.07/211.23  |- skos__hiddenLabel mesh__D026683 Commission, Governmental
% 211.07/211.23  |- skos__hiddenLabel mesh__D026683 Committee, Advisory
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D026683 2006
% 211.07/211.23  |- mesh__dateEstablished mesh__D026683 2002-01-01
% 211.07/211.23  |- skos__hiddenLabel mesh__D026683 Advisory Committee
% 211.07/211.23  |- mesh__publicMeSHNote mesh__D026683 2002   
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D026683 2003
% 211.07/211.23  |- skos__hiddenLabel mesh__D026683 Task Force
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D026683 2005
% 211.07/211.23  |- skos__hiddenLabel mesh__D026683 Committees, Review
% 211.07/211.23  |- mesh__dateEstablished mesh__D012663 1966-01-01
% 211.07/211.23  |- mesh__historyNote mesh__D012663 66   
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012663 2002
% 211.07/211.23  |- mesh__publicMeSHNote mesh__D012663 66   
% 211.07/211.23  |- mesh__dateCreated mesh__D012663 1999-01-01
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012663 1994
% 211.07/211.23  |- skos__broader mesh__D012663smesh__D009930
% 211.07/211.23  |- mesh__dateRevised mesh__D012663 1992-05-20
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012663 2006
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012663 1999
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012663 2001
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012663 1993
% 211.07/211.23  |- mesh__recordMaintainer mesh__D012663 TAP
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012663 2005
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012663 1998
% 211.07/211.23  |- mesh__recordOriginator mesh__D012663 NLM
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012663 2000
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012663 2004
% 211.07/211.23  |- skos__prefLabel mesh__D012663 Semicarbazides
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012663 1997
% 211.07/211.23  |- rdf__type mesh__D012663sskos__Concept
% 211.07/211.23  |- mesh__recordAuthorizer mesh__D012663 PLS
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012663 2003
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012663 1996
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D012663 1995
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D006626 2000
% 211.07/211.23  |- mesh__dateCreated mesh__D006626 1999-01-01
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D006626 2003
% 211.07/211.23  |- skos__broader mesh__D006626smesh__D001549
% 211.07/211.23  |- mesh__recordOriginator mesh__D006626 NLM
% 211.07/211.23  |- mesh__dateRevised mesh__D006626 1998-06-10
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D006626 2001
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D006626 2005
% 211.07/211.23  |- mesh__recordAuthorizer mesh__D006626 SJN
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D006626 2004
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D006626 1999
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D006626 2006
% 211.07/211.23  |- skos__scopeNote mesh__D006626 Salts and esters of hippuric acid.     
% 211.07/211.23  |- mesh__activeMeSHYear mesh__D006626 2002
% 211.07/211.23  |- mesh__recordMaintainer mesh__D006626 ADP
% 211.07/211.23  |- skos__broader mesh__D006626smesh__D007651
% 211.07/211.23  |- skos__prefLabel mesh__D006626 Hippurates
% 211.07/211.23  |- rdf__type mesh__D006626sskos__Concept
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D039002 2005
% 211.07/211.24  |- mesh__dateEstablished mesh__D039002 2003-01-01
% 211.07/211.24  |- skos__scopeNote mesh__D039002
% 211.07/211.24       Genomes of temperate BACTERIOPHAGES integrated into the DNA of their bacterial host cell. The prophages can be duplicated for many cell generations until some stimulus induces its activation and virulence.%A%    
% 211.07/211.24  |- mesh__historyNote mesh__D039002 2003   
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D039002 2006
% 211.07/211.24  |- skos__related mesh__D039002smesh__D008242
% 211.07/211.24  |- skos__annotation mesh__D039002
% 211.07/211.24       coord IM with specific bacteriophage %28%IM%29%   
% 211.07/211.24  |- skos__altLabel mesh__D039002 Prophage
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D039002 2003
% 211.07/211.24  |- mesh__dateCreated mesh__D039002 2002-07-03
% 211.07/211.24  |- mesh__publicMeSHNote mesh__D039002 2003   
% 211.07/211.24  |- skos__historyNote mesh__D039002 Bacteriophages %28%1965-2002%29%
% 211.07/211.24  |- skos__prefLabel mesh__D039002 Prophages
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D039002 2004
% 211.07/211.24  |- rdf__type mesh__D039002sskos__Concept
% 211.07/211.24  |- skos__broader mesh__D039002smesh__D001435
% 211.07/211.24  |- skos__related mesh__D039002smesh__D011533
% 211.07/211.24  |- skos__hiddenLabel mesh__D050782 pH Monitoring, Esophageal
% 211.07/211.24  |- skos__hiddenLabel mesh__D050782 Recordings, Esophageal pH
% 211.07/211.24  |- mesh__recordMaintainer mesh__D050782 ags
% 211.07/211.24  |- skos__hiddenLabel mesh__D050782 pH Recordings, Esophageal
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D050782 2006
% 211.07/211.24  |- skos__hiddenLabel mesh__D050782 Monitorings, Esophageal pH
% 211.07/211.24  |- mesh__recordAuthorizer mesh__D050782 sjn
% 211.07/211.24  |- skos__hiddenLabel mesh__D050782
% 211.07/211.24       Ambulatory 24 hour Esophageal pH Monitoring
% 211.07/211.24  |- rdf__type mesh__D050782sskos__Concept
% 211.07/211.24  |- skos__altLabel mesh__D050782 Monitoring, Esophageal pH
% 211.07/211.24  |- skos__prefLabel mesh__D050782 Esophageal pH Monitoring
% 211.07/211.24  |- skos__historyNote mesh__D050782
% 211.07/211.24       Hydrogen-Ion Concentration %28%1975-2005%29%
% 211.07/211.24  |- skos__hiddenLabel mesh__D050782 pH Recording, Esophageal
% 211.07/211.24  |- skos__broader mesh__D050782smesh__D018670
% 211.07/211.24  |- skos__hiddenLabel mesh__D050782 Recording, Esophageal pH
% 211.07/211.24  |- skos__hiddenLabel mesh__D050782 Esophageal pH Monitorings
% 211.07/211.24  |- mesh__dateEstablished mesh__D050782 2006-01-01
% 211.07/211.24  |- skos__broader mesh__D050782smesh__D019963
% 211.07/211.24  |- skos__hiddenLabel mesh__D050782 pH Monitorings, Esophageal
% 211.07/211.24  |- skos__altLabel mesh__D050782 Esophageal pH Recording
% 211.07/211.24  |- skos__hiddenLabel mesh__D050782 Esophageal pH Recordings
% 211.07/211.24  |- skos__altLabel mesh__D050782 Ambulatory 24-hour Esophageal pH Monitoring
% 211.07/211.24  |- skos__scopeNote mesh__D050782
% 211.07/211.24       Analysis of the HYDROGEN ION CONCENTRATION in the lumen of the ESOPHAGUS. It is used to record the pattern, frequency, and duration of GASTROESOPHAGEAL REFLUX.%A%    
% 211.07/211.24  |- mesh__dateCreated mesh__D050782 2005-06-30
% 211.07/211.24  |- mesh__publicMeSHNote mesh__D050782 2006   
% 211.07/211.24  |- mesh__historyNote mesh__D050782 2006   
% 211.07/211.24  |- skos__broader mesh__D050782smesh__D008991
% 211.07/211.24  |- skos__broader mesh__D050782smesh__D003938
% 211.07/211.24  |- skos__historyNote mesh__D050782 Esophagus %28%1975-2005%29%
% 211.07/211.24  |- mesh__recordOriginator mesh__D050782 ags
% 211.07/211.24  |- skos__altLabel mesh__D016256 SSEA 1 Determinant
% 211.07/211.24  |- skos__historyNote mesh__D016256 Antigenic Determinants %28%1970-1990%29%
% 211.07/211.24  |- skos__altLabel mesh__D016256 Stage-Specific Embryonic Antigen-1
% 211.07/211.24  |- skos__hiddenLabel mesh__D016256 Sialyl SSEA 1
% 211.07/211.24  |- skos__hiddenLabel mesh__D016256 Embryonic Antigen-1, Stage-Specific
% 211.07/211.24  |- skos__hiddenLabel mesh__D016256 Fucosyl SSEA 1
% 211.07/211.24  |- skos__hiddenLabel mesh__D016256 SSEA-1, Sialyl
% 211.07/211.24  |- skos__altLabel mesh__D016256 SSEA-1
% 211.07/211.24  |- skos__annotation mesh__D016256
% 211.07/211.24       do not coord FUCOSYL SSEA-1 or SIALYL SSEA-1 with FUCOSE or SIALIC ACID unless particularly discussed; DF: SSEA1%A%  
% 211.07/211.24  |- mesh__onlineNote mesh__D016256
% 211.07/211.24       use ANTIGENS, CD15 to search STAGE-SPECIFIC EMBRYONIC ANTIGEN-1 1991-94; use ANTIGENS, CD15 %28%NM%29% to search CD15 ANTIGEN %26% LEWIS X HAPTEN 1987-94; use ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC to search LEU-M1 ANTIGENS 1989-94%A%  
% 211.07/211.24  |- skos__hiddenLabel mesh__D016256 3 Fucosyl N acetyl lactosamine
% 211.07/211.24  |- skos__historyNote mesh__D016256 Glycolipids %28%1966-1990%29%
% 211.07/211.24  |- skos__altLabel mesh__D016256 Hapten X
% 211.07/211.24  |- skos__hiddenLabel mesh__D016256 Determinant, SSEA 1
% 211.07/211.24  |- mesh__publicMeSHNote mesh__D016256
% 211.07/211.24       95; was STAGE-SPECIFIC EMBRYONIC ANTIGEN-1 1991-94; LEU-M1 ANTIGENS was see ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94; CD 15 ANTIGEN was indexed under ANTIGENS, CD %26% ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1992-94 %26% ANTIGENS, DIFFERENTIATION 1987-91; LEWIS X HAPTEN was indexed under GANGLIOSIDES 1987-94%A%  
% 211.07/211.24  |- mesh__recordOriginator mesh__D016256 RLS
% 211.07/211.24  |- mesh__dateRevised mesh__D016256 2005-06-30
% 211.07/211.24  |- skos__altLabel mesh__D016256 Le%28%X%29% Antigen
% 211.07/211.24  |- skos__altLabel mesh__D016256 Hapten Y
% 211.07/211.24  |- skos__altLabel mesh__D016256 CD15 Antigens
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D016256 2006
% 211.07/211.24  |- skos__altLabel mesh__D016256 CD15 Antigen
% 211.07/211.24  |- skos__altLabel mesh__D016256 SSEA 1
% 211.07/211.24  |- mesh__recordAuthorizer mesh__D016256 sjn
% 211.07/211.24  |- skos__altLabel mesh__D016256 Lewis X Antigen
% 211.07/211.24  |- skos__broader mesh__D016256smesh__D020384
% 211.07/211.24  |- mesh__historyNote mesh__D016256
% 211.07/211.24       95; was STAGE-SPECIFIC EMBRYONIC ANTIGEN-1 1991-94; LEU-M1 ANTIGENS was see ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94; CD15 ANTIGENS was CD15 ANTIGEN %28%NM%29% 1987-94; LEWIS X HAPTEN was NM 1987-94%A%  
% 211.07/211.24  |- skos__historyNote mesh__D016256
% 211.07/211.24       Tumor Markers, Biological %28%1988-1990%29%
% 211.07/211.24  |- skos__hiddenLabel mesh__D016256 3 Fucosyllactosamine Determinant
% 211.07/211.24  |- mesh__dateCreated mesh__D016256 1990-06-08
% 211.07/211.24  |- skos__hiddenLabel mesh__D016256 Stage Specific Embryonic Antigen 1
% 211.07/211.24  |- skos__hiddenLabel mesh__D016256 1 Determinant, SSEA
% 211.07/211.24  |- skos__historyNote mesh__D016256 Antigens, Neoplasm %28%1973-1990%29%
% 211.07/211.24  |- skos__broader mesh__D016256smesh__D015703
% 211.07/211.24  |- skos__altLabel mesh__D016256 Leu-M1 Antigens
% 211.07/211.24  |- skos__broader mesh__D016256smesh__D015295
% 211.07/211.24  |- rdf__type mesh__D016256sskos__Concept
% 211.07/211.24  |- skos__altLabel mesh__D016256 Lewis X Hapten
% 211.07/211.24  |- skos__prefLabel mesh__D016256 Antigens, CD15
% 211.07/211.24  |- mesh__recordMaintainer mesh__D016256 ssb
% 211.07/211.24  |- skos__scopeNote mesh__D016256
% 211.07/211.24       Carbohydrate antigen which is accumulated in various human cancer tissues and secreted into the blood stream. The carbohydrate moiety can be further modified with fucose or sialic acid. Monoclonal antibodies have been determined which can discriminate each subgroup of this antigen in the sera of cancer patients. Sialyl SSEA-1 antigen is particularly elevated in the sera of patients with a variety of tumors.%A%    
% 211.07/211.24  |- skos__hiddenLabel mesh__D016256 SSEA-1, Fucosyl
% 211.07/211.24  |- skos__broader mesh__D016256smesh__D015214
% 211.07/211.24  |- mesh__dateEstablished mesh__D016256 1991-01-01
% 211.07/211.24  |- skos__hiddenLabel mesh__D016256 Leu M1 Antigens
% 211.07/211.24  |- skos__altLabel mesh__D016256 SSEA-1 Determinant
% 211.07/211.24  |- mesh__recordMaintainer mesh__D002236 nns
% 211.07/211.24  |- skos__annotation mesh__D002236
% 211.07/211.24       IM general only; coord NIM with specific carbohydrate %28%IM%29%; do not confuse CARBOHYDRATE LINKAGE see CARBOHYDRATE CONFORMATION with CARBOHYDRATE SEQUENCE: conform = spatial or 3-dimensional struct, sequ = order in which components are arranged%A%  
% 211.07/211.24  |- skos__hiddenLabel mesh__D002236 Conformations, Carbohydrate
% 211.07/211.24  |- mesh__dateCreated mesh__D002236 1979-05-24
% 211.07/211.24  |- skos__hiddenLabel mesh__D002236 Conformation, Carbohydrate
% 211.07/211.24  |- skos__hiddenLabel mesh__D002236 Carbohydrate Linkages
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D002236 2006
% 211.07/211.24  |- mesh__dateRevised mesh__D002236 2004-07-07
% 211.07/211.24  |- mesh__publicMeSHNote mesh__D002236 80   
% 211.07/211.24  |- skos__prefLabel mesh__D002236 Carbohydrate Conformation
% 211.07/211.24  |- skos__broader mesh__D002236smesh__D008968
% 211.07/211.24  |- mesh__dateEstablished mesh__D002236 1980-01-01
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D002236 2005
% 211.07/211.24  |- skos__hiddenLabel mesh__D002236 Linkage, Carbohydrate
% 211.07/211.24  |- mesh__recordOriginator mesh__D002236 VDK
% 211.07/211.24  |- skos__scopeNote mesh__D002236
% 211.07/211.24       The characteristic 3-dimensional shape of a carbohydrate.%A%    
% 211.07/211.24  |- skos__historyNote mesh__D002236 Molecular Conformation %28%1973-1979%29%
% 211.07/211.24  |- skos__hiddenLabel mesh__D002236 Linkages, Carbohydrate
% 211.07/211.24  |- rdf__type mesh__D002236sskos__Concept
% 211.07/211.24  |- mesh__historyNote mesh__D002236 80   
% 211.07/211.24  |- mesh__recordAuthorizer mesh__D002236 sjn
% 211.07/211.24  |- skos__hiddenLabel mesh__D002236 Carbohydrate Conformations
% 211.07/211.24  |- mesh__historyNote mesh__D026684
% 211.07/211.24       2002; for SELF DETERMINATION use FREEDOM 1990-2001   
% 211.07/211.24  |- skos__scopeNote mesh__D026684
% 211.07/211.24       Self-directing freedom and especially moral independence. An ethical principle holds that the autonomy of persons ought to be respected. %28%Bioethics Thesaurus%29%%A%    
% 211.07/211.24  |- skos__broader mesh__D026684smesh__D011579
% 211.07/211.24  |- skos__broader mesh__D026684smesh__D005610
% 211.07/211.24  |- skos__prefLabel mesh__D026684 Personal Autonomy
% 211.07/211.24  |- mesh__publicMeSHNote mesh__D026684
% 211.07/211.24       2002; for SELF DETERMINATION see FREEDOM 1990-2001   
% 211.07/211.24  |- skos__altLabel mesh__D026684 Autonomy, Personal
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D026684 2004
% 211.07/211.24  |- mesh__recordAuthorizer mesh__D026684 sjn
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D026684 2006
% 211.07/211.24  |- mesh__dateCreated mesh__D026684 2001-07-25
% 211.07/211.24  |- skos__related mesh__D026684smesh__D012649
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D026684 2003
% 211.07/211.24  |- mesh__recordMaintainer mesh__D026684 jrf
% 211.07/211.24  |- skos__related mesh__D026684smesh__D026706
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D026684 2005
% 211.07/211.24  |- mesh__dateEstablished mesh__D026684 2002-01-01
% 211.07/211.24  |- mesh__recordOriginator mesh__D026684 jrf
% 211.07/211.24  |- skos__historyNote mesh__D026684 Freedom %28%1974-2001%29%
% 211.07/211.24  |- skos__related mesh__D026684smesh__D017009
% 211.07/211.24  |- rdf__type mesh__D026684sskos__Concept
% 211.07/211.24  |- skos__broader mesh__D026684smesh__D028662
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D026684 2002
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012664 1994
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012664 2006
% 211.07/211.24  |- mesh__recordAuthorizer mesh__D012664 PLS
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012664 1999
% 211.07/211.24  |- mesh__publicMeSHNote mesh__D012664 74   
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012664 1993
% 211.07/211.24  |- skos__historyNote mesh__D012664 Semicarbazides %28%1966-1971%29%
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012664 2005
% 211.07/211.24  |- skos__historyNote mesh__D012664 Hemostatics %28%1966-1971%29%
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012664 1998
% 211.07/211.24  |- skos__prefLabel mesh__D012664 Semicarbazones
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012664 2002
% 211.07/211.24  |- mesh__dateRevised mesh__D012664 1992-05-20
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012664 2004
% 211.07/211.24  |- skos__broader mesh__D012664smesh__D012663
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012664 1997
% 211.07/211.24  |- rdf__type mesh__D012664sskos__Concept
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012664 2001
% 211.07/211.24  |- skos__historyNote mesh__D012664 Nitrofurazone %28%1966-1971%29%
% 211.07/211.24  |- mesh__recordMaintainer mesh__D012664 TAP
% 211.07/211.24  |- mesh__historyNote mesh__D012664 74%28%72%29%   
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012664 2003
% 211.07/211.24  |- mesh__dateEstablished mesh__D012664 1974-01-01
% 211.07/211.24  |- skos__historyNote mesh__D012664 Thiosemicarbazones %28%1966-1971%29%
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012664 1996
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012664 1995
% 211.07/211.24  |- mesh__recordOriginator mesh__D012664 NLM
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012664 2000
% 211.07/211.24  |- mesh__dateCreated mesh__D012664 1999-01-01
% 211.07/211.24  |- mesh__onlineNote mesh__D006627 search MEGACOLON 1966-82   
% 211.07/211.24  |- mesh__recordMaintainer mesh__D006627 lkt
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D006627 2006
% 211.07/211.24  |- mesh__historyNote mesh__D006627
% 211.07/211.24       83; was HIRSCHSPRUNG%27%S DISEASE see MEGACOLON 1963-82   
% 211.07/211.24  |- skos__altLabel mesh__D006627 Total Colonic Aganglionosis
% 211.07/211.24  |- skos__altLabel mesh__D006627 Hirschsprung%27%s Disease
% 211.07/211.24  |- skos__broader mesh__D006627smesh__D008531
% 211.07/211.24  |- skos__altLabel mesh__D006627 Rectosigmoid Aganglionosis
% 211.07/211.24  |- mesh__dateRevised mesh__D006627 2003-07-09
% 211.07/211.24  |- skos__altLabel mesh__D006627 Colonic Aganglionosis
% 211.07/211.24  |- skos__scopeNote mesh__D006627
% 211.07/211.24       Congenital MEGACOLON resulting from the absence of  ganglion cells %28%aganglionosis%29% in a distal segment of the LARGE INTESTINE. The aganglionic segment is permanently contracted thus causing dilatation proximal to it. In most cases, the aganglionic segment is within the RECTUM and SIGMOID COLON.%A%    
% 211.07/211.24  |- skos__annotation mesh__D006627 acquired megacolon = MEGACOLON   
% 211.07/211.24  |- skos__hiddenLabel mesh__D006627 Hirschsprungs Disease
% 211.07/211.24  |- skos__altLabel mesh__D006627 Megacolon, Congenital
% 211.07/211.24  |- skos__prefLabel mesh__D006627 Hirschsprung Disease
% 211.07/211.24  |- mesh__publicMeSHNote mesh__D006627
% 211.07/211.24       83; was HIRSCHSPRUNG%27%S DISEASE see MEGACOLON 1963-82   
% 211.07/211.24  |- skos__broader mesh__D006627smesh__D004065
% 211.07/211.24  |- mesh__dateCreated mesh__D006627 1982-04-27
% 211.07/211.24  |- mesh__recordOriginator mesh__D006627 RC
% 211.07/211.24  |- skos__historyNote mesh__D006627 Megacolon %28%1966-1982%29%
% 211.07/211.24  |- rdf__type mesh__D006627sskos__Concept
% 211.07/211.24  |- mesh__dateEstablished mesh__D006627 1983-01-01
% 211.07/211.24  |- skos__hiddenLabel mesh__D006627 Disease, Hirschsprung
% 211.07/211.24  |- skos__hiddenLabel mesh__D006627 Disease, Hirschsprung%27%s
% 211.07/211.24  |- skos__hiddenLabel mesh__D006627 Rectosigmoid Colon Aganglionosis
% 211.07/211.24  |- skos__hiddenLabel mesh__D006627 Aganglionosis, Rectosigmoid
% 211.07/211.24  |- mesh__recordAuthorizer mesh__D006627 sjn
% 211.07/211.24  |- skos__altLabel mesh__D006627 Congenital Megacolon
% 211.07/211.24  |- skos__altLabel mesh__D006627 Aganglionosis, Total Colonic
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D006627 2005
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D006627 2004
% 211.07/211.24  |- skos__broader mesh__D011618Q000139smesh__D011618
% 211.07/211.24  |- mesh__preferredCombination mesh__D011618Q000139smesh__D011605
% 211.07/211.24  |- rdf__type mesh__D011618Q000139smesh__CompoundConcept
% 211.07/211.24  |- skos__hiddenLabel mesh__D050783 Transcription Factors, ets
% 211.07/211.24  |- skos__broader mesh__D050783smesh__D004268
% 211.07/211.24  |- skos__altLabel mesh__D050783 Proto-Oncogene Protein ets
% 211.07/211.24  |- skos__altLabel mesh__D050783 c-ets Protein
% 211.07/211.24  |- mesh__recordOriginator mesh__D050783 jmp
% 211.07/211.24  |- skos__broader mesh__D050783smesh__D014157
% 211.07/211.24  |- skos__prefLabel mesh__D050783 Proto-Oncogene Proteins c-ets
% 211.07/211.24  |- skos__hiddenLabel mesh__D050783 Proto Oncogene Proteins c ets
% 211.07/211.24  |- mesh__publicMeSHNote mesh__D050783
% 211.07/211.24       2006; PROTO-ONCOGENE PROTEINS C-ETS was indexed under PROTO-ONCOGENE PROTEINS %26% TRANSCRIPTION FACTORS 1986-2005%A%  
% 211.07/211.24  |- skos__hiddenLabel mesh__D050783 c-ets, Proto-Oncogene Proteins
% 211.07/211.24  |- mesh__dateCreated mesh__D050783 2005-06-30
% 211.07/211.24  |- mesh__recordMaintainer mesh__D050783 jmp
% 211.07/211.24  |- skos__hiddenLabel mesh__D050783 Proto Oncogene Protein ets
% 211.07/211.24  |- skos__altLabel mesh__D050783 c-ets Proto-Oncogene Proteins
% 211.07/211.24  |- skos__altLabel mesh__D050783 ets Transcription Factors
% 211.07/211.24  |- skos__hiddenLabel mesh__D050783 c ets Proto Oncogene Proteins
% 211.07/211.24  |- skos__historyNote mesh__D050783 Transcription Factors %28%1986-2005%29%
% 211.07/211.24  |- skos__broader mesh__D050783smesh__D011518
% 211.07/211.24  |- mesh__historyNote mesh__D050783 2006%28%1986%29%   
% 211.07/211.24  |- skos__historyNote mesh__D050783
% 211.07/211.24       Proto-Oncogene Proteins %28%1986-2005%29%
% 211.07/211.24  |- skos__hiddenLabel mesh__D050783 Proto-Oncogene Proteins, ets
% 211.07/211.24  |- mesh__recordAuthorizer mesh__D050783 sjn
% 211.07/211.24  |- skos__scopeNote mesh__D050783
% 211.07/211.24       A family of transcription factors that share a unique DNA-binding domain. The name derives from viral oncogene-derived protein ONCOGENE PROTEIN V-ETS of the AVIAN ERYTHROBLASTOSIS VIRUS.%A%    
% 211.07/211.24  |- skos__altLabel mesh__D050783 ets Proto-Oncogene Proteins
% 211.07/211.24  |- skos__hiddenLabel mesh__D050783 c ets Protein
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D050783 2006
% 211.07/211.24  |- mesh__dateEstablished mesh__D050783 2006-01-01
% 211.07/211.24  |- skos__hiddenLabel mesh__D050783 Proto-Oncogene Proteins, c-ets
% 211.07/211.24  |- skos__hiddenLabel mesh__D050783 ets Proto Oncogene Proteins
% 211.07/211.24  |- rdf__type mesh__D050783sskos__Concept
% 211.07/211.24  |- skos__annotation mesh__D016257 D25-26 qualif   
% 211.07/211.24  |- skos__prefLabel mesh__D016257 Fura-2
% 211.07/211.24  |- skos__historyNote mesh__D016257 Chelating Agents %28%1966-1990%29%
% 211.07/211.24  |- skos__broader mesh__D016257smesh__D010080
% 211.07/211.24  |- skos__historyNote mesh__D016257 Benzofurans %28%1966-1990%29%
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D016257 2006
% 211.07/211.24  |- mesh__dateEstablished mesh__D016257 1991-01-01
% 211.07/211.24  |- mesh__dateRevised mesh__D016257 2005-06-30
% 211.07/211.24  |- skos__broader mesh__D016257smesh__D001572
% 211.07/211.24  |- mesh__recordMaintainer mesh__D016257 ssb
% 211.07/211.24  |- mesh__recordOriginator mesh__D016257 RLS
% 211.07/211.24  |- skos__historyNote mesh__D016257 Oxazoles %28%1966-1990%29%
% 211.07/211.24  |- skos__historyNote mesh__D016257 Fluorescent Dyes %28%1966-1990%29%
% 211.07/211.24  |- skos__scopeNote mesh__D016257
% 211.07/211.24       A fluorescent calcium chelating agent which is used to study intracellular calcium in many tissues. The fluorescent and chelating properties of Fura-2 aid in the quantitation of endothelial cell injury, in monitoring ATP-dependent calcium uptake by membrane vesicles, and in the determination of the relationship between cytoplasmic free calcium and oxidase activation in rat neutrophils.%A%    
% 211.07/211.24  |- skos__hiddenLabel mesh__D016257 Fura 2
% 211.07/211.24  |- mesh__historyNote mesh__D016257 91   
% 211.07/211.24  |- rdf__type mesh__D016257sskos__Concept
% 211.07/211.24  |- mesh__recordAuthorizer mesh__D016257 sjn
% 211.07/211.24  |- mesh__dateCreated mesh__D016257 1990-05-07
% 211.07/211.24  |- mesh__publicMeSHNote mesh__D016257 91   
% 211.07/211.24  |- skos__hiddenLabel mesh__D002237 Oxidoreductases, Carbohydrate
% 211.07/211.24  |- skos__scopeNote mesh__D002237
% 211.07/211.24       Reversibly catalyze the oxidation of a hydroxyl group of carbohydrates to form a keto sugar, aldehyde or lactone. Any acceptor except molecular oxygen is permitted. Includes EC 1.1.1.; EC 1.1.2.; and 1.1.99.%A%    
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D002237 2004
% 211.07/211.24  |- skos__altLabel mesh__D002237 Carbohydrate Oxidoreductases
% 211.07/211.24  |- skos__broader mesh__D002237smesh__D000429
% 211.07/211.24  |- mesh__publicMeSHNote mesh__D002237
% 211.07/211.24       78; FRUCTURONATE REDUCTASE, PHOSPHOGLYCERATE DEHYDROGENASE, TAGATURONATE REDUCTASE %26% URIDINE DIPHOSPHATE GLUCOSE DEHYDROGENASE were see under ALCOHOL OXIDOREDUCTASES 1975-77%A%  
% 211.07/211.24  |- mesh__historyNote mesh__D002237 78   
% 211.07/211.24  |- mesh__recordOriginator mesh__D002237 RLS
% 211.07/211.24  |- mesh__dateRevised mesh__D002237 2003-07-09
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D002237 2006
% 211.07/211.24  |- skos__hiddenLabel mesh__D002237 Dehydrogenases, Carbohydrate
% 211.07/211.24  |- skos__prefLabel mesh__D002237 Carbohydrate Dehydrogenases
% 211.07/211.24  |- mesh__recordMaintainer mesh__D002237 ssb
% 211.07/211.24  |- rdf__type mesh__D002237sskos__Concept
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D002237 2005
% 211.07/211.24  |- skos__historyNote mesh__D002237
% 211.07/211.24       Alcohol Oxidoreductases %28%1966-1977%29%
% 211.07/211.24  |- mesh__recordAuthorizer mesh__D002237 sjn
% 211.07/211.24  |- mesh__dateEstablished mesh__D002237 1978-01-01
% 211.07/211.24  |- mesh__dateCreated mesh__D002237 1977-04-15
% 211.07/211.24  |- skos__broader mesh__D007720smesh__D007595
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D007720 2001
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D007720 1998
% 211.07/211.24  |- skos__annotation mesh__D007720
% 211.07/211.24       do not use /util except by MeSH definition   
% 211.07/211.24  |- mesh__recordAuthorizer mesh__D007720 SJN
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D007720 2005
% 211.07/211.24  |- skos__hiddenLabel mesh__D007720 Knee Prostheses
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D007720 2002
% 211.07/211.24  |- skos__scopeNote mesh__D007720 Replacement for a knee joint.     
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D007720 1999
% 211.07/211.24  |- mesh__recordOriginator mesh__D007720 SMH
% 211.07/211.24  |- skos__historyNote mesh__D007720 Knee Joint %28%1966-1979%29%
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D007720 2003
% 211.07/211.24  |- skos__historyNote mesh__D007720 Knee %28%1966-1979%29%
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D007720 2006
% 211.07/211.24  |- skos__hiddenLabel mesh__D007720 Prostheses, Knee
% 211.07/211.24  |- skos__historyNote mesh__D007720 Prosthesis %28%1966-1970%29%
% 211.07/211.24  |- mesh__historyNote mesh__D007720 80   
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D007720 2004
% 211.07/211.24  |- skos__related mesh__D007720smesh__D019645
% 211.07/211.24  |- skos__historyNote mesh__D007720 Arthroplasty %28%1966-1979%29%
% 211.07/211.24  |- mesh__publicMeSHNote mesh__D007720 80   
% 211.07/211.24  |- skos__historyNote mesh__D007720 Joint Prosthesis %28%1971-1979%29%
% 211.07/211.24  |- skos__prefLabel mesh__D007720 Knee Prosthesis
% 211.07/211.24  |- mesh__dateCreated mesh__D007720 1978-12-19
% 211.07/211.24  |- mesh__dateRevised mesh__D007720 1997-06-20
% 211.07/211.24  |- skos__hiddenLabel mesh__D007720 Prosthesis, Knee
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D007720 2000
% 211.07/211.24  |- mesh__dateEstablished mesh__D007720 1980-01-01
% 211.07/211.24  |- mesh__recordMaintainer mesh__D007720 PXP
% 211.07/211.24  |- rdf__type mesh__D007720sskos__Concept
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012665 1991
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012665 1999
% 211.07/211.24  |- skos__scopeNote mesh__D012665
% 211.07/211.24       Three long canals %28%anterior, posterior, and lateral%29% of the labyrinth. They are set at right angles to each other and are situated superior and posterior to the vestibule.%A%    
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012665 1994
% 211.07/211.24  |- mesh__dateRevised mesh__D012665 1989-05-16
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012665 1990
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012665 1998
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012665 2006
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012665 1993
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012665 2002
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012665 1997
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012665 2005
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012665 1992
% 211.07/211.24  |- rdf__type mesh__D012665sskos__Concept
% 211.07/211.24  |- skos__hiddenLabel mesh__D012665 Canal, Semicircular
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012665 2001
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012665 1996
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012665 2004
% 211.07/211.24  |- mesh__recordOriginator mesh__D012665 NLM
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012665 2000
% 211.07/211.24  |- mesh__recordMaintainer mesh__D012665 PXP
% 211.07/211.24  |- skos__hiddenLabel mesh__D012665 Semicircular Canal
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012665 2003
% 211.07/211.24  |- mesh__dateCreated mesh__D012665 1999-01-01
% 211.07/211.24  |- skos__broader mesh__D012665smesh__D007758
% 211.07/211.24  |- skos__hiddenLabel mesh__D012665 Canals, Semicircular
% 211.07/211.24  |- skos__prefLabel mesh__D012665 Semicircular Canals
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D012665 1995
% 211.07/211.24  |- mesh__recordAuthorizer mesh__D012665 PLS
% 211.07/211.24  |- mesh__recordAuthorizer mesh__D006628 sjn
% 211.07/211.24  |- mesh__recordMaintainer mesh__D006628 lkt
% 211.07/211.24  |- mesh__publicMeSHNote mesh__D006628
% 211.07/211.24       66; was see under HYPERTRICHOSIS 1963-65   
% 211.07/211.24  |- rdf__type mesh__D006628sskos__Concept
% 211.07/211.24  |- mesh__historyNote mesh__D006628
% 211.07/211.24       66%28%64%29%; was see under HYPERTRICHOSIS 1963-65   
% 211.07/211.24  |- skos__prefLabel mesh__D006628 Hirsutism
% 211.07/211.24  |- skos__broader mesh__D006628smesh__D014770
% 211.07/211.24  |- skos__broader mesh__D006628smesh__D006201
% 211.07/211.24  |- mesh__dateCreated mesh__D006628 1999-01-01
% 211.07/211.24  |- skos__related mesh__D006628smesh__D006983
% 211.07/211.24  |- skos__scopeNote mesh__D006628
% 211.07/211.24       A condition observed in WOMEN and CHILDREN when there is excess coarse body hair of an adult male distribution pattern, such as facial and chest areas. It is the result of elevated ANDROGENS from the OVARIES, the ADRENAL GLANDS, or exogenous sources. The concept does not include HYPERTRICHOSIS, which is an androgen-independent excessive hair growth.%A%    
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D006628 2005
% 211.07/211.24  |- mesh__recordOriginator mesh__D006628 NLM
% 211.07/211.24  |- mesh__dateRevised mesh__D006628 2004-07-07
% 211.07/211.24  |- mesh__dateEstablished mesh__D006628 1966-01-01
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D006628 2006
% 211.07/211.24  |- skos__broader mesh__D017350smesh__D017349
% 211.07/211.24  |- skos__hiddenLabel mesh__D017350 Transferases, N-Acetylgalactosamine
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D017350 2006
% 211.07/211.24  |- mesh__dateCreated mesh__D017350 1992-05-22
% 211.07/211.24  |- skos__hiddenLabel mesh__D017350 N Acetylgalactosaminyltransferases
% 211.07/211.24  |- skos__prefLabel mesh__D017350 N-Acetylgalactosaminyltransferases
% 211.07/211.24  |- skos__altLabel mesh__D017350 N-Acetylgalactosamine Transferases
% 211.07/211.24  |- mesh__recordAuthorizer mesh__D017350 sjn
% 211.07/211.24  |- mesh__dateEstablished mesh__D017350 1993-01-01
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D017350 2005
% 211.07/211.24  |- mesh__historyNote mesh__D017350 93   
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D017350 2004
% 211.07/211.24  |- rdf__type mesh__D017350sskos__Concept
% 211.07/211.24  |- skos__hiddenLabel mesh__D017350 N Acetylgalactosamine Transferases
% 211.07/211.24  |- mesh__dateRevised mesh__D017350 2003-07-09
% 211.07/211.24  |- skos__historyNote mesh__D017350 Galactosyltransferases %28%1976-1992%29%
% 211.07/211.24  |- skos__scopeNote mesh__D017350
% 211.07/211.24       Enzymes that catalyze the transfer of N-acetylgalactosamine from a nucleoside diphosphate N-acetylgalactosamine to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-.%A%    
% 211.07/211.24  |- mesh__recordMaintainer mesh__D017350 ssb
% 211.07/211.24  |- mesh__publicMeSHNote mesh__D017350 93   
% 211.07/211.24  |- mesh__recordOriginator mesh__D017350 TPW
% 211.07/211.24  |- mesh__historyNote mesh__D031021 2003   
% 211.07/211.24  |- skos__broader mesh__D031021smesh__D027926
% 211.07/211.24  |- mesh__recordAuthorizer mesh__D031021 sjn
% 211.07/211.24  |- rdf__type mesh__D031021sskos__Concept
% 211.07/211.24  |- skos__scopeNote mesh__D031021
% 211.07/211.24       A plant genus of the family ANACARDIACEAE. This is the source of the familiar cashew nuts, which are heat treated to remove the irritant toxin. Cashew nut shell liquid %28%frequently abbreviated as CNSL%29% is a major source of alkenyl phenolic compounds, especially ANACARDIC ACIDS, cardol, and cardanol.%A%    
% 211.07/211.24  |- skos__annotation mesh__D031021
% 211.07/211.24       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.07/211.24  |- mesh__dateRevised mesh__D031021 2004-07-07
% 211.07/211.24  |- mesh__recordMaintainer mesh__D031021 ssb
% 211.07/211.24  |- mesh__recordOriginator mesh__D031021 ssb
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D031021 2006
% 211.07/211.24  |- mesh__dateEstablished mesh__D031021 2003-01-01
% 211.07/211.24  |- mesh__publicMeSHNote mesh__D031021 2003   
% 211.07/211.24  |- skos__prefLabel mesh__D031021 Anacardium
% 211.07/211.24  |- mesh__dateCreated mesh__D031021 2002-07-02
% 211.07/211.24  |- mesh__activeMeSHYear mesh__D031021 2005
% 211.07/211.24  |- skos__hiddenLabel mesh__D050784 c ets 1 Protein
% 211.07/211.24  |- mesh__dateEstablished mesh__D050784 2006-01-01
% 211.07/211.24  |- skos__altLabel mesh__D050784 Ets-1 Transcription Factor
% 211.07/211.24  |- skos__altLabel mesh__D050784 Proto-Oncogene Protein ets-1
% 211.07/211.24  |- mesh__recordMaintainer mesh__D050784 jmp
% 211.07/211.24  |- skos__hiddenLabel mesh__D050784 c ets1 Transcription Factor
% 211.07/211.24  |- skos__hiddenLabel mesh__D050784 Proto Oncogene Protein c ets 1
% 211.07/211.24  |- skos__historyNote mesh__D050784 Transcription Factors %28%1986-2005%29%
% 211.07/211.24  |- mesh__recordOriginator mesh__D050784 jmp
% 211.07/211.24  |- skos__altLabel mesh__D050784 c-ets-1 Protein
% 211.07/211.24  |- skos__hiddenLabel mesh__D050784 Ets 1 Transcription Factor
% 211.07/211.24  |- skos__prefLabel mesh__D050784 Proto-Oncogene Protein c-ets-1
% 211.07/211.24  |- mesh__dateCreated mesh__D050784 2005-06-30
% 211.07/211.24  |- skos__hiddenLabel mesh__D050784 Proto Oncogene Proteins c ets 1
% 211.07/211.24  |- mesh__historyNote mesh__D050784 2006%28%1986%29%   
% 211.07/211.25  |- skos__hiddenLabel mesh__D050784 Transcription Factor, c-ets1
% 211.07/211.25  |- skos__broader mesh__D050784smesh__D050783
% 211.07/211.25  |- skos__hiddenLabel mesh__D050784 Proto Oncogene Protein ets 1
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D050784 2006
% 211.07/211.25  |- skos__hiddenLabel mesh__D050784 Transcription Factor, Ets-1
% 211.07/211.25  |- rdf__type mesh__D050784sskos__Concept
% 211.07/211.25  |- skos__altLabel mesh__D050784 Proto-Oncogene Proteins c-ets-1
% 211.07/211.25  |- skos__altLabel mesh__D050784 c-ets1 Transcription Factor
% 211.07/211.25  |- mesh__publicMeSHNote mesh__D050784
% 211.07/211.25       2006; PROTO-ONCOGENE PROTEINS C-ETS-1 was indexed under PROTO-ONCOGENE PROTEINS %26% TRANSCRIPTION FACTORS 1986-2005%A%  
% 211.07/211.25  |- skos__historyNote mesh__D050784
% 211.07/211.25       Proto-Oncogene Proteins %28%1986-2005%29%
% 211.07/211.25  |- mesh__recordAuthorizer mesh__D050784 sjn
% 211.07/211.25  |- skos__hiddenLabel mesh__D050784 c-ets-1, Proto-Oncogene Proteins
% 211.07/211.25  |- skos__hiddenLabel mesh__D050784 ets-1, Proto-Oncogene Protein
% 211.07/211.25  |- skos__hiddenLabel mesh__D050784 c-ets-1, Proto-Oncogene Protein
% 211.07/211.25  |- skos__annotation mesh__D050784 see SCR for organism-specific terms   
% 211.07/211.25  |- skos__scopeNote mesh__D050784
% 211.07/211.25       An ets proto-oncogene expressed primarily in adult LYMPHOID TISSUE; BRAIN; and VASCULAR ENDOTHELIAL CELLS.%A%    
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D003330 2005
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D003330 2000
% 211.07/211.25  |- mesh__dateCreated mesh__D003330 1999-01-01
% 211.07/211.25  |- skos__broader mesh__D003330smesh__D006330
% 211.07/211.25  |- skos__hiddenLabel mesh__D003330 Coronary Vessel Anomaly
% 211.07/211.25  |- mesh__recordOriginator mesh__D003330 NLM
% 211.07/211.25  |- skos__hiddenLabel mesh__D003330 Anomalies, Coronary Vessel
% 211.07/211.25  |- skos__scopeNote mesh__D003330
% 211.07/211.25       Defects of coronary arteries or veins including anomalous origin, arteriovenous fistula or aneurysm, myocardial bridging, or other abnormalities of structure or development.%A%    
% 211.07/211.25  |- mesh__recordAuthorizer mesh__D003330 sjn
% 211.07/211.25  |- mesh__recordMaintainer mesh__D003330 kle
% 211.07/211.25  |- rdf__type mesh__D003330sskos__Concept
% 211.07/211.25  |- mesh__dateRevised mesh__D003330 1999-11-03
% 211.07/211.25  |- skos__prefLabel mesh__D003330 Coronary Vessel Anomalies
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D003330 2002
% 211.07/211.25  |- skos__annotation mesh__D003330
% 211.07/211.25       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 211.07/211.25  |- skos__hiddenLabel mesh__D003330 Anomaly, Coronary Vessel
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D003330 2004
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D003330 2001
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D003330 2006
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D003330 2003
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 Genes, v-mos
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 mos Gene
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 v mos Oncogenes
% 211.07/211.25  |- skos__historyNote mesh__D016258 Oncogenes %28%1983-1985%29%
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 c-mos Gene
% 211.07/211.25  |- skos__altLabel mesh__D016258 mos Genes
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 mos Oncogene
% 211.07/211.25  |- mesh__dateRevised mesh__D016258 2005-06-30
% 211.07/211.25  |- mesh__recordMaintainer mesh__D016258 nns
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 Oncogenes, v-mos
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 Proto-Oncogenes, mos
% 211.07/211.25  |- skos__scopeNote mesh__D016258
% 211.07/211.25       Retrovirus-associated DNA sequences %28%mos%29% originally isolated from the Moloney murine sarcoma virus %28%Mo-MSV%29%. The proto-oncogene mos %28%c-mos%29% codes for a protein which is a member of the serine kinase family. There is no evidence as yet that human c-mos can become transformed or has a role in human cancer. However, in mice, activation can occur when the retrovirus-like intracisternal A-particle inserts itself near the c-mos sequence. The human c-mos gene is located at 8q22 on the long arm of chromosome 8.%A%    
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 c mos Proto Oncogenes
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 c mos Genes
% 211.07/211.25  |- mesh__recordAuthorizer mesh__D016258 sjn
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 mos Proto-Oncogene
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 mos Proto Oncogenes
% 211.07/211.25  |- skos__historyNote mesh__D016258 Proto-Oncogenes %28%1986-1990%29%
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 v-mos Oncogene
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 Proto-Oncogenes, c-mos
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 Oncogene, v-mos
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 c-mos Proto-Oncogene
% 211.07/211.25  |- mesh__dateCreated mesh__D016258 1990-05-07
% 211.07/211.25  |- skos__annotation mesh__D016258 mos stands for %22%MOloney Sarcoma%22%   
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D016258 2006
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 v-mos Gene
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 v mos Genes
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 Oncogenes, mos
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 Gene, c-mos
% 211.07/211.25  |- skos__broader mesh__D016258smesh__D011519
% 211.07/211.25  |- mesh__historyNote mesh__D016258 91   
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 Proto-Oncogene, c-mos
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 Gene, mos
% 211.07/211.25  |- skos__prefLabel mesh__D016258 Genes, mos
% 211.07/211.25  |- mesh__dateEstablished mesh__D016258 1991-01-01
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 Gene, v-mos
% 211.07/211.25  |- mesh__publicMeSHNote mesh__D016258 91   
% 211.07/211.25  |- skos__related mesh__D016258smesh__D007426
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 Proto-Oncogene, mos
% 211.07/211.25  |- rdf__type mesh__D016258sskos__Concept
% 211.07/211.25  |- mesh__recordOriginator mesh__D016258 AGS
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 Oncogene, mos
% 211.07/211.25  |- skos__historyNote mesh__D016258 Genes, Viral %28%1982%29%
% 211.07/211.25  |- skos__hiddenLabel mesh__D016258 Genes, c-mos
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D002238 2004
% 211.07/211.25  |- mesh__recordAuthorizer mesh__D002238 sjn
% 211.07/211.25  |- mesh__recordOriginator mesh__D002238 NLM
% 211.07/211.25  |- skos__hiddenLabel mesh__D002238 Epimerases, Carbohydrate
% 211.07/211.25  |- skos__altLabel mesh__D002238 Carbohydrate Isomerases
% 211.07/211.25  |- mesh__publicMeSHNote mesh__D002238 73   
% 211.07/211.25  |- mesh__historyNote mesh__D002238 73   
% 211.07/211.25  |- mesh__dateRevised mesh__D002238 2003-07-09
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D002238 2006
% 211.07/211.25  |- skos__historyNote mesh__D002238 Isomerases %28%1966-1972%29%
% 211.07/211.25  |- skos__hiddenLabel mesh__D002238 Isomerases, Carbohydrate
% 211.07/211.25  |- skos__prefLabel mesh__D002238 Carbohydrate Epimerases
% 211.07/211.25  |- rdf__type mesh__D002238sskos__Concept
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D002238 2005
% 211.07/211.25  |- mesh__dateCreated mesh__D002238 1999-01-01
% 211.07/211.25  |- skos__scopeNote mesh__D002238
% 211.07/211.25       Enzymes that catalyze the epimerization of chiral centers within carbohydrates or their derivatives. EC 5.1.3.%A%    
% 211.07/211.25  |- mesh__dateEstablished mesh__D002238 1973-01-01
% 211.07/211.25  |- skos__broader mesh__D002238smesh__D019998
% 211.07/211.25  |- mesh__recordMaintainer mesh__D002238 ssb
% 211.07/211.25  |- mesh__publicMeSHNote mesh__D007721
% 211.07/211.25       79; was KNOWLEDGE OF RESULTS 1965-78   
% 211.07/211.25  |- mesh__onlineNote mesh__D007721
% 211.07/211.25       use KNOWLEDGE OF RESULTS %28%PSYCHOLOGY%29% to search KNOWLEDGE OF RESULTS 1966-78%A%  
% 211.07/211.25  |- mesh__dateEstablished mesh__D007721 1965-01-01
% 211.07/211.25  |- skos__hiddenLabel mesh__D007721 Results Knowledge %28%Psychology%29%
% 211.07/211.25  |- skos__annotation mesh__D007721 no qualif; DF: KNOWLEDGE OF RESULTS   
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D007721 2001
% 211.07/211.25  |- skos__broader mesh__D007721smesh__D012054
% 211.07/211.25  |- skos__related mesh__D007721smesh__D005246
% 211.07/211.25  |- rdf__type mesh__D007721sskos__Concept
% 211.07/211.25  |- mesh__recordOriginator mesh__D007721 NLM
% 211.07/211.25  |- skos__scopeNote mesh__D007721
% 211.07/211.25       A principle that learning is facilitated when the learner receives immediate evaluation of learning performance. The concept also hypothesizes that learning is facilitated when the learner is promptly informed whether a response is correct, and, if incorrect, of the direction of error.%A%    
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D007721 2000
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D007721 2004
% 211.07/211.25  |- mesh__dateCreated mesh__D007721 1999-01-01
% 211.07/211.25  |- skos__prefLabel mesh__D007721 Knowledge of Results %28%Psychology%29%
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D007721 2006
% 211.07/211.25  |- mesh__historyNote mesh__D007721 79; was KNOWLEDGE OF RESULTS 1965-78   
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D007721 2003
% 211.07/211.25  |- mesh__recordMaintainer mesh__D007721 jls
% 211.07/211.25  |- mesh__recordAuthorizer mesh__D007721 sjn
% 211.07/211.25  |- mesh__dateRevised mesh__D007721 1999-11-03
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D007721 2005
% 211.07/211.25  |- skos__altLabel mesh__D007721 Knowledge of Results
% 211.07/211.25  |- skos__hiddenLabel mesh__D007721 Results Knowledges %28%Psychology%29%
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D007721 2002
% 211.07/211.25  |- skos__broader mesh__D012601Q000031smesh__D012601
% 211.07/211.25  |- mesh__preferredCombination mesh__D012601Q000031smesh__D012602
% 211.07/211.25  |- rdf__type mesh__D012601Q000031smesh__CompoundConcept
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D026686 2005
% 211.07/211.25  |- skos__prefLabel mesh__D026686 Beneficence
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D026686 2004
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D026686 2002
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D026686 2006
% 211.07/211.25  |- skos__historyNote mesh__D026686 Altruism %28%1974-2001%29%
% 211.07/211.25  |- skos__related mesh__D026686smesh__D026706
% 211.07/211.25  |- skos__altLabel mesh__D026686 Benevolence
% 211.07/211.25  |- skos__related mesh__D026686smesh__D000533
% 211.07/211.25  |- rdf__type mesh__D026686sskos__Concept
% 211.07/211.25  |- mesh__dateCreated mesh__D026686 2001-07-25
% 211.07/211.25  |- skos__broader mesh__D026686smesh__D028662
% 211.07/211.25  |- mesh__historyNote mesh__D026686 2002; use ALTRUISM 1978-2001   
% 211.07/211.25  |- mesh__dateEstablished mesh__D026686 2002-01-01
% 211.07/211.25  |- skos__scopeNote mesh__D026686
% 211.07/211.25       The state or quality of being kind, charitable, or beneficial. %28%from American Heritage Dictionary of the English Language, 4th ed%29%. The ethical principle of BENEFICENCE requires producing net benefit over harm. %28%Bioethics Thesaurus%29%%A%    
% 211.07/211.25  |- mesh__publicMeSHNote mesh__D026686 2002; see ALTRUISM 1978-2001   
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D026686 2003
% 211.07/211.25  |- skos__broader mesh__D012666smesh__D004581
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D012666 1997
% 211.07/211.25  |- mesh__recordOriginator mesh__D012666 NLM
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D012666 2005
% 211.07/211.25  |- rdf__type mesh__D012666sskos__Concept
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D012666 2000
% 211.07/211.25  |- mesh__dateRevised mesh__D012666 1992-05-18
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D012666 1996
% 211.07/211.25  |- mesh__publicMeSHNote mesh__D012666 73   
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D012666 2004
% 211.07/211.25  |- skos__prefLabel mesh__D012666 Semiconductors
% 211.07/211.25  |- skos__annotation mesh__D012666 NIM   
% 211.07/211.25  |- skos__hiddenLabel mesh__D012666 Semiconductor
% 211.07/211.25  |- mesh__historyNote mesh__D012666
% 211.07/211.25       73%28%67%29%; was in Cat H %26% J 1967-82   
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D012666 2003
% 211.07/211.25  |- mesh__recordAuthorizer mesh__D012666 PLS
% 211.07/211.25  |- mesh__dateCreated mesh__D012666 1999-01-01
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D012666 1995
% 211.07/211.25  |- skos__historyNote mesh__D012666 Electronics %28%1966%29%
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D012666 1999
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D012666 1994
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D012666 2002
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D012666 1998
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D012666 2006
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D012666 1993
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D012666 2001
% 211.07/211.25  |- skos__historyNote mesh__D012666 Electricity %28%1966%29%
% 211.07/211.25  |- mesh__dateEstablished mesh__D012666 1973-01-01
% 211.07/211.25  |- mesh__recordMaintainer mesh__D012666 TAP
% 211.07/211.25  |- mesh__dateCreated mesh__D045042 2003-07-09
% 211.07/211.25  |- skos__prefLabel mesh__D045042 Pedunculopontine Tegmental Nucleus
% 211.07/211.25  |- mesh__dateEstablished mesh__D045042 2004-01-01
% 211.07/211.25  |- mesh__publicMeSHNote mesh__D045042 2004   
% 211.07/211.25  |- skos__historyNote mesh__D045042 Mesencephalon %28%1980-2003%29%
% 211.07/211.25  |- skos__broader mesh__D045042smesh__D013681
% 211.07/211.25  |- skos__historyNote mesh__D045042 Tegmentum Mesencephali %28%1980-2003%29%
% 211.07/211.25  |- skos__scopeNote mesh__D045042
% 211.07/211.25       Dense collection of cells in the caudal pontomesencephalic tegmentum known to play a role in the functional organization of the BASAL GANGLIA and in the modulation of the thalamocortical neuronal system.%A%    
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D045042 2005
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D045042 2004
% 211.07/211.25  |- skos__hiddenLabel mesh__D045042 Tegmental Nucleus, Pedunculopontine
% 211.07/211.25  |- mesh__historyNote mesh__D045042 2004   
% 211.07/211.25  |- skos__hiddenLabel mesh__D045042 Nucleus, Pedunculopontine Tegmental
% 211.07/211.25  |- rdf__type mesh__D045042sskos__Concept
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D045042 2006
% 211.07/211.25  |- skos__altLabel mesh__D045042 Nucleus tegmentalis pedunculopontinus
% 211.07/211.25  |- skos__scopeNote mesh__D006629
% 211.07/211.25       Single-chain polypeptides of about 65 amino acids %28%7 kDa%29% from LEECHES that have a neutral hydrophobic N terminus, an acidic hydrophilic C terminus, and a compact, hydrophobic core region. Recombinant hirudins lack tyr-63 sulfation so are referred to as %27%desulfato-hirudins%27%. They form a stable non-covalent complex with ALPHA-THROMBIN, thereby abolishing its ability to cleave FIBRINOGEN.%A%    
% 211.07/211.25  |- skos__broader mesh__D006629smesh__D000991
% 211.07/211.25  |- mesh__historyNote mesh__D006629 2005%28%1963%29%   
% 211.07/211.25  |- mesh__dateRevised mesh__D006629 2004-08-06
% 211.07/211.25  |- mesh__recordOriginator mesh__D006629 NLM
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D006629 2006
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D006629 2005
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D006629 2005B
% 211.07/211.25  |- mesh__recordMaintainer mesh__D006629 jls
% 211.07/211.25  |- rdf__type mesh__D006629sskos__Concept
% 211.07/211.25  |- mesh__dateCreated mesh__D006629 1999-01-01
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D006629 2005A
% 211.07/211.25  |- mesh__recordAuthorizer mesh__D006629 jls
% 211.07/211.25  |- skos__prefLabel mesh__D006629 Hirudins
% 211.07/211.25  |- mesh__publicMeSHNote mesh__D006629 2005; see HIRUDIN 1963-2004   
% 211.07/211.25  |- mesh__recordMaintainer mesh__D017351 ssb
% 211.07/211.25  |- skos__hiddenLabel mesh__D017351 Transferases, N-Acetylglucosamine
% 211.07/211.25  |- mesh__publicMeSHNote mesh__D017351 93   
% 211.07/211.25  |- mesh__recordOriginator mesh__D017351 TPW
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D017351 2005
% 211.07/211.25  |- mesh__historyNote mesh__D017351 93   
% 211.07/211.25  |- skos__historyNote mesh__D017351 Glucosyltransferases %28%1966-1992%29%
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D017351 2004
% 211.07/211.25  |- rdf__type mesh__D017351sskos__Concept
% 211.07/211.25  |- skos__altLabel mesh__D017351 N-Acetylglucosamine Transferases
% 211.07/211.25  |- skos__prefLabel mesh__D017351 N-Acetylglucosaminyltransferases
% 211.07/211.25  |- mesh__dateCreated mesh__D017351 1992-05-22
% 211.07/211.25  |- mesh__dateRevised mesh__D017351 2003-07-09
% 211.07/211.25  |- mesh__recordAuthorizer mesh__D017351 sjn
% 211.07/211.25  |- mesh__dateEstablished mesh__D017351 1993-01-01
% 211.07/211.25  |- skos__scopeNote mesh__D017351
% 211.07/211.25       Enzymes that catalyze the transfer of N-acetylglucosamine from a nucleoside diphosphate N-acetylglucosamine to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-.%A%    
% 211.07/211.25  |- skos__broader mesh__D017351smesh__D017349
% 211.07/211.25  |- skos__hiddenLabel mesh__D017351 N Acetylglucosamine Transferases
% 211.07/211.25  |- skos__hiddenLabel mesh__D017351 N Acetylglucosaminyltransferases
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D017351 2006
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D031022 2004
% 211.07/211.25  |- rdf__type mesh__D031022sskos__Concept
% 211.07/211.25  |- mesh__dateEstablished mesh__D031022 2003-01-01
% 211.07/211.25  |- skos__scopeNote mesh__D031022
% 211.07/211.25       A plant genus of the family ANACARDIACEAE best known for the edible fruit.%A%    
% 211.07/211.25  |- skos__annotation mesh__D031022
% 211.07/211.25       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D031022 2003
% 211.07/211.25  |- mesh__historyNote mesh__D031022 2003   
% 211.07/211.25  |- skos__broader mesh__D031022smesh__D027926
% 211.07/211.25  |- mesh__dateCreated mesh__D031022 2002-07-03
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D031022 2006
% 211.07/211.25  |- mesh__publicMeSHNote mesh__D031022 2003   
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D031022 2005
% 211.07/211.25  |- skos__prefLabel mesh__D031022 Mangifera
% 211.07/211.25  |- mesh__historyNote mesh__D050785
% 211.07/211.25       2006; use HYPOTHERMIA, INDUCED 1984-2005   
% 211.07/211.25  |- skos__historyNote mesh__D050785 Anesthesia %28%1968-2005%29%
% 211.07/211.25  |- mesh__recordOriginator mesh__D050785 lkt
% 211.07/211.25  |- mesh__recordMaintainer mesh__D050785 lkt
% 211.07/211.25  |- mesh__publicMeSHNote mesh__D050785
% 211.07/211.25       2006; see HYPOTHERMIA, INDUCED 1984-2005   
% 211.07/211.25  |- mesh__recordAuthorizer mesh__D050785 sjn
% 211.07/211.25  |- skos__broader mesh__D050785smesh__D000758
% 211.07/211.25  |- skos__prefLabel mesh__D050785 Cryoanesthesia
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D050785 2006
% 211.07/211.25  |- mesh__dateEstablished mesh__D050785 2006-01-01
% 211.07/211.25  |- skos__scopeNote mesh__D050785
% 211.07/211.25       ANESTHESIA achieved by lowering either BODY TEMPERATURE %28%core cooling%29% or SKIN TEMPERATURE %28%external cooling%29%.%A%    
% 211.07/211.25  |- skos__altLabel mesh__D050785 Refrigeration Anesthesia
% 211.07/211.25  |- rdf__type mesh__D050785sskos__Concept
% 211.07/211.25  |- mesh__dateCreated mesh__D050785 2005-06-30
% 211.07/211.25  |- skos__altLabel mesh__D050785 Anesthesia, Refrigeration
% 211.07/211.25  |- rdf__type mesh__D003331sskos__Concept
% 211.07/211.25  |- skos__hiddenLabel mesh__D003331 Sinus Node Arteries
% 211.07/211.25  |- skos__scopeNote mesh__D003331 The veins and arteries of the HEART.     
% 211.07/211.25  |- skos__hiddenLabel mesh__D003331 Arteries, Coronary
% 211.07/211.25  |- skos__hiddenLabel mesh__D003331 Arteries, Sinus Node
% 211.07/211.25  |- skos__prefLabel mesh__D003331 Coronary Vessels
% 211.07/211.25  |- skos__hiddenLabel mesh__D003331 Artery, Coronary
% 211.07/211.25  |- skos__hiddenLabel mesh__D003331 Vessels, Coronary
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D003331 2006
% 211.07/211.25  |- skos__hiddenLabel mesh__D003331 Artery, Sinus Node
% 211.07/211.25  |- mesh__recordOriginator mesh__D003331 NLM
% 211.07/211.25  |- skos__hiddenLabel mesh__D003331 Coronary Vessel
% 211.07/211.25  |- mesh__dateRevised mesh__D003331 2005-06-30
% 211.07/211.25  |- skos__broader mesh__D003331smesh__D014680
% 211.07/211.25  |- mesh__recordMaintainer mesh__D003331 ags
% 211.07/211.25  |- skos__annotation mesh__D003331
% 211.07/211.25       consider also CORONARY CIRCULATION; /surg: consider also CORONARY ARTERY BYPASS%A%  
% 211.07/211.25  |- skos__hiddenLabel mesh__D003331 Vessel, Coronary
% 211.07/211.25  |- mesh__dateCreated mesh__D003331 1999-01-01
% 211.07/211.25  |- mesh__recordAuthorizer mesh__D003331 sjn
% 211.07/211.25  |- skos__related mesh__D003331smesh__D001026
% 211.07/211.25  |- skos__hiddenLabel mesh__D003331 Coronary Artery
% 211.07/211.25  |- skos__broader mesh__D003331smesh__D001158
% 211.07/211.25  |- skos__prefLabel mesh__D016259 Genes, myc
% 211.07/211.25  |- skos__historyNote mesh__D016259 Oncogenes %28%1983-1990%29%
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 Gene, N-myc
% 211.07/211.25  |- mesh__dateRevised mesh__D016259 2005-06-30
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 c myc Proto Oncogenes
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 Proto-Oncogenes, N-myc
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 Oncogene, myc
% 211.07/211.25  |- mesh__dateEstablished mesh__D016259 1991-01-01
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 Genes, c-myc
% 211.07/211.25  |- mesh__recordOriginator mesh__D016259 AGS
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 Oncogene, v-myc
% 211.07/211.25  |- mesh__recordAuthorizer mesh__D016259 sjn
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 v-myc Oncogene
% 211.07/211.25  |- skos__related mesh__D016259smesh__D016271
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D016259 2006
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 L myc Proto Oncogenes
% 211.07/211.25  |- mesh__recordMaintainer mesh__D016259 nns
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 L-myc Gene
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 v myc Oncogenes
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 Proto-Oncogene, N-myc
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 Proto-Oncogenes, c-myc
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 c-myc Proto-Oncogene
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 Proto-Oncogene, c-myc
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 N-myc Proto-Oncogene
% 211.07/211.25  |- mesh__dateCreated mesh__D016259 1990-06-28
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 myc Oncogenes
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 N myc Proto Oncogenes
% 211.07/211.25  |- mesh__historyNote mesh__D016259
% 211.07/211.25       91; was MYC GENES see ONCOGENES 1985-90   
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 N-myc Gene
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 Gene, myc
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 Genes, N-myc
% 211.07/211.25  |- skos__historyNote mesh__D016259 Genes, Viral %28%1982%29%
% 211.07/211.25  |- mesh__onlineNote mesh__D016259
% 211.07/211.25       use ONCOGENES to search MYC GENES 1985-90   
% 211.07/211.25  |- skos__broader mesh__D016259smesh__D011519
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 v-myc Gene
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 v myc Genes
% 211.07/211.25  |- rdf__type mesh__D016259sskos__Concept
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 Gene, L-myc
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 Genes, L-myc
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 c myc Genes
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 Genes, v-myc
% 211.07/211.25  |- mesh__publicMeSHNote mesh__D016259
% 211.07/211.25       91; was MYC GENES see ONCOGENES 1985-90   
% 211.07/211.25  |- skos__altLabel mesh__D016259 myc Genes
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 Gene, v-myc
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 N myc Genes
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 Oncogenes, myc
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 L-myc Proto-Oncogene
% 211.07/211.25  |- skos__annotation mesh__D016259
% 211.07/211.25       myc stands for %22%MYeloCytomatosis%22%   
% 211.07/211.25  |- skos__related mesh__D016259smesh__D016274
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 Proto-Oncogene, L-myc
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 Gene, c-myc
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 Oncogenes, v-myc
% 211.07/211.25  |- skos__scopeNote mesh__D016259
% 211.07/211.25       Family of retrovirus-associated DNA sequences %28%myc%29% originally isolated from an avian myelocytomatosis virus. The proto-oncogene myc %28%c-myc%29% codes for a nuclear protein which is involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Truncation of the first exon, which appears to regulate c-myc expression, is crucial for tumorigenicity. The human c-myc gene is located at 8q24 on the long arm of chromosome 8.%A%    
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 c-myc Gene
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 L myc Genes
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 myc Gene
% 211.07/211.25  |- skos__hiddenLabel mesh__D016259 Proto-Oncogenes, L-myc
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D002239 2006
% 211.07/211.25  |- skos__prefLabel mesh__D002239 Carbohydrate Metabolism, Inborn Errors
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D002239 2002
% 211.07/211.25  |- rdf__type mesh__D002239sskos__Concept
% 211.07/211.25  |- mesh__publicMeSHNote mesh__D002239 65   
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D002239 2005
% 211.07/211.25  |- mesh__dateCreated mesh__D002239 1999-01-01
% 211.07/211.25  |- mesh__recordMaintainer mesh__D002239 nns
% 211.07/211.25  |- mesh__recordAuthorizer mesh__D002239 sjn
% 211.07/211.25  |- mesh__historyNote mesh__D002239 65   
% 211.07/211.25  |- mesh__dateRevised mesh__D002239 2001-07-25
% 211.07/211.25  |- mesh__recordOriginator mesh__D002239 NLM
% 211.07/211.25  |- skos__annotation mesh__D002239
% 211.07/211.25       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific carbohydrate /metab %28%IM%29%; FRUCTOSE METABOLISM, INBORN ERRORS %26% PYRUVATE METABOLISM, INBORN ERRORS are also available; DF: CARB METAB INBORN ERR%A%  
% 211.07/211.25  |- skos__broader mesh__D002239smesh__D008661
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D002239 2004
% 211.07/211.25  |- skos__altLabel mesh__D002239 Carbohydrate Metabolism, Inborn Error
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D002239 2003
% 211.07/211.25  |- mesh__dateEstablished mesh__D002239 1965-01-01
% 211.07/211.25  |- rdf__type mesh__D007722sskos__Concept
% 211.07/211.25  |- skos__annotation mesh__D007722
% 211.07/211.25       examples include FAMILY PLANNING; knowledge of physicians see CLINICAL COMPETENCE; do not use for knowledge or attitude or practice in psychol literature %28% = possibly KNOWLEDGE OF RESULTS or ATTITUDE or PRACTICE %28%PSYCHOLOGY%29% %29%; DF: KAP%A%  
% 211.07/211.25  |- mesh__dateCreated mesh__D007722 1974-11-11
% 211.07/211.25  |- skos__scopeNote mesh__D007722
% 211.07/211.25       Knowledge, attitudes, and associated behaviors which pertain to health-related topics such as PATHOLOGIC PROCESSES or diseases, their prevention, and treatment. This term refers to non-health workers and health workers %28%HEALTH PERSONNEL%29%.%A%    
% 211.07/211.25  |- skos__prefLabel mesh__D007722 Health Knowledge, Attitudes, Practice
% 211.07/211.25  |- skos__broader mesh__D007722smesh__D001294
% 211.07/211.25  |- mesh__publicMeSHNote mesh__D007722
% 211.07/211.25       %60%2004; see KNOWLEDGE ATTITUDES PRACTICE 1975-2003   
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D007722 2004
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D007722 2006
% 211.07/211.25  |- skos__altLabel mesh__D007722 Knowledge, Attitudes, Practice
% 211.07/211.25  |- mesh__historyNote mesh__D007722 2004 %28%1975%29%   
% 211.07/211.25  |- mesh__recordOriginator mesh__D007722 NLM
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D007722 2005
% 211.07/211.25  |- mesh__dateEstablished mesh__D007722 1990-01-01
% 211.07/211.25  |- mesh__recordMaintainer mesh__D007722 lkt
% 211.07/211.25  |- mesh__recordAuthorizer mesh__D007722 sjn
% 211.07/211.25  |- mesh__dateRevised mesh__D007722 2003-07-09
% 211.07/211.25  |- skos__altLabel mesh__D051080 Malonyl-CoA-ACP-Transacylase
% 211.07/211.25  |- skos__altLabel mesh__D051080
% 211.07/211.25       Malonyl Coenzyme A-Acyl Carrier Protein Transacylase
% 211.07/211.25  |- skos__altLabel mesh__D051080 Malonyl CoA Transferase
% 211.07/211.25  |- skos__altLabel mesh__D051080
% 211.07/211.25       %28%Acyl-Carrier-Protein%29% S-Malonyltransferase
% 211.07/211.25  |- skos__altLabel mesh__D051080 Malonyl Coenzyme A Transferase
% 211.07/211.25  |- mesh__historyNote mesh__D051080
% 211.07/211.25       2006%28%1980%29%; use ACYLTRANSFERASES %26% CARRIER PROTEINS 1973-1979%A%  
% 211.07/211.25  |- skos__hiddenLabel mesh__D051080
% 211.07/211.25       Malonyl Coenzyme A Acyl Carrier Protein Transacylase
% 211.07/211.25  |- skos__hiddenLabel mesh__D051080
% 211.07/211.25       S-Malonyltransferase, Acyl-Carrier Protein
% 211.07/211.25  |- mesh__recordMaintainer mesh__D051080 ags
% 211.07/211.25  |- skos__broader mesh__D051080smesh__D000217
% 211.07/211.25  |- skos__prefLabel mesh__D051080 Acyl-Carrier Protein S-Malonyltransferase
% 211.07/211.25  |- rdf__type mesh__D051080sskos__Concept
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D051080 2006A
% 211.07/211.25  |- skos__scopeNote mesh__D051080
% 211.07/211.25       This enzyme catalyzes the transacylation of malonate from MALONYL CoA to activated holo-ACP, to generate malonyl-%28%acyl-carrier protein%29%, which is an elongation substrate in FATTY ACIDS biosynthesis. It is an essential enzyme in the biosynthesis of FATTY ACIDS in all BACTERIA.%A%    
% 211.07/211.25  |- skos__hiddenLabel mesh__D051080
% 211.07/211.25       Acyl Carrier Protein S Malonyltransferase
% 211.07/211.25  |- skos__hiddenLabel mesh__D051080 Malonyl CoA ACP Transacylase
% 211.07/211.25  |- mesh__publicMeSHNote mesh__D051080
% 211.07/211.25       2006; %28%ACYL-CARRIER PROTEIN%29% MALONYLTRANSFERASE was indexed under ACYLTRANSFERASES 1973-2005, %26% under CARRIER PROTEINS 1973-1979%A%  
% 211.07/211.25  |- mesh__dateCreated mesh__D051080 2005-06-30
% 211.07/211.25  |- skos__hiddenLabel mesh__D051080 Transacylase, Malonyl
% 211.07/211.25  |- mesh__dateEstablished mesh__D051080 2006-01-01
% 211.07/211.25  |- mesh__activeMeSHYear mesh__D051080 2006
% 211.07/211.25  |- mesh__recordOriginator mesh__D051080 AKE
% 211.07/211.25  |- skos__hiddenLabel mesh__D051080 Transferase, Malonyl CoA
% 211.07/211.25  |- skos__altLabel mesh__D051080
% 211.07/211.25       %28%Acyl-Carrier-Protein%29% Malonyltransferase
% 211.07/211.26  |- skos__hiddenLabel mesh__D051080 CoA Transferase, Malonyl
% 211.07/211.26  |- skos__altLabel mesh__D051080 Malonyl Transacylase
% 211.07/211.26  |- mesh__dateRevised mesh__D051080 2005-07-13
% 211.07/211.26  |- mesh__recordAuthorizer mesh__D051080 ags
% 211.07/211.26  |- skos__broader mesh__D012667smesh__D002348
% 211.07/211.26  |- skos__hiddenLabel mesh__D012667 Lunate Bones
% 211.07/211.26  |- skos__prefLabel mesh__D012667 Lunate Bone
% 211.07/211.26  |- mesh__recordAuthorizer mesh__D012667 ags
% 211.07/211.26  |- skos__altLabel mesh__D012667 Semilunar Bone
% 211.07/211.26  |- mesh__recordOriginator mesh__D012667 NLM
% 211.07/211.26  |- mesh__dateCreated mesh__D012667 1999-01-01
% 211.07/211.26  |- mesh__recordMaintainer mesh__D012667 ags
% 211.07/211.26  |- skos__hiddenLabel mesh__D012667 Semilunar Bones
% 211.07/211.26  |- mesh__publicMeSHNote mesh__D012667 2006; see SEMILUNAR BONE 1963-2005   
% 211.07/211.26  |- skos__scopeNote mesh__D012667
% 211.07/211.26       A moon-shaped carpal bone which is located between the SCAPHOID BONE and TRIQUETRUM BONE.%A%    
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D012667 2006A
% 211.07/211.26  |- mesh__historyNote mesh__D012667 2006 %28%1963%29%   
% 211.07/211.26  |- skos__altLabel mesh__D012667 Os Lunatum
% 211.07/211.26  |- skos__hiddenLabel mesh__D012667 Bones, Lunate
% 211.07/211.26  |- mesh__dateRevised mesh__D012667 2005-08-02
% 211.07/211.26  |- skos__hiddenLabel mesh__D012667 Bone, Semilunar
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D012667 2006
% 211.07/211.26  |- skos__hiddenLabel mesh__D012667 Bone, Lunate
% 211.07/211.26  |- rdf__type mesh__D012667sskos__Concept
% 211.07/211.26  |- skos__hiddenLabel mesh__D012667 Bones, Semilunar
% 211.07/211.26  |- mesh__dateEstablished mesh__D031821 2003-01-01
% 211.07/211.26  |- skos__scopeNote mesh__D031821
% 211.07/211.26       A plant family of the order Najadales, subclass Alismatidae, class Liliopsida  %28%monocotyledons%29%.%A%    
% 211.07/211.26  |- mesh__publicMeSHNote mesh__D031821 2003   
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D031821 2006
% 211.07/211.26  |- skos__broader mesh__D031821smesh__D035961
% 211.07/211.26  |- mesh__historyNote mesh__D031821 2003   
% 211.07/211.26  |- skos__prefLabel mesh__D031821 Potamogetonaceae
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D031821 2005
% 211.07/211.26  |- rdf__type mesh__D031821sskos__Concept
% 211.07/211.26  |- mesh__dateCreated mesh__D031821 2002-07-03
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D031821 2004
% 211.07/211.26  |- skos__annotation mesh__D031821
% 211.07/211.26       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D031821 2003
% 211.07/211.26  |- mesh__recordAuthorizer mesh__D017352 SJN
% 211.07/211.26  |- skos__hiddenLabel mesh__D017352 Imagings, Echo-Planar
% 211.07/211.26  |- skos__altLabel mesh__D017352 Echoplanar Imaging
% 211.07/211.26  |- skos__hiddenLabel mesh__D017352 MR Tomography, Echo Planar
% 211.07/211.26  |- mesh__historyNote mesh__D017352 93   
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D017352 2006
% 211.07/211.26  |- skos__broader mesh__D017352smesh__D008279
% 211.07/211.26  |- skos__historyNote mesh__D017352
% 211.07/211.26       Nuclear Magnetic Resonance %28%1984-1987%29%
% 211.07/211.26  |- skos__hiddenLabel mesh__D017352 Echoplanar Imagings
% 211.07/211.26  |- skos__altLabel mesh__D017352 MR Tomography, Echo-Planar
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D017352 1999
% 211.07/211.26  |- skos__scopeNote mesh__D017352
% 211.07/211.26       A type of MAGNETIC RESONANCE IMAGING that uses only one nuclear spin excitation per image and therefore can obtain images in a fraction of a second rather than the minutes required in traditional MRI techniques. It is used in a variety of medical and scientific applications.%A%    
% 211.07/211.26  |- skos__altLabel mesh__D017352 Echo-Planar Magnetic Resonance Imaging
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D017352 2005
% 211.07/211.26  |- mesh__recordOriginator mesh__D017352 PXP
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D017352 2001
% 211.07/211.26  |- skos__altLabel mesh__D017352 Magnetic Resonance Imaging, Echoplanar
% 211.07/211.26  |- mesh__dateEstablished mesh__D017352 1993-01-01
% 211.07/211.26  |- skos__hiddenLabel mesh__D017352 Tomography, Echo-Planar MR
% 211.07/211.26  |- skos__hiddenLabel mesh__D017352 Imaging, Echoplanar
% 211.07/211.26  |- skos__historyNote mesh__D017352
% 211.07/211.26       Magnetic Resonance Imaging %28%1988-1992%29%
% 211.07/211.26  |- skos__altLabel mesh__D017352 Magnetic Resonance Imaging, Echo-Planar
% 211.07/211.26  |- rdf__type mesh__D017352sskos__Concept
% 211.07/211.26  |- skos__hiddenLabel mesh__D017352 Echo Planar Magnetic Resonance Imaging
% 211.07/211.26  |- skos__hiddenLabel mesh__D017352 Tomographies, Echo-Planar MR
% 211.07/211.26  |- skos__hiddenLabel mesh__D017352 Imagings, Echoplanar
% 211.07/211.26  |- mesh__dateCreated mesh__D017352 1992-05-08
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D017352 1998
% 211.07/211.26  |- skos__hiddenLabel mesh__D017352 Tomography, Echoplanar MR
% 211.07/211.26  |- skos__altLabel mesh__D017352 MR Tomography, Echoplanar
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D017352 2000
% 211.07/211.26  |- skos__hiddenLabel mesh__D017352 Echoplanar MR Tomographies
% 211.07/211.26  |- skos__altLabel mesh__D017352 Echoplanar MR Tomography
% 211.07/211.26  |- mesh__publicMeSHNote mesh__D017352 93   
% 211.07/211.26  |- skos__hiddenLabel mesh__D017352 Echo-Planar Imagings
% 211.07/211.26  |- skos__hiddenLabel mesh__D017352 Tomographies, Echoplanar MR
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D017352 2004
% 211.07/211.26  |- skos__hiddenLabel mesh__D017352 Echo Planar MR Tomography
% 211.07/211.26  |- skos__hiddenLabel mesh__D017352 Magnetic Resonance Imaging, Echo Planar
% 211.07/211.26  |- skos__hiddenLabel mesh__D017352 Echo-Planar MR Tomographies
% 211.07/211.26  |- mesh__recordMaintainer mesh__D017352 PXP
% 211.07/211.26  |- skos__altLabel mesh__D017352 Echoplanar Magnetic Resonance Imaging
% 211.07/211.26  |- skos__hiddenLabel mesh__D017352 MR Tomographies, Echo-Planar
% 211.07/211.26  |- mesh__dateRevised mesh__D017352 1997-06-20
% 211.07/211.26  |- skos__hiddenLabel mesh__D017352 MR Tomographies, Echoplanar
% 211.07/211.26  |- skos__hiddenLabel mesh__D017352 Imaging, Echo-Planar
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D017352 2003
% 211.07/211.26  |- skos__prefLabel mesh__D017352 Echo-Planar Imaging
% 211.07/211.26  |- skos__annotation mesh__D017352
% 211.07/211.26       a type of magnetic resonance imaging; for coord see note on MAGNETIC RESONANCE IMAGING%A%  
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D017352 2002
% 211.07/211.26  |- skos__hiddenLabel mesh__D017352 Echo Planar Imaging
% 211.07/211.26  |- rdf__type mesh__D031023sskos__Concept
% 211.07/211.26  |- skos__prefLabel mesh__D031023 Semecarpus
% 211.07/211.26  |- skos__annotation mesh__D031023
% 211.07/211.26       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.07/211.26  |- mesh__dateEstablished mesh__D031023 2003-01-01
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D031023 2005
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D031023 2006
% 211.07/211.26  |- skos__scopeNote mesh__D031023
% 211.07/211.26       A plant genus of the family ANACARDIACEAE that is the source of anacarcin forte. The nut milk extract is cytotoxic.%A%    
% 211.07/211.26  |- mesh__publicMeSHNote mesh__D031023 2003   
% 211.07/211.26  |- mesh__historyNote mesh__D031023 2003   
% 211.07/211.26  |- skos__broader mesh__D031023smesh__D027926
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D031023 2003
% 211.07/211.26  |- mesh__dateCreated mesh__D031023 2002-07-03
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D031023 2004
% 211.07/211.26  |- skos__broader mesh__D050786smesh__D007036
% 211.07/211.26  |- mesh__dateCreated mesh__D050786 2005-06-30
% 211.07/211.26  |- mesh__publicMeSHNote mesh__D050786
% 211.07/211.26       2006; see HYPOTHERMIA, INDUCED 1984-2005   
% 211.07/211.26  |- skos__hiddenLabel mesh__D050786 Cold Gastric Lavages
% 211.07/211.26  |- skos__hiddenLabel mesh__D050786 Gastric Lavage, Cold
% 211.07/211.26  |- skos__scopeNote mesh__D050786
% 211.07/211.26       A method of lowering core BODY TEMPERATURE by filling the STOMACH with chilled fluids.%A%    
% 211.07/211.26  |- skos__prefLabel mesh__D050786 Gastric Hypothermia
% 211.07/211.26  |- mesh__historyNote mesh__D050786
% 211.07/211.26       2006; use HYPOTHERMIA, INDUCED 1984-2005   
% 211.07/211.26  |- mesh__recordMaintainer mesh__D050786 lkt
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D050786 2006
% 211.07/211.26  |- skos__hiddenLabel mesh__D050786 Gastric Lavages, Cold
% 211.07/211.26  |- mesh__recordAuthorizer mesh__D050786 sjn
% 211.07/211.26  |- rdf__type mesh__D050786sskos__Concept
% 211.07/211.26  |- skos__altLabel mesh__D050786 Cold Gastric Lavage
% 211.07/211.26  |- skos__hiddenLabel mesh__D050786 Lavages, Cold Gastric
% 211.07/211.26  |- skos__hiddenLabel mesh__D050786 Lavage, Cold Gastric
% 211.07/211.26  |- skos__hiddenLabel mesh__D050786 Hypothermia, Gastric
% 211.07/211.26  |- mesh__dateEstablished mesh__D050786 2006-01-01
% 211.07/211.26  |- mesh__recordOriginator mesh__D050786 lkt
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D003332 2004
% 211.07/211.26  |- mesh__historyNote mesh__D003332 81; was CORONAVIRUSES 1974-80   
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D003332 2002
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D003332 2006
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D003332 2003
% 211.07/211.26  |- skos__broader mesh__D003332smesh__D028381
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D003332 2005
% 211.07/211.26  |- mesh__dateRevised mesh__D003332 2001-07-25
% 211.07/211.26  |- mesh__recordMaintainer mesh__D003332 ags
% 211.07/211.26  |- mesh__dateCreated mesh__D003332 1999-01-01
% 211.07/211.26  |- mesh__publicMeSHNote mesh__D003332 81; was CORONAVIRUSES 1974-80   
% 211.07/211.26  |- mesh__dateEstablished mesh__D003332 1974-01-01
% 211.07/211.26  |- skos__annotation mesh__D003332 infection = CORONAVIRIDAE INFECTIONS   
% 211.07/211.26  |- mesh__onlineNote mesh__D003332
% 211.07/211.26       use CORONAVIRIDAE to search CORONAVIRUSES 1974-80   
% 211.07/211.26  |- mesh__recordOriginator mesh__D003332 NLM
% 211.07/211.26  |- rdf__type mesh__D003332sskos__Concept
% 211.07/211.26  |- skos__scopeNote mesh__D003332
% 211.07/211.26       Spherical RNA viruses, in the order NIDOVIRALES, infecting a wide range of animals including humans. Transmission is by fecal-oral and respiratory routes. Mechanical transmission is also common. There are two genera: CORONAVIRUS and TOROVIRUS.%A%    
% 211.07/211.26  |- skos__prefLabel mesh__D003332 Coronaviridae
% 211.07/211.26  |- mesh__recordAuthorizer mesh__D003332 sjn
% 211.07/211.26  |- mesh__publicMeSHNote mesh__D013760
% 211.07/211.26       91; was see under HYDROCORTISONE 1973-90   
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D013760 2005
% 211.07/211.26  |- mesh__dateCreated mesh__D013760 1999-01-01
% 211.07/211.26  |- mesh__recordOriginator mesh__D013760 NLM
% 211.07/211.26  |- mesh__dateRevised mesh__D013760 2003-07-09
% 211.07/211.26  |- skos__annotation mesh__D013760
% 211.07/211.26       do not confuse with TETRAHYDROCORTISONE   
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D013760 2006
% 211.07/211.26  |- skos__broader mesh__D013760smesh__D011278
% 211.07/211.26  |- mesh__recordAuthorizer mesh__D013760 sjn
% 211.07/211.26  |- skos__broader mesh__D013760smesh__D015065
% 211.07/211.26  |- skos__prefLabel mesh__D013760 Tetrahydrocortisol
% 211.07/211.26  |- mesh__dateEstablished mesh__D013760 1991-01-01
% 211.07/211.26  |- rdf__type mesh__D013760sskos__Concept
% 211.07/211.26  |- mesh__historyNote mesh__D013760
% 211.07/211.26       91%28%73%29%; was see under HYDROCORTISONE 1973-90   
% 211.07/211.26  |- mesh__recordMaintainer mesh__D013760 ssb
% 211.07/211.26  |- skos__historyNote mesh__D013760 Hydrocortisone %28%1966-1972%29%
% 211.07/211.26  |- skos__broader mesh__D013760smesh__D015062
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D013760 2004
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D007723 1993
% 211.07/211.26  |- skos__broader mesh__D007723smesh__D005202
% 211.07/211.26  |- mesh__recordMaintainer mesh__D007723 PLS
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D007723 1996
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D007723 1995
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D007723 2003
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D007723 1998
% 211.07/211.26  |- skos__prefLabel mesh__D007723 Korea
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D007723 2005
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D007723 1992
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D007723 1994
% 211.07/211.26  |- mesh__recordAuthorizer mesh__D007723 PLS
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D007723 2002
% 211.07/211.26  |- rdf__type mesh__D007723sskos__Concept
% 211.07/211.26  |- skos__altLabel mesh__D007723 Korea, Democratic People%27%s Republic of
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D007723 2001
% 211.07/211.26  |- skos__altLabel mesh__D007723 South Korea
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D007723 1997
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D007723 2004
% 211.07/211.26  |- mesh__recordOriginator mesh__D007723 NLM
% 211.07/211.26  |- mesh__dateCreated mesh__D007723 1999-01-01
% 211.07/211.26  |- mesh__dateRevised mesh__D007723 1991-11-25
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D007723 2000
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D007723 1999
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D007723 2006
% 211.07/211.26  |- skos__related mesh__D026688smesh__D028701
% 211.07/211.26  |- skos__related mesh__D026688smesh__D005065
% 211.07/211.26  |- skos__hiddenLabel mesh__D026688 Issue, Bioethical
% 211.07/211.26  |- mesh__historyNote mesh__D026688 2002; use BIOETHICS 1978-2001   
% 211.07/211.26  |- mesh__publicMeSHNote mesh__D026688 2002; see BIOETHICS 1978-2001   
% 211.07/211.26  |- skos__broader mesh__D026688smesh__D004989
% 211.07/211.26  |- skos__historyNote mesh__D026688 Bioethics %28%1974-2001%29%
% 211.07/211.26  |- mesh__dateCreated mesh__D026688 2001-07-25
% 211.07/211.26  |- mesh__recordMaintainer mesh__D026688 jls
% 211.07/211.26  |- skos__related mesh__D026688smesh__D006805
% 211.07/211.26  |- mesh__dateEstablished mesh__D026688 2002-01-01
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D026688 2005
% 211.07/211.26  |- mesh__recordOriginator mesh__D026688 jrf
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D026688 2004
% 211.07/211.26  |- mesh__recordAuthorizer mesh__D026688 sjn
% 211.07/211.26  |- skos__hiddenLabel mesh__D026688 Issues, Bioethical
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D026688 2006
% 211.07/211.26  |- skos__related mesh__D026688smesh__D032761
% 211.07/211.26  |- skos__annotation mesh__D026688
% 211.07/211.26       used for discussions of several specific issues that fall within the domain of BIOETHICS but not for discussions of the field or discipline as such; BIOETHICS is available for the specialty and BIOETHICISTS see ETHICISTS is available for the person%A%  
% 211.07/211.26  |- skos__hiddenLabel mesh__D026688 Bioethical Issue
% 211.07/211.26  |- skos__prefLabel mesh__D026688 Bioethical Issues
% 211.07/211.26  |- skos__scopeNote mesh__D026688
% 211.07/211.26       Clusters of topics that fall within the domain of BIOETHICS, the field of study concerned with value questions that arise in biomedicine and health care delivery.%A%    
% 211.07/211.26  |- mesh__dateRevised mesh__D026688 2003-07-09
% 211.07/211.26  |- rdf__type mesh__D026688sskos__Concept
% 211.07/211.26  |- skos__hiddenLabel mesh__D051081 Acetylase, Glucosamine-6-Phosphate
% 211.07/211.26  |- skos__hiddenLabel mesh__D051081
% 211.07/211.26       Acetyltransferase, Glucosamine-6-Phosphate
% 211.07/211.26  |- skos__broader mesh__D051081smesh__D000123
% 211.07/211.26  |- mesh__historyNote mesh__D051081
% 211.07/211.26       2006%28%1980%29%; use ACETYLTRANSFERASES 1977-1979   
% 211.07/211.26  |- mesh__recordMaintainer mesh__D051081 AKE
% 211.07/211.26  |- mesh__dateEstablished mesh__D051081 2006-01-01
% 211.07/211.26  |- skos__hiddenLabel mesh__D051081 Glucosamine 6 Phosphate Acetylase
% 211.07/211.26  |- skos__altLabel mesh__D051081 Glucosamine-Phosphate Acetyltransferase
% 211.07/211.26  |- skos__hiddenLabel mesh__D051081
% 211.07/211.26       Glucosamine 6 Phosphate N Acetyltransferase
% 211.07/211.26  |- mesh__recordAuthorizer mesh__D051081 sjn
% 211.07/211.26  |- skos__scopeNote mesh__D051081
% 211.07/211.26       An enzyme that catalyses the reaction of D-glucosamine 6-phosphate with ACETYL-COA to form N-acetylglucosamine 6-phosphate.%A%    
% 211.07/211.26  |- skos__altLabel mesh__D051081 Glucosamine-6-Phosphate Acetyltransferase
% 211.07/211.26  |- mesh__dateCreated mesh__D051081 2005-06-30
% 211.07/211.26  |- skos__hiddenLabel mesh__D051081
% 211.07/211.26       N-Acetyltransferase, Glucosamine-Phosphate
% 211.07/211.26  |- rdf__type mesh__D051081sskos__Concept
% 211.07/211.26  |- skos__hiddenLabel mesh__D051081
% 211.07/211.26       6-Phosphate N-Acetyltransferase, Glucosamine
% 211.07/211.26  |- skos__prefLabel mesh__D051081
% 211.07/211.26       Glucosamine 6-Phosphate N-Acetyltransferase
% 211.07/211.26  |- skos__hiddenLabel mesh__D051081 Acetyltransferase, Glucosamine-Phosphate
% 211.07/211.26  |- skos__hiddenLabel mesh__D051081
% 211.07/211.26       N-Acetyltransferase, Glucosamine 6-Phosphate
% 211.07/211.26  |- skos__altLabel mesh__D051081 GlcNP-AcT
% 211.07/211.26  |- skos__hiddenLabel mesh__D051081
% 211.07/211.26       Glucosamine Phosphate N Acetyltransferase
% 211.07/211.26  |- mesh__recordOriginator mesh__D051081 AKE
% 211.07/211.26  |- mesh__publicMeSHNote mesh__D051081
% 211.07/211.26       2006; GLUCOSAMINE 6-PHOSPHATE N-ACETYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1977-2005%A%  
% 211.07/211.26  |- skos__hiddenLabel mesh__D051081
% 211.07/211.26       Glucosamine 6 Phosphate Acetyltransferase
% 211.07/211.26  |- skos__altLabel mesh__D051081 Glucosamine-Phosphate N-Acetyltransferase
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D051081 2006
% 211.07/211.26  |- skos__altLabel mesh__D051081 Glucosamine-6-Phosphate Acetylase
% 211.07/211.26  |- skos__hiddenLabel mesh__D051081 Glucosamine Phosphate Acetyltransferase
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D012668 2003
% 211.07/211.26  |- mesh__recordOriginator mesh__D012668 NLM
% 211.07/211.26  |- skos__hiddenLabel mesh__D012668 Gasser Ganglion
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D012668 2002
% 211.07/211.26  |- mesh__dateEstablished mesh__D012668 1990-01-01
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D012668 1997
% 211.07/211.26  |- rdf__type mesh__D012668sskos__Concept
% 211.07/211.26  |- skos__broader mesh__D012668smesh__D017950
% 211.07/211.26  |- skos__altLabel mesh__D012668 Gasserian Ganglion
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D012668 2006
% 211.07/211.26  |- mesh__dateCreated mesh__D012668 1999-01-01
% 211.07/211.26  |- skos__hiddenLabel mesh__D012668 Trigeminal Ganglias
% 211.07/211.26  |- skos__hiddenLabel mesh__D012668 Trigeminal Ganglions
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D012668 1996
% 211.07/211.26  |- skos__broader mesh__D012668smesh__D014276
% 211.07/211.26  |- mesh__historyNote mesh__D012668
% 211.07/211.26       90%28%75%29%; was SEMILUNAR GANGLION see under TRIGEMINAL NERVE 1963-89%A%  
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D012668 2001
% 211.07/211.26  |- skos__prefLabel mesh__D012668 Trigeminal Ganglion
% 211.07/211.26  |- skos__hiddenLabel mesh__D012668 Gassers Ganglion
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D012668 2005
% 211.07/211.26  |- skos__hiddenLabel mesh__D012668 Ganglia, Trigeminal
% 211.07/211.26  |- mesh__recordAuthorizer mesh__D012668 PLS
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D012668 1999
% 211.07/211.26  |- skos__altLabel mesh__D012668 Trigeminal Ganglia
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D012668 2000
% 211.07/211.26  |- mesh__publicMeSHNote mesh__D012668
% 211.07/211.26       90; was SEMILUNAR GANGLION see under TRIGEMINAL NERVE 1963-89%A%  
% 211.07/211.26  |- skos__hiddenLabel mesh__D012668 Ganglion, Gasserian
% 211.07/211.26  |- skos__hiddenLabel mesh__D012668 Ganglion, Trigeminal
% 211.07/211.26  |- skos__hiddenLabel mesh__D012668 Ganglion, Gasser%27%s
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D012668 1995
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D012668 1998
% 211.07/211.26  |- mesh__dateRevised mesh__D012668 1994-04-11
% 211.07/211.26  |- skos__annotation mesh__D012668
% 211.07/211.26       neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D012668 2004
% 211.07/211.26  |- skos__hiddenLabel mesh__D012668 Ganglion, Semilunar
% 211.07/211.26  |- skos__altLabel mesh__D012668 Semilunar Ganglion
% 211.07/211.26  |- mesh__recordMaintainer mesh__D012668 TGC
% 211.07/211.26  |- skos__scopeNote mesh__D012668
% 211.07/211.26       The semilunar-shaped ganglion containing the cells of origin of most of the sensory fibers of the trigeminal nerve. It is situated within the dural cleft on the cerebral surface of the petrous portion of the temporal bone and gives off the ophthalmic, maxillary, and part of the mandibular nerves.%A%    
% 211.07/211.26  |- skos__altLabel mesh__D012668 Gasser%27%s Ganglion
% 211.07/211.26  |- skos__hiddenLabel mesh__D012668 Semilunar Ganglions
% 211.07/211.26  |- mesh__onlineNote mesh__D012668
% 211.07/211.26       use TRIGEMINAL NERVE to search SEMILUNAR GANGLION 1966-74; use TRIGEMINAL GANGLION 1975-89%A%  
% 211.07/211.26  |- skos__altLabel mesh__D031822 Portulaca oleracae
% 211.07/211.26  |- mesh__dateCreated mesh__D031822 2002-07-03
% 211.07/211.26  |- mesh__dateEstablished mesh__D031822 2003-01-01
% 211.07/211.26  |- rdf__type mesh__D031822sskos__Concept
% 211.07/211.26  |- skos__scopeNote mesh__D031822
% 211.07/211.26       A plant genus of the family PORTULACACEAE.     
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D031822 2004
% 211.07/211.26  |- skos__altLabel mesh__D031822 Purslane
% 211.07/211.26  |- skos__annotation mesh__D031822
% 211.07/211.26       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.07/211.26  |- skos__prefLabel mesh__D031822 Portulaca
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D031822 2003
% 211.07/211.26  |- mesh__publicMeSHNote mesh__D031822 2003   
% 211.07/211.26  |- mesh__historyNote mesh__D031822 2003   
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D031822 2006
% 211.07/211.26  |- skos__broader mesh__D031822smesh__D029622
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D031822 2005
% 211.07/211.26  |- mesh__onlineNote mesh__D017353
% 211.07/211.26       use CHROMOSOME DELETION to search GENE DELETION 1984-92   
% 211.07/211.26  |- rdf__type mesh__D017353sskos__Concept
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D017353 2004
% 211.07/211.26  |- skos__hiddenLabel mesh__D017353 Deletion, Gene
% 211.07/211.26  |- mesh__recordAuthorizer mesh__D017353 sjn
% 211.07/211.26  |- mesh__dateRevised mesh__D017353 2002-07-03
% 211.07/211.26  |- mesh__publicMeSHNote mesh__D017353
% 211.07/211.26       93; was see CHROMOSOME DELETION 1984-92   
% 211.07/211.26  |- skos__historyNote mesh__D017353 Mutation %28%1972-1975%29%
% 211.07/211.26  |- skos__historyNote mesh__D017353 Chromosome Deletion %28%1976-1992%29%
% 211.07/211.26  |- mesh__dateEstablished mesh__D017353 1993-01-01
% 211.07/211.26  |- skos__scopeNote mesh__D017353
% 211.07/211.26       A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus.%A%    
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D017353 2005
% 211.07/211.26  |- skos__prefLabel mesh__D017353 Gene Deletion
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D017353 2006
% 211.07/211.26  |- skos__broader mesh__D017353smesh__D017384
% 211.07/211.26  |- mesh__recordOriginator mesh__D017353 PXP
% 211.07/211.26  |- skos__hiddenLabel mesh__D017353 Gene Deletions
% 211.07/211.26  |- mesh__historyNote mesh__D017353
% 211.07/211.26       93; was see CHROMOSOME DELETION 1984-92   
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D017353 2003
% 211.07/211.26  |- mesh__dateCreated mesh__D017353 1992-05-20
% 211.07/211.26  |- mesh__recordMaintainer mesh__D017353 PXP
% 211.07/211.26  |- skos__hiddenLabel mesh__D017353 Deletions, Gene
% 211.07/211.26  |- mesh__dateEstablished mesh__D050787 2006-01-01
% 211.07/211.26  |- mesh__publicMeSHNote mesh__D050787
% 211.07/211.26       2006; PROTO-ONCOGENE PROTEINS ETS-2 was indexed under PROTO-ONCOGENE PROTEINS %26% TRANS-ACTIVATORS 1990-2005%A%  
% 211.07/211.26  |- skos__hiddenLabel mesh__D050787 c-ets-2, Proto-Oncogene Protein
% 211.07/211.26  |- rdf__type mesh__D050787sskos__Concept
% 211.07/211.26  |- skos__prefLabel mesh__D050787 Proto-Oncogene Protein c-ets-2
% 211.07/211.26  |- skos__altLabel mesh__D050787 c-ets-2 Protein
% 211.07/211.26  |- skos__hiddenLabel mesh__D050787 Proto Oncogene Protein c ets 2
% 211.07/211.26  |- mesh__recordOriginator mesh__D050787 jmp
% 211.07/211.26  |- skos__hiddenLabel mesh__D050787 c ets 2 Protein
% 211.07/211.26  |- mesh__historyNote mesh__D050787 2006%28%1990%29%   
% 211.07/211.26  |- skos__hiddenLabel mesh__D050787 c-ets-2, Proto-Oncogene Proteins
% 211.07/211.26  |- skos__hiddenLabel mesh__D050787 Proto Oncogene Proteins ets 2
% 211.07/211.26  |- mesh__dateCreated mesh__D050787 2005-06-30
% 211.07/211.26  |- skos__hiddenLabel mesh__D050787 ets-2, Proto-Oncogene Proteins
% 211.07/211.26  |- skos__altLabel mesh__D050787 Proto-Oncogene Protein ets-2
% 211.07/211.26  |- mesh__recordMaintainer mesh__D050787 jmp
% 211.07/211.26  |- skos__broader mesh__D050787smesh__D050783
% 211.07/211.26  |- skos__altLabel mesh__D050787 Proto-Oncogene Proteins ets-2
% 211.07/211.26  |- skos__hiddenLabel mesh__D050787 Proto Oncogene Proteins c ets 2
% 211.07/211.26  |- skos__scopeNote mesh__D050787
% 211.07/211.26       A ubiquitously expressed ets proto-oncogene protein that may play a role in regulation of CELL PROLIFERATION and CELL DIFFERENTIATION.%A%    
% 211.07/211.26  |- mesh__recordAuthorizer mesh__D050787 sjn
% 211.07/211.26  |- skos__annotation mesh__D050787 see SCR for organism-specific terms   
% 211.07/211.26  |- skos__altLabel mesh__D050787 Proto-Oncogene Proteins c-ets-2
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D050787 2006
% 211.07/211.26  |- mesh__onlineNote mesh__D003333
% 211.07/211.26       use CORONAVIRIDAE INFECTIONS to search CORONAVIRUS INFECTIONS 1977-93%A%  
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D003333 2005
% 211.07/211.26  |- skos__hiddenLabel mesh__D003333 Infection, Coronaviridae
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D003333 2004
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D003333 2002
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D003333 2006
% 211.07/211.26  |- skos__prefLabel mesh__D003333 Coronaviridae Infections
% 211.07/211.26  |- skos__broader mesh__D003333smesh__D030341
% 211.07/211.26  |- skos__scopeNote mesh__D003333
% 211.07/211.26       Virus diseases caused by CORONAVIRIDAE.     
% 211.07/211.26  |- mesh__recordAuthorizer mesh__D003333 sjn
% 211.07/211.26  |- mesh__recordMaintainer mesh__D003333 ags
% 211.07/211.26  |- skos__hiddenLabel mesh__D003333 Coronaviridae Infection
% 211.07/211.26  |- mesh__publicMeSHNote mesh__D003333
% 211.07/211.26       94; was CORONAVIRUS INFECTIONS 1977-93   
% 211.07/211.26  |- mesh__dateCreated mesh__D003333 1976-04-27
% 211.07/211.26  |- skos__altLabel mesh__D003333 Infections, Coronaviridae
% 211.07/211.26  |- mesh__dateRevised mesh__D003333 2001-07-25
% 211.07/211.26  |- skos__historyNote mesh__D003333 Virus Diseases %28%1968-1976%29%
% 211.07/211.26  |- skos__annotation mesh__D003333
% 211.07/211.26       caused by members of the Coronaviridae family: do not confuse with CORONAVIRUS INFECTIONS caused by members of the Coronavirus genus; GEN or unspecified; prefer specifics%A%  
% 211.07/211.26  |- rdf__type mesh__D003333sskos__Concept
% 211.07/211.26  |- mesh__recordOriginator mesh__D003333 FPG
% 211.07/211.26  |- mesh__historyNote mesh__D003333
% 211.07/211.26       94; was CORONAVIRUS INFECTIONS 1977-93   
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D003333 2003
% 211.07/211.26  |- mesh__dateEstablished mesh__D003333 1977-01-01
% 211.07/211.26  |- skos__altLabel mesh__D027781 Shallot
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D027781 2005
% 211.07/211.26  |- skos__prefLabel mesh__D027781 Shallots
% 211.07/211.26  |- skos__annotation mesh__D027781
% 211.07/211.26       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D027781 2006
% 211.07/211.26  |- skos__historyNote mesh__D027781 Allium %28%1998-2001%29%
% 211.07/211.26  |- mesh__publicMeSHNote mesh__D027781 2002; see Allium 1998-2001   
% 211.07/211.26  |- skos__broader mesh__D027781smesh__D000490
% 211.07/211.26  |- mesh__dateCreated mesh__D027781 2001-07-25
% 211.07/211.26  |- rdf__type mesh__D027781sskos__Concept
% 211.07/211.26  |- mesh__dateEstablished mesh__D027781 2002-01-01
% 211.07/211.26  |- mesh__recordAuthorizer mesh__D027781 sjn
% 211.07/211.26  |- mesh__historyNote mesh__D027781 2002; use Allium 1998-2001   
% 211.07/211.26  |- mesh__recordMaintainer mesh__D027781 ssb
% 211.07/211.26  |- mesh__recordOriginator mesh__D027781 ssb
% 211.07/211.26  |- mesh__dateRevised mesh__D027781 2004-07-07
% 211.07/211.26  |- skos__scopeNote mesh__D027781
% 211.07/211.26       Mildly aromatic herb in the Allium genus related to ONIONS and garlic used in SPICES.%A%    
% 211.07/211.26  |- skos__broader mesh__D027781smesh__D014675
% 211.07/211.26  |- skos__annotation mesh__D013761 do not confuse with TETRAHYDROCORTISOL   
% 211.07/211.26  |- mesh__dateRevised mesh__D013761 2003-07-09
% 211.07/211.26  |- mesh__activeMeSHYear mesh__D013761 2006
% 211.07/211.26  |- skos__prefLabel mesh__D013761 Tetrahydrocortisone
% 211.07/211.26  |- mesh__publicMeSHNote mesh__D013761
% 211.07/211.26       91; was see under CORTISONE 1973-90   
% 211.07/211.26  |- mesh__dateEstablished mesh__D013761 1991-01-01
% 211.07/211.27  |- rdf__type mesh__D013761sskos__Concept
% 211.07/211.27  |- skos__broader mesh__D013761smesh__D011277
% 211.07/211.27  |- mesh__recordOriginator mesh__D013761 NLM
% 211.07/211.27  |- mesh__recordAuthorizer mesh__D013761 sjn
% 211.07/211.27  |- skos__broader mesh__D013761smesh__D015065
% 211.07/211.27  |- mesh__historyNote mesh__D013761
% 211.07/211.27       91%28%73%29%; was see under CORTISONE 1973-90   
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D013761 2004
% 211.07/211.27  |- mesh__recordMaintainer mesh__D013761 ssb
% 211.07/211.27  |- skos__historyNote mesh__D013761 Cortisone %28%1966-1972%29%
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D013761 2005
% 211.07/211.27  |- mesh__dateCreated mesh__D013761 1999-01-01
% 211.07/211.27  |- mesh__recordOriginator mesh__D007724 NLM
% 211.07/211.27  |- skos__altLabel mesh__D007724 Kraurosis Vulvae
% 211.07/211.27  |- mesh__recordMaintainer mesh__D007724 lkt
% 211.07/211.27  |- skos__hiddenLabel mesh__D007724 Lichen Sclerosus, Vulvar
% 211.07/211.27  |- rdf__type mesh__D007724sskos__Concept
% 211.07/211.27  |- mesh__publicMeSHNote mesh__D007724
% 211.07/211.27       2006; see KRAUROSIS VULVAE 1963-2005   
% 211.07/211.27  |- skos__hiddenLabel mesh__D007724 Vulvae, Kraurosis
% 211.07/211.27  |- mesh__dateRevised mesh__D007724 2005-06-30
% 211.07/211.27  |- mesh__recordAuthorizer mesh__D007724 sjn
% 211.07/211.27  |- skos__scopeNote mesh__D007724
% 211.07/211.27       Atrophy and shriveling of the SKIN of the VULVA that is characterized by the whitish LICHEN SCLEROSUS appearance, inflammation, and PRURITUS.%A%    
% 211.07/211.27  |- skos__hiddenLabel mesh__D007724 Vulva Lichen Sclerosus
% 211.07/211.27  |- skos__hiddenLabel mesh__D007724 Sclerosus, Vulvar Lichen
% 211.07/211.27  |- skos__altLabel mesh__D007724 Lichen Sclerosus of Vulva
% 211.07/211.27  |- mesh__dateCreated mesh__D007724 1999-01-01
% 211.07/211.27  |- skos__broader mesh__D007724smesh__D014845
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D007724 2006
% 211.07/211.27  |- skos__prefLabel mesh__D007724 Vulvar Lichen Sclerosus
% 211.07/211.27  |- mesh__historyNote mesh__D007724 2006 %28%1963%29%   
% 211.07/211.27  |- mesh__recordMaintainer mesh__D051880 ags
% 211.07/211.27  |- mesh__dateCreated mesh__D051880 2005-06-30
% 211.07/211.27  |- skos__scopeNote mesh__D051880
% 211.07/211.27       A family of conserved cell surface receptors that contain EPIDERMAL GROWTH FACTOR repeats in their extracellular domain and ANKYRIN repeats in their cytoplasmic domains. The cytoplasmic domain of notch receptors is released upon ligand binding and translocates to the CELL NUCLEUS where it acts as transcription factor.%A%    
% 211.07/211.27  |- skos__altLabel mesh__D051880 Notch Receptors
% 211.07/211.27  |- skos__altLabel mesh__D051880 Notch Proteins
% 211.07/211.27  |- mesh__dateRevised mesh__D051880 2005-07-19
% 211.07/211.27  |- mesh__publicMeSHNote mesh__D051880
% 211.07/211.27       2006; RECEPTORS, NOTCH was indexed under MEMBRANE PROTEINS 1990-2005, %26% under INSECT HORMONES 1990-1995%A%  
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D051880 2006A
% 211.07/211.27  |- mesh__historyNote mesh__D051880 2006%28%1990%29%   
% 211.07/211.27  |- skos__prefLabel mesh__D051880 Receptors, Notch
% 211.07/211.27  |- mesh__dateEstablished mesh__D051880 2006-01-01
% 211.07/211.27  |- mesh__recordOriginator mesh__D051880 DRC
% 211.07/211.27  |- skos__broader mesh__D051880smesh__D014157
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D051880 2006
% 211.07/211.27  |- rdf__type mesh__D051880sskos__Concept
% 211.07/211.27  |- skos__broader mesh__D051880smesh__D011956
% 211.07/211.27  |- mesh__recordAuthorizer mesh__D051880 ags
% 211.07/211.27  |- skos__prefLabel mesh__D026689 Ethical Analysis
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D026689 2003
% 211.07/211.27  |- mesh__dateEstablished mesh__D026689 2002-01-01
% 211.07/211.27  |- skos__scopeNote mesh__D026689
% 211.07/211.27       The use of systematic methods of ethical examination, such as CASUISTRY or ETHICAL THEORY, in reasoning about moral problems.%A%    
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D026689 2005
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D026689 2004
% 211.07/211.27  |- skos__hiddenLabel mesh__D026689 Analyses, Ethical
% 211.07/211.27  |- skos__broader mesh__D026689smesh__D004989
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D026689 2006
% 211.07/211.27  |- skos__historyNote mesh__D026689 Ethics %28%1979-2001%29%
% 211.07/211.27  |- mesh__dateCreated mesh__D026689 2001-07-25
% 211.07/211.27  |- mesh__publicMeSHNote mesh__D026689 2002; see ETHICS 1979-2001   
% 211.07/211.27  |- mesh__historyNote mesh__D026689 2002; use ETHICS 1978-2001   
% 211.07/211.27  |- mesh__recordMaintainer mesh__D026689 hjn
% 211.07/211.27  |- mesh__recordOriginator mesh__D026689 hjn
% 211.07/211.27  |- mesh__recordAuthorizer mesh__D026689 sjn
% 211.07/211.27  |- rdf__type mesh__D026689sskos__Concept
% 211.07/211.27  |- mesh__dateRevised mesh__D026689 2002-07-02
% 211.07/211.27  |- skos__hiddenLabel mesh__D026689 Ethical Analyses
% 211.07/211.27  |- skos__altLabel mesh__D026689 Analysis, Ethical
% 211.07/211.27  |- mesh__publicMeSHNote mesh__D051082
% 211.07/211.27       2006; HOMOSERINE O-SUCCINYLTRANSFERASE was indexed under ACYLTRANSFERASES 1971-2005%A%  
% 211.07/211.27  |- skos__hiddenLabel mesh__D051082 Transsuccinylase, Homoserine
% 211.07/211.27  |- mesh__historyNote mesh__D051082
% 211.07/211.27       2006%28%1980%29%; use ACYLTRANSFERASES 1971-1979   
% 211.07/211.27  |- rdf__type mesh__D051082sskos__Concept
% 211.07/211.27  |- skos__hiddenLabel mesh__D051082 Succinyltransferase, Homoserine
% 211.07/211.27  |- mesh__dateEstablished mesh__D051082 2006-01-01
% 211.07/211.27  |- skos__prefLabel mesh__D051082 Homoserine O-Succinyltransferase
% 211.07/211.27  |- skos__hiddenLabel mesh__D051082 O-Succinyltransferase, Homoserine
% 211.07/211.27  |- skos__altLabel mesh__D051082 Homoserine Succinyltransferase
% 211.07/211.27  |- mesh__recordAuthorizer mesh__D051082 sjn
% 211.07/211.27  |- skos__hiddenLabel mesh__D051082 Homoserine O Succinyltransferase
% 211.07/211.27  |- mesh__dateCreated mesh__D051082 2005-06-30
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D051082 2006
% 211.07/211.27  |- skos__altLabel mesh__D051082 Homoserine Transsuccinylase
% 211.07/211.27  |- skos__broader mesh__D051082smesh__D000217
% 211.07/211.27  |- skos__scopeNote mesh__D051082
% 211.07/211.27       The first enzyme in the METHIONINE biosynthetic pathway, this enzyme catalyzes the succinylation reaction of L-homoserine to O-succinyl-L-homoserine and COENZYME A using succinyl-CoA.%A%    
% 211.07/211.27  |- mesh__recordOriginator mesh__D051082 AKE
% 211.07/211.27  |- mesh__recordMaintainer mesh__D051082 AKE
% 211.07/211.27  |- skos__scopeNote mesh__D012669
% 211.07/211.27       A saclike, glandular diverticulum on each ductus deferens in male vertebrates. It is united with the excretory duct and serves for temporary storage of semen. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 211.07/211.27  |- mesh__dateRevised mesh__D012669 1995-05-23
% 211.07/211.27  |- skos__broader mesh__D012669smesh__D005837
% 211.07/211.27  |- skos__hiddenLabel mesh__D012669 Vesicle, Seminal
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D012669 1998
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D012669 2002
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D012669 1999
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D012669 2005
% 211.07/211.27  |- skos__hiddenLabel mesh__D012669 Vesicles, Seminal
% 211.07/211.27  |- skos__hiddenLabel mesh__D012669 Seminal Vesicle
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D012669 1996
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D012669 2006
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D012669 2000
% 211.07/211.27  |- mesh__recordMaintainer mesh__D012669 KEV
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D012669 1997
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D012669 2003
% 211.07/211.27  |- rdf__type mesh__D012669sskos__Concept
% 211.07/211.27  |- mesh__dateCreated mesh__D012669 1999-01-01
% 211.07/211.27  |- skos__prefLabel mesh__D012669 Seminal Vesicles
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D012669 2001
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D012669 2004
% 211.07/211.27  |- mesh__recordAuthorizer mesh__D012669 PLS
% 211.07/211.27  |- mesh__recordOriginator mesh__D012669 NLM
% 211.07/211.27  |- skos__broader mesh__D031823smesh__D029623
% 211.07/211.27  |- rdf__type mesh__D031823sskos__Concept
% 211.07/211.27  |- skos__altLabel mesh__D031823 Pimpernel
% 211.07/211.27  |- mesh__dateCreated mesh__D031823 2002-07-02
% 211.07/211.27  |- mesh__dateRevised mesh__D031823 2004-07-19
% 211.07/211.27  |- skos__scopeNote mesh__D031823
% 211.07/211.27       A plant genus of the family PRIMULACEAE that contains anagallosides, which are molluscacidal triterpenoid saponins.%A%    
% 211.07/211.27  |- mesh__recordOriginator mesh__D031823 ssb
% 211.07/211.27  |- skos__annotation mesh__D031823
% 211.07/211.27       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.07/211.27  |- mesh__dateEstablished mesh__D031823 2003-01-01
% 211.07/211.27  |- skos__prefLabel mesh__D031823 Anagallis
% 211.07/211.27  |- mesh__publicMeSHNote mesh__D031823 2003   
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D031823 2006
% 211.07/211.27  |- mesh__recordMaintainer mesh__D031823 jls
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D031823 2005
% 211.07/211.27  |- mesh__recordAuthorizer mesh__D031823 sjn
% 211.07/211.27  |- mesh__historyNote mesh__D031823 2003   
% 211.07/211.27  |- skos__broader mesh__D017354smesh__D009154
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D017354 2005
% 211.07/211.27  |- skos__historyNote mesh__D017354 Mutation %28%1966-1992%29%
% 211.07/211.27  |- mesh__publicMeSHNote mesh__D017354 93   
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D017354 2006
% 211.07/211.27  |- mesh__dateCreated mesh__D017354 1992-05-22
% 211.07/211.27  |- mesh__recordMaintainer mesh__D017354 NDW
% 211.07/211.27  |- skos__annotation mesh__D017354
% 211.07/211.27       see MUTATION for correct use of /drug eff %26% /rad eff   
% 211.07/211.27  |- mesh__dateRevised mesh__D017354 2002-07-03
% 211.07/211.27  |- mesh__dateEstablished mesh__D017354 1993-01-01
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D017354 2003
% 211.07/211.27  |- mesh__recordAuthorizer mesh__D017354 sjn
% 211.07/211.27  |- mesh__historyNote mesh__D017354 93   
% 211.07/211.27  |- skos__hiddenLabel mesh__D017354 Mutations, Point
% 211.07/211.27  |- mesh__recordOriginator mesh__D017354 PXP
% 211.07/211.27  |- skos__hiddenLabel mesh__D017354 Point Mutations
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D017354 2004
% 211.07/211.27  |- rdf__type mesh__D017354sskos__Concept
% 211.07/211.27  |- skos__scopeNote mesh__D017354
% 211.07/211.27       A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair.%A%    
% 211.07/211.27  |- skos__prefLabel mesh__D017354 Point Mutation
% 211.07/211.27  |- skos__related mesh__D017354smesh__D020125
% 211.07/211.27  |- skos__altLabel mesh__D017354 Mutation, Point
% 211.07/211.27  |- rdf__type mesh__D050788sskos__Concept
% 211.07/211.27  |- skos__hiddenLabel mesh__D050788 Dehydrogenase, Alanine
% 211.07/211.27  |- mesh__historyNote mesh__D050788
% 211.07/211.27       2006%28%1980%29% use AMINO ACID OXIDOREDUCTASES %26% ALANINE 1972-1979%A%  
% 211.07/211.27  |- mesh__recordAuthorizer mesh__D050788 sjn
% 211.07/211.27  |- mesh__dateEstablished mesh__D050788 2006-01-01
% 211.07/211.27  |- mesh__publicMeSHNote mesh__D050788
% 211.07/211.27       2006; ALANINE DEHYDROGENASE was indexed under AMINO ACID OXIDOREDUCTASES 1972-2005, %26% under ALANINE 1972-1980%A%  
% 211.07/211.27  |- skos__prefLabel mesh__D050788 Alanine Dehydrogenase
% 211.07/211.27  |- mesh__dateCreated mesh__D050788 2005-06-30
% 211.07/211.27  |- skos__hiddenLabel mesh__D050788 L Alanine Dehydrogenase
% 211.07/211.27  |- mesh__recordOriginator mesh__D050788 AKE
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D050788 2006
% 211.07/211.27  |- skos__broader mesh__D050788smesh__D000594
% 211.07/211.27  |- skos__scopeNote mesh__D050788
% 211.07/211.27       An NAD-dependent enzyme that catalyzes the reversible DEAMINATION of L-ALANINE to PYRUVATE and AMMONIA. The enzyme is needed for growth when ALANINE is the sole CARBON or NITROGEN source. It may also play a role in CELL WALL synthesis because L-ALANINE is an important constituent of the PEPTIDOGLYCAN layer.%A%    
% 211.07/211.27  |- skos__hiddenLabel mesh__D050788 Dehydrogenase, L-Alanine
% 211.07/211.27  |- mesh__recordMaintainer mesh__D050788 AKE
% 211.07/211.27  |- skos__altLabel mesh__D050788 L-Alanine Dehydrogenase
% 211.07/211.27  |- mesh__dateRevised mesh__D003334 1992-05-14
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003334 1996
% 211.07/211.27  |- skos__prefLabel mesh__D003334 Coroners and Medical Examiners
% 211.07/211.27  |- skos__annotation mesh__D003334 IM; DF: CORONERS   
% 211.07/211.27  |- skos__broader mesh__D003334smesh__D006282
% 211.07/211.27  |- mesh__recordMaintainer mesh__D003334 TAP
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003334 1998
% 211.07/211.27  |- skos__scopeNote mesh__D003334
% 211.07/211.27       Physicians appointed to investigate all cases of sudden or violent death.%A%    
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003334 1997
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003334 1994
% 211.07/211.27  |- skos__hiddenLabel mesh__D003334 Coroner
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003334 1999
% 211.07/211.27  |- skos__altLabel mesh__D003334 Medical Examiner
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003334 2002
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003334 1993
% 211.07/211.27  |- mesh__recordOriginator mesh__D003334 NLM
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003334 1995
% 211.07/211.27  |- skos__altLabel mesh__D003334 Medical Examiners and Coroners
% 211.07/211.27  |- skos__altLabel mesh__D003334 Medical Examiners
% 211.07/211.27  |- mesh__recordAuthorizer mesh__D003334 PLS
% 211.07/211.27  |- rdf__type mesh__D003334sskos__Concept
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003334 2003
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003334 2000
% 211.07/211.27  |- skos__altLabel mesh__D003334 Examiners, Medical
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003334 2005
% 211.07/211.27  |- mesh__dateCreated mesh__D003334 1999-01-01
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003334 2004
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003334 2001
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003334 2006
% 211.07/211.27  |- mesh__historyNote mesh__D027782 2002; use Allium 1998-2001   
% 211.07/211.27  |- skos__historyNote mesh__D027782 Allium %28%1998-2001%29%
% 211.07/211.27  |- mesh__recordMaintainer mesh__D027782 ssb
% 211.07/211.27  |- mesh__publicMeSHNote mesh__D027782 2002; see Allium 1998-2001   
% 211.07/211.27  |- skos__hiddenLabel mesh__D027782 Chive, Chinese
% 211.07/211.27  |- skos__altLabel mesh__D027782 Chives
% 211.07/211.27  |- skos__hiddenLabel mesh__D027782 Chinese Chives
% 211.07/211.27  |- skos__altLabel mesh__D027782 Allium schoenoprasum
% 211.07/211.27  |- rdf__type mesh__D027782sskos__Concept
% 211.07/211.27  |- skos__scopeNote mesh__D027782
% 211.07/211.27       A plant in the genus ALLIUM, similar to ONIONS.     
% 211.07/211.27  |- skos__altLabel mesh__D027782 Allium tuberosum
% 211.07/211.27  |- mesh__dateEstablished mesh__D027782 2002-01-01
% 211.07/211.27  |- skos__broader mesh__D027782smesh__D000490
% 211.07/211.27  |- mesh__dateCreated mesh__D027782 2001-07-25
% 211.07/211.27  |- skos__annotation mesh__D027782
% 211.07/211.27       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.07/211.27  |- mesh__recordOriginator mesh__D027782 ssb
% 211.07/211.27  |- skos__hiddenLabel mesh__D027782 Chives, Chinese
% 211.07/211.27  |- mesh__dateRevised mesh__D027782 2004-07-07
% 211.07/211.27  |- skos__broader mesh__D027782smesh__D014675
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D027782 2005
% 211.07/211.27  |- mesh__recordAuthorizer mesh__D027782 sjn
% 211.07/211.27  |- skos__prefLabel mesh__D027782 Chive
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D027782 2006
% 211.07/211.27  |- skos__hiddenLabel mesh__D013762 Dehydrogenase, Dihydrofolate
% 211.07/211.27  |- skos__altLabel mesh__D013762 Dihydrofolate Reductase
% 211.07/211.27  |- skos__hiddenLabel mesh__D013762 Dehydrogenase, Tetrahydrofolate
% 211.07/211.27  |- skos__scopeNote mesh__D013762
% 211.07/211.27       An enzyme of the oxidoreductase class that catalyzes the reaction 7,8-dihyrofolate and NADPH to yield 5,6,7,8-tetrahydrofolate and NADPH+, producing reduced folate for amino acid metabolism, purine ring synthesis, and the formation of deoxythymidine monophosphate. Methotrexate and other folic acid antagonists used as chemotherapeutic drugs act by inhibiting this enzyme. %28%Dorland, 27th ed%29% EC 1.5.1.3.%A%    
% 211.07/211.27  |- skos__prefLabel mesh__D013762 Tetrahydrofolate Dehydrogenase
% 211.07/211.27  |- mesh__dateEstablished mesh__D013762 1966-01-01
% 211.07/211.27  |- skos__hiddenLabel mesh__D013762 Reductase, Folic Acid
% 211.07/211.27  |- mesh__onlineNote mesh__D013762
% 211.07/211.27       use TETRAHYDROFOLATE DEHYDROGENASE to search DIHYDROFOLATE DEHYDROGENASE 1966-88%A%  
% 211.07/211.27  |- mesh__recordMaintainer mesh__D013762 jmp
% 211.07/211.27  |- skos__altLabel mesh__D013762 Folic Acid Reductase
% 211.07/211.27  |- skos__hiddenLabel mesh__D013762 Acid Reductase, Folic
% 211.07/211.27  |- mesh__publicMeSHNote mesh__D013762
% 211.07/211.27       66; DIHYDROFOLATE DEHYDROGENASE was heading 1966-88   
% 211.07/211.27  |- mesh__historyNote mesh__D013762
% 211.07/211.27       66; DIHYDROFOLATE DEHYDROGENASE was heading 1966-88   
% 211.07/211.27  |- mesh__dateRevised mesh__D013762 2005-06-30
% 211.07/211.27  |- mesh__dateCreated mesh__D013762 1999-01-01
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D013762 2006
% 211.07/211.27  |- skos__hiddenLabel mesh__D013762 Reductase, Dihydrofolate
% 211.07/211.27  |- skos__broader mesh__D013762smesh__D000587
% 211.07/211.27  |- mesh__recordOriginator mesh__D013762 NLM
% 211.07/211.27  |- mesh__recordAuthorizer mesh__D013762 sjn
% 211.07/211.27  |- rdf__type mesh__D013762sskos__Concept
% 211.07/211.27  |- skos__altLabel mesh__D013762 Dihydrofolate Dehydrogenase
% 211.07/211.27  |- skos__historyNote mesh__D007725 Ovarian Neoplasms %28%1966-1974%29%
% 211.07/211.27  |- skos__hiddenLabel mesh__D007725 Tumor, Krukenberg
% 211.07/211.27  |- skos__hiddenLabel mesh__D007725 Tumor, Krukenberg%27%s
% 211.07/211.27  |- mesh__dateRevised mesh__D007725 2003-07-09
% 211.07/211.27  |- skos__prefLabel mesh__D007725 Krukenberg Tumor
% 211.07/211.27  |- mesh__dateCreated mesh__D007725 1974-11-19
% 211.07/211.27  |- skos__scopeNote mesh__D007725
% 211.07/211.27       Mucocellular carcinoma of the ovary, usually metastatic from the gastrointestinal tract, characterized by areas of mucoid degeneration and the presence of signet-ring-like cells. It accounts for 30%25%-40%25% of metastatic cancers to the ovaries and possibly 1%25%-2%25% of all malignant ovarian tumors. The lesions may not be discovered until the primary disease is advanced, and most patients die of their disease within a year. In some cases, a primary tumor is not found. %28%From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1685%29%%A%    
% 211.07/211.27  |- skos__annotation mesh__D007725
% 211.07/211.27       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with OVARIAN NEOPLASMS %28%IM%29%%A%  
% 211.07/211.27  |- rdf__type mesh__D007725sskos__Concept
% 211.07/211.27  |- mesh__recordOriginator mesh__D007725 NLM
% 211.07/211.27  |- skos__altLabel mesh__D007725 Krukenberg%27%s Tumor
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D007725 2005
% 211.07/211.27  |- mesh__historyNote mesh__D007725 94; was KRUKENBERG%27%S TUMOR 1975-93   
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D007725 2004
% 211.07/211.27  |- skos__broader mesh__D007725smesh__D018279
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D007725 2006
% 211.07/211.27  |- mesh__recordMaintainer mesh__D007725 mdb
% 211.07/211.27  |- mesh__publicMeSHNote mesh__D007725
% 211.07/211.27       94; was KRUKENBERG%27%S TUMOR 1975-93   
% 211.07/211.27  |- skos__hiddenLabel mesh__D007725 Krukenbergs Tumor
% 211.07/211.27  |- mesh__onlineNote mesh__D007725
% 211.07/211.27       use KRUKENBERG TUMOR to search KRUKENBERG%27%S TUMOR 1975-93%A%  
% 211.07/211.27  |- mesh__recordAuthorizer mesh__D007725 sjn
% 211.07/211.27  |- mesh__dateEstablished mesh__D007725 1975-09-01
% 211.07/211.27  |- mesh__historyNote mesh__D051881 2006%28%1991%29%   
% 211.07/211.27  |- mesh__dateCreated mesh__D051881 2005-06-30
% 211.07/211.27  |- skos__altLabel mesh__D051881 Notch1 Protein
% 211.07/211.27  |- mesh__recordAuthorizer mesh__D051881 sjn
% 211.07/211.27  |- mesh__recordMaintainer mesh__D051881 DRC
% 211.07/211.27  |- skos__altLabel mesh__D051881 Notch1 Receptor
% 211.07/211.27  |- mesh__recordOriginator mesh__D051881 DRC
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D051881 2006
% 211.07/211.27  |- rdf__type mesh__D051881sskos__Concept
% 211.07/211.27  |- mesh__publicMeSHNote mesh__D051881
% 211.07/211.27       2006; RECEPTOR, NOTCH1 was indexed under TRANSCRIPTION FACTORS 1991-2005, under RECEPTORS, CELL SURFACE 2004-2005, %26% under MEMBRANE PROTEINS 1991-2003%A%  
% 211.07/211.27  |- mesh__dateEstablished mesh__D051881 2006-01-01
% 211.07/211.27  |- skos__scopeNote mesh__D051881
% 211.07/211.27       A notch receptor that interacts with a variety of ligands and regulates SIGNAL TRANSDUCTION PATHWAYS for multiple cellular processes. It is widely expressed during EMBRYOGENESIS and is essential for EMBRYONIC DEVELOPMENT.%A%    
% 211.07/211.27  |- skos__broader mesh__D051881smesh__D051880
% 211.07/211.27  |- skos__prefLabel mesh__D051881 Receptor, Notch1
% 211.07/211.27  |- skos__scopeNote mesh__D031824
% 211.07/211.27       A plant genus of the family PRIMULACEAE that contains triterpenoid saponins.%A%    
% 211.07/211.27  |- rdf__type mesh__D031824sskos__Concept
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D031824 2004
% 211.07/211.27  |- mesh__historyNote mesh__D031824 2003   
% 211.07/211.27  |- skos__annotation mesh__D031824
% 211.07/211.27       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D031824 2005
% 211.07/211.27  |- mesh__publicMeSHNote mesh__D031824 2003   
% 211.07/211.27  |- skos__prefLabel mesh__D031824 Cyclamen
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D031824 2006
% 211.07/211.27  |- mesh__dateEstablished mesh__D031824 2003-01-01
% 211.07/211.27  |- skos__broader mesh__D031824smesh__D029623
% 211.07/211.27  |- mesh__dateCreated mesh__D031824 2002-07-03
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D031824 2003
% 211.07/211.27  |- skos__historyNote mesh__D017355 Gram-Negative Bacteria %28%1984-1992%29%
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D017355 2006
% 211.07/211.27  |- mesh__publicMeSHNote mesh__D017355 93   
% 211.07/211.27  |- mesh__historyNote mesh__D017355 93   
% 211.07/211.27  |- mesh__recordOriginator mesh__D017355 PXP
% 211.07/211.27  |- mesh__dateRevised mesh__D017355 2005-06-30
% 211.07/211.27  |- skos__broader mesh__D017355smesh__D042301
% 211.07/211.27  |- rdf__type mesh__D017355sskos__Concept
% 211.07/211.27  |- skos__scopeNote mesh__D017355
% 211.07/211.27       A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that is not known to be pathogenic for man, animals, or plants. Its organisms are spoilers for beers and ciders and in sweet English ciders they are the causative agents of a secondary fermentation known as %22%cider sickness.%22% The species Z. mobilis is used for experiments in molecular genetic studies.%A%    
% 211.07/211.27  |- skos__prefLabel mesh__D017355 Zymomonas
% 211.07/211.27  |- mesh__recordMaintainer mesh__D017355 SYSTEM
% 211.07/211.27  |- mesh__dateCreated mesh__D017355 1992-05-22
% 211.07/211.27  |- mesh__dateEstablished mesh__D017355 1993-01-01
% 211.07/211.27  |- skos__annotation mesh__D017355
% 211.07/211.27       non-pathogenic but spoils fermented beverages   
% 211.07/211.27  |- mesh__recordAuthorizer mesh__D017355 sjn
% 211.07/211.27  |- skos__broader mesh__D017355smesh__D006092
% 211.07/211.27  |- skos__historyNote mesh__D017355
% 211.07/211.27       Gram-Negative Anaerobic Bacteria %28%1987-1992%29%
% 211.07/211.27  |- skos__historyNote mesh__D017355 Bacteria %28%1967-1983%29%
% 211.07/211.27  |- skos__hiddenLabel mesh__D050789 Dehydrogenase, Glycine
% 211.07/211.27  |- skos__prefLabel mesh__D050789 Glycine Dehydrogenase
% 211.07/211.27  |- mesh__recordMaintainer mesh__D050789 AKE
% 211.07/211.27  |- rdf__type mesh__D050789sskos__Concept
% 211.07/211.27  |- skos__broader mesh__D050789smesh__D000594
% 211.07/211.27  |- mesh__dateCreated mesh__D050789 2005-06-30
% 211.07/211.27  |- mesh__recordAuthorizer mesh__D050789 sjn
% 211.07/211.27  |- mesh__publicMeSHNote mesh__D050789
% 211.07/211.27       2006; GLYCINE DEHYDROGENASE was indexed under AMINO ACID OXIDOREDUCTASES 1977-2005%A%  
% 211.07/211.27  |- skos__scopeNote mesh__D050789
% 211.07/211.27       An oxidoreductase that catalyzes the oxidative DEAMINATION of GLYCINE to GLYOXYLATE and AMMONIA in the presence of NAD. In BACTERIA lacking transaminating pathways the enzyme can act in the reverse direction to synthesize glycine from glyoxylate and ammonia and NADH.%A%    
% 211.07/211.27  |- mesh__recordOriginator mesh__D050789 AKE
% 211.07/211.27  |- mesh__historyNote mesh__D050789 2006%28%1977%29%   
% 211.07/211.27  |- mesh__dateEstablished mesh__D050789 2006-01-01
% 211.07/211.27  |- skos__historyNote mesh__D050789
% 211.07/211.27       Amino Acid Oxidoreductases %28%1977-2005%29%
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D050789 2006
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003335 1995
% 211.07/211.27  |- skos__annotation mesh__D003335
% 211.07/211.27       hormone-secreting bodies in head of insects   
% 211.07/211.27  |- skos__prefLabel mesh__D003335 Corpora Allata
% 211.07/211.27  |- rdf__type mesh__D003335sskos__Concept
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003335 2000
% 211.07/211.27  |- skos__altLabel mesh__D003335 Corpus Allatum
% 211.07/211.27  |- mesh__recordOriginator mesh__D003335 FPG
% 211.07/211.27  |- skos__broader mesh__D003335smesh__D009490
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003335 2003
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003335 2001
% 211.07/211.27  |- mesh__dateEstablished mesh__D003335 1977-01-01
% 211.07/211.27  |- mesh__dateRevised mesh__D003335 1992-05-14
% 211.07/211.27  |- mesh__recordMaintainer mesh__D003335 TAP
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003335 2005
% 211.07/211.27  |- skos__broader mesh__D003335smesh__D000825
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003335 2004
% 211.07/211.27  |- mesh__dateCreated mesh__D003335 1976-04-16
% 211.07/211.27  |- mesh__publicMeSHNote mesh__D003335 77   
% 211.07/211.27  |- skos__historyNote mesh__D003335 Neurosecretion %28%1966-1967%29%
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003335 2006
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003335 1996
% 211.07/211.27  |- skos__scopeNote mesh__D003335
% 211.07/211.27       Paired or fused ganglion-like bodies in the head of insects. The bodies secrete hormones important in the regulation of metamorphosis and the development of some adult tissues.%A%    
% 211.07/211.27  |- skos__historyNote mesh__D003335
% 211.07/211.27       Metamorphosis, Biological %28%1966-1976%29%
% 211.07/211.27  |- skos__hiddenLabel mesh__D003335 Allatum, Corpus
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003335 1998
% 211.07/211.27  |- skos__historyNote mesh__D003335 Juvenile Hormones %28%1972-1976%29%
% 211.07/211.27  |- skos__hiddenLabel mesh__D003335 Allata, Corpora
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003335 2002
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003335 1997
% 211.07/211.27  |- mesh__historyNote mesh__D003335 77   
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003335 1994
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003335 1999
% 211.07/211.27  |- mesh__recordAuthorizer mesh__D003335 PLS
% 211.07/211.27  |- skos__historyNote mesh__D003335 Neurosecretory Systems %28%1970-1976%29%
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D003335 1993
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D008020 2001
% 211.07/211.27  |- mesh__dateRevised mesh__D008020 1997-06-20
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D008020 1999
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D008020 2005
% 211.07/211.27  |- skos__broader mesh__D008020smesh__D005791
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D008020 2004
% 211.07/211.27  |- skos__scopeNote mesh__D008020
% 211.07/211.27       Care provided patients requiring extraordinary therapeutic measures in order to sustain and prolong life.%A%    
% 211.07/211.27  |- skos__annotation mesh__D008020
% 211.07/211.27       extraordinary measures in patient care: do not confuse with LIFE SUPPORT SYSTEMS which is non-med%A%  
% 211.07/211.27  |- skos__hiddenLabel mesh__D008020 Extraordinary Treatments
% 211.07/211.27  |- mesh__historyNote mesh__D008020 78   
% 211.07/211.27  |- mesh__recordAuthorizer mesh__D008020 SJN
% 211.07/211.27  |- mesh__recordOriginator mesh__D008020 EC
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D008020 2006
% 211.07/211.27  |- mesh__recordMaintainer mesh__D008020 PXP
% 211.07/211.27  |- skos__hiddenLabel mesh__D008020 Care, Life Support
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D008020 2002
% 211.07/211.27  |- mesh__publicMeSHNote mesh__D008020 78   
% 211.07/211.27  |- skos__hiddenLabel mesh__D008020 Treatments, Extraordinary
% 211.07/211.27  |- skos__prefLabel mesh__D008020 Life Support Care
% 211.07/211.27  |- mesh__dateEstablished mesh__D008020 1978-01-01
% 211.07/211.27  |- skos__historyNote mesh__D008020 Ethics, Medical %28%1966-1977%29%
% 211.07/211.27  |- skos__hiddenLabel mesh__D008020 Treatment, Extraordinary
% 211.07/211.27  |- skos__altLabel mesh__D008020 Prolongation of Life
% 211.07/211.27  |- skos__related mesh__D008020smesh__D016414
% 211.07/211.27  |- skos__hiddenLabel mesh__D008020 Life Prolongation
% 211.07/211.27  |- mesh__dateCreated mesh__D008020 1977-04-22
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D008020 2000
% 211.07/211.27  |- skos__historyNote mesh__D008020 Longevity %28%1966-1977%29%
% 211.07/211.27  |- skos__historyNote mesh__D008020 Life Expectancy %28%1966-1977%29%
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D008020 1998
% 211.07/211.27  |- mesh__activeMeSHYear mesh__D008020 2003
% 211.07/211.27  |- rdf__type mesh__D008020sskos__Concept
% 211.07/211.27  |- mesh__recordOriginator mesh__D013763 NLM
% 211.07/211.27  |- skos__historyNote mesh__D013763 Coenzymes %28%1966-1971%29%
% 211.07/211.27  |- skos__annotation mesh__D013763
% 211.07/211.27       deficiency: coordinate TETRAHYDROFOLATES /defic %28%IM%29% with FOLIC ACID DEFICIENCY %28%IM%29%%A%  
% 211.07/211.27  |- mesh__recordAuthorizer mesh__D013763 sjn
% 211.07/211.27  |- skos__scopeNote mesh__D013763
% 211.07/211.27       Compounds based on 5,6,7,8-tetrahydrofolate.     
% 211.07/211.27  |- mesh__dateCreated mesh__D013763 1999-01-01
% 211.07/211.27  |- skos__broader mesh__D013763smesh__D003067
% 211.07/211.28  |- mesh__recordMaintainer mesh__D013763 ssb
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D013763 2006
% 211.07/211.28  |- mesh__dateEstablished mesh__D013763 1974-01-01
% 211.07/211.28  |- skos__broader mesh__D013763smesh__D005492
% 211.07/211.28  |- mesh__dateRevised mesh__D013763 2005-06-30
% 211.07/211.28  |- rdf__type mesh__D013763sskos__Concept
% 211.07/211.28  |- mesh__publicMeSHNote mesh__D013763 74   
% 211.07/211.28  |- skos__prefLabel mesh__D013763 Tetrahydrofolates
% 211.07/211.28  |- skos__historyNote mesh__D013763 Folic Acid %28%1966-1971%29%
% 211.07/211.28  |- mesh__historyNote mesh__D013763 74%28%72%29%   
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007726 2000
% 211.07/211.28  |- mesh__dateCreated mesh__D007726 1999-01-01
% 211.07/211.28  |- skos__broader mesh__D007726smesh__D005741
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007726 2001
% 211.07/211.28  |- rdf__type mesh__D007726sskos__Concept
% 211.07/211.28  |- mesh__recordOriginator mesh__D007726 NLM
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007726 1998
% 211.07/211.28  |- mesh__dateRevised mesh__D007726 1997-06-20
% 211.07/211.28  |- mesh__recordMaintainer mesh__D007726 ADP
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007726 2003
% 211.07/211.28  |- skos__related mesh__D007726smesh__D007727
% 211.07/211.28  |- skos__annotation mesh__D007726
% 211.07/211.28       a rare gas; Kr-84; Kr-78, 80, 82, 83, 86 = KRYPTON %28%IM%29% + ISOTOPES %28%NIM%29%; Kr-74-77, 79, 81, 85, 87-94 = KRYPTON RADIOISOTOPES %28%IM%29%%A%  
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007726 2002
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007726 1999
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007726 2005
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007726 2004
% 211.07/211.28  |- mesh__recordAuthorizer mesh__D007726 SJN
% 211.07/211.28  |- skos__prefLabel mesh__D007726 Krypton
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007726 2006
% 211.07/211.28  |- skos__scopeNote mesh__D007726
% 211.07/211.28       A noble gas that is found in the atmosphere. It has the atomic symbol Kr, atomic number 36, atomic weight 83.80, and has been used in electric bulbs.%A%    
% 211.07/211.28  |- skos__altLabel mesh__D031825 Primrose
% 211.07/211.28  |- skos__annotation mesh__D031825
% 211.07/211.28       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D031825 2005
% 211.07/211.28  |- skos__scopeNote mesh__D031825
% 211.07/211.28       A plant genus of the family PRIMULACEAE. It can cause CONTACT DERMATITIS. SAPONINS have been identified in the root.%A%    
% 211.07/211.28  |- mesh__publicMeSHNote mesh__D031825 2003   
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D031825 2006
% 211.07/211.28  |- skos__broader mesh__D031825smesh__D029623
% 211.07/211.28  |- mesh__historyNote mesh__D031825 2003   
% 211.07/211.28  |- skos__prefLabel mesh__D031825 Primula
% 211.07/211.28  |- mesh__dateEstablished mesh__D031825 2003-01-01
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D031825 2003
% 211.07/211.28  |- rdf__type mesh__D031825sskos__Concept
% 211.07/211.28  |- mesh__dateCreated mesh__D031825 2002-07-03
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D031825 2004
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017356 2002
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017356 1993
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017356 1994
% 211.07/211.28  |- skos__scopeNote mesh__D017356
% 211.07/211.28       Devices for accelerating protons or electrons in closed orbits where the accelerating voltage and magnetic field strength varies %28%the accelerating voltage is held constant for electrons%29% in order to keep the orbit radius constant.%A%    
% 211.07/211.28  |- mesh__publicMeSHNote mesh__D017356
% 211.07/211.28       93; was see PARTICLE ACCELERATORS 1978-92   
% 211.07/211.28  |- mesh__onlineNote mesh__D017356
% 211.07/211.28       use PARTICLE ACCELERATORS to search SYNCHROTRONS 1978-92   
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017356 1999
% 211.07/211.28  |- mesh__dateCreated mesh__D017356 1992-05-22
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017356 2006
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017356 1998
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017356 2001
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017356 1997
% 211.07/211.28  |- skos__annotation mesh__D017356
% 211.07/211.28       particle accelerators; do not confuse with SYNCHROCYCLOTRONS see CYCLOTRONS%A%  
% 211.07/211.28  |- mesh__historyNote mesh__D017356
% 211.07/211.28       93; was see PARTICLE ACCELERATORS 1978-92   
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017356 2005
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017356 2004
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017356 1996
% 211.07/211.28  |- skos__hiddenLabel mesh__D017356 Synchrotron
% 211.07/211.28  |- mesh__dateEstablished mesh__D017356 1993-01-01
% 211.07/211.28  |- skos__historyNote mesh__D017356 Particle Accelerators %28%1978-1992%29%
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017356 2000
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017356 2003
% 211.07/211.28  |- skos__prefLabel mesh__D017356 Synchrotrons
% 211.07/211.28  |- skos__broader mesh__D017356smesh__D010315
% 211.07/211.28  |- rdf__type mesh__D017356sskos__Concept
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017356 1995
% 211.07/211.28  |- skos__broader mesh__D001141Q000037smesh__D001141
% 211.07/211.28  |- mesh__preferredCombination mesh__D001141Q000037smesh__D047072
% 211.07/211.28  |- rdf__type mesh__D001141Q000037smesh__CompoundConcept
% 211.07/211.28  |- skos__hiddenLabel mesh__D003336 Quadrigeminal Plates
% 211.07/211.28  |- mesh__recordAuthorizer mesh__D003336 sjn
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D003336 2005
% 211.07/211.28  |- mesh__dateCreated mesh__D003336 1999-01-01
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D003336 2004
% 211.07/211.28  |- skos__scopeNote mesh__D003336
% 211.07/211.28       A composite substructure of the mesencephalic tectum comprised of the SUPERIOR COLLICULUS and INFERIOR COLLICULUS.%A%    
% 211.07/211.28  |- skos__hiddenLabel mesh__D003336 Mesencephalus, Tectum
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D003336 2006
% 211.07/211.28  |- skos__hiddenLabel mesh__D003336 Plates, Quadrigeminal
% 211.07/211.28  |- skos__hiddenLabel mesh__D003336 Quadrigemina, Lamina
% 211.07/211.28  |- skos__prefLabel mesh__D003336 Corpora Quadrigemina
% 211.07/211.28  |- skos__hiddenLabel mesh__D003336 Tectum Mesencephalus
% 211.07/211.28  |- skos__hiddenLabel mesh__D003336 Lobes, Human Optic
% 211.07/211.28  |- skos__hiddenLabel mesh__D003336 Human Optic Lobes
% 211.07/211.28  |- skos__hiddenLabel mesh__D003336 Optic Lobes, Human
% 211.07/211.28  |- mesh__recordMaintainer mesh__D003336 ags
% 211.07/211.28  |- skos__hiddenLabel mesh__D003336 Quadrigemina, Corpora
% 211.07/211.28  |- skos__altLabel mesh__D003336 Lamina Quadrigemina
% 211.07/211.28  |- skos__broader mesh__D003336smesh__D008636
% 211.07/211.28  |- skos__hiddenLabel mesh__D003336 Plate, Quadrigeminal
% 211.07/211.28  |- skos__altLabel mesh__D003336 Quadrigeminal Plate
% 211.07/211.28  |- skos__hiddenLabel mesh__D003336 Human Optic Lobe
% 211.07/211.28  |- rdf__type mesh__D003336sskos__Concept
% 211.07/211.28  |- skos__hiddenLabel mesh__D003336 Lobe, Human Optic
% 211.07/211.28  |- mesh__recordOriginator mesh__D003336 NLM
% 211.07/211.28  |- skos__altLabel mesh__D003336 Optic Lobe, Human
% 211.07/211.28  |- mesh__dateRevised mesh__D003336 2003-07-09
% 211.07/211.28  |- skos__broader mesh__D008021smesh__D004780
% 211.07/211.28  |- skos__related mesh__D008021smesh__D007185
% 211.07/211.28  |- skos__hiddenLabel mesh__D008021 Support Systems, Life
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D008021 2006
% 211.07/211.28  |- mesh__dateCreated mesh__D008021 1999-01-01
% 211.07/211.28  |- skos__hiddenLabel mesh__D008021 Systems, Life Support
% 211.07/211.28  |- skos__hiddenLabel mesh__D008021 System, Life Support
% 211.07/211.28  |- skos__prefLabel mesh__D008021 Life Support Systems
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D008021 2001
% 211.07/211.28  |- mesh__dateRevised mesh__D008021 1997-06-20
% 211.07/211.28  |- mesh__recordAuthorizer mesh__D008021 SJN
% 211.07/211.28  |- mesh__recordOriginator mesh__D008021 NLM
% 211.07/211.28  |- mesh__recordMaintainer mesh__D008021 PXP
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D008021 1998
% 211.07/211.28  |- mesh__historyNote mesh__D008021
% 211.07/211.28       91%28%66%29%; was see under SEALED CABIN ECOLOGY 1966-90   
% 211.07/211.28  |- rdf__type mesh__D008021sskos__Concept
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D008021 2002
% 211.07/211.28  |- skos__hiddenLabel mesh__D008021 Support System, Life
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D008021 2003
% 211.07/211.28  |- skos__hiddenLabel mesh__D008021 Life Support System
% 211.07/211.28  |- skos__scopeNote mesh__D008021
% 211.07/211.28       Systems that provide all or most of the items necessary for maintaining life and health. Provisions are made for the supplying of oxygen, food, water, temperature and pressure control, disposition of carbon dioxide and body waste. The milieu may be a spacecraft, a submarine, or the surface of the moon. In medical care, usually under hospital conditions, LIFE SUPPORT CARE is available. %28%From Webster%27%s New Collegiate Dictionary%29%%A%    
% 211.07/211.28  |- mesh__dateEstablished mesh__D008021 1991-01-01
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D008021 1999
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D008021 2005
% 211.07/211.28  |- mesh__publicMeSHNote mesh__D008021
% 211.07/211.28       91; was see under SEALED CABIN ECOLOGY 1966-90   
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D008021 2004
% 211.07/211.28  |- skos__annotation mesh__D008021
% 211.07/211.28       do not confuse with LIFE SUPPORT CARE: read MeSH definition%A%  
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D008021 2000
% 211.07/211.28  |- rdf__type mesh__D013764sskos__Concept
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D013764 2000
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D013764 1997
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D013764 2004
% 211.07/211.28  |- mesh__dateRevised mesh__D013764 1993-06-03
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D013764 2003
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D013764 1996
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D013764 1995
% 211.07/211.28  |- mesh__dateEstablished mesh__D013764 1991-01-01
% 211.07/211.28  |- skos__historyNote mesh__D013764 Naphthalenes %28%1966-1977%29%
% 211.07/211.28  |- skos__scopeNote mesh__D013764
% 211.07/211.28       Partially saturated 1,2,3,4-tetrahydronaphthalene compounds.%A%    
% 211.07/211.28  |- skos__altLabel mesh__D013764 Tetralins
% 211.07/211.28  |- mesh__dateCreated mesh__D013764 1977-05-17
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D013764 1994
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D013764 2002
% 211.07/211.28  |- mesh__historyNote mesh__D013764
% 211.07/211.28       91%28%78%29%; was see under NAPHTHALENES 1978-90   
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D013764 1999
% 211.07/211.28  |- mesh__recordAuthorizer mesh__D013764 PLS
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D013764 2006
% 211.07/211.28  |- skos__broader mesh__D013764smesh__D009281
% 211.07/211.28  |- mesh__publicMeSHNote mesh__D013764
% 211.07/211.28       91; was see under NAPHTHALENES 1978-90   
% 211.07/211.28  |- mesh__recordMaintainer mesh__D013764 PLS
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D013764 2001
% 211.07/211.28  |- skos__prefLabel mesh__D013764 Tetrahydronaphthalenes
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D013764 1998
% 211.07/211.28  |- mesh__recordOriginator mesh__D013764 RLS
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D013764 2005
% 211.07/211.28  |- skos__historyNote mesh__D007727 Radioisotopes %28%1966-1987%29%
% 211.07/211.28  |- mesh__recordMaintainer mesh__D007727 TPW
% 211.07/211.28  |- rdf__type mesh__D007727sskos__Concept
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007727 1996
% 211.07/211.28  |- skos__annotation mesh__D007727
% 211.07/211.28       Kr-74-77, 79, 81, 85, 87-94; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 211.07/211.28  |- mesh__historyNote mesh__D007727 88   
% 211.07/211.28  |- skos__broader mesh__D007727smesh__D011868
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007727 2000
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007727 1998
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007727 1997
% 211.07/211.28  |- skos__hiddenLabel mesh__D007727 Radioisotopes, Krypton
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007727 2003
% 211.07/211.28  |- mesh__dateRevised mesh__D007727 1993-06-02
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007727 2001
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007727 1999
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007727 2005
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007727 2004
% 211.07/211.28  |- skos__scopeNote mesh__D007727
% 211.07/211.28       Unstable isotopes of krypton that decay or disintegrate emitting radiation. Kr atoms with atomic weights 74-77, 79, 81, 85, and 87-94 are radioactive krypton isotopes.%A%    
% 211.07/211.28  |- mesh__recordAuthorizer mesh__D007727 PLS
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007727 1994
% 211.07/211.28  |- mesh__dateEstablished mesh__D007727 1988-01-01
% 211.07/211.28  |- skos__prefLabel mesh__D007727 Krypton Radioisotopes
% 211.07/211.28  |- skos__historyNote mesh__D007727 Krypton %28%1966-1987%29%
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007727 2006
% 211.07/211.28  |- mesh__dateCreated mesh__D007727 1987-04-08
% 211.07/211.28  |- mesh__publicMeSHNote mesh__D007727 88   
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007727 1995
% 211.07/211.28  |- mesh__recordOriginator mesh__D007727 RLS
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007727 2002
% 211.07/211.28  |- skos__prefLabel mesh__D051883 Receptor, Notch2
% 211.07/211.28  |- mesh__dateEstablished mesh__D051883 2006-01-01
% 211.07/211.28  |- mesh__publicMeSHNote mesh__D051883
% 211.07/211.28       2006; RECEPTOR, NOTCH2 was indexed under RECEPTORS, CELL SURFACE 1995-2005%A%  
% 211.07/211.28  |- rdf__type mesh__D051883sskos__Concept
% 211.07/211.28  |- mesh__recordOriginator mesh__D051883 DRC
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D051883 2006
% 211.07/211.28  |- skos__broader mesh__D051883smesh__D051880
% 211.07/211.28  |- skos__altLabel mesh__D051883 Notch2 Receptor
% 211.07/211.28  |- skos__scopeNote mesh__D051883
% 211.07/211.28       A notch receptor that plays an important role in CELL DIFFERENTIATION in a variety of cell types. It is the preferentially expressed notch receptor in mature B-LYMPHOCYTES.%A%    
% 211.07/211.28  |- mesh__dateCreated mesh__D051883 2005-06-30
% 211.07/211.28  |- mesh__recordMaintainer mesh__D051883 DRC
% 211.07/211.28  |- skos__altLabel mesh__D051883 Notch2 Protein
% 211.07/211.28  |- mesh__historyNote mesh__D051883 2006%28%1995%29%   
% 211.07/211.28  |- mesh__recordAuthorizer mesh__D051883 sjn
% 211.07/211.28  |- mesh__dateCreated mesh__D031826 2002-07-03
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D031826 2003
% 211.07/211.28  |- rdf__type mesh__D031826sskos__Concept
% 211.07/211.28  |- skos__prefLabel mesh__D031826 Punicaceae
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D031826 2004
% 211.07/211.28  |- skos__scopeNote mesh__D031826
% 211.07/211.28       A plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida that is a small family with a single genus.%A%    
% 211.07/211.28  |- skos__annotation mesh__D031826
% 211.07/211.28       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.07/211.28  |- skos__broader mesh__D031826smesh__D019684
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D031826 2005
% 211.07/211.28  |- mesh__publicMeSHNote mesh__D031826 2003   
% 211.07/211.28  |- mesh__historyNote mesh__D031826 2003   
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D031826 2006
% 211.07/211.28  |- mesh__dateEstablished mesh__D031826 2003-01-01
% 211.07/211.28  |- skos__broader mesh__D017357smesh__D010315
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017357 1999
% 211.07/211.28  |- mesh__onlineNote mesh__D017357
% 211.07/211.28       use PARTICLE ACCELERATORS to search CYCLOTRONS %26% SYNCHROCYCLOTRONS 1978-92%A%  
% 211.07/211.28  |- skos__historyNote mesh__D017357 Neutrons %28%1966-1977%29%
% 211.07/211.28  |- mesh__publicMeSHNote mesh__D017357
% 211.07/211.28       93; was see PARTICLE ACCELERATORS 1978-92; SYNCHROCYCLOTRONS was see PARTICLE ACCELERATORS 1978-92%A%  
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017357 2006
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017357 1998
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017357 2002
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017357 1997
% 211.07/211.28  |- mesh__dateCreated mesh__D017357 1992-05-07
% 211.07/211.28  |- skos__hiddenLabel mesh__D017357 Cyclotron
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017357 2005
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017357 2004
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017357 1996
% 211.07/211.28  |- skos__historyNote mesh__D017357 Particle Accelerators %28%1978-1992%29%
% 211.07/211.28  |- skos__historyNote mesh__D017357 Fast Neutrons %28%1971-1977%29%
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017357 2003
% 211.07/211.28  |- skos__annotation mesh__D017357
% 211.07/211.28       particle accelerators; do not confuse X ref SYNCHROCYCLOTRONS with SYNCHROTRONS%A%  
% 211.07/211.28  |- rdf__type mesh__D017357sskos__Concept
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017357 2001
% 211.07/211.28  |- skos__hiddenLabel mesh__D017357 Synchrocyclotron
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017357 1995
% 211.07/211.28  |- mesh__dateEstablished mesh__D017357 1993-01-01
% 211.07/211.28  |- skos__historyNote mesh__D017357 Nuclear Medicine %28%1967-1977%29%
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017357 1993
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017357 1994
% 211.07/211.28  |- skos__prefLabel mesh__D017357 Cyclotrons
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D017357 2000
% 211.07/211.28  |- skos__scopeNote mesh__D017357
% 211.07/211.28       Devices for accelerating charged particles in a spiral path by a constant-frequency alternating electric field. This electric field is synchronized with the movement of the particles in a constant magnetic field.%A%    
% 211.07/211.28  |- mesh__historyNote mesh__D017357
% 211.07/211.28       93; was see PARTICLE ACCELERATORS 1978-92; SYNCHROCYCLOTRONS was see PARTICLE ACCELERATORS 1978-92%A%  
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D003337 1995
% 211.07/211.28  |- mesh__dateCreated mesh__D003337 1999-01-01
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D003337 2003
% 211.07/211.28  |- skos__hiddenLabel mesh__D003337 Callosum, Corpus
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D003337 1996
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D003337 2000
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D003337 2005
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D003337 2004
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D003337 1998
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D003337 1997
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D003337 2001
% 211.07/211.28  |- mesh__dateRevised mesh__D003337 1992-05-14
% 211.07/211.28  |- skos__scopeNote mesh__D003337
% 211.07/211.28       Broad plate of dense myelinated fibers that reciprocally interconnect regions of the cortex in all lobes with corresponding regions of the opposite hemisphere. The corpus callosum is located deep in the longitudinal fissure.%A%    
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D003337 2006
% 211.07/211.28  |- mesh__recordMaintainer mesh__D003337 TAP
% 211.07/211.28  |- skos__hiddenLabel mesh__D003337 Corpus Callosums
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D003337 1999
% 211.07/211.28  |- skos__broader mesh__D003337smesh__D013687
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D003337 1994
% 211.07/211.28  |- mesh__recordOriginator mesh__D003337 NLM
% 211.07/211.28  |- rdf__type mesh__D003337sskos__Concept
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D003337 1993
% 211.07/211.28  |- skos__hiddenLabel mesh__D003337 Callosums, Corpus
% 211.07/211.28  |- skos__prefLabel mesh__D003337 Corpus Callosum
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D003337 2002
% 211.07/211.28  |- mesh__recordAuthorizer mesh__D003337 PLS
% 211.07/211.28  |- mesh__recordOriginator mesh__D008820 NLM
% 211.07/211.28  |- mesh__historyNote mesh__D008820 75   
% 211.07/211.28  |- skos__altLabel mesh__D008820 Hyperglycemic Mice
% 211.07/211.28  |- mesh__dateEstablished mesh__D008820 1975-09-01
% 211.07/211.28  |- skos__hiddenLabel mesh__D008820 Obese Mouse
% 211.07/211.28  |- skos__prefLabel mesh__D008820 Mice, Obese
% 211.07/211.28  |- mesh__recordAuthorizer mesh__D008820 sjn
% 211.07/211.28  |- mesh__publicMeSHNote mesh__D008820 75   
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D008820 2006
% 211.07/211.28  |- skos__altLabel mesh__D008820 Obese Mice
% 211.07/211.28  |- mesh__recordMaintainer mesh__D008820 ags
% 211.07/211.28  |- skos__broader mesh__D008820smesh__D008817
% 211.07/211.28  |- mesh__dateCreated mesh__D008820 1974-11-11
% 211.07/211.28  |- skos__scopeNote mesh__D008820
% 211.07/211.28       Mutant mice exhibiting a marked obesity coupled with overeating, hyperglycemia, hyperinsulinemia, marked insulin resistance, and infertility when in a homozygous state. They may be inbred or hybrid.%A%    
% 211.07/211.28  |- skos__altLabel mesh__D008820 Mouse, Obese
% 211.07/211.28  |- skos__hiddenLabel mesh__D008820 Hyperglycemic Mouse
% 211.07/211.28  |- skos__annotation mesh__D008820
% 211.07/211.28       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE; for X ref HYPERGLYCEMIC MICE do not add HYPERGLYCEMIA or OBESITY unless particularly discussed as diseases%A%  
% 211.07/211.28  |- skos__hiddenLabel mesh__D008820 Mice, Hyperglycemic
% 211.07/211.28  |- skos__historyNote mesh__D008820 Mice %28%1966-1974%29%
% 211.07/211.28  |- rdf__type mesh__D008820sskos__Concept
% 211.07/211.28  |- mesh__dateRevised mesh__D008820 2005-06-30
% 211.07/211.28  |- skos__annotation mesh__D008022
% 211.07/211.28       IM; coord with site %28%IM%29%; joint ligaments = LIGAMENTS, ARTICULAR%A%  
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D008022 2003
% 211.07/211.28  |- skos__prefLabel mesh__D008022 Ligaments
% 211.07/211.28  |- mesh__recordAuthorizer mesh__D008022 sjn
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D008022 2006
% 211.07/211.28  |- skos__scopeNote mesh__D008022
% 211.07/211.28       Shiny, flexible bands of fibrous tissue connecting together articular extremities of bones. They are pliant, tough, and inextensile.%A%    
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D008022 2002
% 211.07/211.28  |- mesh__dateCreated mesh__D008022 1999-01-01
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D008022 2005
% 211.07/211.28  |- mesh__dateRevised mesh__D008022 1999-11-03
% 211.07/211.28  |- skos__broader mesh__D008022smesh__D009141
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D008022 2004
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D008022 2001
% 211.07/211.28  |- rdf__type mesh__D008022sskos__Concept
% 211.07/211.28  |- mesh__recordMaintainer mesh__D008022 KEV
% 211.07/211.28  |- mesh__recordOriginator mesh__D008022 NLM
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D008022 2000
% 211.07/211.28  |- skos__hiddenLabel mesh__D008022 Ligament
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D013765 2005
% 211.07/211.28  |- mesh__dateRevised mesh__D013765 2003-07-09
% 211.07/211.28  |- mesh__publicMeSHNote mesh__D013765
% 211.07/211.28       91; was see under PAPAVERINE 1978-90   
% 211.07/211.28  |- skos__broader mesh__D013765smesh__D010208
% 211.07/211.28  |- skos__scopeNote mesh__D013765
% 211.07/211.28       A leukomaine %28%animal alkaloid%29% formed in brain and liver from dopamine and L-dopa; it may be implicated in psychiatric problems.%A%    
% 211.07/211.28  |- skos__historyNote mesh__D013765 Quinolines %28%1966-1973%29%
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D013765 2004
% 211.07/211.28  |- mesh__dateEstablished mesh__D013765 1991-01-01
% 211.07/211.28  |- skos__historyNote mesh__D013765 Papaverine %28%1966-1977%29%
% 211.07/211.28  |- skos__altLabel mesh__D013765 Tetrahydroxypapaveroline
% 211.07/211.28  |- skos__annotation mesh__D013765 /biosyn /physiol permitted   
% 211.07/211.28  |- mesh__recordMaintainer mesh__D013765 ssb
% 211.07/211.28  |- mesh__recordAuthorizer mesh__D013765 sjn
% 211.07/211.28  |- mesh__historyNote mesh__D013765
% 211.07/211.28       91%28%78%29%; was see under PAPAVERINE 1978-90   
% 211.07/211.28  |- skos__historyNote mesh__D013765 Alcohols %28%1966-1973%29%
% 211.07/211.28  |- skos__altLabel mesh__D013765 Norlaudanosoline
% 211.07/211.28  |- skos__prefLabel mesh__D013765 Tetrahydropapaveroline
% 211.07/211.28  |- skos__historyNote mesh__D013765 Benzene Derivatives %28%1968-1973%29%
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D013765 2006
% 211.07/211.28  |- rdf__type mesh__D013765sskos__Concept
% 211.07/211.28  |- mesh__dateCreated mesh__D013765 1977-03-01
% 211.07/211.28  |- mesh__recordOriginator mesh__D013765 SH
% 211.07/211.28  |- skos__annotation mesh__D007728
% 211.07/211.28       also called reticuloendothelial cells of liver   
% 211.07/211.28  |- skos__historyNote mesh__D007728 Macrophages %28%1966-1972%29%
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007728 2005
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007728 2004
% 211.07/211.28  |- skos__broader mesh__D007728smesh__D008264
% 211.07/211.28  |- skos__prefLabel mesh__D007728 Kupffer Cells
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D007728 2006
% 211.07/211.28  |- skos__hiddenLabel mesh__D007728 Cells, Kupffer
% 211.07/211.28  |- mesh__recordAuthorizer mesh__D007728 sjn
% 211.07/211.28  |- mesh__recordMaintainer mesh__D007728 nns
% 211.07/211.28  |- mesh__historyNote mesh__D007728 73   
% 211.07/211.28  |- mesh__dateEstablished mesh__D007728 1973-01-01
% 211.07/211.28  |- mesh__dateCreated mesh__D007728 1999-01-01
% 211.07/211.28  |- rdf__type mesh__D007728sskos__Concept
% 211.07/211.28  |- mesh__publicMeSHNote mesh__D007728 73   
% 211.07/211.28  |- skos__scopeNote mesh__D007728
% 211.07/211.28       Specialized phagocytic cells of the RETICULOENDOTHELIAL SYSTEM found on the luminal surface of the hepatic sinusoids. They filter bacteria and small foreign proteins out of the blood, and dispose of worn out red blood cells.%A%    
% 211.07/211.28  |- mesh__dateRevised mesh__D007728 2003-07-09
% 211.07/211.28  |- mesh__recordOriginator mesh__D007728 NLM
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D018450 2002
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D018450 2004
% 211.07/211.28  |- mesh__recordOriginator mesh__D018450 AGS
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D018450 2001
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D018450 2003
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D018450 2000
% 211.07/211.28  |- skos__hiddenLabel mesh__D018450 Progression, Disease
% 211.07/211.28  |- skos__hiddenLabel mesh__D018450 Progressions, Disease
% 211.07/211.28  |- mesh__dateRevised mesh__D018450 1999-11-03
% 211.07/211.28  |- mesh__recordMaintainer mesh__D018450 KEV
% 211.07/211.28  |- skos__broader mesh__D018450smesh__D020969
% 211.07/211.28  |- skos__prefLabel mesh__D018450 Disease Progression
% 211.07/211.28  |- skos__hiddenLabel mesh__D018450 Disease Progressions
% 211.07/211.28  |- mesh__historyNote mesh__D018450 95   
% 211.07/211.28  |- skos__scopeNote mesh__D018450
% 211.07/211.28       The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.%A%    
% 211.07/211.28  |- mesh__dateEstablished mesh__D018450 1995-01-01
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D018450 2006
% 211.07/211.28  |- skos__annotation mesh__D018450
% 211.07/211.28       almost never IM; coord NIM with specific disease %28%IM%29%; since most dis %22%progress%22% unless arrested spontaneously, by med intervention or death, do not index here at all unless particularly discussed as a stage in determ of progn or ther; no qualif; DF: DIS PROGRESSION%A%  
% 211.07/211.28  |- mesh__recordAuthorizer mesh__D018450 sjn
% 211.07/211.28  |- mesh__publicMeSHNote mesh__D018450 95   
% 211.07/211.28  |- rdf__type mesh__D018450sskos__Concept
% 211.07/211.28  |- mesh__dateCreated mesh__D018450 1994-04-19
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D018450 2005
% 211.07/211.28  |- mesh__publicMeSHNote mesh__D032121 2003   
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D032121 2006
% 211.07/211.28  |- skos__prefLabel mesh__D032121 Salvadoraceae
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D032121 2005
% 211.07/211.28  |- rdf__type mesh__D032121sskos__Concept
% 211.07/211.28  |- skos__scopeNote mesh__D032121
% 211.07/211.28       A plant family of the order Celastrales, subclass Rosidae, class Magnoliopsida, a small family growing in the tropics. Members contain piperidine alkaloids and GLUCOSINOLATES.%A%    
% 211.07/211.28  |- mesh__dateEstablished mesh__D032121 2003-01-01
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D032121 2004
% 211.07/211.28  |- skos__annotation mesh__D032121
% 211.07/211.28       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.07/211.28  |- mesh__dateCreated mesh__D032121 2002-07-03
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D032121 2003
% 211.07/211.28  |- skos__broader mesh__D032121smesh__D019684
% 211.07/211.28  |- mesh__historyNote mesh__D032121 2003   
% 211.07/211.28  |- skos__hiddenLabel mesh__D004430 Earplug
% 211.07/211.28  |- mesh__activeMeSHYear mesh__D004430 2003
% 211.07/211.29  |- skos__hiddenLabel mesh__D004430 Protective Device, Ear
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D004430 2005
% 211.07/211.29  |- mesh__recordMaintainer mesh__D004430 lkt
% 211.07/211.29  |- skos__hiddenLabel mesh__D004430 Earmuff
% 211.07/211.29  |- skos__hiddenLabel mesh__D004430 Ear Protective Device
% 211.07/211.29  |- mesh__recordAuthorizer mesh__D004430 sjn
% 211.07/211.29  |- mesh__recordOriginator mesh__D004430 NLM
% 211.07/211.29  |- skos__hiddenLabel mesh__D004430 Device, Ear Protective
% 211.07/211.29  |- skos__scopeNote mesh__D004430
% 211.07/211.29       Personal devices for protection of the ears from loud or high intensity noise, water, or cold. These include earmuffs and earplugs.%A%    
% 211.07/211.29  |- skos__hiddenLabel mesh__D004430 Device, Hearing Protective
% 211.07/211.29  |- rdf__type mesh__D004430sskos__Concept
% 211.07/211.29  |- skos__hiddenLabel mesh__D004430 Devices, Ear Protective
% 211.07/211.29  |- skos__hiddenLabel mesh__D004430 Hearing Protective Device
% 211.07/211.29  |- mesh__dateEstablished mesh__D004430 1991-01-01
% 211.07/211.29  |- skos__hiddenLabel mesh__D004430 Protective Devices, Hearing
% 211.07/211.29  |- skos__broader mesh__D004430smesh__D011481
% 211.07/211.29  |- skos__hiddenLabel mesh__D004430 Devices, Hearing Protective
% 211.07/211.29  |- mesh__historyNote mesh__D004430 91%28%75%29%   
% 211.07/211.29  |- mesh__dateRevised mesh__D004430 2002-07-03
% 211.07/211.29  |- skos__broader mesh__D004430smesh__D011482
% 211.07/211.29  |- mesh__publicMeSHNote mesh__D004430 91; see PROTECTIVE DEVICES 1975-90   
% 211.07/211.29  |- skos__hiddenLabel mesh__D004430 Protective Device, Hearing
% 211.07/211.29  |- skos__prefLabel mesh__D004430 Ear Protective Devices
% 211.07/211.29  |- mesh__dateCreated mesh__D004430 1974-12-12
% 211.07/211.29  |- skos__hiddenLabel mesh__D004430 Protective Devices, Ear
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D004430 2004
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D004430 2006
% 211.07/211.29  |- mesh__historyNote mesh__D031827 2003   
% 211.07/211.29  |- mesh__dateEstablished mesh__D031827 2003-01-01
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D031827 2003
% 211.07/211.29  |- rdf__type mesh__D031827sskos__Concept
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D031827 2004
% 211.07/211.29  |- skos__annotation mesh__D031827
% 211.07/211.29       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D031827 2005
% 211.07/211.29  |- mesh__dateCreated mesh__D031827 2002-07-03
% 211.07/211.29  |- mesh__publicMeSHNote mesh__D031827 2003   
% 211.07/211.29  |- skos__scopeNote mesh__D031827
% 211.07/211.29       A plant family of the order Ericales, subclass Dilleniidae, class Magnoliopsida.%A%    
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D031827 2006
% 211.07/211.29  |- skos__prefLabel mesh__D031827 Pyrolaceae
% 211.07/211.29  |- skos__broader mesh__D031827smesh__D019684
% 211.07/211.29  |- skos__historyNote mesh__D017358 Peptides %28%1974-1975%29%
% 211.07/211.29  |- mesh__onlineNote mesh__D017358
% 211.07/211.29       use CELL WALL SKELETON %28%NM%29% to search CELL WALL SKELETON 1982-92%A%  
% 211.07/211.29  |- rdf__type mesh__D017358sskos__Concept
% 211.07/211.29  |- skos__historyNote mesh__D017358 Mycolic Acids %28%1976-1992%29%
% 211.07/211.29  |- mesh__recordMaintainer mesh__D017358 lkt
% 211.07/211.29  |- mesh__recordOriginator mesh__D017358 TPW
% 211.07/211.29  |- skos__annotation mesh__D017358
% 211.07/211.29       restrict to bacteria; a mucoprotein of the bact cell wall: do not confuse with CYTOSKELETON, a network within the cytoplasm; coord IM with specific bacterium /ultrastruct, /chem or other pertinent qualif%A%  
% 211.07/211.29  |- skos__historyNote mesh__D017358 Polysaccharides %28%1974-1975%29%
% 211.07/211.29  |- mesh__dateCreated mesh__D017358 1992-05-13
% 211.07/211.29  |- mesh__historyNote mesh__D017358
% 211.07/211.29       93; was CELL WALL SKELETON %28%NM%29% 1974-92   
% 211.07/211.29  |- mesh__dateRevised mesh__D017358 2005-06-30
% 211.07/211.29  |- mesh__publicMeSHNote mesh__D017358
% 211.07/211.29       93; CELL WALL SKELETON was indexed under MYCOLIC ACIDS %26% MUCOPROTEINS 1976-92 %26% POLYSACCHARIDES %26% PEPTIDES 1974-75%A%  
% 211.07/211.29  |- skos__historyNote mesh__D017358 Mucoproteins %28%1976-1992%29%
% 211.07/211.29  |- skos__broader mesh__D017358smesh__D009088
% 211.07/211.29  |- skos__broader mesh__D017358smesh__D001426
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D017358 2006
% 211.07/211.29  |- mesh__recordAuthorizer mesh__D017358 sjn
% 211.07/211.29  |- skos__prefLabel mesh__D017358 Cell Wall Skeleton
% 211.07/211.29  |- mesh__dateEstablished mesh__D017358 1993-01-01
% 211.07/211.29  |- skos__broader mesh__D017358smesh__D002473
% 211.07/211.29  |- skos__scopeNote mesh__D017358
% 211.07/211.29       A mucoprotein found in the cell wall of various types of bacteria. It has adjuvant and antitumor activities and has been used to augment the production of lymphokine-activated killer %28%LAK%29% cells.%A%    
% 211.07/211.29  |- rdf__type mesh__D003338sskos__Concept
% 211.07/211.29  |- mesh__recordMaintainer mesh__D003338 lkt
% 211.07/211.29  |- mesh__recordOriginator mesh__D003338 NLM
% 211.07/211.29  |- mesh__dateRevised mesh__D003338 2002-07-03
% 211.07/211.29  |- skos__related mesh__D003338smesh__D008186
% 211.07/211.29  |- skos__broader mesh__D003338smesh__D010053
% 211.07/211.29  |- mesh__recordAuthorizer mesh__D003338 sjn
% 211.07/211.29  |- skos__altLabel mesh__D003338 Corpora Lutea
% 211.07/211.29  |- skos__hiddenLabel mesh__D003338 Lutea, Corpora
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D003338 2004
% 211.07/211.29  |- mesh__dateCreated mesh__D003338 1999-01-01
% 211.07/211.29  |- skos__annotation mesh__D003338 /cytol: consider also LUTEAL CELLS   
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D003338 2003
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D003338 2006
% 211.07/211.29  |- skos__prefLabel mesh__D003338 Corpus Luteum
% 211.07/211.29  |- skos__scopeNote mesh__D003338
% 211.07/211.29       The yellow body derived from the ruptured OVARIAN FOLLICLE after OVULATION. The process of corpus luteum formation, LUTEINIZATION, is regulated by LUTEINIZING HORMONE.%A%    
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D003338 2005
% 211.07/211.29  |- mesh__dateCreated mesh__D014060 1999-01-01
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D014060 1994
% 211.07/211.29  |- skos__annotation mesh__D014060 inflamm dis = GLOSSITIS   
% 211.07/211.29  |- skos__broader mesh__D014060smesh__D009059
% 211.07/211.29  |- mesh__recordMaintainer mesh__D014060 PLS
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D014060 1993
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D014060 2005
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D014060 1999
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D014060 1991
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D014060 1992
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D014060 2004
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D014060 1998
% 211.07/211.29  |- rdf__type mesh__D014060sskos__Concept
% 211.07/211.29  |- mesh__recordOriginator mesh__D014060 NLM
% 211.07/211.29  |- mesh__recordAuthorizer mesh__D014060 NLM
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D014060 2002
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D014060 2003
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D014060 1997
% 211.07/211.29  |- mesh__dateEstablished mesh__D014060 1965-01-01
% 211.07/211.29  |- skos__hiddenLabel mesh__D014060 Tongue Disease
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D014060 2001
% 211.07/211.29  |- mesh__dateRevised mesh__D014060 1990-05-29
% 211.07/211.29  |- skos__prefLabel mesh__D014060 Tongue Diseases
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D014060 1996
% 211.07/211.29  |- mesh__historyNote mesh__D014060 65   
% 211.07/211.29  |- skos__hiddenLabel mesh__D014060 Disease, Tongue
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D014060 2000
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D014060 1995
% 211.07/211.29  |- mesh__publicMeSHNote mesh__D014060 65   
% 211.07/211.29  |- skos__hiddenLabel mesh__D014060 Diseases, Tongue
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D014060 2006
% 211.07/211.29  |- skos__hiddenLabel mesh__D008821 Quaking Mice
% 211.07/211.29  |- skos__prefLabel mesh__D008821 Mice, Quaking
% 211.07/211.29  |- mesh__dateRevised mesh__D008821 2005-06-30
% 211.07/211.29  |- mesh__publicMeSHNote mesh__D008821 78   
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D008821 2006
% 211.07/211.29  |- skos__historyNote mesh__D008821 Mice %28%1966-1977%29%
% 211.07/211.29  |- mesh__dateCreated mesh__D008821 1977-05-12
% 211.07/211.29  |- mesh__recordMaintainer mesh__D008821 ags
% 211.07/211.29  |- skos__annotation mesh__D008821
% 211.07/211.29       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%  
% 211.07/211.29  |- mesh__recordOriginator mesh__D008821 EC
% 211.07/211.29  |- mesh__historyNote mesh__D008821 78   
% 211.07/211.29  |- mesh__recordAuthorizer mesh__D008821 sjn
% 211.07/211.29  |- mesh__dateEstablished mesh__D008821 1978-01-01
% 211.07/211.29  |- skos__historyNote mesh__D008821 Mutation %28%1966-1977%29%
% 211.07/211.29  |- rdf__type mesh__D008821sskos__Concept
% 211.07/211.29  |- skos__broader mesh__D008821smesh__D008817
% 211.07/211.29  |- skos__scopeNote mesh__D008821
% 211.07/211.29       Mice homozygous for the mutant autosomal recessive gene, quaking %28%qk%29%, associated with disorder in myelin formation and manifested by axial tremors.%A%    
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D008023 2001
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D008023 1998
% 211.07/211.29  |- skos__annotation mesh__D008023
% 211.07/211.29       IM; coord with specific joint %28%IM%29%   
% 211.07/211.29  |- mesh__publicMeSHNote mesh__D008023 65   
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D008023 2006
% 211.07/211.29  |- mesh__recordOriginator mesh__D008023 NLM
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D008023 2000
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D008023 1994
% 211.07/211.29  |- mesh__dateCreated mesh__D008023 1999-01-01
% 211.07/211.29  |- skos__broader mesh__D008023smesh__D007596
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D008023 2005
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D008023 1989
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D008023 1997
% 211.07/211.29  |- mesh__recordMaintainer mesh__D008023 GJB
% 211.07/211.29  |- skos__hiddenLabel mesh__D008023 Ligament, Articular
% 211.07/211.29  |- mesh__dateRevised mesh__D008023 1978-11-24
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D008023 1991
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D008023 1993
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D008023 2002
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D008023 1996
% 211.07/211.29  |- mesh__dateEstablished mesh__D008023 1965-01-01
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D008023 2004
% 211.07/211.29  |- mesh__recordAuthorizer mesh__D008023 NLM
% 211.07/211.29  |- skos__prefLabel mesh__D008023 Ligaments, Articular
% 211.07/211.29  |- rdf__type mesh__D008023sskos__Concept
% 211.07/211.29  |- skos__hiddenLabel mesh__D008023 Articular Ligaments
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D008023 1992
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D008023 1999
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D008023 2003
% 211.07/211.29  |- skos__hiddenLabel mesh__D008023 Articular Ligament
% 211.07/211.29  |- mesh__historyNote mesh__D008023 65   
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D008023 1990
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D008023 1995
% 211.07/211.29  |- skos__broader mesh__D008023smesh__D008022
% 211.07/211.29  |- rdf__type mesh__D000040sskos__Concept
% 211.07/211.29  |- mesh__dateEstablished mesh__D000040 1991-01-01
% 211.07/211.29  |- skos__altLabel mesh__D000040 Abscissins
% 211.07/211.29  |- skos__broader mesh__D000040smesh__D012717
% 211.07/211.29  |- mesh__publicMeSHNote mesh__D000040
% 211.07/211.29       93; see ABSCISSINS 1991-92, see CYCLOHEXANECARBOXYLIC ACID 1975-90%A%  
% 211.07/211.29  |- skos__altLabel mesh__D000040 Abscissic Acid
% 211.07/211.29  |- skos__broader mesh__D000040smesh__D003509
% 211.07/211.29  |- mesh__recordAuthorizer mesh__D000040 sjn
% 211.07/211.29  |- mesh__historyNote mesh__D000040 93%28%75%29%   
% 211.07/211.29  |- mesh__dateCreated mesh__D000040 1974-11-19
% 211.07/211.29  |- mesh__dateRevised mesh__D000040 2005-06-30
% 211.07/211.29  |- mesh__recordOriginator mesh__D000040 NLM
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D000040 2006
% 211.07/211.29  |- skos__historyNote mesh__D000040 Cyclohexanecarboxylic Acids %28%1974%29%
% 211.07/211.29  |- skos__scopeNote mesh__D000040
% 211.07/211.29       Abscission-accelerating plant growth substance isolated from young cotton fruit, leaves of sycamore, birch, and other plants, and from potatoes, lemons, avocados, and other fruits.%A%    
% 211.07/211.29  |- mesh__recordMaintainer mesh__D000040 ssb
% 211.07/211.29  |- skos__prefLabel mesh__D000040 Abscisic Acid
% 211.07/211.29  |- mesh__historyNote mesh__D046940 2005   
% 211.07/211.29  |- mesh__dateCreated mesh__D046940 2004-07-07
% 211.07/211.29  |- mesh__recordOriginator mesh__D046940 ags
% 211.07/211.29  |- skos__scopeNote mesh__D046940
% 211.07/211.29       A form-genus of spherical to rod-shaped CYANOBACTERIA in the order Chroococcales. They contain THYLAKOIDS and are found in a wide range of habitats.%A%    
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D046940 2006
% 211.07/211.29  |- mesh__dateRevised mesh__D046940 2005-06-30
% 211.07/211.29  |- skos__historyNote mesh__D046940 Cyanobacteria %28%1971-2004%29%
% 211.07/211.29  |- skos__broader mesh__D046940smesh__D000458
% 211.07/211.29  |- rdf__type mesh__D046940sskos__Concept
% 211.07/211.29  |- mesh__recordAuthorizer mesh__D046940 sjn
% 211.07/211.29  |- skos__prefLabel mesh__D046940 Synechococcus
% 211.07/211.29  |- mesh__publicMeSHNote mesh__D046940 2005   
% 211.07/211.29  |- mesh__dateEstablished mesh__D046940 2005-01-01
% 211.07/211.29  |- mesh__recordMaintainer mesh__D046940 SYSTEM
% 211.07/211.29  |- mesh__dateEstablished mesh__D013766 1991-01-01
% 211.07/211.29  |- skos__altLabel mesh__D013766
% 211.07/211.29       Methyltetrahydrofolate Homocysteine Methyltransferase
% 211.07/211.29  |- mesh__historyNote mesh__D013766 98%28%75%29%   
% 211.07/211.29  |- skos__historyNote mesh__D013766 Methyltransferases %28%1973-1974%29%
% 211.07/211.29  |- skos__hiddenLabel mesh__D013766
% 211.07/211.29       Homocysteine Methyltransferase, Methyltetrahydrofolate
% 211.07/211.29  |- skos__related mesh__D013766smesh__D006712
% 211.07/211.29  |- skos__hiddenLabel mesh__D013766
% 211.07/211.29       Methyltransferase, Methyltetrahydrofolate Homocysteine
% 211.07/211.29  |- mesh__dateRevised mesh__D013766 2005-06-30
% 211.07/211.29  |- skos__altLabel mesh__D013766 Methionine Synthase
% 211.07/211.29  |- skos__historyNote mesh__D013766 Methionine %28%1973-1974%29%
% 211.07/211.29  |- skos__hiddenLabel mesh__D013766 Synthetase, Methionine
% 211.07/211.29  |- skos__broader mesh__D013766smesh__D008780
% 211.07/211.29  |- mesh__recordMaintainer mesh__D013766 ags
% 211.07/211.29  |- mesh__recordOriginator mesh__D013766 NLM
% 211.07/211.29  |- skos__annotation mesh__D013766
% 211.07/211.29       /defic: consider also HOMOCYSTINURIA; DF: note short X ref%A%  
% 211.07/211.29  |- skos__hiddenLabel mesh__D013766 Synthase, Methionine
% 211.07/211.29  |- skos__altLabel mesh__D013766
% 211.07/211.29       Tetrahydropteroylglutamate Methyltransferase
% 211.07/211.29  |- skos__historyNote mesh__D013766 Tetrahydrofolates %28%1973-1974%29%
% 211.07/211.29  |- skos__altLabel mesh__D013766 Methionine Synthetase
% 211.07/211.29  |- skos__prefLabel mesh__D013766
% 211.07/211.29       5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase
% 211.07/211.29  |- mesh__recordAuthorizer mesh__D013766 sjn
% 211.07/211.29  |- mesh__dateCreated mesh__D013766 1974-11-19
% 211.07/211.29  |- mesh__publicMeSHNote mesh__D013766
% 211.07/211.29       98; see TETRAHYDROPTEROYLGLUTAMATE METHYLTRANSFERASE 1991-97; see METHYLTRANSFERASES 1975-90%A%  
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D013766 2006
% 211.07/211.29  |- rdf__type mesh__D013766sskos__Concept
% 211.07/211.29  |- skos__hiddenLabel mesh__D013766
% 211.07/211.29       Methyltransferase, Tetrahydropteroylglutamate
% 211.07/211.29  |- skos__hiddenLabel mesh__D013766
% 211.07/211.29       S-Methyltransferase, 5-Methyltetrahydrofolate-Homocysteine
% 211.07/211.29  |- skos__scopeNote mesh__D013766
% 211.07/211.29       An enzyme that catalyzes the formation of methionine by transfer of a methyl group from 5-methyltetrahydrofolate to homocysteine. It requires a cobamide coenzyme. The enzyme can act on mono- or triglutamate derivatives. EC 2.1.1.13.%A%    
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D007729 2001
% 211.07/211.29  |- mesh__recordOriginator mesh__D007729 NLM
% 211.07/211.29  |- mesh__recordAuthorizer mesh__D007729 jls
% 211.07/211.29  |- mesh__dateRevised mesh__D007729 2004-07-28
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D007729 2006
% 211.07/211.29  |- skos__broader mesh__D007729smesh__D017096
% 211.07/211.29  |- skos__altLabel mesh__D007729 Kuru Encephalopathy
% 211.07/211.29  |- mesh__dateCreated mesh__D007729 1999-01-01
% 211.07/211.29  |- rdf__type mesh__D007729sskos__Concept
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D007729 2005A
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D007729 2002
% 211.07/211.29  |- skos__scopeNote mesh__D007729
% 211.07/211.29       A prion disease found exclusively among the Fore linguistic group natives of the highlands of NEW GUINEA. The illness is primarily restricted to adult females and children of both sexes. It is marked by the subacute onset of tremor and ataxia followed by motor weakness and incontinence. Death occurs within 3-6 months of disease onset. The condition is associated with ritual cannibalism, and has become rare since this practice has been discontinued. Pathologic features include a noninflammatory loss of neurons that is most prominent in the cerebellum, glial proliferation, and amyloid plaques. %28%From Adams et al., Principles of Neurology, 6th ed, p773%29%%A%    
% 211.07/211.29  |- skos__altLabel mesh__D007729 Encephalopathy, Kuru
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D007729 2003
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D007729 2000
% 211.07/211.29  |- skos__prefLabel mesh__D007729 Kuru
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D007729 2005
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D007729 2004
% 211.07/211.29  |- skos__annotation mesh__D007729
% 211.07/211.29       do not confuse with KORO, a depersonalization disord   
% 211.07/211.29  |- mesh__recordMaintainer mesh__D007729 jls
% 211.07/211.29  |- skos__annotation mesh__D018451 check tag MALE   
% 211.07/211.29  |- skos__historyNote mesh__D018451 Homosexuality %28%1966-1994%29%
% 211.07/211.29  |- mesh__recordMaintainer mesh__D018451 lkt
% 211.07/211.29  |- skos__broader mesh__D018451smesh__D006716
% 211.07/211.29  |- mesh__historyNote mesh__D018451 95   
% 211.07/211.29  |- mesh__recordAuthorizer mesh__D018451 sjn
% 211.07/211.29  |- mesh__publicMeSHNote mesh__D018451 95   
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D018451 2006
% 211.07/211.29  |- skos__scopeNote mesh__D018451
% 211.07/211.29       Sexual attraction or relationship between males.     
% 211.07/211.29  |- mesh__dateRevised mesh__D018451 2004-07-07
% 211.07/211.29  |- skos__prefLabel mesh__D018451 Homosexuality, Male
% 211.07/211.29  |- rdf__type mesh__D018451sskos__Concept
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D018451 2005
% 211.07/211.29  |- skos__hiddenLabel mesh__D018451 Male Homosexuality
% 211.07/211.29  |- mesh__recordOriginator mesh__D018451 TGC
% 211.07/211.29  |- skos__hiddenLabel mesh__D018451 Gay
% 211.07/211.29  |- mesh__dateCreated mesh__D018451 1994-04-16
% 211.07/211.29  |- mesh__dateEstablished mesh__D018451 1995-01-01
% 211.07/211.29  |- rdf__type mesh__D032122sskos__Concept
% 211.07/211.29  |- mesh__dateCreated mesh__D032122 2002-07-03
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D032122 2004
% 211.07/211.29  |- skos__broader mesh__D032122smesh__D029630
% 211.07/211.29  |- skos__prefLabel mesh__D032122 Pyrularia
% 211.07/211.29  |- skos__annotation mesh__D032122
% 211.07/211.29       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D032122 2003
% 211.07/211.29  |- mesh__historyNote mesh__D032122 2003   
% 211.07/211.29  |- mesh__publicMeSHNote mesh__D032122 2003   
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D032122 2006
% 211.07/211.29  |- mesh__dateEstablished mesh__D032122 2003-01-01
% 211.07/211.29  |- skos__scopeNote mesh__D032122
% 211.07/211.29       A plant genus of the family SANTALACEAE. Members contain thionin toxin, which shouldn%27%t be confused with thionine.%A%    
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D032122 2005
% 211.07/211.29  |- skos__broader mesh__D004431smesh__D004423
% 211.07/211.29  |- skos__hiddenLabel mesh__D004431 Outer Ears
% 211.07/211.29  |- rdf__type mesh__D004431sskos__Concept
% 211.07/211.29  |- mesh__onlineNote mesh__D004431
% 211.07/211.29       use EAR /AB %26% EAR, EXTERNAL /AB %26% EAR DEFORMITIES, ACQUIRED to search EAR, EXTERNAL, DEFORMITY 1966-70; in searching non-acquired ear abnormalities consider EAR DEFORMITIES, ACQUIRED 1966-74%A%  
% 211.07/211.29  |- skos__hiddenLabel mesh__D004431 Ears, Outer
% 211.07/211.29  |- mesh__recordMaintainer mesh__D004431 lkt
% 211.07/211.29  |- skos__hiddenLabel mesh__D004431 External Ears
% 211.07/211.29  |- mesh__publicMeSHNote mesh__D004431
% 211.07/211.29       EAR, EXTERNAL, DEFORMITY was heading 1966-70   
% 211.07/211.29  |- skos__prefLabel mesh__D004431 Ear, External
% 211.07/211.29  |- mesh__recordOriginator mesh__D004431 NLM
% 211.07/211.29  |- mesh__recordAuthorizer mesh__D004431 sjn
% 211.07/211.29  |- skos__scopeNote mesh__D004431
% 211.07/211.29       The outer part of the hearing system of the body. It includes the external EAR CANAL, cartilages of the auricle %28%EAR CARTILAGES%29%, and the TYMPANIC MEMBRANE.%A%    
% 211.07/211.29  |- skos__altLabel mesh__D004431 External Ear
% 211.07/211.29  |- skos__hiddenLabel mesh__D004431 Ears, External
% 211.07/211.29  |- skos__annotation mesh__D004431
% 211.07/211.29       /abnorm permitted for congenital deformities but acquired deformities = EAR DEFORMITIES, ACQUIRED; inflammation = OTITIS EXTERNA; ear acupuncture or auriculoacupuncture or otoacupuncture %28%acupuncture therapy with ear as pressure point%29% goes here %28%IM%29% + ACUPUNCTURE THERAPY %28%IM%29%%A%  
% 211.07/211.29  |- mesh__historyNote mesh__D004431
% 211.07/211.29       EAR, EXTERNAL, DEFORMITY was heading 1966-70   
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D004431 2006
% 211.07/211.29  |- mesh__dateRevised mesh__D004431 2005-06-30
% 211.07/211.29  |- skos__altLabel mesh__D004431 Outer Ear
% 211.07/211.29  |- skos__hiddenLabel mesh__D004431 Ear, Outer
% 211.07/211.29  |- mesh__dateCreated mesh__D004431 1999-01-01
% 211.07/211.29  |- mesh__dateCreated mesh__D045848 2003-07-09
% 211.07/211.29  |- skos__annotation mesh__D045848
% 211.07/211.29       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 211.07/211.29  |- rdf__type mesh__D045848sskos__Concept
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D045848 2006
% 211.07/211.29  |- mesh__dateRevised mesh__D045848 2005-06-30
% 211.07/211.29  |- mesh__recordMaintainer mesh__D045848 SYSTEM
% 211.07/211.29  |- mesh__recordAuthorizer mesh__D045848 sjn
% 211.07/211.29  |- mesh__recordOriginator mesh__D045848 ags
% 211.07/211.29  |- mesh__dateEstablished mesh__D045848 2004-01-01
% 211.07/211.29  |- skos__scopeNote mesh__D045848
% 211.07/211.29       A genus of gram-negative, anaerobic bacteria in the family Fibrobacteraceae, isolated from the human GASTROINTESTINAL TRACT.%A%    
% 211.07/211.29  |- skos__broader mesh__D045848smesh__D016965
% 211.07/211.29  |- mesh__historyNote mesh__D045848 2004   
% 211.07/211.29  |- skos__prefLabel mesh__D045848 Fibrobacter
% 211.07/211.29  |- mesh__publicMeSHNote mesh__D045848 2004   
% 211.07/211.29  |- skos__altLabel mesh__D031828 Shinleaf
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D031828 2005
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D031828 2004
% 211.07/211.29  |- mesh__dateCreated mesh__D031828 2002-07-03
% 211.07/211.29  |- rdf__type mesh__D031828sskos__Concept
% 211.07/211.29  |- skos__prefLabel mesh__D031828 Pyrola
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D031828 2003
% 211.07/211.29  |- mesh__dateEstablished mesh__D031828 2003-01-01
% 211.07/211.29  |- skos__scopeNote mesh__D031828
% 211.07/211.29       A plant genus of the family PYROLACEAE. The common name of wintergreen is more often used for GAULTHERIA.%A%    
% 211.07/211.29  |- skos__broader mesh__D031828smesh__D031827
% 211.07/211.29  |- mesh__publicMeSHNote mesh__D031828 2003   
% 211.07/211.29  |- skos__annotation mesh__D031828
% 211.07/211.29       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D031828 2006
% 211.07/211.29  |- mesh__historyNote mesh__D031828 2003   
% 211.07/211.29  |- skos__broader mesh__D017359smesh__D046110
% 211.07/211.29  |- mesh__dateEstablished mesh__D017359 1993-01-01
% 211.07/211.29  |- mesh__recordOriginator mesh__D017359 TGC
% 211.07/211.29  |- skos__hiddenLabel mesh__D017359 Syndrome, HELLP
% 211.07/211.29  |- skos__scopeNote mesh__D017359
% 211.07/211.29       A syndrome of HEMOLYSIS, elevated liver ENZYMES, and low blood platelets count %28%THROMBOCYTOPENIA%29%. HELLP syndrome is observed in pregnant women with PRE-ECLAMPSIA or ECLAMPSIA who also exhibit LIVER damage and abnormalities in BLOOD COAGULATION.%A%    
% 211.07/211.29  |- skos__historyNote mesh__D017359 Eclampsia %28%1985-1992%29%
% 211.07/211.29  |- mesh__recordMaintainer mesh__D017359 lkt
% 211.07/211.29  |- mesh__publicMeSHNote mesh__D017359 93   
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D017359 2006
% 211.07/211.29  |- skos__historyNote mesh__D017359 Pre-Eclampsia %28%1982-1992%29%
% 211.07/211.29  |- mesh__dateCreated mesh__D017359 1992-05-18
% 211.07/211.29  |- mesh__dateRevised mesh__D017359 2005-06-30
% 211.07/211.29  |- skos__annotation mesh__D017359
% 211.07/211.29       Hemolysis-Elevated Liver enzymes-Low Platelet count syndrome; DF: HELLP%A%  
% 211.07/211.29  |- skos__historyNote mesh__D017359 Hemolysis %28%1982-1992%29%
% 211.07/211.29  |- skos__prefLabel mesh__D017359 HELLP Syndrome
% 211.07/211.29  |- mesh__historyNote mesh__D017359 93   
% 211.07/211.29  |- skos__historyNote mesh__D017359 Liver/enzymology %28%1982-1992%29%
% 211.07/211.29  |- mesh__recordAuthorizer mesh__D017359 sjn
% 211.07/211.29  |- skos__historyNote mesh__D017359 Thrombocytopenia %28%1982-1992%29%
% 211.07/211.29  |- rdf__type mesh__D017359sskos__Concept
% 211.07/211.29  |- skos__broader mesh__D028081smesh__D027981
% 211.07/211.29  |- mesh__dateEstablished mesh__D028081 2002-01-01
% 211.07/211.29  |- mesh__recordAuthorizer mesh__D028081 sjn
% 211.07/211.29  |- skos__hiddenLabel mesh__D028081 H+ Pi Symporter
% 211.07/211.29  |- skos__altLabel mesh__D028081 Proton-Phosphate Cotransporters
% 211.07/211.29  |- skos__historyNote mesh__D028081 Carrier Proteins %28%1991-2001%29%
% 211.07/211.29  |- mesh__dateRevised mesh__D028081 2005-06-30
% 211.07/211.29  |- mesh__recordMaintainer mesh__D028081 SYSTEM
% 211.07/211.29  |- skos__scopeNote mesh__D028081
% 211.07/211.29       Proteins that cotransport hydrogen ions and phosphate ions across cellular membranes.%A%    
% 211.07/211.29  |- skos__altLabel mesh__D028081 H+-Pi Symporter
% 211.07/211.29  |- skos__broader mesh__D028081smesh__D028061
% 211.07/211.29  |- skos__altLabel mesh__D028081 Proton-Phosphate Symporter
% 211.07/211.29  |- skos__prefLabel mesh__D028081 Proton-Phosphate Symporters
% 211.07/211.29  |- mesh__publicMeSHNote mesh__D028081
% 211.07/211.29       2002; H+-PI SYMPORTER was indexed under CARRIER PROTEINS 1991-2001; PROTON-PHOSPHATE SYMPORTER was indexed under CARRIER PROTEINS 1991-2001%A%  
% 211.07/211.29  |- skos__hiddenLabel mesh__D028081 Proton Phosphate Symporters
% 211.07/211.29  |- rdf__type mesh__D028081sskos__Concept
% 211.07/211.29  |- skos__hiddenLabel mesh__D028081 Symporter, Proton-Phosphate
% 211.07/211.29  |- mesh__recordOriginator mesh__D028081 jmp
% 211.07/211.29  |- skos__hiddenLabel mesh__D028081 Cotransporters, Proton-Phosphate
% 211.07/211.29  |- mesh__dateCreated mesh__D028081 2001-07-25
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D028081 2006
% 211.07/211.29  |- skos__hiddenLabel mesh__D028081 Symporter, H+-Pi
% 211.07/211.29  |- skos__hiddenLabel mesh__D028081 Proton Phosphate Symporter
% 211.07/211.29  |- mesh__historyNote mesh__D028081
% 211.07/211.29       2002; for H+-PI SYMPORTER use PHOSPHATE-BINDING PROTEINS 1991-2001; for PROTON-PHOSPHATE SYMPORTER use PHOSPHATE-BINDING PROTEINS 1991-2001%A%  
% 211.07/211.29  |- skos__hiddenLabel mesh__D028081 Symporters, Proton-Phosphate
% 211.07/211.29  |- skos__hiddenLabel mesh__D028081 Proton Phosphate Cotransporters
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D003339 2004
% 211.07/211.29  |- skos__hiddenLabel mesh__D003339 Luteum Hormones, Corpus
% 211.07/211.29  |- mesh__dateCreated mesh__D003339 1999-01-01
% 211.07/211.29  |- mesh__recordMaintainer mesh__D003339 lkt
% 211.07/211.29  |- mesh__recordOriginator mesh__D003339 NLM
% 211.07/211.29  |- skos__annotation mesh__D003339 /biosyn /physiol permitted   
% 211.07/211.29  |- skos__broader mesh__D003339smesh__D042341
% 211.07/211.29  |- mesh__recordAuthorizer mesh__D003339 sjn
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D003339 2006
% 211.07/211.29  |- skos__hiddenLabel mesh__D003339 Hormones, Corpus Luteum
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D003339 2005
% 211.07/211.29  |- rdf__type mesh__D003339sskos__Concept
% 211.07/211.29  |- skos__prefLabel mesh__D003339 Corpus Luteum Hormones
% 211.07/211.29  |- mesh__dateRevised mesh__D003339 2003-07-09
% 211.07/211.29  |- skos__prefLabel mesh__D014061 Tongue Habits
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D014061 2003
% 211.07/211.29  |- mesh__dateEstablished mesh__D014061 1965-01-01
% 211.07/211.29  |- mesh__activeMeSHYear mesh__D014061 2004
% 211.07/211.29  |- mesh__recordMaintainer mesh__D014061 JLS
% 211.07/211.29  |- skos__broader mesh__D014061smesh__D006184
% 211.07/211.29  |- skos__scopeNote mesh__D014061
% 211.07/211.29       Acquired responses regularly manifested by tongue movement or positioning.%A%    
% 211.07/211.29  |- mesh__historyNote mesh__D014061 65   
% 211.07/211.29  |- rdf__type mesh__D014061sskos__Concept
% 211.07/211.29  |- mesh__dateCreated mesh__D014061 1999-01-01
% 211.25/211.40  |- skos__hiddenLabel mesh__D014061 Habits, Tongue
% 211.25/211.40  |- mesh__dateRevised mesh__D014061 2002-07-03
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D014061 2005
% 211.25/211.40  |- mesh__recordAuthorizer mesh__D014061 sjn
% 211.25/211.40  |- mesh__recordOriginator mesh__D014061 NLM
% 211.25/211.40  |- mesh__publicMeSHNote mesh__D014061 65   
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D014061 2006
% 211.25/211.40  |- skos__altLabel mesh__D008822 Transgenic Mice
% 211.25/211.40  |- skos__scopeNote mesh__D008822
% 211.25/211.40       Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO.%A%    
% 211.25/211.40  |- skos__altLabel mesh__D008822 Mouse, Transgenic
% 211.25/211.40  |- skos__hiddenLabel mesh__D008822 Transgenic Founder Mice
% 211.25/211.40  |- mesh__dateCreated mesh__D008822 1987-05-08
% 211.25/211.40  |- mesh__publicMeSHNote mesh__D008822 88   
% 211.25/211.40  |- skos__broader mesh__D008822smesh__D030801
% 211.25/211.40  |- skos__broader mesh__D008822smesh__D051379
% 211.25/211.40  |- skos__hiddenLabel mesh__D008822 Transgenic Mouse
% 211.25/211.40  |- mesh__historyNote mesh__D008822 88   
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008822 2006
% 211.25/211.40  |- skos__prefLabel mesh__D008822 Mice, Transgenic
% 211.25/211.40  |- mesh__dateRevised mesh__D008822 2005-06-30
% 211.25/211.40  |- skos__annotation mesh__D008822
% 211.25/211.40       NIM with no qualifiers when experimental animal; check the tag MICE; for transgenic founder mice, coordinate with FOUNDER EFFECT%A%  
% 211.25/211.40  |- skos__altLabel mesh__D008822 Mouse, Founder, Transgenic
% 211.25/211.40  |- mesh__recordOriginator mesh__D008822 SCD
% 211.25/211.40  |- mesh__dateEstablished mesh__D008822 1988-01-01
% 211.25/211.40  |- mesh__recordAuthorizer mesh__D008822 sjn
% 211.25/211.40  |- mesh__recordMaintainer mesh__D008822 ags
% 211.25/211.40  |- rdf__type mesh__D008822sskos__Concept
% 211.25/211.40  |- skos__hiddenLabel mesh__D008822 Mice, Transgenic Founder
% 211.25/211.40  |- skos__annotation mesh__D008024
% 211.25/211.40       IM for general only; usually NIM with specific cpd IM; no qualif%A%  
% 211.25/211.40  |- mesh__recordMaintainer mesh__D008024 ssb
% 211.25/211.40  |- mesh__dateEstablished mesh__D008024 1974-01-01
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008024 2004
% 211.25/211.40  |- rdf__type mesh__D008024sskos__Concept
% 211.25/211.40  |- skos__related mesh__D008024smesh__D011956
% 211.25/211.40  |- skos__related mesh__D008024smesh__D011869
% 211.25/211.40  |- mesh__historyNote mesh__D008024 74%28%73%29%   
% 211.25/211.40  |- skos__historyNote mesh__D008024 Metals %28%1966-1972%29%
% 211.25/211.40  |- mesh__recordOriginator mesh__D008024 NLM
% 211.25/211.40  |- skos__scopeNote mesh__D008024
% 211.25/211.40       A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. %28%From Dorland, 27th ed%29%%A%    
% 211.25/211.40  |- mesh__publicMeSHNote mesh__D008024 74   
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008024 2006
% 211.25/211.40  |- skos__historyNote mesh__D008024
% 211.25/211.40       Organometallic Compounds %28%1968-1972%29%
% 211.25/211.40  |- mesh__dateCreated mesh__D008024 1999-01-01
% 211.25/211.40  |- mesh__recordAuthorizer mesh__D008024 sjn
% 211.25/211.40  |- skos__prefLabel mesh__D008024 Ligands
% 211.25/211.40  |- skos__broader mesh__D008024smesh__D019995
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008024 2005
% 211.25/211.40  |- mesh__dateRevised mesh__D008024 2003-07-09
% 211.25/211.40  |- skos__annotation mesh__D000041 IM; no qualif   
% 211.25/211.40  |- mesh__recordAuthorizer mesh__D000041 PLS
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000041 2004
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000041 2002
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000041 2006
% 211.25/211.40  |- mesh__recordMaintainer mesh__D000041 JLS
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000041 2003
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000041 2001
% 211.25/211.40  |- mesh__dateCreated mesh__D000041 1999-01-01
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000041 2005
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000041 1997
% 211.25/211.40  |- skos__broader mesh__D000041smesh__D011590
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000041 1999
% 211.25/211.40  |- skos__scopeNote mesh__D000041
% 211.25/211.40       Chronic absence from work or other duty.     
% 211.25/211.40  |- mesh__recordOriginator mesh__D000041 NLM
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000041 1996
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000041 2000
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000041 1995
% 211.25/211.40  |- mesh__historyNote mesh__D000041
% 211.25/211.40       was in Cat F %26% J 1967-82, was in Cat F %26% I 1963-66   
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000041 1998
% 211.25/211.40  |- rdf__type mesh__D000041sskos__Concept
% 211.25/211.40  |- skos__prefLabel mesh__D000041 Absenteeism
% 211.25/211.40  |- mesh__dateRevised mesh__D000041 1994-05-27
% 211.25/211.40  |- skos__altLabel mesh__D052180 Publication Formats %5B%Pub Type%5D%
% 211.25/211.40  |- mesh__recordOriginator mesh__D052180 jls
% 211.25/211.40  |- mesh__dateCreated mesh__D052180 2005-06-30
% 211.25/211.40  |- rdf__type mesh__D052180sskos__Concept
% 211.25/211.40  |- mesh__dateEstablished mesh__D052180 2006-01-01
% 211.25/211.40  |- mesh__runningHead mesh__D052180 V2 - PUBLICATION FORMATS   
% 211.25/211.40  |- skos__scopeNote mesh__D052180 Specific genre of publication.     
% 211.25/211.40  |- skos__annotation mesh__D052180 not used for indexing or cataloging   
% 211.25/211.40  |- mesh__recordMaintainer mesh__D052180 jls
% 211.25/211.40  |- mesh__historyNote mesh__D052180 2006   
% 211.25/211.40  |- skos__altLabel mesh__D052180 Publication Formats %5B%PT%5D%
% 211.25/211.40  |- mesh__recordAuthorizer mesh__D052180 sjn
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D052180 2006
% 211.25/211.40  |- skos__prefLabel mesh__D052180
% 211.25/211.40       Publication Formats %5B%Publication Type%5D%
% 211.25/211.40  |- mesh__historyNote mesh__D013767
% 211.25/211.40       91%28%75%29%; was see under URIDINE 1975-90   
% 211.25/211.40  |- mesh__recordAuthorizer mesh__D013767 sjn
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D013767 2002
% 211.25/211.40  |- skos__historyNote mesh__D013767 Uridine %28%1971-1974%29%
% 211.25/211.40  |- rdf__type mesh__D013767sskos__Concept
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D013767 2006
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D013767 2005
% 211.25/211.40  |- skos__broader mesh__D013767smesh__D014529
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D013767 2004
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D013767 2003
% 211.25/211.40  |- skos__scopeNote mesh__D013767
% 211.25/211.40       An inhibitor of nucleotide metabolism.     
% 211.25/211.40  |- mesh__publicMeSHNote mesh__D013767 91; was see under URIDINE 1975-90   
% 211.25/211.40  |- skos__prefLabel mesh__D013767 Tetrahydrouridine
% 211.25/211.40  |- mesh__dateEstablished mesh__D013767 1991-01-01
% 211.25/211.40  |- mesh__recordOriginator mesh__D013767 NLM
% 211.25/211.40  |- mesh__dateCreated mesh__D013767 1974-11-19
% 211.25/211.40  |- mesh__recordMaintainer mesh__D013767 ssb
% 211.25/211.40  |- mesh__dateRevised mesh__D013767 2001-07-25
% 211.25/211.40  |- mesh__historyNote mesh__D032921 2003; use DECISION MAKING 1997-2002   
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D032921 2003
% 211.25/211.40  |- mesh__recordMaintainer mesh__D032921 hjn
% 211.25/211.40  |- mesh__dateEstablished mesh__D032921 2003-01-01
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D032921 2006
% 211.25/211.40  |- skos__prefLabel mesh__D032921 Consensus
% 211.25/211.40  |- mesh__recordOriginator mesh__D032921 jrf
% 211.25/211.40  |- mesh__publicMeSHNote mesh__D032921
% 211.25/211.40       2003; see DECISION MAKING 1997-2002   
% 211.25/211.40  |- skos__broader mesh__D032921smesh__D006126
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D032921 2005
% 211.25/211.40  |- skos__related mesh__D032921smesh__D003245
% 211.25/211.40  |- skos__scopeNote mesh__D032921
% 211.25/211.40       General agreement or collective opinion; the judgment arrived at by most of those concerned.%A%    
% 211.25/211.40  |- skos__hiddenLabel mesh__D032921 Development, Consensus
% 211.25/211.40  |- rdf__type mesh__D032921sskos__Concept
% 211.25/211.40  |- skos__related mesh__D032921smesh__D034462
% 211.25/211.40  |- mesh__recordAuthorizer mesh__D032921 sjn
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D032921 2004
% 211.25/211.40  |- mesh__dateCreated mesh__D032921 2002-07-03
% 211.25/211.40  |- skos__broader mesh__D032921smesh__D003657
% 211.25/211.40  |- skos__annotation mesh__D018452 check tag FEMALE   
% 211.25/211.40  |- mesh__dateEstablished mesh__D018452 1995-01-01
% 211.25/211.40  |- skos__hiddenLabel mesh__D018452 Female Homosexuality
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D018452 2006
% 211.25/211.40  |- mesh__dateRevised mesh__D018452 2004-07-07
% 211.25/211.40  |- mesh__onlineNote mesh__D018452
% 211.25/211.40       use HOMOSEXUALITY to search HOMOSEXUALITY, FEMALE 1976-80 %26% LESBIANISM 1968-94%A%  
% 211.25/211.40  |- skos__prefLabel mesh__D018452 Homosexuality, Female
% 211.25/211.40  |- rdf__type mesh__D018452sskos__Concept
% 211.25/211.40  |- skos__scopeNote mesh__D018452
% 211.25/211.40       Sexual attraction or relationship between females.     
% 211.25/211.40  |- mesh__recordMaintainer mesh__D018452 lkt
% 211.25/211.40  |- skos__historyNote mesh__D018452 Homosexuality %28%1966-1994%29%
% 211.25/211.40  |- mesh__publicMeSHNote mesh__D018452
% 211.25/211.40       95; was see under HOMOSEXUALITY 1976-80; LESBIANISM was see HOMOSEXUALITY 1981-94, was see HOMOSEXUALITY, FEMALE 1976-80, %26% was see under HOMOSEXUALITY 1968-75%A%  
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D018452 2005
% 211.25/211.40  |- skos__broader mesh__D018452smesh__D006716
% 211.25/211.40  |- mesh__historyNote mesh__D018452
% 211.25/211.40       95; was see under HOMOSEXUALITY 1976-80; LESBIANISM was see HOMOSEXUALITY 1981-94, was see HOMOSEXUALITY, FEMALE 1976-80, %26% was see under HOMOSEXUALITY 1968-75%A%  
% 211.25/211.40  |- mesh__recordAuthorizer mesh__D018452 sjn
% 211.25/211.40  |- skos__hiddenLabel mesh__D018452 Lesbian
% 211.25/211.40  |- mesh__dateCreated mesh__D018452 1994-04-16
% 211.25/211.40  |- skos__altLabel mesh__D018452 Lesbianism
% 211.25/211.40  |- mesh__recordOriginator mesh__D018452 TGC
% 211.25/211.40  |- skos__scopeNote mesh__D032123
% 211.25/211.40       A plant genus of the family SANTALACEAE which is the source of sandalwood oil.%A%    
% 211.25/211.40  |- skos__annotation mesh__D032123
% 211.25/211.40       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D032123 2003
% 211.25/211.40  |- mesh__dateCreated mesh__D032123 2002-07-03
% 211.25/211.40  |- mesh__publicMeSHNote mesh__D032123 2003   
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D032123 2006
% 211.25/211.40  |- mesh__historyNote mesh__D032123 2003   
% 211.25/211.40  |- skos__prefLabel mesh__D032123 Santalum
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D032123 2005
% 211.25/211.40  |- rdf__type mesh__D032123sskos__Concept
% 211.25/211.40  |- skos__altLabel mesh__D032123 Sandalwood
% 211.25/211.40  |- mesh__dateEstablished mesh__D032123 2003-01-01
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D032123 2004
% 211.25/211.40  |- skos__broader mesh__D032123smesh__D029630
% 211.25/211.40  |- skos__hiddenLabel mesh__D004432 Tympanums
% 211.25/211.40  |- skos__related mesh__D004432smesh__D000158
% 211.25/211.40  |- skos__hiddenLabel mesh__D004432 Ears, Middle
% 211.25/211.40  |- skos__altLabel mesh__D004432 Middle Ear
% 211.25/211.40  |- mesh__dateRevised mesh__D004432 2005-06-30
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D004432 2006
% 211.25/211.40  |- skos__altLabel mesh__D004432 Tympanum
% 211.25/211.40  |- mesh__dateCreated mesh__D004432 1999-01-01
% 211.25/211.40  |- mesh__recordMaintainer mesh__D004432 lkt
% 211.25/211.40  |- skos__hiddenLabel mesh__D004432 Cavities, Tympanic
% 211.25/211.40  |- skos__hiddenLabel mesh__D004432 Middle Ears
% 211.25/211.40  |- skos__broader mesh__D004432smesh__D004423
% 211.25/211.40  |- skos__prefLabel mesh__D004432 Ear, Middle
% 211.25/211.40  |- rdf__type mesh__D004432sskos__Concept
% 211.25/211.40  |- skos__hiddenLabel mesh__D004432 Cavity, Tympanic
% 211.25/211.40  |- mesh__recordOriginator mesh__D004432 NLM
% 211.25/211.40  |- mesh__recordAuthorizer mesh__D004432 sjn
% 211.25/211.40  |- skos__annotation mesh__D004432
% 211.25/211.40       /surg: consider TYMPANOPLASTY; inflammation = OTITIS MEDIA; inj caused by pressure = EAR, MIDDLE /inj %28%IM%29% + BAROTRAUMA %28%IM%29%; middle ear effusions = OTITIS MEDIA%A%  
% 211.25/211.40  |- skos__related mesh__D004432smesh__D014433
% 211.25/211.40  |- skos__hiddenLabel mesh__D004432 Tympanic Cavities
% 211.25/211.40  |- mesh__dateEstablished mesh__D028082 2002-01-01
% 211.25/211.40  |- mesh__publicMeSHNote mesh__D028082 2002   
% 211.25/211.40  |- skos__annotation mesh__D028082
% 211.25/211.40       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.25/211.40  |- skos__scopeNote mesh__D028082
% 211.25/211.40       The Borage plant family is in the class Magnoliopsida, subclass Asteridae, order Lamiales. It is characterized by hairy foliage, usually alternate and simple; flowers are funnel-shaped or tubular. Some of the species contain PYRROLIZIDINE ALKALOIDS.%A%    
% 211.25/211.40  |- mesh__historyNote mesh__D028082 2002   
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D028082 2005
% 211.25/211.40  |- mesh__dateRevised mesh__D028082 2003-07-09
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D028082 2004
% 211.25/211.40  |- rdf__type mesh__D028082sskos__Concept
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D028082 2006
% 211.25/211.40  |- skos__broader mesh__D028082smesh__D019684
% 211.25/211.40  |- mesh__recordAuthorizer mesh__D028082 sjn
% 211.25/211.40  |- mesh__recordOriginator mesh__D028082 ssb
% 211.25/211.40  |- mesh__recordMaintainer mesh__D028082 ssb
% 211.25/211.40  |- skos__prefLabel mesh__D028082 Boraginaceae
% 211.25/211.40  |- mesh__dateCreated mesh__D028082 2001-07-25
% 211.25/211.40  |- rdf__type mesh__D014860sskos__Concept
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D014860 2003
% 211.25/211.40  |- skos__broader mesh__D014860smesh__D017193
% 211.25/211.40  |- skos__scopeNote mesh__D014860
% 211.25/211.40       Benign epidermal proliferations or tumors; some are viral in origin.%A%    
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D014860 2006
% 211.25/211.40  |- mesh__dateRevised mesh__D014860 2001-07-25
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D014860 2005
% 211.25/211.40  |- skos__broader mesh__D014860smesh__D030361
% 211.25/211.40  |- mesh__dateCreated mesh__D014860 1999-01-01
% 211.25/211.40  |- skos__broader mesh__D014860smesh__D014412
% 211.25/211.40  |- skos__hiddenLabel mesh__D014860 Wart
% 211.25/211.40  |- skos__altLabel mesh__D014860 Verruca
% 211.25/211.40  |- mesh__recordOriginator mesh__D014860 NLM
% 211.25/211.40  |- mesh__recordAuthorizer mesh__D014860 sjn
% 211.25/211.40  |- skos__annotation mesh__D014860
% 211.25/211.40       a non-neoplastic tumor virus infect; coord IM with precoord organ/dis term %28%IM%29%%A%  
% 211.25/211.40  |- mesh__recordMaintainer mesh__D014860 ags
% 211.25/211.40  |- skos__hiddenLabel mesh__D014860 Verrucas
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D014860 2004
% 211.25/211.40  |- skos__prefLabel mesh__D014860 Warts
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D014860 2002
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D014062 2000
% 211.25/211.40  |- skos__altLabel mesh__D014062 Cancer of the Tongue
% 211.25/211.40  |- mesh__recordOriginator mesh__D014062 NLM
% 211.25/211.40  |- mesh__recordAuthorizer mesh__D014062 sjn
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D014062 2004
% 211.25/211.40  |- skos__broader mesh__D014062smesh__D014060
% 211.25/211.40  |- rdf__type mesh__D014062sskos__Concept
% 211.25/211.40  |- skos__hiddenLabel mesh__D014062 Cancers, Tongue
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D014062 2001
% 211.25/211.40  |- skos__annotation mesh__D014062
% 211.25/211.40       coord IM with histol type of neopl %28%IM%29%   
% 211.25/211.40  |- skos__hiddenLabel mesh__D014062 Cancer, Tongue
% 211.25/211.40  |- skos__broader mesh__D014062smesh__D009062
% 211.25/211.40  |- mesh__dateCreated mesh__D014062 1999-01-01
% 211.25/211.40  |- skos__prefLabel mesh__D014062 Tongue Neoplasms
% 211.25/211.40  |- skos__hiddenLabel mesh__D014062 Tongue Neoplasm
% 211.25/211.40  |- skos__hiddenLabel mesh__D014062 Neoplasm, Tongue
% 211.25/211.40  |- skos__scopeNote mesh__D014062 Tumors or cancer of the TONGUE.     
% 211.25/211.40  |- skos__altLabel mesh__D014062 Tongue Cancer
% 211.25/211.40  |- mesh__dateRevised mesh__D014062 1999-11-03
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D014062 2005
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D014062 2002
% 211.25/211.40  |- skos__altLabel mesh__D014062 Neoplasms, Tongue
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D014062 2006
% 211.25/211.40  |- skos__hiddenLabel mesh__D014062 Tongue Cancers
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D014062 2003
% 211.25/211.40  |- mesh__recordMaintainer mesh__D014062 nns
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008823 2002
% 211.25/211.40  |- mesh__recordOriginator mesh__D008823 NLM
% 211.25/211.40  |- mesh__recordMaintainer mesh__D008823 NLM
% 211.25/211.40  |- mesh__dateCreated mesh__D008823 1974-11-11
% 211.25/211.40  |- mesh__dateRevised mesh__D008823 1990-04-13
% 211.25/211.40  |- skos__annotation mesh__D008823 no qualif   
% 211.25/211.40  |- skos__scopeNote mesh__D008823
% 211.25/211.40       Electrically charged colloidal particles or ions consisting of oriented molecules; aggregates of a number of molecules held loosely together by secondary bonds.%A%    
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008823 1997
% 211.25/211.40  |- skos__prefLabel mesh__D008823 Micelles
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008823 2004
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008823 1991
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008823 2001
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008823 1999
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008823 2006
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008823 1993
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008823 1996
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008823 1995
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008823 2003
% 211.25/211.40  |- skos__broader mesh__D008823smesh__D003102
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008823 2000
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008823 1998
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008823 2005
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008823 1992
% 211.25/211.40  |- skos__hiddenLabel mesh__D008823 Micelle
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008823 1994
% 211.25/211.40  |- mesh__publicMeSHNote mesh__D008823 91; was see under COLLOIDS 1975-90   
% 211.25/211.40  |- rdf__type mesh__D008823sskos__Concept
% 211.25/211.40  |- mesh__recordAuthorizer mesh__D008823 PLS
% 211.25/211.40  |- mesh__historyNote mesh__D008823
% 211.25/211.40       91%28%75%29%; was see under COLLOIDS 1975-90   
% 211.25/211.40  |- skos__historyNote mesh__D008823 Colloids %28%1968-1974%29%
% 211.25/211.40  |- mesh__dateEstablished mesh__D008823 1991-01-01
% 211.25/211.40  |- skos__scopeNote mesh__D000840
% 211.25/211.40       A group of compounds that are structurally related to methoxybenzene and contain the general formula R-C7H70.%A%    
% 211.25/211.40  |- skos__broader mesh__D000840smesh__D010636
% 211.25/211.40  |- skos__altLabel mesh__D000840 Methylphenyl Ethers
% 211.25/211.40  |- skos__broader mesh__D000840smesh__D010647
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000840 2002
% 211.25/211.40  |- mesh__publicMeSHNote mesh__D000840 73   
% 211.25/211.40  |- skos__broader mesh__D000840smesh__D008738
% 211.25/211.40  |- rdf__type mesh__D000840sskos__Concept
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000840 2006
% 211.25/211.40  |- mesh__onlineNote mesh__D000840
% 211.25/211.40       use ANISOLES to search ANISOLE 1971-72 %28%as Prov%29%   
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000840 2004
% 211.25/211.40  |- mesh__dateRevised mesh__D000840 1995-05-18
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000840 2005
% 211.25/211.40  |- skos__prefLabel mesh__D000840 Anisoles
% 211.25/211.40  |- mesh__historyNote mesh__D000840 73; was ANISOLE 1971-72 %28%Prov%29%   
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000840 2001
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000840 2003
% 211.25/211.40  |- mesh__recordAuthorizer mesh__D000840 PLS
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000840 1999
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000840 1997
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000840 2000
% 211.25/211.40  |- skos__historyNote mesh__D000840 Phenols %28%1966-1970%29%
% 211.25/211.40  |- mesh__recordOriginator mesh__D000840 NLM
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000840 1998
% 211.25/211.40  |- skos__historyNote mesh__D000840 Ethers %28%1966-1970%29%
% 211.25/211.40  |- mesh__recordMaintainer mesh__D000840 KEV
% 211.25/211.40  |- skos__hiddenLabel mesh__D000840 Ethers, Methylphenyl
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000840 1996
% 211.25/211.40  |- mesh__dateCreated mesh__D000840 1999-01-01
% 211.25/211.40  |- mesh__dateEstablished mesh__D000840 1973-01-01
% 211.25/211.40  |- mesh__publicMeSHNote mesh__D008025
% 211.25/211.40       CARBOXYLASES was see under CARBOXY-LYASES %26% LIGASES 1964-74, was heading 1963; CARBAMYL PHOSPHATE SYNTHASE %28%AMMONIA%29% %26% CARBAMYL PHOSPHATE SYNTHASE %28%GLUTAMINE%29% were see under PHOSPHOTRANSFERASES, ATP 1975-80%A%  
% 211.25/211.40  |- mesh__recordAuthorizer mesh__D008025 sjn
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008025 2004
% 211.25/211.40  |- rdf__type mesh__D008025sskos__Concept
% 211.25/211.40  |- skos__altLabel mesh__D008025 Synthetases
% 211.25/211.40  |- skos__scopeNote mesh__D008025
% 211.25/211.40       A class of enzymes that catalyze the formation of a bond between two substrate molecules, coupled with the hydrolysis of a pyrophosphate bond in ATP or a similar energy donor. %28%Dorland, 28th ed%29% EC 6.%A%    
% 211.25/211.40  |- mesh__recordMaintainer mesh__D008025 ssb
% 211.25/211.40  |- skos__prefLabel mesh__D008025 Ligases
% 211.25/211.40  |- mesh__onlineNote mesh__D008025
% 211.25/211.40       use LIGASES %26% CARBOXY-LYASES to search CARBOXYLASES 1966-74%A%  
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008025 2006
% 211.25/211.40  |- mesh__historyNote mesh__D008025
% 211.25/211.40       CARBOXYLASES was see under CARBOXY-LYASES %26% LIGASES 1964-74, was heading 1963%A%  
% 211.25/211.40  |- skos__broader mesh__D008025smesh__D004798
% 211.25/211.40  |- mesh__dateCreated mesh__D008025 1999-01-01
% 211.25/211.40  |- skos__altLabel mesh__D008025 Synthetase
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D008025 2005
% 211.25/211.40  |- mesh__dateRevised mesh__D008025 2003-07-09
% 211.25/211.40  |- mesh__recordOriginator mesh__D008025 NLM
% 211.25/211.40  |- mesh__recordOriginator mesh__D000042 NLM
% 211.25/211.40  |- mesh__dateRevised mesh__D000042 2005-06-30
% 211.25/211.40  |- skos__scopeNote mesh__D000042
% 211.25/211.40       The physical or physiological processes by which substances or energy are absorbed.%A%    
% 211.25/211.40  |- mesh__dateCreated mesh__D000042 1999-01-01
% 211.25/211.40  |- skos__broader mesh__D000042smesh__D008660
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D000042 2006
% 211.25/211.40  |- skos__hiddenLabel mesh__D000042 Absorptions
% 211.25/211.40  |- skos__prefLabel mesh__D000042 Absorption
% 211.25/211.40  |- skos__related mesh__D000042smesh__D012869
% 211.25/211.40  |- skos__broader mesh__D000042smesh__D002627
% 211.25/211.40  |- skos__related mesh__D000042smesh__D007408
% 211.25/211.40  |- rdf__type mesh__D000042sskos__Concept
% 211.25/211.40  |- skos__annotation mesh__D000042
% 211.25/211.40       almost never IM; coordinate NIM with substance /pharmacokin %28%IM%29% or /metab %28%IM%29% or organ /metab %28%IM%29%%A%  
% 211.25/211.40  |- mesh__recordMaintainer mesh__D000042 lkt
% 211.25/211.40  |- mesh__recordAuthorizer mesh__D000042 sjn
% 211.25/211.40  |- rdf__type mesh__D052181sskos__Concept
% 211.25/211.40  |- skos__altLabel mesh__D052181 Publication Components %5B%PT%5D%
% 211.25/211.40  |- skos__prefLabel mesh__D052181
% 211.25/211.40       Publication Components %5B%Publication Type%5D%
% 211.25/211.40  |- mesh__runningHead mesh__D052181 V1 - PUBLICATION COMPONENTS   
% 211.25/211.40  |- mesh__dateCreated mesh__D052181 2005-06-30
% 211.25/211.40  |- skos__altLabel mesh__D052181 Publication Components %5B%Pub Type%5D%
% 211.25/211.40  |- mesh__dateEstablished mesh__D052181 2006-01-01
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D052181 2006
% 211.25/211.40  |- skos__annotation mesh__D052181 not used for indexing or cataloging   
% 211.25/211.40  |- mesh__recordMaintainer mesh__D052181 jls
% 211.25/211.40  |- mesh__historyNote mesh__D052181 2006   
% 211.25/211.40  |- mesh__recordAuthorizer mesh__D052181 sjn
% 211.25/211.40  |- skos__scopeNote mesh__D052181 Specific parts of publications.     
% 211.25/211.40  |- mesh__recordOriginator mesh__D052181 jls
% 211.25/211.40  |- mesh__recordMaintainer mesh__D013768 ags
% 211.25/211.40  |- mesh__recordOriginator mesh__D013768 NLM
% 211.25/211.40  |- rdf__type mesh__D013768sskos__Concept
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D013768 2006
% 211.25/211.40  |- mesh__recordAuthorizer mesh__D013768 sjn
% 211.25/211.40  |- mesh__dateRevised mesh__D013768 2003-07-09
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D013768 2005
% 211.25/211.40  |- mesh__dateCreated mesh__D013768 1999-01-01
% 211.25/211.40  |- mesh__activeMeSHYear mesh__D013768 2004
% 211.25/211.40  |- skos__prefLabel mesh__D013768 Tetrahymena
% 211.25/211.40  |- skos__annotation mesh__D013768
% 211.25/211.40       a genus of ciliate protozoa: do not confuse with suborder TETRAHYMENINA; a much used research tool%A%  
% 211.25/211.40  |- skos__scopeNote mesh__D013768
% 211.25/211.40       A genus of ciliate protozoa commonly used in genetic, cytological, and other research.%A%    
% 211.25/211.40  |- skos__broader mesh__D013768smesh__D016806
% 211.25/211.40  |- skos__hiddenLabel mesh__D018453 Child, Homeless
% 211.25/211.40  |- mesh__historyNote mesh__D018453 95   
% 211.25/211.40  |- skos__prefLabel mesh__D018453 Homeless Youth
% 211.25/211.41  |- skos__altLabel mesh__D018453 Street Child
% 211.25/211.41  |- mesh__dateRevised mesh__D018453 2002-07-03
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D018453 2006
% 211.25/211.41  |- skos__hiddenLabel mesh__D018453 Children, Homeless
% 211.25/211.41  |- skos__broader mesh__D018453smesh__D006703
% 211.25/211.41  |- mesh__dateCreated mesh__D018453 1994-04-16
% 211.25/211.41  |- rdf__type mesh__D018453sskos__Concept
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D018453 2003
% 211.25/211.41  |- mesh__recordOriginator mesh__D018453 TGC
% 211.25/211.41  |- skos__altLabel mesh__D018453 Homeless Children
% 211.25/211.41  |- skos__hiddenLabel mesh__D018453 Child, Street
% 211.25/211.41  |- skos__hiddenLabel mesh__D018453 Children, Street
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D018453 2004
% 211.25/211.41  |- skos__hiddenLabel mesh__D018453 Youths, Homeless
% 211.25/211.41  |- skos__hiddenLabel mesh__D018453 Youth, Street
% 211.25/211.41  |- skos__hiddenLabel mesh__D018453 Youth, Homeless
% 211.25/211.41  |- skos__historyNote mesh__D018453 Homeless Persons %28%1987-1994%29%
% 211.25/211.41  |- skos__scopeNote mesh__D018453
% 211.25/211.41       Runaway and homeless children and adolescents living on the streets of cities and having no fixed place of residence.%A%    
% 211.25/211.41  |- skos__hiddenLabel mesh__D018453 Runaway
% 211.25/211.41  |- mesh__dateEstablished mesh__D018453 1995-01-01
% 211.25/211.41  |- skos__altLabel mesh__D018453 Homeless Child
% 211.25/211.41  |- skos__hiddenLabel mesh__D018453 Youths, Street
% 211.25/211.41  |- skos__hiddenLabel mesh__D018453 Homeless Youths
% 211.25/211.41  |- mesh__recordAuthorizer mesh__D018453 sjn
% 211.25/211.41  |- mesh__publicMeSHNote mesh__D018453 95   
% 211.25/211.41  |- mesh__recordMaintainer mesh__D018453 PXP
% 211.25/211.41  |- skos__annotation mesh__D018453
% 211.25/211.41       check the tag CHILD or specific age group; specify geog if pertinent%A%  
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D018453 2005
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D010470 2001
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D010470 1994
% 211.25/211.41  |- mesh__dateCreated mesh__D010470 1999-01-01
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D010470 2006
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D010470 1999
% 211.25/211.41  |- skos__altLabel mesh__D010470 Masking, Perceptual
% 211.25/211.41  |- skos__historyNote mesh__D010470 Visual Perception %28%1966-1971%29%
% 211.25/211.41  |- skos__hiddenLabel mesh__D010470 Perceptual Maskings
% 211.25/211.41  |- skos__broader mesh__D010470smesh__D001307
% 211.25/211.41  |- mesh__publicMeSHNote mesh__D010470 72   
% 211.25/211.41  |- skos__prefLabel mesh__D010470 Perceptual Masking
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D010470 2002
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D010470 1995
% 211.25/211.41  |- skos__historyNote mesh__D010470 Auditory Threshold %28%1968-1971%29%
% 211.25/211.41  |- mesh__recordOriginator mesh__D010470 NLM
% 211.25/211.41  |- mesh__recordAuthorizer mesh__D010470 PLS
% 211.25/211.41  |- skos__hiddenLabel mesh__D010470 Maskings, Perceptual
% 211.25/211.41  |- mesh__recordMaintainer mesh__D010470 TAP
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D010470 2003
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D010470 1996
% 211.25/211.41  |- mesh__historyNote mesh__D010470 72   
% 211.25/211.41  |- mesh__dateRevised mesh__D010470 1992-05-15
% 211.25/211.41  |- rdf__type mesh__D010470sskos__Concept
% 211.25/211.41  |- skos__broader mesh__D010470smesh__D014796
% 211.25/211.41  |- skos__scopeNote mesh__D010470
% 211.25/211.41       The interference of one perceptual stimulus with another causing a decrease or lessening in perceptual effectiveness.%A%    
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D010470 2004
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D010470 1997
% 211.25/211.41  |- skos__historyNote mesh__D010470 Auditory Perception %28%1967-1971%29%
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D010470 2005
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D010470 1998
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D010470 2000
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D010470 1993
% 211.25/211.41  |- mesh__dateEstablished mesh__D010470 1972-01-01
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D032124 2004
% 211.25/211.41  |- mesh__dateEstablished mesh__D032124 2003-01-01
% 211.25/211.41  |- skos__annotation mesh__D032124
% 211.25/211.41       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.25/211.41  |- skos__broader mesh__D032124smesh__D029631
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D032124 2003
% 211.25/211.41  |- skos__scopeNote mesh__D032124
% 211.25/211.41       A plant genus of the family SAPINDACEAE. Members contain hypoglycins and ackee oil.%A%    
% 211.25/211.41  |- skos__prefLabel mesh__D032124 Blighia
% 211.25/211.41  |- mesh__publicMeSHNote mesh__D032124 2003   
% 211.25/211.41  |- rdf__type mesh__D032124sskos__Concept
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D032124 2006
% 211.25/211.41  |- mesh__historyNote mesh__D032124 2003   
% 211.25/211.41  |- skos__altLabel mesh__D032124 Akee
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D032124 2005
% 211.25/211.41  |- mesh__dateCreated mesh__D032124 2002-07-02
% 211.25/211.41  |- skos__altLabel mesh__D032124 Ackee
% 211.25/211.41  |- skos__prefLabel mesh__D004433 Earache
% 211.25/211.41  |- mesh__recordAuthorizer mesh__D004433 sjn
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D004433 2004
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D004433 2002
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D004433 2006
% 211.25/211.41  |- mesh__historyNote mesh__D004433 83   
% 211.25/211.41  |- mesh__publicMeSHNote mesh__D004433 83   
% 211.25/211.41  |- skos__historyNote mesh__D004433 Pain %28%1966-1982%29%
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D004433 2003
% 211.25/211.41  |- mesh__dateCreated mesh__D004433 1982-04-26
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D004433 2001
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D004433 2005
% 211.25/211.41  |- skos__altLabel mesh__D004433 Otalgia
% 211.25/211.41  |- mesh__recordOriginator mesh__D004433 RC
% 211.25/211.41  |- mesh__dateEstablished mesh__D004433 1983-01-01
% 211.25/211.41  |- skos__historyNote mesh__D004433 Ear %28%1966-1982%29%
% 211.25/211.41  |- skos__hiddenLabel mesh__D004433 Earaches
% 211.25/211.41  |- mesh__recordMaintainer mesh__D004433 KEV
% 211.25/211.41  |- skos__broader mesh__D004433smesh__D004427
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D004433 2000
% 211.25/211.41  |- rdf__type mesh__D004433sskos__Concept
% 211.25/211.41  |- skos__broader mesh__D004433smesh__D010146
% 211.25/211.41  |- mesh__dateRevised mesh__D004433 1999-11-03
% 211.25/211.41  |- skos__scopeNote mesh__D004433 Pain in the ear.     
% 211.25/211.41  |- skos__hiddenLabel mesh__D004433 Otalgias
% 211.25/211.41  |- skos__historyNote mesh__D004433 Ear Diseases %28%1966-1982%29%
% 211.25/211.41  |- mesh__recordMaintainer mesh__D028083 ssb
% 211.25/211.41  |- rdf__type mesh__D028083sskos__Concept
% 211.25/211.41  |- mesh__dateCreated mesh__D028083 2001-07-25
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D028083 2006
% 211.25/211.41  |- skos__annotation mesh__D028083
% 211.25/211.41       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.25/211.41  |- mesh__historyNote mesh__D028083 2002   
% 211.25/211.41  |- skos__prefLabel mesh__D028083 Scrophulariaceae
% 211.25/211.41  |- mesh__recordOriginator mesh__D028083 ssb
% 211.25/211.41  |- skos__broader mesh__D028083smesh__D019684
% 211.25/211.41  |- skos__scopeNote mesh__D028083
% 211.25/211.41       The figwort plant family of the order Scrophulariales, subclass Asteridae, class Magnoliopsida. The family is characterized by bisexual flowers with tubular corollas %28%fused petals%29% that are bilaterally symmetrical %28%two-lips%29% and have four stamens in most, two of which are usually shorter.%A%    
% 211.25/211.41  |- mesh__dateEstablished mesh__D028083 2002-01-01
% 211.25/211.41  |- mesh__publicMeSHNote mesh__D028083 2002   
% 211.25/211.41  |- mesh__recordAuthorizer mesh__D028083 sjn
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D028083 2005
% 211.25/211.41  |- mesh__dateRevised mesh__D028083 2003-07-09
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D028083 2004
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014861 1999
% 211.25/211.41  |- rdf__type mesh__D014861sskos__Concept
% 211.25/211.41  |- skos__broader mesh__D014861smesh__D019601
% 211.25/211.41  |- mesh__dateCreated mesh__D014861 1999-01-01
% 211.25/211.41  |- mesh__recordMaintainer mesh__D014861 PXP
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014861 2006
% 211.25/211.41  |- mesh__recordOriginator mesh__D014861 NLM
% 211.25/211.41  |- mesh__recordAuthorizer mesh__D014861 SJN
% 211.25/211.41  |- skos__broader mesh__D014861smesh__D015205
% 211.25/211.41  |- mesh__dateRevised mesh__D014861 1997-06-20
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014861 2000
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014861 2003
% 211.25/211.41  |- skos__annotation mesh__D014861
% 211.25/211.41       the state; for Washington, D. C. use DISTRICT OF COLUMBIA%A%  
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014861 2001
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014861 2004
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014861 1998
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014861 2002
% 211.25/211.41  |- skos__prefLabel mesh__D014861 Washington
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014861 2005
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014063 1994
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014063 2002
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014063 2005
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014063 1995
% 211.25/211.41  |- skos__hiddenLabel mesh__D014063 Fissured Tongue
% 211.25/211.41  |- skos__altLabel mesh__D014063 Tongue, Furrowed
% 211.25/211.41  |- skos__broader mesh__D014063smesh__D014060
% 211.25/211.41  |- skos__hiddenLabel mesh__D014063 Tongues, Fissured
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014063 2006
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014063 2000
% 211.25/211.41  |- mesh__recordMaintainer mesh__D014063 TGC
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014063 1998
% 211.25/211.41  |- mesh__recordOriginator mesh__D014063 NLM
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014063 2003
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014063 1999
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014063 2001
% 211.25/211.41  |- mesh__recordAuthorizer mesh__D014063 PLS
% 211.25/211.41  |- skos__hiddenLabel mesh__D014063 Fissured Tongues
% 211.25/211.41  |- skos__hiddenLabel mesh__D014063 Furrowed Tongue
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014063 2004
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014063 1996
% 211.25/211.41  |- skos__hiddenLabel mesh__D014063 Furrowed Tongues
% 211.25/211.41  |- mesh__dateRevised mesh__D014063 1992-12-28
% 211.25/211.41  |- rdf__type mesh__D014063sskos__Concept
% 211.25/211.41  |- skos__hiddenLabel mesh__D014063 Tongues, Furrowed
% 211.25/211.41  |- skos__related mesh__D014063smesh__D008556
% 211.25/211.41  |- skos__prefLabel mesh__D014063 Tongue, Fissured
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D014063 1997
% 211.25/211.41  |- mesh__dateCreated mesh__D014063 1999-01-01
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D008824 2003
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D008824 1998
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D008824 2005
% 211.25/211.41  |- skos__prefLabel mesh__D008824 Michigan
% 211.25/211.41  |- mesh__dateCreated mesh__D008824 1999-01-01
% 211.25/211.41  |- mesh__recordMaintainer mesh__D008824 PXP
% 211.25/211.41  |- rdf__type mesh__D008824sskos__Concept
% 211.25/211.41  |- mesh__dateRevised mesh__D008824 1997-06-20
% 211.25/211.41  |- mesh__recordOriginator mesh__D008824 NLM
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D008824 2002
% 211.25/211.41  |- skos__broader mesh__D008824smesh__D006114
% 211.25/211.41  |- skos__broader mesh__D008824smesh__D015146
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D008824 2001
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D008824 2004
% 211.25/211.41  |- mesh__recordAuthorizer mesh__D008824 SJN
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D008824 2000
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D008824 1999
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D008824 2006
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D000841 2004
% 211.25/211.41  |- mesh__publicMeSHNote mesh__D000841
% 211.25/211.41       91; was see under PYRROLIDINES 1975-90; FLAGECIDIN was see ANISOMYCIN 1975-95%A%  
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D000841 2005
% 211.25/211.41  |- mesh__dateCreated mesh__D000841 1974-11-19
% 211.25/211.41  |- mesh__recordOriginator mesh__D000841 NLM
% 211.25/211.41  |- skos__historyNote mesh__D000841 Pyrrolidines %28%1968-1974%29%
% 211.25/211.41  |- mesh__dateEstablished mesh__D000841 1991-01-01
% 211.25/211.41  |- mesh__dateRevised mesh__D000841 2003-07-30
% 211.25/211.41  |- skos__historyNote mesh__D000841 Antibiotics %28%1968-1974%29%
% 211.25/211.41  |- mesh__recordAuthorizer mesh__D000841 NLM
% 211.25/211.41  |- skos__historyNote mesh__D000841 Benzyl Compounds %28%1972-1974%29%
% 211.25/211.41  |- mesh__historyNote mesh__D000841
% 211.25/211.41       91%28%75%29%; was see under PYRROLIDINES 1975-90; FLAGECIDIN was see ANISOMYCIN 1975-95%A%  
% 211.25/211.41  |- skos__broader mesh__D000841smesh__D011759
% 211.25/211.41  |- mesh__recordMaintainer mesh__D000841 SYSTEM
% 211.25/211.41  |- skos__scopeNote mesh__D000841
% 211.25/211.41       An antibiotic isolated from various Streptomyces species. It interferes with protein and DNA synthesis by inhibiting peptidyl transferase or the 80S ribosome system.%A%    
% 211.25/211.41  |- rdf__type mesh__D000841sskos__Concept
% 211.25/211.41  |- skos__prefLabel mesh__D000841 Anisomycin
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D000841 2006
% 211.25/211.41  |- skos__broader mesh__D008026smesh__D013514
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D008026 2004
% 211.25/211.41  |- mesh__dateEstablished mesh__D008026 1977-01-01
% 211.25/211.41  |- rdf__type mesh__D008026sskos__Concept
% 211.25/211.41  |- skos__hiddenLabel mesh__D008026 Ligatures
% 211.25/211.41  |- mesh__recordOriginator mesh__D008026 NLM
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D008026 2002
% 211.25/211.41  |- mesh__historyNote mesh__D008026 77%28%71%29%   
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D008026 2005
% 211.25/211.41  |- mesh__dateCreated mesh__D008026 1999-01-01
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D008026 2006
% 211.25/211.41  |- mesh__publicMeSHNote mesh__D008026 77   
% 211.25/211.41  |- mesh__recordAuthorizer mesh__D008026 sjn
% 211.25/211.41  |- mesh__recordMaintainer mesh__D008026 ndw
% 211.25/211.41  |- skos__hiddenLabel mesh__D008026 Ligations
% 211.25/211.41  |- skos__historyNote mesh__D008026
% 211.25/211.41       specific heading/surgery %28%1966-1970%29%
% 211.25/211.41  |- skos__annotation mesh__D008026
% 211.25/211.41       never IM; do not use /util except by MeSH definition   
% 211.25/211.41  |- mesh__dateRevised mesh__D008026 1999-11-03
% 211.25/211.41  |- skos__historyNote mesh__D008026
% 211.25/211.41       Surgical Procedures, Operative %28%1966-1970%29%
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D008026 2000
% 211.25/211.41  |- skos__prefLabel mesh__D008026 Ligation
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D008026 2003
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D008026 2001
% 211.25/211.41  |- skos__scopeNote mesh__D008026
% 211.25/211.41       Application of a ligature to tie a vessel or strangulate a part.%A%    
% 211.25/211.41  |- skos__altLabel mesh__D000043 Indexes
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D000043 2004
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D000043 2006
% 211.25/211.41  |- mesh__dateRevised mesh__D000043 2005-07-07
% 211.25/211.41  |- mesh__recordOriginator mesh__D000043 NLM
% 211.25/211.41  |- skos__prefLabel mesh__D000043 Abstracting and Indexing
% 211.25/211.41  |- mesh__publicMeSHNote mesh__D000043
% 211.25/211.41       66; INDEXES see REFERENCE BOOKS 1996-98   
% 211.25/211.41  |- skos__annotation mesh__D000043
% 211.25/211.41       IM; med abstracting %26% indexing: do not coord with MEDICINE; do not confuse with ABSTRACTS %5B%PUBLICATION TYPE%5D% or with MEETING ABSTRACTS %5B%PUBLICATION TYPE%5D%%A%  
% 211.25/211.41  |- rdf__type mesh__D000043sskos__Concept
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D000043 2006A
% 211.25/211.41  |- skos__broader mesh__D000043smesh__D004282
% 211.25/211.41  |- skos__scopeNote mesh__D000043
% 211.25/211.41       Shortening or summarizing of documents; assigning of descriptors for referencing documents.%A%    
% 211.25/211.41  |- mesh__historyNote mesh__D000043
% 211.25/211.41       66; INDEXES see REFERENCE BOOKS 1996-98; INDEX see REFERENCE BOOKS 1984-98%A%  
% 211.25/211.41  |- skos__altLabel mesh__D000043 Indexing and Abstracting
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D000043 2003
% 211.25/211.41  |- skos__hiddenLabel mesh__D000043 Indices
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D000043 2005
% 211.25/211.41  |- mesh__dateCreated mesh__D000043 1999-01-01
% 211.25/211.41  |- mesh__recordAuthorizer mesh__D000043 ags
% 211.25/211.41  |- mesh__recordMaintainer mesh__D000043 ags
% 211.25/211.41  |- skos__prefLabel mesh__D052182
% 211.25/211.41       Study Characteristics %5B%Publication Type%5D%
% 211.25/211.41  |- mesh__dateEstablished mesh__D052182 2006-01-01
% 211.25/211.41  |- mesh__historyNote mesh__D052182 2006   
% 211.25/211.41  |- mesh__recordAuthorizer mesh__D052182 sjn
% 211.25/211.41  |- mesh__dateCreated mesh__D052182 2005-06-30
% 211.25/211.41  |- mesh__recordOriginator mesh__D052182 jls
% 211.25/211.41  |- rdf__type mesh__D052182sskos__Concept
% 211.25/211.41  |- mesh__recordMaintainer mesh__D052182 jls
% 211.25/211.41  |- mesh__runningHead mesh__D052182 V3 - STUDY CHARACTERISTICS   
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D052182 2006
% 211.25/211.41  |- skos__annotation mesh__D052182 not used for indexing or cataloging   
% 211.25/211.41  |- skos__prefLabel mesh__D013769 Tetrahymena pyriformis
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D013769 2006
% 211.25/211.41  |- rdf__type mesh__D013769sskos__Concept
% 211.25/211.41  |- mesh__dateEstablished mesh__D013769 1972-01-01
% 211.25/211.41  |- skos__scopeNote mesh__D013769
% 211.25/211.41       A species of ciliate protozoa used extensively in genetic research.%A%    
% 211.25/211.41  |- mesh__dateRevised mesh__D013769 2003-07-09
% 211.25/211.41  |- skos__historyNote mesh__D013769 Tetrahymena %28%1966-1971%29%
% 211.25/211.41  |- mesh__publicMeSHNote mesh__D013769 72   
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D013769 2004
% 211.25/211.41  |- skos__annotation mesh__D013769 a protozoon used in genetic research   
% 211.25/211.41  |- mesh__recordOriginator mesh__D013769 NLM
% 211.25/211.41  |- mesh__recordAuthorizer mesh__D013769 sjn
% 211.25/211.41  |- mesh__historyNote mesh__D013769 72   
% 211.25/211.41  |- mesh__dateCreated mesh__D013769 1999-01-01
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D013769 2005
% 211.25/211.41  |- mesh__recordMaintainer mesh__D013769 ags
% 211.25/211.41  |- skos__broader mesh__D013769smesh__D013768
% 211.25/211.41  |- mesh__publicMeSHNote mesh__D018454 95   
% 211.25/211.41  |- skos__historyNote mesh__D018454 Marriage %28%1966-1994%29%
% 211.25/211.41  |- skos__hiddenLabel mesh__D018454 Partners, Domestic
% 211.25/211.41  |- mesh__recordMaintainer mesh__D018454 JLS
% 211.25/211.41  |- skos__hiddenLabel mesh__D018454 Husband
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D018454 2003
% 211.25/211.41  |- mesh__dateCreated mesh__D018454 1994-04-16
% 211.25/211.41  |- rdf__type mesh__D018454sskos__Concept
% 211.25/211.41  |- skos__hiddenLabel mesh__D018454 Partner, Domestic
% 211.25/211.41  |- skos__scopeNote mesh__D018454
% 211.25/211.41       Married persons, i.e., husbands and wives, or partners. Domestic partners, or spousal equivalents, are two adults who have chosen to share their lives in an intimate and committed relationship, reside together, and share a mutual obligation of support for the basic necessities of life.%A%    
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D018454 2000
% 211.25/211.41  |- mesh__recordAuthorizer mesh__D018454 SJN
% 211.25/211.41  |- skos__annotation mesh__D018454
% 211.25/211.41       husbands, wives, or partners as persons: differentiate from MARRIAGE, the sociol or anthropol concept%A%  
% 211.25/211.41  |- skos__hiddenLabel mesh__D018454 Notification, Spousal
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D018454 2004
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D018454 2001
% 211.25/211.41  |- skos__altLabel mesh__D018454 Married Persons
% 211.25/211.41  |- skos__broader mesh__D018454smesh__D009679
% 211.25/211.41  |- skos__prefLabel mesh__D018454 Spouses
% 211.25/211.41  |- skos__altLabel mesh__D018454 Spouse
% 211.25/211.41  |- skos__hiddenLabel mesh__D018454 Persons, Married
% 211.25/211.41  |- skos__hiddenLabel mesh__D018454 Married Person
% 211.25/211.41  |- skos__hiddenLabel mesh__D018454 Domestic Partner
% 211.25/211.41  |- mesh__recordOriginator mesh__D018454 TGC
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D018454 1999
% 211.25/211.41  |- skos__hiddenLabel mesh__D018454 Person, Married
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D018454 2005
% 211.25/211.41  |- mesh__dateRevised mesh__D018454 1998-06-11
% 211.25/211.41  |- skos__broader mesh__D018454smesh__D009272
% 211.25/211.41  |- mesh__historyNote mesh__D018454 95   
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D018454 2002
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D018454 2006
% 211.25/211.41  |- skos__altLabel mesh__D018454 Wife
% 211.25/211.41  |- mesh__dateEstablished mesh__D018454 1995-01-01
% 211.25/211.41  |- skos__historyNote mesh__D010471 Fishes %28%1966-1986%29%
% 211.25/211.41  |- skos__scopeNote mesh__D010471
% 211.25/211.41       A common name for fish of the family Percidae, belonging to the suborder Percoidei, order PERCIFORMES.%A%    
% 211.25/211.41  |- mesh__historyNote mesh__D010471
% 211.25/211.41       91%28%87%29%; was see under PERCIFORMES 1987-90   
% 211.25/211.41  |- mesh__dateRevised mesh__D010471 2004-07-30
% 211.25/211.41  |- rdf__type mesh__D010471sskos__Concept
% 211.25/211.41  |- skos__prefLabel mesh__D010471 Perches
% 211.25/211.41  |- mesh__recordAuthorizer mesh__D010471 jls
% 211.25/211.41  |- mesh__dateEstablished mesh__D010471 1991-01-01
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D010471 2004
% 211.25/211.41  |- skos__broader mesh__D010471smesh__D010473
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D010471 2005
% 211.25/211.41  |- mesh__recordOriginator mesh__D010471 EC
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D010471 2006
% 211.25/211.41  |- mesh__recordMaintainer mesh__D010471 jls
% 211.25/211.41  |- skos__altLabel mesh__D010471 Percidae
% 211.25/211.41  |- mesh__publicMeSHNote mesh__D010471
% 211.25/211.41       91; was see under PERCIFORMES 1987-90   
% 211.25/211.41  |- mesh__dateCreated mesh__D010471 1986-04-15
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D010471 2005A
% 211.25/211.41  |- skos__annotation mesh__D032125
% 211.25/211.41       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.25/211.41  |- mesh__historyNote mesh__D032125 2003   
% 211.25/211.41  |- mesh__dateRevised mesh__D032125 2004-07-13
% 211.25/211.41  |- mesh__dateEstablished mesh__D032125 2003-01-01
% 211.25/211.41  |- mesh__recordOriginator mesh__D032125 ssb
% 211.25/211.41  |- skos__prefLabel mesh__D032125 Litchi
% 211.25/211.41  |- skos__altLabel mesh__D032125 Leechee
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D032125 2005
% 211.25/211.41  |- mesh__recordMaintainer mesh__D032125 sjn
% 211.25/211.41  |- skos__altLabel mesh__D032125 Lychee
% 211.25/211.41  |- mesh__publicMeSHNote mesh__D032125 2003   
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D032125 2006
% 211.25/211.41  |- rdf__type mesh__D032125sskos__Concept
% 211.25/211.41  |- skos__broader mesh__D032125smesh__D029631
% 211.25/211.41  |- mesh__dateCreated mesh__D032125 2002-07-03
% 211.25/211.41  |- mesh__recordAuthorizer mesh__D032125 sjn
% 211.25/211.41  |- skos__scopeNote mesh__D032125
% 211.25/211.41       A plant genus of the family SAPINDACEAE that bears sweet fruits. Unusual fatty acids such as cyclopropanoic fatty acids have been identified in the seeds.%A%    
% 211.25/211.41  |- skos__altLabel mesh__D004434 Accelerated Ambulation
% 211.25/211.41  |- skos__altLabel mesh__D004434 Ambulation, Early
% 211.25/211.41  |- skos__hiddenLabel mesh__D004434 Mobilization, Early
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D004434 2006
% 211.25/211.41  |- skos__historyNote mesh__D004434
% 211.25/211.41       specific heading/rehabilitation %28%1966-1975%29%
% 211.25/211.41  |- mesh__publicMeSHNote mesh__D004434 76   
% 211.25/211.41  |- skos__hiddenLabel mesh__D004434 Ambulation, Accelerated
% 211.25/211.41  |- mesh__recordMaintainer mesh__D004434 lkt
% 211.25/211.41  |- mesh__recordAuthorizer mesh__D004434 sjn
% 211.25/211.41  |- skos__broader mesh__D004434smesh__D012046
% 211.25/211.41  |- rdf__type mesh__D004434sskos__Concept
% 211.25/211.41  |- mesh__historyNote mesh__D004434 76   
% 211.25/211.41  |- skos__annotation mesh__D004434
% 211.25/211.41       for patient recovery not child development   
% 211.25/211.41  |- mesh__recordOriginator mesh__D004434 SMH
% 211.25/211.41  |- mesh__dateCreated mesh__D004434 1975-07-23
% 211.25/211.41  |- mesh__dateRevised mesh__D004434 2005-06-30
% 211.25/211.41  |- skos__scopeNote mesh__D004434
% 211.25/211.41       Procedure to accelerate the ability of a patient to walk or move about by reducing the time to AMBULATION. It is characterized by a shorter period of hospitalization or recumbency than is normally practiced.%A%    
% 211.25/211.41  |- skos__prefLabel mesh__D004434 Early Ambulation
% 211.25/211.41  |- mesh__dateEstablished mesh__D004434 1976-01-01
% 211.25/211.41  |- mesh__recordMaintainer mesh__D028084 ssb
% 211.25/211.41  |- mesh__historyNote mesh__D028084 2002; use Theales 1999-2001   
% 211.25/211.41  |- mesh__dateCreated mesh__D028084 2001-07-25
% 211.25/211.41  |- skos__prefLabel mesh__D028084 Clusiaceae
% 211.25/211.41  |- mesh__dateEstablished mesh__D028084 2002-01-01
% 211.25/211.41  |- mesh__recordAuthorizer mesh__D028084 sjn
% 211.25/211.41  |- rdf__type mesh__D028084sskos__Concept
% 211.25/211.41  |- skos__altLabel mesh__D028084 Plum, Waika
% 211.25/211.41  |- skos__scopeNote mesh__D028084
% 211.25/211.41       The mangosteen plant family %28%sometimes classified as Guttiferae; also known as Hypericaceae%29% of the order THEALES, subclass Dilleniidae, class Magnoliopsida. It includes trees and shrubs with resinous, sticky sap, usually with broad-ended, oblong, leathery leaves with a strong, central vein, flowers with many stamens.%A%    
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D028084 2006
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D028084 2005
% 211.25/211.41  |- mesh__recordOriginator mesh__D028084 ssb
% 211.25/211.41  |- skos__broader mesh__D028084smesh__D020448
% 211.25/211.41  |- skos__annotation mesh__D028084
% 211.25/211.41       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.25/211.41  |- mesh__activeMeSHYear mesh__D028084 2004
% 211.25/211.41  |- skos__historyNote mesh__D028084 Theales %28%1999-2001%29%
% 211.25/211.41  |- mesh__publicMeSHNote mesh__D028084 2002; see Theales 1989-2001   
% 211.25/211.41  |- mesh__dateRevised mesh__D028084 2003-07-09
% 211.25/211.41  |- skos__altLabel mesh__D014862 Vespid Venoms
% 211.25/211.41  |- skos__hiddenLabel mesh__D014862 Venom, Vespid
% 211.25/211.41  |- mesh__dateCreated mesh__D014862 1977-04-27
% 211.25/211.41  |- mesh__publicMeSHNote mesh__D014862
% 211.25/211.41       91; was see under BEE VENOMS 1978-90   
% 211.25/211.41  |- skos__prefLabel mesh__D014862 Wasp Venoms
% 211.25/211.41  |- mesh__historyNote mesh__D014862
% 211.25/211.41       91%28%78%29%; was see under BEE VENOMS 1978-90   
% 211.25/211.41  |- mesh__dateRevised mesh__D014862 2005-06-30
% 211.25/211.41  |- mesh__recordOriginator mesh__D014862 SH
% 211.25/211.41  |- skos__hiddenLabel mesh__D014862 Venoms, Vespid
% 211.25/211.41  |- skos__historyNote mesh__D014862
% 211.25/211.41       Insect Bites and Stings %28%1966-1974%29%
% 211.25/211.41  |- skos__altLabel mesh__D014862 Vespid Venom
% 211.25/211.41  |- mesh__recordAuthorizer mesh__D014862 sjn
% 211.25/211.41  |- skos__annotation mesh__D014862
% 211.25/211.41       /antag permitted but consider also ANTIVENINS; /enzymol permitted%A%  
% 211.25/211.41  |- mesh__recordMaintainer mesh__D014862 ssb
% 211.25/211.41  |- skos__historyNote mesh__D014862 Insects %28%1966-1975%29%
% 211.25/211.42  |- mesh__dateEstablished mesh__D014862 1991-01-01
% 211.25/211.42  |- skos__altLabel mesh__D014862 Vespa Venoms
% 211.25/211.42  |- skos__hiddenLabel mesh__D014862 Venoms, Vespa
% 211.25/211.42  |- skos__altLabel mesh__D014862 Wasp Venom
% 211.25/211.42  |- skos__historyNote mesh__D014862 Wasps %28%1975-1977%29%
% 211.25/211.42  |- rdf__type mesh__D014862sskos__Concept
% 211.25/211.42  |- skos__hiddenLabel mesh__D014862 Venoms, Wasp
% 211.25/211.42  |- skos__historyNote mesh__D014862 Venoms %28%1966-1977%29%
% 211.25/211.42  |- skos__broader mesh__D014862smesh__D001180
% 211.25/211.42  |- skos__historyNote mesh__D014862 Bees %28%1966-1974%29%
% 211.25/211.42  |- skos__hiddenLabel mesh__D014862 Venom, Wasp
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D014862 2006
% 211.25/211.42  |- skos__scopeNote mesh__D014862
% 211.25/211.42       Venoms produced by the wasp %28%Vespid%29% family of stinging insects, including hornets; the venoms contain enzymes, biogenic amines, histamine releasing factors, kinins, toxic polypeptides, etc., and are similar to bee venoms.%A%    
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D014064 2005
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D014064 1995
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D014064 2006
% 211.25/211.42  |- mesh__recordMaintainer mesh__D014064 TGC
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D014064 1998
% 211.25/211.42  |- mesh__onlineNote mesh__D014064 search TONGUE DISEASES 1966-74   
% 211.25/211.42  |- mesh__historyNote mesh__D014064
% 211.25/211.42       91%28%75%29%; was see under TONGUE DISEASES 1975-90   
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D014064 2002
% 211.25/211.42  |- skos__related mesh__D014064smesh__D017733
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D014064 2003
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D014064 1999
% 211.25/211.42  |- skos__scopeNote mesh__D014064
% 211.25/211.42       A benign condition of the tongue characterized by hypertrophy of the filiform papillae that give the dorsum of the tongue a furry appearance. The color of the elongated papillae varies from yellowish white to brown or black, depending upon staining by substances such as tobacco, food, or drugs. %28%Dorland, 27th ed%29%%A%    
% 211.25/211.42  |- skos__hiddenLabel mesh__D014064 Tongues, Hairy
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D014064 2004
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D014064 1996
% 211.25/211.42  |- skos__annotation mesh__D014064
% 211.25/211.42       hairy refers to appearance of hypertrophied papillae on tongue%A%  
% 211.25/211.42  |- skos__broader mesh__D014064smesh__D014060
% 211.25/211.42  |- rdf__type mesh__D014064sskos__Concept
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D014064 2000
% 211.25/211.42  |- mesh__dateEstablished mesh__D014064 1991-01-01
% 211.25/211.42  |- skos__hiddenLabel mesh__D014064 Hairy Tongues
% 211.25/211.42  |- mesh__recordOriginator mesh__D014064 NLM
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D014064 1997
% 211.25/211.42  |- mesh__publicMeSHNote mesh__D014064
% 211.25/211.42       91; was see under TONGUE DISEASES 1975-90   
% 211.25/211.42  |- skos__prefLabel mesh__D014064 Tongue, Hairy
% 211.25/211.42  |- skos__hiddenLabel mesh__D014064 Hairy Tongue
% 211.25/211.42  |- mesh__dateCreated mesh__D014064 1999-01-01
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D014064 2001
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D014064 1994
% 211.25/211.42  |- mesh__recordAuthorizer mesh__D014064 PLS
% 211.25/211.42  |- mesh__dateRevised mesh__D014064 1993-06-03
% 211.25/211.42  |- mesh__publicMeSHNote mesh__D008825
% 211.25/211.42       84; was see under IMIDAZOLES 1975-83   
% 211.25/211.42  |- rdf__type mesh__D008825sskos__Concept
% 211.25/211.42  |- mesh__recordMaintainer mesh__D008825 ssb
% 211.25/211.42  |- mesh__dateCreated mesh__D008825 1974-11-19
% 211.25/211.42  |- skos__historyNote mesh__D008825 Ethers %28%1971-1974%29%
% 211.25/211.42  |- mesh__dateRevised mesh__D008825 2005-06-30
% 211.25/211.42  |- skos__altLabel mesh__D008825 Miconasil Nitrate
% 211.25/211.42  |- skos__hiddenLabel mesh__D008825 R 14,889
% 211.25/211.42  |- mesh__dateEstablished mesh__D008825 1984-01-01
% 211.25/211.42  |- skos__historyNote mesh__D008825 Benzyl Compounds %28%1972-1974%29%
% 211.25/211.42  |- skos__scopeNote mesh__D008825
% 211.25/211.42       An imidazole antifungal agent that is used topically and by intravenous infusion.%A%    
% 211.25/211.42  |- mesh__recordOriginator mesh__D008825 NLM
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D008825 2006
% 211.25/211.42  |- mesh__recordAuthorizer mesh__D008825 sjn
% 211.25/211.42  |- mesh__historyNote mesh__D008825
% 211.25/211.42       84%28%75%29%; was see under IMIDAZOLES 1975-83   
% 211.25/211.42  |- skos__prefLabel mesh__D008825 Miconazole
% 211.25/211.42  |- skos__hiddenLabel mesh__D008825 R14,889
% 211.25/211.42  |- skos__broader mesh__D008825smesh__D007093
% 211.25/211.42  |- skos__historyNote mesh__D008825 Imidazoles %28%1971-1974%29%
% 211.25/211.42  |- skos__altLabel mesh__D000842 Regio tarsalis
% 211.25/211.42  |- skos__related mesh__D000842smesh__D013639
% 211.25/211.42  |- skos__altLabel mesh__D000842 Tarsus
% 211.25/211.42  |- skos__related mesh__D000842smesh__D000843
% 211.25/211.42  |- mesh__dateCreated mesh__D000842 1999-01-01
% 211.25/211.42  |- mesh__recordOriginator mesh__D000842 NLM
% 211.25/211.42  |- skos__scopeNote mesh__D000842
% 211.25/211.42       The region of the lower limb between the FOOT and  the LEG.%A%    
% 211.25/211.42  |- mesh__recordMaintainer mesh__D000842 ags
% 211.25/211.42  |- skos__hiddenLabel mesh__D000842 Ankles
% 211.25/211.42  |- mesh__dateRevised mesh__D000842 2002-07-02
% 211.25/211.42  |- mesh__historyNote mesh__D000842
% 211.25/211.42       1963; use ANKLE INJURIES to search ANKLE/injuries 1966-91%A%  
% 211.25/211.42  |- mesh__publicMeSHNote mesh__D000842
% 211.25/211.42       1963; see ANKLE INJURIES to search ANKLE/injuries 1966-91; for TARSUS see TARSUS 1988-2001%A%  
% 211.25/211.42  |- mesh__recordAuthorizer mesh__D000842 sjn
% 211.25/211.42  |- rdf__type mesh__D000842sskos__Concept
% 211.25/211.42  |- skos__prefLabel mesh__D000842 Ankle
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D000842 2006
% 211.25/211.42  |- skos__annotation mesh__D000842
% 211.25/211.42       primates only; use TARSUS, ANIMAL for non-primate vertebrates; differentiate from ANKLE JOINT; ANKLE BONES see TARSAL BONES is also available; do not confuse X ref TARSUS with tarsus or tarsal referring to the eyelid%A%  
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D000842 2004
% 211.25/211.42  |- skos__broader mesh__D000842smesh__D005528
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D000842 2005
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D000842 2003
% 211.25/211.42  |- skos__scopeNote mesh__D008027
% 211.25/211.42       That portion of the electromagnetic spectrum to which the human eye is sensitive. Light is about 400 to 800 nanometers in wavelength, i.e., between the ultraviolet and infrared spectra.%A%    
% 211.25/211.42  |- skos__related mesh__D008027smesh__D008029
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D008027 2005
% 211.25/211.42  |- skos__annotation mesh__D008027
% 211.25/211.42       differentiate from LIGHTING %28%the environment%29%; light scattering = SCATTERING, RADIATION %28%IM%29% + LIGHT %28%NIM%29%; LIGHT + PERIODICITY is not necessarily CIRCADIAN RHYTHM; luminance goes here or under LIGHTING but not under LUMINESCENCE, PHYSICAL; black light: index under INFRARED RAYS or ULTRAVIOLET RAYS depending on text but unspecified, index under ULTRAVIOLET RAYS%A%  
% 211.25/211.42  |- skos__related mesh__D008027smesh__D010783
% 211.25/211.42  |- skos__related mesh__D008027smesh__D018462
% 211.25/211.42  |- skos__hiddenLabel mesh__D008027 Radiations, Visible
% 211.25/211.42  |- mesh__dateRevised mesh__D008027 2004-07-13
% 211.25/211.42  |- mesh__dateCreated mesh__D008027 1999-01-01
% 211.25/211.42  |- skos__hiddenLabel mesh__D008027 Photoradiations
% 211.25/211.42  |- skos__related mesh__D008027smesh__D013472
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D008027 2006
% 211.25/211.42  |- skos__hiddenLabel mesh__D008027 Visible Light
% 211.25/211.42  |- skos__altLabel mesh__D008027 Photoradiation
% 211.25/211.42  |- mesh__recordMaintainer mesh__D008027 sjn
% 211.25/211.42  |- mesh__recordOriginator mesh__D008027 NLM
% 211.25/211.42  |- skos__broader mesh__D008027smesh__D011840
% 211.25/211.42  |- skos__broader mesh__D008027smesh__D009906
% 211.25/211.42  |- skos__related mesh__D008027smesh__D018524
% 211.25/211.42  |- skos__related mesh__D008027smesh__D010778
% 211.25/211.42  |- skos__altLabel mesh__D008027 Radiation, Visible
% 211.25/211.42  |- skos__prefLabel mesh__D008027 Light
% 211.25/211.42  |- mesh__recordAuthorizer mesh__D008027 sjn
% 211.25/211.42  |- skos__related mesh__D008027smesh__D010777
% 211.25/211.42  |- skos__related mesh__D008027smesh__D010789
% 211.25/211.42  |- mesh__considerAlso mesh__D008027
% 211.25/211.42       consider also terms at PHOTIC and PHOTO-   
% 211.25/211.42  |- rdf__type mesh__D008027sskos__Concept
% 211.25/211.42  |- skos__related mesh__D008027smesh__D014467
% 211.25/211.42  |- skos__hiddenLabel mesh__D008027 Visible Radiations
% 211.25/211.42  |- skos__related mesh__D008027smesh__D010775
% 211.25/211.42  |- skos__related mesh__D008027smesh__D010788
% 211.25/211.42  |- skos__related mesh__D008027smesh__D008163
% 211.25/211.42  |- skos__altLabel mesh__D008027 Visible Radiation
% 211.25/211.42  |- skos__related mesh__D008027smesh__D010787
% 211.25/211.42  |- skos__prefLabel mesh__D000044 Dental Abutments
% 211.25/211.42  |- skos__altLabel mesh__D000044 Abutments, Dental
% 211.25/211.42  |- skos__annotation mesh__D000044
% 211.25/211.42       tooth or root used as anchor for denture or implant, etc.; DF: DENT ABUTMENTS%A%  
% 211.25/211.42  |- rdf__type mesh__D000044sskos__Concept
% 211.25/211.42  |- mesh__recordAuthorizer mesh__D000044 SJN
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D000044 2000
% 211.25/211.42  |- mesh__recordMaintainer mesh__D000044 PXP
% 211.25/211.42  |- skos__altLabel mesh__D000044 Dental Abutment
% 211.25/211.42  |- skos__altLabel mesh__D000044 Abutment, Dental
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D000044 2003
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D000044 2001
% 211.25/211.42  |- mesh__dateCreated mesh__D000044 1999-01-01
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D000044 2005
% 211.25/211.42  |- mesh__onlineNote mesh__D000044
% 211.25/211.42       use DENTAL ABUTMENTS to search ABUTMENTS, DENTAL 1970-90   
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D000044 2004
% 211.25/211.42  |- mesh__publicMeSHNote mesh__D000044 91; was ABUTMENTS, DENTAL 1970-90   
% 211.25/211.42  |- mesh__recordOriginator mesh__D000044 NLM
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D000044 2006
% 211.25/211.42  |- mesh__dateEstablished mesh__D000044 1970-01-01
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D000044 1998
% 211.25/211.42  |- skos__scopeNote mesh__D000044
% 211.25/211.42       Natural teeth or teeth roots used as anchorage for a fixed or removable denture or other prosthesis %28%such as an implant%29% serving the same purpose.%A%    
% 211.25/211.42  |- mesh__historyNote mesh__D000044 91; was ABUTMENTS, DENTAL 1970-90   
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D000044 2002
% 211.25/211.42  |- mesh__dateRevised mesh__D000044 1997-06-20
% 211.25/211.42  |- skos__historyNote mesh__D000044 Denture, Partial %28%1966-1969%29%
% 211.25/211.42  |- skos__historyNote mesh__D000044
% 211.25/211.42       Dental Cavity Preparation %28%1966-1969%29%
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D000044 1999
% 211.25/211.42  |- skos__broader mesh__D000044smesh__D017266
% 211.25/211.42  |- skos__broader mesh__D018455smesh__D001796
% 211.25/211.42  |- mesh__dateEstablished mesh__D018455 1995-01-01
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D018455 2002
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D018455 1999
% 211.25/211.42  |- mesh__recordMaintainer mesh__D018455 NNS
% 211.25/211.42  |- skos__broader mesh__D018455smesh__D019851
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D018455 2005
% 211.25/211.42  |- skos__prefLabel mesh__D018455 Protein S Deficiency
% 211.25/211.42  |- skos__annotation mesh__D018455
% 211.25/211.42       a blood protein disord causing thromboses; DF: PROTEIN S DEFIC%A%  
% 211.25/211.42  |- mesh__historyNote mesh__D018455 95   
% 211.25/211.42  |- skos__historyNote mesh__D018455
% 211.25/211.42       Glycoproteins/deficiency %28%1984-1992%29%
% 211.25/211.42  |- mesh__publicMeSHNote mesh__D018455 95   
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D018455 2006
% 211.25/211.42  |- skos__hiddenLabel mesh__D018455 Protein S Deficiencies
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D018455 2000
% 211.25/211.42  |- mesh__recordAuthorizer mesh__D018455 SJN
% 211.25/211.42  |- skos__broader mesh__D018455smesh__D001778
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D018455 2003
% 211.25/211.42  |- mesh__dateCreated mesh__D018455 1994-04-16
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D018455 2001
% 211.25/211.42  |- rdf__type mesh__D018455sskos__Concept
% 211.25/211.42  |- skos__historyNote mesh__D018455 Protein S/deficiency %28%1993-1994%29%
% 211.25/211.42  |- mesh__dateRevised mesh__D018455 1998-06-10
% 211.25/211.42  |- skos__scopeNote mesh__D018455
% 211.25/211.42       An autosomal dominant disorder showing decreased levels of plasma protein S antigen or activity, associated with venous thrombosis and pulmonary embolism. PROTEIN S is a vitamin K-dependent plasma protein that inhibits blood clotting by serving as a cofactor for activated PROTEIN C %28%also a vitamin K-dependent protein%29%, and the clinical manifestations of its deficiency are virtually identical to those of protein C deficiency. Treatment with heparin for acute thrombotic processes is usually followed by maintenance administration of coumarin drugs for the prevention of recurrent thrombosis. %28%From Harrison%27%s Principles of Internal Medicine, 12th ed, p1511; Wintrobe%27%s Clinical Hematology, 9th ed, p1523%29%%A%    
% 211.25/211.42  |- skos__hiddenLabel mesh__D018455 Deficiencies, Protein S
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D018455 2004
% 211.25/211.42  |- skos__altLabel mesh__D018455 Deficiency, Protein S
% 211.25/211.42  |- mesh__recordOriginator mesh__D018455 TGC
% 211.25/211.42  |- rdf__type mesh__D010472sskos__Concept
% 211.25/211.42  |- mesh__onlineNote mesh__D010472
% 211.25/211.42       use PERCHLORIC ACID to search PERCHLORIC ACIDS 1966-93   
% 211.25/211.42  |- skos__broader mesh__D010472smesh__D017606
% 211.25/211.42  |- mesh__dateRevised mesh__D010472 1997-06-20
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D010472 2004
% 211.25/211.42  |- skos__hiddenLabel mesh__D010472 Acid, Perchloric
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D010472 2005
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D010472 1998
% 211.25/211.42  |- mesh__recordMaintainer mesh__D010472 KEV
% 211.25/211.42  |- skos__broader mesh__D010472smesh__D000148
% 211.25/211.42  |- mesh__dateCreated mesh__D010472 1999-01-01
% 211.25/211.42  |- skos__prefLabel mesh__D010472 Perchloric Acid
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D010472 2006
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D010472 2000
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D010472 1999
% 211.25/211.42  |- mesh__publicMeSHNote mesh__D010472
% 211.25/211.42       94; was PERCHLORIC ACIDS 1963-93; PERCHLORIC ACID was indexed under PERCHLORIC ACIDS 1981-93%A%  
% 211.25/211.42  |- skos__hiddenLabel mesh__D010472 Acids, Perchloric
% 211.25/211.42  |- mesh__historyNote mesh__D010472
% 211.25/211.42       94; was PERCHLORIC ACIDS 1963-93; PERCHLORIC ACID was NM 1981-93%A%  
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D010472 2001
% 211.25/211.42  |- skos__annotation mesh__D010472
% 211.25/211.42       used in anal chem to separate potassium from sodium   
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D010472 2002
% 211.25/211.42  |- skos__scopeNote mesh__D010472
% 211.25/211.42       An oxidizing agent that is used in analytical chemistry for separation of potassium from sodium. %28%From Merck Index, 11th ed%29%%A%    
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D010472 2003
% 211.25/211.42  |- mesh__recordOriginator mesh__D010472 NLM
% 211.25/211.42  |- mesh__recordAuthorizer mesh__D010472 SJN
% 211.25/211.42  |- mesh__dateCreated mesh__D032126 2002-07-02
% 211.25/211.42  |- skos__altLabel mesh__D032126 Barbasco
% 211.25/211.42  |- skos__altLabel mesh__D032126 Guarana
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D032126 2005
% 211.25/211.42  |- mesh__historyNote mesh__D032126 2003   
% 211.25/211.42  |- skos__prefLabel mesh__D032126 Paullinia
% 211.25/211.42  |- mesh__publicMeSHNote mesh__D032126 2003   
% 211.25/211.42  |- rdf__type mesh__D032126sskos__Concept
% 211.25/211.42  |- mesh__dateEstablished mesh__D032126 2003-01-01
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D032126 2006
% 211.25/211.42  |- skos__broader mesh__D032126smesh__D029631
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D032126 2003
% 211.25/211.42  |- skos__scopeNote mesh__D032126
% 211.25/211.42       A plant genus of the family SAPINDACEAE. The seed of P. cupana is the source of guarana powder which contains 4%25% CAFFEINE.%A%    
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D032126 2004
% 211.25/211.42  |- skos__annotation mesh__D032126
% 211.25/211.42       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.25/211.42  |- mesh__publicMeSHNote mesh__D004435 73   
% 211.25/211.42  |- skos__altLabel mesh__D004435 Food Intake
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D004435 1996
% 211.25/211.42  |- skos__prefLabel mesh__D004435 Eating
% 211.25/211.42  |- mesh__recordMaintainer mesh__D004435 TAP
% 211.25/211.42  |- mesh__dateEstablished mesh__D004435 1973-01-01
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D004435 1998
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D004435 1997
% 211.25/211.42  |- rdf__type mesh__D004435sskos__Concept
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D004435 2002
% 211.25/211.42  |- skos__hiddenLabel mesh__D004435 Intakes, Food
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D004435 1994
% 211.25/211.42  |- mesh__historyNote mesh__D004435 73%28%66%29%   
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D004435 1999
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D004435 1993
% 211.25/211.42  |- skos__broader mesh__D004435smesh__D004068
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D004435 1995
% 211.25/211.42  |- mesh__recordAuthorizer mesh__D004435 PLS
% 211.25/211.42  |- skos__annotation mesh__D004435
% 211.25/211.42       the act of eating: do not confuse with FOOD %28%the substance eaten%29% or EATING BEHAVIOR see FEEDING BEHAVIOR %28%the manner of eating%29%: TN 63%A%  
% 211.25/211.42  |- mesh__recordOriginator mesh__D004435 NLM
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D004435 2003
% 211.25/211.42  |- skos__hiddenLabel mesh__D004435 Intake, Food
% 211.25/211.42  |- mesh__dateCreated mesh__D004435 1999-01-01
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D004435 2000
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D004435 2005
% 211.25/211.42  |- skos__hiddenLabel mesh__D004435 Eatings
% 211.25/211.42  |- skos__hiddenLabel mesh__D004435 Food Intakes
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D004435 2004
% 211.25/211.42  |- mesh__dateRevised mesh__D004435 1992-05-15
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D004435 2001
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D004435 2006
% 211.25/211.42  |- skos__hiddenLabel mesh__D009120 Cramps, Limb
% 211.25/211.42  |- skos__hiddenLabel mesh__D009120 Cramps, Muscular
% 211.25/211.42  |- skos__hiddenLabel mesh__D009120 Muscle Cramps
% 211.25/211.42  |- skos__altLabel mesh__D009120 Cramp
% 211.25/211.42  |- mesh__recordOriginator mesh__D009120 NLM
% 211.25/211.42  |- mesh__dateRevised mesh__D009120 2003-07-25
% 211.25/211.42  |- rdf__type mesh__D009120sskos__Concept
% 211.25/211.42  |- skos__hiddenLabel mesh__D009120 Cramp, Muscular
% 211.25/211.42  |- mesh__recordMaintainer mesh__D009120 sjn
% 211.25/211.42  |- mesh__dateCreated mesh__D009120 1999-01-01
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D009120 2005
% 211.25/211.42  |- mesh__recordAuthorizer mesh__D009120 sjn
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D009120 2004
% 211.25/211.42  |- skos__hiddenLabel mesh__D009120 Cramp, Muscle
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D009120 2006
% 211.25/211.42  |- skos__scopeNote mesh__D009120
% 211.25/211.42       A sustained and usually painful contraction of muscle fibers. This may occur as an isolated phenomenon or as a manifestation of an underlying disease process %28%e.g., UREMIA; HYPOTHYROIDISM; MOTOR NEURON DISEASE; etc.%29%. %28%From Adams et al., Principles of Neurology, 6th ed, p1398%29%%A%    
% 211.25/211.42  |- skos__hiddenLabel mesh__D009120 Cramp, Limb
% 211.25/211.42  |- skos__related mesh__D009120smesh__D013035
% 211.25/211.42  |- skos__hiddenLabel mesh__D009120 Muscular Cramps
% 211.25/211.42  |- skos__hiddenLabel mesh__D009120 Limb Cramps
% 211.25/211.42  |- skos__prefLabel mesh__D009120 Muscle Cramp
% 211.25/211.42  |- skos__broader mesh__D009120smesh__D009135
% 211.25/211.42  |- skos__broader mesh__D009120smesh__D020879
% 211.25/211.42  |- skos__hiddenLabel mesh__D009120 Cramps
% 211.25/211.42  |- skos__hiddenLabel mesh__D009120 Cramps, Muscle
% 211.25/211.42  |- skos__altLabel mesh__D009120 Muscular Cramp
% 211.25/211.42  |- mesh__dateCreated mesh__D014863 1974-12-12
% 211.25/211.42  |- skos__prefLabel mesh__D014863 Wasps
% 211.25/211.42  |- skos__annotation mesh__D014863
% 211.25/211.42       /microbiol /parasitol /virol permitted; wasp stings: coord IM with INSECT BITES AND STINGS %28%IM%29%%A%  
% 211.25/211.42  |- mesh__publicMeSHNote mesh__D014863
% 211.25/211.42       91; was see under HYMENOPTERA 1975-90   
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D014863 2004
% 211.25/211.42  |- mesh__dateRevised mesh__D014863 2003-07-09
% 211.25/211.42  |- mesh__recordMaintainer mesh__D014863 ags
% 211.25/211.42  |- mesh__dateEstablished mesh__D014863 1991-01-01
% 211.25/211.42  |- rdf__type mesh__D014863sskos__Concept
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D014863 2005
% 211.25/211.42  |- skos__scopeNote mesh__D014863
% 211.25/211.42       Any of numerous winged hymenopterous insects of social as well as solitary habits and having formidable stings.%A%    
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D014863 2006
% 211.25/211.42  |- mesh__historyNote mesh__D014863
% 211.25/211.42       91%28%75%29%; was see under HYMENOPTERA 1975-90   
% 211.25/211.42  |- mesh__recordAuthorizer mesh__D014863 sjn
% 211.25/211.42  |- mesh__recordOriginator mesh__D014863 NLM
% 211.25/211.42  |- skos__broader mesh__D014863smesh__D006927
% 211.25/211.42  |- skos__prefLabel mesh__D014065 Tonometry, Ocular
% 211.25/211.42  |- mesh__recordOriginator mesh__D014065 NLM
% 211.25/211.42  |- mesh__recordAuthorizer mesh__D014065 sjn
% 211.25/211.42  |- mesh__publicMeSHNote mesh__D014065 2004; see TONOMETRY 1966-2003   
% 211.25/211.42  |- mesh__dateCreated mesh__D014065 1999-01-01
% 211.25/211.42  |- mesh__dateRevised mesh__D014065 2003-07-09
% 211.25/211.42  |- mesh__recordMaintainer mesh__D014065 lkt
% 211.25/211.42  |- mesh__historyNote mesh__D014065 2004; use TONOMETRY 1966-2003   
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D014065 2006
% 211.25/211.42  |- skos__broader mesh__D014065smesh__D003941
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D014065 2005
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D014065 2004
% 211.25/211.42  |- skos__scopeNote mesh__D014065
% 211.25/211.42       Measurement of ocular tension %28%INTRAOCULAR PRESSURE%29% with a tonometer. %28%Cline, et al., Dictionary of Visual Science, 4th ed%29%%A%    
% 211.25/211.42  |- skos__annotation mesh__D014065
% 211.25/211.42       TONOMETRY see MANOMETRY is available for non-ocular tension or pressure%A%  
% 211.25/211.42  |- rdf__type mesh__D014065sskos__Concept
% 211.25/211.42  |- skos__altLabel mesh__D014065 Ocular Tonometry
% 211.25/211.42  |- skos__historyNote mesh__D008826 Antibiotics %28%1966-1969%29%
% 211.25/211.42  |- mesh__dateEstablished mesh__D008826 1970-01-01
% 211.25/211.42  |- mesh__historyNote mesh__D008826 70   
% 211.25/211.42  |- skos__hiddenLabel mesh__D008826 Test, Microbial Sensitivity
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D008826 2001
% 211.25/211.42  |- skos__scopeNote mesh__D008826
% 211.25/211.42       Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms %28%i.e., bacteria, fungi, viruses%29%.%A%    
% 211.25/211.42  |- skos__hiddenLabel mesh__D008826 Sensitivity Test, Microbial
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D008826 2005
% 211.25/211.42  |- skos__altLabel mesh__D008826 Viral Drug Sensitivity Tests
% 211.25/211.42  |- mesh__recordAuthorizer mesh__D008826 sjn
% 211.25/211.42  |- skos__historyNote mesh__D008826
% 211.25/211.42       Drug Resistance, Microbial %28%1966-1969%29%
% 211.25/211.42  |- skos__hiddenLabel mesh__D008826 Inhibitory Concentrations, Minimum
% 211.25/211.42  |- skos__annotation mesh__D008826
% 211.25/211.42       IM when general; NIM when with specific drug %28%IM%29% %26% specific micro-organisms  %28%IM%29%; note X ref MINIMUM INHIBITORY CONCENTRATION but bactericidal eff of an antimicrobial drug using patient%27%s blood %28%= SERUM BACTERICIDAL TEST + specific drug%29%; PARASITIC SENSITIVITY TESTS is also available%A%  
% 211.25/211.42  |- mesh__recordMaintainer mesh__D008826 NDW
% 211.25/211.42  |- skos__related mesh__D008826smesh__D021261
% 211.25/211.42  |- skos__altLabel mesh__D008826 Bacterial Sensitivity Test
% 211.25/211.42  |- rdf__type mesh__D008826sskos__Concept
% 211.25/211.42  |- skos__altLabel mesh__D008826 Sensitivity Test, Bacterial
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D008826 2002
% 211.25/211.42  |- skos__related mesh__D008826smesh__D020128
% 211.25/211.42  |- skos__hiddenLabel mesh__D008826 Inhibitory Concentration, Minimum
% 211.25/211.42  |- skos__altLabel mesh__D008826 Sensitivity Tests, Bacterial
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D008826 2006
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D008826 2003
% 211.25/211.42  |- skos__hiddenLabel mesh__D008826 Concentrations, Minimum Inhibitory
% 211.25/211.42  |- skos__broader mesh__D008826smesh__D008828
% 211.25/211.42  |- skos__altLabel mesh__D008826 Drug Sensitivity Assay, Microbial
% 211.25/211.42  |- mesh__dateCreated mesh__D008826 1999-01-01
% 211.25/211.42  |- mesh__publicMeSHNote mesh__D008826 70   
% 211.25/211.42  |- skos__hiddenLabel mesh__D008826 Microbial Sensitivity Test
% 211.25/211.42  |- skos__hiddenLabel mesh__D008826 Sensitivity Tests, Microbial
% 211.25/211.42  |- skos__altLabel mesh__D008826 Fungal Drug Sensitivity Tests
% 211.25/211.42  |- skos__related mesh__D008826smesh__D004352
% 211.25/211.42  |- skos__hiddenLabel mesh__D008826 Minimum Inhibitory Concentrations
% 211.25/211.42  |- mesh__recordOriginator mesh__D008826 NLM
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D008826 2004
% 211.25/211.42  |- skos__prefLabel mesh__D008826 Microbial Sensitivity Tests
% 211.25/211.42  |- skos__broader mesh__D008826smesh__D004353
% 211.25/211.42  |- skos__altLabel mesh__D008826 Test, Bacterial Sensitivity
% 211.25/211.42  |- skos__hiddenLabel mesh__D008826 Concentration, Minimum Inhibitory
% 211.25/211.42  |- skos__altLabel mesh__D008826 Tests, Bacterial Sensitivity
% 211.25/211.42  |- skos__hiddenLabel mesh__D008826 Tests, Microbial Sensitivity
% 211.25/211.42  |- mesh__dateRevised mesh__D008826 2000-06-22
% 211.25/211.42  |- mesh__recordAuthorizer mesh__D000843 sjn
% 211.25/211.42  |- mesh__onlineNote mesh__D000843
% 211.25/211.42       use ANKLE INJURIES to search ANKLE JOINT/injuries 1966-91%A%  
% 211.25/211.42  |- mesh__recordMaintainer mesh__D000843 ags
% 211.25/211.42  |- skos__scopeNote mesh__D000843
% 211.25/211.42       The joint that is formed by the inferior articular and malleolar articular surfaces of the TIBIA; the malleolar articular surface of the FIBULA; and the medial malleolar, lateral malleolar, and superior surfaces of the TALUS.%A%    
% 211.25/211.42  |- skos__related mesh__D000843smesh__D000842
% 211.25/211.42  |- mesh__publicMeSHNote mesh__D000843
% 211.25/211.42       65; /injuries was ANKLE JOINT/injuries 1965-91   
% 211.25/211.42  |- skos__hiddenLabel mesh__D000843 Joint, Ankle
% 211.25/211.42  |- skos__hiddenLabel mesh__D000843 Ankle Joints
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D000843 2005
% 211.25/211.42  |- mesh__dateRevised mesh__D000843 2002-07-02
% 211.25/211.42  |- mesh__historyNote mesh__D000843
% 211.25/211.42       65; /injuries was ANKLE JOINT/injuries 1965-91   
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D000843 2003
% 211.25/211.42  |- mesh__dateEstablished mesh__D000843 1965-01-01
% 211.25/211.42  |- rdf__type mesh__D000843sskos__Concept
% 211.25/211.42  |- skos__hiddenLabel mesh__D000843 Joints, Ankle
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D000843 2006
% 211.25/211.42  |- skos__prefLabel mesh__D000843 Ankle Joint
% 211.25/211.42  |- mesh__recordOriginator mesh__D000843 NLM
% 211.25/211.42  |- skos__altLabel mesh__D000843 Articulatio talocruralis
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D000843 2004
% 211.25/211.42  |- mesh__dateCreated mesh__D000843 1999-01-01
% 211.25/211.42  |- skos__annotation mesh__D000843
% 211.25/211.42       primates only; differentiation from ANKLE   
% 211.25/211.42  |- skos__broader mesh__D000843smesh__D033023
% 211.25/211.42  |- skos__hiddenLabel mesh__D008028 Coagulation, Light
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D008028 2003
% 211.25/211.42  |- skos__prefLabel mesh__D008028 Light Coagulation
% 211.25/211.42  |- skos__hiddenLabel mesh__D008028 Light Coagulations
% 211.25/211.42  |- skos__altLabel mesh__D008028 Photocoagulation
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D008028 1998
% 211.25/211.42  |- skos__scopeNote mesh__D008028
% 211.25/211.42       The coagulation of tissue by an intense beam of light, including laser %28%LASER COAGULATION%29%. In the eye it is used in the treatment of retinal detachments, retinal holes, aneurysms, hemorrhages, and malignant and benign neoplasms. %28%Dictionary of Visual Science, 3d ed%29%%A%    
% 211.25/211.42  |- skos__hiddenLabel mesh__D008028 Coagulations, Light
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D008028 2000
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D008028 2004
% 211.25/211.42  |- skos__broader mesh__D008028smesh__D013508
% 211.25/211.42  |- rdf__type mesh__D008028sskos__Concept
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D008028 2001
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D008028 1999
% 211.25/211.42  |- skos__hiddenLabel mesh__D008028 Photocoagulations
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D008028 2005
% 211.25/211.42  |- mesh__dateRevised mesh__D008028 1997-06-20
% 211.25/211.42  |- mesh__dateCreated mesh__D008028 1999-01-01
% 211.25/211.42  |- mesh__recordOriginator mesh__D008028 NLM
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D008028 2002
% 211.25/211.42  |- mesh__activeMeSHYear mesh__D008028 2006
% 211.25/211.42  |- mesh__recordAuthorizer mesh__D008028 SJN
% 211.25/211.42  |- mesh__recordMaintainer mesh__D008028 PXP
% 211.25/211.42  |- skos__annotation mesh__D008028
% 211.25/211.42       non-ionizing; used predominantly in eye surg; do not confuse with LASER COAGULATION also used in ophthalmol surg; do not use /util except by MeSH definition; coord IM with Cat A or C term with /surg; DF: LIGHT COAG%A%  
% 211.25/211.43  |- mesh__historyNote mesh__D000045
% 211.25/211.43       91%28%86%29%63; was see under TREES 1986-90; was heading 1963-85%A%  
% 211.25/211.43  |- mesh__dateRevised mesh__D000045 2002-07-02
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D000045 2003
% 211.25/211.43  |- skos__annotation mesh__D000045
% 211.25/211.43       acacia pharmaceut agents are probably GUM ARABIC; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.25/211.43  |- mesh__dateCreated mesh__D000045 1999-01-01
% 211.25/211.43  |- skos__altLabel mesh__D000045 Wattle Tree
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D000045 2005
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D000045 2004
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D000045 2006
% 211.25/211.43  |- skos__altLabel mesh__D000045 Locust Tree
% 211.25/211.43  |- mesh__dateEstablished mesh__D000045 1991-01-01
% 211.25/211.43  |- mesh__recordAuthorizer mesh__D000045 sjn
% 211.25/211.43  |- skos__scopeNote mesh__D000045
% 211.25/211.43       A plant genus of the family FABACEAE. The gums and tanning agents obtained from Acacia are called GUM ARABIC. The common name of catechu is more often used for Areca catechu %28%ARECA%29%.%A%    
% 211.25/211.43  |- mesh__recordMaintainer mesh__D000045 ssb
% 211.25/211.43  |- skos__broader mesh__D000045smesh__D007887
% 211.25/211.43  |- mesh__recordOriginator mesh__D000045 NLM
% 211.25/211.43  |- skos__prefLabel mesh__D000045 Acacia
% 211.25/211.43  |- mesh__publicMeSHNote mesh__D000045
% 211.25/211.43       91,63-85; was see under TREES 1986-90; was heading 1963-85%A%  
% 211.25/211.43  |- rdf__type mesh__D000045sskos__Concept
% 211.25/211.43  |- skos__broader mesh__D018456smesh__D013040
% 211.25/211.43  |- skos__prefLabel mesh__D018456 Reproductive Medicine
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D018456 2005
% 211.25/211.43  |- skos__altLabel mesh__D018456 Medicine, Reproductive
% 211.25/211.43  |- mesh__recordOriginator mesh__D018456 TGC
% 211.25/211.43  |- mesh__historyNote mesh__D018456 95   
% 211.25/211.43  |- skos__hiddenLabel mesh__D018456 Health, Reproductive
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D018456 2006
% 211.25/211.43  |- mesh__recordMaintainer mesh__D018456 NLM
% 211.25/211.43  |- skos__scopeNote mesh__D018456
% 211.25/211.43       A medical-surgical specialty concerned with the morphology, physiology, biochemistry, and pathology of reproduction in man and other animals, and on the biological, medical, and veterinary problems of fertility and lactation. It includes ovulation induction, diagnosis of infertility and recurrent pregnancy loss, and assisted reproductive technologies such as embryo transfer, in vitro fertilization, and intrafallopian transfer of zygotes. %28%From Infertility and Reproductive Medicine Clinics of North America, Foreword 1990; Journal of Reproduction and Fertility, Notice to Contributors, Jan 1979%29%%A%    
% 211.25/211.43  |- mesh__dateEstablished mesh__D018456 1995-01-01
% 211.25/211.43  |- skos__related mesh__D018456smesh__D012099
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D018456 2002
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D018456 2003
% 211.25/211.43  |- rdf__type mesh__D018456sskos__Concept
% 211.25/211.43  |- mesh__dateRevised mesh__D018456 2001-08-14
% 211.25/211.43  |- mesh__publicMeSHNote mesh__D018456 95   
% 211.25/211.43  |- skos__annotation mesh__D018456
% 211.25/211.43       SPEC: SPEC qualif; DF: REPRODUCTIVE MED   
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D018456 2004
% 211.25/211.43  |- mesh__recordAuthorizer mesh__D018456 NLM
% 211.25/211.43  |- mesh__dateCreated mesh__D018456 1994-03-17
% 211.25/211.43  |- skos__hiddenLabel mesh__D010473 Mackerel
% 211.25/211.43  |- skos__historyNote mesh__D010473 Fishes %28%1966-1986%29%
% 211.25/211.43  |- mesh__publicMeSHNote mesh__D010473 87   
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D010473 2004
% 211.25/211.43  |- skos__broader mesh__D010473smesh__D005399
% 211.25/211.43  |- mesh__dateEstablished mesh__D010473 1987-01-01
% 211.25/211.43  |- rdf__type mesh__D010473sskos__Concept
% 211.25/211.43  |- mesh__recordOriginator mesh__D010473 EC
% 211.25/211.43  |- skos__hiddenLabel mesh__D010473 Bluegills
% 211.25/211.43  |- mesh__dateRevised mesh__D010473 2003-07-09
% 211.25/211.43  |- skos__altLabel mesh__D010473 Centrarchidae
% 211.25/211.43  |- skos__annotation mesh__D010473
% 211.25/211.43       GEN; prefer specifics; do not confuse X ref DOLPHIN FISH with DOLPHINS which are mammals%A%  
% 211.25/211.43  |- mesh__dateCreated mesh__D010473 1986-04-15
% 211.25/211.43  |- mesh__historyNote mesh__D010473 87   
% 211.25/211.43  |- skos__altLabel mesh__D010473 Mahi-Mahi
% 211.25/211.43  |- mesh__recordAuthorizer mesh__D010473 sjn
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D010473 2006
% 211.25/211.43  |- skos__altLabel mesh__D010473 Mackerels
% 211.25/211.43  |- skos__prefLabel mesh__D010473 Perciformes
% 211.25/211.43  |- skos__scopeNote mesh__D010473
% 211.25/211.43       The most diversified of all fish orders and the largest vertebrate order. It includes many of the commonly known fish such as porgies, croakers, sunfishes, dolphin fish, mackerels, TUNA, etc.%A%    
% 211.25/211.43  |- skos__hiddenLabel mesh__D010473 Fish, Sparid
% 211.25/211.43  |- mesh__recordMaintainer mesh__D010473 ags
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D010473 2005
% 211.25/211.43  |- skos__hiddenLabel mesh__D010473 Croaker
% 211.25/211.43  |- mesh__publicMeSHNote mesh__D032127 2003   
% 211.25/211.43  |- skos__altLabel mesh__D032127 Soapberry
% 211.25/211.43  |- rdf__type mesh__D032127sskos__Concept
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D032127 2006
% 211.25/211.43  |- skos__broader mesh__D032127smesh__D029631
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D032127 2003
% 211.25/211.43  |- mesh__dateCreated mesh__D032127 2002-07-03
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D032127 2004
% 211.25/211.43  |- skos__annotation mesh__D032127
% 211.25/211.43       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.25/211.43  |- mesh__dateEstablished mesh__D032127 2003-01-01
% 211.25/211.43  |- skos__prefLabel mesh__D032127 Sapindus
% 211.25/211.43  |- mesh__historyNote mesh__D032127 2003   
% 211.25/211.43  |- skos__scopeNote mesh__D032127
% 211.25/211.43       A plant genus of the family SAPINDACEAE that contain SAPONINS.%A%    
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D032127 2005
% 211.25/211.43  |- mesh__dateCreated mesh__D009121 1999-01-01
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D009121 2005
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D009121 2004
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D009121 1999
% 211.25/211.43  |- mesh__dateRevised mesh__D009121 1997-06-20
% 211.25/211.43  |- skos__broader mesh__D009121smesh__D003714
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D009121 2006
% 211.25/211.43  |- mesh__recordAuthorizer mesh__D009121 SJN
% 211.25/211.43  |- skos__prefLabel mesh__D009121 Muscle Denervation
% 211.25/211.43  |- skos__scopeNote mesh__D009121
% 211.25/211.43       The resection or removal of the innervation of a muscle or muscle tissue.%A%    
% 211.25/211.43  |- skos__hiddenLabel mesh__D009121 Muscle Denervations
% 211.25/211.43  |- skos__hiddenLabel mesh__D009121 Denervation, Muscle
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D009121 2002
% 211.25/211.43  |- mesh__publicMeSHNote mesh__D009121 65   
% 211.25/211.43  |- mesh__recordOriginator mesh__D009121 NLM
% 211.25/211.43  |- mesh__recordMaintainer mesh__D009121 PXP
% 211.25/211.43  |- skos__hiddenLabel mesh__D009121 Denervations, Muscle
% 211.25/211.43  |- mesh__dateEstablished mesh__D009121 1965-01-01
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D009121 2000
% 211.25/211.43  |- rdf__type mesh__D009121sskos__Concept
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D009121 2003
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D009121 1998
% 211.25/211.43  |- skos__annotation mesh__D009121
% 211.25/211.43       coord with specific muscle /innerv; NIM when a study technique; do not use /util except by MeSH definition%A%  
% 211.25/211.43  |- mesh__historyNote mesh__D009121 65   
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D009121 2001
% 211.25/211.43  |- skos__altLabel mesh__D028884 Importin
% 211.25/211.43  |- mesh__dateEstablished mesh__D028884 2002-01-01
% 211.25/211.43  |- mesh__dateCreated mesh__D028884 2001-07-25
% 211.25/211.43  |- mesh__publicMeSHNote mesh__D028884
% 211.25/211.43       2002; IMPORTIN %28%now KARYOPHERINS%29% was indexed under NUCLEAR PROTEINS 1995-2001; TRANSPORTIN %28%now KARYOPHERINS%29% was indexed under NUCLEAR PROTEINS %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1995-2001%A%  
% 211.25/211.43  |- skos__related mesh__D028884smesh__D021581
% 211.25/211.43  |- skos__historyNote mesh__D028884 Nuclear Proteins %28%1995-2001%29%
% 211.25/211.43  |- mesh__historyNote mesh__D028884
% 211.25/211.43       2002; use KARYOPHERINS %28%NM%29% 1995-2001   
% 211.25/211.43  |- skos__prefLabel mesh__D028884 Karyopherins
% 211.25/211.43  |- mesh__recordOriginator mesh__D028884 jmp
% 211.25/211.43  |- skos__altLabel mesh__D028884 Transportin
% 211.25/211.43  |- mesh__recordMaintainer mesh__D028884 nns
% 211.25/211.43  |- mesh__dateRevised mesh__D028884 2005-06-30
% 211.25/211.43  |- skos__broader mesh__D028884smesh__D029543
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D028884 2006
% 211.25/211.43  |- skos__broader mesh__D028884smesh__D009687
% 211.25/211.43  |- skos__scopeNote mesh__D028884
% 211.25/211.43       A family of proteins involved in NUCLEOCYTOPLASMIC TRANSPORT. Karyopherins are heteromeric molecules composed two major types of components, ALPHA KARYOPHERINS and BETA KARYOPHERINS, that function together to transport molecules through the NUCLEAR PORE COMPLEX. Several other proteins such as RAN GTP BINDING PROTEIN and CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN bind to karyopherins and participate in the transport process.%A%    
% 211.25/211.43  |- skos__historyNote mesh__D028884
% 211.25/211.43       Receptors, Cytoplasmic and Nuclear %28%1995-2001%29%
% 211.25/211.43  |- skos__altLabel mesh__D028884 Transportins
% 211.25/211.43  |- rdf__type mesh__D028884sskos__Concept
% 211.25/211.43  |- mesh__recordAuthorizer mesh__D028884 sjn
% 211.25/211.43  |- mesh__dateCreated mesh__D014066 1999-01-01
% 211.25/211.43  |- mesh__dateRevised mesh__D014066 2003-07-09
% 211.25/211.43  |- skos__broader mesh__D014066smesh__D009960
% 211.25/211.43  |- skos__annotation mesh__D014066
% 211.25/211.43       /surg: probably TONSILLECTOMY; inflammation = TONSILLITIS %28%note -LL-%29%; lingual tonsils = TONSIL %28%IM%29% + TONGUE %28%NIM%29%; pharyngeal tonsil = ADENOIDS; enlarged tonsils = TONSIL /pathol %28%IM%29% + HYPERPLASIA %28%NIM%29%%A%  
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D014066 2006
% 211.25/211.43  |- skos__hiddenLabel mesh__D014066 Palatine Tonsils
% 211.25/211.43  |- mesh__recordOriginator mesh__D014066 NLM
% 211.25/211.43  |- skos__related mesh__D014066smesh__D014068
% 211.25/211.43  |- mesh__recordAuthorizer mesh__D014066 sjn
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D014066 2005
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D014066 2004
% 211.25/211.43  |- skos__altLabel mesh__D014066 Palatine Tonsil
% 211.25/211.43  |- skos__hiddenLabel mesh__D014066 Tonsils
% 211.25/211.43  |- mesh__recordMaintainer mesh__D014066 lkt
% 211.25/211.43  |- skos__scopeNote mesh__D014066
% 211.25/211.43       A round-to-oval mass of lymphoid tissue embedded in the lateral wall of the PHARYNX situated on each side of the fauces, between the anterior and posterior pillars of the soft palate %28%PALATE, SOFT%29%.%A%    
% 211.25/211.43  |- skos__prefLabel mesh__D014066 Tonsil
% 211.25/211.43  |- rdf__type mesh__D014066sskos__Concept
% 211.25/211.43  |- skos__broader mesh__D014066smesh__D008221
% 211.25/211.43  |- skos__hiddenLabel mesh__D014066 Tonsils, Palatine
% 211.25/211.43  |- skos__altLabel mesh__D014066 Tonsil, Palatine
% 211.25/211.43  |- skos__hiddenLabel mesh__D008827 Phenomena, Microbiological
% 211.25/211.43  |- rdf__type mesh__D008827sskos__Concept
% 211.25/211.43  |- mesh__dateEstablished mesh__D008827 1998-01-01
% 211.25/211.43  |- skos__prefLabel mesh__D008827 Microbiologic Phenomena
% 211.25/211.43  |- skos__annotation mesh__D008827
% 211.25/211.43       not used for indexing; DF: MICROBIOL PHENOMENA      CATALOG: do not use%A%  
% 211.25/211.43  |- skos__related mesh__D008827smesh__D018407
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D008827 2001
% 211.25/211.43  |- skos__altLabel mesh__D008827 Phenomena, Microbiologic
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D008827 1998
% 211.25/211.43  |- mesh__historyNote mesh__D008827 98; use explode   
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D008827 2003
% 211.25/211.43  |- mesh__publicMeSHNote mesh__D008827 98   
% 211.25/211.43  |- mesh__recordMaintainer mesh__D008827 TGC
% 211.25/211.43  |- mesh__dateCreated mesh__D008827 1999-01-01
% 211.25/211.43  |- skos__scopeNote mesh__D008827
% 211.25/211.43       Physiological processes and activities of microorganisms, including archaea, bacteria, rickettsia, viruses, protozoa, and fungi.%A%    
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D008827 2002
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D008827 1999
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D008827 2005
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D008827 2004
% 211.25/211.43  |- skos__altLabel mesh__D008827 Microbiological Phenomena
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D008827 2006
% 211.25/211.43  |- mesh__recordOriginator mesh__D008827 NLM
% 211.25/211.43  |- skos__related mesh__D008827smesh__D018406
% 211.25/211.43  |- mesh__recordAuthorizer mesh__D008827 SJN
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D008827 2000
% 211.25/211.43  |- skos__broader mesh__D008827smesh__D001686
% 211.25/211.43  |- mesh__dateRevised mesh__D008827 1997-06-26
% 211.25/211.43  |- skos__scopeNote mesh__D000844 Fixation and immobility of a joint.     
% 211.25/211.43  |- skos__broader mesh__D000844smesh__D007592
% 211.25/211.43  |- mesh__recordAuthorizer mesh__D000844 sjn
% 211.25/211.43  |- skos__prefLabel mesh__D000844 Ankylosis
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D000844 2005
% 211.25/211.43  |- rdf__type mesh__D000844sskos__Concept
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D000844 2003
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D000844 2006
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D000844 2000
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D000844 2004
% 211.25/211.43  |- skos__hiddenLabel mesh__D000844 Ankyloses
% 211.25/211.43  |- mesh__dateCreated mesh__D000844 1999-01-01
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D000844 2001
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D000844 2002
% 211.25/211.43  |- mesh__recordOriginator mesh__D000844 NLM
% 211.25/211.43  |- mesh__dateRevised mesh__D000844 1999-11-03
% 211.25/211.43  |- mesh__recordMaintainer mesh__D000844 KEV
% 211.25/211.43  |- mesh__recordAuthorizer mesh__D008029 SJN
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D008029 2003
% 211.25/211.43  |- mesh__recordMaintainer mesh__D008029 JLS
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D008029 2004
% 211.25/211.43  |- rdf__type mesh__D008029sskos__Concept
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D008029 1999
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D008029 2005
% 211.25/211.43  |- mesh__dateCreated mesh__D008029 1999-01-01
% 211.25/211.43  |- skos__prefLabel mesh__D008029 Lighting
% 211.25/211.43  |- skos__annotation mesh__D008029
% 211.25/211.43       the environment: differentiate from LIGHT, a principle of physics; /adv eff permitted but do not confuse with LIGHT /adv eff%A%  
% 211.25/211.43  |- mesh__dateRevised mesh__D008029 1998-06-10
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D008029 2006
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D008029 2000
% 211.25/211.43  |- skos__broader mesh__D008029smesh__D004780
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D008029 2001
% 211.25/211.43  |- skos__scopeNote mesh__D008029
% 211.25/211.43       The illumination of an environment and the arrangement of lights to achieve an effect or optimal visibility. Its application is in domestic or in public settings and in medical and non-medical environments.%A%    
% 211.25/211.43  |- mesh__recordOriginator mesh__D008029 NLM
% 211.25/211.43  |- skos__altLabel mesh__D008029 Illumination
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D008029 2002
% 211.25/211.43  |- skos__broader mesh__D000046smesh__D006268
% 211.25/211.43  |- mesh__recordAuthorizer mesh__D000046 sjn
% 211.25/211.43  |- mesh__dateRevised mesh__D000046 1999-11-03
% 211.25/211.43  |- mesh__onlineNote mesh__D000046 search HOSPITALS, UNIVERSITY 1979   
% 211.25/211.43  |- mesh__recordMaintainer mesh__D000046 kle
% 211.25/211.43  |- mesh__publicMeSHNote mesh__D000046
% 211.25/211.43       80; was see HOSPITALS, UNIVERSITY 1979   
% 211.25/211.43  |- skos__altLabel mesh__D000046 Center, Academic Medical
% 211.25/211.43  |- skos__altLabel mesh__D000046 Centers, University Medical
% 211.25/211.43  |- rdf__type mesh__D000046sskos__Concept
% 211.25/211.43  |- skos__altLabel mesh__D000046 Medical Centers, University
% 211.25/211.43  |- mesh__recordOriginator mesh__D000046 EC
% 211.25/211.43  |- mesh__dateEstablished mesh__D000046 1980-01-01
% 211.25/211.43  |- skos__annotation mesh__D000046 specify geog; DF: ACAD MED CENTERS   
% 211.25/211.43  |- skos__altLabel mesh__D000046 Medical Centers, Academic
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D000046 2001
% 211.25/211.43  |- skos__altLabel mesh__D000046 University Medical Centers
% 211.25/211.43  |- skos__altLabel mesh__D000046 Medical Center, University
% 211.25/211.43  |- skos__altLabel mesh__D000046 Academic Medical Center
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D000046 2004
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D000046 2000
% 211.25/211.43  |- mesh__dateCreated mesh__D000046 1979-06-01
% 211.25/211.43  |- skos__altLabel mesh__D000046 Medical Center, Academic
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D000046 2003
% 211.25/211.43  |- skos__scopeNote mesh__D000046
% 211.25/211.43       Medical complexes consisting of medical school, hospitals, clinics, libraries, administrative facilities, etc.%A%    
% 211.25/211.43  |- skos__altLabel mesh__D000046 University Medical Center
% 211.25/211.43  |- skos__altLabel mesh__D000046 Centers, Academic Medical
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D000046 2006
% 211.25/211.43  |- skos__historyNote mesh__D000046 Hospitals, University %28%1975-1979%29%
% 211.25/211.43  |- skos__prefLabel mesh__D000046 Academic Medical Centers
% 211.25/211.43  |- skos__historyNote mesh__D000046 Hospitals, Teaching %28%1968-1974%29%
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D000046 2002
% 211.25/211.43  |- mesh__historyNote mesh__D000046
% 211.25/211.43       80; was see HOSPITALS, UNIVERSITY 1979   
% 211.25/211.43  |- skos__altLabel mesh__D000046 Center, University Medical
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D000046 2005
% 211.25/211.43  |- skos__broader mesh__D046148smesh__D009927
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D046148 2006
% 211.25/211.43  |- mesh__recordMaintainer mesh__D046148 ags
% 211.25/211.43  |- skos__altLabel mesh__D046148 Donor Screening
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D046148 2005
% 211.25/211.43  |- mesh__dateCreated mesh__D046148 2004-07-07
% 211.25/211.43  |- rdf__type mesh__D046148sskos__Concept
% 211.25/211.43  |- mesh__historyNote mesh__D046148 2005   
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D046148 2006A
% 211.25/211.43  |- mesh__publicMeSHNote mesh__D046148 2005   
% 211.25/211.43  |- skos__hiddenLabel mesh__D046148 Selection, Donor
% 211.25/211.43  |- skos__hiddenLabel mesh__D046148 Donor Screenings
% 211.25/211.43  |- mesh__dateEstablished mesh__D046148 2005-01-01
% 211.25/211.43  |- skos__prefLabel mesh__D046148 Donor Selection
% 211.25/211.43  |- mesh__dateRevised mesh__D046148 2005-07-22
% 211.25/211.43  |- skos__broader mesh__D046148smesh__D020858
% 211.25/211.43  |- skos__scopeNote mesh__D046148
% 211.25/211.43       The procedure established to evaluate the health status and risk factors of the potential DONORS of biological materials. Donors are selected based on the principles that their health will not be compromised in the process, and the donated materials, such as TISSUES or organs, are safe for reuse in the recipients.%A%    
% 211.25/211.43  |- mesh__recordOriginator mesh__D046148 lkt
% 211.25/211.43  |- skos__hiddenLabel mesh__D046148 Donor Exclusions
% 211.25/211.43  |- mesh__recordAuthorizer mesh__D046148 ags
% 211.25/211.43  |- skos__historyNote mesh__D046148 Tissue Donors %28%1966-2004%29%
% 211.25/211.43  |- mesh__publicMeSHNote mesh__D018457 95   
% 211.25/211.43  |- mesh__recordMaintainer mesh__D018457 lkt
% 211.25/211.43  |- mesh__recordAuthorizer mesh__D018457 sjn
% 211.25/211.43  |- skos__hiddenLabel mesh__D018457 Retained Placentas
% 211.25/211.43  |- skos__altLabel mesh__D018457 Retained Placenta
% 211.25/211.43  |- skos__prefLabel mesh__D018457 Placenta, Retained
% 211.25/211.43  |- skos__hiddenLabel mesh__D018457 Placentas, Retained
% 211.25/211.43  |- skos__historyNote mesh__D018457 Placenta Diseases %28%1970-1994%29%
% 211.25/211.43  |- mesh__historyNote mesh__D018457 95   
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D018457 2006
% 211.25/211.43  |- skos__historyNote mesh__D018457 Placenta %28%1966-1994%29%
% 211.25/211.43  |- mesh__dateRevised mesh__D018457 2005-06-30
% 211.25/211.43  |- skos__broader mesh__D018457smesh__D010922
% 211.25/211.43  |- skos__scopeNote mesh__D018457
% 211.25/211.43       A placenta that fails to be expelled after BIRTH of the FETUS. A PLACENTA is retained when the UTERUS fails to contract after the delivery of its content, or when the placenta is abnormally attached to the MYOMETRIUM.%A%    
% 211.25/211.43  |- rdf__type mesh__D018457sskos__Concept
% 211.25/211.43  |- mesh__recordOriginator mesh__D018457 TGC
% 211.25/211.43  |- skos__annotation mesh__D018457 check the tags FEMALE %26% PREGNANCY   
% 211.25/211.43  |- mesh__dateCreated mesh__D018457 1994-04-16
% 211.25/211.43  |- mesh__dateEstablished mesh__D018457 1995-01-01
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D010474 2001
% 211.25/211.43  |- mesh__dateCreated mesh__D010474 1999-01-01
% 211.25/211.43  |- rdf__type mesh__D010474sskos__Concept
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D010474 2003
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D010474 2000
% 211.25/211.43  |- mesh__recordAuthorizer mesh__D010474 SJN
% 211.25/211.43  |- skos__prefLabel mesh__D010474 Percussion
% 211.25/211.43  |- skos__scopeNote mesh__D010474
% 211.25/211.43       Act of striking a part with short, sharp blows as an aid in diagnosing the condition beneath the sound obtained.%A%    
% 211.25/211.43  |- skos__annotation mesh__D010474
% 211.25/211.43       diag from sound obtained by short sharp blows   
% 211.25/211.43  |- mesh__dateRevised mesh__D010474 1997-06-20
% 211.25/211.43  |- mesh__recordMaintainer mesh__D010474 PXP
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D010474 2006
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D010474 1999
% 211.25/211.43  |- mesh__recordOriginator mesh__D010474 NLM
% 211.25/211.43  |- skos__broader mesh__D010474smesh__D010808
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D010474 2005
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D010474 1998
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D010474 2002
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D010474 2004
% 211.25/211.43  |- skos__hiddenLabel mesh__D010474 Percussions
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D032128 2003
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D032128 2004
% 211.25/211.43  |- skos__prefLabel mesh__D032128 Madhuca
% 211.25/211.43  |- skos__annotation mesh__D032128
% 211.25/211.43       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.25/211.43  |- skos__broader mesh__D032128smesh__D029632
% 211.25/211.43  |- mesh__dateCreated mesh__D032128 2002-07-03
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D032128 2005
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D032128 2006
% 211.25/211.43  |- mesh__publicMeSHNote mesh__D032128 2003   
% 211.25/211.43  |- rdf__type mesh__D032128sskos__Concept
% 211.25/211.43  |- mesh__dateEstablished mesh__D032128 2003-01-01
% 211.25/211.43  |- skos__scopeNote mesh__D032128
% 211.25/211.43       A plant genus of the family SAPOTACEAE that is the source of mahua oil. Members contain oleanene triterpenoid saponins.%A%    
% 211.25/211.43  |- mesh__historyNote mesh__D032128 2003   
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D004437 2000
% 211.25/211.43  |- skos__prefLabel mesh__D004437 Ebstein%27%s Anomaly
% 211.25/211.43  |- skos__scopeNote mesh__D004437
% 211.25/211.43       Congenital downward displacement of the tricuspid valve with the septal and posterior leaflets being attached to the wall of the right ventricle.%A%    
% 211.25/211.43  |- mesh__dateCreated mesh__D004437 1999-01-01
% 211.25/211.43  |- skos__hiddenLabel mesh__D004437 Ebsteins Anomaly
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D004437 2001
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D004437 2003
% 211.25/211.43  |- skos__annotation mesh__D004437
% 211.25/211.43       a congen heart defect; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D004437 2005
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D004437 2004
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D004437 2002
% 211.25/211.43  |- skos__hiddenLabel mesh__D004437 Anomaly, Ebstein%27%s
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D004437 2006
% 211.25/211.43  |- rdf__type mesh__D004437sskos__Concept
% 211.25/211.43  |- skos__broader mesh__D004437smesh__D006330
% 211.25/211.43  |- mesh__recordAuthorizer mesh__D004437 sjn
% 211.25/211.43  |- mesh__recordOriginator mesh__D004437 NLM
% 211.25/211.43  |- mesh__dateRevised mesh__D004437 1999-11-03
% 211.25/211.43  |- mesh__recordMaintainer mesh__D004437 kle
% 211.25/211.43  |- skos__hiddenLabel mesh__D004437 Ebstein Anomaly
% 211.25/211.43  |- mesh__recordOriginator mesh__D009920 NLM
% 211.25/211.43  |- skos__broader mesh__D009920smesh__D013733
% 211.25/211.43  |- rdf__type mesh__D009920sskos__Concept
% 211.25/211.43  |- mesh__dateCreated mesh__D009920 1999-01-01
% 211.25/211.43  |- mesh__dateRevised mesh__D009920 2005-06-30
% 211.25/211.43  |- mesh__recordMaintainer mesh__D009920 lkt
% 211.25/211.43  |- skos__prefLabel mesh__D009920 Orchitis
% 211.25/211.43  |- mesh__recordAuthorizer mesh__D009920 sjn
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D009920 2006
% 211.25/211.43  |- skos__scopeNote mesh__D009920
% 211.25/211.43       Inflammation of a TESTIS. It has many features of EPIDIDYMITIS, such as swollen SCROTUM; PAIN; PYURIA; and FEVER. It is usually related to infections in the URINARY TRACT, which likely spread to the EPIDIDYMIS and then the TESTIS through either the VAS DEFERENS or the lymphatics of the SPERMATIC CORD.%A%    
% 211.25/211.43  |- skos__hiddenLabel mesh__D009920 Orchitides
% 211.25/211.43  |- skos__hiddenLabel mesh__D009122 Hypertonias, Neonatal
% 211.25/211.43  |- skos__hiddenLabel mesh__D009122 Hypertonias, Infantile
% 211.25/211.43  |- skos__hiddenLabel mesh__D009122 Muscular Hypertonicities
% 211.25/211.43  |- skos__hiddenLabel mesh__D009122 Neonatal Hypertonias
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D009122 2002
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D009122 2003
% 211.25/211.43  |- skos__hiddenLabel mesh__D009122 Increased, Muscle Tone
% 211.25/211.43  |- mesh__historyNote mesh__D009122 1979   
% 211.25/211.43  |- skos__hiddenLabel mesh__D009122 Hypertonias, Muscle
% 211.25/211.43  |- skos__historyNote mesh__D009122 Muscle Tonus %28%1970-1978%29%
% 211.25/211.43  |- skos__broader mesh__D009122smesh__D020879
% 211.25/211.43  |- skos__hiddenLabel mesh__D009122 Tone Increased, Muscle
% 211.25/211.43  |- skos__hiddenLabel mesh__D009122 Detrusor Muscle Hypertonia
% 211.25/211.43  |- skos__hiddenLabel mesh__D009122 Hypertonias, Sphincter
% 211.25/211.43  |- mesh__dateRevised mesh__D009122 1999-12-06
% 211.25/211.43  |- skos__annotation mesh__D009122
% 211.25/211.43       coord IM with specific muscle/physiopathol %28%IM%29% if available%A%  
% 211.25/211.43  |- skos__hiddenLabel mesh__D009122 Neonatal Hypertonia
% 211.25/211.43  |- skos__hiddenLabel mesh__D009122 Hypertonias, Transient
% 211.25/211.43  |- skos__hiddenLabel mesh__D009122 Transient Hypertonias
% 211.25/211.43  |- mesh__recordOriginator mesh__D009122 RC
% 211.25/211.43  |- skos__hiddenLabel mesh__D009122 Hypertonicity, Muscular
% 211.25/211.43  |- skos__hiddenLabel mesh__D009122 Infantile Hypertonias
% 211.25/211.43  |- skos__hiddenLabel mesh__D009122 Muscle Hypertonias, Detrusor
% 211.25/211.43  |- skos__altLabel mesh__D009122 Muscle Tone Increased
% 211.25/211.43  |- skos__historyNote mesh__D009122 Muscle Spasticity %28%1977-1978%29%
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D009122 2001
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D009122 2000A
% 211.25/211.43  |- mesh__recordMaintainer mesh__D009122 ags
% 211.25/211.43  |- skos__altLabel mesh__D009122 Muscular Hypertonicity
% 211.25/211.43  |- skos__hiddenLabel mesh__D009122 Hypermyotonias
% 211.25/211.43  |- skos__hiddenLabel mesh__D009122 Muscle Hypertonias
% 211.25/211.43  |- skos__prefLabel mesh__D009122 Muscle Hypertonia
% 211.25/211.43  |- skos__hiddenLabel mesh__D009122 Transient Hypertonia
% 211.25/211.43  |- mesh__activeMeSHYear mesh__D009122 2006
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D009122 2000
% 211.25/211.44  |- skos__hiddenLabel mesh__D009122 Hypertonia, Muscle
% 211.25/211.44  |- mesh__dateEstablished mesh__D009122 1979-01-01
% 211.25/211.44  |- skos__scopeNote mesh__D009122
% 211.25/211.44       Abnormal increase in skeletal or smooth muscle tone. Skeletal muscle hypertonicity may be associated with PYRAMIDAL TRACT lesions or BASAL GANGLIA DISEASES.%A%    
% 211.25/211.44  |- mesh__publicMeSHNote mesh__D009122 1979   
% 211.25/211.44  |- skos__hiddenLabel mesh__D009122 Sphincter Hypertonias
% 211.25/211.44  |- mesh__dateCreated mesh__D009122 1978-05-17
% 211.25/211.44  |- skos__altLabel mesh__D009122 Hypermyotonia
% 211.25/211.44  |- skos__hiddenLabel mesh__D009122 Sphincter Hypertonia
% 211.25/211.44  |- skos__hiddenLabel mesh__D009122 Detrusor Muscle Hypertonias
% 211.25/211.44  |- skos__hiddenLabel mesh__D009122 Muscle Hypertonia, Detrusor
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D009122 2005
% 211.25/211.44  |- skos__hiddenLabel mesh__D009122 Infantile Hypertonia
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D009122 2004
% 211.25/211.44  |- rdf__type mesh__D009122sskos__Concept
% 211.25/211.44  |- skos__hiddenLabel mesh__D009122 Hypertonias, Detrusor Muscle
% 211.25/211.44  |- skos__hiddenLabel mesh__D009122 Hypertonicities, Muscular
% 211.25/211.44  |- skos__historyNote mesh__D009122 Spasm %28%1966-1976%29%
% 211.25/211.44  |- mesh__recordAuthorizer mesh__D009122 ags
% 211.25/211.44  |- skos__broader mesh__D014865smesh__D012498
% 211.25/211.44  |- rdf__type mesh__D014865sskos__Concept
% 211.25/211.44  |- skos__hiddenLabel mesh__D014865 Disposal, Fluid Waste
% 211.25/211.44  |- mesh__recordMaintainer mesh__D014865 JLS
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D014865 2004
% 211.25/211.44  |- skos__broader mesh__D014865smesh__D012722
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D014865 1999
% 211.25/211.44  |- mesh__dateCreated mesh__D014865 1999-01-01
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D014865 2000
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D014865 2005
% 211.25/211.44  |- skos__prefLabel mesh__D014865 Waste Disposal, Fluid
% 211.25/211.44  |- skos__hiddenLabel mesh__D014865 Fluid Waste Disposal
% 211.25/211.44  |- mesh__publicMeSHNote mesh__D014865 91; was see under SEWAGE 1975-90   
% 211.25/211.44  |- skos__scopeNote mesh__D014865
% 211.25/211.44       The discarding or destroying of liquid waste products or their transformation into something useful or innocuous.%A%    
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D014865 2001
% 211.25/211.44  |- skos__broader mesh__D014865smesh__D012037
% 211.25/211.44  |- skos__hiddenLabel mesh__D014865 Fluid Waste Disposals
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D014865 1995
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D014865 1996
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D014865 2006
% 211.25/211.44  |- mesh__onlineNote mesh__D014865 search SEWAGE 1969-74   
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D014865 2002
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D014865 1997
% 211.25/211.44  |- mesh__historyNote mesh__D014865
% 211.25/211.44       91%28%75%29%; was see under SEWAGE 1975-90   
% 211.25/211.44  |- mesh__recordOriginator mesh__D014865 NLM
% 211.25/211.44  |- skos__hiddenLabel mesh__D014865 Waste Disposals, Fluid
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D014865 2003
% 211.25/211.44  |- skos__hiddenLabel mesh__D014865 Disposals, Fluid Waste
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D014865 1998
% 211.25/211.44  |- mesh__dateRevised mesh__D014865 1994-07-01
% 211.25/211.44  |- mesh__recordAuthorizer mesh__D014865 PLS
% 211.25/211.44  |- mesh__dateEstablished mesh__D014865 1991-01-01
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D014067 2001
% 211.25/211.44  |- skos__hiddenLabel mesh__D014067 Cancer, Tonsillar
% 211.25/211.44  |- skos__broader mesh__D014067smesh__D009959
% 211.25/211.44  |- skos__altLabel mesh__D014067 Tonsillar Cancer
% 211.25/211.44  |- skos__altLabel mesh__D014067 Neoplasms, Tonsillar
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D014067 2003
% 211.25/211.44  |- skos__annotation mesh__D014067
% 211.25/211.44       coord IM with histol type of neopl %28%IM%29%   
% 211.25/211.44  |- skos__hiddenLabel mesh__D014067 Tonsillar Neoplasm
% 211.25/211.44  |- skos__altLabel mesh__D014067 Cancer of the Tonsil
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D014067 2000
% 211.25/211.44  |- rdf__type mesh__D014067sskos__Concept
% 211.25/211.44  |- skos__hiddenLabel mesh__D014067 Tonsillar Cancers
% 211.25/211.44  |- skos__altLabel mesh__D014067 Tonsil Neoplasms
% 211.25/211.44  |- skos__hiddenLabel mesh__D014067 Tonsil Cancers
% 211.25/211.44  |- skos__hiddenLabel mesh__D014067 Cancers, Tonsil
% 211.25/211.44  |- skos__scopeNote mesh__D014067 Tumors or cancer of the TONSIL.     
% 211.25/211.44  |- skos__hiddenLabel mesh__D014067 Cancers, Tonsillar
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D014067 2002
% 211.25/211.44  |- mesh__dateCreated mesh__D014067 1999-01-01
% 211.25/211.44  |- skos__altLabel mesh__D014067 Tonsil Cancer
% 211.25/211.44  |- mesh__recordOriginator mesh__D014067 NLM
% 211.25/211.44  |- skos__hiddenLabel mesh__D014067 Tonsil Neoplasm
% 211.25/211.44  |- mesh__recordAuthorizer mesh__D014067 sjn
% 211.25/211.44  |- skos__hiddenLabel mesh__D014067 Cancer, Tonsil
% 211.25/211.44  |- skos__altLabel mesh__D014067 Neoplasms, Tonsil
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D014067 2006
% 211.25/211.44  |- skos__hiddenLabel mesh__D014067 Neoplasm, Tonsil
% 211.25/211.44  |- skos__prefLabel mesh__D014067 Tonsillar Neoplasms
% 211.25/211.44  |- skos__hiddenLabel mesh__D014067 Neoplasm, Tonsillar
% 211.25/211.44  |- mesh__recordMaintainer mesh__D014067 nns
% 211.25/211.44  |- mesh__dateRevised mesh__D014067 1999-11-03
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D014067 2005
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D014067 2004
% 211.25/211.44  |- mesh__historyNote mesh__D008828
% 211.25/211.44       91; was MICROBIOLOGICAL TECHNICS 1978-90   
% 211.25/211.44  |- skos__altLabel mesh__D008828 Technics, Microbiological
% 211.25/211.44  |- skos__annotation mesh__D008828
% 211.25/211.44       GEN or unspecified; bacteriologic techniques = BACTERIOLOGICAL TECHNIQUES; virologic techniques = VIROLOGY /methods; mycologic techniques = MYCOLOGY /methods; parasitologic techniques = PARASITOLOGY /methods; do not use /util except by MeSH definition: DF: MICROBIOL TECHNIQUES%A%  
% 211.25/211.44  |- skos__altLabel mesh__D008828 Techniques, Microbiologic
% 211.25/211.44  |- mesh__recordMaintainer mesh__D008828 kle
% 211.25/211.44  |- skos__hiddenLabel mesh__D008828 Technic, Microbiological
% 211.25/211.44  |- mesh__recordAuthorizer mesh__D008828 sjn
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D008828 2003
% 211.25/211.44  |- skos__altLabel mesh__D008828 Technic, Microbiologic
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D008828 2001
% 211.25/211.44  |- skos__broader mesh__D008828smesh__D019411
% 211.25/211.44  |- skos__altLabel mesh__D008828 Technique, Microbiologic
% 211.25/211.44  |- skos__altLabel mesh__D008828 Microbiologic Technic
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D008828 2005
% 211.25/211.44  |- skos__historyNote mesh__D008828 Microbiology %28%1966-1977%29%
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D008828 2004
% 211.25/211.44  |- mesh__onlineNote mesh__D008828
% 211.25/211.44       use MICROBIOLOGICAL TECHNIQUES to search MICROBIOLOGICAL TECHNICS 1978-90%A%  
% 211.25/211.44  |- skos__hiddenLabel mesh__D008828 Microbiological Technique
% 211.25/211.44  |- skos__hiddenLabel mesh__D008828 Technics, Microbiologic
% 211.25/211.44  |- skos__historyNote mesh__D008828 Mycology %28%1966-1977%29%
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D008828 2006
% 211.25/211.44  |- mesh__recordOriginator mesh__D008828 SMH
% 211.25/211.44  |- skos__historyNote mesh__D008828 Parasitology %28%1966-1977%29%
% 211.25/211.44  |- skos__hiddenLabel mesh__D008828 Microbiological Technic
% 211.25/211.44  |- skos__hiddenLabel mesh__D008828 Microbiologic Techniques
% 211.25/211.44  |- skos__altLabel mesh__D008828 Microbiological Technics
% 211.25/211.44  |- skos__scopeNote mesh__D008828 Techniques used in microbiology.     
% 211.25/211.44  |- skos__altLabel mesh__D008828 Microbiologic Technics
% 211.25/211.44  |- skos__altLabel mesh__D008828 Microbiologic Technique
% 211.25/211.44  |- rdf__type mesh__D008828sskos__Concept
% 211.25/211.44  |- skos__prefLabel mesh__D008828 Microbiological Techniques
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D008828 2002
% 211.25/211.44  |- mesh__dateRevised mesh__D008828 2000-06-22
% 211.25/211.44  |- mesh__publicMeSHNote mesh__D008828
% 211.25/211.44       91; was MICROBIOLOGICAL TECHNICS 1978-90   
% 211.25/211.44  |- skos__hiddenLabel mesh__D008828 Techniques, Microbiological
% 211.25/211.44  |- skos__hiddenLabel mesh__D008828 Technique, Microbiological
% 211.25/211.44  |- mesh__dateCreated mesh__D008828 1977-03-01
% 211.25/211.44  |- mesh__dateEstablished mesh__D008828 1978-01-01
% 211.25/211.44  |- rdf__type mesh__D000845sskos__Concept
% 211.25/211.44  |- skos__altLabel mesh__D000845 Segmented Worms
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D000845 2006
% 211.25/211.44  |- skos__annotation mesh__D000845
% 211.25/211.44       a phylum of segmented worms; GEN or unspecified; prefer specifics; /microbiol /parasitol /virol permitted%A%  
% 211.25/211.44  |- skos__prefLabel mesh__D000845 Annelida
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D000845 2004
% 211.25/211.44  |- mesh__dateCreated mesh__D000845 1999-01-01
% 211.25/211.44  |- mesh__recordOriginator mesh__D000845 NLM
% 211.25/211.44  |- mesh__dateRevised mesh__D000845 2003-07-09
% 211.25/211.44  |- skos__broader mesh__D000845smesh__D007448
% 211.25/211.44  |- skos__altLabel mesh__D000845 Worms, Segmented
% 211.25/211.44  |- mesh__recordAuthorizer mesh__D000845 sjn
% 211.25/211.44  |- skos__scopeNote mesh__D000845
% 211.25/211.44       A phylum of metazoan invertebrates comprising the segmented worms, and including marine annelids %28%POLYCHAETA%29%, freshwater annelids, earthworms %28%OLIGOCHAETA%29%, and LEECHES. Only the leeches are of medical interest. %28%Dorland, 27th ed%29%%A%    
% 211.25/211.44  |- mesh__recordMaintainer mesh__D000845 ags
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D000845 2005
% 211.25/211.44  |- skos__prefLabel mesh__D019550 Environmental Medicine
% 211.25/211.44  |- skos__broader mesh__D019550smesh__D011634
% 211.25/211.44  |- mesh__dateRevised mesh__D019550 2004-07-13
% 211.25/211.44  |- mesh__recordOriginator mesh__D019550 JLS
% 211.25/211.44  |- skos__historyNote mesh__D019550 Environmental Health %28%1990-1996%29%
% 211.25/211.44  |- mesh__publicMeSHNote mesh__D019550 97   
% 211.25/211.44  |- mesh__dateEstablished mesh__D019550 1997-01-01
% 211.25/211.44  |- mesh__historyNote mesh__D019550 97   
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D019550 2006
% 211.25/211.44  |- skos__altLabel mesh__D019550 Medicine, Environmental
% 211.25/211.44  |- mesh__recordAuthorizer mesh__D019550 sjn
% 211.25/211.44  |- rdf__type mesh__D019550sskos__Concept
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D019550 2005
% 211.25/211.44  |- mesh__dateCreated mesh__D019550 1996-06-24
% 211.25/211.44  |- skos__scopeNote mesh__D019550
% 211.25/211.44       Medical specialty concerned with environmental factors that may impinge upon human disease, and development of methods for the detection, prevention, and control of environmentally related disease.%A%    
% 211.25/211.44  |- mesh__recordMaintainer mesh__D019550 sjn
% 211.25/211.44  |- skos__annotation mesh__D019550
% 211.25/211.44       SPEC dealing with envir factors in human dis; SPEC qualif; DF: ENVIR MED%A%  
% 211.25/211.44  |- skos__broader mesh__D019550smesh__D011315
% 211.25/211.44  |- skos__annotation mesh__D033221 specify geog if pertinent   
% 211.25/211.44  |- mesh__publicMeSHNote mesh__D033221 2003; see CHRISTIANITY 1978-2002   
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D033221 2003
% 211.25/211.44  |- skos__prefLabel mesh__D033221 Jehovah%27%s Witnesses
% 211.25/211.44  |- mesh__dateCreated mesh__D033221 2002-07-03
% 211.25/211.44  |- skos__hiddenLabel mesh__D033221 Witnesses, Jehovah%27%s
% 211.25/211.44  |- skos__hiddenLabel mesh__D033221 Jehovah Witnesses
% 211.25/211.44  |- skos__hiddenLabel mesh__D033221 Jehovahs Witnesses
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D033221 2006
% 211.25/211.44  |- mesh__historyNote mesh__D033221 2003; use CHRISTIANITY 1978-2002   
% 211.25/211.44  |- skos__historyNote mesh__D033221 Christianity %28%1974-2002%29%
% 211.25/211.44  |- skos__scopeNote mesh__D033221
% 211.25/211.44       Members of a religious denomination founded in the United States during the late 19th century in which active evangelism is practiced, the imminent approach of the millennium is preached, and war and organized government authority in matters of conscience are strongly opposed %28%from American Heritage Dictionary of the English Language, 4th ed%29%. Jehovah%27%s Witnesses generally refuse blood transfusions and other blood-based treatments based on religious belief.%A%    
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D033221 2005
% 211.25/211.44  |- skos__broader mesh__D033221smesh__D002835
% 211.25/211.44  |- skos__altLabel mesh__D033221 Watchtower Bible and Tract Society
% 211.25/211.44  |- skos__broader mesh__D033221smesh__D009272
% 211.25/211.44  |- rdf__type mesh__D033221sskos__Concept
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D033221 2004
% 211.25/211.44  |- mesh__dateEstablished mesh__D033221 2003-01-01
% 211.25/211.44  |- rdf__type mesh__D000047sskos__Concept
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D000047 2002
% 211.25/211.44  |- mesh__publicMeSHNote mesh__D000047 70   
% 211.25/211.44  |- skos__altLabel mesh__D000047 Academy and Institute
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D000047 2004
% 211.25/211.44  |- mesh__recordAuthorizer mesh__D000047 sjn
% 211.25/211.44  |- mesh__dateRevised mesh__D000047 1999-11-03
% 211.25/211.44  |- mesh__historyNote mesh__D000047 70%28%65%29%   
% 211.25/211.44  |- mesh__recordMaintainer mesh__D000047 kle
% 211.25/211.44  |- mesh__dateEstablished mesh__D000047 1970-01-01
% 211.25/211.44  |- skos__scopeNote mesh__D000047
% 211.25/211.44       Organizations representing specialized fields which are accepted as authoritative; may be non-governmental, university or an independent research organization, e.g., National Academy of Sciences, Brookings Institution, etc.%A%    
% 211.25/211.44  |- skos__hiddenLabel mesh__D000047 Institute, Research
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D000047 2003
% 211.25/211.44  |- mesh__dateCreated mesh__D000047 1999-01-01
% 211.25/211.44  |- mesh__recordOriginator mesh__D000047 NLM
% 211.25/211.44  |- skos__annotation mesh__D000047
% 211.25/211.44       not for educ acad %26% institutes %28% = SCHOOLS or its indentions%29%; Acad of Med: do not index also under MEDICINE; NY Acad of Med: when geog coord needed use NEW YORK CITY; DF: ACADEMIES%A%  
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D000047 2001
% 211.25/211.44  |- skos__altLabel mesh__D000047 Institutes and Academies
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D000047 2006
% 211.25/211.44  |- skos__prefLabel mesh__D000047 Academies and Institutes
% 211.25/211.44  |- skos__hiddenLabel mesh__D000047 Institute and Academy
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D000047 2000
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D000047 2005
% 211.25/211.44  |- skos__broader mesh__D000047smesh__D009938
% 211.25/211.44  |- skos__hiddenLabel mesh__D000047 Institutes, Research
% 211.25/211.44  |- skos__hiddenLabel mesh__D000047 Academy
% 211.25/211.44  |- skos__hiddenLabel mesh__D000047 Research Institute
% 211.25/211.44  |- rdf__type mesh__D005530sskos__Concept
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D005530 2005
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D005530 1998
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D005530 2002
% 211.25/211.44  |- skos__hiddenLabel mesh__D005530 Deformity, Cavus
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D005530 2003
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D005530 2006
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D005530 1999
% 211.25/211.44  |- skos__hiddenLabel mesh__D005530 Deformity, Metatarsal
% 211.25/211.44  |- skos__hiddenLabel mesh__D005530 Deformities, Foot
% 211.25/211.44  |- skos__hiddenLabel mesh__D005530 Deformities, Cavus
% 211.25/211.44  |- skos__hiddenLabel mesh__D005530 Cavus Deformities
% 211.25/211.44  |- skos__altLabel mesh__D005530 Talipes Cavus
% 211.25/211.44  |- skos__scopeNote mesh__D005530
% 211.25/211.44       Alterations or deviations from normal shape or size which result in a disfigurement of the foot.%A%    
% 211.25/211.44  |- mesh__recordMaintainer mesh__D005530 TGC
% 211.25/211.44  |- skos__hiddenLabel mesh__D005530 Metatarsal Deformities
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D005530 2004
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D005530 1997
% 211.25/211.44  |- skos__broader mesh__D005530smesh__D009140
% 211.25/211.44  |- mesh__historyNote mesh__D005530 88   
% 211.25/211.44  |- mesh__dateCreated mesh__D005530 1987-04-02
% 211.25/211.44  |- skos__annotation mesh__D005530 GEN or unspecified; prefer specifics   
% 211.25/211.44  |- mesh__dateRevised mesh__D005530 1996-06-10
% 211.25/211.44  |- skos__prefLabel mesh__D005530 Foot Deformities
% 211.25/211.44  |- mesh__dateEstablished mesh__D005530 1988-01-01
% 211.25/211.44  |- mesh__recordOriginator mesh__D005530 EC
% 211.25/211.44  |- skos__historyNote mesh__D005530 Foot/abnormalities %28%1966-1987%29%
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D005530 2000
% 211.25/211.44  |- mesh__publicMeSHNote mesh__D005530 88   
% 211.25/211.44  |- skos__hiddenLabel mesh__D005530 Foot Deformity
% 211.25/211.44  |- skos__hiddenLabel mesh__D005530 Deformities, Metatarsal
% 211.25/211.44  |- mesh__recordAuthorizer mesh__D005530 PLS
% 211.25/211.44  |- skos__hiddenLabel mesh__D005530 Deformity, Foot
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D005530 2001
% 211.25/211.44  |- skos__hiddenLabel mesh__D046149 Culture Technique, Blastocyst
% 211.25/211.44  |- mesh__recordMaintainer mesh__D046149 ags
% 211.25/211.44  |- skos__annotation mesh__D046149
% 211.25/211.44       restrict to whole mammalian embryos; for cultures of embryonic tissue or cells, use TISSUE CULTURE TECHNIQUES or CELL CULTURE%A%  
% 211.25/211.44  |- skos__broader mesh__D046149smesh__D046508
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D046149 2006
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D046149 2006A
% 211.25/211.44  |- rdf__type mesh__D046149sskos__Concept
% 211.25/211.44  |- skos__scopeNote mesh__D046149
% 211.25/211.44       The technique of maintaining or growing mammalian EMBRYOS in vitro. This method offers an opportunity to observe EMBRYONIC DEVELOPMENT; METABOLISM; and susceptibility to TERATOGENS%A%    
% 211.25/211.44  |- skos__historyNote mesh__D046149 Culture Techniques %28%1965-2004%29%
% 211.25/211.44  |- skos__hiddenLabel mesh__D046149 Embryo Culture Technique
% 211.25/211.44  |- skos__prefLabel mesh__D046149 Embryo Culture Techniques
% 211.25/211.44  |- skos__historyNote mesh__D046149 Embryo %28%1966-2004%29%
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D046149 2005
% 211.25/211.44  |- mesh__historyNote mesh__D046149 2005   
% 211.25/211.44  |- skos__hiddenLabel mesh__D046149 Blastocyst Culture Technique
% 211.25/211.44  |- mesh__dateCreated mesh__D046149 2004-07-07
% 211.25/211.44  |- mesh__dateRevised mesh__D046149 2005-08-02
% 211.25/211.44  |- mesh__publicMeSHNote mesh__D046149 2005   
% 211.25/211.44  |- mesh__dateEstablished mesh__D046149 2005-01-01
% 211.25/211.44  |- skos__hiddenLabel mesh__D046149 Culture Techniques, Blastocyst
% 211.25/211.44  |- skos__hiddenLabel mesh__D046149 Culture Technique, Embryo
% 211.25/211.44  |- mesh__recordOriginator mesh__D046149 lkt
% 211.25/211.44  |- skos__hiddenLabel mesh__D046149 Culture Techniques, Embryo
% 211.25/211.44  |- mesh__recordAuthorizer mesh__D046149 ags
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D046149 2006B
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 States, Minimally Conscious
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 State, Vegetative
% 211.25/211.44  |- skos__related mesh__D018458smesh__D000405
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Vegetative States, Persistent
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Unawareness, Prolonged Post-Traumatic
% 211.25/211.44  |- skos__altLabel mesh__D018458 Posttraumatic Unawareness State
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 State, Posttraumatic Unawareness
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D018458 2003
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Vegetative State, Post-Traumatic
% 211.25/211.44  |- skos__altLabel mesh__D018458 PVS %28%Persistent Vegetative State%29%
% 211.25/211.44  |- skos__altLabel mesh__D018458 Vegetative State, Persistent
% 211.25/211.44  |- mesh__publicMeSHNote mesh__D018458
% 211.25/211.44       1995; VEGETATIVE STATE was see COMA 1980-1994   
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 States, Persistent Vegetative
% 211.25/211.44  |- skos__broader mesh__D018458smesh__D001925
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Prolonged Post Traumatic Unawareness
% 211.25/211.44  |- skos__related mesh__D018458smesh__D003128
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Prolonged Post-Traumatic Unawarenesses
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 States, Post-Comatose Unawareness
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Unawareness State, Post-Traumatic
% 211.25/211.44  |- skos__historyNote mesh__D018458 Coma %28%1972-1994%29%
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 State, Persistent Unawareness
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Permanent Vegetative States
% 211.25/211.44  |- skos__broader mesh__D018458smesh__D014474
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Unawareness State, Posttraumatic
% 211.25/211.44  |- mesh__dateEstablished mesh__D018458 1995-01-01
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 States, Postcomatose Unawareness
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Post-Traumatic Unawareness, Prolonged
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D018458 2002
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 State, Transient Vegetative
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Transient Vegetative States
% 211.25/211.44  |- mesh__recordOriginator mesh__D018458 TGC
% 211.25/211.44  |- rdf__type mesh__D018458sskos__Concept
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D018458 2004
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 State, Post-Traumatic Unawareness
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Vegetative States, Post-Traumatic
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 States, Vegetative
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Unawareness States, Posttraumatic
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D018458 2005
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Post Traumatic Unawareness State
% 211.25/211.44  |- mesh__dateCreated mesh__D018458 1994-04-16
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Vegetative States
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 PVSs %28%Persistent Vegetative State%29%
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 States, Posttraumatic Unawareness
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Post Comatose Unawareness State
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Post-Traumatic Unawareness States
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Post Traumatic Vegetative State
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 State, Permanent Vegetative
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 States, Post-Traumatic Vegetative
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 State, Persistent Vegetative
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Unawareness State, Postcomatose
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Unawarenesses, Prolonged Post-Traumatic
% 211.25/211.44  |- skos__prefLabel mesh__D018458 Persistent Vegetative State
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D018458 2006
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Unawareness States, Postcomatose
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 States, Persistent Unawareness
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 State, Post-Comatose Unawareness
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Post-Traumatic Unawarenesses, Prolonged
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Vegetative State, Transient
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Vegetative States, Permanent
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 States, Permanent Vegetative
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Unawareness State, Persistent
% 211.25/211.44  |- skos__altLabel mesh__D018458 Postcomatose Unawareness State
% 211.25/211.44  |- mesh__recordAuthorizer mesh__D018458 sjn
% 211.25/211.44  |- mesh__recordMaintainer mesh__D018458 lkt
% 211.25/211.44  |- mesh__historyNote mesh__D018458
% 211.25/211.44       1995; VEGETATIVE STATE was see COMA 1980-1994   
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Unawareness State, Post-Comatose
% 211.25/211.44  |- skos__altLabel mesh__D018458 Persistent Unawareness State
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 State, Minimally Conscious
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Minimally Conscious States
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 States, Post-Traumatic Unawareness
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Post-Comatose Unawareness States
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Post-Traumatic Vegetative States
% 211.25/211.44  |- mesh__dateRevised mesh__D018458 2001-07-25
% 211.25/211.44  |- skos__altLabel mesh__D018458 Post-Traumatic Unawareness State
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Vegetative States, Transient
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Posttraumatic Unawareness States
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Unawareness States, Post-Traumatic
% 211.25/211.44  |- skos__annotation mesh__D018458 see also AKINETIC MUTISM   
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Postcomatose Unawareness States
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 State, Post-Traumatic Vegetative
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 State, Postcomatose Unawareness
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Vegetative State, Permanent
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Unawareness States, Persistent
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 States, Transient Vegetative
% 211.25/211.44  |- skos__scopeNote mesh__D018458
% 211.25/211.44       Vegetative state refers to the neurocognitive status of individuals with severe brain damage, in whom physiologic functions %28%sleep-wake cycles, autonomic control, and breathing%29% persist, but awareness %28%including all cognitive function and emotion%29% is abolished.%A%    
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Unawareness States, Post-Comatose
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Persistent Vegetative States
% 211.25/211.44  |- skos__hiddenLabel mesh__D018458 Persistent Unawareness States
% 211.25/211.44  |- skos__altLabel mesh__D032129 Achras zapotilla
% 211.25/211.44  |- mesh__recordAuthorizer mesh__D032129 sjn
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D032129 2006
% 211.25/211.44  |- mesh__publicMeSHNote mesh__D032129 2003   
% 211.25/211.44  |- rdf__type mesh__D032129sskos__Concept
% 211.25/211.44  |- mesh__recordMaintainer mesh__D032129 sjn
% 211.25/211.44  |- skos__altLabel mesh__D032129 Zapote
% 211.25/211.44  |- skos__altLabel mesh__D032129 Sapodilla
% 211.25/211.44  |- skos__annotation mesh__D032129
% 211.25/211.44       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D032129 2005
% 211.25/211.44  |- mesh__historyNote mesh__D032129 2003   
% 211.25/211.44  |- mesh__dateRevised mesh__D032129 2004-07-13
% 211.25/211.44  |- skos__prefLabel mesh__D032129 Manilkara
% 211.25/211.44  |- skos__broader mesh__D032129smesh__D029632
% 211.25/211.44  |- skos__altLabel mesh__D032129 Sapote
% 211.25/211.44  |- skos__altLabel mesh__D032129 Lucuma mammosa
% 211.25/211.44  |- mesh__dateCreated mesh__D032129 2002-07-02
% 211.25/211.44  |- skos__altLabel mesh__D032129 Sapota zapotilla
% 211.25/211.44  |- mesh__recordOriginator mesh__D032129 ssb
% 211.25/211.44  |- skos__scopeNote mesh__D032129
% 211.25/211.44       A plant genus of the family SAPOTACEAE that bears sweet fruit.%A%    
% 211.25/211.44  |- mesh__dateEstablished mesh__D032129 2003-01-01
% 211.25/211.44  |- mesh__dateCreated mesh__D004438 1999-01-01
% 211.25/211.44  |- mesh__historyNote mesh__D004438 64   
% 211.25/211.44  |- mesh__dateEstablished mesh__D004438 1964-01-01
% 211.25/211.44  |- mesh__recordAuthorizer mesh__D004438 sjn
% 211.25/211.44  |- mesh__recordOriginator mesh__D004438 NLM
% 211.25/211.44  |- mesh__dateRevised mesh__D004438 1999-11-03
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D004438 2003
% 211.25/211.44  |- skos__broader mesh__D004438smesh__D012877
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D004438 2000
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D004438 2005
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D004438 2004
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D004438 2001
% 211.25/211.44  |- skos__related mesh__D004438smesh__D011693
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D004438 2006
% 211.25/211.44  |- skos__broader mesh__D004438smesh__D006470
% 211.25/211.44  |- skos__hiddenLabel mesh__D004438 Ecchymoses
% 211.25/211.44  |- skos__scopeNote mesh__D004438
% 211.25/211.44       Extravasation of blood into the skin, resulting in a nonelevated, rounded or irregular, blue or purplish patch, larger than a petechia.%A%    
% 211.25/211.44  |- rdf__type mesh__D004438sskos__Concept
% 211.25/211.44  |- skos__prefLabel mesh__D004438 Ecchymosis
% 211.25/211.44  |- mesh__recordMaintainer mesh__D004438 KEV
% 211.25/211.44  |- mesh__publicMeSHNote mesh__D004438 64   
% 211.25/211.44  |- skos__annotation mesh__D004438
% 211.25/211.44       differentiate from CONTUSIONS: use term in the text   
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D004438 2002
% 211.25/211.44  |- skos__broader mesh__D015160smesh__D017085
% 211.25/211.44  |- skos__historyNote mesh__D015160 Fetal Diseases %28%1966-1988%29%
% 211.25/211.44  |- mesh__recordAuthorizer mesh__D015160 sjn
% 211.25/211.44  |- mesh__historyNote mesh__D015160 89   
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D015160 2006
% 211.25/211.44  |- skos__altLabel mesh__D015160 Non-Immune Hydrops Fetalis
% 211.25/211.44  |- skos__historyNote mesh__D015160 Edema %28%1966-1988%29%
% 211.25/211.44  |- skos__scopeNote mesh__D015160
% 211.25/211.44       Abnormal accumulation of serous fluid in two or more fetal compartments, such as SKIN; PLEURA; PERICARDIUM; PLACENTA; PERITONEUM; AMNIOTIC FLUID. General fetal EDEMA may be of non-immunologic origin, or of immunologic origin as in the case of ERYTHROBLASTOSIS FETALIS.%A%    
% 211.25/211.44  |- mesh__recordOriginator mesh__D015160 EC
% 211.25/211.44  |- skos__altLabel mesh__D015160 Edema, Fetal
% 211.25/211.44  |- rdf__type mesh__D015160sskos__Concept
% 211.25/211.44  |- skos__broader mesh__D015160smesh__D004899
% 211.25/211.44  |- skos__altLabel mesh__D015160 Hydrops Fetalis, Immune
% 211.25/211.44  |- mesh__dateCreated mesh__D015160 1988-03-28
% 211.25/211.44  |- skos__prefLabel mesh__D015160 Hydrops Fetalis
% 211.25/211.44  |- skos__broader mesh__D015160smesh__D004487
% 211.25/211.44  |- skos__altLabel mesh__D015160 Fetal Hydrops
% 211.25/211.44  |- mesh__publicMeSHNote mesh__D015160 89   
% 211.25/211.44  |- skos__hiddenLabel mesh__D015160 Hydrops, Fetal
% 211.25/211.44  |- mesh__recordMaintainer mesh__D015160 lkt
% 211.25/211.44  |- mesh__dateEstablished mesh__D015160 1989-01-01
% 211.25/211.44  |- mesh__dateRevised mesh__D015160 2005-06-30
% 211.25/211.44  |- skos__altLabel mesh__D015160 Fetal Edema
% 211.25/211.44  |- skos__scopeNote mesh__D009921
% 211.25/211.44       A beta-adrenergic agonist used in the treatment of asthma and bronchospasms.%A%    
% 211.25/211.44  |- mesh__recordAuthorizer mesh__D009921 sjn
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D009921 2005
% 211.25/211.44  |- skos__broader mesh__D009921smesh__D002395
% 211.25/211.44  |- mesh__historyNote mesh__D009921 72%28%65%29%   
% 211.25/211.44  |- skos__altLabel mesh__D009921 Metaproterenol
% 211.25/211.44  |- mesh__dateEstablished mesh__D009921 1972-01-01
% 211.25/211.44  |- skos__broader mesh__D009921smesh__D004983
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D009921 2003
% 211.25/211.44  |- mesh__recordOriginator mesh__D009921 NLM
% 211.25/211.44  |- mesh__activeMeSHYear mesh__D009921 2006
% 211.25/211.44  |- mesh__recordMaintainer mesh__D009921 ssb
% 211.25/211.45  |- mesh__publicMeSHNote mesh__D009921 72   
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D009921 2004
% 211.25/211.45  |- mesh__dateRevised mesh__D009921 2001-07-25
% 211.25/211.45  |- skos__hiddenLabel mesh__D009921 Polistirex, Metaproterenol
% 211.25/211.45  |- skos__prefLabel mesh__D009921 Orciprenaline
% 211.25/211.45  |- rdf__type mesh__D009921sskos__Concept
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D009921 2002
% 211.25/211.45  |- mesh__dateCreated mesh__D009921 1999-01-01
% 211.25/211.45  |- skos__altLabel mesh__D009123 Muscle Flaccidity
% 211.25/211.45  |- mesh__recordMaintainer mesh__D009123 nns
% 211.25/211.45  |- skos__hiddenLabel mesh__D009123 Tone Atonic, Muscle
% 211.25/211.45  |- skos__hiddenLabel mesh__D009123 Hypotonia, Muscular
% 211.25/211.45  |- skos__hiddenLabel mesh__D009123 Flaccidity, Muscular
% 211.25/211.45  |- skos__hiddenLabel mesh__D009123 Muscle Tone Atonics
% 211.25/211.45  |- skos__hiddenLabel mesh__D009123 Muscle Tone, Decreased
% 211.25/211.45  |- skos__altLabel mesh__D009123 Decreased Muscle Tone
% 211.25/211.45  |- skos__altLabel mesh__D009123 Muscular Flaccidity
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D009123 2006
% 211.25/211.45  |- skos__hiddenLabel mesh__D009123 Muscle, Floppy
% 211.25/211.45  |- skos__altLabel mesh__D009123 Hypomyotonia
% 211.25/211.45  |- mesh__historyNote mesh__D009123 1977   
% 211.25/211.45  |- skos__altLabel mesh__D009123 Muscle Tone Poor
% 211.25/211.45  |- skos__altLabel mesh__D009123 Muscular Hypotonia
% 211.25/211.45  |- skos__hiddenLabel mesh__D009123 Muscles, Floppy
% 211.25/211.45  |- mesh__dateEstablished mesh__D009123 1977-01-01
% 211.25/211.45  |- skos__hiddenLabel mesh__D009123 Hypotonias, Neonatal
% 211.25/211.45  |- skos__historyNote mesh__D009123 Muscular Diseases %28%1966-1976%29%
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D009123 2003
% 211.25/211.45  |- skos__hiddenLabel mesh__D009123 Tone Poor, Muscle
% 211.25/211.45  |- rdf__type mesh__D009123sskos__Concept
% 211.25/211.45  |- mesh__recordAuthorizer mesh__D009123 sjn
% 211.25/211.45  |- skos__hiddenLabel mesh__D009123 Hypotonia, Muscle
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D009123 2002
% 211.25/211.45  |- mesh__dateRevised mesh__D009123 2001-07-25
% 211.25/211.45  |- skos__hiddenLabel mesh__D009123 Muscular Flaccidities
% 211.25/211.45  |- skos__altLabel mesh__D009123 Hypotonia
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D009123 2004
% 211.25/211.45  |- skos__hiddenLabel mesh__D009123 Neonatal Hypotonias
% 211.25/211.45  |- skos__prefLabel mesh__D009123 Muscle Hypotonia
% 211.25/211.45  |- mesh__recordOriginator mesh__D009123 MM
% 211.25/211.45  |- skos__altLabel mesh__D009123 Hypotony, Muscle
% 211.25/211.45  |- skos__hiddenLabel mesh__D009123 Muscle Hypotony
% 211.25/211.45  |- skos__hiddenLabel mesh__D009123 Hypotonia, Unilateral
% 211.25/211.45  |- skos__scopeNote mesh__D009123
% 211.25/211.45       A diminution of the skeletal muscle tone marked by a diminished resistance to passive stretching.%A%    
% 211.25/211.45  |- skos__hiddenLabel mesh__D009123 Floppy Muscle
% 211.25/211.45  |- skos__hiddenLabel mesh__D009123 Muscle Tone, Flaccid
% 211.25/211.45  |- mesh__publicMeSHNote mesh__D009123 1977   
% 211.25/211.45  |- skos__hiddenLabel mesh__D009123 Flaccidity, Muscle
% 211.25/211.45  |- skos__hiddenLabel mesh__D009123 Hypotonias, Unilateral
% 211.25/211.45  |- mesh__dateCreated mesh__D009123 1976-05-19
% 211.25/211.45  |- skos__hiddenLabel mesh__D009123 Hypotonia, Neonatal
% 211.25/211.45  |- skos__broader mesh__D009123smesh__D020879
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D009123 2005
% 211.25/211.45  |- skos__annotation mesh__D001140
% 211.25/211.45       indust chem, a widespread environ pollutant; TN 111: eff on insects; AROCLOR 1254 also available%A%  
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D001140 2006
% 211.25/211.45  |- mesh__recordMaintainer mesh__D001140 jls
% 211.25/211.45  |- skos__scopeNote mesh__D001140
% 211.25/211.45       Industrial chemicals which have become widespread environmental pollutants. Each aroclor is a mixture of chlorinated biphenyls %28%1200 series%29% or chlorinated terphenyls %28%5400 series%29% or a combination of both %28%4400 series%29%.%A%    
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D001140 2005
% 211.25/211.45  |- mesh__dateRevised mesh__D001140 2004-07-07
% 211.25/211.45  |- mesh__recordOriginator mesh__D001140 NLM
% 211.25/211.45  |- mesh__recordAuthorizer mesh__D001140 sjn
% 211.25/211.45  |- rdf__type mesh__D001140sskos__Concept
% 211.25/211.45  |- skos__broader mesh__D001140smesh__D011080
% 211.25/211.45  |- mesh__onlineNote mesh__D001140
% 211.25/211.45       search POLYCHLOROBIPHENYL COMPOUNDS 1973-74   
% 211.25/211.45  |- skos__broader mesh__D001140smesh__D011078
% 211.25/211.45  |- skos__prefLabel mesh__D001140 Aroclors
% 211.25/211.45  |- mesh__dateEstablished mesh__D001140 1991-01-01
% 211.25/211.45  |- mesh__publicMeSHNote mesh__D001140
% 211.25/211.45       91; was see under POLYCHLOROBIPHENYL COMPOUNDS 1975-90   
% 211.25/211.45  |- mesh__historyNote mesh__D001140
% 211.25/211.45       91%28%75%29%; was see under POLYCHLOROBIPHENYL COMPOUNDS 1975-90%A%  
% 211.25/211.45  |- mesh__dateCreated mesh__D001140 1999-01-01
% 211.25/211.45  |- skos__prefLabel mesh__D014866 Waste Products
% 211.25/211.45  |- mesh__dateCreated mesh__D014866 1999-01-01
% 211.25/211.45  |- skos__hiddenLabel mesh__D014866 Product, Waste
% 211.25/211.45  |- mesh__dateEstablished mesh__D014866 1976-01-01
% 211.25/211.45  |- skos__hiddenLabel mesh__D014866 Products, Waste
% 211.25/211.45  |- mesh__recordAuthorizer mesh__D014866 sjn
% 211.25/211.45  |- mesh__recordOriginator mesh__D014866 NLM
% 211.25/211.45  |- skos__annotation mesh__D014866
% 211.25/211.45       MEDICAL WASTE %26% DENTAL WASTE are also available   
% 211.25/211.45  |- mesh__dateRevised mesh__D014866 2005-06-30
% 211.25/211.45  |- rdf__type mesh__D014866sskos__Concept
% 211.25/211.45  |- mesh__publicMeSHNote mesh__D014866 76   
% 211.25/211.45  |- skos__scopeNote mesh__D014866
% 211.25/211.45       Debris resulting from a process that is of no further use to the system producing it. The concept includes materials discharged from or stored in a system in inert form as a by-product of vital activities. %28%From Webster%27%s New Collegiate Dictionary, 1981%29%%A%    
% 211.25/211.45  |- mesh__historyNote mesh__D014866 76; was NON MESH before 1976   
% 211.25/211.45  |- skos__hiddenLabel mesh__D014866 Waste Product
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D014866 2006
% 211.25/211.45  |- skos__broader mesh__D014866smesh__D045424
% 211.25/211.45  |- mesh__recordMaintainer mesh__D014866 ssb
% 211.25/211.45  |- skos__broader mesh__D014866smesh__D004787
% 211.25/211.45  |- rdf__type mesh__D014068sskos__Concept
% 211.25/211.45  |- skos__broader mesh__D014068smesh__D013517
% 211.25/211.45  |- skos__scopeNote mesh__D014068
% 211.25/211.45       Surgical removal of a tonsil or tonsils. %28%Dorland, 28th ed%29%%A%    
% 211.25/211.45  |- mesh__recordAuthorizer mesh__D014068 SJN
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D014068 2001
% 211.25/211.45  |- skos__hiddenLabel mesh__D014068 Tonsillectomies
% 211.25/211.45  |- mesh__dateCreated mesh__D014068 1999-01-01
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D014068 2000
% 211.25/211.45  |- mesh__dateRevised mesh__D014068 1997-06-20
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D014068 2006
% 211.25/211.45  |- mesh__recordMaintainer mesh__D014068 PXP
% 211.25/211.45  |- skos__prefLabel mesh__D014068 Tonsillectomy
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D014068 2005
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D014068 1999
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D014068 2004
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D014068 2002
% 211.25/211.45  |- mesh__recordOriginator mesh__D014068 NLM
% 211.25/211.45  |- skos__annotation mesh__D014068
% 211.25/211.45       do not use /util except by MeSH definition; post-tonsillectomy hemorrh = HEMORRHAGE + POSTOPERATIVE COMPLICATIONS, not HEMORRHAGE, ORAL%A%  
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D014068 1998
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D014068 2003
% 211.25/211.45  |- mesh__dateRevised mesh__D008829 2001-07-25
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D008829 2005
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D008829 2004
% 211.25/211.45  |- skos__related mesh__D008829smesh__D014780
% 211.25/211.45  |- skos__related mesh__D008829smesh__D001105
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D008829 2002
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D008829 2006
% 211.25/211.45  |- skos__related mesh__D008829smesh__D005658
% 211.25/211.45  |- skos__annotation mesh__D008829
% 211.25/211.45       SPEC only; prefer /microbiol with specific organ, higher animal %26% disease: Manual 19.7+, 19.8.46; note precoord microbiology terms %28%AIR MICROBIOLOGY; FOOD MICROBIOLOGY; etc%29%; presence of microbes in the blood: coord with the disease /microbiol, not /blood ; DF: MICROBIOL%A%  
% 211.25/211.45  |- rdf__type mesh__D008829sskos__Concept
% 211.25/211.45  |- mesh__recordOriginator mesh__D008829 NLM
% 211.25/211.45  |- skos__broader mesh__D008829smesh__D001695
% 211.25/211.45  |- skos__prefLabel mesh__D008829 Microbiology
% 211.25/211.45  |- mesh__recordAuthorizer mesh__D008829 sjn
% 211.25/211.45  |- skos__related mesh__D008829smesh__D001419
% 211.25/211.45  |- skos__related mesh__D008829smesh__D011527
% 211.25/211.45  |- skos__scopeNote mesh__D008829
% 211.25/211.45       The study of microorganisms such as fungi, bacteria, algae, archaea, and viruses.%A%    
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D008829 2003
% 211.25/211.45  |- mesh__recordMaintainer mesh__D008829 jls
% 211.25/211.45  |- mesh__dateCreated mesh__D008829 1999-01-01
% 211.25/211.45  |- skos__broader mesh__D000846smesh__D006664
% 211.25/211.45  |- skos__hiddenLabel mesh__D000846 Special Event
% 211.25/211.45  |- mesh__historyNote mesh__D000846
% 211.25/211.45       91%28%Aug 77%29%; was see under PUBLIC RELATIONS 1977-90   
% 211.25/211.45  |- skos__prefLabel mesh__D000846 Anniversaries and Special Events
% 211.25/211.45  |- skos__broader mesh__D000846smesh__D011641
% 211.25/211.45  |- mesh__recordOriginator mesh__D000846 EC
% 211.25/211.45  |- skos__hiddenLabel mesh__D000846 Anniversary
% 211.25/211.45  |- mesh__publicMeSHNote mesh__D000846
% 211.25/211.45       91; was see under PUBLIC RELATIONS 1977-90   
% 211.25/211.45  |- mesh__recordMaintainer mesh__D000846 jls
% 211.25/211.45  |- skos__scopeNote mesh__D000846
% 211.25/211.45       Occasions to commemorate an event or occasions designated for a specific purpose.%A%    
% 211.25/211.45  |- skos__hiddenLabel mesh__D000846 Events, Special
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D000846 2005
% 211.25/211.45  |- rdf__type mesh__D000846sskos__Concept
% 211.25/211.45  |- skos__annotation mesh__D000846
% 211.25/211.45       NIM; no qualif; note X ref below: do not index here for anniversaries, centennials, etc. in historical articles; do not coord here for ANNIVERSARY REACTION; DF: ANNIVERSARIES%A%  
% 211.25/211.45  |- mesh__recordAuthorizer mesh__D000846 sjn
% 211.25/211.45  |- mesh__dateRevised mesh__D000846 2004-07-07
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D000846 2006
% 211.25/211.45  |- skos__hiddenLabel mesh__D000846 Event, Special
% 211.25/211.45  |- mesh__dateEstablished mesh__D000846 1991-01-01
% 211.25/211.45  |- mesh__dateCreated mesh__D000846 1977-05-05
% 211.25/211.45  |- mesh__recordMaintainer mesh__D019551 ssb
% 211.25/211.45  |- mesh__recordOriginator mesh__D019551 JLS
% 211.25/211.45  |- skos__broader mesh__D019551smesh__D004202
% 211.25/211.45  |- skos__historyNote mesh__D019551 Disinfectants %28%1967-1996%29%
% 211.25/211.45  |- mesh__historyNote mesh__D019551 97   
% 211.25/211.45  |- mesh__dateCreated mesh__D019551 1996-06-10
% 211.25/211.45  |- mesh__dateRevised mesh__D019551 2003-07-09
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D019551 2006
% 211.25/211.45  |- rdf__type mesh__D019551sskos__Concept
% 211.25/211.45  |- skos__altLabel mesh__D019551 Disinfectants, Dental
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D019551 2005
% 211.25/211.45  |- mesh__publicMeSHNote mesh__D019551 97   
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D019551 2004
% 211.25/211.45  |- skos__annotation mesh__D019551 DF: DENT DISINFECTANTS   
% 211.25/211.45  |- mesh__dateEstablished mesh__D019551 1997-01-01
% 211.25/211.45  |- mesh__recordAuthorizer mesh__D019551 sjn
% 211.25/211.45  |- skos__prefLabel mesh__D019551 Dental Disinfectants
% 211.25/211.45  |- skos__scopeNote mesh__D019551
% 211.25/211.45       Chemicals especially for use on instruments to destroy pathogenic organisms. %28%Boucher, Clinical Dental Terminology, 4th ed%29%%A%    
% 211.25/211.45  |- skos__hiddenLabel mesh__D033222 Action, Court
% 211.25/211.45  |- skos__hiddenLabel mesh__D033222 Actions, Court
% 211.25/211.45  |- skos__altLabel mesh__D033222 Court Action
% 211.25/211.45  |- mesh__dateEstablished mesh__D033222 2003-01-01
% 211.25/211.45  |- skos__hiddenLabel mesh__D033222 Judicial Roles
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D033222 2006
% 211.25/211.45  |- skos__hiddenLabel mesh__D033222 Court Actions
% 211.25/211.45  |- skos__hiddenLabel mesh__D033222 Action, Judicial
% 211.25/211.45  |- mesh__recordOriginator mesh__D033222 jrf
% 211.25/211.45  |- skos__prefLabel mesh__D033222 Judicial Role
% 211.25/211.45  |- skos__hiddenLabel mesh__D033222 Actions, Judicial
% 211.25/211.45  |- mesh__recordMaintainer mesh__D033222 sjn
% 211.25/211.45  |- skos__hiddenLabel mesh__D033222 Judicial Actions
% 211.25/211.45  |- mesh__historyNote mesh__D033222 2003; use JURISPRUDENCE 1978-2002   
% 211.25/211.45  |- mesh__dateRevised mesh__D033222 2003-07-25
% 211.25/211.45  |- mesh__recordAuthorizer mesh__D033222 sjn
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D033222 2005
% 211.25/211.45  |- skos__altLabel mesh__D033222 Judicial Action
% 211.25/211.45  |- skos__hiddenLabel mesh__D033222 Consent, Judicial
% 211.25/211.45  |- rdf__type mesh__D033222sskos__Concept
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D033222 2004
% 211.25/211.45  |- skos__historyNote mesh__D033222 Jurisprudence %28%1975-2002%29%
% 211.25/211.45  |- skos__annotation mesh__D033222
% 211.25/211.45       use only for discussions of the role of judges or courts in decision making, not routinely for individual court cases%A%  
% 211.25/211.45  |- skos__hiddenLabel mesh__D033222 Bypass, Judicial
% 211.25/211.45  |- mesh__publicMeSHNote mesh__D033222 2003; see JURISPRUDENCE 1978-2002   
% 211.25/211.45  |- skos__hiddenLabel mesh__D033222 Role, Judicial
% 211.25/211.45  |- skos__scopeNote mesh__D033222
% 211.25/211.45       The kind of action or activity proper to the judiciary, particularly its responsibility for decision making.%A%    
% 211.25/211.45  |- skos__broader mesh__D033222smesh__D007603
% 211.25/211.45  |- skos__hiddenLabel mesh__D033222 Roles, Judicial
% 211.25/211.45  |- mesh__dateCreated mesh__D033222 2002-07-02
% 211.25/211.45  |- skos__historyNote mesh__D000048 Amoeba %28%1966-1987%29%
% 211.25/211.45  |- mesh__dateEstablished mesh__D000048 1988-01-01
% 211.25/211.45  |- mesh__recordAuthorizer mesh__D000048 sjn
% 211.25/211.45  |- mesh__publicMeSHNote mesh__D000048 88   
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D000048 2004
% 211.25/211.45  |- skos__broader mesh__D000048smesh__D016842
% 211.25/211.45  |- mesh__dateCreated mesh__D000048 1987-04-30
% 211.25/211.45  |- mesh__recordMaintainer mesh__D000048 ags
% 211.25/211.45  |- mesh__recordOriginator mesh__D000048 EC
% 211.25/211.45  |- skos__prefLabel mesh__D000048 Acanthamoeba
% 211.25/211.45  |- skos__scopeNote mesh__D000048
% 211.25/211.45       A genus of free-living soil amoebae that produces no flagellate stage. Its organisms are pathogens for several infections in humans and have been found in the eye, bone, brain, and respiratory tract.%A%    
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D000048 2006
% 211.25/211.45  |- mesh__historyNote mesh__D000048 88   
% 211.25/211.45  |- mesh__dateRevised mesh__D000048 2003-07-09
% 211.25/211.45  |- skos__annotation mesh__D000048
% 211.25/211.45       infection: coord IM with AMEBIASIS %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D000048 2005
% 211.25/211.45  |- rdf__type mesh__D000048sskos__Concept
% 211.25/211.45  |- skos__historyNote mesh__D005531 Foot Diseases %28%1966-1970%29%
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D005531 2001
% 211.25/211.45  |- skos__broader mesh__D005531smesh__D005530
% 211.25/211.45  |- skos__prefLabel mesh__D005531 Foot Deformities, Acquired
% 211.25/211.45  |- skos__scopeNote mesh__D005531
% 211.25/211.45       Distortion or disfigurement of the foot, or a part of the foot, acquired through disease or injury after birth.%A%    
% 211.25/211.45  |- mesh__recordMaintainer mesh__D005531 TGC
% 211.25/211.45  |- skos__hiddenLabel mesh__D005531 Deformity, Acquired Foot
% 211.25/211.45  |- rdf__type mesh__D005531sskos__Concept
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D005531 2000
% 211.25/211.45  |- skos__hiddenLabel mesh__D005531 Acquired Foot Deformity
% 211.25/211.45  |- skos__annotation mesh__D005531 deformity of bone, joint, muscle, etc.   
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D005531 2004
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D005531 1997
% 211.25/211.45  |- mesh__publicMeSHNote mesh__D005531 71   
% 211.25/211.45  |- skos__hiddenLabel mesh__D005531 Deformities, Acquired Foot
% 211.25/211.45  |- mesh__dateEstablished mesh__D005531 1971-01-01
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D005531 2006
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D005531 1999
% 211.25/211.45  |- mesh__dateRevised mesh__D005531 1992-05-20
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D005531 2003
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D005531 1996
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D005531 1993
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D005531 1995
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D005531 2005
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D005531 1998
% 211.25/211.45  |- mesh__historyNote mesh__D005531 71   
% 211.25/211.45  |- mesh__recordOriginator mesh__D005531 NLM
% 211.25/211.45  |- skos__hiddenLabel mesh__D005531 Acquired Foot Deformities
% 211.25/211.45  |- skos__hiddenLabel mesh__D005531 Foot Deformity, Acquired
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D005531 1994
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D005531 2002
% 211.25/211.45  |- mesh__recordAuthorizer mesh__D005531 PLS
% 211.25/211.45  |- mesh__dateCreated mesh__D005531 1999-01-01
% 211.25/211.45  |- mesh__dateEstablished mesh__D046948 2005-01-01
% 211.25/211.45  |- rdf__type mesh__D046948sskos__Concept
% 211.25/211.45  |- skos__hiddenLabel mesh__D046948 Tryptamine Alkaloids, Secologanin
% 211.25/211.45  |- skos__hiddenLabel mesh__D046948 Alkaloids, Secologanin Tryptamine
% 211.25/211.45  |- skos__prefLabel mesh__D046948 Secologanin Tryptamine Alkaloids
% 211.25/211.45  |- skos__hiddenLabel mesh__D046948 Indole Alkaloids, Monoterpenoid
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D046948 2006
% 211.25/211.45  |- skos__altLabel mesh__D046948 Monoterpenoid Indole Alkaloids
% 211.25/211.45  |- skos__hiddenLabel mesh__D046948 Alkaloids, Rauwolfia
% 211.25/211.45  |- skos__hiddenLabel mesh__D046948 Alkaloids, Monoterpenoid Indole
% 211.25/211.45  |- skos__broader mesh__D046948smesh__D026121
% 211.25/211.45  |- mesh__dateCreated mesh__D046948 2004-07-07
% 211.25/211.45  |- mesh__recordMaintainer mesh__D046948 ssb
% 211.25/211.45  |- skos__hiddenLabel mesh__D046948 Indole Alkaloids, Terpenoid
% 211.25/211.45  |- skos__hiddenLabel mesh__D046948 Alkaloids, Rauvolfia
% 211.25/211.45  |- mesh__recordAuthorizer mesh__D046948 sjn
% 211.25/211.45  |- mesh__recordOriginator mesh__D046948 ssb
% 211.25/211.45  |- skos__historyNote mesh__D046948 Rauwolfia Alkaloids %28%1975-2004%29%
% 211.25/211.45  |- skos__altLabel mesh__D046948 Secologanin Indole Alkaloids
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D046948 2005
% 211.25/211.45  |- mesh__publicMeSHNote mesh__D046948
% 211.25/211.45       2005; for YOHIMBANS see YOHIMBANS 1969-2004; for RAUWOLFIA ALKALOIDS see RAUWOLFIA ALKALOIDS 1975-2004%A%  
% 211.25/211.45  |- skos__altLabel mesh__D046948 Rauvolfia Alkaloids
% 211.25/211.45  |- skos__hiddenLabel mesh__D046948 Alkaloids, Terpenoid Indole
% 211.25/211.45  |- skos__scopeNote mesh__D046948
% 211.25/211.45       Compounds formed by condensation of secologanin with tryptamine resulting in a tetrahydro-beta-carboline which is processed further to a number of bioactive compounds. These are especially found in plants of the APOCYNACEAE; LOGANIACEAE; and RUBIACEAE families.%A%    
% 211.25/211.45  |- skos__hiddenLabel mesh__D046948 Indole Alkaloids, Secologanin
% 211.25/211.45  |- mesh__historyNote mesh__D046948
% 211.25/211.45       2005; for YOHIMBANS use YOHIMBANS 1969-2004; for RAUWOLFIA ALKALOIDS use RAUWOLFIA ALKALOIDS 1975-2004%A%  
% 211.25/211.45  |- skos__hiddenLabel mesh__D046948 Alkaloids, Secologanin Indole
% 211.25/211.45  |- skos__altLabel mesh__D046948 Terpenoid Indole Alkaloids
% 211.25/211.45  |- rdf__type mesh__D018459sskos__Concept
% 211.25/211.45  |- mesh__dateRevised mesh__D018459 2005-07-01
% 211.25/211.45  |- mesh__dateCreated mesh__D018459 1994-04-16
% 211.25/211.45  |- skos__historyNote mesh__D018459 Skin Diseases %28%1966-1992%29%
% 211.25/211.45  |- mesh__dateEstablished mesh__D018459 1995-01-01
% 211.25/211.45  |- skos__historyNote mesh__D018459 Lichenoid Eruptions %28%1993-1994%29%
% 211.25/211.45  |- mesh__recordMaintainer mesh__D018459 sjn
% 211.25/211.45  |- mesh__recordOriginator mesh__D018459 TGC
% 211.25/211.45  |- skos__broader mesh__D018459smesh__D017512
% 211.25/211.45  |- skos__altLabel mesh__D018459 Lichen Sclerosus
% 211.25/211.45  |- skos__annotation mesh__D018459
% 211.25/211.45       a skin dis; do not confuse with lichen planus atrophicus %28%index under LICHEN PLANUS%29%; DF: note short X ref%A%  
% 211.25/211.45  |- mesh__publicMeSHNote mesh__D018459 95   
% 211.25/211.45  |- skos__prefLabel mesh__D018459 Lichen Sclerosus et Atrophicus
% 211.25/211.45  |- mesh__recordAuthorizer mesh__D018459 sjn
% 211.25/211.45  |- mesh__historyNote mesh__D018459 95   
% 211.25/211.45  |- skos__scopeNote mesh__D018459
% 211.25/211.45       A chronic, atrophic skin disease characterized by white, angular, flat, well-defined, indurated papules with an erythematous halo and follicular, black, keratotic plugs. It is the most common cause of VULVAR LICHEN SCLEROSUS in females and balanitis xerotica obliterans in males. It is called also white spot disease and Csillag%27%s disease. %28%Dorland, 27th ed%29%%A%    
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D018459 2006
% 211.25/211.45  |- mesh__recordMaintainer mesh__D010476 ssb
% 211.25/211.45  |- mesh__recordAuthorizer mesh__D010476 sjn
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D010476 2006
% 211.25/211.45  |- skos__annotation mesh__D010476
% 211.25/211.45       IM; coord with specific substance if pertinent %28%IM%29%; D25-26 qualif%A%  
% 211.25/211.45  |- skos__broader mesh__D010476smesh__D003358
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D010476 2005
% 211.25/211.45  |- mesh__dateCreated mesh__D010476 1999-01-01
% 211.25/211.45  |- rdf__type mesh__D010476sskos__Concept
% 211.25/211.45  |- skos__prefLabel mesh__D010476 Perfume
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D010476 2004
% 211.25/211.45  |- skos__scopeNote mesh__D010476
% 211.25/211.45       A substance, extract, or preparation for diffusing or imparting an agreeable or attractive smell, especially a fluid containing fragrant natural oils extracted from flowers, woods, etc., or similar synthetic oils. %28%Random House Unabridged Dictionary, 2d ed%29%%A%    
% 211.25/211.45  |- mesh__recordOriginator mesh__D010476 NLM
% 211.25/211.45  |- mesh__dateRevised mesh__D010476 2003-07-09
% 211.25/211.45  |- mesh__publicMeSHNote mesh__D029181 2002   
% 211.25/211.45  |- rdf__type mesh__D029181sskos__Concept
% 211.25/211.45  |- skos__scopeNote mesh__D029181
% 211.25/211.45       Sensitivity or attachment to religious values, or  to things of the spirit as opposed to material or worldly interests. %28%from Merriam-Webster%27%s Collegiate Dictionary, 10th ed, and Oxford English Dictionary, 2nd ed%29%%A%    
% 211.25/211.45  |- mesh__dateEstablished mesh__D029181 2002-01-01
% 211.25/211.45  |- mesh__dateCreated mesh__D029181 2001-07-25
% 211.25/211.45  |- mesh__historyNote mesh__D029181 2002   
% 211.25/211.45  |- skos__broader mesh__D029181smesh__D012069
% 211.25/211.45  |- skos__related mesh__D029181smesh__D026443
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D029181 2003
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D029181 2002
% 211.25/211.45  |- skos__hiddenLabel mesh__D029181 Spiritualities
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D029181 2005
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D029181 2004
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D029181 2006
% 211.25/211.45  |- skos__prefLabel mesh__D029181 Spirituality
% 211.25/211.45  |- mesh__dateEstablished mesh__D004439 1991-01-01
% 211.25/211.45  |- mesh__dateRevised mesh__D004439 2002-07-03
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D004439 2004
% 211.25/211.45  |- skos__hiddenLabel mesh__D004439 Gland, Eccrine
% 211.25/211.45  |- mesh__historyNote mesh__D004439
% 211.25/211.45       91%28%75%29%; was see under SWEAT GLANDS 1975-90   
% 211.25/211.45  |- mesh__dateCreated mesh__D004439 1999-01-01
% 211.25/211.45  |- mesh__recordOriginator mesh__D004439 NLM
% 211.25/211.45  |- skos__annotation mesh__D004439
% 211.25/211.45       /secret: see also SWEAT or SWEATING: TN 181   
% 211.25/211.45  |- skos__scopeNote mesh__D004439
% 211.25/211.45       Simple sweat glands that secrete sweat directly onto the SKIN.%A%    
% 211.25/211.45  |- mesh__recordAuthorizer mesh__D004439 sjn
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D004439 2003
% 211.25/211.45  |- mesh__recordMaintainer mesh__D004439 NNS
% 211.25/211.45  |- skos__hiddenLabel mesh__D004439 Glands, Eccrine
% 211.25/211.45  |- mesh__publicMeSHNote mesh__D004439
% 211.25/211.45       91; was see under SWEAT GLANDS 1975-90   
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D004439 2006
% 211.25/211.45  |- mesh__onlineNote mesh__D004439 search SWEAT GLANDS 1971-74   
% 211.25/211.45  |- rdf__type mesh__D004439sskos__Concept
% 211.25/211.45  |- skos__hiddenLabel mesh__D004439 Eccrine Gland
% 211.25/211.45  |- skos__prefLabel mesh__D004439 Eccrine Glands
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D004439 2005
% 211.25/211.45  |- skos__broader mesh__D004439smesh__D013545
% 211.25/211.45  |- mesh__publicMeSHNote mesh__D015161 1989   
% 211.25/211.45  |- skos__hiddenLabel mesh__D015161 Dementias, Multiinfarct
% 211.25/211.45  |- mesh__recordAuthorizer mesh__D015161 sjn
% 211.25/211.45  |- skos__hiddenLabel mesh__D015161 Multiinfarct Dementias
% 211.25/211.45  |- skos__hiddenLabel mesh__D015161 Multiinfarct Dementia
% 211.25/211.45  |- skos__hiddenLabel mesh__D015161 Multi-Infarct Dementias
% 211.25/211.45  |- skos__hiddenLabel mesh__D015161 Multi Infarct Dementia
% 211.25/211.45  |- rdf__type mesh__D015161sskos__Concept
% 211.25/211.45  |- mesh__dateCreated mesh__D015161 1988-04-06
% 211.25/211.45  |- skos__hiddenLabel mesh__D015161 Dementias, Multi-Infarct
% 211.25/211.45  |- skos__prefLabel mesh__D015161 Dementia, Multi-Infarct
% 211.25/211.45  |- mesh__historyNote mesh__D015161 1989   
% 211.25/211.45  |- skos__altLabel mesh__D015161 Dementia, Multiinfarct
% 211.25/211.45  |- mesh__dateEstablished mesh__D015161 1989-01-01
% 211.25/211.45  |- mesh__recordOriginator mesh__D015161 EC
% 211.25/211.45  |- skos__hiddenLabel mesh__D015161 Dementias, Lacunar
% 211.25/211.45  |- skos__hiddenLabel mesh__D015161 Dementia, Lacunar
% 211.25/211.45  |- skos__hiddenLabel mesh__D015161 Dementia, Multi Infarct
% 211.25/211.45  |- skos__hiddenLabel mesh__D015161 Lacunar Dementias
% 211.25/211.45  |- mesh__recordMaintainer mesh__D015161 ssb
% 211.25/211.45  |- skos__broader mesh__D015161smesh__D015140
% 211.25/211.45  |- skos__altLabel mesh__D015161 Multi-Infarct Dementia
% 211.25/211.45  |- skos__historyNote mesh__D015161 Dementia %28%1981-1988%29%
% 211.25/211.45  |- mesh__dateRevised mesh__D015161 2005-06-30
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D015161 2006
% 211.25/211.45  |- skos__broader mesh__D015161smesh__D002544
% 211.25/211.45  |- skos__scopeNote mesh__D015161
% 211.25/211.45       Loss of higher cortical functions with retained awareness due to multiple cortical or subcortical CEREBRAL INFARCTION. Memory, judgment, attention span, and impulse control are often impaired, and may be accompanied by PSEUDOBULBAR PALSY; HEMIPARESIS; reflex abnormalities, and other signs of localized neurologic dysfunction. %28%From Adams et al., Principles of Neurology, 6th ed, p1060%29%%A%    
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D009922 2005
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D009922 2002
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D009922 1998
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D009922 2006
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D009922 2003
% 211.25/211.45  |- mesh__recordAuthorizer mesh__D009922 SJN
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D009922 1999
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D009922 2004
% 211.25/211.45  |- skos__broader mesh__D009922smesh__D015205
% 211.25/211.45  |- mesh__recordMaintainer mesh__D009922 PXP
% 211.25/211.45  |- skos__broader mesh__D009922smesh__D019601
% 211.25/211.45  |- skos__prefLabel mesh__D009922 Oregon
% 211.25/211.45  |- rdf__type mesh__D009922sskos__Concept
% 211.25/211.45  |- mesh__recordOriginator mesh__D009922 NLM
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D009922 2000
% 211.25/211.45  |- mesh__dateCreated mesh__D009922 1999-01-01
% 211.25/211.45  |- mesh__dateRevised mesh__D009922 1997-06-20
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D009922 2001
% 211.25/211.45  |- skos__hiddenLabel mesh__D009124 Proteins, Muscle
% 211.25/211.45  |- mesh__activeMeSHYear mesh__D009124 2006
% 211.25/211.45  |- mesh__recordOriginator mesh__D009124 NLM
% 211.25/211.45  |- skos__altLabel mesh__D009124 Muscle Protein
% 211.25/211.45  |- skos__hiddenLabel mesh__D009124 Protein, Muscle
% 211.25/211.46  |- skos__scopeNote mesh__D009124
% 211.25/211.46       The protein constituents of muscle, the major ones being ACTINS and MYOSINS. More than a dozen accessory proteins exist including TROPONIN; TROPOMYOSIN; and DYSTROPHIN.%A%    
% 211.25/211.46  |- mesh__recordAuthorizer mesh__D009124 sjn
% 211.25/211.46  |- rdf__type mesh__D009124sskos__Concept
% 211.25/211.46  |- skos__broader mesh__D009124smesh__D003285
% 211.25/211.46  |- skos__annotation mesh__D009124
% 211.25/211.46       /biosyn /drug eff /physiol permitted; for contractile proteins in muscle, index only under MUSCLE PROTEINS or specifics %26% not also under CONTRACTILE PROTEINS%A%  
% 211.25/211.46  |- mesh__dateRevised mesh__D009124 2005-06-30
% 211.25/211.46  |- mesh__recordMaintainer mesh__D009124 SYSTEM
% 211.25/211.46  |- skos__prefLabel mesh__D009124 Muscle Proteins
% 211.25/211.46  |- mesh__dateCreated mesh__D009124 1999-01-01
% 211.25/211.46  |- skos__altLabel mesh__D001141 Estrogen Synthase
% 211.25/211.46  |- mesh__recordMaintainer mesh__D001141 ssb
% 211.25/211.46  |- rdf__type mesh__D001141sskos__Concept
% 211.25/211.46  |- skos__prefLabel mesh__D001141 Aromatase
% 211.25/211.46  |- mesh__historyNote mesh__D001141
% 211.25/211.46       86%28%75%29%; was see under OXIDOREDUCTASES 1975-85   
% 211.25/211.46  |- skos__altLabel mesh__D001141 CYP19
% 211.25/211.46  |- mesh__dateCreated mesh__D001141 1974-11-19
% 211.25/211.46  |- skos__altLabel mesh__D001141 Estrogen Synthetase
% 211.25/211.46  |- mesh__publicMeSHNote mesh__D001141
% 211.25/211.46       86; was see under OXIDOREDUCTASES 1975-85   
% 211.25/211.46  |- skos__altLabel mesh__D001141 Cytochrome P-450 CYP19
% 211.25/211.46  |- skos__altLabel mesh__D001141 Androstenedione Aromatase
% 211.25/211.46  |- skos__historyNote mesh__D001141 Estrogens %28%1972-1974%29%
% 211.25/211.46  |- skos__historyNote mesh__D001141 Androstanes %28%1972-1974%29%
% 211.25/211.46  |- skos__altLabel mesh__D001141 CYP19 Protein
% 211.25/211.46  |- skos__broader mesh__D001141smesh__D013250
% 211.25/211.46  |- skos__hiddenLabel mesh__D001141 Cytochrome P 450 CYP19
% 211.25/211.46  |- mesh__dateEstablished mesh__D001141 1986-01-01
% 211.25/211.46  |- skos__altLabel mesh__D001141 P450AROM
% 211.25/211.46  |- skos__hiddenLabel mesh__D001141 Aromatase, Androstenedione
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D001141 2006
% 211.25/211.46  |- mesh__recordOriginator mesh__D001141 NLM
% 211.25/211.46  |- skos__altLabel mesh__D001141 Cytochrome P450 19
% 211.25/211.46  |- mesh__recordAuthorizer mesh__D001141 sjn
% 211.25/211.46  |- skos__altLabel mesh__D001141 Cytochrome P-450%28%AROM%29%
% 211.25/211.46  |- skos__historyNote mesh__D001141 Oxidoreductases %28%1972-1974%29%
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D001141 2005
% 211.25/211.46  |- mesh__dateRevised mesh__D001141 2004-07-07
% 211.25/211.46  |- skos__scopeNote mesh__D001141
% 211.25/211.46       An enzyme that catalyzes the desaturation %28%aromatization%29% of the ring A of C19 androgens and converts them to C18 estrogens. In this process, the 19-methyl is removed. This enzyme is membrane-bound, located in the endoplasmic reticulum of estrogen-producing cells of ovaries, placenta, testes, adipose, and brain tissues. Aromatase is encoded by the CYP19 gene, and functions in complex with NADPH-FERRIHEMOPROTEIN REDUCTASE in the cytochrome P-450 system.%A%    
% 211.25/211.46  |- skos__altLabel mesh__D001141 CYP 19
% 211.25/211.46  |- skos__hiddenLabel mesh__D001141 Protein, CYP19
% 211.25/211.46  |- skos__hiddenLabel mesh__D014867 Hydrogen Oxides
% 211.25/211.46  |- mesh__dateRevised mesh__D014867 1995-06-09
% 211.25/211.46  |- skos__hiddenLabel mesh__D014867 Oxides, Hydrogen
% 211.25/211.46  |- skos__prefLabel mesh__D014867 Water
% 211.25/211.46  |- skos__scopeNote mesh__D014867
% 211.25/211.46       Water. A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014867 2003
% 211.25/211.46  |- skos__annotation mesh__D014867
% 211.25/211.46       note category: D1 as H2O, G3 as environmental; in body or tissue = BODY WATER; /admin: consider also FLUID THERAPY or INFUSIONS, PARENTERAL or REHYDRATION SOLUTIONS; /adv eff: consider also WATER INTOXICATION; /metab must refer to metab of exogenous water: for water content of organs %26% tissue use BODY WATER /metab or BODY WATER /chem; /stand: consider also WATER SUPPLY; /ther use: try HYDROTHERAPY %26% related terms; /microbiol = WATER MICROBIOLOGY %28%IM%29% + specific microbe %28%IM%29%, /parasitol permitted: coord IM with specific parasite %28%IM%29%, /virol = WATER MICROBIOLOGY %28%IM%29% + specific virus %28%IM%29%; atmospheric water = HUMIDITY; heavy water = DEUTERIUM OXIDE; water intake = DRINKING; hardness or softness of water: probably WATER /chem %26% not also HARDNESS but consider also WATER SOFTENING; water consumption = WATER or WATER SUPPLY if on a wide scale: on a personal level = DRINKING%A%  
% 211.25/211.46  |- rdf__type mesh__D014867sskos__Concept
% 211.25/211.46  |- skos__broader mesh__D014867smesh__D004777
% 211.25/211.46  |- skos__related mesh__D014867smesh__D012623
% 211.25/211.46  |- skos__hiddenLabel mesh__D014867 Oxide, Hydrogen
% 211.25/211.46  |- mesh__recordAuthorizer mesh__D014867 PLS
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014867 1999
% 211.25/211.46  |- skos__related mesh__D014867smesh__D008900
% 211.25/211.46  |- mesh__recordMaintainer mesh__D014867 PLS
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014867 1998
% 211.25/211.46  |- mesh__recordOriginator mesh__D014867 NLM
% 211.25/211.46  |- skos__altLabel mesh__D014867 Hydrogen Oxide
% 211.25/211.46  |- skos__related mesh__D014867smesh__D005618
% 211.25/211.46  |- skos__broader mesh__D014867smesh__D010087
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014867 1997
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014867 2006
% 211.25/211.46  |- skos__related mesh__D014867smesh__D001834
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014867 2002
% 211.25/211.46  |- skos__hiddenLabel mesh__D014867 Waters
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014867 1996
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014867 2005
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014867 2001
% 211.25/211.46  |- mesh__dateCreated mesh__D014867 1999-01-01
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014867 2004
% 211.25/211.46  |- skos__broader mesh__D014867smesh__D006878
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014867 2000
% 211.25/211.46  |- mesh__dateCreated mesh__D014069 1999-01-01
% 211.25/211.46  |- rdf__type mesh__D014069sskos__Concept
% 211.25/211.46  |- skos__scopeNote mesh__D014069
% 211.25/211.46       Inflammation of the tonsils, especially the palatine tonsils. It is often caused by a bacterium. Tonsillitis may be acute, chronic, or recurrent.%A%    
% 211.25/211.46  |- mesh__recordMaintainer mesh__D014069 TGC
% 211.25/211.46  |- skos__broader mesh__D014069smesh__D010608
% 211.25/211.46  |- skos__hiddenLabel mesh__D014069 Tonsillitides
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014069 1994
% 211.25/211.46  |- mesh__recordOriginator mesh__D014069 NLM
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014069 2005
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014069 1995
% 211.25/211.46  |- skos__annotation mesh__D014069
% 211.25/211.46       coord IM with infection %28%IM%29% if specified; lingual tonsillitis: coord IM with TONGUE %28%NIM%29%%A%  
% 211.25/211.46  |- skos__broader mesh__D014069smesh__D012141
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014069 2000
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014069 1993
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014069 2006
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014069 1998
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014069 2003
% 211.25/211.46  |- mesh__dateRevised mesh__D014069 1992-05-22
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014069 2001
% 211.25/211.46  |- skos__prefLabel mesh__D014069 Tonsillitis
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014069 2004
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014069 1999
% 211.25/211.46  |- mesh__recordAuthorizer mesh__D014069 PLS
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014069 1996
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014069 2002
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014069 1997
% 211.25/211.46  |- skos__prefLabel mesh__D000847 Annual Reports
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D000847 2006
% 211.25/211.46  |- mesh__recordAuthorizer mesh__D000847 sjn
% 211.25/211.46  |- skos__broader mesh__D000847smesh__D009934
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D000847 2003
% 211.25/211.46  |- mesh__publicMeSHNote mesh__D000847
% 211.25/211.46       91; was see under ORGANIZATION AND ADMINISTRATION 1977-90%A%  
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D000847 2005
% 211.25/211.46  |- skos__annotation mesh__D000847
% 211.25/211.46       NIM; no qualif; coord with specific organiz or society %28%IM%29% + geog; do not confuse with Publication Type ANNUAL REPORTS%A%  
% 211.25/211.46  |- mesh__dateEstablished mesh__D000847 1991-01-01
% 211.25/211.46  |- skos__hiddenLabel mesh__D000847 Reports, Annual
% 211.25/211.46  |- skos__scopeNote mesh__D000847
% 211.25/211.46       Annual statements reviewing the status of  the administrative and operational functions and accomplishments of an institution or organization.%A%    
% 211.25/211.46  |- mesh__dateCreated mesh__D000847 1977-05-05
% 211.25/211.46  |- mesh__historyNote mesh__D000847
% 211.25/211.46       91%28%Aug 77%29%; was see under ORGANIZATION AND ADMINISTRATION 1977-90%A%  
% 211.25/211.46  |- skos__hiddenLabel mesh__D000847 Report, Annual
% 211.25/211.46  |- mesh__dateRevised mesh__D000847 2002-07-24
% 211.25/211.46  |- mesh__recordMaintainer mesh__D000847 sjn
% 211.25/211.46  |- mesh__recordOriginator mesh__D000847 EC
% 211.25/211.46  |- skos__hiddenLabel mesh__D000847 Annual Report
% 211.25/211.46  |- rdf__type mesh__D000847sskos__Concept
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D000847 2004
% 211.25/211.46  |- mesh__publicMeSHNote mesh__D019552 97   
% 211.25/211.46  |- rdf__type mesh__D019552sskos__Concept
% 211.25/211.46  |- skos__hiddenLabel mesh__D019552 Infection Controls, Dental
% 211.25/211.46  |- skos__altLabel mesh__D019552 Dental Infection Control
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D019552 2005
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D019552 1999
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D019552 2001
% 211.25/211.46  |- skos__annotation mesh__D019552
% 211.25/211.46       prev of infect in dent health facilities, not prev of tooth infect in mouth; DF: INFECT CONTROL DENT%A%  
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D019552 2004
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D019552 2000
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D019552 1998
% 211.25/211.46  |- skos__scopeNote mesh__D019552
% 211.25/211.46       Efforts to prevent and control the spread of infections within dental health facilities or those involving provision of dental care.%A%    
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D019552 2003
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D019552 1997
% 211.25/211.46  |- skos__broader mesh__D019552smesh__D017053
% 211.25/211.46  |- skos__prefLabel mesh__D019552 Infection Control, Dental
% 211.25/211.46  |- skos__hiddenLabel mesh__D019552 Dental Infection Controls
% 211.25/211.46  |- skos__broader mesh__D019552smesh__D003813
% 211.25/211.46  |- skos__hiddenLabel mesh__D019552 Control, Dental Infection
% 211.25/211.46  |- skos__historyNote mesh__D019552 Infection Control %28%1990-1996%29%
% 211.25/211.46  |- mesh__dateCreated mesh__D019552 1996-06-13
% 211.25/211.46  |- mesh__dateEstablished mesh__D019552 1997-01-01
% 211.25/211.46  |- mesh__historyNote mesh__D019552 97   
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D019552 2006
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D019552 2002
% 211.25/211.46  |- skos__hiddenLabel mesh__D019552 Controls, Dental Infection
% 211.25/211.46  |- mesh__dateEstablished mesh__D000049 1974-01-01
% 211.25/211.46  |- mesh__recordMaintainer mesh__D000049 ags
% 211.25/211.46  |- skos__broader mesh__D000049smesh__D006376
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D000049 2006
% 211.25/211.46  |- mesh__dateRevised mesh__D000049 2003-07-09
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D000049 2005
% 211.25/211.46  |- mesh__historyNote mesh__D000049 74; was see under HELMINTHS 1963-73   
% 211.25/211.46  |- rdf__type mesh__D000049sskos__Concept
% 211.25/211.46  |- mesh__recordAuthorizer mesh__D000049 sjn
% 211.25/211.46  |- mesh__onlineNote mesh__D000049 search HELMINTHS 1966-73   
% 211.25/211.46  |- skos__annotation mesh__D000049
% 211.25/211.46       infection: coord IM with HELMINTHIASIS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 211.25/211.46  |- skos__altLabel mesh__D000049 Thorny-Headed Worms
% 211.25/211.46  |- mesh__recordOriginator mesh__D000049 NLM
% 211.25/211.46  |- skos__scopeNote mesh__D000049
% 211.25/211.46       A phylum of parasitic worms, closely related to tapeworms and containing two genera: Moniliformis, which sometimes infects man, and Macracanthorhynchus, which infects swine.%A%    
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D000049 2004
% 211.25/211.46  |- mesh__publicMeSHNote mesh__D000049
% 211.25/211.46       74; was see under HELMINTHS 1963-73   
% 211.25/211.46  |- mesh__dateCreated mesh__D000049 1999-01-01
% 211.25/211.46  |- skos__prefLabel mesh__D000049 Acanthocephala
% 211.25/211.46  |- skos__prefLabel mesh__D005532 Foot Deformities, Congenital
% 211.25/211.46  |- rdf__type mesh__D005532sskos__Concept
% 211.25/211.46  |- mesh__dateEstablished mesh__D005532 1988-01-01
% 211.25/211.46  |- skos__annotation mesh__D005532
% 211.25/211.46       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D005532 2004
% 211.25/211.46  |- skos__altLabel mesh__D005532 Deformity, Congenital Foot
% 211.25/211.46  |- mesh__recordAuthorizer mesh__D005532 sjn
% 211.25/211.46  |- skos__altLabel mesh__D005532 Foot Deformity, Congenital
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D005532 2006
% 211.25/211.46  |- mesh__recordOriginator mesh__D005532 EC
% 211.25/211.46  |- skos__altLabel mesh__D005532 Congenital Foot Deformity
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D005532 2003
% 211.25/211.46  |- skos__altLabel mesh__D005532 Deformities, Congenital Foot
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D005532 2005
% 211.25/211.46  |- skos__altLabel mesh__D005532 Congenital Foot Deformities
% 211.25/211.46  |- skos__broader mesh__D005532smesh__D017880
% 211.25/211.46  |- mesh__dateRevised mesh__D005532 2002-07-03
% 211.25/211.46  |- skos__scopeNote mesh__D005532
% 211.25/211.46       Alterations or deviations from normal shape or size which result in a disfigurement of the foot occurring at or before birth.%A%    
% 211.25/211.46  |- mesh__publicMeSHNote mesh__D005532 88   
% 211.25/211.46  |- mesh__recordMaintainer mesh__D005532 kle
% 211.25/211.46  |- mesh__dateCreated mesh__D005532 1987-04-02
% 211.25/211.46  |- mesh__historyNote mesh__D005532 88   
% 211.25/211.46  |- skos__broader mesh__D005532smesh__D005530
% 211.25/211.46  |- skos__broader mesh__D005532smesh__D038061
% 211.25/211.46  |- mesh__historyNote mesh__D046949 2005   
% 211.25/211.46  |- skos__prefLabel mesh__D046949 Thermotoga neapolitana
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D046949 2006
% 211.25/211.46  |- mesh__dateCreated mesh__D046949 2004-07-07
% 211.25/211.46  |- mesh__publicMeSHNote mesh__D046949 2005   
% 211.25/211.46  |- mesh__dateEstablished mesh__D046949 2005-01-01
% 211.25/211.46  |- skos__historyNote mesh__D046949
% 211.25/211.46       Gram-Negative Anaerobic Straight, Curved, and Helical Rods %28%1998-2004%29%
% 211.25/211.46  |- skos__broader mesh__D046949smesh__D016965
% 211.25/211.46  |- mesh__recordOriginator mesh__D046949 ags
% 211.25/211.46  |- mesh__recordAuthorizer mesh__D046949 sjn
% 211.25/211.46  |- skos__historyNote mesh__D046949
% 211.25/211.46       Gram-Negative Anaerobic Bacteria %28%1993-1998%29%
% 211.25/211.46  |- mesh__dateRevised mesh__D046949 2005-06-30
% 211.25/211.46  |- mesh__recordMaintainer mesh__D046949 SYSTEM
% 211.25/211.46  |- skos__scopeNote mesh__D046949
% 211.25/211.46       A species of extremophilic bacteria in the family Thermotogaceae. Generally anaerobic but in the presence of OXYGEN, it can produce hydrogen gas as a byproduct of metabolism.%A%    
% 211.25/211.46  |- rdf__type mesh__D046949sskos__Concept
% 211.25/211.46  |- mesh__recordOriginator mesh__D010477 NLM
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D010477 1993
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D010477 1998
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D010477 2006
% 211.25/211.46  |- skos__prefLabel mesh__D010477 Perfusion
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D010477 1997
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D010477 2005
% 211.25/211.46  |- mesh__recordMaintainer mesh__D010477 TAP
% 211.25/211.46  |- skos__annotation mesh__D010477
% 211.25/211.46       note category; a technique: not for perfusion of blood through a vessel %28% = a circulation concept%29%; REPERFUSION is available for restoration of blood supply to tissue %26% MYOCARDIAL REPERFUSION for heart%A%  
% 211.25/211.46  |- mesh__dateCreated mesh__D010477 1999-01-01
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D010477 2002
% 211.25/211.46  |- rdf__type mesh__D010477sskos__Concept
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D010477 1996
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D010477 2004
% 211.25/211.46  |- skos__broader mesh__D010477smesh__D008919
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D010477 2001
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D010477 2003
% 211.25/211.46  |- mesh__recordAuthorizer mesh__D010477 PLS
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D010477 2000
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D010477 1995
% 211.25/211.46  |- skos__hiddenLabel mesh__D010477 Perfusions
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D010477 1999
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D010477 1994
% 211.25/211.46  |- mesh__dateRevised mesh__D010477 1992-05-15
% 211.25/211.46  |- skos__altLabel mesh__D015162 Micronucleus Assays
% 211.25/211.46  |- mesh__dateRevised mesh__D015162 2004-07-07
% 211.25/211.46  |- mesh__recordMaintainer mesh__D015162 nns
% 211.25/211.46  |- skos__historyNote mesh__D015162 Cell Nucleus %28%1971-1988%29%
% 211.25/211.46  |- skos__annotation mesh__D015162 NIM   
% 211.25/211.46  |- skos__hiddenLabel mesh__D015162 Micronucleus Assay
% 211.25/211.46  |- rdf__type mesh__D015162sskos__Concept
% 211.25/211.46  |- skos__hiddenLabel mesh__D015162 Assays, Micronucleus
% 211.25/211.46  |- skos__hiddenLabel mesh__D015162 Micronucleus Test
% 211.25/211.46  |- mesh__publicMeSHNote mesh__D015162 89   
% 211.25/211.46  |- skos__prefLabel mesh__D015162 Micronucleus Tests
% 211.25/211.46  |- mesh__dateEstablished mesh__D015162 1989-01-01
% 211.25/211.46  |- mesh__dateCreated mesh__D015162 1988-04-06
% 211.25/211.46  |- mesh__recordAuthorizer mesh__D015162 sjn
% 211.25/211.46  |- mesh__recordOriginator mesh__D015162 SCD
% 211.25/211.46  |- skos__hiddenLabel mesh__D015162 Tests, Micronucleus
% 211.25/211.46  |- mesh__historyNote mesh__D015162 89   
% 211.25/211.46  |- skos__historyNote mesh__D015162 Mutagenicity Tests %28%1981-1988%29%
% 211.25/211.46  |- skos__historyNote mesh__D015162 Genetic Techniques %28%1972-1980%29%
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D015162 2005
% 211.25/211.46  |- skos__related mesh__D015162smesh__D048629
% 211.25/211.46  |- skos__broader mesh__D015162smesh__D009152
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D015162 2006
% 211.25/211.46  |- skos__scopeNote mesh__D015162
% 211.25/211.46       Induction and quantitative measurement of chromosomal damage leading to the formation of micronuclei %28%MICRONUCLEI, CHROMOSOME-DEFECTIVE%29% in cells which have been exposed to genotoxic agents or IONIZING RADIATION.%A%    
% 211.25/211.46  |- skos__hiddenLabel mesh__D015162 Assay, Micronucleus
% 211.25/211.46  |- skos__hiddenLabel mesh__D015162 Test, Micronucleus
% 211.25/211.46  |- mesh__dateCreated mesh__D009923 1974-12-12
% 211.25/211.46  |- skos__altLabel mesh__D009923 Sheep Contagious Pustular Dermatitis Virus
% 211.25/211.46  |- skos__altLabel mesh__D009923 Contagious Ecthyma Virus of Sheep
% 211.25/211.46  |- skos__hiddenLabel mesh__D009923 ecthyma viruses, Contagious
% 211.25/211.46  |- mesh__recordOriginator mesh__D009923 NLM
% 211.25/211.46  |- skos__hiddenLabel mesh__D009923 viruses, Contagious ecthyma
% 211.25/211.46  |- skos__hiddenLabel mesh__D009923 Viruses, Ecthyma contagiosum
% 211.25/211.46  |- skos__prefLabel mesh__D009923 Orf virus
% 211.25/211.46  |- skos__broader mesh__D009923smesh__D018157
% 211.25/211.46  |- mesh__publicMeSHNote mesh__D009923
% 211.25/211.46       91; was see under POXVIRIDAE 1981-90; was see under POXVIRUSES 1975-80%A%  
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D009923 2004
% 211.25/211.46  |- mesh__dateRevised mesh__D009923 2001-07-25
% 211.25/211.46  |- skos__hiddenLabel mesh__D009923 virus, Contagious ecthyma
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D009923 2006
% 211.25/211.46  |- skos__annotation mesh__D009923
% 211.25/211.46       infection = ECTHYMA, CONTAGIOUS but see note there   
% 211.25/211.46  |- mesh__dateEstablished mesh__D009923 1991-01-01
% 211.25/211.46  |- skos__hiddenLabel mesh__D009923 Virus, Ecthyma contagiosum
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D009923 2003
% 211.25/211.46  |- skos__hiddenLabel mesh__D009923 virus, Orf
% 211.25/211.46  |- skos__altLabel mesh__D009923 Sheep Contagious Ecthyma Virus
% 211.25/211.46  |- mesh__historyNote mesh__D009923
% 211.25/211.46       91%28%75%29%; was see under POXVIRIDAE 1981-90; was see under POXVIRUSES 1975-80%A%  
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D009923 2005
% 211.25/211.46  |- mesh__recordAuthorizer mesh__D009923 sjn
% 211.25/211.46  |- skos__hiddenLabel mesh__D009923 ecthyma virus, Contagious
% 211.25/211.46  |- skos__hiddenLabel mesh__D009923 Orf viruses
% 211.25/211.46  |- skos__altLabel mesh__D009923 Ecthyma contagiosum Virus
% 211.25/211.46  |- skos__altLabel mesh__D009923
% 211.25/211.46       Contagious Pustular Dermatitis Virus of Sheep
% 211.25/211.46  |- rdf__type mesh__D009923sskos__Concept
% 211.25/211.46  |- skos__altLabel mesh__D009923 Contagious ecthyma virus
% 211.25/211.46  |- skos__hiddenLabel mesh__D009923 viruses, Orf
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D009923 2002
% 211.25/211.46  |- skos__altLabel mesh__D009923 Contagious pustular dermatitis virus
% 211.25/211.46  |- mesh__recordMaintainer mesh__D009923 ags
% 211.25/211.46  |- skos__hiddenLabel mesh__D009923 Contagious ecthyma viruses
% 211.25/211.46  |- skos__hiddenLabel mesh__D009923 Ecthyma contagiosum Viruses
% 211.25/211.46  |- skos__scopeNote mesh__D009923
% 211.25/211.46       The type species of PARAPOXVIRUS which causes a skin infection in natural hosts, usually young sheep. Humans may contract local skin lesions by contact. The virus apparently persists in soil.%A%    
% 211.25/211.46  |- mesh__considerAlso mesh__D001940
% 211.25/211.46       consider also terms at MAMMA- and MAST-   
% 211.25/211.46  |- skos__hiddenLabel mesh__D001940 Breasts
% 211.25/211.46  |- mesh__recordMaintainer mesh__D001940 lkt
% 211.25/211.46  |- skos__related mesh__D001940smesh__D008321
% 211.25/211.46  |- rdf__type mesh__D001940sskos__Concept
% 211.25/211.46  |- skos__scopeNote mesh__D001940
% 211.25/211.46       In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.%A%    
% 211.25/211.46  |- skos__related mesh__D001940smesh__D016462
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D001940 2006
% 211.25/211.46  |- skos__related mesh__D001940smesh__D008327
% 211.25/211.46  |- mesh__recordAuthorizer mesh__D001940 sjn
% 211.25/211.46  |- mesh__dateRevised mesh__D001940 2003-07-09
% 211.25/211.46  |- skos__broader mesh__D001940smesh__D001829
% 211.25/211.46  |- skos__prefLabel mesh__D001940 Breast
% 211.25/211.46  |- skos__annotation mesh__D001940
% 211.25/211.46       human only; animal is MAMMARY GLANDS, ANIMAL; /surg: consider also MASTECTOMY %26% MAMMAPLASTY; inflammation = MASTITIS; tuberc of breast = MASTITIS %28%IM%29% + TUBERCULOSIS %28%IM%29%, not TUBERCULOSIS, ENDOCRINE; self-examination = BREAST SELF-EXAMINATION%A%  
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D001940 2004
% 211.25/211.46  |- mesh__recordOriginator mesh__D001940 NLM
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D001940 2005
% 211.25/211.46  |- skos__related mesh__D001940smesh__D008408
% 211.25/211.46  |- skos__related mesh__D001940smesh__D007774
% 211.25/211.46  |- mesh__dateCreated mesh__D001940 1999-01-01
% 211.25/211.46  |- mesh__recordMaintainer mesh__D009125 ssb
% 211.25/211.46  |- skos__prefLabel mesh__D009125 Muscle Relaxants, Central
% 211.25/211.46  |- mesh__dateRevised mesh__D009125 2005-06-30
% 211.25/211.46  |- rdf__type mesh__D009125sskos__Concept
% 211.25/211.46  |- skos__altLabel mesh__D009125 Centrally Acting Muscle Relaxants
% 211.25/211.46  |- skos__scopeNote mesh__D009125
% 211.25/211.46       A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in multiple sclerosis. %28%From Smith and Reynard, Textbook of Pharmacology, 1991, p358%29%%A%    
% 211.25/211.46  |- skos__annotation mesh__D009125
% 211.25/211.46       GEN or unspecified; prefer specifics; refers to skeletal muscle relaxants only: smooth muscle relaxants = PARASYMPATHOLYTICS%A%  
% 211.25/211.46  |- mesh__dateCreated mesh__D009125 1999-01-01
% 211.25/211.46  |- skos__broader mesh__D009125smesh__D002491
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D009125 2006
% 211.25/211.46  |- mesh__onlineNote mesh__D009125
% 211.25/211.46       search MUSCLE RELAXANTS under CURARE-LIKE AGENTS %26% MUSCLE RELAXANTS, CENTRAL %26% NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74 %26% MUSCLES 1966-69%A%  
% 211.25/211.46  |- mesh__historyNote mesh__D009125
% 211.25/211.46       70; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS %26% MUSCLE RELAXANTS, CENTRAL %26% NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69%A%  
% 211.25/211.46  |- skos__hiddenLabel mesh__D009125 Relaxants, Central Muscle
% 211.25/211.46  |- mesh__recordOriginator mesh__D009125 NLM
% 211.25/211.46  |- skos__hiddenLabel mesh__D009125 Central Muscle Relaxants
% 211.25/211.46  |- skos__historyNote mesh__D009125 Muscles %28%1966-1969%29%
% 211.25/211.46  |- mesh__dateEstablished mesh__D009125 1970-01-01
% 211.25/211.46  |- mesh__publicMeSHNote mesh__D009125
% 211.25/211.46       70; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS %26% MUSCLE RELAXANTS, CENTRAL %26% NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69%A%  
% 211.25/211.46  |- skos__broader mesh__D009125smesh__D045505
% 211.25/211.46  |- skos__broader mesh__D009125smesh__D009465
% 211.25/211.46  |- mesh__recordAuthorizer mesh__D009125 sjn
% 211.25/211.46  |- mesh__recordAuthorizer mesh__D001142 sjn
% 211.25/211.46  |- skos__altLabel mesh__D001142 5-HTPase
% 211.25/211.46  |- mesh__recordMaintainer mesh__D001142 ssb
% 211.25/211.46  |- mesh__dateCreated mesh__D001142 1979-02-21
% 211.25/211.46  |- skos__hiddenLabel mesh__D001142 Aromatic L Amino Acid Decarboxylases
% 211.25/211.46  |- skos__altLabel mesh__D001142 Hydroxytryptophan Decarboxylase
% 211.25/211.46  |- mesh__recordOriginator mesh__D001142 RLS
% 211.25/211.46  |- skos__altLabel mesh__D001142 Amino Acid Decarboxylases, Aromatic
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D001142 2004
% 211.25/211.46  |- skos__altLabel mesh__D001142 Aromatic Amino Acid Decarboxylases
% 211.25/211.46  |- skos__altLabel mesh__D001142 5-Hydroxytryptophan Decarboxylase
% 211.25/211.46  |- skos__hiddenLabel mesh__D001142 Decarboxylase, Tryptophan
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D001142 2006
% 211.25/211.46  |- mesh__publicMeSHNote mesh__D001142
% 211.25/211.46       98; see AROMATIC AMINO ACID DECARBOXYLASES 1980-97   
% 211.25/211.46  |- mesh__historyNote mesh__D001142 98%28%80%29%   
% 211.25/211.46  |- skos__hiddenLabel mesh__D001142 Decarboxylase, 5-Hydroxytryptophan
% 211.25/211.46  |- skos__altLabel mesh__D001142 Tryptophan Decarboxylase
% 211.25/211.46  |- skos__hiddenLabel mesh__D001142 Decarboxylases, Aromatic-L-Amino-Acid
% 211.25/211.46  |- skos__historyNote mesh__D001142 Dopa Decarboxylase %28%1966-1979%29%
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D001142 2005
% 211.25/211.46  |- skos__hiddenLabel mesh__D001142 5 Hydroxytryptophan Decarboxylase
% 211.25/211.46  |- skos__scopeNote mesh__D001142
% 211.25/211.46       An enzyme group with broad specificity. The enzymes decarboxylate a range of aromatic amino acids including dihydroxyphenylalanine %28%DOPA DECARBOXYLASE%29%, tryptophan, and hydroxytryptophan. EC 4.1.1.28.%A%    
% 211.25/211.46  |- rdf__type mesh__D001142sskos__Concept
% 211.25/211.46  |- skos__broader mesh__D001142smesh__D002262
% 211.25/211.46  |- skos__annotation mesh__D001142 DF: AAAD   
% 211.25/211.46  |- skos__prefLabel mesh__D001142 Aromatic-L-Amino-Acid Decarboxylases
% 211.25/211.46  |- skos__hiddenLabel mesh__D001142 Decarboxylase, Hydroxytryptophan
% 211.25/211.46  |- skos__hiddenLabel mesh__D001142 5 HTPase
% 211.25/211.46  |- mesh__dateEstablished mesh__D001142 1980-01-01
% 211.25/211.46  |- mesh__dateRevised mesh__D001142 2003-07-09
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014868 1993
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014868 2002
% 211.25/211.46  |- skos__historyNote mesh__D014868 Motivation %28%1966-1968%29%
% 211.25/211.46  |- skos__annotation mesh__D014868
% 211.25/211.46       human %26% animal; /physiol permitted for physiol %26% metab eff%A%  
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014868 1997
% 211.25/211.46  |- skos__hiddenLabel mesh__D014868 Water Deprivations
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014868 1992
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014868 2006
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014868 2001
% 211.25/211.46  |- mesh__dateEstablished mesh__D014868 1969-01-01
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014868 1996
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014868 2005
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014868 2000
% 211.25/211.46  |- mesh__recordMaintainer mesh__D014868 TGC
% 211.25/211.46  |- skos__broader mesh__D014868smesh__D009042
% 211.25/211.46  |- mesh__dateRevised mesh__D014868 1991-06-20
% 211.25/211.46  |- mesh__dateCreated mesh__D014868 1999-01-01
% 211.25/211.46  |- skos__scopeNote mesh__D014868
% 211.25/211.46       The withholding of water in a structured experimental situation.%A%    
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014868 2004
% 211.25/211.46  |- mesh__recordAuthorizer mesh__D014868 PLS
% 211.25/211.46  |- skos__prefLabel mesh__D014868 Water Deprivation
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014868 2003
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014868 1995
% 211.25/211.46  |- rdf__type mesh__D014868sskos__Concept
% 211.25/211.46  |- skos__related mesh__D014868smesh__D013894
% 211.25/211.46  |- skos__hiddenLabel mesh__D014868 Deprivations, Water
% 211.25/211.46  |- mesh__recordOriginator mesh__D014868 NLM
% 211.25/211.46  |- skos__hiddenLabel mesh__D014868 Deprivation, Water
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014868 1999
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014868 1994
% 211.25/211.46  |- skos__historyNote mesh__D014868 Thirst %28%1966-1968%29%
% 211.25/211.46  |- mesh__historyNote mesh__D014868 69   
% 211.25/211.46  |- mesh__publicMeSHNote mesh__D014868 69   
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D014868 1998
% 211.25/211.46  |- skos__hiddenLabel mesh__D019553 Endodontically-Treated Teeth
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D019553 2004
% 211.25/211.46  |- mesh__dateEstablished mesh__D019553 1997-01-01
% 211.25/211.46  |- skos__hiddenLabel mesh__D019553 Pulpless Tooth
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D019553 1998
% 211.25/211.46  |- mesh__activeMeSHYear mesh__D019553 2002
% 211.25/211.47  |- skos__altLabel mesh__D019553 Teeth, Pulpless
% 211.25/211.47  |- mesh__publicMeSHNote mesh__D019553 97   
% 211.25/211.47  |- mesh__recordMaintainer mesh__D019553 JLS
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D019553 2003
% 211.25/211.47  |- skos__hiddenLabel mesh__D019553 Tooth, Endodontically Treated
% 211.25/211.47  |- mesh__dateRevised mesh__D019553 1997-06-20
% 211.25/211.47  |- skos__scopeNote mesh__D019553
% 211.25/211.47       A tooth from which the dental pulp has been removed or is necrotic. %28%Boucher, Clinical Dental Terminology, 4th ed%29%%A%    
% 211.25/211.47  |- skos__hiddenLabel mesh__D019553 Teeth, Endodontically Treated
% 211.25/211.47  |- skos__hiddenLabel mesh__D019553 Devitalized Tooth
% 211.25/211.47  |- skos__altLabel mesh__D019553 Tooth, Pulpless
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D019553 2001
% 211.25/211.47  |- skos__altLabel mesh__D019553 Tooth, Devitalized
% 211.25/211.47  |- skos__hiddenLabel mesh__D019553 Nonvital Teeth
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D019553 2000
% 211.25/211.47  |- mesh__recordOriginator mesh__D019553 JLS
% 211.25/211.47  |- skos__broader mesh__D019553smesh__D003788
% 211.25/211.47  |- skos__hiddenLabel mesh__D019553 Nonvital Tooth
% 211.25/211.47  |- mesh__historyNote mesh__D019553 97   
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D019553 2006
% 211.25/211.47  |- skos__hiddenLabel mesh__D019553 Devitalized Teeth
% 211.25/211.47  |- skos__altLabel mesh__D019553 Tooth, Endodontically-Treated
% 211.25/211.47  |- rdf__type mesh__D019553sskos__Concept
% 211.25/211.47  |- skos__hiddenLabel mesh__D019553 Pulpless Teeth
% 211.25/211.47  |- skos__hiddenLabel mesh__D019553 Endodontically-Treated Tooth
% 211.25/211.47  |- skos__altLabel mesh__D019553 Teeth, Nonvital
% 211.25/211.47  |- mesh__dateCreated mesh__D019553 1996-06-10
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D019553 2005
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D019553 1999
% 211.25/211.47  |- skos__annotation mesh__D019553 a devitalized tooth: note X ref   
% 211.25/211.47  |- mesh__recordAuthorizer mesh__D019553 SJN
% 211.25/211.47  |- skos__prefLabel mesh__D019553 Tooth, Nonvital
% 211.25/211.47  |- skos__altLabel mesh__D019553 Teeth, Devitalized
% 211.25/211.47  |- mesh__historyNote mesh__D000848 65   
% 211.25/211.47  |- mesh__dateRevised mesh__D000848 1999-11-03
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D000848 2005
% 211.25/211.47  |- mesh__recordOriginator mesh__D000848 NLM
% 211.25/211.47  |- skos__prefLabel mesh__D000848 Anodontia
% 211.25/211.47  |- mesh__recordAuthorizer mesh__D000848 sjn
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D000848 2002
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D000848 2001
% 211.25/211.47  |- mesh__dateEstablished mesh__D000848 1965-01-01
% 211.25/211.47  |- mesh__recordMaintainer mesh__D000848 kle
% 211.25/211.47  |- rdf__type mesh__D000848sskos__Concept
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D000848 2004
% 211.25/211.47  |- skos__broader mesh__D000848smesh__D014071
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D000848 2000
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D000848 2006
% 211.25/211.47  |- skos__scopeNote mesh__D000848
% 211.25/211.47       Congenital absence of the teeth; it may involve all %28%total anodontia%29% or only some of the teeth %28%partial anodontia, hypodontia%29%, and both the deciduous and the permanent dentition, or only teeth of the permanent dentition. %28%Dorland, 27th ed%29%%A%    
% 211.25/211.47  |- mesh__dateCreated mesh__D000848 1999-01-01
% 211.25/211.47  |- skos__annotation mesh__D000848
% 211.25/211.47       congen absence of teeth; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; congen absence of one or more teeth: do not confuse with JAW, EDENTULOUS %28%total lack of teeth in either jaw through disease or extraction%29%, JAW, EDENTULOUS, PARTIALLY %28%partial lack in either jaw%29% or MOUTH, EDENTULOUS %28%total lack of teeth in both jaws through disease or extraction%29%%A%  
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D000848 2003
% 211.25/211.47  |- mesh__publicMeSHNote mesh__D000848 65   
% 211.25/211.47  |- skos__hiddenLabel mesh__D011570 Psychiatrist
% 211.25/211.47  |- skos__broader mesh__D011570smesh__D001525
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011570 2006
% 211.25/211.47  |- skos__broader mesh__D011570smesh__D008511
% 211.25/211.47  |- skos__prefLabel mesh__D011570 Psychiatry
% 211.25/211.47  |- mesh__dateRevised mesh__D011570 1999-11-03
% 211.25/211.47  |- mesh__recordOriginator mesh__D011570 NLM
% 211.25/211.47  |- skos__annotation mesh__D011570
% 211.25/211.47       SPEC only: SPEC qualif; do not confuse with MENTAL DISORDERS%A%  
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011570 2000
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011570 2003
% 211.25/211.47  |- mesh__recordAuthorizer mesh__D011570 sjn
% 211.25/211.47  |- mesh__recordMaintainer mesh__D011570 kle
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011570 2001
% 211.25/211.47  |- rdf__type mesh__D011570sskos__Concept
% 211.25/211.47  |- mesh__dateCreated mesh__D011570 1999-01-01
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011570 2004
% 211.25/211.47  |- skos__broader mesh__D011570smesh__D013040
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011570 2002
% 211.25/211.47  |- skos__scopeNote mesh__D011570
% 211.25/211.47       The medical science that deals with the origin, diagnosis, prevention, and treatment of mental disorders.%A%    
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011570 2005
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D005533 2003
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D005533 2005
% 211.25/211.47  |- mesh__dateCreated mesh__D005533 1999-01-01
% 211.25/211.47  |- mesh__dateRevised mesh__D005533 1999-11-03
% 211.25/211.47  |- mesh__recordOriginator mesh__D005533 NLM
% 211.25/211.47  |- skos__annotation mesh__D005533
% 211.25/211.47       GEN %26% coord for specific diseases of the foot; not as coord for neoplasms of the foot %28%use neopl coords %28%IM%29% with FOOT DISEASES %28%IM%29%%29%; consider synonym for dermatitis of foot %26% do not add DERMATITIS unless one of the specific DERMATITIS terms in MeSH%A%  
% 211.25/211.47  |- skos__hiddenLabel mesh__D005533 Dermatoses, Foot
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D005533 2002
% 211.25/211.47  |- skos__altLabel mesh__D005533 Foot Dermatosis
% 211.25/211.47  |- mesh__publicMeSHNote mesh__D005533 66   
% 211.25/211.47  |- skos__hiddenLabel mesh__D005533 Dermatosis, Foot
% 211.25/211.47  |- skos__prefLabel mesh__D005533 Foot Dermatoses
% 211.25/211.47  |- mesh__recordAuthorizer mesh__D005533 sjn
% 211.25/211.47  |- skos__broader mesh__D005533smesh__D005534
% 211.25/211.47  |- rdf__type mesh__D005533sskos__Concept
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D005533 2001
% 211.25/211.47  |- mesh__dateEstablished mesh__D005533 1966-01-01
% 211.25/211.47  |- skos__scopeNote mesh__D005533
% 211.25/211.47       Skin diseases of the foot, general or unspecified.     
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D005533 2004
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D005533 2000
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D005533 2006
% 211.25/211.47  |- mesh__historyNote mesh__D005533 66   
% 211.25/211.47  |- mesh__recordMaintainer mesh__D005533 KEV
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D029981 2003
% 211.25/211.47  |- mesh__dateEstablished mesh__D029981 2002-01-01
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D029981 2006
% 211.25/211.47  |- rdf__type mesh__D029981sskos__Concept
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D029981 2004
% 211.25/211.47  |- skos__altLabel mesh__D029981 Hemlock, Spotted Water
% 211.25/211.47  |- skos__annotation mesh__D029981
% 211.25/211.47       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.25/211.47  |- mesh__recordOriginator mesh__D029981 ssb
% 211.25/211.47  |- skos__historyNote mesh__D029981 Hemlock %28%1995-2001%29%
% 211.25/211.47  |- skos__broader mesh__D029981smesh__D018652
% 211.25/211.47  |- mesh__recordAuthorizer mesh__D029981 sjn
% 211.25/211.47  |- mesh__recordMaintainer mesh__D029981 ssb
% 211.25/211.47  |- skos__altLabel mesh__D029981 Water Hemlock
% 211.25/211.47  |- mesh__dateRevised mesh__D029981 2002-07-03
% 211.25/211.47  |- mesh__historyNote mesh__D029981
% 211.25/211.47       2002; for CICUTA MAJOR %26% CICUTA VIROSA use HEMLOCK 1995-2001%A%  
% 211.25/211.47  |- mesh__dateCreated mesh__D029981 2001-07-25
% 211.25/211.47  |- skos__altLabel mesh__D029981 Hemlock, Water
% 211.25/211.47  |- skos__scopeNote mesh__D029981
% 211.25/211.47       A plant genus of the family APIACEAE. It is a source of cicutoxin.%A%    
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D029981 2005
% 211.25/211.47  |- mesh__publicMeSHNote mesh__D029981
% 211.25/211.47       2002; for CICUTA MAJOR %26% CICUTA VIROSA see HEMLOCK 1995-2001%A%  
% 211.25/211.47  |- skos__prefLabel mesh__D029981 Cicuta
% 211.25/211.47  |- skos__scopeNote mesh__D010478
% 211.25/211.47       Neoplasm drug therapy involving an extracorporeal circuit with temporary exclusion of the tumor-bearing area from the general circulation during which high concentrations of the drug are perfused to the isolated part.%A%    
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D010478 2006
% 211.25/211.47  |- mesh__dateRevised mesh__D010478 2005-06-30
% 211.25/211.47  |- skos__prefLabel mesh__D010478 Chemotherapy, Cancer, Regional Perfusion
% 211.25/211.47  |- skos__altLabel mesh__D010478 Cancer Chemotherapy, Regional Perfusion
% 211.25/211.47  |- rdf__type mesh__D010478sskos__Concept
% 211.25/211.47  |- mesh__recordOriginator mesh__D010478 NLM
% 211.25/211.47  |- mesh__publicMeSHNote mesh__D010478
% 211.25/211.47       2006; see PERFUSION, REGIONAL 1978-2005, see ISOLATION PERFUSION 1964-1977%A%  
% 211.25/211.47  |- mesh__recordMaintainer mesh__D010478 nns
% 211.25/211.47  |- skos__altLabel mesh__D010478 Perfusion Cancer Chemotherapy, Regional
% 211.25/211.47  |- skos__altLabel mesh__D010478 Regional Perfusion Cancer Chemotherapy
% 211.25/211.47  |- mesh__historyNote mesh__D010478 2006 %28%1963%29%   
% 211.25/211.47  |- mesh__recordAuthorizer mesh__D010478 sjn
% 211.25/211.47  |- mesh__dateEstablished mesh__D010478 1964-01-01
% 211.25/211.47  |- skos__broader mesh__D010478smesh__D005112
% 211.25/211.47  |- skos__annotation mesh__D010478
% 211.25/211.47       restricted to a special technique in cancer therapy; do not confuse with INFUSIONS, INTRA-ARTERIAL which is also used in cancer therapy; Manual 24.4.2.5+%A%  
% 211.25/211.47  |- skos__altLabel mesh__D010478 Isolation Perfusion Cancer Chemotherapy
% 211.25/211.47  |- mesh__dateCreated mesh__D010478 1999-01-01
% 211.25/211.47  |- skos__broader mesh__D010478smesh__D004333
% 211.25/211.47  |- skos__altLabel mesh__D010478
% 211.25/211.47       Regional Perfusion Antineoplastic Chemotherapy
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D015163 2004
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D015163 2000A
% 211.25/211.47  |- rdf__type mesh__D015163sskos__Concept
% 211.25/211.47  |- skos__hiddenLabel mesh__D015163 Superinvasions, Microbial
% 211.25/211.47  |- skos__altLabel mesh__D015163 Superinvasion, Microbial
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D015163 2001
% 211.25/211.47  |- mesh__dateEstablished mesh__D015163 1989-01-01
% 211.25/211.47  |- mesh__recordOriginator mesh__D015163 SCD
% 211.25/211.47  |- skos__prefLabel mesh__D015163 Superinfection
% 211.25/211.47  |- skos__historyNote mesh__D015163 Cell Line %28%1969-1988%29%
% 211.25/211.47  |- mesh__publicMeSHNote mesh__D015163 1989   
% 211.25/211.47  |- skos__historyNote mesh__D015163 Tissue Culture %28%1967-1980%29%
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D015163 2005
% 211.25/211.47  |- skos__hiddenLabel mesh__D015163 Microbial Superinvasions
% 211.25/211.47  |- skos__related mesh__D015163smesh__D014762
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D015163 2002
% 211.25/211.47  |- skos__historyNote mesh__D015163 Cells, Cultured %28%1974-1988%29%
% 211.25/211.47  |- mesh__dateRevised mesh__D015163 1999-12-16
% 211.25/211.47  |- skos__historyNote mesh__D015163
% 211.25/211.47       Drug Resistance, Microbial %28%1966-1988%29%
% 211.25/211.47  |- mesh__recordAuthorizer mesh__D015163 ags
% 211.25/211.47  |- mesh__historyNote mesh__D015163 1989   
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D015163 2006
% 211.25/211.47  |- skos__altLabel mesh__D015163 Microbial Superinvasion
% 211.25/211.47  |- skos__hiddenLabel mesh__D015163 Superinfections
% 211.25/211.47  |- mesh__dateCreated mesh__D015163 1988-04-06
% 211.25/211.47  |- mesh__recordMaintainer mesh__D015163 ags
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D015163 1999
% 211.25/211.47  |- skos__broader mesh__D015163smesh__D009894
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D015163 2003
% 211.25/211.47  |- skos__annotation mesh__D015163
% 211.25/211.47       opportunistic infect; IM; coord with specific infect %28%IM%29%%A%  
% 211.25/211.47  |- skos__scopeNote mesh__D015163
% 211.25/211.47       A frequent complication of drug therapy for microbial infection. It may result from opportunistic colonization following immunosuppression by the primary pathogen and can be influenced by the time interval between infections, microbial physiology, or host resistance. Experimental challenge and in vitro models are sometimes used in virulence and infectivity studies.%A%    
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D015163 2000
% 211.25/211.47  |- skos__prefLabel mesh__D009924 Organ Culture Techniques
% 211.25/211.47  |- mesh__dateRevised mesh__D009924 2004-07-07
% 211.25/211.47  |- skos__related mesh__D009924smesh__D023822
% 211.25/211.47  |- skos__hiddenLabel mesh__D009924 Organ Culture Technique
% 211.25/211.47  |- skos__hiddenLabel mesh__D009924 Culture Technique, Organ
% 211.25/211.47  |- skos__hiddenLabel mesh__D009924 Culture Techniques, Organ
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D009924 2006
% 211.25/211.47  |- mesh__historyNote mesh__D009924 2005 %28%1972%29%   
% 211.25/211.47  |- skos__altLabel mesh__D009924 Organ Culture
% 211.25/211.47  |- mesh__recordOriginator mesh__D009924 NLM
% 211.25/211.47  |- skos__broader mesh__D009924smesh__D046508
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D009924 2005
% 211.25/211.47  |- skos__annotation mesh__D009924 NIM   
% 211.25/211.47  |- rdf__type mesh__D009924sskos__Concept
% 211.25/211.47  |- skos__scopeNote mesh__D009924
% 211.25/211.47       A technique for maintenance or growth of animal organs in vitro. It refers to three-dimensional cultures of undisaggregated tissue retaining some or all of the histological features of the tissue in vivo. %28%Freshney, Culture of Animal Cells, 3d ed, p1%29%%A%    
% 211.25/211.47  |- mesh__dateCreated mesh__D009924 1999-01-01
% 211.25/211.47  |- mesh__publicMeSHNote mesh__D009924 2005; see ORGAN CULTURE 1972-2004   
% 211.25/211.47  |- skos__hiddenLabel mesh__D009924 Organ Cultures
% 211.25/211.47  |- skos__historyNote mesh__D009924 Tissue Culture %28%1966-1968%29%
% 211.25/211.47  |- mesh__dateEstablished mesh__D009924 1972-01-01
% 211.25/211.47  |- skos__related mesh__D009924smesh__D002478
% 211.25/211.47  |- mesh__recordMaintainer mesh__D009924 lkt
% 211.25/211.47  |- mesh__recordAuthorizer mesh__D009924 sjn
% 211.25/211.47  |- mesh__recordOriginator mesh__D001941 NLM
% 211.25/211.47  |- skos__hiddenLabel mesh__D001941 Endocrine Breast Disease
% 211.25/211.47  |- skos__hiddenLabel mesh__D001941 Breast Disease, Endocrine
% 211.25/211.47  |- skos__hiddenLabel mesh__D001941 Breast Disease
% 211.25/211.47  |- rdf__type mesh__D001941sskos__Concept
% 211.25/211.47  |- skos__broader mesh__D001941smesh__D012871
% 211.25/211.47  |- mesh__recordMaintainer mesh__D001941 lkt
% 211.25/211.47  |- skos__scopeNote mesh__D001941 Pathological processes of the BREAST.     
% 211.25/211.47  |- skos__hiddenLabel mesh__D001941 Diseases, Breast
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D001941 2006
% 211.25/211.47  |- skos__annotation mesh__D001941
% 211.25/211.47       inflamm dis = MASTITIS; tuberc of breast = MASTITIS %28%IM%29% + TUBERCULOSIS %28%IM%29%, not TUBERCULOSIS, ENDOCRINE%A%  
% 211.25/211.47  |- mesh__dateRevised mesh__D001941 2004-07-07
% 211.25/211.47  |- skos__hiddenLabel mesh__D001941 Diseases, Endocrine Breast
% 211.25/211.47  |- skos__hiddenLabel mesh__D001941 Breast Diseases, Endocrine
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D001941 2005
% 211.25/211.47  |- skos__hiddenLabel mesh__D001941 Disease, Endocrine Breast
% 211.25/211.47  |- skos__prefLabel mesh__D001941 Breast Diseases
% 211.25/211.47  |- mesh__dateCreated mesh__D001941 1999-01-01
% 211.25/211.47  |- mesh__recordAuthorizer mesh__D001941 sjn
% 211.25/211.47  |- skos__hiddenLabel mesh__D001941 Disease, Breast
% 211.25/211.47  |- skos__prefLabel mesh__D009126 Muscle Relaxation
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D009126 2004
% 211.25/211.47  |- rdf__type mesh__D009126sskos__Concept
% 211.25/211.47  |- mesh__historyNote mesh__D009126
% 211.25/211.47       91%28%77%29%; was see under MUSCLE CONTRACTION 1977-90   
% 211.25/211.47  |- mesh__recordAuthorizer mesh__D009126 sjn
% 211.25/211.47  |- mesh__dateEstablished mesh__D009126 1991-01-01
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D009126 2006
% 211.25/211.47  |- skos__scopeNote mesh__D009126
% 211.25/211.47       That phase of a muscle twitch during which a muscle returns to a resting position.%A%    
% 211.25/211.47  |- mesh__dateCreated mesh__D009126 1976-04-27
% 211.25/211.47  |- mesh__dateRevised mesh__D009126 2003-07-09
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D009126 2005
% 211.25/211.47  |- skos__annotation mesh__D009126
% 211.25/211.47       do not use as coord for relaxation of cardiac muscle %28% = MYOCARDIAL CONTRACTION%29%%A%  
% 211.25/211.47  |- skos__hiddenLabel mesh__D009126 Muscle Relaxations
% 211.25/211.47  |- skos__hiddenLabel mesh__D009126 Relaxation, Muscle
% 211.25/211.47  |- skos__broader mesh__D009126smesh__D009119
% 211.25/211.47  |- skos__historyNote mesh__D009126 Muscle Contraction %28%1966-1976%29%
% 211.25/211.47  |- mesh__publicMeSHNote mesh__D009126
% 211.25/211.47       91; was see under MUSCLE CONTRACTION 1977-90   
% 211.25/211.47  |- mesh__recordOriginator mesh__D009126 MM
% 211.25/211.47  |- mesh__recordMaintainer mesh__D009126 nns
% 211.25/211.47  |- skos__hiddenLabel mesh__D009126 Relaxations, Muscle
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D001143 2001
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D001143 2003
% 211.25/211.47  |- mesh__dateRevised mesh__D001143 1999-11-03
% 211.25/211.47  |- mesh__recordMaintainer mesh__D001143 ags
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D001143 2005
% 211.25/211.47  |- skos__scopeNote mesh__D001143
% 211.25/211.47       Cortical vigilance or readiness of tone, presumed to be in response to sensory stimulation via the reticular activating system.%A%    
% 211.25/211.47  |- mesh__publicMeSHNote mesh__D001143 66   
% 211.25/211.47  |- mesh__recordOriginator mesh__D001143 NLM
% 211.25/211.47  |- skos__hiddenLabel mesh__D001143 Cortical Vigilance
% 211.25/211.47  |- mesh__recordAuthorizer mesh__D001143 sjn
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D001143 2004
% 211.25/211.47  |- mesh__dateEstablished mesh__D001143 1966-01-01
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D001143 2002
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D001143 2006
% 211.25/211.47  |- skos__prefLabel mesh__D001143 Arousal
% 211.25/211.47  |- skos__broader mesh__D001143smesh__D009424
% 211.25/211.47  |- skos__hiddenLabel mesh__D001143 Arousals
% 211.25/211.47  |- rdf__type mesh__D001143sskos__Concept
% 211.25/211.47  |- mesh__historyNote mesh__D001143 66%28%64%29%   
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D001143 2000
% 211.25/211.47  |- skos__annotation mesh__D001143 human %26% animal   
% 211.25/211.47  |- mesh__dateCreated mesh__D001143 1999-01-01
% 211.25/211.47  |- skos__broader mesh__D001143smesh__D011603
% 211.25/211.47  |- mesh__recordOriginator mesh__D014869 NLM
% 211.25/211.47  |- mesh__historyNote mesh__D014869 65   
% 211.25/211.47  |- mesh__publicMeSHNote mesh__D014869 65   
% 211.25/211.47  |- mesh__recordMaintainer mesh__D014869 adp
% 211.25/211.47  |- skos__broader mesh__D014869smesh__D014883
% 211.25/211.47  |- skos__scopeNote mesh__D014869
% 211.25/211.47       A condition resulting from the excessive retention of water with sodium depletion.%A%    
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D014869 2005
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D014869 2002
% 211.25/211.47  |- mesh__dateCreated mesh__D014869 1999-01-01
% 211.25/211.47  |- skos__broader mesh__D014869smesh__D011041
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D014869 2004
% 211.25/211.47  |- skos__related mesh__D014869smesh__D014883
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D014869 2001
% 211.25/211.47  |- mesh__dateRevised mesh__D014869 1999-11-03
% 211.25/211.47  |- rdf__type mesh__D014869sskos__Concept
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D014869 2003
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D014869 2000
% 211.25/211.47  |- skos__prefLabel mesh__D014869 Water Intoxication
% 211.25/211.47  |- mesh__dateEstablished mesh__D014869 1965-01-01
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D014869 2006
% 211.25/211.47  |- mesh__recordAuthorizer mesh__D014869 sjn
% 211.25/211.47  |- skos__historyNote mesh__D019554 Surface Properties %28%1986-1996%29%
% 211.25/211.47  |- skos__altLabel mesh__D019554 Wear, Restoration Occlusal
% 211.25/211.47  |- skos__altLabel mesh__D019554 Occlusal Wear, Restoration
% 211.25/211.47  |- skos__altLabel mesh__D019554 Wear, Dental Restoration
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D019554 2004
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D019554 2002
% 211.25/211.47  |- skos__hiddenLabel mesh__D019554 Wear, Denture
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D019554 1997
% 211.25/211.47  |- skos__prefLabel mesh__D019554 Dental Restoration Wear
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D019554 2005
% 211.25/211.47  |- skos__altLabel mesh__D019554 Restoration Occlusal Wear
% 211.25/211.47  |- mesh__dateCreated mesh__D019554 1996-06-13
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D019554 2000
% 211.25/211.47  |- mesh__dateEstablished mesh__D019554 1997-01-01
% 211.25/211.47  |- skos__altLabel mesh__D019554 Restoration Wear, Dental
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D019554 2006
% 211.25/211.47  |- mesh__publicMeSHNote mesh__D019554 97   
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D019554 1998
% 211.25/211.47  |- skos__broader mesh__D019554smesh__D003793
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D019554 2001
% 211.25/211.47  |- mesh__historyNote mesh__D019554 97   
% 211.25/211.47  |- skos__annotation mesh__D019554
% 211.25/211.47       surface wear of restorations %26% dentures; DF: DENT RESTORATION WEAR%A%  
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D019554 2003
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D019554 1999
% 211.25/211.47  |- rdf__type mesh__D019554sskos__Concept
% 211.25/211.47  |- skos__scopeNote mesh__D019554
% 211.25/211.47       Occlusal wear of the surfaces of restorations and surface wear of dentures.%A%    
% 211.25/211.47  |- mesh__recordAuthorizer mesh__D000849 sjn
% 211.25/211.47  |- skos__hiddenLabel mesh__D000849 Dysphasia, Anomic
% 211.25/211.47  |- mesh__recordOriginator mesh__D000849 RC
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D000849 2001
% 211.25/211.47  |- skos__hiddenLabel mesh__D000849 Amnesic Aphasia
% 211.25/211.47  |- skos__hiddenLabel mesh__D000849 Anomias, Color
% 211.25/211.47  |- mesh__historyNote mesh__D000849
% 211.25/211.47       1991%28%1980%29%; use APHASIA 1975-1979   
% 211.25/211.47  |- skos__prefLabel mesh__D000849 Anomia
% 211.25/211.47  |- mesh__dateEstablished mesh__D000849 1991-01-01
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D000849 2005
% 211.25/211.47  |- skos__hiddenLabel mesh__D000849 Dysphasia, Nominal
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D000849 2002
% 211.25/211.47  |- skos__altLabel mesh__D000849 Aphasia, Anomic
% 211.25/211.47  |- mesh__dateCreated mesh__D000849 1978-12-14
% 211.25/211.47  |- skos__hiddenLabel mesh__D000849 Dysphasias, Nominal
% 211.25/211.47  |- skos__historyNote mesh__D000849 Aphasia %28%1966-1979%29%
% 211.25/211.47  |- skos__altLabel mesh__D000849 Aphasia, Amnesic
% 211.25/211.47  |- skos__hiddenLabel mesh__D000849 Dysphasias, Anomic
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D000849 2006
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D000849 2003
% 211.25/211.47  |- skos__altLabel mesh__D000849 Nominal Dysphasia
% 211.25/211.47  |- mesh__publicMeSHNote mesh__D000849
% 211.25/211.47       1991; see under APHASIA 1980-1990, see APHASIA 1975-1979   
% 211.25/211.47  |- skos__hiddenLabel mesh__D000849 Color Anomias
% 211.25/211.47  |- rdf__type mesh__D000849sskos__Concept
% 211.25/211.47  |- skos__hiddenLabel mesh__D000849 Dysnomias
% 211.25/211.47  |- skos__scopeNote mesh__D000849
% 211.25/211.47       A language dysfunction characterized by the inability to name people and objects that are correctly perceived. The individual is able to describe the object in question, but cannot provide the name. This condition is associated with lesions of the dominant hemisphere involving the language areas, in particular the TEMPORAL LOBE. %28%From Adams et al., Principles of Neurology, 6th ed, p484%29%%A%    
% 211.25/211.47  |- skos__hiddenLabel mesh__D000849 Nominal Dysphasias
% 211.25/211.47  |- skos__hiddenLabel mesh__D000849 Anomic Dysphasias
% 211.25/211.47  |- mesh__dateRevised mesh__D000849 1999-11-08
% 211.25/211.47  |- skos__altLabel mesh__D000849 Dysnomia
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D000849 2004
% 211.25/211.47  |- mesh__recordMaintainer mesh__D000849 KEV
% 211.25/211.47  |- skos__altLabel mesh__D000849 Aphasia, Nominal
% 211.25/211.47  |- skos__altLabel mesh__D000849 Anomic Dysphasia
% 211.25/211.47  |- skos__hiddenLabel mesh__D000849 Nominal Aphasia
% 211.25/211.47  |- skos__hiddenLabel mesh__D000849 Anomic Aphasia
% 211.25/211.47  |- skos__hiddenLabel mesh__D000849 Anomia, Color
% 211.25/211.47  |- skos__broader mesh__D000849smesh__D007806
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D000849 2000
% 211.25/211.47  |- skos__annotation mesh__D000849
% 211.25/211.47       inability to name objects: do not confuse with ANOMIE %28%%22%state of social disorganization %26% demoralization in society...%22%, often called %22%anomia%22%%29%%A%  
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011571 2006
% 211.25/211.47  |- mesh__publicMeSHNote mesh__D011571 72   
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011571 1998
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011571 2002
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011571 1993
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011571 1994
% 211.25/211.47  |- mesh__dateRevised mesh__D011571 1989-05-16
% 211.25/211.47  |- mesh__recordMaintainer mesh__D011571 TGC
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011571 1999
% 211.25/211.47  |- mesh__recordAuthorizer mesh__D011571 PLS
% 211.25/211.47  |- skos__hiddenLabel mesh__D011571 Psychoacoustic
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011571 1990
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011571 1995
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011571 2003
% 211.25/211.47  |- skos__broader mesh__D011571smesh__D000162
% 211.25/211.47  |- rdf__type mesh__D011571sskos__Concept
% 211.25/211.47  |- mesh__dateCreated mesh__D011571 1999-01-01
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011571 1991
% 211.25/211.47  |- mesh__historyNote mesh__D011571 72%28%68%29%   
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011571 2004
% 211.25/211.47  |- mesh__recordOriginator mesh__D011571 NLM
% 211.25/211.47  |- skos__scopeNote mesh__D011571
% 211.25/211.47       The science pertaining to the interrelationship of psychologic phenomena and the individual%27%s response to the physical properties of sound.%A%    
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011571 1996
% 211.25/211.47  |- skos__historyNote mesh__D011571 Auditory Perception %28%1967%29%
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011571 2005
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011571 2000
% 211.25/211.47  |- skos__prefLabel mesh__D011571 Psychoacoustics
% 211.25/211.47  |- skos__broader mesh__D011571smesh__D011601
% 211.25/211.47  |- skos__historyNote mesh__D011571 Acoustics %28%1966-1967%29%
% 211.25/211.47  |- mesh__dateEstablished mesh__D011571 1972-01-01
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011571 2001
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011571 1992
% 211.25/211.47  |- skos__annotation mesh__D011571 IM; no qualif   
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D011571 1997
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D005534 2000
% 211.25/211.47  |- skos__prefLabel mesh__D005534 Foot Diseases
% 211.25/211.47  |- skos__hiddenLabel mesh__D005534 Foot Disease
% 211.25/211.47  |- mesh__dateCreated mesh__D005534 1999-01-01
% 211.25/211.47  |- skos__scopeNote mesh__D005534
% 211.25/211.47       Anatomical and functional disorders affecting the foot.%A%    
% 211.25/211.47  |- rdf__type mesh__D005534sskos__Concept
% 211.25/211.47  |- skos__annotation mesh__D005534
% 211.25/211.47       skin dis on foot = FOOT DERMATOSES; neopl of foot: use neopl coords %28%IM%29% + FOOT DISEASES %28%IM%29%%A%  
% 211.25/211.47  |- skos__broader mesh__D005534smesh__D012871
% 211.25/211.47  |- mesh__dateRevised mesh__D005534 1999-11-03
% 211.25/211.47  |- mesh__recordOriginator mesh__D005534 NLM
% 211.25/211.47  |- skos__broader mesh__D005534smesh__D009140
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D005534 2004
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D005534 2002
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D005534 2006
% 211.25/211.47  |- skos__hiddenLabel mesh__D005534 Disease, Foot
% 211.25/211.47  |- mesh__recordAuthorizer mesh__D005534 sjn
% 211.25/211.47  |- mesh__recordMaintainer mesh__D005534 KEV
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D005534 2003
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D005534 2001
% 211.25/211.47  |- mesh__activeMeSHYear mesh__D005534 2005
% 211.25/211.47  |- skos__hiddenLabel mesh__D005534 Diseases, Foot
% 211.25/211.47  |- rdf__type mesh__D029982sskos__Concept
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D029982 2004
% 211.25/211.48  |- mesh__recordOriginator mesh__D029982 ssb
% 211.25/211.48  |- skos__prefLabel mesh__D029982 Conium
% 211.25/211.48  |- skos__broader mesh__D029982smesh__D018652
% 211.25/211.48  |- skos__altLabel mesh__D029982 Poison Hemlock
% 211.25/211.48  |- skos__scopeNote mesh__D029982
% 211.25/211.48       A plant genus of the family APIACEAE that is a source of coniine.%A%    
% 211.25/211.48  |- skos__altLabel mesh__D029982 Hemlock, Poison
% 211.25/211.48  |- skos__historyNote mesh__D029982 Hemlock %28%1995-2001%29%
% 211.25/211.48  |- skos__annotation mesh__D029982
% 211.25/211.48       note X ref POISON HEMLOCK: use only for this plant and not for poisoning by other HEMLOCK plants; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.25/211.48  |- mesh__publicMeSHNote mesh__D029982
% 211.25/211.48       2002; for CONIUM MACULATUM see HEMLOCK 1995-2001   
% 211.25/211.48  |- mesh__historyNote mesh__D029982
% 211.25/211.48       2002; for CONIUM MACULATUM use HEMLOCK 1995-2001   
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D029982 2005
% 211.25/211.48  |- mesh__dateRevised mesh__D029982 2002-07-03
% 211.25/211.48  |- mesh__recordAuthorizer mesh__D029982 sjn
% 211.25/211.48  |- mesh__recordMaintainer mesh__D029982 ssb
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D029982 2003
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D029982 2006
% 211.25/211.48  |- mesh__dateCreated mesh__D029982 2001-07-25
% 211.25/211.48  |- mesh__dateEstablished mesh__D029982 2002-01-01
% 211.25/211.48  |- skos__altLabel mesh__D010479 Draxis Brand of Pergolide Mesylate
% 211.25/211.48  |- skos__hiddenLabel mesh__D010479 Mesylate, Pergolide
% 211.25/211.48  |- skos__hiddenLabel mesh__D010479 LY127809
% 211.25/211.48  |- rdf__type mesh__D010479sskos__Concept
% 211.25/211.48  |- skos__altLabel mesh__D010479 Athena Brand of Pergolide Mesylate
% 211.25/211.48  |- skos__historyNote mesh__D010479 Ergolines %28%1969-1986%29%
% 211.25/211.48  |- mesh__recordMaintainer mesh__D010479 lkw
% 211.25/211.48  |- skos__altLabel mesh__D010479 Celance
% 211.25/211.48  |- skos__altLabel mesh__D010479 Elanco Brand of Pergolide Mesylate
% 211.25/211.48  |- mesh__dateRevised mesh__D010479 2005-06-30
% 211.25/211.48  |- mesh__dateEstablished mesh__D010479 1987-01-01
% 211.25/211.48  |- skos__broader mesh__D010479smesh__D004873
% 211.25/211.48  |- skos__historyNote mesh__D010479 Ergot Alkaloids %28%1966-1986%29%
% 211.25/211.48  |- mesh__recordOriginator mesh__D010479 RLS
% 211.25/211.48  |- skos__hiddenLabel mesh__D010479 LY127,809
% 211.25/211.48  |- skos__altLabel mesh__D010479 Parkotil
% 211.25/211.48  |- skos__altLabel mesh__D010479 Lilly Brand of Pergolide Mesylate
% 211.25/211.48  |- skos__altLabel mesh__D010479 LY-127,809
% 211.25/211.48  |- skos__prefLabel mesh__D010479 Pergolide
% 211.25/211.48  |- skos__altLabel mesh__D010479 Lilly Brand of Pergolide
% 211.25/211.48  |- mesh__dateCreated mesh__D010479 1986-06-12
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D010479 2006
% 211.25/211.48  |- mesh__recordAuthorizer mesh__D010479 sjn
% 211.25/211.48  |- mesh__historyNote mesh__D010479 87   
% 211.25/211.48  |- mesh__publicMeSHNote mesh__D010479 87   
% 211.25/211.48  |- skos__scopeNote mesh__D010479
% 211.25/211.48       A long-acting dopamine agonist which is effective in the treatment of Parkinson%27%s disease and hyperprolactinemia. It has also been observed to have antihypertensive effects.%A%    
% 211.25/211.48  |- mesh__recordOriginator mesh__D015164 SCD
% 211.25/211.48  |- skos__hiddenLabel mesh__D015164 Inactivated Vaccines
% 211.25/211.48  |- skos__broader mesh__D015164smesh__D014612
% 211.25/211.48  |- mesh__recordAuthorizer mesh__D015164 sjn
% 211.25/211.48  |- skos__annotation mesh__D015164
% 211.25/211.48       coord NIM with specific vaccine %28%IM%29%   
% 211.25/211.48  |- mesh__historyNote mesh__D015164 89   
% 211.25/211.48  |- skos__altLabel mesh__D015164 Killed Vaccines
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D015164 2006
% 211.25/211.48  |- mesh__recordMaintainer mesh__D015164 ssb
% 211.25/211.48  |- skos__historyNote mesh__D015164 Vaccines, Attenuated %28%1973-1988%29%
% 211.25/211.48  |- skos__scopeNote mesh__D015164
% 211.25/211.48       Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment %28%e.g., formalin, beta-propiolactone, gamma radiation%29% without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins.%A%    
% 211.25/211.48  |- skos__altLabel mesh__D015164 Vaccines, Killed
% 211.25/211.48  |- rdf__type mesh__D015164sskos__Concept
% 211.25/211.48  |- mesh__publicMeSHNote mesh__D015164 89   
% 211.25/211.48  |- mesh__dateRevised mesh__D015164 2005-06-30
% 211.25/211.48  |- mesh__dateEstablished mesh__D015164 1989-01-01
% 211.25/211.48  |- mesh__dateCreated mesh__D015164 1988-04-06
% 211.25/211.48  |- skos__prefLabel mesh__D015164 Vaccines, Inactivated
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009925 2005
% 211.25/211.48  |- rdf__type mesh__D009925sskos__Concept
% 211.25/211.48  |- skos__hiddenLabel mesh__D009925 Spiral Organs
% 211.25/211.48  |- mesh__dateCreated mesh__D009925 1999-01-01
% 211.25/211.48  |- skos__hiddenLabel mesh__D009925 Organs, Spiral
% 211.25/211.48  |- mesh__recordAuthorizer mesh__D009925 jls
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009925 2005A
% 211.25/211.48  |- mesh__dateEstablished mesh__D009925 1968-01-01
% 211.25/211.48  |- mesh__recordMaintainer mesh__D009925 jls
% 211.25/211.48  |- skos__altLabel mesh__D009925 Spiral Organ
% 211.25/211.48  |- skos__prefLabel mesh__D009925 Organ of Corti
% 211.25/211.48  |- skos__broader mesh__D009925smesh__D003051
% 211.25/211.48  |- skos__hiddenLabel mesh__D009925 Organ, Spiral
% 211.25/211.48  |- skos__scopeNote mesh__D009925
% 211.25/211.48       The organ that contains the special sensory receptors for hearing. It is composed of a series of epithelial structures placed upon the inner part of the basilar membrane.%A%    
% 211.25/211.48  |- mesh__historyNote mesh__D009925 68%28%65%29%   
% 211.25/211.48  |- skos__hiddenLabel mesh__D009925 Papilla, Basilar
% 211.25/211.48  |- mesh__recordOriginator mesh__D009925 NLM
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009925 2004
% 211.25/211.48  |- skos__hiddenLabel mesh__D009925 Cortis Organ
% 211.25/211.48  |- mesh__publicMeSHNote mesh__D009925 68   
% 211.25/211.48  |- skos__hiddenLabel mesh__D009925 Corti Organ
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009925 2006
% 211.25/211.48  |- skos__altLabel mesh__D009925 Corti%27%s Organ
% 211.25/211.48  |- mesh__dateRevised mesh__D009925 2004-07-29
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009925 2003
% 211.25/211.48  |- skos__hiddenLabel mesh__D009925 Organ, Corti%27%s
% 211.25/211.48  |- mesh__recordMaintainer mesh__D001942 sjn
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D001942 2006
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D001942 2004
% 211.25/211.48  |- skos__broader mesh__D001942smesh__D007227
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D001942 2005
% 211.25/211.48  |- mesh__recordAuthorizer mesh__D001942 sjn
% 211.25/211.48  |- mesh__dateCreated mesh__D001942 1999-01-01
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D001942 2003
% 211.25/211.48  |- mesh__recordOriginator mesh__D001942 NLM
% 211.25/211.48  |- skos__altLabel mesh__D001942 Breastfeeding
% 211.25/211.48  |- skos__annotation mesh__D001942
% 211.25/211.48       human only; /adv eff: refers to eff on infant or mother   
% 211.25/211.48  |- skos__altLabel mesh__D001942 Breastfeeding, Exclusive
% 211.25/211.48  |- skos__hiddenLabel mesh__D001942 Feeding, Breast
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D001942 2005A
% 211.25/211.48  |- skos__related mesh__D001942smesh__D001903
% 211.25/211.48  |- skos__prefLabel mesh__D001942 Breast Feeding
% 211.25/211.48  |- rdf__type mesh__D001942sskos__Concept
% 211.25/211.48  |- skos__hiddenLabel mesh__D001942 Exclusive Breast Feeding
% 211.25/211.48  |- mesh__dateRevised mesh__D001942 2005-05-18
% 211.25/211.48  |- skos__hiddenLabel mesh__D001942 Exclusive Breastfeeding
% 211.25/211.48  |- skos__scopeNote mesh__D001942
% 211.25/211.48       The nursing of an infant at the mother%27%s breast.     
% 211.25/211.48  |- skos__broader mesh__D009127smesh__D009122
% 211.25/211.48  |- mesh__dateCreated mesh__D009127 1999-01-01
% 211.25/211.48  |- skos__hiddenLabel mesh__D009127 Rigidity, Cogwheel
% 211.25/211.48  |- skos__hiddenLabel mesh__D009127 Rigidities, Cogwheel
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009127 2004
% 211.25/211.48  |- mesh__dateEstablished mesh__D009127 1973-01-01
% 211.25/211.48  |- rdf__type mesh__D009127sskos__Concept
% 211.25/211.48  |- skos__broader mesh__D009127smesh__D009135
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009127 2002
% 211.25/211.48  |- skos__scopeNote mesh__D009127
% 211.25/211.48       Continuous involuntary sustained muscle contraction which is often a manifestation of BASAL GANGLIA DISEASES. When an affected muscle is passively stretched, the degree of resistance remains constant regardless of the rate at which the muscle is stretched. This feature helps to distinguish rigidity from MUSCLE SPASTICITY. %28%From Adams et al., Principles of Neurology, 6th ed, p73%29%%A%    
% 211.25/211.48  |- skos__hiddenLabel mesh__D009127 Rigidity, Nuchal
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009127 2005
% 211.25/211.48  |- skos__historyNote mesh__D009127 Muscular Diseases %28%1966-1971%29%
% 211.25/211.48  |- skos__prefLabel mesh__D009127 Muscle Rigidity
% 211.25/211.48  |- skos__hiddenLabel mesh__D009127 Gegenhaltens
% 211.25/211.48  |- skos__hiddenLabel mesh__D009127 Cogwheel Rigidities
% 211.25/211.48  |- mesh__recordOriginator mesh__D009127 NLM
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009127 2006
% 211.25/211.48  |- skos__hiddenLabel mesh__D009127 Rigidity, Muscle
% 211.25/211.48  |- mesh__publicMeSHNote mesh__D009127 1973   
% 211.25/211.48  |- mesh__recordAuthorizer mesh__D009127 ags
% 211.25/211.48  |- skos__hiddenLabel mesh__D009127 Rigidity, Catatonic
% 211.25/211.48  |- mesh__recordMaintainer mesh__D009127 ags
% 211.25/211.48  |- skos__hiddenLabel mesh__D009127 Rigidity, Extensor
% 211.25/211.48  |- mesh__historyNote mesh__D009127 1973%28%1972%29%   
% 211.25/211.48  |- mesh__dateRevised mesh__D009127 1999-12-06
% 211.25/211.48  |- skos__hiddenLabel mesh__D009127 Rigidity, Extrapyramidal
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009127 2000A
% 211.25/211.48  |- skos__altLabel mesh__D009127 Rigidity, Muscular
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009127 2000
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009127 2003
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009127 2001
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009127 2000B
% 211.25/211.48  |- skos__hiddenLabel mesh__D009127 Muscular Rigidity
% 211.25/211.48  |- skos__annotation mesh__D019555
% 211.25/211.48       no qualif; IM; coord with med %26% nurs spec %28%IM%29% if pertinent; DF: PHYSICIAN NURSE RELAT%A%  
% 211.25/211.48  |- skos__hiddenLabel mesh__D019555 Nurse-Physician Relation
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D019555 1997
% 211.25/211.48  |- skos__hiddenLabel mesh__D019555 Relationships, Physician Nurse
% 211.25/211.48  |- skos__broader mesh__D019555smesh__D007400
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D019555 2005
% 211.25/211.48  |- skos__altLabel mesh__D019555 Physician Nurse Relationship
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D019555 2002
% 211.25/211.48  |- skos__hiddenLabel mesh__D019555 Physician Nurse Relations
% 211.25/211.48  |- skos__hiddenLabel mesh__D019555 Nurse Relationship, Physician
% 211.25/211.48  |- skos__prefLabel mesh__D019555 Physician-Nurse Relations
% 211.25/211.48  |- skos__historyNote mesh__D019555 Nurses %28%1966-1996%29%
% 211.25/211.48  |- skos__historyNote mesh__D019555
% 211.25/211.48       Interprofessional Relations %28%1966-1996%29%
% 211.25/211.48  |- mesh__dateCreated mesh__D019555 1996-06-10
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D019555 2006
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D019555 1998
% 211.25/211.48  |- skos__hiddenLabel mesh__D019555 Nurse Physician Relations
% 211.25/211.48  |- skos__hiddenLabel mesh__D019555 Relations, Nurse-Physician
% 211.25/211.48  |- skos__hiddenLabel mesh__D019555 Nurse Relationships, Physician
% 211.25/211.48  |- mesh__historyNote mesh__D019555 97   
% 211.25/211.48  |- skos__hiddenLabel mesh__D019555 Relationship, Physician Nurse
% 211.25/211.48  |- skos__altLabel mesh__D019555 Nurse-Physician Relations
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D019555 2003
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D019555 1999
% 211.25/211.48  |- rdf__type mesh__D019555sskos__Concept
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D019555 2000
% 211.25/211.48  |- mesh__dateEstablished mesh__D019555 1997-01-01
% 211.25/211.48  |- skos__hiddenLabel mesh__D019555 Relation, Nurse-Physician
% 211.25/211.48  |- skos__hiddenLabel mesh__D019555 Relations, Physician-Nurse
% 211.25/211.48  |- skos__hiddenLabel mesh__D019555 Physician-Nurse Relation
% 211.25/211.48  |- mesh__publicMeSHNote mesh__D019555 97   
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D019555 2004
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D019555 2001
% 211.25/211.48  |- skos__scopeNote mesh__D019555
% 211.25/211.48       The reciprocal interaction of physicians and nurses.     
% 211.25/211.48  |- skos__hiddenLabel mesh__D019555 Relation, Physician-Nurse
% 211.25/211.48  |- skos__historyNote mesh__D019555 Physicians %28%1966-1996%29%
% 211.25/211.48  |- skos__hiddenLabel mesh__D019555 Physician Nurse Relationships
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D011572 2003
% 211.25/211.48  |- rdf__type mesh__D011572sskos__Concept
% 211.25/211.48  |- mesh__dateCreated mesh__D011572 1999-01-01
% 211.25/211.48  |- mesh__recordOriginator mesh__D011572 NLM
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D011572 2000
% 211.25/211.48  |- mesh__recordMaintainer mesh__D011572 adp
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D011572 2004
% 211.25/211.48  |- mesh__recordAuthorizer mesh__D011572 sjn
% 211.25/211.48  |- skos__broader mesh__D011572smesh__D011570
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D011572 2001
% 211.25/211.48  |- skos__hiddenLabel mesh__D011572 Psychoanalyses
% 211.25/211.48  |- skos__scopeNote mesh__D011572
% 211.25/211.48       The separation or resolution of the psyche into its constituent elements. The term has two separate meanings: 1. a procedure devised by Sigmund Freud, for investigating mental processes by means of free association, dream interpretation and interpretation of resistance and transference manifestations; and 2. a theory of psychology developed by Freud from his clinical experience with hysterical patients. %28%From Campbell, Psychiatric Dictionary, 1996%29%.%A%    
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D011572 2005
% 211.25/211.48  |- skos__annotation mesh__D011572
% 211.25/211.48       SPEC only: SPEC qualif; as ther = PSYCHOANALYTIC THERAPY   
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D011572 2002
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D011572 2006
% 211.25/211.48  |- mesh__dateRevised mesh__D011572 1999-11-08
% 211.25/211.48  |- skos__prefLabel mesh__D011572 Psychoanalysis
% 211.25/211.48  |- skos__hiddenLabel mesh__D005535 Rot, Foot
% 211.25/211.48  |- mesh__historyNote mesh__D005535 70   
% 211.25/211.48  |- skos__related mesh__D005535smesh__D020376
% 211.25/211.48  |- skos__historyNote mesh__D005535 Foot Diseases %28%1966-1969%29%
% 211.25/211.48  |- mesh__recordAuthorizer mesh__D005535 sjn
% 211.25/211.48  |- mesh__dateRevised mesh__D005535 2003-07-30
% 211.25/211.48  |- skos__broader mesh__D005535smesh__D000820
% 211.25/211.48  |- skos__historyNote mesh__D005535 Sheep Diseases %28%1966-1969%29%
% 211.25/211.48  |- skos__annotation mesh__D005535
% 211.25/211.48       coord IM with appropriate infection term %28%IM%29% + precoord animal/dis term %28%IM%29% + animal %28%NIM%29% or animal %28%IM%29% in absence of precoord + check tag ANIMALS%A%  
% 211.25/211.48  |- mesh__dateEstablished mesh__D005535 1970-01-01
% 211.25/211.48  |- skos__historyNote mesh__D005535 Swine Diseases %28%1966-1969%29%
% 211.25/211.48  |- rdf__type mesh__D005535sskos__Concept
% 211.25/211.48  |- skos__hiddenLabel mesh__D005535 Rots, Foot
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D005535 2005
% 211.25/211.48  |- skos__historyNote mesh__D005535 Cattle Diseases %28%1966-1969%29%
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D005535 2004
% 211.25/211.48  |- skos__hiddenLabel mesh__D005535 Foot Rots
% 211.25/211.48  |- skos__scopeNote mesh__D005535
% 211.25/211.48       A disease of the horny parts and of the adjacent soft structures of the feet of cattle, swine, and sheep. It is usually caused by Corynebacterium pyogenes or Bacteroides nodosus %28%see DICHELOBACTER NODOSUS%29%. It is also known as interdigital necrobacillosis. %28%From Black%27%s Veterinary Dictionary, 18th ed%29%%A%    
% 211.25/211.48  |- skos__related mesh__D005535smesh__D005675
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D005535 2006
% 211.25/211.48  |- mesh__publicMeSHNote mesh__D005535 70   
% 211.25/211.48  |- skos__prefLabel mesh__D005535 Foot Rot
% 211.25/211.48  |- mesh__dateCreated mesh__D005535 1999-01-01
% 211.25/211.48  |- mesh__recordMaintainer mesh__D005535 sjn
% 211.25/211.48  |- mesh__recordOriginator mesh__D005535 NLM
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009926 2006
% 211.25/211.48  |- rdf__type mesh__D009926sskos__Concept
% 211.25/211.48  |- mesh__dateCreated mesh__D009926 1999-01-01
% 211.25/211.48  |- skos__hiddenLabel mesh__D009926 Organ Preservations
% 211.25/211.48  |- mesh__publicMeSHNote mesh__D009926
% 211.25/211.48       84; was see under TISSUE PRESERVATION 1970-83   
% 211.25/211.48  |- skos__related mesh__D009926smesh__D020858
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009926 2005
% 211.25/211.48  |- mesh__recordMaintainer mesh__D009926 NLM
% 211.25/211.48  |- skos__hiddenLabel mesh__D009926 Preservation, Organ
% 211.25/211.48  |- mesh__recordOriginator mesh__D009926 NLM
% 211.25/211.48  |- skos__prefLabel mesh__D009926 Organ Preservation
% 211.25/211.48  |- skos__annotation mesh__D009926
% 211.25/211.48       cryopreservation of organ: coord IM with organ %28%no qualif%29% + CRYOPRESERVATION%A%  
% 211.25/211.48  |- skos__scopeNote mesh__D009926
% 211.25/211.48       The process by which organs are kept viable outside of the organism from which they were removed %28%i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism%29%.%A%    
% 211.25/211.48  |- mesh__historyNote mesh__D009926
% 211.25/211.48       84%28%75%29%; was see under TISSUE PRESERVATION 1969-83   
% 211.25/211.48  |- mesh__dateRevised mesh__D009926 2004-07-20
% 211.25/211.48  |- mesh__recordAuthorizer mesh__D009926 NLM
% 211.25/211.48  |- mesh__dateEstablished mesh__D009926 1984-01-01
% 211.25/211.48  |- skos__broader mesh__D009926smesh__D014021
% 211.25/211.48  |- skos__hiddenLabel mesh__D009926 Preservations, Organ
% 211.25/211.48  |- mesh__onlineNote mesh__D009926 search TISSUE PRESERVATION 1969-74   
% 211.25/211.48  |- skos__hiddenLabel mesh__D001943 Mammary Carcinomas, Human
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D001943 2005
% 211.25/211.48  |- skos__broader mesh__D001943smesh__D009371
% 211.25/211.48  |- skos__altLabel mesh__D001943 Cancer of Breast
% 211.25/211.48  |- mesh__dateCreated mesh__D001943 1999-01-01
% 211.25/211.48  |- skos__hiddenLabel mesh__D001943 Breast Tumor
% 211.25/211.48  |- skos__hiddenLabel mesh__D001943 Human Mammary Neoplasms
% 211.25/211.48  |- skos__hiddenLabel mesh__D001943 Human Mammary Neoplasm
% 211.25/211.48  |- skos__altLabel mesh__D001943 Tumors, Breast
% 211.25/211.48  |- skos__altLabel mesh__D001943 Human Mammary Carcinoma
% 211.25/211.48  |- mesh__recordMaintainer mesh__D001943 sjn
% 211.25/211.48  |- mesh__dateRevised mesh__D001943 2004-07-13
% 211.25/211.48  |- skos__hiddenLabel mesh__D001943 Neoplasms, Human Mammary
% 211.25/211.48  |- skos__hiddenLabel mesh__D001943 Neoplasm, Breast
% 211.25/211.48  |- skos__hiddenLabel mesh__D001943 Human Mammary Carcinomas
% 211.25/211.48  |- skos__altLabel mesh__D001943 Cancer of the Breast
% 211.25/211.48  |- skos__altLabel mesh__D001943 Breast Tumors
% 211.25/211.48  |- skos__hiddenLabel mesh__D001943 Cancer, Breast
% 211.25/211.48  |- mesh__recordAuthorizer mesh__D001943 sjn
% 211.25/211.48  |- skos__hiddenLabel mesh__D001943 Tumor, Breast
% 211.25/211.48  |- skos__prefLabel mesh__D001943 Breast Neoplasms
% 211.25/211.48  |- skos__hiddenLabel mesh__D001943 Breast Neoplasm
% 211.25/211.48  |- rdf__type mesh__D001943sskos__Concept
% 211.25/211.48  |- mesh__recordOriginator mesh__D001943 NLM
% 211.25/211.48  |- skos__annotation mesh__D001943
% 211.25/211.48       human only; BREAST NEOPLASMS, MALE is also available; for animal use MAMMARY NEOPLASMS, ANIMAL or MAMMARY NEOPLASMS, EXPERIMENTAL: Manual 24.5+, 24.6+;  coordinate IM with histological type of neoplasm %28%IM%29%%A%  
% 211.25/211.48  |- skos__broader mesh__D001943smesh__D001941
% 211.25/211.48  |- skos__scopeNote mesh__D001943 Tumors or cancer of the human BREAST.     
% 211.25/211.48  |- skos__altLabel mesh__D001943 Mammary Neoplasm, Human
% 211.25/211.48  |- skos__hiddenLabel mesh__D001943 Carcinomas, Human Mammary
% 211.25/211.48  |- skos__hiddenLabel mesh__D001943 Neoplasm, Human Mammary
% 211.25/211.48  |- skos__altLabel mesh__D001943 Neoplasms, Breast
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D001943 2006
% 211.25/211.48  |- skos__hiddenLabel mesh__D001943 Carcinoma, Human Mammary
% 211.25/211.48  |- skos__broader mesh__D011976Q000037smesh__D011976
% 211.25/211.48  |- mesh__preferredCombination mesh__D011976Q000037smesh__D018727
% 211.25/211.48  |- rdf__type mesh__D011976Q000037smesh__CompoundConcept
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009128 2000
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009128 2001
% 211.25/211.48  |- mesh__recordOriginator mesh__D009128 MM
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009128 2006
% 211.25/211.48  |- skos__broader mesh__D009128smesh__D009122
% 211.25/211.48  |- mesh__dateEstablished mesh__D009128 1977-01-01
% 211.25/211.48  |- mesh__publicMeSHNote mesh__D009128 1977   
% 211.25/211.48  |- skos__broader mesh__D009128smesh__D009135
% 211.25/211.48  |- skos__hiddenLabel mesh__D009128 Spasticity, Muscle
% 211.25/211.48  |- skos__hiddenLabel mesh__D009128 Clasp Knife Spasticity
% 211.25/211.48  |- mesh__recordAuthorizer mesh__D009128 ags
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009128 2002
% 211.25/211.48  |- mesh__recordMaintainer mesh__D009128 ags
% 211.25/211.48  |- skos__related mesh__D009128smesh__D013035
% 211.25/211.48  |- skos__scopeNote mesh__D009128
% 211.25/211.48       A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance %28%a %22%free interval%22%%29% followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. %28%From Adams et al., Principles of Neurology, 6th ed, p54%29%%A%    
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009128 2000A
% 211.25/211.48  |- skos__prefLabel mesh__D009128 Muscle Spasticity
% 211.25/211.48  |- mesh__dateCreated mesh__D009128 1976-05-19
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009128 2003
% 211.25/211.48  |- skos__annotation mesh__D009128
% 211.25/211.48       skeletal muscle only; note category: not physiological; spastic paralysis: coord NIM with PARALYSIS %28%IM%29%; spasticity in cerebral palsy: coord NIM with CEREBRAL PALSY only if musc spasticity is especially discussed%A%  
% 211.25/211.48  |- skos__hiddenLabel mesh__D009128 Spasticity, Clasp-Knife
% 211.25/211.48  |- skos__historyNote mesh__D009128 Spasm %28%1966-1976%29%
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009128 2004
% 211.25/211.48  |- rdf__type mesh__D009128sskos__Concept
% 211.25/211.48  |- mesh__dateRevised mesh__D009128 1999-12-06
% 211.25/211.48  |- mesh__historyNote mesh__D009128 1977   
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D009128 2005
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D001145 2002
% 211.25/211.48  |- skos__broader mesh__D001145smesh__D010335
% 211.25/211.48  |- skos__related mesh__D001145smesh__D000889
% 211.25/211.48  |- skos__broader mesh__D001145smesh__D006331
% 211.25/211.48  |- rdf__type mesh__D001145sskos__Concept
% 211.25/211.48  |- skos__hiddenLabel mesh__D001145 Arrhythmias
% 211.25/211.48  |- skos__altLabel mesh__D001145 Arrythmia
% 211.25/211.48  |- mesh__dateCreated mesh__D001145 1999-01-01
% 211.25/211.48  |- skos__scopeNote mesh__D001145
% 211.25/211.48       Any variation from the normal rhythm or rate of the heart beat.%A%    
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D001145 2000
% 211.25/211.48  |- skos__related mesh__D001145smesh__D004554
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D001145 2003
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D001145 2001
% 211.25/211.48  |- mesh__dateRevised mesh__D001145 1999-11-03
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D001145 2005
% 211.25/211.48  |- mesh__recordMaintainer mesh__D001145 KEV
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D001145 2004
% 211.25/211.48  |- skos__prefLabel mesh__D001145 Arrhythmia
% 211.25/211.48  |- skos__annotation mesh__D001145
% 211.25/211.48       GEN: prefer specifics; /drug ther: consider also ANTI-ARRHYTHMIA AGENTS%A%  
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D001145 2006
% 211.25/211.48  |- mesh__recordAuthorizer mesh__D001145 sjn
% 211.25/211.48  |- mesh__recordOriginator mesh__D001145 NLM
% 211.25/211.48  |- skos__hiddenLabel mesh__D019556 Cell, COS
% 211.25/211.48  |- mesh__dateEstablished mesh__D019556 1997-01-01
% 211.25/211.48  |- skos__hiddenLabel mesh__D019556 COS-7 Cell
% 211.25/211.48  |- skos__hiddenLabel mesh__D019556 Cell, COS-1
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D019556 2006
% 211.25/211.48  |- skos__hiddenLabel mesh__D019556 COS 7 Cells
% 211.25/211.48  |- skos__prefLabel mesh__D019556 COS Cells
% 211.25/211.48  |- mesh__historyNote mesh__D019556 97   
% 211.25/211.48  |- skos__hiddenLabel mesh__D019556 Cell, COS-7
% 211.25/211.48  |- skos__hiddenLabel mesh__D019556 COS Cell
% 211.25/211.48  |- mesh__publicMeSHNote mesh__D019556 97   
% 211.25/211.48  |- rdf__type mesh__D019556sskos__Concept
% 211.25/211.48  |- skos__scopeNote mesh__D019556
% 211.25/211.48       CELL LINES derived from the CV-1 cell line by transformation with a replication origin defective mutant of SV40 VIRUS, which codes for wild type large T antigen %28%ANTIGENS, POLYOMAVIRUS TRANSFORMING%29%. They are used for transfection and cloning. %28%The CV-1 cell line was derived from the kidney of an adult male African green monkey %28%CERCOPITHECUS AETHIOPS%29%.%29%%A%    
% 211.25/211.48  |- mesh__recordMaintainer mesh__D019556 nns
% 211.25/211.48  |- mesh__recordAuthorizer mesh__D019556 sjn
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D019556 2004
% 211.25/211.48  |- mesh__dateRevised mesh__D019556 2003-07-30
% 211.25/211.48  |- skos__annotation mesh__D019556
% 211.25/211.48       almost always NIM with no subheadings; check ANIMALS %26% add CERCOPITHECUS AETHIOPS %28%NIM%29%%A%  
% 211.25/211.48  |- mesh__recordOriginator mesh__D019556 AGS
% 211.25/211.48  |- skos__hiddenLabel mesh__D019556 Cells, COS
% 211.25/211.48  |- skos__hiddenLabel mesh__D019556 COS 1 Cells
% 211.25/211.48  |- skos__hiddenLabel mesh__D019556 COS-1 Cell
% 211.25/211.48  |- skos__hiddenLabel mesh__D019556 Cells, COS-1
% 211.25/211.48  |- skos__broader mesh__D019556smesh__D002461
% 211.25/211.48  |- mesh__dateCreated mesh__D019556 1996-06-10
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D019556 2005
% 211.25/211.48  |- skos__historyNote mesh__D019556 Cell Line %28%1983-1996%29%
% 211.25/211.48  |- skos__broader mesh__D019556smesh__D005347
% 211.25/211.48  |- skos__hiddenLabel mesh__D019556 Cells, COS-7
% 211.25/211.48  |- skos__altLabel mesh__D011573 Interpretation, Psychoanalytic
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D011573 2004
% 211.25/211.48  |- skos__hiddenLabel mesh__D011573 Psychoanalytic Interpretations
% 211.25/211.48  |- skos__hiddenLabel mesh__D011573 Interpretations, Psychoanalytic
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D011573 1996
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D011573 2005
% 211.25/211.48  |- mesh__recordMaintainer mesh__D011573 TAP
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D011573 2006
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D011573 1997
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D011573 2000
% 211.25/211.48  |- mesh__recordOriginator mesh__D011573 NLM
% 211.25/211.48  |- skos__broader mesh__D011573smesh__D004191
% 211.25/211.48  |- skos__altLabel mesh__D011573 Psychoanalytical Interpretation
% 211.25/211.48  |- skos__hiddenLabel mesh__D011573 Psychoanalytical Interpretations
% 211.25/211.48  |- skos__scopeNote mesh__D011573
% 211.25/211.48       Utilization of Freudian theories to explain various psychologic aspects of art, literature, biographical material, etc.%A%    
% 211.25/211.48  |- skos__prefLabel mesh__D011573 Psychoanalytic Interpretation
% 211.25/211.48  |- skos__annotation mesh__D011573
% 211.25/211.48       IM; no qualif; differentiate from PSYCHOANALYTIC THEORY in that the theory is on a more universal level%A%  
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D011573 1998
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D011573 1993
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D011573 2001
% 211.25/211.48  |- mesh__dateRevised mesh__D011573 1992-05-18
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D011573 1994
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D011573 1999
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D011573 2002
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D011573 1995
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D011573 2003
% 211.25/211.48  |- rdf__type mesh__D011573sskos__Concept
% 211.25/211.48  |- skos__hiddenLabel mesh__D011573 Interpretations, Psychoanalytical
% 211.25/211.48  |- skos__hiddenLabel mesh__D011573 Interpretation, Psychoanalytical
% 211.25/211.48  |- mesh__dateCreated mesh__D011573 1999-01-01
% 211.25/211.48  |- mesh__recordAuthorizer mesh__D011573 PLS
% 211.25/211.48  |- mesh__dateRevised mesh__D005536 2003-07-30
% 211.25/211.48  |- skos__prefLabel mesh__D005536 Foot-and-Mouth Disease
% 211.25/211.48  |- skos__annotation mesh__D005536
% 211.25/211.48       caused by a picornavirus: do not confuse with HAND, FOOT AND MOUTH DISEASE, a Coxsackie virus infect; check tag ANIMALS; DF: FOOT MOUTH DIS%A%  
% 211.25/211.48  |- mesh__recordOriginator mesh__D005536 NLM
% 211.25/211.48  |- mesh__recordMaintainer mesh__D005536 ags
% 211.25/211.48  |- rdf__type mesh__D005536sskos__Concept
% 211.25/211.48  |- mesh__activeMeSHYear mesh__D005536 2005
% 211.25/211.48  |- skos__altLabel mesh__D005536 Foot and Mouth Disease
% 211.25/211.49  |- mesh__activeMeSHYear mesh__D005536 2004
% 211.25/211.49  |- mesh__recordAuthorizer mesh__D005536 sjn
% 211.25/211.49  |- skos__broader mesh__D005536smesh__D000820
% 211.25/211.49  |- mesh__activeMeSHYear mesh__D005536 2006
% 211.25/211.49  |- skos__hiddenLabel mesh__D005536 Diseases, Foot-and-Mouth
% 211.25/211.49  |- mesh__dateCreated mesh__D005536 1999-01-01
% 211.25/211.49  |- skos__hiddenLabel mesh__D005536 Disease, Foot-and-Mouth
% 211.25/211.49  |- skos__broader mesh__D005536smesh__D010850
% 211.25/211.49  |- skos__hiddenLabel mesh__D005536 Foot-and-Mouth Diseases
% 211.25/211.49  |- skos__altLabel mesh__D015964 Regulation of Gene Expression, Bacterial
% 211.25/211.49  |- mesh__activeMeSHYear mesh__D015964 2003
% 211.25/211.49  |- mesh__historyNote mesh__D015964 90   
% 211.25/211.49  |- skos__historyNote mesh__D015964
% 211.25/211.49       Gene Expression Regulation %28%1981-1989%29%
% 211.25/211.49  |- mesh__recordMaintainer mesh__D015964 NDW
% 211.25/211.49  |- skos__scopeNote mesh__D015964
% 211.25/211.49       Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in bacteria.%A%    
% 211.25/211.49  |- skos__prefLabel mesh__D015964 Gene Expression Regulation, Bacterial
% 211.25/211.49  |- rdf__type mesh__D015964sskos__Concept
% 211.25/211.49  |- mesh__activeMeSHYear mesh__D015964 2004
% 211.25/211.49  |- mesh__dateCreated mesh__D015964 1989-05-25
% 211.25/211.49  |- skos__broader mesh__D015964smesh__D005786
% 211.25/211.49  |- mesh__activeMeSHYear mesh__D015964 2005
% 211.25/211.49  |- skos__altLabel mesh__D015964 Regulation, Gene Expression, Bacterial
% 211.25/211.49  |- mesh__dateEstablished mesh__D015964 1990-01-01
% 211.25/211.49  |- mesh__recordOriginator mesh__D015964 PXP
% 211.25/211.49  |- mesh__activeMeSHYear mesh__D015964 2006
% 211.25/211.49  |- mesh__dateRevised mesh__D015964 2002-07-02
% 211.25/211.49  |- mesh__publicMeSHNote mesh__D015964 90   
% 211.25/211.49  |- skos__annotation mesh__D015964
% 211.25/211.49       coord IM with specific bacterium /genet %28%IM%29%; DF: GENE EXPRESSION REG BACT%A%  
% 211.25/211.49  |- mesh__recordAuthorizer mesh__D015964 sjn
% 211.25/211.49  |- skos__historyNote mesh__D015964 specific bacteria %28%1973-1989%29%
% 211.25/211.49  |- skos__historyNote mesh__D015964 Genes, Regulator %28%1973-1980%29%
% 211.25/211.49  |- skos__altLabel mesh__D015964 Bacterial Gene Expression Regulation
% 211.25/211.49  |- skos__hiddenLabel mesh__D015166 Radioimmunological Monitoring
% 211.25/211.49  |- mesh__historyNote mesh__D015166 89   
% 211.25/211.49  |- skos__historyNote mesh__D015166
% 211.25/211.49       Monitoring, Physiologic %28%1976-1988%29%
% 211.25/211.49  |- skos__altLabel mesh__D015166 Immunosurveillance
% 211.25/211.49  |- mesh__recordAuthorizer mesh__D015166 SJN
% 211.25/211.49  |- mesh__activeMeSHYear mesh__D015166 2006
% 211.25/211.49  |- mesh__activeMeSHYear mesh__D015166 2001
% 211.25/211.49  |- skos__historyNote mesh__D015166 Immunotherapy %28%1974-1988%29%
% 211.25/211.49  |- skos__altLabel mesh__D015166 Monitoring, Immunological
% 211.25/211.49  |- mesh__activeMeSHYear mesh__D015166 1999
% 211.25/211.49  |- skos__altLabel mesh__D015166 Monitoring, Immune
% 211.25/211.49  |- mesh__activeMeSHYear mesh__D015166 2005
% 211.25/211.49  |- skos__altLabel mesh__D015166 Monitoring, Radioimmunological
% 211.25/211.49  |- mesh__activeMeSHYear mesh__D015166 2004
% 211.25/211.49  |- skos__broader mesh__D015166smesh__D007158
% 211.25/211.49  |- skos__broader mesh__D015166smesh__D007159
% 211.25/211.49  |- skos__annotation mesh__D015166
% 211.25/211.49       determ of immune status of patient in diag %26% ther: do not confuse X ref IMMUNOSURVEILLANCE with IMMUNOLOGIC SURVEILLANCE, a function of T-lymphocytes; IM GEN only; avoid indexing routinely every word %22%monitoring%22% as %22%monitoring%22%: read MeSH definition; DF: MONITORING IMMUNOL%A%  
% 211.25/211.49  |- mesh__publicMeSHNote mesh__D015166 89   
% 211.25/211.49  |- skos__altLabel mesh__D015166 Immunologic Monitoring
% 211.25/211.49  |- mesh__activeMeSHYear mesh__D015166 1998
% 211.25/211.49  |- mesh__activeMeSHYear mesh__D015166 2000
% 211.25/211.49  |- mesh__dateEstablished mesh__D015166 1989-01-01
% 211.25/211.49  |- mesh__dateRevised mesh__D015166 1997-06-20
% 211.25/211.49  |- mesh__activeMeSHYear mesh__D015166 2003
% 211.25/211.49  |- mesh__dateCreated mesh__D015166 1988-04-08
% 211.25/211.49  |- skos__hiddenLabel mesh__D015166 Immunological Monitoring
% 211.25/211.49  |- rdf__type mesh__D015166sskos__Concept
% 211.25/211.49  |- skos__scopeNote mesh__D015166
% 211.25/211.49       Testing of immune status in the diagnosis and therapy of cancer, immunoproliferative and immunodeficiency disorders, and autoimmune abnormalities. Changes in immune parameters are of special significance before, during and following organ transplantation. Strategies include measurement of tumor antigen and other markers %28%often by RADIOIMMUNOASSAY%29%, studies of cellular or humoral immunity in cancer etiology, IMMUNOTHERAPY trials, etc.%A%    
% 211.25/211.49  |- skos__altLabel mesh__D015166 Monitoring, Radioimmunologic
% 211.25/211.49  |- skos__altLabel mesh__D015166 Immune Monitoring
% 211.25/211.49  |- mesh__recordOriginator mesh__D015166 SCD
% 211.25/211.49  |- mesh__recordMaintainer mesh__D015166 PXP
% 211.25/211.49  |- skos__prefLabel mesh__D015166 Monitoring, Immunologic
% 211.25/211.49  |- skos__historyNote mesh__D015166 Immunosuppression %28%1977-1988%29%
% 211.25/211.49  |- mesh__activeMeSHYear mesh__D015166 2002
% 211.25/211.49  |- skos__broader mesh__D015166smesh__D008991
% 211.25/211.49  |- skos__hiddenLabel mesh__D009927 Organ Procurements
% 211.25/211.49  |- skos__prefLabel mesh__D009927 Tissue and Organ Procurement
% 211.25/211.49  |- mesh__publicMeSHNote mesh__D009927
% 211.25/211.49       2005; see ORGAN PROCUREMENT 1987-2004   
% 211.25/211.49  |- skos__hiddenLabel mesh__D009927 Organ Procurement System
% 211.25/211.49  |- skos__altLabel mesh__D009927 Required Request
% 211.25/211.49  |- skos__related mesh__D009927smesh__D014019
% 211.25/211.49  |- mesh__historyNote mesh__D009927 2005 %28%1987%29%   
% 211.25/211.49  |- skos__related mesh__D009927smesh__D014015
% 211.25/211.49  |- skos__hiddenLabel mesh__D009927 Required Requests
% 211.25/211.49  |- skos__hiddenLabel mesh__D009927 Cards, Donor
% 211.25/211.49  |- mesh__recordAuthorizer mesh__D009927 sjn
% 211.25/211.49  |- skos__historyNote mesh__D009927 Tissue Donors %28%1966-1986%29%
% 211.25/211.49  |- mesh__dateRevised mesh__D009927 2004-07-13
% 211.25/211.49  |- skos__hiddenLabel mesh__D009927 Tissue Donations
% 211.25/211.49  |- skos__broader mesh__D009927smesh__D006296
% 211.25/211.49  |- skos__hiddenLabel mesh__D009927 Tissue Procurements
% 211.25/211.49  |- skos__hiddenLabel mesh__D009927 Donor Card
% 211.25/211.49  |- mesh__dateEstablished mesh__D009927 1987-01-01
% 211.25/211.49  |- mesh__recordMaintainer mesh__D009927 sjn
% 211.25/211.49  |- mesh__recordOriginator mesh__D009927 EC
% 211.34/211.49  |- skos__hiddenLabel mesh__D009927 Organ Donations
% 211.34/211.49  |- mesh__activeMeSHYear mesh__D009927 2006
% 211.34/211.49  |- rdf__type mesh__D009927sskos__Concept
% 211.34/211.49  |- skos__scopeNote mesh__D009927
% 211.34/211.49       The administrative procedures involved with acquiring TISSUES or organs for TRANSPLANTATION through various programs, systems, or organizations. These procedures include obtaining consent from TISSUE DONORS and arranging for transportation of donated tissues and organs, after TISSUE HARVESTING, to HOSPITALS for processing and transplantation.%A%    
% 211.34/211.49  |- skos__related mesh__D009927smesh__D020858
% 211.34/211.49  |- mesh__dateCreated mesh__D009927 1986-05-30
% 211.34/211.49  |- skos__hiddenLabel mesh__D009927 Card, Donor
% 211.34/211.49  |- mesh__activeMeSHYear mesh__D009927 2005
% 211.34/211.49  |- mesh__recordOriginator mesh__D001944 NLM
% 211.34/211.49  |- mesh__activeMeSHYear mesh__D001944 1999
% 211.34/211.49  |- skos__prefLabel mesh__D001944 Breath Tests
% 211.34/211.49  |- skos__hiddenLabel mesh__D001944 Tests, Breath
% 211.34/211.49  |- skos__hiddenLabel mesh__D001944 Tests, Breathalyzer
% 211.34/211.49  |- mesh__activeMeSHYear mesh__D001944 2000
% 211.34/211.49  |- skos__hiddenLabel mesh__D001944 Test, Breathalyzer
% 211.34/211.49  |- rdf__type mesh__D001944sskos__Concept
% 211.34/211.49  |- skos__broader mesh__D001944smesh__D019937
% 211.34/211.49  |- skos__hiddenLabel mesh__D001944 Breath Test
% 211.34/211.49  |- mesh__historyNote mesh__D001944 74   
% 211.34/211.49  |- mesh__dateRevised mesh__D001944 1997-06-20
% 211.34/211.49  |- mesh__activeMeSHYear mesh__D001944 2005
% 211.34/211.49  |- mesh__dateCreated mesh__D001944 1999-01-01
% 211.34/211.49  |- skos__annotation mesh__D001944 NIM   
% 211.34/211.49  |- mesh__activeMeSHYear mesh__D001944 2001
% 211.34/211.49  |- mesh__activeMeSHYear mesh__D001944 2003
% 211.34/211.49  |- skos__scopeNote mesh__D001944 Any tests done on exhaled air.     
% 211.34/211.49  |- mesh__dateEstablished mesh__D001944 1974-01-01
% 211.34/211.49  |- skos__hiddenLabel mesh__D001944 Test, Breath
% 211.34/211.49  |- mesh__recordMaintainer mesh__D001944 PXP
% 211.34/211.49  |- mesh__publicMeSHNote mesh__D001944 74   
% 211.34/211.49  |- mesh__activeMeSHYear mesh__D001944 2006
% 211.34/211.49  |- mesh__activeMeSHYear mesh__D001944 2002
% 211.34/211.49  |- mesh__activeMeSHYear mesh__D001944 1998
% 211.34/211.49  |- mesh__activeMeSHYear mesh__D001944 2004
% 211.34/211.49  |- mesh__recordAuthorizer mesh__D001944 SJN
% 211.34/211.49  |- skos__hiddenLabel mesh__D001944 Breathalyzer Test
% 211.34/211.49  |- mesh__historyNote mesh__D009129 72%28%70%29%   
% 211.34/211.49  |- skos__scopeNote mesh__D009129
% 211.34/211.49       The state of activity or tension of a muscle beyond that related to its physical properties, that is, its active resistance to stretch. In skeletal muscle, tonus is dependent upon efferent innervation. %28%Stedman, 25th ed%29%%A%    
% 211.34/211.49  |- mesh__recordAuthorizer mesh__D009129 sjn
% 211.34/211.49  |- skos__related mesh__D009129smesh__D004421
% 211.34/211.49  |- mesh__recordMaintainer mesh__D009129 nns
% 211.34/211.49  |- skos__historyNote mesh__D009129 Muscle Contraction %28%1966-1969%29%
% 211.34/211.49  |- mesh__dateCreated mesh__D009129 1999-01-01
% 211.34/211.49  |- mesh__activeMeSHYear mesh__D009129 2004
% 211.34/211.49  |- rdf__type mesh__D009129sskos__Concept
% 211.34/211.49  |- skos__related mesh__D009129smesh__D009123
% 211.34/211.49  |- skos__prefLabel mesh__D009129 Muscle Tonus
% 211.34/211.49  |- mesh__activeMeSHYear mesh__D009129 2005
% 211.34/211.49  |- skos__broader mesh__D009129smesh__D043703
% 211.34/211.49  |- mesh__publicMeSHNote mesh__D009129 72   
% 211.34/211.49  |- skos__related mesh__D009129smesh__D009122
% 211.34/211.49  |- mesh__activeMeSHYear mesh__D009129 2006
% 211.35/211.49  |- mesh__dateRevised mesh__D009129 2003-07-09
% 211.35/211.49  |- skos__hiddenLabel mesh__D009129 Tonus, Muscle
% 211.35/211.49  |- mesh__recordOriginator mesh__D009129 NLM
% 211.35/211.49  |- mesh__dateEstablished mesh__D009129 1972-01-01
% 211.35/211.49  |- mesh__dateCreated mesh__D001146 1999-01-01
% 211.35/211.49  |- mesh__recordOriginator mesh__D001146 NLM
% 211.35/211.49  |- mesh__recordAuthorizer mesh__D001146 sjn
% 211.35/211.49  |- skos__scopeNote mesh__D001146
% 211.35/211.49       Irregularity of the heart rate related to functioning of the sinoatrial node.%A%    
% 211.35/211.49  |- skos__hiddenLabel mesh__D001146 Sinus Arrhythmias
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D001146 2002
% 211.35/211.49  |- skos__prefLabel mesh__D001146 Arrhythmia, Sinus
% 211.35/211.49  |- skos__altLabel mesh__D001146 Sinus Arrhythmia
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D001146 2003
% 211.35/211.49  |- skos__annotation mesh__D001146
% 211.35/211.49       sinus refers to sinoatrial node; sinus parasystole: coord IM with PARASYSTOLE %28%IM%29%%A%  
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D001146 2005
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D001146 2004
% 211.35/211.49  |- skos__hiddenLabel mesh__D001146 Arrhythmias, Sinus
% 211.35/211.49  |- skos__broader mesh__D001146smesh__D001145
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D001146 2006
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D001146 2000
% 211.35/211.49  |- mesh__recordMaintainer mesh__D001146 TPW
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D001146 2001
% 211.35/211.49  |- mesh__dateRevised mesh__D001146 1999-11-03
% 211.35/211.49  |- rdf__type mesh__D001146sskos__Concept
% 211.35/211.49  |- skos__hiddenLabel mesh__D020300 Posterior Fossa Hemorrhages
% 211.35/211.49  |- skos__prefLabel mesh__D020300 Intracranial Hemorrhages
% 211.35/211.49  |- skos__broader mesh__D020300smesh__D006470
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D020300 2000
% 211.35/211.49  |- mesh__dateCreated mesh__D020300 1999-11-03
% 211.35/211.49  |- rdf__type mesh__D020300sskos__Concept
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D020300 2005
% 211.35/211.49  |- mesh__publicMeSHNote mesh__D020300 2000   
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D020300 2001
% 211.35/211.49  |- skos__hiddenLabel mesh__D020300 Hemorrhage, Posterior Fossa
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D020300 2003
% 211.35/211.49  |- skos__historyNote mesh__D020300 Cerebral Hemorrhage %28%1966-1999%29%
% 211.35/211.49  |- skos__hiddenLabel mesh__D020300 Hemorrhage, Brain
% 211.35/211.49  |- skos__scopeNote mesh__D020300
% 211.35/211.49       Bleeding within the intracranial cavity, including hemorrhages in the brain and within the cranial epidural, subdural, and subarachnoid spaces.%A%    
% 211.35/211.49  |- mesh__historyNote mesh__D020300 2000   
% 211.35/211.49  |- skos__broader mesh__D020300smesh__D002561
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D020300 2006
% 211.35/211.49  |- skos__hiddenLabel mesh__D020300 Hemorrhages, Brain
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D020300 2002
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D020300 2004
% 211.35/211.49  |- skos__hiddenLabel mesh__D020300 Hemorrhages, Posterior Fossa
% 211.35/211.49  |- skos__hiddenLabel mesh__D020300 Intracranial Hemorrhage
% 211.35/211.49  |- skos__hiddenLabel mesh__D020300 Hemorrhages, Intracranial
% 211.35/211.49  |- mesh__dateEstablished mesh__D020300 2000-01-01
% 211.35/211.49  |- skos__altLabel mesh__D020300 Hemorrhage, Intracranial
% 211.35/211.49  |- skos__hiddenLabel mesh__D020300 Brain Hemorrhages
% 211.35/211.49  |- skos__hiddenLabel mesh__D047248 Compounds, Thia Crown
% 211.35/211.49  |- skos__hiddenLabel mesh__D047248 Crown Compounds, Aza-Thia
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D047248 2006
% 211.35/211.49  |- mesh__recordMaintainer mesh__D047248 ssb
% 211.35/211.49  |- mesh__recordOriginator mesh__D047248 ssb
% 211.35/211.49  |- skos__hiddenLabel mesh__D047248 Compounds, Aza-Thia Crown
% 211.35/211.49  |- skos__historyNote mesh__D047248 Crown Ethers %28%1992-2004%29%
% 211.35/211.49  |- mesh__dateCreated mesh__D047248 2004-07-07
% 211.35/211.49  |- mesh__historyNote mesh__D047248 2005; use CROWN ETHERS 1993-2004   
% 211.35/211.49  |- skos__hiddenLabel mesh__D047248 Aza Thia Crown Compounds
% 211.35/211.49  |- skos__hiddenLabel mesh__D047248 Compounds, Aza Crown
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D047248 2005
% 211.35/211.49  |- skos__hiddenLabel mesh__D047248 Crown Compounds, Aza
% 211.35/211.49  |- skos__hiddenLabel mesh__D047248 Compounds, Crown
% 211.35/211.49  |- skos__hiddenLabel mesh__D047248 Crown Compounds, Thia
% 211.35/211.49  |- mesh__publicMeSHNote mesh__D047248 2005; see CROWN ETHERS 1993-2004   
% 211.35/211.49  |- rdf__type mesh__D047248sskos__Concept
% 211.35/211.49  |- mesh__dateEstablished mesh__D047248 2005-01-01
% 211.35/211.49  |- skos__scopeNote mesh__D047248
% 211.35/211.49       Macrocyclic compounds analogous to CROWN ETHERS but which lack any OXYGEN atoms.%A%    
% 211.35/211.49  |- skos__prefLabel mesh__D047248 Crown Compounds
% 211.35/211.49  |- mesh__recordAuthorizer mesh__D047248 sjn
% 211.35/211.49  |- skos__broader mesh__D047248smesh__D047028
% 211.35/211.49  |- rdf__type mesh__D019557sskos__Concept
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D019557 2003
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D019557 1999
% 211.35/211.49  |- skos__altLabel mesh__D019557 Periocular Dermatitis
% 211.35/211.49  |- skos__broader mesh__D019557smesh__D005148
% 211.35/211.49  |- mesh__dateEstablished mesh__D019557 1997-01-01
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D019557 2004
% 211.35/211.49  |- skos__altLabel mesh__D019557 Perioral Dermatitis
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D019557 2000
% 211.35/211.49  |- skos__annotation mesh__D019557
% 211.35/211.49       note X ref DERMATITIS, PERIOCULAR: can extend to this area%A%  
% 211.35/211.49  |- skos__historyNote mesh__D019557 Facial Dermatoses %28%1968-1996%29%
% 211.35/211.49  |- mesh__publicMeSHNote mesh__D019557 97   
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D019557 2001
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D019557 1997
% 211.35/211.49  |- skos__hiddenLabel mesh__D019557 Periocular Dermatitides
% 211.35/211.49  |- skos__scopeNote mesh__D019557
% 211.35/211.49       A papular eruption of unknown etiology that progresses to residual papular erythema and scaling usually confined to the area of the mouth, and almost exclusively occurring in young women. It may also be localized or extend to involve the eyelids and adjacent glabella area of the forehead %28%periocular dermatitis%29%. %28%Dorland, 28th ed%29%%A%    
% 211.35/211.49  |- skos__hiddenLabel mesh__D019557 Perioral Dermatitides
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D019557 2005
% 211.35/211.49  |- skos__historyNote mesh__D019557 Dermatitis %28%1969-1996%29%
% 211.35/211.49  |- mesh__dateCreated mesh__D019557 1996-06-13
% 211.35/211.49  |- skos__broader mesh__D019557smesh__D003872
% 211.35/211.49  |- skos__hiddenLabel mesh__D019557 Dermatitides, Perioral
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D019557 2006
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D019557 1998
% 211.35/211.49  |- skos__prefLabel mesh__D019557 Dermatitis, Perioral
% 211.35/211.49  |- skos__hiddenLabel mesh__D019557 Dermatitides, Periocular
% 211.35/211.49  |- mesh__historyNote mesh__D019557 97   
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D019557 2002
% 211.35/211.49  |- skos__annotation mesh__D011574
% 211.35/211.49       IM; no qualif; /hist = PSYCHOANALYSIS /hist; differentiate from PSYCHOANALYTIC INTERPRETATION in that the theory is on a more universal, less subjective level%A%  
% 211.35/211.49  |- skos__altLabel mesh__D011574 Theory, Psychoanalytic
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D011574 2004
% 211.35/211.49  |- skos__scopeNote mesh__D011574
% 211.35/211.49       Conceptual system developed by Freud and his followers in which unconscious motivations are considered to shape normal and abnormal personality development and behavior.%A%    
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D011574 1998
% 211.35/211.49  |- rdf__type mesh__D011574sskos__Concept
% 211.35/211.49  |- skos__hiddenLabel mesh__D011574 Characters, Oral
% 211.35/211.49  |- mesh__dateEstablished mesh__D011574 1966-01-01
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D011574 2003
% 211.35/211.49  |- skos__hiddenLabel mesh__D011574 Psychoanalytic Theories
% 211.35/211.49  |- skos__altLabel mesh__D011574 Psychoanalytical Theory
% 211.35/211.49  |- skos__broader mesh__D011574smesh__D011582
% 211.35/211.49  |- skos__hiddenLabel mesh__D011574 Character, Oral
% 211.35/211.49  |- mesh__publicMeSHNote mesh__D011574
% 211.35/211.49       66; ORAL CHARACTER was heading 1975-96 %28%see under PSYCHOANALYTIC THEORY 1975-90%29%%A%  
% 211.35/211.49  |- skos__hiddenLabel mesh__D011574 Theories, Psychoanalytic
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D011574 1997
% 211.35/211.49  |- skos__hiddenLabel mesh__D011574 Oral Characters
% 211.35/211.49  |- mesh__dateRevised mesh__D011574 1996-06-10
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D011574 2002
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D011574 2006
% 211.35/211.49  |- skos__hiddenLabel mesh__D011574 Theories, Psychoanalytical
% 211.35/211.49  |- skos__hiddenLabel mesh__D011574 Theory, Psychoanalytical
% 211.35/211.49  |- mesh__recordMaintainer mesh__D011574 PXP
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D011574 2001
% 211.35/211.49  |- mesh__recordOriginator mesh__D011574 NLM
% 211.35/211.49  |- mesh__dateCreated mesh__D011574 1999-01-01
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D011574 2005
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D011574 2000
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D011574 1999
% 211.35/211.49  |- mesh__historyNote mesh__D011574
% 211.35/211.49       66; ORAL CHARACTER was heading 1975-96 %28%see under PSYCHOANALYTIC THEORY 1975-90%29%%A%  
% 211.35/211.49  |- skos__prefLabel mesh__D011574 Psychoanalytic Theory
% 211.35/211.49  |- skos__hiddenLabel mesh__D011574 Psychoanalytical Theories
% 211.35/211.49  |- mesh__recordAuthorizer mesh__D011574 PLS
% 211.35/211.49  |- skos__prefLabel mesh__D005537 Aphthovirus
% 211.35/211.49  |- rdf__type mesh__D005537sskos__Concept
% 211.35/211.49  |- mesh__dateRevised mesh__D005537 2001-07-25
% 211.35/211.49  |- skos__broader mesh__D005537smesh__D010849
% 211.35/211.49  |- mesh__recordMaintainer mesh__D005537 ags
% 211.35/211.49  |- skos__hiddenLabel mesh__D005537 rhinovirus 1, Equine
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D005537 2003
% 211.35/211.49  |- mesh__recordAuthorizer mesh__D005537 sjn
% 211.35/211.49  |- skos__annotation mesh__D005537
% 211.35/211.49       infection: coord IM with PICORNAVIRIDAE INFECTIONS %28%IM%29%   
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D005537 2005
% 211.35/211.49  |- mesh__dateCreated mesh__D005537 1999-01-01
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D005537 2004
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D005537 2006
% 211.35/211.49  |- skos__scopeNote mesh__D005537
% 211.35/211.49       A genus of the family PICORNAVIRIDAE infecting mainly cloven-hoofed animals. They cause vesicular lesions and upper respiratory tract infections. FOOT AND MOUTH DISEASE VIRUS is the type species.%A%    
% 211.35/211.49  |- skos__hiddenLabel mesh__D005537 Aphthoviruses
% 211.35/211.49  |- mesh__historyNote mesh__D005537 1994 %28%1963%29%   
% 211.35/211.49  |- skos__altLabel mesh__D005537 Equine rhinovirus 1
% 211.35/211.49  |- mesh__publicMeSHNote mesh__D005537
% 211.35/211.49       1994; see FOOT-AND-MOUTH DISEASE VIRUS 1963-1993   
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D005537 2002
% 211.35/211.49  |- mesh__recordOriginator mesh__D005537 NLM
% 211.35/211.49  |- skos__scopeNote mesh__D015167
% 211.35/211.49       Bilateral dissection of the abdominal branches of the vagus nerve. It is used frequently in the surgical management of duodenal and gastric ulcers, as well as in physiologic studies of gastrointestinal secretion and motility.%A%    
% 211.35/211.49  |- skos__annotation mesh__D015167
% 211.35/211.49       do not use /util except by MeSH definition   
% 211.35/211.49  |- mesh__recordMaintainer mesh__D015167 PXP
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D015167 2006
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D015167 2002
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D015167 1999
% 211.35/211.49  |- mesh__historyNote mesh__D015167 89   
% 211.35/211.49  |- skos__hiddenLabel mesh__D015167 Truncal Vagotomies
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D015167 2005
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D015167 2004
% 211.35/211.49  |- skos__historyNote mesh__D015167 Vagotomy %28%1966-1988%29%
% 211.35/211.49  |- mesh__publicMeSHNote mesh__D015167 89   
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D015167 1998
% 211.35/211.49  |- mesh__recordAuthorizer mesh__D015167 SJN
% 211.35/211.49  |- mesh__dateEstablished mesh__D015167 1989-01-01
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D015167 2003
% 211.35/211.49  |- skos__broader mesh__D015167smesh__D014628
% 211.35/211.49  |- skos__hiddenLabel mesh__D015167 Vagotomies, Truncal
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D015167 2001
% 211.35/211.49  |- rdf__type mesh__D015167sskos__Concept
% 211.35/211.49  |- mesh__recordOriginator mesh__D015167 SCD
% 211.35/211.49  |- skos__altLabel mesh__D015167 Truncal Vagotomy
% 211.35/211.49  |- skos__prefLabel mesh__D015167 Vagotomy, Truncal
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D015167 2000
% 211.35/211.49  |- mesh__dateRevised mesh__D015167 1997-06-20
% 211.35/211.49  |- mesh__dateCreated mesh__D015167 1988-04-08
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D009928 1995
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D009928 2001
% 211.35/211.49  |- mesh__recordOriginator mesh__D009928 NLM
% 211.35/211.49  |- skos__scopeNote mesh__D009928
% 211.35/211.49       Restriction of a characteristic or response to a particular organ of the body; it usually refers to that property of the immune response which differentiates one organ from another on the basis of antigen recognition, but the concept is not limited to immunology.%A%    
% 211.35/211.49  |- skos__broader mesh__D009928smesh__D000918
% 211.35/211.49  |- skos__hiddenLabel mesh__D009928 Specificity, Organ
% 211.35/211.49  |- mesh__recordMaintainer mesh__D009928 TAP
% 211.35/211.49  |- skos__hiddenLabel mesh__D009928 Organ Specificities
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D009928 1996
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D009928 2003
% 211.35/211.49  |- mesh__dateCreated mesh__D009928 1999-01-01
% 211.35/211.49  |- mesh__dateEstablished mesh__D009928 1967-01-01
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D009928 1998
% 211.35/211.49  |- skos__hiddenLabel mesh__D009928 Specificities, Organ
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D009928 1997
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D009928 2002
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D009928 2005
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D009928 2004
% 211.35/211.49  |- skos__prefLabel mesh__D009928 Organ Specificity
% 211.35/211.49  |- skos__annotation mesh__D009928
% 211.35/211.49       IM GEN only; coord NIM with specific organ %28%IM%29%; %22%tissue specificity%22% goes here if reasonable %28%i.e., liver tissue specificity = LIVER + ORGAN SPECIFICITY but connective tissue specificity is not CONNECTIVE TISSUE + ORGAN SPECIFICITY%29%%A%  
% 211.35/211.49  |- mesh__dateRevised mesh__D009928 1992-05-15
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D009928 1999
% 211.35/211.49  |- rdf__type mesh__D009928sskos__Concept
% 211.35/211.49  |- mesh__recordAuthorizer mesh__D009928 PLS
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D009928 2006
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D009928 1994
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D009928 2000
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D009928 1993
% 211.35/211.49  |- mesh__historyNote mesh__D009928 67%28%64%29%   
% 211.35/211.49  |- mesh__publicMeSHNote mesh__D009928 67   
% 211.35/211.49  |- skos__hiddenLabel mesh__D001945 Muscle Training, Respiratory
% 211.35/211.49  |- mesh__recordAuthorizer mesh__D001945 sjn
% 211.35/211.49  |- skos__related mesh__D001945smesh__D015013
% 211.35/211.49  |- skos__hiddenLabel mesh__D001945 Gong, Qi
% 211.35/211.49  |- skos__hiddenLabel mesh__D001945 Training, Respiratory Muscle
% 211.35/211.49  |- mesh__recordOriginator mesh__D001945 NLM
% 211.35/211.49  |- skos__scopeNote mesh__D001945
% 211.35/211.49       Therapeutic exercises aimed to deepen inspiration or expiration or even to alter the rate and rhythm of respiration.%A%    
% 211.35/211.49  |- rdf__type mesh__D001945sskos__Concept
% 211.35/211.49  |- skos__altLabel mesh__D001945 Respiratory Muscle Training
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D001945 2005
% 211.35/211.49  |- mesh__dateCreated mesh__D001945 1999-01-01
% 211.35/211.49  |- skos__hiddenLabel mesh__D001945 Exercise, Breathing
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D001945 2003
% 211.35/211.49  |- skos__hiddenLabel mesh__D001945 Kung, Ch%27%i
% 211.35/211.49  |- skos__broader mesh__D001945smesh__D026441
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D001945 2006
% 211.35/211.49  |- skos__prefLabel mesh__D001945 Breathing Exercises
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D001945 2004
% 211.35/211.49  |- skos__altLabel mesh__D001945 Qi Gong
% 211.35/211.49  |- mesh__dateRevised mesh__D001945 2002-07-02
% 211.35/211.49  |- skos__broader mesh__D001945smesh__D026241
% 211.35/211.49  |- mesh__recordMaintainer mesh__D001945 mdb
% 211.35/211.49  |- skos__scopeNote mesh__D034321
% 211.35/211.49       A condition with abnormally elevated level of AMYLASES in the serum.  Hyperamylasemia due to PANCREATITIS or other causes may be differentiated by identifying the amylase isoenzymes.%A%    
% 211.35/211.49  |- skos__broader mesh__D034321smesh__D008659
% 211.35/211.49  |- mesh__dateCreated mesh__D034321 2002-07-03
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D034321 2003
% 211.35/211.49  |- mesh__historyNote mesh__D034321 2003   
% 211.35/211.49  |- mesh__activeMeSHYear mesh__D034321 2004
% 211.35/211.50  |- mesh__dateEstablished mesh__D034321 2003-01-01
% 211.35/211.50  |- rdf__type mesh__D034321sskos__Concept
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D034321 2005
% 211.35/211.50  |- skos__historyNote mesh__D034321 Amylases %28%1967-2002%29%
% 211.35/211.50  |- skos__prefLabel mesh__D034321 Hyperamylasemia
% 211.35/211.50  |- skos__historyNote mesh__D034321 Metabolic Diseases %28%1970-2002%29%
% 211.35/211.50  |- mesh__publicMeSHNote mesh__D034321 2003   
% 211.35/211.50  |- skos__related mesh__D034321smesh__D000681
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D034321 2006
% 211.35/211.50  |- skos__broader mesh__D006521Q000139smesh__D006521
% 211.35/211.50  |- mesh__preferredCombination mesh__D006521Q000139smesh__D019702
% 211.35/211.50  |- rdf__type mesh__D006521Q000139smesh__CompoundConcept
% 211.35/211.50  |- skos__hiddenLabel mesh__D001147 Acid, Arsanilic
% 211.35/211.50  |- skos__altLabel mesh__D001147 p-Aminophenylarsonic Acid
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D001147 2002
% 211.35/211.50  |- mesh__historyNote mesh__D001147
% 211.35/211.50       91%28%79%29%; was see under ARSENICALS 1979-90   
% 211.35/211.50  |- mesh__dateCreated mesh__D001147 1978-05-17
% 211.35/211.50  |- skos__hiddenLabel mesh__D001147 p Aminophenylarsonic Acid
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D001147 2005
% 211.35/211.50  |- skos__altLabel mesh__D001147 4-Aminobenzenearsonic Acid
% 211.35/211.50  |- skos__historyNote mesh__D001147 Arsenicals %28%1966-1978%29%
% 211.35/211.50  |- rdf__type mesh__D001147sskos__Concept
% 211.35/211.50  |- skos__altLabel mesh__D001147 Sodium Arsanilate
% 211.35/211.50  |- skos__hiddenLabel mesh__D001147 4 Aminobenzenearsonic Acid
% 211.35/211.50  |- mesh__recordMaintainer mesh__D001147 CCR
% 211.35/211.50  |- mesh__recordOriginator mesh__D001147 RLS
% 211.35/211.50  |- skos__broader mesh__D001147smesh__D001152
% 211.35/211.50  |- skos__prefLabel mesh__D001147 Arsanilic Acid
% 211.35/211.50  |- skos__hiddenLabel mesh__D001147 Acid, p-Aminophenylarsonic
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D001147 2001
% 211.35/211.50  |- mesh__recordAuthorizer mesh__D001147 sjn
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D001147 2004
% 211.35/211.50  |- mesh__dateEstablished mesh__D001147 1991-01-01
% 211.35/211.50  |- skos__scopeNote mesh__D001147
% 211.35/211.50       An arsenical which has been used as a feed additive for enteric conditions in pigs and poultry. It causes blindness and is ototoxic and nephrotoxic in animals.%A%    
% 211.35/211.50  |- mesh__dateRevised mesh__D001147 2000-06-21
% 211.35/211.50  |- skos__hiddenLabel mesh__D001147 Arsenilate, Sodium
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D001147 2003
% 211.35/211.50  |- skos__hiddenLabel mesh__D001147 Arsanilate, Sodium
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D001147 2006
% 211.35/211.50  |- skos__hiddenLabel mesh__D001147 Acid, 4-Aminobenzenearsonic
% 211.35/211.50  |- mesh__publicMeSHNote mesh__D001147
% 211.35/211.50       91; was see under ARSENICALS 1979-90   
% 211.35/211.50  |- skos__hiddenLabel mesh__D006630 Hispanic American
% 211.35/211.50  |- skos__historyNote mesh__D006630 Mexico %28%1966-1977%29%
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D006630 2004
% 211.35/211.50  |- skos__historyNote mesh__D006630 Ethnic Groups %28%1968-1977%29%
% 211.35/211.50  |- mesh__dateEstablished mesh__D006630 1978-01-01
% 211.35/211.50  |- mesh__publicMeSHNote mesh__D006630 78   
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D006630 2004B
% 211.35/211.50  |- skos__hiddenLabel mesh__D006630 Cuban American
% 211.35/211.50  |- skos__annotation mesh__D006630
% 211.35/211.50       does not include Brazilian Americans %28% = UNITED STATES + BRAZIL /ethnol%29% nor Portuguese Americans %28% = UNITED STATES + PORTUGAL /ethnol%29%; specify geog; despite X refs specify NIM PUERTO RICO/ethnol or other Hispanic country with /ethnol when pertinent; MEXICAN AMERICANS is available%A%  
% 211.35/211.50  |- mesh__dateCreated mesh__D006630 1977-03-01
% 211.35/211.50  |- skos__hiddenLabel mesh__D006630 Hispanic
% 211.35/211.50  |- skos__hiddenLabel mesh__D006630 Puerto Rican
% 211.35/211.50  |- skos__hiddenLabel mesh__D006630 American, Hispanic
% 211.35/211.50  |- mesh__recordAuthorizer mesh__D006630 jls
% 211.35/211.50  |- skos__scopeNote mesh__D006630
% 211.35/211.50       Persons living in the United States of Mexican %28%MEXICAN AMERICANS%29%, Puerto Rican, Cuban, Central or South American, or other Spanish culture or origin. The concept does not include Brazilian Americans or Portuguese Americans.%A%    
% 211.35/211.50  |- skos__hiddenLabel mesh__D006630 Americans, Spanish
% 211.35/211.50  |- skos__historyNote mesh__D006630 Puerto Rico %28%1966-1977%29%
% 211.35/211.50  |- skos__historyNote mesh__D006630 United States %28%1966-1977%29%
% 211.35/211.50  |- rdf__type mesh__D006630sskos__Concept
% 211.35/211.50  |- skos__prefLabel mesh__D006630 Hispanic Americans
% 211.35/211.50  |- skos__hiddenLabel mesh__D006630 Latina
% 211.35/211.50  |- mesh__recordMaintainer mesh__D006630 jls
% 211.35/211.50  |- skos__historyNote mesh__D006630 specific state %28%1966-1977%29%
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D006630 2005
% 211.35/211.50  |- skos__broader mesh__D006630smesh__D005006
% 211.35/211.50  |- skos__hiddenLabel mesh__D006630 Spanish American
% 211.35/211.50  |- mesh__historyNote mesh__D006630 78   
% 211.35/211.50  |- mesh__recordOriginator mesh__D006630 SMH
% 211.35/211.50  |- skos__hiddenLabel mesh__D006630 Americans, Cuban
% 211.35/211.50  |- skos__hiddenLabel mesh__D006630 Americans, Hispanic
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D006630 2006
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D006630 2004A
% 211.35/211.50  |- skos__altLabel mesh__D006630 Spanish Americans
% 211.35/211.50  |- mesh__dateRevised mesh__D006630 2003-10-30
% 211.35/211.50  |- skos__hiddenLabel mesh__D006630 Latino
% 211.35/211.50  |- rdf__type mesh__D020301sskos__Concept
% 211.35/211.50  |- skos__hiddenLabel mesh__D020301 Vascular Spasm, Intracranial
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D020301 2005
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D020301 2003
% 211.35/211.50  |- skos__broader mesh__D020301smesh__D002561
% 211.35/211.50  |- skos__hiddenLabel mesh__D020301 Vasospasms, Intracranial
% 211.35/211.50  |- skos__hiddenLabel mesh__D020301 Spasms, Cerebral Artery
% 211.35/211.50  |- skos__hiddenLabel mesh__D020301 Artery Spasm, Cerebral
% 211.35/211.50  |- skos__hiddenLabel mesh__D020301 Spasms, Cerebrovascular
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D020301 2006
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D020301 2000
% 211.35/211.50  |- skos__hiddenLabel mesh__D020301 Vascular Spasms, Intracranial
% 211.35/211.50  |- skos__altLabel mesh__D020301 Intracranial Vascular Spasm
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D020301 2004
% 211.35/211.50  |- mesh__dateCreated mesh__D020301 1999-11-03
% 211.35/211.50  |- skos__hiddenLabel mesh__D020301 Intracranial Vasospasms
% 211.35/211.50  |- skos__hiddenLabel mesh__D020301 Spasms, Intracranial Vascular
% 211.35/211.50  |- mesh__publicMeSHNote mesh__D020301
% 211.35/211.50       2000; for CEREBRAL VASOSPASM see CEREBRAL ISCHEMIA, TRANSIENT 1966-1999%A%  
% 211.35/211.50  |- skos__altLabel mesh__D020301 Cerebrovascular Spasm
% 211.35/211.50  |- skos__altLabel mesh__D020301 Intracranial Vasospasm
% 211.35/211.50  |- skos__hiddenLabel mesh__D020301 Vasospasms, Cerebral
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D020301 2001
% 211.35/211.50  |- skos__historyNote mesh__D020301
% 211.35/211.50       Ischemic Attack, Transient %28%1966-1999%29%
% 211.35/211.50  |- skos__hiddenLabel mesh__D020301 Vasospasm, Cerebral
% 211.35/211.50  |- skos__hiddenLabel mesh__D020301 Spasm, Cerebrovascular
% 211.35/211.50  |- skos__hiddenLabel mesh__D020301 Artery Spasms, Cerebral
% 211.35/211.50  |- skos__hiddenLabel mesh__D020301 Cerebrovascular Spasms
% 211.35/211.50  |- skos__hiddenLabel mesh__D020301 Cerebral Artery Spasms
% 211.35/211.50  |- skos__prefLabel mesh__D020301 Vasospasm, Intracranial
% 211.35/211.50  |- mesh__dateEstablished mesh__D020301 2000-01-01
% 211.35/211.50  |- skos__scopeNote mesh__D020301
% 211.35/211.50       Narrowing of the lumen of one or more intracranial arteries due to contraction of arterial smooth muscle or to morphologic changes of the blood vessel wall. Large blood vessels near the base of the brain are primarily affected and reduced blood flow may result in hypoxic-ischemic brain injury %28%HYPOXIA-ISCHEMIA, BRAIN%29%. Vasospasm may be associated with SUBARACHNOID HEMORRHAGE; CRANIOCEREBRAL TRAUMA; and other disorders. %28%From Neurosurg Clin N Am, 1998 Jul;9%28%3%29%:615-27%29%%A%    
% 211.35/211.50  |- skos__hiddenLabel mesh__D020301 Intracranial Vascular Spasms
% 211.35/211.50  |- skos__hiddenLabel mesh__D020301 Spasm, Cerebral Artery
% 211.35/211.50  |- mesh__historyNote mesh__D020301
% 211.35/211.50       2000; for CEREBRAL VASOSPASM use CEREBRAL ISCHEMIA, TRANSIENT 1966-1999%A%  
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D020301 2002
% 211.35/211.50  |- skos__hiddenLabel mesh__D020301 Cerebral Vasospasms
% 211.35/211.50  |- skos__hiddenLabel mesh__D020301 Spasm, Intracranial Vascular
% 211.35/211.50  |- skos__altLabel mesh__D020301 Cerebral Artery Spasm
% 211.35/211.50  |- mesh__dateEstablished mesh__D019558 1997-01-01
% 211.35/211.50  |- skos__broader mesh__D019558smesh__D009971
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D019558 2006
% 211.35/211.50  |- skos__prefLabel mesh__D019558 Occlusal Adjustment
% 211.35/211.50  |- skos__historyNote mesh__D019558
% 211.35/211.50       Dental Occlusion, Balanced %28%1993-1996%29%
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D019558 2001
% 211.35/211.50  |- mesh__historyNote mesh__D019558
% 211.35/211.50       97; OCCLUSAL EQUILIBRATION was see DENTAL OCCLUSION, BALANCED 1975-96; was see under DENTAL OCCLUSION, BALANCED 1969-74%A%  
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D019558 2004
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D019558 2005
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D019558 1999
% 211.35/211.50  |- skos__scopeNote mesh__D019558
% 211.35/211.50       Selective grinding of occlusal surfaces of the teeth in an effort to eliminate premature contacts and occlusal interferences; to establish optimal masticatory effectiveness, stable occlusal relationships, direction of main occlusal forces, and efficient multidirectional patterns, to improve functional relations and to induce physiologic stimulation of the masticatory system; to eliminate occlusal trauma; to eliminate abnormal muscle tension; to aid in the stabilization of orthodontic results; to treat periodontal and temporomandibular joint problems; and in restorative procedures. %28%From Jablonski, Dictionary of Dentistry, 1992%29%%A%    
% 211.35/211.50  |- rdf__type mesh__D019558sskos__Concept
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D019558 2000
% 211.35/211.50  |- skos__annotation mesh__D019558
% 211.35/211.50       grinding of occlusal surfaces of teeth to achieve optimal occlusion%A%  
% 211.35/211.50  |- mesh__onlineNote mesh__D019558
% 211.35/211.50       use DENTAL OCCLUSION, BALANCED to search OCCLUSAL ADJUSTMENT 1969-96%A%  
% 211.35/211.50  |- skos__hiddenLabel mesh__D019558 Equilibrations, Occlusal
% 211.35/211.50  |- skos__hiddenLabel mesh__D019558 Adjustments, Occlusal
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D019558 2003
% 211.35/211.50  |- skos__altLabel mesh__D019558 Occlusal Equilibration
% 211.35/211.50  |- mesh__recordAuthorizer mesh__D019558 jls
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D019558 1997
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D019558 1998
% 211.35/211.50  |- mesh__publicMeSHNote mesh__D019558
% 211.35/211.50       97; OCCLUSAL EQUILIBRATION was see DENTAL OCCLUSION, BALANCED 1975-96; was see under DENTAL OCCLUSION, BALANCED 1969-74%A%  
% 211.35/211.50  |- skos__hiddenLabel mesh__D019558 Adjustment, Occlusal
% 211.35/211.50  |- mesh__dateRevised mesh__D019558 2004-07-29
% 211.35/211.50  |- skos__hiddenLabel mesh__D019558 Occlusal Adjustments
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D019558 2002
% 211.35/211.50  |- mesh__recordMaintainer mesh__D019558 jls
% 211.35/211.50  |- mesh__dateCreated mesh__D019558 1996-06-13
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D019558 2005B
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D019558 2005A
% 211.35/211.50  |- mesh__recordOriginator mesh__D019558 JLS
% 211.35/211.50  |- skos__hiddenLabel mesh__D011575 Therapies, Psychoanalytical
% 211.35/211.50  |- skos__altLabel mesh__D011575 Therapy, Balint Psychoanalytic
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D011575 2003
% 211.35/211.50  |- skos__scopeNote mesh__D011575
% 211.35/211.50       A form of psychiatric treatment, based on Freudian principles, which seeks to eliminate or diminish the undesirable effects of unconscious conflicts by making the patient aware of their existence, origin, and inappropriate expression in current emotions and behavior.%A%    
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D011575 2000
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D011575 1997
% 211.35/211.50  |- mesh__recordMaintainer mesh__D011575 PLS
% 211.35/211.50  |- mesh__recordAuthorizer mesh__D011575 PLS
% 211.35/211.50  |- mesh__dateRevised mesh__D011575 1995-05-31
% 211.35/211.50  |- skos__hiddenLabel mesh__D011575 Psychoanalytical Therapies
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D011575 1996
% 211.35/211.50  |- skos__altLabel mesh__D011575 Therapy, Psychoanalytic
% 211.35/211.50  |- skos__hiddenLabel mesh__D011575 Psychoanalytic Therapies
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D011575 2006
% 211.35/211.50  |- skos__prefLabel mesh__D011575 Psychoanalytic Therapy
% 211.35/211.50  |- skos__broader mesh__D011575smesh__D011613
% 211.35/211.50  |- skos__annotation mesh__D011575
% 211.35/211.50       a psychother technique; DF: PSYCHOANAL THER   
% 211.35/211.50  |- mesh__dateCreated mesh__D011575 1999-01-01
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D011575 2005
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D011575 2002
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D011575 1999
% 211.35/211.50  |- skos__hiddenLabel mesh__D011575 Therapy, Psychoanalytical
% 211.35/211.50  |- skos__altLabel mesh__D011575 Psychoanalytical Therapy
% 211.35/211.50  |- skos__altLabel mesh__D011575 Psychoanalytic Therapy, Balint
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D011575 2004
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D011575 2001
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D011575 1998
% 211.35/211.50  |- rdf__type mesh__D011575sskos__Concept
% 211.35/211.50  |- mesh__recordOriginator mesh__D011575 NLM
% 211.35/211.50  |- skos__hiddenLabel mesh__D011575 Therapies, Psychoanalytic
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D005538 2005
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D005538 2004
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D005538 1999
% 211.35/211.50  |- skos__historyNote mesh__D005538 Sports %28%1966-1975%29%
% 211.35/211.50  |- skos__broader mesh__D005538smesh__D013177
% 211.35/211.50  |- mesh__recordAuthorizer mesh__D005538 PLS
% 211.35/211.50  |- skos__scopeNote mesh__D005538
% 211.35/211.50       A competitive team sport played on a rectangular field. This is the American or Canadian version of the game and also includes the form known as rugby. It does not include non-North American football %28%= SOCCER%29%.%A%    
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D005538 2002
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D005538 2006
% 211.35/211.50  |- mesh__dateRevised mesh__D005538 1996-06-10
% 211.35/211.50  |- mesh__recordMaintainer mesh__D005538 TPW
% 211.35/211.50  |- skos__hiddenLabel mesh__D005538 Rugbies
% 211.35/211.50  |- skos__annotation mesh__D005538
% 211.35/211.50       /inj: coord IM with specific inj %28%IM%29%; /physiol permitted; Manual 30.15+; note X ref RUGBY; does not include non-North American %22%football%22% %28% = SOCCER%29%%A%  
% 211.35/211.50  |- skos__prefLabel mesh__D005538 Football
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D005538 2000
% 211.35/211.50  |- mesh__dateEstablished mesh__D005538 1976-01-01
% 211.35/211.50  |- mesh__dateCreated mesh__D005538 1975-07-25
% 211.35/211.50  |- mesh__recordOriginator mesh__D005538 JW
% 211.35/211.50  |- rdf__type mesh__D005538sskos__Concept
% 211.35/211.50  |- mesh__historyNote mesh__D005538 76   
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D005538 2001
% 211.35/211.50  |- mesh__publicMeSHNote mesh__D005538 76   
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D005538 1998
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D005538 2003
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D005538 1997
% 211.35/211.50  |- skos__prefLabel mesh__D016260 Monocytes, Activated Killer
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D016260 2004
% 211.35/211.50  |- mesh__dateCreated mesh__D016260 1990-06-06
% 211.35/211.50  |- skos__historyNote mesh__D016260 Monocytes %28%1988-1990%29%
% 211.35/211.50  |- mesh__dateRevised mesh__D016260 2003-07-09
% 211.35/211.50  |- mesh__historyNote mesh__D016260 91   
% 211.35/211.50  |- skos__hiddenLabel mesh__D016260 Activated Killer Monocyte
% 211.35/211.50  |- skos__altLabel mesh__D016260 Killer Monocytes, Activated
% 211.35/211.50  |- mesh__dateEstablished mesh__D016260 1991-01-01
% 211.35/211.50  |- skos__altLabel mesh__D016260 Activated Killer Monocytes
% 211.35/211.50  |- skos__hiddenLabel mesh__D016260 Killer Monocyte, Activated
% 211.35/211.50  |- skos__related mesh__D016260smesh__D016219
% 211.35/211.50  |- skos__scopeNote mesh__D016260
% 211.35/211.50       Monocytes made cytotoxic by ex vivo incubation with cytokines, especially interferon-gamma. AKM cells are used for adoptive immunotherapy in cancer patients.%A%    
% 211.35/211.50  |- mesh__publicMeSHNote mesh__D016260 91   
% 211.35/211.50  |- skos__annotation mesh__D016260 A 11 qualif; DF: AKM   
% 211.35/211.50  |- skos__hiddenLabel mesh__D016260 Monocyte, Activated Killer
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D016260 2006
% 211.35/211.50  |- skos__broader mesh__D016260smesh__D009000
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D016260 2005
% 211.35/211.50  |- rdf__type mesh__D016260sskos__Concept
% 211.35/211.50  |- skos__annotation mesh__D002240
% 211.35/211.50       IM for general only; coord NIM with specific carbohydrate %28%IM%29%; do not confuse with CARBOHYDRATE LINKAGE see CARBOHYDRATE CONFORMATION: sequ = order in which components are arranged, conform = spatial or 3-dimensional struct; when to index with MOLECULAR SEQUENCE DATA: see note there; DF: CARB SEQ%A%  
% 211.35/211.50  |- skos__broader mesh__D002240smesh__D008969
% 211.35/211.50  |- mesh__dateRevised mesh__D002240 2005-07-27
% 211.35/211.50  |- mesh__recordAuthorizer mesh__D002240 ags
% 211.35/211.50  |- mesh__dateCreated mesh__D002240 1979-05-24
% 211.35/211.50  |- skos__hiddenLabel mesh__D002240 Sequences, Carbohydrate
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D002240 2006A
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D002240 2004
% 211.35/211.50  |- mesh__recordMaintainer mesh__D002240 ags
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D002240 2006
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D002240 2003
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D002240 2005
% 211.35/211.50  |- skos__prefLabel mesh__D002240 Carbohydrate Sequence
% 211.35/211.50  |- mesh__dateEstablished mesh__D002240 1980-01-01
% 211.35/211.50  |- skos__broader mesh__D002240smesh__D015394
% 211.35/211.50  |- mesh__recordOriginator mesh__D002240 VDK
% 211.35/211.50  |- mesh__publicMeSHNote mesh__D002240 80   
% 211.35/211.50  |- skos__hiddenLabel mesh__D002240 Sequence, Carbohydrate
% 211.35/211.50  |- skos__hiddenLabel mesh__D002240 Carbohydrate Sequences
% 211.35/211.50  |- mesh__historyNote mesh__D002240 80   
% 211.35/211.50  |- rdf__type mesh__D002240sskos__Concept
% 211.35/211.50  |- skos__scopeNote mesh__D002240
% 211.35/211.50       The sequence of carbohydrates within POLYSACCHARIDES; GLYCOPROTEINS; and GLYCOLIPIDS.%A%    
% 211.35/211.50  |- mesh__dateEstablished mesh__D015966 1990-01-01
% 211.35/211.50  |- mesh__historyNote mesh__D015966 90   
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D015966 2004
% 211.35/211.50  |- skos__historyNote mesh__D015966 specific fungi %28%1972-1989%29%
% 211.35/211.50  |- mesh__recordMaintainer mesh__D015966 NDW
% 211.35/211.50  |- mesh__recordOriginator mesh__D015966 PXP
% 211.35/211.50  |- mesh__publicMeSHNote mesh__D015966 90   
% 211.35/211.50  |- skos__scopeNote mesh__D015966
% 211.35/211.50       Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in fungi.%A%    
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D015966 2005
% 211.35/211.50  |- skos__historyNote mesh__D015966 Genes, Regulator %28%1972-1980%29%
% 211.35/211.50  |- skos__historyNote mesh__D015966
% 211.35/211.50       Gene Expression Regulation %28%1981-1989%29%
% 211.35/211.50  |- skos__broader mesh__D015966smesh__D005786
% 211.35/211.50  |- skos__altLabel mesh__D015966 Fungal Gene Expression Regulation
% 211.35/211.50  |- mesh__dateRevised mesh__D015966 2002-07-03
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D015966 2006
% 211.35/211.50  |- mesh__dateCreated mesh__D015966 1989-05-25
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D015966 2003
% 211.35/211.50  |- rdf__type mesh__D015966sskos__Concept
% 211.35/211.50  |- skos__annotation mesh__D015966
% 211.35/211.50       coord IM with specific fungus /genet %28%IM%29%; DF: GENE EXPRESSION REG FUNGAL%A%  
% 211.35/211.50  |- skos__altLabel mesh__D015966 Regulation, Gene Expression, Fungal
% 211.35/211.50  |- skos__prefLabel mesh__D015966 Gene Expression Regulation, Fungal
% 211.35/211.50  |- mesh__recordAuthorizer mesh__D015966 sjn
% 211.35/211.50  |- skos__altLabel mesh__D015966 Regulation of Gene Expression, Fungal
% 211.35/211.50  |- skos__prefLabel mesh__D015168 Lightning Injuries
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D015168 1998
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D015168 1997
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D015168 2003
% 211.35/211.50  |- skos__hiddenLabel mesh__D015168 Lightning Injury
% 211.35/211.50  |- mesh__dateCreated mesh__D015168 1988-04-08
% 211.35/211.50  |- rdf__type mesh__D015168sskos__Concept
% 211.35/211.50  |- mesh__recordAuthorizer mesh__D015168 PLS
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D015168 1996
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D015168 2000
% 211.35/211.50  |- skos__historyNote mesh__D015168 Electric Injuries %28%1966-1988%29%
% 211.35/211.50  |- mesh__dateRevised mesh__D015168 1992-03-25
% 211.35/211.50  |- mesh__recordMaintainer mesh__D015168 TGC
% 211.35/211.50  |- mesh__recordOriginator mesh__D015168 SCD
% 211.35/211.50  |- skos__scopeNote mesh__D015168
% 211.35/211.50       Accidental injuries caused by brief high-voltage electrical discharges during thunderstorms. Cardiopulmonary arrest, coma and other neurologic symptoms, myocardial necrosis, and dermal burns are common. Prompt treatment of the acute sequelae, including cardiopulmonary resuscitation, is indicated for survival.%A%    
% 211.35/211.50  |- skos__hiddenLabel mesh__D015168 Lightning Strokes
% 211.35/211.50  |- skos__hiddenLabel mesh__D015168 Strokes, Lightning
% 211.35/211.50  |- skos__historyNote mesh__D015168 Burns, Electric %28%1966-1988%29%
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D015168 1995
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D015168 2002
% 211.35/211.50  |- mesh__historyNote mesh__D015168
% 211.35/211.50       91%28%89%29%; was see under ELECTRIC INJURIES 1989-90   
% 211.35/211.50  |- skos__annotation mesh__D015168 DF: LIGHTNING INJ   
% 211.35/211.50  |- skos__altLabel mesh__D015168 Injuries, Lightning
% 211.35/211.50  |- skos__historyNote mesh__D015168 Lightning %28%1966-1988%29%
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D015168 1994
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D015168 1993
% 211.35/211.50  |- skos__hiddenLabel mesh__D015168 Stroke, Lightning
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D015168 2006
% 211.35/211.50  |- skos__hiddenLabel mesh__D015168 Injury, Lightning
% 211.35/211.50  |- mesh__publicMeSHNote mesh__D015168
% 211.35/211.50       91; was see under ELECTRIC INJURIES 1989-90   
% 211.35/211.50  |- skos__broader mesh__D015168smesh__D004556
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D015168 1999
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D015168 2005
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D015168 2004
% 211.35/211.50  |- mesh__dateEstablished mesh__D015168 1991-01-01
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D015168 2001
% 211.35/211.50  |- mesh__recordMaintainer mesh__D009929 lkt
% 211.35/211.50  |- mesh__dateCreated mesh__D009929 1999-01-01
% 211.35/211.50  |- mesh__recordOriginator mesh__D009929 NLM
% 211.35/211.50  |- mesh__historyNote mesh__D009929 2005 %28%1966%29%   
% 211.35/211.50  |- skos__scopeNote mesh__D009929
% 211.35/211.50       The measurement of an organ in volume, mass, or heaviness.%A%    
% 211.35/211.50  |- skos__hiddenLabel mesh__D009929 Size, Organ
% 211.35/211.50  |- skos__broader mesh__D009929smesh__D001837
% 211.35/211.50  |- rdf__type mesh__D009929sskos__Concept
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D009929 2006
% 211.35/211.50  |- skos__prefLabel mesh__D009929 Organ Size
% 211.35/211.50  |- skos__annotation mesh__D009929
% 211.35/211.50       almost never IM; coordinate NIM with organ /anat %28%IM%29% or /growth %28%IM%29% or /pathol %28%IM%29% or disease /pathol %28%IM%29%%A%  
% 211.35/211.50  |- mesh__dateRevised mesh__D009929 2005-06-30
% 211.35/211.50  |- skos__hiddenLabel mesh__D009929 Weight, Organ
% 211.35/211.50  |- skos__broader mesh__D009929smesh__D006128
% 211.35/211.50  |- mesh__dateEstablished mesh__D009929 1966-01-01
% 211.35/211.50  |- mesh__recordAuthorizer mesh__D009929 sjn
% 211.35/211.50  |- mesh__publicMeSHNote mesh__D009929 2005; see ORGAN WEIGHT 1966-2004   
% 211.35/211.50  |- skos__broader mesh__D001946smesh__D007744
% 211.35/211.50  |- mesh__onlineNote mesh__D001946 search LABOR PRESENTATION 1966-74   
% 211.35/211.50  |- mesh__dateRevised mesh__D001946 2005-06-30
% 211.35/211.50  |- mesh__dateCreated mesh__D001946 1999-01-01
% 211.35/211.50  |- skos__hiddenLabel mesh__D001946 Presentation, Breech Fetal
% 211.35/211.50  |- skos__hiddenLabel mesh__D001946 Breech Presentation, Frank
% 211.35/211.50  |- mesh__publicMeSHNote mesh__D001946
% 211.35/211.50       85; was see under LABOR PRESENTATION 1963-84   
% 211.35/211.50  |- skos__annotation mesh__D001946 check the tags FEMALE %26% PREGNANCY   
% 211.35/211.50  |- skos__altLabel mesh__D001946 Presentation, Breech
% 211.35/211.50  |- mesh__activeMeSHYear mesh__D001946 2006
% 211.35/211.50  |- skos__altLabel mesh__D001946 Fetal Presentation, Breech
% 211.35/211.50  |- skos__hiddenLabel mesh__D001946 Presentation, Breech Labor
% 211.35/211.50  |- skos__hiddenLabel mesh__D001946 Breech Labor Presentation
% 211.36/211.50  |- mesh__dateEstablished mesh__D001946 1985-01-01
% 211.36/211.50  |- skos__hiddenLabel mesh__D001946 Breech Fetal Presentation
% 211.36/211.50  |- mesh__recordAuthorizer mesh__D001946 sjn
% 211.36/211.50  |- mesh__historyNote mesh__D001946
% 211.36/211.50       85%28%75%29%; was see under LABOR PRESENTATION 1963-84   
% 211.36/211.50  |- mesh__recordOriginator mesh__D001946 NLM
% 211.36/211.50  |- skos__altLabel mesh__D001946 Labor Presentation, Breech
% 211.36/211.50  |- skos__hiddenLabel mesh__D001946 Breech, Complete
% 211.36/211.50  |- skos__scopeNote mesh__D001946
% 211.36/211.50       A malpresentation of the FETUS at near term or during OBSTETRIC LABOR with the fetal cephalic pole in the fundus of the UTERUS. There are three types of breech: the complete breech with flexed hips and knees; the incomplete breech with one or both hips partially or fully extended; the frank breech with flexed hips and extended knees.%A%    
% 211.36/211.50  |- skos__hiddenLabel mesh__D001946 Presentation, Frank Breech
% 211.36/211.50  |- mesh__recordMaintainer mesh__D001946 lkt
% 211.36/211.50  |- skos__historyNote mesh__D001946 Labor Presentation %28%1966-1974%29%
% 211.36/211.50  |- skos__prefLabel mesh__D001946 Breech Presentation
% 211.36/211.50  |- skos__hiddenLabel mesh__D001946 Breech, Incomplete
% 211.36/211.50  |- skos__broader mesh__D001946smesh__D007746
% 211.36/211.50  |- rdf__type mesh__D001946sskos__Concept
% 211.36/211.50  |- rdf__type mesh__D001148sskos__Concept
% 211.36/211.50  |- mesh__activeMeSHYear mesh__D001148 2006
% 211.36/211.50  |- mesh__dateCreated mesh__D001148 1974-11-19
% 211.36/211.50  |- skos__prefLabel mesh__D001148 Arsenamide
% 211.36/211.50  |- mesh__recordMaintainer mesh__D001148 CCR
% 211.36/211.50  |- mesh__activeMeSHYear mesh__D001148 2005
% 211.36/211.50  |- skos__broader mesh__D001148smesh__D001152
% 211.36/211.50  |- skos__scopeNote mesh__D001148
% 211.36/211.50       Proposed chemotherapeutic agent against filaria and trichomonas.%A%    
% 211.36/211.50  |- skos__historyNote mesh__D001148 Benzamides %28%1973-1974%29%
% 211.36/211.50  |- skos__historyNote mesh__D001148 Arsenicals %28%1969-1974%29%
% 211.36/211.50  |- mesh__recordOriginator mesh__D001148 NLM
% 211.36/211.50  |- mesh__activeMeSHYear mesh__D001148 2001
% 211.36/211.50  |- mesh__recordAuthorizer mesh__D001148 sjn
% 211.36/211.50  |- mesh__dateEstablished mesh__D001148 1991-01-01
% 211.36/211.50  |- mesh__dateRevised mesh__D001148 2000-06-21
% 211.36/211.50  |- mesh__publicMeSHNote mesh__D001148
% 211.36/211.50       91; was see under ARSENICALS 1975-90   
% 211.36/211.50  |- mesh__activeMeSHYear mesh__D001148 2004
% 211.36/211.50  |- mesh__historyNote mesh__D001148
% 211.36/211.50       91%28%75%29%; was see under ARSENICALS 1975-90   
% 211.36/211.50  |- skos__altLabel mesh__D001148 Thiacetarsamide
% 211.36/211.50  |- skos__altLabel mesh__D001148 Thioarsenite
% 211.36/211.50  |- skos__historyNote mesh__D001148 Sulfides %28%1973-1974%29%
% 211.36/211.50  |- mesh__activeMeSHYear mesh__D001148 2003
% 211.36/211.50  |- mesh__activeMeSHYear mesh__D001148 2002
% 211.36/211.50  |- skos__hiddenLabel mesh__D006631 Copper-Containing Amine Oxidase
% 211.36/211.50  |- skos__hiddenLabel mesh__D006631 Oxidase, Semicarbazide-Sensitive Amine
% 211.36/211.50  |- mesh__recordOriginator mesh__D006631 NLM
% 211.36/211.50  |- skos__hiddenLabel mesh__D006631 Oxidase, Xylylene Diamine
% 211.36/211.50  |- skos__altLabel mesh__D006631 Xylylene Diamine Oxidase
% 211.36/211.50  |- skos__hiddenLabel mesh__D006631 Amine Oxidase, Copper Containing
% 211.36/211.50  |- mesh__onlineNote mesh__D006631
% 211.36/211.50       use AMINE OXIDASE %28%COPPER-CONTAINING%29% to search HISTAMINASE 1966-91; use AMINE OXIDASE %28%NM%29% to search COPPER AMINE OXIDASE 1978-91%A%  
% 211.36/211.51  |- skos__hiddenLabel mesh__D006631 Semicarbazide Sensitive Amine Oxidase
% 211.36/211.51  |- mesh__dateRevised mesh__D006631 2005-06-30
% 211.36/211.51  |- skos__prefLabel mesh__D006631 Amine Oxidase %28%Copper-Containing%29%
% 211.36/211.51  |- skos__hiddenLabel mesh__D006631 Oxidase, Diamine
% 211.36/211.51  |- skos__altLabel mesh__D006631 Copper Amine Oxidase
% 211.36/211.51  |- skos__hiddenLabel mesh__D006631 Amine Oxidase, Semicarbazide-Sensitive
% 211.36/211.51  |- skos__altLabel mesh__D006631 Amine Oxidase, Copper-Containing
% 211.36/211.51  |- skos__hiddenLabel mesh__D006631 Amine Oxidase, Copper
% 211.36/211.51  |- mesh__dateCreated mesh__D006631 1999-01-01
% 211.36/211.51  |- rdf__type mesh__D006631sskos__Concept
% 211.36/211.51  |- mesh__historyNote mesh__D006631
% 211.36/211.51       92; was HISTAMINASE 1963-91; COPPER AMINE OXIDASE was SY to AMINE OXIDASE %28%NM%29% 1978-91%A%  
% 211.36/211.51  |- skos__hiddenLabel mesh__D006631 Oxidase, Copper-Containing Amine
% 211.36/211.51  |- mesh__recordAuthorizer mesh__D006631 sjn
% 211.36/211.51  |- mesh__recordMaintainer mesh__D006631 jmp
% 211.36/211.51  |- skos__hiddenLabel mesh__D006631 Oxidase, Diaminobenzidine
% 211.36/211.51  |- skos__altLabel mesh__D006631 Diamine Oxidase
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D006631 2006
% 211.36/211.51  |- skos__altLabel mesh__D006631 Semicarbazide-Sensitive Amine Oxidase
% 211.36/211.51  |- skos__scopeNote mesh__D006631
% 211.36/211.51       A group of enzymes including those oxidizing primary monoamines, diamines, and histamine. They are copper proteins, and, as their action depends on a carbonyl group, they are sensitive to inhibition by semicarbazide. EC 1.4.3.6.%A%    
% 211.36/211.51  |- skos__hiddenLabel mesh__D006631 Oxidase, Copper Amine
% 211.36/211.51  |- skos__broader mesh__D006631smesh__D050891
% 211.36/211.51  |- skos__hiddenLabel mesh__D006631 Diamine Oxidase, Xylylene
% 211.36/211.51  |- mesh__publicMeSHNote mesh__D006631
% 211.36/211.51       92; was HISTAMINASE 1963-91; COPPER AMINE OXIDASE was indexed under AMINE OXIDOREDUCTASES 1978-91%A%  
% 211.36/211.51  |- skos__altLabel mesh__D006631 Histaminase
% 211.36/211.51  |- skos__historyNote mesh__D020302 Cytoplasmic Granules %28%1981-1998%29%
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D020302 2004
% 211.36/211.51  |- mesh__recordOriginator mesh__D020302 AGS
% 211.36/211.51  |- mesh__recordMaintainer mesh__D020302 nns
% 211.36/211.51  |- mesh__recordAuthorizer mesh__D020302 sjn
% 211.36/211.51  |- skos__prefLabel mesh__D020302 Weibel-Palade Bodies
% 211.36/211.51  |- mesh__dateEstablished mesh__D020302 1999-01-01
% 211.36/211.51  |- skos__broader mesh__D020302smesh__D003594
% 211.36/211.51  |- mesh__dateRevised mesh__D020302 2003-07-09
% 211.36/211.51  |- skos__historyNote mesh__D020302 Organelles %28%1981-1998%29%
% 211.36/211.51  |- skos__related mesh__D020302smesh__D014841
% 211.36/211.51  |- skos__scopeNote mesh__D020302
% 211.36/211.51       Rod-shaped storage granules for VON WILLEBRAND FACTOR specific to endothelial cells.%A%    
% 211.36/211.51  |- rdf__type mesh__D020302sskos__Concept
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D020302 2005
% 211.36/211.51  |- skos__hiddenLabel mesh__D020302 Bodies, Weibel-Palade
% 211.36/211.51  |- mesh__dateCreated mesh__D020302 1998-06-11
% 211.36/211.51  |- skos__hiddenLabel mesh__D020302 Weibel Palade Bodies
% 211.36/211.51  |- mesh__publicMeSHNote mesh__D020302 99   
% 211.36/211.51  |- mesh__historyNote mesh__D020302 99   
% 211.36/211.51  |- skos__historyNote mesh__D020302 Inclusion Bodies %28%1987-1998%29%
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D020302 2006
% 211.36/211.51  |- mesh__publicMeSHNote mesh__D019559 97   
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D019559 2004
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D019559 2005
% 211.36/211.51  |- skos__broader mesh__D019559smesh__D014652
% 211.36/211.51  |- rdf__type mesh__D019559sskos__Concept
% 211.36/211.51  |- skos__prefLabel mesh__D019559 Capillary Leak Syndrome
% 211.36/211.51  |- skos__hiddenLabel mesh__D019559 Capillary Leak Syndromes
% 211.36/211.51  |- mesh__dateEstablished mesh__D019559 1997-01-01
% 211.36/211.51  |- mesh__recordAuthorizer mesh__D019559 sjn
% 211.36/211.51  |- skos__historyNote mesh__D019559 Capillary Permeability %28%1972-1996%29%
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D019559 2003
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D019559 2001
% 211.36/211.51  |- skos__scopeNote mesh__D019559
% 211.36/211.51       A rare and sometimes fatal disease characterized by recurring attacks of leakage of intravascular fluids into the extravascular space.  This syndrome is observed in patients who demonstrate a state of generalized leaky capillaries following shock syndromes, low-flow states, ischemia-reperfusion injuries, toxemias, or poisoning. It can lead to generalized edema and MULTIPLE ORGAN FAILURE. %28%Zikria, et al. %28%eds.%29%, Reperfusion Injuries and Clinical Capillary Leak Syndrome, pp. 470-72, 1994%29%%A%    
% 211.36/211.51  |- mesh__dateRevised mesh__D019559 1999-11-03
% 211.36/211.51  |- mesh__recordMaintainer mesh__D019559 KEV
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D019559 2000
% 211.36/211.51  |- mesh__recordOriginator mesh__D019559 AGS
% 211.36/211.51  |- mesh__dateCreated mesh__D019559 1996-06-10
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D019559 2006
% 211.36/211.51  |- skos__related mesh__D019559smesh__D009102
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D019559 2002
% 211.36/211.51  |- mesh__historyNote mesh__D019559 97   
% 211.36/211.51  |- skos__altLabel mesh__D019559 Systemic Capillary Leak Syndrome
% 211.36/211.51  |- mesh__dateEstablished mesh__D011576 1973-01-01
% 211.36/211.51  |- mesh__historyNote mesh__D011576
% 211.36/211.51       85; was see SANDFLIES 1975-84; was SANDFLIES see PHLEBOTOMUS 1963-72%A%  
% 211.36/211.51  |- mesh__recordMaintainer mesh__D011576 ags
% 211.36/211.51  |- skos__scopeNote mesh__D011576
% 211.36/211.51       Small, hairy, moth-like flies which are of considerable public health importance as vectors of certain pathogenic organisms. Important disease-related genera are PHLEBOTOMUS, Lutzomyia, and Sergentomyia.%A%    
% 211.36/211.51  |- mesh__dateCreated mesh__D011576 1999-01-01
% 211.36/211.51  |- skos__broader mesh__D011576smesh__D004175
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D011576 2006
% 211.36/211.51  |- skos__historyNote mesh__D011576 Phlebotomus %28%1966-1972%29%
% 211.36/211.51  |- mesh__onlineNote mesh__D011576
% 211.36/211.51       use PSYCHODIDAE to search SANDFLIES 1973-84; use PHLEBOTOMUS 1966-72%A%  
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D011576 2005
% 211.36/211.51  |- mesh__recordOriginator mesh__D011576 NLM
% 211.36/211.51  |- skos__annotation mesh__D011576
% 211.36/211.51       do not use /drug eff for insecticides: TN 111   
% 211.36/211.51  |- rdf__type mesh__D011576sskos__Concept
% 211.36/211.51  |- skos__altLabel mesh__D011576 Phlebotominae
% 211.36/211.51  |- mesh__publicMeSHNote mesh__D011576
% 211.36/211.51       85; was see SANDFLIES 1975-84; was SANDFLIES see PHLEBOTOMUS 1963-72%A%  
% 211.36/211.51  |- mesh__dateRevised mesh__D011576 2003-07-09
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D011576 2004
% 211.36/211.51  |- mesh__recordAuthorizer mesh__D011576 sjn
% 211.36/211.51  |- skos__altLabel mesh__D011576 Psychodinae
% 211.36/211.51  |- skos__prefLabel mesh__D011576 Psychodidae
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D005539 1993
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D005539 2006
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D005539 1990
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D005539 1995
% 211.36/211.51  |- skos__hiddenLabel mesh__D005539 Foramen Magnums
% 211.36/211.51  |- skos__hiddenLabel mesh__D005539 Magnum, Foramen
% 211.36/211.51  |- skos__hiddenLabel mesh__D005539 Magnums, Foramen
% 211.36/211.51  |- mesh__recordAuthorizer mesh__D005539 PLS
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D005539 2002
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D005539 1996
% 211.36/211.51  |- mesh__dateRevised mesh__D005539 1989-03-14
% 211.36/211.51  |- rdf__type mesh__D005539sskos__Concept
% 211.36/211.51  |- mesh__recordOriginator mesh__D005539 NLM
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D005539 1991
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D005539 2003
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D005539 1998
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D005539 1997
% 211.36/211.51  |- skos__prefLabel mesh__D005539 Foramen Magnum
% 211.36/211.51  |- skos__broader mesh__D005539smesh__D009777
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D005539 2000
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D005539 2005
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D005539 1992
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D005539 1999
% 211.36/211.51  |- mesh__dateCreated mesh__D005539 1999-01-01
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D005539 2004
% 211.36/211.51  |- mesh__recordMaintainer mesh__D005539 TGC
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D005539 2001
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D005539 1994
% 211.36/211.51  |- skos__scopeNote mesh__D002241
% 211.36/211.51       The largest class of organic compounds, including STARCH; GLYCOGEN; CELLULOSE; POLYSACCHARIDES; and simple MONOSACCHARIDES. Carbohydrates are composed of carbon, hydrogen, and oxygen in a ratio of Cn%28%H2O%29%n.%A%    
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D002241 2006
% 211.36/211.51  |- mesh__historyNote mesh__D002241
% 211.36/211.51       /metabolism was CARBOHYDRATE METABOLISM 1963-65   
% 211.36/211.51  |- mesh__onlineNote mesh__D002241
% 211.36/211.51       pre-explosion = CARBOHYDRATES %28%PX%29%   
% 211.36/211.51  |- mesh__recordAuthorizer mesh__D002241 sjn
% 211.36/211.51  |- mesh__publicMeSHNote mesh__D002241
% 211.36/211.51       /metabolism was CARBOHYDRATE METABOLISM 1963-65   
% 211.36/211.51  |- mesh__recordMaintainer mesh__D002241 lkt
% 211.36/211.51  |- mesh__recordOriginator mesh__D002241 NLM
% 211.36/211.51  |- rdf__type mesh__D002241sskos__Concept
% 211.36/211.51  |- skos__annotation mesh__D002241
% 211.36/211.51       general only; prefer specifics; glucides go here but could also be GLYCOSIDES; carbohydrates in the diet = DIETARY CARBOHYDRATES%A%  
% 211.36/211.51  |- mesh__runningHead mesh__D002241 D9 - CARBOHYDRATES   
% 211.36/211.51  |- mesh__dateCreated mesh__D002241 1999-01-01
% 211.36/211.51  |- skos__related mesh__D002241smesh__D004040
% 211.36/211.51  |- mesh__dateRevised mesh__D002241 2005-06-30
% 211.36/211.51  |- skos__prefLabel mesh__D002241 Carbohydrates
% 211.36/211.51  |- skos__altLabel mesh__D015967 Viral Gene Expression Regulation
% 211.36/211.51  |- rdf__type mesh__D015967sskos__Concept
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D015967 2004
% 211.36/211.51  |- mesh__dateEstablished mesh__D015967 1990-01-01
% 211.36/211.51  |- skos__broader mesh__D015967smesh__D005786
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D015967 2003
% 211.36/211.51  |- mesh__recordOriginator mesh__D015967 PXP
% 211.36/211.51  |- mesh__recordAuthorizer mesh__D015967 sjn
% 211.36/211.51  |- mesh__publicMeSHNote mesh__D015967 90   
% 211.36/211.51  |- skos__altLabel mesh__D015967 Regulation of Gene Expression, Viral
% 211.36/211.51  |- skos__historyNote mesh__D015967 Genes, Regulator %28%1973-1980%29%
% 211.36/211.51  |- skos__prefLabel mesh__D015967 Gene Expression Regulation, Viral
% 211.36/211.51  |- skos__altLabel mesh__D015967 Regulation, Gene Expression, Viral
% 211.36/211.51  |- mesh__recordMaintainer mesh__D015967 NDW
% 211.36/211.51  |- mesh__dateCreated mesh__D015967 1989-05-25
% 211.36/211.51  |- skos__historyNote mesh__D015967 specific viruses %28%1973-1989%29%
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D015967 2006
% 211.36/211.51  |- skos__historyNote mesh__D015967
% 211.36/211.51       Gene Expression Regulation %28%1981-1989%29%
% 211.36/211.51  |- skos__scopeNote mesh__D015967
% 211.36/211.51       Any of the processes by which cytoplasmic factors influence the differential control of gene action in viruses.%A%    
% 211.36/211.51  |- skos__annotation mesh__D015967
% 211.36/211.51       coord IM with specific virus /genet %28%IM%29%; DF: GENE EXPRESSION REG VIRAL%A%  
% 211.36/211.51  |- mesh__dateRevised mesh__D015967 2002-07-03
% 211.36/211.51  |- mesh__historyNote mesh__D015967 90   
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D015967 2005
% 211.36/211.51  |- skos__related mesh__D015169smesh__D050296
% 211.36/211.51  |- mesh__historyNote mesh__D015169 89   
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Count, Pour Plate
% 211.36/211.51  |- skos__altLabel mesh__D015169 Colony Forming Units Assays, Microbial
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Count, Fungal
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Streak Plate Counts
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Counts, Pour Plate
% 211.36/211.51  |- skos__altLabel mesh__D015169 Count, Bacterial
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Counts, Microbial Colony
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Count, Spore
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Count, Microbial Colony
% 211.36/211.51  |- mesh__publicMeSHNote mesh__D015169 89   
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Dilution Counts, Agar
% 211.36/211.51  |- rdf__type mesh__D015169sskos__Concept
% 211.36/211.51  |- mesh__dateEstablished mesh__D015169 1989-01-01
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D015169 2006
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Counts, Spore
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Pour Plate Counts
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Agar Dilution Counts
% 211.36/211.51  |- mesh__dateRevised mesh__D015169 2005-06-30
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Count, Agar Dilution
% 211.36/211.51  |- skos__broader mesh__D015169smesh__D008828
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Microbial Colony Count
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Counts, Fungal
% 211.36/211.51  |- mesh__recordAuthorizer mesh__D015169 sjn
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Spore Counts
% 211.36/211.51  |- skos__prefLabel mesh__D015169 Colony Count, Microbial
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Colony Counts, Microbial
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Counts, Spread Plate
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Spread Plate Counts
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Microbial Colony Counts
% 211.36/211.51  |- skos__scopeNote mesh__D015169
% 211.36/211.51       Enumeration by direct count of viable, isolated bacterial, archaeal, or fungal CELLS or SPORES capable of growth on solid CULTURE MEDIA. Each colony %28%i.e., microbial colony-forming unit%29% represents the progeny of a single cell in the original inoculum. The method is used routinely by environmental microbiologists for quantifying organisms in AIR; FOOD; and WATER; by clinicians for measuring patients%27% microbial load; and in antimicrobial drug testing.%A%    
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Count, Streak Plate
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Fungal Counts
% 211.36/211.51  |- skos__annotation mesh__D015169
% 211.36/211.51       coordinate NIM with organism /growth or /isol %28%IM%29% as appropriate%A%  
% 211.36/211.51  |- skos__altLabel mesh__D015169 Bacterial Counts
% 211.36/211.51  |- skos__altLabel mesh__D015169 Counts, Bacterial
% 211.36/211.51  |- mesh__recordOriginator mesh__D015169 SCD
% 211.36/211.51  |- skos__historyNote mesh__D015169
% 211.36/211.51       Microbiological Techniques %28%1978-1988%29%
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Counts, Agar Dilution
% 211.36/211.51  |- skos__altLabel mesh__D015169 Colony-Forming Units Assay, Microbial
% 211.36/211.51  |- mesh__dateCreated mesh__D015169 1988-04-08
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Dilution Count, Agar
% 211.36/211.51  |- skos__historyNote mesh__D015169
% 211.36/211.51       Bacteriological Techniques %28%1967-1988%29%
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Counts, Streak Plate
% 211.36/211.51  |- mesh__recordMaintainer mesh__D015169 ags
% 211.36/211.51  |- skos__altLabel mesh__D015169 Colony Forming Units Assay, Microbial
% 211.36/211.51  |- skos__hiddenLabel mesh__D015169 Count, Spread Plate
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D001947 2003
% 211.36/211.51  |- skos__broader mesh__D001947smesh__D039361
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D001947 2006
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D001947 2004
% 211.36/211.51  |- skos__prefLabel mesh__D001947 Breeding
% 211.36/211.51  |- skos__broader mesh__D001947smesh__D012099
% 211.36/211.51  |- skos__hiddenLabel mesh__D001947 Breedings
% 211.36/211.51  |- mesh__dateRevised mesh__D001947 2002-07-02
% 211.36/211.51  |- skos__annotation mesh__D001947 animals %26% plants only   
% 211.36/211.51  |- mesh__recordAuthorizer mesh__D001947 sjn
% 211.36/211.51  |- rdf__type mesh__D001947sskos__Concept
% 211.36/211.51  |- mesh__recordOriginator mesh__D001947 NLM
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D001947 2005
% 211.36/211.51  |- mesh__dateCreated mesh__D001947 1999-01-01
% 211.36/211.51  |- skos__scopeNote mesh__D001947
% 211.36/211.51       The production of offspring by selective mating or HYBRIDIZATION, GENETIC in animals or plants.%A%    
% 211.36/211.51  |- mesh__recordMaintainer mesh__D001947 lkt
% 211.36/211.51  |- skos__broader mesh__D005333Q000293smesh__D005333
% 211.36/211.51  |- mesh__preferredCombination mesh__D005333Q000293smesh__D049188
% 211.36/211.51  |- rdf__type mesh__D005333Q000293smesh__CompoundConcept
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D001149 2005
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D001149 1998
% 211.36/211.51  |- skos__broader mesh__D001149smesh__D001152
% 211.36/211.51  |- mesh__publicMeSHNote mesh__D001149 91; was see under ARSENIC 1975-90   
% 211.36/211.51  |- mesh__dateCreated mesh__D001149 1999-01-01
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D001149 2002
% 211.36/211.51  |- mesh__dateEstablished mesh__D001149 1991-01-01
% 211.36/211.51  |- mesh__recordMaintainer mesh__D001149 JRT
% 211.36/211.51  |- mesh__recordAuthorizer mesh__D001149 PLS
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D001149 2004
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D001149 1997
% 211.36/211.51  |- skos__prefLabel mesh__D001149 Arsenates
% 211.36/211.51  |- skos__annotation mesh__D001149 do not confuse with ARSENITES   
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D001149 2001
% 211.36/211.51  |- skos__scopeNote mesh__D001149
% 211.36/211.51       Inorganic or organic salts and esters of arsenic acid.     
% 211.36/211.51  |- mesh__recordOriginator mesh__D001149 NLM
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D001149 2003
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D001149 1996
% 211.36/211.51  |- skos__broader mesh__D001149smesh__D000838
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D001149 2000
% 211.36/211.51  |- mesh__onlineNote mesh__D001149 search ARSENATES 1968-74   
% 211.36/211.51  |- rdf__type mesh__D001149sskos__Concept
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D001149 2006
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D001149 1999
% 211.36/211.51  |- mesh__historyNote mesh__D001149
% 211.36/211.51       91%28%75%29%; was see under ARSENIC 1975-90   
% 211.36/211.51  |- mesh__dateRevised mesh__D001149 1995-06-08
% 211.36/211.51  |- skos__broader mesh__D006632smesh__D007093
% 211.36/211.51  |- skos__related mesh__D006632smesh__D011968
% 211.36/211.51  |- skos__prefLabel mesh__D006632 Histamine
% 211.36/211.51  |- skos__related mesh__D006632smesh__D006969
% 211.36/211.51  |- skos__hiddenLabel mesh__D006632 Dichloride, Histamine
% 211.36/211.51  |- skos__broader mesh__D006632smesh__D012898
% 211.36/211.51  |- skos__hiddenLabel mesh__D006632 Dihydrochloride, Histamine
% 211.36/211.51  |- mesh__onlineNote mesh__D006632
% 211.36/211.51       search HISTAMINE /antagonists %26% inhibitors under HISTAMINE H1 RECEPTOR BLOCKADERS 1966-76%A%  
% 211.36/211.51  |- mesh__dateCreated mesh__D006632 1999-01-01
% 211.36/211.51  |- mesh__publicMeSHNote mesh__D006632
% 211.36/211.51       /antagonists %26% inhibitors was ANTIHISTAMINICS 1963-76   
% 211.36/211.51  |- skos__broader mesh__D006632smesh__D005021
% 211.36/211.51  |- skos__broader mesh__D006632smesh__D015306
% 211.36/211.51  |- mesh__dateRevised mesh__D006632 2005-06-30
% 211.36/211.51  |- rdf__type mesh__D006632sskos__Concept
% 211.36/211.51  |- mesh__historyNote mesh__D006632
% 211.36/211.51       /antagonists %26% inhibitors was ANTIHISTAMINICS 1963-76   
% 211.36/211.51  |- skos__altLabel mesh__D006632 Histamine Dichloride
% 211.36/211.51  |- mesh__recordOriginator mesh__D006632 NLM
% 211.36/211.51  |- skos__annotation mesh__D006632
% 211.36/211.51       /secret or histamine liberation = HISTAMINE RELEASE   
% 211.36/211.51  |- skos__scopeNote mesh__D006632
% 211.36/211.51       An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter.%A%    
% 211.36/211.51  |- mesh__recordAuthorizer mesh__D006632 sjn
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D006632 2006
% 211.36/211.51  |- mesh__recordMaintainer mesh__D006632 ssb
% 211.36/211.51  |- mesh__historyNote mesh__D020303 99   
% 211.36/211.51  |- skos__hiddenLabel mesh__D020303 Rats, Dahl Hypertensive
% 211.36/211.51  |- skos__hiddenLabel mesh__D020303 Rats, Dahl
% 211.36/211.51  |- skos__hiddenLabel mesh__D020303 Dahl Salt Resistant Rats
% 211.36/211.51  |- mesh__recordOriginator mesh__D020303 NDW
% 211.36/211.51  |- skos__altLabel mesh__D020303 Dahl Rats
% 211.36/211.51  |- skos__prefLabel mesh__D020303 Rats, Inbred Dahl
% 211.36/211.51  |- skos__annotation mesh__D020303 NIM when exper animal; check tag RATS   
% 211.36/211.51  |- skos__hiddenLabel mesh__D020303 Hypertensive Rats, Dahl
% 211.36/211.51  |- skos__hiddenLabel mesh__D020303 Dahl Rats, Inbred
% 211.36/211.51  |- mesh__dateRevised mesh__D020303 2005-06-30
% 211.36/211.51  |- skos__hiddenLabel mesh__D020303 Dahl Salt Sensitive Rats
% 211.36/211.51  |- skos__altLabel mesh__D020303 Dahl Hypertensive Rats
% 211.36/211.51  |- rdf__type mesh__D020303sskos__Concept
% 211.36/211.51  |- skos__historyNote mesh__D020303 Rats, Inbred Strains %28%1982-1998%29%
% 211.36/211.51  |- skos__hiddenLabel mesh__D020303 Inbred Dahl Rats
% 211.36/211.51  |- mesh__recordAuthorizer mesh__D020303 sjn
% 211.36/211.51  |- mesh__dateEstablished mesh__D020303 1999-01-01
% 211.36/211.51  |- mesh__dateCreated mesh__D020303 1998-06-11
% 211.36/211.51  |- mesh__publicMeSHNote mesh__D020303 99   
% 211.36/211.51  |- skos__scopeNote mesh__D020303
% 211.36/211.51       Inbred rats derived from Sprague-Dawley rats and used for the study of salt-dependent hypertension. Salt-sensitive and salt-resistant strains have been selectively bred to show the opposite genetically determined blood pressure responses to excess sodium chloride ingestion.%A%    
% 211.36/211.51  |- skos__historyNote mesh__D020303 Rats %28%1980-1981%29%
% 211.36/211.51  |- skos__hiddenLabel mesh__D020303 Rats, Dahl Salt-Sensitive
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D020303 2006
% 211.36/211.51  |- skos__hiddenLabel mesh__D020303 Salt-Resistant Rats, Dahl
% 211.36/211.51  |- skos__hiddenLabel mesh__D020303 Salt-Sensitive Rats, Dahl
% 211.36/211.51  |- skos__hiddenLabel mesh__D020303 Rats, Dahl Salt-Resistant
% 211.36/211.51  |- mesh__recordMaintainer mesh__D020303 ags
% 211.36/211.51  |- skos__broader mesh__D020303smesh__D011919
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D011577 2002
% 211.36/211.51  |- mesh__dateCreated mesh__D011577 1999-01-01
% 211.36/211.51  |- skos__scopeNote mesh__D011577
% 211.36/211.51       Primarily a technique of group psychotherapy which involves a structure, directed, and dramatized acting out of the patient%27%s personal and emotional problems.%A%    
% 211.36/211.51  |- skos__hiddenLabel mesh__D011577 Psychodramas
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D011577 2006
% 211.36/211.51  |- mesh__recordOriginator mesh__D011577 NLM
% 211.36/211.51  |- skos__annotation mesh__D011577 a group psychother technique   
% 211.36/211.51  |- skos__broader mesh__D011577smesh__D026421
% 211.36/211.51  |- mesh__recordAuthorizer mesh__D011577 sjn
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D011577 2005
% 211.36/211.51  |- mesh__dateRevised mesh__D011577 2001-07-25
% 211.36/211.51  |- skos__broader mesh__D011577smesh__D011615
% 211.36/211.51  |- rdf__type mesh__D011577sskos__Concept
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D011577 2004
% 211.36/211.51  |- skos__related mesh__D011577smesh__D000184
% 211.36/211.51  |- mesh__recordMaintainer mesh__D011577 ssb
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D011577 2003
% 211.36/211.51  |- skos__prefLabel mesh__D011577 Psychodrama
% 211.36/211.51  |- skos__broader mesh__D001182Q000295smesh__D001182
% 211.36/211.51  |- mesh__preferredCombination mesh__D001182Q000295smesh__D020679
% 211.36/211.51  |- rdf__type mesh__D001182Q000295smesh__CompoundConcept
% 211.36/211.51  |- mesh__historyNote mesh__D016262 1991   
% 211.36/211.51  |- skos__hiddenLabel mesh__D016262 Post-Poliomyelitis Muscular Atrophies
% 211.36/211.51  |- skos__altLabel mesh__D016262 Post-Poliomyelitis Syndrome
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D016262 2006
% 211.36/211.51  |- mesh__recordAuthorizer mesh__D016262 sjn
% 211.36/211.51  |- skos__broader mesh__D016262smesh__D020966
% 211.36/211.51  |- mesh__recordOriginator mesh__D016262 PXP
% 211.36/211.51  |- skos__altLabel mesh__D016262 Muscular Atrophy, Postpoliomyelitis
% 211.36/211.51  |- skos__altLabel mesh__D016262 Post-Poliomyelitis Muscular Atrophy
% 211.36/211.51  |- skos__hiddenLabel mesh__D016262 Postpoliomyelitis Muscular Atrophies
% 211.36/211.51  |- skos__hiddenLabel mesh__D016262 Muscular Atrophies, Post-Poliomyelitis
% 211.36/211.51  |- skos__broader mesh__D016262smesh__D011051
% 211.36/211.51  |- rdf__type mesh__D016262sskos__Concept
% 211.36/211.51  |- skos__hiddenLabel mesh__D016262 Post-Polio Syndromes
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D016262 2005
% 211.36/211.51  |- skos__altLabel mesh__D016262 Post-Polio Syndrome
% 211.36/211.51  |- mesh__dateRevised mesh__D016262 2000-06-22
% 211.36/211.51  |- skos__historyNote mesh__D016262
% 211.36/211.51       Poliomyelitis/complications %28%1983-1990%29%
% 211.36/211.51  |- skos__altLabel mesh__D016262 Postpoliomyelitis Muscular Atrophy
% 211.36/211.51  |- skos__hiddenLabel mesh__D016262 Muscular Atrophies, Postpoliomyelitis
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D016262 2004
% 211.36/211.51  |- skos__hiddenLabel mesh__D016262 Post Poliomyelitis Syndrome
% 211.36/211.51  |- skos__prefLabel mesh__D016262 Postpoliomyelitis Syndrome
% 211.36/211.51  |- skos__annotation mesh__D016262 DF: POSTPOLIO SYNDROME or PPMA   
% 211.36/211.51  |- skos__hiddenLabel mesh__D016262 Post Poliomyelitis Muscular Atrophy
% 211.36/211.51  |- skos__related mesh__D016262smesh__D011051
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D016262 2002
% 211.36/211.51  |- skos__hiddenLabel mesh__D016262 Muscular Atrophy, Post-Poliomyelitis
% 211.36/211.51  |- mesh__recordMaintainer mesh__D016262 sjn
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D016262 2003
% 211.36/211.51  |- mesh__dateCreated mesh__D016262 1999-11-08
% 211.36/211.51  |- mesh__publicMeSHNote mesh__D016262 1991   
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D016262 2001
% 211.36/211.51  |- skos__scopeNote mesh__D016262
% 211.36/211.51       A syndrome characterized by new neuromuscular symptoms that occur at least 15 years after clinical stability has been attained in patients with a prior history of symptomatic poliomyelitis. Clinical features include new muscular weakness and atrophy of the limbs, bulbar innervated musculature, and muscles of respiration, combined with excessive fatigue, joint pain, and reduced stamina. The process is marked by slow progression and periods of stabilization. %28%From Ann NY Acad Sci 1995 May 25;753:68-80%29%%A%    
% 211.36/211.51  |- mesh__dateEstablished mesh__D016262 1991-01-01
% 211.36/211.51  |- skos__broader mesh__D016262smesh__D019636
% 211.36/211.51  |- skos__broader mesh__D014867Q000600smesh__D014867
% 211.36/211.51  |- mesh__preferredCombination mesh__D014867Q000600smesh__D014881
% 211.36/211.51  |- rdf__type mesh__D014867Q000600smesh__CompoundConcept
% 211.36/211.51  |- mesh__recordAuthorizer mesh__D026690 sjn
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D026690 2003
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D026690 2006
% 211.36/211.51  |- mesh__recordOriginator mesh__D026690 tjk
% 211.36/211.51  |- mesh__dateEstablished mesh__D026690 2002-01-01
% 211.36/211.51  |- mesh__activeMeSHYear mesh__D026690 2004
% 211.36/211.51  |- skos__related mesh__D026690smesh__D026822
% 211.36/211.51  |- mesh__recordMaintainer mesh__D026690 jrf
% 211.36/211.51  |- skos__annotation mesh__D026690
% 211.36/211.51       ETHICS, MEDICAL is available for ethics in relation to the physician. Do not use routinely; reserve for discussions of clinical ethics as a topic in its own right%A%  
% 211.36/211.51  |- rdf__type mesh__D026690sskos__Concept
% 211.36/211.51  |- skos__broader mesh__D026690smesh__D001675
% 211.36/211.51  |- mesh__publicMeSHNote mesh__D026690
% 211.36/211.51       2002; see ETHICS, MEDICAL 1993-2001   
% 211.36/211.51  |- mesh__dateCreated mesh__D026690 2001-07-25
% 211.36/211.51  |- mesh__historyNote mesh__D026690 2002; use ETHICS, MEDICAL 1993-2001   
% 211.36/211.51  |- skos__scopeNote mesh__D026690
% 211.36/211.51       The identification, analysis, and resolution of moral problems that arise in the care of patients. %28%Bioethics Thesaurus%29%%A%    
% 211.36/211.51  |- skos__related mesh__D026690smesh__D028741
% 211.36/211.51  |- skos__prefLabel mesh__D026690 Ethics, Clinical
% 211.36/211.51  |- skos__historyNote mesh__D026690 Ethics, Medical %28%1992-2001%29%
% 211.36/211.51  |- skos__altLabel mesh__D026690 Clinical Ethics
% 211.36/211.51  |- skos__broader mesh__D026690smesh__D004995
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D026690 2005
% 211.36/211.52  |- skos__related mesh__D026690smesh__D033061
% 211.36/211.52  |- mesh__dateRevised mesh__D026690 2002-07-03
% 211.36/211.52  |- skos__hiddenLabel mesh__D040361 People Programs, Healthy
% 211.36/211.52  |- skos__scopeNote mesh__D040361
% 211.36/211.52       Healthy People Programs are a set of health objectives to be used by governments, communities, professional organizations, and others to help develop programs to improve health. It builds on initiatives pursued over the past two decades beginning with the 1979 Surgeon General%27%s Report, Healthy People, Healthy People 2000: National Health Promotion and Disease Prevention Objectives, and Healthy People 2010. These established national health objectives and served as the basis for the development of state and community plans. These are administered by the Office of Disease Prevention and Health Promotion %28%ODPHP%29%. Similar programs are conducted by other national governments.%A%    
% 211.36/211.52  |- skos__prefLabel mesh__D040361 Healthy People Programs
% 211.36/211.52  |- mesh__recordAuthorizer mesh__D040361 jls
% 211.36/211.52  |- mesh__dateRevised mesh__D040361 2004-07-27
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D040361 2005
% 211.36/211.52  |- skos__historyNote mesh__D040361 Health Promotion %28%1990-2002%29%
% 211.36/211.52  |- mesh__dateCreated mesh__D040361 2002-07-03
% 211.36/211.52  |- skos__hiddenLabel mesh__D040361 Program, Healthy People
% 211.36/211.52  |- mesh__dateEstablished mesh__D040361 2003-01-01
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D040361 2005B
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D040361 2006
% 211.36/211.52  |- mesh__recordOriginator mesh__D040361 jls
% 211.36/211.52  |- mesh__recordMaintainer mesh__D040361 jls
% 211.36/211.52  |- skos__annotation mesh__D040361 specify geog if pertinent   
% 211.36/211.52  |- skos__hiddenLabel mesh__D040361 People Program, Healthy
% 211.36/211.52  |- rdf__type mesh__D040361sskos__Concept
% 211.36/211.52  |- skos__hiddenLabel mesh__D040361 Programs, Healthy People
% 211.36/211.52  |- mesh__historyNote mesh__D040361 2003   
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D040361 2004
% 211.36/211.52  |- skos__hiddenLabel mesh__D040361 Healthy People Program
% 211.36/211.52  |- mesh__publicMeSHNote mesh__D040361 2003   
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D040361 2005A
% 211.36/211.52  |- skos__broader mesh__D040361smesh__D006293
% 211.36/211.52  |- skos__broader mesh__D001948smesh__D010051
% 211.36/211.52  |- mesh__recordAuthorizer mesh__D001948 sjn
% 211.36/211.52  |- rdf__type mesh__D001948sskos__Concept
% 211.36/211.52  |- skos__prefLabel mesh__D001948 Brenner Tumor
% 211.36/211.52  |- skos__hiddenLabel mesh__D001948 Brenner Tumor, Proliferative
% 211.36/211.52  |- mesh__recordOriginator mesh__D001948 NLM
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D001948 2006
% 211.36/211.52  |- skos__scopeNote mesh__D001948
% 211.36/211.52       A smooth, solid or cystic fibroepithelial %28%FIBROEPITHELIAL NEOPLASMS%29% tumor, usually found in the OVARIES but can also be found in the adnexal region and the KIDNEYS. It consists of a fibrous stroma with nests of epithelial cells that sometimes resemble the transitional cells lining the urinary bladder. Brenner tumors generally are benign and asymptomatic. Malignant Brenner tumors have been reported.%A%    
% 211.36/211.52  |- skos__hiddenLabel mesh__D001948 Brenner Tumor, Benign
% 211.36/211.52  |- skos__hiddenLabel mesh__D001948 Brenner Tumor, Malignant
% 211.36/211.52  |- mesh__recordMaintainer mesh__D001948 lkt
% 211.36/211.52  |- skos__annotation mesh__D001948
% 211.36/211.52       coordinate IM with OVARIAN NEOPLASMS %28%IM%29%   
% 211.36/211.52  |- mesh__dateRevised mesh__D001948 2005-06-30
% 211.36/211.52  |- mesh__dateCreated mesh__D001948 1999-01-01
% 211.36/211.52  |- skos__broader mesh__D001948smesh__D018225
% 211.36/211.52  |- mesh__dateCreated mesh__D012670 1974-11-11
% 211.36/211.52  |- mesh__recordMaintainer mesh__D012670 lkt
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D012670 2004
% 211.36/211.52  |- mesh__publicMeSHNote mesh__D012670 91; was see under TESTIS 1975-90   
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D012670 2003
% 211.36/211.52  |- skos__hiddenLabel mesh__D012670 Epitheliums, Seminiferous
% 211.36/211.52  |- skos__scopeNote mesh__D012670
% 211.36/211.52       The epithelium lining the seminiferous tubules composed of primary male germ cells %28%SPERMATOGONIA%29% and supporting SERTOLI CELLS.  As SPERMATOGENESIS proceeds, the developing germ cells migrate toward the lumen. The adluminal compartment, the inner two thirds of the tubules, contains SPERMATOCYTES and the more advanced germ cells.%A%    
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D012670 2006
% 211.36/211.52  |- mesh__historyNote mesh__D012670
% 211.36/211.52       91%28%75%29%; was see under TESTIS 1975-90   
% 211.36/211.52  |- mesh__recordOriginator mesh__D012670 NLM
% 211.36/211.52  |- mesh__dateRevised mesh__D012670 2002-07-03
% 211.36/211.52  |- skos__prefLabel mesh__D012670 Seminiferous Epithelium
% 211.36/211.52  |- skos__broader mesh__D012670smesh__D012671
% 211.36/211.52  |- skos__hiddenLabel mesh__D012670 Epithelium, Seminiferous
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D012670 2005
% 211.36/211.52  |- skos__hiddenLabel mesh__D012670 Seminiferous Epitheliums
% 211.36/211.52  |- mesh__dateEstablished mesh__D012670 1991-01-01
% 211.36/211.52  |- skos__broader mesh__D012670smesh__D004848
% 211.36/211.52  |- mesh__recordAuthorizer mesh__D012670 sjn
% 211.36/211.52  |- rdf__type mesh__D012670sskos__Concept
% 211.36/211.52  |- skos__historyNote mesh__D006633
% 211.36/211.52       Histamine H1 Receptor Blockaders %28%1966-1976%29%
% 211.36/211.52  |- skos__annotation mesh__D006633
% 211.36/211.52       GEN or unspecified; prefer specifics; do not confuse with HISTAMINE AGONISTS; DF: HISTAMINE ANTAG%A%  
% 211.36/211.52  |- mesh__recordMaintainer mesh__D006633 ssb
% 211.36/211.52  |- skos__hiddenLabel mesh__D006633 Antagonists, Histamine
% 211.36/211.52  |- mesh__publicMeSHNote mesh__D006633
% 211.36/211.52       77; was see ANTIHISTAMINICS 1963-76   
% 211.36/211.52  |- rdf__type mesh__D006633sskos__Concept
% 211.36/211.52  |- skos__prefLabel mesh__D006633 Histamine Antagonists
% 211.36/211.52  |- mesh__dateEstablished mesh__D006633 1977-01-01
% 211.36/211.52  |- mesh__dateCreated mesh__D006633 1976-05-05
% 211.36/211.52  |- mesh__onlineNote mesh__D006633
% 211.36/211.52       search HISTAMINE H1 RECEPTOR BLOCKADERS 1966-76   
% 211.36/211.52  |- skos__scopeNote mesh__D006633
% 211.36/211.52       Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only.%A%    
% 211.36/211.52  |- mesh__recordOriginator mesh__D006633 SH
% 211.36/211.52  |- mesh__dateRevised mesh__D006633 2005-06-30
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D006633 2006
% 211.36/211.52  |- mesh__historyNote mesh__D006633 77; was see ANTIHISTAMINICS 1963-76   
% 211.36/211.52  |- skos__broader mesh__D006633smesh__D018494
% 211.36/211.52  |- mesh__recordAuthorizer mesh__D006633 sjn
% 211.36/211.52  |- mesh__dateRevised mesh__D020304 2004-12-02
% 211.36/211.52  |- skos__altLabel mesh__D020304 Bird of Prey
% 211.36/211.52  |- mesh__dateEstablished mesh__D020304 1999-01-01
% 211.36/211.52  |- mesh__recordAuthorizer mesh__D020304 ags
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D020304 2005
% 211.36/211.52  |- skos__broader mesh__D020304smesh__D001717
% 211.36/211.52  |- mesh__publicMeSHNote mesh__D020304 99   
% 211.36/211.52  |- skos__altLabel mesh__D020304 Birds of Prey
% 211.36/211.52  |- mesh__recordOriginator mesh__D020304 NDW
% 211.36/211.52  |- mesh__historyNote mesh__D020304 99   
% 211.36/211.52  |- skos__scopeNote mesh__D020304
% 211.36/211.52       BIRDS that hunt and kill other animals, especially higher vertebrates, for food. They include the FALCONIFORMES order, or diurnal birds of prey, comprised of EAGLES, falcons, HAWKS, and others, as well as the STRIGIFORMES order, or nocturnal birds of prey, which includes OWLS.%A%    
% 211.36/211.52  |- mesh__recordMaintainer mesh__D020304 ags
% 211.36/211.52  |- skos__hiddenLabel mesh__D020304 Prey Birds
% 211.36/211.52  |- skos__hiddenLabel mesh__D020304 Raptor
% 211.36/211.52  |- skos__prefLabel mesh__D020304 Raptors
% 211.36/211.52  |- mesh__dateCreated mesh__D020304 1998-06-11
% 211.36/211.52  |- skos__historyNote mesh__D020304 Birds %28%1984-1998%29%
% 211.36/211.52  |- skos__hiddenLabel mesh__D020304 Prey Bird
% 211.36/211.52  |- rdf__type mesh__D020304sskos__Concept
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D020304 2005A
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D020304 2006
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011578 1999
% 211.36/211.52  |- skos__hiddenLabel mesh__D011578 Psycholinguistic
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011578 1994
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011578 2005
% 211.36/211.52  |- rdf__type mesh__D011578sskos__Concept
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011578 1991
% 211.36/211.52  |- mesh__recordMaintainer mesh__D011578 TGC
% 211.36/211.52  |- mesh__historyNote mesh__D011578 67   
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011578 2002
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011578 1998
% 211.36/211.52  |- mesh__dateEstablished mesh__D011578 1967-01-01
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011578 1993
% 211.36/211.52  |- skos__broader mesh__D011578smesh__D011579
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011578 2004
% 211.36/211.52  |- skos__broader mesh__D011578smesh__D001525
% 211.36/211.52  |- skos__broader mesh__D011578smesh__D008037
% 211.36/211.52  |- mesh__dateRevised mesh__D011578 1989-05-16
% 211.36/211.52  |- mesh__recordOriginator mesh__D011578 NLM
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011578 1990
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011578 2001
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011578 1997
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011578 1992
% 211.36/211.52  |- skos__scopeNote mesh__D011578
% 211.36/211.52       A discipline concerned with relations between messages and the characteristics of individuals who select and interpret them; it deals directly with the processes of encoding %28%phonetics%29% and decoding %28%psychoacoustics%29% as they relate states of messages to states of communicators.%A%    
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011578 2003
% 211.36/211.52  |- skos__annotation mesh__D011578
% 211.36/211.52       SPEC: IM, SPEC qualif; coord with specific linguistic %26% psychol concepts %28%IM%29%; NIM coord, no qualif%A%  
% 211.36/211.52  |- skos__prefLabel mesh__D011578 Psycholinguistics
% 211.36/211.52  |- skos__historyNote mesh__D011578 Language %28%1966%29%
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011578 2000
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011578 1996
% 211.36/211.52  |- skos__related mesh__D011578smesh__D007804
% 211.36/211.52  |- mesh__recordAuthorizer mesh__D011578 PLS
% 211.36/211.52  |- mesh__publicMeSHNote mesh__D011578 67   
% 211.36/211.52  |- mesh__dateCreated mesh__D011578 1999-01-01
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011578 1995
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011578 2006
% 211.36/211.52  |- skos__hiddenLabel mesh__D016263 AIDS Nephropathies
% 211.36/211.52  |- skos__altLabel mesh__D016263 Nephropathies, HIV-Related
% 211.36/211.52  |- skos__altLabel mesh__D016263 Nephropathy, HIV-Associated
% 211.36/211.52  |- skos__hiddenLabel mesh__D016263 Nephropathy, AIDS Associated
% 211.36/211.52  |- skos__scopeNote mesh__D016263
% 211.36/211.52       Renal syndrome in human immunodeficiency virus-infected patients characterized by nephrotic syndrome, severe proteinuria, focal and segmental glomerulosclerosis with distinctive tubular and interstitial changes, enlarged kidneys, and peculiar tubuloreticular structures. The syndrome is distinct from heroin-associated nephropathy as well as other forms of kidney disease seen in HIV-infected patients.%A%    
% 211.36/211.52  |- skos__hiddenLabel mesh__D016263
% 211.36/211.52       Human Immunodeficiency Virus Associated Nephropathy
% 211.36/211.52  |- skos__historyNote mesh__D016263
% 211.36/211.52       Acquired Immunodeficiency Syndrome %28%1984-1990%29%
% 211.36/211.52  |- skos__broader mesh__D016263smesh__D015658
% 211.36/211.52  |- skos__hiddenLabel mesh__D016263 Nephropathies, AIDS Associated
% 211.36/211.52  |- skos__broader mesh__D016263smesh__D007674
% 211.36/211.52  |- skos__hiddenLabel mesh__D016263 Nephropathies, HIV Associated
% 211.36/211.52  |- skos__hiddenLabel mesh__D016263 HIV Related Nephropathies
% 211.36/211.52  |- mesh__recordAuthorizer mesh__D016263 sjn
% 211.36/211.52  |- mesh__recordOriginator mesh__D016263 AGS
% 211.36/211.52  |- mesh__dateCreated mesh__D016263 1990-05-25
% 211.36/211.52  |- skos__altLabel mesh__D016263 Nephropathies, AIDS-Associated
% 211.36/211.52  |- skos__historyNote mesh__D016263
% 211.36/211.52       specific kidney diseases %28%1984-1990%29%
% 211.36/211.52  |- skos__hiddenLabel mesh__D016263 AIDS Associated Nephropathies
% 211.36/211.52  |- mesh__dateEstablished mesh__D016263 1991-01-01
% 211.36/211.52  |- skos__altLabel mesh__D016263 HIV-Related Nephropathy
% 211.36/211.52  |- skos__hiddenLabel mesh__D016263 HIV Associated Nephropathies
% 211.36/211.52  |- skos__historyNote mesh__D016263 Kidney Diseases %28%1984-1990%29%
% 211.36/211.52  |- skos__hiddenLabel mesh__D016263 Nephropathy, AIDS
% 211.36/211.52  |- skos__hiddenLabel mesh__D016263 AIDS Associated Nephropathy
% 211.36/211.52  |- skos__hiddenLabel mesh__D016263 HIV Related Nephropathy
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D016263 2006
% 211.36/211.52  |- skos__altLabel mesh__D016263 HIV-Related Nephropathies
% 211.36/211.52  |- skos__altLabel mesh__D016263 HIV-Associated Nephropathy
% 211.36/211.52  |- skos__hiddenLabel mesh__D016263 Nephropathy, HIV Associated
% 211.36/211.52  |- skos__altLabel mesh__D016263 Nephropathy, HIV-Related
% 211.36/211.52  |- skos__altLabel mesh__D016263
% 211.36/211.52       Human Immunodeficiency Virus-Associated Nephropathy
% 211.36/211.52  |- skos__altLabel mesh__D016263 Nephropathy, AIDS-Associated
% 211.36/211.52  |- skos__altLabel mesh__D016263 AIDS-Associated Nephropathies
% 211.36/211.52  |- mesh__historyNote mesh__D016263 91   
% 211.36/211.52  |- skos__hiddenLabel mesh__D016263 Nephropathy, HIV Related
% 211.36/211.52  |- skos__altLabel mesh__D016263 Nephropathies, HIV-Associated
% 211.36/211.52  |- skos__annotation mesh__D016263
% 211.36/211.52       coord IM with specific kidney dis %28%IM%29%; specify HIV-1 or HIV-2 %28%IM or NIM%29% if pertinent; DF: HIVAN%A%  
% 211.36/211.52  |- skos__altLabel mesh__D016263 HIV-Associated Nephropathies
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D016263 2005
% 211.36/211.52  |- mesh__publicMeSHNote mesh__D016263 91   
% 211.36/211.52  |- skos__hiddenLabel mesh__D016263 HIV Associated Nephropathy
% 211.36/211.52  |- skos__altLabel mesh__D016263 AIDS Nephropathy
% 211.36/211.52  |- mesh__dateRevised mesh__D016263 2004-07-13
% 211.36/211.52  |- skos__hiddenLabel mesh__D016263 Nephropathies, AIDS
% 211.36/211.52  |- mesh__recordMaintainer mesh__D016263 sjn
% 211.36/211.52  |- rdf__type mesh__D016263sskos__Concept
% 211.36/211.52  |- skos__hiddenLabel mesh__D016263 Nephropathies, HIV Related
% 211.36/211.52  |- skos__prefLabel mesh__D016263 AIDS-Associated Nephropathy
% 211.36/211.52  |- rdf__type mesh__D002243sskos__Concept
% 211.36/211.52  |- mesh__recordOriginator mesh__D002243 NLM
% 211.36/211.52  |- skos__scopeNote mesh__D002243
% 211.36/211.52       A group of pyrido-indole compounds. Included are any points of fusion of pyridine with the five-membered ring of indole and any derivatives of these compounds. These are similar to CARBAZOLES which are benzo-indoles.%A%    
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D002243 2004
% 211.36/211.52  |- skos__broader mesh__D002243smesh__D006575
% 211.36/211.52  |- mesh__recordMaintainer mesh__D002243 ssb
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D002243 2006
% 211.36/211.52  |- mesh__publicMeSHNote mesh__D002243 86; was see under INDOLES 1975-85   
% 211.36/211.52  |- mesh__dateEstablished mesh__D002243 1986-01-01
% 211.36/211.52  |- skos__prefLabel mesh__D002243 Carbolines
% 211.36/211.52  |- skos__broader mesh__D002243smesh__D011725
% 211.36/211.52  |- skos__hiddenLabel mesh__D002243 Beta Carbolines
% 211.36/211.52  |- skos__historyNote mesh__D002243 Pyridines %28%1969-1974%29%
% 211.36/211.52  |- skos__altLabel mesh__D002243 Pyrido%5B%4,3-b%5D%Indole
% 211.36/211.52  |- skos__hiddenLabel mesh__D002243 Pyrido%5B%4,3 b%5D%Indole
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D002243 2005
% 211.36/211.52  |- mesh__dateCreated mesh__D002243 1974-11-19
% 211.36/211.52  |- mesh__dateRevised mesh__D002243 2003-07-09
% 211.36/211.52  |- mesh__historyNote mesh__D002243
% 211.36/211.52       86%28%75%29%; was see under INDOLES 1975-85   
% 211.36/211.52  |- skos__historyNote mesh__D002243 Indoles %28%1969-1974%29%
% 211.36/211.52  |- mesh__recordAuthorizer mesh__D002243 sjn
% 211.36/211.52  |- skos__broader mesh__D002243smesh__D007211
% 211.36/211.52  |- mesh__dateCreated mesh__D015969 1989-07-03
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D015969 1993
% 211.36/211.52  |- mesh__publicMeSHNote mesh__D015969 90   
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D015969 2006
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D015969 1998
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D015969 2001
% 211.36/211.52  |- skos__altLabel mesh__D015969 Institute of Medicine
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D015969 1997
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D015969 2000
% 211.36/211.52  |- skos__prefLabel mesh__D015969 Institute of Medicine %28%U.S.%29%
% 211.36/211.52  |- mesh__historyNote mesh__D015969 90   
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D015969 2005
% 211.36/211.52  |- skos__broader mesh__D015969smesh__D009307
% 211.36/211.52  |- rdf__type mesh__D015969sskos__Concept
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D015969 2004
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D015969 1996
% 211.36/211.52  |- mesh__recordOriginator mesh__D015969 EGC
% 211.36/211.52  |- mesh__recordMaintainer mesh__D015969 TAP
% 211.36/211.52  |- skos__hiddenLabel mesh__D015969 Medicine Institute %28%U.S.%29%
% 211.36/211.52  |- mesh__recordAuthorizer mesh__D015969 PLS
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D015969 2003
% 211.36/211.52  |- skos__annotation mesh__D015969
% 211.36/211.52       add UNITED STATES %28%NIM%29%; research support by this agency is checked as NON-US GOVT SUP; DF: IOM      CATALOG: use NAF entry%A%  
% 211.36/211.52  |- mesh__dateRevised mesh__D015969 1992-05-14
% 211.36/211.52  |- mesh__dateEstablished mesh__D015969 1990-01-01
% 211.36/211.52  |- skos__scopeNote mesh__D015969
% 211.36/211.52       Identifies, for study and analysis, important issues and problems that relate to health and medicine. The Institute initiates and conducts studies of national policy and planning for health care and health-related education and research; it also responds to requests from the federal government and other agencies for studies and advice.%A%    
% 211.36/211.52  |- skos__hiddenLabel mesh__D015969 Medicine Institutes %28%U.S.%29%
% 211.36/211.52  |- skos__historyNote mesh__D015969 Organizations %28%1986-1989%29%
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D015969 1995
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D015969 1999
% 211.36/211.52  |- skos__historyNote mesh__D015969
% 211.36/211.52       Academies and Institutes %28%1970-1989%29%
% 211.36/211.52  |- skos__historyNote mesh__D015969
% 211.36/211.52       National Academy of Sciences %28%1986-1989%29%
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D015969 2002
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D015969 1994
% 211.36/211.52  |- skos__prefLabel mesh__D040362 Geographic Information Systems
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D040362 2005
% 211.36/211.52  |- skos__broader mesh__D040362smesh__D016208
% 211.36/211.52  |- skos__broader mesh__D040362smesh__D007256
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D040362 2006
% 211.36/211.52  |- mesh__recordOriginator mesh__D040362 jls
% 211.36/211.52  |- rdf__type mesh__D040362sskos__Concept
% 211.36/211.52  |- skos__hiddenLabel mesh__D040362 Geographic Information System
% 211.36/211.52  |- mesh__dateCreated mesh__D040362 2002-07-03
% 211.36/211.52  |- mesh__dateEstablished mesh__D040362 2003-01-01
% 211.36/211.52  |- skos__hiddenLabel mesh__D040362 Information Systems, Geographic
% 211.36/211.52  |- skos__scopeNote mesh__D040362
% 211.36/211.52       Computer systems capable of assembling, storing, manipulating, and displaying geographically referenced information, i.e. data identified according to their locations.%A%    
% 211.36/211.52  |- mesh__recordMaintainer mesh__D040362 jls
% 211.36/211.52  |- mesh__historyNote mesh__D040362 2003   
% 211.36/211.52  |- mesh__dateRevised mesh__D040362 2004-07-07
% 211.36/211.52  |- mesh__publicMeSHNote mesh__D040362 2003   
% 211.36/211.52  |- skos__hiddenLabel mesh__D040362 Information System, Geographic
% 211.36/211.52  |- mesh__recordAuthorizer mesh__D040362 sjn
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D001949 2006
% 211.36/211.52  |- skos__broader mesh__D001949smesh__D000644
% 211.36/211.52  |- mesh__recordAuthorizer mesh__D001949 sjn
% 211.36/211.52  |- mesh__recordOriginator mesh__D001949 NLM
% 211.36/211.52  |- mesh__dateCreated mesh__D001949 1999-01-01
% 211.36/211.52  |- skos__annotation mesh__D001949 ammonium cpds; DF: BRETYLIUM CPDS   
% 211.36/211.52  |- skos__broader mesh__D001949smesh__D050339
% 211.36/211.52  |- skos__hiddenLabel mesh__D001949 Compounds, Bretylium
% 211.36/211.52  |- mesh__recordMaintainer mesh__D001949 ssb
% 211.36/211.52  |- rdf__type mesh__D001949sskos__Concept
% 211.36/211.52  |- skos__prefLabel mesh__D001949 Bretylium Compounds
% 211.36/211.52  |- mesh__dateRevised mesh__D001949 2005-06-30
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D012671 2004
% 211.36/211.52  |- mesh__dateEstablished mesh__D012671 1991-01-01
% 211.36/211.52  |- mesh__publicMeSHNote mesh__D012671 91; was see under TESTIS 1975-90   
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D012671 2005
% 211.36/211.52  |- mesh__recordAuthorizer mesh__D012671 sjn
% 211.36/211.52  |- skos__hiddenLabel mesh__D012671 Seminiferous Tubule
% 211.36/211.52  |- skos__scopeNote mesh__D012671
% 211.36/211.52       The convoluted tubules in the TESTIS where sperm are produced %28%SPERMATOGENESIS%29% and conveyed to the RETE TESTIS. Spermatogenic tubules are composed of developing germ cells and the supporting SERTOLI CELLS.%A%    
% 211.36/211.52  |- skos__broader mesh__D012671smesh__D013737
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D012671 2006
% 211.36/211.52  |- mesh__historyNote mesh__D012671
% 211.36/211.52       91%28%75%29%; was see under TESTIS 1975-90   
% 211.36/211.52  |- mesh__recordMaintainer mesh__D012671 lkt
% 211.36/211.52  |- mesh__dateCreated mesh__D012671 1974-11-11
% 211.36/211.52  |- skos__hiddenLabel mesh__D012671 Tubules, Seminiferous
% 211.36/211.52  |- mesh__dateRevised mesh__D012671 2002-07-03
% 211.36/211.52  |- mesh__recordOriginator mesh__D012671 NLM
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D012671 2003
% 211.36/211.52  |- skos__prefLabel mesh__D012671 Seminiferous Tubules
% 211.36/211.52  |- rdf__type mesh__D012671sskos__Concept
% 211.36/211.52  |- skos__hiddenLabel mesh__D012671 Tubule, Seminiferous
% 211.36/211.52  |- mesh__dateRevised mesh__D006634 2005-06-30
% 211.36/211.52  |- skos__hiddenLabel mesh__D006634 Blockers, Histamine H1
% 211.36/211.52  |- skos__hiddenLabel mesh__D006634 Classical Antihistaminics
% 211.36/211.52  |- skos__altLabel mesh__D006634 Blockaders, Histamine H1 Receptor
% 211.36/211.52  |- mesh__historyNote mesh__D006634
% 211.36/211.52       95; was HISTAMINE H1 RECEPTOR BLOCKADERS 1977-94; was ANTIHISTAMINICS 1963-76; ANTIHISTAMINICS, CLASSICAL was ANTIHISTAMINICS see HISTAMINE H1 RECEPTOR BLOCKADERS 1977-90%A%  
% 211.36/211.52  |- skos__hiddenLabel mesh__D006634 Classical Antihistamines
% 211.36/211.52  |- skos__altLabel mesh__D006634 Antihistamines, Classical
% 211.36/211.52  |- skos__altLabel mesh__D006634 Histamine H1 Receptor Blockaders
% 211.36/211.52  |- skos__altLabel mesh__D006634 Antagonists, Histamine H1 Receptor
% 211.36/211.52  |- mesh__recordOriginator mesh__D006634 SH
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D006634 2006
% 211.36/211.52  |- mesh__recordAuthorizer mesh__D006634 sjn
% 211.36/211.52  |- skos__hiddenLabel mesh__D006634 Blockaders, H1 Receptor
% 211.36/211.52  |- skos__related mesh__D006634smesh__D001993
% 211.36/211.52  |- skos__hiddenLabel mesh__D006634 H1 Blockers, Histamine
% 211.36/211.52  |- skos__altLabel mesh__D006634 Histamine H1 Receptor Antagonists
% 211.36/211.52  |- skos__broader mesh__D006634smesh__D006633
% 211.36/211.52  |- skos__hiddenLabel mesh__D006634 H1 Antihistaminics
% 211.36/211.52  |- mesh__recordMaintainer mesh__D006634 ssb
% 211.36/211.52  |- mesh__dateEstablished mesh__D006634 1977-01-01
% 211.36/211.52  |- skos__altLabel mesh__D006634 Antagonists, Histamine H1
% 211.36/211.52  |- skos__related mesh__D006634smesh__D018926
% 211.36/211.52  |- skos__related mesh__D006634smesh__D006969
% 211.36/211.52  |- mesh__publicMeSHNote mesh__D006634
% 211.36/211.52       95; was HISTAMINE H1 RECEPTOR BLOCKADERS 1977-94; was ANTIHISTAMINICS 1963-76; ANTIHISTAMINICS, CLASSICAL was ANTIHISTAMINICS see HISTAMINE H1 RECEPTOR BLOCKADERS 1977-90%A%  
% 211.36/211.52  |- rdf__type mesh__D006634sskos__Concept
% 211.36/211.52  |- skos__altLabel mesh__D006634 Antihistaminics, H1
% 211.36/211.52  |- skos__scopeNote mesh__D006634
% 211.36/211.52       Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood.%A%    
% 211.36/211.52  |- skos__prefLabel mesh__D006634 Histamine H1 Antagonists
% 211.36/211.52  |- skos__annotation mesh__D006634
% 211.36/211.52       the %22%classical antihistaminics%22%: note X refs; GEN or unspecified; prefer specifics; DF: HISTAMINE H1 ANTAG%A%  
% 211.36/211.52  |- mesh__onlineNote mesh__D006634
% 211.36/211.52       use HISTAMINE H1 ANTAGONISTS to search HISTAMINE H1 RECEPTOR BLOCKADERS 1977-94 and ANTIHISTAMINICS 1966-76%A%  
% 211.36/211.52  |- skos__hiddenLabel mesh__D006634 H1 Antagonists, Histamine
% 211.36/211.52  |- skos__altLabel mesh__D006634 Receptor Blockaders, H1
% 211.36/211.52  |- skos__altLabel mesh__D006634 Histamine H1 Blockers
% 211.36/211.52  |- skos__altLabel mesh__D006634 H1 Receptor Blockaders
% 211.36/211.52  |- skos__altLabel mesh__D006634 Antihistaminics, Classical
% 211.36/211.52  |- mesh__dateCreated mesh__D006634 1976-05-05
% 211.36/211.52  |- skos__hiddenLabel mesh__D020305 Owls, Great Horned
% 211.36/211.52  |- mesh__historyNote mesh__D020305 2005 %28%1999%29%   
% 211.36/211.52  |- mesh__recordOriginator mesh__D020305 NDW
% 211.36/211.52  |- mesh__publicMeSHNote mesh__D020305 2005; see OWLS 1999-2004   
% 211.36/211.52  |- mesh__recordMaintainer mesh__D020305 ags
% 211.36/211.52  |- mesh__dateEstablished mesh__D020305 1999-01-01
% 211.36/211.52  |- skos__hiddenLabel mesh__D020305 Owl
% 211.36/211.52  |- skos__historyNote mesh__D020305 Birds %28%1966-1998%29%
% 211.36/211.52  |- rdf__type mesh__D020305sskos__Concept
% 211.36/211.52  |- skos__altLabel mesh__D020305 Barn Owl
% 211.36/211.52  |- mesh__dateRevised mesh__D020305 2004-11-18
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D020305 2006
% 211.36/211.52  |- skos__hiddenLabel mesh__D020305 Great Horned Owl
% 211.36/211.52  |- skos__broader mesh__D020305smesh__D020304
% 211.36/211.52  |- skos__hiddenLabel mesh__D020305 Owl, Great Horned
% 211.36/211.52  |- mesh__dateCreated mesh__D020305 1998-06-10
% 211.36/211.52  |- skos__altLabel mesh__D020305 Owls
% 211.36/211.52  |- skos__scopeNote mesh__D020305
% 211.36/211.52       An order of BIRDS with the common name owls characterized by strongly hooked beaks, sharp talons, large heads, forward facing eyes, and facial disks. While considered nocturnal RAPTORS, some owls do hunt by day.%A%    
% 211.36/211.52  |- skos__prefLabel mesh__D020305 Strigiformes
% 211.36/211.52  |- skos__broader mesh__D020305smesh__D001717
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D020305 2005A
% 211.36/211.52  |- mesh__recordAuthorizer mesh__D020305 ags
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D020305 2005
% 211.36/211.52  |- skos__altLabel mesh__D050790 L-Glutamate Synthetase
% 211.36/211.52  |- mesh__recordMaintainer mesh__D050790 AKE
% 211.36/211.52  |- mesh__publicMeSHNote mesh__D050790
% 211.36/211.52       2006; GLUTAMATE SYNTHASE %28%NADH%29%  was indexed under AMINO ACID OXIDOREDUCTASES 1998-2005%A%  
% 211.36/211.52  |- mesh__dateEstablished mesh__D050790 2006-01-01
% 211.36/211.52  |- skos__scopeNote mesh__D050790
% 211.36/211.52       A FLAVOPROTEIN enzyme for AMMONIA assimilation in BACTERIA, microorganisms and PLANTS. It catalyzes the oxidation of 2 molecules of L-GLUTAMATE to generate L-GLUTAMINE and 2-oxoglutarate in the presence of NAD+.%A%    
% 211.36/211.52  |- skos__altLabel mesh__D050790 NADH-Glutamate Synthase
% 211.36/211.52  |- mesh__recordAuthorizer mesh__D050790 sjn
% 211.36/211.52  |- rdf__type mesh__D050790sskos__Concept
% 211.36/211.52  |- skos__hiddenLabel mesh__D050790 Synthase, NADH-Dependent Glutamate
% 211.36/211.52  |- skos__hiddenLabel mesh__D050790 L Glutamate Synthetase
% 211.36/211.52  |- skos__historyNote mesh__D050790
% 211.36/211.52       Amino Acid Oxidoreductases %28%1998-2005%29%
% 211.36/211.52  |- skos__hiddenLabel mesh__D050790 NADH GOGAT
% 211.36/211.52  |- skos__hiddenLabel mesh__D050790 NADH Dependent Glutamate Synthase
% 211.36/211.52  |- skos__hiddenLabel mesh__D050790 NADH Glutamate Synthase
% 211.36/211.52  |- mesh__dateCreated mesh__D050790 2005-06-30
% 211.36/211.52  |- skos__hiddenLabel mesh__D050790 Synthetase, L-Glutamate
% 211.36/211.52  |- mesh__recordOriginator mesh__D050790 AKE
% 211.36/211.52  |- mesh__historyNote mesh__D050790 2006%28%1998%29%   
% 211.36/211.52  |- skos__broader mesh__D050790smesh__D005420
% 211.36/211.52  |- skos__altLabel mesh__D050790 NADH-GOGAT
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D050790 2006
% 211.36/211.52  |- skos__broader mesh__D050790smesh__D000594
% 211.36/211.52  |- skos__hiddenLabel mesh__D050790 Glutamate Synthase, NADH-Dependent
% 211.36/211.52  |- skos__altLabel mesh__D050790 NADH-Dependent Glutamate Synthase
% 211.36/211.52  |- skos__prefLabel mesh__D050790 Glutamate Synthase %28%NADH%29%
% 211.36/211.52  |- mesh__recordMaintainer mesh__D011579 TGC
% 211.36/211.52  |- skos__altLabel mesh__D011579 Psychologic Processes and Principles
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011579 1999
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011579 2003
% 211.36/211.52  |- rdf__type mesh__D011579sskos__Concept
% 211.36/211.52  |- mesh__dateEstablished mesh__D011579 1998-01-01
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011579 2002
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011579 2004
% 211.36/211.52  |- skos__prefLabel mesh__D011579 Psychological Phenomena and Processes
% 211.36/211.52  |- mesh__dateCreated mesh__D011579 1999-01-01
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011579 2000
% 211.36/211.52  |- mesh__recordAuthorizer mesh__D011579 SJN
% 211.36/211.52  |- mesh__onlineNote mesh__D011579
% 211.36/211.52       pre-explosion = PSYCHOLOGICAL PHENOMENA PROCESSES %28%PX%29%   
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011579 2005
% 211.36/211.52  |- mesh__historyNote mesh__D011579 98; use pre-explosion   
% 211.36/211.52  |- mesh__dateRevised mesh__D011579 1997-06-26
% 211.36/211.52  |- mesh__publicMeSHNote mesh__D011579 98   
% 211.36/211.52  |- mesh__recordOriginator mesh__D011579 NLM
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011579 2001
% 211.36/211.52  |- skos__annotation mesh__D011579
% 211.36/211.52       not used for indexing; DF: PSYCHOL PHENOMENA      CATALOG: do not use%A%  
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011579 1998
% 211.36/211.52  |- skos__scopeNote mesh__D011579
% 211.36/211.52       Mechanisms and underlying psychological principles of mental processes and their applications.%A%    
% 211.36/211.52  |- mesh__activeMeSHYear mesh__D011579 2006
% 211.36/211.52  |- mesh__runningHead mesh__D011579
% 211.36/211.52       F2 - PSYCHOLOGICAL PHENOMENA AND PROCESSES   
% 211.36/211.53  |- skos__scopeNote mesh__D016264
% 211.36/211.53       Long-chain polymer of glucose containing 17-20%25% sulfur. It has been used as an anticoagulant and also has been shown to inhibit the binding of HIV-1 to CD4+ T-lymphocytes. It is commonly used as both an experimental and clinical laboratory reagent and has been investigated for use as an antiviral agent, in the treatment of hypolipidemia, and for the prevention of free radical damage, among other applications.%A%    
% 211.36/211.53  |- mesh__dateEstablished mesh__D016264 1991-01-01
% 211.36/211.53  |- rdf__type mesh__D016264sskos__Concept
% 211.36/211.53  |- skos__historyNote mesh__D016264 Dextrans %28%1966-1990%29%
% 211.36/211.53  |- mesh__dateRevised mesh__D016264 2004-07-07
% 211.36/211.53  |- skos__hiddenLabel mesh__D016264 Sulfate, Dextran
% 211.36/211.53  |- skos__hiddenLabel mesh__D016264 Dextran Sulfate, Sodium
% 211.36/211.53  |- mesh__historyNote mesh__D016264 91   
% 211.36/211.53  |- skos__altLabel mesh__D016264 Sodium Dextran Sulfate
% 211.36/211.53  |- skos__hiddenLabel mesh__D016264 Sulfate, Sodium Dextran
% 211.36/211.53  |- skos__hiddenLabel mesh__D016264 Sulfate Sodium, Dextran
% 211.36/211.53  |- skos__broader mesh__D016264smesh__D003911
% 211.36/211.53  |- skos__prefLabel mesh__D016264 Dextran Sulfate
% 211.36/211.53  |- mesh__recordAuthorizer mesh__D016264 sjn
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D016264 2005
% 211.36/211.53  |- mesh__publicMeSHNote mesh__D016264 91   
% 211.36/211.53  |- mesh__dateCreated mesh__D016264 1990-05-25
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D016264 2006
% 211.36/211.53  |- mesh__recordMaintainer mesh__D016264 jmp
% 211.36/211.53  |- mesh__recordOriginator mesh__D016264 AGS
% 211.36/211.53  |- rdf__type mesh__D002244sskos__Concept
% 211.36/211.53  |- mesh__recordMaintainer mesh__D002244 mdb
% 211.36/211.53  |- skos__prefLabel mesh__D002244 Carbon
% 211.36/211.53  |- mesh__recordAuthorizer mesh__D002244 sjn
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002244 2003
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002244 2005
% 211.36/211.53  |- skos__hiddenLabel mesh__D002244 Black, Carbon
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002244 2004
% 211.36/211.53  |- mesh__dateRevised mesh__D002244 2001-07-25
% 211.36/211.53  |- mesh__recordOriginator mesh__D002244 NLM
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002244 2002
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002244 2006
% 211.36/211.53  |- skos__related mesh__D002244smesh__D002250
% 211.36/211.53  |- skos__hiddenLabel mesh__D002244 Carbon, Vitreous
% 211.36/211.53  |- skos__annotation mesh__D002244 C-12   
% 211.36/211.53  |- skos__scopeNote mesh__D002244
% 211.36/211.53       A nonmetallic element with atomic symbol C, atomic number 6, and atomic weight 12.011. It may occur as several different allotropes including DIAMOND; CHARCOAL; and GRAPHITE.%A%    
% 211.36/211.53  |- skos__broader mesh__D002244smesh__D004602
% 211.36/211.53  |- mesh__dateCreated mesh__D002244 1999-01-01
% 211.36/211.53  |- skos__related mesh__D002244smesh__D002247
% 211.36/211.53  |- mesh__publicMeSHNote mesh__D040363
% 211.36/211.53       2003; see SOCIETIES, SCIENTIFIC 1980-2002   
% 211.36/211.53  |- skos__annotation mesh__D040363 DF: AM PUBLIC HEALTH ASSOC   
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D040363 2005
% 211.36/211.53  |- rdf__type mesh__D040363sskos__Concept
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D040363 2003
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D040363 2006
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D040363 2004
% 211.36/211.53  |- skos__scopeNote mesh__D040363
% 211.36/211.53       Professional organization concerned with issues affecting personal and environmental health, including federal and state funding for health programs, programs related to chronic and infectious diseases, and professional education in public health.%A%    
% 211.36/211.53  |- skos__broader mesh__D040363smesh__D012952
% 211.36/211.53  |- mesh__dateEstablished mesh__D040363 2003-01-01
% 211.36/211.53  |- mesh__historyNote mesh__D040363
% 211.36/211.53       2003; use SOCIETIES, SCIENTIFIC 1980-2002   
% 211.36/211.53  |- skos__prefLabel mesh__D040363 American Public Health Association
% 211.36/211.53  |- mesh__dateCreated mesh__D040363 2002-07-02
% 211.36/211.53  |- mesh__dateRevised mesh__D012672 2001-07-25
% 211.36/211.53  |- mesh__recordOriginator mesh__D012672 NLM
% 211.36/211.53  |- skos__prefLabel mesh__D012672 Semliki forest virus
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D012672 2006
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D012672 2002
% 211.36/211.53  |- mesh__recordMaintainer mesh__D012672 ags
% 211.36/211.53  |- mesh__recordAuthorizer mesh__D012672 sjn
% 211.36/211.53  |- mesh__dateCreated mesh__D012672 1999-01-01
% 211.36/211.53  |- mesh__publicMeSHNote mesh__D012672 66   
% 211.36/211.53  |- mesh__historyNote mesh__D012672 66%28%64%29%   
% 211.36/211.53  |- skos__broader mesh__D012672smesh__D000524
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D012672 2003
% 211.36/211.53  |- rdf__type mesh__D012672sskos__Concept
% 211.36/211.53  |- skos__annotation mesh__D012672
% 211.36/211.53       infection: coord IM with ALPHAVIRUS INFECTIONS %28%IM%29%   
% 211.36/211.53  |- mesh__dateEstablished mesh__D012672 1966-01-01
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D012672 2004
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D012672 2005
% 211.36/211.53  |- skos__scopeNote mesh__D012672
% 211.36/211.53       A species of ALPHAVIRUS isolated in central, eastern, and southern Africa.%A%    
% 211.36/211.53  |- skos__related mesh__D006635smesh__D000897
% 211.36/211.53  |- skos__altLabel mesh__D006635 H2 Receptor Blockaders
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D006635 2006
% 211.36/211.53  |- skos__broader mesh__D006635smesh__D006633
% 211.36/211.53  |- skos__hiddenLabel mesh__D006635 Blockaders, H2 Receptor
% 211.36/211.53  |- mesh__dateRevised mesh__D006635 2005-06-30
% 211.36/211.53  |- skos__scopeNote mesh__D006635
% 211.36/211.53       Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood.%A%    
% 211.36/211.53  |- mesh__onlineNote mesh__D006635
% 211.36/211.53       use HISTAMINE H2 ANTAGONISTS to search HISTAMINE H2 RECEPTOR BLOCKADERS 1977-94%A%  
% 211.36/211.53  |- skos__altLabel mesh__D006635 Antagonists, Histamine H2
% 211.36/211.53  |- skos__altLabel mesh__D006635 Histamine H2 Receptor Blockaders
% 211.36/211.53  |- mesh__recordAuthorizer mesh__D006635 sjn
% 211.36/211.53  |- skos__hiddenLabel mesh__D006635 H2 Blockers, Histamine
% 211.36/211.53  |- mesh__publicMeSHNote mesh__D006635
% 211.36/211.53       95; was HISTAMINE H2 RECEPTOR BLOCKADERS 1977-94   
% 211.36/211.53  |- skos__hiddenLabel mesh__D006635 Blockers, Histamine H2
% 211.36/211.53  |- skos__hiddenLabel mesh__D006635 H2 Antihistaminics
% 211.36/211.53  |- skos__altLabel mesh__D006635 Antihistaminics, H2
% 211.36/211.53  |- rdf__type mesh__D006635sskos__Concept
% 211.36/211.53  |- mesh__recordMaintainer mesh__D006635 ssb
% 211.36/211.53  |- skos__altLabel mesh__D006635 Receptor Blockaders, H2
% 211.36/211.53  |- skos__altLabel mesh__D006635 Histamine H2 Blockers
% 211.36/211.53  |- mesh__dateEstablished mesh__D006635 1977-01-01
% 211.36/211.53  |- skos__prefLabel mesh__D006635 Histamine H2 Antagonists
% 211.36/211.53  |- mesh__dateCreated mesh__D006635 1976-05-05
% 211.36/211.53  |- skos__hiddenLabel mesh__D006635 H2 Antagonists, Histamine
% 211.36/211.53  |- skos__altLabel mesh__D006635 Histamine H2 Receptor Antagonists
% 211.36/211.53  |- skos__altLabel mesh__D006635 Blockaders, Histamine H2 Receptor
% 211.36/211.53  |- skos__annotation mesh__D006635
% 211.36/211.53       GEN or unspecified; prefer specifics; DF: HISTAMINE H2 ANTAG%A%  
% 211.36/211.53  |- skos__altLabel mesh__D006635 Receptor Antagonists, Histamine H2
% 211.36/211.53  |- mesh__historyNote mesh__D006635
% 211.36/211.53       95; was HISTAMINE H2 RECEPTOR BLOCKADERS 1977-94   
% 211.36/211.53  |- mesh__recordOriginator mesh__D006635 SH
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D020306 2000
% 211.36/211.53  |- mesh__dateEstablished mesh__D020306 2000-01-01
% 211.36/211.53  |- rdf__type mesh__D020306sskos__Concept
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D020306 2004
% 211.36/211.53  |- skos__broader mesh__D020306smesh__D020806
% 211.36/211.53  |- mesh__publicMeSHNote mesh__D020306 2000   
% 211.36/211.53  |- skos__altLabel mesh__D020306 Central Nervous System Tuberculosis
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D020306 2006
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D020306 2003
% 211.36/211.53  |- mesh__dateCreated mesh__D020306 1999-11-03
% 211.36/211.53  |- skos__historyNote mesh__D020306 Tuberculoma %28%1966-1999%29%
% 211.36/211.53  |- mesh__historyNote mesh__D020306 2000   
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D020306 2005
% 211.36/211.53  |- skos__scopeNote mesh__D020306
% 211.36/211.53       Tuberculosis of the brain, spinal cord, or meninges %28%TUBERCULOSIS, MENINGEAL%29%, most often caused by MYCOBACTERIUM TUBERCULOSIS and rarely by MYCOBACTERIUM BOVIS. The infection may be limited to the nervous system or coexist in other organs %28%e.g., TUBERCULOSIS, PULMONARY%29%. The organism tends to seed the meninges causing a diffuse meningitis and leads to the formation of TUBERCULOMA, which may occur within the brain, spinal cord, or perimeningeal spaces. Tuberculous involvement of the vertebral column %28%TUBERCULOSIS, SPINAL%29% may result in nerve root or spinal cord compression. %28%From Adams et al., Principles of Neurology, 6th ed, pp717-20%29%%A%    
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D020306 2002
% 211.36/211.53  |- skos__annotation mesh__D020306 DF: TUBERCULOSIS CNS   
% 211.36/211.53  |- skos__prefLabel mesh__D020306 Tuberculosis, Central Nervous System
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D020306 2001
% 211.36/211.53  |- skos__historyNote mesh__D020306
% 211.36/211.53       Tuberculosis, Meningeal %28%1966-1999%29%
% 211.36/211.53  |- skos__broader mesh__D020306smesh__D014376
% 211.36/211.53  |- mesh__recordMaintainer mesh__D050791 ags
% 211.36/211.53  |- mesh__recordAuthorizer mesh__D050791 ags
% 211.36/211.53  |- rdf__type mesh__D050791sskos__Concept
% 211.36/211.53  |- skos__altLabel mesh__D050791
% 211.36/211.53       STAT %28%Signal Transducers and Activators of Transcription%29% Proteins
% 211.36/211.53  |- mesh__dateEstablished mesh__D050791 2006-01-01
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D050791 2006A
% 211.36/211.53  |- mesh__dateRevised mesh__D050791 2005-08-01
% 211.36/211.53  |- skos__scopeNote mesh__D050791
% 211.36/211.53       A family of transcription factors containing SH2 DOMAINS that are involved in CYTOKINE-mediated SIGNAL TRANSDUCTION. STAT transcription factors are recruited to the cytoplasmic region of CELL SURFACE RECEPTORS and are activated via PHOSPHORYLATION. Once activated they dimerize and translocate into the CELL NUCLEUS where they influence GENE expression. They play a role in regulating CELL GROWTH PROCESSES and CELL DIFFERENTIATION. STAT transcription factors are inhibited by SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS and PROTEIN INHIBITORS OF ACTIVATED STAT.%A%    
% 211.36/211.53  |- mesh__historyNote mesh__D050791 2006   
% 211.36/211.53  |- mesh__dateCreated mesh__D050791 2005-06-30
% 211.36/211.53  |- mesh__publicMeSHNote mesh__D050791 2006   
% 211.36/211.53  |- skos__hiddenLabel mesh__D050791 Transcription Factors, STAT
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D050791 2006B
% 211.36/211.53  |- skos__annotation mesh__D050791 general; prefer specifics   
% 211.36/211.53  |- skos__prefLabel mesh__D050791 STAT Transcription Factors
% 211.36/211.53  |- skos__broader mesh__D050791smesh__D048868
% 211.36/211.53  |- skos__broader mesh__D050791smesh__D014157
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D050791 2006
% 211.36/211.53  |- mesh__recordOriginator mesh__D050791 DRC
% 211.36/211.53  |- mesh__dateCreated mesh__D016265 1990-05-25
% 211.36/211.53  |- mesh__publicMeSHNote mesh__D016265 1991   
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D016265 2002
% 211.36/211.53  |- mesh__recordAuthorizer mesh__D016265 sjn
% 211.36/211.53  |- skos__prefLabel mesh__D016265 Conflict of Interest
% 211.36/211.53  |- skos__broader mesh__D016265smesh__D004989
% 211.36/211.53  |- mesh__recordMaintainer mesh__D016265 jrf
% 211.36/211.53  |- skos__related mesh__D016265smesh__D028743
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D016265 2005
% 211.36/211.53  |- skos__historyNote mesh__D016265
% 211.36/211.53       Conflict %28%Psychology%29% %28%1966-1990%29%
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D016265 2006
% 211.36/211.53  |- skos__hiddenLabel mesh__D016265 Interest Conflict
% 211.36/211.53  |- skos__scopeNote mesh__D016265
% 211.36/211.53       A situation in which an individual might benefit personally from official or professional actions. It includes a conflict between a person%27%s private interests and official responsibilities in a position of trust. The term is not restricted to government officials. The concept refers both to actual conflict of interest and the appearance or perception of conflict.%A%    
% 211.36/211.53  |- skos__historyNote mesh__D016265 Ethics %28%1966-1990%29%
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D016265 2003
% 211.36/211.53  |- rdf__type mesh__D016265sskos__Concept
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D016265 2004
% 211.36/211.53  |- mesh__recordOriginator mesh__D016265 TGC
% 211.36/211.53  |- mesh__dateRevised mesh__D016265 2001-07-25
% 211.36/211.53  |- mesh__dateEstablished mesh__D016265 1991-01-01
% 211.36/211.53  |- mesh__historyNote mesh__D016265 1991   
% 211.36/211.53  |- skos__hiddenLabel mesh__D016265 Interest Conflicts
% 211.36/211.53  |- mesh__dateRevised mesh__D002245 1996-06-13
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002245 2003
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002245 2000
% 211.36/211.53  |- skos__scopeNote mesh__D002245
% 211.36/211.53       A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals.%A%    
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002245 2005
% 211.36/211.53  |- skos__annotation mesh__D002245
% 211.36/211.53       in respiration, /physiol permitted; /metab permitted for cell %26% tissue resp %26% non-lung tissue but do not use /metab for gas exchange in lung %28% = PULMONARY GAS EXCHANGE%29% or blood CO2 transport %28% = /blood but consider also HYPERCAPNIA %26% HYPOCAPNIA%29%%A%  
% 211.36/211.53  |- skos__prefLabel mesh__D002245 Carbon Dioxide
% 211.36/211.53  |- skos__hiddenLabel mesh__D002245 Dioxide, Carbon
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002245 2004
% 211.36/211.53  |- skos__broader mesh__D002245smesh__D005740
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002245 2001
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002245 2006
% 211.36/211.53  |- skos__related mesh__D002245smesh__D019296
% 211.36/211.53  |- skos__related mesh__D002245smesh__D006935
% 211.36/211.53  |- skos__broader mesh__D002245smesh__D010087
% 211.36/211.53  |- skos__related mesh__D002245smesh__D016857
% 211.36/211.53  |- mesh__recordMaintainer mesh__D002245 TGC
% 211.36/211.53  |- skos__altLabel mesh__D002245 Carbonic Anhydride
% 211.36/211.53  |- mesh__dateCreated mesh__D002245 1999-01-01
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002245 2002
% 211.36/211.53  |- mesh__recordOriginator mesh__D002245 NLM
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002245 1998
% 211.36/211.53  |- mesh__recordAuthorizer mesh__D002245 PLS
% 211.36/211.53  |- skos__hiddenLabel mesh__D002245 Anhydride, Carbonic
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002245 1997
% 211.36/211.53  |- rdf__type mesh__D002245sskos__Concept
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002245 1999
% 211.36/211.53  |- skos__broader mesh__D002245smesh__D017554
% 211.36/211.53  |- skos__historyNote mesh__D012673 Nitrosourea Compounds %28%1973-1974%29%
% 211.36/211.53  |- skos__hiddenLabel mesh__D012673 NSC 95441
% 211.36/211.53  |- skos__altLabel mesh__D012673 MeCCNU
% 211.36/211.53  |- skos__scopeNote mesh__D012673
% 211.36/211.53       4-Methyl derivative of LOMUSTINE; %28%CCNU%29%. An antineoplastic agent which functions as an alkylating agent.%A%    
% 211.36/211.53  |- skos__historyNote mesh__D012673 Nitroso Compounds %28%1966-1972%29%
% 211.36/211.53  |- skos__broader mesh__D012673smesh__D008130
% 211.36/211.53  |- skos__hiddenLabel mesh__D012673 NSC95441
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D012673 2003
% 211.36/211.53  |- rdf__type mesh__D012673sskos__Concept
% 211.36/211.53  |- skos__altLabel mesh__D012673 Me-CCNU
% 211.36/211.53  |- mesh__publicMeSHNote mesh__D012673
% 211.36/211.53       91; was see under NITROSOUREA COMPOUNDS 1975-90   
% 211.36/211.53  |- mesh__dateCreated mesh__D012673 1974-11-19
% 211.36/211.53  |- mesh__dateRevised mesh__D012673 2001-07-25
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D012673 2004
% 211.36/211.53  |- mesh__recordOriginator mesh__D012673 NLM
% 211.36/211.53  |- skos__historyNote mesh__D012673 Cyclohexanes %28%1966-1974%29%
% 211.36/211.53  |- skos__hiddenLabel mesh__D012673 Methyl CCNU
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D012673 2005
% 211.36/211.53  |- mesh__dateEstablished mesh__D012673 1991-01-01
% 211.36/211.53  |- skos__hiddenLabel mesh__D012673 Me CCNU
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D012673 2002
% 211.36/211.53  |- mesh__recordAuthorizer mesh__D012673 sjn
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D012673 2006
% 211.36/211.53  |- mesh__recordMaintainer mesh__D012673 mdb
% 211.36/211.53  |- skos__prefLabel mesh__D012673 Semustine
% 211.36/211.53  |- mesh__historyNote mesh__D012673
% 211.36/211.53       91%28%75%29%; was see under NITROSOUREA COMPOUNDS 1975-90   
% 211.36/211.53  |- skos__altLabel mesh__D012673 Methyl-CCNU
% 211.36/211.53  |- skos__historyNote mesh__D012673 Urea %28%1966-1972%29%
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D006636 2006
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D006636 2002
% 211.36/211.53  |- mesh__dateCreated mesh__D006636 1999-01-01
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D006636 1996
% 211.36/211.53  |- skos__altLabel mesh__D006636 Histamine Liberation
% 211.36/211.53  |- mesh__dateRevised mesh__D006636 1995-01-06
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D006636 1998
% 211.36/211.53  |- skos__hiddenLabel mesh__D006636 Histamine Liberations
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D006636 1997
% 211.36/211.53  |- mesh__historyNote mesh__D006636 96; was HISTAMINE LIBERATION 1963-95   
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D006636 1999
% 211.36/211.53  |- skos__prefLabel mesh__D006636 Histamine Release
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D006636 2000
% 211.36/211.53  |- skos__broader mesh__D006636smesh__D007109
% 211.36/211.53  |- rdf__type mesh__D006636sskos__Concept
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D006636 2001
% 211.36/211.53  |- mesh__recordAuthorizer mesh__D006636 PLS
% 211.36/211.53  |- mesh__publicMeSHNote mesh__D006636
% 211.36/211.53       96; was HISTAMINE LIBERATION 1963-95   
% 211.36/211.53  |- mesh__recordOriginator mesh__D006636 NLM
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D006636 2003
% 211.36/211.53  |- mesh__recordMaintainer mesh__D006636 AGS
% 211.36/211.53  |- skos__related mesh__D006636smesh__D003189
% 211.36/211.53  |- skos__scopeNote mesh__D006636
% 211.36/211.53       The secretion of histamine from mast cell and basophil granules by exocytosis. This can be initiated by a number of factors, all of which involve binding of IgE, cross-linked by antigen, to the mast cell or basophil%27%s Fc receptors. Once released, histamine binds to a number of different target cell receptors and exerts a wide variety of effects.%A%    
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D006636 2005
% 211.36/211.53  |- skos__hiddenLabel mesh__D006636 Histamine Releases
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D006636 2004
% 211.36/211.53  |- rdf__type mesh__D020307sskos__Concept
% 211.36/211.53  |- skos__scopeNote mesh__D020307
% 211.36/211.53       Large members of the FALCONIFORMES order of birds, family Accipitridae, most especially the genera Aquila, Haliaeetus, Harpia, and Circaetus. They are characterized by their powerful talons, which carry long, curved, pointed claws and by their opposable hindtoe.%A%    
% 211.36/211.53  |- mesh__dateRevised mesh__D020307 2004-07-07
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D020307 2006
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D020307 2005
% 211.36/211.53  |- mesh__publicMeSHNote mesh__D020307 1999   
% 211.36/211.53  |- skos__broader mesh__D020307smesh__D046093
% 211.36/211.53  |- mesh__dateCreated mesh__D020307 1998-06-10
% 211.36/211.53  |- skos__historyNote mesh__D020307 Birds %28%1970-1998%29%
% 211.36/211.53  |- mesh__recordOriginator mesh__D020307 NDW
% 211.36/211.53  |- mesh__recordAuthorizer mesh__D020307 sjn
% 211.36/211.53  |- mesh__dateEstablished mesh__D020307 1999-01-01
% 211.36/211.53  |- skos__hiddenLabel mesh__D020307 Eagle
% 211.36/211.53  |- mesh__recordMaintainer mesh__D020307 ags
% 211.36/211.53  |- mesh__historyNote mesh__D020307 1999   
% 211.36/211.53  |- skos__prefLabel mesh__D020307 Eagles
% 211.36/211.53  |- skos__altLabel mesh__D050792 Deep Hypothermic Circulatory Arrest
% 211.36/211.53  |- mesh__recordOriginator mesh__D050792 lkt
% 211.36/211.53  |- mesh__recordAuthorizer mesh__D050792 sjn
% 211.36/211.53  |- skos__broader mesh__D050792smesh__D006324
% 211.36/211.53  |- mesh__dateEstablished mesh__D050792 2006-01-01
% 211.36/211.53  |- mesh__publicMeSHNote mesh__D050792 2006   
% 211.36/211.53  |- skos__historyNote mesh__D050792 Hypothermia, Induced %28%1966-2005%29%
% 211.36/211.53  |- skos__prefLabel mesh__D050792
% 211.36/211.53       Circulatory Arrest, Deep Hypothermia Induced
% 211.36/211.53  |- skos__scopeNote mesh__D050792
% 211.36/211.53       A technique to arrest the flow of blood by lowering BODY TEMPERATURE to about 20 degrees Centigrade, usually achieved by infusing chilled perfusate. The technique provides a bloodless surgical field for complex surgeries.%A%    
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D050792 2006
% 211.36/211.53  |- mesh__historyNote mesh__D050792 2006   
% 211.36/211.53  |- mesh__dateCreated mesh__D050792 2005-06-30
% 211.36/211.53  |- mesh__recordMaintainer mesh__D050792 lkt
% 211.36/211.53  |- rdf__type mesh__D050792sskos__Concept
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D016266 2005
% 211.36/211.53  |- mesh__recordOriginator mesh__D016266 TGC
% 211.36/211.53  |- mesh__dateRevised mesh__D016266 2001-07-25
% 211.36/211.53  |- skos__broader mesh__D016266smesh__D005524
% 211.36/211.53  |- skos__annotation mesh__D016266
% 211.36/211.53       coord with specific food /parasitol and specific parasite; DF: FOOD PARASITOL%A%  
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D016266 2006
% 211.36/211.53  |- mesh__dateCreated mesh__D016266 1990-05-25
% 211.36/211.53  |- mesh__publicMeSHNote mesh__D016266 91   
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D016266 2002
% 211.36/211.53  |- mesh__recordAuthorizer mesh__D016266 sjn
% 211.36/211.53  |- skos__scopeNote mesh__D016266
% 211.36/211.53       The presence of parasites in food and food products. For the presence of bacteria, viruses, and fungi in food, FOOD MICROBIOLOGY is available.%A%    
% 211.36/211.53  |- skos__historyNote mesh__D016266 Food Contamination %28%1966-1990%29%
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D016266 2003
% 211.36/211.53  |- skos__historyNote mesh__D016266 specific parasite %28%1966-1990%29%
% 211.36/211.53  |- rdf__type mesh__D016266sskos__Concept
% 211.36/211.53  |- skos__broader mesh__D016266smesh__D010274
% 211.36/211.53  |- skos__broader mesh__D016266smesh__D005506
% 211.36/211.53  |- skos__altLabel mesh__D016266 Parasitology, Food
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D016266 2004
% 211.36/211.53  |- mesh__historyNote mesh__D016266 91   
% 211.36/211.53  |- mesh__dateEstablished mesh__D016266 1991-01-01
% 211.36/211.53  |- skos__prefLabel mesh__D016266 Food Parasitology
% 211.36/211.53  |- mesh__recordMaintainer mesh__D016266 jls
% 211.36/211.53  |- skos__broader mesh__D002246smesh__D004220
% 211.36/211.53  |- skos__scopeNote mesh__D002246
% 211.36/211.53       Carbon disulfide %28%CS2%29%. A colorless, flammable, poisonous liquid, CS2. It is used as a solvent, and is a counterirritant and has local anesthetic properties but is not used as such. It is highly toxic with pronounced CNS, hematologic, and dermatologic effects.%A%    
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002246 2002
% 211.36/211.53  |- mesh__recordOriginator mesh__D002246 NLM
% 211.36/211.53  |- skos__prefLabel mesh__D002246 Carbon Disulfide
% 211.36/211.53  |- mesh__recordMaintainer mesh__D002246 TPW
% 211.36/211.53  |- mesh__recordAuthorizer mesh__D002246 PLS
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002246 1996
% 211.36/211.53  |- mesh__dateCreated mesh__D002246 1999-01-01
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002246 1998
% 211.36/211.53  |- skos__annotation mesh__D002246
% 211.36/211.53       a poisonous liquid; a solvent %26% counterirritant   
% 211.36/211.53  |- mesh__dateRevised mesh__D002246 1993-06-29
% 211.36/211.53  |- rdf__type mesh__D002246sskos__Concept
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002246 1997
% 211.36/211.53  |- skos__hiddenLabel mesh__D002246 Disulfide, Carbon
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002246 1994
% 211.36/211.53  |- skos__broader mesh__D002246smesh__D017554
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002246 1999
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002246 2000
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002246 1995
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002246 2003
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002246 2001
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002246 2005
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002246 2004
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D002246 2006
% 211.36/211.53  |- rdf__type mesh__D048348sskos__Concept
% 211.36/211.53  |- skos__prefLabel mesh__D048348 Reverse Transcription
% 211.36/211.53  |- mesh__recordMaintainer mesh__D048348 nns
% 211.36/211.53  |- mesh__recordAuthorizer mesh__D048348 sjn
% 211.36/211.53  |- skos__scopeNote mesh__D048348
% 211.36/211.53       The biosynthesis of DNA carried out on a template of RNA.%A%    
% 211.36/211.53  |- skos__related mesh__D048348smesh__D020133
% 211.36/211.53  |- mesh__publicMeSHNote mesh__D048348
% 211.36/211.53       2005; see TRANSCRIPTION, GENETIC 1988-2004   
% 211.36/211.53  |- mesh__recordOriginator mesh__D048348 nns
% 211.36/211.53  |- skos__broader mesh__D048348smesh__D014158
% 211.36/211.53  |- skos__historyNote mesh__D048348 Transcription, Genetic %28%1971-2004%29%
% 211.36/211.53  |- mesh__dateEstablished mesh__D048348 2005-01-01
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D048348 2005
% 211.36/211.53  |- mesh__dateCreated mesh__D048348 2004-07-07
% 211.36/211.53  |- skos__related mesh__D048348smesh__D012194
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D048348 2006
% 211.36/211.53  |- mesh__historyNote mesh__D048348
% 211.36/211.53       2005; use TRANSCRIPTION, GENETIC 1988-2004   
% 211.36/211.53  |- skos__altLabel mesh__D048348 Transcription, Reverse
% 211.36/211.53  |- rdf__type mesh__D012674sskos__Concept
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D012674 2003
% 211.36/211.53  |- skos__annotation mesh__D012674 poisonous to livestock   
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D012674 2004
% 211.36/211.53  |- skos__scopeNote mesh__D012674
% 211.36/211.53       A species of toxic plants of the Compositae. The poisonous compounds are alkaloids which cause cattle diseases, neoplasms, and liver damage and are used to produce cancers in experimental animals.%A%    
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D012674 2005
% 211.36/211.53  |- skos__prefLabel mesh__D012674 Senecio
% 211.36/211.53  |- mesh__recordMaintainer mesh__D012674 ssb
% 211.36/211.53  |- skos__related mesh__D012674smesh__D011763
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D012674 2006
% 211.36/211.53  |- mesh__dateRevised mesh__D012674 2001-07-25
% 211.36/211.53  |- mesh__recordOriginator mesh__D012674 NLM
% 211.36/211.53  |- mesh__dateCreated mesh__D012674 1999-01-01
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D012674 2002
% 211.36/211.53  |- skos__broader mesh__D012674smesh__D019659
% 211.36/211.53  |- mesh__recordAuthorizer mesh__D012674 sjn
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D006637 2005
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D006637 2004
% 211.36/211.53  |- mesh__dateCreated mesh__D006637 1974-11-19
% 211.36/211.53  |- skos__altLabel mesh__D006637 Histamine Methyltransferase
% 211.36/211.53  |- skos__broader mesh__D006637smesh__D008780
% 211.36/211.53  |- skos__hiddenLabel mesh__D006637 N-Methyltransferase, Histamine
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D006637 2006
% 211.36/211.53  |- skos__hiddenLabel mesh__D006637 Methyltransferase, Histamine
% 211.36/211.53  |- skos__historyNote mesh__D006637 Histamine %28%1973-1974%29%
% 211.36/211.53  |- mesh__dateEstablished mesh__D006637 1991-01-01
% 211.36/211.53  |- mesh__dateRevised mesh__D006637 2003-07-09
% 211.36/211.53  |- skos__scopeNote mesh__D006637
% 211.36/211.53       An enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine to histamine, forming N-methylhistamine, the major metabolite of histamine in man. EC 2.1.1.8.%A%    
% 211.36/211.53  |- skos__hiddenLabel mesh__D006637 Histamine N Methyltransferase
% 211.36/211.53  |- rdf__type mesh__D006637sskos__Concept
% 211.36/211.53  |- mesh__recordMaintainer mesh__D006637 ssb
% 211.36/211.53  |- mesh__recordOriginator mesh__D006637 NLM
% 211.36/211.53  |- mesh__historyNote mesh__D006637 98%28%75%29%   
% 211.36/211.53  |- skos__historyNote mesh__D006637 Methyltransferases %28%1973-1974%29%
% 211.36/211.53  |- mesh__recordAuthorizer mesh__D006637 sjn
% 211.36/211.53  |- skos__prefLabel mesh__D006637 Histamine N-Methyltransferase
% 211.36/211.53  |- mesh__publicMeSHNote mesh__D006637
% 211.36/211.53       98; see HISTAMINE METHYLTRANSFERASE 1991-97; see METHYLTRANSFERASES 1975-90%A%  
% 211.36/211.53  |- rdf__type mesh__D020308sskos__Concept
% 211.36/211.53  |- mesh__recordOriginator mesh__D020308 NDW
% 211.36/211.53  |- skos__altLabel mesh__D020308 Turdidae
% 211.36/211.53  |- skos__annotation mesh__D020308
% 211.36/211.53       prefer specifics; X ref EREMOPHILA ALPESTRIS: EREMOPHILA PLANT and EREMOPHILUS MUTISII see CATFISHES are also available%A%  
% 211.36/211.53  |- skos__hiddenLabel mesh__D020308 Horned Larks
% 211.36/211.53  |- mesh__recordAuthorizer mesh__D020308 sjn
% 211.36/211.53  |- skos__altLabel mesh__D020308 Horned Lark
% 211.36/211.53  |- skos__hiddenLabel mesh__D020308 Robin
% 211.36/211.53  |- mesh__activeMeSHYear mesh__D020308 2006
% 211.36/211.53  |- skos__altLabel mesh__D020308 Oscines
% 211.36/211.53  |- mesh__dateEstablished mesh__D020308 1999-01-01
% 211.36/211.53  |- skos__historyNote mesh__D020308 Birds %28%1966-1998%29%
% 211.36/211.53  |- skos__broader mesh__D020308smesh__D046109
% 211.36/211.53  |- mesh__recordMaintainer mesh__D020308 ags
% 211.36/211.53  |- mesh__historyNote mesh__D020308 1999   
% 211.36/211.53  |- skos__prefLabel mesh__D020308 Songbirds
% 211.36/211.53  |- mesh__dateCreated mesh__D020308 1998-06-11
% 211.36/211.53  |- mesh__dateRevised mesh__D020308 2004-07-07
% 211.36/211.53  |- skos__hiddenLabel mesh__D020308 Songbird
% 211.36/211.53  |- skos__hiddenLabel mesh__D020308 Larks, Horned
% 211.36/211.53  |- skos__hiddenLabel mesh__D020308 Flycatcher
% 211.36/211.53  |- skos__hiddenLabel mesh__D020308 Oscine
% 211.36/211.53  |- skos__hiddenLabel mesh__D020308 Wren
% 211.36/211.53  |- skos__altLabel mesh__D020308 Troglodytidae
% 211.36/211.54  |- skos__hiddenLabel mesh__D020308 Lark, Horned
% 211.36/211.54  |- skos__hiddenLabel mesh__D020308 Warbler
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D020308 2005
% 211.36/211.54  |- skos__scopeNote mesh__D020308
% 211.36/211.54       PASSERIFORMES of the suborder, Oscines, in which the flexor tendons of the toes are separate, and the lower syrinx has 4 to 9 pairs of tensor muscles inserted at both ends of the tracheal half rings. They include many commonly recognized birds such as CROWS; FINCHES; robins; SPARROWS; and SWALLOWS.%A%    
% 211.36/211.54  |- mesh__publicMeSHNote mesh__D020308 1999   
% 211.36/211.54  |- skos__altLabel mesh__D020308 Troglodytinae
% 211.36/211.54  |- skos__historyNote mesh__D050793 Tooth Movement %28%1974-2005%29%
% 211.36/211.54  |- mesh__publicMeSHNote mesh__D050793 2006; see TOOTH MOVEMENT 1998-2005   
% 211.36/211.54  |- rdf__type mesh__D050793sskos__Concept
% 211.36/211.54  |- skos__hiddenLabel mesh__D050793 Extrusion, Tooth
% 211.36/211.54  |- skos__hiddenLabel mesh__D050793 Forced Eruptions
% 211.36/211.54  |- mesh__dateCreated mesh__D050793 2005-06-30
% 211.36/211.54  |- mesh__recordMaintainer mesh__D050793 ssb
% 211.36/211.54  |- skos__hiddenLabel mesh__D050793 Tooth Extrusions
% 211.36/211.54  |- skos__hiddenLabel mesh__D050793 Extrusion, Orthodontic
% 211.36/211.54  |- skos__hiddenLabel mesh__D050793 Orthodontic Extrusions
% 211.36/211.54  |- skos__broader mesh__D050793smesh__D009971
% 211.36/211.54  |- mesh__recordAuthorizer mesh__D050793 sjn
% 211.36/211.54  |- skos__scopeNote mesh__D050793
% 211.36/211.54       Orthodontic movement in the coronal direction achieved by outward tension on the PERIODONTAL LIGAMENT. It does not include the operative procedure that CROWN LENGTHENING involves.%A%    
% 211.36/211.54  |- mesh__historyNote mesh__D050793 2006; use TOOTH MOVEMENT 1998-2005   
% 211.36/211.54  |- skos__altLabel mesh__D050793 Tooth Extrusion
% 211.36/211.54  |- skos__related mesh__D050793smesh__D016556
% 211.36/211.54  |- skos__hiddenLabel mesh__D050793 Eruption, Forced
% 211.36/211.54  |- skos__altLabel mesh__D050793 Forced Eruption
% 211.36/211.54  |- mesh__recordOriginator mesh__D050793 ssb
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D050793 2006
% 211.36/211.54  |- mesh__dateEstablished mesh__D050793 2006-01-01
% 211.36/211.54  |- skos__prefLabel mesh__D050793 Orthodontic Extrusion
% 211.36/211.54  |- skos__hiddenLabel mesh__D016267 External Fixation Devices
% 211.36/211.54  |- skos__hiddenLabel mesh__D016267 External Fixation Device
% 211.36/211.54  |- mesh__recordMaintainer mesh__D016267 PXP
% 211.36/211.54  |- skos__hiddenLabel mesh__D016267 Device, External Fixation
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D016267 2002
% 211.36/211.54  |- mesh__dateEstablished mesh__D016267 1991-01-01
% 211.36/211.54  |- mesh__recordOriginator mesh__D016267 PXP
% 211.36/211.54  |- mesh__recordAuthorizer mesh__D016267 SJN
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D016267 1999
% 211.36/211.54  |- mesh__dateCreated mesh__D016267 1990-05-25
% 211.36/211.54  |- skos__hiddenLabel mesh__D016267 External Fixator
% 211.36/211.54  |- skos__altLabel mesh__D016267 Fixation Devices, External
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D016267 1998
% 211.36/211.54  |- skos__annotation mesh__D016267 for fracture fixation   
% 211.36/211.54  |- skos__hiddenLabel mesh__D016267 Devices, External Fixation
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D016267 2006
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D016267 2001
% 211.36/211.54  |- skos__broader mesh__D016267smesh__D009984
% 211.36/211.54  |- skos__prefLabel mesh__D016267 External Fixators
% 211.36/211.54  |- skos__related mesh__D016267smesh__D019857
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D016267 2005
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D016267 2004
% 211.36/211.54  |- rdf__type mesh__D016267sskos__Concept
% 211.36/211.54  |- skos__hiddenLabel mesh__D016267 Fixation Device, External
% 211.36/211.54  |- mesh__dateRevised mesh__D016267 1997-06-20
% 211.36/211.54  |- mesh__publicMeSHNote mesh__D016267 91   
% 211.36/211.54  |- skos__hiddenLabel mesh__D016267 Fixator, External
% 211.36/211.54  |- skos__historyNote mesh__D016267
% 211.36/211.54       Orthopedic Fixation Devices %28%1979-1990%29%
% 211.36/211.54  |- skos__historyNote mesh__D016267 Fracture Fixation %28%1979-1990%29%
% 211.36/211.54  |- skos__scopeNote mesh__D016267
% 211.36/211.54       External devices which hold wires or pins that are placed through one or both cortices of bone in order to hold the position of a fracture in proper alignment. These devices allow easy access to wounds, adjustment during the course of healing, and more functional use of the limbs involved.%A%    
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D016267 2000
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D016267 2003
% 211.36/211.54  |- skos__hiddenLabel mesh__D016267 Fixators, External
% 211.36/211.54  |- mesh__historyNote mesh__D016267 91   
% 211.36/211.54  |- rdf__type mesh__D035421sskos__Concept
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D035421 2004
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D035421 2005
% 211.36/211.54  |- mesh__publicMeSHNote mesh__D035421 2003   
% 211.36/211.54  |- skos__scopeNote mesh__D035421
% 211.36/211.54       The region of the face on either side, around the PAROTID GLAND.%A%    
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D035421 2006
% 211.36/211.54  |- mesh__historyNote mesh__D035421 2003   
% 211.36/211.54  |- skos__hiddenLabel mesh__D035421 Region, Parotid
% 211.36/211.54  |- mesh__dateCreated mesh__D035421 2002-07-03
% 211.36/211.54  |- skos__prefLabel mesh__D035421 Parotid Region
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D035421 2003
% 211.36/211.54  |- skos__broader mesh__D035421smesh__D005145
% 211.36/211.54  |- mesh__dateEstablished mesh__D035421 2003-01-01
% 211.36/211.54  |- mesh__dateCreated mesh__D002247 1999-01-01
% 211.36/211.54  |- mesh__recordAuthorizer mesh__D002247 sjn
% 211.36/211.54  |- rdf__type mesh__D002247sskos__Concept
% 211.36/211.54  |- mesh__recordOriginator mesh__D002247 NLM
% 211.36/211.54  |- mesh__recordMaintainer mesh__D002247 nns
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D002247 2002
% 211.36/211.54  |- skos__hiddenLabel mesh__D002247 Isotopes, Carbon
% 211.36/211.54  |- mesh__dateRevised mesh__D002247 2000-06-22
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D002247 2003
% 211.36/211.54  |- skos__annotation mesh__D002247 C-13; NIM   
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D002247 2005
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D002247 2004
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D002247 2006
% 211.36/211.54  |- skos__scopeNote mesh__D002247
% 211.36/211.54       Stable carbon atoms that have the same atomic number as the element carbon, but differ in atomic weight. C-13 is a stable carbon isotope.%A%    
% 211.36/211.54  |- skos__prefLabel mesh__D002247 Carbon Isotopes
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D002247 2001
% 211.36/211.54  |- skos__broader mesh__D002247smesh__D007554
% 211.36/211.54  |- mesh__dateRevised mesh__D007730 1992-05-20
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007730 1995
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007730 2002
% 211.36/211.54  |- rdf__type mesh__D007730sskos__Concept
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007730 1998
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007730 2005
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007730 1993
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007730 1996
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007730 2003
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007730 1999
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007730 2006
% 211.36/211.54  |- skos__prefLabel mesh__D007730 Kuwait
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007730 1997
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007730 2004
% 211.36/211.54  |- mesh__recordAuthorizer mesh__D007730 PLS
% 211.36/211.54  |- skos__broader mesh__D007730smesh__D008877
% 211.36/211.54  |- mesh__dateCreated mesh__D007730 1999-01-01
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007730 2000
% 211.36/211.54  |- mesh__recordOriginator mesh__D007730 NLM
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007730 1994
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007730 2001
% 211.36/211.54  |- mesh__recordMaintainer mesh__D007730 PLS
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D012675 2005
% 211.36/211.54  |- mesh__recordOriginator mesh__D012675 NLM
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D012675 2000
% 211.36/211.54  |- skos__prefLabel mesh__D012675 Senegal
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D012675 1998
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D012675 2004
% 211.36/211.54  |- rdf__type mesh__D012675sskos__Concept
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D012675 1997
% 211.36/211.54  |- mesh__recordAuthorizer mesh__D012675 PLS
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D012675 2003
% 211.36/211.54  |- mesh__recordMaintainer mesh__D012675 TGC
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D012675 1996
% 211.36/211.54  |- skos__scopeNote mesh__D012675
% 211.36/211.54       A republic in western Africa, southwest of MAURITANIA and east of MALI. Its capital is Dakar. The first settlements were by the Portuguese in the 15th century and the French in the 17th century, with the coastal region becoming the object of much rivalry and conflict between the two until French possession was recognized in 1814. Senegal became independent in 1960. The nation was named for the Senegal River, its main river, which possibly derived its name from a local African word meaning navigable. %28%From Webster%27%s New Geographical Dictionary, 1988, p1097 %26% Room, Brewer%27%s Dictionary of Names, 1992, p493%29%%A%    
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D012675 2002
% 211.36/211.54  |- mesh__dateCreated mesh__D012675 1999-01-01
% 211.36/211.54  |- skos__broader mesh__D012675smesh__D000354
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D012675 2006
% 211.36/211.54  |- skos__annotation mesh__D012675 a republic in western Africa   
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D012675 2001
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D012675 1999
% 211.36/211.54  |- mesh__dateRevised mesh__D012675 1995-02-21
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D006638 2006
% 211.36/211.54  |- skos__hiddenLabel mesh__D006638 Deaminase, Histidine
% 211.36/211.54  |- skos__altLabel mesh__D006638 Histidinase
% 211.36/211.54  |- mesh__dateEstablished mesh__D006638 1991-01-01
% 211.36/211.54  |- skos__hiddenLabel mesh__D006638 Histidine Ammonia Lyase
% 211.36/211.54  |- mesh__dateRevised mesh__D006638 2003-07-09
% 211.36/211.54  |- skos__prefLabel mesh__D006638 Histidine Ammonia-Lyase
% 211.36/211.54  |- rdf__type mesh__D006638sskos__Concept
% 211.36/211.54  |- skos__scopeNote mesh__D006638
% 211.36/211.54       An enzyme that catalyzes the first step of histidine catabolism, forming UROCANIC ACID and AMMONIA from HISTIDINE. Deficiency of this enzyme is associated with elevated levels of serum histidine. EC 4.3.1.3.%A%    
% 211.36/211.54  |- mesh__publicMeSHNote mesh__D006638
% 211.36/211.54       98; see HISTIDASE 1991-97, see AMMONIA-LYASES 1973-90   
% 211.36/211.54  |- skos__altLabel mesh__D006638 Histidine Deaminase
% 211.36/211.54  |- skos__altLabel mesh__D006638 Histidase
% 211.36/211.54  |- skos__hiddenLabel mesh__D006638 alpha-Deaminase, Histidine
% 211.36/211.54  |- skos__altLabel mesh__D006638 Histidine alpha-Deaminase
% 211.36/211.54  |- skos__hiddenLabel mesh__D006638 Histidine alpha Deaminase
% 211.36/211.54  |- mesh__dateCreated mesh__D006638 1999-01-01
% 211.36/211.54  |- skos__broader mesh__D006638smesh__D000642
% 211.36/211.54  |- mesh__recordMaintainer mesh__D006638 ssb
% 211.36/211.54  |- mesh__recordOriginator mesh__D006638 NLM
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D006638 2005
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D006638 2004
% 211.36/211.54  |- skos__hiddenLabel mesh__D006638 Ammonia-Lyase, Histidine
% 211.36/211.54  |- skos__annotation mesh__D006638 /defic: consider also HISTIDINEMIA   
% 211.36/211.54  |- mesh__historyNote mesh__D006638 98%28%73%29%   
% 211.36/211.54  |- mesh__recordAuthorizer mesh__D006638 sjn
% 211.36/211.54  |- skos__altLabel mesh__D017360 Cress, Mouse-ear
% 211.36/211.54  |- skos__historyNote mesh__D017360 Plants %28%1966-1992%29%
% 211.36/211.54  |- skos__scopeNote mesh__D017360
% 211.36/211.54       A plant genus of the family BRASSICACEAE that contains ARABIDOPSIS PROTEINS and MADS DOMAIN PROTEINS. The species A. thaliana is used for experiments in classical plant genetics as well as molecular genetic studies in plant physiology, biochemistry, and development.%A%    
% 211.36/211.54  |- mesh__recordAuthorizer mesh__D017360 sjn
% 211.36/211.54  |- mesh__recordMaintainer mesh__D017360 JLS
% 211.36/211.54  |- mesh__dateCreated mesh__D017360 1992-05-07
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D017360 2006
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D017360 2005
% 211.36/211.54  |- mesh__dateEstablished mesh__D017360 1993-01-01
% 211.36/211.54  |- mesh__historyNote mesh__D017360 93   
% 211.36/211.54  |- skos__broader mesh__D017360smesh__D019607
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D017360 2004
% 211.36/211.54  |- rdf__type mesh__D017360sskos__Concept
% 211.36/211.54  |- skos__prefLabel mesh__D017360 Arabidopsis
% 211.36/211.54  |- mesh__recordOriginator mesh__D017360 PXP
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D017360 2003
% 211.36/211.54  |- mesh__publicMeSHNote mesh__D017360 93   
% 211.36/211.54  |- skos__annotation mesh__D017360
% 211.36/211.54       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.36/211.54  |- mesh__dateRevised mesh__D017360 2002-07-02
% 211.36/211.54  |- skos__broader mesh__D050794smesh__D050833
% 211.36/211.54  |- mesh__recordMaintainer mesh__D050794 DRC
% 211.36/211.54  |- skos__hiddenLabel mesh__D050794 Gamma Activated Factor, 91 kDa
% 211.36/211.54  |- skos__altLabel mesh__D050794 STAT91 Transcription Factor
% 211.36/211.54  |- mesh__dateEstablished mesh__D050794 2006-01-01
% 211.36/211.54  |- skos__altLabel mesh__D050794 Transcription Factor STAT91
% 211.36/211.54  |- skos__altLabel mesh__D050794 STAT-91 Protein
% 211.36/211.54  |- skos__hiddenLabel mesh__D050794 Transcription Factor, STAT-91
% 211.36/211.54  |- skos__hiddenLabel mesh__D050794 Transcription Factor, STAT91
% 211.36/211.54  |- skos__scopeNote mesh__D050794
% 211.36/211.54       A signal transducer and activator of transcription that mediates cellular responses to INTERFERONS. Stat1 interacts with P53 TUMOR SUPPRESSOR PROTEIN and regulates expression of GENES involved in growth control and APOPTOSIS.%A%    
% 211.36/211.54  |- mesh__dateCreated mesh__D050794 2005-06-30
% 211.36/211.54  |- skos__altLabel mesh__D050794 STAT1 Protein
% 211.36/211.54  |- skos__broader mesh__D050794smesh__D050791
% 211.36/211.54  |- skos__altLabel mesh__D050794 STAT-91 Transcription Factor
% 211.36/211.54  |- skos__hiddenLabel mesh__D050794 STAT 91 Protein
% 211.36/211.54  |- skos__altLabel mesh__D050794
% 211.36/211.54       Signal Transducer and Activator of Transcription 1
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D050794 2006
% 211.36/211.54  |- mesh__historyNote mesh__D050794 2006%28%1993%29%   
% 211.36/211.54  |- mesh__publicMeSHNote mesh__D050794
% 211.36/211.54       2006; STAT1 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1992-2005%A%  
% 211.36/211.54  |- mesh__recordAuthorizer mesh__D050794 sjn
% 211.36/211.54  |- skos__prefLabel mesh__D050794 STAT1 Transcription Factor
% 211.36/211.54  |- skos__altLabel mesh__D050794 Gamma-Activated Factor, 91 kDa
% 211.36/211.54  |- skos__hiddenLabel mesh__D050794 STAT 91 Transcription Factor
% 211.36/211.54  |- mesh__recordOriginator mesh__D050794 DRC
% 211.36/211.54  |- rdf__type mesh__D050794sskos__Concept
% 211.36/211.54  |- skos__hiddenLabel mesh__D050794 Transcription Factor, STAT1
% 211.36/211.54  |- skos__hiddenLabel mesh__D003340 Luteum Maintenance, Corpus
% 211.36/211.54  |- skos__historyNote mesh__D003340 Corpus Luteum %28%1966-1974%29%
% 211.36/211.54  |- skos__altLabel mesh__D003340 Luteal Maintenance
% 211.36/211.54  |- mesh__historyNote mesh__D003340
% 211.36/211.54       76%28%75%29%; was see under CORPUS LUTEUM 1975   
% 211.36/211.54  |- mesh__dateRevised mesh__D003340 2004-07-07
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D003340 2005
% 211.36/211.54  |- mesh__recordOriginator mesh__D003340 NLM
% 211.36/211.54  |- skos__hiddenLabel mesh__D003340 Luteal Function Maintenance
% 211.36/211.54  |- skos__broader mesh__D003340smesh__D034461
% 211.36/211.54  |- mesh__recordAuthorizer mesh__D003340 sjn
% 211.36/211.54  |- skos__altLabel mesh__D003340 Maintenance of Luteal Function
% 211.36/211.54  |- skos__hiddenLabel mesh__D003340 Luteum Maintenances, Corpus
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D003340 2006
% 211.36/211.54  |- skos__scopeNote mesh__D003340
% 211.36/211.54       Process of maintaining the functions of CORPORA LUTEA, specifically PROGESTERONE production which is regulated primarily by pituitary LUTEINIZING HORMONE in cycling females, and by PLACENTAL HORMONES in pregnant females. The ability to maintain luteal functions is important in PREGNANCY MAINTENANCE.%A%    
% 211.36/211.54  |- mesh__dateEstablished mesh__D003340 1976-01-01
% 211.36/211.54  |- mesh__publicMeSHNote mesh__D003340
% 211.36/211.54       76; was see under CORPUS LUTEUM 1975   
% 211.36/211.54  |- mesh__dateCreated mesh__D003340 1974-11-11
% 211.36/211.54  |- mesh__recordMaintainer mesh__D003340 lkt
% 211.36/211.54  |- skos__prefLabel mesh__D003340 Corpus Luteum Maintenance
% 211.36/211.54  |- rdf__type mesh__D003340sskos__Concept
% 211.36/211.54  |- skos__broader mesh__D003340smesh__D011255
% 211.36/211.54  |- skos__hiddenLabel mesh__D016268 Internal Fixation Device
% 211.36/211.54  |- mesh__recordOriginator mesh__D016268 PXP
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D016268 2000
% 211.36/211.54  |- skos__scopeNote mesh__D016268
% 211.36/211.54       Internal devices used in osteosynthesis to hold the position of the fracture in proper alignment. By applying the principles of biomedical engineering, the surgeon uses metal plates, nails, rods, etc., for the correction of skeletal defects.%A%    
% 211.36/211.54  |- skos__broader mesh__D016268smesh__D019736
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D016268 1999
% 211.36/211.54  |- skos__hiddenLabel mesh__D016268 Internal Fixator
% 211.36/211.54  |- skos__historyNote mesh__D016268
% 211.36/211.54       Fracture Fixation, Internal %28%1986-1990%29%
% 211.36/211.54  |- skos__hiddenLabel mesh__D016268 Devices, Internal Fixation
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D016268 1998
% 211.36/211.54  |- mesh__recordMaintainer mesh__D016268 PXP
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D016268 2006
% 211.36/211.54  |- skos__broader mesh__D016268smesh__D009984
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D016268 2002
% 211.36/211.54  |- mesh__dateCreated mesh__D016268 1990-05-29
% 211.36/211.54  |- skos__hiddenLabel mesh__D016268 Fixators, Internal
% 211.36/211.54  |- mesh__recordAuthorizer mesh__D016268 SJN
% 211.36/211.54  |- skos__altLabel mesh__D016268 Fixation Devices, Internal
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D016268 2005
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D016268 2004
% 211.36/211.54  |- skos__prefLabel mesh__D016268 Internal Fixators
% 211.36/211.54  |- skos__hiddenLabel mesh__D016268 Fixation Device, Internal
% 211.36/211.54  |- skos__hiddenLabel mesh__D016268 Device, Internal Fixation
% 211.36/211.54  |- rdf__type mesh__D016268sskos__Concept
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D016268 2003
% 211.36/211.54  |- skos__annotation mesh__D016268 for fracture fixation   
% 211.36/211.54  |- skos__historyNote mesh__D016268
% 211.36/211.54       Orthopedic Fixation Devices %28%1986-1990%29%
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D016268 2001
% 211.36/211.54  |- mesh__historyNote mesh__D016268 91   
% 211.36/211.54  |- skos__hiddenLabel mesh__D016268 Internal Fixation Devices
% 211.36/211.54  |- skos__hiddenLabel mesh__D016268 Fixator, Internal
% 211.36/211.54  |- mesh__dateEstablished mesh__D016268 1991-01-01
% 211.36/211.54  |- mesh__dateRevised mesh__D016268 1997-06-20
% 211.36/211.54  |- mesh__publicMeSHNote mesh__D016268 91   
% 211.36/211.54  |- skos__prefLabel mesh__D035422 Pleural Cavity
% 211.36/211.54  |- mesh__dateCreated mesh__D035422 2002-07-03
% 211.36/211.54  |- mesh__publicMeSHNote mesh__D035422 2003   
% 211.36/211.54  |- mesh__dateEstablished mesh__D035422 2003-01-01
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D035422 2006
% 211.36/211.54  |- skos__historyNote mesh__D035422 Pleura %28%1965-2002%29%
% 211.36/211.54  |- skos__scopeNote mesh__D035422
% 211.36/211.54       Paired but separate cavity within the THORACIC CAVITY. It consists of the space between the parietal and visceral PLEURA and normally contains a capillary layer of serous fluid that lubricates the pleural surfaces.%A%    
% 211.36/211.54  |- skos__hiddenLabel mesh__D035422 Pleural Cavities
% 211.36/211.54  |- skos__hiddenLabel mesh__D035422 Cavity, Pleural
% 211.36/211.54  |- mesh__historyNote mesh__D035422 2003   
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D035422 2003
% 211.36/211.54  |- skos__hiddenLabel mesh__D035422 Cavities, Pleural
% 211.36/211.54  |- rdf__type mesh__D035422sskos__Concept
% 211.36/211.54  |- skos__broader mesh__D035422smesh__D035423
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D035422 2004
% 211.36/211.54  |- skos__annotation mesh__D035422 PLEURA is also available   
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D035422 2005
% 211.36/211.54  |- mesh__recordMaintainer mesh__D002248 ADP
% 211.36/211.54  |- skos__broader mesh__D002248smesh__D010087
% 211.36/211.54  |- rdf__type mesh__D002248sskos__Concept
% 211.36/211.54  |- skos__hiddenLabel mesh__D002248 Monoxide, Carbon
% 211.36/211.54  |- mesh__recordOriginator mesh__D002248 NLM
% 211.36/211.54  |- skos__scopeNote mesh__D002248
% 211.36/211.54       Carbon monoxide %28%CO%29%. A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. %28%From Merck Index, 11th ed%29%%A%    
% 211.36/211.54  |- skos__broader mesh__D002248smesh__D017554
% 211.36/211.54  |- mesh__recordAuthorizer mesh__D002248 SJN
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D002248 1999
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D002248 2002
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D002248 2003
% 211.36/211.54  |- skos__broader mesh__D002248smesh__D005740
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D002248 2000
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D002248 2005
% 211.36/211.54  |- mesh__dateRevised mesh__D002248 1998-06-10
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D002248 2004
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D002248 2001
% 211.36/211.54  |- skos__annotation mesh__D002248
% 211.36/211.54       a poisonous gas; /tox permitted but consider also CARBON MONOXIDE POISONING%A%  
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D002248 2006
% 211.36/211.54  |- mesh__dateCreated mesh__D002248 1999-01-01
% 211.36/211.54  |- skos__prefLabel mesh__D002248 Carbon Monoxide
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007731 2003
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007731 1999
% 211.36/211.54  |- mesh__dateEstablished mesh__D007731 1991-01-01
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007731 2006
% 211.36/211.54  |- skos__prefLabel mesh__D007731 Kveim Test
% 211.36/211.54  |- mesh__publicMeSHNote mesh__D007731
% 211.36/211.54       91; was see under SKIN TESTS 1975-90   
% 211.36/211.54  |- mesh__dateRevised mesh__D007731 1997-06-20
% 211.36/211.54  |- skos__scopeNote mesh__D007731
% 211.36/211.54       Intradermal injection of a heated %28%pasteurized%29% saline suspension of sarcoid tissue obtained from a sarcoid spleen or lymph node. In patients with active sarcoidosis a dusky red nodule develops slowly over the next few weeks at the injection site. Histologic examination, an essential part of the complete test, reveals sarcoid tissue.%A%    
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007731 2000
% 211.36/211.54  |- mesh__recordOriginator mesh__D007731 NLM
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007731 2004
% 211.36/211.54  |- mesh__recordMaintainer mesh__D007731 PXP
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007731 2001
% 211.36/211.54  |- mesh__dateCreated mesh__D007731 1974-12-12
% 211.36/211.54  |- mesh__recordAuthorizer mesh__D007731 SJN
% 211.36/211.54  |- mesh__historyNote mesh__D007731
% 211.36/211.54       91%28%75%29%; was see under SKIN TESTS 1975-90   
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007731 2002
% 211.36/211.54  |- skos__hiddenLabel mesh__D007731 Test, Kveim
% 211.36/211.54  |- skos__broader mesh__D007731smesh__D007428
% 211.36/211.54  |- rdf__type mesh__D007731sskos__Concept
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007731 1998
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D007731 2005
% 211.36/211.54  |- skos__annotation mesh__D007731 for diag of sarcoidosis   
% 211.36/211.54  |- mesh__dateEstablished mesh__D045850 2004-01-01
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D045850 2006
% 211.36/211.54  |- mesh__dateRevised mesh__D045850 2005-06-30
% 211.36/211.54  |- skos__prefLabel mesh__D045850 Acidaminococcus
% 211.36/211.54  |- mesh__dateCreated mesh__D045850 2003-07-09
% 211.36/211.54  |- rdf__type mesh__D045850sskos__Concept
% 211.36/211.54  |- skos__scopeNote mesh__D045850
% 211.36/211.54       A genus of gram-negative bacteria in the family ACIDAMINOCOCCACEAE, isolated from the INTESTINES of PIGS and humans.%A%    
% 211.36/211.54  |- mesh__publicMeSHNote mesh__D045850 2004   
% 211.36/211.54  |- mesh__recordOriginator mesh__D045850 ags
% 211.36/211.54  |- mesh__recordAuthorizer mesh__D045850 sjn
% 211.36/211.54  |- mesh__historyNote mesh__D045850 2004   
% 211.36/211.54  |- mesh__recordMaintainer mesh__D045850 SYSTEM
% 211.36/211.54  |- skos__broader mesh__D045850smesh__D045854
% 211.36/211.54  |- skos__annotation mesh__D045850
% 211.36/211.54       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 211.36/211.54  |- mesh__publicMeSHNote mesh__D012676 2002; see SENNA 1963-2001   
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D012676 2006A
% 211.36/211.54  |- rdf__type mesh__D012676sskos__Concept
% 211.36/211.54  |- skos__broader mesh__D012676smesh__D010936
% 211.36/211.54  |- skos__annotation mesh__D012676 SENNA PLANT is also available   
% 211.36/211.54  |- mesh__recordAuthorizer mesh__D012676 ags
% 211.36/211.54  |- mesh__dateRevised mesh__D012676 2005-07-29
% 211.36/211.54  |- mesh__recordMaintainer mesh__D012676 ags
% 211.36/211.54  |- mesh__dateCreated mesh__D012676 1999-01-01
% 211.36/211.54  |- mesh__historyNote mesh__D012676 2002%28%1963%29%   
% 211.36/211.54  |- skos__scopeNote mesh__D012676
% 211.36/211.54       Preparations of Cassia senna and C. angustifolia %28%see SENNA PLANT%29%. They contain sennosides, which are anthraquinone type CATHARTICS and are used in many different preparations as laxatives.%A%    
% 211.36/211.54  |- skos__prefLabel mesh__D012676 Senna Extract
% 211.36/211.54  |- skos__hiddenLabel mesh__D012676 Extract, Senna
% 211.36/211.54  |- mesh__recordOriginator mesh__D012676 NLM
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D012676 2006
% 211.36/211.54  |- skos__hiddenLabel mesh__D006639 Histidine, L isomer
% 211.36/211.54  |- mesh__recordOriginator mesh__D006639 NLM
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D006639 2003
% 211.36/211.54  |- skos__broader mesh__D006639smesh__D000598
% 211.36/211.54  |- skos__prefLabel mesh__D006639 Histidine
% 211.36/211.54  |- mesh__dateCreated mesh__D006639 1999-01-01
% 211.36/211.54  |- mesh__recordAuthorizer mesh__D006639 sjn
% 211.36/211.54  |- skos__altLabel mesh__D006639 Histidine, L-isomer
% 211.36/211.54  |- skos__annotation mesh__D006639 /biosyn /defic /physiol permitted   
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D006639 2005
% 211.36/211.54  |- mesh__recordMaintainer mesh__D006639 jmp
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D006639 2004
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D006639 2002
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D006639 2006
% 211.36/211.54  |- skos__hiddenLabel mesh__D006639 L-isomer Histidine
% 211.36/211.54  |- skos__broader mesh__D006639smesh__D000601
% 211.36/211.54  |- skos__altLabel mesh__D006639 L-Histidine
% 211.36/211.54  |- mesh__dateRevised mesh__D006639 2001-07-25
% 211.36/211.54  |- skos__scopeNote mesh__D006639
% 211.36/211.54       An essential amino acid that is required for the production of HISTAMINE.%A%    
% 211.36/211.54  |- rdf__type mesh__D006639sskos__Concept
% 211.36/211.54  |- skos__altLabel mesh__D017361 Viral Nonstructural Protein
% 211.36/211.54  |- mesh__activeMeSHYear mesh__D017361 2006
% 211.36/211.54  |- skos__annotation mesh__D017361
% 211.36/211.54       coordinate IM with specific protein %28%IM%29% + specific virus %28%IM%29%%A%  
% 211.36/211.54  |- skos__historyNote mesh__D017361 Viral Proteins %28%1980-1988%29%
% 211.36/211.54  |- mesh__publicMeSHNote mesh__D017361
% 211.36/211.54       93; NS PROTEINS was indexed under VIRAL CORE PROTEINS %26% CAPSID 1988-92, %26% VIRAL PROTEINS 1980-88%A%  
% 211.36/211.54  |- skos__historyNote mesh__D017361 Capsid %28%1988-1992%29%
% 211.36/211.54  |- skos__broader mesh__D017361smesh__D014764
% 211.36/211.54  |- skos__hiddenLabel mesh__D017361 Proteins, Viral Nonstructural
% 211.36/211.54  |- skos__hiddenLabel mesh__D017361 Proteins, Viral Non-Structural
% 211.36/211.54  |- mesh__dateRevised mesh__D017361 2005-06-30
% 211.36/211.54  |- skos__hiddenLabel mesh__D017361 Proteins, Viral NS
% 211.36/211.54  |- skos__hiddenLabel mesh__D017361 Viral Non Structural Proteins
% 211.36/211.54  |- mesh__recordOriginator mesh__D017361 TPW
% 211.36/211.54  |- skos__historyNote mesh__D017361 Viral Core Proteins %28%1988-1992%29%
% 211.36/211.54  |- skos__altLabel mesh__D017361 Viral NS Proteins
% 211.36/211.54  |- mesh__recordMaintainer mesh__D017361 nns
% 211.36/211.54  |- mesh__dateCreated mesh__D017361 1992-05-22
% 211.36/211.54  |- skos__prefLabel mesh__D017361 Viral Nonstructural Proteins
% 211.36/211.54  |- mesh__recordAuthorizer mesh__D017361 sjn
% 211.36/211.54  |- skos__altLabel mesh__D017361 Nonstructural Proteins, Viral
% 211.36/211.54  |- rdf__type mesh__D017361sskos__Concept
% 211.36/211.54  |- skos__hiddenLabel mesh__D017361 Nonstructural Protein, Viral
% 211.36/211.54  |- mesh__historyNote mesh__D017361
% 211.36/211.54       93; was NS PROTEINS %28%NM%29% 1980-92   
% 211.36/211.54  |- skos__hiddenLabel mesh__D017361 Protein, Viral Nonstructural
% 211.36/211.55  |- mesh__dateEstablished mesh__D017361 1993-01-01
% 211.36/211.55  |- skos__altLabel mesh__D017361 NS Proteins, Viral
% 211.36/211.55  |- skos__scopeNote mesh__D017361
% 211.36/211.55       Proteins encoded by a VIRAL GENOME that are produced in the organisms they infect, but not packaged into the VIRUS PARTICLES. Some of these proteins may play roles within the infected cell during VIRUS REPLICATION or act in regulation of virus replication or VIRUS ASSEMBLY.%A%    
% 211.36/211.55  |- mesh__onlineNote mesh__D017361
% 211.36/211.55       use VIRAL NONSTRUCTURAL PROTEINS %28%NM%29% to search NS PROTEINS 1980-92%A%  
% 211.36/211.55  |- skos__hiddenLabel mesh__D017361 Non-Structural Proteins, Viral
% 211.36/211.55  |- skos__altLabel mesh__D017361 Viral Non-Structural Proteins
% 211.36/211.55  |- skos__altLabel mesh__D050795 STAT2 Protein
% 211.36/211.55  |- skos__prefLabel mesh__D050795 STAT2 Transcription Factor
% 211.36/211.55  |- mesh__recordAuthorizer mesh__D050795 sjn
% 211.36/211.55  |- mesh__publicMeSHNote mesh__D050795
% 211.36/211.55       2006; STAT2 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1995-2005%A%  
% 211.36/211.55  |- mesh__recordMaintainer mesh__D050795 DRC
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D050795 2006
% 211.36/211.55  |- mesh__historyNote mesh__D050795 2006%28%1995%29%   
% 211.36/211.55  |- mesh__dateEstablished mesh__D050795 2006-01-01
% 211.36/211.55  |- skos__altLabel mesh__D050795 Transcription Factor STAT2
% 211.36/211.55  |- rdf__type mesh__D050795sskos__Concept
% 211.36/211.55  |- mesh__recordOriginator mesh__D050795 DRC
% 211.36/211.55  |- skos__scopeNote mesh__D050795
% 211.36/211.55       A signal transducer and activator of transcription that mediates cellular responses to TYPE I INTERFERONS. Stat2 protein is associated constitutively with INTERFERON REGULATORY FACTOR-9. After PHOSPHORYLATION Stat2 forms the IFN-STIMULATED GENE FACTOR 3 COMPLEX to regulate expression of target GENES.%A%    
% 211.36/211.55  |- skos__hiddenLabel mesh__D050795 Transcription Factor, STAT2
% 211.36/211.55  |- skos__altLabel mesh__D050795
% 211.36/211.55       Signal Transducer and Activator of Transcription 2
% 211.36/211.55  |- mesh__dateCreated mesh__D050795 2005-06-30
% 211.36/211.55  |- skos__hiddenLabel mesh__D050795 Factor STAT2, Transcription
% 211.36/211.55  |- skos__broader mesh__D050795smesh__D050833
% 211.36/211.55  |- skos__broader mesh__D050795smesh__D050791
% 211.36/211.55  |- skos__scopeNote mesh__D003341
% 211.36/211.55       Degradation of CORPUS LUTEUM. In the absence of pregnancy and diminishing trophic hormones, the corpus luteum undergoes luteolysis which is characterized by the involution and cessation of its endocrine function.%A%    
% 211.36/211.55  |- skos__hiddenLabel mesh__D003341 Regression, Corpus Luteum
% 211.36/211.55  |- skos__prefLabel mesh__D003341 Luteolysis
% 211.36/211.55  |- mesh__dateRevised mesh__D003341 2004-07-07
% 211.36/211.55  |- skos__broader mesh__D003341smesh__D010060
% 211.36/211.55  |- mesh__recordMaintainer mesh__D003341 lkt
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003341 2006
% 211.36/211.55  |- mesh__publicMeSHNote mesh__D003341
% 211.36/211.55       2003; see CORPUS LUTEUM REGRESSION 1976-2002; see CORPUS LUTEUM 1975%A%  
% 211.36/211.55  |- mesh__recordOriginator mesh__D003341 NLM
% 211.36/211.55  |- mesh__dateCreated mesh__D003341 1974-11-11
% 211.36/211.55  |- mesh__recordAuthorizer mesh__D003341 sjn
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003341 2005
% 211.36/211.55  |- mesh__historyNote mesh__D003341
% 211.36/211.55       2003 %28%1976%29%; use CORPUS LUTEUM 1975   
% 211.36/211.55  |- skos__altLabel mesh__D003341 Corpus Luteum Regression
% 211.36/211.55  |- skos__altLabel mesh__D003341 Luteal Regression
% 211.36/211.55  |- skos__hiddenLabel mesh__D003341 Regression, Luteal
% 211.36/211.55  |- mesh__dateEstablished mesh__D003341 1976-01-01
% 211.36/211.55  |- skos__historyNote mesh__D003341 Corpus Luteum %28%1966-1974%29%
% 211.36/211.55  |- rdf__type mesh__D003341sskos__Concept
% 211.36/211.55  |- skos__hiddenLabel mesh__D016269 Allergies, Milk
% 211.36/211.55  |- skos__annotation mesh__D016269
% 211.36/211.55       coord IM with specific milk product /adv eff %28%IM%29% if pertinent; do not confuse with LACTOSE INTOLERANCE, a lactase defic%A%  
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D016269 2004
% 211.36/211.55  |- skos__hiddenLabel mesh__D016269 Milk Allergies
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D016269 2005
% 211.36/211.55  |- skos__broader mesh__D016269smesh__D005512
% 211.36/211.55  |- mesh__recordMaintainer mesh__D016269 tpw
% 211.36/211.55  |- skos__historyNote mesh__D016269 Food Hypersensitivity %28%1966-1990%29%
% 211.36/211.55  |- rdf__type mesh__D016269sskos__Concept
% 211.36/211.55  |- skos__altLabel mesh__D016269 Allergy, Milk
% 211.36/211.55  |- skos__altLabel mesh__D016269 Hypersensitivity, Milk
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D016269 2003
% 211.36/211.55  |- mesh__recordOriginator mesh__D016269 TGC
% 211.36/211.55  |- mesh__publicMeSHNote mesh__D016269 91   
% 211.36/211.55  |- mesh__historyNote mesh__D016269 91   
% 211.36/211.55  |- mesh__recordAuthorizer mesh__D016269 sjn
% 211.36/211.55  |- skos__altLabel mesh__D016269 Milk Allergy
% 211.36/211.55  |- skos__related mesh__D016269smesh__D007787
% 211.36/211.55  |- skos__historyNote mesh__D016269 Milk/adverse effects %28%1966-1990%29%
% 211.36/211.55  |- skos__scopeNote mesh__D016269
% 211.36/211.55       Allergic reaction to milk %28%usually cow%27%s milk%29% or milk products. MILK HYPERSENSITIVITY should be differentiated from LACTOSE INTOLERANCE, an intolerance to milk as a result of congenital deficiency of lactase.%A%    
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D016269 2002
% 211.36/211.55  |- mesh__dateEstablished mesh__D016269 1991-01-01
% 211.36/211.55  |- mesh__dateRevised mesh__D016269 2001-07-25
% 211.36/211.55  |- skos__hiddenLabel mesh__D016269 Hypersensitivities, Milk
% 211.36/211.55  |- skos__prefLabel mesh__D016269 Milk Hypersensitivity
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D016269 2006
% 211.36/211.55  |- skos__hiddenLabel mesh__D016269 Milk Hypersensitivities
% 211.36/211.55  |- mesh__dateCreated mesh__D016269 1990-05-29
% 211.36/211.55  |- rdf__type mesh__D035423sskos__Concept
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D035423 2003
% 211.36/211.55  |- mesh__dateRevised mesh__D035423 2002-09-24
% 211.36/211.55  |- skos__prefLabel mesh__D035423 Thoracic Cavity
% 211.36/211.55  |- mesh__publicMeSHNote mesh__D035423 2003   
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D035423 2006
% 211.36/211.55  |- mesh__historyNote mesh__D035423 2003   
% 211.36/211.55  |- skos__annotation mesh__D035423 prefer specifics   
% 211.36/211.55  |- skos__scopeNote mesh__D035423
% 211.36/211.55       The region of the thorax that includes the PLEURAL CAVITY and MEDIASTINUM.%A%    
% 211.36/211.55  |- mesh__dateEstablished mesh__D035423 2003-01-01
% 211.36/211.55  |- skos__hiddenLabel mesh__D035423 Cavity, Thoracic
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D035423 2005
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D035423 2003A
% 211.36/211.55  |- mesh__recordAuthorizer mesh__D035423 sjn
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D035423 2004
% 211.36/211.55  |- skos__broader mesh__D035423smesh__D013909
% 211.36/211.55  |- mesh__dateCreated mesh__D035423 2002-07-03
% 211.36/211.55  |- skos__altLabel mesh__D035423 Cavitas thoracis
% 211.36/211.55  |- mesh__recordOriginator mesh__D035423 ags
% 211.36/211.55  |- mesh__recordMaintainer mesh__D035423 sjn
% 211.36/211.55  |- skos__hiddenLabel mesh__D002249 Monoxide Poisonings, Carbon
% 211.36/211.55  |- skos__hiddenLabel mesh__D002249 Monoxide Poisoning, Carbon
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D002249 2002
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D002249 1997
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D002249 2006
% 211.36/211.55  |- mesh__recordMaintainer mesh__D002249 TGC
% 211.36/211.55  |- skos__prefLabel mesh__D002249 Carbon Monoxide Poisoning
% 211.36/211.55  |- mesh__onlineNote mesh__D002249
% 211.36/211.55       use CARBON MONOXIDE POISONING to search ILLUMINATING GAS POISONING 1969-78%A%  
% 211.36/211.55  |- mesh__recordAuthorizer mesh__D002249 PLS
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D002249 1996
% 211.36/211.55  |- skos__hiddenLabel mesh__D002249 Poisonings, Carbon Monoxide
% 211.36/211.55  |- skos__hiddenLabel mesh__D002249 Gas Poisonings, Illuminating
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D002249 2005
% 211.36/211.55  |- mesh__dateCreated mesh__D002249 1999-01-01
% 211.36/211.55  |- rdf__type mesh__D002249sskos__Concept
% 211.36/211.55  |- skos__hiddenLabel mesh__D002249 Carbon Monoxide Poisonings
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D002249 1993
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D002249 2001
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D002249 1999
% 211.36/211.55  |- mesh__recordOriginator mesh__D002249 NLM
% 211.36/211.55  |- skos__hiddenLabel mesh__D002249 Poisonings, Illuminating Gas
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D002249 2000
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D002249 1998
% 211.36/211.55  |- skos__broader mesh__D002249smesh__D005739
% 211.36/211.55  |- mesh__dateRevised mesh__D002249 1992-05-07
% 211.36/211.55  |- skos__altLabel mesh__D002249 Poisoning, Carbon Monoxide
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D002249 2004
% 211.36/211.55  |- skos__hiddenLabel mesh__D002249 Illuminating Gas Poisonings
% 211.36/211.55  |- skos__hiddenLabel mesh__D002249 Gas Poisoning, Illuminating
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D002249 1995
% 211.36/211.55  |- skos__altLabel mesh__D002249 Illuminating Gas Poisoning
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D002249 2003
% 211.36/211.55  |- mesh__historyNote mesh__D002249
% 211.36/211.55       ILLUMINATING GAS POISONING was see under CARBON MONOXIDE POISONING 1969-78%A%  
% 211.36/211.55  |- skos__scopeNote mesh__D002249
% 211.36/211.55       Toxic asphyxiation due to the displacement of oxygen from oxyhemoglobin by carbon monoxide.%A%    
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D002249 1994
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D007732 2004
% 211.36/211.55  |- skos__annotation mesh__D007732 severe form of protein malnutrition   
% 211.36/211.55  |- mesh__dateRevised mesh__D007732 2003-07-09
% 211.36/211.55  |- mesh__dateCreated mesh__D007732 1999-01-01
% 211.36/211.55  |- mesh__recordOriginator mesh__D007732 NLM
% 211.36/211.55  |- skos__hiddenLabel mesh__D007732 Kwashiorkors
% 211.36/211.55  |- rdf__type mesh__D007732sskos__Concept
% 211.36/211.55  |- skos__prefLabel mesh__D007732 Kwashiorkor
% 211.36/211.55  |- mesh__recordMaintainer mesh__D007732 lkt
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D007732 2005
% 211.36/211.55  |- skos__scopeNote mesh__D007732
% 211.36/211.55       A syndrome produced by severe protein deficiency, characterized by retarded growth, changes in skin and hair pigment, edema, and pathologic changes in the liver, including fatty infiltration, necrosis, and fibrosis. The word is a local name in Gold Coast, Africa, meaning %22%displaced child%22%. Although first reported from Africa, kwashiorkor is now known throughout the world, but mainly in the tropics and subtropics. It is considered to be related to marasmus. %28%From Dorland, 27th ed%29%%A%    
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D007732 2006
% 211.36/211.55  |- mesh__recordAuthorizer mesh__D007732 sjn
% 211.36/211.55  |- skos__broader mesh__D007732smesh__D011502
% 211.36/211.55  |- skos__annotation mesh__D045851
% 211.36/211.55       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 211.36/211.55  |- mesh__dateCreated mesh__D045851 2003-07-09
% 211.36/211.55  |- rdf__type mesh__D045851sskos__Concept
% 211.36/211.55  |- mesh__publicMeSHNote mesh__D045851 2004   
% 211.36/211.55  |- mesh__dateEstablished mesh__D045851 2004-01-01
% 211.36/211.55  |- skos__prefLabel mesh__D045851 Megasphaera
% 211.36/211.55  |- skos__broader mesh__D045851smesh__D016964
% 211.36/211.55  |- mesh__dateRevised mesh__D045851 2005-06-30
% 211.36/211.55  |- mesh__recordMaintainer mesh__D045851 SYSTEM
% 211.36/211.55  |- mesh__recordOriginator mesh__D045851 ags
% 211.36/211.55  |- mesh__recordAuthorizer mesh__D045851 sjn
% 211.36/211.55  |- mesh__historyNote mesh__D045851 2004   
% 211.36/211.55  |- skos__scopeNote mesh__D045851
% 211.36/211.55       A genus of gram-negative bacteria in the family ACIDAMINOCOCCACEAE, found in the RUMEN of SHEEP and CATTLE, and also in humans.%A%    
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D045851 2006
% 211.36/211.55  |- skos__historyNote mesh__D045851 Veillonellaceae %28%1975-2003%29%
% 211.36/211.55  |- skos__related mesh__D012677smesh__D010465
% 211.36/211.55  |- mesh__recordOriginator mesh__D012677 NLM
% 211.36/211.55  |- skos__annotation mesh__D012677
% 211.36/211.55       SENSATION DISORDERS is available but burning, tingling or prickling sensations go under PARESTHESIA%A%  
% 211.36/211.55  |- skos__broader mesh__D012677smesh__D011603
% 211.36/211.55  |- mesh__dateCreated mesh__D012677 1999-01-01
% 211.36/211.55  |- mesh__recordAuthorizer mesh__D012677 sjn
% 211.36/211.55  |- mesh__dateRevised mesh__D012677 2005-06-30
% 211.36/211.55  |- skos__broader mesh__D012677smesh__D009424
% 211.36/211.55  |- skos__altLabel mesh__D012677 Organoleptic
% 211.36/211.55  |- skos__hiddenLabel mesh__D012677 Sensations
% 211.36/211.55  |- mesh__recordMaintainer mesh__D012677 ssb
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D012677 2006
% 211.36/211.55  |- skos__scopeNote mesh__D012677
% 211.36/211.55       Transduction of physical or chemical changes in the external or internal environment into nerve impulses by specialized receptors, transmission of these impulses by afferent neurons to the effectors, either directly or through the CNS.%A%    
% 211.36/211.55  |- rdf__type mesh__D012677sskos__Concept
% 211.36/211.55  |- skos__prefLabel mesh__D012677 Sensation
% 211.36/211.55  |- rdf__type mesh__D017362sskos__Concept
% 211.36/211.55  |- skos__hiddenLabel mesh__D017362
% 211.36/211.55       DNA Binding Protein, Cyclic AMP Responsive
% 211.36/211.55  |- mesh__recordMaintainer mesh__D017362 DRC
% 211.36/211.55  |- mesh__historyNote mesh__D017362
% 211.36/211.55       93; was CYCLIC AMP-RESPONSIVE DNA-BINDING PROTEIN %28%NM%29% 1989-92%A%  
% 211.36/211.55  |- skos__scopeNote mesh__D017362
% 211.36/211.55       A protein that has been shown to function as a calcium-regulated transcription factor as well as a substrate for depolarization-activated CALCIUM-CALMODULIN DEPENDENT PROTEIN KINASES. This protein functions to integrate both calcium and cAMP signals.%A%    
% 211.36/211.55  |- skos__prefLabel mesh__D017362
% 211.36/211.55       Cyclic AMP Response Element-Binding Protein
% 211.36/211.55  |- skos__altLabel mesh__D017362 Cyclic AMP-Responsive DNA-Binding Protein
% 211.36/211.55  |- skos__hiddenLabel mesh__D017362 cAMP Response Element Binding Protein
% 211.36/211.55  |- mesh__recordOriginator mesh__D017362 PXP
% 211.36/211.55  |- skos__hiddenLabel mesh__D017362
% 211.36/211.55       Cyclic AMP Responsive DNA Binding Protein
% 211.36/211.55  |- mesh__publicMeSHNote mesh__D017362
% 211.36/211.55       93; CYCLIC AMP-RESPONSIVE DNA-BINDING PROTEIN was indexed under DNA-BINDING PROTEINS 1989-92%A%  
% 211.36/211.55  |- mesh__dateCreated mesh__D017362 1992-05-14
% 211.36/211.55  |- skos__altLabel mesh__D017362 cAMP Response Element-Binding Protein
% 211.36/211.55  |- mesh__dateRevised mesh__D017362 2005-06-30
% 211.36/211.55  |- skos__broader mesh__D017362smesh__D050976
% 211.36/211.55  |- mesh__onlineNote mesh__D017362
% 211.36/211.55       use DNA-BINDING PROTEIN, CYCLIC AMP-RESPONSIVE %28%NM%29% to search CYCLIC AMP-RESPONSIVE DNA-BINDING PROTEIN 1989-92%A%  
% 211.36/211.55  |- skos__historyNote mesh__D017362 DNA-Binding Proteins %28%1989-1992%29%
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D017362 2006
% 211.36/211.55  |- skos__altLabel mesh__D017362 CREB Protein
% 211.36/211.55  |- mesh__recordAuthorizer mesh__D017362 sjn
% 211.36/211.55  |- mesh__dateEstablished mesh__D017362 1993-01-01
% 211.36/211.55  |- skos__altLabel mesh__D017362 DNA-Binding Protein, Cyclic AMP-Responsive
% 211.36/211.55  |- skos__broader mesh__D050796smesh__D050791
% 211.36/211.55  |- skos__altLabel mesh__D050796
% 211.36/211.55       Signal Transducer and Activator of Transcription 3
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D050796 2006
% 211.36/211.55  |- skos__altLabel mesh__D050796 LIF-Response Factor
% 211.36/211.55  |- skos__altLabel mesh__D050796 APRF Transcription Factor
% 211.36/211.55  |- skos__hiddenLabel mesh__D050796 Transcription Factor, APRF
% 211.36/211.55  |- skos__prefLabel mesh__D050796 STAT3 Transcription Factor
% 211.36/211.55  |- skos__hiddenLabel mesh__D050796 Transcription Factor, STAT3a
% 211.36/211.55  |- rdf__type mesh__D050796sskos__Concept
% 211.36/211.55  |- mesh__recordOriginator mesh__D050796 DRC
% 211.36/211.55  |- mesh__recordAuthorizer mesh__D050796 sjn
% 211.36/211.55  |- skos__scopeNote mesh__D050796
% 211.36/211.55       A signal transducer and activator of transcription that mediates cellular responses to INTERLEUKIN-6 family members. STAT3 is constitutively activated in a variety of TUMORS and is a major downstream transducer for the CYTOKINE RECEPTOR GP130.%A%    
% 211.36/211.55  |- skos__hiddenLabel mesh__D050796 IL6 Response Factor
% 211.36/211.55  |- skos__altLabel mesh__D050796 Stat3beta Transcription Factor
% 211.36/211.55  |- mesh__recordMaintainer mesh__D050796 DRC
% 211.36/211.55  |- mesh__dateEstablished mesh__D050796 2006-01-01
% 211.36/211.55  |- mesh__publicMeSHNote mesh__D050796
% 211.36/211.55       2006; STAT3 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANSACTIVATORS 1994-2005%A%  
% 211.36/211.55  |- skos__hiddenLabel mesh__D050796 Acute Phase Response Factor
% 211.36/211.55  |- skos__altLabel mesh__D050796 Stat3alpha Transcription Factor
% 211.36/211.55  |- skos__hiddenLabel mesh__D050796 Transcription Factor, STAT3b
% 211.36/211.55  |- skos__hiddenLabel mesh__D050796 Transcription Factor, Stat3beta
% 211.36/211.55  |- skos__hiddenLabel mesh__D050796 Transcription Factor, STAT3
% 211.36/211.55  |- skos__altLabel mesh__D050796 IL6-Response Factor
% 211.36/211.55  |- skos__hiddenLabel mesh__D050796 Transcription Factor, Stat3alpha
% 211.36/211.55  |- mesh__historyNote mesh__D050796 2006   
% 211.36/211.55  |- skos__hiddenLabel mesh__D050796 LIF Response Factor
% 211.36/211.55  |- skos__altLabel mesh__D050796 Acute-Phase Response Factor
% 211.36/211.55  |- mesh__dateCreated mesh__D050796 2005-06-30
% 211.36/211.55  |- skos__altLabel mesh__D050796 STAT3 Protein
% 211.36/211.55  |- skos__hiddenLabel mesh__D050796 Response Factor, Acute-Phase
% 211.36/211.55  |- skos__hiddenLabel mesh__D003342 Lentiformis, Nucleus
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003342 2002
% 211.36/211.55  |- mesh__recordMaintainer mesh__D003342 ags
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003342 2004
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003342 2001
% 211.36/211.55  |- skos__hiddenLabel mesh__D003342 Nucleus, Lentiform
% 211.36/211.55  |- skos__broader mesh__D003342smesh__D001479
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003342 2006
% 211.36/211.55  |- skos__scopeNote mesh__D003342
% 211.36/211.55       Striped gray and white matter consisting of the NEOSTRIATUM and paleostriatum %28%GLOBUS PALLIDUS%29%. It is located in front of and lateral to the thalamus in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus %28%the latter consisting of the GLOBUS PALLIDUS and PUTAMEN%29%. The white matter is the internal capsule.%A%    
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003342 2003
% 211.36/211.55  |- skos__altLabel mesh__D003342 Nucleus Lentiformis
% 211.36/211.55  |- mesh__historyNote mesh__D003342
% 211.36/211.55       74%28%72%29%; LENTICULAR NUCLEUS was see under CORPUS STRIATUM 1974-78; was see under GANGLIA, BASAL 1963-73%A%  
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003342 2005
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003342 2000
% 211.36/211.55  |- mesh__publicMeSHNote mesh__D003342
% 211.36/211.55       74; LENTICULAR NUCLEUS was see under CORPUS STRIATUM 1974-78; was see under GANGLIA, BASAL 1963-73%A%  
% 211.36/211.55  |- mesh__dateEstablished mesh__D003342 1974-01-01
% 211.36/211.55  |- mesh__dateCreated mesh__D003342 1999-01-01
% 211.36/211.55  |- mesh__recordOriginator mesh__D003342 NLM
% 211.36/211.55  |- rdf__type mesh__D003342sskos__Concept
% 211.36/211.55  |- skos__annotation mesh__D003342
% 211.36/211.55       do not confuse with STRIATE CORTEX see VISUAL CORTEX or VENTRAL STRIATUM see BASAL GANGLIA%A%  
% 211.36/211.55  |- mesh__recordAuthorizer mesh__D003342 sjn
% 211.36/211.55  |- skos__historyNote mesh__D003342 Basal Ganglia %28%1966-1971%29%
% 211.36/211.55  |- skos__hiddenLabel mesh__D003342 Striatum, Corpus
% 211.36/211.55  |- mesh__onlineNote mesh__D003342
% 211.36/211.55       use CORPUS STRIATUM to search LENTICULAR NUCLEUS 1974-78; use BASAL GANGLIA 1966-73%A%  
% 211.36/211.55  |- skos__altLabel mesh__D003342 Lentiform Nucleus
% 211.36/211.55  |- skos__hiddenLabel mesh__D003342 Nucleus, Lenticular
% 211.36/211.55  |- mesh__dateRevised mesh__D003342 1999-11-03
% 211.36/211.55  |- skos__prefLabel mesh__D003342 Corpus Striatum
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D013770 2006
% 211.36/211.55  |- mesh__recordMaintainer mesh__D013770 JRT
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D013770 1998
% 211.36/211.55  |- mesh__recordOriginator mesh__D013770 NLM
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D013770 2005
% 211.36/211.55  |- skos__prefLabel mesh__D013770 Tetraisopropylpyrophosphamide
% 211.36/211.55  |- mesh__recordAuthorizer mesh__D013770 PLS
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D013770 2002
% 211.36/211.55  |- rdf__type mesh__D013770sskos__Concept
% 211.36/211.55  |- skos__scopeNote mesh__D013770
% 211.36/211.55       N,N%27%,N%27%%27%,N%27%%27%%27%-Tetraisopropylpyrophosphamide. A specific inhibitor of pseudocholinesterases. It is commonly used experimentally to determine whether pseudo- or acetylcholinesterases are involved in an enzymatic process.%A%    
% 211.36/211.55  |- skos__historyNote mesh__D013770 Amides %28%1972-1974%29%
% 211.36/211.55  |- skos__hiddenLabel mesh__D013770 Iso OMPA
% 211.36/211.55  |- mesh__dateRevised mesh__D013770 1995-06-08
% 211.36/211.55  |- mesh__dateCreated mesh__D013770 1974-11-19
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D013770 1997
% 211.36/211.55  |- skos__altLabel mesh__D013770 Iso-OMPA
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D013770 2004
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D013770 2001
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D013770 1996
% 211.36/211.55  |- mesh__dateEstablished mesh__D013770 1991-01-01
% 211.36/211.55  |- skos__annotation mesh__D013770 a cholinesterase inhib   
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D013770 2003
% 211.36/211.55  |- skos__broader mesh__D013770smesh__D009943
% 211.36/211.55  |- skos__historyNote mesh__D013770
% 211.36/211.55       Organophosphorus Compounds %28%1972-1974%29%
% 211.36/211.55  |- mesh__publicMeSHNote mesh__D013770
% 211.36/211.55       91; was see under ORGANOPHOSPHORUS COMPOUNDS 1975-90   
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D013770 2000
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D013770 1999
% 211.36/211.55  |- mesh__historyNote mesh__D013770
% 211.36/211.55       91%28%75%29%; was see under ORGANOPHOSPHORUS COMPOUNDS 1975-90   
% 211.36/211.55  |- skos__hiddenLabel mesh__D007733 Forest Disease, Kyasanur
% 211.36/211.55  |- skos__broader mesh__D007733smesh__D006482
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D007733 1999
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D007733 2006
% 211.36/211.55  |- mesh__dateRevised mesh__D007733 1993-06-04
% 211.36/211.55  |- mesh__historyNote mesh__D007733
% 211.36/211.55       78%28%75%29%; was see under ARBOVIRUS INFECTIONS 1977, was see under EPIDEMIC HEMORRHAGIC FEVER 1975-76%A%  
% 211.36/211.55  |- skos__broader mesh__D007733smesh__D017282
% 211.36/211.55  |- skos__prefLabel mesh__D007733 Kyasanur Forest Disease
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D007733 1996
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D007733 1995
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D007733 2003
% 211.36/211.55  |- mesh__recordAuthorizer mesh__D007733 PLS
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D007733 1998
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D007733 2005
% 211.36/211.55  |- mesh__publicMeSHNote mesh__D007733
% 211.36/211.55       78; was see under ARBOVIRUS INFECTIONS 1977, was see under EPIDEMIC HEMORRHAGIC FEVER 1975-76%A%  
% 211.36/211.55  |- mesh__recordMaintainer mesh__D007733 AGS
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D007733 1994
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D007733 2002
% 211.36/211.55  |- skos__historyNote mesh__D007733 Arbovirus Infections %28%1966-1977%29%
% 211.36/211.55  |- skos__scopeNote mesh__D007733
% 211.36/211.55       Tick-borne flavivirus infection occurring in the Kyasanur Forest in India.%A%    
% 211.36/211.55  |- skos__hiddenLabel mesh__D007733 Disease, Kyasanur Forest
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D007733 2001
% 211.36/211.55  |- mesh__dateEstablished mesh__D007733 1978-01-01
% 211.36/211.55  |- mesh__dateCreated mesh__D007733 1974-11-11
% 211.36/211.55  |- rdf__type mesh__D007733sskos__Concept
% 211.36/211.55  |- skos__historyNote mesh__D007733
% 211.36/211.55       Hemorrhagic Fevers, Viral %28%1966-1974%29%
% 211.36/211.55  |- mesh__recordOriginator mesh__D007733 NLM
% 211.36/211.55  |- skos__broader mesh__D007733smesh__D018177
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D007733 2000
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D007733 1997
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D007733 2004
% 211.36/211.55  |- skos__annotation mesh__D007733
% 211.36/211.55       note spelling: not Kyanasur; the forest is in India; a hemorrhagic fever caused by a flavivirus%A%  
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D045852 2006
% 211.36/211.55  |- rdf__type mesh__D045852sskos__Concept
% 211.36/211.55  |- mesh__dateCreated mesh__D045852 2003-07-09
% 211.36/211.55  |- mesh__publicMeSHNote mesh__D045852 2004   
% 211.36/211.55  |- mesh__dateEstablished mesh__D045852 2004-01-01
% 211.36/211.55  |- mesh__dateRevised mesh__D045852 2005-06-30
% 211.36/211.55  |- mesh__recordAuthorizer mesh__D045852 sjn
% 211.36/211.55  |- mesh__recordOriginator mesh__D045852 ags
% 211.36/211.55  |- skos__scopeNote mesh__D045852
% 211.36/211.55       A genus of gram-negative bacteria in the family ACIDAMINOCOCCACEAE, isolated from spoiled BEER and pitching yeast.%A%    
% 211.36/211.55  |- mesh__recordMaintainer mesh__D045852 SYSTEM
% 211.36/211.55  |- mesh__historyNote mesh__D045852 2004   
% 211.36/211.55  |- skos__broader mesh__D045852smesh__D045854
% 211.36/211.55  |- skos__prefLabel mesh__D045852 Pectinatus
% 211.36/211.55  |- skos__scopeNote mesh__D012678
% 211.36/211.55       Disorders of the special senses %28%i.e., VISION; HEARING; TASTE; and SMELL%29% or somatosensory system %28%i.e., afferent components of the PERIPHERAL NERVOUS SYSTEM%29%.%A%    
% 211.36/211.55  |- mesh__dateRevised mesh__D012678 2003-07-09
% 211.36/211.55  |- skos__hiddenLabel mesh__D012678 Senses Disorder, Special
% 211.36/211.55  |- skos__broader mesh__D012678smesh__D009461
% 211.36/211.55  |- skos__hiddenLabel mesh__D012678 Sensory Disorder
% 211.36/211.55  |- skos__hiddenLabel mesh__D012678 Special Senses Disorder
% 211.36/211.55  |- mesh__recordMaintainer mesh__D012678 lkt
% 211.36/211.55  |- skos__hiddenLabel mesh__D012678 Sensation Disorder
% 211.36/211.55  |- skos__hiddenLabel mesh__D012678 Senses Disorders, Special
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D012678 2006
% 211.36/211.55  |- skos__annotation mesh__D012678 GEN or unspecified: prefer specifics   
% 211.36/211.55  |- skos__historyNote mesh__D012678 Sensation %28%1969-1992%29%
% 211.36/211.55  |- mesh__recordOriginator mesh__D012678 NLM
% 211.36/211.55  |- skos__prefLabel mesh__D012678 Sensation Disorders
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D012678 2005
% 211.36/211.55  |- rdf__type mesh__D012678sskos__Concept
% 211.36/211.55  |- mesh__historyNote mesh__D012678
% 211.36/211.55       1993; was SENSATION DISORDERS %28%NON MESH%29% 1967-92   
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D012678 2004
% 211.36/211.55  |- mesh__publicMeSHNote mesh__D012678 1993   
% 211.36/211.55  |- skos__historyNote mesh__D012678
% 211.36/211.55       Nervous System Diseases %28%1980-1992%29%
% 211.36/211.55  |- mesh__recordAuthorizer mesh__D012678 sjn
% 211.36/211.55  |- mesh__dateCreated mesh__D012678 1999-01-01
% 211.36/211.55  |- mesh__dateEstablished mesh__D012678 1993-01-01
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D050797 2006
% 211.36/211.55  |- mesh__dateEstablished mesh__D050797 2006-01-01
% 211.36/211.55  |- skos__scopeNote mesh__D050797
% 211.36/211.55       A signal transducer and activator of transcription that mediates cellular responses to INTERLEUKIN-12 in T-LYMPHOCYTES. Stat4 is an important signaling molecule for differentiation in TH1 CELLS.%A%    
% 211.36/211.55  |- skos__altLabel mesh__D050797
% 211.36/211.55       Signal Transducer and Activator of Transcription 4
% 211.36/211.55  |- mesh__historyNote mesh__D050797 2006%28%1994%29%   
% 211.36/211.55  |- rdf__type mesh__D050797sskos__Concept
% 211.36/211.55  |- mesh__dateCreated mesh__D050797 2005-06-30
% 211.36/211.55  |- skos__broader mesh__D050797smesh__D050791
% 211.36/211.55  |- skos__hiddenLabel mesh__D050797 Transcription Factor, STAT4A
% 211.36/211.55  |- mesh__publicMeSHNote mesh__D050797
% 211.36/211.55       2006; STAT4 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1994-2005%A%  
% 211.36/211.55  |- skos__altLabel mesh__D050797 Transcription Factor STAT4
% 211.36/211.55  |- skos__hiddenLabel mesh__D050797 Transcription Factor, STAT4b
% 211.36/211.55  |- skos__altLabel mesh__D050797 STAT4beta Protein
% 211.36/211.55  |- mesh__recordMaintainer mesh__D050797 DRC
% 211.36/211.55  |- skos__hiddenLabel mesh__D050797 Transcription Factor, STAT4
% 211.36/211.55  |- mesh__recordAuthorizer mesh__D050797 sjn
% 211.36/211.55  |- skos__altLabel mesh__D050797 STAT4 Protein
% 211.36/211.55  |- mesh__recordOriginator mesh__D050797 DRC
% 211.36/211.55  |- skos__prefLabel mesh__D050797 STAT4 Transcription Factor
% 211.36/211.55  |- skos__altLabel mesh__D050797 STAT4alpha Protein
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003343 2003
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003343 2005
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003343 1990
% 211.36/211.55  |- mesh__recordOriginator mesh__D003343 NLM
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003343 1997
% 211.36/211.55  |- skos__historyNote mesh__D003343 Chemistry, Physical %28%1966-1969%29%
% 211.36/211.55  |- skos__prefLabel mesh__D003343 Corrosion
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003343 1999
% 211.36/211.55  |- mesh__historyNote mesh__D003343 73%28%70%29%   
% 211.36/211.55  |- mesh__dateCreated mesh__D003343 1999-01-01
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003343 1993
% 211.36/211.55  |- rdf__type mesh__D003343sskos__Concept
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003343 1996
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003343 1995
% 211.36/211.55  |- skos__hiddenLabel mesh__D003343 Corrosions
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003343 1998
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003343 2002
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003343 1992
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003343 1994
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003343 2001
% 211.36/211.55  |- mesh__publicMeSHNote mesh__D003343 73   
% 211.36/211.55  |- mesh__recordAuthorizer mesh__D003343 PLS
% 211.36/211.55  |- skos__broader mesh__D003343smesh__D002627
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003343 2004
% 211.36/211.55  |- skos__annotation mesh__D003343 almost never IM; no qualif   
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003343 2000
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003343 2006
% 211.36/211.55  |- mesh__activeMeSHYear mesh__D003343 1991
% 211.36/211.55  |- mesh__dateEstablished mesh__D003343 1973-01-01
% 211.36/211.55  |- mesh__dateRevised mesh__D003343 1989-06-14
% 211.36/211.55  |- mesh__recordMaintainer mesh__D003343 TGC
% 211.36/211.55  |- mesh__dateCreated mesh__D013771 1999-01-01
% 211.36/211.55  |- rdf__type mesh__D013771sskos__Concept
% 211.36/211.55  |- skos__scopeNote mesh__D013771
% 211.36/211.55       A combination of congenital cardiac defects consisting of pulmonary stenosis, interventricular septal defects, dextroposition of the aorta so that it overrides the interventricular septum and receives venous as well as arterial blood, and right ventricular hypertrophy.%A%    
% 211.36/211.56  |- skos__altLabel mesh__D013771 Fallot%27%s Tetralogy
% 211.36/211.56  |- skos__hiddenLabel mesh__D013771 Tetralogy, Fallot
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D013771 2000
% 211.36/211.56  |- skos__hiddenLabel mesh__D013771 Tetralogy, Fallots
% 211.36/211.56  |- mesh__dateRevised mesh__D013771 1999-11-03
% 211.36/211.56  |- mesh__recordOriginator mesh__D013771 NLM
% 211.36/211.56  |- mesh__recordMaintainer mesh__D013771 kle
% 211.36/211.56  |- skos__hiddenLabel mesh__D013771 Fallots Tetralogy
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D013771 2004
% 211.36/211.56  |- mesh__recordAuthorizer mesh__D013771 sjn
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D013771 2002
% 211.36/211.56  |- skos__hiddenLabel mesh__D013771 Fallot Tetralogy
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D013771 2003
% 211.36/211.56  |- skos__prefLabel mesh__D013771 Tetralogy of Fallot
% 211.36/211.56  |- skos__annotation mesh__D013771
% 211.36/211.56       multiple heart defects; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; do not confuse with TRILOGY OF FALLOT%A%  
% 211.36/211.56  |- skos__broader mesh__D013771smesh__D006330
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D013771 2006
% 211.36/211.56  |- skos__altLabel mesh__D013771 Tetralogy, Fallot%27%s
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D013771 2001
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D013771 2005
% 211.36/211.56  |- mesh__recordOriginator mesh__D007734 NLM
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D007734 2000
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D007734 2005
% 211.36/211.56  |- skos__prefLabel mesh__D007734 Kymography
% 211.36/211.56  |- skos__broader mesh__D007734smesh__D019937
% 211.36/211.56  |- mesh__recordAuthorizer mesh__D007734 sjn
% 211.36/211.56  |- skos__scopeNote mesh__D007734
% 211.36/211.56       The recording of wavelike motions or undulations. It is usually used on arteries to detect variations in blood pressure.%A%    
% 211.36/211.56  |- mesh__dateRevised mesh__D007734 1999-11-03
% 211.36/211.56  |- rdf__type mesh__D007734sskos__Concept
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D007734 2002
% 211.36/211.56  |- skos__annotation mesh__D007734 DF: KYMOGR   
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D007734 2004
% 211.36/211.56  |- mesh__dateCreated mesh__D007734 1999-01-01
% 211.36/211.56  |- mesh__recordMaintainer mesh__D007734 KEV
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D007734 2001
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D007734 2006
% 211.36/211.56  |- skos__hiddenLabel mesh__D007734 Kymographies
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D007734 2003
% 211.36/211.56  |- skos__broader mesh__D045853smesh__D015656
% 211.36/211.56  |- skos__hiddenLabel mesh__D045853 Exhalations
% 211.36/211.56  |- mesh__historyNote mesh__D045853 2004   
% 211.36/211.56  |- skos__hiddenLabel mesh__D045853 Expirations, Respiratory
% 211.36/211.56  |- skos__altLabel mesh__D045853 Exhaling
% 211.36/211.56  |- skos__altLabel mesh__D045853 Expiration, Respiratory
% 211.36/211.56  |- skos__prefLabel mesh__D045853 Exhalation
% 211.36/211.56  |- mesh__dateEstablished mesh__D045853 2004-01-01
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D045853 2006
% 211.36/211.56  |- rdf__type mesh__D045853sskos__Concept
% 211.36/211.56  |- skos__scopeNote mesh__D045853 The act of BREATHING out.     
% 211.36/211.56  |- mesh__dateCreated mesh__D045853 2003-07-09
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D045853 2004
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D045853 2005
% 211.36/211.56  |- skos__hiddenLabel mesh__D045853 Respiratory Expirations
% 211.36/211.56  |- mesh__publicMeSHNote mesh__D045853 2004   
% 211.36/211.56  |- skos__hiddenLabel mesh__D045853 Respiratory Expiration
% 211.36/211.56  |- mesh__recordAuthorizer mesh__D012679 sjn
% 211.36/211.56  |- skos__historyNote mesh__D012679 Sensation %28%1966-1971%29%
% 211.36/211.56  |- skos__annotation mesh__D012679 GEN: prefer specifics   
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D012679 2006
% 211.36/211.56  |- mesh__runningHead mesh__D012679 A9 - ANATOMY-SENSE ORGANS   
% 211.36/211.56  |- skos__hiddenLabel mesh__D012679 Sense Organ
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D012679 2005
% 211.36/211.56  |- rdf__type mesh__D012679sskos__Concept
% 211.36/211.56  |- skos__prefLabel mesh__D012679 Sense Organs
% 211.36/211.56  |- skos__hiddenLabel mesh__D012679 Organs, Sense
% 211.36/211.56  |- skos__related mesh__D012679smesh__D011984
% 211.36/211.56  |- mesh__recordOriginator mesh__D012679 NLM
% 211.36/211.56  |- mesh__dateRevised mesh__D012679 2004-07-07
% 211.36/211.56  |- mesh__dateCreated mesh__D012679 1999-01-01
% 211.36/211.56  |- mesh__historyNote mesh__D012679 72   
% 211.36/211.56  |- mesh__publicMeSHNote mesh__D012679 72   
% 211.36/211.56  |- mesh__dateEstablished mesh__D012679 1972-01-01
% 211.36/211.56  |- skos__historyNote mesh__D012679 Receptors, Sensory %28%1966-1971%29%
% 211.36/211.56  |- mesh__recordMaintainer mesh__D012679 ags
% 211.36/211.56  |- skos__hiddenLabel mesh__D012679 Organ, Sense
% 211.36/211.56  |- skos__altLabel mesh__D017364 Collagen-Degrading Enzyme
% 211.36/211.56  |- skos__hiddenLabel mesh__D017364 Collagen Degrading Enzyme
% 211.36/211.56  |- mesh__recordOriginator mesh__D017364 TPW
% 211.36/211.56  |- mesh__recordAuthorizer mesh__D017364 ags
% 211.36/211.56  |- skos__broader mesh__D017364smesh__D008666
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D017364 2005
% 211.36/211.56  |- mesh__publicMeSHNote mesh__D017364
% 211.36/211.56       93; COLLAGENASE was see CLOSTRIDIUM HISTOLYTICUM COLLAGENASE 1966-92%A%  
% 211.36/211.56  |- mesh__dateRevised mesh__D017364 2005-07-11
% 211.36/211.56  |- mesh__onlineNote mesh__D017364
% 211.36/211.56       use CLOSTRIDIUM HISTOLYTICUM COLLAGENASE to search COLLAGENASE 1966-92%A%  
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D017364 2006
% 211.36/211.56  |- mesh__historyNote mesh__D017364
% 211.36/211.56       93; COLLAGENASE was see CLOSTRIDIUM HISTOLYTICUM COLLAGENASE 1966-92%A%  
% 211.36/211.56  |- skos__annotation mesh__D017364
% 211.36/211.56       72-KDA TYPE IV COLLAGENASE see GELATINASE A and 92-KDA TYPE IV COLLAGENASE see GELATINASE B are available%A%  
% 211.36/211.56  |- skos__altLabel mesh__D017364 Collagen Peptidase
% 211.36/211.56  |- skos__altLabel mesh__D017364 Collagenase
% 211.36/211.56  |- skos__hiddenLabel mesh__D017364 Peptidase, Collagen
% 211.36/211.56  |- skos__historyNote mesh__D017364
% 211.36/211.56       Clostridium histolyticum Collagenase %28%1975-1992%29%
% 211.36/211.56  |- mesh__dateEstablished mesh__D017364 1993-01-01
% 211.36/211.56  |- skos__scopeNote mesh__D017364
% 211.36/211.56       Enzymes that catalyze the degradation of collagen by acting on the peptide bonds. EC 3.4.24.-.%A%    
% 211.36/211.56  |- mesh__recordMaintainer mesh__D017364 ags
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D017364 2004
% 211.36/211.56  |- mesh__dateCreated mesh__D017364 1992-05-13
% 211.36/211.56  |- rdf__type mesh__D017364sskos__Concept
% 211.36/211.56  |- skos__prefLabel mesh__D017364 Collagenases
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D017364 2006A
% 211.36/211.56  |- rdf__type mesh__D050798sskos__Concept
% 211.36/211.56  |- mesh__dateEstablished mesh__D050798 2006-01-01
% 211.36/211.56  |- skos__annotation mesh__D050798
% 211.36/211.56       SUNCT = shortlasting, unilateral, neuralgiform, conjunctival, tearing.%A%  
% 211.36/211.56  |- mesh__recordOriginator mesh__D050798 lkt
% 211.36/211.56  |- skos__historyNote mesh__D050798 Neuralgia %28%1991-2005%29%
% 211.36/211.56  |- skos__historyNote mesh__D050798 Tears %28%1991-2005%29%
% 211.36/211.56  |- mesh__historyNote mesh__D050798 2006   
% 211.36/211.56  |- skos__broader mesh__D050798smesh__D051303
% 211.36/211.56  |- mesh__dateCreated mesh__D050798 2005-06-30
% 211.36/211.56  |- skos__prefLabel mesh__D050798 SUNCT Syndrome
% 211.36/211.56  |- mesh__publicMeSHNote mesh__D050798 2006   
% 211.36/211.56  |- skos__hiddenLabel mesh__D050798 Syndrome, SUNCT
% 211.36/211.56  |- skos__historyNote mesh__D050798 Headache %28%1991-2005%29%
% 211.36/211.56  |- mesh__recordMaintainer mesh__D050798 lkt
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D050798 2006
% 211.36/211.56  |- skos__hiddenLabel mesh__D050798 Syndromes, SUNCT
% 211.36/211.56  |- skos__scopeNote mesh__D050798
% 211.36/211.56       A primary headache disorder that is characterized by frequent short-lasting, unilateral, neuralgiform pain attacks in the ocular area, with CONJUNCTIVA fluid-filling and tearing. SUNCT syndrome is usually resistant to treatment.%A%    
% 211.36/211.56  |- skos__hiddenLabel mesh__D050798 SUNCT Syndromes
% 211.36/211.56  |- mesh__recordAuthorizer mesh__D050798 sjn
% 211.36/211.56  |- skos__hiddenLabel mesh__D003344 Synchronization, Cortical
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D003344 1999
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D003344 2000
% 211.36/211.56  |- mesh__dateCreated mesh__D003344 1999-01-01
% 211.36/211.56  |- skos__hiddenLabel mesh__D003344 Desynchronizations, Cortical
% 211.36/211.56  |- rdf__type mesh__D003344sskos__Concept
% 211.36/211.56  |- mesh__recordAuthorizer mesh__D003344 SJN
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D003344 1998
% 211.36/211.56  |- skos__prefLabel mesh__D003344 Cortical Synchronization
% 211.36/211.56  |- skos__hiddenLabel mesh__D003344 Desynchronization, Cortical
% 211.36/211.56  |- skos__hiddenLabel mesh__D003344 Synchronizations, Cortical
% 211.36/211.56  |- mesh__recordOriginator mesh__D003344 NLM
% 211.36/211.56  |- skos__historyNote mesh__D003344 Electroencephalography %28%1966-1971%29%
% 211.36/211.56  |- skos__annotation mesh__D003344 /drug eff /rad eff permitted   
% 211.36/211.56  |- skos__broader mesh__D003344smesh__D004569
% 211.36/211.56  |- mesh__dateRevised mesh__D003344 1997-06-20
% 211.36/211.56  |- mesh__publicMeSHNote mesh__D003344
% 211.36/211.56       91; was see under ELECTROENCEPHALOGRAPHY 1975-90; CORTICAL DESYNCHRONIZATION was see under ELECTROENCEPHALOGRAPHY 1975-83%A%  
% 211.36/211.56  |- mesh__dateEstablished mesh__D003344 1991-01-01
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D003344 2004
% 211.36/211.56  |- skos__hiddenLabel mesh__D003344 Cortical Desynchronizations
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D003344 2002
% 211.36/211.56  |- mesh__onlineNote mesh__D003344
% 211.36/211.56       use CORTICAL SYNCHRONIZATION to search CORTICAL DESYNCHRONIZATION 1972-83 %28%as Prov 1972-74%29%%A%  
% 211.36/211.56  |- mesh__historyNote mesh__D003344
% 211.36/211.56       91%28%72%29%; was see under ELECTROENCEPHALOGRAPHY 1972-90 %28%Prov 1972-74%29%; CORTICAL DESYNCHRONIZATION was see under ELECTROENCEPHALOGRAPHY 1972-83 %28%Prov 1972-74%29%%A%  
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D003344 2006
% 211.36/211.56  |- mesh__recordMaintainer mesh__D003344 PXP
% 211.36/211.56  |- skos__hiddenLabel mesh__D003344 Cortical Synchronizations
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D003344 2003
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D003344 2001
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D003344 2005
% 211.36/211.56  |- mesh__dateEstablished mesh__D013772 1991-01-01
% 211.36/211.56  |- mesh__historyNote mesh__D013772
% 211.36/211.56       91%28%75%29%; was see under PHENYLENEDIAMINES 1975-90   
% 211.36/211.56  |- rdf__type mesh__D013772sskos__Concept
% 211.36/211.56  |- skos__hiddenLabel mesh__D013772 Wursters Blue
% 211.36/211.56  |- skos__altLabel mesh__D013772 Wurster%27%s Blue
% 211.36/211.56  |- skos__historyNote mesh__D013772 Dimethylamines %28%1974%29%
% 211.36/211.56  |- skos__hiddenLabel mesh__D013772 Blue, Wurster%27%s
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D013772 2003
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D013772 2001
% 211.36/211.56  |- skos__scopeNote mesh__D013772
% 211.36/211.56       Used in the form of the hydrochloride as a reagent in analytical chemistry.%A%    
% 211.36/211.56  |- skos__altLabel mesh__D013772 Wurster%27%s Reagent
% 211.36/211.56  |- skos__broader mesh__D013772smesh__D010655
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D013772 2004
% 211.36/211.56  |- mesh__publicMeSHNote mesh__D013772
% 211.36/211.56       91; was see under PHENYLENEDIAMINES 1975-90   
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D013772 2002
% 211.36/211.56  |- skos__hiddenLabel mesh__D013772 Reagent, Wurster%27%s
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D013772 2005
% 211.36/211.56  |- skos__prefLabel mesh__D013772 Tetramethylphenylenediamine
% 211.36/211.56  |- skos__hiddenLabel mesh__D013772 Blue, Wurster
% 211.36/211.56  |- mesh__recordMaintainer mesh__D013772 CCR
% 211.36/211.56  |- skos__historyNote mesh__D013772 Phenylenediamines %28%1974%29%
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D013772 2006
% 211.36/211.56  |- mesh__recordOriginator mesh__D013772 NLM
% 211.36/211.56  |- mesh__recordAuthorizer mesh__D013772 sjn
% 211.36/211.56  |- skos__hiddenLabel mesh__D013772 Wurster Reagent
% 211.36/211.56  |- skos__annotation mesh__D013772 D25-26 qualif   
% 211.36/211.56  |- skos__altLabel mesh__D013772 Wurster Blue
% 211.36/211.56  |- mesh__dateRevised mesh__D013772 2000-06-22
% 211.36/211.56  |- skos__hiddenLabel mesh__D013772 Wursters Reagent
% 211.36/211.56  |- mesh__dateCreated mesh__D013772 1974-11-19
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D007735 2002
% 211.36/211.56  |- rdf__type mesh__D007735sskos__Concept
% 211.36/211.56  |- skos__historyNote mesh__D007735 Amines %28%1972-1974%29%
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D007735 2001
% 211.36/211.56  |- skos__historyNote mesh__D007735 Propiophenones %28%1972-1974%29%
% 211.36/211.56  |- mesh__historyNote mesh__D007735
% 211.36/211.56       91%28%75%29%; was see under PROPIOPHENONES 1975-90   
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D007735 2004
% 211.36/211.56  |- mesh__recordOriginator mesh__D007735 NLM
% 211.36/211.56  |- mesh__recordMaintainer mesh__D007735 CCR
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D007735 2006
% 211.36/211.56  |- mesh__dateCreated mesh__D007735 1974-11-19
% 211.36/211.56  |- mesh__dateRevised mesh__D007735 2000-06-22
% 211.36/211.56  |- skos__prefLabel mesh__D007735 Kynuramine
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D007735 2003
% 211.36/211.56  |- skos__hiddenLabel mesh__D007735 2,3 Diaminopropiophenone
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D007735 2005
% 211.36/211.56  |- mesh__publicMeSHNote mesh__D007735
% 211.36/211.56       91; was see under PROPIOPHENONES 1975-90   
% 211.36/211.56  |- mesh__recordAuthorizer mesh__D007735 sjn
% 211.36/211.56  |- mesh__dateEstablished mesh__D007735 1991-01-01
% 211.36/211.56  |- skos__broader mesh__D007735smesh__D011427
% 211.36/211.56  |- skos__altLabel mesh__D007735 Diaminopropiophenone
% 211.36/211.56  |- skos__altLabel mesh__D007735 2,3-Diaminopropiophenone
% 211.36/211.56  |- skos__scopeNote mesh__D045854
% 211.36/211.56       A family of gram-negative bacteria, in the order Clostridiales.%A%    
% 211.36/211.56  |- mesh__dateRevised mesh__D045854 2005-06-30
% 211.36/211.56  |- mesh__recordOriginator mesh__D045854 ags
% 211.36/211.56  |- mesh__recordAuthorizer mesh__D045854 sjn
% 211.36/211.56  |- mesh__recordMaintainer mesh__D045854 SYSTEM
% 211.36/211.56  |- rdf__type mesh__D045854sskos__Concept
% 211.36/211.56  |- mesh__historyNote mesh__D045854 2004   
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D045854 2006
% 211.36/211.56  |- mesh__dateCreated mesh__D045854 2003-07-09
% 211.36/211.56  |- mesh__publicMeSHNote mesh__D045854 2004   
% 211.36/211.56  |- mesh__dateEstablished mesh__D045854 2004-01-01
% 211.36/211.56  |- skos__prefLabel mesh__D045854 Acidaminococcaceae
% 211.36/211.56  |- skos__broader mesh__D045854smesh__D016965
% 211.36/211.56  |- mesh__dateRevised mesh__D017365 2001-07-25
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D017365 2002
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D017365 2006
% 211.36/211.56  |- mesh__historyNote mesh__D017365
% 211.36/211.56       93; was see CONDIMENTS 1984-92; was see under CONDIMENTS 1963-82%A%  
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D017365 2003
% 211.36/211.56  |- mesh__recordOriginator mesh__D017365 TPW
% 211.36/211.56  |- skos__annotation mesh__D017365
% 211.36/211.56       coord with specific plant + specific plant component %28%if pertinent%29%; for use in therapy coord with PHYTOTHERAPY %28%IM%29% + disease /*drug ther %28%IM%29%%A%  
% 211.36/211.56  |- mesh__publicMeSHNote mesh__D017365
% 211.36/211.56       93; was see CONDIMENTS 1984-92; was see under CONDIMENTS 1963-82%A%  
% 211.36/211.56  |- mesh__dateCreated mesh__D017365 1992-05-22
% 211.36/211.56  |- skos__scopeNote mesh__D017365
% 211.36/211.56       The dried seeds, bark, root, stems, buds, leaves, or fruit of aromatic plants used to season food.%A%    
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D017365 2004
% 211.36/211.56  |- mesh__recordAuthorizer mesh__D017365 sjn
% 211.36/211.56  |- rdf__type mesh__D017365sskos__Concept
% 211.36/211.56  |- mesh__dateEstablished mesh__D017365 1993-01-01
% 211.36/211.56  |- skos__prefLabel mesh__D017365 Spices
% 211.36/211.56  |- skos__historyNote mesh__D017365 Condiments %28%1966-1992%29%
% 211.36/211.56  |- skos__hiddenLabel mesh__D017365 Spice
% 211.36/211.56  |- mesh__recordMaintainer mesh__D017365 ssb
% 211.36/211.56  |- skos__broader mesh__D017365smesh__D003212
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D017365 2005
% 211.36/211.56  |- skos__altLabel mesh__D050799 STAT5 Protein
% 211.36/211.56  |- skos__broader mesh__D050799smesh__D050791
% 211.36/211.56  |- skos__altLabel mesh__D050799
% 211.36/211.56       Signal Transducer and Activator of Transcription 5A
% 211.36/211.56  |- skos__altLabel mesh__D050799 STAT5a Protein
% 211.36/211.56  |- mesh__recordMaintainer mesh__D050799 DRC
% 211.36/211.56  |- skos__hiddenLabel mesh__D050799 Mammary Gland Specific Nuclear Factor
% 211.36/211.56  |- mesh__recordOriginator mesh__D050799 DRC
% 211.36/211.56  |- skos__altLabel mesh__D050799
% 211.36/211.56       Signal Transducer and Activator of Transcription 5
% 211.36/211.56  |- mesh__historyNote mesh__D050799 2006%28%1992%29%   
% 211.36/211.56  |- skos__altLabel mesh__D050799
% 211.36/211.56       Signal Transducer and Activator of Transcription 5B
% 211.36/211.56  |- mesh__recordAuthorizer mesh__D050799 sjn
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D050799 2006
% 211.36/211.56  |- skos__prefLabel mesh__D050799 STAT5 Transcription Factor
% 211.36/211.56  |- mesh__publicMeSHNote mesh__D050799
% 211.36/211.56       2006; STAT5 PROTEIN was indexed under DNA-BINDING PROTEINS; MILK PROTEINS; %26% TRANS-ACTIVATORS 1992-2005%A%  
% 211.36/211.56  |- mesh__dateEstablished mesh__D050799 2006-01-01
% 211.36/211.56  |- skos__hiddenLabel mesh__D050799 Transcription Factor, STAT5b
% 211.36/211.56  |- skos__altLabel mesh__D050799 STAT5b Protein
% 211.36/211.56  |- skos__hiddenLabel mesh__D050799 Factor, STAT5 Transcription
% 211.36/211.56  |- skos__altLabel mesh__D050799 STAT5beta Protein
% 211.36/211.56  |- skos__altLabel mesh__D050799 Mammary Gland Factor
% 211.36/211.56  |- rdf__type mesh__D050799sskos__Concept
% 211.36/211.56  |- skos__hiddenLabel mesh__D050799 Transcription Factor, STAT5a
% 211.36/211.56  |- skos__altLabel mesh__D050799 STAT5alpha Protein
% 211.36/211.56  |- skos__altLabel mesh__D050799 Mammary Gland-Specific Nuclear Factor
% 211.36/211.56  |- skos__hiddenLabel mesh__D050799 Transcription Factor, STAT5
% 211.36/211.56  |- skos__scopeNote mesh__D050799
% 211.36/211.56       A signal transducer and activator of transcription that mediates cellular responses to a variety of CYTOKINES. Stat5 activation is associated with transcription of CELL CYCLE regulators such as CYCLIN KINASE INHIBITOR P21 and anti-apoptotic genes such as BCL-2 GENES. Stat5 is constitutively activated in many patients with acute MYELOID LEUKEMIA.%A%    
% 211.36/211.56  |- mesh__dateCreated mesh__D050799 2005-06-30
% 211.36/211.56  |- rdf__type mesh__D003345sskos__Concept
% 211.36/211.56  |- skos__broader mesh__D003345smesh__D015062
% 211.36/211.56  |- mesh__dateRevised mesh__D003345 2003-07-09
% 211.36/211.56  |- skos__annotation mesh__D003345 /biosyn /physiol permitted   
% 211.36/211.56  |- skos__prefLabel mesh__D003345 Corticosterone
% 211.36/211.56  |- skos__broader mesh__D003345smesh__D011282
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D003345 2005
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D003345 2004
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D003345 2006
% 211.36/211.56  |- mesh__dateCreated mesh__D003345 1999-01-01
% 211.36/211.56  |- skos__scopeNote mesh__D003345
% 211.36/211.56       An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. %28%From Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 8th ed, p1437%29%%A%    
% 211.36/211.56  |- mesh__recordAuthorizer mesh__D003345 sjn
% 211.36/211.56  |- mesh__recordOriginator mesh__D003345 NLM
% 211.36/211.56  |- mesh__recordMaintainer mesh__D003345 ssb
% 211.36/211.56  |- rdf__type mesh__D008030sskos__Concept
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D008030 1994
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D008030 1993
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D008030 1999
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D008030 2005
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D008030 2004
% 211.36/211.56  |- skos__annotation mesh__D008030
% 211.36/211.56       no qualif; /adv eff = probably LIGHTNING INJURIES   
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D008030 1995
% 211.36/211.56  |- mesh__recordOriginator mesh__D008030 NLM
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D008030 1991
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D008030 2002
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D008030 2006
% 211.36/211.56  |- mesh__dateCreated mesh__D008030 1999-01-01
% 211.36/211.56  |- mesh__recordAuthorizer mesh__D008030 PLS
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D008030 2000
% 211.36/211.56  |- mesh__dateRevised mesh__D008030 1989-04-28
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D008030 1996
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D008030 1990
% 211.36/211.56  |- mesh__recordMaintainer mesh__D008030 TGC
% 211.36/211.56  |- skos__prefLabel mesh__D008030 Lightning
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D008030 2001
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D008030 1992
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D008030 1998
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D008030 1997
% 211.36/211.56  |- skos__hiddenLabel mesh__D008030 Lightnings
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D008030 2003
% 211.36/211.56  |- skos__broader mesh__D008030smesh__D014887
% 211.36/211.56  |- mesh__recordAuthorizer mesh__D013773 sjn
% 211.36/211.56  |- mesh__historyNote mesh__D013773 74   
% 211.36/211.56  |- skos__broader mesh__D013773smesh__D007093
% 211.36/211.56  |- skos__prefLabel mesh__D013773 Tetramisole
% 211.36/211.56  |- mesh__recordMaintainer mesh__D013773 ssb
% 211.36/211.56  |- mesh__dateCreated mesh__D013773 1999-01-01
% 211.36/211.56  |- skos__broader mesh__D013773smesh__D013844
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D013773 2006
% 211.36/211.56  |- mesh__dateRevised mesh__D013773 2005-06-30
% 211.36/211.56  |- mesh__publicMeSHNote mesh__D013773 74   
% 211.36/211.56  |- mesh__dateEstablished mesh__D013773 1974-01-01
% 211.36/211.56  |- rdf__type mesh__D013773sskos__Concept
% 211.36/211.56  |- mesh__recordOriginator mesh__D013773 NLM
% 211.36/211.56  |- mesh__recordAuthorizer mesh__D007736 sjn
% 211.36/211.56  |- skos__broader mesh__D007736smesh__D006912
% 211.36/211.56  |- mesh__dateRevised mesh__D007736 2000-06-21
% 211.36/211.56  |- skos__scopeNote mesh__D007736
% 211.36/211.56       A broad-spectrum excitatory amino acid antagonist used as a research tool.%A%    
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D007736 2004
% 211.36/211.56  |- mesh__dateCreated mesh__D007736 1999-01-01
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D007736 2002
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D007736 2006
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D007736 2003
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D007736 2001
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D007736 2005
% 211.36/211.56  |- mesh__recordOriginator mesh__D007736 NLM
% 211.36/211.56  |- skos__broader mesh__D007736smesh__D014977
% 211.36/211.56  |- skos__hiddenLabel mesh__D007736 Acid, Kynurenic
% 211.36/211.56  |- mesh__recordMaintainer mesh__D007736 TWD
% 211.36/211.56  |- rdf__type mesh__D007736sskos__Concept
% 211.36/211.56  |- skos__prefLabel mesh__D007736 Kynurenic Acid
% 211.36/211.56  |- skos__annotation mesh__D045855 do not confuse with ACETOBACTER   
% 211.36/211.56  |- skos__broader mesh__D045855smesh__D016988
% 211.36/211.56  |- mesh__dateEstablished mesh__D045855 2004-01-01
% 211.36/211.56  |- skos__scopeNote mesh__D045855
% 211.36/211.56       A genus of gram-negative bacteria in the family Eubacteriaceae. Species are homoacetogenic, having the ability to use CARBON DIOXIDE as an electron sink, and to reduce it producing acetate as a typical fermentation product.%A%    
% 211.36/211.56  |- rdf__type mesh__D045855sskos__Concept
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D045855 2006
% 211.36/211.56  |- mesh__dateRevised mesh__D045855 2005-06-30
% 211.36/211.56  |- skos__historyNote mesh__D045855 Gram Positive Rods %28%1981-2003%29%
% 211.36/211.56  |- mesh__dateCreated mesh__D045855 2003-07-09
% 211.36/211.56  |- mesh__recordOriginator mesh__D045855 ags
% 211.36/211.56  |- mesh__recordAuthorizer mesh__D045855 sjn
% 211.36/211.56  |- mesh__publicMeSHNote mesh__D045855 2004   
% 211.36/211.56  |- skos__prefLabel mesh__D045855 Acetobacterium
% 211.36/211.56  |- mesh__recordMaintainer mesh__D045855 SYSTEM
% 211.36/211.56  |- mesh__historyNote mesh__D045855 2004   
% 211.36/211.56  |- skos__altLabel mesh__D017366 5-HT1 Agonist
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 5 HT Agonist
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 Agonist, 5-HT1
% 211.36/211.56  |- skos__altLabel mesh__D017366 5-HT3 Agonist
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 5 HT1 Agonist
% 211.36/211.56  |- mesh__dateEstablished mesh__D017366 1993-01-01
% 211.36/211.56  |- mesh__dateRevised mesh__D017366 2005-07-01
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 5 Hydroxytrytamine Agonist
% 211.36/211.56  |- mesh__publicMeSHNote mesh__D017366 93   
% 211.36/211.56  |- mesh__recordOriginator mesh__D017366 TPW
% 211.36/211.56  |- skos__scopeNote mesh__D017366
% 211.36/211.56       Agents that have an affinity for serotonin receptors and are able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. These compounds are used as antidepressants, anxiolytics, and in the treatment of MIGRAINE DISORDERS.%A%    
% 211.36/211.56  |- skos__broader mesh__D017366smesh__D018490
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 Agonists, Serotonin Receptor
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 Agonists, 5-HT1
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 Agonist, 5-HT2
% 211.36/211.56  |- skos__altLabel mesh__D017366 Serotonin Receptor Agonists
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 Agonists, Serotonin
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 Agonist, 5-HT3
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 Agonists, 5-HT
% 211.36/211.56  |- skos__altLabel mesh__D017366 Serotonin Agonist
% 211.36/211.56  |- skos__altLabel mesh__D017366 Receptor Agonists, Serotonin
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 Receptor Agonist, Serotonin
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 5 HT Agonists
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 Agonists, 5-HT2
% 211.36/211.56  |- skos__altLabel mesh__D017366 5-Hydroxytryptamine Agonists
% 211.36/211.56  |- skos__altLabel mesh__D017366 5-HT Agonist
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 Agonist, Serotonin
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 Agonists, 5-Hydroxytryptamine
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 5 HT1 Agonists
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 5 HT2 Agonists
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 5 Hydroxytryptamine Agonists
% 211.36/211.56  |- skos__historyNote mesh__D017366 Serotonin/physiology %28%1966-1992%29%
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 Agonist, 5-Hydroxytrytamine
% 211.36/211.56  |- skos__altLabel mesh__D017366 Serotonergic Agonists
% 211.36/211.56  |- skos__altLabel mesh__D017366 5-Hydroxytrytamine Agonist
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 Agonist, 5-HT
% 211.36/211.56  |- skos__prefLabel mesh__D017366 Serotonin Agonists
% 211.36/211.56  |- skos__altLabel mesh__D017366 Serotonin Receptor Agonist
% 211.36/211.56  |- skos__altLabel mesh__D017366 Serotonergic Agonist
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 5 HT3 Agonist
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 Agonist, Serotonergic
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 5 HT2 Agonist
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 Agonist, Serotonin Receptor
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 5 HT3 Agonists
% 211.36/211.56  |- mesh__activeMeSHYear mesh__D017366 2006
% 211.36/211.56  |- skos__annotation mesh__D017366
% 211.36/211.56       GEN or unspecified; prefer specifics; do not confuse with SEROTONIN ANTAGONISTS; DF: SEROTONIN AGON or SEROTONIN AG%A%  
% 211.36/211.56  |- mesh__historyNote mesh__D017366 93   
% 211.36/211.56  |- skos__hiddenLabel mesh__D017366 Agonists, Serotonergic
% 211.36/211.56  |- mesh__dateCreated mesh__D017366 1992-05-22
% 211.36/211.56  |- rdf__type mesh__D017366sskos__Concept
% 211.36/211.57  |- skos__hiddenLabel mesh__D017366 Agonists, 5-HT3
% 211.36/211.57  |- skos__altLabel mesh__D017366 5-HT2 Agonist
% 211.36/211.57  |- skos__altLabel mesh__D017366 5-HT Agonists
% 211.36/211.57  |- mesh__recordAuthorizer mesh__D017366 sjn
% 211.36/211.57  |- mesh__recordMaintainer mesh__D017366 sjn
% 211.36/211.57  |- skos__annotation mesh__D003346 DF: CRH   
% 211.36/211.57  |- mesh__recordMaintainer mesh__D003346 ssb
% 211.36/211.57  |- skos__hiddenLabel mesh__D003346 Corticotropin Releasing Hormone
% 211.36/211.57  |- skos__hiddenLabel mesh__D003346 Factor, Corticotropin-Releasing
% 211.36/211.57  |- skos__broader mesh__D003346smesh__D010906
% 211.36/211.57  |- skos__prefLabel mesh__D003346 Corticotropin-Releasing Hormone
% 211.36/211.57  |- skos__altLabel mesh__D003346 ACTH-Releasing Factor
% 211.36/211.57  |- skos__altLabel mesh__D003346 Corticoliberin
% 211.36/211.57  |- skos__broader mesh__D003346smesh__D009479
% 211.36/211.57  |- skos__broader mesh__D003346smesh__D036361
% 211.36/211.57  |- mesh__publicMeSHNote mesh__D003346
% 211.36/211.57       90; was CORTICOTROPIN RELEASING HORMONE 1974-89; was CORTICOTROPIN RELEASING FACTOR 1968-73%A%  
% 211.36/211.57  |- skos__scopeNote mesh__D003346
% 211.36/211.57       A neuropeptide of about 41 amino acids released by the HYPOTHALAMUS that stimulates the release of CORTICOTROPIN by the ANTERIOR PITUITARY GLAND.%A%    
% 211.36/211.57  |- skos__historyNote mesh__D003346
% 211.36/211.57       Adrenocorticotropic Hormone %28%1966-1967%29%
% 211.36/211.57  |- mesh__dateEstablished mesh__D003346 1968-01-01
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D003346 2006
% 211.36/211.57  |- mesh__dateCreated mesh__D003346 1999-01-01
% 211.36/211.57  |- skos__hiddenLabel mesh__D003346 Corticotropin Releasing Hormone 41
% 211.36/211.57  |- skos__altLabel mesh__D003346 CRF-41
% 211.36/211.57  |- skos__altLabel mesh__D003346 Corticotropin-Releasing Hormone-41
% 211.36/211.57  |- skos__hiddenLabel mesh__D003346 Corticotropin Releasing Factor
% 211.36/211.57  |- skos__hiddenLabel mesh__D003346 Corticotropin Releasing Factor 41
% 211.36/211.57  |- skos__altLabel mesh__D003346 Corticotropin-Releasing Factor
% 211.36/211.57  |- skos__hiddenLabel mesh__D003346 Hormone, Corticotropin-Releasing
% 211.36/211.57  |- mesh__dateRevised mesh__D003346 2005-06-30
% 211.36/211.57  |- skos__hiddenLabel mesh__D003346 Factor, ACTH-Releasing
% 211.36/211.57  |- mesh__historyNote mesh__D003346
% 211.36/211.57       90; was CORTICOTROPIN RELEASING HORMONE 1974-89; was CORTICOTROPIN RELEASING FACTOR 1968-73%A%  
% 211.36/211.57  |- skos__altLabel mesh__D003346 Corticotropin-Releasing Factor-41
% 211.36/211.57  |- skos__hiddenLabel mesh__D003346 ACTH Releasing Factor
% 211.36/211.57  |- skos__related mesh__D003346smesh__D018019
% 211.36/211.57  |- rdf__type mesh__D003346sskos__Concept
% 211.36/211.57  |- mesh__recordOriginator mesh__D003346 NLM
% 211.36/211.57  |- mesh__recordAuthorizer mesh__D003346 sjn
% 211.36/211.57  |- skos__historyNote mesh__D003346
% 211.36/211.57       Hypothalamo-Hypophyseal System/physiology %28%1966-1967%29%
% 211.36/211.57  |- mesh__onlineNote mesh__D003346
% 211.36/211.57       use CORTICOTROPIN-RELEASING HORMONE to search CORTICOTROPIN RELEASING HORMONE 1974-89 %26% CORTICOTROPIN RELEASING FACTOR 1968-73%A%  
% 211.36/211.57  |- mesh__dateRevised mesh__D008031 2004-07-07
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D008031 2006
% 211.36/211.57  |- mesh__dateCreated mesh__D008031 1999-01-01
% 211.36/211.57  |- mesh__recordMaintainer mesh__D008031 jmp
% 211.36/211.57  |- skos__scopeNote mesh__D008031
% 211.36/211.57       The most abundant natural aromatic organic polymer found in all vascular plants. Lignin together with cellulose and hemicellulose are the major cell wall components of the fibers of all wood and grass species. Lignin is composed of coniferyl, p-coumaryl, and sinapyl alcohols in varying ratios in different plant species. %28%From Merck Index, 11th ed%29%%A%    
% 211.36/211.57  |- skos__prefLabel mesh__D008031 Lignin
% 211.36/211.57  |- skos__annotation mesh__D008031
% 211.36/211.57       do not confuse with LIGNANS; D25-26 qualif   
% 211.36/211.57  |- mesh__recordOriginator mesh__D008031 NLM
% 211.36/211.57  |- skos__broader mesh__D008031smesh__D001704
% 211.36/211.57  |- skos__broader mesh__D008031smesh__D002482
% 211.36/211.57  |- mesh__recordAuthorizer mesh__D008031 sjn
% 211.36/211.57  |- rdf__type mesh__D008031sskos__Concept
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D008031 2005
% 211.36/211.57  |- rdf__type mesh__D049448sskos__Concept
% 211.36/211.57  |- mesh__dateCreated mesh__D049448 2004-07-07
% 211.36/211.57  |- mesh__publicMeSHNote mesh__D049448 2005   
% 211.36/211.57  |- mesh__recordAuthorizer mesh__D049448 sjn
% 211.36/211.57  |- skos__historyNote mesh__D049448
% 211.36/211.57       Magnetic Resonance Imaging %28%1995-2004%29%
% 211.36/211.57  |- skos__prefLabel mesh__D049448
% 211.36/211.57       Cholangiopancreatography, Magnetic Resonance
% 211.36/211.57  |- mesh__recordMaintainer mesh__D049448 ags
% 211.36/211.57  |- mesh__historyNote mesh__D049448 2005   
% 211.36/211.57  |- skos__altLabel mesh__D049448 Magnetic Resonance Cholangiopancreatography
% 211.36/211.57  |- mesh__dateEstablished mesh__D049448 2005-01-01
% 211.36/211.57  |- skos__hiddenLabel mesh__D049448
% 211.36/211.57       Magnetic Resonance Cholangiopancreatographies
% 211.36/211.57  |- skos__scopeNote mesh__D049448
% 211.36/211.57       Non-invasive diagnostic technique for visualizing the PANCREATIC DUCTS and BILE DUCTS. It has excellent sensitivity for duct dilatation, biliary stricture, and intraductal abnormalities.%A%    
% 211.36/211.57  |- skos__hiddenLabel mesh__D049448
% 211.36/211.57       Cholangiopancreatographies, Magnetic Resonance
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D049448 2005
% 211.36/211.57  |- mesh__recordOriginator mesh__D049448 ags
% 211.36/211.57  |- skos__broader mesh__D049448smesh__D008279
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D049448 2006
% 211.36/211.57  |- skos__broader mesh__D049448smesh__D002758
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D013774 2005
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D013774 2002
% 211.36/211.57  |- mesh__historyNote mesh__D013774
% 211.36/211.57       91%28%75%29%; was see under METHANE 1975-90   
% 211.36/211.57  |- mesh__dateCreated mesh__D013774 1974-11-11
% 211.36/211.57  |- mesh__recordMaintainer mesh__D013774 CCR
% 211.36/211.57  |- skos__broader mesh__D013774smesh__D009595
% 211.36/211.57  |- skos__historyNote mesh__D013774 Nitro Compounds %28%1972-1974%29%
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D013774 2006
% 211.36/211.57  |- mesh__publicMeSHNote mesh__D013774 91; was see under METHANE 1975-90   
% 211.36/211.57  |- skos__scopeNote mesh__D013774
% 211.36/211.57       Corrosive oxidant, explosive; additive to diesel and rocket fuels; causes skin and lung irritation; proposed war gas. A useful reagent for studying the modification of specific amino acids, particularly tyrosine residues in proteins. Has also been used for studying carbanion formation and for detecting the presence of double bonds in organic compounds.%A%    
% 211.36/211.57  |- mesh__recordOriginator mesh__D013774 NLM
% 211.36/211.57  |- mesh__recordAuthorizer mesh__D013774 sjn
% 211.36/211.57  |- skos__annotation mesh__D013774 D25-26 qualif   
% 211.36/211.57  |- skos__prefLabel mesh__D013774 Tetranitromethane
% 211.36/211.57  |- rdf__type mesh__D013774sskos__Concept
% 211.36/211.57  |- skos__broader mesh__D013774smesh__D008697
% 211.36/211.57  |- mesh__dateRevised mesh__D013774 2000-06-22
% 211.36/211.57  |- skos__historyNote mesh__D013774 Methane %28%1972-1974%29%
% 211.36/211.57  |- mesh__dateEstablished mesh__D013774 1991-01-01
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D013774 2003
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D013774 2004
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D013774 2001
% 211.36/211.57  |- skos__historyNote mesh__D046150 Dwarfism %28%1976-2004%29%
% 211.36/211.57  |- mesh__dateRevised mesh__D046150 2005-06-30
% 211.36/211.57  |- mesh__dateEstablished mesh__D046150 2005-01-01
% 211.36/211.57  |- skos__hiddenLabel mesh__D046150 Dwarfism, Laron
% 211.36/211.57  |- mesh__recordOriginator mesh__D046150 lkt
% 211.36/211.57  |- mesh__recordMaintainer mesh__D046150 lkt
% 211.36/211.57  |- rdf__type mesh__D046150sskos__Concept
% 211.36/211.57  |- skos__prefLabel mesh__D046150 Laron Syndrome
% 211.36/211.57  |- skos__altLabel mesh__D046150 Laron Type Dwarfism I
% 211.36/211.57  |- skos__altLabel mesh__D046150 Laron Dwarfism
% 211.36/211.57  |- skos__scopeNote mesh__D046150
% 211.36/211.57       An autosomal recessive disorder characterized by short stature, defective GROWTH HORMONE RECEPTOR, and failure to generate INSULIN-LIKE GROWTH FACTOR I by GROWTH HORMONE. Laron syndrome is not a form of primary pituitary dwarfism %28%GROWTH HORMONE DEFICIENCY DWARFISM%29% but the result of mutation of the human GHR gene on chromosome 5.%A%    
% 211.36/211.57  |- skos__historyNote mesh__D046150
% 211.36/211.57       Receptors, Somatotropin %28%1991-2004%29%
% 211.36/211.57  |- mesh__publicMeSHNote mesh__D046150 2005   
% 211.36/211.57  |- skos__altLabel mesh__D046150 Severe GH Insensitivity
% 211.36/211.57  |- mesh__historyNote mesh__D046150 2005   
% 211.36/211.57  |- skos__altLabel mesh__D046150 Growth Hormone Insensitivity Syndrome
% 211.36/211.57  |- skos__altLabel mesh__D046150 Growth Hormone Receptor Defect
% 211.36/211.57  |- skos__hiddenLabel mesh__D046150 Syndrome, Laron
% 211.36/211.57  |- skos__altLabel mesh__D046150 Primary GH Resistance
% 211.36/211.57  |- skos__broader mesh__D046150smesh__D004392
% 211.36/211.57  |- skos__hiddenLabel mesh__D046150 GH Resistance, Primary
% 211.36/211.57  |- skos__altLabel mesh__D046150 Primary Growth Hormone Resistance
% 211.36/211.57  |- skos__historyNote mesh__D046150
% 211.36/211.57       Receptors, Cell Surface %28%1976-2004%29%
% 211.36/211.57  |- mesh__dateCreated mesh__D046150 2004-07-07
% 211.36/211.57  |- mesh__recordAuthorizer mesh__D046150 sjn
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D046150 2006
% 211.36/211.57  |- skos__historyNote mesh__D046150 Growth Hormone %28%1976-2004%29%
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007737 1997
% 211.36/211.57  |- mesh__dateCreated mesh__D007737 1999-01-01
% 211.36/211.57  |- mesh__recordMaintainer mesh__D007737 TAP
% 211.36/211.57  |- mesh__dateRevised mesh__D007737 1992-05-18
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007737 2002
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007737 1996
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007737 1999
% 211.36/211.57  |- skos__annotation mesh__D007737 an amino acid   
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007737 2004
% 211.36/211.57  |- skos__broader mesh__D007737smesh__D000596
% 211.36/211.57  |- skos__prefLabel mesh__D007737 Kynurenine
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007737 2001
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007737 1998
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007737 1993
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007737 2003
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007737 2006
% 211.36/211.57  |- mesh__recordOriginator mesh__D007737 NLM
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007737 2000
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007737 1995
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007737 2005
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007737 1994
% 211.36/211.57  |- rdf__type mesh__D007737sskos__Concept
% 211.36/211.57  |- mesh__recordAuthorizer mesh__D007737 PLS
% 211.36/211.57  |- mesh__dateCreated mesh__D032130 2002-07-03
% 211.36/211.57  |- skos__prefLabel mesh__D032130 Mimusops
% 211.36/211.57  |- rdf__type mesh__D032130sskos__Concept
% 211.36/211.57  |- skos__broader mesh__D032130smesh__D029632
% 211.36/211.57  |- mesh__dateEstablished mesh__D032130 2003-01-01
% 211.36/211.57  |- skos__annotation mesh__D032130
% 211.36/211.57       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.36/211.57  |- mesh__historyNote mesh__D032130 2003   
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D032130 2003
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D032130 2004
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D032130 2005
% 211.36/211.57  |- skos__scopeNote mesh__D032130
% 211.36/211.57       A plant genus of the family SAPOTACEAE. Members contain triterpenoid saponins. Latex from bark incisions is processed into gutta balata.%A%    
% 211.36/211.57  |- mesh__publicMeSHNote mesh__D032130 2003   
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D032130 2006
% 211.36/211.57  |- skos__historyNote mesh__D045856
% 211.36/211.57       Gram-Negative Anaerobic Bacteria %28%1975-2003%29%
% 211.36/211.57  |- mesh__historyNote mesh__D045856 2004   
% 211.36/211.57  |- skos__prefLabel mesh__D045856 Butyrivibrio
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D045856 2006
% 211.36/211.57  |- rdf__type mesh__D045856sskos__Concept
% 211.36/211.57  |- mesh__dateCreated mesh__D045856 2003-07-09
% 211.36/211.57  |- skos__broader mesh__D045856smesh__D016965
% 211.36/211.57  |- skos__broader mesh__D045856smesh__D016988
% 211.36/211.57  |- mesh__publicMeSHNote mesh__D045856 2004   
% 211.36/211.57  |- mesh__dateEstablished mesh__D045856 2004-01-01
% 211.36/211.57  |- mesh__recordMaintainer mesh__D045856 SYSTEM
% 211.36/211.57  |- mesh__dateRevised mesh__D045856 2005-06-30
% 211.36/211.57  |- mesh__recordAuthorizer mesh__D045856 sjn
% 211.36/211.57  |- skos__scopeNote mesh__D045856
% 211.36/211.57       A species of anaerobic bacteria, in the family Lachnospiraceae, found in RUMINANTS. It is considered both gram-positive and gram-negative.%A%    
% 211.36/211.57  |- mesh__recordOriginator mesh__D045856 ags
% 211.36/211.57  |- skos__annotation mesh__D045856
% 211.36/211.57       infection: coord IM with BACTERIAL INFECTIONS %28%IM%29%   
% 211.36/211.57  |- skos__broader mesh__D017367smesh__D014179
% 211.36/211.57  |- skos__related mesh__D017367smesh__D018687
% 211.36/211.57  |- skos__altLabel mesh__D017367 Inhibitors, Serotonin Reuptake
% 211.36/211.57  |- mesh__dateRevised mesh__D017367 2005-06-30
% 211.36/211.57  |- skos__altLabel mesh__D017367 5-Hydroxytryptamine Uptake Inhibitors
% 211.36/211.57  |- skos__altLabel mesh__D017367 Uptake Inhibitors, 5-Hydroxytryptamine
% 211.36/211.57  |- rdf__type mesh__D017367sskos__Concept
% 211.36/211.57  |- skos__altLabel mesh__D017367 Reuptake Inhibitors, Serotonin
% 211.36/211.57  |- mesh__dateCreated mesh__D017367 1992-05-22
% 211.36/211.57  |- skos__hiddenLabel mesh__D017367 5 Hydroxytryptamine Uptake Inhibitors
% 211.36/211.57  |- mesh__dateEstablished mesh__D017367 1993-01-01
% 211.36/211.57  |- skos__related mesh__D017367smesh__D018759
% 211.36/211.57  |- skos__altLabel mesh__D017367 Inhibitors, 5-Hydroxytryptamine Uptake
% 211.36/211.57  |- mesh__recordAuthorizer mesh__D017367 sjn
% 211.36/211.57  |- skos__hiddenLabel mesh__D017367 Inhibitors, 5 Hydroxytryptamine Uptake
% 211.36/211.57  |- skos__altLabel mesh__D017367 Uptake Inhibitors, 5-HT
% 211.36/211.57  |- skos__hiddenLabel mesh__D017367 Inhibitors, 5 HT Uptake
% 211.36/211.57  |- mesh__recordMaintainer mesh__D017367 ssb
% 211.36/211.57  |- skos__altLabel mesh__D017367 Inhibitors, Serotonin Uptake
% 211.36/211.57  |- skos__altLabel mesh__D017367 Inhibitors, 5-HT Uptake
% 211.36/211.57  |- skos__annotation mesh__D017367
% 211.36/211.57       GEN or unspecified; prefer specifics; do not confuse with SEROTONIN ANTAGONISTS; DF: SEROTONIN UPTAKE INHIB%A%  
% 211.36/211.57  |- skos__historyNote mesh__D017367 Serotonin Antagonists %28%1978-1992%29%
% 211.36/211.57  |- skos__altLabel mesh__D017367 5-HT Uptake Inhibitors
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D017367 2006
% 211.36/211.57  |- skos__hiddenLabel mesh__D017367 Uptake Inhibitors, 5 Hydroxytryptamine
% 211.36/211.57  |- skos__altLabel mesh__D017367 Uptake Inhibitors, Serotonin
% 211.36/211.57  |- skos__broader mesh__D017367smesh__D018490
% 211.36/211.57  |- skos__hiddenLabel mesh__D017367 5 HT Uptake Inhibitors
% 211.36/211.57  |- mesh__recordOriginator mesh__D017367 TPW
% 211.36/211.57  |- mesh__publicMeSHNote mesh__D017367 93   
% 211.36/211.57  |- skos__scopeNote mesh__D017367
% 211.36/211.57       Compounds that specifically inhibit the reuptake of serotonin in the brain. This increases the serotonin concentration in the synaptic cleft which then activates serotonin receptors to a greater extent. These agents have been used in treatment of depression, panic disorder, obsessive-compulsive behavior, and alcoholism, as analgesics, and to treat obesity and bulimia. Many of the ADRENERGIC UPTAKE INHIBITORS also inhibit serotonin uptake; they are not included here.%A%    
% 211.36/211.57  |- skos__hiddenLabel mesh__D017367 Uptake Inhibitors, 5 HT
% 211.36/211.57  |- skos__prefLabel mesh__D017367 Serotonin Uptake Inhibitors
% 211.36/211.57  |- mesh__historyNote mesh__D017367 93   
% 211.36/211.57  |- skos__altLabel mesh__D017367 Serotonin Reuptake Inhibitors
% 211.36/211.57  |- rdf__type mesh__D008830sskos__Concept
% 211.36/211.57  |- skos__broader mesh__D008830smesh__D003594
% 211.36/211.57  |- mesh__recordOriginator mesh__D008830 NLM
% 211.36/211.57  |- mesh__dateEstablished mesh__D008830 1984-01-01
% 211.36/211.57  |- mesh__recordAuthorizer mesh__D008830 ags
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D008830 2006A
% 211.36/211.57  |- skos__historyNote mesh__D008830 Organoids %28%1966-1972%29%
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D008830 2005
% 211.36/211.57  |- mesh__dateCreated mesh__D008830 1999-01-01
% 211.36/211.57  |- mesh__recordMaintainer mesh__D008830 ags
% 211.36/211.57  |- skos__scopeNote mesh__D008830
% 211.36/211.57       Electron-dense cytoplasmic particles bounded by a single membrane, such as PEROXISOMES; GLYOXYSOMES; and glycosomes.%A%    
% 211.36/211.57  |- skos__prefLabel mesh__D008830 Microbodies
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D008830 2006
% 211.36/211.57  |- skos__hiddenLabel mesh__D008830 Glycosome
% 211.36/211.57  |- mesh__historyNote mesh__D008830
% 211.36/211.57       84%28%73%29%; was see under ORGANOIDS 1975-83   
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D008830 2004
% 211.36/211.57  |- mesh__publicMeSHNote mesh__D008830
% 211.36/211.57       84; was see under ORGANOIDS 1975-83   
% 211.36/211.57  |- mesh__dateRevised mesh__D008830 2005-07-22
% 211.36/211.57  |- skos__hiddenLabel mesh__D008830 Microbody
% 211.36/211.57  |- mesh__dateRevised mesh__D022501 2005-06-30
% 211.36/211.57  |- mesh__publicMeSHNote mesh__D022501 2001   
% 211.36/211.57  |- mesh__recordAuthorizer mesh__D022501 sjn
% 211.36/211.57  |- mesh__dateEstablished mesh__D022501 2001-01-01
% 211.36/211.57  |- skos__prefLabel mesh__D022501 Marek Disease Vaccines
% 211.36/211.57  |- skos__scopeNote mesh__D022501
% 211.36/211.57       Vaccines or candidate vaccines used to prevent MAREK DISEASE, an avian disease caused by a herpesvirus.%A%    
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D022501 2006
% 211.36/211.57  |- skos__altLabel mesh__D022501 Marek%27%s Disease Vaccines
% 211.36/211.57  |- rdf__type mesh__D022501sskos__Concept
% 211.36/211.57  |- skos__historyNote mesh__D022501 Viral Vaccines %28%1970-2000%29%
% 211.36/211.57  |- mesh__historyNote mesh__D022501 2001   
% 211.36/211.57  |- mesh__dateCreated mesh__D022501 2000-06-22
% 211.36/211.57  |- skos__broader mesh__D022501smesh__D022283
% 211.36/211.57  |- skos__hiddenLabel mesh__D022501 Vaccines, Marek%27%s Disease
% 211.36/211.57  |- skos__hiddenLabel mesh__D022501 Disease Vaccines, Marek
% 211.36/211.57  |- skos__hiddenLabel mesh__D022501 Vaccines, Marek Disease
% 211.36/211.57  |- mesh__recordMaintainer mesh__D022501 ssb
% 211.36/211.57  |- skos__hiddenLabel mesh__D022501 Mareks Disease Vaccines
% 211.36/211.57  |- mesh__recordOriginator mesh__D022501 ags
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D008032 2006A
% 211.36/211.57  |- skos__prefLabel mesh__D008032 Limbic System
% 211.36/211.57  |- skos__hiddenLabel mesh__D008032 Limbic Systems
% 211.36/211.57  |- rdf__type mesh__D008032sskos__Concept
% 211.36/211.57  |- skos__broader mesh__D008032smesh__D001921
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D008032 2005
% 211.36/211.57  |- skos__scopeNote mesh__D008032
% 211.36/211.57       A set of forebrain structures common to all mammals that is defined functionally and anatomically. It is implicated in the higher integration of visceral, olfactory, and somatic information as well as homeostatic responses including fundamental survival behaviors %28%feeding, mating, emotion%29%. For most authors, it includes the AMYGDALA; EPITHALAMUS; GYRUS CINGULI; hippocampal formation %28%see HIPPOCAMPUS%29%; HYPOTHALAMUS; PARAHIPPOCAMPAL GYRUS; SEPTAL NUCLEI; anterior nuclear group of thalamus, and portions of the basal ganglia. %28%Parent, Carpenter%27%s Human Neuroanatomy, 9th ed, p744; NeuroNames, http://rprcsgi.rprc.washington.edu/neuronames/index.html %28%September 2, 1998%29%%29%.%A%    
% 211.36/211.57  |- mesh__dateCreated mesh__D008032 1999-01-01
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D008032 2006
% 211.36/211.57  |- mesh__recordOriginator mesh__D008032 NLM
% 211.36/211.57  |- mesh__dateRevised mesh__D008032 2005-07-07
% 211.36/211.57  |- mesh__recordAuthorizer mesh__D008032 ags
% 211.36/211.57  |- mesh__recordMaintainer mesh__D008032 ags
% 211.36/211.57  |- skos__hiddenLabel mesh__D008032 Systems, Limbic
% 211.36/211.57  |- skos__hiddenLabel mesh__D008032 System, Limbic
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D049449 2006
% 211.36/211.57  |- skos__altLabel mesh__D049449 Luminescence, Physical
% 211.36/211.57  |- mesh__recordAuthorizer mesh__D049449 sjn
% 211.36/211.57  |- mesh__dateCreated mesh__D049449 2004-07-07
% 211.36/211.57  |- mesh__recordMaintainer mesh__D049449 ssb
% 211.36/211.57  |- mesh__recordOriginator mesh__D049449 ssb
% 211.36/211.57  |- mesh__publicMeSHNote mesh__D049449
% 211.36/211.57       2006; see LUMINESCENCE, PHYSICAL 2005-2006; for CHEMILUMENCENCE see CHEMILUMINESCENCE, PHYSICAL 2005-2006%A%  
% 211.36/211.57  |- mesh__dateEstablished mesh__D049449 2005-01-01
% 211.36/211.57  |- skos__hiddenLabel mesh__D049449 Physical Luminescence
% 211.36/211.57  |- mesh__dateRevised mesh__D049449 2005-06-30
% 211.36/211.57  |- skos__historyNote mesh__D049449
% 211.36/211.57       Luminescent Measurements %28%1964-2004%29%
% 211.36/211.57  |- skos__broader mesh__D049449smesh__D008027
% 211.36/211.57  |- rdf__type mesh__D049449sskos__Concept
% 211.36/211.57  |- skos__altLabel mesh__D049449 Chemiluminescence, Physical
% 211.36/211.57  |- skos__scopeNote mesh__D049449
% 211.36/211.57       Emission of LIGHT when ELECTRONS return to the electronic ground state from an excited state and lose the energy as PHOTONS. It is sometimes called cool light in contrast to INCANDESCENCE. LUMINESCENT MEASUREMENTS take advantage of this type of light emitted from LUMINESCENT AGENTS.%A%    
% 211.36/211.57  |- skos__prefLabel mesh__D049449 Luminescence
% 211.36/211.57  |- mesh__historyNote mesh__D049449 2006   
% 211.36/211.57  |- skos__hiddenLabel mesh__D049449 Physical Chemiluminescence
% 211.36/211.57  |- skos__hiddenLabel mesh__D013775 Ammonium Salt Tetraphenylborate
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D013775 2001
% 211.36/211.57  |- skos__historyNote mesh__D013775 Boron Compounds %28%1973-1974%29%
% 211.36/211.57  |- skos__scopeNote mesh__D013775
% 211.36/211.57       An anionic compound that is used as a reagent for determination of potassium, ammonium, rubidium, and cesium ions. It also uncouples oxidative phosphorylation and forms complexes with biological materials, and is used in biological assays.%A%    
% 211.36/211.57  |- skos__altLabel mesh__D013775 Sodium Tetraphenylborate
% 211.36/211.57  |- skos__historyNote mesh__D013775 Benzene Derivatives %28%1973-1974%29%
% 211.36/211.57  |- rdf__type mesh__D013775sskos__Concept
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D013775 2002
% 211.36/211.57  |- mesh__recordMaintainer mesh__D013775 CCR
% 211.36/211.57  |- mesh__dateEstablished mesh__D013775 1991-01-01
% 211.36/211.57  |- skos__hiddenLabel mesh__D013775 Tetraphenylborate, Sodium
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D013775 2003
% 211.36/211.57  |- skos__hiddenLabel mesh__D013775 Potassium Salt Tetraphenylborate
% 211.36/211.57  |- skos__broader mesh__D013775smesh__D001894
% 211.36/211.57  |- skos__prefLabel mesh__D013775 Tetraphenylborate
% 211.36/211.57  |- mesh__dateRevised mesh__D013775 2000-06-21
% 211.36/211.57  |- mesh__recordOriginator mesh__D013775 NLM
% 211.36/211.57  |- mesh__dateCreated mesh__D013775 1974-11-19
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D013775 2004
% 211.36/211.57  |- mesh__recordAuthorizer mesh__D013775 sjn
% 211.36/211.57  |- skos__hiddenLabel mesh__D013775 Sodium Salt, Tetraphenylborate
% 211.36/211.57  |- skos__annotation mesh__D013775 D25-26 qualif   
% 211.36/211.57  |- mesh__publicMeSHNote mesh__D013775
% 211.36/211.57       91; was see under BORON COMPOUNDS 1975-90   
% 211.36/211.57  |- skos__hiddenLabel mesh__D013775 Sodium, Tetraphenylboron
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D013775 2005
% 211.36/211.57  |- skos__altLabel mesh__D013775 Kalignost
% 211.36/211.57  |- skos__altLabel mesh__D013775 Tetraphenylborate Sodium Salt
% 211.36/211.57  |- skos__altLabel mesh__D013775 Tetraphenylboron
% 211.36/211.57  |- mesh__historyNote mesh__D013775
% 211.36/211.57       91%28%75%29%; was see under BORON COMPOUNDS 1975-90   
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D013775 2006
% 211.36/211.57  |- skos__hiddenLabel mesh__D046151 Lingual Thyroids
% 211.36/211.57  |- skos__hiddenLabel mesh__D046151 Thyroid, Lingual
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D046151 2006
% 211.36/211.57  |- mesh__recordAuthorizer mesh__D046151 sjn
% 211.36/211.57  |- mesh__dateEstablished mesh__D046151 2005-01-01
% 211.36/211.57  |- mesh__historyNote mesh__D046151 2005   
% 211.36/211.57  |- skos__historyNote mesh__D046151 Thyroid Gland %28%1965-2004%29%
% 211.36/211.57  |- skos__scopeNote mesh__D046151
% 211.36/211.57       A condition characterized by the presence of rudimentary THYROID tissue at the base of the TONGUE. It is due to failed embryonic development and migration of thyroid tissue to its normal location. The lingual thyroid usually cannot maintain adequate hormone production thereby resulting in HYPOTHYROIDISM.%A%    
% 211.36/211.57  |- mesh__dateRevised mesh__D046151 2005-06-30
% 211.36/211.57  |- rdf__type mesh__D046151sskos__Concept
% 211.36/211.57  |- mesh__publicMeSHNote mesh__D046151 2005   
% 211.36/211.57  |- skos__broader mesh__D046151smesh__D050033
% 211.36/211.57  |- mesh__dateCreated mesh__D046151 2004-07-07
% 211.36/211.57  |- mesh__recordMaintainer mesh__D046151 lkt
% 211.36/211.57  |- skos__prefLabel mesh__D046151 Lingual Thyroid
% 211.36/211.57  |- skos__historyNote mesh__D046151 Tongue %28%1965-2004%29%
% 211.36/211.57  |- skos__hiddenLabel mesh__D046151 Thyroids, Lingual
% 211.36/211.57  |- mesh__recordOriginator mesh__D046151 lkt
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007738 1997
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007738 2003
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007738 2002
% 211.36/211.57  |- skos__prefLabel mesh__D007738 Kyphosis
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007738 1999
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007738 2005
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007738 2004
% 211.36/211.57  |- mesh__recordMaintainer mesh__D007738 TGC
% 211.36/211.57  |- skos__annotation mesh__D007738 a type of spinal curvature   
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007738 2006
% 211.36/211.57  |- skos__hiddenLabel mesh__D007738 Kyphoses
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007738 2000
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007738 1995
% 211.36/211.57  |- skos__scopeNote mesh__D007738
% 211.36/211.57       Abnormally increased convexity in the curvature of the thoracic spine as viewed from the side. %28%Dorland, 27th ed%29%%A%    
% 211.36/211.57  |- mesh__dateCreated mesh__D007738 1999-01-01
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007738 2001
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007738 1996
% 211.36/211.57  |- rdf__type mesh__D007738sskos__Concept
% 211.36/211.57  |- mesh__recordOriginator mesh__D007738 NLM
% 211.36/211.57  |- mesh__dateRevised mesh__D007738 1994-04-11
% 211.36/211.57  |- mesh__recordAuthorizer mesh__D007738 PLS
% 211.36/211.57  |- skos__broader mesh__D007738smesh__D013121
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D007738 1998
% 211.36/211.57  |- skos__prefLabel mesh__D018460 Fractures, Comminuted
% 211.36/211.57  |- skos__broader mesh__D018460smesh__D050723
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D018460 2006
% 211.36/211.57  |- mesh__dateRevised mesh__D018460 2005-06-30
% 211.36/211.57  |- skos__hiddenLabel mesh__D018460 Fracture, Comminuted
% 211.36/211.57  |- rdf__type mesh__D018460sskos__Concept
% 211.36/211.57  |- mesh__recordOriginator mesh__D018460 TGC
% 211.36/211.57  |- skos__hiddenLabel mesh__D018460 Comminuted Fractures
% 211.36/211.57  |- skos__scopeNote mesh__D018460
% 211.36/211.57       A fracture in which the bone is splintered or crushed. %28%Dorland, 27th ed%29%%A%    
% 211.36/211.57  |- mesh__recordMaintainer mesh__D018460 ssb
% 211.36/211.57  |- mesh__historyNote mesh__D018460 95   
% 211.36/211.57  |- mesh__dateCreated mesh__D018460 1994-04-16
% 211.36/211.57  |- skos__historyNote mesh__D018460 specific fracture %28%1966-1994%29%
% 211.36/211.57  |- mesh__publicMeSHNote mesh__D018460 95   
% 211.36/211.57  |- mesh__recordAuthorizer mesh__D018460 sjn
% 211.36/211.57  |- skos__historyNote mesh__D018460 Fractures %28%1966-1994%29%
% 211.36/211.57  |- skos__annotation mesh__D018460
% 211.36/211.57       fract where bone is splintered or crushed; IM; coord with specific organ/inj or precoord organ/fract term %28%IM%29%%A%  
% 211.36/211.57  |- skos__hiddenLabel mesh__D018460 Comminuted Fracture
% 211.36/211.57  |- mesh__dateEstablished mesh__D018460 1995-01-01
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D032131 2003
% 211.36/211.57  |- mesh__dateCreated mesh__D032131 2002-07-03
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D032131 2004
% 211.36/211.57  |- mesh__dateEstablished mesh__D032131 2003-01-01
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D032131 2005
% 211.36/211.57  |- skos__scopeNote mesh__D032131
% 211.36/211.57       A plant genus of the family SAPOTACEAE. Latex from bark incisions is processed into GUTTA-PERCHA.%A%    
% 211.36/211.57  |- mesh__historyNote mesh__D032131 2003   
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D032131 2006
% 211.36/211.57  |- mesh__publicMeSHNote mesh__D032131 2003   
% 211.36/211.57  |- skos__prefLabel mesh__D032131 Palaquium
% 211.36/211.57  |- rdf__type mesh__D032131sskos__Concept
% 211.36/211.57  |- skos__broader mesh__D032131smesh__D029632
% 211.36/211.57  |- skos__annotation mesh__D032131
% 211.36/211.57       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.36/211.57  |- skos__broader mesh__D004440smesh__D026461
% 211.36/211.57  |- mesh__recordAuthorizer mesh__D004440 sjn
% 211.36/211.57  |- mesh__recordOriginator mesh__D004440 NLM
% 211.36/211.57  |- mesh__publicMeSHNote mesh__D004440 1967   
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D004440 2005
% 211.36/211.57  |- skos__annotation mesh__D004440 do not confuse with ECDYSTERONE   
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D004440 2003
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D004440 2006
% 211.36/211.57  |- skos__scopeNote mesh__D004440
% 211.36/211.57       A steroid hormone that regulates the processes of MOLTING or ecdysis in insects.%A%    
% 211.36/211.57  |- mesh__dateEstablished mesh__D004440 1967-01-01
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D004440 2004
% 211.36/211.57  |- mesh__dateRevised mesh__D004440 2001-07-25
% 211.36/211.57  |- mesh__historyNote mesh__D004440 1967%28%1964%29%   
% 211.36/211.57  |- skos__prefLabel mesh__D004440 Ecdysone
% 211.36/211.57  |- rdf__type mesh__D004440sskos__Concept
% 211.36/211.57  |- mesh__activeMeSHYear mesh__D004440 2002
% 211.36/211.57  |- mesh__recordMaintainer mesh__D004440 lkt
% 211.36/211.57  |- skos__altLabel mesh__D004440 Molting Hormone
% 211.36/211.57  |- mesh__dateCreated mesh__D004440 1999-01-01
% 211.36/211.58  |- skos__broader mesh__D051096smesh__D011518
% 211.36/211.58  |- mesh__recordOriginator mesh__D051096 DRC
% 211.36/211.58  |- mesh__historyNote mesh__D051096 2006%28%1999%29%   
% 211.36/211.58  |- rdf__type mesh__D051096sskos__Concept
% 211.36/211.58  |- skos__altLabel mesh__D051096 Receptor Tyrosine Kinase RET
% 211.36/211.58  |- skos__hiddenLabel mesh__D051096 Proto Oncogene Proteins c ret
% 211.36/211.58  |- skos__altLabel mesh__D051096 Proto-Oncogene Protein Ret
% 211.36/211.58  |- skos__hiddenLabel mesh__D051096 c-ret, Proto-Oncogene Proteins
% 211.36/211.58  |- mesh__dateEstablished mesh__D051096 2006-01-01
% 211.36/211.58  |- mesh__publicMeSHNote mesh__D051096
% 211.36/211.58       2006; PROTO-ONCOGENE PROTEIN C-RET was indexed under PROTO-ONCOGENE PROTEINS %26% RECEPTOR PROTEIN-TYROSINE KINASES 1999-2005%A%  
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D051096 2006A
% 211.36/211.58  |- skos__scopeNote mesh__D051096
% 211.36/211.58       Receptor protein-tyrosine kinases involved in the signaling of GLIAL CELL-LINE DERIVED NEUROTROPHIC FACTOR ligands. They contain an extracellular cadherin domain and form a receptor complexes with GDNF RECEPTORS. Mutations in ret protein are responsible for HIRSCHSPRUNG DISEASE and MULTIPLE ENDOCRINE NEOPLASIA TYPE 2.%A%    
% 211.36/211.58  |- skos__hiddenLabel mesh__D051096 Proto Oncogene Protein Ret
% 211.36/211.58  |- skos__prefLabel mesh__D051096 Proto-Oncogene Proteins c-ret
% 211.36/211.58  |- skos__hiddenLabel mesh__D051096 ret Proto Oncogene Proteins
% 211.36/211.58  |- skos__hiddenLabel mesh__D051096 Proto Oncogene Protein c ret
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D051096 2006
% 211.36/211.58  |- mesh__dateRevised mesh__D051096 2005-07-15
% 211.36/211.58  |- mesh__recordMaintainer mesh__D051096 ags
% 211.36/211.58  |- mesh__recordAuthorizer mesh__D051096 ags
% 211.36/211.58  |- skos__hiddenLabel mesh__D051096 Proto-Oncogene Proteins, ret
% 211.36/211.58  |- mesh__dateCreated mesh__D051096 2005-06-30
% 211.36/211.58  |- skos__altLabel mesh__D051096 ret Proto-Oncogene Proteins
% 211.36/211.58  |- skos__broader mesh__D051096smesh__D020794
% 211.36/211.58  |- skos__altLabel mesh__D051096 Proto-Oncogene Protein c-ret
% 211.36/211.58  |- skos__hiddenLabel mesh__D051096 c-ret, Proto-Oncogene Protein
% 211.36/211.58  |- skos__altLabel mesh__D051096 c-ret Protein
% 211.36/211.58  |- skos__hiddenLabel mesh__D051096 Ret, Proto-Oncogene Protein
% 211.36/211.58  |- mesh__dateRevised mesh__D045857 2005-06-30
% 211.36/211.58  |- mesh__publicMeSHNote mesh__D045857 2004   
% 211.36/211.58  |- mesh__recordAuthorizer mesh__D045857 sjn
% 211.36/211.58  |- mesh__recordOriginator mesh__D045857 ags
% 211.36/211.58  |- skos__broader mesh__D045857smesh__D006095
% 211.36/211.58  |- mesh__recordMaintainer mesh__D045857 SYSTEM
% 211.36/211.58  |- mesh__historyNote mesh__D045857 2004   
% 211.36/211.58  |- skos__annotation mesh__D045857
% 211.36/211.58       infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 211.36/211.58  |- skos__historyNote mesh__D045857 Gram-Positive Cocci %28%1977-2003%29%
% 211.36/211.58  |- mesh__dateEstablished mesh__D045857 2004-01-01
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D045857 2006
% 211.36/211.58  |- rdf__type mesh__D045857sskos__Concept
% 211.36/211.58  |- skos__scopeNote mesh__D045857
% 211.36/211.58       A genus of gram-positive bacteria in the family Lachnospiraceae that inhabits the RUMEN; LARGE INTESTINE; and CECUM of MAMMALS.%A%    
% 211.36/211.58  |- mesh__dateCreated mesh__D045857 2003-07-09
% 211.36/211.58  |- skos__prefLabel mesh__D045857 Ruminococcus
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D017368 2005
% 211.36/211.58  |- skos__prefLabel mesh__D017368 Protein Isoprenylation
% 211.36/211.58  |- mesh__dateEstablished mesh__D017368 1993-01-01
% 211.36/211.58  |- skos__annotation mesh__D017368 a post-translational protein change   
% 211.36/211.58  |- mesh__historyNote mesh__D017368 93   
% 211.36/211.58  |- skos__altLabel mesh__D017368 Post-Translational Isoprenylation
% 211.36/211.58  |- mesh__publicMeSHNote mesh__D017368 93   
% 211.36/211.58  |- rdf__type mesh__D017368sskos__Concept
% 211.36/211.58  |- skos__scopeNote mesh__D017368
% 211.36/211.58       A post-translational modification of proteins by the attachment of an isoprenoid to the C-terminal cysteine residue. The isoprenoids used, farnesyl diphosphate or geranylgeranyl diphosphate, are derived from the same biochemical pathway that produces cholesterol.%A%    
% 211.36/211.58  |- skos__broader mesh__D017368smesh__D011499
% 211.36/211.58  |- skos__hiddenLabel mesh__D017368 Prenylation, Protein
% 211.36/211.58  |- mesh__dateCreated mesh__D017368 1992-06-03
% 211.36/211.58  |- mesh__recordOriginator mesh__D017368 TPW
% 211.36/211.58  |- skos__hiddenLabel mesh__D017368 Post Translational Isoprenylation
% 211.36/211.58  |- skos__hiddenLabel mesh__D017368 Geranylgeranylation, Protein
% 211.36/211.58  |- skos__hiddenLabel mesh__D017368 Isoprenylation, Protein
% 211.36/211.58  |- skos__altLabel mesh__D017368 Protein Prenylation
% 211.36/211.58  |- mesh__recordMaintainer mesh__D017368 nns
% 211.36/211.58  |- mesh__recordAuthorizer mesh__D017368 sjn
% 211.36/211.58  |- skos__historyNote mesh__D017368
% 211.36/211.58       Protein Processing, Post-Translational %28%1987-1992%29%
% 211.36/211.58  |- skos__hiddenLabel mesh__D017368 Farnesylation, Protein
% 211.36/211.58  |- skos__hiddenLabel mesh__D017368 Polyisoprenylation, Protein
% 211.36/211.58  |- skos__hiddenLabel mesh__D017368 Isoprenylation, Post-Translational
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D017368 2006
% 211.36/211.58  |- mesh__dateRevised mesh__D017368 2004-07-07
% 211.36/211.58  |- skos__annotation mesh__D003348 /biosyn/physiol permitted   
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D003348 2005
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D003348 2004
% 211.36/211.58  |- mesh__recordOriginator mesh__D003348 NLM
% 211.36/211.58  |- mesh__recordAuthorizer mesh__D003348 sjn
% 211.36/211.58  |- skos__broader mesh__D003348smesh__D015065
% 211.36/211.58  |- mesh__publicMeSHNote mesh__D003348
% 211.36/211.58       /adverse effects /poisoning /toxicity were CORTISONE TOXICOLOGY 1963-65; /therapeutic use was CORTISONE, THERAPEUTIC 1965%A%  
% 211.36/211.58  |- mesh__historyNote mesh__D003348
% 211.36/211.58       /adv eff-pois-tox was CORTISONE TOXICOLOGY 1963-65; /ther use was CORTISONE, THERAPEUTIC 1965%A%  
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D003348 2006
% 211.36/211.58  |- skos__prefLabel mesh__D003348 Cortisone
% 211.36/211.58  |- mesh__recordMaintainer mesh__D003348 ssb
% 211.36/211.58  |- skos__scopeNote mesh__D003348
% 211.36/211.58       A naturally occurring glucocorticoid. It has been used in replacement therapy for adrenal insufficiency and as an anti-inflammatory agent. Cortisone itself is inactive. It is converted in the liver to the active metabolite HYDROCORTISONE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p726%29%%A%    
% 211.36/211.58  |- rdf__type mesh__D003348sskos__Concept
% 211.36/211.58  |- skos__broader mesh__D003348smesh__D011283
% 211.36/211.58  |- mesh__dateRevised mesh__D003348 2003-07-09
% 211.36/211.58  |- mesh__dateCreated mesh__D003348 1999-01-01
% 211.36/211.58  |- mesh__publicMeSHNote mesh__D014070
% 211.36/211.58       65; was TEETH 1963-64; /transplantation was TOOTH TRANSPLANTATION 1965%A%  
% 211.36/211.58  |- mesh__dateCreated mesh__D014070 1999-01-01
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D014070 2006
% 211.36/211.58  |- skos__related mesh__D014070smesh__D009805
% 211.36/211.58  |- mesh__dateRevised mesh__D014070 2003-07-09
% 211.36/211.58  |- skos__related mesh__D014070smesh__D003817
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D014070 2005
% 211.36/211.58  |- skos__prefLabel mesh__D014070 Tooth
% 211.36/211.58  |- mesh__recordOriginator mesh__D014070 NLM
% 211.36/211.58  |- mesh__recordAuthorizer mesh__D014070 sjn
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D014070 2004
% 211.36/211.58  |- skos__related mesh__D014070smesh__D008409
% 211.36/211.58  |- rdf__type mesh__D014070sskos__Concept
% 211.36/211.58  |- mesh__recordMaintainer mesh__D014070 lkt
% 211.36/211.58  |- mesh__historyNote mesh__D014070
% 211.36/211.58       65; was TEETH 1963-64; /transplantation was TOOTH TRANSPLANTATION 1965%A%  
% 211.36/211.58  |- mesh__dateEstablished mesh__D014070 1965-01-01
% 211.36/211.58  |- skos__broader mesh__D014070smesh__D003817
% 211.36/211.58  |- skos__altLabel mesh__D014070 Teeth
% 211.36/211.58  |- skos__related mesh__D014070smesh__D008310
% 211.36/211.58  |- mesh__considerAlso mesh__D014070
% 211.36/211.58       consider also terms at DENT- and ODONTO-   
% 211.36/211.58  |- skos__annotation mesh__D014070
% 211.36/211.58       /embryol: consider also TOOTH GERM %26% ODONTOGENESIS; /ph permitted but consider DENTAL PHYSIOLOGY for function of dentition as a whole; tooth size %26% dimension = TOOTH /anat %28%IM%29% + ODONTOMETRY %28%NIM%29%; permanent tooth = TOOTH, deciduous tooth = TOOTH, DECIDUOUS; tooth pain = TOOTHACHE; tooth avulsion or luxation = TOOTH AVULSION; tooth socket: index under ALVEOLAR PROCESS; tooth sensitivity = DENTIN SENSITIVITY%A%  
% 211.36/211.58  |- skos__related mesh__D014070smesh__D010161
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D008831 2002
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D008831 2005
% 211.36/211.58  |- mesh__dateCreated mesh__D008831 1999-01-01
% 211.36/211.58  |- skos__hiddenLabel mesh__D008831 Microcephalies
% 211.36/211.58  |- skos__broader mesh__D008831smesh__D019465
% 211.36/211.58  |- skos__scopeNote mesh__D008831
% 211.36/211.58       Abnormal smallness of the head, usually associated with mental retardation. %28%Dorland, 27th ed%29%%A%    
% 211.36/211.58  |- mesh__recordOriginator mesh__D008831 NLM
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D008831 2003
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D008831 2006
% 211.36/211.58  |- skos__annotation mesh__D008831
% 211.36/211.58       abnormally small head; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 211.36/211.58  |- mesh__dateRevised mesh__D008831 1999-11-03
% 211.36/211.58  |- mesh__recordAuthorizer mesh__D008831 sjn
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D008831 2004
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D008831 2000
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D008831 2001
% 211.36/211.58  |- rdf__type mesh__D008831sskos__Concept
% 211.36/211.58  |- mesh__recordMaintainer mesh__D008831 kle
% 211.36/211.58  |- skos__prefLabel mesh__D008831 Microcephaly
% 211.36/211.58  |- mesh__dateCreated mesh__D022502 2000-06-22
% 211.36/211.58  |- mesh__publicMeSHNote mesh__D022502 2001   
% 211.36/211.58  |- skos__historyNote mesh__D022502 Cytoskeleton %28%1978-2000%29%
% 211.36/211.58  |- mesh__dateEstablished mesh__D022502 2001-01-01
% 211.36/211.58  |- skos__hiddenLabel mesh__D022502 Fibers, Stress
% 211.36/211.58  |- skos__broader mesh__D022502smesh__D008841
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D022502 2005
% 211.36/211.58  |- mesh__historyNote mesh__D022502 2001   
% 211.36/211.58  |- skos__historyNote mesh__D022502 Actins %28%1978-2000%29%
% 211.36/211.58  |- skos__hiddenLabel mesh__D022502 Stress Fiber
% 211.36/211.58  |- skos__prefLabel mesh__D022502 Stress Fibers
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D022502 2006
% 211.36/211.58  |- rdf__type mesh__D022502sskos__Concept
% 211.36/211.58  |- skos__hiddenLabel mesh__D022502 Stress Fibre
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D022502 2004
% 211.36/211.58  |- skos__hiddenLabel mesh__D022502 Fiber, Stress
% 211.36/211.58  |- skos__scopeNote mesh__D022502
% 211.36/211.58       Bundles of actin filaments %28%MICROFILAMENTS%29% and myosin-II that span across the cell attaching to the cell membrane at FOCAL ADHESIONS and to the network of INTERMEDIATE FILAMENTS that surrounds the nucleus.%A%    
% 211.36/211.58  |- mesh__dateRevised mesh__D022502 2003-07-09
% 211.36/211.58  |- skos__hiddenLabel mesh__D022502 Fibre, Stress
% 211.36/211.58  |- skos__altLabel mesh__D022502 Stress Fibres
% 211.36/211.58  |- skos__hiddenLabel mesh__D022502 Fibres, Stress
% 211.36/211.58  |- mesh__recordMaintainer mesh__D008033 PXP
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D008033 2002
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D008033 2003
% 211.36/211.58  |- rdf__type mesh__D008033sskos__Concept
% 211.36/211.58  |- mesh__recordAuthorizer mesh__D008033 sjn
% 211.36/211.58  |- skos__broader mesh__D008033smesh__D001431
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D008033 2004
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D008033 2005
% 211.36/211.58  |- mesh__dateCreated mesh__D008033 1977-04-27
% 211.36/211.58  |- skos__broader mesh__D008033smesh__D019963
% 211.36/211.58  |- mesh__dateRevised mesh__D008033 2000-06-22
% 211.36/211.58  |- skos__prefLabel mesh__D008033 Limulus Test
% 211.36/211.58  |- skos__historyNote mesh__D008033 Endotoxins %28%1966-1977%29%
% 211.36/211.58  |- skos__hiddenLabel mesh__D008033 Limulus Tests
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D008033 2006
% 211.36/211.58  |- skos__annotation mesh__D008033
% 211.36/211.58       for detection of bact endotoxins using horseshoe crab blood%A%  
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D008033 2001
% 211.36/211.58  |- skos__scopeNote mesh__D008033
% 211.36/211.58       Sensitive method for detection of bacterial endotoxins and endotoxin-like substances that depends on the in vitro gelation of Limulus amebocyte lysate %28%LAL%29%, prepared from the circulating blood %28%amebocytes%29% of the horseshoe crab, by the endotoxin or related compound. Used for detection of endotoxin in body fluids and parenteral pharmaceuticals.%A%    
% 211.36/211.58  |- skos__broader mesh__D008033smesh__D001681
% 211.36/211.58  |- mesh__recordOriginator mesh__D008033 SMH
% 211.36/211.58  |- skos__hiddenLabel mesh__D008033 Test, Limulus
% 211.36/211.58  |- mesh__publicMeSHNote mesh__D008033 78   
% 211.36/211.58  |- skos__hiddenLabel mesh__D008033 Tests, Limulus
% 211.36/211.58  |- mesh__dateEstablished mesh__D008033 1978-01-01
% 211.36/211.58  |- mesh__historyNote mesh__D008033 78   
% 211.36/211.58  |- mesh__dateRevised mesh__D000050 2003-07-09
% 211.36/211.58  |- skos__prefLabel mesh__D000050 Acanthocytes
% 211.36/211.58  |- mesh__recordAuthorizer mesh__D000050 sjn
% 211.36/211.58  |- skos__scopeNote mesh__D000050
% 211.36/211.58       Erythrocytes with protoplasmic projections giving the cell a thorny appearance.%A%    
% 211.36/211.58  |- skos__annotation mesh__D000050 A 11 qualif   
% 211.36/211.58  |- mesh__recordMaintainer mesh__D000050 nns
% 211.36/211.58  |- mesh__dateCreated mesh__D000050 1974-11-11
% 211.36/211.58  |- mesh__recordOriginator mesh__D000050 NLM
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D000050 2004
% 211.36/211.58  |- mesh__publicMeSHNote mesh__D000050
% 211.36/211.58       91; was see under ERYTHROCYTES, ABNORMAL 1975-90   
% 211.36/211.58  |- mesh__historyNote mesh__D000050
% 211.36/211.58       91%28%75%29%; was see under ERYTHROCYTES, ABNORMAL 1975-90   
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D000050 2006
% 211.36/211.58  |- skos__broader mesh__D000050smesh__D004913
% 211.36/211.58  |- skos__hiddenLabel mesh__D000050 Acanthocyte
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D000050 2005
% 211.36/211.58  |- rdf__type mesh__D000050sskos__Concept
% 211.36/211.58  |- mesh__dateEstablished mesh__D000050 1991-01-01
% 211.36/211.58  |- skos__prefLabel mesh__D046950 Thermoanaerobacterium
% 211.36/211.58  |- mesh__recordOriginator mesh__D046950 ags
% 211.36/211.58  |- skos__annotation mesh__D046950 do not confuse with THERMOANAEROBACTER   
% 211.36/211.58  |- skos__historyNote mesh__D046950 Bacteria, Anaerobic %28%1985-2004%29%
% 211.36/211.58  |- mesh__recordMaintainer mesh__D046950 ags
% 211.36/211.58  |- skos__broader mesh__D046950smesh__D016988
% 211.36/211.58  |- skos__scopeNote mesh__D046950
% 211.36/211.58       A genus of gram-negative, anaerobic bacteria in the family Thermoanaerobacteriaceae. They are thermophilic and saccharolytic.%A%    
% 211.36/211.58  |- mesh__dateRevised mesh__D046950 2005-08-02
% 211.36/211.58  |- mesh__dateCreated mesh__D046950 2004-07-07
% 211.36/211.58  |- mesh__dateEstablished mesh__D046950 2005-01-01
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D046950 2006A
% 211.36/211.58  |- mesh__recordAuthorizer mesh__D046950 ags
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D046950 2006
% 211.36/211.58  |- rdf__type mesh__D046950sskos__Concept
% 211.36/211.58  |- mesh__publicMeSHNote mesh__D046950 2005   
% 211.36/211.58  |- mesh__historyNote mesh__D046950 2005   
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D013776 2006
% 211.36/211.58  |- rdf__type mesh__D013776sskos__Concept
% 211.36/211.58  |- skos__hiddenLabel mesh__D013776 Tetrathionate, Sodium
% 211.36/211.58  |- mesh__dateEstablished mesh__D013776 1991-01-01
% 211.36/211.58  |- skos__prefLabel mesh__D013776 Tetrathionic Acid
% 211.36/211.58  |- mesh__dateRevised mesh__D013776 2002-07-02
% 211.36/211.58  |- skos__scopeNote mesh__D013776
% 211.36/211.58       A sulfuric acid dimer, formed by disulfide linkage. This compound has been used to prolong coagulation time and as an antidote in cyanide poisoning.%A%    
% 211.36/211.58  |- mesh__recordOriginator mesh__D013776 NLM
% 211.36/211.58  |- mesh__historyNote mesh__D013776
% 211.36/211.58       91%28%75%29%; was see under THIOSULFATES 1975-90   
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D013776 2003
% 211.36/211.58  |- mesh__recordAuthorizer mesh__D013776 sjn
% 211.36/211.58  |- mesh__dateCreated mesh__D013776 1974-11-19
% 211.36/211.58  |- mesh__recordMaintainer mesh__D013776 ags
% 211.36/211.58  |- skos__hiddenLabel mesh__D013776 Tetrathionate, Potassium
% 211.36/211.58  |- skos__annotation mesh__D013776 D25-26 qualif   
% 211.36/211.58  |- skos__historyNote mesh__D013776 Thiosulfates %28%1970-1974%29%
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D013776 2004
% 211.36/211.58  |- skos__broader mesh__D013776smesh__D013464
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D013776 2005
% 211.36/211.58  |- mesh__publicMeSHNote mesh__D013776
% 211.36/211.58       91; was see under THIOSULFATES 1975-90   
% 211.36/211.58  |- skos__hiddenLabel mesh__D046152 Stromal Tumor, Gastrointestinal
% 211.36/211.58  |- skos__hiddenLabel mesh__D046152 Neoplasm, Gastrointestinal Stromal
% 211.36/211.58  |- skos__hiddenLabel mesh__D046152 Gastrointestinal Stromal Neoplasm
% 211.36/211.58  |- skos__hiddenLabel mesh__D046152 Neoplasms, Gastrointestinal Stromal
% 211.36/211.58  |- skos__scopeNote mesh__D046152
% 211.36/211.58       All tumors in the GASTROINTESTINAL TRACT arising from mesenchymal cells %28%MESODERM%29% except those of smooth muscle cells %28%LEIOMYOMA%29% or SCHWANN CELLS %28%SCHWANNOMA%29%.%A%    
% 211.36/211.58  |- skos__hiddenLabel mesh__D046152 Gastrointestinal Stromal Tumor
% 211.36/211.58  |- rdf__type mesh__D046152sskos__Concept
% 211.36/211.58  |- mesh__publicMeSHNote mesh__D046152 2005   
% 211.36/211.58  |- skos__historyNote mesh__D046152
% 211.36/211.58       Digestive System Neoplasms %28%1988-2004%29%
% 211.36/211.58  |- mesh__dateCreated mesh__D046152 2004-07-07
% 211.36/211.58  |- mesh__dateEstablished mesh__D046152 2005-01-01
% 211.36/211.58  |- mesh__historyNote mesh__D046152 2005   
% 211.36/211.58  |- mesh__recordAuthorizer mesh__D046152 sjn
% 211.36/211.58  |- skos__hiddenLabel mesh__D046152 Stromal Neoplasms, Gastrointestinal
% 211.36/211.58  |- mesh__recordOriginator mesh__D046152 lkt
% 211.36/211.58  |- mesh__dateRevised mesh__D046152 2005-06-30
% 211.36/211.58  |- skos__altLabel mesh__D046152 Gastrointestinal Stromal Neoplasms
% 211.36/211.58  |- skos__hiddenLabel mesh__D046152 Stromal Neoplasm, Gastrointestinal
% 211.36/211.58  |- skos__broader mesh__D046152smesh__D005770
% 211.36/211.58  |- skos__historyNote mesh__D046152
% 211.36/211.58       Gastrointestinal Neoplasms %28%1987-2004%29%
% 211.36/211.58  |- skos__hiddenLabel mesh__D046152 Stromal Tumors, Gastrointestinal
% 211.36/211.58  |- skos__prefLabel mesh__D046152 Gastrointestinal Stromal Tumors
% 211.36/211.58  |- mesh__recordMaintainer mesh__D046152 lkt
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D046152 2006
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D007739 2005
% 211.36/211.58  |- mesh__recordOriginator mesh__D007739 NLM
% 211.36/211.58  |- skos__hiddenLabel mesh__D007739 Cell, L %28%Cell Line%29%
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D007739 2004
% 211.36/211.58  |- skos__broader mesh__D007739smesh__D005347
% 211.36/211.58  |- skos__annotation mesh__D007739
% 211.36/211.58       almost always NIM with no subheadings; check ANIMALS %26% MICE; do not routinely add FIBROBLASTS%A%  
% 211.36/211.58  |- skos__hiddenLabel mesh__D007739 L Cell %28%Cell Line%29%
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D007739 2006
% 211.36/211.58  |- mesh__dateRevised mesh__D007739 2003-07-30
% 211.36/211.58  |- mesh__dateEstablished mesh__D007739 1966-01-01
% 211.36/211.58  |- mesh__recordAuthorizer mesh__D007739 sjn
% 211.36/211.58  |- mesh__dateCreated mesh__D007739 1999-01-01
% 211.36/211.58  |- rdf__type mesh__D007739sskos__Concept
% 211.36/211.58  |- skos__scopeNote mesh__D007739
% 211.36/211.58       A cultured line of C3H mouse FIBROBLASTS that do not adhere to one another and do not express CADHERINS.%A%    
% 211.36/211.58  |- skos__hiddenLabel mesh__D007739 Cells, L %28%Cell Line%29%
% 211.36/211.58  |- mesh__historyNote mesh__D007739 98%28%64%29%   
% 211.36/211.58  |- mesh__publicMeSHNote mesh__D007739 98; see L CELLS 1966-97   
% 211.36/211.58  |- mesh__recordMaintainer mesh__D007739 nns
% 211.36/211.58  |- skos__prefLabel mesh__D007739 L Cells %28%Cell Line%29%
% 211.36/211.58  |- skos__broader mesh__D007739smesh__D002460
% 211.36/211.58  |- mesh__publicMeSHNote mesh__D018461 95   
% 211.36/211.58  |- mesh__recordAuthorizer mesh__D018461 sjn
% 211.36/211.58  |- skos__hiddenLabel mesh__D018461 Soft Tissue Infection
% 211.36/211.58  |- mesh__recordMaintainer mesh__D018461 sjn
% 211.36/211.58  |- skos__altLabel mesh__D018461 Infections, Soft Tissue
% 211.36/211.58  |- mesh__historyNote mesh__D018461 95   
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D018461 2006
% 211.36/211.58  |- mesh__dateRevised mesh__D018461 2004-07-13
% 211.36/211.58  |- skos__broader mesh__D018461smesh__D007239
% 211.36/211.58  |- skos__hiddenLabel mesh__D018461 Infection, Soft Tissue
% 211.36/211.58  |- rdf__type mesh__D018461sskos__Concept
% 211.36/211.58  |- skos__annotation mesh__D018461
% 211.36/211.58       GEN or unspecified soft tissue; coord IM with organism/infect precoord %28%IM%29%; DF: SOFT TISSUE INFECT%A%  
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D018461 2005
% 211.36/211.58  |- mesh__recordOriginator mesh__D018461 TGC
% 211.36/211.58  |- skos__related mesh__D018461smesh__D012874
% 211.36/211.58  |- skos__scopeNote mesh__D018461
% 211.36/211.58       Infections of non-skeletal tissue, i.e., exclusive of bone, ligaments, cartilage, and fibrous tissue. The concept is usually referred to as skin and soft tissue infections and usually subcutaneous and muscle tissue are involved. The predisposing factors in anaerobic infections are trauma, ischemia, and surgery. The organisms often derive from the fecal or oral flora, particularly in wounds associated with intestinal surgery, decubitus ulcer, and human bites. %28%From Cecil Textbook of Medicine, 19th ed, p1688%29%%A%    
% 211.36/211.58  |- skos__prefLabel mesh__D018461 Soft Tissue Infections
% 211.36/211.58  |- mesh__dateEstablished mesh__D018461 1995-01-01
% 211.36/211.58  |- mesh__dateCreated mesh__D018461 1994-04-16
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D032132 2005
% 211.36/211.58  |- mesh__dateCreated mesh__D032132 2002-07-03
% 211.36/211.58  |- skos__scopeNote mesh__D032132
% 211.36/211.58       A plant genus of the family SAPOTACEAE.  Members contain triterpenes. Some species in this genus are called mamey which is also a common name for MAMMEA.%A%    
% 211.36/211.58  |- rdf__type mesh__D032132sskos__Concept
% 211.36/211.58  |- skos__prefLabel mesh__D032132 Pouteria
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D032132 2004
% 211.36/211.58  |- mesh__historyNote mesh__D032132 2003   
% 211.36/211.58  |- skos__annotation mesh__D032132
% 211.36/211.58       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D032132 2003
% 211.36/211.58  |- skos__broader mesh__D032132smesh__D029632
% 211.36/211.58  |- skos__altLabel mesh__D032132 Sapote, Yellow
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D032132 2006
% 211.36/211.58  |- mesh__publicMeSHNote mesh__D032132 2003   
% 211.36/211.58  |- mesh__dateEstablished mesh__D032132 2003-01-01
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D004441 2005
% 211.36/211.58  |- skos__annotation mesh__D004441 do not confuse with ECDYSONE   
% 211.36/211.58  |- skos__altLabel mesh__D004441 Beta-Ecdysone
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D004441 2002
% 211.36/211.58  |- mesh__recordMaintainer mesh__D004441 lkt
% 211.36/211.58  |- skos__historyNote mesh__D004441 Ecdysone %28%1966-1974%29%
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D004441 2003
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D004441 2006
% 211.36/211.58  |- skos__prefLabel mesh__D004441 Ecdysterone
% 211.36/211.58  |- skos__broader mesh__D004441smesh__D026461
% 211.36/211.58  |- skos__historyNote mesh__D004441 Insects %28%1966%29%
% 211.36/211.58  |- skos__altLabel mesh__D004441 20-Hydroxyecdysone
% 211.36/211.58  |- mesh__historyNote mesh__D004441 1977 %28%1969%29%   
% 211.36/211.58  |- skos__scopeNote mesh__D004441
% 211.36/211.58       A steroid hormone that regulates the processes of MOLTING or ecdysis in insects. Ecdysterone is the 20-hydroxylated ECDYSONE.%A%    
% 211.36/211.58  |- skos__altLabel mesh__D004441 Crustecdysone
% 211.36/211.58  |- mesh__recordOriginator mesh__D004441 NLM
% 211.36/211.58  |- mesh__recordAuthorizer mesh__D004441 sjn
% 211.36/211.58  |- mesh__dateEstablished mesh__D004441 1977-01-01
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D004441 2004
% 211.36/211.58  |- skos__hiddenLabel mesh__D004441 Beta Ecdysone
% 211.36/211.58  |- rdf__type mesh__D004441sskos__Concept
% 211.36/211.58  |- skos__historyNote mesh__D004441 Cholestanes %28%1968-1972%29%
% 211.36/211.58  |- mesh__dateCreated mesh__D004441 1999-01-01
% 211.36/211.58  |- skos__hiddenLabel mesh__D004441 20 Hydroxyecdysone
% 211.36/211.58  |- skos__historyNote mesh__D004441 Hormones %28%1966%29%
% 211.36/211.58  |- mesh__dateRevised mesh__D004441 2001-07-25
% 211.36/211.58  |- mesh__publicMeSHNote mesh__D004441
% 211.36/211.58       1977; see CHOLESTENES 1975-1977, see INVERTEBRATE HORMONES 1972-1974, see CHOLESTANES 1969-1971%A%  
% 211.36/211.58  |- skos__historyNote mesh__D004441 Invertebrate Hormones %28%1967-1974%29%
% 211.36/211.58  |- skos__altLabel mesh__D051097
% 211.36/211.58       Glial Derived Neurotrophic Factor Receptor 4
% 211.36/211.58  |- skos__altLabel mesh__D051097
% 211.36/211.58       Glial Derived Neurotrophic Factor Receptor 1
% 211.36/211.58  |- mesh__recordAuthorizer mesh__D051097 sjn
% 211.36/211.58  |- rdf__type mesh__D051097sskos__Concept
% 211.36/211.58  |- skos__altLabel mesh__D051097 GDNF Family Receptor Alpha 4
% 211.36/211.58  |- skos__altLabel mesh__D051097 GDNF Family Receptor Alpha 1
% 211.36/211.58  |- mesh__dateCreated mesh__D051097 2005-06-30
% 211.36/211.58  |- skos__altLabel mesh__D051097 GDNF Family Receptor 3
% 211.36/211.58  |- mesh__recordMaintainer mesh__D051097 DRC
% 211.36/211.58  |- skos__altLabel mesh__D051097 GDNF Family Receptor Alpha 2
% 211.36/211.58  |- skos__broader mesh__D051097smesh__D017475
% 211.36/211.58  |- skos__altLabel mesh__D051097 GDNF Family Receptor 1
% 211.36/211.58  |- skos__altLabel mesh__D051097 GDNF Family Receptor Alpha 3
% 211.36/211.58  |- skos__prefLabel mesh__D051097
% 211.36/211.58       Glial Cell Line-Derived Neurotrophic Factor Receptors
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D051097 2006
% 211.36/211.58  |- mesh__publicMeSHNote mesh__D051097
% 211.36/211.58       2006; GLIAL CELL-LINE DERIVED NEUROTROPHIC FACTOR RECEPTORS was indexed under PROTO-ONCOGENE PROTEINS %26% RECEPTOR PROTEIN-TYROSINE KINASES 1999-2005%A%  
% 211.36/211.58  |- skos__altLabel mesh__D051097 GDNF Family Receptor 2
% 211.36/211.58  |- skos__altLabel mesh__D051097 GDNF Family Receptor 4
% 211.36/211.58  |- mesh__recordOriginator mesh__D051097 DRC
% 211.36/211.58  |- mesh__historyNote mesh__D051097 2006%28%1999%29%   
% 211.36/211.58  |- skos__altLabel mesh__D051097
% 211.36/211.58       Glial Derived Neurotrophic Factor Receptor 2
% 211.36/211.58  |- skos__hiddenLabel mesh__D051097
% 211.36/211.58       Glial Cell Line Derived Neurotrophic Factor Receptors
% 211.36/211.58  |- skos__altLabel mesh__D051097 GDNF Receptors
% 211.36/211.58  |- skos__scopeNote mesh__D051097
% 211.36/211.58       A family of GLYCOSYLPHOSPHATIDYLINOSITOL-anchored cell surface receptors that are specific for GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTORS. They form a multi-component receptor complex with PROTO-ONCOGENE PROTEIN C-RET and regulate a variety of intracellular SIGNAL TRANSDUCTION PATHWAYS in conjunction with c-ret protein.%A%    
% 211.36/211.58  |- skos__altLabel mesh__D051097
% 211.36/211.58       Glial Derived Neurotrophic Factor Receptor 3
% 211.36/211.58  |- mesh__dateEstablished mesh__D051097 2006-01-01
% 211.36/211.58  |- mesh__dateEstablished mesh__D045858 2004-01-01
% 211.36/211.58  |- skos__broader mesh__D045858smesh__D016999
% 211.36/211.58  |- mesh__recordMaintainer mesh__D045858 SYSTEM
% 211.36/211.58  |- mesh__dateRevised mesh__D045858 2005-06-30
% 211.36/211.58  |- mesh__recordAuthorizer mesh__D045858 sjn
% 211.36/211.58  |- mesh__recordOriginator mesh__D045858 ags
% 211.36/211.58  |- skos__prefLabel mesh__D045858 Desulfitobacterium
% 211.36/211.58  |- rdf__type mesh__D045858sskos__Concept
% 211.36/211.58  |- mesh__historyNote mesh__D045858 2004   
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D045858 2006
% 211.36/211.58  |- mesh__dateCreated mesh__D045858 2003-07-09
% 211.36/211.58  |- skos__scopeNote mesh__D045858
% 211.36/211.58       A genus of anaerobic, gram-positive bacteria in the family Peptococcaceae, that reductively dechlorinates CHLOROPHENOLS.%A%    
% 211.36/211.58  |- mesh__publicMeSHNote mesh__D045858 2004   
% 211.36/211.58  |- mesh__dateCreated mesh__D003349 1974-11-27
% 211.36/211.58  |- skos__hiddenLabel mesh__D003349 20 beta Hydroxysteroid Dehydrogenase
% 211.36/211.58  |- skos__broader mesh__D003349smesh__D015089
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D003349 2006
% 211.36/211.58  |- skos__altLabel mesh__D003349 20-beta-Hydroxysteroid Dehydrogenase
% 211.36/211.58  |- rdf__type mesh__D003349sskos__Concept
% 211.36/211.58  |- mesh__historyNote mesh__D003349
% 211.36/211.58       91%28%75%29%; was see under 20-HYDROXYSTEROID DEHYDROGENASES 1975-90%A%  
% 211.36/211.58  |- mesh__dateEstablished mesh__D003349 1991-01-01
% 211.36/211.58  |- skos__prefLabel mesh__D003349 Cortisone Reductase
% 211.36/211.58  |- skos__hiddenLabel mesh__D003349 Dehydrogenase, 20-beta-Hydroxysteroid
% 211.36/211.58  |- mesh__recordOriginator mesh__D003349 NLM
% 211.36/211.58  |- mesh__recordAuthorizer mesh__D003349 sjn
% 211.36/211.58  |- skos__hiddenLabel mesh__D003349 Reductase, Cortisone
% 211.36/211.58  |- mesh__publicMeSHNote mesh__D003349
% 211.36/211.58       91; was see under 20-HYDROXYSTEROID DEHYDROGENASES 1975-90%A%  
% 211.36/211.58  |- mesh__recordMaintainer mesh__D003349 ssb
% 211.36/211.58  |- skos__historyNote mesh__D003349
% 211.36/211.58       Hydroxysteroid Dehydrogenases %28%1972-1974%29%
% 211.36/211.58  |- skos__scopeNote mesh__D003349
% 211.36/211.58       An enzyme that catalyzes the interconversion of a ketone and hydroxy group at C-20 of cortisone and other 17,20,21-trihydroxy steroids. EC 1.1.1.53.%A%    
% 211.36/211.58  |- mesh__dateRevised mesh__D003349 2003-07-09
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D003349 2005
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D003349 2004
% 211.36/211.58  |- skos__historyNote mesh__D003349 Cortisone %28%1972-1974%29%
% 211.36/211.58  |- skos__broader mesh__D014071smesh__D014076
% 211.36/211.58  |- skos__hiddenLabel mesh__D014071 Odontomes
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D014071 2004
% 211.36/211.58  |- skos__prefLabel mesh__D014071 Tooth Abnormalities
% 211.36/211.58  |- skos__altLabel mesh__D014071 Abnormalities, Teeth
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D014071 2000
% 211.36/211.58  |- mesh__dateRevised mesh__D014071 1999-11-03
% 211.36/211.58  |- rdf__type mesh__D014071sskos__Concept
% 211.36/211.58  |- mesh__publicMeSHNote mesh__D014071 65   
% 211.36/211.58  |- mesh__activeMeSHYear mesh__D014071 2003
% 211.36/211.59  |- skos__hiddenLabel mesh__D014071 Abnormality, Tooth
% 211.36/211.59  |- skos__scopeNote mesh__D014071
% 211.36/211.59       Congenital absence of or defects in structures of the teeth.%A%    
% 211.36/211.59  |- mesh__historyNote mesh__D014071 65   
% 211.36/211.59  |- skos__annotation mesh__D014071
% 211.36/211.59       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; duplication of teeth = TOOTH, SUPERNUMERARY; abnorm in congen syphilis = HUTCHINSON%27%S TEETH see SYPHILIS, CONGENITAL; X ref ODONTOME %28%a form of developmental dental anomaly%29%: do not confuse with ODONTOMA%A%  
% 211.36/211.59  |- skos__altLabel mesh__D014071 Abnormalities, Tooth
% 211.36/211.59  |- skos__broader mesh__D014071smesh__D018640
% 211.36/211.59  |- skos__hiddenLabel mesh__D014071 Teeth Abnormality
% 211.36/211.59  |- skos__hiddenLabel mesh__D014071 Tooth Abnormality
% 211.36/211.59  |- mesh__dateCreated mesh__D014071 1999-01-01
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D014071 2006
% 211.36/211.59  |- mesh__recordOriginator mesh__D014071 NLM
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D014071 2002
% 211.36/211.59  |- mesh__recordAuthorizer mesh__D014071 sjn
% 211.36/211.59  |- mesh__dateEstablished mesh__D014071 1965-01-01
% 211.36/211.59  |- mesh__recordMaintainer mesh__D014071 kle
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D014071 2005
% 211.36/211.59  |- skos__hiddenLabel mesh__D014071 Abnormality, Teeth
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D014071 2001
% 211.36/211.59  |- skos__altLabel mesh__D014071 Teeth Abnormalities
% 211.36/211.59  |- mesh__recordMaintainer mesh__D008832 nns
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D008832 2004
% 211.36/211.59  |- skos__prefLabel mesh__D008832 Microchemistry
% 211.36/211.59  |- skos__related mesh__D008832smesh__D008904
% 211.36/211.59  |- rdf__type mesh__D008832sskos__Concept
% 211.36/211.59  |- skos__scopeNote mesh__D008832
% 211.36/211.59       The development and use of techniques and equipment to study or perform chemical reactions, with small quantities of materials, frequently less than a milligram or a milliliter.%A%    
% 211.36/211.59  |- skos__related mesh__D008832smesh__D036103
% 211.36/211.59  |- skos__broader mesh__D008832smesh__D002621
% 211.36/211.59  |- mesh__dateRevised mesh__D008832 2002-07-03
% 211.36/211.59  |- mesh__recordOriginator mesh__D008832 NLM
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D008832 2005
% 211.36/211.59  |- mesh__dateCreated mesh__D008832 1999-01-01
% 211.36/211.59  |- skos__broader mesh__D008832smesh__D002623
% 211.36/211.59  |- mesh__recordAuthorizer mesh__D008832 sjn
% 211.36/211.59  |- skos__related mesh__D008832smesh__D015374
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D008832 2003
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D008832 2006
% 211.36/211.59  |- skos__hiddenLabel mesh__D008034 Monohydrochloride, Lincomycin
% 211.36/211.59  |- skos__scopeNote mesh__D008034
% 211.36/211.59       An antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections.%A%    
% 211.36/211.59  |- mesh__recordMaintainer mesh__D008034 ssb
% 211.36/211.59  |- skos__altLabel mesh__D008034 Lincolnensin
% 211.36/211.59  |- skos__broader mesh__D008034smesh__D006027
% 211.36/211.59  |- mesh__publicMeSHNote mesh__D008034 66   
% 211.36/211.59  |- skos__altLabel mesh__D008034 Epilincomycin
% 211.36/211.59  |- skos__hiddenLabel mesh__D008034 Hemihydrate Lincomycin Monohydrochloride
% 211.36/211.59  |- rdf__type mesh__D008034sskos__Concept
% 211.36/211.59  |- mesh__historyNote mesh__D008034 66%28%64%29%   
% 211.36/211.59  |- mesh__recordOriginator mesh__D008034 NLM
% 211.36/211.59  |- skos__broader mesh__D008034smesh__D011759
% 211.36/211.59  |- skos__prefLabel mesh__D008034 Lincomycin
% 211.36/211.59  |- mesh__recordAuthorizer mesh__D008034 sjn
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D008034 2006
% 211.36/211.59  |- skos__hiddenLabel mesh__D008034 Hydrochloride, Lincomycin
% 211.36/211.59  |- mesh__dateRevised mesh__D008034 2004-07-07
% 211.36/211.59  |- mesh__dateCreated mesh__D008034 1999-01-01
% 211.36/211.59  |- mesh__dateEstablished mesh__D008034 1966-01-01
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D008034 2005
% 211.36/211.59  |- mesh__publicMeSHNote mesh__D000051
% 211.36/211.59       91; was see under SKIN DISEASES 1969-90   
% 211.36/211.59  |- skos__scopeNote mesh__D000051
% 211.36/211.59       Separation of the prickle cells of the stratum spinosum of the epidermis, resulting in atrophy of the prickle cell layer. It is seen in diseases such as pemphigus vulgaris %28%see PEMPHIGUS%29% and KERATOSIS FOLLICULARIS.%A%    
% 211.36/211.59  |- skos__historyNote mesh__D000051 Skin/pathology %28%1966-1968%29%
% 211.36/211.59  |- skos__historyNote mesh__D000051
% 211.36/211.59       specific skin disease/pathology %28%1966-1968%29%
% 211.36/211.59  |- skos__hiddenLabel mesh__D000051 Acantholyses
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000051 2002
% 211.36/211.59  |- skos__annotation mesh__D000051
% 211.36/211.59       ACANTHOLYSIS BULLOSA see EPIDERMOLYSIS BULLOSA is also available%A%  
% 211.36/211.59  |- skos__broader mesh__D000051smesh__D012872
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000051 2004
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000051 2001
% 211.36/211.59  |- mesh__dateRevised mesh__D000051 1999-11-03
% 211.36/211.59  |- mesh__historyNote mesh__D000051
% 211.36/211.59       91%28%69%29%; was see under SKIN DISEASES 1969-90   
% 211.36/211.59  |- mesh__recordAuthorizer mesh__D000051 sjn
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000051 2006
% 211.36/211.59  |- mesh__recordMaintainer mesh__D000051 KEV
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000051 2003
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000051 2005
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000051 2000
% 211.36/211.59  |- skos__prefLabel mesh__D000051 Acantholysis
% 211.36/211.59  |- mesh__recordOriginator mesh__D000051 NLM
% 211.36/211.59  |- skos__broader mesh__D000051smesh__D010335
% 211.36/211.59  |- mesh__dateCreated mesh__D000051 1999-01-01
% 211.36/211.59  |- rdf__type mesh__D000051sskos__Concept
% 211.36/211.59  |- mesh__dateEstablished mesh__D000051 1991-01-01
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013777 2002
% 211.36/211.59  |- mesh__historyNote mesh__D013777
% 211.36/211.59       91%28%73%29%; was see under AZOLES 1973-90   
% 211.36/211.59  |- mesh__recordAuthorizer mesh__D013777 PLS
% 211.36/211.59  |- mesh__recordMaintainer mesh__D013777 TAP
% 211.36/211.59  |- skos__broader mesh__D013777smesh__D001393
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013777 1999
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013777 1994
% 211.36/211.59  |- mesh__onlineNote mesh__D013777 search AZOLES 1966-72   
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013777 2001
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013777 1998
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013777 1993
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013777 2006
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013777 2000
% 211.36/211.59  |- rdf__type mesh__D013777sskos__Concept
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013777 1997
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013777 2005
% 211.36/211.59  |- mesh__dateCreated mesh__D013777 1999-01-01
% 211.36/211.59  |- skos__prefLabel mesh__D013777 Tetrazoles
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013777 1996
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013777 2004
% 211.36/211.59  |- mesh__dateEstablished mesh__D013777 1991-01-01
% 211.36/211.59  |- mesh__dateRevised mesh__D013777 1992-05-20
% 211.36/211.59  |- skos__historyNote mesh__D013777 Azoles %28%1966-1972%29%
% 211.36/211.59  |- mesh__recordOriginator mesh__D013777 NLM
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013777 2003
% 211.36/211.59  |- mesh__publicMeSHNote mesh__D013777 91; was see under AZOLES 1973-90   
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013777 1995
% 211.36/211.59  |- skos__broader mesh__D018462smesh__D001695
% 211.36/211.59  |- mesh__historyNote mesh__D018462 95   
% 211.36/211.59  |- mesh__dateEstablished mesh__D018462 1995-01-01
% 211.36/211.59  |- skos__annotation mesh__D018462
% 211.36/211.59       SPEC or GEN only; photobiol eff on or eff of light on = LIGHT %28%IM%29% + specific target %28%IM%29%; photobiol eff of ultraviolet light = ULTRAVIOLET RAYS %28%IM%29% + specific target %28%IM%29%; DF: PHOTOBIOL%A%  
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D018462 2006
% 211.36/211.59  |- skos__related mesh__D018462smesh__D010777
% 211.36/211.59  |- mesh__publicMeSHNote mesh__D018462 95   
% 211.36/211.59  |- skos__historyNote mesh__D018462 Light %28%1966-1994%29%
% 211.36/211.59  |- mesh__recordAuthorizer mesh__D018462 sjn
% 211.36/211.59  |- skos__prefLabel mesh__D018462 Photobiology
% 211.36/211.59  |- mesh__dateRevised mesh__D018462 2001-07-25
% 211.36/211.59  |- rdf__type mesh__D018462sskos__Concept
% 211.36/211.59  |- skos__related mesh__D018462smesh__D010788
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D018462 2005
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D018462 2002
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D018462 2004
% 211.36/211.59  |- skos__scopeNote mesh__D018462
% 211.36/211.59       The branch of biology dealing with the effect of light on organisms.%A%    
% 211.36/211.59  |- mesh__dateCreated mesh__D018462 1994-06-07
% 211.36/211.59  |- skos__related mesh__D018462smesh__D008027
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D018462 2003
% 211.36/211.59  |- mesh__recordMaintainer mesh__D018462 jls
% 211.36/211.59  |- mesh__recordOriginator mesh__D018462 TGC
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D032133 2004
% 211.36/211.59  |- mesh__dateEstablished mesh__D032133 2003-01-01
% 211.36/211.59  |- skos__scopeNote mesh__D032133
% 211.36/211.59       A plant genus of the family SAPOTACEAE. Members contain miraculin %28%also spelled mieraculin%29%, a sweet protein.%A%    
% 211.36/211.59  |- skos__altLabel mesh__D032133 Fruit, Miracle
% 211.36/211.59  |- skos__annotation mesh__D032133
% 211.36/211.59       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D032133 2003
% 211.36/211.59  |- skos__prefLabel mesh__D032133 Synsepalum
% 211.36/211.59  |- mesh__dateCreated mesh__D032133 2002-07-03
% 211.36/211.59  |- skos__broader mesh__D032133smesh__D029632
% 211.36/211.59  |- mesh__historyNote mesh__D032133 2003   
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D032133 2006
% 211.36/211.59  |- mesh__publicMeSHNote mesh__D032133 2003   
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D032133 2005
% 211.36/211.59  |- rdf__type mesh__D032133sskos__Concept
% 211.36/211.59  |- skos__altLabel mesh__D032133 Miracle Fruit
% 211.36/211.59  |- skos__broader mesh__D051896smesh__D051785
% 211.36/211.59  |- skos__hiddenLabel mesh__D051896 Smad Proteins, Receptor Regulated
% 211.36/211.59  |- skos__hiddenLabel mesh__D051896 Receptor Regulated Smad Proteins
% 211.36/211.59  |- skos__altLabel mesh__D051896 R-Smad Proteins
% 211.36/211.59  |- mesh__dateEstablished mesh__D051896 2006-01-01
% 211.36/211.59  |- mesh__publicMeSHNote mesh__D051896 2006   
% 211.36/211.59  |- skos__broader mesh__D051896smesh__D010750
% 211.36/211.59  |- mesh__historyNote mesh__D051896 2006   
% 211.36/211.59  |- mesh__recordMaintainer mesh__D051896 DRC
% 211.36/211.59  |- mesh__dateCreated mesh__D051896 2005-06-30
% 211.36/211.59  |- skos__prefLabel mesh__D051896 Smad Proteins, Receptor-Regulated
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D051896 2006
% 211.36/211.59  |- mesh__recordAuthorizer mesh__D051896 sjn
% 211.36/211.59  |- rdf__type mesh__D051896sskos__Concept
% 211.36/211.59  |- skos__altLabel mesh__D051896 Receptor-Regulated Smad Proteins
% 211.36/211.59  |- mesh__recordOriginator mesh__D051896 DRC
% 211.36/211.59  |- skos__scopeNote mesh__D051896
% 211.36/211.59       A family of smad proteins that undergo PHOSPHORYLATION by CELL SURFACE RECEPTORS in response to TRANSFORMING GROWTH FACTOR BETA; ACTIVIN; or BONE MORPHOGENETIC PROTEIN signaling.%A%    
% 211.36/211.59  |- mesh__dateRevised mesh__D004442 2003-07-09
% 211.36/211.59  |- mesh__publicMeSHNote mesh__D004442
% 211.36/211.59       91; was see under MONOTREMATA 1975-90   
% 211.36/211.59  |- skos__prefLabel mesh__D004442 Echidna
% 211.36/211.59  |- mesh__dateEstablished mesh__D004442 1991-01-01
% 211.36/211.59  |- skos__hiddenLabel mesh__D004442 Anteaters, Spiny
% 211.36/211.59  |- skos__hiddenLabel mesh__D004442 Ant-Eater, Spiny
% 211.36/211.59  |- mesh__historyNote mesh__D004442
% 211.36/211.59       91%28%75%29%; was see under MONOTREMATA 1975-90   
% 211.36/211.59  |- skos__broader mesh__D004442smesh__D009007
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D004442 2004
% 211.36/211.59  |- skos__hiddenLabel mesh__D004442 Anteater, Spiny
% 211.36/211.59  |- skos__hiddenLabel mesh__D004442 Spiny Ant-Eaters
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D004442 2006
% 211.36/211.59  |- mesh__recordMaintainer mesh__D004442 ags
% 211.36/211.59  |- skos__hiddenLabel mesh__D004442 Ant-Eaters, Spiny
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D004442 2005
% 211.36/211.59  |- skos__altLabel mesh__D004442 Spiny Anteater
% 211.36/211.59  |- mesh__recordAuthorizer mesh__D004442 sjn
% 211.36/211.59  |- mesh__recordOriginator mesh__D004442 NLM
% 211.36/211.59  |- mesh__dateCreated mesh__D004442 1974-11-19
% 211.36/211.59  |- skos__annotation mesh__D004442
% 211.36/211.59       do not confuse X ref SPINY ANTEATER with X ref ANTEATERS see XENARTHRA; IM; qualif permitted%A%  
% 211.36/211.59  |- rdf__type mesh__D004442sskos__Concept
% 211.36/211.59  |- skos__hiddenLabel mesh__D004442 Spiny Anteaters
% 211.36/211.59  |- skos__hiddenLabel mesh__D004442 Spiny Ant Eater
% 211.36/211.59  |- skos__scopeNote mesh__D004442
% 211.36/211.59       An oviparous burrowing mammal of the order Monotremata native to Australia, Tasmania, and New Guinea. It has hair mingled with spines on the upper part of the body and is adapted for feeding on ants.%A%    
% 211.36/211.59  |- skos__altLabel mesh__D004442 Spiny Ant-Eater
% 211.36/211.59  |- mesh__dateEstablished mesh__D051098 2006-01-01
% 211.36/211.59  |- mesh__recordAuthorizer mesh__D051098 sjn
% 211.36/211.59  |- skos__broader mesh__D051098smesh__D009414
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D051098 2006
% 211.36/211.59  |- mesh__dateCreated mesh__D051098 2005-06-30
% 211.36/211.59  |- skos__annotation mesh__D051098
% 211.36/211.59       GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR is also available%A%  
% 211.36/211.59  |- mesh__recordOriginator mesh__D051098 DRC
% 211.36/211.59  |- skos__prefLabel mesh__D051098
% 211.36/211.59       Glial Cell Line-Derived Neurotrophic Factors
% 211.36/211.59  |- mesh__recordMaintainer mesh__D051098 DRC
% 211.36/211.59  |- mesh__publicMeSHNote mesh__D051098 2006   
% 211.36/211.59  |- skos__hiddenLabel mesh__D051098
% 211.36/211.59       Glial Cell Line Derived Neurotrophic Factors
% 211.36/211.59  |- skos__altLabel mesh__D051098 GDNF Family Ligands
% 211.36/211.59  |- mesh__historyNote mesh__D051098 2006   
% 211.36/211.59  |- skos__scopeNote mesh__D051098
% 211.36/211.59       A family of closely related nerve growth factors that promote NEURON survival. They bind to GDNF RECEPTORS and stimulate SIGNAL TRANSDUCTION through PROTO-ONCOGENE PROTEIN C-RET.%A%    
% 211.36/211.59  |- rdf__type mesh__D051098sskos__Concept
% 211.36/211.59  |- skos__altLabel mesh__D051098 GDNF Protein Family
% 211.36/211.59  |- skos__broader mesh__D045859smesh__D016999
% 211.36/211.59  |- skos__scopeNote mesh__D045859
% 211.36/211.59       A genus of anaerobic bacteria in the family PEPTOCOCCACEAE, widely distributed in SOIL and the RUMEN of animals. Stains gram-negative but cell well is gram-positive type.%A%    
% 211.36/211.59  |- mesh__recordMaintainer mesh__D045859 SYSTEM
% 211.36/211.59  |- skos__broader mesh__D045859smesh__D016937
% 211.36/211.59  |- skos__prefLabel mesh__D045859 Desulfotomaculum
% 211.36/211.59  |- mesh__publicMeSHNote mesh__D045859 2004   
% 211.36/211.59  |- mesh__dateRevised mesh__D045859 2005-06-30
% 211.36/211.59  |- mesh__dateCreated mesh__D045859 2003-07-09
% 211.36/211.59  |- mesh__recordAuthorizer mesh__D045859 sjn
% 211.36/211.59  |- mesh__recordOriginator mesh__D045859 ags
% 211.36/211.59  |- mesh__dateEstablished mesh__D045859 2004-01-01
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D045859 2006
% 211.36/211.59  |- rdf__type mesh__D045859sskos__Concept
% 211.36/211.59  |- mesh__historyNote mesh__D045859 2004   
% 211.36/211.59  |- mesh__dateEstablished mesh__D042561 2004-01-01
% 211.36/211.59  |- skos__annotation mesh__D042561 see SCR for organism-specific terms   
% 211.36/211.59  |- mesh__historyNote mesh__D042561
% 211.36/211.59       2004; use VASCULAR ENDOTHELIAL GROWTH FACTOR B %28%NM%29% 1996-2003%A%  
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D042561 2006
% 211.36/211.59  |- rdf__type mesh__D042561sskos__Concept
% 211.36/211.59  |- mesh__recordOriginator mesh__D042561 jmp
% 211.36/211.59  |- skos__hiddenLabel mesh__D042561 VEGF Related Factor, VEGF B
% 211.36/211.59  |- skos__altLabel mesh__D042561 Vascular Endothelial Growth Factor-B
% 211.36/211.59  |- mesh__recordAuthorizer mesh__D042561 sjn
% 211.36/211.59  |- skos__altLabel mesh__D042561 VEGF-Related Factor, VEGF-B
% 211.36/211.59  |- mesh__recordMaintainer mesh__D042561 ssb
% 211.36/211.59  |- skos__broader mesh__D042561smesh__D042442
% 211.36/211.59  |- skos__hiddenLabel mesh__D042561 VEGF-B VEGF-Related Factor
% 211.36/211.59  |- mesh__dateCreated mesh__D042561 2003-07-09
% 211.36/211.59  |- skos__prefLabel mesh__D042561 Vascular Endothelial Growth Factor B
% 211.36/211.59  |- skos__historyNote mesh__D042561
% 211.36/211.59       Endothelial Growth Factors %28%1996-2003%29%
% 211.36/211.59  |- mesh__dateRevised mesh__D042561 2005-06-30
% 211.36/211.59  |- skos__hiddenLabel mesh__D042561 VEGF Related Protein, VEGF B
% 211.36/211.59  |- skos__scopeNote mesh__D042561
% 211.36/211.59       A vascular endothelial growth factor expressed in a variety of tissues. It binds with high specificity to VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1 and NEUROPILIN-1.%A%    
% 211.36/211.59  |- skos__hiddenLabel mesh__D042561 VEGF-B VEGF-Related Protein
% 211.36/211.59  |- skos__altLabel mesh__D042561 VEGF-B
% 211.36/211.59  |- skos__altLabel mesh__D042561 VEGF-Related Protein, VEGF-B
% 211.36/211.59  |- mesh__publicMeSHNote mesh__D042561
% 211.36/211.59       2004; VASCULAR ENDOTHELIAL GROWTH FACTOR B was indexed under ENDOTHELIAL GROWTH FACTORS 1996-2003%A%  
% 211.36/211.59  |- rdf__type mesh__D014870sskos__Concept
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D014870 2003
% 211.36/211.59  |- skos__historyNote mesh__D014870 Respiration %28%1966-1971%29%
% 211.36/211.59  |- skos__scopeNote mesh__D014870
% 211.36/211.59       Loss of water by diffusion through the skin and by evaporation from the respiratory tract.%A%    
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D014870 2001
% 211.36/211.59  |- skos__broader mesh__D014870smesh__D014882
% 211.36/211.59  |- mesh__dateRevised mesh__D014870 2000-06-22
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D014870 2006
% 211.36/211.59  |- mesh__historyNote mesh__D014870 74%28%72%29%   
% 211.36/211.59  |- skos__prefLabel mesh__D014870 Water Loss, Insensible
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D014870 2005
% 211.36/211.59  |- mesh__recordMaintainer mesh__D014870 TGC
% 211.36/211.59  |- mesh__dateEstablished mesh__D014870 1974-01-01
% 211.36/211.59  |- skos__historyNote mesh__D014870 Sweating %28%1966-1971%29%
% 211.36/211.59  |- skos__hiddenLabel mesh__D014870 Insensible Water Loss
% 211.36/211.59  |- mesh__publicMeSHNote mesh__D014870 74   
% 211.36/211.59  |- mesh__recordAuthorizer mesh__D014870 sjn
% 211.36/211.59  |- mesh__recordOriginator mesh__D014870 NLM
% 211.36/211.59  |- mesh__dateCreated mesh__D014870 1999-01-01
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D014870 2002
% 211.36/211.59  |- skos__hiddenLabel mesh__D014870 Insensible Water Losses
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D014870 2004
% 211.36/211.59  |- mesh__recordOriginator mesh__D014072 NLM
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D014072 2003
% 211.36/211.59  |- mesh__dateEstablished mesh__D014072 1965-01-01
% 211.36/211.59  |- skos__prefLabel mesh__D014072 Tooth Abrasion
% 211.36/211.59  |- skos__altLabel mesh__D014072 Abrasion, Dental
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D014072 2001
% 211.36/211.59  |- skos__annotation mesh__D014072
% 211.36/211.59       loss of substance caused by friction: differentiate from TOOTH ATTRITION %28%wearing away by tooth-to-tooth contact like mastication%29% %26% TOOTH EROSION %28%loss of substance by chemical action without bact action%29%%A%  
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D014072 2000
% 211.36/211.59  |- mesh__historyNote mesh__D014072 65   
% 211.36/211.59  |- mesh__publicMeSHNote mesh__D014072 65   
% 211.36/211.59  |- mesh__dateCreated mesh__D014072 1999-01-01
% 211.36/211.59  |- skos__hiddenLabel mesh__D014072 Abrasion, Tooth
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D014072 2006
% 211.36/211.59  |- mesh__recordMaintainer mesh__D014072 TGC
% 211.36/211.59  |- mesh__recordAuthorizer mesh__D014072 PLS
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D014072 1999
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D014072 2005
% 211.36/211.59  |- skos__scopeNote mesh__D014072
% 211.36/211.59       The pathologic wearing away of the tooth substance by brushing, bruxism, clenching, and other mechanical causes. It is differentiated from TOOTH ATTRITION in that this type of wearing away is the result of tooth-to-tooth contact, as in mastication, occurring only on the occlusal, incisal, and proximal surfaces. It differs also from TOOTH EROSION, the progressive loss of the hard substance of a tooth by chemical processes not involving bacterial action. %28%From Jablonski, Dictionary of Dentistry, 1992, p2%29%%A%    
% 211.36/211.59  |- skos__broader mesh__D014072smesh__D014076
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D014072 2004
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D014072 1998
% 211.36/211.59  |- rdf__type mesh__D014072sskos__Concept
% 211.36/211.59  |- skos__altLabel mesh__D014072 Dental Abrasion
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D014072 2002
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D014072 1997
% 211.36/211.59  |- mesh__dateRevised mesh__D014072 1996-06-10
% 211.36/211.59  |- skos__hiddenLabel mesh__D008833 Microcirculations
% 211.36/211.59  |- mesh__recordAuthorizer mesh__D008833 sjn
% 211.36/211.59  |- skos__annotation mesh__D008833
% 211.36/211.59       IM GEN only; NIM as coord with specific organ /blood supply; not for lymphatic microcirc %28% = LYMPHATIC SYSTEM /physiol%29%; Manual 21.5; DF: MICROCIRC%A%  
% 211.36/211.59  |- mesh__dateEstablished mesh__D008833 1972-01-01
% 211.36/211.59  |- rdf__type mesh__D008833sskos__Concept
% 211.36/211.59  |- skos__prefLabel mesh__D008833 Microcirculation
% 211.36/211.59  |- mesh__recordMaintainer mesh__D008833 nns
% 211.36/211.59  |- skos__historyNote mesh__D008833 Capillaries %28%1966-1969%29%
% 211.36/211.59  |- mesh__publicMeSHNote mesh__D008833 72   
% 211.36/211.59  |- mesh__historyNote mesh__D008833 72%28%70%29%   
% 211.36/211.59  |- skos__scopeNote mesh__D008833
% 211.36/211.59       The circulation of the BLOOD through the microvascular network lying between the ARTERIOLES and VENULES. This network includes CAPILLARIES, metarterioles, and ARTERIOVENOUS ANASTOMOSES; and the flow of blood through this network.%A%    
% 211.36/211.59  |- mesh__dateCreated mesh__D008833 1999-01-01
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D008833 2005
% 211.36/211.59  |- skos__historyNote mesh__D008833 Blood Circulation %28%1966-1969%29%
% 211.36/211.59  |- skos__broader mesh__D008833smesh__D001775
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D008833 2006
% 211.36/211.59  |- mesh__dateRevised mesh__D008833 2003-07-09
% 211.36/211.59  |- skos__broader mesh__D008833smesh__D001808
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D008833 2004
% 211.36/211.59  |- mesh__recordOriginator mesh__D008833 NLM
% 211.36/211.59  |- skos__historyNote mesh__D000850 Social Problems %28%1968-1970%29%
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000850 2004
% 211.36/211.59  |- skos__historyNote mesh__D000850
% 211.36/211.59       Social Behavior Disorders %28%1969-1970%29%
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000850 2005
% 211.36/211.59  |- skos__hiddenLabel mesh__D000850 Disorganizations, Social
% 211.36/211.59  |- mesh__dateRevised mesh__D000850 2002-07-02
% 211.36/211.59  |- mesh__historyNote mesh__D000850 71   
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000850 2003
% 211.36/211.59  |- skos__annotation mesh__D000850
% 211.36/211.59       no qualif; %22%state of social disorganization %26% demoralization in society...%22%; sometimes called %22%anomia%22% but do not confuse with ANOMIA %28%%22%inability to name objects%22%%29%%A%  
% 211.36/211.59  |- mesh__recordOriginator mesh__D000850 NLM
% 211.36/211.59  |- mesh__publicMeSHNote mesh__D000850 71   
% 211.36/211.59  |- mesh__dateEstablished mesh__D000850 1971-01-01
% 211.36/211.59  |- mesh__recordAuthorizer mesh__D000850 sjn
% 211.36/211.59  |- skos__hiddenLabel mesh__D000850 Anomies
% 211.36/211.59  |- skos__broader mesh__D000850smesh__D012924
% 211.36/211.59  |- skos__related mesh__D000850smesh__D012920
% 211.36/211.59  |- skos__related mesh__D000850smesh__D010554
% 211.36/211.59  |- skos__hiddenLabel mesh__D000850 Social Disorganizations
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000850 2006
% 211.36/211.59  |- mesh__dateCreated mesh__D000850 1999-01-01
% 211.36/211.59  |- skos__scopeNote mesh__D000850
% 211.36/211.59       A state of social disorganization and demoralization in society which is largely the result of disharmony between cultural goals and the means for attaining them. This may be reflected in the behavior of the individual in many ways - non-conformity, social withdrawal, deviant behavior, etc.%A%    
% 211.36/211.59  |- skos__prefLabel mesh__D000850 Anomie
% 211.36/211.59  |- skos__broader mesh__D000850smesh__D012919
% 211.36/211.59  |- skos__hiddenLabel mesh__D000850 Disorganization, Social
% 211.36/211.59  |- rdf__type mesh__D000850sskos__Concept
% 211.36/211.59  |- mesh__recordMaintainer mesh__D000850 JLS
% 211.36/211.59  |- skos__hiddenLabel mesh__D008035 Frenums, Lingual
% 211.36/211.59  |- mesh__dateEstablished mesh__D008035 1965-01-01
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D008035 2004
% 211.36/211.59  |- rdf__type mesh__D008035sskos__Concept
% 211.36/211.59  |- skos__hiddenLabel mesh__D008035 Lingual Frenums
% 211.36/211.59  |- mesh__historyNote mesh__D008035 65   
% 211.36/211.59  |- mesh__publicMeSHNote mesh__D008035 65   
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D008035 2006
% 211.36/211.59  |- mesh__recordMaintainer mesh__D008035 lkt
% 211.36/211.59  |- skos__prefLabel mesh__D008035 Lingual Frenum
% 211.36/211.59  |- skos__broader mesh__D008035smesh__D014059
% 211.36/211.59  |- mesh__recordOriginator mesh__D008035 NLM
% 211.36/211.59  |- skos__altLabel mesh__D008035 Frenum, Lingual
% 211.36/211.59  |- mesh__dateCreated mesh__D008035 1999-01-01
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D008035 2005
% 211.36/211.59  |- mesh__dateRevised mesh__D008035 2003-07-09
% 211.36/211.59  |- mesh__recordAuthorizer mesh__D008035 sjn
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000052 2006
% 211.36/211.59  |- mesh__recordOriginator mesh__D000052 NLM
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000052 2003
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000052 2005
% 211.36/211.59  |- skos__scopeNote mesh__D000052
% 211.36/211.59       A circumscribed melanosis consisting of a brown-pigmented, velvety verrucosity or fine papillomatosis appearing in the axillae and other body folds. It occurs in association with endocrine disorders, underlying malignancy, administration of certain drugs, or as in inherited disorder.%A%    
% 211.36/211.59  |- mesh__dateRevised mesh__D000052 1993-06-02
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000052 1997
% 211.36/211.59  |- mesh__dateCreated mesh__D000052 1999-01-01
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000052 1999
% 211.36/211.59  |- rdf__type mesh__D000052sskos__Concept
% 211.36/211.59  |- mesh__recordMaintainer mesh__D000052 TAP
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000052 1996
% 211.36/211.59  |- skos__prefLabel mesh__D000052 Acanthosis Nigricans
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000052 1995
% 211.36/211.59  |- skos__broader mesh__D000052smesh__D008548
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000052 1998
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000052 2002
% 211.36/211.59  |- mesh__recordAuthorizer mesh__D000052 PLS
% 211.36/211.59  |- skos__annotation mesh__D000052 a type of melanosis   
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000052 1994
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000052 2001
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000052 2004
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D000052 2000
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013778 1998
% 211.36/211.59  |- mesh__recordMaintainer mesh__D013778 JRT
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013778 2006
% 211.36/211.59  |- skos__broader mesh__D013778smesh__D013777
% 211.36/211.59  |- rdf__type mesh__D013778sskos__Concept
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013778 2002
% 211.36/211.59  |- mesh__recordAuthorizer mesh__D013778 PLS
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013778 1997
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013778 2005
% 211.36/211.59  |- mesh__dateCreated mesh__D013778 1999-01-01
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013778 2001
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013778 1996
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013778 2004
% 211.36/211.59  |- skos__prefLabel mesh__D013778 Tetrazolium Salts
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013778 2000
% 211.36/211.59  |- skos__hiddenLabel mesh__D013778 Salts, Tetrazolium
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013778 2003
% 211.36/211.59  |- skos__scopeNote mesh__D013778
% 211.36/211.59       Quaternary salts derived from tetrazoles. They are used in tests to distinguish between reducing sugars and simple aldehydes, for detection of dehydrogenase in tissues, cells, and bacteria, for determination of corticosteroids, and in color photography. %28%From Mall%27%s Dictionary of Chemistry, 5th ed, p455%29%%A%    
% 211.36/211.59  |- skos__annotation mesh__D013778
% 211.36/211.59       indicators %26% reagents; D25-26 qualif   
% 211.36/211.59  |- mesh__dateRevised mesh__D013778 1995-06-16
% 211.36/211.59  |- mesh__activeMeSHYear mesh__D013778 1999
% 211.36/211.59  |- mesh__recordOriginator mesh__D013778 NLM
% 211.36/211.60  |- skos__prefLabel mesh__D018463 Filtering Surgery
% 211.36/211.60  |- rdf__type mesh__D018463sskos__Concept
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D018463 2005
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D018463 2001
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D018463 2004
% 211.36/211.60  |- mesh__recordMaintainer mesh__D018463 PXP
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D018463 2000
% 211.36/211.60  |- mesh__recordOriginator mesh__D018463 TGC
% 211.36/211.60  |- skos__altLabel mesh__D018463 Surgery, Filtering
% 211.36/211.60  |- mesh__dateRevised mesh__D018463 1997-06-20
% 211.36/211.60  |- mesh__recordAuthorizer mesh__D018463 SJN
% 211.36/211.60  |- skos__historyNote mesh__D018463 Glaucoma/surgery %28%1966-1994%29%
% 211.36/211.60  |- skos__scopeNote mesh__D018463
% 211.36/211.60       A surgical procedure used in treatment of glaucoma in which an opening is created through which aqueous fluid may pass from the anterior chamber into a sac created beneath the conjunctiva, thus lowering the pressure within the eye. %28%Hoffman, Pocket Glossary of Ophthalmologic Terminology, 1989%29%%A%    
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D018463 2003
% 211.36/211.60  |- mesh__dateEstablished mesh__D018463 1995-01-01
% 211.36/211.60  |- mesh__dateCreated mesh__D018463 1994-04-16
% 211.36/211.60  |- skos__altLabel mesh__D018463 Filtration Surgery
% 211.36/211.60  |- skos__altLabel mesh__D018463 Surgery, Filtration
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D018463 1999
% 211.36/211.60  |- mesh__publicMeSHNote mesh__D018463 95   
% 211.36/211.60  |- mesh__historyNote mesh__D018463 95   
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D018463 2006
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D018463 1998
% 211.36/211.60  |- skos__broader mesh__D018463smesh__D013508
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D018463 2002
% 211.36/211.60  |- skos__related mesh__D018463smesh__D018465
% 211.36/211.60  |- skos__annotation mesh__D018463
% 211.36/211.60       in glaucoma surg; do not use /util except by MeSH definition; DF: FILTERING SURG%A%  
% 211.36/211.60  |- mesh__publicMeSHNote mesh__D010480
% 211.36/211.60       84; was see under PIPERIDINES 1975-83   
% 211.36/211.60  |- mesh__dateCreated mesh__D010480 1999-01-01
% 211.36/211.60  |- skos__annotation mesh__D010480 a vasodilator calcium channel blocker   
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D010480 2000
% 211.36/211.60  |- mesh__dateEstablished mesh__D010480 1984-01-01
% 211.36/211.60  |- mesh__recordOriginator mesh__D010480 NLM
% 211.36/211.60  |- skos__altLabel mesh__D010480 Perhexilene
% 211.36/211.60  |- skos__historyNote mesh__D010480 Piperidines %28%1966-1974%29%
% 211.36/211.60  |- skos__broader mesh__D010480smesh__D010880
% 211.36/211.60  |- rdf__type mesh__D010480sskos__Concept
% 211.36/211.60  |- mesh__historyNote mesh__D010480
% 211.36/211.60       84%28%73%29%; was see under PIPERIDINES 1975-83, was Prov 1973-74%A%  
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D010480 2004
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D010480 1997
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D010480 2002
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D010480 2003
% 211.36/211.60  |- skos__prefLabel mesh__D010480 Perhexiline
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D010480 1996
% 211.36/211.60  |- mesh__recordAuthorizer mesh__D010480 PLS
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D010480 2006
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D010480 1999
% 211.36/211.60  |- skos__scopeNote mesh__D010480
% 211.36/211.60       2-%28%2,2-Dicyclohexylethyl%29%piperidine. Coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis.%A%    
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D010480 2001
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D010480 2005
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D010480 1998
% 211.36/211.60  |- mesh__dateRevised mesh__D010480 1995-06-08
% 211.36/211.60  |- mesh__recordMaintainer mesh__D010480 JRT
% 211.36/211.60  |- skos__scopeNote mesh__D032134
% 211.36/211.60       A plant family of the order Piperales, subclass Magnoliidae class Magnoliopsida. Members contain sauristolactam, and aristololactam BII.%A%    
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D032134 2006
% 211.36/211.60  |- mesh__publicMeSHNote mesh__D032134 2003   
% 211.36/211.60  |- mesh__dateEstablished mesh__D032134 2003-01-01
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D032134 2005
% 211.36/211.60  |- skos__broader mesh__D032134smesh__D019684
% 211.36/211.60  |- rdf__type mesh__D032134sskos__Concept
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D032134 2004
% 211.36/211.60  |- mesh__dateCreated mesh__D032134 2002-07-03
% 211.36/211.60  |- skos__annotation mesh__D032134
% 211.36/211.60       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D032134 2003
% 211.36/211.60  |- skos__prefLabel mesh__D032134 Saururaceae
% 211.36/211.60  |- mesh__historyNote mesh__D032134 2003   
% 211.36/211.60  |- skos__altLabel mesh__D051897 I-Smad Proteins
% 211.36/211.60  |- skos__broader mesh__D051897smesh__D051785
% 211.36/211.60  |- mesh__publicMeSHNote mesh__D051897 2006   
% 211.36/211.60  |- mesh__dateEstablished mesh__D051897 2006-01-01
% 211.36/211.60  |- skos__scopeNote mesh__D051897
% 211.36/211.60       A sub-family of smad proteins that inhibit cell signaling by RECEPTOR-REGULATED SMAD PROTEINS. They form autoinhibitory feedback loops in the TGF-BETA signaling pathway and mediate signaling cross-talk with other signaling pathways%A%    
% 211.36/211.60  |- skos__prefLabel mesh__D051897 Smad Proteins, Inhibitory
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D051897 2006
% 211.36/211.60  |- rdf__type mesh__D051897sskos__Concept
% 211.36/211.60  |- mesh__recordOriginator mesh__D051897 DRC
% 211.36/211.60  |- mesh__historyNote mesh__D051897 2006   
% 211.36/211.60  |- mesh__recordMaintainer mesh__D051897 DRC
% 211.36/211.60  |- skos__altLabel mesh__D051897 Inhibitory Smad Proteins
% 211.36/211.60  |- mesh__dateCreated mesh__D051897 2005-06-30
% 211.36/211.60  |- mesh__recordAuthorizer mesh__D051897 sjn
% 211.36/211.60  |- mesh__recordMaintainer mesh__D004443 jls
% 211.36/211.60  |- skos__altLabel mesh__D004443 Hydatidosis
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D004443 2002
% 211.36/211.60  |- skos__hiddenLabel mesh__D004443 Hydatid Cysts
% 211.36/211.60  |- mesh__dateRevised mesh__D004443 1999-11-09
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D004443 2004
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D004443 2001
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D004443 2006
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D004443 2003
% 211.36/211.60  |- mesh__dateCreated mesh__D004443 1999-01-01
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D004443 2005
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D004443 2000
% 211.36/211.60  |- skos__prefLabel mesh__D004443 Echinococcosis
% 211.36/211.60  |- skos__scopeNote mesh__D004443
% 211.36/211.60       An infection caused by the infestation of the larval form of tapeworms of the genus Echinococcus. The liver, lungs, and kidney are the most common areas of infestation.%A%    
% 211.36/211.60  |- skos__hiddenLabel mesh__D004443 Echinococcoses
% 211.36/211.60  |- skos__hiddenLabel mesh__D004443 Cyst, Hydatid
% 211.36/211.60  |- skos__hiddenLabel mesh__D004443 Hydatidoses
% 211.36/211.60  |- rdf__type mesh__D004443sskos__Concept
% 211.36/211.60  |- skos__altLabel mesh__D004443 Hydatid Cyst
% 211.36/211.60  |- skos__altLabel mesh__D004443 Cysts, Hydatid
% 211.36/211.60  |- skos__annotation mesh__D004443
% 211.36/211.60       of liver = ECHINOCOCCOSIS, HEPATIC, of lung = ECHINOCOCCOSIS, PULMONARY; Taenia echinococcus infect = Echinococcus granulosus infect = ECHINOCOCCOSIS%A%  
% 211.36/211.60  |- skos__broader mesh__D004443smesh__D002590
% 211.36/211.60  |- mesh__recordAuthorizer mesh__D004443 sjn
% 211.36/211.60  |- mesh__recordOriginator mesh__D004443 NLM
% 211.36/211.60  |- skos__historyNote mesh__D051099 Primates %28%1968-2005%29%
% 211.36/211.60  |- skos__prefLabel mesh__D051099 Tarsii
% 211.36/211.60  |- mesh__dateEstablished mesh__D051099 2006-01-01
% 211.36/211.60  |- mesh__recordAuthorizer mesh__D051099 sjn
% 211.36/211.60  |- skos__altLabel mesh__D051099 Tarsiiformes
% 211.36/211.60  |- mesh__recordMaintainer mesh__D051099 ags
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D051099 2006
% 211.36/211.60  |- skos__scopeNote mesh__D051099
% 211.36/211.60       An infraorder %28%or suborder%29% of small PRIMATES comprised of a single family and genus.%A%    
% 211.36/211.60  |- mesh__dateCreated mesh__D051099 2005-06-30
% 211.36/211.60  |- mesh__publicMeSHNote mesh__D051099 2006   
% 211.36/211.60  |- skos__annotation mesh__D051099
% 211.36/211.60       diseases: coordinate IM with PRIMATE DISEASES %28%IM%29%   
% 211.36/211.60  |- skos__broader mesh__D051099smesh__D000882
% 211.36/211.60  |- mesh__historyNote mesh__D051099 2006   
% 211.36/211.60  |- rdf__type mesh__D051099sskos__Concept
% 211.36/211.60  |- mesh__recordOriginator mesh__D051099 ags
% 211.36/211.60  |- mesh__recordMaintainer mesh__D014871 jls
% 211.36/211.60  |- mesh__recordAuthorizer mesh__D014871 sjn
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D014871 2005
% 211.36/211.60  |- mesh__recordOriginator mesh__D014871 NLM
% 211.36/211.60  |- skos__annotation mesh__D014871
% 211.36/211.60       IM; coord with specific bact, virus or fungus %28%IM%29%; DF: WATER MICROBIOL%A%  
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D014871 2002
% 211.36/211.60  |- skos__prefLabel mesh__D014871 Water Microbiology
% 211.36/211.60  |- mesh__dateCreated mesh__D014871 1999-01-01
% 211.36/211.60  |- skos__broader mesh__D014871smesh__D004783
% 211.36/211.60  |- skos__altLabel mesh__D014871 Microbiology, Water
% 211.36/211.60  |- mesh__dateRevised mesh__D014871 2001-07-25
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D014871 2004
% 211.36/211.60  |- rdf__type mesh__D014871sskos__Concept
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D014871 2003
% 211.36/211.60  |- skos__scopeNote mesh__D014871
% 211.36/211.60       The presence of bacteria, viruses, and fungi in water. This term is not restricted to pathogenic organisms.%A%    
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D014871 2006
% 211.36/211.60  |- mesh__dateCreated mesh__D014073 1999-01-01
% 211.36/211.60  |- skos__historyNote mesh__D014073 Root Canal Therapy %28%1966-1970%29%
% 211.36/211.60  |- skos__prefLabel mesh__D014073 Tooth Bleaching
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D014073 2000
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D014073 2005
% 211.36/211.60  |- mesh__recordAuthorizer mesh__D014073 sjn
% 211.36/211.60  |- mesh__recordOriginator mesh__D014073 NLM
% 211.36/211.60  |- mesh__dateEstablished mesh__D014073 1972-01-01
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D014073 2006
% 211.36/211.60  |- mesh__publicMeSHNote mesh__D014073 72   
% 211.36/211.60  |- skos__hiddenLabel mesh__D014073 Bleaching, Tooth
% 211.36/211.60  |- skos__scopeNote mesh__D014073
% 211.36/211.60       The use of a chemical oxidizing agent %28%sometimes in combination with heat%29% to lighten tooth discolorations. %28%Boucher%27%s Clinical Dental Terminology, 4th ed, p34%29%%A%    
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D014073 2001
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D014073 2003
% 211.36/211.60  |- mesh__recordMaintainer mesh__D014073 ags
% 211.36/211.60  |- skos__historyNote mesh__D014073
% 211.36/211.60       Tooth Discoloration/therapy %28%1966-1970%29%
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D014073 2004
% 211.36/211.60  |- mesh__historyNote mesh__D014073 72%28%71%29%   
% 211.36/211.60  |- skos__broader mesh__D014073smesh__D004955
% 211.36/211.60  |- rdf__type mesh__D014073sskos__Concept
% 211.36/211.60  |- skos__annotation mesh__D014073 to lighten tooth discoloration   
% 211.36/211.60  |- mesh__dateRevised mesh__D014073 1999-11-03
% 211.36/211.60  |- skos__hiddenLabel mesh__D014073 Tooth Bleachings
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D014073 2002
% 211.36/211.60  |- skos__historyNote mesh__D014073 Mottled Enamel/therapy %28%1966-1970%29%
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008834 1999
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008834 1993
% 211.36/211.60  |- mesh__recordAuthorizer mesh__D008834 PLS
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008834 2003
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008834 1996
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008834 1995
% 211.36/211.60  |- skos__prefLabel mesh__D008834 Microclimate
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008834 2005
% 211.36/211.60  |- skos__hiddenLabel mesh__D008834 Microclimates
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008834 1998
% 211.36/211.60  |- mesh__dateCreated mesh__D008834 1974-12-12
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008834 1992
% 211.36/211.60  |- mesh__recordOriginator mesh__D008834 NLM
% 211.36/211.60  |- mesh__publicMeSHNote mesh__D008834 91; was see under CLIMATE 1975-90   
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008834 2002
% 211.36/211.60  |- skos__broader mesh__D008834smesh__D002980
% 211.36/211.60  |- skos__annotation mesh__D008834
% 211.36/211.60       no qualif; refers to climate in a limited geog or environ area, as in a forest or factory%A%  
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008834 1994
% 211.36/211.60  |- mesh__dateRevised mesh__D008834 1990-04-13
% 211.36/211.60  |- rdf__type mesh__D008834sskos__Concept
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008834 1991
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008834 2001
% 211.36/211.60  |- skos__scopeNote mesh__D008834 The climate of a very small area.     
% 211.36/211.60  |- mesh__recordMaintainer mesh__D008834 NLM
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008834 2000
% 211.36/211.60  |- mesh__dateEstablished mesh__D008834 1991-01-01
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008834 2004
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008834 1997
% 211.36/211.60  |- mesh__historyNote mesh__D008834
% 211.36/211.60       91%28%75%29%; was see under CLIMATE 1975-90   
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008834 2006
% 211.36/211.60  |- skos__annotation mesh__D000851 no qualif; DF: ANONYMS   
% 211.36/211.60  |- mesh__dateRevised mesh__D000851 1995-03-13
% 211.36/211.60  |- mesh__recordAuthorizer mesh__D000851 PLS
% 211.36/211.60  |- mesh__recordMaintainer mesh__D000851 TGC
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D000851 2004
% 211.36/211.60  |- mesh__recordOriginator mesh__D000851 NLM
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D000851 2005
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D000851 2003
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D000851 1999
% 211.36/211.60  |- skos__broader mesh__D000851smesh__D009275
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D000851 2002
% 211.36/211.60  |- skos__hiddenLabel mesh__D000851 Pseudonym
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D000851 1997
% 211.36/211.60  |- skos__scopeNote mesh__D000851
% 211.36/211.60       Designations for persons whose names are not known or who wish to remain anonymous %28%anonyms%29% and for persons who wish to conceal or obscure their identity by assuming a fictitious name %28%pseudonyms%29%.%A%    
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D000851 1998
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D000851 1996
% 211.36/211.60  |- skos__altLabel mesh__D000851 Pseudonyms and Anonyms
% 211.36/211.60  |- mesh__dateCreated mesh__D000851 1999-01-01
% 211.36/211.60  |- rdf__type mesh__D000851sskos__Concept
% 211.36/211.60  |- skos__hiddenLabel mesh__D000851 Anonym
% 211.36/211.60  |- skos__prefLabel mesh__D000851 Anonyms and Pseudonyms
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D000851 2001
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D000851 2006
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D000851 2000
% 211.36/211.60  |- skos__historyNote mesh__D008036 Mandibular Nerve %28%1966-1970%29%
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008036 2000
% 211.36/211.60  |- mesh__recordOriginator mesh__D008036 NLM
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008036 2006
% 211.36/211.60  |- mesh__dateEstablished mesh__D008036 1991-01-01
% 211.36/211.60  |- skos__prefLabel mesh__D008036 Lingual Nerve
% 211.36/211.60  |- mesh__dateCreated mesh__D008036 1999-01-01
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008036 2005
% 211.36/211.60  |- mesh__recordMaintainer mesh__D008036 MSR
% 211.36/211.60  |- skos__hiddenLabel mesh__D008036 Nerves, Lingual
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008036 2002
% 211.36/211.60  |- mesh__recordAuthorizer mesh__D008036 SJN
% 211.36/211.60  |- skos__scopeNote mesh__D008036
% 211.36/211.60       A sensory branch of the MANDIBULAR NERVE, which is part of the trigeminal %28%5th cranial%29% nerve. The lingual nerve carries general afferent fibers from the anterior two-thirds of the tongue, the floor of the mouth, and the mandibular gingivae.%A%    
% 211.36/211.60  |- skos__hiddenLabel mesh__D008036 Nerve, Lingual
% 211.36/211.60  |- skos__broader mesh__D008036smesh__D008340
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008036 2004
% 211.36/211.60  |- mesh__dateRevised mesh__D008036 1998-06-10
% 211.36/211.60  |- mesh__publicMeSHNote mesh__D008036
% 211.36/211.60       91; was see under MANDIBULAR NERVE 1971-90   
% 211.36/211.60  |- rdf__type mesh__D008036sskos__Concept
% 211.36/211.60  |- skos__annotation mesh__D008036
% 211.36/211.60       a branch of the trigeminal %28%5th cranial%29% nerve; dis: coord IM with CRANIAL NERVE DISEASES %28%IM%29%; neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 211.36/211.60  |- mesh__historyNote mesh__D008036
% 211.36/211.60       91%28%71%29%; was see under MANDIBULAR NERVE 1971-90   
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008036 2001
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008036 1999
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D008036 2003
% 211.36/211.60  |- skos__hiddenLabel mesh__D008036 Lingual Nerves
% 211.36/211.60  |- mesh__recordAuthorizer mesh__D000053 sjn
% 211.36/211.60  |- skos__annotation mesh__D000053
% 211.36/211.60       acaricides: index under INSECTICIDES even though Acari are not insects%A%  
% 211.36/211.60  |- skos__scopeNote mesh__D000053
% 211.36/211.60       A large, subclass of arachnids comprising the MITES and TICKS, including parasites of plants, animals, and humans, as well as several important disease vectors.%A%    
% 211.36/211.60  |- mesh__dateCreated mesh__D000053 1999-01-01
% 211.36/211.60  |- mesh__dateRevised mesh__D000053 2003-07-09
% 211.36/211.60  |- rdf__type mesh__D000053sskos__Concept
% 211.36/211.60  |- mesh__recordOriginator mesh__D000053 NLM
% 211.36/211.60  |- mesh__historyNote mesh__D000053 75   
% 211.36/211.60  |- skos__broader mesh__D000053smesh__D001097
% 211.36/211.60  |- mesh__dateEstablished mesh__D000053 1975-01-01
% 211.36/211.60  |- skos__historyNote mesh__D000053 Arachnida %28%1966-1974%29%
% 211.36/211.60  |- skos__prefLabel mesh__D000053 Acari
% 211.36/211.60  |- mesh__publicMeSHNote mesh__D000053 75   
% 211.36/211.60  |- mesh__recordMaintainer mesh__D000053 ags
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D000053 2004
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D000053 2006
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D000053 2005
% 211.36/211.60  |- skos__altLabel mesh__D013779 Tarichatoxin
% 211.36/211.60  |- skos__broader mesh__D013779smesh__D008387
% 211.36/211.60  |- skos__altLabel mesh__D013779 Tetradotoxin
% 211.36/211.60  |- skos__altLabel mesh__D013779 Fugu Toxin
% 211.36/211.60  |- mesh__dateRevised mesh__D013779 2005-06-30
% 211.36/211.60  |- mesh__dateEstablished mesh__D013779 1968-01-01
% 211.36/211.60  |- mesh__recordOriginator mesh__D013779 NLM
% 211.36/211.60  |- skos__broader mesh__D013779smesh__D011799
% 211.36/211.60  |- mesh__recordMaintainer mesh__D013779 ssb
% 211.36/211.60  |- skos__hiddenLabel mesh__D013779 Toxin, Fugu
% 211.36/211.60  |- mesh__recordAuthorizer mesh__D013779 sjn
% 211.36/211.60  |- skos__prefLabel mesh__D013779 Tetrodotoxin
% 211.36/211.60  |- mesh__historyNote mesh__D013779 68%28%64%29%   
% 211.36/211.60  |- skos__scopeNote mesh__D013779
% 211.36/211.60       An aminoperhydroquinazoline poison found mainly in the liver and ovaries of fishes in the order TETRAODONTIFORMES, which are eaten. The toxin causes paresthesia and paralysis through interference with neuromuscular conduction.%A%    
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D013779 2006
% 211.36/211.60  |- skos__annotation mesh__D013779
% 211.36/211.60       /antag permitted but consider also ANTITOXINS   
% 211.36/211.60  |- rdf__type mesh__D013779sskos__Concept
% 211.36/211.60  |- mesh__publicMeSHNote mesh__D013779 68   
% 211.36/211.60  |- mesh__dateCreated mesh__D013779 1999-01-01
% 211.36/211.60  |- skos__historyNote mesh__D010481 Anus %28%1966-1967%29%
% 211.36/211.60  |- mesh__recordMaintainer mesh__D010481 TGC
% 211.36/211.60  |- mesh__dateRevised mesh__D010481 1991-01-08
% 211.36/211.60  |- skos__broader mesh__D010481smesh__D000825
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D010481 2003
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D010481 2000
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D010481 1996
% 211.36/211.60  |- mesh__publicMeSHNote mesh__D010481 68   
% 211.36/211.60  |- mesh__dateEstablished mesh__D010481 1968-01-01
% 211.36/211.60  |- skos__prefLabel mesh__D010481 Perianal Glands
% 211.36/211.60  |- skos__hiddenLabel mesh__D010481 Glands, Perianal
% 211.36/211.60  |- skos__altLabel mesh__D010481 Circumanal Glands
% 211.36/211.60  |- mesh__activeMeSHYear mesh__D010481 2001
% 211.36/211.60  |- rdf__type mesh__D010481sskos__Concept
% 211.36/211.60  |- skos__hiddenLabel mesh__D010481 Gland, Circumanal
% 211.46/211.60  |- skos__hiddenLabel mesh__D010481 Circumanal Gland
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D010481 1992
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D010481 2004
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D010481 1997
% 211.46/211.60  |- skos__annotation mesh__D010481 animal only   
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D010481 2002
% 211.46/211.60  |- skos__hiddenLabel mesh__D010481 Perianal Gland
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D010481 2005
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D010481 1998
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D010481 1993
% 211.46/211.60  |- skos__hiddenLabel mesh__D010481 Gland, Perianal
% 211.46/211.60  |- mesh__recordOriginator mesh__D010481 NLM
% 211.46/211.60  |- mesh__recordAuthorizer mesh__D010481 PLS
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D010481 1994
% 211.46/211.60  |- mesh__dateCreated mesh__D010481 1999-01-01
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D010481 2006
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D010481 1999
% 211.46/211.60  |- skos__hiddenLabel mesh__D010481 Glands, Circumanal
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D010481 1995
% 211.46/211.60  |- mesh__historyNote mesh__D010481 68   
% 211.46/211.60  |- mesh__historyNote mesh__D032135 2003   
% 211.46/211.60  |- skos__broader mesh__D032135smesh__D029633
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D032135 2006
% 211.46/211.60  |- mesh__publicMeSHNote mesh__D032135 2003   
% 211.46/211.60  |- mesh__dateEstablished mesh__D032135 2003-01-01
% 211.46/211.60  |- rdf__type mesh__D032135sskos__Concept
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D032135 2005
% 211.46/211.60  |- skos__prefLabel mesh__D032135 Kadsura
% 211.46/211.60  |- skos__scopeNote mesh__D032135
% 211.46/211.60       A plant genus of the family SCHISANDRACEAE that is used in folk medicine much like SCHISANDRA. Members contain kadsurenone and kadsurin.%A%    
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D032135 2004
% 211.46/211.60  |- mesh__dateCreated mesh__D032135 2002-07-03
% 211.46/211.60  |- skos__annotation mesh__D032135
% 211.46/211.60       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D032135 2003
% 211.46/211.60  |- skos__scopeNote mesh__D051898
% 211.46/211.60       A receptor-regulated smad protein that undergoes PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS. It regulates BONE MORPHOGENETIC PROTEIN signaling and plays an essential role in EMBRYONIC DEVELOPMENT.%A%    
% 211.46/211.60  |- mesh__historyNote mesh__D051898 2006   
% 211.46/211.60  |- mesh__dateEstablished mesh__D051898 2006-01-01
% 211.46/211.60  |- mesh__publicMeSHNote mesh__D051898 2006   
% 211.46/211.60  |- mesh__recordOriginator mesh__D051898 DRC
% 211.46/211.60  |- mesh__dateCreated mesh__D051898 2005-06-30
% 211.46/211.60  |- skos__prefLabel mesh__D051898 Smad1 Protein
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D051898 2006
% 211.46/211.60  |- mesh__recordMaintainer mesh__D051898 ags
% 211.46/211.60  |- rdf__type mesh__D051898sskos__Concept
% 211.46/211.60  |- skos__broader mesh__D051898smesh__D051896
% 211.46/211.60  |- mesh__recordAuthorizer mesh__D051898 ags
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D051898 2006A
% 211.46/211.60  |- mesh__dateRevised mesh__D051898 2005-07-08
% 211.46/211.60  |- mesh__dateCreated mesh__D004444 1999-01-01
% 211.46/211.60  |- skos__hiddenLabel mesh__D004444 Hepatic Hydatid Cyst
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D004444 2005
% 211.46/211.60  |- skos__hiddenLabel mesh__D004444 Echinococcis, Hepatic Alveolar
% 211.46/211.60  |- mesh__recordMaintainer mesh__D004444 lkt
% 211.46/211.60  |- skos__hiddenLabel mesh__D004444 Echinococcoses, Hepatic Alveolar
% 211.46/211.60  |- skos__prefLabel mesh__D004444 Echinococcosis, Hepatic
% 211.46/211.60  |- skos__broader mesh__D004444smesh__D008109
% 211.46/211.60  |- rdf__type mesh__D004444sskos__Concept
% 211.46/211.60  |- skos__hiddenLabel mesh__D004444 Alveolar Echinococcosis, Hepatic
% 211.46/211.60  |- mesh__recordAuthorizer mesh__D004444 sjn
% 211.46/211.60  |- skos__altLabel mesh__D004444 Hydatid Cyst, Hepatic
% 211.46/211.60  |- skos__hiddenLabel mesh__D004444 Echinococcoses, Hepatic
% 211.46/211.60  |- mesh__recordOriginator mesh__D004444 NLM
% 211.46/211.60  |- skos__scopeNote mesh__D004444
% 211.46/211.60       Liver disease caused by infections with parasitic tapeworms of the genus ECHINOCOCCUS, such as Echinococcus granulosus or Echinococcus multilocularis. Ingested Echinococcus ova burrow into the intestinal mucosa. The larval migration to the liver via the PORTAL VEIN leads to watery vesicles %28%HYDATID CYST%29%.%A%    
% 211.46/211.60  |- skos__hiddenLabel mesh__D004444 Alveolar Echinococcoses, Hepatic
% 211.46/211.60  |- skos__altLabel mesh__D004444 Alveolar Echinococcis, Hepatic
% 211.46/211.60  |- skos__hiddenLabel mesh__D004444 Hepatic Alveolar Echinococcis
% 211.46/211.60  |- skos__hiddenLabel mesh__D004444 Cysts, Hepatic Hydatid
% 211.46/211.60  |- skos__hiddenLabel mesh__D004444 Hepatic Echinococcoses
% 211.46/211.60  |- skos__altLabel mesh__D004444 Hydatidosis, Hepatic
% 211.46/211.60  |- skos__hiddenLabel mesh__D004444 Hepatic Hydatidosis
% 211.46/211.60  |- mesh__dateRevised mesh__D004444 2004-07-07
% 211.46/211.60  |- skos__altLabel mesh__D004444 Echinococcosis, Hepatic Alveolar
% 211.46/211.60  |- skos__hiddenLabel mesh__D004444 Hydatidoses, Hepatic
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D004444 2006
% 211.46/211.60  |- skos__hiddenLabel mesh__D004444 Hydatid Cysts, Hepatic
% 211.46/211.60  |- skos__hiddenLabel mesh__D004444 Hepatic Echinococcosis
% 211.46/211.60  |- skos__hiddenLabel mesh__D004444 Hepatic Hydatidoses
% 211.46/211.60  |- skos__hiddenLabel mesh__D004444 Cyst, Hepatic Hydatid
% 211.46/211.60  |- skos__hiddenLabel mesh__D004444 Hepatic Alveolar Echinococcoses
% 211.46/211.60  |- skos__hiddenLabel mesh__D004444 Hepatic Hydatid Cysts
% 211.46/211.60  |- skos__hiddenLabel mesh__D004444 Hepatic Alveolar Echinococcosis
% 211.46/211.60  |- skos__broader mesh__D004444smesh__D004443
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D014872 2000
% 211.46/211.60  |- mesh__recordMaintainer mesh__D014872 TGC
% 211.46/211.60  |- skos__historyNote mesh__D014872 Oceanography %28%1966-1971%29%
% 211.46/211.60  |- mesh__dateCreated mesh__D014872 1999-01-01
% 211.46/211.60  |- skos__prefLabel mesh__D014872 Water Movements
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D014872 1997
% 211.46/211.60  |- mesh__publicMeSHNote mesh__D014872 74   
% 211.46/211.60  |- skos__historyNote mesh__D014872 Water %28%1966-1971%29%
% 211.46/211.60  |- skos__annotation mesh__D014872
% 211.46/211.60       no qualif; for waves, currents, tides; floods = NATURAL DISASTERS%A%  
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D014872 2004
% 211.46/211.60  |- mesh__dateRevised mesh__D014872 1989-05-16
% 211.46/211.60  |- rdf__type mesh__D014872sskos__Concept
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D014872 2002
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D014872 1993
% 211.46/211.60  |- mesh__recordOriginator mesh__D014872 NLM
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D014872 1991
% 211.46/211.60  |- mesh__activeMeSHYear mesh__D014872 1996
% 211.46/211.60  |- skos__broader mesh__D014872smesh__D014867
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014872 2003
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014872 1999
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014872 1992
% 211.46/211.61  |- skos__hiddenLabel mesh__D014872 Movements, Water
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014872 2006
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014872 1995
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014872 1998
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014872 2001
% 211.46/211.61  |- skos__hiddenLabel mesh__D014872 Water Movement
% 211.46/211.61  |- skos__hiddenLabel mesh__D014872 Movement, Water
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014872 2005
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014872 1990
% 211.46/211.61  |- mesh__dateEstablished mesh__D014872 1974-01-01
% 211.46/211.61  |- mesh__recordAuthorizer mesh__D014872 PLS
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014872 1994
% 211.46/211.61  |- mesh__historyNote mesh__D014872 74%28%72%29%   
% 211.46/211.61  |- skos__altLabel mesh__D014074 Calcification, Tooth
% 211.46/211.61  |- skos__altLabel mesh__D014074 Teeth Calcification
% 211.46/211.61  |- skos__hiddenLabel mesh__D014074 Calcifications, Teeth
% 211.46/211.61  |- mesh__recordMaintainer mesh__D014074 TGC
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014074 2005
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014074 2002
% 211.46/211.61  |- skos__scopeNote mesh__D014074
% 211.46/211.61       The process whereby calcium salts are deposited in the dental enamel. The process is normal in the development of bones and teeth. %28%Boucher%27%s Clinical Dental Terminology, 4th ed, p43%29%%A%    
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014074 2006
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014074 1998
% 211.46/211.61  |- skos__annotation mesh__D014074
% 211.46/211.61       the physiol process; hypocalcification is probably indexed under AMELOGENESIS IMPERFECTA or DENTAL ENAMEL HYPOPLASIA%A%  
% 211.46/211.61  |- skos__hiddenLabel mesh__D014074 Teeth Calcifications
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014074 2003
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014074 1999
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014074 2000
% 211.46/211.61  |- skos__broader mesh__D014074smesh__D009063
% 211.46/211.61  |- skos__hiddenLabel mesh__D014074 Calcifications, Tooth
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014074 2004
% 211.46/211.61  |- mesh__recordOriginator mesh__D014074 NLM
% 211.46/211.61  |- mesh__dateRevised mesh__D014074 1996-06-10
% 211.46/211.61  |- mesh__publicMeSHNote mesh__D014074 65   
% 211.46/211.61  |- skos__hiddenLabel mesh__D014074 Calcification, Teeth
% 211.46/211.61  |- skos__prefLabel mesh__D014074 Tooth Calcification
% 211.46/211.61  |- skos__hiddenLabel mesh__D014074 Tooth Calcifications
% 211.46/211.61  |- mesh__historyNote mesh__D014074 65   
% 211.46/211.61  |- rdf__type mesh__D014074sskos__Concept
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014074 2001
% 211.46/211.61  |- mesh__recordAuthorizer mesh__D014074 PLS
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014074 1997
% 211.46/211.61  |- mesh__dateCreated mesh__D014074 1999-01-01
% 211.46/211.61  |- mesh__dateEstablished mesh__D014074 1965-01-01
% 211.46/211.61  |- skos__broader mesh__D014074smesh__D002113
% 211.46/211.61  |- skos__prefLabel mesh__D008835 Micrococcaceae
% 211.46/211.61  |- skos__broader mesh__D008835smesh__D000192
% 211.46/211.61  |- mesh__dateCreated mesh__D008835 1999-01-01
% 211.46/211.61  |- mesh__historyNote mesh__D008835 75   
% 211.46/211.61  |- mesh__dateRevised mesh__D008835 2005-06-30
% 211.46/211.61  |- rdf__type mesh__D008835sskos__Concept
% 211.46/211.61  |- skos__historyNote mesh__D008835 Bacteria %28%1966-1974%29%
% 211.46/211.61  |- mesh__publicMeSHNote mesh__D008835 75   
% 211.46/211.61  |- mesh__recordOriginator mesh__D008835 NLM
% 211.46/211.61  |- skos__scopeNote mesh__D008835
% 211.46/211.61       A family of bacteria ranging from free living and saprophytic to parasitic and pathogenic forms.%A%    
% 211.46/211.61  |- mesh__recordMaintainer mesh__D008835 SYSTEM
% 211.46/211.61  |- mesh__recordAuthorizer mesh__D008835 sjn
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D008835 2006
% 211.46/211.61  |- skos__broader mesh__D008835smesh__D006095
% 211.46/211.61  |- mesh__dateEstablished mesh__D008835 1975-01-01
% 211.46/211.61  |- mesh__dateRevised mesh__D000852 2003-07-09
% 211.46/211.61  |- skos__prefLabel mesh__D000852 Anopheles
% 211.46/211.61  |- skos__annotation mesh__D000852
% 211.46/211.61       mosquito; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111%A%  
% 211.46/211.61  |- mesh__recordMaintainer mesh__D000852 ags
% 211.46/211.61  |- mesh__recordOriginator mesh__D000852 NLM
% 211.46/211.61  |- mesh__recordAuthorizer mesh__D000852 sjn
% 211.46/211.61  |- mesh__dateCreated mesh__D000852 1999-01-01
% 211.46/211.61  |- rdf__type mesh__D000852sskos__Concept
% 211.46/211.61  |- skos__scopeNote mesh__D000852
% 211.46/211.61       A genus of mosquitoes %28%CULICIDAE%29% that are known vectors of MALARIA.%A%    
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000852 2006
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000852 2004
% 211.46/211.61  |- skos__broader mesh__D000852smesh__D009033
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000852 2005
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D008037 2001
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D008037 2005
% 211.46/211.61  |- mesh__recordAuthorizer mesh__D008037 PLS
% 211.46/211.61  |- mesh__dateRevised mesh__D008037 1995-05-18
% 211.46/211.61  |- mesh__dateCreated mesh__D008037 1999-01-01
% 211.46/211.61  |- mesh__recordOriginator mesh__D008037 NLM
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D008037 2000
% 211.46/211.61  |- mesh__dateEstablished mesh__D008037 1967-01-01
% 211.46/211.61  |- mesh__recordMaintainer mesh__D008037 TGC
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D008037 1997
% 211.46/211.61  |- mesh__historyNote mesh__D008037 67%28%65%29%   
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D008037 1996
% 211.46/211.61  |- skos__hiddenLabel mesh__D008037 Linguistic
% 211.46/211.61  |- skos__broader mesh__D008037smesh__D007802
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D008037 2004
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D008037 2002
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D008037 1999
% 211.46/211.61  |- rdf__type mesh__D008037sskos__Concept
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D008037 2003
% 211.46/211.61  |- skos__annotation mesh__D008037
% 211.46/211.61       = science of LANGUAGE %26% SPEECH; do not confuse with LANGUAGE %28%what is spoken%29%, SEMANTICS %28%hist or psychol study of language %26% meaning changes%29%, NOMENCLATURE %28%names of things %26% etymology, the origin or words%29%, PHONETICS %28%how words are sounded%29%, LITERATURE %28%literary works%29%, PHILOLOGY %28%study of literature or language as used in literature%29% or VOCABULARY %28%a person%27%s stock of words%29%; grammar, syntax, accent go here; SPEC: SPEC qualif%A%  
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D008037 1998
% 211.46/211.61  |- skos__scopeNote mesh__D008037
% 211.46/211.61       The science of language, including phonetics, phonology, morphology, syntax, semantics, pragmatics, and historical linguistics. %28%Random House Unabridged Dictionary, 2d ed%29%%A%    
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D008037 2006
% 211.46/211.61  |- skos__prefLabel mesh__D008037 Linguistics
% 211.46/211.61  |- mesh__publicMeSHNote mesh__D008037 67   
% 211.46/211.61  |- mesh__recordMaintainer mesh__D000054 TAP
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000054 1997
% 211.46/211.61  |- skos__hiddenLabel mesh__D000054 Accelerations
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000054 1994
% 211.46/211.61  |- rdf__type mesh__D000054sskos__Concept
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000054 1999
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000054 2000
% 211.46/211.61  |- skos__annotation mesh__D000054 IM   
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000054 1993
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000054 1995
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000054 2001
% 211.46/211.61  |- mesh__dateRevised mesh__D000054 1992-03-25
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000054 2003
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000054 2005
% 211.46/211.61  |- mesh__recordOriginator mesh__D000054 NLM
% 211.46/211.61  |- skos__prefLabel mesh__D000054 Acceleration
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000054 2004
% 211.46/211.61  |- mesh__dateCreated mesh__D000054 1999-01-01
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000054 2002
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000054 2006
% 211.46/211.61  |- mesh__recordAuthorizer mesh__D000054 PLS
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000054 1996
% 211.46/211.61  |- skos__broader mesh__D000054smesh__D009038
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000054 1998
% 211.46/211.61  |- skos__broader mesh__D004798Q000097smesh__D004798
% 211.46/211.61  |- rdf__type mesh__D004798Q000097smesh__CompoundConcept
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D018465 2004
% 211.46/211.61  |- skos__altLabel mesh__D018465 Molteno Shunts
% 211.46/211.61  |- skos__historyNote mesh__D018465 Implants, Artificial %28%1980-1994%29%
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D018465 2002
% 211.46/211.61  |- mesh__dateEstablished mesh__D018465 1995-01-01
% 211.46/211.61  |- mesh__publicMeSHNote mesh__D018465 95   
% 211.46/211.61  |- skos__altLabel mesh__D018465 Implants, Molteno
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D018465 2005
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D018465 1999
% 211.46/211.61  |- skos__historyNote mesh__D018465 Glaucoma/surgery %28%1980-1994%29%
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D018465 2000
% 211.46/211.61  |- mesh__historyNote mesh__D018465 95   
% 211.46/211.61  |- mesh__recordAuthorizer mesh__D018465 SJN
% 211.46/211.61  |- mesh__recordMaintainer mesh__D018465 NDW
% 211.46/211.61  |- skos__hiddenLabel mesh__D018465 Shunts, Molteno
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D018465 2006
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D018465 2001
% 211.46/211.61  |- mesh__dateRevised mesh__D018465 1998-06-10
% 211.46/211.61  |- skos__prefLabel mesh__D018465 Molteno Implants
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D018465 2003
% 211.46/211.61  |- mesh__dateCreated mesh__D018465 1994-04-16
% 211.46/211.61  |- skos__broader mesh__D018465smesh__D020327
% 211.46/211.61  |- rdf__type mesh__D018465sskos__Concept
% 211.46/211.61  |- mesh__recordOriginator mesh__D018465 TGC
% 211.46/211.61  |- skos__scopeNote mesh__D018465
% 211.46/211.61       Devices implanted to control intraocular pressure by allowing aqueous fluid to drain from the anterior chamber. %28%Hoffman, Pocket Glossary of Ophthalmologic Terminology, 1989%29%%A%    
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D010482 2002
% 211.46/211.61  |- skos__hiddenLabel mesh__D010482 Periapical Abscesses
% 211.46/211.61  |- skos__hiddenLabel mesh__D010482 Abscess, Apical Alveolar
% 211.46/211.61  |- skos__altLabel mesh__D010482 Alveolar Abscess, Apical
% 211.46/211.61  |- mesh__recordOriginator mesh__D010482 NLM
% 211.46/211.61  |- rdf__type mesh__D010482sskos__Concept
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D010482 1999
% 211.46/211.61  |- skos__hiddenLabel mesh__D010482 Apical Alveolar Abscess
% 211.46/211.61  |- skos__annotation mesh__D010482
% 211.46/211.61       do not confuse with PERIODONTAL ABSCESS: note X refs below; for coord read note on ABSCESS%A%  
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D010482 2006
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D010482 2001
% 211.46/211.61  |- skos__hiddenLabel mesh__D010482 Abscesses, Periapical
% 211.46/211.61  |- skos__prefLabel mesh__D010482 Periapical Abscess
% 211.46/211.61  |- mesh__dateEstablished mesh__D010482 1965-01-01
% 211.46/211.61  |- skos__hiddenLabel mesh__D010482 Apical Dentoalveolar Abscess
% 211.46/211.61  |- skos__hiddenLabel mesh__D010482 Dentoalveolar Abscesses, Apical
% 211.46/211.61  |- mesh__recordAuthorizer mesh__D010482 PLS
% 211.46/211.61  |- skos__hiddenLabel mesh__D010482 Apical Alveolar Abscesses
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D010482 1998
% 211.46/211.61  |- skos__altLabel mesh__D010482 Dentoalveolar Abscess, Apical
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D010482 2005
% 211.46/211.61  |- skos__altLabel mesh__D010482 Abscess, Periapical
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D010482 2000
% 211.46/211.61  |- mesh__publicMeSHNote mesh__D010482 65   
% 211.46/211.61  |- skos__hiddenLabel mesh__D010482 Periodontitis, Suppurative Periapical
% 211.46/211.61  |- skos__altLabel mesh__D010482 Periapical Periodontitis, Suppurative
% 211.46/211.61  |- skos__broader mesh__D010482smesh__D000038
% 211.46/211.61  |- skos__hiddenLabel mesh__D010482 Periodontitides, Suppurative Periapical
% 211.46/211.61  |- skos__hiddenLabel mesh__D010482 Abscesses, Apical Dentoalveolar
% 211.46/211.61  |- skos__scopeNote mesh__D010482
% 211.46/211.61       Acute or chronic inflammation of tissues surrounding the apical portion of a tooth, associated with the collection of pus, resulting from infection following pulp infection through a carious lesion or as a result of an injury causing pulp necrosis. %28%Dorland, 27th ed%29%%A%    
% 211.46/211.61  |- skos__hiddenLabel mesh__D010482 Abscesses, Apical Alveolar
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D010482 1997
% 211.46/211.61  |- mesh__historyNote mesh__D010482 65   
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D010482 2004
% 211.46/211.61  |- skos__broader mesh__D010482smesh__D010485
% 211.46/211.61  |- skos__hiddenLabel mesh__D010482 Abscess, Apical Dentoalveolar
% 211.46/211.61  |- mesh__dateRevised mesh__D010482 1994-05-27
% 211.46/211.61  |- skos__hiddenLabel mesh__D010482 Suppurative Periapical Periodontitides
% 211.46/211.61  |- skos__hiddenLabel mesh__D010482 Apical Dentoalveolar Abscesses
% 211.46/211.61  |- skos__hiddenLabel mesh__D010482 Suppurative Periapical Periodontitis
% 211.46/211.61  |- mesh__dateCreated mesh__D010482 1999-01-01
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D010482 1996
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D010482 2003
% 211.46/211.61  |- skos__altLabel mesh__D010482 Periodontitis, Apical, Suppurative
% 211.46/211.61  |- skos__hiddenLabel mesh__D010482 Alveolar Abscesses, Apical
% 211.46/211.61  |- skos__hiddenLabel mesh__D010482 Periapical Periodontitides, Suppurative
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D010482 1995
% 211.46/211.61  |- mesh__recordMaintainer mesh__D010482 PLS
% 211.46/211.61  |- skos__altLabel mesh__D051899 MADR2 Protein
% 211.46/211.61  |- skos__hiddenLabel mesh__D051899 MAD Related 2 Protein
% 211.46/211.61  |- mesh__dateEstablished mesh__D051899 2006-01-01
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D051899 2006
% 211.46/211.61  |- mesh__recordMaintainer mesh__D051899 ags
% 211.46/211.61  |- mesh__recordAuthorizer mesh__D051899 ags
% 211.46/211.61  |- rdf__type mesh__D051899sskos__Concept
% 211.46/211.61  |- mesh__dateCreated mesh__D051899 2005-06-30
% 211.46/211.61  |- mesh__dateRevised mesh__D051899 2005-08-03
% 211.46/211.61  |- skos__prefLabel mesh__D051899 Smad2 Protein
% 211.46/211.61  |- skos__scopeNote mesh__D051899
% 211.46/211.61       A receptor-regulated smad protein that undergoes PHOSPHORYLATION by ACTIVIN RECEPTORS, TYPE I. It regulates TRANSFORMING GROWTH FACTOR BETA and ACTIVIN signaling.%A%    
% 211.46/211.61  |- mesh__historyNote mesh__D051899 2006%28%1996%29%   
% 211.46/211.61  |- skos__broader mesh__D051899smesh__D051896
% 211.46/211.61  |- mesh__publicMeSHNote mesh__D051899
% 211.46/211.61       2006; SMAD2 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1996-2005%A%  
% 211.46/211.61  |- skos__altLabel mesh__D051899 MAD-Related 2 Protein
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D051899 2006A
% 211.46/211.61  |- mesh__recordOriginator mesh__D051899 DRC
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D004445 2000
% 211.46/211.61  |- skos__altLabel mesh__D004445 Pulmonary Echinococcosis
% 211.46/211.61  |- skos__broader mesh__D004445smesh__D008174
% 211.46/211.61  |- rdf__type mesh__D004445sskos__Concept
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D004445 1999
% 211.46/211.61  |- skos__altLabel mesh__D004445 Pulmonary Hydatid Cyst
% 211.46/211.61  |- skos__altLabel mesh__D004445 Cyst, Pulmonary Hydatid
% 211.46/211.61  |- mesh__recordAuthorizer mesh__D004445 SJN
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D004445 1998
% 211.46/211.61  |- skos__prefLabel mesh__D004445 Echinococcosis, Pulmonary
% 211.46/211.61  |- skos__altLabel mesh__D004445 Cysts, Pulmonary Hydatid
% 211.46/211.61  |- skos__altLabel mesh__D004445 Hydatid Cyst, Pulmonary
% 211.46/211.61  |- mesh__recordMaintainer mesh__D004445 TPW
% 211.46/211.61  |- skos__altLabel mesh__D004445 Pulmonary Echinococcoses
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D004445 2004
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D004445 2002
% 211.46/211.61  |- mesh__recordOriginator mesh__D004445 NLM
% 211.46/211.61  |- skos__altLabel mesh__D004445 Pulmonary Hydatidosis
% 211.46/211.61  |- mesh__dateRevised mesh__D004445 1997-06-20
% 211.46/211.61  |- skos__altLabel mesh__D004445 Hydatidoses, Pulmonary
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D004445 2006
% 211.46/211.61  |- skos__altLabel mesh__D004445 Pulmonary Hydatid Cysts
% 211.46/211.61  |- skos__altLabel mesh__D004445 Hydatid Cysts, Pulmonary
% 211.46/211.61  |- skos__altLabel mesh__D004445 Echinococcoses, Pulmonary
% 211.46/211.61  |- skos__broader mesh__D004445smesh__D004443
% 211.46/211.61  |- skos__scopeNote mesh__D004445
% 211.46/211.61       Helminth infection of the lung caused by Echinococcus granulosus or Echinococcus multilocularis.%A%    
% 211.46/211.61  |- skos__annotation mesh__D004445
% 211.46/211.61       tapeworm infect of the lung; DF: ECHINOCOCCOSIS PULM   
% 211.46/211.61  |- skos__altLabel mesh__D004445 Hydatidosis, Pulmonary
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D004445 2003
% 211.46/211.61  |- skos__altLabel mesh__D004445 Pulmonary Hydatidoses
% 211.46/211.61  |- mesh__dateCreated mesh__D004445 1999-01-01
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D004445 2001
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D004445 2005
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D009130 2004
% 211.46/211.61  |- mesh__recordOriginator mesh__D009130 NLM
% 211.46/211.61  |- skos__hiddenLabel mesh__D009130 Muscles, Involuntary
% 211.46/211.61  |- skos__scopeNote mesh__D009130
% 211.46/211.61       Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. %28%From Stedman, 25th ed%29%%A%    
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D009130 2002
% 211.46/211.61  |- skos__hiddenLabel mesh__D009130 Muscles, Smooth
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D009130 2003
% 211.46/211.61  |- mesh__recordAuthorizer mesh__D009130 sjn
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D009130 2006
% 211.46/211.61  |- skos__hiddenLabel mesh__D009130 Smooth Muscle
% 211.46/211.61  |- skos__altLabel mesh__D009130 Muscle, Involuntary
% 211.46/211.61  |- skos__hiddenLabel mesh__D009130 Involuntary Muscles
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D009130 2005
% 211.46/211.61  |- mesh__dateRevised mesh__D009130 2001-07-25
% 211.46/211.61  |- skos__hiddenLabel mesh__D009130 Smooth Muscles
% 211.46/211.61  |- skos__broader mesh__D009130smesh__D009132
% 211.46/211.61  |- mesh__dateCreated mesh__D009130 1999-01-01
% 211.46/211.61  |- skos__prefLabel mesh__D009130 Muscle, Smooth
% 211.46/211.61  |- skos__annotation mesh__D009130
% 211.46/211.61       coord IM with specific organ %28%NIM %26% then only if pertinent%29%; /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 211.46/211.61  |- mesh__recordMaintainer mesh__D009130 nns
% 211.46/211.61  |- skos__hiddenLabel mesh__D009130 Involuntary Muscle
% 211.46/211.61  |- rdf__type mesh__D009130sskos__Concept
% 211.46/211.61  |- skos__hiddenLabel mesh__D014873 Pollutants, Water
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014873 2004
% 211.46/211.61  |- rdf__type mesh__D014873sskos__Concept
% 211.46/211.61  |- mesh__publicMeSHNote mesh__D014873 75   
% 211.46/211.61  |- mesh__dateRevised mesh__D014873 2003-07-09
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014873 2005
% 211.46/211.61  |- mesh__recordAuthorizer mesh__D014873 sjn
% 211.46/211.61  |- skos__broader mesh__D014873smesh__D004785
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014873 2006
% 211.46/211.61  |- mesh__recordMaintainer mesh__D014873 ssb
% 211.46/211.61  |- mesh__dateCreated mesh__D014873 1999-01-01
% 211.46/211.61  |- skos__historyNote mesh__D014873 Water Pollution %28%1966-1974%29%
% 211.46/211.61  |- mesh__historyNote mesh__D014873 75   
% 211.46/211.61  |- mesh__recordOriginator mesh__D014873 NLM
% 211.46/211.61  |- skos__scopeNote mesh__D014873
% 211.46/211.61       Substances which pollute the water or bodies of water. Use for water pollutants in general or for which there is no specific heading.%A%    
% 211.46/211.61  |- mesh__dateEstablished mesh__D014873 1975-09-01
% 211.46/211.61  |- skos__prefLabel mesh__D014873 Water Pollutants
% 211.46/211.61  |- skos__annotation mesh__D014873
% 211.46/211.61       specify pollutant if pertinent %28%IM or NIM%29%   
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014075 2003
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014075 1999
% 211.46/211.61  |- mesh__dateEstablished mesh__D014075 1965-01-01
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014075 2001
% 211.46/211.61  |- skos__related mesh__D014075smesh__D019243
% 211.46/211.61  |- skos__hiddenLabel mesh__D014075 Discolorations, Tooth
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014075 2004
% 211.46/211.61  |- mesh__recordMaintainer mesh__D014075 ags
% 211.46/211.61  |- mesh__historyNote mesh__D014075 65   
% 211.46/211.61  |- rdf__type mesh__D014075sskos__Concept
% 211.46/211.61  |- mesh__dateRevised mesh__D014075 2005-07-14
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014075 1997
% 211.46/211.61  |- mesh__dateCreated mesh__D014075 1999-01-01
% 211.46/211.61  |- skos__prefLabel mesh__D014075 Tooth Discoloration
% 211.46/211.61  |- skos__scopeNote mesh__D014075
% 211.46/211.61       Any change in the hue, color, or translucency of a tooth due to any cause. Restorative filling materials, drugs %28%both topical and systemic%29%, pulpal necrosis, or hemorrhage may be responsible. %28%Jablonski, Dictionary of Dentistry, 1992, p253%29%%A%    
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014075 2002
% 211.46/211.61  |- skos__annotation mesh__D014075
% 211.46/211.61       external staining or staining within pulp; from any cause; coord IM with cause if pertinent %28%IM or NIM%29%; do not confuse with FLUOROSIS, DENTAL %28%occurring during tooth calcification%29%%A%  
% 211.46/211.61  |- skos__related mesh__D014075smesh__D014073
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014075 2005
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014075 2006A
% 211.46/211.61  |- mesh__recordAuthorizer mesh__D014075 ags
% 211.46/211.61  |- skos__broader mesh__D014075smesh__D014076
% 211.46/211.61  |- skos__hiddenLabel mesh__D014075 Tooth Discolorations
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014075 2006
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014075 2000
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D014075 1998
% 211.46/211.61  |- skos__hiddenLabel mesh__D014075 Discoloration, Tooth
% 211.46/211.61  |- mesh__recordOriginator mesh__D014075 NLM
% 211.46/211.61  |- mesh__publicMeSHNote mesh__D014075 65   
% 211.46/211.61  |- mesh__recordAuthorizer mesh__D008836 sjn
% 211.46/211.61  |- skos__broader mesh__D008836smesh__D004722
% 211.46/211.61  |- skos__prefLabel mesh__D008836 Micrococcal Nuclease
% 211.46/211.61  |- skos__altLabel mesh__D008836 Thermostable Nuclease
% 211.46/211.61  |- mesh__dateEstablished mesh__D008836 1973-01-01
% 211.46/211.61  |- skos__scopeNote mesh__D008836
% 211.46/211.61       An enzyme that catalyzes the endonucleolytic cleavage to 3%27%-phosphomononucleotide and 3%27%-phospholigonucleotide end-products. It can cause hydrolysis of double- or single-stranded DNA or RNA. %28%From Enzyme Nomenclature, 1992%29% EC 3.1.31.1.%A%    
% 211.46/211.61  |- skos__altLabel mesh__D008836 Thermonuclease
% 211.46/211.61  |- mesh__historyNote mesh__D008836 73%28%65%29%   
% 211.46/211.61  |- skos__altLabel mesh__D008836 TNase
% 211.46/211.61  |- skos__broader mesh__D008836smesh__D004706
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D008836 2004
% 211.46/211.61  |- skos__hiddenLabel mesh__D008836 Nuclease, Micrococcal
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D008836 2006
% 211.46/211.61  |- skos__annotation mesh__D008836 DF: STAPH NUCLEASE   
% 211.46/211.61  |- mesh__recordMaintainer mesh__D008836 ssb
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D008836 2005
% 211.46/211.61  |- skos__hiddenLabel mesh__D008836 Nuclease, Thermostable
% 211.46/211.61  |- mesh__publicMeSHNote mesh__D008836 73   
% 211.46/211.61  |- mesh__dateRevised mesh__D008836 2003-07-09
% 211.46/211.61  |- mesh__dateCreated mesh__D008836 1999-01-01
% 211.46/211.61  |- skos__hiddenLabel mesh__D008836 Nuclease, Staphylococcal
% 211.46/211.61  |- skos__altLabel mesh__D008836 Staphylococcal Nuclease
% 211.46/211.61  |- mesh__recordOriginator mesh__D008836 NLM
% 211.46/211.61  |- rdf__type mesh__D008836sskos__Concept
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000853 2002
% 211.46/211.61  |- skos__scopeNote mesh__D000853
% 211.46/211.61       Congenital absence of the eye or eyes.     
% 211.46/211.61  |- mesh__dateCreated mesh__D000853 1999-01-01
% 211.46/211.61  |- rdf__type mesh__D000853sskos__Concept
% 211.46/211.61  |- skos__prefLabel mesh__D000853 Anophthalmos
% 211.46/211.61  |- skos__hiddenLabel mesh__D000853 Anophthalmias
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000853 2006
% 211.46/211.61  |- mesh__dateRevised mesh__D000853 1999-11-03
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000853 2001
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000853 2004
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000853 2005
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000853 2000
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000853 2003
% 211.46/211.61  |- mesh__recordOriginator mesh__D000853 NLM
% 211.46/211.61  |- skos__broader mesh__D000853smesh__D005124
% 211.46/211.61  |- skos__altLabel mesh__D000853 Anophthalmia
% 211.46/211.61  |- skos__annotation mesh__D000853
% 211.46/211.61       absence of one or both eyes; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 211.46/211.61  |- mesh__recordMaintainer mesh__D000853 kle
% 211.46/211.61  |- mesh__recordAuthorizer mesh__D000853 sjn
% 211.46/211.61  |- skos__broader mesh__D008038smesh__D004304
% 211.46/211.61  |- mesh__dateRevised mesh__D008038 2003-07-09
% 211.46/211.61  |- skos__annotation mesh__D008038
% 211.46/211.61       IM for general only, qualif permitted; NIM %28%no qualif%29% with specific drug IM %28%with qualif%29%; /adv eff permitted but be careful: it may be the adv eff of the drug in liniment form, not the liniment%A%  
% 211.46/211.61  |- skos__prefLabel mesh__D008038 Liniments
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D008038 2004
% 211.46/211.61  |- skos__scopeNote mesh__D008038
% 211.46/211.61       Heat-generating liquids that are thinner than ointments and are applied to the skin with friction. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 211.46/211.61  |- mesh__recordOriginator mesh__D008038 NLM
% 211.46/211.61  |- rdf__type mesh__D008038sskos__Concept
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D008038 2005
% 211.46/211.61  |- mesh__dateCreated mesh__D008038 1999-01-01
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D008038 2006
% 211.46/211.61  |- mesh__recordMaintainer mesh__D008038 ssb
% 211.46/211.61  |- mesh__recordAuthorizer mesh__D008038 sjn
% 211.46/211.61  |- skos__hiddenLabel mesh__D000055 Accessory Nerves, Spinal
% 211.46/211.61  |- skos__hiddenLabel mesh__D000055 Nerves, Accessory
% 211.46/211.61  |- skos__hiddenLabel mesh__D000055 Nerves, Spinal Accessory
% 211.46/211.61  |- skos__hiddenLabel mesh__D000055 Nerves, Eleventh Cranial
% 211.46/211.61  |- skos__hiddenLabel mesh__D000055 Nerve, Spinal Accessory
% 211.46/211.61  |- skos__altLabel mesh__D000055 Spinal Accessory Nerve
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000055 2003
% 211.46/211.61  |- mesh__recordMaintainer mesh__D000055 ags
% 211.46/211.61  |- skos__hiddenLabel mesh__D000055 Cranial Nerve, Eleventh
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000055 2005
% 211.46/211.61  |- skos__broader mesh__D000055smesh__D003391
% 211.46/211.61  |- skos__altLabel mesh__D000055 Eleventh Cranial Nerve
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000055 2004
% 211.46/211.61  |- mesh__dateCreated mesh__D000055 1999-01-01
% 211.46/211.61  |- mesh__recordAuthorizer mesh__D000055 sjn
% 211.46/211.61  |- mesh__activeMeSHYear mesh__D000055 2006
% 211.46/211.61  |- skos__scopeNote mesh__D000055
% 211.46/211.61       The 11th cranial nerve. The accessory nerve originates from neurons in the medulla and in the cervical spinal cord. It has a cranial root, which joins the vagus %28%10th cranial%29% nerve and sends motor fibers to the muscles of the larynx, and a spinal root, which sends motor fibers to the trapezius and the sternocleidomastoid muscles. Damage to the nerve produces weakness in head rotation and shoulder elevation.%A%    
% 211.46/211.62  |- skos__hiddenLabel mesh__D000055 Cranial Nerves, Eleventh
% 211.46/211.62  |- skos__prefLabel mesh__D000055 Accessory Nerve
% 211.46/211.62  |- skos__annotation mesh__D000055
% 211.46/211.62       neopl = ACCESSORY NERVE DISEASES %28%IM%29% + CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 211.46/211.62  |- skos__hiddenLabel mesh__D000055 Nerve, Accessory
% 211.46/211.62  |- skos__hiddenLabel mesh__D000055 Eleventh Cranial Nerves
% 211.46/211.62  |- skos__hiddenLabel mesh__D000055 Spinal Accessory Nerves
% 211.46/211.62  |- skos__altLabel mesh__D000055 Cranial Nerve XI
% 211.46/211.62  |- skos__hiddenLabel mesh__D000055 Accessory Nerves
% 211.46/211.62  |- mesh__dateRevised mesh__D000055 2001-07-25
% 211.46/211.62  |- skos__hiddenLabel mesh__D000055 Nerve, Eleventh Cranial
% 211.46/211.62  |- skos__hiddenLabel mesh__D000055 Accessory Nerve, Spinal
% 211.46/211.62  |- mesh__recordOriginator mesh__D000055 NLM
% 211.46/211.62  |- rdf__type mesh__D000055sskos__Concept
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D000055 2002
% 211.46/211.62  |- skos__historyNote mesh__D018466 Gravitation %28%1966-1994%29%
% 211.46/211.62  |- skos__hiddenLabel mesh__D018466 Sensing, Gravity
% 211.46/211.62  |- skos__altLabel mesh__D018466 Gravity Sensing
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018466 2005
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018466 1999
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018466 2002
% 211.46/211.62  |- mesh__historyNote mesh__D018466 95   
% 211.46/211.62  |- skos__prefLabel mesh__D018466 Gravity Perception
% 211.46/211.62  |- skos__annotation mesh__D018466 human, animal or plant   
% 211.46/211.62  |- skos__altLabel mesh__D018466 Gravisensing
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018466 2006
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018466 1996
% 211.46/211.62  |- skos__hiddenLabel mesh__D018466 Gravisensings
% 211.46/211.62  |- mesh__dateEstablished mesh__D018466 1995-01-01
% 211.46/211.62  |- mesh__publicMeSHNote mesh__D018466 95   
% 211.46/211.62  |- skos__broader mesh__D018466smesh__D018521
% 211.46/211.62  |- skos__broader mesh__D018466smesh__D012677
% 211.46/211.62  |- skos__broader mesh__D018466smesh__D010465
% 211.46/211.62  |- skos__hiddenLabel mesh__D018466 Perception, Gravity
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018466 2003
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018466 1997
% 211.46/211.62  |- rdf__type mesh__D018466sskos__Concept
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018466 2000
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018466 2004
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018466 2001
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018466 1995
% 211.46/211.62  |- skos__scopeNote mesh__D018466
% 211.46/211.62       Process whereby a bodily structure or organism %28%animal or plant%29% receives or detects a gravity stimulus. The sensing may be direct or indirect and may or may not initiate a reaction to the stimulus.%A%    
% 211.46/211.62  |- mesh__dateCreated mesh__D018466 1994-06-07
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018466 1998
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D010483 2006
% 211.46/211.62  |- skos__broader mesh__D010483smesh__D009059
% 211.46/211.62  |- skos__hiddenLabel mesh__D010483 Diseases, Periapical
% 211.46/211.62  |- skos__historyNote mesh__D010483 Periodontal Diseases %28%1966-1979%29%
% 211.46/211.62  |- mesh__recordOriginator mesh__D010483 SMH
% 211.46/211.62  |- skos__prefLabel mesh__D010483 Periapical Diseases
% 211.46/211.62  |- skos__hiddenLabel mesh__D010483 Periapical Disease
% 211.46/211.62  |- mesh__recordAuthorizer mesh__D010483 sjn
% 211.46/211.62  |- skos__historyNote mesh__D010483 Periapical Tissue %28%1972-1979%29%
% 211.46/211.62  |- mesh__dateRevised mesh__D010483 2003-07-09
% 211.46/211.62  |- skos__annotation mesh__D010483 inflamm dis = PERIAPICAL PERIODONTITIS   
% 211.46/211.62  |- skos__scopeNote mesh__D010483
% 211.46/211.62       Diseases of the PERIAPICAL TISSUE surrounding the root of the tooth, which is distinguished from DENTAL PULP DISEASES inside the root.%A%    
% 211.46/211.62  |- mesh__dateCreated mesh__D010483 1979-04-25
% 211.46/211.62  |- skos__related mesh__D010483smesh__D003788
% 211.46/211.62  |- rdf__type mesh__D010483sskos__Concept
% 211.46/211.62  |- mesh__historyNote mesh__D010483 80   
% 211.46/211.62  |- mesh__publicMeSHNote mesh__D010483 80   
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D010483 2004
% 211.46/211.62  |- mesh__recordMaintainer mesh__D010483 ssb
% 211.46/211.62  |- skos__hiddenLabel mesh__D010483 Disease, Periapical
% 211.46/211.62  |- mesh__dateEstablished mesh__D010483 1980-01-01
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D010483 2005
% 211.46/211.62  |- rdf__type mesh__D004446sskos__Concept
% 211.46/211.62  |- mesh__dateRevised mesh__D004446 2004-07-07
% 211.46/211.62  |- skos__annotation mesh__D004446
% 211.46/211.62       infection = ECHINOCOCCOSIS or its specifics; coordinate with specific helminth terms %28%for example, ANTIGENS, HELMINTH%29% if pertinent%A%  
% 211.46/211.62  |- skos__scopeNote mesh__D004446
% 211.46/211.62       A genus of very small TAPEWORMS, in the family Taeniidae. The adult form is  found in various CARNIVORA but not humans. The larval form is seen in humans under certain epidemiologic circumstances.%A%    
% 211.46/211.62  |- skos__broader mesh__D004446smesh__D002589
% 211.46/211.62  |- mesh__dateCreated mesh__D004446 1999-01-01
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D004446 2005
% 211.46/211.62  |- skos__prefLabel mesh__D004446 Echinococcus
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D004446 2006
% 211.46/211.62  |- mesh__recordMaintainer mesh__D004446 ags
% 211.46/211.62  |- mesh__recordAuthorizer mesh__D004446 sjn
% 211.46/211.62  |- mesh__recordOriginator mesh__D004446 NLM
% 211.46/211.62  |- skos__historyNote mesh__D009131 Muscle, Smooth %28%1966-1979%29%
% 211.46/211.62  |- skos__broader mesh__D009131smesh__D001808
% 211.46/211.62  |- skos__altLabel mesh__D009131 Vascular Smooth Muscle
% 211.46/211.62  |- skos__annotation mesh__D009131
% 211.46/211.62       coord IM with specific vein or artery %28%NIM %26% then only if pertinent%29%; /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D009131 2005
% 211.46/211.62  |- mesh__dateEstablished mesh__D009131 1980-01-01
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D009131 2004
% 211.46/211.62  |- skos__hiddenLabel mesh__D009131 Muscle, Vascular Smooth
% 211.46/211.62  |- skos__hiddenLabel mesh__D009131 Smooth Muscles, Vascular
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D009131 2002
% 211.46/211.62  |- mesh__historyNote mesh__D009131 80   
% 211.46/211.62  |- skos__scopeNote mesh__D009131
% 211.46/211.62       The nonstriated, involuntary muscle tissue of blood vessels.%A%    
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D009131 2006
% 211.46/211.62  |- mesh__dateCreated mesh__D009131 1979-04-25
% 211.46/211.62  |- skos__hiddenLabel mesh__D009131 Vascular Smooth Muscles
% 211.46/211.62  |- mesh__publicMeSHNote mesh__D009131 80   
% 211.46/211.62  |- mesh__dateRevised mesh__D009131 2001-07-25
% 211.46/211.62  |- mesh__recordOriginator mesh__D009131 VDK
% 211.46/211.62  |- skos__hiddenLabel mesh__D009131 Muscles, Vascular Smooth
% 211.46/211.62  |- mesh__recordAuthorizer mesh__D009131 sjn
% 211.46/211.62  |- rdf__type mesh__D009131sskos__Concept
% 211.46/211.62  |- skos__hiddenLabel mesh__D009131 Smooth Muscle, Vascular
% 211.46/211.62  |- mesh__recordMaintainer mesh__D009131 nns
% 211.46/211.62  |- skos__broader mesh__D009131smesh__D009130
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D009131 2003
% 211.46/211.62  |- skos__prefLabel mesh__D009131 Muscle, Smooth, Vascular
% 211.46/211.62  |- skos__annotation mesh__D014874
% 211.46/211.62       restrict to in situ water in rivers, reservoirs, streams, lakes, sea %26% the like; specify pollutant if pertinent %28%IM or NIM%29%%A%  
% 211.46/211.62  |- mesh__dateEstablished mesh__D014874 1991-01-01
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D014874 2004
% 211.46/211.62  |- skos__hiddenLabel mesh__D014874 Pollutants, Chemical Water
% 211.46/211.62  |- rdf__type mesh__D014874sskos__Concept
% 211.46/211.62  |- mesh__historyNote mesh__D014874
% 211.46/211.62       91%28%75%29%; was see under WATER POLLUTANTS 1975-90   
% 211.46/211.62  |- mesh__dateRevised mesh__D014874 2003-07-09
% 211.46/211.62  |- skos__broader mesh__D014874smesh__D014873
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D014874 2005
% 211.46/211.62  |- mesh__publicMeSHNote mesh__D014874
% 211.46/211.62       91; was see under WATER POLLUTANTS 1975-90   
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D014874 2006
% 211.46/211.62  |- skos__prefLabel mesh__D014874 Water Pollutants, Chemical
% 211.46/211.62  |- mesh__dateCreated mesh__D014874 1999-01-01
% 211.46/211.62  |- skos__scopeNote mesh__D014874
% 211.46/211.62       Chemical compounds which pollute the water of rivers, streams, lakes, the sea, reservoirs, or other bodies of water.%A%    
% 211.46/211.62  |- skos__altLabel mesh__D014874 Chemical Water Pollutants
% 211.46/211.62  |- mesh__recordAuthorizer mesh__D014874 sjn
% 211.46/211.62  |- mesh__recordMaintainer mesh__D014874 ssb
% 211.46/211.62  |- mesh__recordOriginator mesh__D014874 NLM
% 211.46/211.62  |- mesh__dateEstablished mesh__D047250 2005-01-01
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D047250 2006
% 211.46/211.62  |- skos__altLabel mesh__D047250 Calix%28%n%29%Arenes
% 211.46/211.62  |- skos__broader mesh__D047250smesh__D047028
% 211.46/211.62  |- rdf__type mesh__D047250sskos__Concept
% 211.46/211.62  |- mesh__dateCreated mesh__D047250 2004-07-08
% 211.46/211.62  |- mesh__recordAuthorizer mesh__D047250 sjn
% 211.46/211.62  |- skos__scopeNote mesh__D047250
% 211.46/211.62       Phenolic metacyclophanes derived from condensation of PHENOLS and ALDEHYDES. The name derives from the vase-like molecular structures. A bracketed %5B%n%5D% indicates the number of aromatic rings.%A%    
% 211.46/211.62  |- mesh__recordMaintainer mesh__D047250 ssb
% 211.46/211.62  |- skos__altLabel mesh__D047250 Calixarene
% 211.46/211.62  |- skos__prefLabel mesh__D047250 Calixarenes
% 211.46/211.62  |- mesh__publicMeSHNote mesh__D047250 2005   
% 211.46/211.62  |- mesh__historyNote mesh__D047250 2005   
% 211.46/211.62  |- mesh__recordOriginator mesh__D047250 ssb
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D047250 2005
% 211.46/211.62  |- skos__broader mesh__D014076smesh__D009057
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D014076 2004
% 211.46/211.62  |- mesh__historyNote mesh__D014076 65   
% 211.46/211.62  |- rdf__type mesh__D014076sskos__Concept
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D014076 2000
% 211.46/211.62  |- skos__hiddenLabel mesh__D014076 Diseases, Tooth
% 211.46/211.62  |- skos__hiddenLabel mesh__D014076 Disease, Tooth
% 211.46/211.62  |- mesh__publicMeSHNote mesh__D014076 65   
% 211.46/211.62  |- mesh__recordMaintainer mesh__D014076 kle
% 211.46/211.62  |- mesh__recordOriginator mesh__D014076 NLM
% 211.46/211.62  |- mesh__recordAuthorizer mesh__D014076 sjn
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D014076 2001
% 211.46/211.62  |- skos__prefLabel mesh__D014076 Tooth Diseases
% 211.46/211.62  |- mesh__dateCreated mesh__D014076 1999-01-01
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D014076 2005
% 211.46/211.62  |- mesh__dateRevised mesh__D014076 1999-11-03
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D014076 2006
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D014076 2002
% 211.46/211.62  |- skos__annotation mesh__D014076 GEN: prefer specifics   
% 211.46/211.62  |- skos__hiddenLabel mesh__D014076 Tooth Disease
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D014076 2003
% 211.46/211.62  |- skos__related mesh__D014076smesh__D009065
% 211.46/211.62  |- skos__broader mesh__D008837smesh__D008835
% 211.46/211.62  |- skos__scopeNote mesh__D008837
% 211.46/211.62       A genus of gram-positive, spherical bacteria found in soils and fresh water, and frequently on the skin of man and other animals.%A%    
% 211.46/211.62  |- mesh__recordMaintainer mesh__D008837 SYSTEM
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D008837 2006
% 211.46/211.62  |- mesh__historyNote mesh__D008837
% 211.46/211.62       GAFFKYA TETRAGENA was see MICROCOCCUS 1979-91; GAFFKYA was see under MICROCOCCACEAE 1976-78, was heading 1963-75%A%  
% 211.46/211.62  |- skos__prefLabel mesh__D008837 Micrococcus
% 211.46/211.62  |- mesh__dateCreated mesh__D008837 1999-01-01
% 211.46/211.62  |- mesh__recordOriginator mesh__D008837 NLM
% 211.46/211.62  |- mesh__dateRevised mesh__D008837 2005-06-30
% 211.46/211.62  |- skos__annotation mesh__D008837
% 211.46/211.62       found in soil %26% fresh water %26% on mammalian skin   
% 211.46/211.62  |- rdf__type mesh__D008837sskos__Concept
% 211.46/211.62  |- mesh__publicMeSHNote mesh__D008837
% 211.46/211.62       GAFFKYA TETRAGENA was see MICROCOCCUS 1979-91; GAFFKYA was see under MICROCOCCACEAE 1976-78, was heading 1963-75%A%  
% 211.46/211.62  |- mesh__recordAuthorizer mesh__D008837 sjn
% 211.46/211.62  |- mesh__onlineNote mesh__D008837
% 211.46/211.62       use MICROCOCCUS to search GAFFKYA TETRAGENA 1979-91 %26% GAFFKYA 1966-78%A%  
% 211.46/211.62  |- mesh__recordAuthorizer mesh__D000854 jls
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D000854 2006A
% 211.46/211.62  |- skos__annotation mesh__D000854
% 211.46/211.62       do not use /drug eff for insecticides: TN 111   
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D000854 2006
% 211.46/211.62  |- skos__prefLabel mesh__D000854 Anoplura
% 211.46/211.62  |- skos__altLabel mesh__D000854 Sucking Lice
% 211.46/211.62  |- skos__broader mesh__D000854smesh__D008003
% 211.46/211.62  |- mesh__dateEstablished mesh__D000854 1972-01-01
% 211.46/211.62  |- skos__scopeNote mesh__D000854
% 211.46/211.62       An order of insects comprising the sucking lice, which are blood-sucking ectoparasites of mammals. Recognized families include: Echinphthiriidae, Haematopinidae, and Pediculidae. The latter contains the medically important genera affecting humans: PEDICULUS and PHTHIRUS.%A%    
% 211.46/211.62  |- mesh__dateRevised mesh__D000854 2005-07-29
% 211.46/211.62  |- mesh__historyNote mesh__D000854 72   
% 211.46/211.62  |- skos__historyNote mesh__D000854 Lice %28%1966-1971%29%
% 211.46/211.62  |- skos__altLabel mesh__D000854 Sucking Louse
% 211.46/211.62  |- mesh__publicMeSHNote mesh__D000854 72   
% 211.46/211.62  |- mesh__dateCreated mesh__D000854 1999-01-01
% 211.46/211.62  |- mesh__recordOriginator mesh__D000854 NLM
% 211.46/211.62  |- mesh__recordMaintainer mesh__D000854 jls
% 211.46/211.62  |- rdf__type mesh__D000854sskos__Concept
% 211.46/211.62  |- mesh__historyNote mesh__D008039
% 211.46/211.62       91%28%75%29%; was see under CARCINOMA, SCIRRHOUS 1975-90   
% 211.46/211.62  |- mesh__onlineNote mesh__D008039 search CARCINOMA, SCIRRHOUS 1966-74   
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D008039 2003
% 211.46/211.62  |- mesh__recordAuthorizer mesh__D008039 sjn
% 211.46/211.62  |- mesh__dateEstablished mesh__D008039 1991-01-01
% 211.46/211.62  |- mesh__recordMaintainer mesh__D008039 KEV
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D008039 2004
% 211.46/211.62  |- skos__annotation mesh__D008039
% 211.46/211.62       neoplastic; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with STOMACH NEOPLASMS %28%IM%29%%A%  
% 211.46/211.62  |- rdf__type mesh__D008039sskos__Concept
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D008039 2005
% 211.46/211.62  |- mesh__dateRevised mesh__D008039 1999-11-03
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D008039 2000
% 211.46/211.62  |- mesh__dateCreated mesh__D008039 1999-01-01
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D008039 2001
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D008039 2006
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D008039 2002
% 211.46/211.62  |- mesh__recordOriginator mesh__D008039 NLM
% 211.46/211.62  |- skos__scopeNote mesh__D008039
% 211.46/211.62       A condition where the stomach wall becomes thickened, rubbery and loses its ability to distend. The stomach assumes a %22%leather bottle%22% shape. It is most often seen in adenocarcinoma of the stomach. The term is often used synonymously with diffuse adenocarcinoma of the stomach.%A%    
% 211.46/211.62  |- skos__prefLabel mesh__D008039 Linitis Plastica
% 211.46/211.62  |- skos__broader mesh__D008039smesh__D002293
% 211.46/211.62  |- mesh__publicMeSHNote mesh__D008039
% 211.46/211.62       91; was see under CARCINOMA, SCIRRHOUS 1975-90   
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D000056 2005
% 211.46/211.62  |- skos__hiddenLabel mesh__D000056 Accident Preventions
% 211.46/211.62  |- skos__broader mesh__D000056smesh__D000059
% 211.46/211.62  |- mesh__dateCreated mesh__D000056 1999-01-01
% 211.46/211.62  |- skos__hiddenLabel mesh__D000056 Preventions, Accident
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D000056 2006
% 211.46/211.62  |- mesh__recordOriginator mesh__D000056 NLM
% 211.46/211.62  |- skos__altLabel mesh__D000056 Prevention, Accident
% 211.46/211.62  |- mesh__dateRevised mesh__D000056 2004-07-07
% 211.46/211.62  |- skos__prefLabel mesh__D000056 Accident Prevention
% 211.46/211.62  |- skos__scopeNote mesh__D000056
% 211.46/211.62       Efforts and designs to reduce the incidence of unexpected undesirable events in various environments and situations.%A%    
% 211.46/211.62  |- rdf__type mesh__D000056sskos__Concept
% 211.46/211.62  |- mesh__recordMaintainer mesh__D000056 lkt
% 211.46/211.62  |- skos__related mesh__D000056smesh__D011482
% 211.46/211.62  |- mesh__recordAuthorizer mesh__D000056 sjn
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018467 2000
% 211.46/211.62  |- skos__broader mesh__D018467smesh__D012131
% 211.46/211.62  |- skos__hiddenLabel mesh__D018467
% 211.46/211.62       Positive Pressure Respiration, Non Therapeutic
% 211.46/211.62  |- mesh__dateRevised mesh__D018467 1996-06-10
% 211.46/211.62  |- skos__hiddenLabel mesh__D018467 Occult PEEP
% 211.46/211.62  |- skos__hiddenLabel mesh__D018467
% 211.46/211.62       Non Therapeutic Positive Pressure Respiration
% 211.46/211.62  |- mesh__dateCreated mesh__D018467 1994-04-16
% 211.46/211.62  |- rdf__type mesh__D018467sskos__Concept
% 211.46/211.62  |- skos__altLabel mesh__D018467
% 211.46/211.62       Positive-Pressure Respiration, Non-Therapeutic
% 211.46/211.62  |- skos__altLabel mesh__D018467 Auto-PEEP
% 211.46/211.62  |- skos__hiddenLabel mesh__D018467
% 211.46/211.62       Positive Pressure Respiration, Nontherapeutic
% 211.46/211.62  |- skos__hiddenLabel mesh__D018467
% 211.46/211.62       Respiration, Non Therapeutic Positive Pressure
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018467 1999
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018467 2004
% 211.46/211.62  |- skos__altLabel mesh__D018467 PEEP, Intrinsic
% 211.46/211.62  |- skos__hiddenLabel mesh__D018467 Intrinsic Positive-Pressure Respiration
% 211.46/211.62  |- skos__scopeNote mesh__D018467
% 211.46/211.62       Non-therapeutic positive end-expiratory pressure occurring frequently in patients with severe airway obstruction. It can appear with or without the administration of external positive end-expiratory pressure %28%POSITIVE-PRESSURE RESPIRATION%29%. It presents an important load on the inspiratory muscles which are operating at a mechanical disadvantage due to hyperinflation. Auto-PEEP may cause profound hypotension that should be treated by intravascular volume expansion, increasing the time for expiration, and/or changing from assist mode to intermittent mandatory ventilation mode. %28%From Harrison%27%s Principles of Internal Medicine, 12th ed, p1127%29%%A%    
% 211.46/211.62  |- skos__altLabel mesh__D018467 AutoPEEP
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018467 2002
% 211.46/211.62  |- skos__altLabel mesh__D018467 PEEP, Occult
% 211.46/211.62  |- skos__altLabel mesh__D018467
% 211.46/211.62       Respiration, Non-Therapeutic Positive-Pressure
% 211.46/211.62  |- skos__annotation mesh__D018467
% 211.46/211.62       note category: a type of resp insuff; do not confuse with POSITIVE END-EXPIRATORY PRESSURE or PEEP see POSITIVE-PRESSURE RESPIRATION, a form of artif resp %28%Cat E%29%; DF: note short X ref%A%  
% 211.46/211.62  |- skos__hiddenLabel mesh__D018467 Intrinsic PEEP
% 211.46/211.62  |- mesh__recordMaintainer mesh__D018467 TGC
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018467 1998
% 211.46/211.62  |- skos__hiddenLabel mesh__D018467 Positive Pressure Respiration, Intrinsic
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018467 2003
% 211.46/211.62  |- skos__hiddenLabel mesh__D018467 Respiration, Occult Positive-Pressure
% 211.46/211.62  |- skos__altLabel mesh__D018467
% 211.46/211.62       Non-Therapeutic Positive-Pressure Respiration
% 211.46/211.62  |- skos__hiddenLabel mesh__D018467 Respiration, Intrinsic Positive-Pressure
% 211.46/211.62  |- skos__altLabel mesh__D018467
% 211.46/211.62       Positive-Pressure Respiration, Nontherapeutic
% 211.46/211.62  |- skos__altLabel mesh__D018467 Positive-Pressure Respiration, Occult
% 211.46/211.62  |- skos__historyNote mesh__D018467
% 211.46/211.62       Positive-Pressure Respiration %28%1982-1994%29%
% 211.46/211.62  |- skos__prefLabel mesh__D018467 Positive-Pressure Respiration, Intrinsic
% 211.46/211.62  |- skos__altLabel mesh__D018467
% 211.46/211.62       Respiration, Nontherapeutic Positive-Pressure
% 211.46/211.62  |- skos__altLabel mesh__D018467
% 211.46/211.62       Nontherapeutic Positive-Pressure Respiration
% 211.46/211.62  |- skos__hiddenLabel mesh__D018467
% 211.46/211.62       Nontherapeutic Positive Pressure Respiration
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018467 2006
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018467 2001
% 211.46/211.62  |- mesh__publicMeSHNote mesh__D018467 95   
% 211.46/211.62  |- skos__hiddenLabel mesh__D018467 Occult Positive-Pressure Respiration
% 211.46/211.62  |- mesh__dateEstablished mesh__D018467 1995-01-01
% 211.46/211.62  |- mesh__historyNote mesh__D018467 95   
% 211.46/211.62  |- mesh__recordOriginator mesh__D018467 TGC
% 211.46/211.62  |- mesh__recordAuthorizer mesh__D018467 PLS
% 211.46/211.62  |- skos__hiddenLabel mesh__D018467 Auto PEEP
% 211.46/211.62  |- skos__hiddenLabel mesh__D018467 Positive Pressure Respiration, Occult
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018467 1997
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D018467 2005
% 211.46/211.62  |- skos__hiddenLabel mesh__D018467
% 211.46/211.62       Respiration, Nontherapeutic Positive Pressure
% 211.46/211.62  |- skos__prefLabel mesh__D010484 Periapical Granuloma
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D010484 2001
% 211.46/211.62  |- skos__altLabel mesh__D010484 Dental Granuloma
% 211.46/211.62  |- mesh__onlineNote mesh__D010484
% 211.46/211.62       use PERIAPICAL GRANULOMA to search GRANULOMA, PERIAPICAL 1966-79%A%  
% 211.46/211.62  |- skos__hiddenLabel mesh__D010484 Granulomas, Periapical
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D010484 2002
% 211.46/211.62  |- skos__altLabel mesh__D010484 Granuloma, Periapical
% 211.46/211.62  |- skos__altLabel mesh__D010484 Granuloma, Dental
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D010484 2003
% 211.46/211.62  |- mesh__dateRevised mesh__D010484 1999-11-03
% 211.46/211.62  |- mesh__recordOriginator mesh__D010484 NLM
% 211.46/211.62  |- skos__scopeNote mesh__D010484
% 211.46/211.62       Chronic nonsuppurative inflammation of periapical tissue resulting from irritation following pulp disease or endodontic treatment.%A%    
% 211.46/211.62  |- mesh__publicMeSHNote mesh__D010484
% 211.46/211.62       80; was GRANULOMA, PERIAPICAL 1965-79   
% 211.46/211.62  |- rdf__type mesh__D010484sskos__Concept
% 211.46/211.62  |- skos__altLabel mesh__D010484 Granulomas, Dental
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D010484 2004
% 211.46/211.62  |- mesh__recordAuthorizer mesh__D010484 sjn
% 211.46/211.62  |- skos__broader mesh__D010484smesh__D010485
% 211.46/211.62  |- mesh__dateEstablished mesh__D010484 1965-01-01
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D010484 2005
% 211.46/211.62  |- mesh__recordMaintainer mesh__D010484 KEV
% 211.46/211.62  |- mesh__historyNote mesh__D010484 80; was GRANULOMA, PERIAPICAL 1965-79   
% 211.46/211.62  |- mesh__dateCreated mesh__D010484 1999-01-01
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D010484 2006
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D010484 2000
% 211.46/211.62  |- skos__hiddenLabel mesh__D010484 Periapical Granulomas
% 211.46/211.62  |- mesh__dateRevised mesh__D037621 2005-06-30
% 211.46/211.62  |- mesh__recordOriginator mesh__D037621 ssb
% 211.46/211.62  |- skos__broader mesh__D037621smesh__D012717
% 211.46/211.62  |- rdf__type mesh__D037621sskos__Concept
% 211.46/211.62  |- skos__historyNote mesh__D037621 Sesquiterpenes %28%1982-2002%29%
% 211.46/211.62  |- mesh__recordAuthorizer mesh__D037621 sjn
% 211.46/211.62  |- mesh__historyNote mesh__D037621 2003   
% 211.46/211.62  |- mesh__publicMeSHNote mesh__D037621 2003   
% 211.46/211.62  |- skos__prefLabel mesh__D037621 Artemisinins
% 211.46/211.62  |- skos__scopeNote mesh__D037621
% 211.46/211.62       A group of SESQUITERPENES and their analogs that contain a peroxide group %28%PEROXIDES%29% within an oxepin ring %28%OXEPINS%29%.%A%    
% 211.46/211.62  |- mesh__dateCreated mesh__D037621 2002-07-02
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D037621 2006
% 211.46/211.62  |- mesh__dateEstablished mesh__D037621 2003-01-01
% 211.46/211.62  |- skos__broader mesh__D037621smesh__D010545
% 211.46/211.62  |- mesh__recordMaintainer mesh__D037621 ssb
% 211.46/211.62  |- mesh__dateRevised mesh__D004447 2003-07-09
% 211.46/211.62  |- skos__annotation mesh__D004447
% 211.46/211.62       includes SEA URCHINS; STARFISH; sea lilies, SEA CUCUMBERS %26% brittle stars; /microbiol /parasitol /virol permitted%A%  
% 211.46/211.62  |- mesh__recordAuthorizer mesh__D004447 sjn
% 211.46/211.62  |- mesh__recordOriginator mesh__D004447 NLM
% 211.46/211.62  |- mesh__dateCreated mesh__D004447 1999-01-01
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D004447 2005
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D004447 2004
% 211.46/211.62  |- skos__broader mesh__D004447smesh__D007448
% 211.46/211.62  |- skos__scopeNote mesh__D004447
% 211.46/211.62       A phylum of the most familiar marine invertebrates. Its class Stelleroidea contains two subclasses, the Asteroidea %28%the STARFISH or sea stars%29% and the Ophiuroidea %28%the brittle stars, also called basket stars and serpent stars%29%. There are 1500 described species of STARFISH found throughout the world. The second class, Echinoidea, contains about 950 species of SEA URCHINS, heart urchins, and sand dollars. A third class, Holothuroidea, comprises about 900 echinoderms known as SEA CUCUMBERS. Echinoderms are used extensively in biological research. %28%From Barnes, Invertebrate Zoology, 5th ed, pp773-826%29%%A%    
% 211.46/211.62  |- skos__prefLabel mesh__D004447 Echinodermata
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D004447 2006
% 211.46/211.62  |- mesh__recordMaintainer mesh__D004447 ags
% 211.46/211.62  |- rdf__type mesh__D004447sskos__Concept
% 211.46/211.62  |- mesh__recordOriginator mesh__D009930 NLM
% 211.46/211.62  |- mesh__dateRevised mesh__D009930 2000-06-22
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D009930 2001
% 211.46/211.62  |- mesh__publicMeSHNote mesh__D009930 98   
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D009930 2006
% 211.46/211.62  |- mesh__runningHead mesh__D009930 D2 - ORGANIC CHEMICALS   
% 211.46/211.62  |- mesh__dateCreated mesh__D009930 1999-01-01
% 211.46/211.62  |- mesh__recordAuthorizer mesh__D009930 sjn
% 211.46/211.62  |- skos__hiddenLabel mesh__D009930 Chemicals, Organic
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D009930 2005
% 211.46/211.62  |- mesh__dateEstablished mesh__D009930 1998-01-01
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D009930 2004
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D009930 2002
% 211.46/211.62  |- skos__scopeNote mesh__D009930
% 211.46/211.62       A broad class of substances containing carbon and its derivatives. Many of these chemicals will frequently contain hydrogen with or without oxygen, nitrogen, sulfur, phosphorus, and other elements. They exist in either carbon chain or carbon ring form.%A%    
% 211.46/211.62  |- rdf__type mesh__D009930sskos__Concept
% 211.46/211.62  |- skos__annotation mesh__D009930
% 211.46/211.62       GEN or unspecified; prefer specific groups or specific chemicals%A%  
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D009930 2003
% 211.46/211.62  |- mesh__recordMaintainer mesh__D009930 jls
% 211.46/211.62  |- skos__prefLabel mesh__D009930 Organic Chemicals
% 211.46/211.62  |- mesh__historyNote mesh__D009930 98; use explode 1967-97   
% 211.46/211.62  |- mesh__dateCreated mesh__D009132 1999-01-01
% 211.46/211.62  |- mesh__recordMaintainer mesh__D009132 ags
% 211.46/211.62  |- skos__annotation mesh__D009132
% 211.46/211.62       Manual 21.8; as tissue: Manual 21.9, 21.52; unspecified as smooth or striated; MUSCLES, SKELETAL and  MUSCLE, SMOOTH and their indentions are available; /innerv: consider also NEUROMUSCULAR JUNCTION %26% MUSCLE DENERVATION; /surg: consider also SURGICAL FLAPS but see note there;  /embryol: coord with MUSCLE DEVELOPMENT if pertinent; inflammation = MYOSITIS%A%  
% 211.46/211.62  |- skos__scopeNote mesh__D009132
% 211.46/211.62       Contractile tissue that produces movement in animals.     
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D009132 2006
% 211.46/211.62  |- mesh__publicMeSHNote mesh__D009132
% 211.46/211.62       /transplantation was MUSCLE TRANSPLANTATION 1963-65   
% 211.46/211.62  |- mesh__dateRevised mesh__D009132 2004-07-07
% 211.46/211.62  |- skos__broader mesh__D009132smesh__D014024
% 211.46/211.62  |- mesh__considerAlso mesh__D009132 consider also terms at MYO-   
% 211.46/211.62  |- skos__prefLabel mesh__D009132 Muscles
% 211.46/211.62  |- skos__broader mesh__D009132smesh__D009141
% 211.46/211.62  |- rdf__type mesh__D009132sskos__Concept
% 211.46/211.62  |- skos__related mesh__D009132smesh__D009213
% 211.46/211.62  |- mesh__historyNote mesh__D009132
% 211.46/211.62       /transplantation was MUSCLE TRANSPLANTATION 1963-65   
% 211.46/211.62  |- skos__hiddenLabel mesh__D009132 Muscle
% 211.46/211.62  |- mesh__recordOriginator mesh__D009132 NLM
% 211.46/211.62  |- skos__related mesh__D009132smesh__D012508
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D009132 2005
% 211.46/211.62  |- mesh__recordAuthorizer mesh__D009132 sjn
% 211.46/211.62  |- skos__related mesh__D009132smesh__D012519
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D014875 2006
% 211.46/211.62  |- skos__broader mesh__D014875smesh__D011848
% 211.46/211.62  |- skos__annotation mesh__D014875
% 211.46/211.62       specify radiopollutant if pertinent %28%IM or NIM%29%   
% 211.46/211.62  |- mesh__dateCreated mesh__D014875 1999-01-01
% 211.46/211.62  |- mesh__recordAuthorizer mesh__D014875 sjn
% 211.46/211.62  |- mesh__recordMaintainer mesh__D014875 ssb
% 211.46/211.62  |- skos__hiddenLabel mesh__D014875 Radioactive Water Pollutants
% 211.46/211.62  |- skos__hiddenLabel mesh__D014875 Pollutants, Radioactive Water
% 211.46/211.62  |- mesh__recordOriginator mesh__D014875 NLM
% 211.46/211.62  |- skos__prefLabel mesh__D014875 Water Pollutants, Radioactive
% 211.46/211.62  |- skos__scopeNote mesh__D014875
% 211.46/211.62       Pollutants, present in water or bodies of water, which exhibit radioactivity.%A%    
% 211.46/211.62  |- mesh__publicMeSHNote mesh__D014875
% 211.46/211.62       91; was see under WATER POLLUTANTS 1975-90   
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D014875 2004
% 211.46/211.62  |- rdf__type mesh__D014875sskos__Concept
% 211.46/211.62  |- mesh__historyNote mesh__D014875
% 211.46/211.62       91%28%75%29%; was see under WATER POLLUTANTS 1975-90   
% 211.46/211.62  |- mesh__dateRevised mesh__D014875 2003-07-09
% 211.46/211.62  |- skos__broader mesh__D014875smesh__D014873
% 211.46/211.62  |- mesh__dateEstablished mesh__D014875 1991-01-01
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D014875 2005
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D014077 2005
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D014077 1999
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D014077 2004
% 211.46/211.62  |- skos__broader mesh__D014077smesh__D014076
% 211.46/211.62  |- mesh__activeMeSHYear mesh__D014077 2000
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014077 2003
% 211.46/211.63  |- mesh__publicMeSHNote mesh__D014077 65   
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014077 1998
% 211.46/211.63  |- skos__prefLabel mesh__D014077 Tooth Erosion
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014077 1997
% 211.46/211.63  |- rdf__type mesh__D014077sskos__Concept
% 211.46/211.63  |- mesh__recordAuthorizer mesh__D014077 PLS
% 211.46/211.63  |- mesh__recordMaintainer mesh__D014077 TGC
% 211.46/211.63  |- mesh__historyNote mesh__D014077 65   
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014077 2002
% 211.46/211.63  |- skos__scopeNote mesh__D014077
% 211.46/211.63       Progressive loss of the hard substance of a tooth by chemical processes that do not involve bacterial action. %28%Jablonski, Dictionary of Dentistry, 1992, p296%29%%A%    
% 211.46/211.63  |- mesh__recordOriginator mesh__D014077 NLM
% 211.46/211.63  |- mesh__dateCreated mesh__D014077 1999-01-01
% 211.46/211.63  |- skos__hiddenLabel mesh__D014077 Erosions, Tooth
% 211.46/211.63  |- skos__hiddenLabel mesh__D014077 Erosion, Tooth
% 211.46/211.63  |- skos__annotation mesh__D014077
% 211.46/211.63       loss of substance caused by chem action without bact action: differentiate from TOOTH ABRASION %28%loss of substance caused by friction%29% %26% TOOTH ATTRITION %28%wearing away through tooth-to-tooth contact%29%%A%  
% 211.46/211.63  |- skos__hiddenLabel mesh__D014077 Tooth Erosions
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014077 2006
% 211.46/211.63  |- mesh__dateRevised mesh__D014077 1996-06-10
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014077 2001
% 211.46/211.63  |- mesh__publicMeSHNote mesh__D008838
% 211.46/211.63       89; was see under COMPUTERS 1980-88   
% 211.46/211.63  |- mesh__recordAuthorizer mesh__D008838 sjn
% 211.46/211.63  |- skos__prefLabel mesh__D008838 Microcomputers
% 211.46/211.63  |- skos__scopeNote mesh__D008838
% 211.46/211.63       Small computers using LSI %28%large-scale integration%29% microprocessor chips as the CPU %28%central processing unit%29% and semiconductor memories for compact, inexpensive storage of program instructions and data. They are smaller and less expensive than minicomputers and are usually built into a dedicated system where they are optimized for a particular application. %22%Microprocessor%22% may refer to just the CPU or the entire microcomputer.%A%    
% 211.46/211.63  |- skos__hiddenLabel mesh__D008838 Microcomputer
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D008838 2006
% 211.46/211.63  |- skos__broader mesh__D008838smesh__D003201
% 211.46/211.63  |- mesh__dateEstablished mesh__D008838 1989-01-01
% 211.46/211.63  |- mesh__dateRevised mesh__D008838 2004-07-07
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D008838 2005
% 211.46/211.63  |- skos__hiddenLabel mesh__D008838 Microprocessor
% 211.46/211.63  |- skos__annotation mesh__D008838 do not confuse with MINICOMPUTERS   
% 211.46/211.63  |- rdf__type mesh__D008838sskos__Concept
% 211.46/211.63  |- mesh__recordOriginator mesh__D008838 SMH
% 211.46/211.63  |- mesh__dateCreated mesh__D008838 1979-05-31
% 211.46/211.63  |- skos__hiddenLabel mesh__D008838 Personal Computer
% 211.46/211.63  |- mesh__recordMaintainer mesh__D008838 jls
% 211.46/211.63  |- skos__hiddenLabel mesh__D008838 Personal Computers
% 211.46/211.63  |- mesh__historyNote mesh__D008838
% 211.46/211.63       89%28%80%29%; was see under COMPUTERS 1980-88   
% 211.46/211.63  |- skos__historyNote mesh__D008838 Computers %28%1966-1979%29%
% 211.46/211.63  |- skos__hiddenLabel mesh__D008838 Computer, Personal
% 211.46/211.63  |- skos__prefLabel mesh__D000855 Anorexia
% 211.46/211.63  |- mesh__dateEstablished mesh__D000855 1991-01-01
% 211.46/211.63  |- mesh__publicMeSHNote mesh__D000855
% 211.46/211.63       91; was see under EATING DISORDERS 1975-90   
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D000855 2006
% 211.46/211.63  |- skos__scopeNote mesh__D000855
% 211.46/211.63       The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.%A%    
% 211.46/211.63  |- mesh__dateRevised mesh__D000855 2005-06-30
% 211.46/211.63  |- mesh__recordOriginator mesh__D000855 NLM
% 211.46/211.63  |- skos__annotation mesh__D000855 ANOREXIA NERVOSA is also available   
% 211.46/211.63  |- mesh__recordAuthorizer mesh__D000855 sjn
% 211.46/211.63  |- mesh__historyNote mesh__D000855
% 211.46/211.63       91%28%75%29%; was see under EATING DISORDERS 1975-90   
% 211.46/211.63  |- skos__broader mesh__D000855smesh__D012817
% 211.46/211.63  |- skos__related mesh__D000855smesh__D000856
% 211.46/211.63  |- skos__hiddenLabel mesh__D000855 Anorexias
% 211.46/211.63  |- mesh__recordMaintainer mesh__D000855 lkt
% 211.46/211.63  |- mesh__dateCreated mesh__D000855 1974-11-11
% 211.46/211.63  |- rdf__type mesh__D000855sskos__Concept
% 211.46/211.63  |- skos__hiddenLabel mesh__D019560 3D Echocardiographies
% 211.46/211.63  |- skos__broader mesh__D019560smesh__D004452
% 211.46/211.63  |- skos__annotation mesh__D019560
% 211.46/211.63       ECHOCARDIOGRAPHY, FOUR-DIMENSIONAL is also available; DF: ECHOCARDIOGR 3D%A%  
% 211.46/211.63  |- rdf__type mesh__D019560sskos__Concept
% 211.46/211.63  |- skos__hiddenLabel mesh__D019560 Three Dimensional Echocardiography
% 211.46/211.63  |- mesh__recordMaintainer mesh__D019560 PXP
% 211.46/211.63  |- skos__scopeNote mesh__D019560
% 211.46/211.63       Echocardiography amplified by the addition of depth to the conventional two-dimensional ECHOCARDIOGRAPHY visualizing only the length and width of the heart. Three-dimensional ultrasound imaging was first described in 1961 but its application to echocardiography did not take place until 1974. %28%Mayo Clin Proc 1993;68:221-40%29%%A%    
% 211.46/211.63  |- skos__altLabel mesh__D019560 Echocardiography, 3D
% 211.46/211.63  |- mesh__publicMeSHNote mesh__D019560 97   
% 211.46/211.63  |- mesh__recordOriginator mesh__D019560 TGC
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D019560 2003
% 211.46/211.63  |- skos__altLabel mesh__D019560 Echocardiography, 3-D
% 211.46/211.63  |- skos__hiddenLabel mesh__D019560 Three-Dimensional Echocardiographies
% 211.46/211.63  |- mesh__historyNote mesh__D019560 97   
% 211.46/211.63  |- skos__hiddenLabel mesh__D019560 Echocardiographies, Three-Dimensional
% 211.46/211.63  |- skos__hiddenLabel mesh__D019560 Echocardiographies, 3D
% 211.46/211.63  |- mesh__recordAuthorizer mesh__D019560 sjn
% 211.46/211.63  |- skos__altLabel mesh__D019560 3D Echocardiography
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D019560 2004
% 211.46/211.63  |- skos__hiddenLabel mesh__D019560 Echocardiography, 3 D
% 211.46/211.63  |- skos__prefLabel mesh__D019560 Echocardiography, Three-Dimensional
% 211.46/211.63  |- mesh__dateRevised mesh__D019560 2000-06-21
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D019560 2001
% 211.46/211.63  |- skos__hiddenLabel mesh__D019560 Echocardiographies, 3-D
% 211.46/211.63  |- skos__historyNote mesh__D019560 Echocardiography %28%1974-1996%29%
% 211.46/211.63  |- skos__broader mesh__D019560smesh__D021621
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D019560 2005
% 211.46/211.63  |- mesh__dateCreated mesh__D019560 1996-06-10
% 211.46/211.63  |- skos__altLabel mesh__D019560 Three-Dimensional Echocardiography
% 211.46/211.63  |- skos__hiddenLabel mesh__D019560 Echocardiography, Three Dimensional
% 211.46/211.63  |- skos__hiddenLabel mesh__D019560 3-D Echocardiographies
% 211.46/211.63  |- skos__hiddenLabel mesh__D019560 3 D Echocardiography
% 211.46/211.63  |- skos__altLabel mesh__D019560 3-D Echocardiography
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D019560 2002
% 211.46/211.63  |- mesh__dateEstablished mesh__D019560 1997-01-01
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D019560 2006
% 211.46/211.63  |- mesh__recordAuthorizer mesh__D000057 sjn
% 211.46/211.63  |- skos__hiddenLabel mesh__D000057 Pronenesses, Accident
% 211.46/211.63  |- skos__annotation mesh__D000057 no qualif   
% 211.46/211.63  |- mesh__dateCreated mesh__D000057 1974-11-11
% 211.46/211.63  |- rdf__type mesh__D000057sskos__Concept
% 211.46/211.63  |- skos__historyNote mesh__D000057 Accidents %28%1966-1974%29%
% 211.46/211.63  |- mesh__recordOriginator mesh__D000057 NLM
% 211.46/211.63  |- skos__prefLabel mesh__D000057 Accident Proneness
% 211.46/211.63  |- skos__broader mesh__D000057smesh__D001519
% 211.46/211.63  |- mesh__historyNote mesh__D000057 75   
% 211.46/211.63  |- skos__hiddenLabel mesh__D000057 Proneness, Accident
% 211.46/211.63  |- mesh__recordMaintainer mesh__D000057 TGC
% 211.46/211.63  |- mesh__publicMeSHNote mesh__D000057 75   
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D000057 2003
% 211.46/211.63  |- skos__scopeNote mesh__D000057
% 211.46/211.63       Tendency toward involvement in accidents. Implies certain personality characteristics which predispose to accidents.%A%    
% 211.46/211.63  |- mesh__dateRevised mesh__D000057 2002-07-02
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D000057 2005
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D000057 2004
% 211.46/211.63  |- mesh__dateEstablished mesh__D000057 1975-09-01
% 211.46/211.63  |- skos__hiddenLabel mesh__D000057 Accident Pronenesses
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D000057 2006
% 211.46/211.63  |- skos__annotation mesh__D005540
% 211.46/211.63       GEN or unspecified; prefer specifics; do not confuse with FORCED EXPIRATORY VOLUME, a specific test of pulm ventilation; usually NIM%A%  
% 211.46/211.63  |- rdf__type mesh__D005540sskos__Concept
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D005540 2005
% 211.46/211.63  |- mesh__recordMaintainer mesh__D005540 nns
% 211.46/211.63  |- skos__altLabel mesh__D005540 Flow Rates, Forced Expiratory
% 211.46/211.63  |- mesh__recordOriginator mesh__D005540 NLM
% 211.46/211.63  |- skos__altLabel mesh__D005540 Expiratory Forced Flow Rates
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D005540 2006
% 211.46/211.63  |- mesh__publicMeSHNote mesh__D005540 75   
% 211.46/211.63  |- skos__scopeNote mesh__D005540
% 211.46/211.63       The rate of airflow measured during a FORCED VITAL CAPACITY determination.%A%    
% 211.46/211.63  |- mesh__historyNote mesh__D005540 75   
% 211.46/211.63  |- skos__altLabel mesh__D005540 Flow Rates, Expiratory Forced
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D005540 2004
% 211.46/211.63  |- mesh__recordAuthorizer mesh__D005540 sjn
% 211.46/211.63  |- mesh__dateCreated mesh__D005540 1974-11-19
% 211.46/211.63  |- mesh__dateEstablished mesh__D005540 1975-09-01
% 211.46/211.63  |- skos__historyNote mesh__D005540 Spirometry %28%1966-1974%29%
% 211.46/211.63  |- mesh__dateRevised mesh__D005540 2003-07-09
% 211.46/211.63  |- skos__prefLabel mesh__D005540 Forced Expiratory Flow Rates
% 211.46/211.63  |- skos__broader mesh__D005540smesh__D012123
% 211.46/211.63  |- skos__historyNote mesh__D005540 Respiratory Airflow %28%1971-1974%29%
% 211.46/211.63  |- mesh__dateEstablished mesh__D052196 2006-01-01
% 211.46/211.63  |- skos__historyNote mesh__D052196 Lactobacillus %28%1967-2005%29%
% 211.46/211.63  |- rdf__type mesh__D052196sskos__Concept
% 211.46/211.63  |- mesh__historyNote mesh__D052196 2006   
% 211.46/211.63  |- mesh__recordAuthorizer mesh__D052196 sjn
% 211.46/211.63  |- mesh__recordMaintainer mesh__D052196 ags
% 211.46/211.63  |- mesh__dateCreated mesh__D052196 2005-06-30
% 211.46/211.63  |- mesh__publicMeSHNote mesh__D052196 2006   
% 211.46/211.63  |- mesh__recordOriginator mesh__D052196 ags
% 211.46/211.63  |- skos__broader mesh__D052196smesh__D007778
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D052196 2006
% 211.46/211.63  |- skos__scopeNote mesh__D052196
% 211.46/211.63       A species of gram-positive, rod-shaped LACTIC ACID bacteria that is frequently used as starter culture in SILAGE fermentation, sourdough, and lactic-acid-fermented types of beer and wine.%A%    
% 211.46/211.63  |- skos__prefLabel mesh__D052196 Lactobacillus brevis
% 211.46/211.63  |- skos__scopeNote mesh__D010485
% 211.46/211.63       Inflammation of the PERIAPICAL TISSUE. It includes general, unspecified, or acute nonsuppurative inflammation. Chronic nonsuppurative inflammation is PERIAPICAL GRANULOMA. Suppurative inflammation is PERIAPICAL ABSCESS.%A%    
% 211.46/211.63  |- skos__prefLabel mesh__D010485 Periapical Periodontitis
% 211.46/211.63  |- mesh__recordMaintainer mesh__D010485 ssb
% 211.46/211.63  |- mesh__recordAuthorizer mesh__D010485 sjn
% 211.46/211.63  |- skos__hiddenLabel mesh__D010485 Periodontitis, Periapical
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D010485 2006
% 211.46/211.63  |- skos__altLabel mesh__D010485 Periodontitis, Apical
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D010485 2005
% 211.46/211.63  |- skos__hiddenLabel mesh__D010485 Nonsuppurative Periodontitis, Acute
% 211.46/211.63  |- skos__historyNote mesh__D010485 Periodontal Diseases %28%1966-1979%29%
% 211.46/211.63  |- skos__annotation mesh__D010485 GEN or unspecified   
% 211.46/211.63  |- skos__related mesh__D010485smesh__D011671
% 211.46/211.63  |- skos__hiddenLabel mesh__D010485 Periodontitides, Apical
% 211.46/211.63  |- skos__hiddenLabel mesh__D010485 Nonsuppurative Periodontitides, Acute
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D010485 2004
% 211.46/211.63  |- skos__hiddenLabel mesh__D010485 Periapical Periodontitides
% 211.46/211.63  |- skos__hiddenLabel mesh__D010485 Acute Nonsuppurative Periodontitis
% 211.46/211.63  |- mesh__historyNote mesh__D010485 80   
% 211.46/211.63  |- skos__hiddenLabel mesh__D010485 Apical Periodontitides
% 211.46/211.63  |- mesh__dateCreated mesh__D010485 1979-04-25
% 211.46/211.63  |- mesh__publicMeSHNote mesh__D010485 80   
% 211.46/211.63  |- skos__broader mesh__D010485smesh__D010483
% 211.46/211.63  |- rdf__type mesh__D010485sskos__Concept
% 211.46/211.63  |- mesh__dateEstablished mesh__D010485 1980-01-01
% 211.46/211.63  |- mesh__dateRevised mesh__D010485 2003-07-09
% 211.46/211.63  |- skos__hiddenLabel mesh__D010485 Acute Nonsuppurative Periodontitides
% 211.46/211.63  |- skos__hiddenLabel mesh__D010485 Apical Periodontitis
% 211.46/211.63  |- mesh__recordOriginator mesh__D010485 SMH
% 211.46/211.63  |- skos__historyNote mesh__D010485 Periodontitis %28%1966-1979%29%
% 211.46/211.63  |- skos__hiddenLabel mesh__D010485 Periodontitides, Periapical
% 211.46/211.63  |- skos__hiddenLabel mesh__D010485 Periodontitides, Acute Nonsuppurative
% 211.46/211.63  |- mesh__dateRevised mesh__D004448 2004-07-07
% 211.46/211.63  |- skos__hiddenLabel mesh__D004448 NSC526417
% 211.46/211.63  |- mesh__recordOriginator mesh__D004448 SH
% 211.46/211.63  |- skos__hiddenLabel mesh__D004448 NSC 526417
% 211.46/211.63  |- skos__historyNote mesh__D004448 Quinoxalines %28%1972-1975%29%
% 211.46/211.63  |- skos__prefLabel mesh__D004448 Echinomycin
% 211.46/211.63  |- skos__historyNote mesh__D004448 Antibiotics %28%1968-1975%29%
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D004448 2005
% 211.46/211.63  |- skos__broader mesh__D004448smesh__D011810
% 211.46/211.63  |- mesh__dateEstablished mesh__D004448 1991-01-01
% 211.46/211.63  |- skos__historyNote mesh__D004448 Peptides, Cyclic %28%1975%29%
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D004448 2006
% 211.46/211.63  |- mesh__historyNote mesh__D004448
% 211.46/211.63       91%28%76%29%; was see under QUINOXALINES 1976-90   
% 211.46/211.63  |- mesh__dateCreated mesh__D004448 1975-07-18
% 211.46/211.63  |- rdf__type mesh__D004448sskos__Concept
% 211.46/211.63  |- skos__altLabel mesh__D004448 Quinomycin A
% 211.46/211.63  |- mesh__recordMaintainer mesh__D004448 ssb
% 211.46/211.63  |- mesh__publicMeSHNote mesh__D004448
% 211.46/211.63       91; was see under QUINOXALINES 1976-90   
% 211.46/211.63  |- skos__scopeNote mesh__D004448
% 211.46/211.63       A cytotoxic polypeptide quinoxaline antibiotic isolated from Streptomyces echinatus that binds to DNA and inhibits RNA synthesis.%A%    
% 211.46/211.63  |- skos__broader mesh__D004448smesh__D010456
% 211.46/211.63  |- mesh__recordAuthorizer mesh__D004448 sjn
% 211.46/211.63  |- mesh__publicMeSHNote mesh__D015170 89   
% 211.46/211.63  |- skos__historyNote mesh__D015170 Pressure %28%1966-1988%29%
% 211.46/211.63  |- skos__altLabel mesh__D015170 Pressure, Cerebrospinal Fluid
% 211.46/211.63  |- mesh__dateCreated mesh__D015170 1988-04-12
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D015170 2004
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D015170 1996
% 211.46/211.63  |- rdf__type mesh__D015170sskos__Concept
% 211.46/211.63  |- skos__altLabel mesh__D015170 Cerebrospinal Fluid Pressures
% 211.46/211.63  |- skos__prefLabel mesh__D015170 Cerebrospinal Fluid Pressure
% 211.46/211.63  |- skos__historyNote mesh__D015170 Cerebrospinal Fluid %28%1966-1988%29%
% 211.46/211.63  |- skos__altLabel mesh__D015170 Pressures, Cerebrospinal Fluid
% 211.46/211.63  |- skos__hiddenLabel mesh__D015170 Fluid Pressure, Cerebrospinal
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D015170 2005
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D015170 1997
% 211.46/211.63  |- skos__hiddenLabel mesh__D015170 Pressure, Spinal Fluid
% 211.46/211.63  |- skos__hiddenLabel mesh__D015170 Fluid Pressures, Spinal
% 211.46/211.63  |- skos__related mesh__D015170smesh__D007427
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D015170 2006
% 211.46/211.63  |- skos__hiddenLabel mesh__D015170 Pressures, Spinal Fluid
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D015170 2000
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D015170 1998
% 211.46/211.63  |- skos__hiddenLabel mesh__D015170 Fluid Pressures, Cerebrospinal
% 211.46/211.63  |- skos__historyNote mesh__D015170 Intracranial Pressure %28%1966-1988%29%
% 211.46/211.63  |- mesh__historyNote mesh__D015170 89   
% 211.46/211.63  |- mesh__dateRevised mesh__D015170 1993-06-02
% 211.46/211.63  |- mesh__dateEstablished mesh__D015170 1989-01-01
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D015170 1994
% 211.46/211.63  |- skos__hiddenLabel mesh__D015170 Spinal Fluid Pressures
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D015170 2001
% 211.46/211.63  |- skos__hiddenLabel mesh__D015170 Fluid Pressure, Spinal
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D015170 1999
% 211.46/211.63  |- mesh__recordAuthorizer mesh__D015170 PLS
% 211.46/211.63  |- skos__annotation mesh__D015170 DF: CSF PRESSURE   
% 211.46/211.63  |- skos__broader mesh__D015170smesh__D009424
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D015170 2003
% 211.46/211.63  |- mesh__recordMaintainer mesh__D015170 TAP
% 211.46/211.63  |- mesh__recordOriginator mesh__D015170 SCD
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D015170 1995
% 211.46/211.63  |- skos__scopeNote mesh__D015170
% 211.46/211.63       Manometric pressure of the cerebrospinal fluid as measured by lumbar, cerebroventricular, or cisternal puncture. Within the cranial cavity it is called INTRACRANIAL PRESSURE.%A%    
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D015170 2002
% 211.46/211.63  |- skos__altLabel mesh__D009133 Atrophy, Muscle
% 211.46/211.63  |- skos__hiddenLabel mesh__D009133 Atrophy, Neurogenic Muscular
% 211.46/211.63  |- skos__hiddenLabel mesh__D009133 Muscular Atrophy, Neurotrophic
% 211.46/211.63  |- skos__hiddenLabel mesh__D009133 Muscular Atrophies, Neurogenic
% 211.46/211.63  |- skos__hiddenLabel mesh__D009133 Muscular Atrophies, Neurotrophic
% 211.46/211.63  |- rdf__type mesh__D009133sskos__Concept
% 211.46/211.63  |- skos__hiddenLabel mesh__D009133 Atrophies, Neurogenic Muscular
% 211.46/211.63  |- mesh__dateRevised mesh__D009133 1999-11-04
% 211.46/211.63  |- skos__hiddenLabel mesh__D009133 Muscular Atrophies
% 211.46/211.63  |- skos__hiddenLabel mesh__D009133 Atrophy, Muscular
% 211.46/211.63  |- mesh__recordOriginator mesh__D009133 NLM
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D009133 2000
% 211.46/211.63  |- skos__broader mesh__D009133smesh__D020879
% 211.46/211.63  |- mesh__recordAuthorizer mesh__D009133 sjn
% 211.46/211.63  |- skos__prefLabel mesh__D009133 Muscular Atrophy
% 211.46/211.63  |- skos__annotation mesh__D009133
% 211.46/211.63       MUSCULAR ATROPHY, SPINAL is also available   
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D009133 2003
% 211.46/211.63  |- skos__hiddenLabel mesh__D009133 Atrophies, Muscular
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D009133 2001
% 211.46/211.63  |- skos__hiddenLabel mesh__D009133 Neurotrophic Muscular Atrophies
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D009133 2004
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D009133 2005
% 211.46/211.63  |- mesh__dateCreated mesh__D009133 1999-01-01
% 211.46/211.63  |- skos__hiddenLabel mesh__D009133 Muscle Atrophy
% 211.46/211.63  |- skos__hiddenLabel mesh__D009133 Atrophies, Muscle
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D009133 2006
% 211.46/211.63  |- skos__hiddenLabel mesh__D009133 Muscular Atrophy, Neurogenic
% 211.46/211.63  |- skos__hiddenLabel mesh__D009133 Neurogenic Muscular Atrophies
% 211.46/211.63  |- skos__broader mesh__D009133smesh__D001284
% 211.46/211.63  |- skos__altLabel mesh__D009133 Neurotrophic Muscular Atrophy
% 211.46/211.63  |- skos__scopeNote mesh__D009133
% 211.46/211.63       Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.%A%    
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D009133 2002
% 211.46/211.63  |- skos__hiddenLabel mesh__D009133 Muscle Atrophies
% 211.46/211.63  |- skos__hiddenLabel mesh__D009133 Atrophies, Neurotrophic Muscular
% 211.46/211.63  |- skos__related mesh__D009133smesh__D020966
% 211.46/211.63  |- mesh__recordMaintainer mesh__D009133 KEV
% 211.46/211.63  |- skos__hiddenLabel mesh__D009133 Atrophy, Neurotrophic Muscular
% 211.46/211.63  |- skos__prefLabel mesh__D001150 Arsenazo III
% 211.46/211.63  |- mesh__recordOriginator mesh__D001150 SH
% 211.46/211.63  |- skos__annotation mesh__D001150 D25-26 qualif   
% 211.46/211.63  |- skos__historyNote mesh__D001150 Dyes %28%1966-1979%29%
% 211.46/211.63  |- skos__scopeNote mesh__D001150
% 211.46/211.63       Metallochrome indicator that changes color when complexed to the calcium ion under physiological conditions. It is used to measure local calcium ion concentrations in vivo.%A%    
% 211.46/211.63  |- mesh__recordAuthorizer mesh__D001150 NLM
% 211.46/211.63  |- skos__broader mesh__D001150smesh__D001391
% 211.46/211.63  |- skos__historyNote mesh__D001150
% 211.46/211.63       Indicators and Reagents %28%1966-1979%29%
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D001150 2006
% 211.46/211.63  |- skos__hiddenLabel mesh__D001150 III, Arsenazo
% 211.46/211.63  |- mesh__historyNote mesh__D001150
% 211.46/211.63       91%28%80%29%; was see under AZO COMPOUNDS 1980-90   
% 211.46/211.63  |- mesh__publicMeSHNote mesh__D001150
% 211.46/211.63       91; was see under AZO COMPOUNDS 1980-90   
% 211.46/211.63  |- skos__historyNote mesh__D001150 Azo Compounds %28%1966-1979%29%
% 211.46/211.63  |- mesh__dateCreated mesh__D001150 1979-05-30
% 211.46/211.63  |- skos__broader mesh__D001150smesh__D001152
% 211.46/211.63  |- mesh__recordMaintainer mesh__D001150 NLM
% 211.46/211.63  |- rdf__type mesh__D001150sskos__Concept
% 211.46/211.63  |- skos__historyNote mesh__D001150 Arsenicals %28%1966-1979%29%
% 211.46/211.63  |- mesh__dateRevised mesh__D001150 2005-07-06
% 211.46/211.63  |- mesh__dateEstablished mesh__D001150 1991-01-01
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014876 2005
% 211.46/211.63  |- mesh__dateCreated mesh__D014876 1999-01-01
% 211.46/211.63  |- skos__hiddenLabel mesh__D014876 Pollutions, Thermal Water
% 211.46/211.63  |- mesh__recordAuthorizer mesh__D014876 sjn
% 211.46/211.63  |- mesh__publicMeSHNote mesh__D014876
% 211.46/211.63       WATER POLLUTION, THERMAL was heading 1973-96; THERMAL WATER POLLUTION was see WATER POLLUTION, THERMAL 1973-96%A%  
% 211.46/211.63  |- mesh__historyNote mesh__D014876
% 211.46/211.63       WATER POLLUTION, THERMAL was heading 1971-96 %28%Prov 1971-72%29%; THERMAL WATER POLLUTION was see WATER POLLUTION, THERMAL 1973-96%A%  
% 211.46/211.63  |- mesh__recordOriginator mesh__D014876 NLM
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014876 2006
% 211.46/211.63  |- skos__hiddenLabel mesh__D014876 Pollution, Water
% 211.46/211.63  |- skos__hiddenLabel mesh__D014876 Pollutions, Water
% 211.46/211.63  |- mesh__dateRevised mesh__D014876 1999-11-03
% 211.46/211.63  |- mesh__recordMaintainer mesh__D014876 kle
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014876 2000
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014876 2003
% 211.46/211.63  |- skos__hiddenLabel mesh__D014876 Pollution, Thermal Water
% 211.46/211.63  |- rdf__type mesh__D014876sskos__Concept
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014876 2001
% 211.46/211.63  |- skos__broader mesh__D014876smesh__D004787
% 211.46/211.63  |- skos__hiddenLabel mesh__D014876 Water Pollutions
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014876 2004
% 211.46/211.63  |- skos__hiddenLabel mesh__D014876 Thermal Water Pollutions
% 211.46/211.63  |- skos__prefLabel mesh__D014876 Water Pollution
% 211.46/211.63  |- skos__annotation mesh__D014876
% 211.46/211.63       IM; coord with source of pollution %28%IM%29%; note X ref THERMAL WATER POLLUTION: coord with HEAT %28%IM%29% only if heat is particularly discussed; specify geog if pertinent%A%  
% 211.46/211.63  |- skos__hiddenLabel mesh__D014876 Water Pollutions, Thermal
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014876 2002
% 211.46/211.63  |- skos__altLabel mesh__D014876 Water Pollution, Thermal
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014078 1998
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014078 2003
% 211.46/211.63  |- mesh__dateEstablished mesh__D014078 1965-01-01
% 211.46/211.63  |- mesh__recordAuthorizer mesh__D014078 SJN
% 211.46/211.63  |- skos__broader mesh__D014078smesh__D009063
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014078 2001
% 211.46/211.63  |- skos__prefLabel mesh__D014078 Tooth Eruption
% 211.46/211.63  |- skos__hiddenLabel mesh__D014078 Eruptions, Tooth
% 211.46/211.63  |- rdf__type mesh__D014078sskos__Concept
% 211.46/211.63  |- mesh__recordMaintainer mesh__D014078 TGC
% 211.46/211.63  |- skos__hiddenLabel mesh__D014078 Eruption, Tooth
% 211.46/211.63  |- mesh__historyNote mesh__D014078 65   
% 211.46/211.63  |- skos__hiddenLabel mesh__D014078 Tooth Eruptions
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014078 2000
% 211.46/211.63  |- mesh__publicMeSHNote mesh__D014078 65   
% 211.46/211.63  |- mesh__dateRevised mesh__D014078 1997-06-20
% 211.46/211.63  |- mesh__dateCreated mesh__D014078 1999-01-01
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014078 2006
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014078 2002
% 211.46/211.63  |- mesh__recordOriginator mesh__D014078 NLM
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014078 2005
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014078 1999
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D014078 2004
% 211.46/211.63  |- skos__scopeNote mesh__D008839
% 211.46/211.63       Electrodes with an extremely small tip, used in a voltage clamp or other apparatus to stimulate or record bioelectric potentials of single cells intracellularly or extracellularly. %28%Dorland, 28th ed%29%%A%    
% 211.46/211.63  |- skos__historyNote mesh__D008839 Electrodes %28%1968-1970%29%
% 211.46/211.63  |- mesh__dateCreated mesh__D008839 1999-01-01
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D008839 2002
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D008839 2005
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D008839 2004
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D008839 1999
% 211.46/211.63  |- mesh__recordOriginator mesh__D008839 NLM
% 211.46/211.63  |- mesh__publicMeSHNote mesh__D008839 73   
% 211.46/211.63  |- mesh__recordMaintainer mesh__D008839 PXP
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D008839 2006
% 211.46/211.63  |- skos__altLabel mesh__D008839 Electrodes, Miniaturized
% 211.46/211.63  |- skos__hiddenLabel mesh__D008839 Miniaturized Electrode
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D008839 2000
% 211.46/211.63  |- mesh__recordAuthorizer mesh__D008839 SJN
% 211.46/211.63  |- rdf__type mesh__D008839sskos__Concept
% 211.46/211.63  |- mesh__historyNote mesh__D008839 73%28%71%29%   
% 211.46/211.63  |- skos__annotation mesh__D008839 NIM   
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D008839 2001
% 211.46/211.63  |- skos__prefLabel mesh__D008839 Microelectrodes
% 211.46/211.63  |- skos__hiddenLabel mesh__D008839 Miniaturized Electrodes
% 211.46/211.63  |- skos__broader mesh__D008839smesh__D004566
% 211.46/211.63  |- skos__hiddenLabel mesh__D008839 Microelectrode
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D008839 2003
% 211.46/211.63  |- skos__hiddenLabel mesh__D008839 Electrode, Miniaturized
% 211.46/211.63  |- mesh__dateEstablished mesh__D008839 1973-01-01
% 211.46/211.63  |- mesh__activeMeSHYear mesh__D008839 1998
% 211.46/211.63  |- mesh__dateRevised mesh__D008839 1997-06-20
% 211.46/211.63  |- skos__hiddenLabel mesh__D000856 Nervosas, Anorexia
% 211.46/211.63  |- skos__related mesh__D000856smesh__D000855
% 211.46/211.63  |- skos__broader mesh__D000856smesh__D001068
% 211.46/211.63  |- mesh__dateCreated mesh__D000856 1999-01-01
% 211.46/211.63  |- skos__annotation mesh__D000856 ANOREXIA is also available   
% 211.46/211.63  |- skos__hiddenLabel mesh__D000856 Anorexia Nervosas
% 211.46/211.63  |- skos__scopeNote mesh__D000856
% 211.46/211.63       An eating disorder that is characterized by the lack or loss of APPETITE, known as ANOREXIA. Other features include excess fear of becoming OVERWEIGHT; BODY IMAGE disturbance; significant WEIGHT LOSS; refusal to maintain minimal normal weight; and AMENORRHEA. This disorder occurs most frequently in adolescent females. %28%APA, Thesaurus of Psychological Index Terms, 1994%29%%A%    
% 211.46/211.63  |- skos__hiddenLabel mesh__D000856 Nervosa, Anorexia
% 211.46/211.63  |- mesh__dateRevised mesh__D000856 2005-06-30
% 211.46/211.63  |- mesh__recordOriginator mesh__D000856 NLM
% 211.46/211.63  |- mesh__recordAuthorizer mesh__D000856 sjn
% 211.46/211.63  |- rdf__type mesh__D000856sskos__Concept
% 211.46/211.64  |- skos__prefLabel mesh__D000856 Anorexia Nervosa
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D000856 2006
% 211.46/211.64  |- mesh__recordMaintainer mesh__D000856 lkt
% 211.46/211.64  |- skos__hiddenLabel mesh__D019561 Four Dimensional Echocardiography
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D019561 2002
% 211.46/211.64  |- skos__hiddenLabel mesh__D019561 Echocardiographies, 4D
% 211.46/211.64  |- mesh__dateEstablished mesh__D019561 1997-01-01
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D019561 2003
% 211.46/211.64  |- skos__hiddenLabel mesh__D019561 Echocardiography, Four Dimensional
% 211.46/211.64  |- mesh__historyNote mesh__D019561 97   
% 211.46/211.64  |- skos__altLabel mesh__D019561 4D Echocardiography
% 211.46/211.64  |- skos__hiddenLabel mesh__D019561 Echocardiographies, Four-Dimensional
% 211.46/211.64  |- skos__prefLabel mesh__D019561 Echocardiography, Four-Dimensional
% 211.46/211.64  |- skos__annotation mesh__D019561
% 211.46/211.64       ECHOCARDIOGRAPHY, THREE-DIMENSIONAL is also available; DF: ECHOCARDIOGR 4D%A%  
% 211.46/211.64  |- skos__hiddenLabel mesh__D019561 4 D Echocardiography
% 211.46/211.64  |- skos__hiddenLabel mesh__D019561 Echocardiography, 4 D
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D019561 2004
% 211.46/211.64  |- skos__hiddenLabel mesh__D019561 Echocardiographies, 4-D
% 211.46/211.64  |- skos__altLabel mesh__D019561 Echocardiography, 4-D
% 211.46/211.64  |- skos__broader mesh__D019561smesh__D019560
% 211.46/211.64  |- mesh__recordMaintainer mesh__D019561 PXP
% 211.46/211.64  |- mesh__publicMeSHNote mesh__D019561 97   
% 211.46/211.64  |- mesh__dateRevised mesh__D019561 2000-06-21
% 211.46/211.64  |- skos__hiddenLabel mesh__D019561 Four-Dimensional Echocardiographies
% 211.46/211.64  |- mesh__recordOriginator mesh__D019561 TGC
% 211.46/211.64  |- skos__altLabel mesh__D019561 Four-Dimensional Echocardiography
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D019561 2005
% 211.46/211.64  |- skos__hiddenLabel mesh__D019561 4-D Echocardiographies
% 211.46/211.64  |- mesh__recordAuthorizer mesh__D019561 sjn
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D019561 2006
% 211.46/211.64  |- skos__hiddenLabel mesh__D019561 4D Echocardiographies
% 211.46/211.64  |- skos__altLabel mesh__D019561 Echocardiography, 4D
% 211.46/211.64  |- skos__scopeNote mesh__D019561
% 211.46/211.64       Dynamic three-dimensional echocardiography using the added dimension of time to impart the cinematic perception of motion. %28%Mayo Clin Proc 1993;68:221-40%29%%A%    
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D019561 2001
% 211.46/211.64  |- rdf__type mesh__D019561sskos__Concept
% 211.46/211.64  |- mesh__dateCreated mesh__D019561 1996-06-10
% 211.46/211.64  |- skos__altLabel mesh__D019561 4-D Echocardiography
% 211.46/211.64  |- skos__historyNote mesh__D019561 Echocardiography %28%1993-1996%29%
% 211.46/211.64  |- skos__prefLabel mesh__D000058 Accidental Falls
% 211.46/211.64  |- mesh__historyNote mesh__D000058
% 211.46/211.64       91%28%87%29%; was see under ACCIDENTS 1987-90   
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D000058 2006
% 211.46/211.64  |- mesh__dateRevised mesh__D000058 2003-07-09
% 211.46/211.64  |- mesh__recordOriginator mesh__D000058 SH
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D000058 2005
% 211.46/211.64  |- skos__hiddenLabel mesh__D000058 Fall, Accidental
% 211.46/211.64  |- skos__hiddenLabel mesh__D000058 Accidental Fall
% 211.46/211.64  |- skos__scopeNote mesh__D000058
% 211.46/211.64       Falls due to slipping or tripping which result in injury.%A%    
% 211.46/211.64  |- skos__altLabel mesh__D000058 Falls, Accidental
% 211.46/211.64  |- mesh__recordAuthorizer mesh__D000058 sjn
% 211.46/211.64  |- rdf__type mesh__D000058sskos__Concept
% 211.46/211.64  |- mesh__dateEstablished mesh__D000058 1991-01-01
% 211.46/211.64  |- skos__broader mesh__D000058smesh__D000059
% 211.46/211.64  |- mesh__publicMeSHNote mesh__D000058
% 211.46/211.64       91; was see under ACCIDENTS 1987-90   
% 211.46/211.64  |- mesh__recordMaintainer mesh__D000058 lkt
% 211.46/211.64  |- mesh__dateCreated mesh__D000058 1986-06-24
% 211.46/211.64  |- skos__annotation mesh__D000058
% 211.46/211.64       coord IM with specific inj %28%IM%29% if pertinent   
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D000058 2004
% 211.46/211.64  |- skos__historyNote mesh__D000058 Accidents %28%1966-1986%29%
% 211.46/211.64  |- skos__hiddenLabel mesh__D005541 Vital Capacities, Timed
% 211.46/211.64  |- skos__prefLabel mesh__D005541 Forced Expiratory Volume
% 211.46/211.64  |- skos__hiddenLabel mesh__D005541 Timed Vital Capacities
% 211.46/211.64  |- skos__altLabel mesh__D005541 Vital Capacity, Timed
% 211.46/211.64  |- mesh__historyNote mesh__D005541 75   
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D005541 2004
% 211.46/211.64  |- skos__hiddenLabel mesh__D005541 Expiratory Volume, Forced
% 211.46/211.64  |- skos__scopeNote mesh__D005541
% 211.46/211.64       Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity.%A%    
% 211.46/211.64  |- skos__hiddenLabel mesh__D005541 Forced Expiratory Volumes
% 211.46/211.64  |- skos__altLabel mesh__D005541 Timed Vital Capacity
% 211.46/211.64  |- mesh__dateRevised mesh__D005541 2003-07-09
% 211.46/211.64  |- skos__broader mesh__D005541smesh__D012123
% 211.46/211.64  |- mesh__recordMaintainer mesh__D005541 nns
% 211.46/211.64  |- mesh__dateEstablished mesh__D005541 1975-09-01
% 211.46/211.64  |- skos__hiddenLabel mesh__D005541 Capacity, Timed Vital
% 211.46/211.64  |- skos__hiddenLabel mesh__D005541 Volume, Forced Expiratory
% 211.46/211.64  |- skos__annotation mesh__D005541
% 211.46/211.64       usually NIM; do not confuse with FORCED EXPIRATORY FLOW RATES; DF: FEV%A%  
% 211.46/211.64  |- skos__altLabel mesh__D005541 FEVt
% 211.46/211.64  |- skos__altLabel mesh__D005541 Forced Vital Capacity, Timed
% 211.46/211.64  |- mesh__recordOriginator mesh__D005541 NLM
% 211.46/211.64  |- rdf__type mesh__D005541sskos__Concept
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D005541 2005
% 211.46/211.64  |- mesh__publicMeSHNote mesh__D005541 75   
% 211.46/211.64  |- skos__hiddenLabel mesh__D005541 Expiratory Volumes, Forced
% 211.46/211.64  |- mesh__dateCreated mesh__D005541 1974-11-19
% 211.46/211.64  |- skos__historyNote mesh__D005541 Vital Capacity %28%1969-1974%29%
% 211.46/211.64  |- skos__historyNote mesh__D005541 Spirometry %28%1966-1974%29%
% 211.46/211.64  |- skos__hiddenLabel mesh__D005541 Volumes, Forced Expiratory
% 211.46/211.64  |- skos__hiddenLabel mesh__D005541 Capacities, Timed Vital
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D005541 2006
% 211.46/211.64  |- mesh__recordAuthorizer mesh__D005541 sjn
% 211.46/211.64  |- rdf__type mesh__D052197sskos__Concept
% 211.46/211.64  |- mesh__recordMaintainer mesh__D052197 ags
% 211.46/211.64  |- mesh__dateEstablished mesh__D052197 2006-01-01
% 211.46/211.64  |- mesh__publicMeSHNote mesh__D052197 2006   
% 211.46/211.64  |- skos__prefLabel mesh__D052197 Lactobacillus fermentum
% 211.46/211.64  |- skos__broader mesh__D052197smesh__D007778
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D052197 2006
% 211.46/211.64  |- skos__altLabel mesh__D052197 Lactobacillus cellobiosus
% 211.46/211.64  |- mesh__historyNote mesh__D052197 2006   
% 211.46/211.64  |- skos__scopeNote mesh__D052197
% 211.46/211.64       A species of gram-positive, rod-shaped bacteria associated with DENTAL CARIES.%A%    
% 211.46/211.64  |- mesh__recordAuthorizer mesh__D052197 sjn
% 211.46/211.64  |- mesh__dateCreated mesh__D052197 2005-06-30
% 211.46/211.64  |- mesh__recordOriginator mesh__D052197 ags
% 211.46/211.64  |- skos__historyNote mesh__D052197 Lactobacillus %28%1975-2005%29%
% 211.46/211.64  |- mesh__dateRevised mesh__D018469 2005-06-30
% 211.46/211.64  |- skos__scopeNote mesh__D018469
% 211.46/211.64       A species of gram-negative bacteria that is the causative agent of human EHRLICHIOSIS. This organism was first discovered at Fort Chaffee, Arkansas, when blood samples from suspected human ehrlichiosis patients were studied.%A%    
% 211.46/211.64  |- mesh__recordOriginator mesh__D018469 PXP
% 211.46/211.64  |- rdf__type mesh__D018469sskos__Concept
% 211.46/211.64  |- skos__historyNote mesh__D018469 Ehrlichia %28%1991-1994%29%
% 211.46/211.64  |- mesh__dateEstablished mesh__D018469 1995-01-01
% 211.46/211.64  |- mesh__publicMeSHNote mesh__D018469 95   
% 211.46/211.64  |- mesh__recordMaintainer mesh__D018469 SYSTEM
% 211.46/211.64  |- mesh__recordAuthorizer mesh__D018469 sjn
% 211.46/211.64  |- skos__prefLabel mesh__D018469 Ehrlichia chaffeensis
% 211.46/211.64  |- skos__broader mesh__D018469smesh__D004536
% 211.46/211.64  |- skos__annotation mesh__D018469
% 211.46/211.64       chaffeensis refers to Fort Chaffee, Arkansas, where first discovered; infection: coord IM with EHRLICHIOSIS %28%IM%29%%A%  
% 211.46/211.64  |- mesh__dateCreated mesh__D018469 1994-06-03
% 211.46/211.64  |- mesh__historyNote mesh__D018469 95   
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D018469 2006
% 211.46/211.64  |- skos__hiddenLabel mesh__D010486 Periodontiums, Apical
% 211.46/211.64  |- mesh__recordOriginator mesh__D010486 NLM
% 211.46/211.64  |- mesh__publicMeSHNote mesh__D010486 73   
% 211.46/211.64  |- mesh__historyNote mesh__D010486 73%28%72%29%   
% 211.46/211.64  |- skos__historyNote mesh__D010486 Periodontium %28%1966-1971%29%
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D010486 2005
% 211.46/211.64  |- mesh__recordAuthorizer mesh__D010486 sjn
% 211.46/211.64  |- mesh__dateEstablished mesh__D010486 1973-01-01
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D010486 2004
% 211.46/211.64  |- skos__hiddenLabel mesh__D010486 Apical Periodontium
% 211.46/211.64  |- mesh__dateCreated mesh__D010486 1999-01-01
% 211.46/211.64  |- rdf__type mesh__D010486sskos__Concept
% 211.46/211.64  |- skos__hiddenLabel mesh__D010486 Apical Periodontiums
% 211.46/211.64  |- skos__hiddenLabel mesh__D010486 Tissue, Periapical
% 211.46/211.64  |- skos__altLabel mesh__D010486 Periodontium, Apical
% 211.46/211.64  |- mesh__dateRevised mesh__D010486 2003-07-09
% 211.46/211.64  |- mesh__recordMaintainer mesh__D010486 lkt
% 211.46/211.64  |- skos__scopeNote mesh__D010486
% 211.46/211.64       Tissue surrounding the apex of a tooth, including the apical portion of the periodontal membrane and alveolar bone.%A%    
% 211.46/211.64  |- skos__hiddenLabel mesh__D010486 Tissues, Periapical
% 211.46/211.64  |- skos__broader mesh__D010486smesh__D010519
% 211.46/211.64  |- skos__prefLabel mesh__D010486 Periapical Tissue
% 211.46/211.64  |- skos__annotation mesh__D010486
% 211.46/211.64       diseases = PERIAPICAL DISEASES; inflammation = PERIAPICAL PERIODONTITIS%A%  
% 211.46/211.64  |- skos__hiddenLabel mesh__D010486 Periapical Tissues
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D010486 2006
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D004449 2005
% 211.46/211.64  |- skos__altLabel mesh__D004449 Fascioletta ilocanum
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D004449 2004
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D004449 2006
% 211.46/211.64  |- skos__altLabel mesh__D004449 Euparyphium ilocanum
% 211.46/211.64  |- rdf__type mesh__D004449sskos__Concept
% 211.46/211.64  |- mesh__recordMaintainer mesh__D004449 ags
% 211.46/211.64  |- mesh__recordAuthorizer mesh__D004449 sjn
% 211.46/211.64  |- skos__broader mesh__D004449smesh__D004450
% 211.46/211.64  |- mesh__recordOriginator mesh__D004449 NLM
% 211.46/211.64  |- skos__annotation mesh__D004449
% 211.46/211.64       infection = ECHINOSTOMIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 211.46/211.64  |- skos__prefLabel mesh__D004449 Echinostoma
% 211.46/211.64  |- mesh__dateCreated mesh__D004449 1999-01-01
% 211.46/211.64  |- mesh__dateRevised mesh__D004449 2003-07-09
% 211.46/211.64  |- skos__scopeNote mesh__D004449
% 211.46/211.64       A genus of intestinal flukes of the family Echinostomatidae which consists of many species. They occur in man and other vertebrates. The intermediate hosts are frequently mollusks.%A%    
% 211.46/211.64  |- skos__broader mesh__D015171smesh__D003714
% 211.46/211.64  |- skos__historyNote mesh__D015171 Sympathectomy %28%1966-1988%29%
% 211.46/211.64  |- skos__hiddenLabel mesh__D015171 Ganglionectomies
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D015171 2006
% 211.46/211.64  |- skos__historyNote mesh__D015171
% 211.46/211.64       Ganglia, Autonomic or specific %28%1966-1988%29%
% 211.46/211.64  |- mesh__recordMaintainer mesh__D015171 PXP
% 211.46/211.64  |- mesh__historyNote mesh__D015171 89   
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D015171 2005
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D015171 1999
% 211.46/211.64  |- mesh__recordAuthorizer mesh__D015171 SJN
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D015171 2002
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D015171 2004
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D015171 1998
% 211.46/211.64  |- rdf__type mesh__D015171sskos__Concept
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D015171 2001
% 211.46/211.64  |- skos__scopeNote mesh__D015171
% 211.46/211.64       Removal of an autonomic or sensory ganglion by any means.%A%    
% 211.46/211.64  |- skos__annotation mesh__D015171
% 211.46/211.64       do not use /util except by MeSH definition; coord IM with specific ganglion %28%NIM%29%; coord IM with disease /surg %28%IM%29%%A%  
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D015171 2003
% 211.46/211.64  |- mesh__publicMeSHNote mesh__D015171 89   
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D015171 2000
% 211.46/211.64  |- mesh__dateEstablished mesh__D015171 1989-01-01
% 211.46/211.64  |- mesh__dateRevised mesh__D015171 1997-06-20
% 211.46/211.64  |- mesh__recordOriginator mesh__D015171 SCD
% 211.46/211.64  |- skos__broader mesh__D015171smesh__D013562
% 211.46/211.64  |- skos__prefLabel mesh__D015171 Ganglionectomy
% 211.46/211.64  |- skos__historyNote mesh__D015171
% 211.46/211.64       Sympathectomy, Chemical %28%1984-1988%29%
% 211.46/211.64  |- mesh__dateCreated mesh__D015171 1988-04-13
% 211.46/211.64  |- skos__annotation mesh__D009134
% 211.46/211.64       MUSCULAR ATROPHY, SPINAL, INFANTILE see SPINAL MUSCULAR ATROPHIES OF CHILDHOOD is also available%A%  
% 211.46/211.64  |- mesh__publicMeSHNote mesh__D009134 1988   
% 211.46/211.64  |- skos__hiddenLabel mesh__D009134 Atrophy, Myelopathic Muscular
% 211.46/211.64  |- skos__altLabel mesh__D009134 Progressive Myelopathic Muscular Atrophy
% 211.46/211.64  |- skos__scopeNote mesh__D009134
% 211.46/211.64       A group of disorders marked by progressive degeneration of motor neurons in the spinal cord resulting in weakness and muscular atrophy, usually without evidence of injury to the corticospinal tracts. Diseases in this category include Werdnig-Hoffmann disease and later onset SPINAL MUSCULAR ATROPHIES OF CHILDHOOD, most of which are hereditary. %28%Adams et al., Principles of Neurology, 6th ed, p1089%29%%A%    
% 211.46/211.64  |- skos__hiddenLabel mesh__D009134 X Linked Bulbo Spinal Atrophy
% 211.46/211.64  |- mesh__dateEstablished mesh__D009134 1988-01-01
% 211.46/211.64  |- mesh__recordMaintainer mesh__D009134 ags
% 211.46/211.64  |- skos__altLabel mesh__D009134 Adult Spinal Muscular Atrophy
% 211.46/211.64  |- skos__altLabel mesh__D009134 Spinal Muscular Atrophy, Distal
% 211.46/211.64  |- skos__altLabel mesh__D009134
% 211.46/211.64       Proximal Myelopathic Muscular Atrophy, Progressive
% 211.46/211.64  |- mesh__recordAuthorizer mesh__D009134 sjn
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D009134 2006
% 211.46/211.64  |- skos__altLabel mesh__D009134 Bulbo-Spinal Atrophy, X-Linked
% 211.46/211.64  |- skos__hiddenLabel mesh__D009134 Bulbo Spinal Atrophy, X Linked
% 211.46/211.64  |- skos__altLabel mesh__D009134 Myelopathic Muscular Atrophy, Progressive
% 211.46/211.64  |- skos__broader mesh__D009134smesh__D013118
% 211.46/211.64  |- skos__hiddenLabel mesh__D009134 X-Linked Bulbo-Spinal Atrophies
% 211.46/211.64  |- skos__broader mesh__D009134smesh__D016472
% 211.46/211.64  |- skos__prefLabel mesh__D009134 Muscular Atrophy, Spinal
% 211.46/211.64  |- mesh__recordOriginator mesh__D009134 SD
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D009134 2005
% 211.46/211.64  |- skos__altLabel mesh__D009134
% 211.46/211.64       Spinal Muscular Atrophy, Scapuloperoneal Form
% 211.46/211.64  |- skos__hiddenLabel mesh__D009134 Atrophy, Spinal Muscular
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D009134 2004
% 211.46/211.64  |- rdf__type mesh__D009134sskos__Concept
% 211.46/211.64  |- mesh__dateCreated mesh__D009134 1987-03-10
% 211.46/211.64  |- mesh__historyNote mesh__D009134 1988   
% 211.46/211.64  |- skos__hiddenLabel mesh__D009134 Bulbo-Spinal Atrophies, X-Linked
% 211.46/211.64  |- skos__altLabel mesh__D009134 Spinal Muscular Atrophy
% 211.46/211.64  |- skos__altLabel mesh__D009134 X-Linked Bulbo-Spinal Atrophy
% 211.46/211.64  |- skos__hiddenLabel mesh__D009134 Syndrome, Kennedy
% 211.46/211.64  |- skos__hiddenLabel mesh__D009134 Atrophy, X-Linked Bulbo-Spinal
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D009134 2002
% 211.46/211.64  |- skos__altLabel mesh__D009134 Kennedy Syndrome
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D009134 2003
% 211.46/211.64  |- skos__hiddenLabel mesh__D009134 Bulbospinal Neuronopathies
% 211.46/211.64  |- skos__hiddenLabel mesh__D009134 Neuronopathies, Bulbospinal
% 211.46/211.64  |- skos__hiddenLabel mesh__D009134 Muscular Atrophy, Myelopathic
% 211.46/211.64  |- skos__hiddenLabel mesh__D009134 Atrophies, X-Linked Bulbo-Spinal
% 211.46/211.64  |- skos__hiddenLabel mesh__D009134 Neuronopathy, Bulbospinal
% 211.46/211.64  |- skos__altLabel mesh__D009134 Spinal Muscular Atrophy, Oculopharyngeal
% 211.46/211.64  |- skos__broader mesh__D009134smesh__D009468
% 211.46/211.64  |- mesh__dateRevised mesh__D009134 2001-07-25
% 211.46/211.64  |- skos__historyNote mesh__D009134 Spinal Cord Diseases %28%1966-1987%29%
% 211.46/211.64  |- skos__historyNote mesh__D009134 Muscular Atrophy %28%1966-1987%29%
% 211.46/211.64  |- skos__prefLabel mesh__D001151 Arsenic
% 211.46/211.64  |- mesh__dateRevised mesh__D001151 2005-06-30
% 211.46/211.64  |- rdf__type mesh__D001151sskos__Concept
% 211.46/211.64  |- skos__annotation mesh__D001151
% 211.46/211.64       As-75; As-69-81, except As-75 = ARSENIC %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 211.46/211.64  |- skos__scopeNote mesh__D001151
% 211.46/211.64       A shiny gray element with atomic symbol As, atomic number 33, and atomic weight 75. It occurs throughout the universe, mostly in the form of metallic arsenides. Most forms are toxic. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%, arsenic and certain arsenic compounds have been listed as known carcinogens. %28%From Merck Index, 11th ed%29%%A%    
% 211.46/211.64  |- mesh__dateCreated mesh__D001151 1999-01-01
% 211.46/211.64  |- mesh__recordOriginator mesh__D001151 NLM
% 211.46/211.64  |- mesh__recordAuthorizer mesh__D001151 sjn
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D001151 2006
% 211.46/211.64  |- skos__broader mesh__D001151smesh__D004602
% 211.46/211.64  |- mesh__recordMaintainer mesh__D001151 ssb
% 211.46/211.64  |- skos__broader mesh__D004865Q000458smesh__D004865
% 211.46/211.64  |- mesh__preferredCombination mesh__D004865Q000458smesh__D008421
% 211.46/211.64  |- rdf__type mesh__D004865Q000458smesh__CompoundConcept
% 211.46/211.64  |- skos__hiddenLabel mesh__D014877 Pollution, Chemical Water
% 211.46/211.64  |- mesh__publicMeSHNote mesh__D014877 73   
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014877 2006
% 211.46/211.64  |- skos__hiddenLabel mesh__D014877 Chemical Water Pollutions
% 211.46/211.64  |- skos__broader mesh__D014877smesh__D014876
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014877 2002
% 211.46/211.64  |- skos__altLabel mesh__D014877 Chemical Water Pollution
% 211.46/211.64  |- mesh__recordAuthorizer mesh__D014877 sjn
% 211.46/211.64  |- skos__historyNote mesh__D014877 Water Pollution %28%1966-1970%29%
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014877 2003
% 211.46/211.64  |- mesh__recordOriginator mesh__D014877 NLM
% 211.46/211.64  |- skos__hiddenLabel mesh__D014877 Pollutions, Chemical Water
% 211.46/211.64  |- rdf__type mesh__D014877sskos__Concept
% 211.46/211.64  |- skos__related mesh__D014877smesh__D005068
% 211.46/211.64  |- mesh__dateEstablished mesh__D014877 1973-01-01
% 211.46/211.64  |- mesh__historyNote mesh__D014877 73%28%71%29%   
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014877 2004
% 211.46/211.64  |- skos__historyNote mesh__D014877 specific chemical %28%1966-1970%29%
% 211.46/211.64  |- skos__prefLabel mesh__D014877 Water Pollution, Chemical
% 211.46/211.64  |- mesh__dateRevised mesh__D014877 1999-11-03
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014877 2000
% 211.46/211.64  |- mesh__recordMaintainer mesh__D014877 kle
% 211.46/211.64  |- skos__hiddenLabel mesh__D014877 Water Pollutions, Chemical
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014877 2005
% 211.46/211.64  |- mesh__dateCreated mesh__D014877 1999-01-01
% 211.46/211.64  |- skos__annotation mesh__D014877
% 211.46/211.64       IM; coord with specific source of pollution %28%IM%29%; specify geog if pertinent%A%  
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014877 2001
% 211.46/211.64  |- mesh__dateRevised mesh__D014079 1990-05-29
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014079 2002
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014079 1995
% 211.46/211.64  |- mesh__dateCreated mesh__D014079 1999-01-01
% 211.46/211.64  |- skos__hiddenLabel mesh__D014079 Eruptions, Ectopic Tooth
% 211.46/211.64  |- mesh__recordOriginator mesh__D014079 NLM
% 211.46/211.64  |- skos__hiddenLabel mesh__D014079 Ectopic Tooth Eruption
% 211.46/211.64  |- skos__hiddenLabel mesh__D014079 Eruption, Ectopic Tooth
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014079 2006
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014079 1994
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014079 1993
% 211.46/211.64  |- skos__prefLabel mesh__D014079 Tooth Eruption, Ectopic
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014079 2005
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014079 2004
% 211.46/211.64  |- mesh__publicMeSHNote mesh__D014079 66   
% 211.46/211.64  |- mesh__dateEstablished mesh__D014079 1966-01-01
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014079 1999
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014079 1992
% 211.46/211.64  |- mesh__historyNote mesh__D014079 66%28%65%29%   
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014079 2001
% 211.46/211.64  |- skos__hiddenLabel mesh__D014079 Ectopic Tooth Eruptions
% 211.46/211.64  |- skos__broader mesh__D014079smesh__D014076
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014079 2003
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014079 1998
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014079 1997
% 211.46/211.64  |- skos__annotation mesh__D014079 note category   
% 211.46/211.64  |- skos__hiddenLabel mesh__D014079 Tooth Eruptions, Ectopic
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014079 2000
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014079 1996
% 211.46/211.64  |- mesh__recordAuthorizer mesh__D014079 NLM
% 211.46/211.64  |- rdf__type mesh__D014079sskos__Concept
% 211.46/211.64  |- mesh__recordMaintainer mesh__D014079 PLS
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D014079 1991
% 211.46/211.64  |- mesh__publicMeSHNote mesh__D000857 2000; see ANOSMIA 1963-1999   
% 211.46/211.64  |- mesh__dateEstablished mesh__D000857 1966-01-01
% 211.46/211.64  |- mesh__recordAuthorizer mesh__D000857 sjn
% 211.46/211.64  |- mesh__recordMaintainer mesh__D000857 KEV
% 211.46/211.64  |- mesh__historyNote mesh__D000857 2000%28%1963%29%   
% 211.46/211.64  |- skos__broader mesh__D000857smesh__D012678
% 211.46/211.64  |- skos__hiddenLabel mesh__D000857 Cacosmias
% 211.46/211.64  |- skos__hiddenLabel mesh__D000857 Dysosmias
% 211.46/211.64  |- rdf__type mesh__D000857sskos__Concept
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D000857 2000
% 211.46/211.64  |- skos__altLabel mesh__D000857 Smell Disorders
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D000857 2005
% 211.46/211.64  |- skos__prefLabel mesh__D000857 Olfaction Disorders
% 211.46/211.64  |- skos__related mesh__D000857smesh__D020431
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D000857 2003
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D000857 2006
% 211.46/211.64  |- mesh__dateRevised mesh__D000857 1999-11-03
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D000857 2001
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D000857 2004
% 211.46/211.64  |- skos__scopeNote mesh__D000857
% 211.46/211.64       Loss of or impaired ability to smell. This may be caused by OLFACTORY NERVE DISEASES; PARANASAL SINUS DISEASES; viral RESPIRATORY TRACT INFECTIONS; CRANIOCEREBRAL TRAUMA; SMOKING; and other conditions.%A%    
% 211.46/211.64  |- skos__altLabel mesh__D000857 Dysosmia
% 211.46/211.64  |- skos__hiddenLabel mesh__D000857 Smell Disorder
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D000857 2002
% 211.46/211.64  |- skos__hiddenLabel mesh__D000857 Olfaction Disorder
% 211.46/211.64  |- skos__hiddenLabel mesh__D000857 Paraosmias
% 211.46/211.64  |- mesh__dateCreated mesh__D000857 1999-01-01
% 211.46/211.64  |- mesh__recordOriginator mesh__D000857 NLM
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D019562 2001
% 211.46/211.64  |- rdf__type mesh__D019562sskos__Concept
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D019562 2005
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D019562 2004
% 211.46/211.64  |- skos__broader mesh__D019562smesh__D008828
% 211.46/211.64  |- mesh__dateRevised mesh__D019562 2000-06-22
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D019562 2003
% 211.46/211.64  |- skos__altLabel mesh__D019562 Viral Burden
% 211.46/211.64  |- skos__hiddenLabel mesh__D019562 Load, Viral
% 211.46/211.64  |- mesh__dateCreated mesh__D019562 1996-06-10
% 211.46/211.64  |- skos__prefLabel mesh__D019562 Viral Load
% 211.46/211.64  |- skos__hiddenLabel mesh__D019562 Burden, Viral
% 211.46/211.64  |- skos__scopeNote mesh__D019562
% 211.46/211.64       The quantity of measurable virus in the blood. Change in viral load, measured in plasma, is used as a surrogate marker in HIV disease progression.%A%    
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D019562 2002
% 211.46/211.64  |- mesh__publicMeSHNote mesh__D019562 97   
% 211.46/211.64  |- mesh__historyNote mesh__D019562 97   
% 211.46/211.64  |- mesh__dateEstablished mesh__D019562 1997-01-01
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D019562 2006
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D000059 2003
% 211.46/211.64  |- mesh__dateCreated mesh__D000059 1999-01-01
% 211.46/211.64  |- skos__hiddenLabel mesh__D000059 Accident
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D000059 2002
% 211.46/211.64  |- skos__broader mesh__D000059smesh__D011634
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D000059 2006
% 211.46/211.64  |- mesh__recordAuthorizer mesh__D000059 sjn
% 211.46/211.64  |- rdf__type mesh__D000059sskos__Concept
% 211.46/211.64  |- skos__annotation mesh__D000059 GEN or unspecified; prefer specifics   
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D000059 2005
% 211.46/211.64  |- mesh__dateRevised mesh__D000059 1999-11-03
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D000059 2001
% 211.46/211.64  |- mesh__recordMaintainer mesh__D000059 kle
% 211.46/211.64  |- mesh__recordOriginator mesh__D000059 NLM
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D000059 2000
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D000059 2004
% 211.46/211.64  |- skos__prefLabel mesh__D000059 Accidents
% 211.46/211.64  |- mesh__recordMaintainer mesh__D005542 TAP
% 211.46/211.64  |- mesh__recordAuthorizer mesh__D005542 sjn
% 211.46/211.64  |- skos__prefLabel mesh__D005542 Forearm
% 211.46/211.64  |- skos__hiddenLabel mesh__D005542 Forearms
% 211.46/211.64  |- skos__annotation mesh__D005542
% 211.46/211.64       primates only: use FORELIMB for non-primate vertebrates %26% EXTREMITIES for invertebrates: TN 117; for bones use RADIUS or ULNA; NIM when merely locational as in skin dis %28%IM%29%%A%  
% 211.46/211.64  |- mesh__dateRevised mesh__D005542 2002-07-03
% 211.46/211.64  |- skos__broader mesh__D005542smesh__D034941
% 211.46/211.64  |- rdf__type mesh__D005542sskos__Concept
% 211.46/211.64  |- mesh__activeMeSHYear mesh__D005542 2005
% 211.46/211.65  |- mesh__dateCreated mesh__D005542 1999-01-01
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D005542 2003
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D005542 2006
% 211.46/211.65  |- mesh__recordOriginator mesh__D005542 NLM
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D005542 2004
% 211.46/211.65  |- rdf__type mesh__D052198sskos__Concept
% 211.46/211.65  |- skos__broader mesh__D052198smesh__D007778
% 211.46/211.65  |- skos__prefLabel mesh__D052198 Lactobacillus helveticus
% 211.46/211.65  |- mesh__recordOriginator mesh__D052198 ags
% 211.46/211.65  |- mesh__publicMeSHNote mesh__D052198 2006   
% 211.46/211.65  |- skos__historyNote mesh__D052198 Lactobacillus %28%1970-2005%29%
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D052198 2006
% 211.46/211.65  |- skos__scopeNote mesh__D052198
% 211.46/211.65       A species of gram-positive bacteria isolated from MILK and cheese-starter cultures.%A%    
% 211.46/211.65  |- mesh__dateEstablished mesh__D052198 2006-01-01
% 211.46/211.65  |- mesh__historyNote mesh__D052198 2006   
% 211.46/211.65  |- mesh__recordAuthorizer mesh__D052198 sjn
% 211.46/211.65  |- mesh__recordMaintainer mesh__D052198 ags
% 211.46/211.65  |- mesh__dateCreated mesh__D052198 2005-06-30
% 211.46/211.65  |- skos__prefLabel mesh__D010487 Periaqueductal Gray
% 211.46/211.65  |- mesh__dateRevised mesh__D010487 2002-07-03
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D010487 2006
% 211.46/211.65  |- mesh__recordAuthorizer mesh__D010487 sjn
% 211.46/211.65  |- skos__hiddenLabel mesh__D010487 Gray, Periaqueductal
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D010487 2005
% 211.46/211.65  |- mesh__recordOriginator mesh__D010487 RC
% 211.46/211.65  |- mesh__dateEstablished mesh__D010487 1983-01-01
% 211.46/211.65  |- skos__broader mesh__D010487smesh__D013681
% 211.46/211.65  |- skos__altLabel mesh__D010487 Mesencephalic Central Gray
% 211.46/211.65  |- rdf__type mesh__D010487sskos__Concept
% 211.46/211.65  |- skos__hiddenLabel mesh__D010487 Gray, Midbrain Central
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D010487 2004
% 211.46/211.65  |- mesh__recordMaintainer mesh__D010487 mdb
% 211.46/211.65  |- mesh__publicMeSHNote mesh__D010487 83   
% 211.46/211.65  |- skos__altLabel mesh__D010487 Midbrain Central Gray
% 211.46/211.65  |- skos__historyNote mesh__D010487 Mesencephalon %28%1966-1982%29%
% 211.46/211.65  |- skos__hiddenLabel mesh__D010487 Central Gray, Mesencephalic
% 211.46/211.65  |- mesh__historyNote mesh__D010487 83   
% 211.46/211.65  |- skos__hiddenLabel mesh__D010487 Central Gray, Midbrain
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D010487 2003
% 211.46/211.65  |- skos__hiddenLabel mesh__D010487 Gray, Mesencephalic Central
% 211.46/211.65  |- skos__historyNote mesh__D010487 Brain %28%1966-1982%29%
% 211.46/211.65  |- skos__scopeNote mesh__D010487
% 211.46/211.65       Central gray matter surrounding the cerebral aqueduct in the mesencephalon. Physiologically it is probably involved in rage reactions, the lordosis reflex, feeding responses, bladder tonus, and pain.%A%    
% 211.46/211.65  |- skos__historyNote mesh__D010487 Cerebral Aqueduct %28%1971-1982%29%
% 211.46/211.65  |- mesh__dateCreated mesh__D010487 1982-04-26
% 211.46/211.65  |- skos__altLabel mesh__D001950 American Regent Brand of Bretylium Tosilate
% 211.46/211.65  |- skos__altLabel mesh__D001950 Bretylium Tosilate
% 211.46/211.65  |- mesh__dateEstablished mesh__D001950 1991-01-01
% 211.46/211.65  |- skos__broader mesh__D001950smesh__D001949
% 211.46/211.65  |- skos__scopeNote mesh__D001950
% 211.46/211.65       An agent that blocks the release of adrenergic transmitters and may have other actions. It was formerly used as an antihypertensive agent, but is now proposed as an anti-arrhythmic.%A%    
% 211.46/211.65  |- skos__historyNote mesh__D001950 Bretylium Compounds %28%1969-1975%29%
% 211.46/211.65  |- skos__altLabel mesh__D001950 GlaxoSmithKline Brand of Bretylium Tosilate
% 211.46/211.65  |- skos__hiddenLabel mesh__D001950 Injection, Bretylium Tosylate
% 211.46/211.65  |- skos__hiddenLabel mesh__D001950 Tosilate, Bretylium
% 211.46/211.65  |- skos__historyNote mesh__D001950 Aryl Sulfonates %28%1974-1975%29%
% 211.46/211.65  |- mesh__dateRevised mesh__D001950 2005-06-30
% 211.46/211.65  |- skos__prefLabel mesh__D001950 Bretylium Tosylate
% 211.46/211.65  |- skos__altLabel mesh__D001950 Sabex Brand of Bretylium Tosilate
% 211.46/211.65  |- skos__altLabel mesh__D001950 Abbott Brand of Bretylium Tosilate
% 211.46/211.65  |- mesh__dateCreated mesh__D001950 1975-07-23
% 211.46/211.65  |- mesh__publicMeSHNote mesh__D001950
% 211.46/211.65       91; was see under BRETYLIUM COMPOUNDS 1976-90   
% 211.46/211.65  |- mesh__recordMaintainer mesh__D001950 ssb
% 211.46/211.65  |- skos__hiddenLabel mesh__D001950 Tosylate, Bretylium
% 211.46/211.65  |- skos__altLabel mesh__D001950 Du Pont Brand of Bretylium Tosilate
% 211.46/211.65  |- mesh__recordOriginator mesh__D001950 RLS
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D001950 2006
% 211.46/211.65  |- rdf__type mesh__D001950sskos__Concept
% 211.46/211.65  |- mesh__historyNote mesh__D001950
% 211.46/211.65       91%28%76%29%; was see under BRETYLIUM COMPOUNDS 1976-90   
% 211.46/211.65  |- mesh__recordAuthorizer mesh__D001950 sjn
% 211.46/211.65  |- skos__hiddenLabel mesh__D001950 Tosylate Injection, Bretylium
% 211.46/211.65  |- skos__hiddenLabel mesh__D009135 Myopathy
% 211.46/211.65  |- skos__altLabel mesh__D009135 Myopathic Conditions
% 211.46/211.65  |- mesh__dateRevised mesh__D009135 1999-11-08
% 211.46/211.65  |- skos__broader mesh__D009135smesh__D009140
% 211.46/211.65  |- rdf__type mesh__D009135sskos__Concept
% 211.46/211.65  |- skos__hiddenLabel mesh__D009135 Muscle Disorder
% 211.46/211.65  |- skos__altLabel mesh__D009135 Myopathies
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D009135 2004
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D009135 2001
% 211.46/211.65  |- skos__hiddenLabel mesh__D009135 Myopathic Condition
% 211.46/211.65  |- skos__hiddenLabel mesh__D009135 Muscular Disease
% 211.46/211.65  |- skos__scopeNote mesh__D009135
% 211.46/211.65       Acquired, familial, and congenital disorders of skeletal muscle %28%MUSCLE, SKELETAL%29% and smooth muscle %28%MUSCLE, SMOOTH%29%.%A%    
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D009135 2000
% 211.46/211.65  |- skos__broader mesh__D009135smesh__D009468
% 211.46/211.65  |- mesh__recordMaintainer mesh__D009135 adp
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D009135 2003
% 211.46/211.65  |- skos__prefLabel mesh__D009135 Muscular Diseases
% 211.46/211.65  |- skos__annotation mesh__D009135
% 211.46/211.65       GEN; prefer specifics; inflamm dis = MYOSITIS. /congen: consider also Myopathies, Structural, Congenital %26% its indentions%A%  
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D009135 2006
% 211.46/211.65  |- mesh__recordOriginator mesh__D009135 NLM
% 211.46/211.65  |- mesh__dateCreated mesh__D009135 1999-01-01
% 211.46/211.65  |- skos__altLabel mesh__D009135 Muscle Disorders
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D009135 2002
% 211.46/211.65  |- mesh__recordAuthorizer mesh__D009135 sjn
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D009135 2005
% 211.46/211.65  |- skos__hiddenLabel mesh__D001152 Compounds, Arsenic
% 211.46/211.65  |- skos__prefLabel mesh__D001152 Arsenicals
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D001152 2002
% 211.46/211.65  |- skos__scopeNote mesh__D001152
% 211.46/211.65       Inorganic or organic compounds that contain arsenic.     
% 211.46/211.65  |- mesh__historyNote mesh__D001152 ARSENIC COMPOUNDS was heading 1994-95   
% 211.46/211.65  |- mesh__dateCreated mesh__D001152 1999-01-01
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D001152 2004
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D001152 2001
% 211.46/211.65  |- mesh__publicMeSHNote mesh__D001152
% 211.46/211.65       ARSENIC COMPOUNDS was heading 1994-95   
% 211.46/211.65  |- skos__annotation mesh__D001152 inorganic or organic arsenic cpds   
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D001152 2006
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D001152 2003
% 211.46/211.65  |- skos__broader mesh__D001152smesh__D009942
% 211.46/211.65  |- skos__altLabel mesh__D001152 Arsenic Compounds
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D001152 2005
% 211.46/211.65  |- mesh__dateRevised mesh__D001152 1999-11-03
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D001152 2000
% 211.46/211.65  |- skos__broader mesh__D001152smesh__D007287
% 211.46/211.65  |- mesh__recordOriginator mesh__D001152 NLM
% 211.46/211.65  |- mesh__recordAuthorizer mesh__D001152 sjn
% 211.46/211.65  |- rdf__type mesh__D001152sskos__Concept
% 211.46/211.65  |- mesh__recordMaintainer mesh__D001152 tpw
% 211.46/211.65  |- skos__broader mesh__D014878smesh__D011870
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D014878 2001
% 211.46/211.65  |- skos__hiddenLabel mesh__D014878 Water Pollutions, Radioactive
% 211.46/211.65  |- skos__broader mesh__D014878smesh__D014876
% 211.46/211.65  |- skos__hiddenLabel mesh__D014878 Pollutions, Radioactive Water
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D014878 2006
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D014878 2000
% 211.46/211.65  |- skos__hiddenLabel mesh__D014878 Radioactive Water Pollution
% 211.46/211.65  |- mesh__dateRevised mesh__D014878 1999-11-03
% 211.46/211.65  |- mesh__historyNote mesh__D014878 66   
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D014878 2005
% 211.46/211.65  |- mesh__dateEstablished mesh__D014878 1966-01-01
% 211.46/211.65  |- skos__annotation mesh__D014878
% 211.46/211.65       IM; coord with specific source of pollution %28%IM%29%; specify geog if pertinent%A%  
% 211.46/211.65  |- skos__hiddenLabel mesh__D014878 Pollution, Radioactive Water
% 211.46/211.65  |- mesh__recordMaintainer mesh__D014878 kle
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D014878 2004
% 211.46/211.65  |- skos__prefLabel mesh__D014878 Water Pollution, Radioactive
% 211.46/211.65  |- rdf__type mesh__D014878sskos__Concept
% 211.46/211.65  |- mesh__recordAuthorizer mesh__D014878 sjn
% 211.46/211.65  |- mesh__dateCreated mesh__D014878 1999-01-01
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D014878 2003
% 211.46/211.65  |- mesh__recordOriginator mesh__D014878 NLM
% 211.46/211.65  |- skos__hiddenLabel mesh__D014878 Radioactive Water Pollutions
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D014878 2002
% 211.46/211.65  |- mesh__publicMeSHNote mesh__D014878 66   
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D019563 1999
% 211.46/211.65  |- skos__historyNote mesh__D019563 Physics %28%1966-1996%29%
% 211.46/211.65  |- skos__related mesh__D019563smesh__D001696
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D019563 2002
% 211.46/211.65  |- mesh__publicMeSHNote mesh__D019563 97   
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D019563 2004
% 211.46/211.65  |- mesh__dateEstablished mesh__D019563 1997-01-01
% 211.46/211.65  |- skos__prefLabel mesh__D019563 Mechanics
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D019563 1998
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D019563 2001
% 211.46/211.65  |- skos__scopeNote mesh__D019563
% 211.46/211.65       The branch of physics which deals with the motions of material bodies, including kinematics, dynamics, and statics. When the laws of mechanics are applied to living structures, as to the locomotor system, it is referred to as BIOMECHANICS. %28%From Dorland, 28th ed%29%%A%    
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D019563 2003
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D019563 1997
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D019563 2000
% 211.46/211.65  |- mesh__dateCreated mesh__D019563 1996-06-20
% 211.46/211.65  |- skos__annotation mesh__D019563
% 211.46/211.65       for materials, machines %26% other inanimate objects; for structures in living bodies index under BIOMECHANICS; GEN; prefer specifics; IM for principle of physics, NIM as coord for object described %28%IM%29%%A%  
% 211.46/211.65  |- mesh__historyNote mesh__D019563 97   
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D019563 2006
% 211.46/211.65  |- rdf__type mesh__D019563sskos__Concept
% 211.46/211.65  |- skos__broader mesh__D019563smesh__D010825
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D019563 2005
% 211.46/211.65  |- mesh__dateCreated mesh__D000858 1974-11-11
% 211.46/211.65  |- skos__scopeNote mesh__D000858
% 211.46/211.65       Suspension or cessation of OVULATION in animals or humans with follicle-containing ovaries %28%OVARIAN FOLLICLE%29%. Depending on the etiology, OVULATION may be induced with appropriate therapy.%A%    
% 211.46/211.65  |- rdf__type mesh__D000858sskos__Concept
% 211.46/211.65  |- mesh__recordOriginator mesh__D000858 NLM
% 211.46/211.65  |- mesh__dateRevised mesh__D000858 2004-07-07
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D000858 2005
% 211.46/211.65  |- mesh__recordAuthorizer mesh__D000858 sjn
% 211.46/211.65  |- skos__broader mesh__D000858smesh__D010049
% 211.46/211.65  |- skos__historyNote mesh__D000858 Ovulation %28%1966-1974%29%
% 211.46/211.65  |- skos__broader mesh__D000858smesh__D010060
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D000858 2006
% 211.46/211.65  |- mesh__recordMaintainer mesh__D000858 lkt
% 211.46/211.65  |- skos__prefLabel mesh__D000858 Anovulation
% 211.46/211.65  |- mesh__publicMeSHNote mesh__D000858 75   
% 211.46/211.65  |- skos__hiddenLabel mesh__D000858 Anovulations
% 211.46/211.65  |- mesh__historyNote mesh__D000858 75   
% 211.46/211.65  |- mesh__dateEstablished mesh__D000858 1975-09-01
% 211.46/211.65  |- skos__hiddenLabel mesh__D011580 Technics, Theoretical
% 211.46/211.65  |- skos__altLabel mesh__D011580 Techniques, Psychological
% 211.46/211.65  |- mesh__recordMaintainer mesh__D011580 TGC
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D011580 2000
% 211.46/211.65  |- skos__altLabel mesh__D011580 Theoretical Technics
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D011580 1999
% 211.46/211.65  |- mesh__dateCreated mesh__D011580 1999-01-01
% 211.46/211.65  |- skos__broader mesh__D011580smesh__D004191
% 211.46/211.65  |- mesh__historyNote mesh__D011580 98; use explode 1970-97   
% 211.46/211.65  |- skos__scopeNote mesh__D011580
% 211.46/211.65       Methods used in the diagnosis and treatment of behavioral, personality, and mental disorders.%A%    
% 211.46/211.65  |- skos__prefLabel mesh__D011580 Psychological Techniques
% 211.46/211.65  |- skos__hiddenLabel mesh__D011580 Technics, Psychologic
% 211.46/211.65  |- skos__hiddenLabel mesh__D011580 Psychologic Technique
% 211.46/211.65  |- skos__hiddenLabel mesh__D011580 Psychologic Technic
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D011580 2001
% 211.46/211.65  |- skos__hiddenLabel mesh__D011580 Technic, Psychologic
% 211.46/211.65  |- skos__altLabel mesh__D011580 Technics, Psychological
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D011580 2005
% 211.46/211.65  |- skos__hiddenLabel mesh__D011580 Technique, Psychologic
% 211.46/211.65  |- mesh__recordOriginator mesh__D011580 NLM
% 211.46/211.65  |- skos__hiddenLabel mesh__D011580 Techniques, Theoretical
% 211.46/211.65  |- skos__hiddenLabel mesh__D011580 Theoretical Technic
% 211.46/211.65  |- skos__annotation mesh__D011580
% 211.46/211.65       GEN or unspecified; prefer specifics; DF: PSYCHOL TECHNIQUES%A%  
% 211.46/211.65  |- skos__altLabel mesh__D011580 Technic, Psychological
% 211.46/211.65  |- mesh__recordAuthorizer mesh__D011580 SJN
% 211.46/211.65  |- skos__hiddenLabel mesh__D011580 Theoretical Technique
% 211.46/211.65  |- skos__altLabel mesh__D011580 Psychological Technic
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D011580 2006
% 211.46/211.65  |- skos__hiddenLabel mesh__D011580 Technique, Theoretical
% 211.46/211.65  |- mesh__publicMeSHNote mesh__D011580 98   
% 211.46/211.65  |- skos__hiddenLabel mesh__D011580 Technic, Theoretical
% 211.46/211.65  |- skos__altLabel mesh__D011580 Psychologic Techniques
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D011580 2002
% 211.46/211.65  |- mesh__dateEstablished mesh__D011580 1998-01-01
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D011580 2003
% 211.46/211.65  |- skos__hiddenLabel mesh__D011580 Techniques, Psychologic
% 211.46/211.65  |- skos__altLabel mesh__D011580 Psychological Technics
% 211.46/211.65  |- rdf__type mesh__D011580sskos__Concept
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D011580 1998
% 211.46/211.65  |- skos__altLabel mesh__D011580 Theoretical Techniques
% 211.46/211.65  |- mesh__dateRevised mesh__D011580 1997-06-20
% 211.46/211.65  |- skos__altLabel mesh__D011580 Technique, Psychological
% 211.46/211.65  |- skos__altLabel mesh__D011580 Psychological Technique
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D011580 2004
% 211.46/211.65  |- skos__altLabel mesh__D011580 Psychologic Technics
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D005543 2003
% 211.46/211.65  |- skos__prefLabel mesh__D005543 Forearm Injuries
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D005543 2005
% 211.46/211.65  |- mesh__recordOriginator mesh__D005543 NLM
% 211.46/211.65  |- skos__annotation mesh__D005543
% 211.46/211.65       GEN %26% unspecified for soft tissue %26% bones; consider also /inj with specific bones %26% also specific fracture terms; available also are HAND INJURIES; FINGER INJURIES %26% WRIST INJURIES%A%  
% 211.46/211.65  |- skos__scopeNote mesh__D005543
% 211.46/211.65       Injuries to the part of the upper limb of the body between the wrist and elbow.%A%    
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D005543 2002
% 211.46/211.65  |- skos__broader mesh__D005543smesh__D001134
% 211.46/211.65  |- skos__altLabel mesh__D005543 Injuries, Forearm
% 211.46/211.65  |- mesh__dateRevised mesh__D005543 2001-07-25
% 211.46/211.65  |- mesh__dateCreated mesh__D005543 1999-01-01
% 211.46/211.65  |- mesh__recordAuthorizer mesh__D005543 sjn
% 211.46/211.65  |- skos__hiddenLabel mesh__D005543 Injury, Forearm
% 211.46/211.65  |- skos__hiddenLabel mesh__D005543 Forearm Injury
% 211.46/211.65  |- rdf__type mesh__D005543sskos__Concept
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D005543 2004
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D005543 2006
% 211.46/211.65  |- mesh__recordMaintainer mesh__D005543 mdb
% 211.46/211.65  |- skos__scopeNote mesh__D052199
% 211.46/211.65       A species of gram-negative bacteria isolated from MILK, cheese, and compressed yeast.%A%    
% 211.46/211.65  |- mesh__dateCreated mesh__D052199 2005-06-30
% 211.46/211.65  |- mesh__recordOriginator mesh__D052199 ags
% 211.46/211.65  |- skos__broader mesh__D052199smesh__D007778
% 211.46/211.65  |- mesh__publicMeSHNote mesh__D052199 2006   
% 211.46/211.65  |- skos__prefLabel mesh__D052199 Lactobacillus leichmannii
% 211.46/211.65  |- skos__historyNote mesh__D052199 Lactobacillus %28%1965-2005%29%
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D052199 2006
% 211.46/211.65  |- mesh__recordAuthorizer mesh__D052199 sjn
% 211.46/211.65  |- mesh__historyNote mesh__D052199 2006   
% 211.46/211.65  |- mesh__dateEstablished mesh__D052199 2006-01-01
% 211.46/211.65  |- rdf__type mesh__D052199sskos__Concept
% 211.46/211.65  |- mesh__recordMaintainer mesh__D052199 ags
% 211.46/211.65  |- mesh__dateCreated mesh__D010488 1999-01-01
% 211.46/211.65  |- skos__hiddenLabel mesh__D010488 Arteritis, Necrotizing
% 211.46/211.65  |- mesh__onlineNote mesh__D010488
% 211.46/211.65       use POLYARTERITIS NODOSA to search PERIARTERITIS NODOSA 1966-94;%A%  
% 211.46/211.65  |- rdf__type mesh__D010488sskos__Concept
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D010488 2004
% 211.46/211.65  |- skos__hiddenLabel mesh__D010488 Polyarteritis, Essential
% 211.46/211.65  |- skos__hiddenLabel mesh__D010488 Polyarteritides, Essential
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D010488 2003
% 211.46/211.65  |- skos__annotation mesh__D010488 a form of necrotizing vasculitis   
% 211.46/211.65  |- mesh__recordOriginator mesh__D010488 NLM
% 211.46/211.65  |- mesh__historyNote mesh__D010488
% 211.46/211.65       95; was PERIARTERITIS NODOSA 1963-94; POLYARTERITIS NODOSA was see PERIARTERITIS NODOSA 1968-94%A%  
% 211.46/211.65  |- skos__hiddenLabel mesh__D010488 Essential Polyarteritides
% 211.46/211.65  |- skos__broader mesh__D010488smesh__D001167
% 211.46/211.65  |- mesh__recordAuthorizer mesh__D010488 sjn
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D010488 2002
% 211.46/211.65  |- mesh__recordMaintainer mesh__D010488 KEV
% 211.46/211.65  |- skos__related mesh__D010488smesh__D020293
% 211.46/211.65  |- skos__hiddenLabel mesh__D010488 Arteritides, Necrotizing
% 211.46/211.65  |- skos__scopeNote mesh__D010488
% 211.46/211.65       A form of necrotizing vasculitis involving small- and medium-sized arteries. The signs and symptoms result from infarction and scarring of the affected organ system.%A%    
% 211.46/211.65  |- skos__broader mesh__D010488smesh__D017445
% 211.46/211.65  |- skos__hiddenLabel mesh__D010488 Necrotizing Arteritides
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D010488 2006
% 211.46/211.65  |- skos__prefLabel mesh__D010488 Polyarteritis Nodosa
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D010488 2001
% 211.46/211.65  |- skos__altLabel mesh__D010488 Periarteritis Nodosa
% 211.46/211.65  |- mesh__publicMeSHNote mesh__D010488
% 211.46/211.65       95; was PERIARTERITIS NODOSA 1963-94; POLYARTERITIS NODOSA was see PERIARTERITIS NODOSA 1968-94%A%  
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D010488 2005
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D010488 2000
% 211.46/211.65  |- mesh__dateRevised mesh__D010488 1999-11-08
% 211.46/211.65  |- skos__historyNote mesh__D015971 Genes, Regulator %28%1972-1980%29%
% 211.46/211.65  |- mesh__publicMeSHNote mesh__D015971 90   
% 211.46/211.65  |- skos__historyNote mesh__D015971 Enzymes %28%1972-1989%29%
% 211.46/211.65  |- mesh__dateRevised mesh__D015971 2002-07-03
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D015971 2003
% 211.46/211.65  |- skos__altLabel mesh__D015971 Regulation of Gene Expression, Enzymologic
% 211.46/211.65  |- mesh__historyNote mesh__D015971 90   
% 211.46/211.65  |- skos__altLabel mesh__D015971 Enzymologic Gene Expression Regulation
% 211.46/211.65  |- skos__altLabel mesh__D015971 Regulation, Gene Expression, Enzymologic
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D015971 2006
% 211.46/211.65  |- skos__prefLabel mesh__D015971 Gene Expression Regulation, Enzymologic
% 211.46/211.65  |- mesh__dateCreated mesh__D015971 1989-05-25
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D015971 2005
% 211.46/211.65  |- mesh__recordMaintainer mesh__D015971 NDW
% 211.46/211.65  |- mesh__recordOriginator mesh__D015971 PXP
% 211.46/211.65  |- skos__annotation mesh__D015971
% 211.46/211.65       coord IM with specific enzyme /genet %28%IM%29%; DF: GENE EXPRESSION REG ENZYMOL%A%  
% 211.46/211.65  |- skos__broader mesh__D015971smesh__D005786
% 211.46/211.65  |- skos__historyNote mesh__D015971
% 211.46/211.65       Gene Expression Regulation %28%1981-1989%29%
% 211.46/211.65  |- mesh__recordAuthorizer mesh__D015971 sjn
% 211.46/211.65  |- skos__scopeNote mesh__D015971
% 211.46/211.65       Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in enzyme synthesis.%A%    
% 211.46/211.65  |- rdf__type mesh__D015971sskos__Concept
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D015971 2004
% 211.46/211.65  |- mesh__dateEstablished mesh__D015971 1990-01-01
% 211.46/211.65  |- skos__hiddenLabel mesh__D015173 Neoplasms, Primary Supratentorial
% 211.46/211.65  |- skos__altLabel mesh__D015173 Supratentorial Neoplasms, Malignant
% 211.46/211.65  |- skos__hiddenLabel mesh__D015173 Supratentorial Tumor
% 211.46/211.65  |- skos__scopeNote mesh__D015173
% 211.46/211.65       Primary and metastatic %28%secondary%29% tumors of the brain located above the tentorium cerebelli, a fold of dura mater separating the CEREBELLUM and BRAIN STEM from the cerebral hemispheres and DIENCEPHALON %28%i.e., THALAMUS and HYPOTHALAMUS and related structures%29%. In adults, primary neoplasms tend to arise in the supratentorial compartment, whereas in children they occur more frequently in the infratentorial space. Clinical manifestations vary with the location of the lesion, but SEIZURES; APHASIA; HEMIANOPSIA; hemiparesis; and sensory deficits are relatively common features. Metastatic supratentorial neoplasms are frequently multiple at the time of presentation.%A%    
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D015173 2004
% 211.46/211.65  |- skos__hiddenLabel mesh__D015173 Supratentorial Neoplasm, Benign
% 211.46/211.65  |- skos__hiddenLabel mesh__D015173 Benign Supratentorial Neoplasm
% 211.46/211.65  |- skos__altLabel mesh__D015173 Neoplasms, Supratentorial
% 211.46/211.65  |- skos__prefLabel mesh__D015173 Supratentorial Neoplasms
% 211.46/211.65  |- rdf__type mesh__D015173sskos__Concept
% 211.46/211.65  |- skos__hiddenLabel mesh__D015173 Primary Supratentorial Neoplasm
% 211.46/211.65  |- mesh__historyNote mesh__D015173 1989   
% 211.46/211.65  |- skos__hiddenLabel mesh__D015173 Neoplasm, Malignant Supratentorial
% 211.46/211.65  |- skos__hiddenLabel mesh__D015173 Supratentorial Neoplasm, Primary
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D015173 2005
% 211.46/211.65  |- skos__altLabel mesh__D015173 Malignant Supratentorial Neoplasms
% 211.46/211.65  |- skos__historyNote mesh__D015173 Brain Neoplasms %28%1966-1988%29%
% 211.46/211.65  |- skos__hiddenLabel mesh__D015173 Neoplasms, Malignant Supratentorial
% 211.46/211.65  |- skos__hiddenLabel mesh__D015173 Tumor, Supratentorial
% 211.46/211.65  |- mesh__dateCreated mesh__D015173 1988-04-13
% 211.46/211.65  |- mesh__dateRevised mesh__D015173 1999-12-08
% 211.46/211.65  |- skos__hiddenLabel mesh__D015173 Neoplasms, Benign Supratentorial
% 211.46/211.65  |- mesh__recordAuthorizer mesh__D015173 ags
% 211.46/211.65  |- skos__altLabel mesh__D015173 Supratentorial Neoplasms, Benign
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D015173 2000
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D015173 2006
% 211.46/211.65  |- mesh__publicMeSHNote mesh__D015173 1989   
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D015173 2000A
% 211.46/211.65  |- skos__broader mesh__D015173smesh__D001932
% 211.46/211.65  |- skos__annotation mesh__D015173
% 211.46/211.65       GEN: prefer specifics; coord IM with histol type of neopl %28%IM%29%%A%  
% 211.46/211.65  |- skos__hiddenLabel mesh__D015173 Supratentorial Cancer
% 211.46/211.65  |- mesh__recordOriginator mesh__D015173 EJB
% 211.46/211.65  |- skos__hiddenLabel mesh__D015173 Tumors, Supratentorial
% 211.46/211.65  |- skos__hiddenLabel mesh__D015173 Supratentorial Neoplasm
% 211.46/211.65  |- skos__altLabel mesh__D015173 Supratentorial Neoplasms, Primary
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D015173 2001
% 211.46/211.65  |- mesh__dateEstablished mesh__D015173 1989-01-01
% 211.46/211.65  |- skos__hiddenLabel mesh__D015173 Supratentorial Cancers
% 211.46/211.65  |- skos__hiddenLabel mesh__D015173 Malignant Supratentorial Neoplasm
% 211.46/211.65  |- skos__hiddenLabel mesh__D015173 Cancers, Supratentorial
% 211.46/211.65  |- mesh__recordMaintainer mesh__D015173 ags
% 211.46/211.65  |- skos__hiddenLabel mesh__D015173 Neoplasm, Benign Supratentorial
% 211.46/211.65  |- skos__hiddenLabel mesh__D015173 Neoplasm, Primary Supratentorial
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D015173 2002
% 211.46/211.65  |- skos__hiddenLabel mesh__D015173 Supratentorial Neoplasm, Malignant
% 211.46/211.65  |- skos__hiddenLabel mesh__D015173 Neoplasm, Supratentorial
% 211.46/211.65  |- skos__altLabel mesh__D015173 Supratentorial Tumors
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D015173 2003
% 211.46/211.65  |- mesh__onlineNote mesh__D009934
% 211.46/211.65       use ORGANIZATION AND ADMINISTRATION to search ADMINISTRATIVE MANAGEMENT 1966-67%A%  
% 211.46/211.65  |- skos__altLabel mesh__D009934 Administrative Technics
% 211.46/211.65  |- mesh__recordOriginator mesh__D009934 NLM
% 211.46/211.65  |- mesh__publicMeSHNote mesh__D009934
% 211.46/211.65       68; was ADMINISTRATIVE MANAGEMENT 1963-67   
% 211.46/211.65  |- skos__prefLabel mesh__D009934 Organization and Administration
% 211.46/211.65  |- skos__altLabel mesh__D009934 Administration and Organization
% 211.46/211.65  |- skos__broader mesh__D009934smesh__D006298
% 211.46/211.65  |- skos__altLabel mesh__D009934 Administrative Techniques
% 211.46/211.65  |- mesh__dateCreated mesh__D009934 1999-01-01
% 211.46/211.65  |- mesh__dateRevised mesh__D009934 2002-07-02
% 211.46/211.65  |- skos__hiddenLabel mesh__D009934 Administrative Technic
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D009934 2005
% 211.46/211.65  |- skos__hiddenLabel mesh__D009934 Technic, Administrative
% 211.46/211.65  |- mesh__historyNote mesh__D009934
% 211.46/211.65       68; was ADMINISTRATIVE MANAGEMENT 1963-67   
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D009934 2006
% 211.46/211.65  |- mesh__recordMaintainer mesh__D009934 jrf
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D009934 2003
% 211.46/211.65  |- skos__scopeNote mesh__D009934
% 211.46/211.65       The planning and managing of programs, services, and resources.%A%    
% 211.46/211.65  |- skos__hiddenLabel mesh__D009934 Administrative Technique
% 211.46/211.65  |- skos__hiddenLabel mesh__D009934 Administrative Coordination
% 211.46/211.65  |- mesh__recordAuthorizer mesh__D009934 sjn
% 211.46/211.65  |- mesh__dateEstablished mesh__D009934 1968-01-01
% 211.46/211.65  |- skos__hiddenLabel mesh__D009934 Technique, Administrative
% 211.46/211.65  |- skos__annotation mesh__D009934
% 211.46/211.65       GEN only: prefer /organ: Manual 19.7+, 19.8.49; almost never IM; DF: ORGAN ADMIN but do not confuse with ORGAN for ORGANIZATIONS%A%  
% 211.46/211.65  |- mesh__activeMeSHYear mesh__D009934 2004
% 211.46/211.65  |- skos__altLabel mesh__D009934 Technics, Administrative
% 211.46/211.65  |- rdf__type mesh__D009934sskos__Concept
% 211.46/211.65  |- mesh__dateCreated mesh__D001951 1999-01-01
% 211.46/211.65  |- skos__annotation mesh__D001951
% 211.46/211.65       in soil, water, dairy prod %26% decaying matter   
% 211.46/211.65  |- skos__prefLabel mesh__D001951 Brevibacterium
% 211.46/211.65  |- skos__broader mesh__D001951smesh__D039903
% 211.46/211.65  |- mesh__recordMaintainer mesh__D001951 SYSTEM
% 211.46/211.65  |- mesh__dateRevised mesh__D001951 2005-06-30
% 211.46/211.66  |- skos__broader mesh__D001951smesh__D000192
% 211.46/211.66  |- skos__scopeNote mesh__D001951
% 211.46/211.66       A gram-positive organism found in dairy products, fresh and salt water, marine organisms, insects, and decaying organic matter.%A%    
% 211.46/211.66  |- rdf__type mesh__D001951sskos__Concept
% 211.46/211.66  |- mesh__recordAuthorizer mesh__D001951 sjn
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001951 2006
% 211.46/211.66  |- mesh__recordOriginator mesh__D001951 NLM
% 211.46/211.66  |- skos__annotation mesh__D009136
% 211.46/211.66       GEN: prefer specifics; do not confuse with MYOTONIC DYSTROPHY%A%  
% 211.46/211.66  |- skos__hiddenLabel mesh__D009136 Myodystrophicas
% 211.46/211.66  |- mesh__recordMaintainer mesh__D009136 lkt
% 211.46/211.66  |- skos__prefLabel mesh__D009136 Muscular Dystrophies
% 211.46/211.66  |- skos__hiddenLabel mesh__D009136 Dystrophies, Muscular
% 211.46/211.66  |- mesh__publicMeSHNote mesh__D009136
% 211.46/211.66       2000; see MUSCULAR DYSTROPHY 1966-1999   
% 211.46/211.66  |- mesh__recordAuthorizer mesh__D009136 sjn
% 211.46/211.66  |- skos__related mesh__D009136smesh__D018101
% 211.46/211.66  |- skos__altLabel mesh__D009136 Myodystrophy
% 211.46/211.66  |- mesh__dateCreated mesh__D009136 1999-11-08
% 211.46/211.66  |- skos__altLabel mesh__D009136 Muscular Dystrophy
% 211.46/211.66  |- skos__scopeNote mesh__D009136
% 211.46/211.66       A heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS.%A%    
% 211.46/211.66  |- skos__broader mesh__D009136smesh__D030342
% 211.46/211.66  |- skos__hiddenLabel mesh__D009136 Dystrophy, Muscular
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D009136 2006
% 211.46/211.66  |- mesh__historyNote mesh__D009136 2000%28%1966%29%   
% 211.46/211.66  |- mesh__dateRevised mesh__D009136 2004-07-07
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D009136 2005
% 211.46/211.66  |- skos__altLabel mesh__D009136 Myodystrophica
% 211.46/211.66  |- mesh__recordOriginator mesh__D009136 NLM
% 211.46/211.66  |- skos__broader mesh__D009136smesh__D020966
% 211.46/211.66  |- rdf__type mesh__D009136sskos__Concept
% 211.46/211.66  |- skos__hiddenLabel mesh__D009136 Myodystrophies
% 211.46/211.66  |- mesh__dateCreated mesh__D001153 1999-01-01
% 211.46/211.66  |- mesh__dateEstablished mesh__D001153 1968-01-01
% 211.46/211.66  |- skos__altLabel mesh__D001153 Arsenobenzol
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001153 2004
% 211.46/211.66  |- skos__prefLabel mesh__D001153 Arsphenamine
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001153 2006
% 211.46/211.66  |- mesh__recordOriginator mesh__D001153 NLM
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001153 2003
% 211.46/211.66  |- mesh__recordAuthorizer mesh__D001153 sjn
% 211.46/211.66  |- mesh__onlineNote mesh__D001153
% 211.46/211.66       use ARSPHENAMINE to search ARSPHENAMINES 1966-67   
% 211.46/211.66  |- mesh__dateRevised mesh__D001153 2000-06-21
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001153 2005
% 211.46/211.66  |- mesh__historyNote mesh__D001153 68; was ARSPHENAMINES 1963-67   
% 211.46/211.66  |- rdf__type mesh__D001153sskos__Concept
% 211.46/211.66  |- mesh__publicMeSHNote mesh__D001153 68; was ARSPHENAMINES 1963-67   
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001153 2002
% 211.46/211.66  |- skos__hiddenLabel mesh__D001153 Arsenobenzol, Sodium
% 211.46/211.66  |- mesh__recordMaintainer mesh__D001153 CCR
% 211.46/211.66  |- skos__broader mesh__D001153smesh__D001152
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001153 2001
% 211.46/211.66  |- skos__scopeNote mesh__D019564
% 211.46/211.66       Diagnostic, therapeutic, and investigative procedures prescribed and performed by health professionals, the results of which do not justify the benefits or hazards and costs to the patient.%A%    
% 211.46/211.66  |- mesh__dateCreated mesh__D019564 1996-06-10
% 211.46/211.66  |- skos__broader mesh__D019564smesh__D006300
% 211.46/211.66  |- mesh__recordOriginator mesh__D019564 TGC
% 211.46/211.66  |- mesh__recordAuthorizer mesh__D019564 SJN
% 211.46/211.66  |- skos__annotation mesh__D019564
% 211.46/211.66       IM; coord with specific procedure %28%IM%29% with probably /util%A%  
% 211.46/211.66  |- mesh__historyNote mesh__D019564 97   
% 211.46/211.66  |- mesh__dateEstablished mesh__D019564 1997-01-01
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D019564 2006
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D019564 2002
% 211.46/211.66  |- mesh__publicMeSHNote mesh__D019564 97   
% 211.46/211.66  |- rdf__type mesh__D019564sskos__Concept
% 211.46/211.66  |- skos__hiddenLabel mesh__D019564 Procedures, Unnecessary
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D019564 2005
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D019564 1999
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D019564 2001
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D019564 2004
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D019564 2000
% 211.46/211.66  |- mesh__dateRevised mesh__D019564 1998-06-11
% 211.46/211.66  |- mesh__recordMaintainer mesh__D019564 TPW
% 211.46/211.66  |- skos__hiddenLabel mesh__D019564 Unnecessary Procedure
% 211.46/211.66  |- skos__hiddenLabel mesh__D019564 Procedure, Unnecessary
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D019564 2003
% 211.46/211.66  |- skos__altLabel mesh__D019564 Surgery, Unnecessary
% 211.46/211.66  |- skos__prefLabel mesh__D019564 Unnecessary Procedures
% 211.46/211.66  |- skos__prefLabel mesh__D000859 Anoxemia
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D000859 2000
% 211.46/211.66  |- mesh__dateRevised mesh__D000859 1999-11-03
% 211.46/211.66  |- skos__scopeNote mesh__D000859
% 211.46/211.66       Clinical manifestation of respiratory distress consisting of relatively complete absence of oxygen in arterial blood.%A%    
% 211.46/211.66  |- mesh__recordMaintainer mesh__D000859 KEV
% 211.46/211.66  |- skos__hiddenLabel mesh__D000859 Anoxemias
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D000859 2004
% 211.46/211.66  |- rdf__type mesh__D000859sskos__Concept
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D000859 2006
% 211.46/211.66  |- mesh__recordOriginator mesh__D000859 NLM
% 211.46/211.66  |- mesh__dateCreated mesh__D000859 1999-01-01
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D000859 2003
% 211.46/211.66  |- mesh__recordAuthorizer mesh__D000859 sjn
% 211.46/211.66  |- skos__annotation mesh__D000859 differentiate from ANOXIA   
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D000859 2002
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D000859 2005
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D000859 2001
% 211.46/211.66  |- skos__broader mesh__D000859smesh__D000860
% 211.46/211.66  |- skos__hiddenLabel mesh__D000859 Hypoxemias
% 211.46/211.66  |- skos__scopeNote mesh__D011581
% 211.46/211.66       Standardized tests designed to measure abilities, as in intelligence, aptitude, and achievement tests, or to evaluate personality traits.%A%    
% 211.46/211.66  |- mesh__recordMaintainer mesh__D011581 JLS
% 211.46/211.66  |- skos__altLabel mesh__D011581 Test, Psychological
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011581 2000
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011581 1999
% 211.46/211.66  |- rdf__type mesh__D011581sskos__Concept
% 211.46/211.66  |- skos__annotation mesh__D011581 DF: PSYCHOL TESTS   
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011581 1995
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011581 1998
% 211.46/211.66  |- skos__altLabel mesh__D011581 Psychologic Tests
% 211.46/211.66  |- skos__hiddenLabel mesh__D011581 Tests, Psychologic
% 211.46/211.66  |- mesh__dateRevised mesh__D011581 1993-06-04
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011581 2004
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011581 1994
% 211.46/211.66  |- skos__hiddenLabel mesh__D011581 Psychologic Test
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011581 2002
% 211.46/211.66  |- skos__altLabel mesh__D011581 Psychological Test
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011581 2003
% 211.46/211.66  |- skos__hiddenLabel mesh__D011581 Test, Psychologic
% 211.46/211.66  |- skos__broader mesh__D011581smesh__D004191
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011581 2006
% 211.46/211.66  |- mesh__recordOriginator mesh__D011581 NLM
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011581 1997
% 211.46/211.66  |- mesh__recordAuthorizer mesh__D011581 PLS
% 211.46/211.66  |- mesh__dateCreated mesh__D011581 1999-01-01
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011581 2001
% 211.46/211.66  |- skos__prefLabel mesh__D011581 Psychological Tests
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011581 2005
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011581 1996
% 211.46/211.66  |- skos__altLabel mesh__D011581 Tests, Psychological
% 211.46/211.66  |- skos__altLabel mesh__D005544 Projections and Predictions
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D005544 1998
% 211.46/211.66  |- skos__hiddenLabel mesh__D005544 Population Forecasts
% 211.46/211.66  |- mesh__dateEstablished mesh__D005544 1971-01-01
% 211.46/211.66  |- skos__hiddenLabel mesh__D005544 Population Projections
% 211.46/211.66  |- mesh__dateCreated mesh__D005544 1999-01-01
% 211.46/211.66  |- skos__hiddenLabel mesh__D005544 Predictions and Projections
% 211.46/211.66  |- skos__prefLabel mesh__D005544 Forecasting
% 211.46/211.66  |- skos__altLabel mesh__D005544 Population Projection
% 211.46/211.66  |- skos__broader mesh__D005544smesh__D012942
% 211.46/211.66  |- mesh__dateRevised mesh__D005544 1996-06-10
% 211.46/211.66  |- mesh__recordOriginator mesh__D005544 NLM
% 211.46/211.66  |- skos__hiddenLabel mesh__D005544 Projection, Population
% 211.46/211.66  |- mesh__onlineNote mesh__D005544
% 211.46/211.66       use FORECASTING to search FUTUROLOGY 1971-79   
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D005544 2002
% 211.46/211.66  |- mesh__publicMeSHNote mesh__D005544 80; was FUTUROLOGY 1971-79   
% 211.46/211.66  |- mesh__recordMaintainer mesh__D005544 TGC
% 211.46/211.66  |- rdf__type mesh__D005544sskos__Concept
% 211.46/211.66  |- mesh__recordAuthorizer mesh__D005544 PLS
% 211.46/211.66  |- mesh__historyNote mesh__D005544 80; was FUTUROLOGY 1971-79   
% 211.46/211.66  |- skos__scopeNote mesh__D005544
% 211.46/211.66       The prediction or projection of the nature of future problems or existing conditions based upon the extrapolation or interpretation of existing scientific data or by the application of scientific methodology.%A%    
% 211.46/211.66  |- skos__hiddenLabel mesh__D005544 Forecasts, Population
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D005544 2004
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D005544 2001
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D005544 1997
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D005544 2006
% 211.46/211.66  |- skos__annotation mesh__D005544
% 211.46/211.66       IM general only; consider also as IM coord with specific subject /trends %28%IM%29% if future is particularly significant: Manual 19.8.76, 35.2.9%A%  
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D005544 1999
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D005544 2003
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D005544 2000
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D005544 2005
% 211.46/211.66  |- skos__prefLabel mesh__D010489 Periarthritis
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D010489 2003
% 211.46/211.66  |- mesh__recordAuthorizer mesh__D010489 PLS
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D010489 2000
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D010489 1995
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D010489 1999
% 211.46/211.66  |- skos__annotation mesh__D010489
% 211.46/211.66       %22%inflamm of tissues around a joint%22%   
% 211.46/211.66  |- skos__scopeNote mesh__D010489
% 211.46/211.66       Inflammation of the tissues around a joint. %28%Dorland, 27th ed%29%%A%    
% 211.46/211.66  |- skos__broader mesh__D010489smesh__D001168
% 211.46/211.66  |- mesh__dateRevised mesh__D010489 1994-05-24
% 211.46/211.66  |- mesh__recordOriginator mesh__D010489 NLM
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D010489 1998
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D010489 2006
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D010489 1997
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D010489 2005
% 211.46/211.66  |- skos__broader mesh__D010489smesh__D002062
% 211.46/211.66  |- mesh__recordMaintainer mesh__D010489 TGC
% 211.46/211.66  |- mesh__dateCreated mesh__D010489 1999-01-01
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D010489 2002
% 211.46/211.66  |- rdf__type mesh__D010489sskos__Concept
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D010489 1996
% 211.46/211.66  |- skos__hiddenLabel mesh__D010489 Periarthritides
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D010489 2004
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D010489 2001
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D015972 2005
% 211.46/211.66  |- skos__annotation mesh__D015972
% 211.46/211.66       coord IM with specific organ/neopl term with /genet %28%IM%29% + specific histol type of neopl /genet %28%IM%29%; DF: GENE EXPRESSION REG NEOPL%A%  
% 211.46/211.66  |- skos__broader mesh__D015972smesh__D005786
% 211.46/211.66  |- skos__historyNote mesh__D015972 specific neoplasm %28%1972-1989%29%
% 211.46/211.66  |- mesh__recordAuthorizer mesh__D015972 sjn
% 211.46/211.66  |- mesh__recordOriginator mesh__D015972 PXP
% 211.46/211.66  |- skos__altLabel mesh__D015972 Regulation, Gene Expression, Neoplastic
% 211.46/211.66  |- skos__altLabel mesh__D015972 Regulation of Gene Expression, Neoplastic
% 211.46/211.66  |- mesh__historyNote mesh__D015972 90   
% 211.46/211.66  |- mesh__dateRevised mesh__D015972 2002-07-03
% 211.46/211.66  |- skos__prefLabel mesh__D015972 Gene Expression Regulation, Neoplastic
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D015972 2004
% 211.46/211.66  |- rdf__type mesh__D015972sskos__Concept
% 211.46/211.66  |- skos__scopeNote mesh__D015972
% 211.46/211.66       Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.%A%    
% 211.46/211.66  |- skos__historyNote mesh__D015972 Genes %28%1972-1989%29%
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D015972 2003
% 211.46/211.66  |- mesh__dateEstablished mesh__D015972 1990-01-01
% 211.46/211.66  |- skos__historyNote mesh__D015972
% 211.46/211.66       Gene Expression Regulation %28%1981-1989%29%
% 211.46/211.66  |- skos__altLabel mesh__D015972 Neoplastic Gene Expression Regulation
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D015972 2006
% 211.46/211.66  |- mesh__recordMaintainer mesh__D015972 NDW
% 211.46/211.66  |- mesh__publicMeSHNote mesh__D015972 90   
% 211.46/211.66  |- mesh__dateCreated mesh__D015972 1989-05-25
% 211.46/211.66  |- mesh__dateEstablished mesh__D015174 1989-01-01
% 211.46/211.66  |- skos__hiddenLabel mesh__D015174 Epidural Neoplasm
% 211.46/211.66  |- skos__annotation mesh__D015174
% 211.46/211.66       coord IM with histol type of neopl %28%IM%29%; coord IM with specific vertebrae %28%NIM%29% to locate site on spinal cord%A%  
% 211.46/211.66  |- skos__altLabel mesh__D015174 Epidural Tumors
% 211.46/211.66  |- mesh__dateRevised mesh__D015174 1999-12-08
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D015174 2000
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D015174 2005
% 211.46/211.66  |- skos__historyNote mesh__D015174 Spinal Neoplasms %28%1966-1988%29%
% 211.46/211.66  |- skos__historyNote mesh__D015174 Spinal Cord Diseases %28%1966-1988%29%
% 211.46/211.66  |- skos__hiddenLabel mesh__D015174 Epidural Neoplasms, Malignant
% 211.46/211.66  |- skos__prefLabel mesh__D015174 Epidural Neoplasms
% 211.46/211.66  |- mesh__dateCreated mesh__D015174 1988-04-13
% 211.46/211.66  |- mesh__recordAuthorizer mesh__D015174 ags
% 211.46/211.66  |- mesh__historyNote mesh__D015174 1989   
% 211.46/211.66  |- skos__historyNote mesh__D015174
% 211.46/211.66       Spinal Cord Compression %28%1966-1988%29%
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D015174 2006
% 211.46/211.66  |- skos__hiddenLabel mesh__D015174 Epidural Tumor
% 211.46/211.66  |- skos__altLabel mesh__D015174 Malignant Epidural Neoplasm
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D015174 2001
% 211.46/211.66  |- mesh__recordMaintainer mesh__D015174 ags
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D015174 2003
% 211.46/211.66  |- mesh__recordOriginator mesh__D015174 EJB
% 211.46/211.66  |- skos__broader mesh__D015174smesh__D013120
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D015174 2004
% 211.46/211.66  |- rdf__type mesh__D015174sskos__Concept
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D015174 2000A
% 211.46/211.66  |- mesh__publicMeSHNote mesh__D015174 1989   
% 211.46/211.66  |- skos__altLabel mesh__D015174 Neoplasms, Epidural
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D015174 2002
% 211.46/211.66  |- skos__hiddenLabel mesh__D015174 Malignant Epidural Neoplasms
% 211.46/211.66  |- skos__historyNote mesh__D015174 Spinal Cord Neoplasms %28%1966-1988%29%
% 211.46/211.66  |- skos__scopeNote mesh__D015174
% 211.46/211.66       Neoplasms located in the space between the vertebral PERIOSTEUM and DURA MATER surrounding the SPINAL CORD. Tumors in this location are most often metastatic in origin and may cause neurologic deficits by mass effect on the spinal cord or nerve roots or by interfering with blood supply to the spinal cord.%A%    
% 211.46/211.66  |- skos__hiddenLabel mesh__D009935 Affiliations, Organizational
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D009935 2003
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D009935 1999
% 211.46/211.66  |- skos__scopeNote mesh__D009935
% 211.46/211.66       Formal relationships established between otherwise independent organizations. These include affiliation agreements, interlocking boards, common controls, hospital medical school affiliations, etc.%A%    
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D009935 2005
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D009935 1996
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D009935 1995
% 211.46/211.66  |- mesh__historyNote mesh__D009935 68   
% 211.46/211.66  |- rdf__type mesh__D009935sskos__Concept
% 211.46/211.66  |- mesh__dateCreated mesh__D009935 1999-01-01
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D009935 2002
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D009935 1998
% 211.46/211.66  |- mesh__dateEstablished mesh__D009935 1968-01-01
% 211.46/211.66  |- mesh__recordMaintainer mesh__D009935 TGC
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D009935 2001
% 211.46/211.66  |- skos__historyNote mesh__D009935 specific organization %28%1966-1967%29%
% 211.46/211.66  |- skos__annotation mesh__D009935
% 211.46/211.66       med or non-med affiliation; DF: ORGAN AFFILIATION   
% 211.46/211.66  |- skos__prefLabel mesh__D009935 Organizational Affiliation
% 211.46/211.66  |- mesh__dateRevised mesh__D009935 1994-05-05
% 211.46/211.66  |- mesh__recordAuthorizer mesh__D009935 PLS
% 211.46/211.66  |- skos__broader mesh__D009935smesh__D009934
% 211.46/211.66  |- mesh__recordOriginator mesh__D009935 NLM
% 211.46/211.66  |- skos__altLabel mesh__D009935 Affiliation, Organizational
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D009935 2000
% 211.46/211.66  |- skos__hiddenLabel mesh__D009935 Organizational Affiliations
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D009935 2004
% 211.46/211.66  |- mesh__publicMeSHNote mesh__D009935 68   
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D009935 2006
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D009935 1997
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001952 2001
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001952 2006
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001952 2000
% 211.46/211.66  |- skos__hiddenLabel mesh__D001952 Compounds, Bridged
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001952 2004
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001952 2005
% 211.46/211.66  |- mesh__recordOriginator mesh__D001952 NLM
% 211.46/211.66  |- skos__broader mesh__D001952smesh__D006844
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001952 1999
% 211.46/211.66  |- mesh__dateCreated mesh__D001952 1999-01-01
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001952 2003
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001952 1997
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001952 1998
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001952 2002
% 211.46/211.66  |- skos__annotation mesh__D001952 DF: BRIDGED CPDS   
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001952 1996
% 211.46/211.66  |- skos__broader mesh__D001952smesh__D011083
% 211.46/211.66  |- mesh__recordAuthorizer mesh__D001952 PLS
% 211.46/211.66  |- mesh__recordMaintainer mesh__D001952 JRT
% 211.46/211.66  |- skos__prefLabel mesh__D001952 Bridged Compounds
% 211.46/211.66  |- mesh__dateRevised mesh__D001952 1995-06-08
% 211.46/211.66  |- skos__scopeNote mesh__D001952
% 211.46/211.66       Cyclic hydrocarbons that contain multiple rings and share one or more atoms.%A%    
% 211.46/211.66  |- rdf__type mesh__D001952sskos__Concept
% 211.46/211.66  |- skos__annotation mesh__D009137
% 211.46/211.66       exper or vet but do not use /vet; don%27%t forget to check tag ANIMALS%A%  
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D009137 2006
% 211.46/211.66  |- skos__hiddenLabel mesh__D009137 Animal Muscular Dystrophy
% 211.46/211.66  |- skos__broader mesh__D009137smesh__D000820
% 211.46/211.66  |- mesh__dateCreated mesh__D009137 1999-01-01
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D009137 2005
% 211.46/211.66  |- skos__hiddenLabel mesh__D009137 Dystrophy, Animal Muscular
% 211.46/211.66  |- skos__prefLabel mesh__D009137 Muscular Dystrophy, Animal
% 211.46/211.66  |- mesh__recordMaintainer mesh__D009137 ags
% 211.46/211.66  |- mesh__dateEstablished mesh__D009137 1970-01-01
% 211.46/211.66  |- mesh__historyNote mesh__D009137 70   
% 211.46/211.66  |- mesh__recordOriginator mesh__D009137 NLM
% 211.46/211.66  |- mesh__dateRevised mesh__D009137 2003-07-30
% 211.46/211.66  |- mesh__recordAuthorizer mesh__D009137 sjn
% 211.46/211.66  |- skos__hiddenLabel mesh__D009137 Dystrophies, Animal Muscular
% 211.46/211.66  |- skos__hiddenLabel mesh__D009137 Animal Muscular Dystrophies
% 211.46/211.66  |- rdf__type mesh__D009137sskos__Concept
% 211.46/211.66  |- skos__hiddenLabel mesh__D009137 Muscular Dystrophies, Animal
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D009137 2004
% 211.46/211.66  |- mesh__publicMeSHNote mesh__D009137 70   
% 211.46/211.66  |- skos__historyNote mesh__D009137 Muscular Dystrophy %28%1966-1969%29%
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001154 2006
% 211.46/211.66  |- skos__broader mesh__D001154smesh__D006809
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001154 2003
% 211.46/211.66  |- skos__related mesh__D001154smesh__D000716
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001154 2001
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001154 1997
% 211.46/211.66  |- skos__hiddenLabel mesh__D001154 Arts
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001154 2005
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001154 1999
% 211.46/211.66  |- rdf__type mesh__D001154sskos__Concept
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001154 2000
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001154 1998
% 211.46/211.66  |- mesh__recordMaintainer mesh__D001154 TGC
% 211.46/211.66  |- skos__annotation mesh__D001154
% 211.46/211.66       works of art, the field of fine arts, artistic production; art as therapy = ART THERAPY%A%  
% 211.46/211.66  |- mesh__recordOriginator mesh__D001154 NLM
% 211.46/211.66  |- mesh__dateRevised mesh__D001154 1996-06-10
% 211.46/211.66  |- skos__related mesh__D001154smesh__D008488
% 211.46/211.66  |- skos__prefLabel mesh__D001154 Art
% 211.46/211.66  |- skos__related mesh__D001154smesh__D008512
% 211.46/211.66  |- mesh__dateCreated mesh__D001154 1999-01-01
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001154 2004
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D001154 2002
% 211.46/211.66  |- mesh__recordAuthorizer mesh__D001154 PLS
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D019565 2000
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D019565 2006
% 211.46/211.66  |- skos__annotation mesh__D019565 GEN: prefer specifics   
% 211.46/211.66  |- mesh__historyNote mesh__D019565 97   
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D019565 2005
% 211.46/211.66  |- skos__broader mesh__D019565smesh__D008670
% 211.46/211.66  |- skos__scopeNote mesh__D019565
% 211.46/211.66       Metals with low specific gravity, typically smaller than 5, characterized by a single valence %28%1, 2, or 3%29%, a simple spectrum, strong electromotive force %28%positive%29%, and colorless compounds. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D019565 1999
% 211.46/211.66  |- mesh__recordMaintainer mesh__D019565 TGC
% 211.46/211.66  |- rdf__type mesh__D019565sskos__Concept
% 211.46/211.66  |- mesh__recordOriginator mesh__D019565 PXP
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D019565 1998
% 211.46/211.66  |- mesh__recordAuthorizer mesh__D019565 SJN
% 211.46/211.66  |- mesh__dateEstablished mesh__D019565 1997-01-01
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D019565 2004
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D019565 2002
% 211.46/211.66  |- skos__historyNote mesh__D019565 Metals or specifics %28%1966-1996%29%
% 211.46/211.66  |- skos__broader mesh__D019565smesh__D004602
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D019565 2003
% 211.46/211.66  |- mesh__publicMeSHNote mesh__D019565 97   
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D019565 2001
% 211.46/211.66  |- mesh__onlineNote mesh__D019565
% 211.46/211.66       pre-explosion = METALS, LIGHT %28%PX%29%   
% 211.46/211.66  |- mesh__dateRevised mesh__D019565 1997-06-20
% 211.46/211.66  |- skos__prefLabel mesh__D019565 Metals, Light
% 211.46/211.66  |- skos__altLabel mesh__D019565 Light Metals
% 211.46/211.66  |- mesh__dateCreated mesh__D019565 1996-06-20
% 211.46/211.66  |- skos__scopeNote mesh__D011582
% 211.46/211.66       Principles applied to the analysis and explanation of psychological or behavioral phenomena.%A%    
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011582 1999
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011582 2000
% 211.46/211.66  |- skos__broader mesh__D011582smesh__D011579
% 211.46/211.66  |- rdf__type mesh__D011582sskos__Concept
% 211.46/211.66  |- mesh__recordOriginator mesh__D011582 NLM
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011582 2003
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011582 2001
% 211.46/211.66  |- mesh__publicMeSHNote mesh__D011582 69   
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011582 1995
% 211.46/211.66  |- skos__altLabel mesh__D011582 Theories, Psychological
% 211.46/211.66  |- mesh__dateRevised mesh__D011582 1993-06-04
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011582 2004
% 211.46/211.66  |- skos__hiddenLabel mesh__D011582 Theory, Psychologic
% 211.46/211.66  |- mesh__dateCreated mesh__D011582 1999-01-01
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011582 2002
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011582 2005
% 211.46/211.66  |- skos__historyNote mesh__D011582 Psychology %28%1966-1968%29%
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011582 1996
% 211.46/211.66  |- mesh__recordMaintainer mesh__D011582 JLS
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011582 2006
% 211.46/211.66  |- skos__annotation mesh__D011582 no qualif; DF: PSYCHOL THEORY   
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011582 1997
% 211.46/211.66  |- skos__hiddenLabel mesh__D011582 Theories, Psychologic
% 211.46/211.66  |- mesh__recordAuthorizer mesh__D011582 PLS
% 211.46/211.66  |- skos__altLabel mesh__D011582 Psychologic Theory
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011582 1998
% 211.46/211.66  |- skos__hiddenLabel mesh__D011582 Psychologic Theories
% 211.46/211.66  |- mesh__historyNote mesh__D011582 69   
% 211.46/211.66  |- skos__altLabel mesh__D011582 Psychological Theories
% 211.46/211.66  |- mesh__dateEstablished mesh__D011582 1969-01-01
% 211.46/211.66  |- skos__prefLabel mesh__D011582 Psychological Theory
% 211.46/211.66  |- skos__altLabel mesh__D011582 Theory, Psychological
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D011582 1994
% 211.46/211.66  |- skos__annotation mesh__D005545
% 211.46/211.66       do not confuse with FORELIMB for non-primate vertebrates   
% 211.46/211.66  |- skos__scopeNote mesh__D005545
% 211.46/211.66       The forepart of the foot including the metatarsals and the TOES.%A%    
% 211.46/211.66  |- mesh__recordAuthorizer mesh__D005545 sjn
% 211.46/211.66  |- skos__prefLabel mesh__D005545 Forefoot, Human
% 211.46/211.66  |- rdf__type mesh__D005545sskos__Concept
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D005545 2004
% 211.46/211.66  |- mesh__recordMaintainer mesh__D005545 TGC
% 211.46/211.66  |- mesh__dateRevised mesh__D005545 2002-07-03
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D005545 2006
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D005545 2003
% 211.46/211.66  |- mesh__activeMeSHYear mesh__D005545 2005
% 211.46/211.66  |- mesh__historyNote mesh__D005545 88   
% 211.46/211.66  |- mesh__publicMeSHNote mesh__D005545 88   
% 211.46/211.66  |- skos__broader mesh__D005545smesh__D005528
% 211.46/211.67  |- mesh__dateEstablished mesh__D005545 1988-01-01
% 211.46/211.67  |- skos__altLabel mesh__D005545 Human Forefoot
% 211.46/211.67  |- mesh__dateCreated mesh__D005545 1987-04-02
% 211.46/211.67  |- mesh__recordOriginator mesh__D005545 EC
% 211.46/211.67  |- skos__altLabel mesh__D015973 Regulation of Gene Expression, Leukemic
% 211.46/211.67  |- mesh__recordMaintainer mesh__D015973 NDW
% 211.46/211.67  |- skos__annotation mesh__D015973
% 211.46/211.67       coord IM with specific type of LEUKEMIA /genet %28%IM%29%; DF: GENE EXPRESSION REG LEUKEMIC%A%  
% 211.46/211.67  |- skos__altLabel mesh__D015973 Leukemic Gene Expression Regulation
% 211.46/211.67  |- skos__scopeNote mesh__D015973
% 211.46/211.67       Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in leukemia.%A%    
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D015973 2004
% 211.46/211.67  |- skos__broader mesh__D015973smesh__D015972
% 211.46/211.67  |- skos__prefLabel mesh__D015973 Gene Expression Regulation, Leukemic
% 211.46/211.67  |- rdf__type mesh__D015973sskos__Concept
% 211.46/211.67  |- skos__historyNote mesh__D015973 Genes %28%1973-1980%29%
% 211.46/211.67  |- mesh__recordAuthorizer mesh__D015973 sjn
% 211.46/211.67  |- skos__historyNote mesh__D015973 specific leukemia %28%1973-1989%29%
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D015973 2003
% 211.46/211.67  |- mesh__historyNote mesh__D015973 90   
% 211.46/211.67  |- mesh__dateEstablished mesh__D015973 1990-01-01
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D015973 2006
% 211.46/211.67  |- mesh__dateRevised mesh__D015973 2002-07-03
% 211.46/211.67  |- mesh__publicMeSHNote mesh__D015973 90   
% 211.46/211.67  |- skos__altLabel mesh__D015973 Regulation, Gene Expression, Leukemic
% 211.46/211.67  |- mesh__dateCreated mesh__D015973 1989-05-25
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D015973 2005
% 211.46/211.67  |- skos__historyNote mesh__D015973
% 211.46/211.67       Gene Expression Regulation %28%1981-1989%29%
% 211.46/211.67  |- mesh__recordOriginator mesh__D015973 PXP
% 211.46/211.67  |- skos__hiddenLabel mesh__D015175 Pituitary Adenomas, Prolactin-Secreting
% 211.46/211.67  |- skos__hiddenLabel mesh__D015175 Pituitary Adenoma, Prolactin-Producing
% 211.46/211.67  |- mesh__dateRevised mesh__D015175 2005-06-30
% 211.46/211.67  |- mesh__dateCreated mesh__D015175 1988-04-13
% 211.46/211.67  |- skos__broader mesh__D015175smesh__D000236
% 211.46/211.67  |- skos__hiddenLabel mesh__D015175 Macroprolactinomas
% 211.46/211.67  |- skos__hiddenLabel mesh__D015175 Prolactin Secreting Pituitary Adenoma
% 211.46/211.67  |- skos__altLabel mesh__D015175 Adenoma, Prolactin-Secreting, Pituitary
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D015175 2006
% 211.46/211.67  |- skos__hiddenLabel mesh__D015175 Pituitary Adenoma, PRL-Secreting
% 211.46/211.67  |- skos__hiddenLabel mesh__D015175 Pituitary Adenomas, Prolactin-Producing
% 211.46/211.67  |- skos__annotation mesh__D015175
% 211.46/211.67       coordinate IM with PITUITARY NEOPLASMS %28%IM%29%   
% 211.46/211.67  |- skos__altLabel mesh__D015175 Prolactin-Producing Pituitary Adenoma
% 211.46/211.67  |- skos__hiddenLabel mesh__D015175 Adenoma, Lactotroph
% 211.46/211.67  |- skos__hiddenLabel mesh__D015175 Pituitary Adenoma, Prolactin Secreting
% 211.46/211.67  |- skos__hiddenLabel mesh__D015175 Pituitary Adenomas, PRL-Secreting
% 211.46/211.67  |- skos__hiddenLabel mesh__D015175 Prolactinomas
% 211.46/211.67  |- skos__altLabel mesh__D015175 Lactotroph Adenoma
% 211.46/211.67  |- mesh__dateEstablished mesh__D015175 1989-01-01
% 211.46/211.67  |- skos__hiddenLabel mesh__D015175 PRL-Secreting Pituitary Adenomas
% 211.46/211.67  |- skos__altLabel mesh__D015175 Pituitary Adenoma, Prolactin-Secreting
% 211.46/211.67  |- skos__historyNote mesh__D015175 Adenoma %28%1966-1988%29%
% 211.46/211.67  |- mesh__historyNote mesh__D015175 1989   
% 211.46/211.67  |- skos__hiddenLabel mesh__D015175 Prolactin-Secreting Pituitary Adenomas
% 211.46/211.67  |- skos__historyNote mesh__D015175 Prolactin %28%1966-1988%29%
% 211.46/211.67  |- mesh__recordAuthorizer mesh__D015175 sjn
% 211.46/211.67  |- skos__hiddenLabel mesh__D015175 PRL Secreting Pituitary Adenoma
% 211.46/211.67  |- skos__hiddenLabel mesh__D015175 Microprolactinomas
% 211.46/211.67  |- skos__broader mesh__D015175smesh__D010911
% 211.46/211.67  |- skos__hiddenLabel mesh__D015175 Prolactin Producing Pituitary Adenoma
% 211.46/211.67  |- skos__historyNote mesh__D015175 Pituitary Neoplasms %28%1966-1988%29%
% 211.46/211.67  |- skos__hiddenLabel mesh__D015175 Lactotroph Adenomas
% 211.46/211.67  |- mesh__publicMeSHNote mesh__D015175 1989   
% 211.46/211.67  |- mesh__recordOriginator mesh__D015175 EJB
% 211.46/211.67  |- skos__prefLabel mesh__D015175 Prolactinoma
% 211.46/211.67  |- mesh__recordMaintainer mesh__D015175 lkt
% 211.46/211.67  |- skos__altLabel mesh__D015175 PRL-Secreting Pituitary Adenoma
% 211.46/211.67  |- skos__related mesh__D015175smesh__D006966
% 211.46/211.67  |- rdf__type mesh__D015175sskos__Concept
% 211.46/211.67  |- skos__scopeNote mesh__D015175
% 211.46/211.67       A pituitary adenoma which secretes PROLACTIN, leading to HYPERPROLACTINEMIA. Clinical manifestations include AMENORRHEA; GALACTORRHEA; IMPOTENCE; HEADACHE; visual disturbances; and CEREBROSPINAL FLUID RHINORRHEA.%A%    
% 211.46/211.67  |- skos__hiddenLabel mesh__D015175 Prolactin-Producing Pituitary Adenomas
% 211.46/211.67  |- skos__altLabel mesh__D015175 Prolactin-Secreting Pituitary Adenoma
% 211.46/211.67  |- skos__hiddenLabel mesh__D015175 Adenomas, Lactotroph
% 211.46/211.67  |- mesh__publicMeSHNote mesh__D009936
% 211.46/211.67       89; was see under ORGANIZATION AND ADMINISTRATION 1982-88%A%  
% 211.46/211.67  |- rdf__type mesh__D009936sskos__Concept
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009936 1998
% 211.46/211.67  |- skos__hiddenLabel mesh__D009936 Innovations, Organizational
% 211.46/211.67  |- skos__altLabel mesh__D009936 Organizational Change
% 211.46/211.67  |- skos__prefLabel mesh__D009936 Organizational Innovation
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009936 1994
% 211.46/211.67  |- skos__hiddenLabel mesh__D009936 Organizational Innovations
% 211.46/211.67  |- mesh__dateEstablished mesh__D009936 1989-01-01
% 211.46/211.67  |- skos__broader mesh__D009936smesh__D009934
% 211.46/211.67  |- mesh__dateCreated mesh__D009936 1981-05-19
% 211.46/211.67  |- skos__hiddenLabel mesh__D009936 Changes, Organizational
% 211.46/211.67  |- mesh__historyNote mesh__D009936
% 211.46/211.67       89%28%82%29%; was see under ORGANIZATION AND ADMINISTRATION 1982-88%A%  
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009936 2002
% 211.46/211.67  |- skos__scopeNote mesh__D009936
% 211.46/211.67       Introduction of changes which are new to the organization and are created by management.%A%    
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009936 2004
% 211.46/211.67  |- mesh__dateRevised mesh__D009936 1992-05-15
% 211.46/211.67  |- skos__annotation mesh__D009936
% 211.46/211.67       NIM; coord with specific organiz %28%IM%29%; DF: ORGAN INNOVATION%A%  
% 211.46/211.67  |- skos__altLabel mesh__D009936 Innovation, Organizational
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009936 2001
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009936 2006
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009936 1997
% 211.46/211.67  |- mesh__recordAuthorizer mesh__D009936 PLS
% 211.46/211.67  |- skos__hiddenLabel mesh__D009936 Organizational Changes
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009936 2003
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009936 1999
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009936 2000
% 211.46/211.67  |- mesh__recordOriginator mesh__D009936 EC
% 211.46/211.67  |- mesh__recordMaintainer mesh__D009936 TAP
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009936 2005
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009936 1993
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009936 1996
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009936 1995
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009138 2001
% 211.46/211.67  |- mesh__dateCreated mesh__D009138 1999-01-01
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009138 2005
% 211.46/211.67  |- skos__scopeNote mesh__D009138
% 211.46/211.67       A major nerve of the upper extremity. The fibers of the musculocutaneous nerve originate in the lower cervical spinal cord %28%usually C5 to C7%29%, travel via the lateral cord of the brachial plexus, and supply sensory and motor innervation to the upper arm, elbow, and forearm.%A%    
% 211.46/211.67  |- skos__hiddenLabel mesh__D009138 Nerve, Musculocutaneous
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009138 2000
% 211.46/211.67  |- skos__hiddenLabel mesh__D009138 Nerves, Musculocutaneous
% 211.46/211.67  |- skos__hiddenLabel mesh__D009138 Musculocutaneous Nerves
% 211.46/211.67  |- rdf__type mesh__D009138sskos__Concept
% 211.46/211.67  |- skos__broader mesh__D009138smesh__D001917
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009138 2004
% 211.46/211.67  |- mesh__recordOriginator mesh__D009138 NLM
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009138 2002
% 211.46/211.67  |- skos__prefLabel mesh__D009138 Musculocutaneous Nerve
% 211.46/211.67  |- mesh__dateRevised mesh__D009138 1999-11-03
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009138 2003
% 211.46/211.67  |- mesh__recordAuthorizer mesh__D009138 sjn
% 211.46/211.67  |- mesh__recordMaintainer mesh__D009138 kle
% 211.46/211.67  |- skos__annotation mesh__D009138
% 211.46/211.67       dis: coord IM with PERIPHERAL NERVOUS SYSTEM DISEASES %28%IM%29%; neopl: coord IM with PERIPHERAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl%A%  
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009138 2006
% 211.46/211.67  |- mesh__dateEstablished mesh__D001155 1974-01-01
% 211.46/211.67  |- mesh__publicMeSHNote mesh__D001155 74   
% 211.46/211.67  |- skos__broader mesh__D001155smesh__D011613
% 211.46/211.67  |- skos__hiddenLabel mesh__D001155 Therapies, Art
% 211.46/211.67  |- mesh__dateRevised mesh__D001155 2001-07-25
% 211.46/211.67  |- rdf__type mesh__D001155sskos__Concept
% 211.46/211.67  |- mesh__historyNote mesh__D001155 74   
% 211.46/211.67  |- skos__prefLabel mesh__D001155 Art Therapy
% 211.46/211.67  |- mesh__dateCreated mesh__D001155 1999-01-01
% 211.46/211.67  |- skos__hiddenLabel mesh__D001155 Art Therapies
% 211.46/211.67  |- skos__annotation mesh__D001155 a psychother technique; DF: ART THER   
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D001155 2003
% 211.46/211.67  |- mesh__recordMaintainer mesh__D001155 ssb
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D001155 2005
% 211.46/211.67  |- skos__broader mesh__D001155smesh__D026421
% 211.46/211.67  |- skos__broader mesh__D001155smesh__D012046
% 211.46/211.67  |- mesh__recordAuthorizer mesh__D001155 sjn
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D001155 2004
% 211.46/211.67  |- skos__altLabel mesh__D001155 Therapy, Art
% 211.46/211.67  |- mesh__recordOriginator mesh__D001155 NLM
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D001155 2002
% 211.46/211.67  |- skos__scopeNote mesh__D001155
% 211.46/211.67       The use of art as an adjunctive therapy in the treatment of neurological, mental, or behavioral disorders.%A%    
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D001155 2006
% 211.46/211.67  |- skos__hiddenLabel mesh__D011583 Warfare, Psychologic
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D011583 2004
% 211.46/211.67  |- mesh__dateCreated mesh__D011583 1999-01-01
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D011583 2000
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D011583 2005
% 211.46/211.67  |- skos__annotation mesh__D011583 no qualif; DF: PSYCHOL WARFARE   
% 211.46/211.67  |- skos__altLabel mesh__D011583 Warfare, Psychological
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D011583 1996
% 211.46/211.67  |- mesh__recordOriginator mesh__D011583 NLM
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D011583 2001
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D011583 2006
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D011583 1997
% 211.46/211.67  |- mesh__dateRevised mesh__D011583 1993-06-04
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D011583 2002
% 211.46/211.67  |- skos__altLabel mesh__D011583 Psychologic Warfare
% 211.46/211.67  |- skos__prefLabel mesh__D011583 Psychological Warfare
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D011583 1998
% 211.46/211.67  |- skos__related mesh__D011583smesh__D010565
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D011583 1994
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D011583 1999
% 211.46/211.67  |- skos__scopeNote mesh__D011583
% 211.46/211.67       The manipulation of psychological influences, primarily concerned with morale, to strengthen the ability of one%27%s own country and weaken the enemy.%A%    
% 211.46/211.67  |- skos__related mesh__D011583smesh__D011406
% 211.46/211.67  |- mesh__recordMaintainer mesh__D011583 JLS
% 211.46/211.67  |- skos__broader mesh__D011583smesh__D014857
% 211.46/211.67  |- rdf__type mesh__D011583sskos__Concept
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D011583 2003
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D011583 1995
% 211.46/211.67  |- mesh__recordAuthorizer mesh__D011583 PLS
% 211.46/211.67  |- skos__prefLabel mesh__D005546 Forehead
% 211.46/211.67  |- mesh__dateCreated mesh__D005546 1976-04-16
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D005546 2004
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D005546 2002
% 211.46/211.67  |- mesh__recordAuthorizer mesh__D005546 PLS
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D005546 1997
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D005546 2006
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D005546 1999
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D005546 2003
% 211.46/211.67  |- mesh__recordMaintainer mesh__D005546 TAP
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D005546 1993
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D005546 2001
% 211.46/211.67  |- skos__annotation mesh__D005546 NIM as locational, no qualif   
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D005546 2005
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D005546 1996
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D005546 1995
% 211.46/211.67  |- skos__historyNote mesh__D005546 Face %28%1966-1976%29%
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D005546 1998
% 211.46/211.67  |- skos__scopeNote mesh__D005546 The part of the face above the eyes.     
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D005546 2000
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D005546 1994
% 211.46/211.67  |- mesh__publicMeSHNote mesh__D005546 77   
% 211.46/211.67  |- skos__broader mesh__D005546smesh__D005145
% 211.46/211.67  |- mesh__recordOriginator mesh__D005546 MM
% 211.46/211.67  |- mesh__historyNote mesh__D005546 77   
% 211.46/211.67  |- mesh__dateEstablished mesh__D005546 1977-01-01
% 211.46/211.67  |- skos__hiddenLabel mesh__D005546 Foreheads
% 211.46/211.67  |- rdf__type mesh__D005546sskos__Concept
% 211.46/211.67  |- mesh__dateRevised mesh__D005546 1992-05-15
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D015974 2000
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D015974 2003
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D015974 1996
% 211.46/211.67  |- mesh__historyNote mesh__D015974 90   
% 211.46/211.67  |- mesh__recordOriginator mesh__D015974 EGC
% 211.46/211.67  |- skos__prefLabel mesh__D015974 Wrongful Life
% 211.46/211.67  |- mesh__dateRevised mesh__D015974 2002-10-31
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D015974 2001
% 211.46/211.67  |- mesh__dateCreated mesh__D015974 1989-07-05
% 211.46/211.67  |- rdf__type mesh__D015974sskos__Concept
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D015974 2004
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D015974 1997
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D015974 2003A
% 211.46/211.67  |- skos__historyNote mesh__D015974 Jurisprudence %28%1978-1989%29%
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D015974 2002
% 211.46/211.67  |- mesh__dateEstablished mesh__D015974 1990-01-01
% 211.46/211.67  |- skos__hiddenLabel mesh__D015974 Lives, Wrongful
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D015974 2005
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D015974 1998
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D015974 1993
% 211.46/211.67  |- skos__altLabel mesh__D015974 Wrongful Lives
% 211.46/211.67  |- mesh__publicMeSHNote mesh__D015974 90   
% 211.46/211.67  |- skos__scopeNote mesh__D015974
% 211.46/211.67       In civil law a cause of action which alleges that a defendant has wrongfully caused a child to be born.%A%    
% 211.46/211.67  |- skos__broader mesh__D015974smesh__D007603
% 211.46/211.67  |- mesh__recordMaintainer mesh__D015974 jls
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D015974 1994
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D015974 2006
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D015974 1999
% 211.46/211.67  |- skos__hiddenLabel mesh__D015974 Life, Wrongful
% 211.46/211.67  |- skos__hiddenLabel mesh__D015974 Birth, Wrongful
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D015974 1995
% 211.46/211.67  |- skos__hiddenLabel mesh__D015974 Births, Wrongful
% 211.46/211.67  |- skos__hiddenLabel mesh__D015974 Wrongful Births
% 211.46/211.67  |- skos__historyNote mesh__D015974 Malpractice %28%1973-1989%29%
% 211.46/211.67  |- skos__annotation mesh__D015974
% 211.46/211.67       legal action alleging %22%that a defendant has wrongfully caused a child to be born%22%%A%  
% 211.46/211.67  |- mesh__recordAuthorizer mesh__D015974 jls
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009937 1993
% 211.46/211.67  |- skos__hiddenLabel mesh__D009937 Organizational Objective
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009937 2005
% 211.46/211.67  |- mesh__historyNote mesh__D009937
% 211.46/211.67       91%28%82%29%; was see under ORGANIZATION AND ADMINISTRATION 1982-90%A%  
% 211.46/211.67  |- skos__prefLabel mesh__D009937 Organizational Objectives
% 211.46/211.67  |- skos__scopeNote mesh__D009937
% 211.46/211.67       The purposes, missions, and goals of an individual organization or its units, established through administrative processes. It includes an organization%27%s long-range plans and administrative philosophy.%A%    
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009937 1995
% 211.46/211.67  |- skos__altLabel mesh__D009937 Goals, Organizational
% 211.46/211.67  |- skos__hiddenLabel mesh__D009937 Objective, Organizational
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009937 1994
% 211.46/211.67  |- mesh__publicMeSHNote mesh__D009937
% 211.46/211.67       91; was see under ORGANIZATION AND ADMINISTRATION 1982-90%A%  
% 211.46/211.67  |- skos__hiddenLabel mesh__D009937 Goal, Organizational
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009937 2002
% 211.46/211.67  |- mesh__dateCreated mesh__D009937 1981-05-19
% 211.46/211.67  |- skos__hiddenLabel mesh__D009937 Organizational Goal
% 211.46/211.67  |- skos__broader mesh__D009937smesh__D009934
% 211.46/211.67  |- skos__annotation mesh__D009937
% 211.46/211.67       NIM; coord with specific organiz %28%IM%29%; DF: ORGAN OBJECTIVES%A%  
% 211.46/211.67  |- mesh__dateRevised mesh__D009937 1992-05-15
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009937 2001
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009937 1997
% 211.46/211.67  |- mesh__recordAuthorizer mesh__D009937 PLS
% 211.46/211.67  |- mesh__dateEstablished mesh__D009937 1991-01-01
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009937 2004
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009937 2000
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009937 1996
% 211.46/211.67  |- skos__altLabel mesh__D009937 Organizational Goals
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009937 1999
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009937 2003
% 211.46/211.67  |- mesh__recordMaintainer mesh__D009937 TAP
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009937 2006
% 211.46/211.67  |- mesh__recordOriginator mesh__D009937 EC
% 211.46/211.67  |- rdf__type mesh__D009937sskos__Concept
% 211.46/211.67  |- skos__altLabel mesh__D009937 Objectives, Organizational
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009937 1998
% 211.46/211.67  |- mesh__recordMaintainer mesh__D001954 ssb
% 211.46/211.67  |- skos__altLabel mesh__D001954 Brinase
% 211.46/211.67  |- rdf__type mesh__D001954sskos__Concept
% 211.46/211.67  |- mesh__historyNote mesh__D001954
% 211.46/211.67       91%28%75%29%; was see under PEPTIDE HYDROLASES 1975-90   
% 211.46/211.67  |- skos__broader mesh__D001954smesh__D010450
% 211.46/211.67  |- skos__historyNote mesh__D001954 Peptide Hydrolases %28%1972-1974%29%
% 211.46/211.67  |- skos__scopeNote mesh__D001954
% 211.46/211.67       A fibrinolytic and thrombolytic enzyme from Aspergillus oryzae. EC 3.4.99.-.%A%    
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D001954 2006
% 211.46/211.67  |- mesh__dateRevised mesh__D001954 2003-07-09
% 211.46/211.67  |- skos__prefLabel mesh__D001954 Brinolase
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D001954 2004
% 211.46/211.67  |- mesh__publicMeSHNote mesh__D001954
% 211.46/211.67       91; was see under PEPTIDE HYDROLASES 1975-90   
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D001954 2005
% 211.46/211.67  |- skos__historyNote mesh__D001954 Aspergillus/enzymology %28%1972-1974%29%
% 211.46/211.67  |- mesh__dateCreated mesh__D001954 1974-11-19
% 211.46/211.67  |- mesh__recordAuthorizer mesh__D001954 sjn
% 211.46/211.67  |- mesh__recordOriginator mesh__D001954 NLM
% 211.46/211.67  |- mesh__dateEstablished mesh__D001954 1991-01-01
% 211.46/211.67  |- mesh__publicMeSHNote mesh__D009139 98   
% 211.46/211.67  |- mesh__historyNote mesh__D009139 98; use explode 1971-97   
% 211.46/211.67  |- skos__broader mesh__D009139smesh__D000013
% 211.46/211.67  |- mesh__recordAuthorizer mesh__D009139 sjn
% 211.46/211.67  |- mesh__recordMaintainer mesh__D009139 kle
% 211.46/211.67  |- skos__hiddenLabel mesh__D009139 Musculoskeletal Abnormality
% 211.46/211.67  |- mesh__dateRevised mesh__D009139 1999-11-03
% 211.46/211.67  |- skos__historyNote mesh__D009139
% 211.46/211.67       Musculoskeletal System/abnormalities %28%1966-1997%29%
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009139 2000
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009139 2003
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009139 2001
% 211.46/211.67  |- skos__annotation mesh__D009139
% 211.46/211.67       for congen struct abnorm only; GEN or unspecified; prefer specifics or specific organ /abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: MUSCULOSKELETAL ABNORM%A%  
% 211.46/211.67  |- rdf__type mesh__D009139sskos__Concept
% 211.46/211.67  |- skos__prefLabel mesh__D009139 Musculoskeletal Abnormalities
% 211.46/211.67  |- skos__scopeNote mesh__D009139
% 211.46/211.67       Congenital structural abnormalities and deformities of the musculoskeletal system.%A%    
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009139 2004
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009139 2002
% 211.46/211.67  |- skos__hiddenLabel mesh__D009139 Abnormality, Musculoskeletal
% 211.46/211.67  |- mesh__dateCreated mesh__D009139 1999-01-01
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009139 2005
% 211.46/211.67  |- skos__altLabel mesh__D009139 Abnormalities, Musculoskeletal
% 211.46/211.67  |- mesh__dateEstablished mesh__D009139 1998-01-01
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D009139 2006
% 211.46/211.67  |- skos__broader mesh__D009139smesh__D009140
% 211.46/211.67  |- mesh__recordOriginator mesh__D009139 NLM
% 211.46/211.67  |- skos__annotation mesh__D001156
% 211.46/211.67       note X ref BRINE SHRIMP: several other shrimp terms are available; check text and MeSH; unspecified shrimp as food is probably PENAEIDAE%A%  
% 211.46/211.67  |- mesh__recordAuthorizer mesh__D001156 sjn
% 211.46/211.67  |- rdf__type mesh__D001156sskos__Concept
% 211.46/211.67  |- mesh__publicMeSHNote mesh__D001156 79   
% 211.46/211.67  |- skos__historyNote mesh__D001156 Crustacea %28%1966-1978%29%
% 211.46/211.67  |- mesh__dateRevised mesh__D001156 2003-07-09
% 211.46/211.67  |- skos__altLabel mesh__D001156 Shrimp, Brine
% 211.46/211.67  |- skos__scopeNote mesh__D001156
% 211.46/211.67       A genus of CRUSTACEA of the order ANOSTRACA, found in briny pools and lakes and often cultured for fish food. It has 168 chromosomes and differs from most crustaceans in that its blood contains hemoglobin.%A%    
% 211.46/211.67  |- skos__prefLabel mesh__D001156 Artemia
% 211.46/211.67  |- skos__historyNote mesh__D001156 Shrimp %28%1972-1978%29%
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D001156 2005
% 211.46/211.67  |- mesh__recordMaintainer mesh__D001156 ags
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D001156 2004
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D001156 2006
% 211.46/211.67  |- mesh__recordOriginator mesh__D001156 AEP
% 211.46/211.67  |- skos__altLabel mesh__D001156 Brine Shrimp
% 211.46/211.67  |- mesh__dateCreated mesh__D001156 1978-03-20
% 211.46/211.67  |- mesh__historyNote mesh__D001156 79   
% 211.46/211.67  |- mesh__dateEstablished mesh__D001156 1979-01-01
% 211.46/211.67  |- skos__broader mesh__D001156smesh__D033202
% 211.46/211.67  |- mesh__recordOriginator mesh__D020310 NDW
% 211.46/211.67  |- rdf__type mesh__D020310sskos__Concept
% 211.46/211.67  |- skos__scopeNote mesh__D020310
% 211.46/211.67       An order of flightless birds comprising the ostriches, which naturally inhabit open, low rainfall areas of Africa.%A%    
% 211.46/211.67  |- skos__historyNote mesh__D020310 Birds %28%1968-1998%29%
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D020310 2006
% 211.46/211.67  |- mesh__dateCreated mesh__D020310 1998-06-10
% 211.46/211.67  |- mesh__publicMeSHNote mesh__D020310 2005; see OSTRICHES 1999-2004   
% 211.46/211.67  |- mesh__recordMaintainer mesh__D020310 ags
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D020310 2005
% 211.46/211.67  |- mesh__dateRevised mesh__D020310 2004-07-07
% 211.46/211.67  |- mesh__historyNote mesh__D020310 2005 %28%1999%29%   
% 211.46/211.67  |- mesh__recordAuthorizer mesh__D020310 sjn
% 211.46/211.67  |- skos__broader mesh__D020310smesh__D046108
% 211.46/211.67  |- mesh__dateEstablished mesh__D020310 1999-01-01
% 211.46/211.67  |- skos__altLabel mesh__D020310 Ostriches
% 211.46/211.67  |- skos__prefLabel mesh__D020310 Struthioniformes
% 211.46/211.67  |- skos__annotation mesh__D020310
% 211.46/211.67       OSTRICH, AMERICAN see RHEIFORMES is available   
% 211.46/211.67  |- skos__broader mesh__D006321Q000276smesh__D006321
% 211.46/211.67  |- mesh__preferredCombination mesh__D006321Q000276smesh__D009206Q000276
% 211.46/211.67  |- rdf__type mesh__D006321Q000276smesh__CompoundConcept
% 211.46/211.67  |- skos__related mesh__D019567smesh__D013124
% 211.46/211.67  |- mesh__publicMeSHNote mesh__D019567 98   
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D019567 2003
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D019567 1999
% 211.46/211.67  |- skos__prefLabel mesh__D019567 Back Injuries
% 211.46/211.67  |- rdf__type mesh__D019567sskos__Concept
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D019567 2000
% 211.46/211.67  |- skos__altLabel mesh__D019567 Injuries, Back
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D019567 2004
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D019567 2001
% 211.46/211.67  |- skos__hiddenLabel mesh__D019567 Back Injury
% 211.46/211.67  |- mesh__dateEstablished mesh__D019567 1998-01-01
% 211.46/211.67  |- skos__hiddenLabel mesh__D019567 Injury, Back
% 211.46/211.67  |- skos__annotation mesh__D019567
% 211.46/211.67       GEN or unspecified; coord IM with specific inj %28%IM%29% or specific region %28%NIM%29%; do not confuse with SPINAL INJURIES which refers to vertebrae only: see note there; DF: BACK INJ%A%  
% 211.46/211.67  |- mesh__historyNote mesh__D019567 98   
% 211.46/211.67  |- mesh__dateCreated mesh__D019567 1997-06-20
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D019567 2005
% 211.46/211.67  |- skos__broader mesh__D019567smesh__D014947
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D019567 2002
% 211.46/211.67  |- skos__scopeNote mesh__D019567
% 211.46/211.67       General or unspecified injuries to the posterior part of the trunk. It includes injuries to the muscles of the back.%A%    
% 211.46/211.67  |- skos__historyNote mesh__D019567 Back/injuries %28%1966-1997%29%
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D019567 2006
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D019567 1998
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D011584 2006
% 211.46/211.67  |- skos__prefLabel mesh__D011584 Psychology
% 211.46/211.67  |- skos__hiddenLabel mesh__D011584 Psychological Factor
% 211.46/211.67  |- skos__broader mesh__D011584smesh__D001525
% 211.46/211.67  |- skos__scopeNote mesh__D011584
% 211.46/211.67       The science dealing with the study of mental processes and behavior in man and animals.%A%    
% 211.46/211.67  |- skos__hiddenLabel mesh__D011584 Psychologist
% 211.46/211.67  |- skos__hiddenLabel mesh__D011584 Factor, Psychological
% 211.46/211.67  |- mesh__dateRevised mesh__D011584 1999-11-03
% 211.46/211.67  |- skos__altLabel mesh__D011584 Psychological Side Effects
% 211.46/211.67  |- rdf__type mesh__D011584sskos__Concept
% 211.46/211.67  |- skos__hiddenLabel mesh__D011584 Factor, Psychosocial
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D011584 2003
% 211.46/211.67  |- skos__hiddenLabel mesh__D011584 Psychological Side Effect
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D011584 2000
% 211.46/211.67  |- skos__annotation mesh__D011584
% 211.46/211.67       SPEC: IM, SPEC qualif; prefer /psychol: Manual 19.7+, 19.8.59; NIM for %22%psychological aspects of%22% terms not in Cat C, E1-6 %26% F3: no qualif; as NIM: Manual 27.10 DF: PSYCHOL%A%  
% 211.46/211.67  |- skos__hiddenLabel mesh__D011584 Psychosocial Factor
% 211.46/211.67  |- skos__hiddenLabel mesh__D011584 Side Effect, Psychological
% 211.46/211.67  |- mesh__activeMeSHYear mesh__D011584 2004
% 211.46/211.67  |- mesh__recordAuthorizer mesh__D011584 sjn
% 211.46/211.67  |- skos__hiddenLabel mesh__D011584 Factors, Psychosocial
% 211.46/211.68  |- mesh__recordOriginator mesh__D011584 NLM
% 211.46/211.68  |- mesh__dateCreated mesh__D011584 1999-01-01
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D011584 2001
% 211.46/211.68  |- mesh__recordMaintainer mesh__D011584 kle
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D011584 2005
% 211.46/211.68  |- skos__altLabel mesh__D011584 Factors, Psychological
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D011584 2002
% 211.46/211.68  |- skos__hiddenLabel mesh__D005547 Foreign Body
% 211.46/211.68  |- skos__prefLabel mesh__D005547 Foreign Bodies
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D005547 2006
% 211.46/211.68  |- mesh__dateCreated mesh__D005547 1999-01-01
% 211.46/211.68  |- mesh__recordOriginator mesh__D005547 NLM
% 211.46/211.68  |- skos__hiddenLabel mesh__D005547 Bodies, Foreign
% 211.46/211.68  |- skos__scopeNote mesh__D005547
% 211.46/211.68       Objects that inadvertently enter the body or body cavities from the environment.%A%    
% 211.46/211.68  |- mesh__dateRevised mesh__D005547 2004-07-07
% 211.46/211.68  |- skos__annotation mesh__D005547
% 211.46/211.68       coord IM with organ %28%IM%29%, not organ/dis: Manual 21.39; EYE FOREIGN BODIES is available; FOREIGN-BODY MIGRATION %26% FOREIGN-BODY REACTION are also available%A%  
% 211.46/211.68  |- mesh__recordAuthorizer mesh__D005547 sjn
% 211.46/211.68  |- mesh__recordMaintainer mesh__D005547 lkt
% 211.46/211.68  |- skos__hiddenLabel mesh__D005547 Body, Foreign
% 211.46/211.68  |- skos__broader mesh__D005547smesh__D014947
% 211.46/211.68  |- rdf__type mesh__D005547sskos__Concept
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D005547 2005
% 211.46/211.68  |- mesh__recordAuthorizer mesh__D024701 sjn
% 211.46/211.68  |- skos__annotation mesh__D024701
% 211.46/211.68       do not confuse with MYOSIN V1 and MYOSIN V3 see VENTRICULAR MYOSINS%A%  
% 211.46/211.68  |- mesh__historyNote mesh__D024701
% 211.46/211.68       2002; for MYOSIN-V P190 use CHICKEN BRAIN MYOSIN-V P190 %28%NM%29% 1993-2001%A%  
% 211.46/211.68  |- skos__hiddenLabel mesh__D024701 Myosin V p190
% 211.46/211.68  |- skos__scopeNote mesh__D024701
% 211.46/211.68       A subclass of myosin involved in organelle transport and membrane targeting. It is abundantly found in nervous tissue and neurosecretory cells.  The heavy chains of myosin V contain unusually long neck domains that are believed to aid in translocating molecules over large distances.%A%    
% 211.46/211.68  |- rdf__type mesh__D024701sskos__Concept
% 211.46/211.68  |- skos__broader mesh__D024701smesh__D009218
% 211.46/211.68  |- mesh__dateRevised mesh__D024701 2005-06-30
% 211.46/211.68  |- mesh__dateEstablished mesh__D024701 2002-01-01
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D024701 2006
% 211.46/211.68  |- mesh__recordOriginator mesh__D024701 jmp
% 211.46/211.68  |- mesh__dateCreated mesh__D024701 2001-07-25
% 211.46/211.68  |- mesh__recordMaintainer mesh__D024701 DRC
% 211.46/211.68  |- skos__historyNote mesh__D024701 Nerve Tissue Proteins %28%1993-2001%29%
% 211.46/211.68  |- skos__historyNote mesh__D024701
% 211.46/211.68       Calmodulin-Binding Proteins %28%1993-2001%29%
% 211.46/211.68  |- skos__altLabel mesh__D024701 Myosin V
% 211.46/211.68  |- skos__prefLabel mesh__D024701 Myosin Type V
% 211.46/211.68  |- mesh__publicMeSHNote mesh__D024701 2002   
% 211.46/211.68  |- skos__broader mesh__D015975smesh__D003245
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D015975 2004
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D015975 1997
% 211.46/211.68  |- rdf__type mesh__D015975sskos__Concept
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D015975 2000A
% 211.46/211.68  |- skos__historyNote mesh__D015975
% 211.46/211.68       Consensus Development Conferences %28%1988-1989%29%
% 211.46/211.68  |- mesh__dateEstablished mesh__D015975 1990-01-01
% 211.46/211.68  |- skos__prefLabel mesh__D015975 Consensus Development Conferences, NIH
% 211.46/211.68  |- mesh__dateCreated mesh__D015975 1989-05-26
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D015975 2000
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D015975 2005
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D015975 1998
% 211.46/211.68  |- mesh__historyNote mesh__D015975
% 211.46/211.68       90; was see CONSENSUS DEVELOPMENT CONFERENCES 1988-89; was NIH CONSENSUS DEVELOPMENT see NATIONAL INSTITUTES OF HEALTH %28%U.S.%29% 1982-87; for both the publication type %26% the main heading 1988-90; main heading only 1991 forward%A%  
% 211.46/211.68  |- skos__annotation mesh__D015975
% 211.46/211.68       no qualif; do not confuse with Publication Type CONSENSUS DEVELOPMENT CONFERENCE, NIH; IM for NIH conf as a means of scientific communication; for any article in any publication of the NIH Office of Medical Applications of Research %28%OMAR%29%; Manual section 12 %26% TN L; include name of NIH conf as part of title when it appears in author position, in footnote or at end of article; add UNITED STATES %28%NIM%29%; DF: CONSENS DEV CONF NIH%A%  
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D015975 2001
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D015975 2006
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D015975 1999
% 211.46/211.68  |- skos__historyNote mesh__D015975
% 211.46/211.68       National Institutes of Health %28%U.S.%29% %28%1982-1987%29%
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D015975 2002
% 211.46/211.68  |- mesh__onlineNote mesh__D015975
% 211.46/211.68       use CONSENSUS DEVELOPMENT CONFERENCES, NIH to search for conferences reported in OMAR publications 1977-90; use CONSENSUS DEVELOPMENT CONFERENCES to search NIH CONSENSUS DEVELOPMENT reported in non-OMAR publications 1988-89; use NATIONAL INSTITUTES OF HEALTH %28%U.S.%29% for conferences reported in non-OMAR publications 1982-87; use CONSENSUS DEVELOPMENT CONFERENCES, NIH %28%PUBLICATION TYPE%29% to search for OMAR %26% non-OMAR publications 1991 forward%A%  
% 211.46/211.68  |- mesh__recordOriginator mesh__D015975 PLS
% 211.46/211.68  |- mesh__publicMeSHNote mesh__D015975
% 211.46/211.68       90; was see CONSENSUS DEVELOPMENT CONFERENCES 1988-89; was NIH CONSENSUS DEVELOPMENT see NATIONAL INSTITUTES OF HEALTH %28%U.S%29% 1982-87%A%  
% 211.46/211.68  |- skos__scopeNote mesh__D015975
% 211.46/211.68       Articles on conferences sponsored by NIH presenting summary statements representing the majority agreement of physicians, scientists, and other professionals convening for the purpose of reaching a consensus on a subject of interest. This heading is used for NIH consensus conferences as a means of scientific communication. In indexing it is viewed as a type of review article and as a tag for any article appearing in any publication of the NIH Office of Medical Applications of Research %28%OMAR%29%.%A%    
% 211.46/211.68  |- mesh__recordAuthorizer mesh__D015975 ags
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D015975 2003
% 211.46/211.68  |- mesh__recordMaintainer mesh__D015975 ags
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D015975 1996
% 211.46/211.68  |- skos__altLabel mesh__D015975 NIH Consensus Development Conferences
% 211.46/211.68  |- mesh__dateRevised mesh__D015975 1999-12-16
% 211.46/211.68  |- mesh__dateEstablished mesh__D009938 1968-01-01
% 211.46/211.68  |- skos__broader mesh__D009938smesh__D004472
% 211.46/211.68  |- mesh__recordOriginator mesh__D009938 NLM
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D009938 2004
% 211.46/211.68  |- mesh__publicMeSHNote mesh__D009938 68   
% 211.46/211.68  |- skos__annotation mesh__D009938
% 211.46/211.68       has a limited use since there are other more specific terms available; read notes under SOCIETIES; SOCIETIES, MEDICAL %26% SOCIETIES, SCIENTIFIC for likely exclusions: ORGANIZATIONS tends to be for groups with a common goal based on interest, SOCIETIES tends to be for groups with common educ or professional status: TN 174; policy: Manual 35.9; specify geog: Manual 36.15; DF: ORGAN but do not confuse with ORGAN ADMIN for ORGANIZATION AND ADMINISTRATION%A%  
% 211.46/211.68  |- skos__hiddenLabel mesh__D009938 Organization
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D009938 2003
% 211.46/211.68  |- mesh__recordMaintainer mesh__D009938 mdb
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D009938 2006
% 211.46/211.68  |- mesh__dateCreated mesh__D009938 1999-01-01
% 211.46/211.68  |- rdf__type mesh__D009938sskos__Concept
% 211.46/211.68  |- mesh__dateRevised mesh__D009938 2001-07-25
% 211.46/211.68  |- mesh__recordAuthorizer mesh__D009938 sjn
% 211.46/211.68  |- skos__scopeNote mesh__D009938
% 211.46/211.68       Administration and functional structures for the purpose of collectively systematizing activities for a particular goal.%A%    
% 211.46/211.68  |- skos__hiddenLabel mesh__D009938 Organization, Nongovernmental
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D009938 2005
% 211.46/211.68  |- skos__related mesh__D009938smesh__D012952
% 211.46/211.68  |- skos__altLabel mesh__D009938 Organizations, Nongovernmental
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D009938 2002
% 211.46/211.68  |- mesh__historyNote mesh__D009938 68   
% 211.46/211.68  |- skos__prefLabel mesh__D009938 Organizations
% 211.46/211.68  |- skos__historyNote mesh__D009938 specific organization %28%1966-1967%29%
% 211.46/211.68  |- skos__hiddenLabel mesh__D009938 Nongovernmental Organization
% 211.46/211.68  |- rdf__type mesh__D001955sskos__Concept
% 211.46/211.68  |- mesh__recordOriginator mesh__D001955 NLM
% 211.46/211.68  |- skos__annotation mesh__D001955
% 211.46/211.68       a province of Canada on the Pacific coast   
% 211.46/211.68  |- mesh__recordMaintainer mesh__D001955 TGC
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001955 2006
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001955 2002
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001955 2004
% 211.46/211.68  |- mesh__recordAuthorizer mesh__D001955 PLS
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001955 2005
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001955 1999
% 211.46/211.68  |- mesh__dateCreated mesh__D001955 1999-01-01
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001955 2003
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001955 1997
% 211.46/211.68  |- skos__prefLabel mesh__D001955 British Columbia
% 211.46/211.68  |- skos__scopeNote mesh__D001955
% 211.46/211.68       A province of Canada on the Pacific coast. Its capital is Victoria. The name given in 1858 derives from the Columbia River which was named by the American captain Robert Gray for his ship Columbia which in turn was named for Columbus. %28%From Webster%27%s New Geographical Dictionary, 1988, p178 %26% Room, Brewer%27%s Dictionary of Names, 1992, p81-2%29%%A%    
% 211.46/211.68  |- mesh__dateRevised mesh__D001955 1995-02-17
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001955 1998
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001955 2001
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001955 1996
% 211.46/211.68  |- skos__broader mesh__D001955smesh__D002170
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001955 2000
% 211.46/211.68  |- skos__hiddenLabel mesh__D001157 Occlusive Diseases, Arterial
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001157 2003
% 211.46/211.68  |- mesh__dateRevised mesh__D001157 1998-06-10
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001157 2001
% 211.46/211.68  |- skos__hiddenLabel mesh__D001157 Arterial Obstructive Disease
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001157 2005
% 211.46/211.68  |- skos__hiddenLabel mesh__D001157 Diseases, Arterial Obstructive
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001157 2004
% 211.46/211.68  |- skos__hiddenLabel mesh__D001157 Obstructive Disease, Arterial
% 211.46/211.68  |- skos__hiddenLabel mesh__D001157 Obstructive Diseases, Arterial
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001157 2006
% 211.46/211.68  |- skos__prefLabel mesh__D001157 Arterial Occlusive Diseases
% 211.46/211.68  |- skos__broader mesh__D001157smesh__D014652
% 211.46/211.68  |- skos__hiddenLabel mesh__D001157 Disease, Arterial Occlusive
% 211.46/211.68  |- mesh__recordOriginator mesh__D001157 NLM
% 211.46/211.68  |- mesh__recordAuthorizer mesh__D001157 SJN
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001157 2002
% 211.46/211.68  |- skos__historyNote mesh__D001157 Vascular Diseases %28%1966-1972%29%
% 211.46/211.68  |- mesh__historyNote mesh__D001157 73   
% 211.46/211.68  |- skos__annotation mesh__D001157
% 211.46/211.68       IM for general or specific artery occlusion %28%as POPLITEAL ARTERY %28%IM%29% + ARTERIAL OCCLUSIVE DISEASES %28%IM%29%%29%%A%  
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001157 1999
% 211.46/211.68  |- skos__scopeNote mesh__D001157
% 211.46/211.68       Diseases in which arterial vessels are partially or completely obstructed or in which the blood flow through the vessels is impeded.%A%    
% 211.46/211.68  |- skos__hiddenLabel mesh__D001157 Diseases, Arterial Occlusive
% 211.46/211.68  |- rdf__type mesh__D001157sskos__Concept
% 211.46/211.68  |- skos__hiddenLabel mesh__D001157 Disease, Arterial Obstructive
% 211.46/211.68  |- mesh__dateEstablished mesh__D001157 1973-01-01
% 211.46/211.68  |- mesh__dateCreated mesh__D001157 1999-01-01
% 211.46/211.68  |- mesh__publicMeSHNote mesh__D001157 73   
% 211.46/211.68  |- skos__hiddenLabel mesh__D001157 Occlusive Disease, Arterial
% 211.46/211.68  |- mesh__recordMaintainer mesh__D001157 NDW
% 211.46/211.68  |- skos__hiddenLabel mesh__D001157 Arterial Occlusive Disease
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001157 2000
% 211.46/211.68  |- skos__altLabel mesh__D001157 Arterial Obstructive Diseases
% 211.46/211.68  |- mesh__recordAuthorizer mesh__D006640 sjn
% 211.46/211.68  |- mesh__publicMeSHNote mesh__D006640
% 211.46/211.68       91; was see under CARBOXY-LYASES 1975-90   
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D006640 2004
% 211.46/211.68  |- skos__altLabel mesh__D006640 Histidine Carboxy-Lyase
% 211.46/211.68  |- mesh__historyNote mesh__D006640
% 211.46/211.68       91%28%75%29%; was see under CARBOXY-LYASES 1975-90   
% 211.46/211.68  |- mesh__dateEstablished mesh__D006640 1991-01-01
% 211.46/211.68  |- skos__historyNote mesh__D006640 Carboxy-Lyases %28%1973-1974%29%
% 211.46/211.68  |- rdf__type mesh__D006640sskos__Concept
% 211.46/211.68  |- skos__historyNote mesh__D006640 Histidine %28%1973-1974%29%
% 211.46/211.68  |- skos__hiddenLabel mesh__D006640 Histidine Carboxy Lyase
% 211.46/211.68  |- skos__hiddenLabel mesh__D006640 Carboxy-Lyase, Histidine
% 211.46/211.68  |- mesh__recordMaintainer mesh__D006640 ssb
% 211.46/211.68  |- skos__scopeNote mesh__D006640
% 211.46/211.68       An enzyme that catalyzes the decarboxylation of histidine to histamine and carbon dioxide. It requires pyridoxal phosphate in animal tissues, but not in microorganisms. EC 4.1.1.22.%A%    
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D006640 2005
% 211.46/211.68  |- mesh__dateCreated mesh__D006640 1974-11-19
% 211.46/211.68  |- skos__broader mesh__D006640smesh__D002262
% 211.46/211.68  |- skos__hiddenLabel mesh__D006640 Decarboxylase, Histidine
% 211.46/211.68  |- mesh__recordOriginator mesh__D006640 NLM
% 211.46/211.68  |- mesh__dateRevised mesh__D006640 2003-07-09
% 211.46/211.68  |- skos__prefLabel mesh__D006640 Histidine Decarboxylase
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D006640 2006
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D020311 2006
% 211.46/211.68  |- skos__hiddenLabel mesh__D020311 American Ostrich
% 211.46/211.68  |- skos__hiddenLabel mesh__D020311 American Ostrichs
% 211.46/211.68  |- skos__altLabel mesh__D020311 Rheas
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D020311 2005
% 211.46/211.68  |- skos__hiddenLabel mesh__D020311 Ostrichs, American
% 211.46/211.68  |- mesh__dateRevised mesh__D020311 2004-07-13
% 211.46/211.68  |- skos__altLabel mesh__D020311 Rhea americana
% 211.46/211.68  |- skos__prefLabel mesh__D020311 Rheiformes
% 211.46/211.68  |- skos__altLabel mesh__D020311 Ostriches, American
% 211.46/211.68  |- skos__hiddenLabel mesh__D020311 American Ostriches
% 211.46/211.68  |- mesh__recordMaintainer mesh__D020311 sjn
% 211.46/211.68  |- mesh__publicMeSHNote mesh__D020311 2005; see RHEAS 1999-2004   
% 211.46/211.68  |- skos__annotation mesh__D020311
% 211.46/211.68       note X ref OSTRICH, AMERICAN: OSTRICHES see STRUTHIONIFORMES is available%A%  
% 211.46/211.68  |- skos__historyNote mesh__D020311 Birds %28%1971-1998%29%
% 211.46/211.68  |- skos__scopeNote mesh__D020311
% 211.46/211.68       An order of large, long-necked, long-legged, flightless birds, found in South America. Known as rheas, they are sometimes called American ostriches, though they are in a separate order from true OSTRICHES.%A%    
% 211.46/211.68  |- mesh__historyNote mesh__D020311 2005 %28%1999%29%   
% 211.46/211.68  |- mesh__recordAuthorizer mesh__D020311 sjn
% 211.46/211.68  |- mesh__recordOriginator mesh__D020311 NDW
% 211.46/211.68  |- rdf__type mesh__D020311sskos__Concept
% 211.46/211.68  |- skos__broader mesh__D020311smesh__D046108
% 211.46/211.68  |- mesh__dateEstablished mesh__D020311 1999-01-01
% 211.46/211.68  |- mesh__dateCreated mesh__D020311 1998-06-11
% 211.46/211.68  |- skos__hiddenLabel mesh__D019568 Lungs, Hyperlucent
% 211.46/211.68  |- skos__prefLabel mesh__D019568 Lung, Hyperlucent
% 211.46/211.68  |- mesh__dateCreated mesh__D019568 1997-06-20
% 211.46/211.68  |- skos__historyNote mesh__D019568 Lung Diseases %28%1966-1997%29%
% 211.46/211.68  |- mesh__dateRevised mesh__D019568 2001-07-25
% 211.46/211.68  |- mesh__recordMaintainer mesh__D019568 lkt
% 211.46/211.68  |- skos__hiddenLabel mesh__D019568 Hyperlucent Thorax
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D019568 2002
% 211.46/211.68  |- mesh__historyNote mesh__D019568 98   
% 211.46/211.68  |- skos__broader mesh__D019568smesh__D011656
% 211.46/211.68  |- skos__altLabel mesh__D019568 MacLeod Syndrome
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D019568 2005
% 211.46/211.68  |- skos__historyNote mesh__D019568 Pulmonary Emphysema %28%1966-1997%29%
% 211.46/211.68  |- mesh__publicMeSHNote mesh__D019568 98   
% 211.46/211.68  |- skos__annotation mesh__D019568
% 211.46/211.68       a type of pulm emphysema manifesting as hyperlucency on x-ray%A%  
% 211.46/211.68  |- skos__hiddenLabel mesh__D019568 Syndrome, Swyer-James
% 211.46/211.68  |- skos__hiddenLabel mesh__D019568 Syndrome, MacLeod
% 211.46/211.68  |- skos__altLabel mesh__D019568 Thorax, Hyperlucent
% 211.46/211.68  |- mesh__recordOriginator mesh__D019568 TGC
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D019568 2006
% 211.46/211.68  |- skos__scopeNote mesh__D019568
% 211.46/211.68       Hyperlucency of one lung with decreased size and vascularity of the lung. It is often associated with BRONCHIOLITIS OBLITERANS and with adenovirus infection in childhood.%A%    
% 211.46/211.68  |- mesh__dateEstablished mesh__D019568 1998-01-01
% 211.46/211.68  |- skos__hiddenLabel mesh__D019568 Swyer James Syndrome
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D019568 2003
% 211.46/211.68  |- rdf__type mesh__D019568sskos__Concept
% 211.46/211.68  |- skos__hiddenLabel mesh__D019568 Hyperlucent Lung
% 211.46/211.68  |- skos__hiddenLabel mesh__D019568 Hyperlucent Lungs
% 211.46/211.68  |- mesh__recordAuthorizer mesh__D019568 sjn
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D019568 2004
% 211.46/211.68  |- mesh__dateRevised mesh__D011585 1991-06-28
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D011585 2001
% 211.46/211.68  |- skos__scopeNote mesh__D011585
% 211.46/211.68       The science which utilizes psychologic principles to derive more effective means in dealing with practical problems.%A%    
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D011585 1993
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D011585 1998
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D011585 2002
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D011585 1994
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D011585 1999
% 211.46/211.68  |- mesh__recordMaintainer mesh__D011585 TGC
% 211.46/211.68  |- rdf__type mesh__D011585sskos__Concept
% 211.46/211.68  |- skos__hiddenLabel mesh__D011585 Psychologies, Applied
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D011585 2003
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D011585 1995
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D011585 2004
% 211.46/211.68  |- mesh__recordAuthorizer mesh__D011585 PLS
% 211.46/211.68  |- skos__altLabel mesh__D011585 Applied Psychology
% 211.46/211.68  |- mesh__dateCreated mesh__D011585 1999-01-01
% 211.46/211.68  |- skos__hiddenLabel mesh__D011585 Applied Psychologies
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D011585 2005
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D011585 1996
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D011585 2006
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D011585 2000
% 211.46/211.68  |- skos__prefLabel mesh__D011585 Psychology, Applied
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D011585 1992
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D011585 1997
% 211.46/211.68  |- skos__annotation mesh__D011585 SPEC: SPEC qualif; DF: PSYCHOL APPLIED   
% 211.46/211.68  |- mesh__recordOriginator mesh__D011585 NLM
% 211.46/211.68  |- skos__broader mesh__D011585smesh__D011579
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D005548 1997
% 211.46/211.68  |- mesh__recordAuthorizer mesh__D005548 PLS
% 211.46/211.68  |- mesh__historyNote mesh__D005548
% 211.46/211.68       91%28%75%29%; was FOREIGN BODY MIGRATION see under FOREIGN BODIES 1975-90%A%  
% 211.46/211.68  |- mesh__recordMaintainer mesh__D005548 TGC
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D005548 2002
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D005548 2005
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D005548 2004
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D005548 1999
% 211.46/211.68  |- mesh__recordOriginator mesh__D005548 NLM
% 211.46/211.68  |- mesh__onlineNote mesh__D005548
% 211.46/211.68       use FOREIGN-BODY MIGRATION to search FOREIGN BODY MIGRATION 1975-90%A%  
% 211.46/211.68  |- skos__hiddenLabel mesh__D005548 Foreign-Body Migrations
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D005548 2006
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D005548 1994
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D005548 1993
% 211.46/211.68  |- skos__annotation mesh__D005548 note category   
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D005548 2000
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D005548 1995
% 211.46/211.68  |- skos__hiddenLabel mesh__D005548 Migration, Foreign-Body
% 211.46/211.68  |- skos__hiddenLabel mesh__D005548 Foreign Body Migration
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D005548 2001
% 211.46/211.68  |- mesh__dateEstablished mesh__D005548 1991-01-01
% 211.46/211.68  |- skos__scopeNote mesh__D005548
% 211.46/211.68       Migration of a foreign body from its original location to some other location in the body.%A%    
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D005548 1996
% 211.46/211.68  |- rdf__type mesh__D005548sskos__Concept
% 211.46/211.68  |- mesh__publicMeSHNote mesh__D005548
% 211.46/211.68       91; was FOREIGN BODY MIGRATION see under FOREIGN BODIES 1975-90%A%  
% 211.46/211.68  |- skos__hiddenLabel mesh__D005548 Migrations, Foreign-Body
% 211.46/211.68  |- skos__broader mesh__D005548smesh__D005547
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D005548 2003
% 211.46/211.68  |- skos__prefLabel mesh__D005548 Foreign-Body Migration
% 211.46/211.68  |- mesh__dateCreated mesh__D005548 1974-11-11
% 211.46/211.68  |- mesh__dateRevised mesh__D005548 1992-05-15
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D005548 1998
% 211.46/211.68  |- skos__annotation mesh__D016270
% 211.46/211.68       add UNITED STATES %28%NIM%29%; research support by this agency is checked as NIH/PHS SUP; DF: AHCPR      CATALOG: use NAF entry%A%  
% 211.46/211.68  |- mesh__historyNote mesh__D016270 91   
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D016270 2006
% 211.46/211.68  |- mesh__recordMaintainer mesh__D016270 jls
% 211.46/211.68  |- mesh__dateCreated mesh__D016270 1990-05-29
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D016270 2001
% 211.46/211.68  |- mesh__recordOriginator mesh__D016270 TGC
% 211.46/211.68  |- rdf__type mesh__D016270sskos__Concept
% 211.46/211.68  |- skos__altLabel mesh__D016270
% 211.46/211.68       United States Agency for Health Care Policy and Research
% 211.46/211.68  |- skos__prefLabel mesh__D016270
% 211.46/211.68       United States Agency for Healthcare Research and Quality
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D016270 2005A
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D016270 2003
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D016270 2002
% 211.46/211.68  |- mesh__dateEstablished mesh__D016270 1991-01-01
% 211.46/211.68  |- mesh__publicMeSHNote mesh__D016270 91   
% 211.46/211.68  |- skos__scopeNote mesh__D016270
% 211.46/211.68       An agency of the PUBLIC HEALTH SERVICE established in 1990 to %22%provide indexing, abstracting, translating, publishing, and other services leading to a more effective and timely dissemination of information on research, demonstration projects, and evaluations with respect to health care to public and private entities and individuals engaged in the improvement of health care delivery...%22% It supersedes the National Center for Health Services Research. The United States Agency for Health Care Policy and Research was renamed Agency for Healthcare Research and Quality %28%AHRQ%29% under the Healthcare Research and Quality Act of 1999.%A%    
% 211.46/211.68  |- mesh__recordAuthorizer mesh__D016270 jls
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D016270 2004
% 211.46/211.68  |- skos__altLabel mesh__D016270 Agency for Health Care Policy and Research
% 211.46/211.68  |- skos__broader mesh__D016270smesh__D014492
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D016270 2005
% 211.46/211.68  |- mesh__dateRevised mesh__D016270 2004-08-03
% 211.46/211.68  |- mesh__recordMaintainer mesh__D002250 TPW
% 211.46/211.68  |- skos__hiddenLabel mesh__D002250 Radioisotopes, Carbon
% 211.46/211.68  |- mesh__publicMeSHNote mesh__D002250 74   
% 211.46/211.68  |- skos__scopeNote mesh__D002250
% 211.46/211.68       Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes.%A%    
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D002250 1995
% 211.46/211.68  |- mesh__historyNote mesh__D002250 74   
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D002250 2001
% 211.46/211.68  |- mesh__recordOriginator mesh__D002250 NLM
% 211.46/211.68  |- rdf__type mesh__D002250sskos__Concept
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D002250 1998
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D002250 2002
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D002250 1996
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D002250 1999
% 211.46/211.68  |- mesh__onlineNote mesh__D002250 search CARBON ISOTOPES 1966-73   
% 211.46/211.68  |- skos__annotation mesh__D002250
% 211.46/211.68       C-10,11,14-16; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D002250 1997
% 211.46/211.68  |- skos__prefLabel mesh__D002250 Carbon Radioisotopes
% 211.46/211.68  |- skos__broader mesh__D002250smesh__D002247
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D002250 2005
% 211.46/211.68  |- mesh__dateEstablished mesh__D002250 1974-01-01
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D002250 2003
% 211.46/211.68  |- skos__broader mesh__D002250smesh__D011868
% 211.46/211.68  |- mesh__dateCreated mesh__D002250 1999-01-01
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D002250 2006
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D002250 2000
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D002250 1994
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D002250 2004
% 211.46/211.68  |- mesh__recordAuthorizer mesh__D002250 PLS
% 211.46/211.68  |- mesh__dateRevised mesh__D002250 1993-06-04
% 211.46/211.68  |- mesh__recordMaintainer mesh__D009939 TGC
% 211.46/211.68  |- mesh__dateEstablished mesh__D009939 1982-01-01
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D009939 2002
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D009939 1997
% 211.46/211.68  |- skos__hiddenLabel mesh__D009939 Non-Profit Organization
% 211.46/211.68  |- skos__scopeNote mesh__D009939
% 211.46/211.68       Organizations which are not operated for a profit and may be supported by endowments or private contributions.%A%    
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D009939 2004
% 211.46/211.68  |- skos__hiddenLabel mesh__D009939 Organization, Non-Profit
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D009939 2001
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D009939 1999
% 211.46/211.68  |- skos__annotation mesh__D009939 DF: ORGAN NONPROFIT   
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D009939 2006
% 211.46/211.68  |- mesh__recordAuthorizer mesh__D009939 PLS
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D009939 2003
% 211.46/211.68  |- mesh__recordOriginator mesh__D009939 EC
% 211.46/211.68  |- skos__prefLabel mesh__D009939 Organizations, Nonprofit
% 211.46/211.68  |- rdf__type mesh__D009939sskos__Concept
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D009939 2000
% 211.46/211.68  |- skos__hiddenLabel mesh__D009939 Organization, Nonprofit
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D009939 1998
% 211.46/211.68  |- mesh__historyNote mesh__D009939 82   
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D009939 2005
% 211.46/211.68  |- mesh__dateCreated mesh__D009939 1981-03-04
% 211.46/211.68  |- mesh__publicMeSHNote mesh__D009939 82   
% 211.46/211.68  |- skos__hiddenLabel mesh__D009939 Non Profit Organizations
% 211.46/211.68  |- skos__broader mesh__D009939smesh__D009938
% 211.46/211.68  |- skos__hiddenLabel mesh__D009939 Nonprofit Organization
% 211.46/211.68  |- skos__altLabel mesh__D009939 Organizations, Non-Profit
% 211.46/211.68  |- mesh__dateRevised mesh__D009939 1996-06-10
% 211.46/211.68  |- skos__altLabel mesh__D009939 Nonprofit Organizations
% 211.46/211.68  |- skos__altLabel mesh__D009939 Non-Profit Organizations
% 211.46/211.68  |- skos__hiddenLabel mesh__D009939 Organizations, Non Profit
% 211.46/211.68  |- skos__annotation mesh__D001956
% 211.46/211.68       an adnexal ligament; inflammation = PARAMETRITIS   
% 211.46/211.68  |- rdf__type mesh__D001956sskos__Concept
% 211.46/211.68  |- mesh__dateRevised mesh__D001956 1990-02-12
% 211.46/211.68  |- mesh__onlineNote mesh__D001956 search ADNEXA UTERI 1966-74   
% 211.46/211.68  |- mesh__dateEstablished mesh__D001956 1991-01-01
% 211.46/211.68  |- skos__broader mesh__D001956smesh__D008022
% 211.46/211.68  |- skos__broader mesh__D001956smesh__D000290
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001956 2005
% 211.46/211.68  |- mesh__dateCreated mesh__D001956 1999-01-01
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001956 2001
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001956 2003
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001956 1994
% 211.46/211.68  |- mesh__publicMeSHNote mesh__D001956
% 211.46/211.68       91; was see under ADNEXA UTERI 1975-90   
% 211.46/211.68  |- skos__hiddenLabel mesh__D001956 Ligament, Broad
% 211.46/211.68  |- mesh__historyNote mesh__D001956
% 211.46/211.68       91%28%75%29%; was see under ADNEXA UTERI 1975-90   
% 211.46/211.68  |- mesh__recordMaintainer mesh__D001956 PXP
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001956 2006
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001956 1992
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001956 2002
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001956 1998
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001956 2004
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001956 1995
% 211.46/211.68  |- skos__hiddenLabel mesh__D001956 Ligaments, Broad
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001956 1991
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001956 1996
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001956 1993
% 211.46/211.68  |- mesh__recordAuthorizer mesh__D001956 PLS
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001956 1999
% 211.46/211.68  |- mesh__recordOriginator mesh__D001956 NLM
% 211.46/211.68  |- mesh__activeMeSHYear mesh__D001956 1997
% 211.46/211.68  |- skos__scopeNote mesh__D001956
% 211.46/211.68       A broad fold of peritoneum that extends from the side of the uterus to the wall of the pelvis.%A%    
% 211.46/211.68  |- skos__hiddenLabel mesh__D001956 Broad Ligaments
% 211.46/211.68  |- skos__prefLabel mesh__D001956 Broad Ligament
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001956 2000
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001158 2005
% 211.46/211.69  |- skos__scopeNote mesh__D001158
% 211.46/211.69       The vessels carrying blood away from the heart.     
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001158 2004
% 211.46/211.69  |- skos__annotation mesh__D001158
% 211.46/211.69       IM GEN only; NIM as coord to indicate specific artery, as %22%pancreatic artery%22% = PANCREAS /blood supply %28%IM%29% + ARTERIES %28%NIM%29%; /surg: consider also ENDARTERECTOMY; inflammation = ARTERITIS; arterial blood: index only if significant %26% coord BLOOD %28%NIM%29% + ARTERIES or specific artery %28%NIM%29%; arterial pressure = BLOOD PRESSURE %28%IM%29% only: specify specific artery only if pertinent%A%  
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001158 1996
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001158 2006
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001158 2000
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001158 1998
% 211.46/211.69  |- skos__prefLabel mesh__D001158 Arteries
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001158 1997
% 211.46/211.69  |- skos__related mesh__D001158smesh__D000792
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001158 2001
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001158 1994
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001158 1999
% 211.46/211.69  |- mesh__dateRevised mesh__D001158 1992-03-25
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001158 1993
% 211.46/211.69  |- rdf__type mesh__D001158sskos__Concept
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001158 1995
% 211.46/211.69  |- mesh__dateCreated mesh__D001158 1999-01-01
% 211.46/211.69  |- skos__broader mesh__D001158smesh__D001808
% 211.46/211.69  |- skos__hiddenLabel mesh__D001158 Artery
% 211.46/211.69  |- mesh__recordOriginator mesh__D001158 NLM
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001158 2002
% 211.46/211.69  |- mesh__recordAuthorizer mesh__D001158 PLS
% 211.46/211.69  |- skos__related mesh__D001158smesh__D004691
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001158 2003
% 211.46/211.69  |- mesh__recordMaintainer mesh__D001158 TAP
% 211.46/211.69  |- skos__broader mesh__D006641smesh__D007093
% 211.46/211.69  |- mesh__recordOriginator mesh__D006641 NLM
% 211.46/211.69  |- skos__historyNote mesh__D006641 Imidazoles %28%1972-1974%29%
% 211.46/211.69  |- skos__altLabel mesh__D006641 Histidol
% 211.46/211.69  |- mesh__dateEstablished mesh__D006641 1991-01-01
% 211.46/211.69  |- mesh__recordAuthorizer mesh__D006641 sjn
% 211.46/211.69  |- skos__scopeNote mesh__D006641
% 211.46/211.69       The penultimate step in the pathway of histidine biosynthesis. Oxidation of the alcohol group on the side chain gives the acid group forming histidine. Histidinol has also been used as an inhibitor of protein synthesis.%A%    
% 211.46/211.69  |- skos__broader mesh__D006641smesh__D011412
% 211.46/211.69  |- rdf__type mesh__D006641sskos__Concept
% 211.46/211.69  |- mesh__historyNote mesh__D006641
% 211.46/211.69       91%28%75%29%; was see under IMIDAZOLES 1975-90   
% 211.46/211.69  |- mesh__publicMeSHNote mesh__D006641
% 211.46/211.69       91; was see under IMIDAZOLES 1975-90   
% 211.46/211.69  |- skos__prefLabel mesh__D006641 Histidinol
% 211.46/211.69  |- skos__historyNote mesh__D006641 Amino Alcohols %28%1972-1974%29%
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D006641 2006
% 211.46/211.69  |- mesh__recordMaintainer mesh__D006641 ssb
% 211.46/211.69  |- mesh__dateCreated mesh__D006641 1974-11-19
% 211.46/211.69  |- mesh__dateRevised mesh__D006641 2005-06-30
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D020312 2006
% 211.46/211.69  |- skos__altLabel mesh__D020312 Emus
% 211.46/211.69  |- mesh__recordAuthorizer mesh__D020312 sjn
% 211.46/211.69  |- mesh__recordOriginator mesh__D020312 NDW
% 211.46/211.69  |- skos__broader mesh__D020312smesh__D046108
% 211.46/211.69  |- skos__altLabel mesh__D020312 Dromaius novaehollandiae
% 211.46/211.69  |- mesh__dateEstablished mesh__D020312 1999-01-01
% 211.46/211.69  |- skos__scopeNote mesh__D020312
% 211.46/211.69       A family of flightless, running BIRDS, in the order Casuariiformes. The emu is the only surviving member of the family. They naturally inhabit forests, open plains, and grasslands in Australia.%A%    
% 211.46/211.69  |- skos__prefLabel mesh__D020312 Dromaiidae
% 211.46/211.69  |- rdf__type mesh__D020312sskos__Concept
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D020312 2005
% 211.46/211.69  |- mesh__dateRevised mesh__D020312 2004-07-07
% 211.46/211.69  |- mesh__historyNote mesh__D020312 2005 %28%1999%29%   
% 211.46/211.69  |- skos__historyNote mesh__D020312 Birds %28%1973-1998%29%
% 211.46/211.69  |- mesh__publicMeSHNote mesh__D020312 2005; see EMUS 1999   
% 211.46/211.69  |- mesh__recordMaintainer mesh__D020312 ags
% 211.46/211.69  |- mesh__dateCreated mesh__D020312 1998-06-10
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D019569 2001
% 211.46/211.69  |- mesh__historyNote mesh__D019569 1998   
% 211.46/211.69  |- skos__hiddenLabel mesh__D019569 Spasms, Unilateral Facial
% 211.46/211.69  |- skos__hiddenLabel mesh__D019569 Unilateral Facial Spasms
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D019569 2005
% 211.46/211.69  |- skos__hiddenLabel mesh__D019569 Spasm, Unilateral Facial
% 211.46/211.69  |- skos__historyNote mesh__D019569 Facial Nerve Diseases %28%1981-1997%29%
% 211.46/211.69  |- skos__historyNote mesh__D019569 Facial Muscles %28%1966-1997%29%
% 211.46/211.69  |- skos__hiddenLabel mesh__D019569 Unilateral Facial Spasm
% 211.46/211.69  |- mesh__recordAuthorizer mesh__D019569 ags
% 211.46/211.69  |- mesh__dateCreated mesh__D019569 1997-06-20
% 211.46/211.69  |- skos__broader mesh__D019569smesh__D009059
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D019569 2006
% 211.46/211.69  |- skos__altLabel mesh__D019569 Spasm, Hemifacial
% 211.46/211.69  |- skos__broader mesh__D019569smesh__D013035
% 211.46/211.69  |- mesh__publicMeSHNote mesh__D019569 1998   
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D019569 2002
% 211.46/211.69  |- mesh__recordMaintainer mesh__D019569 ags
% 211.46/211.69  |- skos__hiddenLabel mesh__D019569 Hemifacial Spasms
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D019569 2003
% 211.46/211.69  |- rdf__type mesh__D019569sskos__Concept
% 211.46/211.69  |- skos__historyNote mesh__D019569 Spasm %28%1966-1997%29%
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D019569 2000A
% 211.46/211.69  |- skos__hiddenLabel mesh__D019569 Myokymia, Hemifacial
% 211.46/211.69  |- skos__altLabel mesh__D019569 Facial Spasm, Unilateral
% 211.46/211.69  |- mesh__recordOriginator mesh__D019569 TGC
% 211.46/211.69  |- skos__hiddenLabel mesh__D019569 Facial Spasms, Unilateral
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D019569 2004
% 211.46/211.69  |- skos__prefLabel mesh__D019569 Hemifacial Spasm
% 211.46/211.69  |- mesh__dateEstablished mesh__D019569 1998-01-01
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D019569 2000
% 211.46/211.69  |- skos__hiddenLabel mesh__D019569 Spasms, Hemifacial
% 211.46/211.69  |- mesh__dateRevised mesh__D019569 1999-12-13
% 211.46/211.69  |- skos__scopeNote mesh__D019569
% 211.46/211.69       Recurrent clonic contraction of facial muscles, restricted to one side. It may occur as a manifestation of compressive lesions involving the seventh cranial nerve %28%FACIAL NERVE DISEASES%29%, during recovery from BELL PALSY, or in association with other disorders. %28%From Adams et al., Principles of Neurology, 6th ed, p1378%29%%A%    
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011586 2006
% 211.46/211.69  |- skos__scopeNote mesh__D011586
% 211.46/211.69       The branch of psychology concerned with psychological methods of recognizing and treating behavior disorders.%A%    
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011586 1996
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011586 1995
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011586 2001
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011586 2005
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011586 1994
% 211.46/211.69  |- mesh__recordOriginator mesh__D011586 NLM
% 211.46/211.69  |- skos__annotation mesh__D011586 SPEC: SPEC qualif; DF: PSYCHOL CLIN   
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011586 2000
% 211.46/211.69  |- mesh__dateCreated mesh__D011586 1999-01-01
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011586 1999
% 211.46/211.69  |- rdf__type mesh__D011586sskos__Concept
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011586 2004
% 211.46/211.69  |- skos__altLabel mesh__D011586 Clinical Psychology
% 211.46/211.69  |- mesh__recordAuthorizer mesh__D011586 PLS
% 211.46/211.69  |- mesh__dateRevised mesh__D011586 1993-06-04
% 211.46/211.69  |- skos__prefLabel mesh__D011586 Psychology, Clinical
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011586 1998
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011586 2003
% 211.46/211.69  |- mesh__recordMaintainer mesh__D011586 JLS
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011586 1997
% 211.46/211.69  |- skos__broader mesh__D011586smesh__D011584
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011586 2002
% 211.46/211.69  |- skos__broader mesh__D005549smesh__D007249
% 211.46/211.69  |- mesh__recordMaintainer mesh__D005549 KEV
% 211.46/211.69  |- mesh__publicMeSHNote mesh__D005549
% 211.46/211.69       91; was FOREIGN BODY REACTION 1974-90   
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D005549 2006
% 211.46/211.69  |- skos__hiddenLabel mesh__D005549 Foreign Body Reaction
% 211.46/211.69  |- skos__historyNote mesh__D005549 Foreign Bodies %28%1966-1971%29%
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D005549 2002
% 211.46/211.69  |- skos__hiddenLabel mesh__D005549 Reaction, Foreign-Body
% 211.46/211.69  |- skos__annotation mesh__D005549
% 211.46/211.69       note category: in presence of a dis, use /etiol, not /compl%A%  
% 211.46/211.69  |- mesh__recordOriginator mesh__D005549 NLM
% 211.46/211.69  |- mesh__dateEstablished mesh__D005549 1974-01-01
% 211.46/211.69  |- skos__scopeNote mesh__D005549
% 211.46/211.69       Chronic inflammation and granuloma formation around irritating foreign bodies.%A%    
% 211.46/211.69  |- rdf__type mesh__D005549sskos__Concept
% 211.46/211.69  |- skos__prefLabel mesh__D005549 Foreign-Body Reaction
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D005549 2000
% 211.46/211.69  |- skos__broader mesh__D005549smesh__D005547
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D005549 2003
% 211.46/211.69  |- mesh__recordAuthorizer mesh__D005549 sjn
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D005549 2001
% 211.46/211.69  |- mesh__historyNote mesh__D005549
% 211.46/211.69       91%28%72%29%; was FOREIGN BODY REACTION 1972-90 %28%Prov 1972-73%29%   
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D005549 2005
% 211.46/211.69  |- mesh__dateRevised mesh__D005549 1999-11-03
% 211.46/211.69  |- mesh__dateCreated mesh__D005549 1999-01-01
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D005549 2004
% 211.46/211.69  |- mesh__onlineNote mesh__D005549
% 211.46/211.69       use FOREIGN-BODY REACTION to search FOREIGN BODY REACTION 1972-90 %28%as Prov 1972-73%29%%A%  
% 211.46/211.69  |- skos__hiddenLabel mesh__D016271 myc Proto Oncogene Proteins
% 211.46/211.69  |- skos__historyNote mesh__D016271 Phosphoproteins %28%1985%29%
% 211.46/211.69  |- skos__broader mesh__D016271smesh__D009687
% 211.46/211.69  |- mesh__dateCreated mesh__D016271 1990-06-19
% 211.46/211.69  |- skos__altLabel mesh__D016271 c-myc Proteins
% 211.46/211.69  |- skos__hiddenLabel mesh__D016271 L myc Proteins
% 211.46/211.69  |- skos__altLabel mesh__D016271 Proto-Oncogene Products c-myc
% 211.46/211.69  |- skos__hiddenLabel mesh__D016271 p62 c myc
% 211.46/211.69  |- skos__altLabel mesh__D016271 Proto-Oncogene Proteins myc
% 211.46/211.69  |- skos__broader mesh__D016271smesh__D011518
% 211.46/211.69  |- skos__prefLabel mesh__D016271 Proto-Oncogene Proteins c-myc
% 211.46/211.69  |- skos__scopeNote mesh__D016271
% 211.46/211.69       Cellular DNA-binding proteins encoded by the c-myc genes. They are normally involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Elevated and deregulated %28%constitutive%29% expression of c-myc proteins can cause tumorigenesis.%A%    
% 211.46/211.69  |- skos__hiddenLabel mesh__D016271 Proto Oncogene Proteins myc
% 211.46/211.69  |- mesh__recordOriginator mesh__D016271 AGS
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D016271 2006
% 211.46/211.69  |- skos__hiddenLabel mesh__D016271 myc Proto Oncogene Product p62
% 211.46/211.69  |- skos__altLabel mesh__D016271 myc Proto-Oncogene Product p62
% 211.46/211.69  |- skos__hiddenLabel mesh__D016271 Proto-Oncogene Proteins, myc
% 211.46/211.69  |- skos__hiddenLabel mesh__D016271 myc, Proto-Oncogene Proteins
% 211.46/211.69  |- skos__historyNote mesh__D016271
% 211.46/211.69       Proto-Oncogene Proteins %28%1986-1990%29%
% 211.46/211.69  |- skos__hiddenLabel mesh__D016271 c myc Proteins
% 211.46/211.69  |- skos__altLabel mesh__D016271 p62%28%c-myc%29%
% 211.46/211.69  |- rdf__type mesh__D016271sskos__Concept
% 211.46/211.69  |- mesh__dateRevised mesh__D016271 2005-06-30
% 211.46/211.69  |- skos__annotation mesh__D016271
% 211.46/211.69       /drug eff /ultrastruct permitted; DF: note short X refs   
% 211.46/211.69  |- skos__historyNote mesh__D016271 Neoplasm Proteins %28%1983-1984%29%
% 211.46/211.69  |- skos__altLabel mesh__D016271 myc Proto-Oncogene Proteins
% 211.46/211.69  |- mesh__recordMaintainer mesh__D016271 DRC
% 211.46/211.69  |- skos__hiddenLabel mesh__D016271 Proto Oncogene Products c myc
% 211.46/211.69  |- skos__hiddenLabel mesh__D016271 Proteins myc, Proto-Oncogene
% 211.46/211.69  |- mesh__recordAuthorizer mesh__D016271 sjn
% 211.46/211.69  |- skos__hiddenLabel mesh__D016271 Proto Oncogene Proteins c myc
% 211.46/211.69  |- skos__broader mesh__D016271smesh__D004268
% 211.46/211.69  |- mesh__historyNote mesh__D016271 91   
% 211.46/211.69  |- skos__hiddenLabel mesh__D016271 N myc Proteins
% 211.46/211.69  |- skos__altLabel mesh__D016271 p62 c-myc
% 211.46/211.69  |- mesh__publicMeSHNote mesh__D016271 91   
% 211.46/211.69  |- mesh__dateEstablished mesh__D016271 1991-01-01
% 211.46/211.69  |- rdf__type mesh__D002251sskos__Concept
% 211.46/211.69  |- skos__scopeNote mesh__D002251
% 211.46/211.69       A solvent for oils, fats, lacquers, varnishes, rubber waxes, and resins, and a starting material in the manufacturing of organic compounds. Poisoning by inhalation, ingestion or skin absorption is possible and may be fatal. %28%Merck Index, 11th ed%29%%A%    
% 211.46/211.69  |- skos__altLabel mesh__D002251 Tetrachloromethane
% 211.46/211.69  |- mesh__recordAuthorizer mesh__D002251 sjn
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D002251 2001
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D002251 2005
% 211.46/211.69  |- mesh__recordOriginator mesh__D002251 NLM
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D002251 2002
% 211.46/211.69  |- mesh__dateRevised mesh__D002251 2000-06-22
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D002251 2003
% 211.46/211.69  |- skos__hiddenLabel mesh__D002251 Tetrachloride, Carbon
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D002251 2006
% 211.46/211.69  |- skos__prefLabel mesh__D002251 Carbon Tetrachloride
% 211.46/211.69  |- skos__broader mesh__D002251smesh__D006843
% 211.46/211.69  |- mesh__dateCreated mesh__D002251 1999-01-01
% 211.46/211.69  |- skos__annotation mesh__D002251
% 211.46/211.69       /tox permitted but consider also CARBON TETRACHLORIDE POISONING; DF: CCL4%A%  
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D002251 2004
% 211.46/211.69  |- mesh__recordMaintainer mesh__D002251 CCR
% 211.46/211.69  |- mesh__historyNote mesh__D015977 2003%28%1990%29%   
% 211.46/211.69  |- skos__hiddenLabel mesh__D015977 Peptide Initiation Factor EIF 1
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D015977 2006
% 211.46/211.69  |- mesh__recordAuthorizer mesh__D015977 sjn
% 211.46/211.69  |- mesh__recordOriginator mesh__D015977 AGS
% 211.46/211.69  |- skos__historyNote mesh__D015977
% 211.46/211.69       Peptide Initiation Factors %28%1978-1989%29%
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D015977 2003
% 211.46/211.69  |- skos__altLabel mesh__D015977 Peptide Initiation Factor EIF-1
% 211.46/211.69  |- skos__broader mesh__D015977smesh__D039642
% 211.46/211.69  |- rdf__type mesh__D015977sskos__Concept
% 211.46/211.69  |- skos__altLabel mesh__D015977 Eukaryotic Peptide Initiation Factor-1
% 211.46/211.69  |- skos__altLabel mesh__D015977 EIF-1
% 211.46/211.69  |- skos__scopeNote mesh__D015977
% 211.46/211.69       A eukaryotic initiation factor that binds to 40S ribosomal subunits. Although initially considered a %22%non-essential%22% factor for eukaryotic transcription initiation,  eukaryotic initiation factor-1 is now thought to play an important role in localizing RIBOSOMES at the initiation codon of MRNA.%A%    
% 211.46/211.69  |- mesh__recordMaintainer mesh__D015977 jmp
% 211.46/211.69  |- skos__hiddenLabel mesh__D015977 Eukaryotic Peptide Initiation Factor 1
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D015977 2004
% 211.46/211.69  |- mesh__dateEstablished mesh__D015977 1990-01-01
% 211.46/211.69  |- mesh__publicMeSHNote mesh__D015977 2003; see EIF-1 1990-2002   
% 211.46/211.69  |- mesh__dateRevised mesh__D015977 2002-07-03
% 211.46/211.69  |- mesh__dateCreated mesh__D015977 1989-10-18
% 211.46/211.69  |- skos__prefLabel mesh__D015977 Eukaryotic Initiation Factor-1
% 211.46/211.69  |- skos__hiddenLabel mesh__D015977 Eukaryotic Initiation Factor 1
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D015977 2005
% 211.46/211.69  |- mesh__dateEstablished mesh__D015179 1989-01-01
% 211.46/211.69  |- skos__historyNote mesh__D015179 Colonic Neoplasms %28%1966-1988%29%
% 211.46/211.69  |- skos__hiddenLabel mesh__D015179 Neoplasm, Colorectal
% 211.46/211.69  |- skos__hiddenLabel mesh__D015179 Tumors, Colorectal
% 211.46/211.69  |- rdf__type mesh__D015179sskos__Concept
% 211.46/211.69  |- skos__broader mesh__D015179smesh__D012002
% 211.46/211.69  |- skos__hiddenLabel mesh__D015179 Carcinomas, Colorectal
% 211.46/211.69  |- skos__hiddenLabel mesh__D015179 Colorectal Neoplasm
% 211.46/211.69  |- mesh__dateRevised mesh__D015179 2005-06-30
% 211.46/211.69  |- skos__related mesh__D015179smesh__D016163
% 211.46/211.69  |- skos__hiddenLabel mesh__D015179 Cancers, Colorectal
% 211.46/211.69  |- skos__broader mesh__D015179smesh__D003108
% 211.46/211.69  |- skos__historyNote mesh__D015179 Rectal Neoplasms %28%1966-1988%29%
% 211.46/211.69  |- skos__broader mesh__D015179smesh__D007414
% 211.46/211.69  |- skos__hiddenLabel mesh__D015179 Colorectal Carcinomas
% 211.46/211.69  |- mesh__recordAuthorizer mesh__D015179 sjn
% 211.46/211.69  |- skos__hiddenLabel mesh__D015179 Colorectal Cancers
% 211.46/211.69  |- skos__altLabel mesh__D015179 Neoplasms, Colorectal
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D015179 2006
% 211.46/211.69  |- mesh__recordOriginator mesh__D015179 EJB
% 211.46/211.69  |- skos__altLabel mesh__D015179 Colorectal Tumors
% 211.46/211.69  |- skos__scopeNote mesh__D015179
% 211.46/211.69       Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.%A%    
% 211.46/211.69  |- skos__hiddenLabel mesh__D015179 Colorectal Tumor
% 211.46/211.69  |- skos__hiddenLabel mesh__D015179 Carcinoma, Colorectal
% 211.46/211.69  |- mesh__historyNote mesh__D015179 89   
% 211.46/211.69  |- mesh__dateCreated mesh__D015179 1988-04-14
% 211.46/211.69  |- skos__prefLabel mesh__D015179 Colorectal Neoplasms
% 211.46/211.69  |- skos__hiddenLabel mesh__D015179 Cancer, Colorectal
% 211.46/211.69  |- mesh__recordMaintainer mesh__D015179 ags
% 211.46/211.69  |- skos__annotation mesh__D015179
% 211.46/211.69       a clinical entity: not a synonym for COLONIC NEOPLASMS + RECTAL NEOPLASMS; coord IM with histol type of neopl %28%IM%29%; GENES, DCC %28%for %22%Deleted in Colorectal Cancer%22%%29% %26% GENES, MCC %28%for %22%Mutated in Colorectal Cancer%22%%29% are available: see MeSH scope notes and annotations there%A%  
% 211.46/211.69  |- skos__related mesh__D015179smesh__D017431
% 211.46/211.69  |- mesh__publicMeSHNote mesh__D015179 89   
% 211.46/211.69  |- skos__hiddenLabel mesh__D015179 Tumor, Colorectal
% 211.46/211.69  |- mesh__dateCreated mesh__D001957 1999-01-01
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001957 2003
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001957 2006
% 211.46/211.69  |- skos__scopeNote mesh__D001957
% 211.46/211.69       Published pieces of paper or other material, usually printed on one side and intended to be read unfolded and usually intended to be posted, publicly distributed, or sold. %28%From Genre Terms: A Thesaurus for Use in Rare Book and Special Collections Cataloguing, 2d ed%29%%A%    
% 211.46/211.69  |- mesh__recordMaintainer mesh__D001957 sjn
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001957 2004
% 211.46/211.69  |- mesh__dateRevised mesh__D001957 2002-07-24
% 211.46/211.69  |- mesh__recordAuthorizer mesh__D001957 sjn
% 211.46/211.69  |- skos__prefLabel mesh__D001957 Broadsides
% 211.46/211.69  |- skos__broader mesh__D001957smesh__D011642
% 211.46/211.69  |- skos__annotation mesh__D001957
% 211.46/211.69       IM; coord with subject %28%IM%29%; do not confuse with Publication  Type BROADSIDES%A%  
% 211.46/211.69  |- mesh__recordOriginator mesh__D001957 NLM
% 211.46/211.69  |- rdf__type mesh__D001957sskos__Concept
% 211.46/211.69  |- skos__hiddenLabel mesh__D001957 Broadside
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001957 2005
% 211.46/211.69  |- mesh__dateRevised mesh__D001159 1999-11-08
% 211.46/211.69  |- skos__hiddenLabel mesh__D001159 Arterio Arterial Fistula
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001159 2000
% 211.46/211.69  |- mesh__dateEstablished mesh__D001159 1987-01-01
% 211.46/211.69  |- skos__scopeNote mesh__D001159
% 211.46/211.69       Abnormal communication between two arteries that may result from injury or occur as a congenital abnormality.%A%    
% 211.46/211.69  |- skos__annotation mesh__D001159
% 211.46/211.69       coord IM with specific arteries %28%IM%29% or precoord artery/dis term %28%IM%29%; if congenital use /abnorm on the arteries and /congen on the artery/dis term and fistula%A%  
% 211.46/211.69  |- mesh__publicMeSHNote mesh__D001159 87   
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001159 2005
% 211.46/211.69  |- mesh__dateCreated mesh__D001159 1986-04-18
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001159 2004
% 211.46/211.69  |- skos__hiddenLabel mesh__D001159 Fistula, Arterio-Arterial
% 211.46/211.69  |- skos__prefLabel mesh__D001159 Arterio-Arterial Fistula
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001159 2001
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001159 2006
% 211.46/211.69  |- rdf__type mesh__D001159sskos__Concept
% 211.46/211.69  |- mesh__historyNote mesh__D001159 87   
% 211.46/211.69  |- mesh__recordAuthorizer mesh__D001159 sjn
% 211.46/211.69  |- skos__broader mesh__D001159smesh__D016157
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001159 2002
% 211.46/211.69  |- skos__hiddenLabel mesh__D001159 Fistulas, Arterio-Arterial
% 211.46/211.69  |- skos__historyNote mesh__D001159 specific arteries %28%1966-1986%29%
% 211.46/211.69  |- skos__hiddenLabel mesh__D001159 Arterio-Arterial Fistulas
% 211.46/211.69  |- mesh__recordOriginator mesh__D001159 VDK
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D001159 2003
% 211.46/211.69  |- skos__broader mesh__D001159smesh__D018376
% 211.46/211.69  |- mesh__recordMaintainer mesh__D001159 KEV
% 211.46/211.69  |- mesh__dateEstablished mesh__D006642 1991-01-01
% 211.46/211.69  |- mesh__publicMeSHNote mesh__D006642
% 211.46/211.69       94; was HISTIDINOLPHOSPHATASE 1975-93 %28%see under PHOSPHOMONOESTERASES 1975-90%29%%A%  
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D006642 2005
% 211.46/211.69  |- mesh__dateCreated mesh__D006642 1974-11-19
% 211.46/211.69  |- mesh__recordMaintainer mesh__D006642 ssb
% 211.46/211.69  |- skos__scopeNote mesh__D006642
% 211.46/211.69       An enzyme that catalyzes the hydrolysis of histidinol-phosphate to histidinol. One of the regulatory enzymes in histidine biosynthesis. EC 3.1.3.15.%A%    
% 211.46/211.69  |- mesh__historyNote mesh__D006642
% 211.46/211.69       94; was HISTIDINOLPHOSPHATASE 1975-93 %28%see under PHOSPHOMONOESTERASES 1975-90%29%%A%  
% 211.46/211.69  |- skos__historyNote mesh__D006642 Imidazoles %28%1972-1974%29%
% 211.46/211.69  |- skos__historyNote mesh__D006642 Amino Alcohols %28%1972-1974%29%
% 211.46/211.69  |- skos__altLabel mesh__D006642 Histidinolphosphatase
% 211.46/211.69  |- mesh__dateRevised mesh__D006642 2003-07-09
% 211.46/211.69  |- skos__altLabel mesh__D006642 Histidinol Phosphate Phosphatase
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D006642 2006
% 211.46/211.69  |- mesh__recordOriginator mesh__D006642 NLM
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D006642 2004
% 211.46/211.69  |- skos__prefLabel mesh__D006642 Histidinol-Phosphatase
% 211.46/211.69  |- mesh__recordAuthorizer mesh__D006642 sjn
% 211.46/211.69  |- mesh__onlineNote mesh__D006642
% 211.46/211.69       use HISTIDINOL-PHOSPHATASE to search HISTIDINOLPHOSPHATASE 1975-93%A%  
% 211.46/211.69  |- skos__historyNote mesh__D006642 Phosphatases %28%1973-1974%29%
% 211.46/211.69  |- skos__broader mesh__D006642smesh__D010744
% 211.46/211.69  |- rdf__type mesh__D006642sskos__Concept
% 211.46/211.69  |- mesh__recordOriginator mesh__D020313 ADP
% 211.46/211.69  |- mesh__recordAuthorizer mesh__D020313 ags
% 211.46/211.69  |- mesh__publicMeSHNote mesh__D020313
% 211.46/211.69       2004; see USES OF CHEMICALS AND DRUGS 1999-2003 and SPECIALTY CHEMICALS AND PRODUCTS 1975-2003%A%  
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D020313 2006A
% 211.46/211.69  |- skos__altLabel mesh__D020313 Specialty Chemicals and Products
% 211.46/211.69  |- mesh__historyNote mesh__D020313 2004%28%1999%29%   
% 211.46/211.69  |- rdf__type mesh__D020313sskos__Concept
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D020313 2005
% 211.46/211.69  |- mesh__dateEstablished mesh__D020313 1999-01-01
% 211.46/211.69  |- skos__broader mesh__D020313smesh__D020164
% 211.46/211.69  |- mesh__dateCreated mesh__D020313 1998-06-11
% 211.46/211.69  |- skos__scopeNote mesh__D020313
% 211.46/211.69       Uses of chemicals in a research, industrial, or household setting. This does not include PHARMACOLOGIC ACTIONS.%A%    
% 211.46/211.69  |- skos__prefLabel mesh__D020313 Specialty Uses of Chemicals
% 211.46/211.69  |- mesh__recordMaintainer mesh__D020313 ags
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D020313 2006
% 211.46/211.69  |- mesh__dateRevised mesh__D020313 2005-07-22
% 211.46/211.69  |- skos__annotation mesh__D020313
% 211.46/211.69       not used for indexing      CATALOG: do not use   
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D020313 2004
% 211.46/211.69  |- skos__hiddenLabel mesh__D011587 Comparative Psychologies
% 211.46/211.69  |- skos__broader mesh__D011587smesh__D011584
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011587 2001
% 211.46/211.69  |- skos__altLabel mesh__D011587 Comparative Psychology
% 211.46/211.69  |- mesh__recordOriginator mesh__D011587 NLM
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011587 2006
% 211.46/211.69  |- mesh__recordMaintainer mesh__D011587 TGC
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011587 2000
% 211.46/211.69  |- skos__annotation mesh__D011587
% 211.46/211.69       SPEC: IM, SPEC qualif; NIM coord, no qualif; do not check COMPARATIVE STUDY for as a field it is not a substitute for a comparison of two or more psychol concepts %28% = COMPARATIVE STUDY tag%29%: Manual 18.13.4; DF: PSYCHOL COMPARATIVE%A%  
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011587 1995
% 211.46/211.69  |- mesh__dateCreated mesh__D011587 1999-01-01
% 211.46/211.69  |- skos__scopeNote mesh__D011587
% 211.46/211.69       The branch of psychology concerned with similarities or differences in the behavior of different animal species or of different races or peoples.%A%    
% 211.46/211.69  |- rdf__type mesh__D011587sskos__Concept
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011587 2005
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011587 1999
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011587 1994
% 211.46/211.69  |- mesh__recordAuthorizer mesh__D011587 PLS
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011587 2004
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011587 1993
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011587 1998
% 211.46/211.69  |- skos__prefLabel mesh__D011587 Psychology, Comparative
% 211.46/211.69  |- mesh__activeMeSHYear mesh__D011587 2003
% 211.55/211.69  |- mesh__dateRevised mesh__D011587 1991-06-28
% 211.55/211.69  |- mesh__activeMeSHYear mesh__D011587 1992
% 211.55/211.69  |- mesh__activeMeSHYear mesh__D011587 1997
% 211.55/211.69  |- skos__hiddenLabel mesh__D011587 Psychologies, Comparative
% 211.55/211.69  |- mesh__activeMeSHYear mesh__D011587 2002
% 211.55/211.69  |- mesh__activeMeSHYear mesh__D011587 1996
% 211.55/211.69  |- mesh__historyNote mesh__D030741 2002   
% 211.55/211.69  |- mesh__dateCreated mesh__D030741 2001-07-25
% 211.55/211.69  |- mesh__activeMeSHYear mesh__D030741 2005
% 211.55/211.69  |- mesh__activeMeSHYear mesh__D030741 2004
% 211.55/211.69  |- mesh__publicMeSHNote mesh__D030741 2002   
% 211.55/211.69  |- skos__scopeNote mesh__D030741
% 211.55/211.69       A membrane-bound carbonic anhydrase found in lung capillaries and kidney.%A%    
% 211.55/211.69  |- skos__hiddenLabel mesh__D030741 Anhydrase 4, Carbonic
% 211.55/211.69  |- mesh__activeMeSHYear mesh__D030741 2006
% 211.55/211.69  |- rdf__type mesh__D030741sskos__Concept
% 211.55/211.69  |- mesh__dateEstablished mesh__D030741 2002-01-01
% 211.55/211.69  |- skos__altLabel mesh__D030741 Carbonic Anhydrase Isozyme IV
% 211.55/211.69  |- skos__altLabel mesh__D030741 Carbonic Anhydrase 4
% 211.55/211.69  |- mesh__dateRevised mesh__D030741 2003-07-09
% 211.55/211.69  |- skos__historyNote mesh__D030741 Carbonic Anhydrases %28%1990-2001%29%
% 211.55/211.69  |- skos__prefLabel mesh__D030741 Carbonic Anhydrase IV
% 211.55/211.69  |- skos__broader mesh__D030741smesh__D002256
% 211.55/211.69  |- skos__annotation mesh__D030741
% 211.55/211.69       /antag: coord with CARBONIC ANHYDRASE INHIBITORS   
% 211.55/211.69  |- mesh__recordAuthorizer mesh__D016272 sjn
% 211.55/211.69  |- mesh__recordMaintainer mesh__D016272 kle
% 211.55/211.69  |- skos__scopeNote mesh__D016272
% 211.55/211.69       The promotion and maintenance of physical and mental health in the work environment.%A%    
% 211.55/211.69  |- mesh__recordOriginator mesh__D016272 PXP
% 211.55/211.69  |- skos__historyNote mesh__D016272 Occupational Medicine %28%1966-1990%29%
% 211.55/211.69  |- mesh__publicMeSHNote mesh__D016272 91   
% 211.55/211.69  |- mesh__activeMeSHYear mesh__D016272 2006
% 211.55/211.69  |- skos__altLabel mesh__D016272 Occupational Safety
% 211.55/211.69  |- skos__altLabel mesh__D016272 Industrial Health
% 211.55/211.69  |- mesh__dateRevised mesh__D016272 1999-11-03
% 211.55/211.69  |- mesh__dateCreated mesh__D016272 1990-05-29
% 211.55/211.70  |- skos__broader mesh__D016272smesh__D006262
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D016272 2005
% 211.55/211.70  |- rdf__type mesh__D016272sskos__Concept
% 211.55/211.70  |- skos__hiddenLabel mesh__D016272 Health, Employee
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D016272 2002
% 211.55/211.70  |- skos__historyNote mesh__D016272
% 211.55/211.70       Occupational Health Services %28%1968-1990%29%
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D016272 2004
% 211.55/211.70  |- skos__prefLabel mesh__D016272 Occupational Health
% 211.55/211.70  |- skos__annotation mesh__D016272
% 211.55/211.70       %22%promotion %26% maintenance of physical %26% mental health in the work environment%22%: do not confuse with OCCUPATIONAL MEDICINE %28%the specialty%29% or OCCUPATIONAL HEALTH SERVICES; note X ref OCCUPATIONAL SAFETY which is GEN only: do not use as coord for safety in an industrial milieu %28% = SAFETY + specific indust or occup heading%29%; DF: OCCUP HEALTH%A%  
% 211.55/211.70  |- skos__altLabel mesh__D016272 Health, Industrial
% 211.55/211.70  |- mesh__historyNote mesh__D016272 91   
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D016272 2001
% 211.55/211.70  |- skos__historyNote mesh__D016272
% 211.55/211.70       Occupational Health Nursing %28%1966-1990%29%
% 211.55/211.70  |- mesh__dateEstablished mesh__D016272 1991-01-01
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D016272 2003
% 211.55/211.70  |- skos__hiddenLabel mesh__D016272 Health, Occupational
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D016272 2000
% 211.55/211.70  |- skos__altLabel mesh__D016272 Hygiene, Industrial
% 211.55/211.70  |- skos__altLabel mesh__D002252 CCl4 Poisoning
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D002252 2002
% 211.55/211.70  |- skos__hiddenLabel mesh__D002252 CCl4 Poisonings
% 211.55/211.70  |- skos__hiddenLabel mesh__D002252 Carbon Tetrachloride Poisonings
% 211.55/211.70  |- rdf__type mesh__D002252sskos__Concept
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D002252 2001
% 211.55/211.70  |- skos__prefLabel mesh__D002252 Carbon Tetrachloride Poisoning
% 211.55/211.70  |- skos__altLabel mesh__D002252 Poisoning, Carbon Tetrachloride
% 211.55/211.70  |- skos__hiddenLabel mesh__D002252 Poisonings, Carbon Tetrachloride
% 211.55/211.70  |- mesh__dateCreated mesh__D002252 1999-01-01
% 211.55/211.70  |- mesh__recordAuthorizer mesh__D002252 sjn
% 211.55/211.70  |- skos__broader mesh__D002252smesh__D011041
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D002252 2000
% 211.55/211.70  |- mesh__recordOriginator mesh__D002252 NLM
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D002252 2004
% 211.55/211.70  |- mesh__dateRevised mesh__D002252 1999-11-03
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D002252 2006
% 211.55/211.70  |- skos__annotation mesh__D002252 DF: CCL4 POIS   
% 211.55/211.70  |- mesh__recordMaintainer mesh__D002252 ags
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D002252 2003
% 211.55/211.70  |- skos__altLabel mesh__D002252 Poisoning, CCl4
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D002252 2005
% 211.55/211.70  |- skos__hiddenLabel mesh__D015978 alpha Trichosanthin
% 211.55/211.70  |- skos__hiddenLabel mesh__D015978 GLQ 223
% 211.55/211.70  |- mesh__dateRevised mesh__D015978 2004-07-07
% 211.55/211.70  |- skos__altLabel mesh__D015978 Compound Q
% 211.55/211.70  |- rdf__type mesh__D015978sskos__Concept
% 211.55/211.70  |- skos__altLabel mesh__D015978 GLQ223
% 211.55/211.70  |- mesh__dateCreated mesh__D015978 1989-05-25
% 211.55/211.70  |- skos__altLabel mesh__D015978 T%27%ien-hua-fen
% 211.55/211.70  |- skos__annotation mesh__D015978 /drug eff /ultrastruct permitted   
% 211.55/211.70  |- skos__scopeNote mesh__D015978
% 211.55/211.70       Plant-derived ribosome-inactivating protein %28%RIP%29% purified from the Chinese medicinal herb tian-hua-fen which is obtained from the root tubers of Trichosanthes kirilowii. It has been used as an abortifacient and in the treatment of trophoblastic tumors. GLQ223 %28%Compound Q%29%, a highly purified form of trichosanthin, has been proposed as antiviral treatment for AIDS.%A%    
% 211.55/211.70  |- mesh__recordAuthorizer mesh__D015978 sjn
% 211.55/211.70  |- mesh__recordOriginator mesh__D015978 AGS
% 211.55/211.70  |- mesh__recordMaintainer mesh__D015978 jmp
% 211.55/211.70  |- skos__historyNote mesh__D015978
% 211.55/211.70       Abortifacient Agents, Non-Steroidal %28%1977-1989%29%
% 211.55/211.70  |- skos__altLabel mesh__D015978 alpha-Trichosanthin
% 211.55/211.70  |- mesh__historyNote mesh__D015978 90   
% 211.55/211.70  |- mesh__dateEstablished mesh__D015978 1990-01-01
% 211.55/211.70  |- mesh__publicMeSHNote mesh__D015978 90   
% 211.55/211.70  |- skos__prefLabel mesh__D015978 Trichosanthin
% 211.55/211.70  |- skos__historyNote mesh__D015978 Plant Proteins %28%1976-1989%29%
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D015978 2005
% 211.55/211.70  |- skos__broader mesh__D015978smesh__D010940
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D015978 2006
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D001958 2002
% 211.55/211.70  |- skos__prefLabel mesh__D001958 Brocresine
% 211.55/211.70  |- skos__scopeNote mesh__D001958 A histidine decarboxylase inhibitor.     
% 211.55/211.70  |- skos__historyNote mesh__D001958 Cresols %28%1968-1974%29%
% 211.55/211.70  |- mesh__recordOriginator mesh__D001958 SJJ
% 211.55/211.70  |- mesh__publicMeSHNote mesh__D001958 91; was see under CRESOLS 1975-90   
% 211.55/211.70  |- skos__historyNote mesh__D001958 Hydroxylamines %28%1971-1974%29%
% 211.55/211.70  |- skos__hiddenLabel mesh__D001958 NSD1055
% 211.55/211.70  |- rdf__type mesh__D001958sskos__Concept
% 211.55/211.70  |- mesh__dateRevised mesh__D001958 2000-06-22
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D001958 2005
% 211.55/211.70  |- mesh__historyNote mesh__D001958
% 211.55/211.70       91%28%75%29%; was see under CRESOLS 1975-90   
% 211.55/211.70  |- mesh__dateCreated mesh__D001958 1974-11-19
% 211.55/211.70  |- mesh__recordMaintainer mesh__D001958 CCR
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D001958 2003
% 211.55/211.70  |- mesh__dateEstablished mesh__D001958 1991-01-01
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D001958 2006
% 211.55/211.70  |- skos__hiddenLabel mesh__D001958 NSD 1055
% 211.55/211.70  |- skos__broader mesh__D001958smesh__D003408
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D001958 2001
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D001958 2004
% 211.55/211.70  |- mesh__recordAuthorizer mesh__D001958 sjn
% 211.55/211.70  |- rdf__type mesh__D012680sskos__Concept
% 211.55/211.70  |- skos__broader mesh__D012680smesh__D013223
% 211.55/211.70  |- mesh__onlineNote mesh__D012680
% 211.55/211.70       use SENSITIVITY AND SPECIFICITY to search SENSITIVITY AND SPECIFICITY %28%EPIDEMIOLOGY%29% 1987-90%A%  
% 211.55/211.70  |- skos__scopeNote mesh__D012680
% 211.55/211.70       Measures for assessing the results of diagnostic and screening tests. Sensitivity represents the proportion of truly diseased persons in a screened population who are identified as being diseased by the test. It is a measure of the probability of correctly diagnosing a condition. Specificity is the proportion of truly nondiseased persons who are so identified by the screening test. It is a measure of the probability of correctly identifying a nondiseased person. %28%From Last, Dictionary of Epidemiology, 2d ed%29%%A%    
% 211.55/211.70  |- mesh__historyNote mesh__D012680
% 211.55/211.70       91; was SENSITIVITY AND SPECIFICITY %28%EPIDEMIOLOGY%29% 1987-90%A%  
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D012680 2006
% 211.55/211.70  |- mesh__dateCreated mesh__D012680 1986-03-25
% 211.55/211.70  |- mesh__dateEstablished mesh__D012680 1987-01-01
% 211.55/211.70  |- skos__related mesh__D012680smesh__D019937
% 211.55/211.70  |- skos__hiddenLabel mesh__D012680 Specificity and Sensitivity
% 211.55/211.70  |- skos__prefLabel mesh__D012680 Sensitivity and Specificity
% 211.55/211.70  |- mesh__dateRevised mesh__D012680 2005-06-30
% 211.55/211.70  |- mesh__recordOriginator mesh__D012680 EC
% 211.55/211.70  |- mesh__recordAuthorizer mesh__D012680 sjn
% 211.55/211.70  |- mesh__recordMaintainer mesh__D012680 ssb
% 211.55/211.70  |- skos__broader mesh__D012680smesh__D015340
% 211.55/211.70  |- skos__annotation mesh__D012680
% 211.55/211.70       IM general only; coordinate %28%NIM%29% with specific concept %28%IM%29%%A%  
% 211.55/211.70  |- mesh__publicMeSHNote mesh__D012680
% 211.55/211.70       91; was SENSITIVITY AND SPECIFICITY %28%EPIDEMIOLOGY%29% 1987-90%A%  
% 211.55/211.70  |- skos__hiddenLabel mesh__D006643 Histidyl tRNA Synthetase
% 211.55/211.70  |- skos__altLabel mesh__D006643 Histidyl T RNA Synthetase
% 211.55/211.70  |- skos__prefLabel mesh__D006643 Histidine-tRNA Ligase
% 211.55/211.70  |- skos__historyNote mesh__D006643
% 211.55/211.70       Amino Acyl T RNA Synthetases %28%1972-1974%29%
% 211.55/211.70  |- mesh__dateRevised mesh__D006643 2003-07-09
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D006643 2006
% 211.55/211.70  |- mesh__publicMeSHNote mesh__D006643
% 211.55/211.70       98; see HISTIDYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASE 1975-90%A%  
% 211.55/211.70  |- skos__hiddenLabel mesh__D006643 Antigen, Jo-1
% 211.55/211.70  |- mesh__historyNote mesh__D006643 98%28%75%29%   
% 211.55/211.70  |- skos__scopeNote mesh__D006643
% 211.55/211.70       An enzyme that activates histidine with its specific transfer RNA. EC 6.1.1.21.%A%    
% 211.55/211.70  |- skos__hiddenLabel mesh__D006643 His tRNA Ligase
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D006643 2004
% 211.55/211.70  |- mesh__dateCreated mesh__D006643 1974-11-19
% 211.55/211.70  |- mesh__recordMaintainer mesh__D006643 ssb
% 211.55/211.70  |- skos__altLabel mesh__D006643 His-tRNA Ligase
% 211.55/211.70  |- skos__hiddenLabel mesh__D006643 Histidine tRNA Ligase
% 211.55/211.70  |- skos__altLabel mesh__D006643 Jo-1 Antigen
% 211.55/211.70  |- skos__broader mesh__D006643smesh__D000604
% 211.55/211.70  |- mesh__recordOriginator mesh__D006643 NLM
% 211.55/211.70  |- skos__hiddenLabel mesh__D006643 Ligase, Histidine-tRNA
% 211.55/211.70  |- rdf__type mesh__D006643sskos__Concept
% 211.55/211.70  |- skos__hiddenLabel mesh__D006643 Synthetase, Histidyl-tRNA
% 211.55/211.70  |- skos__hiddenLabel mesh__D006643 Jo 1 Antigen
% 211.55/211.70  |- mesh__dateEstablished mesh__D006643 1991-01-01
% 211.55/211.70  |- mesh__recordAuthorizer mesh__D006643 sjn
% 211.55/211.70  |- skos__altLabel mesh__D006643 Histidyl-tRNA Synthetase
% 211.55/211.70  |- skos__historyNote mesh__D006643 Histidine %28%1972-1974%29%
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D006643 2005
% 211.55/211.70  |- skos__hiddenLabel mesh__D006643 Ligase, His-tRNA
% 211.55/211.70  |- skos__scopeNote mesh__D020314
% 211.55/211.70       MYCOSES of the brain, spinal cord, and meninges which may result in ENCEPHALITIS; MENINGITIS, FUNGAL; MYELITIS; BRAIN ABSCESS; and EPIDURAL ABSCESS. Certain types of fungi may produce disease in immunologically normal hosts, while others are classified as opportunistic pathogens, causing illness primarily in immunocompromised individuals %28%e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME%29%.%A%    
% 211.55/211.70  |- skos__broader mesh__D020314smesh__D009181
% 211.55/211.70  |- rdf__type mesh__D020314sskos__Concept
% 211.55/211.70  |- skos__prefLabel mesh__D020314 Central Nervous System Fungal Infections
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D020314 2000
% 211.55/211.70  |- skos__altLabel mesh__D020314 Fungal Infections, Central Nervous System
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D020314 2005
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D020314 2003
% 211.55/211.70  |- mesh__historyNote mesh__D020314 2000   
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D020314 2006
% 211.55/211.70  |- mesh__publicMeSHNote mesh__D020314 2000   
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D020314 2001
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D020314 2004
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D020314 2002
% 211.55/211.70  |- skos__altLabel mesh__D020314 Mycoses, Central Nervous System
% 211.55/211.70  |- skos__annotation mesh__D020314
% 211.55/211.70       coord IM with precoord fungal infection %28%IM%29% and specific site/dis term %28%IM%29% if pertinent; DF: CNS FUNGAL INFECT%A%  
% 211.55/211.70  |- skos__altLabel mesh__D020314 Infections, Fungal, Central Nervous System
% 211.55/211.70  |- skos__altLabel mesh__D020314 Central Nervous System Mycoses
% 211.55/211.70  |- skos__broader mesh__D020314smesh__D002494
% 211.55/211.70  |- mesh__dateEstablished mesh__D020314 2000-01-01
% 211.55/211.70  |- mesh__dateCreated mesh__D020314 1999-11-04
% 211.55/211.70  |- skos__scopeNote mesh__D044762
% 211.55/211.70       A genus of ALGAE in the family Saprolegniaceae. It is a parasite and pathogen of freshwater FISHES.%A%    
% 211.55/211.70  |- mesh__recordOriginator mesh__D044762 ags
% 211.55/211.70  |- skos__broader mesh__D044762smesh__D009868
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D044762 2006
% 211.55/211.70  |- mesh__recordAuthorizer mesh__D044762 sjn
% 211.55/211.70  |- skos__annotation mesh__D044762
% 211.55/211.70       infection: coord IM with INFECTION %28%IM%29%   
% 211.55/211.70  |- skos__prefLabel mesh__D044762 Saprolegnia
% 211.55/211.70  |- skos__historyNote mesh__D044762 Fungi %28%1968-1983%29%
% 211.55/211.70  |- rdf__type mesh__D044762sskos__Concept
% 211.55/211.70  |- mesh__historyNote mesh__D044762 2004   
% 211.55/211.70  |- mesh__dateCreated mesh__D044762 2003-07-09
% 211.55/211.70  |- mesh__recordMaintainer mesh__D044762 SYSTEM
% 211.55/211.70  |- mesh__dateRevised mesh__D044762 2005-06-30
% 211.55/211.70  |- mesh__publicMeSHNote mesh__D044762 2004   
% 211.55/211.70  |- mesh__dateEstablished mesh__D044762 2004-01-01
% 211.55/211.70  |- skos__historyNote mesh__D044762 Oomycetes %28%1977-2003%29%
% 211.55/211.70  |- skos__broader mesh__D011588smesh__D011585
% 211.55/211.70  |- skos__hiddenLabel mesh__D011588 Psychologies, Educational
% 211.55/211.70  |- mesh__recordMaintainer mesh__D011588 TGC
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D011588 2006
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D011588 1995
% 211.55/211.70  |- mesh__dateCreated mesh__D011588 1999-01-01
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D011588 2002
% 211.55/211.70  |- skos__prefLabel mesh__D011588 Psychology, Educational
% 211.55/211.70  |- rdf__type mesh__D011588sskos__Concept
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D011588 2005
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D011588 1999
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D011588 1994
% 211.55/211.70  |- skos__hiddenLabel mesh__D011588 Educational Psychologies
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D011588 2001
% 211.55/211.70  |- skos__altLabel mesh__D011588 Educational Psychology
% 211.55/211.70  |- skos__annotation mesh__D011588 SPEC: SPEC qualif; DF: PSYCHOL EDUC   
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D011588 2004
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D011588 1993
% 211.55/211.70  |- mesh__recordOriginator mesh__D011588 NLM
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D011588 1998
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D011588 2000
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D011588 2003
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D011588 1992
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D011588 1997
% 211.55/211.70  |- mesh__recordAuthorizer mesh__D011588 PLS
% 211.55/211.70  |- skos__scopeNote mesh__D011588
% 211.55/211.70       The branch of psychology concerned with psychological aspects of teaching and the formal learning process in school.%A%    
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D011588 1996
% 211.55/211.70  |- skos__broader mesh__D011588smesh__D011584
% 211.55/211.70  |- mesh__dateRevised mesh__D011588 1991-06-28
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D016273 2005
% 211.55/211.70  |- rdf__type mesh__D016273sskos__Concept
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D016273 2001
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D016273 1996
% 211.55/211.70  |- skos__historyNote mesh__D016273 Environmental Exposure %28%1967-1990%29%
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D016273 2004
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D016273 2000
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D016273 2003
% 211.55/211.70  |- skos__annotation mesh__D016273
% 211.55/211.70       coord IM with specific occup dis %28%IM%29% or specific occupation %28%IM%29%; DF: OCCUP EXPOSURE%A%  
% 211.55/211.70  |- mesh__historyNote mesh__D016273
% 211.55/211.70       91; was see ENVIRONMENTAL EXPOSURE 1989-90   
% 211.55/211.70  |- skos__related mesh__D016273smesh__D018777
% 211.55/211.70  |- mesh__publicMeSHNote mesh__D016273
% 211.55/211.70       91; was see ENVIRONMENTAL EXPOSURE 1989-90   
% 211.55/211.70  |- mesh__dateEstablished mesh__D016273 1991-01-01
% 211.55/211.70  |- mesh__recordAuthorizer mesh__D016273 PLS
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D016273 1999
% 211.55/211.70  |- skos__historyNote mesh__D016273 Occupational Diseases %28%1966-1989%29%
% 211.55/211.70  |- mesh__dateRevised mesh__D016273 1995-05-18
% 211.55/211.70  |- mesh__onlineNote mesh__D016273
% 211.55/211.70       use ENVIRONMENTAL EXPOSURE to search OCCUPATIONAL EXPOSURE 1989-90%A%  
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D016273 1998
% 211.55/211.70  |- mesh__recordMaintainer mesh__D016273 KEV
% 211.55/211.70  |- skos__broader mesh__D016273smesh__D004781
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D016273 2006
% 211.55/211.70  |- skos__hiddenLabel mesh__D016273 Exposures, Occupational
% 211.55/211.70  |- skos__scopeNote mesh__D016273
% 211.55/211.70       The exposure to potentially harmful chemical, physical, or biological agents that occurs as a result of one%27%s occupation.%A%    
% 211.55/211.70  |- skos__prefLabel mesh__D016273 Occupational Exposure
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D016273 2002
% 211.55/211.70  |- skos__altLabel mesh__D016273 Exposure, Occupational
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D016273 1997
% 211.55/211.70  |- mesh__recordOriginator mesh__D016273 PXP
% 211.55/211.70  |- skos__hiddenLabel mesh__D016273 Occupational Exposures
% 211.55/211.70  |- mesh__dateCreated mesh__D016273 1990-05-29
% 211.55/211.70  |- skos__related mesh__D016273smesh__D000395
% 211.55/211.70  |- mesh__dateEstablished mesh__D002253 1991-01-01
% 211.55/211.70  |- mesh__historyNote mesh__D002253
% 211.55/211.70       91%28%75%29%; was see under BEVERAGES 1975-90   
% 211.55/211.70  |- rdf__type mesh__D002253sskos__Concept
% 211.55/211.70  |- skos__broader mesh__D002253smesh__D001628
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D002253 1999
% 211.55/211.70  |- mesh__recordMaintainer mesh__D002253 JLS
% 211.55/211.70  |- skos__scopeNote mesh__D002253
% 211.55/211.70       Drinkable liquids combined with or impregnated with carbon dioxide.%A%    
% 211.55/211.70  |- mesh__dateCreated mesh__D002253 1999-01-01
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D002253 2002
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D002253 1998
% 211.55/211.70  |- mesh__recordAuthorizer mesh__D002253 SJN
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D002253 2004
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D002253 2001
% 211.55/211.70  |- mesh__publicMeSHNote mesh__D002253
% 211.55/211.70       91; was see under BEVERAGES 1975-90   
% 211.55/211.70  |- mesh__dateRevised mesh__D002253 1997-06-20
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D002253 2006
% 211.55/211.70  |- skos__prefLabel mesh__D002253 Carbonated Beverages
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D002253 2003
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D002253 2005
% 211.55/211.70  |- skos__hiddenLabel mesh__D002253 Carbonated Beverage
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D002253 2000
% 211.55/211.70  |- mesh__onlineNote mesh__D002253 search BEVERAGES 1966-74   
% 211.55/211.70  |- mesh__recordOriginator mesh__D002253 NLM
% 211.55/211.70  |- skos__hiddenLabel mesh__D002253 Beverages, Carbonated
% 211.55/211.70  |- skos__hiddenLabel mesh__D002253 Beverage, Carbonated
% 211.55/211.70  |- skos__hiddenLabel mesh__D015979 Cells, LAK
% 211.55/211.70  |- skos__annotation mesh__D015979
% 211.55/211.70       A 11 qualif; subpopulations: coord IM with LYMPHOCYTE SUBSETS %28%IM%29%; DF: note short X ref%A%  
% 211.55/211.70  |- skos__hiddenLabel mesh__D015979 LAK Cell
% 211.55/211.70  |- skos__hiddenLabel mesh__D015979 Killer Cells, Lymphokine Activated
% 211.55/211.70  |- skos__hiddenLabel mesh__D015979 Killer Cell, Lymphokine-Activated
% 211.55/211.70  |- skos__historyNote mesh__D015979 Killer Cells, Natural %28%1982-1989%29%
% 211.55/211.70  |- skos__prefLabel mesh__D015979 Killer Cells, Lymphokine-Activated
% 211.55/211.70  |- mesh__dateRevised mesh__D015979 2003-07-09
% 211.55/211.70  |- skos__hiddenLabel mesh__D015979 Lymphokine-Activated Killer Cell
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D015979 2006
% 211.55/211.70  |- skos__scopeNote mesh__D015979
% 211.55/211.70       Cytolytic lymphocytes with the unique capacity of killing natural killer %28%NK%29%-resistant fresh tumor cells. They are interleukin-2-activated NK cells that have no MHC %28%major histocompatibility complex%29% restriction or need for antigen stimulation. LAK cells are used for adoptive immunotherapy in cancer patients.%A%    
% 211.55/211.70  |- mesh__recordOriginator mesh__D015979 AGS
% 211.55/211.70  |- skos__related mesh__D015979smesh__D016219
% 211.55/211.70  |- skos__altLabel mesh__D015979 Lymphokine-Activated Killer Cells
% 211.55/211.70  |- skos__broader mesh__D015979smesh__D007694
% 211.55/211.70  |- mesh__historyNote mesh__D015979 90   
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D015979 2005
% 211.55/211.70  |- skos__hiddenLabel mesh__D015979 Cell, Lymphokine-Activated Killer
% 211.55/211.70  |- skos__hiddenLabel mesh__D015979 Cells, Lymphokine-Activated Killer
% 211.55/211.70  |- mesh__recordMaintainer mesh__D015979 jmp
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D015979 2004
% 211.55/211.70  |- rdf__type mesh__D015979sskos__Concept
% 211.55/211.70  |- skos__related mesh__D015979smesh__D007376
% 211.55/211.70  |- mesh__dateEstablished mesh__D015979 1990-01-01
% 211.55/211.70  |- skos__altLabel mesh__D015979 LAK Cells
% 211.55/211.70  |- skos__hiddenLabel mesh__D015979 Cell, LAK
% 211.55/211.70  |- skos__hiddenLabel mesh__D015979 Lymphokine Activated Killer Cells
% 211.55/211.70  |- mesh__recordAuthorizer mesh__D015979 sjn
% 211.55/211.70  |- mesh__dateCreated mesh__D015979 1989-06-26
% 211.55/211.70  |- mesh__publicMeSHNote mesh__D015979 90   
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D001959 2001A
% 211.55/211.70  |- mesh__publicMeSHNote mesh__D001959 91; was see under BROMINE 1971-90   
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D001959 2002
% 211.55/211.70  |- skos__prefLabel mesh__D001959 Bromates
% 211.55/211.70  |- mesh__historyNote mesh__D001959
% 211.55/211.70       91%28%71%29%; was see under BROMINE 1971-90   
% 211.55/211.70  |- mesh__recordAuthorizer mesh__D001959 sjn
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D001959 2005
% 211.55/211.70  |- skos__historyNote mesh__D001959 Bromine %28%1966-1970%29%
% 211.55/211.70  |- mesh__dateRevised mesh__D001959 2000-08-22
% 211.55/211.70  |- rdf__type mesh__D001959sskos__Concept
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D001959 1994
% 211.55/211.70  |- mesh__recordOriginator mesh__D001959 NLM
% 211.55/211.70  |- mesh__dateCreated mesh__D001959 1999-01-01
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D001959 2003
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D001959 2006
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D001959 1998
% 211.55/211.70  |- mesh__recordMaintainer mesh__D001959 sjn
% 211.55/211.70  |- skos__scopeNote mesh__D001959
% 211.55/211.70       Negative ions or salts derived from bromic acid, HBrO3.%A%    
% 211.55/211.70  |- mesh__dateEstablished mesh__D001959 1991-01-01
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D001959 1995
% 211.55/211.70  |- skos__broader mesh__D001959smesh__D000838
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D001959 2004
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D001959 1996
% 211.55/211.70  |- skos__broader mesh__D001959smesh__D017605
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D001959 1999
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D001959 2000
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D001959 1997
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D001959 2001
% 211.55/211.70  |- skos__hiddenLabel mesh__D012681 Training Group, Sensitivity
% 211.55/211.70  |- skos__hiddenLabel mesh__D012681 T Groups
% 211.55/211.70  |- skos__altLabel mesh__D012681 T-Groups
% 211.55/211.70  |- mesh__dateRevised mesh__D012681 1996-06-10
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D012681 2000
% 211.55/211.70  |- skos__hiddenLabel mesh__D012681 Groups, Sensitivity Training
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D012681 2006
% 211.55/211.70  |- skos__hiddenLabel mesh__D012681 Sensitivity Training Group
% 211.55/211.70  |- skos__hiddenLabel mesh__D012681 Training Groups, Sensitivity
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D012681 1999
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D012681 2005
% 211.55/211.70  |- skos__scopeNote mesh__D012681
% 211.55/211.70       A group of people who meet in an unstructured setting to learn about themselves, interpersonal relationships, and group processes and about larger social systems.%A%    
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D012681 1998
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D012681 2002
% 211.55/211.70  |- skos__hiddenLabel mesh__D012681 Groups, Encounter
% 211.55/211.70  |- skos__hiddenLabel mesh__D012681 Encounter Group
% 211.55/211.70  |- mesh__publicMeSHNote mesh__D012681
% 211.55/211.70       72; ENCOUNTER GROUPS was heading 1975-96 %28%see under SENSITIVITY TRAINING GROUPS 1975-90%29%%A%  
% 211.55/211.70  |- mesh__historyNote mesh__D012681
% 211.55/211.70       72%28%69%29%; ENCOUNTER GROUPS was heading 1975-96 %28%see under SENSITIVITY TRAINING GROUPS 1975-90%29%%A%  
% 211.55/211.70  |- rdf__type mesh__D012681sskos__Concept
% 211.55/211.70  |- skos__hiddenLabel mesh__D012681 Group, Sensitivity Training
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D012681 2004
% 211.55/211.70  |- mesh__dateCreated mesh__D012681 1999-01-01
% 211.55/211.70  |- skos__historyNote mesh__D012681 Group Processes %28%1966-1968%29%
% 211.55/211.70  |- mesh__dateEstablished mesh__D012681 1972-01-01
% 211.55/211.70  |- mesh__recordOriginator mesh__D012681 NLM
% 211.55/211.70  |- skos__prefLabel mesh__D012681 Sensitivity Training Groups
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D012681 2001
% 211.55/211.70  |- skos__hiddenLabel mesh__D012681 Group, Encounter
% 211.55/211.70  |- mesh__recordMaintainer mesh__D012681 PXP
% 211.55/211.70  |- skos__hiddenLabel mesh__D012681 T-Group
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D012681 1997
% 211.55/211.70  |- mesh__recordAuthorizer mesh__D012681 PLS
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D012681 2003
% 211.55/211.70  |- skos__broader mesh__D012681smesh__D011615
% 211.55/211.70  |- skos__broader mesh__D012681smesh__D006126
% 211.55/211.70  |- skos__broader mesh__D006644smesh__D008264
% 211.55/211.70  |- mesh__recordMaintainer mesh__D006644 ags
% 211.55/211.70  |- mesh__recordOriginator mesh__D006644 NLM
% 211.55/211.70  |- mesh__recordAuthorizer mesh__D006644 sjn
% 211.55/211.70  |- skos__prefLabel mesh__D006644 Histiocytes
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D006644 2006
% 211.55/211.70  |- mesh__historyNote mesh__D006644 65%28%64%29%   
% 211.55/211.70  |- skos__scopeNote mesh__D006644
% 211.55/211.70       Macrophages found in the TISSUES, as opposed to those found in the blood %28%MONOCYTES%29% or serous cavities %28%SEROUS MEMBRANE%29%.%A%    
% 211.55/211.70  |- mesh__publicMeSHNote mesh__D006644 65   
% 211.55/211.70  |- skos__hiddenLabel mesh__D006644 Histiocyte
% 211.55/211.70  |- mesh__dateCreated mesh__D006644 1999-01-01
% 211.55/211.70  |- mesh__dateEstablished mesh__D006644 1965-01-01
% 211.55/211.70  |- mesh__dateRevised mesh__D006644 2005-06-30
% 211.55/211.70  |- rdf__type mesh__D006644sskos__Concept
% 211.55/211.70  |- skos__related mesh__D020315smesh__D012408
% 211.55/211.70  |- mesh__historyNote mesh__D020315 2002   
% 211.55/211.70  |- skos__historyNote mesh__D020315
% 211.55/211.70       Hypersensitivity, Immediate %28%1989-1998%29%
% 211.55/211.70  |- skos__related mesh__D020315smesh__D017449
% 211.55/211.70  |- skos__hiddenLabel mesh__D020315 Allergies, Rubber
% 211.55/211.70  |- mesh__dateEstablished mesh__D020315 1999-01-01
% 211.55/211.70  |- rdf__type mesh__D020315sskos__Concept
% 211.55/211.70  |- skos__hiddenLabel mesh__D020315 Allergy, Rubber
% 211.55/211.70  |- skos__hiddenLabel mesh__D020315 Allergy, Rubber Latex
% 211.55/211.70  |- mesh__activeMeSHYear mesh__D020315 2005
% 211.55/211.70  |- skos__broader mesh__D020315smesh__D006967
% 211.55/211.70  |- skos__historyNote mesh__D020315 Hypersensitivity %28%1988-1998%29%
% 211.55/211.70  |- skos__hiddenLabel mesh__D020315 Latex Hypersensitivities
% 211.55/211.70  |- skos__historyNote mesh__D020315 Rubber %28%1986-1998%29%
% 211.55/211.70  |- skos__hiddenLabel mesh__D020315 Latex Allergies
% 211.55/211.70  |- skos__altLabel mesh__D020315 Latex Allergy
% 211.55/211.70  |- mesh__recordAuthorizer mesh__D020315 sjn
% 211.55/211.70  |- skos__altLabel mesh__D020315 Natural Rubber Latex Allergy
% 211.55/211.70  |- mesh__recordOriginator mesh__D020315 AGS
% 211.55/211.70  |- skos__prefLabel mesh__D020315 Latex Hypersensitivity
% 211.55/211.70  |- skos__hiddenLabel mesh__D020315 Hypersensitivities, Latex
% 211.55/211.70  |- skos__related mesh__D020315smesh__D006969
% 211.55/211.70  |- mesh__dateCreated mesh__D020315 1998-06-10
% 211.55/211.71  |- skos__hiddenLabel mesh__D020315 Allergies, Latex
% 211.55/211.71  |- skos__hiddenLabel mesh__D020315 Allergies, Rubber Latex
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D020315 2004
% 211.55/211.71  |- mesh__dateRevised mesh__D020315 2001-07-25
% 211.55/211.71  |- skos__hiddenLabel mesh__D020315 Rubber Allergies
% 211.55/211.71  |- skos__altLabel mesh__D020315 Allergy, Latex
% 211.55/211.71  |- mesh__recordMaintainer mesh__D020315 tpw
% 211.55/211.71  |- skos__scopeNote mesh__D020315
% 211.55/211.71       Allergic reaction to products containing processed natural rubber latex such as rubber gloves, condoms, catheters, dental dams, balloons, and sporting equipment. Both T-cell mediated %28%HYPERSENSITIVITY, DELAYED%29% and IgE antibody-mediated %28%HYPERSENSITIVITY, IMMEDIATE%29% allergic responses are possible. Delayed hypersensitivity results from exposure to antioxidants present in the rubber; immediate hypersensitivity results from exposure to a latex protein.%A%    
% 211.55/211.71  |- skos__historyNote mesh__D020315 Latex %28%1987-1998%29%
% 211.55/211.71  |- skos__altLabel mesh__D020315 Rubber Allergy
% 211.55/211.71  |- skos__altLabel mesh__D020315 Hypersensitivity, Latex
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D020315 2002
% 211.55/211.71  |- mesh__publicMeSHNote mesh__D020315 2002; see LATEX ALLERGY 1999-2001   
% 211.55/211.71  |- skos__hiddenLabel mesh__D020315 Rubber Latex Allergies
% 211.55/211.71  |- skos__altLabel mesh__D020315 Rubber Latex Allergy
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D020315 2003
% 211.55/211.71  |- skos__annotation mesh__D020315
% 211.55/211.71       coord with HYPERSENSITIVITY, IMMEDIATE or HYPERSENSITIVITY, DELAYED if pertinent%A%  
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D020315 2006
% 211.55/211.71  |- skos__hiddenLabel mesh__D044763 Enzymes, Ubiquitin-Conjugating
% 211.55/211.71  |- mesh__historyNote mesh__D044763
% 211.55/211.71       2004; use UBIQUITIN-CONJUGATING ENZYMES %28%NM%29% 1990-2003   
% 211.55/211.71  |- rdf__type mesh__D044763sskos__Concept
% 211.55/211.71  |- skos__scopeNote mesh__D044763
% 211.55/211.71       A class of enzymes that form a thioester bond to UBIQUITIN with the assistance of UBIQUITIN-ACTIVATING ENZYMES. They transfer ubiquitin to the LYSINE of a substrate protein with the assistance of UBIQUITIN-PROTEIN LIGASES.%A%    
% 211.55/211.71  |- mesh__publicMeSHNote mesh__D044763
% 211.55/211.71       2004;  UBIQUITIN-CONJUGATING ENZYME E2 %28% UBIQUITIN-CONJUGATING ENZYMES%29% was indexed under LIGASES %28%1990-2003%29%; HHR6 PROTEIN was indexed under LIGASES 1996-2003%A%  
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D044763 2006
% 211.55/211.71  |- skos__altLabel mesh__D044763 Ubiquitin-Conjugating Enzyme E2
% 211.55/211.71  |- skos__hiddenLabel mesh__D044763 Ubiquitin Conjugating Enzymes
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D044763 2004
% 211.55/211.71  |- skos__historyNote mesh__D044763 Ligases %28%1989-2003%29%
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D044763 2005
% 211.55/211.71  |- skos__broader mesh__D044763smesh__D043743
% 211.55/211.71  |- skos__historyNote mesh__D044763 Ubiquitins %28%1986-1988%29%
% 211.55/211.71  |- skos__hiddenLabel mesh__D044763 E2, Ubiquitin-Conjugating Enzyme
% 211.55/211.71  |- mesh__dateCreated mesh__D044763 2003-07-09
% 211.55/211.71  |- skos__prefLabel mesh__D044763 Ubiquitin-Conjugating Enzymes
% 211.55/211.71  |- skos__hiddenLabel mesh__D044763 Enzyme E2, Ubiquitin-Conjugating
% 211.55/211.71  |- mesh__dateEstablished mesh__D044763 2004-01-01
% 211.55/211.71  |- mesh__recordAuthorizer mesh__D044763 sjn
% 211.55/211.71  |- mesh__recordMaintainer mesh__D044763 jmp
% 211.55/211.71  |- mesh__recordOriginator mesh__D044763 jmp
% 211.55/211.71  |- skos__hiddenLabel mesh__D044763 Ubiquitin Conjugating Enzyme E2
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D011589 1993
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D011589 1998
% 211.55/211.71  |- mesh__recordAuthorizer mesh__D011589 PLS
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D011589 2003
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D011589 1992
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D011589 1997
% 211.55/211.71  |- skos__scopeNote mesh__D011589
% 211.55/211.71       The branch of psychology which seeks to learn more about the fundamental causes of behavior by studying various psychologic phenomena in controlled experimental situations.%A%    
% 211.55/211.71  |- skos__hiddenLabel mesh__D011589 Experimental Psychologies
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D011589 1996
% 211.55/211.71  |- mesh__dateRevised mesh__D011589 1991-06-28
% 211.55/211.71  |- skos__hiddenLabel mesh__D011589 Psychologies, Experimental
% 211.55/211.71  |- skos__broader mesh__D011589smesh__D011584
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D011589 2002
% 211.55/211.71  |- skos__prefLabel mesh__D011589 Psychology, Experimental
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D011589 2006
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D011589 2001
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D011589 1995
% 211.55/211.71  |- mesh__dateCreated mesh__D011589 1999-01-01
% 211.55/211.71  |- mesh__recordOriginator mesh__D011589 NLM
% 211.55/211.71  |- rdf__type mesh__D011589sskos__Concept
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D011589 2005
% 211.55/211.71  |- mesh__recordMaintainer mesh__D011589 TGC
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D011589 2000
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D011589 1999
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D011589 1994
% 211.55/211.71  |- skos__altLabel mesh__D011589 Experimental Psychology
% 211.55/211.71  |- skos__annotation mesh__D011589
% 211.55/211.71       SPEC: SPEC qualif; avoid as NIM coord; DF: PSYCHOL EXPER   
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D011589 2004
% 211.55/211.71  |- skos__broader mesh__D016274smesh__D015682
% 211.55/211.71  |- skos__broader mesh__D016274smesh__D004268
% 211.55/211.71  |- mesh__historyNote mesh__D016274 91   
% 211.55/211.71  |- skos__annotation mesh__D016274
% 211.55/211.71       IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 211.55/211.71  |- skos__historyNote mesh__D016274 Retroviridae Proteins %28%1987-1989%29%
% 211.55/211.71  |- skos__hiddenLabel mesh__D016274 p55 v myc
% 211.55/211.71  |- mesh__recordOriginator mesh__D016274 AGS
% 211.55/211.71  |- skos__altLabel mesh__D016274 v-myc Protein p55
% 211.55/211.71  |- skos__altLabel mesh__D016274 Oncogene Product p55%28%v-myc%29%
% 211.55/211.71  |- mesh__dateEstablished mesh__D016274 1991-01-01
% 211.55/211.71  |- mesh__recordMaintainer mesh__D016274 DRC
% 211.55/211.71  |- skos__prefLabel mesh__D016274 Oncogene Protein p55%28%v-myc%29%
% 211.55/211.71  |- skos__broader mesh__D016274smesh__D009687
% 211.55/211.71  |- mesh__dateCreated mesh__D016274 1990-06-19
% 211.55/211.71  |- mesh__dateRevised mesh__D016274 2005-06-30
% 211.55/211.71  |- skos__scopeNote mesh__D016274
% 211.55/211.71       Transforming protein coded by myc oncogenes. The v-myc protein has been found in several replication-defective avian retrovirus isolates which induce a broad spectrum of malignancies.%A%    
% 211.55/211.71  |- skos__hiddenLabel mesh__D016274 Protein p55, v-myc
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D016274 2006
% 211.55/211.71  |- mesh__recordAuthorizer mesh__D016274 sjn
% 211.55/211.71  |- skos__hiddenLabel mesh__D016274 v myc Protein p55
% 211.55/211.71  |- mesh__publicMeSHNote mesh__D016274 91   
% 211.55/211.71  |- skos__altLabel mesh__D016274 myc Oncogene Protein p55
% 211.55/211.71  |- skos__altLabel mesh__D016274 myc Oncogene Product p55
% 211.55/211.71  |- rdf__type mesh__D016274sskos__Concept
% 211.55/211.71  |- skos__historyNote mesh__D016274
% 211.55/211.71       Retroviridae Proteins, Oncogenic %28%1990%29%
% 211.55/211.71  |- skos__altLabel mesh__D016274 p55%28%v-myc%29%
% 211.55/211.71  |- skos__altLabel mesh__D016274 p55 v-myc
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002254 1995
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002254 1998
% 211.55/211.71  |- skos__annotation mesh__D002254 GEN or unspecified; prefer specifics   
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002254 2004
% 211.55/211.71  |- skos__broader mesh__D002254smesh__D000838
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002254 1994
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002254 2000
% 211.55/211.71  |- mesh__dateRevised mesh__D002254 1993-06-04
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002254 2006
% 211.55/211.71  |- skos__broader mesh__D002254smesh__D000468
% 211.55/211.71  |- mesh__recordOriginator mesh__D002254 NLM
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002254 2003
% 211.55/211.71  |- mesh__recordMaintainer mesh__D002254 TPW
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002254 2005
% 211.55/211.71  |- skos__scopeNote mesh__D002254
% 211.55/211.71       Salts or ions of the theoretical carbonic acid, containing the radical CO2%28%3-%29%. Carbonates are readily decomposed by acids. The carbonates of the alkali metals are water-soluble; all others are insoluble. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 211.55/211.71  |- skos__prefLabel mesh__D002254 Carbonates
% 211.55/211.71  |- skos__broader mesh__D002254smesh__D002255
% 211.55/211.71  |- rdf__type mesh__D002254sskos__Concept
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002254 2002
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002254 1997
% 211.55/211.71  |- mesh__recordAuthorizer mesh__D002254 PLS
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002254 1999
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002254 2001
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002254 1996
% 211.55/211.71  |- mesh__dateCreated mesh__D002254 1999-01-01
% 211.55/211.71  |- skos__annotation mesh__D012682
% 211.55/211.71       for deafness consider HEARING AIDS; for Braille coord IM with BLINDNESS %28%IM%29% + READING %28%IM%29%%A%  
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012682 2005
% 211.55/211.71  |- skos__hiddenLabel mesh__D012682 Aids, Sensory
% 211.55/211.71  |- skos__hiddenLabel mesh__D012682 Aid, Sensory
% 211.55/211.71  |- mesh__recordAuthorizer mesh__D012682 PLS
% 211.55/211.71  |- mesh__publicMeSHNote mesh__D012682 74   
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012682 1995
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012682 1998
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012682 2000
% 211.55/211.71  |- skos__hiddenLabel mesh__D012682 Sensory Aid
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012682 1994
% 211.55/211.71  |- rdf__type mesh__D012682sskos__Concept
% 211.55/211.71  |- mesh__dateCreated mesh__D012682 1999-01-01
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012682 2004
% 211.55/211.71  |- skos__prefLabel mesh__D012682 Sensory Aids
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012682 2002
% 211.55/211.71  |- skos__broader mesh__D012682smesh__D004864
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012682 1997
% 211.55/211.71  |- skos__historyNote mesh__D012682
% 211.55/211.71       Blindness/rehabilitation %28%1966-1972%29%
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012682 2003
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012682 1996
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012682 1993
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012682 2006
% 211.55/211.71  |- skos__historyNote mesh__D012682
% 211.55/211.71       Deafness/rehabilitation %28%1966-1972%29%
% 211.55/211.71  |- mesh__recordMaintainer mesh__D012682 PLS
% 211.55/211.71  |- mesh__dateRevised mesh__D012682 1992-05-18
% 211.55/211.71  |- mesh__dateEstablished mesh__D012682 1974-01-01
% 211.55/211.71  |- mesh__recordOriginator mesh__D012682 NLM
% 211.55/211.71  |- mesh__historyNote mesh__D012682 74%28%73%29%   
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012682 1999
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012682 2001
% 211.55/211.71  |- skos__hiddenLabel mesh__D039021 Reservoirs, Ileal
% 211.55/211.71  |- mesh__recordAuthorizer mesh__D039021 sjn
% 211.55/211.71  |- skos__hiddenLabel mesh__D039021 S Pouch
% 211.55/211.71  |- skos__hiddenLabel mesh__D039021 Reservoirs, Ileoanal
% 211.55/211.71  |- skos__hiddenLabel mesh__D039021 Reservoir, Ileal
% 211.55/211.71  |- skos__hiddenLabel mesh__D039021 Pouches, Ileoanal
% 211.55/211.71  |- skos__hiddenLabel mesh__D039021 Ileal Reservoir
% 211.55/211.71  |- mesh__publicMeSHNote mesh__D039021
% 211.55/211.71       2003; for ILEALANAL POUCHES %26% ILEAL RESERVOIRS %26% J-POUCH %26% KOCH POUCH %26% W-POUCH see PROCTOCOLECTOMY, RESTORATIVE 1992-2002%A%  
% 211.55/211.71  |- skos__altLabel mesh__D039021 Ileal Reservoirs
% 211.55/211.71  |- skos__hiddenLabel mesh__D039021 Reservoir, Ileoanal
% 211.55/211.71  |- skos__related mesh__D039021smesh__D016737
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D039021 2006
% 211.55/211.71  |- mesh__dateEstablished mesh__D039021 2003-01-01
% 211.55/211.71  |- skos__hiddenLabel mesh__D039021 Ileoanal Reservoir
% 211.55/211.71  |- skos__hiddenLabel mesh__D039021 Pouche, Ileal
% 211.55/211.71  |- skos__hiddenLabel mesh__D039021 Ileal Pouche
% 211.55/211.71  |- skos__scopeNote mesh__D039021
% 211.55/211.71       Sacs or reservoirs created to function in place of the COLON and/or RECTUM in patients who have undergone restorative proctocolectomy %28%PROCTOCOLECTOMY, RESTORATIVE%29%.%A%    
% 211.55/211.71  |- skos__historyNote mesh__D039021
% 211.55/211.71       Proctocolectomy, Restorative %28%1989-2002%29%
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D039021 2005
% 211.55/211.71  |- skos__altLabel mesh__D039021 Ileoanal Reservoirs
% 211.55/211.71  |- mesh__historyNote mesh__D039021
% 211.55/211.71       2003; for ILEALANAL POUCHES %26% ILEAL RESERVOIRS %26% J-POUCH %26% KOCH POUCH %26% W-POUCH use PROCTOCOLECTOMY, RESTORATIVE 1992-2002%A%  
% 211.55/211.71  |- skos__altLabel mesh__D039021 Pelvic Pouches
% 211.55/211.71  |- skos__hiddenLabel mesh__D039021 S-Pouchs
% 211.55/211.71  |- skos__hiddenLabel mesh__D039021 W Pouch
% 211.55/211.71  |- skos__prefLabel mesh__D039021 Colonic Pouches
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D039021 2004
% 211.55/211.71  |- rdf__type mesh__D039021sskos__Concept
% 211.55/211.71  |- skos__hiddenLabel mesh__D039021 Pouche, Colonic
% 211.55/211.71  |- skos__broader mesh__D039021smesh__D019738
% 211.55/211.71  |- skos__hiddenLabel mesh__D039021 J Pouch
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D039021 2003
% 211.55/211.71  |- skos__hiddenLabel mesh__D039021 Colonic Pouche
% 211.55/211.71  |- skos__hiddenLabel mesh__D039021 Pouches, Colonic
% 211.55/211.71  |- skos__hiddenLabel mesh__D039021 Pouch, Kock
% 211.55/211.71  |- skos__hiddenLabel mesh__D039021 Pouches, Pelvic
% 211.55/211.71  |- skos__hiddenLabel mesh__D039021 Pouches, Ileal
% 211.55/211.71  |- mesh__recordMaintainer mesh__D039021 ags
% 211.55/211.71  |- mesh__dateCreated mesh__D039021 2002-07-03
% 211.55/211.71  |- mesh__recordOriginator mesh__D039021 ags
% 211.55/211.71  |- skos__scopeNote mesh__D025001
% 211.55/211.71       An isoenzyme of GLYCOGEN PHOSPHORYLASE that catalyzes the degradation of GLYCOGEN in liver tissue. Mutation of the gene coding this enzyme on chromosome 14 is the cause of GLYCOGEN STORAGE DISEASE TYPE VI.%A%    
% 211.55/211.71  |- mesh__historyNote mesh__D025001 2002   
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D025001 2004
% 211.55/211.71  |- skos__broader mesh__D025001smesh__D024981
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D025001 2006
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D025001 2005
% 211.55/211.71  |- mesh__dateRevised mesh__D025001 2003-07-09
% 211.55/211.71  |- skos__related mesh__D025001smesh__D006013
% 211.55/211.71  |- rdf__type mesh__D025001sskos__Concept
% 211.55/211.71  |- skos__historyNote mesh__D025001 Glucosyltransferases %28%1966-1971%29%
% 211.55/211.71  |- mesh__dateCreated mesh__D025001 2001-07-25
% 211.55/211.71  |- skos__prefLabel mesh__D025001 Glycogen Phosphorylase, Liver Form
% 211.55/211.71  |- skos__historyNote mesh__D025001 Phosphorylases %28%1972-2001%29%
% 211.55/211.71  |- mesh__publicMeSHNote mesh__D025001 2002   
% 211.55/211.71  |- mesh__dateEstablished mesh__D025001 2002-01-01
% 211.55/211.71  |- skos__scopeNote mesh__D044764
% 211.55/211.71       A class of enzymes that catalyzes the ATP-dependent formation of a thioester bond between itself and UBIQUITIN. It then transfers the activated ubiquitin to one of the UBIQUITIN-PROTEIN LIGASES.%A%    
% 211.55/211.71  |- mesh__dateEstablished mesh__D044764 2004-01-01
% 211.55/211.71  |- mesh__dateCreated mesh__D044764 2003-07-09
% 211.55/211.71  |- skos__historyNote mesh__D044764 Ligases %28%1983-2003%29%
% 211.55/211.71  |- skos__hiddenLabel mesh__D044764 Ubiquitin Activating Enzymes
% 211.55/211.71  |- skos__altLabel mesh__D044764 Ubiquitination Activating Enzyme E1
% 211.55/211.71  |- skos__altLabel mesh__D044764 Ubiquitin-Activating Enzyme E1
% 211.55/211.71  |- skos__hiddenLabel mesh__D044764 Enzymes, Ubiquitin-Activating
% 211.55/211.71  |- skos__altLabel mesh__D044764 Ubiquitin-Activating Enzyme
% 211.55/211.71  |- mesh__publicMeSHNote mesh__D044764
% 211.55/211.71       2004; UBIQUITIN-ACTIVATING ENZYME was indexed under LIGASES 1983-2003%A%  
% 211.55/211.71  |- rdf__type mesh__D044764sskos__Concept
% 211.55/211.71  |- skos__broader mesh__D044764smesh__D043743
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D044764 2006
% 211.55/211.71  |- skos__hiddenLabel mesh__D044764 Ubiquitin Activating Enzyme E1
% 211.55/211.71  |- skos__hiddenLabel mesh__D044764 Ubiquitin Activating Enzyme
% 211.55/211.71  |- skos__hiddenLabel mesh__D044764 Enzyme, Ubiquitin-Activating
% 211.55/211.71  |- skos__prefLabel mesh__D044764 Ubiquitin-Activating Enzymes
% 211.55/211.71  |- skos__hiddenLabel mesh__D044764 Enzyme E1, Ubiquitin-Activating
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D044764 2004
% 211.55/211.71  |- mesh__historyNote mesh__D044764
% 211.55/211.71       2004; use UBIQUITIN-ACTIVATING ENZYMES %28%NM%29% 1983-2003   
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D044764 2005
% 211.55/211.71  |- mesh__recordAuthorizer mesh__D016275 sjn
% 211.55/211.71  |- skos__scopeNote mesh__D016275
% 211.55/211.71       The hemodynamic and electrophysiological action of the HEART ATRIA.%A%    
% 211.55/211.71  |- skos__historyNote mesh__D016275 Heart/physiology %28%1966-1990%29%
% 211.55/211.71  |- mesh__dateRevised mesh__D016275 2003-07-09
% 211.55/211.71  |- mesh__historyNote mesh__D016275 91   
% 211.55/211.71  |- mesh__dateCreated mesh__D016275 1990-05-25
% 211.55/211.71  |- mesh__recordOriginator mesh__D016275 PXP
% 211.55/211.71  |- mesh__publicMeSHNote mesh__D016275 91   
% 211.55/211.71  |- skos__hiddenLabel mesh__D016275 Atrial Functions
% 211.55/211.71  |- skos__hiddenLabel mesh__D016275 Functions, Atrial
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D016275 2005
% 211.55/211.71  |- skos__prefLabel mesh__D016275 Atrial Function
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D016275 2006
% 211.55/211.71  |- skos__hiddenLabel mesh__D016275 Function, Atrial
% 211.55/211.71  |- skos__broader mesh__D016275smesh__D045125
% 211.55/211.71  |- mesh__dateEstablished mesh__D016275 1991-01-01
% 211.55/211.71  |- skos__historyNote mesh__D016275
% 211.55/211.71       Heart Atrium/physiology %28%1968-1990%29%
% 211.55/211.71  |- rdf__type mesh__D016275sskos__Concept
% 211.55/211.71  |- mesh__recordMaintainer mesh__D016275 nns
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D016275 2004
% 211.55/211.71  |- mesh__onlineNote mesh__D002255 search CARBON DIOXIDE 1966-74   
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002255 2003
% 211.55/211.71  |- mesh__recordMaintainer mesh__D002255 TPW
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002255 2001
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002255 2005
% 211.55/211.71  |- mesh__historyNote mesh__D002255
% 211.55/211.71       91%28%75%29%; was see under CARBONATES 1975-90; was see under CARBON DIOXIDE 1963-74%A%  
% 211.55/211.71  |- skos__scopeNote mesh__D002255
% 211.55/211.71       Carbonic acid %28%H2C03%29%. The hypothetical acid of carbon dioxide and water. It exists only in the form of its salts %28%carbonates%29%, acid salts %28%hydrogen carbonates%29%, amines %28%carbamic acid%29%, and acid chlorides %28%carbonyl chloride%29%. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002255 2000
% 211.55/211.71  |- mesh__dateRevised mesh__D002255 1993-06-04
% 211.55/211.71  |- skos__prefLabel mesh__D002255 Carbonic Acid
% 211.55/211.71  |- mesh__publicMeSHNote mesh__D002255
% 211.55/211.71       91; was see under CARBONATES 1975-90; was see under CARBON DIOXIDE 1963-74%A%  
% 211.55/211.71  |- rdf__type mesh__D002255sskos__Concept
% 211.55/211.71  |- mesh__recordOriginator mesh__D002255 NLM
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002255 1997
% 211.55/211.71  |- skos__broader mesh__D002255smesh__D017554
% 211.55/211.71  |- mesh__dateEstablished mesh__D002255 1991-01-01
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002255 1999
% 211.55/211.71  |- mesh__dateCreated mesh__D002255 1999-01-01
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002255 1996
% 211.55/211.71  |- skos__annotation mesh__D002255
% 211.55/211.71       %22%the hypothetical acid of carbon dioxide %26% water%22%   
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002255 1995
% 211.55/211.71  |- skos__hiddenLabel mesh__D002255 Acid, Carbonic
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002255 1998
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002255 2004
% 211.55/211.71  |- skos__broader mesh__D002255smesh__D000148
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002255 2002
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002255 2006
% 211.55/211.71  |- mesh__recordAuthorizer mesh__D002255 PLS
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D002255 1994
% 211.55/211.71  |- skos__annotation mesh__D012683 human %26% animal   
% 211.55/211.71  |- mesh__recordAuthorizer mesh__D012683 PLS
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012683 1995
% 211.55/211.71  |- mesh__dateCreated mesh__D012683 1999-01-01
% 211.55/211.71  |- skos__hiddenLabel mesh__D012683 Deprivations, Sensory
% 211.55/211.71  |- skos__scopeNote mesh__D012683
% 211.55/211.71       The absence or restriction of the usual external sensory stimuli to which the individual responds.%A%    
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012683 2000
% 211.55/211.71  |- mesh__recordMaintainer mesh__D012683 TAP
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012683 2003
% 211.55/211.71  |- rdf__type mesh__D012683sskos__Concept
% 211.55/211.71  |- mesh__recordOriginator mesh__D012683 NLM
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012683 2001
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012683 1996
% 211.55/211.71  |- skos__prefLabel mesh__D012683 Sensory Deprivation
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012683 2004
% 211.55/211.71  |- mesh__dateRevised mesh__D012683 1992-05-18
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012683 2002
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012683 1997
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012683 2005
% 211.55/211.71  |- skos__hiddenLabel mesh__D012683 Sensory Deprivations
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012683 1998
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012683 1993
% 211.55/211.71  |- skos__broader mesh__D012683smesh__D010465
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012683 2006
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012683 1994
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D012683 1999
% 211.55/211.71  |- skos__hiddenLabel mesh__D012683 Deprivation, Sensory
% 211.55/211.71  |- skos__hiddenLabel mesh__D006646 Histiocytoses, Generalized
% 211.55/211.71  |- skos__broader mesh__D006646smesh__D017563
% 211.55/211.71  |- skos__scopeNote mesh__D006646
% 211.55/211.71       Group of disorders characterized by monoclonal proliferation of CD1+ HISTIOCYTES. The demonstration of the LANGERHANS CELLS Birbeck granules is the gold standard of the phenotype. EOSINOPHILIC GRANULOMA  makes up 60-80%25% of all the cases.%A%    
% 211.55/211.71  |- skos__hiddenLabel mesh__D006646 Granulomatosis, Langerhans-Cell
% 211.55/211.71  |- skos__hiddenLabel mesh__D006646 Disease, Schueller-Christian
% 211.55/211.71  |- skos__altLabel mesh__D006646 Letterer-Siwe Disease
% 211.55/211.71  |- skos__hiddenLabel mesh__D006646 Histiocytosis, Langerhans Cell
% 211.55/211.71  |- mesh__dateCreated mesh__D006646 1975-07-25
% 211.55/211.71  |- skos__hiddenLabel mesh__D006646 Schueller Christian Disease
% 211.55/211.71  |- skos__altLabel mesh__D006646 Schueller-Christian Disease
% 211.55/211.71  |- skos__prefLabel mesh__D006646 Histiocytosis, Langerhans-Cell
% 211.55/211.71  |- skos__hiddenLabel mesh__D006646 Generalized Histiocytoses
% 211.55/211.71  |- skos__hiddenLabel mesh__D006646 Generalized Histiocytosis
% 211.55/211.71  |- skos__hiddenLabel mesh__D006646 Syndrome, Hand-Schueller-Christian
% 211.55/211.71  |- mesh__recordOriginator mesh__D006646 SMH
% 211.55/211.71  |- rdf__type mesh__D006646sskos__Concept
% 211.55/211.71  |- skos__broader mesh__D006646smesh__D015614
% 211.55/211.71  |- skos__hiddenLabel mesh__D006646 Letterer Siwe Disease
% 211.55/211.71  |- skos__annotation mesh__D006646 GEN or unspecified; prefer specifics   
% 211.55/211.71  |- mesh__dateRevised mesh__D006646 2005-06-30
% 211.55/211.71  |- mesh__dateEstablished mesh__D006646 1976-01-01
% 211.55/211.71  |- mesh__onlineNote mesh__D006646
% 211.55/211.71       use HISTIOCYTOSIS, LANGERHANS-CELL to search HISTIOCYTOSIS X 1975-89; use RETICULOENDOTHELIOSIS 1966-74%A%  
% 211.55/211.71  |- mesh__recordMaintainer mesh__D006646 ags
% 211.55/211.71  |- mesh__historyNote mesh__D006646
% 211.55/211.71       90%28%75%29%; was see under RETICULOENDOTHELIOSIS 1966-75; was HISTIOCYTOSIS X 1975-89%A%  
% 211.55/211.71  |- skos__hiddenLabel mesh__D006646 Hand Schueller Christian Syndrome
% 211.55/211.71  |- skos__hiddenLabel mesh__D006646 Langerhans Cell Granulomatosis
% 211.55/211.71  |- skos__altLabel mesh__D006646 Histiocytosis-X
% 211.55/211.71  |- skos__altLabel mesh__D006646 Hand-Schueller-Christian Syndrome
% 211.55/211.71  |- skos__altLabel mesh__D006646 Histiocytosis, Generalized
% 211.55/211.71  |- skos__historyNote mesh__D006646 Reticuloendotheliosis %28%1966-1974%29%
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D006646 2006
% 211.55/211.71  |- mesh__recordAuthorizer mesh__D006646 sjn
% 211.55/211.71  |- skos__hiddenLabel mesh__D006646 Disease, Letterer-Siwe
% 211.55/211.71  |- skos__altLabel mesh__D006646 Histiocytosis X
% 211.55/211.71  |- mesh__publicMeSHNote mesh__D006646
% 211.55/211.71       90; was see under RETICULOENDOTHELIOSIS 1965-75; was HISTIOCYTOSIS X 1975-89%A%  
% 211.55/211.71  |- skos__hiddenLabel mesh__D006646 Langerhans-Cell Histiocytosis
% 211.55/211.71  |- skos__altLabel mesh__D006646 Langerhans-Cell Granulomatosis
% 211.55/211.71  |- skos__altLabel mesh__D020317 Salmon, Atlantic
% 211.55/211.71  |- mesh__dateRevised mesh__D020317 2003-07-09
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D020317 2004
% 211.55/211.71  |- skos__prefLabel mesh__D020317 Salmo salar
% 211.55/211.71  |- skos__historyNote mesh__D020317 Salmon %28%1972-1998%29%
% 211.55/211.71  |- skos__hiddenLabel mesh__D020317 Atlantic Salmons
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D020317 2006
% 211.55/211.71  |- skos__historyNote mesh__D020317 Fishes %28%1966-1968%29%
% 211.55/211.71  |- skos__scopeNote mesh__D020317
% 211.55/211.71       A commercially important species of SALMON in the family SALMONIDAE, order SALMONIFORMES, which occurs in the North Atlantic.%A%    
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D020317 2005
% 211.55/211.71  |- mesh__recordAuthorizer mesh__D020317 sjn
% 211.55/211.71  |- mesh__publicMeSHNote mesh__D020317 1999   
% 211.55/211.71  |- mesh__recordOriginator mesh__D020317 NDW
% 211.55/211.71  |- mesh__recordMaintainer mesh__D020317 ags
% 211.55/211.71  |- skos__hiddenLabel mesh__D020317 Salmons, Atlantic
% 211.55/211.71  |- skos__altLabel mesh__D020317 Atlantic Salmon
% 211.55/211.71  |- mesh__historyNote mesh__D020317 1999   
% 211.55/211.71  |- skos__historyNote mesh__D020317 Salmonidae %28%1969-1971%29%
% 211.55/211.71  |- mesh__dateEstablished mesh__D020317 1999-01-01
% 211.55/211.71  |- mesh__dateCreated mesh__D020317 1998-06-11
% 211.55/211.71  |- rdf__type mesh__D020317sskos__Concept
% 211.55/211.71  |- skos__hiddenLabel mesh__D020317 salar, Salmo
% 211.55/211.71  |- skos__broader mesh__D020317smesh__D012474
% 211.55/211.71  |- skos__historyNote mesh__D025002 Phosphorylases %28%1978-2001%29%
% 211.55/211.71  |- mesh__dateRevised mesh__D025002 2003-07-09
% 211.55/211.71  |- rdf__type mesh__D025002sskos__Concept
% 211.55/211.71  |- mesh__publicMeSHNote mesh__D025002 2002   
% 211.55/211.71  |- mesh__historyNote mesh__D025002 2002   
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D025002 2004
% 211.55/211.71  |- mesh__dateEstablished mesh__D025002 2002-01-01
% 211.55/211.71  |- skos__broader mesh__D025002smesh__D024981
% 211.55/211.71  |- skos__historyNote mesh__D025002 Glucosyltransferases %28%1968-1977%29%
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D025002 2006
% 211.55/211.71  |- skos__scopeNote mesh__D025002
% 211.55/211.71       An isoenzyme of GLYCOGEN PHOSPHORYLASE that catalyzes the degradation of GLYCOGEN in brain tissue.%A%    
% 211.55/211.71  |- skos__prefLabel mesh__D025002 Glycogen Phosphorylase, Brain Form
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D025002 2005
% 211.55/211.71  |- mesh__dateCreated mesh__D025002 2001-07-25
% 211.55/211.71  |- skos__scopeNote mesh__D049450
% 211.55/211.71       Emission of LIGHT by a substance as its temperature is raised. It is sometimes called hot light in contrast to LUMINESCENCE.%A%    
% 211.55/211.71  |- mesh__recordOriginator mesh__D049450 ssb
% 211.55/211.71  |- mesh__dateCreated mesh__D049450 2004-07-07
% 211.55/211.71  |- mesh__historyNote mesh__D049450 2005   
% 211.55/211.71  |- mesh__dateRevised mesh__D049450 2005-07-01
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D049450 2006
% 211.55/211.71  |- rdf__type mesh__D049450sskos__Concept
% 211.55/211.71  |- mesh__publicMeSHNote mesh__D049450 2005   
% 211.55/211.71  |- skos__prefLabel mesh__D049450 Incandescence
% 211.55/211.71  |- mesh__recordAuthorizer mesh__D049450 sjn
% 211.55/211.71  |- skos__broader mesh__D049450smesh__D008027
% 211.55/211.71  |- mesh__dateEstablished mesh__D049450 2005-01-01
% 211.55/211.71  |- mesh__recordMaintainer mesh__D049450 sjn
% 211.55/211.71  |- skos__prefLabel mesh__D016276 Ventricular Function
% 211.55/211.71  |- mesh__recordMaintainer mesh__D016276 nns
% 211.55/211.71  |- skos__historyNote mesh__D016276
% 211.55/211.71       Heart Ventricle/physiology %28%1968-1990%29%
% 211.55/211.71  |- mesh__activeMeSHYear mesh__D016276 2005
% 211.55/211.71  |- skos__scopeNote mesh__D016276
% 211.55/211.71       The hemodynamic and electrophysiological action of the HEART VENTRICLES.%A%    
% 211.55/211.71  |- skos__hiddenLabel mesh__D016276 Function, Ventricular
% 211.55/211.71  |- mesh__recordAuthorizer mesh__D016276 sjn
% 211.55/211.71  |- mesh__publicMeSHNote mesh__D016276 91   
% 211.55/211.71  |- skos__historyNote mesh__D016276 Heart/physiology %28%1966-1990%29%
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D016276 2006
% 211.55/211.72  |- mesh__dateCreated mesh__D016276 1990-05-29
% 211.55/211.72  |- skos__hiddenLabel mesh__D016276 Functions, Ventricular
% 211.55/211.72  |- skos__hiddenLabel mesh__D016276 Ventricular Functions
% 211.55/211.72  |- skos__related mesh__D016276smesh__D006334
% 211.55/211.72  |- skos__broader mesh__D016276smesh__D045125
% 211.55/211.72  |- mesh__dateEstablished mesh__D016276 1991-01-01
% 211.55/211.72  |- rdf__type mesh__D016276sskos__Concept
% 211.55/211.72  |- mesh__dateRevised mesh__D016276 2003-07-09
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D016276 2004
% 211.55/211.72  |- mesh__historyNote mesh__D016276 91   
% 211.55/211.72  |- mesh__recordOriginator mesh__D016276 PXP
% 211.55/211.72  |- skos__hiddenLabel mesh__D002256 Dehydratase, Carbonate
% 211.55/211.72  |- skos__hiddenLabel mesh__D002256 Anhydrases, Carbonic
% 211.55/211.72  |- skos__scopeNote mesh__D002256
% 211.55/211.72       A family of zinc-containing enzymes that catalyze the reversible hydration of carbon dioxide. They play an important role in the transport of CARBON DIOXIDE from the tissues to the LUNG.  EC 4.2.1.1.%A%    
% 211.55/211.72  |- mesh__dateCreated mesh__D002256 1999-01-01
% 211.55/211.72  |- mesh__dateRevised mesh__D002256 2003-07-09
% 211.55/211.72  |- skos__broader mesh__D002256smesh__D006836
% 211.55/211.72  |- rdf__type mesh__D002256sskos__Concept
% 211.55/211.72  |- mesh__publicMeSHNote mesh__D002256
% 211.55/211.72       2002; see CARBONATE DEHYDRATASE 1992-2001, see CARBONIC ANHYDRASE 1963-1991%A%  
% 211.55/211.72  |- mesh__recordAuthorizer mesh__D002256 sjn
% 211.55/211.72  |- mesh__historyNote mesh__D002256 2002%28%1963%29%   
% 211.55/211.72  |- skos__altLabel mesh__D002256 Carbonate Dehydratase
% 211.55/211.72  |- skos__prefLabel mesh__D002256 Carbonic Anhydrases
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D002256 2005
% 211.55/211.72  |- skos__altLabel mesh__D002256 Carbonic Anhydrase
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D002256 2004
% 211.55/211.72  |- mesh__recordOriginator mesh__D002256 NLM
% 211.55/211.72  |- mesh__recordMaintainer mesh__D002256 ssb
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D002256 2006
% 211.55/211.72  |- skos__annotation mesh__D002256 note specifics   
% 211.55/211.72  |- skos__annotation mesh__D012684
% 211.55/211.72       IM GEN or unspecified; AUDITORY THRESHOLD; DIFFERENTIAL THRESHOLD; PAIN THRESHOLD; SUBLIMINAL STIMULATION %26% TASTE THRESHOLD are also available; coord NIM with specific sensory concept %28%IM%29%, e.g., visual threshold = SENSORY THRESHOLD %28%NIM%29% + VISUAL PERCEPTION %28%IM%29%%A%  
% 211.55/211.72  |- skos__broader mesh__D012684smesh__D010465
% 211.55/211.72  |- mesh__dateEstablished mesh__D012684 1979-01-01
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D012684 2003
% 211.55/211.72  |- skos__hiddenLabel mesh__D012684 Sensory Threshold
% 211.55/211.72  |- rdf__type mesh__D012684sskos__Concept
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D012684 2004
% 211.55/211.72  |- skos__prefLabel mesh__D012684 Sensory Thresholds
% 211.55/211.72  |- skos__scopeNote mesh__D012684
% 211.55/211.72       The minimum amount of stimulus energy necessary to elicit a sensory response.%A%    
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D012684 2005
% 211.55/211.72  |- mesh__recordMaintainer mesh__D012684 mdb
% 211.55/211.72  |- skos__hiddenLabel mesh__D012684 Threshold, Sensory
% 211.55/211.72  |- mesh__dateRevised mesh__D012684 2001-07-25
% 211.55/211.72  |- mesh__historyNote mesh__D012684
% 211.55/211.72       79; was THRESHOLD %28%NON MESH%29% before 1979   
% 211.55/211.72  |- mesh__recordOriginator mesh__D012684 NLM
% 211.55/211.72  |- mesh__publicMeSHNote mesh__D012684 79   
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D012684 2006
% 211.55/211.72  |- skos__hiddenLabel mesh__D012684 Thresholds, Sensory
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D012684 2002
% 211.55/211.72  |- mesh__recordAuthorizer mesh__D012684 sjn
% 211.55/211.72  |- mesh__dateCreated mesh__D012684 1999-01-01
% 211.55/211.72  |- skos__related mesh__D012684smesh__D017603
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D039821 2006
% 211.55/211.72  |- mesh__dateEstablished mesh__D039821 2003-01-01
% 211.55/211.72  |- skos__prefLabel mesh__D039821 Monoterpenes
% 211.55/211.72  |- mesh__publicMeSHNote mesh__D039821 2003   
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D039821 2005
% 211.55/211.72  |- skos__broader mesh__D039821smesh__D013729
% 211.55/211.72  |- skos__historyNote mesh__D039821 Terpenes %28%1965-2002%29%
% 211.55/211.72  |- skos__altLabel mesh__D039821 Monoterpenoids
% 211.55/211.72  |- mesh__dateCreated mesh__D039821 2002-07-03
% 211.55/211.72  |- mesh__historyNote mesh__D039821 2003   
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D039821 2004
% 211.55/211.72  |- rdf__type mesh__D039821sskos__Concept
% 211.55/211.72  |- skos__scopeNote mesh__D039821
% 211.55/211.72       Compounds with a core of 10 carbons generally formed via the mevalonate pathway from the combination of 3,3-dimethylallyl pyrophosphate and isopentenyl pyrophosphate. They are cyclized and oxidized in a variety of ways. Due to the low molecular weight many of them exist in the form of essential oils %28%OILS, VOLATILE%29%.%A%    
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D039821 2003
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D006647 1998
% 211.55/211.72  |- skos__hiddenLabel mesh__D006647 Malignant Histiocytoses
% 211.55/211.72  |- mesh__publicMeSHNote mesh__D006647 87   
% 211.55/211.72  |- skos__broader mesh__D006647smesh__D008223
% 211.55/211.72  |- rdf__type mesh__D006647sskos__Concept
% 211.55/211.72  |- mesh__recordAuthorizer mesh__D006647 PLS
% 211.55/211.72  |- skos__altLabel mesh__D006647 Reticulosis, Histiocytic Medullary
% 211.55/211.72  |- skos__broader mesh__D006647smesh__D015620
% 211.55/211.72  |- skos__hiddenLabel mesh__D006647 Medullary Reticuloses, Histiocytic
% 211.55/211.72  |- mesh__dateRevised mesh__D006647 1995-06-08
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D006647 2004
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D006647 2002
% 211.55/211.72  |- skos__hiddenLabel mesh__D006647 Histiocytoses, Malignant
% 211.55/211.72  |- mesh__recordMaintainer mesh__D006647 KEV
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D006647 2006
% 211.55/211.72  |- skos__annotation mesh__D006647
% 211.55/211.72       do not use /blood supply /chem /second /secret /ultrastruct; do not confuse with HISTIOCYTIC DISORDERS, MALIGNANT%A%  
% 211.55/211.72  |- skos__hiddenLabel mesh__D006647 Reticuloses, Histiocytic Medullary
% 211.55/211.72  |- skos__hiddenLabel mesh__D006647 Medullary Reticulosis, Histiocytic
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D006647 2003
% 211.55/211.72  |- skos__hiddenLabel mesh__D006647 Histiocytic Medullary Reticuloses
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D006647 2001
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D006647 1997
% 211.55/211.72  |- skos__altLabel mesh__D006647 Histiocytic Medullary Reticulosis
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D006647 2005
% 211.55/211.72  |- skos__historyNote mesh__D006647 Reticuloendotheliosis %28%1966-1986%29%
% 211.55/211.72  |- mesh__recordOriginator mesh__D006647 VDK
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D006647 1999
% 211.55/211.72  |- mesh__historyNote mesh__D006647 87   
% 211.55/211.72  |- mesh__dateCreated mesh__D006647 1986-04-18
% 211.55/211.72  |- mesh__dateEstablished mesh__D006647 1987-01-01
% 211.55/211.72  |- skos__altLabel mesh__D006647 Malignant Histiocytosis
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D006647 2000
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D006647 1996
% 211.55/211.72  |- skos__scopeNote mesh__D006647
% 211.55/211.72       A rare, usually rapidly progressive disorder, characterized by abrupt onset, fever, weight loss, hepato-splenomegaly, pancytopenia, and lymphadenopathy.%A%    
% 211.55/211.72  |- skos__prefLabel mesh__D006647 Histiocytosis, Malignant
% 211.55/211.72  |- skos__hiddenLabel mesh__D020318 Rats, Long Evans
% 211.55/211.72  |- skos__hiddenLabel mesh__D020318 Evans Rats, Long
% 211.55/211.72  |- mesh__dateEstablished mesh__D020318 1999-01-01
% 211.55/211.72  |- mesh__publicMeSHNote mesh__D020318 99   
% 211.55/211.72  |- skos__related mesh__D020318smesh__D020332
% 211.55/211.72  |- skos__altLabel mesh__D020318 Long Evans Rats
% 211.55/211.72  |- mesh__recordOriginator mesh__D020318 NDW
% 211.55/211.72  |- mesh__historyNote mesh__D020318 99   
% 211.55/211.72  |- mesh__dateCreated mesh__D020318 1998-06-11
% 211.55/211.72  |- mesh__recordMaintainer mesh__D020318 ags
% 211.55/211.72  |- skos__prefLabel mesh__D020318 Rats, Long-Evans
% 211.55/211.72  |- skos__related mesh__D020318smesh__D020334
% 211.55/211.72  |- rdf__type mesh__D020318sskos__Concept
% 211.55/211.72  |- skos__historyNote mesh__D020318 Rats %28%1968-1998%29%
% 211.55/211.72  |- skos__annotation mesh__D020318 NIM when exper animal; check tag RATS   
% 211.55/211.72  |- mesh__dateRevised mesh__D020318 2005-06-30
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D020318 2006
% 211.55/211.72  |- skos__scopeNote mesh__D020318
% 211.55/211.72       An outbred strain of rats developed in 1915 by crossing several Wistar Institute white females with a wild gray male. Inbred strains have been derived from this original outbred strain, including Long-Evans cinnamon rats %28%RATS, INBRED LEC%29% and Otsuka-Long-Evans-Tokushima Fatty rats %28%RATS, INBRED OLETF%29%, which are models for Wilson%27%s disease and non-insulin dependent diabetes mellitus, respectively.%A%    
% 211.55/211.72  |- skos__hiddenLabel mesh__D020318 Long-Evans Rats
% 211.55/211.72  |- skos__broader mesh__D020318smesh__D051381
% 211.55/211.72  |- mesh__recordAuthorizer mesh__D020318 sjn
% 211.55/211.72  |- skos__scopeNote mesh__D025801
% 211.55/211.72       A highly conserved 76-amino acid peptide universally found in eukaryotic cells that functions as a marker for intracellular PROTEIN TRANSPORT and degradation. Ubiquitin becomes activated through a series of complicated steps and forms an isopeptide bond to lysine residues of specific proteins within the cell. These %22%ubiquitinated%22% proteins can be recognized and degraded by proteosomes or be transported to specific compartments within the cell.%A%    
% 211.55/211.72  |- mesh__recordMaintainer mesh__D025801 jmp
% 211.55/211.72  |- rdf__type mesh__D025801sskos__Concept
% 211.55/211.72  |- skos__historyNote mesh__D025801 Ubiquitins %28%1985-2001%29%
% 211.55/211.72  |- skos__historyNote mesh__D025801 Peptides %28%1975-1980%29%
% 211.55/211.72  |- skos__altLabel mesh__D025801 APF-1
% 211.55/211.72  |- mesh__recordAuthorizer mesh__D025801 sjn
% 211.55/211.72  |- skos__hiddenLabel mesh__D025801 Human Ubiquitin
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D025801 2006
% 211.55/211.72  |- skos__historyNote mesh__D025801 Nucleoproteins %28%1966-1977%29%
% 211.55/211.72  |- skos__altLabel mesh__D025801 ATP-Dependent Proteolysis Factor 1
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D025801 2004
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D025801 2005
% 211.55/211.72  |- skos__annotation mesh__D025801 UBIQUITINS   
% 211.55/211.72  |- skos__historyNote mesh__D025801
% 211.55/211.72       Chromosomal Proteins, Non-Histone %28%1977-1984%29%
% 211.55/211.72  |- skos__hiddenLabel mesh__D025801 ATP Dependent Proteolysis Factor 1
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D025801 2003
% 211.55/211.72  |- mesh__dateEstablished mesh__D025801 2002-01-01
% 211.55/211.72  |- skos__prefLabel mesh__D025801 Ubiquitin
% 211.55/211.72  |- mesh__recordOriginator mesh__D025801 jmp
% 211.55/211.72  |- mesh__publicMeSHNote mesh__D025801
% 211.55/211.72       2002; see UBIQUITINS %28%1985-2001%29%   
% 211.55/211.72  |- skos__altLabel mesh__D025801 HMG-20
% 211.55/211.72  |- skos__altLabel mesh__D025801 High Mobility Protein 20
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D025801 2002
% 211.55/211.72  |- skos__broader mesh__D025801smesh__D014452
% 211.55/211.72  |- mesh__dateCreated mesh__D025801 2001-07-25
% 211.55/211.72  |- mesh__historyNote mesh__D025801
% 211.55/211.72       2002; use UBIQUITINS %28%1985-2001%29%   
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D049451 2005
% 211.55/211.72  |- skos__hiddenLabel mesh__D049451 Nomogram
% 211.55/211.72  |- mesh__dateCreated mesh__D049451 2004-07-07
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D049451 2006
% 211.55/211.72  |- rdf__type mesh__D049451sskos__Concept
% 211.55/211.72  |- skos__broader mesh__D049451smesh__D015233
% 211.55/211.72  |- mesh__publicMeSHNote mesh__D049451 2005   
% 211.55/211.72  |- skos__broader mesh__D049451smesh__D003661
% 211.55/211.72  |- mesh__historyNote mesh__D049451 2005   
% 211.55/211.72  |- mesh__recordOriginator mesh__D049451 ags
% 211.55/211.72  |- skos__prefLabel mesh__D049451 Nomograms
% 211.55/211.72  |- skos__scopeNote mesh__D049451
% 211.55/211.72       Graphical representation of a statistical model containing scales for calculating the prognostic weight of a value for each individual variable. Nomograms are instruments that can be used to predict outcomes using specific clinical parameters. They use ALGORITHMS that incorporate several variables to calculate the predicted probability that a patient will achieve a particular clinical endpoint.%A%    
% 211.55/211.72  |- mesh__recordMaintainer mesh__D049451 ags
% 211.55/211.72  |- mesh__recordAuthorizer mesh__D049451 sjn
% 211.55/211.72  |- mesh__dateEstablished mesh__D049451 2005-01-01
% 211.55/211.72  |- mesh__dateCreated mesh__D016277 1990-05-29
% 211.55/211.72  |- skos__hiddenLabel mesh__D016277 Ventricular Functions, Left
% 211.55/211.72  |- skos__altLabel mesh__D016277 Left Ventricular Function
% 211.55/211.72  |- mesh__recordMaintainer mesh__D016277 nns
% 211.55/211.72  |- skos__hiddenLabel mesh__D016277 Left Ventricular Functions
% 211.55/211.72  |- skos__prefLabel mesh__D016277 Ventricular Function, Left
% 211.55/211.72  |- rdf__type mesh__D016277sskos__Concept
% 211.55/211.72  |- skos__scopeNote mesh__D016277
% 211.55/211.72       The hemodynamic and electrophysiological action of the left HEART VENTRICLE. Its measurement is an important aspect of the clinical evaluation of patients with heart disease to determine the effects of the disease on cardiac performance.%A%    
% 211.55/211.72  |- mesh__dateRevised mesh__D016277 2003-07-09
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D016277 2004
% 211.55/211.72  |- mesh__dateEstablished mesh__D016277 1991-01-01
% 211.55/211.72  |- mesh__historyNote mesh__D016277 91   
% 211.55/211.72  |- skos__historyNote mesh__D016277 Heart/physiology %28%1966-1990%29%
% 211.55/211.72  |- skos__historyNote mesh__D016277
% 211.55/211.72       Heart Ventricle/physiology %28%1968-1990%29%
% 211.55/211.72  |- skos__broader mesh__D016277smesh__D016276
% 211.55/211.72  |- skos__hiddenLabel mesh__D016277 Functions, Left Ventricular
% 211.55/211.72  |- mesh__publicMeSHNote mesh__D016277 91   
% 211.55/211.72  |- mesh__recordAuthorizer mesh__D016277 sjn
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D016277 2005
% 211.55/211.72  |- mesh__recordOriginator mesh__D016277 PXP
% 211.55/211.72  |- skos__hiddenLabel mesh__D016277 Function, Left Ventricular
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D016277 2006
% 211.55/211.72  |- skos__hiddenLabel mesh__D002257 Inhibitors, Carboxyanhydrase
% 211.55/211.72  |- skos__scopeNote mesh__D002257
% 211.55/211.72       A class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of CARBONIC ANHYDRASES.%A%    
% 211.55/211.72  |- skos__hiddenLabel mesh__D002257 Inhibitors, Carbonic Anhydrase
% 211.55/211.72  |- mesh__recordOriginator mesh__D002257 NLM
% 211.55/211.72  |- mesh__dateCreated mesh__D002257 1999-01-01
% 211.55/211.72  |- mesh__recordMaintainer mesh__D002257 ssb
% 211.55/211.72  |- mesh__dateRevised mesh__D002257 2003-07-09
% 211.55/211.72  |- mesh__publicMeSHNote mesh__D002257 65   
% 211.55/211.72  |- rdf__type mesh__D002257sskos__Concept
% 211.55/211.72  |- mesh__historyNote mesh__D002257 65%28%64%29%   
% 211.55/211.72  |- skos__annotation mesh__D002257 DF: CARBONIC ANHYDRASE INHIB   
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D002257 2005
% 211.55/211.72  |- skos__prefLabel mesh__D002257 Carbonic Anhydrase Inhibitors
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D002257 2004
% 211.55/211.72  |- mesh__dateEstablished mesh__D002257 1965-01-01
% 211.55/211.72  |- skos__hiddenLabel mesh__D002257 Inhibitors, Carbonate Dehydratase
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D002257 2006
% 211.55/211.72  |- skos__altLabel mesh__D002257 Carboxyanhydrase Inhibitors
% 211.55/211.72  |- mesh__recordAuthorizer mesh__D002257 sjn
% 211.55/211.72  |- skos__altLabel mesh__D002257 Carbonate Dehydratase Inhibitors
% 211.55/211.72  |- skos__broader mesh__D002257smesh__D004791
% 211.55/211.72  |- mesh__recordMaintainer mesh__D007740 SYSTEM
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D007740 2006
% 211.55/211.72  |- mesh__recordAuthorizer mesh__D007740 sjn
% 211.55/211.72  |- mesh__dateRevised mesh__D007740 2005-06-30
% 211.55/211.72  |- skos__prefLabel mesh__D007740 L Forms
% 211.55/211.72  |- mesh__historyNote mesh__D007740 66%28%65%29%   
% 211.55/211.72  |- skos__scopeNote mesh__D007740
% 211.55/211.72       Bacterial variants, unable to form a complete cell wall, which are formed in cultures by various bacteria; granules %28%L bodies%29% appear, unite, and grow into amorphous bodies which multiply and give rise to bacterial cells morphologically indistinguishable from the parent strain.%A%    
% 211.55/211.72  |- skos__annotation mesh__D007740
% 211.55/211.72       coord IM with specific bacterium %28%IM%29%   
% 211.55/211.72  |- skos__broader mesh__D007740smesh__D001295
% 211.55/211.72  |- mesh__recordOriginator mesh__D007740 NLM
% 211.55/211.72  |- mesh__publicMeSHNote mesh__D007740 66   
% 211.55/211.72  |- mesh__dateEstablished mesh__D007740 1966-01-01
% 211.55/211.72  |- mesh__dateCreated mesh__D007740 1999-01-01
% 211.55/211.72  |- rdf__type mesh__D007740sskos__Concept
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D012685 2005
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D012685 2006
% 211.55/211.72  |- mesh__recordAuthorizer mesh__D012685 sjn
% 211.55/211.72  |- skos__altLabel mesh__D012685 Agarose
% 211.55/211.72  |- skos__broader mesh__D012685smesh__D011134
% 211.55/211.72  |- mesh__publicMeSHNote mesh__D012685
% 211.55/211.72       84; was see under POLYSACCHARIDES 1975-83   
% 211.55/211.72  |- mesh__dateEstablished mesh__D012685 1984-01-01
% 211.55/211.72  |- mesh__dateCreated mesh__D012685 1999-01-01
% 211.55/211.72  |- skos__hiddenLabel mesh__D012685 4B, Sepharose C1
% 211.55/211.72  |- skos__prefLabel mesh__D012685 Sepharose
% 211.55/211.72  |- rdf__type mesh__D012685sskos__Concept
% 211.55/211.72  |- mesh__dateRevised mesh__D012685 2004-07-07
% 211.55/211.72  |- skos__hiddenLabel mesh__D012685 4B, Sepharose
% 211.55/211.72  |- mesh__recordMaintainer mesh__D012685 ssb
% 211.55/211.72  |- mesh__historyNote mesh__D012685
% 211.55/211.72       84%28%75%29%; was see under POLYSACCHARIDES 1975-83   
% 211.55/211.72  |- skos__hiddenLabel mesh__D012685 C1 4B, Sepharose
% 211.55/211.72  |- mesh__onlineNote mesh__D012685 search POLYSACCHARIDES 1974   
% 211.55/211.72  |- mesh__recordOriginator mesh__D012685 NLM
% 211.55/211.72  |- skos__altLabel mesh__D020319 Anti-Sense Oligodeoxyribonucleotides
% 211.55/211.72  |- skos__broader mesh__D020319smesh__D016376
% 211.55/211.72  |- skos__historyNote mesh__D020319 DNA, Antisense %28%1991-1998%29%
% 211.55/211.72  |- skos__altLabel mesh__D020319 Oligodeoxyribonucleotide, Antisense
% 211.55/211.72  |- skos__annotation mesh__D020319 DF: ANTISENSE OLIGODNA   
% 211.55/211.72  |- skos__historyNote mesh__D020319
% 211.55/211.72       Oligonucleotides, Antisense %28%1991-1998%29%
% 211.55/211.72  |- skos__altLabel mesh__D020319 Antisense OligoDNA
% 211.55/211.72  |- skos__altLabel mesh__D020319 Antisense Oligodeoxyribonucleotides
% 211.55/211.72  |- mesh__dateEstablished mesh__D020319 1999-01-01
% 211.55/211.72  |- skos__broader mesh__D020319smesh__D016373
% 211.55/211.72  |- rdf__type mesh__D020319sskos__Concept
% 211.55/211.72  |- mesh__historyNote mesh__D020319
% 211.55/211.72       99; was OLIGONUCLEOTIDES, ANTISENSE 1991-98   
% 211.55/211.72  |- mesh__dateRevised mesh__D020319 2003-07-09
% 211.55/211.72  |- skos__prefLabel mesh__D020319 Oligodeoxyribonucleotides, Antisense
% 211.55/211.72  |- skos__hiddenLabel mesh__D020319 Antisense Oligodeoxyribonucleotide
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D020319 2004
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D020319 2006
% 211.55/211.72  |- skos__hiddenLabel mesh__D020319 OligoDNA, Antisense
% 211.55/211.72  |- mesh__publicMeSHNote mesh__D020319
% 211.55/211.72       99; see OLIGONUCLEOTIDES, ANTISENSE 1991-98   
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D020319 2005
% 211.55/211.72  |- skos__hiddenLabel mesh__D020319 Anti Sense Oligodeoxyribonucleotides
% 211.55/211.72  |- skos__hiddenLabel mesh__D020319 Oligodeoxyribonucleotides, Anti-Sense
% 211.55/211.72  |- mesh__dateCreated mesh__D020319 1998-06-10
% 211.55/211.72  |- skos__scopeNote mesh__D020319
% 211.55/211.72       Short fragments of DNA that are used to alter the function of target RNAs or DNAs to which they hybridize.%A%    
% 211.55/211.72  |- rdf__type mesh__D006648sskos__Concept
% 211.55/211.72  |- skos__historyNote mesh__D006648
% 211.55/211.72       Transplantation Immunology %28%1966-1967%29%
% 211.55/211.72  |- skos__hiddenLabel mesh__D006648 Histocompatibilities
% 211.55/211.72  |- skos__prefLabel mesh__D006648 Histocompatibility
% 211.55/211.72  |- skos__hiddenLabel mesh__D006648 Compatibility, Tissue
% 211.55/211.72  |- skos__hiddenLabel mesh__D006648 Tissue Compatibilities
% 211.55/211.72  |- mesh__historyNote mesh__D006648 70%28%68%29%   
% 211.55/211.72  |- skos__altLabel mesh__D006648 Tissue Compatibility
% 211.55/211.72  |- mesh__recordMaintainer mesh__D006648 nns
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D006648 2006
% 211.55/211.72  |- mesh__recordOriginator mesh__D006648 NLM
% 211.55/211.72  |- mesh__dateEstablished mesh__D006648 1970-01-01
% 211.55/211.72  |- skos__broader mesh__D006648smesh__D014181
% 211.55/211.72  |- mesh__dateRevised mesh__D006648 2005-06-30
% 211.55/211.72  |- mesh__dateCreated mesh__D006648 1999-01-01
% 211.55/211.72  |- mesh__recordAuthorizer mesh__D006648 sjn
% 211.55/211.72  |- skos__hiddenLabel mesh__D006648 Compatibilities, Tissue
% 211.55/211.72  |- mesh__publicMeSHNote mesh__D006648 70   
% 211.55/211.72  |- skos__scopeNote mesh__D006648
% 211.55/211.72       The degree of antigenic similarity between the tissues of different individuals, which determines the acceptance or rejection of allografts.%A%    
% 211.55/211.72  |- mesh__publicMeSHNote mesh__D017370
% 211.55/211.72       93; INTERLEUKIN-11 was indexed under INTERLEUKINS 1990-92%A%  
% 211.55/211.72  |- mesh__recordMaintainer mesh__D017370 ssb
% 211.55/211.72  |- mesh__recordAuthorizer mesh__D017370 sjn
% 211.55/211.72  |- skos__historyNote mesh__D017370 Interleukins %28%1990-1992%29%
% 211.55/211.72  |- skos__altLabel mesh__D017370 IL11
% 211.55/211.72  |- skos__prefLabel mesh__D017370 Interleukin-11
% 211.55/211.72  |- skos__hiddenLabel mesh__D017370 Factor, Adipogenesis Inhibitory
% 211.55/211.72  |- skos__annotation mesh__D017370 DF: IL 11 or IL11   
% 211.55/211.72  |- skos__altLabel mesh__D017370 Adipogenesis Inhibitory Factor
% 211.55/211.72  |- mesh__onlineNote mesh__D017370
% 211.55/211.72       use INTERLEUKIN-11 %28%NM%29% to search INTERLEUKIN 11 1990-92   
% 211.55/211.72  |- mesh__dateEstablished mesh__D017370 1993-01-01
% 211.55/211.72  |- skos__broader mesh__D017370smesh__D007378
% 211.55/211.72  |- skos__scopeNote mesh__D017370
% 211.55/211.72       Lymphohematopoietic cytokine that has the ability to modulate antigen-specific antibody responses, potentiate megakaryocytes, and regulate bone marrow adipogenesis.%A%    
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D017370 2006
% 211.55/211.72  |- skos__altLabel mesh__D017370 IL-11
% 211.55/211.72  |- mesh__dateRevised mesh__D017370 2005-06-30
% 211.55/211.72  |- skos__hiddenLabel mesh__D017370 Interleukin 11
% 211.55/211.72  |- mesh__recordOriginator mesh__D017370 AGS
% 211.55/211.72  |- mesh__dateCreated mesh__D017370 1992-05-20
% 211.55/211.72  |- mesh__historyNote mesh__D017370
% 211.55/211.72       93; was INTERLEUKIN 11 %28%NM%29% 1990-92   
% 211.55/211.72  |- skos__hiddenLabel mesh__D017370 Inhibitory Factor, Adipogenesis
% 211.55/211.72  |- rdf__type mesh__D017370sskos__Concept
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D031041 2004
% 211.55/211.72  |- mesh__dateCreated mesh__D031041 2002-07-02
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D031041 2005
% 211.55/211.72  |- skos__broader mesh__D031041smesh__D029061
% 211.55/211.72  |- skos__prefLabel mesh__D031041 Annona
% 211.55/211.72  |- skos__scopeNote mesh__D031041
% 211.55/211.72       A plant genus of the family ANNONACEAE. It has edible fruit and seeds which contain acetogenins and benzoquinazoline and other alkaloids.%A%    
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D031041 2006
% 211.55/211.72  |- mesh__publicMeSHNote mesh__D031041 2003   
% 211.55/211.72  |- mesh__historyNote mesh__D031041 2003   
% 211.55/211.72  |- skos__altLabel mesh__D031041 Cherimoya
% 211.55/211.72  |- skos__altLabel mesh__D031041 Soursop
% 211.55/211.72  |- skos__annotation mesh__D031041
% 211.55/211.72       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D031041 2003
% 211.55/211.72  |- mesh__dateEstablished mesh__D031041 2003-01-01
% 211.55/211.72  |- rdf__type mesh__D031041sskos__Concept
% 211.55/211.72  |- rdf__type mesh__D025802sskos__Concept
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D025802 2002
% 211.55/211.72  |- mesh__dateCreated mesh__D025802 2001-07-25
% 211.55/211.72  |- skos__hiddenLabel mesh__D025802 Capacitance, Electric
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D025802 2006
% 211.55/211.72  |- mesh__publicMeSHNote mesh__D025802
% 211.55/211.72       2002; see ELECTRIC CONDUCTIVITY 1968-2001   
% 211.55/211.72  |- skos__historyNote mesh__D025802 Electric Conductivity %28%1968-2001%29%
% 211.55/211.72  |- skos__altLabel mesh__D025802 Capacitance, Electrical
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D025802 2004
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D025802 2005
% 211.55/211.72  |- skos__prefLabel mesh__D025802 Electric Capacitance
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D025802 2003
% 211.55/211.72  |- mesh__dateEstablished mesh__D025802 2002-01-01
% 211.55/211.72  |- mesh__historyNote mesh__D025802
% 211.55/211.72       2002; use ELECTRIC CONDUCTIVITY 1968-2001   
% 211.55/211.72  |- skos__broader mesh__D025802smesh__D004594
% 211.55/211.72  |- skos__scopeNote mesh__D025802
% 211.55/211.72       The ability of a substrate to retain an electrical charge.%A%    
% 211.55/211.72  |- skos__broader mesh__D025802smesh__D004560
% 211.55/211.72  |- skos__altLabel mesh__D025802 Electrical Capacitance
% 211.55/211.72  |- mesh__recordAuthorizer mesh__D003350 sjn
% 211.55/211.72  |- mesh__recordOriginator mesh__D003350 NLM
% 211.55/211.72  |- skos__hiddenLabel mesh__D003350 S, Reichstein%27%s Substance
% 211.55/211.72  |- skos__hiddenLabel mesh__D003350 Substance S, Reichstein%27%s
% 211.55/211.72  |- skos__hiddenLabel mesh__D003350 Reichstein Substance S
% 211.55/211.72  |- skos__broader mesh__D003350smesh__D015065
% 211.55/211.72  |- skos__broader mesh__D003350smesh__D011282
% 211.55/211.72  |- skos__altLabel mesh__D003350 11-Desoxycortisol
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D003350 2005
% 211.55/211.72  |- skos__annotation mesh__D003350 an anti-inflamm agent   
% 211.55/211.72  |- mesh__publicMeSHNote mesh__D003350
% 211.55/211.72       91; was see under 17-HYDROXYCORTICOSTEROIDS 1975-90   
% 211.55/211.72  |- skos__altLabel mesh__D003350 Cortexolone
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D003350 2006
% 211.55/211.72  |- skos__scopeNote mesh__D003350
% 211.55/211.72       17,21-Dihydroxypregn-4-ene-3,20-dione. A 17-hydroxycorticosteroid with glucocorticoid and anti-inflammatory activities.%A%    
% 211.55/211.72  |- skos__altLabel mesh__D003350 11-Deoxycortisol
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D003350 2004
% 211.55/211.72  |- skos__hiddenLabel mesh__D003350 11 Desoxycortisol
% 211.55/211.72  |- mesh__dateEstablished mesh__D003350 1991-01-01
% 211.55/211.72  |- skos__historyNote mesh__D003350 Pregnenediones %28%1974%29%
% 211.55/211.72  |- skos__hiddenLabel mesh__D003350 11 Deoxycortisol
% 211.55/211.72  |- rdf__type mesh__D003350sskos__Concept
% 211.55/211.72  |- skos__historyNote mesh__D003350 17-Hydroxycorticosteroids %28%1974%29%
% 211.55/211.72  |- skos__hiddenLabel mesh__D003350 11 Desoxycortisone
% 211.55/211.72  |- skos__altLabel mesh__D003350 Reichstein%27%s Substance S
% 211.55/211.72  |- mesh__dateRevised mesh__D003350 2003-07-09
% 211.55/211.72  |- mesh__historyNote mesh__D003350
% 211.55/211.72       91%28%75%29%; was see under 17-HYDROXYCORTICOSTEROIDS 1975-90   
% 211.55/211.72  |- skos__altLabel mesh__D003350 11-Desoxycortisone
% 211.55/211.72  |- skos__hiddenLabel mesh__D003350 Reichsteins Substance S
% 211.55/211.72  |- mesh__recordMaintainer mesh__D003350 ssb
% 211.55/211.72  |- mesh__dateCreated mesh__D003350 1974-11-11
% 211.55/211.72  |- skos__prefLabel mesh__D003350 Cortodoxone
% 211.55/211.72  |- skos__scopeNote mesh__D044767
% 211.55/211.72       A diverse class of enzymes that interact with UBIQUITIN-CONJUGATING ENZYMES and ubiquitination-specific protein substrates. Each member of this enzyme group has its own distinct specificity for a substrate and ubiquitin-conjugating enzyme. Ubiquitin-protein ligases exist as both monomeric proteins multiprotein complexes.%A%    
% 211.55/211.72  |- mesh__recordAuthorizer mesh__D044767 sjn
% 211.55/211.72  |- skos__altLabel mesh__D044767 E3 Ubiquitin Ligase
% 211.55/211.72  |- mesh__dateEstablished mesh__D044767 2004-01-01
% 211.55/211.72  |- skos__hiddenLabel mesh__D044767 Ubiquitin Protein Ligase E3
% 211.55/211.72  |- mesh__recordMaintainer mesh__D044767 jmp
% 211.55/211.72  |- mesh__recordOriginator mesh__D044767 jmp
% 211.55/211.72  |- mesh__historyNote mesh__D044767
% 211.55/211.72       2004; use UBIQUITIN-PROTEIN LIGASE %28%NM%29% 1983-2003   
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D044767 2005
% 211.55/211.72  |- skos__hiddenLabel mesh__D044767 Ligase, E3 Ubiquitin
% 211.55/211.72  |- skos__hiddenLabel mesh__D044767 E3, Ubiquitin Ligase
% 211.55/211.72  |- skos__broader mesh__D044767smesh__D043743
% 211.55/211.72  |- rdf__type mesh__D044767sskos__Concept
% 211.55/211.72  |- skos__hiddenLabel mesh__D044767 Ligase, Ubiquitin-Protein
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D044767 2006
% 211.55/211.72  |- skos__altLabel mesh__D044767 E3 Ligase
% 211.55/211.72  |- skos__altLabel mesh__D044767 Ubiquitin-Protein Ligase
% 211.55/211.72  |- mesh__activeMeSHYear mesh__D044767 2004
% 211.55/211.72  |- skos__historyNote mesh__D044767 Ligases %28%1983-2003%29%
% 211.55/211.72  |- skos__prefLabel mesh__D044767 Ubiquitin-Protein Ligases
% 211.55/211.72  |- skos__hiddenLabel mesh__D044767 Ubiquitin Protein Ligases
% 211.55/211.72  |- skos__altLabel mesh__D044767 Ubiquitin-Protein Ligase E3
% 211.55/211.72  |- skos__hiddenLabel mesh__D044767 Ligases, Ubiquitin-Protein
% 211.55/211.72  |- skos__hiddenLabel mesh__D044767 Ubiquitin Ligase, E3
% 211.55/211.72  |- skos__hiddenLabel mesh__D044767 Ligase E3, Ubiquitin-Protein
% 211.55/211.72  |- skos__annotation mesh__D044767
% 211.55/211.72       UBIQUITIN-PROTEIN LIGASE COMPLEXES is also available   
% 211.55/211.72  |- mesh__publicMeSHNote mesh__D044767
% 211.55/211.72       2004; UBIQUITIN-PROTEIN LIGASE was indexed under LIGASES 1983-2003; E3 UBIQUITIN LIGASE was indexed under LIGASES 1993-2003%A%  
% 211.55/211.72  |- skos__hiddenLabel mesh__D044767 Ubiquitin Protein Ligase
% 211.55/211.72  |- mesh__dateCreated mesh__D044767 2003-07-09
% 211.55/211.72  |- skos__hiddenLabel mesh__D044767 Ligase E3, Ubiquitin
% 211.55/211.72  |- skos__altLabel mesh__D044767 Ubiquitin Ligase E3
% 211.55/211.72  |- skos__hiddenLabel mesh__D044767 Ligase, E3
% 211.55/211.72  |- skos__hiddenLabel mesh__D049452 Proteins, Green-Fluorescent
% 211.55/211.72  |- mesh__dateEstablished mesh__D049452 2005-01-01
% 211.55/211.72  |- mesh__dateCreated mesh__D049452 2004-07-08
% 211.55/211.73  |- mesh__recordMaintainer mesh__D049452 SYSTEM
% 211.55/211.73  |- skos__historyNote mesh__D049452 Luminescent Proteins %28%1992-2004%29%
% 211.55/211.73  |- mesh__recordAuthorizer mesh__D049452 sjn
% 211.55/211.73  |- skos__hiddenLabel mesh__D049452 Proteins, Green Fluorescent
% 211.55/211.73  |- mesh__historyNote mesh__D049452 2005%28%1992%29%   
% 211.55/211.73  |- skos__altLabel mesh__D049452 Green-Fluorescent Proteins
% 211.55/211.73  |- skos__prefLabel mesh__D049452 Green Fluorescent Proteins
% 211.55/211.73  |- mesh__dateRevised mesh__D049452 2005-06-30
% 211.55/211.73  |- mesh__recordOriginator mesh__D049452 ssb
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D049452 2006
% 211.55/211.73  |- mesh__publicMeSHNote mesh__D049452
% 211.55/211.73       2005; GREEN FLUORESCENT PROTEIN %28%now GREEN FLUORESCENT PROTEINS%29% was indexed under LUMINESCENT PROTEINS 1992-2004%A%  
% 211.55/211.73  |- skos__scopeNote mesh__D049452
% 211.55/211.73       Protein analogs and derivatives of the Aequorea victoria green fluorescent protein that emit light %28%FLUORESCENCE%29% when excited with ULTRAVIOLET RAYS. They are used in REPORTER GENES in doing GENETIC TECHNIQUES. Numerous mutants have been made to emit other colors or be sensitive to pH.%A%    
% 211.55/211.73  |- skos__hiddenLabel mesh__D049452 Fluorescent Proteins, Green
% 211.55/211.73  |- rdf__type mesh__D049452sskos__Concept
% 211.55/211.73  |- skos__broader mesh__D049452smesh__D008164
% 211.55/211.73  |- skos__prefLabel mesh__D016278 Ventricular Function, Right
% 211.55/211.73  |- skos__hiddenLabel mesh__D016278 Ventricular Functions, Right
% 211.55/211.73  |- rdf__type mesh__D016278sskos__Concept
% 211.55/211.73  |- skos__altLabel mesh__D016278 Right Ventricular Function
% 211.55/211.73  |- mesh__dateRevised mesh__D016278 2003-07-09
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D016278 2004
% 211.55/211.73  |- mesh__dateEstablished mesh__D016278 1991-01-01
% 211.55/211.73  |- mesh__historyNote mesh__D016278 91   
% 211.55/211.73  |- skos__broader mesh__D016278smesh__D016276
% 211.55/211.73  |- skos__scopeNote mesh__D016278
% 211.55/211.73       The hemodynamic and electrophysiological action of the right HEART VENTRICLE.%A%    
% 211.55/211.73  |- mesh__recordMaintainer mesh__D016278 nns
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D016278 2005
% 211.55/211.73  |- mesh__recordOriginator mesh__D016278 PXP
% 211.55/211.73  |- skos__hiddenLabel mesh__D016278 Right Ventricular Functions
% 211.55/211.73  |- skos__historyNote mesh__D016278 Heart/physiology %28%1966-1990%29%
% 211.55/211.73  |- skos__historyNote mesh__D016278
% 211.55/211.73       Heart Ventricle/physiology %28%1968-1990%29%
% 211.55/211.73  |- skos__hiddenLabel mesh__D016278 Functions, Right Ventricular
% 211.55/211.73  |- skos__hiddenLabel mesh__D016278 Function, Right Ventricular
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D016278 2006
% 211.55/211.73  |- mesh__dateCreated mesh__D016278 1990-05-29
% 211.55/211.73  |- mesh__publicMeSHNote mesh__D016278 91   
% 211.55/211.73  |- mesh__recordAuthorizer mesh__D016278 sjn
% 211.55/211.73  |- mesh__dateRevised mesh__D002258 2000-06-22
% 211.55/211.73  |- mesh__historyNote mesh__D002258
% 211.55/211.73       91%28%75%29%; was see under NITRILES 1975-90   
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D002258 2003
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D002258 2001
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D002258 2005
% 211.55/211.73  |- skos__broader mesh__D002258smesh__D006835
% 211.55/211.73  |- skos__broader mesh__D002258smesh__D009570
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D002258 2004
% 211.55/211.73  |- skos__historyNote mesh__D002258 Chlorobenzenes %28%1974%29%
% 211.55/211.73  |- mesh__recordAuthorizer mesh__D002258 sjn
% 211.55/211.73  |- mesh__recordMaintainer mesh__D002258 CCR
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D002258 2006
% 211.55/211.73  |- skos__scopeNote mesh__D002258
% 211.55/211.73       A proton ionophore. It is commonly used as an uncoupling agent and inhibitor of photosynthesis because of its effects on mitochondrial and chloroplast membranes.%A%    
% 211.55/211.73  |- skos__altLabel mesh__D002258 CCCP
% 211.55/211.73  |- mesh__recordOriginator mesh__D002258 NLM
% 211.55/211.73  |- mesh__publicMeSHNote mesh__D002258 91; was see under NITRILES 1975-90   
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D002258 2002
% 211.55/211.73  |- skos__altLabel mesh__D002258 Carbonyl Cyanide m Chlorophenyl Hydrazone
% 211.55/211.73  |- mesh__dateCreated mesh__D002258 1974-11-11
% 211.55/211.73  |- mesh__dateEstablished mesh__D002258 1991-01-01
% 211.55/211.73  |- skos__historyNote mesh__D002258 Nitriles %28%1970-1974%29%
% 211.55/211.73  |- skos__prefLabel mesh__D002258 Carbonyl Cyanide m-Chlorophenyl Hydrazone
% 211.55/211.73  |- skos__hiddenLabel mesh__D002258
% 211.55/211.73       Carbonyl Cyanide meta Chlorophenyl Hydrazone
% 211.55/211.73  |- skos__altLabel mesh__D002258
% 211.55/211.73       Carbonyl Cyanide meta-Chlorophenyl Hydrazone
% 211.55/211.73  |- skos__historyNote mesh__D002258 Hydrazones %28%1972-1974%29%
% 211.55/211.73  |- rdf__type mesh__D002258sskos__Concept
% 211.55/211.73  |- skos__hiddenLabel mesh__D007741 Hydrochloride, Labetalol
% 211.55/211.73  |- skos__altLabel mesh__D007741
% 211.55/211.73       Glaxo Wellcome Brand of Labetalol Hydrochloride
% 211.55/211.73  |- mesh__recordOriginator mesh__D007741 NLM
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D007741 2006
% 211.55/211.73  |- mesh__publicMeSHNote mesh__D007741
% 211.55/211.73       86; was see under ETHANOLAMINES 1978-85; was AH 5158 see under ETHANOLAMINES 1975-77%A%  
% 211.55/211.73  |- skos__altLabel mesh__D007741 Labetolol
% 211.55/211.73  |- skos__scopeNote mesh__D007741
% 211.55/211.73       Blocker of both alpha- and beta-adrenergic receptors that is used as an antihypertensive.%A%    
% 211.55/211.73  |- skos__hiddenLabel mesh__D007741 SCH 19927
% 211.55/211.73  |- skos__altLabel mesh__D007741 Apotex Brand of Labetalol Hydrochloride
% 211.55/211.73  |- skos__altLabel mesh__D007741 Kern Brand of Labetalol Hydrochloride
% 211.55/211.73  |- skos__broader mesh__D007741smesh__D004983
% 211.55/211.73  |- skos__hiddenLabel mesh__D007741 SCH19927
% 211.55/211.73  |- skos__altLabel mesh__D007741 Alphapharm Brand of Labetalol Hydrochloride
% 211.55/211.73  |- skos__altLabel mesh__D007741 Celltech Brand of Labetalol Hydrochloride
% 211.55/211.73  |- mesh__recordMaintainer mesh__D007741 jmp
% 211.55/211.73  |- skos__altLabel mesh__D007741 Shire Brand of Labetalol Hydrochloride
% 211.55/211.73  |- mesh__dateCreated mesh__D007741 1974-11-19
% 211.55/211.73  |- skos__historyNote mesh__D007741 Ethanolamines %28%1974%29%
% 211.55/211.73  |- skos__prefLabel mesh__D007741 Labetalol
% 211.55/211.73  |- mesh__recordAuthorizer mesh__D007741 sjn
% 211.55/211.73  |- skos__historyNote mesh__D007741 Salicylamides %28%1974%29%
% 211.55/211.73  |- skos__altLabel mesh__D007741
% 211.55/211.73       GlaxoSmithKline Brand of Labetalol Hydrochloride
% 211.55/211.73  |- skos__altLabel mesh__D007741 Prometheus Brand of Labetalol Hydrochloride
% 211.55/211.73  |- mesh__historyNote mesh__D007741
% 211.55/211.73       86%28%78%29%; was see under ETHANOLAMINES 1978-85; was AH 5158 see under ETHANOLAMINES 1975-77%A%  
% 211.55/211.73  |- mesh__dateEstablished mesh__D007741 1986-01-01
% 211.55/211.73  |- skos__hiddenLabel mesh__D007741 AH5158
% 211.55/211.73  |- mesh__onlineNote mesh__D007741
% 211.55/211.73       use LABETALOL to search AH 5158 1975-77   
% 211.55/211.73  |- skos__altLabel mesh__D007741 Sigma Brand of Labetalol Hydrochloride
% 211.55/211.73  |- rdf__type mesh__D007741sskos__Concept
% 211.55/211.73  |- skos__historyNote mesh__D007741 Butylamines %28%1974%29%
% 211.55/211.73  |- mesh__dateRevised mesh__D007741 2004-07-07
% 211.55/211.73  |- skos__hiddenLabel mesh__D007741 AH 5158
% 211.55/211.73  |- skos__hiddenLabel mesh__D007741 ApoLabetalol
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D007741 2005
% 211.55/211.73  |- skos__hiddenLabel mesh__D007741 Apo Labetalol
% 211.55/211.73  |- skos__altLabel mesh__D007741 Schering Brand of Labetalol Hydrochloride
% 211.55/211.73  |- skos__hiddenLabel mesh__D012686 Septal Nucleus, Triangular
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D012686 2006
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D012686 2000
% 211.55/211.73  |- mesh__recordOriginator mesh__D012686 NLM
% 211.55/211.73  |- skos__prefLabel mesh__D012686 Septal Nuclei
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D012686 2001
% 211.55/211.73  |- mesh__dateEstablished mesh__D012686 1978-01-01
% 211.55/211.73  |- mesh__publicMeSHNote mesh__D012686
% 211.55/211.73       78; was see under SEPTUM PELLUCIDUM 1975-77   
% 211.55/211.73  |- mesh__dateCreated mesh__D012686 1999-01-01
% 211.55/211.73  |- skos__historyNote mesh__D012686 Cerebral Ventricles %28%1966-1971%29%
% 211.55/211.73  |- skos__hiddenLabel mesh__D012686 Nuclei, Septal
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D012686 2002
% 211.55/211.73  |- mesh__recordAuthorizer mesh__D012686 sjn
% 211.55/211.73  |- mesh__recordMaintainer mesh__D012686 ags
% 211.55/211.73  |- skos__scopeNote mesh__D012686
% 211.55/211.73       Neural nuclei situated in the septal region. They have afferent and cholinergic efferent connections with a variety of forebrain and brainstem areas including the hippocampus, the lateral hypothalamus, the tegmentum, and the amygdala. Included are the dorsal, lateral, medial, and triangular septal nuclei, septofimbrial nucleus, nucleus of diagonal band, nucleus of anterior commissure, and the nucleus of stria terminalis.%A%    
% 211.55/211.73  |- skos__hiddenLabel mesh__D012686 Septal Nucleus, Medial
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D012686 2003
% 211.55/211.73  |- rdf__type mesh__D012686sskos__Concept
% 211.55/211.73  |- skos__hiddenLabel mesh__D012686 Anterior Commissure Nucleus
% 211.55/211.73  |- skos__historyNote mesh__D012686 Limbic System %28%1966-1971%29%
% 211.55/211.73  |- skos__hiddenLabel mesh__D012686 Septal Nucleus, Dorsal
% 211.55/211.73  |- skos__hiddenLabel mesh__D012686 Stria Terminalis Nucleus
% 211.55/211.73  |- skos__hiddenLabel mesh__D012686 Nucleus, Septofimbrial
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D012686 2004
% 211.55/211.73  |- skos__hiddenLabel mesh__D012686 Septal Nucleus, Lateral
% 211.55/211.73  |- skos__broader mesh__D012686smesh__D020665
% 211.55/211.73  |- skos__historyNote mesh__D012686 Hippocampus %28%1966-1971%29%
% 211.55/211.73  |- mesh__dateRevised mesh__D012686 1999-11-04
% 211.55/211.73  |- skos__hiddenLabel mesh__D012686 Nucleus, Medial Septal
% 211.55/211.73  |- skos__hiddenLabel mesh__D012686 Nucleus, Lateral Septal
% 211.55/211.73  |- mesh__historyNote mesh__D012686
% 211.55/211.73       78%28%72%29%; was see under SEPTUM PELLUCIDUM 1975-77   
% 211.55/211.73  |- skos__hiddenLabel mesh__D012686 Nucleus, Triangular Septal
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D012686 2005
% 211.55/211.73  |- skos__hiddenLabel mesh__D012686 Nucleus, Dorsal Septal
% 211.55/211.73  |- skos__altLabel mesh__D012686 Bed Nucleus of Stria Terminalis
% 211.55/211.73  |- skos__hiddenLabel mesh__D012686 Diagonal Band Nucleus
% 211.55/211.73  |- mesh__recordAuthorizer mesh__D039823 sjn
% 211.55/211.73  |- skos__broader mesh__D039823smesh__D039821
% 211.55/211.73  |- mesh__publicMeSHNote mesh__D039823
% 211.55/211.73       2003; IRIDOIDGLUCOSIDES was indexed under GLUCOSIDES 1975-2002%A%  
% 211.55/211.73  |- skos__hiddenLabel mesh__D039823 Glucosides, Secoiridoid
% 211.55/211.73  |- mesh__dateCreated mesh__D039823 2002-07-03
% 211.55/211.73  |- mesh__recordMaintainer mesh__D039823 ssb
% 211.55/211.73  |- skos__prefLabel mesh__D039823 Iridoids
% 211.55/211.73  |- skos__historyNote mesh__D039823 Pyrans %28%1972-2002%29%
% 211.55/211.73  |- mesh__historyNote mesh__D039823
% 211.55/211.73       2003; for IRIDOIDGLUCOSIDES use IRIDOIDS %28%NM%29% 1975-2002   
% 211.55/211.73  |- skos__historyNote mesh__D039823 Terpenes %28%1968-2002%29%
% 211.55/211.73  |- mesh__dateEstablished mesh__D039823 2003-01-01
% 211.55/211.73  |- rdf__type mesh__D039823sskos__Concept
% 211.55/211.73  |- skos__altLabel mesh__D039823 Iridoid Glucosides
% 211.55/211.73  |- skos__annotation mesh__D039823
% 211.55/211.73       do not confuse with iridal see TRITERPENES   
% 211.55/211.73  |- skos__hiddenLabel mesh__D039823 Glucosides, Iridoid
% 211.55/211.73  |- mesh__dateRevised mesh__D039823 2005-06-30
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D039823 2006
% 211.55/211.73  |- mesh__recordOriginator mesh__D039823 ssb
% 211.55/211.73  |- skos__scopeNote mesh__D039823
% 211.55/211.73       A type of MONOTERPENES, derived from geraniol.  They have the general form of cyclopentanopyran, but in some cases, one of the rings is broken as in the case of secoiridoid. They are different from the similarly named iridals %28%TRITERPENES%29%.%A%    
% 211.55/211.73  |- skos__broader mesh__D039823smesh__D011714
% 211.55/211.73  |- skos__altLabel mesh__D006649 Antigens, Transplantation
% 211.55/211.73  |- rdf__type mesh__D006649sskos__Concept
% 211.55/211.73  |- skos__scopeNote mesh__D006649
% 211.55/211.73       A group of antigens that includes both the major and minor histocompatibility antigens. The former are genetically determined by the major histocompatibility complex. They determine tissue type for transplantation and cause allograft rejections. The latter are systems of allelic alloantigens that can cause weak transplant rejection.%A%    
% 211.55/211.73  |- mesh__publicMeSHNote mesh__D006649 73   
% 211.55/211.73  |- mesh__historyNote mesh__D006649 73   
% 211.55/211.73  |- skos__altLabel mesh__D006649 Histocompatibility Antigen
% 211.55/211.73  |- mesh__recordOriginator mesh__D006649 NLM
% 211.55/211.73  |- mesh__recordAuthorizer mesh__D006649 ags
% 211.55/211.73  |- skos__historyNote mesh__D006649 Transplantation %28%1966-1972%29%
% 211.55/211.73  |- skos__broader mesh__D006649smesh__D007519
% 211.55/211.73  |- skos__historyNote mesh__D006649 Immunology %28%1966-1972%29%
% 211.55/211.73  |- skos__hiddenLabel mesh__D006649 Antigens, Histocompatibility
% 211.55/211.73  |- mesh__recordMaintainer mesh__D006649 ags
% 211.55/211.73  |- skos__historyNote mesh__D006649
% 211.55/211.73       Transplantation Immunology %28%1966-1969%29%
% 211.55/211.73  |- skos__hiddenLabel mesh__D006649 Antigens, SD
% 211.55/211.73  |- mesh__dateCreated mesh__D006649 1999-01-01
% 211.55/211.73  |- skos__annotation mesh__D006649
% 211.55/211.73       GEN or unspecified only; prefer specifics but for humans, use HLA ANTIGENS; /genet permitted but consider also MAJOR HISTOCOMPATIBILITY COMPLEX%A%  
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D006649 2006
% 211.55/211.73  |- skos__historyNote mesh__D006649 Histocompatibility %28%1970-1972%29%
% 211.55/211.73  |- skos__hiddenLabel mesh__D006649 Antigens, LD
% 211.55/211.73  |- mesh__dateEstablished mesh__D006649 1973-01-01
% 211.55/211.73  |- skos__prefLabel mesh__D006649 Histocompatibility Antigens
% 211.55/211.73  |- skos__broader mesh__D006649smesh__D000954
% 211.55/211.73  |- skos__altLabel mesh__D006649 Transplantation Antigens
% 211.55/211.73  |- mesh__dateRevised mesh__D006649 2005-07-18
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D006649 2006A
% 211.55/211.73  |- skos__hiddenLabel mesh__D006649 Antigen, Histocompatibility
% 211.55/211.73  |- skos__altLabel mesh__D017371 8-OH-DPAT
% 211.55/211.73  |- mesh__dateRevised mesh__D017371 2001-07-25
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D017371 2004
% 211.55/211.73  |- mesh__recordMaintainer mesh__D017371 ssb
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D017371 2005
% 211.55/211.73  |- mesh__recordAuthorizer mesh__D017371 sjn
% 211.55/211.73  |- mesh__recordOriginator mesh__D017371 TPW
% 211.55/211.73  |- skos__prefLabel mesh__D017371
% 211.55/211.73       8-Hydroxy-2-%28%di-n-propylamino%29%tetralin
% 211.55/211.73  |- mesh__publicMeSHNote mesh__D017371
% 211.55/211.73       93; 8-HYDROXY-2-%28%DI-N-PROPYLAMINO%29%TETRALIN was indexed under TETRAHYDRONAPHTHALENES 1982-92%A%  
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D017371 2006
% 211.55/211.73  |- skos__scopeNote mesh__D017371
% 211.55/211.73       A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.%A%    
% 211.55/211.73  |- mesh__dateEstablished mesh__D017371 1993-01-01
% 211.55/211.73  |- mesh__historyNote mesh__D017371
% 211.55/211.73       93; was 8-HYDROXY-2-%28%DI-N-PROPYLAMINO%29%TETRALIN %28%NM%29% 1982-92%A%  
% 211.55/211.73  |- rdf__type mesh__D017371sskos__Concept
% 211.55/211.73  |- skos__broader mesh__D017371smesh__D013764
% 211.55/211.73  |- mesh__onlineNote mesh__D017371
% 211.55/211.73       use 8-HYDROXY-2-%28%DI-N-PROPYLAMINO%29%TETRALIN %28%NM%29% to search 8-HYDROXY-2-%28%DI-N-PROPYLAMINO%29%TETRALIN 1982-92%A%  
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D017371 2002
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D017371 2003
% 211.55/211.73  |- skos__historyNote mesh__D017371 Tetrahydronaphthalenes %28%1982-1992%29%
% 211.55/211.73  |- mesh__dateCreated mesh__D017371 1992-05-22
% 211.55/211.73  |- mesh__dateEstablished mesh__D031042 2003-01-01
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D031042 2006
% 211.55/211.73  |- mesh__publicMeSHNote mesh__D031042 2003   
% 211.55/211.73  |- mesh__dateCreated mesh__D031042 2002-07-02
% 211.55/211.73  |- skos__broader mesh__D031042smesh__D029061
% 211.55/211.73  |- skos__annotation mesh__D031042
% 211.55/211.73       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D031042 2003
% 211.55/211.73  |- rdf__type mesh__D031042sskos__Concept
% 211.55/211.73  |- skos__scopeNote mesh__D031042
% 211.55/211.73       A plant genus of the family ANNONACEAE. It has edible fruit and seeds which contain asitrocin, asitrilobins, and other tetrahydrofuran acetogenins.%A%    
% 211.55/211.73  |- skos__altLabel mesh__D031042 Pawpaw
% 211.55/211.73  |- mesh__historyNote mesh__D031042 2003   
% 211.55/211.73  |- skos__prefLabel mesh__D031042 Asimina
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D031042 2004
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D031042 2005
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D025803 2006A
% 211.55/211.73  |- skos__scopeNote mesh__D025803
% 211.55/211.73       A gene product of the p16 tumor suppressor gene %28%GENES, P16%29%. It antagonizes the function of MDM2 PROTEIN %28%which regulates P53 TUMOR SUPPRESSOR PROTEIN by targeting it for degradation%29%. p14ARF is produced from the beta mRNA transcript of the p16 gene. The other gene product, produced from the alternatively spliced alpha transcript, is CYCLIN-DEPENDENT KINASE INHIBITOR P16.  Both p16 gene products have tumor suppressor functions.%A%    
% 211.55/211.73  |- mesh__recordOriginator mesh__D025803 nns
% 211.55/211.73  |- mesh__dateEstablished mesh__D025803 2002-01-01
% 211.55/211.73  |- skos__related mesh__D025803smesh__D019942
% 211.55/211.73  |- mesh__historyNote mesh__D025803 2002%28%1996%29%   
% 211.55/211.73  |- skos__related mesh__D025803smesh__D019941
% 211.55/211.73  |- mesh__recordMaintainer mesh__D025803 ags
% 211.55/211.73  |- skos__broader mesh__D025803smesh__D018797
% 211.55/211.73  |- mesh__publicMeSHNote mesh__D025803
% 211.55/211.73       2002; TUMOR SUPPRESSOR PROTEIN P14ARF was indexed under P14ARF PROTEIN 2002-2005, %26% under PROTEINS 1996-2001%A%  
% 211.55/211.73  |- mesh__recordAuthorizer mesh__D025803 ags
% 211.55/211.73  |- mesh__dateRevised mesh__D025803 2005-07-22
% 211.55/211.73  |- skos__prefLabel mesh__D025803 Tumor Suppressor Protein p14ARF
% 211.55/211.73  |- skos__altLabel mesh__D025803 p14%28%ARF%29%
% 211.55/211.73  |- mesh__dateCreated mesh__D025803 2001-07-25
% 211.55/211.73  |- skos__altLabel mesh__D025803 p14ARF
% 211.55/211.73  |- skos__altLabel mesh__D025803 p%28%ARF%29% Protein
% 211.55/211.73  |- rdf__type mesh__D025803sskos__Concept
% 211.55/211.73  |- skos__altLabel mesh__D025803 p14ARF Protein
% 211.55/211.73  |- skos__altLabel mesh__D025803 Cdkn2a%28%p14ARF%29%
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D025803 2006
% 211.55/211.73  |- skos__broader mesh__D025803smesh__D025521
% 211.55/211.73  |- skos__hiddenLabel mesh__D049453 Bacterial Luciferases
% 211.55/211.73  |- skos__hiddenLabel mesh__D049453 Vibrio Luciferases
% 211.55/211.73  |- skos__prefLabel mesh__D049453 Luciferases, Bacterial
% 211.55/211.73  |- mesh__historyNote mesh__D049453 2005   
% 211.55/211.73  |- skos__broader mesh__D049453smesh__D001426
% 211.55/211.73  |- skos__hiddenLabel mesh__D049453 Photorhabdus Luciferases
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D049453 2005
% 211.55/211.73  |- mesh__dateEstablished mesh__D049453 2005-01-01
% 211.55/211.73  |- mesh__recordMaintainer mesh__D049453 ssb
% 211.55/211.73  |- mesh__dateCreated mesh__D049453 2004-07-07
% 211.55/211.73  |- skos__hiddenLabel mesh__D049453 Photobacterium Luciferases
% 211.55/211.73  |- mesh__recordOriginator mesh__D049453 ssb
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D049453 2006
% 211.55/211.73  |- mesh__recordAuthorizer mesh__D049453 sjn
% 211.55/211.73  |- skos__historyNote mesh__D049453 Luciferases %28%1967-2004%29%
% 211.55/211.73  |- rdf__type mesh__D049453sskos__Concept
% 211.55/211.73  |- mesh__publicMeSHNote mesh__D049453 2005   
% 211.55/211.73  |- skos__broader mesh__D049453smesh__D008156
% 211.55/211.73  |- skos__scopeNote mesh__D049453
% 211.55/211.73       Luciferases from BACTERIA such as PHOTOBACTERIUM; VIBRIO; and PHOTORHABDUS.%A%    
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D016279 2006
% 211.55/211.73  |- skos__hiddenLabel mesh__D016279 Functions, Left Atrial
% 211.55/211.73  |- skos__historyNote mesh__D016279
% 211.55/211.73       Heart Atrium/physiology %28%1968-1990%29%
% 211.55/211.73  |- skos__hiddenLabel mesh__D016279 Function, Left Atrial
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D016279 2005
% 211.55/211.73  |- mesh__dateRevised mesh__D016279 2003-07-09
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D016279 2004
% 211.55/211.73  |- skos__broader mesh__D016279smesh__D016275
% 211.55/211.73  |- skos__altLabel mesh__D016279 Left Atrial Function
% 211.55/211.73  |- mesh__recordAuthorizer mesh__D016279 sjn
% 211.55/211.73  |- mesh__publicMeSHNote mesh__D016279 91   
% 211.55/211.73  |- rdf__type mesh__D016279sskos__Concept
% 211.55/211.73  |- skos__hiddenLabel mesh__D016279 Left Atrial Functions
% 211.55/211.73  |- mesh__historyNote mesh__D016279 91   
% 211.55/211.73  |- skos__hiddenLabel mesh__D016279 Atrial Functions, Left
% 211.55/211.73  |- skos__scopeNote mesh__D016279
% 211.55/211.73       The hemodynamic and electrophysiological action of the LEFT ATRIUM.%A%    
% 211.55/211.73  |- skos__historyNote mesh__D016279 Heart/physiology %28%1966-1990%29%
% 211.55/211.73  |- skos__prefLabel mesh__D016279 Atrial Function, Left
% 211.55/211.73  |- mesh__dateEstablished mesh__D016279 1991-01-01
% 211.55/211.73  |- mesh__recordMaintainer mesh__D016279 nns
% 211.55/211.73  |- mesh__recordOriginator mesh__D016279 PXP
% 211.55/211.73  |- mesh__dateCreated mesh__D016279 1990-05-25
% 211.55/211.73  |- skos__altLabel mesh__D002259
% 211.55/211.73       %28%4-%28%Trifluoromethoxy%29%phenyl%29%hydrazonopropanedinitrile
% 211.55/211.73  |- mesh__historyNote mesh__D002259
% 211.55/211.73       91%28%75%29%; was see under NITRILES 1975-90   
% 211.55/211.73  |- skos__scopeNote mesh__D002259
% 211.55/211.73       A proton ionophore that is commonly used as an uncoupling agent in biochemical studies.%A%    
% 211.55/211.73  |- skos__hiddenLabel mesh__D002259
% 211.55/211.73       p-Trifluoromethoxyphenylhydrazone, Carbonyl Cyanide
% 211.55/211.73  |- skos__altLabel mesh__D002259
% 211.55/211.73       Carbonyl Cyanide para-Trifluoromethoxyphenylhydrazone
% 211.55/211.73  |- skos__altLabel mesh__D002259
% 211.55/211.73       Carbonyl Cyanide p Trifluoromethoxyphenylhydrazone
% 211.55/211.73  |- skos__historyNote mesh__D002259 Hydrazones %28%1973-1974%29%
% 211.55/211.73  |- mesh__recordAuthorizer mesh__D002259 sjn
% 211.55/211.73  |- skos__broader mesh__D002259smesh__D006835
% 211.55/211.73  |- skos__broader mesh__D002259smesh__D009570
% 211.55/211.73  |- skos__historyNote mesh__D002259 Nitriles %28%1973-1974%29%
% 211.55/211.73  |- mesh__recordOriginator mesh__D002259 NLM
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D002259 2005
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D002259 2004
% 211.55/211.73  |- mesh__recordMaintainer mesh__D002259 ssb
% 211.55/211.73  |- skos__hiddenLabel mesh__D002259
% 211.55/211.73       Cyanide para-Trifluoromethoxyphenylhydrazone, Carbonyl
% 211.55/211.73  |- mesh__dateEstablished mesh__D002259 1991-01-01
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D002259 2006
% 211.55/211.73  |- skos__hiddenLabel mesh__D002259
% 211.55/211.73       Cyanide p-Trifluoromethoxyphenylhydrazone, Carbonyl
% 211.55/211.73  |- skos__prefLabel mesh__D002259
% 211.55/211.73       Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone
% 211.55/211.73  |- mesh__publicMeSHNote mesh__D002259 91; was see under NITRILES 1975-90   
% 211.55/211.73  |- skos__hiddenLabel mesh__D002259
% 211.55/211.73       para-Trifluoromethoxyphenylhydrazone, Carbonyl Cyanide
% 211.55/211.73  |- rdf__type mesh__D002259sskos__Concept
% 211.55/211.73  |- mesh__dateCreated mesh__D002259 1974-11-19
% 211.55/211.73  |- skos__altLabel mesh__D002259 FCCP
% 211.55/211.73  |- mesh__dateRevised mesh__D002259 2003-07-09
% 211.55/211.73  |- skos__hiddenLabel mesh__D002259
% 211.55/211.73       Carbonyl Cyanide para Trifluoromethoxyphenylhydrazone
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D007742 2004
% 211.55/211.73  |- mesh__dateRevised mesh__D007742 2003-07-09
% 211.55/211.73  |- mesh__dateCreated mesh__D007742 1999-01-01
% 211.55/211.73  |- mesh__recordOriginator mesh__D007742 NLM
% 211.55/211.73  |- mesh__historyNote mesh__D007742 65   
% 211.55/211.73  |- mesh__dateEstablished mesh__D007742 1965-01-01
% 211.55/211.73  |- rdf__type mesh__D007742sskos__Concept
% 211.55/211.73  |- skos__altLabel mesh__D007742 Frenum, Labial
% 211.55/211.73  |- mesh__recordMaintainer mesh__D007742 lkt
% 211.55/211.73  |- mesh__publicMeSHNote mesh__D007742 65   
% 211.55/211.73  |- skos__hiddenLabel mesh__D007742 Labial Frenums
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D007742 2005
% 211.55/211.73  |- mesh__recordAuthorizer mesh__D007742 sjn
% 211.55/211.73  |- skos__hiddenLabel mesh__D007742 Frenums, Labial
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D007742 2006
% 211.55/211.73  |- skos__broader mesh__D007742smesh__D008046
% 211.55/211.73  |- skos__prefLabel mesh__D007742 Labial Frenum
% 211.55/211.73  |- mesh__recordOriginator mesh__D012687 NLM
% 211.55/211.73  |- skos__annotation mesh__D012687
% 211.55/211.73       a type of sepsis; GEN or unspecified only: prefer BACTEREMIA; FUNGEMIA; PARASITEMIA or VIREMIA; HEMORRHAGIC BACTEREMIA, a Pasteurella infect, is also available%A%  
% 211.55/211.73  |- mesh__dateCreated mesh__D012687 1999-01-01
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D012687 2006
% 211.55/211.73  |- mesh__dateRevised mesh__D012687 2001-07-25
% 211.55/211.73  |- skos__altLabel mesh__D012687 Poisoning, Blood
% 211.55/211.73  |- mesh__recordAuthorizer mesh__D012687 sjn
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D012687 2002
% 211.55/211.73  |- rdf__type mesh__D012687sskos__Concept
% 211.55/211.73  |- skos__prefLabel mesh__D012687 Septicemia
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D012687 2003
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D012687 2004
% 211.55/211.73  |- skos__altLabel mesh__D012687 Blood Poisoning
% 211.55/211.73  |- skos__related mesh__D012687smesh__D019446
% 211.55/211.73  |- skos__broader mesh__D012687smesh__D018805
% 211.55/211.73  |- skos__scopeNote mesh__D012687
% 211.55/211.73       Systemic disease associated with the presence and persistence of pathogenic microorganisms or their toxins in the blood. %28%Dorland, 27th ed%29%%A%    
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D012687 2005
% 211.55/211.73  |- mesh__recordMaintainer mesh__D012687 mdb
% 211.55/211.73  |- mesh__historyNote mesh__D031841 2003   
% 211.55/211.73  |- mesh__dateRevised mesh__D031841 2004-07-07
% 211.55/211.73  |- rdf__type mesh__D031841sskos__Concept
% 211.55/211.73  |- mesh__recordAuthorizer mesh__D031841 sjn
% 211.55/211.73  |- mesh__recordMaintainer mesh__D031841 ssb
% 211.55/211.73  |- mesh__recordOriginator mesh__D031841 ssb
% 211.55/211.73  |- mesh__dateEstablished mesh__D031841 2003-01-01
% 211.55/211.73  |- mesh__publicMeSHNote mesh__D031841
% 211.55/211.73       2003; for ACONITE see ACONITE 1963-2004   
% 211.55/211.73  |- skos__broader mesh__D031841smesh__D029626
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D031841 2005
% 211.55/211.73  |- skos__scopeNote mesh__D031841
% 211.55/211.73       A plant genus of the family RANUNCULACEAE. Members contain a number of diterpenoid alkaloids including: aconitans, hypaconitine, ACONITINE, jesaconitine, ignavine, napelline, and mesaconitine. The common name of Wolfbane is similar to the common name for ARNICA.%A%    
% 211.55/211.73  |- mesh__dateCreated mesh__D031841 2002-07-02
% 211.55/211.73  |- skos__annotation mesh__D031841
% 211.55/211.73       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D031841 2006
% 211.55/211.73  |- skos__altLabel mesh__D031841 Monkshood
% 211.55/211.73  |- skos__altLabel mesh__D031841 Radix Aconiti
% 211.55/211.73  |- skos__prefLabel mesh__D031841 Aconitum
% 211.55/211.73  |- skos__broader mesh__D031043smesh__D029061
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D031043 2006
% 211.55/211.73  |- mesh__publicMeSHNote mesh__D031043 2003   
% 211.55/211.73  |- mesh__dateEstablished mesh__D031043 2003-01-01
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D031043 2005
% 211.55/211.73  |- mesh__historyNote mesh__D031043 2003   
% 211.55/211.73  |- mesh__dateCreated mesh__D031043 2002-07-03
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D031043 2004
% 211.55/211.73  |- rdf__type mesh__D031043sskos__Concept
% 211.55/211.73  |- skos__prefLabel mesh__D031043 Guatteria
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D031043 2003
% 211.55/211.73  |- skos__scopeNote mesh__D031043
% 211.55/211.73       A plant genus of the family ANNONACEAE. Members contain asarone, isoguattouregidine %28%an isoquinoline alkaloid%29%, norlaureline, puterine, noraporphine alkaloids.%A%    
% 211.55/211.73  |- skos__annotation mesh__D031043
% 211.55/211.73       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.55/211.73  |- skos__annotation mesh__D003352
% 211.55/211.73       GEN; prefer specific; infection = CORYNEBACTERIUM INFECTIONS unless DIPHTHERIA %28%if C. diphtheriae in man%29%; DF: CORYNEBACT%A%  
% 211.55/211.73  |- rdf__type mesh__D003352sskos__Concept
% 211.55/211.73  |- skos__scopeNote mesh__D003352
% 211.55/211.73       A genus of asporogenous bacteria that is widely distributed in nature. Its organisms appear as straight to slightly curved rods and are known to be human and animal parasites and pathogens.%A%    
% 211.55/211.73  |- skos__broader mesh__D003352smesh__D016988
% 211.55/211.73  |- mesh__dateRevised mesh__D003352 2005-06-30
% 211.55/211.73  |- mesh__dateCreated mesh__D003352 1999-01-01
% 211.55/211.73  |- skos__broader mesh__D003352smesh__D000192
% 211.55/211.73  |- mesh__recordOriginator mesh__D003352 NLM
% 211.55/211.73  |- mesh__recordAuthorizer mesh__D003352 sjn
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D003352 2006
% 211.55/211.73  |- mesh__recordMaintainer mesh__D003352 SYSTEM
% 211.55/211.73  |- skos__prefLabel mesh__D003352 Corynebacterium
% 211.55/211.73  |- mesh__publicMeSHNote mesh__D049454 2005   
% 211.55/211.73  |- mesh__historyNote mesh__D049454 2005   
% 211.55/211.73  |- mesh__recordOriginator mesh__D049454 ssb
% 211.55/211.73  |- mesh__dateRevised mesh__D049454 2005-07-01
% 211.55/211.73  |- mesh__recordMaintainer mesh__D049454 sjn
% 211.55/211.73  |- mesh__dateCreated mesh__D049454 2004-07-07
% 211.55/211.73  |- skos__prefLabel mesh__D049454 Firefly Luciferin
% 211.55/211.73  |- skos__scopeNote mesh__D049454
% 211.55/211.73       A benzothaizole which is oxidized by LUCIFERASES, FIREFLY to cause emission of light %28%LUMINESCENCE%29%.%A%    
% 211.55/211.73  |- mesh__dateEstablished mesh__D049454 2005-01-01
% 211.55/211.73  |- skos__hiddenLabel mesh__D049454 Luciferin, Firefly
% 211.55/211.73  |- mesh__activeMeSHYear mesh__D049454 2006
% 211.55/211.73  |- skos__broader mesh__D049454smesh__D013844
% 211.55/211.73  |- rdf__type mesh__D049454sskos__Concept
% 211.55/211.73  |- mesh__recordAuthorizer mesh__D049454 sjn
% 211.55/211.73  |- mesh__recordOriginator mesh__D013780 NLM
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D013780 2006
% 211.55/211.74  |- mesh__recordAuthorizer mesh__D013780 sjn
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D013780 2005
% 211.55/211.74  |- mesh__dateCreated mesh__D013780 1999-01-01
% 211.55/211.74  |- rdf__type mesh__D013780sskos__Concept
% 211.55/211.74  |- skos__prefLabel mesh__D013780 Tetroses
% 211.55/211.74  |- mesh__recordMaintainer mesh__D013780 ssb
% 211.55/211.74  |- mesh__dateRevised mesh__D013780 2004-07-07
% 211.55/211.74  |- skos__broader mesh__D013780smesh__D009005
% 211.55/211.74  |- skos__related mesh__D007743smesh__D010120
% 211.55/211.74  |- skos__annotation mesh__D007743
% 211.55/211.74       check tags FEMALE %26% PREGNANCY; LABOR, INDUCED is also available%A%  
% 211.55/211.74  |- mesh__recordAuthorizer mesh__D007743 sjn
% 211.55/211.74  |- skos__altLabel mesh__D007743 Obstetric Labor
% 211.55/211.74  |- skos__related mesh__D007743smesh__D009321
% 211.55/211.74  |- mesh__dateRevised mesh__D007743 2005-06-30
% 211.55/211.74  |- rdf__type mesh__D007743sskos__Concept
% 211.55/211.74  |- skos__scopeNote mesh__D007743
% 211.55/211.74       The repetitive uterine contraction during childbirth which is associated with the progressive dilation of the uterine cervix %28%CERVIX UTERI%29%. Successful labor results in the expulsion of the FETUS and PLACENTA. Obstetric labor can be spontaneous or induced %28%LABOR, INDUCED%29%.%A%    
% 211.55/211.74  |- mesh__historyNote mesh__D007743 2003   
% 211.55/211.74  |- mesh__publicMeSHNote mesh__D007743 2003; see LABOR 1966-2002   
% 211.55/211.74  |- skos__broader mesh__D007743smesh__D011247
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D007743 2006
% 211.55/211.74  |- skos__related mesh__D007743smesh__D005323
% 211.55/211.74  |- skos__related mesh__D007743smesh__D014219
% 211.55/211.74  |- mesh__recordOriginator mesh__D007743 NLM
% 211.55/211.74  |- skos__prefLabel mesh__D007743 Labor, Obstetric
% 211.55/211.74  |- mesh__dateCreated mesh__D007743 1999-01-01
% 211.55/211.74  |- mesh__recordMaintainer mesh__D007743 lkt
% 211.55/211.74  |- mesh__dateCreated mesh__D012688 1999-01-01
% 211.55/211.74  |- mesh__recordMaintainer mesh__D012688 ags
% 211.55/211.74  |- skos__prefLabel mesh__D012688 Septum Pellucidum
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D012688 2002
% 211.55/211.74  |- skos__hiddenLabel mesh__D012688 Pellucidum, Septum
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D012688 2001
% 211.55/211.74  |- mesh__recordOriginator mesh__D012688 NLM
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D012688 2006
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D012688 2000
% 211.55/211.74  |- mesh__historyNote mesh__D012688 73   
% 211.55/211.74  |- skos__scopeNote mesh__D012688
% 211.55/211.74       A triangular double membrane separating the anterior horns of the lateral ventricles of the brain. It is situated in the median plane and bounded by the corpus callosum and the body and columns of the fornix.%A%    
% 211.55/211.74  |- mesh__publicMeSHNote mesh__D012688 73   
% 211.55/211.74  |- mesh__dateEstablished mesh__D012688 1973-01-01
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D012688 2005
% 211.55/211.74  |- mesh__recordAuthorizer mesh__D012688 sjn
% 211.55/211.74  |- rdf__type mesh__D012688sskos__Concept
% 211.55/211.74  |- mesh__dateRevised mesh__D012688 1999-11-03
% 211.55/211.74  |- skos__broader mesh__D012688smesh__D002552
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D012688 2004
% 211.55/211.74  |- skos__historyNote mesh__D012688 Cerebral Ventricles %28%1966-1972%29%
% 211.55/211.74  |- skos__broader mesh__D012688smesh__D020665
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D012688 2003
% 211.55/211.74  |- skos__historyNote mesh__D045064 Tetrahydrofolates %28%1974-1982%29%
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D045064 2004
% 211.55/211.74  |- skos__prefLabel mesh__D045064 Methenyltetrahydrofolate Cyclohydrolase
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D045064 2006
% 211.55/211.74  |- skos__historyNote mesh__D045064 Hydrolases %28%1974-1977%29%
% 211.55/211.74  |- rdf__type mesh__D045064sskos__Concept
% 211.55/211.74  |- skos__related mesh__D045064smesh__D008754
% 211.55/211.74  |- mesh__historyNote mesh__D045064
% 211.55/211.74       2004; use METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE %28%NM%29% 1980-2003%A%  
% 211.55/211.74  |- mesh__dateCreated mesh__D045064 2003-07-09
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D045064 2005
% 211.55/211.74  |- skos__altLabel mesh__D045064
% 211.55/211.74       5,10-Methenyltetrahydrofolate Cyclohydrolase
% 211.55/211.74  |- skos__hiddenLabel mesh__D045064 5,10 MTHF Cyclohydrolase
% 211.55/211.74  |- mesh__publicMeSHNote mesh__D045064
% 211.55/211.74       2004; METHENYLTETRAHYDRODROFOLATE CYCLOHYDROLASE was indexed under AMINOHYDROLASES 1983-2003, under TETRAHYDROFOLATES 1974-1982, under HYDROLASES 1974-1977%A%  
% 211.55/211.74  |- skos__altLabel mesh__D045064
% 211.55/211.74       5,10-Methenyltetrahydrofolate 5-Hydrolase %28%Decyclizing%29%
% 211.55/211.74  |- mesh__dateEstablished mesh__D045064 2004-01-01
% 211.55/211.74  |- skos__altLabel mesh__D045064 5,10-MTHF Cyclohydrolase
% 211.55/211.74  |- skos__hiddenLabel mesh__D045064
% 211.55/211.74       5,10 Methenyltetrahydrofolate Cyclohydrolase
% 211.55/211.74  |- skos__scopeNote mesh__D045064
% 211.55/211.74       An aminohydrolase that catalyzes the hydrolysis of 5,10-methenyltetrahydrofolate to 10-formyltetrahydrofolate. In most higher eucaryotic organisms this enzyme also includes METHYLENETETRAHYDROFOLATE DEHYDROGENASE %28%NADP%29% and FORMATE-TETRAHYDROFOLATE LIGASE activities.%A%    
% 211.55/211.74  |- skos__historyNote mesh__D045064 Aminohydrolases %28%1983-2003%29%
% 211.55/211.74  |- skos__broader mesh__D045064smesh__D000619
% 211.55/211.74  |- skos__hiddenLabel mesh__D045064 Cyclohydrolase, 5,10-MTHF
% 211.55/211.74  |- skos__hiddenLabel mesh__D045064
% 211.55/211.74       Cyclohydrolase, 5,10-Methenyltetrahydrofolate
% 211.55/211.74  |- skos__related mesh__D045064smesh__D005574
% 211.55/211.74  |- skos__hiddenLabel mesh__D045064 Cyclohydrolase, Methenyltetrahydrofolate
% 211.55/211.74  |- skos__annotation mesh__D031842
% 211.55/211.74       ACTAEA RACEMOSA see CIMICIFUGA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.55/211.74  |- mesh__dateCreated mesh__D031842 2002-07-02
% 211.55/211.74  |- skos__broader mesh__D031842smesh__D029626
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031842 2004
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031842 2005
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031842 2006
% 211.55/211.74  |- skos__prefLabel mesh__D031842 Actaea
% 211.55/211.74  |- mesh__publicMeSHNote mesh__D031842 2003   
% 211.55/211.74  |- mesh__historyNote mesh__D031842 2003   
% 211.55/211.74  |- skos__scopeNote mesh__D031842
% 211.55/211.74       A plant genus of the family RANUNCULACEAE. Cycloartanes have been found in the rhizomes.%A%    
% 211.55/211.74  |- mesh__dateEstablished mesh__D031842 2003-01-01
% 211.55/211.74  |- skos__altLabel mesh__D031842 Bugbane
% 211.55/211.74  |- rdf__type mesh__D031842sskos__Concept
% 211.55/211.74  |- skos__altLabel mesh__D031842 Baneberry
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031842 2003
% 211.55/211.74  |- skos__prefLabel mesh__D017373 Cyproterone Acetate
% 211.55/211.74  |- mesh__dateEstablished mesh__D017373 1993-01-01
% 211.55/211.74  |- skos__scopeNote mesh__D017373
% 211.55/211.74       An agent with anti-androgen and progestational properties. It shows competitive binding with dihydrotestosterone at androgen receptor sites.%A%    
% 211.55/211.74  |- mesh__dateRevised mesh__D017373 2003-07-25
% 211.55/211.74  |- skos__historyNote mesh__D017373
% 211.55/211.74       Cyproterone/analogs %26% derivatives %28%1980-1992%29%
% 211.55/211.74  |- mesh__historyNote mesh__D017373
% 211.55/211.74       93; was CYPROTERONE ACETATE %28%NM%29% 1980-92   
% 211.55/211.74  |- mesh__onlineNote mesh__D017373
% 211.55/211.74       use CYPROTERONE ACETATE %28%NM%29% to search CYPROTERONE ACETATE 1980-92%A%  
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D017373 2006
% 211.55/211.74  |- mesh__recordOriginator mesh__D017373 TPW
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D017373 2005
% 211.55/211.74  |- skos__broader mesh__D017373smesh__D003534
% 211.55/211.74  |- rdf__type mesh__D017373sskos__Concept
% 211.55/211.74  |- mesh__dateCreated mesh__D017373 1992-05-13
% 211.55/211.74  |- mesh__recordMaintainer mesh__D017373 lkt
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D017373 2004
% 211.55/211.74  |- mesh__recordAuthorizer mesh__D017373 sjn
% 211.55/211.74  |- mesh__publicMeSHNote mesh__D017373
% 211.55/211.74       93; CYPROTERONE ACETATE was indexed under CYPROTERONE/analogs %26% derivatives 1980-92%A%  
% 211.55/211.74  |- skos__scopeNote mesh__D031044
% 211.55/211.74       A plant genus of the family ANNONACEAE. Members contain 8-oxopolyalthiaine.%A%    
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031044 2006
% 211.55/211.74  |- skos__prefLabel mesh__D031044 Polyalthia
% 211.55/211.74  |- mesh__publicMeSHNote mesh__D031044 2003   
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031044 2005
% 211.55/211.74  |- skos__broader mesh__D031044smesh__D029061
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031044 2004
% 211.55/211.74  |- rdf__type mesh__D031044sskos__Concept
% 211.55/211.74  |- mesh__dateEstablished mesh__D031044 2003-01-01
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031044 2003
% 211.55/211.74  |- skos__annotation mesh__D031044
% 211.55/211.74       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.55/211.74  |- mesh__historyNote mesh__D031044 2003   
% 211.55/211.74  |- mesh__dateCreated mesh__D031044 2002-07-03
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D003353 2006
% 211.55/211.74  |- mesh__recordOriginator mesh__D003353 NLM
% 211.55/211.74  |- mesh__recordAuthorizer mesh__D003353 sjn
% 211.55/211.74  |- skos__scopeNote mesh__D003353
% 211.55/211.74       A species of gram-positive, asporogenous bacteria in which three cultural types are recognized. These types %28%gravis, intermedius, and mitis%29% were originally given in accordance with the clinical severity of the cases from which the different strains were most frequently isolated. This species is the causative agent of DIPHTHERIA.%A%    
% 211.55/211.74  |- skos__related mesh__D003353smesh__D004167
% 211.55/211.74  |- skos__prefLabel mesh__D003353 Corynebacterium diphtheriae
% 211.55/211.74  |- mesh__dateCreated mesh__D003353 1999-01-01
% 211.55/211.74  |- rdf__type mesh__D003353sskos__Concept
% 211.55/211.74  |- mesh__recordMaintainer mesh__D003353 SYSTEM
% 211.55/211.74  |- skos__annotation mesh__D003353
% 211.55/211.74       infection in man = DIPHTHERIA; DF: CORYNEBACT DIPHTHERIAE%A%  
% 211.55/211.74  |- mesh__dateRevised mesh__D003353 2005-06-30
% 211.55/211.74  |- skos__broader mesh__D003353smesh__D003352
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D013781 2005
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D013781 2000
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D013781 1998
% 211.55/211.74  |- skos__broader mesh__D013781smesh__D015206
% 211.55/211.74  |- mesh__dateCreated mesh__D013781 1999-01-01
% 211.55/211.74  |- mesh__recordOriginator mesh__D013781 NLM
% 211.55/211.74  |- rdf__type mesh__D013781sskos__Concept
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D013781 2002
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D013781 2004
% 211.55/211.74  |- skos__prefLabel mesh__D013781 Texas
% 211.55/211.74  |- mesh__recordMaintainer mesh__D013781 PXP
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D013781 2003
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D013781 2001
% 211.55/211.74  |- mesh__dateRevised mesh__D013781 1997-06-20
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D013781 2006
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D013781 1999
% 211.55/211.74  |- mesh__recordAuthorizer mesh__D013781 SJN
% 211.55/211.74  |- rdf__type mesh__D007744sskos__Concept
% 211.55/211.74  |- skos__broader mesh__D007744smesh__D011248
% 211.55/211.74  |- skos__hiddenLabel mesh__D007744 Labor Complication
% 211.55/211.74  |- mesh__recordMaintainer mesh__D007744 lkt
% 211.55/211.74  |- mesh__historyNote mesh__D007744 2006 %28%1964%29%   
% 211.55/211.74  |- skos__hiddenLabel mesh__D007744 Complication, Labor
% 211.55/211.74  |- skos__hiddenLabel mesh__D007744 Complication, Obstetric Labor
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D007744 2006
% 211.55/211.74  |- mesh__recordAuthorizer mesh__D007744 sjn
% 211.55/211.74  |- mesh__dateRevised mesh__D007744 2005-06-30
% 211.55/211.74  |- skos__prefLabel mesh__D007744 Obstetric Labor Complications
% 211.55/211.74  |- skos__hiddenLabel mesh__D007744 Labor Complication, Obstetric
% 211.55/211.74  |- skos__altLabel mesh__D007744 Labor Complications
% 211.55/211.74  |- mesh__dateCreated mesh__D007744 1999-01-01
% 211.55/211.74  |- mesh__dateEstablished mesh__D007744 1964-01-01
% 211.55/211.74  |- skos__scopeNote mesh__D007744
% 211.55/211.74       Medical problems associated with OBSTETRIC LABOR, such as BREECH PRESENTATION; PREMATURE OBSTETRIC LABOR; HEMORRHAGE; or others. These complications can affect the well-being of the mother, the FETUS, or both.%A%    
% 211.55/211.74  |- skos__altLabel mesh__D007744 Complications, Labor
% 211.55/211.74  |- skos__hiddenLabel mesh__D007744 Obstetric Labor Complication
% 211.55/211.74  |- skos__hiddenLabel mesh__D007744 Complications, Obstetric Labor
% 211.55/211.74  |- skos__hiddenLabel mesh__D007744 Labor Complications, Obstetric
% 211.55/211.74  |- mesh__publicMeSHNote mesh__D007744
% 211.55/211.74       2006; see LABOR COMPLICATIONS 1964-2005   
% 211.55/211.74  |- mesh__recordOriginator mesh__D007744 NLM
% 211.55/211.74  |- skos__annotation mesh__D007744
% 211.55/211.74       check the tags FEMALE %26% PREGNANCY; DF: LABOR COMPL   
% 211.55/211.74  |- mesh__dateEstablished mesh__D012689 1991-01-01
% 211.55/211.74  |- mesh__publicMeSHNote mesh__D012689
% 211.55/211.74       91; was see under BASE SEQUENCE 1986-90   
% 211.55/211.74  |- skos__historyNote mesh__D012689 Base Sequence %28%1971-1985%29%
% 211.55/211.74  |- mesh__recordOriginator mesh__D012689 AEP
% 211.55/211.74  |- skos__hiddenLabel mesh__D012689 Sequence Homologies, Base
% 211.55/211.74  |- skos__hiddenLabel mesh__D012689 Base Sequence Homologies
% 211.55/211.74  |- skos__related mesh__D012689smesh__D016415
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D012689 2006
% 211.55/211.74  |- mesh__recordMaintainer mesh__D012689 nns
% 211.55/211.74  |- skos__broader mesh__D012689smesh__D017385
% 211.55/211.74  |- skos__altLabel mesh__D012689 Sequence Homology, Base
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D012689 2005
% 211.55/211.74  |- rdf__type mesh__D012689sskos__Concept
% 211.55/211.74  |- skos__scopeNote mesh__D012689
% 211.55/211.74       The sequential correspondence of nucleotides in one nucleic acid molecule  with those of another nucleic acid molecule. Sequence homology is an indication of the genetic relatedness of different organisms and gene function.%A%    
% 211.55/211.74  |- skos__hiddenLabel mesh__D012689 Homologies, Base Sequence
% 211.55/211.74  |- skos__altLabel mesh__D012689 Nucleic Acid Sequence Homology
% 211.55/211.74  |- mesh__dateCreated mesh__D012689 1985-05-03
% 211.55/211.74  |- skos__altLabel mesh__D012689 Homologs, Nucleic Acid Sequence
% 211.55/211.74  |- skos__altLabel mesh__D012689 Homology, Base Sequence
% 211.55/211.74  |- skos__altLabel mesh__D012689 Base Sequence Homology
% 211.55/211.74  |- mesh__historyNote mesh__D012689
% 211.55/211.74       91%28%86%29%; was see under BASE SEQUENCE 1986-90   
% 211.55/211.74  |- mesh__dateRevised mesh__D012689 2004-07-07
% 211.55/211.74  |- skos__annotation mesh__D012689
% 211.55/211.74       coord IM with specific nucleic acid %28%IM%29%; no qualif; DF: SEQ HOMOL NUCLEIC ACID%A%  
% 211.55/211.74  |- skos__historyNote mesh__D012689
% 211.55/211.74       Nucleic Acid Hybridization %28%1971-1985%29%
% 211.55/211.74  |- mesh__recordAuthorizer mesh__D012689 sjn
% 211.55/211.74  |- skos__altLabel mesh__D012689 Nucleic Acid Sequence Homologs
% 211.55/211.74  |- skos__prefLabel mesh__D012689 Sequence Homology, Nucleic Acid
% 211.55/211.74  |- skos__altLabel mesh__D012689 Homology, Nucleic Acid Sequence
% 211.55/211.74  |- skos__annotation mesh__D031843
% 211.55/211.74       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031843 2006
% 211.55/211.74  |- mesh__publicMeSHNote mesh__D031843 2003   
% 211.55/211.74  |- mesh__dateCreated mesh__D031843 2002-07-02
% 211.55/211.74  |- skos__altLabel mesh__D031843 Daisy, Oxeye
% 211.55/211.74  |- skos__scopeNote mesh__D031843
% 211.55/211.74       A plant genus of the family RANUNCULACEAE. Members contain cardenolide oligoglycosides such as adoniside, adonisidum and alepposide.%A%    
% 211.55/211.74  |- rdf__type mesh__D031843sskos__Concept
% 211.55/211.74  |- skos__altLabel mesh__D031843 Oxeye Daisy
% 211.55/211.74  |- mesh__historyNote mesh__D031843 2003   
% 211.55/211.74  |- skos__prefLabel mesh__D031843 Adonis
% 211.55/211.74  |- mesh__dateEstablished mesh__D031843 2003-01-01
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031843 2003
% 211.55/211.74  |- skos__broader mesh__D031843smesh__D029626
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031843 2004
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031843 2005
% 211.55/211.74  |- mesh__publicMeSHNote mesh__D017374
% 211.55/211.74       93; PAROXETINE was indexed under PIPERIDINES 1982-92 %26% DIOXOLANES 1978-82%A%  
% 211.55/211.74  |- skos__broader mesh__D017374smesh__D010880
% 211.55/211.74  |- skos__hiddenLabel mesh__D017374 Hemihydrate Paroxetine Hydrochloride
% 211.55/211.74  |- skos__hiddenLabel mesh__D017374 Maleate, Paroxetine
% 211.55/211.74  |- mesh__onlineNote mesh__D017374
% 211.55/211.74       use PAROXETINE %28%NM%29% to search PAROXETINE 1980-92   
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D017374 2006
% 211.55/211.74  |- mesh__dateCreated mesh__D017374 1992-05-22
% 211.55/211.74  |- skos__hiddenLabel mesh__D017374 BRL 29060
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D017374 2002
% 211.55/211.74  |- mesh__recordAuthorizer mesh__D017374 sjn
% 211.55/211.74  |- mesh__dateEstablished mesh__D017374 1993-01-01
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D017374 2005
% 211.55/211.74  |- rdf__type mesh__D017374sskos__Concept
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D017374 2001
% 211.55/211.74  |- mesh__recordMaintainer mesh__D017374 jmp
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D017374 2004
% 211.55/211.74  |- mesh__dateRevised mesh__D017374 2000-06-21
% 211.55/211.74  |- skos__hiddenLabel mesh__D017374 Hydrochloride, Hemihydrate Paroxetine
% 211.55/211.74  |- skos__hiddenLabel mesh__D017374 BRL29060
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D017374 2003
% 211.55/211.74  |- skos__hiddenLabel mesh__D017374 Acetate, Paroxetine
% 211.55/211.74  |- skos__historyNote mesh__D017374 Dioxolanes %28%1978-1982%29%
% 211.55/211.74  |- skos__scopeNote mesh__D017374
% 211.55/211.74       A serotonin uptake inhibitor that is effective in the treatment of depression.%A%    
% 211.55/211.74  |- skos__historyNote mesh__D017374 Piperidines %28%1982-1992%29%
% 211.55/211.74  |- skos__prefLabel mesh__D017374 Paroxetine
% 211.55/211.74  |- mesh__recordOriginator mesh__D017374 TPW
% 211.55/211.74  |- skos__hiddenLabel mesh__D017374 Hydrochloride, Paroxetine
% 211.55/211.74  |- mesh__historyNote mesh__D017374 93; was PAROXETINE %28%NM%29% 1978-92   
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031045 2004
% 211.55/211.74  |- mesh__historyNote mesh__D031045 2003   
% 211.55/211.74  |- rdf__type mesh__D031045sskos__Concept
% 211.55/211.74  |- mesh__dateCreated mesh__D031045 2002-07-03
% 211.55/211.74  |- skos__annotation mesh__D031045
% 211.55/211.74       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031045 2003
% 211.55/211.74  |- skos__broader mesh__D031045smesh__D029061
% 211.55/211.74  |- skos__scopeNote mesh__D031045
% 211.55/211.74       A plant genus of the family ANNONACEAE. Members contain aporphines, acetogenins and rollinone.%A%    
% 211.55/211.74  |- skos__prefLabel mesh__D031045 Rollinia
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031045 2006
% 211.55/211.74  |- mesh__publicMeSHNote mesh__D031045 2003   
% 211.55/211.74  |- mesh__dateEstablished mesh__D031045 2003-01-01
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031045 2005
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D003354 2000
% 211.55/211.74  |- skos__prefLabel mesh__D003354 Corynebacterium Infections
% 211.55/211.74  |- mesh__publicMeSHNote mesh__D003354 72   
% 211.55/211.74  |- mesh__dateRevised mesh__D003354 1993-06-02
% 211.55/211.74  |- skos__hiddenLabel mesh__D003354 Infection, Corynebacterium
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D003354 1997
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D003354 1999
% 211.55/211.74  |- skos__hiddenLabel mesh__D003354 Corynebacterium Infection
% 211.55/211.74  |- mesh__historyNote mesh__D003354 72   
% 211.55/211.74  |- mesh__dateCreated mesh__D003354 1999-01-01
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D003354 1996
% 211.55/211.74  |- mesh__recordOriginator mesh__D003354 NLM
% 211.55/211.74  |- rdf__type mesh__D003354sskos__Concept
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D003354 1995
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D003354 1998
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D003354 1994
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D003354 2002
% 211.55/211.74  |- mesh__dateEstablished mesh__D003354 1972-01-01
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D003354 2004
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D003354 2001
% 211.55/211.74  |- skos__scopeNote mesh__D003354
% 211.55/211.74       Infections with bacteria of the genus CORYNEBACTERIUM.     
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D003354 2006
% 211.55/211.74  |- skos__altLabel mesh__D003354 Infections, Corynebacterium
% 211.55/211.74  |- mesh__recordAuthorizer mesh__D003354 PLS
% 211.55/211.74  |- skos__annotation mesh__D003354
% 211.55/211.74       gram-pos bact infect; note C. diphtheriae infection in man = DIPHTHERIA; Corynebacterium equi infection = RHODOCOCCUS EQUI %28%IM%29% + ACTINOMYCETALES INFECTIONS %28%IM%29%; DF: CORYNEBACT INFECT%A%  
% 211.55/211.74  |- mesh__recordMaintainer mesh__D003354 TAP
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D003354 2003
% 211.55/211.74  |- skos__broader mesh__D003354smesh__D000193
% 211.55/211.74  |- skos__historyNote mesh__D003354 Corynebacterium %28%1966-1971%29%
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D003354 2005
% 211.55/211.74  |- skos__broader mesh__D013782smesh__D013664
% 211.55/211.74  |- mesh__recordMaintainer mesh__D013782 ags
% 211.55/211.74  |- mesh__recordOriginator mesh__D013782 SMH
% 211.55/211.74  |- mesh__dateRevised mesh__D013782 2004-07-07
% 211.55/211.74  |- skos__related mesh__D013782smesh__D012013
% 211.55/211.74  |- skos__historyNote mesh__D013782 Books %28%1966-1980%29%
% 211.55/211.74  |- mesh__dateEstablished mesh__D013782 1991-01-01
% 211.55/211.74  |- skos__broader mesh__D013782smesh__D001877
% 211.55/211.74  |- skos__historyNote mesh__D013782 Teaching Materials %28%1974-1980%29%
% 211.55/211.74  |- skos__prefLabel mesh__D013782 Textbooks
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D013782 2006
% 211.55/211.74  |- mesh__historyNote mesh__D013782
% 211.55/211.74       91%28%81%29%; was see under BOOKS 1981-90   
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D013782 2005
% 211.55/211.74  |- skos__scopeNote mesh__D013782
% 211.55/211.74       Books used in the study of a subject that contain a systematic presentation of the principles and vocabulary of a subject.%A%    
% 211.55/211.74  |- mesh__recordAuthorizer mesh__D013782 sjn
% 211.55/211.74  |- skos__hiddenLabel mesh__D013782 Textbook
% 211.55/211.74  |- mesh__publicMeSHNote mesh__D013782 91; was see under BOOKS 1981-90   
% 211.55/211.74  |- rdf__type mesh__D013782sskos__Concept
% 211.55/211.74  |- mesh__dateCreated mesh__D013782 1980-05-19
% 211.55/211.74  |- mesh__dateCreated mesh__D007745 1974-11-11
% 211.55/211.74  |- rdf__type mesh__D007745sskos__Concept
% 211.55/211.74  |- skos__hiddenLabel mesh__D007745 Labor Onsets
% 211.55/211.74  |- skos__hiddenLabel mesh__D007745 Onset, Labor
% 211.55/211.74  |- skos__prefLabel mesh__D007745 Labor Onset
% 211.55/211.74  |- mesh__recordOriginator mesh__D007745 NLM
% 211.55/211.74  |- mesh__dateEstablished mesh__D007745 1991-01-01
% 211.55/211.74  |- skos__broader mesh__D007745smesh__D007743
% 211.55/211.74  |- mesh__recordMaintainer mesh__D007745 lkt
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D007745 2006
% 211.55/211.74  |- mesh__dateRevised mesh__D007745 2004-07-07
% 211.55/211.74  |- mesh__historyNote mesh__D007745
% 211.55/211.74       91%28%75%29%; was see under LABOR 1975-90   
% 211.55/211.74  |- skos__scopeNote mesh__D007745
% 211.55/211.74       The beginning of true OBSTETRIC LABOR which is characterized by the cyclic uterine contractions of increasing frequency, duration, and strength causing CERVICAL DILATATION to begin %28%LABOR STAGE, FIRST %29%.%A%    
% 211.55/211.74  |- mesh__publicMeSHNote mesh__D007745 91; was see under LABOR 1975-90   
% 211.55/211.74  |- skos__hiddenLabel mesh__D007745 Onsets, Labor
% 211.55/211.74  |- mesh__recordAuthorizer mesh__D007745 sjn
% 211.55/211.74  |- skos__annotation mesh__D007745
% 211.55/211.74       human only;  check tags FEMALE %26% PREGNANCY   
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D007745 2005
% 211.55/211.74  |- mesh__historyNote mesh__D031844 2003   
% 211.55/211.74  |- skos__annotation mesh__D031844
% 211.55/211.74       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.55/211.74  |- skos__prefLabel mesh__D031844 Nigella
% 211.55/211.74  |- skos__scopeNote mesh__D031844
% 211.55/211.74       A plant genus of the family RANUNCULACEAE.     
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031844 2003
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031844 2006
% 211.55/211.74  |- mesh__publicMeSHNote mesh__D031844 2003   
% 211.55/211.74  |- mesh__dateCreated mesh__D031844 2002-07-03
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031844 2005
% 211.55/211.74  |- mesh__dateEstablished mesh__D031844 2003-01-01
% 211.55/211.74  |- rdf__type mesh__D031844sskos__Concept
% 211.55/211.74  |- skos__broader mesh__D031844smesh__D029626
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031844 2004
% 211.55/211.74  |- mesh__dateEstablished mesh__D031046 2003-01-01
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031046 2005
% 211.55/211.74  |- skos__prefLabel mesh__D031046 Uvaria
% 211.55/211.74  |- rdf__type mesh__D031046sskos__Concept
% 211.55/211.74  |- skos__scopeNote mesh__D031046
% 211.55/211.74       A plant genus of the family ANNONACEAE. Members contain uvarigrin, uvarigrandin, chamuvaritin and other acetogenins and benzylisoquinoline alkaloids.%A%    
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031046 2004
% 211.55/211.74  |- mesh__historyNote mesh__D031046 2003   
% 211.55/211.74  |- skos__annotation mesh__D031046
% 211.55/211.74       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.55/211.74  |- mesh__dateCreated mesh__D031046 2002-07-03
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031046 2003
% 211.55/211.74  |- skos__broader mesh__D031046smesh__D029061
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D031046 2006
% 211.55/211.74  |- mesh__publicMeSHNote mesh__D031046 2003   
% 211.55/211.74  |- skos__prefLabel mesh__D003355 Corynebacterium pyogenes
% 211.55/211.74  |- skos__historyNote mesh__D003355 Corynebacterium %28%1966-1971%29%
% 211.55/211.74  |- mesh__dateEstablished mesh__D003355 1991-01-01
% 211.55/211.74  |- mesh__recordMaintainer mesh__D003355 SYSTEM
% 211.55/211.74  |- skos__broader mesh__D003355smesh__D003352
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D003355 2006
% 211.55/211.74  |- mesh__dateRevised mesh__D003355 2005-06-30
% 211.55/211.74  |- mesh__historyNote mesh__D003355
% 211.55/211.74       91%28%72%29%; was see under CORYNEBACTERIUM 1972-90   
% 211.55/211.74  |- skos__annotation mesh__D003355
% 211.55/211.74       infection: coord IM with CORYNEBACTERIUM INFECTIONS %28%IM%29%; DF: CORYNEBACT PYOGENES%A%  
% 211.55/211.74  |- mesh__recordAuthorizer mesh__D003355 sjn
% 211.55/211.74  |- mesh__recordOriginator mesh__D003355 NLM
% 211.55/211.74  |- mesh__dateCreated mesh__D003355 1999-01-01
% 211.55/211.74  |- mesh__publicMeSHNote mesh__D003355
% 211.55/211.74       91; was see under CORYNEBACTERIUM 1972-90   
% 211.55/211.74  |- rdf__type mesh__D003355sskos__Concept
% 211.55/211.74  |- skos__scopeNote mesh__D003355
% 211.55/211.74       A species of CORYNEBACTERIUM isolated from abscesses of warm-blooded animals.%A%    
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D008040 2003
% 211.55/211.74  |- skos__historyNote mesh__D008040 Genetics %28%1966-1969%29%
% 211.55/211.74  |- skos__prefLabel mesh__D008040 Linkage %28%Genetics%29%
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D008040 2006
% 211.55/211.74  |- mesh__recordOriginator mesh__D008040 NLM
% 211.55/211.74  |- skos__annotation mesh__D008040 DF: LINKAGE   
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D008040 2005
% 211.55/211.74  |- mesh__dateRevised mesh__D008040 2002-07-03
% 211.55/211.74  |- skos__related mesh__D008040smesh__D023061
% 211.55/211.74  |- skos__scopeNote mesh__D008040
% 211.55/211.74       The association in inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME.%A%    
% 211.55/211.74  |- skos__broader mesh__D008040smesh__D040341
% 211.55/211.74  |- mesh__dateCreated mesh__D008040 1999-01-01
% 211.55/211.74  |- mesh__recordAuthorizer mesh__D008040 sjn
% 211.55/211.74  |- skos__altLabel mesh__D008040 Genetic Linkage
% 211.55/211.74  |- skos__hiddenLabel mesh__D008040 Linkage, Genetic
% 211.55/211.74  |- skos__related mesh__D008040smesh__D026801
% 211.55/211.74  |- mesh__historyNote mesh__D008040 73%28%70%29%   
% 211.55/211.74  |- mesh__publicMeSHNote mesh__D008040 73   
% 211.55/211.74  |- mesh__recordMaintainer mesh__D008040 nns
% 211.55/211.74  |- rdf__type mesh__D008040sskos__Concept
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D008040 2004
% 211.55/211.74  |- mesh__dateEstablished mesh__D008040 1973-01-01
% 211.55/211.74  |- skos__scopeNote mesh__D013783
% 211.55/211.74       The aggregate business enterprise of manufacturing textiles. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D013783 2003
% 211.55/211.74  |- skos__hiddenLabel mesh__D013783 Textile Industries
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D013783 1996
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D013783 2006
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D013783 1999
% 211.55/211.74  |- skos__prefLabel mesh__D013783 Textile Industry
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D013783 2001
% 211.55/211.74  |- skos__broader mesh__D013783smesh__D007221
% 211.55/211.74  |- mesh__activeMeSHYear mesh__D013783 2005
% 211.55/211.74  |- mesh__dateCreated mesh__D013783 1999-01-01
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013783 1998
% 211.55/211.75  |- skos__hiddenLabel mesh__D013783 Industries, Textile
% 211.55/211.75  |- skos__annotation mesh__D013783 SPEC: SPEC qualif; DF: TEXTILE INDUST   
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013783 2000
% 211.55/211.75  |- rdf__type mesh__D013783sskos__Concept
% 211.55/211.75  |- mesh__dateRevised mesh__D013783 1995-05-22
% 211.55/211.75  |- mesh__recordOriginator mesh__D013783 NLM
% 211.55/211.75  |- skos__altLabel mesh__D013783 Industry, Textile
% 211.55/211.75  |- mesh__recordAuthorizer mesh__D013783 PLS
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013783 2004
% 211.55/211.75  |- mesh__recordMaintainer mesh__D013783 KEV
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013783 2002
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013783 1997
% 211.55/211.75  |- skos__related mesh__D007746smesh__D036861
% 211.55/211.75  |- mesh__dateCreated mesh__D007746 1999-01-01
% 211.55/211.75  |- skos__altLabel mesh__D007746 Fetal Presentation
% 211.55/211.75  |- mesh__dateRevised mesh__D007746 2004-07-07
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D007746 2006
% 211.55/211.75  |- skos__broader mesh__D007746smesh__D011247
% 211.55/211.75  |- skos__related mesh__D007746smesh__D014710
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D007746 2005
% 211.55/211.75  |- mesh__recordOriginator mesh__D007746 NLM
% 211.55/211.75  |- skos__prefLabel mesh__D007746 Labor Presentation
% 211.55/211.75  |- skos__hiddenLabel mesh__D007746 Presentation, Labor
% 211.55/211.75  |- mesh__recordMaintainer mesh__D007746 lkt
% 211.55/211.75  |- skos__annotation mesh__D007746 check tags FEMALE %26% PREGNANCY   
% 211.55/211.75  |- skos__scopeNote mesh__D007746
% 211.55/211.75       The position or orientation of the FETUS at near term or during OBSTETRIC LABOR, determined by its relation to the SPINE of the mother and the birth canal. The normal position is a vertical, cephalic presentation with the fetal vertex flexed on the NECK.%A%    
% 211.55/211.75  |- skos__altLabel mesh__D007746 Presentation, Fetal
% 211.55/211.75  |- mesh__recordAuthorizer mesh__D007746 sjn
% 211.55/211.75  |- skos__hiddenLabel mesh__D007746 Malpresentation, Fetal
% 211.55/211.75  |- rdf__type mesh__D007746sskos__Concept
% 211.55/211.75  |- skos__hiddenLabel mesh__D007746 Fetal Malpresentations
% 211.55/211.75  |- skos__hiddenLabel mesh__D031845 Multicentric Osteolysis
% 211.55/211.75  |- skos__hiddenLabel mesh__D031845 Osteolyses, Multicentric
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D031845 2006
% 211.55/211.75  |- skos__hiddenLabel mesh__D031845 Multicentric Osteolyses
% 211.55/211.75  |- mesh__historyNote mesh__D031845
% 211.55/211.75       2003; use OSTEOLYSIS, ESSENTIAL 1987-2002   
% 211.55/211.75  |- skos__broader mesh__D031845smesh__D030342
% 211.55/211.75  |- skos__historyNote mesh__D031845
% 211.55/211.75       Bone Diseases, Developmental %28%1973-1984%29%
% 211.55/211.75  |- skos__hiddenLabel mesh__D031845 Hajdu Cheney Syndrome
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D031845 2005
% 211.55/211.75  |- mesh__publicMeSHNote mesh__D031845
% 211.55/211.75       2003; see OSTEOLYSIS, ESSENTIAL 1987-2002   
% 211.55/211.75  |- rdf__type mesh__D031845sskos__Concept
% 211.55/211.75  |- skos__historyNote mesh__D031845 Osteolysis, Essential %28%1980-2002%29%
% 211.55/211.75  |- mesh__dateCreated mesh__D031845 2002-07-03
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D031845 2004
% 211.55/211.75  |- skos__broader mesh__D031845smesh__D009139
% 211.55/211.75  |- skos__prefLabel mesh__D031845 Hajdu-Cheney Syndrome
% 211.55/211.75  |- skos__historyNote mesh__D031845 Osteolysis %28%1976-1986%29%
% 211.55/211.75  |- skos__scopeNote mesh__D031845
% 211.55/211.75       Rare, autosomal dominant syndrome characterized by ACRO-OSTEOLYSIS, generalized OSTEOPOROSIS, and skull deformations.%A%    
% 211.55/211.75  |- skos__altLabel mesh__D031845 Osteolysis, Multicentric
% 211.55/211.75  |- skos__broader mesh__D031845smesh__D030981
% 211.55/211.75  |- mesh__dateEstablished mesh__D031845 2003-01-01
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D031845 2003
% 211.55/211.75  |- skos__scopeNote mesh__D017376
% 211.55/211.75       Proteins found in the tail sections of DNA and RNA viruses. It is believed that these proteins play a role in directing chain folding and assembly of polypeptide chains.%A%    
% 211.55/211.75  |- skos__hiddenLabel mesh__D017376 Proteins, Virus Tail
% 211.55/211.75  |- mesh__dateEstablished mesh__D017376 1993-01-01
% 211.55/211.75  |- mesh__recordOriginator mesh__D017376 PXP
% 211.55/211.75  |- mesh__historyNote mesh__D017376
% 211.55/211.75       93; was VIRAL TAIL PROTEINS %28%NM%29% 1981-92   
% 211.55/211.75  |- skos__historyNote mesh__D017376 Viral Proteins %28%1980-1992%29%
% 211.55/211.75  |- skos__hiddenLabel mesh__D017376 Proteins, Viral Tail
% 211.55/211.75  |- mesh__publicMeSHNote mesh__D017376
% 211.55/211.75       93; VIRAL TAIL PROTEINS was indexed under VIRAL PROTEINS 1981-92%A%  
% 211.55/211.75  |- rdf__type mesh__D017376sskos__Concept
% 211.55/211.75  |- mesh__recordMaintainer mesh__D017376 SYSTEM
% 211.55/211.75  |- skos__prefLabel mesh__D017376 Viral Tail Proteins
% 211.55/211.75  |- skos__annotation mesh__D017376
% 211.55/211.75       found in tails of viruses; coord IM with specific virus %28%IM%29%%A%  
% 211.55/211.75  |- mesh__dateRevised mesh__D017376 2005-06-30
% 211.55/211.75  |- skos__hiddenLabel mesh__D017376 Tail Proteins, Virus
% 211.55/211.75  |- skos__altLabel mesh__D017376 Virus Tail Proteins
% 211.55/211.75  |- mesh__onlineNote mesh__D017376
% 211.55/211.75       use VIRAL TAIL PROTEINS %28%NM%29% to search VIRAL TAIL PROTEINS 1981-92%A%  
% 211.55/211.75  |- skos__hiddenLabel mesh__D017376 Tail Proteins, Viral
% 211.55/211.75  |- skos__broader mesh__D017376smesh__D015678
% 211.55/211.75  |- mesh__dateCreated mesh__D017376 1992-05-22
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D017376 2006
% 211.55/211.75  |- mesh__recordAuthorizer mesh__D017376 sjn
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D008041 2005
% 211.55/211.75  |- skos__prefLabel mesh__D008041 Linoleic Acids
% 211.55/211.75  |- skos__annotation mesh__D008041 do not confuse with LINOLENIC ACIDS   
% 211.55/211.75  |- mesh__historyNote mesh__D008041 75; was LINOLEIC ACID 1963-74   
% 211.55/211.75  |- mesh__dateCreated mesh__D008041 1999-01-01
% 211.55/211.75  |- skos__broader mesh__D008041smesh__D005228
% 211.55/211.75  |- skos__hiddenLabel mesh__D008041 Acids, Linoleic
% 211.55/211.75  |- mesh__recordOriginator mesh__D008041 NLM
% 211.55/211.75  |- skos__broader mesh__D008041smesh__D043371
% 211.55/211.75  |- mesh__dateRevised mesh__D008041 2003-07-09
% 211.55/211.75  |- skos__scopeNote mesh__D008041
% 211.55/211.75       Eighteen-carbon essential fatty acids that contain two double bonds.%A%    
% 211.55/211.75  |- rdf__type mesh__D008041sskos__Concept
% 211.55/211.75  |- mesh__recordAuthorizer mesh__D008041 sjn
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D008041 2004
% 211.55/211.75  |- mesh__recordMaintainer mesh__D008041 ssb
% 211.55/211.75  |- mesh__publicMeSHNote mesh__D008041 75; was LINOLEIC ACID 1963-74   
% 211.55/211.75  |- mesh__onlineNote mesh__D008041
% 211.55/211.75       use LINOLEIC ACIDS to search LINOLEIC ACID 1966-74   
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D008041 2006
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013784 2005
% 211.55/211.75  |- mesh__dateCreated mesh__D013784 1999-01-01
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013784 1998
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013784 2006
% 211.55/211.75  |- mesh__recordOriginator mesh__D013784 NLM
% 211.55/211.75  |- skos__hiddenLabel mesh__D013784 Textile
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013784 1999
% 211.55/211.75  |- mesh__dateRevised mesh__D013784 1997-06-20
% 211.55/211.75  |- skos__prefLabel mesh__D013784 Textiles
% 211.55/211.75  |- skos__broader mesh__D013784smesh__D013783
% 211.55/211.75  |- mesh__recordAuthorizer mesh__D013784 SJN
% 211.55/211.75  |- rdf__type mesh__D013784sskos__Concept
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013784 2000
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013784 2003
% 211.55/211.75  |- mesh__recordMaintainer mesh__D013784 JLS
% 211.55/211.75  |- skos__annotation mesh__D013784 textile mesh is probably SURGICAL MESH   
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013784 2001
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013784 2004
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013784 2002
% 211.55/211.75  |- mesh__publicMeSHNote mesh__D007747
% 211.55/211.75       91; was see under LABOR 1977-90; was LABOR, FIRST STAGE see under LABOR 1975-76%A%  
% 211.55/211.75  |- mesh__dateEstablished mesh__D007747 1991-01-01
% 211.55/211.75  |- skos__broader mesh__D007747smesh__D007745
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D007747 2005
% 211.55/211.75  |- skos__hiddenLabel mesh__D007747 First Labor Stage
% 211.55/211.75  |- mesh__recordAuthorizer mesh__D007747 sjn
% 211.55/211.75  |- skos__prefLabel mesh__D007747 Labor Stage, First
% 211.55/211.75  |- skos__altLabel mesh__D007747 Labor, First Stage
% 211.55/211.75  |- mesh__dateCreated mesh__D007747 1974-11-11
% 211.55/211.75  |- skos__scopeNote mesh__D007747
% 211.55/211.75       Period from the onset of true OBSTETRIC LABOR to the complete dilatation of the CERVIX UTERI.%A%    
% 211.55/211.75  |- skos__annotation mesh__D007747
% 211.55/211.75       human only; check tags FEMALE %26% PREGNANCY   
% 211.55/211.75  |- skos__hiddenLabel mesh__D007747 Cervical Dilatations
% 211.55/211.75  |- rdf__type mesh__D007747sskos__Concept
% 211.55/211.75  |- skos__hiddenLabel mesh__D007747 First Stage Labor
% 211.55/211.75  |- skos__hiddenLabel mesh__D007747 Dilatation, Cervical
% 211.55/211.75  |- mesh__onlineNote mesh__D007747
% 211.55/211.75       use LABOR STAGE, FIRST to search LABOR, FIRST STAGE 1975-76%A%  
% 211.55/211.75  |- skos__hiddenLabel mesh__D007747 Dilatations, Cervical
% 211.55/211.75  |- mesh__recordMaintainer mesh__D007747 lkt
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D007747 2006
% 211.55/211.75  |- mesh__dateRevised mesh__D007747 2004-07-07
% 211.55/211.75  |- mesh__historyNote mesh__D007747
% 211.55/211.75       91%28%77%29%; was see under LABOR 1977-90; was LABOR, FIRST STAGE see under LABOR 1975-76%A%  
% 211.55/211.75  |- mesh__recordOriginator mesh__D007747 NLM
% 211.55/211.75  |- skos__broader mesh__D026901smesh__D002352
% 211.55/211.75  |- skos__historyNote mesh__D026901 Permeases %28%1968-2001%29%
% 211.55/211.75  |- mesh__recordAuthorizer mesh__D026901 sjn
% 211.55/211.75  |- skos__hiddenLabel mesh__D026901 Transport Proteins, Membrane
% 211.55/211.75  |- mesh__historyNote mesh__D026901
% 211.55/211.75       2002; for BIOLOGICAL PUMP %26% METABOLIC PUMP use BIOLOGICAL TRANSPORT ACTIVE 1991-2001%A%  
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D026901 2006
% 211.55/211.75  |- skos__historyNote mesh__D026901 Biological Transport %28%1966-2001%29%
% 211.55/211.75  |- skos__scopeNote mesh__D026901
% 211.55/211.75       Membrane proteins whose primary function is to facilitate the transport of molecules across a biological membrane. Included in this broad category are proteins involved in active transport %28%BIOLOGICAL TRANSPORT, ACTIVE%29%, facilitated transport and ION CHANNELS.%A%    
% 211.55/211.75  |- skos__altLabel mesh__D026901 Pump, Metabolic
% 211.55/211.75  |- mesh__recordMaintainer mesh__D026901 ssb
% 211.55/211.75  |- mesh__dateEstablished mesh__D026901 2002-01-01
% 211.55/211.75  |- skos__prefLabel mesh__D026901 Membrane Transport Proteins
% 211.55/211.75  |- skos__altLabel mesh__D026901 Pump, Biological
% 211.55/211.75  |- skos__related mesh__D026901smesh__D001692
% 211.55/211.75  |- skos__hiddenLabel mesh__D026901 Transporters, Membrane
% 211.55/211.75  |- skos__altLabel mesh__D026901 Biological Pump
% 211.55/211.75  |- skos__altLabel mesh__D026901 Pump, Biologic
% 211.55/211.75  |- skos__hiddenLabel mesh__D026901 Biologic Pump
% 211.55/211.75  |- mesh__recordOriginator mesh__D026901 jmp
% 211.55/211.75  |- skos__broader mesh__D026901smesh__D008565
% 211.55/211.75  |- skos__altLabel mesh__D026901 Membrane Transporters
% 211.55/211.75  |- skos__altLabel mesh__D026901 Metabolic Pumps
% 211.55/211.75  |- mesh__dateRevised mesh__D026901 2005-06-30
% 211.55/211.75  |- mesh__dateCreated mesh__D026901 2001-07-25
% 211.55/211.75  |- rdf__type mesh__D026901sskos__Concept
% 211.55/211.75  |- skos__altLabel mesh__D026901 Pumps, Biological
% 211.55/211.75  |- skos__historyNote mesh__D026901 Ion Pumps %28%1992-2001%29%
% 211.55/211.75  |- skos__altLabel mesh__D026901 Pumps, Metabolic
% 211.55/211.75  |- skos__altLabel mesh__D026901 Metabolic Pump
% 211.55/211.75  |- mesh__publicMeSHNote mesh__D026901
% 211.55/211.75       2002; for BIOLOGICAL PUMP %26% METABOLIC PUMP see BIOLOGICAL TRANSPORT ACTIVE 1991-2001%A%  
% 211.55/211.75  |- rdf__type mesh__D017377sskos__Concept
% 211.55/211.75  |- skos__related mesh__D017377smesh__D010839
% 211.55/211.75  |- mesh__historyNote mesh__D017377 93   
% 211.55/211.75  |- mesh__recordMaintainer mesh__D017377 SYSTEM
% 211.55/211.75  |- mesh__recordAuthorizer mesh__D017377 sjn
% 211.55/211.75  |- skos__broader mesh__D017377smesh__D000456
% 211.55/211.75  |- mesh__dateEstablished mesh__D017377 1993-01-01
% 211.55/211.75  |- skos__prefLabel mesh__D017377 Diatoms
% 211.55/211.75  |- skos__hiddenLabel mesh__D017377 Diatom
% 211.55/211.75  |- skos__scopeNote mesh__D017377
% 211.55/211.75       The common name for the phylum of microscopic unicellular ALGAE. Most are aquatic, being found in fresh, brackish, and salt water. Diatoms are noted for the symmetry and sculpturing of their siliceous cell walls. They account for 40%25% of PHYTOPLANKTON, but not all diatoms are planktonic.%A%    
% 211.55/211.75  |- skos__historyNote mesh__D017377 Algae %28%1966-1992%29%
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D017377 2006
% 211.55/211.75  |- mesh__publicMeSHNote mesh__D017377 93   
% 211.55/211.75  |- skos__altLabel mesh__D017377 Bacillariophyta
% 211.55/211.75  |- mesh__dateRevised mesh__D017377 2005-06-30
% 211.55/211.75  |- skos__hiddenLabel mesh__D017377 Bacillariophytas
% 211.55/211.75  |- mesh__recordOriginator mesh__D017377 PXP
% 211.55/211.75  |- mesh__dateCreated mesh__D017377 1992-05-14
% 211.55/211.75  |- mesh__dateCreated mesh__D031048 2002-07-03
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D031048 2004
% 211.55/211.75  |- skos__annotation mesh__D031048
% 211.55/211.75       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.55/211.75  |- skos__broader mesh__D031048smesh__D019661
% 211.55/211.75  |- skos__prefLabel mesh__D031048 Cnidium
% 211.55/211.75  |- mesh__dateEstablished mesh__D031048 2003-01-01
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D031048 2005
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D031048 2006
% 211.55/211.75  |- mesh__publicMeSHNote mesh__D031048 2003   
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D031048 2003
% 211.55/211.75  |- mesh__historyNote mesh__D031048 2003   
% 211.55/211.75  |- rdf__type mesh__D031048sskos__Concept
% 211.55/211.75  |- skos__scopeNote mesh__D031048
% 211.55/211.75       A plant genus of the family APIACEAE. Members contain osthol.%A%    
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D003357 2005
% 211.55/211.75  |- mesh__dateEstablished mesh__D003357 1998-01-01
% 211.55/211.75  |- skos__hiddenLabel mesh__D003357 Technics, Cosmetic
% 211.55/211.75  |- mesh__recordMaintainer mesh__D003357 TGC
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D003357 2004
% 211.55/211.75  |- mesh__dateRevised mesh__D003357 1997-06-20
% 211.55/211.75  |- skos__annotation mesh__D003357
% 211.55/211.75       GEN or unspecified; usually surg improvement of external parts of the body; coord IM with organ /surg %28%IM%29% or surg procedure %28%IM%29%%A%  
% 211.55/211.75  |- skos__hiddenLabel mesh__D003357 Techniques, Cosmetic
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D003357 2002
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D003357 2006
% 211.55/211.75  |- mesh__dateCreated mesh__D003357 1999-01-01
% 211.55/211.75  |- skos__prefLabel mesh__D003357 Cosmetic Techniques
% 211.55/211.75  |- mesh__recordOriginator mesh__D003357 NLM
% 211.55/211.75  |- skos__altLabel mesh__D003357 Cosmetic Technics
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D003357 1998
% 211.55/211.75  |- skos__hiddenLabel mesh__D003357 Technic, Cosmetic
% 211.55/211.75  |- mesh__publicMeSHNote mesh__D003357 98   
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D003357 1999
% 211.55/211.75  |- skos__hiddenLabel mesh__D003357 Cosmetic Technic
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D003357 2000
% 211.55/211.75  |- skos__scopeNote mesh__D003357
% 211.55/211.75       Procedures for the improvement or enhancement of the appearance of the visible parts of the body.%A%    
% 211.55/211.75  |- rdf__type mesh__D003357sskos__Concept
% 211.55/211.75  |- skos__hiddenLabel mesh__D003357 Cosmetic Technique
% 211.55/211.75  |- mesh__historyNote mesh__D003357 98; use explode 1974-97   
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D003357 2001
% 211.55/211.75  |- mesh__recordAuthorizer mesh__D003357 SJN
% 211.55/211.75  |- skos__broader mesh__D003357smesh__D013812
% 211.55/211.75  |- skos__historyNote mesh__D003357 Surgery, Plastic %28%1969-1997%29%
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D003357 2003
% 211.55/211.75  |- skos__hiddenLabel mesh__D003357 Technique, Cosmetic
% 211.55/211.75  |- mesh__dateCreated mesh__D008840 1984-06-11
% 211.55/211.75  |- mesh__recordMaintainer mesh__D008840 DRC
% 211.55/211.75  |- mesh__recordAuthorizer mesh__D008840 sjn
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D008840 2006
% 211.55/211.75  |- skos__scopeNote mesh__D008840
% 211.55/211.75       Filaments which are composed primarily of actin and found in the cytoplasmic matrix of almost all cells. They are often associated with microtubules and may play a role in cytoskeletal function and/or mediate movement of the cell or the organelles within the cell.%A%    
% 211.55/211.75  |- skos__annotation mesh__D008840
% 211.55/211.75       /biosyn /drug eff /physiol /ultrastruct permitted   
% 211.55/211.75  |- skos__hiddenLabel mesh__D008840 Proteins, Microfilament
% 211.55/211.75  |- skos__prefLabel mesh__D008840 Microfilament Proteins
% 211.55/211.75  |- mesh__historyNote mesh__D008840 85   
% 211.55/211.75  |- skos__hiddenLabel mesh__D008840 Proteins, Actin-Binding
% 211.55/211.75  |- mesh__publicMeSHNote mesh__D008840 85   
% 211.55/211.75  |- skos__broader mesh__D008840smesh__D001704
% 211.55/211.75  |- mesh__recordOriginator mesh__D008840 RLS
% 211.55/211.75  |- skos__broader mesh__D008840smesh__D003598
% 211.55/211.75  |- rdf__type mesh__D008840sskos__Concept
% 211.55/211.75  |- skos__hiddenLabel mesh__D008840 Actin Binding Proteins
% 211.55/211.75  |- mesh__dateRevised mesh__D008840 2005-06-30
% 211.55/211.75  |- mesh__dateEstablished mesh__D008840 1985-01-01
% 211.55/211.75  |- mesh__recordAuthorizer mesh__D008042 sjn
% 211.55/211.75  |- skos__annotation mesh__D008042 do not confuse with LINOLEIC ACIDS   
% 211.55/211.75  |- skos__broader mesh__D008042smesh__D005228
% 211.55/211.75  |- mesh__historyNote mesh__D008042
% 211.55/211.75       75; was LINOLENIC ACID 1973-74, was LINOLENIC ACID see under FATTY ACIDS, ESSENTIAL 1963-72%A%  
% 211.55/211.75  |- mesh__dateRevised mesh__D008042 2003-07-09
% 211.55/211.75  |- skos__historyNote mesh__D008042 Fatty Acids, Essential %28%1966-1972%29%
% 211.55/211.75  |- skos__broader mesh__D008042smesh__D005231
% 211.55/211.75  |- rdf__type mesh__D008042sskos__Concept
% 211.55/211.75  |- mesh__publicMeSHNote mesh__D008042
% 211.55/211.75       75; was LINOLENIC ACID 1973-74, was LINOLENIC ACID see under FATTY ACIDS, ESSENTIAL 1963-72%A%  
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D008042 2005
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D008042 2004
% 211.55/211.75  |- mesh__dateEstablished mesh__D008042 1973-01-01
% 211.55/211.75  |- mesh__recordOriginator mesh__D008042 NLM
% 211.55/211.75  |- mesh__recordMaintainer mesh__D008042 ssb
% 211.55/211.75  |- mesh__onlineNote mesh__D008042
% 211.55/211.75       use LINOLENIC ACIDS to search LINOLENIC ACID 1973-74; use FATTY ACIDS, ESSENTIAL 1966-72%A%  
% 211.55/211.75  |- skos__prefLabel mesh__D008042 Linolenic Acids
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D008042 2006
% 211.55/211.75  |- mesh__dateCreated mesh__D008042 1999-01-01
% 211.55/211.75  |- skos__scopeNote mesh__D008042
% 211.55/211.75       Eighteen-carbon essential fatty acids that contain three double bonds.%A%    
% 211.55/211.75  |- skos__broader mesh__D002374Q000172smesh__D002374
% 211.55/211.75  |- mesh__preferredCombination mesh__D002374Q000172smesh__D020642
% 211.55/211.75  |- rdf__type mesh__D002374Q000172smesh__CompoundConcept
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013785 2001
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013785 2006
% 211.55/211.75  |- mesh__recordAuthorizer mesh__D013785 PLS
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013785 1999
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013785 2002
% 211.55/211.75  |- rdf__type mesh__D013785sskos__Concept
% 211.55/211.75  |- mesh__recordOriginator mesh__D013785 NLM
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013785 2003
% 211.55/211.75  |- skos__broader mesh__D013785smesh__D001210
% 211.55/211.75  |- mesh__dateRevised mesh__D013785 1995-05-23
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013785 1996
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013785 2004
% 211.55/211.75  |- mesh__recordMaintainer mesh__D013785 KEV
% 211.55/211.75  |- skos__annotation mesh__D013785 = Siam   
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013785 1997
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013785 2000
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013785 2005
% 211.55/211.75  |- mesh__dateCreated mesh__D013785 1999-01-01
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D013785 1998
% 211.55/211.75  |- skos__prefLabel mesh__D013785 Thailand
% 211.55/211.75  |- mesh__dateRevised mesh__D007748 2004-07-07
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D007748 2006
% 211.55/211.75  |- mesh__recordAuthorizer mesh__D007748 sjn
% 211.55/211.75  |- skos__hiddenLabel mesh__D007748 Labor Stages, Second
% 211.55/211.75  |- skos__prefLabel mesh__D007748 Labor Stage, Second
% 211.55/211.75  |- skos__hiddenLabel mesh__D007748 Stages, Second Labor
% 211.55/211.75  |- skos__broader mesh__D007748smesh__D007745
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D007748 2005
% 211.55/211.75  |- skos__hiddenLabel mesh__D007748 Stage, Second Labor
% 211.55/211.75  |- mesh__dateCreated mesh__D007748 1974-11-11
% 211.55/211.75  |- skos__hiddenLabel mesh__D007748 Second Stage Labor
% 211.55/211.75  |- rdf__type mesh__D007748sskos__Concept
% 211.55/211.75  |- skos__annotation mesh__D007748
% 211.55/211.75       human only; check tags FEMALE %26% PREGNANCY   
% 211.55/211.75  |- skos__hiddenLabel mesh__D007748 Second Labor Stages
% 211.55/211.75  |- mesh__onlineNote mesh__D007748
% 211.55/211.75       use LABOR STAGE, SECOND to search LABOR, SECOND STAGE 1975-76%A%  
% 211.55/211.75  |- skos__scopeNote mesh__D007748
% 211.55/211.75       The period of OBSTETRIC LABOR that is from the complete dilatation of the CERVIX UTERI to the expulsion of the FETUS.%A%    
% 211.55/211.75  |- mesh__historyNote mesh__D007748
% 211.55/211.75       91%28%77%29%; was see under LABOR 1977-90; was LABOR, SECOND STAGE see under LABOR 1975-76%A%  
% 211.55/211.75  |- mesh__publicMeSHNote mesh__D007748
% 211.55/211.75       91; was see under LABOR 1977-90; was LABOR, SECOND STAGE see under LABOR 1975-76%A%  
% 211.55/211.75  |- skos__hiddenLabel mesh__D007748 Second Labor Stage
% 211.55/211.75  |- skos__altLabel mesh__D007748 Labor, Second Stage
% 211.55/211.75  |- mesh__recordOriginator mesh__D007748 NLM
% 211.55/211.75  |- mesh__dateEstablished mesh__D007748 1991-01-01
% 211.55/211.75  |- mesh__recordMaintainer mesh__D007748 lkt
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D018470 2000
% 211.55/211.75  |- mesh__dateEstablished mesh__D018470 1995-01-01
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D018470 2005
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D018470 1999
% 211.55/211.75  |- skos__scopeNote mesh__D018470
% 211.55/211.75       A change in, or manipulation of, gravitational force. This may be a natural or artificial effect.%A%    
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D018470 2001
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D018470 1995
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D018470 2006
% 211.55/211.75  |- skos__historyNote mesh__D018470 Gravitation %28%1966-1994%29%
% 211.55/211.75  |- skos__hiddenLabel mesh__D018470 Artificial Gravity
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D018470 2002
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D018470 1996
% 211.55/211.75  |- mesh__dateCreated mesh__D018470 1994-06-07
% 211.55/211.75  |- rdf__type mesh__D018470sskos__Concept
% 211.55/211.75  |- skos__prefLabel mesh__D018470 Gravity, Altered
% 211.55/211.75  |- skos__annotation mesh__D018470
% 211.55/211.75       natural or artificial; /adv eff permitted   
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D018470 2003
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D018470 1997
% 211.55/211.75  |- mesh__publicMeSHNote mesh__D018470 95   
% 211.55/211.75  |- mesh__historyNote mesh__D018470 95   
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D018470 2004
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D018470 1998
% 211.55/211.75  |- skos__broader mesh__D018470smesh__D006112
% 211.55/211.75  |- skos__altLabel mesh__D032141 Wuweizi
% 211.55/211.75  |- skos__annotation mesh__D032141
% 211.55/211.75       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.55/211.75  |- rdf__type mesh__D032141sskos__Concept
% 211.55/211.75  |- mesh__dateCreated mesh__D032141 2002-07-03
% 211.55/211.75  |- skos__altLabel mesh__D032141 Schizandra
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D032141 2003
% 211.55/211.75  |- mesh__historyNote mesh__D032141 2003   
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D032141 2004
% 211.55/211.75  |- skos__scopeNote mesh__D032141
% 211.55/211.75       A plant genus of the family SCHISANDRACEAE. Members contain schisandrins %28%Russian%29% which are also called gomisins %28%Japanese%29% or wuweizins %28%Chinese%29%. The compounds in this genus are very similar to those in the related KADSURA and medicinal usage is very similar.  It is sometimes adulterated with KADSURA.%A%    
% 211.55/211.75  |- skos__altLabel mesh__D032141 Gomisi
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D032141 2005
% 211.55/211.75  |- mesh__dateEstablished mesh__D032141 2003-01-01
% 211.55/211.75  |- skos__prefLabel mesh__D032141 Schisandra
% 211.55/211.75  |- mesh__publicMeSHNote mesh__D032141 2003   
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D032141 2006
% 211.55/211.75  |- skos__broader mesh__D032141smesh__D029633
% 211.55/211.75  |- skos__hiddenLabel mesh__D026902 Blockers, Potassium Channel
% 211.55/211.75  |- mesh__dateRevised mesh__D026902 2005-06-30
% 211.55/211.75  |- skos__broader mesh__D026902smesh__D049990
% 211.55/211.75  |- mesh__recordMaintainer mesh__D026902 ssb
% 211.55/211.75  |- skos__related mesh__D026902smesh__D000889
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D026902 2006
% 211.55/211.75  |- mesh__publicMeSHNote mesh__D026902 2002   
% 211.55/211.75  |- skos__scopeNote mesh__D026902
% 211.55/211.75       A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS.%A%    
% 211.55/211.75  |- mesh__recordAuthorizer mesh__D026902 sjn
% 211.55/211.75  |- skos__annotation mesh__D026902 DF: K CHANNEL BLOCK   
% 211.55/211.75  |- mesh__historyNote mesh__D026902 2002   
% 211.55/211.75  |- skos__related mesh__D026902smesh__D014665
% 211.55/211.75  |- mesh__dateEstablished mesh__D026902 2002-01-01
% 211.55/211.75  |- mesh__recordOriginator mesh__D026902 ags
% 211.55/211.75  |- mesh__dateCreated mesh__D026902 2001-07-25
% 211.55/211.75  |- skos__broader mesh__D026902smesh__D002317
% 211.55/211.75  |- skos__altLabel mesh__D026902 Channel Blockers, Potassium
% 211.55/211.75  |- skos__prefLabel mesh__D026902 Potassium Channel Blockers
% 211.55/211.75  |- skos__historyNote mesh__D026902 Ion Channels %28%1980-1988%29%
% 211.55/211.75  |- skos__historyNote mesh__D026902
% 211.55/211.75       Potassium Channels/antagonists %26% inhibitors %28%1988-2001%29%
% 211.55/211.75  |- rdf__type mesh__D026902sskos__Concept
% 211.55/211.75  |- mesh__recordAuthorizer mesh__D004450 sjn
% 211.55/211.75  |- mesh__recordMaintainer mesh__D004450 ags
% 211.55/211.75  |- skos__broader mesh__D004450smesh__D014200
% 211.55/211.75  |- mesh__historyNote mesh__D004450 98; use explode 1982-97   
% 211.55/211.75  |- mesh__dateEstablished mesh__D004450 1998-01-01
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D004450 2005
% 211.55/211.75  |- skos__scopeNote mesh__D004450
% 211.55/211.75       A family of flukes %28%TREMATODA%29% characterized by a collar of spines at their anterior end. The body is elongated and is covered with spines, and the two suckers are usually close together. %28%Noble et al., Parasitology: the Biology of Animal Parasites, 6th ed, p183%29%%A%    
% 211.55/211.75  |- mesh__publicMeSHNote mesh__D004450 98   
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D004450 2006
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D004450 2004
% 211.55/211.75  |- skos__historyNote mesh__D004450 Trematoda %28%1966-1997%29%
% 211.55/211.75  |- skos__prefLabel mesh__D004450 Echinostomatidae
% 211.55/211.75  |- mesh__dateCreated mesh__D004450 1981-05-15
% 211.55/211.75  |- mesh__recordOriginator mesh__D004450 EC
% 211.55/211.75  |- skos__annotation mesh__D004450
% 211.55/211.75       a family of trematodes; infection: coord IM with TREMATODE INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 211.55/211.75  |- rdf__type mesh__D004450sskos__Concept
% 211.55/211.75  |- mesh__dateRevised mesh__D004450 2003-07-09
% 211.55/211.75  |- mesh__publicMeSHNote mesh__D017378
% 211.55/211.75       93; QUINOLINIC ACID was indexed under QUINOLINIC ACIDS 1981-92%A%  
% 211.55/211.75  |- mesh__onlineNote mesh__D017378
% 211.55/211.75       use QUINOLINIC ACID %28%NM%29% to search QUINOLINIC ACID 1981-92%A%  
% 211.55/211.75  |- skos__historyNote mesh__D017378 Quinolinic Acids %28%1981-1992%29%
% 211.55/211.75  |- mesh__historyNote mesh__D017378
% 211.55/211.75       93; was QUINOLINIC ACID %28%NM%29% 1981-92   
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D017378 2005
% 211.55/211.75  |- mesh__recordOriginator mesh__D017378 AGS
% 211.55/211.75  |- skos__scopeNote mesh__D017378
% 211.55/211.75       A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS.%A%    
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D017378 2006
% 211.55/211.75  |- skos__broader mesh__D017378smesh__D011805
% 211.55/211.75  |- mesh__dateCreated mesh__D017378 1992-05-22
% 211.55/211.75  |- mesh__dateEstablished mesh__D017378 1993-01-01
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D017378 2003
% 211.55/211.75  |- mesh__recordAuthorizer mesh__D017378 sjn
% 211.55/211.75  |- rdf__type mesh__D017378sskos__Concept
% 211.55/211.75  |- mesh__recordMaintainer mesh__D017378 ssb
% 211.55/211.75  |- mesh__activeMeSHYear mesh__D017378 2004
% 211.55/211.76  |- mesh__dateRevised mesh__D017378 2001-07-25
% 211.55/211.76  |- skos__prefLabel mesh__D017378 Quinolinic Acid
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D017378 2002
% 211.55/211.76  |- mesh__historyNote mesh__D031049 2003   
% 211.55/211.76  |- skos__scopeNote mesh__D031049
% 211.55/211.76       A plant genus of the family APIACEAE. Members contain SAPONINS.%A%    
% 211.55/211.76  |- mesh__dateCreated mesh__D031049 2002-07-03
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D031049 2005
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D031049 2006
% 211.55/211.76  |- skos__altLabel mesh__D031049 Holly, Sea
% 211.55/211.76  |- mesh__publicMeSHNote mesh__D031049 2003   
% 211.55/211.76  |- skos__broader mesh__D031049smesh__D019661
% 211.55/211.76  |- mesh__dateEstablished mesh__D031049 2003-01-01
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D031049 2003
% 211.55/211.76  |- skos__prefLabel mesh__D031049 Eryngium
% 211.55/211.76  |- skos__annotation mesh__D031049
% 211.55/211.76       Holly see ILEX is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.55/211.76  |- rdf__type mesh__D031049sskos__Concept
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D031049 2004
% 211.55/211.76  |- skos__altLabel mesh__D031049 Sea Holly
% 211.55/211.76  |- skos__broader mesh__D003358smesh__D006795
% 211.55/211.76  |- skos__prefLabel mesh__D003358 Cosmetics
% 211.55/211.76  |- skos__hiddenLabel mesh__D003358 Cosmetic
% 211.55/211.76  |- skos__scopeNote mesh__D003358
% 211.55/211.76       Substances intended to be applied to the human body for cleansing, beautifying, promoting attractiveness, or altering the appearance without affecting the body%27%s structure or functions. Included in this definition are skin creams, lotions, perfumes, lipsticks, fingernail polishes, eye and facial makeup preparations, permanent waves, hair colors, toothpastes, and deodorants, as well as any material intended for use as a component of a cosmetic product. %28%U.S. Food %26% Drug Administration Center for Food Safety %26% Applied Nutrition Office of Cosmetics Fact Sheet %28%web page%29% Feb 1995%29%%A%    
% 211.55/211.76  |- rdf__type mesh__D003358sskos__Concept
% 211.55/211.76  |- mesh__recordAuthorizer mesh__D003358 sjn
% 211.55/211.76  |- mesh__recordOriginator mesh__D003358 NLM
% 211.55/211.76  |- mesh__dateRevised mesh__D003358 2004-07-13
% 211.55/211.76  |- skos__annotation mesh__D003358 GEN: prefer specifics   
% 211.55/211.76  |- skos__broader mesh__D003358smesh__D020313
% 211.55/211.76  |- mesh__recordMaintainer mesh__D003358 sjn
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D003358 2005
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D003358 2006
% 211.55/211.76  |- mesh__dateCreated mesh__D003358 1999-01-01
% 211.55/211.76  |- mesh__recordMaintainer mesh__D014080 AGS
% 211.55/211.76  |- mesh__dateCreated mesh__D014080 1999-01-01
% 211.55/211.76  |- mesh__publicMeSHNote mesh__D014080 72   
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D014080 2004
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D014080 1996
% 211.55/211.76  |- mesh__dateEstablished mesh__D014080 1972-01-01
% 211.55/211.76  |- skos__historyNote mesh__D014080 Tooth, Deciduous %28%1966-1967%29%
% 211.55/211.76  |- skos__broader mesh__D014080smesh__D009063
% 211.55/211.76  |- skos__hiddenLabel mesh__D014080 Exfoliation, Tooth
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D014080 2005
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D014080 1997
% 211.55/211.76  |- mesh__recordAuthorizer mesh__D014080 PLS
% 211.55/211.76  |- mesh__recordOriginator mesh__D014080 NLM
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D014080 2000
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D014080 2006
% 211.55/211.76  |- skos__hiddenLabel mesh__D014080 Exfoliations, Tooth
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D014080 1998
% 211.55/211.76  |- skos__scopeNote mesh__D014080
% 211.55/211.76       Physiologic loss of the primary dentition. %28%Zwemer, Boucher%27%s Clinical Dental Terminology, 4th ed%29%%A%    
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D014080 2001
% 211.55/211.76  |- skos__prefLabel mesh__D014080 Tooth Exfoliation
% 211.55/211.76  |- skos__historyNote mesh__D014080 Periodontal Diseases %28%1966-1967%29%
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D014080 1999
% 211.55/211.76  |- skos__annotation mesh__D014080 use Cat C qualif   
% 211.55/211.76  |- skos__hiddenLabel mesh__D014080 Tooth Exfoliations
% 211.55/211.76  |- mesh__dateRevised mesh__D014080 1995-05-31
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D014080 2002
% 211.55/211.76  |- rdf__type mesh__D014080sskos__Concept
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D014080 2003
% 211.55/211.76  |- mesh__historyNote mesh__D014080 72%28%68%29%   
% 211.55/211.76  |- skos__historyNote mesh__D008841 Cytoskeleton %28%1977-1985%29%
% 211.55/211.76  |- skos__hiddenLabel mesh__D008841 Actin Filament
% 211.55/211.76  |- mesh__dateEstablished mesh__D008841 1991-01-01
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D008841 2006
% 211.55/211.76  |- skos__hiddenLabel mesh__D008841 Filament, Actin
% 211.55/211.76  |- mesh__dateRevised mesh__D008841 2003-07-09
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D008841 2005
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D008841 2004
% 211.55/211.76  |- skos__altLabel mesh__D008841 Actin Filaments
% 211.55/211.76  |- skos__hiddenLabel mesh__D008841 Filaments, Actin
% 211.55/211.76  |- mesh__recordOriginator mesh__D008841 AEP
% 211.55/211.76  |- mesh__recordAuthorizer mesh__D008841 sjn
% 211.55/211.76  |- skos__prefLabel mesh__D008841 Microfilaments
% 211.55/211.76  |- skos__broader mesh__D008841smesh__D003599
% 211.55/211.76  |- rdf__type mesh__D008841sskos__Concept
% 211.55/211.76  |- mesh__onlineNote mesh__D008841
% 211.55/211.76       use CYTOSKELETON to search MICROFILAMENTS 1977-85   
% 211.55/211.76  |- skos__altLabel mesh__D008841 Myofilaments
% 211.55/211.76  |- mesh__dateCreated mesh__D008841 1985-02-25
% 211.55/211.76  |- skos__historyNote mesh__D008841 Cytoplasm %28%1966-1976%29%
% 211.55/211.76  |- skos__hiddenLabel mesh__D008841 Myofilament
% 211.55/211.76  |- skos__hiddenLabel mesh__D008841 Microfilament
% 211.55/211.76  |- mesh__recordMaintainer mesh__D008841 nns
% 211.55/211.76  |- mesh__publicMeSHNote mesh__D008841
% 211.55/211.76       91; was see under CYTOSKELETON 1986-90; was see CYTOPLASMIC FILAMENTS 1980-85; was see under CYTOPLASM 1977-79%A%  
% 211.55/211.76  |- skos__scopeNote mesh__D008841
% 211.55/211.76       The smallest of the cytoskeletal filaments. They are composed chiefly of actin.%A%    
% 211.55/211.76  |- mesh__historyNote mesh__D008841
% 211.55/211.76       91%28%86%29%; was see under CYTOSKELETON 1986-90; was see CYTOPLASMIC FILAMENTS 1980-85; was see under CYTOPLASM 1977-79%A%  
% 211.55/211.76  |- skos__hiddenLabel mesh__D008043 Oil, Linseed
% 211.55/211.76  |- mesh__publicMeSHNote mesh__D008043 87; was LINSEED 1963-86   
% 211.55/211.76  |- mesh__recordAuthorizer mesh__D008043 sjn
% 211.55/211.76  |- mesh__historyNote mesh__D008043 87; was LINSEED 1963-86   
% 211.55/211.76  |- skos__altLabel mesh__D008043 Flaxseed Oil
% 211.55/211.76  |- skos__annotation mesh__D008043 D25-26 qualif   
% 211.55/211.76  |- rdf__type mesh__D008043sskos__Concept
% 211.55/211.76  |- skos__prefLabel mesh__D008043 Linseed Oil
% 211.55/211.76  |- mesh__dateCreated mesh__D008043 1999-01-01
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D008043 2006
% 211.55/211.76  |- skos__hiddenLabel mesh__D008043 Oil, Flaxseed
% 211.55/211.76  |- mesh__onlineNote mesh__D008043
% 211.55/211.76       use LINSEED OIL to search LINSEED 1966-86   
% 211.55/211.76  |- skos__broader mesh__D008043smesh__D010938
% 211.55/211.76  |- mesh__dateRevised mesh__D008043 2005-06-30
% 211.55/211.76  |- skos__scopeNote mesh__D008043
% 211.55/211.76       The fixed oil obtained from the dried ripe seed of linseed, Linum usitatissimum %28%L. Linaceae%29%. It is used as an emollient in liniments, pastes, and medicinal soaps, and in veterinary medicine as a laxative. It is also called flaxseed oil. %28%Dorland, 28th ed%29%%A%    
% 211.55/211.76  |- mesh__recordOriginator mesh__D008043 NLM
% 211.55/211.76  |- mesh__recordMaintainer mesh__D008043 ssb
% 211.55/211.76  |- skos__broader mesh__D008043smesh__D005224
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D000060 2003
% 211.55/211.76  |- mesh__recordAuthorizer mesh__D000060 sjn
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D000060 2006
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D000060 2000
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D000060 2004
% 211.55/211.76  |- skos__hiddenLabel mesh__D000060 Aviation Accidents
% 211.55/211.76  |- rdf__type mesh__D000060sskos__Concept
% 211.55/211.76  |- skos__hiddenLabel mesh__D000060 Aviation Accident
% 211.55/211.76  |- mesh__recordOriginator mesh__D000060 NLM
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D000060 2001
% 211.55/211.76  |- skos__hiddenLabel mesh__D000060 Accident, Aviation
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D000060 2002
% 211.55/211.76  |- skos__prefLabel mesh__D000060 Accidents, Aviation
% 211.55/211.76  |- mesh__dateCreated mesh__D000060 1999-01-01
% 211.55/211.76  |- skos__broader mesh__D000060smesh__D000059
% 211.55/211.76  |- mesh__recordMaintainer mesh__D000060 kle
% 211.55/211.76  |- skos__annotation mesh__D000060 IM; coord with specific inj %28%IM%29%   
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D000060 2005
% 211.55/211.76  |- mesh__dateRevised mesh__D000060 1999-11-03
% 211.55/211.76  |- mesh__historyNote mesh__D013786 1981   
% 211.55/211.76  |- skos__hiddenLabel mesh__D013786 Disease, Thalamic
% 211.55/211.76  |- skos__scopeNote mesh__D013786
% 211.55/211.76       Disorders of the centrally located thalamus, which integrates a wide range of cortical and subcortical information. Manifestations include sensory loss, MOVEMENT DISORDERS; ATAXIA, pain syndromes, visual disorders, a variety of neuropsychological conditions, and COMA. Relatively common etiologies include CEREBROVASCULAR DISORDERS; CRANIOCEREBRAL TRAUMA; BRAIN NEOPLASMS; BRAIN HYPOXIA; INTRACRANIAL HEMORRHAGES; and infectious processes.%A%    
% 211.55/211.76  |- skos__hiddenLabel mesh__D013786 Syndrome, Dejerine-Roussy
% 211.55/211.76  |- skos__broader mesh__D013786smesh__D001927
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D013786 2003
% 211.55/211.76  |- skos__hiddenLabel mesh__D013786 Thalamic Disease
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D013786 2000
% 211.55/211.76  |- mesh__recordMaintainer mesh__D013786 ags
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D013786 2004
% 211.55/211.76  |- skos__hiddenLabel mesh__D013786 Dejerine Roussy Syndrome
% 211.55/211.76  |- skos__historyNote mesh__D013786 Thalamus %28%1966-1980%29%
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D013786 2000A
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D013786 2001
% 211.55/211.76  |- mesh__recordOriginator mesh__D013786 RC
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D013786 2005
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D013786 2002
% 211.55/211.76  |- skos__hiddenLabel mesh__D013786 Diseases, Thalamic
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D013786 2006
% 211.55/211.76  |- mesh__recordAuthorizer mesh__D013786 ags
% 211.55/211.76  |- skos__historyNote mesh__D013786 Brain Diseases %28%1966-1980%29%
% 211.55/211.76  |- mesh__publicMeSHNote mesh__D013786 1981   
% 211.55/211.76  |- mesh__dateCreated mesh__D013786 1980-04-09
% 211.55/211.76  |- skos__prefLabel mesh__D013786 Thalamic Diseases
% 211.55/211.76  |- mesh__dateRevised mesh__D013786 1999-12-08
% 211.55/211.76  |- mesh__dateEstablished mesh__D013786 1981-01-01
% 211.55/211.76  |- rdf__type mesh__D013786sskos__Concept
% 211.55/211.76  |- mesh__recordOriginator mesh__D007749 NLM
% 211.55/211.76  |- skos__broader mesh__D007749smesh__D007745
% 211.55/211.76  |- mesh__publicMeSHNote mesh__D007749
% 211.55/211.76       91; was see under LABOR 1977-90; was LABOR, THIRD STAGE see under LABOR 1975-76%A%  
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D007749 2005
% 211.55/211.76  |- mesh__recordMaintainer mesh__D007749 lkt
% 211.55/211.76  |- mesh__dateCreated mesh__D007749 1974-11-11
% 211.55/211.76  |- skos__prefLabel mesh__D007749 Labor Stage, Third
% 211.55/211.76  |- rdf__type mesh__D007749sskos__Concept
% 211.55/211.76  |- skos__hiddenLabel mesh__D007749 Stage, Third Labor
% 211.55/211.76  |- skos__hiddenLabel mesh__D007749 Third Labor Stages
% 211.55/211.76  |- skos__annotation mesh__D007749
% 211.55/211.76       human only; check tags FEMALE %26% PREGNANCY   
% 211.55/211.76  |- skos__altLabel mesh__D007749 Labor, Third Stage
% 211.55/211.76  |- skos__hiddenLabel mesh__D007749 Stages, Third Labor
% 211.55/211.76  |- mesh__recordAuthorizer mesh__D007749 sjn
% 211.55/211.76  |- mesh__onlineNote mesh__D007749
% 211.55/211.76       use LABOR STAGE, THIRD to search LABOR, THIRD STAGE 1975-76%A%  
% 211.55/211.76  |- skos__scopeNote mesh__D007749
% 211.55/211.76       The final period of OBSTETRIC LABOR that is from the expulsion of the FETUS to the expulsion of the PLACENTA.%A%    
% 211.55/211.76  |- skos__hiddenLabel mesh__D007749 Labor Stages, Third
% 211.55/211.76  |- skos__hiddenLabel mesh__D007749 Third Stage Labor
% 211.55/211.76  |- mesh__historyNote mesh__D007749
% 211.55/211.76       91%28%77%29%; was see under LABOR 1977-90; was LABOR, THIRD STAGE see under LABOR 1975-76%A%  
% 211.55/211.76  |- mesh__dateEstablished mesh__D007749 1991-01-01
% 211.55/211.76  |- mesh__dateRevised mesh__D007749 2004-07-07
% 211.55/211.76  |- skos__hiddenLabel mesh__D007749 Third Labor Stage
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D007749 2006
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D018471 1996
% 211.55/211.76  |- mesh__publicMeSHNote mesh__D018471 95   
% 211.55/211.76  |- mesh__dateCreated mesh__D018471 1994-06-07
% 211.55/211.76  |- rdf__type mesh__D018471sskos__Concept
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D018471 2003
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D018471 1997
% 211.55/211.76  |- mesh__dateEstablished mesh__D018471 1995-01-01
% 211.55/211.76  |- mesh__historyNote mesh__D018471 95   
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D018471 2000
% 211.55/211.76  |- skos__annotation mesh__D018471
% 211.55/211.76       natural or artificial; do not confuse with HYPOGRAVITY; /adv eff permitted%A%  
% 211.55/211.76  |- skos__hiddenLabel mesh__D018471 Gravity, High
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D018471 2004
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D018471 1998
% 211.55/211.76  |- skos__altLabel mesh__D018471 Increased Gravity
% 211.55/211.76  |- skos__hiddenLabel mesh__D018471 Gravity, Increased
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D018471 2001
% 211.55/211.76  |- skos__altLabel mesh__D018471 High Gravity
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D018471 2005
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D018471 1999
% 211.55/211.76  |- skos__scopeNote mesh__D018471
% 211.55/211.76       Condition wherein the force of gravity is greater than or is increased above that on the surface of the earth. This is expressed as being greater than 1 g.%A%    
% 211.55/211.76  |- skos__historyNote mesh__D018471 Gravitation %28%1966-1994%29%
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D018471 2002
% 211.55/211.76  |- skos__prefLabel mesh__D018471 Hypergravity
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D018471 1995
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D018471 2006
% 211.55/211.76  |- skos__broader mesh__D018471smesh__D018470
% 211.55/211.76  |- skos__scopeNote mesh__D004451
% 211.55/211.76       Infection by flukes of the genus Echinostoma.     
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D004451 2005
% 211.55/211.76  |- skos__prefLabel mesh__D004451 Echinostomiasis
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D004451 1994
% 211.55/211.76  |- mesh__historyNote mesh__D004451
% 211.55/211.76       91%28%75%29%; was see under TREMATODE INFECTIONS 1975-90   
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D004451 2003
% 211.55/211.76  |- mesh__recordOriginator mesh__D004451 NLM
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D004451 2006
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D004451 1995
% 211.55/211.76  |- mesh__dateEstablished mesh__D004451 1991-01-01
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D004451 2004
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D004451 1998
% 211.55/211.76  |- skos__broader mesh__D004451smesh__D014201
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D004451 2000
% 211.55/211.76  |- skos__annotation mesh__D004451 trematode infect   
% 211.55/211.76  |- skos__hiddenLabel mesh__D004451 Echinostomiases
% 211.55/211.76  |- rdf__type mesh__D004451sskos__Concept
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D004451 1996
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D004451 2001
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D004451 1999
% 211.55/211.76  |- mesh__dateRevised mesh__D004451 1993-06-04
% 211.55/211.76  |- mesh__publicMeSHNote mesh__D004451
% 211.55/211.76       91; was see under TREMATODE INFECTIONS 1975-90   
% 211.55/211.76  |- mesh__onlineNote mesh__D004451 search TREMATODE INFECTIONS 1967-74   
% 211.55/211.76  |- mesh__dateCreated mesh__D004451 1999-01-01
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D004451 2002
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D004451 1997
% 211.55/211.76  |- mesh__recordAuthorizer mesh__D004451 PLS
% 211.55/211.76  |- mesh__recordMaintainer mesh__D004451 JLS
% 211.55/211.76  |- mesh__dateEstablished mesh__D045868 2004-01-01
% 211.55/211.76  |- skos__prefLabel mesh__D045868 Sorghum
% 211.55/211.76  |- skos__altLabel mesh__D045868 Johnsongrass
% 211.55/211.76  |- skos__altLabel mesh__D045868 Kafir
% 211.55/211.76  |- skos__annotation mesh__D045868
% 211.55/211.76       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.55/211.76  |- mesh__historyNote mesh__D045868 2004   
% 211.55/211.76  |- skos__broader mesh__D045868smesh__D006109
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D045868 2005
% 211.55/211.76  |- skos__altLabel mesh__D045868 Kaffir Corn
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D045868 2006
% 211.55/211.76  |- rdf__type mesh__D045868sskos__Concept
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D045868 2004
% 211.55/211.76  |- mesh__dateCreated mesh__D045868 2003-07-09
% 211.55/211.76  |- skos__scopeNote mesh__D045868
% 211.55/211.76       A plant genus of the family POACEAE. The grain is used for FOOD and for ANIMAL FEED. This should not be confused with KAFFIR LIME or with KEFIR milk product.%A%    
% 211.55/211.76  |- skos__altLabel mesh__D045868 Sudangrass
% 211.55/211.76  |- mesh__publicMeSHNote mesh__D045868 2004   
% 211.55/211.76  |- skos__prefLabel mesh__D017379 Hypertrophy, Left Ventricular
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D017379 2006
% 211.55/211.76  |- skos__hiddenLabel mesh__D017379 Ventricular Hypertrophies, Left
% 211.55/211.76  |- skos__altLabel mesh__D017379 Left Ventricular Hypertrophy
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D017379 2002
% 211.55/211.76  |- mesh__recordMaintainer mesh__D017379 PLS
% 211.55/211.76  |- skos__scopeNote mesh__D017379
% 211.55/211.76       Enlargement of the left ventricle of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.%A%    
% 211.55/211.76  |- skos__hiddenLabel mesh__D017379 Hypertrophies, Left Ventricular
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D017379 2003
% 211.55/211.76  |- mesh__publicMeSHNote mesh__D017379 93   
% 211.55/211.76  |- mesh__dateCreated mesh__D017379 1992-05-20
% 211.55/211.76  |- rdf__type mesh__D017379sskos__Concept
% 211.55/211.76  |- skos__altLabel mesh__D017379 Ventricular Hypertrophy, Left
% 211.55/211.76  |- mesh__historyNote mesh__D017379 93   
% 211.55/211.76  |- mesh__recordOriginator mesh__D017379 PXP
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D017379 2004
% 211.55/211.76  |- skos__historyNote mesh__D017379 Heart Hypertrophy %28%1966-1992%29%
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D017379 2000
% 211.55/211.76  |- mesh__dateEstablished mesh__D017379 1993-01-01
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D017379 2001
% 211.55/211.76  |- skos__broader mesh__D017379smesh__D006332
% 211.55/211.76  |- mesh__recordAuthorizer mesh__D017379 sjn
% 211.55/211.76  |- skos__hiddenLabel mesh__D017379 Left Ventricular Hypertrophies
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D017379 2005
% 211.55/211.76  |- mesh__dateRevised mesh__D017379 1999-11-03
% 211.55/211.76  |- skos__broader mesh__D011954Q000819smesh__D011954
% 211.55/211.76  |- mesh__preferredCombination mesh__D011954Q000819smesh__D018491
% 211.55/211.76  |- rdf__type mesh__D011954Q000819smesh__CompoundConcept
% 211.55/211.76  |- skos__annotation mesh__D003359
% 211.55/211.76       ionizing; radiation policy: see Manual index under RADIATION %26% entries following; X ref HZE PARTICLES stands for High atomic number %28%Z%29% Energy particles%A%  
% 211.55/211.76  |- skos__broader mesh__D003359smesh__D001272
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D003359 1998
% 211.55/211.76  |- mesh__recordMaintainer mesh__D003359 JLS
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D003359 2006
% 211.55/211.76  |- mesh__dateRevised mesh__D003359 1997-06-20
% 211.55/211.76  |- skos__hiddenLabel mesh__D003359 HZE Particle
% 211.55/211.76  |- rdf__type mesh__D003359sskos__Concept
% 211.55/211.76  |- skos__hiddenLabel mesh__D003359 Particles, HZE
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D003359 1999
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D003359 2002
% 211.55/211.76  |- mesh__recordOriginator mesh__D003359 NLM
% 211.55/211.76  |- skos__altLabel mesh__D003359 Radiation, Cosmic
% 211.55/211.76  |- skos__hiddenLabel mesh__D003359 Radiations, Cosmic
% 211.55/211.76  |- skos__broader mesh__D003359smesh__D011839
% 211.55/211.76  |- skos__prefLabel mesh__D003359 Cosmic Radiation
% 211.55/211.76  |- skos__hiddenLabel mesh__D003359 Cosmic Radiations
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D003359 2000
% 211.55/211.76  |- skos__hiddenLabel mesh__D003359 Particle, HZE
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D003359 2003
% 211.55/211.76  |- mesh__recordAuthorizer mesh__D003359 SJN
% 211.55/211.76  |- skos__related mesh__D003359smesh__D019445
% 211.55/211.76  |- mesh__dateCreated mesh__D003359 1999-01-01
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D003359 2001
% 211.55/211.76  |- skos__scopeNote mesh__D003359
% 211.55/211.76       High-energy radiation or particles from extraterrestrial space that strike the earth, its atmosphere, or spacecraft and may create secondary radiation as a result of collisions with the atmosphere or spacecraft.%A%    
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D003359 2005
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D003359 2004
% 211.55/211.76  |- skos__broader mesh__D014081smesh__D019647
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D014081 1999
% 211.55/211.76  |- skos__hiddenLabel mesh__D014081 Extractions, Tooth
% 211.55/211.76  |- rdf__type mesh__D014081sskos__Concept
% 211.55/211.76  |- mesh__dateEstablished mesh__D014081 1965-01-01
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D014081 2004
% 211.55/211.76  |- mesh__dateRevised mesh__D014081 1997-06-20
% 211.55/211.76  |- mesh__recordMaintainer mesh__D014081 PXP
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D014081 1998
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D014081 2003
% 211.55/211.76  |- skos__hiddenLabel mesh__D014081 Extraction, Tooth
% 211.55/211.76  |- mesh__historyNote mesh__D014081 65; was TEETH EXTRACTION 1963-64   
% 211.55/211.76  |- mesh__recordAuthorizer mesh__D014081 SJN
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D014081 2002
% 211.55/211.76  |- skos__annotation mesh__D014081
% 211.55/211.76       SERIAL EXTRACTION is available as orthodontic proced for sequential removal of teeth over a period of years%A%  
% 211.55/211.76  |- skos__hiddenLabel mesh__D014081 Tooth Extractions
% 211.55/211.76  |- mesh__recordOriginator mesh__D014081 NLM
% 211.55/211.76  |- mesh__publicMeSHNote mesh__D014081 65; was TEETH EXTRACTION 1963-64   
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D014081 2006
% 211.55/211.76  |- skos__prefLabel mesh__D014081 Tooth Extraction
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D014081 2001
% 211.55/211.76  |- skos__scopeNote mesh__D014081
% 211.55/211.76       The surgical removal of a tooth. %28%Dorland, 28th ed%29%     
% 211.55/211.76  |- mesh__dateCreated mesh__D014081 1999-01-01
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D014081 2005
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D014081 2000
% 211.55/211.76  |- mesh__publicMeSHNote mesh__D008842
% 211.55/211.76       91; was see under FILARIOIDEA 1975-90   
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D008842 2006
% 211.55/211.76  |- mesh__dateRevised mesh__D008842 2003-07-09
% 211.55/211.76  |- skos__scopeNote mesh__D008842
% 211.55/211.76       The prelarval stage of Filarioidea in the blood and other tissues of mammals and birds. They are removed from these hosts by blood-sucking insects in which they metamorphose into mature larvae.%A%    
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D008842 2004
% 211.55/211.76  |- skos__prefLabel mesh__D008842 Microfilaria
% 211.55/211.76  |- mesh__dateEstablished mesh__D008842 1991-01-01
% 211.55/211.76  |- skos__broader mesh__D008842smesh__D005370
% 211.55/211.76  |- rdf__type mesh__D008842sskos__Concept
% 211.55/211.76  |- mesh__recordOriginator mesh__D008842 NLM
% 211.55/211.76  |- mesh__onlineNote mesh__D008842 search FILARIOIDEA 1966-74   
% 211.55/211.76  |- mesh__recordAuthorizer mesh__D008842 sjn
% 211.55/211.76  |- mesh__historyNote mesh__D008842
% 211.55/211.76       91%28%75%29%; was see under FILARIOIDEA 1975-90   
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D008842 2005
% 211.55/211.76  |- mesh__dateCreated mesh__D008842 1999-01-01
% 211.55/211.76  |- skos__annotation mesh__D008842
% 211.55/211.76       coord with specific helminth terms %28%ANTIGENS, HELMINTH, etc%29% if pertinent; /drug eff: consider FILARICIDES%A%  
% 211.55/211.76  |- mesh__recordMaintainer mesh__D008842 ags
% 211.55/211.76  |- mesh__historyNote mesh__D008044
% 211.55/211.76       91%28%72%29%; was see under HERBICIDES, UREA 1972-90   
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D008044 2005
% 211.55/211.76  |- skos__historyNote mesh__D008044 Herbicides %28%1966-1971%29%
% 211.55/211.76  |- mesh__publicMeSHNote mesh__D008044
% 211.55/211.76       91; was see under HERBICIDES, UREA 1972-90   
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D008044 2006
% 211.55/211.76  |- mesh__dateCreated mesh__D008044 1999-01-01
% 211.55/211.76  |- mesh__dateRevised mesh__D008044 2004-07-07
% 211.55/211.76  |- mesh__recordMaintainer mesh__D008044 ssb
% 211.55/211.76  |- mesh__recordOriginator mesh__D008044 NLM
% 211.55/211.76  |- skos__scopeNote mesh__D008044
% 211.55/211.76       A selective pre- and post-emergence herbicide. %28%From Merck Index, 11th ed%29%%A%    
% 211.55/211.76  |- skos__broader mesh__D008044smesh__D010671
% 211.55/211.76  |- mesh__recordAuthorizer mesh__D008044 sjn
% 211.55/211.76  |- skos__prefLabel mesh__D008044 Linuron
% 211.55/211.76  |- skos__historyNote mesh__D008044 Urea %28%1966-1971%29%
% 211.55/211.76  |- rdf__type mesh__D008044sskos__Concept
% 211.55/211.76  |- mesh__dateEstablished mesh__D008044 1991-01-01
% 211.55/211.76  |- skos__annotation mesh__D000061 IM; coord with specific inj %28%IM%29%   
% 211.55/211.76  |- rdf__type mesh__D000061sskos__Concept
% 211.55/211.76  |- mesh__dateRevised mesh__D000061 1999-11-03
% 211.55/211.76  |- skos__altLabel mesh__D000061 Home Accidents
% 211.55/211.76  |- skos__hiddenLabel mesh__D000061 Accident, Home
% 211.55/211.76  |- skos__historyNote mesh__D000061 Accidents %28%1966-1968%29%
% 211.55/211.76  |- mesh__recordAuthorizer mesh__D000061 sjn
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D000061 2000
% 211.55/211.76  |- skos__prefLabel mesh__D000061 Accidents, Home
% 211.55/211.76  |- mesh__historyNote mesh__D000061 70%28%69%29%   
% 211.55/211.76  |- mesh__dateEstablished mesh__D000061 1970-01-01
% 211.55/211.76  |- mesh__dateCreated mesh__D000061 1999-01-01
% 211.55/211.76  |- mesh__recordOriginator mesh__D000061 NLM
% 211.55/211.76  |- skos__hiddenLabel mesh__D000061 Home Accident
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D000061 2001
% 211.55/211.76  |- mesh__publicMeSHNote mesh__D000061 70   
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D000061 2005
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D000061 2002
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D000061 2003
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D000061 2006
% 211.55/211.76  |- skos__broader mesh__D000061smesh__D000059
% 211.55/211.76  |- mesh__recordMaintainer mesh__D000061 kle
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D000061 2004
% 211.55/211.76  |- skos__prefLabel mesh__D013787 Thalamic Nuclei
% 211.55/211.76  |- skos__hiddenLabel mesh__D013787 Nuclei, Thalamic
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D013787 2000
% 211.55/211.76  |- skos__scopeNote mesh__D013787
% 211.55/211.76       Several groups of nuclei in the thalamus that serve as the major relay centers for sensory impulses in the brain.%A%    
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D013787 2003
% 211.55/211.76  |- mesh__dateEstablished mesh__D013787 1971-01-01
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D013787 2001
% 211.55/211.76  |- mesh__recordMaintainer mesh__D013787 ags
% 211.55/211.76  |- mesh__dateCreated mesh__D013787 1999-01-01
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D013787 2004
% 211.55/211.76  |- skos__broader mesh__D013787smesh__D013788
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D013787 2002
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D013787 2005
% 211.55/211.76  |- mesh__publicMeSHNote mesh__D013787 71   
% 211.55/211.76  |- mesh__recordOriginator mesh__D013787 NLM
% 211.55/211.76  |- mesh__recordAuthorizer mesh__D013787 sjn
% 211.55/211.76  |- mesh__historyNote mesh__D013787 71   
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D013787 2006
% 211.55/211.76  |- skos__historyNote mesh__D013787 Thalamus %28%1966-1970%29%
% 211.55/211.76  |- mesh__dateRevised mesh__D013787 1999-11-03
% 211.55/211.76  |- rdf__type mesh__D013787sskos__Concept
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D018472 2002
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D018472 1997
% 211.55/211.76  |- mesh__activeMeSHYear mesh__D018472 2003
% 211.55/211.76  |- skos__related mesh__D018472smesh__D014893
% 211.55/211.76  |- mesh__historyNote mesh__D018472 95   
% 211.55/211.76  |- skos__broader mesh__D018472smesh__D018470
% 211.55/211.77  |- skos__hiddenLabel mesh__D018472 Gravity, Low
% 211.55/211.77  |- skos__altLabel mesh__D018472 Low Gravity
% 211.55/211.77  |- mesh__publicMeSHNote mesh__D018472 95   
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D018472 2004
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D018472 1998
% 211.55/211.77  |- skos__altLabel mesh__D018472 Reduced Gravity
% 211.55/211.77  |- skos__hiddenLabel mesh__D018472 Gravity, Reduced
% 211.55/211.77  |- mesh__dateEstablished mesh__D018472 1995-01-01
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D018472 1999
% 211.55/211.77  |- skos__annotation mesh__D018472
% 211.55/211.77       natural or artificial; do not confuse with HYPERGRAVITY; /adv eff permitted%A%  
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D018472 2005
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D018472 2000
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D018472 1995
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D018472 2006
% 211.55/211.77  |- skos__scopeNote mesh__D018472
% 211.55/211.77       Condition wherein the force of gravity is less than or is decreased below that on the surface of the earth. This is expressed as being between 0 and 1 g.%A%    
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D018472 2001
% 211.55/211.77  |- mesh__dateCreated mesh__D018472 1994-06-07
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D018472 1996
% 211.55/211.77  |- rdf__type mesh__D018472sskos__Concept
% 211.55/211.77  |- skos__prefLabel mesh__D018472 Hypogravity
% 211.55/211.77  |- skos__historyNote mesh__D018472 Gravitation %28%1966-1994%29%
% 211.55/211.77  |- skos__hiddenLabel mesh__D004452 Echocardiography, Two Dimensional
% 211.55/211.77  |- skos__scopeNote mesh__D004452
% 211.55/211.77       Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic.%A%    
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D004452 2004
% 211.55/211.77  |- skos__prefLabel mesh__D004452 Echocardiography
% 211.55/211.77  |- skos__altLabel mesh__D004452 2-D Echocardiography
% 211.55/211.77  |- skos__hiddenLabel mesh__D004452 Echocardiography, M Mode
% 211.55/211.77  |- mesh__dateRevised mesh__D004452 2001-07-25
% 211.55/211.77  |- skos__hiddenLabel mesh__D004452 Echocardiography, Cross Sectional
% 211.55/211.77  |- skos__altLabel mesh__D004452 M-Mode Echocardiography
% 211.55/211.77  |- skos__hiddenLabel mesh__D004452 Two Dimensional Echocardiography
% 211.55/211.77  |- mesh__dateEstablished mesh__D004452 1973-01-01
% 211.55/211.77  |- skos__altLabel mesh__D004452 Cross-Sectional Echocardiography
% 211.55/211.77  |- rdf__type mesh__D004452sskos__Concept
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D004452 2002
% 211.55/211.77  |- mesh__publicMeSHNote mesh__D004452 73   
% 211.55/211.77  |- skos__hiddenLabel mesh__D004452 2 D Echocardiography
% 211.55/211.77  |- skos__altLabel mesh__D004452 Echocardiography, 2D
% 211.55/211.77  |- mesh__dateCreated mesh__D004452 1999-01-01
% 211.55/211.77  |- skos__broader mesh__D004452smesh__D006334
% 211.55/211.77  |- skos__altLabel mesh__D004452 Echocardiography, 2-D
% 211.55/211.77  |- skos__altLabel mesh__D004452 Echocardiography, Two-Dimensional
% 211.55/211.77  |- skos__historyNote mesh__D004452 Ultrasonics %28%1966%29%
% 211.55/211.77  |- skos__altLabel mesh__D004452 Contrast Echocardiography
% 211.55/211.77  |- skos__annotation mesh__D004452
% 211.55/211.77       GEN only; prefer /ultrasonogr with specific heart dis; note X ref ECHOCARDIOGRAPHY, TRANSTHORACIC; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL is also available; DF: ECHOCARDIOGR%A%  
% 211.55/211.77  |- skos__hiddenLabel mesh__D004452 M Mode Echocardiography
% 211.55/211.77  |- mesh__historyNote mesh__D004452 73%28%67%29%   
% 211.55/211.77  |- mesh__recordAuthorizer mesh__D004452 sjn
% 211.55/211.77  |- skos__broader mesh__D004452smesh__D014463
% 211.55/211.77  |- skos__hiddenLabel mesh__D004452 Cross Sectional Echocardiography
% 211.55/211.77  |- mesh__recordOriginator mesh__D004452 NLM
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D004452 2005
% 211.55/211.77  |- skos__hiddenLabel mesh__D004452 Echocardiography, 2 D
% 211.55/211.77  |- mesh__recordMaintainer mesh__D004452 nns
% 211.55/211.77  |- skos__altLabel mesh__D004452 Transthoracic Echocardiography
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D004452 2003
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D004452 2006
% 211.55/211.77  |- skos__altLabel mesh__D004452 Two-Dimensional Echocardiography
% 211.55/211.77  |- skos__altLabel mesh__D004452 Echocardiography, Transthoracic
% 211.55/211.77  |- mesh__dateCreated mesh__D014880 1999-01-01
% 211.55/211.77  |- skos__hiddenLabel mesh__D014880 Softenings, Water
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014880 2002
% 211.55/211.77  |- skos__hiddenLabel mesh__D014880 Softening, Water
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014880 1996
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014880 2003
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014880 1998
% 211.55/211.77  |- mesh__dateRevised mesh__D014880 1994-07-20
% 211.55/211.77  |- skos__broader mesh__D014880smesh__D012498
% 211.55/211.77  |- rdf__type mesh__D014880sskos__Concept
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014880 2005
% 211.55/211.77  |- mesh__recordMaintainer mesh__D014880 PLS
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014880 1997
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014880 1994
% 211.55/211.77  |- mesh__recordAuthorizer mesh__D014880 PLS
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014880 2004
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014880 1999
% 211.55/211.77  |- mesh__recordOriginator mesh__D014880 NLM
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014880 2006
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014880 2000
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014880 1993
% 211.55/211.77  |- skos__hiddenLabel mesh__D014880 Water Softenings
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014880 1995
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014880 2001
% 211.55/211.77  |- skos__prefLabel mesh__D014880 Water Softening
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014082 1998
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014082 2001
% 211.55/211.77  |- mesh__dateRevised mesh__D014082 1995-02-23
% 211.55/211.77  |- skos__annotation mesh__D014082
% 211.55/211.77       coord IM with specific tooth /inj %28%IM%29%   
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014082 2003
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014082 1997
% 211.55/211.77  |- mesh__dateEstablished mesh__D014082 1966-01-01
% 211.55/211.77  |- skos__prefLabel mesh__D014082 Tooth Fractures
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014082 2000
% 211.55/211.77  |- skos__hiddenLabel mesh__D014082 Fracture, Tooth
% 211.55/211.77  |- mesh__recordMaintainer mesh__D014082 TGC
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014082 1996
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014082 2006
% 211.55/211.77  |- mesh__recordAuthorizer mesh__D014082 PLS
% 211.55/211.77  |- skos__scopeNote mesh__D014082
% 211.55/211.77       Break or rupture of a tooth or tooth root.     
% 211.55/211.77  |- mesh__dateCreated mesh__D014082 1999-01-01
% 211.55/211.77  |- skos__hiddenLabel mesh__D014082 Fractures, Tooth
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014082 2005
% 211.55/211.77  |- mesh__publicMeSHNote mesh__D014082 66   
% 211.55/211.77  |- mesh__historyNote mesh__D014082 66%28%65%29%   
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014082 1999
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014082 2002
% 211.55/211.77  |- skos__hiddenLabel mesh__D014082 Tooth Fracture
% 211.55/211.77  |- rdf__type mesh__D014082sskos__Concept
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014082 2004
% 211.55/211.77  |- skos__broader mesh__D014082smesh__D018677
% 211.55/211.77  |- mesh__recordOriginator mesh__D014082 NLM
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D008843 2004
% 211.55/211.77  |- skos__hiddenLabel mesh__D008843 Microforms
% 211.55/211.77  |- skos__broader mesh__D008843smesh__D003308
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D008843 2000
% 211.55/211.77  |- skos__annotation mesh__D008843 IM   
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D008843 2001
% 211.55/211.77  |- rdf__type mesh__D008843sskos__Concept
% 211.55/211.77  |- mesh__recordMaintainer mesh__D008843 kle
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D008843 2002
% 211.55/211.77  |- skos__prefLabel mesh__D008843 Microfilming
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D008843 2005
% 211.55/211.77  |- mesh__dateCreated mesh__D008843 1999-01-01
% 211.55/211.77  |- mesh__recordOriginator mesh__D008843 NLM
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D008843 2003
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D008843 2006
% 211.55/211.77  |- mesh__dateRevised mesh__D008843 1999-11-03
% 211.55/211.77  |- skos__hiddenLabel mesh__D008843 Microfilmings
% 211.55/211.77  |- mesh__recordAuthorizer mesh__D008843 sjn
% 211.55/211.77  |- skos__hiddenLabel mesh__D000860 Hypoxias
% 211.55/211.77  |- mesh__recordMaintainer mesh__D000860 sjn
% 211.55/211.77  |- mesh__dateCreated mesh__D000860 1999-01-01
% 211.55/211.77  |- mesh__recordOriginator mesh__D000860 NLM
% 211.55/211.77  |- skos__prefLabel mesh__D000860 Anoxia
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000860 2006
% 211.55/211.77  |- mesh__recordAuthorizer mesh__D000860 sjn
% 211.55/211.77  |- skos__related mesh__D000860smesh__D002534
% 211.55/211.77  |- skos__annotation mesh__D000860
% 211.55/211.77       differentiate from ANOXEMIA; do not confuse X ref HYPOXIA with HYPEROXIA; fetal anoxia = FETAL HYPOXIA; CEREBRAL ANOXIA see HYPOXIA, BRAIN; restrict to dis or clin state in human %26% higher animals: do not confuse with anoxic or hypoxic state in lower animals or micro-organisms %28% = OXYGEN or ANAEROBIOSIS%29%; TN 145: ANOXIA %26% HYPOXIA see ANOXIA as clin entities in C23 %26% not for decrease of oxygen in tissues %26% cells %28% = CELL HYPOXIA%29%%A%  
% 211.55/211.77  |- skos__hiddenLabel mesh__D000860 Oxygen Deficiencies
% 211.55/211.77  |- rdf__type mesh__D000860sskos__Concept
% 211.55/211.77  |- mesh__dateRevised mesh__D000860 2005-07-01
% 211.55/211.77  |- skos__altLabel mesh__D000860 Oxygen Deficiency
% 211.55/211.77  |- skos__hiddenLabel mesh__D000860 Anoxias
% 211.55/211.77  |- skos__scopeNote mesh__D000860
% 211.55/211.77       Clinical manifestation of respiratory distress consisting of a relatively complete absence of oxygen.%A%    
% 211.55/211.77  |- skos__broader mesh__D000860smesh__D012818
% 211.55/211.77  |- skos__related mesh__D000860smesh__D020925
% 211.55/211.77  |- skos__altLabel mesh__D000860 Deficiency, Oxygen
% 211.55/211.77  |- skos__hiddenLabel mesh__D000860 Deficiencies, Oxygen
% 211.55/211.77  |- skos__broader mesh__D014070Q000002smesh__D014070
% 211.55/211.77  |- mesh__preferredCombination mesh__D014070Q000002smesh__D014071
% 211.55/211.77  |- rdf__type mesh__D014070Q000002smesh__CompoundConcept
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D008045 2006
% 211.55/211.77  |- mesh__dateRevised mesh__D008045 2004-07-07
% 211.55/211.77  |- skos__broader mesh__D008045smesh__D046009
% 211.55/211.77  |- skos__prefLabel mesh__D008045 Lions
% 211.55/211.77  |- mesh__dateCreated mesh__D008045 1974-12-12
% 211.55/211.77  |- mesh__recordMaintainer mesh__D008045 ags
% 211.55/211.77  |- skos__hiddenLabel mesh__D008045 Lion
% 211.55/211.77  |- skos__scopeNote mesh__D008045
% 211.55/211.77       Large, chiefly nocturnal mammals of the cat family FELIDAE, species Panthera leo. They are found in Africa and southern Asia.%A%    
% 211.55/211.77  |- mesh__recordOriginator mesh__D008045 NLM
% 211.55/211.77  |- mesh__historyNote mesh__D008045
% 211.55/211.77       91%28%75%29%; was see under CARNIVORA 1975-90   
% 211.55/211.77  |- rdf__type mesh__D008045sskos__Concept
% 211.55/211.77  |- mesh__dateEstablished mesh__D008045 1991-01-01
% 211.55/211.77  |- mesh__recordAuthorizer mesh__D008045 sjn
% 211.55/211.77  |- skos__altLabel mesh__D008045 Panthera leo
% 211.55/211.77  |- mesh__publicMeSHNote mesh__D008045
% 211.55/211.77       91; was see under CARNIVORA 1975-90   
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D008045 2005
% 211.55/211.77  |- skos__annotation mesh__D008045 IM; qualif permitted   
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000062 2004
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000062 2006
% 211.55/211.77  |- mesh__onlineNote mesh__D000062
% 211.55/211.77       use ACCIDENTS, OCCUPATIONAL to search ACCIDENTS, INDUSTRIAL 1966-78%A%  
% 211.55/211.77  |- skos__hiddenLabel mesh__D000062 Occupational Accident
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000062 2003
% 211.55/211.77  |- skos__prefLabel mesh__D000062 Accidents, Occupational
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000062 2005
% 211.55/211.77  |- skos__scopeNote mesh__D000062
% 211.55/211.77       Unforeseen occurrences, especially of an injurious character due to factors involving one%27%s employment. %28%From Dorland, 28th ed, p10%29%%A%    
% 211.55/211.77  |- skos__hiddenLabel mesh__D000062 Accident, Industrial
% 211.55/211.77  |- mesh__dateCreated mesh__D000062 1999-01-01
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000062 2002
% 211.55/211.77  |- rdf__type mesh__D000062sskos__Concept
% 211.55/211.77  |- skos__annotation mesh__D000062
% 211.55/211.77       IM; coord with specific occupation %28%IM%29%; DF: ACCIDENTS OCCUP%A%  
% 211.55/211.77  |- skos__hiddenLabel mesh__D000062 Industrial Accident
% 211.55/211.77  |- skos__hiddenLabel mesh__D000062 Accident, Occupational
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000062 2001
% 211.55/211.77  |- mesh__dateRevised mesh__D000062 1999-11-03
% 211.55/211.77  |- skos__altLabel mesh__D000062 Industrial Accidents
% 211.55/211.77  |- mesh__recordAuthorizer mesh__D000062 sjn
% 211.55/211.77  |- skos__altLabel mesh__D000062 Occupational Accidents
% 211.55/211.77  |- mesh__historyNote mesh__D000062
% 211.55/211.77       79; was in Cat G %26% J 1979-82, was ACCIDENTS, INDUSTRIAL in Cat G %26% J 1967-78 %26% Cat G %26% I 1963-66%A%  
% 211.55/211.77  |- skos__broader mesh__D000062smesh__D000059
% 211.55/211.77  |- mesh__recordMaintainer mesh__D000062 kle
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000062 2000
% 211.55/211.77  |- mesh__publicMeSHNote mesh__D000062
% 211.55/211.77       79; was ACCIDENTS, INDUSTRIAL 1963-78   
% 211.55/211.77  |- mesh__recordOriginator mesh__D000062 NLM
% 211.55/211.77  |- mesh__dateRevised mesh__D013788 1999-11-03
% 211.55/211.77  |- mesh__recordMaintainer mesh__D013788 ags
% 211.55/211.77  |- mesh__dateCreated mesh__D013788 1999-01-01
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D013788 2004
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D013788 2000
% 211.55/211.77  |- skos__scopeNote mesh__D013788
% 211.55/211.77       Paired bodies containing mostly gray substance and forming part of the lateral wall of the third ventricle of the brain. The thalamus represents the major portion of the diencephalon and is commonly divided into cellular aggregates known as nuclear groups.%A%    
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D013788 2005
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D013788 2001
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D013788 2006
% 211.55/211.77  |- skos__prefLabel mesh__D013788 Thalamus
% 211.55/211.77  |- rdf__type mesh__D013788sskos__Concept
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D013788 2002
% 211.55/211.77  |- skos__broader mesh__D013788smesh__D004027
% 211.55/211.77  |- mesh__recordOriginator mesh__D013788 NLM
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D013788 2003
% 211.55/211.77  |- mesh__recordAuthorizer mesh__D013788 sjn
% 211.55/211.77  |- skos__broader mesh__D010490smesh__D006331
% 211.55/211.77  |- skos__related mesh__D010490smesh__D002305
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D010490 2005
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D010490 2000
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D010490 1995
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D010490 1998
% 211.55/211.77  |- mesh__recordOriginator mesh__D010490 NLM
% 211.55/211.77  |- mesh__dateCreated mesh__D010490 1999-01-01
% 211.55/211.77  |- mesh__onlineNote mesh__D010490
% 211.55/211.77       use PERICARDIAL EFFUSION to search HEMOPERICARDIUM 1969-83%A%  
% 211.55/211.77  |- mesh__historyNote mesh__D010490 66; was in Cat A %26% C 1966-83   
% 211.55/211.77  |- mesh__recordMaintainer mesh__D010490 TGC
% 211.55/211.77  |- skos__annotation mesh__D010490 fluid within the pericardium   
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D010490 2002
% 211.55/211.77  |- rdf__type mesh__D010490sskos__Concept
% 211.55/211.77  |- mesh__publicMeSHNote mesh__D010490
% 211.55/211.77       66; HEMOPERICARDIUM was see under PERICARDIAL EFFUSION 1969-83, was in Cat A %26% C 1969-83%A%  
% 211.55/211.77  |- skos__hiddenLabel mesh__D010490 Pericardial Effusions
% 211.55/211.77  |- skos__hiddenLabel mesh__D010490 Effusion, Pericardial
% 211.55/211.77  |- skos__hiddenLabel mesh__D010490 Chylopericardiums
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D010490 2004
% 211.55/211.77  |- skos__prefLabel mesh__D010490 Pericardial Effusion
% 211.55/211.77  |- mesh__recordAuthorizer mesh__D010490 PLS
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D010490 1997
% 211.55/211.77  |- skos__hiddenLabel mesh__D010490 Effusions, Pericardial
% 211.55/211.77  |- skos__scopeNote mesh__D010490
% 211.55/211.77       Presence of fluid within the pericardium.     
% 211.55/211.77  |- mesh__dateRevised mesh__D010490 1994-04-16
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D010490 2003
% 211.55/211.77  |- mesh__dateEstablished mesh__D010490 1966-01-01
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D010490 1996
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D010490 2001
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D010490 2006
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D010490 1999
% 211.55/211.77  |- skos__scopeNote mesh__D026905
% 211.55/211.77       Cellular proteins and protein complexes that transport amino acids across biological membranes.%A%    
% 211.55/211.77  |- mesh__dateEstablished mesh__D026905 2002-01-01
% 211.55/211.77  |- skos__historyNote mesh__D026905 Permeases %28%1981-2001%29%
% 211.55/211.77  |- mesh__publicMeSHNote mesh__D026905
% 211.55/211.77       2002; AMINO ACID PERMEASE was indexed under PERMEASES 1981-2001; AMINO ACID TRANSPORTER was indexed under CARRIER PROTEINS 1987-2001%A%  
% 211.55/211.77  |- skos__altLabel mesh__D026905 Amino Acid Transporters
% 211.55/211.77  |- rdf__type mesh__D026905sskos__Concept
% 211.55/211.77  |- skos__hiddenLabel mesh__D026905 Transporters, Amino Acid
% 211.55/211.77  |- skos__altLabel mesh__D026905 Amino Acid Permease
% 211.55/211.77  |- mesh__recordAuthorizer mesh__D026905 sjn
% 211.55/211.77  |- skos__historyNote mesh__D026905 Carrier Proteins %28%1987-2001%29%
% 211.55/211.77  |- skos__hiddenLabel mesh__D026905 Permeases, Amino Acid
% 211.55/211.77  |- skos__broader mesh__D026905smesh__D026901
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D026905 2006
% 211.55/211.77  |- mesh__dateCreated mesh__D026905 2001-07-25
% 211.55/211.77  |- skos__annotation mesh__D026905 GEN or unspecified; prefer specifics   
% 211.55/211.77  |- skos__prefLabel mesh__D026905 Amino Acid Transport Systems
% 211.55/211.77  |- mesh__recordMaintainer mesh__D026905 SYSTEM
% 211.55/211.77  |- skos__hiddenLabel mesh__D026905 Permease, Amino Acid
% 211.55/211.77  |- mesh__recordOriginator mesh__D026905 jmp
% 211.55/211.77  |- mesh__dateRevised mesh__D026905 2005-06-30
% 211.55/211.77  |- skos__altLabel mesh__D026905 Amino Acid Transporter
% 211.55/211.77  |- mesh__historyNote mesh__D026905
% 211.55/211.77       2002; for AMINO ACID PERMEASE use AMINO ACID TRANSPORT SYSTEMS %28%NM%29% 1981-2001; for AMINO ACID TRANSPORTER use AMINO ACID TRANSPORT SYSTEMS %28%NM%29% 1987-2001%A%  
% 211.55/211.77  |- rdf__type mesh__D004453sskos__Concept
% 211.55/211.77  |- skos__hiddenLabel mesh__D004453 Echoencephalographies
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D004453 1999
% 211.55/211.77  |- mesh__recordMaintainer mesh__D004453 PXP
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D004453 2000
% 211.55/211.77  |- mesh__dateCreated mesh__D004453 1999-01-01
% 211.55/211.77  |- skos__broader mesh__D004453smesh__D009485
% 211.55/211.77  |- mesh__historyNote mesh__D004453 67%28%64%29%   
% 211.55/211.77  |- mesh__dateRevised mesh__D004453 1997-06-20
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D004453 2001
% 211.55/211.77  |- skos__broader mesh__D004453smesh__D014463
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D004453 2005
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D004453 2002
% 211.55/211.77  |- skos__scopeNote mesh__D004453
% 211.55/211.77       Use of reflected ultrasound in the diagnosis of intracranial pathologic processes.%A%    
% 211.55/211.77  |- skos__annotation mesh__D004453
% 211.55/211.77       /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ECHOENCEPHALOGR%A%  
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D004453 2003
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D004453 2006
% 211.55/211.77  |- mesh__dateEstablished mesh__D004453 1967-01-01
% 211.55/211.77  |- mesh__recordOriginator mesh__D004453 NLM
% 211.55/211.77  |- skos__prefLabel mesh__D004453 Echoencephalography
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D004453 2004
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D004453 1998
% 211.55/211.77  |- mesh__publicMeSHNote mesh__D004453 67   
% 211.55/211.77  |- mesh__recordAuthorizer mesh__D004453 SJN
% 211.55/211.77  |- mesh__recordOriginator mesh__D014881 NLM
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014881 2002
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014881 2005
% 211.55/211.77  |- skos__prefLabel mesh__D014881 Water Supply
% 211.55/211.77  |- skos__hiddenLabel mesh__D014881 Supplies, Water
% 211.55/211.77  |- mesh__recordMaintainer mesh__D014881 kle
% 211.55/211.77  |- mesh__dateRevised mesh__D014881 1999-11-03
% 211.55/211.77  |- skos__annotation mesh__D014881
% 211.55/211.77       do not use WATER SUPPLY with regard to FLUORIDATION: assume to be of the water supply%A%  
% 211.55/211.77  |- skos__related mesh__D014881smesh__D018508
% 211.55/211.77  |- mesh__dateCreated mesh__D014881 1999-01-01
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014881 2001
% 211.55/211.77  |- skos__hiddenLabel mesh__D014881 Supply, Water
% 211.55/211.77  |- skos__hiddenLabel mesh__D014881 Water Supplies
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014881 2004
% 211.55/211.77  |- rdf__type mesh__D014881sskos__Concept
% 211.55/211.77  |- skos__scopeNote mesh__D014881
% 211.55/211.77       Source, means, or process of supplying water %28%as for a community%29% usually including reservoirs, tunnels, and pipelines and often the watershed from which the water is ultimately drawn. %28%Webster, 3d ed%29%%A%    
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014881 2000
% 211.55/211.77  |- skos__broader mesh__D014881smesh__D012498
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014881 2003
% 211.55/211.77  |- mesh__recordAuthorizer mesh__D014881 sjn
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014881 2006
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014083 2006
% 211.55/211.77  |- skos__scopeNote mesh__D014083
% 211.55/211.77       The collective tissues from which an entire tooth is formed, including the DENTAL SAC; ENAMEL ORGAN; and DENTAL PAPILLA. %28%From Jablonski, Dictionary of Dentistry, 1992%29%%A%    
% 211.55/211.77  |- mesh__recordAuthorizer mesh__D014083 sjn
% 211.55/211.77  |- mesh__dateCreated mesh__D014083 1999-01-01
% 211.55/211.77  |- mesh__dateRevised mesh__D014083 2003-07-09
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014083 2005
% 211.55/211.77  |- mesh__recordOriginator mesh__D014083 NLM
% 211.55/211.77  |- mesh__recordMaintainer mesh__D014083 lkt
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D014083 2004
% 211.55/211.77  |- rdf__type mesh__D014083sskos__Concept
% 211.55/211.77  |- skos__broader mesh__D014083smesh__D019589
% 211.55/211.77  |- skos__annotation mesh__D014083 /embryol: consider also ODONTOGENESIS   
% 211.55/211.77  |- skos__hiddenLabel mesh__D014083 Germs, Tooth
% 211.55/211.77  |- skos__hiddenLabel mesh__D014083 Tooth Germs
% 211.55/211.77  |- skos__hiddenLabel mesh__D014083 Germ, Tooth
% 211.55/211.77  |- skos__prefLabel mesh__D014083 Tooth Germ
% 211.55/211.77  |- skos__related mesh__D014083smesh__D009805
% 211.55/211.77  |- skos__scopeNote mesh__D008844
% 211.55/211.77       Unusual or undue smallness of the jaws. %28%Dorland, 27th ed%29%%A%    
% 211.55/211.77  |- skos__prefLabel mesh__D008844 Micrognathism
% 211.55/211.77  |- mesh__publicMeSHNote mesh__D008844 66   
% 211.55/211.77  |- mesh__dateRevised mesh__D008844 1999-11-03
% 211.55/211.77  |- mesh__dateEstablished mesh__D008844 1966-01-01
% 211.55/211.77  |- mesh__recordOriginator mesh__D008844 NLM
% 211.55/211.77  |- mesh__dateCreated mesh__D008844 1999-01-01
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D008844 2005
% 211.55/211.77  |- skos__hiddenLabel mesh__D008844 Micrognathisms
% 211.55/211.77  |- skos__annotation mesh__D008844
% 211.55/211.77       abnormally small jaw; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 211.55/211.77  |- mesh__recordAuthorizer mesh__D008844 sjn
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D008844 2006
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D008844 2003
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D008844 2000
% 211.55/211.77  |- mesh__historyNote mesh__D008844 66%28%64%29%   
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D008844 2004
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D008844 2001
% 211.55/211.77  |- mesh__recordMaintainer mesh__D008844 kle
% 211.55/211.77  |- skos__broader mesh__D008844smesh__D007569
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D008844 2002
% 211.55/211.77  |- rdf__type mesh__D008844sskos__Concept
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000861 2006
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000861 1997
% 211.55/211.77  |- skos__altLabel mesh__D000861 Beta-Alanyl-3-Methylhistidine
% 211.55/211.77  |- skos__broader mesh__D000861smesh__D004151
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000861 1994
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000861 2002
% 211.55/211.77  |- rdf__type mesh__D000861sskos__Concept
% 211.55/211.77  |- skos__hiddenLabel mesh__D000861 Beta Alanyl 3 Methylhistidine
% 211.55/211.77  |- skos__altLabel mesh__D000861 Ophidine
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000861 1995
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000861 2003
% 211.55/211.77  |- mesh__recordOriginator mesh__D000861 NLM
% 211.55/211.77  |- mesh__historyNote mesh__D000861
% 211.55/211.77       91%28%75%29%; was see under DIPEPTIDES 1967-90; was see under PEPTIDES 1963-66%A%  
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000861 1998
% 211.55/211.77  |- mesh__dateRevised mesh__D000861 1992-05-07
% 211.55/211.77  |- mesh__onlineNote mesh__D000861
% 211.55/211.77       search DIPEPTIDES 1967-74 %26% PEPTIDES 1966   
% 211.55/211.77  |- mesh__dateEstablished mesh__D000861 1991-01-01
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000861 2004
% 211.55/211.77  |- mesh__recordMaintainer mesh__D000861 TGC
% 211.55/211.77  |- skos__altLabel mesh__D000861 Balanine
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000861 2000
% 211.55/211.77  |- mesh__recordAuthorizer mesh__D000861 PLS
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000861 1999
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000861 1993
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000861 2001
% 211.55/211.77  |- mesh__publicMeSHNote mesh__D000861
% 211.55/211.77       91; was see under DIPEPTIDES 1967-90; was see under PEPTIDES 1963-66%A%  
% 211.55/211.77  |- skos__prefLabel mesh__D000861 Anserine
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000861 2005
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000861 1996
% 211.55/211.77  |- mesh__dateCreated mesh__D000861 1999-01-01
% 211.55/211.77  |- skos__annotation mesh__D000861 a dipeptide   
% 211.55/211.77  |- skos__broader mesh__D008046smesh__D009055
% 211.55/211.77  |- mesh__recordAuthorizer mesh__D008046 sjn
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D008046 2006
% 211.55/211.77  |- skos__prefLabel mesh__D008046 Lip
% 211.55/211.77  |- skos__scopeNote mesh__D008046
% 211.55/211.77       Either of the two fleshy, full-blooded margins of the mouth.%A%    
% 211.55/211.77  |- mesh__historyNote mesh__D008046 65; was LIPS 1963-64   
% 211.55/211.77  |- mesh__dateEstablished mesh__D008046 1965-01-01
% 211.55/211.77  |- mesh__dateCreated mesh__D008046 1999-01-01
% 211.55/211.77  |- skos__hiddenLabel mesh__D008046 Lips
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D008046 2005
% 211.55/211.77  |- mesh__dateRevised mesh__D008046 2003-07-09
% 211.55/211.77  |- mesh__publicMeSHNote mesh__D008046 65; was LIPS 1963-64   
% 211.55/211.77  |- skos__annotation mesh__D008046 inflammation = CHEILITIS   
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D008046 2004
% 211.55/211.77  |- mesh__recordMaintainer mesh__D008046 lkt
% 211.55/211.77  |- mesh__recordOriginator mesh__D008046 NLM
% 211.55/211.77  |- rdf__type mesh__D008046sskos__Concept
% 211.55/211.77  |- skos__broader mesh__D000063smesh__D000059
% 211.55/211.77  |- skos__hiddenLabel mesh__D000063 Traffic Accident
% 211.55/211.77  |- mesh__activeMeSHYear mesh__D000063 2005
% 211.55/211.77  |- skos__scopeNote mesh__D000063
% 211.55/211.77       Accidents on streets, roads, and highways involving drivers, passengers, pedestrians, or vehicles. Traffic accidents refer to AUTOMOBILES %28%passenger cars, buses, and trucks%29%, BICYCLING, and MOTORCYCLES but not OFF-ROAD MOTOR VEHICLES; RAILROADS nor snowmobiles.%A%    
% 211.55/211.78  |- skos__prefLabel mesh__D000063 Accidents, Traffic
% 211.55/211.78  |- mesh__recordMaintainer mesh__D000063 mdb
% 211.55/211.78  |- skos__annotation mesh__D000063
% 211.55/211.78       implies automobile accid so do not coord with AUTOMOBILES unless the auto is especially discussed; coord IM with BICYCLING %28%IM%29% or MOTORCYCLES %28%IM%29% if pertinent; not for railroad accidents %28% = RAILROADS + ACCIDENTS%29% or all-terrain vehicles, motorbikes or snowmobiles %28% = OFF-ROAD MOTOR VEHICLES + ACCIDENTS%29%%A%  
% 211.55/211.78  |- mesh__recordOriginator mesh__D000063 NLM
% 211.55/211.78  |- mesh__dateCreated mesh__D000063 1999-01-01
% 211.55/211.78  |- rdf__type mesh__D000063sskos__Concept
% 211.55/211.78  |- mesh__dateRevised mesh__D000063 2001-07-25
% 211.55/211.78  |- skos__hiddenLabel mesh__D000063 Accident, Traffic
% 211.55/211.78  |- skos__related mesh__D000063smesh__D017278
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D000063 2002
% 211.55/211.78  |- skos__altLabel mesh__D000063 Traffic Accidents
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D000063 2004
% 211.55/211.78  |- skos__related mesh__D000063smesh__D012622
% 211.55/211.78  |- mesh__recordAuthorizer mesh__D000063 sjn
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D000063 2006
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D000063 2003
% 211.55/211.78  |- mesh__historyNote mesh__D013789
% 211.55/211.78       65; was ANEMIA, ERYTHROBLASTIC 1963-64; ANEMIA, TARGET-CELL was see THALASSEMIA 1965-92%A%  
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D013789 2005
% 211.55/211.78  |- mesh__dateCreated mesh__D013789 1999-01-01
% 211.55/211.78  |- mesh__onlineNote mesh__D013789
% 211.55/211.78       use THALASSEMIA to search ANEMIA, TARGET-CELL 1966-92   
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D013789 2004
% 211.55/211.78  |- mesh__recordMaintainer mesh__D013789 nns
% 211.55/211.78  |- mesh__recordOriginator mesh__D013789 NLM
% 211.55/211.78  |- skos__hiddenLabel mesh__D013789 Thalassemias
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D013789 2003
% 211.55/211.78  |- mesh__dateRevised mesh__D013789 2001-07-25
% 211.55/211.78  |- mesh__recordAuthorizer mesh__D013789 sjn
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D013789 2002
% 211.55/211.78  |- skos__broader mesh__D013789smesh__D006453
% 211.55/211.78  |- skos__scopeNote mesh__D013789
% 211.55/211.78       A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.%A%    
% 211.55/211.78  |- mesh__publicMeSHNote mesh__D013789
% 211.55/211.78       65; was ANEMIA, ERYTHROBLASTIC 1963-64; ANEMIA, TARGET-CELL was see THALASSEMIA 1965-92%A%  
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D013789 2006
% 211.55/211.78  |- skos__prefLabel mesh__D013789 Thalassemia
% 211.55/211.78  |- skos__annotation mesh__D013789
% 211.55/211.78       a congen hemolytic anemia; GEN or unspecified: prefer specifics; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 211.55/211.78  |- rdf__type mesh__D013789sskos__Concept
% 211.55/211.78  |- skos__broader mesh__D013789smesh__D000745
% 211.55/211.78  |- mesh__dateEstablished mesh__D013789 1965-01-01
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D018474 2004
% 211.55/211.78  |- skos__broader mesh__D018474smesh__D008919
% 211.55/211.78  |- mesh__dateCreated mesh__D018474 1994-06-07
% 211.55/211.78  |- mesh__recordOriginator mesh__D018474 JLS
% 211.55/211.78  |- mesh__dateRevised mesh__D018474 2000-06-22
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D018474 2001
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D018474 2003
% 211.55/211.78  |- skos__hiddenLabel mesh__D018474 Simulation, Weightlessness
% 211.55/211.78  |- skos__hiddenLabel mesh__D018474 Weightlessness Model
% 211.55/211.78  |- skos__scopeNote mesh__D018474
% 211.55/211.78       Condition under normal Earth gravity where the force of gravity itself is not actually altered but its influence or effect may be modified and studied. %28%From ASGSB Bull 1992;5%28%2%29%:27%29%%A%    
% 211.55/211.78  |- skos__historyNote mesh__D018474 Weightlessness %28%1966-1994%29%
% 211.55/211.78  |- skos__hiddenLabel mesh__D018474 Weightlessness Models
% 211.55/211.78  |- mesh__historyNote mesh__D018474 95   
% 211.55/211.78  |- skos__prefLabel mesh__D018474 Weightlessness Simulation
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D018474 2006
% 211.55/211.78  |- mesh__dateEstablished mesh__D018474 1995-01-01
% 211.55/211.78  |- skos__hiddenLabel mesh__D018474 Simulation, Microgravity
% 211.55/211.78  |- mesh__recordAuthorizer mesh__D018474 sjn
% 211.55/211.78  |- mesh__publicMeSHNote mesh__D018474 95   
% 211.55/211.78  |- skos__broader mesh__D018474smesh__D018561
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D018474 2005
% 211.55/211.78  |- rdf__type mesh__D018474sskos__Concept
% 211.55/211.78  |- mesh__recordMaintainer mesh__D018474 ags
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D018474 2002
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D010491 2005
% 211.55/211.78  |- skos__hiddenLabel mesh__D010491 Window Technics, Pericardial
% 211.55/211.78  |- skos__historyNote mesh__D010491
% 211.55/211.78       Pericardial Effusion/surgery %28%1966-1987%29%
% 211.55/211.78  |- skos__broader mesh__D010491smesh__D006348
% 211.55/211.78  |- skos__hiddenLabel mesh__D010491 Technics, Pericardial Window
% 211.55/211.78  |- skos__hiddenLabel mesh__D010491 Techniques, Pericardial Window
% 211.55/211.78  |- skos__historyNote mesh__D010491
% 211.55/211.78       Cardiac Tamponade/surgery %28%1966-1987%29%
% 211.55/211.78  |- skos__annotation mesh__D010491
% 211.55/211.78       do not use /util except by MeSH definition   
% 211.55/211.78  |- mesh__recordMaintainer mesh__D010491 PXP
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D010491 2006
% 211.55/211.78  |- skos__broader mesh__D010491smesh__D000714
% 211.55/211.78  |- mesh__publicMeSHNote mesh__D010491
% 211.55/211.78       91; was PERICARDIAL WINDOW TECHNICS 1988-90   
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D010491 1998
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D010491 2002
% 211.55/211.78  |- skos__scopeNote mesh__D010491
% 211.55/211.78       Surgical construction of an opening or window in the pericardium. It is often called subxiphoid pericardial window technique.%A%    
% 211.55/211.78  |- skos__altLabel mesh__D010491 Pericardiostomy
% 211.55/211.78  |- skos__hiddenLabel mesh__D010491 Window Techniques, Pericardial
% 211.55/211.78  |- skos__hiddenLabel mesh__D010491 Technique, Pericardial Window
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D010491 2003
% 211.55/211.78  |- skos__hiddenLabel mesh__D010491 Window Technic, Pericardial
% 211.55/211.78  |- skos__altLabel mesh__D010491 Pericardial Window Technics
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D010491 1999
% 211.55/211.78  |- mesh__onlineNote mesh__D010491
% 211.55/211.78       use PERICARDIAL WINDOW TECHNIQUES to search PERICARDIAL WINDOW TECHNICS 1988-90%A%  
% 211.55/211.78  |- skos__hiddenLabel mesh__D010491 Pericardial Window Technic
% 211.55/211.78  |- skos__hiddenLabel mesh__D010491 Pericardiostomies
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D010491 2004
% 211.55/211.78  |- skos__hiddenLabel mesh__D010491 Window Technique, Pericardial
% 211.55/211.78  |- skos__hiddenLabel mesh__D010491 Pericardial Window Technique
% 211.55/211.78  |- mesh__recordOriginator mesh__D010491 SCD
% 211.55/211.78  |- skos__historyNote mesh__D010491 Pericarditis/surgery %28%1966-1987%29%
% 211.55/211.78  |- skos__prefLabel mesh__D010491 Pericardial Window Techniques
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D010491 2000
% 211.55/211.78  |- skos__historyNote mesh__D010491 Pericardium/surgery %28%1966-1987%29%
% 211.55/211.78  |- mesh__recordAuthorizer mesh__D010491 SJN
% 211.55/211.78  |- rdf__type mesh__D010491sskos__Concept
% 211.55/211.78  |- mesh__dateEstablished mesh__D010491 1988-01-01
% 211.55/211.78  |- skos__hiddenLabel mesh__D010491 Technic, Pericardial Window
% 211.55/211.78  |- mesh__dateRevised mesh__D010491 1997-06-25
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D010491 2001
% 211.55/211.78  |- mesh__historyNote mesh__D010491
% 211.55/211.78       91; was PERICARDIAL WINDOW TECHNICS 1988-90   
% 211.55/211.78  |- mesh__dateCreated mesh__D010491 1987-03-20
% 211.55/211.78  |- skos__broader mesh__D014680Q000530smesh__D014680
% 211.55/211.78  |- mesh__preferredCombination mesh__D014680Q000530smesh__D010690
% 211.55/211.78  |- rdf__type mesh__D014680Q000530smesh__CompoundConcept
% 211.55/211.78  |- mesh__historyNote mesh__D004454 1969%28%1964%29%   
% 211.55/211.78  |- skos__altLabel mesh__D004454 Echo Speech
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D004454 2001
% 211.55/211.78  |- skos__scopeNote mesh__D004454
% 211.55/211.78       Involuntary %28%%22%parrot-like%22%%29%, meaningless repetition of a recently heard word, phrase, or song. This condition may be associated with transcortical APHASIA; SCHIZOPHRENIA; or other disorders. %28%From Adams et al., Principles of Neurology, 6th ed, p485%29%%A%    
% 211.55/211.78  |- mesh__publicMeSHNote mesh__D004454 1969   
% 211.55/211.78  |- mesh__recordAuthorizer mesh__D004454 sjn
% 211.55/211.78  |- mesh__dateEstablished mesh__D004454 1969-01-01
% 211.55/211.78  |- skos__hiddenLabel mesh__D004454 Reactions, Echo
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D004454 2000
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D004454 2004
% 211.55/211.78  |- skos__prefLabel mesh__D004454 Echolalia
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D004454 2006
% 211.55/211.78  |- skos__altLabel mesh__D004454 Echophrasia
% 211.55/211.78  |- skos__altLabel mesh__D004454 Echo Reaction
% 211.55/211.78  |- mesh__recordMaintainer mesh__D004454 KEV
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D004454 2003
% 211.55/211.78  |- skos__hiddenLabel mesh__D004454 Reaction, Echo
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D004454 2005
% 211.55/211.78  |- mesh__dateRevised mesh__D004454 1999-11-03
% 211.55/211.78  |- mesh__recordOriginator mesh__D004454 NLM
% 211.55/211.78  |- skos__broader mesh__D004454smesh__D013064
% 211.55/211.78  |- rdf__type mesh__D004454sskos__Concept
% 211.55/211.78  |- skos__hiddenLabel mesh__D004454 Speech, Echo
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D004454 2002
% 211.55/211.78  |- mesh__dateCreated mesh__D004454 1999-01-01
% 211.55/211.78  |- skos__related mesh__D014882smesh__D015532
% 211.55/211.78  |- skos__hiddenLabel mesh__D014882 Water Electrolyte Balance
% 211.55/211.78  |- skos__hiddenLabel mesh__D014882 Balance, Electrolyte
% 211.55/211.78  |- mesh__recordMaintainer mesh__D014882 nns
% 211.55/211.78  |- mesh__recordAuthorizer mesh__D014882 sjn
% 211.55/211.78  |- skos__hiddenLabel mesh__D014882 Balance, Water-Electrolyte
% 211.55/211.78  |- mesh__dateCreated mesh__D014882 1999-01-01
% 211.55/211.78  |- skos__prefLabel mesh__D014882 Water-Electrolyte Balance
% 211.55/211.78  |- mesh__recordOriginator mesh__D014882 NLM
% 211.55/211.78  |- skos__broader mesh__D014882smesh__D006706
% 211.55/211.78  |- skos__related mesh__D014882smesh__D014883
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D014882 2004
% 211.55/211.78  |- skos__related mesh__D014882smesh__D005440
% 211.55/211.78  |- rdf__type mesh__D014882sskos__Concept
% 211.55/211.78  |- skos__related mesh__D014882smesh__D009994
% 211.55/211.78  |- skos__broader mesh__D014882smesh__D001669
% 211.55/211.78  |- skos__scopeNote mesh__D014882
% 211.55/211.78       The balance of fluid in the BODY FLUID COMPARTMENTS; total BODY WATER; BLOOD VOLUME; EXTRACELLULAR SPACE; INTRACELLULAR SPACE, etc., maintained by processes in the body that regulate the intake and excretion of WATER and ELECTROLYTES, particularly SODIUM and POTASSIUM.%A%    
% 211.55/211.78  |- mesh__dateRevised mesh__D014882 2003-07-25
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D014882 2006
% 211.55/211.78  |- skos__hiddenLabel mesh__D014882 Balance, Fluid
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D014882 2005
% 211.55/211.78  |- skos__scopeNote mesh__D014084
% 211.55/211.78       Partial or complete displacement of a tooth from its alveolar support. It is commonly the result of trauma. %28%From Boucher%27%s Clinical Dental Terminology, 4th ed, p312%29%%A%    
% 211.55/211.78  |- skos__altLabel mesh__D014084 Avulsed Tooth
% 211.55/211.78  |- mesh__dateCreated mesh__D014084 1999-01-01
% 211.55/211.78  |- skos__historyNote mesh__D014084 specific tooth %28%1966-1969%29%
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D014084 2005
% 211.55/211.78  |- mesh__recordMaintainer mesh__D014084 ags
% 211.55/211.78  |- skos__hiddenLabel mesh__D014084 Tooth Dislocation
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D014084 2004
% 211.55/211.78  |- rdf__type mesh__D014084sskos__Concept
% 211.55/211.78  |- mesh__historyNote mesh__D014084
% 211.55/211.78       97; was TOOTH LUXATION 1970-96; TOOTH AVULSION was see TOOTH LUXATION 1984-96%A%  
% 211.55/211.78  |- skos__broader mesh__D014084smesh__D018677
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D014084 2002
% 211.55/211.78  |- mesh__recordAuthorizer mesh__D014084 sjn
% 211.55/211.78  |- skos__hiddenLabel mesh__D014084 Avulsion, Tooth
% 211.55/211.78  |- skos__hiddenLabel mesh__D014084 Tooth, Avulsed
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D014084 2003
% 211.55/211.78  |- skos__hiddenLabel mesh__D014084 Tooth Dislocations
% 211.55/211.78  |- mesh__recordOriginator mesh__D014084 NLM
% 211.55/211.78  |- skos__hiddenLabel mesh__D014084 Tooth Luxations
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D014084 2001
% 211.55/211.78  |- mesh__publicMeSHNote mesh__D014084
% 211.55/211.78       97; was TOOTH LUXATION 1970-96; TOOTH AVULSION was see TOOTH LUXATION 1984-96%A%  
% 211.55/211.78  |- skos__hiddenLabel mesh__D014084 Avulsions, Tooth
% 211.55/211.78  |- skos__hiddenLabel mesh__D014084 Luxations, Tooth
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D014084 2000
% 211.55/211.78  |- mesh__dateRevised mesh__D014084 1999-11-03
% 211.55/211.78  |- skos__annotation mesh__D014084
% 211.55/211.78       partial or complete displacement of tooth from socket; coord IM with specific tooth /inj %28%IM%29%%A%  
% 211.55/211.78  |- skos__hiddenLabel mesh__D014084 Dislocations, Tooth
% 211.55/211.78  |- skos__altLabel mesh__D014084 Tooth Luxation
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D014084 2006
% 211.55/211.78  |- skos__prefLabel mesh__D014084 Tooth Avulsion
% 211.55/211.78  |- skos__hiddenLabel mesh__D014084 Tooth Avulsions
% 211.55/211.78  |- skos__hiddenLabel mesh__D014084 Luxation, Tooth
% 211.55/211.78  |- mesh__dateEstablished mesh__D014084 1970-01-01
% 211.55/211.78  |- mesh__dateCreated mesh__D008845 1999-01-01
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D008845 2005
% 211.55/211.78  |- skos__hiddenLabel mesh__D008845 Microinjection
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D008845 2006
% 211.55/211.78  |- skos__broader mesh__D008845smesh__D008846
% 211.55/211.78  |- mesh__dateRevised mesh__D008845 2004-07-07
% 211.55/211.78  |- mesh__recordOriginator mesh__D008845 NLM
% 211.55/211.78  |- mesh__publicMeSHNote mesh__D008845 73   
% 211.55/211.78  |- skos__prefLabel mesh__D008845 Microinjections
% 211.55/211.78  |- mesh__recordAuthorizer mesh__D008845 sjn
% 211.55/211.78  |- skos__annotation mesh__D008845 DF: MICROINJECT   
% 211.55/211.78  |- skos__historyNote mesh__D008845 Injections %28%1966-1972%29%
% 211.55/211.78  |- rdf__type mesh__D008845sskos__Concept
% 211.55/211.78  |- skos__scopeNote mesh__D008845
% 211.55/211.78       The injection of very small amounts of fluid, often with the aid of a microscope and microsyringes.%A%    
% 211.55/211.78  |- mesh__recordMaintainer mesh__D008845 nns
% 211.55/211.78  |- skos__broader mesh__D008845smesh__D007267
% 211.55/211.78  |- mesh__historyNote mesh__D008845 73   
% 211.55/211.78  |- mesh__dateEstablished mesh__D008845 1973-01-01
% 211.55/211.78  |- skos__hiddenLabel mesh__D000862 Venoms, Formicoidea
% 211.55/211.78  |- rdf__type mesh__D000862sskos__Concept
% 211.55/211.78  |- skos__hiddenLabel mesh__D000862 Venoms, Ant
% 211.55/211.78  |- skos__prefLabel mesh__D000862 Ant Venoms
% 211.55/211.78  |- mesh__dateRevised mesh__D000862 2005-06-30
% 211.55/211.78  |- mesh__recordMaintainer mesh__D000862 ssb
% 211.55/211.78  |- mesh__historyNote mesh__D000862
% 211.55/211.78       91%28%78%29%; was see under ARTHROPOD VENOMS 1978-90   
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D000862 2006
% 211.55/211.78  |- skos__historyNote mesh__D000862 Ants %28%1966-1977%29%
% 211.55/211.78  |- skos__historyNote mesh__D000862 Venoms %28%1966-1977%29%
% 211.55/211.78  |- mesh__dateEstablished mesh__D000862 1991-01-01
% 211.55/211.78  |- mesh__recordAuthorizer mesh__D000862 sjn
% 211.55/211.78  |- mesh__publicMeSHNote mesh__D000862
% 211.55/211.78       91; was see under ARTHROPOD VENOMS 1978-90   
% 211.55/211.78  |- skos__broader mesh__D000862smesh__D001180
% 211.55/211.78  |- skos__altLabel mesh__D000862 Ant Venom
% 211.55/211.78  |- skos__altLabel mesh__D000862 Formicoidea Venoms
% 211.55/211.78  |- skos__hiddenLabel mesh__D000862 Venoms, Fire Ant
% 211.55/211.78  |- skos__hiddenLabel mesh__D000862 Venom, Ant
% 211.55/211.78  |- skos__scopeNote mesh__D000862
% 211.55/211.78       Venoms from the superfamily Formicoidea, Ants. They may contain protein factors and toxins, histamine, enzymes, and alkaloids and are often allergenic or immunogenic.%A%    
% 211.55/211.78  |- mesh__recordOriginator mesh__D000862 SH
% 211.55/211.78  |- skos__annotation mesh__D000862
% 211.55/211.78       /antag permitted but consider also ANTIVENINS; /enzymol permitted%A%  
% 211.55/211.78  |- mesh__dateCreated mesh__D000862 1977-04-27
% 211.55/211.78  |- skos__historyNote mesh__D008047 Mouth Diseases %28%1966-1971%29%
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D008047 2001
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D008047 2006
% 211.55/211.78  |- mesh__dateEstablished mesh__D008047 1972-01-01
% 211.55/211.78  |- skos__hiddenLabel mesh__D008047 Disease, Lip
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D008047 1998
% 211.55/211.78  |- mesh__recordOriginator mesh__D008047 NLM
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D008047 2000
% 211.55/211.78  |- mesh__dateCreated mesh__D008047 1999-01-01
% 211.55/211.78  |- mesh__publicMeSHNote mesh__D008047 72   
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D008047 2005
% 211.55/211.78  |- mesh__recordMaintainer mesh__D008047 TGC
% 211.55/211.78  |- mesh__dateRevised mesh__D008047 1997-06-20
% 211.55/211.78  |- skos__broader mesh__D008047smesh__D009059
% 211.55/211.78  |- skos__prefLabel mesh__D008047 Lip Diseases
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D008047 2002
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D008047 2004
% 211.55/211.78  |- mesh__recordAuthorizer mesh__D008047 SJN
% 211.55/211.78  |- skos__annotation mesh__D008047 inflamm dis = CHEILITIS   
% 211.55/211.78  |- rdf__type mesh__D008047sskos__Concept
% 211.55/211.78  |- skos__historyNote mesh__D008047 Lip %28%1966-1971%29%
% 211.55/211.78  |- skos__hiddenLabel mesh__D008047 Diseases, Lip
% 211.55/211.78  |- skos__hiddenLabel mesh__D008047 Lip Disease
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D008047 2003
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D008047 1999
% 211.55/211.78  |- mesh__historyNote mesh__D008047 72   
% 211.55/211.78  |- skos__broader mesh__D000064smesh__D000222
% 211.55/211.78  |- mesh__recordMaintainer mesh__D000064 lkt
% 211.55/211.78  |- mesh__recordAuthorizer mesh__D000064 sjn
% 211.55/211.78  |- skos__altLabel mesh__D000064 Acclimation
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D000064 2004
% 211.55/211.78  |- skos__prefLabel mesh__D000064 Acclimatization
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D000064 2006
% 211.55/211.78  |- mesh__recordOriginator mesh__D000064 NLM
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D000064 2005
% 211.55/211.78  |- skos__annotation mesh__D000064
% 211.55/211.78       includes to climate, altitude, weather but not to gravity %28% = ADAPTATION, PHYSIOLOGICAL%29%%A%  
% 211.55/211.78  |- skos__scopeNote mesh__D000064
% 211.55/211.78       Adaptation to a new environment or to a change in the old.%A%    
% 211.55/211.78  |- mesh__dateCreated mesh__D000064 1999-01-01
% 211.55/211.78  |- mesh__dateRevised mesh__D000064 2003-07-09
% 211.55/211.78  |- rdf__type mesh__D000064sskos__Concept
% 211.55/211.78  |- skos__historyNote mesh__D027201 Carrier Proteins %28%1992-2001%29%
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D027201 2006
% 211.55/211.78  |- skos__altLabel mesh__D027201
% 211.55/211.78       Solute Carrier Family 7-%28%Cationic Amino Acid Transporter, y+ System%29%, Member 1
% 211.55/211.78  |- skos__historyNote mesh__D027201 Membrane Proteins %28%1992-2001%29%
% 211.55/211.78  |- mesh__recordOriginator mesh__D027201 jmp
% 211.55/211.78  |- rdf__type mesh__D027201sskos__Concept
% 211.55/211.78  |- skos__scopeNote mesh__D027201
% 211.55/211.78       A high-affinity, low capacity system y+ amino acid transporter found ubiquitously. It has specificity for the transport of ARGININE; LYSINE; and ORNITHINE. It may also act as an ecotropic leukemia retroviral receptor.%A%    
% 211.55/211.78  |- skos__hiddenLabel mesh__D027201 CAT 1 Transporter
% 211.55/211.78  |- mesh__historyNote mesh__D027201
% 211.55/211.78       2002; for ATRC1 use BASIC AMINO ACID TRANSPORT SYSTEMS %28%NM%29% 1992-2001; for CAT-1 TRANSPORTER use BASIC AMINO ACID TRANSPORT SYSTEMS %28%NM%29% 1996-2001%A%  
% 211.55/211.78  |- skos__hiddenLabel mesh__D027201 Transporter, SLC7A1
% 211.55/211.78  |- skos__altLabel mesh__D027201 SLC7A1 Transporter
% 211.55/211.78  |- skos__altLabel mesh__D027201 ATRC1
% 211.55/211.78  |- mesh__dateCreated mesh__D027201 2001-08-03
% 211.55/211.78  |- skos__hiddenLabel mesh__D027201 Transport Protein, CAT-1
% 211.55/211.78  |- mesh__recordMaintainer mesh__D027201 ags
% 211.55/211.78  |- mesh__dateRevised mesh__D027201 2005-07-08
% 211.55/211.78  |- skos__hiddenLabel mesh__D027201 CAT 1 Transport Protein
% 211.55/211.78  |- mesh__dateEstablished mesh__D027201 2002-01-01
% 211.55/211.78  |- skos__altLabel mesh__D027201 CAT-1 Transporter
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D027201 2005
% 211.55/211.78  |- skos__prefLabel mesh__D027201 Cationic Amino Acid Transporter 1
% 211.55/211.78  |- mesh__publicMeSHNote mesh__D027201
% 211.55/211.78       2002; ATRC1 was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1992-2001; CAT-1 TRANSPORTER was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1996-2001%A%  
% 211.55/211.78  |- skos__hiddenLabel mesh__D027201 Transporter, CAT-1
% 211.55/211.78  |- mesh__recordAuthorizer mesh__D027201 ags
% 211.55/211.78  |- skos__broader mesh__D027201smesh__D027182
% 211.55/211.78  |- skos__altLabel mesh__D027201 CAT-1 Transport Protein
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D027201 2006A
% 211.55/211.78  |- skos__hiddenLabel mesh__D018475 Position, Trendelenburg
% 211.55/211.78  |- mesh__recordMaintainer mesh__D018475 nns
% 211.55/211.78  |- skos__prefLabel mesh__D018475 Head-Down Tilt
% 211.55/211.78  |- skos__scopeNote mesh__D018475
% 211.55/211.78       Posture while lying with the head lower than the rest of the body. Extended time in this position is associated with temporary physiologic disturbances.%A%    
% 211.55/211.78  |- mesh__recordAuthorizer mesh__D018475 sjn
% 211.55/211.78  |- mesh__publicMeSHNote mesh__D018475 95   
% 211.55/211.78  |- mesh__historyNote mesh__D018475 95   
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D018475 2006
% 211.55/211.78  |- skos__historyNote mesh__D018475 Posture %28%1966-1994%29%
% 211.55/211.78  |- skos__related mesh__D018475smesh__D018667
% 211.55/211.78  |- skos__hiddenLabel mesh__D018475 Tilt, Head-Down
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D018475 2005
% 211.55/211.78  |- rdf__type mesh__D018475sskos__Concept
% 211.55/211.78  |- skos__annotation mesh__D018475
% 211.55/211.78       not restricted to space flight; /adv eff /physiol permitted%A%  
% 211.55/211.78  |- mesh__dateRevised mesh__D018475 2003-07-09
% 211.55/211.78  |- skos__hiddenLabel mesh__D018475 Head Down Tilt
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D018475 2004
% 211.55/211.78  |- mesh__dateCreated mesh__D018475 1994-06-07
% 211.55/211.78  |- mesh__recordOriginator mesh__D018475 JLS
% 211.55/211.78  |- skos__broader mesh__D018475smesh__D011187
% 211.55/211.78  |- mesh__dateEstablished mesh__D018475 1995-01-01
% 211.55/211.78  |- mesh__dateCreated mesh__D010492 1987-03-25
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D010492 2003
% 211.55/211.78  |- mesh__dateEstablished mesh__D010492 1988-01-01
% 211.55/211.78  |- skos__historyNote mesh__D010492 Pericardium/surgery %28%1966-1987%29%
% 211.55/211.78  |- mesh__recordAuthorizer mesh__D010492 SJN
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D010492 2006
% 211.55/211.78  |- skos__altLabel mesh__D010492 Pericardectomy
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D010492 1999
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D010492 2001
% 211.55/211.78  |- mesh__dateRevised mesh__D010492 1997-06-20
% 211.55/211.78  |- skos__hiddenLabel mesh__D010492 Pericardectomies
% 211.55/211.78  |- skos__hiddenLabel mesh__D010492 Pericardotomies
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D010492 2005
% 211.55/211.78  |- skos__altLabel mesh__D010492 Pericardotomy
% 211.55/211.78  |- skos__prefLabel mesh__D010492 Pericardiectomy
% 211.55/211.78  |- skos__scopeNote mesh__D010492
% 211.55/211.78       Surgical excision %28%total or partial%29% of a portion of the pericardium. Pericardiotomy refers to incision of the pericardium.%A%    
% 211.55/211.78  |- mesh__publicMeSHNote mesh__D010492 88   
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D010492 1998
% 211.55/211.78  |- skos__broader mesh__D010492smesh__D006348
% 211.55/211.78  |- skos__hiddenLabel mesh__D010492 Pericardiotomies
% 211.55/211.78  |- skos__annotation mesh__D010492
% 211.55/211.78       do not use /util except by MeSH definition   
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D010492 2000
% 211.55/211.78  |- skos__hiddenLabel mesh__D010492 Pericardiectomies
% 211.55/211.78  |- mesh__recordOriginator mesh__D010492 SCD
% 211.55/211.78  |- mesh__historyNote mesh__D010492 88   
% 211.55/211.78  |- rdf__type mesh__D010492sskos__Concept
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D010492 2004
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D010492 2002
% 211.55/211.78  |- mesh__recordMaintainer mesh__D010492 PXP
% 211.55/211.78  |- skos__altLabel mesh__D051300 WASP Protein Family
% 211.55/211.78  |- mesh__recordOriginator mesh__D051300 DRC
% 211.55/211.78  |- skos__altLabel mesh__D051300 WASF2 Protein
% 211.55/211.78  |- skos__altLabel mesh__D051300 WAVE1 Protein
% 211.55/211.78  |- rdf__type mesh__D051300sskos__Concept
% 211.55/211.78  |- skos__hiddenLabel mesh__D051300
% 211.55/211.78       Wiskott Aldrich Syndrome Protein Family, Member 2
% 211.55/211.78  |- skos__broader mesh__D051300smesh__D008840
% 211.55/211.78  |- skos__altLabel mesh__D051300 WASF1 Protein
% 211.55/211.78  |- skos__annotation mesh__D051300
% 211.55/211.78       WISKOTT-ALDRICH SYNDROME PROTEIN and WISKOTT-ALDRICH SYNDROME PROTEIN, NEURONAL are also available%A%  
% 211.55/211.78  |- skos__altLabel mesh__D051300 WAS Protein Family, Member 1
% 211.55/211.78  |- skos__altLabel mesh__D051300 WAS Protein Family, Member 3
% 211.55/211.78  |- skos__hiddenLabel mesh__D051300
% 211.55/211.78       Wiskott Aldrich Syndrome Protein Family, Member 1
% 211.55/211.78  |- skos__hiddenLabel mesh__D051300
% 211.55/211.78       WASP Family Verprolin Homologous Proteins
% 211.55/211.78  |- skos__prefLabel mesh__D051300 Wiskott-Aldrich Syndrome Protein Family
% 211.55/211.78  |- mesh__dateCreated mesh__D051300 2005-06-30
% 211.55/211.78  |- skos__scopeNote mesh__D051300
% 211.55/211.78       A family of microfilament proteins whose name derives from the fact that mutations in members of this protein family have been associated with WISKOTT-ALDRICH SYNDROME.  They are involved in ACTIN polymerization and contain a polyproline-rich region that binds to PROFILIN, and a verprolin homology domain that binds G-ACTIN.%A%    
% 211.55/211.78  |- skos__altLabel mesh__D051300 WAVE Proteins
% 211.55/211.78  |- mesh__publicMeSHNote mesh__D051300
% 211.55/211.78       2006; WAVE PROTEINS was indexed under MICROFILAMENT PROTEINS 1999-2005%A%  
% 211.55/211.78  |- mesh__historyNote mesh__D051300 2006%28%1999%29%   
% 211.55/211.78  |- skos__altLabel mesh__D051300 WAS Protein Family, Member 2
% 211.55/211.78  |- skos__altLabel mesh__D051300 WAVE2 Protein
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D051300 2006
% 211.55/211.78  |- skos__altLabel mesh__D051300 WAVE3 Protein
% 211.55/211.78  |- skos__hiddenLabel mesh__D051300 Wiskott Aldrich Syndrome Protein Family
% 211.55/211.78  |- skos__altLabel mesh__D051300 WAS Protein Family
% 211.55/211.78  |- skos__altLabel mesh__D051300 WASF3 Protein
% 211.55/211.78  |- mesh__recordAuthorizer mesh__D051300 sjn
% 211.55/211.78  |- mesh__recordMaintainer mesh__D051300 DRC
% 211.55/211.78  |- mesh__dateEstablished mesh__D051300 2006-01-01
% 211.55/211.78  |- skos__hiddenLabel mesh__D051300
% 211.55/211.78       Wiskott Aldrich Syndrome Protein Family, Member 3
% 211.55/211.78  |- mesh__dateRevised mesh__D004455 2004-07-13
% 211.55/211.78  |- mesh__dateEstablished mesh__D004455 1991-01-01
% 211.55/211.78  |- skos__scopeNote mesh__D004455
% 211.55/211.78       An auditory orientation mechanism involving the emission of high frequency sounds which are reflected back to the emitter %28%animal%29%.%A%    
% 211.55/211.78  |- skos__broader mesh__D004455smesh__D000819
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D004455 2006
% 211.55/211.78  |- skos__annotation mesh__D004455
% 211.55/211.78       animal only; for human consider SOUND LOCALIZATION   
% 211.55/211.78  |- mesh__recordAuthorizer mesh__D004455 sjn
% 211.55/211.78  |- skos__hiddenLabel mesh__D004455 Echolocations
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D004455 2005
% 211.55/211.78  |- skos__prefLabel mesh__D004455 Echolocation
% 211.55/211.78  |- rdf__type mesh__D004455sskos__Concept
% 211.55/211.78  |- skos__historyNote mesh__D004455 Orientation %28%1966-1971%29%
% 211.55/211.78  |- mesh__historyNote mesh__D004455
% 211.55/211.78       91%28%72%29%; was see under ORIENTATION 1972-90   
% 211.55/211.78  |- mesh__dateCreated mesh__D004455 1999-01-01
% 211.55/211.78  |- skos__historyNote mesh__D004455 Auditory Perception %28%1967-1971%29%
% 211.55/211.78  |- mesh__recordMaintainer mesh__D004455 sjn
% 211.55/211.78  |- mesh__publicMeSHNote mesh__D004455
% 211.55/211.78       91; was see under ORIENTATION 1972-90   
% 211.55/211.78  |- mesh__recordOriginator mesh__D004455 NLM
% 211.55/211.78  |- mesh__publicMeSHNote mesh__D009140 92   
% 211.55/211.78  |- mesh__recordOriginator mesh__D009140 NLM
% 211.55/211.78  |- skos__hiddenLabel mesh__D009140 Musculoskeletal Disease
% 211.55/211.78  |- mesh__onlineNote mesh__D009140
% 211.55/211.78       pre-explosion = MUSCULOSKELETAL DISEASES %28%PX%29%   
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D009140 2002
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D009140 2004
% 211.55/211.78  |- mesh__dateEstablished mesh__D009140 1992-01-01
% 211.55/211.78  |- skos__prefLabel mesh__D009140 Musculoskeletal Diseases
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D009140 2001
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D009140 1999
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D009140 2003
% 211.55/211.78  |- mesh__activeMeSHYear mesh__D009140 2006
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D009140 2000
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D009140 1998
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D009140 2005
% 211.55/211.79  |- skos__historyNote mesh__D009140 Muscular Diseases %28%1967-1991%29%
% 211.55/211.79  |- skos__hiddenLabel mesh__D009140 Disease, Musculoskeletal
% 211.55/211.79  |- skos__historyNote mesh__D009140 Musculoskeletal System %28%1966%29%
% 211.55/211.79  |- mesh__dateCreated mesh__D009140 1999-01-01
% 211.55/211.79  |- skos__hiddenLabel mesh__D009140 Diseases, Musculoskeletal
% 211.55/211.79  |- mesh__recordMaintainer mesh__D009140 TGC
% 211.55/211.79  |- skos__annotation mesh__D009140
% 211.55/211.79       GEN: prefer MUSCULAR DISEASES %26% BONE DISEASES or specifics%A%  
% 211.55/211.79  |- skos__scopeNote mesh__D009140
% 211.55/211.79       Diseases of the muscles and their associated ligaments and other connective tissue and of the bones and cartilage viewed collectively.%A%    
% 211.55/211.79  |- rdf__type mesh__D009140sskos__Concept
% 211.55/211.79  |- mesh__runningHead mesh__D009140 C5 - DISEASES-MUSCULOSKELETAL   
% 211.55/211.79  |- mesh__recordAuthorizer mesh__D009140 SJN
% 211.55/211.79  |- mesh__dateRevised mesh__D009140 1997-06-20
% 211.55/211.79  |- skos__historyNote mesh__D009140 Bone Diseases %28%1967-1991%29%
% 211.55/211.79  |- mesh__historyNote mesh__D009140
% 211.55/211.79       92; was MUSCULOSKELETAL DISEASES %28%NON MESH%29% 1967-91   
% 211.55/211.79  |- skos__hiddenLabel mesh__D014883 Water Electrolyte Imbalance
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014883 2004
% 211.55/211.79  |- rdf__type mesh__D014883sskos__Concept
% 211.55/211.79  |- mesh__dateRevised mesh__D014883 2003-07-09
% 211.55/211.79  |- mesh__dateCreated mesh__D014883 1975-07-25
% 211.55/211.79  |- skos__hiddenLabel mesh__D014883 Imbalances, Water-Electrolyte
% 211.55/211.79  |- mesh__historyNote mesh__D014883 76; was NON MESH before 1976   
% 211.55/211.79  |- mesh__recordMaintainer mesh__D014883 nns
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014883 2006
% 211.55/211.79  |- skos__annotation mesh__D014883 note category   
% 211.55/211.79  |- skos__broader mesh__D014883smesh__D008659
% 211.55/211.79  |- skos__related mesh__D014883smesh__D014882
% 211.55/211.79  |- skos__scopeNote mesh__D014883
% 211.55/211.79       Disturbances in the body%27%s WATER-ELECTROLYTE BALANCE.     
% 211.55/211.79  |- mesh__recordAuthorizer mesh__D014883 sjn
% 211.55/211.79  |- skos__historyNote mesh__D014883
% 211.55/211.79       Water-Electrolyte Balance %28%1966-1975%29%
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014883 2005
% 211.55/211.79  |- mesh__publicMeSHNote mesh__D014883 76   
% 211.55/211.79  |- skos__related mesh__D014883smesh__D015532
% 211.55/211.79  |- skos__related mesh__D014883smesh__D005440
% 211.55/211.79  |- skos__prefLabel mesh__D014883 Water-Electrolyte Imbalance
% 211.55/211.79  |- mesh__dateEstablished mesh__D014883 1976-01-01
% 211.55/211.79  |- mesh__recordOriginator mesh__D014883 SMH
% 211.55/211.79  |- skos__hiddenLabel mesh__D014883 Imbalance, Water-Electrolyte
% 211.55/211.79  |- skos__hiddenLabel mesh__D014883 Water-Electrolyte Imbalances
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014085 2001
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014085 1998
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014085 2003
% 211.55/211.79  |- mesh__publicMeSHNote mesh__D014085 66   
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014085 1993
% 211.55/211.79  |- mesh__recordAuthorizer mesh__D014085 PLS
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014085 1999
% 211.55/211.79  |- skos__broader mesh__D014085smesh__D010510
% 211.55/211.79  |- rdf__type mesh__D014085sskos__Concept
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014085 2004
% 211.55/211.79  |- skos__hiddenLabel mesh__D014085 Migration, Tooth
% 211.55/211.79  |- skos__hiddenLabel mesh__D014085 Tooth Migrations
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014085 1996
% 211.55/211.79  |- mesh__historyNote mesh__D014085 66%28%65%29%   
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014085 2002
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014085 1997
% 211.55/211.79  |- mesh__dateRevised mesh__D014085 1992-05-18
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014085 1994
% 211.55/211.79  |- mesh__recordMaintainer mesh__D014085 TGC
% 211.55/211.79  |- mesh__dateCreated mesh__D014085 1999-01-01
% 211.55/211.79  |- skos__hiddenLabel mesh__D014085 Migrations, Tooth
% 211.55/211.79  |- mesh__dateEstablished mesh__D014085 1966-01-01
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014085 2000
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014085 2005
% 211.55/211.79  |- skos__prefLabel mesh__D014085 Tooth Migration
% 211.55/211.79  |- skos__annotation mesh__D014085
% 211.55/211.79       movement to another position along the line of the dental arch %28%alveolar process%29%: do not confuse with TOOTH MOBILITY; use Cat C qualif%A%  
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014085 1995
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014085 2006
% 211.55/211.79  |- mesh__recordOriginator mesh__D014085 NLM
% 211.55/211.79  |- skos__broader mesh__D014085smesh__D009063
% 211.55/211.79  |- skos__hiddenLabel mesh__D008846 Micromanipulations
% 211.55/211.79  |- mesh__historyNote mesh__D008846 73%28%64%29%   
% 211.55/211.79  |- mesh__dateEstablished mesh__D008846 1973-01-01
% 211.55/211.79  |- skos__prefLabel mesh__D008846 Micromanipulation
% 211.55/211.79  |- skos__related mesh__D008846smesh__D046208
% 211.55/211.79  |- mesh__recordMaintainer mesh__D008846 nns
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D008846 2006
% 211.55/211.79  |- mesh__publicMeSHNote mesh__D008846 73   
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D008846 2005
% 211.55/211.79  |- mesh__dateRevised mesh__D008846 2004-07-07
% 211.55/211.79  |- skos__broader mesh__D008846smesh__D008919
% 211.55/211.79  |- mesh__recordOriginator mesh__D008846 NLM
% 211.55/211.79  |- mesh__dateCreated mesh__D008846 1999-01-01
% 211.55/211.79  |- skos__scopeNote mesh__D008846
% 211.55/211.79       The performance of dissections, injections, surgery, etc., by the use of micromanipulators %28%attachments to a microscope%29% that manipulate tiny instruments.%A%    
% 211.55/211.79  |- mesh__recordAuthorizer mesh__D008846 sjn
% 211.55/211.79  |- rdf__type mesh__D008846sskos__Concept
% 211.55/211.79  |- mesh__dateCreated mesh__D000863 1999-01-01
% 211.55/211.79  |- mesh__recordMaintainer mesh__D000863 ssb
% 211.55/211.79  |- skos__scopeNote mesh__D000863
% 211.55/211.79       Substances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT.%A%    
% 211.55/211.79  |- skos__broader mesh__D000863smesh__D045504
% 211.55/211.79  |- rdf__type mesh__D000863sskos__Concept
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D000863 2006
% 211.55/211.79  |- mesh__dateRevised mesh__D000863 2005-06-30
% 211.55/211.79  |- mesh__recordOriginator mesh__D000863 NLM
% 211.55/211.79  |- mesh__recordAuthorizer mesh__D000863 sjn
% 211.55/211.79  |- skos__prefLabel mesh__D000863 Antacids
% 211.55/211.79  |- skos__related mesh__D000863smesh__D000897
% 211.55/211.79  |- skos__prefLabel mesh__D008048 Lip Neoplasms
% 211.55/211.79  |- skos__altLabel mesh__D008048 Cancer of the Lip
% 211.55/211.79  |- skos__annotation mesh__D008048
% 211.55/211.79       coord IM with histol type of neopl %28%IM%29%   
% 211.55/211.79  |- mesh__recordMaintainer mesh__D008048 nns
% 211.55/211.79  |- skos__hiddenLabel mesh__D008048 Neoplasm, Lip
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D008048 2004
% 211.55/211.79  |- skos__hiddenLabel mesh__D008048 Lip Cancers
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D008048 2001
% 211.55/211.79  |- skos__scopeNote mesh__D008048 Tumors or cancer of the LIP.     
% 211.55/211.79  |- rdf__type mesh__D008048sskos__Concept
% 211.55/211.79  |- skos__altLabel mesh__D008048 Lip Cancer
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D008048 2003
% 211.55/211.79  |- mesh__recordOriginator mesh__D008048 NLM
% 211.55/211.79  |- skos__broader mesh__D008048smesh__D008047
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D008048 2000
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D008048 2006
% 211.55/211.79  |- skos__hiddenLabel mesh__D008048 Cancer, Lip
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D008048 2005
% 211.55/211.79  |- skos__broader mesh__D008048smesh__D009062
% 211.55/211.79  |- mesh__recordAuthorizer mesh__D008048 sjn
% 211.55/211.79  |- mesh__dateCreated mesh__D008048 1999-01-01
% 211.55/211.79  |- skos__hiddenLabel mesh__D008048 Lip Neoplasm
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D008048 2002
% 211.55/211.79  |- skos__hiddenLabel mesh__D008048 Cancers, Lip
% 211.55/211.79  |- mesh__dateRevised mesh__D008048 1999-11-03
% 211.55/211.79  |- skos__altLabel mesh__D008048 Neoplasms, Lip
% 211.55/211.79  |- skos__hiddenLabel mesh__D000065 Lens Accommodation
% 211.55/211.79  |- skos__prefLabel mesh__D000065 Accommodation, Ocular
% 211.55/211.79  |- skos__hiddenLabel mesh__D000065 Ocular Distance Accommodations
% 211.55/211.79  |- skos__annotation mesh__D000065
% 211.55/211.79       do not confuse with ADAPTATION, OCULAR, adjustment of eye to light%A%  
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D000065 2006
% 211.55/211.79  |- skos__altLabel mesh__D000065 Ocular Accommodation
% 211.55/211.79  |- skos__hiddenLabel mesh__D000065 Accommodation, Ocular Distance
% 211.55/211.79  |- mesh__recordAuthorizer mesh__D000065 sjn
% 211.55/211.79  |- mesh__dateRevised mesh__D000065 2005-06-30
% 211.55/211.79  |- mesh__dateCreated mesh__D000065 1999-01-01
% 211.55/211.79  |- rdf__type mesh__D000065sskos__Concept
% 211.55/211.79  |- skos__scopeNote mesh__D000065
% 211.55/211.79       The dioptric adjustment of the EYE %28%to attain maximal sharpness of retinal imagery for an object of regard%29% referring to the ability, to the mechanism, or to the process. Ocular accommodation is the effecting of refractive changes by changes in the shape of the CRYSTALLINE LENS. Loosely, it refers to ocular adjustments for VISION at various distances. %28%Cline et al., Dictionary of Visual Science, 4th ed%29%%A%    
% 211.55/211.79  |- skos__altLabel mesh__D000065 Ocular Distance Accommodation
% 211.55/211.79  |- mesh__recordOriginator mesh__D000065 NLM
% 211.55/211.79  |- skos__broader mesh__D000065smesh__D043723
% 211.55/211.79  |- mesh__recordMaintainer mesh__D000065 ssb
% 211.55/211.79  |- skos__hiddenLabel mesh__D000065 Distance Accommodation, Ocular
% 211.55/211.79  |- mesh__recordAuthorizer mesh__D027202 ags
% 211.55/211.79  |- mesh__recordMaintainer mesh__D027202 ags
% 211.55/211.79  |- skos__historyNote mesh__D027202 Membrane Proteins %28%1996-2001%29%
% 211.55/211.79  |- skos__historyNote mesh__D027202 Carrier Proteins %28%1996-2001%29%
% 211.55/211.79  |- skos__altLabel mesh__D027202
% 211.55/211.79       Solute-Carrier Family 7 %28%Cationic Amino Acid Transporter, y+ System%29%, Member 2
% 211.55/211.79  |- skos__altLabel mesh__D027202 ATRC2 Transporter
% 211.55/211.79  |- skos__hiddenLabel mesh__D027202 CAT 2 Gene Product
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D027202 2004
% 211.55/211.79  |- mesh__historyNote mesh__D027202
% 211.55/211.79       2002; for CAT2 GENE PRODUCT use BASIC AMINO ACID TRANSPORT SYSTEMS %28%NM%29% 1996-2001%A%  
% 211.55/211.79  |- skos__altLabel mesh__D027202 CAT-2 Transporter
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D027202 2006
% 211.55/211.79  |- skos__hiddenLabel mesh__D027202 CAT 2B Transporter
% 211.55/211.79  |- skos__hiddenLabel mesh__D027202 Transport Protein, CAT-2
% 211.55/211.79  |- skos__altLabel mesh__D027202 CAT-2B Transporter
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D027202 2003
% 211.55/211.79  |- skos__prefLabel mesh__D027202 Cationic Amino Acid Transporter 2
% 211.55/211.79  |- rdf__type mesh__D027202sskos__Concept
% 211.55/211.79  |- skos__hiddenLabel mesh__D027202 CAT 2A Transporter
% 211.55/211.79  |- skos__scopeNote mesh__D027202
% 211.55/211.79       A high-affinity, low capacity system y+ amino acid transporter with strong similarity to CATIONIC AMINO ACID TRANSPORTER 1. The two isoforms of the protein, CAT-2A and CAT-2B, exist due to alternative mRNA splicing. The transporter has specificity for the transport of ARGININE; LYSINE; and ORNITHINE.%A%    
% 211.55/211.79  |- mesh__publicMeSHNote mesh__D027202
% 211.55/211.79       2002; CAT-2 GENE PRODUCT was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1996-2001%A%  
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D027202 2005
% 211.55/211.79  |- skos__hiddenLabel mesh__D027202 Transporter, CAT-2A
% 211.55/211.79  |- skos__hiddenLabel mesh__D027202 Transporter, CAT-2
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D027202 2006B
% 211.55/211.79  |- mesh__dateEstablished mesh__D027202 2002-01-01
% 211.55/211.79  |- mesh__dateCreated mesh__D027202 2001-07-25
% 211.55/211.79  |- skos__altLabel mesh__D027202 SLC7A2 Protein
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D027202 2002
% 211.55/211.79  |- mesh__dateRevised mesh__D027202 2005-07-11
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D027202 2006A
% 211.55/211.79  |- skos__hiddenLabel mesh__D027202 CAT 2 Transporter
% 211.55/211.79  |- skos__altLabel mesh__D027202 CAT-2 Gene Product
% 211.55/211.79  |- skos__hiddenLabel mesh__D027202 Transporter, CAT-2B
% 211.55/211.79  |- skos__altLabel mesh__D027202 CAT-2 Transport Protein
% 211.55/211.79  |- skos__broader mesh__D027202smesh__D027182
% 211.55/211.79  |- skos__hiddenLabel mesh__D027202 CAT 2 Transport Protein
% 211.55/211.79  |- mesh__recordOriginator mesh__D027202 jmp
% 211.55/211.79  |- skos__altLabel mesh__D027202 CAT-2A Transporter
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D018476 2006
% 211.55/211.79  |- skos__historyNote mesh__D018476 Immobilization %28%1967-1994%29%
% 211.55/211.79  |- mesh__publicMeSHNote mesh__D018476
% 211.55/211.79       1995; for HYPOKINESIA use IMMOBILIZATION 1992-1994   
% 211.55/211.79  |- skos__prefLabel mesh__D018476 Hypokinesia
% 211.55/211.79  |- mesh__recordMaintainer mesh__D018476 nns
% 211.55/211.79  |- mesh__dateEstablished mesh__D018476 1995-01-01
% 211.55/211.79  |- skos__scopeNote mesh__D018476
% 211.55/211.79       Slow or diminished movement of body musculature. It may be associated with BASAL GANGLIA DISEASES; MENTAL DISORDERS; prolonged inactivity due to illness; and other conditions.%A%    
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D018476 2005
% 211.55/211.79  |- mesh__dateRevised mesh__D018476 2004-07-07
% 211.55/211.79  |- skos__annotation mesh__D018476
% 211.55/211.79       in Russian lit %22%hypokinesia%22% = IMMOBILIZATION   
% 211.55/211.79  |- skos__related mesh__D018476smesh__D007103
% 211.55/211.79  |- rdf__type mesh__D018476sskos__Concept
% 211.55/211.79  |- mesh__recordAuthorizer mesh__D018476 sjn
% 211.55/211.79  |- skos__hiddenLabel mesh__D018476 Bradykinesias
% 211.55/211.79  |- mesh__recordOriginator mesh__D018476 JLS
% 211.55/211.79  |- skos__hiddenLabel mesh__D018476 Antiorthostatic Hypokinesias
% 211.55/211.79  |- mesh__dateCreated mesh__D018476 1994-06-07
% 211.55/211.79  |- skos__broader mesh__D018476smesh__D020820
% 211.55/211.79  |- skos__hiddenLabel mesh__D018476 Antiorthostatic Hypokinesia
% 211.55/211.79  |- mesh__historyNote mesh__D018476
% 211.55/211.79       1995; for KINESIA use IMMOBILIZATION 1992-1994   
% 211.55/211.79  |- skos__hiddenLabel mesh__D018476 Hypokinesias, Antiorthostatic
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D010493 2002
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D010493 1997
% 211.55/211.79  |- skos__hiddenLabel mesh__D010493 Pericarditides
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D010493 2005
% 211.55/211.79  |- mesh__recordOriginator mesh__D010493 NLM
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D010493 1998
% 211.55/211.79  |- mesh__recordAuthorizer mesh__D010493 PLS
% 211.55/211.79  |- mesh__dateCreated mesh__D010493 1999-01-01
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D010493 2006
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D010493 1994
% 211.55/211.79  |- skos__scopeNote mesh__D010493
% 211.55/211.79       Inflammation of the pericardium. %28%Dorland, 27th ed%29%     
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D010493 1999
% 211.55/211.79  |- mesh__recordMaintainer mesh__D010493 TAP
% 211.55/211.79  |- skos__annotation mesh__D010493 inflamm of pericardium   
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D010493 1995
% 211.55/211.79  |- skos__prefLabel mesh__D010493 Pericarditis
% 211.55/211.79  |- mesh__dateRevised mesh__D010493 1993-06-02
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D010493 2000
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D010493 2003
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D010493 2001
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D010493 1996
% 211.55/211.79  |- rdf__type mesh__D010493sskos__Concept
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D010493 2004
% 211.55/211.79  |- skos__broader mesh__D010493smesh__D006331
% 211.55/211.79  |- mesh__recordMaintainer mesh__D051301 DRC
% 211.55/211.79  |- mesh__recordAuthorizer mesh__D051301 sjn
% 211.55/211.79  |- skos__scopeNote mesh__D051301
% 211.55/211.79       A CALCIUM-dependent adhesion molecule of DESMOSOMES that also plays a role in embryonic STEM CELL proliferation.%A%    
% 211.55/211.79  |- skos__prefLabel mesh__D051301 Desmoglein 2
% 211.55/211.79  |- mesh__publicMeSHNote mesh__D051301
% 211.55/211.79       2006; DESMOGLEIN 2 was indexed under CYTOSKELETAL PROTEINS %28%2001-2005%29%%A%  
% 211.55/211.79  |- mesh__dateEstablished mesh__D051301 2006-01-01
% 211.55/211.79  |- mesh__recordOriginator mesh__D051301 DRC
% 211.55/211.79  |- rdf__type mesh__D051301sskos__Concept
% 211.55/211.79  |- skos__broader mesh__D051301smesh__D051182
% 211.55/211.79  |- skos__altLabel mesh__D051301 Desmoglein II
% 211.55/211.79  |- mesh__historyNote mesh__D051301 2006%28%2001%29%   
% 211.55/211.79  |- skos__altLabel mesh__D051301 Desmosomal Glycoprotein 2
% 211.55/211.79  |- mesh__dateCreated mesh__D051301 2005-06-30
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D051301 2006
% 211.55/211.79  |- skos__hiddenLabel mesh__D004456 Iodide, Echothiophate
% 211.55/211.79  |- skos__hiddenLabel mesh__D004456 Iodide, Ecothiopate
% 211.55/211.79  |- mesh__dateEstablished mesh__D004456 1965-01-01
% 211.55/211.79  |- rdf__type mesh__D004456sskos__Concept
% 211.55/211.79  |- skos__prefLabel mesh__D004456 Echothiophate Iodide
% 211.55/211.79  |- mesh__dateCreated mesh__D004456 1999-01-01
% 211.55/211.79  |- skos__hiddenLabel mesh__D004456 Iodide, Phospholine
% 211.55/211.79  |- skos__altLabel mesh__D004456 Ecothiophate Iodide
% 211.55/211.79  |- mesh__recordOriginator mesh__D004456 NLM
% 211.55/211.79  |- mesh__publicMeSHNote mesh__D004456
% 211.55/211.79       65; PHOSPHOLINE IODIDE was see ECHOTHIOPHATE IODIDE 1975-91%A%  
% 211.55/211.79  |- mesh__historyNote mesh__D004456
% 211.55/211.79       65; PHOSPHOLINE IODIDE was see ECHOTHIOPHATE IODIDE 1975-91%A%  
% 211.55/211.79  |- skos__broader mesh__D004456smesh__D009946
% 211.55/211.79  |- mesh__onlineNote mesh__D004456
% 211.55/211.79       use ECHOTHIOPHATE IODIDE to search PHOSPHOLINE IODIDE 1975-91%A%  
% 211.55/211.79  |- mesh__recordMaintainer mesh__D004456 ssb
% 211.55/211.79  |- skos__altLabel mesh__D004456
% 211.55/211.79       2-%28%%28%Diethoxyphosphinyl%29%thio%29%-N,N,N,-trimethylethanaminium iodide
% 211.55/211.79  |- skos__altLabel mesh__D004456 Ecothiopate Iodide
% 211.55/211.79  |- mesh__recordAuthorizer mesh__D004456 sjn
% 211.55/211.79  |- mesh__dateRevised mesh__D004456 2005-06-30
% 211.55/211.79  |- skos__scopeNote mesh__D004456
% 211.55/211.79       A potent, long-acting cholinesterase inhibitor used as a miotic in the treatment of glaucoma.%A%    
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D004456 2006
% 211.55/211.79  |- skos__hiddenLabel mesh__D004456 Iodide, Ecothiophate
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D009141 2006
% 211.55/211.79  |- mesh__onlineNote mesh__D009141
% 211.55/211.79       pre-explosion = MUSCULOSKELETAL SYSTEM %28%PX%29%   
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D009141 2005
% 211.55/211.79  |- mesh__dateCreated mesh__D009141 1999-01-01
% 211.55/211.79  |- skos__hiddenLabel mesh__D009141 Musculoskeletal Systems
% 211.55/211.79  |- mesh__dateRevised mesh__D009141 2003-07-09
% 211.55/211.79  |- mesh__recordOriginator mesh__D009141 NLM
% 211.55/211.79  |- rdf__type mesh__D009141sskos__Concept
% 211.55/211.79  |- skos__scopeNote mesh__D009141
% 211.55/211.79       The MUSCLES, bones %28%BONE AND BONES%29%, and CARTILAGE of the body.%A%    
% 211.55/211.79  |- mesh__recordAuthorizer mesh__D009141 sjn
% 211.55/211.79  |- skos__hiddenLabel mesh__D009141 System, Musculoskeletal
% 211.55/211.79  |- skos__prefLabel mesh__D009141 Musculoskeletal System
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D009141 2004
% 211.55/211.79  |- skos__hiddenLabel mesh__D009141 Systems, Musculoskeletal
% 211.55/211.79  |- skos__annotation mesh__D009141
% 211.55/211.79       GEN; must be both musculo + skeletal, otherwise prefer BONE AND BONES or MUSCLES%A%  
% 211.55/211.79  |- skos__related mesh__D009141smesh__D041641
% 211.55/211.79  |- mesh__runningHead mesh__D009141 A2 - ANATOMY-MUSCULOSKELETAL SYSTEM   
% 211.55/211.79  |- mesh__recordMaintainer mesh__D009141 nns
% 211.55/211.79  |- skos__hiddenLabel mesh__D014884
% 211.55/211.79       Meningococcal Waterhouse Friderichsen Syndrome
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014884 2006
% 211.55/211.79  |- skos__broader mesh__D014884smesh__D008585
% 211.55/211.79  |- skos__hiddenLabel mesh__D014884 Hemorrhagic Adrenalitis, Meningococcal
% 211.55/211.79  |- skos__altLabel mesh__D014884 Waterhouse-Friederichsen Syndrome
% 211.55/211.79  |- skos__broader mesh__D014884smesh__D000309
% 211.55/211.79  |- mesh__dateEstablished mesh__D014884 1991-01-01
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014884 2005
% 211.55/211.79  |- mesh__historyNote mesh__D014884
% 211.55/211.79       1991, 1963-1983; use MENINGOCOCCAL INFECTIONS 1984-1990   
% 211.55/211.79  |- mesh__recordMaintainer mesh__D014884 lkt
% 211.55/211.79  |- skos__hiddenLabel mesh__D014884 Meningococcal Hemorrhagic Adrenalitides
% 211.55/211.79  |- skos__scopeNote mesh__D014884
% 211.55/211.79       A condition caused by overwhelming BACTERIAL INFECTIONS or SEPTICEMIA, leading to HEMORRHAGE and NECROSIS of the ADRENAL GLAND. It is characterized by rapidly developing ADRENAL INSUFFICIENCY; HYPOTENSION; and widespread cutaneous PURPURA. This syndrome may occur at any age but is more common in children.%A%    
% 211.55/211.79  |- skos__hiddenLabel mesh__D014884 Adrenalitides, Meningococcal Hemorrhagic
% 211.55/211.79  |- skos__altLabel mesh__D014884
% 211.55/211.79       Purpura Fulminans %28%Waterhouse-Friderichsen Syndrome%29%
% 211.55/211.79  |- skos__broader mesh__D014884smesh__D006474
% 211.55/211.79  |- skos__hiddenLabel mesh__D014884
% 211.55/211.79       Waterhouse-Friderichsen Syndrome, Meningococcal
% 211.55/211.79  |- skos__hiddenLabel mesh__D014884 Waterhouse Friederichsen Syndrome
% 211.55/211.79  |- mesh__dateCreated mesh__D014884 1999-01-01
% 211.55/211.79  |- skos__hiddenLabel mesh__D014884 Hemorrhagic Adrenalitides, Meningococcal
% 211.55/211.79  |- mesh__dateRevised mesh__D014884 2004-07-07
% 211.55/211.79  |- skos__hiddenLabel mesh__D014884 Adrenalitis, Meningococcal Hemorrhagic
% 211.55/211.79  |- skos__altLabel mesh__D014884
% 211.55/211.79       Fulminant Meningococcal Sepsis with Adrenal Apoplexy
% 211.55/211.79  |- skos__annotation mesh__D014884
% 211.55/211.79       do not coord with NEISSERIA MENINGITIDIS unless particularly discussed; if caused by other organism, coord IM with precoord organism/infection term%A%  
% 211.55/211.79  |- mesh__recordAuthorizer mesh__D014884 sjn
% 211.55/211.79  |- skos__hiddenLabel mesh__D014884
% 211.55/211.79       Syndrome, Meningococcal Waterhouse-Friderichsen
% 211.55/211.79  |- skos__prefLabel mesh__D014884 Waterhouse-Friderichsen Syndrome
% 211.55/211.79  |- skos__hiddenLabel mesh__D014884 Waterhouse Friderichsen Syndrome
% 211.55/211.79  |- mesh__publicMeSHNote mesh__D014884
% 211.55/211.79       1991, 1963-1983; see MENINGOCOCCAL INFECTIONS 1984-1990, see WATERHOUSE-FRIDERICHSEN SYNDROME 1963-1983%A%  
% 211.55/211.79  |- rdf__type mesh__D014884sskos__Concept
% 211.55/211.79  |- mesh__recordOriginator mesh__D014884 NLM
% 211.55/211.79  |- skos__altLabel mesh__D014884 Meningococcal Hemorrhagic Adrenalitis
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014086 1999
% 211.55/211.79  |- rdf__type mesh__D014086sskos__Concept
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014086 2004
% 211.55/211.79  |- mesh__dateRevised mesh__D014086 1996-06-10
% 211.55/211.79  |- mesh__publicMeSHNote mesh__D014086 65   
% 211.55/211.79  |- mesh__historyNote mesh__D014086 65   
% 211.55/211.79  |- mesh__recordOriginator mesh__D014086 NLM
% 211.55/211.79  |- skos__broader mesh__D014086smesh__D009063
% 211.55/211.79  |- skos__annotation mesh__D014086
% 211.55/211.79       physiol mobility of deciduous teeth or pathol mobility of permanent teeth in periodontal dis or trauma; use Cat C qualif; do not confuse with TOOTH MOVEMENT %28%an orthodontic procedure%29%%A%  
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014086 2001
% 211.55/211.79  |- skos__prefLabel mesh__D014086 Tooth Mobility
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014086 1997
% 211.55/211.79  |- mesh__recordAuthorizer mesh__D014086 PLS
% 211.55/211.79  |- skos__hiddenLabel mesh__D014086 Tooth Mobilities
% 211.55/211.79  |- skos__broader mesh__D014086smesh__D010510
% 211.55/211.79  |- mesh__dateEstablished mesh__D014086 1965-01-01
% 211.55/211.79  |- mesh__recordMaintainer mesh__D014086 TGC
% 211.55/211.79  |- mesh__dateCreated mesh__D014086 1999-01-01
% 211.55/211.79  |- skos__hiddenLabel mesh__D014086 Mobility, Tooth
% 211.55/211.79  |- skos__hiddenLabel mesh__D014086 Mobilities, Tooth
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014086 2005
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014086 2002
% 211.55/211.79  |- skos__scopeNote mesh__D014086
% 211.55/211.79       Horizontal and, to a lesser degree, axial movement of a tooth in response to normal forces, as in occlusion. It refers also to the movability of a tooth resulting from loss of all or a portion of its attachment and supportive apparatus, as seen in periodontitis, occlusal trauma, and periodontosis. %28%From Jablonski, Dictionary of Dentistry, 1992, p507 %26% Boucher%27%s Clinical Dental Terminology, 4th ed, p313%29%%A%    
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014086 2006
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014086 1998
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014086 2003
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D014086 2000
% 211.55/211.79  |- skos__prefLabel mesh__D008847 Micromonospora
% 211.55/211.79  |- mesh__recordAuthorizer mesh__D008847 sjn
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D008847 2006
% 211.55/211.79  |- skos__scopeNote mesh__D008847
% 211.55/211.79       A genus of gram-positive bacteria that forms a branched mycelium. It commonly occurs as a saprophytic form in soil and aquatic environments.%A%    
% 211.55/211.79  |- skos__broader mesh__D008847smesh__D008848
% 211.55/211.79  |- mesh__dateCreated mesh__D008847 1999-01-01
% 211.55/211.79  |- skos__annotation mesh__D008847
% 211.55/211.79       in soil; a genus: do not confuse with the family MICROMONOSPORACEAE%A%  
% 211.55/211.79  |- mesh__dateRevised mesh__D008847 2005-06-30
% 211.55/211.79  |- rdf__type mesh__D008847sskos__Concept
% 211.55/211.79  |- mesh__recordMaintainer mesh__D008847 SYSTEM
% 211.55/211.79  |- mesh__recordOriginator mesh__D008847 NLM
% 211.55/211.79  |- rdf__type mesh__D000864sskos__Concept
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D000864 2002
% 211.55/211.79  |- mesh__dateRevised mesh__D000864 1995-02-17
% 211.55/211.79  |- skos__broader mesh__D000864smesh__D005842
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D000864 2006
% 211.55/211.79  |- mesh__recordMaintainer mesh__D000864 TGC
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D000864 2004
% 211.55/211.79  |- skos__annotation mesh__D000864
% 211.55/211.79       note spelling: -ARCTIC: neither spelled nor pronounced %22%antartic%22%%A%  
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D000864 2005
% 211.55/211.79  |- skos__scopeNote mesh__D000864
% 211.55/211.79       The continent lying around the South Pole and the southern waters of the Atlantic, Pacific, and Indian Oceans. It includes the Falkland Islands Dependencies. %28%From Webster%27%s New Geographical Dictionary, 1988, p55%29%%A%    
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D000864 2001
% 211.55/211.79  |- mesh__activeMeSHYear mesh__D000864 2003
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D000864 1999
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D000864 2000
% 211.67/211.89  |- mesh__recordAuthorizer mesh__D000864 PLS
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D000864 1997
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D000864 1998
% 211.67/211.89  |- mesh__recordOriginator mesh__D000864 NLM
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D000864 1996
% 211.67/211.89  |- skos__prefLabel mesh__D000864 Antarctic Regions
% 211.67/211.89  |- mesh__dateCreated mesh__D000864 1999-01-01
% 211.67/211.89  |- skos__hiddenLabel mesh__D008049 A, Acid Lipase
% 211.67/211.89  |- skos__hiddenLabel mesh__D008049 I, Acid Lipase
% 211.67/211.89  |- mesh__recordAuthorizer mesh__D008049 sjn
% 211.67/211.89  |- skos__altLabel mesh__D008049 Tributyrinase
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D008049 2004
% 211.67/211.89  |- skos__hiddenLabel mesh__D008049 Lipase II, Acid
% 211.67/211.89  |- skos__hiddenLabel mesh__D008049 Lipase A, Acid
% 211.67/211.89  |- skos__altLabel mesh__D008049 Triglyceridase
% 211.67/211.89  |- skos__hiddenLabel mesh__D008049 Lipase I, Acid
% 211.67/211.89  |- skos__hiddenLabel mesh__D008049 Hydrolase, Triacylglycerol
% 211.67/211.89  |- rdf__type mesh__D008049sskos__Concept
% 211.67/211.89  |- skos__altLabel mesh__D008049 Triacylglycerol Lipase
% 211.67/211.89  |- skos__hiddenLabel mesh__D008049 Lipase, Triglyceride
% 211.67/211.89  |- skos__broader mesh__D008049smesh__D002265
% 211.67/211.89  |- skos__hiddenLabel mesh__D008049 B, Acid Lipase
% 211.67/211.89  |- mesh__recordMaintainer mesh__D008049 ssb
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D008049 2006
% 211.67/211.89  |- skos__hiddenLabel mesh__D008049 Hydrolase, Triolean
% 211.67/211.89  |- skos__annotation mesh__D008049
% 211.67/211.89       /defic: consider also LIPID METABOLISM, INBORN ERRORS %26% CHOLESTEROL ESTER STORAGE DISEASE %26% WOLMAN DISEASE; LIPOPROTEIN LIPASE is also available%A%  
% 211.67/211.89  |- skos__altLabel mesh__D008049 Triacylglycerol Hydrolase
% 211.67/211.89  |- skos__scopeNote mesh__D008049
% 211.67/211.89       An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. It is produced by glands on the tongue and by the pancreas and initiates the digestion of dietary fats. %28%From Dorland, 27th ed%29% EC 3.1.1.3.%A%    
% 211.67/211.89  |- skos__hiddenLabel mesh__D008049 Lipase, Monoester
% 211.67/211.89  |- skos__hiddenLabel mesh__D008049 II, Acid Lipase
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D008049 2005
% 211.67/211.89  |- skos__hiddenLabel mesh__D008049 Lipase, Acid
% 211.67/211.89  |- skos__altLabel mesh__D008049 Triolean Hydrolase
% 211.67/211.89  |- mesh__dateCreated mesh__D008049 1999-01-01
% 211.67/211.89  |- mesh__dateRevised mesh__D008049 2003-07-09
% 211.67/211.89  |- mesh__recordOriginator mesh__D008049 NLM
% 211.67/211.89  |- skos__altLabel mesh__D008049 Triglyceride Lipase
% 211.67/211.89  |- skos__prefLabel mesh__D008049 Lipase
% 211.67/211.89  |- skos__hiddenLabel mesh__D008049 Lipase B, Acid
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D000066 2003
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D000066 2005
% 211.67/211.89  |- skos__scopeNote mesh__D000066
% 211.67/211.89       System of recording financial transactions.     
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D000066 2004
% 211.67/211.89  |- mesh__dateCreated mesh__D000066 1999-01-01
% 211.67/211.89  |- mesh__recordOriginator mesh__D000066 NLM
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D000066 2002
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D000066 2006
% 211.67/211.89  |- mesh__recordAuthorizer mesh__D000066 PLS
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D000066 1998
% 211.67/211.89  |- skos__broader mesh__D000066smesh__D005376
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D000066 1997
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D000066 1999
% 211.67/211.89  |- skos__prefLabel mesh__D000066 Accounting
% 211.67/211.89  |- mesh__dateRevised mesh__D000066 1996-06-10
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D000066 2000
% 211.67/211.89  |- rdf__type mesh__D000066sskos__Concept
% 211.67/211.89  |- skos__hiddenLabel mesh__D000066 Accountings
% 211.67/211.89  |- skos__annotation mesh__D000066
% 211.67/211.89       IM; coord with SPEC %28%IM%29% or specific financial endeavor %28%IM%29%%A%  
% 211.67/211.89  |- mesh__recordMaintainer mesh__D000066 TGC
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D000066 2001
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D010494 2001
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D010494 2006
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D010494 1994
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D010494 1999
% 211.67/211.89  |- skos__hiddenLabel mesh__D010494 Heart Pick%27%s Disease
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D010494 2002
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D010494 1995
% 211.67/211.89  |- mesh__recordAuthorizer mesh__D010494 PLS
% 211.67/211.89  |- mesh__recordOriginator mesh__D010494 NLM
% 211.67/211.89  |- mesh__recordMaintainer mesh__D010494 TGC
% 211.67/211.89  |- skos__hiddenLabel mesh__D010494 Pick Disease, Heart
% 211.67/211.89  |- skos__hiddenLabel mesh__D010494 Pericarditides, Constrictive
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D010494 2003
% 211.67/211.89  |- mesh__dateRevised mesh__D010494 1991-02-14
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D010494 1996
% 211.67/211.89  |- rdf__type mesh__D010494sskos__Concept
% 211.67/211.89  |- mesh__publicMeSHNote mesh__D010494
% 211.67/211.89       64; PICK%27%S DISEASE OF HEART was see under PERICARDITIS 1963%A%  
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D010494 2004
% 211.67/211.89  |- skos__altLabel mesh__D010494 Pick%27%s Disease of Heart
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D010494 1992
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D010494 1997
% 211.67/211.89  |- mesh__dateEstablished mesh__D010494 1964-01-01
% 211.67/211.89  |- mesh__historyNote mesh__D010494
% 211.67/211.89       64; PICK%27%S DISEASE OF HEART was see under PERICARDITIS 1963%A%  
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D010494 2000
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D010494 2005
% 211.67/211.89  |- skos__altLabel mesh__D010494 Constrictive Pericarditis
% 211.67/211.89  |- skos__hiddenLabel mesh__D010494 Constrictive Pericarditides
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D010494 1993
% 211.67/211.89  |- mesh__activeMeSHYear mesh__D010494 1998
% 211.67/211.89  |- skos__prefLabel mesh__D010494 Pericarditis, Constrictive
% 211.67/211.89  |- mesh__dateCreated mesh__D010494 1999-01-01
% 211.67/211.89  |- skos__broader mesh__D010494smesh__D010493
% 211.67/211.89  |- skos__hiddenLabel mesh__D010494 Picks Disease, Heart
% 211.67/211.89  |- skos__hiddenLabel mesh__D051302 Episodic Paroxysmal Hemicranias
% 211.67/211.89  |- mesh__publicMeSHNote mesh__D051302
% 211.67/211.89       2006; see VASCULAR HEADACHES 2000-2005   
% 211.67/211.90  |- mesh__dateCreated mesh__D051302 2005-06-30
% 211.67/211.90  |- mesh__recordOriginator mesh__D051302 lkt
% 211.67/211.90  |- skos__hiddenLabel mesh__D051302 Paroxysmal Hemicranias, Chronic
% 211.67/211.90  |- skos__hiddenLabel mesh__D051302 Paroxysmal Hemicrania, Episodic
% 211.67/211.90  |- skos__hiddenLabel mesh__D051302 Chronic Paroxysmal Hemicranias
% 211.67/211.90  |- mesh__historyNote mesh__D051302
% 211.67/211.90       2006; use VASCULAR HEADACHES 2000-2005   
% 211.67/211.90  |- rdf__type mesh__D051302sskos__Concept
% 211.67/211.90  |- mesh__recordMaintainer mesh__D051302 lkt
% 211.67/211.90  |- mesh__recordAuthorizer mesh__D051302 sjn
% 211.67/211.90  |- skos__hiddenLabel mesh__D051302 Paroxysmal Hemicrania, Chronic
% 211.67/211.90  |- skos__hiddenLabel mesh__D051302 Paroxysmal Hemicranias
% 211.67/211.90  |- skos__hiddenLabel mesh__D051302 Hemicranias, Paroxysmal
% 211.67/211.90  |- skos__scopeNote mesh__D051302
% 211.67/211.90       A primary headache disorder that is similar to the CLUSTER HEADACHE with unilateral head pain, but differs by its multiple short severe attacks. It is usually seen in females, and may be responsive to non-steroidal-anti-inflammatory drugs %28%NSAIDS%29%.%A%    
% 211.67/211.90  |- skos__hiddenLabel mesh__D051302 Hemicrania, Paroxysmal
% 211.67/211.90  |- skos__hiddenLabel mesh__D051302 Hemicrania, Episodic Paroxysmal
% 211.67/211.90  |- mesh__dateEstablished mesh__D051302 2006-01-01
% 211.67/211.90  |- skos__hiddenLabel mesh__D051302 Hemicrania, Chronic Paroxysmal
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D051302 2006
% 211.67/211.90  |- skos__hiddenLabel mesh__D051302 Hemicranias, Chronic Paroxysmal
% 211.67/211.90  |- skos__prefLabel mesh__D051302 Paroxysmal Hemicrania
% 211.67/211.90  |- skos__broader mesh__D051302smesh__D051303
% 211.67/211.90  |- skos__hiddenLabel mesh__D051302 Paroxysmal Hemicranias, Episodic
% 211.67/211.90  |- skos__hiddenLabel mesh__D051302 Hemicranias, Episodic Paroxysmal
% 211.67/211.90  |- mesh__recordMaintainer mesh__D004457 PLS
% 211.67/211.90  |- rdf__type mesh__D004457sskos__Concept
% 211.67/211.90  |- mesh__onlineNote mesh__D004457
% 211.67/211.90       use ECHOVIRUS INFECTIONS to search ECHO VIRUS INFECTIONS 1968-77%A%  
% 211.67/211.90  |- skos__prefLabel mesh__D004457 Echovirus Infections
% 211.67/211.90  |- mesh__dateEstablished mesh__D004457 1968-01-01
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D004457 1996
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D004457 1995
% 211.67/211.90  |- skos__scopeNote mesh__D004457
% 211.67/211.90       Infectious disease processes, including meningitis, diarrhea, and respiratory disorders, caused by echoviruses.%A%    
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D004457 2000
% 211.67/211.90  |- mesh__dateCreated mesh__D004457 1999-01-01
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D004457 1998
% 211.67/211.90  |- mesh__recordAuthorizer mesh__D004457 PLS
% 211.67/211.90  |- skos__hiddenLabel mesh__D004457 Infection, Echovirus
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D004457 1994
% 211.67/211.90  |- skos__hiddenLabel mesh__D004457 Echo Virus Infection
% 211.67/211.90  |- skos__altLabel mesh__D004457 Infections, Echo Virus
% 211.67/211.90  |- mesh__publicMeSHNote mesh__D004457
% 211.67/211.90       78; was ECHO VIRUS INFECTIONS 1968-77   
% 211.67/211.90  |- skos__altLabel mesh__D004457 Infections, Echovirus
% 211.67/211.90  |- mesh__recordOriginator mesh__D004457 NLM
% 211.67/211.90  |- skos__broader mesh__D004457smesh__D004769
% 211.67/211.90  |- skos__annotation mesh__D004457
% 211.67/211.90       caused by an enterovirus; coord IM with specific Echovirus %28%IM%29%%A%  
% 211.67/211.90  |- skos__hiddenLabel mesh__D004457 Infection, Echo Virus
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D004457 2004
% 211.67/211.90  |- skos__historyNote mesh__D004457 Enterovirus Infections %28%1966-1967%29%
% 211.67/211.90  |- skos__hiddenLabel mesh__D004457 Echovirus Infection
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D004457 2002
% 211.67/211.90  |- mesh__dateRevised mesh__D004457 1993-05-27
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D004457 2006
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D004457 2003
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D004457 1997
% 211.67/211.90  |- skos__altLabel mesh__D004457 Echo Virus Infections
% 211.67/211.90  |- mesh__historyNote mesh__D004457 78; was ECHO VIRUS INFECTIONS 1968-77   
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D004457 2001
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D004457 2005
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D004457 1999
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D009940 2001
% 211.67/211.90  |- mesh__recordMaintainer mesh__D009940 TAP
% 211.67/211.90  |- mesh__dateRevised mesh__D009940 2000-06-22
% 211.67/211.90  |- skos__prefLabel mesh__D009940 Organoids
% 211.67/211.90  |- skos__hiddenLabel mesh__D009940 Organoid
% 211.67/211.90  |- mesh__dateEstablished mesh__D009940 1965-01-01
% 211.67/211.90  |- mesh__recordAuthorizer mesh__D009940 sjn
% 211.67/211.90  |- skos__annotation mesh__D009940
% 211.67/211.90       do not confuse with ORGANELLES: read MeSH definitions %26% follow text%A%  
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D009940 2006
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D009940 2002
% 211.67/211.90  |- mesh__dateCreated mesh__D009940 1999-01-01
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D009940 2005
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D009940 2004
% 211.67/211.90  |- mesh__historyNote mesh__D009940 1965   
% 211.67/211.90  |- skos__broader mesh__D009940smesh__D014024
% 211.67/211.90  |- rdf__type mesh__D009940sskos__Concept
% 211.67/211.90  |- skos__scopeNote mesh__D009940
% 211.67/211.90       An organization of cells into an organ-like structure. Organoids can be generated in culture. They are also found in certain neoplasms.%A%    
% 211.67/211.90  |- mesh__publicMeSHNote mesh__D009940 1965   
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D009940 2003
% 211.67/211.90  |- mesh__recordOriginator mesh__D009940 NLM
% 211.67/211.90  |- skos__scopeNote mesh__D009142
% 211.67/211.90       Functions, activities, and properties of the MUSCULOSKELETAL SYSTEM.%A%    
% 211.67/211.90  |- mesh__dateCreated mesh__D009142 1999-01-01
% 211.67/211.90  |- mesh__recordMaintainer mesh__D009142 nns
% 211.67/211.90  |- skos__annotation mesh__D009142
% 211.67/211.90       GEN or unspecified; prefer specifics; consider also MUSCLES /physiol %26% BONE AND BONES /physiol or /physiol with specific muscle %26% bone terms; DF: MUSCULOSKELETAL PHYSIOL%A%  
% 211.67/211.90  |- mesh__dateRevised mesh__D009142 2003-07-09
% 211.67/211.90  |- rdf__type mesh__D009142sskos__Concept
% 211.67/211.90  |- mesh__dateEstablished mesh__D009142 1998-01-01
% 211.67/211.90  |- skos__altLabel mesh__D009142 Physiology, Musculoskeletal
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D009142 2004
% 211.67/211.90  |- skos__hiddenLabel mesh__D009142 Musculoskeletal Physiologies
% 211.67/211.90  |- mesh__recordOriginator mesh__D009142 NLM
% 211.67/211.90  |- skos__historyNote mesh__D009142
% 211.67/211.90       Musculoskeletal System/physiology %28%1966-1997%29%
% 211.67/211.90  |- skos__prefLabel mesh__D009142 Musculoskeletal Physiology
% 211.67/211.90  |- mesh__publicMeSHNote mesh__D009142 98   
% 211.67/211.90  |- mesh__recordAuthorizer mesh__D009142 sjn
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D009142 2006
% 211.67/211.90  |- skos__hiddenLabel mesh__D009142 Physiologies, Musculoskeletal
% 211.67/211.90  |- mesh__historyNote mesh__D009142 98; use explode 1970-97   
% 211.67/211.90  |- skos__broader mesh__D009142smesh__D009143
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D009142 2005
% 211.67/211.90  |- mesh__recordAuthorizer mesh__D014885 sjn
% 211.67/211.90  |- skos__scopeNote mesh__D014885
% 211.67/211.90       A plastic substance deposited by insects or obtained from plants. Waxes are esters of various fatty acids with higher, usually monohydric alcohols. The wax of pharmacy is principally yellow wax %28%beeswax%29%, the material of which honeycomb is made. It consists chiefly of cerotic acid and myricin and is used in making ointments, cerates, etc. %28%Dorland, 27th ed%29%%A%    
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D014885 2006
% 211.67/211.90  |- skos__annotation mesh__D014885 D25-26 qualif   
% 211.67/211.90  |- mesh__recordMaintainer mesh__D014885 ssb
% 211.67/211.90  |- mesh__dateCreated mesh__D014885 1999-01-01
% 211.67/211.90  |- mesh__recordOriginator mesh__D014885 NLM
% 211.67/211.90  |- skos__related mesh__D014885smesh__D002571
% 211.67/211.90  |- skos__broader mesh__D014885smesh__D008055
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D014885 2004
% 211.67/211.90  |- skos__prefLabel mesh__D014885 Waxes
% 211.67/211.90  |- rdf__type mesh__D014885sskos__Concept
% 211.67/211.90  |- skos__related mesh__D014885smesh__D007283
% 211.67/211.90  |- mesh__dateRevised mesh__D014885 2003-07-09
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D014885 2005
% 211.67/211.90  |- mesh__recordMaintainer mesh__D014087 ssb
% 211.67/211.90  |- mesh__historyNote mesh__D014087 97; was TOOTH MOVEMENT, MINOR 1973-96   
% 211.67/211.90  |- skos__hiddenLabel mesh__D014087 Uprighting, Tooth
% 211.67/211.90  |- skos__hiddenLabel mesh__D014087 Minor Tooth Movements
% 211.67/211.90  |- skos__hiddenLabel mesh__D014087 Tooth Intrusions
% 211.67/211.90  |- skos__hiddenLabel mesh__D014087 Depressions, Tooth
% 211.67/211.90  |- skos__hiddenLabel mesh__D014087 Uprightings, Tooth
% 211.67/211.90  |- mesh__dateCreated mesh__D014087 1999-01-01
% 211.67/211.90  |- skos__hiddenLabel mesh__D014087 Movements, Tooth
% 211.67/211.90  |- skos__hiddenLabel mesh__D014087 Intrusions, Tooth
% 211.67/211.90  |- skos__hiddenLabel mesh__D014087 Depression, Tooth
% 211.67/211.90  |- mesh__dateRevised mesh__D014087 2005-06-30
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D014087 2006
% 211.67/211.90  |- mesh__publicMeSHNote mesh__D014087
% 211.67/211.90       97; was TOOTH MOVEMENT, MINOR 1973-96   
% 211.67/211.90  |- skos__scopeNote mesh__D014087
% 211.67/211.90       Orthodontic techniques used to correct the malposition of a single tooth.%A%    
% 211.67/211.90  |- skos__hiddenLabel mesh__D014087 Tooth Movements, Minor
% 211.67/211.90  |- skos__hiddenLabel mesh__D014087 Minor Tooth Movement
% 211.67/211.90  |- mesh__recordAuthorizer mesh__D014087 sjn
% 211.67/211.90  |- skos__hiddenLabel mesh__D014087 Movement, Tooth
% 211.67/211.90  |- mesh__recordOriginator mesh__D014087 NLM
% 211.67/211.90  |- skos__hiddenLabel mesh__D014087 Tooth Depressions
% 211.67/211.90  |- skos__prefLabel mesh__D014087 Tooth Movement
% 211.67/211.90  |- skos__broader mesh__D014087smesh__D009971
% 211.67/211.90  |- rdf__type mesh__D014087sskos__Concept
% 211.67/211.90  |- mesh__dateEstablished mesh__D014087 1973-01-01
% 211.67/211.90  |- skos__annotation mesh__D014087
% 211.67/211.90       note category; do not confuse with TOOTH MIGRATION or TOOTH MOBILITY%A%  
% 211.67/211.90  |- skos__hiddenLabel mesh__D014087 Intrusion, Tooth
% 211.67/211.90  |- skos__historyNote mesh__D014087
% 211.67/211.90       Orthodontics, Corrective %28%1966-1972%29%
% 211.67/211.90  |- skos__hiddenLabel mesh__D014087 Tooth Movements
% 211.67/211.90  |- skos__hiddenLabel mesh__D014087 Tooth Uprightings
% 211.67/211.90  |- mesh__recordMaintainer mesh__D008848 SYSTEM
% 211.67/211.90  |- skos__scopeNote mesh__D008848
% 211.67/211.90       A family of gram-positive, saprophytic bacteria occurring in soil and aquatic environments.%A%    
% 211.67/211.90  |- mesh__historyNote mesh__D008848 76   
% 211.67/211.90  |- skos__prefLabel mesh__D008848 Micromonosporaceae
% 211.67/211.90  |- mesh__recordOriginator mesh__D008848 JW
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D008848 2006
% 211.67/211.90  |- skos__historyNote mesh__D008848 Streptomycetaceae %28%1975%29%
% 211.67/211.90  |- mesh__dateEstablished mesh__D008848 1976-01-01
% 211.67/211.90  |- skos__broader mesh__D008848smesh__D016937
% 211.67/211.90  |- skos__annotation mesh__D008848 in soil %26% water   
% 211.67/211.90  |- mesh__dateCreated mesh__D008848 1975-07-21
% 211.67/211.90  |- mesh__publicMeSHNote mesh__D008848 76   
% 211.67/211.90  |- rdf__type mesh__D008848sskos__Concept
% 211.67/211.90  |- skos__broader mesh__D008848smesh__D000192
% 211.67/211.90  |- mesh__dateRevised mesh__D008848 2005-06-30
% 211.67/211.90  |- skos__historyNote mesh__D008848 Bacteria %28%1966-1974%29%
% 211.67/211.90  |- mesh__recordAuthorizer mesh__D008848 sjn
% 211.67/211.90  |- skos__scopeNote mesh__D000865
% 211.67/211.90       An antagonist of histamine H1 receptors.     
% 211.67/211.90  |- skos__historyNote mesh__D000865 Imidazoles %28%1968-1975%29%
% 211.67/211.90  |- skos__altLabel mesh__D000865 Lannett Brand of Antazoline Phosphate
% 211.67/211.90  |- skos__hiddenLabel mesh__D000865 Phosphate, Antazoline
% 211.67/211.90  |- skos__broader mesh__D000865smesh__D007093
% 211.67/211.90  |- mesh__dateCreated mesh__D000865 1974-11-19
% 211.67/211.90  |- mesh__dateRevised mesh__D000865 2005-06-30
% 211.67/211.90  |- skos__altLabel mesh__D000865 Imidamine
% 211.67/211.90  |- mesh__recordOriginator mesh__D000865 NLM
% 211.67/211.90  |- mesh__recordAuthorizer mesh__D000865 sjn
% 211.67/211.90  |- mesh__dateEstablished mesh__D000865 1991-01-01
% 211.67/211.90  |- skos__prefLabel mesh__D000865 Antazoline
% 211.67/211.90  |- skos__historyNote mesh__D000865 Benzyl Compounds %28%1973-1974%29%
% 211.67/211.90  |- rdf__type mesh__D000865sskos__Concept
% 211.67/211.90  |- skos__historyNote mesh__D000865 Aniline Compounds %28%1968-1974%29%
% 211.67/211.90  |- skos__hiddenLabel mesh__D000865 Hydrochloride, Antazoline
% 211.67/211.90  |- skos__altLabel mesh__D000865 Phenazoline
% 211.67/211.90  |- mesh__recordMaintainer mesh__D000865 ssb
% 211.67/211.90  |- mesh__publicMeSHNote mesh__D000865
% 211.67/211.90       91; was see under IMIDAZOLES 1975-90   
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D000865 2006
% 211.67/211.90  |- mesh__historyNote mesh__D000865
% 211.67/211.90       91%28%75%29%; was see under IMIDAZOLES 1975-90   
% 211.67/211.90  |- skos__hiddenLabel mesh__D019570 Exposure, Inhalation
% 211.67/211.90  |- mesh__dateEstablished mesh__D019570 1998-01-01
% 211.67/211.90  |- skos__historyNote mesh__D019570 Occupational Exposure %28%1991-1997%29%
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D019570 2006
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D019570 1998
% 211.67/211.90  |- rdf__type mesh__D019570sskos__Concept
% 211.67/211.90  |- skos__hiddenLabel mesh__D019570 Inhalation Exposures
% 211.67/211.90  |- skos__annotation mesh__D019570
% 211.67/211.90       may or may not result in a disease; coord IM with specific inhalant %28%IM%29%%A%  
% 211.67/211.90  |- skos__scopeNote mesh__D019570
% 211.67/211.90       The exposure to potentially harmful chemical, physical, or biological agents by inhaling them.%A%    
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D019570 1999
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D019570 2000
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D019570 2003
% 211.67/211.90  |- skos__historyNote mesh__D019570 Environmental Exposure %28%1966-1997%29%
% 211.67/211.90  |- mesh__publicMeSHNote mesh__D019570 98   
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D019570 2001
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D019570 2004
% 211.67/211.90  |- mesh__historyNote mesh__D019570 98   
% 211.67/211.90  |- skos__prefLabel mesh__D019570 Inhalation Exposure
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D019570 2002
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D019570 2005
% 211.67/211.90  |- skos__hiddenLabel mesh__D019570 Exposures, Inhalation
% 211.67/211.90  |- skos__broader mesh__D019570smesh__D004781
% 211.67/211.90  |- mesh__dateCreated mesh__D019570 1997-06-20
% 211.67/211.90  |- skos__altLabel mesh__D033241 Attorneys
% 211.67/211.90  |- mesh__dateEstablished mesh__D033241 2003-01-01
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D033241 2003
% 211.67/211.90  |- mesh__historyNote mesh__D033241 2003; use JURISPRUDENCE 1992-2002   
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D033241 2004
% 211.67/211.90  |- skos__scopeNote mesh__D033241
% 211.67/211.90       Persons whose profession is to give legal advice and assistance to clients and represent them in legal matters. %28%American Heritage Dictionary, 3d ed%29%%A%    
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D033241 2005
% 211.67/211.90  |- skos__hiddenLabel mesh__D033241 Public Defender
% 211.67/211.90  |- skos__prefLabel mesh__D033241 Lawyers
% 211.67/211.90  |- skos__hiddenLabel mesh__D033241 Lawyer
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D033241 2006
% 211.67/211.90  |- skos__hiddenLabel mesh__D033241 Defender, Public
% 211.67/211.90  |- skos__historyNote mesh__D033241 Jurisprudence %28%1964-2002%29%
% 211.67/211.90  |- skos__hiddenLabel mesh__D033241 Defenders, Public
% 211.67/211.90  |- mesh__publicMeSHNote mesh__D033241 2003; see JURISPRUDENCE 1992-2002   
% 211.67/211.90  |- skos__hiddenLabel mesh__D033241 Attorney
% 211.67/211.90  |- skos__related mesh__D033241smesh__D007603
% 211.67/211.90  |- mesh__dateCreated mesh__D033241 2002-07-02
% 211.67/211.90  |- skos__broader mesh__D033241smesh__D009274
% 211.67/211.90  |- rdf__type mesh__D033241sskos__Concept
% 211.67/211.90  |- mesh__recordOriginator mesh__D000067 EC
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D000067 2001
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D000067 2006
% 211.67/211.90  |- mesh__dateEstablished mesh__D000067 1991-01-01
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D000067 1996
% 211.67/211.90  |- mesh__dateCreated mesh__D000067 1977-05-05
% 211.67/211.90  |- skos__historyNote mesh__D000067 Accounting %28%1966-1977%29%
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D000067 1998
% 211.67/211.90  |- mesh__dateRevised mesh__D000067 1990-05-30
% 211.67/211.90  |- skos__broader mesh__D000067smesh__D000066
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D000067 1997
% 211.67/211.90  |- mesh__publicMeSHNote mesh__D000067
% 211.67/211.90       91; was see under ACCOUNTING 1978-90   
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D000067 1992
% 211.67/211.90  |- skos__scopeNote mesh__D000067
% 211.67/211.90       Short-term debt obligations and assets occurring in the regular course of operational transactions.%A%    
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D000067 1994
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D000067 1999
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D000067 2002
% 211.67/211.90  |- rdf__type mesh__D000067sskos__Concept
% 211.67/211.90  |- mesh__recordAuthorizer mesh__D000067 PLS
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D000067 1993
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D000067 1995
% 211.67/211.90  |- mesh__recordMaintainer mesh__D000067 PLS
% 211.67/211.90  |- skos__annotation mesh__D000067 no qualif; DF: ACCOUNTS PAYABLE   
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D000067 2003
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D000067 2000
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D000067 2005
% 211.67/211.90  |- mesh__historyNote mesh__D000067
% 211.67/211.90       91%28%78%29%; was see under ACCOUNTING 1978-90   
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D000067 2004
% 211.67/211.90  |- skos__prefLabel mesh__D000067 Accounts Payable and Receivable
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D000067 1991
% 211.67/211.90  |- skos__altLabel mesh__D005550 Graduate, Foreign Medical
% 211.67/211.90  |- skos__broader mesh__D005550smesh__D010820
% 211.67/211.90  |- skos__historyNote mesh__D005550 Physicians %28%1966-1967%29%
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D005550 2006
% 211.67/211.90  |- mesh__recordOriginator mesh__D005550 NLM
% 211.67/211.90  |- skos__scopeNote mesh__D005550
% 211.67/211.90       Physicians who hold degrees from medical schools in countries other than the ones in which they practice.%A%    
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D005550 2004
% 211.67/211.90  |- skos__altLabel mesh__D005550 Foreign Medical Graduate
% 211.67/211.90  |- mesh__dateRevised mesh__D005550 1999-11-03
% 211.67/211.90  |- mesh__dateCreated mesh__D005550 1999-01-01
% 211.67/211.90  |- skos__altLabel mesh__D005550 Graduates, Foreign Medical
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D005550 2005
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D005550 2002
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D005550 2003
% 211.67/211.90  |- mesh__recordAuthorizer mesh__D005550 sjn
% 211.67/211.90  |- mesh__dateEstablished mesh__D005550 1970-01-01
% 211.67/211.90  |- skos__annotation mesh__D005550 specify geog; DF: FOREIGN MED GRAD   
% 211.67/211.90  |- mesh__recordMaintainer mesh__D005550 kle
% 211.67/211.90  |- skos__broader mesh__D005550smesh__D005551
% 211.67/211.90  |- skos__altLabel mesh__D005550 Medical Graduates, Foreign
% 211.67/211.90  |- skos__altLabel mesh__D005550 Medical Graduate, Foreign
% 211.67/211.90  |- mesh__historyNote mesh__D005550 70%28%68%29%   
% 211.67/211.90  |- mesh__publicMeSHNote mesh__D005550 70   
% 211.67/211.90  |- rdf__type mesh__D005550sskos__Concept
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D005550 2001
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D005550 2000
% 211.67/211.90  |- skos__prefLabel mesh__D005550 Foreign Medical Graduates
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D046169 2005
% 211.67/211.90  |- skos__prefLabel mesh__D046169 Dermoscopy
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D046169 2006
% 211.67/211.90  |- skos__hiddenLabel mesh__D046169 Epiluminescence Microscopies
% 211.67/211.90  |- skos__hiddenLabel mesh__D046169 Microscopy, Skin Surface
% 211.67/211.90  |- skos__hiddenLabel mesh__D046169 Microscopies, Epiluminescence
% 211.67/211.90  |- skos__scopeNote mesh__D046169
% 211.67/211.90       A noninvasive diagnostic technique that enables an experienced clinician to perform direct microscopic examination of the surface and architecture of pigmented SKIN lesions. The four major dermoscopic criteria are ABCD: asymmetry %28%A%29%, borders %28%B%29%, colors %28%C%29%, and different structural components %28%D%29% providing a semiquantitative scoring system for each lesion.%A%    
% 211.67/211.90  |- mesh__dateCreated mesh__D046169 2004-07-07
% 211.67/211.90  |- skos__hiddenLabel mesh__D046169 Dermoscopies
% 211.67/211.90  |- skos__altLabel mesh__D046169 Dermatoscopy
% 211.67/211.90  |- skos__historyNote mesh__D046169
% 211.67/211.90       Luminescent Measurements %28%1993-2004%29%
% 211.67/211.90  |- skos__altLabel mesh__D046169 Skin Surface Microscopy
% 211.67/211.90  |- mesh__recordAuthorizer mesh__D046169 sjn
% 211.67/211.90  |- skos__hiddenLabel mesh__D046169 Skin Surface Microscopies
% 211.67/211.90  |- mesh__historyNote mesh__D046169 2005   
% 211.67/211.90  |- rdf__type mesh__D046169sskos__Concept
% 211.67/211.90  |- skos__hiddenLabel mesh__D046169 Surface Microscopies, Skin
% 211.67/211.90  |- skos__hiddenLabel mesh__D046169 Microscopies, Skin Surface
% 211.67/211.90  |- skos__hiddenLabel mesh__D046169 Surface Microscopy, Skin
% 211.67/211.90  |- mesh__publicMeSHNote mesh__D046169 2005   
% 211.67/211.90  |- skos__hiddenLabel mesh__D046169 Microscopy, Epiluminescence
% 211.67/211.90  |- mesh__recordMaintainer mesh__D046169 lkt
% 211.67/211.90  |- skos__hiddenLabel mesh__D046169 Dermatoscopies
% 211.67/211.90  |- mesh__recordOriginator mesh__D046169 lkt
% 211.67/211.90  |- skos__historyNote mesh__D046169 Microscopy %28%1993-2004%29%
% 211.67/211.90  |- skos__broader mesh__D046169smesh__D008853
% 211.67/211.90  |- skos__altLabel mesh__D046169 Epiluminescence Microscopy
% 211.67/211.90  |- mesh__dateEstablished mesh__D046169 2005-01-01
% 211.67/211.90  |- skos__historyNote mesh__D046169 Skin Pigmentation %28%1993-2004%29%
% 211.67/211.90  |- mesh__publicMeSHNote mesh__D018478 95   
% 211.67/211.90  |- mesh__recordMaintainer mesh__D018478 JLS
% 211.67/211.90  |- skos__prefLabel mesh__D018478 Extravehicular Activity
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D018478 2003
% 211.67/211.90  |- skos__scopeNote mesh__D018478
% 211.67/211.90       Activities by crew members conducted outside the pressurized hull of a spacecraft.%A%    
% 211.67/211.90  |- rdf__type mesh__D018478sskos__Concept
% 211.67/211.90  |- skos__historyNote mesh__D018478
% 211.67/211.90       Extraterrestrial Environment %28%1966-1994%29%
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D018478 2000
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D018478 2004
% 211.67/211.90  |- mesh__recordAuthorizer mesh__D018478 SJN
% 211.67/211.90  |- mesh__dateRevised mesh__D018478 1997-06-20
% 211.67/211.90  |- mesh__recordOriginator mesh__D018478 JLS
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D018478 2001
% 211.67/211.90  |- skos__hiddenLabel mesh__D018478 Space Walk
% 211.67/211.90  |- skos__altLabel mesh__D018478 EVA
% 211.67/211.90  |- mesh__dateCreated mesh__D018478 1994-06-07
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D018478 1998
% 211.67/211.90  |- skos__annotation mesh__D018478
% 211.67/211.90       activity of crew members outside a spacecraft; /adv eff /physiol permitted; DF: note short X ref%A%  
% 211.67/211.90  |- skos__broader mesh__D018478smesh__D013026
% 211.67/211.90  |- skos__hiddenLabel mesh__D018478 Activity, Extravehicular
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D018478 2005
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D018478 1999
% 211.67/211.90  |- skos__historyNote mesh__D018478 Space Flight %28%1966-1994%29%
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D018478 2002
% 211.67/211.90  |- mesh__historyNote mesh__D018478 95   
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D018478 2006
% 211.67/211.90  |- skos__hiddenLabel mesh__D018478 Space-Walks
% 211.67/211.90  |- mesh__dateEstablished mesh__D018478 1995-01-01
% 211.67/211.90  |- mesh__publicMeSHNote mesh__D010495
% 211.67/211.90       91; was see under TUBERCULOSIS, CARDIOVASCULAR 1975-90   
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D010495 2003
% 211.67/211.90  |- mesh__dateRevised mesh__D010495 1991-06-12
% 211.67/211.90  |- skos__prefLabel mesh__D010495 Pericarditis, Tuberculous
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D010495 1996
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D010495 2000
% 211.67/211.90  |- rdf__type mesh__D010495sskos__Concept
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D010495 2004
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D010495 1992
% 211.67/211.90  |- mesh__dateEstablished mesh__D010495 1991-01-01
% 211.67/211.90  |- mesh__activeMeSHYear mesh__D010495 1997
% 211.76/211.90  |- mesh__activeMeSHYear mesh__D010495 2001
% 211.76/211.90  |- mesh__onlineNote mesh__D010495
% 211.76/211.90       search TUBERCULOSIS, CARDIOVASCULAR 1966-74   
% 211.76/211.90  |- mesh__historyNote mesh__D010495
% 211.76/211.90       91%28%75%29%; was see under TUBERCULOSIS, CARDIOVASCULAR 1975-90%A%  
% 211.76/211.90  |- mesh__activeMeSHYear mesh__D010495 2005
% 211.76/211.90  |- skos__broader mesh__D010495smesh__D014381
% 211.76/211.90  |- skos__scopeNote mesh__D010495
% 211.76/211.90       Infection of the pericardium with tubercle bacilli. This condition arises by contiguous extension of tuberculous lesions of the hilar or mediastinal lymph nodes or by pleuropulmonary tuberculosis.%A%    
% 211.76/211.90  |- mesh__activeMeSHYear mesh__D010495 1993
% 211.76/211.90  |- mesh__activeMeSHYear mesh__D010495 2002
% 211.76/211.90  |- mesh__activeMeSHYear mesh__D010495 1998
% 211.76/211.90  |- mesh__dateCreated mesh__D010495 1999-01-01
% 211.76/211.90  |- skos__hiddenLabel mesh__D010495 Pericarditides, Tuberculous
% 211.76/211.90  |- mesh__recordMaintainer mesh__D010495 PXP
% 211.76/211.90  |- skos__broader mesh__D010495smesh__D010493
% 211.76/211.90  |- skos__hiddenLabel mesh__D010495 Tuberculous Pericarditides
% 211.76/211.90  |- mesh__activeMeSHYear mesh__D010495 2006
% 211.76/211.90  |- mesh__activeMeSHYear mesh__D010495 1994
% 211.76/211.90  |- mesh__activeMeSHYear mesh__D010495 1999
% 211.76/211.90  |- mesh__recordAuthorizer mesh__D010495 PLS
% 211.76/211.90  |- mesh__recordOriginator mesh__D010495 NLM
% 211.76/211.90  |- mesh__activeMeSHYear mesh__D010495 1995
% 211.76/211.90  |- skos__hiddenLabel mesh__D010495 Tuberculous Pericarditis
% 211.76/211.90  |- skos__hiddenLabel mesh__D051303 Trigeminal Autonomic Cephalalgia
% 211.76/211.90  |- mesh__historyNote mesh__D051303 2006   
% 211.76/211.90  |- skos__broader mesh__D051303smesh__D051270
% 211.76/211.90  |- mesh__activeMeSHYear mesh__D051303 2006
% 211.76/211.90  |- mesh__dateCreated mesh__D051303 2005-06-30
% 211.76/211.90  |- skos__scopeNote mesh__D051303
% 211.76/211.90       Primary headache disorders that show symptoms caused by the activation of the AUTONOMIC NERVOUS SYSTEM of the TRIGEMINAL NERVE. These autonomic features include redness and tearing of the EYE, nasal congestion or discharge, facial SWEATING and other symptoms. Most subgroups show unilateral cranial PAIN.%A%    
% 211.76/211.90  |- mesh__recordMaintainer mesh__D051303 lkt
% 211.76/211.90  |- skos__hiddenLabel mesh__D051303 Cephalalgia, Trigeminal Autonomic
% 211.76/211.90  |- mesh__recordOriginator mesh__D051303 lkt
% 211.76/211.90  |- mesh__recordAuthorizer mesh__D051303 sjn
% 211.76/211.90  |- skos__hiddenLabel mesh__D051303 Cephalalgias, Trigeminal Autonomic
% 211.76/211.90  |- mesh__dateEstablished mesh__D051303 2006-01-01
% 211.76/211.90  |- mesh__publicMeSHNote mesh__D051303 2006   
% 211.76/211.90  |- rdf__type mesh__D051303sskos__Concept
% 211.76/211.90  |- skos__prefLabel mesh__D051303 Trigeminal Autonomic Cephalalgias
% 211.76/211.90  |- skos__annotation mesh__D004458
% 211.76/211.90       do not confuse with ECHOVIRUS 9; infection: coord IM with ECHOVIRUS INFECTIONS %28%IM%29%%A%  
% 211.76/211.90  |- rdf__type mesh__D004458sskos__Concept
% 211.76/211.90  |- mesh__dateEstablished mesh__D004458 1991-01-01
% 211.76/211.91  |- mesh__dateCreated mesh__D004458 1974-12-12
% 211.76/211.91  |- skos__altLabel mesh__D004458 Burgess Virus
% 211.76/211.91  |- skos__altLabel mesh__D004458 Echo Virus 6
% 211.76/211.91  |- skos__scopeNote mesh__D004458
% 211.76/211.91       A species of ENTEROVIRUS that has caused outbreaks of aseptic meningitis in children and adults.%A%    
% 211.76/211.91  |- skos__broader mesh__D004458smesh__D029822
% 211.76/211.91  |- mesh__recordMaintainer mesh__D004458 ags
% 211.76/211.91  |- mesh__recordAuthorizer mesh__D004458 sjn
% 211.76/211.91  |- mesh__dateRevised mesh__D004458 2001-07-25
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D004458 2003
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D004458 2005
% 211.76/211.91  |- skos__prefLabel mesh__D004458 Echovirus 6, Human
% 211.76/211.91  |- skos__hiddenLabel mesh__D004458 Virus, Burgess
% 211.76/211.91  |- mesh__historyNote mesh__D004458 2002 %28%1975%29%   
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D004458 2004
% 211.76/211.91  |- skos__altLabel mesh__D004458 Human echovirus 6
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D004458 2002
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D004458 2006
% 211.76/211.91  |- skos__altLabel mesh__D004458 Echovirus 6
% 211.76/211.91  |- mesh__publicMeSHNote mesh__D004458
% 211.76/211.91       2002; see ECHOVIRUS 6 1991-2001, see ECHOVIRUSES 1975-1990%A%  
% 211.76/211.91  |- mesh__recordOriginator mesh__D004458 NLM
% 211.76/211.91  |- skos__hiddenLabel mesh__D015180 Gel Electrophoresis, 2D
% 211.76/211.91  |- skos__altLabel mesh__D015180 Polyacrylamide Gel Electrophoresis, 2-D
% 211.76/211.91  |- skos__broader mesh__D015180smesh__D004591
% 211.76/211.91  |- skos__historyNote mesh__D015180 Electrophoresis %28%1975-1988%29%
% 211.76/211.91  |- skos__hiddenLabel mesh__D015180 PAGE, 2D
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D015180 2004
% 211.76/211.91  |- skos__altLabel mesh__D015180 2D PAGE
% 211.76/211.91  |- skos__scopeNote mesh__D015180
% 211.76/211.91       Electrophoresis in which a second perpendicular electrophoretic transport is performed on the separate components resulting from the first electrophoresis. This technique is usually performed on polyacrylamide gels.%A%    
% 211.76/211.91  |- skos__hiddenLabel mesh__D015180 Electrophoresis, 2-D Gel
% 211.76/211.91  |- skos__annotation mesh__D015180
% 211.76/211.91       usually performed on polyacrylamide gel %28%note X ref%29% but agarose gel is also used; NIM; DF: 2D PAGE%A%  
% 211.76/211.91  |- skos__altLabel mesh__D015180 2-D Polyacrylamide Gel Electrophoresis
% 211.76/211.91  |- skos__altLabel mesh__D015180 Electrophoresis, Gel, 2D
% 211.76/211.91  |- skos__broader mesh__D015180smesh__D004586
% 211.76/211.91  |- mesh__historyNote mesh__D015180 89   
% 211.76/211.91  |- skos__hiddenLabel mesh__D015180 Electrophoresis, 2D Gel
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D015180 2003
% 211.76/211.91  |- skos__hiddenLabel mesh__D015180 Two-Dimensional Gel Electrophoresis
% 211.76/211.91  |- skos__altLabel mesh__D015180 2-D Gel Electrophoresis
% 211.76/211.91  |- skos__hiddenLabel mesh__D015180 Electrophoresis, Two-Dimensional Gel
% 211.76/211.91  |- skos__hiddenLabel mesh__D015180 2 D Polyacrylamide Gel Electrophoresis
% 211.76/211.91  |- mesh__recordAuthorizer mesh__D015180 sjn
% 211.76/211.91  |- skos__hiddenLabel mesh__D015180
% 211.76/211.91       Polyacrylamide Gel Electrophoresis, Two Dimensional
% 211.76/211.91  |- mesh__dateRevised mesh__D015180 2002-07-03
% 211.76/211.91  |- skos__altLabel mesh__D015180 Electrophoresis, Gel, Two Dimensional
% 211.76/211.91  |- skos__hiddenLabel mesh__D015180 Gel Electrophoresis, 2-D
% 211.76/211.91  |- skos__altLabel mesh__D015180 Electrophoresis, Gel, 2-D
% 211.76/211.91  |- skos__hiddenLabel mesh__D015180 2 D Gel Electrophoresis
% 211.76/211.91  |- mesh__dateEstablished mesh__D015180 1989-01-01
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D015180 2006
% 211.76/211.91  |- mesh__recordOriginator mesh__D015180 EJB
% 211.76/211.91  |- skos__historyNote mesh__D015180
% 211.76/211.91       Electrophoresis, Polyacrylamide Gel %28%1975-1988%29%
% 211.76/211.91  |- skos__hiddenLabel mesh__D015180 Gel Electrophoresis, Two Dimensional
% 211.76/211.91  |- skos__altLabel mesh__D015180 Two Dimensional Gel Electrophoresis
% 211.76/211.91  |- skos__altLabel mesh__D015180 Gel Electrophoresis, Two-Dimensional
% 211.76/211.91  |- skos__prefLabel mesh__D015180 Electrophoresis, Gel, Two-Dimensional
% 211.76/211.91  |- skos__altLabel mesh__D015180 2D Gel Electrophoresis
% 211.76/211.91  |- skos__altLabel mesh__D015180 Polyacrylamide Gel Electrophoresis, 2D
% 211.76/211.91  |- skos__altLabel mesh__D015180
% 211.76/211.91       Polyacrylamide Gel Electrophoresis, Two-Dimensional
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D015180 2005
% 211.76/211.91  |- mesh__dateCreated mesh__D015180 1988-04-16
% 211.76/211.91  |- skos__hiddenLabel mesh__D015180 Polyacrylamide Gel Electrophoresis, 2 D
% 211.76/211.91  |- mesh__publicMeSHNote mesh__D015180 89   
% 211.76/211.91  |- rdf__type mesh__D015180sskos__Concept
% 211.76/211.91  |- mesh__recordMaintainer mesh__D015180 lkt
% 211.76/211.91  |- mesh__dateCreated mesh__D009941 1976-04-16
% 211.76/211.91  |- mesh__historyNote mesh__D009941 77   
% 211.76/211.91  |- mesh__recordAuthorizer mesh__D009941 PLS
% 211.76/211.91  |- skos__scopeNote mesh__D009941
% 211.76/211.91       Organic compounds which contain mercury as an integral part of the molecule.%A%    
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009941 1994
% 211.76/211.91  |- skos__annotation mesh__D009941 DF: ORGANOMERCURY CPDS   
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009941 1993
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009941 2006
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009941 1999
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009941 2005
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009941 2004
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009941 2001
% 211.76/211.91  |- mesh__recordMaintainer mesh__D009941 TAP
% 211.76/211.91  |- skos__historyNote mesh__D009941
% 211.76/211.91       Organometallic Compounds %28%1968-1976%29%
% 211.76/211.91  |- mesh__dateRevised mesh__D009941 1992-05-19
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009941 1998
% 211.76/211.91  |- mesh__recordOriginator mesh__D009941 RLS
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009941 1997
% 211.76/211.91  |- rdf__type mesh__D009941sskos__Concept
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009941 2003
% 211.76/211.91  |- mesh__publicMeSHNote mesh__D009941 77   
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009941 2000
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009941 1996
% 211.76/211.91  |- skos__historyNote mesh__D009941 Mercury %28%1968-1976%29%
% 211.76/211.91  |- skos__broader mesh__D009941smesh__D009942
% 211.76/211.91  |- mesh__dateEstablished mesh__D009941 1977-01-01
% 211.76/211.91  |- skos__prefLabel mesh__D009941 Organomercury Compounds
% 211.76/211.91  |- skos__hiddenLabel mesh__D009941 Compounds, Organomercury
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009941 2002
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009941 1995
% 211.76/211.91  |- mesh__recordOriginator mesh__D009143 NLM
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009143 2000
% 211.76/211.91  |- mesh__recordMaintainer mesh__D009143 TGC
% 211.76/211.91  |- skos__prefLabel mesh__D009143
% 211.76/211.91       Musculoskeletal, Neural, and Ocular Physiology
% 211.76/211.91  |- mesh__publicMeSHNote mesh__D009143 98   
% 211.76/211.91  |- mesh__historyNote mesh__D009143 98; use explode   
% 211.76/211.91  |- mesh__runningHead mesh__D009143
% 211.76/211.91       G11 - PHYSIOLOGY-MUSCULOSKELETAL, NEURAL, AND OCULAR   
% 211.76/211.91  |- rdf__type mesh__D009143sskos__Concept
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009143 2001
% 211.76/211.91  |- skos__annotation mesh__D009143
% 211.76/211.91       not used for indexing      CATALOG: do not use   
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009143 2003
% 211.76/211.91  |- skos__scopeNote mesh__D009143
% 211.76/211.91       Activities and functions of the musculoskeletal system, the nervous system, and the eye and their parts.%A%    
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009143 1998
% 211.76/211.91  |- mesh__recordAuthorizer mesh__D009143 SJN
% 211.76/211.91  |- mesh__dateEstablished mesh__D009143 1998-01-01
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009143 2005
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009143 2004
% 211.76/211.91  |- mesh__dateRevised mesh__D009143 1997-06-27
% 211.76/211.91  |- mesh__dateCreated mesh__D009143 1999-01-01
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009143 1999
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009143 2002
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D009143 2006
% 211.76/211.91  |- skos__broader mesh__D001160smesh__D001158
% 211.76/211.91  |- skos__broader mesh__D001160smesh__D008833
% 211.76/211.91  |- mesh__dateRevised mesh__D001160 1992-03-25
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D001160 2001
% 211.76/211.91  |- mesh__dateCreated mesh__D001160 1977-03-01
% 211.76/211.91  |- skos__hiddenLabel mesh__D001160 Arteriole
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D001160 2002
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D001160 1994
% 211.76/211.91  |- mesh__recordOriginator mesh__D001160 VDK
% 211.76/211.91  |- skos__scopeNote mesh__D001160
% 211.76/211.91       The smallest divisions of the arteries located between the muscular arteries and the capillaries.%A%    
% 211.76/211.91  |- mesh__publicMeSHNote mesh__D001160 91; was see under ARTERIES 1978-90   
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D001160 2005
% 211.76/211.91  |- skos__prefLabel mesh__D001160 Arterioles
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D001160 1995
% 211.76/211.91  |- mesh__recordMaintainer mesh__D001160 TAP
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D001160 2003
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D001160 1993
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D001160 2006
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D001160 1998
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D001160 2004
% 211.76/211.91  |- mesh__historyNote mesh__D001160
% 211.76/211.91       91%28%78%29%; was see under ARTERIES 1978-90   
% 211.76/211.91  |- skos__annotation mesh__D001160
% 211.76/211.91       IM GEN only; NIM as coord with specific organ /blood supply %28%IM%29%%A%  
% 211.76/211.91  |- skos__historyNote mesh__D001160 Arteries %28%1966-1977%29%
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D001160 1996
% 211.76/211.91  |- rdf__type mesh__D001160sskos__Concept
% 211.76/211.91  |- mesh__dateEstablished mesh__D001160 1991-01-01
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D001160 1999
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D001160 2000
% 211.76/211.91  |- skos__historyNote mesh__D001160 specific artery
% 211.76/211.91  |- mesh__recordAuthorizer mesh__D001160 PLS
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D001160 1997
% 211.76/211.91  |- mesh__dateCreated mesh__D014886 1999-01-01
% 211.76/211.91  |- mesh__historyNote mesh__D014886 66%28%63%29%   
% 211.76/211.91  |- mesh__publicMeSHNote mesh__D014886 66   
% 211.76/211.91  |- mesh__recordMaintainer mesh__D014886 TPW
% 211.76/211.91  |- mesh__dateEstablished mesh__D014886 1966-01-01
% 211.76/211.91  |- skos__annotation mesh__D014886
% 211.76/211.91       human %26% animal; no qualif; NIM when merely an aspect of growth %28%as %22%in newborn, suckling %26% weaned%22%%29%%A%  
% 211.76/211.91  |- mesh__recordAuthorizer mesh__D014886 sjn
% 211.76/211.91  |- skos__hiddenLabel mesh__D014886 Weanings
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D014886 2003
% 211.76/211.91  |- mesh__recordOriginator mesh__D014886 NLM
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D014886 2004
% 211.76/211.91  |- rdf__type mesh__D014886sskos__Concept
% 211.76/211.91  |- skos__prefLabel mesh__D014886 Weaning
% 211.76/211.91  |- skos__broader mesh__D014886smesh__D007227
% 211.76/211.91  |- mesh__dateRevised mesh__D014886 2002-07-03
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D014886 2005
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D014886 2006
% 211.76/211.91  |- skos__scopeNote mesh__D014886
% 211.76/211.91       Permanent deprivation of breast milk and commencement of nourishment with other food. %28%From Stedman, 25th ed%29%%A%    
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D014088 1995
% 211.76/211.91  |- mesh__recordAuthorizer mesh__D014088 PLS
% 211.76/211.91  |- skos__hiddenLabel mesh__D014088 Tooth Permeabilities
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D014088 2006
% 211.76/211.91  |- skos__hiddenLabel mesh__D014088 Permeabilities, Tooth
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D014088 1998
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D014088 2002
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D014088 2003
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D014088 1999
% 211.76/211.91  |- skos__altLabel mesh__D014088 Permeability, Tooth
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D014088 1993
% 211.76/211.91  |- skos__broader mesh__D014088smesh__D009063
% 211.76/211.91  |- rdf__type mesh__D014088sskos__Concept
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D014088 2004
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D014088 1996
% 211.76/211.91  |- mesh__recordMaintainer mesh__D014088 TAP
% 211.76/211.91  |- mesh__historyNote mesh__D014088 65   
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D014088 2000
% 211.76/211.91  |- mesh__dateRevised mesh__D014088 1992-05-18
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D014088 2001
% 211.76/211.91  |- mesh__publicMeSHNote mesh__D014088 65   
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D014088 1997
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D014088 1994
% 211.76/211.91  |- skos__prefLabel mesh__D014088 Tooth Permeability
% 211.76/211.91  |- mesh__recordOriginator mesh__D014088 NLM
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D014088 2005
% 211.76/211.91  |- mesh__dateEstablished mesh__D014088 1965-01-01
% 211.76/211.91  |- mesh__dateCreated mesh__D014088 1999-01-01
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D008849 2006
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D008849 1998
% 211.76/211.91  |- skos__altLabel mesh__D008849 Ellice Islands
% 211.76/211.91  |- mesh__dateCreated mesh__D008849 1999-01-01
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D008849 2005
% 211.76/211.91  |- mesh__recordOriginator mesh__D008849 NLM
% 211.76/211.91  |- skos__prefLabel mesh__D008849 Micronesia
% 211.76/211.91  |- rdf__type mesh__D008849sskos__Concept
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D008849 2002
% 211.76/211.91  |- mesh__recordAuthorizer mesh__D008849 ags
% 211.76/211.91  |- skos__scopeNote mesh__D008849
% 211.76/211.91       The collective name for islands of the Pacific Ocean east of the Philippines, including the Mariana, PALAU, Caroline, Marshall, and Kiribati Islands. Micronesia is from the Greek micro, small + nesos, island, so named because the islands in this group are much smaller than those in MELANESIA. Micronesia is inhabited by a mixed race of Melanesians, Polynesians, and some Malaysians. %28%From Webster%27%s New Geographical Dictionary, 1988, p761 %26% Room, Brewer%27%s Dictionary of Names, 1992, p350%29%%A%    
% 211.76/211.91  |- mesh__dateRevised mesh__D008849 2005-07-19
% 211.76/211.91  |- skos__altLabel mesh__D008849 Christmas Island
% 211.76/211.91  |- skos__annotation mesh__D008849
% 211.76/211.91       a group of islands east of the Philippines; includes Christmas Island; of the X ref MARIANA ISLANDS; GUAM is available; PALAU is also available%A%  
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D008849 2001
% 211.76/211.91  |- skos__altLabel mesh__D008849 Canton and Enderbury Islands
% 211.76/211.91  |- mesh__historyNote mesh__D008849 68   
% 211.76/211.91  |- mesh__recordMaintainer mesh__D008849 ags
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D008849 2006A
% 211.76/211.91  |- skos__broader mesh__D008849smesh__D010139
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D008849 1997
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D008849 2000
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D008849 2004
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D008849 1996
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D008849 1999
% 211.76/211.91  |- skos__altLabel mesh__D008849 Kiribati
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D008849 2003
% 211.76/211.91  |- mesh__dateRevised mesh__D000866 2003-07-09
% 211.76/211.91  |- skos__annotation mesh__D000866
% 211.76/211.91       includes dik-dik, eland, gazelle, gnu, hartebeest, impala, springbok, wildebeest; IM; qualif permitted%A%  
% 211.76/211.91  |- skos__broader mesh__D000866smesh__D012418
% 211.76/211.91  |- skos__hiddenLabel mesh__D000866 Antelopine
% 211.76/211.91  |- mesh__dateEstablished mesh__D000866 1991-01-01
% 211.76/211.91  |- skos__hiddenLabel mesh__D000866 Hippotragine
% 211.76/211.91  |- skos__scopeNote mesh__D000866
% 211.76/211.91       Any of various ruminant mammals of the order Bovidae. They include numerous species in Africa and the American pronghorn.%A%    
% 211.76/211.91  |- skos__prefLabel mesh__D000866 Antelopes
% 211.76/211.91  |- skos__altLabel mesh__D000866 Antelopines
% 211.76/211.91  |- mesh__recordMaintainer mesh__D000866 ags
% 211.76/211.91  |- mesh__dateCreated mesh__D000866 1974-11-19
% 211.76/211.91  |- mesh__recordOriginator mesh__D000866 NLM
% 211.76/211.91  |- rdf__type mesh__D000866sskos__Concept
% 211.76/211.91  |- mesh__recordAuthorizer mesh__D000866 sjn
% 211.76/211.91  |- mesh__historyNote mesh__D000866
% 211.76/211.91       91%28%75%29%; was see under ARTIODACTYLA 1975-90   
% 211.76/211.91  |- skos__hiddenLabel mesh__D000866 Antelope
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D000866 2006
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D000866 2004
% 211.76/211.91  |- mesh__publicMeSHNote mesh__D000866
% 211.76/211.91       91; was see under ARTIODACTYLA 1975-90   
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D000866 2005
% 211.76/211.91  |- skos__prefLabel mesh__D019571 Arrhythmogenic Right Ventricular Dysplasia
% 211.76/211.91  |- rdf__type mesh__D019571sskos__Concept
% 211.76/211.91  |- skos__altLabel mesh__D019571 Right Ventricular Dysplasia, Arrhythmogenic
% 211.76/211.91  |- mesh__recordMaintainer mesh__D019571 kle
% 211.76/211.91  |- mesh__dateCreated mesh__D019571 1997-06-20
% 211.76/211.91  |- skos__altLabel mesh__D019571
% 211.76/211.91       Ventricular Dysplasia, Right, Arrhythmogenic
% 211.76/211.91  |- skos__broader mesh__D019571smesh__D006330
% 211.76/211.91  |- skos__altLabel mesh__D019571
% 211.76/211.91       Arrhythmogenic Right Ventricular Cardiomyopathy
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D019571 2003
% 211.76/211.91  |- mesh__dateEstablished mesh__D019571 1998-01-01
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D019571 2004
% 211.76/211.91  |- skos__historyNote mesh__D019571 Arrhythmia %28%1981-1992%29%
% 211.76/211.91  |- mesh__recordOriginator mesh__D019571 TGC
% 211.76/211.91  |- mesh__historyNote mesh__D019571 98   
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D019571 2000
% 211.76/211.91  |- skos__historyNote mesh__D019571
% 211.76/211.91       Tachycardia, Ventricular %28%1993-1997%29%
% 211.76/211.91  |- mesh__recordAuthorizer mesh__D019571 sjn
% 211.76/211.91  |- skos__historyNote mesh__D019571 Heart Ventricle %28%1978-1997%29%
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D019571 2005
% 211.76/211.91  |- skos__annotation mesh__D019571
% 211.76/211.91       a congen myocardial dis; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: ARVD%A%  
% 211.76/211.91  |- mesh__publicMeSHNote mesh__D019571 98   
% 211.76/211.91  |- skos__scopeNote mesh__D019571
% 211.76/211.91       A congenital cardiomyopathy in which transmural infiltration of adipose tissue results in weakness and aneurysmal bulging of the infundibulum, apex, and posterior basilar region of the right ventricle and leads to ventricular tachycardia arising in the right ventricle. %28%Dorland, 28th ed%29%%A%    
% 211.76/211.91  |- skos__historyNote mesh__D019571 Tachycardia %28%1978-1992%29%
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D019571 2001
% 211.76/211.91  |- skos__historyNote mesh__D019571 Myocardial Diseases %28%1981-1997%29%
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D019571 2006
% 211.76/211.91  |- mesh__dateRevised mesh__D019571 1999-11-03
% 211.76/211.91  |- skos__broader mesh__D019571smesh__D017180
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D019571 2002
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D033242 2004
% 211.76/211.91  |- skos__hiddenLabel mesh__D033242 Minor
% 211.76/211.91  |- skos__prefLabel mesh__D033242 Minors
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D033242 2005
% 211.76/211.91  |- mesh__dateEstablished mesh__D033242 2003-01-01
% 211.76/211.91  |- skos__related mesh__D033242smesh__D002648
% 211.76/211.91  |- skos__related mesh__D033242smesh__D000293
% 211.76/211.91  |- skos__scopeNote mesh__D033242
% 211.76/211.91       A person who has not attained the age at which full civil rights are accorded.%A%    
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D033242 2006
% 211.76/211.91  |- skos__historyNote mesh__D033242 Adolescence %28%1965-2002%29%
% 211.76/211.91  |- skos__broader mesh__D033242smesh__D009272
% 211.76/211.91  |- skos__historyNote mesh__D033242 Child %28%1965-2002%29%
% 211.76/211.91  |- mesh__historyNote mesh__D033242 2003; use ADOLESCENCE 1982-2002   
% 211.76/211.91  |- mesh__dateCreated mesh__D033242 2002-07-03
% 211.76/211.91  |- mesh__publicMeSHNote mesh__D033242 2003; see ADOLESCENCE 1982-2002   
% 211.76/211.91  |- rdf__type mesh__D033242sskos__Concept
% 211.76/211.91  |- skos__annotation mesh__D033242
% 211.76/211.91       check appropriate age check tag; do not routinely add this term; use only when specified by author%A%  
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D033242 2003
% 211.76/211.91  |- skos__scopeNote mesh__D000068
% 211.76/211.91       Certification as complying with a standard set by non-governmental organizations, applied for by institutions, programs, and facilities on a voluntary basis.%A%    
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D000068 1999
% 211.76/211.91  |- mesh__recordMaintainer mesh__D000068 NLM
% 211.76/211.91  |- rdf__type mesh__D000068sskos__Concept
% 211.76/211.91  |- mesh__historyNote mesh__D000068 66%28%64%29%   
% 211.76/211.91  |- skos__broader mesh__D000068smesh__D003406
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D000068 1995
% 211.76/211.91  |- skos__hiddenLabel mesh__D000068 Accreditations
% 211.76/211.91  |- skos__prefLabel mesh__D000068 Accreditation
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D000068 2000
% 211.76/211.91  |- skos__related mesh__D000068smesh__D002568
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D000068 2003
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D000068 2001
% 211.76/211.91  |- mesh__dateEstablished mesh__D000068 1966-01-01
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D000068 2005
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D000068 2004
% 211.76/211.91  |- mesh__dateCreated mesh__D000068 1999-01-01
% 211.76/211.91  |- mesh__dateRevised mesh__D000068 1994-06-03
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D000068 2006
% 211.76/211.91  |- skos__annotation mesh__D000068
% 211.76/211.91       by the profession; do not confuse with LICENSURE %28%by the state%29%%A%  
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D000068 1996
% 211.76/211.91  |- mesh__recordOriginator mesh__D000068 NLM
% 211.76/211.91  |- mesh__publicMeSHNote mesh__D000068 66   
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D000068 2002
% 211.76/211.91  |- skos__related mesh__D000068smesh__D008004
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D000068 1998
% 211.76/211.91  |- mesh__recordAuthorizer mesh__D000068 PLS
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D000068 1997
% 211.76/211.91  |- skos__broader mesh__D006861Q000031smesh__D006861
% 211.76/211.91  |- mesh__preferredCombination mesh__D006861Q000031smesh__D010545
% 211.76/211.91  |- rdf__type mesh__D006861Q000031smesh__CompoundConcept
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D005551 2003
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D005551 2006
% 211.76/211.91  |- mesh__recordOriginator mesh__D005551 EC
% 211.76/211.91  |- skos__annotation mesh__D005551 specify geog   
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D005551 2001
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D005551 2004
% 211.76/211.91  |- mesh__dateEstablished mesh__D005551 1971-01-01
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D005551 2002
% 211.76/211.91  |- skos__hiddenLabel mesh__D005551 Personnel, Foreign Professional
% 211.76/211.91  |- skos__hiddenLabel mesh__D005551 Professional Personnel, Foreign
% 211.76/211.91  |- mesh__publicMeSHNote mesh__D005551 71   
% 211.76/211.91  |- mesh__historyNote mesh__D005551 71   
% 211.76/211.91  |- skos__prefLabel mesh__D005551 Foreign Professional Personnel
% 211.76/211.91  |- skos__historyNote mesh__D005551 Health Manpower %28%1968-1970%29%
% 211.76/211.91  |- mesh__dateRevised mesh__D005551 1999-11-03
% 211.76/211.91  |- mesh__dateCreated mesh__D005551 1978-03-29
% 211.76/211.91  |- skos__broader mesh__D005551smesh__D009274
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D005551 2005
% 211.76/211.91  |- rdf__type mesh__D005551sskos__Concept
% 211.76/211.91  |- mesh__recordAuthorizer mesh__D005551 sjn
% 211.76/211.91  |- skos__scopeNote mesh__D005551
% 211.76/211.91       Persons who have acquired academic or specialized training in countries other than that in which they are working. The concept excludes physicians for which FOREIGN MEDICAL GRADUATES is the likely heading.%A%    
% 211.76/211.91  |- mesh__recordMaintainer mesh__D005551 kle
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D005551 2000
% 211.76/211.91  |- skos__historyNote mesh__D046968 Bacteria, Anaerobic %28%1985-2004%29%
% 211.76/211.91  |- mesh__historyNote mesh__D046968 2005   
% 211.76/211.91  |- mesh__dateEstablished mesh__D046968 2005-01-01
% 211.76/211.91  |- mesh__recordOriginator mesh__D046968 ags
% 211.76/211.91  |- mesh__recordAuthorizer mesh__D046968 sjn
% 211.76/211.91  |- mesh__dateCreated mesh__D046968 2004-07-07
% 211.76/211.91  |- skos__broader mesh__D046968smesh__D016988
% 211.76/211.91  |- mesh__dateRevised mesh__D046968 2005-06-30
% 211.76/211.91  |- skos__scopeNote mesh__D046968
% 211.76/211.91       A genus of gram-positive, anaerobic bacteria in the family Thermoanaerobacteriaceae. Cultures consist of rods interspersed with coccoid cells.%A%    
% 211.76/211.91  |- skos__annotation mesh__D046968
% 211.76/211.91       do not confuse with THERMOANAEROBACTERIUM   
% 211.76/211.91  |- rdf__type mesh__D046968sskos__Concept
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D046968 2006
% 211.76/211.91  |- mesh__recordMaintainer mesh__D046968 SYSTEM
% 211.76/211.91  |- skos__prefLabel mesh__D046968 Thermoanaerobacter
% 211.76/211.91  |- mesh__publicMeSHNote mesh__D046968 2005   
% 211.76/211.91  |- mesh__recordOriginator mesh__D018479 TGC
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D018479 2002
% 211.76/211.91  |- mesh__dateEstablished mesh__D018479 1995-01-01
% 211.76/211.91  |- skos__hiddenLabel mesh__D018479 Program, Head Start
% 211.76/211.91  |- mesh__recordMaintainer mesh__D018479 JLS
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D018479 2005
% 211.76/211.91  |- skos__altLabel mesh__D018479 Early Intervention
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D018479 1999
% 211.76/211.91  |- skos__hiddenLabel mesh__D018479 Interventions, Early %28%Education%29%
% 211.76/211.91  |- skos__broader mesh__D018479smesh__D002662
% 211.76/211.91  |- skos__hiddenLabel mesh__D018479 Intervention, Early
% 211.76/211.91  |- skos__hiddenLabel mesh__D018479 Early Interventions %28%Education%29%
% 211.76/211.91  |- skos__hiddenLabel mesh__D018479 Head Start Programs
% 211.76/211.91  |- skos__hiddenLabel mesh__D018479 Interventions, Early
% 211.76/211.91  |- mesh__publicMeSHNote mesh__D018479 95   
% 211.76/211.91  |- skos__broader mesh__D018479smesh__D011314
% 211.76/211.91  |- mesh__historyNote mesh__D018479 95   
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D018479 2006
% 211.76/211.91  |- mesh__dateCreated mesh__D018479 1994-06-02
% 211.76/211.91  |- skos__hiddenLabel mesh__D018479 Early Interventions
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D018479 2000
% 211.76/211.91  |- mesh__recordAuthorizer mesh__D018479 SJN
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D018479 2003
% 211.76/211.91  |- mesh__activeMeSHYear mesh__D018479 2001
% 211.76/211.91  |- skos__scopeNote mesh__D018479
% 211.76/211.91       Procedures and programs that facilitate the development or skill acquisition in infants and young children who have disabilities, who are at risk for developing disabilities, or who are gifted. It includes programs that are designed to prevent handicapping conditions in infants and young children and family-centered programs designed to affect the functioning of infants and children with special needs. %28%From Journal of Early Intervention, Editorial, 1989, vol. 13, no. 1, p. 3; A Discursive Dictionary of Health Care, prepared for the U.S. House of Representatives Committee on Interstate and Foreign Commerce, 1976%29%%A%    
% 211.76/211.91  |- mesh__dateRevised mesh__D018479 1998-06-10
% 211.76/211.92  |- rdf__type mesh__D018479sskos__Concept
% 211.76/211.92  |- skos__hiddenLabel mesh__D018479 Intervention, Early %28%Education%29%
% 211.76/211.92  |- skos__prefLabel mesh__D018479 Early Intervention %28%Education%29%
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D018479 2004
% 211.76/211.92  |- skos__annotation mesh__D018479
% 211.76/211.92       restrict to procedures for developing skills in children with special needs: do not use for early intervention in various organic %26% systemic dis; DF: EARLY INTERVENTION%A%  
% 211.76/211.92  |- mesh__recordAuthorizer mesh__D010496 ags
% 211.76/211.92  |- rdf__type mesh__D010496sskos__Concept
% 211.76/211.92  |- skos__hiddenLabel mesh__D010496 Pericardium, Parietal
% 211.76/211.92  |- skos__broader mesh__D010496smesh__D012704
% 211.76/211.92  |- skos__altLabel mesh__D010496 Visceral Pericardium
% 211.76/211.92  |- mesh__recordMaintainer mesh__D010496 ags
% 211.76/211.92  |- mesh__dateCreated mesh__D010496 1999-01-01
% 211.76/211.92  |- skos__hiddenLabel mesh__D010496 Pericardiums, Fibrous
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D010496 2006
% 211.76/211.92  |- skos__prefLabel mesh__D010496 Pericardium
% 211.76/211.92  |- skos__altLabel mesh__D010496 Serous Pericardium
% 211.76/211.92  |- skos__hiddenLabel mesh__D010496 Pericardium, Visceral
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D010496 2006A
% 211.76/211.92  |- skos__scopeNote mesh__D010496
% 211.76/211.92       A conical fibro-serous sac surrounding the HEART and the roots of the great vessels %28%AORTA; VENAE CAVAE; PULMONARY ARTERY%29%. The pericardium consists of two layers or sacs, the outer fibrous pericardium and the inner serous pericardium %28%or epicardium%29%.%A%    
% 211.76/211.92  |- skos__annotation mesh__D010496
% 211.76/211.92       inflammation = PERICARDITIS or its specifics; simple mediastinal cyst adjacent to pericardium = MEDIASTINAL CYST %28%do not coordinate with PERICARDIUM%29%%A%  
% 211.76/211.92  |- skos__hiddenLabel mesh__D010496 Pericardium, Serous
% 211.76/211.92  |- skos__hiddenLabel mesh__D010496 Pericardium, Fibrous
% 211.76/211.92  |- skos__broader mesh__D010496smesh__D006321
% 211.76/211.92  |- mesh__dateRevised mesh__D010496 2005-08-03
% 211.76/211.92  |- skos__related mesh__D010496smesh__D010492
% 211.76/211.92  |- mesh__recordOriginator mesh__D010496 NLM
% 211.76/211.92  |- mesh__dateEstablished mesh__D051304 2006-01-01
% 211.76/211.92  |- skos__scopeNote mesh__D051304
% 211.76/211.92       A family of low molecular weight proteins that bind ACTIN and control actin polymerization. They are found in eukaryotes and are ubiquitously expressed.%A%    
% 211.76/211.92  |- skos__altLabel mesh__D051304 Profilin-2
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D051304 2006
% 211.76/211.92  |- skos__altLabel mesh__D051304 Profilin I
% 211.76/211.92  |- mesh__publicMeSHNote mesh__D051304
% 211.76/211.92       2006; PROFILINS was indexed under MICROFILAMENT PROTEINS %26% CONTRACTILE PROTEINS 2005, %26% under CYTOSKELETAL PROTEINS 1977-2004, %26% under PROTEINS 1977-1987%A%  
% 211.76/211.92  |- skos__altLabel mesh__D051304 Profilin-4
% 211.76/211.92  |- skos__altLabel mesh__D051304 Profilin
% 211.76/211.92  |- mesh__historyNote mesh__D051304
% 211.76/211.92       2006%28%1990%29%; CYTOSKELETAL PROTEINS 1977-1979   
% 211.76/211.92  |- skos__broader mesh__D051304smesh__D009124
% 211.76/211.92  |- skos__altLabel mesh__D051304 Profilin-1
% 211.76/211.92  |- skos__prefLabel mesh__D051304 Profilins
% 211.76/211.92  |- mesh__recordOriginator mesh__D051304 DRC
% 211.76/211.92  |- rdf__type mesh__D051304sskos__Concept
% 211.76/211.92  |- mesh__recordMaintainer mesh__D051304 DRC
% 211.76/211.92  |- mesh__dateCreated mesh__D051304 2005-06-30
% 211.76/211.92  |- skos__broader mesh__D051304smesh__D008840
% 211.76/211.92  |- skos__altLabel mesh__D051304 Profilin Proteins
% 211.76/211.92  |- skos__altLabel mesh__D051304 Profilin-3
% 211.76/211.92  |- mesh__recordAuthorizer mesh__D051304 sjn
% 211.76/211.92  |- skos__altLabel mesh__D004459 Echo Virus 9
% 211.76/211.92  |- mesh__dateCreated mesh__D004459 1974-12-12
% 211.76/211.92  |- skos__altLabel mesh__D004459 Echovirus 9, Human
% 211.76/211.92  |- skos__altLabel mesh__D004459 Human echovirus 9
% 211.76/211.92  |- mesh__recordAuthorizer mesh__D004459 sjn
% 211.76/211.92  |- skos__annotation mesh__D004459
% 211.76/211.92       infection: coord IM with ECHOVIRUS INFECTIONS %28%IM%29%   
% 211.76/211.92  |- skos__prefLabel mesh__D004459 Echovirus 9
% 211.76/211.92  |- mesh__recordMaintainer mesh__D004459 ags
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D004459 2003
% 211.76/211.92  |- skos__broader mesh__D004459smesh__D029822
% 211.76/211.92  |- mesh__dateRevised mesh__D004459 2001-07-25
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D004459 2002
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D004459 2005
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D004459 2004
% 211.76/211.92  |- mesh__historyNote mesh__D004459 1991 %28%1975%29%   
% 211.76/211.92  |- mesh__recordOriginator mesh__D004459 NLM
% 211.76/211.92  |- mesh__publicMeSHNote mesh__D004459
% 211.76/211.92       2002; see ECHOVIRUS 9 1991-2001, see ECHOVIRUSES 1975-1990%A%  
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D004459 2006
% 211.76/211.92  |- rdf__type mesh__D004459sskos__Concept
% 211.76/211.92  |- skos__scopeNote mesh__D004459
% 211.76/211.92       A species of ENTEROVIRUS associated with outbreaks of aseptic meningitis %28%MENINGITIS, ASEPTIC%29%.%A%    
% 211.76/211.92  |- mesh__dateEstablished mesh__D004459 1991-01-01
% 211.76/211.92  |- mesh__recordMaintainer mesh__D015181 hjn
% 211.76/211.92  |- mesh__recordAuthorizer mesh__D015181 sjn
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D015181 2004
% 211.76/211.92  |- skos__hiddenLabel mesh__D015181 Transfer, Gamete Intrafallopian
% 211.76/211.92  |- skos__historyNote mesh__D015181 Embryo Transfer %28%1985-1988%29%
% 211.76/211.92  |- skos__hiddenLabel mesh__D015181 Intrafallopian Transfer, Gamete
% 211.76/211.92  |- mesh__dateRevised mesh__D015181 2002-07-03
% 211.76/211.92  |- mesh__recordOriginator mesh__D015181 EJB
% 211.76/211.92  |- skos__scopeNote mesh__D015181
% 211.76/211.92       A technique that came into use in the mid-1980%27%s for assisted conception in infertile women with normal fallopian tubes. The protocol consists of hormonal stimulation of the ovaries, followed by laparoscopic follicular aspiration of oocytes, and then the transfer of sperm and oocytes by catheterization into the fallopian tubes.%A%    
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D015181 2005
% 211.76/211.92  |- mesh__dateEstablished mesh__D015181 1989-01-01
% 211.76/211.92  |- skos__historyNote mesh__D015181
% 211.76/211.92       Insemination, Artificial %28%1985-1988%29%
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D015181 2006
% 211.76/211.92  |- mesh__dateCreated mesh__D015181 1988-04-18
% 211.76/211.92  |- skos__prefLabel mesh__D015181 Gamete Intrafallopian Transfer
% 211.76/211.92  |- skos__historyNote mesh__D015181 Fertilization in Vitro %28%1985-1988%29%
% 211.76/211.92  |- skos__historyNote mesh__D015181 Fallopian Tubes %28%1985-1988%29%
% 211.76/211.92  |- mesh__historyNote mesh__D015181 89   
% 211.76/211.92  |- mesh__publicMeSHNote mesh__D015181 89   
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D015181 2003
% 211.76/211.92  |- rdf__type mesh__D015181sskos__Concept
% 211.76/211.92  |- skos__broader mesh__D015181smesh__D027724
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D009942 2006
% 211.76/211.92  |- mesh__dateCreated mesh__D009942 1999-01-01
% 211.76/211.92  |- mesh__recordAuthorizer mesh__D009942 sjn
% 211.76/211.92  |- mesh__historyNote mesh__D009942 68   
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D009942 2005
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D009942 2004
% 211.76/211.92  |- rdf__type mesh__D009942sskos__Concept
% 211.76/211.92  |- skos__annotation mesh__D009942
% 211.76/211.92       GEN or unspecified; prefer specifics; DF: ORGANOMETALLIC CPDS%A%  
% 211.76/211.92  |- skos__prefLabel mesh__D009942 Organometallic Compounds
% 211.76/211.92  |- mesh__dateRevised mesh__D009942 2003-07-09
% 211.76/211.92  |- mesh__publicMeSHNote mesh__D009942 68   
% 211.76/211.92  |- skos__broader mesh__D009942smesh__D009930
% 211.76/211.92  |- mesh__dateEstablished mesh__D009942 1968-01-01
% 211.76/211.92  |- mesh__recordOriginator mesh__D009942 NLM
% 211.76/211.92  |- skos__hiddenLabel mesh__D009942 Compounds, Metallo-Organic
% 211.76/211.92  |- skos__scopeNote mesh__D009942
% 211.76/211.92       A class of compounds of the type R-M, where a C atom is joined directly to any other element except H, C, N, O, F, Cl, Br, I, or At. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 211.76/211.92  |- mesh__recordMaintainer mesh__D009942 ssb
% 211.76/211.92  |- skos__hiddenLabel mesh__D009942 Compounds, Organometallic
% 211.76/211.92  |- skos__hiddenLabel mesh__D009942 Metallo Organic Compounds
% 211.76/211.92  |- skos__altLabel mesh__D009942 Metallo-Organic Compounds
% 211.76/211.92  |- skos__broader mesh__D009144smesh__D001109
% 211.76/211.92  |- rdf__type mesh__D009144sskos__Concept
% 211.76/211.92  |- skos__hiddenLabel mesh__D009144 Museum
% 211.76/211.92  |- mesh__recordOriginator mesh__D009144 NLM
% 211.76/211.92  |- mesh__recordAuthorizer mesh__D009144 sjn
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D009144 2005
% 211.76/211.92  |- mesh__dateCreated mesh__D009144 1999-01-01
% 211.76/211.92  |- skos__annotation mesh__D009144
% 211.76/211.92       medical museums: do not coord with MEDICINE   
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D009144 2006
% 211.76/211.92  |- mesh__dateRevised mesh__D009144 2004-07-07
% 211.76/211.92  |- skos__prefLabel mesh__D009144 Museums
% 211.76/211.92  |- mesh__recordMaintainer mesh__D009144 jls
% 211.76/211.92  |- mesh__recordMaintainer mesh__D001161 lkt
% 211.76/211.92  |- skos__related mesh__D001161smesh__D017073
% 211.76/211.92  |- skos__related mesh__D001161smesh__D004036
% 211.76/211.92  |- mesh__historyNote mesh__D001161 1964   
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D001161 2006
% 211.76/211.92  |- mesh__publicMeSHNote mesh__D001161 1964   
% 211.76/211.92  |- mesh__dateCreated mesh__D001161 1999-01-01
% 211.76/211.92  |- skos__scopeNote mesh__D001161
% 211.76/211.92       Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.%A%    
% 211.76/211.92  |- rdf__type mesh__D001161sskos__Concept
% 211.76/211.92  |- mesh__recordAuthorizer mesh__D001161 sjn
% 211.76/211.92  |- mesh__recordOriginator mesh__D001161 NLM
% 211.76/211.92  |- skos__annotation mesh__D001161
% 211.76/211.92       general; prefer specifics; do not confuse with ARTERIOLOSCLEROSIS%A%  
% 211.76/211.92  |- skos__related mesh__D001161smesh__D017700
% 211.76/211.92  |- skos__broader mesh__D001161smesh__D001157
% 211.76/211.92  |- skos__prefLabel mesh__D001161 Arteriosclerosis
% 211.76/211.92  |- mesh__dateRevised mesh__D001161 2005-06-30
% 211.76/211.92  |- skos__hiddenLabel mesh__D001161 Arterioscleroses
% 211.76/211.92  |- skos__broader mesh__D006903Q000037smesh__D006903
% 211.76/211.92  |- mesh__preferredCombination mesh__D006903Q000037smesh__D019161
% 211.76/211.92  |- rdf__type mesh__D006903Q000037smesh__CompoundConcept
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014887 2002
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014887 2006
% 211.76/211.92  |- skos__annotation mesh__D014887
% 211.76/211.92       no qualif; do not confuse X ref FOG with SMOG, a mixture of smoke %26% fog%A%  
% 211.76/211.92  |- mesh__recordAuthorizer mesh__D014887 SJN
% 211.76/211.92  |- mesh__recordMaintainer mesh__D014887 TGC
% 211.76/211.92  |- mesh__recordOriginator mesh__D014887 NLM
% 211.76/211.92  |- skos__broader mesh__D014887smesh__D001272
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014887 2003
% 211.76/211.92  |- mesh__dateRevised mesh__D014887 1997-06-20
% 211.76/211.92  |- rdf__type mesh__D014887sskos__Concept
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014887 1998
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014887 2000
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014887 2004
% 211.76/211.92  |- skos__prefLabel mesh__D014887 Weather
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014887 1999
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014887 2001
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014887 2005
% 211.76/211.92  |- mesh__dateCreated mesh__D014887 1999-01-01
% 211.76/211.92  |- skos__hiddenLabel mesh__D014887 Fogs
% 211.76/211.92  |- skos__broader mesh__D014089smesh__D003813
% 211.76/211.92  |- skos__hiddenLabel mesh__D014089 Remineralization, Tooth
% 211.76/211.92  |- mesh__onlineNote mesh__D014089 search TOOTH CALCIFICATION 1966-84   
% 211.76/211.92  |- skos__historyNote mesh__D014089 Tooth Calcification %28%1966-1984%29%
% 211.76/211.92  |- mesh__recordAuthorizer mesh__D014089 PLS
% 211.76/211.92  |- mesh__dateRevised mesh__D014089 1992-05-18
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014089 1995
% 211.76/211.92  |- mesh__dateCreated mesh__D014089 1984-04-30
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014089 2006
% 211.76/211.92  |- skos__prefLabel mesh__D014089 Tooth Remineralization
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014089 2001
% 211.76/211.92  |- mesh__historyNote mesh__D014089
% 211.76/211.92       85; was see TOOTH CALCIFICATION 1975-84; was see under TOOTH CALCIFICATION 1969-74%A%  
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014089 1993
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014089 1994
% 211.76/211.92  |- mesh__recordOriginator mesh__D014089 RC
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014089 2005
% 211.76/211.92  |- mesh__publicMeSHNote mesh__D014089
% 211.76/211.92       85; was see TOOTH CALCIFICATION 1975-84; was see under TOOTH CALCIFICATION 1969-74%A%  
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014089 2004
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014089 1999
% 211.76/211.92  |- mesh__dateEstablished mesh__D014089 1985-01-01
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014089 2000
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014089 2003
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014089 1998
% 211.76/211.92  |- rdf__type mesh__D014089sskos__Concept
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014089 1997
% 211.76/211.92  |- skos__annotation mesh__D014089
% 211.76/211.92       note category: replacement of minerals in partially decalcified teeth%A%  
% 211.76/211.92  |- mesh__recordMaintainer mesh__D014089 TAP
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014089 1996
% 211.76/211.92  |- skos__scopeNote mesh__D014089
% 211.76/211.92       Therapeutic technique for replacement of minerals in partially decalcified teeth.%A%    
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D014089 2002
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000867 1999
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000867 1997
% 211.76/211.92  |- skos__broader mesh__D000867smesh__D000869
% 211.76/211.92  |- mesh__dateEstablished mesh__D000867 1966-01-01
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000867 2000
% 211.76/211.92  |- mesh__recordAuthorizer mesh__D000867 PLS
% 211.76/211.92  |- skos__hiddenLabel mesh__D000867 Anterior Chambers
% 211.76/211.92  |- rdf__type mesh__D000867sskos__Concept
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000867 2005
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000867 2001
% 211.76/211.92  |- skos__hiddenLabel mesh__D000867 Chamber, Anterior
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000867 2003
% 211.76/211.92  |- skos__scopeNote mesh__D000867
% 211.76/211.92       The space in the eye, filled with aqueous humor, bounded anteriorly by the cornea and a small portion of the sclera and posteriorly by a small portion of the ciliary body, the iris, and that part of the crystalline lens which presents through the pupil. %28%Cline et al., Dictionary of Visual Science, 4th ed, p109%29%%A%    
% 211.76/211.92  |- skos__annotation mesh__D000867
% 211.76/211.92       the space between the cornea %26% lens which contains the aqueous humor; do not confuse with ANTERIOR EYE SEGMENT; hemorrhage within anterior chamber = HYPHEMA; anterior chamber endothelium = ENDOTHELIUM, ANTERIOR CHAMBER see ENDOTHELIUM, CORNEAL%A%  
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000867 2006
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000867 2002
% 211.76/211.92  |- mesh__dateRevised mesh__D000867 1995-05-18
% 211.76/211.92  |- mesh__recordMaintainer mesh__D000867 TGC
% 211.76/211.92  |- mesh__publicMeSHNote mesh__D000867
% 211.76/211.92       66; was see under AQUEOUS HUMOR 1963-65   
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000867 2004
% 211.76/211.92  |- skos__hiddenLabel mesh__D000867 Chambers, Anterior
% 211.76/211.92  |- mesh__historyNote mesh__D000867
% 211.76/211.92       66%28%64%29%; was see under AQUEOUS HUMOR 1963-65   
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000867 1998
% 211.76/211.92  |- skos__prefLabel mesh__D000867 Anterior Chamber
% 211.76/211.92  |- mesh__recordOriginator mesh__D000867 NLM
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000867 1996
% 211.76/211.92  |- mesh__dateCreated mesh__D000867 1999-01-01
% 211.76/211.92  |- skos__altLabel mesh__D019572 Neoplasms, Retinal
% 211.76/211.92  |- skos__broader mesh__D019572smesh__D005134
% 211.76/211.92  |- mesh__historyNote mesh__D019572 98   
% 211.76/211.92  |- skos__altLabel mesh__D019572 Retinal Tumors
% 211.76/211.92  |- mesh__publicMeSHNote mesh__D019572 98   
% 211.76/211.92  |- skos__altLabel mesh__D019572 Cancer, Retinal
% 211.76/211.92  |- skos__hiddenLabel mesh__D019572 Neoplasm, Retinal
% 211.76/211.92  |- skos__hiddenLabel mesh__D019572 Tumor, Retinal
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D019572 2005
% 211.76/211.92  |- mesh__recordMaintainer mesh__D019572 nns
% 211.76/211.92  |- mesh__dateRevised mesh__D019572 2004-07-07
% 211.76/211.92  |- skos__historyNote mesh__D019572 Eye Neoplasms %28%1968-1997%29%
% 211.76/211.92  |- skos__scopeNote mesh__D019572 Tumors or cancer of the RETINA.     
% 211.76/211.92  |- skos__hiddenLabel mesh__D019572 Retinal Tumor
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D019572 2006
% 211.76/211.92  |- mesh__dateEstablished mesh__D019572 1998-01-01
% 211.76/211.92  |- skos__prefLabel mesh__D019572 Retinal Neoplasms
% 211.76/211.92  |- skos__historyNote mesh__D019572 Retinal Diseases %28%1973-1997%29%
% 211.76/211.92  |- mesh__dateCreated mesh__D019572 1997-06-20
% 211.76/211.92  |- skos__altLabel mesh__D019572 Cancer of the Retina
% 211.76/211.92  |- skos__broader mesh__D019572smesh__D012164
% 211.76/211.92  |- rdf__type mesh__D019572sskos__Concept
% 211.76/211.92  |- skos__hiddenLabel mesh__D019572 Retinal Cancers
% 211.76/211.92  |- skos__hiddenLabel mesh__D019572 Cancers, Retinal
% 211.76/211.92  |- skos__historyNote mesh__D019572 Retinoblastoma %28%1968-1997%29%
% 211.76/211.92  |- skos__historyNote mesh__D019572 Retina %28%1969-1978%29%
% 211.76/211.92  |- skos__altLabel mesh__D019572 Tumors, Retinal
% 211.76/211.92  |- skos__related mesh__D019572smesh__D012175
% 211.76/211.92  |- skos__annotation mesh__D019572
% 211.76/211.92       coordinate IM with histologic type of neoplasm %28%IM%29% but majority will be RETINOBLASTOMA%A%  
% 211.76/211.92  |- mesh__recordOriginator mesh__D019572 TGC
% 211.76/211.92  |- skos__hiddenLabel mesh__D019572 Retinal Neoplasm
% 211.76/211.92  |- mesh__recordAuthorizer mesh__D019572 sjn
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000069 2002
% 211.76/211.92  |- mesh__recordAuthorizer mesh__D000069 PLS
% 211.76/211.92  |- skos__hiddenLabel mesh__D000069 Assimilations
% 211.76/211.92  |- mesh__onlineNote mesh__D000069
% 211.76/211.92       use ACCULTURATION to search ASSIMILATION 1968-82   
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000069 2003
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000069 2005
% 211.76/211.92  |- skos__prefLabel mesh__D000069 Acculturation
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000069 2004
% 211.76/211.92  |- mesh__dateCreated mesh__D000069 1999-01-01
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000069 2006
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000069 2000
% 211.76/211.92  |- mesh__dateRevised mesh__D000069 1991-11-02
% 211.76/211.92  |- mesh__historyNote mesh__D000069
% 211.76/211.92       ASSIMILATION was see under ACCULTURATION 1968-82   
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000069 1996
% 211.76/211.92  |- skos__scopeNote mesh__D000069
% 211.76/211.92       Process of cultural change in which one group or members of a group assimilates various cultural patterns from another.%A%    
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000069 2001
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000069 1998
% 211.76/211.92  |- skos__hiddenLabel mesh__D000069 Acculturations
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000069 1997
% 211.76/211.92  |- skos__annotation mesh__D000069 no qualif   
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000069 1992
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000069 1994
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000069 1999
% 211.76/211.92  |- skos__broader mesh__D000069smesh__D003469
% 211.76/211.92  |- rdf__type mesh__D000069sskos__Concept
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000069 1993
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D000069 1995
% 211.76/211.92  |- mesh__recordMaintainer mesh__D000069 PLS
% 211.76/211.92  |- mesh__recordOriginator mesh__D000069 NLM
% 211.76/211.92  |- mesh__historyNote mesh__D005552 68   
% 211.76/211.92  |- mesh__recordAuthorizer mesh__D005552 sjn
% 211.76/211.92  |- skos__annotation mesh__D005552
% 211.76/211.92       non-primate vertebrates only: for human use ARM; for invertebrates use EXTREMITIES; TN 75: animal extremities; TN 117: table of animal extremities%A%  
% 211.76/211.92  |- mesh__recordOriginator mesh__D005552 EC
% 211.76/211.92  |- skos__prefLabel mesh__D005552 Forelimb
% 211.76/211.92  |- skos__historyNote mesh__D005552 Extremities %28%1966-1967%29%
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D005552 2005
% 211.76/211.92  |- rdf__type mesh__D005552sskos__Concept
% 211.76/211.92  |- skos__scopeNote mesh__D005552
% 211.76/211.92       A front limb of a quadruped. %28%The Random House College Dictionary, 1980%29%%A%    
% 211.76/211.92  |- skos__broader mesh__D005552smesh__D000825
% 211.76/211.92  |- mesh__recordMaintainer mesh__D005552 sjn
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D005552 2006
% 211.76/211.92  |- mesh__publicMeSHNote mesh__D005552 68   
% 211.76/211.92  |- mesh__dateEstablished mesh__D005552 1968-01-01
% 211.76/211.92  |- skos__hiddenLabel mesh__D005552 Forelimbs
% 211.76/211.92  |- mesh__dateCreated mesh__D005552 1978-03-29
% 211.76/211.92  |- mesh__dateRevised mesh__D005552 2004-07-13
% 211.76/211.92  |- skos__annotation mesh__D046969
% 211.76/211.92       infection: coordinate IM with CLOSTRIDIUM INFECTIONS %28%IM%29%%A%  
% 211.76/211.92  |- skos__prefLabel mesh__D046969 Clostridium acetobutylicum
% 211.76/211.92  |- mesh__dateCreated mesh__D046969 2004-07-07
% 211.76/211.92  |- skos__historyNote mesh__D046969 Clostridium %28%1966-2004%29%
% 211.76/211.92  |- mesh__historyNote mesh__D046969 2005   
% 211.76/211.92  |- skos__broader mesh__D046969smesh__D003013
% 211.76/211.92  |- mesh__dateEstablished mesh__D046969 2005-01-01
% 211.76/211.92  |- mesh__recordOriginator mesh__D046969 ags
% 211.76/211.92  |- rdf__type mesh__D046969sskos__Concept
% 211.76/211.92  |- mesh__recordAuthorizer mesh__D046969 sjn
% 211.76/211.92  |- mesh__recordMaintainer mesh__D046969 SYSTEM
% 211.76/211.92  |- mesh__dateRevised mesh__D046969 2005-06-30
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D046969 2006
% 211.76/211.92  |- skos__scopeNote mesh__D046969
% 211.76/211.92       A species of gram-positive bacteria in the family Clostridiaceae, used for the industrial production of SOLVENTS.%A%    
% 211.76/211.92  |- mesh__publicMeSHNote mesh__D046969 2005   
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D010497 2004
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D010497 1997
% 211.76/211.92  |- mesh__dateCreated mesh__D010497 1999-01-01
% 211.76/211.92  |- rdf__type mesh__D010497sskos__Concept
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D010497 2003
% 211.76/211.92  |- skos__prefLabel mesh__D010497 Pericoronitis
% 211.76/211.92  |- mesh__dateEstablished mesh__D010497 1965-01-01
% 211.76/211.92  |- mesh__recordOriginator mesh__D010497 NLM
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D010497 1996
% 211.76/211.92  |- mesh__publicMeSHNote mesh__D010497 65   
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D010497 1995
% 211.76/211.92  |- skos__annotation mesh__D010497
% 211.76/211.92       inflamm of gingiva surrounding crown of tooth   
% 211.76/211.92  |- skos__hiddenLabel mesh__D010497 Pericoronitides
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D010497 2002
% 211.76/211.92  |- mesh__dateRevised mesh__D010497 1993-06-02
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D010497 1994
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D010497 2006
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D010497 1999
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D010497 2001
% 211.76/211.92  |- mesh__recordMaintainer mesh__D010497 TGC
% 211.76/211.92  |- skos__broader mesh__D010497smesh__D005882
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D010497 2005
% 211.76/211.92  |- mesh__recordAuthorizer mesh__D010497 PLS
% 211.76/211.92  |- skos__scopeNote mesh__D010497
% 211.76/211.92       Inflammation of the gingiva surrounding the crown of a tooth.%A%    
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D010497 1998
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D010497 2000
% 211.76/211.92  |- mesh__historyNote mesh__D010497 65   
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D015980 2000
% 211.76/211.92  |- skos__broader mesh__D015980smesh__D011634
% 211.76/211.92  |- skos__hiddenLabel mesh__D015980 Practice, Public Health
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D015980 2003
% 211.76/211.92  |- skos__prefLabel mesh__D015980 Public Health Practice
% 211.76/211.92  |- mesh__recordAuthorizer mesh__D015980 SJN
% 211.76/211.92  |- mesh__publicMeSHNote mesh__D015980 98   
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D015980 2001
% 211.76/211.92  |- skos__scopeNote mesh__D015980
% 211.76/211.92       The activities and endeavors of the public health services in a community on any level.%A%    
% 211.76/211.92  |- rdf__type mesh__D015980sskos__Concept
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D015980 2005
% 211.76/211.92  |- mesh__historyNote mesh__D015980 98; use explode 1990-97   
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D015980 2004
% 211.76/211.92  |- skos__hiddenLabel mesh__D015980 Health Practices, Public
% 211.76/211.92  |- skos__hiddenLabel mesh__D015980 Public Health Practices
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D015980 2006
% 211.76/211.92  |- skos__historyNote mesh__D015980 Public Health %28%1966-1997%29%
% 211.76/211.92  |- skos__annotation mesh__D015980 GEN or unspecified; prefer specifics   
% 211.76/211.92  |- skos__historyNote mesh__D015980
% 211.76/211.92       Public Health Administration %28%1968-1997%29%
% 211.76/211.92  |- mesh__dateCreated mesh__D015980 1989-05-25
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D015980 2002
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D015980 1998
% 211.76/211.92  |- skos__hiddenLabel mesh__D015980 Practices, Public Health
% 211.76/211.92  |- mesh__dateRevised mesh__D015980 1997-06-20
% 211.76/211.92  |- mesh__recordOriginator mesh__D015980 PLS
% 211.76/211.92  |- mesh__recordMaintainer mesh__D015980 TGC
% 211.76/211.92  |- mesh__dateEstablished mesh__D015980 1998-01-01
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D015980 1999
% 211.76/211.92  |- skos__hiddenLabel mesh__D015980 Health Practice, Public
% 211.76/211.92  |- skos__historyNote mesh__D015182
% 211.76/211.92       Radiotherapy, High Energy %28%1966-1988%29%
% 211.76/211.92  |- skos__altLabel mesh__D015182 Irradiation, Lymphoid
% 211.76/211.92  |- skos__altLabel mesh__D015182 Lymphatic Radiotherapy
% 211.76/211.92  |- skos__altLabel mesh__D015182 Irradiation, Lymphatic
% 211.76/211.92  |- skos__broader mesh__D015182smesh__D011878
% 211.76/211.92  |- skos__hiddenLabel mesh__D015182 Radiation Therapies, Lymphatic
% 211.76/211.92  |- skos__altLabel mesh__D015182 Lymphatic Radiation Therapy
% 211.76/211.92  |- rdf__type mesh__D015182sskos__Concept
% 211.76/211.92  |- skos__altLabel mesh__D015182 Radiotherapy, Lymphatic
% 211.76/211.92  |- mesh__dateRevised mesh__D015182 2005-06-30
% 211.76/211.92  |- skos__hiddenLabel mesh__D015182 Radiotherapies, Lymphatic
% 211.76/211.92  |- mesh__dateCreated mesh__D015182 1988-04-18
% 211.76/211.92  |- mesh__recordMaintainer mesh__D015182 lkt
% 211.76/211.92  |- skos__prefLabel mesh__D015182 Lymphatic Irradiation
% 211.76/211.92  |- mesh__publicMeSHNote mesh__D015182 89   
% 211.76/211.92  |- skos__altLabel mesh__D015182 Therapy, Lymphatic Radiation
% 211.76/211.92  |- mesh__dateEstablished mesh__D015182 1989-01-01
% 211.76/211.92  |- mesh__recordOriginator mesh__D015182 EJB
% 211.76/211.92  |- mesh__recordAuthorizer mesh__D015182 sjn
% 211.76/211.92  |- skos__hiddenLabel mesh__D015182 Lymphatic Radiation Therapies
% 211.76/211.92  |- mesh__historyNote mesh__D015182 89   
% 211.76/211.92  |- skos__hiddenLabel mesh__D015182 Lymphatic Irradiations
% 211.76/211.92  |- skos__historyNote mesh__D015182 Radiotherapy %28%1966-1988%29%
% 211.76/211.92  |- skos__hiddenLabel mesh__D015182 Therapies, Lymphatic Radiation
% 211.76/211.92  |- skos__annotation mesh__D015182
% 211.76/211.92       ionizing; a radiother procedure: do not confuse with eff of rad on lymphatic system or lymph nodes %28% = LYMPHATIC SYSTEM /rad eff or LYMPH NODES /rad eff%29%; do not use /util except by MeSH definition%A%  
% 211.76/211.92  |- skos__hiddenLabel mesh__D015182 Lymphoid Irradiations
% 211.76/211.92  |- skos__historyNote mesh__D015182 Radiotherapy Dosage %28%1966-1988%29%
% 211.76/211.92  |- mesh__activeMeSHYear mesh__D015182 2006
% 211.76/211.92  |- skos__hiddenLabel mesh__D015182 Irradiations, Lymphatic
% 211.76/211.93  |- skos__hiddenLabel mesh__D015182 Irradiations, Lymphoid
% 211.76/211.93  |- skos__hiddenLabel mesh__D015182 Lymphatic Radiotherapies
% 211.76/211.93  |- skos__scopeNote mesh__D015182
% 211.76/211.93       External or interstitial irradiation to treat lymphomas %28%e.g., Hodgkin%27%s and non-Hodgkin%27%s lymphomas%29% and lymph node metastases and also some autoimmune diseases, such as rheumatoid arthritis.%A%    
% 211.76/211.93  |- skos__altLabel mesh__D015182 Lymphoid Irradiation
% 211.76/211.93  |- skos__historyNote mesh__D009943 Phosphorus %28%1966-1970%29%
% 211.76/211.93  |- skos__scopeNote mesh__D009943
% 211.76/211.93       Organic compounds that contain phosphorus as an integral part of the molecule.%A%    
% 211.76/211.93  |- skos__hiddenLabel mesh__D009943 Compounds, Organophosphorus
% 211.76/211.93  |- skos__broader mesh__D009943smesh__D009930
% 211.76/211.93  |- skos__related mesh__D009943smesh__D017553
% 211.76/211.93  |- rdf__type mesh__D009943sskos__Concept
% 211.76/211.93  |- mesh__recordAuthorizer mesh__D009943 sjn
% 211.76/211.93  |- skos__related mesh__D009943smesh__D019606
% 211.76/211.93  |- skos__annotation mesh__D009943
% 211.76/211.93       /antag permitted but consider also CHOLINESTERASE REACTIVATORS; DF: ORGANOPHOSPHORUS CPDS%A%  
% 211.76/211.93  |- skos__hiddenLabel mesh__D009943 Compounds, Organopyrophosphorus
% 211.76/211.93  |- skos__historyNote mesh__D009943 Phosphorous Acids %28%1968-1970%29%
% 211.76/211.93  |- skos__historyNote mesh__D009943 Phosphates %28%1966-1970%29%
% 211.76/211.93  |- mesh__dateCreated mesh__D009943 1999-01-01
% 211.76/211.93  |- skos__historyNote mesh__D009943 Phosphoric Acids %28%1968-1970%29%
% 211.76/211.93  |- mesh__dateRevised mesh__D009943 2004-07-07
% 211.76/211.93  |- skos__related mesh__D009943smesh__D002801
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D009943 2005
% 211.76/211.93  |- mesh__recordMaintainer mesh__D009943 ssb
% 211.76/211.93  |- skos__historyNote mesh__D009943 Phosphonic Acids %28%1966-1970%29%
% 211.76/211.93  |- mesh__historyNote mesh__D009943 72%28%71%29%   
% 211.76/211.93  |- skos__prefLabel mesh__D009943 Organophosphorus Compounds
% 211.76/211.93  |- mesh__recordOriginator mesh__D009943 NLM
% 211.76/211.93  |- mesh__publicMeSHNote mesh__D009943 72   
% 211.76/211.93  |- skos__related mesh__D009943smesh__D002800
% 211.76/211.93  |- mesh__dateEstablished mesh__D009943 1972-01-01
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D009943 2006
% 211.76/211.93  |- skos__hiddenLabel mesh__D001960 Bromazepam Roche Brand
% 211.76/211.93  |- skos__altLabel mesh__D001960 Genpharm Brand of Bromazepam
% 211.76/211.93  |- skos__altLabel mesh__D001960 betapharm Brand of Bromazepam
% 211.76/211.93  |- skos__altLabel mesh__D001960 Lexatin
% 211.76/211.93  |- skos__altLabel mesh__D001960 neuraxpharm Brand of Bromazepam
% 211.76/211.93  |- skos__altLabel mesh__D001960 Apotex Brand of Bromazepam
% 211.76/211.93  |- skos__historyNote mesh__D001960 Benzodiazepinones %28%1974%29%
% 211.76/211.93  |- skos__hiddenLabel mesh__D001960 Apo Bromazepam
% 211.76/211.93  |- mesh__recordOriginator mesh__D001960 SJJ
% 211.76/211.93  |- skos__broader mesh__D001960smesh__D001570
% 211.76/211.93  |- mesh__dateCreated mesh__D001960 1974-11-19
% 211.76/211.93  |- skos__altLabel mesh__D001960 Aliud Brand of Bromazepam
% 211.76/211.93  |- mesh__recordMaintainer mesh__D001960 CCR
% 211.76/211.93  |- mesh__historyNote mesh__D001960
% 211.76/211.93       91%28%75%29%; was see under BENZODIAZEPINE TRANQUILIZERS 1975-90%A%  
% 211.76/211.93  |- rdf__type mesh__D001960sskos__Concept
% 211.76/211.93  |- skos__altLabel mesh__D001960 Heumann Brand of Bromazepam
% 211.76/211.93  |- skos__altLabel mesh__D001960 Lexomil
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D001960 2006
% 211.76/211.93  |- skos__altLabel mesh__D001960 Roche Brand of Bromazepam
% 211.76/211.93  |- skos__altLabel mesh__D001960 ct-Arzneimittel Brand of Bromazepam
% 211.76/211.93  |- skos__altLabel mesh__D001960 Merck dura Brand of Bromazepam
% 211.76/211.93  |- skos__altLabel mesh__D001960 Lexotanil
% 211.76/211.93  |- skos__hiddenLabel mesh__D001960 ct Arzneimittel Brand of Bromazepam
% 211.76/211.93  |- skos__historyNote mesh__D001960 Pyridines %28%1974%29%
% 211.76/211.93  |- skos__altLabel mesh__D001960 Lichtenstein Brand of Bromazepam
% 211.76/211.93  |- mesh__dateEstablished mesh__D001960 1991-01-01
% 211.76/211.93  |- skos__hiddenLabel mesh__D001960 Ro 53350
% 211.76/211.93  |- skos__hiddenLabel mesh__D001960 Gen Bromazepam
% 211.76/211.93  |- skos__hiddenLabel mesh__D001960 Bromazepam ratiopharm
% 211.76/211.93  |- mesh__publicMeSHNote mesh__D001960
% 211.76/211.93       91; was see under BENZODIAZEPINE TRANQUILIZERS 1975-90   
% 211.76/211.93  |- skos__altLabel mesh__D001960 Irex Brand of Bromazepam
% 211.76/211.93  |- mesh__recordAuthorizer mesh__D001960 sjn
% 211.76/211.93  |- skos__altLabel mesh__D001960 1A Brand of Bromazepam
% 211.76/211.93  |- mesh__dateRevised mesh__D001960 2005-06-30
% 211.76/211.93  |- skos__scopeNote mesh__D001960
% 211.76/211.93       One of the BENZODIAZEPINES that is used in the treatment of ANXIETY DISORDERS.%A%    
% 211.76/211.93  |- skos__altLabel mesh__D001960 ratiopharm Brand of Bromazepam
% 211.76/211.93  |- skos__altLabel mesh__D001960 Hexal Brand of Bromazepam
% 211.76/211.93  |- skos__prefLabel mesh__D001960 Bromazepam
% 211.76/211.93  |- skos__hiddenLabel mesh__D001960 Bromazepam Lichtenstein Brand
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D009145 2005
% 211.76/211.93  |- skos__broader mesh__D009145smesh__D015651
% 211.76/211.93  |- skos__historyNote mesh__D009145 Mushrooms %28%1966-1967%29%
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D009145 1994
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D009145 1993
% 211.76/211.93  |- mesh__dateCreated mesh__D009145 1999-01-01
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D009145 1999
% 211.76/211.93  |- skos__scopeNote mesh__D009145
% 211.76/211.93       Poisoning from ingestion of mushrooms, primarily from, but not restricted to, toxic varieties.%A%    
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D009145 2006
% 211.76/211.93  |- skos__broader mesh__D009145smesh__D005517
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D009145 1995
% 211.76/211.93  |- mesh__historyNote mesh__D009145 68   
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D009145 2002
% 211.76/211.93  |- skos__historyNote mesh__D009145 Food Poisoning %28%1966-1967%29%
% 211.76/211.93  |- skos__hiddenLabel mesh__D009145 Poisonings, Mushroom
% 211.76/211.93  |- skos__related mesh__D009145smesh__D009183
% 211.76/211.93  |- skos__altLabel mesh__D009145 Poisoning, Mushroom
% 211.76/211.93  |- mesh__dateRevised mesh__D009145 1992-05-15
% 211.76/211.93  |- mesh__dateEstablished mesh__D009145 1968-01-01
% 211.76/211.93  |- mesh__recordAuthorizer mesh__D009145 PLS
% 211.76/211.93  |- skos__annotation mesh__D009145
% 211.76/211.93       = pois by mushroom toxins; TN 133: relation to food pois from canned mushrooms%A%  
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D009145 2000
% 211.76/211.93  |- mesh__recordMaintainer mesh__D009145 TGC
% 211.76/211.93  |- mesh__recordOriginator mesh__D009145 NLM
% 211.76/211.93  |- rdf__type mesh__D009145sskos__Concept
% 211.76/211.93  |- skos__hiddenLabel mesh__D009145 Mushroom Poisonings
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D009145 1996
% 211.76/211.93  |- mesh__publicMeSHNote mesh__D009145 68   
% 211.76/211.93  |- skos__prefLabel mesh__D009145 Mushroom Poisoning
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D009145 2003
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D009145 1997
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D009145 2001
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D009145 1998
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D009145 2004
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D001162 2003
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D001162 2006
% 211.76/211.93  |- mesh__dateRevised mesh__D001162 2002-07-02
% 211.76/211.93  |- skos__annotation mesh__D001162
% 211.76/211.93       TN 11: relation to other obliterative arterial dis   
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D001162 2004
% 211.76/211.93  |- mesh__dateCreated mesh__D001162 1999-01-01
% 211.76/211.93  |- skos__broader mesh__D001162smesh__D001161
% 211.76/211.93  |- rdf__type mesh__D001162sskos__Concept
% 211.76/211.93  |- skos__prefLabel mesh__D001162 Arteriosclerosis Obliterans
% 211.76/211.93  |- mesh__recordMaintainer mesh__D001162 mdb
% 211.76/211.93  |- mesh__recordOriginator mesh__D001162 NLM
% 211.76/211.93  |- mesh__recordAuthorizer mesh__D001162 sjn
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D001162 2005
% 211.76/211.93  |- skos__hiddenLabel mesh__D001162 Obliterans, Arteriosclerosis
% 211.76/211.93  |- skos__scopeNote mesh__D001162
% 211.76/211.93       Arteriosclerosis in which proliferation of the intima leads to occlusion of the lumen of the arteries.%A%    
% 211.76/211.93  |- mesh__dateRevised mesh__D014888 1992-05-18
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D014888 2003
% 211.76/211.93  |- mesh__recordMaintainer mesh__D014888 TAP
% 211.76/211.93  |- rdf__type mesh__D014888sskos__Concept
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D014888 1998
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D014888 2001
% 211.76/211.93  |- mesh__historyNote mesh__D014888
% 211.76/211.93       79%28%75%29%; was see under INTELLIGENCE TESTS 1963-78   
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D014888 2004
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D014888 1993
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D014888 1999
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D014888 2002
% 211.76/211.93  |- mesh__dateEstablished mesh__D014888 1979-01-01
% 211.76/211.93  |- mesh__publicMeSHNote mesh__D014888
% 211.76/211.93       79; was see under INTELLIGENCE TESTS 1963-78   
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D014888 2005
% 211.76/211.93  |- mesh__dateCreated mesh__D014888 1999-01-01
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D014888 1994
% 211.76/211.93  |- skos__hiddenLabel mesh__D014888 Scales, Wechsler
% 211.76/211.93  |- skos__prefLabel mesh__D014888 Wechsler Scales
% 211.76/211.93  |- mesh__onlineNote mesh__D014888 search INTELLIGENCE TESTS 1966-74   
% 211.76/211.93  |- skos__broader mesh__D014888smesh__D007361
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D014888 2006
% 211.76/211.93  |- mesh__recordOriginator mesh__D014888 NLM
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D014888 1996
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D014888 1995
% 211.76/211.93  |- skos__historyNote mesh__D014888 Intelligence Tests %28% 66-1974%29%
% 211.76/211.93  |- skos__scopeNote mesh__D014888
% 211.76/211.93       Tests designed to measure intellectual functioning in children and adults.%A%    
% 211.76/211.93  |- mesh__recordAuthorizer mesh__D014888 PLS
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D014888 2000
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D014888 1997
% 211.76/211.93  |- skos__altLabel mesh__D019573 Corneal Epithelium
% 211.76/211.93  |- skos__scopeNote mesh__D019573
% 211.76/211.93       Stratified squamous epithelium that covers the outer surface of the CORNEA. It is smooth and contains many free nerve endings.%A%    
% 211.76/211.93  |- mesh__recordOriginator mesh__D019573 TGC
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D019573 2005
% 211.76/211.93  |- skos__annotation mesh__D019573
% 211.76/211.93       do not confuse with ENDOTHELIUM, CORNEAL; do not confuse X ref ANTERIOR CORNEAL EPITHELIUM with ANTERIOR CHAMBER EPITHELIUM see ENDOTHELIUM, CORNEAL%A%  
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D019573 2000
% 211.76/211.93  |- mesh__recordAuthorizer mesh__D019573 sjn
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D019573 2006
% 211.76/211.93  |- skos__altLabel mesh__D019573 Anterior Corneal Epithelium
% 211.76/211.93  |- mesh__dateRevised mesh__D019573 1999-11-03
% 211.76/211.93  |- mesh__publicMeSHNote mesh__D019573 98   
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D019573 2001
% 211.76/211.93  |- rdf__type mesh__D019573sskos__Concept
% 211.76/211.93  |- skos__historyNote mesh__D019573 Epithelium %28%1966-1997%29%
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D019573 2002
% 211.76/211.93  |- skos__altLabel mesh__D019573 Corneal Epithelium, Anterior
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D019573 2003
% 211.76/211.93  |- mesh__dateEstablished mesh__D019573 1998-01-01
% 211.76/211.93  |- skos__broader mesh__D019573smesh__D004848
% 211.76/211.93  |- skos__prefLabel mesh__D019573 Epithelium, Corneal
% 211.76/211.93  |- skos__broader mesh__D019573smesh__D003315
% 211.76/211.93  |- mesh__dateCreated mesh__D019573 1997-06-20
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D019573 2004
% 211.76/211.93  |- skos__historyNote mesh__D019573 Cornea %28%1966-1997%29%
% 211.76/211.93  |- mesh__historyNote mesh__D019573 98   
% 211.76/211.93  |- skos__altLabel mesh__D019573 Epithelium, Anterior Corneal
% 211.76/211.93  |- mesh__recordMaintainer mesh__D019573 KEV
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D000868 2003
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D000868 2006
% 211.76/211.93  |- skos__hiddenLabel mesh__D000868 Syndromes, Anterior Tibial
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D000868 1996
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D000868 2002
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D000868 1999
% 211.76/211.93  |- skos__hiddenLabel mesh__D000868 Compartment Syndromes, Anterior
% 211.76/211.93  |- mesh__dateCreated mesh__D000868 1999-01-01
% 211.76/211.93  |- skos__hiddenLabel mesh__D000868 Syndromes, Anterior Compartment
% 211.76/211.93  |- skos__hiddenLabel mesh__D000868 Anterior Compartment Syndromes
% 211.76/211.93  |- mesh__historyNote mesh__D000868
% 211.76/211.93       91%28%81%29%72; was see under COMPARTMENT SYNDROMES 1981-90; was heading 1972-80%A%  
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D000868 2005
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D000868 1995
% 211.76/211.93  |- mesh__dateRevised mesh__D000868 1993-05-24
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D000868 2001
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D000868 1998
% 211.76/211.93  |- skos__hiddenLabel mesh__D000868 Syndrome, Anterior Tibial
% 211.76/211.93  |- skos__annotation mesh__D000868
% 211.76/211.93       in tibia; note X ref: restricted to anterior muscle   
% 211.76/211.93  |- skos__scopeNote mesh__D000868
% 211.76/211.93       Rapid swelling, increased tension, pain, and ischemic necrosis of the muscles of the anterior tibial compartment of the leg, often following excessive exertion.%A%    
% 211.76/211.93  |- skos__historyNote mesh__D000868 Muscular Diseases %28%1966-1971%29%
% 211.76/211.93  |- skos__hiddenLabel mesh__D000868 Compartment Syndrome, Anterior
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D000868 2000
% 211.76/211.93  |- skos__broader mesh__D000868smesh__D003161
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D000868 1994
% 211.76/211.93  |- mesh__recordAuthorizer mesh__D000868 PLS
% 211.76/211.93  |- skos__altLabel mesh__D000868 Anterior Tibial Syndrome
% 211.76/211.93  |- skos__hiddenLabel mesh__D000868 Syndrome, Anterior Compartment
% 211.76/211.93  |- mesh__recordMaintainer mesh__D000868 TGC
% 211.76/211.93  |- skos__hiddenLabel mesh__D000868 Tibial Syndrome, Anterior
% 211.76/211.93  |- mesh__publicMeSHNote mesh__D000868
% 211.76/211.93       91,72-80; was see under COMPARTMENT SYNDROMES 1981-90; was heading 1972-80%A%  
% 211.76/211.93  |- skos__historyNote mesh__D000868 Vascular Diseases %28%1966-1971%29%
% 211.76/211.93  |- rdf__type mesh__D000868sskos__Concept
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D000868 2004
% 211.76/211.93  |- skos__prefLabel mesh__D000868 Anterior Compartment Syndrome
% 211.76/211.93  |- mesh__recordOriginator mesh__D000868 NLM
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D000868 1997
% 211.76/211.93  |- skos__hiddenLabel mesh__D000868 Tibial Syndromes, Anterior
% 211.76/211.93  |- skos__hiddenLabel mesh__D000868 Anterior Tibial Syndromes
% 211.76/211.93  |- skos__historyNote mesh__D000868 Tibia %28%1966-1971%29%
% 211.76/211.93  |- mesh__dateEstablished mesh__D000868 1972-01-01
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D011590 1997
% 211.76/211.93  |- mesh__dateCreated mesh__D011590 1999-01-01
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D011590 2002
% 211.76/211.93  |- mesh__recordMaintainer mesh__D011590 KEV
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D011590 2005
% 211.76/211.93  |- skos__hiddenLabel mesh__D011590 Industrial Psychologies
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D011590 1996
% 211.76/211.93  |- skos__hiddenLabel mesh__D011590 Psychologies, Industrial
% 211.76/211.93  |- skos__broader mesh__D011590smesh__D011584
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D011590 1999
% 211.76/211.93  |- rdf__type mesh__D011590sskos__Concept
% 211.76/211.93  |- skos__prefLabel mesh__D011590 Psychology, Industrial
% 211.76/211.93  |- mesh__recordOriginator mesh__D011590 NLM
% 211.76/211.93  |- mesh__recordAuthorizer mesh__D011590 PLS
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D011590 2001
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D011590 1998
% 211.76/211.93  |- skos__broader mesh__D011590smesh__D011585
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D011590 2004
% 211.76/211.93  |- skos__scopeNote mesh__D011590
% 211.76/211.93       The branch of applied psychology concerned with the application of psychologic principles and methods to industrial problems including selection and training of workers, working conditions, etc.%A%    
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D011590 2000
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D011590 2003
% 211.76/211.93  |- skos__annotation mesh__D011590 SPEC: SPEC qualif; DF: PSYCHOL INDUST   
% 211.76/211.93  |- skos__related mesh__D011590smesh__D006804
% 211.76/211.93  |- mesh__dateRevised mesh__D011590 1995-05-22
% 211.76/211.93  |- skos__altLabel mesh__D011590 Industrial Psychology
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D011590 2006
% 211.76/211.93  |- skos__altLabel mesh__D005553 Dentistry, Forensic
% 211.76/211.93  |- skos__scopeNote mesh__D005553
% 211.76/211.93       The application of dental knowledge to questions of law.%A%    
% 211.76/211.93  |- skos__prefLabel mesh__D005553 Forensic Dentistry
% 211.76/211.93  |- mesh__recordOriginator mesh__D005553 NLM
% 211.76/211.93  |- rdf__type mesh__D005553sskos__Concept
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D005553 2005
% 211.76/211.93  |- mesh__onlineNote mesh__D005553
% 211.76/211.93       use FORENSIC DENTISTRY %26% FORENSIC MEDICINE to search CRIMINAL INVESTIGATION 1966-74%A%  
% 211.76/211.93  |- mesh__dateCreated mesh__D005553 1999-01-01
% 211.76/211.93  |- mesh__dateRevised mesh__D005553 2004-07-13
% 211.76/211.93  |- mesh__publicMeSHNote mesh__D005553
% 211.76/211.93       65; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY %26% FORENSIC MEDICINE 1965-74; was heading 1963-64%A%  
% 211.76/211.93  |- mesh__recordAuthorizer mesh__D005553 sjn
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D005553 2006
% 211.76/211.93  |- skos__broader mesh__D005553smesh__D003813
% 211.76/211.93  |- skos__annotation mesh__D005553
% 211.76/211.93       SPEC qualif; see note on FORENSIC MEDICINE; for human identif by teeth: coord FORENSIC DENTISTRY %28%IM%29% + specific dent heading %28%IM%29%; DF: FORENSIC DENT%A%  
% 211.76/211.93  |- skos__broader mesh__D005553smesh__D044707
% 211.76/211.93  |- mesh__dateEstablished mesh__D005553 1965-01-01
% 211.76/211.93  |- mesh__historyNote mesh__D005553
% 211.76/211.93       65; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY %26% FORENSIC MEDICINE 1965-74; was heading 1963-64%A%  
% 211.76/211.93  |- mesh__recordMaintainer mesh__D005553 sjn
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D010498 2005
% 211.76/211.93  |- mesh__publicMeSHNote mesh__D010498
% 211.76/211.93       91; was see under LABYRINTHINE FLUIDS 1975-90   
% 211.76/211.93  |- mesh__dateCreated mesh__D010498 1999-01-01
% 211.76/211.93  |- skos__prefLabel mesh__D010498 Perilymph
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D010498 2004
% 211.76/211.93  |- mesh__recordOriginator mesh__D010498 NLM
% 211.76/211.93  |- rdf__type mesh__D010498sskos__Concept
% 211.76/211.93  |- skos__broader mesh__D010498smesh__D007761
% 211.76/211.93  |- skos__hiddenLabel mesh__D010498 Perilymphs
% 211.76/211.93  |- mesh__historyNote mesh__D010498
% 211.76/211.93       91%28%75%29%; was see under LABYRINTHINE FLUIDS 1975-90   
% 211.76/211.93  |- mesh__dateEstablished mesh__D010498 1991-01-01
% 211.76/211.93  |- mesh__recordAuthorizer mesh__D010498 sjn
% 211.76/211.93  |- mesh__dateRevised mesh__D010498 2003-07-09
% 211.76/211.93  |- mesh__recordMaintainer mesh__D010498 nns
% 211.76/211.93  |- mesh__onlineNote mesh__D010498 search LABYRINTHINE FLUIDS 1966-74   
% 211.76/211.93  |- skos__scopeNote mesh__D010498
% 211.76/211.93       The fluid separating the membranous labyrinth from the osseous labyrinth of the ear. It is entirely separate from the ENDOLYMPH which is contained in the membranous labyrinth. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1396, 642%29%%A%    
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D010498 2006
% 211.76/211.93  |- skos__annotation mesh__D010498 a labyrinthine fluid   
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D015981 2003
% 211.76/211.93  |- rdf__type mesh__D015981sskos__Concept
% 211.76/211.93  |- skos__altLabel mesh__D015981 Determinant, Epidemiologic
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D015981 2005
% 211.76/211.93  |- mesh__historyNote mesh__D015981 90   
% 211.76/211.93  |- skos__prefLabel mesh__D015981 Epidemiologic Factors
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D015981 2004
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D015981 2006
% 211.76/211.93  |- mesh__dateCreated mesh__D015981 1989-05-26
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D015981 2000
% 211.76/211.93  |- skos__broader mesh__D015981smesh__D011634
% 211.76/211.93  |- skos__historyNote mesh__D015981 Epidemiology %28%1966-1989%29%
% 211.76/211.93  |- skos__altLabel mesh__D015981 Determinants, Epidemiologic
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D015981 2001
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D015981 1996
% 211.76/211.93  |- skos__altLabel mesh__D015981 Epidemiologic Determinants
% 211.76/211.93  |- skos__altLabel mesh__D015981 Factor, Epidemiologic
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D015981 1998
% 211.76/211.93  |- skos__altLabel mesh__D015981 Epidemiologic Determinant
% 211.76/211.93  |- mesh__recordOriginator mesh__D015981 PLS
% 211.76/211.93  |- mesh__recordMaintainer mesh__D015981 TGC
% 211.76/211.93  |- skos__scopeNote mesh__D015981
% 211.76/211.93       Events, characteristics, or other definable entities that have the potential to bring about a change in a health condition or other defined outcome.%A%    
% 211.76/211.93  |- skos__altLabel mesh__D015981 Factors, Epidemiologic
% 211.76/211.93  |- mesh__dateRevised mesh__D015981 1993-05-27
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D015981 1997
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D015981 1994
% 211.76/211.93  |- skos__broader mesh__D015981smesh__D011787
% 211.76/211.93  |- mesh__dateEstablished mesh__D015981 1990-01-01
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D015981 1999
% 211.76/211.93  |- skos__altLabel mesh__D015981 Epidemiologic Factor
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D015981 1995
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D015981 2002
% 211.76/211.93  |- mesh__publicMeSHNote mesh__D015981 90   
% 211.76/211.93  |- skos__annotation mesh__D015981
% 211.76/211.93       IM GEN only; for epidemiol factors of a disease, index only as disease /epidemiol %28%IM%29%; no qualif; DF: EPIDEMIOL FACTORS%A%  
% 211.76/211.93  |- mesh__recordAuthorizer mesh__D015981 PLS
% 211.76/211.93  |- skos__hiddenLabel mesh__D051306 L Lysine 6 Transaminase
% 211.76/211.93  |- mesh__historyNote mesh__D051306
% 211.76/211.93       2006%28%1980%29% use TRANSAMINASES 1978-1979, %26% KETOGLUTARIC ACIDS 1978-1979%A%  
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D051306 2006A
% 211.76/211.93  |- skos__altLabel mesh__D051306 Lysine 6-Aminotransferase
% 211.76/211.93  |- mesh__recordOriginator mesh__D051306 AKE
% 211.76/211.93  |- skos__scopeNote mesh__D051306
% 211.76/211.93       A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the transfer of amino group of L-LYSINE onto 2-OXOGLUTARATE to generate 2-aminoadipate 6-semialdehyde and L-GLUTAMATE.%A%    
% 211.76/211.93  |- mesh__publicMeSHNote mesh__D051306
% 211.76/211.93       2006; LYSINE 6-AMINOTRANSFERASE was indexed under TRANSAMINASES 1978-2005, %26% under KETOGLUTARIC ACIDS 1978-1980%A%  
% 211.76/211.93  |- skos__altLabel mesh__D051306 Lysine 2-Oxoglutarate 6-Aminotransferase
% 211.76/211.93  |- mesh__dateCreated mesh__D051306 2005-06-30
% 211.76/211.93  |- skos__altLabel mesh__D051306 Lysine epsilon-Transaminase
% 211.76/211.93  |- skos__hiddenLabel mesh__D051306 Lysine epsilon Aminotransferase
% 211.76/211.93  |- skos__hiddenLabel mesh__D051306 epsilon-Transaminase, Lysine
% 211.76/211.93  |- mesh__recordMaintainer mesh__D051306 ags
% 211.76/211.93  |- skos__hiddenLabel mesh__D051306 Lysine 6 Aminotransferase
% 211.76/211.93  |- skos__hiddenLabel mesh__D051306
% 211.76/211.93       6-Aminotransferase, Lysine 2-Oxoglutarate
% 211.76/211.93  |- skos__prefLabel mesh__D051306 L-Lysine 6-Transaminase
% 211.76/211.93  |- rdf__type mesh__D051306sskos__Concept
% 211.76/211.93  |- skos__broader mesh__D051306smesh__D000637
% 211.76/211.93  |- skos__hiddenLabel mesh__D051306 Lysine 2 Oxoglutarate 6 Aminotransferase
% 211.76/211.93  |- skos__altLabel mesh__D051306 Lysine-epsilon Aminotransferase
% 211.76/211.93  |- mesh__recordAuthorizer mesh__D051306 ags
% 211.76/211.93  |- skos__hiddenLabel mesh__D051306 Lysine epsilon Transaminase
% 211.76/211.93  |- skos__hiddenLabel mesh__D051306 6-Aminotransferase, Lysine
% 211.76/211.93  |- skos__hiddenLabel mesh__D051306 6-Transaminase, L-Lysine
% 211.76/211.93  |- skos__hiddenLabel mesh__D051306 Aminotransferase, Lysine-epsilon
% 211.76/211.93  |- mesh__dateEstablished mesh__D051306 2006-01-01
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D051306 2006
% 211.76/211.93  |- mesh__dateRevised mesh__D051306 2005-07-07
% 211.76/211.93  |- skos__altLabel mesh__D051306 Lysine-6-Aminotransferase
% 211.76/211.93  |- skos__hiddenLabel mesh__D051306
% 211.76/211.93       2-Oxoglutarate 6-Aminotransferase, Lysine
% 211.76/211.93  |- skos__hiddenLabel mesh__D015183 Restriction Enzyme Mapping
% 211.76/211.93  |- skos__hiddenLabel mesh__D015183 Restriction Enzyme Analyses
% 211.76/211.93  |- mesh__historyNote mesh__D015183 89   
% 211.76/211.93  |- skos__historyNote mesh__D015183
% 211.76/211.93       DNA Restriction Enzymes %28%1975-1988%29%
% 211.76/211.93  |- skos__hiddenLabel mesh__D015183 Analyses, Restriction Enzyme
% 211.76/211.93  |- mesh__recordAuthorizer mesh__D015183 SJN
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D015183 2006
% 211.76/211.93  |- skos__hiddenLabel mesh__D015183 Enzyme Mappings, Restriction
% 211.76/211.93  |- skos__prefLabel mesh__D015183 Restriction Mapping
% 211.76/211.93  |- skos__altLabel mesh__D015183 Analysis, Restriction Enzyme
% 211.76/211.93  |- skos__hiddenLabel mesh__D015183 Mapping, Restriction
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D015183 2000
% 211.76/211.93  |- skos__hiddenLabel mesh__D015183 Enzyme Analyses, Restriction
% 211.76/211.93  |- skos__altLabel mesh__D015183 Restriction Enzyme Analysis
% 211.76/211.93  |- mesh__publicMeSHNote mesh__D015183 89   
% 211.76/211.93  |- mesh__dateEstablished mesh__D015183 1989-01-01
% 211.76/211.93  |- skos__historyNote mesh__D015183 Chromosome Mapping %28%1966-1988%29%
% 211.76/211.93  |- skos__hiddenLabel mesh__D015183 Site Mappings, Restriction
% 211.76/211.93  |- skos__hiddenLabel mesh__D015183 Restriction Endonuclease Mapping
% 211.76/211.93  |- skos__hiddenLabel mesh__D015183 Mappings, Restriction Endonuclease
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D015183 1999
% 211.76/211.93  |- skos__hiddenLabel mesh__D015183 Restriction Endonuclease Mappings
% 211.76/211.93  |- mesh__dateRevised mesh__D015183 1998-06-11
% 211.76/211.93  |- skos__broader mesh__D015183smesh__D020161
% 211.76/211.93  |- rdf__type mesh__D015183sskos__Concept
% 211.76/211.93  |- skos__hiddenLabel mesh__D015183 Restriction Mappings
% 211.76/211.93  |- skos__altLabel mesh__D015183 Endonuclease Mapping, Restriction
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D015183 2001
% 211.76/211.93  |- skos__hiddenLabel mesh__D015183 Mappings, Restriction Site
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D015183 2003
% 211.76/211.93  |- skos__altLabel mesh__D015183 Enzyme Mapping, Restriction
% 211.76/211.93  |- skos__hiddenLabel mesh__D015183 Restriction Site Mapping
% 211.76/211.93  |- mesh__dateCreated mesh__D015183 1988-04-18
% 211.76/211.93  |- skos__hiddenLabel mesh__D015183 Mappings, Restriction Enzyme
% 211.76/211.93  |- skos__hiddenLabel mesh__D015183 Mapping, Restriction Site
% 211.76/211.93  |- skos__altLabel mesh__D015183 Site Mapping, Restriction
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D015183 2002
% 211.76/211.93  |- skos__hiddenLabel mesh__D015183 Mappings, Restriction
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D015183 2004
% 211.76/211.93  |- skos__scopeNote mesh__D015183
% 211.76/211.93       Use of restriction endonucleases to analyze and generate a physical map of genomes, genes, or other segments of DNA.%A%    
% 211.76/211.93  |- skos__hiddenLabel mesh__D015183 Restriction Site Mappings
% 211.76/211.93  |- skos__hiddenLabel mesh__D015183 Mapping, Restriction Endonuclease
% 211.76/211.93  |- skos__hiddenLabel mesh__D015183 Restriction Enzyme Mappings
% 211.76/211.93  |- skos__hiddenLabel mesh__D015183 Endonuclease Mappings, Restriction
% 211.76/211.93  |- skos__altLabel mesh__D015183 Enzyme Analysis, Restriction
% 211.76/211.93  |- mesh__recordMaintainer mesh__D015183 NDW
% 211.76/211.93  |- skos__historyNote mesh__D015183 Endonucleases %28%1971-1975%29%
% 211.76/211.93  |- mesh__recordOriginator mesh__D015183 EJB
% 211.76/211.93  |- skos__hiddenLabel mesh__D015183 Mapping, Restriction Enzyme
% 211.76/211.93  |- skos__broader mesh__D015183smesh__D005821
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D015183 2005
% 211.76/211.93  |- mesh__dateEstablished mesh__D009944 1978-01-01
% 211.76/211.93  |- mesh__dateRevised mesh__D009944 1992-05-19
% 211.76/211.93  |- skos__broader mesh__D009944smesh__D009942
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D009944 2000
% 211.76/211.93  |- mesh__activeMeSHYear mesh__D009944 1997
% 211.76/211.93  |- rdf__type mesh__D009944sskos__Concept
% 211.76/211.93  |- mesh__historyNote mesh__D009944 78   
% 211.76/211.94  |- mesh__dateCreated mesh__D009944 1977-05-17
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009944 2001
% 211.76/211.94  |- mesh__recordMaintainer mesh__D009944 TAP
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009944 1994
% 211.76/211.94  |- skos__historyNote mesh__D009944
% 211.76/211.94       Organometallic Compounds %28%1968-1977%29%
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009944 2002
% 211.76/211.94  |- mesh__recordAuthorizer mesh__D009944 PLS
% 211.76/211.94  |- skos__prefLabel mesh__D009944 Organoplatinum Compounds
% 211.76/211.94  |- mesh__publicMeSHNote mesh__D009944 78   
% 211.76/211.94  |- skos__annotation mesh__D009944 DF: ORGANOPLATINUM CPDS   
% 211.76/211.94  |- mesh__recordOriginator mesh__D009944 RLS
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009944 1995
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009944 2005
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009944 1998
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009944 1993
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009944 2006
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009944 2003
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009944 1999
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009944 1996
% 211.76/211.94  |- skos__hiddenLabel mesh__D009944 Compounds, Organoplatinum
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009944 2004
% 211.76/211.94  |- skos__scopeNote mesh__D009944
% 211.76/211.94       Organic compounds which contain platinum as an integral part of the molecule.%A%    
% 211.76/211.94  |- skos__historyNote mesh__D009944 Platinum %28%1966-1977%29%
% 211.76/211.94  |- mesh__historyNote mesh__D001961
% 211.76/211.94       91%28%75%29%; was see under CRESOLS 1975-90   
% 211.76/211.94  |- rdf__type mesh__D001961sskos__Concept
% 211.76/211.94  |- skos__historyNote mesh__D001961 Cresols %28%1969-1974%29%
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D001961 2006
% 211.76/211.94  |- skos__prefLabel mesh__D001961 Bromcresol Green
% 211.76/211.94  |- skos__broader mesh__D001961smesh__D014105
% 211.76/211.94  |- skos__hiddenLabel mesh__D001961 Green, Bromocresol
% 211.76/211.94  |- mesh__recordAuthorizer mesh__D001961 sjn
% 211.76/211.94  |- skos__altLabel mesh__D001961 Bromocresol Green
% 211.76/211.94  |- skos__historyNote mesh__D001961 Tosyl Compounds %28%1974%29%
% 211.76/211.94  |- skos__hiddenLabel mesh__D001961 Green, Bromcresol
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D001961 2004
% 211.76/211.94  |- skos__annotation mesh__D001961 D25-26 qualif   
% 211.76/211.94  |- mesh__recordMaintainer mesh__D001961 ssb
% 211.76/211.94  |- mesh__publicMeSHNote mesh__D001961 91; was see under CRESOLS 1975-90   
% 211.76/211.94  |- mesh__dateEstablished mesh__D001961 1991-01-01
% 211.76/211.94  |- mesh__dateCreated mesh__D001961 1974-11-19
% 211.76/211.94  |- skos__altLabel mesh__D001961 Tetrabromocresolsulfonphthalein
% 211.76/211.94  |- skos__historyNote mesh__D001961 Bromine %28%1972-1974%29%
% 211.76/211.94  |- mesh__dateRevised mesh__D001961 2003-07-09
% 211.76/211.94  |- skos__broader mesh__D001961smesh__D003408
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D001961 2005
% 211.76/211.94  |- mesh__recordOriginator mesh__D001961 NLM
% 211.76/211.94  |- skos__broader mesh__D001961smesh__D014050
% 211.76/211.94  |- skos__scopeNote mesh__D001961
% 211.76/211.94       An indicator and reagent. It has been used in serum albumin determinations and as a pH indicator.%A%    
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009146 2001
% 211.76/211.94  |- skos__broader mesh__D009146smesh__D006809
% 211.76/211.94  |- rdf__type mesh__D009146sskos__Concept
% 211.76/211.94  |- mesh__recordMaintainer mesh__D009146 TGC
% 211.76/211.94  |- mesh__dateRevised mesh__D009146 1996-06-10
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009146 2002
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009146 2003
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009146 1997
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009146 1998
% 211.76/211.94  |- skos__hiddenLabel mesh__D009146 Musics
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009146 2004
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009146 2005
% 211.76/211.94  |- mesh__recordAuthorizer mesh__D009146 PLS
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009146 2000
% 211.76/211.94  |- skos__annotation mesh__D009146 music as ther = MUSIC THERAPY   
% 211.76/211.94  |- mesh__recordOriginator mesh__D009146 NLM
% 211.76/211.94  |- mesh__dateCreated mesh__D009146 1999-01-01
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009146 1999
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009146 2006
% 211.76/211.94  |- skos__prefLabel mesh__D009146 Music
% 211.76/211.94  |- skos__hiddenLabel mesh__D001163 Anastomoses, Arteriovenous
% 211.76/211.94  |- mesh__recordMaintainer mesh__D001163 nns
% 211.76/211.94  |- mesh__recordAuthorizer mesh__D001163 sjn
% 211.76/211.94  |- skos__altLabel mesh__D001163 Arteriovenous Anastomoses
% 211.76/211.94  |- mesh__publicMeSHNote mesh__D001163 66   
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D001163 2004
% 211.76/211.94  |- skos__scopeNote mesh__D001163
% 211.76/211.94       A vessel that directly interconnects an artery and a vein, and that acts as a shunt to bypass the capillary bed.  Not to be confused with surgical anastomosis, nor with arteriovenous fistula.%A%    
% 211.76/211.94  |- skos__hiddenLabel mesh__D001163 Anastomosis, Arteriovenous
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D001163 2006
% 211.76/211.94  |- mesh__recordOriginator mesh__D001163 NLM
% 211.76/211.94  |- skos__hiddenLabel mesh__D001163 Anastomose, Arteriovenous
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D001163 2005
% 211.76/211.94  |- skos__prefLabel mesh__D001163 Arteriovenous Anastomosis
% 211.76/211.94  |- rdf__type mesh__D001163sskos__Concept
% 211.76/211.94  |- mesh__dateEstablished mesh__D001163 1966-01-01
% 211.76/211.94  |- skos__broader mesh__D001163smesh__D008833
% 211.76/211.94  |- skos__hiddenLabel mesh__D001163 Arteriovenous Anastomose
% 211.76/211.94  |- mesh__dateRevised mesh__D001163 2003-07-09
% 211.76/211.94  |- mesh__historyNote mesh__D001163 66%28%64%29%   
% 211.76/211.94  |- skos__annotation mesh__D001163
% 211.76/211.94       note category: do not confuse with ARTERIOVENOUS FISTULA; Manual 23.19.6.2%A%  
% 211.76/211.94  |- mesh__dateCreated mesh__D001163 1999-01-01
% 211.76/211.94  |- mesh__recordMaintainer mesh__D019574 lkt
% 211.76/211.94  |- skos__hiddenLabel mesh__D019574 Neoplasm, Optic Nerve
% 211.76/211.94  |- skos__altLabel mesh__D019574 Tumor, Malignant, Optic Nerve
% 211.76/211.94  |- skos__altLabel mesh__D019574 Optic Nerve Neoplasm, Benign
% 211.76/211.94  |- skos__altLabel mesh__D019574 Malignant Optic Nerve Tumor
% 211.76/211.94  |- mesh__historyNote mesh__D019574 98   
% 211.76/211.94  |- mesh__recordOriginator mesh__D019574 TGC
% 211.76/211.94  |- skos__altLabel mesh__D019574 Tumor, Optic Nerve, Malignant
% 211.76/211.94  |- mesh__publicMeSHNote mesh__D019574 98   
% 211.76/211.94  |- skos__altLabel mesh__D019574 Neoplasms, Optic Nerve
% 211.76/211.94  |- mesh__dateCreated mesh__D019574 1997-06-20
% 211.76/211.94  |- skos__altLabel mesh__D019574 Neoplasm, Benign, Optic Nerve
% 211.76/211.94  |- skos__altLabel mesh__D019574 Malignant Optic Nerve Sheath Tumors
% 211.76/211.94  |- skos__historyNote mesh__D019574 Optic Nerve %28%1966-1997%29%
% 211.76/211.94  |- skos__annotation mesh__D019574
% 211.76/211.94       coordinate IM with histologic type of neoplasm %28%IM%29%   
% 211.76/211.94  |- skos__altLabel mesh__D019574 Optic Nerve Sheath Neoplasms, Malignant
% 211.76/211.94  |- skos__altLabel mesh__D019574 Optic Nerve Sheath Tumors, Benign
% 211.76/211.94  |- skos__scopeNote mesh__D019574
% 211.76/211.94       Benign and malignant neoplasms that arise from the optic nerve or its sheath. OPTIC NERVE GLIOMA is the most common histologic type. Optic nerve neoplasms tend to cause unilateral visual loss and an afferent pupillary defect and may spread via neural pathways to the brain.%A%    
% 211.76/211.94  |- skos__historyNote mesh__D019574 Optic Nerve Diseases %28%1978-1997%29%
% 211.76/211.94  |- skos__altLabel mesh__D019574 Tumor, Optic Nerve, Benign
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D019574 2006
% 211.76/211.94  |- mesh__dateRevised mesh__D019574 2005-06-30
% 211.76/211.94  |- mesh__recordAuthorizer mesh__D019574 sjn
% 211.76/211.94  |- skos__altLabel mesh__D019574 Benign Optic Nerve Sheath Tumors
% 211.76/211.94  |- skos__broader mesh__D019574smesh__D003390
% 211.76/211.94  |- skos__altLabel mesh__D019574 Neoplasm, Optic Nerve, Benign
% 211.76/211.94  |- rdf__type mesh__D019574sskos__Concept
% 211.76/211.94  |- skos__altLabel mesh__D019574 Optic Nerve Tumor, Malignant
% 211.76/211.94  |- skos__broader mesh__D019574smesh__D009901
% 211.76/211.94  |- skos__historyNote mesh__D019574
% 211.76/211.94       Cranial Nerve Neoplasms %28%1976-1997%29%
% 211.76/211.94  |- skos__altLabel mesh__D019574 Benign Optic Nerve Tumor
% 211.76/211.94  |- skos__altLabel mesh__D019574 Optic Nerve Sheath Tumors, Malignant
% 211.76/211.94  |- skos__prefLabel mesh__D019574 Optic Nerve Neoplasms
% 211.76/211.94  |- mesh__dateEstablished mesh__D019574 1998-01-01
% 211.76/211.94  |- skos__hiddenLabel mesh__D019574 Optic Nerve Neoplasm
% 211.76/211.94  |- skos__altLabel mesh__D019574 Tumor, Benign, Optic Nerve
% 211.76/211.94  |- skos__altLabel mesh__D019574 Optic Nerve Sheath Tumors
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D000869 2006
% 211.76/211.94  |- skos__hiddenLabel mesh__D000869 Eye Segment, Anterior
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D000869 1994
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D000869 2001
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D000869 2004
% 211.76/211.94  |- skos__broader mesh__D000869smesh__D005123
% 211.76/211.94  |- skos__historyNote mesh__D000869 Cornea %28%1966-1984%29%
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D000869 1992
% 211.76/211.94  |- mesh__recordAuthorizer mesh__D000869 CAB
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D000869 1998
% 211.76/211.94  |- skos__scopeNote mesh__D000869
% 211.76/211.94       That part of the eyeball anterior to the lens.     
% 211.76/211.94  |- mesh__dateRevised mesh__D000869 1984-06-05
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D000869 2002
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D000869 1995
% 211.76/211.94  |- skos__prefLabel mesh__D000869 Anterior Eye Segment
% 211.76/211.94  |- skos__hiddenLabel mesh__D000869 Segments, Anterior Eye
% 211.76/211.94  |- skos__hiddenLabel mesh__D000869 Segment, Anterior Eye
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D000869 1996
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D000869 1990
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D000869 1993
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D000869 1999
% 211.76/211.94  |- mesh__dateCreated mesh__D000869 1984-04-30
% 211.76/211.94  |- mesh__dateEstablished mesh__D000869 1985-01-01
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D000869 1997
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D000869 1991
% 211.76/211.94  |- skos__historyNote mesh__D000869 Anterior Chamber %28%1966-1984%29%
% 211.76/211.94  |- skos__historyNote mesh__D000869 Eye %28%1966-1984%29%
% 211.76/211.94  |- skos__hiddenLabel mesh__D000869 Anterior Eye Segments
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D000869 1989
% 211.76/211.94  |- mesh__recordOriginator mesh__D000869 RC
% 211.76/211.94  |- skos__hiddenLabel mesh__D000869 Eye Segments, Anterior
% 211.76/211.94  |- mesh__publicMeSHNote mesh__D000869 85   
% 211.76/211.94  |- skos__annotation mesh__D000869 do not confuse with ANTERIOR CHAMBER   
% 211.76/211.94  |- rdf__type mesh__D000869sskos__Concept
% 211.76/211.94  |- mesh__recordMaintainer mesh__D000869 RRC
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D000869 2000
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D000869 2005
% 211.76/211.94  |- mesh__historyNote mesh__D000869 85   
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D000869 2003
% 211.76/211.94  |- mesh__dateCreated mesh__D011591 1982-04-26
% 211.76/211.94  |- skos__scopeNote mesh__D011591
% 211.76/211.94       A branch of psychology in which there is collaboration between psychologists and physicians in the management of medical problems. It differs from clinical psychology, which is concerned with the diagnosis and treatment of behavior disorders.%A%    
% 211.76/211.94  |- mesh__recordOriginator mesh__D011591 EC
% 211.76/211.94  |- skos__broader mesh__D011591smesh__D011584
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D011591 1999
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D011591 1992
% 211.76/211.94  |- skos__broader mesh__D011591smesh__D006281
% 211.76/211.94  |- rdf__type mesh__D011591sskos__Concept
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D011591 2002
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D011591 1995
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D011591 1998
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D011591 2004
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D011591 1994
% 211.76/211.94  |- mesh__recordMaintainer mesh__D011591 TAP
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D011591 2003
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D011591 2001
% 211.76/211.94  |- mesh__historyNote mesh__D011591 83   
% 211.76/211.94  |- mesh__recordAuthorizer mesh__D011591 PLS
% 211.76/211.94  |- skos__annotation mesh__D011591 SPEC: SPEC qualif; DF: PSYCHOL MED   
% 211.76/211.94  |- skos__prefLabel mesh__D011591 Psychology, Medical
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D011591 2006
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D011591 1997
% 211.76/211.94  |- skos__altLabel mesh__D011591 Medical Psychology
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D011591 1991
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D011591 2005
% 211.76/211.94  |- mesh__dateRevised mesh__D011591 1990-05-17
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D011591 2000
% 211.76/211.94  |- mesh__publicMeSHNote mesh__D011591 83   
% 211.76/211.94  |- mesh__dateEstablished mesh__D011591 1983-01-01
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D011591 1996
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D011591 1993
% 211.76/211.94  |- rdf__type mesh__D005554sskos__Concept
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D005554 2005
% 211.76/211.94  |- mesh__dateEstablished mesh__D005554 1965-01-01
% 211.76/211.94  |- mesh__dateCreated mesh__D005554 1999-01-01
% 211.76/211.94  |- mesh__historyNote mesh__D005554
% 211.76/211.94       65; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY %26% FORENSIC MEDICINE 1965-74; was heading 1963-64%A%  
% 211.76/211.94  |- mesh__recordMaintainer mesh__D005554 sjn
% 211.76/211.94  |- mesh__publicMeSHNote mesh__D005554
% 211.76/211.94       65; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY %26% FORENSIC MEDICINE 1965-74; was heading 1963-64%A%  
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D005554 2006
% 211.76/211.94  |- skos__broader mesh__D005554smesh__D013040
% 211.76/211.94  |- mesh__recordOriginator mesh__D005554 NLM
% 211.76/211.94  |- mesh__onlineNote mesh__D005554
% 211.76/211.94       use FORENSIC MEDICINE %26% FORENSIC DENTISTRY to search CRIMINAL INVESTIGATION 1966-74%A%  
% 211.76/211.94  |- skos__annotation mesh__D005554
% 211.76/211.94       SPEC qualif; for crime or identification: differentiate from JURISPRUDENCE, usually civil suits; for human identif of skeletal remains see FORENSIC ANTHROPOLOGY; for human identif by teeth see FORENSIC DENTISTRY; ballistics goes under BALLISTICS, WOUND see WOUNDS, GUNSHOT but here also if pertinent; DF: FORENSIC MED%A%  
% 211.76/211.94  |- skos__broader mesh__D005554smesh__D044707
% 211.76/211.94  |- mesh__dateRevised mesh__D005554 2004-07-13
% 211.76/211.94  |- skos__related mesh__D005554smesh__D035846
% 211.76/211.94  |- mesh__recordAuthorizer mesh__D005554 sjn
% 211.76/211.94  |- skos__altLabel mesh__D005554 Medicine, Forensic
% 211.76/211.94  |- skos__scopeNote mesh__D005554
% 211.76/211.94       The application of medical knowledge to questions of law.%A%    
% 211.76/211.94  |- skos__prefLabel mesh__D005554 Forensic Medicine
% 211.76/211.94  |- skos__altLabel mesh__D005554 Legal Medicine
% 211.76/211.94  |- rdf__type mesh__D010499sskos__Concept
% 211.76/211.94  |- skos__annotation mesh__D010499
% 211.76/211.94       do not use /util except by MeSH definition   
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D010499 2000
% 211.76/211.94  |- mesh__recordAuthorizer mesh__D010499 SJN
% 211.76/211.94  |- skos__prefLabel mesh__D010499 Perimetry
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D010499 2003
% 211.76/211.94  |- skos__broader mesh__D010499smesh__D014787
% 211.76/211.94  |- mesh__dateRevised mesh__D010499 1997-06-20
% 211.76/211.94  |- mesh__recordOriginator mesh__D010499 NLM
% 211.76/211.94  |- skos__scopeNote mesh__D010499
% 211.76/211.94       Determination of the extent of the visual field for various types and intensities of stimuli.%A%    
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D010499 1999
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D010499 2006
% 211.76/211.94  |- skos__hiddenLabel mesh__D010499 Perimetries
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D010499 1998
% 211.76/211.94  |- mesh__recordMaintainer mesh__D010499 PXP
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D010499 2002
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D010499 2005
% 211.76/211.94  |- skos__hiddenLabel mesh__D010499 Campimetries
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D010499 2001
% 211.76/211.94  |- mesh__dateCreated mesh__D010499 1999-01-01
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D010499 2004
% 211.76/211.94  |- skos__altLabel mesh__D015982 Statistical Bias
% 211.76/211.94  |- mesh__onlineNote mesh__D015982
% 211.76/211.94       use RESEARCH to search BIAS %28%EPIDEMIOLOGY%29% 1987-89   
% 211.76/211.94  |- skos__altLabel mesh__D015982 Ecological Fallacy
% 211.76/211.94  |- skos__altLabel mesh__D015982 Ecological Fallacies
% 211.76/211.94  |- skos__altLabel mesh__D015982 Bias
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D015982 2004
% 211.76/211.94  |- skos__altLabel mesh__D015982 Biases, Ecological
% 211.76/211.94  |- skos__broader mesh__D015982smesh__D015981
% 211.76/211.94  |- skos__historyNote mesh__D015982 Research Design %28%1972-1989%29%
% 211.76/211.94  |- skos__hiddenLabel mesh__D015982 Bias, Truncation
% 211.76/211.94  |- skos__altLabel mesh__D015982 Biases, Epidemiologic
% 211.76/211.94  |- skos__scopeNote mesh__D015982
% 211.76/211.94       Any deviation of results or inferences from the truth, or processes leading to such deviation. Bias can result from several sources: one-sided or systematic variations in measurement from the true value %28%systematic error%29%; flaws in study design; deviation of inferences, interpretations, or analyses based on flawed data or data collection; etc. There is no sense of prejudice or subjectivity implied in the assessment of bias under these conditions.%A%    
% 211.76/211.94  |- skos__historyNote mesh__D015982 Risk %28%1966-1989%29%
% 211.76/211.94  |- mesh__historyNote mesh__D015982 90; was BIAS see RESEARCH 1987-89   
% 211.76/211.94  |- skos__hiddenLabel mesh__D015982 Errors, Outcome Measurement
% 211.76/211.94  |- mesh__dateCreated mesh__D015982 1989-05-25
% 211.76/211.94  |- mesh__dateRevised mesh__D015982 2002-07-02
% 211.76/211.94  |- skos__prefLabel mesh__D015982 Bias %28%Epidemiology%29%
% 211.76/211.94  |- mesh__recordMaintainer mesh__D015982 mdb
% 211.76/211.94  |- skos__historyNote mesh__D015982 Epidemiologic Methods %28%1966-1989%29%
% 211.76/211.94  |- skos__altLabel mesh__D015982 Statistical Biases
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D015982 2005
% 211.76/211.94  |- skos__annotation mesh__D015982
% 211.76/211.94       do not use for %22%bias%22% as prejudice or subjectivity %28% = PREJUDICE%29%; IM GEN only; coord NIM with disease /epidemiol %28%IM%29%, not /etiol; specify geog if pertinent; DF: BIAS%A%  
% 211.76/211.94  |- mesh__recordAuthorizer mesh__D015982 sjn
% 211.76/211.94  |- mesh__recordOriginator mesh__D015982 PLS
% 211.76/211.94  |- mesh__publicMeSHNote mesh__D015982 90; was BIAS see RESEARCH 1987-89   
% 211.76/211.94  |- skos__altLabel mesh__D015982 Bias, Systematic
% 211.76/211.94  |- skos__hiddenLabel mesh__D015982 Biases, Truncation
% 211.76/211.94  |- skos__altLabel mesh__D015982 Fallacies, Ecological
% 211.76/211.94  |- skos__hiddenLabel mesh__D015982 Error, Outcome Measurement
% 211.76/211.94  |- skos__altLabel mesh__D015982 Bias, Epidemiologic
% 211.76/211.94  |- skos__altLabel mesh__D015982 Bias, Ecological
% 211.76/211.94  |- skos__altLabel mesh__D015982 Epidemiologic Biases
% 211.76/211.94  |- skos__altLabel mesh__D015982 Bias, Statistical
% 211.76/211.94  |- skos__altLabel mesh__D015982 Truncation Bias
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D015982 2006
% 211.76/211.94  |- skos__altLabel mesh__D015982 Aggregation Bias
% 211.76/211.94  |- skos__hiddenLabel mesh__D015982 Outcome Measurement Error
% 211.76/211.94  |- skos__altLabel mesh__D015982 Ecological Biases
% 211.76/211.94  |- mesh__dateEstablished mesh__D015982 1990-01-01
% 211.76/211.94  |- rdf__type mesh__D015982sskos__Concept
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D015982 2003
% 211.76/211.94  |- skos__altLabel mesh__D015982 Fallacy, Ecological
% 211.76/211.94  |- skos__altLabel mesh__D051307
% 211.76/211.94       2-Aminoadipate-2-Oxoglutarate Aminotransferase
% 211.76/211.94  |- mesh__dateEstablished mesh__D051307 2006-01-01
% 211.76/211.94  |- rdf__type mesh__D051307sskos__Concept
% 211.76/211.94  |- skos__hiddenLabel mesh__D051307 2 Aminoadipate Transaminase
% 211.76/211.94  |- mesh__recordMaintainer mesh__D051307 ags
% 211.76/211.94  |- skos__hiddenLabel mesh__D051307 Aminotransferase, alpha-Aminoadipate
% 211.76/211.94  |- skos__hiddenLabel mesh__D051307
% 211.76/211.94       Aminotransferase, 2-Aminoadipate-2-Oxoglutarate
% 211.76/211.94  |- mesh__recordOriginator mesh__D051307 AKE
% 211.76/211.94  |- mesh__recordAuthorizer mesh__D051307 ags
% 211.76/211.94  |- skos__historyNote mesh__D051307 Transaminases %28%1983-2005%29%
% 211.76/211.94  |- mesh__historyNote mesh__D051307 2006%28%1983%29%   
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D051307 2006A
% 211.76/211.94  |- mesh__dateRevised mesh__D051307 2005-07-07
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D051307 2006
% 211.76/211.94  |- skos__prefLabel mesh__D051307 2-Aminoadipate Transaminase
% 211.76/211.94  |- skos__hiddenLabel mesh__D051307 Aminotransferase, 2-Aminoadipate
% 211.76/211.94  |- skos__altLabel mesh__D051307 alpha-Aminoadipate Aminotransferase
% 211.76/211.94  |- mesh__publicMeSHNote mesh__D051307
% 211.76/211.94       2006; 2-AMINOADIPATE TRANSAMINASE was indexed under TRANSAMINASES 1983-2005%A%  
% 211.76/211.94  |- mesh__dateCreated mesh__D051307 2005-06-30
% 211.76/211.94  |- skos__hiddenLabel mesh__D051307
% 211.76/211.94       2 Aminoadipate 2 Oxoglutarate Aminotransferase
% 211.76/211.94  |- skos__hiddenLabel mesh__D051307 Transaminase, 2-Aminoadipate
% 211.76/211.94  |- skos__hiddenLabel mesh__D051307 alpha Aminoadipate Aminotransferase
% 211.76/211.94  |- skos__hiddenLabel mesh__D051307 2 Aminoadipate Aminotransferase
% 211.76/211.94  |- skos__broader mesh__D051307smesh__D000637
% 211.76/211.94  |- skos__scopeNote mesh__D051307
% 211.76/211.94       A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the transfer of amino group of L-2-aminoadipate onto 2-OXOGLUTARATE to generate 2-oxoadipate and L-GLUTAMATE.%A%    
% 211.76/211.94  |- skos__altLabel mesh__D051307 2-Aminoadipate Aminotransferase
% 211.76/211.94  |- skos__broader mesh__D009945smesh__D001691
% 211.76/211.94  |- mesh__recordAuthorizer mesh__D009945 sjn
% 211.76/211.94  |- mesh__dateCreated mesh__D009945 1999-01-01
% 211.76/211.94  |- skos__scopeNote mesh__D009945
% 211.76/211.94       Historically, the treatment of disease by the administration of animal organs or their extracts %28%after Brown-Sequard%29%. At present synthetic preparations substitute for the extracts of a gland. %28%From Stedman, 26th ed%29%%A%    
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009945 2005
% 211.76/211.94  |- skos__prefLabel mesh__D009945 Organotherapy
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009945 2006
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009945 2003
% 211.76/211.94  |- mesh__recordMaintainer mesh__D009945 ssb
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009945 2004
% 211.76/211.94  |- mesh__recordOriginator mesh__D009945 NLM
% 211.76/211.94  |- mesh__dateRevised mesh__D009945 2001-07-25
% 211.76/211.94  |- rdf__type mesh__D009945sskos__Concept
% 211.76/211.94  |- skos__hiddenLabel mesh__D009945 Organotherapies
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009945 2002
% 211.76/211.94  |- skos__broader mesh__D009945smesh__D000529
% 211.76/211.94  |- skos__annotation mesh__D009945
% 211.76/211.94       ther using animal organs or their extracts; TISSUE THERAPY is also available; do not use /util except by MeSH definition%A%  
% 211.76/211.94  |- skos__broader mesh__D001962smesh__D003408
% 211.76/211.94  |- mesh__historyNote mesh__D001962
% 211.76/211.94       91%28%75%29%; was see under CRESOLS 1975-90   
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D001962 2005
% 211.76/211.94  |- mesh__recordAuthorizer mesh__D001962 sjn
% 211.76/211.94  |- skos__hiddenLabel mesh__D001962 Purple, Bromocresol
% 211.76/211.94  |- skos__broader mesh__D001962smesh__D014105
% 211.76/211.94  |- skos__historyNote mesh__D001962 Cresols %28%1969-1974%29%
% 211.76/211.94  |- mesh__dateRevised mesh__D001962 2004-07-19
% 211.76/211.94  |- skos__broader mesh__D001962smesh__D014050
% 211.76/211.94  |- skos__prefLabel mesh__D001962 Bromcresol Purple
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D001962 2006
% 211.76/211.94  |- mesh__recordMaintainer mesh__D001962 jls
% 211.76/211.94  |- skos__altLabel mesh__D001962 Bromocresol Purple
% 211.76/211.94  |- skos__historyNote mesh__D001962 Bromine %28%1973-1974%29%
% 211.76/211.94  |- skos__scopeNote mesh__D001962
% 211.76/211.94       An indicator and reagent. It has been used for several purposes including the determination of serum albumin concentrations%A%    
% 211.76/211.94  |- mesh__publicMeSHNote mesh__D001962 91; was see under CRESOLS 1975-90   
% 211.76/211.94  |- mesh__dateEstablished mesh__D001962 1991-01-01
% 211.76/211.94  |- mesh__dateCreated mesh__D001962 1974-11-19
% 211.76/211.94  |- skos__annotation mesh__D001962 D25-26 qualif   
% 211.76/211.94  |- skos__hiddenLabel mesh__D001962 Purple, Bromcresol
% 211.76/211.94  |- mesh__recordOriginator mesh__D001962 NLM
% 211.76/211.94  |- skos__historyNote mesh__D001962 Tosyl Compounds %28%1973-1974%29%
% 211.76/211.94  |- rdf__type mesh__D001962sskos__Concept
% 211.76/211.94  |- skos__broader mesh__D009147smesh__D026421
% 211.76/211.94  |- skos__annotation mesh__D009147 DF: MUSIC THER   
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D009147 2006
% 211.76/211.94  |- mesh__publicMeSHNote mesh__D009147 74   
% 211.76/211.94  |- mesh__dateCreated mesh__D009147 1999-01-01
% 211.76/211.94  |- mesh__recordOriginator mesh__D009147 NLM
% 211.76/211.94  |- mesh__recordMaintainer mesh__D009147 lkt
% 211.76/211.94  |- skos__broader mesh__D009147smesh__D012046
% 211.76/211.94  |- mesh__recordAuthorizer mesh__D009147 sjn
% 211.76/211.94  |- skos__prefLabel mesh__D009147 Music Therapy
% 211.76/211.94  |- mesh__dateRevised mesh__D009147 2005-06-30
% 211.76/211.94  |- skos__scopeNote mesh__D009147
% 211.76/211.94       The use of music as an adjunctive therapy in the treatment of neurological, mental, or behavioral disorders.%A%    
% 211.76/211.94  |- skos__related mesh__D009147smesh__D000161
% 211.76/211.94  |- skos__altLabel mesh__D009147 Therapy, Music
% 211.76/211.94  |- rdf__type mesh__D009147sskos__Concept
% 211.76/211.94  |- mesh__historyNote mesh__D009147 74   
% 211.76/211.94  |- mesh__dateEstablished mesh__D009147 1974-01-01
% 211.76/211.94  |- skos__broader mesh__D009147smesh__D011613
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D001164 2001
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D001164 2006
% 211.76/211.94  |- skos__scopeNote mesh__D001164
% 211.76/211.94       An abnormal communication between an artery and a vein.%A%    
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D001164 2003
% 211.76/211.94  |- rdf__type mesh__D001164sskos__Concept
% 211.76/211.94  |- skos__related mesh__D001164smesh__D001165
% 211.76/211.94  |- skos__prefLabel mesh__D001164 Arteriovenous Fistula
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D001164 2005
% 211.76/211.94  |- skos__hiddenLabel mesh__D001164 Aneurysms, Arteriovenous
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D001164 2000
% 211.76/211.94  |- mesh__dateRevised mesh__D001164 1999-11-08
% 211.76/211.94  |- mesh__publicMeSHNote mesh__D001164
% 211.76/211.94       67; was FISTULA, ARTERIOVENOUS 1963-66   
% 211.76/211.94  |- mesh__recordAuthorizer mesh__D001164 sjn
% 211.76/211.94  |- skos__hiddenLabel mesh__D001164 Fistulas, Arteriovenous
% 211.76/211.94  |- mesh__onlineNote mesh__D001164
% 211.76/211.94       use ARTERIOVENOUS FISTULA to search FISTULA, ARTERIOVENOUS 1966%A%  
% 211.76/211.94  |- mesh__recordOriginator mesh__D001164 NLM
% 211.76/211.94  |- skos__altLabel mesh__D001164 Arteriovenous Aneurysm
% 211.76/211.94  |- mesh__historyNote mesh__D001164
% 211.76/211.94       67; was FISTULA, ARTERIOVENOUS 1963-66   
% 211.76/211.94  |- mesh__dateEstablished mesh__D001164 1967-01-01
% 211.76/211.94  |- mesh__recordMaintainer mesh__D001164 KEV
% 211.76/211.94  |- skos__annotation mesh__D001164
% 211.76/211.94       do not confuse with ARTERIOVENOUS ANASTOMOSIS %28%Cat A%29%; coord IM with specific artery /abnorm + specific vein /abnorm %28%IM%29% or precoord vessel/dis headings %28%IM%29%; Manual 23.19.6+; congen cerebral arteriovenous fistula = INTRACRANIAL ARTERIOVENOUS MALFORMATIONS %28%IM%29% + ARTERIOVENOUS FISTULA /congen %28%IM%29%; surgically created arteriovenous fistula = ARTERIOVENOUS SHUNT, SURGICAL%A%  
% 211.76/211.94  |- skos__hiddenLabel mesh__D001164 Fistula, Arteriovenous
% 211.76/211.94  |- skos__altLabel mesh__D001164 Aneurysm, Arteriovenous
% 211.76/211.94  |- mesh__dateCreated mesh__D001164 1999-01-01
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D001164 2002
% 211.76/211.94  |- skos__broader mesh__D001164smesh__D016157
% 211.76/211.94  |- skos__broader mesh__D001164smesh__D001165
% 211.76/211.94  |- skos__hiddenLabel mesh__D001164 Arteriovenous Fistulas
% 211.76/211.94  |- skos__hiddenLabel mesh__D001164 Arteriovenous Aneurysms
% 211.76/211.94  |- mesh__activeMeSHYear mesh__D001164 2004
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D028301 2005
% 211.76/211.95  |- skos__broader mesh__D028301smesh__D017992
% 211.76/211.95  |- skos__historyNote mesh__D028301 Parvovirus, Feline %28%1975-2001%29%
% 211.76/211.95  |- skos__altLabel mesh__D028301 Feline Infectious Enteritis Virus
% 211.76/211.95  |- mesh__recordOriginator mesh__D028301 ags
% 211.76/211.95  |- skos__historyNote mesh__D028301 DNA Viruses %28%1970-1974%29%
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D028301 2003
% 211.76/211.95  |- skos__scopeNote mesh__D028301
% 211.76/211.95       A species of PARVOVIRUS infecting cats with a highly contagious enteric disease. Host range variants include mink enteritis virus, canine parvovirus %28%PARVOVIRUS, CANINE%29%, and raccoon parvovirus. After infecting their new hosts, many of these viruses have further evolved and are now considered distinct species.%A%    
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D028301 2006
% 211.76/211.95  |- skos__hiddenLabel mesh__D028301 panleukopenia viruses, Feline
% 211.76/211.95  |- skos__altLabel mesh__D028301 FPLV
% 211.76/211.95  |- rdf__type mesh__D028301sskos__Concept
% 211.76/211.95  |- skos__altLabel mesh__D028301 Infectious Enteritis Virus, Feline
% 211.76/211.95  |- mesh__recordMaintainer mesh__D028301 ags
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D028301 2004
% 211.76/211.95  |- skos__hiddenLabel mesh__D028301 Feline panleukopenia viruses
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D028301 2002
% 211.76/211.95  |- skos__hiddenLabel mesh__D028301 panleukopenia virus, Feline
% 211.76/211.95  |- mesh__recordAuthorizer mesh__D028301 sjn
% 211.76/211.95  |- mesh__dateEstablished mesh__D028301 2002-01-01
% 211.76/211.95  |- mesh__dateCreated mesh__D028301 2001-07-25
% 211.76/211.95  |- mesh__publicMeSHNote mesh__D028301
% 211.76/211.95       2002; see PARVOVIRUS FELINE 1994-2001, see FELINE INFECTIOUS ENTERITIS VIRUS 1991-1993, see PARVOVIRIDAE 1981-1990, see PARVOVIRUSES 1975-1980%A%  
% 211.76/211.95  |- skos__annotation mesh__D028301
% 211.76/211.95       infection = FELINE PANLEUKOPENIA but see note there   
% 211.76/211.95  |- skos__prefLabel mesh__D028301 Feline panleukopenia virus
% 211.76/211.95  |- skos__altLabel mesh__D028301 Panleukopenia Virus of Cats
% 211.76/211.95  |- mesh__historyNote mesh__D028301 2002; use PARVOVIRUS FELINE 1976-2001   
% 211.76/211.95  |- skos__prefLabel mesh__D019575 Blindness, Cortical
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D019575 2000A
% 211.76/211.95  |- skos__historyNote mesh__D019575 Blindness %28%1966-1997%29%
% 211.76/211.95  |- mesh__dateEstablished mesh__D019575 1998-01-01
% 211.76/211.95  |- skos__altLabel mesh__D019575 Psychic Denial of Blindness
% 211.76/211.95  |- mesh__recordMaintainer mesh__D019575 ags
% 211.76/211.95  |- skos__broader mesh__D019575smesh__D001766
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D019575 2006
% 211.76/211.95  |- skos__scopeNote mesh__D019575
% 211.76/211.95       Total loss of vision in all or part of the visual field due to bilateral OCCIPITAL LOBE %28%i.e., VISUAL CORTEX%29% damage or dysfunction. Anton syndrome is characterized by the psychic denial of true, organic cortical blindness. %28%Adams et al., Principles of Neurology, 6th ed, p460%29%%A%    
% 211.76/211.95  |- mesh__publicMeSHNote mesh__D019575 1998   
% 211.76/211.95  |- mesh__recordOriginator mesh__D019575 TGC
% 211.76/211.95  |- skos__hiddenLabel mesh__D019575 Anton Syndromes
% 211.76/211.95  |- mesh__dateCreated mesh__D019575 1997-06-20
% 211.76/211.95  |- rdf__type mesh__D019575sskos__Concept
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D019575 2005
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D019575 2002
% 211.76/211.95  |- mesh__recordAuthorizer mesh__D019575 ags
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D019575 2004
% 211.76/211.95  |- skos__hiddenLabel mesh__D019575 Syndrome, Anton
% 211.76/211.95  |- mesh__historyNote mesh__D019575 1998   
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D019575 2001
% 211.76/211.95  |- mesh__dateRevised mesh__D019575 1999-12-13
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D019575 2003
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D019575 2000
% 211.76/211.95  |- skos__hiddenLabel mesh__D019575 Syndromes, Anton
% 211.76/211.95  |- skos__hiddenLabel mesh__D019575 Cortical Blindness
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011592 2004
% 211.76/211.95  |- skos__altLabel mesh__D011592 Military Psychology
% 211.76/211.95  |- mesh__recordOriginator mesh__D011592 NLM
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011592 1994
% 211.76/211.95  |- mesh__recordAuthorizer mesh__D011592 PLS
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011592 2001
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011592 2003
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011592 2000
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011592 2006
% 211.76/211.95  |- skos__scopeNote mesh__D011592
% 211.76/211.95       The branch of applied psychology concerned with psychological aspects of selection, assignment, training, morale, etc., of Armed Forces personnel.%A%    
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011592 1997
% 211.76/211.95  |- mesh__dateCreated mesh__D011592 1999-01-01
% 211.76/211.95  |- skos__prefLabel mesh__D011592 Psychology, Military
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011592 2005
% 211.76/211.95  |- mesh__dateRevised mesh__D011592 1991-06-28
% 211.76/211.95  |- skos__annotation mesh__D011592
% 211.76/211.95       SPEC: SPEC qualif; consider also MILITARY PERSONNEL /psychol; DF: PSYCHOL MILITARY%A%  
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011592 1996
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011592 1993
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011592 2002
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011592 1999
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011592 1992
% 211.76/211.95  |- mesh__recordMaintainer mesh__D011592 TGC
% 211.76/211.95  |- rdf__type mesh__D011592sskos__Concept
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011592 1995
% 211.76/211.95  |- skos__broader mesh__D011592smesh__D011585
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011592 1998
% 211.76/211.95  |- skos__broader mesh__D005555smesh__D011570
% 211.76/211.95  |- mesh__recordMaintainer mesh__D005555 lkt
% 211.76/211.95  |- skos__hiddenLabel mesh__D005555 Psychiatry, Forensic
% 211.76/211.95  |- skos__annotation mesh__D005555 SPEC qualif   
% 211.76/211.95  |- mesh__onlineNote mesh__D005555
% 211.76/211.95       use FORENSIC PSYCHIATRY to search JURISPRUDENCE, PSYCHIATRIC 1967-68; use FORENSIC DENTISTRY %26% FORENSIC MEDICINE to search CRIMINAL INVESTIGATION 1966-74%A%  
% 211.76/211.95  |- mesh__dateRevised mesh__D005555 2003-07-09
% 211.76/211.95  |- rdf__type mesh__D005555sskos__Concept
% 211.76/211.95  |- mesh__publicMeSHNote mesh__D005555
% 211.76/211.95       69; was JURISPRUDENCE, PSYCHIATRIC 1967-68; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY %26% FORENSIC MEDICINE 1965-74, was heading 1963-64%A%  
% 211.76/211.95  |- skos__broader mesh__D005555smesh__D005554
% 211.76/211.95  |- mesh__historyNote mesh__D005555
% 211.76/211.95       69; was JURISPRUDENCE, PSYCHIATRIC 1967-68; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY %26% FORENSIC MEDICINE 1965-74, was heading 1963-64%A%  
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D005555 2004
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D005555 2006
% 211.76/211.95  |- skos__scopeNote mesh__D005555
% 211.76/211.95       Psychiatry in its legal aspects. This includes criminology, penology, commitment of mentally ill, the psychiatrist%27%s role in compensation cases, the problems of releasing information to the court, and of expert testimony.%A%    
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D005555 2005
% 211.76/211.95  |- skos__hiddenLabel mesh__D005555 Psychiatric Jurisprudence
% 211.76/211.95  |- mesh__recordOriginator mesh__D005555 NLM
% 211.76/211.95  |- mesh__dateEstablished mesh__D005555 1969-01-01
% 211.76/211.95  |- skos__prefLabel mesh__D005555 Forensic Psychiatry
% 211.76/211.95  |- mesh__dateCreated mesh__D005555 1999-01-01
% 211.76/211.95  |- mesh__recordAuthorizer mesh__D005555 sjn
% 211.76/211.95  |- skos__broader mesh__D005555smesh__D007603
% 211.76/211.95  |- rdf__type mesh__D015983sskos__Concept
% 211.76/211.95  |- skos__prefLabel mesh__D015983 Selection Bias
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015983 1994
% 211.76/211.95  |- mesh__historyNote mesh__D015983
% 211.76/211.95       91%28%90%29%; was see under BIAS %28%EPIDEMIOLOGY%29% 1990   
% 211.76/211.95  |- skos__altLabel mesh__D015983 Selection Biases
% 211.76/211.95  |- mesh__recordAuthorizer mesh__D015983 PLS
% 211.76/211.95  |- skos__altLabel mesh__D015983 Bias, Selection
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015983 2003
% 211.76/211.95  |- skos__scopeNote mesh__D015983
% 211.76/211.95       The introduction of error due to systematic differences in the characteristics between those selected and those not selected for a given study. In sampling bias, error is the result of failure to ensure that all members of the reference population have a known chance of selection in the sample.%A%    
% 211.76/211.95  |- skos__hiddenLabel mesh__D015983 Sampling Errors
% 211.76/211.95  |- mesh__recordMaintainer mesh__D015983 PLS
% 211.76/211.95  |- skos__annotation mesh__D015983
% 211.76/211.95       IM GEN only; coord NIM with disease /epidemiol %28%IM%29% or specific non-disease term /statist; no qualif; specify geog if pertinent%A%  
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015983 2001
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015983 2006
% 211.76/211.95  |- skos__hiddenLabel mesh__D015983 Errors, Sampling
% 211.76/211.95  |- skos__historyNote mesh__D015983 Research Design %28%1972-1989%29%
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015983 1997
% 211.76/211.95  |- mesh__recordOriginator mesh__D015983 PLS
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015983 2000
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015983 2005
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015983 1993
% 211.76/211.95  |- mesh__dateRevised mesh__D015983 1992-05-22
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015983 1996
% 211.76/211.95  |- skos__hiddenLabel mesh__D015983 Bias, Sampling
% 211.76/211.95  |- mesh__dateCreated mesh__D015983 1989-05-25
% 211.76/211.95  |- skos__hiddenLabel mesh__D015983 Biases, Selection
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015983 1999
% 211.76/211.95  |- mesh__dateEstablished mesh__D015983 1991-01-01
% 211.76/211.95  |- skos__hiddenLabel mesh__D015983 Error, Sampling
% 211.76/211.95  |- skos__broader mesh__D015983smesh__D015982
% 211.76/211.95  |- skos__historyNote mesh__D015983 Epidemiologic Methods %28%1966-1989%29%
% 211.76/211.95  |- skos__hiddenLabel mesh__D015983 Biases, Sampling
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015983 2002
% 211.76/211.95  |- skos__altLabel mesh__D015983 Sampling Biases
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015983 1995
% 211.76/211.95  |- mesh__publicMeSHNote mesh__D015983
% 211.76/211.95       91; was see under BIAS %28%EPIDEMIOLOGY%29% 1990   
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015983 1998
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015983 2004
% 211.76/211.95  |- skos__scopeNote mesh__D051308
% 211.76/211.95       A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the transfer of amino group of GLYCINE onto 2-OXOGLUTARATE to generate GLYOXYLATE and L-GLUTAMATE.%A%    
% 211.76/211.95  |- skos__broader mesh__D051308smesh__D000637
% 211.76/211.95  |- mesh__recordAuthorizer mesh__D051308 ags
% 211.76/211.95  |- skos__hiddenLabel mesh__D051308 Transaminase, Glycine
% 211.76/211.95  |- skos__altLabel mesh__D051308 Glycine-2-Oxoglutarate Aminotransferase
% 211.76/211.95  |- mesh__dateEstablished mesh__D051308 2006-01-01
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D051308 2006
% 211.76/211.95  |- mesh__dateRevised mesh__D051308 2005-07-07
% 211.76/211.95  |- skos__hiddenLabel mesh__D051308 Glycine 2 Oxoglutarate Aminotransferase
% 211.76/211.95  |- skos__altLabel mesh__D051308 Glycine Aminotransferase
% 211.76/211.95  |- skos__hiddenLabel mesh__D051308 Aminotransferase, Glycine
% 211.76/211.95  |- mesh__recordOriginator mesh__D051308 AKE
% 211.76/211.95  |- skos__hiddenLabel mesh__D051308 Aminotransferase, Glycine-2-Oxoglutarate
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D051308 2006A
% 211.76/211.95  |- mesh__historyNote mesh__D051308
% 211.76/211.95       2006%28%1980%29%; use TRANSAMINASES 1974-1979, %26% KETOGLUTARIC ACID 1974-1979%A%  
% 211.76/211.95  |- skos__prefLabel mesh__D051308 Glycine Transaminase
% 211.76/211.95  |- mesh__dateCreated mesh__D051308 2005-06-30
% 211.76/211.95  |- rdf__type mesh__D051308sskos__Concept
% 211.76/211.95  |- mesh__recordMaintainer mesh__D051308 ags
% 211.76/211.95  |- mesh__publicMeSHNote mesh__D051308
% 211.76/211.95       2006; GLYCINE TRANSAMINASES was indexed under TRANSAMINASES 1974-2005, %26% under KETOGLUTARIC ACID 1974-2005%A%  
% 211.76/211.95  |- skos__annotation mesh__D009946
% 211.76/211.95       includes organothiophosphates; /antag permitted but consider also CHOLINESTERASE REACTIVATORS; DF: ORGANOTHIOPHOSPHORUS CPDS%A%  
% 211.76/211.95  |- skos__historyNote mesh__D009946 Phosphorous Acids %28%1968-1970%29%
% 211.76/211.95  |- skos__hiddenLabel mesh__D009946 Compounds, Organothiophosphorus
% 211.76/211.95  |- skos__historyNote mesh__D009946 Phosphonic Acids %28%1966-1970%29%
% 211.76/211.95  |- skos__historyNote mesh__D009946 Phosphates %28%1966-1970%29%
% 211.76/211.95  |- skos__broader mesh__D009946smesh__D013457
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D009946 2006
% 211.76/211.95  |- mesh__recordAuthorizer mesh__D009946 sjn
% 211.76/211.95  |- skos__historyNote mesh__D009946 Phosphorus %28%1966-1970%29%
% 211.76/211.95  |- skos__scopeNote mesh__D009946
% 211.76/211.95       Compounds containing carbon-phosphorus bonds in which the phosphorus component is also bonded to one or more sulfur atoms. Many of these compounds function as CHOLINERGIC AGENTS and as INSECTICIDES.%A%    
% 211.76/211.95  |- rdf__type mesh__D009946sskos__Concept
% 211.76/211.95  |- skos__historyNote mesh__D009946 Phosphoric Acids %28%1968-1970%29%
% 211.76/211.95  |- mesh__recordMaintainer mesh__D009946 ssb
% 211.76/211.95  |- mesh__dateEstablished mesh__D009946 1972-01-01
% 211.76/211.95  |- mesh__historyNote mesh__D009946 72%28%71%29%   
% 211.76/211.95  |- mesh__recordOriginator mesh__D009946 NLM
% 211.76/211.95  |- mesh__publicMeSHNote mesh__D009946 72   
% 211.76/211.95  |- skos__broader mesh__D009946smesh__D009943
% 211.76/211.95  |- skos__prefLabel mesh__D009946 Organothiophosphorus Compounds
% 211.76/211.95  |- mesh__dateRevised mesh__D009946 2005-06-30
% 211.76/211.95  |- mesh__dateCreated mesh__D009946 1999-01-01
% 211.76/211.95  |- skos__broader mesh__D001963smesh__D003546
% 211.76/211.95  |- skos__altLabel mesh__D001963 Ursapharm Brand of Bromelains
% 211.76/211.95  |- skos__altLabel mesh__D001963 Bromelins
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D001963 2006
% 211.76/211.95  |- skos__altLabel mesh__D001963 Bromelin
% 211.76/211.95  |- mesh__publicMeSHNote mesh__D001963
% 211.76/211.95       67; was see under PEPTIDE PEPTIDOHYDROLASES 1963-66   
% 211.76/211.95  |- skos__hiddenLabel mesh__D001963 Bromelains Rottapharm Brand
% 211.76/211.95  |- mesh__historyNote mesh__D001963
% 211.76/211.95       67%28%65%29%; was see under ENDOPEPTIDASES 1963-66   
% 211.76/211.95  |- mesh__dateEstablished mesh__D001963 1967-01-01
% 211.76/211.95  |- skos__scopeNote mesh__D001963
% 211.76/211.95       Protein-digesting and milk-clotting enzymes found in pineapple fruit juice and stem tissue. Enzymes from the two sources are distinguished as fruit bromelain and stem bromelain. They have anti-inflammatory activity and the enzymatic activity does not disappear as the fruit ripens. %28%From Merck Index, 11th ed%29%. This enzyme was formerly listed as EC 3.4.22.4.%A%    
% 211.76/211.95  |- mesh__recordAuthorizer mesh__D001963 sjn
% 211.76/211.95  |- skos__altLabel mesh__D001963 Bromelain
% 211.76/211.95  |- mesh__recordMaintainer mesh__D001963 jmp
% 211.76/211.95  |- mesh__dateCreated mesh__D001963 1999-01-01
% 211.76/211.95  |- skos__altLabel mesh__D001963 Wiedemann Brand of Bromelains
% 211.76/211.95  |- skos__hiddenLabel mesh__D001963 Bromelains Mucos Brand
% 211.76/211.95  |- skos__prefLabel mesh__D001963 Bromelains
% 211.76/211.95  |- skos__hiddenLabel mesh__D001963 Bromelains Wiedemann Brand
% 211.76/211.95  |- mesh__dateRevised mesh__D001963 2005-06-30
% 211.76/211.95  |- skos__annotation mesh__D001963
% 211.76/211.95       cysteine endopeptidases %26% non-steroidal anti-inflamm agents%A%  
% 211.76/211.95  |- skos__hiddenLabel mesh__D001963
% 211.76/211.95       Rh%C3%%B4%ne Poulenc Rorer Brand 1 of Bromelains
% 211.76/211.95  |- skos__hiddenLabel mesh__D001963 Bromelains Ursapharm Brand
% 211.76/211.95  |- skos__hiddenLabel mesh__D001963 Bromelains Aventis Brand
% 211.76/211.95  |- skos__altLabel mesh__D001963 Aventis Brand of Bromelains
% 211.76/211.95  |- skos__altLabel mesh__D001963
% 211.76/211.95       Rh%C3%%B4%ne-Poulenc Rorer Brand 2 of Bromelains
% 211.76/211.95  |- rdf__type mesh__D001963sskos__Concept
% 211.76/211.95  |- skos__altLabel mesh__D001963
% 211.76/211.95       Rh%C3%%B4%ne-Poulenc Rorer Brand 1 of Bromelains
% 211.76/211.95  |- skos__altLabel mesh__D001963 Nattermann Brand of Bromelains
% 211.76/211.95  |- skos__altLabel mesh__D001963
% 211.76/211.95       Rh%C3%%B4%ne-Poulenc Rorer Brand 3 of Bromelains
% 211.76/211.95  |- skos__altLabel mesh__D001963 Mucos Brand of Bromelains
% 211.76/211.95  |- skos__hiddenLabel mesh__D001963
% 211.76/211.95       Rh%C3%%B4%ne Poulenc Rorer Brand 3 of Bromelains
% 211.76/211.95  |- skos__hiddenLabel mesh__D001963
% 211.76/211.95       Rh%C3%%B4%ne Poulenc Rorer Brand 2 of Bromelains
% 211.76/211.95  |- skos__hiddenLabel mesh__D001963 BromelainPOS
% 211.76/211.95  |- skos__altLabel mesh__D001963 Rottapharm Brand of Bromelains
% 211.76/211.95  |- mesh__recordOriginator mesh__D001963 NLM
% 211.76/211.95  |- skos__hiddenLabel mesh__D001963 Bromelain POS
% 211.76/211.95  |- skos__hiddenLabel mesh__D001963 Bromelains Nattermann Brand
% 211.76/211.95  |- skos__annotation mesh__D001165
% 211.76/211.95       GEN or unspecified; coord IM with specific artery /abnorm %28%IM%29% + specific vein /abnorm %28%IM%29% or specific available precoord arterial or venous abnorm %28%IM%29%; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 211.76/211.95  |- mesh__publicMeSHNote mesh__D001165 73   
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D001165 2002
% 211.76/211.95  |- skos__broader mesh__D001165smesh__D014652
% 211.76/211.95  |- skos__related mesh__D001165smesh__D000798
% 211.76/211.95  |- skos__hiddenLabel mesh__D001165 Arteriovenous Malformation
% 211.76/211.95  |- mesh__dateCreated mesh__D001165 1999-01-01
% 211.76/211.95  |- mesh__dateEstablished mesh__D001165 1973-01-01
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D001165 2001
% 211.76/211.95  |- skos__historyNote mesh__D001165
% 211.76/211.95       Arteriovenous Fistula/congenital %28%1966-1968%29%
% 211.76/211.95  |- mesh__dateRevised mesh__D001165 1999-11-03
% 211.76/211.95  |- skos__hiddenLabel mesh__D001165 Malformation, Arteriovenous
% 211.76/211.95  |- skos__related mesh__D001165smesh__D006391
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D001165 2004
% 211.76/211.95  |- skos__related mesh__D001165smesh__D001164
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D001165 2006
% 211.76/211.95  |- skos__prefLabel mesh__D001165 Arteriovenous Malformations
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D001165 2003
% 211.76/211.95  |- mesh__recordAuthorizer mesh__D001165 sjn
% 211.76/211.95  |- mesh__historyNote mesh__D001165 73%28%69%29%   
% 211.76/211.95  |- skos__scopeNote mesh__D001165
% 211.76/211.95       Abnormal, tangled collections of dilated blood vessels that result from congenitally malformed vascular structures in which arterial afferents flow directly into venous efferents without the usual resistance of an intervening capillary bed. A common type is the congenital arteriovenous fistula %28%ARTERIOVENOUS FISTULA /congenital%29%. For arteriovenous malformations in the brain, INTRACRANIAL ARTERIOVENOUS MALFORMATIONS is available. %28%From Merck Manual, 15th ed%29%%A%    
% 211.76/211.95  |- skos__hiddenLabel mesh__D001165 Malformations, Arteriovenous
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D001165 2005
% 211.76/211.95  |- mesh__recordOriginator mesh__D001165 NLM
% 211.76/211.95  |- mesh__recordMaintainer mesh__D001165 sjn
% 211.76/211.95  |- rdf__type mesh__D001165sskos__Concept
% 211.76/211.95  |- skos__broader mesh__D001165smesh__D018376
% 211.76/211.95  |- skos__hiddenLabel mesh__D019576 Spectacled Porpoises
% 211.76/211.95  |- mesh__recordMaintainer mesh__D019576 ags
% 211.76/211.95  |- skos__altLabel mesh__D019576 Australophocaena dioptrica
% 211.76/211.95  |- skos__hiddenLabel mesh__D019576 Porpoises, Finless
% 211.76/211.95  |- rdf__type mesh__D019576sskos__Concept
% 211.76/211.95  |- mesh__dateRevised mesh__D019576 2005-06-30
% 211.76/211.95  |- mesh__recordAuthorizer mesh__D019576 sjn
% 211.76/211.95  |- mesh__dateEstablished mesh__D019576 1998-01-01
% 211.76/211.95  |- skos__hiddenLabel mesh__D019576 Porpoise, Finless
% 211.76/211.95  |- skos__hiddenLabel mesh__D019576 Porpoise, Dall
% 211.76/211.95  |- skos__altLabel mesh__D019576 Neophocaena phocaenoides
% 211.76/211.95  |- skos__broader mesh__D019576smesh__D002591
% 211.76/211.95  |- skos__altLabel mesh__D019576 Phocoenidae
% 211.76/211.95  |- skos__hiddenLabel mesh__D019576 Finless Porpoises
% 211.76/211.95  |- skos__scopeNote mesh__D019576
% 211.76/211.95       Mammals of the family Phocoenidae comprising four genera found in the North Pacific Ocean and both sides of the North Atlantic Ocean and in various other seas. They differ from DOLPHINS in that porpoises have a blunt snout and a rather stocky body while dolphins have a beak-like snout and a slender, streamlined body. They usually travel in small groups. %28%From Walker%27%s Mammals of the World, 5th ed, pp1003-4%29%%A%    
% 211.76/211.95  |- skos__hiddenLabel mesh__D019576 Porpoise, Spectacled
% 211.76/211.95  |- mesh__publicMeSHNote mesh__D019576 98; see DOLPHINS 1968-97   
% 211.76/211.95  |- mesh__historyNote mesh__D019576 98; use DOLPHINS 1968-97   
% 211.76/211.95  |- skos__historyNote mesh__D019576 Dolphins %28%1967-1997%29%
% 211.76/211.95  |- skos__hiddenLabel mesh__D019576 Porpoises, Spectacled
% 211.76/211.95  |- mesh__dateCreated mesh__D019576 1997-06-20
% 211.76/211.95  |- skos__altLabel mesh__D019576 Phocoenoides dalli
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D019576 2006
% 211.76/211.95  |- mesh__recordOriginator mesh__D019576 TGC
% 211.76/211.95  |- skos__prefLabel mesh__D019576 Porpoises
% 211.76/211.95  |- skos__hiddenLabel mesh__D019576 Porpoise
% 211.76/211.95  |- skos__historyNote mesh__D019576 Cetacea %28%1966-1975%29%
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011593 2003
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011593 2006
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011593 1997
% 211.76/211.95  |- skos__hiddenLabel mesh__D011593 Psychologies, Social
% 211.76/211.95  |- mesh__recordOriginator mesh__D011593 NLM
% 211.76/211.95  |- mesh__recordAuthorizer mesh__D011593 PLS
% 211.76/211.95  |- mesh__dateCreated mesh__D011593 1999-01-01
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011593 2001
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011593 2005
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011593 1996
% 211.76/211.95  |- skos__prefLabel mesh__D011593 Psychology, Social
% 211.76/211.95  |- skos__broader mesh__D011593smesh__D011584
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011593 2000
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011593 1999
% 211.76/211.95  |- mesh__dateRevised mesh__D011593 1993-06-03
% 211.76/211.95  |- rdf__type mesh__D011593sskos__Concept
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011593 1995
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011593 1998
% 211.76/211.95  |- skos__scopeNote mesh__D011593
% 211.76/211.95       The branch of psychology concerned with the effects of group membership upon the behavior, attitudes, and beliefs of an individual.%A%    
% 211.76/211.95  |- skos__related mesh__D011593smesh__D011822
% 211.76/211.95  |- skos__hiddenLabel mesh__D011593 Social Psychologies
% 211.76/211.95  |- skos__altLabel mesh__D011593 Social Psychology
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011593 2004
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011593 1994
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D011593 2002
% 211.76/211.95  |- skos__annotation mesh__D011593
% 211.76/211.95       SPEC: IM, SPEC qualif; NIM coord, no qualif; DF: PSYCHOL SOCIAL%A%  
% 211.76/211.95  |- skos__broader mesh__D011593smesh__D001520
% 211.76/211.95  |- mesh__recordMaintainer mesh__D011593 PLS
% 211.76/211.95  |- mesh__dateRevised mesh__D005556 2003-07-09
% 211.76/211.95  |- skos__scopeNote mesh__D005556
% 211.76/211.95       The sensory discrimination of a pattern shape or outline.%A%    
% 211.76/211.95  |- rdf__type mesh__D005556sskos__Concept
% 211.76/211.95  |- skos__hiddenLabel mesh__D005556 Perceptions, Contour
% 211.76/211.95  |- skos__broader mesh__D005556smesh__D014796
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D005556 2004
% 211.76/211.95  |- mesh__recordAuthorizer mesh__D005556 sjn
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D005556 2006
% 211.76/211.95  |- mesh__onlineNote mesh__D005556
% 211.76/211.95       use FORM PERCEPTION to search CONTOUR PERCEPTION 1970-78   
% 211.76/211.95  |- skos__hiddenLabel mesh__D005556 Perceptions, Form
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D005556 2005
% 211.76/211.95  |- skos__hiddenLabel mesh__D005556 Contour Perceptions
% 211.76/211.95  |- skos__broader mesh__D005556smesh__D013028
% 211.76/211.95  |- skos__hiddenLabel mesh__D005556 Form Perceptions
% 211.76/211.95  |- mesh__historyNote mesh__D005556
% 211.76/211.95       CONTOUR PERCEPTION was see under FORM PERCEPTION 1970-78   
% 211.76/211.95  |- skos__hiddenLabel mesh__D005556 Perception, Contour
% 211.76/211.95  |- skos__hiddenLabel mesh__D005556 Perception, Form
% 211.76/211.95  |- mesh__dateCreated mesh__D005556 1999-01-01
% 211.76/211.95  |- skos__prefLabel mesh__D005556 Form Perception
% 211.76/211.95  |- mesh__recordOriginator mesh__D005556 NLM
% 211.76/211.95  |- skos__broader mesh__D005556smesh__D010465
% 211.76/211.95  |- skos__altLabel mesh__D005556 Contour Perception
% 211.76/211.95  |- skos__related mesh__D005556smesh__D015350
% 211.76/211.95  |- mesh__recordMaintainer mesh__D005556 nns
% 211.76/211.95  |- skos__hiddenLabel mesh__D015984 Factors, Predisposing
% 211.76/211.95  |- skos__hiddenLabel mesh__D015984 Factor, Enabling
% 211.76/211.95  |- rdf__type mesh__D015984sskos__Concept
% 211.76/211.95  |- skos__hiddenLabel mesh__D015984 Causations
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015984 2003
% 211.76/211.95  |- skos__hiddenLabel mesh__D015984 Factor, Predisposing
% 211.76/211.95  |- skos__hiddenLabel mesh__D015984 Causation, Multiple
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015984 1998
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015984 1995
% 211.76/211.95  |- skos__prefLabel mesh__D015984 Causality
% 211.76/211.95  |- skos__hiddenLabel mesh__D015984 Multifactorial Causalities
% 211.76/211.95  |- mesh__publicMeSHNote mesh__D015984 90   
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015984 2004
% 211.76/211.95  |- skos__historyNote mesh__D015984 Risk %28%1966-1989%29%
% 211.76/211.95  |- skos__hiddenLabel mesh__D015984 Causality, Multifactorial
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015984 1999
% 211.76/211.95  |- skos__scopeNote mesh__D015984
% 211.76/211.95       The relating of causes to the effects they produce. Causes are termed necessary when they must always precede an effect and sufficient when they initiate or produce an effect. Any of several factors may be associated with the potential disease causation or outcome, including predisposing factors, enabling factors, precipitating factors, reinforcing factors, and risk factors.%A%    
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015984 2000
% 211.76/211.95  |- skos__broader mesh__D015984smesh__D015981
% 211.76/211.95  |- mesh__dateRevised mesh__D015984 1992-05-13
% 211.76/211.95  |- skos__hiddenLabel mesh__D015984 Factors, Reinforcing
% 211.76/211.95  |- mesh__historyNote mesh__D015984 90   
% 211.76/211.95  |- mesh__dateCreated mesh__D015984 1989-05-25
% 211.76/211.95  |- skos__annotation mesh__D015984
% 211.76/211.95       an epidemiol concept: do not confuse with the cause of a disease %28% = /etiol%29%; IM GEN only; coord NIM with disease /epidemiol %28%IM%29%, not /etiol; no qualif; specify geog if pertinent%A%  
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015984 2001
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015984 1996
% 211.76/211.95  |- skos__historyNote mesh__D015984
% 211.76/211.95       specific disease/epidemiology %28%1966-1989%29%
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015984 1993
% 211.76/211.95  |- skos__hiddenLabel mesh__D015984 Multiple Causations
% 211.76/211.95  |- skos__hiddenLabel mesh__D015984 Factor, Reinforcing
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015984 2005
% 211.76/211.95  |- skos__hiddenLabel mesh__D015984 Reinforcing Factor
% 211.76/211.95  |- mesh__recordOriginator mesh__D015984 PLS
% 211.76/211.95  |- skos__hiddenLabel mesh__D015984 Factors, Enabling
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015984 1997
% 211.76/211.95  |- mesh__recordMaintainer mesh__D015984 PLS
% 211.76/211.95  |- skos__hiddenLabel mesh__D015984 Causalities, Multifactorial
% 211.76/211.95  |- skos__hiddenLabel mesh__D015984 Causations, Multiple
% 211.76/211.95  |- skos__hiddenLabel mesh__D015984 Causalities
% 211.76/211.95  |- mesh__dateEstablished mesh__D015984 1990-01-01
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015984 2006
% 211.76/211.95  |- skos__hiddenLabel mesh__D015984 Enabling Factor
% 211.76/211.95  |- skos__historyNote mesh__D015984
% 211.76/211.95       specific disease/etiology %28%1966-1989%29%
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015984 2002
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015984 1994
% 211.76/211.95  |- skos__hiddenLabel mesh__D015984 Predisposing Factor
% 211.76/211.95  |- mesh__recordAuthorizer mesh__D015984 PLS
% 211.76/211.95  |- skos__broader mesh__D015220Q000819smesh__D015220
% 211.76/211.95  |- mesh__preferredCombination mesh__D015220Q000819smesh__D002120
% 211.76/211.95  |- rdf__type mesh__D015220Q000819smesh__CompoundConcept
% 211.76/211.95  |- skos__altLabel mesh__D015186 Hominids
% 211.76/211.95  |- mesh__recordMaintainer mesh__D015186 ags
% 211.76/211.95  |- skos__hiddenLabel mesh__D015186 Ape
% 211.76/211.95  |- skos__broader mesh__D015186smesh__D051079
% 211.76/211.95  |- rdf__type mesh__D015186sskos__Concept
% 211.76/211.95  |- mesh__dateRevised mesh__D015186 2005-06-30
% 211.76/211.95  |- skos__hiddenLabel mesh__D015186 Hominid
% 211.76/211.95  |- mesh__publicMeSHNote mesh__D015186 89   
% 211.76/211.95  |- skos__historyNote mesh__D015186 Primates %28%1968-1988%29%
% 211.76/211.95  |- mesh__recordAuthorizer mesh__D015186 sjn
% 211.76/211.95  |- mesh__dateEstablished mesh__D015186 1989-01-01
% 211.76/211.95  |- mesh__recordOriginator mesh__D015186 SCD
% 211.76/211.95  |- mesh__historyNote mesh__D015186 89   
% 211.76/211.95  |- skos__altLabel mesh__D015186 Apes
% 211.76/211.95  |- skos__annotation mesh__D015186
% 211.76/211.95       diseases: coordinate IM with PRIMATE DISEASES %28%IM%29%; note X ref APES: diseases in an unspecified ape, index APE DISEASES %28%IM%29% + HOMINIDAE %28%NIM%29%; extinct humans %28%Homo sp. other than Homo sapiens%29%  go here but neanderthals are indexed with both HUMANS + HOMINIDAE%A%  
% 211.76/211.95  |- mesh__dateCreated mesh__D015186 1988-04-19
% 211.76/211.95  |- mesh__activeMeSHYear mesh__D015186 2006
% 211.76/211.95  |- skos__prefLabel mesh__D015186 Hominidae
% 211.76/211.95  |- skos__scopeNote mesh__D015186
% 211.76/211.95       Family of the suborder HAPLORHINI %28%Anthropoidea%29% comprising bipedal primate MAMMALS. It includes modern man %28%HOMO SAPIENS%29% and the great apes: gorillas %28%GORILLA GORILLA%29%, chimpanzees %28%PAN PANISCUS and PAN TROGLODYTES%29%, and orangutans %28%PONGO PYGMAEUS%29%.%A%    
% 211.76/211.95  |- skos__historyNote mesh__D015186 Anthropoidea %28%1981-1988%29%
% 211.76/211.95  |- skos__broader mesh__D009947smesh__D009942
% 211.76/211.95  |- mesh__dateEstablished mesh__D009947 1975-09-01
% 211.76/211.95  |- mesh__recordOriginator mesh__D009947 NLM
% 211.76/211.95  |- mesh__recordAuthorizer mesh__D009947 PLS
% 211.76/211.96  |- mesh__dateRevised mesh__D009947 1992-05-19
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D009947 2000
% 211.76/211.96  |- skos__scopeNote mesh__D009947
% 211.76/211.96       Organic compounds which contain tin in the molecule. Used widely in industry and agriculture.%A%    
% 211.76/211.96  |- mesh__recordMaintainer mesh__D009947 TAP
% 211.76/211.96  |- mesh__publicMeSHNote mesh__D009947 75   
% 211.76/211.96  |- skos__historyNote mesh__D009947 Organometallic Compounds %28%1974%29%
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D009947 2004
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D009947 2006
% 211.76/211.96  |- skos__historyNote mesh__D009947 Tin %28%1974%29%
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D009947 2003
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D009947 1997
% 211.76/211.96  |- mesh__historyNote mesh__D009947 75   
% 211.76/211.96  |- skos__annotation mesh__D009947 DF: ORGANOTIN CPDS   
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D009947 2005
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D009947 1999
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D009947 1993
% 211.76/211.96  |- skos__hiddenLabel mesh__D009947 Compounds, Organotin
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D009947 2002
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D009947 1996
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D009947 1995
% 211.76/211.96  |- rdf__type mesh__D009947sskos__Concept
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D009947 1998
% 211.76/211.96  |- mesh__dateCreated mesh__D009947 1974-11-11
% 211.76/211.96  |- skos__prefLabel mesh__D009947 Organotin Compounds
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D009947 2001
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D009947 1994
% 211.76/211.96  |- skos__scopeNote mesh__D001964
% 211.76/211.96       A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p744%29%%A%    
% 211.76/211.96  |- skos__hiddenLabel mesh__D001964 Bromhexin BerlinChemie
% 211.76/211.96  |- skos__hiddenLabel mesh__D001964
% 211.76/211.96       ct Arzneimittel Brand of Bromhexine Hydrochloride
% 211.76/211.96  |- skos__hiddenLabel mesh__D001964
% 211.76/211.96       Berlin Chemie Brand of Bromhexine Hydrochloride
% 211.76/211.96  |- skos__altLabel mesh__D001964 Boots Brand of Bromhexine Hydrochloride
% 211.76/211.96  |- skos__hiddenLabel mesh__D001964 DurElix
% 211.76/211.96  |- skos__hiddenLabel mesh__D001964 Hustentabs ratiopharm
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001964 2006B
% 211.76/211.96  |- skos__altLabel mesh__D001964 Bromhexin Berlin-Chemie
% 211.76/211.96  |- skos__altLabel mesh__D001964 Quentan
% 211.76/211.96  |- mesh__recordOriginator mesh__D001964 NLM
% 211.76/211.96  |- skos__hiddenLabel mesh__D001964 BC, Bromhexin
% 211.76/211.96  |- skos__hiddenLabel mesh__D001964 Dur Elix
% 211.76/211.96  |- skos__altLabel mesh__D001964 Hoechst Brand of Bromhexine Hydrochloride
% 211.76/211.96  |- skos__hiddenLabel mesh__D001964 von ct, bromhexin
% 211.76/211.96  |- mesh__dateRevised mesh__D001964 2005-07-30
% 211.76/211.96  |- skos__altLabel mesh__D001964 Apex Brand of Bromhexine Hydrochloride
% 211.76/211.96  |- skos__altLabel mesh__D001964
% 211.76/211.96       Berlin-Chemie Brand of Bromhexine Hydrochloride
% 211.76/211.96  |- skos__altLabel mesh__D001964 Fher Brand of Bromhexine Hydrochloride
% 211.76/211.96  |- mesh__publicMeSHNote mesh__D001964 74   
% 211.76/211.96  |- skos__hiddenLabel mesh__D001964 Bromhexine, Famel
% 211.76/211.96  |- skos__altLabel mesh__D001964 bromhexin von ct
% 211.76/211.96  |- skos__altLabel mesh__D001964
% 211.76/211.96       ct-Arzneimittel Brand of Bromhexine Hydrochloride
% 211.76/211.96  |- mesh__dateEstablished mesh__D001964 1974-01-01
% 211.76/211.96  |- skos__altLabel mesh__D001964 Boehrvet Brand of Bromhexine Hydrochloride
% 211.76/211.96  |- skos__hiddenLabel mesh__D001964 Monohydrochloride, Bromhexine
% 211.76/211.96  |- skos__altLabel mesh__D001964
% 211.76/211.96       ratiopharm Brand of Bromhexine Hydrochloride
% 211.76/211.96  |- mesh__historyNote mesh__D001964 74   
% 211.76/211.96  |- mesh__dateCreated mesh__D001964 1999-01-01
% 211.76/211.96  |- skos__altLabel mesh__D001964
% 211.76/211.96       Omniapharm Brand of Bromhexine Hydrochloride
% 211.76/211.96  |- skos__hiddenLabel mesh__D001964 Bromhexin ratiopharm
% 211.76/211.96  |- skos__hiddenLabel mesh__D001964 SB CH Brand of Bromhexine Hydrochloride
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001964 2005
% 211.76/211.96  |- skos__prefLabel mesh__D001964 Bromhexine
% 211.76/211.96  |- skos__altLabel mesh__D001964
% 211.76/211.96       Boehringer Ingelheim Brand of Bromhexine Hydrochloride
% 211.76/211.96  |- skos__altLabel mesh__D001964 Novartis Brand of Bromhexine Hydrochloride
% 211.76/211.96  |- skos__broader mesh__D001964smesh__D000814
% 211.76/211.96  |- skos__altLabel mesh__D001964 Krewel Brand of Bromhexine Hydrochloride
% 211.76/211.96  |- skos__hiddenLabel mesh__D001964 NA 274
% 211.76/211.96  |- skos__altLabel mesh__D001964 SB-CH Brand of Bromhexine Hydrochloride
% 211.76/211.96  |- skos__altLabel mesh__D001964 3M Brand of Bromhexine Hydrochloride
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001964 2006A
% 211.76/211.96  |- skos__hiddenLabel mesh__D001964 Hydrochloride, Bromhexine
% 211.76/211.96  |- skos__hiddenLabel mesh__D001964 Bromhexinratiopharm
% 211.76/211.96  |- mesh__recordAuthorizer mesh__D001964 jls
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001964 2006
% 211.76/211.96  |- skos__hiddenLabel mesh__D001964 ct, bromhexin von
% 211.76/211.96  |- skos__altLabel mesh__D001964 Promeco Brand of Bromhexine Hydrochloride
% 211.76/211.96  |- skos__altLabel mesh__D001964 Bromhexine Monohydrochloride
% 211.76/211.96  |- skos__broader mesh__D001964smesh__D003514
% 211.76/211.96  |- skos__hiddenLabel mesh__D001964 Bromhexin Berlin Chemie
% 211.76/211.96  |- skos__altLabel mesh__D001964 Bromhexin-ratiopharm
% 211.76/211.96  |- skos__hiddenLabel mesh__D001964 Hustentabsratiopharm
% 211.76/211.96  |- mesh__recordMaintainer mesh__D001964 jls
% 211.76/211.96  |- rdf__type mesh__D001964sskos__Concept
% 211.76/211.96  |- skos__altLabel mesh__D001964 Merckle Brand of Bromhexine Hydrochloride
% 211.76/211.96  |- skos__hiddenLabel mesh__D001964 NA274
% 211.76/211.96  |- skos__related mesh__D009149smesh__D031226
% 211.76/211.96  |- mesh__recordAuthorizer mesh__D009149 sjn
% 211.76/211.96  |- mesh__recordMaintainer mesh__D009149 ssb
% 211.76/211.96  |- mesh__dateRevised mesh__D009149 2005-06-30
% 211.76/211.96  |- skos__broader mesh__D009149smesh__D001937
% 211.76/211.96  |- skos__broader mesh__D009149smesh__D000821
% 211.76/211.96  |- mesh__historyNote mesh__D009149 2004%28%1963%29%   
% 211.76/211.96  |- rdf__type mesh__D009149sskos__Concept
% 211.76/211.96  |- skos__hiddenLabel mesh__D009149 Foods, Mustard
% 211.76/211.96  |- skos__hiddenLabel mesh__D009149 Food, Mustard
% 211.76/211.96  |- skos__annotation mesh__D009149
% 211.76/211.96       for mustard plant family use BRASSICACEAE; coordinate with specific PLANT COMPONENTS term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D009149 2006
% 211.76/211.96  |- skos__hiddenLabel mesh__D009149 Mustard Foods
% 211.76/211.96  |- skos__hiddenLabel mesh__D009149 Mustard Plants
% 211.76/211.96  |- mesh__dateEstablished mesh__D009149 1991-01-01
% 211.76/211.96  |- mesh__publicMeSHNote mesh__D009149
% 211.76/211.96       2004; see MUSTARD 1991-2003, see BRASSICA 1986-1990, see MUSTARD 1963-1985%A%  
% 211.76/211.96  |- skos__altLabel mesh__D009149 Mustard Food
% 211.76/211.96  |- mesh__dateCreated mesh__D009149 1999-01-01
% 211.76/211.96  |- skos__prefLabel mesh__D009149 Mustard Plant
% 211.76/211.96  |- mesh__recordOriginator mesh__D009149 NLM
% 211.76/211.96  |- skos__scopeNote mesh__D009149
% 211.76/211.96       Any of several BRASSICA species that are commonly called mustard. Brassica alba is white mustard, B. juncea is brown or Chinese mustard, and B. nigra is black, brown, or red mustard. The plant is grown both for mustard seed from which oil is extracted and for greens or animal feed. It was formerly used as an emetic, counter-irritant, and carminative.  There is no relationship to MUSTARD COMPOUNDS.%A%    
% 211.76/211.96  |- skos__broader mesh__D009149smesh__D014675
% 211.76/211.96  |- skos__hiddenLabel mesh__D001166 Surgical Arteriovenous Shunts
% 211.76/211.96  |- skos__broader mesh__D001166smesh__D014656
% 211.76/211.96  |- mesh__recordOriginator mesh__D001166 NLM
% 211.76/211.96  |- mesh__dateCreated mesh__D001166 1999-01-01
% 211.76/211.96  |- skos__prefLabel mesh__D001166 Arteriovenous Shunt, Surgical
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001166 2004
% 211.76/211.96  |- mesh__dateRevised mesh__D001166 1997-06-20
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001166 2002
% 211.76/211.96  |- skos__altLabel mesh__D001166 Shunt, Surgical Arteriovenous
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001166 1999
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001166 2006
% 211.76/211.96  |- mesh__publicMeSHNote mesh__D001166 70   
% 211.76/211.96  |- mesh__recordAuthorizer mesh__D001166 SJN
% 211.76/211.96  |- skos__hiddenLabel mesh__D001166 Arteriovenous Shunts, Surgical
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001166 2003
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001166 2001
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001166 1998
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001166 2005
% 211.76/211.96  |- skos__broader mesh__D001166smesh__D000714
% 211.76/211.96  |- rdf__type mesh__D001166sskos__Concept
% 211.76/211.96  |- skos__annotation mesh__D001166
% 211.76/211.96       do not use /util except by MeSH definition; Manual 23.19.6.2%A%  
% 211.76/211.96  |- skos__historyNote mesh__D001166 Arteriovenous Fistula %28%1966-1969%29%
% 211.76/211.96  |- mesh__dateEstablished mesh__D001166 1970-01-01
% 211.76/211.96  |- mesh__recordMaintainer mesh__D001166 PXP
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001166 2000
% 211.76/211.96  |- skos__historyNote mesh__D001166 Arteries/surgery %28%1966-1969%29%
% 211.76/211.96  |- skos__hiddenLabel mesh__D001166 Shunts, Surgical Arteriovenous
% 211.76/211.96  |- mesh__historyNote mesh__D001166 70   
% 211.76/211.96  |- skos__altLabel mesh__D001166 Surgical Arteriovenous Shunt
% 211.76/211.96  |- skos__scopeNote mesh__D001166
% 211.76/211.96       Surgical shunt allowing direct passage of blood from an artery to a vein. %28%From Dorland, 28th ed%29%%A%    
% 211.76/211.96  |- skos__altLabel mesh__D020320 Antisense Oligoribonucleotide
% 211.76/211.96  |- skos__historyNote mesh__D020320
% 211.76/211.96       Oligonucleotides, Antisense %28%1991-1998%29%
% 211.76/211.96  |- skos__altLabel mesh__D020320 Anti-Sense Oligoribonucleotides
% 211.76/211.96  |- skos__hiddenLabel mesh__D020320 Oligoribonucleotide, Anti-Sense
% 211.76/211.96  |- mesh__dateEstablished mesh__D020320 1999-01-01
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D020320 2004
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D020320 2005
% 211.76/211.96  |- skos__hiddenLabel mesh__D020320 Oligoribonucleotides, Anti-Sense
% 211.76/211.96  |- mesh__publicMeSHNote mesh__D020320
% 211.76/211.96       99; see OLIGONUCLEOTIDES, ANTISENSE 1991-98   
% 211.76/211.96  |- skos__broader mesh__D020320smesh__D016376
% 211.76/211.96  |- skos__hiddenLabel mesh__D020320 Anti Sense Oligoribonucleotide
% 211.76/211.96  |- mesh__dateRevised mesh__D020320 2003-07-09
% 211.76/211.96  |- mesh__dateCreated mesh__D020320 1998-06-10
% 211.76/211.96  |- skos__prefLabel mesh__D020320 Oligoribonucleotides, Antisense
% 211.76/211.96  |- skos__altLabel mesh__D020320 Antisense OligoRNA
% 211.76/211.96  |- skos__broader mesh__D020320smesh__D016372
% 211.76/211.96  |- skos__hiddenLabel mesh__D020320 OligoRNA, Antisense
% 211.76/211.96  |- mesh__historyNote mesh__D020320
% 211.76/211.96       99; was OLIGONUCLEOTIDES, ANTISENSE 1991-98   
% 211.76/211.96  |- skos__hiddenLabel mesh__D020320 Anti Sense Oligoribonucleotides
% 211.76/211.96  |- skos__altLabel mesh__D020320 Antisense Oligoribonucleotides
% 211.76/211.96  |- skos__historyNote mesh__D020320 RNA, Antisense %28%1991-1998%29%
% 211.76/211.96  |- skos__altLabel mesh__D020320 Oligoribonucleotide, Antisense
% 211.76/211.96  |- rdf__type mesh__D020320sskos__Concept
% 211.76/211.96  |- skos__scopeNote mesh__D020320
% 211.76/211.96       Short fragments of RNA that are used to alter the function of target RNAs or DNAs to which they hybridize.%A%    
% 211.76/211.96  |- skos__altLabel mesh__D020320 Anti-Sense Oligoribonucleotide
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D020320 2006
% 211.76/211.96  |- mesh__recordOriginator mesh__D047268 lkt
% 211.76/211.96  |- skos__hiddenLabel mesh__D047268 Goiters, Lingual
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D047268 2006
% 211.76/211.96  |- skos__broader mesh__D047268smesh__D006042
% 211.76/211.96  |- skos__broader mesh__D047268smesh__D046151
% 211.76/211.96  |- skos__prefLabel mesh__D047268 Lingual Goiter
% 211.76/211.96  |- skos__scopeNote mesh__D047268
% 211.76/211.96       Pathological enlargement of the LINGUAL THYROID, ectopic thyroid tissue at the base of the TONGUE. It may cause upper AIRWAY OBSTRUCTION; DYSPHAGIA; or HYPOTHYROIDISM symptoms.%A%    
% 211.76/211.96  |- skos__historyNote mesh__D047268 Tongue Diseases %28%1965-2004%29%
% 211.76/211.96  |- mesh__dateCreated mesh__D047268 2004-07-07
% 211.76/211.96  |- mesh__dateRevised mesh__D047268 2005-06-30
% 211.76/211.96  |- rdf__type mesh__D047268sskos__Concept
% 211.76/211.96  |- mesh__dateEstablished mesh__D047268 2005-01-01
% 211.76/211.96  |- skos__hiddenLabel mesh__D047268 Goiter, Lingual
% 211.76/211.96  |- mesh__recordMaintainer mesh__D047268 lkt
% 211.76/211.96  |- skos__historyNote mesh__D047268 Goiter %28%1965-2004%29%
% 211.76/211.96  |- mesh__recordAuthorizer mesh__D047268 sjn
% 211.76/211.96  |- mesh__historyNote mesh__D047268 2005   
% 211.76/211.96  |- skos__hiddenLabel mesh__D047268 Lingual Goiters
% 211.76/211.96  |- mesh__publicMeSHNote mesh__D047268 2005   
% 211.76/211.96  |- mesh__dateCreated mesh__D019577 1997-06-20
% 211.76/211.96  |- mesh__publicMeSHNote mesh__D019577 98   
% 211.76/211.96  |- mesh__recordOriginator mesh__D019577 TGC
% 211.76/211.96  |- skos__annotation mesh__D019577 NIM when experimental animal   
% 211.76/211.96  |- skos__hiddenLabel mesh__D019577 Mole-Rat
% 211.76/211.96  |- skos__hiddenLabel mesh__D019577 Rat, Mole
% 211.76/211.96  |- skos__historyNote mesh__D019577 Rodentia %28%1968-1997%29%
% 211.76/211.96  |- mesh__historyNote mesh__D019577 98   
% 211.76/211.96  |- skos__scopeNote mesh__D019577
% 211.76/211.96       Any of several burrowing rodents of the families MURIDAE and Bathyergidae, found in eastern Europe, Africa, and Asia. They have short limbs, small eyes with permanently closed lids, and no tail. Three genera SPALAX %28%Muridae%29%, Heterocephalus %28%Bathyergidae%29% and Cryptomys %28%Bathyergidae%29% are used frequently as experimental animals in biomedical research. %28%From Walker%27%s Mammals of the World, 6th ed%29%%A%    
% 211.76/211.96  |- skos__broader mesh__D019577smesh__D012377
% 211.76/211.96  |- skos__hiddenLabel mesh__D019577 Rats, Mole
% 211.76/211.96  |- mesh__recordAuthorizer mesh__D019577 sjn
% 211.76/211.96  |- skos__altLabel mesh__D019577 Mole-Rats
% 211.76/211.96  |- skos__hiddenLabel mesh__D019577 Mole Rat
% 211.76/211.96  |- mesh__dateEstablished mesh__D019577 1998-01-01
% 211.76/211.96  |- skos__hiddenLabel mesh__D019577 Molerat
% 211.76/211.96  |- skos__prefLabel mesh__D019577 Mole Rats
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D019577 2006
% 211.76/211.96  |- skos__historyNote mesh__D019577 Muridae %28%1982-1997%29%
% 211.76/211.96  |- mesh__dateRevised mesh__D019577 2004-07-07
% 211.76/211.96  |- skos__altLabel mesh__D019577 Molerats
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D019577 2005
% 211.76/211.96  |- mesh__recordMaintainer mesh__D019577 ags
% 211.76/211.96  |- rdf__type mesh__D019577sskos__Concept
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D011594 1996
% 211.76/211.96  |- mesh__dateRevised mesh__D011594 1978-07-14
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D011594 2006
% 211.76/211.96  |- skos__broader mesh__D011594smesh__D011581
% 211.76/211.96  |- skos__annotation mesh__D011594
% 211.76/211.96       SPEC: SPEC qualif; NIM coord: no qualif; includes statist analysis of psychol tests, validation, applic of statist theory or formulae to psychol%A%  
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D011594 1997
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D011594 1992
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D011594 1990
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D011594 1998
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D011594 1993
% 211.76/211.96  |- skos__hiddenLabel mesh__D011594 Psychometric
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D011594 1991
% 211.76/211.96  |- skos__prefLabel mesh__D011594 Psychometrics
% 211.76/211.96  |- mesh__recordAuthorizer mesh__D011594 NLM
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D011594 1994
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D011594 1999
% 211.76/211.96  |- skos__scopeNote mesh__D011594
% 211.76/211.96       Assessment of psychological variables by the application of mathematical procedures.%A%    
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D011594 2000
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D011594 1989
% 211.76/211.96  |- rdf__type mesh__D011594sskos__Concept
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D011594 2003
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D011594 1995
% 211.76/211.96  |- mesh__recordMaintainer mesh__D011594 GJB
% 211.76/211.96  |- mesh__recordOriginator mesh__D011594 NLM
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D011594 2001
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D011594 2004
% 211.76/211.96  |- mesh__dateCreated mesh__D011594 1999-01-01
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D011594 2002
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D011594 2005
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D005557 2005
% 211.76/211.96  |- mesh__recordMaintainer mesh__D005557 ssb
% 211.76/211.96  |- mesh__recordOriginator mesh__D005557 NLM
% 211.76/211.96  |- mesh__dateCreated mesh__D005557 1999-01-01
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D005557 2002
% 211.76/211.96  |- mesh__dateRevised mesh__D005557 2001-07-25
% 211.76/211.96  |- mesh__recordAuthorizer mesh__D005557 sjn
% 211.76/211.96  |- skos__broader mesh__D005557smesh__D000447
% 211.76/211.96  |- rdf__type mesh__D005557sskos__Concept
% 211.76/211.96  |- skos__altLabel mesh__D005557 Methanal
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D005557 2004
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D005557 2006
% 211.76/211.96  |- skos__scopeNote mesh__D005557
% 211.76/211.96       A highly reactive aldehyde gas formed by oxidation or incomplete combustion of hydrocarbons. In solution, it has a wide range of uses: in the manufacture of resins and textiles, as a disinfectant, and as a laboratory fixative or preservative. Formaldehyde solution %28%formalin%29% is considered a hazardous compound, and its vapor toxic. %28%From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p717%29%%A%    
% 211.76/211.96  |- skos__prefLabel mesh__D005557 Formaldehyde
% 211.76/211.96  |- skos__altLabel mesh__D005557 Oxomethane
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D005557 2003
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D015985 1996
% 211.76/211.96  |- skos__hiddenLabel mesh__D015985 Precipitating Factor
% 211.76/211.96  |- mesh__dateCreated mesh__D015985 1989-05-25
% 211.76/211.96  |- skos__historyNote mesh__D015985
% 211.76/211.96       specific disease/epidemiology %28%1966-1989%29%
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D015985 2000
% 211.76/211.96  |- skos__hiddenLabel mesh__D015985 Factors, Precipitating
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D015985 1999
% 211.76/211.96  |- skos__historyNote mesh__D015985 Risk %28%1966-1989%29%
% 211.76/211.96  |- mesh__publicMeSHNote mesh__D015985 90   
% 211.76/211.96  |- mesh__dateEstablished mesh__D015985 1990-01-01
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D015985 1995
% 211.76/211.96  |- skos__scopeNote mesh__D015985
% 211.76/211.96       Factors associated with the definitive onset of a disease, illness, accident, behavioral response, or course of action. Usually one factor is more important or more obviously recognizable than others, if several are involved, and one may often be regarded as %22%necessary%22%. Examples include exposure to specific disease; amount or level of an infectious organism, drug, or noxious agent, etc.%A%    
% 211.76/211.96  |- mesh__dateRevised mesh__D015985 1994-04-11
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D015985 1998
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D015985 2004
% 211.76/211.96  |- rdf__type mesh__D015985sskos__Concept
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D015985 2002
% 211.76/211.96  |- skos__historyNote mesh__D015985
% 211.76/211.96       specific disease/etiology %28%1966-1989%29%
% 211.76/211.96  |- skos__annotation mesh__D015985
% 211.76/211.96       IM GEN only; coord NIM with disease %28%IM%29%; no qualif; specify geog if pertinent%A%  
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D015985 2003
% 211.76/211.96  |- mesh__historyNote mesh__D015985 90   
% 211.76/211.96  |- skos__broader mesh__D015985smesh__D015984
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D015985 2006
% 211.76/211.96  |- skos__prefLabel mesh__D015985 Precipitating Factors
% 211.76/211.96  |- mesh__recordMaintainer mesh__D015985 TGC
% 211.76/211.96  |- mesh__recordAuthorizer mesh__D015985 PLS
% 211.76/211.96  |- mesh__recordOriginator mesh__D015985 PLS
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D015985 1997
% 211.76/211.96  |- skos__hiddenLabel mesh__D015985 Factor, Precipitating
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D015985 2001
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D015985 2005
% 211.76/211.96  |- skos__historyNote mesh__D015187 Surgery, Plastic %28%1967-1988%29%
% 211.76/211.96  |- skos__scopeNote mesh__D015187
% 211.76/211.96       Removal of localized SUBCUTANEOUS FAT deposits by SUCTION CURETTAGE or blunt CANNULATION in the cosmetic correction of OBESITY and other esthetic contour defects.%A%    
% 211.76/211.96  |- skos__altLabel mesh__D015187 Liposuction
% 211.76/211.96  |- mesh__dateCreated mesh__D015187 1988-04-19
% 211.76/211.96  |- skos__hiddenLabel mesh__D015187 Lipectomies
% 211.76/211.96  |- skos__historyNote mesh__D015187 Adipose Tissue/surgery %28%1967-1988%29%
% 211.76/211.96  |- skos__altLabel mesh__D015187 Lipolysis, Suction
% 211.76/211.96  |- rdf__type mesh__D015187sskos__Concept
% 211.76/211.96  |- mesh__publicMeSHNote mesh__D015187 89   
% 211.76/211.96  |- mesh__dateEstablished mesh__D015187 1989-01-01
% 211.76/211.96  |- skos__hiddenLabel mesh__D015187 Suction Lipolysis
% 211.76/211.96  |- skos__broader mesh__D015187smesh__D003357
% 211.76/211.96  |- skos__hiddenLabel mesh__D015187 Lipectomies, Suction
% 211.76/211.96  |- mesh__recordOriginator mesh__D015187 SCD
% 211.76/211.96  |- skos__hiddenLabel mesh__D015187 Lipolysis, Aspiration
% 211.76/211.96  |- skos__hiddenLabel mesh__D015187 Lipectomies, Aspiration
% 211.76/211.96  |- skos__hiddenLabel mesh__D015187 Lipectomy, Suction
% 211.76/211.96  |- skos__broader mesh__D015187smesh__D019651
% 211.76/211.96  |- skos__historyNote mesh__D015187 Suction %28%1982-1988%29%
% 211.76/211.96  |- skos__hiddenLabel mesh__D015187 Lipectomy, Aspiration
% 211.76/211.96  |- skos__altLabel mesh__D015187 Suction Lipectomy
% 211.76/211.96  |- mesh__dateRevised mesh__D015187 2005-06-30
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D015187 2006
% 211.76/211.96  |- mesh__recordMaintainer mesh__D015187 lkt
% 211.76/211.96  |- skos__hiddenLabel mesh__D015187 Lipoplasties
% 211.76/211.96  |- skos__broader mesh__D015187smesh__D050110
% 211.76/211.96  |- mesh__historyNote mesh__D015187 89   
% 211.76/211.96  |- skos__hiddenLabel mesh__D015187 Liposuctions
% 211.76/211.96  |- mesh__recordAuthorizer mesh__D015187 sjn
% 211.76/211.96  |- skos__hiddenLabel mesh__D015187 Suction Lipectomies
% 211.76/211.96  |- skos__hiddenLabel mesh__D015187 Aspiration Lipectomies
% 211.76/211.96  |- skos__altLabel mesh__D015187 Aspiration Lipolysis
% 211.76/211.96  |- skos__annotation mesh__D015187
% 211.76/211.96       do not use /util except by MeSH definition   
% 211.76/211.96  |- skos__prefLabel mesh__D015187 Lipectomy
% 211.76/211.96  |- mesh__dateEstablished mesh__D009948 1969-01-01
% 211.76/211.96  |- mesh__historyNote mesh__D009948 69   
% 211.76/211.96  |- skos__hiddenLabel mesh__D009948 Orgasms
% 211.76/211.96  |- mesh__dateRevised mesh__D009948 2004-07-07
% 211.76/211.96  |- skos__prefLabel mesh__D009948 Orgasm
% 211.76/211.96  |- mesh__recordAuthorizer mesh__D009948 sjn
% 211.76/211.96  |- skos__scopeNote mesh__D009948
% 211.76/211.96       The crisis of sexual excitement in either humans or animals.%A%    
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D009948 2006
% 211.76/211.96  |- mesh__dateCreated mesh__D009948 1999-01-01
% 211.76/211.96  |- mesh__recordMaintainer mesh__D009948 lkt
% 211.76/211.96  |- rdf__type mesh__D009948sskos__Concept
% 211.76/211.96  |- mesh__publicMeSHNote mesh__D009948 69   
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D009948 2005
% 211.76/211.96  |- skos__broader mesh__D009948smesh__D012098
% 211.76/211.96  |- mesh__recordOriginator mesh__D009948 NLM
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001965 2006
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001965 1999
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001965 1994
% 211.76/211.96  |- mesh__recordMaintainer mesh__D001965 TPW
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001965 2004
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001965 1997
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001965 2005
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001965 1998
% 211.76/211.96  |- skos__scopeNote mesh__D001965
% 211.76/211.96       Salts of hydrobromic acid, HBr, with the bromine atom in the 1- oxidation state. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 211.76/211.96  |- mesh__recordAuthorizer mesh__D001965 PLS
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001965 2003
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001965 2001
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001965 1996
% 211.76/211.96  |- skos__annotation mesh__D001965 only for inorganic cpds or bromide ion   
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001965 2000
% 211.76/211.96  |- mesh__recordOriginator mesh__D001965 NLM
% 211.76/211.96  |- mesh__dateCreated mesh__D001965 1999-01-01
% 211.76/211.96  |- skos__broader mesh__D001965smesh__D000838
% 211.76/211.96  |- skos__prefLabel mesh__D001965 Bromides
% 211.76/211.96  |- rdf__type mesh__D001965sskos__Concept
% 211.76/211.96  |- mesh__dateRevised mesh__D001965 1993-06-04
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001965 2002
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001965 1995
% 211.76/211.96  |- skos__broader mesh__D001965smesh__D018054
% 211.76/211.96  |- skos__historyNote mesh__D034341 Phenanthrenes %28%1965-2002%29%
% 211.76/211.96  |- mesh__historyNote mesh__D034341 2003   
% 211.76/211.96  |- skos__scopeNote mesh__D034341
% 211.76/211.96       Nitro-phenanthrenes occurring in ARISTOLOCHIACEAE and other plants. They derive from stephanine %28%APORPHINE%29% by oxidative ring cleavage. The nitro group is a reactive alkylator %28%ALKYLATING AGENTS%29% that binds to biological macromolecules. Ingestion by humans is associated with nephropathy %28%NEPHRITIS%29%. There is no relationship to the similar named aristolochene %28%SESQUITERPENES%29%.%A%    
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D034341 2004
% 211.76/211.96  |- rdf__type mesh__D034341sskos__Concept
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D034341 2003
% 211.76/211.96  |- skos__prefLabel mesh__D034341 Aristolochic Acids
% 211.76/211.96  |- mesh__dateEstablished mesh__D034341 2003-01-01
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D034341 2006
% 211.76/211.96  |- skos__broader mesh__D034341smesh__D009574
% 211.76/211.96  |- mesh__publicMeSHNote mesh__D034341 2003   
% 211.76/211.96  |- skos__broader mesh__D034341smesh__D010616
% 211.76/211.96  |- mesh__dateCreated mesh__D034341 2002-07-02
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D034341 2005
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001167 2001
% 211.76/211.96  |- mesh__dateRevised mesh__D001167 1993-06-02
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001167 1996
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001167 2003
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001167 1998
% 211.76/211.96  |- mesh__recordAuthorizer mesh__D001167 PLS
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001167 2005
% 211.76/211.96  |- skos__broader mesh__D001167smesh__D014657
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001167 1997
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001167 2004
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001167 1994
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001167 2002
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001167 1999
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001167 2006
% 211.76/211.96  |- mesh__recordOriginator mesh__D001167 NLM
% 211.76/211.96  |- skos__hiddenLabel mesh__D001167 Arteritides
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001167 1995
% 211.76/211.96  |- skos__prefLabel mesh__D001167 Arteritis
% 211.76/211.96  |- rdf__type mesh__D001167sskos__Concept
% 211.76/211.96  |- mesh__recordMaintainer mesh__D001167 TAP
% 211.76/211.96  |- mesh__dateCreated mesh__D001167 1999-01-01
% 211.76/211.96  |- skos__broader mesh__D001167smesh__D014652
% 211.76/211.96  |- skos__annotation mesh__D001167
% 211.76/211.96       GEN on unspecified inflamm of an artery; coord IM with specific artery %28%IM%29%%A%  
% 211.76/211.96  |- mesh__activeMeSHYear mesh__D001167 2000
% 211.76/211.96  |- skos__scopeNote mesh__D001167 Inflammation of an artery.     
% 211.76/211.96  |- skos__hiddenLabel mesh__D006650 Typings, Tissue
% 211.76/211.97  |- skos__hiddenLabel mesh__D006650 Tissue Crossmatchings
% 211.76/211.97  |- skos__altLabel mesh__D006650 Crossmatching, Tissue
% 211.76/211.97  |- skos__prefLabel mesh__D006650 Histocompatibility Testing
% 211.76/211.97  |- rdf__type mesh__D006650sskos__Concept
% 211.76/211.97  |- skos__broader mesh__D006650smesh__D007159
% 211.76/211.97  |- skos__hiddenLabel mesh__D006650 Testings, Histocompatibility
% 211.76/211.97  |- skos__hiddenLabel mesh__D006650 Tissue Typings
% 211.76/211.97  |- skos__broader mesh__D006650smesh__D007158
% 211.76/211.97  |- skos__hiddenLabel mesh__D006650 Testing, Histocompatibility
% 211.76/211.97  |- mesh__dateEstablished mesh__D006650 1970-01-01
% 211.76/211.97  |- skos__hiddenLabel mesh__D006650 Typing, Tissue
% 211.76/211.97  |- skos__hiddenLabel mesh__D006650 HLA Typings
% 211.76/211.97  |- skos__hiddenLabel mesh__D006650 Histocompatibility Testings
% 211.76/211.97  |- skos__hiddenLabel mesh__D006650 Typings, HLA
% 211.76/211.97  |- skos__hiddenLabel mesh__D006650 Typing, HLA
% 211.76/211.97  |- skos__altLabel mesh__D006650 Tissue Typing
% 211.76/211.97  |- mesh__publicMeSHNote mesh__D006650 70   
% 211.76/211.97  |- mesh__dateRevised mesh__D006650 2005-06-30
% 211.76/211.97  |- skos__annotation mesh__D006650
% 211.76/211.97       human or animal; do not confuse with HEMOCOMPATIBILITY TESTING see MATERIALS TESTING%A%  
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D006650 2006
% 211.76/211.97  |- skos__hiddenLabel mesh__D006650 Crossmatchings, Tissue
% 211.76/211.97  |- mesh__dateCreated mesh__D006650 1999-01-01
% 211.76/211.97  |- mesh__historyNote mesh__D006650 70%28%68%29%   
% 211.76/211.97  |- mesh__recordOriginator mesh__D006650 NLM
% 211.76/211.97  |- mesh__recordAuthorizer mesh__D006650 sjn
% 211.76/211.97  |- skos__historyNote mesh__D006650
% 211.76/211.97       Transplantation Immunology %28%1966-1967%29%
% 211.76/211.97  |- skos__hiddenLabel mesh__D006650 Tissue Crossmatching
% 211.76/211.97  |- skos__scopeNote mesh__D006650
% 211.76/211.97       Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. %28%King, Dictionary of Genetics, 4th ed%29%%A%    
% 211.76/211.97  |- mesh__recordMaintainer mesh__D006650 nns
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D047269 2005
% 211.76/211.97  |- mesh__historyNote mesh__D047269 2005   
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D047269 2006
% 211.76/211.97  |- skos__scopeNote mesh__D047269
% 211.76/211.97       A genus of SEA URCHINS in the family Strongylocentrotidae. They possess more than three pore pairs per ambulacral plate. The species STRONGYLOCENTROTUS PURPURATUS is commonly used for research.%A%    
% 211.76/211.97  |- mesh__dateCreated mesh__D047269 2004-07-07
% 211.76/211.97  |- skos__prefLabel mesh__D047269 Strongylocentrotus
% 211.76/211.97  |- skos__historyNote mesh__D047269 Sea Urchins %28%1971-2004%29%
% 211.76/211.97  |- rdf__type mesh__D047269sskos__Concept
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D047269 2006A
% 211.76/211.97  |- skos__historyNote mesh__D047269 Echinodermata %28%1965-1971%29%
% 211.76/211.97  |- mesh__publicMeSHNote mesh__D047269 2005   
% 211.76/211.97  |- skos__broader mesh__D047269smesh__D012617
% 211.76/211.97  |- mesh__recordAuthorizer mesh__D047269 ags
% 211.76/211.97  |- mesh__dateEstablished mesh__D047269 2005-01-01
% 211.76/211.97  |- mesh__recordMaintainer mesh__D047269 ags
% 211.76/211.97  |- mesh__recordOriginator mesh__D047269 ags
% 211.76/211.97  |- mesh__dateRevised mesh__D047269 2005-07-29
% 211.76/211.97  |- mesh__dateCreated mesh__D019578 1997-06-20
% 211.76/211.97  |- skos__hiddenLabel mesh__D019578 Multisystem Atrophies
% 211.76/211.97  |- skos__related mesh__D019578smesh__D012791
% 211.76/211.97  |- skos__hiddenLabel mesh__D019578 Atrophies, Multisystemic
% 211.76/211.97  |- mesh__publicMeSHNote mesh__D019578 1998   
% 211.76/211.97  |- mesh__recordMaintainer mesh__D019578 ags
% 211.76/211.97  |- skos__broader mesh__D019578smesh__D001480
% 211.76/211.97  |- rdf__type mesh__D019578sskos__Concept
% 211.76/211.97  |- mesh__recordAuthorizer mesh__D019578 ags
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D019578 2000
% 211.76/211.97  |- skos__scopeNote mesh__D019578
% 211.76/211.97       A syndrome complex composed of three conditions which represent clinical variants of the same disease process: STRIATONIGRAL DEGENERATION; SHY-DRAGER SYNDROME; and the sporadic form of OLIVOPONTOCEREBELLAR ATROPHIES. Clinical features include autonomic, cerebellar, and basal ganglia dysfunction. Pathologic examination reveals atrophy of the basal ganglia, cerebellum, pons, and medulla, with prominent loss of autonomic neurons in the brain stem and spinal cord. %28%From Adams et al., Principles of Neurology, 6th ed, p1076; Baillieres Clin Neurol 1997 Apr;6%28%1%29%:187-204; Med Clin North Am 1999 Mar;83%28%2%29%:381-92%29%%A%    
% 211.76/211.97  |- mesh__historyNote mesh__D019578 1998   
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D019578 2004
% 211.76/211.97  |- mesh__dateEstablished mesh__D019578 1998-01-01
% 211.76/211.97  |- skos__historyNote mesh__D019578
% 211.76/211.97       Nervous System Diseases %28%1969-1997%29%
% 211.76/211.97  |- skos__annotation mesh__D019578
% 211.76/211.97       a specific neurodegenerative syndrome complex; not for atrophy in other systems%A%  
% 211.76/211.97  |- skos__hiddenLabel mesh__D019578 Atrophy, Multisystem
% 211.76/211.97  |- skos__prefLabel mesh__D019578 Multiple System Atrophy
% 211.76/211.97  |- skos__altLabel mesh__D019578 Multisystemic Atrophy
% 211.76/211.97  |- skos__altLabel mesh__D019578 Multisystem Atrophy
% 211.76/211.97  |- skos__historyNote mesh__D019578 Brain Diseases %28%1981-1993%29%
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D019578 2003
% 211.76/211.97  |- skos__broader mesh__D019578smesh__D019636
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D019578 2002
% 211.76/211.97  |- skos__hiddenLabel mesh__D019578 Atrophy, Multiple System
% 211.76/211.97  |- skos__hiddenLabel mesh__D019578 Atrophy, Multisystemic
% 211.76/211.97  |- skos__historyNote mesh__D019578 Shy-Drager Syndrome %28%1981-1997%29%
% 211.76/211.97  |- skos__broader mesh__D019578smesh__D009069
% 211.76/211.97  |- skos__hiddenLabel mesh__D019578 Atrophies, Multisystem
% 211.76/211.97  |- mesh__dateRevised mesh__D019578 1999-12-13
% 211.76/211.97  |- skos__altLabel mesh__D019578 Multiple System Atrophy Syndrome
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D019578 2006
% 211.76/211.97  |- skos__historyNote mesh__D019578
% 211.76/211.97       Autonomic Nervous System Diseases %28%1981-1997%29%
% 211.76/211.97  |- skos__hiddenLabel mesh__D019578 Multiple System Atrophies
% 211.76/211.97  |- skos__related mesh__D019578smesh__D009849
% 211.76/211.97  |- skos__hiddenLabel mesh__D019578 Multisystemic Atrophies
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D019578 2005
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D019578 2000A
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D019578 2001
% 211.76/211.97  |- mesh__recordOriginator mesh__D019578 TGC
% 211.76/211.97  |- mesh__dateEstablished mesh__D011595 1978-01-01
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D011595 2002
% 211.76/211.97  |- mesh__recordMaintainer mesh__D011595 KEV
% 211.76/211.97  |- skos__altLabel mesh__D011595 Restlessness
% 211.76/211.97  |- skos__altLabel mesh__D011595 Psychomotor Restlessness
% 211.76/211.97  |- skos__prefLabel mesh__D011595 Psychomotor Agitation
% 211.76/211.97  |- skos__historyNote mesh__D011595 Psychomotor Disorders %28%1969-1977%29%
% 211.76/211.97  |- skos__altLabel mesh__D011595 Psychomotor Hyperactivity
% 211.76/211.97  |- mesh__dateRevised mesh__D011595 1999-11-08
% 211.76/211.97  |- mesh__historyNote mesh__D011595 1978   
% 211.76/211.97  |- skos__broader mesh__D011595smesh__D011596
% 211.76/211.97  |- rdf__type mesh__D011595sskos__Concept
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D011595 2003
% 211.76/211.97  |- mesh__dateCreated mesh__D011595 1977-05-13
% 211.76/211.97  |- skos__hiddenLabel mesh__D011595 Restlessness, Psychomotor
% 211.76/211.97  |- skos__altLabel mesh__D011595 Excitement, Psychomotor
% 211.76/211.97  |- skos__hiddenLabel mesh__D011595 Psychomotor Excitement
% 211.76/211.97  |- skos__scopeNote mesh__D011595
% 211.76/211.97       A feeling of restlessness associated with increased motor activity. This may occur as a manifestation of nervous system drug toxicity or other conditions.%A%    
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D011595 2004
% 211.76/211.97  |- skos__altLabel mesh__D011595 Agitation, Psychomotor
% 211.76/211.97  |- skos__broader mesh__D011595smesh__D020820
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D011595 2000
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D011595 2005
% 211.76/211.97  |- mesh__recordOriginator mesh__D011595 EC
% 211.76/211.97  |- mesh__recordAuthorizer mesh__D011595 sjn
% 211.76/211.97  |- mesh__publicMeSHNote mesh__D011595 1978   
% 211.76/211.97  |- skos__historyNote mesh__D011595 Motor Activity %28%1968-1977%29%
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D011595 2001
% 211.76/211.97  |- skos__annotation mesh__D011595
% 211.76/211.97       do not confuse X ref AKATHISIA with AKATHISIA, DRUG-INDUCED: see note there%A%  
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D011595 2006
% 211.76/211.97  |- skos__hiddenLabel mesh__D011595 Hyperactivity, Psychomotor
% 211.76/211.97  |- skos__hiddenLabel mesh__D005558 Formamidase, Kynurenine
% 211.76/211.97  |- mesh__dateCreated mesh__D005558 1999-01-01
% 211.76/211.97  |- mesh__recordMaintainer mesh__D005558 ssb
% 211.76/211.97  |- skos__broader mesh__D005558smesh__D000581
% 211.76/211.97  |- mesh__onlineNote mesh__D005558
% 211.76/211.97       use ARYLFORMAMIDASE to search FORMAMIDASE 1966-95   
% 211.76/211.97  |- mesh__dateRevised mesh__D005558 2003-07-09
% 211.76/211.97  |- rdf__type mesh__D005558sskos__Concept
% 211.76/211.97  |- mesh__recordOriginator mesh__D005558 NLM
% 211.76/211.97  |- mesh__historyNote mesh__D005558
% 211.76/211.97       96; was FORMAMIDASE 1964-95 %28%see under AMIDOHYDROLASES 1964-90%29%%A%  
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D005558 2004
% 211.76/211.97  |- skos__scopeNote mesh__D005558
% 211.76/211.97       An enzyme that catalyzes the conversion of N-formyl-L-kynurenine and water to formate and L-kynurenine. It also acts on other aromatic formylamines. %28%Enzyme Nomenclature, 1992%29% EC 3.5.1.9.%A%    
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D005558 2006
% 211.76/211.97  |- skos__altLabel mesh__D005558 Kynurenine Formamidase
% 211.76/211.97  |- skos__prefLabel mesh__D005558 Arylformamidase
% 211.76/211.97  |- mesh__recordAuthorizer mesh__D005558 sjn
% 211.76/211.97  |- mesh__dateEstablished mesh__D005558 1991-01-01
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D005558 2005
% 211.76/211.97  |- mesh__publicMeSHNote mesh__D005558
% 211.76/211.97       96; was FORMAMIDASE 1964-95 %28%see under AMIDOHYDROLASES 1964-90%29%%A%  
% 211.76/211.97  |- skos__scopeNote mesh__D016280
% 211.76/211.97       The hemodynamic and electrophysiological action of the RIGHT ATRIUM.%A%    
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D016280 2005
% 211.76/211.97  |- mesh__recordOriginator mesh__D016280 PXP
% 211.76/211.97  |- skos__historyNote mesh__D016280 Heart/physiology %28%1966-1990%29%
% 211.76/211.97  |- mesh__historyNote mesh__D016280 91   
% 211.76/211.97  |- skos__hiddenLabel mesh__D016280 Atrial Functions, Right
% 211.76/211.97  |- skos__broader mesh__D016280smesh__D016275
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D016280 2006
% 211.76/211.97  |- mesh__recordAuthorizer mesh__D016280 sjn
% 211.76/211.97  |- skos__prefLabel mesh__D016280 Atrial Function, Right
% 211.76/211.97  |- mesh__recordMaintainer mesh__D016280 nns
% 211.76/211.97  |- mesh__publicMeSHNote mesh__D016280 91   
% 211.76/211.97  |- mesh__dateEstablished mesh__D016280 1991-01-01
% 211.76/211.97  |- mesh__dateRevised mesh__D016280 2003-07-09
% 211.76/211.97  |- rdf__type mesh__D016280sskos__Concept
% 211.76/211.97  |- mesh__dateCreated mesh__D016280 1990-05-25
% 211.76/211.97  |- skos__hiddenLabel mesh__D016280 Right Atrial Functions
% 211.76/211.97  |- skos__historyNote mesh__D016280
% 211.76/211.97       Heart Atrium/physiology %28%1968-1990%29%
% 211.76/211.97  |- skos__hiddenLabel mesh__D016280 Function, Right Atrial
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D016280 2004
% 211.76/211.97  |- skos__altLabel mesh__D016280 Right Atrial Function
% 211.76/211.97  |- skos__hiddenLabel mesh__D016280 Functions, Right Atrial
% 211.76/211.97  |- skos__hiddenLabel mesh__D002260 15 Methylprostaglandin F2alpha
% 211.76/211.97  |- skos__altLabel mesh__D002260 15-Methylprostaglandin F2alpha
% 211.76/211.97  |- skos__historyNote mesh__D002260 Prostaglandins %28%1966-1974%29%
% 211.76/211.97  |- skos__prefLabel mesh__D002260 Carboprost
% 211.76/211.97  |- skos__historyNote mesh__D002260 Prostaglandins, Synthetic %28%1977%29%
% 211.76/211.97  |- rdf__type mesh__D002260sskos__Concept
% 211.76/211.97  |- skos__historyNote mesh__D002260 Prostaglandins F %28%1975-1977%29%
% 211.76/211.97  |- mesh__recordOriginator mesh__D002260 RLS
% 211.76/211.97  |- mesh__publicMeSHNote mesh__D002260
% 211.76/211.97       91; was see under PROSTAGLANDINS F, SYNTHETIC 1980-90; METHYLDINOPROST %26% 15-METHYLPROSTAGLANDIN F2ALPHA METHYL ESTER were see CARBOPROST 1980-93%A%  
% 211.76/211.97  |- mesh__dateRevised mesh__D002260 2005-06-30
% 211.76/211.97  |- skos__broader mesh__D002260smesh__D011461
% 211.76/211.97  |- skos__scopeNote mesh__D002260
% 211.76/211.97       A nonsteroidal abortifacient agent that is effective in both the first and second trimesters of PREGNANCY.%A%    
% 211.76/211.97  |- mesh__historyNote mesh__D002260
% 211.76/211.97       91%28%80%29%; was see under PROSTAGLANDINS F, SYNTHETIC 1980-90; METHYLDINOPROST %26% 15-METHYLPROSTAGLANDIN F2ALPHA METHYL ESTER were see CARBOPROST 1980-93%A%  
% 211.76/211.97  |- skos__historyNote mesh__D002260
% 211.76/211.97       Prostaglandins F, Synthetic %28%1978-1979%29%
% 211.76/211.97  |- mesh__recordMaintainer mesh__D002260 ssb
% 211.76/211.97  |- mesh__onlineNote mesh__D002260
% 211.76/211.97       use CARBOPROST to search METHYLDINOPROST %26% 15-METHYLPROSTAGLANDIN F2ALPHA METHYL ESTER 1980-93%A%  
% 211.76/211.97  |- mesh__dateEstablished mesh__D002260 1991-01-01
% 211.76/211.97  |- mesh__recordAuthorizer mesh__D002260 sjn
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D002260 2006
% 211.76/211.97  |- mesh__dateCreated mesh__D002260 1979-05-23
% 211.76/211.97  |- skos__altLabel mesh__D002260 15%28%S%29%-15-Methyl PGF2alpha
% 211.76/211.97  |- skos__hiddenLabel mesh__D015986 Factor, Epidemiologic Confounding
% 211.76/211.97  |- skos__altLabel mesh__D015986 Confounding Variables
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D015986 1994
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D015986 2000
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D015986 1999
% 211.76/211.97  |- skos__altLabel mesh__D015986 Confounding Factor, Epidemiologic
% 211.76/211.97  |- mesh__historyNote mesh__D015986 90   
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D015986 2003
% 211.76/211.97  |- skos__hiddenLabel mesh__D015986
% 211.76/211.97       Factors, Confounding %28%Epidemiology%29%
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D015986 1995
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D015986 2001
% 211.76/211.97  |- skos__broader mesh__D015986smesh__D015981
% 211.76/211.97  |- skos__hiddenLabel mesh__D015986 Epidemiologic Confounding Factor
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D015986 2004
% 211.76/211.97  |- skos__hiddenLabel mesh__D015986 Confounding Factors, Epidemiologic
% 211.76/211.97  |- rdf__type mesh__D015986sskos__Concept
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D015986 2002
% 211.76/211.97  |- skos__hiddenLabel mesh__D015986 Confounding Variable
% 211.76/211.97  |- skos__hiddenLabel mesh__D015986 Factors, Epidemiologic Confounding
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D015986 2005
% 211.76/211.97  |- mesh__recordMaintainer mesh__D015986 TGC
% 211.76/211.97  |- skos__annotation mesh__D015986
% 211.76/211.97       IM GEN only; coord NIM with disease /epidemiol %28%IM%29%, not /etiol; no qualif; specify geog if pertinent; DF: CONFOUNDING FACTORS%A%  
% 211.76/211.97  |- skos__hiddenLabel mesh__D015986 Factor, Confounding %28%Epidemiology%29%
% 211.76/211.97  |- skos__prefLabel mesh__D015986 Confounding Factors %28%Epidemiology%29%
% 211.76/211.97  |- skos__hiddenLabel mesh__D015986 Confounding Factor %28%Epidemiology%29%
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D015986 1996
% 211.76/211.97  |- mesh__dateCreated mesh__D015986 1989-05-25
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D015986 2006
% 211.76/211.97  |- skos__hiddenLabel mesh__D015986 Epidemiologic Confounding Factors
% 211.76/211.97  |- mesh__recordAuthorizer mesh__D015986 PLS
% 211.76/211.97  |- mesh__recordOriginator mesh__D015986 PLS
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D015986 1997
% 211.76/211.97  |- skos__scopeNote mesh__D015986
% 211.76/211.97       Factors that can cause or prevent the outcome of interest, are not intermediate variables, and are not associated with the factor%28%s%29% under investigation. They give rise to situations in which the effects of two processes are not separated, or the contribution of causal factors cannot be separated, or the measure of the effect of exposure or risk is distorted because of its association with other factors influencing the outcome of the study.%A%    
% 211.76/211.97  |- skos__hiddenLabel mesh__D015986 Variable, Confounding
% 211.76/211.97  |- skos__hiddenLabel mesh__D015986 Variables, Confounding
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D015986 1998
% 211.76/211.97  |- mesh__publicMeSHNote mesh__D015986 90   
% 211.76/211.97  |- mesh__dateEstablished mesh__D015986 1990-01-01
% 211.76/211.97  |- mesh__dateRevised mesh__D015986 1993-05-26
% 211.76/211.97  |- skos__prefLabel mesh__D009949 Orientation
% 211.76/211.97  |- mesh__dateRevised mesh__D009949 1992-05-15
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D009949 2001
% 211.76/211.97  |- skos__broader mesh__D009949smesh__D000223
% 211.76/211.97  |- mesh__recordOriginator mesh__D009949 NLM
% 211.76/211.97  |- mesh__recordAuthorizer mesh__D009949 PLS
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D009949 2004
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D009949 1997
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D009949 2000
% 211.76/211.97  |- skos__broader mesh__D009949smesh__D011603
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D009949 2006
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D009949 2003
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D009949 1999
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D009949 1996
% 211.76/211.97  |- skos__annotation mesh__D009949 human %26% animal   
% 211.76/211.97  |- mesh__recordMaintainer mesh__D009949 TAP
% 211.76/211.97  |- mesh__dateCreated mesh__D009949 1999-01-01
% 211.76/211.97  |- rdf__type mesh__D009949sskos__Concept
% 211.76/211.97  |- skos__scopeNote mesh__D009949
% 211.76/211.97       Awareness of oneself in relation to time, place and person.%A%    
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D009949 2005
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D009949 1993
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D009949 1998
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D009949 1995
% 211.76/211.97  |- skos__hiddenLabel mesh__D009949 Orientations
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D009949 1994
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D009949 2002
% 211.76/211.97  |- skos__annotation mesh__D001966
% 211.76/211.97       a halogen; Br-79; Br-81 = BROMINE %28%IM%29% + ISOTOPES %28%NIM%29%; Br-74-78, 80, 82-90 = BROMINE RADIOISOTOPES %28%IM%29%%A%  
% 211.76/211.97  |- mesh__dateCreated mesh__D001966 1999-01-01
% 211.76/211.97  |- skos__related mesh__D001966smesh__D001967
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D001966 2002
% 211.76/211.97  |- rdf__type mesh__D001966sskos__Concept
% 211.76/211.97  |- mesh__recordMaintainer mesh__D001966 ADP
% 211.76/211.97  |- skos__broader mesh__D001966smesh__D006219
% 211.76/211.97  |- skos__scopeNote mesh__D001966
% 211.76/211.97       A halogen with the atomic symbol Br, atomic number 36, and atomic weight 79.904. It is a volatile reddish-brown liquid that gives off suffocating vapors, is corrosive to the skin, and may cause severe gastroenteritis if ingested.%A%    
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D001966 2006
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D001966 1999
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D001966 2001
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D001966 2004
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D001966 2000
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D001966 2005
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D001966 1998
% 211.76/211.97  |- mesh__dateRevised mesh__D001966 1997-06-20
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D001966 2003
% 211.76/211.97  |- mesh__recordAuthorizer mesh__D001966 SJN
% 211.76/211.97  |- skos__prefLabel mesh__D001966 Bromine
% 211.76/211.97  |- mesh__recordOriginator mesh__D001966 NLM
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D001168 2005
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D001168 2004
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D001168 2006
% 211.76/211.97  |- skos__annotation mesh__D001168
% 211.76/211.97       inflamm: do not confuse with ARTHRALGIA which is non-inflamm; note X ref POLYARTHRITIS but polyarthrite chronique %C3%%A9%volutive %28%PCE%29% = ARTHRITIS, RHEUMATOID; septic arthritis = ARTHRITIS, INFECTIOUS; tends to be chronic so do not coord with CHRONIC DISEASE; degenerative arthritis = OSTEOARTHRITIS; ARTHRITIS, PSORIATIC is also available%A%  
% 211.76/211.97  |- skos__hiddenLabel mesh__D001168 Polyarthritides
% 211.76/211.97  |- rdf__type mesh__D001168sskos__Concept
% 211.76/211.97  |- skos__related mesh__D001168smesh__D015210
% 211.76/211.97  |- skos__prefLabel mesh__D001168 Arthritis
% 211.76/211.97  |- mesh__recordAuthorizer mesh__D001168 sjn
% 211.76/211.97  |- mesh__dateCreated mesh__D001168 1999-01-01
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D001168 2002
% 211.76/211.97  |- mesh__publicMeSHNote mesh__D001168
% 211.76/211.97       ARTHRITIS, ADJUVANT was ADJUVANT ARTHRITIS see under ARTHRITIS, RHEUMATOID 1975-76%A%  
% 211.76/211.97  |- mesh__recordOriginator mesh__D001168 NLM
% 211.76/211.97  |- skos__hiddenLabel mesh__D001168 Arthritides
% 211.76/211.97  |- mesh__dateRevised mesh__D001168 2001-08-13
% 211.76/211.97  |- skos__related mesh__D001168smesh__D015535
% 211.76/211.97  |- skos__broader mesh__D001168smesh__D007592
% 211.76/211.97  |- mesh__recordMaintainer mesh__D001168 jls
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D001168 2003
% 211.76/211.97  |- mesh__recordOriginator mesh__D006651 NLM
% 211.76/211.97  |- mesh__dateRevised mesh__D006651 2004-07-07
% 211.76/211.97  |- rdf__type mesh__D006651sskos__Concept
% 211.76/211.97  |- mesh__publicMeSHNote mesh__D006651
% 211.76/211.97       67; CYTOCHEMISTRY was heading 1966; HISTOCHEMISTRY was heading 1964-66%A%  
% 211.76/211.97  |- mesh__recordAuthorizer mesh__D006651 sjn
% 211.76/211.97  |- skos__scopeNote mesh__D006651
% 211.76/211.97       Study of intracellular distribution of chemicals, reaction sites, enzymes, etc., by means of staining reactions, radioactive isotope uptake, selective metal distribution in electron microscopy, or other methods.%A%    
% 211.76/211.97  |- mesh__dateEstablished mesh__D006651 1967-01-01
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D006651 2006
% 211.76/211.97  |- skos__broader mesh__D006651smesh__D006652
% 211.76/211.97  |- mesh__dateCreated mesh__D006651 1999-01-01
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D006651 2005
% 211.76/211.97  |- skos__prefLabel mesh__D006651 Histocytochemistry
% 211.76/211.97  |- mesh__onlineNote mesh__D006651
% 211.76/211.97       use HISTOCYTOCHEMISTRY to search CYTOCHEMISTRY %26% HISTOCHEMISTRY 1966%A%  
% 211.76/211.97  |- mesh__historyNote mesh__D006651
% 211.76/211.97       67; CYTOCHEMISTRY was heading 1966; HISTOCHEMISTRY was heading 1964-66%A%  
% 211.76/211.97  |- mesh__recordMaintainer mesh__D006651 ags
% 211.76/211.97  |- skos__broader mesh__D006651smesh__D001671
% 211.76/211.97  |- skos__annotation mesh__D006651
% 211.76/211.97       = histochem or cytochem or both; NIM usually with no qualif; SPEC qualif when IM; histochem of disease is disease /metab; Manual 26.11+%A%  
% 211.76/211.97  |- skos__broader mesh__D006651smesh__D003584
% 211.76/211.97  |- mesh__recordAuthorizer mesh__D019579 sjn
% 211.76/211.97  |- skos__broader mesh__D019579smesh__D002540
% 211.76/211.97  |- skos__scopeNote mesh__D019579
% 211.76/211.97       The largest portion of the CEREBRAL CORTEX. It is composed of NEURONS arranged in six layers.%A%    
% 211.76/211.97  |- skos__prefLabel mesh__D019579 Neocortex
% 211.76/211.97  |- mesh__historyNote mesh__D019579 98   
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D019579 2005
% 211.76/211.97  |- mesh__dateCreated mesh__D019579 1997-06-20
% 211.76/211.97  |- mesh__dateRevised mesh__D019579 1999-11-03
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D019579 2002
% 211.76/211.97  |- mesh__recordMaintainer mesh__D019579 KEV
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D019579 2006
% 211.76/211.97  |- skos__historyNote mesh__D019579 Cerebral Cortex %28%1966-1997%29%
% 211.76/211.97  |- mesh__publicMeSHNote mesh__D019579 98   
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D019579 2003
% 211.76/211.97  |- mesh__recordOriginator mesh__D019579 TGC
% 211.76/211.97  |- rdf__type mesh__D019579sskos__Concept
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D019579 2000
% 211.76/211.97  |- skos__hiddenLabel mesh__D019579 Neocortices
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D019579 2004
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D019579 2001
% 211.76/211.97  |- mesh__dateEstablished mesh__D019579 1998-01-01
% 211.76/211.97  |- skos__historyNote mesh__D019579 specific part of brain %28%1966-1997%29%
% 211.76/211.97  |- rdf__type mesh__D011596sskos__Concept
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D011596 2003
% 211.76/211.97  |- skos__prefLabel mesh__D011596 Psychomotor Disorders
% 211.76/211.97  |- skos__hiddenLabel mesh__D011596 Impairments, Psychomotor
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D011596 2000
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D011596 2004
% 211.76/211.97  |- mesh__recordAuthorizer mesh__D011596 sjn
% 211.76/211.97  |- mesh__recordOriginator mesh__D011596 NLM
% 211.76/211.97  |- mesh__dateCreated mesh__D011596 1999-01-01
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D011596 2001
% 211.76/211.97  |- skos__hiddenLabel mesh__D011596 Impairment, Psychomotor
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D011596 2005
% 211.76/211.97  |- skos__broader mesh__D011596smesh__D019954
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D011596 2002
% 211.76/211.97  |- skos__historyNote mesh__D011596 Movement Disorders %28%1966-1968%29%
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D011596 2006
% 211.76/211.97  |- mesh__publicMeSHNote mesh__D011596 1969   
% 211.76/211.97  |- skos__hiddenLabel mesh__D011596 Psychomotor Impairments
% 211.76/211.97  |- skos__hiddenLabel mesh__D011596 Psychomotor Disorder, Developmental
% 211.76/211.97  |- mesh__historyNote mesh__D011596 1969   
% 211.76/211.97  |- mesh__recordMaintainer mesh__D011596 KEV
% 211.76/211.97  |- skos__hiddenLabel mesh__D011596 Developmental Psychomotor Disorder
% 211.76/211.97  |- skos__scopeNote mesh__D011596
% 211.76/211.97       Abnormalities of motor function that are associated with organic and non-organic cognitive disorders.%A%    
% 211.76/211.97  |- mesh__dateEstablished mesh__D011596 1969-01-01
% 211.76/211.97  |- mesh__dateRevised mesh__D011596 1999-11-03
% 211.76/211.97  |- skos__altLabel mesh__D011596 Psychomotor Disorders, Developmental
% 211.76/211.97  |- skos__scopeNote mesh__D005559
% 211.76/211.97       A group of amides with the general formula of R-CONH2.     
% 211.76/211.97  |- skos__prefLabel mesh__D005559 Formamides
% 211.76/211.97  |- skos__broader mesh__D005559smesh__D000577
% 211.76/211.97  |- skos__annotation mesh__D005559 D25-26 qualif   
% 211.76/211.97  |- mesh__recordOriginator mesh__D005559 NLM
% 211.76/211.97  |- rdf__type mesh__D005559sskos__Concept
% 211.76/211.97  |- mesh__recordAuthorizer mesh__D005559 PLS
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D005559 1997
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D005559 2002
% 211.76/211.97  |- mesh__dateRevised mesh__D005559 1995-05-18
% 211.76/211.97  |- mesh__dateEstablished mesh__D005559 1973-01-01
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D005559 2004
% 211.76/211.97  |- mesh__onlineNote mesh__D005559
% 211.76/211.97       use FORMAMIDES to search FORMAMIDE 1966-74 %28%as Prov 1966-72%29%%A%  
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D005559 1996
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D005559 1999
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D005559 2001
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D005559 2003
% 211.76/211.97  |- mesh__recordMaintainer mesh__D005559 KEV
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D005559 2006
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D005559 1998
% 211.76/211.97  |- mesh__publicMeSHNote mesh__D005559 75; was FORMAMIDE 1973-74   
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D005559 2000
% 211.76/211.97  |- skos__broader mesh__D005559smesh__D005564
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D005559 2005
% 211.76/211.97  |- mesh__dateCreated mesh__D005559 1999-01-01
% 211.76/211.97  |- mesh__historyNote mesh__D005559
% 211.76/211.97       75; was FORMAMIDE 1964-74 %28%Prov 1964-72%29%   
% 211.76/211.97  |- skos__altLabel mesh__D016281 v-fms Protein
% 211.76/211.97  |- mesh__recordOriginator mesh__D016281 AGS
% 211.76/211.97  |- skos__hiddenLabel mesh__D016281 v fms Protein
% 211.76/211.97  |- skos__scopeNote mesh__D016281
% 211.76/211.97       Transforming glycoprotein coded by the fms oncogene from the Susan McDonough strain of feline sarcoma virus %28%SM-FeSV%29%. The oncogene protein v-fms lacks sequences, which, in the highly homologous proto-oncogene protein c-fms %28%CSF-1 receptor%29%, normally serve to regulate its tyrosine kinase activity. The missing sequences in v-fms mimic the effect of ligand and lead to constitutive cell growth. The protein gp120%28%v-fms%29% is post-translationally modified to generate gp140%28%v-fms%29%.%A%    
% 211.76/211.97  |- skos__prefLabel mesh__D016281 Oncogene Protein gp140%28%v-fms%29%
% 211.76/211.97  |- skos__altLabel mesh__D016281 fms Oncogene Protein gp140
% 211.76/211.97  |- rdf__type mesh__D016281sskos__Concept
% 211.76/211.97  |- skos__altLabel mesh__D016281 gp120 v-fms
% 211.76/211.97  |- mesh__dateEstablished mesh__D016281 1991-01-01
% 211.76/211.97  |- skos__hiddenLabel mesh__D016281 gp140 v fms
% 211.76/211.97  |- skos__hiddenLabel mesh__D016281 v-fms, gp140
% 211.76/211.97  |- skos__hiddenLabel mesh__D016281 gp120 v fms
% 211.76/211.97  |- skos__broader mesh__D016281smesh__D015682
% 211.76/211.97  |- skos__hiddenLabel mesh__D016281 v-fms, gp120
% 211.76/211.97  |- mesh__dateRevised mesh__D016281 2005-06-30
% 211.76/211.97  |- skos__annotation mesh__D016281
% 211.76/211.97       IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted; DF: note short X refs%A%  
% 211.76/211.97  |- skos__altLabel mesh__D016281 fms Oncogene Product gp140
% 211.76/211.97  |- mesh__recordAuthorizer mesh__D016281 sjn
% 211.76/211.97  |- skos__altLabel mesh__D016281 gp140%28%v-fms%29%
% 211.76/211.97  |- mesh__recordMaintainer mesh__D016281 SYSTEM
% 211.76/211.97  |- skos__historyNote mesh__D016281 Retroviridae Proteins %28%1987-1989%29%
% 211.76/211.97  |- mesh__historyNote mesh__D016281 91   
% 211.76/211.97  |- mesh__publicMeSHNote mesh__D016281 91   
% 211.76/211.97  |- mesh__activeMeSHYear mesh__D016281 2006
% 211.76/211.98  |- skos__historyNote mesh__D016281
% 211.76/211.98       Retroviridae Proteins, Oncogenic %28%1990%29%
% 211.76/211.98  |- skos__historyNote mesh__D016281
% 211.76/211.98       Oncogene Proteins, Viral %28%1985-1989%29%
% 211.76/211.98  |- mesh__dateCreated mesh__D016281 1990-06-19
% 211.76/211.98  |- skos__altLabel mesh__D016281 gp140 v-fms
% 211.76/211.98  |- mesh__recordAuthorizer mesh__D002261 sjn
% 211.76/211.98  |- skos__historyNote mesh__D002261 Oxathiins %28%1972-1974%29%
% 211.76/211.98  |- rdf__type mesh__D002261sskos__Concept
% 211.76/211.98  |- skos__hiddenLabel mesh__D002261 D 735
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D002261 2001
% 211.76/211.98  |- mesh__recordOriginator mesh__D002261 NLM
% 211.76/211.98  |- skos__historyNote mesh__D002261 Anilides %28%1972-1974%29%
% 211.76/211.98  |- skos__prefLabel mesh__D002261 Carboxin
% 211.76/211.98  |- skos__altLabel mesh__D002261
% 211.76/211.98       5,6-Dihydro-2-methyl-N-phenyl-1,4-oxathiin-3-carboxamide
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D002261 2002
% 211.76/211.98  |- skos__hiddenLabel mesh__D002261 D735
% 211.76/211.98  |- mesh__historyNote mesh__D002261
% 211.76/211.98       91%28%75%29%; was see under ANILIDES 1975-90   
% 211.76/211.98  |- skos__broader mesh__D002261smesh__D000813
% 211.76/211.98  |- skos__broader mesh__D002261smesh__D010075
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D002261 2005
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D002261 2003
% 211.76/211.98  |- mesh__dateEstablished mesh__D002261 1991-01-01
% 211.76/211.98  |- mesh__dateRevised mesh__D002261 2000-06-21
% 211.76/211.98  |- mesh__dateCreated mesh__D002261 1974-11-11
% 211.76/211.98  |- skos__scopeNote mesh__D002261
% 211.76/211.98       A systemic agricultural fungicide and seed treatment agent.%A%    
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D002261 2006
% 211.76/211.98  |- mesh__recordMaintainer mesh__D002261 CCR
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D002261 2004
% 211.76/211.98  |- mesh__publicMeSHNote mesh__D002261 91; was see under ANILIDES 1975-90   
% 211.76/211.98  |- mesh__recordMaintainer mesh__D015987 TGC
% 211.76/211.98  |- skos__altLabel mesh__D015987 Epidemiologic Effect Modifier
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015987 1994
% 211.76/211.98  |- skos__annotation mesh__D015987
% 211.76/211.98       IM GEN only; coord NIM with disease /epidemiol %28%IM%29%; no qualif; specify geog if pertinent; DF: EFF MODIFIERS%A%  
% 211.76/211.98  |- skos__hiddenLabel mesh__D015987 Effect, Hawthorne
% 211.76/211.98  |- mesh__publicMeSHNote mesh__D015987 90   
% 211.76/211.98  |- mesh__historyNote mesh__D015987 90   
% 211.76/211.98  |- skos__hiddenLabel mesh__D015987 Halo Effects
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015987 2003
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015987 1998
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015987 2002
% 211.76/211.98  |- skos__altLabel mesh__D015987 Conditional Variables
% 211.76/211.98  |- skos__hiddenLabel mesh__D015987 Modifier, Effect %28%Epidemiology%29%
% 211.76/211.98  |- mesh__recordAuthorizer mesh__D015987 PLS
% 211.76/211.98  |- skos__altLabel mesh__D015987 Modifiers, Epidemiologic Effect
% 211.76/211.98  |- skos__scopeNote mesh__D015987
% 211.76/211.98       Factors that modify the effect of the putative causal factor%28%s%29% under study.%A%    
% 211.76/211.98  |- skos__altLabel mesh__D015987 Moderator Variables
% 211.76/211.98  |- mesh__recordOriginator mesh__D015987 PLS
% 211.76/211.98  |- skos__hiddenLabel mesh__D015987 Modifiers, Effect %28%Epidemiology%29%
% 211.76/211.98  |- skos__hiddenLabel mesh__D015987 Moderator Variable
% 211.76/211.98  |- mesh__dateRevised mesh__D015987 1993-05-27
% 211.76/211.98  |- skos__hiddenLabel mesh__D015987 Variable, Conditional
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015987 1997
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015987 2001
% 211.76/211.98  |- skos__broader mesh__D015987smesh__D015981
% 211.76/211.98  |- skos__hiddenLabel mesh__D015987 Variables, Moderator
% 211.76/211.98  |- skos__hiddenLabel mesh__D015987 Conditional Variable
% 211.76/211.98  |- skos__altLabel mesh__D015987 Effect Modifier, Epidemiologic
% 211.76/211.98  |- skos__hiddenLabel mesh__D015987 Effects, Halo
% 211.76/211.98  |- skos__hiddenLabel mesh__D015987 Variables, Conditional
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015987 2006
% 211.76/211.98  |- skos__hiddenLabel mesh__D015987 Variable, Moderator
% 211.76/211.98  |- skos__hiddenLabel mesh__D015987 Effects, Interviewer
% 211.76/211.98  |- mesh__dateCreated mesh__D015987 1989-05-25
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015987 1996
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015987 2000
% 211.76/211.98  |- skos__hiddenLabel mesh__D015987 Effect, Halo
% 211.76/211.98  |- skos__altLabel mesh__D015987 Epidemiologic Effect Modifiers
% 211.76/211.98  |- mesh__dateEstablished mesh__D015987 1990-01-01
% 211.76/211.98  |- rdf__type mesh__D015987sskos__Concept
% 211.76/211.98  |- skos__hiddenLabel mesh__D015987 Interviewer Effects
% 211.76/211.98  |- skos__prefLabel mesh__D015987 Effect Modifiers %28%Epidemiology%29%
% 211.76/211.98  |- skos__hiddenLabel mesh__D015987 Modifier, Epidemiologic Effect
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015987 2005
% 211.76/211.98  |- skos__altLabel mesh__D015987 Effect Modifiers, Epidemiologic
% 211.76/211.98  |- skos__hiddenLabel mesh__D015987 Effect Modifier %28%Epidemiology%29%
% 211.76/211.98  |- skos__hiddenLabel mesh__D015987 Effect, Interviewer
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015987 1995
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015987 2004
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015987 1999
% 211.76/211.98  |- mesh__recordOriginator mesh__D001967 RLS
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D001967 2000
% 211.76/211.98  |- mesh__publicMeSHNote mesh__D001967 88   
% 211.76/211.98  |- rdf__type mesh__D001967sskos__Concept
% 211.76/211.98  |- skos__broader mesh__D001967smesh__D011868
% 211.76/211.98  |- skos__prefLabel mesh__D001967 Bromine Radioisotopes
% 211.76/211.98  |- skos__historyNote mesh__D001967 Radioisotopes %28%1966-1987%29%
% 211.76/211.98  |- mesh__dateCreated mesh__D001967 1987-04-06
% 211.76/211.98  |- skos__scopeNote mesh__D001967
% 211.76/211.98       Unstable isotopes of bromine that decay or disintegrate emitting radiation. Br atoms with atomic weights 74-78, 80, and 82-90 are radioactive bromine isotopes.%A%    
% 211.76/211.98  |- mesh__dateRevised mesh__D001967 1993-06-01
% 211.76/211.98  |- skos__hiddenLabel mesh__D001967 Radioisotopes, Bromine
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D001967 1995
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D001967 2006
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D001967 1999
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D001967 2002
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D001967 2004
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D001967 1994
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D001967 1997
% 211.76/211.98  |- mesh__recordMaintainer mesh__D001967 TPW
% 211.76/211.98  |- mesh__dateEstablished mesh__D001967 1988-01-01
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D001967 2005
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D001967 1998
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D001967 2003
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D001967 1996
% 211.76/211.98  |- mesh__recordAuthorizer mesh__D001967 PLS
% 211.76/211.98  |- skos__historyNote mesh__D001967 Bromine %28%1966-1987%29%
% 211.76/211.98  |- skos__annotation mesh__D001967
% 211.76/211.98       Br-74-78, 80, 82-90; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D001967 2001
% 211.76/211.98  |- mesh__historyNote mesh__D001967 88   
% 211.76/211.98  |- mesh__dateCreated mesh__D001169 1976-05-05
% 211.76/211.98  |- mesh__publicMeSHNote mesh__D001169
% 211.76/211.98       1991; see ARTHRITIS 1977-90; see ARTHRITIS, RHEUMATOID 1975-76%A%  
% 211.76/211.98  |- rdf__type mesh__D001169sskos__Concept
% 211.76/211.98  |- skos__hiddenLabel mesh__D001169 Arthritis, Collagen
% 211.76/211.98  |- mesh__dateEstablished mesh__D001169 1991-01-01
% 211.76/211.98  |- skos__annotation mesh__D001169
% 211.76/211.98       coord with specific type of arthritis if pertinent   
% 211.76/211.98  |- skos__scopeNote mesh__D001169
% 211.76/211.98       ARTHRITIS that is induced in experimental animals. Immunological methods and infectious agents can be used to develop experimental arthritis models. These methods include injections of stimulators of the immune response, such as an adjuvant %28%ADJUVANTS, IMMUNOLOGIC%29% or COLLAGEN.%A%    
% 211.76/211.98  |- mesh__historyNote mesh__D001169
% 211.76/211.98       1991%28%77%29%; use ARTHRITIS 1977-90; use ARTHRITIS, RHEUMATOID 1975-76%A%  
% 211.76/211.98  |- skos__broader mesh__D001169smesh__D001168
% 211.76/211.98  |- mesh__recordMaintainer mesh__D001169 lkt
% 211.76/211.98  |- skos__historyNote mesh__D001169 Arthritis %28%1966-1974%29%
% 211.76/211.98  |- skos__altLabel mesh__D001169 Adjuvant Arthritis
% 211.76/211.98  |- skos__hiddenLabel mesh__D001169 Collagen-Induced Arthritis
% 211.76/211.98  |- skos__hiddenLabel mesh__D001169 Collagen Arthritides
% 211.76/211.98  |- skos__historyNote mesh__D001169 Arthritis, Rheumatoid %28%1966-1974%29%
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D001169 2005
% 211.76/211.98  |- skos__broader mesh__D001169smesh__D004195
% 211.76/211.98  |- skos__altLabel mesh__D001169 Collagen Arthritis
% 211.76/211.98  |- skos__hiddenLabel mesh__D001169 Arthritides, Collagen
% 211.76/211.98  |- skos__altLabel mesh__D001169 Arthritis, Adjuvant
% 211.76/211.98  |- mesh__recordOriginator mesh__D001169 MM
% 211.76/211.98  |- skos__prefLabel mesh__D001169 Arthritis, Experimental
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D001169 2006
% 211.76/211.98  |- mesh__dateRevised mesh__D001169 2004-07-07
% 211.76/211.98  |- mesh__recordAuthorizer mesh__D001169 sjn
% 211.76/211.98  |- skos__hiddenLabel mesh__D001169 Collagen-Induced Arthritides
% 211.76/211.98  |- skos__altLabel mesh__D006652 Technique, Histologic
% 211.76/211.98  |- rdf__type mesh__D006652sskos__Concept
% 211.76/211.98  |- skos__altLabel mesh__D006652 Histologic Technic
% 211.76/211.98  |- skos__altLabel mesh__D006652 Histologic Technique
% 211.76/211.98  |- mesh__dateRevised mesh__D006652 2000-06-22
% 211.76/211.98  |- skos__broader mesh__D006652smesh__D019411
% 211.76/211.98  |- skos__altLabel mesh__D006652 Histological Technics
% 211.76/211.98  |- mesh__publicMeSHNote mesh__D006652
% 211.76/211.98       91; was HISTOLOGICAL TECHNICS 1963-90   
% 211.76/211.98  |- mesh__dateCreated mesh__D006652 1999-01-01
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D006652 2005
% 211.76/211.98  |- skos__altLabel mesh__D006652 Technic, Histologic
% 211.76/211.98  |- skos__annotation mesh__D006652 NIM   
% 211.76/211.98  |- mesh__onlineNote mesh__D006652
% 211.76/211.98       use HISTOLOGICAL TECHNIQUES to search HISTOLOGICAL TECHNICS 1966-90%A%  
% 211.76/211.98  |- mesh__historyNote mesh__D006652 91; was HISTOLOGICAL TECHNICS 1963-90   
% 211.76/211.98  |- skos__hiddenLabel mesh__D006652 Techniques, Histological
% 211.76/211.98  |- skos__altLabel mesh__D006652 Technics, Histologic
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D006652 2003
% 211.76/211.98  |- mesh__recordOriginator mesh__D006652 NLM
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D006652 2006
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D006652 2001
% 211.76/211.98  |- skos__prefLabel mesh__D006652 Histological Techniques
% 211.76/211.98  |- skos__altLabel mesh__D006652 Techniques, Histologic
% 211.76/211.98  |- mesh__recordMaintainer mesh__D006652 kle
% 211.76/211.98  |- skos__hiddenLabel mesh__D006652 Technic, Histological
% 211.76/211.98  |- mesh__recordAuthorizer mesh__D006652 sjn
% 211.76/211.98  |- skos__hiddenLabel mesh__D006652 Histological Technique
% 211.76/211.98  |- skos__hiddenLabel mesh__D006652 Technique, Histological
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D006652 2004
% 211.76/211.98  |- skos__hiddenLabel mesh__D006652 Technics, Histological
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D006652 2002
% 211.76/211.98  |- skos__altLabel mesh__D006652 Histologic Techniques
% 211.76/211.98  |- skos__hiddenLabel mesh__D006652 Histological Technic
% 211.76/211.98  |- skos__altLabel mesh__D006652 Histologic Technics
% 211.76/211.98  |- rdf__type mesh__D020323sskos__Concept
% 211.76/211.98  |- skos__hiddenLabel mesh__D020323 Tics, Vocal
% 211.76/211.98  |- skos__hiddenLabel mesh__D020323 Chorea, Habit
% 211.76/211.98  |- mesh__dateEstablished mesh__D020323 2000-01-01
% 211.76/211.98  |- skos__hiddenLabel mesh__D020323 Habit Choreas
% 211.76/211.98  |- skos__altLabel mesh__D020323 Habit Chorea
% 211.76/211.98  |- skos__hiddenLabel mesh__D020323 Motor Tic
% 211.76/211.98  |- skos__hiddenLabel mesh__D020323 Habituation Spasms
% 211.76/211.98  |- skos__hiddenLabel mesh__D020323 Tics, Motor
% 211.76/211.98  |- skos__hiddenLabel mesh__D020323 Spasms, Habituation
% 211.76/211.98  |- skos__altLabel mesh__D020323 Habituation Spasm
% 211.76/211.98  |- skos__hiddenLabel mesh__D020323 Tics, Gestural
% 211.76/211.98  |- skos__hiddenLabel mesh__D020323 Spasm, Habit
% 211.76/211.98  |- skos__prefLabel mesh__D020323 Tics
% 211.76/211.98  |- skos__hiddenLabel mesh__D020323 Gestural Tics
% 211.76/211.98  |- skos__hiddenLabel mesh__D020323 Motor Tics
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D020323 2002
% 211.76/211.98  |- skos__altLabel mesh__D020323 Tic
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D020323 2003
% 211.76/211.98  |- skos__hiddenLabel mesh__D020323 Transient Tic
% 211.76/211.98  |- skos__annotation mesh__D020323 TIC DISORDERS is available   
% 211.76/211.98  |- skos__hiddenLabel mesh__D020323 Spasm, Habituation
% 211.76/211.98  |- skos__hiddenLabel mesh__D020323 Tics, Transient
% 211.76/211.98  |- mesh__publicMeSHNote mesh__D020323 2000   
% 211.76/211.98  |- skos__hiddenLabel mesh__D020323 Vocal Tic
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D020323 2004
% 211.76/211.98  |- mesh__dateCreated mesh__D020323 1999-11-04
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D020323 2005
% 211.76/211.98  |- skos__hiddenLabel mesh__D020323 Habit Spasms
% 211.76/211.98  |- skos__hiddenLabel mesh__D020323 Gestural Tic
% 211.76/211.98  |- skos__historyNote mesh__D020323 Tic Disorders %28%1966-1999%29%
% 211.76/211.98  |- mesh__historyNote mesh__D020323 2000   
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D020323 2000
% 211.76/211.98  |- skos__related mesh__D020323smesh__D005879
% 211.76/211.98  |- skos__hiddenLabel mesh__D020323 Vocal Tics
% 211.76/211.98  |- skos__hiddenLabel mesh__D020323 Spasms, Habit
% 211.76/211.98  |- skos__altLabel mesh__D020323 Habit Spasm
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D020323 2006
% 211.76/211.98  |- skos__broader mesh__D020323smesh__D020820
% 211.76/211.98  |- skos__hiddenLabel mesh__D020323 Choreas, Habit
% 211.76/211.98  |- skos__hiddenLabel mesh__D020323 Transient Tics
% 211.76/211.98  |- skos__scopeNote mesh__D020323
% 211.76/211.98       Habitual, repeated, rapid contraction of certain muscles, resulting in stereotyped individualized actions that can be voluntarily suppressed for only brief periods. They often involve the face, vocal cords, neck, and less often the extremities. Examples include repetitive throat clearing, vocalizations, sniffing, pursing the lips, and excessive blinking. Tics tend to be aggravated by emotional stress. When frequent they may interfere with speech and INTERPERSONAL RELATIONS. Conditions which feature frequent and prominent tics as a primary manifestation of disease are referred to as TIC DISORDERS. %28%From Adams et al., Principles of Neurology, 6th ed, pp109-10%29%%A%    
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D020323 2001
% 211.76/211.98  |- skos__hiddenLabel mesh__D011597 Psychomotor Performances
% 211.76/211.98  |- skos__hiddenLabel mesh__D011597 Motor Coordination, Visual
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D011597 2005
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D011597 1996
% 211.76/211.98  |- skos__hiddenLabel mesh__D011597 Performance, Perceptual Motor
% 211.76/211.98  |- skos__hiddenLabel mesh__D011597 Coordination, Visual Motor
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D011597 1995
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D011597 2004
% 211.76/211.98  |- mesh__recordMaintainer mesh__D011597 TAP
% 211.76/211.98  |- skos__hiddenLabel mesh__D011597 Coordinations, Visual Motor
% 211.76/211.98  |- mesh__recordOriginator mesh__D011597 EC
% 211.76/211.98  |- skos__scopeNote mesh__D011597
% 211.76/211.98       The coordination of a sensory or ideational %28%cognitive%29% process and a motor activity.%A%    
% 211.76/211.98  |- skos__hiddenLabel mesh__D011597 Motor Performances, Perceptual
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D011597 1993
% 211.76/211.98  |- mesh__recordAuthorizer mesh__D011597 PLS
% 211.76/211.98  |- skos__hiddenLabel mesh__D011597 Performances, Perceptual Motor
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D011597 1999
% 211.76/211.98  |- skos__prefLabel mesh__D011597 Psychomotor Performance
% 211.76/211.98  |- skos__hiddenLabel mesh__D011597 Performances, Sensory Motor
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D011597 1994
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D011597 2002
% 211.76/211.98  |- mesh__dateCreated mesh__D011597 1982-04-27
% 211.76/211.98  |- skos__historyNote mesh__D011597 Motor Skills %28%1966-1982%29%
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D011597 2003
% 211.76/211.98  |- skos__hiddenLabel mesh__D011597 Motor Performance, Sensory
% 211.76/211.98  |- skos__hiddenLabel mesh__D011597 Motor Performances, Sensory
% 211.76/211.98  |- skos__hiddenLabel mesh__D011597 Performance, Sensory Motor
% 211.76/211.98  |- skos__hiddenLabel mesh__D011597 Perceptual Motor Performances
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D011597 1998
% 211.76/211.98  |- skos__hiddenLabel mesh__D011597 Visual Motor Coordinations
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D011597 2001
% 211.76/211.98  |- skos__hiddenLabel mesh__D011597 Motor Coordinations, Visual
% 211.76/211.98  |- skos__hiddenLabel mesh__D011597 Sensory Motor Performances
% 211.76/211.98  |- mesh__dateEstablished mesh__D011597 1983-01-01
% 211.76/211.98  |- mesh__publicMeSHNote mesh__D011597 83   
% 211.76/211.98  |- skos__historyNote mesh__D011597 Visual Perception %28%1966-1982%29%
% 211.76/211.98  |- skos__hiddenLabel mesh__D011597 Motor Performance, Perceptual
% 211.76/211.98  |- skos__broader mesh__D011597smesh__D011579
% 211.76/211.98  |- skos__hiddenLabel mesh__D011597 Performance, Psychomotor
% 211.76/211.98  |- rdf__type mesh__D011597sskos__Concept
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D011597 2006
% 211.76/211.98  |- mesh__historyNote mesh__D011597 83   
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D011597 1997
% 211.76/211.98  |- mesh__dateRevised mesh__D011597 1992-05-18
% 211.76/211.98  |- skos__hiddenLabel mesh__D011597 Performances, Psychomotor
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D011597 2000
% 211.76/211.98  |- skos__historyNote mesh__D016282
% 211.76/211.98       Peptide Peptidohydrolases %28%1966-1990%29%
% 211.76/211.98  |- mesh__recordOriginator mesh__D016282 RLS
% 211.76/211.98  |- mesh__dateEstablished mesh__D016282 1991-01-01
% 211.76/211.98  |- skos__altLabel mesh__D016282 Aspartyl Proteinases
% 211.76/211.98  |- skos__broader mesh__D016282smesh__D010450
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D016282 2004
% 211.76/211.98  |- mesh__dateCreated mesh__D016282 1990-05-25
% 211.76/211.98  |- skos__altLabel mesh__D016282 Carboxylic Proteinases
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D016282 2005
% 211.76/211.98  |- skos__altLabel mesh__D016282 Carboxyl %28%Acid%29% Proteinases
% 211.76/211.98  |- skos__altLabel mesh__D016282 Aspartyl Proteases
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D016282 2006
% 211.76/211.98  |- skos__prefLabel mesh__D016282 Aspartic Endopeptidases
% 211.76/211.98  |- mesh__recordMaintainer mesh__D016282 ssb
% 211.76/211.98  |- mesh__historyNote mesh__D016282 2000%28%1991%29%   
% 211.76/211.98  |- mesh__publicMeSHNote mesh__D016282
% 211.76/211.98       2000; see ASPARTIC PROTEINASES 1991-1999   
% 211.76/211.98  |- rdf__type mesh__D016282sskos__Concept
% 211.76/211.98  |- mesh__dateRevised mesh__D016282 2003-07-09
% 211.76/211.98  |- mesh__recordAuthorizer mesh__D016282 sjn
% 211.76/211.98  |- skos__altLabel mesh__D016282 Aspartic Proteinases
% 211.76/211.98  |- skos__scopeNote mesh__D016282
% 211.76/211.98       A sub-subclass of ENDOPEPTIDASES that depend on an ASPARTIC ACID residue for their activity. EC 3.4.23.%A%    
% 211.76/211.98  |- mesh__publicMeSHNote mesh__D002262
% 211.76/211.98       64; was DECARBOXYLASES 1963; CARBOXYLASES was see under CARBOXY-LYASES %26% LIGASES 1964-74, was heading 1963%A%  
% 211.76/211.98  |- skos__scopeNote mesh__D002262
% 211.76/211.98       Enzymes that catalyze the addition of a carboxyl group to a compound %28%carboxylases%29% or the removal of a carboxyl group from a compound %28%decarboxylases%29%. EC 4.1.1.%A%    
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D002262 2005
% 211.76/211.98  |- skos__altLabel mesh__D002262 Decarboxylases
% 211.76/211.98  |- mesh__historyNote mesh__D002262
% 211.76/211.98       64; was DECARBOXYLASES 1963; CARBOXYLASES was see under CARBOXY-LYASES %26% LIGASES 1964-74, was heading 1963%A%  
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D002262 2006
% 211.76/211.98  |- skos__prefLabel mesh__D002262 Carboxy-Lyases
% 211.76/211.98  |- mesh__dateRevised mesh__D002262 2003-07-09
% 211.76/211.98  |- mesh__dateCreated mesh__D002262 1999-01-01
% 211.76/211.98  |- mesh__recordMaintainer mesh__D002262 ssb
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D002262 2004
% 211.76/211.98  |- mesh__recordAuthorizer mesh__D002262 sjn
% 211.76/211.98  |- skos__broader mesh__D002262smesh__D019755
% 211.76/211.98  |- mesh__onlineNote mesh__D002262
% 211.76/211.98       use CARBOXY-LYASES %26% LIGASES to search CARBOXYLASES 1966-74%A%  
% 211.76/211.98  |- mesh__dateEstablished mesh__D002262 1964-01-01
% 211.76/211.98  |- mesh__recordOriginator mesh__D002262 NLM
% 211.76/211.98  |- rdf__type mesh__D002262sskos__Concept
% 211.76/211.98  |- skos__hiddenLabel mesh__D002262 Carboxy Lyases
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015988 1994
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015988 2003
% 211.76/211.98  |- skos__hiddenLabel mesh__D015988 Generation Effects
% 211.76/211.98  |- mesh__dateRevised mesh__D015988 1992-05-13
% 211.76/211.98  |- rdf__type mesh__D015988sskos__Concept
% 211.76/211.98  |- skos__annotation mesh__D015988
% 211.76/211.98       IM GEN only; coord NIM with disease /epidemiol %28%IM%29%; no qualif; specify geog if pertinent%A%  
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015988 2000
% 211.76/211.98  |- skos__hiddenLabel mesh__D015988 Effects, Cohort
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015988 2004
% 211.76/211.98  |- mesh__historyNote mesh__D015988 90   
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015988 1995
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015988 1996
% 211.76/211.98  |- mesh__dateCreated mesh__D015988 1989-05-25
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015988 2001
% 211.76/211.98  |- mesh__recordOriginator mesh__D015988 PLS
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015988 2005
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015988 1997
% 211.76/211.98  |- skos__hiddenLabel mesh__D015988 Effect, Cohort
% 211.76/211.98  |- mesh__recordMaintainer mesh__D015988 PLS
% 211.76/211.98  |- mesh__publicMeSHNote mesh__D015988 90   
% 211.76/211.98  |- mesh__dateEstablished mesh__D015988 1990-01-01
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015988 2002
% 211.76/211.98  |- skos__altLabel mesh__D015988 Generation Effect
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015988 2006
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015988 1998
% 211.76/211.98  |- skos__scopeNote mesh__D015988
% 211.76/211.98       Variation in health status arising from different causal factors to which each birth cohort in a population is exposed as environment and society change.%A%    
% 211.76/211.98  |- skos__hiddenLabel mesh__D015988 Effects, Generation
% 211.76/211.98  |- skos__broader mesh__D015988smesh__D015987
% 211.76/211.98  |- skos__hiddenLabel mesh__D015988 Cohort Effects
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015988 1993
% 211.76/211.98  |- mesh__recordAuthorizer mesh__D015988 PLS
% 211.76/211.98  |- skos__hiddenLabel mesh__D015988 Effect, Generation
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D015988 1999
% 211.76/211.98  |- skos__prefLabel mesh__D015988 Cohort Effect
% 211.76/211.98  |- mesh__dateCreated mesh__D040381 2002-07-03
% 211.76/211.98  |- skos__altLabel mesh__D040381 Public Health Education for Professionals
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D040381 2006
% 211.76/211.98  |- skos__scopeNote mesh__D040381
% 211.76/211.98       Education and training in PUBLIC HEALTH for the practice of the profession.%A%    
% 211.76/211.98  |- skos__related mesh__D040381smesh__D011634
% 211.76/211.98  |- rdf__type mesh__D040381sskos__Concept
% 211.76/211.98  |- skos__prefLabel mesh__D040381 Education, Public Health Professional
% 211.76/211.98  |- mesh__historyNote mesh__D040381 2003   
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D040381 2004
% 211.76/211.98  |- skos__annotation mesh__D040381
% 211.76/211.98       educ of general public about public health issues = PUBLIC HEALTH/educ%A%  
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D040381 2005
% 211.76/211.98  |- mesh__dateEstablished mesh__D040381 2003-01-01
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D040381 2003
% 211.76/211.98  |- mesh__publicMeSHNote mesh__D040381 2003   
% 211.76/211.98  |- skos__broader mesh__D040381smesh__D004517
% 211.76/211.98  |- mesh__dateRevised mesh__D001968 2003-07-09
% 211.76/211.98  |- rdf__type mesh__D001968sskos__Concept
% 211.76/211.98  |- skos__altLabel mesh__D001968 Bromoisovalerylurea
% 211.76/211.98  |- skos__broader mesh__D001968smesh__D014508
% 211.76/211.98  |- skos__altLabel mesh__D001968 Bromisoval
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D001968 2005
% 211.76/211.98  |- mesh__recordMaintainer mesh__D001968 ssb
% 211.76/211.98  |- skos__scopeNote mesh__D001968
% 211.76/211.98       A sedative and mild hypnotic with potentially toxic effects.%A%    
% 211.76/211.98  |- mesh__dateEstablished mesh__D001968 1991-01-01
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D001968 2006
% 211.76/211.98  |- mesh__dateCreated mesh__D001968 1974-11-19
% 211.76/211.98  |- skos__historyNote mesh__D001968 Urea %28%1969-1974%29%
% 211.76/211.98  |- skos__altLabel mesh__D001968 Bromovalcarbamide
% 211.76/211.98  |- skos__altLabel mesh__D001968 Bromovalerylurea
% 211.76/211.98  |- mesh__historyNote mesh__D001968
% 211.76/211.98       91%28%75%29%; was see under UREA 1975-90   
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D001968 2004
% 211.76/211.98  |- skos__altLabel mesh__D001968 %28%alpha-Bromoisovaleryl%29%urea
% 211.76/211.98  |- skos__historyNote mesh__D001968 Valerates %28%1972-1974%29%
% 211.76/211.98  |- skos__prefLabel mesh__D001968 Bromisovalum
% 211.76/211.98  |- mesh__publicMeSHNote mesh__D001968 91; was see under UREA 1975-90   
% 211.76/211.98  |- mesh__recordAuthorizer mesh__D001968 sjn
% 211.76/211.98  |- mesh__recordOriginator mesh__D001968 SJJ
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D012690 2001
% 211.76/211.98  |- skos__hiddenLabel mesh__D012690 Extraction, Serial
% 211.76/211.98  |- skos__prefLabel mesh__D012690 Serial Extraction
% 211.76/211.98  |- mesh__recordAuthorizer mesh__D012690 SJN
% 211.76/211.98  |- mesh__dateCreated mesh__D012690 1999-01-01
% 211.76/211.98  |- mesh__dateEstablished mesh__D012690 1973-01-01
% 211.76/211.98  |- mesh__publicMeSHNote mesh__D012690 73   
% 211.76/211.98  |- mesh__historyNote mesh__D012690 73%28%71%29%   
% 211.76/211.98  |- rdf__type mesh__D012690sskos__Concept
% 211.76/211.98  |- mesh__recordOriginator mesh__D012690 NLM
% 211.76/211.98  |- skos__historyNote mesh__D012690 Tooth Extraction %28%1966-1970%29%
% 211.76/211.98  |- skos__annotation mesh__D012690
% 211.76/211.98       an orthodontic proced of sequentially extracting selected teeth over a period of years: do not confuse with TOOTH EXTRACTION; do not use /util except by MeSH definition%A%  
% 211.76/211.98  |- mesh__dateRevised mesh__D012690 1997-06-20
% 211.76/211.98  |- mesh__activeMeSHYear mesh__D012690 2002
% 211.76/211.99  |- skos__hiddenLabel mesh__D012690 Serial Extractions
% 211.85/211.99  |- skos__hiddenLabel mesh__D012690 Extractions, Serial
% 211.85/211.99  |- skos__broader mesh__D012690smesh__D009972
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D012690 1998
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D012690 2003
% 211.85/211.99  |- mesh__recordMaintainer mesh__D012690 PXP
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D012690 2005
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D012690 1999
% 211.85/211.99  |- skos__historyNote mesh__D012690
% 211.85/211.99       Orthodontics, Corrective %28%1966-1970%29%
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D012690 2004
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D012690 2006
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D012690 2000
% 211.85/211.99  |- skos__scopeNote mesh__D012690
% 211.85/211.99       The selective extraction of deciduous teeth during the stage of mixed dentition in accordance with the shedding and eruption of the teeth. It is done over an extended period to allow autonomous adjustment to relieve crowding of the dental arches during the eruption of the lateral incisors, canines, and premolars, eventually involving the extraction of the first premolar teeth. %28%Dorland, 28th ed%29%%A%    
% 211.85/211.99  |- skos__broader mesh__D012690smesh__D014081
% 211.85/211.99  |- skos__broader mesh__D006653smesh__D000715
% 211.85/211.99  |- mesh__dateCreated mesh__D006653 1999-01-01
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D006653 2005
% 211.85/211.99  |- mesh__dateRevised mesh__D006653 2001-07-25
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D006653 2003
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D006653 2006
% 211.85/211.99  |- mesh__recordMaintainer mesh__D006653 jls
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D006653 2004
% 211.85/211.99  |- skos__annotation mesh__D006653
% 211.85/211.99       SPEC only: SPEC qualif; prefer /anat %26% histol with specific organs %26% organisms: Manual 19.7+, 19.8.7; DF: HISTOL%A%  
% 211.85/211.99  |- skos__prefLabel mesh__D006653 Histology
% 211.85/211.99  |- mesh__recordOriginator mesh__D006653 NLM
% 211.85/211.99  |- mesh__recordAuthorizer mesh__D006653 sjn
% 211.85/211.99  |- rdf__type mesh__D006653sskos__Concept
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D006653 2002
% 211.85/211.99  |- skos__altLabel mesh__D020324 Anterograde Amnesia
% 211.85/211.99  |- mesh__dateEstablished mesh__D020324 2000-01-01
% 211.85/211.99  |- skos__prefLabel mesh__D020324 Amnesia, Anterograde
% 211.85/211.99  |- rdf__type mesh__D020324sskos__Concept
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D020324 2000
% 211.85/211.99  |- skos__hiddenLabel mesh__D020324 Post-Ictal Amnesia
% 211.85/211.99  |- skos__hiddenLabel mesh__D020324 Anterograde Amnesias
% 211.85/211.99  |- skos__hiddenLabel mesh__D020324 Anterograde Memory Losses
% 211.85/211.99  |- skos__broader mesh__D020324smesh__D000647
% 211.85/211.99  |- skos__hiddenLabel mesh__D020324 Amnesias, Post-Ictal
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D020324 2005
% 211.85/211.99  |- skos__historyNote mesh__D020324 Amnesia %28%1967-1999%29%
% 211.85/211.99  |- skos__hiddenLabel mesh__D020324 Post-Ictal Amnesias
% 211.85/211.99  |- skos__hiddenLabel mesh__D020324 Loss, Post-Ictal Memory
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D020324 2001
% 211.85/211.99  |- mesh__dateCreated mesh__D020324 1999-11-03
% 211.85/211.99  |- skos__hiddenLabel mesh__D020324 Memory Loss, Post-Ictal
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D020324 2003
% 211.85/211.99  |- mesh__historyNote mesh__D020324 2000   
% 211.85/211.99  |- skos__hiddenLabel mesh__D020324 Post-Ictal Memory Losses
% 211.85/211.99  |- mesh__publicMeSHNote mesh__D020324 2000   
% 211.85/211.99  |- skos__hiddenLabel mesh__D020324 Amnesias, Anterograde
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D020324 2006
% 211.85/211.99  |- skos__hiddenLabel mesh__D020324 Losses, Post-Ictal Memory
% 211.85/211.99  |- skos__hiddenLabel mesh__D020324 Memory Losses, Anterograde
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D020324 2002
% 211.85/211.99  |- skos__scopeNote mesh__D020324
% 211.85/211.99       Loss of the ability to form new memories beyond a certain point in time. This condition may be organic or psychogenic in origin. Organically induced anterograde amnesia may follow CRANIOCEREBRAL TRAUMA; SEIZURES; ANOXIA; and other conditions which adversely affect neural structures associated with memory formation %28%e.g., the HIPPOCAMPUS; FORNIX %28%BRAIN%29%; MAMMILLARY BODIES; and ANTERIOR THALAMIC NUCLEI%29%. %28%From Memory 1997 Jan-Mar;5%28%1-2%29%:49-71%29%%A%    
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D020324 2004
% 211.85/211.99  |- skos__hiddenLabel mesh__D020324 Anterograde Memory Loss
% 211.85/211.99  |- skos__hiddenLabel mesh__D020324 Memory Losses, Post-Ictal
% 211.85/211.99  |- skos__altLabel mesh__D020324 Memory Loss, Anterograde
% 211.85/211.99  |- skos__hiddenLabel mesh__D020324 Amnesia, Post Ictal
% 211.85/211.99  |- skos__altLabel mesh__D020324 Amnesia, Post-Ictal
% 211.85/211.99  |- skos__hiddenLabel mesh__D020324 Post Ictal Memory Loss
% 211.85/211.99  |- skos__annotation mesh__D011598
% 211.85/211.99       SPEC: IM; SPEC qualif; relation of brain, behavior %26% immune system; prefer specific terms with /physiol or /immunol; avoid as NIM coord %26% use no qualif; DF: PSYCHONEUROIMMUNOL%A%  
% 211.85/211.99  |- mesh__recordMaintainer mesh__D011598 ssb
% 211.85/211.99  |- skos__prefLabel mesh__D011598 Psychoneuroimmunology
% 211.85/211.99  |- mesh__historyNote mesh__D011598 88   
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D011598 2004
% 211.85/211.99  |- mesh__dateCreated mesh__D011598 1987-04-30
% 211.85/211.99  |- mesh__recordOriginator mesh__D011598 EC
% 211.85/211.99  |- mesh__dateRevised mesh__D011598 2001-07-25
% 211.85/211.99  |- skos__broader mesh__D011598smesh__D011603
% 211.85/211.99  |- mesh__recordAuthorizer mesh__D011598 sjn
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D011598 2005
% 211.85/211.99  |- mesh__publicMeSHNote mesh__D011598 88   
% 211.85/211.99  |- mesh__dateEstablished mesh__D011598 1988-01-01
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D011598 2006
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D011598 2002
% 211.85/211.99  |- rdf__type mesh__D011598sskos__Concept
% 211.85/211.99  |- skos__related mesh__D011598smesh__D015213
% 211.85/211.99  |- skos__scopeNote mesh__D011598
% 211.85/211.99       The field concerned with the interrelationship between the brain, behavior and the immune system. Neuropsychologic, neuroanatomic and psychosocial studies have demonstrated their role in accentuating or diminishing immune/allergic responses.%A%    
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D011598 2003
% 211.85/211.99  |- mesh__publicMeSHNote mesh__D016283
% 211.85/211.99       2006; for P21%28%RAS%29% see ONCOGENE PROTEIN P21%28%RAS%29% 1990   
% 211.85/211.99  |- skos__altLabel mesh__D016283 p21%28%c-Ha-ras%29%
% 211.85/211.99  |- skos__altLabel mesh__D016283 c-Ha-ras p21
% 211.85/211.99  |- mesh__recordMaintainer mesh__D016283 DRC
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D016283 2006
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 c-Ki-ras, p21
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 Proteins c-ras, Proto-Oncogene
% 211.85/211.99  |- skos__historyNote mesh__D016283 Neoplasm Proteins %28%1983-1986%29%
% 211.85/211.99  |- skos__prefLabel mesh__D016283 Proto-Oncogene Proteins p21%28%ras%29%
% 211.85/211.99  |- skos__broader mesh__D016283smesh__D011518
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 ras Proto Oncogene Protein p21
% 211.85/211.99  |- skos__altLabel mesh__D016283 c-ras Proteins
% 211.85/211.99  |- skos__altLabel mesh__D016283 p21%28%N-ras%29%
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 c Ha ras p21
% 211.85/211.99  |- skos__altLabel mesh__D016283 p21 c-H-ras
% 211.85/211.99  |- mesh__dateRevised mesh__D016283 2005-06-30
% 211.85/211.99  |- skos__scopeNote mesh__D016283
% 211.85/211.99       Cellular proteins encoded by the H-ras, K-ras and N-ras genes. The proteins have GTPase activity and is involved in signal transduction as a monomeric GTP-binding proteins. Elevated levels of p21 c-ras have been associated with neoplasia. This enzyme was formerly listed as EC 3.6.1.47.%A%    
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 Proto Oncogene Protein ras
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 c Ki ras p21
% 211.85/211.99  |- skos__broader mesh__D016283smesh__D018631
% 211.85/211.99  |- skos__altLabel mesh__D016283 p21%28%c-ras%29%
% 211.85/211.99  |- skos__altLabel mesh__D016283 Proto-Oncogene Proteins c-ras
% 211.85/211.99  |- skos__altLabel mesh__D016283 p21 c-Ki-ras
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 ras, Proto-Oncogene Protein
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 p21 c K ras
% 211.85/211.99  |- skos__altLabel mesh__D016283 ras Proto-Oncogene Product p21
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 p21 c Ha ras
% 211.85/211.99  |- mesh__dateCreated mesh__D016283 1990-06-19
% 211.85/211.99  |- skos__altLabel mesh__D016283 Proto-Oncogene Protein ras
% 211.85/211.99  |- skos__historyNote mesh__D016283
% 211.85/211.99       Proto-Oncogene Proteins %28%1987-1990%29%
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 c-Ha-ras, p21
% 211.85/211.99  |- skos__altLabel mesh__D016283 p21 c-ras
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 p21 c ras
% 211.85/211.99  |- skos__altLabel mesh__D016283 c-Ki-ras p21
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 Proto Oncogene Proteins c ras
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 p21 c Ki ras
% 211.85/211.99  |- mesh__recordOriginator mesh__D016283 AGS
% 211.85/211.99  |- rdf__type mesh__D016283sskos__Concept
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 ras Proto Oncogene Product p21
% 211.85/211.99  |- skos__altLabel mesh__D016283 p21 c-Ha-ras
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 c-ras, p21
% 211.85/211.99  |- mesh__recordAuthorizer mesh__D016283 sjn
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 c-K-ras, p21
% 211.85/211.99  |- skos__altLabel mesh__D016283 p21 c-K-ras
% 211.85/211.99  |- skos__altLabel mesh__D016283 Proto-Oncogene Protein p21%28%ras%29%
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 c-ras, Proto-Oncogene Proteins
% 211.85/211.99  |- mesh__dateEstablished mesh__D016283 1991-01-01
% 211.85/211.99  |- skos__altLabel mesh__D016283 p21%28%ras%29%
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 c ras Proteins
% 211.85/211.99  |- skos__altLabel mesh__D016283 ras Proto-Oncogene Protein p21
% 211.85/211.99  |- skos__altLabel mesh__D016283 p21%28%c-Ki-ras%29%
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 p21, c-Ki-ras
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 p21, c-Ha-ras
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 c-H-ras, p21
% 211.85/211.99  |- mesh__historyNote mesh__D016283 2006%28%1991%29%   
% 211.85/211.99  |- skos__hiddenLabel mesh__D016283 p21 c H ras
% 211.85/211.99  |- mesh__dateEstablished mesh__D002263 1987-01-01
% 211.85/211.99  |- skos__altLabel mesh__D002263 Carbonylhemoglobin
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D002263 2003
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D002263 2006
% 211.85/211.99  |- skos__prefLabel mesh__D002263 Carboxyhemoglobin
% 211.85/211.99  |- skos__altLabel mesh__D002263 Carbomonoxyhemoglobin
% 211.85/211.99  |- mesh__historyNote mesh__D002263
% 211.85/211.99       87%28%73%29%; was see under HEMOGLOBINS 1975-86   
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D002263 1994
% 211.85/211.99  |- mesh__dateCreated mesh__D002263 1999-01-01
% 211.85/211.99  |- mesh__dateRevised mesh__D002263 1992-05-11
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D002263 2004
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D002263 1995
% 211.85/211.99  |- mesh__publicMeSHNote mesh__D002263
% 211.85/211.99       87; was see under HEMOGLOBINS 1975-86   
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D002263 1998
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D002263 1993
% 211.85/211.99  |- mesh__recordMaintainer mesh__D002263 TAP
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D002263 2000
% 211.85/211.99  |- rdf__type mesh__D002263sskos__Concept
% 211.85/211.99  |- skos__altLabel mesh__D002263 Carbonmonoxyhemoglobin
% 211.85/211.99  |- mesh__recordAuthorizer mesh__D002263 PLS
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D002263 1996
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D002263 2001
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D002263 1999
% 211.85/211.99  |- mesh__recordOriginator mesh__D002263 NLM
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D002263 2005
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D002263 1997
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D002263 2002
% 211.85/211.99  |- skos__broader mesh__D002263smesh__D006454
% 211.85/211.99  |- mesh__recordOriginator mesh__D015989 PLS
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D015989 2005
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D015989 1997
% 211.85/211.99  |- skos__broader mesh__D015989smesh__D015987
% 211.85/211.99  |- mesh__recordAuthorizer mesh__D015989 PLS
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D015989 2006
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D015989 1998
% 211.85/211.99  |- skos__prefLabel mesh__D015989 Healthy Worker Effect
% 211.85/211.99  |- mesh__publicMeSHNote mesh__D015989 90   
% 211.85/211.99  |- mesh__dateEstablished mesh__D015989 1990-01-01
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D015989 1993
% 211.85/211.99  |- mesh__historyNote mesh__D015989 90   
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D015989 1999
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D015989 2000
% 211.85/211.99  |- skos__hiddenLabel mesh__D015989 Healthy Worker Effects
% 211.85/211.99  |- skos__hiddenLabel mesh__D015989 Effect, Healthy Worker
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D015989 1994
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D015989 2003
% 211.85/211.99  |- skos__scopeNote mesh__D015989
% 211.85/211.99       Phenomenon of workers%27% usually exhibiting overall death rates lower than those of the general population due to the fact that the severely ill and disabled are ordinarily excluded from employment.%A%    
% 211.85/211.99  |- rdf__type mesh__D015989sskos__Concept
% 211.85/211.99  |- mesh__recordMaintainer mesh__D015989 PLS
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D015989 2001
% 211.85/211.99  |- skos__hiddenLabel mesh__D015989 Effects, Healthy Worker
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D015989 2004
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D015989 1995
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D015989 1996
% 211.85/211.99  |- mesh__dateRevised mesh__D015989 1992-05-20
% 211.85/211.99  |- mesh__dateCreated mesh__D015989 1989-05-25
% 211.85/211.99  |- skos__annotation mesh__D015989
% 211.85/211.99       IM GEN only; coord NIM with disease /epidemiol %28%IM%29%; no qualif; specify geog if pertinent%A%  
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D015989 2002
% 211.85/211.99  |- mesh__dateRevised mesh__D001969 1992-05-08
% 211.85/211.99  |- skos__historyNote mesh__D001969
% 211.85/211.99       Hydrocarbons, Halogenated %28%1969-1974%29%
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D001969 2005
% 211.85/211.99  |- mesh__dateEstablished mesh__D001969 1975-09-01
% 211.85/211.99  |- mesh__recordAuthorizer mesh__D001969 PLS
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D001969 1998
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D001969 1995
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D001969 2003
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D001969 1993
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D001969 1996
% 211.85/211.99  |- skos__scopeNote mesh__D001969
% 211.85/211.99       Derivatives of benzene in which one or more hydrogen atoms on the benzene ring are replaced by bromine atoms.%A%    
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D001969 2006
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D001969 1999
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D001969 2000
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D001969 2004
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D001969 1997
% 211.85/211.99  |- mesh__historyNote mesh__D001969 75   
% 211.85/211.99  |- skos__prefLabel mesh__D001969 Bromobenzenes
% 211.85/211.99  |- skos__historyNote mesh__D001969 Bromine %28%1973-1974%29%
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D001969 2001
% 211.85/211.99  |- mesh__publicMeSHNote mesh__D001969 75   
% 211.85/211.99  |- skos__broader mesh__D001969smesh__D006842
% 211.85/211.99  |- mesh__dateCreated mesh__D001969 1974-11-19
% 211.85/211.99  |- mesh__recordMaintainer mesh__D001969 TAP
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D001969 2002
% 211.85/211.99  |- mesh__recordOriginator mesh__D001969 NLM
% 211.85/211.99  |- skos__broader mesh__D001969smesh__D001555
% 211.85/211.99  |- rdf__type mesh__D001969sskos__Concept
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D001969 1994
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D012691 1999
% 211.85/211.99  |- skos__hiddenLabel mesh__D012691 Learning, Serial
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D012691 2006
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D012691 1995
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D012691 1998
% 211.85/211.99  |- mesh__dateRevised mesh__D012691 1992-05-18
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D012691 2002
% 211.85/211.99  |- mesh__historyNote mesh__D012691 67%28%64%29%   
% 211.85/211.99  |- skos__broader mesh__D012691smesh__D014706
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D012691 2005
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D012691 1994
% 211.85/211.99  |- skos__hiddenLabel mesh__D012691 Serial Learnings
% 211.85/211.99  |- skos__hiddenLabel mesh__D012691 Learnings, Serial
% 211.85/211.99  |- rdf__type mesh__D012691sskos__Concept
% 211.85/211.99  |- mesh__recordAuthorizer mesh__D012691 PLS
% 211.85/211.99  |- mesh__recordMaintainer mesh__D012691 TAP
% 211.85/211.99  |- skos__scopeNote mesh__D012691
% 211.85/211.99       Learning to make a series of responses in exact order.     
% 211.85/211.99  |- mesh__dateCreated mesh__D012691 1999-01-01
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D012691 2001
% 211.85/211.99  |- skos__prefLabel mesh__D012691 Serial Learning
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D012691 1997
% 211.85/211.99  |- mesh__recordOriginator mesh__D012691 NLM
% 211.85/211.99  |- mesh__publicMeSHNote mesh__D012691 67   
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D012691 2004
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D012691 1993
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D012691 1996
% 211.85/211.99  |- mesh__dateEstablished mesh__D012691 1967-01-01
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D012691 2000
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D012691 2003
% 211.85/211.99  |- mesh__recordOriginator mesh__D006654 NLM
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D006654 2004
% 211.85/211.99  |- skos__annotation mesh__D006654
% 211.85/211.99       IM: SPEC only, SPEC qualif; usually NIM coord: no qualif; Manual 18.13; more likely is tag COMPARATIVE STUDY with specific A or B term with /anat %26% histol: Manual 18.13; DF: HISTOL COMPARATIVE%A%  
% 211.85/211.99  |- mesh__recordAuthorizer mesh__D006654 sjn
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D006654 2002
% 211.85/211.99  |- skos__altLabel mesh__D006654 Comparative Histology
% 211.85/211.99  |- rdf__type mesh__D006654sskos__Concept
% 211.85/211.99  |- mesh__dateRevised mesh__D006654 2001-07-25
% 211.85/211.99  |- mesh__recordMaintainer mesh__D006654 jls
% 211.85/211.99  |- mesh__dateCreated mesh__D006654 1999-01-01
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D006654 2005
% 211.85/211.99  |- skos__prefLabel mesh__D006654 Histology, Comparative
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D006654 2003
% 211.85/211.99  |- skos__broader mesh__D006654smesh__D006653
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D006654 2006
% 211.85/211.99  |- skos__hiddenLabel mesh__D020325 Hemiplegic Migraines, Familial
% 211.85/211.99  |- mesh__recordMaintainer mesh__D020325 lkt
% 211.85/211.99  |- skos__altLabel mesh__D020325 Complicated Migraine
% 211.85/211.99  |- skos__altLabel mesh__D020325 Classic Migraine
% 211.85/211.99  |- skos__prefLabel mesh__D020325 Migraine with Aura
% 211.85/211.99  |- skos__altLabel mesh__D020325 Migraine, Prolonged Aura
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D020325 2006
% 211.85/211.99  |- skos__altLabel mesh__D020325 Familial Hemiplegic Migraine
% 211.85/211.99  |- mesh__publicMeSHNote mesh__D020325
% 211.85/211.99       2006; use CLASSIC MIGRAINE 2000-2005; for COMPLICATED MIGRAINE see MIGRAINE 2000-2005%A%  
% 211.85/211.99  |- mesh__dateCreated mesh__D020325 1999-11-04
% 211.85/211.99  |- skos__hiddenLabel mesh__D020325 Migraine, Classical
% 211.85/211.99  |- skos__hiddenLabel mesh__D020325 Migraine, Complicated
% 211.85/211.99  |- mesh__historyNote mesh__D020325
% 211.85/211.99       2006 %28%2000%29%; for COMPLICATED MIGRAINE use MIGRAINE 2000-2005%A%  
% 211.85/211.99  |- skos__hiddenLabel mesh__D020325 Prolonged Aura Migraine
% 211.85/211.99  |- skos__hiddenLabel mesh__D020325 Migraine, Basilar
% 211.85/211.99  |- skos__altLabel mesh__D020325 Acute Onset Aura Migraine
% 211.85/211.99  |- mesh__dateRevised mesh__D020325 2005-06-30
% 211.85/211.99  |- skos__altLabel mesh__D020325 Migraine, Classic
% 211.85/211.99  |- skos__broader mesh__D020325smesh__D008881
% 211.85/211.99  |- skos__hiddenLabel mesh__D020325 Prolonged Aura Migraines
% 211.85/211.99  |- skos__hiddenLabel mesh__D020325 Migraines, Complicated
% 211.85/211.99  |- skos__scopeNote mesh__D020325
% 211.85/211.99       A subtype of migraine disorder, characterized by recurrent attacks of reversible neurological symptoms %28%aura%29% that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred VISION; HALLUCINATIONS; VERTIGO; NUMBNESS; and difficulty in concentrating and speaking. Aura is usually followed by features of the COMMON MIGRAINE, such as PHOTOPHOBIA; PHONOPHOBIA; and NAUSEA. %28%International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1%29%%A%    
% 211.85/211.99  |- skos__hiddenLabel mesh__D020325 Migraine with Auras
% 211.85/211.99  |- mesh__dateEstablished mesh__D020325 2000-01-01
% 211.85/211.99  |- skos__hiddenLabel mesh__D020325 Familial Hemiplegic Migraines
% 211.85/211.99  |- skos__hiddenLabel mesh__D020325 Basilar Migraines
% 211.85/211.99  |- mesh__recordOriginator mesh__D020325 KEV
% 211.85/211.99  |- mesh__recordAuthorizer mesh__D020325 sjn
% 211.85/211.99  |- skos__altLabel mesh__D020325 Classical Migraine
% 211.85/211.99  |- skos__hiddenLabel mesh__D020325 Classical Migraines
% 211.85/211.99  |- skos__historyNote mesh__D020325 Migraine %28%1966-1999%29%
% 211.85/211.99  |- skos__hiddenLabel mesh__D020325 Complicated Migraines
% 211.85/211.99  |- rdf__type mesh__D020325sskos__Concept
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D011599 2004
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D011599 1998
% 211.85/211.99  |- skos__scopeNote mesh__D011599
% 211.85/211.99       The study of significant causes and processes in the development of mental illness.%A%    
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D011599 2003
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D011599 1997
% 211.85/211.99  |- mesh__dateRevised mesh__D011599 1996-06-10
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D011599 2002
% 211.85/211.99  |- skos__broader mesh__D011599smesh__D001525
% 211.85/211.99  |- skos__annotation mesh__D011599
% 211.85/211.99       SPEC: IM, SPEC qualif; NIM coord, no qualif; do not confuse with MENTAL DISORDERS: Manual 27.14; DF: PSYCHOPATHOL%A%  
% 211.85/211.99  |- skos__prefLabel mesh__D011599 Psychopathology
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D011599 2001
% 211.85/211.99  |- mesh__recordMaintainer mesh__D011599 TAP
% 211.85/211.99  |- mesh__recordOriginator mesh__D011599 NLM
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D011599 2006
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D011599 2000
% 211.85/211.99  |- mesh__dateCreated mesh__D011599 1999-01-01
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D011599 2005
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D011599 1999
% 211.85/211.99  |- rdf__type mesh__D011599sskos__Concept
% 211.85/211.99  |- mesh__recordAuthorizer mesh__D011599 PLS
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D016284 2004
% 211.85/211.99  |- skos__hiddenLabel mesh__D016284 Technetium DTPA
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D016284 2001
% 211.85/211.99  |- skos__historyNote mesh__D016284 DTPA %28%1966-1990%29%
% 211.85/211.99  |- skos__altLabel mesh__D016284 Technetium %28%99m%29% Pentetate
% 211.85/211.99  |- skos__altLabel mesh__D016284 Tc-DTPA
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D016284 2003
% 211.85/211.99  |- skos__broader mesh__D016284smesh__D015609
% 211.85/211.99  |- mesh__dateEstablished mesh__D016284 1991-01-01
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D016284 2000
% 211.85/211.99  |- skos__historyNote mesh__D016284 Technetium %28%1966-1990%29%
% 211.85/211.99  |- skos__hiddenLabel mesh__D016284 Tc 99m DTPA
% 211.85/211.99  |- skos__altLabel mesh__D016284 Tc 99m-DTPA
% 211.85/211.99  |- skos__annotation mesh__D016284 as label, use /diag use; DF: TCDTPA   
% 211.85/211.99  |- mesh__onlineNote mesh__D016284
% 211.85/211.99       use TECHNETIUM TC 99M PENTETATE to search 99MTC-DTPA 1991-92%A%  
% 211.85/211.99  |- skos__prefLabel mesh__D016284 Technetium Tc 99m Pentetate
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D016284 1999
% 211.85/211.99  |- mesh__publicMeSHNote mesh__D016284
% 211.85/211.99       91; 99MTC-DTPA was see TECHNETIUM TC 99M PENTETATE 1991-92%A%  
% 211.85/211.99  |- skos__altLabel mesh__D016284
% 211.85/211.99       Technetium diethylenetriamine pentaacetic acid
% 211.85/211.99  |- mesh__recordMaintainer mesh__D016284 ADP
% 211.85/211.99  |- mesh__historyNote mesh__D016284
% 211.85/211.99       91; 99MTC-DTPA was see TECHNETIUM TC 99M PENTETATE 1991-92%A%  
% 211.85/211.99  |- skos__broader mesh__D016284smesh__D004369
% 211.85/211.99  |- mesh__recordOriginator mesh__D016284 RLS
% 211.85/211.99  |- skos__historyNote mesh__D016284 Organotechnetium Compounds %28%1990%29%
% 211.85/211.99  |- skos__hiddenLabel mesh__D016284 99m-DTPA, Tc
% 211.85/211.99  |- skos__historyNote mesh__D016284
% 211.85/211.99       Organometallic Compounds %28%1968-1989%29%
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D016284 2006
% 211.85/211.99  |- mesh__dateCreated mesh__D016284 1990-06-08
% 211.85/211.99  |- mesh__recordAuthorizer mesh__D016284 SJN
% 211.85/211.99  |- skos__altLabel mesh__D016284 Technetium-DTPA
% 211.85/211.99  |- skos__scopeNote mesh__D016284
% 211.85/211.99       A technetium imaging agent used in renal scintigraphy, computed tomography, lung ventilation imaging, gastrointestinal scintigraphy, and many other procedures which employ radionuclide imaging agents.%A%    
% 211.85/211.99  |- mesh__dateRevised mesh__D016284 1998-06-11
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D016284 2005
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D016284 2002
% 211.85/211.99  |- rdf__type mesh__D016284sskos__Concept
% 211.85/211.99  |- skos__hiddenLabel mesh__D016284 Pentetic Acid, Technetium
% 211.85/211.99  |- skos__annotation mesh__D002264
% 211.85/211.99       do not confuse with CARBOCYCLIC ACIDS see ACIDS, CARBOCYCLIC%A%  
% 211.85/211.99  |- mesh__dateCreated mesh__D002264 1999-01-01
% 211.85/211.99  |- mesh__publicMeSHNote mesh__D002264 73   
% 211.85/211.99  |- mesh__recordAuthorizer mesh__D002264 sjn
% 211.85/211.99  |- skos__hiddenLabel mesh__D002264 Acids, Carboxylic
% 211.85/211.99  |- mesh__recordOriginator mesh__D002264 NLM
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D002264 2004
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D002264 2006
% 211.85/211.99  |- mesh__dateEstablished mesh__D002264 1973-01-01
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D002264 2003
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D002264 2005
% 211.85/211.99  |- skos__scopeNote mesh__D002264
% 211.85/211.99       Organic compounds containing the carboxy group %28%-COOH%29%. This group of compounds includes amino acids and fatty acids. Carboxylic acids can be saturated, unsaturated, or aromatic.%A%    
% 211.85/211.99  |- skos__broader mesh__D002264smesh__D009930
% 211.85/211.99  |- skos__historyNote mesh__D002264 Fatty Acids %28%1966-1970%29%
% 211.85/211.99  |- mesh__activeMeSHYear mesh__D002264 2002
% 211.85/212.00  |- skos__prefLabel mesh__D002264 Carboxylic Acids
% 211.85/212.00  |- mesh__recordMaintainer mesh__D002264 adp
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D002264 2001
% 211.85/212.00  |- rdf__type mesh__D002264sskos__Concept
% 211.85/212.00  |- skos__historyNote mesh__D002264 Acids %28%1966-1970%29%
% 211.85/212.00  |- mesh__historyNote mesh__D002264 73%28%71%29%   
% 211.85/212.00  |- mesh__dateRevised mesh__D002264 2000-06-21
% 211.85/212.00  |- skos__prefLabel mesh__D029401 Betulaceae
% 211.85/212.00  |- mesh__dateEstablished mesh__D029401 2002-01-01
% 211.85/212.00  |- skos__altLabel mesh__D029401 Hornbeam
% 211.85/212.00  |- mesh__historyNote mesh__D029401 2002   
% 211.85/212.00  |- mesh__dateCreated mesh__D029401 2001-07-25
% 211.85/212.00  |- mesh__recordMaintainer mesh__D029401 ssb
% 211.85/212.00  |- mesh__dateRevised mesh__D029401 2002-07-02
% 211.85/212.00  |- skos__broader mesh__D029401smesh__D019684
% 211.85/212.00  |- mesh__recordAuthorizer mesh__D029401 sjn
% 211.85/212.00  |- skos__annotation mesh__D029401
% 211.85/212.00       GEN or unspecified; prefer specifics; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.85/212.00  |- skos__scopeNote mesh__D029401
% 211.85/212.00       A plant family of the order Fagales, subclass Hamamelidae, class Magnoliopsida. They have simple, serrate, alternate leaves. Male flowers are borne in long, pendulous catkins; the female in shorter, pendulous or erect catkins. The fruit is usually a small nut or a short-winged samara.%A%    
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D029401 2005
% 211.85/212.00  |- rdf__type mesh__D029401sskos__Concept
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D029401 2003
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D029401 2006
% 211.85/212.00  |- skos__altLabel mesh__D029401 Hop Hornbeam
% 211.85/212.00  |- mesh__recordOriginator mesh__D029401 ssb
% 211.85/212.00  |- skos__altLabel mesh__D029401 Hornbeam, Hop
% 211.85/212.00  |- mesh__publicMeSHNote mesh__D029401 2002   
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D029401 2004
% 211.85/212.00  |- skos__hiddenLabel mesh__D012692 Serial Passages
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D012692 2005
% 211.85/212.00  |- mesh__dateRevised mesh__D012692 2000-06-22
% 211.85/212.00  |- mesh__recordAuthorizer mesh__D012692 sjn
% 211.85/212.00  |- skos__hiddenLabel mesh__D012692 Passage, Serial
% 211.85/212.00  |- skos__annotation mesh__D012692
% 211.85/212.00       restrict to in vivo or in vitro passage of infectious organisms or develop of vaccines: do not use for passage of cultured cells, cell lines, etc.; NIM; coord with organism or vaccine %28%IM%29%%A%  
% 211.85/212.00  |- skos__prefLabel mesh__D012692 Serial Passage
% 211.85/212.00  |- mesh__historyNote mesh__D012692
% 211.85/212.00       91%28%88%29%; was see under MICROBIOLOGICAL TECHNIQUES 1988-90   
% 211.85/212.00  |- skos__broader mesh__D012692smesh__D008828
% 211.85/212.00  |- rdf__type mesh__D012692sskos__Concept
% 211.85/212.00  |- skos__scopeNote mesh__D012692
% 211.85/212.00       Inoculation of a series of animals or in vitro tissue with an infectious bacterium or virus, as in VIRULENCE studies and the development of vaccines.%A%    
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D012692 2002
% 211.85/212.00  |- skos__hiddenLabel mesh__D012692 Passages, Serial
% 211.85/212.00  |- skos__historyNote mesh__D012692 Virus Cultivation %28%1966-1987%29%
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D012692 2004
% 211.85/212.00  |- mesh__publicMeSHNote mesh__D012692
% 211.85/212.00       91; was see under MICROBIOLOGICAL TECHNIQUES 1988-90   
% 211.85/212.00  |- skos__historyNote mesh__D012692 Virulence %28%1966-1987%29%
% 211.85/212.00  |- mesh__recordOriginator mesh__D012692 SCD
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D012692 2003
% 211.85/212.00  |- mesh__dateCreated mesh__D012692 1987-05-09
% 211.85/212.00  |- mesh__dateEstablished mesh__D012692 1991-01-01
% 211.85/212.00  |- mesh__recordMaintainer mesh__D012692 KEV
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D012692 2001
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D012692 2006
% 211.85/212.00  |- skos__scopeNote mesh__D006655
% 211.85/212.00       Deacetylases that remove N-acetyl groups from amino side chains of the amino acids of HISTONES. Some of these belong to the SIRTUINS protein family.%A%    
% 211.85/212.00  |- skos__annotation mesh__D006655
% 211.85/212.00       if NAD-dependent histone deacetylase coord with SIRTUINS   
% 211.85/212.00  |- rdf__type mesh__D006655sskos__Concept
% 211.85/212.00  |- skos__historyNote mesh__D006655 Histones %28%1971-1974%29%
% 211.85/212.00  |- skos__altLabel mesh__D006655 HDAC Proteins
% 211.85/212.00  |- mesh__recordOriginator mesh__D006655 NLM
% 211.85/212.00  |- skos__related mesh__D006655smesh__D037761
% 211.85/212.00  |- mesh__dateEstablished mesh__D006655 1991-01-01
% 211.85/212.00  |- mesh__recordAuthorizer mesh__D006655 sjn
% 211.85/212.00  |- skos__hiddenLabel mesh__D006655 Deacetylases, Histone
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D006655 2005
% 211.85/212.00  |- mesh__publicMeSHNote mesh__D006655
% 211.85/212.00       2003; see HISTONE DEACETYLASE 1991-2002; see AMIDOHYDROLASES 1975-1990%A%  
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D006655 2006
% 211.85/212.00  |- skos__hiddenLabel mesh__D006655 Deacetylase, Histone
% 211.85/212.00  |- mesh__dateRevised mesh__D006655 2003-07-09
% 211.85/212.00  |- skos__prefLabel mesh__D006655 Histone Deacetylases
% 211.85/212.00  |- skos__historyNote mesh__D006655 Amidohydrolases %28%1971-1974%29%
% 211.85/212.00  |- skos__historyNote mesh__D006655 Acetic Acids %28%1971-1974%29%
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D006655 2004
% 211.85/212.00  |- skos__broader mesh__D006655smesh__D000581
% 211.85/212.00  |- skos__hiddenLabel mesh__D006655 Proteins, HDAC
% 211.85/212.00  |- skos__altLabel mesh__D006655 Histone Deacetylase
% 211.85/212.00  |- mesh__historyNote mesh__D006655 2003; use AMIDOHYDROLASES 1975-1990   
% 211.85/212.00  |- mesh__recordMaintainer mesh__D006655 ssb
% 211.85/212.00  |- mesh__dateCreated mesh__D006655 1974-11-19
% 211.85/212.00  |- mesh__dateRevised mesh__D020326 2005-06-30
% 211.85/212.00  |- mesh__recordOriginator mesh__D020326 KEV
% 211.85/212.00  |- mesh__historyNote mesh__D020326 2006 %28%2000%29%   
% 211.85/212.00  |- skos__altLabel mesh__D020326 Migraine, Common
% 211.85/212.00  |- skos__altLabel mesh__D020326 Common Migraine
% 211.85/212.00  |- mesh__recordAuthorizer mesh__D020326 sjn
% 211.85/212.00  |- skos__hiddenLabel mesh__D020326 Migraines, Common
% 211.85/212.00  |- mesh__publicMeSHNote mesh__D020326
% 211.85/212.00       2006; see COMMON MIGRAINE 2000-2005   
% 211.85/212.00  |- mesh__recordMaintainer mesh__D020326 lkt
% 211.85/212.00  |- skos__hiddenLabel mesh__D020326 Common Migraines
% 211.85/212.00  |- skos__historyNote mesh__D020326 Migraine %28%1966-1999%29%
% 211.85/212.00  |- rdf__type mesh__D020326sskos__Concept
% 211.85/212.00  |- mesh__dateEstablished mesh__D020326 2000-01-01
% 211.85/212.00  |- mesh__dateCreated mesh__D020326 1999-11-03
% 211.85/212.00  |- skos__broader mesh__D020326smesh__D008881
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D020326 2006
% 211.85/212.00  |- skos__prefLabel mesh__D020326 Migraine without Aura
% 211.85/212.00  |- skos__scopeNote mesh__D020326
% 211.85/212.00       Recurrent unilateral pulsatile headaches, not preceded or accompanied by an aura, in attacks lasting 4-72 hours. It is characterized by PAIN of moderate to severe intensity; aggravated by physical activity; and associated with NAUSEA and / or PHOTOPHOBIA and PHONOPHOBIA. %28%International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1%29%%A%    
% 211.85/212.00  |- mesh__publicMeSHNote mesh__D016285 91   
% 211.85/212.00  |- mesh__dateEstablished mesh__D016285 1991-01-01
% 211.85/212.00  |- skos__broader mesh__D016285smesh__D011465
% 211.85/212.00  |- skos__hiddenLabel mesh__D016285 ZK 36374
% 211.85/212.00  |- skos__scopeNote mesh__D016285
% 211.85/212.00       An eicosanoid, derived from the cyclooxygenase pathway of arachidonic acid metabolism. It is a stable and synthetic analog of EPOPROSTENOL, but with a longer half-life than the parent compound. Its actions are similar to prostacyclin. Iloprost produces vasodilation and inhibits platelet aggregation.%A%    
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D016285 2006
% 211.85/212.00  |- mesh__recordMaintainer mesh__D016285 ssb
% 211.85/212.00  |- skos__prefLabel mesh__D016285 Iloprost
% 211.85/212.00  |- mesh__dateCreated mesh__D016285 1990-05-29
% 211.85/212.00  |- skos__altLabel mesh__D016285 CoTherix Brand of Iloprost
% 211.85/212.00  |- skos__hiddenLabel mesh__D016285 ZK36374
% 211.85/212.00  |- rdf__type mesh__D016285sskos__Concept
% 211.85/212.00  |- skos__historyNote mesh__D016285 Epoprostenol %28%1978-1990%29%
% 211.85/212.00  |- skos__historyNote mesh__D016285 Cardiovascular Agents %28%1979-1990%29%
% 211.85/212.00  |- skos__altLabel mesh__D016285 Ciloprost
% 211.85/212.00  |- mesh__historyNote mesh__D016285 91   
% 211.85/212.00  |- mesh__dateRevised mesh__D016285 2005-06-30
% 211.85/212.00  |- mesh__recordOriginator mesh__D016285 RLS
% 211.85/212.00  |- mesh__recordAuthorizer mesh__D016285 sjn
% 211.85/212.00  |- skos__historyNote mesh__D016285 Vasodilator Agents %28%1966-1990%29%
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D002265 2004
% 211.85/212.00  |- skos__altLabel mesh__D002265 Carboxylesterases
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D002265 2006
% 211.85/212.00  |- skos__prefLabel mesh__D002265 Carboxylic Ester Hydrolases
% 211.85/212.00  |- mesh__recordAuthorizer mesh__D002265 sjn
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D002265 2005
% 211.85/212.00  |- mesh__dateCreated mesh__D002265 1975-07-25
% 211.85/212.00  |- mesh__dateRevised mesh__D002265 2003-07-09
% 211.85/212.00  |- skos__hiddenLabel mesh__D002265 Hydrolases, Carboxylic Ester
% 211.85/212.00  |- mesh__recordOriginator mesh__D002265 RLS
% 211.85/212.00  |- skos__scopeNote mesh__D002265
% 211.85/212.00       Enzymes which catalyze the hydrolysis of carboxylic acid esters with the formation of an alcohol and a carboxylic acid anion.%A%    
% 211.85/212.00  |- mesh__dateEstablished mesh__D002265 1976-01-01
% 211.85/212.00  |- rdf__type mesh__D002265sskos__Concept
% 211.85/212.00  |- mesh__historyNote mesh__D002265 76   
% 211.85/212.00  |- mesh__publicMeSHNote mesh__D002265
% 211.85/212.00       76; ALDONOLACTONASE, CHOLESTEROL ESTERASE, DEHYDROASCORBATASE, MONOACYLGLYCEROL LIPASES %26% NAPHTHOL AS D ESTERASE were see under ESTERASES 1975%A%  
% 211.85/212.00  |- skos__broader mesh__D002265smesh__D004950
% 211.85/212.00  |- mesh__recordMaintainer mesh__D002265 ssb
% 211.85/212.00  |- skos__historyNote mesh__D002265 Esterases %28%1972-1975%29%
% 211.85/212.00  |- skos__hiddenLabel mesh__D002265 Ester Hydrolases, Carboxylic
% 211.85/212.00  |- skos__annotation mesh__D029402
% 211.85/212.00       GEN or unspecified; prefer specifics; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D029402 2005
% 211.85/212.00  |- rdf__type mesh__D029402sskos__Concept
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D029402 2006
% 211.85/212.00  |- mesh__historyNote mesh__D029402 2002   
% 211.85/212.00  |- mesh__publicMeSHNote mesh__D029402 2002   
% 211.85/212.00  |- skos__broader mesh__D029402smesh__D019684
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D029402 2004
% 211.85/212.00  |- mesh__recordOriginator mesh__D029402 ssb
% 211.85/212.00  |- skos__prefLabel mesh__D029402 Bignoniaceae
% 211.85/212.00  |- skos__scopeNote mesh__D029402
% 211.85/212.00       A plant family of the order Scrophulariales, subclass Asteridae, class Magnoliopsida. The family is characterized by oppositely paired, usually compound leaves and bell- or funnel-shaped, bisexual flowers having a five-lobed calyx and corolla.%A%    
% 211.85/212.00  |- mesh__dateCreated mesh__D029402 2001-07-25
% 211.85/212.00  |- mesh__recordMaintainer mesh__D029402 ssb
% 211.85/212.00  |- mesh__recordAuthorizer mesh__D029402 sjn
% 211.85/212.00  |- mesh__dateEstablished mesh__D029402 2002-01-01
% 211.85/212.00  |- mesh__dateRevised mesh__D029402 2003-07-09
% 211.85/212.00  |- mesh__dateCreated mesh__D012693 1999-01-01
% 211.85/212.00  |- skos__scopeNote mesh__D012693
% 211.85/212.00       Publications in any medium issued in successive parts bearing numerical or chronological designations and intended to be continued indefinitely. %28%ALA Glossary of Library and Information Science, 1983, p203%29%%A%    
% 211.85/212.00  |- skos__hiddenLabel mesh__D012693 Serial Publication
% 211.85/212.00  |- mesh__dateRevised mesh__D012693 1997-06-20
% 211.85/212.00  |- skos__annotation mesh__D012693
% 211.85/212.00       GEN or unspecified; prefer specifics; IM; coord with subject of the publication %28%IM%29%%A%  
% 211.85/212.00  |- skos__historyNote mesh__D012693 specific publication %28%1966-1997%29%
% 211.85/212.00  |- skos__broader mesh__D012693smesh__D011642
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D012693 2004
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D012693 2001
% 211.85/212.00  |- mesh__recordOriginator mesh__D012693 NLM
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D012693 2003
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D012693 1999
% 211.85/212.00  |- mesh__dateEstablished mesh__D012693 1998-01-01
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D012693 2000
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D012693 2006
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D012693 1998
% 211.85/212.00  |- mesh__recordMaintainer mesh__D012693 TGC
% 211.85/212.00  |- mesh__publicMeSHNote mesh__D012693 98   
% 211.85/212.00  |- skos__hiddenLabel mesh__D012693 Publications, Serial
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D012693 2005
% 211.85/212.00  |- skos__prefLabel mesh__D012693 Serial Publications
% 211.85/212.00  |- skos__hiddenLabel mesh__D012693 Publication, Serial
% 211.85/212.00  |- mesh__recordAuthorizer mesh__D012693 SJN
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D012693 2002
% 211.85/212.00  |- mesh__historyNote mesh__D012693 98; use explode 1975-97   
% 211.85/212.00  |- rdf__type mesh__D012693sskos__Concept
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D006656 2005
% 211.85/212.00  |- skos__historyNote mesh__D006656 Histones %28%1974%29%
% 211.85/212.00  |- skos__broader mesh__D006656smesh__D017867
% 211.85/212.00  |- mesh__dateRevised mesh__D006656 2004-07-07
% 211.85/212.00  |- skos__historyNote mesh__D006656 Protein Kinases %28%1974%29%
% 211.85/212.00  |- mesh__dateCreated mesh__D006656 1974-11-19
% 211.85/212.00  |- skos__prefLabel mesh__D006656 Protamine Kinase
% 211.85/212.00  |- mesh__publicMeSHNote mesh__D006656
% 211.85/212.00       94; was HISTONE KINASE 1975-93 %28%see under PROTEIN KINASES 1980-90, see under PROTEIN KINASE 1975-79%29%; PROTAMINE KINASE was indexed under PROTEIN KINASES 1982-93%A%  
% 211.85/212.00  |- rdf__type mesh__D006656sskos__Concept
% 211.85/212.00  |- mesh__onlineNote mesh__D006656
% 211.85/212.00       use PROTAMINE KINASE to search HISTONE KINASE 1975-93; use PROTAMINE KINASE %28%NM%29% to search PROTAMINE KINASE 1982-93%A%  
% 211.85/212.00  |- mesh__recordOriginator mesh__D006656 NLM
% 211.85/212.00  |- mesh__recordMaintainer mesh__D006656 jmp
% 211.85/212.00  |- skos__hiddenLabel mesh__D006656 Kinase, Protamine
% 211.85/212.00  |- mesh__recordAuthorizer mesh__D006656 sjn
% 211.85/212.00  |- mesh__historyNote mesh__D006656
% 211.85/212.00       94; was HISTONE KINASE 1975-93 %28%see under PROTEIN KINASES 1980-90, see under PROTEIN KINASE 1975-79%29%; PROTAMINE KINASE was %28%NM%29% 1982-93%A%  
% 211.85/212.00  |- skos__scopeNote mesh__D006656
% 211.85/212.00       An aspect of protein kinase %28%EC 2.7.1.37%29% in which serine residues in protamines and histones are phosphorylated in the presence of ATP. EC 2.7.1.70.%A%    
% 211.85/212.00  |- mesh__dateEstablished mesh__D006656 1991-01-01
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D006656 2006
% 211.85/212.00  |- skos__altLabel mesh__D006656 Histone Kinase
% 211.85/212.00  |- skos__hiddenLabel mesh__D006656 Kinase, Histone
% 211.85/212.00  |- skos__hiddenLabel mesh__D020327 Shunts, Aqueous
% 211.85/212.00  |- skos__hiddenLabel mesh__D020327 Implant, Glaucoma Filtration
% 211.85/212.00  |- skos__broader mesh__D020327smesh__D019736
% 211.85/212.00  |- skos__hiddenLabel mesh__D020327 Shunts, Aqueous Humor
% 211.85/212.00  |- skos__hiddenLabel mesh__D020327 Shunt, Aqueous
% 211.85/212.00  |- skos__hiddenLabel mesh__D020327 Implants, Glaucoma Drainage
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D020327 2001
% 211.85/212.00  |- skos__hiddenLabel mesh__D020327 Drainage Implants, Glaucoma
% 211.85/212.00  |- skos__altLabel mesh__D020327 Aqueous Humor Shunts
% 211.85/212.00  |- mesh__dateCreated mesh__D020327 1998-06-10
% 211.85/212.00  |- skos__altLabel mesh__D020327 Glaucoma Filtration Implants
% 211.85/212.00  |- rdf__type mesh__D020327sskos__Concept
% 211.85/212.00  |- skos__hiddenLabel mesh__D020327 Glaucoma Drainage Implant
% 211.85/212.00  |- skos__hiddenLabel mesh__D020327 Implant, Glaucoma Drainage
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D020327 2002
% 211.85/212.00  |- skos__scopeNote mesh__D020327
% 211.85/212.00       Devices, usually incorporating unidirectional valves, which are surgically inserted in the sclera to maintain normal intraocular pressure.%A%    
% 211.85/212.00  |- skos__hiddenLabel mesh__D020327 Implants, Glaucoma Filtration
% 211.85/212.00  |- skos__hiddenLabel mesh__D020327 Drainage Implant, Glaucoma
% 211.85/212.00  |- skos__hiddenLabel mesh__D020327 Aqueous Shunt
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D020327 2005
% 211.85/212.00  |- skos__hiddenLabel mesh__D020327 Filtration Implants, Glaucoma
% 211.85/212.00  |- mesh__dateEstablished mesh__D020327 1999-01-01
% 211.85/212.00  |- skos__altLabel mesh__D020327 Aqueous Shunts
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D020327 2003
% 211.85/212.00  |- skos__hiddenLabel mesh__D020327 Implants, Baerveldt
% 211.85/212.00  |- skos__hiddenLabel mesh__D020327 Glaucoma Filtration Implant
% 211.85/212.00  |- mesh__historyNote mesh__D020327
% 211.85/212.00       99; for AQUEOUS SHUNTS use MOLTENO IMPLANTS 1995-98   
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D020327 2006
% 211.85/212.00  |- skos__hiddenLabel mesh__D020327 Shunt, Aqueous Humor
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D020327 1999
% 211.85/212.00  |- skos__hiddenLabel mesh__D020327 Filtration Implant, Glaucoma
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D020327 2004
% 211.85/212.00  |- skos__hiddenLabel mesh__D020327 Aqueous Humor Shunt
% 211.85/212.00  |- mesh__publicMeSHNote mesh__D020327
% 211.85/212.00       99; for AQUEOUS SHUNTS see MOLTENO IMPLANTS 1995-98   
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D020327 2000
% 211.85/212.00  |- skos__prefLabel mesh__D020327 Glaucoma Drainage Implants
% 211.85/212.00  |- skos__hiddenLabel mesh__D020327 Valves, Krupin
% 211.85/212.00  |- mesh__onlineNote mesh__D002266 search METHYLCELLULOSE 1966-74   
% 211.85/212.00  |- skos__hiddenLabel mesh__D002266 Sodium, Croscarmellose
% 211.85/212.00  |- skos__altLabel mesh__D002266 Carboxymethyl Cellulose
% 211.85/212.00  |- rdf__type mesh__D002266sskos__Concept
% 211.85/212.00  |- mesh__recordMaintainer mesh__D002266 ssb
% 211.85/212.00  |- mesh__dateEstablished mesh__D002266 1991-01-01
% 211.85/212.00  |- mesh__dateRevised mesh__D002266 2005-06-30
% 211.85/212.00  |- skos__scopeNote mesh__D002266
% 211.85/212.00       A cellulose derivative which is a Beta-%28%1-%3E%4%29%-D-glucopyranose polymer. It is used as a bulk laxative and as an emulsifier and thickener in cosmetics and pharmaceuticals and as a stabilizer for reagents.%A%    
% 211.85/212.00  |- mesh__publicMeSHNote mesh__D002266
% 211.85/212.00       91; was see under METHYLCELLULOSE 1975-90   
% 211.85/212.00  |- mesh__dateCreated mesh__D002266 1999-01-01
% 211.85/212.00  |- skos__hiddenLabel mesh__D002266 Sodium, Carboxymethylcellulose
% 211.85/212.00  |- mesh__historyNote mesh__D002266
% 211.85/212.00       91%28%75%29%; was see under METHYLCELLULOSE 1975-90   
% 211.85/212.00  |- mesh__recordAuthorizer mesh__D002266 sjn
% 211.85/212.00  |- skos__prefLabel mesh__D002266 Carboxymethylcellulose
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D002266 2006
% 211.85/212.00  |- skos__broader mesh__D002266smesh__D008747
% 211.85/212.00  |- skos__hiddenLabel mesh__D002266 Carboxymethylcellulose, Sodium
% 211.85/212.00  |- skos__altLabel mesh__D002266 Sodium Carboxymethylcellulose
% 211.85/212.00  |- mesh__recordOriginator mesh__D002266 NLM
% 211.85/212.00  |- skos__historyNote mesh__D002266 Methylcellulose %28%1966-1974%29%
% 211.85/212.00  |- skos__hiddenLabel mesh__D002266 Cellulose, Carboxymethyl
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D029403 2005
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D029403 2002
% 211.85/212.00  |- skos__scopeNote mesh__D029403
% 211.85/212.00       A plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida.  They are resinous trees and shrubs with alternate leaves composed of many leaflets.%A%    
% 211.85/212.00  |- rdf__type mesh__D029403sskos__Concept
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D029403 2006
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D029403 2003
% 211.85/212.00  |- mesh__publicMeSHNote mesh__D029403 2002   
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D029403 2004
% 211.85/212.00  |- mesh__dateEstablished mesh__D029403 2002-01-01
% 211.85/212.00  |- skos__prefLabel mesh__D029403 Burseraceae
% 211.85/212.00  |- mesh__historyNote mesh__D029403 2002   
% 211.85/212.00  |- skos__annotation mesh__D029403
% 211.85/212.00       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.85/212.00  |- skos__broader mesh__D029403smesh__D019684
% 211.85/212.00  |- mesh__dateCreated mesh__D029403 2001-07-25
% 211.85/212.00  |- mesh__publicMeSHNote mesh__D048368 2005   
% 211.85/212.00  |- mesh__historyNote mesh__D048368 2005   
% 211.85/212.00  |- skos__hiddenLabel mesh__D048368 Koalas
% 211.85/212.00  |- skos__prefLabel mesh__D048368 Phascolarctidae
% 211.85/212.00  |- skos__broader mesh__D048368smesh__D008394
% 211.85/212.00  |- mesh__recordMaintainer mesh__D048368 ags
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D048368 2006
% 211.85/212.00  |- skos__historyNote mesh__D048368 Marsupialia %28%1967-2004%29%
% 211.85/212.00  |- skos__scopeNote mesh__D048368
% 211.85/212.00       A family of marsupials in the order Diprotodontia, native to Australia and possessing vestigial tails. There is a single living genus and species: Phascolarctos cinereus, the koala.%A%    
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D048368 2005
% 211.85/212.00  |- rdf__type mesh__D048368sskos__Concept
% 211.85/212.00  |- mesh__dateCreated mesh__D048368 2004-07-07
% 211.85/212.00  |- mesh__dateEstablished mesh__D048368 2005-01-01
% 211.85/212.00  |- mesh__recordOriginator mesh__D048368 ags
% 211.85/212.00  |- skos__altLabel mesh__D048368 Koala
% 211.85/212.00  |- mesh__recordAuthorizer mesh__D048368 sjn
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D012694 2002
% 211.85/212.00  |- skos__scopeNote mesh__D012694
% 211.85/212.00       A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES, PYRIMIDINES, and other amino acids.%A%    
% 211.85/212.00  |- skos__broader mesh__D012694smesh__D000596
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D012694 2003
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D012694 2006
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D012694 2001
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D012694 2005
% 211.85/212.00  |- mesh__recordOriginator mesh__D012694 NLM
% 211.85/212.00  |- mesh__recordMaintainer mesh__D012694 adp
% 211.85/212.00  |- mesh__dateRevised mesh__D012694 2000-06-22
% 211.85/212.00  |- mesh__recordAuthorizer mesh__D012694 sjn
% 211.85/212.00  |- skos__altLabel mesh__D012694 L-Serine
% 211.85/212.00  |- rdf__type mesh__D012694sskos__Concept
% 211.85/212.00  |- skos__prefLabel mesh__D012694 Serine
% 211.85/212.00  |- mesh__dateCreated mesh__D012694 1999-01-01
% 211.85/212.00  |- skos__broader mesh__D012694smesh__D021542
% 211.85/212.00  |- skos__hiddenLabel mesh__D012694 L Serine
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D012694 2004
% 211.85/212.00  |- mesh__dateCreated mesh__D006657 1999-01-01
% 211.85/212.00  |- mesh__recordMaintainer mesh__D006657 SYSTEM
% 211.85/212.00  |- rdf__type mesh__D006657sskos__Concept
% 211.85/212.00  |- skos__scopeNote mesh__D006657
% 211.85/212.00       Small chromosomal proteins %28%approx 12-20 kD%29% possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types %28%designated histone I, histone II, etc.%29% is based on the relative amounts of arginine and lysine in each.%A%    
% 211.85/212.00  |- skos__annotation mesh__D006657 H1, H2a, H2b, H3, etc. go here   
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D006657 2006
% 211.85/212.00  |- mesh__dateRevised mesh__D006657 2005-06-30
% 211.85/212.00  |- mesh__recordOriginator mesh__D006657 NLM
% 211.85/212.00  |- skos__prefLabel mesh__D006657 Histones
% 211.85/212.00  |- skos__broader mesh__D006657smesh__D009698
% 211.85/212.00  |- mesh__recordAuthorizer mesh__D006657 sjn
% 211.85/212.00  |- skos__broader mesh__D006657smesh__D009687
% 211.85/212.00  |- skos__altLabel mesh__D006657 Histone
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D031050 2004
% 211.85/212.00  |- mesh__dateCreated mesh__D031050 2002-07-03
% 211.85/212.00  |- skos__prefLabel mesh__D031050 Oenanthe
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D031050 2003
% 211.85/212.00  |- skos__altLabel mesh__D031050 Dropwort, Water
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D031050 2006
% 211.85/212.00  |- skos__scopeNote mesh__D031050
% 211.85/212.00       A plant genus of the family APIACEAE that is sometimes called Hemlock Water Dropwort but should not be confused with HEMLOCK. It contains enanthotoxin.%A%    
% 211.85/212.00  |- skos__broader mesh__D031050smesh__D019661
% 211.85/212.00  |- skos__annotation mesh__D031050
% 211.85/212.00       X ref WATER DROPWORT: DROPWORT see FILIPENDULA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.85/212.00  |- mesh__publicMeSHNote mesh__D031050 2003   
% 211.85/212.00  |- mesh__dateEstablished mesh__D031050 2003-01-01
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D031050 2005
% 211.85/212.00  |- mesh__historyNote mesh__D031050 2003   
% 211.85/212.00  |- rdf__type mesh__D031050sskos__Concept
% 211.85/212.00  |- skos__altLabel mesh__D031050 Water Dropwort
% 211.85/212.00  |- skos__hiddenLabel mesh__D016287 Equipment, Computer Peripheral
% 211.85/212.00  |- skos__hiddenLabel mesh__D016287 Computer Peripheral Device
% 211.85/212.00  |- mesh__dateCreated mesh__D016287 1990-05-07
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D016287 2006
% 211.85/212.00  |- skos__hiddenLabel mesh__D016287 Equipments, Computer Peripheral
% 211.85/212.00  |- skos__hiddenLabel mesh__D016287 Peripheral, Computer
% 211.85/212.00  |- skos__altLabel mesh__D016287 Peripheral Equipment, Computer
% 211.85/212.00  |- skos__hiddenLabel mesh__D016287 Computer Peripheral
% 211.85/212.00  |- skos__hiddenLabel mesh__D016287 Peripherals, Computer
% 211.85/212.00  |- skos__broader mesh__D016287smesh__D003201
% 211.85/212.00  |- skos__historyNote mesh__D016287 Computers %28%1966-1990%29%
% 211.85/212.00  |- mesh__recordOriginator mesh__D016287 TGC
% 211.85/212.00  |- skos__hiddenLabel mesh__D016287 Computer Peripheral Equipments
% 211.85/212.00  |- mesh__dateEstablished mesh__D016287 1991-01-01
% 211.85/212.00  |- rdf__type mesh__D016287sskos__Concept
% 211.85/212.00  |- mesh__historyNote mesh__D016287 91   
% 211.85/212.00  |- skos__annotation mesh__D016287 modem: index under TELECOMMUNICATIONS   
% 211.85/212.00  |- skos__hiddenLabel mesh__D016287 Peripheral Device, Computer
% 211.85/212.00  |- mesh__recordAuthorizer mesh__D016287 sjn
% 211.85/212.00  |- mesh__publicMeSHNote mesh__D016287 91   
% 211.85/212.00  |- skos__hiddenLabel mesh__D016287 Computer Peripheral Devices
% 211.85/212.00  |- skos__scopeNote mesh__D016287
% 211.85/212.00       Various units or machines that operate in combination or in conjunction with a computer but are not physically part of it. Peripheral devices typically display computer data, store data from the computer and return the data to the computer on demand, prepare data for human use, or acquire data from a source and convert it to a form usable by a computer. %28%Computer Dictionary, 4th ed.%29%%A%    
% 211.85/212.00  |- mesh__dateRevised mesh__D016287 2004-07-13
% 211.85/212.00  |- skos__hiddenLabel mesh__D016287 Device, Computer Peripheral
% 211.85/212.00  |- mesh__recordMaintainer mesh__D016287 sjn
% 211.85/212.00  |- skos__hiddenLabel mesh__D016287 Computer Peripheral Equipment
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D016287 2005
% 211.85/212.00  |- skos__hiddenLabel mesh__D016287 Devices, Computer Peripheral
% 211.85/212.00  |- skos__hiddenLabel mesh__D016287 Peripheral Equipments, Computer
% 211.85/212.00  |- skos__prefLabel mesh__D016287 Computer Peripherals
% 211.85/212.00  |- skos__altLabel mesh__D016287 Peripheral Devices, Computer
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D035441 2003
% 211.85/212.00  |- skos__related mesh__D035441smesh__D010369
% 211.85/212.00  |- mesh__publicMeSHNote mesh__D035441 2003   
% 211.85/212.00  |- mesh__dateEstablished mesh__D035441 2003-01-01
% 211.85/212.00  |- skos__hiddenLabel mesh__D035441 Wall, Thoracic
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D035441 2006
% 211.85/212.00  |- skos__related mesh__D035441smesh__D012132
% 211.85/212.00  |- mesh__historyNote mesh__D035441 2003   
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D035441 2005
% 211.85/212.00  |- skos__broader mesh__D035441smesh__D013909
% 211.85/212.00  |- skos__altLabel mesh__D035441 Chest Wall
% 211.85/212.00  |- mesh__dateCreated mesh__D035441 2002-07-03
% 211.85/212.00  |- skos__prefLabel mesh__D035441 Thoracic Wall
% 211.85/212.00  |- mesh__activeMeSHYear mesh__D035441 2004
% 211.85/212.00  |- rdf__type mesh__D035441sskos__Concept
% 211.85/212.00  |- skos__scopeNote mesh__D035441
% 211.85/212.00       The outer margins of the thorax containing SKIN, deep FASCIA; THORACIC VERTEBRAE; RIBS; STERNUM; and MUSCLES.%A%    
% 211.85/212.00  |- skos__hiddenLabel mesh__D035441 Wall, Chest
% 211.85/212.00  |- rdf__type mesh__D002267sskos__Concept
% 211.85/212.00  |- mesh__recordOriginator mesh__D002267 NLM
% 211.85/212.00  |- skos__scopeNote mesh__D002267
% 211.85/212.00       Enzyme which catalyzes the peptide cross-linking of nascent CELL WALL; PEPTIDOGLYCAN.%A%    
% 211.85/212.00  |- mesh__publicMeSHNote mesh__D002267
% 211.85/212.00       97; was CARBOXYPEPTIDASE TRANSPEPTIDASE 1975-96 %28%see under CARBOXYPEPTIDASES 1975-86%29%; MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE was see CARBOXYPEPTIDASE TRANSPEPTIDASE 1979-96%A%  
% 211.85/212.00  |- skos__prefLabel mesh__D002267 Muramoylpentapeptide Carboxypeptidase
% 211.85/212.01  |- mesh__historyNote mesh__D002267
% 211.85/212.01       97; was CARBOXYPEPTIDASE TRANSPEPTIDASE 1975-96 %28%see under CARBOXYPEPTIDASES 1975-86%29%; MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE was see CARBOXYPEPTIDASE TRANSPEPTIDASE 1979-96%A%  
% 211.85/212.01  |- skos__historyNote mesh__D002267 Acyltransferases %28%1974%29%
% 211.85/212.01  |- skos__hiddenLabel mesh__D002267 Transpeptidase, Carboxypeptidase
% 211.85/212.01  |- mesh__recordMaintainer mesh__D002267 jmp
% 211.85/212.01  |- mesh__dateEstablished mesh__D002267 1987-01-01
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D002267 2006
% 211.85/212.01  |- skos__broader mesh__D002267smesh__D002268
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D002267 2005
% 211.85/212.01  |- skos__historyNote mesh__D002267 Carboxypeptidases %28%1974%29%
% 211.85/212.01  |- mesh__dateCreated mesh__D002267 1974-11-19
% 211.85/212.01  |- skos__hiddenLabel mesh__D002267 Carboxypeptidase, Muramoylpentapeptide
% 211.85/212.01  |- skos__altLabel mesh__D002267 Carboxypeptidase Transpeptidase
% 211.85/212.01  |- mesh__recordAuthorizer mesh__D002267 sjn
% 211.85/212.01  |- skos__historyNote mesh__D002267 Peptidoglycan %28%1974%29%
% 211.85/212.01  |- mesh__dateRevised mesh__D002267 2004-07-07
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D007750 1999
% 211.85/212.01  |- skos__hiddenLabel mesh__D007750 Union, Trade
% 211.85/212.01  |- mesh__recordAuthorizer mesh__D007750 NLM
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D007750 1997
% 211.85/212.01  |- skos__hiddenLabel mesh__D007750 Unions, Trade
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D007750 1998
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D007750 2006
% 211.85/212.01  |- skos__related mesh__D007750smesh__D013317
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D007750 2002
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D007750 1996
% 211.85/212.01  |- mesh__dateRevised mesh__D007750 1993-09-16
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D007750 2004
% 211.85/212.01  |- skos__scopeNote mesh__D007750
% 211.85/212.01       Organizations comprising wage and salary workers in health-related fields for the purpose of improving their status and conditions. The concept includes labor union activities toward providing health services to members.%A%    
% 211.85/212.01  |- skos__related mesh__D007750smesh__D003098
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D007750 2005
% 211.85/212.01  |- mesh__recordMaintainer mesh__D007750 PLS
% 211.85/212.01  |- skos__hiddenLabel mesh__D007750 Unions, Labor
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D007750 2003
% 211.85/212.01  |- skos__hiddenLabel mesh__D007750 Trade Union
% 211.85/212.01  |- mesh__dateEstablished mesh__D007750 1967-01-01
% 211.85/212.01  |- mesh__historyNote mesh__D007750 67%28%64%29%   
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D007750 1995
% 211.85/212.01  |- mesh__dateCreated mesh__D007750 1999-01-01
% 211.85/212.01  |- mesh__recordOriginator mesh__D007750 NLM
% 211.85/212.01  |- skos__prefLabel mesh__D007750 Labor Unions
% 211.85/212.01  |- mesh__publicMeSHNote mesh__D007750 67   
% 211.85/212.01  |- rdf__type mesh__D007750sskos__Concept
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D007750 2001
% 211.85/212.01  |- skos__broader mesh__D007750smesh__D009938
% 211.85/212.01  |- skos__hiddenLabel mesh__D007750 Labor Union
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D007750 2000
% 211.85/212.01  |- skos__hiddenLabel mesh__D007750 Union, Labor
% 211.85/212.01  |- skos__hiddenLabel mesh__D029404 Receptor-like Kinases, Activin
% 211.85/212.01  |- mesh__historyNote mesh__D029404
% 211.85/212.01       2002; use ACTIVIN RECEPTORS %28%NM%29% 1991-2001   
% 211.85/212.01  |- mesh__dateRevised mesh__D029404 2003-07-09
% 211.85/212.01  |- skos__altLabel mesh__D029404 Activin Receptor-like Kinase
% 211.85/212.01  |- skos__hiddenLabel mesh__D029404 Kinase, Activin Receptor-like
% 211.85/212.01  |- skos__prefLabel mesh__D029404 Activin Receptors
% 211.85/212.01  |- mesh__recordAuthorizer mesh__D029404 sjn
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D029404 2004
% 211.85/212.01  |- skos__hiddenLabel mesh__D029404 Receptor-like Kinase, Activin
% 211.85/212.01  |- rdf__type mesh__D029404sskos__Concept
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D029404 2006
% 211.85/212.01  |- skos__hiddenLabel mesh__D029404 Activin Receptor like Kinases
% 211.85/212.01  |- skos__altLabel mesh__D029404 Receptor, Activin
% 211.85/212.01  |- mesh__dateEstablished mesh__D029404 2002-01-01
% 211.85/212.01  |- skos__historyNote mesh__D029404
% 211.85/212.01       Receptors, Cell Surface %28%1989-1992%29%
% 211.85/212.01  |- skos__altLabel mesh__D029404 Activin Receptor
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D029404 2005
% 211.85/212.01  |- skos__scopeNote mesh__D029404
% 211.85/212.01       Receptors for ACTIVINS are membrane protein kinases belonging to the family of PROTEIN-SERINE-THREONINE KINASES, thus also named activin receptor-like kinases %28%ALK%27%s%29%. Activin receptors also bind TRANSFORMING GROWTH FACTOR BETA. As those transmembrane receptors of the TGF-beta superfamily %28%RECEPTORS, TRANSFORMING GROWTH FACTOR BETA%29%, ALK%27%s consist of two different but related protein kinases, Type I and Type II. Activins initiate cellular signal transduction by first binding to the type II receptors %28%ACTIVIN RECEPTORS, TYPE II %29% which then recruit and phosphorylate the type I receptors %28%ACTIVIN RECEPTORS, TYPE I %29% with subsequent activation of the type I kinase activity.%A%    
% 211.85/212.01  |- skos__hiddenLabel mesh__D029404 Activin Receptor like Kinase
% 211.85/212.01  |- skos__historyNote mesh__D029404
% 211.85/212.01       Protein-Serine-Threonine Kinases %28%1993-2001%29%
% 211.85/212.01  |- skos__hiddenLabel mesh__D029404 Kinases, Activin Receptor-like
% 211.85/212.01  |- mesh__recordOriginator mesh__D029404 lkt
% 211.85/212.01  |- skos__broader mesh__D029404smesh__D017346
% 211.85/212.01  |- skos__altLabel mesh__D029404 Activin Receptor-Like Kinases
% 211.85/212.01  |- skos__broader mesh__D029404smesh__D018125
% 211.85/212.01  |- mesh__publicMeSHNote mesh__D029404
% 211.85/212.01       2002; ACTIVIN RECEPTORS was indexed under RECEPTORS, GROWTH FACTOR%A%  
% 211.85/212.01  |- mesh__dateCreated mesh__D029404 2001-07-25
% 211.85/212.01  |- mesh__recordMaintainer mesh__D029404 ssb
% 211.85/212.01  |- mesh__dateEstablished mesh__D048369 2005-01-01
% 211.85/212.01  |- skos__altLabel mesh__D048369 MAPK Kinase 1
% 211.85/212.01  |- skos__historyNote mesh__D048369
% 211.85/212.01       Mitogen-Activated Protein Kinase Kinases %28%2000-2004%29%
% 211.85/212.01  |- skos__hiddenLabel mesh__D048369
% 211.85/212.01       Mitogen Activated Protein Kinase Kinase 1
% 211.85/212.01  |- skos__altLabel mesh__D048369 MKK-1 Protein Kinase
% 211.85/212.01  |- skos__prefLabel mesh__D048369 MAP Kinase Kinase 1
% 211.85/212.01  |- mesh__recordMaintainer mesh__D048369 jmp
% 211.85/212.01  |- skos__scopeNote mesh__D048369
% 211.85/212.01       An abundant 43-kDa mitogen-activated protein kinase kinase subtype with specificity for MITOGEN-ACTIVATED PROTEIN KINASE 1 and MITOGEN-ACTIVATED PROTEIN KINASE 3.%A%    
% 211.85/212.01  |- skos__altLabel mesh__D048369 MEK-1 Protein Kinase
% 211.85/212.01  |- skos__hiddenLabel mesh__D048369 MEK 1 Protein Kinase
% 211.85/212.01  |- skos__historyNote mesh__D048369
% 211.85/212.01       Protein-Serine-Threonine Kinases %28%1992-2004%29%
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D048369 2005
% 211.85/212.01  |- skos__altLabel mesh__D048369 MAP2K1 Protein
% 211.85/212.01  |- mesh__recordAuthorizer mesh__D048369 sjn
% 211.85/212.01  |- mesh__recordOriginator mesh__D048369 jmp
% 211.85/212.01  |- skos__hiddenLabel mesh__D048369 MKK 1 Protein Kinase
% 211.85/212.01  |- skos__historyNote mesh__D048369
% 211.85/212.01       Protein-Tyrosine Kinase %28%1992-1999%29%
% 211.85/212.01  |- mesh__dateCreated mesh__D048369 2004-07-07
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D048369 2006
% 211.85/212.01  |- skos__altLabel mesh__D048369 MKK1 Protein Kinase
% 211.85/212.01  |- mesh__publicMeSHNote mesh__D048369
% 211.85/212.01       2005; MAP KINASE KINASE 1 was indexed under MITOGEN-ACTIVATED PROTEIN KINASE KINASES 2000-2004, under PROTEIN-SERINE-THREONINE KINASES 1992-2004 %26% under PROTEIN-TYROSINE KINASE 1992-1999%A%  
% 211.85/212.01  |- rdf__type mesh__D048369sskos__Concept
% 211.85/212.01  |- skos__broader mesh__D048369smesh__D020929
% 211.85/212.01  |- mesh__historyNote mesh__D048369 2005%28%1999%29%   
% 211.85/212.01  |- skos__altLabel mesh__D048369 MEK1 Protein Kinase
% 211.85/212.01  |- skos__altLabel mesh__D048369 Mitogen-Activated Protein Kinase Kinase 1
% 211.85/212.01  |- skos__broader mesh__D014965Q000627smesh__D014965
% 211.85/212.01  |- mesh__preferredCombination mesh__D014965Q000627smesh__D014964
% 211.85/212.01  |- rdf__type mesh__D014965Q000627smesh__CompoundConcept
% 211.85/212.01  |- mesh__historyNote mesh__D012695
% 211.85/212.01       98%28%67%29%; for SERINE DEAMINASE use HYDRO-LYASES 1963-71   
% 211.85/212.01  |- skos__prefLabel mesh__D012695 L-Serine Dehydratase
% 211.85/212.01  |- skos__scopeNote mesh__D012695
% 211.85/212.01       A PYRIDOXAL-phosphate containing enzyme that catalyzes the dehydration and deamination of L-serine to form pyruvate. This enzyme was formerly listed as EC 4.2.1.13.%A%    
% 211.85/212.01  |- skos__hiddenLabel mesh__D012695 Ammonia-Lyase, L-Serine
% 211.85/212.01  |- mesh__recordAuthorizer mesh__D012695 sjn
% 211.85/212.01  |- mesh__publicMeSHNote mesh__D012695
% 211.85/212.01       98; see SERINE DEHYDRATASE 1972-97; for SERINE DEAMINASE see HYDRO-LYASES 1963-71%A%  
% 211.85/212.01  |- mesh__dateRevised mesh__D012695 2005-06-30
% 211.85/212.01  |- skos__hiddenLabel mesh__D012695 Serine Threonine Dehydratase
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D012695 2006
% 211.85/212.01  |- skos__historyNote mesh__D012695 Hydro-Lyases %28%1966%29%
% 211.85/212.01  |- skos__hiddenLabel mesh__D012695 Dehydratase, Serine
% 211.85/212.01  |- skos__hiddenLabel mesh__D012695 L Serine Ammonia Lyase
% 211.85/212.01  |- mesh__dateEstablished mesh__D012695 1972-01-01
% 211.85/212.01  |- skos__hiddenLabel mesh__D012695 Dehydratase, Serine-Threonine
% 211.85/212.01  |- mesh__dateCreated mesh__D012695 1999-01-01
% 211.85/212.01  |- skos__annotation mesh__D012695 specific for L-serine   
% 211.85/212.01  |- mesh__recordMaintainer mesh__D012695 jmp
% 211.85/212.01  |- skos__altLabel mesh__D012695 Serine Dehydratase
% 211.85/212.01  |- skos__broader mesh__D012695smesh__D000642
% 211.85/212.01  |- skos__hiddenLabel mesh__D012695 Deaminase, Serine
% 211.85/212.01  |- skos__altLabel mesh__D012695 Serine-Threonine Dehydratase
% 211.85/212.01  |- skos__altLabel mesh__D012695 Serine Deaminase
% 211.85/212.01  |- rdf__type mesh__D012695sskos__Concept
% 211.85/212.01  |- skos__hiddenLabel mesh__D012695 L Serine Dehydratase
% 211.85/212.01  |- skos__altLabel mesh__D012695 L-Serine Ammonia-Lyase
% 211.85/212.01  |- skos__hiddenLabel mesh__D012695 Dehydratase, L-Serine
% 211.85/212.01  |- mesh__recordOriginator mesh__D012695 NLM
% 211.85/212.01  |- mesh__publicMeSHNote mesh__D020329 2000   
% 211.85/212.01  |- skos__hiddenLabel mesh__D020329 Tremor, Benign Essential
% 211.85/212.01  |- skos__hiddenLabel mesh__D020329 Tremor, Familial
% 211.85/212.01  |- skos__altLabel mesh__D020329 Benign Essential Tremor
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D020329 2002
% 211.85/212.01  |- skos__broader mesh__D020329smesh__D009069
% 211.85/212.01  |- mesh__dateEstablished mesh__D020329 2000-01-01
% 211.85/212.01  |- mesh__dateCreated mesh__D020329 1999-11-03
% 211.85/212.01  |- skos__hiddenLabel mesh__D020329 Familial Tremors
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D020329 2001
% 211.85/212.01  |- skos__hiddenLabel mesh__D020329 Tremors, Benign Essential
% 211.85/212.01  |- skos__hiddenLabel mesh__D020329 Tremors, Familial
% 211.85/212.01  |- rdf__type mesh__D020329sskos__Concept
% 211.85/212.01  |- skos__hiddenLabel mesh__D020329 Tremor, Essential
% 211.85/212.01  |- skos__historyNote mesh__D020329 Tremor %28%1966-1999%29%
% 211.85/212.01  |- skos__hiddenLabel mesh__D020329 Essential Tremors, Benign
% 211.85/212.01  |- skos__prefLabel mesh__D020329 Essential Tremor
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D020329 2004
% 211.85/212.01  |- skos__scopeNote mesh__D020329
% 211.85/212.01       A relatively common disorder characterized by a fairly specific pattern of tremors which are most prominent in the upper extremities and neck, inducing titubations of the head. The tremor is usually mild, but when severe may be disabling. An autosomal dominant pattern of inheritance may occur in some families %28%i.e., familial tremor%29%. %28%Mov Disord 1988;13%28%1%29%:5-10%29%%A%    
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D020329 2000
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D020329 2006
% 211.85/212.01  |- skos__hiddenLabel mesh__D020329 Benign Essential Tremors
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D020329 2003
% 211.85/212.01  |- mesh__historyNote mesh__D020329 2000   
% 211.85/212.01  |- skos__hiddenLabel mesh__D020329 Essential Tremors
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D020329 2005
% 211.85/212.01  |- skos__hiddenLabel mesh__D020329 Essential Tremor, Benign
% 211.85/212.01  |- skos__hiddenLabel mesh__D020329 Tremors, Essential
% 211.85/212.01  |- mesh__recordMaintainer mesh__D006658 SYSTEM
% 211.85/212.01  |- skos__annotation mesh__D006658 infection = HISTOPLASMOSIS   
% 211.85/212.01  |- mesh__dateRevised mesh__D006658 2005-06-30
% 211.85/212.01  |- mesh__recordOriginator mesh__D006658 NLM
% 211.85/212.01  |- skos__scopeNote mesh__D006658
% 211.85/212.01       A mitosporic Onygenales fungal genus causing HISTOPLASMOSIS in humans and animals. Its single species is Histoplasma capsulatum which has two varieties: H. capsulatum var. capsulatum and H. capsulatum var. duboisii. Its teleomorph is AJELLOMYCES capsulatus.%A%    
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D006658 2006
% 211.85/212.01  |- mesh__recordAuthorizer mesh__D006658 sjn
% 211.85/212.01  |- skos__broader mesh__D006658smesh__D003904
% 211.85/212.01  |- skos__prefLabel mesh__D006658 Histoplasma
% 211.85/212.01  |- mesh__dateCreated mesh__D006658 1999-01-01
% 211.85/212.01  |- rdf__type mesh__D006658sskos__Concept
% 211.85/212.01  |- mesh__recordAuthorizer mesh__D017380 sjn
% 211.85/212.01  |- skos__hiddenLabel mesh__D017380 Ventricular Hypertrophies, Right
% 211.85/212.01  |- skos__prefLabel mesh__D017380 Hypertrophy, Right Ventricular
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D017380 2000
% 211.85/212.01  |- rdf__type mesh__D017380sskos__Concept
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D017380 2003
% 211.85/212.01  |- mesh__recordOriginator mesh__D017380 PXP
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D017380 2001
% 211.85/212.01  |- skos__scopeNote mesh__D017380
% 211.85/212.01       Enlargement of the right ventricle of the heart. This increase in ventricular mass is often attributed to pulmonary hypertension and is a contributor to cardiovascular morbidity and mortality.%A%    
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D017380 2004
% 211.85/212.01  |- skos__hiddenLabel mesh__D017380 Hypertrophies, Right Ventricular
% 211.85/212.01  |- mesh__dateRevised mesh__D017380 1999-11-03
% 211.85/212.01  |- mesh__dateEstablished mesh__D017380 1993-01-01
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D017380 2002
% 211.85/212.01  |- mesh__recordMaintainer mesh__D017380 PLS
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D017380 2005
% 211.85/212.01  |- mesh__historyNote mesh__D017380 93   
% 211.85/212.01  |- mesh__publicMeSHNote mesh__D017380 93   
% 211.85/212.01  |- skos__altLabel mesh__D017380 Ventricular Hypertrophy, Right
% 211.85/212.01  |- skos__hiddenLabel mesh__D017380 Right Ventricular Hypertrophies
% 211.85/212.01  |- skos__altLabel mesh__D017380 Right Ventricular Hypertrophy
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D017380 2006
% 211.85/212.01  |- mesh__dateCreated mesh__D017380 1992-05-20
% 211.85/212.01  |- skos__historyNote mesh__D017380 Heart Hypertrophy %28%1966-1992%29%
% 211.85/212.01  |- skos__broader mesh__D017380smesh__D006332
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D031051 2004
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D031051 2005
% 211.85/212.01  |- mesh__historyNote mesh__D031051 2003   
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D031051 2006
% 211.85/212.01  |- skos__scopeNote mesh__D031051
% 211.85/212.01       A plant genus of the family APOCYNACEAE. Members contain echitovenidine, echitamine, venenatine %28%an indole alkaloid%29%, and anti-inflammatory triterpenoids%A%    
% 211.85/212.01  |- skos__prefLabel mesh__D031051 Alstonia
% 211.85/212.01  |- mesh__publicMeSHNote mesh__D031051 2003   
% 211.85/212.01  |- mesh__dateEstablished mesh__D031051 2003-01-01
% 211.85/212.01  |- skos__annotation mesh__D031051
% 211.85/212.01       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.85/212.01  |- rdf__type mesh__D031051sskos__Concept
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D031051 2003
% 211.85/212.01  |- skos__broader mesh__D031051smesh__D029062
% 211.85/212.01  |- mesh__dateCreated mesh__D031051 2002-07-02
% 211.85/212.01  |- mesh__dateCreated mesh__D003360 1985-02-25
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D003360 2006
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D003360 2004
% 211.85/212.01  |- skos__altLabel mesh__D003360 Cosmid
% 211.85/212.01  |- skos__prefLabel mesh__D003360 Cosmids
% 211.85/212.01  |- mesh__historyNote mesh__D003360 86   
% 211.85/212.01  |- skos__historyNote mesh__D003360 Genetic Vectors %28%1980-1985%29%
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D003360 2005
% 211.85/212.01  |- skos__historyNote mesh__D003360 Cloning, Molecular %28%1980-1985%29%
% 211.85/212.01  |- skos__historyNote mesh__D003360 Plasmids %28%1978-1985%29%
% 211.85/212.01  |- mesh__recordMaintainer mesh__D003360 nns
% 211.85/212.01  |- mesh__publicMeSHNote mesh__D003360 86   
% 211.85/212.01  |- rdf__type mesh__D003360sskos__Concept
% 211.85/212.01  |- mesh__dateRevised mesh__D003360 2003-07-09
% 211.85/212.01  |- skos__broader mesh__D003360smesh__D005822
% 211.85/212.01  |- mesh__dateEstablished mesh__D003360 1986-01-01
% 211.85/212.01  |- skos__related mesh__D003360smesh__D010582
% 211.85/212.01  |- skos__related mesh__D003360smesh__D003001
% 211.85/212.01  |- skos__broader mesh__D003360smesh__D010957
% 211.85/212.01  |- skos__scopeNote mesh__D003360
% 211.85/212.01       Plasmids containing at least one cos %28%cohesive-end site%29% of PHAGE LAMBDA. They are used as cloning vehicles.%A%    
% 211.85/212.01  |- mesh__recordAuthorizer mesh__D003360 sjn
% 211.85/212.01  |- mesh__recordOriginator mesh__D003360 AEP
% 211.85/212.01  |- skos__hiddenLabel mesh__D016288 Terminals, Video Display
% 211.85/212.01  |- mesh__historyNote mesh__D016288 91; was see COMPUTER SYSTEMS 1987-90   
% 211.85/212.01  |- skos__scopeNote mesh__D016288
% 211.85/212.01       Input/output devices designed to receive data in an environment associated with the job to be performed, and capable of transmitting entries to, and obtaining output from, the system of which it is a part. %28%Computer Dictionary, 4th ed.%29%%A%    
% 211.85/212.01  |- skos__hiddenLabel mesh__D016288 Display Terminal, Video
% 211.85/212.01  |- skos__hiddenLabel mesh__D016288 Terminal, Video Display
% 211.85/212.01  |- mesh__dateEstablished mesh__D016288 1991-01-01
% 211.85/212.01  |- rdf__type mesh__D016288sskos__Concept
% 211.85/212.01  |- skos__hiddenLabel mesh__D016288 Computer Terminal
% 211.85/212.01  |- skos__altLabel mesh__D016288 Terminals, Computer
% 211.85/212.01  |- mesh__dateRevised mesh__D016288 2004-07-07
% 211.85/212.01  |- skos__hiddenLabel mesh__D016288 Terminal, Computer
% 211.85/212.01  |- skos__hiddenLabel mesh__D016288 Video Display Terminal
% 211.85/212.01  |- skos__hiddenLabel mesh__D016288 Display Terminals, Video
% 211.85/212.01  |- skos__broader mesh__D016288smesh__D016287
% 211.85/212.01  |- mesh__recordMaintainer mesh__D016288 jls
% 211.85/212.01  |- mesh__publicMeSHNote mesh__D016288
% 211.85/212.01       91; was see COMPUTER SYSTEMS 1987-90   
% 211.85/212.01  |- mesh__recordOriginator mesh__D016288 TGC
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D016288 2005
% 211.85/212.01  |- skos__altLabel mesh__D016288 Video Display Terminals
% 211.85/212.01  |- mesh__onlineNote mesh__D016288
% 211.85/212.01       use COMPUTER SYSTEMS to search COMPUTER TERMINALS 1987-90%A%  
% 211.85/212.01  |- mesh__recordAuthorizer mesh__D016288 sjn
% 211.85/212.01  |- skos__historyNote mesh__D016288 Computer Systems %28%1987-1990%29%
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D016288 2006
% 211.85/212.01  |- mesh__dateCreated mesh__D016288 1990-05-07
% 211.85/212.01  |- skos__prefLabel mesh__D016288 Computer Terminals
% 211.85/212.01  |- rdf__type mesh__D002268sskos__Concept
% 211.85/212.01  |- skos__broader mesh__D002268smesh__D020689
% 211.85/212.01  |- skos__scopeNote mesh__D002268
% 211.85/212.01       Enzymes that act at a free C-terminus of a polypeptide to liberate a single amino acid residue. They are further divided based on their catalytic mechanism into serine-type carboxypeptidases EC 3.4.16; metallocarboxypeptidases, EC 3.4.17; and cysteine-type carboxypeptidases, EC 3.4.18. EC 3.4.-.%A%    
% 211.85/212.01  |- mesh__recordAuthorizer mesh__D002268 sjn
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D002268 2005
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D002268 2004
% 211.85/212.01  |- mesh__recordOriginator mesh__D002268 NLM
% 211.85/212.01  |- mesh__recordMaintainer mesh__D002268 ssb
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D002268 2006
% 211.85/212.01  |- mesh__dateCreated mesh__D002268 1999-01-01
% 211.85/212.01  |- mesh__dateRevised mesh__D002268 2003-07-09
% 211.85/212.01  |- skos__annotation mesh__D002268
% 211.85/212.01       GEN or unspecified; note CARBOXYPEPTIDASE N see LYSINE CARBOXYPEPTIDASE%A%  
% 211.85/212.01  |- skos__prefLabel mesh__D002268 Carboxypeptidases
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D007751 2004
% 211.85/212.01  |- mesh__recordOriginator mesh__D007751 NLM
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D007751 2003
% 211.85/212.01  |- mesh__dateCreated mesh__D007751 1999-01-01
% 211.85/212.01  |- rdf__type mesh__D007751sskos__Concept
% 211.85/212.01  |- skos__related mesh__D007751smesh__D010120
% 211.85/212.01  |- mesh__recordMaintainer mesh__D007751 sjn
% 211.85/212.01  |- mesh__recordAuthorizer mesh__D007751 sjn
% 211.85/212.01  |- skos__prefLabel mesh__D007751 Labor, Induced
% 211.85/212.01  |- mesh__dateRevised mesh__D007751 2002-07-03
% 211.85/212.01  |- skos__altLabel mesh__D007751 Induced Labor
% 211.85/212.01  |- skos__annotation mesh__D007751
% 211.85/212.01       check tags FEMALE %26% PREGNANCY; amniotomy in inducing labor: coord IM with AMNION /surg %28%IM%29%%A%  
% 211.85/212.01  |- skos__scopeNote mesh__D007751
% 211.85/212.01       Artificially induced UTERINE CONTRACTION. Generally, LABOR, OBSTETRIC is induced with the intent to cause delivery of the fetus and termination of pregnancy.%A%    
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D007751 2006
% 211.85/212.01  |- skos__broader mesh__D007751smesh__D036861
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D007751 2005
% 211.85/212.01  |- skos__altLabel mesh__D029405 GBV-A
% 211.85/212.01  |- mesh__dateRevised mesh__D029405 2002-07-03
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D029405 2004
% 211.85/212.01  |- skos__prefLabel mesh__D029405 GB virus A
% 211.85/212.01  |- mesh__dateCreated mesh__D029405 2001-07-25
% 211.85/212.01  |- rdf__type mesh__D029405sskos__Concept
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D029405 2006
% 211.85/212.01  |- skos__historyNote mesh__D029405 Hepatitis Agents, GB %28%1998-2001%29%
% 211.85/212.01  |- mesh__dateEstablished mesh__D029405 2002-01-01
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D029405 2003
% 211.85/212.01  |- mesh__publicMeSHNote mesh__D029405
% 211.85/212.01       2002; see HEPATITIS AGENTS, GB 1997-2001   
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D029405 2005
% 211.85/212.01  |- skos__annotation mesh__D029405
% 211.85/212.01       infection: coord IM with FLAVIVIRIDAE INFECTIONS %28%IM%29%   
% 211.85/212.01  |- mesh__historyNote mesh__D029405
% 211.85/212.01       2002; use HEPATITIS AGENTS, GB 1997-2001   
% 211.85/212.01  |- skos__scopeNote mesh__D029405
% 211.85/212.01       A species of virus %28%unassigned to a genus%29% in the family FLAVIVIRIDAE, that have been identified in at least six species of New World monkeys. They do not cause HEPATITIS in the host or other susceptible species.%A%    
% 211.85/212.01  |- skos__broader mesh__D029405smesh__D018067
% 211.85/212.01  |- skos__hiddenLabel mesh__D012696 Aldolase, Allothreonine
% 211.85/212.01  |- skos__altLabel mesh__D012696 Threonine Aldolase
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D012696 2006
% 211.85/212.01  |- skos__historyNote mesh__D012696 Transferases %28%1973-1974%29%
% 211.85/212.01  |- mesh__recordOriginator mesh__D012696 NLM
% 211.85/212.01  |- mesh__recordAuthorizer mesh__D012696 sjn
% 211.85/212.01  |- skos__hiddenLabel mesh__D012696 Aldolase, Serine
% 211.85/212.01  |- mesh__historyNote mesh__D012696 98%28%75%29%   
% 211.85/212.01  |- skos__broader mesh__D012696smesh__D019877
% 211.85/212.01  |- skos__hiddenLabel mesh__D012696 Hydroxymethyltransferase, Glycine
% 211.85/212.01  |- skos__hiddenLabel mesh__D012696 Aldolase, Threonine
% 211.85/212.01  |- skos__altLabel mesh__D012696 Serine Hydroxymethyltransferase
% 211.85/212.01  |- rdf__type mesh__D012696sskos__Concept
% 211.85/212.01  |- mesh__dateEstablished mesh__D012696 1991-01-01
% 211.85/212.01  |- mesh__publicMeSHNote mesh__D012696
% 211.85/212.01       98; see SERINE HYDROXYMETHYLTRANSFERASE 1991-97, see TRANSFERASES 1975-90%A%  
% 211.85/212.01  |- skos__hiddenLabel mesh__D012696 Hydroxymethylase, Serine
% 211.85/212.01  |- skos__hiddenLabel mesh__D012696 Transhydroxymethylase, Serine
% 211.85/212.01  |- mesh__dateRevised mesh__D012696 2003-07-09
% 211.85/212.01  |- skos__historyNote mesh__D012696 Tetrahydrofolates %28%1973-1974%29%
% 211.85/212.01  |- skos__hiddenLabel mesh__D012696 Hydroxymethyltransferase, Serine
% 211.85/212.01  |- skos__altLabel mesh__D012696 Allothreonine Aldolase
% 211.85/212.01  |- skos__altLabel mesh__D012696 Serine Hydroxymethylase
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D012696 2004
% 211.85/212.01  |- skos__historyNote mesh__D012696 Serine %28%1973-1974%29%
% 211.85/212.01  |- skos__altLabel mesh__D012696 Serine Transhydroxymethylase
% 211.85/212.01  |- skos__prefLabel mesh__D012696 Glycine Hydroxymethyltransferase
% 211.85/212.01  |- mesh__dateCreated mesh__D012696 1974-11-19
% 211.85/212.01  |- mesh__recordMaintainer mesh__D012696 ssb
% 211.85/212.01  |- skos__scopeNote mesh__D012696
% 211.85/212.01       A pyridoxal phosphate enzyme that catalyzes the reaction of glycine and 5,10-methylene-tetrahydrofolate to form serine. It also catalyzes the reaction of glycine with acetaldehyde to form L-threonine. EC 2.1.2.1.%A%    
% 211.85/212.01  |- skos__altLabel mesh__D012696 Serine Aldolase
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D012696 2005
% 211.85/212.01  |- mesh__dateRevised mesh__D006659 2005-06-30
% 211.85/212.01  |- mesh__recordAuthorizer mesh__D006659 sjn
% 211.85/212.01  |- mesh__dateEstablished mesh__D006659 1991-01-01
% 211.85/212.01  |- mesh__publicMeSHNote mesh__D006659
% 211.85/212.01       91; was see under ANTIGENS, FUNGAL 1986-90; was heading 1963-85%A%  
% 211.85/212.01  |- mesh__historyNote mesh__D006659
% 211.85/212.01       91%28%86%29%63; was see under ANTIGENS, FUNGAL 1986-90; was heading 1963-85%A%  
% 211.85/212.01  |- mesh__recordMaintainer mesh__D006659 ssb
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D006659 2006
% 211.85/212.01  |- skos__prefLabel mesh__D006659 Histoplasmin
% 211.85/212.01  |- mesh__dateCreated mesh__D006659 1999-01-01
% 211.85/212.01  |- rdf__type mesh__D006659sskos__Concept
% 211.85/212.01  |- skos__broader mesh__D006659smesh__D000946
% 211.85/212.01  |- mesh__recordOriginator mesh__D006659 NLM
% 211.85/212.01  |- mesh__recordOriginator mesh__D017381 PXP
% 211.85/212.01  |- skos__broader mesh__D017381smesh__D042581
% 211.85/212.01  |- skos__historyNote mesh__D017381 Ribonucleoproteins %28%1986-1992%29%
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D017381 2004
% 211.85/212.01  |- mesh__recordAuthorizer mesh__D017381 sjn
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D017381 2005
% 211.85/212.01  |- mesh__historyNote mesh__D017381 93   
% 211.85/212.01  |- skos__related mesh__D017381smesh__D012326
% 211.85/212.01  |- skos__hiddenLabel mesh__D017381 Spliceosome
% 211.85/212.01  |- skos__prefLabel mesh__D017381 Spliceosomes
% 211.85/212.01  |- skos__scopeNote mesh__D017381
% 211.85/212.01       Organelles in which the splicing and excision reactions that remove introns from precursor messenger RNA molecules occur. One component of a spliceosome is five small nuclear RNA molecules %28%U1, U2, U4, U5, U6%29% that, working in conjunction with proteins, help to fold pieces of RNA into the right shapes and later splice them into the message.%A%    
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D017381 2006
% 211.85/212.01  |- mesh__dateEstablished mesh__D017381 1993-01-01
% 211.85/212.01  |- mesh__publicMeSHNote mesh__D017381 93   
% 211.85/212.01  |- skos__annotation mesh__D017381
% 211.85/212.01       organelles in which splicing of mRNA occurs; A 11 qualif except /cytol; /genet permitted%A%  
% 211.85/212.01  |- mesh__dateCreated mesh__D017381 1992-05-22
% 211.85/212.01  |- mesh__recordMaintainer mesh__D017381 nns
% 211.85/212.01  |- mesh__dateRevised mesh__D017381 2003-07-09
% 211.85/212.01  |- rdf__type mesh__D017381sskos__Concept
% 211.85/212.01  |- skos__altLabel mesh__D031052 Yellow Oleander Tree
% 211.85/212.01  |- skos__scopeNote mesh__D031052
% 211.85/212.01       A plant genus of the family APOCYNACEAE. Members contain thevetin.%A%    
% 211.85/212.01  |- skos__broader mesh__D031052smesh__D029062
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D031052 2006
% 211.85/212.01  |- mesh__publicMeSHNote mesh__D031052 2003   
% 211.85/212.01  |- skos__prefLabel mesh__D031052 Thevetia
% 211.85/212.01  |- skos__altLabel mesh__D031052 Oleander Tree, Yellow
% 211.85/212.01  |- mesh__historyNote mesh__D031052 2003   
% 211.85/212.01  |- rdf__type mesh__D031052sskos__Concept
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D031052 2003
% 211.85/212.01  |- skos__annotation mesh__D031052
% 211.85/212.01       Oleander see NERIUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.85/212.01  |- mesh__dateCreated mesh__D031052 2002-07-03
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D031052 2004
% 211.85/212.01  |- mesh__dateEstablished mesh__D031052 2003-01-01
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D031052 2005
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D003361 2003
% 211.85/212.01  |- skos__hiddenLabel mesh__D003361 Cost Allocations
% 211.85/212.01  |- mesh__recordOriginator mesh__D003361 EC
% 211.85/212.01  |- mesh__recordMaintainer mesh__D003361 PLS
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D003361 2006
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D003361 1995
% 211.85/212.01  |- skos__prefLabel mesh__D003361 Cost Allocation
% 211.85/212.01  |- skos__scopeNote mesh__D003361
% 211.85/212.01       The assignment, to each of several particular cost-centers, of an equitable proportion of the costs of activities that serve all of them. Cost-center usually refers to institutional departments or services.%A%    
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D003361 2004
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D003361 2001
% 211.85/212.01  |- skos__altLabel mesh__D003361 Cost Apportionment
% 211.85/212.01  |- skos__hiddenLabel mesh__D003361 Shiftings, Cost
% 211.85/212.01  |- mesh__publicMeSHNote mesh__D003361
% 211.85/212.01       91; was see under COSTS AND COST ANALYSIS 1979-90   
% 211.85/212.01  |- skos__hiddenLabel mesh__D003361 Cost Shiftings
% 211.85/212.01  |- skos__broader mesh__D003361smesh__D003365
% 211.85/212.01  |- mesh__activeMeSHYear mesh__D003361 1998
% 211.85/212.02  |- mesh__dateRevised mesh__D003361 1993-09-16
% 211.85/212.02  |- mesh__dateEstablished mesh__D003361 1991-01-01
% 211.85/212.02  |- skos__hiddenLabel mesh__D003361 Shifting, Cost
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003361 2002
% 211.85/212.02  |- mesh__dateCreated mesh__D003361 1978-05-08
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003361 1996
% 211.85/212.02  |- skos__historyNote mesh__D003361
% 211.85/212.02       Costs and Cost Analysis %28%1966-1978%29%
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003361 1999
% 211.85/212.02  |- rdf__type mesh__D003361sskos__Concept
% 211.85/212.02  |- skos__hiddenLabel mesh__D003361 Apportionments, Cost
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003361 1997
% 211.85/212.02  |- skos__annotation mesh__D003361 NIM   
% 211.85/212.02  |- skos__hiddenLabel mesh__D003361 Allocation, Cost
% 211.85/212.02  |- skos__hiddenLabel mesh__D003361 Allocations, Cost
% 211.85/212.02  |- mesh__recordAuthorizer mesh__D003361 NLM
% 211.85/212.02  |- mesh__historyNote mesh__D003361
% 211.85/212.02       91%28%79%29%; was see under COSTS AND COST ANALYSIS 1979-90   
% 211.85/212.02  |- skos__hiddenLabel mesh__D003361 Cost Apportionments
% 211.85/212.02  |- skos__hiddenLabel mesh__D003361 Apportionment, Cost
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003361 2000
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003361 2005
% 211.85/212.02  |- mesh__dateEstablished mesh__D007752 1967-01-01
% 211.85/212.02  |- mesh__historyNote mesh__D007752 2006 %28%1964%29%   
% 211.85/212.02  |- skos__broader mesh__D007752smesh__D007744
% 211.85/212.02  |- skos__hiddenLabel mesh__D007752 Labor, Preterm
% 211.85/212.02  |- mesh__publicMeSHNote mesh__D007752
% 211.85/212.02       2006; see LABOR, PREMATURE 1964-2005   
% 211.85/212.02  |- mesh__dateCreated mesh__D007752 1999-01-01
% 211.85/212.02  |- rdf__type mesh__D007752sskos__Concept
% 211.85/212.02  |- mesh__recordMaintainer mesh__D007752 lkt
% 211.85/212.02  |- skos__hiddenLabel mesh__D007752 Labor, Premature Obstetric
% 211.85/212.02  |- mesh__recordOriginator mesh__D007752 NLM
% 211.85/212.02  |- skos__altLabel mesh__D007752 Premature Obstetric Labor
% 211.85/212.02  |- skos__altLabel mesh__D007752 Labor, Premature
% 211.85/212.02  |- skos__altLabel mesh__D007752 Premature Labor
% 211.85/212.02  |- skos__annotation mesh__D007752
% 211.85/212.02       check the tags FEMALE %26% PREGNANCY; PREMATURE BIRTH is also available%A%  
% 211.85/212.02  |- skos__related mesh__D007752smesh__D015149
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D007752 2006
% 211.85/212.02  |- mesh__recordAuthorizer mesh__D007752 sjn
% 211.85/212.02  |- skos__prefLabel mesh__D007752 Obstetric Labor, Premature
% 211.85/212.02  |- skos__altLabel mesh__D007752 Preterm Labor
% 211.85/212.02  |- skos__scopeNote mesh__D007752
% 211.85/212.02       Onset of OBSTETRIC LABOR before term %28%TERM BIRTH%29% but usually after the FETUS has become viable. In humans, it occurs sometime during the 29th through 38th week of PREGNANCY. TOCOLYSIS inhibits premature labor and can prevent the BIRTH of premature infants %28%INFANT, PREMATURE%29%.%A%    
% 211.85/212.02  |- mesh__dateRevised mesh__D007752 2005-06-30
% 211.85/212.02  |- skos__related mesh__D007752smesh__D007234
% 211.85/212.02  |- skos__broader mesh__D029406smesh__D018067
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D029406 2005
% 211.85/212.02  |- mesh__historyNote mesh__D029406
% 211.85/212.02       2002; use HEPATITIS AGENTS, GB 1997-2001   
% 211.85/212.02  |- skos__prefLabel mesh__D029406 GB virus B
% 211.85/212.02  |- mesh__dateEstablished mesh__D029406 2002-01-01
% 211.85/212.02  |- mesh__dateRevised mesh__D029406 2004-07-13
% 211.85/212.02  |- skos__historyNote mesh__D029406 Hepatitis Agents, GB %28%1999-2001%29%
% 211.85/212.02  |- mesh__recordOriginator mesh__D029406 ags
% 211.85/212.02  |- skos__scopeNote mesh__D029406
% 211.85/212.02       A species of virus %28%unassigned to a genus%29% in the family FLAVIVIRIDAE, that was recovered from a tamarin monkey, but may have been of human origin. It causes HEPATITIS in several species of New World monkeys.%A%    
% 211.85/212.02  |- mesh__dateCreated mesh__D029406 2001-07-25
% 211.85/212.02  |- skos__annotation mesh__D029406
% 211.85/212.02       infection: coord IM with FLAVIVIRIDAE INFECTIONS %28%IM%29% + HEPATITIS, VIRAL, HUMAN %28%IM%29% or HEPATITIS, VIRAL, ANIMAL %28%IM%29%%A%  
% 211.85/212.02  |- skos__altLabel mesh__D029406 GBV-B
% 211.85/212.02  |- rdf__type mesh__D029406sskos__Concept
% 211.85/212.02  |- mesh__publicMeSHNote mesh__D029406
% 211.85/212.02       2002; see HEPATITIS AGENTS, GB 1997-2001   
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D029406 2006
% 211.85/212.02  |- mesh__recordAuthorizer mesh__D029406 sjn
% 211.85/212.02  |- mesh__recordMaintainer mesh__D029406 sjn
% 211.85/212.02  |- skos__broader mesh__D029406smesh__D006518
% 211.85/212.02  |- rdf__type mesh__D012697sskos__Concept
% 211.85/212.02  |- skos__altLabel mesh__D012697 Serine Protein Hydrolases
% 211.85/212.02  |- skos__hiddenLabel mesh__D012697 Hydrolases, Serine Protein
% 211.85/212.02  |- skos__altLabel mesh__D012697 Serine Protease
% 211.85/212.02  |- skos__hiddenLabel mesh__D012697 Protease, Serine
% 211.85/212.02  |- skos__hiddenLabel mesh__D012697 Endopeptidases, Serine
% 211.85/212.02  |- skos__hiddenLabel mesh__D012697 Protein Hydrolases, Serine
% 211.85/212.02  |- mesh__recordMaintainer mesh__D012697 ssb
% 211.85/212.02  |- mesh__dateRevised mesh__D012697 2003-07-09
% 211.85/212.02  |- mesh__publicMeSHNote mesh__D012697
% 211.85/212.02       2000; see SERINE PROTEINASES 1988-1999   
% 211.85/212.02  |- skos__altLabel mesh__D012697 Serine Proteinase
% 211.85/212.02  |- mesh__dateEstablished mesh__D012697 1988-01-01
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D012697 2004
% 211.85/212.02  |- skos__historyNote mesh__D012697
% 211.85/212.02       Peptide Peptidohydrolases %28%1966-1987%29%
% 211.85/212.02  |- mesh__recordOriginator mesh__D012697 RLS
% 211.85/212.02  |- mesh__historyNote mesh__D012697 2000%28%1988%29%   
% 211.85/212.02  |- skos__hiddenLabel mesh__D012697 Proteinase, Serine
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D012697 2005
% 211.85/212.02  |- skos__broader mesh__D012697smesh__D010450
% 211.85/212.02  |- skos__scopeNote mesh__D012697
% 211.85/212.02       Any member of the group of ENDOPEPTIDASES containing at the active site a serine residue involved in catalysis. EC 3.4.21.%A%    
% 211.85/212.02  |- mesh__recordAuthorizer mesh__D012697 sjn
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D012697 2006
% 211.85/212.02  |- skos__hiddenLabel mesh__D012697 Proteases, Serine
% 211.85/212.02  |- skos__altLabel mesh__D012697 Serine Proteases
% 211.85/212.02  |- skos__hiddenLabel mesh__D012697 Proteinases, Serine
% 211.85/212.02  |- skos__altLabel mesh__D012697 Serine Proteinases
% 211.85/212.02  |- skos__prefLabel mesh__D012697 Serine Endopeptidases
% 211.85/212.02  |- mesh__dateCreated mesh__D012697 1987-05-04
% 211.85/212.02  |- skos__hiddenLabel mesh__D017382 Pro Oxidants
% 211.85/212.02  |- skos__related mesh__D017382smesh__D018384
% 211.85/212.02  |- skos__scopeNote mesh__D017382
% 211.85/212.02       Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of signal transduction and gene expression, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS.%A%    
% 211.85/212.02  |- skos__broader mesh__D017382smesh__D005609
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D017382 2006
% 211.85/212.02  |- skos__prefLabel mesh__D017382 Reactive Oxygen Species
% 211.85/212.02  |- mesh__dateCreated mesh__D017382 1992-05-22
% 211.85/212.02  |- mesh__historyNote mesh__D017382 1993   
% 211.85/212.02  |- mesh__dateRevised mesh__D017382 2005-06-30
% 211.85/212.02  |- skos__altLabel mesh__D017382 Oxygen Species, Reactive
% 211.85/212.02  |- mesh__publicMeSHNote mesh__D017382 1993   
% 211.85/212.02  |- rdf__type mesh__D017382sskos__Concept
% 211.85/212.02  |- skos__altLabel mesh__D017382 Active Oxygen
% 211.85/212.02  |- skos__related mesh__D017382smesh__D005609
% 211.85/212.02  |- skos__hiddenLabel mesh__D017382 Oxygen, Active
% 211.85/212.02  |- mesh__recordMaintainer mesh__D017382 ssb
% 211.85/212.02  |- mesh__recordAuthorizer mesh__D017382 sjn
% 211.85/212.02  |- mesh__recordOriginator mesh__D017382 TPW
% 211.85/212.02  |- skos__broader mesh__D017382smesh__D017601
% 211.85/212.02  |- skos__altLabel mesh__D017382 Oxygen Radicals
% 211.85/212.02  |- skos__altLabel mesh__D017382 Pro-Oxidants
% 211.85/212.02  |- mesh__dateEstablished mesh__D017382 1993-01-01
% 211.85/212.02  |- skos__altLabel mesh__D031053 Periwinkle
% 211.85/212.02  |- mesh__recordMaintainer mesh__D031053 ags
% 211.85/212.02  |- mesh__dateCreated mesh__D031053 2002-07-03
% 211.85/212.02  |- mesh__dateEstablished mesh__D031053 2003-01-01
% 211.85/212.02  |- mesh__recordAuthorizer mesh__D031053 ags
% 211.85/212.02  |- rdf__type mesh__D031053sskos__Concept
% 211.85/212.02  |- mesh__recordOriginator mesh__D031053 ssb
% 211.85/212.02  |- skos__prefLabel mesh__D031053 Vinca
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D031053 2003
% 211.85/212.02  |- mesh__dateRevised mesh__D031053 2005-08-03
% 211.85/212.02  |- skos__broader mesh__D031053smesh__D029062
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D031053 2004
% 211.85/212.02  |- skos__scopeNote mesh__D031053
% 211.85/212.02       A plant genus of the family APOCYNACEAE.  Vinca rosea has been changed to  CATHARANTHUS roseus.%A%    
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D031053 2005
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D031053 2006A
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D031053 2006
% 211.85/212.02  |- mesh__historyNote mesh__D031053 2003   
% 211.85/212.02  |- skos__annotation mesh__D031053
% 211.85/212.02       for VINCA ROSEA; %28%= PERIWINKLE, MADAGASCAR;%29% see CATHARANTHUS is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.85/212.02  |- mesh__publicMeSHNote mesh__D031053 2003   
% 211.85/212.02  |- mesh__publicMeSHNote mesh__D003362 76   
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003362 2004
% 211.85/212.02  |- skos__scopeNote mesh__D003362
% 211.85/212.02       A method of comparing the cost of a program with its expected benefits in dollars %28%or other currency%29%. The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.%A%    
% 211.85/212.02  |- skos__hiddenLabel mesh__D003362 Cost-Benefit Analyses
% 211.85/212.02  |- skos__hiddenLabel mesh__D003362 Analyses, Cost Benefit
% 211.85/212.02  |- skos__broader mesh__D003362smesh__D003365
% 211.85/212.02  |- skos__hiddenLabel mesh__D003362 Effectiveness, Cost
% 211.85/212.02  |- skos__hiddenLabel mesh__D003362 Cost Benefit Data
% 211.85/212.02  |- skos__altLabel mesh__D003362 Benefits and Costs
% 211.85/212.02  |- mesh__recordOriginator mesh__D003362 EC
% 211.85/212.02  |- rdf__type mesh__D003362sskos__Concept
% 211.85/212.02  |- skos__hiddenLabel mesh__D003362 Data, Cost-Benefit
% 211.85/212.02  |- skos__hiddenLabel mesh__D003362 Cost Benefit Analyses
% 211.85/212.02  |- skos__historyNote mesh__D003362
% 211.85/212.02       Costs and Cost Analysis %28%1966-1975%29%
% 211.85/212.02  |- skos__altLabel mesh__D003362 Cost Benefit Analysis
% 211.85/212.02  |- skos__hiddenLabel mesh__D003362 Analysis, Cost Benefit
% 211.85/212.02  |- skos__prefLabel mesh__D003362 Cost-Benefit Analysis
% 211.85/212.02  |- mesh__historyNote mesh__D003362 76   
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003362 2002
% 211.85/212.02  |- mesh__dateCreated mesh__D003362 1975-07-25
% 211.85/212.02  |- mesh__recordAuthorizer mesh__D003362 sjn
% 211.85/212.02  |- mesh__recordMaintainer mesh__D003362 jls
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003362 2005
% 211.85/212.02  |- skos__altLabel mesh__D003362 Costs and Benefits
% 211.85/212.02  |- skos__annotation mesh__D003362 NIM   
% 211.85/212.02  |- skos__hiddenLabel mesh__D003362 Analysis, Cost-Benefit
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003362 2003
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003362 2006
% 211.85/212.02  |- skos__hiddenLabel mesh__D003362 Analyses, Cost-Benefit
% 211.85/212.02  |- mesh__dateRevised mesh__D003362 2001-07-25
% 211.85/212.02  |- mesh__dateEstablished mesh__D003362 1976-01-01
% 211.85/212.02  |- skos__prefLabel mesh__D013790 Thalassotherapy
% 211.85/212.02  |- mesh__recordAuthorizer mesh__D013790 sjn
% 211.85/212.02  |- mesh__recordMaintainer mesh__D013790 lkt
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D013790 2006
% 211.85/212.02  |- mesh__dateCreated mesh__D013790 1999-01-01
% 211.85/212.02  |- skos__broader mesh__D013790smesh__D013812
% 211.85/212.02  |- mesh__dateRevised mesh__D013790 2005-06-30
% 211.85/212.02  |- skos__annotation mesh__D013790
% 211.85/212.02       do not use /util except by MeSH definition; includes sea bathing, sea voyages or sea air%A%  
% 211.85/212.02  |- skos__hiddenLabel mesh__D013790 Thalassotherapies
% 211.85/212.02  |- mesh__recordOriginator mesh__D013790 NLM
% 211.85/212.02  |- rdf__type mesh__D013790sskos__Concept
% 211.85/212.02  |- skos__scopeNote mesh__D013790
% 211.85/212.02       The therapeutic use of seaside resorts; includes treatment by sea air, sea voyages, and sea bathing.%A%    
% 211.85/212.02  |- mesh__recordAuthorizer mesh__D007753 sjn
% 211.85/212.02  |- mesh__dateRevised mesh__D007753 1999-11-03
% 211.85/212.02  |- rdf__type mesh__D007753sskos__Concept
% 211.85/212.02  |- skos__scopeNote mesh__D007753
% 211.85/212.02       Facilities equipped to carry out investigative procedures.%A%    
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D007753 2005
% 211.85/212.02  |- skos__annotation mesh__D007753
% 211.85/212.02       coord IM with type of lab %28%IM%29%, as hematol lab = LABORATORIES %28%IM%29% + HEMATOLOGY %28%IM%29%%A%  
% 211.85/212.02  |- skos__related mesh__D007753smesh__D019411
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D007753 2000
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D007753 2003
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D007753 2006
% 211.85/212.02  |- skos__prefLabel mesh__D007753 Laboratories
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D007753 2001
% 211.85/212.02  |- mesh__recordOriginator mesh__D007753 NLM
% 211.85/212.02  |- skos__broader mesh__D007753smesh__D006268
% 211.85/212.02  |- mesh__dateCreated mesh__D007753 1999-01-01
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D007753 2004
% 211.85/212.02  |- mesh__recordMaintainer mesh__D007753 jls
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D007753 2002
% 211.85/212.02  |- skos__hiddenLabel mesh__D007753 Laboratory
% 211.85/212.02  |- mesh__dateRevised mesh__D029407 2004-07-13
% 211.85/212.02  |- mesh__recordMaintainer mesh__D029407 sjn
% 211.85/212.02  |- skos__broader mesh__D029407smesh__D018067
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D029407 2005
% 211.85/212.02  |- skos__prefLabel mesh__D029407 GB virus C
% 211.85/212.02  |- skos__scopeNote mesh__D029407
% 211.85/212.02       A species of virus %28%unassigned to a genus%29% in the family FLAVIVIRIDAE. It is genetically heterogeneous, of human origin, and transmitted by blood or blood products. Despite its alternate name %28%Hepatitis G virus%29%, its pathogenicity remains controversial.%A%    
% 211.85/212.02  |- mesh__recordOriginator mesh__D029407 ags
% 211.85/212.02  |- skos__historyNote mesh__D029407 Hepatitis Agents, GB %28%1996-2001%29%
% 211.85/212.02  |- skos__altLabel mesh__D029407 GBV-C
% 211.85/212.02  |- skos__altLabel mesh__D029407 Hepatitis G virus
% 211.85/212.02  |- mesh__dateCreated mesh__D029407 2001-07-25
% 211.85/212.02  |- rdf__type mesh__D029407sskos__Concept
% 211.85/212.02  |- mesh__recordAuthorizer mesh__D029407 sjn
% 211.85/212.02  |- skos__broader mesh__D029407smesh__D006518
% 211.85/212.02  |- skos__historyNote mesh__D029407 Flaviviridae %28%1996%29%
% 211.85/212.02  |- mesh__publicMeSHNote mesh__D029407
% 211.85/212.02       2002; see HEPATITIS AGENTS, GB 1997-2001   
% 211.85/212.02  |- mesh__historyNote mesh__D029407
% 211.85/212.02       2002; use HEPATITIS AGENTS, GB 1997-2001   
% 211.85/212.02  |- skos__annotation mesh__D029407
% 211.85/212.02       infection: coord IM with FLAVIVIRIDAE INFECTIONS %28%IM%29% + HEPATITIS, VIRAL, HUMAN %28%IM%29% or HEPATITIS, VIRAL, ANIMAL %28%IM%29% if pertinent%A%  
% 211.85/212.02  |- mesh__dateEstablished mesh__D029407 2002-01-01
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D029407 2006
% 211.85/212.02  |- rdf__type mesh__D012698sskos__Concept
% 211.85/212.02  |- skos__hiddenLabel mesh__D012698 Tests, Serological
% 211.85/212.02  |- skos__hiddenLabel mesh__D012698 Test, Serological
% 211.85/212.02  |- skos__altLabel mesh__D012698 Serologic Test
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D012698 2000
% 211.85/212.02  |- mesh__publicMeSHNote mesh__D012698 98; see SERODIAGNOSIS 1963-97   
% 211.85/212.02  |- mesh__recordMaintainer mesh__D012698 PXP
% 211.85/212.02  |- skos__scopeNote mesh__D012698
% 211.85/212.02       Diagnostic procedures involving immunoglobulin reactions.%A%    
% 211.85/212.02  |- skos__altLabel mesh__D012698 Test, Serologic
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D012698 2003
% 211.85/212.02  |- skos__annotation mesh__D012698
% 211.85/212.02       GEN or unspecified; prefer specifics; NIM; Manual 26.9-26.9.2; restrict to determ of immune cpds %28%e.g., antibodies%29% in serum: do not confuse with SEROLOGY, the specialty; DF: SERODIAG%A%  
% 211.85/212.02  |- skos__hiddenLabel mesh__D012698 Serodiagnoses
% 211.85/212.02  |- skos__altLabel mesh__D012698 Serological Tests
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D012698 1998
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D012698 2001
% 211.85/212.02  |- mesh__recordOriginator mesh__D012698 NLM
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D012698 2004
% 211.85/212.02  |- mesh__recordAuthorizer mesh__D012698 SJN
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D012698 1999
% 211.85/212.02  |- mesh__historyNote mesh__D012698 98%28%63%29%   
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D012698 2002
% 211.85/212.02  |- skos__hiddenLabel mesh__D012698 Serological Test
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D012698 2005
% 211.85/212.02  |- mesh__dateCreated mesh__D012698 1999-01-01
% 211.85/212.02  |- skos__prefLabel mesh__D012698 Serologic Tests
% 211.85/212.02  |- skos__altLabel mesh__D012698 Tests, Serologic
% 211.85/212.02  |- mesh__dateRevised mesh__D012698 1997-06-20
% 211.85/212.02  |- skos__broader mesh__D012698smesh__D007159
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D012698 2006
% 211.85/212.02  |- skos__hiddenLabel mesh__D003363 Cost Containments
% 211.85/212.02  |- skos__hiddenLabel mesh__D003363 Control, Cost
% 211.85/212.02  |- skos__altLabel mesh__D003363 Cost Containment
% 211.85/212.02  |- mesh__historyNote mesh__D003363
% 211.85/212.02       80%28%79%29%; was see under COSTS AND COST ANALYSIS 1979   
% 211.85/212.02  |- mesh__recordMaintainer mesh__D003363 ags
% 211.85/212.02  |- mesh__dateRevised mesh__D003363 2004-07-07
% 211.85/212.02  |- skos__hiddenLabel mesh__D003363 Cost Controls
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003363 2005
% 211.85/212.02  |- skos__hiddenLabel mesh__D003363 Controls, Cost
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003363 2006
% 211.85/212.02  |- mesh__recordOriginator mesh__D003363 EC
% 211.85/212.02  |- skos__prefLabel mesh__D003363 Cost Control
% 211.85/212.02  |- skos__hiddenLabel mesh__D003363 Containments, Cost
% 211.85/212.02  |- skos__scopeNote mesh__D003363
% 211.85/212.02       The containment, regulation, or restraint of costs. Costs are said to be contained when the value of resources committed to an activity is not considered excessive. This determination is frequently subjective and dependent upon the specific geographic area of the activity being measured. %28%From Dictionary of Health Services Management, 2d ed%29%%A%    
% 211.85/212.02  |- skos__broader mesh__D003363smesh__D003365
% 211.85/212.02  |- mesh__dateEstablished mesh__D003363 1980-01-01
% 211.85/212.02  |- mesh__publicMeSHNote mesh__D003363
% 211.85/212.02       80; was see under COSTS AND COST ANALYSIS 1979   
% 211.85/212.02  |- mesh__dateCreated mesh__D003363 1978-05-08
% 211.85/212.02  |- skos__hiddenLabel mesh__D003363 Containment, Cost
% 211.85/212.02  |- skos__historyNote mesh__D003363
% 211.85/212.02       Costs and Cost Analysis %28%1966-1978%29%
% 211.85/212.02  |- skos__annotation mesh__D003363 NIM   
% 211.85/212.02  |- rdf__type mesh__D003363sskos__Concept
% 211.85/212.02  |- mesh__recordAuthorizer mesh__D003363 sjn
% 211.85/212.02  |- mesh__recordMaintainer mesh__D007754 jls
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D007754 2002
% 211.85/212.02  |- skos__prefLabel mesh__D007754 Laboratories, Dental
% 211.85/212.02  |- skos__scopeNote mesh__D007754
% 211.85/212.02       Facilities for the performance of services related to dental treatment but not done directly in the patient%27%s mouth.%A%    
% 211.85/212.02  |- mesh__dateEstablished mesh__D007754 1974-01-01
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D007754 2005
% 211.85/212.02  |- mesh__recordAuthorizer mesh__D007754 sjn
% 211.85/212.02  |- mesh__dateRevised mesh__D007754 1999-11-03
% 211.85/212.02  |- skos__altLabel mesh__D007754 Dental Laboratory
% 211.85/212.02  |- skos__altLabel mesh__D007754 Dental Laboratories
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D007754 2003
% 211.85/212.02  |- mesh__publicMeSHNote mesh__D007754 74   
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D007754 2006
% 211.85/212.02  |- skos__broader mesh__D007754smesh__D003749
% 211.85/212.02  |- mesh__dateCreated mesh__D007754 1999-01-01
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D007754 2004
% 211.85/212.02  |- skos__altLabel mesh__D007754 Laboratory, Dental
% 211.85/212.02  |- mesh__historyNote mesh__D007754 74%28%72%29%   
% 211.85/212.02  |- skos__annotation mesh__D007754 DF: LABORATORIES DENT   
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D007754 2000
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D007754 2001
% 211.85/212.02  |- mesh__recordOriginator mesh__D007754 NLM
% 211.85/212.02  |- rdf__type mesh__D007754sskos__Concept
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D012699 2003
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D012699 1998
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D012699 2004
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D012699 1999
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D012699 2000
% 211.85/212.02  |- mesh__recordMaintainer mesh__D012699 PXP
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D012699 2005
% 211.85/212.02  |- mesh__dateCreated mesh__D012699 1999-01-01
% 211.85/212.02  |- skos__prefLabel mesh__D012699 Serology
% 211.85/212.02  |- skos__annotation mesh__D012699
% 211.85/212.02       field of immunology dealing with in vitro antigen-antibody reactions; SPEC: SPEC qualif; do not confuse with SEROLOGIC TESTS; DF: SEROL%A%  
% 211.85/212.02  |- mesh__recordOriginator mesh__D012699 NLM
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D012699 2001
% 211.85/212.02  |- skos__scopeNote mesh__D012699
% 211.85/212.02       The study of serum, especially of antigen-antibody reactions in vitro.%A%    
% 211.85/212.02  |- mesh__recordAuthorizer mesh__D012699 SJN
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D012699 2006
% 211.85/212.02  |- skos__broader mesh__D012699smesh__D006281
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D012699 2002
% 211.85/212.02  |- rdf__type mesh__D012699sskos__Concept
% 211.85/212.02  |- mesh__dateRevised mesh__D012699 1997-06-20
% 211.85/212.02  |- mesh__dateCreated mesh__D017384 1992-05-22
% 211.85/212.02  |- skos__hiddenLabel mesh__D017384 Deletion, Sequence
% 211.85/212.02  |- skos__historyNote mesh__D017384 Mutation %28%1976-1992%29%
% 211.85/212.02  |- skos__hiddenLabel mesh__D017384 Deletions, Sequence
% 211.85/212.02  |- mesh__recordAuthorizer mesh__D017384 sjn
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D017384 2006
% 211.85/212.02  |- skos__broader mesh__D017384smesh__D009154
% 211.85/212.02  |- skos__scopeNote mesh__D017384
% 211.85/212.02       Deletion of sequences of nucleic acids from the genetic material of an individual.%A%    
% 211.85/212.02  |- mesh__recordMaintainer mesh__D017384 PXP
% 211.85/212.02  |- skos__prefLabel mesh__D017384 Sequence Deletion
% 211.85/212.02  |- mesh__dateRevised mesh__D017384 2002-07-03
% 211.85/212.02  |- mesh__dateEstablished mesh__D017384 1993-01-01
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D017384 2005
% 211.85/212.02  |- mesh__historyNote mesh__D017384 93   
% 211.85/212.02  |- rdf__type mesh__D017384sskos__Concept
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D017384 2004
% 211.85/212.02  |- skos__broader mesh__D017384smesh__D016296
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D017384 2003
% 211.85/212.02  |- mesh__publicMeSHNote mesh__D017384 93   
% 211.85/212.02  |- mesh__recordOriginator mesh__D017384 PXP
% 211.85/212.02  |- skos__hiddenLabel mesh__D017384 Sequence Deletions
% 211.85/212.02  |- skos__annotation mesh__D017384
% 211.85/212.02       coord IM with BASE SEQUENCE or AMINO ACID SEQUENCE %28%IM%29%; DF: SEQ DELETION%A%  
% 211.85/212.02  |- mesh__publicMeSHNote mesh__D031055 2003   
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D031055 2005
% 211.85/212.02  |- rdf__type mesh__D031055sskos__Concept
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D031055 2004
% 211.85/212.02  |- skos__broader mesh__D031055smesh__D029064
% 211.85/212.02  |- skos__annotation mesh__D031055
% 211.85/212.02       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D031055 2003
% 211.85/212.02  |- mesh__dateCreated mesh__D031055 2002-07-02
% 211.85/212.02  |- skos__altLabel mesh__D031055 Taro, Giant
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D031055 2006
% 211.85/212.02  |- skos__scopeNote mesh__D031055
% 211.85/212.02       A plant genus of the family ARACEAE. Members contain beta-glucosidases and trypsin inhibitors.%A%    
% 211.85/212.02  |- mesh__dateEstablished mesh__D031055 2003-01-01
% 211.85/212.02  |- skos__prefLabel mesh__D031055 Alocasia
% 211.85/212.02  |- mesh__historyNote mesh__D031055 2003   
% 211.85/212.02  |- mesh__dateRevised mesh__D003364 1991-11-05
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003364 2005
% 211.85/212.02  |- mesh__dateCreated mesh__D003364 1999-01-01
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003364 1989
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003364 1994
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003364 2002
% 211.85/212.02  |- mesh__recordAuthorizer mesh__D003364 PLS
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003364 1991
% 211.85/212.02  |- skos__prefLabel mesh__D003364 Costa Rica
% 211.85/212.02  |- mesh__recordOriginator mesh__D003364 NLM
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003364 2003
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003364 1992
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003364 2006
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003364 1995
% 211.85/212.02  |- skos__broader mesh__D003364smesh__D002489
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003364 1998
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003364 2004
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003364 1993
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003364 1996
% 211.85/212.02  |- mesh__recordMaintainer mesh__D003364 PLS
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003364 1999
% 211.85/212.02  |- rdf__type mesh__D003364sskos__Concept
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003364 2000
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003364 1997
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003364 2001
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D003364 1990
% 211.85/212.02  |- skos__prefLabel mesh__D013792 Thalidomide
% 211.85/212.02  |- skos__broader mesh__D013792smesh__D010797
% 211.85/212.02  |- skos__scopeNote mesh__D013792
% 211.85/212.02       A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppresive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.%A%    
% 211.85/212.02  |- mesh__dateRevised mesh__D013792 2005-06-30
% 211.85/212.02  |- skos__broader mesh__D013792smesh__D010881
% 211.85/212.02  |- mesh__recordMaintainer mesh__D013792 CCR
% 211.85/212.02  |- mesh__recordOriginator mesh__D013792 NLM
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D013792 2006
% 211.85/212.02  |- mesh__recordAuthorizer mesh__D013792 sjn
% 211.85/212.02  |- skos__altLabel mesh__D013792 Celgene Brand of Thalidomide
% 211.85/212.02  |- mesh__dateCreated mesh__D013792 1999-01-01
% 211.85/212.02  |- rdf__type mesh__D013792sskos__Concept
% 211.85/212.02  |- skos__broader mesh__D019938Q000031smesh__D019938
% 211.85/212.02  |- mesh__preferredCombination mesh__D019938Q000031smesh__D016213
% 211.85/212.02  |- rdf__type mesh__D019938Q000031smesh__CompoundConcept
% 211.85/212.02  |- skos__altLabel mesh__D007755 Laboratory, Hospital
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D007755 2003
% 211.85/212.02  |- mesh__dateEstablished mesh__D007755 1988-01-01
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D007755 2000
% 211.85/212.02  |- skos__altLabel mesh__D007755 Hospital Laboratories
% 211.85/212.02  |- mesh__dateCreated mesh__D007755 1987-05-02
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D007755 2004
% 211.85/212.02  |- mesh__recordMaintainer mesh__D007755 TGC
% 211.85/212.02  |- mesh__activeMeSHYear mesh__D007755 1994
% 211.85/212.03  |- skos__prefLabel mesh__D007755 Laboratories, Hospital
% 211.85/212.03  |- skos__annotation mesh__D007755 DF: LABORATORIES HOSP   
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007755 2001
% 211.85/212.03  |- mesh__dateRevised mesh__D007755 1992-03-25
% 211.85/212.03  |- skos__broader mesh__D007755smesh__D007753
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007755 1995
% 211.85/212.03  |- skos__altLabel mesh__D007755 Hospital Laboratory
% 211.85/212.03  |- mesh__publicMeSHNote mesh__D007755 88   
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007755 2002
% 211.85/212.03  |- mesh__recordOriginator mesh__D007755 EC
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007755 1993
% 211.85/212.03  |- skos__broader mesh__D007755smesh__D006748
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007755 1998
% 211.85/212.03  |- rdf__type mesh__D007755sskos__Concept
% 211.85/212.03  |- mesh__historyNote mesh__D007755 88   
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007755 1999
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007755 1996
% 211.85/212.03  |- skos__historyNote mesh__D007755 Laboratories %28%1966-1987%29%
% 211.85/212.03  |- mesh__recordAuthorizer mesh__D007755 PLS
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007755 2005
% 211.85/212.03  |- skos__scopeNote mesh__D007755
% 211.85/212.03       Hospital facilities equipped to carry out investigative procedures.%A%    
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007755 1997
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007755 2006
% 211.85/212.03  |- skos__hiddenLabel mesh__D017385 Sequence Homolog
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D017385 2006
% 211.85/212.03  |- skos__broader mesh__D017385smesh__D040341
% 211.85/212.03  |- mesh__dateRevised mesh__D017385 2004-07-07
% 211.85/212.03  |- skos__hiddenLabel mesh__D017385 Homolog, Sequence
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D017385 2005
% 211.85/212.03  |- mesh__recordMaintainer mesh__D017385 nns
% 211.85/212.03  |- mesh__dateCreated mesh__D017385 1992-05-22
% 211.85/212.03  |- rdf__type mesh__D017385sskos__Concept
% 211.85/212.03  |- skos__hiddenLabel mesh__D017385 Sequence, Homologous
% 211.85/212.03  |- mesh__historyNote mesh__D017385 93   
% 211.85/212.03  |- mesh__recordAuthorizer mesh__D017385 sjn
% 211.85/212.03  |- skos__broader mesh__D017385smesh__D001669
% 211.85/212.03  |- skos__altLabel mesh__D017385 Homologs, Sequence
% 211.85/212.03  |- mesh__recordOriginator mesh__D017385 PXP
% 211.85/212.03  |- skos__hiddenLabel mesh__D017385 Homologous Sequence
% 211.85/212.03  |- mesh__dateEstablished mesh__D017385 1993-01-01
% 211.85/212.03  |- skos__hiddenLabel mesh__D017385 Sequences, Homologous
% 211.85/212.03  |- skos__historyNote mesh__D017385
% 211.85/212.03       Molecular Sequence Data %28%1988-1992%29%
% 211.85/212.03  |- skos__prefLabel mesh__D017385 Sequence Homology
% 211.85/212.03  |- skos__historyNote mesh__D017385
% 211.85/212.03       Nucleic Acid Hybridization %28%1971-1985%29%
% 211.85/212.03  |- skos__hiddenLabel mesh__D017385 Sequence Homologies
% 211.85/212.03  |- skos__hiddenLabel mesh__D017385 Homology, Sequence
% 211.85/212.03  |- skos__altLabel mesh__D017385 Sequence Homologs
% 211.85/212.03  |- skos__historyNote mesh__D017385 Amino Acid Sequence %28%1967-1992%29%
% 211.85/212.03  |- skos__hiddenLabel mesh__D017385 Homologies, Sequence
% 211.85/212.03  |- skos__annotation mesh__D017385
% 211.85/212.03       GEN or unspecified; prefer specifics;  DF: SEQ HOMOL   
% 211.85/212.03  |- skos__scopeNote mesh__D017385
% 211.85/212.03       The degree of similarity between sequences. Studies of AMINO ACID SEQUENCE HOMOLOGY and NUCLEIC ACID SEQUENCE HOMOLOGY provide useful information about the genetic relatedness of genes, gene products, and species.%A%    
% 211.85/212.03  |- skos__historyNote mesh__D017385 Base Sequence %28%1971-1992%29%
% 211.85/212.03  |- mesh__publicMeSHNote mesh__D017385 93   
% 211.85/212.03  |- rdf__type mesh__D031056sskos__Concept
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D031056 2004
% 211.85/212.03  |- mesh__dateEstablished mesh__D031056 2003-01-01
% 211.85/212.03  |- mesh__historyNote mesh__D031056 2003   
% 211.85/212.03  |- skos__annotation mesh__D031056
% 211.85/212.03       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D031056 2003
% 211.85/212.03  |- skos__scopeNote mesh__D031056
% 211.85/212.03       A plant genus of the family ARACEAE. Members contain konjac glucomannan %28%MANNANS%29% and SEROTONIN.%A%    
% 211.85/212.03  |- skos__broader mesh__D031056smesh__D029064
% 211.85/212.03  |- skos__prefLabel mesh__D031056 Amorphophallus
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D031056 2006
% 211.85/212.03  |- skos__altLabel mesh__D031056 Konjac
% 211.85/212.03  |- mesh__publicMeSHNote mesh__D031056 2003   
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D031056 2005
% 211.85/212.03  |- mesh__dateCreated mesh__D031056 2002-07-02
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D003365 1996
% 211.85/212.03  |- mesh__publicMeSHNote mesh__D003365 66   
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D003365 1995
% 211.85/212.03  |- mesh__historyNote mesh__D003365 66   
% 211.85/212.03  |- mesh__dateEstablished mesh__D003365 1966-01-01
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D003365 1998
% 211.85/212.03  |- mesh__recordAuthorizer mesh__D003365 NLM
% 211.85/212.03  |- skos__altLabel mesh__D003365 Costs and Cost Analyses
% 211.85/212.03  |- mesh__dateRevised mesh__D003365 1993-09-16
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D003365 2000
% 211.85/212.03  |- skos__hiddenLabel mesh__D003365 Analyses, Cost
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D003365 2004
% 211.85/212.03  |- skos__hiddenLabel mesh__D003365 Measure, Cost
% 211.85/212.03  |- skos__prefLabel mesh__D003365 Costs and Cost Analysis
% 211.85/212.03  |- skos__hiddenLabel mesh__D003365 Cost, Cost Analysis
% 211.85/212.03  |- skos__hiddenLabel mesh__D003365 Cost Measure
% 211.85/212.03  |- skos__hiddenLabel mesh__D003365 Cost Analyses
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D003365 2006
% 211.85/212.03  |- mesh__recordMaintainer mesh__D003365 PLS
% 211.85/212.03  |- mesh__recordOriginator mesh__D003365 NLM
% 211.85/212.03  |- skos__annotation mesh__D003365
% 211.85/212.03       NIM; %22%cost shifting%22%: index under COST ALLOCATION; DF: COSTS%A%  
% 211.85/212.03  |- skos__hiddenLabel mesh__D003365 Costs
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D003365 2003
% 211.85/212.03  |- skos__broader mesh__D003365smesh__D004467
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D003365 2005
% 211.85/212.03  |- skos__hiddenLabel mesh__D003365 Measures, Cost
% 211.85/212.03  |- skos__scopeNote mesh__D003365
% 211.85/212.03       Absolute, comparative, or differential costs pertaining to services, institutions, resources, etc., or the analysis and study of these costs.%A%    
% 211.85/212.03  |- skos__altLabel mesh__D003365 Costs, Cost Analysis
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D003365 1997
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D003365 2002
% 211.85/212.03  |- mesh__dateCreated mesh__D003365 1999-01-01
% 211.85/212.03  |- skos__altLabel mesh__D003365 Analysis, Cost
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D003365 1999
% 211.85/212.03  |- rdf__type mesh__D003365sskos__Concept
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D003365 2001
% 211.85/212.03  |- mesh__dateRevised mesh__D008050 2005-06-30
% 211.85/212.03  |- skos__broader mesh__D008050smesh__D008070
% 211.85/212.03  |- skos__hiddenLabel mesh__D008050 A, Lipid
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D008050 2006
% 211.85/212.03  |- mesh__dateCreated mesh__D008050 1976-04-13
% 211.85/212.03  |- mesh__dateEstablished mesh__D008050 1984-01-01
% 211.85/212.03  |- mesh__recordAuthorizer mesh__D008050 sjn
% 211.85/212.03  |- skos__prefLabel mesh__D008050 Lipid A
% 211.85/212.03  |- mesh__recordMaintainer mesh__D008050 ssb
% 211.85/212.03  |- mesh__publicMeSHNote mesh__D008050
% 211.85/212.03       84; was see under LIPOPOLYSACCHARIDES 1977-83   
% 211.85/212.03  |- skos__scopeNote mesh__D008050
% 211.85/212.03       Lipid A is the biologically active component of lipopolysaccharides. It shows strong endotoxic activity and exhibits immunogenic properties.%A%    
% 211.85/212.03  |- skos__historyNote mesh__D008050 Lipids %28%1972-1976%29%
% 211.85/212.03  |- mesh__recordOriginator mesh__D008050 RLS
% 211.85/212.03  |- rdf__type mesh__D008050sskos__Concept
% 211.85/212.03  |- skos__historyNote mesh__D008050 Lipopolysaccharides %28%1972-1976%29%
% 211.85/212.03  |- mesh__historyNote mesh__D008050
% 211.85/212.03       84%28%77%29%; was see under LIPOPOLYSACCHARIDES 1977-83   
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013793 2004
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013793 2003
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013793 2001
% 211.85/212.03  |- mesh__recordMaintainer mesh__D013793 ADP
% 211.85/212.03  |- mesh__dateRevised mesh__D013793 1997-06-20
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013793 2006
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013793 1999
% 211.85/212.03  |- mesh__recordAuthorizer mesh__D013793 SJN
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013793 2005
% 211.85/212.03  |- skos__prefLabel mesh__D013793 Thallium
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013793 2000
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013793 1998
% 211.85/212.03  |- mesh__dateCreated mesh__D013793 1999-01-01
% 211.85/212.03  |- skos__annotation mesh__D013793
% 211.85/212.03       Tl-205; Tl-203 = THALLIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Tl-198-202, 204, 206-210 = THALLIUM RADIOISOTOPES %28%IM%29%%A%  
% 211.85/212.03  |- mesh__recordOriginator mesh__D013793 NLM
% 211.85/212.03  |- skos__scopeNote mesh__D013793
% 211.85/212.03       A heavy, soft, bluish white metal, atomic number 81, atomic weight 204.37, symbol Tl. %28%From Dorland, 28th ed%29%%A%    
% 211.85/212.03  |- skos__related mesh__D013793smesh__D013794
% 211.85/212.03  |- rdf__type mesh__D013793sskos__Concept
% 211.85/212.03  |- skos__broader mesh__D013793smesh__D019216
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013793 2002
% 211.85/212.03  |- skos__hiddenLabel mesh__D007756 Sciences, Laboratory Animal
% 211.85/212.03  |- skos__hiddenLabel mesh__D007756 Laboratory Animal Sciences
% 211.85/212.03  |- skos__prefLabel mesh__D007756 Laboratory Animal Science
% 211.85/212.03  |- mesh__dateEstablished mesh__D007756 1987-01-01
% 211.85/212.03  |- mesh__historyNote mesh__D007756 87   
% 211.85/212.03  |- rdf__type mesh__D007756sskos__Concept
% 211.85/212.03  |- skos__hiddenLabel mesh__D007756 Science, Laboratory Animal
% 211.85/212.03  |- mesh__recordMaintainer mesh__D007756 jls
% 211.85/212.03  |- mesh__dateRevised mesh__D007756 2001-07-25
% 211.85/212.03  |- skos__annotation mesh__D007756 SPEC: SPEC qualif   
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007756 2005
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007756 2002
% 211.85/212.03  |- mesh__recordOriginator mesh__D007756 EC
% 211.85/212.03  |- skos__broader mesh__D007756smesh__D001695
% 211.85/212.03  |- skos__hiddenLabel mesh__D007756 Animal Science, Laboratory
% 211.85/212.03  |- skos__hiddenLabel mesh__D007756 Animal Sciences, Laboratory
% 211.85/212.03  |- mesh__publicMeSHNote mesh__D007756 87   
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007756 2006
% 211.85/212.03  |- mesh__recordAuthorizer mesh__D007756 sjn
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007756 2003
% 211.85/212.03  |- skos__historyNote mesh__D007756 Animals, Laboratory %28%1966-1986%29%
% 211.85/212.03  |- mesh__dateCreated mesh__D007756 1986-05-28
% 211.85/212.03  |- skos__scopeNote mesh__D007756
% 211.85/212.03       The science and technology dealing with the procurement, breeding, care, health, and selection of animals used in biomedical research and testing.%A%    
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007756 2004
% 211.85/212.03  |- skos__related mesh__D017386smesh__D040681
% 211.85/212.03  |- mesh__recordMaintainer mesh__D017386 jls
% 211.85/212.03  |- mesh__dateRevised mesh__D017386 2004-08-02
% 211.85/212.03  |- skos__altLabel mesh__D017386 Sequence Homology, Protein
% 211.85/212.03  |- skos__hiddenLabel mesh__D017386 Sequence Homolog, Protein
% 211.85/212.03  |- mesh__publicMeSHNote mesh__D017386 93   
% 211.85/212.03  |- mesh__recordOriginator mesh__D017386 PXP
% 211.85/212.03  |- skos__historyNote mesh__D017386 Amino Acid Sequence %28%1967-1992%29%
% 211.85/212.03  |- skos__altLabel mesh__D017386 Protein Sequence Homology
% 211.85/212.03  |- skos__annotation mesh__D017386 no qualif; DF: SEQ HOMOL AA   
% 211.85/212.03  |- skos__broader mesh__D017386smesh__D017385
% 211.85/212.03  |- skos__hiddenLabel mesh__D017386 Sequence Homologs, Protein
% 211.85/212.03  |- skos__hiddenLabel mesh__D017386 Protein Sequence Homolog
% 211.85/212.03  |- skos__hiddenLabel mesh__D017386 Protein Sequence Homologies
% 211.85/212.03  |- skos__altLabel mesh__D017386 Homologs, Amino Acid Sequence
% 211.85/212.03  |- skos__hiddenLabel mesh__D017386 Homolog, Protein Sequence
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D017386 2006
% 211.85/212.03  |- mesh__dateCreated mesh__D017386 1992-05-22
% 211.85/212.03  |- skos__hiddenLabel mesh__D017386 Homologies, Protein Sequence
% 211.85/212.03  |- skos__altLabel mesh__D017386 Homology, Protein Sequence
% 211.85/212.03  |- skos__altLabel mesh__D017386 Homologs, Protein Sequence
% 211.85/212.03  |- skos__altLabel mesh__D017386 Amino Acid Sequence Homology
% 211.85/212.03  |- skos__scopeNote mesh__D017386
% 211.85/212.03       The degree of similarity between sequences of amino acids. This information is useful for the analyzing genetic relatedness of proteins and species.%A%    
% 211.85/212.03  |- skos__altLabel mesh__D017386 Protein Sequence Homologs
% 211.85/212.03  |- skos__prefLabel mesh__D017386 Sequence Homology, Amino Acid
% 211.85/212.03  |- mesh__dateEstablished mesh__D017386 1993-01-01
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D017386 2005
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D017386 2005A
% 211.85/212.03  |- skos__historyNote mesh__D017386
% 211.85/212.03       Molecular Sequence Data %28%1988-1992%29%
% 211.85/212.03  |- skos__hiddenLabel mesh__D017386 Sequence Homologies, Protein
% 211.85/212.03  |- rdf__type mesh__D017386sskos__Concept
% 211.85/212.03  |- mesh__historyNote mesh__D017386 93   
% 211.85/212.03  |- mesh__recordAuthorizer mesh__D017386 jls
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D031057 2004
% 211.85/212.03  |- skos__altLabel mesh__D031057 Dragon, Green
% 211.85/212.03  |- mesh__dateEstablished mesh__D031057 2003-01-01
% 211.85/212.03  |- skos__annotation mesh__D031057
% 211.85/212.03       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.85/212.03  |- skos__altLabel mesh__D031057 Green Dragon
% 211.85/212.03  |- mesh__historyNote mesh__D031057 2003   
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D031057 2003
% 211.85/212.03  |- skos__broader mesh__D031057smesh__D029064
% 211.85/212.03  |- skos__scopeNote mesh__D031057
% 211.85/212.03       A plant genus of the family ARACEAE. It has a stemless, tuberous root.%A%    
% 211.85/212.03  |- skos__prefLabel mesh__D031057 Arisaema
% 211.85/212.03  |- skos__altLabel mesh__D031057 Dragonroot
% 211.85/212.03  |- skos__altLabel mesh__D031057 Jack-in-the-Pulpit
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D031057 2006
% 211.85/212.03  |- rdf__type mesh__D031057sskos__Concept
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D031057 2005
% 211.85/212.03  |- mesh__publicMeSHNote mesh__D031057 2003   
% 211.85/212.03  |- mesh__dateCreated mesh__D031057 2002-07-02
% 211.85/212.03  |- mesh__dateRevised mesh__D003366 2002-07-02
% 211.85/212.03  |- skos__altLabel mesh__D003366 alpha-1,24-Corticotropin
% 211.85/212.03  |- mesh__dateCreated mesh__D003366 1974-11-19
% 211.85/212.03  |- skos__altLabel mesh__D003366 Corticotropin %28%1-24%29%-Peptide
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D003366 2004
% 211.85/212.03  |- mesh__recordMaintainer mesh__D003366 ssb
% 211.85/212.03  |- skos__altLabel mesh__D003366 1-24-Corticotropin
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D003366 2006
% 211.85/212.03  |- skos__hiddenLabel mesh__D003366 ACTH, Synthetic
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D003366 2003
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D003366 2005
% 211.85/212.03  |- skos__altLabel mesh__D003366 Synthetic ACTH
% 211.85/212.03  |- skos__altLabel mesh__D003366 Tetracosactrin
% 211.85/212.03  |- skos__prefLabel mesh__D003366 Cosyntropin
% 211.85/212.03  |- mesh__historyNote mesh__D003366
% 211.85/212.03       88%28%75%29%; was see under ADRENOCORTICOTROPIC HORMONE 1987; was see under CORTICOTROPIN 1974-86%A%  
% 211.85/212.03  |- mesh__dateEstablished mesh__D003366 1988-01-01
% 211.85/212.03  |- skos__scopeNote mesh__D003366
% 211.85/212.03       A synthetic polypeptide with adrenocorticotropic %28%CORTICOTROPIN%29% activity.%A%    
% 211.85/212.03  |- skos__historyNote mesh__D003366
% 211.85/212.03       Adrenocorticotropic Hormone %28%1971-1974%29%
% 211.85/212.03  |- mesh__publicMeSHNote mesh__D003366
% 211.85/212.03       88; was see under ADRENOCORTICOTROPIC HORMONE 1987; was see under CORTICOTROPIN 1974-86%A%  
% 211.85/212.03  |- skos__altLabel mesh__D003366 Tetracosapeptide
% 211.85/212.03  |- skos__broader mesh__D003366smesh__D000324
% 211.85/212.03  |- mesh__recordAuthorizer mesh__D003366 sjn
% 211.85/212.03  |- skos__altLabel mesh__D003366 1-24-ACTH
% 211.85/212.03  |- mesh__recordOriginator mesh__D003366 NLM
% 211.85/212.03  |- rdf__type mesh__D003366sskos__Concept
% 211.85/212.03  |- skos__altLabel mesh__D003366 ACTH 1-24
% 211.85/212.03  |- skos__altLabel mesh__D003366 Tetracosactide
% 211.85/212.03  |- skos__altLabel mesh__D003366 Corticotropin %28%1-24%29%-Tetracosapeptide
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D008051 2005
% 211.85/212.03  |- skos__hiddenLabel mesh__D008051 Bilayer, Lipid
% 211.85/212.03  |- skos__altLabel mesh__D008051 Bilayers, Lipid
% 211.85/212.03  |- skos__broader mesh__D008051smesh__D008563
% 211.85/212.03  |- mesh__dateRevised mesh__D008051 2004-07-07
% 211.85/212.03  |- skos__historyNote mesh__D008051 Membranes, Artificial %28%1966-1979%29%
% 211.85/212.03  |- skos__broader mesh__D008051smesh__D008567
% 211.85/212.03  |- skos__prefLabel mesh__D008051 Lipid Bilayers
% 211.85/212.03  |- mesh__historyNote mesh__D008051 80   
% 211.85/212.03  |- mesh__recordAuthorizer mesh__D008051 sjn
% 211.85/212.03  |- skos__scopeNote mesh__D008051
% 211.85/212.03       Layers of lipid molecules which are two molecules thick. Bilayer systems are frequently studied as models of biological membranes.%A%    
% 211.85/212.03  |- rdf__type mesh__D008051sskos__Concept
% 211.85/212.03  |- mesh__dateCreated mesh__D008051 1979-05-24
% 211.85/212.03  |- mesh__recordOriginator mesh__D008051 VDK
% 211.85/212.03  |- skos__hiddenLabel mesh__D008051 Lipid Bilayer
% 211.85/212.03  |- skos__related mesh__D008051smesh__D008081
% 211.85/212.03  |- skos__annotation mesh__D008051
% 211.85/212.03       coord IM with specific lipid %28%IM or NIM%29%   
% 211.85/212.03  |- mesh__publicMeSHNote mesh__D008051 80   
% 211.85/212.03  |- mesh__dateEstablished mesh__D008051 1980-01-01
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D008051 2006
% 211.85/212.03  |- mesh__recordMaintainer mesh__D008051 nns
% 211.85/212.03  |- skos__hiddenLabel mesh__D049468 Pro Metaphase
% 211.85/212.03  |- skos__broader mesh__D049468smesh__D048750
% 211.85/212.03  |- mesh__recordMaintainer mesh__D049468 nns
% 211.85/212.03  |- mesh__historyNote mesh__D049468 2005   
% 211.85/212.03  |- skos__altLabel mesh__D049468 Pro-Metaphase
% 211.85/212.03  |- skos__hiddenLabel mesh__D049468 Pro-Metaphases
% 211.85/212.03  |- mesh__dateRevised mesh__D049468 2005-06-30
% 211.85/212.03  |- mesh__dateCreated mesh__D049468 2004-07-07
% 211.85/212.03  |- skos__prefLabel mesh__D049468 Prometaphase
% 211.85/212.03  |- skos__scopeNote mesh__D049468
% 211.85/212.03       The phase of cell nucleus division following PROPHASE, when the breakdown of the NUCLEAR ENVELOPE occurs and the MITOTIC SPINDLE APPARATUS enters the nuclear region and attaches to the KINETOCHORES.%A%    
% 211.85/212.03  |- mesh__recordOriginator mesh__D049468 nns
% 211.85/212.03  |- skos__hiddenLabel mesh__D049468 Prometaphases
% 211.85/212.03  |- mesh__dateEstablished mesh__D049468 2005-01-01
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D049468 2006
% 211.85/212.03  |- skos__historyNote mesh__D049468 Metaphase %28%1978-2004%29%
% 211.85/212.03  |- skos__broader mesh__D049468smesh__D008938
% 211.85/212.03  |- rdf__type mesh__D049468sskos__Concept
% 211.85/212.03  |- mesh__publicMeSHNote mesh__D049468 2005   
% 211.85/212.03  |- mesh__recordAuthorizer mesh__D049468 sjn
% 211.85/212.03  |- skos__hiddenLabel mesh__D013794 Radioisotopes, Thallium
% 211.85/212.03  |- skos__scopeNote mesh__D013794
% 211.85/212.03       Unstable isotopes of thallium that decay or disintegrate emitting radiation. Tl atoms with atomic weights 198-202, 204, and 206-210 are thallium radioisotopes.%A%    
% 211.85/212.03  |- mesh__dateCreated mesh__D013794 1987-04-08
% 211.85/212.03  |- mesh__recordAuthorizer mesh__D013794 PLS
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013794 1995
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013794 2005
% 211.85/212.03  |- skos__broader mesh__D013794smesh__D011868
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013794 1998
% 211.85/212.03  |- mesh__dateRevised mesh__D013794 1993-06-03
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013794 2002
% 211.85/212.03  |- mesh__dateEstablished mesh__D013794 1988-01-01
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013794 1994
% 211.85/212.03  |- rdf__type mesh__D013794sskos__Concept
% 211.85/212.03  |- mesh__recordMaintainer mesh__D013794 TPW
% 211.85/212.03  |- skos__historyNote mesh__D013794 Radioisotopes %28%1966-1987%29%
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013794 2004
% 211.85/212.03  |- skos__annotation mesh__D013794
% 211.85/212.03       Tl-198-202, 204, 206-210; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013794 1997
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013794 2001
% 211.85/212.03  |- skos__prefLabel mesh__D013794 Thallium Radioisotopes
% 211.85/212.03  |- mesh__publicMeSHNote mesh__D013794 88   
% 211.85/212.03  |- mesh__recordOriginator mesh__D013794 RLS
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013794 2003
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013794 1996
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013794 2000
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013794 2006
% 211.85/212.03  |- mesh__historyNote mesh__D013794 88   
% 211.85/212.03  |- skos__historyNote mesh__D013794 Thallium %28%1966-1987%29%
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D013794 1999
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007757 2006
% 211.85/212.03  |- mesh__recordAuthorizer mesh__D007757 PLS
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007757 1992
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007757 1994
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007757 2003
% 211.85/212.03  |- mesh__historyNote mesh__D007757 68%28%64%29%   
% 211.85/212.03  |- skos__hiddenLabel mesh__D007757 Infection, Laboratory
% 211.85/212.03  |- skos__annotation mesh__D007757
% 211.85/212.03       %22%accidentally acquired infect in laboratory%22%; IM; coord with specific infection %28%IM%29% + lab animal %28%IM%29%%A%  
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007757 2005
% 211.85/212.03  |- skos__broader mesh__D007757smesh__D009784
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007757 2002
% 211.85/212.03  |- skos__broader mesh__D007757smesh__D007239
% 211.85/212.03  |- skos__hiddenLabel mesh__D007757 Infections, Laboratory
% 211.85/212.03  |- skos__hiddenLabel mesh__D007757 Laboratory Infections
% 211.85/212.03  |- skos__prefLabel mesh__D007757 Laboratory Infection
% 211.85/212.03  |- mesh__dateEstablished mesh__D007757 1968-01-01
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007757 2001
% 211.85/212.03  |- rdf__type mesh__D007757sskos__Concept
% 211.85/212.03  |- skos__scopeNote mesh__D007757
% 211.85/212.03       Accidentally acquired infection in laboratory workers.     
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007757 1997
% 211.85/212.03  |- mesh__publicMeSHNote mesh__D007757 68   
% 211.85/212.03  |- mesh__recordMaintainer mesh__D007757 TGC
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007757 1999
% 211.85/212.03  |- mesh__dateRevised mesh__D007757 1991-06-18
% 211.85/212.03  |- mesh__dateCreated mesh__D007757 1999-01-01
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007757 2000
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007757 1993
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007757 1996
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007757 1995
% 211.85/212.03  |- mesh__recordOriginator mesh__D007757 NLM
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007757 2004
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D007757 1998
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D017387 2001
% 211.85/212.03  |- mesh__dateRevised mesh__D017387 1994-04-11
% 211.85/212.03  |- mesh__recordMaintainer mesh__D017387 PXP
% 211.85/212.03  |- skos__broader mesh__D017387smesh__D017277
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D017387 2000
% 211.85/212.03  |- skos__scopeNote mesh__D017387
% 211.85/212.03       An application that must be submitted to a regulatory agency %28%the FDA in the United States%29% before a drug can be studied in humans. This application includes results of previous experiments; how, where, and by whom the new studies will be conducted; the chemical structure of the compound; how it is thought to work in the body; any toxic effects found in animal studies; and how the compound is manufactured. %28%From the %22%New Medicines in Development%22% Series produced by the Pharmaceutical Manufacturers Association and published irregularly.%29%%A%    
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D017387 1999
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D017387 2006
% 211.85/212.03  |- skos__prefLabel mesh__D017387 Investigational New Drug Application
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D017387 1998
% 211.85/212.03  |- skos__historyNote mesh__D017387 Drugs, Investigational %28%1990-1992%29%
% 211.85/212.03  |- mesh__recordAuthorizer mesh__D017387 PLS
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D017387 2005
% 211.85/212.03  |- skos__altLabel mesh__D017387 Investigational New Drug Applications
% 211.85/212.03  |- mesh__recordOriginator mesh__D017387 TPW
% 211.85/212.03  |- mesh__publicMeSHNote mesh__D017387 93   
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D017387 1997
% 211.85/212.03  |- mesh__dateCreated mesh__D017387 1992-05-20
% 211.85/212.03  |- mesh__historyNote mesh__D017387 93   
% 211.85/212.03  |- rdf__type mesh__D017387sskos__Concept
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D017387 2004
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D017387 2002
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D017387 1996
% 211.85/212.03  |- skos__annotation mesh__D017387
% 211.85/212.03       U.S. or foreign, but if U.S., new drug %22%must be submitted to the FDA%22% before study in humans; DF: IND APPLICATION%A%  
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D017387 1995
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D017387 2003
% 211.85/212.03  |- mesh__dateEstablished mesh__D017387 1993-01-01
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D031058 2006
% 211.85/212.03  |- mesh__dateEstablished mesh__D031058 2003-01-01
% 211.85/212.03  |- mesh__dateCreated mesh__D031058 2002-07-02
% 211.85/212.03  |- rdf__type mesh__D031058sskos__Concept
% 211.85/212.03  |- mesh__publicMeSHNote mesh__D031058 2003   
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D031058 2005
% 211.85/212.03  |- skos__broader mesh__D031058smesh__D029064
% 211.85/212.03  |- mesh__historyNote mesh__D031058 2003   
% 211.85/212.03  |- skos__prefLabel mesh__D031058 Arum
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D031058 2004
% 211.85/212.03  |- skos__scopeNote mesh__D031058
% 211.85/212.03       A plant genus of the family ARACEAE. The name derived from ar %28%fire in Arabic%29% due to the irritating sap. Flower is a spathe.%A%    
% 211.85/212.03  |- skos__annotation mesh__D031058
% 211.85/212.03       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D031058 2003
% 211.85/212.03  |- mesh__dateRevised mesh__D036541 2003-07-25
% 211.85/212.03  |- skos__hiddenLabel mesh__D036541 Cyclic ADP ribose Hydrolase
% 211.85/212.03  |- skos__historyNote mesh__D036541
% 211.85/212.03       Antigens, Differentiation %28%1991-2002%29%
% 211.85/212.03  |- mesh__activeMeSHYear mesh__D036541 2004
% 211.85/212.03  |- skos__altLabel mesh__D036541 cADPR Hydrolase
% 211.85/212.03  |- skos__altLabel mesh__D036541 Adenosine Diphosphate Ribose Cyclase
% 211.85/212.03  |- mesh__historyNote mesh__D036541
% 211.85/212.03       2003; use CD38 ANTIGEN %28%NM%29% 1988-2002   
% 211.85/212.03  |- skos__hiddenLabel mesh__D036541 Hydrolase, Cyclic ADP-ribose
% 211.85/212.03  |- skos__altLabel mesh__D036541
% 211.85/212.03       2%27%-Phospho-adenosine Diphosphate Ribose Cyclase
% 211.85/212.03  |- skos__hiddenLabel mesh__D036541 Cyclase, 2%27%-P-ADPR
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D036541 2006
% 211.85/212.04  |- skos__hiddenLabel mesh__D036541 Hydrolase, cADPR
% 211.85/212.04  |- skos__hiddenLabel mesh__D036541 2%27% P ADPR Cyclase
% 211.85/212.04  |- skos__historyNote mesh__D036541 NAD+ Nucleosidase %28%1993-2002%29%
% 211.85/212.04  |- skos__altLabel mesh__D036541 ADP Ribose Cyclase
% 211.85/212.04  |- mesh__recordOriginator mesh__D036541 nns
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D036541 2005
% 211.85/212.04  |- skos__prefLabel mesh__D036541 ADP-ribosyl Cyclase
% 211.85/212.04  |- mesh__publicMeSHNote mesh__D036541
% 211.85/212.04       2003; ADP-RIBOSYL CYCLASE was indexed under ANTIGENS, DIFFERENTIATION  1988-2002, NUCLEOSIDASES 1988-1997, and NAD+ NUCLEOSIDASES 1998-2002%A%  
% 211.85/212.04  |- skos__hiddenLabel mesh__D036541 ADP-ribose Hydrolase, Cyclic
% 211.85/212.04  |- mesh__dateEstablished mesh__D036541 2003-01-01
% 211.85/212.04  |- skos__altLabel mesh__D036541 ADPR Cyclase
% 211.85/212.04  |- skos__scopeNote mesh__D036541
% 211.85/212.04       A membrane-bound or cytosolic enzyme that catalyzes the synthesis of CYCLIC ADP-RIBOSE %28%cADPR%29% from nicotinamide adenine dinucleotide %28%NAD%29%. This enzyme generally catalyzes the hydrolysis of cADPR to ADP-RIBOSE, as well, and sometimes the synthesis of cyclic ADP-ribose 2%27% phosphate %28%2%27%-P-cADPR%29% from NADP.%A%    
% 211.85/212.04  |- mesh__dateCreated mesh__D036541 2002-07-02
% 211.85/212.04  |- skos__hiddenLabel mesh__D036541 Ribose Cyclase, ADP
% 211.85/212.04  |- skos__hiddenLabel mesh__D036541 ADP ribosyl Cyclase
% 211.85/212.04  |- skos__hiddenLabel mesh__D036541 Cyclase, ADP Ribose
% 211.85/212.04  |- mesh__recordAuthorizer mesh__D036541 sjn
% 211.85/212.04  |- skos__broader mesh__D036541smesh__D009244
% 211.85/212.04  |- skos__hiddenLabel mesh__D036541
% 211.85/212.04       2%27% Phospho adenosine Diphosphate Ribose Cyclase
% 211.85/212.04  |- mesh__recordMaintainer mesh__D036541 ssb
% 211.85/212.04  |- skos__hiddenLabel mesh__D036541 Cyclase, ADPR
% 211.85/212.04  |- rdf__type mesh__D036541sskos__Concept
% 211.85/212.04  |- skos__hiddenLabel mesh__D036541 Cyclase, ADP-ribosyl
% 211.85/212.04  |- skos__historyNote mesh__D003367 Pyridines %28%1974%29%
% 211.85/212.04  |- skos__scopeNote mesh__D003367
% 211.85/212.04       The N-glucuronide conjugate of cotinine is a major urinary metabolite of NICOTINE.  It thus serves as a biomarker of exposure to tobacco SMOKING.  It has CNS stimulating properties.%A%    
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D003367 2005
% 211.85/212.04  |- mesh__recordAuthorizer mesh__D003367 sjn
% 211.85/212.04  |- mesh__recordOriginator mesh__D003367 NLM
% 211.85/212.04  |- mesh__publicMeSHNote mesh__D003367
% 211.85/212.04       91; was see under PYRROLIDINONES 1975-90   
% 211.85/212.04  |- skos__broader mesh__D003367smesh__D011760
% 211.85/212.04  |- mesh__dateCreated mesh__D003367 1974-11-19
% 211.85/212.04  |- rdf__type mesh__D003367sskos__Concept
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D003367 2002
% 211.85/212.04  |- skos__altLabel mesh__D003367 Scotine
% 211.85/212.04  |- mesh__recordMaintainer mesh__D003367 ssb
% 211.85/212.04  |- skos__historyNote mesh__D003367 Pyrrolidinones %28%1969-1974%29%
% 211.85/212.04  |- mesh__dateRevised mesh__D003367 2001-07-25
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D003367 2004
% 211.85/212.04  |- mesh__historyNote mesh__D003367
% 211.85/212.04       91%28%75%29%; was see under PYRROLIDINONES 1975-90   
% 211.85/212.04  |- mesh__dateEstablished mesh__D003367 1991-01-01
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D003367 2006
% 211.85/212.04  |- skos__prefLabel mesh__D003367 Cotinine
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D003367 2003
% 211.85/212.04  |- skos__prefLabel mesh__D008850 Microphthalmos
% 211.85/212.04  |- mesh__dateEstablished mesh__D008850 1967-01-01
% 211.85/212.04  |- mesh__dateRevised mesh__D008850 1999-11-03
% 211.85/212.04  |- skos__annotation mesh__D008850
% 211.85/212.04       abnormally small eyeball; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 211.85/212.04  |- skos__scopeNote mesh__D008850
% 211.85/212.04       Congenital or developmental anomaly in which the eyeballs are abnormally small.%A%    
% 211.85/212.04  |- skos__broader mesh__D008850smesh__D005124
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008850 2006
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008850 2004
% 211.85/212.04  |- mesh__dateCreated mesh__D008850 1999-01-01
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008850 2001
% 211.85/212.04  |- mesh__recordMaintainer mesh__D008850 kle
% 211.85/212.04  |- mesh__publicMeSHNote mesh__D008850 67   
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008850 2000
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008850 2005
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008850 2003
% 211.85/212.04  |- rdf__type mesh__D008850sskos__Concept
% 211.85/212.04  |- mesh__recordOriginator mesh__D008850 NLM
% 211.85/212.04  |- mesh__recordAuthorizer mesh__D008850 sjn
% 211.85/212.04  |- mesh__historyNote mesh__D008850 67%28%64%29%   
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008850 2002
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D022521 2003
% 211.85/212.04  |- mesh__historyNote mesh__D022521 2001   
% 211.85/212.04  |- mesh__dateCreated mesh__D022521 2000-06-22
% 211.85/212.04  |- rdf__type mesh__D022521sskos__Concept
% 211.85/212.04  |- mesh__publicMeSHNote mesh__D022521 2001   
% 211.85/212.04  |- skos__hiddenLabel mesh__D022521 Reaction, Ligase Chain
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D022521 2004
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D022521 2001
% 211.85/212.04  |- skos__broader mesh__D022521smesh__D021141
% 211.85/212.04  |- skos__related mesh__D022521smesh__D016133
% 211.85/212.04  |- skos__historyNote mesh__D022521 Gene Amplification %28%1980-2000%29%
% 211.85/212.04  |- skos__hiddenLabel mesh__D022521 Reactions, Ligase Chain
% 211.85/212.04  |- skos__hiddenLabel mesh__D022521 Chain Reactions, Ligase
% 211.85/212.04  |- skos__prefLabel mesh__D022521 Ligase Chain Reaction
% 211.85/212.04  |- skos__hiddenLabel mesh__D022521 Ligase Chain Reactions
% 211.85/212.04  |- skos__scopeNote mesh__D022521
% 211.85/212.04       A DNA amplification technique based upon the ligation of OLIGONUCLEOTIDE PROBES. The probes are designed to exactly match two adjacent sequences of a specific target DNA. The chain reaction is repeated in three steps in the presence of excess probe: %28%1%29% heat denaturation of double-stranded DNA, %28%2%29% annealing of probes to target DNA, and %28%3%29% joining of the probes by thermostable DNA ligase. After the reaction is repeated for 20-30 cycles the production of ligated probe is measured.%A%    
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D022521 2005
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D022521 2002
% 211.85/212.04  |- mesh__dateEstablished mesh__D022521 2001-01-01
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D022521 2006
% 211.85/212.04  |- skos__hiddenLabel mesh__D022521 Chain Reaction, Ligase
% 211.85/212.04  |- skos__annotation mesh__D008052
% 211.85/212.04       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific lipid /metab %28%IM%29%; DF: LIPID METAB INBORN ERR%A%  
% 211.85/212.04  |- skos__broader mesh__D008052smesh__D008661
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008052 2002
% 211.85/212.04  |- mesh__recordMaintainer mesh__D008052 nns
% 211.85/212.04  |- rdf__type mesh__D008052sskos__Concept
% 211.85/212.04  |- mesh__publicMeSHNote mesh__D008052 65   
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008052 2004
% 211.85/212.04  |- skos__prefLabel mesh__D008052 Lipid Metabolism, Inborn Errors
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008052 2003
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008052 2006
% 211.85/212.04  |- mesh__historyNote mesh__D008052 65   
% 211.85/212.04  |- mesh__recordOriginator mesh__D008052 NLM
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008052 2005
% 211.85/212.04  |- skos__altLabel mesh__D008052 Lipid Metabolism, Inborn Error
% 211.85/212.04  |- mesh__dateEstablished mesh__D008052 1965-01-01
% 211.85/212.04  |- mesh__dateCreated mesh__D008052 1999-01-01
% 211.85/212.04  |- mesh__recordAuthorizer mesh__D008052 sjn
% 211.85/212.04  |- mesh__dateRevised mesh__D008052 2001-07-25
% 211.85/212.04  |- skos__hiddenLabel mesh__D049469 Zygotene Stages
% 211.85/212.04  |- skos__hiddenLabel mesh__D049469 Zygonemas
% 211.85/212.04  |- skos__hiddenLabel mesh__D049469 Stages, Zygotene
% 211.85/212.04  |- mesh__dateCreated mesh__D049469 2004-07-07
% 211.85/212.04  |- skos__broader mesh__D049469smesh__D011418
% 211.85/212.04  |- skos__altLabel mesh__D049469 Prophase 1
% 211.85/212.04  |- mesh__recordAuthorizer mesh__D049469 sjn
% 211.85/212.04  |- skos__historyNote mesh__D049469 Meiosis %28%1968-2004%29%
% 211.85/212.04  |- skos__hiddenLabel mesh__D049469 Stage, Diplotene
% 211.85/212.04  |- skos__hiddenLabel mesh__D049469 Diplonemas
% 211.85/212.04  |- mesh__recordOriginator mesh__D049469 nns
% 211.85/212.04  |- mesh__recordMaintainer mesh__D049469 nns
% 211.85/212.04  |- skos__altLabel mesh__D049469 Prophase I
% 211.85/212.04  |- skos__altLabel mesh__D049469 Diplonema
% 211.85/212.04  |- skos__prefLabel mesh__D049469 Meiotic Prophase I
% 211.85/212.04  |- skos__altLabel mesh__D049469 Zygonema
% 211.85/212.04  |- mesh__historyNote mesh__D049469 2005   
% 211.85/212.04  |- skos__hiddenLabel mesh__D049469 Stage, Leptotene
% 211.85/212.04  |- skos__hiddenLabel mesh__D049469 Diakineses
% 211.85/212.04  |- skos__scopeNote mesh__D049469
% 211.85/212.04       The prophase of the first division of MEIOSIS %28%in which homologous CHROMOSOME SEGREGATION occurs%29%. It is divided into five stages: leptonema, zygonema, PACHYNEMA, diplonema, and diakinesis.%A%    
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D049469 2006
% 211.85/212.04  |- mesh__dateRevised mesh__D049469 2005-06-30
% 211.85/212.04  |- skos__broader mesh__D049469smesh__D008540
% 211.85/212.04  |- skos__hiddenLabel mesh__D049469 Stage, Zygotene
% 211.85/212.04  |- rdf__type mesh__D049469sskos__Concept
% 211.85/212.04  |- skos__hiddenLabel mesh__D049469 Prophase I, Meiotic
% 211.85/212.04  |- mesh__publicMeSHNote mesh__D049469 2005   
% 211.85/212.04  |- mesh__dateEstablished mesh__D049469 2005-01-01
% 211.85/212.04  |- skos__historyNote mesh__D049469 Prophase %28%1978-2004%29%
% 211.85/212.04  |- skos__altLabel mesh__D049469 Meiotic Prophase 1
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D013795 2000
% 211.85/212.04  |- mesh__onlineNote mesh__D013795 search DEATH 1974   
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D013795 1994
% 211.85/212.04  |- skos__prefLabel mesh__D013795 Thanatology
% 211.85/212.04  |- rdf__type mesh__D013795sskos__Concept
% 211.85/212.04  |- mesh__publicMeSHNote mesh__D013795 90; was see under DEATH 1974-89   
% 211.85/212.04  |- mesh__recordAuthorizer mesh__D013795 PLS
% 211.85/212.04  |- mesh__recordOriginator mesh__D013795 NLM
% 211.85/212.04  |- skos__broader mesh__D013795smesh__D010684
% 211.85/212.04  |- mesh__historyNote mesh__D013795
% 211.85/212.04       90%28%75%29%; was see under DEATH 1974-89   
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D013795 2004
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D013795 2002
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D013795 1997
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D013795 2003
% 211.85/212.04  |- skos__annotation mesh__D013795
% 211.85/212.04       %22%the study of the theory, philosophy %26% doctrine of death%22%; do not confuse with DEATH, the physiol concept; DF: THANATOL%A%  
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D013795 1996
% 211.85/212.04  |- mesh__recordMaintainer mesh__D013795 JLS
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D013795 2006
% 211.85/212.04  |- mesh__dateRevised mesh__D013795 1993-07-11
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D013795 1999
% 211.85/212.04  |- mesh__dateEstablished mesh__D013795 1990-01-01
% 211.85/212.04  |- skos__historyNote mesh__D013795 Death %28%1966-1974%29%
% 211.85/212.04  |- skos__scopeNote mesh__D013795
% 211.85/212.04       The study of the theory, philosophy, and doctrine of death.%A%    
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D013795 2001
% 211.85/212.04  |- skos__related mesh__D013795smesh__D003643
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D013795 1995
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D013795 2005
% 211.85/212.04  |- mesh__dateCreated mesh__D013795 1999-01-01
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D013795 1998
% 211.85/212.04  |- skos__annotation mesh__D007758
% 211.85/212.04       /inj: pressure-induced injuries = EAR, INNER / inj %28%IM%29% + BAROTRAUMA %28%IM%29%, noise-induced injuries = HEARING LOSS, NOISE-INDUCED; inflammation = LABYRINTHITIS; neoplasms = LABYRINTH DISEASES %28%IM%29% + EAR NEOPLASMS %28%IM%29% + histological type of neoplasm %28%IM%29%%A%  
% 211.85/212.04  |- skos__hiddenLabel mesh__D007758 Ears, Inner
% 211.85/212.04  |- skos__hiddenLabel mesh__D007758 Labyrinths, Bony
% 211.85/212.04  |- skos__hiddenLabel mesh__D007758 Labyrinths
% 211.85/212.04  |- skos__hiddenLabel mesh__D007758 Membranous Labyrinths
% 211.85/212.04  |- mesh__recordOriginator mesh__D007758 NLM
% 211.85/212.04  |- mesh__recordMaintainer mesh__D007758 lkt
% 211.85/212.04  |- skos__altLabel mesh__D007758 Ear, Internal
% 211.85/212.04  |- skos__altLabel mesh__D007758 Inner Ear
% 211.85/212.04  |- mesh__recordAuthorizer mesh__D007758 sjn
% 211.85/212.04  |- rdf__type mesh__D007758sskos__Concept
% 211.85/212.04  |- skos__scopeNote mesh__D007758
% 211.85/212.04       The inner ear, containing the essential parts of the organ of hearing. It consists of two labyrinthine compartments. The bony labyrinth is a complex of three interconnecting cavities or spaces %28%SEMICIRCULAR CANAL; VESTIBULE; and COCHLEA%29% in the TEMPORAL BONE. Within the bony labyrinth, lies the membranous labyrinth which is a complex of sacs and tubules %28%SACCULE AND UTRICLE; COCHLEAR DUCT%29% forming a continuous space enclosed by EPITHELIUM and connective tissue. These spaces are filled with LABYRINTHINE FLUIDS of various compositions.%A%    
% 211.85/212.04  |- skos__prefLabel mesh__D007758 Ear, Inner
% 211.85/212.04  |- mesh__publicMeSHNote mesh__D007758 2006; see LABYRINTH 1963-2005   
% 211.85/212.04  |- skos__broader mesh__D007758smesh__D004423
% 211.85/212.04  |- skos__hiddenLabel mesh__D007758 Internal Ear
% 211.85/212.04  |- skos__related mesh__D007758smesh__D004710
% 211.85/212.04  |- skos__hiddenLabel mesh__D007758 Labyrinth, Bony
% 211.85/212.04  |- mesh__dateCreated mesh__D007758 1999-01-01
% 211.85/212.04  |- mesh__dateRevised mesh__D007758 2005-06-30
% 211.85/212.04  |- skos__hiddenLabel mesh__D007758 Labyrinth, Membranous
% 211.85/212.04  |- skos__altLabel mesh__D007758 Labyrinth
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D007758 2006
% 211.85/212.04  |- skos__hiddenLabel mesh__D007758 Ears, Internal
% 211.85/212.04  |- skos__hiddenLabel mesh__D007758 Labyrinths, Membranous
% 211.85/212.04  |- skos__hiddenLabel mesh__D007758 Internal Ears
% 211.85/212.04  |- mesh__historyNote mesh__D007758 2006 %28%1963%29%   
% 211.85/212.04  |- skos__hiddenLabel mesh__D007758 Bony Labyrinths
% 211.85/212.04  |- skos__hiddenLabel mesh__D007758 Inner Ears
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D018480 2004
% 211.85/212.04  |- skos__annotation mesh__D018480 for crew or travelers   
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D018480 2002
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D018480 2003
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D018480 1997
% 211.85/212.04  |- mesh__historyNote mesh__D018480 95   
% 211.85/212.04  |- skos__historyNote mesh__D018480 Space Flight %28%1966-1994%29%
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D018480 1996
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D018480 2006
% 211.85/212.04  |- mesh__dateEstablished mesh__D018480 1995-01-01
% 211.85/212.04  |- skos__prefLabel mesh__D018480 Astronauts
% 211.85/212.04  |- mesh__dateCreated mesh__D018480 1994-06-07
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D018480 2001
% 211.85/212.04  |- skos__altLabel mesh__D018480 Cosmonauts
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D018480 2005
% 211.85/212.04  |- mesh__publicMeSHNote mesh__D018480 95   
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D018480 1999
% 211.85/212.04  |- skos__scopeNote mesh__D018480
% 211.85/212.04       Members of spacecraft crew including those who travel in space, and those in training for space flight. %28%From Webster, 10th ed; Jane%27%s Aerospace Dictionary, 3d ed%29%%A%    
% 211.85/212.04  |- rdf__type mesh__D018480sskos__Concept
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D018480 2000
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D018480 1995
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D018480 1998
% 211.85/212.04  |- skos__broader mesh__D018480smesh__D012108
% 211.85/212.04  |- mesh__publicMeSHNote mesh__D017388 93   
% 211.85/212.04  |- mesh__recordOriginator mesh__D017388 AGS
% 211.85/212.04  |- skos__altLabel mesh__D017388 PROST
% 211.85/212.04  |- skos__hiddenLabel mesh__D017388 Transfers, Pronuclear Stage
% 211.85/212.04  |- skos__hiddenLabel mesh__D017388 Stage Transfer, Pronuclear
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D017388 2005
% 211.85/212.04  |- skos__altLabel mesh__D017388 Pronuclear Stage Transfer
% 211.85/212.04  |- skos__broader mesh__D017388smesh__D027724
% 211.85/212.04  |- skos__hiddenLabel mesh__D017388 Transfer, Pronuclear Stage
% 211.85/212.04  |- skos__altLabel mesh__D017388 Pronuclear Stage Tubal Transfer
% 211.85/212.04  |- mesh__recordMaintainer mesh__D017388 lkt
% 211.85/212.04  |- mesh__dateCreated mesh__D017388 1992-05-22
% 211.85/212.04  |- skos__hiddenLabel mesh__D017388 Stage Transfers, Pronuclear
% 211.85/212.04  |- skos__hiddenLabel mesh__D017388 Intrafallopian Transfers, Zygote
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D017388 2006
% 211.85/212.04  |- skos__hiddenLabel mesh__D017388 Pronuclear Stage Transfers
% 211.85/212.04  |- mesh__recordAuthorizer mesh__D017388 sjn
% 211.85/212.04  |- skos__historyNote mesh__D017388 Zygote %28%1988-1992%29%
% 211.85/212.04  |- skos__hiddenLabel mesh__D017388 Transfer, Zygote Intrafallopian
% 211.85/212.04  |- mesh__dateEstablished mesh__D017388 1993-01-01
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D017388 2003
% 211.85/212.04  |- skos__scopeNote mesh__D017388
% 211.85/212.04       A technique in assisted reproduction %28%REPRODUCTIVE TECHNIQUES, ASSISTED%29% consisting of hormonal stimulation of the ovaries, follicular aspiration of preovulatory oocytes, in-vitro fertilization, and intrafallopian transfer of zygotes at the pronuclear stage %28%before cleavage%29%.%A%    
% 211.85/212.04  |- rdf__type mesh__D017388sskos__Concept
% 211.85/212.04  |- skos__hiddenLabel mesh__D017388 Zygote Intrafallopian Transfers
% 211.85/212.04  |- skos__hiddenLabel mesh__D017388 Intrafallopian Transfer, Zygote
% 211.85/212.04  |- skos__prefLabel mesh__D017388 Zygote Intrafallopian Transfer
% 211.85/212.04  |- mesh__historyNote mesh__D017388 93   
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D017388 2004
% 211.85/212.04  |- mesh__dateRevised mesh__D017388 2001-07-25
% 211.85/212.04  |- skos__historyNote mesh__D017388 Embryo Transfer %28%1988-1992%29%
% 211.85/212.04  |- skos__hiddenLabel mesh__D017388 Transfers, Zygote Intrafallopian
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D017388 2002
% 211.85/212.04  |- skos__altLabel mesh__D017388 ZIFT
% 211.85/212.04  |- skos__historyNote mesh__D017388
% 211.85/212.04       Gamete Intrafallopian Transfer %28%1988-1992%29%
% 211.85/212.04  |- skos__historyNote mesh__D017388 Fertilization in Vitro %28%1988-1992%29%
% 211.85/212.04  |- mesh__dateCreated mesh__D031059 2002-07-03
% 211.85/212.04  |- skos__prefLabel mesh__D031059 Calla Plant
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D031059 2006
% 211.85/212.04  |- rdf__type mesh__D031059sskos__Concept
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D031059 2005
% 211.85/212.04  |- mesh__publicMeSHNote mesh__D031059 2003   
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D031059 2004
% 211.85/212.04  |- mesh__dateEstablished mesh__D031059 2003-01-01
% 211.85/212.04  |- skos__annotation mesh__D031059
% 211.85/212.04       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.85/212.04  |- skos__scopeNote mesh__D031059
% 211.85/212.04       A plant genus of the family ARACEAE. Calla Lily %28%Callalily%29% also refers to the ZANTEDESCHIA. There is no relationship with CALLA ANTIGEN.%A%    
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D031059 2003
% 211.85/212.04  |- skos__broader mesh__D031059smesh__D029064
% 211.85/212.04  |- mesh__historyNote mesh__D031059 2003   
% 211.85/212.04  |- skos__altLabel mesh__D036542 Spiral CT
% 211.85/212.04  |- skos__altLabel mesh__D036542 Helical Computed Tomography
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D036542 2006
% 211.85/212.04  |- skos__scopeNote mesh__D036542
% 211.85/212.04       Computed tomography where there is continuous X-ray exposure to the patient while being transported through a rotating fan beam. This provides improved three-dimensional contrast and spatial resolution compared to conventional computed tomography, where data is obtained and computed from individual sequential exposures.%A%    
% 211.85/212.04  |- skos__hiddenLabel mesh__D036542 Tomographies, Helical Computed
% 211.85/212.04  |- skos__altLabel mesh__D036542 Tomography, Spiral Volumetric Computed
% 211.85/212.04  |- skos__hiddenLabel mesh__D036542 Computed Tomographies, Helical
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D036542 2005
% 211.85/212.04  |- skos__historyNote mesh__D036542
% 211.85/212.04       Tomography, X-Ray Computed %28%1985-2002%29%
% 211.85/212.04  |- mesh__publicMeSHNote mesh__D036542 2003   
% 211.85/212.04  |- mesh__dateCreated mesh__D036542 2002-07-03
% 211.85/212.04  |- skos__broader mesh__D036542smesh__D014057
% 211.85/212.04  |- skos__hiddenLabel mesh__D036542 Tomographies, Spiral Computed
% 211.85/212.04  |- skos__altLabel mesh__D036542 Spiral Computed Tomography
% 211.85/212.04  |- skos__hiddenLabel mesh__D036542 Spiral Volumetric CTs
% 211.85/212.04  |- skos__hiddenLabel mesh__D036542 Spiral Computed Tomographies
% 211.85/212.04  |- skos__prefLabel mesh__D036542 Tomography, Spiral Computed
% 211.85/212.04  |- skos__hiddenLabel mesh__D036542 Spiral CTs
% 211.85/212.04  |- skos__altLabel mesh__D036542 Tomography, Helical Computed
% 211.85/212.04  |- skos__hiddenLabel mesh__D036542 CTs, Spiral Volumetric
% 211.85/212.04  |- skos__altLabel mesh__D036542 Helical CT
% 211.85/212.04  |- rdf__type mesh__D036542sskos__Concept
% 211.85/212.04  |- skos__hiddenLabel mesh__D036542 Helical CTs
% 211.85/212.04  |- skos__altLabel mesh__D036542 Spiral Volumetric CT
% 211.85/212.04  |- mesh__historyNote mesh__D036542 2003   
% 211.85/212.04  |- skos__hiddenLabel mesh__D036542 CTs, Helical
% 211.85/212.04  |- skos__hiddenLabel mesh__D036542 Computed Tomography, Helical
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D036542 2004
% 211.85/212.04  |- skos__hiddenLabel mesh__D036542 CTs, Spiral
% 211.85/212.04  |- skos__hiddenLabel mesh__D036542 CT, Spiral
% 211.85/212.04  |- skos__hiddenLabel mesh__D036542 Volumetric CT, Spiral
% 211.85/212.04  |- skos__hiddenLabel mesh__D036542 Helical Computed Tomographies
% 211.85/212.04  |- mesh__dateEstablished mesh__D036542 2003-01-01
% 211.85/212.04  |- skos__hiddenLabel mesh__D036542 Computed Tomographies, Spiral
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D036542 2003
% 211.85/212.04  |- skos__hiddenLabel mesh__D036542 CT, Helical
% 211.85/212.04  |- skos__hiddenLabel mesh__D036542 Computed Tomography, Spiral
% 211.85/212.04  |- skos__hiddenLabel mesh__D036542 Volumetric CTs, Spiral
% 211.85/212.04  |- skos__hiddenLabel mesh__D036542 CT, Spiral Volumetric
% 211.85/212.04  |- skos__broader mesh__D003368smesh__D019660
% 211.85/212.04  |- mesh__dateCreated mesh__D003368 1999-01-01
% 211.85/212.04  |- skos__altLabel mesh__D003368 Cotton Plant
% 211.85/212.04  |- mesh__historyNote mesh__D003368 2003%28%1963%29%   
% 211.85/212.04  |- mesh__publicMeSHNote mesh__D003368 2003; see COTTON 1963-2002   
% 211.85/212.04  |- skos__scopeNote mesh__D003368
% 211.85/212.04       A plant genus of the family MALVACEAE. It is the source of COTTON FIBER; COTTONSEED OIL, which is used for cooking, and GOSSYPOL. The economically important cotton crop is a major user of agricultural PESTICIDES.%A%    
% 211.85/212.04  |- rdf__type mesh__D003368sskos__Concept
% 211.85/212.04  |- skos__prefLabel mesh__D003368 Gossypium
% 211.85/212.04  |- skos__related mesh__D003368smesh__D032561
% 211.85/212.04  |- mesh__recordAuthorizer mesh__D003368 sjn
% 211.85/212.04  |- mesh__recordOriginator mesh__D003368 NLM
% 211.85/212.04  |- mesh__dateRevised mesh__D003368 2003-07-09
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D003368 2004
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D003368 2006
% 211.85/212.04  |- mesh__recordMaintainer mesh__D003368 ssb
% 211.85/212.04  |- skos__annotation mesh__D003368
% 211.85/212.04       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29; X ref COTTON PLANT; COTTON FIBER is also available for textile fiber%A%  
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D003368 2005
% 211.85/212.04  |- mesh__dateRevised mesh__D014090 1997-06-20
% 211.85/212.04  |- rdf__type mesh__D014090sskos__Concept
% 211.85/212.04  |- mesh__dateEstablished mesh__D014090 1965-01-01
% 211.85/212.04  |- mesh__dateCreated mesh__D014090 1999-01-01
% 211.85/212.04  |- skos__hiddenLabel mesh__D014090 Replantations, Tooth
% 211.85/212.04  |- skos__broader mesh__D014090smesh__D019647
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D014090 2004
% 211.85/212.04  |- skos__altLabel mesh__D014090 Reimplantation, Tooth
% 211.85/212.04  |- skos__scopeNote mesh__D014090
% 211.85/212.04       Reinsertion of a tooth into the alveolus from which it was removed or otherwise lost.%A%    
% 211.85/212.04  |- mesh__recordOriginator mesh__D014090 NLM
% 211.85/212.04  |- skos__annotation mesh__D014090
% 211.85/212.04       differentiate from DENTAL IMPLANTATION: see note there; do not use /util except by MeSH definition%A%  
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D014090 2000
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D014090 2005
% 211.85/212.04  |- skos__prefLabel mesh__D014090 Tooth Replantation
% 211.85/212.04  |- skos__broader mesh__D014090smesh__D012092
% 211.85/212.04  |- skos__broader mesh__D014090smesh__D004708
% 211.85/212.04  |- skos__hiddenLabel mesh__D014090 Tooth Reimplantations
% 211.85/212.04  |- mesh__recordAuthorizer mesh__D014090 SJN
% 211.85/212.04  |- mesh__recordMaintainer mesh__D014090 PXP
% 211.85/212.04  |- skos__hiddenLabel mesh__D014090 Reimplantations, Tooth
% 211.85/212.04  |- mesh__publicMeSHNote mesh__D014090
% 211.85/212.04       82; was TOOTH REIMPLANTATION 1965-81   
% 211.85/212.04  |- skos__altLabel mesh__D014090 Tooth Reimplantation
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D014090 2001
% 211.85/212.04  |- skos__hiddenLabel mesh__D014090 Tooth Replantations
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D014090 2006
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D014090 1998
% 211.85/212.04  |- skos__altLabel mesh__D014090 Replantation, Tooth
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D014090 2002
% 211.85/212.04  |- mesh__historyNote mesh__D014090 82; was TOOTH REIMPLANTATION 1965-81   
% 211.85/212.04  |- mesh__onlineNote mesh__D014090
% 211.85/212.04       use TOOTH REPLANTATION to search TOOTH REIMPLANTATION 1966-81%A%  
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D014090 1999
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D014090 2003
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008851 1993
% 211.85/212.04  |- skos__prefLabel mesh__D008851 Micropore Filters
% 211.85/212.04  |- skos__broader mesh__D008851smesh__D005374
% 211.85/212.04  |- mesh__recordOriginator mesh__D008851 NLM
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008851 2006
% 211.85/212.04  |- skos__broader mesh__D008851smesh__D004864
% 211.85/212.04  |- skos__hiddenLabel mesh__D008851 Filter, Micropore
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008851 2002
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008851 1999
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008851 1992
% 211.85/212.04  |- mesh__publicMeSHNote mesh__D008851 73   
% 211.85/212.04  |- skos__historyNote mesh__D008851 Filtration %28%1966-1971%29%
% 211.85/212.04  |- mesh__dateRevised mesh__D008851 1990-05-29
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008851 2005
% 211.85/212.04  |- mesh__dateCreated mesh__D008851 1999-01-01
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008851 2004
% 211.85/212.04  |- skos__hiddenLabel mesh__D008851 Filters, Micropore
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008851 1998
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008851 1997
% 211.85/212.04  |- skos__annotation mesh__D008851 includes millipore filters   
% 211.85/212.04  |- skos__hiddenLabel mesh__D008851 Micropore Filter
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008851 2003
% 211.85/212.04  |- mesh__recordAuthorizer mesh__D008851 NLM
% 211.85/212.04  |- mesh__historyNote mesh__D008851 73%28%72%29%   
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008851 1996
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008851 2001
% 211.85/212.04  |- mesh__recordMaintainer mesh__D008851 PLS
% 211.85/212.04  |- rdf__type mesh__D008851sskos__Concept
% 211.85/212.04  |- mesh__dateEstablished mesh__D008851 1973-01-01
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008851 2000
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008851 1995
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008851 1991
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008851 1994
% 211.85/212.04  |- rdf__type mesh__D008053sskos__Concept
% 211.85/212.04  |- skos__scopeNote mesh__D008053
% 211.85/212.04       LIPOLYSIS of stored LIPIDS in the ADIPOSE TISSUE to release FREE FATTY ACIDS. Mobilization of stored lipids is under the regulation of lipolytic signals %28%CATECHOLAMINES%29% or anti-lipolytic signals %28%INSULIN%29% via their actions on the hormone-sensitive LIPASE. This concept does not include lipid transport.%A%    
% 211.85/212.04  |- mesh__recordAuthorizer mesh__D008053 sjn
% 211.85/212.04  |- skos__historyNote mesh__D008053 Lipids/metabolism %28%1966-1969%29%
% 211.85/212.04  |- mesh__activeMeSHYear mesh__D008053 2006
% 211.85/212.04  |- mesh__historyNote mesh__D008053 70   
% 211.85/212.04  |- mesh__recordMaintainer mesh__D008053 lkt
% 211.85/212.04  |- skos__broader mesh__D008053smesh__D008066
% 211.85/212.04  |- mesh__dateCreated mesh__D008053 1999-01-01
% 211.85/212.04  |- mesh__dateRevised mesh__D008053 2005-06-30
% 211.85/212.04  |- skos__hiddenLabel mesh__D008053 Lipid Mobilizations
% 211.85/212.04  |- skos__hiddenLabel mesh__D008053 Mobilizations, Lipid
% 211.85/212.04  |- mesh__recordOriginator mesh__D008053 NLM
% 211.85/212.04  |- skos__hiddenLabel mesh__D008053 Mobilization, Lipid
% 211.85/212.04  |- mesh__dateEstablished mesh__D008053 1970-01-01
% 211.85/212.04  |- skos__prefLabel mesh__D008053 Lipid Mobilization
% 211.85/212.04  |- mesh__publicMeSHNote mesh__D008053 70   
% 211.85/212.04  |- skos__historyNote mesh__D000070 Phenyl Ethers %28%1974%29%
% 211.85/212.04  |- skos__hiddenLabel mesh__D000070 Apo Acebutolol
% 211.85/212.05  |- skos__historyNote mesh__D000070 Anilides %28%1974%29%
% 211.85/212.05  |- skos__altLabel mesh__D000070
% 211.85/212.05       Rhodiapharm Brand of Acebutolol Hydrochloride
% 211.85/212.05  |- skos__hiddenLabel mesh__D000070 NovoAcebutolol
% 211.85/212.05  |- rdf__type mesh__D000070sskos__Concept
% 211.85/212.05  |- skos__hiddenLabel mesh__D000070 Acebutolol Gepepharm Brand
% 211.85/212.05  |- skos__altLabel mesh__D000070
% 211.85/212.05       Rh%C3%%B4%ne-Poulenc Rorer Brand of Acebutolol Hydrochloride
% 211.85/212.05  |- skos__altLabel mesh__D000070 Heumann Brand of Acebutolol Hydrochloride
% 211.85/212.05  |- skos__hiddenLabel mesh__D000070 Ac%C3%%A9%butolol ratiopharm
% 211.85/212.05  |- skos__hiddenLabel mesh__D000070 Novo Acebutolol
% 211.85/212.05  |- skos__hiddenLabel mesh__D000070 Heumann, Acebutolol
% 211.85/212.05  |- mesh__dateCreated mesh__D000070 1974-11-19
% 211.85/212.05  |- skos__hiddenLabel mesh__D000070 ApoAcebutolol
% 211.85/212.05  |- mesh__historyNote mesh__D000070 75   
% 211.85/212.05  |- skos__historyNote mesh__D000070 Ethanolamines %28%1974%29%
% 211.85/212.05  |- skos__altLabel mesh__D000070 M %26% B 17803A
% 211.85/212.05  |- mesh__dateEstablished mesh__D000070 1975-09-01
% 211.85/212.05  |- skos__altLabel mesh__D000070 Gepepharm Brand of Acebutolol
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D000070 2006
% 211.85/212.05  |- skos__hiddenLabel mesh__D000070 Hydrochloride, Acebutolol
% 211.85/212.05  |- skos__altLabel mesh__D000070
% 211.85/212.05       Italfarmaco Brand of Acebutolol Hydrochloride
% 211.85/212.05  |- skos__prefLabel mesh__D000070 Acebutolol
% 211.85/212.05  |- skos__altLabel mesh__D000070 Acetobutolol
% 211.85/212.05  |- mesh__recordAuthorizer mesh__D000070 sjn
% 211.85/212.05  |- skos__altLabel mesh__D000070 Bayer Brand of Acebutolol Hydrochloride
% 211.85/212.05  |- skos__altLabel mesh__D000070 Apotex Brand of Acebutolol Hydrochloride
% 211.85/212.05  |- skos__scopeNote mesh__D000070
% 211.85/212.05       A cardioselective beta-adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm as well as weak inherent sympathomimetic action.%A%    
% 211.85/212.05  |- mesh__publicMeSHNote mesh__D000070 75   
% 211.85/212.05  |- skos__altLabel mesh__D000070
% 211.85/212.05       Proctor %26% Gamble Brand of Acebutolol Hydrochloride
% 211.85/212.05  |- skos__altLabel mesh__D000070 Novopharm Brand of Acebutolol Hydrochloride
% 211.85/212.05  |- skos__altLabel mesh__D000070 Specia Brand of Acebutolol Hydrochloride
% 211.85/212.05  |- skos__hiddenLabel mesh__D000070
% 211.85/212.05       Lafon Ratiopharm Brand of Acebutolol Hydrochloride
% 211.85/212.05  |- skos__hiddenLabel mesh__D000070 M%26%B17803 A
% 211.85/212.05  |- mesh__recordMaintainer mesh__D000070 ssb
% 211.85/212.05  |- skos__altLabel mesh__D000070 Wyeth Brand of Acebutolol Hydrochloride
% 211.85/212.05  |- skos__altLabel mesh__D000070
% 211.85/212.05       Lafon-Ratiopharm Brand of Acebutolol Hydrochloride
% 211.85/212.05  |- mesh__recordOriginator mesh__D000070 NLM
% 211.85/212.05  |- skos__hiddenLabel mesh__D000070
% 211.85/212.05       Rh%C3%%B4%ne Poulenc Rorer Brand of Acebutolol Hydrochloride
% 211.85/212.05  |- skos__hiddenLabel mesh__D000070 Ac%C3%%A9%butololratiopharm
% 211.85/212.05  |- skos__broader mesh__D000070smesh__D011412
% 211.85/212.05  |- mesh__dateRevised mesh__D000070 2005-06-30
% 211.85/212.05  |- skos__broader mesh__D000070smesh__D050198
% 211.85/212.05  |- skos__hiddenLabel mesh__D000070 M%26%B 17803 A
% 211.85/212.05  |- skos__historyNote mesh__D000070 Propylamines %28%1974%29%
% 211.85/212.05  |- skos__altLabel mesh__D000070 Monitan
% 211.85/212.05  |- skos__broader mesh__D002386Q000601smesh__D002386
% 211.85/212.05  |- mesh__preferredCombination mesh__D002386Q000601smesh__D002387
% 211.85/212.05  |- rdf__type mesh__D002386Q000601smesh__CompoundConcept
% 211.85/212.05  |- mesh__dateRevised mesh__D046970 2005-06-30
% 211.85/212.05  |- mesh__recordMaintainer mesh__D046970 SYSTEM
% 211.85/212.05  |- skos__historyNote mesh__D046970 Clostridium %28%1974-2004%29%
% 211.85/212.05  |- mesh__recordAuthorizer mesh__D046970 sjn
% 211.85/212.05  |- skos__prefLabel mesh__D046970 Clostridium beijerinckii
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D046970 2006
% 211.85/212.05  |- skos__scopeNote mesh__D046970
% 211.85/212.05       A species of gram-positive bacteria in the family Clostridiaceae, capable of solventogenesis, and isolated from SOIL, infected WOUNDS, fermenting OLIVES, and spoiled CANDY.%A%    
% 211.85/212.05  |- skos__annotation mesh__D046970
% 211.85/212.05       infection: coordinate IM with CLOSTRIDIUM INFECTIONS %28%IM%29%%A%  
% 211.85/212.05  |- mesh__dateCreated mesh__D046970 2004-07-07
% 211.85/212.05  |- mesh__historyNote mesh__D046970 2005   
% 211.85/212.05  |- rdf__type mesh__D046970sskos__Concept
% 211.85/212.05  |- mesh__dateEstablished mesh__D046970 2005-01-01
% 211.85/212.05  |- mesh__publicMeSHNote mesh__D046970 2005   
% 211.85/212.05  |- skos__broader mesh__D046970smesh__D003013
% 211.85/212.05  |- mesh__recordOriginator mesh__D046970 ags
% 211.85/212.05  |- mesh__dateCreated mesh__D013796 1984-04-06
% 211.85/212.05  |- skos__hiddenLabel mesh__D013796 Dwarfisms, Thanatophoric
% 211.85/212.05  |- mesh__dateEstablished mesh__D013796 1991-01-01
% 211.85/212.05  |- rdf__type mesh__D013796sskos__Concept
% 211.85/212.05  |- skos__scopeNote mesh__D013796
% 211.85/212.05       A severe form of neonatal dwarfism with very short limbs. All cases have died at birth or later in the neonatal period.%A%    
% 211.85/212.05  |- mesh__dateRevised mesh__D013796 2004-07-07
% 211.85/212.05  |- skos__historyNote mesh__D013796 Skull %28%1966-1984%29%
% 211.85/212.05  |- skos__broader mesh__D013796smesh__D007232
% 211.85/212.05  |- mesh__publicMeSHNote mesh__D013796
% 211.85/212.05       91; was see under OSTEOCHONDRODYSPLASIAS 1985-90   
% 211.85/212.05  |- skos__hiddenLabel mesh__D013796 Thanatophoric Dysplasias
% 211.85/212.05  |- mesh__recordMaintainer mesh__D013796 nns
% 211.85/212.05  |- skos__historyNote mesh__D013796 Dwarfism %28%1966-1984%29%
% 211.85/212.05  |- mesh__historyNote mesh__D013796
% 211.85/212.05       91%28%85%29%; was see under OSTEOCHONDRODYSPLASIAS 1985-90   
% 211.85/212.05  |- skos__hiddenLabel mesh__D013796 Dysplasia, Thanatophoric
% 211.85/212.05  |- skos__broader mesh__D013796smesh__D004392
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D013796 2005
% 211.85/212.05  |- mesh__recordOriginator mesh__D013796 RC
% 211.85/212.05  |- skos__hiddenLabel mesh__D013796 Dysplasias, Thanatophoric
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D013796 2006
% 211.85/212.05  |- mesh__recordAuthorizer mesh__D013796 sjn
% 211.85/212.05  |- skos__broader mesh__D013796smesh__D010009
% 211.85/212.05  |- skos__prefLabel mesh__D013796 Thanatophoric Dysplasia
% 211.85/212.05  |- skos__altLabel mesh__D013796 Thanatophoric Dwarfism
% 211.85/212.05  |- skos__broader mesh__D013796smesh__D017880
% 211.85/212.05  |- skos__hiddenLabel mesh__D013796 Thanatophoric Dwarfisms
% 211.85/212.05  |- skos__altLabel mesh__D013796 Dwarfism, Thanatophoric
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D007759 1994
% 211.85/212.05  |- mesh__recordAuthorizer mesh__D007759 NLM
% 211.85/212.05  |- skos__broader mesh__D007759smesh__D004427
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D007759 2005
% 211.85/212.05  |- mesh__recordMaintainer mesh__D007759 PLS
% 211.85/212.05  |- rdf__type mesh__D007759sskos__Concept
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D007759 1997
% 211.85/212.05  |- skos__prefLabel mesh__D007759 Labyrinth Diseases
% 211.85/212.05  |- mesh__dateCreated mesh__D007759 1999-01-01
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D007759 1991
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D007759 1996
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D007759 1999
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D007759 2002
% 211.85/212.05  |- skos__hiddenLabel mesh__D007759 Diseases, Labyrinth
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D007759 1998
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D007759 2001
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D007759 1993
% 211.85/212.05  |- skos__hiddenLabel mesh__D007759 Disease, Labyrinth
% 211.85/212.05  |- skos__annotation mesh__D007759 inflamm dis = LABYRINTHITIS   
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D007759 2004
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D007759 2000
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D007759 1995
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D007759 1992
% 211.85/212.05  |- mesh__dateRevised mesh__D007759 1990-05-29
% 211.85/212.05  |- skos__hiddenLabel mesh__D007759 Labyrinth Disease
% 211.85/212.05  |- mesh__recordOriginator mesh__D007759 NLM
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D007759 2003
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D007759 2006
% 211.85/212.05  |- skos__broader mesh__D018481smesh__D013816
% 211.85/212.05  |- skos__scopeNote mesh__D018481
% 211.85/212.05       Transmission of energy or mass by a medium involving movement of the medium itself. The circulatory movement that occurs in a fluid at a nonuniform temperature owing to the variation of its density and the action of gravity. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed; Webster, 10th ed%29%%A%    
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D018481 2001
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D018481 2004
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D018481 1996
% 211.85/212.05  |- mesh__publicMeSHNote mesh__D018481 95   
% 211.85/212.05  |- mesh__dateEstablished mesh__D018481 1995-01-01
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D018481 2002
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D018481 1997
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D018481 2005
% 211.85/212.05  |- mesh__historyNote mesh__D018481 95   
% 211.85/212.05  |- skos__annotation mesh__D018481
% 211.85/212.05       a principle of thermodynamics; no qualif   
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D018481 1998
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D018481 2006
% 211.85/212.05  |- mesh__dateCreated mesh__D018481 1994-06-07
% 211.85/212.05  |- skos__prefLabel mesh__D018481 Convection
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D018481 1999
% 211.85/212.05  |- rdf__type mesh__D018481sskos__Concept
% 211.85/212.05  |- skos__historyNote mesh__D018481 Heat %28%1966-1994%29%
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D018481 2000
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D018481 1995
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D018481 2003
% 211.85/212.05  |- skos__scopeNote mesh__D004461
% 211.85/212.05       Onset of HYPERREFLEXIA; SEIZURES; or COMA in a previously diagnosed pre-eclamptic patient %28%PRE-ECLAMPSIA%29%.%A%    
% 211.85/212.05  |- mesh__recordAuthorizer mesh__D004461 sjn
% 211.85/212.05  |- mesh__dateRevised mesh__D004461 2005-06-30
% 211.85/212.05  |- skos__related mesh__D004461smesh__D012640
% 211.85/212.05  |- skos__prefLabel mesh__D004461 Eclampsia
% 211.85/212.05  |- skos__broader mesh__D004461smesh__D046110
% 211.85/212.05  |- skos__hiddenLabel mesh__D004461 Eclampsias
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D004461 2006
% 211.85/212.05  |- mesh__recordOriginator mesh__D004461 NLM
% 211.85/212.05  |- mesh__dateCreated mesh__D004461 1999-01-01
% 211.85/212.05  |- mesh__recordMaintainer mesh__D004461 lkt
% 211.85/212.05  |- rdf__type mesh__D004461sskos__Concept
% 211.85/212.05  |- rdf__type mesh__D003369sskos__Concept
% 211.85/212.05  |- mesh__publicMeSHNote mesh__D003369 87; was COTTONSEED 1963-86   
% 211.85/212.05  |- skos__prefLabel mesh__D003369 Cottonseed Oil
% 211.85/212.05  |- skos__hiddenLabel mesh__D003369 Oil, Cottonseed
% 211.85/212.05  |- skos__hiddenLabel mesh__D003369 Cottonseed Oils
% 211.85/212.05  |- skos__hiddenLabel mesh__D003369 Oils, Cottonseed
% 211.85/212.05  |- skos__related mesh__D003369smesh__D006072
% 211.85/212.05  |- mesh__dateRevised mesh__D003369 2005-06-30
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D003369 2006
% 211.85/212.05  |- mesh__dateCreated mesh__D003369 1999-01-01
% 211.85/212.05  |- mesh__recordAuthorizer mesh__D003369 sjn
% 211.85/212.05  |- mesh__recordOriginator mesh__D003369 NLM
% 211.85/212.05  |- skos__scopeNote mesh__D003369
% 211.85/212.05       Oil obtained from the seeds of Gossypium herbaceum L., the cotton plant. It is used in dietary products such as oleomargarine and many cooking oils. Cottonseed oil is commonly used in soaps and cosmetics.%A%    
% 211.85/212.05  |- skos__hiddenLabel mesh__D003369 Cottonseeds
% 211.85/212.05  |- skos__broader mesh__D003369smesh__D004042
% 211.85/212.05  |- mesh__recordMaintainer mesh__D003369 ssb
% 211.85/212.05  |- mesh__historyNote mesh__D003369 87; was COTTONSEED 1963-86   
% 211.85/212.05  |- skos__broader mesh__D003369smesh__D005224
% 211.85/212.05  |- skos__broader mesh__D003369smesh__D010938
% 211.85/212.05  |- mesh__onlineNote mesh__D003369
% 211.85/212.05       use COTTONSEED OIL to search COTTONSEED 1966-86   
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D014091 2005
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D014091 1997
% 211.85/212.05  |- skos__hiddenLabel mesh__D014091 Resorptions, Tooth
% 211.85/212.05  |- skos__annotation mesh__D014091
% 211.85/212.05       resorpt of calcified dent tissue; only Cat C qualif   
% 211.85/212.05  |- skos__prefLabel mesh__D014091 Tooth Resorption
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D014091 2002
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D014091 2006
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D014091 1998
% 211.85/212.05  |- mesh__dateEstablished mesh__D014091 1965-01-01
% 211.85/212.05  |- mesh__historyNote mesh__D014091 65   
% 211.85/212.05  |- mesh__publicMeSHNote mesh__D014091 65   
% 211.85/212.05  |- mesh__recordMaintainer mesh__D014091 TGC
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D014091 1999
% 211.85/212.05  |- skos__broader mesh__D014091smesh__D009063
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D014091 2003
% 211.85/212.05  |- rdf__type mesh__D014091sskos__Concept
% 211.85/212.05  |- skos__scopeNote mesh__D014091
% 211.85/212.05       Resorption of calcified dental tissue, involving demineralization due to reversal of the cation exchange and lacunar resorption by osteoclasts. There are two types: external %28%as a result of tooth pathology%29% and internal %28%apparently initiated by a peculiar inflammatory hyperplasia of the pulp%29%. %28%From Jablonski, Dictionary of Dentistry, 1992, p676%29%%A%    
% 211.85/212.05  |- mesh__recordAuthorizer mesh__D014091 PLS
% 211.85/212.05  |- skos__hiddenLabel mesh__D014091 Tooth Resorptions
% 211.85/212.05  |- mesh__recordOriginator mesh__D014091 NLM
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D014091 2000
% 211.85/212.05  |- mesh__dateCreated mesh__D014091 1999-01-01
% 211.85/212.05  |- skos__broader mesh__D014091smesh__D014076
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D014091 2004
% 211.85/212.05  |- skos__hiddenLabel mesh__D014091 Resorption, Tooth
% 211.85/212.05  |- mesh__dateRevised mesh__D014091 1996-06-10
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D014091 2001
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D008852 2003
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D008852 2000
% 211.85/212.05  |- skos__broader mesh__D008852smesh__D011859
% 211.85/212.05  |- rdf__type mesh__D008852sskos__Concept
% 211.85/212.05  |- skos__annotation mesh__D008852 NIM; DF: MICRORADIOGR   
% 211.85/212.05  |- mesh__dateRevised mesh__D008852 1997-06-20
% 211.85/212.05  |- mesh__recordOriginator mesh__D008852 NLM
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D008852 2002
% 211.85/212.05  |- skos__prefLabel mesh__D008852 Microradiography
% 211.85/212.05  |- skos__scopeNote mesh__D008852
% 211.85/212.05       Production of a radiographic image of a small or very thin object on fine-grained photographic film under conditions which permit subsequent microscopic examination or enlargement of the radiograph at linear magnifications of up to several hundred and with a resolution approaching the resolving power of the photographic emulsion %28%about 1000 lines per millimeter%29%.%A%    
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D008852 2006
% 211.85/212.05  |- mesh__recordAuthorizer mesh__D008852 SJN
% 211.85/212.05  |- skos__hiddenLabel mesh__D008852 Microradiographies
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D008852 1999
% 211.85/212.05  |- mesh__recordMaintainer mesh__D008852 PXP
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D008852 2005
% 211.85/212.05  |- mesh__dateCreated mesh__D008852 1999-01-01
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D008852 2004
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D008852 1998
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D008852 2001
% 211.85/212.05  |- skos__broader mesh__D004194Q000175smesh__D004194
% 211.85/212.05  |- mesh__preferredCombination mesh__D004194Q000175smesh__D003933
% 211.85/212.05  |- rdf__type mesh__D004194Q000175smesh__CompoundConcept
% 211.85/212.05  |- skos__hiddenLabel mesh__D008054 Acid Hydroperoxides, Fatty
% 211.85/212.05  |- skos__broader mesh__D008054smesh__D010545
% 211.85/212.05  |- rdf__type mesh__D008054sskos__Concept
% 211.85/212.05  |- mesh__dateRevised mesh__D008054 2005-06-30
% 211.85/212.05  |- skos__hiddenLabel mesh__D008054 Hydroperoxide, Lipid
% 211.85/212.05  |- skos__historyNote mesh__D008054 Lipids %28%1966-1979%29%
% 211.85/212.05  |- mesh__dateEstablished mesh__D008054 1980-01-01
% 211.85/212.05  |- mesh__recordMaintainer mesh__D008054 ssb
% 211.85/212.05  |- skos__hiddenLabel mesh__D008054 Peroxides, Lipid
% 211.85/212.05  |- skos__prefLabel mesh__D008054 Lipid Peroxides
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D008054 2006
% 211.85/212.05  |- skos__hiddenLabel mesh__D008054 Hydroperoxides, Fatty Acid
% 211.85/212.05  |- skos__altLabel mesh__D008054 Lipid Hydroperoxide
% 211.85/212.05  |- mesh__publicMeSHNote mesh__D008054 80   
% 211.85/212.05  |- skos__historyNote mesh__D008054 Peroxides %28%1966-1979%29%
% 211.85/212.05  |- mesh__recordAuthorizer mesh__D008054 sjn
% 211.85/212.05  |- mesh__historyNote mesh__D008054 80   
% 211.85/212.05  |- skos__scopeNote mesh__D008054
% 211.85/212.05       Peroxides produced in the presence of a free radical by the oxidation of unsaturated fatty acids in the cell in the presence of molecular oxygen. The formation of lipid peroxides results in the destruction of the original lipid leading to the loss of integrity of the membranes. They therefore cause a variety of toxic effects in vivo and their formation is considered a pathological process in biological systems. Their formation can be inhibited by antioxidants, such as vitamin E, structural separation or low oxygen tension.%A%    
% 211.85/212.05  |- mesh__dateCreated mesh__D008054 1979-02-21
% 211.85/212.05  |- skos__broader mesh__D008054smesh__D008055
% 211.85/212.05  |- mesh__recordOriginator mesh__D008054 RLS
% 211.85/212.05  |- skos__altLabel mesh__D008054 Lipoperoxides
% 211.85/212.05  |- skos__altLabel mesh__D008054 Fatty Acid Hydroperoxides
% 211.85/212.05  |- mesh__dateEstablished mesh__D046971 2005-01-01
% 211.85/212.05  |- skos__prefLabel mesh__D046971 Clostridium bifermentans
% 211.85/212.05  |- skos__historyNote mesh__D046971 Clostridium %28%1965-2004%29%
% 211.85/212.05  |- mesh__historyNote mesh__D046971 2005   
% 211.85/212.05  |- skos__scopeNote mesh__D046971
% 211.85/212.05       A species of gram-positive bacteria in the family Clostridiaceae that ferments both CARBOHYDRATES and AMINO ACIDS.%A%    
% 211.85/212.05  |- mesh__dateCreated mesh__D046971 2004-07-07
% 211.85/212.05  |- mesh__recordOriginator mesh__D046971 ags
% 211.85/212.05  |- mesh__dateRevised mesh__D046971 2005-06-30
% 211.85/212.05  |- mesh__recordMaintainer mesh__D046971 SYSTEM
% 211.85/212.05  |- mesh__recordAuthorizer mesh__D046971 sjn
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D046971 2006
% 211.85/212.05  |- skos__broader mesh__D046971smesh__D003013
% 211.85/212.05  |- rdf__type mesh__D046971sskos__Concept
% 211.85/212.05  |- mesh__publicMeSHNote mesh__D046971 2005   
% 211.85/212.05  |- skos__annotation mesh__D046971
% 211.85/212.05       infection: coordinate IM with CLOSTRIDIUM INFECTIONS %28%IM%29%%A%  
% 211.85/212.05  |- mesh__recordAuthorizer mesh__D013797 sjn
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D013797 2003
% 211.85/212.05  |- mesh__publicMeSHNote mesh__D013797
% 211.85/212.05       THEBAINE DERIVATIVES was see under THEBAINE 1975-77; was see under MORPHINANS 1969-74%A%  
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D013797 2004
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D013797 2005
% 211.85/212.05  |- skos__annotation mesh__D013797
% 211.85/212.05       thebaine derivatives = THEBAINE /analogs   
% 211.85/212.05  |- mesh__dateCreated mesh__D013797 1999-01-01
% 211.85/212.05  |- skos__broader mesh__D013797smesh__D009022
% 211.85/212.05  |- mesh__historyNote mesh__D013797
% 211.85/212.05       THEBAINE DERIVATIVES was see under THEBAINE 1975-77; was see under MORPHINANS 1969-74%A%  
% 211.85/212.05  |- mesh__recordMaintainer mesh__D013797 TWD
% 211.85/212.05  |- mesh__onlineNote mesh__D013797
% 211.85/212.05       use THEBAINE/analogs %26% derivatives to search THEBAINE DERIVATIVES 1975-77; use MORPHINANS 1969-74%A%  
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D013797 2001
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D013797 2006
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D013797 2002
% 211.85/212.05  |- mesh__dateRevised mesh__D013797 2000-06-22
% 211.85/212.05  |- skos__prefLabel mesh__D013797 Thebaine
% 211.85/212.05  |- skos__scopeNote mesh__D013797
% 211.85/212.05       A drug that is derived from opium, which contains from 0.3-1.5%25% thebaine depending on its origin. It produces strychnine-like convulsions rather than narcosis. It may be habit-forming and is a controlled substance %28%opiate%29% listed in the U.S. Code of Federal Regulations, Title 21 Part 1308.12 %28%1985%29%. %28%From Merck Index, 11th ed%29%%A%    
% 211.85/212.05  |- rdf__type mesh__D013797sskos__Concept
% 211.85/212.05  |- mesh__recordOriginator mesh__D013797 NLM
% 211.85/212.05  |- skos__hiddenLabel mesh__D018482 Muscles, Voluntary
% 211.85/212.05  |- skos__broader mesh__D018482smesh__D009132
% 211.85/212.05  |- skos__hiddenLabel mesh__D018482 Voluntary Muscles
% 211.85/212.05  |- skos__altLabel mesh__D018482 Skeletal Muscle
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D018482 2005
% 211.85/212.05  |- skos__hiddenLabel mesh__D018482 Muscle, Gastrocnemius
% 211.85/212.05  |- skos__hiddenLabel mesh__D018482 Muscle, Soleus
% 211.85/212.05  |- mesh__recordMaintainer mesh__D018482 nns
% 211.85/212.05  |- mesh__historyNote mesh__D018482 95   
% 211.85/212.05  |- mesh__recordOriginator mesh__D018482 JLS
% 211.85/212.05  |- skos__annotation mesh__D018482
% 211.85/212.05       /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 211.85/212.05  |- skos__hiddenLabel mesh__D018482 Muscles, Striated
% 211.85/212.05  |- mesh__dateRevised mesh__D018482 2001-07-25
% 211.85/212.05  |- skos__hiddenLabel mesh__D018482 Tibial Muscle, Anterior
% 211.85/212.05  |- mesh__publicMeSHNote mesh__D018482 95   
% 211.85/212.05  |- skos__historyNote mesh__D018482 Muscles %28%1966-1994%29%
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D018482 2006
% 211.85/212.05  |- mesh__dateEstablished mesh__D018482 1995-01-01
% 211.85/212.05  |- mesh__dateCreated mesh__D018482 1994-06-07
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D018482 2002
% 211.85/212.05  |- skos__altLabel mesh__D018482 Muscle, Voluntary
% 211.85/212.05  |- skos__hiddenLabel mesh__D018482 Muscle, Anterior Tibial
% 211.85/212.05  |- skos__hiddenLabel mesh__D018482 Skeletal Muscles
% 211.85/212.05  |- rdf__type mesh__D018482sskos__Concept
% 211.85/212.05  |- skos__hiddenLabel mesh__D018482 Striated Muscles
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D018482 2003
% 211.85/212.05  |- skos__hiddenLabel mesh__D018482 Muscle, Plantaris
% 211.85/212.05  |- skos__hiddenLabel mesh__D018482 Voluntary Muscle
% 211.85/212.05  |- skos__hiddenLabel mesh__D018482 Striated Muscle
% 211.85/212.05  |- skos__scopeNote mesh__D018482
% 211.85/212.05       Striated muscles having fibers connected at either or both extremities with the bony framework of the body. These are found in appendicular and axial muscles. %28%From Stedman, 25th ed%29%%A%    
% 211.85/212.05  |- skos__hiddenLabel mesh__D018482 Muscles, Skeletal
% 211.85/212.05  |- mesh__recordAuthorizer mesh__D018482 sjn
% 211.85/212.05  |- skos__prefLabel mesh__D018482 Muscle, Skeletal
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D018482 2004
% 211.85/212.05  |- skos__hiddenLabel mesh__D042581 Intranuclear Spaces
% 211.85/212.05  |- mesh__recordAuthorizer mesh__D042581 sjn
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D042581 2004
% 211.85/212.05  |- mesh__dateCreated mesh__D042581 2003-07-09
% 211.85/212.05  |- skos__scopeNote mesh__D042581 The area within the CELL NUCLEUS.     
% 211.85/212.05  |- skos__hiddenLabel mesh__D042581 Space, Intranuclear
% 211.85/212.05  |- skos__hiddenLabel mesh__D042581 Spaces, Intranuclear
% 211.85/212.05  |- skos__hiddenLabel mesh__D042581 Subnuclear Spaces
% 211.85/212.05  |- mesh__historyNote mesh__D042581 2004   
% 211.85/212.05  |- mesh__publicMeSHNote mesh__D042581 2004   
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D042581 2005
% 211.85/212.05  |- skos__hiddenLabel mesh__D042581 Space, Subnuclear
% 211.85/212.05  |- skos__prefLabel mesh__D042581 Intranuclear Space
% 211.85/212.05  |- mesh__dateEstablished mesh__D042581 2004-01-01
% 211.85/212.05  |- rdf__type mesh__D042581sskos__Concept
% 211.85/212.05  |- skos__related mesh__D042581smesh__D045584
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D042581 2006
% 211.85/212.05  |- mesh__recordOriginator mesh__D042581 nns
% 211.85/212.05  |- mesh__recordMaintainer mesh__D042581 nns
% 211.85/212.05  |- skos__broader mesh__D042581smesh__D022003
% 211.85/212.05  |- skos__hiddenLabel mesh__D042581 Spaces, Subnuclear
% 211.85/212.05  |- skos__altLabel mesh__D014890 Granulomatosis, Wegener%27%s
% 211.85/212.05  |- skos__scopeNote mesh__D014890
% 211.85/212.05       A multisystem disease chiefly affecting males, characterized by necrotizing granulomatous vasculitis involving the upper and lower respiratory tracts, glomerulonephritis, and variable degrees of systemic, small vessel vasculitis, which is generally considered to represent an aberrant hypersensitivity reaction to an unknown antigen. %28%Dorland, 27th ed%29%%A%    
% 211.85/212.05  |- skos__annotation mesh__D014890
% 211.85/212.05       necrotizing granulomas of resp tract %26% multisystem dis   
% 211.85/212.05  |- mesh__dateCreated mesh__D014890 1999-01-01
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D014890 2002
% 211.85/212.05  |- skos__broader mesh__D014890smesh__D017563
% 211.85/212.05  |- skos__broader mesh__D014890smesh__D014657
% 211.85/212.05  |- skos__hiddenLabel mesh__D014890 Granulomatosis, Wegener
% 211.85/212.05  |- mesh__recordAuthorizer mesh__D014890 sjn
% 211.85/212.05  |- mesh__dateRevised mesh__D014890 1999-11-08
% 211.85/212.05  |- skos__hiddenLabel mesh__D014890 Granulomatosis, Wegeners
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D014890 2003
% 211.85/212.05  |- skos__hiddenLabel mesh__D014890 Wegener Granulomatosis
% 211.85/212.05  |- mesh__recordOriginator mesh__D014890 NLM
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D014890 2005
% 211.85/212.05  |- rdf__type mesh__D014890sskos__Concept
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D014890 2000
% 211.85/212.05  |- skos__related mesh__D014890smesh__D020293
% 211.85/212.05  |- skos__hiddenLabel mesh__D014890 Wegeners Granulomatosis
% 211.85/212.05  |- skos__broader mesh__D014890smesh__D007674
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D014890 2004
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D014890 2001
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D014890 2006
% 211.85/212.05  |- skos__prefLabel mesh__D014890 Wegener%27%s Granulomatosis
% 211.85/212.05  |- mesh__recordMaintainer mesh__D014890 KEV
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D014092 2006
% 211.85/212.05  |- skos__broader mesh__D014092smesh__D019589
% 211.85/212.05  |- mesh__historyNote mesh__D014092 65   
% 211.85/212.05  |- skos__hiddenLabel mesh__D014092 Root, Tooth
% 211.85/212.05  |- skos__hiddenLabel mesh__D014092 Tooth Roots
% 211.85/212.05  |- rdf__type mesh__D014092sskos__Concept
% 211.85/212.05  |- skos__hiddenLabel mesh__D014092 Roots, Tooth
% 211.85/212.05  |- skos__related mesh__D014092smesh__D016745
% 211.85/212.05  |- mesh__dateCreated mesh__D014092 1999-01-01
% 211.85/212.05  |- mesh__publicMeSHNote mesh__D014092 65   
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D014092 2004
% 211.85/212.05  |- skos__related mesh__D014092smesh__D012391
% 211.85/212.05  |- skos__annotation mesh__D014092
% 211.85/212.05       dis: coord IM with TOOTH DISEASES %28%IM%29%; root fract or radicular fract: index under TOOTH ROOT /inj %28%IM%29% + TOOTH FRACTURES %28%IM%29%; dilaceration of root: index under TOOTH ROOT /abnorm; TOOTH APEX is available%A%  
% 211.85/212.05  |- mesh__recordAuthorizer mesh__D014092 sjn
% 211.85/212.05  |- skos__scopeNote mesh__D014092
% 211.85/212.05       The part of a tooth from the neck to the apex, embedded in the alveolar process and covered with cementum. A root may be single or divided into several branches, usually identified by their relative position, e.g., lingual root or buccal root. Single-rooted teeth include mandibular first and second premolars and the maxillary second premolar teeth. The maxillary first premolar has two roots in most cases. Maxillary molars have three roots. %28%Jablonski, Dictionary of Dentistry, 1992, p690%29%%A%    
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D014092 2005
% 211.85/212.05  |- mesh__recordMaintainer mesh__D014092 lkt
% 211.85/212.05  |- mesh__recordOriginator mesh__D014092 NLM
% 211.85/212.05  |- skos__prefLabel mesh__D014092 Tooth Root
% 211.85/212.05  |- mesh__dateRevised mesh__D014092 2003-07-09
% 211.85/212.05  |- mesh__dateRevised mesh__D008853 2004-07-07
% 211.85/212.05  |- rdf__type mesh__D008853sskos__Concept
% 211.85/212.05  |- skos__prefLabel mesh__D008853 Microscopy
% 211.85/212.05  |- mesh__recordMaintainer mesh__D008853 nns
% 211.85/212.05  |- skos__hiddenLabel mesh__D008853 Microscopies
% 211.85/212.05  |- skos__broader mesh__D008853smesh__D008919
% 211.85/212.05  |- skos__annotation mesh__D008853
% 211.85/212.05       do not index here routinely for histol %26% cytol studies: Manual 26.12+%A%  
% 211.85/212.05  |- skos__scopeNote mesh__D008853
% 211.85/212.05       The use of instrumentation and techniques for visualizing material and details that cannot be seen by the unaided eye. It is usually done by enlarging images, transmitted by light or electron beams, with optical or magnetic lenses that magnify the entire image field. With scanning microscopy, images are generated by collecting output from the specimen in a point-by-point fashion, on a magnified scale, as it is scanned by a narrow beam of light or electrons, a laser, a conductive probe, or a topographical probe.%A%    
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D008853 2006
% 211.85/212.05  |- skos__broader mesh__D008853smesh__D003952
% 211.85/212.05  |- mesh__recordOriginator mesh__D008853 NLM
% 211.85/212.05  |- mesh__activeMeSHYear mesh__D008853 2005
% 211.85/212.05  |- mesh__dateCreated mesh__D008853 1999-01-01
% 211.85/212.05  |- skos__broader mesh__D008853smesh__D009906
% 211.85/212.05  |- mesh__recordAuthorizer mesh__D008853 sjn
% 211.85/212.05  |- skos__altLabel mesh__D000870 Neurons, Ventral Horn
% 211.85/212.06  |- mesh__recordMaintainer mesh__D000870 ags
% 211.85/212.06  |- mesh__recordOriginator mesh__D000870 NLM
% 211.85/212.06  |- mesh__recordAuthorizer mesh__D000870 sjn
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000870 2005
% 211.85/212.06  |- skos__hiddenLabel mesh__D000870 Cell, Ventral Horn
% 211.85/212.06  |- mesh__dateCreated mesh__D000870 1999-01-01
% 211.85/212.06  |- skos__hiddenLabel mesh__D000870 Ventral Horn Cell
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000870 2000
% 211.85/212.06  |- mesh__historyNote mesh__D000870
% 211.85/212.06       91%28%64%29%; was see under MOTOR NEURONS 1964-90 %28%Prov 1964-72%29%%A%  
% 211.85/212.06  |- skos__hiddenLabel mesh__D000870 Ventral Horn Neuron
% 211.85/212.06  |- skos__hiddenLabel mesh__D000870 Neuron, Anterior Horn
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000870 2006
% 211.85/212.06  |- skos__hiddenLabel mesh__D000870 Cells, Ventral Horn
% 211.85/212.06  |- mesh__publicMeSHNote mesh__D000870
% 211.85/212.06       91; was see under MOTOR NEURONS 1973-90   
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000870 2001
% 211.85/212.06  |- skos__altLabel mesh__D000870 Anterior Horn Neurons
% 211.85/212.06  |- skos__broader mesh__D000870smesh__D013116
% 211.85/212.06  |- skos__broader mesh__D000870smesh__D009046
% 211.85/212.06  |- rdf__type mesh__D000870sskos__Concept
% 211.85/212.06  |- skos__hiddenLabel mesh__D000870 Cells, Anterior Horn
% 211.85/212.06  |- skos__hiddenLabel mesh__D000870 Cell, Anterior Horn
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000870 2003
% 211.85/212.06  |- skos__altLabel mesh__D000870 Ventral Horn Cells
% 211.85/212.06  |- mesh__dateEstablished mesh__D000870 1991-01-01
% 211.85/212.06  |- mesh__dateRevised mesh__D000870 1999-11-03
% 211.85/212.06  |- skos__prefLabel mesh__D000870 Anterior Horn Cells
% 211.85/212.06  |- skos__scopeNote mesh__D000870
% 211.85/212.06       Motor neurons in the anterior %28%ventral%29% horn of the spinal cord which project to skeletal muscles.%A%    
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000870 2004
% 211.85/212.06  |- skos__hiddenLabel mesh__D000870 Anterior Horn Neuron
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000870 2002
% 211.85/212.06  |- skos__hiddenLabel mesh__D000870 Anterior Horn Cell
% 211.85/212.06  |- mesh__onlineNote mesh__D000870 search MOTOR NEURONS 1966-74   
% 211.85/212.06  |- skos__altLabel mesh__D000870 Ventral Horn Neurons
% 211.85/212.06  |- skos__altLabel mesh__D000870 Neurons, Anterior Horn
% 211.85/212.06  |- skos__hiddenLabel mesh__D000870 Neuron, Ventral Horn
% 211.85/212.06  |- skos__scopeNote mesh__D008055
% 211.85/212.06       A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids %28%lipochromes%29%, and fatty acids. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 211.85/212.06  |- skos__prefLabel mesh__D008055 Lipids
% 211.85/212.06  |- mesh__dateCreated mesh__D008055 1999-01-01
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D008055 2006
% 211.85/212.06  |- mesh__runningHead mesh__D008055 D10 - LIPIDS   
% 211.85/212.06  |- mesh__dateRevised mesh__D008055 2005-06-30
% 211.85/212.06  |- mesh__publicMeSHNote mesh__D008055
% 211.85/212.06       /blood was BLOOD LIPIDS 1963-67; /metabolism was LIPID METABOLISM 1963-65%A%  
% 211.85/212.06  |- mesh__recordMaintainer mesh__D008055 lkt
% 211.85/212.06  |- mesh__recordOriginator mesh__D008055 NLM
% 211.85/212.06  |- skos__annotation mesh__D008055
% 211.85/212.06       GEN or unspecified only: prefer specifics; differentiate from FATS %28%%22%outside the body%22%%29%; /blood: consider also HYPERLIPIDEMIA %26% specifics; dyslipidemia, especially in foreign lit, is probably HYPERLIPIDEMIA or its specifics; DIETARY FATS is also available%A%  
% 211.85/212.06  |- skos__related mesh__D008055smesh__D006949
% 211.85/212.06  |- mesh__historyNote mesh__D008055
% 211.85/212.06       /blood was BLOOD LIPIDS 1963-67; /metabolism was LIPID METABOLISM 1963-65%A%  
% 211.85/212.06  |- mesh__recordAuthorizer mesh__D008055 sjn
% 211.85/212.06  |- rdf__type mesh__D008055sskos__Concept
% 211.85/212.06  |- mesh__onlineNote mesh__D008055 pre-explosion = LIPIDS %28%PX%29%   
% 211.85/212.06  |- skos__related mesh__D008055smesh__D005223
% 211.85/212.06  |- skos__related mesh__D008055smesh__D000960
% 211.85/212.06  |- skos__altLabel mesh__D000072 Sulfadiamine
% 211.85/212.06  |- skos__altLabel mesh__D000072 Acetyldiphenazonum
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000072 2002
% 211.85/212.06  |- mesh__dateCreated mesh__D000072 1975-07-25
% 211.85/212.06  |- skos__historyNote mesh__D000072 Sulfones %28%1972-1974%29%
% 211.85/212.06  |- skos__historyNote mesh__D000072 Acetamides %28%1975%29%
% 211.85/212.06  |- skos__altLabel mesh__D000072 4,4%27%-Diacetyldiaminodiphenylsulfone
% 211.85/212.06  |- skos__hiddenLabel mesh__D000072 4,4%27% Diacetyldiaminodiphenylsulfone
% 211.85/212.06  |- skos__broader mesh__D000072smesh__D003622
% 211.85/212.06  |- skos__altLabel mesh__D000072
% 211.85/212.06       4%27%,4%27%%27%%27%-Sulfonylbis%28%acetanilide%29%
% 211.85/212.06  |- skos__scopeNote mesh__D000072
% 211.85/212.06       Acetylated sulfone that is slowly metabolized to give long-term, low blood levels of DAPSONE. It has antimicrobial and antimalarial action, but is mainly used as a depot leprostatic agent.%A%    
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000072 2005
% 211.85/212.06  |- skos__altLabel mesh__D000072 DADDS
% 211.85/212.06  |- mesh__recordMaintainer mesh__D000072 CCR
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000072 2003
% 211.85/212.06  |- mesh__recordAuthorizer mesh__D000072 sjn
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000072 2006
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000072 2004
% 211.85/212.06  |- mesh__dateEstablished mesh__D000072 1991-01-01
% 211.85/212.06  |- mesh__recordOriginator mesh__D000072 SH
% 211.85/212.06  |- mesh__publicMeSHNote mesh__D000072 91; was see under DAPSONE 1976-90   
% 211.85/212.06  |- skos__altLabel mesh__D000072 Diacetyldapsone
% 211.85/212.06  |- mesh__historyNote mesh__D000072
% 211.85/212.06       91%28%76%29%; was see under DAPSONE 1976-90   
% 211.85/212.06  |- skos__prefLabel mesh__D000072 Acedapsone
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000072 2001
% 211.85/212.06  |- rdf__type mesh__D000072sskos__Concept
% 211.85/212.06  |- skos__historyNote mesh__D000072 Acetanilides %28%1972-1974%29%
% 211.85/212.06  |- skos__historyNote mesh__D000072
% 211.85/212.06       Dapsone/analogs %26% derivatives %28%1975%29%
% 211.85/212.06  |- mesh__dateRevised mesh__D000072 2000-06-21
% 211.85/212.06  |- mesh__dateCreated mesh__D046972 2004-07-07
% 211.85/212.06  |- skos__annotation mesh__D046972
% 211.85/212.06       infection: coordinate IM with CLOSTRIDIUM INFECTIONS %28%IM%29%%A%  
% 211.85/212.06  |- mesh__dateEstablished mesh__D046972 2005-01-01
% 211.85/212.06  |- skos__historyNote mesh__D046972 Clostridium %28%1965-2004%29%
% 211.85/212.06  |- mesh__recordMaintainer mesh__D046972 SYSTEM
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D046972 2006
% 211.85/212.06  |- mesh__historyNote mesh__D046972 2005   
% 211.85/212.06  |- skos__broader mesh__D046972smesh__D003013
% 211.85/212.06  |- skos__prefLabel mesh__D046972 Clostridium butyricum
% 211.85/212.06  |- rdf__type mesh__D046972sskos__Concept
% 211.85/212.06  |- mesh__recordOriginator mesh__D046972 ags
% 211.85/212.06  |- mesh__publicMeSHNote mesh__D046972 2005   
% 211.85/212.06  |- mesh__dateRevised mesh__D046972 2005-06-30
% 211.85/212.06  |- mesh__recordAuthorizer mesh__D046972 sjn
% 211.85/212.06  |- skos__scopeNote mesh__D046972
% 211.85/212.06       Type species of the genus CLOSTRIDIUM, a gram-positive bacteria in the family Clostridiaceae. It is used as a source of PROBIOTICS.%A%    
% 211.85/212.06  |- skos__hiddenLabel mesh__D013798 Tumor, Theca Cell
% 211.85/212.06  |- mesh__dateCreated mesh__D013798 1999-01-01
% 211.85/212.06  |- mesh__publicMeSHNote mesh__D013798
% 211.85/212.06       94; was THECA CELL TUMOR 1963-93; THECOMA was see THECA CELL TUMOR 1981-93%A%  
% 211.85/212.06  |- skos__altLabel mesh__D013798 Theca Cell Tumor
% 211.85/212.06  |- mesh__historyNote mesh__D013798
% 211.85/212.06       94; was THECA CELL TUMOR 1963-93; THECOMA was see THECA CELL TUMOR 1981-93%A%  
% 211.85/212.06  |- skos__scopeNote mesh__D013798
% 211.85/212.06       A gonadal stromal neoplasm composed only of THECA CELLS, occurring mostly in the postmenopausal OVARY. It is filled with lipid-containing spindle cells and produces ESTROGENS that can lead to ENDOMETRIAL HYPERPLASIA; UTERINE HEMORRHAGE; or other malignancies in postmenopausal women and sexual precocity in girls. When tumors containing theca cells also contain FIBROBLASTS, they are identified as thecoma-fibroma tumors with less active hormone production.%A%    
% 211.85/212.06  |- mesh__recordMaintainer mesh__D013798 lkt
% 211.85/212.06  |- skos__hiddenLabel mesh__D013798 Tumors, Theca Cell
% 211.85/212.06  |- skos__prefLabel mesh__D013798 Thecoma
% 211.85/212.06  |- skos__hiddenLabel mesh__D013798 Thecomas
% 211.85/212.06  |- skos__broader mesh__D013798smesh__D018312
% 211.85/212.06  |- skos__hiddenLabel mesh__D013798 Theca Cell Tumors
% 211.85/212.06  |- skos__broader mesh__D013798smesh__D010051
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D013798 2006
% 211.85/212.06  |- mesh__dateRevised mesh__D013798 2005-06-30
% 211.85/212.06  |- mesh__recordOriginator mesh__D013798 NLM
% 211.85/212.06  |- rdf__type mesh__D013798sskos__Concept
% 211.85/212.06  |- mesh__recordAuthorizer mesh__D013798 sjn
% 211.85/212.06  |- skos__annotation mesh__D013798
% 211.85/212.06       coord IM with OVARIAN NEOPLASMS %28%IM%29%   
% 211.85/212.06  |- mesh__onlineNote mesh__D013798
% 211.85/212.06       use THECOMA to search THECA CELL TUMOR 1966-93   
% 211.85/212.06  |- skos__altLabel mesh__D018483 Diaphysis
% 211.85/212.06  |- mesh__dateCreated mesh__D018483 1994-06-07
% 211.85/212.06  |- skos__scopeNote mesh__D018483 The shaft of long bones.     
% 211.85/212.06  |- skos__broader mesh__D018483smesh__D001842
% 211.85/212.06  |- skos__prefLabel mesh__D018483 Diaphyses
% 211.85/212.06  |- rdf__type mesh__D018483sskos__Concept
% 211.85/212.06  |- mesh__recordAuthorizer mesh__D018483 sjn
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D018483 2003
% 211.85/212.06  |- mesh__recordMaintainer mesh__D018483 KEV
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D018483 2000
% 211.85/212.06  |- skos__historyNote mesh__D018483 Bone and Bones %28%1966-1994%29%
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D018483 2004
% 211.85/212.06  |- mesh__dateEstablished mesh__D018483 1995-01-01
% 211.85/212.06  |- mesh__dateRevised mesh__D018483 1999-11-03
% 211.85/212.06  |- skos__annotation mesh__D018483
% 211.85/212.06       IM GEN or unspecified; NIM with specific long bone IM; EPIPHYSES %28%end of long bones%29% is also available%A%  
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D018483 2001
% 211.85/212.06  |- mesh__publicMeSHNote mesh__D018483 95   
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D018483 2005
% 211.85/212.06  |- mesh__historyNote mesh__D018483 95   
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D018483 2002
% 211.85/212.06  |- mesh__recordOriginator mesh__D018483 JLS
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D018483 2006
% 211.85/212.06  |- skos__scopeNote mesh__D004463
% 211.85/212.06       The branch of science concerned with the interrelationship of organisms and their ENVIRONMENT, especially as manifested by natural cycles and rhythms, community development and structure, interactions between different kinds of organisms, geographic distributions, and population alterations. %28%Webster%27%s, 3d ed%29%%A%    
% 211.85/212.06  |- mesh__dateCreated mesh__D004463 1999-01-01
% 211.85/212.06  |- mesh__dateRevised mesh__D004463 2003-07-09
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D004463 2005
% 211.85/212.06  |- mesh__recordOriginator mesh__D004463 NLM
% 211.85/212.06  |- skos__annotation mesh__D004463
% 211.85/212.06       for humans, animals, plants, micro-organisms; Specialty; NIM for ecological aspects other than organism-organism relationship %28% = ECOSYSTEM%29% but HOST-PARASITE RELATIONS is also available; DF: ECOL%A%  
% 211.85/212.06  |- skos__hiddenLabel mesh__D004463 Science, Environmental
% 211.85/212.06  |- mesh__recordMaintainer mesh__D004463 nns
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D004463 2006
% 211.85/212.06  |- skos__hiddenLabel mesh__D004463 Environmental Sciences
% 211.85/212.06  |- skos__broader mesh__D004463smesh__D001695
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D004463 2004
% 211.85/212.06  |- skos__related mesh__D004463smesh__D017753
% 211.85/212.06  |- skos__prefLabel mesh__D004463 Ecology
% 211.85/212.06  |- skos__altLabel mesh__D004463 Environmental Science
% 211.85/212.06  |- rdf__type mesh__D004463sskos__Concept
% 211.85/212.06  |- skos__hiddenLabel mesh__D004463 Ecologies
% 211.85/212.06  |- mesh__recordAuthorizer mesh__D004463 sjn
% 211.85/212.06  |- skos__related mesh__D004463smesh__D004782
% 211.85/212.06  |- skos__hiddenLabel mesh__D004463 Sciences, Environmental
% 211.85/212.06  |- skos__annotation mesh__D042582 see SCR for organism-specific terms   
% 211.85/212.06  |- mesh__recordOriginator mesh__D042582 jmp
% 211.85/212.06  |- mesh__recordAuthorizer mesh__D042582 sjn
% 211.85/212.06  |- skos__altLabel mesh__D042582 VEGF-C
% 211.85/212.06  |- mesh__historyNote mesh__D042582
% 211.85/212.06       2004; use VASCULAR ENDOTHELIAL GROWTH FACTOR C %28%NM%29% 1996-2003%A%  
% 211.85/212.06  |- skos__altLabel mesh__D042582 Vascular Endothelial Growth Factor-C
% 211.85/212.06  |- rdf__type mesh__D042582sskos__Concept
% 211.85/212.06  |- mesh__publicMeSHNote mesh__D042582
% 211.85/212.06       2004; VASCULAR ENDOTHELIAL GROWTH FACTOR C was indexed under ENDOTHELIAL GROWTH FACTORS 1996-2003%A%  
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D042582 2006
% 211.85/212.06  |- mesh__dateRevised mesh__D042582 2005-06-30
% 211.85/212.06  |- mesh__recordMaintainer mesh__D042582 ssb
% 211.85/212.06  |- mesh__dateEstablished mesh__D042582 2004-01-01
% 211.85/212.06  |- skos__scopeNote mesh__D042582
% 211.85/212.06       A vascular endothelial growth factor that specifically binds to VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 and VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3. In addition to being an angiogenic factor it can act on LYMPHATIC VESSELS to stimulate LYMPHANGIOGENESIS. It is similar in structure to VASCULAR ENDOTHELIAL GROWTH FACTOR D in that they both contain N- and C-terminal extensions that were not found in other VEGF family members.%A%    
% 211.85/212.06  |- skos__historyNote mesh__D042582
% 211.85/212.06       Endothelial Growth Factors %28%1996-2003%29%
% 211.85/212.06  |- skos__prefLabel mesh__D042582 Vascular Endothelial Growth Factor C
% 211.85/212.06  |- skos__broader mesh__D042582smesh__D042442
% 211.85/212.06  |- mesh__dateCreated mesh__D042582 2003-07-09
% 211.85/212.06  |- skos__historyNote mesh__D014891 Sports %28%1966-1975%29%
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014891 2000
% 211.85/212.06  |- mesh__recordOriginator mesh__D014891 JW
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014891 2003
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014891 2001
% 211.85/212.06  |- mesh__recordMaintainer mesh__D014891 TGC
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014891 1998
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014891 2005
% 211.85/212.06  |- mesh__historyNote mesh__D014891
% 211.85/212.06       90%28%76%29%; was see under SPORTS 1976-89   
% 211.85/212.06  |- rdf__type mesh__D014891sskos__Concept
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014891 2004
% 211.85/212.06  |- mesh__publicMeSHNote mesh__D014891 90; was see under SPORTS 1976-89   
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014891 1999
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014891 2006
% 211.85/212.06  |- mesh__dateEstablished mesh__D014891 1990-01-01
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014891 2002
% 211.85/212.06  |- skos__hiddenLabel mesh__D014891 Lifting, Weight
% 211.85/212.06  |- skos__scopeNote mesh__D014891
% 211.85/212.06       A sport in which weights are lifted competitively or as an exercise.%A%    
% 211.85/212.06  |- skos__hiddenLabel mesh__D014891 Weight Liftings
% 211.85/212.06  |- mesh__recordAuthorizer mesh__D014891 SJN
% 211.85/212.06  |- skos__hiddenLabel mesh__D014891 Liftings, Weight
% 211.85/212.06  |- skos__annotation mesh__D014891
% 211.85/212.06       /inj: coord IM with specific inj %28%IM%29%; /physiol permitted; Manual 30.15+; includes body building if restricted to weight lifting, otherwise index under EXERCISE%A%  
% 211.85/212.06  |- skos__prefLabel mesh__D014891 Weight Lifting
% 211.85/212.06  |- mesh__dateCreated mesh__D014891 1975-07-23
% 211.85/212.06  |- skos__broader mesh__D014891smesh__D013177
% 211.85/212.06  |- mesh__dateRevised mesh__D014891 1997-06-20
% 211.85/212.06  |- skos__hiddenLabel mesh__D050216 Oxidative Metabolic Detoxication
% 211.85/212.06  |- skos__altLabel mesh__D050216 Phase I Detoxification
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D050216 2006
% 211.85/212.06  |- mesh__publicMeSHNote mesh__D050216 2006   
% 211.85/212.06  |- mesh__dateCreated mesh__D050216 2005-06-30
% 211.85/212.06  |- mesh__historyNote mesh__D050216 2006   
% 211.85/212.06  |- skos__hiddenLabel mesh__D050216 Detoxication, Oxidative Metabolic
% 211.85/212.06  |- skos__scopeNote mesh__D050216
% 211.85/212.06       Functionalization of exogenous substances to prepare them for conjugation in PHASE II DETOXIFICATION. Phase I enzymes include CYTOCHROME P450 enzymes and some OXIDOREDUCTASES. Excess induction of phase I over phase II detoxification leads to higher levels of FREE RADICALS that can induce CANCER and other cell damage. Induction or antagonism of phase I detoxication is the basis of a number of DRUG INTERACTIONS.%A%    
% 211.85/212.06  |- skos__hiddenLabel mesh__D050216 Detoxifications, Phase I
% 211.85/212.06  |- mesh__recordMaintainer mesh__D050216 ssb
% 211.85/212.06  |- skos__broader mesh__D050216smesh__D008658
% 211.85/212.06  |- skos__altLabel mesh__D050216 Metabolic Detoxification, Phase I
% 211.85/212.06  |- skos__altLabel mesh__D050216 Metabolic Detoxication, Oxidative
% 211.85/212.06  |- skos__hiddenLabel mesh__D050216 Metabolic Detoxications, Oxidative
% 211.85/212.06  |- skos__prefLabel mesh__D050216 Metabolic Detoxication, Phase I
% 211.85/212.06  |- rdf__type mesh__D050216sskos__Concept
% 211.85/212.06  |- skos__hiddenLabel mesh__D050216 Detoxification, Phase I
% 211.85/212.06  |- mesh__recordOriginator mesh__D050216 ssb
% 211.85/212.06  |- mesh__recordAuthorizer mesh__D050216 sjn
% 211.85/212.06  |- mesh__dateEstablished mesh__D050216 2006-01-01
% 211.85/212.06  |- skos__related mesh__D050216smesh__D004347
% 211.85/212.06  |- skos__hiddenLabel mesh__D050216 Oxidative Metabolic Detoxications
% 211.85/212.06  |- skos__hiddenLabel mesh__D050216 Detoxications, Oxidative Metabolic
% 211.85/212.06  |- skos__broader mesh__D014093smesh__D017266
% 211.85/212.06  |- mesh__historyNote mesh__D014093 65   
% 211.85/212.06  |- mesh__recordAuthorizer mesh__D014093 SJN
% 211.85/212.06  |- skos__scopeNote mesh__D014093
% 211.85/212.06       A fabricated tooth substituting for a natural tooth in a prosthesis. It is usually made of porcelain or plastic.%A%    
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014093 2002
% 211.85/212.06  |- skos__related mesh__D014093smesh__D000180
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014093 2006
% 211.85/212.06  |- mesh__recordOriginator mesh__D014093 NLM
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014093 2001
% 211.85/212.06  |- skos__hiddenLabel mesh__D014093 Artificial Tooth
% 211.85/212.06  |- mesh__dateCreated mesh__D014093 1999-01-01
% 211.85/212.06  |- skos__hiddenLabel mesh__D014093 Teeth, Artificial
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014093 2005
% 211.85/212.06  |- skos__related mesh__D014093smesh__D003776
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014093 2000
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014093 1999
% 211.85/212.06  |- skos__prefLabel mesh__D014093 Tooth, Artificial
% 211.85/212.06  |- mesh__dateEstablished mesh__D014093 1965-01-01
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014093 2004
% 211.85/212.06  |- mesh__recordMaintainer mesh__D014093 PXP
% 211.85/212.06  |- mesh__publicMeSHNote mesh__D014093 65   
% 211.85/212.06  |- mesh__dateRevised mesh__D014093 1997-06-20
% 211.85/212.06  |- rdf__type mesh__D014093sskos__Concept
% 211.85/212.06  |- skos__altLabel mesh__D014093 Artificial Teeth
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014093 1998
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014093 2003
% 211.85/212.06  |- mesh__recordMaintainer mesh__D008854 jls
% 211.85/212.06  |- rdf__type mesh__D008854sskos__Concept
% 211.85/212.06  |- skos__prefLabel mesh__D008854 Microscopy, Electron
% 211.85/212.06  |- mesh__recordOriginator mesh__D008854 NLM
% 211.85/212.06  |- skos__altLabel mesh__D008854 Electron Microscopy
% 211.85/212.06  |- skos__annotation mesh__D008854
% 211.85/212.06       GEN: prefer specifics; relation to /ultrastruct: Manual 26.12.1%A%  
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D008854 2005
% 211.85/212.06  |- mesh__dateRevised mesh__D008854 2004-07-28
% 211.85/212.06  |- mesh__dateCreated mesh__D008854 1999-01-01
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D008854 2005A
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D008854 2006
% 211.85/212.06  |- mesh__recordAuthorizer mesh__D008854 jls
% 211.85/212.06  |- skos__broader mesh__D008854smesh__D008853
% 211.85/212.06  |- skos__scopeNote mesh__D008854
% 211.85/212.06       Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen.%A%    
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000871 2005
% 211.85/212.06  |- mesh__dateCreated mesh__D000871 1999-01-01
% 211.85/212.06  |- skos__broader mesh__D000871smesh__D000977
% 211.85/212.06  |- skos__scopeNote mesh__D000871
% 211.85/212.06       Agents destructive to parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal.%A%    
% 211.85/212.06  |- mesh__recordMaintainer mesh__D000871 ssb
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000871 2006
% 211.85/212.06  |- skos__annotation mesh__D000871
% 211.85/212.06       GEN or unspecified; prefer specific groups or specific anthelmintic; consider also HELMINTHS /drug eff %26% HELMINTHIASIS /drug ther or pertinent specifics%A%  
% 211.85/212.06  |- mesh__recordOriginator mesh__D000871 NLM
% 211.85/212.06  |- rdf__type mesh__D000871sskos__Concept
% 211.85/212.06  |- mesh__recordAuthorizer mesh__D000871 sjn
% 211.85/212.06  |- skos__altLabel mesh__D000871 Vermifuges
% 211.85/212.06  |- skos__prefLabel mesh__D000871 Anthelmintics
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000871 2004
% 211.85/212.06  |- mesh__dateRevised mesh__D000871 2003-07-09
% 211.85/212.06  |- mesh__dateCreated mesh__D000073 1999-01-01
% 211.85/212.06  |- skos__broader mesh__D000073smesh__D011084
% 211.85/212.06  |- mesh__recordOriginator mesh__D000073 NLM
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000073 2005
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000073 1994
% 211.85/212.06  |- skos__annotation mesh__D000073 aromatic hydrocarbons   
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000073 2002
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000073 2003
% 211.85/212.06  |- mesh__historyNote mesh__D000073 73%28%72%29%   
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000073 2006
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000073 1995
% 211.85/212.06  |- mesh__dateRevised mesh__D000073 1993-06-03
% 211.85/212.06  |- skos__historyNote mesh__D000073 Naphthalenes %28%1966-1971%29%
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000073 1998
% 211.85/212.06  |- skos__prefLabel mesh__D000073 Acenaphthenes
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000073 2004
% 211.85/212.06  |- skos__scopeNote mesh__D000073
% 211.85/212.06       Tricyclic ethylene-bridged naphthalene derivatives. They are found in petroleum residues and coal tar and used as dye intermediates, in the manufacture of plastics, and in insecticides and fungicides.%A%    
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000073 1996
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000073 1999
% 211.85/212.06  |- mesh__dateEstablished mesh__D000073 1973-01-01
% 211.85/212.06  |- rdf__type mesh__D000073sskos__Concept
% 211.85/212.06  |- mesh__recordMaintainer mesh__D000073 PLS
% 211.85/212.06  |- mesh__publicMeSHNote mesh__D000073 73   
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000073 2000
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000073 1997
% 211.85/212.06  |- mesh__recordAuthorizer mesh__D000073 PLS
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D000073 2001
% 211.85/212.06  |- skos__prefLabel mesh__D046973 Clostridium cellulolyticum
% 211.85/212.06  |- mesh__dateRevised mesh__D046973 2005-06-30
% 211.85/212.06  |- mesh__recordMaintainer mesh__D046973 SYSTEM
% 211.85/212.06  |- rdf__type mesh__D046973sskos__Concept
% 211.85/212.06  |- mesh__recordAuthorizer mesh__D046973 sjn
% 211.85/212.06  |- mesh__publicMeSHNote mesh__D046973 2005   
% 211.85/212.06  |- mesh__dateEstablished mesh__D046973 2005-01-01
% 211.85/212.06  |- skos__historyNote mesh__D046973 Clostridium %28%1988-2004%29%
% 211.85/212.06  |- mesh__historyNote mesh__D046973 2005   
% 211.85/212.06  |- mesh__dateCreated mesh__D046973 2004-07-07
% 211.85/212.06  |- skos__scopeNote mesh__D046973
% 211.85/212.06       A species of gram-positive bacteria in the family Clostridiaceae. It is a cellulolytic, mesophilic species isolated from decayed GRASS.%A%    
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D046973 2006
% 211.85/212.06  |- mesh__recordOriginator mesh__D046973 ags
% 211.85/212.06  |- skos__broader mesh__D046973smesh__D003013
% 211.85/212.06  |- skos__hiddenLabel mesh__D013799 Cells, Theca
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D013799 2005
% 211.85/212.06  |- mesh__historyNote mesh__D013799
% 211.85/212.06       78%28%75%29%; was see under GRAAFIAN FOLLICLE 1975-77; OVARIAN INTERSTITIAL CELLS was see under OVARY 1975-77%A%  
% 211.85/212.06  |- skos__hiddenLabel mesh__D013799 Interstitial Cells, Ovarian
% 211.85/212.06  |- mesh__recordOriginator mesh__D013799 VDK
% 211.85/212.06  |- skos__hiddenLabel mesh__D013799 Ovarian Interstitial Cell
% 211.85/212.06  |- skos__broader mesh__D013799smesh__D003239
% 211.85/212.06  |- skos__hiddenLabel mesh__D013799 Externa, Theca
% 211.85/212.06  |- mesh__recordAuthorizer mesh__D013799 sjn
% 211.85/212.06  |- skos__hiddenLabel mesh__D013799 Interstitial Cell, Ovarian
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D013799 2006
% 211.85/212.06  |- skos__hiddenLabel mesh__D013799 Cell, Theca
% 211.85/212.06  |- skos__altLabel mesh__D013799 Ovarian Interstitial Cells
% 211.85/212.06  |- rdf__type mesh__D013799sskos__Concept
% 211.85/212.06  |- skos__hiddenLabel mesh__D013799 Interna, Theca
% 211.85/212.06  |- skos__broader mesh__D013799smesh__D006080
% 211.85/212.06  |- skos__prefLabel mesh__D013799 Theca Cells
% 211.85/212.06  |- mesh__dateEstablished mesh__D013799 1978-01-01
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D013799 2003
% 211.85/212.06  |- mesh__dateRevised mesh__D013799 2002-07-03
% 211.85/212.06  |- skos__related mesh__D013799smesh__D006080
% 211.85/212.06  |- mesh__recordMaintainer mesh__D013799 lkt
% 211.85/212.06  |- skos__scopeNote mesh__D013799
% 211.85/212.06       The flattened stroma cells forming a sheath or theca outside the basal lamina lining the mature OVARIAN FOLLICLE. Thecal interstitial or stromal cells are steroidogenic, and produce primarily ANDROGENS which serve as precusors of ESTROGENS in the GRANULOSA CELLS.%A%    
% 211.85/212.06  |- skos__hiddenLabel mesh__D013799 Theca Cell
% 211.85/212.06  |- mesh__publicMeSHNote mesh__D013799
% 211.85/212.06       78; was see under GRAAFIAN FOLLICLE 1975-77; OVARIAN INTERSTITIAL CELLS was see under OVARY 1975-77%A%  
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D013799 2004
% 211.85/212.06  |- mesh__dateCreated mesh__D013799 1977-05-09
% 211.85/212.06  |- skos__hiddenLabel mesh__D013799 Cell, Ovarian Interstitial
% 211.85/212.06  |- skos__hiddenLabel mesh__D013799 Cells, Ovarian Interstitial
% 211.85/212.06  |- mesh__onlineNote mesh__D013799
% 211.85/212.06       use THECA CELLS to search OVARIAN INTERSTITIAL CELLS 1975-77%A%  
% 211.85/212.06  |- skos__scopeNote mesh__D004464
% 211.85/212.06       A broad spectrum antimycotic with some action against Gram positive bacteria. It is used topically in dermatomycoses also orally and parenterally.%A%    
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D004464 2006
% 211.85/212.06  |- skos__hiddenLabel mesh__D004464 Gyno Pevaryl
% 211.85/212.06  |- skos__altLabel mesh__D004464 Gyno-Pevaril
% 211.85/212.06  |- skos__broader mesh__D004464smesh__D007093
% 211.85/212.06  |- mesh__recordAuthorizer mesh__D004464 sjn
% 211.85/212.06  |- skos__hiddenLabel mesh__D004464 Nitrate, Econazole
% 211.85/212.06  |- mesh__dateRevised mesh__D004464 2005-06-30
% 211.85/212.06  |- skos__prefLabel mesh__D004464 Econazole
% 211.85/212.06  |- mesh__recordMaintainer mesh__D004464 ssb
% 211.85/212.06  |- rdf__type mesh__D004464sskos__Concept
% 211.85/212.06  |- skos__hiddenLabel mesh__D004464 Gyno Pevaril
% 211.85/212.06  |- mesh__recordOriginator mesh__D004464 SH
% 211.85/212.06  |- mesh__dateEstablished mesh__D004464 1991-01-01
% 211.85/212.06  |- mesh__dateCreated mesh__D004464 1976-04-16
% 211.85/212.06  |- mesh__publicMeSHNote mesh__D004464
% 211.85/212.06       91; was see under IMIDAZOLES 1977-90   
% 211.85/212.06  |- skos__historyNote mesh__D004464 Chlorobenzenes %28%1974-1975%29%
% 211.85/212.06  |- skos__altLabel mesh__D004464 Ekonazole
% 211.85/212.06  |- mesh__historyNote mesh__D004464
% 211.85/212.06       91%28%77%29%; was see under IMIDAZOLES 1977-90   
% 211.85/212.06  |- skos__hiddenLabel mesh__D004464 GynoPevaril
% 211.85/212.06  |- skos__historyNote mesh__D004464 Imidazoles %28%1974-1976%29%
% 211.85/212.06  |- skos__hiddenLabel mesh__D004464 Gyno Pervaryl 150
% 211.85/212.06  |- mesh__dateRevised mesh__D042583 2004-07-07
% 211.85/212.06  |- skos__scopeNote mesh__D042583 The formation of LYMPHATIC VESSELS.     
% 211.85/212.06  |- skos__hiddenLabel mesh__D042583 Lymphangiogeneses
% 211.85/212.06  |- mesh__publicMeSHNote mesh__D042583 2004   
% 211.85/212.06  |- skos__related mesh__D042583smesh__D042601
% 211.85/212.06  |- mesh__recordOriginator mesh__D042583 jmp
% 211.85/212.06  |- mesh__dateEstablished mesh__D042583 2004-01-01
% 211.85/212.06  |- mesh__recordAuthorizer mesh__D042583 sjn
% 211.85/212.06  |- rdf__type mesh__D042583sskos__Concept
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D042583 2006
% 211.85/212.06  |- skos__prefLabel mesh__D042583 Lymphangiogenesis
% 211.85/212.06  |- skos__broader mesh__D042583smesh__D038081
% 211.85/212.06  |- mesh__recordMaintainer mesh__D042583 lkt
% 211.85/212.06  |- mesh__historyNote mesh__D042583 2004   
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D042583 2005
% 211.85/212.06  |- mesh__dateCreated mesh__D042583 2003-07-09
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014892 1998
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014892 2005
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014892 2004
% 211.85/212.06  |- mesh__recordAuthorizer mesh__D014892 PLS
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014892 1997
% 211.85/212.06  |- mesh__recordOriginator mesh__D014892 NLM
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014892 1994
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014892 2006
% 211.85/212.06  |- mesh__activeMeSHYear mesh__D014892 1999
% 211.85/212.06  |- mesh__publicMeSHNote mesh__D014892 70   
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014892 2000
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014892 1993
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014892 2001
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014892 1995
% 211.85/212.07  |- skos__hiddenLabel mesh__D014892 Weight Perceptions
% 211.85/212.07  |- skos__prefLabel mesh__D014892 Weight Perception
% 211.85/212.07  |- skos__hiddenLabel mesh__D014892 Perception, Weight
% 211.85/212.07  |- mesh__recordMaintainer mesh__D014892 TAP
% 211.85/212.07  |- mesh__dateCreated mesh__D014892 1999-01-01
% 211.85/212.07  |- skos__hiddenLabel mesh__D014892 Perceptions, Weight
% 211.85/212.07  |- skos__broader mesh__D014892smesh__D010465
% 211.85/212.07  |- mesh__dateRevised mesh__D014892 1992-05-18
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014892 2002
% 211.85/212.07  |- mesh__dateEstablished mesh__D014892 1970-01-01
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014892 1996
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014892 2003
% 211.85/212.07  |- rdf__type mesh__D014892sskos__Concept
% 211.85/212.07  |- skos__scopeNote mesh__D014892
% 211.85/212.07       Recognition and discrimination of the heaviness of a lifted object.%A%    
% 211.85/212.07  |- mesh__historyNote mesh__D014892 70%28%64%29%   
% 211.85/212.07  |- skos__hiddenLabel mesh__D050217 Phase II Detoxifications
% 211.85/212.07  |- skos__hiddenLabel mesh__D050217 Conjugative Metabolic Detoxications
% 211.85/212.07  |- skos__broader mesh__D050217smesh__D008658
% 211.85/212.07  |- skos__related mesh__D050217smesh__D011499
% 211.85/212.07  |- skos__hiddenLabel mesh__D050217 Detoxications, Conjugative Metabolic
% 211.85/212.07  |- skos__hiddenLabel mesh__D050217 Detoxication, Conjugative Metabolic
% 211.85/212.07  |- skos__hiddenLabel mesh__D050217 Metabolic Detoxications, Conjugative
% 211.85/212.07  |- skos__hiddenLabel mesh__D050217 Detoxifications, Phase II
% 211.85/212.07  |- mesh__dateCreated mesh__D050217 2005-06-30
% 211.85/212.07  |- mesh__historyNote mesh__D050217 2006   
% 211.85/212.07  |- rdf__type mesh__D050217sskos__Concept
% 211.85/212.07  |- mesh__recordOriginator mesh__D050217 ssb
% 211.85/212.07  |- mesh__recordMaintainer mesh__D050217 ssb
% 211.85/212.07  |- skos__prefLabel mesh__D050217 Metabolic Detoxication, Phase II
% 211.85/212.07  |- skos__hiddenLabel mesh__D050217 Detoxification, Phase II
% 211.85/212.07  |- skos__hiddenLabel mesh__D050217 Conjugative Metabolic Detoxication
% 211.85/212.07  |- skos__altLabel mesh__D050217 Phase II Detoxification
% 211.85/212.07  |- skos__altLabel mesh__D050217 Metabolic Detoxification, Phase II
% 211.85/212.07  |- skos__altLabel mesh__D050217 Metabolic Detoxication, Conjugative
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D050217 2006
% 211.85/212.07  |- skos__scopeNote mesh__D050217
% 211.85/212.07       Conjugation of exogenous substances with various hydrophilic substituents to form water soluble products that are excretable in URINE. Phase II modifications include GLUTATHIONE; ACYLATION; and AMINATION. Phase II enzymes include GLUTATHIONE TRANSFERASE and GLUCURONOSYLTRANSFERASE. In a sense these reactions detoxify phase I reaction products.%A%    
% 211.85/212.07  |- mesh__publicMeSHNote mesh__D050217 2006   
% 211.85/212.07  |- mesh__recordAuthorizer mesh__D050217 sjn
% 211.85/212.07  |- mesh__dateEstablished mesh__D050217 2006-01-01
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014094 2006
% 211.85/212.07  |- skos__altLabel mesh__D014094 Primary Teeth
% 211.85/212.07  |- mesh__dateCreated mesh__D014094 1999-01-01
% 211.85/212.07  |- mesh__historyNote mesh__D014094 65; was TEETH, DECIDUOUS 1963-64   
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014094 2005
% 211.85/212.07  |- mesh__dateRevised mesh__D014094 2003-07-09
% 211.85/212.07  |- skos__prefLabel mesh__D014094 Tooth, Deciduous
% 211.85/212.07  |- skos__altLabel mesh__D014094 Teeth, Primary
% 211.85/212.07  |- skos__altLabel mesh__D014094 Primary Tooth
% 211.85/212.07  |- mesh__recordAuthorizer mesh__D014094 sjn
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014094 2004
% 211.85/212.07  |- rdf__type mesh__D014094sskos__Concept
% 211.85/212.07  |- skos__broader mesh__D014094smesh__D014070
% 211.85/212.07  |- mesh__recordOriginator mesh__D014094 NLM
% 211.85/212.07  |- skos__hiddenLabel mesh__D014094 Deciduous Teeth
% 211.85/212.07  |- skos__altLabel mesh__D014094 Teeth, Deciduous
% 211.85/212.07  |- skos__scopeNote mesh__D014094
% 211.85/212.07       The 20 teeth of the first dentition, which are shed and replaced by the permanent teeth, usually by the age of six years. All deciduous teeth are normally expected to erupt by the age of two and a half years.%A%    
% 211.85/212.07  |- mesh__publicMeSHNote mesh__D014094 65; was TEETH, DECIDUOUS 1963-64   
% 211.85/212.07  |- mesh__recordMaintainer mesh__D014094 lkt
% 211.85/212.07  |- skos__hiddenLabel mesh__D014094 Deciduous Tooth
% 211.85/212.07  |- skos__altLabel mesh__D014094 Tooth, Primary
% 211.85/212.07  |- mesh__dateEstablished mesh__D014094 1965-01-01
% 211.85/212.07  |- skos__annotation mesh__D014094
% 211.85/212.07       do not confuse with DENTITION, DECIDUOUS see DENTITION, PRIMARY: see note there%A%  
% 211.85/212.07  |- skos__hiddenLabel mesh__D008855 Scanning Electron Microscopies
% 211.85/212.07  |- skos__hiddenLabel mesh__D008855 Microscopies, Electron Scanning
% 211.85/212.07  |- mesh__dateCreated mesh__D008855 1999-01-01
% 211.85/212.07  |- skos__hiddenLabel mesh__D008855 Scanning Microscopies, Electron
% 211.85/212.07  |- skos__hiddenLabel mesh__D008855 Electron Microscopy, Scanning
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D008855 2005
% 211.85/212.07  |- skos__related mesh__D008855smesh__D016319
% 211.85/212.07  |- skos__hiddenLabel mesh__D008855 Microscopy, Electron Scanning
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D008855 2006
% 211.85/212.07  |- mesh__recordOriginator mesh__D008855 NLM
% 211.85/212.07  |- skos__hiddenLabel mesh__D008855 Electron Microscopies, Scanning
% 211.85/212.07  |- skos__hiddenLabel mesh__D008855 Electron Scanning Microscopies
% 211.85/212.07  |- mesh__recordAuthorizer mesh__D008855 sjn
% 211.85/212.07  |- mesh__dateRevised mesh__D008855 2004-07-07
% 211.85/212.07  |- skos__prefLabel mesh__D008855 Microscopy, Electron, Scanning
% 211.85/212.07  |- skos__hiddenLabel mesh__D008855 Scanning Microscopy, Electron
% 211.85/212.07  |- skos__altLabel mesh__D008855 Scanning Electron Microscopy
% 211.85/212.07  |- skos__broader mesh__D008855smesh__D008854
% 211.85/212.07  |- skos__historyNote mesh__D008855 Microscopy, Electron %28%1966-1968%29%
% 211.85/212.07  |- skos__hiddenLabel mesh__D008855 Microscopy, Scanning Electron
% 211.85/212.07  |- skos__annotation mesh__D008855
% 211.85/212.07       NIM; do not confuse with MICROSCOPY, ELECTRON, SCANNING TRANSMISSION or STEM; if in doubt, follow words of author; MICROSCOPY, SCANNING TUNNELING is also available%A%  
% 211.85/212.07  |- skos__hiddenLabel mesh__D008855 Microscopies, Scanning Electron
% 211.85/212.07  |- mesh__dateEstablished mesh__D008855 1972-01-01
% 211.85/212.07  |- mesh__publicMeSHNote mesh__D008855 72   
% 211.85/212.07  |- mesh__recordMaintainer mesh__D008855 nns
% 211.85/212.07  |- skos__altLabel mesh__D008855 Electron Scanning Microscopy
% 211.85/212.07  |- mesh__historyNote mesh__D008855 72%28%69%29%   
% 211.85/212.07  |- rdf__type mesh__D008855sskos__Concept
% 211.85/212.07  |- skos__scopeNote mesh__D008855
% 211.85/212.07       Microscopy in which the object is examined directly by an electron beam scanning the specimen point-by-point. The image is constructed by detecting the products of specimen interactions that are projected above the plane of the sample, such as backscattered electrons. Although SCANNING TRANSMISSION ELECTRON MICROSCOPY also scans the specimen point by point with the electron beam, the image is constructed by detecting the electrons, or their interaction products that are transmitted through the sample plane, so that is a form of TRANSMISSION ELECTRON MICROSCOPY.%A%    
% 211.85/212.07  |- skos__broader mesh__D000872smesh__D005419
% 211.85/212.07  |- mesh__dateRevised mesh__D000872 2005-06-30
% 211.85/212.07  |- mesh__publicMeSHNote mesh__D000872
% 211.85/212.07       1963; ANTHOCYANIN was indexed under ANTHOCYANINS   
% 211.85/212.07  |- mesh__historyNote mesh__D000872
% 211.85/212.07       1963; for ANTHOCYANIN use ANTHOCYANINS %28%NM%29%   
% 211.85/212.07  |- skos__altLabel mesh__D000872 Anthocyanin
% 211.85/212.07  |- skos__broader mesh__D000872smesh__D010860
% 211.85/212.07  |- mesh__recordMaintainer mesh__D000872 ssb
% 211.85/212.07  |- mesh__dateCreated mesh__D000872 1999-01-01
% 211.85/212.07  |- mesh__recordOriginator mesh__D000872 NLM
% 211.85/212.07  |- skos__altLabel mesh__D000872 Anthocyanidin
% 211.85/212.07  |- skos__broader mesh__D000872smesh__D006027
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D000872 2006
% 211.85/212.07  |- mesh__recordAuthorizer mesh__D000872 sjn
% 211.85/212.07  |- rdf__type mesh__D000872sskos__Concept
% 211.85/212.07  |- skos__prefLabel mesh__D000872 Anthocyanins
% 211.85/212.07  |- skos__scopeNote mesh__D000872
% 211.85/212.07       A group of FLAVONOIDS derived from FLAVONOLS, which lack the ketone oxygen at the 4-position. They are glycosylated versions of cyanidin, pelargonidin or delphinidin. The conjugated bonds result in blue, red, and purple colors in flowers of plants.%A%    
% 211.85/212.07  |- skos__broader mesh__D004194Q000178smesh__D004194
% 211.85/212.07  |- mesh__preferredCombination mesh__D004194Q000178smesh__D004035
% 211.85/212.07  |- rdf__type mesh__D004194Q000178smesh__CompoundConcept
% 211.85/212.07  |- rdf__type mesh__D000074sskos__Concept
% 211.85/212.07  |- skos__altLabel mesh__D000074 Alliance Brand of Acenocoumarol
% 211.85/212.07  |- skos__broader mesh__D000074smesh__D015110
% 211.85/212.07  |- mesh__recordAuthorizer mesh__D000074 sjn
% 211.85/212.07  |- skos__scopeNote mesh__D000074
% 211.85/212.07       A coumarin that is used as an anticoagulant. Its actions and uses are similar to those of WARFARIN. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p233%29%%A%    
% 211.85/212.07  |- skos__hiddenLabel mesh__D000074 Ciba Geigy Brand of Acenocoumarol
% 211.85/212.07  |- skos__altLabel mesh__D000074 Nicoumalone
% 211.85/212.07  |- mesh__dateRevised mesh__D000074 2005-06-30
% 211.85/212.07  |- skos__altLabel mesh__D000074 Mini-Sintrom
% 211.85/212.07  |- skos__altLabel mesh__D000074 Novartis Brand of Acenocoumarol
% 211.85/212.07  |- skos__prefLabel mesh__D000074 Acenocoumarol
% 211.85/212.07  |- mesh__recordOriginator mesh__D000074 NLM
% 211.85/212.07  |- skos__hiddenLabel mesh__D000074 MiniSintrom
% 211.85/212.07  |- skos__hiddenLabel mesh__D000074 Acenocoumarol Novartis Brand
% 211.85/212.07  |- skos__hiddenLabel mesh__D000074 Acenocoumarol Alliance Brand
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D000074 2006
% 211.85/212.07  |- skos__hiddenLabel mesh__D000074 Mini Sintrom
% 211.85/212.07  |- mesh__recordMaintainer mesh__D000074 ssb
% 211.85/212.07  |- skos__altLabel mesh__D000074 Ciba-Geigy Brand of Acenocoumarol
% 211.85/212.07  |- skos__hiddenLabel mesh__D000074 Acenocoumarol Ciba-Geigy Brand
% 211.85/212.07  |- skos__altLabel mesh__D000074 Acenocoumarin
% 211.85/212.07  |- mesh__dateCreated mesh__D000074 1999-01-01
% 211.85/212.07  |- rdf__type mesh__D046974sskos__Concept
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D046974 2006
% 211.85/212.07  |- mesh__dateRevised mesh__D046974 2005-06-30
% 211.85/212.07  |- mesh__publicMeSHNote mesh__D046974 2005   
% 211.85/212.07  |- mesh__recordMaintainer mesh__D046974 SYSTEM
% 211.85/212.07  |- skos__scopeNote mesh__D046974
% 211.85/212.07       A species of gram-positive, cellulolytic bacteria in the family Clostridiaceae. It produces CELLULOSOMES which are involved in plant CELL WALL degradation.%A%    
% 211.85/212.07  |- skos__prefLabel mesh__D046974 Clostridium cellulovorans
% 211.85/212.07  |- mesh__dateEstablished mesh__D046974 2005-01-01
% 211.85/212.07  |- skos__historyNote mesh__D046974 Clostridium %28%1990-2004%29%
% 211.85/212.07  |- mesh__historyNote mesh__D046974 2005   
% 211.85/212.07  |- skos__broader mesh__D046974smesh__D003013
% 211.85/212.07  |- mesh__recordOriginator mesh__D046974 ags
% 211.85/212.07  |- mesh__dateCreated mesh__D046974 2004-07-07
% 211.85/212.07  |- mesh__recordAuthorizer mesh__D046974 sjn
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D018485 2006
% 211.85/212.07  |- skos__annotation mesh__D018485
% 211.85/212.07       MUSCLE FIBERS, FAST-TWITCH %26% MUSCLE FIBERS, SLOW-TWITCH are also available%A%  
% 211.85/212.07  |- skos__hiddenLabel mesh__D018485 Skeletal Myocyte
% 211.85/212.07  |- skos__altLabel mesh__D018485 Myocytes, Skeletal
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D018485 2005
% 211.85/212.07  |- rdf__type mesh__D018485sskos__Concept
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D018485 2004
% 211.85/212.07  |- mesh__dateCreated mesh__D018485 1994-06-07
% 211.85/212.07  |- mesh__publicMeSHNote mesh__D018485 95   
% 211.85/212.07  |- skos__hiddenLabel mesh__D018485 Myotube
% 211.85/212.07  |- skos__broader mesh__D018485smesh__D032342
% 211.85/212.07  |- mesh__historyNote mesh__D018485 95   
% 211.85/212.07  |- skos__altLabel mesh__D018485 Myotubes
% 211.85/212.07  |- skos__hiddenLabel mesh__D018485 Fibers, Muscle
% 211.85/212.07  |- mesh__recordOriginator mesh__D018485 JLS
% 211.85/212.07  |- skos__historyNote mesh__D018485 Muscles %28%1966-1994%29%
% 211.85/212.07  |- skos__broader mesh__D018485smesh__D009132
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D018485 2003
% 211.85/212.07  |- skos__altLabel mesh__D018485 Skeletal Myocytes
% 211.85/212.07  |- skos__hiddenLabel mesh__D018485 Myocyte, Skeletal
% 211.85/212.07  |- skos__prefLabel mesh__D018485 Muscle Fibers
% 211.85/212.07  |- mesh__dateRevised mesh__D018485 2002-07-03
% 211.85/212.07  |- mesh__recordMaintainer mesh__D018485 ags
% 211.85/212.07  |- skos__related mesh__D018485smesh__D032448
% 211.85/212.07  |- mesh__recordAuthorizer mesh__D018485 sjn
% 211.85/212.07  |- mesh__dateEstablished mesh__D018485 1995-01-01
% 211.85/212.07  |- skos__scopeNote mesh__D018485
% 211.85/212.07       Large, multinucleate single cells, either cylindrical or prismatic in shape, that form the basic unit of skeletal muscle tissue. They consist of a soft contractile substance enclosed in a tubular sheath. They are derived from the fusion of skeletal myoblasts %28%MYOBLASTS, SKELETAL%29% into a syncytium, followed by differentiation.%A%    
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D004465 1996
% 211.85/212.07  |- skos__prefLabel mesh__D004465 Economic Competition
% 211.85/212.07  |- mesh__recordMaintainer mesh__D004465 PLS
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D004465 1999
% 211.85/212.07  |- rdf__type mesh__D004465sskos__Concept
% 211.85/212.07  |- mesh__recordAuthorizer mesh__D004465 NLM
% 211.85/212.07  |- skos__broader mesh__D004465smesh__D004467
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D004465 1997
% 211.85/212.07  |- mesh__dateCreated mesh__D004465 1981-02-26
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D004465 2000
% 211.85/212.07  |- mesh__dateRevised mesh__D004465 1993-09-16
% 211.85/212.07  |- mesh__dateEstablished mesh__D004465 1991-01-01
% 211.85/212.07  |- mesh__publicMeSHNote mesh__D004465
% 211.85/212.07       91; was see under ECONOMICS 1982-90   
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D004465 2001
% 211.85/212.07  |- skos__hiddenLabel mesh__D004465 Competitions, Economic
% 211.85/212.07  |- skos__altLabel mesh__D004465 Competition, Economic
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D004465 2005
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D004465 2002
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D004465 1995
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D004465 2003
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D004465 2006
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D004465 1998
% 211.85/212.07  |- skos__annotation mesh__D004465
% 211.85/212.07       unfair competition goes here but consider also ANTITRUST LAWS%A%  
% 211.85/212.07  |- mesh__historyNote mesh__D004465
% 211.85/212.07       91%28%82%29%; was see under ECONOMICS 1982-90   
% 211.85/212.07  |- mesh__recordOriginator mesh__D004465 EC
% 211.85/212.07  |- skos__hiddenLabel mesh__D004465 Economic Competitions
% 211.85/212.07  |- skos__scopeNote mesh__D004465
% 211.85/212.07       The effort of two or more parties to secure the business of a third party by offering, usually under fair or equitable rules of business practice, the most favorable terms.%A%    
% 211.85/212.07  |- skos__related mesh__D004465smesh__D016363
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D004465 2004
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D009150 2004
% 211.85/212.07  |- skos__broader mesh__D009150smesh__D006846
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D009150 2000
% 211.85/212.07  |- mesh__dateRevised mesh__D009150 1993-06-03
% 211.85/212.07  |- rdf__type mesh__D009150sskos__Concept
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D009150 1994
% 211.85/212.07  |- mesh__dateEstablished mesh__D009150 1968-01-01
% 211.85/212.07  |- skos__scopeNote mesh__D009150
% 211.85/212.07       Strong alkylating and immunosuppressive agents whose biological activity is based on the presence of bis%28%2-chloroethyl%29%- groups. Although otherwise structurally diverse, the compounds have in common the capacity to contribute alkyl groups to DNA. They are generally highly toxic but include among their number many widely used and effective antineoplastic agents.%A%    
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D009150 2001
% 211.85/212.07  |- skos__annotation mesh__D009150 DF: MUSTARD CPDS   
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D009150 1998
% 211.85/212.07  |- mesh__dateCreated mesh__D009150 1999-01-01
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D009150 1995
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D009150 2002
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D009150 1999
% 211.85/212.07  |- skos__hiddenLabel mesh__D009150 Compounds, Mustard
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D009150 1996
% 211.85/212.07  |- mesh__recordAuthorizer mesh__D009150 PLS
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D009150 2005
% 211.85/212.07  |- mesh__recordMaintainer mesh__D009150 PLS
% 211.85/212.07  |- skos__prefLabel mesh__D009150 Mustard Compounds
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D009150 1997
% 211.85/212.07  |- mesh__historyNote mesh__D009150 68   
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D009150 2006
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D009150 2003
% 211.85/212.07  |- mesh__recordOriginator mesh__D009150 NLM
% 211.85/212.07  |- mesh__publicMeSHNote mesh__D009150
% 211.85/212.07       68; MUSTARD GAS was heading 1963-67   
% 211.85/212.07  |- mesh__recordAuthorizer mesh__D014893 PLS
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014893 1997
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014893 2004
% 211.85/212.07  |- skos__hiddenLabel mesh__D014893 Gravity, Zero
% 211.85/212.07  |- rdf__type mesh__D014893sskos__Concept
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014893 2000
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014893 2003
% 211.85/212.07  |- skos__prefLabel mesh__D014893 Weightlessness
% 211.85/212.07  |- skos__annotation mesh__D014893
% 211.85/212.07       natural only: WEIGHTLESSNESS SIMULATION is also available; /adv eff permitted%A%  
% 211.85/212.07  |- mesh__dateRevised mesh__D014893 1996-06-10
% 211.85/212.07  |- skos__scopeNote mesh__D014893
% 211.85/212.07       Condition in which no acceleration, whether due to gravity or any other force, can be detected by an observer within a system. It also means the absence of weight or the absence of the force of gravity acting on a body. Microgravity, gravitational force between 0 and 10 -6 g, is included here. %28%From NASA Thesaurus, 1988%29%%A%    
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014893 1999
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014893 2006
% 211.85/212.07  |- mesh__recordOriginator mesh__D014893 NLM
% 211.85/212.07  |- skos__broader mesh__D014893smesh__D018472
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014893 2002
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014893 1998
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014893 2005
% 211.85/212.07  |- mesh__recordMaintainer mesh__D014893 TGC
% 211.85/212.07  |- skos__altLabel mesh__D014893 Zero Gravity
% 211.85/212.07  |- skos__related mesh__D014893smesh__D018472
% 211.85/212.07  |- mesh__dateCreated mesh__D014893 1999-01-01
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014893 2001
% 211.85/212.07  |- rdf__type mesh__D050218sskos__Concept
% 211.85/212.07  |- skos__altLabel mesh__D050218 Body Fat Patterning
% 211.85/212.07  |- skos__hiddenLabel mesh__D050218 Fat Distribution, Body
% 211.85/212.07  |- mesh__dateEstablished mesh__D050218 2006-01-01
% 211.85/212.07  |- skos__related mesh__D050218smesh__D050154
% 211.85/212.07  |- skos__broader mesh__D050218smesh__D001837
% 211.85/212.07  |- mesh__recordAuthorizer mesh__D050218 sjn
% 211.85/212.07  |- skos__scopeNote mesh__D050218
% 211.85/212.07       Deposits of ADIPOSE TISSUE throughout the body. The pattern of fat deposits in the body regions is an indicator of health status. Excess ABDOMINAL FAT increases health risks more than excess fat around the hips or thighs, therefore, WAIST-HIP RATIO is often used to determine health risks.%A%    
% 211.85/212.07  |- mesh__recordMaintainer mesh__D050218 lkt
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D050218 2006
% 211.85/212.07  |- skos__hiddenLabel mesh__D050218 Distribution, Body Fat
% 211.85/212.07  |- mesh__publicMeSHNote mesh__D050218 2006   
% 211.85/212.07  |- skos__related mesh__D050218smesh__D049629
% 211.85/212.07  |- skos__historyNote mesh__D050218 Adipose Tissue %28%1967-2005%29%
% 211.85/212.07  |- skos__prefLabel mesh__D050218 Body Fat Distribution
% 211.85/212.07  |- skos__broader mesh__D050218smesh__D001823
% 211.85/212.07  |- mesh__dateCreated mesh__D050218 2005-06-30
% 211.85/212.07  |- mesh__recordOriginator mesh__D050218 lkt
% 211.85/212.07  |- skos__hiddenLabel mesh__D050218 Patterning, Body Fat
% 211.85/212.07  |- mesh__historyNote mesh__D050218 2006   
% 211.85/212.07  |- skos__hiddenLabel mesh__D050218 Fat Patterning, Body
% 211.85/212.07  |- mesh__dateRevised mesh__D014095 1993-06-03
% 211.85/212.07  |- skos__annotation mesh__D014095 do not confuse with TOOTH, UNERUPTED   
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014095 2000
% 211.85/212.07  |- skos__broader mesh__D014095smesh__D014076
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014095 1998
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014095 2003
% 211.85/212.07  |- mesh__publicMeSHNote mesh__D014095 65   
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014095 1997
% 211.85/212.07  |- skos__hiddenLabel mesh__D014095 Impacted Teeth
% 211.85/212.07  |- skos__altLabel mesh__D014095 Teeth, Impacted
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014095 1996
% 211.85/212.07  |- mesh__historyNote mesh__D014095 65   
% 211.85/212.07  |- mesh__recordMaintainer mesh__D014095 PLS
% 211.85/212.07  |- mesh__recordAuthorizer mesh__D014095 PLS
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014095 1995
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014095 2006
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014095 2002
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014095 1994
% 211.85/212.07  |- mesh__dateCreated mesh__D014095 1999-01-01
% 211.85/212.07  |- skos__prefLabel mesh__D014095 Tooth, Impacted
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014095 2005
% 211.85/212.07  |- skos__scopeNote mesh__D014095
% 211.85/212.07       A tooth that is prevented from erupting by a physical barrier, usually other teeth. Impaction may also result from orientation of the tooth in an other than vertical position in the periodontal structures.%A%    
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014095 1999
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014095 2001
% 211.85/212.07  |- mesh__recordOriginator mesh__D014095 NLM
% 211.85/212.07  |- rdf__type mesh__D014095sskos__Concept
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D014095 2004
% 211.85/212.07  |- mesh__dateEstablished mesh__D014095 1965-01-01
% 211.85/212.07  |- skos__hiddenLabel mesh__D014095 Impacted Tooth
% 211.85/212.07  |- skos__hiddenLabel mesh__D008856 Immunofluorescence Microscopies
% 211.85/212.07  |- mesh__recordMaintainer mesh__D008856 nns
% 211.85/212.07  |- mesh__dateRevised mesh__D008856 2004-07-07
% 211.85/212.07  |- skos__scopeNote mesh__D008856
% 211.85/212.07       Microscopy of specimens stained with fluorescent dye %28%usually fluorescein isothiocyanate%29% or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. Immunofluorescence microscopy utilizes antibodies that are labeled with fluorescent dye.%A%    
% 211.85/212.07  |- skos__altLabel mesh__D008856 Fluorescence Microscopy
% 211.85/212.07  |- skos__altLabel mesh__D008856 Microscopy, Immunofluorescence
% 211.85/212.07  |- rdf__type mesh__D008856sskos__Concept
% 211.85/212.07  |- mesh__dateCreated mesh__D008856 1999-01-01
% 211.85/212.07  |- mesh__recordOriginator mesh__D008856 NLM
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D008856 2005
% 211.85/212.07  |- skos__prefLabel mesh__D008856 Microscopy, Fluorescence
% 211.85/212.07  |- mesh__recordAuthorizer mesh__D008856 sjn
% 211.85/212.07  |- skos__hiddenLabel mesh__D008856 Microscopies, Immunofluorescence
% 211.85/212.07  |- skos__hiddenLabel mesh__D008856 Microscopies, Fluorescence
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D008856 2006
% 211.85/212.07  |- skos__annotation mesh__D008856 NIM   
% 211.85/212.07  |- skos__broader mesh__D008856smesh__D008853
% 211.85/212.07  |- skos__hiddenLabel mesh__D008856 Fluorescence Microscopies
% 211.85/212.07  |- skos__annotation mesh__D000873
% 211.85/212.07       X ref ANTHRONES: for two ketone groups use ANTHRAQUINONES%A%  
% 211.85/212.07  |- skos__prefLabel mesh__D000873 Anthracenes
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D000873 2004
% 211.85/212.07  |- mesh__recordMaintainer mesh__D000873 ssb
% 211.85/212.07  |- skos__broader mesh__D000873smesh__D011084
% 211.85/212.07  |- mesh__dateCreated mesh__D000873 1999-01-01
% 211.85/212.07  |- mesh__recordOriginator mesh__D000873 NLM
% 211.85/212.07  |- mesh__dateRevised mesh__D000873 2003-07-09
% 211.85/212.07  |- mesh__recordAuthorizer mesh__D000873 sjn
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D000873 2005
% 211.85/212.07  |- rdf__type mesh__D000873sskos__Concept
% 211.85/212.07  |- skos__scopeNote mesh__D000873
% 211.85/212.07       A group of compounds with three aromatic rings joined in linear arrangement.%A%    
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D000873 2006
% 211.85/212.07  |- skos__altLabel mesh__D008058 Lipoamide Dehydrogenase
% 211.85/212.07  |- skos__altLabel mesh__D008058 Glycine Decarboxylase Complex L-Protein
% 211.85/212.07  |- skos__broader mesh__D008058smesh__D007655
% 211.85/212.07  |- skos__scopeNote mesh__D008058
% 211.85/212.07       A flavoprotein containing oxidoreductase that catalyzes the reduction of lipoamide by NADH to yield dihydrolipoamide and NAD+. The enzyme is a component of several MULTIENZYME COMPLEXES.%A%    
% 211.85/212.07  |- mesh__dateRevised mesh__D008058 2005-06-30
% 211.85/212.07  |- skos__altLabel mesh__D008058 Lipoamide Dehydrogenase, Valine
% 211.85/212.07  |- skos__hiddenLabel mesh__D008058 Diaphorase, NAD
% 211.85/212.07  |- skos__altLabel mesh__D008058 Dihydrolipoyl Dehydrogenase
% 211.85/212.07  |- skos__altLabel mesh__D008058 Diaphorase %28%Lipoamide Dehydrogenase%29%
% 211.85/212.07  |- skos__hiddenLabel mesh__D008058 Dehydrogenase, Valine Lipoamide
% 211.85/212.07  |- skos__altLabel mesh__D008058 L-Protein, Glycine Decarboxylase Complex
% 211.85/212.07  |- mesh__recordOriginator mesh__D008058 NLM
% 211.85/212.07  |- skos__hiddenLabel mesh__D008058 Dehydrogenase, Lipoamide
% 211.85/212.07  |- rdf__type mesh__D008058sskos__Concept
% 211.85/212.07  |- mesh__historyNote mesh__D008058 2004%28%1966%29%   
% 211.85/212.07  |- skos__hiddenLabel mesh__D008058 Dehydrogenase, Lipoic Acid
% 211.85/212.07  |- skos__altLabel mesh__D008058 NAD Diaphorase
% 211.85/212.07  |- skos__hiddenLabel mesh__D008058 Glycine Decarboxylase Complex L Protein
% 211.85/212.07  |- skos__broader mesh__D008058smesh__D050959
% 211.85/212.07  |- skos__broader mesh__D008058smesh__D050862
% 211.85/212.07  |- skos__broader mesh__D008058smesh__D011768
% 211.85/212.07  |- skos__hiddenLabel mesh__D008058 Diaphorase, NADH
% 211.85/212.07  |- mesh__recordAuthorizer mesh__D008058 sjn
% 211.85/212.07  |- skos__hiddenLabel mesh__D008058 Dehydrogenase, Dihydrolipoyl
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D008058 2006
% 211.85/212.07  |- skos__prefLabel mesh__D008058 Dihydrolipoamide Dehydrogenase
% 211.85/212.07  |- skos__hiddenLabel mesh__D008058 Dehydrogenase, Dihydrolipoamide
% 211.85/212.07  |- skos__hiddenLabel mesh__D008058 Dehydrogenase, Lipoyl
% 211.85/212.07  |- mesh__recordMaintainer mesh__D008058 jmp
% 211.85/212.07  |- skos__altLabel mesh__D008058 NADH Diaphorase
% 211.85/212.07  |- skos__altLabel mesh__D008058 Lipoic Acid Dehydrogenase
% 211.85/212.07  |- mesh__publicMeSHNote mesh__D008058
% 211.85/212.07       2004; see LIPOAMIDE DEHYDROGENASE 1966-2003   
% 211.85/212.07  |- mesh__dateCreated mesh__D008058 1999-01-01
% 211.85/212.07  |- skos__altLabel mesh__D008058 Lipoyl Dehydrogenase
% 211.85/212.07  |- skos__broader mesh__D008058smesh__D005420
% 211.85/212.07  |- skos__scopeNote mesh__D000075
% 211.85/212.07       A phenothiazine that is used in the treatment of PSYCHOSES.%A%    
% 211.85/212.07  |- skos__altLabel mesh__D000075 Sanofi Brand of Acepromazine Maleate
% 211.85/212.07  |- skos__altLabel mesh__D000075
% 211.85/212.07       V%C3%%A9%toquinol Brand of Acepromazine Maleate
% 211.85/212.07  |- skos__altLabel mesh__D000075 Seid Brand of Acepromazine Maleate
% 211.85/212.07  |- skos__altLabel mesh__D000075 Acetylpromazine
% 211.85/212.07  |- mesh__recordAuthorizer mesh__D000075 sjn
% 211.85/212.07  |- mesh__activeMeSHYear mesh__D000075 2006
% 211.85/212.07  |- mesh__dateRevised mesh__D000075 2005-06-30
% 211.85/212.07  |- skos__altLabel mesh__D000075 Acetazine
% 211.85/212.07  |- skos__prefLabel mesh__D000075 Acepromazine
% 211.85/212.07  |- skos__altLabel mesh__D000075 Acetopromazine
% 211.85/212.07  |- skos__hiddenLabel mesh__D000075 Maleate, Acepromazine
% 211.85/212.07  |- mesh__recordOriginator mesh__D000075 NLM
% 211.85/212.07  |- mesh__dateCreated mesh__D000075 1999-01-01
% 211.85/212.07  |- mesh__recordMaintainer mesh__D000075 ssb
% 211.85/212.07  |- rdf__type mesh__D000075sskos__Concept
% 211.85/212.07  |- skos__broader mesh__D000075smesh__D010640
% 211.85/212.07  |- mesh__publicMeSHNote mesh__D046975 2005   
% 211.85/212.07  |- mesh__recordMaintainer mesh__D046975 SYSTEM
% 211.85/212.07  |- mesh__recordOriginator mesh__D046975 ags
% 211.85/212.07  |- skos__scopeNote mesh__D046975
% 211.85/212.07       A species of gram-positive bacteria in the family Clostridiaceae isolated from infected CATTLE; SHEEP; and other animals. It causes blackleg in cattle and sheep and is transmitted through soil-borne spores.%A%    
% 211.85/212.07  |- mesh__recordAuthorizer mesh__D046975 sjn
% 211.85/212.07  |- mesh__dateRevised mesh__D046975 2005-06-30
% 211.85/212.07  |- skos__annotation mesh__D046975
% 211.85/212.07       infection: coordinate IM with CLOSTRIDIUM INFECTIONS %28%IM%29%%A%  
% 211.85/212.08  |- skos__broader mesh__D046975smesh__D003013
% 211.85/212.08  |- mesh__dateEstablished mesh__D046975 2005-01-01
% 211.85/212.08  |- skos__prefLabel mesh__D046975 Clostridium chauvoei
% 211.85/212.08  |- mesh__dateCreated mesh__D046975 2004-07-07
% 211.85/212.08  |- skos__historyNote mesh__D046975 Clostridium %28%1965-2004%29%
% 211.85/212.08  |- rdf__type mesh__D046975sskos__Concept
% 211.85/212.08  |- mesh__activeMeSHYear mesh__D046975 2006
% 211.85/212.08  |- mesh__historyNote mesh__D046975 2005   
% 211.85/212.08  |- rdf__type mesh__D018486sskos__Concept
% 211.85/212.08  |- skos__annotation mesh__D018486
% 211.85/212.08       publication type only; twin studies as a subject are indexed under the main heading TWIN STUDIES%A%  
% 211.85/212.08  |- mesh__recordAuthorizer mesh__D018486 sjn
% 211.85/212.08  |- mesh__historyNote mesh__D018486 1995   
% 211.85/212.08  |- skos__prefLabel mesh__D018486 Twin Study %5B%Publication Type%5D%
% 211.85/212.08  |- mesh__dateRevised mesh__D018486 2005-06-30
% 211.85/212.08  |- mesh__dateEstablished mesh__D018486 1996-01-01
% 211.85/212.08  |- mesh__recordMaintainer mesh__D018486 jls
% 211.85/212.08  |- skos__broader mesh__D018486smesh__D052182
% 211.85/212.08  |- skos__altLabel mesh__D018486 Twin Study %28%PT%29%
% 211.85/212.08  |- mesh__recordOriginator mesh__D018486 TGC
% 211.85/212.08  |- mesh__activeMeSHYear mesh__D018486 2006
% 211.85/212.08  |- skos__scopeNote mesh__D018486
% 211.85/212.08       Work consisting of reporting using a method of detecting genetic causes in human traits and genetic factors in behavior using sets of twins.%A%    
% 211.85/212.08  |- mesh__dateCreated mesh__D018486 1995-06-23
% 211.85/212.08  |- skos__altLabel mesh__D009151 Mustardgas
% 211.85/212.08  |- mesh__activeMeSHYear mesh__D009151 2003
% 211.85/212.08  |- skos__hiddenLabel mesh__D009151 Sulfide, Di-2-chloroethyl
% 211.85/212.08  |- mesh__activeMeSHYear mesh__D009151 2006
% 211.85/212.08  |- mesh__recordMaintainer mesh__D009151 ags
% 211.85/212.08  |- skos__hiddenLabel mesh__D009151 Sulfide, Dichlorodiethyl
% 211.85/212.08  |- skos__scopeNote mesh__D009151
% 211.85/212.08       Severe irritant and vesicant of skin, eyes, and lungs. It may cause blindness and lethal lung edema and was formerly used as a war gas. The substance has been proposed as a cytostatic and for treatment of psoriasis. It has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens %28%NTP-85-002, 1985%29% %28%Merck, 11th ed%29%.%A%    
% 211.85/212.08  |- skos__altLabel mesh__D009151 Yperite
% 211.85/212.08  |- skos__altLabel mesh__D009151 Di-2-chloroethyl Sulfide
% 211.85/212.08  |- skos__hiddenLabel mesh__D009151 Di 2 chloroethyl Sulfide
% 211.85/212.08  |- mesh__activeMeSHYear mesh__D009151 2005
% 211.85/212.08  |- mesh__recordOriginator mesh__D009151 NLM
% 211.85/212.08  |- skos__altLabel mesh__D009151 Yellow Cross Liquid
% 211.85/212.08  |- mesh__dateCreated mesh__D009151 1999-01-01
% 211.85/212.08  |- skos__broader mesh__D009151smesh__D009150
% 211.85/212.08  |- mesh__activeMeSHYear mesh__D009151 2003B
% 211.85/212.08  |- mesh__activeMeSHYear mesh__D009151 2002
% 211.85/212.08  |- skos__altLabel mesh__D009151 Dichlorodiethyl Sulfide
% 211.85/212.08  |- mesh__dateRevised mesh__D009151 2003-03-21
% 211.85/212.08  |- skos__hiddenLabel mesh__D009151 Mustard, Sulfur
% 211.85/212.08  |- mesh__recordAuthorizer mesh__D009151 ags
% 211.85/212.08  |- mesh__onlineNote mesh__D009151
% 211.85/212.08       use MUSTARD COMPOUNDS to search MUSTARD GAS 1966-74   
% 211.85/212.08  |- mesh__activeMeSHYear mesh__D009151 2001
% 211.85/212.08  |- rdf__type mesh__D009151sskos__Concept
% 211.85/212.08  |- skos__hiddenLabel mesh__D009151 Gas, Mustard
% 211.85/212.08  |- skos__annotation mesh__D009151 D25-26 qualif   
% 211.85/212.08  |- skos__altLabel mesh__D009151 Bis%28%beta-chloroethyl%29% Sulfide
% 211.85/212.08  |- mesh__historyNote mesh__D009151
% 211.85/212.08       91%28%75%29%63-67; was see under MUSTARD COMPOUNDS 1968-90; was heading 1963-67%A%  
% 211.85/212.08  |- skos__altLabel mesh__D009151 Sulfur Mustard
% 211.85/212.08  |- mesh__activeMeSHYear mesh__D009151 2003A
% 211.85/212.08  |- skos__prefLabel mesh__D009151 Mustard Gas
% 211.85/212.08  |- mesh__publicMeSHNote mesh__D009151
% 211.85/212.08       91,63-67; was see under MUSTARD COMPOUNDS 1968-90; was heading 1963-67%A%  
% 211.85/212.08  |- mesh__activeMeSHYear mesh__D009151 2004
% 211.85/212.08  |- mesh__dateEstablished mesh__D009151 1991-01-01
% 211.85/212.08  |- mesh__dateCreated mesh__D050219 2005-06-30
% 211.85/212.08  |- skos__prefLabel mesh__D050219 Amblyospora
% 211.85/212.08  |- skos__scopeNote mesh__D050219
% 211.85/212.08       A genus of FUNGI, in the family Amblyosporidae, which is a parasite of MOSQUITOES.%A%    
% 211.85/212.08  |- mesh__historyNote mesh__D050219 2006   
% 211.85/212.08  |- skos__historyNote mesh__D050219 Protozoa %28%1979-1990%29%
% 211.85/212.08  |- mesh__activeMeSHYear mesh__D050219 2006
% 211.85/212.08  |- mesh__publicMeSHNote mesh__D050219 2006   
% 211.85/212.08  |- mesh__dateEstablished mesh__D050219 2006-01-01
% 211.85/212.08  |- skos__annotation mesh__D050219
% 211.85/212.08       coordinate with specific fungal terms %28%ANTIGENS, FUNGAL, etc%29% if pertinent%A%  
% 211.85/212.08  |- mesh__recordAuthorizer mesh__D050219 sjn
% 211.85/212.08  |- skos__broader mesh__D050219smesh__D050175
% 211.85/212.08  |- skos__historyNote mesh__D050219 Microsporidia %28%1991-2005%29%
% 211.85/212.08  |- mesh__recordOriginator mesh__D050219 ags
% 211.93/212.08  |- rdf__type mesh__D050219sskos__Concept
% 211.93/212.08  |- mesh__recordMaintainer mesh__D050219 ags
% 211.93/212.08  |- rdf__type mesh__D014894sskos__Concept
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D014894 1996
% 211.93/212.08  |- mesh__recordMaintainer mesh__D014894 KEV
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D014894 2003
% 211.93/212.08  |- skos__hiddenLabel mesh__D014894 Measure
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D014894 2001
% 211.93/212.08  |- mesh__dateRevised mesh__D014894 1995-05-23
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D014894 1999
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D014894 2006
% 211.93/212.08  |- skos__prefLabel mesh__D014894 Weights and Measures
% 211.93/212.08  |- mesh__recordAuthorizer mesh__D014894 PLS
% 211.93/212.08  |- skos__annotation mesh__D014894
% 211.93/212.08       METRIC SYSTEM is available; TN 192: not for %22%weight%22% of anything; DF: WEIGHTS%A%  
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D014894 2000
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D014894 1998
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D014894 2005
% 211.93/212.08  |- skos__broader mesh__D014894smesh__D010811
% 211.93/212.08  |- mesh__dateCreated mesh__D014894 1999-01-01
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D014894 2002
% 211.93/212.08  |- mesh__recordOriginator mesh__D014894 NLM
% 211.93/212.08  |- skos__scopeNote mesh__D014894
% 211.93/212.08       A unit or standard of measurement. %28%Random House Unabridged Dictionary, 2d ed%29%%A%    
% 211.93/212.08  |- skos__hiddenLabel mesh__D014894 Measures and Weights
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D014894 1997
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D014894 2004
% 211.93/212.08  |- skos__scopeNote mesh__D047270
% 211.93/212.08       A species of SEA URCHINS in the family Strongylocentrotidae found on the Pacific coastline from Alaska to Mexico. This species serves as a major research model for molecular developmental biology and other fields.%A%    
% 211.93/212.08  |- skos__historyNote mesh__D047270 Echinodermata %28%1965-1971%29%
% 211.93/212.08  |- skos__historyNote mesh__D047270 Sea Urchins %28%1971-2004%29%
% 211.93/212.08  |- mesh__dateEstablished mesh__D047270 2005-01-01
% 211.93/212.08  |- mesh__recordAuthorizer mesh__D047270 ags
% 211.93/212.08  |- skos__broader mesh__D047270smesh__D047269
% 211.93/212.08  |- mesh__recordOriginator mesh__D047270 ags
% 211.93/212.08  |- skos__altLabel mesh__D047270 Purple Sea Urchin
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D047270 2006
% 211.93/212.08  |- rdf__type mesh__D047270sskos__Concept
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D047270 2006A
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D047270 2005
% 211.93/212.08  |- mesh__dateCreated mesh__D047270 2004-07-07
% 211.93/212.08  |- mesh__dateRevised mesh__D047270 2005-07-29
% 211.93/212.08  |- skos__prefLabel mesh__D047270 Strongylocentrotus purpuratus
% 211.93/212.08  |- mesh__historyNote mesh__D047270 2005   
% 211.93/212.08  |- mesh__recordMaintainer mesh__D047270 ags
% 211.93/212.08  |- mesh__publicMeSHNote mesh__D047270 2005   
% 211.93/212.08  |- skos__hiddenLabel mesh__D014096 Fourth Molar
% 211.93/212.08  |- skos__scopeNote mesh__D014096
% 211.93/212.08       An extra tooth, erupted or unerupted, resembling or unlike the other teeth in the group to which it belongs. Its presence may cause malposition of adjacent teeth or prevent their eruption.%A%    
% 211.93/212.08  |- mesh__recordMaintainer mesh__D014096 kle
% 211.93/212.08  |- skos__broader mesh__D014096smesh__D014071
% 211.93/212.08  |- mesh__recordOriginator mesh__D014096 NLM
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D014096 2001
% 211.93/212.08  |- mesh__onlineNote mesh__D014096
% 211.93/212.08       use TOOTH, SUPERNUMERARY to search MOLAR, FOURTH 1966-78   
% 211.93/212.08  |- mesh__dateEstablished mesh__D014096 1965-01-01
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D014096 2000
% 211.93/212.08  |- mesh__dateRevised mesh__D014096 1999-11-03
% 211.93/212.08  |- skos__annotation mesh__D014096
% 211.93/212.08       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; may refer to erupted or unerupted tooth: if erupted do not use TOOTH ERUPTION; if unerupted coord IM with TOOTH, UNERUPTED %28%NIM%29%%A%  
% 211.93/212.08  |- skos__hiddenLabel mesh__D014096 Molars, Fourth
% 211.93/212.08  |- mesh__publicMeSHNote mesh__D014096 65   
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D014096 2006
% 211.93/212.08  |- skos__prefLabel mesh__D014096 Tooth, Supernumerary
% 211.93/212.08  |- skos__hiddenLabel mesh__D014096 Supernumerary Teeth
% 211.93/212.08  |- mesh__dateCreated mesh__D014096 1999-01-01
% 211.93/212.08  |- mesh__historyNote mesh__D014096
% 211.93/212.08       65; MOLAR, FOURTH was see under TOOTH, SUPERNUMERARY 1965-78%A%  
% 211.93/212.08  |- skos__hiddenLabel mesh__D014096 Fourth Molars
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D014096 2005
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D014096 2004
% 211.93/212.08  |- rdf__type mesh__D014096sskos__Concept
% 211.93/212.08  |- skos__hiddenLabel mesh__D014096 Supernumerary Tooth
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D014096 2002
% 211.93/212.08  |- skos__altLabel mesh__D014096 Teeth, Supernumerary
% 211.93/212.08  |- mesh__recordAuthorizer mesh__D014096 sjn
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D014096 2003
% 211.93/212.08  |- skos__altLabel mesh__D008857 Interferometry, Microscopic
% 211.93/212.08  |- mesh__publicMeSHNote mesh__D008857 65   
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D008857 2005A
% 211.93/212.08  |- rdf__type mesh__D008857sskos__Concept
% 211.93/212.08  |- skos__altLabel mesh__D008857 Microinterferometry
% 211.93/212.08  |- mesh__recordAuthorizer mesh__D008857 jls
% 211.93/212.08  |- skos__broader mesh__D008857smesh__D007368
% 211.93/212.08  |- mesh__dateEstablished mesh__D008857 1965-01-01
% 211.93/212.08  |- skos__hiddenLabel mesh__D008857 Interference Reflection Microscopy
% 211.93/212.08  |- skos__scopeNote mesh__D008857
% 211.93/212.08       The science and application of a double-beam transmission interference microscope in which the illuminating light beam is split into two paths. One beam passes through the specimen while the other beam reflects off a reference mirror before joining and interfering with the other. The observed optical path difference between the two beams can be measured and used to discriminate minute differences in thickness and refraction of non-stained transparent specimens, such as living cells in culture.%A%    
% 211.93/212.08  |- skos__hiddenLabel mesh__D008857 Microscopic Interferometry
% 211.93/212.08  |- mesh__dateCreated mesh__D008857 1999-01-01
% 211.93/212.08  |- skos__hiddenLabel mesh__D008857 Interference Microscopy
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D008857 2005
% 211.93/212.08  |- mesh__dateRevised mesh__D008857 2004-07-28
% 211.93/212.08  |- skos__hiddenLabel mesh__D008857 Reflection Microscopy, Interference
% 211.93/212.08  |- mesh__recordMaintainer mesh__D008857 jls
% 211.93/212.08  |- skos__altLabel mesh__D008857 Microscopy, Nomarski Interference Contrast
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D008857 2006
% 211.93/212.08  |- mesh__historyNote mesh__D008857 65%28%64%29%   
% 211.93/212.08  |- skos__broader mesh__D008857smesh__D008853
% 211.93/212.08  |- skos__prefLabel mesh__D008857 Microscopy, Interference
% 211.93/212.08  |- mesh__recordOriginator mesh__D008857 NLM
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D000874 1995
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D000874 2004
% 211.93/212.08  |- skos__prefLabel mesh__D000874 Anthracosilicosis
% 211.93/212.08  |- skos__broader mesh__D000874smesh__D012829
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D000874 2001
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D000874 1999
% 211.93/212.08  |- skos__scopeNote mesh__D000874
% 211.93/212.08       A mixed condition of anthracosis and silicosis. %28%Dorland, 27th ed%29%%A%    
% 211.93/212.08  |- mesh__recordMaintainer mesh__D000874 TGC
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D000874 1996
% 211.93/212.08  |- mesh__dateCreated mesh__D000874 1999-01-01
% 211.93/212.08  |- skos__hiddenLabel mesh__D000874 Anthracosilicoses
% 211.93/212.08  |- skos__annotation mesh__D000874
% 211.93/212.08       anthracosis with silicosis; do not coord with OCCUPATIONAL DISEASES%A%  
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D000874 1997
% 211.93/212.08  |- mesh__dateRevised mesh__D000874 1993-03-03
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D000874 2005
% 211.93/212.08  |- rdf__type mesh__D000874sskos__Concept
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D000874 2002
% 211.93/212.08  |- mesh__recordOriginator mesh__D000874 NLM
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D000874 2006
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D000874 1994
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D000874 2003
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D000874 2000
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D000874 1998
% 211.93/212.08  |- mesh__recordAuthorizer mesh__D000874 PLS
% 211.93/212.08  |- skos__hiddenLabel mesh__D008059 Mucopolysaccharidosis Is
% 211.93/212.08  |- skos__related mesh__D008059smesh__D007068
% 211.93/212.08  |- skos__altLabel mesh__D008059 Hurler%27%s Syndrome
% 211.93/212.08  |- skos__hiddenLabel mesh__D008059 Hurlers Syndrome
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D008059 2005A
% 211.93/212.08  |- skos__hiddenLabel mesh__D008059 Disease, Hurler%27%s
% 211.93/212.08  |- mesh__recordAuthorizer mesh__D008059 jls
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D008059 2005
% 211.93/212.08  |- skos__hiddenLabel mesh__D008059 Hurlers Disease
% 211.93/212.08  |- skos__altLabel mesh__D008059 Pfaundler-Hurler Syndrome
% 211.93/212.08  |- skos__scopeNote mesh__D008059
% 211.93/212.08       Systemic lysosomal storage disease caused by a deficiency of alpha-L-iduronidase %28%IDURONIDASE%29% and characterized by progressive physical deterioration with urinary excretion of dermatan sulfate and heparan sulfate. There are three recognized phenotypes representing a spectrum of clinical severity from severe to mild: Hurler%27%s syndrome, Hurler-Scheie syndrome and Scheie%27%s syndrome %28%formerly mucopolysaccharidosis V%29%. Symptoms may include dwarfism, hepatosplenomegaly, gargoyle-like facies, corneal clouding, cardiac complications, and noisy breathing. Hunter syndrome %28%MUCOPOLYSACCHARIDOSIS II%29% and Hurler syndrome were each originally called %22%gargoylism%22% because of the coarseness of the facial features of affected individuals.%A%    
% 211.93/212.08  |- skos__altLabel mesh__D008059 MPS I S
% 211.93/212.08  |- skos__related mesh__D008059smesh__D016532
% 211.93/212.08  |- mesh__publicMeSHNote mesh__D008059
% 211.93/212.08       92; was LIPOCHONDRODYSTROPHY 1966-91; MUCOPOLYSACCHARIDOSIS 5 was heading 1991, was see under MUCOPOLYSACCHARIDOSIS 1975-90; MUCOPOLYSACCHARIDOSIS 1 was see LIPOCHONDRODYSTROPHY 1976-91; HURLER%27%S DISEASE was see LIPOCHONDRODYSTROPHY 1975-91; SCHEIE%27%S SYNDROME was see MUCOPOLYSACCHARIDOSIS 5 1975-91%A%  
% 211.93/212.08  |- mesh__historyNote mesh__D008059
% 211.93/212.08       92; was LIPOCHONDRODYSTROPHY 1966-91; MUCOPOLYSACCHARIDOSIS 5 was heading 1991, was see under MUCOPOLYSACCHARIDOSIS 1975-90; MUCOPOLYSACCHARIDOSIS 1 was see LIPOCHONDRODYSTROPHY 1976-91; HURLER%27%S DISEASE was see LIPOCHONDRODYSTROPHY 1975-91; SCHEIE%27%S SYNDROME was see MUCOPOLYSACCHARIDOSIS 5 1975-91;%A%  
% 211.93/212.08  |- skos__hiddenLabel mesh__D008059 Syndrome, Hurler-Scheie
% 211.93/212.08  |- mesh__onlineNote mesh__D008059
% 211.93/212.08       use MUCOPOLYSACCHARIDOSIS I to search LIPOCHONDRODYSTROPHY 1966-91, MUCOPOLYSACCHARIDOSIS 5 1975-91, MUCOPOLYSACCHARIDOSIS 1 1976-91, HURLER%27%S DISEASE %26% SCHEIE%27%S DISEASE 1975-91%A%  
% 211.93/212.08  |- skos__hiddenLabel mesh__D008059 Syndrome, Pfaundler-Hurler
% 211.93/212.08  |- skos__hiddenLabel mesh__D008059 Hurler Scheie Syndrome
% 211.93/212.08  |- mesh__dateCreated mesh__D008059 1999-01-01
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D008059 2006
% 211.93/212.08  |- skos__altLabel mesh__D008059 MPS I H-S
% 211.93/212.08  |- skos__hiddenLabel mesh__D008059 Pfaundler Hurler Syndrome
% 211.93/212.08  |- skos__altLabel mesh__D008059 Mucopolysaccharidosis V
% 211.93/212.08  |- skos__annotation mesh__D008059 DF: MPS I   
% 211.93/212.08  |- skos__hiddenLabel mesh__D008059 Hurler Syndrome
% 211.93/212.08  |- rdf__type mesh__D008059sskos__Concept
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D008059 2003
% 211.93/212.08  |- skos__altLabel mesh__D008059 Mucopolysaccharidosis 1
% 211.93/212.08  |- mesh__dateRevised mesh__D008059 2004-07-28
% 211.93/212.08  |- skos__hiddenLabel mesh__D008059 Hurler Syndrome Gargoylism
% 211.93/212.08  |- skos__hiddenLabel mesh__D008059 Is, Mucopolysaccharidosis
% 211.93/212.08  |- skos__altLabel mesh__D008059 MPS I H
% 211.93/212.08  |- mesh__recordOriginator mesh__D008059 NLM
% 211.93/212.08  |- skos__hiddenLabel mesh__D008059 Scheies Syndrome
% 211.93/212.08  |- skos__altLabel mesh__D008059 Mucopolysaccharidosis 5
% 211.93/212.08  |- skos__altLabel mesh__D008059 Lipochondrodystrophy
% 211.93/212.08  |- skos__hiddenLabel mesh__D008059 Syndrome, Hurler%27%s
% 211.93/212.08  |- skos__altLabel mesh__D008059 Hurler Disease
% 211.93/212.08  |- skos__altLabel mesh__D008059 Hurler%27%s Disease
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D008059 2002
% 211.93/212.08  |- skos__broader mesh__D008059smesh__D009083
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D008059 2004
% 211.93/212.08  |- mesh__recordMaintainer mesh__D008059 jls
% 211.93/212.08  |- skos__hiddenLabel mesh__D008059 Scheie Syndrome
% 211.93/212.08  |- skos__prefLabel mesh__D008059 Mucopolysaccharidosis I
% 211.93/212.08  |- skos__hiddenLabel mesh__D008059 Syndrome, Scheie%27%s
% 211.93/212.08  |- skos__hiddenLabel mesh__D008059 Lipochondrodystrophies
% 211.93/212.08  |- skos__hiddenLabel mesh__D008059 Disease, Hurler
% 211.93/212.08  |- mesh__recordOriginator mesh__D000076 NLM
% 211.93/212.08  |- skos__prefLabel mesh__D000076 Acetabularia
% 211.93/212.08  |- mesh__historyNote mesh__D000076
% 211.93/212.08       91%28%72%29%; was see under ALGAE, GREEN 1972-90   
% 211.93/212.08  |- skos__broader mesh__D000076smesh__D000460
% 211.93/212.08  |- mesh__dateCreated mesh__D000076 1999-01-01
% 211.93/212.08  |- skos__annotation mesh__D000076 a green alga   
% 211.93/212.08  |- rdf__type mesh__D000076sskos__Concept
% 211.93/212.08  |- mesh__publicMeSHNote mesh__D000076
% 211.93/212.08       91; was see under ALGAE, GREEN 1972-90   
% 211.93/212.08  |- mesh__dateEstablished mesh__D000076 1991-01-01
% 211.93/212.08  |- mesh__recordAuthorizer mesh__D000076 sjn
% 211.93/212.08  |- skos__scopeNote mesh__D000076
% 211.93/212.08       A genus of green algae found in the Mediterranean and other warm seas.%A%    
% 211.93/212.08  |- mesh__dateRevised mesh__D000076 2005-06-30
% 211.93/212.08  |- skos__historyNote mesh__D000076 Algae, Green %28%1970-1971%29%
% 211.93/212.08  |- skos__hiddenLabel mesh__D000076 Acetabularias
% 211.93/212.08  |- mesh__recordMaintainer mesh__D000076 SYSTEM
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D000076 2006
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D018487 1997
% 211.93/212.08  |- skos__altLabel mesh__D018487 Left Ventricular Dysfunction
% 211.93/212.08  |- skos__hiddenLabel mesh__D018487 Dysfunctions, Left Ventricular
% 211.93/212.08  |- skos__prefLabel mesh__D018487 Ventricular Dysfunction, Left
% 211.93/212.08  |- skos__scopeNote mesh__D018487
% 211.93/212.08       A condition in which the left ventricle of the heart exhibits a decreased functionality. This decreased function could lead to congestive heart failure or myocardial infarction, among other cardiovascular diseases. Diagnostic measurements that indicate this condition include a diminished ejection fraction and a depressed level of motility of the left ventricular wall.%A%    
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D018487 2006
% 211.93/212.08  |- mesh__dateEstablished mesh__D018487 1995-01-01
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D018487 2002
% 211.93/212.08  |- mesh__dateRevised mesh__D018487 1996-06-10
% 211.93/212.08  |- mesh__recordAuthorizer mesh__D018487 PLS
% 211.93/212.08  |- mesh__dateCreated mesh__D018487 1994-02-28
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D018487 2005
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D018487 1999
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D018487 2001
% 211.93/212.08  |- skos__hiddenLabel mesh__D018487 Ventricular Dysfunctions, Left
% 211.93/212.08  |- skos__hiddenLabel mesh__D018487 Dysfunction, Left Ventricular
% 211.93/212.08  |- mesh__recordOriginator mesh__D018487 PXP
% 211.93/212.08  |- skos__broader mesh__D018487smesh__D018754
% 211.93/212.08  |- skos__hiddenLabel mesh__D018487 Left Ventricular Dysfunctions
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D018487 1998
% 211.93/212.08  |- mesh__recordMaintainer mesh__D018487 TGC
% 211.93/212.08  |- rdf__type mesh__D018487sskos__Concept
% 211.93/212.08  |- mesh__historyNote mesh__D018487 95   
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D018487 2004
% 211.93/212.08  |- skos__annotation mesh__D018487
% 211.93/212.08       ventric refers to the heart, not the cerebral ventricles   
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D018487 2000
% 211.93/212.08  |- mesh__publicMeSHNote mesh__D018487 95   
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D018487 2003
% 211.93/212.08  |- skos__broader mesh__D004467smesh__D012942
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D004467 2006
% 211.93/212.08  |- mesh__dateRevised mesh__D004467 2002-07-03
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Economic Factor
% 211.93/212.08  |- rdf__type mesh__D004467sskos__Concept
% 211.93/212.08  |- mesh__recordMaintainer mesh__D004467 hjn
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D004467 2003
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Indices, Consumer Price
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Factor, Macroeconomic
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Living Costs
% 211.93/212.08  |- skos__related mesh__D004467smesh__D005062
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Factor, Economic
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Consumer Price Indices
% 211.93/212.08  |- skos__related mesh__D004467smesh__D012959
% 211.93/212.08  |- skos__altLabel mesh__D004467 Policy, Economic
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D004467 2004
% 211.93/212.08  |- skos__altLabel mesh__D004467 Economic Factors
% 211.93/212.08  |- mesh__recordOriginator mesh__D004467 NLM
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Consumption, Household
% 211.93/212.08  |- skos__altLabel mesh__D004467 Economics, Home
% 211.93/212.08  |- skos__altLabel mesh__D004467 Development, Economic
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Condition, Economic
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Household Consumptions
% 211.93/212.08  |- skos__prefLabel mesh__D004467 Economics
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Factor, Microeconomic
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Remittance
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Economic Recessions
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Factors, Microeconomic
% 211.93/212.08  |- skos__altLabel mesh__D004467 Economic Policy
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Factors, Macroeconomic
% 211.93/212.08  |- skos__broader mesh__D004467smesh__D004472
% 211.93/212.08  |- skos__altLabel mesh__D004467 Conditions, Economic
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Recessions, Economic
% 211.93/212.08  |- skos__altLabel mesh__D004467 Policies, Economic
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Hypothesis, Easterlin
% 211.93/212.08  |- skos__annotation mesh__D004467
% 211.93/212.08       GEN or unspecified only: prefer /econ: Manual 19.7+, 19.8.27; for purely economic aspects use ECONOMICS, for combination of social %26% economic aspects use SOCIOECONOMIC FACTORS; DF: ECON%A%  
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Index, Consumer Price
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Theory, Utility
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Theories, Utility
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D004467 2005
% 211.93/212.08  |- mesh__dateCreated mesh__D004467 1999-01-01
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Utility Theories
% 211.93/212.08  |- mesh__recordAuthorizer mesh__D004467 sjn
% 211.93/212.08  |- skos__scopeNote mesh__D004467
% 211.93/212.08       The science of utilization, distribution, and consumption of services and materials.%A%    
% 211.93/212.08  |- skos__altLabel mesh__D004467 Economic Recession
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Living Cost
% 211.93/212.08  |- skos__hiddenLabel mesh__D004467 Economic Condition
% 211.93/212.08  |- skos__related mesh__D004467smesh__D018803
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D009950 2006
% 211.93/212.08  |- skos__hiddenLabel mesh__D009950 Ro7 0207
% 211.93/212.08  |- mesh__onlineNote mesh__D009950
% 211.93/212.08       use ORNIDAZOLE to search RO 7-0207 1975-80   
% 211.93/212.08  |- skos__altLabel mesh__D009950 Ro-70207
% 211.93/212.08  |- skos__historyNote mesh__D009950 Imidazoles %28%1966-1973%29%
% 211.93/212.08  |- skos__prefLabel mesh__D009950 Ornidazole
% 211.93/212.08  |- mesh__recordAuthorizer mesh__D009950 sjn
% 211.93/212.08  |- rdf__type mesh__D009950sskos__Concept
% 211.93/212.08  |- mesh__recordMaintainer mesh__D009950 ssb
% 211.93/212.08  |- skos__altLabel mesh__D009950 Ro7-0207
% 211.93/212.08  |- skos__historyNote mesh__D009950 Nitroimidazoles %28%1974%29%
% 211.93/212.08  |- skos__historyNote mesh__D009950 Alcohol, Propyl %28%1966-1974%29%
% 211.93/212.08  |- skos__hiddenLabel mesh__D009950 Ro 7 0207
% 211.93/212.08  |- mesh__publicMeSHNote mesh__D009950
% 211.93/212.08       91; was see under NITROIMIDAZOLES 1981-90; was RO 7-0207 see under NITROIMIDAZOLES 1975-80%A%  
% 211.93/212.08  |- mesh__recordOriginator mesh__D009950 NLM
% 211.93/212.08  |- skos__broader mesh__D009950smesh__D009593
% 211.93/212.08  |- mesh__dateCreated mesh__D009950 1974-11-19
% 211.93/212.08  |- skos__hiddenLabel mesh__D009950 Ro 70207
% 211.93/212.08  |- skos__scopeNote mesh__D009950
% 211.93/212.08       A nitroimidazole antiprotozoal agent used in ameba and trichomonas infections. It is partially plasma-bound and also has radiation-sensitizing action.%A%    
% 211.93/212.08  |- mesh__historyNote mesh__D009950
% 211.93/212.08       91%28%81%29%; was see under NITROIMIDAZOLES 1981-90; was RO 7-0207 see under NITROIMIDAZOLES 1975-80%A%  
% 211.93/212.08  |- skos__hiddenLabel mesh__D009950 Ro70207
% 211.93/212.08  |- mesh__dateRevised mesh__D009950 2005-06-30
% 211.93/212.08  |- mesh__dateEstablished mesh__D009950 1991-01-01
% 211.93/212.08  |- skos__hiddenLabel mesh__D009152 Screenings, Mutagen
% 211.93/212.08  |- skos__hiddenLabel mesh__D009152 Mutagen Screenings
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D009152 2005
% 211.93/212.08  |- skos__hiddenLabel mesh__D009152 Genetic Toxicity Test
% 211.93/212.08  |- skos__prefLabel mesh__D009152 Mutagenicity Tests
% 211.93/212.08  |- mesh__dateCreated mesh__D009152 1980-05-19
% 211.93/212.08  |- skos__hiddenLabel mesh__D009152 Genotoxicity Test
% 211.93/212.08  |- skos__historyNote mesh__D009152 Mutation %28%1966-1980%29%
% 211.93/212.08  |- skos__altLabel mesh__D009152 Genotoxicity Tests
% 211.93/212.08  |- skos__hiddenLabel mesh__D009152 Mutagenicity Test
% 211.93/212.08  |- skos__historyNote mesh__D009152 Mutagens %28%1966-1980%29%
% 211.93/212.08  |- mesh__publicMeSHNote mesh__D009152 81   
% 211.93/212.08  |- skos__hiddenLabel mesh__D009152 Tests, Genotoxicity
% 211.93/212.08  |- skos__broader mesh__D009152smesh__D005821
% 211.93/212.08  |- rdf__type mesh__D009152sskos__Concept
% 211.93/212.08  |- skos__related mesh__D009152smesh__D015197
% 211.93/212.08  |- skos__hiddenLabel mesh__D009152 Test, Genotoxicity
% 211.93/212.08  |- skos__altLabel mesh__D009152 Mutagen Screening
% 211.93/212.08  |- skos__hiddenLabel mesh__D009152 Screening, Mutagen
% 211.93/212.08  |- mesh__activeMeSHYear mesh__D009152 2002
% 211.93/212.09  |- mesh__recordAuthorizer mesh__D009152 sjn
% 211.93/212.09  |- mesh__activeMeSHYear mesh__D009152 2004
% 211.93/212.09  |- skos__broader mesh__D009152smesh__D018675
% 211.93/212.09  |- skos__scopeNote mesh__D009152
% 211.93/212.09       Tests of chemical substances and physical agents for mutagenic potential. They include microbial, insect, mammalian cell, and whole animal tests.%A%    
% 211.93/212.09  |- skos__altLabel mesh__D009152 Genetic Toxicity Tests
% 211.93/212.09  |- mesh__activeMeSHYear mesh__D009152 2001
% 211.93/212.09  |- skos__hiddenLabel mesh__D009152 Toxicity Test, Genetic
% 211.93/212.09  |- skos__annotation mesh__D009152 NIM   
% 211.93/212.09  |- mesh__activeMeSHYear mesh__D009152 2003
% 211.93/212.09  |- skos__altLabel mesh__D009152 Toxicity Tests, Genetic
% 211.93/212.09  |- mesh__activeMeSHYear mesh__D009152 2006
% 211.93/212.09  |- mesh__dateRevised mesh__D009152 1999-11-03
% 211.93/212.09  |- mesh__recordMaintainer mesh__D009152 ags
% 211.93/212.09  |- mesh__dateEstablished mesh__D009152 1981-01-01
% 211.93/212.09  |- skos__altLabel mesh__D009152 Tests, Genetic Toxicity
% 211.93/212.09  |- mesh__activeMeSHYear mesh__D009152 2000
% 211.93/212.09  |- mesh__historyNote mesh__D009152 81   
% 211.93/212.09  |- mesh__recordOriginator mesh__D009152 SMH
% 211.93/212.09  |- skos__hiddenLabel mesh__D014895 Icterohemorrhagic Leptospirosis
% 211.93/212.09  |- mesh__activeMeSHYear mesh__D014895 2005
% 211.93/212.09  |- skos__broader mesh__D014895smesh__D007922
% 211.93/212.09  |- skos__annotation mesh__D014895
% 211.93/212.09       if not caused by LEPTOSPIRA INTERROGANS SEROVAR ICTEROHAEMORRHAGIAE, coord IM with specific Leptospira interrogans serovar %28%IM%29% or LEPTOSPIRA INTERROGANS %28%IM%29%%A%  
% 211.93/212.09  |- mesh__historyNote mesh__D014895 2003 %28%1963%29%   
% 211.93/212.09  |- mesh__recordOriginator mesh__D014895 NLM
% 211.93/212.09  |- skos__hiddenLabel mesh__D014895 Spirochetal Jaundice
% 211.93/212.09  |- skos__hiddenLabel mesh__D014895 Weils Disease
% 211.93/212.09  |- skos__altLabel mesh__D014895 Leptospirosis, Icterohemorrhagic
% 211.93/212.09  |- mesh__dateCreated mesh__D014895 1999-01-01
% 211.93/212.09  |- skos__hiddenLabel mesh__D014895 Disease, Weil%27%s
% 211.93/212.09  |- mesh__dateRevised mesh__D014895 2002-07-03
% 211.93/212.09  |- skos__prefLabel mesh__D014895 Weil Disease
% 211.93/212.09  |- skos__altLabel mesh__D014895 Weil%27%s Disease
% 211.93/212.09  |- mesh__activeMeSHYear mesh__D014895 2004
% 211.93/212.09  |- mesh__recordMaintainer mesh__D014895 ags
% 211.93/212.09  |- skos__altLabel mesh__D014895 Jaundice, Spirochetal
% 211.93/212.09  |- rdf__type mesh__D014895sskos__Concept
% 211.93/212.09  |- mesh__activeMeSHYear mesh__D014895 2003
% 211.93/212.09  |- mesh__activeMeSHYear mesh__D014895 2006
% 211.93/212.09  |- mesh__publicMeSHNote mesh__D014895
% 211.93/212.09       2003; see WEIL%27%S DISEASE 1963-2002   
% 211.93/212.09  |- skos__hiddenLabel mesh__D014895 Disease, Weil
% 211.93/212.09  |- skos__scopeNote mesh__D014895
% 211.93/212.09       A severe form of LEPTOSPIROSIS, usually caused by LEPTOSPIRA INTERROGANS SEROVAR ICTEROHAEMORRHAGIAE and occasionally other serovars. It is transmitted to humans by the rat and is characterized by hemorrhagic and renal symptoms with accompanying JAUNDICE.%A%    
% 211.93/212.09  |- mesh__recordAuthorizer mesh__D014895 sjn
% 211.93/212.09  |- mesh__historyNote mesh__D047271 2005   
% 211.93/212.09  |- skos__prefLabel mesh__D047271 Asterias
% 211.93/212.09  |- mesh__dateEstablished mesh__D047271 2005-01-01
% 211.93/212.09  |- mesh__activeMeSHYear mesh__D047271 2006
% 211.93/212.09  |- skos__broader mesh__D047271smesh__D013215
% 211.93/212.09  |- rdf__type mesh__D047271sskos__Concept
% 211.93/212.09  |- mesh__activeMeSHYear mesh__D047271 2005
% 211.93/212.09  |- mesh__recordOriginator mesh__D047271 ags
% 211.93/212.09  |- mesh__dateCreated mesh__D047271 2004-07-07
% 211.93/212.09  |- mesh__recordAuthorizer mesh__D047271 sjn
% 211.93/212.09  |- mesh__recordMaintainer mesh__D047271 ags
% 211.93/212.09  |- skos__historyNote mesh__D047271 Starfish %28%1971-2004%29%
% 211.93/212.09  |- mesh__publicMeSHNote mesh__D047271 2005   
% 211.93/212.09  |- skos__historyNote mesh__D047271 Echinodermata %28%1965-1971%29%
% 211.93/212.09  |- skos__scopeNote mesh__D047271
% 211.93/212.09       A genus of STARFISH in the family Asteriidae. One species, Asterias rubens, is the most common in the north-east Atlantic region.%A%    
% 211.93/212.09  |- skos__related mesh__D014097smesh__D014095
% 211.93/212.09  |- skos__broader mesh__D014097smesh__D014070
% 211.93/212.09  |- mesh__dateCreated mesh__D014097 1999-01-01
% 211.93/212.09  |- mesh__historyNote mesh__D014097 73   
% 211.93/212.09  |- mesh__activeMeSHYear mesh__D014097 2005
% 211.93/212.09  |- skos__hiddenLabel mesh__D014097 Unerupted Teeth
% 211.93/212.09  |- mesh__publicMeSHNote mesh__D014097 73   
% 211.93/212.09  |- mesh__recordAuthorizer mesh__D014097 sjn
% 211.93/212.09  |- skos__prefLabel mesh__D014097 Tooth, Unerupted
% 211.93/212.09  |- mesh__activeMeSHYear mesh__D014097 2006
% 211.93/212.09  |- skos__broader mesh__D014097smesh__D014076
% 211.93/212.09  |- mesh__recordOriginator mesh__D014097 NLM
% 211.93/212.09  |- skos__historyNote mesh__D014097 Tooth Eruption %28%1966-1972%29%
% 211.93/212.09  |- skos__annotation mesh__D014097
% 211.93/212.09       note categories; do not confuse with TOOTH, IMPACTED   
% 211.93/212.09  |- mesh__dateRevised mesh__D014097 2003-07-09
% 211.93/212.09  |- mesh__recordMaintainer mesh__D014097 lkt
% 211.93/212.09  |- mesh__activeMeSHYear mesh__D014097 2004
% 211.93/212.09  |- rdf__type mesh__D014097sskos__Concept
% 211.93/212.09  |- skos__hiddenLabel mesh__D014097 Unerupted Tooth
% 211.93/212.09  |- mesh__dateEstablished mesh__D014097 1973-01-01
% 211.93/212.09  |- skos__scopeNote mesh__D014097
% 211.93/212.09       A normal developing tooth which has not yet perforated the oral mucosa or one that fails to erupt in the normal sequence or time interval expected for the type of tooth in a given gender, age, or population group.%A%    
% 211.93/212.09  |- skos__altLabel mesh__D014097 Teeth, Unerupted
% 211.93/212.09  |- mesh__dateRevised mesh__D008858 2004-07-07
% 211.93/212.09  |- mesh__activeMeSHYear mesh__D008858 2005
% 211.93/212.09  |- skos__altLabel mesh__D008858 Phase-Contrast Microscopy
% 211.93/212.09  |- rdf__type mesh__D008858sskos__Concept
% 211.93/212.09  |- mesh__recordOriginator mesh__D008858 NLM
% 211.93/212.09  |- mesh__recordAuthorizer mesh__D008858 sjn
% 211.93/212.09  |- skos__scopeNote mesh__D008858
% 211.93/212.09       A form of interference microscopy in which variations of the refracting index in the object are converted into variations of intensity in the image. This is achieved by the action of a phase plate.%A%    
% 211.93/212.09  |- skos__annotation mesh__D008858 NIM   
% 211.93/212.09  |- skos__hiddenLabel mesh__D008858 Phase-Contrast Microscopies
% 211.93/212.09  |- mesh__dateCreated mesh__D008858 1999-01-01
% 211.94/212.09  |- skos__hiddenLabel mesh__D008858 Phase Contrast Microscopy
% 211.94/212.09  |- mesh__historyNote mesh__D008858
% 211.94/212.09       91; was MICROSCOPY, PHASE CONTRAST 1963-90   
% 211.94/212.09  |- mesh__onlineNote mesh__D008858
% 211.94/212.09       use MICROSCOPY, PHASE-CONTRAST to search MICROSCOPY, PHASE CONTRAST 1966-90%A%  
% 211.94/212.09  |- skos__prefLabel mesh__D008858 Microscopy, Phase-Contrast
% 211.94/212.09  |- skos__hiddenLabel mesh__D008858 Microscopy, Phase Contrast
% 211.94/212.09  |- skos__broader mesh__D008858smesh__D008857
% 211.94/212.09  |- skos__hiddenLabel mesh__D008858 Microscopies, Phase-Contrast
% 211.94/212.09  |- mesh__publicMeSHNote mesh__D008858
% 211.94/212.09       91; was MICROSCOPY, PHASE CONTRAST 1963-90   
% 211.94/212.09  |- mesh__recordMaintainer mesh__D008858 nns
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D008858 2006
% 211.94/212.09  |- skos__altLabel mesh__D000875 Cignolin
% 211.94/212.09  |- skos__altLabel mesh__D000875 1,8,9-Anthracenetriol
% 211.94/212.09  |- mesh__dateRevised mesh__D000875 2005-06-30
% 211.94/212.09  |- mesh__recordOriginator mesh__D000875 NLM
% 211.94/212.09  |- skos__altLabel mesh__D000875 Dermal Brand of Anthralin
% 211.94/212.09  |- skos__scopeNote mesh__D000875
% 211.94/212.09       An anti-inflammatory anthracene derivative used for the treatment of DERMATOSES, especially PSORIASIS. It may cause folliculitis.%A%    
% 211.94/212.09  |- skos__altLabel mesh__D000875 Dithranol
% 211.94/212.09  |- skos__altLabel mesh__D000875 Vinas Brand of Anthralin
% 211.94/212.09  |- skos__altLabel mesh__D000875 FNA Brand of Anthralin
% 211.94/212.09  |- skos__altLabel mesh__D000875 Dihydroxyanthranol
% 211.94/212.09  |- mesh__recordAuthorizer mesh__D000875 sjn
% 211.94/212.09  |- skos__altLabel mesh__D000875 1,8-Dihydroxy-9-anthrone
% 211.94/212.09  |- mesh__dateCreated mesh__D000875 1974-11-19
% 211.94/212.09  |- mesh__recordMaintainer mesh__D000875 exl
% 211.94/212.09  |- skos__altLabel mesh__D000875 Stiefel Brand 1 of Anthralin
% 211.94/212.09  |- skos__altLabel mesh__D000875 Stiefel Brand 2 of Anthralin
% 211.94/212.09  |- skos__hiddenLabel mesh__D000875 Schering Plough Brand of Anthralin
% 211.94/212.09  |- skos__altLabel mesh__D000875 Schering-Plough Brand of Anthralin
% 211.94/212.09  |- skos__altLabel mesh__D000875 Anthranol
% 211.94/212.09  |- mesh__historyNote mesh__D000875
% 211.94/212.09       87%28%75%29%; was see under ANTHRACENES 1975-86   
% 211.94/212.09  |- mesh__dateEstablished mesh__D000875 1987-01-01
% 211.94/212.09  |- skos__historyNote mesh__D000875 Anthracenes %28%1968-1974%29%
% 211.94/212.09  |- skos__altLabel mesh__D000875 Cahill May Roberts Brand of Anthralin
% 211.94/212.09  |- skos__broader mesh__D000875smesh__D000873
% 211.94/212.09  |- skos__altLabel mesh__D000875 Bioglan Brand of Anthralin
% 211.94/212.09  |- skos__altLabel mesh__D000875 1,8-Dihydroxy-9%28%10H%29%-anthracenone
% 211.94/212.09  |- rdf__type mesh__D000875sskos__Concept
% 211.94/212.09  |- mesh__publicMeSHNote mesh__D000875
% 211.94/212.09       87; was see under ANTHRACENES 1975-86   
% 211.94/212.09  |- skos__prefLabel mesh__D000875 Anthralin
% 211.94/212.09  |- skos__hiddenLabel mesh__D000875 1,8 Dihydroxy 9 anthrone
% 211.94/212.09  |- skos__altLabel mesh__D000875 Hamilton Brand of Anthralin
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D000875 2006
% 211.94/212.09  |- rdf__type mesh__D019580sskos__Concept
% 211.94/212.09  |- skos__scopeNote mesh__D019580
% 211.94/212.09       A pathway of fibers originating in the lateral part of the entorhinal area, perforating the subiculum of the hippocampus, and running into the stratum moleculare of the hippocampus, where these fibers synapse with others that go to the dentate gyrus. It is also called the perforating fasciculus. %28%Dorland, 28th ed%29%%A%    
% 211.94/212.09  |- skos__hiddenLabel mesh__D019580 Paths, Perforant
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D019580 2002
% 211.94/212.09  |- mesh__dateEstablished mesh__D019580 1998-01-01
% 211.94/212.09  |- skos__historyNote mesh__D019580 Neural Pathways %28%1977-1997%29%
% 211.94/212.09  |- skos__altLabel mesh__D019580 Perforant Path
% 211.94/212.09  |- skos__historyNote mesh__D019580 Hippocampus %28%1977-1997%29%
% 211.94/212.09  |- mesh__recordOriginator mesh__D019580 TGC
% 211.94/212.09  |- mesh__dateCreated mesh__D019580 1997-06-20
% 211.94/212.09  |- mesh__recordAuthorizer mesh__D019580 sjn
% 211.94/212.09  |- skos__hiddenLabel mesh__D019580 Path, Perforant
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D019580 2004
% 211.94/212.09  |- mesh__recordMaintainer mesh__D019580 ags
% 211.94/212.09  |- mesh__historyNote mesh__D019580 98   
% 211.94/212.09  |- mesh__publicMeSHNote mesh__D019580 98   
% 211.94/212.09  |- skos__related mesh__D019580smesh__D006624
% 211.94/212.09  |- mesh__dateRevised mesh__D019580 1999-11-03
% 211.94/212.09  |- skos__hiddenLabel mesh__D019580 Pathway, Perforant
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D019580 2001
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D019580 2003
% 211.94/212.09  |- skos__hiddenLabel mesh__D019580 Fasciculus, Perforating
% 211.94/212.09  |- skos__altLabel mesh__D019580 Perforating Fasciculus
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D019580 2000
% 211.94/212.09  |- skos__hiddenLabel mesh__D019580 Perforant Paths
% 211.94/212.09  |- skos__prefLabel mesh__D019580 Perforant Pathway
% 211.94/212.09  |- skos__related mesh__D019580smesh__D018728
% 211.94/212.09  |- skos__annotation mesh__D019580
% 211.94/212.09       in the entorhinal cortex; DF: PERFORANT PATH   
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D019580 2006
% 211.94/212.09  |- skos__hiddenLabel mesh__D019580 Perforant Pathways
% 211.94/212.09  |- skos__historyNote mesh__D019580 Limbic System %28%1978-1993%29%
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D019580 2005
% 211.94/212.09  |- skos__hiddenLabel mesh__D019580 Pathways, Perforant
% 211.94/212.09  |- skos__broader mesh__D019580smesh__D009434
% 211.94/212.09  |- mesh__dateCreated mesh__D000077 1999-01-01
% 211.94/212.09  |- skos__broader mesh__D000077smesh__D010384
% 211.94/212.09  |- skos__prefLabel mesh__D000077 Acetabulum
% 211.94/212.09  |- rdf__type mesh__D000077sskos__Concept
% 211.94/212.09  |- mesh__recordOriginator mesh__D000077 NLM
% 211.94/212.09  |- mesh__dateRevised mesh__D000077 2005-07-14
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D000077 2006A
% 211.94/212.09  |- skos__annotation mesh__D000077
% 211.94/212.09       point of union of the 3 pelvic bones; do not confuse with HIP or HIP JOINT or PELVIC BONES; fract = ACETABULUM /inj %28%IM%29% + FRACTURES, BONE %28%IM%29%%A%  
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D000077 2006
% 211.94/212.09  |- mesh__recordMaintainer mesh__D000077 ags
% 211.94/212.09  |- mesh__recordAuthorizer mesh__D000077 ags
% 211.94/212.09  |- skos__hiddenLabel mesh__D000077 Acetabulums
% 211.94/212.09  |- mesh__dateCreated mesh__D005560 1979-05-23
% 211.94/212.09  |- skos__historyNote mesh__D005560 Formic Acids %28%1968-1979%29%
% 211.94/212.09  |- mesh__dateEstablished mesh__D005560 1991-01-01
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D005560 2006
% 211.94/212.09  |- skos__altLabel mesh__D005560 NAD-Formate Dehydrogenase
% 211.94/212.09  |- skos__broader mesh__D005560smesh__D050837
% 211.94/212.09  |- skos__historyNote mesh__D005560
% 211.94/212.09       Aldehyde Oxidoreductases %28%1973-1979%29%
% 211.94/212.09  |- skos__altLabel mesh__D005560 Formate Hydrogenlyases
% 211.94/212.09  |- mesh__publicMeSHNote mesh__D005560
% 211.94/212.09       91; was see under ALDEHYDE OXIDOREDUCTASES 1980-90   
% 211.94/212.09  |- mesh__recordOriginator mesh__D005560 RLS
% 211.94/212.09  |- mesh__recordAuthorizer mesh__D005560 sjn
% 211.94/212.09  |- skos__hiddenLabel mesh__D005560 Hydrogenlyases, Formate
% 211.94/212.09  |- skos__scopeNote mesh__D005560
% 211.94/212.09       Flavoproteins that catalyze reversibly the reduction of carbon dioxide to formate. Many compounds can act as acceptors, but the only physiologically active acceptor is NAD. The enzymes are active in the fermentation of sugars and other compounds to carbon dioxide and are the key enzymes in obtaining energy when bacteria are grown on formate as the main carbon source. They have been purified from bovine blood. EC 1.2.1.2.%A%    
% 211.94/212.09  |- skos__hiddenLabel mesh__D005560 Dehydrogenase, NAD-Formate
% 211.94/212.09  |- skos__historyNote mesh__D005560 Oxidoreductases %28%1966-1972%29%
% 211.94/212.09  |- mesh__recordMaintainer mesh__D005560 jmp
% 211.94/212.09  |- skos__hiddenLabel mesh__D005560 Dehydrogenases, Formate
% 211.94/212.09  |- mesh__historyNote mesh__D005560
% 211.94/212.09       91%28%80%29%; was see under ALDEHYDE OXIDOREDUCTASES 1980-90   
% 211.94/212.09  |- mesh__dateRevised mesh__D005560 2005-06-30
% 211.94/212.09  |- skos__hiddenLabel mesh__D005560 NAD Formate Dehydrogenase
% 211.94/212.09  |- skos__historyNote mesh__D005560 Formates %28%1966-1967%29%
% 211.94/212.09  |- skos__prefLabel mesh__D005560 Formate Dehydrogenases
% 211.94/212.09  |- rdf__type mesh__D005560sskos__Concept
% 211.94/212.09  |- skos__broader mesh__D009211Q000652smesh__D009211
% 211.94/212.09  |- mesh__preferredCombination mesh__D009211Q000652smesh__D009212
% 211.94/212.09  |- rdf__type mesh__D009211Q000652smesh__CompoundConcept
% 211.94/212.09  |- skos__related mesh__D018488smesh__D010024
% 211.94/212.09  |- skos__historyNote mesh__D018488 Bone Diseases %28%1966-1994%29%
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D018488 2000
% 211.94/212.09  |- mesh__publicMeSHNote mesh__D018488 95   
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D018488 2006
% 211.94/212.09  |- skos__scopeNote mesh__D018488
% 211.94/212.09       Decrease, loss, or removal of the mineral constituents of bones. Temporary loss of bone mineral content is especially associated with space flight, weightlessness, and extended immobilization. OSTEOPOROSIS is permanent, includes reduction of total bone mass, and is associated with increased rate of fractures. CALCIFICATION, PHYSIOLOGIC is the process of bone remineralizing. %28%From Dorland, 27th ed; Stedman, 25th ed; Nicogossian, Space Physiology and Medicine, 2d ed, pp327-33%29%%A%    
% 211.94/212.09  |- skos__altLabel mesh__D018488 Pathologic Bone Demineralization
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D018488 2005
% 211.94/212.09  |- skos__prefLabel mesh__D018488 Bone Demineralization, Pathologic
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D018488 1999
% 211.94/212.09  |- skos__historyNote mesh__D018488 Bone and Bones %28%1966-1994%29%
% 211.94/212.09  |- rdf__type mesh__D018488sskos__Concept
% 211.94/212.09  |- skos__annotation mesh__D018488
% 211.94/212.09       a metab bone dis; do not confuse with BONE DEMINERALIZATION TECHNIQUE, a histol technique: DF: BONE DEMINERALIZATION PATHOL%A%  
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D018488 1998
% 211.94/212.09  |- mesh__recordMaintainer mesh__D018488 TGC
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D018488 2004
% 211.94/212.09  |- mesh__historyNote mesh__D018488 95   
% 211.94/212.09  |- mesh__dateCreated mesh__D018488 1994-06-07
% 211.94/212.09  |- mesh__dateEstablished mesh__D018488 1995-01-01
% 211.94/212.09  |- mesh__recordOriginator mesh__D018488 JLS
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D018488 2002
% 211.94/212.09  |- mesh__dateRevised mesh__D018488 1996-06-10
% 211.94/212.09  |- mesh__recordAuthorizer mesh__D018488 PLS
% 211.94/212.09  |- skos__broader mesh__D018488smesh__D001851
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D018488 2003
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D018488 2001
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D018488 1997
% 211.94/212.09  |- skos__prefLabel mesh__D004468 Economics, Dental
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D004468 2001
% 211.94/212.09  |- mesh__recordAuthorizer mesh__D004468 sjn
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D004468 2004
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D004468 2000
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D004468 2006
% 211.94/212.09  |- skos__scopeNote mesh__D004468
% 211.94/212.09       Economic aspects of the dental profession and dental care.%A%    
% 211.94/212.09  |- skos__broader mesh__D004468smesh__D004467
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D004468 2003
% 211.94/212.09  |- skos__altLabel mesh__D004468 Dental Economics
% 211.94/212.09  |- mesh__recordMaintainer mesh__D004468 kle
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D004468 2005
% 211.94/212.09  |- mesh__dateRevised mesh__D004468 1999-11-03
% 211.94/212.09  |- rdf__type mesh__D004468sskos__Concept
% 211.94/212.09  |- skos__related mesh__D004468smesh__D009817
% 211.94/212.09  |- mesh__dateCreated mesh__D004468 1999-01-01
% 211.94/212.09  |- skos__annotation mesh__D004468
% 211.94/212.09       GEN or unspecified only: prefer /econ with specific dent subject: Manual 19.8.27; DF: ECON DENT%A%  
% 211.94/212.09  |- mesh__recordOriginator mesh__D004468 NLM
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D004468 2002
% 211.94/212.09  |- skos__broader mesh__D015190smesh__D008991
% 211.94/212.09  |- skos__hiddenLabel mesh__D015190 Sugar Self-Monitoring, Blood
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D015190 2001
% 211.94/212.09  |- skos__prefLabel mesh__D015190 Blood Glucose Self-Monitoring
% 211.94/212.09  |- skos__broader mesh__D015190smesh__D012648
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D015190 2006
% 211.94/212.09  |- mesh__dateRevised mesh__D015190 1997-06-20
% 211.94/212.09  |- skos__altLabel mesh__D015190 Monitoring, Home Blood Glucose
% 211.94/212.09  |- skos__hiddenLabel mesh__D015190 Self Monitoring, Blood Glucose
% 211.94/212.09  |- skos__historyNote mesh__D015190 Blood Glucose %28%1978-1988%29%
% 211.94/212.09  |- skos__altLabel mesh__D015190 Glucose, Blood, Self Monitoring
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D015190 2000
% 211.94/212.09  |- skos__hiddenLabel mesh__D015190 Self-Monitoring, Blood Sugar
% 211.94/212.09  |- skos__broader mesh__D015190smesh__D003940
% 211.94/212.09  |- skos__annotation mesh__D015190
% 211.94/212.09       NIM; coord with dis /blood, not /physiopathol; DF: BGSM   
% 211.94/212.09  |- skos__altLabel mesh__D015190 Self-Monitoring, Blood Glucose
% 211.94/212.09  |- skos__hiddenLabel mesh__D015190 Blood Sugar Self Monitoring
% 211.94/212.09  |- skos__broader mesh__D015190smesh__D001774
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D015190 2005
% 211.94/212.09  |- skos__hiddenLabel mesh__D015190 Self-Monitorings, Blood Glucose
% 211.94/212.09  |- skos__altLabel mesh__D015190 Glucose, Blood, Self-Monitoring
% 211.94/212.09  |- mesh__recordMaintainer mesh__D015190 PXP
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D015190 1999
% 211.94/212.09  |- mesh__dateCreated mesh__D015190 1988-04-20
% 211.94/212.09  |- rdf__type mesh__D015190sskos__Concept
% 211.94/212.09  |- skos__altLabel mesh__D015190 Home Blood Glucose Monitoring
% 211.94/212.09  |- mesh__dateEstablished mesh__D015190 1989-01-01
% 211.94/212.09  |- skos__altLabel mesh__D015190 Blood Sugar Self-Monitoring
% 211.94/212.09  |- skos__scopeNote mesh__D015190
% 211.94/212.09       Self evaluation of whole blood glucose levels outside the clinical laboratory. A digital or battery-operated reflectance meter may be used. It has wide application in controlling unstable insulin-dependent diabetes.%A%    
% 211.94/212.09  |- skos__historyNote mesh__D015190
% 211.94/212.09       Monitoring, Physiologic %28%1978-1988%29%
% 211.94/212.09  |- skos__hiddenLabel mesh__D015190 Glucose Self-Monitoring, Blood
% 211.94/212.09  |- skos__hiddenLabel mesh__D015190 Self-Monitorings, Blood Sugar
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D015190 2004
% 211.94/212.09  |- mesh__historyNote mesh__D015190 89   
% 211.94/212.09  |- skos__historyNote mesh__D015190 Self Care %28%1981-1988%29%
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D015190 1998
% 211.94/212.09  |- skos__hiddenLabel mesh__D015190 Blood Glucose Self-Monitorings
% 211.94/212.09  |- mesh__recordOriginator mesh__D015190 SCD
% 211.94/212.09  |- skos__hiddenLabel mesh__D015190 Blood Glucose Self Monitoring
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D015190 2003
% 211.94/212.09  |- skos__hiddenLabel mesh__D015190 Blood Sugar Self-Monitorings
% 211.94/212.09  |- mesh__recordAuthorizer mesh__D015190 SJN
% 211.94/212.09  |- mesh__publicMeSHNote mesh__D015190 89   
% 211.94/212.09  |- skos__hiddenLabel mesh__D015190 Sugar Self-Monitorings, Blood
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D015190 2002
% 211.94/212.09  |- skos__hiddenLabel mesh__D015190 Glucose Self-Monitorings, Blood
% 211.94/212.09  |- mesh__publicMeSHNote mesh__D009951
% 211.94/212.09       91; was see under VASOPRESSINS 1979-90   
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D009951 2006
% 211.94/212.09  |- mesh__dateCreated mesh__D009951 1977-12-09
% 211.94/212.09  |- skos__hiddenLabel mesh__D009951 Ornithine 8 Vasopressin
% 211.94/212.09  |- skos__altLabel mesh__D009951 Ornithine-8-Vasopressin
% 211.94/212.09  |- skos__historyNote mesh__D009951 Ornithine %28%1966-1978%29%
% 211.94/212.09  |- mesh__dateRevised mesh__D009951 2005-06-30
% 211.94/212.09  |- skos__scopeNote mesh__D009951
% 211.94/212.09       A synthetic analog of vasopressin with ornithine in position 8 of the cyclic nonapeptide. It is used as a local vasoconstrictor and hemostatic.%A%    
% 211.94/212.09  |- mesh__dateEstablished mesh__D009951 1991-01-01
% 211.94/212.09  |- mesh__recordMaintainer mesh__D009951 ssb
% 211.94/212.09  |- skos__altLabel mesh__D009951 Orpressin
% 211.94/212.09  |- mesh__historyNote mesh__D009951
% 211.94/212.09       91%28%79%29%; was see under VASOPRESSINS 1979-90   
% 211.94/212.09  |- skos__altLabel mesh__D009951 Vasopressin, Ornithine
% 211.94/212.09  |- mesh__recordOriginator mesh__D009951 SH
% 211.94/212.09  |- rdf__type mesh__D009951sskos__Concept
% 211.94/212.09  |- skos__altLabel mesh__D009951 Ornithine Vasopressin
% 211.94/212.09  |- mesh__recordAuthorizer mesh__D009951 sjn
% 211.94/212.09  |- skos__prefLabel mesh__D009951 Ornipressin
% 211.94/212.09  |- skos__broader mesh__D009951smesh__D014667
% 211.94/212.09  |- skos__historyNote mesh__D009951 Vasopressins %28%1966-1978%29%
% 211.94/212.09  |- mesh__dateRevised mesh__D009153 2003-07-09
% 211.94/212.09  |- rdf__type mesh__D009153sskos__Concept
% 211.94/212.09  |- mesh__recordAuthorizer mesh__D009153 sjn
% 211.94/212.09  |- skos__altLabel mesh__D009153 Genotoxins
% 211.94/212.09  |- skos__annotation mesh__D009153 consider also MUTATION   
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D009153 2004
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D009153 2006
% 211.94/212.09  |- skos__prefLabel mesh__D009153 Mutagens
% 211.94/212.09  |- mesh__historyNote mesh__D009153 66%28%65%29%   
% 211.94/212.09  |- skos__broader mesh__D009153smesh__D009676
% 211.94/212.09  |- skos__scopeNote mesh__D009153
% 211.94/212.09       Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes.%A%    
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D009153 2005
% 211.94/212.09  |- skos__related mesh__D009153smesh__D000477
% 211.94/212.09  |- skos__related mesh__D009153smesh__D016296
% 211.94/212.09  |- mesh__dateCreated mesh__D009153 1999-01-01
% 211.94/212.09  |- mesh__recordMaintainer mesh__D009153 ssb
% 211.94/212.09  |- mesh__dateEstablished mesh__D009153 1966-01-01
% 211.94/212.09  |- skos__related mesh__D009153smesh__D018736
% 211.94/212.09  |- mesh__recordOriginator mesh__D009153 NLM
% 211.94/212.09  |- mesh__publicMeSHNote mesh__D009153 66   
% 211.94/212.09  |- mesh__dateEstablished mesh__D001170 1965-01-01
% 211.94/212.09  |- mesh__recordAuthorizer mesh__D001170 sjn
% 211.94/212.09  |- mesh__publicMeSHNote mesh__D001170 65   
% 211.94/212.09  |- skos__hiddenLabel mesh__D001170 Arthritis, Suppurative
% 211.94/212.09  |- mesh__historyNote mesh__D001170 65   
% 211.94/212.09  |- skos__hiddenLabel mesh__D001170 Septic Arthritides
% 211.94/212.09  |- skos__hiddenLabel mesh__D001170 Arthritides, Viral
% 211.94/212.09  |- skos__hiddenLabel mesh__D001170 Septic Arthritis
% 211.94/212.09  |- mesh__recordOriginator mesh__D001170 NLM
% 211.94/212.09  |- skos__prefLabel mesh__D001170 Arthritis, Infectious
% 211.94/212.09  |- skos__hiddenLabel mesh__D001170 Arthritides, Septic
% 211.94/212.09  |- skos__hiddenLabel mesh__D001170 Suppurative Arthritides
% 211.94/212.09  |- skos__broader mesh__D001170smesh__D001168
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D001170 2006
% 211.94/212.09  |- mesh__recordMaintainer mesh__D001170 lkt
% 211.94/212.09  |- skos__hiddenLabel mesh__D001170 Viral Arthritides
% 211.94/212.09  |- rdf__type mesh__D001170sskos__Concept
% 211.94/212.09  |- skos__scopeNote mesh__D001170
% 211.94/212.09       Arthritis caused by BACTERIA; RICKETTSIA; MYCOPLASMA; VIRUSES; FUNGI; or PARASITES.%A%    
% 211.94/212.09  |- skos__altLabel mesh__D001170 Bacterial Arthritides
% 211.94/212.09  |- mesh__dateRevised mesh__D001170 2005-06-30
% 211.94/212.09  |- skos__annotation mesh__D001170
% 211.94/212.09       coordinate IM with specific infection %28%IM%29% + site %28%IM%29%   
% 211.94/212.09  |- skos__altLabel mesh__D001170 Arthritis, Septic
% 211.94/212.09  |- mesh__dateCreated mesh__D001170 1999-01-01
% 211.94/212.09  |- skos__altLabel mesh__D001170 Suppurative Arthritis
% 211.94/212.09  |- skos__altLabel mesh__D001170 Infectious Arthritis
% 211.94/212.09  |- skos__broader mesh__D001170smesh__D007239
% 211.94/212.09  |- skos__altLabel mesh__D001170 Arthritides, Bacterial
% 211.94/212.09  |- skos__hiddenLabel mesh__D001170 Arthritides, Infectious
% 211.94/212.09  |- skos__hiddenLabel mesh__D001170 Arthritides, Suppurative
% 211.94/212.09  |- skos__hiddenLabel mesh__D001170 Infectious Arthritides
% 211.94/212.09  |- skos__altLabel mesh__D001170 Bacterial Arthritis
% 211.94/212.09  |- skos__hiddenLabel mesh__D001170 Viral Arthritis
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D014896 2000
% 211.94/212.09  |- skos__hiddenLabel mesh__D014896 Weldings
% 211.94/212.09  |- mesh__dateCreated mesh__D014896 1999-01-01
% 211.94/212.09  |- skos__prefLabel mesh__D014896 Welding
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D014896 2004
% 211.94/212.09  |- mesh__activeMeSHYear mesh__D014896 2002
% 211.94/212.09  |- mesh__recordOriginator mesh__D014896 NLM
% 211.94/212.09  |- rdf__type mesh__D014896sskos__Concept
% 211.94/212.10  |- mesh__recordMaintainer mesh__D014896 JLS
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014896 2003
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014896 1999
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014896 2006
% 211.94/212.10  |- mesh__recordAuthorizer mesh__D014896 SJN
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014896 2001
% 211.94/212.10  |- skos__broader mesh__D014896smesh__D008669
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014896 1998
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014896 2005
% 211.94/212.10  |- mesh__dateRevised mesh__D014896 1997-06-20
% 211.94/212.10  |- mesh__dateCreated mesh__D014098 1999-01-01
% 211.94/212.10  |- skos__prefLabel mesh__D014098 Toothache
% 211.94/212.10  |- skos__scopeNote mesh__D014098
% 211.94/212.10       Pain in the adjacent areas of the teeth.     
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014098 2006
% 211.94/212.10  |- skos__hiddenLabel mesh__D014098 Odontalgias
% 211.94/212.10  |- skos__broader mesh__D014098smesh__D014076
% 211.94/212.10  |- mesh__dateRevised mesh__D014098 2005-06-30
% 211.94/212.10  |- mesh__recordMaintainer mesh__D014098 ags
% 211.94/212.10  |- skos__altLabel mesh__D014098 Odontalgia
% 211.94/212.10  |- mesh__recordAuthorizer mesh__D014098 sjn
% 211.94/212.10  |- rdf__type mesh__D014098sskos__Concept
% 211.94/212.10  |- mesh__recordOriginator mesh__D014098 NLM
% 211.94/212.10  |- skos__broader mesh__D014098smesh__D005157
% 211.94/212.10  |- skos__hiddenLabel mesh__D014098 Toothaches
% 211.94/212.10  |- skos__hiddenLabel mesh__D008859 Light Microscopy, Polarized
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D008859 2006
% 211.94/212.10  |- mesh__dateRevised mesh__D008859 2004-07-07
% 211.94/212.10  |- skos__hiddenLabel mesh__D008859 Polarized Light Microscopies
% 211.94/212.10  |- skos__hiddenLabel mesh__D008859 Light Microscopies, Polarized
% 211.94/212.10  |- skos__altLabel mesh__D008859 Microscopy, Polarized Light
% 211.94/212.10  |- mesh__recordOriginator mesh__D008859 NLM
% 211.94/212.10  |- mesh__recordAuthorizer mesh__D008859 sjn
% 211.94/212.10  |- mesh__publicMeSHNote mesh__D008859 67   
% 211.94/212.10  |- rdf__type mesh__D008859sskos__Concept
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D008859 2005
% 211.94/212.10  |- mesh__dateCreated mesh__D008859 1999-01-01
% 211.94/212.10  |- skos__broader mesh__D008859smesh__D008853
% 211.94/212.10  |- skos__annotation mesh__D008859 NIM   
% 211.94/212.10  |- skos__hiddenLabel mesh__D008859 Microscopies, Polarized Light
% 211.94/212.10  |- skos__scopeNote mesh__D008859
% 211.94/212.10       Microscopy using polarized light in which phenomena due to the preferential orientation of optical properties with respect to the vibration plane of the polarized light are made visible and correlated parameters are made measurable.%A%    
% 211.94/212.10  |- skos__hiddenLabel mesh__D008859 Microscopies, Polarization
% 211.94/212.10  |- skos__prefLabel mesh__D008859 Microscopy, Polarization
% 211.94/212.10  |- mesh__historyNote mesh__D008859 67%28%64%29%   
% 211.94/212.10  |- skos__hiddenLabel mesh__D008859 Polarized Light Microscopy
% 211.94/212.10  |- skos__hiddenLabel mesh__D008859 Polarization Microscopies
% 211.94/212.10  |- skos__altLabel mesh__D008859 Polarization Microscopy
% 211.94/212.10  |- mesh__recordMaintainer mesh__D008859 nns
% 211.94/212.10  |- mesh__dateEstablished mesh__D008859 1967-01-01
% 211.94/212.10  |- mesh__recordMaintainer mesh__D000876 TWD
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000876 2001
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000876 2003
% 211.94/212.10  |- mesh__dateEstablished mesh__D000876 1991-01-01
% 211.94/212.10  |- skos__historyNote mesh__D000876 Acrylamides %28%1973-1974%29%
% 211.94/212.10  |- skos__prefLabel mesh__D000876 Anthramycin
% 211.94/212.10  |- mesh__recordOriginator mesh__D000876 NLM
% 211.94/212.10  |- skos__historyNote mesh__D000876 Pyrroles %28%1972-1974%29%
% 211.94/212.10  |- mesh__historyNote mesh__D000876
% 211.94/212.10       91%28%75%29%; was see under BENZODIAZEPINONES 1975-90   
% 211.94/212.10  |- skos__historyNote mesh__D000876 Benzodiazepinones %28%1974%29%
% 211.94/212.10  |- mesh__recordAuthorizer mesh__D000876 sjn
% 211.94/212.10  |- mesh__dateRevised mesh__D000876 2000-06-21
% 211.94/212.10  |- skos__scopeNote mesh__D000876
% 211.94/212.10       A broad-spectrum spectrum antineoplastic antibiotic isolated from Streptomyces refuineus var. thermotolerans. It has low toxicity, some activity against Trichomonas and Endamoeba, and inhibits RNA and DNA synthesis. It binds irreversibly to DNA.%A%    
% 211.94/212.10  |- skos__broader mesh__D000876smesh__D001570
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000876 2002
% 211.94/212.10  |- rdf__type mesh__D000876sskos__Concept
% 211.94/212.10  |- mesh__publicMeSHNote mesh__D000876
% 211.94/212.10       91; was see under BENZODIAZEPINONES 1975-90   
% 211.94/212.10  |- skos__broader mesh__D000876smesh__D006575
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000876 2006
% 211.94/212.10  |- mesh__dateCreated mesh__D000876 1974-11-11
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000876 2004
% 211.94/212.10  |- skos__altLabel mesh__D000876 Antramycin
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000876 2005
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D019581 1998
% 211.94/212.10  |- skos__scopeNote mesh__D019581
% 211.94/212.10       A dense intricate feltwork of interwoven fine glial processes, fibrils, synaptic terminals, axons, and dendrites interspersed among the nerve cells in the gray matter of the central nervous system.%A%    
% 211.94/212.10  |- skos__broader mesh__D019581smesh__D009474
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D019581 2004
% 211.94/212.10  |- mesh__historyNote mesh__D019581 98   
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D019581 2002
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D019581 2003
% 211.94/212.10  |- mesh__dateEstablished mesh__D019581 1998-01-01
% 211.94/212.10  |- skos__hiddenLabel mesh__D019581 Neuropiles
% 211.94/212.10  |- mesh__dateCreated mesh__D019581 1997-06-20
% 211.94/212.10  |- skos__prefLabel mesh__D019581 Neuropil
% 211.94/212.10  |- skos__annotation mesh__D019581
% 211.94/212.10       a dense %22%felt%22% of interwoven neuronal components %26% neuroglia in the CNS; do not confuse with NEUROPIL THREADS, abnormal neuronal structures: read MeSH definitions; A 11 qualif%A%  
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D019581 2006
% 211.94/212.10  |- mesh__publicMeSHNote mesh__D019581 98   
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D019581 2001
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D019581 2005
% 211.94/212.10  |- skos__hiddenLabel mesh__D019581 Neuropils
% 211.94/212.10  |- rdf__type mesh__D019581sskos__Concept
% 211.94/212.10  |- skos__altLabel mesh__D019581 Neuropile
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D019581 2000
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D019581 1999
% 211.94/212.10  |- skos__broader mesh__D019581smesh__D009457
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D005561 2001
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D005561 1998
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D005561 2003
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D005561 1996
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D005561 2000
% 211.94/212.10  |- mesh__recordAuthorizer mesh__D005561 PLS
% 211.94/212.10  |- skos__broader mesh__D005561smesh__D005564
% 211.94/212.10  |- mesh__recordOriginator mesh__D005561 NLM
% 211.94/212.10  |- rdf__type mesh__D005561sskos__Concept
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D005561 1995
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D005561 2002
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D005561 1993
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D005561 1994
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D005561 2006
% 211.94/212.10  |- mesh__dateRevised mesh__D005561 1992-05-19
% 211.94/212.10  |- skos__prefLabel mesh__D005561 Formates
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D005561 1999
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D005561 2004
% 211.94/212.10  |- mesh__dateCreated mesh__D005561 1999-01-01
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D005561 1997
% 211.94/212.10  |- mesh__recordMaintainer mesh__D005561 TGC
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D005561 2005
% 211.94/212.10  |- mesh__dateRevised mesh__D018489 2002-07-02
% 211.94/212.10  |- skos__prefLabel mesh__D018489 Space Motion Sickness
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D018489 2006
% 211.94/212.10  |- mesh__dateEstablished mesh__D018489 1995-01-01
% 211.94/212.10  |- skos__hiddenLabel mesh__D018489 Adaptation Syndrome, Space
% 211.94/212.10  |- skos__hiddenLabel mesh__D018489 Motion Sickness, Space
% 211.94/212.10  |- skos__historyNote mesh__D018489 Space Flight %28%1979-1994%29%
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D018489 2003
% 211.94/212.10  |- mesh__publicMeSHNote mesh__D018489 95   
% 211.94/212.10  |- rdf__type mesh__D018489sskos__Concept
% 211.94/212.10  |- mesh__historyNote mesh__D018489 95   
% 211.94/212.10  |- mesh__dateCreated mesh__D018489 1994-06-07
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D018489 2004
% 211.94/212.10  |- skos__scopeNote mesh__D018489
% 211.94/212.10       Disorder characterized by nausea, vomiting, and dizziness, possibly in response to vestibular disorientation or fluid shifts associated with space flight. %28%From Webster%27%s New World Dictionary%29%%A%    
% 211.94/212.10  |- skos__altLabel mesh__D018489 Space Adaptation Syndrome
% 211.94/212.10  |- skos__hiddenLabel mesh__D018489 Syndrome, Space Adaptation
% 211.94/212.10  |- skos__broader mesh__D018489smesh__D009041
% 211.94/212.10  |- skos__historyNote mesh__D018489 Motion Sickness %28%1979-1994%29%
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D018489 2005
% 211.94/212.10  |- mesh__recordOriginator mesh__D004469 NLM
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D004469 2004
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D004469 2002
% 211.94/212.10  |- skos__hiddenLabel mesh__D004469 Economic, Hospital
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D004469 2006
% 211.94/212.10  |- skos__hiddenLabel mesh__D004469 Hospital Economic
% 211.94/212.10  |- skos__broader mesh__D004469smesh__D004467
% 211.94/212.10  |- skos__annotation mesh__D004469
% 211.94/212.10       GEN or unspecified only: prefer /econ with specific hosp subject: Manual 19.8.27; DF: ECON HOSP%A%  
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D004469 2003
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D004469 2001
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D004469 2005
% 211.94/212.10  |- mesh__recordAuthorizer mesh__D004469 sjn
% 211.94/212.10  |- skos__related mesh__D004469smesh__D005377
% 211.94/212.10  |- rdf__type mesh__D004469sskos__Concept
% 211.94/212.10  |- skos__scopeNote mesh__D004469
% 211.94/212.10       Economic aspects related to the management and operation of a hospital.%A%    
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D004469 2000
% 211.94/212.10  |- mesh__dateCreated mesh__D004469 1999-01-01
% 211.94/212.10  |- mesh__recordMaintainer mesh__D004469 kle
% 211.94/212.10  |- skos__related mesh__D004469smesh__D011682
% 211.94/212.10  |- skos__altLabel mesh__D004469 Hospital Economics
% 211.94/212.10  |- skos__prefLabel mesh__D004469 Economics, Hospital
% 211.94/212.10  |- mesh__dateRevised mesh__D004469 1999-11-03
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D009952 2006
% 211.94/212.10  |- mesh__dateCreated mesh__D009952 1999-01-01
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D009952 2005
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D009952 2004
% 211.94/212.10  |- skos__broader mesh__D009952smesh__D024361
% 211.94/212.10  |- skos__annotation mesh__D009952 /biosyn /physiol permitted   
% 211.94/212.10  |- skos__broader mesh__D009952smesh__D000599
% 211.94/212.10  |- mesh__recordOriginator mesh__D009952 NLM
% 211.94/212.10  |- rdf__type mesh__D009952sskos__Concept
% 211.94/212.10  |- skos__altLabel mesh__D009952 2,5-Diaminopentanoic Acid
% 211.94/212.10  |- mesh__dateRevised mesh__D009952 2003-07-09
% 211.94/212.10  |- mesh__recordMaintainer mesh__D009952 ssb
% 211.94/212.10  |- skos__scopeNote mesh__D009952
% 211.94/212.10       An amino acid produced in the urea cycle by the splitting off of urea from arginine.%A%    
% 211.94/212.10  |- skos__hiddenLabel mesh__D009952 2,5 Diaminopentanoic Acid
% 211.94/212.10  |- skos__prefLabel mesh__D009952 Ornithine
% 211.94/212.10  |- mesh__recordAuthorizer mesh__D009952 sjn
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D009154 2004
% 211.94/212.10  |- mesh__recordOriginator mesh__D009154 NLM
% 211.94/212.10  |- skos__scopeNote mesh__D009154
% 211.94/212.10       Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.%A%    
% 211.94/212.10  |- mesh__recordAuthorizer mesh__D009154 sjn
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D009154 2006
% 211.94/212.10  |- skos__broader mesh__D009154smesh__D014644
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D009154 2005
% 211.94/212.10  |- mesh__dateEstablished mesh__D009154 1964-01-01
% 211.94/212.10  |- skos__related mesh__D009154smesh__D013489
% 211.94/212.10  |- skos__related mesh__D009154smesh__D012150
% 211.94/212.10  |- skos__related mesh__D009154smesh__D004249
% 211.94/212.10  |- skos__hiddenLabel mesh__D009154 Mutations
% 211.94/212.10  |- mesh__dateCreated mesh__D009154 1999-01-01
% 211.94/212.10  |- mesh__recordMaintainer mesh__D009154 nns
% 211.94/212.10  |- skos__related mesh__D009154smesh__D016587
% 211.94/212.10  |- skos__prefLabel mesh__D009154 Mutation
% 211.94/212.10  |- mesh__publicMeSHNote mesh__D009154 64   
% 211.94/212.10  |- mesh__historyNote mesh__D009154 64   
% 211.94/212.10  |- skos__related mesh__D009154smesh__D009153
% 211.94/212.10  |- mesh__dateRevised mesh__D009154 2003-07-09
% 211.94/212.10  |- rdf__type mesh__D009154sskos__Concept
% 211.94/212.10  |- skos__related mesh__D009154smesh__D016296
% 211.94/212.10  |- skos__annotation mesh__D009154
% 211.94/212.10       drug-induced mutation = MUTATION %28%IM%29% + specific drug with pertinent qualif %28%IM%29%; radiation-induced mutation = MUTATION %28%IM%29% + RADIATION EFFECTS or specific rad term %28%IM%29%; /drug eff %26% /rad eff permitted only for eff of drugs or eff of rad on an already mutated organism or after mutation but read text carefully%A%  
% 211.94/212.10  |- skos__hiddenLabel mesh__D001171 Rheumatoid Arthritis, Juvenile
% 211.94/212.10  |- skos__hiddenLabel mesh__D001171 Arthritides, Juvenile Idiopathic
% 211.94/212.10  |- skos__hiddenLabel mesh__D001171 Juvenile Rheumatoid Arthritis
% 211.94/212.10  |- skos__altLabel mesh__D001171 Arthritis, Juvenile Chronic
% 211.94/212.10  |- skos__altLabel mesh__D001171 Arthritis, Juvenile Idiopathic
% 211.94/212.10  |- skos__scopeNote mesh__D001171
% 211.94/212.10       Rheumatoid arthritis of children occurring in three major subtypes defined by the symptoms present during the first six months following onset: systemic-onset %28%Still%27%s Disease, Juvenile-Onset%29%, polyarticular-onset, and pauciarticular-onset. Adult-onset cases of Still%27%s disease %28%STILL%27%S DISEASE, ADULT-ONSET%29% are also known. Only one subtype of juvenile rheumatoid arthritis %28%polyarticular-onset, rheumatoid factor-positive%29% clinically resembles adult rheumatoid arthritis and is considered its childhood equivalent.%A%    
% 211.94/212.10  |- skos__annotation mesh__D001171
% 211.94/212.10       juvenile arthritis unspecified probably goes here; do not confuse X ref STILL%27%S DISEASE, JUVENILE-ONSET with STILL%27%S DISEASE, ADULT-ONSET%A%  
% 211.94/212.10  |- skos__altLabel mesh__D001171 Still%27%s Disease, Juvenile-Onset
% 211.94/212.10  |- mesh__dateCreated mesh__D001171 1999-01-01
% 211.94/212.10  |- skos__broader mesh__D001171smesh__D001172
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D001171 2006
% 211.94/212.10  |- skos__hiddenLabel mesh__D001171 Idiopathic Arthritis, Juvenile
% 211.94/212.10  |- skos__hiddenLabel mesh__D001171 Idiopathic Arthritides, Juvenile
% 211.94/212.10  |- skos__altLabel mesh__D001171 Still Disease, Juvenile-Onset
% 211.94/212.10  |- mesh__recordAuthorizer mesh__D001171 sjn
% 211.94/212.10  |- rdf__type mesh__D001171sskos__Concept
% 211.94/212.10  |- skos__hiddenLabel mesh__D001171 Chronic Arthritis, Juvenile
% 211.94/212.10  |- skos__hiddenLabel mesh__D001171 Juvenile Onset Still Disease
% 211.94/212.10  |- skos__hiddenLabel mesh__D001171 Juvenile Chronic Arthritis
% 211.94/212.10  |- skos__prefLabel mesh__D001171 Arthritis, Juvenile Rheumatoid
% 211.94/212.10  |- mesh__recordOriginator mesh__D001171 NLM
% 211.94/212.10  |- skos__hiddenLabel mesh__D001171 Juvenile-Onset Still%27%s Disease
% 211.94/212.10  |- skos__hiddenLabel mesh__D001171 Still Disease, Juvenile Onset
% 211.94/212.10  |- skos__hiddenLabel mesh__D001171 Still%27%s Disease, Juvenile Onset
% 211.94/212.10  |- skos__altLabel mesh__D001171 Juvenile Idiopathic Arthritis
% 211.94/212.10  |- skos__hiddenLabel mesh__D001171 Juvenile Onset Stills Disease
% 211.94/212.10  |- skos__hiddenLabel mesh__D001171 Juvenile Idiopathic Arthritides
% 211.94/212.10  |- skos__altLabel mesh__D001171 Juvenile-Onset Stills Disease
% 211.94/212.10  |- skos__hiddenLabel mesh__D001171 Stills Disease, Juvenile-Onset
% 211.94/212.10  |- mesh__recordMaintainer mesh__D001171 lkt
% 211.94/212.10  |- mesh__dateRevised mesh__D001171 2005-06-30
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014897 2005
% 211.94/212.10  |- skos__hiddenLabel mesh__D014897 Kugelberg Welander Disease
% 211.94/212.10  |- skos__altLabel mesh__D014897 Spinal Muscular Atrophy, Type I
% 211.94/212.10  |- skos__altLabel mesh__D014897 Infantile Spinal Muscular Atrophy
% 211.94/212.10  |- mesh__historyNote mesh__D014897 2000%28%1988%29%   
% 211.94/212.10  |- skos__altLabel mesh__D014897 Spinal Muscular Atrophy Type I
% 211.94/212.10  |- skos__hiddenLabel mesh__D014897 Disease, Werdnig-Hoffmann
% 211.94/212.10  |- skos__broader mesh__D014897smesh__D020271
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014897 2004
% 211.94/212.10  |- skos__prefLabel mesh__D014897 Spinal Muscular Atrophies of Childhood
% 211.94/212.10  |- mesh__recordOriginator mesh__D014897 SCD
% 211.94/212.10  |- skos__historyNote mesh__D014897 Spinal Cord Diseases %28%1966-1987%29%
% 211.94/212.10  |- skos__altLabel mesh__D014897 Spinal Muscular Atrophy, Type II
% 211.94/212.10  |- rdf__type mesh__D014897sskos__Concept
% 211.94/212.10  |- skos__altLabel mesh__D014897 Spinal Muscular Atrophy Type III
% 211.94/212.10  |- skos__altLabel mesh__D014897 Werdnig-Hoffmann Disease
% 211.94/212.10  |- skos__hiddenLabel mesh__D014897 Werdnig Hoffmann Disease
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014897 2003
% 211.94/212.10  |- skos__annotation mesh__D014897
% 211.94/212.10       infantile, childhood or adolescent: for other, MUSCULAR ATROPHY, SPINAL is available%A%  
% 211.94/212.10  |- skos__altLabel mesh__D014897 Werdnig Hoffman Disease
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014897 2002
% 211.94/212.10  |- skos__altLabel mesh__D014897 Type I Spinal Muscular Atrophy
% 211.94/212.10  |- skos__hiddenLabel mesh__D014897 Hoffman Disease, Werdnig
% 211.94/212.10  |- mesh__dateCreated mesh__D014897 1987-04-28
% 211.94/212.10  |- skos__altLabel mesh__D014897 Type III Spinal Muscular Atrophy
% 211.94/212.10  |- skos__altLabel mesh__D014897 Muscular Atrophy, Spinal, Type III
% 211.94/212.10  |- skos__altLabel mesh__D014897 Spinal Muscular Atrophy, Type III
% 211.94/212.10  |- skos__altLabel mesh__D014897 Spinal Muscular Atrophy, Infantile
% 211.94/212.10  |- mesh__dateRevised mesh__D014897 2001-07-25
% 211.94/212.10  |- skos__altLabel mesh__D014897 Kugelberg-Welander Disease
% 211.94/212.10  |- skos__altLabel mesh__D014897 Spinal Muscular Atrophy Type II
% 211.94/212.10  |- mesh__recordMaintainer mesh__D014897 nns
% 211.94/212.10  |- skos__scopeNote mesh__D014897
% 211.94/212.10       A group of recessively inherited diseases that feature progressive muscular atrophy and hypotonia. They are classified as type I %28%Werdnig-Hoffman disease%29%, type II %28%intermediate form%29%, and type III %28%Kugelberg-Welander disease%29%. Type I is fatal in infancy, type II has a late infantile onset and is associated with survival into the second or third decade. Type III has its onset in childhood, and is slowly progressive. %28%J Med Genet 1996 Apr:33%28%4%29%:281-3%29%%A%    
% 211.94/212.10  |- skos__altLabel mesh__D014897 Spinal Muscular Atrophy, Juvenile
% 211.94/212.10  |- skos__hiddenLabel mesh__D014897 Disease, Kugelberg-Welander
% 211.94/212.10  |- skos__hiddenLabel mesh__D014897 Disease, Werdnig Hoffman
% 211.94/212.10  |- skos__altLabel mesh__D014897 Muscular Atrophy, Spinal, Type I
% 211.94/212.10  |- skos__broader mesh__D014897smesh__D009134
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014897 2006
% 211.94/212.10  |- mesh__recordAuthorizer mesh__D014897 sjn
% 211.94/212.10  |- skos__historyNote mesh__D014897 Muscular Atrophy %28%1966-1987%29%
% 211.94/212.10  |- skos__hiddenLabel mesh__D014897 Diseases, Werdnig Hoffman
% 211.94/212.10  |- skos__altLabel mesh__D014897 Type II Spinal Muscular Atrophy
% 211.94/212.10  |- mesh__dateEstablished mesh__D014897 1991-01-01
% 211.94/212.10  |- skos__altLabel mesh__D014897 HMN Proximal Type I
% 211.94/212.10  |- skos__hiddenLabel mesh__D014897 Hoffman Diseases, Werdnig
% 211.94/212.10  |- mesh__publicMeSHNote mesh__D014897
% 211.94/212.10       2000; see WERDNIG-HOFFMAN DISEASE 1991-1999, see MUSCULAR ATROPHY, SPINAL 1988-90%A%  
% 211.94/212.10  |- skos__hiddenLabel mesh__D014897 Werdnig Hoffman Diseases
% 211.94/212.10  |- skos__altLabel mesh__D014897 Proximal Hereditary Motor Neuropathy Type I
% 211.94/212.10  |- skos__altLabel mesh__D014897 Muscular Atrophy, Spinal, Infantile
% 211.94/212.10  |- skos__scopeNote mesh__D014099
% 211.94/212.10       The act of cleaning teeth with a brush to remove plaque and prevent tooth decay. %28%From Webster, 3d ed%29%%A%    
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014099 2003
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014099 2001
% 211.94/212.10  |- mesh__dateEstablished mesh__D014099 1970-01-01
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014099 1999
% 211.94/212.10  |- skos__broader mesh__D014099smesh__D009910
% 211.94/212.10  |- mesh__recordOriginator mesh__D014099 NLM
% 211.94/212.10  |- mesh__dateRevised mesh__D014099 1995-05-18
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014099 2004
% 211.94/212.10  |- mesh__historyNote mesh__D014099 70; was TOOTHBRUSHES 1963-69   
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014099 1996
% 211.94/212.10  |- skos__prefLabel mesh__D014099 Toothbrushing
% 211.94/212.10  |- skos__hiddenLabel mesh__D014099 Toothbrushings
% 211.94/212.10  |- rdf__type mesh__D014099sskos__Concept
% 211.94/212.10  |- mesh__recordAuthorizer mesh__D014099 PLS
% 211.94/212.10  |- mesh__publicMeSHNote mesh__D014099 70; was TOOTHBRUSHES 1963-69   
% 211.94/212.10  |- mesh__onlineNote mesh__D014099
% 211.94/212.10       use TOOTHBRUSHING to search TOOTHBRUSHES 1966-69   
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014099 2002
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014099 1997
% 211.94/212.10  |- skos__annotation mesh__D014099
% 211.94/212.10       restrict to brushing with a toothbrush: see note at DENTAL DEVICES, HOME CARE%A%  
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014099 2005
% 211.94/212.10  |- mesh__dateCreated mesh__D014099 1999-01-01
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014099 2006
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014099 1998
% 211.94/212.10  |- mesh__recordMaintainer mesh__D014099 KEV
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D014099 2000
% 211.94/212.10  |- skos__hiddenLabel mesh__D000877 Phosphoribosyltransferase, Anthranilate
% 211.94/212.10  |- mesh__publicMeSHNote mesh__D000877
% 211.94/212.10       91; was see under PENTOSYLTRANSFERASES 1975-90   
% 211.94/212.10  |- skos__historyNote mesh__D000877 Pyrophosphoric Acids %28%1972-1974%29%
% 211.94/212.10  |- skos__historyNote mesh__D000877 Pentosephosphates %28%1972-1974%29%
% 211.94/212.10  |- skos__altLabel mesh__D000877
% 211.94/212.10       Phosphoribosylanthranilate Pyrophosphorylase
% 211.94/212.10  |- mesh__recordMaintainer mesh__D000877 ssb
% 211.94/212.10  |- rdf__type mesh__D000877sskos__Concept
% 211.94/212.10  |- skos__hiddenLabel mesh__D000877 PR Transferase, Anthranilate
% 211.94/212.10  |- mesh__historyNote mesh__D000877
% 211.94/212.10       91%28%75%29%; was see under PENTOSYLTRANSFERASES 1975-90   
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000877 2006
% 211.94/212.10  |- skos__broader mesh__D000877smesh__D009097
% 211.94/212.10  |- skos__scopeNote mesh__D000877
% 211.94/212.10       An enzyme that catalyzes the formation of N-5%27%-phosphoribosylanthranilic acid from anthranilate and phosphoribosylpyrophosphate, the first step in tryptophan synthesis in E. coli. It exists in a complex with ANTHRANILATE SYNTHASE in bacteria. EC 2.4.2.18.%A%    
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000877 2004
% 211.94/212.10  |- skos__historyNote mesh__D000877 Anthranilic Acids %28%1972-1974%29%
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000877 2005
% 211.94/212.10  |- skos__broader mesh__D000877smesh__D010430
% 211.94/212.10  |- mesh__dateCreated mesh__D000877 1974-11-19
% 211.94/212.10  |- mesh__recordOriginator mesh__D000877 NLM
% 211.94/212.10  |- skos__prefLabel mesh__D000877 Anthranilate Phosphoribosyltransferase
% 211.94/212.10  |- skos__hiddenLabel mesh__D000877
% 211.94/212.10       Pyrophosphorylase, Phosphoribosylanthranilate
% 211.94/212.10  |- mesh__dateRevised mesh__D000877 2003-07-09
% 211.94/212.10  |- skos__altLabel mesh__D000877 Anthranilate PR Transferase
% 211.94/212.10  |- mesh__recordAuthorizer mesh__D000877 sjn
% 211.94/212.10  |- skos__historyNote mesh__D000877 Pentosyltransferases %28%1972-1974%29%
% 211.94/212.10  |- mesh__dateEstablished mesh__D000877 1991-01-01
% 211.94/212.10  |- skos__altLabel mesh__D019582 Amyloid Plaques
% 211.94/212.10  |- skos__hiddenLabel mesh__D019582 Neuritic Plaque
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D019582 2001
% 211.94/212.10  |- skos__hiddenLabel mesh__D019582 Plaque, Amyloid
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D019582 2004
% 211.94/212.10  |- skos__altLabel mesh__D019582 Neuritic Plaques
% 211.94/212.10  |- mesh__historyNote mesh__D019582 98   
% 211.94/212.10  |- skos__hiddenLabel mesh__D019582 Plaques, Neuritic
% 211.94/212.10  |- mesh__recordOriginator mesh__D019582 AGS
% 211.94/212.10  |- mesh__recordMaintainer mesh__D019582 KEV
% 211.94/212.10  |- mesh__dateRevised mesh__D019582 1999-11-03
% 211.94/212.10  |- skos__scopeNote mesh__D019582
% 211.94/212.10       Spherical masses consisting of amyloid fibrils and neuronal processes.%A%    
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D019582 2002
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D019582 2005
% 211.94/212.10  |- skos__related mesh__D019582smesh__D016229
% 211.94/212.10  |- mesh__dateCreated mesh__D019582 1997-06-20
% 211.94/212.10  |- skos__hiddenLabel mesh__D019582 Plaque, Senile
% 211.94/212.10  |- mesh__dateEstablished mesh__D019582 1998-01-01
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D019582 2006
% 211.94/212.10  |- skos__annotation mesh__D019582
% 211.94/212.10       note category; in neurons; not restricted to Alzheimer dis%A%  
% 211.94/212.10  |- skos__broader mesh__D019582smesh__D009474
% 211.94/212.10  |- rdf__type mesh__D019582sskos__Concept
% 211.94/212.10  |- skos__hiddenLabel mesh__D019582 Senile Plaque
% 211.94/212.10  |- skos__hiddenLabel mesh__D019582 Plaque, Neuritic
% 211.94/212.10  |- skos__hiddenLabel mesh__D019582 Plaques, Senile
% 211.94/212.10  |- skos__hiddenLabel mesh__D019582 Amyloid Plaque
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D019582 2000
% 211.94/212.10  |- mesh__recordAuthorizer mesh__D019582 sjn
% 211.94/212.10  |- skos__prefLabel mesh__D019582 Senile Plaques
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D019582 2003
% 211.94/212.10  |- skos__hiddenLabel mesh__D019582 Plaques, Amyloid
% 211.94/212.10  |- mesh__publicMeSHNote mesh__D019582 98   
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000079 1993
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000079 1995
% 211.94/212.10  |- mesh__dateRevised mesh__D000079 1992-05-07
% 211.94/212.10  |- skos__broader mesh__D000079smesh__D000447
% 211.94/212.10  |- mesh__recordMaintainer mesh__D000079 TAP
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000079 2003
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000079 2000
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000079 2005
% 211.94/212.10  |- skos__scopeNote mesh__D000079
% 211.94/212.10       A colorless, flammable liquid used in the manufacture of acetic acid, perfumes, and flavors. It is also an intermediate in the metabolism of alcohol. It has a general narcotic action and also causes irritation of mucous membranes. Large doses may cause death from respiratory paralysis.%A%    
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000079 2004
% 211.94/212.10  |- mesh__dateCreated mesh__D000079 1999-01-01
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000079 2001
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000079 2006
% 211.94/212.10  |- skos__prefLabel mesh__D000079 Acetaldehyde
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000079 1996
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000079 1998
% 211.94/212.10  |- mesh__recordOriginator mesh__D000079 NLM
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000079 1997
% 211.94/212.10  |- rdf__type mesh__D000079sskos__Concept
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000079 2002
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000079 1999
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D000079 1994
% 211.94/212.10  |- mesh__recordAuthorizer mesh__D000079 PLS
% 211.94/212.10  |- skos__altLabel mesh__D000079 Ethanal
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D005562 2001
% 211.94/212.10  |- mesh__dateCreated mesh__D005562 1974-11-19
% 211.94/212.10  |- mesh__historyNote mesh__D005562
% 211.94/212.10       91%28%75%29%; was see under AZO COMPOUNDS 1975-90   
% 211.94/212.10  |- skos__prefLabel mesh__D005562 Formazans
% 211.94/212.10  |- rdf__type mesh__D005562sskos__Concept
% 211.94/212.10  |- mesh__dateRevised mesh__D005562 2000-06-22
% 211.94/212.10  |- skos__historyNote mesh__D005562 Formic Acids %28%1972-1974%29%
% 211.94/212.10  |- skos__broader mesh__D005562smesh__D001391
% 211.94/212.10  |- mesh__activeMeSHYear mesh__D005562 2006
% 211.94/212.11  |- mesh__recordOriginator mesh__D005562 NLM
% 211.94/212.11  |- mesh__activeMeSHYear mesh__D005562 2005
% 211.94/212.11  |- skos__scopeNote mesh__D005562
% 211.94/212.11       Colored azo compounds formed by the reduction of tetrazolium salts. Employing this reaction, oxidoreductase activity can be determined quantitatively in tissue sections by allowing the enzymes to act on their specific substrates in the presence of tetrazolium salts.%A%    
% 211.94/212.11  |- mesh__activeMeSHYear mesh__D005562 2004
% 211.94/212.11  |- mesh__dateEstablished mesh__D005562 1991-01-01
% 211.94/212.11  |- mesh__activeMeSHYear mesh__D005562 2002
% 211.94/212.11  |- mesh__publicMeSHNote mesh__D005562
% 211.94/212.11       91; was see under AZO COMPOUNDS 1975-90   
% 211.94/212.11  |- skos__historyNote mesh__D005562 Azo Compounds %28%1972-1974%29%
% 211.94/212.11  |- mesh__recordMaintainer mesh__D005562 CCR
% 211.94/212.11  |- mesh__activeMeSHYear mesh__D005562 2003
% 211.94/212.11  |- mesh__recordAuthorizer mesh__D005562 sjn
% 211.94/212.11  |- skos__annotation mesh__D005562 D25-26 qualif   
% 211.94/212.11  |- mesh__publicMeSHNote mesh__D015990 90   
% 211.94/212.11  |- mesh__historyNote mesh__D015990 90   
% 211.94/212.11  |- mesh__activeMeSHYear mesh__D015990 2001
% 211.94/212.11  |- mesh__activeMeSHYear mesh__D015990 1995
% 211.94/212.11  |- skos__hiddenLabel mesh__D015990 Effects, Placebo
% 211.94/212.11  |- mesh__activeMeSHYear mesh__D015990 2003
% 211.94/212.11  |- skos__scopeNote mesh__D015990
% 211.94/212.11       An effect usually, but not necessarily, beneficial that is attributable to an expectation that the regimen will have an effect, i.e., the effect is due to the power of suggestion.%A%    
% 211.94/212.11  |- rdf__type mesh__D015990sskos__Concept
% 211.94/212.11  |- mesh__activeMeSHYear mesh__D015990 2005
% 211.94/212.11  |- mesh__dateRevised mesh__D015990 1994-04-11
% 211.94/212.11  |- skos__prefLabel mesh__D015990 Placebo Effect
% 211.94/212.11  |- mesh__activeMeSHYear mesh__D015990 2004
% 211.94/212.11  |- skos__hiddenLabel mesh__D015990 Effect, Placebo
% 211.94/212.11  |- mesh__activeMeSHYear mesh__D015990 2002
% 211.94/212.11  |- mesh__activeMeSHYear mesh__D015990 2006
% 211.94/212.11  |- mesh__recordAuthorizer mesh__D015990 PLS
% 211.94/212.11  |- mesh__activeMeSHYear mesh__D015990 1996
% 211.94/212.11  |- mesh__recordMaintainer mesh__D015990 TGC
% 211.94/212.11  |- skos__broader mesh__D015990smesh__D015987
% 211.94/212.11  |- skos__historyNote mesh__D015990 Placebos %28%1966-1989%29%
% 211.94/212.11  |- mesh__dateCreated mesh__D015990 1989-05-25
% 211.94/212.11  |- mesh__activeMeSHYear mesh__D015990 1998
% 211.94/212.11  |- mesh__dateEstablished mesh__D015990 1990-01-01
% 211.94/212.11  |- skos__annotation mesh__D015990
% 211.94/212.11       %22%placebo%22% is not restricted to drugs; IM GEN only; coord NIM with disease %28%IM%29%; no qualif; DF: PLACEBO EFF%A%  
% 211.94/212.11  |- mesh__activeMeSHYear mesh__D015990 1997
% 211.94/212.11  |- mesh__recordOriginator mesh__D015990 PLS
% 211.94/212.11  |- skos__hiddenLabel mesh__D015990 Placebo Effects
% 211.94/212.11  |- mesh__activeMeSHYear mesh__D015990 2000
% 211.94/212.11  |- mesh__activeMeSHYear mesh__D015990 1999
% 211.94/212.11  |- skos__hiddenLabel mesh__D015192 Posterior Fossa Tumor
% 211.94/212.11  |- skos__hiddenLabel mesh__D015192 Infratentorial Neoplasm, Benign
% 211.94/212.11  |- skos__hiddenLabel mesh__D015192 Cancer, Infratentorial
% 211.94/212.11  |- mesh__activeMeSHYear mesh__D015192 2001
% 211.94/212.11  |- skos__altLabel mesh__D015192 Infratentorial Neoplasms, Malignant
% 211.94/212.11  |- skos__hiddenLabel mesh__D015192 Posterior Fossa Neoplasm
% 211.96/212.11  |- skos__altLabel mesh__D015192 Neoplasms, Infratentorial
% 211.96/212.11  |- skos__hiddenLabel mesh__D015192 Neoplasms, Benign Infratentorial
% 211.96/212.11  |- mesh__historyNote mesh__D015192 1989   
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D015192 2000
% 211.96/212.11  |- mesh__recordMaintainer mesh__D015192 ags
% 211.96/212.11  |- skos__altLabel mesh__D015192 Infratentorial Neoplasms, Benign
% 211.96/212.11  |- skos__hiddenLabel mesh__D015192 Cancers, Infratentorial
% 211.96/212.11  |- skos__hiddenLabel mesh__D015192 Neoplasm, Infratentorial
% 211.96/212.11  |- skos__prefLabel mesh__D015192 Infratentorial Neoplasms
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D015192 2006
% 211.96/212.11  |- skos__altLabel mesh__D015192 Posterior Fossa Neoplasms
% 211.96/212.11  |- skos__altLabel mesh__D015192 Neoplasms, Posterior Fossa
% 211.96/212.11  |- mesh__recordOriginator mesh__D015192 EJB
% 211.96/212.11  |- skos__hiddenLabel mesh__D015192 Infratentorial Neoplasm, Malignant
% 211.96/212.11  |- skos__hiddenLabel mesh__D015192 Neoplasms, Malignant Infratentorial
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D015192 2000A
% 211.96/212.11  |- skos__annotation mesh__D015192
% 211.96/212.11       coord IM with histol type of neopl %28%IM%29%   
% 211.96/212.11  |- skos__altLabel mesh__D015192 Posterior Fossa Tumors
% 211.96/212.11  |- skos__altLabel mesh__D015192 Infratentorial Tumors
% 211.96/212.11  |- skos__hiddenLabel mesh__D015192 Neoplasm, Posterior Fossa
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D015192 2005
% 211.96/212.11  |- skos__historyNote mesh__D015192 Cerebellar Neoplasms %28%1971-1988%29%
% 211.96/212.11  |- skos__altLabel mesh__D015192 Malignant Infratentorial Neoplasms
% 211.96/212.11  |- skos__hiddenLabel mesh__D015192 Neoplasm, Malignant Infratentorial
% 211.96/212.11  |- mesh__recordAuthorizer mesh__D015192 ags
% 211.96/212.11  |- skos__hiddenLabel mesh__D015192 Tumor, Posterior Fossa
% 211.96/212.11  |- rdf__type mesh__D015192sskos__Concept
% 211.96/212.11  |- mesh__dateCreated mesh__D015192 1988-04-21
% 211.96/212.11  |- mesh__dateRevised mesh__D015192 1999-12-08
% 211.96/212.11  |- mesh__dateEstablished mesh__D015192 1989-01-01
% 211.96/212.11  |- mesh__publicMeSHNote mesh__D015192 1989   
% 211.96/212.11  |- skos__hiddenLabel mesh__D015192 Neoplasm, Benign Infratentorial
% 211.96/212.11  |- skos__hiddenLabel mesh__D015192 Infratentorial Tumor
% 211.96/212.11  |- skos__hiddenLabel mesh__D015192 Infratentorial Neoplasm
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D015192 2004
% 211.96/212.11  |- skos__hiddenLabel mesh__D015192 Malignant Infratentorial Neoplasm
% 211.96/212.11  |- skos__broader mesh__D015192smesh__D001932
% 211.96/212.11  |- skos__hiddenLabel mesh__D015192 Tumor, Infratentorial
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D015192 2002
% 211.96/212.11  |- skos__hiddenLabel mesh__D015192 Infratentorial Cancers
% 211.96/212.11  |- skos__hiddenLabel mesh__D015192 Benign Infratentorial Neoplasm
% 211.96/212.11  |- skos__scopeNote mesh__D015192
% 211.96/212.11       Intracranial tumors originating in the region of the brain inferior to the tentorium cerebelli, which contains the cerebellum, fourth ventricle, cerebellopontine angle, brain stem, and related structures. Primary tumors of this region are more frequent in children, and may present with ATAXIA; CRANIAL NERVE DISEASES; vomiting; HEADACHE; HYDROCEPHALUS; or other signs of neurologic dysfunction. Relatively frequent histologic subtypes include TERATOMA; MEDULLOBLASTOMA; GLIOBLASTOMA; ASTROCYTOMA; EPENDYMOMA; CRANIOPHARYNGIOMA; and choroid plexus papilloma %28%PAPILLOMA, CHOROID PLEXUS%29%.%A%    
% 211.96/212.11  |- skos__hiddenLabel mesh__D015192 Tumors, Posterior Fossa
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D015192 2003
% 211.96/212.11  |- skos__hiddenLabel mesh__D015192 Tumors, Infratentorial
% 211.96/212.11  |- skos__historyNote mesh__D015192 Brain Neoplasms %28%1966-1988%29%
% 211.96/212.11  |- skos__hiddenLabel mesh__D009953 Ornithine Oxo Acid Transaminase
% 211.96/212.11  |- skos__scopeNote mesh__D009953
% 211.96/212.11       A pyridoxal phosphate enzyme that catalyzes the formation of glutamate gamma-semialdehyde and an L-amino acid from L-ornithine and a 2-keto-acid. EC 2.6.1.13.%A%    
% 211.96/212.11  |- skos__hiddenLabel mesh__D009953
% 211.96/212.11       Aminotransferase, Ornithine-2-Ketoglutarate
% 211.96/212.11  |- skos__altLabel mesh__D009953 Pyrroline-5-Carboxylate Synthase
% 211.96/212.11  |- skos__altLabel mesh__D009953 Ornithine-2-Ketoglutarate Aminotransferase
% 211.96/212.11  |- skos__hiddenLabel mesh__D009953 Pyrroline 5 Carboxylate Synthase
% 211.96/212.11  |- mesh__dateRevised mesh__D009953 2003-07-09
% 211.96/212.11  |- skos__hiddenLabel mesh__D009953 Transaminase, Ornithine-Oxo-Acid
% 211.96/212.11  |- skos__altLabel mesh__D009953 L-Ornithine-2-Oxoglutarate Aminotransferase
% 211.96/212.11  |- skos__hiddenLabel mesh__D009953 Aminotransferase, Ornithine Ketoacid
% 211.96/212.11  |- mesh__recordAuthorizer mesh__D009953 sjn
% 211.96/212.11  |- skos__historyNote mesh__D009953 Aminotransferases %28%1969-1974%29%
% 211.96/212.11  |- skos__hiddenLabel mesh__D009953 Aminotransferase, Ornithine
% 211.96/212.11  |- mesh__publicMeSHNote mesh__D009953
% 211.96/212.11       98; see ORNITHINE AMINOTRANSFERASE 1991-97; see AMINOTRANSFERASES 1975-90%A%  
% 211.96/212.11  |- mesh__dateCreated mesh__D009953 1974-11-19
% 211.96/212.11  |- skos__hiddenLabel mesh__D009953 Ornithine Keto Acid Transaminase
% 211.96/212.11  |- skos__altLabel mesh__D009953 L-Ornithine-2-Oxo-Acid Aminotransferase
% 211.96/212.11  |- skos__hiddenLabel mesh__D009953
% 211.96/212.11       L Ornithine 2 Oxoglutarate Aminotransferase
% 211.96/212.11  |- mesh__recordMaintainer mesh__D009953 ssb
% 211.96/212.11  |- skos__hiddenLabel mesh__D009953 Ketoacid Aminotransferase, Ornithine
% 211.96/212.11  |- rdf__type mesh__D009953sskos__Concept
% 211.96/212.11  |- mesh__historyNote mesh__D009953 98%28%75%29%   
% 211.96/212.11  |- skos__altLabel mesh__D009953 Ornithine-Ketoacid-Transaminase
% 211.96/212.11  |- skos__prefLabel mesh__D009953 Ornithine-Oxo-Acid Transaminase
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D009953 2004
% 211.96/212.11  |- mesh__recordOriginator mesh__D009953 NLM
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D009953 2005
% 211.96/212.11  |- skos__altLabel mesh__D009953 Ornithine Transaminase
% 211.96/212.11  |- skos__hiddenLabel mesh__D009953 L Ornithine 2 Oxo Acid Aminotransferase
% 211.96/212.11  |- skos__hiddenLabel mesh__D009953
% 211.96/212.11       Aminotransferase, L-Ornithine-2-Oxoglutarate
% 211.96/212.11  |- skos__altLabel mesh__D009953 Ornithine Ketoacid Aminotransferase
% 211.96/212.11  |- skos__broader mesh__D009953smesh__D000637
% 211.96/212.11  |- skos__altLabel mesh__D009953 Ornithine Aminotransferase
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D009953 2006
% 211.96/212.11  |- skos__altLabel mesh__D009953 Ornithine-Keto-Acid-Transaminase
% 211.96/212.11  |- mesh__dateEstablished mesh__D009953 1991-01-01
% 211.96/212.11  |- skos__historyNote mesh__D009953 Ornithine %28%1969-1974%29%
% 211.96/212.11  |- skos__hiddenLabel mesh__D009953 Synthase, Pyrroline-5-Carboxylate
% 211.96/212.11  |- skos__hiddenLabel mesh__D009953 Transaminase, Ornithine
% 211.96/212.11  |- skos__hiddenLabel mesh__D009953 Ornithine Ketoacid Transaminase
% 211.96/212.11  |- skos__hiddenLabel mesh__D009953
% 211.96/212.11       Ornithine 2 Ketoglutarate Aminotransferase
% 211.96/212.11  |- skos__hiddenLabel mesh__D009953 Aminotransferase, L-Ornithine-2-Oxo-Acid
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D001970 2000
% 211.96/212.11  |- rdf__type mesh__D001970sskos__Concept
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D001970 2006
% 211.96/212.11  |- skos__historyNote mesh__D001970 Benzoates %28%1966-1974%29%
% 211.96/212.11  |- mesh__recordAuthorizer mesh__D001970 SJN
% 211.96/212.11  |- mesh__dateRevised mesh__D001970 1998-06-10
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D001970 1999
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D001970 2005
% 211.96/212.11  |- mesh__recordOriginator mesh__D001970 NLM
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D001970 2004
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D001970 2002
% 211.96/212.11  |- skos__prefLabel mesh__D001970 Bromobenzoates
% 211.96/212.11  |- mesh__dateCreated mesh__D001970 1974-11-11
% 211.96/212.11  |- mesh__dateEstablished mesh__D001970 1975-09-01
% 211.96/212.11  |- skos__broader mesh__D001970smesh__D001565
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D001970 2003
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D001970 2001
% 211.96/212.11  |- mesh__historyNote mesh__D001970 75   
% 211.96/212.11  |- skos__scopeNote mesh__D001970
% 211.96/212.11       Benzoic acid or benzoic acid esters substituted with one or more bromine atoms.%A%    
% 211.96/212.11  |- mesh__recordMaintainer mesh__D001970 ADP
% 211.96/212.11  |- mesh__publicMeSHNote mesh__D001970 75   
% 211.96/212.11  |- skos__hiddenLabel mesh__D009155 Organic Mutisms
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D009155 2003
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D009155 2000A
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D009155 2002
% 211.96/212.11  |- skos__hiddenLabel mesh__D009155 Aphasia, Kussmaul%27%s
% 211.96/212.11  |- skos__hiddenLabel mesh__D009155 Conversion Mutisms
% 211.96/212.11  |- rdf__type mesh__D009155sskos__Concept
% 211.96/212.11  |- skos__hiddenLabel mesh__D009155 Mutisms
% 211.96/212.11  |- skos__hiddenLabel mesh__D009155 Elective Mutism
% 211.96/212.11  |- mesh__publicMeSHNote mesh__D009155
% 211.96/212.11       1969; see DEAF-MUTISM %26% SPEECH DISORDERS 1963-68   
% 211.96/212.11  |- mesh__recordAuthorizer mesh__D009155 ags
% 211.96/212.11  |- skos__hiddenLabel mesh__D009155 Elective Mutisms
% 211.96/212.11  |- skos__hiddenLabel mesh__D009155 Aphasia, Kussmaul
% 211.96/212.11  |- skos__altLabel mesh__D009155 Mutism, Selective
% 211.96/212.11  |- skos__hiddenLabel mesh__D009155 Mutisms, Organic
% 211.96/212.11  |- skos__hiddenLabel mesh__D009155 Voluntary Mutisms
% 211.96/212.11  |- skos__hiddenLabel mesh__D009155 Mutisms, Elective
% 211.96/212.11  |- mesh__dateEstablished mesh__D009155 1969-01-01
% 211.96/212.11  |- mesh__dateRevised mesh__D009155 1999-12-06
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D009155 2001
% 211.96/212.11  |- skos__hiddenLabel mesh__D009155 Kussmauls Aphasia
% 211.96/212.11  |- mesh__historyNote mesh__D009155 1969%28%1963%29%   
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D009155 2006
% 211.96/212.11  |- skos__altLabel mesh__D009155 Mutism, Elective
% 211.96/212.11  |- skos__altLabel mesh__D009155 Kussmaul%27%s Aphasia
% 211.96/212.11  |- skos__hiddenLabel mesh__D009155 Mutisms, Voluntary
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D009155 2000
% 211.96/212.11  |- skos__prefLabel mesh__D009155 Mutism
% 211.96/212.11  |- skos__broader mesh__D009155smesh__D019952
% 211.96/212.11  |- mesh__recordOriginator mesh__D009155 NLM
% 211.96/212.11  |- skos__hiddenLabel mesh__D009155 Organic Mutism
% 211.96/212.11  |- skos__scopeNote mesh__D009155
% 211.96/212.11       The inability to generate oral-verbal expression, despite normal comprehension of speech. This may be associated with BRAIN DISEASES or MENTAL DISORDERS. Organic mutism may be associated with damage to the FRONTAL LOBE; BRAIN STEM; THALAMUS; and CEREBELLUM. Selective mutism is a psychological condition that usually affects children characterized by continuous refusal to speak in social situations by a child who is able and willing to speak to selected persons. Kussmal aphasia refers to mutism in psychosis. %28%From Fortschr Neurol Psychiatr 1994; 62%28%9%29%:337-44%29%%A%    
% 211.96/212.11  |- skos__hiddenLabel mesh__D009155 Voluntary Mutism
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D009155 2005
% 211.96/212.11  |- mesh__dateCreated mesh__D009155 1999-01-01
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D009155 2004
% 211.96/212.11  |- skos__hiddenLabel mesh__D009155 Conversion Mutism
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D009155 2000B
% 211.96/212.11  |- skos__broader mesh__D009155smesh__D013064
% 211.96/212.11  |- skos__altLabel mesh__D009155 Mutism, Voluntary
% 211.96/212.11  |- skos__hiddenLabel mesh__D009155 Mutisms, Conversion
% 211.96/212.11  |- mesh__recordMaintainer mesh__D009155 ags
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D001172 2003
% 211.96/212.11  |- mesh__dateCreated mesh__D001172 1999-01-01
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D001172 2006
% 211.96/212.11  |- skos__prefLabel mesh__D001172 Arthritis, Rheumatoid
% 211.96/212.11  |- mesh__recordMaintainer mesh__D001172 jls
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D001172 2004
% 211.96/212.11  |- rdf__type mesh__D001172sskos__Concept
% 211.96/212.11  |- skos__broader mesh__D001172smesh__D012216
% 211.96/212.11  |- skos__annotation mesh__D001172
% 211.96/212.11       in children = ARTHRITIS, JUVENILE RHEUMATOID; includes PCE: polyarthrite chronique %C3%%A9%volutive; tends to be chronic so do not coord with CHRONIC DISEASE%A%  
% 211.96/212.11  |- skos__scopeNote mesh__D001172
% 211.96/212.11       A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.%A%    
% 211.96/212.11  |- mesh__dateRevised mesh__D001172 2001-08-13
% 211.96/212.11  |- mesh__recordAuthorizer mesh__D001172 sjn
% 211.96/212.11  |- skos__broader mesh__D001172smesh__D001327
% 211.96/212.11  |- skos__broader mesh__D001172smesh__D001168
% 211.96/212.11  |- skos__altLabel mesh__D001172 Rheumatoid Arthritis
% 211.96/212.11  |- mesh__recordOriginator mesh__D001172 NLM
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D001172 2002
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D001172 2005
% 211.96/212.11  |- skos__broader mesh__D014898smesh__D049914
% 211.96/212.11  |- skos__hiddenLabel mesh__D014898 Syndrome, Werner
% 211.96/212.11  |- skos__broader mesh__D014898smesh__D030342
% 211.96/212.11  |- skos__scopeNote mesh__D014898
% 211.96/212.11       An autosomal recessive disorder that causes premature aging in adults, characterized by sclerodermal skin changes, cataracts, subcutaneous calcification, muscular atrophy, a tendency to diabetes mellitus, aged appearance of the face, baldness, and a high incidence of neoplastic disease.%A%    
% 211.96/212.11  |- skos__prefLabel mesh__D014898 Werner Syndrome
% 211.96/212.11  |- mesh__recordMaintainer mesh__D014898 nns
% 211.96/212.11  |- skos__hiddenLabel mesh__D014898 Werners Syndrome
% 211.96/212.11  |- skos__hiddenLabel mesh__D014898 Adult Progeria
% 211.96/212.11  |- rdf__type mesh__D014898sskos__Concept
% 211.96/212.11  |- mesh__dateEstablished mesh__D014898 1967-01-01
% 211.96/212.11  |- mesh__recordAuthorizer mesh__D014898 sjn
% 211.96/212.11  |- mesh__dateRevised mesh__D014898 2005-06-30
% 211.96/212.11  |- mesh__recordOriginator mesh__D014898 NLM
% 211.96/212.11  |- mesh__dateCreated mesh__D014898 1999-01-01
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D014898 2006
% 211.96/212.11  |- mesh__publicMeSHNote mesh__D014898
% 211.96/212.11       98; was WERNER%27%S SYNDROME 1967-97   
% 211.96/212.11  |- skos__altLabel mesh__D014898 Werner%27%s Syndrome
% 211.96/212.11  |- mesh__historyNote mesh__D014898
% 211.96/212.11       98; was WERNER%27%S SYNDROME 1964-97 %28%Prov 1964-67%29%   
% 211.96/212.11  |- skos__altLabel mesh__D014898 Progeria, Adult
% 211.96/212.11  |- skos__hiddenLabel mesh__D014898 Syndrome, Werner%27%s
% 211.96/212.11  |- rdf__type mesh__D000878sskos__Concept
% 211.96/212.11  |- mesh__recordAuthorizer mesh__D000878 sjn
% 211.96/212.11  |- skos__hiddenLabel mesh__D000878 Synthase, Anthranilate
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D000878 2006
% 211.96/212.11  |- mesh__historyNote mesh__D000878 74   
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D000878 2005
% 211.96/212.11  |- skos__altLabel mesh__D000878 Anthranilate Synthetase
% 211.96/212.11  |- skos__prefLabel mesh__D000878 Anthranilate Synthase
% 211.96/212.11  |- skos__hiddenLabel mesh__D000878 Synthetase, Anthranilate
% 211.96/212.11  |- mesh__dateRevised mesh__D000878 2004-07-19
% 211.96/212.11  |- skos__scopeNote mesh__D000878
% 211.96/212.11       An enzyme that catalyzes the formation of anthranilate %28%o-aminobenzoate%29% and pyruvic acid from chorismate and glutamine. Anthranilate is the biosynthetic precursor of tryptophan and numerous secondary metabolites, including inducible plant defense compounds. EC 4.1.3.27.%A%    
% 211.96/212.11  |- skos__broader mesh__D000878smesh__D009097
% 211.96/212.11  |- mesh__publicMeSHNote mesh__D000878 74   
% 211.96/212.11  |- mesh__dateCreated mesh__D000878 1999-01-01
% 211.96/212.11  |- skos__broader mesh__D000878smesh__D007652
% 211.96/212.11  |- mesh__recordOriginator mesh__D000878 NLM
% 211.96/212.11  |- mesh__recordMaintainer mesh__D000878 jls
% 211.96/212.11  |- mesh__dateEstablished mesh__D000878 1974-01-01
% 211.96/212.11  |- mesh__recordAuthorizer mesh__D019583 sjn
% 211.96/212.11  |- mesh__dateRevised mesh__D019583 2005-06-30
% 211.96/212.11  |- skos__broader mesh__D019583smesh__D011879
% 211.96/212.11  |- skos__hiddenLabel mesh__D019583 Dose Fractionations
% 211.96/212.11  |- mesh__publicMeSHNote mesh__D019583 98   
% 211.96/212.11  |- skos__hiddenLabel mesh__D019583 Radiotherapy Dose Fractionations
% 211.96/212.11  |- skos__hiddenLabel mesh__D019583 Fractionation, Radiotherapy Dose
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D019583 2006
% 211.96/212.11  |- skos__hiddenLabel mesh__D019583 Fractionations, Dose
% 211.96/212.11  |- skos__hiddenLabel mesh__D019583 Dose Fractionation, Radiotherapy
% 211.96/212.11  |- mesh__recordOriginator mesh__D019583 AGS
% 211.96/212.11  |- skos__scopeNote mesh__D019583
% 211.96/212.11       Administration of the total dose of radiation %28%RADIATION DOSAGE%29% in parts, at timed intervals.%A%    
% 211.96/212.11  |- skos__hiddenLabel mesh__D019583 Fractionations, Radiotherapy Dose
% 211.96/212.11  |- skos__hiddenLabel mesh__D019583 Dose Fractionations, Radiotherapy
% 211.96/212.11  |- skos__altLabel mesh__D019583 Radiotherapy Dose Fractionation
% 211.96/212.11  |- mesh__recordMaintainer mesh__D019583 lkt
% 211.96/212.11  |- rdf__type mesh__D019583sskos__Concept
% 211.96/212.11  |- mesh__dateCreated mesh__D019583 1997-06-20
% 211.96/212.11  |- skos__hiddenLabel mesh__D019583 Fractionation, Dose
% 211.96/212.11  |- mesh__dateEstablished mesh__D019583 1998-01-01
% 211.96/212.11  |- skos__prefLabel mesh__D019583 Dose Fractionation
% 211.96/212.11  |- mesh__historyNote mesh__D019583 98   
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D005563 1994
% 211.96/212.11  |- mesh__recordOriginator mesh__D005563 NLM
% 211.96/212.11  |- mesh__dateEstablished mesh__D005563 1991-01-01
% 211.96/212.11  |- mesh__publicMeSHNote mesh__D005563
% 211.96/212.11       91; was see under FORMIC ACIDS 1975-90   
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D005563 1995
% 211.96/212.11  |- skos__hiddenLabel mesh__D005563 Acid Esters, Formic
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D005563 2005
% 211.96/212.11  |- rdf__type mesh__D005563sskos__Concept
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D005563 1998
% 211.96/212.11  |- mesh__dateCreated mesh__D005563 1999-01-01
% 211.96/212.11  |- skos__prefLabel mesh__D005563 Formic Acid Esters
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D005563 2000
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D005563 1993
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D005563 2003
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D005563 2006
% 211.96/212.11  |- mesh__recordAuthorizer mesh__D005563 PLS
% 211.96/212.11  |- mesh__dateRevised mesh__D005563 1992-05-19
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D005563 2001
% 211.96/212.11  |- mesh__recordMaintainer mesh__D005563 TGC
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D005563 1996
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D005563 1999
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D005563 2004
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D005563 2002
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D005563 1997
% 211.96/212.11  |- skos__broader mesh__D005563smesh__D005564
% 211.96/212.11  |- skos__hiddenLabel mesh__D005563 Esters, Formic Acid
% 211.96/212.11  |- mesh__onlineNote mesh__D005563 search FORMIC ACIDS 1968-74   
% 211.96/212.11  |- mesh__historyNote mesh__D005563
% 211.96/212.11       91%28%75%29%; was see under FORMIC ACIDS 1975-90   
% 211.96/212.11  |- mesh__historyNote mesh__D043682
% 211.96/212.11       2004; use RECEPTORS, PURINERGIC P1 1994-2003   
% 211.96/212.11  |- skos__scopeNote mesh__D043682
% 211.96/212.11       A subtype of ADENOSINE RECEPTOR that is found expressed in a variety of tissues including the BRAIN and DORSAL HORN NEURONS. The receptor is generally considered to be coupled to the GI, INHIBITORY G-PROTEIN which causes down regulation of CYCLIC AMP.%A%    
% 211.96/212.11  |- skos__hiddenLabel mesh__D043682 Receptors, Adenosine A1
% 211.96/212.11  |- mesh__dateCreated mesh__D043682 2003-07-09
% 211.96/212.11  |- mesh__publicMeSHNote mesh__D043682
% 211.96/212.11       2004; see RECEPTORS, PURINERGIC P1 1994-2003   
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D043682 2005
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D043682 2006
% 211.96/212.11  |- skos__broader mesh__D043682smesh__D018047
% 211.96/212.11  |- skos__altLabel mesh__D043682 Adenosine A1 Receptors
% 211.96/212.11  |- skos__historyNote mesh__D043682
% 211.96/212.11       Receptors, Purinergic P1 %28%1994-2003%29%
% 211.96/212.11  |- skos__hiddenLabel mesh__D043682 A1 Receptor, Adenosine
% 211.96/212.11  |- skos__hiddenLabel mesh__D043682 A1 Receptors, Adenosine
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D043682 2004
% 211.96/212.11  |- rdf__type mesh__D043682sskos__Concept
% 211.96/212.11  |- skos__prefLabel mesh__D043682 Receptor, Adenosine A1
% 211.96/212.11  |- skos__altLabel mesh__D043682 Adenosine A1 Receptor
% 211.96/212.11  |- mesh__dateEstablished mesh__D043682 2004-01-01
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D015991 2003
% 211.96/212.11  |- mesh__dateEstablished mesh__D015991 1998-01-01
% 211.96/212.11  |- rdf__type mesh__D015991sskos__Concept
% 211.96/212.11  |- skos__altLabel mesh__D015991 Measurements, Epidemiologic
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D015991 2005
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D015991 2000
% 211.96/212.11  |- skos__broader mesh__D015991smesh__D011634
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D015991 2004
% 211.96/212.11  |- mesh__publicMeSHNote mesh__D015991 98   
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D015991 2001
% 211.96/212.11  |- mesh__recordAuthorizer mesh__D015991 SJN
% 211.96/212.11  |- skos__annotation mesh__D015991
% 211.96/212.11       avoid: too general; prefer specifics; DF: EPIDEMIOL MEASUREMENTS%A%  
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D015991 2006
% 211.96/212.11  |- skos__hiddenLabel mesh__D015991 Measurement, Epidemiologic
% 211.96/212.11  |- mesh__recordMaintainer mesh__D015991 TGC
% 211.96/212.11  |- mesh__dateCreated mesh__D015991 1989-05-25
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D015991 1998
% 211.96/212.11  |- mesh__historyNote mesh__D015991 98; use explode 1990-97   
% 211.96/212.11  |- skos__prefLabel mesh__D015991 Epidemiologic Measurements
% 211.96/212.11  |- skos__hiddenLabel mesh__D015991 Epidemiologic Measurement
% 211.96/212.11  |- mesh__recordOriginator mesh__D015991 PLS
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D015991 2002
% 211.96/212.11  |- mesh__activeMeSHYear mesh__D015991 1999
% 211.96/212.11  |- mesh__dateRevised mesh__D015991 1997-06-20
% 211.96/212.11  |- skos__scopeNote mesh__D015991
% 211.96/212.11       Statistical calculations on the occurrence of disease or other health-related conditions in defined populations.%A%    
% 211.96/212.11  |- skos__hiddenLabel mesh__D051316 Wiskott Aldrich Syndrome Protein
% 211.96/212.11  |- rdf__type mesh__D051316sskos__Concept
% 211.96/212.11  |- mesh__dateCreated mesh__D051316 2005-06-30
% 211.96/212.11  |- skos__altLabel mesh__D051316 WASP Protein
% 211.96/212.11  |- mesh__historyNote mesh__D051316 2006%28%1994%29%   
% 211.96/212.11  |- mesh__recordMaintainer mesh__D051316 DRC
% 211.96/212.11  |- mesh__publicMeSHNote mesh__D051316
% 211.96/212.11       2006; WISKOTT-ALDRICH SYNDROME PROTEIN was indexed under PROTEINS 1994-2005%A%  
% 211.97/212.11  |- skos__scopeNote mesh__D051316
% 211.97/212.11       WASP protein is mutated in WISKOTT-ALDRICH SYNDROME and is expressed primarily in hematopoietic cells. It is the founding member of the WASP protein family and interacts with CDC42 PROTEIN to help regulate ACTIN polymerization.%A%    
% 211.97/212.11  |- mesh__recordAuthorizer mesh__D051316 sjn
% 211.97/212.11  |- skos__annotation mesh__D051316
% 211.97/212.11       WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY and WISKOTT-ALDRICH SYNDROME PROTEIN, NEURONAL are also available%A%  
% 211.97/212.11  |- mesh__dateEstablished mesh__D051316 2006-01-01
% 211.97/212.11  |- mesh__activeMeSHYear mesh__D051316 2006
% 211.97/212.11  |- skos__broader mesh__D051316smesh__D051300
% 211.97/212.11  |- mesh__recordOriginator mesh__D051316 DRC
% 211.97/212.11  |- skos__prefLabel mesh__D051316 Wiskott-Aldrich Syndrome Protein
% 211.97/212.11  |- skos__historyNote mesh__D015193 Pregnancy %28%1983-1988%29%
% 211.97/212.11  |- skos__historyNote mesh__D015193 Prenatal Diagnosis %28%1983-1988%29%
% 211.97/212.11  |- skos__altLabel mesh__D015193 Chorionic Villus Sampling
% 211.97/212.11  |- mesh__activeMeSHYear mesh__D015193 2001
% 211.97/212.11  |- skos__scopeNote mesh__D015193
% 211.97/212.11       A method for diagnosis of fetal diseases by sampling the cells of the placental chorionic villi for DNA analysis, presence of bacteria, concentration of metabolites, etc. The advantage over amniocentesis is that the procedure can be carried out in the first trimester.%A%    
% 211.97/212.11  |- skos__broader mesh__D015193smesh__D011677
% 211.97/212.11  |- skos__hiddenLabel mesh__D015193 Chorionic Villi Biopsy
% 211.97/212.11  |- mesh__dateRevised mesh__D015193 1997-06-20
% 211.97/212.11  |- mesh__activeMeSHYear mesh__D015193 2006
% 211.97/212.11  |- mesh__activeMeSHYear mesh__D015193 2000
% 211.97/212.11  |- skos__hiddenLabel mesh__D015193 Samplings, Chorionic Villi
% 211.97/212.11  |- mesh__recordMaintainer mesh__D015193 PXP
% 211.97/212.11  |- mesh__recordOriginator mesh__D015193 EJB
% 211.97/212.11  |- skos__altLabel mesh__D015193 Biopsy, Chorionic Villi
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D015193 2005
% 211.97/212.12  |- skos__prefLabel mesh__D015193 Chorionic Villi Sampling
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D015193 1999
% 211.97/212.12  |- skos__hiddenLabel mesh__D015193 Sampling, Chorionic Villus
% 211.97/212.12  |- rdf__type mesh__D015193sskos__Concept
% 211.97/212.12  |- mesh__dateEstablished mesh__D015193 1989-01-01
% 211.97/212.12  |- mesh__dateCreated mesh__D015193 1988-04-21
% 211.97/212.12  |- skos__broader mesh__D015193smesh__D011296
% 211.97/212.12  |- mesh__historyNote mesh__D015193 89   
% 211.97/212.12  |- skos__historyNote mesh__D015193 Chorionic Villi %28%1983-1988%29%
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D015193 2004
% 211.97/212.12  |- skos__hiddenLabel mesh__D015193 Sampling, Chorionic Villi
% 211.97/212.12  |- skos__hiddenLabel mesh__D015193 Biopsies, Chorionic Villi
% 211.97/212.12  |- skos__hiddenLabel mesh__D015193 Chorionic Villi Biopsies
% 211.97/212.12  |- skos__hiddenLabel mesh__D015193 Chorionic Villus Samplings
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D015193 1998
% 211.97/212.12  |- mesh__recordAuthorizer mesh__D015193 SJN
% 211.97/212.12  |- skos__hiddenLabel mesh__D015193 Chorionic Villi Samplings
% 211.97/212.12  |- skos__historyNote mesh__D015193 Biopsy %28%1983-1988%29%
% 211.97/212.12  |- skos__broader mesh__D015193smesh__D001706
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D015193 2002
% 211.97/212.12  |- skos__broader mesh__D015193smesh__D003581
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D015193 2003
% 211.97/212.12  |- skos__annotation mesh__D015193
% 211.97/212.12       do not use /util except by MeSH definition   
% 211.97/212.12  |- mesh__publicMeSHNote mesh__D015193 89   
% 211.97/212.12  |- skos__hiddenLabel mesh__D015193 Samplings, Chorionic Villus
% 211.97/212.12  |- mesh__dateRevised mesh__D009954 2005-07-18
% 211.97/212.12  |- skos__hiddenLabel mesh__D009954 Carbamoyltransferase, Ornithine
% 211.97/212.12  |- skos__related mesh__D009954smesh__D020163
% 211.97/212.12  |- skos__prefLabel mesh__D009954 Ornithine Carbamoyltransferase
% 211.97/212.12  |- mesh__dateEstablished mesh__D009954 1965-01-01
% 211.97/212.12  |- skos__broader mesh__D009954smesh__D019878
% 211.97/212.12  |- skos__scopeNote mesh__D009954
% 211.97/212.12       A urea cycle enzyme that catalyzes the formation of orthophosphate and L-citrulline %28%CITRULLINE%29% from CARBAMOYL PHOSPHATE and L-ornithine %28%ORNITHINE%29%. Deficiency of this enzyme may be transmitted as an X-linked trait. EC 2.1.3.3.%A%    
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D009954 2006
% 211.97/212.12  |- mesh__recordAuthorizer mesh__D009954 ags
% 211.97/212.12  |- skos__hiddenLabel mesh__D009954 Transcarbamylase, Ornithine
% 211.97/212.12  |- mesh__dateCreated mesh__D009954 1999-01-01
% 211.97/212.12  |- mesh__historyNote mesh__D009954 65%28%64%29%   
% 211.97/212.12  |- skos__altLabel mesh__D009954 Ornithine Carbamylphosphate Transferase
% 211.97/212.12  |- mesh__recordMaintainer mesh__D009954 ags
% 211.97/212.12  |- skos__annotation mesh__D009954
% 211.97/212.12       /defic: consider also ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY DISEASE%A%  
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D009954 2005
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D009954 2004
% 211.97/212.12  |- skos__hiddenLabel mesh__D009954 Transferase, Ornithine Carbamylphosphate
% 211.97/212.12  |- skos__altLabel mesh__D009954 Ornithine Transcarbamylase
% 211.97/212.12  |- skos__hiddenLabel mesh__D009954 Carbamylphosphate Transferase, Ornithine
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D009954 2006A
% 211.97/212.12  |- mesh__publicMeSHNote mesh__D009954 65   
% 211.97/212.12  |- rdf__type mesh__D009954sskos__Concept
% 211.97/212.12  |- mesh__recordOriginator mesh__D009954 NLM
% 211.97/212.12  |- mesh__publicMeSHNote mesh__D001971
% 211.97/212.12       81; was 2-BROMOERGOCRYPTINE 1978-80, was 2-BROMOERGOCRYPTINE see under ERGOTOXINE 1977, was 2-BROMOERGOCRYPTINE see under ERGOLINES 1975-76%A%  
% 211.97/212.12  |- skos__altLabel mesh__D001971 2-Bromoergocryptine Methanesulfonate
% 211.97/212.12  |- mesh__recordAuthorizer mesh__D001971 sjn
% 211.97/212.12  |- rdf__type mesh__D001971sskos__Concept
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D001971 2006
% 211.97/212.12  |- skos__historyNote mesh__D001971 Ergot Alkaloids %28%1966-1974%29%
% 211.97/212.12  |- skos__hiddenLabel mesh__D001971 2 Bromoergocryptine Mesylate
% 211.97/212.12  |- skos__hiddenLabel mesh__D001971 CB154
% 211.97/212.12  |- skos__hiddenLabel mesh__D001971 2 Bromoergokryptine
% 211.97/212.12  |- skos__broader mesh__D001971smesh__D004879
% 211.97/212.12  |- skos__hiddenLabel mesh__D001971 Mesylate, 2-Bromoergocryptine
% 211.97/212.12  |- skos__prefLabel mesh__D001971 Bromocriptine
% 211.97/212.12  |- skos__hiddenLabel mesh__D001971 2 Bromo alpha ergokryptine
% 211.97/212.12  |- skos__altLabel mesh__D001971 Bromocriptin
% 211.97/212.12  |- skos__hiddenLabel mesh__D001971 2 Bromo alpha ergocryptine
% 211.97/212.12  |- mesh__dateCreated mesh__D001971 1974-11-11
% 211.97/212.12  |- skos__altLabel mesh__D001971 2-Bromo-alpha-ergokryptine
% 211.97/212.12  |- skos__hiddenLabel mesh__D001971 Mesylate, Bromocriptine
% 211.97/212.12  |- mesh__historyNote mesh__D001971
% 211.97/212.12       81; was 2-BROMOERGOCRYPTINE 1978-80, was 2-BROMOERGOCRYPTINE see under ERGOTOXINE 1977, was 2-BROMOERGOCRYPTINE see under ERGOLINES 1975-76%A%  
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D001971 2003
% 211.97/212.12  |- mesh__recordMaintainer mesh__D001971 jmp
% 211.97/212.12  |- skos__hiddenLabel mesh__D001971 2 Bromoergocryptine Methanesulfonate
% 211.97/212.12  |- skos__broader mesh__D001971smesh__D004873
% 211.97/212.12  |- skos__altLabel mesh__D001971 2-Bromoergocryptine
% 211.97/212.12  |- mesh__onlineNote mesh__D001971
% 211.97/212.12       use BROMOCRIPTINE to search 2-BROMOERGOCRYPTINE 1975-80   
% 211.97/212.12  |- skos__scopeNote mesh__D001971
% 211.97/212.12       A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion.%A%    
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D001971 2004
% 211.97/212.12  |- skos__hiddenLabel mesh__D001971 CB 154
% 211.97/212.12  |- skos__altLabel mesh__D001971 Bromocriptine Mesylate
% 211.97/212.12  |- skos__hiddenLabel mesh__D001971 2 Bromoergocryptine
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D001971 2002
% 211.97/212.12  |- mesh__dateEstablished mesh__D001971 1978-01-01
% 211.97/212.12  |- skos__altLabel mesh__D001971 2-Bromoergokryptine
% 211.97/212.12  |- mesh__dateRevised mesh__D001971 2001-07-25
% 211.97/212.12  |- skos__altLabel mesh__D001971 Bromocryptin
% 211.97/212.12  |- mesh__recordOriginator mesh__D001971 NLM
% 211.97/212.12  |- skos__altLabel mesh__D001971 2-Bromo-alpha-ergocryptine
% 211.97/212.12  |- skos__hiddenLabel mesh__D001971 Methanesulfonate, 2-Bromoergocryptine
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D001971 2005
% 211.97/212.12  |- skos__broader mesh__D010595Q000193smesh__D010595
% 211.97/212.12  |- mesh__preferredCombination mesh__D010595Q000193smesh__D004512
% 211.97/212.12  |- rdf__type mesh__D010595Q000193smesh__CompoundConcept
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D009156 2006
% 211.97/212.12  |- mesh__historyNote mesh__D009156
% 211.97/212.12       91%28%80%29%; was see under PYRAZOLES 1980-90   
% 211.97/212.12  |- mesh__publicMeSHNote mesh__D009156
% 211.97/212.12       91; was see under PYRAZOLES 1980-90   
% 211.97/212.12  |- skos__historyNote mesh__D009156 Pyrazoles %28%1966-1979%29%
% 211.97/212.12  |- mesh__recordMaintainer mesh__D009156 ssb
% 211.97/212.12  |- skos__scopeNote mesh__D009156
% 211.97/212.12       A pyrazole diuretic with long duration and high capacity of action. It was proposed for kidney failure and hypertension but was withdrawn worldwide because of severe neurological effects.%A%    
% 211.97/212.12  |- skos__hiddenLabel mesh__D009156 2821, Bay G
% 211.97/212.12  |- mesh__dateEstablished mesh__D009156 1991-01-01
% 211.97/212.12  |- skos__hiddenLabel mesh__D009156 G 2821, Bay
% 211.97/212.12  |- rdf__type mesh__D009156sskos__Concept
% 211.97/212.12  |- mesh__recordOriginator mesh__D009156 SH
% 211.97/212.12  |- skos__broader mesh__D009156smesh__D011720
% 211.97/212.12  |- mesh__recordAuthorizer mesh__D009156 sjn
% 211.97/212.12  |- mesh__dateCreated mesh__D009156 1979-05-30
% 211.97/212.12  |- mesh__dateRevised mesh__D009156 2005-06-30
% 211.97/212.12  |- skos__prefLabel mesh__D009156 Muzolimine
% 211.97/212.12  |- mesh__recordAuthorizer mesh__D001173 sjn
% 211.97/212.12  |- mesh__recordOriginator mesh__D001173 NLM
% 211.97/212.12  |- skos__broader mesh__D001173smesh__D008835
% 211.97/212.12  |- skos__prefLabel mesh__D001173 Arthrobacter
% 211.97/212.12  |- skos__broader mesh__D001173smesh__D039903
% 211.97/212.12  |- skos__annotation mesh__D001173 in soil   
% 211.97/212.12  |- mesh__recordMaintainer mesh__D001173 SYSTEM
% 211.97/212.12  |- mesh__dateRevised mesh__D001173 2005-06-30
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D001173 2006
% 211.97/212.12  |- mesh__dateCreated mesh__D001173 1999-01-01
% 211.97/212.12  |- skos__scopeNote mesh__D001173
% 211.97/212.12       A genus of asporogenous bacteria isolated from soil that displays a distinctive rod-coccus growth cycle.%A%    
% 211.97/212.12  |- rdf__type mesh__D001173sskos__Concept
% 211.97/212.12  |- skos__broader mesh__D014899smesh__D013832
% 211.97/212.12  |- skos__hiddenLabel mesh__D014899 Cerebral Beriberi
% 211.97/212.12  |- skos__broader mesh__D014899smesh__D001928
% 211.97/212.12  |- rdf__type mesh__D014899sskos__Concept
% 211.97/212.12  |- skos__altLabel mesh__D014899
% 211.97/212.12       Wernicke%27%s Superior Hemorrhagic Polioencephalitis
% 211.97/212.12  |- skos__altLabel mesh__D014899 Wernicke Disease
% 211.97/212.12  |- mesh__dateEstablished mesh__D014899 1970-01-01
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D014899 2004
% 211.97/212.12  |- skos__scopeNote mesh__D014899
% 211.97/212.12       An acute neurological disorder characterized by the triad of ophthalmoplegia, ataxia, and disturbances of mental activity or consciousness. Eye movement abnormalities include nystagmus, external rectus palsies, and reduced conjugate gaze. THIAMINE DEFICIENCY and chronic ALCOHOLISM are associated conditions. Pathologic features include periventricular petechial hemorrhages and neuropil breakdown in the diencephalon and brainstem. Chronic thiamine deficiency may lead to KORSAKOFF SYNDROME. %28%Adams et al., Principles of Neurology, 6th ed, pp1139-42; Davis %26% Robertson, Textbook of Neuropathology, 2nd ed, pp452-3%29%%A%    
% 211.97/212.12  |- skos__altLabel mesh__D014899 Wernicke%27%s Encephalopathy
% 211.97/212.12  |- skos__altLabel mesh__D014899 Wernicke%27%s Disease
% 211.97/212.12  |- skos__altLabel mesh__D014899
% 211.97/212.12       Wernicke Superior Hemorrhagic Polioencephalitis
% 211.97/212.12  |- skos__altLabel mesh__D014899 Wernicke%27%s Syndrome
% 211.97/212.12  |- skos__altLabel mesh__D014899
% 211.97/212.12       Wernicke%27%s Polioencephalitis, Superior Hemorrhagic
% 211.97/212.12  |- skos__hiddenLabel mesh__D014899 Gayet Wernicke Encephalopathy
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D014899 2006A
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D014899 2005
% 211.97/212.12  |- mesh__dateCreated mesh__D014899 1999-01-01
% 211.97/212.12  |- mesh__dateRevised mesh__D014899 2005-07-18
% 211.97/212.12  |- skos__hiddenLabel mesh__D014899 Encephalopathies, Wernicke
% 211.97/212.12  |- skos__hiddenLabel mesh__D014899 Wernicke Encephalopathies
% 211.97/212.12  |- skos__altLabel mesh__D014899 Wernicke Syndrome
% 211.97/212.12  |- skos__altLabel mesh__D014899 Beriberi, Cerebral
% 211.97/212.12  |- skos__broader mesh__D014899smesh__D019973
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D014899 2006
% 211.97/212.12  |- skos__altLabel mesh__D014899 Encephalopathy, Wernicke
% 211.97/212.12  |- mesh__publicMeSHNote mesh__D014899
% 211.97/212.12       2000; see WERNICKE%27%S ENCEPHALOPATHY 1970-1999, see VITAMIN B DEFICIENCY 1963-1969%A%  
% 211.97/212.12  |- skos__altLabel mesh__D014899 Gayet-Wernicke Encephalopathy
% 211.97/212.12  |- mesh__recordAuthorizer mesh__D014899 ags
% 211.97/212.12  |- skos__altLabel mesh__D014899 Encephalopathy, Gayet-Wernicke
% 211.97/212.12  |- mesh__recordOriginator mesh__D014899 NLM
% 211.97/212.12  |- skos__hiddenLabel mesh__D014899 Encephalopathy, Wernickes
% 211.97/212.12  |- skos__altLabel mesh__D014899
% 211.97/212.12       Wernicke Polioencephalitis, Superior Hemorrhagic
% 211.97/212.12  |- skos__altLabel mesh__D014899 Encephalopathy, Wernicke%27%s
% 211.97/212.12  |- skos__annotation mesh__D014899 DF: WERNICKE ENCEPH   
% 211.97/212.12  |- skos__prefLabel mesh__D014899 Wernicke Encephalopathy
% 211.97/212.12  |- mesh__recordMaintainer mesh__D014899 ags
% 211.97/212.12  |- skos__hiddenLabel mesh__D014899 Encephalopathy, Gayet Wernicke
% 211.97/212.12  |- mesh__historyNote mesh__D014899 2000%28%1964%29%   
% 211.97/212.12  |- skos__broader mesh__D006321Q000293smesh__D006321
% 211.97/212.12  |- mesh__preferredCombination mesh__D006321Q000293smesh__D006335
% 211.97/212.12  |- rdf__type mesh__D006321Q000293smesh__CompoundConcept
% 211.97/212.12  |- skos__broader mesh__D007501Q000737smesh__D007501
% 211.97/212.12  |- rdf__type mesh__D007501Q000737smesh__CompoundConcept
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D000879 2001
% 211.97/212.12  |- skos__hiddenLabel mesh__D000879 Acids, Anthranilic
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D000879 2003
% 211.97/212.12  |- skos__hiddenLabel mesh__D000879 o Aminobenzoic Acids
% 211.97/212.12  |- mesh__dateRevised mesh__D000879 1998-06-10
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D000879 2006
% 211.97/212.12  |- skos__broader mesh__D000879smesh__D000610
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D000879 2002
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D000879 2004
% 211.97/212.12  |- skos__altLabel mesh__D000879 ortho-Aminobenzoic Acids
% 211.97/212.12  |- mesh__recordOriginator mesh__D000879 NLM
% 211.97/212.12  |- mesh__publicMeSHNote mesh__D000879 75; was ANTHRANILIC ACID 1963-74   
% 211.97/212.12  |- skos__hiddenLabel mesh__D000879 Acids, o-Aminobenzoic
% 211.97/212.12  |- skos__hiddenLabel mesh__D000879 Acids, ortho-Aminobenzoic
% 211.97/212.12  |- mesh__dateCreated mesh__D000879 1999-01-01
% 211.97/212.12  |- skos__altLabel mesh__D000879 o-Aminobenzoic Acids
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D000879 1999
% 211.97/212.12  |- mesh__onlineNote mesh__D000879
% 211.97/212.12       use ANTHRANILIC ACIDS to search ANTHRANILIC ACID 1966-74   
% 211.97/212.12  |- mesh__recordMaintainer mesh__D000879 ADP
% 211.97/212.12  |- skos__prefLabel mesh__D000879 Anthranilic Acids
% 211.97/212.12  |- mesh__recordAuthorizer mesh__D000879 SJN
% 211.97/212.12  |- skos__hiddenLabel mesh__D000879 ortho Aminobenzoic Acids
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D000879 2000
% 211.97/212.12  |- skos__scopeNote mesh__D000879
% 211.97/212.12       Benzoic acids which are substituted with an amino group in the C-2 position.%A%    
% 211.97/212.12  |- mesh__historyNote mesh__D000879 75; was ANTHRANILIC ACID 1963-74   
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D000879 2005
% 211.97/212.12  |- rdf__type mesh__D000879sskos__Concept
% 211.97/212.12  |- mesh__dateCreated mesh__D019584 1997-06-20
% 211.97/212.12  |- skos__scopeNote mesh__D019584
% 211.97/212.12       A sudden, temporary sensation of heat predominantly experienced by some women during MENOPAUSE. %28%Random House Unabridged Dictionary, 2d ed%29%%A%    
% 211.97/212.12  |- skos__historyNote mesh__D019584 Climacteric %28%1976-1997%29%
% 211.97/212.12  |- skos__prefLabel mesh__D019584 Hot Flashes
% 211.97/212.12  |- skos__annotation mesh__D019584 do not confuse with FLUSHING   
% 211.97/212.12  |- rdf__type mesh__D019584sskos__Concept
% 211.97/212.12  |- mesh__dateRevised mesh__D019584 1999-11-08
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D019584 2003
% 211.97/212.12  |- skos__historyNote mesh__D019584 Menopause %28%1972-1997%29%
% 211.97/212.12  |- mesh__recordOriginator mesh__D019584 TGC
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D019584 2000
% 211.97/212.12  |- mesh__recordAuthorizer mesh__D019584 sjn
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D019584 2004
% 211.97/212.12  |- mesh__historyNote mesh__D019584 98   
% 211.97/212.12  |- mesh__publicMeSHNote mesh__D019584 98   
% 211.97/212.12  |- mesh__recordMaintainer mesh__D019584 KEV
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D019584 2001
% 211.97/212.12  |- skos__broader mesh__D019584smesh__D012816
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D019584 2005
% 211.97/212.12  |- skos__hiddenLabel mesh__D019584 Flashes, Hot
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D019584 2002
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D019584 2006
% 211.97/212.12  |- mesh__dateEstablished mesh__D019584 1998-01-01
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D005564 1995
% 211.97/212.12  |- skos__prefLabel mesh__D005564 Formic Acids
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D005564 2005
% 211.97/212.12  |- rdf__type mesh__D005564sskos__Concept
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D005564 1998
% 211.97/212.12  |- mesh__dateCreated mesh__D005564 1999-01-01
% 211.97/212.12  |- mesh__recordOriginator mesh__D005564 NLM
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D005564 1993
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D005564 2003
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D005564 2006
% 211.97/212.12  |- mesh__dateRevised mesh__D005564 1992-05-19
% 211.97/212.12  |- mesh__recordMaintainer mesh__D005564 TGC
% 211.97/212.12  |- skos__hiddenLabel mesh__D005564 Acids, Formic
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D005564 1996
% 211.97/212.12  |- mesh__publicMeSHNote mesh__D005564 68   
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D005564 1999
% 211.97/212.12  |- mesh__dateEstablished mesh__D005564 1968-01-01
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D005564 2004
% 211.97/212.12  |- mesh__historyNote mesh__D005564 68   
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D005564 1997
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D005564 2000
% 211.97/212.12  |- mesh__recordAuthorizer mesh__D005564 PLS
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D005564 2001
% 211.97/212.12  |- skos__broader mesh__D005564smesh__D000144
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D005564 1994
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D005564 2002
% 211.97/212.12  |- skos__historyNote mesh__D005564 Formates %28%1966-1967%29%
% 211.97/212.12  |- mesh__publicMeSHNote mesh__D043683
% 211.97/212.12       2004; see RECEPTORS, PURINERGIC P1 1994-2003   
% 211.97/212.12  |- mesh__dateCreated mesh__D043683 2003-07-09
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D043683 2005
% 211.97/212.12  |- mesh__dateEstablished mesh__D043683 2004-01-01
% 211.97/212.12  |- skos__hiddenLabel mesh__D043683 Receptor, Adenosine A2
% 211.97/212.12  |- skos__broader mesh__D043683smesh__D018047
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D043683 2006
% 211.97/212.12  |- skos__historyNote mesh__D043683
% 211.97/212.12       Receptors, Purinergic P1 %28%1994-2003%29%
% 211.97/212.12  |- skos__scopeNote mesh__D043683
% 211.97/212.12       A subclass of ADENOSINE RECEPTORS that are generally considered to be coupled to the GS, STIMULATORY G-PROTEIN which causes up regulation of CYCLIC AMP.%A%    
% 211.97/212.12  |- skos__altLabel mesh__D043683 Adenosine A2 Receptor
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D043683 2004
% 211.97/212.12  |- skos__altLabel mesh__D043683 Adenosine A2 Receptors
% 211.97/212.12  |- rdf__type mesh__D043683sskos__Concept
% 211.97/212.12  |- skos__prefLabel mesh__D043683 Receptors, Adenosine A2
% 211.97/212.12  |- skos__hiddenLabel mesh__D043683 A2 Receptors, Adenosine
% 211.97/212.12  |- skos__hiddenLabel mesh__D043683 A2 Receptor, Adenosine
% 211.97/212.12  |- mesh__historyNote mesh__D043683
% 211.97/212.12       2004; use RECEPTORS, PURINERGIC P1 1994-2003   
% 211.97/212.12  |- skos__broader mesh__D015992smesh__D001837
% 211.97/212.12  |- mesh__dateRevised mesh__D015992 2005-06-30
% 211.97/212.12  |- mesh__dateCreated mesh__D015992 1989-05-25
% 211.97/212.12  |- skos__hiddenLabel mesh__D015992 Index, Body Mass
% 211.97/212.12  |- mesh__recordOriginator mesh__D015992 PLS
% 211.97/212.12  |- skos__hiddenLabel mesh__D015992 Quetelets Index
% 211.97/212.12  |- mesh__dateEstablished mesh__D015992 1990-01-01
% 211.97/212.12  |- skos__historyNote mesh__D015992 Body Weight %28%1966-1989%29%
% 211.97/212.12  |- mesh__historyNote mesh__D015992 90   
% 211.97/212.12  |- skos__prefLabel mesh__D015992 Body Mass Index
% 211.97/212.12  |- skos__broader mesh__D015992smesh__D000886
% 211.97/212.12  |- mesh__publicMeSHNote mesh__D015992 90   
% 211.97/212.12  |- skos__scopeNote mesh__D015992
% 211.97/212.12       An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI=weight %28%kg%29%/height squared %28%m2%29%. BMI correlates with body fat %28%ADIPOSE TISSUE%29%. Their relationship varies with age and gender. For adults, BMI falls into these categories: below 18.5 %28%underweight%29%; 18.5-24.9 %28%normal%29%; 25.0-29.9 %28%overweight%29%; 30.0 and above %28%obese%29%. %28%National Center for Health Statistics, Centers for Disease Control and Prevention%29%%A%    
% 211.97/212.12  |- rdf__type mesh__D015992sskos__Concept
% 211.97/212.12  |- mesh__recordAuthorizer mesh__D015992 sjn
% 211.97/212.12  |- skos__altLabel mesh__D015992 Quetelet Index
% 211.97/212.12  |- mesh__recordMaintainer mesh__D015992 lkt
% 211.97/212.12  |- skos__altLabel mesh__D015992 Quetelet%27%s Index
% 211.97/212.12  |- skos__hiddenLabel mesh__D015992 Index, Quetelet
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D015992 2006
% 211.97/212.12  |- mesh__historyNote mesh__D051317 2006%28%1996%29%   
% 211.97/212.12  |- skos__altLabel mesh__D051317 N-WASP Wiskott-Aldrich Syndrome Protein
% 211.97/212.12  |- skos__altLabel mesh__D051317 WASL Wiskott-Aldrich Syndrome Protein
% 211.97/212.12  |- rdf__type mesh__D051317sskos__Concept
% 211.97/212.12  |- mesh__publicMeSHNote mesh__D051317
% 211.97/212.12       2006; NEURONAL WISKOTT-ALDRICH SYNDROME PROTEIN was indexed under NERVE TISSUE PROTEINS 1998-2005, %26% under PROTEINS 1996-1997%A%  
% 211.97/212.12  |- mesh__dateEstablished mesh__D051317 2006-01-01
% 211.97/212.12  |- skos__hiddenLabel mesh__D051317
% 211.97/212.12       Wiskott Aldrich Syndrome Protein, Neuronal
% 211.97/212.12  |- skos__prefLabel mesh__D051317 Wiskott-Aldrich Syndrome Protein, Neuronal
% 211.97/212.12  |- skos__hiddenLabel mesh__D051317 WASL Wiskott Aldrich Syndrome Protein
% 211.97/212.12  |- mesh__recordMaintainer mesh__D051317 DRC
% 211.97/212.12  |- skos__altLabel mesh__D051317 Neuronal Wiskott-Aldrich Syndrome Protein
% 211.97/212.12  |- skos__hiddenLabel mesh__D051317
% 211.97/212.12       Wiskott Aldrich Syndrome Gene Like Protein
% 211.97/212.12  |- mesh__recordOriginator mesh__D051317 DRC
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D051317 2006
% 211.97/212.12  |- mesh__dateCreated mesh__D051317 2005-06-30
% 211.97/212.12  |- skos__scopeNote mesh__D051317
% 211.97/212.12       A member of the Wiskott-Aldrich syndrome protein family that is found at high levels in NERVE CELLS. It interacts with GRB2 ADAPTOR PROTEIN and with CDC42 PROTEIN.%A%    
% 211.97/212.12  |- skos__annotation mesh__D051317
% 211.97/212.12       WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY and WISKOTT-ALDRICH SYNDROME PROTEIN are also available%A%  
% 211.97/212.12  |- skos__hiddenLabel mesh__D051317
% 211.97/212.12       Neuronal Wiskott Aldrich Syndrome Protein
% 211.97/212.12  |- skos__broader mesh__D051317smesh__D051300
% 211.97/212.12  |- skos__altLabel mesh__D051317 Wiskott-Aldrich Syndrome Gene-Like Protein
% 211.97/212.12  |- skos__altLabel mesh__D051317 N-WASP Protein
% 211.97/212.12  |- skos__hiddenLabel mesh__D051317 N WASP Wiskott Aldrich Syndrome Protein
% 211.97/212.12  |- mesh__recordAuthorizer mesh__D051317 sjn
% 211.97/212.12  |- skos__hiddenLabel mesh__D051317 N WASP Protein
% 211.97/212.12  |- mesh__recordOriginator mesh__D015194 EJB
% 211.97/212.12  |- skos__hiddenLabel mesh__D015194 Chamber, Semipermeable
% 211.97/212.12  |- skos__historyNote mesh__D015194 Cells, Cultured %28%1971-1988%29%
% 211.97/212.12  |- skos__hiddenLabel mesh__D015194 Diffusion Chamber, Culture
% 211.97/212.12  |- mesh__dateCreated mesh__D015194 1988-04-21
% 211.97/212.12  |- skos__historyNote mesh__D015194 Diffusion %28%1966-1988%29%
% 211.97/212.12  |- skos__historyNote mesh__D015194 Cell Differentiation %28%1966-1971%29%
% 211.97/212.12  |- skos__hiddenLabel mesh__D015194 Chambers, Semipermeable
% 211.97/212.12  |- skos__broader mesh__D015194smesh__D003584
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D015194 2006
% 211.97/212.12  |- skos__altLabel mesh__D015194 Semipermeable Chambers
% 211.97/212.12  |- mesh__historyNote mesh__D015194 89   
% 211.97/212.12  |- skos__hiddenLabel mesh__D015194 Cage, Tissue
% 211.97/212.12  |- skos__hiddenLabel mesh__D015194 Cages, Tissue
% 211.97/212.12  |- skos__altLabel mesh__D015194 Semi-Permeable Chambers
% 211.97/212.12  |- skos__broader mesh__D015194smesh__D046508
% 211.97/212.12  |- skos__prefLabel mesh__D015194 Diffusion Chambers, Culture
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D015194 2005
% 211.97/212.12  |- skos__scopeNote mesh__D015194
% 211.97/212.12       Devices used in a technique by which cells or tissues are grown in vitro or, by implantation, in vivo within chambers permeable to diffusion of solutes across the chamber walls. The chambers are used for studies of drug effects, osmotic responses, cytogenic and immunologic phenomena, metabolism, etc., and include tissue cages.%A%    
% 211.97/212.12  |- mesh__dateRevised mesh__D015194 2004-07-08
% 211.97/212.12  |- skos__altLabel mesh__D015194 Culture Diffusion Chambers
% 211.97/212.12  |- skos__hiddenLabel mesh__D015194 Semipermeable Chamber
% 211.97/212.12  |- rdf__type mesh__D015194sskos__Concept
% 211.97/212.12  |- mesh__publicMeSHNote mesh__D015194 89   
% 211.97/212.12  |- mesh__recordMaintainer mesh__D015194 lkt
% 211.97/212.12  |- skos__hiddenLabel mesh__D015194 Culture Diffusion Chamber
% 211.97/212.12  |- skos__hiddenLabel mesh__D015194 Chambers, Culture Diffusion
% 211.97/212.12  |- skos__hiddenLabel mesh__D015194 Chamber, Culture Diffusion
% 211.97/212.12  |- skos__annotation mesh__D015194 NIM   
% 211.97/212.12  |- skos__hiddenLabel mesh__D015194 Chambers, Semi-Permeable
% 211.97/212.12  |- skos__hiddenLabel mesh__D015194 Semi Permeable Chambers
% 211.97/212.12  |- skos__hiddenLabel mesh__D015194 Chamber, Semi-Permeable
% 211.97/212.12  |- mesh__recordAuthorizer mesh__D015194 sjn
% 211.97/212.12  |- skos__hiddenLabel mesh__D015194 Semi-Permeable Chamber
% 211.97/212.12  |- skos__hiddenLabel mesh__D015194 Tissue Cage
% 211.97/212.12  |- mesh__dateEstablished mesh__D015194 1989-01-01
% 211.97/212.12  |- skos__historyNote mesh__D015194 Tissue Culture %28%1966-1988%29%
% 211.97/212.12  |- mesh__dateRevised mesh__D009955 2003-07-09
% 211.97/212.12  |- skos__broader mesh__D009955smesh__D002262
% 211.97/212.12  |- skos__altLabel mesh__D009955 Ornithine Carboxy-lyase
% 211.97/212.12  |- mesh__recordMaintainer mesh__D009955 ssb
% 211.97/212.12  |- mesh__dateCreated mesh__D009955 1974-11-11
% 211.97/212.12  |- skos__historyNote mesh__D009955 Ornithine %28%1972-1974%29%
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D009955 2005
% 211.97/212.12  |- mesh__recordOriginator mesh__D009955 NLM
% 211.97/212.12  |- skos__historyNote mesh__D009955 Carboxy-Lyases %28%1972-1974%29%
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D009955 2006
% 211.97/212.12  |- skos__hiddenLabel mesh__D009955 Decarboxylase, Ornithine
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D009955 2004
% 211.97/212.12  |- mesh__publicMeSHNote mesh__D009955
% 211.97/212.12       84; was see under CARBOXY-LYASES 1975-83   
% 211.97/212.12  |- mesh__historyNote mesh__D009955
% 211.97/212.12       84%28%75%29%; was see under CARBOXY-LYASES 1975-83   
% 211.97/212.12  |- skos__hiddenLabel mesh__D009955 Ornithine Carboxy lyase
% 211.97/212.12  |- mesh__dateEstablished mesh__D009955 1984-01-01
% 211.97/212.12  |- skos__scopeNote mesh__D009955
% 211.97/212.12       A pyridoxal-phosphate protein, believed to be the rate-limiting compound in the biosynthesis of polyamines. It catalyzes the decarboxylation of ornithine to form putrescine, which is then linked to a propylamine moiety of decarboxylated S-adenosylmethionine to form spermidine. EC 4.1.1.17.%A%    
% 211.97/212.12  |- rdf__type mesh__D009955sskos__Concept
% 211.97/212.12  |- skos__prefLabel mesh__D009955 Ornithine Decarboxylase
% 211.97/212.12  |- mesh__recordAuthorizer mesh__D009955 sjn
% 211.97/212.12  |- skos__hiddenLabel mesh__D009955 Carboxy-lyase, Ornithine
% 211.97/212.12  |- mesh__publicMeSHNote mesh__D001972
% 211.97/212.12       91; was see under DEOXYCYTIDINE 1975-90   
% 211.97/212.12  |- skos__altLabel mesh__D001972 5-Bromo-2%27%-Deoxycytidine
% 211.97/212.12  |- mesh__recordAuthorizer mesh__D001972 PLS
% 211.97/212.12  |- skos__historyNote mesh__D001972 Bromine %28%1974%29%
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D001972 1999
% 211.97/212.12  |- mesh__dateEstablished mesh__D001972 1991-01-01
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D001972 2003
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D001972 1993
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D001972 2000
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D001972 2004
% 211.97/212.12  |- mesh__historyNote mesh__D001972
% 211.97/212.12       91%28%75%29%; was see under DEOXYCYTIDINE 1975-90   
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D001972 1996
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D001972 2001
% 211.97/212.12  |- skos__hiddenLabel mesh__D001972 5 Bromo 2%27% Deoxycytidine
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D001972 1997
% 211.97/212.12  |- skos__historyNote mesh__D001972 Deoxycytidine %28%1974%29%
% 211.97/212.12  |- mesh__activeMeSHYear mesh__D001972 1994
% 211.97/212.12  |- mesh__recordOriginator mesh__D001972 BVL
% 211.97/212.13  |- mesh__dateRevised mesh__D001972 1992-05-08
% 211.97/212.13  |- skos__scopeNote mesh__D001972
% 211.97/212.13       5-Bromo-2%27%-deoxycytidine. Can be incorporated into DNA in the presence of DNA polymerase, replacing dCTP.%A%    
% 211.97/212.13  |- skos__prefLabel mesh__D001972 Bromodeoxycytidine
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001972 2005
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001972 1995
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001972 2002
% 211.97/212.13  |- mesh__dateCreated mesh__D001972 1974-11-19
% 211.97/212.13  |- mesh__recordMaintainer mesh__D001972 TGC
% 211.97/212.13  |- skos__broader mesh__D001972smesh__D003841
% 211.97/212.13  |- rdf__type mesh__D001972sskos__Concept
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001972 2006
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001972 1998
% 211.97/212.13  |- skos__broader mesh__D009157smesh__D020511
% 211.97/212.13  |- skos__related mesh__D009157smesh__D013952
% 211.97/212.13  |- mesh__recordOriginator mesh__D009157 NLM
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D009157 2000
% 211.97/212.13  |- skos__hiddenLabel mesh__D009157 Generalized Myasthenia Gravis
% 211.97/212.13  |- rdf__type mesh__D009157sskos__Concept
% 211.97/212.13  |- mesh__recordAuthorizer mesh__D009157 sjn
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D009157 2003
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D009157 2001
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D009157 2004
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D009157 2005
% 211.97/212.13  |- mesh__dateCreated mesh__D009157 1999-01-01
% 211.97/212.13  |- skos__hiddenLabel mesh__D009157 Ocular Myasthenia Gravis
% 211.97/212.13  |- skos__scopeNote mesh__D009157
% 211.97/212.13       A disorder of neuromuscular transmission characterized by weakness of cranial and skeletal muscles. Autoantibodies directed against acetylcholine receptors damage the motor endplate portion of the NEUROMUSCULAR JUNCTION, impairing the transmission of impulses to skeletal muscles. Clinical manifestations may include diplopia, ptosis, and weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles. THYMOMA is commonly associated with this condition. %28%Adams et al., Principles of Neurology, 6th ed, p1459%29%%A%    
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D009157 2006
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D009157 2002
% 211.97/212.13  |- skos__prefLabel mesh__D009157 Myasthenia Gravis
% 211.97/212.13  |- skos__broader mesh__D009157smesh__D020274
% 211.97/212.13  |- skos__annotation mesh__D009157
% 211.97/212.13       %22%myasthenia%22% unqualified in foreign titles is more often MYASTHENIA GRAVIS than MUSCLE WEAKNESS but check text; congen consider MYASTHENIC SYNDROMES, CONGENITAL or specifics%A%  
% 211.97/212.13  |- mesh__recordMaintainer mesh__D009157 KEV
% 211.97/212.13  |- mesh__dateRevised mesh__D009157 1999-11-08
% 211.97/212.13  |- mesh__recordMaintainer mesh__D001174 PXP
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001174 2000
% 211.97/212.13  |- mesh__dateRevised mesh__D001174 1997-06-20
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001174 2001
% 211.97/212.13  |- mesh__recordAuthorizer mesh__D001174 SJN
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001174 1998
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001174 2005
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001174 2002
% 211.97/212.13  |- mesh__recordOriginator mesh__D001174 NLM
% 211.97/212.13  |- skos__prefLabel mesh__D001174 Arthrodesis
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001174 2003
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001174 1999
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001174 2006
% 211.97/212.13  |- skos__hiddenLabel mesh__D001174 Arthrodeses
% 211.97/212.13  |- mesh__dateCreated mesh__D001174 1999-01-01
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001174 2004
% 211.97/212.13  |- rdf__type mesh__D001174sskos__Concept
% 211.97/212.13  |- skos__annotation mesh__D001174
% 211.97/212.13       a method of joint surg; do not use /util except by MeSH definition; vertebral or spinal arthrodesis = SPINAL FUSION%A%  
% 211.97/212.13  |- skos__scopeNote mesh__D001174
% 211.97/212.13       The surgical fixation of a joint by a procedure designed to accomplish fusion of the joint surfaces by promoting the proliferation of bone cells. %28%Dorland, 28th ed%29%%A%    
% 211.97/212.13  |- skos__broader mesh__D001174smesh__D019637
% 211.97/212.13  |- skos__broader mesh__D006321Q000294smesh__D006321
% 211.97/212.13  |- rdf__type mesh__D006321Q000294smesh__CompoundConcept
% 211.97/212.13  |- skos__hiddenLabel mesh__D019585 Hypotension, Intracranial
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D019585 2002
% 211.97/212.13  |- skos__hiddenLabel mesh__D019585 Hypotension, Essential Intracranial
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D019585 2003
% 211.97/212.13  |- mesh__dateEstablished mesh__D019585 1998-01-01
% 211.97/212.13  |- mesh__recordAuthorizer mesh__D019585 ags
% 211.97/212.13  |- skos__altLabel mesh__D019585 Intracranial Hypotension, Spontaneous
% 211.97/212.13  |- skos__hiddenLabel mesh__D019585 Hypotension, Secondary Intracranial
% 211.97/212.13  |- mesh__dateCreated mesh__D019585 1997-06-20
% 211.97/212.13  |- mesh__publicMeSHNote mesh__D019585 1998   
% 211.97/212.13  |- skos__annotation mesh__D019585
% 211.97/212.13       do not confuse with INTRACRANIAL HYPERTENSION; coord IM with disease /physiopathol %28%IM%29% causing or caused by intracranial hypotension%A%  
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D019585 2004
% 211.97/212.13  |- skos__historyNote mesh__D019585 Intracranial Pressure %28%1967-1997%29%
% 211.97/212.13  |- mesh__recordMaintainer mesh__D019585 ags
% 211.97/212.13  |- skos__hiddenLabel mesh__D019585 Spontaneous Intracranial Hypotension
% 211.97/212.13  |- skos__broader mesh__D019585smesh__D001927
% 211.97/212.13  |- skos__hiddenLabel mesh__D019585 Essential Intracranial Hypotension
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D019585 2005
% 211.97/212.13  |- skos__prefLabel mesh__D019585 Intracranial Hypotension
% 211.97/212.13  |- mesh__recordOriginator mesh__D019585 TGC
% 211.97/212.13  |- mesh__historyNote mesh__D019585 1998   
% 211.97/212.13  |- mesh__dateRevised mesh__D019585 2005-07-13
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D019585 2006A
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D019585 2000A
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D019585 2000
% 211.97/212.13  |- skos__hiddenLabel mesh__D019585 Hypotension, Spontaneous Intracranial
% 211.97/212.13  |- skos__scopeNote mesh__D019585
% 211.97/212.13       Reduction of CEREBROSPINAL FLUID pressure characterized clinically by HEADACHE which is maximal in an upright posture and occasionally by an abducens nerve palsy %28%see ABDUCENS NERVE DISEASES%29%, neck stiffness, hearing loss %28%see DEAFNESS%29%; NAUSEA; and other symptoms. This condition may be spontaneous or secondary to SPINAL PUNCTURE; NEUROSURGICAL PROCEDURES; DEHYDRATION; UREMIA; trauma %28%see also CRANIOCEREBRAL TRAUMA%29%; and other processes. Chronic hypotension may be associated with subdural hematomas %28%see HEMATOMA, SUBDURAL%29% or hygromas. %28%From Semin Neurol 1996  Mar;16%28%1%29%:5-10; Adams et al., Principles of Neurology, 6th ed, pp637-8%29%%A%    
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D019585 2006
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D019585 2001
% 211.97/212.13  |- rdf__type mesh__D019585sskos__Concept
% 211.97/212.13  |- skos__hiddenLabel mesh__D019585 Secondary Intracranial Hypotension
% 211.97/212.13  |- skos__historyNote mesh__D005565 Glutarates %28%1970-1974%29%
% 211.97/212.13  |- skos__scopeNote mesh__D005565
% 211.97/212.13       Measurement of this acid in the urine after oral administration of histidine provides the basis for the diagnostic test of folic acid deficiency and of megaloblastic anemia of pregnancy.%A%    
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D005565 2004
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D005565 2001
% 211.97/212.13  |- mesh__publicMeSHNote mesh__D005565
% 211.97/212.13       91; was see under GLUTARATES 1975-90   
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D005565 2002
% 211.97/212.13  |- skos__altLabel mesh__D005565 FIGLU
% 211.97/212.13  |- mesh__dateRevised mesh__D005565 2000-06-21
% 211.97/212.13  |- skos__hiddenLabel mesh__D005565 Acid, Formiminoglutamic
% 211.97/212.13  |- mesh__recordOriginator mesh__D005565 NLM
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D005565 2005
% 211.97/212.13  |- rdf__type mesh__D005565sskos__Concept
% 211.97/212.13  |- mesh__dateEstablished mesh__D005565 1991-01-01
% 211.97/212.13  |- mesh__historyNote mesh__D005565
% 211.97/212.13       91%28%75%29%; was see under GLUTARATES 1975-90   
% 211.97/212.13  |- skos__broader mesh__D005565smesh__D005977
% 211.97/212.13  |- mesh__recordMaintainer mesh__D005565 CCR
% 211.97/212.13  |- mesh__dateCreated mesh__D005565 1974-11-19
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D005565 2003
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D005565 2006
% 211.97/212.13  |- mesh__recordAuthorizer mesh__D005565 sjn
% 211.97/212.13  |- skos__historyNote mesh__D005565 Azo Compounds %28%1971-1974%29%
% 211.97/212.13  |- skos__prefLabel mesh__D005565 Formiminoglutamic Acid
% 211.97/212.13  |- skos__scopeNote mesh__D043684
% 211.97/212.13       A subtype of ADENOSINE RECEPTOR that is found expressed in a variety of locations including the BRAIN and endocrine tissues. The receptor is generally considered to be coupled to the GI, INHIBITORY G-PROTEIN which causes down regulation of CYCLIC AMP.%A%    
% 211.97/212.13  |- mesh__dateCreated mesh__D043684 2003-07-09
% 211.97/212.13  |- skos__historyNote mesh__D043684 Receptors, Purinergic %28%1997-2003%29%
% 211.97/212.13  |- mesh__historyNote mesh__D043684
% 211.97/212.13       2004; use RECEPTOR, ADENOSINE A3 %28%NM%29% 1997-2003   
% 211.97/212.13  |- skos__altLabel mesh__D043684 Adenosine A3 Receptor
% 211.97/212.13  |- skos__hiddenLabel mesh__D043684 Receptors, Adenosine A3
% 211.97/212.13  |- skos__hiddenLabel mesh__D043684 A3 Receptor, Adenosine
% 211.97/212.13  |- skos__broader mesh__D043684smesh__D018047
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D043684 2006
% 211.97/212.13  |- skos__altLabel mesh__D043684 Adenosine A3 Receptors
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D043684 2004
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D043684 2005
% 211.97/212.13  |- skos__prefLabel mesh__D043684 Receptor, Adenosine A3
% 211.97/212.13  |- mesh__publicMeSHNote mesh__D043684
% 211.97/212.13       2004; ADENOSINE A3 RECEPTOR was indexed under RECEPTORS, PURINERGIC P1 1997-2003%A%  
% 211.97/212.13  |- rdf__type mesh__D043684sskos__Concept
% 211.97/212.13  |- mesh__dateEstablished mesh__D043684 2004-01-01
% 211.97/212.13  |- skos__hiddenLabel mesh__D043684 A3 Receptors, Adenosine
% 211.97/212.13  |- skos__hiddenLabel mesh__D015993 Estimate, Life Table
% 211.97/212.13  |- skos__broader mesh__D015993smesh__D000206
% 211.97/212.13  |- skos__historyNote mesh__D015993 Life Expectancy %28%1966-1978%29%
% 211.97/212.13  |- skos__hiddenLabel mesh__D015993 Analysis, Life Table
% 211.97/212.13  |- mesh__recordOriginator mesh__D015993 PLS
% 211.97/212.13  |- skos__prefLabel mesh__D015993 Life Tables
% 211.97/212.13  |- mesh__dateEstablished mesh__D015993 1990-01-01
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015993 2002
% 211.97/212.13  |- skos__hiddenLabel mesh__D015993 Life Table Analyses
% 211.97/212.13  |- skos__hiddenLabel mesh__D015993 Methods, Life Table
% 211.97/212.13  |- skos__hiddenLabel mesh__D015993 Model, Life Table
% 211.97/212.13  |- skos__hiddenLabel mesh__D015993 Method, Life Table
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015993 2003
% 211.97/212.13  |- mesh__recordMaintainer mesh__D015993 kle
% 211.97/212.13  |- skos__annotation mesh__D015993 IM; no qualif   
% 211.97/212.13  |- rdf__type mesh__D015993sskos__Concept
% 211.97/212.13  |- mesh__historyNote mesh__D015993
% 211.97/212.13       90; LIFE TABLE METHODS was see ACTUARIAL ANALYSIS 1979-89%A%  
% 211.97/212.13  |- skos__hiddenLabel mesh__D015993 Models, Life Table
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015993 2005
% 211.97/212.13  |- skos__scopeNote mesh__D015993
% 211.97/212.13       Summarizing techniques used to describe the pattern of mortality and survival in populations. These methods can be applied to the study not only of death, but also of any defined endpoint such as the onset of disease or the occurrence of disease complications.%A%    
% 211.97/212.13  |- mesh__publicMeSHNote mesh__D015993
% 211.97/212.13       90; LIFE TABLE METHODS was see ACTUARIAL ANALYSIS 1979-89%A%  
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015993 2004
% 211.97/212.13  |- skos__hiddenLabel mesh__D015993 Life Table Estimate
% 211.97/212.13  |- skos__hiddenLabel mesh__D015993 Tables, Life
% 211.97/212.13  |- skos__hiddenLabel mesh__D015993 Life Table
% 211.97/212.13  |- skos__altLabel mesh__D015993 Life Table Method
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015993 2006
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015993 2000
% 211.97/212.13  |- skos__hiddenLabel mesh__D015993 Estimates, Life Table
% 211.97/212.13  |- skos__hiddenLabel mesh__D015993 Life Table Model
% 211.97/212.13  |- skos__broader mesh__D015993smesh__D014798
% 211.97/212.13  |- skos__historyNote mesh__D015993 Actuarial Analysis %28%1979-1989%29%
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015993 2001
% 211.97/212.13  |- skos__hiddenLabel mesh__D015993 Analyses, Life Table
% 211.97/212.13  |- mesh__dateRevised mesh__D015993 1999-11-03
% 211.97/212.13  |- mesh__recordAuthorizer mesh__D015993 sjn
% 211.97/212.13  |- mesh__dateCreated mesh__D015993 1989-05-25
% 211.97/212.13  |- mesh__onlineNote mesh__D015993
% 211.97/212.13       use ACTUARIAL ANALYSIS to search LIFE TABLE METHODS 1979-89%A%  
% 211.97/212.13  |- skos__hiddenLabel mesh__D015195 Modeling, Drug
% 211.97/212.13  |- skos__broader mesh__D015195smesh__D002626
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015195 1992
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015195 1998
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015195 2005
% 211.97/212.13  |- skos__annotation mesh__D015195
% 211.97/212.13       no qualif; do not confuse with DESIGNER DRUGS   
% 211.97/212.13  |- mesh__recordOriginator mesh__D015195 EJB
% 211.97/212.13  |- skos__hiddenLabel mesh__D015195 Design, Drug
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015195 2002
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015195 1997
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015195 2004
% 211.97/212.13  |- rdf__type mesh__D015195sskos__Concept
% 211.97/212.13  |- skos__prefLabel mesh__D015195 Drug Design
% 211.97/212.13  |- mesh__publicMeSHNote mesh__D015195 89   
% 211.97/212.13  |- skos__historyNote mesh__D015195
% 211.97/212.13       Chemistry, Pharmaceutical %28%1966-1988%29%
% 211.97/212.13  |- mesh__recordAuthorizer mesh__D015195 PLS
% 211.97/212.13  |- skos__broader mesh__D015195smesh__D002620
% 211.97/212.13  |- mesh__historyNote mesh__D015195 89   
% 211.97/212.13  |- skos__historyNote mesh__D015195 Drugs %28%1966-1988%29%
% 211.97/212.13  |- skos__hiddenLabel mesh__D015195 Modelings, Drug
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015195 2001
% 211.97/212.13  |- skos__hiddenLabel mesh__D015195 Designs, Drug
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015195 1996
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015195 2003
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015195 2000
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015195 1995
% 211.97/212.13  |- mesh__recordMaintainer mesh__D015195 TGC
% 211.97/212.13  |- mesh__dateRevised mesh__D015195 1991-01-08
% 211.97/212.13  |- skos__hiddenLabel mesh__D015195 Drug Modelings
% 211.97/212.13  |- mesh__dateEstablished mesh__D015195 1989-01-01
% 211.97/212.13  |- skos__related mesh__D015195smesh__D015198
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015195 1994
% 211.97/212.13  |- mesh__dateCreated mesh__D015195 1988-04-21
% 211.97/212.13  |- skos__scopeNote mesh__D015195
% 211.97/212.13       The molecular designing of drugs for specific purposes %28%such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.%29% based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include pharmacokinetics, dosage analysis, or drug administration analysis.%A%    
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015195 1993
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015195 1999
% 211.97/212.13  |- skos__hiddenLabel mesh__D015195 Drug Designs
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015195 2006
% 211.97/212.13  |- skos__scopeNote mesh__D009956
% 211.97/212.13       Infection with CHLAMYDOPHILA PSITTACI %28%formerly Chlamydia psittaci%29%, transmitted to humans by inhalation of dust-borne contaminated nasal secretions or excreta of infected BIRDS. This infection results in a febrile illness characterized by PNEUMONITIS and systemic manifestations.%A%    
% 211.97/212.13  |- mesh__recordAuthorizer mesh__D009956 sjn
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D009956 2006
% 211.97/212.13  |- mesh__recordMaintainer mesh__D009956 ags
% 211.97/212.13  |- skos__altLabel mesh__D009956 Ornithosis
% 211.97/212.13  |- mesh__historyNote mesh__D009956 2006 %28%1963%29%   
% 211.97/212.13  |- skos__hiddenLabel mesh__D009956 Psittacoses
% 211.97/212.13  |- skos__broader mesh__D009956smesh__D023521
% 211.97/212.13  |- mesh__recordOriginator mesh__D009956 NLM
% 211.97/212.13  |- rdf__type mesh__D009956sskos__Concept
% 211.97/212.13  |- mesh__publicMeSHNote mesh__D009956 2006; see ORNITHOSIS 1963-2005   
% 211.97/212.13  |- mesh__dateRevised mesh__D009956 2005-06-30
% 211.97/212.13  |- skos__prefLabel mesh__D009956 Psittacosis
% 211.97/212.13  |- skos__hiddenLabel mesh__D009956 Ornithoses
% 211.97/212.13  |- mesh__dateCreated mesh__D009956 1999-01-01
% 211.97/212.13  |- skos__altLabel mesh__D001973 BUdR
% 211.97/212.13  |- skos__prefLabel mesh__D001973 Bromodeoxyuridine
% 211.97/212.13  |- mesh__dateRevised mesh__D001973 2001-07-25
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001973 2006
% 211.97/212.13  |- skos__altLabel mesh__D001973 5-Bromo-2%27%-deoxyuridine
% 211.97/212.13  |- skos__altLabel mesh__D001973 5-Bromodeoxyuridine
% 211.97/212.13  |- mesh__recordAuthorizer mesh__D001973 sjn
% 211.97/212.13  |- skos__hiddenLabel mesh__D001973 5 Bromodeoxyuridine
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001973 2003
% 211.97/212.13  |- mesh__recordMaintainer mesh__D001973 jmp
% 211.97/212.13  |- skos__hiddenLabel mesh__D001973 5 Bromo 2%27% deoxyuridine
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001973 2004
% 211.97/212.13  |- mesh__dateCreated mesh__D001973 1999-01-01
% 211.97/212.13  |- mesh__publicMeSHNote mesh__D001973 66   
% 211.97/212.13  |- skos__altLabel mesh__D001973 BrdU
% 211.97/212.13  |- mesh__historyNote mesh__D001973 66%28%65%29%   
% 211.97/212.13  |- skos__broader mesh__D001973smesh__D003857
% 211.97/212.13  |- skos__altLabel mesh__D001973 Bromouracil Deoxyriboside
% 211.97/212.13  |- skos__hiddenLabel mesh__D001973 Deoxyriboside, Bromouracil
% 211.97/212.13  |- rdf__type mesh__D001973sskos__Concept
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001973 2002
% 211.97/212.13  |- mesh__recordOriginator mesh__D001973 NLM
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001973 2005
% 211.97/212.13  |- mesh__dateEstablished mesh__D001973 1966-01-01
% 211.97/212.13  |- skos__altLabel mesh__D001973 Broxuridine
% 211.97/212.13  |- skos__scopeNote mesh__D001973
% 211.97/212.13       A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors.%A%    
% 211.97/212.13  |- mesh__publicMeSHNote mesh__D009158
% 211.97/212.13       91; was see under ANTIBIOTICS, ANTIFUNGAL 1975-90   
% 211.97/212.13  |- skos__historyNote mesh__D009158 Peptides, Cyclic %28%1973-1974%29%
% 211.97/212.13  |- mesh__dateEstablished mesh__D009158 1991-01-01
% 211.97/212.13  |- skos__broader mesh__D009158smesh__D010456
% 211.97/212.13  |- skos__prefLabel mesh__D009158 Mycobacillin
% 211.97/212.13  |- skos__historyNote mesh__D009158
% 211.97/212.13       Antibiotics, Antifungal %28%1971-1974%29%
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D009158 2005
% 211.97/212.13  |- mesh__recordOriginator mesh__D009158 NLM
% 211.97/212.13  |- mesh__recordAuthorizer mesh__D009158 sjn
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D009158 2006
% 211.97/212.13  |- mesh__dateCreated mesh__D009158 1974-11-19
% 211.97/212.13  |- skos__scopeNote mesh__D009158
% 211.97/212.13       A cyclic polypeptide antibiotic isolated from culture filtrates of Bacillus subtilis that acts as an antifungal agent.%A%    
% 211.97/212.13  |- mesh__dateRevised mesh__D009158 2004-07-07
% 211.97/212.13  |- mesh__historyNote mesh__D009158
% 211.97/212.13       91%28%75%29%; was see under ANTIBIOTICS, ANTIFUNGAL 1975-90   
% 211.97/212.13  |- mesh__recordMaintainer mesh__D009158 ssb
% 211.97/212.13  |- rdf__type mesh__D009158sskos__Concept
% 211.97/212.13  |- mesh__recordOriginator mesh__D001175 SH
% 211.97/212.13  |- rdf__type mesh__D001175sskos__Concept
% 211.97/212.13  |- skos__hiddenLabel mesh__D001175 Arthrographies
% 211.97/212.13  |- skos__prefLabel mesh__D001175 Arthrography
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001175 2002
% 211.97/212.13  |- mesh__publicMeSHNote mesh__D001175 86   
% 211.97/212.13  |- mesh__dateRevised mesh__D001175 1997-06-20
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001175 2001
% 211.97/212.13  |- mesh__recordAuthorizer mesh__D001175 SJN
% 211.97/212.13  |- skos__scopeNote mesh__D001175
% 211.97/212.13       Roentgenography of a joint, usually after injection of either positive or negative contrast medium.%A%    
% 211.97/212.13  |- skos__annotation mesh__D001175
% 211.97/212.13       do not use /util except by MeSH definition; DF: ARTHROGR   
% 211.97/212.13  |- skos__historyNote mesh__D001175 Radiography %28%1966-1985%29%
% 211.97/212.13  |- mesh__recordMaintainer mesh__D001175 PXP
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001175 2000
% 211.97/212.13  |- mesh__historyNote mesh__D001175 86   
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001175 2004
% 211.97/212.13  |- mesh__dateCreated mesh__D001175 1985-06-07
% 211.97/212.13  |- mesh__dateEstablished mesh__D001175 1986-01-01
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001175 1999
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001175 2006
% 211.97/212.13  |- skos__broader mesh__D001175smesh__D011859
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001175 2003
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001175 1998
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D001175 2005
% 211.97/212.13  |- skos__historyNote mesh__D001175 specific joint/RA %28%1967-1985%29%
% 211.97/212.13  |- skos__broader mesh__D010604Q000941smesh__D010604
% 211.97/212.13  |- mesh__preferredCombination mesh__D010604Q000941smesh__D004994
% 211.97/212.13  |- rdf__type mesh__D010604Q000941smesh__CompoundConcept
% 211.97/212.13  |- mesh__publicMeSHNote mesh__D019586 1998   
% 211.97/212.13  |- skos__historyNote mesh__D019586 Intracranial Pressure %28%1966-1997%29%
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D019586 2001
% 211.97/212.13  |- mesh__dateRevised mesh__D019586 1999-12-13
% 211.97/212.13  |- skos__hiddenLabel mesh__D019586 Pressure, Elevated Intracranial
% 211.97/212.13  |- rdf__type mesh__D019586sskos__Concept
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D019586 2000
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D019586 2005
% 211.97/212.13  |- skos__altLabel mesh__D019586 Elevated Intracranial Pressure
% 211.97/212.13  |- skos__altLabel mesh__D019586 Elevated ICP %28%Intracranial Pressure%29%
% 211.97/212.13  |- skos__hiddenLabel mesh__D019586
% 211.97/212.13       ICP, Elevated %28%Intracranial Pressure%29%
% 211.97/212.13  |- mesh__recordAuthorizer mesh__D019586 ags
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D019586 2004
% 211.97/212.13  |- skos__hiddenLabel mesh__D019586 Pressure Increase, Intracranial
% 211.97/212.13  |- mesh__dateEstablished mesh__D019586 1998-01-01
% 211.97/212.13  |- skos__scopeNote mesh__D019586
% 211.97/212.13       Increased pressure within the cranial vault. This may result from several conditions, including HYDROCEPHALUS; BRAIN EDEMA; intracranial masses; severe systemic HYPERTENSION; PSEUDOTUMOR CEREBRI; and other disorders.%A%    
% 211.97/212.13  |- skos__altLabel mesh__D019586 ICP %28%Intracranial Pressure%29% Increase
% 211.97/212.13  |- skos__altLabel mesh__D019586 Intracranial Pressure Increase
% 211.97/212.13  |- skos__hiddenLabel mesh__D019586 Intracranial Pressure, Elevated
% 211.97/212.13  |- skos__prefLabel mesh__D019586 Intracranial Hypertension
% 211.97/212.13  |- skos__annotation mesh__D019586
% 211.97/212.13       do not confuse with INTRACRANIAL HYPOTENSION; coord IM with disease /physiopathol %28%IM%29% causing or caused by intracranial hypertension%A%  
% 211.97/212.13  |- skos__related mesh__D019586smesh__D006849
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D019586 2003
% 211.97/212.13  |- skos__historyNote mesh__D019586 Pseudotumor Cerebri %28%1966-1997%29%
% 211.97/212.13  |- skos__altLabel mesh__D019586 ICP %28%Intracranial Pressure%29% Elevation
% 211.97/212.13  |- mesh__recordOriginator mesh__D019586 TGC
% 211.97/212.13  |- skos__related mesh__D019586smesh__D001929
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D019586 2000A
% 211.97/212.13  |- mesh__dateCreated mesh__D019586 1997-06-20
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D019586 2002
% 211.97/212.13  |- mesh__recordMaintainer mesh__D019586 ags
% 211.97/212.13  |- skos__broader mesh__D019586smesh__D001927
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D019586 2006
% 211.97/212.13  |- mesh__historyNote mesh__D019586 1998   
% 211.97/212.13  |- skos__hiddenLabel mesh__D019586 Hypertension, Intracranial
% 211.97/212.13  |- mesh__dateEstablished mesh__D005566 1973-01-01
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D005566 2000
% 211.97/212.13  |- skos__historyNote mesh__D005566 Formaldehyde %28%1966-1971%29%
% 211.97/212.13  |- skos__historyNote mesh__D005566 Cresols %28%1966-1971%29%
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D005566 1994
% 211.97/212.13  |- mesh__recordAuthorizer mesh__D005566 PLS
% 211.97/212.13  |- skos__broader mesh__D005566smesh__D003408
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D005566 2001
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D005566 1995
% 211.97/212.13  |- skos__broader mesh__D005566smesh__D005557
% 211.97/212.13  |- rdf__type mesh__D005566sskos__Concept
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D005566 2005
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D005566 2002
% 211.97/212.13  |- mesh__dateCreated mesh__D005566 1999-01-01
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D005566 1998
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D005566 1993
% 211.97/212.13  |- mesh__historyNote mesh__D005566 73%28%72%29%   
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D005566 2006
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D005566 2003
% 211.97/212.13  |- mesh__dateRevised mesh__D005566 1992-05-19
% 211.97/212.13  |- mesh__publicMeSHNote mesh__D005566 73   
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D005566 1999
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D005566 1996
% 211.97/212.13  |- mesh__recordOriginator mesh__D005566 NLM
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D005566 2004
% 211.97/212.13  |- mesh__recordMaintainer mesh__D005566 TGC
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D005566 1997
% 211.97/212.13  |- skos__prefLabel mesh__D005566 Formocresols
% 211.97/212.13  |- mesh__dateCreated mesh__D010700 1999-01-01
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D010700 2005
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D010700 1998
% 211.97/212.13  |- mesh__recordMaintainer mesh__D010700 PLS
% 211.97/212.13  |- mesh__dateRevised mesh__D010700 1995-03-13
% 211.97/212.13  |- skos__annotation mesh__D010700 no qualif   
% 211.97/212.13  |- skos__hiddenLabel mesh__D010700 Sound, Speech
% 211.97/212.13  |- skos__hiddenLabel mesh__D010700 Sounds, Speech
% 211.97/212.13  |- rdf__type mesh__D010700sskos__Concept
% 211.97/212.13  |- skos__hiddenLabel mesh__D010700 Speech Sound
% 211.97/212.13  |- skos__prefLabel mesh__D010700 Phonetics
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D010700 2002
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D010700 2004
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D010700 1997
% 211.97/212.13  |- skos__scopeNote mesh__D010700
% 211.97/212.13       The science or study of speech sounds and their production, transmission, and reception, and their analysis, classification, and transcription. %28%Random House Unabridged Dictionary, 2d ed%29%%A%    
% 211.97/212.13  |- skos__broader mesh__D010700smesh__D008037
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D010700 2001
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D010700 2006
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D010700 1999
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D010700 2003
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D010700 1996
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D010700 2000
% 211.97/212.13  |- mesh__recordAuthorizer mesh__D010700 PLS
% 211.97/212.13  |- mesh__recordOriginator mesh__D010700 NLM
% 211.97/212.13  |- mesh__recordOriginator mesh__D015994 PLS
% 211.97/212.13  |- mesh__recordMaintainer mesh__D015994 ags
% 211.97/212.13  |- mesh__onlineNote mesh__D015994
% 211.97/212.13       use INCIDENCE STUDIES to search INCIDENCE 1989   
% 211.97/212.13  |- skos__hiddenLabel mesh__D015994 Incidences
% 211.97/212.13  |- mesh__dateEstablished mesh__D015994 1990-01-01
% 211.97/212.13  |- mesh__recordAuthorizer mesh__D015994 sjn
% 211.97/212.13  |- mesh__dateRevised mesh__D015994 2005-06-30
% 211.97/212.13  |- mesh__historyNote mesh__D015994 90; was see INCIDENCE STUDIES 1989   
% 211.97/212.13  |- skos__historyNote mesh__D015994 Incidence Studies %28%1989%29%
% 211.97/212.13  |- rdf__type mesh__D015994sskos__Concept
% 211.97/212.13  |- skos__broader mesh__D015994smesh__D009017
% 211.97/212.13  |- mesh__dateCreated mesh__D015994 1989-09-06
% 211.97/212.13  |- mesh__publicMeSHNote mesh__D015994 90; was see INCIDENCE STUDIES 1989   
% 211.97/212.13  |- skos__annotation mesh__D015994
% 211.97/212.13       IM GEN only; coord NIM with disease /epidemiol %28%IM%29%; no qualif; total number of new cases: do not confuse with PREVALENCE, total number of new %26% old cases; read MeSH definitions; specify geog if pertinent%A%  
% 211.97/212.13  |- skos__scopeNote mesh__D015994
% 211.97/212.13       The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases, new or old, in the population at a given time.%A%    
% 211.97/212.13  |- skos__prefLabel mesh__D015994 Incidence
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D015994 2006
% 211.97/212.13  |- mesh__activeMeSHYear mesh__D048370 2006
% 211.97/212.13  |- mesh__recordOriginator mesh__D048370 jmp
% 211.97/212.13  |- mesh__dateCreated mesh__D048370 2004-07-07
% 211.97/212.13  |- rdf__type mesh__D048370sskos__Concept
% 211.97/212.13  |- skos__altLabel mesh__D048370
% 211.97/212.13       MEK2 %28%MAPK Extracellular Signal-Regulated Kinase 2%29%
% 211.97/212.13  |- skos__prefLabel mesh__D048370 MAP Kinase Kinase 2
% 211.97/212.14  |- skos__historyNote mesh__D048370
% 211.97/212.14       Protein-Tyrosine Kinase %28%2000-2004%29%
% 211.97/212.14  |- skos__hiddenLabel mesh__D048370
% 211.97/212.14       Mitogen Activated Protein Kinase Kinase 2
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D048370 2005
% 211.97/212.14  |- mesh__dateEstablished mesh__D048370 2005-01-01
% 211.97/212.14  |- skos__historyNote mesh__D048370
% 211.97/212.14       Mitogen-Activated Protein Kinases %28%2000-2004%29%
% 211.97/212.14  |- skos__altLabel mesh__D048370 MAPK Kinase 2
% 211.97/212.14  |- mesh__historyNote mesh__D048370 2005%28%1993%29%   
% 211.97/212.14  |- skos__altLabel mesh__D048370 MAP2K2 Protein
% 211.97/212.14  |- mesh__recordAuthorizer mesh__D048370 sjn
% 211.97/212.14  |- skos__broader mesh__D048370smesh__D020929
% 211.97/212.14  |- mesh__recordMaintainer mesh__D048370 jmp
% 211.97/212.14  |- skos__altLabel mesh__D048370 Kinase Activator Kinase MEK2
% 211.97/212.14  |- skos__altLabel mesh__D048370 MAPK-ERK Kinase 2
% 211.97/212.14  |- skos__altLabel mesh__D048370 Mitogen-Activated Protein Kinase Kinase 2
% 211.97/212.14  |- skos__hiddenLabel mesh__D048370
% 211.97/212.14       MAPK Extracellular Signal Regulated Kinase 2
% 211.97/212.14  |- skos__hiddenLabel mesh__D048370 MAPK ERK Kinase 2
% 211.97/212.14  |- skos__scopeNote mesh__D048370
% 211.97/212.14       A 44 kDa mitogen-activated protein kinase kinase with specificity for MITOGEN-ACTIVATED PROTEIN KINASE 1 and MITOGEN-ACTIVATED PROTEIN KINASE 3.%A%    
% 211.97/212.14  |- skos__altLabel mesh__D048370
% 211.97/212.14       MAPK Extracellular Signal-Regulated Kinase 2
% 211.97/212.14  |- mesh__publicMeSHNote mesh__D048370
% 211.97/212.14       2005; MAP KINASE KINASE 2 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES %26% PROTEIN-TYROSINE KINASE 2000-2004, %26% under PROTEIN-SERINE-THREONINE KINASES 1993-1999%A%  
% 211.97/212.14  |- skos__altLabel mesh__D048370
% 211.97/212.14       MEK-2 %28%MAPK Extracellular Signal-Regulated Kinase 2%29%
% 211.97/212.14  |- skos__historyNote mesh__D048370
% 211.97/212.14       Protein-Serine-Threonine Kinases %28%1993-1999%29%
% 211.97/212.14  |- skos__historyNote mesh__D009957 Fistula %28%1966%29%
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D009957 2004
% 211.97/212.14  |- mesh__publicMeSHNote mesh__D009957 67   
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D009957 2001
% 211.97/212.14  |- mesh__dateRevised mesh__D009957 1999-11-08
% 211.97/212.14  |- skos__broader mesh__D009957smesh__D016155
% 211.97/212.14  |- rdf__type mesh__D009957sskos__Concept
% 211.97/212.14  |- skos__annotation mesh__D009957 fistula policy: Manual 23.19+   
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D009957 2002
% 211.97/212.14  |- skos__hiddenLabel mesh__D009957 Fistulas, Oroantral
% 211.97/212.14  |- mesh__recordAuthorizer mesh__D009957 sjn
% 211.97/212.14  |- mesh__dateCreated mesh__D009957 1999-01-01
% 211.97/212.14  |- skos__hiddenLabel mesh__D009957 Oroantral Fistulas
% 211.97/212.14  |- mesh__dateEstablished mesh__D009957 1967-01-01
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D009957 2005
% 211.97/212.14  |- skos__scopeNote mesh__D009957
% 211.97/212.14       A fistula between the maxillary sinus and the oral cavity.%A%    
% 211.97/212.14  |- mesh__historyNote mesh__D009957 67   
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D009957 2006
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D009957 2003
% 211.97/212.14  |- mesh__recordMaintainer mesh__D009957 KEV
% 211.97/212.14  |- skos__prefLabel mesh__D009957 Oroantral Fistula
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D009957 2000
% 211.97/212.14  |- skos__hiddenLabel mesh__D009957 Fistula, Oroantral
% 211.97/212.14  |- mesh__recordOriginator mesh__D009957 NLM
% 211.97/212.14  |- skos__scopeNote mesh__D001974
% 211.97/212.14       A brominating agent that replaces hydrogen atoms in benzylic or allylic positions. It is used in the oxidation of secondary alcohols to ketones and in controlled low-energy brominations. %28%From Miall%27%s Dictionary of Chemistry, 5th ed; Hawley%27%s Condensed Chemical Dictionary, 12th ed,%29%.%A%    
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001974 2004
% 211.97/212.14  |- skos__altLabel mesh__D001974 N-Bromosuccinimide
% 211.97/212.14  |- mesh__recordMaintainer mesh__D001974 KEV
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001974 2002
% 211.97/212.14  |- mesh__historyNote mesh__D001974
% 211.97/212.14       91%28%75%29%; was see under SUCCINIMIDES 1975-90   
% 211.97/212.14  |- mesh__publicMeSHNote mesh__D001974
% 211.97/212.14       91; was see under SUCCINIMIDES 1975-90   
% 211.97/212.14  |- skos__historyNote mesh__D001974 Bromine %28%1972-1974%29%
% 211.97/212.14  |- skos__hiddenLabel mesh__D001974 N Bromosuccinimide
% 211.97/212.14  |- rdf__type mesh__D001974sskos__Concept
% 211.97/212.14  |- mesh__recordOriginator mesh__D001974 SJJ
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001974 2005
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001974 1998
% 211.97/212.14  |- skos__altLabel mesh__D001974 Succinbromimide
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001974 2000
% 211.97/212.14  |- skos__broader mesh__D001974smesh__D013388
% 211.97/212.14  |- mesh__dateRevised mesh__D001974 1997-06-20
% 211.97/212.14  |- mesh__recordAuthorizer mesh__D001974 SJN
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001974 2006
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001974 1999
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001974 2001
% 211.97/212.14  |- skos__prefLabel mesh__D001974 Bromosuccinimide
% 211.97/212.14  |- skos__related mesh__D001974smesh__D019822
% 211.97/212.14  |- skos__historyNote mesh__D001974 Succinimides %28%1972-1974%29%
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001974 2003
% 211.97/212.14  |- mesh__dateEstablished mesh__D001974 1991-01-01
% 211.97/212.14  |- mesh__dateCreated mesh__D001974 1974-11-19
% 211.97/212.14  |- mesh__dateRevised mesh__D009159 2005-06-30
% 211.97/212.14  |- mesh__dateEstablished mesh__D009159 1975-01-01
% 211.97/212.14  |- skos__historyNote mesh__D009159 Bacteria %28%1966-1974%29%
% 211.97/212.14  |- skos__scopeNote mesh__D009159
% 211.97/212.14       A family of gram-positive bacteria found in soil and dairy products and as parasites on animals and man. Several are important pathogens.%A%    
% 211.97/212.14  |- mesh__publicMeSHNote mesh__D009159 75   
% 211.97/212.14  |- rdf__type mesh__D009159sskos__Concept
% 211.97/212.14  |- skos__broader mesh__D009159smesh__D000192
% 211.97/212.14  |- mesh__recordMaintainer mesh__D009159 SYSTEM
% 211.97/212.14  |- skos__broader mesh__D009159smesh__D016989
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D009159 2006
% 211.97/212.14  |- skos__prefLabel mesh__D009159 Mycobacteriaceae
% 211.97/212.14  |- mesh__recordOriginator mesh__D009159 NLM
% 211.97/212.14  |- mesh__dateCreated mesh__D009159 1999-01-01
% 211.97/212.14  |- mesh__historyNote mesh__D009159 75   
% 211.97/212.14  |- mesh__recordAuthorizer mesh__D009159 sjn
% 211.97/212.14  |- skos__hiddenLabel mesh__D001176 Arthrogryposes
% 211.97/212.14  |- mesh__recordMaintainer mesh__D001176 kle
% 211.97/212.14  |- skos__annotation mesh__D001176
% 211.97/212.14       %22%persistent flexure or contracture of a joint%22%; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 211.97/212.14  |- mesh__publicMeSHNote mesh__D001176 65   
% 211.97/212.14  |- mesh__dateCreated mesh__D001176 1999-01-01
% 211.97/212.14  |- skos__hiddenLabel mesh__D001176 Arthromyodysplasias, Congenital
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001176 2002
% 211.97/212.14  |- mesh__historyNote mesh__D001176 65%28%63%29%   
% 211.97/212.14  |- skos__broader mesh__D001176smesh__D007592
% 211.97/212.14  |- skos__altLabel mesh__D001176 Amyoplasia Congenita
% 211.97/212.14  |- skos__hiddenLabel mesh__D001176 Guerin Stern Syndrome
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001176 2004
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001176 2001
% 211.97/212.14  |- skos__scopeNote mesh__D001176
% 211.97/212.14       Persistent flexure or contracture of a joint. %28%Dorland, 27th ed%29%%A%    
% 211.97/212.14  |- mesh__dateEstablished mesh__D001176 1965-01-01
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001176 2006
% 211.97/212.14  |- skos__altLabel mesh__D001176 Myodystrophia Fetalis Deformans
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001176 2003
% 211.97/212.14  |- skos__hiddenLabel mesh__D001176 Syndrome, Guerin-Stern
% 211.97/212.14  |- skos__altLabel mesh__D001176 Arthromyodysplasia, Congenital
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001176 2005
% 211.97/212.14  |- skos__prefLabel mesh__D001176 Arthrogryposis
% 211.97/212.14  |- mesh__dateRevised mesh__D001176 1999-11-03
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001176 2000
% 211.97/212.14  |- skos__broader mesh__D001176smesh__D009135
% 211.97/212.14  |- skos__altLabel mesh__D001176 Guerin-Stern Syndrome
% 211.97/212.14  |- rdf__type mesh__D001176sskos__Concept
% 211.97/212.14  |- mesh__recordAuthorizer mesh__D001176 sjn
% 211.97/212.14  |- skos__hiddenLabel mesh__D001176 Congenital Arthromyodysplasias
% 211.97/212.14  |- skos__broader mesh__D001176smesh__D009139
% 211.97/212.14  |- skos__altLabel mesh__D001176 Congenital Arthromyodysplasia
% 211.97/212.14  |- mesh__recordOriginator mesh__D001176 NLM
% 211.97/212.14  |- mesh__historyNote mesh__D020330
% 211.97/212.14       2000; for BELL%27%S PALSY use Facial Paralysis 1966-1999   
% 211.97/212.14  |- skos__hiddenLabel mesh__D020330 Palsies, Bell
% 211.97/212.14  |- skos__hiddenLabel mesh__D020330 Palsies, Bell%27%s
% 211.97/212.14  |- mesh__dateEstablished mesh__D020330 2000-01-01
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D020330 2005
% 211.97/212.14  |- mesh__recordAuthorizer mesh__D020330 sjn
% 211.97/212.14  |- skos__hiddenLabel mesh__D020330 Idiopathic Facial Paralysis
% 211.97/212.14  |- skos__hiddenLabel mesh__D020330 Idiopathic Facial Paralyses
% 211.97/212.14  |- skos__hiddenLabel mesh__D020330 Palsy, Bell%27%s
% 211.97/212.14  |- skos__hiddenLabel mesh__D020330 Paralyses, Herpetic Facial
% 211.97/212.14  |- skos__hiddenLabel mesh__D020330 Paralysis, Herpetic Facial
% 211.97/212.14  |- skos__broader mesh__D020330smesh__D009059
% 211.97/212.14  |- mesh__dateCreated mesh__D020330 1999-11-03
% 211.97/212.14  |- mesh__dateRevised mesh__D020330 2004-07-13
% 211.97/212.14  |- skos__prefLabel mesh__D020330 Bell Palsy
% 211.97/212.14  |- skos__hiddenLabel mesh__D020330 Herpetic Facial Paralyses
% 211.97/212.14  |- skos__scopeNote mesh__D020330
% 211.97/212.14       A syndrome characterized by the acute onset of unilateral FACIAL PARALYSIS which progresses over a 2-5 day period. Weakness of the orbicularis oculi muscle and resulting incomplete eye closure may be associated with corneal injury. Pain behind the ear often precedes the onset of paralysis. This condition may be associated with HERPESVIRUS 1, HUMAN infection of the facial nerve. %28%Adams et al., Principles of Neurology, 6th ed, p1376%29%%A%    
% 211.97/212.14  |- skos__hiddenLabel mesh__D020330 Bell%27%s Palsies
% 211.97/212.14  |- skos__altLabel mesh__D020330 Inflammatory Facial Neuropathy, Acute
% 211.97/212.14  |- skos__hiddenLabel mesh__D020330 Facial Paralyses, Idiopathic
% 211.97/212.14  |- skos__hiddenLabel mesh__D020330 Bell Palsies
% 211.97/212.14  |- mesh__recordMaintainer mesh__D020330 sjn
% 211.97/212.14  |- mesh__publicMeSHNote mesh__D020330
% 211.97/212.14       2000; for BELL%27%S PALSY see Facial Paralysis 1966-1999   
% 211.97/212.14  |- skos__hiddenLabel mesh__D020330 Paralyses, Idiopathic Facial
% 211.97/212.14  |- skos__altLabel mesh__D020330 Facial Neuropathy, Inflammatory, Acute
% 211.97/212.14  |- skos__historyNote mesh__D020330 Facial Paralysis %28%1966-1999%29%
% 211.97/212.14  |- skos__hiddenLabel mesh__D020330 Palsy, Bell
% 211.97/212.14  |- skos__broader mesh__D020330smesh__D005155
% 211.97/212.14  |- skos__hiddenLabel mesh__D020330 Bells Palsy
% 211.97/212.14  |- skos__hiddenLabel mesh__D020330 Facial Paralyses, Herpetic
% 211.97/212.14  |- skos__hiddenLabel mesh__D020330 Facial Paralysis, Herpetic
% 211.97/212.14  |- mesh__recordOriginator mesh__D020330 KEV
% 211.97/212.14  |- skos__altLabel mesh__D020330 Bell%27%s Palsy
% 211.97/212.14  |- rdf__type mesh__D020330sskos__Concept
% 211.97/212.14  |- skos__altLabel mesh__D020330 Acute Inflammatory Facial Neuropathy
% 211.97/212.14  |- skos__altLabel mesh__D020330 Acute Idiopathic Facial Neuropathy
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D020330 2006
% 211.97/212.14  |- skos__altLabel mesh__D020330 Idiopathic Acute Facial Neuropathy
% 211.97/212.14  |- skos__broader mesh__D020330smesh__D006566
% 211.97/212.14  |- skos__hiddenLabel mesh__D020330 Paralysis, Idiopathic Facial
% 211.97/212.14  |- skos__altLabel mesh__D020330 Facial Paralysis, Idiopathic
% 211.97/212.14  |- skos__altLabel mesh__D020330 Facial Neuropathy, Idiopathic Acute
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D019587 1999
% 211.97/212.14  |- skos__hiddenLabel mesh__D019587 Food Supplement
% 211.97/212.14  |- rdf__type mesh__D019587sskos__Concept
% 211.97/212.14  |- mesh__publicMeSHNote mesh__D019587
% 211.97/212.14       98; DIETARY SUPPLEMENTATION was see FOOD, FORTIFIED 1995-97; FOOD, SUPPLEMENTED was see FOOD, FORTIFIED 1975-97%A%  
% 211.97/212.14  |- skos__hiddenLabel mesh__D019587 Supplemented Foods
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D019587 2004
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D019587 2001
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D019587 1998
% 211.97/212.14  |- skos__hiddenLabel mesh__D019587 Supplemented Food
% 211.97/212.14  |- skos__historyNote mesh__D019587 Food Additives %28%1966-1974%29%
% 211.97/212.14  |- skos__hiddenLabel mesh__D019587 Supplementations, Dietary
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D019587 2003
% 211.97/212.14  |- skos__hiddenLabel mesh__D019587 Supplements, Dietary
% 211.97/212.14  |- skos__altLabel mesh__D019587 Food Supplements
% 211.97/212.14  |- mesh__onlineNote mesh__D019587
% 211.97/212.14       use FOOD, FORTIFIED to search DIETARY SUPPLEMENTATION 1995-97 %26% FOOD, SUPPLEMENTED 1975-97%A%  
% 211.97/212.14  |- skos__historyNote mesh__D019587 Food, Fortified %28%1972-1997%29%
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D019587 2000
% 211.97/212.14  |- skos__hiddenLabel mesh__D019587 Supplement, Dietary
% 211.97/212.14  |- skos__broader mesh__D019587smesh__D005502
% 211.97/212.14  |- skos__hiddenLabel mesh__D019587 Foods, Supplemented
% 211.97/212.14  |- mesh__dateEstablished mesh__D019587 1998-01-01
% 211.97/212.14  |- skos__prefLabel mesh__D019587 Dietary Supplements
% 211.97/212.14  |- skos__annotation mesh__D019587
% 211.97/212.14       nutrients added during cooking or eating: do not confuse with FOOD, FORTIFIED %28%supplemented during processing before they reach the table%29% or FOOD, FORMULATED %28%see MeSH definition%29% or FOOD ADDITIVES %28%%22%of little or no nutritive value%22%%29%; coord IM with specific nutrient if relevent %28%IM%29%%A%  
% 211.97/212.14  |- mesh__historyNote mesh__D019587
% 211.97/212.14       98; DIETARY SUPPLEMENTATION was see FOOD, FORTIFIED 1995-97; FOOD, SUPPLEMENTED was see FOOD, FORTIFIED 1975-97%A%  
% 211.97/212.14  |- skos__hiddenLabel mesh__D019587 Supplementation, Food
% 211.97/212.14  |- skos__hiddenLabel mesh__D019587 Supplementation, Dietary
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D019587 2006
% 211.97/212.14  |- skos__hiddenLabel mesh__D019587 Supplements, Food
% 211.97/212.14  |- skos__hiddenLabel mesh__D019587 Dietary Supplementations
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D019587 2005
% 211.97/212.14  |- mesh__dateCreated mesh__D019587 1997-06-20
% 211.97/212.14  |- skos__hiddenLabel mesh__D019587 Supplement, Food
% 211.97/212.14  |- skos__scopeNote mesh__D019587
% 211.97/212.14       Products in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance. %28%FDA Backgrounder, June 15, 1993, p2%29%%A%    
% 211.97/212.14  |- skos__hiddenLabel mesh__D019587 Dietary Supplement
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D019587 2002
% 211.97/212.14  |- skos__hiddenLabel mesh__D024721 Elements, E-Box
% 211.97/212.14  |- mesh__publicMeSHNote mesh__D024721 2002   
% 211.97/212.14  |- skos__hiddenLabel mesh__D024721 E-Box Motif
% 211.97/212.14  |- skos__hiddenLabel mesh__D024721 E Box Sites
% 211.97/212.14  |- skos__hiddenLabel mesh__D024721 E Box Sequences
% 211.97/212.14  |- skos__prefLabel mesh__D024721 E-Box Elements
% 211.97/212.14  |- mesh__historyNote mesh__D024721 2002   
% 211.97/212.14  |- skos__hiddenLabel mesh__D024721 Motifs, E-Box
% 211.97/212.14  |- skos__hiddenLabel mesh__D024721 E-Box Element
% 211.97/212.14  |- skos__scopeNote mesh__D024721
% 211.97/212.14       DNA locations with the consensus sequence CANNTG. ENHANCER ELEMENTS %28%GENETICS%29% may contain multiple copies of this element. E-boxes play a regulatory role in the control of transcription. They bind with basic helix-loop-helix %28%bHLH%29% type TRANSCRIPTION FACTORS. Binding specificity is determined by the specific bHLH heterodimer or homodimer combination and by the specific nucleotides at the 3rd and 4th position of the E-box sequence.%A%    
% 211.97/212.14  |- skos__hiddenLabel mesh__D024721 E-Box Sequence
% 211.97/212.14  |- skos__hiddenLabel mesh__D024721 E Box Motifs
% 211.97/212.14  |- mesh__dateEstablished mesh__D024721 2002-01-01
% 211.97/212.14  |- skos__broader mesh__D024721smesh__D004742
% 211.97/212.14  |- rdf__type mesh__D024721sskos__Concept
% 211.97/212.14  |- skos__hiddenLabel mesh__D024721 Site, E-Box
% 211.97/212.14  |- skos__hiddenLabel mesh__D024721 E-Box Site
% 211.97/212.14  |- skos__altLabel mesh__D024721 E-Box Sites
% 211.97/212.14  |- mesh__dateCreated mesh__D024721 2001-07-25
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D024721 2006
% 211.97/212.14  |- skos__hiddenLabel mesh__D024721 Sequences, E-Box
% 211.97/212.14  |- skos__hiddenLabel mesh__D024721 Sequence, E-Box
% 211.97/212.14  |- mesh__recordOriginator mesh__D024721 nns
% 211.97/212.14  |- mesh__dateRevised mesh__D024721 2005-06-30
% 211.97/212.14  |- skos__altLabel mesh__D024721 E-Box Motifs
% 211.97/212.14  |- skos__hiddenLabel mesh__D024721 Sites, E-Box
% 211.97/212.14  |- mesh__recordAuthorizer mesh__D024721 sjn
% 211.97/212.14  |- skos__hiddenLabel mesh__D024721 Motif, E-Box
% 211.97/212.14  |- skos__hiddenLabel mesh__D024721 Element, E-Box
% 211.97/212.14  |- mesh__recordMaintainer mesh__D024721 nns
% 211.97/212.14  |- skos__altLabel mesh__D024721 E-Box Sequences
% 211.97/212.14  |- skos__hiddenLabel mesh__D024721 E Box Elements
% 211.97/212.14  |- mesh__recordMaintainer mesh__D010701 PXP
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D010701 2001
% 211.97/212.14  |- rdf__type mesh__D010701sskos__Concept
% 211.97/212.14  |- mesh__recordOriginator mesh__D010701 NLM
% 211.97/212.14  |- skos__annotation mesh__D010701
% 211.97/212.14       NIM; consider also HEART AUSCULTATION; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: PHONOCARDIOGR%A%  
% 211.97/212.14  |- skos__broader mesh__D010701smesh__D006326
% 211.97/212.14  |- mesh__dateRevised mesh__D010701 1997-06-20
% 211.97/212.14  |- skos__scopeNote mesh__D010701
% 211.97/212.14       Graphic registration of the heart sounds picked up as vibrations and transformed by a piezoelectric crystal microphone into a varying electrical output according to the stresses imposed by the sound waves. The electrical output is amplified by a stethograph amplifier and recorded by a device incorporated into the electrocardiograph or by a multichannel recording machine.%A%    
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D010701 2003
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D010701 2002
% 211.97/212.14  |- skos__prefLabel mesh__D010701 Phonocardiography
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D010701 2004
% 211.97/212.14  |- mesh__dateCreated mesh__D010701 1999-01-01
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D010701 2005
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D010701 1998
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D010701 2006
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D010701 1999
% 211.97/212.14  |- mesh__recordAuthorizer mesh__D010701 SJN
% 211.97/212.14  |- skos__hiddenLabel mesh__D010701 Phonocardiographies
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D010701 2000
% 211.97/212.14  |- skos__hiddenLabel mesh__D015995 Prevalences
% 211.97/212.14  |- mesh__dateEstablished mesh__D015995 1990-01-01
% 211.97/212.14  |- skos__historyNote mesh__D015995 Prevalence Studies %28%1989%29%
% 211.97/212.14  |- skos__scopeNote mesh__D015995
% 211.97/212.14       The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.%A%    
% 211.97/212.14  |- skos__annotation mesh__D015995
% 211.97/212.14       IM GEN only; coord NIM with disease /epidemiol %28%IM%29%; no qualif; total number of cases, new %26% old: do not confuse with INCIDENCE, total number of new cases; read MeSH definitions; specify geog if pertinent%A%  
% 211.97/212.14  |- mesh__historyNote mesh__D015995 90; was see PREVALENCE STUDIES 1989   
% 211.97/212.14  |- mesh__recordAuthorizer mesh__D015995 sjn
% 211.97/212.14  |- rdf__type mesh__D015995sskos__Concept
% 211.97/212.14  |- skos__broader mesh__D015995smesh__D009017
% 211.97/212.14  |- mesh__publicMeSHNote mesh__D015995
% 211.97/212.14       90; was see PREVALENCE STUDIES 1989   
% 211.97/212.14  |- mesh__dateCreated mesh__D015995 1989-09-06
% 211.97/212.14  |- skos__prefLabel mesh__D015995 Prevalence
% 211.97/212.14  |- mesh__onlineNote mesh__D015995
% 211.97/212.14       use PREVALENCE STUDIES to search PREVALENCE 1989   
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D015995 2006
% 211.97/212.14  |- mesh__dateRevised mesh__D015995 2005-06-30
% 211.97/212.14  |- mesh__recordOriginator mesh__D015995 PLS
% 211.97/212.14  |- mesh__recordMaintainer mesh__D015995 ags
% 211.97/212.14  |- skos__historyNote mesh__D048371
% 211.97/212.14       Protein-Serine-Threonine Kinases %28%1995-1999%29%
% 211.97/212.14  |- skos__hiddenLabel mesh__D048371
% 211.97/212.14       Mitogen Activated Protein Kinase Kinase 3
% 211.97/212.14  |- skos__hiddenLabel mesh__D048371 Protein Kinase, MKK-3
% 211.97/212.14  |- skos__historyNote mesh__D048371
% 211.97/212.14       Mitogen-Activated Protein Kinase Kinases %28%2000-2004%29%
% 211.97/212.14  |- skos__hiddenLabel mesh__D048371 Protein Kinase, MEK3
% 211.97/212.14  |- skos__altLabel mesh__D048371 MEK-3 Protein Kinase
% 211.97/212.14  |- skos__altLabel mesh__D048371 MEK3 Protein Kinase
% 211.97/212.14  |- skos__broader mesh__D048371smesh__D020929
% 211.97/212.14  |- mesh__recordMaintainer mesh__D048371 jmp
% 211.97/212.14  |- mesh__dateEstablished mesh__D048371 2005-01-01
% 211.97/212.14  |- skos__altLabel mesh__D048371 MKK3 Protein Kinase
% 211.97/212.14  |- mesh__recordOriginator mesh__D048371 jmp
% 211.97/212.14  |- mesh__publicMeSHNote mesh__D048371
% 211.97/212.14       2005; MAP KINASE KINASE 3 was indexed under MITOGEN-ACTIVATED PROTEIN KINASE KINASES %26% PROTEIN-TYROSINE KINASE 2000-2004, %26% under PROTEIN-SERINE-THREONINE KINASES 1995-1999%A%  
% 211.97/212.14  |- skos__hiddenLabel mesh__D048371
% 211.97/212.14       Dual Specificity Mitogen Activated Protein Kinase Kinase 3
% 211.97/212.14  |- mesh__historyNote mesh__D048371 2005%28%1995%29%   
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D048371 2006
% 211.97/212.14  |- skos__altLabel mesh__D048371 MKK-3 Protein Kinase
% 211.97/212.14  |- mesh__dateCreated mesh__D048371 2004-07-07
% 211.97/212.14  |- skos__hiddenLabel mesh__D048371 MKK 3 Protein Kinase
% 211.97/212.14  |- skos__hiddenLabel mesh__D048371 MEK 3 Protein Kinase
% 211.97/212.14  |- skos__altLabel mesh__D048371 Mitogen-Activated Protein Kinase Kinase 3
% 211.97/212.14  |- rdf__type mesh__D048371sskos__Concept
% 211.97/212.14  |- skos__historyNote mesh__D048371
% 211.97/212.14       Protein-Tyrosine Kinase %28%2000-2004%29%
% 211.97/212.14  |- mesh__recordAuthorizer mesh__D048371 sjn
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D048371 2005
% 211.97/212.14  |- skos__scopeNote mesh__D048371
% 211.97/212.14       A mitogen-activated protein kinase kinase with specificity for a subset of  P38 MITOGEN-ACTIVATED PROTEIN KINASES that includes MITOGEN-ACTIVATED PROTEIN KINASE 12; MITOGEN-ACTIVATED PROTEIN KINASE 13; and MITOGEN-ACTIVATED PROTEIN KINASE 14.%A%    
% 211.97/212.14  |- skos__altLabel mesh__D048371
% 211.97/212.14       Dual Specificity Mitogen-Activated Protein Kinase Kinase 3
% 211.97/212.14  |- skos__hiddenLabel mesh__D048371 Protein Kinase, MKK3
% 211.97/212.14  |- skos__prefLabel mesh__D048371 MAP Kinase Kinase 3
% 211.97/212.14  |- skos__hiddenLabel mesh__D015197 Test, Carcinogenesis
% 211.97/212.14  |- mesh__dateCreated mesh__D015197 1988-04-23
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D015197 2001
% 211.97/212.14  |- skos__related mesh__D015197smesh__D009152
% 211.97/212.14  |- skos__scopeNote mesh__D015197
% 211.97/212.14       Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent %28%e.g., benzanthracenes%29% and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values.%A%    
% 211.97/212.14  |- skos__hiddenLabel mesh__D015197 Test, Carcinogenicity
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D015197 1999
% 211.97/212.14  |- skos__hiddenLabel mesh__D015197 Tests, Carcinogenicity
% 211.97/212.14  |- rdf__type mesh__D015197sskos__Concept
% 211.97/212.14  |- skos__hiddenLabel mesh__D015197 Tests, Carcinogenic Activity
% 211.97/212.14  |- mesh__historyNote mesh__D015197 89   
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D015197 2002
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D015197 2003
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D015197 1995
% 211.97/212.14  |- skos__hiddenLabel mesh__D015197 Potency Test, Carcinogenic
% 211.97/212.14  |- skos__hiddenLabel mesh__D015197 Tumorigenicity Test
% 211.97/212.14  |- skos__historyNote mesh__D015197 Carcinogens %28%1966-1988%29%
% 211.97/212.14  |- skos__hiddenLabel mesh__D015197 Carcinogenic Potency Test
% 211.97/212.14  |- skos__hiddenLabel mesh__D015197 Carcinogenic Activity Test
% 211.97/212.14  |- mesh__publicMeSHNote mesh__D015197 89   
% 211.97/212.14  |- mesh__dateEstablished mesh__D015197 1989-01-01
% 211.97/212.14  |- mesh__recordAuthorizer mesh__D015197 PLS
% 211.97/212.14  |- skos__altLabel mesh__D015197 Tumorigenicity Tests
% 211.97/212.14  |- skos__hiddenLabel mesh__D015197 Potency Tests, Carcinogenic
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D015197 2004
% 211.97/212.14  |- skos__hiddenLabel mesh__D015197 Tests, Tumorigenicity
% 211.97/212.14  |- skos__annotation mesh__D015197 NIM; Manual 24.5.6.2+   
% 211.97/212.14  |- skos__hiddenLabel mesh__D015197 Carcinogenesis Test
% 211.97/212.14  |- skos__hiddenLabel mesh__D015197 Test, Carcinogenic Potency
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D015197 1996
% 211.97/212.14  |- skos__hiddenLabel mesh__D015197 Tests, Carcinogenic Potency
% 211.97/212.14  |- skos__hiddenLabel mesh__D015197 Tests, Carcinogen
% 211.97/212.14  |- mesh__recordMaintainer mesh__D015197 AGS
% 211.97/212.14  |- skos__altLabel mesh__D015197 Carcinogenesis Tests
% 211.97/212.14  |- mesh__recordOriginator mesh__D015197 EJB
% 211.97/212.14  |- skos__hiddenLabel mesh__D015197 Carcinogen Test
% 211.97/212.14  |- skos__historyNote mesh__D015197 Mutagenicity Tests %28%1981-1988%29%
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D015197 2005
% 211.97/212.14  |- skos__hiddenLabel mesh__D015197 Carcinogenicity Test
% 211.97/212.14  |- skos__altLabel mesh__D015197 Carcinogen Tests
% 211.97/212.14  |- skos__hiddenLabel mesh__D015197 Test, Tumorigenicity
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D015197 1997
% 211.97/212.14  |- skos__prefLabel mesh__D015197 Carcinogenicity Tests
% 211.97/212.14  |- skos__hiddenLabel mesh__D015197 Tests, Carcinogenesis
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D015197 2000
% 211.97/212.14  |- skos__altLabel mesh__D015197 Carcinogenic Potency Tests
% 211.97/212.14  |- skos__hiddenLabel mesh__D015197 Test, Carcinogenic Activity
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D015197 2006
% 211.97/212.14  |- skos__hiddenLabel mesh__D015197 Test, Carcinogen
% 211.97/212.14  |- skos__altLabel mesh__D015197 Carcinogenic Activity Tests
% 211.97/212.14  |- mesh__dateRevised mesh__D015197 1994-05-12
% 211.97/212.14  |- skos__broader mesh__D015197smesh__D018675
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D015197 1998
% 211.97/212.14  |- mesh__onlineNote mesh__D009958
% 211.97/212.14       use OROFACIODIGITAL SYNDROMES to search OROFACIODIGITAL SYNDROME 1966-78%28%as Prov 1966-74%29%%A%  
% 211.97/212.14  |- rdf__type mesh__D009958sskos__Concept
% 211.97/212.14  |- skos__hiddenLabel mesh__D009958 Gorlin Psaume Syndrome
% 211.97/212.14  |- skos__prefLabel mesh__D009958 Orofaciodigital Syndromes
% 211.97/212.14  |- skos__scopeNote mesh__D009958
% 211.97/212.14       Two syndromes of oral, facial, and digital malformations. Type I %28%Papillon-Leage and Psaume syndrome, Gorlin-Psaume syndrome%29% is inherited as an X-linked dominant trait and is found only in females and XXY males. Type II %28%Mohr syndrome%29% is inherited as an autosomal recessive trait.%A%    
% 211.97/212.14  |- skos__broader mesh__D009958smesh__D000015
% 211.97/212.14  |- mesh__historyNote mesh__D009958
% 211.97/212.14       79; was OROFACIODIGITAL SYNDROME see under ABNORMALITIES, MULTIPLE 1975-78; was OROFACIODIGITAL SYNDROME 1964-74 %28%Prov%29%%A%  
% 211.97/212.14  |- skos__hiddenLabel mesh__D009958 Syndromes, Orofaciodigital
% 211.97/212.14  |- mesh__recordOriginator mesh__D009958 NLM
% 211.97/212.14  |- skos__hiddenLabel mesh__D009958 Syndrome, Mohr
% 211.97/212.14  |- mesh__dateRevised mesh__D009958 2001-07-25
% 211.97/212.14  |- mesh__dateCreated mesh__D009958 1999-01-01
% 211.97/212.14  |- skos__hiddenLabel mesh__D009958 Syndrome, Orofaciodigital
% 211.97/212.14  |- skos__altLabel mesh__D009958 Gorlin-Psaume Syndrome
% 211.97/212.14  |- skos__broader mesh__D009958smesh__D019465
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D009958 2005
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D009958 2002
% 211.97/212.14  |- mesh__recordMaintainer mesh__D009958 nns
% 211.97/212.14  |- skos__broader mesh__D009958smesh__D025064
% 211.97/212.14  |- skos__hiddenLabel mesh__D009958 Syndrome, Gorlin-Psaume
% 211.97/212.14  |- mesh__dateEstablished mesh__D009958 1991-01-01
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D009958 2006
% 211.97/212.14  |- skos__broader mesh__D009958smesh__D004413
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D009958 2003
% 211.97/212.14  |- mesh__recordAuthorizer mesh__D009958 sjn
% 211.97/212.14  |- skos__hiddenLabel mesh__D009958 Orofaciodigital Syndrome
% 211.97/212.14  |- skos__annotation mesh__D009958
% 211.97/212.14       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 211.97/212.14  |- skos__hiddenLabel mesh__D009958 Papillon Leage and Psaume Syndrome
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D009958 2004
% 211.97/212.14  |- mesh__publicMeSHNote mesh__D009958
% 211.97/212.14       79; was OROFACIODIGITAL SYNDROME see under ABNORMALITIES, MULTIPLE 1975-78%A%  
% 211.97/212.14  |- mesh__recordOriginator mesh__D001975 RLS
% 211.97/212.14  |- skos__prefLabel mesh__D001975 Bromotrichloromethane
% 211.97/212.14  |- skos__altLabel mesh__D001975 Trichlorobromomethane
% 211.97/212.14  |- skos__broader mesh__D001975smesh__D006842
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001975 1994
% 211.97/212.14  |- rdf__type mesh__D001975sskos__Concept
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001975 2005
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001975 1998
% 211.97/212.14  |- mesh__dateRevised mesh__D001975 1992-05-08
% 211.97/212.14  |- mesh__recordMaintainer mesh__D001975 TAP
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001975 1995
% 211.97/212.14  |- mesh__dateCreated mesh__D001975 1975-07-18
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001975 2002
% 211.97/212.14  |- skos__broader mesh__D001975smesh__D002725
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001975 2006
% 211.97/212.14  |- mesh__activeMeSHYear mesh__D001975 1999
% 211.97/212.14  |- mesh__historyNote mesh__D001975
% 211.97/212.14       91%28%76%29%; was see under CHLOROFORM 1976-90   
% 211.97/212.14  |- mesh__recordAuthorizer mesh__D001975 PLS
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001975 2003
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001975 1996
% 211.97/212.15  |- mesh__dateEstablished mesh__D001975 1991-01-01
% 211.97/212.15  |- skos__scopeNote mesh__D001975
% 211.97/212.15       A potent liver poison. In rats, bromotrichloromethane produces about three times the degree of liver microsomal lipid peroxidation as does carbon tetrachloride.%A%    
% 211.97/212.15  |- skos__historyNote mesh__D001975 Chloroform %28%1974%29% /AA %28%1975%29%
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001975 1993
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001975 2000
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001975 2004
% 211.97/212.15  |- mesh__publicMeSHNote mesh__D001975
% 211.97/212.15       91; was see under CHLOROFORM 1976-90   
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001975 1997
% 211.97/212.15  |- skos__historyNote mesh__D001975 Bromine %28%1974-1975%29%
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001975 2001
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001177 1997
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001177 2004
% 211.97/212.15  |- skos__hiddenLabel mesh__D001177 Charcot Joint
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001177 2000
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001177 1999
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001177 2006
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001177 2003
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001177 1996
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001177 1995
% 211.97/212.15  |- skos__hiddenLabel mesh__D001177 Neurogenic Arthropathies
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001177 1998
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001177 2005
% 211.97/212.15  |- skos__hiddenLabel mesh__D001177 Charcots Joint
% 211.97/212.15  |- rdf__type mesh__D001177sskos__Concept
% 211.97/212.15  |- mesh__recordOriginator mesh__D001177 NLM
% 211.97/212.15  |- mesh__recordMaintainer mesh__D001177 TGC
% 211.97/212.15  |- mesh__recordAuthorizer mesh__D001177 PLS
% 211.97/212.15  |- skos__hiddenLabel mesh__D001177 Neurogenic Arthropathy
% 211.97/212.15  |- skos__altLabel mesh__D001177 Charcot%27%s Joint
% 211.97/212.15  |- skos__prefLabel mesh__D001177 Arthropathy, Neurogenic
% 211.97/212.15  |- skos__hiddenLabel mesh__D001177 Arthropathies, Neurogenic
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001177 2002
% 211.97/212.15  |- skos__hiddenLabel mesh__D001177 Joint, Charcot%27%s
% 211.97/212.15  |- skos__broader mesh__D001177smesh__D007592
% 211.97/212.15  |- mesh__dateRevised mesh__D001177 1994-05-24
% 211.97/212.15  |- mesh__dateCreated mesh__D001177 1999-01-01
% 211.97/212.15  |- skos__scopeNote mesh__D001177
% 211.97/212.15       Chronic progressive degeneration of the stress-bearing portion of a joint, with bizarre hypertrophic changes at the periphery. It is probably a complication of a variety of neurologic disorders, particularly TABES DORSALIS, involving loss of sensation, which leads to relaxation of supporting structures and chronic instability of the joint. %28%Dorland, 27th ed%29%%A%    
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001177 2001
% 211.97/212.15  |- skos__scopeNote mesh__D006660
% 211.97/212.15       Infection resulting from inhalation or ingestion of spores of the fungus of the genus HISTOPLASMA, species H. capsulatum. It is worldwide in distribution and particularly common in the midwestern United States. %28%From Dorland, 27th ed%29%%A%    
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D006660 2003
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D006660 1999
% 211.97/212.15  |- skos__prefLabel mesh__D006660 Histoplasmosis
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D006660 1997
% 211.97/212.15  |- rdf__type mesh__D006660sskos__Concept
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D006660 1998
% 211.97/212.15  |- skos__hiddenLabel mesh__D006660 Histoplasmoses
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D006660 2002
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D006660 1996
% 211.97/212.15  |- skos__broader mesh__D006660smesh__D009181
% 211.97/212.15  |- skos__annotation mesh__D006660 fungus dis   
% 211.97/212.15  |- mesh__recordOriginator mesh__D006660 NLM
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D006660 1995
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D006660 2006
% 211.97/212.15  |- mesh__recordMaintainer mesh__D006660 jls
% 211.97/212.15  |- mesh__dateCreated mesh__D006660 1999-01-01
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D006660 2005A
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D006660 2004
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D006660 2001
% 211.97/212.15  |- mesh__dateRevised mesh__D006660 2004-07-28
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D006660 2000
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D006660 1994
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D006660 2005
% 211.97/212.15  |- mesh__recordAuthorizer mesh__D006660 jls
% 211.97/212.15  |- skos__related mesh__D020331smesh__D005158
% 211.97/212.15  |- skos__historyNote mesh__D020331 Facial Paralysis %28%1966-1999%29%
% 211.97/212.15  |- skos__hiddenLabel mesh__D020331 Syndromes, Mobius
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D020331 2003
% 211.97/212.15  |- skos__hiddenLabel mesh__D020331 Syndrome, Moebius
% 211.97/212.15  |- skos__prefLabel mesh__D020331 Mobius Syndrome
% 211.97/212.15  |- skos__hiddenLabel mesh__D020331 Syndromes, Moebius
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D020331 2002
% 211.97/212.15  |- skos__altLabel mesh__D020331 Moebius Congenital Oculofacial Paralysis
% 211.97/212.15  |- skos__hiddenLabel mesh__D020331 Mobius Syndromes
% 211.97/212.15  |- skos__scopeNote mesh__D020331
% 211.97/212.15       A syndrome of congenital facial paralysis, frequently associated with abducens palsy and other congenital abnormalities including lingual palsy, clubfeet, brachial disorders, cognitive deficits, and pectoral muscle defects. Pathologic findings are variable and include brain stem nuclear aplasia, facial nerve aplasia, and facial muscle aplasia, consistent with a multifactorial etiology. %28%Adams et al., Principles of Neurology, 6th ed, p1020%29%%A%    
% 211.97/212.15  |- skos__altLabel mesh__D020331 Moebius Syndrome
% 211.97/212.15  |- mesh__dateRevised mesh__D020331 1999-11-30
% 211.97/212.15  |- skos__broader mesh__D020331smesh__D005155
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D020331 2000A
% 211.97/212.15  |- mesh__recordAuthorizer mesh__D020331 ags
% 211.97/212.15  |- rdf__type mesh__D020331sskos__Concept
% 211.97/212.15  |- skos__altLabel mesh__D020331 Congenital Oculofacial Paralysis, Moebius
% 211.97/212.15  |- mesh__historyNote mesh__D020331 2000; use FACIAL PARALYSIS 1997-1999   
% 211.97/212.15  |- mesh__recordMaintainer mesh__D020331 ags
% 211.97/212.15  |- skos__broader mesh__D020331smesh__D007232
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D020331 2006
% 211.97/212.15  |- mesh__dateCreated mesh__D020331 1999-11-08
% 211.97/212.15  |- mesh__publicMeSHNote mesh__D020331
% 211.97/212.15       2000: see FACIAL PARALYSIS 1997-1999   
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D020331 2001
% 211.97/212.15  |- mesh__dateEstablished mesh__D020331 2000-01-01
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D020331 2004
% 211.97/212.15  |- skos__hiddenLabel mesh__D020331 Moebius Syndromes
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D020331 2005
% 211.97/212.15  |- skos__hiddenLabel mesh__D020331 Syndrome, Mobius
% 211.97/212.15  |- mesh__recordOriginator mesh__D020331 KEV
% 211.97/212.15  |- skos__broader mesh__D020331smesh__D000015
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D020331 2000
% 211.97/212.15  |- mesh__historyNote mesh__D019588 98   
% 211.97/212.15  |- skos__broader mesh__D019588smesh__D012816
% 211.97/212.15  |- skos__historyNote mesh__D019588 Aging %28%1966-1997%29%
% 211.97/212.15  |- skos__annotation mesh__D019588
% 211.97/212.15       unspecified with relation to age; in children, consider PROGERIA; in adults, consider PROGERIA, ADULT see WERNER SYNDROME%A%  
% 211.97/212.15  |- skos__altLabel mesh__D019588 Premature Aging
% 211.97/212.15  |- mesh__recordMaintainer mesh__D019588 KEV
% 211.97/212.15  |- skos__historyNote mesh__D019588 Werner Syndrome %28%1971-1997%29%
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D019588 2006
% 211.97/212.15  |- mesh__publicMeSHNote mesh__D019588 98   
% 211.97/212.15  |- mesh__dateRevised mesh__D019588 1999-11-08
% 211.97/212.15  |- mesh__dateCreated mesh__D019588 1997-06-20
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D019588 2002
% 211.97/212.15  |- mesh__recordOriginator mesh__D019588 TGC
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D019588 2005
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D019588 2001
% 211.97/212.15  |- skos__historyNote mesh__D019588 Cockayne Syndrome %28%1987-1997%29%
% 211.97/212.15  |- rdf__type mesh__D019588sskos__Concept
% 211.97/212.15  |- mesh__recordAuthorizer mesh__D019588 sjn
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D019588 2004
% 211.97/212.15  |- mesh__dateEstablished mesh__D019588 1998-01-01
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D019588 2000
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D019588 2003
% 211.97/212.15  |- skos__prefLabel mesh__D019588 Aging, Premature
% 211.97/212.15  |- skos__scopeNote mesh__D019588
% 211.97/212.15       Changes in the organism associated with senescence, occurring at an accelerated rate.%A%    
% 211.97/212.15  |- skos__historyNote mesh__D019588 Progeria %28%1969-1997%29%
% 211.97/212.15  |- skos__hiddenLabel mesh__D005568 Controls, Records
% 211.97/212.15  |- mesh__dateRevised mesh__D005568 2002-07-03
% 211.97/212.15  |- mesh__publicMeSHNote mesh__D005568
% 211.97/212.15       91; was see under OFFICE MANAGEMENT Aug 1977-90   
% 211.97/212.15  |- skos__hiddenLabel mesh__D005568 Records Controls
% 211.97/212.15  |- skos__related mesh__D005568smesh__D016347
% 211.97/212.15  |- skos__hiddenLabel mesh__D005568 Control, Records
% 211.97/212.15  |- rdf__type mesh__D005568sskos__Concept
% 211.97/212.15  |- skos__annotation mesh__D005568
% 211.97/212.15       coord NIM with specific records heading  %28%e.g., MEDICAL RECORDS; NURSING RECORDS%29% %28%IM%29%; DF: FORMS CONTROL%A%  
% 211.97/212.15  |- skos__scopeNote mesh__D005568
% 211.97/212.15       A management function in which standards and guidelines are developed for the developing, maintaining, and handling of forms and records.%A%    
% 211.97/212.15  |- mesh__recordMaintainer mesh__D005568 tjk
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D005568 2004
% 211.97/212.15  |- mesh__historyNote mesh__D005568
% 211.97/212.15       91%28%Aug 77%29%; was see under OFFICE MANAGEMENT 1977-90   
% 211.97/212.15  |- mesh__recordAuthorizer mesh__D005568 sjn
% 211.97/212.15  |- skos__hiddenLabel mesh__D005568 Control, Forms
% 211.97/212.15  |- skos__broader mesh__D005568smesh__D009817
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D005568 2006
% 211.97/212.15  |- skos__prefLabel mesh__D005568 Forms and Records Control
% 211.97/212.15  |- skos__hiddenLabel mesh__D005568 Controls, Forms
% 211.97/212.15  |- mesh__dateCreated mesh__D005568 1977-05-05
% 211.97/212.15  |- mesh__dateEstablished mesh__D005568 1991-01-01
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D005568 2003
% 211.97/212.15  |- skos__hiddenLabel mesh__D005568 Forms Controls
% 211.97/212.15  |- mesh__recordOriginator mesh__D005568 EC
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D005568 2005
% 211.97/212.15  |- skos__related mesh__D024722smesh__D024741
% 211.97/212.15  |- skos__prefLabel mesh__D024722 Cardiac Myosins
% 211.97/212.15  |- mesh__dateRevised mesh__D024722 2005-06-30
% 211.97/212.15  |- mesh__dateEstablished mesh__D024722 2002-01-01
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D024722 2006
% 211.97/212.15  |- mesh__recordAuthorizer mesh__D024722 sjn
% 211.97/212.15  |- skos__hiddenLabel mesh__D024722 Myosin, Cardiac
% 211.97/212.15  |- mesh__recordMaintainer mesh__D024722 DRC
% 211.97/212.15  |- skos__altLabel mesh__D024722 Cardiac Myosin
% 211.97/212.15  |- skos__hiddenLabel mesh__D024722 Muscle Myosins, Cardiac
% 211.97/212.15  |- skos__hiddenLabel mesh__D024722 Myosins, Cardiac Muscle
% 211.97/212.15  |- skos__altLabel mesh__D024722 Myosins, Cardiac
% 211.97/212.15  |- mesh__historyNote mesh__D024722 2002   
% 211.97/212.15  |- skos__broader mesh__D024722smesh__D024462
% 211.97/212.15  |- skos__historyNote mesh__D024722 Myosins %28%1973-2001%29%
% 211.97/212.15  |- mesh__recordOriginator mesh__D024722 jmp
% 211.97/212.15  |- mesh__publicMeSHNote mesh__D024722 2002   
% 211.97/212.15  |- skos__altLabel mesh__D024722 Cardiac Muscle Myosins
% 211.97/212.15  |- skos__scopeNote mesh__D024722
% 211.97/212.15       Myosin type II isoforms found in cardiac muscle.     
% 211.97/212.15  |- skos__historyNote mesh__D024722 Muscle Proteins %28%1965-1972%29%
% 211.97/212.15  |- mesh__dateCreated mesh__D024722 2001-07-25
% 211.97/212.15  |- rdf__type mesh__D024722sskos__Concept
% 211.97/212.15  |- skos__annotation mesh__D002270
% 211.97/212.15       usually caused by Staph; malignant carbuncle = ANTHRAX   
% 211.97/212.15  |- skos__hiddenLabel mesh__D002270 Carbuncles
% 211.97/212.15  |- rdf__type mesh__D002270sskos__Concept
% 211.97/212.15  |- mesh__recordAuthorizer mesh__D002270 PLS
% 211.97/212.15  |- skos__scopeNote mesh__D002270
% 211.97/212.15       An infection of cutaneous and subcutaneous tissue that consists of a cluster of boils. Commonly, the causative agent is STAPHYLOCOCCUS AUREUS. Carbuncles produce fever, leukocytosis, extreme pain, and prostration.%A%    
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D002270 1999
% 211.97/212.15  |- skos__prefLabel mesh__D002270 Carbuncle
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D002270 1997
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D002270 2002
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D002270 1998
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D002270 1996
% 211.97/212.15  |- mesh__dateRevised mesh__D002270 1994-02-08
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D002270 2006
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D002270 2004
% 211.97/212.15  |- skos__related mesh__D002270smesh__D005667
% 211.97/212.15  |- skos__broader mesh__D002270smesh__D005667
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D002270 2005
% 211.97/212.15  |- mesh__recordMaintainer mesh__D002270 PXP
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D002270 2001
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D002270 1995
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D002270 2003
% 211.97/212.15  |- mesh__recordOriginator mesh__D002270 NLM
% 211.97/212.15  |- mesh__dateCreated mesh__D002270 1999-01-01
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D002270 2000
% 211.97/212.15  |- rdf__type mesh__D010702sskos__Concept
% 211.97/212.15  |- skos__scopeNote mesh__D010702
% 211.97/212.15       A cholinesterase inhibitor that is used as an insecticide.%A%    
% 211.97/212.15  |- skos__prefLabel mesh__D010702 Phorate
% 211.97/212.15  |- mesh__dateEstablished mesh__D010702 1991-01-01
% 211.97/212.15  |- mesh__recordMaintainer mesh__D010702 ssb
% 211.97/212.15  |- mesh__recordAuthorizer mesh__D010702 sjn
% 211.97/212.15  |- mesh__publicMeSHNote mesh__D010702
% 211.97/212.15       91; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90%A%  
% 211.97/212.15  |- mesh__dateCreated mesh__D010702 1999-01-01
% 211.97/212.15  |- mesh__recordOriginator mesh__D010702 NLM
% 211.97/212.15  |- mesh__dateRevised mesh__D010702 2005-06-30
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D010702 2006
% 211.97/212.15  |- mesh__historyNote mesh__D010702
% 211.97/212.15       91%28%72%29%; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90%A%  
% 211.97/212.15  |- skos__hiddenLabel mesh__D010702 Thimet 10G
% 211.97/212.15  |- skos__annotation mesh__D010702 TN 111 for eff on insects   
% 211.97/212.15  |- skos__hiddenLabel mesh__D010702 Thimet 10 G
% 211.97/212.15  |- skos__historyNote mesh__D010702 Insecticides %28%1966-1971%29%
% 211.97/212.15  |- skos__broader mesh__D010702smesh__D009946
% 211.97/212.15  |- skos__hiddenLabel mesh__D015996 Rates, Survival
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D015996 1998
% 211.97/212.15  |- mesh__recordAuthorizer mesh__D015996 PLS
% 211.97/212.15  |- skos__hiddenLabel mesh__D015996 Survival Time, Mean
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D015996 2004
% 211.97/212.15  |- skos__hiddenLabel mesh__D015996 Mean Survival Times
% 211.97/212.15  |- rdf__type mesh__D015996sskos__Concept
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D015996 2001
% 211.97/212.15  |- skos__hiddenLabel mesh__D015996 Survival Rates
% 211.97/212.15  |- skos__hiddenLabel mesh__D015996 Survival Rates, Cumulative
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D015996 2003
% 211.97/212.15  |- skos__hiddenLabel mesh__D015996 Survival Rate, Cumulative
% 211.97/212.15  |- skos__broader mesh__D015996smesh__D009026
% 211.97/212.15  |- skos__annotation mesh__D015996
% 211.97/212.15       IM GEN only; coord NIM with disease /mortal %28%IM%29%; specify geog if pertinent%A%  
% 211.97/212.15  |- skos__scopeNote mesh__D015996
% 211.97/212.15       The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.%A%    
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D015996 2000
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D015996 2006
% 211.97/212.15  |- skos__hiddenLabel mesh__D015996 Rate, Cumulative Survival
% 211.97/212.15  |- skos__hiddenLabel mesh__D015996 Rate, Survival
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D015996 1997
% 211.97/212.15  |- mesh__recordOriginator mesh__D015996 PLS
% 211.97/212.15  |- skos__hiddenLabel mesh__D015996 Time, Mean Survival
% 211.97/212.15  |- skos__hiddenLabel mesh__D015996 Survival Times, Mean
% 211.97/212.15  |- mesh__dateRevised mesh__D015996 1995-05-25
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D015996 2005
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D015996 2002
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D015996 1996
% 211.97/212.15  |- skos__hiddenLabel mesh__D015996 Cumulative Survival Rates
% 211.97/212.15  |- skos__historyNote mesh__D015996 Follow-Up Studies %28%1966-1989%29%
% 211.97/212.15  |- mesh__dateCreated mesh__D015996 1989-05-25
% 211.97/212.15  |- skos__historyNote mesh__D015996
% 211.97/212.15       specific disease/mortality %28%1966-1989%29%
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D015996 1999
% 211.97/212.15  |- skos__hiddenLabel mesh__D015996 Rates, Cumulative Survival
% 211.97/212.15  |- mesh__publicMeSHNote mesh__D015996 90   
% 211.97/212.15  |- skos__hiddenLabel mesh__D015996 Times, Mean Survival
% 211.97/212.15  |- mesh__dateEstablished mesh__D015996 1990-01-01
% 211.97/212.15  |- mesh__historyNote mesh__D015996 90   
% 211.97/212.15  |- mesh__recordMaintainer mesh__D015996 PLS
% 211.97/212.15  |- skos__prefLabel mesh__D015996 Survival Rate
% 211.97/212.15  |- mesh__recordOriginator mesh__D048372 ags
% 211.97/212.15  |- mesh__publicMeSHNote mesh__D048372 2005   
% 211.97/212.15  |- mesh__recordMaintainer mesh__D048372 SYSTEM
% 211.97/212.15  |- mesh__recordAuthorizer mesh__D048372 sjn
% 211.97/212.15  |- skos__prefLabel mesh__D048372 Streptomyces coelicolor
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D048372 2006
% 211.97/212.15  |- mesh__dateCreated mesh__D048372 2004-07-07
% 211.97/212.15  |- rdf__type mesh__D048372sskos__Concept
% 211.97/212.15  |- skos__broader mesh__D048372smesh__D013302
% 211.97/212.15  |- mesh__dateEstablished mesh__D048372 2005-01-01
% 211.97/212.15  |- skos__scopeNote mesh__D048372
% 211.97/212.15       A soil-dwelling actinomycete with a complex lifecycle involving mycelial growth and spore formation. It is involved in the production of a number of medically important ANTIBIOTICS.%A%    
% 211.97/212.15  |- mesh__historyNote mesh__D048372 2005   
% 211.97/212.15  |- skos__historyNote mesh__D048372 Streptomyces %28%1966-2004%29%
% 211.97/212.15  |- mesh__dateRevised mesh__D048372 2005-06-30
% 211.97/212.15  |- skos__related mesh__D015198smesh__D013287
% 211.97/212.15  |- mesh__dateEstablished mesh__D015198 1989-01-01
% 211.97/212.15  |- mesh__dateRevised mesh__D015198 2003-07-09
% 211.97/212.15  |- mesh__recordAuthorizer mesh__D015198 sjn
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D015198 2005
% 211.97/212.15  |- skos__historyNote mesh__D015198
% 211.97/212.15       Chemistry, Pharmaceutical %28%1984-1988%29%
% 211.97/212.15  |- mesh__recordMaintainer mesh__D015198 ssb
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D015198 2006
% 211.97/212.15  |- mesh__historyNote mesh__D015198 89   
% 211.97/212.15  |- skos__historyNote mesh__D015198 Street Drugs %28%1985-1988%29%
% 211.97/212.15  |- skos__hiddenLabel mesh__D015198 Drugs, Customized
% 211.97/212.15  |- skos__scopeNote mesh__D015198
% 211.97/212.15       Drugs designed and synthesized, often for illegal street use, by modification of existing drug structures %28%e.g., amphetamines%29%. Of special interest are MPTP %28%a reverse ester of meperidine%29%, MDA %28%3,4-methylenedioxyamphetamine%29%, and MDMA %28%3,4-methylenedioxymethamphetamine%29%. Many drugs act on the aminergic system, the physiologically active biogenic amines.%A%    
% 211.97/212.15  |- skos__annotation mesh__D015198
% 211.97/212.15       D25-26 qualif; coord IM with specific drug or chemical %28%IM%29%; do not confuse with DRUG DESIGN%A%  
% 211.97/212.15  |- mesh__publicMeSHNote mesh__D015198 89   
% 211.97/212.15  |- skos__broader mesh__D015198smesh__D004364
% 211.97/212.15  |- skos__altLabel mesh__D015198 Customized Drugs
% 211.97/212.15  |- skos__prefLabel mesh__D015198 Designer Drugs
% 211.97/212.15  |- mesh__recordOriginator mesh__D015198 EJB
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D015198 2004
% 211.97/212.15  |- rdf__type mesh__D015198sskos__Concept
% 211.97/212.15  |- skos__hiddenLabel mesh__D015198 Drugs, Designer
% 211.97/212.15  |- mesh__dateCreated mesh__D015198 1988-04-23
% 211.97/212.15  |- skos__hiddenLabel mesh__D009959 Oropharyngeal Neoplasm
% 211.97/212.15  |- skos__scopeNote mesh__D009959 Tumors or cancer of the OROPHARYNX.     
% 211.97/212.15  |- skos__hiddenLabel mesh__D009959 Oropharyngeal Cancers
% 211.97/212.15  |- skos__altLabel mesh__D009959 Oropharynx Neoplasms
% 211.97/212.15  |- skos__hiddenLabel mesh__D009959 Oropharnyx Cancers
% 211.97/212.15  |- mesh__recordAuthorizer mesh__D009959 sjn
% 211.97/212.15  |- skos__broader mesh__D009959smesh__D010610
% 211.97/212.15  |- skos__altLabel mesh__D009959 Cancer of the Oropharynx
% 211.97/212.15  |- skos__altLabel mesh__D009959 Oropharynx Cancer
% 211.97/212.15  |- skos__hiddenLabel mesh__D009959 Cancers, Oropharynx
% 211.97/212.15  |- skos__altLabel mesh__D009959 Oropharyngeal Cancer
% 211.97/212.15  |- rdf__type mesh__D009959sskos__Concept
% 211.97/212.15  |- skos__historyNote mesh__D009959 Oropharynx %28%1979-1984%29%
% 211.97/212.15  |- mesh__dateRevised mesh__D009959 1999-11-04
% 211.97/212.15  |- skos__hiddenLabel mesh__D009959 Neoplasm, Oropharynx
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D009959 2004
% 211.97/212.15  |- skos__prefLabel mesh__D009959 Oropharyngeal Neoplasms
% 211.97/212.15  |- skos__hiddenLabel mesh__D009959 Oropharnyx Cancer
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D009959 2002
% 211.97/212.15  |- skos__annotation mesh__D009959
% 211.97/212.15       coord IM with histol type of neopl %28%IM%29%   
% 211.97/212.15  |- skos__hiddenLabel mesh__D009959 Oropharynx Cancers
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D009959 2003
% 211.97/212.15  |- mesh__recordMaintainer mesh__D009959 nns
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D009959 2006
% 211.97/212.15  |- skos__hiddenLabel mesh__D009959 Neoplasms, Oropharynx
% 211.97/212.15  |- skos__altLabel mesh__D009959 Neoplasms, Oropharyngeal
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D009959 2001
% 211.97/212.15  |- mesh__publicMeSHNote mesh__D009959
% 211.97/212.15       91; was see under PHARYNGEAL NEOPLASMS 1985-90   
% 211.97/212.15  |- skos__historyNote mesh__D009959 Pharyngeal Neoplasms %28%1966-1984%29%
% 211.97/212.15  |- skos__hiddenLabel mesh__D009959 Neoplasm, Oropharyngeal
% 211.97/212.15  |- mesh__historyNote mesh__D009959
% 211.97/212.15       91%28%85%29%; was see under PHARYNGEAL NEOPLASMS 1985-90   
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D009959 2005
% 211.97/212.15  |- mesh__dateCreated mesh__D009959 1984-05-29
% 211.97/212.15  |- mesh__recordOriginator mesh__D009959 VDK
% 211.97/212.15  |- skos__hiddenLabel mesh__D009959 Cancers, Oropharyngeal
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D009959 2000
% 211.97/212.15  |- skos__hiddenLabel mesh__D009959 Cancer, Oropharynx
% 211.97/212.15  |- skos__hiddenLabel mesh__D009959 Cancer, Oropharyngeal
% 211.97/212.15  |- mesh__dateEstablished mesh__D009959 1991-01-01
% 211.97/212.15  |- skos__hiddenLabel mesh__D009959 Oropharynx Neoplasm
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001976 2003
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001976 1996
% 211.97/212.15  |- skos__historyNote mesh__D001976 Uracil %28%1966-1970%29%
% 211.97/212.15  |- skos__prefLabel mesh__D001976 Bromouracil
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001976 2002
% 211.97/212.15  |- mesh__dateCreated mesh__D001976 1999-01-01
% 211.97/212.15  |- mesh__recordMaintainer mesh__D001976 JRT
% 211.97/212.15  |- mesh__dateRevised mesh__D001976 1995-06-08
% 211.97/212.15  |- rdf__type mesh__D001976sskos__Concept
% 211.97/212.15  |- skos__broader mesh__D001976smesh__D014498
% 211.97/212.15  |- skos__annotation mesh__D001976 an antimetabolite   
% 211.97/212.15  |- mesh__recordAuthorizer mesh__D001976 PLS
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001976 2001
% 211.97/212.15  |- skos__altLabel mesh__D001976 Bromuracil
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001976 2006
% 211.97/212.15  |- mesh__historyNote mesh__D001976 74%28%71%29%   
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001976 2000
% 211.97/212.15  |- mesh__dateEstablished mesh__D001976 1974-01-01
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001976 1999
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001976 2004
% 211.97/212.15  |- mesh__publicMeSHNote mesh__D001976 74   
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001976 1997
% 211.97/212.15  |- mesh__recordOriginator mesh__D001976 NLM
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001976 2005
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001976 1998
% 211.97/212.15  |- skos__scopeNote mesh__D001976
% 211.97/212.15       5-Bromo-2,4%28%1H,3H%29%-pyrimidinedione. Brominated derivative of uracil that acts as an antimetabolite, substituting for thymine in DNA. It is used mainly as an experimental mutagen, but its deoxyriboside %28%BROMODEOXYURIDINE%29% is used to treat neoplasms.%A%    
% 211.97/212.15  |- skos__hiddenLabel mesh__D001976 5 Bromouracil
% 211.97/212.15  |- skos__altLabel mesh__D001976 5-Bromouracil
% 211.97/212.15  |- skos__hiddenLabel mesh__D001178 Arthroplasties
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001178 2003
% 211.97/212.15  |- mesh__recordAuthorizer mesh__D001178 SJN
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001178 2001
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001178 1998
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001178 2005
% 211.97/212.15  |- rdf__type mesh__D001178sskos__Concept
% 211.97/212.15  |- mesh__recordMaintainer mesh__D001178 PXP
% 211.97/212.15  |- skos__prefLabel mesh__D001178 Arthroplasty
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001178 2000
% 211.97/212.15  |- skos__annotation mesh__D001178
% 211.97/212.15       surg reconstruct of a joint; total or partial joint replacement = ARTHROPLASTY, REPLACEMENT or its specifics; joint revision %28%see REOPERATION%29% = ARTHROPLASTY %28%IM%29% + REOPERATION %28%NIM%29%; do not use /util except by MeSH definition%A%  
% 211.97/212.15  |- skos__scopeNote mesh__D001178
% 211.97/212.15       Surgical reconstruction of a joint to relieve pain or restore motion.%A%    
% 211.97/212.15  |- mesh__dateCreated mesh__D001178 1999-01-01
% 211.97/212.15  |- mesh__recordOriginator mesh__D001178 NLM
% 211.97/212.15  |- skos__broader mesh__D001178smesh__D019637
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001178 2004
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001178 2002
% 211.97/212.15  |- mesh__dateRevised mesh__D001178 1997-06-20
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001178 1999
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D001178 2006
% 211.97/212.15  |- skos__related mesh__D020332smesh__D020318
% 211.97/212.15  |- skos__hiddenLabel mesh__D020332 Inbred LEC Rats
% 211.97/212.15  |- skos__historyNote mesh__D020332 Rats %28%1989-1998%29%
% 211.97/212.15  |- mesh__publicMeSHNote mesh__D020332 99   
% 211.97/212.15  |- skos__hiddenLabel mesh__D020332 Cinnamon Rats, Long-Evans
% 211.97/212.15  |- skos__prefLabel mesh__D020332 Rats, Inbred LEC
% 211.97/212.15  |- mesh__dateEstablished mesh__D020332 1999-01-01
% 211.97/212.15  |- mesh__recordOriginator mesh__D020332 NDW
% 211.97/212.15  |- skos__hiddenLabel mesh__D020332 LEC Rat, Inbred
% 211.97/212.15  |- skos__hiddenLabel mesh__D020332 Long Evans Cinnamon Rats
% 211.97/212.15  |- rdf__type mesh__D020332sskos__Concept
% 211.97/212.15  |- skos__scopeNote mesh__D020332
% 211.97/212.15       A cinnamon-colored strain of Long-Evans rats which carries a mutation causing fulminant hepatitis and jaundice, with an associated gross accumulation of copper in the liver. This strain is a model for Wilson%27%s Disease %28%see HEPATOLENTICULAR DEGENERATION%29%.%A%    
% 211.97/212.15  |- skos__hiddenLabel mesh__D020332 Rats, Inbred Long Evans Cinnamon
% 211.97/212.15  |- skos__altLabel mesh__D020332 Rats, Inbred Long-Evans Cinnamon
% 211.97/212.15  |- mesh__dateCreated mesh__D020332 1998-06-11
% 211.97/212.15  |- mesh__recordMaintainer mesh__D020332 ags
% 211.97/212.15  |- skos__broader mesh__D020332smesh__D011919
% 211.97/212.15  |- skos__annotation mesh__D020332 NIM when exper animal; check tag RATS   
% 211.97/212.15  |- mesh__dateRevised mesh__D020332 2005-06-30
% 211.97/212.15  |- mesh__activeMeSHYear mesh__D020332 2006
% 211.97/212.15  |- skos__hiddenLabel mesh__D020332 Rats, Long-Evans Cinnamon
% 211.97/212.15  |- skos__hiddenLabel mesh__D020332 LEC Rats, Inbred
% 211.97/212.15  |- mesh__historyNote mesh__D020332 99   
% 211.97/212.15  |- skos__hiddenLabel mesh__D020332 Rat, Inbred LEC
% 211.97/212.15  |- skos__altLabel mesh__D020332 Long-Evans Cinnamon Rats
% 211.97/212.15  |- mesh__recordAuthorizer mesh__D020332 sjn
% 211.97/212.15  |- skos__hiddenLabel mesh__D020332 Inbred LEC Rat
% 211.97/212.16  |- skos__broader mesh__D019589smesh__D003817
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D019589 2006
% 211.97/212.16  |- mesh__dateRevised mesh__D019589 2003-07-09
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D019589 2005
% 211.97/212.16  |- skos__hiddenLabel mesh__D019589 Components, Tooth
% 211.97/212.16  |- rdf__type mesh__D019589sskos__Concept
% 211.97/212.16  |- skos__hiddenLabel mesh__D019589 Tooth Component
% 211.97/212.16  |- mesh__publicMeSHNote mesh__D019589 98   
% 211.97/212.16  |- mesh__dateCreated mesh__D019589 1997-06-20
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D019589 2004
% 211.97/212.16  |- skos__scopeNote mesh__D019589
% 211.97/212.16       The anatomical components of a tooth, its tissues, and correlated parts.%A%    
% 211.97/212.16  |- skos__historyNote mesh__D019589
% 211.97/212.16       specific tooth structure %28%1966-1997%29%
% 211.97/212.16  |- skos__annotation mesh__D019589 not used for indexing or cataloging   
% 211.97/212.16  |- skos__prefLabel mesh__D019589 Tooth Components
% 211.97/212.16  |- skos__historyNote mesh__D019589
% 211.97/212.16       Tooth/anatomy %26% histology %28%1966-1997%29%
% 211.97/212.16  |- mesh__historyNote mesh__D019589 98   
% 211.97/212.16  |- skos__hiddenLabel mesh__D019589 Component, Tooth
% 211.97/212.16  |- mesh__dateEstablished mesh__D019589 1998-01-01
% 211.97/212.16  |- rdf__type mesh__D005569sskos__Concept
% 211.97/212.16  |- mesh__recordAuthorizer mesh__D005569 sjn
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D005569 2001
% 211.97/212.16  |- skos__prefLabel mesh__D005569 Formularies
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D005569 2004
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D005569 2000
% 211.97/212.16  |- skos__annotation mesh__D005569
% 211.97/212.16       IM; GEN or unspecified; prefer specifics; collections of formulas for compounding medicinal prep: do not confuse with PHARMACOPOEIAS which are far more complete: read MeSH definition; do not confuse with NATIONAL FORMULARY see PHARMACOPOEIAS%A%  
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D005569 2006
% 211.97/212.16  |- skos__broader mesh__D005569smesh__D012013
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D005569 2003
% 211.97/212.16  |- skos__related mesh__D005569smesh__D010602
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D005569 2005
% 211.97/212.16  |- mesh__recordMaintainer mesh__D005569 kle
% 211.97/212.16  |- skos__scopeNote mesh__D005569
% 211.97/212.16       Lists of drugs or collections of recipes, formulas, and prescriptions for the compounding of medicinal preparations. Formularies differ from PHARMACOPOEIAS in that they are less complete, lacking full descriptions of the drugs, their formulations, analytic composition, chemical properties, etc. In hospitals, formularies list all drugs commonly stocked in the hospital pharmacy.%A%    
% 211.97/212.16  |- mesh__dateRevised mesh__D005569 1999-11-03
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D005569 2002
% 211.97/212.16  |- mesh__recordOriginator mesh__D005569 NLM
% 211.97/212.16  |- skos__hiddenLabel mesh__D005569 Formulary
% 211.97/212.16  |- mesh__dateCreated mesh__D005569 1999-01-01
% 211.97/212.16  |- skos__broader mesh__D016291smesh__D003986
% 211.97/212.16  |- skos__hiddenLabel mesh__D016291 MK801
% 211.97/212.16  |- mesh__dateRevised mesh__D016291 2000-06-21
% 211.97/212.16  |- mesh__dateEstablished mesh__D016291 1991-01-01
% 211.97/212.16  |- skos__historyNote mesh__D016291 Dibenzocycloheptenes %28%1968-1990%29%
% 211.97/212.16  |- skos__prefLabel mesh__D016291 Dizocilpine Maleate
% 211.97/212.16  |- rdf__type mesh__D016291sskos__Concept
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D016291 2003
% 211.97/212.16  |- skos__annotation mesh__D016291 DF: note short X   
% 211.97/212.16  |- skos__hiddenLabel mesh__D016291 MK 801
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D016291 2001
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D016291 2004
% 211.97/212.16  |- mesh__recordMaintainer mesh__D016291 TWD
% 211.97/212.16  |- mesh__recordAuthorizer mesh__D016291 sjn
% 211.97/212.16  |- skos__scopeNote mesh__D016291
% 211.97/212.16       A potent noncompetitive antagonist of the NMDA receptor %28%RECEPTORS, N-METHYL-D-ASPARTATE%29% used mainly as a research tool. The drug has been considered for the wide variety of neurodegenerative conditions or disorders in which NMDA receptors may play an important role. Its use has been primarily limited to animal and tissue experiments because of its psychotropic effects.%A%    
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D016291 2002
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D016291 2005
% 211.97/212.16  |- skos__historyNote mesh__D016291 Anticonvulsants %28%1966-1990%29%
% 211.97/212.16  |- mesh__publicMeSHNote mesh__D016291 91   
% 211.97/212.16  |- mesh__historyNote mesh__D016291 91   
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D016291 2006
% 211.97/212.16  |- mesh__recordOriginator mesh__D016291 RLS
% 211.97/212.16  |- mesh__dateCreated mesh__D016291 1990-05-25
% 211.97/212.16  |- skos__hiddenLabel mesh__D024723 beta-Myosin, Ventricular Cardiac
% 211.97/212.16  |- skos__altLabel mesh__D024723 Ventricular Cardiac beta-Myosin
% 211.97/212.16  |- skos__hiddenLabel mesh__D024723 Cardiac alpha-Myosin, Ventricular
% 211.97/212.16  |- skos__altLabel mesh__D024723 Ventricular Cardiac alpha-Myosin
% 211.97/212.16  |- skos__related mesh__D024723smesh__D024741
% 211.97/212.16  |- skos__altLabel mesh__D024723 Myosin V1
% 211.97/212.16  |- skos__scopeNote mesh__D024723
% 211.97/212.16       Isoforms of MYOSIN TYPE II, specifically found in the ventricular muscle of the HEART. Defects in the genes encoding ventricular myosins result in FAMILIAL HYPERTROPHIC CARDIOMYOPATHY.%A%    
% 211.97/212.16  |- skos__hiddenLabel mesh__D024723 beta-Myosin, Ventricular
% 211.97/212.16  |- mesh__recordAuthorizer mesh__D024723 sjn
% 211.97/212.16  |- skos__hiddenLabel mesh__D024723 beta-Myosin, Cardiac
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D024723 2006
% 211.97/212.16  |- mesh__dateCreated mesh__D024723 2001-07-25
% 211.97/212.16  |- skos__hiddenLabel mesh__D024723 alpha Myosin
% 211.97/212.16  |- rdf__type mesh__D024723sskos__Concept
% 211.97/212.16  |- skos__hiddenLabel mesh__D024723 alpha-Myosin, Ventricular
% 211.97/212.16  |- skos__historyNote mesh__D024723 Myosins %28%1976-2001%29%
% 211.97/212.16  |- skos__hiddenLabel mesh__D024723 Cardiac beta-Myosin, Ventricular
% 211.97/212.16  |- skos__hiddenLabel mesh__D024723 Cardiac alpha Myosin
% 211.97/212.16  |- mesh__historyNote mesh__D024723
% 211.97/212.16       2002; for MYOSIN V1 %26% MYOSIN V3 use MYOSINS 1988-2001   
% 211.97/212.16  |- skos__hiddenLabel mesh__D024723 Ventricular alpha, beta  Myosin
% 211.97/212.16  |- mesh__recordOriginator mesh__D024723 jmp
% 211.97/212.16  |- skos__broader mesh__D024723smesh__D024722
% 211.97/212.16  |- skos__hiddenLabel mesh__D024723 Ventricular Cardiac beta Myosin
% 211.97/212.16  |- skos__altLabel mesh__D024723 Ventricular Isomyosins
% 211.97/212.16  |- skos__hiddenLabel mesh__D024723 alpha-Myosin, Cardiac
% 211.97/212.16  |- skos__hiddenLabel mesh__D024723 Ventricular alpha Myosin
% 211.97/212.16  |- skos__altLabel mesh__D024723 Ventricular Myosin
% 211.97/212.16  |- skos__altLabel mesh__D024723 alpha-Myosin
% 211.97/212.16  |- skos__hiddenLabel mesh__D024723 Ventricular beta Myosin
% 211.97/212.16  |- skos__altLabel mesh__D024723 beta-Myosin
% 211.97/212.16  |- skos__hiddenLabel mesh__D024723 alpha-Myosin, Ventricular Cardiac
% 211.97/212.16  |- skos__annotation mesh__D024723
% 211.97/212.16       do not confuse X refs MYOSIN V1 and MYOSIN V3 with MYOSIN TYPE V%A%  
% 211.97/212.16  |- skos__hiddenLabel mesh__D024723 Ventricular Cardiac alpha Myosin
% 211.97/212.16  |- skos__altLabel mesh__D024723 Myosin, Ventricular
% 211.97/212.16  |- mesh__dateRevised mesh__D024723 2005-06-30
% 211.97/212.16  |- skos__altLabel mesh__D024723 Myosin V3
% 211.97/212.16  |- skos__hiddenLabel mesh__D024723 Myosins, Ventricular
% 211.97/212.16  |- skos__hiddenLabel mesh__D024723 beta Myosin
% 211.97/212.16  |- skos__hiddenLabel mesh__D024723 Isomyosins, Ventricular
% 211.97/212.16  |- skos__prefLabel mesh__D024723 Ventricular Myosins
% 211.97/212.16  |- mesh__dateEstablished mesh__D024723 2002-01-01
% 211.97/212.16  |- mesh__publicMeSHNote mesh__D024723 2002   
% 211.97/212.16  |- skos__hiddenLabel mesh__D024723 Cardiac beta Myosin
% 211.97/212.16  |- mesh__recordMaintainer mesh__D024723 DRC
% 211.97/212.16  |- skos__altLabel mesh__D024723 Cardiac beta-Myosin
% 211.97/212.16  |- skos__altLabel mesh__D024723 Myosin V2
% 211.97/212.16  |- skos__altLabel mesh__D024723 Cardiac alpha-Myosin
% 211.97/212.16  |- skos__altLabel mesh__D002271 Diabetal
% 211.97/212.16  |- skos__scopeNote mesh__D002271
% 211.97/212.16       A sulfonylurea antidiabetic agent with similar actions and uses to CHLORPROPAMIDE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p277%29%%A%    
% 211.97/212.16  |- skos__broader mesh__D002271smesh__D013453
% 211.97/212.16  |- mesh__recordOriginator mesh__D002271 NLM
% 211.97/212.16  |- skos__altLabel mesh__D002271 Aminophenurobutane
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D002271 2006
% 211.97/212.16  |- mesh__dateRevised mesh__D002271 2005-06-30
% 211.97/212.16  |- mesh__recordMaintainer mesh__D002271 lkw
% 211.97/212.16  |- skos__altLabel mesh__D002271 Servier Brand of Carbutamide
% 211.97/212.16  |- skos__altLabel mesh__D002271 Glybutamide
% 211.97/212.16  |- skos__prefLabel mesh__D002271 Carbutamide
% 211.97/212.16  |- mesh__dateCreated mesh__D002271 1999-01-01
% 211.97/212.16  |- rdf__type mesh__D002271sskos__Concept
% 211.97/212.16  |- skos__altLabel mesh__D002271 Bukarban
% 211.97/212.16  |- skos__altLabel mesh__D002271 Sulfaninylbutylurea
% 211.97/212.16  |- skos__altLabel mesh__D002271 Oranyl
% 211.97/212.16  |- mesh__recordAuthorizer mesh__D002271 sjn
% 211.97/212.16  |- skos__historyNote mesh__D010703 Croton Oil %28%1966-1974%29%
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D010703 2004
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D010703 1997
% 211.97/212.16  |- mesh__historyNote mesh__D010703
% 211.97/212.16       86%28%75%29%; was see under PHORBOLS 1975-85   
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D010703 2005
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D010703 1998
% 211.97/212.16  |- skos__hiddenLabel mesh__D010703 Esters, Phorbol
% 211.97/212.16  |- skos__historyNote mesh__D010703 Diterpenes %28%1974%29%
% 211.97/212.16  |- mesh__dateCreated mesh__D010703 1974-11-14
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D010703 2002
% 211.97/212.16  |- skos__prefLabel mesh__D010703 Phorbol Esters
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D010703 2006
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D010703 1999
% 211.97/212.16  |- mesh__publicMeSHNote mesh__D010703 86; was see under PHORBOLS 1975-85   
% 211.97/212.16  |- skos__hiddenLabel mesh__D010703 Diesters, Phorbol
% 211.97/212.16  |- skos__scopeNote mesh__D010703
% 211.97/212.16       Tumor-promoting compounds obtained from CROTON OIL %28%Croton tiglium%29%. Some of these are used in cell biological experiments as activators of protein kinase C.%A%    
% 211.97/212.16  |- mesh__recordMaintainer mesh__D010703 JRT
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D010703 2000
% 211.97/212.16  |- mesh__recordAuthorizer mesh__D010703 PLS
% 211.97/212.16  |- skos__historyNote mesh__D010703 Esters %28%1974%29%
% 211.97/212.16  |- rdf__type mesh__D010703sskos__Concept
% 211.97/212.16  |- skos__annotation mesh__D010703
% 211.97/212.16       a group of tumor-promoting cpds; GEN or unspecified: prefer specifics; index here only for a specific phorbol ester not in MeSH; D25-26 qualif%A%  
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D010703 2001
% 211.97/212.16  |- mesh__dateEstablished mesh__D010703 1986-01-01
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D010703 2003
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D010703 1996
% 211.97/212.16  |- mesh__recordOriginator mesh__D010703 NLM
% 211.97/212.16  |- skos__broader mesh__D010703smesh__D010704
% 211.97/212.16  |- mesh__dateRevised mesh__D010703 1995-06-08
% 211.97/212.16  |- skos__historyNote mesh__D010703 Terpenes %28%1966-1973%29%
% 211.97/212.16  |- skos__broader mesh__D015997smesh__D003942
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D015997 2003
% 211.97/212.16  |- mesh__historyNote mesh__D015997 90   
% 211.97/212.16  |- skos__altLabel mesh__D015997 Infant, Newborn, Screening
% 211.97/212.16  |- mesh__recordAuthorizer mesh__D015997 sjn
% 211.97/212.16  |- skos__scopeNote mesh__D015997
% 211.97/212.16       The identification of selected parameters in newborn infants by various tests, examinations, or other procedures. Screening may be performed by clinical or laboratory measures. A screening test is designed to sort out healthy neonates %28%INFANT, NEWBORN%29% from those not well, but the screening test is not intended as a diagnostic device, rather instead as epidemiologic.%A%    
% 211.97/212.16  |- skos__prefLabel mesh__D015997 Neonatal Screening
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D015997 2006
% 211.97/212.16  |- mesh__recordMaintainer mesh__D015997 lkt
% 211.97/212.16  |- skos__annotation mesh__D015997 check tag INFANT, NEWBORN   
% 211.97/212.16  |- mesh__recordOriginator mesh__D015997 PLS
% 211.97/212.16  |- skos__historyNote mesh__D015997 Infant, Newborn %28%1966-1989%29%
% 211.97/212.16  |- mesh__dateRevised mesh__D015997 2001-07-25
% 211.97/212.16  |- skos__historyNote mesh__D015997 Mass Screening %28%1966-1989%29%
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D015997 2005
% 211.97/212.16  |- skos__hiddenLabel mesh__D015997 Screening, Neonatal
% 211.97/212.16  |- skos__hiddenLabel mesh__D015997 Screenings, Newborn Infant
% 211.97/212.16  |- skos__broader mesh__D015997smesh__D008403
% 211.97/212.16  |- mesh__dateCreated mesh__D015997 1989-05-25
% 211.97/212.16  |- mesh__publicMeSHNote mesh__D015997 90   
% 211.97/212.16  |- skos__altLabel mesh__D015997 Newborn Infant Screening
% 211.97/212.16  |- mesh__dateEstablished mesh__D015997 1990-01-01
% 211.97/212.16  |- skos__hiddenLabel mesh__D015997 Neonatal Screenings
% 211.97/212.16  |- skos__hiddenLabel mesh__D015997 Screenings, Neonatal
% 211.97/212.16  |- skos__hiddenLabel mesh__D015997 Newborn Infant Screenings
% 211.97/212.16  |- skos__hiddenLabel mesh__D015997 Screening, Newborn Infant
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D015997 2004
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D015997 2002
% 211.97/212.16  |- rdf__type mesh__D015997sskos__Concept
% 211.97/212.16  |- mesh__publicMeSHNote mesh__D048373 2005   
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D048373 2006A
% 211.97/212.16  |- mesh__dateCreated mesh__D048373 2004-07-07
% 211.97/212.16  |- skos__historyNote mesh__D048373 Treponema %28%1971-2004%29%
% 211.97/212.16  |- mesh__historyNote mesh__D048373 2005   
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D048373 2006
% 211.97/212.16  |- mesh__recordOriginator mesh__D048373 ags
% 211.97/212.16  |- skos__broader mesh__D048373smesh__D014208
% 211.97/212.16  |- mesh__recordAuthorizer mesh__D048373 ags
% 211.97/212.16  |- rdf__type mesh__D048373sskos__Concept
% 211.97/212.16  |- mesh__recordMaintainer mesh__D048373 ags
% 211.97/212.16  |- skos__prefLabel mesh__D048373 Treponema denticola
% 211.97/212.16  |- skos__scopeNote mesh__D048373
% 211.97/212.16       A species of bacteria in the family SPIROCHAETACEAE, frequently isolated from periodontal pockets %28%PERIODONTAL POCKET%29%.%A%    
% 211.97/212.16  |- mesh__dateEstablished mesh__D048373 2005-01-01
% 211.97/212.16  |- mesh__dateRevised mesh__D048373 2005-08-01
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D015199 2002
% 211.97/212.16  |- skos__hiddenLabel mesh__D015199 Oxygenations, Extracorporeal Membrane
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D015199 2006
% 211.97/212.16  |- skos__broader mesh__D015199smesh__D005112
% 211.97/212.16  |- skos__broader mesh__D015199smesh__D012138
% 211.97/212.16  |- skos__hiddenLabel mesh__D015199 Membrane Oxygenation, Extracorporeal
% 211.97/212.16  |- mesh__recordAuthorizer mesh__D015199 sjn
% 211.97/212.16  |- skos__altLabel mesh__D015199 ECMO
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D015199 2003
% 211.97/212.16  |- mesh__dateRevised mesh__D015199 1999-11-03
% 211.97/212.16  |- skos__hiddenLabel mesh__D015199 Membrane Oxygenations, Extracorporeal
% 211.97/212.16  |- skos__altLabel mesh__D015199 Oxygenation, Extracorporeal Membrane
% 211.97/212.16  |- mesh__recordMaintainer mesh__D015199 ndw
% 211.97/212.16  |- mesh__publicMeSHNote mesh__D015199 89   
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D015199 2000
% 211.97/212.16  |- mesh__historyNote mesh__D015199 89   
% 211.97/212.16  |- rdf__type mesh__D015199sskos__Concept
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D015199 2004
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D015199 2001
% 211.97/212.16  |- skos__hiddenLabel mesh__D015199 Extracorporeal Membrane Oxygenations
% 211.97/212.16  |- skos__prefLabel mesh__D015199 Extracorporeal Membrane Oxygenation
% 211.97/212.16  |- skos__annotation mesh__D015199
% 211.97/212.16       do not use /util except by MeSH definition; note short X ref%A%  
% 211.97/212.16  |- mesh__dateCreated mesh__D015199 1988-04-23
% 211.97/212.16  |- skos__related mesh__D015199smesh__D010107
% 211.97/212.16  |- skos__historyNote mesh__D015199 Oxygenators, Membrane %28%1971-1988%29%
% 211.97/212.16  |- mesh__dateEstablished mesh__D015199 1989-01-01
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D015199 2005
% 211.97/212.16  |- mesh__recordOriginator mesh__D015199 EJB
% 211.97/212.16  |- skos__scopeNote mesh__D015199
% 211.97/212.16       Application of a life support system that circulates the blood through an oxygenating system, which may consist of a pump, a membrane oxygenator, and a heat exchanger. Examples of its use are to assist victims of smoke inhalation injury, respiratory failure, and cardiac failure.%A%    
% 211.97/212.16  |- skos__historyNote mesh__D015199
% 211.97/212.16       Extracorporeal Circulation %28%1971-1988%29%
% 211.97/212.16  |- skos__altLabel mesh__D001977 Vortech Brand of Brompheniramine Maleate
% 211.97/212.16  |- skos__prefLabel mesh__D001977 Brompheniramine
% 211.97/212.16  |- mesh__recordOriginator mesh__D001977 NLM
% 211.97/212.16  |- skos__hiddenLabel mesh__D001977 Maleate, Brompheniramine
% 211.97/212.16  |- mesh__recordMaintainer mesh__D001977 lkw
% 211.97/212.16  |- skos__altLabel mesh__D001977 Brompheniramine Maleate %28%1:1%29%
% 211.97/212.16  |- rdf__type mesh__D001977sskos__Concept
% 211.97/212.16  |- skos__broader mesh__D001977smesh__D010632
% 211.97/212.16  |- skos__hiddenLabel mesh__D001977 Dimetane Ten
% 211.97/212.16  |- mesh__recordAuthorizer mesh__D001977 sjn
% 211.97/212.16  |- skos__altLabel mesh__D001977 Roberts Brand of Brompheniramine Maleate
% 211.97/212.16  |- skos__hiddenLabel mesh__D001977 para Bromdylamine
% 211.97/212.16  |- skos__altLabel mesh__D001977 Robins Brand of Brompheniramine Maleate
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D001977 2006
% 211.97/212.16  |- skos__hiddenLabel mesh__D001977 Oraminic 2
% 211.97/212.16  |- skos__altLabel mesh__D001977
% 211.97/212.16       Whitehall-Robins Brand of Brompheniramine Maleate
% 211.97/212.16  |- mesh__dateRevised mesh__D001977 2005-06-30
% 211.97/212.16  |- skos__hiddenLabel mesh__D001977 p Bromdylamine
% 211.97/212.16  |- mesh__publicMeSHNote mesh__D001977
% 211.97/212.16       91; was see under PYRIDINES 1966-90   
% 211.97/212.16  |- mesh__dateEstablished mesh__D001977 1991-01-01
% 211.97/212.16  |- skos__scopeNote mesh__D001977
% 211.97/212.16       Histamine H1 antagonist used in treatment of allergies, rhinitis, and urticaria.%A%    
% 211.97/212.16  |- skos__altLabel mesh__D001977 para-Bromdylamine
% 211.97/212.16  |- skos__altLabel mesh__D001977 p-Bromdylamine
% 211.97/212.16  |- skos__altLabel mesh__D001977 Dimetapp Allergy
% 211.97/212.16  |- mesh__historyNote mesh__D001977
% 211.97/212.16       91%28%66%29%; was see under PYRIDINES 1966-90   
% 211.97/212.16  |- mesh__dateCreated mesh__D001977 1999-01-01
% 211.97/212.16  |- mesh__recordOriginator mesh__D001179 NLM
% 211.97/212.16  |- skos__scopeNote mesh__D001179
% 211.97/212.16       Arthropods, other than insects and arachnids, which transmit infective organisms from one host to another or from an inanimate reservoir to an animate host.%A%    
% 211.97/212.16  |- skos__hiddenLabel mesh__D001179 Vectors, Arthropod
% 211.97/212.16  |- skos__hiddenLabel mesh__D001179 Vector, Arthropod
% 211.97/212.16  |- mesh__recordMaintainer mesh__D001179 SYSTEM
% 211.97/212.16  |- rdf__type mesh__D001179sskos__Concept
% 211.97/212.16  |- mesh__dateCreated mesh__D001179 1999-01-01
% 211.97/212.16  |- mesh__dateEstablished mesh__D001179 1964-01-01
% 211.97/212.16  |- skos__broader mesh__D001179smesh__D004199
% 211.97/212.16  |- mesh__publicMeSHNote mesh__D001179 64   
% 211.97/212.16  |- mesh__dateRevised mesh__D001179 2003-07-09
% 211.97/212.16  |- skos__hiddenLabel mesh__D001179 Arthropod Vector
% 211.97/212.16  |- mesh__historyNote mesh__D001179 64   
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D001179 2005
% 211.97/212.16  |- skos__annotation mesh__D001179
% 211.97/212.16       coord IM with specific arthropod %28%IM%29%; specify both infecting organism %26% vector if pertinent; ARACHNID VECTORS and INSECT VECTORS are also avail%A%  
% 211.97/212.16  |- mesh__recordAuthorizer mesh__D001179 sjn
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D001179 2004
% 211.97/212.16  |- skos__prefLabel mesh__D001179 Arthropod Vectors
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D001179 2006
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D020333 2000
% 211.97/212.16  |- skos__historyNote mesh__D020333 Diplopia %28%1966-1999%29%
% 211.97/212.16  |- skos__broader mesh__D020333smesh__D015835
% 211.97/212.16  |- mesh__historyNote mesh__D020333 2000; use OPHTHALMOPLEGIA 1981-1999   
% 211.97/212.16  |- skos__historyNote mesh__D020333 Ophthalmoplegia %28%1973-1999%29%
% 211.97/212.16  |- mesh__publicMeSHNote mesh__D020333
% 211.97/212.16       2000; see OPHTHALMOPLEGIA 1981-1999   
% 211.97/212.16  |- rdf__type mesh__D020333sskos__Concept
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D020333 2002
% 211.97/212.16  |- mesh__dateEstablished mesh__D020333 2000-01-01
% 211.97/212.16  |- skos__prefLabel mesh__D020333 Tolosa-Hunt Syndrome
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D020333 2006
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D020333 2004
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D020333 2005
% 211.97/212.16  |- skos__scopeNote mesh__D020333
% 211.97/212.16       An idiopathic syndrome characterized by the formation of granulation tissue in the anterior cavernous sinus or superior orbital fissure, producing a painful ophthalmoplegia. %28%Adams et al., Principles of Neurology, 6th ed, p271%29%%A%    
% 211.97/212.16  |- skos__hiddenLabel mesh__D020333 Tolosa Hunt Syndrome
% 211.97/212.16  |- skos__historyNote mesh__D020333 Cranial Nerves %28%1966-1999%29%
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D020333 2001
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D020333 2003
% 211.97/212.16  |- mesh__dateCreated mesh__D020333 1999-11-03
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D038744 2005
% 211.97/212.16  |- mesh__publicMeSHNote mesh__D038744
% 211.97/212.16       2005; see RIBOSOMAL PROTEIN S6 KINASES, 90KD 2003-2004; MAP-KINASE-ACTIVATED KINASE 1 %28%now RIBOSOMAL PROTEIN S6 KINASES, 90KDa%29% was indexed under RIBOSOMAL PROTEIN S6 KINASE 1993-2002; for PP90%28%RSK%29% %26% PP90%28%RSK%29% see RIBOSOMAL PROTEIN S6 KINASE 1998-2002%A%  
% 211.97/212.16  |- skos__scopeNote mesh__D038744
% 211.97/212.16       A family of ribosomal protein S6 kinases that are structurally distinguished from RIBOSOMAL PROTEIN KINASES, 70-kDa by their apparent molecular size and the fact they contain two functional kinase domains. Although considered RIBOSOMAL PROTEIN S6 KINASES members of this family are activated via the MAP KINASE SIGNALING SYSTEM and have been shown to act on a diverse array of substrates that are involved in cellular regulation such as RIBOSOMAL PROTEIN S6 and CAMP RESPONSE ELEMENT-BINDING PROTEIN.%A%    
% 211.97/212.16  |- mesh__recordOriginator mesh__D038744 jmp
% 211.97/212.16  |- rdf__type mesh__D038744sskos__Concept
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D038744 2005A
% 211.97/212.16  |- mesh__dateEstablished mesh__D038744 2003-01-01
% 211.97/212.16  |- skos__altLabel mesh__D038744 MAPKAP-K1
% 211.97/212.16  |- skos__altLabel mesh__D038744 p90%28%rsk%29%
% 211.97/212.16  |- mesh__dateRevised mesh__D038744 2004-08-02
% 211.97/212.16  |- skos__historyNote mesh__D038744
% 211.97/212.16       Ribosomal Protein S6 Kinase %28%1998-2002%29%
% 211.97/212.16  |- skos__altLabel mesh__D038744 MAPKAPK1
% 211.97/212.16  |- mesh__recordAuthorizer mesh__D038744 jls
% 211.97/212.16  |- skos__hiddenLabel mesh__D038744 MAPKAP Kinase 1
% 211.97/212.16  |- skos__broader mesh__D038744smesh__D019893
% 211.97/212.16  |- skos__hiddenLabel mesh__D038744 MAP Kinase Activated Protein Kinase 1
% 211.97/212.16  |- mesh__dateCreated mesh__D038744 2002-07-03
% 211.97/212.16  |- skos__hiddenLabel mesh__D038744 Ribosomal Protein S6 Kinase, 90 kDa
% 211.97/212.16  |- skos__historyNote mesh__D038744
% 211.97/212.16       Protein-Serine-Threonine Kinases %28%1993-1997%29%
% 211.97/212.16  |- mesh__historyNote mesh__D038744
% 211.97/212.16       2005%28%2002%29%; for PP90%28%RSK%29% %26% PP90%28%RSK%29% use RIBOSOMAL PROTEIN S6 KINASES 1998-2002%A%  
% 211.97/212.16  |- skos__altLabel mesh__D038744 MAP-Kinase-Activated Protein Kinase 1
% 211.97/212.16  |- skos__hiddenLabel mesh__D038744 MAP Kinase Activated Kinase 1
% 211.97/212.16  |- skos__altLabel mesh__D038744 Ribosomal Protein S6 Kinase, 90-kDa
% 211.97/212.16  |- skos__altLabel mesh__D038744 p90 Ribosomal S6 Kinase
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D038744 2006
% 211.97/212.16  |- skos__altLabel mesh__D038744 MAPKAP Kinase-1
% 211.97/212.16  |- skos__altLabel mesh__D038744 MAP-Kinase-Activated Kinase 1
% 211.97/212.16  |- skos__hiddenLabel mesh__D038744 Ribosomal Protein S6 Kinases, 90 kDa
% 211.97/212.16  |- mesh__recordMaintainer mesh__D038744 jls
% 211.97/212.16  |- skos__altLabel mesh__D038744 pp90%28%rsk%29%
% 211.97/212.16  |- skos__prefLabel mesh__D038744 Ribosomal Protein S6 Kinases, 90-kDa
% 211.97/212.16  |- mesh__recordMaintainer mesh__D016292 PLS
% 211.97/212.16  |- rdf__type mesh__D016292sskos__Concept
% 211.97/212.16  |- skos__prefLabel mesh__D016292 Conscious Sedation
% 211.97/212.16  |- mesh__onlineNote mesh__D016292
% 211.97/212.16       use CONSCIOUS SEDATION to search DENTAL SEDATION 1991-92   
% 211.97/212.16  |- skos__historyNote mesh__D016292 Anesthesia, Dental %28%1973-1990%29%
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D016292 2003
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D016292 1997
% 211.97/212.16  |- mesh__dateCreated mesh__D016292 1990-05-25
% 211.97/212.16  |- skos__altLabel mesh__D016292 Sedation, Conscious
% 211.97/212.16  |- mesh__recordOriginator mesh__D016292 MXR
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D016292 2004
% 211.97/212.16  |- skos__scopeNote mesh__D016292
% 211.97/212.16       An alternative to general anesthesia in patients for whom general anesthesia is refused or considered inadvisable. It involves the administering of an antianxiety drug %28%minor tranquilizer%29% and an analgesic or local anesthetic. This renders the patient free of anxiety and pain while allowing the patient to remain in verbal contact with the physician or dentist.%A%    
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D016292 1998
% 211.97/212.16  |- skos__annotation mesh__D016292
% 211.97/212.16       an alternative to gen anesth: read MeSH definition; coord IM with specific procedure %28%IM%29% or specific sedative, analgesic or anesthetic %28%IM with no qualif%29%%A%  
% 211.97/212.16  |- mesh__historyNote mesh__D016292
% 211.97/212.16       91; DENTAL SEDATION was see CONSCIOUS SEDATION 1991-92   
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D016292 2000
% 211.97/212.16  |- mesh__dateRevised mesh__D016292 1993-02-20
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D016292 1994
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D016292 2005
% 211.97/212.16  |- skos__historyNote mesh__D016292
% 211.97/212.16       Preanesthetic Medication %28%1980-1990%29%
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D016292 1999
% 211.97/212.16  |- skos__broader mesh__D016292smesh__D000760
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D016292 2001
% 211.97/212.16  |- mesh__recordAuthorizer mesh__D016292 NLM
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D016292 1995
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D016292 2006
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D016292 2002
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D016292 1996
% 211.97/212.16  |- mesh__publicMeSHNote mesh__D016292
% 211.97/212.16       91; DENTAL SEDATION was see CONSCIOUS SEDATION 1991-92   
% 211.97/212.16  |- mesh__dateEstablished mesh__D016292 1991-01-01
% 211.97/212.16  |- skos__broader mesh__D002272smesh__D015815
% 211.97/212.16  |- skos__scopeNote mesh__D002272
% 211.97/212.16       A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment.%A%    
% 211.97/212.16  |- skos__prefLabel mesh__D002272 Carcinoembryonic Antigen
% 211.97/212.16  |- skos__altLabel mesh__D002272 Antigens, CD66e
% 211.97/212.16  |- mesh__dateEstablished mesh__D002272 1974-01-01
% 211.97/212.16  |- skos__hiddenLabel mesh__D002272 Antigen, Carcinoembryonic
% 211.97/212.16  |- mesh__recordMaintainer mesh__D002272 ssb
% 211.97/212.16  |- skos__broader mesh__D002272smesh__D014408
% 211.97/212.16  |- mesh__recordAuthorizer mesh__D002272 sjn
% 211.97/212.16  |- mesh__dateCreated mesh__D002272 1999-01-01
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D002272 2006
% 211.97/212.16  |- mesh__publicMeSHNote mesh__D002272 74   
% 211.97/212.16  |- skos__altLabel mesh__D002272 Antigen, CD66e
% 211.97/212.16  |- skos__altLabel mesh__D002272 CD66e Antigen
% 211.97/212.16  |- mesh__recordOriginator mesh__D002272 NLM
% 211.97/212.16  |- skos__broader mesh__D002272smesh__D000951
% 211.97/212.16  |- mesh__historyNote mesh__D002272 74%28%73%29%   
% 211.97/212.16  |- rdf__type mesh__D002272sskos__Concept
% 211.97/212.16  |- skos__hiddenLabel mesh__D002272 CD66e Antigens
% 211.97/212.16  |- skos__annotation mesh__D002272 DF: CEA   
% 211.97/212.16  |- mesh__dateRevised mesh__D002272 2005-06-30
% 211.97/212.16  |- mesh__recordOriginator mesh__D010704 NLM
% 211.97/212.16  |- mesh__publicMeSHNote mesh__D010704 75   
% 211.97/212.16  |- skos__scopeNote mesh__D010704
% 211.97/212.16       The parent alcohol of the tumor promoting compounds from CROTON OIL %28%Croton tiglium%29%.%A%    
% 211.97/212.16  |- mesh__historyNote mesh__D010704 75   
% 211.97/212.16  |- mesh__recordMaintainer mesh__D010704 JRT
% 211.97/212.16  |- skos__historyNote mesh__D010704 Diterpenes %28%1974%29%
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D010704 2002
% 211.97/212.16  |- mesh__dateCreated mesh__D010704 1974-11-11
% 211.97/212.16  |- mesh__dateEstablished mesh__D010704 1975-09-01
% 211.97/212.16  |- skos__broader mesh__D010704smesh__D004224
% 211.97/212.16  |- rdf__type mesh__D010704sskos__Concept
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D010704 2003
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D010704 1996
% 211.97/212.16  |- skos__historyNote mesh__D010704 Terpenes %28%1966-1973%29%
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D010704 2005
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D010704 2000
% 211.97/212.16  |- mesh__activeMeSHYear mesh__D010704 1998
% 211.97/212.16  |- mesh__recordAuthorizer mesh__D010704 PLS
% 211.97/212.16  |- mesh__dateRevised mesh__D010704 1995-06-08
% 211.97/212.16  |- skos__historyNote mesh__D010704 Croton Oil %28%1966-1974%29%
% 211.97/212.16  |- skos__annotation mesh__D010704 carcinogens; D25-26 qualif   
% 211.97/212.17  |- skos__historyNote mesh__D010704 Alcohols %28%1966-1974%29%
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D010704 2004
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D010704 2001
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D010704 1997
% 211.97/212.17  |- skos__prefLabel mesh__D010704 Phorbols
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D010704 2006
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D010704 1999
% 211.97/212.17  |- skos__hiddenLabel mesh__D015998 Abbreviated Injury Scales
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015998 2003
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015998 1994
% 211.97/212.17  |- skos__prefLabel mesh__D015998 Abbreviated Injury Scale
% 211.97/212.17  |- skos__historyNote mesh__D015998
% 211.97/212.17       Wounds and Injuries/classification %28%1966-1989%29%
% 211.97/212.17  |- mesh__recordAuthorizer mesh__D015998 PLS
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015998 1997
% 211.97/212.17  |- mesh__historyNote mesh__D015998
% 211.97/212.17       91%28%90%29%; was see under TRAUMA SEVERITY INDICES 1990   
% 211.97/212.17  |- mesh__recordOriginator mesh__D015998 PLS
% 211.97/212.17  |- skos__hiddenLabel mesh__D015998 Scale, Abbreviated Injury
% 211.97/212.17  |- skos__hiddenLabel mesh__D015998 Scales, Abbreviated Injury
% 211.97/212.17  |- mesh__recordMaintainer mesh__D015998 PLS
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015998 2001
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015998 1996
% 211.97/212.17  |- mesh__dateRevised mesh__D015998 1992-05-13
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015998 2006
% 211.97/212.17  |- skos__scopeNote mesh__D015998
% 211.97/212.17       Classification system for assessing impact injury severity developed and published by the American Association for Automotive Medicine. It is the system of choice for coding single injuries and is the foundation for methods assessing multiple injuries or for assessing cumulative effects of more than one injury. These include Maximum AIS %28%MAIS%29%, Injury Severity Score %28%ISS%29%, and Probability of Death Score %28%PODS%29%.%A%    
% 211.97/212.17  |- mesh__dateCreated mesh__D015998 1989-05-25
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015998 2000
% 211.97/212.17  |- skos__annotation mesh__D015998 no qualif   
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015998 2005
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015998 1993
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015998 1999
% 211.97/212.17  |- mesh__dateEstablished mesh__D015998 1991-01-01
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015998 1998
% 211.97/212.17  |- skos__hiddenLabel mesh__D015998 Injury Scales, Abbreviated
% 211.97/212.17  |- rdf__type mesh__D015998sskos__Concept
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015998 2002
% 211.97/212.17  |- mesh__publicMeSHNote mesh__D015998
% 211.97/212.17       91; was see under TRAUMA SEVERITY INDICES 1990   
% 211.97/212.17  |- skos__broader mesh__D015998smesh__D015599
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015998 1995
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015998 2004
% 211.97/212.17  |- skos__hiddenLabel mesh__D015998 Injury Scale, Abbreviated
% 211.97/212.17  |- mesh__dateRevised mesh__D001978 2005-07-06
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D001978 2006
% 211.97/212.17  |- mesh__recordMaintainer mesh__D001978 NLM
% 211.97/212.17  |- skos__hiddenLabel mesh__D001978 Blue, Tetrabromophenol
% 211.97/212.17  |- skos__broader mesh__D001978smesh__D014050
% 211.97/212.17  |- skos__prefLabel mesh__D001978 Bromphenol Blue
% 211.97/212.17  |- skos__broader mesh__D001978smesh__D010636
% 211.97/212.17  |- mesh__publicMeSHNote mesh__D001978 91; was see under PHENOLS 1975-90   
% 211.97/212.17  |- mesh__recordOriginator mesh__D001978 NLM
% 211.97/212.17  |- skos__broader mesh__D001978smesh__D014105
% 211.97/212.17  |- mesh__historyNote mesh__D001978
% 211.97/212.17       91%28%75%29%; was see under PHENOLS 1975-90   
% 211.97/212.17  |- skos__annotation mesh__D001978 D25-26 qualif   
% 211.97/212.17  |- mesh__dateCreated mesh__D001978 1974-11-19
% 211.97/212.17  |- skos__hiddenLabel mesh__D001978 Blue, Bromophenol
% 211.97/212.17  |- skos__historyNote mesh__D001978 Tosyl Compounds %28%1972-1974%29%
% 211.97/212.17  |- skos__hiddenLabel mesh__D001978 Blue, Bromphenol
% 211.97/212.17  |- skos__altLabel mesh__D001978 Bromophenol Blue
% 211.97/212.17  |- mesh__dateEstablished mesh__D001978 1991-01-01
% 211.97/212.17  |- skos__altLabel mesh__D001978 Tetrabromophenol Blue
% 211.97/212.17  |- skos__historyNote mesh__D001978 Phenols %28%1969-1974%29%
% 211.97/212.17  |- rdf__type mesh__D001978sskos__Concept
% 211.97/212.17  |- mesh__recordAuthorizer mesh__D001978 NLM
% 211.97/212.17  |- skos__historyNote mesh__D001978 Bromine %28%1972-1974%29%
% 211.97/212.17  |- skos__scopeNote mesh__D001978
% 211.97/212.17       A dye that has been used as an industrial dye, a laboratory indicator, and a biological stain.%A%    
% 211.97/212.17  |- mesh__dateCreated mesh__D006663 1999-01-01
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D006663 2005
% 211.97/212.17  |- skos__broader mesh__D006663smesh__D006664
% 211.97/212.17  |- skos__annotation mesh__D006663
% 211.97/212.17       = the writing of histories; no qualif; DF: HISTORIOGR   
% 211.97/212.17  |- skos__hiddenLabel mesh__D006663 Historiographies
% 211.97/212.17  |- mesh__recordMaintainer mesh__D006663 jls
% 211.97/212.17  |- mesh__recordOriginator mesh__D006663 NLM
% 211.97/212.17  |- mesh__dateRevised mesh__D006663 2004-07-07
% 211.97/212.17  |- rdf__type mesh__D006663sskos__Concept
% 211.97/212.17  |- skos__scopeNote mesh__D006663
% 211.97/212.17       The writing of history; the principles, theory, and history of historical writing; the product of historical writing. %28%Webster, 3d ed%29%%A%    
% 211.97/212.17  |- mesh__recordAuthorizer mesh__D006663 sjn
% 211.97/212.17  |- skos__prefLabel mesh__D006663 Historiography
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D006663 2006
% 211.97/212.17  |- skos__hiddenLabel mesh__D020334 Fatty Rats, Otsuka-Long-Evans-Tokushima
% 211.97/212.17  |- skos__prefLabel mesh__D020334 Rats, Inbred OLETF
% 211.97/212.17  |- mesh__dateCreated mesh__D020334 1998-06-11
% 211.97/212.17  |- skos__scopeNote mesh__D020334
% 211.97/212.17       An inbred strain of Long-Evans rats that develops hyperglycemia, hyperinsulinemia, and mild obesity, mostly in males, that resembles non-insulin-dependent diabetes mellitus in humans. It was developed from outbred Long-Evans stock in 1983.%A%    
% 211.97/212.17  |- skos__related mesh__D020334smesh__D003924
% 211.97/212.17  |- skos__broader mesh__D020334smesh__D011919
% 211.97/212.17  |- skos__hiddenLabel mesh__D020334 Rat, Inbred OLETF
% 211.97/212.17  |- skos__hiddenLabel mesh__D020334 OLETF Rats, Inbred
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D020334 2006
% 211.97/212.17  |- mesh__recordMaintainer mesh__D020334 ags
% 211.97/212.17  |- skos__hiddenLabel mesh__D020334 Rats, Otsuka-Long-Evans-Tokushima
% 211.97/212.17  |- skos__altLabel mesh__D020334 Otsuka-Long-Evans-Tokushima Rats
% 211.97/212.17  |- mesh__dateRevised mesh__D020334 2005-06-30
% 211.97/212.17  |- skos__hiddenLabel mesh__D020334 OLETF Rat, Inbred
% 211.97/212.17  |- mesh__historyNote mesh__D020334 99   
% 211.97/212.17  |- mesh__recordAuthorizer mesh__D020334 sjn
% 211.97/212.17  |- mesh__publicMeSHNote mesh__D020334 99   
% 211.97/212.17  |- skos__historyNote mesh__D020334 Rats %28%1993-1998%29%
% 211.97/212.17  |- skos__related mesh__D020334smesh__D020318
% 211.97/212.17  |- skos__hiddenLabel mesh__D020334 Otsuka Long Evans Tokushima Fatty Rats
% 211.97/212.17  |- mesh__dateEstablished mesh__D020334 1999-01-01
% 211.97/212.17  |- skos__altLabel mesh__D020334 Otsuka-Long-Evans-Tokushima Fatty Rats
% 211.97/212.17  |- skos__hiddenLabel mesh__D020334 Otsuka Long Evans Tokushima Rats
% 211.97/212.17  |- skos__hiddenLabel mesh__D020334 Rats, Otsuka-Long-Evans-Tokushima Fatty
% 211.97/212.17  |- skos__annotation mesh__D020334
% 211.97/212.17        a model for  DIABETES MELLITUS, TYPE 2 not DIABETES MELLITUS, EXPERIMENTAL; NIM when exper animal; check tag RATS%A%  
% 211.97/212.17  |- rdf__type mesh__D020334sskos__Concept
% 211.97/212.17  |- skos__hiddenLabel mesh__D020334 Inbred OLETF Rat
% 211.97/212.17  |- skos__hiddenLabel mesh__D020334 Inbred OLETF Rats
% 211.97/212.17  |- mesh__recordOriginator mesh__D020334 NDW
% 211.97/212.17  |- mesh__recordMaintainer mesh__D044782 nns
% 211.97/212.17  |- mesh__historyNote mesh__D044782 2004   
% 211.97/212.17  |- skos__broader mesh__D044782smesh__D020816
% 211.97/212.17  |- skos__hiddenLabel mesh__D044782 F-Box Motif
% 211.97/212.17  |- skos__hiddenLabel mesh__D044782 Motifs, F-Box
% 211.97/212.17  |- skos__hiddenLabel mesh__D044782 Motif, F-Box
% 211.97/212.17  |- mesh__publicMeSHNote mesh__D044782 2004   
% 211.97/212.17  |- mesh__dateEstablished mesh__D044782 2004-01-01
% 211.97/212.17  |- skos__scopeNote mesh__D044782
% 211.97/212.17       Protein structural motifs that play a role in protein-protein binding. The motifs are comprised of approximately 50 residues. Their name derives from the fact that they were found in cyclin F.%A%    
% 211.97/212.17  |- mesh__dateCreated mesh__D044782 2003-07-09
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D044782 2005
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D044782 2006
% 211.97/212.17  |- skos__related mesh__D044782smesh__D044783
% 211.97/212.17  |- skos__prefLabel mesh__D044782 F-Box Motifs
% 211.97/212.17  |- skos__hiddenLabel mesh__D044782 F Box Motifs
% 211.97/212.17  |- mesh__recordOriginator mesh__D044782 jmp
% 211.97/212.17  |- mesh__recordAuthorizer mesh__D044782 sjn
% 211.97/212.17  |- rdf__type mesh__D044782sskos__Concept
% 211.97/212.17  |- mesh__dateRevised mesh__D044782 2004-07-07
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D030762 2006
% 211.97/212.17  |- rdf__type mesh__D030762sskos__Concept
% 211.97/212.17  |- skos__annotation mesh__D030762
% 211.97/212.17       non-primate mammals only; humans %26% other primates, use MENSTRUAL CYCLE%A%  
% 211.97/212.17  |- skos__prefLabel mesh__D030762 Estrous Cycle
% 211.97/212.17  |- mesh__recordAuthorizer mesh__D030762 ags
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D030762 2005
% 211.97/212.17  |- skos__scopeNote mesh__D030762
% 211.97/212.17       The period of cyclic physiological and behavior changes in non-primate female mammals that exhibit ESTRUS. The estrous cycle generally consists of 4 or 5 distinct periods corresponding to the endocrine status %28%PROESTRUS; ESTRUS; METESTRUS; DIESTRUS; and ANESTRUS%29%.%A%    
% 211.97/212.17  |- skos__broader mesh__D030762smesh__D012098
% 211.97/212.17  |- mesh__recordMaintainer mesh__D030762 ags
% 211.97/212.17  |- skos__hiddenLabel mesh__D030762 Cycle, Estrous
% 211.97/212.17  |- mesh__dateCreated mesh__D030762 2001-07-25
% 211.97/212.17  |- mesh__dateEstablished mesh__D030762 2002-01-01
% 211.97/212.17  |- mesh__recordOriginator mesh__D030762 lkt
% 211.97/212.17  |- skos__hiddenLabel mesh__D030762 Estrous Cycles
% 211.97/212.17  |- skos__hiddenLabel mesh__D030762 Cycles, Estrous
% 211.97/212.17  |- mesh__dateRevised mesh__D030762 2005-07-27
% 211.97/212.17  |- mesh__historyNote mesh__D030762 2002; use ESTRUS 1975-2001   
% 211.97/212.17  |- skos__historyNote mesh__D030762 Estrus %28%1964-2001%29%
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D030762 2006A
% 211.97/212.17  |- mesh__publicMeSHNote mesh__D030762 2002; see ESTRUS 1975-2001   
% 211.97/212.17  |- skos__hiddenLabel mesh__D016293 EN 313
% 211.97/212.17  |- skos__broader mesh__D016293smesh__D010640
% 211.97/212.17  |- mesh__recordMaintainer mesh__D016293 ssb
% 211.97/212.17  |- mesh__dateRevised mesh__D016293 2005-06-30
% 211.97/212.17  |- skos__broader mesh__D016293smesh__D009025
% 211.97/212.17  |- mesh__recordAuthorizer mesh__D016293 sjn
% 211.97/212.17  |- skos__historyNote mesh__D016293 Phenothiazines %28%1966-1990%29%
% 211.97/212.17  |- skos__hiddenLabel mesh__D016293 Hydrochloride, Moricizine
% 211.97/212.17  |- skos__hiddenLabel mesh__D016293 EN313
% 211.97/212.17  |- mesh__historyNote mesh__D016293 91   
% 211.97/212.17  |- mesh__recordOriginator mesh__D016293 RLS
% 211.97/212.17  |- skos__altLabel mesh__D016293 Moracizine
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D016293 2006
% 211.97/212.17  |- skos__prefLabel mesh__D016293 Moricizine
% 211.97/212.17  |- mesh__publicMeSHNote mesh__D016293 91   
% 211.97/212.17  |- skos__altLabel mesh__D016293 Ethmozin
% 211.97/212.17  |- mesh__dateCreated mesh__D016293 1990-05-29
% 211.97/212.17  |- skos__altLabel mesh__D016293 Etmozin
% 211.97/212.17  |- skos__historyNote mesh__D016293 Morpholines %28%1966-1990%29%
% 211.97/212.17  |- rdf__type mesh__D016293sskos__Concept
% 211.97/212.17  |- mesh__dateEstablished mesh__D016293 1991-01-01
% 211.97/212.17  |- skos__scopeNote mesh__D016293
% 211.97/212.17       An antiarrhythmia agent used primarily for ventricular rhythm disturbances.%A%    
% 211.97/212.17  |- skos__altLabel mesh__D016293 Moracizin
% 211.97/212.17  |- skos__historyNote mesh__D016293 Anti-Arrhythmia Agents %28%1966-1990%29%
% 211.97/212.17  |- mesh__recordOriginator mesh__D002273 HMM
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D002273 2006
% 211.97/212.17  |- skos__related mesh__D002273smesh__D016588
% 211.97/212.17  |- mesh__recordMaintainer mesh__D002273 nns
% 211.97/212.17  |- skos__related mesh__D002273smesh__D009858
% 211.97/212.17  |- mesh__dateCreated mesh__D002273 1999-01-01
% 211.97/212.17  |- mesh__dateRevised mesh__D002273 2005-06-30
% 211.97/212.17  |- skos__prefLabel mesh__D002273 Carcinogens
% 211.97/212.17  |- skos__related mesh__D002273smesh__D009153
% 211.97/212.17  |- skos__broader mesh__D002273smesh__D009676
% 211.97/212.17  |- skos__hiddenLabel mesh__D002273 Promoters, Tumor
% 211.97/212.17  |- mesh__recordAuthorizer mesh__D002273 sjn
% 211.97/212.17  |- skos__scopeNote mesh__D002273
% 211.97/212.17       Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included.%A%    
% 211.97/212.17  |- skos__hiddenLabel mesh__D002273 Initiators, Tumor
% 211.97/212.17  |- rdf__type mesh__D002273sskos__Concept
% 211.97/212.17  |- skos__annotation mesh__D002273 Manual 24.5.6.2+   
% 211.97/212.17  |- skos__altLabel mesh__D002273 Oncogens
% 211.97/212.17  |- skos__related mesh__D002273smesh__D003043
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D010705 2003
% 211.97/212.17  |- mesh__dateRevised mesh__D010705 2000-06-22
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D010705 2002
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D010705 2006
% 211.97/212.17  |- skos__prefLabel mesh__D010705 Phosgene
% 211.97/212.17  |- mesh__dateCreated mesh__D010705 1999-01-01
% 211.97/212.17  |- mesh__recordAuthorizer mesh__D010705 sjn
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D010705 2005
% 211.97/212.17  |- skos__annotation mesh__D010705 D25-26 qualif   
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D010705 2001
% 211.97/212.17  |- mesh__recordOriginator mesh__D010705 NLM
% 211.97/212.17  |- skos__broader mesh__D010705smesh__D007659
% 211.97/212.17  |- rdf__type mesh__D010705sskos__Concept
% 211.97/212.17  |- mesh__recordMaintainer mesh__D010705 CCR
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D010705 2004
% 211.97/212.17  |- skos__scopeNote mesh__D010705
% 211.97/212.17       A highly toxic gas that has been used as a chemical warfare agent. It is an insidious poison as it is not irritating immediately, even when fatal concentrations are inhaled. %28%From The Merck Index, 11th ed, p7304%29%%A%    
% 211.97/212.17  |- skos__historyNote mesh__D015999 Analysis of Variance %28%1968-1989%29%
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015999 2005
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015999 1997
% 211.97/212.17  |- mesh__recordAuthorizer mesh__D015999 PLS
% 211.97/212.17  |- mesh__recordOriginator mesh__D015999 PLS
% 211.97/212.17  |- mesh__recordMaintainer mesh__D015999 TGC
% 211.97/212.17  |- mesh__publicMeSHNote mesh__D015999 90   
% 211.97/212.17  |- mesh__dateEstablished mesh__D015999 1990-01-01
% 211.97/212.17  |- skos__hiddenLabel mesh__D015999 Analysis, Multivariate
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015999 2006
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015999 1998
% 211.97/212.17  |- skos__broader mesh__D015999smesh__D000704
% 211.97/212.17  |- skos__scopeNote mesh__D015999
% 211.97/212.17       A set of techniques used when variation in several variables has to be studied simultaneously. In statistics, multivariate analysis is interpreted as any analytic method that allows simultaneous study of two or more dependent variables.%A%    
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015999 2000
% 211.97/212.17  |- mesh__historyNote mesh__D015999 90   
% 211.97/212.17  |- skos__prefLabel mesh__D015999 Multivariate Analysis
% 211.97/212.17  |- skos__annotation mesh__D015999
% 211.97/212.17       IM GEN only; coord NIM with specific disease or other concept %28%IM%29%; no qualif%A%  
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015999 1999
% 211.97/212.17  |- skos__hiddenLabel mesh__D015999 Analyses, Multivariate
% 211.97/212.17  |- skos__historyNote mesh__D015999 Statistics %28%1966-1989%29%
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015999 2001
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015999 2003
% 211.97/212.17  |- mesh__dateRevised mesh__D015999 1994-04-11
% 211.97/212.17  |- rdf__type mesh__D015999sskos__Concept
% 211.97/212.17  |- skos__hiddenLabel mesh__D015999 Multivariate Analyses
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015999 2002
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015999 2004
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015999 1995
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D015999 1996
% 211.97/212.17  |- mesh__dateCreated mesh__D015999 1989-05-25
% 211.97/212.17  |- skos__broader mesh__D001979smesh__D013943
% 211.97/212.17  |- skos__historyNote mesh__D001979 Thymol %28%1974%29%
% 211.97/212.17  |- mesh__publicMeSHNote mesh__D001979 91; was see under THYMOL 1975-90   
% 211.97/212.17  |- skos__broader mesh__D001979smesh__D014105
% 211.97/212.17  |- skos__prefLabel mesh__D001979 Bromthymol Blue
% 211.97/212.17  |- skos__hiddenLabel mesh__D001979 Blue, Bromothymol
% 211.97/212.17  |- skos__historyNote mesh__D001979 Tosyl Compounds %28%1974%29%
% 211.97/212.17  |- skos__broader mesh__D001979smesh__D014050
% 211.97/212.17  |- mesh__dateEstablished mesh__D001979 1991-01-01
% 211.97/212.17  |- skos__altLabel mesh__D001979 Bromothymol Blue
% 211.97/212.17  |- mesh__historyNote mesh__D001979
% 211.97/212.17       91%28%75%29%; was see under THYMOL 1975-90   
% 211.97/212.17  |- rdf__type mesh__D001979sskos__Concept
% 211.97/212.17  |- mesh__recordAuthorizer mesh__D001979 NLM
% 211.97/212.17  |- skos__scopeNote mesh__D001979
% 211.97/212.17       A pH sensitive dye that has been used as an indicator in many laboratory reactions.%A%    
% 211.97/212.17  |- mesh__recordOriginator mesh__D001979 NLM
% 211.97/212.17  |- skos__hiddenLabel mesh__D001979 Blue, Bromthymol
% 211.97/212.17  |- skos__annotation mesh__D001979 D25-26 qualif   
% 211.97/212.17  |- mesh__dateCreated mesh__D001979 1974-11-19
% 211.97/212.17  |- skos__altLabel mesh__D001979 Dibromothymolsulfonphthalein
% 211.97/212.17  |- mesh__dateRevised mesh__D001979 2005-07-06
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D001979 2006
% 211.97/212.17  |- mesh__recordMaintainer mesh__D001979 NLM
% 211.97/212.17  |- mesh__recordAuthorizer mesh__D006664 sjn
% 211.97/212.17  |- skos__annotation mesh__D006664
% 211.97/212.17       IM for specialty or general articles on history: Mnual 32.3; prefer /hist with specific subjects: Manual 19.7+, 19.8.36; Saints: 32.18.3%A%  
% 211.97/212.17  |- mesh__dateRevised mesh__D006664 2004-07-07
% 211.97/212.17  |- skos__hiddenLabel mesh__D006664 Histories
% 211.97/212.17  |- skos__prefLabel mesh__D006664 History
% 211.97/212.17  |- skos__broader mesh__D006664smesh__D006809
% 211.97/212.17  |- skos__hiddenLabel mesh__D006664 Historical Aspect
% 211.97/212.17  |- rdf__type mesh__D006664sskos__Concept
% 211.97/212.17  |- skos__hiddenLabel mesh__D006664 Aspect, Historical
% 211.97/212.17  |- mesh__recordMaintainer mesh__D006664 jls
% 211.97/212.17  |- mesh__dateCreated mesh__D006664 1999-01-01
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D006664 2005
% 211.97/212.17  |- skos__altLabel mesh__D006664 Aspects, Historical
% 211.97/212.17  |- mesh__recordOriginator mesh__D006664 NLM
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D006664 2006
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D020335 2006
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D020335 2002
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D020335 2004
% 211.97/212.17  |- mesh__dateEstablished mesh__D020335 2000-01-01
% 211.97/212.17  |- skos__hiddenLabel mesh__D020335 Chronic Progressive Paraparesis
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D020335 2005
% 211.97/212.17  |- skos__hiddenLabel mesh__D020335 Progressive Paraparesis, Chronic
% 211.97/212.17  |- skos__hiddenLabel mesh__D020335 Hypotonic Paraparesis
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D020335 2003
% 211.97/212.17  |- mesh__historyNote mesh__D020335 2000   
% 211.97/212.17  |- skos__hiddenLabel mesh__D020335 Parapareses
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D020335 2001
% 211.97/212.17  |- mesh__dateCreated mesh__D020335 1999-11-04
% 211.97/212.17  |- skos__hiddenLabel mesh__D020335 Spinal Paraparesis
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D020335 2000
% 211.97/212.17  |- skos__hiddenLabel mesh__D020335 Cerebral Paraparesis
% 211.97/212.17  |- skos__broader mesh__D020335smesh__D010291
% 211.97/212.17  |- rdf__type mesh__D020335sskos__Concept
% 211.97/212.17  |- skos__historyNote mesh__D020335 Paralysis %28%1967-1999%29%
% 211.97/212.17  |- skos__scopeNote mesh__D020335
% 211.97/212.17       Mild to moderate loss of bilateral lower extremity motor function, which may be a manifestation of SPINAL CORD DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; MUSCULAR DISEASES; INTRACRANIAL HYPERTENSION; parasagittal brain lesions; and other conditions.%A%    
% 211.97/212.17  |- skos__prefLabel mesh__D020335 Paraparesis
% 211.97/212.17  |- skos__historyNote mesh__D020335 Paresis %28%1967-1999%29%
% 211.97/212.17  |- mesh__publicMeSHNote mesh__D020335 2000   
% 211.97/212.17  |- skos__hiddenLabel mesh__D044783 Protein Family, F-Box
% 211.97/212.17  |- mesh__dateCreated mesh__D044783 2003-07-09
% 211.97/212.17  |- skos__hiddenLabel mesh__D044783 F Box Proteins
% 211.97/212.17  |- skos__hiddenLabel mesh__D044783 F Box Protein Family
% 211.97/212.17  |- skos__hiddenLabel mesh__D044783 Protein, F-Box Domain
% 211.97/212.17  |- mesh__recordOriginator mesh__D044783 jmp
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D044783 2006
% 211.97/212.17  |- skos__hiddenLabel mesh__D044783 Domain Protein, F-Box
% 211.97/212.17  |- mesh__recordAuthorizer mesh__D044783 sjn
% 211.97/212.17  |- skos__hiddenLabel mesh__D044783 F Box Domain Protein
% 211.97/212.17  |- skos__scopeNote mesh__D044783
% 211.97/212.17       A family of proteins that share the F-BOX MOTIF and are involved in protein-protein interactions. They play an important role in process of protein ubiquition by associating with a variety of substrates and then associating into SCF UBIQUITIN LIGASE complexes. They are held in the ubiquitin-ligase complex via binding to SKP DOMAIN PROTEINS.%A%    
% 211.97/212.17  |- skos__broader mesh__D044783smesh__D002352
% 211.97/212.17  |- rdf__type mesh__D044783sskos__Concept
% 211.97/212.17  |- skos__altLabel mesh__D044783 F-Box Domain Protein
% 211.97/212.17  |- mesh__historyNote mesh__D044783 2004   
% 211.97/212.17  |- skos__prefLabel mesh__D044783 F-Box Proteins
% 211.97/212.17  |- mesh__dateEstablished mesh__D044783 2004-01-01
% 211.97/212.17  |- mesh__recordMaintainer mesh__D044783 SYSTEM
% 211.97/212.17  |- skos__related mesh__D044783smesh__D044782
% 211.97/212.17  |- skos__altLabel mesh__D044783 F-Box Protein Family
% 211.97/212.17  |- mesh__dateRevised mesh__D044783 2005-06-30
% 211.97/212.17  |- mesh__publicMeSHNote mesh__D044783 2004   
% 211.97/212.17  |- mesh__dateCreated mesh__D011000 1999-01-01
% 211.97/212.17  |- skos__hiddenLabel mesh__D011000 Epidemic Myalgias
% 211.97/212.17  |- skos__scopeNote mesh__D011000
% 211.97/212.17       An acute, febrile, infectious disease generally occurring in epidemics. It is usually caused by coxsackieviruses B and sometimes by coxsackieviruses A; echoviruses; or other enteroviruses.%A%    
% 211.97/212.17  |- skos__prefLabel mesh__D011000 Pleurodynia, Epidemic
% 211.97/212.17  |- skos__hiddenLabel mesh__D011000 Epidemic Pleurodynias
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D011000 2005
% 211.97/212.17  |- skos__hiddenLabel mesh__D011000 Epidemic Pleurodynia
% 211.97/212.17  |- mesh__recordOriginator mesh__D011000 NLM
% 211.97/212.17  |- skos__hiddenLabel mesh__D011000 Myalgias, Epidemic
% 211.97/212.17  |- rdf__type mesh__D011000sskos__Concept
% 211.97/212.17  |- mesh__dateRevised mesh__D011000 2001-07-25
% 211.97/212.17  |- skos__hiddenLabel mesh__D011000 Pleurodynias, Epidemic
% 211.97/212.17  |- skos__altLabel mesh__D011000 Myalgia, Epidemic
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D011000 2004
% 211.97/212.17  |- skos__altLabel mesh__D011000 Bornholm Disease
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D011000 2002
% 211.97/212.17  |- mesh__recordMaintainer mesh__D011000 ags
% 211.97/212.17  |- skos__hiddenLabel mesh__D011000 Epidemic Myalgia
% 211.97/212.17  |- skos__broader mesh__D011000smesh__D003384
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D011000 2003
% 211.97/212.17  |- mesh__recordAuthorizer mesh__D011000 sjn
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D011000 2006
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D016294 2000
% 211.97/212.17  |- skos__altLabel mesh__D016294 Nursing Model
% 211.97/212.17  |- mesh__historyNote mesh__D016294 91   
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D016294 1995
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D016294 2006
% 211.97/212.17  |- skos__annotation mesh__D016294 no qualif   
% 211.97/212.17  |- skos__hiddenLabel mesh__D016294 Self-Care Models, Orem
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D016294 2001
% 211.97/212.17  |- skos__hiddenLabel mesh__D016294 Orem Self Care Model
% 211.97/212.17  |- skos__altLabel mesh__D016294 Model, Nursing
% 211.97/212.17  |- mesh__dateCreated mesh__D016294 1990-05-29
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D016294 1996
% 211.97/212.17  |- rdf__type mesh__D016294sskos__Concept
% 211.97/212.17  |- skos__hiddenLabel mesh__D016294 Models, Orem Self-Care
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D016294 2002
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D016294 1991
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D016294 2003
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D016294 1997
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D016294 1992
% 211.97/212.17  |- mesh__dateEstablished mesh__D016294 1991-01-01
% 211.97/212.17  |- mesh__publicMeSHNote mesh__D016294 91   
% 211.97/212.17  |- skos__historyNote mesh__D016294 Models, Theoretical %28%1977-1990%29%
% 211.97/212.17  |- skos__hiddenLabel mesh__D016294 Model, Orem Self-Care
% 211.97/212.17  |- skos__scopeNote mesh__D016294
% 211.97/212.17       Theoretical models simulating behavior or activities in nursing, including nursing care, management and economics, theory, assessment, research, and education. Some examples of these models include Orem Self-Care Model, Roy Adaptation Model, and Rogers Life Process Model.%A%    
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D016294 2004
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D016294 1993
% 211.97/212.17  |- skos__prefLabel mesh__D016294 Models, Nursing
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D016294 1998
% 211.97/212.17  |- skos__broader mesh__D016294smesh__D008962
% 211.97/212.17  |- skos__hiddenLabel mesh__D016294 Self-Care Model, Orem
% 211.97/212.17  |- skos__hiddenLabel mesh__D016294 Orem Self-Care Models
% 211.97/212.17  |- skos__altLabel mesh__D016294 Nursing Models
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D016294 1994
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D016294 2005
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D016294 1999
% 211.97/212.17  |- mesh__dateEstablished mesh__D002274 1975-09-01
% 211.97/212.17  |- mesh__recordOriginator mesh__D002274 NLM
% 211.97/212.17  |- mesh__publicMeSHNote mesh__D002274 75   
% 211.97/212.17  |- skos__annotation mesh__D002274 DF: CARCINOGENS ENVIR   
% 211.97/212.17  |- rdf__type mesh__D002274sskos__Concept
% 211.97/212.17  |- skos__broader mesh__D002274smesh__D002273
% 211.97/212.17  |- skos__prefLabel mesh__D002274 Carcinogens, Environmental
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D002274 2005
% 211.97/212.17  |- skos__hiddenLabel mesh__D002274 Carcinogens Environmental
% 211.97/212.17  |- skos__hiddenLabel mesh__D002274 Environmental Carcinogens
% 211.97/212.17  |- mesh__historyNote mesh__D002274 75   
% 211.97/212.17  |- skos__historyNote mesh__D002274 Carcinogens %28%1966-1974%29%
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D002274 2006
% 211.97/212.17  |- skos__scopeNote mesh__D002274
% 211.97/212.17       Carcinogenic substances that are found in the environment.%A%    
% 211.97/212.17  |- mesh__dateRevised mesh__D002274 2003-07-09
% 211.97/212.17  |- mesh__dateCreated mesh__D002274 1999-01-01
% 211.97/212.17  |- skos__altLabel mesh__D002274 Environmental, Carcinogens
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D002274 2004
% 211.97/212.17  |- mesh__recordMaintainer mesh__D002274 ssb
% 211.97/212.17  |- mesh__recordAuthorizer mesh__D002274 sjn
% 211.97/212.17  |- mesh__onlineNote mesh__D010706 use PHOSMET to search IMIDAN 1975-93   
% 211.97/212.17  |- mesh__activeMeSHYear mesh__D010706 2006
% 211.97/212.17  |- mesh__dateEstablished mesh__D010706 1991-01-01
% 211.97/212.17  |- mesh__recordMaintainer mesh__D010706 ssb
% 211.97/212.17  |- skos__scopeNote mesh__D010706
% 211.97/212.17       An organothiophosphorus insecticide that has been used to control pig mange.%A%    
% 211.97/212.17  |- skos__annotation mesh__D010706 TN 111 for eff on insects   
% 211.97/212.17  |- skos__historyNote mesh__D010706 Indoles %28%1974%29%
% 211.97/212.17  |- mesh__publicMeSHNote mesh__D010706
% 211.97/212.17       91; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1979-90, was IMIDAN see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1975-78; IMIDAN was see PHOSMET 1979-93%A%  
% 211.97/212.17  |- mesh__dateCreated mesh__D010706 1974-11-19
% 211.97/212.17  |- skos__altLabel mesh__D010706 Phthalophos
% 211.97/212.17  |- skos__prefLabel mesh__D010706 Phosmet
% 211.97/212.17  |- rdf__type mesh__D010706sskos__Concept
% 211.97/212.18  |- mesh__recordAuthorizer mesh__D010706 sjn
% 211.97/212.18  |- skos__altLabel mesh__D010706
% 211.97/212.18       N-%28%Mercaptomethyl%29%phthalimide S-%28%O,O-dimethyl phosphorothionate%29%
% 211.97/212.18  |- mesh__historyNote mesh__D010706
% 211.97/212.18       91%28%75%29%; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1979-90, was IMIDAN see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1975-78; IMIDAN was see PHOSMET 1979-93%A%  
% 211.97/212.18  |- mesh__recordOriginator mesh__D010706 NLM
% 211.97/212.18  |- skos__broader mesh__D010706smesh__D009946
% 211.97/212.18  |- skos__historyNote mesh__D010706
% 211.97/212.18       Insecticides, Organothiophosphate %28%1974%29%
% 211.97/212.18  |- mesh__dateRevised mesh__D010706 2005-06-30
% 211.97/212.18  |- mesh__historyNote mesh__D006665 65   
% 211.97/212.18  |- mesh__publicMeSHNote mesh__D006665 65   
% 211.97/212.18  |- mesh__recordOriginator mesh__D006665 NLM
% 211.97/212.18  |- skos__annotation mesh__D006665
% 211.97/212.18       general; prefer /hist with specific dentistry term %26% do not coordinate here or wth DENTISTRY; Manual 32.7, 32.8; DF: HIST DENT%A%  
% 211.97/212.18  |- skos__hiddenLabel mesh__D006665 Dentistry History
% 211.97/212.18  |- mesh__recordAuthorizer mesh__D006665 sjn
% 211.97/212.18  |- skos__hiddenLabel mesh__D006665 Dentistries, History
% 211.97/212.18  |- mesh__dateEstablished mesh__D006665 1965-01-01
% 211.97/212.18  |- rdf__type mesh__D006665sskos__Concept
% 211.97/212.18  |- skos__hiddenLabel mesh__D006665 Dentistry Histories
% 211.97/212.18  |- mesh__dateCreated mesh__D006665 1999-01-01
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D006665 2005
% 211.97/212.18  |- skos__prefLabel mesh__D006665 History of Dentistry
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D006665 2006
% 211.97/212.18  |- skos__hiddenLabel mesh__D006665 History Dentistry
% 211.97/212.18  |- skos__hiddenLabel mesh__D006665 History Dentistries
% 211.97/212.18  |- mesh__recordMaintainer mesh__D006665 jls
% 211.97/212.18  |- skos__altLabel mesh__D006665 Dentistry, History
% 211.97/212.18  |- mesh__dateRevised mesh__D006665 2004-07-07
% 211.97/212.18  |- skos__broader mesh__D006665smesh__D006664
% 211.97/212.18  |- skos__altLabel mesh__D020336 Spastic Lower Extremity Weakness
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D020336 2006A
% 211.97/212.18  |- skos__annotation mesh__D020336
% 211.97/212.18       do not confuse with PARAPARESIS, TROPICAL SPASTIC caused by HUMAN T-LYMPHOTROPIC VIRUS 1%A%  
% 211.97/212.18  |- mesh__recordOriginator mesh__D020336 KEV
% 211.97/212.18  |- skos__hiddenLabel mesh__D020336 Parapareses, Spastic
% 211.97/212.18  |- mesh__recordAuthorizer mesh__D020336 ags
% 211.97/212.18  |- skos__altLabel mesh__D020336 Lower Extremity Weakness, Spastic
% 211.97/212.18  |- mesh__dateEstablished mesh__D020336 2000-01-01
% 211.97/212.18  |- skos__altLabel mesh__D020336 Spastic Paraparesis
% 211.97/212.18  |- mesh__dateRevised mesh__D020336 2005-08-01
% 211.97/212.18  |- skos__hiddenLabel mesh__D020336 Spastic Parapareses
% 211.97/212.18  |- skos__prefLabel mesh__D020336 Paraparesis, Spastic
% 211.97/212.18  |- rdf__type mesh__D020336sskos__Concept
% 211.97/212.18  |- mesh__dateCreated mesh__D020336 1999-11-04
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D020336 2005
% 211.97/212.18  |- skos__broader mesh__D020336smesh__D020335
% 211.97/212.18  |- mesh__recordMaintainer mesh__D020336 ags
% 211.97/212.18  |- mesh__historyNote mesh__D020336 2000   
% 211.97/212.18  |- skos__historyNote mesh__D020336 Paraparesis %28%1966-1999%29%
% 211.97/212.18  |- mesh__publicMeSHNote mesh__D020336 2000   
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D020336 2006
% 211.97/212.18  |- skos__scopeNote mesh__D020336
% 211.97/212.18       Mild or moderate loss of motor function accompanied by spasticity in the lower extremities. This condition is a manifestation of CENTRAL NERVOUS SYSTEM DISEASES that cause injury to the motor cortex or descending motor pathways.%A%    
% 211.97/212.18  |- mesh__publicMeSHNote mesh__D039041
% 211.97/212.18       2003; INTEGRIN ALPHA4BETA1 was indexed under INTEGRINS %26% RECEPTORS, LYMPHOCYTE HOMING 1991-2002%A%  
% 211.97/212.18  |- skos__hiddenLabel mesh__D039041 Heterodimer alpha4beta1, Integrin
% 211.97/212.18  |- skos__hiddenLabel mesh__D039041 Antigen-4, Very Late
% 211.97/212.18  |- mesh__recordOriginator mesh__D039041 MDJ
% 211.97/212.18  |- skos__hiddenLabel mesh__D039041 alpha4beta1, Integrin
% 211.97/212.18  |- skos__hiddenLabel mesh__D039041 Late Antigen-4, Very
% 211.97/212.18  |- skos__altLabel mesh__D039041 Very Late Antigen-4
% 211.97/212.18  |- skos__broader mesh__D039041smesh__D016029
% 211.97/212.18  |- skos__historyNote mesh__D039041
% 211.97/212.18       Receptors, Lymphocyte Homing %28%1991-2002%29%
% 211.97/212.18  |- rdf__type mesh__D039041sskos__Concept
% 211.97/212.18  |- skos__historyNote mesh__D039041 Integrins %28%1991-2002%29%
% 211.97/212.18  |- skos__altLabel mesh__D039041 VLA-4
% 211.97/212.18  |- skos__altLabel mesh__D039041 Integrin alpha%28%4%29%beta%28%1%29%
% 211.97/212.18  |- mesh__historyNote mesh__D039041
% 211.97/212.18       2003; use INTEGRIN ALPHA4BETA1 %28%NM%29% 1991-2002   
% 211.97/212.18  |- mesh__dateEstablished mesh__D039041 2003-01-01
% 211.97/212.18  |- skos__hiddenLabel mesh__D039041 alpha4beta1, Integrin Heterodimer
% 211.97/212.18  |- skos__hiddenLabel mesh__D039041 Very Late Antigen 4
% 211.97/212.18  |- skos__altLabel mesh__D039041 Very Late Activation Antigen-4
% 211.97/212.18  |- skos__broader mesh__D039041smesh__D017469
% 211.97/212.18  |- skos__hiddenLabel mesh__D039041 Integrin, alpha4beta1
% 211.97/212.18  |- mesh__dateRevised mesh__D039041 2005-07-20
% 211.97/212.18  |- skos__broader mesh__D039041smesh__D016201
% 211.97/212.18  |- skos__scopeNote mesh__D039041
% 211.97/212.18       Integrin alpha4beta1 is a FIBRONECTIN and VCAM-1 receptor present on LYMPHOCYTES; MONOCYTES; EOSINOPHILS; NK CELLS and thymocytes. It is involved in both cell-cell and cell- EXTRACELLULAR MATRIX adhesion and plays a role in INFLAMMATION, hematopoietic cell homing and immune function, and has been implicated in skeletal MYOGENESIS; NEURAL CREST migration and proliferation, lymphocyte maturation and morphogenesis of the PLACENTA and HEART.%A%    
% 211.97/212.18  |- mesh__recordAuthorizer mesh__D039041 ags
% 211.97/212.18  |- skos__prefLabel mesh__D039041 Integrin alpha4beta1
% 211.97/212.18  |- mesh__dateCreated mesh__D039041 2002-07-02
% 211.97/212.18  |- skos__altLabel mesh__D039041 CD49d-CD29
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D039041 2006A
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D039041 2006
% 211.97/212.18  |- skos__altLabel mesh__D039041 Integrin Heterodimer alpha4beta1
% 211.97/212.18  |- skos__altLabel mesh__D039041 alpha4beta1 Integrin
% 211.97/212.18  |- skos__hiddenLabel mesh__D039041 Very Late Activation Antigen 4
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D039041 2006B
% 211.97/212.18  |- mesh__recordMaintainer mesh__D039041 ags
% 211.97/212.18  |- skos__broader mesh__D025021smesh__D009805
% 211.97/212.18  |- skos__prefLabel mesh__D025021 Cementogenesis
% 211.97/212.18  |- mesh__recordOriginator mesh__D025021 lkt
% 211.97/212.18  |- mesh__recordMaintainer mesh__D025021 lkt
% 211.97/212.18  |- rdf__type mesh__D025021sskos__Concept
% 211.97/212.18  |- skos__related mesh__D025021smesh__D003739
% 211.97/212.18  |- mesh__recordAuthorizer mesh__D025021 sjn
% 211.97/212.18  |- mesh__dateRevised mesh__D025021 2004-07-07
% 211.97/212.18  |- skos__historyNote mesh__D025021 Dental Cementum %28%1967-2001%29%
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D025021 2005
% 211.97/212.18  |- mesh__dateEstablished mesh__D025021 2002-01-01
% 211.97/212.18  |- skos__scopeNote mesh__D025021
% 211.97/212.18       The formation of DENTAL CEMENTUM, a bone-like material that covers the root of the tooth.%A%    
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D025021 2006
% 211.97/212.18  |- mesh__dateCreated mesh__D025021 2001-07-25
% 211.97/212.18  |- mesh__publicMeSHNote mesh__D025021 2002   
% 211.97/212.18  |- mesh__historyNote mesh__D025021 2002   
% 211.97/212.18  |- skos__historyNote mesh__D044784 Plants %28%1969-2003%29%
% 211.97/212.18  |- mesh__dateRevised mesh__D044784 2005-06-30
% 211.97/212.18  |- skos__prefLabel mesh__D044784 Chara
% 211.97/212.18  |- skos__historyNote mesh__D044784 Algae %28%1967-2003%29%
% 211.97/212.18  |- rdf__type mesh__D044784sskos__Concept
% 211.97/212.18  |- mesh__recordAuthorizer mesh__D044784 sjn
% 211.97/212.18  |- mesh__recordMaintainer mesh__D044784 SYSTEM
% 211.97/212.18  |- skos__broader mesh__D044784smesh__D044522
% 211.97/212.18  |- mesh__recordOriginator mesh__D044784 ags
% 211.97/212.18  |- mesh__historyNote mesh__D044784 2004   
% 211.97/212.18  |- skos__scopeNote mesh__D044784
% 211.97/212.18       A genus of ALGAE in the family CHARACEAE. They have a strong garlic-like odor and are an important food source for waterfowl.%A%    
% 211.97/212.18  |- mesh__publicMeSHNote mesh__D044784 2004   
% 211.97/212.18  |- mesh__dateEstablished mesh__D044784 2004-01-01
% 211.97/212.18  |- mesh__dateCreated mesh__D044784 2003-07-09
% 211.97/212.18  |- skos__historyNote mesh__D044784 Algae, Green %28%1972-2003%29%
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D044784 2006
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D011001 1996
% 211.97/212.18  |- mesh__recordAuthorizer mesh__D011001 PLS
% 211.97/212.18  |- skos__annotation mesh__D011001
% 211.97/212.18       do not make a diagnosis: use the term as used by the author%A%  
% 211.97/212.18  |- mesh__dateRevised mesh__D011001 1994-05-27
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D011001 1997
% 211.97/212.18  |- mesh__recordMaintainer mesh__D011001 PXP
% 211.97/212.18  |- skos__broader mesh__D011001smesh__D011014
% 211.97/212.18  |- skos__hiddenLabel mesh__D011001 Pleuropneumonias
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D011001 1998
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D011001 2000
% 211.97/212.18  |- rdf__type mesh__D011001sskos__Concept
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D011001 2003
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D011001 1999
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D011001 2001
% 211.97/212.18  |- mesh__dateCreated mesh__D011001 1999-01-01
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D011001 1995
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D011001 2004
% 211.97/212.18  |- skos__prefLabel mesh__D011001 Pleuropneumonia
% 211.97/212.18  |- mesh__recordOriginator mesh__D011001 NLM
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D011001 2002
% 211.97/212.18  |- skos__broader mesh__D011001smesh__D010998
% 211.97/212.18  |- skos__scopeNote mesh__D011001
% 211.97/212.18       Pleurisy complicated with pneumonia. %28%Dorland, 27th ed%29%%A%    
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D011001 2005
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D011001 2006
% 211.97/212.18  |- skos__broader mesh__D014867Q000633smesh__D014867
% 211.97/212.18  |- mesh__preferredCombination mesh__D014867Q000633smesh__D014869
% 211.97/212.18  |- rdf__type mesh__D014867Q000633smesh__CompoundConcept
% 211.97/212.18  |- skos__broader mesh__D002275smesh__D006331
% 211.97/212.18  |- skos__annotation mesh__D002275
% 211.97/212.18       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D002275 2000
% 211.97/212.18  |- rdf__type mesh__D002275sskos__Concept
% 211.97/212.18  |- mesh__publicMeSHNote mesh__D002275
% 211.97/212.18       91; was see under MALIGNANT CARCINOID SYNDROME 1964-90   
% 211.97/212.18  |- skos__hiddenLabel mesh__D002275 Carcinoid Heart Diseases
% 211.97/212.18  |- mesh__dateRevised mesh__D002275 1996-06-10
% 211.97/212.18  |- mesh__recordAuthorizer mesh__D002275 PLS
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D002275 2001
% 211.97/212.18  |- skos__prefLabel mesh__D002275 Carcinoid Heart Disease
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D002275 1999
% 211.97/212.18  |- skos__hiddenLabel mesh__D002275 Heart Disease, Carcinoid
% 211.97/212.18  |- mesh__historyNote mesh__D002275
% 211.97/212.18       91%28%75%29%%28%64-72%29%; was see under MALIGNANT CARCINOID SYNDROME 1964-90 %28%Prov 1964-72%29%%A%  
% 211.97/212.18  |- mesh__recordOriginator mesh__D002275 NLM
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D002275 2005
% 211.97/212.18  |- skos__hiddenLabel mesh__D002275 Disease, Carcinoid Heart
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D002275 1997
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D002275 2002
% 211.97/212.18  |- mesh__onlineNote mesh__D002275
% 211.97/212.18       search MALIGNANT CARCINOID SYNDROME 1966-74   
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D002275 2003
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D002275 2006
% 211.97/212.18  |- skos__scopeNote mesh__D002275
% 211.97/212.18       Cardiac manifestation of MALIGNANT CARCINOID SYNDROME. It is a unique form of fibrosis involving the endocardium, primarily of the right heart. The fibrous deposits tend to cause constriction of the tricuspid and pulmonary valves. %28%DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1307%29%%A%    
% 211.97/212.18  |- skos__broader mesh__D002275smesh__D008303
% 211.97/212.18  |- mesh__dateCreated mesh__D002275 1999-01-01
% 211.97/212.18  |- skos__hiddenLabel mesh__D002275 Diseases, Carcinoid Heart
% 211.97/212.18  |- mesh__recordMaintainer mesh__D002275 TPW
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D002275 2004
% 211.97/212.18  |- mesh__dateEstablished mesh__D002275 1991-01-01
% 211.97/212.18  |- skos__hiddenLabel mesh__D002275 Heart Diseases, Carcinoid
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D002275 1998
% 211.97/212.18  |- mesh__dateRevised mesh__D010707 2004-07-07
% 211.97/212.18  |- mesh__recordOriginator mesh__D010707 NLM
% 211.97/212.18  |- rdf__type mesh__D010707sskos__Concept
% 211.97/212.18  |- skos__annotation mesh__D010707 TN 111 for eff on insects   
% 211.97/212.18  |- mesh__historyNote mesh__D010707
% 211.97/212.18       91%28%72%29%; was see under INSECTICIDES, ORGANOPHOSPHATE 1972-90%A%  
% 211.97/212.18  |- mesh__recordMaintainer mesh__D010707 ssb
% 211.97/212.18  |- skos__broader mesh__D010707smesh__D009943
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D010707 2006
% 211.97/212.18  |- mesh__dateCreated mesh__D010707 1999-01-01
% 211.97/212.18  |- mesh__publicMeSHNote mesh__D010707
% 211.97/212.18       91; was see under INSECTICIDES, ORGANOPHOSPHATE 1972-90   
% 211.97/212.18  |- skos__historyNote mesh__D010707 Insecticides %28%1966-1971%29%
% 211.97/212.18  |- skos__prefLabel mesh__D010707 Phosphamidon
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D010707 2005
% 211.97/212.18  |- mesh__dateEstablished mesh__D010707 1991-01-01
% 211.97/212.18  |- skos__scopeNote mesh__D010707
% 211.97/212.18       An organophosphate cholinesterase inhibitor that is used as an insecticide.%A%    
% 211.97/212.18  |- mesh__recordAuthorizer mesh__D010707 sjn
% 211.97/212.18  |- mesh__recordMaintainer mesh__D006666 jls
% 211.97/212.18  |- mesh__dateCreated mesh__D006666 1999-01-01
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D006666 2005
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D006666 2006
% 211.97/212.18  |- skos__annotation mesh__D006666
% 211.97/212.18       general; prefer /hist with specific medical concept and do not coordinate here; Manual 18.14+; 32.4-.6; Avicenna %28%Ibn Sina%29%: see note under MEDICINE, ARABIC; DF: HIST MED%A%  
% 211.97/212.18  |- mesh__recordOriginator mesh__D006666 NLM
% 211.97/212.18  |- mesh__dateRevised mesh__D006666 2004-07-07
% 211.97/212.18  |- skos__broader mesh__D006666smesh__D006664
% 211.97/212.18  |- mesh__recordAuthorizer mesh__D006666 sjn
% 211.97/212.18  |- skos__altLabel mesh__D006666 Medicine, History
% 211.97/212.18  |- skos__prefLabel mesh__D006666 History of Medicine
% 211.97/212.18  |- rdf__type mesh__D006666sskos__Concept
% 211.97/212.18  |- skos__broader mesh__D044785smesh__D000456
% 211.97/212.18  |- skos__historyNote mesh__D044785 Algae %28%1975-2003%29%
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D044785 2006
% 211.97/212.18  |- rdf__type mesh__D044785sskos__Concept
% 211.97/212.18  |- mesh__dateRevised mesh__D044785 2005-06-30
% 211.97/212.18  |- skos__altLabel mesh__D044785 Cryptomonads
% 211.97/212.18  |- mesh__recordAuthorizer mesh__D044785 sjn
% 211.97/212.18  |- skos__prefLabel mesh__D044785 Cryptophyta
% 211.97/212.18  |- skos__scopeNote mesh__D044785
% 211.97/212.18       A division %28%some say phylum or class%29% of the ALGAE, characterized by biflagellated cells and found in both freshwater and marine environments. Pigmentation varies but only one CHLOROPLAST is present. Unique structures include a nucleomorph and ejectosomes.%A%    
% 211.97/212.18  |- mesh__recordOriginator mesh__D044785 ags
% 211.97/212.18  |- mesh__recordMaintainer mesh__D044785 SYSTEM
% 211.97/212.18  |- mesh__historyNote mesh__D044785 2004   
% 211.97/212.18  |- mesh__dateCreated mesh__D044785 2003-07-09
% 211.97/212.18  |- mesh__publicMeSHNote mesh__D044785 2004   
% 211.97/212.18  |- mesh__dateEstablished mesh__D044785 2004-01-01
% 211.97/212.18  |- mesh__recordOriginator mesh__D011800 NLM
% 211.97/212.18  |- skos__altLabel mesh__D011800 Ethinyl Estradiol 3-Cyclopentyl Ether
% 211.97/212.18  |- mesh__dateCreated mesh__D011800 1999-01-01
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D011800 2006
% 211.97/212.18  |- skos__altLabel mesh__D011800 Parke Davis Brand of Quinestrol
% 211.97/212.18  |- mesh__recordMaintainer mesh__D011800 CCR
% 211.97/212.18  |- mesh__publicMeSHNote mesh__D011800
% 211.97/212.18       91; was see under NORPREGNATRIENES 1972-90   
% 211.97/212.18  |- mesh__dateRevised mesh__D011800 2005-06-30
% 211.97/212.18  |- skos__prefLabel mesh__D011800 Quinestrol
% 211.97/212.18  |- rdf__type mesh__D011800sskos__Concept
% 211.97/212.18  |- mesh__dateEstablished mesh__D011800 1991-01-01
% 211.97/212.18  |- skos__historyNote mesh__D011800 Estrogens %28%1966-1971%29%
% 211.97/212.18  |- skos__hiddenLabel mesh__D011800 Ethinyl Estradiol 3 Cyclopentyl Ether
% 211.97/212.18  |- mesh__historyNote mesh__D011800
% 211.97/212.18       91%28%72%29%; was see under NORPREGNATRIENES 1972-90   
% 211.97/212.18  |- skos__scopeNote mesh__D011800
% 211.97/212.18       The 3-cyclopentyl ether of ETHINYL ESTRADIOL. After gastrointestinal absorption, it is stored in ADIPOSE TISSUE, slowly released, and metabolized principally to the parent compound. It has been used in ESTROGEN REPLACEMENT THERAPY. %28%From AMA Drug Evaluations Annual, 1992, p1011%29%%A%    
% 211.97/212.18  |- skos__broader mesh__D011800smesh__D004997
% 211.97/212.18  |- skos__historyNote mesh__D011800 Contraceptives, Oral %28%1966-1971%29%
% 211.97/212.18  |- mesh__recordAuthorizer mesh__D011800 sjn
% 211.97/212.18  |- rdf__type mesh__D011002sskos__Concept
% 211.97/212.18  |- skos__broader mesh__D011002smesh__D009175
% 211.97/212.18  |- mesh__onlineNote mesh__D011002
% 211.97/212.18       use MYCOPLASMA INFECTIONS to search PLEUROPNEUMONIA, CONTAGIOUS 1968-74%A%  
% 211.97/212.18  |- skos__annotation mesh__D011002
% 211.97/212.18       Mycoplasma infect; animal only; check tag ANIMALS; coord IM with precoord animal/dis term %28%IM%29% + animal %28%NIM%29% or with animal %28%IM%29% in absence of precoord%A%  
% 211.97/212.18  |- mesh__dateEstablished mesh__D011002 1991-01-01
% 211.97/212.18  |- mesh__historyNote mesh__D011002
% 211.97/212.18       91%28%75%29%; was see under MYCOPLASMA INFECTIONS/veterinary 1979-90; was see under ANIMAL DISEASES 1978; was see under MYCOPLASMA INFECTIONS 1968-77%A%  
% 211.97/212.18  |- mesh__dateCreated mesh__D011002 1999-01-01
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D011002 2004
% 211.97/212.18  |- skos__hiddenLabel mesh__D011002 Pleuropneumonias, Contagious
% 211.97/212.18  |- skos__hiddenLabel mesh__D011002 Contagious Pleuropneumonias
% 211.97/212.18  |- skos__scopeNote mesh__D011002
% 211.97/212.18       A pleuropneumonia of cattle and goats caused by species of MYCOPLASMA.%A%    
% 211.97/212.18  |- mesh__publicMeSHNote mesh__D011002
% 211.97/212.18       91; was see under MYCOPLASMA INFECTIONS/veterinary 1979-90; was see under ANIMAL DISEASES 1978; was see under MYCOPLASMA INFECTIONS 1968-77%A%  
% 211.97/212.18  |- mesh__recordAuthorizer mesh__D011002 sjn
% 211.97/212.18  |- skos__hiddenLabel mesh__D011002 Contagious Pleuropneumonia
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D011002 2005
% 211.97/212.18  |- skos__prefLabel mesh__D011002 Pleuropneumonia, Contagious
% 211.97/212.18  |- mesh__recordMaintainer mesh__D011002 sjn
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D011002 2006
% 211.97/212.18  |- mesh__recordOriginator mesh__D011002 NLM
% 211.97/212.18  |- skos__broader mesh__D011002smesh__D000820
% 211.97/212.18  |- mesh__dateRevised mesh__D011002 2003-07-30
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D016296 2006
% 211.97/212.18  |- mesh__publicMeSHNote mesh__D016296 91   
% 211.97/212.18  |- skos__prefLabel mesh__D016296 Mutagenesis
% 211.97/212.18  |- skos__historyNote mesh__D016296 Mutation %28%1966-1990%29%
% 211.97/212.18  |- mesh__dateRevised mesh__D016296 2002-07-03
% 211.97/212.18  |- skos__related mesh__D016296smesh__D016587
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D016296 2005
% 211.97/212.18  |- mesh__dateCreated mesh__D016296 1990-05-29
% 211.97/212.18  |- rdf__type mesh__D016296sskos__Concept
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D016296 2004
% 211.97/212.18  |- mesh__recordMaintainer mesh__D016296 TGC
% 211.97/212.18  |- mesh__historyNote mesh__D016296 91   
% 211.97/212.18  |- skos__hiddenLabel mesh__D016296 Mutageneses
% 211.97/212.18  |- skos__scopeNote mesh__D016296
% 211.97/212.18       Process of generating a genetic MUTATION. It may occur spontaneously or be induced by MUTAGENS.%A%    
% 211.97/212.18  |- mesh__recordOriginator mesh__D016296 AGS
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D016296 2003
% 211.97/212.18  |- mesh__dateEstablished mesh__D016296 1991-01-01
% 211.97/212.18  |- skos__related mesh__D016296smesh__D009153
% 211.97/212.18  |- skos__broader mesh__D016296smesh__D039361
% 211.97/212.18  |- mesh__recordAuthorizer mesh__D016296 sjn
% 211.97/212.18  |- skos__broader mesh__D002276smesh__D018358
% 211.97/212.18  |- skos__hiddenLabel mesh__D002276 Tumor, Carcinoid
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D002276 2002
% 211.97/212.18  |- rdf__type mesh__D002276sskos__Concept
% 211.97/212.18  |- mesh__onlineNote mesh__D002276
% 211.97/212.18       use CARCINOID TUMOR to search ARGENTAFFINOMA 1966-67   
% 211.97/212.18  |- mesh__dateEstablished mesh__D002276 1968-01-01
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D002276 2001
% 211.97/212.18  |- mesh__recordAuthorizer mesh__D002276 PLS
% 211.97/212.18  |- skos__hiddenLabel mesh__D002276 Tumors, Carcinoid
% 211.97/212.18  |- skos__hiddenLabel mesh__D002276 Goblet Cell Carcinoid
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D002276 1997
% 211.97/212.18  |- skos__hiddenLabel mesh__D002276 Argentaffinomas
% 211.97/212.18  |- skos__hiddenLabel mesh__D002276 Goblet Cell Carcinoids
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D002276 1999
% 211.97/212.18  |- mesh__historyNote mesh__D002276 68; was ARGENTAFFINOMA 1963-67   
% 211.97/212.18  |- skos__altLabel mesh__D002276 Carcinoid
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D002276 2000
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D002276 1996
% 211.97/212.18  |- skos__annotation mesh__D002276
% 211.97/212.18       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; consider also MALIGNANT CARCINOID SYNDROME or CARCINOID HEART DISEASE%A%  
% 211.97/212.18  |- skos__scopeNote mesh__D002276
% 211.97/212.18       A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract %28%and in the lungs and other sites%29%; approximately 90%25% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. %28%From Stedman, 25th ed %26% Holland et al., Cancer Medicine, 3d ed, p1182%29%%A%    
% 211.97/212.18  |- skos__hiddenLabel mesh__D002276 Carcinoids, Goblet Cell
% 211.97/212.18  |- mesh__dateCreated mesh__D002276 1999-01-01
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D002276 1998
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D002276 2004
% 211.97/212.18  |- mesh__dateRevised mesh__D002276 1995-06-08
% 211.97/212.18  |- skos__prefLabel mesh__D002276 Carcinoid Tumor
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D002276 2006
% 211.97/212.18  |- mesh__recordOriginator mesh__D002276 NLM
% 211.97/212.18  |- mesh__publicMeSHNote mesh__D002276 68; was ARGENTAFFINOMA 1963-67   
% 211.97/212.18  |- skos__hiddenLabel mesh__D002276 Carcinoids
% 211.97/212.18  |- skos__broader mesh__D002276smesh__D000230
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D002276 2003
% 211.97/212.18  |- skos__hiddenLabel mesh__D002276 Carcinoid Tumors
% 211.97/212.18  |- mesh__recordMaintainer mesh__D002276 KEV
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D002276 2005
% 211.97/212.18  |- skos__hiddenLabel mesh__D039841 L1 Protein, Leukocyte
% 211.97/212.18  |- skos__hiddenLabel mesh__D039841 Calcium Binding Myeloid Protein P8,14
% 211.97/212.18  |- skos__altLabel mesh__D039841
% 211.97/212.18       Migratory Inhibitory Factor-Related Protein MRP
% 211.97/212.18  |- mesh__dateRevised mesh__D039841 2005-06-30
% 211.97/212.18  |- skos__altLabel mesh__D039841 L1 Antigen
% 211.97/212.18  |- mesh__recordOriginator mesh__D039841 MDJ
% 211.97/212.18  |- skos__altLabel mesh__D039841 Calcium-Binding Myeloid Protein P8,14
% 211.97/212.18  |- skos__broader mesh__D039841smesh__D009418
% 211.97/212.18  |- mesh__recordMaintainer mesh__D039841 ssb
% 211.97/212.18  |- skos__altLabel mesh__D039841 Leukocyte L1 Protein
% 211.97/212.18  |- skos__altLabel mesh__D039841 27E10 Antigen
% 211.97/212.18  |- mesh__recordAuthorizer mesh__D039841 sjn
% 211.97/212.18  |- skos__altLabel mesh__D039841 Calgranulin
% 211.97/212.18  |- skos__altLabel mesh__D039841 Myelomonocytic Antigen L1
% 211.97/212.18  |- skos__historyNote mesh__D039841 Antigens, Surface %28%1984-1991%29%
% 211.97/212.18  |- rdf__type mesh__D039841sskos__Concept
% 211.97/212.18  |- mesh__publicMeSHNote mesh__D039841
% 211.97/212.18       2003; L1 ANTIGEN %28%now LEUKOCYTE L1 ANTIGEN COMPLEX%29% was indexed under MEMBRANE GLYCOPROTEINS 1984-2002, NEURAL CELL ADHESION MOLECULES 1996-2002, CELL ADHESION MOLECULES, NEURONAL 1992-1995 %26% ANTIGENS, SURFACE 1984-1991%A%  
% 211.97/212.18  |- skos__hiddenLabel mesh__D039841
% 211.97/212.18       Migratory Inhibitory Factor Related Protein MRP
% 211.97/212.18  |- skos__historyNote mesh__D039841
% 211.97/212.18       Cell Adhesion Molecules, Neuronal %28%1992-1995%29%
% 211.97/212.18  |- mesh__dateEstablished mesh__D039841 2003-01-01
% 211.97/212.18  |- skos__scopeNote mesh__D039841
% 211.97/212.18       A member of the S-100 protein family that is present at high levels in the blood and interstitial fluid in several infectious, inflammatory, and malignant disorders, including rheumatoid arthritis, inflammatory bowel disease, and cystic fibrosis.  It is a complex of a light chain %28%CALGRANULIN A%29% and a heavy chain %28%CALGRANULIN B%29%.  L1 binds calcium through an EF-hand motif, and has been shown to possess antimicrobial activity.%A%    
% 211.97/212.18  |- skos__historyNote mesh__D039841
% 211.97/212.18       Neural Cell Adhesion Molecules %28%1996-2002%29%
% 211.97/212.18  |- mesh__dateCreated mesh__D039841 2002-07-02
% 211.97/212.18  |- skos__broader mesh__D039841smesh__D000954
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D039841 2006
% 211.97/212.18  |- skos__historyNote mesh__D039841 Membrane Glycoproteins %28%1984-2002%29%
% 211.97/212.18  |- mesh__historyNote mesh__D039841
% 211.97/212.18       2003; use LEUKOCYTE L1 ANTIGEN COMPLEX %28%NM%29% 1984-2002   
% 211.97/212.18  |- skos__altLabel mesh__D039841 Calprotectin
% 211.97/212.18  |- skos__hiddenLabel mesh__D039841 Antigen L1, Myelomonocytic
% 211.97/212.18  |- skos__prefLabel mesh__D039841 Leukocyte L1 Antigen Complex
% 211.97/212.18  |- skos__hiddenLabel mesh__D039841 Antigen, L1
% 211.97/212.18  |- skos__hiddenLabel mesh__D039841 Antigen, 27E10
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Vestibular Neuritides
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Recurrent Vestibulopathies
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Neuritides, Vestibular
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Peripheral Vestibulopathies, Acute
% 211.97/212.18  |- skos__altLabel mesh__D020338 Epidemic Neurolabyrinthitis
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Epidemic Neurolabyrinthitides
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D020338 2004
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Nerve Neuritis, Vestibular
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Vestibular Neuritides, Recurrent
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Subacute Vestibular Neuritides
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D020338 2002
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Neuronitides, Vestibular
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Neuritis, Acute Vestibular
% 211.97/212.18  |- rdf__type mesh__D020338sskos__Concept
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Vestibulopathy, Acute Peripheral
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Vertigo, Episodic Recurrent
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Vestibular Nerve Inflammations
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Neuropathies, Vestibular
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Nerve Neuritides, Vestibular
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Vestibular Neuronitides
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Acute Vestibular Neuritides
% 211.97/212.18  |- mesh__dateCreated mesh__D020338 1999-11-08
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Vestibular Neuritides, Acute
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Acute Peripheral Vestibulopathies
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Vestibulopathies, Acute Peripheral
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Neuritides, Recurrent Vestibular
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Vertigos, Episodic Recurrent
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Vestibular Neuritis, Subacute
% 211.97/212.18  |- skos__scopeNote mesh__D020338
% 211.97/212.18       Idiopathic inflammation of the vestibular nerve, characterized clinically by the acute or subacute onset of vertigo, nausea, and imbalance. The cochlear nerve is typically spared and hearing loss and tinnitus do not usually occur. Symptoms usually resolve over a period of days to weeks. %28%Adams et al., Principles of Neurology, 6th ed, p304%29%%A%    
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D020338 2003
% 211.97/212.18  |- skos__altLabel mesh__D020338 Vestibular Nerve Inflammation
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Neuritides, Acute Vestibular
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D020338 2001
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D020338 2006
% 211.97/212.18  |- mesh__publicMeSHNote mesh__D020338 2000   
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Neuritis, Subacute Vestibular
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Recurrent Vertigos, Episodic
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Nerve Inflammations, Vestibular
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Vestibulopathy, Recurrent
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Recurrent Vestibular Neuritides
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Neurolabyrinthitis, Epidemic
% 211.97/212.18  |- skos__historyNote mesh__D020338 Neuritis %28%1968-1999%29%
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Recurrent Vertigo, Episodic
% 211.97/212.18  |- skos__altLabel mesh__D020338 Neuritis, Vestibular
% 211.97/212.18  |- skos__altLabel mesh__D020338 Episodic Recurrent Vertigo
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D020338 2000
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Vestibular Neuropathies
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Peripheral Vestibulopathy, Acute
% 211.97/212.18  |- skos__related mesh__D020338smesh__D009443
% 211.97/212.18  |- mesh__activeMeSHYear mesh__D020338 2005
% 211.97/212.18  |- skos__hiddenLabel mesh__D020338 Inflammations, Vestibular Nerve
% 211.97/212.19  |- mesh__historyNote mesh__D020338 2000   
% 211.97/212.19  |- skos__hiddenLabel mesh__D020338 Neuropathy, Vestibular
% 211.97/212.19  |- skos__hiddenLabel mesh__D020338 Neurolabyrinthitides, Epidemic
% 211.97/212.19  |- mesh__dateEstablished mesh__D020338 2000-01-01
% 211.97/212.19  |- skos__altLabel mesh__D020338 Vestibular Nerve Neuritis
% 211.97/212.19  |- skos__altLabel mesh__D020338 Vestibular Neuritis
% 211.97/212.19  |- skos__hiddenLabel mesh__D020338 Neuritides, Vestibular Nerve
% 211.97/212.19  |- skos__prefLabel mesh__D020338 Vestibular Neuronitis
% 211.97/212.19  |- skos__altLabel mesh__D020338 Neuronitis, Vestibular
% 211.97/212.19  |- skos__hiddenLabel mesh__D020338 Vestibular Nerve Neuritides
% 211.97/212.19  |- skos__broader mesh__D020338smesh__D000160
% 211.97/212.19  |- skos__hiddenLabel mesh__D020338 Neuritis, Recurrent Vestibular
% 211.97/212.19  |- skos__hiddenLabel mesh__D020338 Episodic Recurrent Vertigos
% 211.97/212.19  |- skos__hiddenLabel mesh__D020338 Neuritides, Subacute Vestibular
% 211.97/212.19  |- skos__hiddenLabel mesh__D020338 Inflammation, Vestibular Nerve
% 211.97/212.19  |- skos__hiddenLabel mesh__D020338 Vestibular Neuritides, Subacute
% 211.97/212.19  |- skos__altLabel mesh__D020338 Acute Vestibular Neuritis
% 211.97/212.19  |- skos__hiddenLabel mesh__D020338 Neuritis, Vestibular Nerve
% 211.97/212.19  |- skos__hiddenLabel mesh__D020338 Vestibular Neuritis, Recurrent
% 211.97/212.19  |- skos__hiddenLabel mesh__D020338 Vestibulopathies, Recurrent
% 211.97/212.19  |- skos__hiddenLabel mesh__D020338 Vestibular Neuritis, Acute
% 211.97/212.19  |- skos__hiddenLabel mesh__D020338 Nerve Inflammation, Vestibular
% 211.97/212.19  |- skos__altLabel mesh__D020338 Recurrent Vestibulopathy
% 211.97/212.19  |- mesh__dateCreated mesh__D031060 2002-07-03
% 211.97/212.19  |- skos__broader mesh__D031060smesh__D029064
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D031060 2004
% 211.97/212.19  |- skos__prefLabel mesh__D031060 Colocasia
% 211.97/212.19  |- skos__altLabel mesh__D031060 Dasheen
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D031060 2003
% 211.97/212.19  |- skos__scopeNote mesh__D031060
% 211.97/212.19       A plant genus of the family ARACEAE. Members contain acrid calcium oxalate and LECTINS. Polynesians prepare the root into poi. Common names of Taro and Coco Yam %28%Cocoyam%29% may be confused with other ARACEAE; XANTHOSOMA; or with common yam %28%DIOSCOREA%29%.%A%    
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D031060 2006
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D031060 2005
% 211.97/212.19  |- mesh__dateEstablished mesh__D031060 2003-01-01
% 211.97/212.19  |- mesh__publicMeSHNote mesh__D031060 2003   
% 211.97/212.19  |- mesh__historyNote mesh__D031060 2003   
% 211.97/212.19  |- skos__annotation mesh__D031060
% 211.97/212.19       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.97/212.19  |- rdf__type mesh__D031060sskos__Concept
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D025821 2003
% 211.97/212.19  |- mesh__dateCreated mesh__D025821 2001-07-25
% 211.97/212.19  |- mesh__recordAuthorizer mesh__D025821 sjn
% 211.97/212.19  |- skos__historyNote mesh__D025821 Polymers %28%1991-1993%29%
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D025821 2002
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D025821 2004
% 211.97/212.19  |- mesh__historyNote mesh__D025821
% 211.97/212.19       2002; use POLYUBIQUITIN %28%NM%29% 1991-2001   
% 211.97/212.19  |- skos__scopeNote mesh__D025821
% 211.97/212.19       An oligomer formed from the repetitive linking of the C-terminal glycine of one  UBIQUITIN molecule via an isopeptide bond to a lysine residue on a second ubiquitin molecule. It is structurally distinct from UBIQUITIN C, which is a single protein containing a tandemly arrayed ubiquitin peptide sequence.%A%    
% 211.97/212.19  |- mesh__recordOriginator mesh__D025821 jmp
% 211.97/212.19  |- mesh__recordMaintainer mesh__D025821 jmp
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D025821 2005
% 211.97/212.19  |- skos__historyNote mesh__D025821 Ubiquitins %28%1994-2001%29%
% 211.97/212.19  |- skos__prefLabel mesh__D025821 Polyubiquitin
% 211.97/212.19  |- rdf__type mesh__D025821sskos__Concept
% 211.97/212.19  |- mesh__publicMeSHNote mesh__D025821
% 211.97/212.19       2002; POLYUBIQUITIN was indexed under UBIQUITIN %26% BIOPOLYMERS 1994-2001, and under POLYMERS 1991-1993%A%  
% 211.97/212.19  |- mesh__dateEstablished mesh__D025821 2002-01-01
% 211.97/212.19  |- skos__broader mesh__D025821smesh__D025801
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D025821 2006
% 211.97/212.19  |- skos__altLabel mesh__D044786 S-Phase Kinase Associated Protein
% 211.97/212.19  |- skos__scopeNote mesh__D044786
% 211.97/212.19       A family of structurally-related proteins that were originally identified by their ability to complex with cyclin proteins %28%CYCLINS%29%. They share a common domain that binds specifically to F-BOX MOTIFS. They take part in SKP CULLIN F-BOX PROTEIN LIGASES, where they can bind to a variety of F-BOX PROTEINS.%A%    
% 211.97/212.19  |- skos__altLabel mesh__D044786 p45%28%SKP2%29%
% 211.97/212.19  |- skos__altLabel mesh__D044786 p45 SKP2
% 211.97/212.19  |- skos__altLabel mesh__D044786 Skp1 Protein
% 211.97/212.19  |- skos__altLabel mesh__D044786 p19%28%SKP1%29% Protein
% 211.97/212.19  |- skos__altLabel mesh__D044786 Skp Domain Protein
% 211.97/212.19  |- skos__hiddenLabel mesh__D044786 Proteins, S-Phase Kinase-Associated
% 211.97/212.19  |- skos__altLabel mesh__D044786 Skp Domain Proteins
% 211.97/212.19  |- skos__altLabel mesh__D044786 SCF%28%SKP2%29%
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D044786 2006
% 211.97/212.19  |- rdf__type mesh__D044786sskos__Concept
% 211.97/212.19  |- mesh__publicMeSHNote mesh__D044786
% 211.97/212.19       2004; P19%28%SKP1%29%PROTEIN and P45%28%SKP%29%PROTEIN were indexed under CELL CYCLE PROTEINS 1995-2003%A%  
% 211.97/212.19  |- skos__altLabel mesh__D044786 Skp2 Protein
% 211.97/212.19  |- skos__hiddenLabel mesh__D044786 SKP2, p45
% 211.97/212.19  |- mesh__dateRevised mesh__D044786 2005-06-30
% 211.97/212.19  |- skos__prefLabel mesh__D044786 S-Phase Kinase-Associated Proteins
% 211.97/212.19  |- mesh__historyNote mesh__D044786
% 211.97/212.19       2004; use S-PHASE KINASE ASSOCIATED PROTEINS %28%NM%29% 1983-2003; for P19%28%SKP1%29%PROTEIN and P45%28%SKP%29% PROTEIN use S-PHASE KINASE ASSOCIATED PROTEINS %28%NM%29% 1995-2003; for P45%28%SKP%29% use UBIQUITIN-PROTEIN LIGASES %28%NM%29% 1999-2003%A%  
% 211.97/212.19  |- skos__hiddenLabel mesh__D044786 SKP1, p19
% 211.97/212.19  |- mesh__recordAuthorizer mesh__D044786 sjn
% 211.97/212.19  |- mesh__recordOriginator mesh__D044786 jmp
% 211.97/212.19  |- skos__altLabel mesh__D044786 p45%28%SKP2%29% Protein
% 211.97/212.19  |- skos__historyNote mesh__D044786 Cell Cycle Proteins %28%1995-2003%29%
% 211.97/212.19  |- skos__hiddenLabel mesh__D044786 Kinase-Associated Proteins, S-Phase
% 211.97/212.19  |- mesh__dateEstablished mesh__D044786 2004-01-01
% 211.97/212.19  |- skos__broader mesh__D044786smesh__D002352
% 211.97/212.19  |- mesh__dateCreated mesh__D044786 2003-07-09
% 211.97/212.19  |- skos__hiddenLabel mesh__D044786 S Phase Kinase Associated Protein
% 211.97/212.19  |- skos__hiddenLabel mesh__D044786 S Phase Kinase Associated Proteins
% 211.97/212.19  |- skos__historyNote mesh__D044786 Ligases %28%1983-2003%29%
% 211.97/212.19  |- skos__altLabel mesh__D044786 p19 SKP1
% 211.97/212.19  |- mesh__recordMaintainer mesh__D044786 SYSTEM
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D011801 2003
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D011801 2000
% 211.97/212.19  |- skos__prefLabel mesh__D011801 Quinic Acid
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D011801 1998
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D011801 2005
% 211.97/212.19  |- mesh__recordOriginator mesh__D011801 NLM
% 211.97/212.19  |- mesh__historyNote mesh__D011801 74%28%64%29%   
% 211.97/212.19  |- skos__broader mesh__D011801smesh__D003509
% 211.97/212.19  |- rdf__type mesh__D011801sskos__Concept
% 211.97/212.19  |- skos__hiddenLabel mesh__D011801 Acid, Quinic
% 211.97/212.19  |- skos__scopeNote mesh__D011801
% 211.97/212.19       An acid which is found in cinchona bark and elsewhere in plants. %28%From Stedman, 26th ed%29%%A%    
% 211.97/212.19  |- mesh__publicMeSHNote mesh__D011801 74   
% 211.97/212.19  |- mesh__recordAuthorizer mesh__D011801 SJN
% 211.97/212.19  |- mesh__dateRevised mesh__D011801 1997-06-20
% 211.97/212.19  |- mesh__dateEstablished mesh__D011801 1974-01-01
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D011801 2002
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D011801 2004
% 211.97/212.19  |- mesh__dateCreated mesh__D011801 1999-01-01
% 211.97/212.19  |- skos__broader mesh__D011801smesh__D006880
% 211.97/212.19  |- mesh__recordMaintainer mesh__D011801 KEV
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D011801 1999
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D011801 2001
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D011801 2006
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D011003 2004
% 211.97/212.19  |- mesh__dateEstablished mesh__D011003 1976-01-01
% 211.97/212.19  |- skos__hiddenLabel mesh__D011003 Ploidy
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D011003 2005
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D011003 2006
% 211.97/212.19  |- skos__historyNote mesh__D011003 specific ploidies heading
% 211.97/212.19  |- mesh__publicMeSHNote mesh__D011003 76   
% 211.97/212.19  |- mesh__historyNote mesh__D011003 76; was NON MESH before 1976   
% 211.97/212.19  |- mesh__recordOriginator mesh__D011003 SMH
% 211.97/212.19  |- skos__prefLabel mesh__D011003 Ploidies
% 211.97/212.19  |- skos__broader mesh__D011003smesh__D040341
% 211.97/212.19  |- rdf__type mesh__D011003sskos__Concept
% 211.97/212.19  |- mesh__dateRevised mesh__D011003 2002-07-03
% 211.97/212.19  |- mesh__dateCreated mesh__D011003 1975-07-25
% 211.97/212.19  |- skos__scopeNote mesh__D011003
% 211.97/212.19       The degree of replication of the chromosome set in the karyotype.%A%    
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D011003 2003
% 211.97/212.19  |- mesh__recordAuthorizer mesh__D011003 sjn
% 211.97/212.19  |- mesh__recordMaintainer mesh__D011003 TGC
% 211.97/212.19  |- rdf__type mesh__D049471sskos__Concept
% 211.97/212.19  |- skos__broader mesh__D049471smesh__D049469
% 211.97/212.19  |- mesh__dateEstablished mesh__D049471 2005-01-01
% 211.97/212.19  |- mesh__publicMeSHNote mesh__D049471 2005   
% 211.97/212.19  |- skos__hiddenLabel mesh__D049471 Stages, Pachytene
% 211.97/212.19  |- mesh__historyNote mesh__D049471 2005   
% 211.97/212.19  |- mesh__recordMaintainer mesh__D049471 nns
% 211.97/212.19  |- skos__hiddenLabel mesh__D049471 Pachytene Stages
% 211.97/212.19  |- mesh__dateCreated mesh__D049471 2004-07-07
% 211.97/212.19  |- skos__scopeNote mesh__D049471
% 211.97/212.19       The stage in the first meiotic prophase, following ZYGOTENE STAGE, when CROSSING OVER between homologous CHROMOSOMES begins.%A%    
% 211.97/212.19  |- skos__prefLabel mesh__D049471 Pachytene Stage
% 211.97/212.19  |- mesh__recordAuthorizer mesh__D049471 sjn
% 211.97/212.19  |- skos__related mesh__D049471smesh__D003434
% 211.97/212.19  |- skos__hiddenLabel mesh__D049471 Stage, Pachytene
% 211.97/212.19  |- skos__hiddenLabel mesh__D049471 Pachynemas
% 211.97/212.19  |- skos__altLabel mesh__D049471 Pachynema
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D049471 2006
% 211.97/212.19  |- mesh__recordOriginator mesh__D049471 nns
% 211.97/212.19  |- mesh__dateRevised mesh__D049471 2005-06-30
% 211.97/212.19  |- skos__hiddenLabel mesh__D016297 Site Directed Mutagenesis
% 211.97/212.19  |- rdf__type mesh__D016297sskos__Concept
% 211.97/212.19  |- mesh__recordOriginator mesh__D016297 AGS
% 211.97/212.19  |- skos__scopeNote mesh__D016297
% 211.97/212.19       Genetically engineered MUTAGENESIS at a specific site in the DNA molecule that introduces a base substitution, or an insertion or deletion.%A%    
% 211.97/212.19  |- skos__hiddenLabel mesh__D016297 Site Specific Mutagenesis
% 211.97/212.19  |- skos__prefLabel mesh__D016297 Mutagenesis, Site-Directed
% 211.97/212.19  |- skos__hiddenLabel mesh__D016297 Oligonucleotide Directed Mutagenesis
% 211.97/212.19  |- mesh__historyNote mesh__D016297 91   
% 211.97/212.19  |- mesh__dateRevised mesh__D016297 2005-06-30
% 211.97/212.19  |- skos__hiddenLabel mesh__D016297 Mutagenesis, Site Directed
% 211.97/212.19  |- skos__altLabel mesh__D016297 Site-Directed Mutagenesis
% 211.97/212.19  |- mesh__recordAuthorizer mesh__D016297 sjn
% 211.97/212.19  |- mesh__recordMaintainer mesh__D016297 nns
% 211.97/212.19  |- skos__hiddenLabel mesh__D016297 Mutagenesis, Oligonucleotide Directed
% 211.97/212.19  |- skos__hiddenLabel mesh__D016297 Mutageneses, Site-Specific
% 211.97/212.19  |- mesh__publicMeSHNote mesh__D016297 91   
% 211.97/212.19  |- mesh__dateEstablished mesh__D016297 1991-01-01
% 211.97/212.19  |- skos__hiddenLabel mesh__D016297 Mutageneses, Oligonucleotide-Directed
% 211.97/212.19  |- skos__historyNote mesh__D016297 Mutation %28%1972-1990%29%
% 211.97/212.19  |- skos__altLabel mesh__D016297 Site-Specific Mutagenesis
% 211.97/212.19  |- skos__hiddenLabel mesh__D016297 Site-Directed Mutageneses
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D016297 2006
% 211.97/212.19  |- skos__altLabel mesh__D016297 Mutagenesis, Oligonucleotide-Directed
% 211.97/212.19  |- skos__hiddenLabel mesh__D016297 Site-Specific Mutageneses
% 211.97/212.19  |- skos__hiddenLabel mesh__D016297 Mutageneses, Site-Directed
% 211.97/212.19  |- skos__altLabel mesh__D016297 Mutagenesis, Site-Specific
% 211.97/212.19  |- skos__hiddenLabel mesh__D016297 Mutagenesis, Site Specific
% 211.97/212.19  |- skos__broader mesh__D016297smesh__D015202
% 211.97/212.19  |- skos__hiddenLabel mesh__D016297 Oligonucleotide-Directed Mutageneses
% 211.97/212.19  |- mesh__dateCreated mesh__D016297 1990-05-29
% 211.97/212.19  |- skos__altLabel mesh__D002277 Epithelioma
% 211.97/212.19  |- skos__hiddenLabel mesh__D002277 Malignant Epithelial Tumors
% 211.97/212.19  |- skos__hiddenLabel mesh__D002277 Carcinomas, Anaplastic
% 211.97/212.19  |- skos__altLabel mesh__D002277 Neoplasms, Malignant Epithelial
% 211.97/212.19  |- skos__hiddenLabel mesh__D002277 Malignant Epithelial Neoplasm
% 211.97/212.19  |- skos__hiddenLabel mesh__D002277 Anaplastic Carcinoma
% 211.97/212.19  |- skos__hiddenLabel mesh__D002277 Anaplastic Carcinomas
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D002277 2005
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D002277 2000
% 211.97/212.19  |- skos__annotation mesh__D002277
% 211.97/212.19       do not use for %22%cancer%22% routinely: use only for carcinoma as a histological type: Manual 24.2.1.3; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; X ref CARCINOMA, ANAPLASTIC: do not coord with ANAPLASIA unless anaplasia is particularly discussed%A%  
% 211.97/212.19  |- skos__hiddenLabel mesh__D002277 Tumors, Malignant Epithelial
% 211.97/212.19  |- skos__hiddenLabel mesh__D002277 Undifferentiated Carcinomas
% 211.97/212.19  |- skos__hiddenLabel mesh__D002277 Carcinomas, Undifferentiated
% 211.97/212.19  |- mesh__recordAuthorizer mesh__D002277 SJN
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D002277 2006
% 211.97/212.19  |- skos__altLabel mesh__D002277 Epithelial Neoplasms, Malignant
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D002277 2001
% 211.97/212.19  |- skos__hiddenLabel mesh__D002277 Spindle-Cell Carcinoma
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D002277 1998
% 211.97/212.19  |- skos__hiddenLabel mesh__D002277 Neoplasm, Malignant Epithelial
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D002277 2003
% 211.97/212.19  |- skos__hiddenLabel mesh__D002277 Epitheliomas
% 211.97/212.19  |- skos__hiddenLabel mesh__D002277 Spindle-Cell Carcinomas
% 211.97/212.19  |- skos__hiddenLabel mesh__D002277 Epithelial Neoplasm, Malignant
% 211.97/212.19  |- skos__hiddenLabel mesh__D002277 Carcinomatoses
% 211.97/212.19  |- mesh__recordOriginator mesh__D002277 NLM
% 211.97/212.19  |- skos__hiddenLabel mesh__D002277 Epithelial Tumor, Malignant
% 211.97/212.19  |- skos__broader mesh__D002277smesh__D009375
% 211.97/212.19  |- skos__hiddenLabel mesh__D002277 Tumor, Malignant Epithelial
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D002277 2002
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D002277 1999
% 211.97/212.19  |- mesh__dateRevised mesh__D002277 1997-06-20
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D002277 2004
% 211.97/212.19  |- skos__hiddenLabel mesh__D002277 Carcinomas
% 211.97/212.19  |- skos__hiddenLabel mesh__D002277 Carcinomas, Spindle-Cell
% 211.97/212.19  |- rdf__type mesh__D002277sskos__Concept
% 211.97/212.19  |- skos__hiddenLabel mesh__D002277 Malignant Epithelial Tumor
% 211.97/212.19  |- skos__altLabel mesh__D002277 Malignant Epithelial Neoplasms
% 211.97/212.19  |- mesh__recordMaintainer mesh__D002277 TGC
% 211.97/212.19  |- skos__prefLabel mesh__D002277 Carcinoma
% 211.97/212.19  |- skos__altLabel mesh__D002277 Epithelial Tumors, Malignant
% 211.97/212.19  |- skos__hiddenLabel mesh__D002277 Undifferentiated Carcinoma
% 211.97/212.19  |- skos__hiddenLabel mesh__D002277 Carcinoma, Spindle Cell
% 211.97/212.19  |- mesh__dateCreated mesh__D002277 1999-01-01
% 211.97/212.19  |- skos__scopeNote mesh__D002277
% 211.97/212.19       A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm but is often wrongly used as a synonym for %22%cancer.%22% %28%From Dorland, 27th ed%29%%A%    
% 211.97/212.19  |- mesh__dateEstablished mesh__D010709 1991-01-01
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D010709 2004
% 211.97/212.19  |- skos__historyNote mesh__D010709 Acetyl Coenzyme A %28%1973-1974%29%
% 211.97/212.19  |- skos__prefLabel mesh__D010709 Phosphate Acetyltransferase
% 211.97/212.19  |- skos__altLabel mesh__D010709 Phosphoacylase
% 211.97/212.19  |- skos__broader mesh__D010709smesh__D000123
% 211.97/212.19  |- skos__hiddenLabel mesh__D010709 Acetyltransferase, Phosphate
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D010709 2005
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D010709 2006
% 211.97/212.19  |- mesh__historyNote mesh__D010709
% 211.97/212.19       91%28%75%29%; was see under ACETYLTRANSFERASES 1975-90   
% 211.97/212.19  |- skos__historyNote mesh__D010709 Acetyltransferases %28%1973-1974%29%
% 211.97/212.19  |- mesh__recordAuthorizer mesh__D010709 sjn
% 211.97/212.19  |- skos__altLabel mesh__D010709 Phosphotransacylase
% 211.97/212.19  |- skos__scopeNote mesh__D010709
% 211.97/212.19       An enzyme that catalyzes the synthesis of acetylphosphate from acetyl-CoA and inorganic phosphate. Acetylphosphate serves as a high-energy phosphate compound. EC 2.3.1.8.%A%    
% 211.97/212.19  |- mesh__recordMaintainer mesh__D010709 ssb
% 211.97/212.19  |- mesh__dateRevised mesh__D010709 2003-07-09
% 211.97/212.19  |- mesh__recordOriginator mesh__D010709 NLM
% 211.97/212.19  |- skos__altLabel mesh__D010709 Phosphotransbutyrylase
% 211.97/212.19  |- skos__historyNote mesh__D010709 Phosphates %28%1973-1974%29%
% 211.97/212.19  |- skos__altLabel mesh__D010709 Phosphotransacetylase
% 211.97/212.19  |- rdf__type mesh__D010709sskos__Concept
% 211.97/212.19  |- mesh__publicMeSHNote mesh__D010709
% 211.97/212.19       91; was see under ACETYLTRANSFERASES 1975-90   
% 211.97/212.19  |- mesh__dateCreated mesh__D010709 1974-11-19
% 211.97/212.19  |- skos__broader mesh__D007760smesh__D004847
% 211.97/212.19  |- mesh__recordOriginator mesh__D007760 RC
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D007760 2004
% 211.97/212.19  |- mesh__dateRevised mesh__D007760 1991-01-07
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D007760 1995
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D007760 2000
% 211.97/212.19  |- mesh__recordMaintainer mesh__D007760 TGC
% 211.97/212.19  |- rdf__type mesh__D007760sskos__Concept
% 211.97/212.19  |- skos__hiddenLabel mesh__D007760 Supporting Cell, Labyrinth
% 211.97/212.19  |- skos__scopeNote mesh__D007760
% 211.97/212.19       Cells forming a framework supporting the organ of Corti. Specific cells are those of Claudius, Deiters and Hensen.%A%    
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D007760 1992
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D007760 1998
% 211.97/212.19  |- mesh__dateEstablished mesh__D007760 1991-01-01
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D007760 2001
% 211.97/212.19  |- mesh__dateCreated mesh__D007760 1978-05-19
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D007760 1993
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D007760 1999
% 211.97/212.19  |- skos__historyNote mesh__D007760 Organ of Corti %28%1967-1978%29%
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D007760 2005
% 211.97/212.19  |- skos__hiddenLabel mesh__D007760 Cells, Labyrinth Supporting
% 211.97/212.19  |- skos__broader mesh__D007760smesh__D009925
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D007760 1996
% 211.97/212.19  |- skos__historyNote mesh__D007760 Cochlea %28%1966%29%
% 211.97/212.19  |- skos__hiddenLabel mesh__D007760 Cell, Labyrinth Supporting
% 211.97/212.19  |- skos__hiddenLabel mesh__D007760 Labyrinth Supporting Cell
% 211.97/212.19  |- skos__prefLabel mesh__D007760 Labyrinth Supporting Cells
% 211.97/212.19  |- skos__annotation mesh__D007760 A 11 qualif   
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D007760 2006
% 211.97/212.19  |- mesh__historyNote mesh__D007760
% 211.97/212.19       91%28%79%29%; was see under ORGAN OF CORTI 1979-90   
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D007760 2002
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D007760 1997
% 211.97/212.19  |- mesh__publicMeSHNote mesh__D007760
% 211.97/212.19       91; was see under ORGAN OF CORTI 1979-90   
% 211.97/212.19  |- mesh__recordAuthorizer mesh__D007760 PLS
% 211.97/212.19  |- skos__altLabel mesh__D007760 Supporting Cells, Labyrinth
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D007760 2003
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D007760 1994
% 211.97/212.19  |- skos__hiddenLabel mesh__D039842
% 211.97/212.19       Nerve Growth Factor Inducible Large External Glycoprotein
% 211.97/212.19  |- skos__altLabel mesh__D039842 NILE Glycoprotein
% 211.97/212.19  |- skos__hiddenLabel mesh__D039842 Glycoprotein, NGF-Inducible
% 211.97/212.19  |- skos__altLabel mesh__D039842 F11 Glycoprotein
% 211.97/212.19  |- skos__altLabel mesh__D039842 CALL Protein
% 211.97/212.19  |- rdf__type mesh__D039842sskos__Concept
% 211.97/212.19  |- mesh__publicMeSHNote mesh__D039842
% 211.97/212.19       2003; NERVE GROWTH FACTOR-INDUCIBLE LARGE EXTERNAL GLYCOPROTEIN %28%now NEURAL CELL ADHESION MOLECULE L1%29% was indexed under MEMBRANE GLYCOPROTEINS 1988-2002 %26% GLYCOPROTEINS 1983-1987; NEURAL CELL ADHESION MOLECULE L1; F11 GLYCOPROTEIN; CELL ADHESION MOLECULE L1; CAML1 GENE PRODUCT; CELL SURFACE GLYCOPROTEIN L1; L1 CELL ADHESION MOLECULE; L1 CAM %26% NEURAL ADHESION MOLECULE L1 were indexed under MEMBRANE GLYCOPROTEINS 1992-2002, NEURAL CELL ADHESION MOLECULES 1996-2002, CELL ADHESION MOLECULES, NEURONAL 1992-1995 %26% ANTIGENS, SURFACE 1984-1991; CALL PROTEIN was indexed under MEMBRANE GLYCOPROTEINS 1999-2002 %26% NEURAL CELL ADHESION MOLECULES 1999-2002; NILE PROTEIN was indexed under MEMBRANE GLYCOPROTEINS 1992-2002 %26% NEURAL CELL ADHESION MOLECULES 1996-2002%A%  
% 211.97/212.19  |- mesh__dateRevised mesh__D039842 2005-06-30
% 211.97/212.19  |- skos__altLabel mesh__D039842 NILE Protein
% 211.97/212.19  |- mesh__recordMaintainer mesh__D039842 ssb
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D039842 2006
% 211.97/212.19  |- skos__hiddenLabel mesh__D039842 NGF Inducible Glycoprotein
% 211.97/212.19  |- mesh__recordAuthorizer mesh__D039842 sjn
% 211.97/212.19  |- skos__altLabel mesh__D039842 Cell Adhesion Molecule L1
% 211.97/212.19  |- skos__historyNote mesh__D039842 Membrane Glycoproteins %28%1992-2002%29%
% 211.97/212.19  |- mesh__historyNote mesh__D039842
% 211.97/212.19       2003; use NEURAL CELL ADHESION MOLECULE L1 %28%NM%29% 1983-2002; for NEURAL CELL ADHESION MOLECULE L1; F11 GLYCOPROTEIN; CELL ADHESION MOLECULE L1; CAML1 GENE PRODUCT; CELL SURFACE GLYCOPROTEIN L1; L1 CELL ADHESION MOLECULE; L1 CAM %26% NEURAL ADHESION MOLECULE L1 use LEUKOCYTE L1 ANTIGEN COMPLEX %28%NM%29% 1992-2002; for CALL PROTEIN  use LEUKOCYTE L1 ANTIGEN COMPLEX %28%NM%29% 1999-2002; for NILE PROTEIN use LEUCKCYTE L1 ANTIGEN COMPLEX %28%NM%29% 1996-2002%A%  
% 211.97/212.19  |- mesh__dateCreated mesh__D039842 2002-07-03
% 211.97/212.19  |- skos__historyNote mesh__D039842 Antigens, Surface %28%1992-2002%29%
% 211.97/212.19  |- skos__historyNote mesh__D039842
% 211.97/212.19       Cell Adhesion Molecules, Neuronal %28%1992-2002%29%
% 211.97/212.19  |- skos__altLabel mesh__D039842 L1 Cell Adhesion Molecule
% 211.97/212.19  |- mesh__dateEstablished mesh__D039842 2003-01-01
% 211.97/212.19  |- skos__altLabel mesh__D039842 CamL1 Gene Product
% 211.97/212.19  |- skos__historyNote mesh__D039842
% 211.97/212.19       Neural Cell Adhesion Molecules %28%1996-2002%29%
% 211.97/212.19  |- skos__altLabel mesh__D039842
% 211.97/212.19       Nerve Growth Factor-Inducible Large External Glycoprotein
% 211.97/212.19  |- skos__hiddenLabel mesh__D039842 Glycoprotein, NILE
% 211.97/212.19  |- skos__broader mesh__D039842smesh__D019006
% 211.97/212.19  |- skos__altLabel mesh__D039842 NGF-Inducible Glycoprotein
% 211.97/212.19  |- skos__altLabel mesh__D039842 Neural Adhesion Molecule L1
% 211.97/212.19  |- skos__altLabel mesh__D039842 Cell Surface Glycoprotein L1
% 211.97/212.19  |- skos__altLabel mesh__D039842 L1CAM
% 211.97/212.19  |- mesh__recordOriginator mesh__D039842 MDJ
% 211.97/212.19  |- skos__prefLabel mesh__D039842 Neural Cell Adhesion Molecule L1
% 211.97/212.19  |- skos__scopeNote mesh__D039842
% 211.97/212.19       A member of the immunoglobulin superfamily of neuronal cell adhesion molecules that is required for proper nervous system development. Neural cell adhesion molecule L1 consists of six Ig domains, five fibronectin domains, a transmembrane region and an intracellular domain. Two splicing variants are known: a neuronal form that contains a four-amino acid RSLE sequence in the cytoplasmic domain, and a non-neuronal form that lacks the RSLE sequence.  Mutations in the L1 gene result in L1 disease. Neural cell adhesion molecule L1 is predominantly expressed during development in neurons and Schwann cells; involved in cell adhesion, neuronal migration, axonal growth and pathfinding, and myelination.%A%    
% 211.97/212.19  |- skos__historyNote mesh__D020339 Optic Nerve Neoplasms %28%1998-1999%29%
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D020339 2005
% 211.97/212.19  |- skos__altLabel mesh__D020339 Optic Nerve Glioma, Childhood
% 211.97/212.19  |- skos__altLabel mesh__D020339 Glioma, Optic Nerve
% 211.97/212.19  |- skos__altLabel mesh__D020339 Optic Nerve, Malignant Astrocytoma
% 211.97/212.19  |- mesh__historyNote mesh__D020339 2000   
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D020339 2003
% 211.97/212.19  |- skos__scopeNote mesh__D020339
% 211.97/212.19       Glial cell derived tumors arising from the optic nerve, usually presenting in childhood. Roughly 50%25% are associated with NEUROFIBROMATOSIS 1. Clinical manifestations include decreased visual acuity; EXOPHTHALMOS; NYSTAGMUS, PATHOLOGIC; STRABISMUS; pallor or swelling of the optic disc; and INTRACRANIAL HYPERTENSION. The tumor may extend into the optic chiasm and hypothalamus. %28%Adams et al., Principles of Neurology, 6th ed, p681%29%%A%    
% 211.97/212.19  |- skos__hiddenLabel mesh__D020339 Glioma, Optic
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D020339 2006
% 211.97/212.19  |- skos__broader mesh__D020339smesh__D019574
% 211.97/212.19  |- skos__altLabel mesh__D020339 Optic Nerve Glioma, Adult
% 211.97/212.19  |- mesh__recordMaintainer mesh__D020339 ags
% 211.97/212.19  |- skos__altLabel mesh__D020339 Malignant Optic Nerve Astrocytoma
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D020339 2004
% 211.97/212.19  |- skos__altLabel mesh__D020339 Glioma, Optic Nerve, Adult
% 211.97/212.19  |- mesh__dateCreated mesh__D020339 1999-11-04
% 211.97/212.19  |- skos__hiddenLabel mesh__D020339 Gliomas, Optic Nerve
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D020339 2000
% 211.97/212.19  |- skos__historyNote mesh__D020339 Orbital Neoplasms %28%1966-1999%29%
% 211.97/212.19  |- skos__altLabel mesh__D020339 Optic Glioma
% 211.97/212.19  |- mesh__recordAuthorizer mesh__D020339 ags
% 211.97/212.19  |- skos__altLabel mesh__D020339 Malignant Astrocytoma, Optic Nerve
% 211.97/212.19  |- skos__broader mesh__D020339smesh__D005910
% 211.97/212.19  |- skos__broader mesh__D020339smesh__D001254
% 211.97/212.19  |- skos__historyNote mesh__D020339 Glioma %28%1966-1997%29%
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D020339 2001
% 211.97/212.19  |- skos__altLabel mesh__D020339 Glioma, Optic Nerve, Childhood
% 211.97/212.19  |- mesh__recordOriginator mesh__D020339 KEV
% 211.97/212.19  |- mesh__publicMeSHNote mesh__D020339 2000   
% 211.97/212.19  |- skos__prefLabel mesh__D020339 Optic Nerve Glioma
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D020339 2002
% 211.97/212.19  |- rdf__type mesh__D020339sskos__Concept
% 211.97/212.19  |- skos__hiddenLabel mesh__D020339 Optic Nerve Gliomas
% 211.97/212.19  |- skos__hiddenLabel mesh__D020339 Optic Gliomas
% 211.97/212.19  |- skos__hiddenLabel mesh__D020339 Gliomas, Optic
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D020339 2006A
% 211.97/212.19  |- mesh__dateEstablished mesh__D020339 2000-01-01
% 211.97/212.19  |- mesh__dateRevised mesh__D020339 2005-07-21
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D031061 2006
% 211.97/212.19  |- mesh__historyNote mesh__D031061 2003   
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D031061 2005
% 211.97/212.19  |- mesh__publicMeSHNote mesh__D031061 2003   
% 211.97/212.19  |- skos__broader mesh__D031061smesh__D029064
% 211.97/212.19  |- mesh__dateCreated mesh__D031061 2002-07-03
% 211.97/212.19  |- skos__altLabel mesh__D031061 Taro, Giant Swamp
% 211.97/212.19  |- skos__annotation mesh__D031061
% 211.97/212.19       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.97/212.19  |- skos__scopeNote mesh__D031061
% 211.97/212.19       A plant genus of the family ARACEAE that may be confused with other ARACEAE having similar common names.%A%    
% 211.97/212.19  |- rdf__type mesh__D031061sskos__Concept
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D031061 2004
% 211.97/212.19  |- skos__prefLabel mesh__D031061 Cyrtosperma
% 211.97/212.19  |- mesh__dateEstablished mesh__D031061 2003-01-01
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D031061 2003
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D025822 2004
% 211.97/212.19  |- mesh__recordMaintainer mesh__D025822 ags
% 211.97/212.19  |- skos__broader mesh__D025822smesh__D025801
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D025822 2006A
% 211.97/212.19  |- skos__altLabel mesh__D025822 Polyubiquitin Gene Product
% 211.97/212.19  |- mesh__dateCreated mesh__D025822 2001-07-25
% 211.97/212.19  |- skos__prefLabel mesh__D025822 Ubiquitin C
% 211.97/212.19  |- skos__historyNote mesh__D025822 Polymers %28%1991-1993%29%
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D025822 2002
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D025822 2005
% 211.97/212.19  |- skos__scopeNote mesh__D025822
% 211.97/212.19       A single protein comprised of tandem repeats of the UBIQUITIN 78-amino acid sequence. It is a product of the polyubiquitin gene which contains multiple copies of the ubiquitin coding sequence. Proteolytic processing of ubiquitin C results in the formation of individual ubiquitin molecules. This protein is distinct from POLYUBIQUITIN, which is a protein formed through isopeptide linkage of multiple ubiquitin species.%A%    
% 211.97/212.19  |- skos__historyNote mesh__D025822 Ubiquitins %28%1994-2001%29%
% 211.97/212.19  |- mesh__historyNote mesh__D025822 2002   
% 211.97/212.19  |- rdf__type mesh__D025822sskos__Concept
% 211.97/212.19  |- mesh__publicMeSHNote mesh__D025822 2002   
% 211.97/212.19  |- mesh__dateEstablished mesh__D025822 2002-01-01
% 211.97/212.19  |- mesh__recordOriginator mesh__D025822 jmp
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D025822 2006
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D025822 2003
% 211.97/212.19  |- mesh__dateRevised mesh__D025822 2005-08-03
% 211.97/212.19  |- mesh__recordAuthorizer mesh__D025822 ags
% 211.97/212.19  |- mesh__historyNote mesh__D003370
% 211.97/212.19       91%28%75%29%; was see under QUAIL 1975-90   
% 211.97/212.19  |- skos__hiddenLabel mesh__D003370 Quails, Japanese
% 211.97/212.19  |- skos__annotation mesh__D003370
% 211.97/212.19       diseases: coord IM with BIRD DISEASES %28%IM%29%   
% 211.97/212.19  |- mesh__activeMeSHYear mesh__D003370 2006
% 211.97/212.19  |- mesh__dateRevised mesh__D003370 2004-07-07
% 211.97/212.19  |- skos__scopeNote mesh__D003370
% 211.97/212.19       A genus of BIRDS in the family Phasianidae, order GALLIFORMES, containing the common European and other Old World QUAIL.%A%    
% 211.97/212.20  |- skos__altLabel mesh__D003370 Coturnix japonica
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D003370 2005
% 211.97/212.20  |- mesh__publicMeSHNote mesh__D003370 91; was see under QUAIL 1975-90   
% 211.97/212.20  |- skos__hiddenLabel mesh__D003370 Japanese Quails
% 211.97/212.20  |- rdf__type mesh__D003370sskos__Concept
% 211.97/212.20  |- skos__prefLabel mesh__D003370 Coturnix
% 211.97/212.20  |- mesh__recordMaintainer mesh__D003370 ags
% 211.97/212.20  |- skos__broader mesh__D003370smesh__D011784
% 211.97/212.20  |- mesh__dateCreated mesh__D003370 1974-11-19
% 211.97/212.20  |- mesh__recordAuthorizer mesh__D003370 sjn
% 211.97/212.20  |- mesh__dateEstablished mesh__D003370 1991-01-01
% 211.97/212.20  |- mesh__recordOriginator mesh__D003370 NLM
% 211.97/212.20  |- skos__hiddenLabel mesh__D003370 Quail, Japanese
% 211.97/212.20  |- mesh__dateRevised mesh__D011802 2005-06-30
% 211.97/212.20  |- skos__hiddenLabel mesh__D011802 Apo Quinidine
% 211.97/212.20  |- skos__altLabel mesh__D011802 Nelson Brand of Quinidine Sulfate
% 211.97/212.20  |- skos__altLabel mesh__D011802 Chinidin
% 211.97/212.20  |- mesh__recordMaintainer mesh__D011802 CCR
% 211.97/212.20  |- rdf__type mesh__D011802sskos__Concept
% 211.97/212.20  |- skos__broader mesh__D011802smesh__D011812
% 211.97/212.20  |- skos__scopeNote mesh__D011802
% 211.97/212.20       An optical isomer of quinine, extracted from the bark of the Cinchona tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular action potential, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission.%A%    
% 211.97/212.20  |- skos__hiddenLabel mesh__D011802 Sulfate, Quinidine
% 211.97/212.20  |- skos__altLabel mesh__D011802
% 211.97/212.20       Fawns %26% McAllan Brand of Quinidine Sulfate
% 211.97/212.20  |- mesh__dateCreated mesh__D011802 1999-01-01
% 211.97/212.20  |- skos__broader mesh__D011802smesh__D011804
% 211.97/212.20  |- skos__altLabel mesh__D011802 Robins Brand of Quinidine Sulfate
% 211.97/212.20  |- mesh__recordOriginator mesh__D011802 NLM
% 211.97/212.20  |- mesh__recordAuthorizer mesh__D011802 sjn
% 211.97/212.20  |- skos__altLabel mesh__D011802 Apotex Brand of Quinidine Sulfate
% 211.97/212.20  |- skos__prefLabel mesh__D011802 Quinidine
% 211.97/212.20  |- skos__broader mesh__D011802smesh__D002930
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D011802 2006
% 211.97/212.20  |- skos__hiddenLabel mesh__D011004 Patterson Kelly Syndrome
% 211.97/212.20  |- mesh__onlineNote mesh__D011004 search DEGLUTITION DISORDERS 1966-74   
% 211.97/212.20  |- mesh__recordOriginator mesh__D011004 NLM
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D011004 2005
% 211.97/212.20  |- skos__altLabel mesh__D011004 Syndrome, Plummer-Vinson
% 211.97/212.20  |- skos__prefLabel mesh__D011004 Plummer-Vinson Syndrome
% 211.97/212.20  |- skos__broader mesh__D011004smesh__D015154
% 211.97/212.20  |- skos__hiddenLabel mesh__D011004 Syndrome, Plummer Vinson
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D011004 2006
% 211.97/212.20  |- skos__scopeNote mesh__D011004
% 211.97/212.20       A syndrome of DYSPHAGIA with IRON-DEFICIENCY ANEMIA that is due to congenital anomalies in the ESOPHAGUS %28%such as cervical esophageal webs%29%. It is known as Patterson-Kelly syndrome in the United Kingdom.%A%    
% 211.97/212.20  |- skos__hiddenLabel mesh__D011004 Syndrome, Patterson-Kelly
% 211.97/212.20  |- mesh__historyNote mesh__D011004
% 211.97/212.20       91%28%75%29%; was see under DEGLUTITION DISORDERS 1975-90   
% 211.97/212.20  |- mesh__recordMaintainer mesh__D011004 lkt
% 211.97/212.20  |- rdf__type mesh__D011004sskos__Concept
% 211.97/212.20  |- skos__altLabel mesh__D011004 Patterson-Kelly Syndrome
% 211.97/212.20  |- mesh__dateRevised mesh__D011004 2004-07-07
% 211.97/212.20  |- mesh__recordAuthorizer mesh__D011004 sjn
% 211.97/212.20  |- mesh__publicMeSHNote mesh__D011004
% 211.97/212.20       91; was see under DEGLUTITION DISORDERS 1975-90   
% 211.97/212.20  |- mesh__dateCreated mesh__D011004 1999-01-01
% 211.97/212.20  |- skos__hiddenLabel mesh__D011004 Plummer Vinson Syndrome
% 211.97/212.20  |- mesh__dateEstablished mesh__D011004 1991-01-01
% 211.97/212.20  |- mesh__historyNote mesh__D016298 91   
% 211.97/212.20  |- skos__altLabel mesh__D016298 Hematopoietins
% 211.97/212.20  |- skos__altLabel mesh__D016298 Hematopoietic Cell Growth Factor
% 211.97/212.20  |- mesh__recordMaintainer mesh__D016298 ssb
% 211.97/212.20  |- skos__related mesh__D016298smesh__D016184
% 211.97/212.20  |- skos__broader mesh__D016298smesh__D006133
% 211.97/212.20  |- mesh__dateEstablished mesh__D016298 1991-01-01
% 211.97/212.20  |- mesh__recordOriginator mesh__D016298 RLS
% 211.97/212.20  |- skos__hiddenLabel mesh__D016298 Hematopoietic CGF
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D016298 2006
% 211.97/212.20  |- mesh__dateRevised mesh__D016298 2005-06-30
% 211.97/212.20  |- skos__hiddenLabel mesh__D016298 Hematopoietin 1
% 211.97/212.20  |- mesh__recordAuthorizer mesh__D016298 sjn
% 211.97/212.20  |- mesh__dateCreated mesh__D016298 1990-05-29
% 211.97/212.20  |- skos__hiddenLabel mesh__D016298 Hematopoietin 2
% 211.97/212.20  |- mesh__publicMeSHNote mesh__D016298 91   
% 211.97/212.20  |- skos__historyNote mesh__D016298 Growth Substances %28%1966-1990%29%
% 211.97/212.20  |- skos__scopeNote mesh__D016298
% 211.97/212.20       These growth factors comprise a family of hematopoietic regulators with biological specificities defined by their ability to support proliferation and differentiation of blood cells of different lineages. ERYTHROPOIETIN and the COLONY-STIMULATING FACTORS belong to this family. Some of these factors have been studied and used in the treatment of chemotherapy-induced neutropenia, myelodysplastic syndromes, and bone marrow failure syndromes.%A%    
% 211.97/212.20  |- skos__prefLabel mesh__D016298 Hematopoietic Cell Growth Factors
% 211.97/212.20  |- skos__annotation mesh__D016298 /drug eff permitted; DF: HCGF   
% 211.97/212.20  |- skos__altLabel mesh__D016298 Hematopoietic-CGF
% 211.97/212.20  |- rdf__type mesh__D016298sskos__Concept
% 211.97/212.20  |- mesh__dateCreated mesh__D002278 1999-01-01
% 211.97/212.20  |- mesh__publicMeSHNote mesh__D002278 73   
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D002278 2004
% 211.97/212.20  |- mesh__dateEstablished mesh__D002278 1973-01-01
% 211.97/212.20  |- mesh__recordAuthorizer mesh__D002278 sjn
% 211.97/212.20  |- skos__hiddenLabel mesh__D002278 Intraepithelial Neoplasm
% 211.97/212.20  |- skos__altLabel mesh__D002278 Intraepithelial Neoplasms
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D002278 2006
% 211.97/212.20  |- mesh__recordMaintainer mesh__D002278 lkt
% 211.97/212.20  |- skos__hiddenLabel mesh__D002278 Preinvasive Carcinoma
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D002278 2003
% 211.97/212.20  |- skos__altLabel mesh__D002278 Carcinoma, Intraepithelial
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D002278 2005
% 211.97/212.20  |- mesh__recordOriginator mesh__D002278 NLM
% 211.97/212.20  |- skos__prefLabel mesh__D002278 Carcinoma in Situ
% 211.97/212.20  |- skos__hiddenLabel mesh__D002278 Intraepithelial Carcinoma
% 211.97/212.20  |- rdf__type mesh__D002278sskos__Concept
% 211.97/212.20  |- mesh__dateRevised mesh__D002278 2001-07-25
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D002278 2002
% 211.97/212.20  |- mesh__historyNote mesh__D002278 73   
% 211.97/212.20  |- skos__hiddenLabel mesh__D002278 Neoplasm, Intraepithelial
% 211.97/212.20  |- skos__altLabel mesh__D002278 Carcinoma, Preinvasive
% 211.97/212.20  |- skos__scopeNote mesh__D002278
% 211.97/212.20       A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.%A%    
% 211.97/212.20  |- skos__annotation mesh__D002278
% 211.97/212.20       coord IM with precoord organ/neopl term %28%IM%29%   
% 211.97/212.20  |- skos__historyNote mesh__D002278 Carcinoma %28%1966-1972%29%
% 211.97/212.20  |- skos__broader mesh__D002278smesh__D002277
% 211.97/212.20  |- mesh__recordOriginator mesh__D007761 NLM
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D007761 2004
% 211.97/212.20  |- skos__hiddenLabel mesh__D007761 Fluid, Labyrinthine
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D007761 2005
% 211.97/212.20  |- skos__scopeNote mesh__D007761
% 211.97/212.20       Fluids found within the osseous labyrinth %28%PERILYMPH%29% and the membranous labyrinth %28%ENDOLYMPH%29% of the inner ear. %28%From Gray%27%s Anatomy, 30th American ed, p1328, 1332%29%%A%    
% 211.97/212.20  |- mesh__recordAuthorizer mesh__D007761 sjn
% 211.97/212.20  |- mesh__dateRevised mesh__D007761 2003-07-09
% 211.97/212.20  |- skos__prefLabel mesh__D007761 Labyrinthine Fluids
% 211.97/212.20  |- mesh__dateCreated mesh__D007761 1999-01-01
% 211.97/212.20  |- mesh__recordMaintainer mesh__D007761 nns
% 211.97/212.20  |- skos__annotation mesh__D007761
% 211.97/212.20       GEN or unspecified; prefer ENDOLYMPH %26% PERILYMPH   
% 211.97/212.20  |- rdf__type mesh__D007761sskos__Concept
% 211.97/212.20  |- skos__broader mesh__D007761smesh__D045604
% 211.97/212.20  |- skos__hiddenLabel mesh__D007761 Labyrinthine Fluid
% 211.97/212.20  |- skos__hiddenLabel mesh__D007761 Fluids, Labyrinthine
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D007761 2006
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D017391 2003
% 211.97/212.20  |- skos__prefLabel mesh__D017391 Epikeratophakia
% 211.97/212.20  |- mesh__recordAuthorizer mesh__D017391 sjn
% 211.97/212.20  |- skos__historyNote mesh__D017391
% 211.97/212.20       Corneal Transplantation %28%1981-1992%29%
% 211.97/212.20  |- mesh__historyNote mesh__D017391 93   
% 211.97/212.20  |- skos__hiddenLabel mesh__D017391 Epikeratophakias
% 211.97/212.20  |- skos__broader mesh__D017391smesh__D016039
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D017391 2006
% 211.97/212.20  |- mesh__dateRevised mesh__D017391 2002-07-03
% 211.97/212.20  |- mesh__recordOriginator mesh__D017391 PXP
% 211.97/212.20  |- mesh__dateEstablished mesh__D017391 1993-01-01
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D017391 2005
% 211.97/212.20  |- skos__annotation mesh__D017391
% 211.97/212.20       a type of corneal transpl; epi- refers to transpl to anterior surface; do not use /util except by MeSH definition; do not coord with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed%A%  
% 211.97/212.20  |- rdf__type mesh__D017391sskos__Concept
% 211.97/212.20  |- mesh__publicMeSHNote mesh__D017391 93   
% 211.97/212.20  |- mesh__recordMaintainer mesh__D017391 lkt
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D017391 2004
% 211.97/212.20  |- mesh__dateCreated mesh__D017391 1992-05-20
% 211.97/212.20  |- skos__scopeNote mesh__D017391
% 211.97/212.20       A procedure that modifies the refractive error of the lens by the transplantation of a donor cornea to the anterior surface of the patient%27%s cornea. The basic indication for epikeratophakia is the incapability of correcting refractive errors with conservative methods, such as glasses, contact lenses, or intraocular lenses.%A%    
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D031062 2005
% 211.97/212.20  |- mesh__dateEstablished mesh__D031062 2003-01-01
% 211.97/212.20  |- skos__prefLabel mesh__D031062 Philodendron
% 211.97/212.20  |- mesh__publicMeSHNote mesh__D031062 2003   
% 211.97/212.20  |- skos__annotation mesh__D031062
% 211.97/212.20       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.97/212.20  |- rdf__type mesh__D031062sskos__Concept
% 211.97/212.20  |- mesh__historyNote mesh__D031062 2003   
% 211.97/212.20  |- skos__broader mesh__D031062smesh__D029064
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D031062 2004
% 211.97/212.20  |- mesh__dateCreated mesh__D031062 2002-07-03
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D031062 2003
% 211.97/212.20  |- skos__scopeNote mesh__D031062
% 211.97/212.20       A plant genus of the family ARACEAE. As a houseplant it sometimes poisons children and animals.%A%    
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D031062 2006
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D003371 2005
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D003371 2001
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D003371 2003
% 211.97/212.20  |- skos__scopeNote mesh__D003371
% 211.97/212.20       A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.%A%    
% 211.97/212.20  |- rdf__type mesh__D003371sskos__Concept
% 211.97/212.20  |- skos__prefLabel mesh__D003371 Cough
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D003371 2000
% 211.97/212.20  |- skos__related mesh__D003371smesh__D000996
% 211.97/212.20  |- mesh__recordAuthorizer mesh__D003371 sjn
% 211.97/212.20  |- mesh__recordOriginator mesh__D003371 NLM
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D003371 2002
% 211.97/212.20  |- skos__broader mesh__D003371smesh__D012818
% 211.97/212.20  |- mesh__dateRevised mesh__D003371 1999-11-08
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D003371 2006
% 211.97/212.20  |- skos__broader mesh__D003371smesh__D012120
% 211.97/212.20  |- mesh__dateCreated mesh__D003371 1999-01-01
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D003371 2004
% 211.97/212.20  |- skos__related mesh__D003371smesh__D005100
% 211.97/212.20  |- skos__hiddenLabel mesh__D003371 Coughs
% 211.97/212.20  |- mesh__recordMaintainer mesh__D003371 adp
% 211.97/212.20  |- skos__annotation mesh__D003371
% 211.97/212.20       /drug ther: consider also ANTITUSSIVE AGENTS   
% 211.97/212.20  |- skos__prefLabel mesh__D011803 Quinine
% 211.97/212.20  |- skos__hiddenLabel mesh__D011803 Hydrochloride, Quinine
% 211.97/212.20  |- rdf__type mesh__D011803sskos__Concept
% 211.97/212.20  |- skos__altLabel mesh__D011803 Quinson
% 211.97/212.20  |- mesh__dateRevised mesh__D011803 2005-06-30
% 211.97/212.20  |- mesh__dateCreated mesh__D011803 1999-01-01
% 211.97/212.20  |- skos__hiddenLabel mesh__D011803 Bisulfate, Quinine
% 211.97/212.20  |- skos__altLabel mesh__D011803 Lafran Brand of Quinine Hydrochloride
% 211.97/212.20  |- skos__broader mesh__D011803smesh__D011804
% 211.97/212.20  |- skos__scopeNote mesh__D011803
% 211.97/212.20       An alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Quinine is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Quinine is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood.%A%    
% 211.97/212.20  |- skos__annotation mesh__D011803 /biosyn permitted if by plant   
% 211.97/212.20  |- skos__altLabel mesh__D011803
% 211.97/212.20       Fawns %26% McAllan Brand of Quinine Bisulfate
% 211.97/212.20  |- skos__broader mesh__D011803smesh__D011812
% 211.97/212.20  |- skos__hiddenLabel mesh__D011803 Sulphate, Quinine
% 211.97/212.20  |- skos__altLabel mesh__D011803 Foy Brand of Quinine Sulfate
% 211.97/212.20  |- skos__altLabel mesh__D011803 Hoechst Brand of Quinine Sulfate
% 211.97/212.20  |- skos__altLabel mesh__D011803 Fawns %26% McAllan Brand of Quinine Sulfate
% 211.97/212.20  |- skos__hiddenLabel mesh__D011803 Sulfate, Quinine
% 211.97/212.20  |- skos__altLabel mesh__D011803 Aventis Brand of Quinine Bisulfate
% 211.97/212.20  |- mesh__recordMaintainer mesh__D011803 lkw
% 211.97/212.20  |- skos__altLabel mesh__D011803 Innotech Brand of Quinine Hydrochloride
% 211.97/212.20  |- skos__altLabel mesh__D011803 Quinsul
% 211.97/212.20  |- mesh__recordOriginator mesh__D011803 NLM
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D011803 2006
% 211.97/212.20  |- mesh__recordAuthorizer mesh__D011803 sjn
% 211.97/212.20  |- skos__broader mesh__D011803smesh__D002930
% 211.97/212.20  |- skos__altLabel mesh__D011803 Quinine Sulphate
% 211.97/212.20  |- skos__altLabel mesh__D011803 Prosana Brand of Quinine Bisulfate
% 211.97/212.20  |- skos__altLabel mesh__D011803 Alphapharm Brand of Quinine Sulfate
% 211.97/212.20  |- skos__altLabel mesh__D011803 Odan Brand of Quinine Sulfate
% 211.97/212.20  |- skos__altLabel mesh__D011803 Plough Brand of Quinine Sulfate
% 211.97/212.20  |- skos__scopeNote mesh__D011005
% 211.97/212.20       Plutonium. A naturally radioactive element of the actinide metals series. It has the atomic symbol Pu, atomic number 94, and atomic weight 242. Plutonium is used as a nuclear fuel, to produce radioisotopes for research, in radionuclide batteries for pacemakers, and as the agent of fission in nuclear weapons.%A%    
% 211.97/212.20  |- mesh__recordOriginator mesh__D011005 NLM
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D011005 2006
% 211.97/212.20  |- mesh__recordMaintainer mesh__D011005 jmp
% 211.97/212.20  |- mesh__dateRevised mesh__D011005 2005-06-30
% 211.97/212.20  |- skos__broader mesh__D011005smesh__D008671
% 211.97/212.20  |- rdf__type mesh__D011005sskos__Concept
% 211.97/212.20  |- skos__annotation mesh__D011005 naturally radioactive; IM   
% 211.97/212.20  |- skos__prefLabel mesh__D011005 Plutonium
% 211.97/212.20  |- mesh__dateCreated mesh__D011005 1999-01-01
% 211.97/212.20  |- skos__broader mesh__D011005smesh__D019216
% 211.97/212.20  |- mesh__recordAuthorizer mesh__D011005 sjn
% 211.97/212.20  |- mesh__historyNote mesh__D016299 91   
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D016299 2002
% 211.97/212.20  |- mesh__dateCreated mesh__D016299 1990-05-25
% 211.97/212.20  |- skos__prefLabel mesh__D016299 Dental Implantation, Subperiosteal
% 211.97/212.20  |- mesh__publicMeSHNote mesh__D016299 91   
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D016299 1998
% 211.97/212.20  |- skos__scopeNote mesh__D016299
% 211.97/212.20       The grafting or inserting of an appliance designed to fit over the surface of the mandible or the maxilla, beneath the specialized connective tissue that covers the bone %28%periosteum%29%.%A%    
% 211.97/212.20  |- skos__altLabel mesh__D016299 Subperiosteal Dental Implantation
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D016299 2005
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D016299 1999
% 211.97/212.20  |- skos__historyNote mesh__D016299 Dental Implantation %28%1966-1990%29%
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D016299 2000
% 211.97/212.20  |- mesh__dateRevised mesh__D016299 1997-06-20
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D016299 2006
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D016299 2001
% 211.97/212.20  |- skos__altLabel mesh__D016299 Implantation, Subperiosteal
% 211.97/212.20  |- skos__broader mesh__D016299smesh__D003757
% 211.97/212.20  |- skos__altLabel mesh__D016299 Subperiosteal Implantation
% 211.97/212.20  |- skos__annotation mesh__D016299
% 211.97/212.20       do not use /util except by MeSH definition; DF: DENT IMPLANT SUBPERIOSTEAL%A%  
% 211.97/212.20  |- mesh__recordOriginator mesh__D016299 MXR
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D016299 2003
% 211.97/212.20  |- mesh__recordMaintainer mesh__D016299 PXP
% 211.97/212.20  |- mesh__dateEstablished mesh__D016299 1991-01-01
% 211.97/212.20  |- rdf__type mesh__D016299sskos__Concept
% 211.97/212.20  |- skos__altLabel mesh__D016299 Implantation, Subperiosteal Dental
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D016299 2004
% 211.97/212.20  |- mesh__recordAuthorizer mesh__D016299 SJN
% 211.97/212.20  |- skos__broader mesh__D011943Q000819smesh__D011943
% 211.97/212.20  |- mesh__preferredCombination mesh__D011943Q000819smesh__D000318
% 211.97/212.20  |- rdf__type mesh__D011943Q000819smesh__CompoundConcept
% 211.97/212.20  |- mesh__dateRevised mesh__D002279 2003-07-30
% 211.97/212.20  |- mesh__recordMaintainer mesh__D002279 ags
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D002279 2005
% 211.97/212.20  |- skos__scopeNote mesh__D002279
% 211.97/212.20       A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. %28%Stedman, 25th ed%29%%A%    
% 211.97/212.20  |- skos__annotation mesh__D002279
% 211.97/212.20       exper neopl; /blood supply /chem /second /secret /ultrastruct permitted; don%27%t forget check tag ANIMALS%A%  
% 211.97/212.20  |- mesh__recordAuthorizer mesh__D002279 sjn
% 211.97/212.20  |- skos__altLabel mesh__D002279 Carcinosarcoma 256, Walker
% 211.97/212.20  |- rdf__type mesh__D002279sskos__Concept
% 211.97/212.20  |- skos__broader mesh__D002279smesh__D002296
% 211.97/212.20  |- skos__hiddenLabel mesh__D002279 Walker Carcinosarcoma 256
% 211.97/212.20  |- mesh__recordOriginator mesh__D002279 NLM
% 211.97/212.20  |- skos__broader mesh__D002279smesh__D009374
% 211.97/212.20  |- skos__hiddenLabel mesh__D002279 Walker Carcinoma 256
% 211.97/212.20  |- mesh__dateCreated mesh__D002279 1999-01-01
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D002279 2004
% 211.97/212.20  |- skos__prefLabel mesh__D002279 Carcinoma 256, Walker
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D002279 2006
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D007762 2003
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D007762 1995
% 211.97/212.20  |- skos__altLabel mesh__D007762 Otitis Interna
% 211.97/212.20  |- mesh__recordAuthorizer mesh__D007762 PLS
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D007762 2001
% 211.97/212.20  |- mesh__dateCreated mesh__D007762 1999-01-01
% 211.97/212.20  |- mesh__recordOriginator mesh__D007762 NLM
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D007762 1994
% 211.97/212.20  |- skos__scopeNote mesh__D007762 Inflammation of the inner ear.     
% 211.97/212.20  |- rdf__type mesh__D007762sskos__Concept
% 211.97/212.20  |- mesh__historyNote mesh__D007762
% 211.97/212.20       91%28%79%29%; was see under LABYRINTH DISEASES 1979-90; was OTITIS INTERNA see under LABYRINTH DISEASES 1963-78%A%  
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D007762 2000
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D007762 1999
% 211.97/212.20  |- skos__broader mesh__D007762smesh__D007759
% 211.97/212.20  |- skos__annotation mesh__D007762 inflamm of inner ear   
% 211.97/212.20  |- mesh__onlineNote mesh__D007762
% 211.97/212.20       use LABYRINTHITIS to search OTITIS INTERNA 1975-78; use LABYRINTH DISEASES 1966-74%A%  
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D007762 1998
% 211.97/212.20  |- skos__prefLabel mesh__D007762 Labyrinthitis
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D007762 1997
% 211.97/212.20  |- mesh__dateEstablished mesh__D007762 1991-01-01
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D007762 2006
% 211.97/212.20  |- mesh__publicMeSHNote mesh__D007762
% 211.97/212.20       91; was see under LABYRINTH DISEASES 1979-90; was OTITIS INTERNA see under LABYRINTH DISEASES 1963-78%A%  
% 211.97/212.20  |- mesh__recordMaintainer mesh__D007762 TGC
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D007762 2002
% 211.97/212.20  |- skos__hiddenLabel mesh__D007762 Labyrinthitides
% 211.97/212.20  |- mesh__dateRevised mesh__D007762 1993-06-02
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D007762 1996
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D007762 2005
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D007762 2004
% 211.97/212.20  |- skos__prefLabel mesh__D031861 Nigella damascena
% 211.97/212.20  |- mesh__dateCreated mesh__D031861 2002-07-03
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D031861 2004
% 211.97/212.20  |- skos__broader mesh__D031861smesh__D031844
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D031861 2003
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D031861 2006
% 211.97/212.20  |- mesh__dateEstablished mesh__D031861 2003-01-01
% 211.97/212.20  |- mesh__publicMeSHNote mesh__D031861 2003   
% 211.97/212.20  |- skos__annotation mesh__D031861
% 211.97/212.20       X ref Fennel, Wild: other fennel terms are also available; check text and MeSH; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D031861 2005
% 211.97/212.20  |- skos__altLabel mesh__D031861 Fennel, Wild
% 211.97/212.20  |- mesh__historyNote mesh__D031861 2003   
% 211.97/212.20  |- skos__scopeNote mesh__D031861
% 211.97/212.20       A plant genus of the family RANUNCULACEAE. The name is similar to giant fennel %28%FERULA%29%, true fennel %28%FOENICULUM%29%, and dog fennel %28%ANTHEMIS%29%.%A%    
% 211.97/212.20  |- rdf__type mesh__D031861sskos__Concept
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D017392 2005
% 211.97/212.20  |- mesh__publicMeSHNote mesh__D017392 93   
% 211.97/212.20  |- mesh__dateCreated mesh__D017392 1992-05-22
% 211.97/212.20  |- mesh__historyNote mesh__D017392 93   
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D017392 2006
% 211.97/212.20  |- skos__broader mesh__D017392smesh__D007202
% 211.97/212.20  |- skos__annotation mesh__D017392 DF: note short X ref   
% 211.97/212.20  |- mesh__recordMaintainer mesh__D017392 ssb
% 211.97/212.20  |- mesh__recordAuthorizer mesh__D017392 sjn
% 211.97/212.20  |- rdf__type mesh__D017392sskos__Concept
% 211.97/212.20  |- skos__altLabel mesh__D017392 TBARs
% 211.97/212.20  |- mesh__dateRevised mesh__D017392 2003-07-09
% 211.97/212.20  |- skos__prefLabel mesh__D017392 Thiobarbituric Acid Reactive Substances
% 211.97/212.20  |- mesh__recordOriginator mesh__D017392 TPW
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D017392 2004
% 211.97/212.20  |- skos__broader mesh__D017392smesh__D008315
% 211.97/212.20  |- skos__scopeNote mesh__D017392
% 211.97/212.20       Low-molecular-weight end products, probably malondialdehyde, that are formed during the decomposition of lipid peroxidation products. These compounds react with thiobarbituric acid to form a fluorescent red adduct.%A%    
% 211.97/212.20  |- mesh__dateEstablished mesh__D017392 1993-01-01
% 211.97/212.20  |- skos__scopeNote mesh__D031063
% 211.97/212.20       A plant genus of the family ARACEAE.  The common names of %27%Coco Yam%27% %28%Cocoyam%29% or %27%Elephant%27%s Ear%27% may be confused with COLOCASIA and other ARACEAE or with common yam %28%DIOSCOREA%29%. It contains LECTINS.%A%    
% 211.97/212.20  |- mesh__dateCreated mesh__D031063 2002-07-03
% 211.97/212.20  |- mesh__publicMeSHNote mesh__D031063 2003   
% 211.97/212.20  |- skos__broader mesh__D031063smesh__D029064
% 211.97/212.20  |- mesh__recordOriginator mesh__D031063 ssb
% 211.97/212.20  |- skos__annotation mesh__D031063
% 211.97/212.20       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 211.97/212.20  |- mesh__dateEstablished mesh__D031063 2003-01-01
% 211.97/212.20  |- skos__altLabel mesh__D031063 Zanthosoma sagittifolium
% 211.97/212.20  |- rdf__type mesh__D031063sskos__Concept
% 211.97/212.20  |- mesh__recordAuthorizer mesh__D031063 sjn
% 211.97/212.20  |- skos__altLabel mesh__D031063 Zanthosoma
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D031063 2004
% 211.97/212.20  |- skos__prefLabel mesh__D031063 Xanthosoma
% 211.97/212.20  |- mesh__dateRevised mesh__D031063 2003-07-22
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D031063 2005
% 211.97/212.20  |- mesh__recordMaintainer mesh__D031063 sjn
% 211.97/212.20  |- mesh__historyNote mesh__D031063 2003   
% 211.97/212.20  |- mesh__activeMeSHYear mesh__D031063 2006
% 211.97/212.20  |- skos__historyNote mesh__D003372 Coumarins %28%1966-1971%29%
% 211.97/212.20  |- skos__broader mesh__D003372smesh__D009946
% 211.97/212.20  |- mesh__dateRevised mesh__D003372 2005-06-30
% 211.97/212.20  |- skos__prefLabel mesh__D003372 Coumaphos
% 211.97/212.20  |- skos__scopeNote mesh__D003372
% 211.97/212.20       A organothiophosphorus cholinesterase inhibitor that is used as an anthelmintic, insecticide, and as a nematocide.%A%    
% 211.97/212.20  |- mesh__recordAuthorizer mesh__D003372 sjn
% 211.97/212.20  |- mesh__recordOriginator mesh__D003372 NLM
% 211.97/212.20  |- mesh__dateEstablished mesh__D003372 1991-01-01
% 212.07/212.20  |- mesh__historyNote mesh__D003372
% 212.07/212.20       91%28%72%29%; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90%A%  
% 212.07/212.20  |- mesh__activeMeSHYear mesh__D003372 2006
% 212.07/212.20  |- skos__annotation mesh__D003372 TN 111 for eff on insects   
% 212.07/212.20  |- mesh__recordMaintainer mesh__D003372 ssb
% 212.07/212.20  |- skos__altLabel mesh__D003372 Coumafos
% 212.07/212.20  |- mesh__dateCreated mesh__D003372 1999-01-01
% 212.07/212.20  |- skos__broader mesh__D003372smesh__D014468
% 212.07/212.20  |- mesh__publicMeSHNote mesh__D003372
% 212.07/212.20       91; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90%A%  
% 212.07/212.20  |- rdf__type mesh__D003372sskos__Concept
% 212.07/212.20  |- mesh__activeMeSHYear mesh__D011804 2003
% 212.07/212.20  |- mesh__activeMeSHYear mesh__D011804 2005
% 212.07/212.20  |- skos__broader mesh__D011804smesh__D006574
% 212.07/212.20  |- mesh__recordOriginator mesh__D011804 NLM
% 212.07/212.20  |- mesh__recordMaintainer mesh__D011804 TWD
% 212.07/212.20  |- mesh__recordAuthorizer mesh__D011804 sjn
% 212.07/212.20  |- mesh__activeMeSHYear mesh__D011804 2004
% 212.07/212.20  |- mesh__activeMeSHYear mesh__D011804 2002
% 212.07/212.20  |- mesh__activeMeSHYear mesh__D011804 2006
% 212.07/212.20  |- mesh__dateRevised mesh__D011804 2000-06-22
% 212.07/212.20  |- skos__annotation mesh__D011804
% 212.07/212.20       do not confuse with QUINOLIZINES nor with QUINOLONES nor its X ref QUINOLINONES%A%  
% 212.07/212.20  |- rdf__type mesh__D011804sskos__Concept
% 212.07/212.20  |- mesh__activeMeSHYear mesh__D011804 2001
% 212.07/212.20  |- skos__prefLabel mesh__D011804 Quinolines
% 212.07/212.20  |- mesh__dateCreated mesh__D011804 1999-01-01
% 212.07/212.20  |- skos__hiddenLabel mesh__D011006 Cystoides Intestinalis, Pneumatosis
% 212.07/212.20  |- skos__broader mesh__D011006smesh__D007410
% 212.07/212.20  |- skos__scopeNote mesh__D011006
% 212.07/212.20       A condition characterized by the presence of multiple gas-filled cysts in the intestinal wall, the submucosa and/or subserosa of the INTESTINE. The majority of the cysts are found in the JEJUNUM and the ILEUM.%A%    
% 212.07/212.20  |- mesh__dateRevised mesh__D011006 2003-07-09
% 212.07/212.20  |- mesh__recordAuthorizer mesh__D011006 sjn
% 212.07/212.20  |- mesh__recordMaintainer mesh__D011006 lkt
% 212.07/212.20  |- mesh__dateCreated mesh__D011006 1999-01-01
% 212.07/212.20  |- mesh__activeMeSHYear mesh__D011006 2006
% 212.07/212.20  |- mesh__recordOriginator mesh__D011006 NLM
% 212.07/212.20  |- rdf__type mesh__D011006sskos__Concept
% 212.07/212.20  |- mesh__activeMeSHYear mesh__D011006 2005
% 212.07/212.20  |- skos__hiddenLabel mesh__D011006 Intestinalis, Pneumatosis Cystoides
% 212.07/212.20  |- skos__prefLabel mesh__D011006 Pneumatosis Cystoides Intestinalis
% 212.07/212.20  |- mesh__activeMeSHYear mesh__D011006 2004
% 212.07/212.20  |- skos__hiddenLabel mesh__D007763 Genes, LacZ
% 212.07/212.20  |- skos__hiddenLabel mesh__D007763 Lac Operons
% 212.07/212.20  |- mesh__recordOriginator mesh__D007763 AEP
% 212.07/212.20  |- mesh__dateRevised mesh__D007763 2005-06-30
% 212.07/212.20  |- skos__hiddenLabel mesh__D007763 Gene, LacZ
% 212.07/212.20  |- skos__hiddenLabel mesh__D007763 Gene, Lac
% 212.07/212.21  |- skos__hiddenLabel mesh__D007763 Operon, Lactose
% 212.07/212.21  |- skos__altLabel mesh__D007763 Lactose Operon
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007763 2006
% 212.07/212.21  |- skos__hiddenLabel mesh__D007763 Genes, Lac
% 212.07/212.21  |- skos__hiddenLabel mesh__D007763 Operons, Lac
% 212.07/212.21  |- skos__hiddenLabel mesh__D007763 Operons, Lactose
% 212.07/212.21  |- mesh__publicMeSHNote mesh__D007763 79   
% 212.07/212.21  |- skos__hiddenLabel mesh__D007763 Lac Genes
% 212.07/212.21  |- skos__hiddenLabel mesh__D007763 LacZ Gene
% 212.07/212.21  |- skos__prefLabel mesh__D007763 Lac Operon
% 212.07/212.21  |- mesh__dateEstablished mesh__D007763 1979-01-01
% 212.07/212.21  |- skos__annotation mesh__D007763
% 212.07/212.21       note category; consider also LAC REPRESSORS %28%see note on REPRESSOR PROTEINS%29%%A%  
% 212.07/212.21  |- mesh__dateCreated mesh__D007763 1978-03-03
% 212.07/212.21  |- skos__hiddenLabel mesh__D007763 Lactose Operons
% 212.07/212.21  |- skos__hiddenLabel mesh__D007763 Operon, Lac
% 212.07/212.21  |- mesh__recordMaintainer mesh__D007763 nns
% 212.07/212.21  |- skos__scopeNote mesh__D007763
% 212.07/212.21       The genetic unit consisting of three structural genes, an operator and a regulatory gene. The regulatory gene controls the synthesis of the three structural genes: BETA-GALACTOSIDASE and beta-galactoside permease %28%involved with the metabolism of lactose%29%, and beta-thiogalactoside acetyltransferase.%A%    
% 212.07/212.21  |- skos__historyNote mesh__D007763 Lactose %28%1966-1978%29%
% 212.07/212.21  |- skos__broader mesh__D007763smesh__D009876
% 212.07/212.21  |- mesh__historyNote mesh__D007763 79   
% 212.07/212.21  |- skos__historyNote mesh__D007763 Operon %28%1969-1978%29%
% 212.07/212.21  |- mesh__recordAuthorizer mesh__D007763 sjn
% 212.07/212.21  |- rdf__type mesh__D007763sskos__Concept
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D017393 2006
% 212.07/212.21  |- mesh__dateRevised mesh__D017393 2004-07-07
% 212.07/212.21  |- mesh__dateEstablished mesh__D017393 1993-01-01
% 212.07/212.21  |- skos__annotation mesh__D017393
% 212.07/212.21       a type of post-transcriptional RNA processing   
% 212.07/212.21  |- skos__scopeNote mesh__D017393
% 212.07/212.21       A process that changes the nucleotide sequence of mRNA from that of the DNA template encoding it. Some major classes of RNA editing are as follows: 1, the conversion of cytosine to uracil in mRNA; 2, the addition of variable number of guanines at pre-determined sites; and 3, the addition and deletion of uracils, templated by guide-RNAs %28%RNA, GUIDE%29%.%A%    
% 212.07/212.21  |- mesh__publicMeSHNote mesh__D017393 93   
% 212.07/212.21  |- skos__broader mesh__D017393smesh__D012323
% 212.07/212.21  |- mesh__dateCreated mesh__D017393 1992-05-22
% 212.07/212.21  |- mesh__recordMaintainer mesh__D017393 nns
% 212.07/212.21  |- rdf__type mesh__D017393sskos__Concept
% 212.07/212.21  |- skos__historyNote mesh__D017393
% 212.07/212.21       RNA Processing, Post-Transcriptional %28%1988-1992%29%
% 212.07/212.21  |- mesh__recordOriginator mesh__D017393 PXP
% 212.07/212.21  |- skos__prefLabel mesh__D017393 RNA Editing
% 212.07/212.21  |- skos__hiddenLabel mesh__D017393 RNA Editings
% 212.07/212.21  |- skos__hiddenLabel mesh__D017393 Editing, RNA
% 212.07/212.21  |- mesh__recordAuthorizer mesh__D017393 sjn
% 212.07/212.21  |- skos__hiddenLabel mesh__D017393 Editings, RNA
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D017393 2005
% 212.07/212.21  |- skos__altLabel mesh__D017393 RNA, Messenger, Editing
% 212.07/212.21  |- mesh__historyNote mesh__D017393 93   
% 212.07/212.21  |- skos__annotation mesh__D031064
% 212.07/212.21       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.07/212.21  |- skos__prefLabel mesh__D031064 Zantedeschia
% 212.07/212.21  |- rdf__type mesh__D031064sskos__Concept
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D031064 2003
% 212.07/212.21  |- mesh__dateCreated mesh__D031064 2002-07-03
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D031064 2004
% 212.07/212.21  |- skos__broader mesh__D031064smesh__D029064
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D031064 2005
% 212.07/212.21  |- mesh__dateEstablished mesh__D031064 2003-01-01
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D031064 2006
% 212.07/212.21  |- skos__scopeNote mesh__D031064
% 212.07/212.21       A plant genus of the family ARACEAE. The common name of Calla Lily or Callalily also refers to the Calla genus %28%CALLA PLANT%29%.%A%    
% 212.07/212.21  |- mesh__publicMeSHNote mesh__D031064 2003   
% 212.07/212.21  |- mesh__historyNote mesh__D031064 2003   
% 212.07/212.21  |- rdf__type mesh__D003373sskos__Concept
% 212.07/212.21  |- mesh__publicMeSHNote mesh__D003373
% 212.07/212.21       91; was see under CINNAMATES 1976-90   
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D003373 1997
% 212.07/212.21  |- skos__historyNote mesh__D003373 Cinnamates %28%1969-1975%29%
% 212.07/212.21  |- skos__altLabel mesh__D003373 Hydroxycinnamic Acids
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D003373 2005
% 212.07/212.21  |- mesh__historyNote mesh__D003373
% 212.07/212.21       91%28%76%29%; was see under CINNAMATES 1976-90   
% 212.07/212.21  |- skos__prefLabel mesh__D003373 Coumaric Acids
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D003373 1994
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D003373 2000
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D003373 2003
% 212.07/212.21  |- skos__broader mesh__D003373smesh__D002934
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D003373 2006
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D003373 2001
% 212.07/212.21  |- mesh__dateRevised mesh__D003373 1992-05-11
% 212.07/212.21  |- skos__hiddenLabel mesh__D003373 Acids, Coumaric
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D003373 1995
% 212.07/212.21  |- skos__scopeNote mesh__D003373
% 212.07/212.21       Hydroxycinnamic acid and its derivatives. Act as activators of the indoleacetic acid oxidizing system, thereby producing a decrease in the endogenous level of bound indoleacetic acid in plants.%A%    
% 212.07/212.21  |- mesh__recordOriginator mesh__D003373 RLS
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D003373 2004
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D003373 2002
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D003373 1998
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D003373 1993
% 212.07/212.21  |- mesh__recordMaintainer mesh__D003373 TGC
% 212.07/212.21  |- mesh__recordAuthorizer mesh__D003373 PLS
% 212.07/212.21  |- mesh__dateCreated mesh__D003373 1975-07-23
% 212.07/212.21  |- mesh__dateEstablished mesh__D003373 1991-01-01
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D003373 1996
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D003373 1999
% 212.07/212.21  |- skos__hiddenLabel mesh__D003373 Acids, Hydroxycinnamic
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011805 1997
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011805 2004
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011805 2001
% 212.07/212.21  |- mesh__historyNote mesh__D011805
% 212.07/212.21       91%28%75%29%; was see under PYRIDINES 1975-90   
% 212.07/212.21  |- mesh__recordAuthorizer mesh__D011805 PLS
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011805 1999
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011805 2006
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011805 1994
% 212.07/212.21  |- skos__broader mesh__D011805smesh__D011725
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011805 1993
% 212.07/212.21  |- mesh__dateEstablished mesh__D011805 1991-01-01
% 212.07/212.21  |- skos__prefLabel mesh__D011805 Quinolinic Acids
% 212.07/212.21  |- mesh__recordOriginator mesh__D011805 NLM
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011805 1995
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011805 2002
% 212.07/212.21  |- rdf__type mesh__D011805sskos__Concept
% 212.07/212.21  |- mesh__dateRevised mesh__D011805 1992-05-20
% 212.07/212.21  |- mesh__publicMeSHNote mesh__D011805
% 212.07/212.21       91; was see under PYRIDINES 1975-90   
% 212.07/212.21  |- mesh__dateCreated mesh__D011805 1999-01-01
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011805 1996
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011805 2003
% 212.07/212.21  |- mesh__onlineNote mesh__D011805 search PYRIDINES 1966-74   
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011805 1998
% 212.07/212.21  |- skos__hiddenLabel mesh__D011805 Acids, Quinolinic
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011805 2005
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011805 2000
% 212.07/212.21  |- mesh__recordMaintainer mesh__D011805 TAP
% 212.07/212.21  |- skos__hiddenLabel mesh__D011007 Pneumocyst, Cranial
% 212.07/212.21  |- skos__altLabel mesh__D011007 Cranial Airocele
% 212.07/212.21  |- skos__hiddenLabel mesh__D011007 Gas, Intracranial
% 212.07/212.21  |- skos__hiddenLabel mesh__D011007 Pneumocephalus, Pressure
% 212.07/212.21  |- skos__hiddenLabel mesh__D011007 Pneumocysts, Cranial
% 212.07/212.21  |- skos__prefLabel mesh__D011007 Pneumocephalus
% 212.07/212.21  |- skos__broader mesh__D011007smesh__D001930
% 212.07/212.21  |- skos__hiddenLabel mesh__D011007 Cranial Airoceles
% 212.07/212.21  |- mesh__recordMaintainer mesh__D011007 adp
% 212.07/212.21  |- mesh__dateCreated mesh__D011007 1999-01-01
% 212.07/212.21  |- skos__broader mesh__D011007smesh__D002493
% 212.07/212.21  |- skos__hiddenLabel mesh__D011007 Cranial Pneumocysts
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011007 2006
% 212.07/212.21  |- skos__hiddenLabel mesh__D011007 Airocele, Cranial
% 212.07/212.21  |- skos__hiddenLabel mesh__D011007 Airoceles, Cranial
% 212.07/212.21  |- mesh__dateRevised mesh__D011007 1999-11-08
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011007 2002
% 212.07/212.21  |- rdf__type mesh__D011007sskos__Concept
% 212.07/212.21  |- mesh__historyNote mesh__D011007 68%28%64%29%   
% 212.07/212.21  |- skos__altLabel mesh__D011007 Intracranial Gas
% 212.07/212.21  |- mesh__publicMeSHNote mesh__D011007 68   
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011007 2005
% 212.07/212.21  |- skos__altLabel mesh__D011007 Cranial Pneumocyst
% 212.07/212.21  |- mesh__recordAuthorizer mesh__D011007 sjn
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011007 2001
% 212.07/212.21  |- skos__hiddenLabel mesh__D011007 Tension Pneumocephalus
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011007 2004
% 212.07/212.21  |- skos__hiddenLabel mesh__D011007 Traumatic Pneumocephalus
% 212.07/212.21  |- skos__scopeNote mesh__D011007
% 212.07/212.21       Presence of air or gas within the intracranial cavity %28%e.g., epidural space, subdural space, intracerebral, etc.%29% which may result from traumatic injuries, fistulous tract formation, erosions of the skull from NEOPLASMS or infection, NEUROSURGICAL PROCEDURES, and other conditions.%A%    
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011007 2000
% 212.07/212.21  |- skos__hiddenLabel mesh__D011007 Epidural Pneumocephalus
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011007 2003
% 212.07/212.21  |- mesh__recordOriginator mesh__D011007 NLM
% 212.07/212.21  |- mesh__dateEstablished mesh__D011007 1968-01-01
% 212.07/212.21  |- skos__broader mesh__D001769Q000502smesh__D001769
% 212.07/212.21  |- mesh__preferredCombination mesh__D001769Q000502smesh__D001790
% 212.07/212.21  |- rdf__type mesh__D001769Q000502smesh__CompoundConcept
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007764 2000
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007764 1998
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007764 1997
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007764 2006
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007764 1996
% 212.07/212.21  |- mesh__dateEstablished mesh__D007764 1991-01-01
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007764 2005
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007764 2004
% 212.07/212.21  |- mesh__recordMaintainer mesh__D007764 TGC
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007764 2002
% 212.07/212.21  |- skos__hiddenLabel mesh__D007764 Lacquers
% 212.07/212.21  |- mesh__dateRevised mesh__D007764 1992-03-25
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007764 2003
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007764 1995
% 212.07/212.21  |- mesh__onlineNote mesh__D007764 use PAINT to search LACQUER 1966-74   
% 212.07/212.21  |- mesh__dateCreated mesh__D007764 1999-01-01
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007764 1994
% 212.07/212.21  |- rdf__type mesh__D007764sskos__Concept
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007764 1993
% 212.07/212.21  |- mesh__recordAuthorizer mesh__D007764 PLS
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007764 2001
% 212.07/212.21  |- skos__prefLabel mesh__D007764 Lacquer
% 212.07/212.21  |- skos__broader mesh__D007764smesh__D010150
% 212.07/212.21  |- mesh__recordOriginator mesh__D007764 NLM
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007764 1999
% 212.07/212.21  |- mesh__historyNote mesh__D007764
% 212.07/212.21       91%28%75%29%; was see under PAINT 1975-90   
% 212.07/212.21  |- mesh__publicMeSHNote mesh__D007764 91; was see under PAINT 1975-90   
% 212.07/212.21  |- skos__hiddenLabel mesh__D012100 Asexual Reproductions
% 212.07/212.21  |- mesh__historyNote mesh__D012100
% 212.07/212.21       91%28%75%29%; was see under REPRODUCTION 1975-90   
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D012100 2006
% 212.07/212.21  |- mesh__recordOriginator mesh__D012100 NLM
% 212.07/212.21  |- mesh__dateEstablished mesh__D012100 1991-01-01
% 212.07/212.21  |- mesh__publicMeSHNote mesh__D012100
% 212.07/212.21       91; was see under REPRODUCTION 1975-90   
% 212.07/212.21  |- skos__prefLabel mesh__D012100 Reproduction, Asexual
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D012100 2005
% 212.07/212.21  |- skos__related mesh__D012100smesh__D019976
% 212.07/212.21  |- skos__broader mesh__D012100smesh__D012098
% 212.07/212.21  |- skos__hiddenLabel mesh__D012100 Asexual Reproduction
% 212.07/212.21  |- mesh__dateCreated mesh__D012100 1974-11-11
% 212.07/212.21  |- mesh__recordMaintainer mesh__D012100 lkt
% 212.07/212.21  |- skos__scopeNote mesh__D012100
% 212.07/212.21       Reproduction without fusion of two types of cells, mostly found in ALGAE; FUNGI; and PLANTS. Asexual reproduction occurs in several ways, such as budding, fission, or splitting from %22%parent%22% cells. Only few groups of ANIMALS reproduce asexually or unisexually %28%PARTHENOGENESIS%29%.%A%    
% 212.07/212.21  |- mesh__dateRevised mesh__D012100 2004-07-07
% 212.07/212.21  |- rdf__type mesh__D012100sskos__Concept
% 212.07/212.21  |- mesh__recordAuthorizer mesh__D012100 sjn
% 212.07/212.21  |- skos__hiddenLabel mesh__D012100 Reproductions, Asexual
% 212.07/212.21  |- skos__altLabel mesh__D017394 gRNA
% 212.07/212.21  |- rdf__type mesh__D017394sskos__Concept
% 212.07/212.21  |- skos__prefLabel mesh__D017394 RNA, Guide
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D017394 2003
% 212.07/212.21  |- skos__altLabel mesh__D017394 Guide RNA
% 212.07/212.21  |- mesh__dateRevised mesh__D017394 2000-06-22
% 212.07/212.21  |- mesh__historyNote mesh__D017394 93; was GUIDE RNA %28%NM%29% 1990-92   
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D017394 2004
% 212.07/212.21  |- mesh__dateEstablished mesh__D017394 1993-01-01
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D017394 2001
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D017394 2005
% 212.07/212.21  |- mesh__publicMeSHNote mesh__D017394
% 212.07/212.21       93; GUIDE RNA was indexed under RNA 1990-92   
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D017394 2002
% 212.07/212.21  |- mesh__onlineNote mesh__D017394
% 212.07/212.21       use RNA, GUIDE %28%NM%29% to search GUIDE RNA 1990-92   
% 212.07/212.21  |- skos__broader mesh__D017394smesh__D022661
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D017394 2006
% 212.07/212.21  |- mesh__dateCreated mesh__D017394 1992-05-22
% 212.07/212.21  |- skos__scopeNote mesh__D017394
% 212.07/212.21       Small kinetoplastid mitochondrial RNA that plays a major role in RNA EDITING. These molecules form perfect hybrids with edited mRNA sequences and possess nucleotide sequences at their 5%27%-ends that are complementary to the sequences of the mRNA%27%s immediately downstream of the pre-edited regions.%A%    
% 212.07/212.21  |- skos__annotation mesh__D017394
% 212.07/212.21       plays a major role in RNA EDITING; DF: note short X ref   
% 212.07/212.21  |- skos__historyNote mesh__D017394 RNA %28%1990-1992%29%
% 212.07/212.21  |- skos__related mesh__D017394smesh__D017393
% 212.07/212.21  |- mesh__dateCreated mesh__D031065 2002-07-02
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D031065 2005
% 212.07/212.21  |- skos__prefLabel mesh__D031065 Acanthopanax
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D031065 2006
% 212.07/212.21  |- skos__scopeNote mesh__D031065
% 212.07/212.21       A plant genus of the family ARALIACEAE. Ciwujia extract, which is prepared from plants of this genus, contains ciwujianosides and is used to enhance PHYSICAL ENDURANCE.%A%    
% 212.07/212.21  |- mesh__historyNote mesh__D031065 2003   
% 212.07/212.21  |- mesh__publicMeSHNote mesh__D031065 2003   
% 212.07/212.21  |- skos__broader mesh__D031065smesh__D027481
% 212.07/212.21  |- skos__altLabel mesh__D031065 Ciwujia
% 212.07/212.21  |- skos__annotation mesh__D031065
% 212.07/212.21       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.07/212.21  |- mesh__dateEstablished mesh__D031065 2003-01-01
% 212.07/212.21  |- rdf__type mesh__D031065sskos__Concept
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D031065 2003
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D031065 2004
% 212.07/212.21  |- skos__altLabel mesh__D003374 1,2-Benzo-Pyrones
% 212.07/212.21  |- mesh__recordOriginator mesh__D003374 NLM
% 212.07/212.21  |- skos__related mesh__D003374smesh__D007202
% 212.07/212.21  |- mesh__recordAuthorizer mesh__D003374 sjn
% 212.07/212.21  |- skos__hiddenLabel mesh__D003374 Benzopyran 2 ones
% 212.07/212.21  |- mesh__dateCreated mesh__D003374 1999-01-01
% 212.07/212.21  |- skos__related mesh__D003374smesh__D000925
% 212.07/212.21  |- skos__prefLabel mesh__D003374 Coumarins
% 212.07/212.21  |- skos__altLabel mesh__D003374 Benzopyran-2-ones
% 212.07/212.21  |- skos__related mesh__D003374smesh__D011753
% 212.07/212.21  |- skos__altLabel mesh__D003374 1,2-Benzopyrones
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D003374 2006
% 212.07/212.21  |- mesh__publicMeSHNote mesh__D003374
% 212.07/212.21       89; ESCULIN was see under BIOFLAVONOIDS 1966-88   
% 212.07/212.21  |- skos__hiddenLabel mesh__D003374 1,2 Benzo Pyrones
% 212.07/212.21  |- skos__scopeNote mesh__D003374
% 212.07/212.21       Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. The various coumarins have a wide range of proposed actions and uses including as ANTICOAGULANTS, pharmaceutical aids, indicators and reagents, photoreactive substances, and ANTINEOPLASTIC AGENTS.%A%    
% 212.07/212.21  |- skos__related mesh__D003374smesh__D010592
% 212.07/212.21  |- rdf__type mesh__D003374sskos__Concept
% 212.07/212.21  |- skos__broader mesh__D003374smesh__D001578
% 212.07/212.21  |- skos__altLabel mesh__D003374 Coumarines
% 212.07/212.21  |- mesh__recordMaintainer mesh__D003374 ssb
% 212.07/212.21  |- mesh__dateRevised mesh__D003374 2005-06-30
% 212.07/212.21  |- skos__hiddenLabel mesh__D003374 1,2 Benzopyrones
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011806 1997
% 212.07/212.21  |- skos__hiddenLabel mesh__D011806 Compounds, Quinolinium
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011806 2004
% 212.07/212.21  |- mesh__dateRevised mesh__D011806 1992-05-20
% 212.07/212.21  |- mesh__recordAuthorizer mesh__D011806 PLS
% 212.07/212.21  |- mesh__historyNote mesh__D011806 68   
% 212.07/212.21  |- mesh__dateCreated mesh__D011806 1999-01-01
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011806 1996
% 212.07/212.21  |- mesh__dateEstablished mesh__D011806 1968-01-01
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011806 2003
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011806 2002
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011806 1999
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011806 1993
% 212.07/212.21  |- mesh__recordMaintainer mesh__D011806 TAP
% 212.07/212.21  |- skos__historyNote mesh__D011806 Quinolines %28%1966-1967%29%
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011806 2006
% 212.07/212.21  |- skos__annotation mesh__D011806 DF: QUINOLINIUM CPDS   
% 212.07/212.21  |- mesh__publicMeSHNote mesh__D011806 68   
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011806 1998
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011806 2005
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011806 1995
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011806 2001
% 212.07/212.21  |- rdf__type mesh__D011806sskos__Concept
% 212.07/212.21  |- mesh__recordOriginator mesh__D011806 NLM
% 212.07/212.21  |- skos__historyNote mesh__D011806 Ammonium Compounds %28%1966-1967%29%
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011806 1994
% 212.07/212.21  |- skos__prefLabel mesh__D011806 Quinolinium Compounds
% 212.07/212.21  |- skos__broader mesh__D011806smesh__D011804
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011806 2000
% 212.07/212.21  |- skos__broader mesh__D011008smesh__D013290
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011008 2001
% 212.07/212.21  |- skos__altLabel mesh__D011008 Infections, Pneumococcal
% 212.07/212.21  |- rdf__type mesh__D011008sskos__Concept
% 212.07/212.21  |- skos__hiddenLabel mesh__D011008 Infection, Pneumococcal
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011008 2000
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011008 2005
% 212.07/212.21  |- skos__scopeNote mesh__D011008
% 212.07/212.21       Infections with bacteria of the species STREPTOCOCCUS PNEUMONIAE.%A%    
% 212.07/212.21  |- skos__hiddenLabel mesh__D011008 Pneumococcal Infection
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011008 2004
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011008 1999
% 212.07/212.21  |- mesh__recordMaintainer mesh__D011008 TGC
% 212.07/212.21  |- mesh__recordOriginator mesh__D011008 NLM
% 212.07/212.21  |- skos__altLabel mesh__D011008 Streptococcus pneumoniae Infections
% 212.07/212.21  |- skos__hiddenLabel mesh__D011008 Infection, Streptococcus pneumoniae
% 212.07/212.21  |- skos__altLabel mesh__D011008 Infections, Streptococcus pneumoniae
% 212.07/212.21  |- skos__annotation mesh__D011008 DF: PNEUMOCOCCAL INFECT   
% 212.07/212.21  |- skos__hiddenLabel mesh__D011008 Streptococcus pneumoniae Infection
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011008 1998
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011008 2003
% 212.07/212.21  |- skos__hiddenLabel mesh__D011008 pneumoniae Infection, Streptococcus
% 212.07/212.21  |- mesh__recordAuthorizer mesh__D011008 SJN
% 212.07/212.21  |- skos__prefLabel mesh__D011008 Pneumococcal Infections
% 212.07/212.21  |- skos__hiddenLabel mesh__D011008 pneumoniae Infections, Streptococcus
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011008 2002
% 212.07/212.21  |- mesh__dateRevised mesh__D011008 1997-06-20
% 212.07/212.21  |- mesh__dateCreated mesh__D011008 1999-01-01
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D011008 2006
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007765 2000
% 212.07/212.21  |- skos__hiddenLabel mesh__D007765 Lacrimal Glands
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007765 2003
% 212.07/212.21  |- skos__prefLabel mesh__D007765 Lacrimal Apparatus
% 212.07/212.21  |- mesh__dateRevised mesh__D007765 1997-06-20
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007765 2006
% 212.07/212.21  |- mesh__recordMaintainer mesh__D007765 TGC
% 212.07/212.21  |- skos__scopeNote mesh__D007765
% 212.07/212.21       The tear-forming and tear-conducting system which includes the lacrimal glands, eyelid margins, conjunctival sac, and the tear drainage system.%A%    
% 212.07/212.21  |- skos__annotation mesh__D007765
% 212.07/212.21       inflammation = DACRYOCYSTITIS; lacrimation: index TEARS /secret unless LACRIMAL APPARATUS /secret or LACRIMAL APPARATUS /physiol is particularly discussed%A%  
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007765 2001
% 212.07/212.21  |- mesh__recordOriginator mesh__D007765 NLM
% 212.07/212.21  |- mesh__dateCreated mesh__D007765 1999-01-01
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007765 2004
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007765 2002
% 212.07/212.21  |- mesh__recordAuthorizer mesh__D007765 SJN
% 212.07/212.21  |- skos__related mesh__D007765smesh__D013666
% 212.07/212.21  |- skos__related mesh__D007765smesh__D003608
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007765 1998
% 212.07/212.21  |- skos__hiddenLabel mesh__D007765 Glands, Lacrimal
% 212.07/212.21  |- skos__broader mesh__D007765smesh__D005088
% 212.07/212.21  |- rdf__type mesh__D007765sskos__Concept
% 212.07/212.21  |- skos__hiddenLabel mesh__D007765 Apparatus, Lacrimal
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007765 1999
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D007765 2005
% 212.07/212.21  |- skos__broader mesh__D007765smesh__D005123
% 212.07/212.21  |- skos__hiddenLabel mesh__D007765 Gland, Lacrimal
% 212.07/212.21  |- skos__historyNote mesh__D026121 Alkaloids %28%1966-2001%29%
% 212.07/212.21  |- rdf__type mesh__D026121sskos__Concept
% 212.07/212.21  |- skos__historyNote mesh__D026121 Indoles %28%1966-2001%29%
% 212.07/212.21  |- mesh__recordOriginator mesh__D026121 ssb
% 212.07/212.21  |- mesh__recordMaintainer mesh__D026121 ssb
% 212.07/212.21  |- mesh__historyNote mesh__D026121 2002   
% 212.07/212.21  |- mesh__dateRevised mesh__D026121 2004-07-07
% 212.07/212.21  |- mesh__dateEstablished mesh__D026121 2002-01-01
% 212.07/212.21  |- skos__prefLabel mesh__D026121 Indole Alkaloids
% 212.07/212.21  |- mesh__dateCreated mesh__D026121 2001-07-25
% 212.07/212.21  |- skos__scopeNote mesh__D026121
% 212.07/212.21       Group of alkaloids containing a benzylpyrrole group %28%derived from TRYPTOPHAN%29%%A%    
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D026121 2005
% 212.07/212.21  |- skos__broader mesh__D026121smesh__D007211
% 212.07/212.21  |- mesh__publicMeSHNote mesh__D026121 2002   
% 212.07/212.21  |- mesh__recordAuthorizer mesh__D026121 sjn
% 212.07/212.21  |- skos__hiddenLabel mesh__D026121 Alkaloids, Indole
% 212.07/212.21  |- skos__annotation mesh__D026121 GEN or unspecified; prefer specifics   
% 212.07/212.21  |- skos__broader mesh__D026121smesh__D000470
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D026121 2006
% 212.07/212.21  |- mesh__runningHead mesh__D012101
% 212.07/212.21       G8 - PHYSIOLOGY-REPRODUCTIVE AND URINARY   
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D012101 2005
% 212.07/212.21  |- mesh__recordAuthorizer mesh__D012101 sjn
% 212.07/212.21  |- mesh__dateCreated mesh__D012101 1999-01-01
% 212.07/212.21  |- mesh__recordMaintainer mesh__D012101 sjn
% 212.07/212.21  |- mesh__onlineNote mesh__D012101
% 212.07/212.21       pre-explosion = REPRODUCTIVE A%23%D URINARY PHYSIOLOGY %28%PX%29%   
% 212.07/212.21  |- skos__historyNote mesh__D012101
% 212.07/212.21       Urinary Tract/physiology %28%1969-1997%29%
% 212.07/212.21  |- mesh__historyNote mesh__D012101 98; use pre-explosion 1975-97   
% 212.07/212.21  |- mesh__recordOriginator mesh__D012101 NLM
% 212.07/212.21  |- skos__prefLabel mesh__D012101 Reproductive and Urinary Physiology
% 212.07/212.21  |- skos__altLabel mesh__D012101 Physiology, Reproductive and Urinary
% 212.07/212.21  |- skos__annotation mesh__D012101
% 212.07/212.21       not used for indexing; DF: REPRODUCTIVE URINARY PHYSIOL      CATALOG: do not use%A%  
% 212.07/212.21  |- mesh__dateEstablished mesh__D012101 1998-01-01
% 212.07/212.21  |- rdf__type mesh__D012101sskos__Concept
% 212.07/212.21  |- mesh__publicMeSHNote mesh__D012101 98   
% 212.07/212.21  |- mesh__dateRevised mesh__D012101 2004-07-13
% 212.07/212.21  |- skos__scopeNote mesh__D012101
% 212.07/212.21       Physiology of the human and animal body, male or female, in the reproductive process and the physiology of the urinary tract.%A%    
% 212.07/212.21  |- skos__historyNote mesh__D012101
% 212.07/212.21       Reproduction/physiology %28%1966-1997%29%
% 212.07/212.21  |- mesh__activeMeSHYear mesh__D012101 2006
% 212.07/212.21  |- mesh__onlineNote mesh__D017395
% 212.07/212.21       use PLASMINOGEN INACTIVATORS to search PAI-1 1990-92   
% 212.07/212.21  |- skos__broader mesh__D017395smesh__D001779
% 212.07/212.21  |- skos__altLabel mesh__D017395 Type 1 Plasminogen Activator Inhibitor
% 212.07/212.21  |- mesh__recordMaintainer mesh__D017395 ssb
% 212.07/212.21  |- mesh__publicMeSHNote mesh__D017395
% 212.07/212.21       93; PAI-1 was see PLASMINOGEN INACTIVATORS 1990-92   
% 212.07/212.21  |- mesh__historyNote mesh__D017395
% 212.07/212.21       93; PAI-1 was see PLASMINOGEN INACTIVATORS 1990-92   
% 212.07/212.21  |- skos__prefLabel mesh__D017395 Plasminogen Activator Inhibitor 1
% 212.07/212.21  |- skos__annotation mesh__D017395 a serpin; DF: note short X ref   
% 212.07/212.21  |- mesh__recordAuthorizer mesh__D017395 sjn
% 212.07/212.22  |- mesh__recordOriginator mesh__D017395 TPW
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D017395 2006
% 212.07/212.22  |- mesh__dateEstablished mesh__D017395 1993-01-01
% 212.07/212.22  |- skos__historyNote mesh__D017395
% 212.07/212.22       Plasminogen Inactivators %28%1990-1992%29%
% 212.07/212.22  |- skos__altLabel mesh__D017395 PAI-1
% 212.07/212.22  |- rdf__type mesh__D017395sskos__Concept
% 212.07/212.22  |- skos__broader mesh__D017395smesh__D015849
% 212.07/212.22  |- mesh__dateCreated mesh__D017395 1992-05-22
% 212.07/212.22  |- skos__scopeNote mesh__D017395
% 212.07/212.22       A member of the serpin family of proteins. It inhibits both the tissue-type and urokinase-type plasminogen activators.%A%    
% 212.07/212.22  |- mesh__dateRevised mesh__D017395 2005-06-30
% 212.07/212.22  |- mesh__recordOriginator mesh__D050220 ags
% 212.07/212.22  |- mesh__publicMeSHNote mesh__D050220 2006   
% 212.07/212.22  |- mesh__recordMaintainer mesh__D050220 ags
% 212.07/212.22  |- mesh__historyNote mesh__D050220 2006   
% 212.07/212.22  |- mesh__dateCreated mesh__D050220 2005-06-30
% 212.07/212.22  |- skos__scopeNote mesh__D050220
% 212.07/212.22       A genus of FUNGI in the family Glugeidae, parasitic on FISHES. The PARASITES cause the formation of large cysts causing hypertrophy.%A%    
% 212.07/212.22  |- rdf__type mesh__D050220sskos__Concept
% 212.07/212.22  |- mesh__dateRevised mesh__D050220 2005-07-14
% 212.07/212.22  |- skos__historyNote mesh__D050220 Protozoa %28%1967-2005%29%
% 212.07/212.22  |- skos__annotation mesh__D050220
% 212.07/212.22       infection: coordinate IM with MICROSPORIDIOSIS %28%IM%29%; coordinate with specific fungal terms %28%ANTIGENS, FUNGAL, etc%29% if pertinent%A%  
% 212.07/212.22  |- skos__prefLabel mesh__D050220 Glugea
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D050220 2006A
% 212.07/212.22  |- mesh__recordAuthorizer mesh__D050220 ags
% 212.07/212.22  |- mesh__dateEstablished mesh__D050220 2006-01-01
% 212.07/212.22  |- skos__broader mesh__D050220smesh__D050175
% 212.07/212.22  |- skos__historyNote mesh__D050220 Microsporidia %28%1994-2005%29%
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D050220 2006
% 212.07/212.22  |- skos__scopeNote mesh__D003375
% 212.07/212.22       A daidzein derivative occurring naturally in forage crops which has some estrogenic activity.%A%    
% 212.07/212.22  |- mesh__historyNote mesh__D003375
% 212.07/212.22       91%28%75%29%; was see under COUMARINS 1975-90   
% 212.07/212.22  |- skos__broader mesh__D003375smesh__D003374
% 212.07/212.22  |- skos__historyNote mesh__D003375 Benzofurans %28%1972-1974%29%
% 212.07/212.22  |- mesh__publicMeSHNote mesh__D003375
% 212.07/212.22       91; was see under COUMARINS 1975-90   
% 212.07/212.22  |- mesh__recordMaintainer mesh__D003375 ssb
% 212.07/212.22  |- mesh__dateRevised mesh__D003375 2005-06-30
% 212.07/212.22  |- skos__broader mesh__D003375smesh__D007529
% 212.07/212.22  |- mesh__recordOriginator mesh__D003375 NLM
% 212.07/212.22  |- mesh__dateCreated mesh__D003375 1974-11-11
% 212.07/212.22  |- rdf__type mesh__D003375sskos__Concept
% 212.07/212.22  |- mesh__recordAuthorizer mesh__D003375 sjn
% 212.07/212.22  |- mesh__dateEstablished mesh__D003375 1991-01-01
% 212.07/212.22  |- skos__historyNote mesh__D003375 Coumarins %28%1972-1974%29%
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D003375 2006
% 212.07/212.22  |- skos__prefLabel mesh__D003375 Coumestrol
% 212.07/212.22  |- mesh__recordOriginator mesh__D011807 NLM
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011807 2003
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011807 1999
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011807 1993
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011807 2000
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011807 2006
% 212.07/212.22  |- mesh__dateRevised mesh__D011807 1992-05-20
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011807 1998
% 212.07/212.22  |- mesh__recordAuthorizer mesh__D011807 PLS
% 212.07/212.22  |- skos__prefLabel mesh__D011807 Quinolizines
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011807 2005
% 212.07/212.22  |- skos__broader mesh__D011807smesh__D006574
% 212.07/212.22  |- skos__annotation mesh__D011807 do not confuse with QUINOLINES   
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011807 1995
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011807 2002
% 212.07/212.22  |- rdf__type mesh__D011807sskos__Concept
% 212.07/212.22  |- mesh__recordMaintainer mesh__D011807 TAP
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011807 1994
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011807 1997
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011807 2004
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011807 2001
% 212.07/212.22  |- mesh__dateCreated mesh__D011807 1999-01-01
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011807 1996
% 212.07/212.22  |- skos__broader mesh__D011954Q000037smesh__D011954
% 212.07/212.22  |- mesh__preferredCombination mesh__D011954Q000037smesh__D018492
% 212.07/212.22  |- rdf__type mesh__D011954Q000037smesh__CompoundConcept
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011009 2002
% 212.07/212.22  |- skos__broader mesh__D011009smesh__D009784
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011009 2004
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011009 1999
% 212.07/212.22  |- mesh__publicMeSHNote mesh__D011009
% 212.07/212.22       66; BAGASSOSIS was see under PNEUMOCONIOSIS 1969-83   
% 212.07/212.22  |- mesh__recordMaintainer mesh__D011009 TGC
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011009 2001
% 212.07/212.22  |- skos__annotation mesh__D011009
% 212.07/212.22       GEN or specific for which there is no term in MeSH; do not use /chem ind for a dust causing this dis: use /etiol; TN 151: compl of pneumoconiosis; index specific pneumoconioses for which there is no MeSH term here + substance yielding dust, as pneumoconiosis in gold mining: PNEUMOCONIOSIS %28%IM%29% + GOLD %28%IM%29% + MINING %28%IM%29%; do not coord with OCCUPATIONAL DISEASES%A%  
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011009 1998
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011009 2003
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011009 2000
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011009 1997
% 212.07/212.22  |- skos__scopeNote mesh__D011009
% 212.07/212.22       Condition characterized by permanent deposition of substantial amounts of particulate matter in the lungs, usually of occupational or environmental origin, and by the tissue reaction to its presence.%A%    
% 212.07/212.22  |- skos__hiddenLabel mesh__D011009 Pneumoconioses
% 212.07/212.22  |- mesh__recordAuthorizer mesh__D011009 PLS
% 212.07/212.22  |- mesh__recordOriginator mesh__D011009 NLM
% 212.07/212.22  |- mesh__onlineNote mesh__D011009
% 212.07/212.22       use PNEUMOCONIOSIS to search BAGASSOSIS 1969-83   
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011009 1996
% 212.07/212.22  |- mesh__dateRevised mesh__D011009 1994-05-27
% 212.07/212.22  |- mesh__dateCreated mesh__D011009 1999-01-01
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011009 2006
% 212.07/212.22  |- skos__broader mesh__D011009smesh__D017563
% 212.07/212.22  |- rdf__type mesh__D011009sskos__Concept
% 212.07/212.22  |- skos__prefLabel mesh__D011009 Pneumoconiosis
% 212.07/212.22  |- mesh__historyNote mesh__D011009
% 212.07/212.22       66; BAGASSOSIS was see under PNEUMOCONIOSIS 1969-83   
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011009 1995
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011009 2005
% 212.07/212.22  |- skos__hiddenLabel mesh__D008060 Lipodystrophies
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D008060 1998
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D008060 1995
% 212.07/212.22  |- rdf__type mesh__D008060sskos__Concept
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D008060 1999
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D008060 1996
% 212.07/212.22  |- skos__prefLabel mesh__D008060 Lipodystrophy
% 212.07/212.22  |- mesh__dateCreated mesh__D008060 1999-01-01
% 212.07/212.22  |- skos__annotation mesh__D008060 atrophy of subcutaneous fat   
% 212.07/212.22  |- skos__broader mesh__D008060smesh__D012875
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D008060 1997
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D008060 2005
% 212.07/212.22  |- mesh__dateRevised mesh__D008060 1993-06-02
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D008060 2000
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D008060 2006
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D008060 2003
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D008060 2001
% 212.07/212.22  |- skos__scopeNote mesh__D008060
% 212.07/212.22       A collection of rare conditions resulting from defective fat metabolism and characterized by atrophy of the subcutaneous fat. They include total, congenital or acquired, partial, abdominal infantile, and localized lipodystrophy.%A%    
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D008060 2004
% 212.07/212.22  |- mesh__recordAuthorizer mesh__D008060 PLS
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D008060 2002
% 212.07/212.22  |- mesh__recordOriginator mesh__D008060 NLM
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D008060 1994
% 212.07/212.22  |- mesh__recordMaintainer mesh__D008060 PLS
% 212.07/212.22  |- skos__hiddenLabel mesh__D007766 Disease, Lacrimal Apparatus
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D007766 2004
% 212.07/212.22  |- mesh__publicMeSHNote mesh__D007766 76   
% 212.07/212.22  |- skos__historyNote mesh__D007766 Lacrimal Apparatus %28%1966-1975%29%
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D007766 2000
% 212.07/212.22  |- skos__broader mesh__D007766smesh__D005128
% 212.07/212.22  |- mesh__dateRevised mesh__D007766 1997-06-20
% 212.07/212.22  |- skos__prefLabel mesh__D007766 Lacrimal Apparatus Diseases
% 212.07/212.22  |- skos__hiddenLabel mesh__D007766 Apparatus Disease, Lacrimal
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D007766 2001
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D007766 1998
% 212.07/212.22  |- rdf__type mesh__D007766sskos__Concept
% 212.07/212.22  |- skos__scopeNote mesh__D007766 Diseases of the lacrimal apparatus.     
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D007766 2002
% 212.07/212.22  |- mesh__recordOriginator mesh__D007766 SMH
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D007766 1999
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D007766 2005
% 212.07/212.22  |- mesh__dateEstablished mesh__D007766 1976-01-01
% 212.07/212.22  |- mesh__recordAuthorizer mesh__D007766 SJN
% 212.07/212.22  |- skos__annotation mesh__D007766 inflamm dis = DACRYOCYSTITIS   
% 212.07/212.22  |- skos__hiddenLabel mesh__D007766 Apparatus Diseases, Lacrimal
% 212.07/212.22  |- mesh__dateCreated mesh__D007766 1975-07-25
% 212.07/212.22  |- skos__hiddenLabel mesh__D007766 Lacrimal Apparatus Disease
% 212.07/212.22  |- skos__hiddenLabel mesh__D007766 Diseases, Lacrimal Apparatus
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D007766 2006
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D007766 2003
% 212.07/212.22  |- mesh__recordMaintainer mesh__D007766 TGC
% 212.07/212.22  |- mesh__historyNote mesh__D007766 76; was NON MESH before 1976   
% 212.07/212.22  |- skos__historyNote mesh__D007766
% 212.07/212.22       specific lacrimal apparatus disease heading
% 212.07/212.22  |- mesh__historyNote mesh__D026122 2002; use TRANSGLUTAMINASE 1990-2001   
% 212.07/212.22  |- mesh__dateEstablished mesh__D026122 2002-01-01
% 212.07/212.22  |- skos__broader mesh__D026122smesh__D005176
% 212.07/212.22  |- skos__historyNote mesh__D026122 Transglutaminases %28%1990-2001%29%
% 212.07/212.22  |- skos__altLabel mesh__D026122 Fibrinoligase
% 212.07/212.22  |- skos__related mesh__D026122smesh__D005177
% 212.07/212.22  |- skos__hiddenLabel mesh__D026122 XIIIa, Factor
% 212.07/212.22  |- mesh__recordMaintainer mesh__D026122 ssb
% 212.07/212.22  |- skos__prefLabel mesh__D026122 Factor XIIIa
% 212.07/212.22  |- skos__altLabel mesh__D026122 Blood Coagulation Factor XIII, Activated
% 212.07/212.22  |- mesh__dateCreated mesh__D026122 2001-07-25
% 212.07/212.22  |- skos__altLabel mesh__D026122 Factor XIII, Activated
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D026122 2006
% 212.07/212.22  |- mesh__publicMeSHNote mesh__D026122
% 212.07/212.22       2002; see PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE 1990-2001%A%  
% 212.07/212.22  |- skos__annotation mesh__D026122
% 212.07/212.22       distinguish X ref PLASMA TRANSGLUTAMINASE from TRANSGLUTAMINASES%A%  
% 212.07/212.22  |- skos__scopeNote mesh__D026122
% 212.07/212.22       Activated form of FACTOR XIII, a transglutaminase, which stabilizes the formation of the fibrin polymer %28%clot%29% culminating the blood coagulation cascade.%A%    
% 212.07/212.22  |- skos__broader mesh__D026122smesh__D011503
% 212.07/212.22  |- skos__hiddenLabel mesh__D026122 Activated Factor XIII
% 212.07/212.22  |- rdf__type mesh__D026122sskos__Concept
% 212.07/212.22  |- mesh__recordOriginator mesh__D026122 ssb
% 212.07/212.22  |- mesh__recordAuthorizer mesh__D026122 sjn
% 212.07/212.22  |- mesh__dateRevised mesh__D026122 2005-06-30
% 212.07/212.22  |- mesh__dateCreated mesh__D012900 1999-01-01
% 212.07/212.22  |- mesh__recordMaintainer mesh__D012900 ssb
% 212.07/212.22  |- skos__broader mesh__D012900smesh__D014765
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D012900 2006
% 212.07/212.22  |- mesh__dateRevised mesh__D012900 2005-06-30
% 212.07/212.22  |- rdf__type mesh__D012900sskos__Concept
% 212.07/212.22  |- skos__hiddenLabel mesh__D012900 Vaccine, Smallpox
% 212.07/212.22  |- skos__prefLabel mesh__D012900 Smallpox Vaccine
% 212.07/212.22  |- mesh__recordAuthorizer mesh__D012900 sjn
% 212.07/212.22  |- skos__scopeNote mesh__D012900
% 212.07/212.22       A live VACCINIA VIRUS vaccine of calf lymph or chick embryo origin, used for immunization against smallpox. It is now recommended only for laboratory workers exposed to smallpox virus. Certain countries continue to vaccinate those in the military service. Complications that result from smallpox vaccination include vaccinia, secondary bacterial infections, and encephalomyelitis. %28%Dorland, 28th ed%29%%A%    
% 212.07/212.22  |- mesh__recordOriginator mesh__D012900 NLM
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D012102 2006A
% 212.07/212.22  |- mesh__publicMeSHNote mesh__D012102 98   
% 212.07/212.22  |- skos__prefLabel mesh__D012102 Reproductive Control Agents
% 212.07/212.22  |- skos__hiddenLabel mesh__D012102 Agents, Reproductive Control
% 212.07/212.22  |- mesh__recordMaintainer mesh__D012102 sjn
% 212.07/212.22  |- mesh__historyNote mesh__D012102 98; use explode 1975-97   
% 212.07/212.22  |- skos__broader mesh__D012102smesh__D045506
% 212.07/212.22  |- skos__annotation mesh__D012102 consider also REPRODUCTION /DE   
% 212.07/212.22  |- mesh__recordAuthorizer mesh__D012102 sjn
% 212.07/212.22  |- skos__broader mesh__D012102smesh__D045505
% 212.07/212.22  |- skos__hiddenLabel mesh__D012102 Control Agents, Reproductive
% 212.07/212.22  |- rdf__type mesh__D012102sskos__Concept
% 212.07/212.22  |- mesh__recordOriginator mesh__D012102 NLM
% 212.07/212.22  |- mesh__dateCreated mesh__D012102 1999-01-01
% 212.07/212.22  |- mesh__dateEstablished mesh__D012102 1998-01-01
% 212.07/212.22  |- skos__scopeNote mesh__D012102
% 212.07/212.22       Substances used either in the prevention or facilitation of pregnancy.%A%    
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D012102 2006
% 212.07/212.22  |- mesh__dateRevised mesh__D012102 2005-08-15
% 212.07/212.22  |- rdf__type mesh__D017396sskos__Concept
% 212.07/212.22  |- skos__historyNote mesh__D017396
% 212.07/212.22       Plasminogen Inactivators %28%1990-1992%29%
% 212.07/212.22  |- mesh__recordMaintainer mesh__D017396 ssb
% 212.07/212.22  |- skos__annotation mesh__D017396 a serpin; DF: note short X ref   
% 212.07/212.22  |- mesh__onlineNote mesh__D017396
% 212.07/212.22       use PLASMINOGEN INACTIVATORS to search PAI-2 1990-92   
% 212.07/212.22  |- skos__altLabel mesh__D017396 PAI-2
% 212.07/212.22  |- skos__altLabel mesh__D017396 Type 2 Plasminogen Activator Inhibitor
% 212.07/212.22  |- skos__prefLabel mesh__D017396 Plasminogen Activator Inhibitor 2
% 212.07/212.22  |- mesh__publicMeSHNote mesh__D017396
% 212.07/212.22       93; PAI-2 was see PLASMINOGEN INACTIVATORS 1990-92   
% 212.07/212.22  |- mesh__dateRevised mesh__D017396 2005-06-30
% 212.07/212.22  |- mesh__recordOriginator mesh__D017396 TPW
% 212.07/212.22  |- mesh__dateCreated mesh__D017396 1992-05-22
% 212.07/212.22  |- skos__scopeNote mesh__D017396
% 212.07/212.22       Member of the serpin family of proteins. It inhibits both the tissue-type and urokinase-type plasminogen activators.%A%    
% 212.07/212.22  |- mesh__recordAuthorizer mesh__D017396 sjn
% 212.07/212.22  |- mesh__historyNote mesh__D017396
% 212.07/212.22       93; PAI-2 was see PLASMINOGEN INACTIVATORS 1990-92   
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D017396 2006
% 212.07/212.22  |- skos__broader mesh__D017396smesh__D001779
% 212.07/212.22  |- skos__broader mesh__D017396smesh__D015849
% 212.07/212.22  |- mesh__dateEstablished mesh__D017396 1993-01-01
% 212.07/212.22  |- mesh__dateEstablished mesh__D003376 1966-01-01
% 212.07/212.22  |- skos__prefLabel mesh__D003376 Counseling
% 212.07/212.22  |- skos__related mesh__D003376smesh__D014830
% 212.07/212.22  |- rdf__type mesh__D003376sskos__Concept
% 212.07/212.22  |- skos__broader mesh__D003376smesh__D008605
% 212.07/212.22  |- mesh__dateRevised mesh__D003376 2002-07-03
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D003376 2005
% 212.07/212.22  |- mesh__dateCreated mesh__D003376 1999-01-01
% 212.07/212.22  |- skos__hiddenLabel mesh__D003376 Counselor
% 212.07/212.22  |- mesh__historyNote mesh__D003376 66%28%64%29%   
% 212.07/212.22  |- mesh__recordOriginator mesh__D003376 NLM
% 212.07/212.22  |- skos__broader mesh__D003376smesh__D011585
% 212.07/212.22  |- skos__annotation mesh__D003376 GEN; prefer specifics   
% 212.07/212.22  |- mesh__recordAuthorizer mesh__D003376 sjn
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D003376 2003
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D003376 2006
% 212.07/212.22  |- skos__scopeNote mesh__D003376
% 212.07/212.22       The giving of advice and assistance to individuals with educational or personal problems.%A%    
% 212.07/212.22  |- mesh__publicMeSHNote mesh__D003376 66   
% 212.07/212.22  |- skos__broader mesh__D003376smesh__D003153
% 212.07/212.22  |- mesh__recordMaintainer mesh__D003376 hjn
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D003376 2004
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011808 2006A
% 212.07/212.22  |- skos__prefLabel mesh__D011808 Quinone Reductases
% 212.07/212.22  |- skos__hiddenLabel mesh__D011808 Reductases, Quinone
% 212.07/212.22  |- rdf__type mesh__D011808sskos__Concept
% 212.07/212.22  |- skos__historyNote mesh__D011808 Vitamin K %28%1973-1974%29%
% 212.07/212.22  |- skos__historyNote mesh__D011808
% 212.07/212.22       NADH, NADPH Oxidoreductases %28%1973-1974%29%
% 212.07/212.22  |- mesh__dateEstablished mesh__D011808 1986-01-01
% 212.07/212.22  |- mesh__historyNote mesh__D011808
% 212.07/212.22       86%28%75%29%; was see under NADH, NADPH OXIDOREDUCTASES 1975-85%A%  
% 212.07/212.22  |- mesh__dateCreated mesh__D011808 1974-11-19
% 212.07/212.22  |- skos__hiddenLabel mesh__D011808 Reductases, Menaquinone
% 212.07/212.22  |- mesh__publicMeSHNote mesh__D011808
% 212.07/212.22       86; was see under NADH, NADPH OXIDOREDUCTASES 1975-85   
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011808 2004
% 212.07/212.22  |- mesh__recordOriginator mesh__D011808 NLM
% 212.07/212.22  |- skos__broader mesh__D011808smesh__D009247
% 212.07/212.22  |- skos__scopeNote mesh__D011808
% 212.07/212.22       NAD%28%P%29%H:%28%quinone acceptor%29% oxidoreductases. A family that includes three enzymes which are distinguished by their sensitivity to various inhibitors. EC 1.6.99.2 %28%NAD%28%P%29%H DEHYDROGENASE %28%QUINONE%29%;%29% is a flavoprotein which reduces various quinones in the presence of NADH or NADPH and is inhibited by dicoumarol. EC 1.6.99.5 %28%NADH dehydrogenase %28%quinone%29%%29% requires NADH, is inhibited by AMP and 2,4-dinitrophenol but not by dicoumarol or folic acid derivatives. EC 1.6.99.6 %28%NADPH dehydrogenase %28%quinone%29%%29% requires NADPH and is inhibited by dicoumarol and folic acid derivatives but not by 2,4-dinitrophenol.%A%    
% 212.07/212.22  |- mesh__dateRevised mesh__D011808 2005-07-15
% 212.07/212.22  |- mesh__recordMaintainer mesh__D011808 ags
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011808 2006
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D011808 2005
% 212.07/212.22  |- mesh__recordAuthorizer mesh__D011808 ags
% 212.07/212.22  |- rdf__type mesh__D008061sskos__Concept
% 212.07/212.22  |- skos__hiddenLabel mesh__D008061 Disease, Whipple%27%s
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D008061 2006A
% 212.07/212.22  |- mesh__dateCreated mesh__D008061 1999-01-01
% 212.07/212.22  |- mesh__recordOriginator mesh__D008061 NLM
% 212.07/212.22  |- skos__broader mesh__D008061smesh__D008286
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D008061 2005
% 212.07/212.22  |- mesh__publicMeSHNote mesh__D008061
% 212.07/212.22       2004; see WHIPPLE%27%S DISEASE 1996-2003, see LIPODYSTROPHY, INTESTINAL 1963-1995%A%  
% 212.07/212.22  |- skos__prefLabel mesh__D008061 Whipple Disease
% 212.07/212.22  |- mesh__recordMaintainer mesh__D008061 ags
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D008061 2006
% 212.07/212.22  |- mesh__dateRevised mesh__D008061 2005-07-18
% 212.07/212.22  |- skos__hiddenLabel mesh__D008061 Intestinal Lipodystrophy
% 212.07/212.22  |- skos__altLabel mesh__D008061 Lipodystrophy, Intestinal
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D008061 2004
% 212.07/212.22  |- skos__hiddenLabel mesh__D008061 Whipples Disease
% 212.07/212.22  |- skos__hiddenLabel mesh__D008061 Disease, Whipple
% 212.07/212.22  |- skos__altLabel mesh__D008061 Whipple%27%s Disease
% 212.07/212.22  |- mesh__historyNote mesh__D008061
% 212.07/212.22       2004 %28%1996%29%; use LIPODYSTROPHY, INTESTINAL 1963-1995   
% 212.07/212.22  |- skos__broader mesh__D008061smesh__D000196
% 212.07/212.22  |- mesh__recordAuthorizer mesh__D008061 ags
% 212.07/212.22  |- skos__scopeNote mesh__D008061
% 212.07/212.22       A chronic systemic infection by a gram-positive bacterium, Tropheryma whippelii, mainly affecting the SMALL INTESTINE but also the JOINTS; CARDIOVASCULAR SYSTEM; and the CENTRAL NERVOUS SYSTEM. The disease is characterized by fat deposits in the INTESTINAL MUCOSA and LYMPH NODES, malabsorption, DIARRHEA with fatty stools, MALNUTRITION, and ARTHRITIS.%A%    
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D007767 1998
% 212.07/212.22  |- rdf__type mesh__D007767sskos__Concept
% 212.07/212.22  |- mesh__recordAuthorizer mesh__D007767 SJN
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D007767 1999
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D007767 2005
% 212.07/212.22  |- skos__hiddenLabel mesh__D007767 Duct Obstructions, Lacrimal
% 212.07/212.22  |- skos__prefLabel mesh__D007767 Lacrimal Duct Obstruction
% 212.07/212.22  |- skos__broader mesh__D007767smesh__D007766
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D007767 2006
% 212.07/212.22  |- skos__hiddenLabel mesh__D007767 Lacrimal Duct Obstructions
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D007767 2003
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D007767 2000
% 212.07/212.22  |- skos__scopeNote mesh__D007767
% 212.07/212.22       Interference with the secretion of tears by the lacrimal glands. Obstruction of the lacrimal sac or nasolacrimal duct causing acute or chronic inflammation of the lacrimal sac %28%DACRYOCYSTITIS%29%. It is caused also in infants by failure of the nasolacrimal duct to open into the inferior meatus and occurs about the third week of life. In adults occlusion may occur spontaneously or after injury or nasal disease. %28%Newell, Ophthalmology: Principles and Concepts, 7th ed, p250%29%%A%    
% 212.07/212.22  |- mesh__dateCreated mesh__D007767 1999-01-01
% 212.07/212.22  |- mesh__dateRevised mesh__D007767 1997-06-20
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D007767 2004
% 212.07/212.22  |- skos__hiddenLabel mesh__D007767 Obstruction, Lacrimal Duct
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D007767 2001
% 212.07/212.22  |- skos__hiddenLabel mesh__D007767 Obstructions, Lacrimal Duct
% 212.07/212.22  |- skos__hiddenLabel mesh__D007767 Duct Obstruction, Lacrimal
% 212.07/212.22  |- mesh__recordOriginator mesh__D007767 NLM
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D007767 2002
% 212.07/212.22  |- mesh__recordMaintainer mesh__D007767 TPW
% 212.07/212.22  |- mesh__dateRevised mesh__D026921 2005-07-07
% 212.07/212.22  |- skos__altLabel mesh__D026921 Neutral Amino Acid Transport Proteins
% 212.07/212.22  |- skos__altLabel mesh__D026921
% 212.07/212.22       Sodium Independent Neutral Amino Acid Transport Proteins
% 212.07/212.22  |- skos__hiddenLabel mesh__D026921
% 212.07/212.22       Na+ Independent Neutral Amino Acid Transporter
% 212.07/212.22  |- mesh__publicMeSHNote mesh__D026921
% 212.07/212.22       2002;  NA+-INDEPENDENT NEUTRAL AMINO ACID TRANSPORTER was indexed under CARRIER PROTEINS 1992-2001%A%  
% 212.07/212.22  |- skos__altLabel mesh__D026921 Neutral Amino Acid Transport Systems
% 212.07/212.22  |- skos__altLabel mesh__D026921
% 212.07/212.22       Na+-Independent Neutral Amino Acid Transporter
% 212.07/212.22  |- skos__historyNote mesh__D026921 Carrier Proteins %28%1992-2001%29%
% 212.07/212.22  |- skos__scopeNote mesh__D026921
% 212.07/212.22       Amino acid transporter systems capable of transporting neutral amino acids %28%AMINO ACIDS, NEUTRAL%29%.%A%    
% 212.07/212.22  |- skos__altLabel mesh__D026921 Zwitterionic Amino Acid Transporters
% 212.07/212.22  |- mesh__recordMaintainer mesh__D026921 ags
% 212.07/212.22  |- mesh__recordOriginator mesh__D026921 jmp
% 212.07/212.22  |- mesh__recordAuthorizer mesh__D026921 ags
% 212.07/212.22  |- mesh__dateEstablished mesh__D026921 2002-01-01
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D026921 2006A
% 212.07/212.22  |- skos__altLabel mesh__D026921
% 212.07/212.22       Sodium Dependent Neutral Amino Acid Transport Proteins
% 212.07/212.22  |- skos__altLabel mesh__D026921 Neutral Amino Acid Transporters
% 212.07/212.22  |- rdf__type mesh__D026921sskos__Concept
% 212.07/212.22  |- skos__broader mesh__D026921smesh__D026905
% 212.07/212.22  |- skos__altLabel mesh__D026921 Zwitterionic Amino Acid Transport Systems
% 212.07/212.22  |- mesh__dateCreated mesh__D026921 2001-07-25
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D026921 2006
% 212.07/212.22  |- skos__altLabel mesh__D026921 Zwitterionic Amino Acid Transport Proteins
% 212.07/212.22  |- mesh__historyNote mesh__D026921
% 212.07/212.22       2002; for NA+-INDEPENDENT NEUTRAL AMINO ACID TRANSPORTER use AMINO ACID TRANSPORT SYSTEMS 1992-2001%A%  
% 212.07/212.22  |- skos__prefLabel mesh__D026921 Amino Acid Transport Systems, Neutral
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D012901 2006
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D012901 2003
% 212.07/212.22  |- skos__hiddenLabel mesh__D012901 Variola viruses
% 212.07/212.22  |- mesh__recordAuthorizer mesh__D012901 sjn
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D012901 2005
% 212.07/212.22  |- mesh__dateRevised mesh__D012901 2001-07-25
% 212.07/212.22  |- rdf__type mesh__D012901sskos__Concept
% 212.07/212.22  |- mesh__recordOriginator mesh__D012901 NLM
% 212.07/212.22  |- skos__altLabel mesh__D012901 Smallpox Virus
% 212.07/212.22  |- mesh__recordMaintainer mesh__D012901 ags
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D012901 2002
% 212.07/212.22  |- skos__prefLabel mesh__D012901 Variola virus
% 212.07/212.22  |- skos__hiddenLabel mesh__D012901 Smallpox Viruses
% 212.07/212.22  |- mesh__dateCreated mesh__D012901 1999-01-01
% 212.07/212.22  |- skos__broader mesh__D012901smesh__D018155
% 212.07/212.22  |- skos__annotation mesh__D012901 infection = SMALLPOX   
% 212.07/212.22  |- mesh__historyNote mesh__D012901
% 212.07/212.22       94; was SMALLPOX VIRUS 1963-93; VARIOLA VIRUS was see SMALLPOX VIRUS 1975-93%A%  
% 212.07/212.22  |- mesh__onlineNote mesh__D012901
% 212.07/212.22       use VARIOLA VIRUS to search SMALLPOX VIRUS 1966-93   
% 212.07/212.22  |- mesh__publicMeSHNote mesh__D012901
% 212.07/212.22       94; was SMALLPOX VIRUS 1963-93; VARIOLA VIRUS was see SMALLPOX VIRUS 1975-93%A%  
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D012901 2004
% 212.07/212.22  |- skos__altLabel mesh__D012901 Poxvirus variolae
% 212.07/212.22  |- skos__scopeNote mesh__D012901
% 212.07/212.22       A species of ORTHOPOXVIRUS causing infections in humans. No infections have been reported since 1977 and the virus is now believed to be virtually extinct.%A%    
% 212.07/212.22  |- skos__broader mesh__D012103smesh__D003435
% 212.07/212.22  |- skos__historyNote mesh__D012103 Venoms %28%1969-1974%29%
% 212.07/212.22  |- mesh__dateEstablished mesh__D012103 1991-01-01
% 212.07/212.22  |- skos__altLabel mesh__D012103 Serono Brand of Batroxobin
% 212.07/212.22  |- skos__scopeNote mesh__D012103
% 212.07/212.22       A proteolytic enzyme obtained from the venom of fer-de-lance %28%Bothrops atrox%29%. It is used as a plasma clotting agent for fibrinogen and for the detection of fibrinogen degradation products. The presence of heparin does not interfere with the clotting test. Hemocoagulase is a mixture containing batroxobin and factor X activator. EC 3.4.21.-.%A%    
% 212.07/212.22  |- skos__historyNote mesh__D012103 Peptide Hydrolases %28%1969-1974%29%
% 212.07/212.22  |- rdf__type mesh__D012103sskos__Concept
% 212.07/212.22  |- mesh__recordMaintainer mesh__D012103 ssb
% 212.07/212.22  |- skos__historyNote mesh__D012103 Snakes %28%1969-1974%29%
% 212.07/212.22  |- skos__hiddenLabel mesh__D012103 Batroxobin Serono Brand
% 212.07/212.22  |- mesh__publicMeSHNote mesh__D012103
% 212.07/212.22       2000; see REPTILASE 1991-1999; see SERINE PROTEINASES 1975-1990; for BATROXOBIN see REPTILASE 1982-199; PLASMOCOAGULASE was indexed under COAGULASE 1979-1999%A%  
% 212.07/212.22  |- skos__hiddenLabel mesh__D012103 Reptilase DEF
% 212.07/212.22  |- skos__prefLabel mesh__D012103 Batroxobin
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D012103 2006
% 212.07/212.22  |- mesh__dateRevised mesh__D012103 2005-06-30
% 212.07/212.22  |- mesh__recordAuthorizer mesh__D012103 sjn
% 212.07/212.22  |- skos__broader mesh__D012103smesh__D020791
% 212.07/212.22  |- mesh__historyNote mesh__D012103
% 212.07/212.22       2000%28%1975%29%; for PLASMOCOAGULASE use BATROXOBIN %28%NM%29% 1979-1999%A%  
% 212.07/212.22  |- skos__altLabel mesh__D012103 Defibrol
% 212.07/212.22  |- mesh__dateCreated mesh__D012103 1974-11-11
% 212.07/212.22  |- mesh__recordOriginator mesh__D012103 NLM
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D017397 2003
% 212.07/212.22  |- skos__broader mesh__D017397smesh__D005625
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D017397 2000
% 212.07/212.22  |- mesh__dateEstablished mesh__D017397 1993-01-01
% 212.07/212.22  |- mesh__recordOriginator mesh__D017397 AGS
% 212.07/212.22  |- mesh__dateRevised mesh__D017397 1998-06-10
% 212.07/212.22  |- skos__prefLabel mesh__D017397 Prefrontal Cortex
% 212.07/212.22  |- skos__annotation mesh__D017397
% 212.07/212.22       %22%rostral part of the frontal lobe%22%   
% 212.07/212.22  |- mesh__publicMeSHNote mesh__D017397 93   
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D017397 2006
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D017397 1999
% 212.07/212.22  |- skos__hiddenLabel mesh__D017397 Cortex, Prefrontal
% 212.07/212.22  |- skos__historyNote mesh__D017397 Frontal Lobe %28%1966-1992%29%
% 212.07/212.22  |- mesh__recordAuthorizer mesh__D017397 SJN
% 212.07/212.22  |- mesh__activeMeSHYear mesh__D017397 2005
% 212.07/212.22  |- mesh__dateCreated mesh__D017397 1992-05-22
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D017397 2002
% 212.07/212.23  |- rdf__type mesh__D017397sskos__Concept
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D017397 2004
% 212.07/212.23  |- mesh__historyNote mesh__D017397 93   
% 212.07/212.23  |- mesh__recordMaintainer mesh__D017397 MSR
% 212.07/212.23  |- skos__scopeNote mesh__D017397
% 212.07/212.23       The rostral part of the frontal lobe, bounded by the inferior precentral fissure in humans, which receives projection fibers from the mediodorsal nucleus of the thalamus. The prefrontal cortex receives afferent fibers from numerous structures of the diencephalon, mesencephalon, and limbic system as well as cortical afferents of visual, auditory, and somatic origin.%A%    
% 212.07/212.23  |- skos__historyNote mesh__D017397 Cerebral Cortex %28%1966-1992%29%
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D017397 2001
% 212.07/212.23  |- mesh__recordAuthorizer mesh__D003377 sjn
% 212.07/212.23  |- mesh__historyNote mesh__D003377 67%28%64%29%   
% 212.07/212.23  |- skos__prefLabel mesh__D003377 Countercurrent Distribution
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D003377 2003
% 212.07/212.23  |- mesh__recordOriginator mesh__D003377 NLM
% 212.07/212.23  |- skos__altLabel mesh__D003377 Countercurrent Chromatography
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D003377 2005
% 212.07/212.23  |- mesh__dateEstablished mesh__D003377 1967-01-01
% 212.07/212.23  |- mesh__publicMeSHNote mesh__D003377 67   
% 212.07/212.23  |- mesh__dateCreated mesh__D003377 1999-01-01
% 212.07/212.23  |- rdf__type mesh__D003377sskos__Concept
% 212.07/212.23  |- skos__scopeNote mesh__D003377
% 212.07/212.23       A method of separation of two or more substances by repeated distribution between two immiscible liquid phases that move past each other in opposite directions. It is a form of liquid-liquid chromatography. %28%Stedman, 25th ed%29%%A%    
% 212.07/212.23  |- skos__broader mesh__D003377smesh__D002623
% 212.07/212.23  |- skos__altLabel mesh__D003377 Chromatography, Countercurrent
% 212.07/212.23  |- skos__hiddenLabel mesh__D003377 Distribution, Countercurrent
% 212.07/212.23  |- mesh__dateRevised mesh__D003377 2002-07-03
% 212.07/212.23  |- skos__broader mesh__D003377smesh__D002853
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D003377 2004
% 212.07/212.23  |- mesh__recordMaintainer mesh__D003377 lkt
% 212.07/212.23  |- skos__annotation mesh__D003377 NIM   
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D003377 2006
% 212.07/212.23  |- mesh__dateRevised mesh__D011809 2003-07-09
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D011809 2004
% 212.07/212.23  |- mesh__dateCreated mesh__D011809 1999-01-01
% 212.07/212.23  |- skos__scopeNote mesh__D011809
% 212.07/212.23       Hydrocarbon rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.%A%    
% 212.07/212.23  |- skos__prefLabel mesh__D011809 Quinones
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D011809 2006
% 212.07/212.23  |- mesh__recordOriginator mesh__D011809 NLM
% 212.07/212.23  |- mesh__recordAuthorizer mesh__D011809 sjn
% 212.07/212.23  |- skos__annotation mesh__D011809
% 212.07/212.23       coord with specific hydrocarbon structure if pertinent   
% 212.07/212.23  |- skos__broader mesh__D011809smesh__D009930
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D011809 2005
% 212.07/212.23  |- mesh__recordMaintainer mesh__D011809 ssb
% 212.07/212.23  |- rdf__type mesh__D011809sskos__Concept
% 212.07/212.23  |- skos__altLabel mesh__D008860 Ultraviolet Microscopy
% 212.07/212.23  |- rdf__type mesh__D008860sskos__Concept
% 212.07/212.23  |- skos__hiddenLabel mesh__D008860 Ultraviolet Microscopies
% 212.07/212.23  |- skos__historyNote mesh__D008860 Ultraviolet Rays %28%1966-1972%29%
% 212.07/212.23  |- skos__historyNote mesh__D008860 Microscopy %28%1966-1972%29%
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D008860 2005
% 212.07/212.23  |- mesh__publicMeSHNote mesh__D008860 73   
% 212.07/212.23  |- skos__prefLabel mesh__D008860 Microscopy, Ultraviolet
% 212.07/212.23  |- mesh__historyNote mesh__D008860 73   
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D008860 2006
% 212.07/212.23  |- skos__annotation mesh__D008860 NIM   
% 212.07/212.23  |- skos__scopeNote mesh__D008860
% 212.07/212.23       Microscopy in which the image is formed by ultraviolet radiation and is displayed and recorded by means of photographic film.%A%    
% 212.07/212.23  |- mesh__recordAuthorizer mesh__D008860 sjn
% 212.07/212.23  |- mesh__recordOriginator mesh__D008860 NLM
% 212.07/212.23  |- mesh__dateEstablished mesh__D008860 1973-01-01
% 212.07/212.23  |- skos__broader mesh__D008860smesh__D008853
% 212.07/212.23  |- mesh__dateCreated mesh__D008860 1999-01-01
% 212.07/212.23  |- mesh__recordMaintainer mesh__D008860 nns
% 212.07/212.23  |- skos__hiddenLabel mesh__D008860 Microscopies, Ultraviolet
% 212.07/212.23  |- mesh__dateRevised mesh__D008860 2004-07-07
% 212.07/212.23  |- skos__historyNote mesh__D008062 Lipids %28%1972-1974%29%
% 212.07/212.23  |- rdf__type mesh__D008062sskos__Concept
% 212.07/212.23  |- mesh__dateRevised mesh__D008062 2005-06-30
% 212.07/212.23  |- skos__historyNote mesh__D008062 Pigments %28%1972-1974%29%
% 212.07/212.23  |- mesh__historyNote mesh__D008062
% 212.07/212.23       91%28%75%29%; was see under PIGMENTS 1975-90   
% 212.07/212.23  |- skos__broader mesh__D008062smesh__D008055
% 212.07/212.23  |- skos__annotation mesh__D008062 a lipid pigment   
% 212.07/212.23  |- skos__scopeNote mesh__D008062
% 212.07/212.23       A naturally occurring lipid pigment with histochemical characteristics similar to ceroid. It accumulates in various normal tissues and apparently increases in quantity with age.%A%    
% 212.07/212.23  |- mesh__dateCreated mesh__D008062 1974-11-19
% 212.07/212.23  |- mesh__dateEstablished mesh__D008062 1991-01-01
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D008062 2006
% 212.07/212.23  |- mesh__recordOriginator mesh__D008062 NLM
% 212.07/212.23  |- skos__prefLabel mesh__D008062 Lipofuscin
% 212.07/212.23  |- mesh__recordAuthorizer mesh__D008062 sjn
% 212.07/212.23  |- mesh__publicMeSHNote mesh__D008062 91; was see under PIGMENTS 1975-90   
% 212.07/212.23  |- mesh__recordMaintainer mesh__D008062 ssb
% 212.07/212.23  |- skos__broader mesh__D008062smesh__D010860
% 212.07/212.23  |- skos__hiddenLabel mesh__D007768 A, alpha-Lactalbumin
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D007768 1999
% 212.07/212.23  |- mesh__recordOriginator mesh__D007768 NLM
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D007768 1996
% 212.07/212.23  |- skos__broader mesh__D007768smesh__D000418
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D007768 2005
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D007768 2002
% 212.07/212.23  |- skos__prefLabel mesh__D007768 Lactalbumin
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D007768 1997
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D007768 2006
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D007768 2003
% 212.07/212.23  |- skos__hiddenLabel mesh__D007768 C, alpha-Lactalbumin
% 212.07/212.23  |- mesh__dateRevised mesh__D007768 1992-05-18
% 212.07/212.23  |- mesh__dateCreated mesh__D007768 1999-01-01
% 212.07/212.23  |- skos__hiddenLabel mesh__D007768 alpha Lactalbumin
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D007768 2004
% 212.07/212.23  |- skos__hiddenLabel mesh__D007768 B, alpha-Lactalbumin
% 212.07/212.23  |- mesh__recordAuthorizer mesh__D007768 PLS
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D007768 1994
% 212.07/212.23  |- mesh__recordMaintainer mesh__D007768 TAP
% 212.07/212.23  |- skos__hiddenLabel mesh__D007768 alpha Lactalbumin C
% 212.07/212.23  |- mesh__onlineNote mesh__D007768 search ALBUMINS 1966-72   
% 212.07/212.23  |- skos__broader mesh__D007768smesh__D008894
% 212.07/212.23  |- mesh__publicMeSHNote mesh__D007768 73; was see under ALBUMINS 1963-72   
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D007768 1995
% 212.07/212.23  |- skos__hiddenLabel mesh__D007768 alpha Lactalbumin A
% 212.07/212.23  |- skos__annotation mesh__D007768 a milk protein   
% 212.07/212.23  |- mesh__dateEstablished mesh__D007768 1973-01-01
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D007768 2000
% 212.07/212.23  |- rdf__type mesh__D007768sskos__Concept
% 212.07/212.23  |- skos__hiddenLabel mesh__D007768 alpha Lactalbumin B
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D007768 1998
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D007768 1993
% 212.07/212.23  |- mesh__historyNote mesh__D007768 73; was see under ALBUMINS 1963-72   
% 212.07/212.23  |- skos__historyNote mesh__D007768 Albumins %28%1966-1972%29%
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D007768 2001
% 212.07/212.23  |- skos__annotation mesh__D018490
% 212.07/212.23       GEN or unspecified; prefer specific groups or specific drugs%A%  
% 212.07/212.23  |- skos__scopeNote mesh__D018490
% 212.07/212.23       Drugs used for their effects on serotonergic systems. Among these are drugs that affect serotonin receptors, the life cycle of serotonin, and the survival of serotonergic neurons.%A%    
% 212.07/212.23  |- skos__prefLabel mesh__D018490 Serotonin Agents
% 212.07/212.23  |- skos__hiddenLabel mesh__D018490 Agents, Serotonin
% 212.07/212.23  |- mesh__recordAuthorizer mesh__D018490 sjn
% 212.07/212.23  |- skos__altLabel mesh__D018490 Serotonin Drugs
% 212.07/212.23  |- skos__hiddenLabel mesh__D018490 Drugs, Serotonin
% 212.07/212.23  |- skos__historyNote mesh__D018490 Serotonin/pharmacology %28%1966-1994%29%
% 212.07/212.23  |- mesh__dateRevised mesh__D018490 2005-06-30
% 212.07/212.23  |- skos__broader mesh__D018490smesh__D018377
% 212.07/212.23  |- skos__hiddenLabel mesh__D018490 Drugs, Serotonergic
% 212.07/212.23  |- mesh__recordMaintainer mesh__D018490 ssb
% 212.07/212.23  |- skos__hiddenLabel mesh__D018490 Agents, Serotonergic
% 212.07/212.23  |- skos__altLabel mesh__D018490 Serotonergic Agents
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D018490 2006
% 212.07/212.23  |- mesh__dateCreated mesh__D018490 1994-06-03
% 212.07/212.23  |- mesh__publicMeSHNote mesh__D018490 95   
% 212.07/212.23  |- mesh__dateEstablished mesh__D018490 1995-01-01
% 212.07/212.23  |- mesh__historyNote mesh__D018490
% 212.07/212.23       95; SEROTONIN NEURON AGENTS %28%NON MESH%29% was heading 1995   
% 212.07/212.23  |- skos__altLabel mesh__D018490 Serotonergic Drugs
% 212.07/212.23  |- mesh__recordOriginator mesh__D018490 TPW
% 212.07/212.23  |- rdf__type mesh__D018490sskos__Concept
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D032161 2006
% 212.07/212.23  |- mesh__dateRevised mesh__D032161 2003-07-22
% 212.07/212.23  |- skos__annotation mesh__D032161
% 212.07/212.23       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D032161 2005
% 212.07/212.23  |- mesh__publicMeSHNote mesh__D032161 2003   
% 212.07/212.23  |- rdf__type mesh__D032161sskos__Concept
% 212.07/212.23  |- skos__altLabel mesh__D032161 Snapdragon
% 212.07/212.23  |- skos__prefLabel mesh__D032161 Antirrhinum
% 212.07/212.23  |- mesh__recordAuthorizer mesh__D032161 sjn
% 212.07/212.23  |- mesh__dateCreated mesh__D032161 2002-07-02
% 212.07/212.23  |- mesh__recordOriginator mesh__D032161 ssb
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D032161 2004
% 212.07/212.23  |- mesh__historyNote mesh__D032161 2003   
% 212.07/212.23  |- skos__broader mesh__D032161smesh__D028083
% 212.07/212.23  |- mesh__dateEstablished mesh__D032161 2003-01-01
% 212.07/212.23  |- mesh__recordMaintainer mesh__D032161 sjn
% 212.07/212.23  |- skos__scopeNote mesh__D032161
% 212.07/212.23       A plant genus of the family SCROPHULARIACEAE. Members contain DEFICIENS PROTEIN.%A%    
% 212.07/212.23  |- skos__altLabel mesh__D026922 Anionic Amino Acid Transporters
% 212.07/212.23  |- skos__altLabel mesh__D026922 Anionic Amino Acid Transport Proteins
% 212.07/212.23  |- skos__altLabel mesh__D026922 Acidic Amino Acid Transport Systems
% 212.07/212.23  |- mesh__recordAuthorizer mesh__D026922 sjn
% 212.07/212.23  |- skos__prefLabel mesh__D026922 Amino Acid Transport Systems, Acidic
% 212.07/212.23  |- skos__scopeNote mesh__D026922
% 212.07/212.23       Amino acid transporter systems capable of transporting acidic amino acids %28%AMINO ACIDS, ACIDIC%29%.%A%    
% 212.07/212.23  |- mesh__historyNote mesh__D026922 2002   
% 212.07/212.23  |- skos__altLabel mesh__D026922 Amino Acid Transport Systems, Anionic
% 212.07/212.23  |- mesh__recordMaintainer mesh__D026922 SYSTEM
% 212.07/212.23  |- rdf__type mesh__D026922sskos__Concept
% 212.07/212.23  |- skos__broader mesh__D026922smesh__D026905
% 212.07/212.23  |- mesh__recordOriginator mesh__D026922 jmp
% 212.07/212.23  |- skos__historyNote mesh__D026922 Carrier Proteins %28%1981-2001%29%
% 212.07/212.23  |- skos__altLabel mesh__D026922 Acidic Amino Acid Transporters
% 212.07/212.23  |- skos__altLabel mesh__D026922 Anionic Amino Acid Transport Systems
% 212.07/212.23  |- mesh__dateEstablished mesh__D026922 2002-01-01
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D026922 2006
% 212.07/212.23  |- skos__altLabel mesh__D026922 Acidic Amino Acid Transport Proteins
% 212.07/212.23  |- mesh__dateCreated mesh__D026922 2001-07-25
% 212.07/212.23  |- mesh__publicMeSHNote mesh__D026922 2002   
% 212.07/212.23  |- mesh__dateRevised mesh__D026922 2005-06-30
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D004470 2004
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D004470 2001
% 212.07/212.23  |- skos__related mesh__D004470smesh__D009817
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D004470 2000
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D004470 2005
% 212.07/212.23  |- rdf__type mesh__D004470sskos__Concept
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D004470 2003
% 212.07/212.23  |- skos__annotation mesh__D004470
% 212.07/212.23       GEN or unspecified only: prefer /econ with specific subject: Manual 19.8.27; DF: ECON MED%A%  
% 212.07/212.23  |- skos__prefLabel mesh__D004470 Economics, Medical
% 212.07/212.23  |- mesh__recordOriginator mesh__D004470 NLM
% 212.07/212.23  |- mesh__dateRevised mesh__D004470 1999-11-03
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D004470 2002
% 212.07/212.23  |- mesh__recordMaintainer mesh__D004470 kle
% 212.07/212.23  |- skos__scopeNote mesh__D004470
% 212.07/212.23       Economic aspects of the field of medicine, the medical profession, and health care. It includes the economic and financial impact of disease in general on the patient, the physician, society, or government.%A%    
% 212.07/212.23  |- mesh__recordAuthorizer mesh__D004470 sjn
% 212.07/212.23  |- skos__broader mesh__D004470smesh__D004467
% 212.07/212.23  |- skos__altLabel mesh__D004470 Medical Economics
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D004470 2006
% 212.07/212.23  |- mesh__dateCreated mesh__D004470 1999-01-01
% 212.07/212.23  |- mesh__recordMaintainer mesh__D012902 KEV
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D012902 2005
% 212.07/212.23  |- rdf__type mesh__D012902sskos__Concept
% 212.07/212.23  |- skos__hiddenLabel mesh__D012902 Smegmas
% 212.07/212.23  |- mesh__recordAuthorizer mesh__D012902 sjn
% 212.07/212.23  |- mesh__dateCreated mesh__D012902 1999-01-01
% 212.07/212.23  |- skos__broader mesh__D012902smesh__D012634
% 212.07/212.23  |- mesh__recordOriginator mesh__D012902 NLM
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D012902 2002
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D012902 2004
% 212.07/212.23  |- skos__scopeNote mesh__D012902
% 212.07/212.23       A foul-smelling accumulation of SEBUM and desquaminated epidermal cells, especially the cheesy substance found under the foreskin of the penis and at the base of the labia minor near the clitoris.%A%    
% 212.07/212.23  |- skos__prefLabel mesh__D012902 Smegma
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D012902 2001
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D012902 2006
% 212.07/212.23  |- mesh__dateRevised mesh__D012902 1999-11-03
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D012902 2003
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D012902 2000
% 212.07/212.23  |- skos__related mesh__D012104smesh__D030162
% 212.07/212.23  |- mesh__recordMaintainer mesh__D012104 ags
% 212.07/212.23  |- skos__broader mesh__D012104smesh__D014714
% 212.07/212.23  |- rdf__type mesh__D012104sskos__Concept
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D012104 2004
% 212.07/212.23  |- mesh__dateCreated mesh__D012104 1999-01-01
% 212.07/212.23  |- mesh__recordAuthorizer mesh__D012104 sjn
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D012104 2005
% 212.07/212.23  |- mesh__dateRevised mesh__D012104 2003-07-09
% 212.07/212.23  |- skos__prefLabel mesh__D012104 Reptiles
% 212.07/212.23  |- skos__hiddenLabel mesh__D012104 Reptile
% 212.07/212.23  |- mesh__recordOriginator mesh__D012104 NLM
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D012104 2006
% 212.07/212.23  |- skos__annotation mesh__D012104
% 212.07/212.23       GEN or unspecified; prefer specifics; IM; qualif permitted%A%  
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D017398 2006
% 212.07/212.23  |- skos__broader mesh__D017398smesh__D012326
% 212.07/212.23  |- mesh__dateCreated mesh__D017398 1992-05-13
% 212.07/212.23  |- mesh__recordAuthorizer mesh__D017398 ags
% 212.07/212.23  |- skos__hiddenLabel mesh__D017398 Transcripts, Nested
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D017398 2005
% 212.07/212.23  |- skos__hiddenLabel mesh__D017398 Splicings, Alternative
% 212.07/212.23  |- mesh__dateEstablished mesh__D017398 1993-01-01
% 212.07/212.23  |- skos__altLabel mesh__D017398 Alternate Splicing
% 212.07/212.23  |- skos__altLabel mesh__D017398 Splicing, Alternative
% 212.07/212.23  |- skos__annotation mesh__D017398
% 212.07/212.23       for NESTED TRANSCRIPTS also index the RNA; do not confuse with NESTED GENES; for nested primers use NESTED PCR; %28%POLYMERASE CHAIN REACTION%29%%A%  
% 212.07/212.23  |- rdf__type mesh__D017398sskos__Concept
% 212.07/212.23  |- skos__hiddenLabel mesh__D017398 Splicing, Alternate
% 212.07/212.23  |- skos__hiddenLabel mesh__D017398 Nested Transcript
% 212.07/212.23  |- skos__scopeNote mesh__D017398
% 212.07/212.23       A process whereby multiple RNA transcripts are generated from a single gene. Alternative splicing involves the splicing together of other possible sets of EXONS during the processing of some, but not all, transcripts of the gene. Thus a particular exon may be connected to any one of several alternative exons to form a mature RNA. The alternative forms of mature MESSENGER RNA produce PROTEIN ISOFORMS in which one part of the isoforms is common while the other parts are different.%A%    
% 212.07/212.23  |- skos__related mesh__D017398smesh__D032041
% 212.07/212.23  |- skos__altLabel mesh__D017398 RNA Splicing, Alternative
% 212.07/212.23  |- skos__hiddenLabel mesh__D017398 Transcript, Nested
% 212.07/212.23  |- skos__hiddenLabel mesh__D017398 Splicing, Alternative RNA
% 212.07/212.23  |- skos__hiddenLabel mesh__D017398 Alternative RNA Splicings
% 212.07/212.23  |- mesh__recordMaintainer mesh__D017398 ags
% 212.07/212.23  |- mesh__historyNote mesh__D017398 93   
% 212.07/212.23  |- skos__hiddenLabel mesh__D017398 Splicings, Alternate
% 212.07/212.23  |- skos__hiddenLabel mesh__D017398 RNA Splicings, Alternative
% 212.07/212.23  |- skos__prefLabel mesh__D017398 Alternative Splicing
% 212.07/212.23  |- skos__historyNote mesh__D017398 RNA Splicing %28%1982-1992%29%
% 212.07/212.23  |- skos__hiddenLabel mesh__D017398 Alternative Splicings
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D017398 2006A
% 212.07/212.23  |- skos__hiddenLabel mesh__D017398 Alternative RNA Splicing
% 212.07/212.23  |- mesh__publicMeSHNote mesh__D017398 93   
% 212.07/212.23  |- mesh__dateRevised mesh__D017398 2005-07-21
% 212.07/212.23  |- skos__hiddenLabel mesh__D017398 Splicings, Alternative RNA
% 212.07/212.23  |- mesh__recordOriginator mesh__D017398 PXP
% 212.07/212.23  |- skos__hiddenLabel mesh__D017398 Alternate Splicings
% 212.07/212.23  |- skos__broader mesh__D003378smesh__D007122
% 212.07/212.23  |- mesh__publicMeSHNote mesh__D003378
% 212.07/212.23       91; was see under IMMUNOELECTROPHORESIS 1976-90   
% 212.07/212.23  |- skos__prefLabel mesh__D003378 Counterimmunoelectrophoresis
% 212.07/212.23  |- skos__historyNote mesh__D003378 Immunoelectrophoresis %28%1966-1975%29%
% 212.07/212.23  |- skos__altLabel mesh__D003378 Immunoelectrophoresis, Crossover
% 212.07/212.23  |- mesh__recordAuthorizer mesh__D003378 sjn
% 212.07/212.23  |- rdf__type mesh__D003378sskos__Concept
% 212.07/212.23  |- skos__altLabel mesh__D003378 Immunoelectrophoresis, Countercurrent
% 212.07/212.23  |- skos__annotation mesh__D003378
% 212.07/212.23       NIM: do not confuse X ref IMMUNOELECTROPHORESIS, CROSSOVER with IMMUNOELECTROPHORESIS, CROSSED see IMMUNOELECTROPHORESIS, TWO-DIMENSIONAL%A%  
% 212.07/212.23  |- mesh__dateEstablished mesh__D003378 1991-01-01
% 212.07/212.23  |- mesh__recordMaintainer mesh__D003378 nns
% 212.07/212.23  |- mesh__dateRevised mesh__D003378 2004-07-07
% 212.07/212.23  |- mesh__dateCreated mesh__D003378 1975-07-25
% 212.07/212.23  |- skos__altLabel mesh__D003378 Immunoelectroosmophoresis
% 212.07/212.23  |- skos__hiddenLabel mesh__D003378 Countercurrent Immunoelectrophoresis
% 212.07/212.23  |- skos__altLabel mesh__D003378 Electrosyneresis
% 212.07/212.23  |- skos__scopeNote mesh__D003378
% 212.07/212.23       Immunoelectrophoresis in which immunoprecipitation occurs when antigen at the cathode is caused to migrate in an electric field through a suitable medium of diffusion against a stream of antibody migrating from the anode as a result of endosmotic flow.%A%    
% 212.07/212.23  |- mesh__recordOriginator mesh__D003378 SMH
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D003378 2006
% 212.07/212.23  |- skos__hiddenLabel mesh__D003378 Crossover Immunoelectrophoresis
% 212.07/212.23  |- mesh__historyNote mesh__D003378
% 212.07/212.23       91%28%76%29%; was see under IMMUNOELECTROPHORESIS 1976-90   
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D003378 2005
% 212.07/212.23  |- mesh__recordOriginator mesh__D008861 NLM
% 212.07/212.23  |- mesh__recordAuthorizer mesh__D008861 sjn
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D008861 2001
% 212.07/212.23  |- mesh__recordMaintainer mesh__D008861 TAP
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D008861 2005
% 212.07/212.23  |- mesh__dateEstablished mesh__D008861 1965-01-01
% 212.07/212.23  |- skos__hiddenLabel mesh__D008861 Microsome
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D008861 2006
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D008861 2002
% 212.07/212.23  |- skos__annotation mesh__D008861 A 11 qualif except /cytol   
% 212.07/212.23  |- mesh__dateCreated mesh__D008861 1999-01-01
% 212.07/212.23  |- mesh__historyNote mesh__D008861 65%28%64%29%   
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D008861 2003
% 212.07/212.23  |- skos__scopeNote mesh__D008861
% 212.07/212.23       Artifactual vesicles formed from the endoplasmic reticulum when cells are disrupted. They are isolated by differential centrifugation and are composed of three structural features: rough vesicles, smooth vesicles, and ribosomes. Numerous enzyme activities are associated with the microsomal fraction. %28%Glick, Glossary of Biochemistry and Molecular Biology, 1990; from Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A%    
% 212.07/212.23  |- mesh__dateRevised mesh__D008861 2000-06-22
% 212.07/212.23  |- skos__broader mesh__D008861smesh__D013347
% 212.07/212.23  |- rdf__type mesh__D008861sskos__Concept
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D008861 2004
% 212.07/212.23  |- skos__prefLabel mesh__D008861 Microsomes
% 212.07/212.23  |- mesh__publicMeSHNote mesh__D008861 65   
% 212.07/212.23  |- mesh__recordAuthorizer mesh__D008063 sjn
% 212.07/212.23  |- rdf__type mesh__D008063sskos__Concept
% 212.07/212.23  |- mesh__recordMaintainer mesh__D008063 ssb
% 212.07/212.23  |- mesh__historyNote mesh__D008063 91; was LIPOIC ACID 1963-90   
% 212.07/212.23  |- skos__prefLabel mesh__D008063 Thioctic Acid
% 212.07/212.23  |- skos__hiddenLabel mesh__D008063 alpha Lipoic Acid
% 212.07/212.23  |- mesh__publicMeSHNote mesh__D008063 91; was LIPOIC ACID 1963-90   
% 212.07/212.23  |- skos__scopeNote mesh__D008063 A vitamin-like antioxidant.     
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D008063 2006
% 212.07/212.23  |- skos__altLabel mesh__D008063 Thioctacid
% 212.07/212.23  |- mesh__dateRevised mesh__D008063 2005-06-30
% 212.07/212.23  |- skos__altLabel mesh__D008063 Lipoic Acid
% 212.07/212.23  |- skos__broader mesh__D008063smesh__D003067
% 212.07/212.23  |- skos__altLabel mesh__D008063 alpha-Lipoic Acid
% 212.07/212.23  |- mesh__recordOriginator mesh__D008063 NLM
% 212.07/212.23  |- skos__hiddenLabel mesh__D008063 Acid, alpha-Lipoic
% 212.07/212.23  |- mesh__onlineNote mesh__D008063
% 212.07/212.23       use THIOCTIC ACID to search LIPOIC ACID 1966-90   
% 212.07/212.23  |- skos__broader mesh__D008063smesh__D013876
% 212.07/212.23  |- mesh__dateCreated mesh__D008063 1999-01-01
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D000080 1993
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D000080 2005
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D000080 2001
% 212.07/212.23  |- mesh__recordOriginator mesh__D000080 NLM
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D000080 2003
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D000080 1994
% 212.07/212.23  |- rdf__type mesh__D000080sskos__Concept
% 212.07/212.23  |- mesh__publicMeSHNote mesh__D000080 74   
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D000080 2000
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D000080 1999
% 212.07/212.23  |- mesh__recordAuthorizer mesh__D000080 PLS
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D000080 1997
% 212.07/212.23  |- mesh__dateEstablished mesh__D000080 1974-01-01
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D000080 1998
% 212.07/212.23  |- skos__broader mesh__D000080smesh__D004987
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D000080 1996
% 212.07/212.23  |- skos__historyNote mesh__D000080 Ethers %28%1966-1971%29%
% 212.07/212.23  |- mesh__recordMaintainer mesh__D000080 TAP
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D000080 2002
% 212.07/212.23  |- mesh__historyNote mesh__D000080 74%28%72%29%   
% 212.07/212.23  |- mesh__dateCreated mesh__D000080 1999-01-01
% 212.07/212.23  |- skos__prefLabel mesh__D000080 Acetals
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D000080 2006
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D000080 2004
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D000080 1995
% 212.07/212.23  |- mesh__dateRevised mesh__D000080 1992-05-07
% 212.07/212.23  |- skos__prefLabel mesh__D007769 Lactams
% 212.07/212.23  |- skos__broader mesh__D007769smesh__D006573
% 212.07/212.23  |- mesh__publicMeSHNote mesh__D007769 74   
% 212.07/212.23  |- rdf__type mesh__D007769sskos__Concept
% 212.07/212.23  |- skos__scopeNote mesh__D007769
% 212.07/212.23       Cyclic AMIDES formed from aminocarboxylic acids by the elimination of water. Lactims are the enol forms of lactams.%A%    
% 212.07/212.23  |- mesh__dateCreated mesh__D007769 1999-01-01
% 212.07/212.23  |- mesh__recordOriginator mesh__D007769 NLM
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D007769 2006
% 212.07/212.23  |- skos__historyNote mesh__D007769 Amides %28%1966-1971%29%
% 212.07/212.23  |- mesh__dateRevised mesh__D007769 2004-07-07
% 212.07/212.23  |- skos__broader mesh__D007769smesh__D000577
% 212.07/212.23  |- mesh__recordAuthorizer mesh__D007769 sjn
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D007769 2005
% 212.07/212.23  |- mesh__recordMaintainer mesh__D007769 ssb
% 212.07/212.23  |- mesh__historyNote mesh__D007769 74%28%72%29%   
% 212.07/212.23  |- mesh__dateEstablished mesh__D007769 1974-01-01
% 212.07/212.23  |- mesh__recordMaintainer mesh__D018491 ssb
% 212.07/212.23  |- skos__hiddenLabel mesh__D018491 Agonist, Dopamine Receptor
% 212.07/212.23  |- skos__altLabel mesh__D018491 Dopamine Agonist
% 212.07/212.23  |- skos__altLabel mesh__D018491 Dopaminergic Agonists
% 212.07/212.23  |- mesh__recordOriginator mesh__D018491 TPW
% 212.07/212.23  |- mesh__publicMeSHNote mesh__D018491
% 212.07/212.23       95; DOPAMINE AGONISTS %26% DOPAMINE RECEPTOR AGONISTS were see DOPAMINERGIC AGENTS 1989-94%A%  
% 212.07/212.23  |- mesh__activeMeSHYear mesh__D018491 2006
% 212.07/212.23  |- skos__hiddenLabel mesh__D018491 Agonist, Dopamine
% 212.07/212.23  |- skos__annotation mesh__D018491
% 212.07/212.23       GEN or unspecified; prefer specifics; DF: DOPAMINE AGON or DOPAMINE AG%A%  
% 212.07/212.23  |- skos__hiddenLabel mesh__D018491 Agonist, Dopaminergic
% 212.07/212.23  |- skos__altLabel mesh__D018491 Dopaminergic Agonist
% 212.07/212.23  |- skos__altLabel mesh__D018491 Agonists, Dopaminergic
% 212.07/212.23  |- skos__historyNote mesh__D018491 Dopamine Agents %28%1989-1994%29%
% 212.07/212.23  |- mesh__historyNote mesh__D018491
% 212.07/212.23       95; DOPAMINE AGONISTS %26% DOPAMINE RECEPTOR AGONISTS were see DOPAMINERGIC AGENTS 1989-94%A%  
% 212.07/212.23  |- skos__altLabel mesh__D018491 Agonists, Dopamine Receptor
% 212.07/212.23  |- rdf__type mesh__D018491sskos__Concept
% 212.07/212.23  |- mesh__recordAuthorizer mesh__D018491 sjn
% 212.07/212.23  |- mesh__onlineNote mesh__D018491
% 212.07/212.23       use DOPAMINERGIC AGENTS to search DOPAMINE AGONISTS %26% DOPAMINE RECEPTOR AGONISTS 1989-94%A%  
% 212.07/212.23  |- skos__prefLabel mesh__D018491 Dopamine Agonists
% 212.07/212.23  |- mesh__dateCreated mesh__D018491 1994-06-01
% 212.07/212.23  |- skos__scopeNote mesh__D018491
% 212.07/212.23       Drugs that bind to and activate dopamine receptors.     
% 212.07/212.23  |- skos__broader mesh__D018491smesh__D015259
% 212.07/212.23  |- skos__altLabel mesh__D018491 Dopamine Receptor Agonist
% 212.07/212.23  |- skos__altLabel mesh__D018491 Dopamine Receptor Agonists
% 212.07/212.23  |- skos__altLabel mesh__D018491 Receptor Agonists, Dopamine
% 212.07/212.23  |- skos__hiddenLabel mesh__D018491 Receptor Agonist, Dopamine
% 212.07/212.24  |- skos__hiddenLabel mesh__D018491 Agonists, Dopamine
% 212.07/212.24  |- mesh__dateRevised mesh__D018491 2005-06-30
% 212.07/212.24  |- mesh__dateEstablished mesh__D018491 1995-01-01
% 212.07/212.24  |- skos__altLabel mesh__D026923 Basic Amino Acid Transport Proteins
% 212.07/212.24  |- skos__historyNote mesh__D026923 Membrane Proteins %28%1992-2001%29%
% 212.07/212.24  |- mesh__dateCreated mesh__D026923 2001-07-25
% 212.07/212.24  |- skos__prefLabel mesh__D026923 Amino Acid Transport Systems, Basic
% 212.07/212.24  |- mesh__dateRevised mesh__D026923 2005-06-30
% 212.07/212.24  |- mesh__recordMaintainer mesh__D026923 SYSTEM
% 212.07/212.24  |- skos__altLabel mesh__D026923 Amino Acid Transport Systems, Cationic
% 212.07/212.24  |- rdf__type mesh__D026923sskos__Concept
% 212.07/212.24  |- mesh__recordAuthorizer mesh__D026923 sjn
% 212.07/212.24  |- skos__historyNote mesh__D026923 Carrier Proteins %28%1992-2001%29%
% 212.07/212.24  |- skos__altLabel mesh__D026923 Cationic Amino Acid Transporters
% 212.07/212.24  |- skos__altLabel mesh__D026923 Cationic Amino Acid Transport Systems
% 212.07/212.24  |- mesh__publicMeSHNote mesh__D026923
% 212.07/212.24       2002; CATIONIC AMINO ACID TRANSPORTER, MAMMALIAN %28%now AMINO ACID TRANSPORT SYTEMS, BASIC%29% was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1992-2001%A%  
% 212.07/212.24  |- mesh__dateEstablished mesh__D026923 2002-01-01
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D026923 2006
% 212.07/212.24  |- skos__altLabel mesh__D026923 Cationic Amino Acid Transport Proteins
% 212.07/212.24  |- skos__scopeNote mesh__D026923
% 212.07/212.24       Amino acid transporter systems capable of transporting basic amino acids %28%AMINO ACIDS, BASIC%29%.%A%    
% 212.07/212.24  |- mesh__historyNote mesh__D026923
% 212.07/212.24       2002; use AMINO ACID TRANSPORT SYSTEMS, BASIC %28%NM%29% 1992-2001%A%  
% 212.07/212.24  |- skos__altLabel mesh__D026923 Basic Amino Acid Transport Systems
% 212.07/212.24  |- skos__broader mesh__D026923smesh__D026905
% 212.07/212.24  |- mesh__recordOriginator mesh__D026923 jmp
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D004471 2003
% 212.07/212.24  |- skos__annotation mesh__D004471
% 212.07/212.24       GEN or unspecified only: prefer /econ with specific nurs subject: Manual 19.8.27; DF: ECON NURS%A%  
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D004471 2001
% 212.07/212.24  |- mesh__dateEstablished mesh__D004471 1966-01-01
% 212.07/212.24  |- mesh__historyNote mesh__D004471 66   
% 212.07/212.24  |- skos__prefLabel mesh__D004471 Economics, Nursing
% 212.07/212.24  |- skos__scopeNote mesh__D004471
% 212.07/212.24       Economic aspects of the nursing profession.     
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D004471 2000
% 212.07/212.24  |- mesh__recordOriginator mesh__D004471 NLM
% 212.07/212.24  |- skos__hiddenLabel mesh__D004471 Economic, Nursing
% 212.07/212.24  |- skos__broader mesh__D004471smesh__D004467
% 212.07/212.24  |- mesh__dateRevised mesh__D004471 1999-11-03
% 212.07/212.24  |- skos__altLabel mesh__D004471 Nursing Economics
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D004471 2006
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D004471 2002
% 212.07/212.24  |- mesh__dateCreated mesh__D004471 1999-01-01
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D004471 2004
% 212.07/212.24  |- mesh__recordMaintainer mesh__D004471 kle
% 212.07/212.24  |- skos__hiddenLabel mesh__D004471 Nursing Economic
% 212.07/212.24  |- mesh__publicMeSHNote mesh__D004471 66   
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D004471 2005
% 212.07/212.24  |- rdf__type mesh__D004471sskos__Concept
% 212.07/212.24  |- mesh__recordAuthorizer mesh__D004471 sjn
% 212.07/212.24  |- skos__scopeNote mesh__D045888
% 212.07/212.24       Nodular tumor-like lesions or mucoid flesh, arising from tendon sheaths, LIGAMENTS, or JOINT CAPSULE, especially of the hands, wrists, or feet. They are not true cysts as they lack epithelial wall. They are distinguished from SYNOVIAL CYSTS by the lack of communication with a joint cavity or the SYNOVIAL MEMBRANE.%A%    
% 212.07/212.24  |- mesh__recordAuthorizer mesh__D045888 sjn
% 212.07/212.24  |- skos__hiddenLabel mesh__D045888 Ganglion Cyst
% 212.07/212.24  |- skos__annotation mesh__D045888
% 212.07/212.24       non-neoplastic; SYNOVIAL CYSTS is also available   
% 212.07/212.24  |- skos__altLabel mesh__D045888 Ganglionic Cysts
% 212.07/212.24  |- skos__broader mesh__D045888smesh__D003560
% 212.07/212.24  |- mesh__recordMaintainer mesh__D045888 lkt
% 212.07/212.24  |- skos__altLabel mesh__D045888 Ganglions
% 212.07/212.24  |- mesh__recordOriginator mesh__D045888 lkt
% 212.07/212.24  |- skos__hiddenLabel mesh__D045888 Ganglion
% 212.07/212.24  |- rdf__type mesh__D045888sskos__Concept
% 212.07/212.24  |- skos__hiddenLabel mesh__D045888 Ganglionic Cyst
% 212.07/212.24  |- skos__hiddenLabel mesh__D045888 Cyst, Ganglionic
% 212.07/212.24  |- mesh__dateCreated mesh__D045888 2003-07-09
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D045888 2006
% 212.07/212.24  |- skos__hiddenLabel mesh__D045888 Myxoid Cysts
% 212.07/212.24  |- skos__hiddenLabel mesh__D045888 Cysts, Myxoid
% 212.07/212.24  |- skos__hiddenLabel mesh__D045888 Cysts, Ganglionic
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D045888 2004
% 212.07/212.24  |- mesh__publicMeSHNote mesh__D045888 2004; see SYNOVIAL CYST 1969-2003   
% 212.07/212.24  |- skos__historyNote mesh__D045888 Synovial Cyst %28%1969-2003%29%
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D045888 2005
% 212.07/212.24  |- skos__prefLabel mesh__D045888 Ganglion Cysts
% 212.07/212.24  |- skos__altLabel mesh__D045888 Myxoid Cyst
% 212.07/212.24  |- skos__hiddenLabel mesh__D045888 Cyst, Myxoid
% 212.07/212.24  |- mesh__historyNote mesh__D045888 2004; use SYNOVIAL CYST 1969-2003   
% 212.07/212.24  |- skos__hiddenLabel mesh__D045888 Cyst, Ganglion
% 212.07/212.24  |- skos__hiddenLabel mesh__D045888 Cysts, Ganglion
% 212.07/212.24  |- mesh__dateEstablished mesh__D045888 2004-01-01
% 212.07/212.24  |- skos__broader mesh__D045888smesh__D017520
% 212.07/212.24  |- mesh__dateCreated mesh__D012903 1999-01-01
% 212.07/212.24  |- rdf__type mesh__D012903sskos__Concept
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D012903 1999
% 212.07/212.24  |- mesh__recordAuthorizer mesh__D012903 PLS
% 212.07/212.24  |- skos__scopeNote mesh__D012903
% 212.07/212.24       The sensation or perception of scents or odors.     
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D012903 2001
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D012903 1994
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D012903 1993
% 212.07/212.24  |- skos__prefLabel mesh__D012903 Smell
% 212.07/212.24  |- mesh__recordMaintainer mesh__D012903 TGC
% 212.07/212.24  |- skos__hiddenLabel mesh__D012903 Olfactions
% 212.07/212.24  |- skos__related mesh__D012903smesh__D000857
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D012903 1995
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D012903 2003
% 212.07/212.24  |- skos__altLabel mesh__D012903 Olfaction
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D012903 2002
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D012903 2004
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D012903 2005
% 212.07/212.24  |- skos__hiddenLabel mesh__D012903 Smells
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D012903 1996
% 212.07/212.24  |- mesh__dateRevised mesh__D012903 1992-05-18
% 212.07/212.24  |- skos__related mesh__D012903smesh__D009812
% 212.07/212.24  |- skos__broader mesh__D012903smesh__D012677
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D012903 2006
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D012903 1997
% 212.07/212.24  |- mesh__recordOriginator mesh__D012903 NLM
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D012903 1998
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D012903 2000
% 212.07/212.24  |- mesh__recordAuthorizer mesh__D003379 ags
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D003379 2001
% 212.07/212.24  |- skos__prefLabel mesh__D003379 Countertransference %28%Psychology%29%
% 212.07/212.24  |- skos__historyNote mesh__D003379
% 212.07/212.24       Transference %28%Psychology%29% %28%1966-1967%29%
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D003379 2004
% 212.07/212.24  |- skos__hiddenLabel mesh__D003379 Countertransferences %28%Psychology%29%
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D003379 2000
% 212.07/212.24  |- skos__broader mesh__D003379smesh__D014167
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D003379 2006
% 212.07/212.24  |- skos__scopeNote mesh__D003379
% 212.07/212.24       Conscious or unconscious emotional reaction of the therapist to the patient which may interfere with treatment. %28%APA, Thesaurus of Psychological Index Terms, 8th ed.%29%%A%    
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D003379 2003
% 212.07/212.24  |- skos__annotation mesh__D003379 no qualif; DF: COUNTERTRANSFERENCE   
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D003379 2005
% 212.07/212.24  |- mesh__recordMaintainer mesh__D003379 ags
% 212.07/212.24  |- mesh__recordOriginator mesh__D003379 NLM
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D003379 2000A
% 212.07/212.24  |- mesh__dateCreated mesh__D003379 1999-01-01
% 212.07/212.24  |- mesh__dateEstablished mesh__D003379 1968-01-01
% 212.07/212.24  |- rdf__type mesh__D003379sskos__Concept
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D003379 2002
% 212.07/212.24  |- skos__altLabel mesh__D003379 Countertransference
% 212.07/212.24  |- mesh__historyNote mesh__D003379 1968   
% 212.07/212.24  |- mesh__dateRevised mesh__D003379 1999-12-13
% 212.07/212.24  |- mesh__publicMeSHNote mesh__D003379 1968   
% 212.07/212.24  |- mesh__dateCreated mesh__D008862 1999-01-01
% 212.07/212.24  |- mesh__dateEstablished mesh__D008862 1970-01-01
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D008862 2003
% 212.07/212.24  |- skos__hiddenLabel mesh__D008862 Microsome, Liver
% 212.07/212.24  |- rdf__type mesh__D008862sskos__Concept
% 212.07/212.24  |- skos__historyNote mesh__D008862 Microsomes %28%1966-1969%29%
% 212.07/212.24  |- mesh__historyNote mesh__D008862 70   
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D008862 2002
% 212.07/212.24  |- skos__scopeNote mesh__D008862
% 212.07/212.24       Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough.%A%    
% 212.07/212.24  |- mesh__recordOriginator mesh__D008862 NLM
% 212.07/212.24  |- skos__hiddenLabel mesh__D008862 Liver Microsome
% 212.07/212.24  |- mesh__recordAuthorizer mesh__D008862 sjn
% 212.07/212.24  |- skos__altLabel mesh__D008862 Liver Microsomes
% 212.07/212.24  |- mesh__recordMaintainer mesh__D008862 KEV
% 212.07/212.24  |- skos__prefLabel mesh__D008862 Microsomes, Liver
% 212.07/212.24  |- skos__broader mesh__D008862smesh__D008861
% 212.07/212.24  |- skos__historyNote mesh__D008862 Liver %28%1966-1969%29%
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D008862 2006
% 212.07/212.24  |- mesh__publicMeSHNote mesh__D008862 70   
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D008862 2001
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D008862 2005
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D008862 2004
% 212.07/212.24  |- mesh__dateRevised mesh__D008862 2000-06-22
% 212.07/212.24  |- skos__broader mesh__D007037Q000151smesh__D007037
% 212.07/212.24  |- mesh__preferredCombination mesh__D007037Q000151smesh__D003409
% 212.07/212.24  |- rdf__type mesh__D007037Q000151smesh__CompoundConcept
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D008064 2003
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D008064 2006
% 212.07/212.24  |- skos__hiddenLabel mesh__D008064 Familial Idiocies, Amaurotic
% 212.07/212.24  |- skos__hiddenLabel mesh__D008064 Idiocy, Amaurotic Familial
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D008064 2005
% 212.07/212.24  |- mesh__recordOriginator mesh__D008064 NLM
% 212.07/212.24  |- skos__scopeNote mesh__D008064
% 212.07/212.24       A disturbance of lipid metabolism with abnormal deposit of lipids in the cells. %28%Dorland, 27th ed%29%%A%    
% 212.07/212.24  |- skos__hiddenLabel mesh__D008064 Lipidoses
% 212.07/212.24  |- skos__prefLabel mesh__D008064 Lipoidosis
% 212.07/212.24  |- mesh__recordAuthorizer mesh__D008064 sjn
% 212.07/212.24  |- mesh__dateRevised mesh__D008064 2001-07-25
% 212.07/212.24  |- mesh__historyNote mesh__D008064
% 212.07/212.24       AMAUROTIC FAMILIAL IDIOCY was heading 1963-84   
% 212.07/212.24  |- mesh__dateCreated mesh__D008064 1999-01-01
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D008064 2002
% 212.07/212.24  |- skos__hiddenLabel mesh__D008064 Familial Idiocy, Amaurotic
% 212.07/212.24  |- rdf__type mesh__D008064sskos__Concept
% 212.07/212.24  |- mesh__recordMaintainer mesh__D008064 nns
% 212.07/212.24  |- skos__annotation mesh__D008064
% 212.07/212.24       an inborn error of lipid metab; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 212.07/212.24  |- skos__hiddenLabel mesh__D008064 Idiocies, Amaurotic Familial
% 212.07/212.24  |- mesh__publicMeSHNote mesh__D008064
% 212.07/212.24       AMAUROTIC FAMILIAL IDIOCY was heading 1963-84   
% 212.07/212.24  |- mesh__onlineNote mesh__D008064
% 212.07/212.24       use LIPOIDOSIS to search AMAUROTIC FAMILIAL IDIOCY 1966-84%A%  
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D008064 2004
% 212.07/212.24  |- skos__altLabel mesh__D008064 Lipidosis
% 212.07/212.24  |- skos__broader mesh__D008064smesh__D008052
% 212.07/212.24  |- skos__hiddenLabel mesh__D008064 Lipoidoses
% 212.07/212.24  |- skos__hiddenLabel mesh__D008064 Amaurotic Familial Idiocies
% 212.07/212.24  |- rdf__type mesh__D000081sskos__Concept
% 212.07/212.24  |- skos__prefLabel mesh__D000081 Acetamides
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D000081 1999
% 212.07/212.24  |- mesh__publicMeSHNote mesh__D000081 73   
% 212.07/212.24  |- mesh__historyNote mesh__D000081 73%28%71%29%   
% 212.07/212.24  |- skos__broader mesh__D000081smesh__D000088
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D000081 2001
% 212.07/212.24  |- mesh__recordOriginator mesh__D000081 NLM
% 212.07/212.24  |- mesh__recordMaintainer mesh__D000081 ADP
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D000081 2000
% 212.07/212.24  |- skos__scopeNote mesh__D000081
% 212.07/212.24       Derivatives of acetamide that are used as solvents, as mild irritants, and in organic synthesis.%A%    
% 212.07/212.24  |- mesh__dateCreated mesh__D000081 1999-01-01
% 212.07/212.24  |- skos__broader mesh__D000081smesh__D000577
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D000081 2006
% 212.07/212.24  |- mesh__dateRevised mesh__D000081 1998-06-10
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D000081 2004
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D000081 2005
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D000081 2002
% 212.07/212.24  |- mesh__recordAuthorizer mesh__D000081 SJN
% 212.07/212.24  |- skos__historyNote mesh__D000081 Amides %28%1966-1970%29%
% 212.07/212.24  |- skos__historyNote mesh__D000081 Acetic Acids %28%1966-1970%29%
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D000081 2003
% 212.07/212.24  |- mesh__dateEstablished mesh__D000081 1973-01-01
% 212.07/212.24  |- skos__historyNote mesh__D032961 Spermatozoa %28%1975-2002%29%
% 212.07/212.24  |- skos__hiddenLabel mesh__D032961 Midpiece, Sperm
% 212.07/212.24  |- skos__hiddenLabel mesh__D032961 Midpieces, Sperm
% 212.07/212.24  |- mesh__dateEstablished mesh__D032961 2003-01-01
% 212.07/212.24  |- skos__scopeNote mesh__D032961
% 212.07/212.24       The middle piece of the spermatozoon is a highly organized segment consisting of MITOCHONDRIA, the outer dense fibers and the core microtubular structure.%A%    
% 212.07/212.24  |- mesh__historyNote mesh__D032961 2003   
% 212.07/212.24  |- skos__prefLabel mesh__D032961 Sperm Midpiece
% 212.07/212.24  |- mesh__publicMeSHNote mesh__D032961 2003   
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D032961 2004
% 212.07/212.24  |- mesh__dateCreated mesh__D032961 2002-07-03
% 212.07/212.24  |- skos__broader mesh__D032961smesh__D013094
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D032961 2003
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D032961 2006
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D032961 2005
% 212.07/212.24  |- skos__hiddenLabel mesh__D032961 Sperm Midpieces
% 212.07/212.24  |- rdf__type mesh__D032961sskos__Concept
% 212.07/212.24  |- mesh__historyNote mesh__D018492 95   
% 212.07/212.24  |- skos__altLabel mesh__D018492 Antagonists, Dopamine
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D018492 2006
% 212.07/212.24  |- skos__altLabel mesh__D018492 Dopaminergic Antagonists
% 212.07/212.24  |- skos__hiddenLabel mesh__D018492 Receptor Antagonists, Dopamine
% 212.07/212.24  |- mesh__dateEstablished mesh__D018492 1995-01-01
% 212.07/212.24  |- mesh__dateRevised mesh__D018492 2005-06-30
% 212.07/212.24  |- mesh__recordMaintainer mesh__D018492 ssb
% 212.07/212.24  |- mesh__publicMeSHNote mesh__D018492 95   
% 212.07/212.24  |- skos__altLabel mesh__D018492 Antagonists, Dopaminergic
% 212.07/212.24  |- mesh__recordOriginator mesh__D018492 TPW
% 212.07/212.24  |- rdf__type mesh__D018492sskos__Concept
% 212.07/212.24  |- skos__prefLabel mesh__D018492 Dopamine Antagonists
% 212.07/212.24  |- skos__broader mesh__D018492smesh__D015259
% 212.07/212.24  |- skos__historyNote mesh__D018492
% 212.07/212.24       Dopamine/antagonists %26% inhibitors %28%1966-1994%29%
% 212.07/212.24  |- skos__annotation mesh__D018492
% 212.07/212.24       GEN or unspecified; prefer specifics; DF: DOPAMINE ANTAG   
% 212.07/212.24  |- skos__altLabel mesh__D018492 Antagonists, Dopamine Receptor
% 212.07/212.24  |- skos__altLabel mesh__D018492 Dopamine Receptor Antagonists
% 212.07/212.24  |- mesh__recordAuthorizer mesh__D018492 sjn
% 212.07/212.24  |- skos__scopeNote mesh__D018492
% 212.07/212.24       Drugs that bind to but do not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders %28%ANTIPSYCHOTIC AGENTS%29% are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup.%A%    
% 212.07/212.24  |- mesh__dateCreated mesh__D018492 1994-06-01
% 212.07/212.24  |- rdf__type mesh__D026924sskos__Concept
% 212.07/212.24  |- skos__altLabel mesh__D026924 System A Transporter
% 212.07/212.24  |- skos__prefLabel mesh__D026924 Amino Acid Transport System A
% 212.07/212.24  |- skos__scopeNote mesh__D026924
% 212.07/212.24       A sodium-dependent neutral amino acid transporter that accounts for most of the sodium-dependent neutral amino acid uptake by mammalian cells. The preferred substrates for this transporter system include ALANINE; SERINE; and GLUTAMINE.%A%    
% 212.07/212.24  |- skos__altLabel mesh__D026924 Amino Acid Transport System A Proteins
% 212.07/212.24  |- skos__historyNote mesh__D026924 Carrier Proteins %28%2000-2001%29%
% 212.07/212.24  |- skos__hiddenLabel mesh__D026924 Transporter, System A
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D026924 2006
% 212.07/212.24  |- mesh__recordOriginator mesh__D026924 jmp
% 212.07/212.24  |- mesh__dateRevised mesh__D026924 2005-07-07
% 212.07/212.24  |- mesh__recordAuthorizer mesh__D026924 ags
% 212.07/212.24  |- mesh__dateEstablished mesh__D026924 2002-01-01
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D026924 2006A
% 212.07/212.24  |- mesh__dateCreated mesh__D026924 2001-07-25
% 212.07/212.24  |- skos__altLabel mesh__D026924 Amino Acid Transporter A
% 212.07/212.24  |- mesh__historyNote mesh__D026924
% 212.07/212.24       2002; for AMINO ACID TRANSPORTER A use AMINO ACID TRANSPORT SYSTEMS %28%NM%29% 2000-2001%A%  
% 212.07/212.24  |- mesh__recordMaintainer mesh__D026924 ags
% 212.07/212.24  |- mesh__publicMeSHNote mesh__D026924
% 212.07/212.24       2002; AMINO ACID TRANSPORTER A was indexed under CARRIER PROTEINS 2000-2001%A%  
% 212.07/212.24  |- skos__broader mesh__D026924smesh__D026921
% 212.07/212.24  |- skos__altLabel mesh__D026924 System A Transporter Proteins
% 212.07/212.24  |- mesh__recordMaintainer mesh__D004472 TPW
% 212.07/212.24  |- mesh__recordAuthorizer mesh__D004472 SJN
% 212.07/212.24  |- skos__altLabel mesh__D004472 Healthcare Economics and Organizations
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D004472 2002
% 212.07/212.24  |- mesh__historyNote mesh__D004472 98; use explode   
% 212.07/212.24  |- mesh__publicMeSHNote mesh__D004472 98   
% 212.07/212.24  |- mesh__runningHead mesh__D004472
% 212.07/212.24       N3 - HEALTH CARE ECONOMICS AND ORGANIZATIONS   
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D004472 2006
% 212.07/212.24  |- mesh__dateCreated mesh__D004472 1999-01-01
% 212.07/212.24  |- mesh__dateEstablished mesh__D004472 1998-01-01
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D004472 2004
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D004472 2005
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D004472 1999
% 212.07/212.24  |- skos__annotation mesh__D004472
% 212.07/212.24       not used for indexing      CATALOG: do not use   
% 212.07/212.24  |- rdf__type mesh__D004472sskos__Concept
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D004472 2001
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D004472 2003
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D004472 2000
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D004472 1998
% 212.07/212.24  |- skos__scopeNote mesh__D004472
% 212.07/212.24       The economic aspects of health care, its planning, and delivery. It includes government agencies and organizations in the private sector.%A%    
% 212.07/212.24  |- skos__prefLabel mesh__D004472 Health Care Economics and Organizations
% 212.07/212.24  |- mesh__dateRevised mesh__D004472 1997-06-27
% 212.07/212.24  |- mesh__recordOriginator mesh__D004472 NLM
% 212.07/212.24  |- rdf__type mesh__D012904sskos__Concept
% 212.07/212.24  |- skos__prefLabel mesh__D012904 Smiling
% 212.07/212.24  |- mesh__recordAuthorizer mesh__D012904 sjn
% 212.07/212.24  |- mesh__onlineNote mesh__D012904 search FACIAL EXPRESSION 1969-74   
% 212.07/212.24  |- skos__broader mesh__D012904smesh__D005149
% 212.07/212.24  |- mesh__recordOriginator mesh__D012904 NLM
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D012904 2003
% 212.07/212.24  |- skos__hiddenLabel mesh__D012904 Smilings
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D012904 2005
% 212.07/212.24  |- mesh__historyNote mesh__D012904
% 212.07/212.24       91%28%75%29%; was see under FACIAL EXPRESSION 1975-90   
% 212.07/212.24  |- skos__scopeNote mesh__D012904
% 212.07/212.24       A facial expression which may denote feelings of pleasure, affection, amusement, etc.%A%    
% 212.07/212.24  |- mesh__recordMaintainer mesh__D012904 TAP
% 212.07/212.24  |- mesh__dateEstablished mesh__D012904 1991-01-01
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D012904 2004
% 212.07/212.24  |- mesh__publicMeSHNote mesh__D012904
% 212.07/212.24       91; was see under FACIAL EXPRESSION 1975-90   
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D012904 2006
% 212.07/212.24  |- mesh__dateRevised mesh__D012904 2002-07-03
% 212.07/212.24  |- mesh__dateCreated mesh__D012904 1999-01-01
% 212.07/212.24  |- mesh__recordOriginator mesh__D012106 NLM
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Technique, Research
% 212.07/212.24  |- mesh__recordAuthorizer mesh__D012106 sjn
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Summary Reports
% 212.07/212.24  |- mesh__recordMaintainer mesh__D012106 jls
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Research Technic
% 212.07/212.24  |- skos__related mesh__D012106smesh__D018865
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D012106 2005
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Investigative Reports
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Studies, Interdisciplinary
% 212.07/212.24  |- mesh__dateCreated mesh__D012106 1999-01-01
% 212.07/212.24  |- skos__related mesh__D012106smesh__D013597
% 212.07/212.24  |- skos__scopeNote mesh__D012106
% 212.07/212.24       Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. %28%Webster, 3d ed%29%%A%    
% 212.07/212.24  |- skos__related mesh__D012106smesh__D007255
% 212.07/212.24  |- skos__broader mesh__D012106smesh__D012586
% 212.07/212.24  |- skos__altLabel mesh__D012106 Methodology, Research
% 212.07/212.24  |- skos__annotation mesh__D012106
% 212.07/212.24       GEN; prefer specifics; research as a field or the progress or status of research in a particular field; do not add routinely for specific studies involving %22%research%22%:  Manual 29.16; /methods: consider RESEARCH DESIGN%A%  
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Report, Investigative
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D012106 2004
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Priorities, Research
% 212.07/212.24  |- rdf__type mesh__D012106sskos__Concept
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Priority, Research
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Study, Interdisciplinary
% 212.07/212.24  |- skos__prefLabel mesh__D012106 Research
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Report, Summary
% 212.07/212.24  |- mesh__dateRevised mesh__D012106 2003-07-09
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Activity, Research
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Research, Laboratory
% 212.07/212.24  |- skos__related mesh__D012106smesh__D015399
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Reports, Investigative
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Development and Research
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Techniques, Research
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Interdisciplinary Study
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Research Activity
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Technic, Research
% 212.07/212.24  |- skos__altLabel mesh__D012106 Research Technics
% 212.07/212.24  |- skos__related mesh__D012106smesh__D009874
% 212.07/212.24  |- skos__related mesh__D012106smesh__D032984
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Research Technique
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Research Priority
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D012106 2006
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Activities, Research
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Technics, Research
% 212.07/212.24  |- skos__hiddenLabel mesh__D012106 Reports, Summary
% 212.07/212.24  |- rdf__type mesh__D008863sskos__Concept
% 212.07/212.24  |- mesh__recordMaintainer mesh__D008863 lkt
% 212.07/212.24  |- skos__hiddenLabel mesh__D008863 Latex Particle
% 212.07/212.24  |- skos__related mesh__D008863smesh__D045423
% 212.07/212.24  |- mesh__publicMeSHNote mesh__D008863
% 212.07/212.24       74; LATEX PARTICLES was heading 1968-80   
% 212.07/212.24  |- skos__related mesh__D008863smesh__D004800
% 212.07/212.24  |- mesh__onlineNote mesh__D008863
% 212.07/212.24       use MICROSPHERES + LATEX to search LATEX PARTICLES 1968-80%A%  
% 212.07/212.24  |- mesh__dateEstablished mesh__D008863 1974-01-01
% 212.07/212.24  |- skos__hiddenLabel mesh__D008863 Sphere, Latex
% 212.07/212.24  |- skos__broader mesh__D008863smesh__D004864
% 212.07/212.24  |- skos__altLabel mesh__D008863 Microbeads
% 212.07/212.24  |- skos__prefLabel mesh__D008863 Microspheres
% 212.07/212.24  |- skos__hiddenLabel mesh__D008863 Microsphere
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D008863 2006
% 212.07/212.24  |- skos__scopeNote mesh__D008863
% 212.07/212.24       Small uniformly-sized spherical particles, of micrometer dimensions, frequently labeled with radioisotopes or various reagents acting as tags or markers.%A%    
% 212.07/212.24  |- skos__annotation mesh__D008863
% 212.07/212.24       note X refs: do not coord with LATEX unless particularly discussed; note MICROCAPSULES see CAPSULES: do not coord with MICROSPHERES%A%  
% 212.07/212.24  |- skos__hiddenLabel mesh__D008863 Spheres, Latex
% 212.07/212.24  |- skos__hiddenLabel mesh__D008863 Particles, Latex
% 212.07/212.24  |- skos__hiddenLabel mesh__D008863 Latex Bead
% 212.07/212.24  |- skos__hiddenLabel mesh__D008863 Particle, Latex
% 212.07/212.24  |- skos__hiddenLabel mesh__D008863 Beads, Latex
% 212.07/212.24  |- mesh__recordOriginator mesh__D008863 NLM
% 212.07/212.24  |- mesh__recordAuthorizer mesh__D008863 sjn
% 212.07/212.24  |- mesh__historyNote mesh__D008863
% 212.07/212.24       74%28%72%29%; LATEX PARTICLES was heading 1968-80   
% 212.07/212.24  |- mesh__dateRevised mesh__D008863 2003-07-09
% 212.07/212.24  |- skos__hiddenLabel mesh__D008863 Bead, Latex
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D008863 2005
% 212.07/212.24  |- skos__hiddenLabel mesh__D008863 Latex Sphere
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D008863 2004
% 212.07/212.24  |- mesh__dateCreated mesh__D008863 1999-01-01
% 212.07/212.24  |- skos__hiddenLabel mesh__D008863 Microbead
% 212.07/212.24  |- mesh__recordOriginator mesh__D000880 NLM
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D000880 2006
% 212.07/212.24  |- mesh__recordAuthorizer mesh__D000880 sjn
% 212.07/212.24  |- skos__broader mesh__D000880smesh__D000873
% 212.07/212.24  |- rdf__type mesh__D000880sskos__Concept
% 212.07/212.24  |- mesh__recordMaintainer mesh__D000880 ssb
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D000880 2005
% 212.07/212.24  |- mesh__dateCreated mesh__D000880 1999-01-01
% 212.07/212.24  |- mesh__activeMeSHYear mesh__D000880 2004
% 212.07/212.24  |- skos__broader mesh__D000880smesh__D011809
% 212.07/212.24  |- mesh__publicMeSHNote mesh__D000880
% 212.07/212.24       EMODIN was see under CATHARTICS 1963-74   
% 212.07/212.24  |- skos__altLabel mesh__D000880 Anthranoids
% 212.07/212.24  |- mesh__dateRevised mesh__D000880 2003-07-09
% 212.07/212.24  |- skos__altLabel mesh__D000880 Anthracenediones
% 212.07/212.24  |- skos__scopeNote mesh__D000880
% 212.07/212.24       Compounds based on ANTHRACENES which contains two KETONES in any position. Substitutions can be in any position except on the ketone groups.%A%    
% 212.07/212.24  |- skos__prefLabel mesh__D000880 Anthraquinones
% 212.07/212.24  |- mesh__dateEstablished mesh__D008065 1991-01-01
% 212.07/212.24  |- skos__broader mesh__D008065smesh__D008064
% 212.07/212.24  |- skos__prefLabel mesh__D008065 Lipoidproteinosis
% 212.07/212.24  |- skos__annotation mesh__D008065
% 212.07/212.24       a lipoidosis; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 212.07/212.24  |- mesh__dateCreated mesh__D008065 1999-01-01
% 212.07/212.25  |- skos__hiddenLabel mesh__D008065 Lipoproteinoses
% 212.07/212.25  |- mesh__recordOriginator mesh__D008065 NLM
% 212.07/212.25  |- mesh__publicMeSHNote mesh__D008065
% 212.07/212.25       91; was see under LIPOIDOSIS 1975-90   
% 212.07/212.25  |- rdf__type mesh__D008065sskos__Concept
% 212.07/212.25  |- mesh__recordAuthorizer mesh__D008065 sjn
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D008065 2004
% 212.07/212.25  |- mesh__dateRevised mesh__D008065 2001-07-25
% 212.07/212.25  |- skos__altLabel mesh__D008065 Lipoproteinosis
% 212.07/212.25  |- skos__scopeNote mesh__D008065
% 212.07/212.25       A familial disease occurring in the course of latent diabetes, marked by yellowish nodules on the skin and mucosae, keratotic lesions on the extremities, and hoarseness due to faulty lipid metabolism. %28%Dorland, 27th ed%29%%A%    
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D008065 2002
% 212.07/212.25  |- mesh__onlineNote mesh__D008065 search LIPOIDOSIS 1966-74   
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D008065 2003
% 212.07/212.25  |- mesh__historyNote mesh__D008065
% 212.07/212.25       91%28%75%29%; was see under LIPOIDOSIS 1975-90   
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D008065 2006
% 212.07/212.25  |- mesh__recordMaintainer mesh__D008065 nns
% 212.07/212.25  |- skos__hiddenLabel mesh__D008065 Lipoidproteinoses
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D008065 2005
% 212.07/212.25  |- mesh__recordMaintainer mesh__D000082 ssb
% 212.07/212.25  |- mesh__historyNote mesh__D000082
% 212.07/212.25       1965; for ACEPHEN use MECLOFENOXATE 1990-2002   
% 212.07/212.25  |- skos__altLabel mesh__D000082 p-Acetamidophenol
% 212.07/212.25  |- mesh__dateCreated mesh__D000082 1999-01-01
% 212.07/212.25  |- skos__broader mesh__D000082smesh__D000083
% 212.07/212.25  |- skos__scopeNote mesh__D000082
% 212.07/212.25       Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.%A%    
% 212.07/212.25  |- skos__hiddenLabel mesh__D000082 Anacin3
% 212.07/212.25  |- skos__altLabel mesh__D000082 p-Hydroxyacetanilide
% 212.07/212.25  |- skos__altLabel mesh__D000082 N-Acetyl-p-aminophenol
% 212.07/212.25  |- skos__altLabel mesh__D000082 Acetamidophenol
% 212.07/212.25  |- mesh__dateRevised mesh__D000082 2002-07-02
% 212.07/212.25  |- mesh__recordAuthorizer mesh__D000082 sjn
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D000082 2005
% 212.07/212.25  |- mesh__publicMeSHNote mesh__D000082
% 212.07/212.25       1965; for ACEPHEN see MECLOFENOXATE 1990-2002   
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D000082 2003
% 212.07/212.25  |- skos__altLabel mesh__D000082 Acetominophen
% 212.07/212.25  |- skos__altLabel mesh__D000082 Hydroxyacetanilide
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D000082 2006
% 212.07/212.25  |- skos__altLabel mesh__D000082 APAP
% 212.07/212.25  |- mesh__recordOriginator mesh__D000082 NLM
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D000082 2004
% 212.07/212.25  |- skos__hiddenLabel mesh__D000082 Anacin 3
% 212.07/212.25  |- skos__altLabel mesh__D000082 N-%28%4-Hydroxyphenyl%29%acetanilide
% 212.07/212.25  |- skos__altLabel mesh__D000082 Paracetamol
% 212.07/212.25  |- skos__prefLabel mesh__D000082 Acetaminophen
% 212.07/212.25  |- mesh__dateEstablished mesh__D000082 1965-01-01
% 212.07/212.25  |- rdf__type mesh__D000082sskos__Concept
% 212.07/212.25  |- skos__broader mesh__D013537Q000379smesh__D013537
% 212.07/212.25  |- mesh__preferredCombination mesh__D013537Q000379smesh__D013536
% 212.07/212.25  |- rdf__type mesh__D013537Q000379smesh__CompoundConcept
% 212.07/212.25  |- skos__historyNote mesh__D032962 Informed Consent %28%1974-2002%29%
% 212.07/212.25  |- skos__altLabel mesh__D032962 Informed Consent Forms
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D032962 2004
% 212.07/212.25  |- skos__hiddenLabel mesh__D032962 Document, Informed Consent
% 212.07/212.25  |- mesh__dateEstablished mesh__D032962 2003-01-01
% 212.07/212.25  |- skos__hiddenLabel mesh__D032962 Informed Consent Form
% 212.07/212.25  |- skos__broader mesh__D032962smesh__D007258
% 212.07/212.25  |- skos__hiddenLabel mesh__D032962 Consent Document, Informed
% 212.07/212.25  |- skos__prefLabel mesh__D032962 Consent Forms
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D032962 2003
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D032962 2006
% 212.07/212.25  |- skos__scopeNote mesh__D032962
% 212.07/212.25       Documents describing a medical treatment or research project, including proposed procedures, risks, and alternatives, that are to be signed by an individual, or the individual%27%s proxy, to indicate his/her understanding of the document and a willingness to undergo the treatment or to participate in the research.%A%    
% 212.07/212.25  |- skos__altLabel mesh__D032962 Informed Consent Documents
% 212.07/212.25  |- skos__hiddenLabel mesh__D032962 Informed Consent Document
% 212.07/212.25  |- skos__altLabel mesh__D032962 Consent Documents
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D032962 2005
% 212.07/212.25  |- skos__hiddenLabel mesh__D032962 Documents, Informed Consent
% 212.07/212.25  |- mesh__dateCreated mesh__D032962 2002-07-03
% 212.07/212.25  |- mesh__historyNote mesh__D032962 2003; use INFORMED CONSENT 1998-2002   
% 212.07/212.25  |- skos__broader mesh__D032962smesh__D011996
% 212.07/212.25  |- rdf__type mesh__D032962sskos__Concept
% 212.07/212.25  |- skos__hiddenLabel mesh__D032962 Consent Form
% 212.07/212.25  |- skos__hiddenLabel mesh__D032962 Consent Documents, Informed
% 212.07/212.25  |- mesh__publicMeSHNote mesh__D032962
% 212.07/212.25       2003; see INFORMED CONSENT 1998-2002   
% 212.07/212.25  |- skos__hiddenLabel mesh__D032962 Consent Document
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D018493 2006
% 212.07/212.25  |- mesh__dateCreated mesh__D018493 1994-06-07
% 212.07/212.25  |- skos__broader mesh__D018493smesh__D045124
% 212.07/212.25  |- mesh__recordAuthorizer mesh__D018493 sjn
% 212.07/212.25  |- skos__prefLabel mesh__D018493 Cardiovascular Deconditioning
% 212.07/212.25  |- rdf__type mesh__D018493sskos__Concept
% 212.07/212.25  |- mesh__recordMaintainer mesh__D018493 nns
% 212.07/212.25  |- skos__historyNote mesh__D018493 Cardiovascular System %28%1966-1994%29%
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D018493 2004
% 212.07/212.25  |- mesh__publicMeSHNote mesh__D018493 95   
% 212.07/212.25  |- mesh__dateEstablished mesh__D018493 1995-01-01
% 212.07/212.25  |- skos__altLabel mesh__D018493 Deconditioning, Cardiovascular
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D018493 2005
% 212.07/212.25  |- skos__scopeNote mesh__D018493
% 212.07/212.25       A change in cardiovascular function resulting in a reduction in BLOOD VOLUME, and reflex DIURESIS. It occurs frequently after actual or simulated WEIGHTLESSNESS.%A%    
% 212.07/212.25  |- mesh__dateRevised mesh__D018493 2003-07-09
% 212.07/212.25  |- mesh__recordOriginator mesh__D018493 JLS
% 212.07/212.25  |- mesh__historyNote mesh__D018493 95   
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D004473 2000
% 212.07/212.25  |- skos__broader mesh__D004473smesh__D011711
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D004473 2006
% 212.07/212.25  |- skos__hiddenLabel mesh__D004473 Ecthymas
% 212.07/212.25  |- mesh__recordOriginator mesh__D004473 NLM
% 212.07/212.25  |- skos__scopeNote mesh__D004473
% 212.07/212.25       An ulcerative pyoderma usually caused by group A beta-hemolytic streptococcal infection at the site of minor trauma. %28%Dorland, 27th ed%29%%A%    
% 212.07/212.25  |- mesh__dateCreated mesh__D004473 1999-01-01
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D004473 2005
% 212.07/212.25  |- mesh__recordMaintainer mesh__D004473 PXP
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D004473 2004
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D004473 1999
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D004473 2002
% 212.07/212.25  |- skos__broader mesh__D004473smesh__D017192
% 212.07/212.25  |- mesh__dateRevised mesh__D004473 1994-02-08
% 212.07/212.25  |- rdf__type mesh__D004473sskos__Concept
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D004473 2003
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D004473 1998
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D004473 1997
% 212.07/212.25  |- mesh__recordAuthorizer mesh__D004473 PLS
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D004473 1996
% 212.07/212.25  |- skos__broader mesh__D004473smesh__D013290
% 212.07/212.25  |- skos__annotation mesh__D004473 Strep infect   
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D004473 2001
% 212.07/212.25  |- skos__prefLabel mesh__D004473 Ecthyma
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D004473 1995
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012905 2005
% 212.07/212.25  |- mesh__recordMaintainer mesh__D012905 kle
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012905 2004
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012905 2002
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012905 2006
% 212.07/212.25  |- mesh__publicMeSHNote mesh__D012905
% 212.07/212.25       74; was see under AIR POLLUTION 1969-73   
% 212.07/212.25  |- mesh__recordAuthorizer mesh__D012905 sjn
% 212.07/212.25  |- mesh__dateCreated mesh__D012905 1999-01-01
% 212.07/212.25  |- mesh__historyNote mesh__D012905
% 212.07/212.25       74%28%71%29%; was see under AIR POLLUTION 1969-73   
% 212.07/212.25  |- mesh__recordOriginator mesh__D012905 NLM
% 212.07/212.25  |- mesh__onlineNote mesh__D012905 search AIR POLLUTION 1966-70   
% 212.07/212.25  |- skos__historyNote mesh__D012905 Air Pollution %28%1966-1970%29%
% 212.07/212.25  |- rdf__type mesh__D012905sskos__Concept
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012905 2000
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012905 2001
% 212.07/212.25  |- mesh__dateRevised mesh__D012905 1999-11-03
% 212.07/212.25  |- skos__scopeNote mesh__D012905
% 212.07/212.25       A mixture of smoke and fog polluting the atmosphere. %28%Dorland, 27th ed%29%%A%    
% 212.07/212.25  |- skos__broader mesh__D012905smesh__D000397
% 212.07/212.25  |- mesh__dateEstablished mesh__D012905 1974-01-01
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012905 2003
% 212.07/212.25  |- skos__prefLabel mesh__D012905 Smog
% 212.07/212.25  |- skos__annotation mesh__D012905 IM   
% 212.07/212.25  |- mesh__recordMaintainer mesh__D012107 ssb
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Problem Formulations
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Design, Research
% 212.07/212.25  |- mesh__dateCreated mesh__D012107 1999-01-01
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Source, Error
% 212.07/212.25  |- skos__altLabel mesh__D012107 Experimental Designs
% 212.07/212.25  |- skos__related mesh__D012107smesh__D026661
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Scoring Method
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012107 2005
% 212.07/212.25  |- mesh__publicMeSHNote mesh__D012107 73   
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Measurements
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Proposals, Research
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Reporting, Data
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Qualities, Data
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Research Designs
% 212.07/212.25  |- skos__annotation mesh__D012107
% 212.07/212.25       /methods: consider also RESEARCH or its specifics/methods or METHODS%A%  
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Quality, Data
% 212.07/212.25  |- mesh__historyNote mesh__D012107 73   
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012107 2006
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Data Adjustments
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Sources, Error
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Designs, Research
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Proposal, Research
% 212.07/212.25  |- skos__scopeNote mesh__D012107
% 212.07/212.25       A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly.%A%    
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Method, Scoring
% 212.07/212.25  |- mesh__dateEstablished mesh__D012107 1973-01-01
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Group, Matched
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Groups, Matched
% 212.07/212.25  |- mesh__dateRevised mesh__D012107 2002-07-03
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Formulation, Problem
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Error Source
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Research Proposals
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012107 2003
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Matched Group
% 212.07/212.25  |- skos__prefLabel mesh__D012107 Research Design
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Methods, Scoring
% 212.07/212.25  |- mesh__recordOriginator mesh__D012107 NLM
% 212.07/212.25  |- mesh__recordAuthorizer mesh__D012107 sjn
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Formulations, Problem
% 212.07/212.25  |- rdf__type mesh__D012107sskos__Concept
% 212.07/212.25  |- skos__altLabel mesh__D012107 Designs, Experimental
% 212.07/212.25  |- skos__hiddenLabel mesh__D012107 Data Qualities
% 212.07/212.25  |- skos__broader mesh__D012107smesh__D012106
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012107 2004
% 212.07/212.25  |- skos__altLabel mesh__D012107 Design, Experimental
% 212.07/212.25  |- mesh__recordOriginator mesh__D008864 NLM
% 212.07/212.25  |- mesh__recordAuthorizer mesh__D008864 sjn
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D008864 2006
% 212.07/212.25  |- mesh__recordMaintainer mesh__D008864 ags
% 212.07/212.25  |- mesh__dateCreated mesh__D008864 1999-01-01
% 212.07/212.25  |- rdf__type mesh__D008864sskos__Concept
% 212.07/212.25  |- skos__broader mesh__D008864smesh__D003904
% 212.07/212.25  |- mesh__dateRevised mesh__D008864 2005-06-30
% 212.07/212.25  |- skos__scopeNote mesh__D008864
% 212.07/212.25       A mitosporic Oxygenales fungal genus causing various diseases of the skin and hair. The species Microsporum canis produces TINEA CAPITIS and tinea corporis, which usually are acquired from domestic cats and dogs. Teleomorphs includes Arthroderma %28%Nannizzia%29%. %28%Alexopoulos et al., Introductory Mycology, 4th edition, p305%29%%A%    
% 212.07/212.25  |- skos__annotation mesh__D008864
% 212.07/212.25       do not confuse with the phylum MICROSPORIDIA, the class MICROSPOREA, nor with the order MICROSPORIDA; infection: coordinate IM with DERMATOMYCOSES %28%IM%29% or specific %28%IM%29%; do not confuse with MICROSPORIDIOSIS%A%  
% 212.07/212.25  |- skos__altLabel mesh__D008864 Microsporon
% 212.07/212.25  |- skos__prefLabel mesh__D008864 Microsporum
% 212.07/212.25  |- rdf__type mesh__D000881sskos__Concept
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D000881 2005
% 212.07/212.25  |- mesh__dateCreated mesh__D000881 1999-01-01
% 212.07/212.25  |- skos__prefLabel mesh__D000881 Anthrax
% 212.07/212.25  |- mesh__recordOriginator mesh__D000881 NLM
% 212.07/212.25  |- mesh__recordAuthorizer mesh__D000881 sjn
% 212.07/212.25  |- skos__scopeNote mesh__D000881
% 212.07/212.25       An acute infection caused by the spore-forming bacteria BACILLUS ANTHRACIS. It commonly affects hoofed animals such as sheep and goats. Infection in humans often involves the skin %28%cutaneous anthrax%29%, the lungs %28%inhalation anthrax%29%, or the gastrointestinal tract. Anthrax is not contagious and can be treated with antibiotics.%A%    
% 212.07/212.25  |- skos__broader mesh__D000881smesh__D016863
% 212.07/212.25  |- mesh__recordMaintainer mesh__D000881 sjn
% 212.07/212.25  |- skos__annotation mesh__D000881
% 212.07/212.25       Bacillus infect; human %26% animal; /vet permitted   
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D000881 2006
% 212.07/212.25  |- mesh__dateRevised mesh__D000881 2004-07-13
% 212.07/212.25  |- mesh__historyNote mesh__D008066 80   
% 212.07/212.25  |- skos__historyNote mesh__D008066 Lipids/metabolism %28%1966-1979%29%
% 212.07/212.25  |- mesh__recordOriginator mesh__D008066 VDK
% 212.07/212.25  |- rdf__type mesh__D008066sskos__Concept
% 212.07/212.25  |- mesh__dateRevised mesh__D008066 2005-06-30
% 212.07/212.25  |- skos__hiddenLabel mesh__D008066 Lipolyses
% 212.07/212.25  |- skos__prefLabel mesh__D008066 Lipolysis
% 212.07/212.25  |- skos__scopeNote mesh__D008066
% 212.07/212.25       The metabolic process of breaking down LIPIDS to release FREE FATTY ACIDS, the major oxidative fuel for the body. Lipolysis may involve dietary lipids in the DIGESTIVE TRACT, circulating lipids in the BLOOD, and stored lipids in the ADIPOSE TISSUE or the LIVER. A number of enzymes are involved in such lipid hydrolysis, such as LIPASE and LIPOPROTEIN LIPASE from various tissues.%A%    
% 212.07/212.25  |- mesh__dateEstablished mesh__D008066 1980-01-01
% 212.07/212.25  |- skos__broader mesh__D008066smesh__D050356
% 212.07/212.25  |- skos__historyNote mesh__D008066 Lipid Mobilization %28%1970-1979%29%
% 212.07/212.25  |- mesh__dateCreated mesh__D008066 1979-05-24
% 212.07/212.25  |- mesh__publicMeSHNote mesh__D008066 80   
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D008066 2006
% 212.07/212.25  |- mesh__recordMaintainer mesh__D008066 lkt
% 212.07/212.25  |- skos__annotation mesh__D008066
% 212.07/212.25       metabolic only: not for %22%suction lipolysis%22% of adipose tissue %28% = LIPOLYSIS, SUCTION see LIPECTOMY%29%%A%  
% 212.07/212.25  |- mesh__recordAuthorizer mesh__D008066 sjn
% 212.07/212.25  |- mesh__dateRevised mesh__D000083 2004-07-07
% 212.07/212.25  |- mesh__dateEstablished mesh__D000083 1968-01-01
% 212.07/212.25  |- mesh__dateCreated mesh__D000083 1999-01-01
% 212.07/212.25  |- skos__altLabel mesh__D000083 N-Phenylacetamides
% 212.07/212.25  |- skos__scopeNote mesh__D000083
% 212.07/212.25       Compounds based on N-phenylacetamide, that are similar in structure to 2-PHENYLACETAMIDES. They are precursors of many other compounds. They were formerly used as ANALGESICS and ANTIPYRETICS, but often caused lethal METHEMOGLOBINEMIA.%A%    
% 212.07/212.25  |- skos__broader mesh__D000083smesh__D000813
% 212.07/212.25  |- skos__related mesh__D000083smesh__D044482
% 212.07/212.25  |- mesh__publicMeSHNote mesh__D000083
% 212.07/212.25       79; was ACETANILIDE 1968-78, was ACETANILID 1963-67   
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D000083 2005
% 212.07/212.25  |- skos__altLabel mesh__D000083 Acetanilid
% 212.07/212.25  |- mesh__recordMaintainer mesh__D000083 ssb
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D000083 2006
% 212.07/212.25  |- skos__altLabel mesh__D000083 Acetylanilines
% 212.07/212.25  |- mesh__recordAuthorizer mesh__D000083 sjn
% 212.07/212.25  |- rdf__type mesh__D000083sskos__Concept
% 212.07/212.25  |- mesh__onlineNote mesh__D000083
% 212.07/212.25       use ACETANILIDES to search ACETANILIDE 1968-78 %26% ACETANILID 1966-67%A%  
% 212.07/212.25  |- mesh__historyNote mesh__D000083
% 212.07/212.25       79; was ACETANILIDE 1968-78, was ACETANILID 1963-67   
% 212.07/212.25  |- mesh__recordOriginator mesh__D000083 NLM
% 212.07/212.25  |- skos__prefLabel mesh__D000083 Acetanilides
% 212.07/212.25  |- skos__annotation mesh__D013200
% 212.07/212.25       in otosclerosis surg; do not use /util except by MeSH definition%A%  
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D013200 2002
% 212.07/212.25  |- skos__prefLabel mesh__D013200 Stapes Mobilization
% 212.07/212.25  |- skos__broader mesh__D013200smesh__D013201
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D013200 2004
% 212.07/212.25  |- mesh__recordOriginator mesh__D013200 NLM
% 212.07/212.25  |- skos__scopeNote mesh__D013200
% 212.07/212.25       An operation to remobilize the footplate of the stapes to relieve conductive hearing impairment caused by its immobilization through otosclerosis or middle ear disease. %28%Stedman, 26th ed%29%%A%    
% 212.07/212.25  |- rdf__type mesh__D013200sskos__Concept
% 212.07/212.25  |- mesh__recordAuthorizer mesh__D013200 SJN
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D013200 2003
% 212.07/212.25  |- skos__hiddenLabel mesh__D013200 Mobilizations, Stapes
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D013200 2001
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D013200 1999
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D013200 2006
% 212.07/212.25  |- skos__hiddenLabel mesh__D013200 Stapes Mobilizations
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D013200 2000
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D013200 1998
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D013200 2005
% 212.07/212.25  |- mesh__dateCreated mesh__D013200 1999-01-01
% 212.07/212.25  |- mesh__recordMaintainer mesh__D013200 PXP
% 212.07/212.25  |- skos__hiddenLabel mesh__D013200 Mobilization, Stapes
% 212.07/212.25  |- mesh__dateRevised mesh__D013200 1997-06-20
% 212.07/212.25  |- skos__scopeNote mesh__D018494
% 212.07/212.25       Drugs used for their actions on histaminergic systems. Included are drugs that act at histamine receptors, affect the life cycle of histamine, or affect the state of histaminergic cells.%A%    
% 212.07/212.25  |- rdf__type mesh__D018494sskos__Concept
% 212.07/212.25  |- mesh__recordOriginator mesh__D018494 TPW
% 212.07/212.25  |- skos__altLabel mesh__D018494 Histaminergic Agents
% 212.07/212.25  |- mesh__recordAuthorizer mesh__D018494 sjn
% 212.07/212.25  |- mesh__recordMaintainer mesh__D018494 ssb
% 212.07/212.25  |- skos__broader mesh__D018494smesh__D018377
% 212.07/212.25  |- mesh__dateCreated mesh__D018494 1994-06-03
% 212.07/212.25  |- skos__hiddenLabel mesh__D018494 Drugs, Histamine
% 212.07/212.25  |- skos__historyNote mesh__D018494 Histamine/pharmacology %28%1966-1994%29%
% 212.07/212.25  |- skos__altLabel mesh__D018494 Histaminergic Drugs
% 212.07/212.25  |- mesh__historyNote mesh__D018494 95   
% 212.07/212.25  |- mesh__dateRevised mesh__D018494 2005-06-30
% 212.07/212.25  |- skos__altLabel mesh__D018494 Histamine Drugs
% 212.07/212.25  |- skos__hiddenLabel mesh__D018494 Drugs, Histaminergic
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D018494 2006
% 212.07/212.25  |- mesh__publicMeSHNote mesh__D018494 95   
% 212.07/212.25  |- skos__hiddenLabel mesh__D018494 Agents, Histamine
% 212.07/212.25  |- skos__hiddenLabel mesh__D018494 Agents, Histaminergic
% 212.07/212.25  |- skos__annotation mesh__D018494
% 212.07/212.25       GEN or unspecified; prefer specific groups or specific drugs%A%  
% 212.07/212.25  |- mesh__dateEstablished mesh__D018494 1995-01-01
% 212.07/212.25  |- skos__prefLabel mesh__D018494 Histamine Agents
% 212.07/212.25  |- mesh__recordAuthorizer mesh__D004474 sjn
% 212.07/212.25  |- skos__scopeNote mesh__D004474
% 212.07/212.25       An infectious dermatitis of sheep and goats, affecting primarily the muzzle and lips. It is caused by a poxvirus and may be transmitted to man.%A%    
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D004474 2006
% 212.07/212.25  |- skos__historyNote mesh__D004474 Poxvirus Infections %28%1966-1969%29%
% 212.07/212.25  |- mesh__recordMaintainer mesh__D004474 ags
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D004474 2004
% 212.07/212.25  |- skos__hiddenLabel mesh__D004474 Dermatitides, Contagious Pustular
% 212.07/212.25  |- skos__hiddenLabel mesh__D004474 Pustular Dermatitides, Contagious
% 212.07/212.25  |- mesh__dateEstablished mesh__D004474 1970-01-01
% 212.07/212.25  |- rdf__type mesh__D004474sskos__Concept
% 212.07/212.25  |- mesh__dateRevised mesh__D004474 2003-07-30
% 212.07/212.25  |- skos__broader mesh__D004474smesh__D012757
% 212.07/212.25  |- skos__hiddenLabel mesh__D004474 Pustular Dermatitis, Contagious
% 212.07/212.25  |- skos__altLabel mesh__D004474 Orf
% 212.07/212.25  |- mesh__publicMeSHNote mesh__D004474
% 212.07/212.25       70; was ECTHYMA CONTAGIOSUM see under POXVIRUS INFECTIONS 1963-69%A%  
% 212.07/212.25  |- mesh__recordOriginator mesh__D004474 NLM
% 212.07/212.25  |- skos__historyNote mesh__D004474 Sheep Diseases %28%1966-1969%29%
% 212.07/212.25  |- skos__hiddenLabel mesh__D004474 Contagious Pustular Dermatitides
% 212.07/212.25  |- skos__hiddenLabel mesh__D004474 Contagious Ecthyma
% 212.07/212.25  |- skos__prefLabel mesh__D004474 Ecthyma, Contagious
% 212.07/212.25  |- skos__altLabel mesh__D004474 Contagious Pustular Dermatitis
% 212.07/212.25  |- mesh__onlineNote mesh__D004474 search POXVIRUS INFECTIONS 1966-69   
% 212.07/212.25  |- skos__broader mesh__D004474smesh__D011213
% 212.07/212.25  |- mesh__historyNote mesh__D004474
% 212.07/212.25       70; was ECTHYMA CONTAGIOSUM see under POXVIRUS INFECTIONS 1963-69%A%  
% 212.07/212.25  |- mesh__dateCreated mesh__D004474 1999-01-01
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D004474 2005
% 212.07/212.25  |- skos__historyNote mesh__D004474 Ecthyma %28%1966-1969%29%
% 212.07/212.25  |- skos__altLabel mesh__D004474 Dermatitis, Contagious Pustular
% 212.07/212.25  |- skos__annotation mesh__D004474
% 212.07/212.25       caused by a poxvirus; usually animal; check tag ANIMALS; don%27%t forget also SHEEP %28%NIM%29% but do not index under SHEEP DISEASES%A%  
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012906 1996
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012906 2006
% 212.07/212.25  |- mesh__recordAuthorizer mesh__D012906 PLS
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012906 1998
% 212.07/212.25  |- mesh__recordMaintainer mesh__D012906 TAP
% 212.07/212.25  |- mesh__dateEstablished mesh__D012906 1974-01-01
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012906 1997
% 212.07/212.25  |- skos__hiddenLabel mesh__D012906 Smokes
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012906 1999
% 212.07/212.25  |- mesh__dateCreated mesh__D012906 1999-01-01
% 212.07/212.25  |- rdf__type mesh__D012906sskos__Concept
% 212.07/212.25  |- skos__historyNote mesh__D012906 Air Pollution %28%1966-1970%29%
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012906 2002
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012906 1994
% 212.07/212.25  |- skos__prefLabel mesh__D012906 Smoke
% 212.07/212.25  |- skos__annotation mesh__D012906
% 212.07/212.25       smoke in any environment, not restricted to industrial smokes; can refer to smoke-filled rooms, elevators, trains, aircraft, from any source including fires, tobacco, etc.; coord IM or NIM with source of smoke %28%tobacco smoke = TOBACCO + SMOKE but remember TOBACCO SMOKE POLLUTION is available%29% provided emphasis is on the nature, composition or eff of the smoke; /adv eff: consider also SMOKE INHALATION INJURY%A%  
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012906 1993
% 212.07/212.25  |- mesh__publicMeSHNote mesh__D012906
% 212.07/212.25       74; was see under AIR POLLUTION 1963-73   
% 212.07/212.25  |- skos__broader mesh__D012906smesh__D000397
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012906 1995
% 212.07/212.25  |- mesh__historyNote mesh__D012906
% 212.07/212.25       74%28%71%29%; was see under AIR POLLUTION 1963-73   
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012906 2003
% 212.07/212.25  |- mesh__onlineNote mesh__D012906 search AIR POLLUTION 1966-70   
% 212.07/212.25  |- mesh__recordOriginator mesh__D012906 NLM
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012906 2005
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012906 2000
% 212.07/212.25  |- mesh__dateRevised mesh__D012906 1992-05-18
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012906 2004
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012906 2001
% 212.07/212.25  |- skos__scopeNote mesh__D012108
% 212.07/212.25       Those individuals engaged in research.     
% 212.07/212.25  |- skos__altLabel mesh__D012108 Researchers
% 212.07/212.25  |- mesh__dateEstablished mesh__D012108 1968-01-01
% 212.07/212.25  |- skos__broader mesh__D012108smesh__D009274
% 212.07/212.25  |- skos__altLabel mesh__D012108 Investigators
% 212.07/212.25  |- skos__hiddenLabel mesh__D012108 Investigator
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012108 2006
% 212.07/212.25  |- skos__altLabel mesh__D012108 Clinical Investigator
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012108 2002
% 212.07/212.25  |- skos__hiddenLabel mesh__D012108 Personnel, Survey
% 212.07/212.25  |- mesh__dateCreated mesh__D012108 1999-01-01
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012108 2005
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012108 2001
% 212.07/212.25  |- mesh__recordMaintainer mesh__D012108 kle
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012108 2004
% 212.07/212.25  |- mesh__publicMeSHNote mesh__D012108 68   
% 212.07/212.25  |- skos__hiddenLabel mesh__D012108 Personnel, Research
% 212.07/212.25  |- skos__historyNote mesh__D012108 Research %28%1966-1967%29%
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012108 2000
% 212.07/212.25  |- skos__altLabel mesh__D012108 Investigator, Clinical
% 212.07/212.25  |- rdf__type mesh__D012108sskos__Concept
% 212.07/212.25  |- skos__prefLabel mesh__D012108 Research Personnel
% 212.07/212.25  |- mesh__dateRevised mesh__D012108 1999-11-03
% 212.07/212.25  |- skos__annotation mesh__D012108 IM   
% 212.07/212.25  |- mesh__recordAuthorizer mesh__D012108 sjn
% 212.07/212.25  |- skos__broader mesh__D012108smesh__D009272
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D012108 2003
% 212.07/212.25  |- skos__hiddenLabel mesh__D012108 Researcher
% 212.07/212.25  |- mesh__historyNote mesh__D012108 68   
% 212.07/212.25  |- mesh__recordOriginator mesh__D012108 NLM
% 212.07/212.25  |- skos__altLabel mesh__D012108 Investigators, Clinical
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D008865 2006
% 212.07/212.25  |- mesh__dateRevised mesh__D008865 1999-11-03
% 212.07/212.25  |- mesh__dateEstablished mesh__D008865 1991-01-01
% 212.07/212.25  |- skos__hiddenLabel mesh__D008865 Microstomias
% 212.07/212.25  |- skos__historyNote mesh__D008865 Mouth Abnormalities %28%1966-1970%29%
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D008865 2005
% 212.07/212.25  |- mesh__historyNote mesh__D008865
% 212.07/212.25       91%28%71%29%; was see under MOUTH DISEASES 1971-90   
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D008865 2004
% 212.07/212.25  |- skos__annotation mesh__D008865
% 212.07/212.25       unusually small mouth; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D008865 2002
% 212.07/212.25  |- skos__broader mesh__D008865smesh__D009056
% 212.07/212.25  |- mesh__recordOriginator mesh__D008865 NLM
% 212.07/212.25  |- mesh__recordAuthorizer mesh__D008865 sjn
% 212.07/212.25  |- mesh__dateCreated mesh__D008865 1999-01-01
% 212.07/212.25  |- mesh__activeMeSHYear mesh__D008865 2003
% 212.07/212.25  |- rdf__type mesh__D008865sskos__Concept
% 212.07/212.26  |- skos__scopeNote mesh__D008865
% 212.07/212.26       A congenital defect in which the mouth is unusually small. %28%Dorland, 27th ed%29%%A%    
% 212.07/212.26  |- mesh__publicMeSHNote mesh__D008865
% 212.07/212.26       91; was see under MOUTH DISEASES 1971-90   
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D008865 2001
% 212.07/212.26  |- skos__prefLabel mesh__D008865 Microstomia
% 212.07/212.26  |- mesh__recordMaintainer mesh__D008865 kle
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D008865 2000
% 212.07/212.26  |- skos__historyNote mesh__D008865 Mouth Diseases %28%1966-1970%29%
% 212.07/212.26  |- rdf__type mesh__D000882sskos__Concept
% 212.07/212.26  |- mesh__dateRevised mesh__D000882 2005-06-30
% 212.07/212.26  |- mesh__publicMeSHNote mesh__D000882
% 212.07/212.26       92; was ANTHROPOIDEA 1981-91; was ANTHROPOIDS see under PRIMATES 1963-80; MONKEYS was heading 1963-80%A%  
% 212.07/212.26  |- skos__broader mesh__D000882smesh__D011323
% 212.07/212.26  |- mesh__historyNote mesh__D000882
% 212.07/212.26       92; was ANTHROPOIDEA 1981-91; was ANTHROPOIDS see under PRIMATES 1963-80; MONKEYS was heading 1963-80%A%  
% 212.07/212.26  |- skos__altLabel mesh__D000882 Anthropoids
% 212.07/212.26  |- mesh__recordMaintainer mesh__D000882 ags
% 212.07/212.26  |- mesh__onlineNote mesh__D000882
% 212.07/212.26       use HAPLORHINI to search ANTHROPOIDEA 1975-91 %26% MONKEYS 1966-80; use PRIMATES to search ANTHROPOIDS 1966-74%A%  
% 212.07/212.26  |- skos__scopeNote mesh__D000882
% 212.07/212.26       A suborder of PRIMATES consisting of six families: CEBIDAE %28%some New World monkeys%29%, ATELIDAE %28%some New World monkeys%29%, CERCOPITHECIDAE %28%Old World monkeys%29%, HYLOBATIDAE %28%gibbons and siamangs%29%, CALLITRICHIDAE %28%marmosets and tamarins%29%, and HOMINIDAE %28%humans and great apes%29%.%A%    
% 212.07/212.26  |- mesh__recordOriginator mesh__D000882 NLM
% 212.07/212.26  |- skos__prefLabel mesh__D000882 Haplorhini
% 212.07/212.26  |- mesh__recordAuthorizer mesh__D000882 sjn
% 212.07/212.26  |- skos__hiddenLabel mesh__D000882 Monkey
% 212.07/212.26  |- mesh__dateCreated mesh__D000882 1999-01-01
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D000882 2006
% 212.07/212.26  |- mesh__dateEstablished mesh__D000882 1981-01-01
% 212.07/212.26  |- skos__annotation mesh__D000882
% 212.07/212.26       note X refs; many Old World %26% New World monkey families %26% genera are available: diseases of monkey families %26% genera: coordinate IM with MONKEY DISEASES %28%IM%29%; Manual 22.28+%A%  
% 212.07/212.26  |- skos__broader mesh__D004194Q000188smesh__D004194
% 212.07/212.26  |- mesh__preferredCombination mesh__D004194Q000188smesh__D004358
% 212.07/212.26  |- rdf__type mesh__D004194Q000188smesh__CompoundConcept
% 212.07/212.26  |- skos__hiddenLabel mesh__D008067 Hibernomas
% 212.07/212.26  |- mesh__recordOriginator mesh__D008067 NLM
% 212.07/212.26  |- mesh__onlineNote mesh__D008067
% 212.07/212.26       use LIPOMA to search FATTY TUMOR 1966-67   
% 212.07/212.26  |- mesh__recordAuthorizer mesh__D008067 sjn
% 212.07/212.26  |- rdf__type mesh__D008067sskos__Concept
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D008067 2003
% 212.07/212.26  |- skos__altLabel mesh__D008067 Fatty Tumor
% 212.07/212.26  |- mesh__historyNote mesh__D008067 FATTY TUMOR was heading 1963-67   
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D008067 2000
% 212.07/212.26  |- skos__hiddenLabel mesh__D008067 Fatty Tumors
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D008067 2004
% 212.07/212.26  |- skos__hiddenLabel mesh__D008067 Tumors, Fatty
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D008067 2005
% 212.07/212.26  |- skos__hiddenLabel mesh__D008067 Tumor, Fatty
% 212.07/212.26  |- skos__hiddenLabel mesh__D008067 Pleomorphic Lipoma
% 212.07/212.26  |- skos__prefLabel mesh__D008067 Lipoma
% 212.07/212.26  |- skos__broader mesh__D008067smesh__D018205
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D008067 2001
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D008067 2006
% 212.07/212.26  |- mesh__recordMaintainer mesh__D008067 KEV
% 212.07/212.26  |- mesh__dateRevised mesh__D008067 1999-11-03
% 212.07/212.26  |- mesh__publicMeSHNote mesh__D008067 FATTY TUMOR was heading 1963-67   
% 212.07/212.26  |- skos__hiddenLabel mesh__D008067 Pleomorphic Lipomas
% 212.07/212.26  |- mesh__dateCreated mesh__D008067 1999-01-01
% 212.07/212.26  |- skos__scopeNote mesh__D008067 A benign tumor composed of fat cells.     
% 212.07/212.26  |- skos__hiddenLabel mesh__D008067 Lipomas, Pleomorphic
% 212.07/212.26  |- skos__annotation mesh__D008067
% 212.07/212.26       solitary; multiple = LIPOMATOSIS; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 212.07/212.26  |- skos__hiddenLabel mesh__D008067 Lipomas
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D008067 2002
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D000084 2006
% 212.07/212.26  |- skos__historyNote mesh__D000084 Acetates %28%1966-1978%29%
% 212.07/212.26  |- mesh__recordAuthorizer mesh__D000084 sjn
% 212.07/212.26  |- skos__hiddenLabel mesh__D000084 Kinase, Acetate
% 212.07/212.26  |- mesh__dateRevised mesh__D000084 2003-07-09
% 212.07/212.26  |- skos__historyNote mesh__D000084 Acetic Acids %28%1968-1978%29%
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D000084 2004
% 212.07/212.26  |- skos__prefLabel mesh__D000084 Acetate Kinase
% 212.07/212.26  |- mesh__dateEstablished mesh__D000084 1991-01-01
% 212.07/212.26  |- mesh__recordOriginator mesh__D000084 RLS
% 212.07/212.26  |- mesh__dateCreated mesh__D000084 1977-12-08
% 212.07/212.26  |- skos__altLabel mesh__D000084 Acetokinase
% 212.07/212.26  |- rdf__type mesh__D000084sskos__Concept
% 212.07/212.26  |- skos__scopeNote mesh__D000084
% 212.07/212.26       An enzyme that catalyzes reversibly the phosphorylation of acetate in the presence of a divalent cation and ATP with the formation of acetylphosphate and ADP. It is important in the glycolysis process. EC 2.7.2.1.%A%    
% 212.07/212.26  |- mesh__historyNote mesh__D000084
% 212.07/212.26       91%28%79%29%; was see under PHOSPHOTRANSFERASES, ATP 1979-90   
% 212.07/212.26  |- skos__historyNote mesh__D000084 Phosphotransferases %28%1966-1973%29%
% 212.07/212.26  |- skos__broader mesh__D000084smesh__D017851
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D000084 2005
% 212.07/212.26  |- mesh__publicMeSHNote mesh__D000084
% 212.07/212.26       91; was see under PHOSPHOTRANSFERASES, ATP 1979-90   
% 212.07/212.26  |- mesh__recordMaintainer mesh__D000084 ssb
% 212.07/212.26  |- skos__historyNote mesh__D000084
% 212.07/212.26       Phosphotransferases, ATP %28%1974-1978%29%
% 212.07/212.26  |- mesh__dateEstablished mesh__D013201 1964-01-01
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013201 2000
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013201 1999
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013201 2006
% 212.07/212.26  |- skos__hiddenLabel mesh__D013201 Surgeries, Stapes
% 212.07/212.26  |- mesh__recordMaintainer mesh__D013201 PXP
% 212.07/212.26  |- skos__altLabel mesh__D013201 Surgery, Stapes
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013201 1998
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013201 2005
% 212.07/212.26  |- mesh__dateRevised mesh__D013201 1997-06-20
% 212.07/212.26  |- mesh__dateCreated mesh__D013201 1999-01-01
% 212.07/212.26  |- mesh__historyNote mesh__D013201 64   
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013201 2002
% 212.07/212.26  |- mesh__publicMeSHNote mesh__D013201 64   
% 212.07/212.26  |- skos__annotation mesh__D013201
% 212.07/212.26       do not use /util except by MeSH definition; STAPES MOBILIZATION is also available%A%  
% 212.07/212.26  |- skos__prefLabel mesh__D013201 Stapes Surgery
% 212.07/212.26  |- mesh__recordOriginator mesh__D013201 NLM
% 212.07/212.26  |- skos__broader mesh__D013201smesh__D013506
% 212.07/212.26  |- skos__hiddenLabel mesh__D013201 Stapes Surgeries
% 212.07/212.26  |- mesh__recordAuthorizer mesh__D013201 SJN
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013201 2004
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013201 2001
% 212.07/212.26  |- rdf__type mesh__D013201sskos__Concept
% 212.07/212.26  |- skos__hiddenLabel mesh__D013201 Stapedectomies
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013201 2003
% 212.07/212.26  |- skos__broader mesh__D018495smesh__D001686
% 212.07/212.26  |- skos__related mesh__D018495smesh__D008150
% 212.07/212.26  |- mesh__dateEstablished mesh__D018495 1995-01-01
% 212.07/212.26  |- skos__hiddenLabel mesh__D018495 Shifts, Fluid
% 212.07/212.26  |- mesh__dateRevised mesh__D018495 2004-07-07
% 212.07/212.26  |- mesh__publicMeSHNote mesh__D018495 95   
% 212.07/212.26  |- skos__historyNote mesh__D018495 Body Fluids/physiology %28%1966-1994%29%
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D018495 2005
% 212.07/212.26  |- mesh__historyNote mesh__D018495 95   
% 212.07/212.26  |- mesh__recordOriginator mesh__D018495 JLS
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D018495 2006
% 212.07/212.26  |- mesh__dateCreated mesh__D018495 1994-06-07
% 212.07/212.26  |- skos__prefLabel mesh__D018495 Fluid Shifts
% 212.07/212.26  |- rdf__type mesh__D018495sskos__Concept
% 212.07/212.26  |- mesh__recordAuthorizer mesh__D018495 sjn
% 212.07/212.26  |- skos__scopeNote mesh__D018495
% 212.07/212.26       Translocation of body fluids from one compartment to another, such as from the vascular to the interstitial compartments. Fluid shifts are associated with profound changes in vascular permeability and WATER-ELECTROLYTE IMBALANCE. The shift can also be from the lower body to the upper body as in conditions of weightlessness.%A%    
% 212.07/212.26  |- mesh__recordMaintainer mesh__D018495 lkt
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D004475 2004
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D004475 1996
% 212.07/212.26  |- mesh__recordMaintainer mesh__D004475 PLS
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D004475 1999
% 212.07/212.26  |- rdf__type mesh__D004475sskos__Concept
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D004475 2000
% 212.07/212.26  |- mesh__recordAuthorizer mesh__D004475 NLM
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D004475 1997
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D004475 2001
% 212.07/212.26  |- skos__annotation mesh__D004475 A 11 qualif   
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D004475 1991
% 212.07/212.26  |- mesh__dateRevised mesh__D004475 1990-05-26
% 212.07/212.26  |- skos__scopeNote mesh__D004475
% 212.07/212.26       The outer of the three germ layers of the embryo.     
% 212.07/212.26  |- skos__broader mesh__D004475smesh__D005855
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D004475 2002
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D004475 1994
% 212.07/212.26  |- mesh__dateCreated mesh__D004475 1999-01-01
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D004475 2005
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D004475 1992
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D004475 1995
% 212.07/212.26  |- mesh__recordOriginator mesh__D004475 NLM
% 212.07/212.26  |- skos__hiddenLabel mesh__D004475 Ectoderms
% 212.07/212.26  |- skos__prefLabel mesh__D004475 Ectoderm
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D004475 2003
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D004475 2006
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D004475 1998
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D004475 1993
% 212.07/212.26  |- skos__related mesh__D012907smesh__D014029
% 212.07/212.26  |- mesh__recordAuthorizer mesh__D012907 sjn
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D012907 2003
% 212.07/212.26  |- mesh__recordOriginator mesh__D012907 NLM
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D012907 2006
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D012907 2005
% 212.07/212.26  |- mesh__recordMaintainer mesh__D012907 TGC
% 212.07/212.26  |- rdf__type mesh__D012907sskos__Concept
% 212.07/212.26  |- skos__related mesh__D012907smesh__D014028
% 212.07/212.26  |- skos__hiddenLabel mesh__D012907 Smokings
% 212.07/212.26  |- mesh__dateCreated mesh__D012907 1999-01-01
% 212.07/212.26  |- mesh__dateRevised mesh__D012907 2002-07-03
% 212.07/212.26  |- skos__prefLabel mesh__D012907 Smoking
% 212.07/212.26  |- skos__annotation mesh__D012907
% 212.07/212.26       almost exclusively tobacco smoking: not for smoking marijuana %28% = MARIJUANA SMOKING%29%; smokers%27% patches, smokers%27% tongue = LEUKOPLAKIA, ORAL; cancer caused by smoking = organ/neopl term with /etiol %28%not /chem ind%29% + SMOKING /adv eff %28%not TOBACCO USE DISORDER%29%; passive smoking = TOBACCO SMOKE POLLUTION; SMOKING CESSATION is also available%A%  
% 212.07/212.26  |- skos__broader mesh__D012907smesh__D006184
% 212.07/212.26  |- skos__scopeNote mesh__D012907
% 212.07/212.26       Inhaling and exhaling the smoke of tobacco or something similar to tobacco.%A%    
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D012907 2004
% 212.07/212.26  |- skos__hiddenLabel mesh__D012109 Research Supports
% 212.07/212.26  |- skos__hiddenLabel mesh__D012109 Support, Research
% 212.07/212.26  |- skos__annotation mesh__D012109 SPEC qualif   
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D012109 2000
% 212.07/212.26  |- mesh__dateCreated mesh__D012109 1999-01-01
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D012109 2005
% 212.07/212.26  |- skos__broader mesh__D012109smesh__D012586
% 212.07/212.26  |- mesh__recordAuthorizer mesh__D012109 sjn
% 212.07/212.26  |- mesh__dateEstablished mesh__D012109 1966-01-01
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D012109 2004
% 212.07/212.26  |- mesh__recordOriginator mesh__D012109 NLM
% 212.07/212.26  |- mesh__historyNote mesh__D012109 66%28%64%29%   
% 212.07/212.26  |- rdf__type mesh__D012109sskos__Concept
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D012109 2003
% 212.07/212.26  |- mesh__publicMeSHNote mesh__D012109 66   
% 212.07/212.26  |- skos__hiddenLabel mesh__D012109 Research Subsidies
% 212.07/212.26  |- skos__hiddenLabel mesh__D012109 Research Subsidy
% 212.07/212.26  |- skos__hiddenLabel mesh__D012109 Supports, Research
% 212.07/212.26  |- skos__broader mesh__D012109smesh__D005378
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D012109 2002
% 212.07/212.26  |- skos__prefLabel mesh__D012109 Research Support
% 212.07/212.26  |- skos__scopeNote mesh__D012109
% 212.07/212.26       Financial support of research activities.     
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D012109 2006
% 212.07/212.26  |- skos__hiddenLabel mesh__D012109 Subsidy, Research
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D012109 2001
% 212.07/212.26  |- mesh__recordMaintainer mesh__D012109 kle
% 212.07/212.26  |- mesh__dateRevised mesh__D012109 1999-11-03
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D009160 2000
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D009160 2004
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D009160 2001
% 212.07/212.26  |- skos__annotation mesh__D009160
% 212.07/212.26       IM; specify species of Mycobacterium if possible %28%IM or NIM%29%%A%  
% 212.07/212.26  |- mesh__recordMaintainer mesh__D009160 AGS
% 212.07/212.26  |- mesh__dateRevised mesh__D009160 1992-05-15
% 212.07/212.26  |- rdf__type mesh__D009160sskos__Concept
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D009160 2002
% 212.07/212.26  |- skos__prefLabel mesh__D009160 Mycobacteriophages
% 212.07/212.26  |- skos__broader mesh__D009160smesh__D001435
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D009160 1994
% 212.07/212.26  |- mesh__recordAuthorizer mesh__D009160 PLS
% 212.07/212.26  |- mesh__dateCreated mesh__D009160 1999-01-01
% 212.07/212.26  |- skos__hiddenLabel mesh__D009160 Mycobacteriophage
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D009160 1998
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D009160 1995
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D009160 1999
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D009160 1993
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D009160 1996
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D009160 2005
% 212.07/212.26  |- mesh__recordOriginator mesh__D009160 NLM
% 212.07/212.26  |- skos__scopeNote mesh__D009160
% 212.07/212.26       Viruses whose host is one or more Mycobacterium species. They include both temperate and virulent types.%A%    
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D009160 1997
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D009160 2006
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D009160 2003
% 212.07/212.26  |- skos__broader mesh__D004298Q000819smesh__D004298
% 212.07/212.26  |- mesh__preferredCombination mesh__D004298Q000819smesh__D018491
% 212.07/212.26  |- rdf__type mesh__D004298Q000819smesh__CompoundConcept
% 212.07/212.26  |- mesh__dateRevised mesh__D008866 2004-07-07
% 212.07/212.26  |- mesh__publicMeSHNote mesh__D008866 72   
% 212.07/212.26  |- mesh__recordMaintainer mesh__D008866 nns
% 212.07/212.26  |- mesh__dateEstablished mesh__D008866 1972-01-01
% 212.07/212.26  |- skos__broader mesh__D008866smesh__D008846
% 212.07/212.26  |- skos__broader mesh__D008866smesh__D013514
% 212.07/212.26  |- rdf__type mesh__D008866sskos__Concept
% 212.07/212.26  |- mesh__historyNote mesh__D008866 72%28%69%29%   
% 212.07/212.26  |- skos__historyNote mesh__D008866
% 212.07/212.26       Surgical Procedures, Operative %28%1966-1968%29%
% 212.07/212.26  |- skos__prefLabel mesh__D008866 Microsurgery
% 212.07/212.26  |- skos__scopeNote mesh__D008866
% 212.07/212.26       The performance of surgical procedures with the aid of a microscope.%A%    
% 212.07/212.26  |- mesh__recordAuthorizer mesh__D008866 sjn
% 212.07/212.26  |- mesh__recordOriginator mesh__D008866 NLM
% 212.07/212.26  |- skos__related mesh__D008866smesh__D042282
% 212.07/212.26  |- skos__historyNote mesh__D008866 Microscopy %28%1966-1968%29%
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D008866 2005
% 212.07/212.26  |- mesh__dateCreated mesh__D008866 1999-01-01
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D008866 2006
% 212.07/212.26  |- skos__annotation mesh__D000883
% 212.07/212.26       IM as SPEC: SPEC qualif; HOMINIDAE is available as taxonomic Man; NIM as coord with no qualif; med anthropology: do not coord with MEDICINE; DF: ANTHROPOL%A%  
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D000883 2004
% 212.07/212.26  |- skos__related mesh__D000883smesh__D015186
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D000883 2001
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D000883 2000A
% 212.07/212.26  |- skos__scopeNote mesh__D000883
% 212.07/212.26       The science devoted to the comparative study of man.     
% 212.07/212.26  |- mesh__recordMaintainer mesh__D000883 ags
% 212.07/212.26  |- skos__broader mesh__D000883smesh__D012942
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D000883 2005
% 212.07/212.26  |- mesh__dateCreated mesh__D000883 1999-01-01
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D000883 2002
% 212.07/212.26  |- skos__prefLabel mesh__D000883 Anthropology
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D000883 2006
% 212.07/212.26  |- mesh__recordOriginator mesh__D000883 NLM
% 212.07/212.26  |- rdf__type mesh__D000883sskos__Concept
% 212.07/212.26  |- mesh__dateRevised mesh__D000883 1999-12-28
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D000883 2003
% 212.07/212.26  |- mesh__recordAuthorizer mesh__D000883 ags
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D000883 2000
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D008068 2004
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D008068 2005
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D008068 2006
% 212.07/212.26  |- mesh__recordMaintainer mesh__D008068 adp
% 212.07/212.26  |- skos__hiddenLabel mesh__D008068 Lipomatoses
% 212.07/212.26  |- mesh__dateCreated mesh__D008068 1999-01-01
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D008068 2002
% 212.07/212.26  |- mesh__recordOriginator mesh__D008068 NLM
% 212.07/212.26  |- skos__scopeNote mesh__D008068
% 212.07/212.26       A disorder consisting of the accumulation of abnormal localized, or tumor-like fat in the tissues.%A%    
% 212.07/212.26  |- skos__prefLabel mesh__D008068 Lipomatosis
% 212.07/212.26  |- mesh__dateRevised mesh__D008068 1999-11-08
% 212.07/212.26  |- skos__annotation mesh__D008068
% 212.07/212.26       solitary is probably LIPOMA which is neoplastic; do not use /blood supply /chem /second /secret /ultrastruct; coord IM with precoord organ/dis term %28%IM%29% if relevant; LIPOMATOSIS, MULTIPLE SYMMETRICAL is also available%A%  
% 212.07/212.26  |- mesh__recordAuthorizer mesh__D008068 sjn
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D008068 2000
% 212.07/212.26  |- skos__broader mesh__D008068smesh__D012871
% 212.07/212.26  |- rdf__type mesh__D008068sskos__Concept
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D008068 2003
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D008068 2001
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D000085 2004
% 212.07/212.26  |- skos__broader mesh__D000085smesh__D019342
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D000085 1999
% 212.07/212.26  |- rdf__type mesh__D000085sskos__Concept
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D000085 2000
% 212.07/212.26  |- skos__annotation mesh__D000085 GEN or unspecified; prefer specifics   
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D000085 2001
% 212.07/212.26  |- mesh__dateCreated mesh__D000085 1999-01-01
% 212.07/212.26  |- mesh__recordOriginator mesh__D000085 NLM
% 212.07/212.26  |- skos__hiddenLabel mesh__D000085 Esters, Acetic Acid
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D000085 2005
% 212.07/212.26  |- mesh__recordMaintainer mesh__D000085 ADP
% 212.07/212.26  |- mesh__publicMeSHNote mesh__D000085
% 212.07/212.26       ACETIC ACID ESTERS was heading 1975-96 %28%see under ACETIC ACIDS 1975-90%29%%A%  
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D000085 2002
% 212.07/212.26  |- skos__prefLabel mesh__D000085 Acetates
% 212.07/212.26  |- mesh__historyNote mesh__D000085
% 212.07/212.26       ACETIC ACID ESTERS was heading 1975-96 %28%see under ACETIC ACIDS 1975-90%29%%A%  
% 212.07/212.26  |- skos__hiddenLabel mesh__D000085 Acid Esters, Acetic
% 212.07/212.26  |- mesh__recordAuthorizer mesh__D000085 SJN
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D000085 2003
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D000085 2006
% 212.07/212.26  |- skos__scopeNote mesh__D000085
% 212.07/212.26       Salts or esters of acetic acid in which the terminal hydrogen atom is replaced by a metal, for instance copper acetate Cu%28%CH3COO%29%2, or where substitution is by a radical, for instance ethyl acetate CH3COOC2H5. %28%From Hawley%27%s Condensed Chemical Dictionary, 12th ed%29%%A%    
% 212.07/212.26  |- mesh__dateRevised mesh__D000085 1998-06-10
% 212.07/212.26  |- skos__hiddenLabel mesh__D013202 Poisonings, Staphylococcal Food
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013202 1995
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013202 2001
% 212.07/212.26  |- mesh__publicMeSHNote mesh__D013202 68   
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013202 1998
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013202 2005
% 212.07/212.26  |- mesh__dateCreated mesh__D013202 1999-01-01
% 212.07/212.26  |- skos__broader mesh__D013202smesh__D013203
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013202 1994
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013202 2000
% 212.07/212.26  |- skos__scopeNote mesh__D013202
% 212.07/212.26       Poisoning by staphylococcal toxins present in contaminated food.%A%    
% 212.07/212.26  |- skos__hiddenLabel mesh__D013202 Staphylococcal Food Poisonings
% 212.07/212.26  |- skos__prefLabel mesh__D013202 Staphylococcal Food Poisoning
% 212.07/212.26  |- skos__annotation mesh__D013202 DF: STAPH FOOD POIS   
% 212.07/212.26  |- mesh__historyNote mesh__D013202 68%28%66%29%   
% 212.07/212.26  |- skos__broader mesh__D013202smesh__D005517
% 212.07/212.26  |- skos__altLabel mesh__D013202 Poisoning, Staphylococcal Food
% 212.07/212.26  |- mesh__recordMaintainer mesh__D013202 TAP
% 212.07/212.26  |- mesh__recordAuthorizer mesh__D013202 PLS
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013202 1997
% 212.07/212.26  |- mesh__dateRevised mesh__D013202 1992-05-18
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013202 2004
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013202 2002
% 212.07/212.26  |- rdf__type mesh__D013202sskos__Concept
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013202 1993
% 212.07/212.26  |- mesh__dateEstablished mesh__D013202 1968-01-01
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013202 1996
% 212.07/212.26  |- skos__altLabel mesh__D013202 Food Poisoning, Staphylococcal
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013202 2003
% 212.07/212.26  |- mesh__recordOriginator mesh__D013202 NLM
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013202 1999
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D013202 2006
% 212.07/212.26  |- skos__hiddenLabel mesh__D013202 Food Poisonings, Staphylococcal
% 212.07/212.26  |- skos__broader mesh__D020051Q000172smesh__D020051
% 212.07/212.26  |- mesh__preferredCombination mesh__D020051Q000172smesh__D009087
% 212.07/212.26  |- rdf__type mesh__D020051Q000172smesh__CompoundConcept
% 212.07/212.26  |- skos__historyNote mesh__D018496 Oxygen/toxicity %28%1966-1994%29%
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D018496 2005
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D018496 2000
% 212.07/212.26  |- mesh__historyNote mesh__D018496 95   
% 212.07/212.26  |- mesh__recordOriginator mesh__D018496 JLS
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D018496 2006
% 212.07/212.26  |- skos__annotation mesh__D018496
% 212.07/212.26       restrict to dis or clin state in humans or higher animals: do not confuse with hyperoxic state in lower animals or micro-organisms %28% = OXYGEN or AEROBIOSIS%29%; do not confuse with HYPOXIA see ANOXIA%A%  
% 212.07/212.26  |- mesh__dateCreated mesh__D018496 1994-06-07
% 212.07/212.26  |- mesh__dateRevised mesh__D018496 1999-11-03
% 212.07/212.26  |- mesh__dateEstablished mesh__D018496 1995-01-01
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D018496 2001
% 212.07/212.26  |- mesh__publicMeSHNote mesh__D018496 95   
% 212.07/212.26  |- rdf__type mesh__D018496sskos__Concept
% 212.07/212.26  |- skos__hiddenLabel mesh__D018496 Hyperoxias
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D018496 2002
% 212.07/212.26  |- skos__broader mesh__D018496smesh__D012818
% 212.07/212.26  |- mesh__recordMaintainer mesh__D018496 KEV
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D018496 2003
% 212.07/212.26  |- skos__scopeNote mesh__D018496
% 212.07/212.26       An abnormal increase in the amount of oxygen in the tissues and organs.%A%    
% 212.07/212.26  |- skos__prefLabel mesh__D018496 Hyperoxia
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D018496 2004
% 212.07/212.26  |- mesh__recordAuthorizer mesh__D018496 sjn
% 212.07/212.26  |- mesh__historyNote mesh__D004476
% 212.07/212.26       65; CHRIST-SIEMENS SYNDROME was see ECTODERMAL DYSPLASIA 1987-92; CHRIST-SIEMENS-WEECH SYNDROME was see ECTODERMAL DYSPLASIA 1968-86; CHRIS-SIEMENS-WEECH SYNDROME was see ECTODERMAL DYSPLASIA 1965-67; ECTODERMAL DEFECT, CONGENITAL was heading 1963-86%A%  
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D004476 2004
% 212.07/212.26  |- mesh__recordMaintainer mesh__D004476 nns
% 212.07/212.26  |- skos__prefLabel mesh__D004476 Ectodermal Dysplasia
% 212.07/212.26  |- skos__hiddenLabel mesh__D004476 Ectodermal Dysplasias, Hidrotic
% 212.07/212.26  |- skos__broader mesh__D004476smesh__D012873
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D004476 2002
% 212.07/212.26  |- skos__altLabel mesh__D004476 Clouston%27%s Syndrome
% 212.07/212.26  |- skos__hiddenLabel mesh__D004476 Congenital Ectodermal Defects
% 212.07/212.26  |- skos__hiddenLabel mesh__D004476 Clouston Syndrome
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D004476 2003
% 212.07/212.26  |- skos__hiddenLabel mesh__D004476 Anhidrotic Ectodermal Dysplasias
% 212.07/212.26  |- skos__hiddenLabel mesh__D004476 Christ Siemens Touraine Syndrome
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D004476 2006
% 212.07/212.26  |- skos__hiddenLabel mesh__D004476 Syndrome, Christ-Siemens-Touraine
% 212.07/212.26  |- skos__hiddenLabel mesh__D004476 Defects, Congenital Ectodermal
% 212.07/212.26  |- rdf__type mesh__D004476sskos__Concept
% 212.07/212.26  |- mesh__recordAuthorizer mesh__D004476 sjn
% 212.07/212.26  |- skos__broader mesh__D004476smesh__D025064
% 212.07/212.26  |- skos__hiddenLabel mesh__D004476 Ectodermal Dysplasias, Anhidrotic
% 212.07/212.26  |- mesh__onlineNote mesh__D004476
% 212.07/212.26       use ECTODERMAL DYSPLASIA to search CHRIST-SIEMENS SYNDROME 1987-92, CHRIST-SIEMENS-WEECH SYNDROME 1968-86, CHRIS-SIEMENS-WEECH SYNDROME 1966, %26% ECTODERMAL DEFECT, CONGENITAL 1966-86%A%  
% 212.07/212.26  |- skos__hiddenLabel mesh__D004476 Hidrotic Ectodermal Dysplasias
% 212.07/212.26  |- skos__hiddenLabel mesh__D004476 Ectodermal Dysplasias
% 212.07/212.26  |- skos__hiddenLabel mesh__D004476 Dysplasia, Ectodermal
% 212.07/212.26  |- skos__hiddenLabel mesh__D004476 Dysplasia, Hidrotic Ectodermal
% 212.07/212.26  |- mesh__activeMeSHYear mesh__D004476 2005
% 212.07/212.26  |- skos__scopeNote mesh__D004476
% 212.07/212.26       A group of hereditary disorders involving tissues and structures derived from the embryonic ectoderm. They are characterized by the presence of abnormalities at birth and involvement of both the epidermis and skin appendages. They are generally nonprogressive and diffuse. Various forms exist, including anhidrotic and hidrotic dysplasias, FOCAL DERMAL HYPOPLASIA, and aplasia cutis congenita.%A%    
% 212.07/212.26  |- mesh__publicMeSHNote mesh__D004476
% 212.07/212.26       65; CHRIST-SIEMENS SYNDROME was see ECTODERMAL DYSPLASIA 1987-92; CHRIST-SIEMENS-WEECH SYNDROME was see ECTODERMAL DYSPLASIA 1968-86; CHRIS-SIEMENS-WEECH SYNDROME was see ECTODERMAL DYSPLASIA 1965-67; ECTODERMAL DEFECT, CONGENITAL was heading 1963-86%A%  
% 212.07/212.26  |- skos__altLabel mesh__D004476 Anhidrotic Ectodermal Dysplasia
% 212.07/212.26  |- skos__altLabel mesh__D004476 Congenital Ectodermal Defect
% 212.07/212.26  |- skos__broader mesh__D004476smesh__D012868
% 212.07/212.26  |- skos__hiddenLabel mesh__D004476 Dysplasias, Ectodermal
% 212.07/212.26  |- skos__annotation mesh__D004476
% 212.07/212.26       multiple skin abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 212.07/212.26  |- skos__altLabel mesh__D004476 Defect, Congenital Ectodermal
% 212.07/212.26  |- mesh__dateRevised mesh__D004476 2001-07-25
% 212.07/212.26  |- skos__altLabel mesh__D004476 Ectodermal Defect, Congenital
% 212.07/212.26  |- mesh__dateCreated mesh__D004476 1999-01-01
% 212.07/212.26  |- skos__hiddenLabel mesh__D004476 Ectodermal Dysplasia, Hidrotic
% 212.07/212.26  |- skos__broader mesh__D004476smesh__D000015
% 212.07/212.26  |- skos__hiddenLabel mesh__D004476 Ectodermal Defects, Congenital
% 212.07/212.26  |- mesh__recordOriginator mesh__D004476 NLM
% 212.07/212.27  |- skos__hiddenLabel mesh__D004476 Dysplasia, Anhidrotic Ectodermal
% 212.07/212.27  |- skos__hiddenLabel mesh__D004476 Cloustons Syndrome
% 212.07/212.27  |- skos__hiddenLabel mesh__D004476 Ectodermal Dysplasia, Anhidrotic
% 212.07/212.27  |- mesh__dateEstablished mesh__D004476 1965-01-01
% 212.07/212.27  |- skos__hiddenLabel mesh__D004476 Dysplasias, Anhidrotic Ectodermal
% 212.07/212.27  |- skos__hiddenLabel mesh__D004476 Syndrome, Clouston%27%s
% 212.07/212.27  |- skos__hiddenLabel mesh__D004476 Dysplasias, Hidrotic Ectodermal
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D012908 2006
% 212.07/212.27  |- mesh__dateRevised mesh__D012908 2005-06-30
% 212.07/212.27  |- skos__prefLabel mesh__D012908 Snails
% 212.07/212.27  |- mesh__recordAuthorizer mesh__D012908 sjn
% 212.07/212.27  |- mesh__recordMaintainer mesh__D012908 ags
% 212.07/212.27  |- skos__broader mesh__D012908smesh__D049851
% 212.07/212.27  |- rdf__type mesh__D012908sskos__Concept
% 212.07/212.27  |- mesh__recordOriginator mesh__D012908 NLM
% 212.07/212.27  |- mesh__dateCreated mesh__D012908 1999-01-01
% 212.07/212.27  |- skos__annotation mesh__D012908
% 212.07/212.27       as animal %26% food; IM; GEN or unspecified; prefer specifics; as food, coord IM with SHELLFISH %28%IM%29%; /microbiol /parasitol /virol permitted%A%  
% 212.07/212.27  |- skos__scopeNote mesh__D012908
% 212.07/212.27       Marine, freshwater, or terrestrial mollusks of the class Gastropoda. Most have an enclosing spiral shell, and several genera harbor parasites pathogenic to man.%A%    
% 212.07/212.27  |- rdf__type mesh__D009161sskos__Concept
% 212.07/212.27  |- skos__scopeNote mesh__D009161
% 212.07/212.27       A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts.%A%    
% 212.07/212.27  |- mesh__dateCreated mesh__D009161 1999-01-01
% 212.07/212.27  |- mesh__recordOriginator mesh__D009161 NLM
% 212.07/212.27  |- mesh__recordAuthorizer mesh__D009161 sjn
% 212.07/212.27  |- skos__broader mesh__D009161smesh__D009159
% 212.07/212.27  |- skos__prefLabel mesh__D009161 Mycobacterium
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D009161 2006
% 212.07/212.27  |- mesh__dateRevised mesh__D009161 2005-06-30
% 212.07/212.27  |- skos__annotation mesh__D009161
% 212.07/212.27       GEN: prefer specifics; infection = MYCOBACTERIUM INFECTIONS; M. paratuberc = MYCOBACTERIUM %28%IM%29% + PARATUBERCULOSIS %28%IM%29%; DF: MYCOBACT%A%  
% 212.07/212.27  |- mesh__recordMaintainer mesh__D009161 SYSTEM
% 212.07/212.27  |- skos__broader mesh__D002118Q000172smesh__D002118
% 212.07/212.27  |- rdf__type mesh__D002118Q000172smesh__CompoundConcept
% 212.07/212.27  |- mesh__recordMaintainer mesh__D008867 TAP
% 212.07/212.27  |- rdf__type mesh__D008867sskos__Concept
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D008867 2001
% 212.07/212.27  |- skos__altLabel mesh__D008867 Thin Sectioning
% 212.07/212.27  |- skos__hiddenLabel mesh__D008867 Sectionings, Thin
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D008867 2002
% 212.07/212.27  |- skos__hiddenLabel mesh__D008867 Sectioning, Thin
% 212.07/212.27  |- skos__prefLabel mesh__D008867 Microtomy
% 212.07/212.27  |- mesh__dateRevised mesh__D008867 2000-06-22
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D008867 2005
% 212.07/212.27  |- mesh__dateCreated mesh__D008867 1999-01-01
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D008867 2006
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D008867 2003
% 212.07/212.27  |- skos__broader mesh__D008867smesh__D016591
% 212.07/212.27  |- mesh__recordAuthorizer mesh__D008867 sjn
% 212.07/212.27  |- skos__hiddenLabel mesh__D008867 Thin Sectionings
% 212.07/212.27  |- mesh__recordOriginator mesh__D008867 NLM
% 212.07/212.27  |- skos__scopeNote mesh__D008867
% 212.07/212.27       The technique of using a microtome to cut thin or ultrathin sections of tissues embedded in a supporting substance. The microtome is an instrument that hold a steel, glass or diamond knife in clamps at an angle to the blocks of prepared tissues, which it cuts in sections of equal thickness.%A%    
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D008867 2004
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D000884 2001
% 212.07/212.27  |- skos__prefLabel mesh__D000884 Anthropology, Cultural
% 212.07/212.27  |- mesh__dateEstablished mesh__D000884 1968-01-01
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D000884 2004
% 212.07/212.27  |- skos__historyNote mesh__D000884 Blacks %28%1966-1967%29%
% 212.07/212.27  |- skos__hiddenLabel mesh__D000884 Ethnographies
% 212.07/212.27  |- mesh__historyNote mesh__D000884 68   
% 212.07/212.27  |- skos__altLabel mesh__D000884 Cultural Anthropology
% 212.07/212.27  |- mesh__dateCreated mesh__D000884 1999-01-01
% 212.07/212.27  |- skos__related mesh__D000884smesh__D005008
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D000884 2002
% 212.07/212.27  |- mesh__dateRevised mesh__D000884 1999-11-03
% 212.07/212.27  |- skos__scopeNote mesh__D000884
% 212.07/212.27       The study of social phenomena which characterize the learned, shared, and transmitted social activities of a particular ethnic group.%A%    
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D000884 2005
% 212.07/212.27  |- mesh__recordOriginator mesh__D000884 NLM
% 212.07/212.27  |- skos__historyNote mesh__D000884 Mongoloid Race %28%1966-1967%29%
% 212.07/212.27  |- skos__historyNote mesh__D000884 Ethnology %28%1966-1967%29%
% 212.07/212.27  |- rdf__type mesh__D000884sskos__Concept
% 212.07/212.27  |- skos__historyNote mesh__D000884 Caucasoid Race %28%1966-1967%29%
% 212.07/212.27  |- mesh__recordAuthorizer mesh__D000884 sjn
% 212.07/212.27  |- skos__annotation mesh__D000884
% 212.07/212.27       IM as SPEC: SPEC qualif; NIM as coord with no qualif; DF: ANTHROPOL CULTURAL%A%  
% 212.07/212.27  |- skos__historyNote mesh__D000884 Anthropology %28%1966-1967%29%
% 212.07/212.27  |- mesh__recordMaintainer mesh__D000884 kle
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D000884 2006
% 212.07/212.27  |- skos__broader mesh__D000884smesh__D000883
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D000884 2000
% 212.07/212.27  |- skos__historyNote mesh__D000884 Australoid Race %28%1966-1967%29%
% 212.07/212.27  |- mesh__publicMeSHNote mesh__D000884 68   
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D000884 2003
% 212.07/212.27  |- skos__historyNote mesh__D000884 Ethnopsychology %28%1966-1967%29%
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D008069 1999
% 212.07/212.27  |- mesh__recordAuthorizer mesh__D008069 PLS
% 212.07/212.27  |- skos__scopeNote mesh__D008069
% 212.07/212.27       Multiple circumscribed or encapsulated lipomas which may be distributed symmetrically or haphazardly or which may form a collar around the neck.%A%    
% 212.07/212.27  |- mesh__dateCreated mesh__D008069 1986-06-23
% 212.07/212.27  |- skos__hiddenLabel mesh__D008069 Madelungs Neck
% 212.07/212.27  |- skos__hiddenLabel mesh__D008069 Circumscribed Lipomatoses, Nodular
% 212.07/212.27  |- skos__altLabel mesh__D008069 Multiple Symmetrical Lipomatosis
% 212.07/212.27  |- skos__hiddenLabel mesh__D008069 Symmetrical Lipomatosis, Multiple
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D008069 1998
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D008069 1997
% 212.07/212.27  |- skos__hiddenLabel mesh__D008069 Symmetrical Lipomatoses, Multiple
% 212.07/212.27  |- mesh__publicMeSHNote mesh__D008069
% 212.07/212.27       91; was see under LIPOMATOSIS 1987-90   
% 212.07/212.27  |- skos__altLabel mesh__D008069 Madelung Neck
% 212.07/212.27  |- skos__historyNote mesh__D008069 Lipoma %28%1966-1986%29%
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D008069 2001
% 212.07/212.27  |- mesh__dateRevised mesh__D008069 1995-06-08
% 212.07/212.27  |- mesh__recordMaintainer mesh__D008069 KEV
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D008069 1996
% 212.07/212.27  |- skos__historyNote mesh__D008069 Lipomatosis %28%1966-1986%29%
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D008069 2006
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D008069 2000
% 212.07/212.27  |- skos__hiddenLabel mesh__D008069 Neck, Madelung
% 212.07/212.27  |- skos__altLabel mesh__D008069 Lipomatosis, Nodular Circumscribed
% 212.07/212.27  |- skos__hiddenLabel mesh__D008069 Neck, Madelung%27%s
% 212.07/212.27  |- skos__prefLabel mesh__D008069 Lipomatosis, Multiple Symmetrical
% 212.07/212.27  |- mesh__dateEstablished mesh__D008069 1991-01-01
% 212.07/212.27  |- skos__hiddenLabel mesh__D008069 Multiple Symmetrical Lipomatoses
% 212.07/212.27  |- rdf__type mesh__D008069sskos__Concept
% 212.07/212.27  |- skos__hiddenLabel mesh__D008069 Lipomatoses, Multiple Symmetrical
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D008069 2005
% 212.07/212.27  |- skos__broader mesh__D008069smesh__D009378
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D008069 2004
% 212.07/212.27  |- mesh__historyNote mesh__D008069
% 212.07/212.27       91%28%87%29%; was see under LIPOMATOSIS 1987-90   
% 212.07/212.27  |- skos__annotation mesh__D008069
% 212.07/212.27       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 212.07/212.27  |- skos__hiddenLabel mesh__D008069 Circumscribed Lipomatosis, Nodular
% 212.07/212.27  |- mesh__recordOriginator mesh__D008069 VDK
% 212.07/212.27  |- skos__hiddenLabel mesh__D008069 Lipomatoses, Nodular Circumscribed
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D008069 2002
% 212.07/212.27  |- skos__hiddenLabel mesh__D008069 Nodular Circumscribed Lipomatoses
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D008069 2003
% 212.07/212.27  |- mesh__dateCreated mesh__D000086 1999-01-01
% 212.07/212.27  |- mesh__dateRevised mesh__D000086 2005-06-30
% 212.07/212.27  |- skos__altLabel mesh__D000086
% 212.07/212.27       Th%C3%%A9%raplix Brand of Acetazolamide Preparation
% 212.07/212.27  |- skos__altLabel mesh__D000086 Grin Brand of Acetazolamide
% 212.07/212.27  |- skos__altLabel mesh__D000086 Wassermann Brand of Acetazolamide
% 212.07/212.27  |- skos__hiddenLabel mesh__D000086 Ak Zol
% 212.07/212.27  |- skos__altLabel mesh__D000086 Dioptic Brand of Acetazolamide
% 212.07/212.27  |- skos__altLabel mesh__D000086 Lederle Brand of Acetazolamide Preparation
% 212.07/212.27  |- skos__altLabel mesh__D000086 Chiesi Brand of Acetazolamide
% 212.07/212.27  |- skos__hiddenLabel mesh__D000086 Apo Acetazolamide
% 212.07/212.27  |- skos__altLabel mesh__D000086 Storz Brand of Acetazolamide Preparation
% 212.07/212.27  |- skos__hiddenLabel mesh__D000086 Acetazolamide Medphano Brand
% 212.07/212.27  |- skos__altLabel mesh__D000086 Whelehan Brand of Acetazolamide Preparation
% 212.07/212.27  |- skos__altLabel mesh__D000086 Ciba Vision Brand of Acetazolamide
% 212.07/212.27  |- mesh__recordAuthorizer mesh__D000086 sjn
% 212.07/212.27  |- skos__hiddenLabel mesh__D000086 Acetazolamide Apotex Brand
% 212.07/212.27  |- skos__hiddenLabel mesh__D000086 Acetazolamide Dioptic Brand
% 212.07/212.27  |- skos__prefLabel mesh__D000086 Acetazolamide
% 212.07/212.27  |- skos__hiddenLabel mesh__D000086 Huma Zolamide
% 212.07/212.27  |- skos__hiddenLabel mesh__D000086 Acetazolamide Chiesi Brand
% 212.07/212.27  |- skos__hiddenLabel mesh__D000086 Acetazolamide Novopharm Brand
% 212.07/212.27  |- skos__altLabel mesh__D000086 Wyeth Brand of Acetazolamide Preparation
% 212.07/212.27  |- skos__altLabel mesh__D000086 Cyanamid Brand of Acetazolamide Preparation
% 212.07/212.27  |- skos__hiddenLabel mesh__D000086 ApoAcetazolamide
% 212.07/212.27  |- mesh__recordOriginator mesh__D000086 NLM
% 212.07/212.27  |- mesh__recordMaintainer mesh__D000086 ssb
% 212.07/212.27  |- skos__altLabel mesh__D000086 Novopharm Brand of Acetazolamide
% 212.07/212.27  |- skos__altLabel mesh__D000086 ICN Brand of Acetazolamide
% 212.07/212.27  |- skos__hiddenLabel mesh__D000086 Acetazolamide Wassermann Brand
% 212.07/212.27  |- skos__altLabel mesh__D000086 Llorens Brand of Acetazolamide
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D000086 2006
% 212.07/212.27  |- skos__hiddenLabel mesh__D000086 Acetazolamide Llorens Brand
% 212.07/212.27  |- skos__hiddenLabel mesh__D000086 Acetazolamide Orion Brand
% 212.07/212.27  |- rdf__type mesh__D000086sskos__Concept
% 212.07/212.27  |- skos__altLabel mesh__D000086 Jumer Brand of Acetazolamide
% 212.07/212.27  |- skos__altLabel mesh__D000086 Orion Brand of Acetazolamide
% 212.07/212.27  |- skos__scopeNote mesh__D000086
% 212.07/212.27       One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. %28%From Smith and Reynard, Textbook of Pharmacology, 1991, p337%29%%A%    
% 212.07/212.27  |- skos__hiddenLabel mesh__D000086 HumaZolamide
% 212.07/212.27  |- skos__hiddenLabel mesh__D000086 Acetazolamide Jumer Brand
% 212.07/212.27  |- skos__hiddenLabel mesh__D000086 AkZol
% 212.07/212.27  |- skos__broader mesh__D000086smesh__D013830
% 212.07/212.27  |- skos__hiddenLabel mesh__D000086 Acetazolamide Grin Brand
% 212.07/212.27  |- skos__hiddenLabel mesh__D000086 Acetazolamide ICN Brand
% 212.07/212.27  |- skos__altLabel mesh__D000086 Medphano Brand of Acetazolamide
% 212.07/212.27  |- skos__hiddenLabel mesh__D000086 Monosodium Salt Acetazolamide
% 212.07/212.27  |- skos__altLabel mesh__D000086 Apotex Brand of Acetazolamide
% 212.07/212.27  |- skos__broader mesh__D007413Q000557smesh__D007413
% 212.07/212.27  |- rdf__type mesh__D007413Q000557smesh__CompoundConcept
% 212.07/212.27  |- skos__altLabel mesh__D046188 Translational Protein Processing
% 212.07/212.27  |- skos__hiddenLabel mesh__D046188 Modifications, Co-Translational Protein
% 212.07/212.27  |- skos__hiddenLabel mesh__D046188 Co Translational Amino Acid Modification
% 212.07/212.27  |- skos__hiddenLabel mesh__D046188 Protein Processing, Co Translational
% 212.07/212.27  |- mesh__recordOriginator mesh__D046188 nns
% 212.07/212.27  |- skos__broader mesh__D046188smesh__D005786
% 212.07/212.27  |- skos__hiddenLabel mesh__D046188 Translational Protein Modifications
% 212.07/212.27  |- skos__altLabel mesh__D046188 Protein Processing, Co-Translational
% 212.07/212.27  |- skos__hiddenLabel mesh__D046188 Processing, Co-Translational Protein
% 212.07/212.27  |- skos__hiddenLabel mesh__D046188 Protein Modifications, Co-Translational
% 212.07/212.27  |- mesh__historyNote mesh__D046188 2005   
% 212.07/212.27  |- mesh__recordMaintainer mesh__D046188 ags
% 212.07/212.27  |- mesh__dateEstablished mesh__D046188 2005-01-01
% 212.07/212.27  |- skos__annotation mesh__D046188
% 212.07/212.27       coord IM with specific protein /metab %28%IM%29% and with specific modification, for example, ACYLATION; AMINATION; DEAMINATION; PROTEIN ISOPRENYLATION; etc.; do not confuse with PROTEIN PROCESSING, POST-TRANSLATIONAL%A%  
% 212.07/212.27  |- skos__hiddenLabel mesh__D046188 Protein Modifications, Cotranslational
% 212.07/212.27  |- skos__broader mesh__D046188smesh__D014176
% 212.07/212.27  |- skos__altLabel mesh__D046188 Amino Acid Modification, Pretranslational
% 212.07/212.27  |- skos__altLabel mesh__D046188 Pretranslational Amino Acid Modification
% 212.07/212.27  |- skos__hiddenLabel mesh__D046188
% 212.07/212.27       Amino Acid Modification, Co Translational
% 212.07/212.27  |- skos__hiddenLabel mesh__D046188 Cotranslational Protein Modifications
% 212.07/212.27  |- mesh__dateRevised mesh__D046188 2005-07-07
% 212.07/212.27  |- skos__hiddenLabel mesh__D046188
% 212.07/212.27       Pre Translational Amino Acid Modification
% 212.07/212.27  |- skos__altLabel mesh__D046188 Amino Acid Modification, Translational
% 212.07/212.27  |- skos__prefLabel mesh__D046188 Protein Modification, Translational
% 212.07/212.27  |- skos__hiddenLabel mesh__D046188 Protein Modification, Cotranslational
% 212.07/212.27  |- skos__hiddenLabel mesh__D046188 Protein Modification, Co Translational
% 212.07/212.27  |- skos__altLabel mesh__D046188 Amino Acid Modification, Pre-Translational
% 212.07/212.27  |- mesh__recordAuthorizer mesh__D046188 ags
% 212.07/212.27  |- mesh__dateCreated mesh__D046188 2004-07-07
% 212.07/212.27  |- skos__hiddenLabel mesh__D046188 Protein Processing, Cotranslational
% 212.07/212.27  |- skos__altLabel mesh__D046188 Translational Protein Modification
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D046188 2005
% 212.07/212.27  |- skos__altLabel mesh__D046188 Protein Modification, Co-Translational
% 212.07/212.27  |- skos__hiddenLabel mesh__D046188
% 212.07/212.27       Amino Acid Modification, Pre Translational
% 212.07/212.27  |- skos__altLabel mesh__D046188 Cotranslational Protein Processing
% 212.07/212.27  |- skos__hiddenLabel mesh__D046188 Modification, Co-Translational Protein
% 212.07/212.27  |- skos__altLabel mesh__D046188 Cotranslational Protein Modification
% 212.07/212.27  |- mesh__publicMeSHNote mesh__D046188 2005   
% 212.07/212.27  |- skos__altLabel mesh__D046188 Co-Translational Protein Processing
% 212.07/212.27  |- skos__hiddenLabel mesh__D046188 Co-Translational Protein Modifications
% 212.07/212.27  |- skos__scopeNote mesh__D046188
% 212.07/212.27       Any of the enzymatically catalyzed modifications of the individual AMINO ACIDS of PROTEINS, and enzymatic cleavage or crosslinking of peptide chains that occur pre-translationally %28%on the amino acid component of AMINO ACYL TRNA%29%, co-translationally %28%during the process of GENETIC TRANSLATION%29%, or after translation is completed %28%POST-TRANSLATIONAL PROTEIN PROCESSING%29%.%A%    
% 212.07/212.27  |- skos__altLabel mesh__D046188 Protein Processing, Translational
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D046188 2006
% 212.07/212.27  |- skos__hiddenLabel mesh__D046188 Co Translational Protein Processing
% 212.07/212.27  |- rdf__type mesh__D046188sskos__Concept
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D046188 2006A
% 212.07/212.27  |- skos__hiddenLabel mesh__D046188 Protein Modifications, Translational
% 212.07/212.27  |- skos__altLabel mesh__D046188 Co-Translational Amino Acid Modification
% 212.07/212.27  |- mesh__onlineNote mesh__D013203
% 212.07/212.27       use STAPHYLOCOCCAL INFECTIONS to search STAPHYLOCOCCAL INFECTIONS, GASTROINTESTINAL %26% STAPHYLOCOCCAL INFECTIONS, RESPIRATORY 1966-67%A%  
% 212.07/212.27  |- skos__hiddenLabel mesh__D013203 Infection, Staphylococcal
% 212.07/212.27  |- mesh__recordOriginator mesh__D013203 NLM
% 212.07/212.27  |- mesh__historyNote mesh__D013203
% 212.07/212.27       STAPHYLOCOCCAL INFECTIONS, GASTROINTESTINAL %26% STAPHYLOCOCCAL INFECTIONS, RESPIRATORY were headings 1963-67%A%  
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D013203 2000
% 212.07/212.27  |- mesh__recordMaintainer mesh__D013203 TGC
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D013203 2003
% 212.07/212.27  |- skos__broader mesh__D013203smesh__D016908
% 212.07/212.27  |- skos__scopeNote mesh__D013203
% 212.07/212.27       Infections with bacteria of the genus STAPHYLOCOCCUS.     
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D013203 2001
% 212.07/212.27  |- mesh__recordAuthorizer mesh__D013203 PLS
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D013203 1997
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D013203 2004
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D013203 2002
% 212.07/212.27  |- rdf__type mesh__D013203sskos__Concept
% 212.07/212.27  |- skos__annotation mesh__D013203
% 212.07/212.27       gram-pos bact infect; STAPHYLOCOCCAL FOOD POISONING is also available; DF: STAPH INFECT%A%  
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D013203 1998
% 212.07/212.27  |- skos__prefLabel mesh__D013203 Staphylococcal Infections
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D013203 2005
% 212.07/212.27  |- mesh__dateCreated mesh__D013203 1999-01-01
% 212.07/212.27  |- skos__altLabel mesh__D013203 Infections, Staphylococcal
% 212.07/212.27  |- skos__hiddenLabel mesh__D013203 Staphylococcal Infection
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D013203 1999
% 212.07/212.27  |- mesh__dateRevised mesh__D013203 1996-06-10
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D013203 2006
% 212.07/212.27  |- mesh__publicMeSHNote mesh__D013203
% 212.07/212.27       STAPHYLOCOCCAL INFECTIONS, GASTROINTESTINAL %26% STAPHYLOCOCCAL INFECTIONS, RESPIRATORY were headings 1963-67%A%  
% 212.07/212.27  |- skos__related mesh__D013203smesh__D003428
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D018497 1997
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D018497 2003
% 212.07/212.27  |- mesh__recordAuthorizer mesh__D018497 PLS
% 212.07/212.27  |- mesh__dateRevised mesh__D018497 1996-06-10
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D018497 2002
% 212.07/212.27  |- skos__hiddenLabel mesh__D018497 Right Ventricular Dysfunctions
% 212.07/212.27  |- skos__altLabel mesh__D018497 Right Ventricular Dysfunction
% 212.07/212.27  |- mesh__dateEstablished mesh__D018497 1995-01-01
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D018497 2006
% 212.07/212.27  |- mesh__recordOriginator mesh__D018497 PXP
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D018497 2001
% 212.07/212.27  |- mesh__dateCreated mesh__D018497 1994-02-28
% 212.07/212.27  |- mesh__recordMaintainer mesh__D018497 TGC
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D018497 2000
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D018497 1999
% 212.07/212.27  |- skos__annotation mesh__D018497
% 212.07/212.27       ventric refers to the heart, not the cerebral ventricles   
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D018497 2005
% 212.07/212.27  |- skos__broader mesh__D018497smesh__D018754
% 212.07/212.27  |- skos__prefLabel mesh__D018497 Ventricular Dysfunction, Right
% 212.07/212.27  |- rdf__type mesh__D018497sskos__Concept
% 212.07/212.27  |- skos__scopeNote mesh__D018497
% 212.07/212.27       A condition in which the right ventricle of the heart exhibits a decreased functionality. This decreased function could lead to congestive heart failure or myocardial infarction, among other cardiovascular diseases. Diagnostic measurements that indicate this condition include a diminished ejection fraction and a depressed level of motility of the right ventricular wall.%A%    
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D018497 2004
% 212.07/212.27  |- skos__hiddenLabel mesh__D018497 Dysfunction, Right Ventricular
% 212.07/212.27  |- mesh__publicMeSHNote mesh__D018497 95   
% 212.07/212.27  |- skos__hiddenLabel mesh__D018497 Ventricular Dysfunctions, Right
% 212.07/212.27  |- skos__hiddenLabel mesh__D018497 Dysfunctions, Right Ventricular
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D018497 1998
% 212.07/212.27  |- mesh__historyNote mesh__D018497 95   
% 212.07/212.27  |- skos__related mesh__D004477smesh__D005307
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D004477 2005
% 212.07/212.27  |- mesh__dateRevised mesh__D004477 2004-07-07
% 212.07/212.27  |- skos__prefLabel mesh__D004477 Ectogenesis
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D004477 2006
% 212.07/212.27  |- skos__hiddenLabel mesh__D004477 Ectogeneses
% 212.07/212.27  |- mesh__recordOriginator mesh__D004477 NLM
% 212.07/212.27  |- mesh__recordMaintainer mesh__D004477 lkt
% 212.07/212.27  |- mesh__dateEstablished mesh__D004477 1975-09-01
% 212.07/212.27  |- skos__scopeNote mesh__D004477
% 212.07/212.27       Embryonic and fetal development that takes place in an artificial environment in vitro.%A%    
% 212.07/212.27  |- skos__broader mesh__D004477smesh__D005314
% 212.07/212.27  |- rdf__type mesh__D004477sskos__Concept
% 212.07/212.27  |- mesh__historyNote mesh__D004477 75   
% 212.07/212.27  |- skos__historyNote mesh__D004477 Embryo %28%1966-1974%29%
% 212.07/212.27  |- mesh__recordAuthorizer mesh__D004477 sjn
% 212.07/212.27  |- mesh__dateCreated mesh__D004477 1974-11-11
% 212.07/212.27  |- mesh__publicMeSHNote mesh__D004477 75   
% 212.07/212.27  |- skos__scopeNote mesh__D012909
% 212.07/212.27       Bites by snakes. The condition of having been bitten by a venomous snake, characterized by stinging pain at the wound puncture. The venom injected at the site of the bite is capable of producing a deleterious effect on the blood or on the nervous system. %28%Webster%27%s 3d ed; from Dorland, 27th ed, at snake, venomous%29%%A%    
% 212.07/212.27  |- rdf__type mesh__D012909sskos__Concept
% 212.07/212.27  |- skos__hiddenLabel mesh__D012909 Snake Bite
% 212.07/212.27  |- mesh__dateCreated mesh__D012909 1999-01-01
% 212.07/212.27  |- skos__broader mesh__D012909smesh__D001733
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D012909 1998
% 212.07/212.27  |- mesh__recordMaintainer mesh__D012909 TGC
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D012909 2001
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D012909 2004
% 212.07/212.27  |- skos__hiddenLabel mesh__D012909 Bites, Snake
% 212.07/212.27  |- skos__related mesh__D012909smesh__D000997
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D012909 2000
% 212.07/212.27  |- skos__related mesh__D012909smesh__D012910
% 212.07/212.27  |- skos__hiddenLabel mesh__D012909 Snake Envenomations
% 212.07/212.27  |- skos__hiddenLabel mesh__D012909 Envenomations, Snake
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D012909 2003
% 212.07/212.27  |- skos__hiddenLabel mesh__D012909 Envenomation, Snake
% 212.07/212.27  |- skos__hiddenLabel mesh__D012909 Bite, Snake
% 212.07/212.27  |- skos__altLabel mesh__D012909 Snake Envenomation
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D012909 2006
% 212.07/212.27  |- skos__prefLabel mesh__D012909 Snake Bites
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D012909 2002
% 212.07/212.27  |- mesh__recordOriginator mesh__D012909 NLM
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D012909 2005
% 212.07/212.27  |- mesh__recordAuthorizer mesh__D012909 SJN
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D012909 1999
% 212.07/212.27  |- mesh__dateRevised mesh__D012909 1997-06-20
% 212.07/212.27  |- skos__annotation mesh__D012909
% 212.07/212.27       IM; coord with specific available snake family or genus %28%IM%29%; ther with antivenins is /ther, not /drug ther%A%  
% 212.07/212.27  |- mesh__recordOriginator mesh__D009960 RC
% 212.07/212.27  |- mesh__recordMaintainer mesh__D009960 lkt
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D009960 2006
% 212.07/212.27  |- skos__historyNote mesh__D009960 Pharynx %28%1966-1978%29%
% 212.07/212.27  |- mesh__recordAuthorizer mesh__D009960 sjn
% 212.07/212.27  |- skos__annotation mesh__D009960
% 212.07/212.27       inflammation: index under PHARYNGITIS %26% do not bother to coord with OROPHARYNX %28%NIM%29% unless particularly discussed%A%  
% 212.07/212.27  |- rdf__type mesh__D009960sskos__Concept
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D009960 2004
% 212.07/212.27  |- mesh__dateEstablished mesh__D009960 1979-01-01
% 212.07/212.27  |- mesh__historyNote mesh__D009960 79   
% 212.07/212.27  |- mesh__dateCreated mesh__D009960 1978-05-19
% 212.07/212.27  |- skos__hiddenLabel mesh__D009960 Oropharynxs
% 212.07/212.27  |- skos__broader mesh__D009960smesh__D010614
% 212.07/212.27  |- skos__scopeNote mesh__D009960 Oral part of the pharynx.     
% 212.07/212.27  |- mesh__publicMeSHNote mesh__D009960 79   
% 212.07/212.27  |- skos__prefLabel mesh__D009960 Oropharynx
% 212.07/212.27  |- mesh__dateRevised mesh__D009960 2003-07-09
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D009960 2005
% 212.07/212.27  |- mesh__historyNote mesh__D009162
% 212.07/212.27       87%28%75%29%; was see under MYCOBACTERIUM 1975-86   
% 212.07/212.27  |- skos__annotation mesh__D009162
% 212.07/212.27       infection in birds = TUBERCULOSIS, AVIAN; infection in other animals = TUBERCULOSIS /vet %28%IM%29% + MYCOBACTERIUM AVIUM %28%IM%29%; DF: MYCOBACT AVIUM%A%  
% 212.07/212.27  |- skos__broader mesh__D009162smesh__D009161
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D009162 2006
% 212.07/212.27  |- mesh__dateCreated mesh__D009162 1974-12-12
% 212.07/212.27  |- mesh__recordOriginator mesh__D009162 NLM
% 212.07/212.27  |- mesh__publicMeSHNote mesh__D009162
% 212.07/212.27       87; was see under MYCOBACTERIUM 1975-86   
% 212.07/212.27  |- mesh__recordAuthorizer mesh__D009162 sjn
% 212.07/212.27  |- mesh__recordMaintainer mesh__D009162 SYSTEM
% 212.07/212.27  |- skos__scopeNote mesh__D009162
% 212.07/212.27       A bacterium causing tuberculosis in domestic fowl and other birds. In pigs, it may cause localized and sometimes disseminated disease. The organism occurs occasionally in sheep and cattle. It should be distinguished from the M. avium complex, which infects primarily humans.%A%    
% 212.07/212.27  |- mesh__dateRevised mesh__D009162 2005-06-30
% 212.07/212.27  |- mesh__dateEstablished mesh__D009162 1987-01-01
% 212.07/212.27  |- rdf__type mesh__D009162sskos__Concept
% 212.07/212.27  |- skos__prefLabel mesh__D009162 Mycobacterium avium
% 212.07/212.27  |- mesh__dateEstablished mesh__D008868 1985-01-01
% 212.07/212.27  |- skos__historyNote mesh__D008868 Cytoskeleton %28%1980-1984%29%
% 212.07/212.27  |- mesh__recordAuthorizer mesh__D008868 sjn
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D008868 2006
% 212.07/212.27  |- mesh__historyNote mesh__D008868 85   
% 212.07/212.27  |- skos__annotation mesh__D008868
% 212.07/212.27       /biosyn /drug eff /physiol permitted; TUBULIN is available%A%  
% 212.07/212.27  |- mesh__publicMeSHNote mesh__D008868 85   
% 212.07/212.27  |- skos__historyNote mesh__D008868 Tubulin %28%1975-1984%29%
% 212.07/212.27  |- skos__scopeNote mesh__D008868 Proteins found in the microtubules.     
% 212.07/212.27  |- mesh__recordMaintainer mesh__D008868 SYSTEM
% 212.07/212.27  |- skos__broader mesh__D008868smesh__D003598
% 212.07/212.27  |- skos__prefLabel mesh__D008868 Microtubule Proteins
% 212.07/212.27  |- skos__historyNote mesh__D008868 Proteins %28%1966-1984%29%
% 212.07/212.27  |- skos__hiddenLabel mesh__D008868 Proteins, Microtubule
% 212.07/212.27  |- skos__historyNote mesh__D008868 Cytoplasm %28%1977-1979%29%
% 212.07/212.27  |- skos__broader mesh__D008868smesh__D001704
% 212.07/212.27  |- rdf__type mesh__D008868sskos__Concept
% 212.07/212.27  |- mesh__recordOriginator mesh__D008868 RLS
% 212.07/212.27  |- mesh__dateCreated mesh__D008868 1984-05-25
% 212.07/212.27  |- mesh__dateRevised mesh__D008868 2005-06-30
% 212.07/212.27  |- mesh__recordOriginator mesh__D000885 NLM
% 212.07/212.27  |- skos__historyNote mesh__D000885 Ethnology %28%1966-1967%29%
% 212.07/212.27  |- mesh__recordAuthorizer mesh__D000885 sjn
% 212.07/212.27  |- skos__related mesh__D000885smesh__D000886
% 212.07/212.27  |- skos__historyNote mesh__D000885 Anthropology %28%1966-1967%29%
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D000885 2005
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D000885 2000
% 212.07/212.27  |- rdf__type mesh__D000885sskos__Concept
% 212.07/212.27  |- skos__related mesh__D000885smesh__D005826
% 212.07/212.27  |- skos__related mesh__D000885smesh__D001699
% 212.07/212.27  |- skos__historyNote mesh__D000885 Genetics, Medical %28%1966-1967%29%
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D000885 2006
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D000885 2001
% 212.07/212.27  |- mesh__recordMaintainer mesh__D000885 jls
% 212.07/212.27  |- skos__broader mesh__D000885smesh__D000883
% 212.07/212.27  |- mesh__publicMeSHNote mesh__D000885 68   
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D000885 2003
% 212.07/212.27  |- skos__historyNote mesh__D000885 Anthropometry %28%1966-1967%29%
% 212.07/212.27  |- skos__altLabel mesh__D000885 Physical Anthropology
% 212.07/212.27  |- mesh__historyNote mesh__D000885 68   
% 212.07/212.27  |- mesh__dateRevised mesh__D000885 1999-11-03
% 212.07/212.27  |- mesh__dateEstablished mesh__D000885 1968-01-01
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D000885 2004
% 212.07/212.27  |- skos__annotation mesh__D000885
% 212.07/212.27       IM as SPEC: SPEC qualif; NIM as coord, no qualif; DF: ANTHROPOL PHYSICAL%A%  
% 212.07/212.27  |- skos__prefLabel mesh__D000885 Anthropology, Physical
% 212.07/212.27  |- mesh__activeMeSHYear mesh__D000885 2002
% 212.07/212.27  |- skos__scopeNote mesh__D000885
% 212.07/212.27       The comparative science dealing with the physical characteristics of humans as related to their origin, evolution, and development in the total environment.%A%    
% 212.07/212.27  |- mesh__dateCreated mesh__D000885 1999-01-01
% 212.07/212.27  |- mesh__dateCreated mesh__D019590 1997-06-20
% 212.07/212.27  |- mesh__dateRevised mesh__D019590 2005-06-30
% 212.07/212.28  |- skos__historyNote mesh__D019590 Viral Proteins %28%1970-1985%29%
% 212.07/212.28  |- mesh__onlineNote mesh__D019590
% 212.07/212.28       use NUCLEOCAPSID to search NUCLEOCAPSID PROTEINS 1997   
% 212.07/212.28  |- skos__historyNote mesh__D019590 Viral Core Proteins %28%1986-1996%29%
% 212.07/212.28  |- mesh__recordAuthorizer mesh__D019590 sjn
% 212.07/212.28  |- mesh__dateEstablished mesh__D019590 1998-01-01
% 212.07/212.28  |- skos__hiddenLabel mesh__D019590 N Protein, Viral
% 212.07/212.28  |- skos__prefLabel mesh__D019590 Nucleocapsid Proteins
% 212.07/212.28  |- mesh__recordMaintainer mesh__D019590 DRC
% 212.07/212.28  |- mesh__publicMeSHNote mesh__D019590 98; was see NUCLEOCAPSID 1997   
% 212.07/212.28  |- skos__scopeNote mesh__D019590
% 212.07/212.28       Viral proteins found in either the NUCLEOCAPSID or the viral core %28%VIRAL CORE PROTEINS%29%.%A%    
% 212.07/212.28  |- skos__broader mesh__D019590smesh__D015678
% 212.07/212.28  |- skos__historyNote mesh__D019590 Nucleocapsid %28%1997%29%
% 212.07/212.28  |- skos__historyNote mesh__D019590 Capsid %28%1984-1996%29%
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D019590 2006
% 212.07/212.28  |- rdf__type mesh__D019590sskos__Concept
% 212.07/212.28  |- skos__altLabel mesh__D019590 Nucleocapsid Protein
% 212.07/212.28  |- mesh__recordOriginator mesh__D019590 AGS
% 212.07/212.28  |- mesh__historyNote mesh__D019590 98; was see NUCLEOCAPSID 1997   
% 212.07/212.28  |- skos__hiddenLabel mesh__D033261 Mother Fetus Relations
% 212.07/212.28  |- skos__hiddenLabel mesh__D033261 Relations, Mother-Fetus
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D033261 2004
% 212.07/212.28  |- skos__altLabel mesh__D033261 Mother-Fetus Relations
% 212.07/212.28  |- skos__hiddenLabel mesh__D033261 Maternal Fetal Relations
% 212.07/212.28  |- skos__prefLabel mesh__D033261 Maternal-Fetal Relations
% 212.07/212.28  |- skos__related mesh__D033261smesh__D011247
% 212.07/212.28  |- mesh__dateEstablished mesh__D033261 2003-01-01
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D033261 2003
% 212.07/212.28  |- mesh__dateCreated mesh__D033261 2002-07-03
% 212.07/212.28  |- mesh__publicMeSHNote mesh__D033261 2003   
% 212.07/212.28  |- skos__hiddenLabel mesh__D033261 Mother Fetus Relationship
% 212.07/212.28  |- skos__broader mesh__D033261smesh__D008425
% 212.07/212.28  |- skos__altLabel mesh__D033261 Mother-Fetus Relationship
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D033261 2006
% 212.07/212.28  |- skos__hiddenLabel mesh__D033261 Mother-Fetus Relationships
% 212.07/212.28  |- skos__hiddenLabel mesh__D033261 Relationship, Mother-Fetus
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D033261 2005
% 212.07/212.28  |- mesh__historyNote mesh__D033261 2003   
% 212.07/212.28  |- skos__hiddenLabel mesh__D033261 Relationships, Mother-Fetus
% 212.07/212.28  |- skos__scopeNote mesh__D033261
% 212.07/212.28       The bond or lack thereof between a pregnant woman and her FETUS.%A%    
% 212.07/212.28  |- rdf__type mesh__D033261sskos__Concept
% 212.07/212.28  |- skos__hiddenLabel mesh__D033261 Relations, Maternal-Fetal
% 212.07/212.28  |- skos__related mesh__D033261smesh__D008431
% 212.07/212.28  |- skos__related mesh__D033261smesh__D037841
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D005570 2000
% 212.07/212.28  |- mesh__recordOriginator mesh__D005570 NLM
% 212.07/212.28  |- skos__annotation mesh__D005570 IM; DF: FORMULARIES DENT   
% 212.07/212.28  |- mesh__recordAuthorizer mesh__D005570 sjn
% 212.07/212.28  |- rdf__type mesh__D005570sskos__Concept
% 212.07/212.28  |- skos__altLabel mesh__D005570 Formulary, Dental
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D005570 2001
% 212.07/212.28  |- mesh__recordMaintainer mesh__D005570 kle
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D005570 2005
% 212.07/212.28  |- skos__broader mesh__D005570smesh__D005569
% 212.07/212.28  |- skos__prefLabel mesh__D005570 Formularies, Dental
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D005570 2006
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D005570 2002
% 212.07/212.28  |- skos__altLabel mesh__D005570 Dental Formularies
% 212.07/212.28  |- mesh__dateCreated mesh__D005570 1999-01-01
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D005570 2003
% 212.07/212.28  |- skos__altLabel mesh__D005570 Dental Formulary
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D005570 2004
% 212.07/212.28  |- mesh__dateRevised mesh__D005570 1999-11-03
% 212.07/212.28  |- mesh__recordOriginator mesh__D013204 NLM
% 212.07/212.28  |- skos__hiddenLabel mesh__D013204 Phages, Staphylococcal
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D013204 2006
% 212.07/212.28  |- skos__hiddenLabel mesh__D013204 Bacteriophage, Staphylococcal
% 212.07/212.28  |- mesh__publicMeSHNote mesh__D013204
% 212.07/212.28       93; was STAPHYLOCOCCAL PHAGES 66-92   
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D013204 2000
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D013204 1995
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D013204 1996
% 212.07/212.28  |- mesh__historyNote mesh__D013204 93; was STAPHYLOCOCCAL PHAGES 66-92   
% 212.07/212.28  |- mesh__dateRevised mesh__D013204 1992-05-18
% 212.07/212.28  |- skos__altLabel mesh__D013204 Staphylococcal Bacteriophages
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D013204 2001
% 212.07/212.28  |- mesh__recordAuthorizer mesh__D013204 PLS
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D013204 1997
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D013204 2003
% 212.07/212.28  |- skos__hiddenLabel mesh__D013204 Phages, Staphylococcus
% 212.07/212.28  |- skos__hiddenLabel mesh__D013204 Phage, Staphylococcal
% 212.07/212.28  |- skos__prefLabel mesh__D013204 Staphylococcus Phages
% 212.07/212.28  |- rdf__type mesh__D013204sskos__Concept
% 212.07/212.28  |- skos__scopeNote mesh__D013204 Viruses whose host is Staphylococcus.     
% 212.07/212.28  |- skos__broader mesh__D013204smesh__D001435
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D013204 2002
% 212.07/212.28  |- mesh__onlineNote mesh__D013204
% 212.07/212.28       use STAPHYLOCOCCUS PHAGES to search STAPHYLOCOCCAL PHAGES 1966-92%A%  
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D013204 1998
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D013204 2004
% 212.07/212.28  |- mesh__dateCreated mesh__D013204 1999-01-01
% 212.07/212.28  |- skos__hiddenLabel mesh__D013204 Phage, Staphylococcus
% 212.07/212.28  |- mesh__recordMaintainer mesh__D013204 AGS
% 212.07/212.28  |- skos__hiddenLabel mesh__D013204 Staphylococcal Phage
% 212.07/212.28  |- skos__annotation mesh__D013204
% 212.07/212.28       coord IM with specific Staph %28%NIM%29%; DF: STAPH PHAGES   
% 212.07/212.28  |- skos__altLabel mesh__D013204 Staphylococcus Phage
% 212.07/212.28  |- skos__altLabel mesh__D013204 Staphylococcal Bacteriophage
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D013204 1993
% 212.07/212.28  |- skos__altLabel mesh__D013204 Staphylococcal Phages
% 212.07/212.28  |- skos__hiddenLabel mesh__D013204 Bacteriophages, Staphylococcal
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D013204 1999
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D013204 2005
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D013204 1994
% 212.07/212.28  |- mesh__publicMeSHNote mesh__D004478 68   
% 212.07/212.28  |- skos__hiddenLabel mesh__D004478 Infestation, Ectoparasitic
% 212.07/212.28  |- mesh__historyNote mesh__D004478 68   
% 212.07/212.28  |- skos__hiddenLabel mesh__D004478 Infestations, Ectoparasitic
% 212.07/212.28  |- skos__broader mesh__D004478smesh__D012876
% 212.07/212.28  |- mesh__recordAuthorizer mesh__D004478 sjn
% 212.07/212.28  |- skos__historyNote mesh__D004478 Parasitic Diseases %28%1966-1967%29%
% 212.07/212.28  |- skos__historyNote mesh__D004478 specific parasite
% 212.07/212.28  |- mesh__recordMaintainer mesh__D004478 ags
% 212.07/212.28  |- mesh__dateRevised mesh__D004478 2005-06-30
% 212.07/212.28  |- skos__hiddenLabel mesh__D004478 Ectoparasitic Infestation
% 212.07/212.28  |- skos__annotation mesh__D004478
% 212.07/212.28       general only: prefer specifics; coordinate IM with ectoparasite %28%IM%29%; refers to ectoparasite on or within the skin so do not coordinate with SKIN DISEASES, PARASITIC%A%  
% 212.07/212.28  |- skos__prefLabel mesh__D004478 Ectoparasitic Infestations
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D004478 2006
% 212.07/212.28  |- skos__scopeNote mesh__D004478
% 212.07/212.28       Infestations by PARASITES which live on, or burrow into, the surface of their host%27%s EPIDERMIS. Most ectoparasites are ARTHROPODS.%A%    
% 212.07/212.28  |- mesh__recordOriginator mesh__D004478 NLM
% 212.07/212.28  |- mesh__dateEstablished mesh__D004478 1968-01-01
% 212.07/212.28  |- rdf__type mesh__D004478sskos__Concept
% 212.07/212.28  |- mesh__dateCreated mesh__D004478 1999-01-01
% 212.07/212.28  |- mesh__historyNote mesh__D009961 74   
% 212.07/212.28  |- skos__hiddenLabel mesh__D009961 Glycoprotein, alpha 1-Acid
% 212.07/212.28  |- skos__altLabel mesh__D009961 alpha 1-Acid Glycoprotein
% 212.07/212.28  |- skos__hiddenLabel mesh__D009961 Acid alpha 1 Glycoprotein
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D009961 2005
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D009961 2000
% 212.07/212.28  |- skos__altLabel mesh__D009961 A%28%1%29%-Acid Seromucoid
% 212.07/212.28  |- skos__prefLabel mesh__D009961 Orosomucoid
% 212.07/212.28  |- mesh__recordOriginator mesh__D009961 NLM
% 212.07/212.28  |- rdf__type mesh__D009961sskos__Concept
% 212.07/212.28  |- skos__altLabel mesh__D009961 Seromucoid
% 212.07/212.28  |- skos__hiddenLabel mesh__D009961 Seromucoid, Acid
% 212.07/212.28  |- skos__broader mesh__D009961smesh__D000209
% 212.07/212.28  |- skos__broader mesh__D009961smesh__D009088
% 212.07/212.28  |- skos__altLabel mesh__D009961 Serum Sialomucin
% 212.07/212.28  |- skos__hiddenLabel mesh__D009961 Seromucoid, alpha 1-Acid
% 212.07/212.28  |- mesh__recordAuthorizer mesh__D009961 SJN
% 212.07/212.28  |- skos__altLabel mesh__D009961 Acid Seromucoid
% 212.07/212.28  |- skos__hiddenLabel mesh__D009961 alpha 1 Acid Glycoprotein
% 212.07/212.28  |- skos__broader mesh__D009961smesh__D000510
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D009961 2004
% 212.07/212.28  |- skos__altLabel mesh__D009961 Alpha%28%1%29%-Acid Glycoprotein
% 212.07/212.28  |- mesh__dateCreated mesh__D009961 1999-01-01
% 212.07/212.28  |- skos__hiddenLabel mesh__D009961 alpha 1 Glycoprotein Acid
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D009961 2002
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D009961 2003
% 212.07/212.28  |- skos__altLabel mesh__D009961 alpha 1-Glycoprotein Acid
% 212.07/212.28  |- skos__annotation mesh__D009961 an alpha-globulin   
% 212.07/212.28  |- skos__altLabel mesh__D009961 alpha 1-Acid Seromucoid
% 212.07/212.28  |- skos__hiddenLabel mesh__D009961 alpha 1 Acid Seromucoid
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D009961 1999
% 212.07/212.28  |- mesh__recordMaintainer mesh__D009961 KEV
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D009961 2006
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D009961 2001
% 212.07/212.28  |- mesh__dateRevised mesh__D009961 1997-06-20
% 212.07/212.28  |- skos__altLabel mesh__D009961 Acid alpha 1-Glycoprotein
% 212.07/212.28  |- skos__hiddenLabel mesh__D009961 Sialomucin, Serum
% 212.07/212.28  |- mesh__dateEstablished mesh__D009961 1974-01-01
% 212.07/212.28  |- mesh__publicMeSHNote mesh__D009961 74   
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D009961 1998
% 212.07/212.28  |- mesh__historyNote mesh__D009163
% 212.07/212.28       BCG was see under MYCOBACTERIUM BOVIS 1975-79   
% 212.07/212.28  |- mesh__dateRevised mesh__D009163 2005-06-30
% 212.07/212.28  |- skos__prefLabel mesh__D009163 Mycobacterium bovis
% 212.07/212.28  |- rdf__type mesh__D009163sskos__Concept
% 212.07/212.28  |- skos__annotation mesh__D009163
% 212.07/212.28       = M. tuberc. bovis; infection = TUBERCULOSIS, BOVINE if in cattle, TUBERCULOSIS /vet %28%IM%29% + MYCOBACTERIUM BOVIS %28%IM%29% if in other animals; DF: MYCOBACT BOVIS or short X ref%A%  
% 212.07/212.28  |- mesh__onlineNote mesh__D009163
% 212.07/212.28       use MYCOBACTERIUM BOVIS to search BCG 1975-78   
% 212.07/212.28  |- skos__altLabel mesh__D009163 Calmette-Guerin Bacillus
% 212.07/212.28  |- mesh__recordMaintainer mesh__D009163 SYSTEM
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D009163 2006
% 212.07/212.28  |- skos__scopeNote mesh__D009163
% 212.07/212.28       The bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis.%A%    
% 212.07/212.28  |- skos__broader mesh__D009163smesh__D009161
% 212.07/212.28  |- mesh__recordOriginator mesh__D009163 NLM
% 212.07/212.28  |- mesh__dateCreated mesh__D009163 1999-01-01
% 212.07/212.28  |- mesh__recordAuthorizer mesh__D009163 sjn
% 212.07/212.28  |- skos__annotation mesh__D001180
% 212.07/212.28       /antag permitted but consider also ANTIVENINS; /enzymol permitted; coord IM with specific arachnid or insect %28%IM or NIM%29% but note available specifics: ANT VENOMS; BEE VENOMS; SCORPION VENOMS; SPIDER VENOMS %26% WASP VENOMS %26% their indentions%A%  
% 212.07/212.28  |- skos__hiddenLabel mesh__D001180 Venom, Arthropod
% 212.07/212.28  |- skos__hiddenLabel mesh__D001180 Venoms, Arthropod
% 212.07/212.28  |- skos__historyNote mesh__D001180 Arthropods %28%1966-1977%29%
% 212.07/212.28  |- skos__historyNote mesh__D001180 Venoms %28%1966-1977%29%
% 212.07/212.28  |- mesh__dateCreated mesh__D001180 1977-04-22
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D001180 2006
% 212.07/212.28  |- mesh__dateRevised mesh__D001180 2005-06-30
% 212.07/212.28  |- mesh__dateEstablished mesh__D001180 1978-01-01
% 212.07/212.28  |- rdf__type mesh__D001180sskos__Concept
% 212.07/212.28  |- skos__broader mesh__D001180smesh__D014688
% 212.07/212.28  |- skos__scopeNote mesh__D001180
% 212.07/212.28       Venoms from animals of the phylum Arthropoda. Those most investigated are from scorpions and spiders of the class Arachnidae and from ant, bee, and wasp families of the Insecta order Hymenoptera. The venoms contain protein toxins, enzymes, and other bioactive substances and may be lethal to man.%A%    
% 212.07/212.28  |- mesh__recordOriginator mesh__D001180 SH
% 212.07/212.28  |- skos__prefLabel mesh__D001180 Arthropod Venoms
% 212.07/212.28  |- mesh__historyNote mesh__D001180 78   
% 212.07/212.28  |- skos__altLabel mesh__D001180 Arthropod Venom
% 212.07/212.28  |- mesh__recordMaintainer mesh__D001180 ssb
% 212.07/212.28  |- mesh__recordAuthorizer mesh__D001180 sjn
% 212.07/212.28  |- mesh__publicMeSHNote mesh__D001180 78   
% 212.07/212.28  |- skos__hiddenLabel mesh__D008869 MAP2 Microtubule Associated Protein
% 212.07/212.28  |- mesh__recordOriginator mesh__D008869 RLS
% 212.07/212.28  |- skos__hiddenLabel mesh__D008869 MAP1 Microtubule Associated Protein
% 212.07/212.28  |- mesh__dateRevised mesh__D008869 2005-06-30
% 212.07/212.28  |- skos__scopeNote mesh__D008869
% 212.07/212.28       High molecular weight proteins found in the MICROTUBULES of the cytoskeletal system. Under certain conditions they are required for TUBULIN assembly into the microtubules and stabilize the assembled microtubules.%A%    
% 212.07/212.28  |- skos__altLabel mesh__D008869 MAP3 Microtubule-Associated Protein
% 212.07/212.28  |- skos__altLabel mesh__D008869 Microtubule Associated Proteins
% 212.07/212.28  |- skos__altLabel mesh__D008869 MAP1 Microtubule-Associated Protein
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D008869 2006
% 212.07/212.28  |- mesh__historyNote mesh__D008869 85   
% 212.07/212.28  |- skos__hiddenLabel mesh__D008869 Microtubule-Associated Protein, MAP1
% 212.07/212.28  |- mesh__dateEstablished mesh__D008869 1985-01-01
% 212.07/212.28  |- mesh__recordMaintainer mesh__D008869 SYSTEM
% 212.07/212.28  |- skos__hiddenLabel mesh__D008869 Microtubule Associated Protein 2
% 212.07/212.28  |- mesh__recordAuthorizer mesh__D008869 sjn
% 212.07/212.28  |- skos__broader mesh__D008869smesh__D009419
% 212.07/212.28  |- skos__hiddenLabel mesh__D008869 MAP3 Microtubule Associated Protein
% 212.07/212.28  |- skos__altLabel mesh__D008869 MAP2 Microtubule-Associated Protein
% 212.07/212.28  |- skos__historyNote mesh__D008869 Nerve Tissue Proteins %28%1966-1984%29%
% 212.07/212.28  |- skos__broader mesh__D008869smesh__D008868
% 212.07/212.28  |- rdf__type mesh__D008869sskos__Concept
% 212.07/212.28  |- skos__prefLabel mesh__D008869 Microtubule-Associated Proteins
% 212.07/212.28  |- skos__hiddenLabel mesh__D008869 Microtubule Associated Protein 1
% 212.07/212.28  |- mesh__publicMeSHNote mesh__D008869 85   
% 212.07/212.28  |- skos__hiddenLabel mesh__D008869 Microtubule Associated Protein 3
% 212.07/212.28  |- skos__hiddenLabel mesh__D008869 Microtubule-Associated Protein, MAP3
% 212.07/212.28  |- skos__historyNote mesh__D008869 Proteins %28%1966-1984%29%
% 212.07/212.28  |- mesh__dateCreated mesh__D008869 1984-06-11
% 212.07/212.28  |- skos__hiddenLabel mesh__D008869 Microtubule-Associated Protein, MAP2
% 212.07/212.28  |- mesh__dateRevised mesh__D000886 2004-07-13
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D000886 2005
% 212.07/212.28  |- skos__scopeNote mesh__D000886
% 212.07/212.28       The technique that deals with the measurement of the size, weight, and proportions of the human or other primate body.%A%    
% 212.07/212.28  |- rdf__type mesh__D000886sskos__Concept
% 212.07/212.28  |- skos__broader mesh__D000886smesh__D010808
% 212.07/212.28  |- mesh__recordOriginator mesh__D000886 NLM
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D000886 2006
% 212.07/212.28  |- mesh__recordAuthorizer mesh__D000886 sjn
% 212.07/212.28  |- skos__prefLabel mesh__D000886 Anthropometry
% 212.07/212.28  |- mesh__recordMaintainer mesh__D000886 sjn
% 212.07/212.28  |- skos__related mesh__D000886smesh__D001823
% 212.07/212.28  |- skos__related mesh__D000886smesh__D001837
% 212.07/212.28  |- skos__annotation mesh__D000886
% 212.07/212.28       primate only; consider also specific terms under BODY WEIGHTS AND MEASURES%A%  
% 212.07/212.28  |- mesh__dateCreated mesh__D000886 1999-01-01
% 212.07/212.28  |- skos__broader mesh__D000886smesh__D001699
% 212.07/212.28  |- skos__broader mesh__D000886smesh__D008919
% 212.07/212.28  |- skos__annotation mesh__D019591
% 212.07/212.28       do not confuse with PSEUDOAPHAKIA see CATARACT   
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D019591 2002
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D019591 2004
% 212.07/212.28  |- mesh__dateCreated mesh__D019591 1997-06-20
% 212.07/212.28  |- mesh__historyNote mesh__D019591 98   
% 212.07/212.28  |- skos__broader mesh__D019591smesh__D012816
% 212.07/212.28  |- skos__prefLabel mesh__D019591 Pseudophakia
% 212.07/212.28  |- skos__historyNote mesh__D019591 Lenses, Intraocular %28%1979-1997%29%
% 212.07/212.28  |- mesh__recordOriginator mesh__D019591 TGC
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D019591 2003
% 212.07/212.28  |- mesh__recordAuthorizer mesh__D019591 sjn
% 212.07/212.28  |- mesh__dateEstablished mesh__D019591 1998-01-01
% 212.07/212.28  |- mesh__recordMaintainer mesh__D019591 KEV
% 212.07/212.28  |- skos__historyNote mesh__D019591 Cataract Extraction %28%1967-1997%29%
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D019591 2001
% 212.07/212.28  |- mesh__publicMeSHNote mesh__D019591 98   
% 212.07/212.28  |- skos__scopeNote mesh__D019591
% 212.07/212.28       Presence of an intraocular lens after cataract extraction.%A%    
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D019591 2006
% 212.07/212.28  |- mesh__dateRevised mesh__D019591 1999-11-03
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D019591 2000
% 212.07/212.28  |- rdf__type mesh__D019591sskos__Concept
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D019591 2005
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D033262 2003
% 212.07/212.28  |- mesh__recordAuthorizer mesh__D033262 sjn
% 212.07/212.28  |- mesh__historyNote mesh__D033262
% 212.07/212.28       2003; for NARRATIVE ETHICS use ETHICS 1998-2002   
% 212.07/212.28  |- skos__hiddenLabel mesh__D033262 Ethics, Narrative
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D033262 2006
% 212.07/212.28  |- skos__prefLabel mesh__D033262 Narration
% 212.07/212.28  |- skos__scopeNote mesh__D033262
% 212.07/212.28       The act, process, or an instance of narrating, i.e., telling a story.  In the context of MEDICINE or ETHICS, narration includes relating the particular and the personal in the life story of an individual.%A%    
% 212.07/212.28  |- skos__hiddenLabel mesh__D033262 Medicine, Narrative
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D033262 2005
% 212.07/212.28  |- mesh__recordMaintainer mesh__D033262 jrf
% 212.07/212.28  |- mesh__dateEstablished mesh__D033262 2003-01-01
% 212.07/212.28  |- mesh__dateCreated mesh__D033262 2002-07-03
% 212.07/212.28  |- mesh__recordOriginator mesh__D033262 jrf
% 212.07/212.28  |- skos__related mesh__D033262smesh__D000739
% 212.07/212.28  |- rdf__type mesh__D033262sskos__Concept
% 212.07/212.28  |- mesh__publicMeSHNote mesh__D033262
% 212.07/212.28       2003; for NARRATIVE ETHICS see ETHICS 1998-2002   
% 212.07/212.28  |- skos__annotation mesh__D033262 do not use for personal narrations   
% 212.07/212.28  |- skos__hiddenLabel mesh__D033262 Narrations
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D033262 2004
% 212.07/212.28  |- skos__broader mesh__D033262smesh__D003625
% 212.07/212.28  |- skos__broader mesh__D033262smesh__D003142
% 212.07/212.28  |- mesh__historyNote mesh__D000088 68   
% 212.07/212.28  |- skos__scopeNote mesh__D000088
% 212.07/212.28       Acetic acid and its derivatives which may be formed by substitution reactions. Mono- and di-substituted, as well as halogenated compounds have been synthesized.%A%    
% 212.07/212.28  |- skos__broader mesh__D000088smesh__D005232
% 212.07/212.28  |- mesh__recordAuthorizer mesh__D000088 sjn
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D000088 2004
% 212.07/212.28  |- mesh__dateEstablished mesh__D000088 1968-01-01
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D000088 2006
% 212.07/212.28  |- skos__hiddenLabel mesh__D000088 Acids, Acetic
% 212.07/212.28  |- mesh__recordOriginator mesh__D000088 NLM
% 212.07/212.28  |- skos__annotation mesh__D000088
% 212.07/212.28       do not confuse with ACETIC ACID; note X ref ACETIC ACID ESTERS see ACETATES; acetic acid salts = ACETATES%A%  
% 212.07/212.28  |- skos__prefLabel mesh__D000088 Acetic Acids
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D000088 2005
% 212.07/212.28  |- mesh__recordMaintainer mesh__D000088 ssb
% 212.07/212.28  |- mesh__dateCreated mesh__D000088 1999-01-01
% 212.07/212.28  |- mesh__publicMeSHNote mesh__D000088 68   
% 212.07/212.28  |- skos__broader mesh__D000088smesh__D000144
% 212.07/212.28  |- mesh__dateRevised mesh__D000088 2003-07-09
% 212.07/212.28  |- rdf__type mesh__D000088sskos__Concept
% 212.07/212.28  |- skos__historyNote mesh__D000088 Acetates %28%1966-1967%29%
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D005571 2005
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D005571 2000
% 212.07/212.28  |- skos__annotation mesh__D005571 IM   
% 212.07/212.28  |- mesh__dateRevised mesh__D005571 1992-05-15
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D005571 1997
% 212.07/212.28  |- mesh__dateCreated mesh__D005571 1999-01-01
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D005571 2003
% 212.07/212.28  |- skos__hiddenLabel mesh__D005571 Homeopathic Formulary
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D005571 1998
% 212.07/212.28  |- mesh__recordAuthorizer mesh__D005571 PLS
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D005571 1996
% 212.07/212.28  |- mesh__recordOriginator mesh__D005571 NLM
% 212.07/212.28  |- rdf__type mesh__D005571sskos__Concept
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D005571 2002
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D005571 1995
% 212.07/212.28  |- skos__broader mesh__D005571smesh__D005569
% 212.07/212.28  |- skos__hiddenLabel mesh__D005571 Homeopathic Formularies
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D005571 1993
% 212.07/212.28  |- mesh__recordMaintainer mesh__D005571 TAP
% 212.07/212.28  |- skos__prefLabel mesh__D005571 Formularies, Homeopathic
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D005571 2006
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D005571 1994
% 212.07/212.28  |- skos__hiddenLabel mesh__D005571 Formulary, Homeopathic
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D005571 2004
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D005571 2001
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D005571 1999
% 212.07/212.28  |- skos__broader mesh__D009420Q000293smesh__D009420
% 212.07/212.28  |- mesh__preferredCombination mesh__D009420Q000293smesh__D020196
% 212.07/212.28  |- rdf__type mesh__D009420Q000293smesh__CompoundConcept
% 212.07/212.28  |- skos__broader mesh__D046988smesh__D010447
% 212.07/212.28  |- skos__altLabel mesh__D046988 20S Proteasome
% 212.07/212.28  |- mesh__recordAuthorizer mesh__D046988 sjn
% 212.07/212.28  |- skos__related mesh__D046988smesh__D043743
% 212.07/212.28  |- mesh__publicMeSHNote mesh__D046988
% 212.07/212.28       2005; PROTEASOME ENDOPEPTIDASE COMPLEX was indexed under CYSTEINE ENDOPEPTIDASES %26% MULTIENZYME COMPLEXES 1986-2004%A%  
% 212.07/212.28  |- skos__altLabel mesh__D046988 Multicatalytic Endopeptidase Complex
% 212.07/212.28  |- skos__altLabel mesh__D046988 Proteasome
% 212.07/212.28  |- skos__historyNote mesh__D046988 Multienzyme Complexes %28%1986-2004%29%
% 212.07/212.28  |- mesh__dateCreated mesh__D046988 2004-07-07
% 212.07/212.28  |- rdf__type mesh__D046988sskos__Concept
% 212.07/212.28  |- skos__hiddenLabel mesh__D046988 Proteinase, Multicatalytic
% 212.07/212.28  |- skos__hiddenLabel mesh__D046988 Proteasome, 20S
% 212.07/212.28  |- skos__hiddenLabel mesh__D046988 Complex, Multicatalytic Endopeptidase
% 212.07/212.28  |- skos__altLabel mesh__D046988 Macropain
% 212.07/212.28  |- skos__altLabel mesh__D046988 Prosome
% 212.07/212.28  |- mesh__dateEstablished mesh__D046988 2005-01-01
% 212.07/212.28  |- skos__historyNote mesh__D046988
% 212.07/212.28       Cysteine Endopeptidases %28%1986-2004%29%
% 212.07/212.28  |- mesh__recordOriginator mesh__D046988 jmp
% 212.07/212.28  |- mesh__recordMaintainer mesh__D046988 jmp
% 212.07/212.28  |- skos__broader mesh__D046988smesh__D009097
% 212.07/212.28  |- skos__scopeNote mesh__D046988
% 212.07/212.28       A large multisubunit complex that plays an important role in the degradation of most of the cytosolic and nuclear proteins in eukaryotic cells. It contains a 700-kDa catalytic sub-complex and two 700-kDa regulatory sub-complexes. The complex digests ubiquitinated proteins and protein activated via ornithine decarboxylase antizyme.%A%    
% 212.07/212.28  |- skos__altLabel mesh__D046988 Multicatalytic Proteinase
% 212.07/212.28  |- skos__hiddenLabel mesh__D046988 Endopeptidase Complex, Proteasome
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D046988 2006
% 212.07/212.28  |- skos__altLabel mesh__D046988 Macroxyproteinase
% 212.07/212.28  |- skos__prefLabel mesh__D046988 Proteasome Endopeptidase Complex
% 212.07/212.28  |- skos__hiddenLabel mesh__D046988 Endopeptidase Complex, Multicatalytic
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D046988 2005
% 212.07/212.28  |- mesh__historyNote mesh__D046988
% 212.07/212.28       2005; use PROTEASOME ENDOPEPTIDASE COMPLEX %28%NM%29% 1986-2004%A%  
% 212.07/212.28  |- skos__hiddenLabel mesh__D046988 Complex, Proteasome Endopeptidase
% 212.07/212.28  |- mesh__recordAuthorizer mesh__D013205 sjn
% 212.07/212.28  |- skos__prefLabel mesh__D013205 Staphylococcal Protein A
% 212.07/212.28  |- skos__annotation mesh__D013205
% 212.07/212.28       /drug eff /ultrastruct permitted; DF: STAPH PROTEIN A   
% 212.07/212.28  |- skos__broader mesh__D013205smesh__D000942
% 212.07/212.28  |- rdf__type mesh__D013205sskos__Concept
% 212.07/212.28  |- skos__historyNote mesh__D013205 Antigens, Bacterial %28%1971-1977%29%
% 212.07/212.28  |- skos__historyNote mesh__D013205 Staphylococcus aureus %28%1976-1977%29%
% 212.07/212.28  |- skos__broader mesh__D013205smesh__D001426
% 212.07/212.28  |- mesh__dateRevised mesh__D013205 2005-06-30
% 212.07/212.28  |- skos__historyNote mesh__D013205 Staphylococcus %28%1966-1975%29%
% 212.07/212.28  |- skos__historyNote mesh__D013205 Bacterial Proteins %28%1966-1977%29%
% 212.07/212.28  |- skos__hiddenLabel mesh__D013205 A, Staphylococcal Protein
% 212.07/212.28  |- skos__scopeNote mesh__D013205
% 212.07/212.28       A protein present in the cell wall of most Staphylococcus aureus strains. The protein selectively binds to the Fc region of human normal and myeloma-derived IMMUNOGLOBULIN G. It elicits antibody activity and may cause hypersensitivity reactions due to histamine release; has also been used as cell surface antigen marker and in the clinical assessment of B lymphocyte function.%A%    
% 212.07/212.28  |- mesh__publicMeSHNote mesh__D013205 78   
% 212.07/212.28  |- skos__hiddenLabel mesh__D013205 A, Protein
% 212.07/212.28  |- skos__altLabel mesh__D013205 Protein A
% 212.07/212.28  |- mesh__recordMaintainer mesh__D013205 ssb
% 212.07/212.28  |- mesh__dateEstablished mesh__D013205 1978-01-01
% 212.07/212.28  |- mesh__recordOriginator mesh__D013205 RLS
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D013205 2006
% 212.07/212.28  |- mesh__historyNote mesh__D013205 78   
% 212.07/212.28  |- skos__hiddenLabel mesh__D013205 Protein A, Staphylococcal
% 212.07/212.28  |- mesh__dateCreated mesh__D013205 1977-05-24
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D018499 2005
% 212.07/212.28  |- mesh__historyNote mesh__D018499
% 212.07/212.28       95; was see ENERGY TRANSFER 1992-94; LET was see ENERGY TRANSFER 1968-94%A%  
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D018499 1999
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D018499 2001
% 212.07/212.28  |- skos__annotation mesh__D018499 DF: note short X ref   
% 212.07/212.28  |- skos__scopeNote mesh__D018499
% 212.07/212.28       Rate of energy dissipation along the path of charged particles. In radiobiology and health physics, exposure is measured in kiloelectron volts per micrometer of tissue %28%keV/micrometer T%29%.%A%    
% 212.07/212.28  |- mesh__onlineNote mesh__D018499
% 212.07/212.28       use ENERGY TRANSFER to search LINEAR ENERGY TRANSFER 1992-94 %26% LET 1968-94%A%  
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D018499 1998
% 212.07/212.28  |- skos__historyNote mesh__D018499 Energy Transfer %28%1968-1994%29%
% 212.07/212.28  |- rdf__type mesh__D018499sskos__Concept
% 212.07/212.28  |- mesh__dateCreated mesh__D018499 1994-06-07
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D018499 2004
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D018499 2000
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D018499 2003
% 212.07/212.28  |- mesh__activeMeSHYear mesh__D018499 1997
% 212.14/212.28  |- mesh__publicMeSHNote mesh__D018499
% 212.14/212.28       95; was see ENERGY TRANSFER 1992-94; LET was see ENERGY TRANSFER 1968-94%A%  
% 212.14/212.28  |- mesh__activeMeSHYear mesh__D018499 1996
% 212.14/212.29  |- skos__hiddenLabel mesh__D018499 Transfer, Linear Energy
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D018499 1995
% 212.14/212.29  |- skos__altLabel mesh__D018499 Energy Transfer, Linear
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D018499 2006
% 212.14/212.29  |- skos__altLabel mesh__D018499 LET
% 212.14/212.29  |- mesh__dateEstablished mesh__D018499 1995-01-01
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D018499 2002
% 212.14/212.29  |- skos__broader mesh__D018499smesh__D004735
% 212.14/212.29  |- skos__prefLabel mesh__D018499 Linear Energy Transfer
% 212.14/212.29  |- mesh__dateCreated mesh__D004479 1977-04-22
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D004479 2002
% 212.14/212.29  |- mesh__dateEstablished mesh__D004479 1991-01-01
% 212.14/212.29  |- skos__historyNote mesh__D004479 Eye Diseases %28%1966-1977%29%
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D004479 2004
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D004479 2001
% 212.14/212.29  |- skos__prefLabel mesh__D004479 Ectopia Lentis
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D004479 2006
% 212.14/212.29  |- mesh__recordAuthorizer mesh__D004479 sjn
% 212.14/212.29  |- skos__broader mesh__D004479smesh__D007906
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D004479 2003
% 212.14/212.29  |- skos__hiddenLabel mesh__D004479 Lentis, Ectopia
% 212.14/212.29  |- mesh__recordOriginator mesh__D004479 RC
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D004479 2000
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D004479 2005
% 212.14/212.29  |- mesh__publicMeSHNote mesh__D004479 91   
% 212.14/212.29  |- rdf__type mesh__D004479sskos__Concept
% 212.14/212.29  |- skos__scopeNote mesh__D004479
% 212.14/212.29       Congenital displacement of the lens resulting from defective zonule formation.%A%    
% 212.14/212.29  |- skos__annotation mesh__D004479
% 212.14/212.29       congen lens dislocation; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 212.14/212.29  |- mesh__recordMaintainer mesh__D004479 kle
% 212.14/212.29  |- skos__historyNote mesh__D004479 Lens, Crystalline %28%1966-1977%29%
% 212.14/212.29  |- mesh__historyNote mesh__D004479 91%28%78%29%   
% 212.14/212.29  |- mesh__dateRevised mesh__D004479 1999-11-03
% 212.14/212.29  |- skos__broader mesh__D004479smesh__D005124
% 212.14/212.29  |- skos__historyNote mesh__D009962 Uracil Nucleotides %28%1975-1976%29%
% 212.14/212.29  |- skos__altLabel mesh__D009962 Orotidine-5%27%-Phosphate Pyrophosphorylase
% 212.14/212.29  |- skos__hiddenLabel mesh__D009962
% 212.14/212.29       Phosphohydrolase, Orotidine-5%27%-Monophosphate
% 212.14/212.29  |- skos__hiddenLabel mesh__D009962 Phosphoribosyltransferase, Orotate
% 212.14/212.29  |- skos__hiddenLabel mesh__D009962
% 212.14/212.29       Orotidine 5%27% Phosphate Pyrophosphorylase
% 212.14/212.29  |- mesh__dateCreated mesh__D009962 1976-04-27
% 212.14/212.29  |- skos__altLabel mesh__D009962
% 212.14/212.29       Orotidine-5%27%-Monophosphate Phosphohydrolase
% 212.14/212.29  |- skos__hiddenLabel mesh__D009962
% 212.14/212.29       Pyrophosphorylase, Orotidine-5%27%-Phosphate
% 212.14/212.29  |- skos__hiddenLabel mesh__D009962 Phosphorylase, Orotidylic Acid
% 212.14/212.29  |- skos__annotation mesh__D009962
% 212.14/212.29       /defic: consider also OROTIC ACID /urine %28%IM%29% + PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS %28%IM%29%%A%  
% 212.14/212.29  |- mesh__dateRevised mesh__D009962 2003-07-09
% 212.14/212.29  |- skos__historyNote mesh__D009962 Ribonucleotides %28%1972-1974%29%
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009962 2005
% 212.14/212.29  |- mesh__recordOriginator mesh__D009962 RLS
% 212.14/212.29  |- skos__altLabel mesh__D009962 Orotidylic Acid Phosphorylase
% 212.14/212.29  |- skos__altLabel mesh__D009962 OMPase
% 212.14/212.29  |- mesh__dateEstablished mesh__D009962 1991-01-01
% 212.14/212.29  |- skos__prefLabel mesh__D009962 Orotate Phosphoribosyltransferase
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009962 2006
% 212.14/212.29  |- skos__broader mesh__D009962smesh__D010430
% 212.14/212.29  |- skos__historyNote mesh__D009962 Pyrimidine Nucleotides %28%1972-1974%29%
% 212.14/212.29  |- skos__hiddenLabel mesh__D009962
% 212.14/212.29       Orotidine 5%27% Monophosphate Phosphohydrolase
% 212.14/212.29  |- skos__historyNote mesh__D009962 Pentosyltransferases %28%1972-1976%29%
% 212.14/212.29  |- mesh__publicMeSHNote mesh__D009962
% 212.14/212.29       91; was see under PENTOSYLTRANSFERASES 1977-90   
% 212.14/212.29  |- mesh__recordAuthorizer mesh__D009962 sjn
% 212.14/212.29  |- skos__scopeNote mesh__D009962
% 212.14/212.29       The enzyme catalyzing the formation of orotidine-5%27%-phosphoric acid %28%orotidylic acid%29% from orotic acid and 5-phosphoribosyl-1-pyrophosphate in the course of pyrimidine nucleotide biosynthesis. EC 2.4.2.10.%A%    
% 212.14/212.29  |- mesh__historyNote mesh__D009962
% 212.14/212.29       91%28%77%29%; was see under PENTOSYLTRANSFERASES 1977-90   
% 212.14/212.29  |- rdf__type mesh__D009962sskos__Concept
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009962 2004
% 212.14/212.29  |- mesh__recordMaintainer mesh__D009962 ssb
% 212.14/212.29  |- mesh__recordOriginator mesh__D009164 NLM
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009164 2002
% 212.14/212.29  |- mesh__dateRevised mesh__D009164 1993-06-02
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009164 2004
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009164 1997
% 212.14/212.29  |- skos__scopeNote mesh__D009164
% 212.14/212.29       Infections with bacteria of the genus MYCOBACTERIUM.     
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009164 2001
% 212.14/212.29  |- mesh__recordMaintainer mesh__D009164 TAP
% 212.14/212.29  |- skos__altLabel mesh__D009164 Infections, Mycobacterium
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009164 2003
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009164 1996
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009164 2006
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009164 1999
% 212.14/212.29  |- mesh__recordAuthorizer mesh__D009164 PLS
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009164 2000
% 212.14/212.29  |- skos__annotation mesh__D009164
% 212.14/212.29       gram-pos bact infect; GEN; consider also TUBERCULOSIS; DF: MYCOBACT INFECT%A%  
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009164 1995
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009164 2005
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009164 1998
% 212.14/212.29  |- mesh__dateEstablished mesh__D009164 1964-01-01
% 212.14/212.29  |- skos__prefLabel mesh__D009164 Mycobacterium Infections
% 212.14/212.29  |- mesh__publicMeSHNote mesh__D009164 64   
% 212.14/212.29  |- mesh__dateCreated mesh__D009164 1999-01-01
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009164 1994
% 212.14/212.29  |- skos__broader mesh__D009164smesh__D000193
% 212.14/212.29  |- mesh__historyNote mesh__D009164 64   
% 212.14/212.29  |- skos__hiddenLabel mesh__D009164 Infection, Mycobacterium
% 212.14/212.29  |- skos__hiddenLabel mesh__D009164 Mycobacterium Infection
% 212.14/212.29  |- rdf__type mesh__D009164sskos__Concept
% 212.14/212.29  |- skos__scopeNote mesh__D001181
% 212.14/212.29       Members of the phylum Arthropoda of the animal kingdom, composed of organisms having a hard, jointed exoskeleton and paired jointed legs, and including among other classes, the ARACHNIDA and INSECTS, many species of which are important medically as parasites or as vectors of organisms capable of causing disease in man. %28%Dorland, 27th ed%29%%A%    
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D001181 2006
% 212.14/212.29  |- skos__prefLabel mesh__D001181 Arthropods
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D001181 2004
% 212.14/212.29  |- rdf__type mesh__D001181sskos__Concept
% 212.14/212.29  |- skos__broader mesh__D001181smesh__D007448
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D001181 2005
% 212.14/212.29  |- mesh__recordAuthorizer mesh__D001181 sjn
% 212.14/212.29  |- mesh__dateCreated mesh__D001181 1999-01-01
% 212.14/212.29  |- mesh__dateRevised mesh__D001181 2003-07-09
% 212.14/212.29  |- mesh__recordOriginator mesh__D001181 NLM
% 212.14/212.29  |- skos__annotation mesh__D001181 /microbiol /parasitol /virol permitted   
% 212.14/212.29  |- mesh__recordMaintainer mesh__D001181 ags
% 212.14/212.29  |- skos__broader mesh__D013963Q000037smesh__D013963
% 212.14/212.29  |- mesh__preferredCombination mesh__D013963Q000037smesh__D013956
% 212.14/212.29  |- rdf__type mesh__D013963Q000037smesh__CompoundConcept
% 212.14/212.29  |- skos__broader mesh__D000887smesh__D000529
% 212.14/212.29  |- skos__scopeNote mesh__D000887
% 212.14/212.29       Knowledge of the nature of man. A spiritual and mystical doctrine that grew out of theosophy and derives mainly from the philosophy of Rudolph Steiner, Austrian social philosopher %28%1861-1925%29%. %28%Webster, 3d ed%29%%A%    
% 212.14/212.29  |- mesh__recordMaintainer mesh__D000887 ssb
% 212.14/212.29  |- mesh__dateCreated mesh__D000887 1999-01-01
% 212.14/212.29  |- mesh__historyNote mesh__D000887 67,63-65   
% 212.14/212.29  |- mesh__publicMeSHNote mesh__D000887 67,63-65   
% 212.14/212.29  |- skos__prefLabel mesh__D000887 Anthroposophy
% 212.14/212.29  |- rdf__type mesh__D000887sskos__Concept
% 212.14/212.29  |- mesh__dateRevised mesh__D000887 2001-07-25
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D000887 2006
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D000887 2004
% 212.14/212.29  |- mesh__recordOriginator mesh__D000887 NLM
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D000887 2005
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D000887 2003
% 212.14/212.29  |- mesh__recordAuthorizer mesh__D000887 sjn
% 212.14/212.29  |- skos__broader mesh__D000887smesh__D012067
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D000887 2002
% 212.14/212.29  |- skos__broader mesh__D000089smesh__D000812
% 212.14/212.29  |- mesh__recordMaintainer mesh__D000089 ADP
% 212.14/212.29  |- mesh__publicMeSHNote mesh__D000089
% 212.14/212.29       91; was see under ACETIC ACIDS 1979-90   
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D000089 2004
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D000089 2002
% 212.14/212.29  |- skos__historyNote mesh__D000089 Acetates %28%1966-1967%29%
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D000089 2006
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D000089 2003
% 212.14/212.29  |- skos__scopeNote mesh__D000089
% 212.14/212.29       Compounds used extensively as acetylation, oxidation and dehydrating agents and in the modification of proteins and enzymes.%A%    
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D000089 2001
% 212.14/212.29  |- skos__historyNote mesh__D000089 Anhydrides %28%1966-1978%29%
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D000089 2005
% 212.14/212.29  |- mesh__dateRevised mesh__D000089 1998-06-10
% 212.14/212.29  |- mesh__recordOriginator mesh__D000089 RLS
% 212.14/212.29  |- mesh__recordAuthorizer mesh__D000089 SJN
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D000089 2000
% 212.14/212.29  |- skos__historyNote mesh__D000089 Acetic Acids %28%1968-1978%29%
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D000089 1999
% 212.14/212.29  |- mesh__historyNote mesh__D000089
% 212.14/212.29       91%28%79%29%; was see under ACETIC ACIDS 1979-90   
% 212.14/212.29  |- rdf__type mesh__D000089sskos__Concept
% 212.14/212.29  |- skos__broader mesh__D000089smesh__D000088
% 212.14/212.29  |- mesh__dateEstablished mesh__D000089 1991-01-01
% 212.14/212.29  |- skos__hiddenLabel mesh__D000089 Anhydrides, Acetic
% 212.14/212.29  |- mesh__dateCreated mesh__D000089 1977-12-08
% 212.14/212.29  |- skos__prefLabel mesh__D000089 Acetic Anhydrides
% 212.14/212.29  |- mesh__recordMaintainer mesh__D005572 kle
% 212.14/212.29  |- skos__altLabel mesh__D005572 Formulary, Hospital
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D005572 2001
% 212.14/212.29  |- rdf__type mesh__D005572sskos__Concept
% 212.14/212.29  |- skos__altLabel mesh__D005572 Hospital Formularies
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D005572 2000
% 212.14/212.29  |- mesh__dateEstablished mesh__D005572 1968-01-01
% 212.14/212.29  |- skos__altLabel mesh__D005572 Hospital Formulary
% 212.14/212.29  |- skos__broader mesh__D005572smesh__D005569
% 212.14/212.29  |- mesh__recordOriginator mesh__D005572 NLM
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D005572 2006
% 212.14/212.29  |- mesh__historyNote mesh__D005572 68   
% 212.14/212.29  |- skos__annotation mesh__D005572 IM; DF: FORMULARIES HOSP   
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D005572 2002
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D005572 2004
% 212.14/212.29  |- mesh__publicMeSHNote mesh__D005572 68   
% 212.14/212.29  |- mesh__dateRevised mesh__D005572 1999-11-03
% 212.14/212.29  |- mesh__recordAuthorizer mesh__D005572 sjn
% 212.14/212.29  |- skos__prefLabel mesh__D005572 Formularies, Hospital
% 212.14/212.29  |- skos__scopeNote mesh__D005572
% 212.14/212.29       Formularies concerned with pharmaceuticals prescribed in hospitals.%A%    
% 212.14/212.29  |- skos__historyNote mesh__D005572 Formularies %28%1966-1967%29%
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D005572 2005
% 212.14/212.29  |- mesh__dateCreated mesh__D005572 1999-01-01
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D005572 2003
% 212.14/212.29  |- mesh__dateCreated mesh__D013206 1985-05-07
% 212.14/212.29  |- skos__annotation mesh__D013206
% 212.14/212.29       in inf; do not confuse with another epidermolytic disease: NONSTAPHYLOCOCCAL SCALDED SKIN SYNDROME see EPIDERMAL NECROLYSIS, TOXIC; DF: SSSS%A%  
% 212.14/212.29  |- skos__hiddenLabel mesh__D013206 Ritters Disease
% 212.14/212.29  |- skos__prefLabel mesh__D013206 Staphylococcal Scalded Skin Syndrome
% 212.14/212.29  |- skos__scopeNote mesh__D013206
% 212.14/212.29       A disease of infants due to group 2 phage type 17 staphylococci that produce an epidermolytic exotoxin. Superficial fine vesicles and bullae form and rupture easily, resulting in loss of large sheets of epidermis.%A%    
% 212.14/212.29  |- skos__hiddenLabel mesh__D013206 Disease, Ritter
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D013206 2003
% 212.14/212.29  |- mesh__publicMeSHNote mesh__D013206
% 212.14/212.29       91; was see under STAPHYLOCOCCAL SKIN INFECTIONS 1986-90; RITTER%27%S DISEASE was see DERMATITIS EXFOLIATIVA 1968-85, was heading 1966-67%A%  
% 212.14/212.29  |- mesh__dateRevised mesh__D013206 1994-02-08
% 212.14/212.29  |- skos__altLabel mesh__D013206 Ritter%27%s Disease
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D013206 2001
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D013206 1996
% 212.14/212.29  |- skos__hiddenLabel mesh__D013206 Syndrome, Staphylococcal Scalded-Skin
% 212.14/212.29  |- skos__altLabel mesh__D013206 Ritter Disease
% 212.14/212.29  |- mesh__recordMaintainer mesh__D013206 PXP
% 212.14/212.29  |- rdf__type mesh__D013206sskos__Concept
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D013206 2000
% 212.14/212.29  |- skos__broader mesh__D013206smesh__D013207
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D013206 1995
% 212.14/212.29  |- skos__altLabel mesh__D013206 Scalded Skin Syndrome, Staphylococcal
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D013206 2006
% 212.14/212.29  |- skos__hiddenLabel mesh__D013206 Scalded-Skin Syndromes, Staphylococcal
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D013206 1999
% 212.14/212.29  |- skos__hiddenLabel mesh__D013206 Disease, Ritter%27%s
% 212.14/212.29  |- mesh__historyNote mesh__D013206
% 212.14/212.29       91%28%86%29%; was see under STAPHYLOCOCCAL SKIN INFECTIONS 1986-90; RITTER%27%S DISEASE was see DERMATITIS EXFOLIATIVA 1968-85, was heading 1966-67%A%  
% 212.14/212.29  |- mesh__recordAuthorizer mesh__D013206 PLS
% 212.14/212.29  |- mesh__recordOriginator mesh__D013206 RC
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D013206 2005
% 212.14/212.29  |- mesh__onlineNote mesh__D013206
% 212.14/212.29       use DERMATITIS EXFOLIATIVA to search RITTER%27%S DISEASE 1966-85%A%  
% 212.14/212.29  |- mesh__dateEstablished mesh__D013206 1991-01-01
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D013206 1998
% 212.14/212.29  |- skos__hiddenLabel mesh__D013206 Syndromes, Staphylococcal Scalded-Skin
% 212.14/212.29  |- skos__hiddenLabel mesh__D013206 Staphylococcal Scalded-Skin Syndromes
% 212.14/212.29  |- skos__historyNote mesh__D013206
% 212.14/212.29       Staphylococcal Infections %28%1966-1985%29%
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D013206 2004
% 212.14/212.29  |- skos__altLabel mesh__D013206 Staphylococcal Scalded-Skin Syndrome
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D013206 2002
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D013206 1997
% 212.14/212.29  |- skos__hiddenLabel mesh__D013206 Scalded-Skin Syndrome, Staphylococcal
% 212.14/212.29  |- skos__historyNote mesh__D013206
% 212.14/212.29       Epidermal Necrolysis, Toxic %28%1966-1985%29%
% 212.14/212.29  |- mesh__dateRevised mesh__D009963 1992-05-19
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009963 2000
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009963 2003
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009963 1998
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009963 1997
% 212.14/212.29  |- rdf__type mesh__D009963sskos__Concept
% 212.14/212.29  |- skos__broader mesh__D009963smesh__D000147
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009963 1996
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009963 2002
% 212.14/212.29  |- mesh__recordAuthorizer mesh__D009963 PLS
% 212.14/212.29  |- skos__hiddenLabel mesh__D009963 Orotate, Sodium
% 212.14/212.29  |- skos__hiddenLabel mesh__D009963 Orotate, Zinc
% 212.14/212.29  |- skos__hiddenLabel mesh__D009963 Orotate, Potassium
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009963 1995
% 212.14/212.29  |- mesh__recordOriginator mesh__D009963 NLM
% 212.14/212.29  |- skos__broader mesh__D009963smesh__D014498
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009963 2006
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009963 2001
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009963 1994
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009963 1993
% 212.14/212.29  |- skos__prefLabel mesh__D009963 Orotic Acid
% 212.14/212.29  |- mesh__dateCreated mesh__D009963 1999-01-01
% 212.14/212.29  |- mesh__recordMaintainer mesh__D009963 TAP
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009963 2005
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009963 2004
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009963 1999
% 212.14/212.29  |- skos__hiddenLabel mesh__D009963 Acid, Orotic
% 212.14/212.29  |- skos__broader mesh__D003113Q000295smesh__D003113
% 212.14/212.29  |- mesh__preferredCombination mesh__D003113Q000295smesh__D020685
% 212.14/212.29  |- rdf__type mesh__D003113Q000295smesh__CompoundConcept
% 212.14/212.29  |- skos__broader mesh__D015220Q000037smesh__D015220
% 212.14/212.29  |- mesh__preferredCombination mesh__D015220Q000037smesh__D002121
% 212.14/212.29  |- rdf__type mesh__D015220Q000037smesh__CompoundConcept
% 212.14/212.29  |- skos__related mesh__D001980smesh__D001993
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D001980 2006
% 212.14/212.29  |- mesh__dateCreated mesh__D001980 1999-01-01
% 212.14/212.29  |- rdf__type mesh__D001980sskos__Concept
% 212.14/212.29  |- mesh__recordOriginator mesh__D001980 NLM
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D001980 2005
% 212.14/212.29  |- mesh__dateRevised mesh__D001980 2000-06-22
% 212.14/212.29  |- skos__annotation mesh__D001980
% 212.14/212.29       /drug eff: consider also BRONCHOCONSTRICTOR AGENTS or BRONCHODILATOR AGENTS; inflammation = BRONCHITIS but note BRONCHIOLITIS is also available; dilatation = BRONCHIECTASIS; bronchial tuberc or tuberc bronchitis: index under TUBERCULOSIS, PULMONARY %26% not also under BRONCHI or BRONCHITIS unless particularly discussed%A%  
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D001980 2002
% 212.14/212.29  |- skos__broader mesh__D001980smesh__D008168
% 212.14/212.29  |- mesh__recordMaintainer mesh__D001980 ags
% 212.14/212.29  |- mesh__recordAuthorizer mesh__D001980 sjn
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D001980 2004
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D001980 2001
% 212.14/212.29  |- skos__related mesh__D001980smesh__D016085
% 212.14/212.29  |- skos__prefLabel mesh__D001980 Bronchi
% 212.14/212.29  |- skos__related mesh__D001980smesh__D001999
% 212.14/212.29  |- skos__hiddenLabel mesh__D001980 Bronchus
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D001980 2003
% 212.14/212.29  |- skos__scopeNote mesh__D001980
% 212.14/212.29       The larger air passages of the lungs arising from the terminal bifurcation of the trachea.%A%    
% 212.14/212.29  |- skos__hiddenLabel mesh__D001980 Bronchiole
% 212.14/212.29  |- skos__related mesh__D001980smesh__D001995
% 212.14/212.29  |- mesh__dateEstablished mesh__D009165 1991-01-01
% 212.14/212.29  |- mesh__dateRevised mesh__D009165 2005-07-21
% 212.14/212.29  |- mesh__publicMeSHNote mesh__D009165
% 212.14/212.29       91; was see under MYCOBACTERIUM INFECTIONS 1977-90   
% 212.14/212.29  |- skos__hiddenLabel mesh__D009165 Infection, Tuberculoid
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009165 2005
% 212.14/212.29  |- mesh__dateCreated mesh__D009165 1976-05-19
% 212.14/212.29  |- skos__altLabel mesh__D009165 Infections, Atypical Mycobacterium
% 212.14/212.29  |- mesh__recordMaintainer mesh__D009165 ags
% 212.14/212.29  |- skos__annotation mesh__D009165
% 212.14/212.29       see MYCOBACTERIUM, ATYPICAL for a list of atypical Mycobact or MeSH definition here; DF: MYCOBACT INFECT ATYPICAL%A%  
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009165 2006A
% 212.14/212.29  |- mesh__recordOriginator mesh__D009165 FPG
% 212.14/212.29  |- skos__hiddenLabel mesh__D009165 Tuberculoid Infection
% 212.14/212.29  |- mesh__recordAuthorizer mesh__D009165 ags
% 212.14/212.29  |- skos__altLabel mesh__D009165 Infections, Tuberculoid
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009165 2002
% 212.14/212.29  |- rdf__type mesh__D009165sskos__Concept
% 212.14/212.29  |- skos__hiddenLabel mesh__D009165 Infection, Atypical Mycobacterium
% 212.14/212.29  |- skos__hiddenLabel mesh__D009165 Mycobacterium Infection, Atypical
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009165 2001
% 212.14/212.29  |- skos__prefLabel mesh__D009165 Mycobacterium Infections, Atypical
% 212.14/212.29  |- skos__historyNote mesh__D009165
% 212.14/212.29       Mycobacterium Infections %28%1966-1976%29%
% 212.14/212.29  |- skos__altLabel mesh__D009165 Atypical Mycobacterium Infections
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009165 2004
% 212.14/212.29  |- mesh__historyNote mesh__D009165
% 212.14/212.29       91%28%77%29%; was see under MYCOBACTERIUM INFECTIONS 1977-90   
% 212.14/212.29  |- skos__hiddenLabel mesh__D009165 Atypical Mycobacterium Infection
% 212.14/212.29  |- skos__altLabel mesh__D009165 Tuberculoid Infections
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009165 2000
% 212.14/212.29  |- skos__broader mesh__D009165smesh__D009164
% 212.14/212.29  |- skos__scopeNote mesh__D009165
% 212.14/212.29       Infections with so called atypical mycobacteria %28%tuberculoid bacilli%29%: M. kansasii, M. marinum, M. scrofulaceum, M. flavescens, M. gordonae, M. obuense, M. gilvum, M. duvali, M. szulgai, M. intracellulare %28%see MYCOBACTERIUM AVIUM COMPLEX%29%, M. xenopi %28%littorale%29%, M. ulcerans, M. buruli, M. terrae, M. fortuitum %28%minetti, giae%29%, M. chelonae.%A%    
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009165 2003
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009165 2006
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D009165 1999
% 212.14/212.29  |- rdf__type mesh__D001182sskos__Concept
% 212.14/212.29  |- skos__broader mesh__D001182smesh__D019637
% 212.14/212.29  |- skos__hiddenLabel mesh__D001182 Surgical Procedure, Arthroscopic
% 212.14/212.29  |- skos__historyNote mesh__D001182 Endoscopy %28%1966-1981%29%
% 212.14/212.29  |- skos__hiddenLabel mesh__D001182 Procedure, Arthroscopic Surgical
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D001182 2005
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D001182 2002
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D001182 2003
% 212.14/212.29  |- skos__altLabel mesh__D001182 Surgery, Arthroscopic
% 212.14/212.29  |- skos__historyNote mesh__D001182 other joint heading
% 212.14/212.29  |- mesh__dateEstablished mesh__D001182 1982-01-01
% 212.14/212.29  |- mesh__publicMeSHNote mesh__D001182 82   
% 212.14/212.29  |- mesh__historyNote mesh__D001182 82   
% 212.14/212.29  |- mesh__dateRevised mesh__D001182 1999-11-03
% 212.14/212.29  |- skos__historyNote mesh__D001182 Knee Joint %28%1966-1981%29%
% 212.14/212.29  |- skos__prefLabel mesh__D001182 Arthroscopy
% 212.14/212.29  |- skos__historyNote mesh__D001182 Knee Injuries %28%1966-1981%29%
% 212.14/212.29  |- skos__hiddenLabel mesh__D001182 Arthroscopic Surgical Procedure
% 212.14/212.29  |- mesh__recordOriginator mesh__D001182 SMH
% 212.14/212.29  |- mesh__dateCreated mesh__D001182 1981-04-15
% 212.14/212.29  |- mesh__recordAuthorizer mesh__D001182 sjn
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D001182 2001
% 212.14/212.29  |- skos__altLabel mesh__D001182 Surgical Procedures, Arthroscopic
% 212.14/212.29  |- mesh__recordMaintainer mesh__D001182 nns
% 212.14/212.29  |- skos__scopeNote mesh__D001182
% 212.14/212.29       Endoscopic examination, therapy and surgery of the joint.%A%    
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D001182 2000
% 212.14/212.29  |- skos__altLabel mesh__D001182 Arthroscopic Surgery
% 212.14/212.29  |- skos__broader mesh__D001182smesh__D004724
% 212.14/212.29  |- skos__hiddenLabel mesh__D001182 Arthroscopies
% 212.14/212.29  |- skos__historyNote mesh__D001182 Joint Diseases %28%1966-1981%29%
% 212.14/212.29  |- skos__hiddenLabel mesh__D001182 Procedures, Arthroscopic Surgical
% 212.14/212.29  |- skos__hiddenLabel mesh__D001182 Arthroscopic Surgeries
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D001182 2006
% 212.14/212.29  |- skos__hiddenLabel mesh__D001182 Surgeries, Arthroscopic
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D001182 2004
% 212.14/212.29  |- skos__hiddenLabel mesh__D000888 Antibodies, Antigamma Globulin
% 212.14/212.29  |- rdf__type mesh__D000888sskos__Concept
% 212.14/212.29  |- skos__hiddenLabel mesh__D000888 Image Antibodies, Internal
% 212.14/212.29  |- skos__hiddenLabel mesh__D000888 Globulin Antibodies, Antigamma
% 212.14/212.29  |- skos__altLabel mesh__D000888 Antiglobulins
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D000888 2006
% 212.14/212.29  |- skos__hiddenLabel mesh__D000888 Antibodies, Anti-Idiotype
% 212.14/212.29  |- skos__prefLabel mesh__D000888 Antibodies, Anti-Idiotypic
% 212.14/212.29  |- mesh__recordMaintainer mesh__D000888 ssb
% 212.14/212.29  |- skos__annotation mesh__D000888
% 212.14/212.29       use only for anti-immunoglobulin antibodies such as anti-IGA antibodies, anti-IGG antibodies, etc.: coordinate IM with IMMUNOGLOBULIN A %28%IM%29%, IMMUNOGLOBULIN G %28%IM%29%, etc.; caution: anti-liver antibodies for example = ANTIBODIES + LIVER  /immunol, not ANTI-ANTIBODIES%A%  
% 212.14/212.29  |- skos__hiddenLabel mesh__D000888 Internal Image Antibodies
% 212.14/212.29  |- skos__hiddenLabel mesh__D000888 Globulin Antibodies, Anti-gamma
% 212.14/212.29  |- skos__altLabel mesh__D000888 Anti-Idiotype Antibodies
% 212.14/212.29  |- skos__altLabel mesh__D000888 Anti Antibodies
% 212.14/212.29  |- skos__hiddenLabel mesh__D000888 Anti gamma Globulin Antibodies
% 212.14/212.29  |- skos__hiddenLabel mesh__D000888 Anti-Idiotypic Antibodies
% 212.14/212.29  |- mesh__publicMeSHNote mesh__D000888 90; was ANTI-ANTIBODIES 1967-89   
% 212.14/212.29  |- mesh__dateEstablished mesh__D000888 1967-01-01
% 212.14/212.29  |- skos__related mesh__D000888smesh__D007130
% 212.14/212.29  |- mesh__historyNote mesh__D000888
% 212.14/212.29       90; was ANTI-ANTIBODIES 1966-89 %28%Prov 1966%29%   
% 212.14/212.29  |- skos__hiddenLabel mesh__D000888 Antibodies, Anti Idiotypic
% 212.14/212.29  |- mesh__onlineNote mesh__D000888
% 212.14/212.29       use ANTIBODIES, ANTI-IDIOTYPIC to search ANTI-ANTIBODIES 1966-89%A%  
% 212.14/212.29  |- skos__scopeNote mesh__D000888
% 212.14/212.29       Antibodies which react with the individual structural determinants %28%idiotopes%29% on the variable region of other antibodies.%A%    
% 212.14/212.29  |- mesh__dateRevised mesh__D000888 2005-06-30
% 212.14/212.29  |- skos__related mesh__D000888smesh__D018716
% 212.14/212.29  |- skos__hiddenLabel mesh__D000888 Anti Idiotype Antibodies
% 212.14/212.29  |- mesh__recordOriginator mesh__D000888 NLM
% 212.14/212.29  |- skos__broader mesh__D000888smesh__D000906
% 212.14/212.29  |- skos__altLabel mesh__D000888 Antigamma Globulin Antibodies
% 212.14/212.29  |- skos__hiddenLabel mesh__D000888 Antibodies, Anti
% 212.14/212.29  |- mesh__recordAuthorizer mesh__D000888 sjn
% 212.14/212.29  |- mesh__dateCreated mesh__D000888 1999-01-01
% 212.14/212.29  |- skos__hiddenLabel mesh__D000888 Antibodies, Anti-gamma Globulin
% 212.14/212.29  |- skos__altLabel mesh__D000888 Anti-gamma Globulin Antibodies
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D005573 2002
% 212.14/212.29  |- mesh__recordOriginator mesh__D005573 NLM
% 212.14/212.29  |- skos__historyNote mesh__D005573 Ribonucleotides %28%1973-1974%29%
% 212.14/212.29  |- skos__historyNote mesh__D005573 Pyrazoles %28%1973-1974%29%
% 212.14/212.29  |- skos__historyNote mesh__D005573 Pyrimidinones %28%1973-1974%29%
% 212.14/212.29  |- mesh__activeMeSHYear mesh__D005573 2006
% 212.14/212.29  |- skos__annotation mesh__D005573 antineoplastic antibiotics   
% 212.14/212.29  |- skos__prefLabel mesh__D005573 Formycins
% 212.14/212.29  |- mesh__recordMaintainer mesh__D005573 JRT
% 212.14/212.30  |- mesh__activeMeSHYear mesh__D005573 1999
% 212.14/212.30  |- mesh__activeMeSHYear mesh__D005573 2005
% 212.14/212.30  |- mesh__activeMeSHYear mesh__D005573 2004
% 212.14/212.30  |- mesh__activeMeSHYear mesh__D005573 2001
% 212.14/212.30  |- mesh__dateEstablished mesh__D005573 1991-01-01
% 212.14/212.30  |- mesh__activeMeSHYear mesh__D005573 1998
% 212.14/212.30  |- mesh__dateCreated mesh__D005573 1974-11-19
% 212.14/212.30  |- mesh__activeMeSHYear mesh__D005573 2003
% 212.14/212.30  |- mesh__activeMeSHYear mesh__D005573 1997
% 212.14/212.30  |- mesh__dateRevised mesh__D005573 1995-06-16
% 212.14/212.30  |- skos__scopeNote mesh__D005573
% 212.14/212.30       Pyrazolopyrimidine ribonucleosides isolated from Nocardia interforma. They are antineoplastic antibiotics with cytostatic properties.%A%    
% 212.14/212.30  |- mesh__activeMeSHYear mesh__D005573 2000
% 212.14/212.30  |- mesh__publicMeSHNote mesh__D005573
% 212.14/212.30       91; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90   
% 212.14/212.30  |- mesh__activeMeSHYear mesh__D005573 1996
% 212.14/212.30  |- skos__historyNote mesh__D005573
% 212.14/212.30       Antibiotics, Antineoplastic %28%1973-1974%29%
% 212.14/212.30  |- skos__broader mesh__D005573smesh__D012263
% 212.14/212.30  |- mesh__historyNote mesh__D005573
% 212.14/212.30       91%28%75%29%; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90%A%  
% 212.14/212.30  |- skos__broader mesh__D005573smesh__D011741
% 212.14/212.30  |- mesh__recordAuthorizer mesh__D005573 PLS
% 212.14/212.30  |- rdf__type mesh__D005573sskos__Concept
% 212.14/212.30  |- skos__historyNote mesh__D005573 Pyrimidines %28%1973-1974%29%
% 212.14/212.30  |- skos__scopeNote mesh__D013207
% 212.14/212.30       Infections to the skin caused by bacteria of the genus STAPHYLOCOCCUS.%A%    
% 212.14/212.30  |- mesh__activeMeSHYear mesh__D013207 2002
% 212.14/212.30  |- skos__hiddenLabel mesh__D013207 Staphylococcal Infection, Skin
% 212.14/212.30  |- mesh__activeMeSHYear mesh__D013207 2003
% 212.14/212.30  |- skos__prefLabel mesh__D013207 Staphylococcal Skin Infections
% 212.14/212.30  |- skos__hiddenLabel mesh__D013207 Skin Staphylococcal Infection
% 212.14/212.30  |- mesh__activeMeSHYear mesh__D013207 1996
% 212.14/212.30  |- skos__hiddenLabel mesh__D013207 Diseases, Staphylococcal Skin
% 212.14/212.30  |- skos__historyNote mesh__D013207
% 212.14/212.30       Skin Diseases, Infectious %28%1968-1985%29%
% 212.14/212.30  |- mesh__dateRevised mesh__D013207 1994-02-08
% 212.14/212.30  |- mesh__activeMeSHYear mesh__D013207 2001
% 212.14/212.30  |- skos__hiddenLabel mesh__D013207 Disease, Staphylococcal Skin
% 212.14/212.30  |- skos__broader mesh__D013207smesh__D017192
% 212.14/212.30  |- rdf__type mesh__D013207sskos__Concept
% 212.14/212.30  |- skos__altLabel mesh__D013207 Skin Diseases, Staphylococcal
% 212.14/212.30  |- mesh__dateEstablished mesh__D013207 1986-01-01
% 212.14/212.30  |- mesh__recordMaintainer mesh__D013207 PXP
% 212.14/212.30  |- skos__hiddenLabel mesh__D013207 Staphylococcal Skin Disease
% 212.14/212.30  |- mesh__publicMeSHNote mesh__D013207 86   
% 212.14/212.30  |- mesh__activeMeSHYear mesh__D013207 1995
% 212.14/212.30  |- mesh__activeMeSHYear mesh__D013207 2000
% 212.14/212.30  |- mesh__activeMeSHYear mesh__D013207 2006
% 212.14/212.30  |- mesh__historyNote mesh__D013207 86   
% 212.14/212.30  |- skos__hiddenLabel mesh__D013207 Infection, Staphylococcal Skin
% 212.14/212.30  |- skos__altLabel mesh__D013207 Skin Infections, Staphylococcal
% 212.14/212.30  |- mesh__activeMeSHYear mesh__D013207 1999
% 212.14/212.30  |- skos__hiddenLabel mesh__D013207 Skin Disease, Staphylococcal
% 212.14/212.30  |- skos__altLabel mesh__D013207 Staphylococcal Skin Diseases
% 212.14/212.30  |- skos__hiddenLabel mesh__D013207 Skin Infection, Staphylococcal
% 212.14/212.30  |- skos__altLabel mesh__D013207 Infections, Staphylococcal Skin
% 212.14/212.30  |- skos__altLabel mesh__D013207 Staphylococcal Infections, Skin
% 212.14/212.30  |- mesh__recordOriginator mesh__D013207 RC
% 212.14/212.30  |- skos__annotation mesh__D013207
% 212.14/212.30       coord IM with specific STAPHYLOCOCCUS %28%IM%29%; DF: STAPH SKIN INFECT%A%  
% 212.14/212.30  |- mesh__activeMeSHYear mesh__D013207 2005
% 212.14/212.30  |- mesh__recordAuthorizer mesh__D013207 PLS
% 212.14/212.30  |- skos__hiddenLabel mesh__D013207 Staphylococcal Skin Infection
% 212.14/212.30  |- skos__hiddenLabel mesh__D013207 Skin Staphylococcal Diseases
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D013207 1998
% 212.14/212.39  |- skos__hiddenLabel mesh__D013207 Skin Staphylococcal Infections
% 212.14/212.39  |- skos__hiddenLabel mesh__D013207 Staphylococcal Disease, Skin
% 212.14/212.39  |- skos__altLabel mesh__D013207 Staphylococcal Diseases, Skin
% 212.14/212.39  |- skos__historyNote mesh__D013207
% 212.14/212.39       Staphylococcal Infections %28%1966-1985%29%
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D013207 2004
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D013207 1997
% 212.14/212.39  |- skos__broader mesh__D013207smesh__D013203
% 212.14/212.39  |- mesh__dateCreated mesh__D013207 1985-05-07
% 212.14/212.39  |- skos__hiddenLabel mesh__D013207 Skin Staphylococcal Disease
% 212.14/212.39  |- skos__broader mesh__D014815Q000172smesh__D014815
% 212.14/212.39  |- mesh__preferredCombination mesh__D014815Q000172smesh__D001361
% 212.14/212.39  |- rdf__type mesh__D014815Q000172smesh__CompoundConcept
% 212.14/212.39  |- skos__hiddenLabel mesh__D009964 Orotidine Phosphate Carboxy Lyase
% 212.14/212.39  |- skos__altLabel mesh__D009964 Orotidine-5-Phosphate Decarboxylase
% 212.14/212.39  |- mesh__dateRevised mesh__D009964 2003-07-09
% 212.14/212.39  |- skos__historyNote mesh__D009964 Carboxy-Lyases %28%1966-1976%29%
% 212.14/212.39  |- skos__altLabel mesh__D009964 Orotidine 5%27% Phosphate Decarboxylase
% 212.14/212.39  |- skos__broader mesh__D009964smesh__D002262
% 212.14/212.39  |- mesh__recordMaintainer mesh__D009964 ssb
% 212.14/212.39  |- mesh__dateCreated mesh__D009964 1976-04-27
% 212.14/212.39  |- mesh__publicMeSHNote mesh__D009964
% 212.14/212.39       91; was see under CARBOXY-LYASES 1977-90   
% 212.14/212.39  |- mesh__recordOriginator mesh__D009964 RLS
% 212.14/212.39  |- skos__historyNote mesh__D009964 Uracil Nucleotides %28%1975-1976%29%
% 212.14/212.39  |- skos__scopeNote mesh__D009964
% 212.14/212.39       Orotidine-5%27%-phosphate carboxy-lyase. Catalyzes the decarboxylation of orotidylic acid to yield uridylic acid in the final step of the pyrimidine nucleotide biosynthesis pathway. EC 4.1.1.23.%A%    
% 212.14/212.39  |- mesh__recordAuthorizer mesh__D009964 sjn
% 212.14/212.39  |- skos__altLabel mesh__D009964 OMP Decarboxylase
% 212.14/212.39  |- skos__hiddenLabel mesh__D009964 Decarboxylase, Orotidylate
% 212.14/212.39  |- skos__altLabel mesh__D009964 Orotidylate Decarboxylase
% 212.14/212.39  |- skos__prefLabel mesh__D009964 Orotidine-5%27%-Phosphate Decarboxylase
% 212.14/212.39  |- skos__historyNote mesh__D009964 Pyrimidine Nucleotides %28%1973-1974%29%
% 212.14/212.39  |- skos__historyNote mesh__D009964 Ribonucleotides %28%1973-1974%29%
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D009964 2006
% 212.14/212.39  |- skos__hiddenLabel mesh__D009964 Phosphate Carboxy-Lyase, Orotidine
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D009964 2005
% 212.14/212.39  |- mesh__dateEstablished mesh__D009964 1991-01-01
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D009964 2004
% 212.14/212.39  |- skos__altLabel mesh__D009964 Orotidine 5 Phosphate Decarboxylase
% 212.14/212.39  |- skos__hiddenLabel mesh__D009964 Decarboxylase, Orotidine-5-Phosphate
% 212.14/212.39  |- mesh__historyNote mesh__D009964
% 212.14/212.39       91%28%77%29%; was see under CARBOXY-LYASES 1977-90   
% 212.14/212.39  |- skos__altLabel mesh__D009964 Orotidine Phosphate Carboxy-Lyase
% 212.14/212.39  |- skos__annotation mesh__D009964
% 212.14/212.39       /defic: consider also OROTIC ACID /urine %28%IM%29% + PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS %28%IM%29%; DF: OMP DECARBOXYLASE%A%  
% 212.14/212.39  |- skos__hiddenLabel mesh__D009964 Decarboxylase, Orotidine-5%27%-Phosphate
% 212.14/212.39  |- skos__hiddenLabel mesh__D009964 Carboxy-Lyase, Orotidine Phosphate
% 212.14/212.39  |- skos__hiddenLabel mesh__D009964 Decarboxylase, OMP
% 212.14/212.39  |- rdf__type mesh__D009964sskos__Concept
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001981 2005
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001981 2001
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001981 1999
% 212.14/212.39  |- mesh__recordAuthorizer mesh__D001981 PLS
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001981 1993
% 212.14/212.39  |- mesh__dateRevised mesh__D001981 1992-05-26
% 212.14/212.39  |- skos__hiddenLabel mesh__D001981 Arteries, Bronchial
% 212.14/212.39  |- mesh__publicMeSHNote mesh__D001981 66   
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001981 2004
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001981 2000
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001981 1998
% 212.14/212.39  |- skos__prefLabel mesh__D001981 Bronchial Arteries
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001981 2003
% 212.14/212.39  |- mesh__historyNote mesh__D001981 66%28%63%29%   
% 212.14/212.39  |- skos__broader mesh__D001981smesh__D001158
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001981 1997
% 212.14/212.39  |- mesh__recordMaintainer mesh__D001981 TAP
% 212.14/212.39  |- mesh__recordOriginator mesh__D001981 NLM
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001981 1996
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001981 1995
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001981 2006
% 212.14/212.39  |- mesh__dateCreated mesh__D001981 1999-01-01
% 212.14/212.39  |- rdf__type mesh__D001981sskos__Concept
% 212.14/212.39  |- skos__scopeNote mesh__D001981
% 212.14/212.39       Left bronchial arteries arise from the thoracic aorta, the right from the first aortic intercostal or the upper left bronchial artery; they supply the bronchi and the lower trachea.%A%    
% 212.14/212.39  |- skos__hiddenLabel mesh__D001981 Artery, Bronchial
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001981 2002
% 212.14/212.39  |- mesh__dateEstablished mesh__D001981 1966-01-01
% 212.14/212.39  |- skos__hiddenLabel mesh__D001981 Bronchial Artery
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001981 1994
% 212.14/212.39  |- mesh__dateCreated mesh__D009166 1999-01-01
% 212.14/212.39  |- skos__related mesh__D009166smesh__D007917
% 212.14/212.39  |- skos__prefLabel mesh__D009166 Mycobacterium leprae
% 212.14/212.39  |- skos__scopeNote mesh__D009166
% 212.14/212.39       A species of gram-positive, aerobic bacteria that causes LEPROSY in man. Its organisms are generally arranged in clumps, rounded masses, or in groups of bacilli side by side.%A%    
% 212.14/212.39  |- skos__broader mesh__D009166smesh__D009161
% 212.14/212.39  |- skos__annotation mesh__D009166
% 212.14/212.39       infection = LEPROSY; /drug eff: consider also LEPROSTATIC AGENTS; DF: MYCOBACT LEPRAE%A%  
% 212.14/212.39  |- rdf__type mesh__D009166sskos__Concept
% 212.14/212.39  |- mesh__recordOriginator mesh__D009166 NLM
% 212.14/212.39  |- mesh__recordAuthorizer mesh__D009166 sjn
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D009166 2006
% 212.14/212.39  |- mesh__dateRevised mesh__D009166 2005-06-30
% 212.14/212.39  |- mesh__recordMaintainer mesh__D009166 SYSTEM
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001183 2002
% 212.14/212.39  |- skos__prefLabel mesh__D001183 Arthus Reaction
% 212.14/212.39  |- mesh__publicMeSHNote mesh__D001183 93; was ARTHUS PHENOMENON 1966-92   
% 212.14/212.39  |- mesh__recordOriginator mesh__D001183 NLM
% 212.14/212.39  |- mesh__dateRevised mesh__D001183 1993-06-02
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001183 1994
% 212.14/212.39  |- mesh__dateEstablished mesh__D001183 1966-01-01
% 212.14/212.39  |- mesh__recordMaintainer mesh__D001183 TAP
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001183 1995
% 212.14/212.39  |- mesh__onlineNote mesh__D001183
% 212.14/212.39       use ARTHUS REACTION to search ARTHUS PHENOMENON 1966-92   
% 212.14/212.39  |- mesh__recordAuthorizer mesh__D001183 PLS
% 212.14/212.39  |- skos__altLabel mesh__D001183 Arthus Phenomenon
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001183 2000
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001183 1998
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001183 2005
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001183 1996
% 212.14/212.39  |- mesh__historyNote mesh__D001183
% 212.14/212.39       93; was ARTHUS PHENOMENON 1966-92 %28%Prov 63-65%29%   
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001183 2003
% 212.14/212.39  |- mesh__dateCreated mesh__D001183 1999-01-01
% 212.14/212.39  |- skos__broader mesh__D001183smesh__D007105
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001183 1999
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001183 2006
% 212.14/212.39  |- skos__hiddenLabel mesh__D001183 Reaction, Arthus
% 212.14/212.39  |- skos__scopeNote mesh__D001183
% 212.14/212.39       A dermal inflammatory reaction produced under conditions of antibody excess, when a second injection of antigen produces intravascular antigen-antibody complexes which bind complement, causing cell clumping, endothelial damage, and vascular necrosis.%A%    
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001183 2004
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001183 1997
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D001183 2001
% 212.14/212.39  |- rdf__type mesh__D001183sskos__Concept
% 212.14/212.39  |- skos__annotation mesh__D001183
% 212.14/212.39       note category; an inflamm skin reaction to antibody excess%A%  
% 212.14/212.39  |- skos__hiddenLabel mesh__D001183 Phenomenon, Arthus
% 212.14/212.39  |- mesh__recordAuthorizer mesh__D014300 PLS
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D014300 2005
% 212.14/212.39  |- mesh__onlineNote mesh__D014300
% 212.14/212.39       use TRINIDAD AND TOBAGO to search TRINIDAD 1966-78   
% 212.14/212.39  |- skos__scopeNote mesh__D014300
% 212.14/212.39       An independent state in the Lesser Antilles in the West Indies, north of Venezuela, comprising the islands of Trinidad and Tobago. Its capital is Port of Spain. Both islands were discovered by Columbus in 1498. The Spanish, English, Dutch, and French figure in their history over four centuries. Trinidad and Tobago united in 1898 and were made part of the British colony of Trinidad and Tobago in 1899. The colony became an independent state in 1962. Trinidad was so named by Columbus either because he arrived on Trinity Sunday or because three mountain peaks suggested the Holy Trinity. Tobago was given the name by Columbus from the Haitian tambaku, pipe, from the natives%27% habit of smoking tobacco leaves. %28%Webster%27%s New Geographical Dictionary, 1988, p1228, 1216 %26% Room, Brewer%27%s Dictionary of Names, 1992, p555, 547%29%%A%    
% 212.14/212.39  |- mesh__recordOriginator mesh__D014300 NLM
% 212.14/212.39  |- rdf__type mesh__D014300sskos__Concept
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D014300 2001
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D014300 1997
% 212.14/212.39  |- mesh__dateRevised mesh__D014300 1995-02-21
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D014300 2004
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D014300 2000
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D014300 1996
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D014300 2003
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D014300 1999
% 212.14/212.39  |- mesh__dateCreated mesh__D014300 1999-01-01
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D014300 2006
% 212.14/212.39  |- mesh__historyNote mesh__D014300 79; was TRINIDAD 1966-78   
% 212.14/212.39  |- skos__broader mesh__D014300smesh__D014900
% 212.14/212.39  |- skos__annotation mesh__D014300
% 212.14/212.39       islands constituting an independent state in the Lesser Antilles in the West Indies; DF: TRINIDAD%A%  
% 212.14/212.39  |- mesh__recordMaintainer mesh__D014300 TGC
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D014300 2002
% 212.14/212.39  |- skos__prefLabel mesh__D014300 Trinidad and Tobago
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D014300 1998
% 212.14/212.39  |- skos__altLabel mesh__D000889 Anti-Arrhythmia Drugs
% 212.14/212.39  |- skos__hiddenLabel mesh__D000889 Drugs, Antiarrhythmic
% 212.14/212.39  |- skos__related mesh__D000889smesh__D000319
% 212.14/212.39  |- skos__related mesh__D000889smesh__D002121
% 212.14/212.39  |- mesh__dateRevised mesh__D000889 2005-06-30
% 212.14/212.39  |- skos__altLabel mesh__D000889 Anti-Arrhythmics
% 212.14/212.39  |- skos__hiddenLabel mesh__D000889 Drugs, Anti-Arrhythmia
% 212.14/212.39  |- skos__hiddenLabel mesh__D000889 Depressants, Myocardial
% 212.14/212.39  |- mesh__recordAuthorizer mesh__D000889 sjn
% 212.14/212.39  |- skos__hiddenLabel mesh__D000889 Anti Arrhythmia Agents
% 212.14/212.39  |- skos__annotation mesh__D000889 consider also ARRHYTHMIA /drug ther   
% 212.14/212.39  |- skos__hiddenLabel mesh__D000889 Depressants, Cardiac
% 212.14/212.39  |- mesh__onlineNote mesh__D000889
% 212.14/212.39       use ANTI-ARRHYTHMIA AGENTS to search MYOCARDIAL DEPRESSANTS 1966-75%A%  
% 212.14/212.39  |- skos__hiddenLabel mesh__D000889 Agents, Antifibrillatory
% 212.14/212.39  |- mesh__publicMeSHNote mesh__D000889
% 212.14/212.39       76; was MYOCARDIAL DEPRESSANTS 1963-75   
% 212.14/212.39  |- skos__hiddenLabel mesh__D000889 Agents, Antiarrhythmia
% 212.14/212.39  |- skos__altLabel mesh__D000889 Antiarrhythmia Agents
% 212.14/212.39  |- mesh__historyNote mesh__D000889
% 212.14/212.39       76; was NON MESH before 1976; MYOCARDIAL DEPRESSANTS was heading 1963-75%A%  
% 212.14/212.39  |- mesh__recordOriginator mesh__D000889 SH
% 212.14/212.39  |- skos__hiddenLabel mesh__D000889 Drugs, Antiarrhythmia
% 212.14/212.39  |- skos__altLabel mesh__D000889 Antiarrhythmia Drugs
% 212.14/212.39  |- skos__hiddenLabel mesh__D000889 Anti Arrhythmics
% 212.14/212.39  |- mesh__recordMaintainer mesh__D000889 ssb
% 212.14/212.39  |- rdf__type mesh__D000889sskos__Concept
% 212.14/212.39  |- skos__prefLabel mesh__D000889 Anti-Arrhythmia Agents
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D000889 2006
% 212.14/212.39  |- skos__hiddenLabel mesh__D000889 Anti Arrhythmia Drugs
% 212.14/212.39  |- skos__altLabel mesh__D000889 Myocardial Depressants
% 212.14/212.39  |- skos__scopeNote mesh__D000889
% 212.14/212.39       Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.%A%    
% 212.14/212.39  |- skos__broader mesh__D000889smesh__D002317
% 212.14/212.39  |- skos__hiddenLabel mesh__D000889 Agents, Anti-Arrhythmia
% 212.14/212.39  |- mesh__dateEstablished mesh__D000889 1976-01-01
% 212.14/212.39  |- skos__altLabel mesh__D000889 Antiarrhythmic Drugs
% 212.14/212.39  |- mesh__dateCreated mesh__D000889 1975-07-25
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D005574 2006
% 212.14/212.39  |- skos__historyNote mesh__D005574 Ligases %28%1969-1974%29%
% 212.14/212.39  |- skos__hiddenLabel mesh__D005574 Formate Tetrahydrofolate Ligase
% 212.14/212.39  |- skos__altLabel mesh__D005574 Formyltetrahydrofolate Synthetase
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D005574 2005
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D005574 2004
% 212.14/212.39  |- mesh__recordOriginator mesh__D005574 NLM
% 212.14/212.39  |- mesh__dateEstablished mesh__D005574 1991-01-01
% 212.14/212.39  |- skos__scopeNote mesh__D005574
% 212.14/212.39       A carbon-nitrogen ligase that catalyzes the formation of 10-formyltetrahydrofolate from formate and TETRAHYDROFOLATE in the presence of ATP. In higher eukaryotes the enzyme also contains METHYLENETETRAHYDROFOLATE DEHYDROGENASE %28%NADP+%29% and METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE activity.%A%    
% 212.14/212.39  |- skos__prefLabel mesh__D005574 Formate-Tetrahydrofolate Ligase
% 212.14/212.39  |- skos__hiddenLabel mesh__D005574 Ligase, Formate-Tetrahydrofolate
% 212.14/212.39  |- mesh__recordAuthorizer mesh__D005574 sjn
% 212.14/212.39  |- skos__historyNote mesh__D005574 Tetrahydrofolates %28%1972-1974%29%
% 212.14/212.39  |- mesh__publicMeSHNote mesh__D005574
% 212.14/212.39       98; see FORMYLTETRAHYDROFOLATE SYNTHETASE 1991-97; see LIGASES 1975-90%A%  
% 212.14/212.39  |- skos__altLabel mesh__D005574 Tetrahydrofolate Formylase
% 212.14/212.39  |- skos__historyNote mesh__D005574 Formic Acids %28%1969-1974%29%
% 212.14/212.39  |- skos__hiddenLabel mesh__D005574 Synthetase, Formyltetrahydrofolate
% 212.14/212.39  |- mesh__dateRevised mesh__D005574 2003-07-09
% 212.14/212.39  |- mesh__historyNote mesh__D005574 98%28%75%29%   
% 212.14/212.39  |- mesh__recordMaintainer mesh__D005574 jmp
% 212.14/212.39  |- mesh__dateCreated mesh__D005574 1974-11-19
% 212.14/212.39  |- rdf__type mesh__D005574sskos__Concept
% 212.14/212.39  |- skos__related mesh__D005574smesh__D045064
% 212.14/212.39  |- skos__related mesh__D005574smesh__D008754
% 212.14/212.39  |- skos__hiddenLabel mesh__D005574 Formylase, Tetrahydrofolate
% 212.14/212.39  |- skos__broader mesh__D005574smesh__D019731
% 212.14/212.39  |- mesh__recordAuthorizer mesh__D013208 sjn
% 212.14/212.39  |- skos__hiddenLabel mesh__D013208 Toxoid, Staphylococcal
% 212.14/212.39  |- skos__broader mesh__D013208smesh__D014121
% 212.14/212.39  |- mesh__recordOriginator mesh__D013208 NLM
% 212.14/212.39  |- mesh__recordMaintainer mesh__D013208 ssb
% 212.14/212.39  |- mesh__activeMeSHYear mesh__D013208 2006
% 212.14/212.39  |- mesh__dateRevised mesh__D013208 2005-06-30
% 212.14/212.39  |- mesh__dateCreated mesh__D013208 1999-01-01
% 212.14/212.39  |- mesh__dateEstablished mesh__D013208 1965-01-01
% 212.14/212.39  |- mesh__historyNote mesh__D013208 65   
% 212.14/212.39  |- skos__annotation mesh__D013208 DF: STAPH TOXOID   
% 212.14/212.39  |- skos__prefLabel mesh__D013208 Staphylococcal Toxoid
% 212.14/212.39  |- rdf__type mesh__D013208sskos__Concept
% 212.14/212.39  |- mesh__publicMeSHNote mesh__D013208 65   
% 212.14/212.39  |- skos__scopeNote mesh__D009965
% 212.14/212.39       Production of drugs or biologicals which are unlikely to be manufactured by private industry unless special incentives are provided by others.%A%    
% 212.25/212.39  |- mesh__recordAuthorizer mesh__D009965 PLS
% 212.25/212.39  |- mesh__activeMeSHYear mesh__D009965 1995
% 212.25/212.39  |- skos__broader mesh__D009965smesh__D004345
% 212.25/212.39  |- mesh__activeMeSHYear mesh__D009965 2006
% 212.25/212.39  |- mesh__dateCreated mesh__D009965 1984-05-24
% 212.25/212.39  |- mesh__activeMeSHYear mesh__D009965 1994
% 212.25/212.39  |- mesh__recordMaintainer mesh__D009965 TGC
% 212.25/212.39  |- mesh__publicMeSHNote mesh__D009965
% 212.25/212.39       91; was see under DRUG INDUSTRY 1985-90   
% 212.25/212.39  |- mesh__activeMeSHYear mesh__D009965 1993
% 212.25/212.39  |- skos__historyNote mesh__D009965 Drug Industry %28%1966-1984%29%
% 212.25/212.39  |- skos__hiddenLabel mesh__D009965 Orphan Drug
% 212.25/212.39  |- skos__historyNote mesh__D009965 Legislation, Medical %28%1966-1967%29%
% 212.25/212.39  |- mesh__activeMeSHYear mesh__D009965 2005
% 212.25/212.39  |- skos__hiddenLabel mesh__D009965 Drug, Orphan
% 212.25/212.39  |- mesh__activeMeSHYear mesh__D009965 2004
% 212.25/212.39  |- mesh__activeMeSHYear mesh__D009965 1999
% 212.25/212.39  |- skos__prefLabel mesh__D009965 Orphan Drug Production
% 212.25/212.39  |- mesh__activeMeSHYear mesh__D009965 2001
% 212.25/212.39  |- skos__hiddenLabel mesh__D009965 Production, Orphan Drug
% 212.25/212.39  |- skos__historyNote mesh__D009965 Legislation, Drug %28%1968-1984%29%
% 212.25/212.39  |- mesh__recordOriginator mesh__D009965 SH
% 212.25/212.39  |- mesh__activeMeSHYear mesh__D009965 2003
% 212.25/212.39  |- mesh__dateEstablished mesh__D009965 1991-01-01
% 212.25/212.39  |- mesh__activeMeSHYear mesh__D009965 1998
% 212.25/212.39  |- rdf__type mesh__D009965sskos__Concept
% 212.25/212.39  |- mesh__activeMeSHYear mesh__D009965 1997
% 212.25/212.39  |- mesh__activeMeSHYear mesh__D009965 2000
% 212.25/212.39  |- skos__hiddenLabel mesh__D009965 Orphan Drugs
% 212.25/212.39  |- mesh__activeMeSHYear mesh__D009965 1996
% 212.25/212.39  |- skos__hiddenLabel mesh__D009965 Drug Production, Orphan
% 212.25/212.39  |- skos__historyNote mesh__D009965 Drugs %28%1966-1984%29%
% 212.25/212.39  |- mesh__historyNote mesh__D009965
% 212.25/212.39       91%28%85%29%; was see under DRUG INDUSTRY 1985-90   
% 212.25/212.39  |- mesh__dateRevised mesh__D009965 1992-05-15
% 212.25/212.39  |- mesh__activeMeSHYear mesh__D009965 2002
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001982 2004
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001982 2002
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001982 1998
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001982 2003
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001982 2001
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001982 2000
% 212.25/212.40  |- rdf__type mesh__D001982sskos__Concept
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001982 2006
% 212.25/212.40  |- mesh__dateCreated mesh__D001982 1999-01-01
% 212.25/212.40  |- mesh__dateRevised mesh__D001982 1997-06-20
% 212.25/212.40  |- mesh__recordAuthorizer mesh__D001982 SJN
% 212.25/212.40  |- skos__hiddenLabel mesh__D001982 Diseases, Bronchial
% 212.25/212.40  |- skos__broader mesh__D001982smesh__D012140
% 212.25/212.40  |- skos__hiddenLabel mesh__D001982 Bronchial Disease
% 212.25/212.40  |- mesh__recordMaintainer mesh__D001982 TGC
% 212.25/212.40  |- skos__annotation mesh__D001982 inflamm dis = BRONCHITIS   
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001982 2005
% 212.25/212.40  |- mesh__recordOriginator mesh__D001982 NLM
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001982 1999
% 212.25/212.40  |- skos__hiddenLabel mesh__D001982 Disease, Bronchial
% 212.25/212.40  |- skos__prefLabel mesh__D001982 Bronchial Diseases
% 212.25/212.40  |- skos__historyNote mesh__D009167 Mycobacterium %28%1966-1972%29%
% 212.25/212.40  |- mesh__historyNote mesh__D009167 73   
% 212.25/212.40  |- mesh__recordOriginator mesh__D009167 NLM
% 212.25/212.40  |- mesh__recordAuthorizer mesh__D009167 sjn
% 212.25/212.40  |- skos__scopeNote mesh__D009167
% 212.25/212.40       The etiologic agent of rat leprosy, also known as murine leprosy.%A%    
% 212.25/212.40  |- skos__prefLabel mesh__D009167 Mycobacterium lepraemurium
% 212.25/212.40  |- mesh__dateRevised mesh__D009167 2005-06-30
% 212.25/212.40  |- mesh__publicMeSHNote mesh__D009167 73   
% 212.25/212.40  |- mesh__dateEstablished mesh__D009167 1973-01-01
% 212.25/212.40  |- rdf__type mesh__D009167sskos__Concept
% 212.25/212.40  |- skos__annotation mesh__D009167
% 212.25/212.40       rat leprosy bacillus; infection: coord IM with MYCOBACTERIUM INFECTIONS %28%IM%29%; DF: MYCOBACT LEPRAEMURIUM%A%  
% 212.25/212.40  |- mesh__recordMaintainer mesh__D009167 SYSTEM
% 212.25/212.40  |- mesh__dateCreated mesh__D009167 1999-01-01
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D009167 2006
% 212.25/212.40  |- skos__broader mesh__D009167smesh__D009161
% 212.25/212.40  |- skos__altLabel mesh__D001184 Phonological Impairments
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001184 2002
% 212.25/212.40  |- skos__hiddenLabel mesh__D001184 Unintelligible Articulations
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001184 2005
% 212.25/212.40  |- skos__hiddenLabel mesh__D001184 Articulation, Unintelligible
% 212.25/212.40  |- skos__altLabel mesh__D001184 Phonology Impairment
% 212.25/212.40  |- skos__hiddenLabel mesh__D001184 Articulations, Unintelligible
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001184 2001
% 212.25/212.40  |- mesh__recordAuthorizer mesh__D001184 jls
% 212.25/212.40  |- skos__hiddenLabel mesh__D001184 Impairments, Phonology
% 212.25/212.40  |- skos__hiddenLabel mesh__D001184 Articulation Disorder, Speech
% 212.25/212.40  |- mesh__dateEstablished mesh__D001184 1979-01-01
% 212.25/212.40  |- skos__scopeNote mesh__D001184
% 212.25/212.40       Disorders of the quality of speech characterized by the substitution, omission, distortion, and addition of phonemes.%A%    
% 212.25/212.40  |- skos__broader mesh__D001184smesh__D013064
% 212.25/212.40  |- skos__hiddenLabel mesh__D001184 Disorders, Disarticulation
% 212.25/212.40  |- skos__hiddenLabel mesh__D001184 Developmental Articulation Disorder
% 212.25/212.40  |- skos__hiddenLabel mesh__D001184 Articulation Disorders, Speech
% 212.25/212.40  |- skos__hiddenLabel mesh__D001184 Articulation Disorder
% 212.25/212.40  |- skos__hiddenLabel mesh__D001184 Disarticulation Disorder
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001184 2000
% 212.25/212.40  |- skos__hiddenLabel mesh__D001184 Impairment, Phonology
% 212.25/212.40  |- mesh__publicMeSHNote mesh__D001184 1979   
% 212.25/212.40  |- skos__altLabel mesh__D001184 Misarticulation
% 212.25/212.40  |- skos__hiddenLabel mesh__D001184 Disorder, Disarticulation
% 212.25/212.40  |- skos__altLabel mesh__D001184 Speech Articulation Disorders
% 212.25/212.40  |- mesh__recordOriginator mesh__D001184 RC
% 212.25/212.40  |- skos__altLabel mesh__D001184 Developmental Articulation Disorders
% 212.25/212.40  |- skos__hiddenLabel mesh__D001184 Articulation Disorder, Developmental
% 212.25/212.40  |- skos__hiddenLabel mesh__D001184 Phonology Impairments
% 212.25/212.40  |- mesh__recordMaintainer mesh__D001184 jls
% 212.25/212.40  |- rdf__type mesh__D001184sskos__Concept
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001184 2004
% 212.25/212.40  |- skos__hiddenLabel mesh__D001184 Phonological Impairment
% 212.25/212.40  |- skos__prefLabel mesh__D001184 Articulation Disorders
% 212.25/212.40  |- skos__annotation mesh__D001184
% 212.25/212.40       note categories: %22%articulation%22% refers to speech, not to joints%A%  
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001184 2006A
% 212.25/212.40  |- skos__hiddenLabel mesh__D001184 Speech Articulation Disorder
% 212.25/212.40  |- skos__hiddenLabel mesh__D001184 Impairment, Phonological
% 212.25/212.40  |- skos__hiddenLabel mesh__D001184 Impairments, Phonological
% 212.25/212.40  |- skos__altLabel mesh__D001184 Disarticulation Disorders
% 212.25/212.40  |- mesh__dateRevised mesh__D001184 2005-07-29
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001184 2003
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001184 2006
% 212.25/212.40  |- mesh__historyNote mesh__D001184 1979   
% 212.25/212.40  |- mesh__dateCreated mesh__D001184 1978-05-22
% 212.25/212.40  |- mesh__dateCreated mesh__D028321 2001-07-25
% 212.25/212.40  |- mesh__publicMeSHNote mesh__D028321 2002   
% 212.25/212.40  |- mesh__dateEstablished mesh__D028321 2002-01-01
% 212.25/212.40  |- skos__prefLabel mesh__D028321 Plant Preparations
% 212.25/212.40  |- mesh__recordMaintainer mesh__D028321 ssb
% 212.25/212.40  |- skos__broader mesh__D028321smesh__D001688
% 212.25/212.40  |- skos__altLabel mesh__D028321 Herbal Preparation
% 212.25/212.40  |- rdf__type mesh__D028321sskos__Concept
% 212.25/212.40  |- skos__hiddenLabel mesh__D028321 Preparation, Plant
% 212.25/212.40  |- skos__altLabel mesh__D028321 Herbal Preparations
% 212.25/212.40  |- mesh__historyNote mesh__D028321 2002   
% 212.25/212.40  |- skos__annotation mesh__D028321
% 212.25/212.40       coord with specific plant and PLANT COMPONENTS term; for use in therapy coord IM or NIM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + specific chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.25/212.40  |- mesh__dateRevised mesh__D028321 2005-06-30
% 212.25/212.40  |- mesh__recordOriginator mesh__D028321 ssb
% 212.25/212.40  |- mesh__recordAuthorizer mesh__D028321 sjn
% 212.25/212.40  |- skos__altLabel mesh__D028321 Plant Preparation
% 212.25/212.40  |- skos__broader mesh__D028321smesh__D045424
% 212.25/212.40  |- skos__scopeNote mesh__D028321
% 212.25/212.40       Material prepared from plants for medicinal purposes.     
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D028321 2006
% 212.25/212.40  |- mesh__recordMaintainer mesh__D014301 TAP
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D014301 2002
% 212.25/212.40  |- mesh__recordAuthorizer mesh__D014301 PLS
% 212.25/212.40  |- rdf__type mesh__D014301sskos__Concept
% 212.25/212.40  |- skos__scopeNote mesh__D014301
% 212.25/212.40       Benzene derivatives which are substituted with three nitro groups in any position.%A%    
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D014301 1997
% 212.25/212.40  |- mesh__recordOriginator mesh__D014301 RLS
% 212.25/212.40  |- mesh__dateEstablished mesh__D014301 1991-01-01
% 212.25/212.40  |- mesh__publicMeSHNote mesh__D014301
% 212.25/212.40       91; was see under NITROBENZENES 1977-90   
% 212.25/212.40  |- mesh__dateCreated mesh__D014301 1976-04-13
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D014301 2004
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D014301 1993
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D014301 1996
% 212.25/212.40  |- skos__historyNote mesh__D014301 Nitrophenols %28%1966-1976%29%
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D014301 2003
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D014301 1999
% 212.25/212.40  |- skos__hiddenLabel mesh__D014301 Compounds, Trinitrophenyl
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D014301 2001
% 212.25/212.40  |- skos__prefLabel mesh__D014301 Trinitrobenzenes
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D014301 2006
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D014301 1995
% 212.25/212.40  |- mesh__historyNote mesh__D014301
% 212.25/212.40       91%28%77%29%; was see under NITROBENZENES 1977-90   
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D014301 1998
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D014301 2000
% 212.25/212.40  |- skos__historyNote mesh__D014301 Nitrobenzenes %28%1966-1976%29%
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D014301 2005
% 212.25/212.40  |- skos__altLabel mesh__D014301 Trinitrophenyl Compounds
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D014301 1994
% 212.25/212.40  |- mesh__dateRevised mesh__D014301 1992-05-20
% 212.25/212.40  |- skos__broader mesh__D014301smesh__D009578
% 212.25/212.40  |- skos__broader mesh__D019595smesh__D003715
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D019595 1999
% 212.25/212.40  |- skos__altLabel mesh__D019595 Hemorrhagic Fever, Dengue
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D019595 2003
% 212.25/212.40  |- mesh__dateEstablished mesh__D019595 1998-01-01
% 212.25/212.40  |- skos__historyNote mesh__D019595 Dengue %28%1966-1997%29%
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D019595 2004
% 212.25/212.40  |- mesh__publicMeSHNote mesh__D019595
% 212.25/212.40       98; was see DENGUE 1997; DENGUE SHOCK SYNDROME was see DENGUE 1997; HEMORRHAGIC FEVER, DENGUE was see DENGUE 1977-97%A%  
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D019595 2000
% 212.25/212.40  |- skos__scopeNote mesh__D019595
% 212.25/212.40       A distinct and virulent form of DENGUE characterized by thrombocytopenia and hemoconcentration %28%grades I and II%29% and distinguished by a positive tourniquet test. When accompanied by circulatory failure and shock %28%grades III and IV%29%, it is called dengue shock syndrome. %28%From Dorland, 28th ed%29%%A%    
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D019595 2005
% 212.25/212.40  |- skos__annotation mesh__D019595 a virulent form of dengue   
% 212.25/212.40  |- skos__prefLabel mesh__D019595 Dengue Hemorrhagic Fever
% 212.25/212.40  |- mesh__historyNote mesh__D019595
% 212.25/212.40       98; was see DENGUE 1997; DENGUE SHOCK SYNDROME was see DENGUE 1997; HEMORRHAGIC FEVER, DENGUE was see DENGUE 1977-97%A%  
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D019595 2001
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D019595 2006
% 212.25/212.40  |- mesh__onlineNote mesh__D019595
% 212.25/212.40       use DENGUE to search DENGUE HEMORRHAGIC FEVER %26% DENGUE SHOCK SYNDROME 1997, %26% HEMORRHAGIC FEVER, DENGUE 1977-97%A%  
% 212.25/212.40  |- rdf__type mesh__D019595sskos__Concept
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D019595 2002
% 212.25/212.40  |- mesh__dateCreated mesh__D019595 1997-06-20
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D019595 1998
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D005575 2006
% 212.25/212.40  |- mesh__dateRevised mesh__D005575 2005-06-30
% 212.25/212.40  |- skos__annotation mesh__D005575
% 212.25/212.40       deficiency: coordinate FORMYLTETRAHYDROFOLATES /defic %28%IM%29% with FOLIC ACID DEFICIENCY %28%IM%29%%A%  
% 212.25/212.40  |- skos__historyNote mesh__D005575 Citrovorum Factor %28%1966-1975%29%
% 212.25/212.40  |- mesh__historyNote mesh__D005575
% 212.25/212.40       91%28%76%29%; was see under TETRAHYDROFOLATES 1976-90   
% 212.25/212.40  |- skos__hiddenLabel mesh__D005575 Acids, Formyltetrahydrofolic
% 212.25/212.40  |- mesh__recordOriginator mesh__D005575 RLS
% 212.25/212.40  |- mesh__dateCreated mesh__D005575 1975-07-25
% 212.25/212.40  |- mesh__recordMaintainer mesh__D005575 ssb
% 212.25/212.40  |- rdf__type mesh__D005575sskos__Concept
% 212.25/212.40  |- mesh__publicMeSHNote mesh__D005575
% 212.25/212.40       91; was see under TETRAHYDROFOLATES 1976-90   
% 212.25/212.40  |- mesh__dateEstablished mesh__D005575 1991-01-01
% 212.25/212.40  |- skos__scopeNote mesh__D005575
% 212.25/212.40       Tetrahydrofolates which are substituted by a formyl group at either the nitrogen atom in the 5 position or the nitrogen atom in the 10 position. N%28%5%29%-Formyltetrahydrofolate is leukovorin %28%citrovorum factor%29% while N%28%10%29%-formyltetrahydrofolate is an active coenzyme which functions as a carrier of the formyl group in a number of enzymatic reactions.%A%    
% 212.25/212.40  |- mesh__recordAuthorizer mesh__D005575 sjn
% 212.25/212.40  |- skos__broader mesh__D005575smesh__D013763
% 212.25/212.40  |- skos__altLabel mesh__D005575 Formyltetrahydrofolic Acids
% 212.25/212.40  |- skos__prefLabel mesh__D005575 Formyltetrahydrofolates
% 212.25/212.40  |- skos__prefLabel mesh__D013209 Staphylococcal Vaccines
% 212.25/212.40  |- mesh__publicMeSHNote mesh__D013209 65   
% 212.25/212.40  |- mesh__recordAuthorizer mesh__D013209 sjn
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D013209 2006
% 212.25/212.40  |- mesh__recordOriginator mesh__D013209 NLM
% 212.25/212.40  |- mesh__dateCreated mesh__D013209 1999-01-01
% 212.25/212.40  |- skos__hiddenLabel mesh__D013209 Vaccines, Staphylococcal
% 212.25/212.40  |- skos__annotation mesh__D013209
% 212.25/212.40       coord IM with specific Staphylococcus; DF: STAPH VACCINES%A%  
% 212.25/212.40  |- mesh__historyNote mesh__D013209 65   
% 212.25/212.40  |- rdf__type mesh__D013209sskos__Concept
% 212.25/212.40  |- mesh__dateRevised mesh__D013209 2005-06-30
% 212.25/212.40  |- mesh__recordMaintainer mesh__D013209 ags
% 212.25/212.40  |- skos__broader mesh__D013209smesh__D001428
% 212.25/212.40  |- mesh__dateEstablished mesh__D013209 1965-01-01
% 212.25/212.40  |- mesh__recordAuthorizer mesh__D009966 sjn
% 212.25/212.40  |- mesh__dateCreated mesh__D009966 1999-01-01
% 212.25/212.40  |- skos__scopeNote mesh__D009966
% 212.25/212.40       A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.%A%    
% 212.25/212.40  |- skos__hiddenLabel mesh__D009966 Orphenadrine Citrate, Norflex
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D009966 2004
% 212.25/212.40  |- skos__hiddenLabel mesh__D009966 Mefenamine, Sodium
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D009966 2005
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D009966 2002
% 212.25/212.40  |- skos__hiddenLabel mesh__D009966 Citrate, Norflex Orphenadrine
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D009966 2003
% 212.25/212.40  |- rdf__type mesh__D009966sskos__Concept
% 212.25/212.40  |- skos__hiddenLabel mesh__D009966 Hydrochloride, Orphenadrine
% 212.25/212.40  |- mesh__recordOriginator mesh__D009966 NLM
% 212.25/212.40  |- skos__hiddenLabel mesh__D009966 Citrate, Orphenadrine
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D009966 2001
% 212.25/212.40  |- mesh__dateRevised mesh__D009966 2000-06-22
% 212.25/212.40  |- skos__altLabel mesh__D009966 Mephenamine
% 212.25/212.40  |- skos__broader mesh__D009966smesh__D005021
% 212.25/212.40  |- skos__altLabel mesh__D009966 Methyldiphenylhydramine
% 212.25/212.40  |- skos__prefLabel mesh__D009966 Orphenadrine
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D009966 2006
% 212.25/212.40  |- mesh__recordMaintainer mesh__D009966 CCR
% 212.25/212.40  |- skos__broader mesh__D009966smesh__D001559
% 212.25/212.40  |- skos__broader mesh__D001983smesh__D001982
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001983 2004
% 212.25/212.40  |- skos__broader mesh__D001983smesh__D016156
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001983 2002
% 212.25/212.40  |- skos__annotation mesh__D001983 fistula policy: Manual 23.19+   
% 212.25/212.40  |- skos__scopeNote mesh__D001983
% 212.25/212.40       An abnormal passage or communication between a bronchus and another part of the body.%A%    
% 212.25/212.40  |- mesh__dateCreated mesh__D001983 1999-01-01
% 212.25/212.40  |- mesh__recordOriginator mesh__D001983 NLM
% 212.25/212.40  |- mesh__recordMaintainer mesh__D001983 KEV
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001983 2005
% 212.25/212.40  |- skos__hiddenLabel mesh__D001983 Bronchial Fistulas
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001983 2000
% 212.25/212.40  |- skos__hiddenLabel mesh__D001983 Fistula, Bronchial
% 212.25/212.40  |- mesh__recordAuthorizer mesh__D001983 sjn
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001983 2006
% 212.25/212.40  |- rdf__type mesh__D001983sskos__Concept
% 212.25/212.40  |- skos__hiddenLabel mesh__D001983 Fistulas, Bronchial
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001983 2001
% 212.25/212.40  |- mesh__dateRevised mesh__D001983 1999-11-08
% 212.25/212.40  |- skos__prefLabel mesh__D001983 Bronchial Fistula
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001983 2003
% 212.25/212.40  |- mesh__dateEstablished mesh__D009168 1991-01-01
% 212.25/212.40  |- rdf__type mesh__D009168sskos__Concept
% 212.25/212.40  |- skos__prefLabel mesh__D009168 Mycobacterium phlei
% 212.25/212.40  |- mesh__recordMaintainer mesh__D009168 SYSTEM
% 212.25/212.40  |- mesh__recordOriginator mesh__D009168 NLM
% 212.25/212.40  |- mesh__recordAuthorizer mesh__D009168 sjn
% 212.25/212.40  |- mesh__dateRevised mesh__D009168 2005-06-30
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D009168 2006
% 212.25/212.40  |- mesh__dateCreated mesh__D009168 1974-12-12
% 212.25/212.40  |- skos__broader mesh__D009168smesh__D009161
% 212.25/212.40  |- skos__annotation mesh__D009168
% 212.25/212.40       in soil, dust %26% plants; DF: MYCOBACT PHLEI   
% 212.25/212.40  |- mesh__publicMeSHNote mesh__D009168
% 212.25/212.40       91; was see under MYCOBACTERIUM 1975-90   
% 212.25/212.40  |- skos__scopeNote mesh__D009168
% 212.25/212.40       A saprophytic bacterium widely distributed in soil and dust and on plants.%A%    
% 212.25/212.40  |- mesh__historyNote mesh__D009168
% 212.25/212.40       91%28%75%29%; was see under MYCOBACTERIUM 1975-90   
% 212.25/212.40  |- skos__hiddenLabel mesh__D001185
% 212.25/212.40       Knowledge Representations %28%Computer%29%
% 212.25/212.40  |- skos__broader mesh__D001185smesh__D003205
% 212.25/212.40  |- skos__related mesh__D001185smesh__D016571
% 212.25/212.40  |- skos__hiddenLabel mesh__D001185 Vision System, Computer
% 212.25/212.40  |- mesh__dateRevised mesh__D001185 2005-06-30
% 212.25/212.40  |- skos__altLabel mesh__D001185 Computer Reasoning
% 212.25/212.40  |- mesh__historyNote mesh__D001185 86   
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D001185 2006
% 212.25/212.40  |- skos__hiddenLabel mesh__D001185 AIs %28%Artificial Intelligence%29%
% 212.25/212.40  |- skos__hiddenLabel mesh__D001185 Acquisitions, Knowledge %28%Computer%29%
% 212.25/212.40  |- mesh__recordOriginator mesh__D001185 EC
% 212.25/212.40  |- rdf__type mesh__D001185sskos__Concept
% 212.25/212.40  |- skos__scopeNote mesh__D001185
% 212.25/212.40       The study and implementation of techniques and methods for designing computer systems to perform functions normally associated with human intelligence, such as understanding language, learning, reasoning, problem solving, etc.%A%    
% 212.25/212.40  |- skos__hiddenLabel mesh__D001185
% 212.25/212.40       Representations, Knowledge %28%Computer%29%
% 212.25/212.40  |- skos__hiddenLabel mesh__D001185 Learning, Machine
% 212.25/212.40  |- mesh__dateEstablished mesh__D001185 1986-01-01
% 212.25/212.40  |- skos__hiddenLabel mesh__D001185 Intelligence, Artificial
% 212.25/212.40  |- mesh__recordAuthorizer mesh__D001185 sjn
% 212.25/212.40  |- mesh__publicMeSHNote mesh__D001185 86   
% 212.25/212.40  |- skos__hiddenLabel mesh__D001185 System, Computer Vision
% 212.25/212.40  |- skos__hiddenLabel mesh__D001185 Acquisition, Knowledge %28%Computer%29%
% 212.25/212.40  |- skos__hiddenLabel mesh__D001185 Vision Systems, Computer
% 212.25/212.40  |- skos__hiddenLabel mesh__D001185 Knowledge Acquisitions %28%Computer%29%
% 212.25/212.40  |- skos__altLabel mesh__D001185 AI %28%Artificial Intelligence%29%
% 212.25/212.40  |- skos__hiddenLabel mesh__D001185 Computer Vision System
% 212.25/212.40  |- skos__prefLabel mesh__D001185 Artificial Intelligence
% 212.25/212.40  |- skos__historyNote mesh__D001185 Computers %28%1966-1985%29%
% 212.25/212.40  |- mesh__dateCreated mesh__D001185 1985-06-06
% 212.25/212.40  |- skos__hiddenLabel mesh__D001185 Systems, Computer Vision
% 212.25/212.40  |- skos__hiddenLabel mesh__D001185
% 212.25/212.40       Representation, Knowledge %28%Computer%29%
% 212.25/212.40  |- skos__altLabel mesh__D001185 Machine Intelligence
% 212.25/212.40  |- mesh__recordMaintainer mesh__D001185 ags
% 212.25/212.40  |- skos__hiddenLabel mesh__D001185 Reasoning, Computer
% 212.25/212.40  |- skos__hiddenLabel mesh__D001185 Intelligence, Machine
% 212.25/212.40  |- rdf__type mesh__D028322sskos__Concept
% 212.25/212.40  |- skos__broader mesh__D028322smesh__D007265
% 212.25/212.40  |- skos__hiddenLabel mesh__D028322 Subunits, Activin-beta
% 212.25/212.40  |- skos__altLabel mesh__D028322 beta-Inhibin
% 212.25/212.40  |- skos__altLabel mesh__D028322 beta-Inhibin Polypeptide
% 212.25/212.40  |- mesh__dateCreated mesh__D028322 2001-07-25
% 212.25/212.40  |- skos__hiddenLabel mesh__D028322 Subunits, Inhibin-beta
% 212.25/212.40  |- skos__scopeNote mesh__D028322
% 212.25/212.40       They are glycopeptides and subunits in INHIBINS and ACTIVINS. Inhibins and activins belong to the transforming growth factor beta superfamily.%A%    
% 212.25/212.40  |- skos__hiddenLabel mesh__D028322 beta Inhibin
% 212.25/212.40  |- skos__hiddenLabel mesh__D028322 beta Activin
% 212.25/212.40  |- skos__altLabel mesh__D028322 beta-Activin
% 212.25/212.40  |- skos__altLabel mesh__D028322 Activin-beta Subunits
% 212.25/212.40  |- skos__prefLabel mesh__D028322 Inhibin-beta Subunits
% 212.25/212.40  |- skos__hiddenLabel mesh__D028322 beta Inhibin Polypeptide
% 212.25/212.40  |- skos__broader mesh__D028322smesh__D028341
% 212.25/212.40  |- skos__hiddenLabel mesh__D028322 Polypeptide, beta-Inhibin
% 212.25/212.40  |- mesh__dateRevised mesh__D028322 2003-07-09
% 212.25/212.40  |- mesh__historyNote mesh__D028322 2002   
% 212.25/212.40  |- skos__altLabel mesh__D028322 beta-Activin Polypeptide
% 212.25/212.40  |- skos__historyNote mesh__D028322 Peptides %28%1984-2001%29%
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D028322 2006
% 212.25/212.40  |- mesh__publicMeSHNote mesh__D028322 2002   
% 212.25/212.40  |- mesh__dateEstablished mesh__D028322 2002-01-01
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D028322 2005
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D028322 2004
% 212.25/212.40  |- skos__hiddenLabel mesh__D014302 Sulfonate, Trinitrobenzene
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D014302 2001
% 212.25/212.40  |- skos__prefLabel mesh__D014302 Trinitrobenzenesulfonic Acid
% 212.25/212.40  |- mesh__recordMaintainer mesh__D014302 CCR
% 212.25/212.40  |- skos__annotation mesh__D014302 DF: TNBS   
% 212.25/212.40  |- mesh__dateEstablished mesh__D014302 1991-01-01
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D014302 2003
% 212.25/212.40  |- skos__historyNote mesh__D014302 Nitrobenzenes %28%1971-1974%29%
% 212.25/212.40  |- skos__scopeNote mesh__D014302
% 212.25/212.40       A reagent that is used to neutralize peptide terminal amino groups.%A%    
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D014302 2006
% 212.25/212.40  |- mesh__dateRevised mesh__D014302 2000-06-22
% 212.25/212.40  |- mesh__dateCreated mesh__D014302 1974-11-19
% 212.25/212.40  |- skos__broader mesh__D014302smesh__D014301
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D014302 2005
% 212.25/212.40  |- skos__historyNote mesh__D014302 Benzenesulfonates %28%1974%29%
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D014302 2002
% 212.25/212.40  |- mesh__historyNote mesh__D014302
% 212.25/212.40       91%28%75%29%; was see under NITROBENZENES 1975-90   
% 212.25/212.40  |- mesh__publicMeSHNote mesh__D014302
% 212.25/212.40       91; was see under NITROBENZENES 1975-90   
% 212.25/212.40  |- rdf__type mesh__D014302sskos__Concept
% 212.25/212.40  |- mesh__recordOriginator mesh__D014302 NLM
% 212.25/212.40  |- mesh__recordAuthorizer mesh__D014302 sjn
% 212.25/212.40  |- skos__broader mesh__D014302smesh__D017739
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D014302 2004
% 212.25/212.40  |- skos__hiddenLabel mesh__D019596 Wolf, Gray
% 212.25/212.40  |- skos__prefLabel mesh__D019596 Wolves
% 212.25/212.40  |- mesh__historyNote mesh__D019596 98   
% 212.25/212.40  |- skos__hiddenLabel mesh__D019596 Wolf, Red
% 212.25/212.40  |- skos__historyNote mesh__D019596 Carnivora %28%1966-1997%29%
% 212.25/212.40  |- mesh__publicMeSHNote mesh__D019596 98   
% 212.25/212.40  |- mesh__dateRevised mesh__D019596 2004-07-07
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D019596 2005
% 212.25/212.40  |- mesh__dateCreated mesh__D019596 1997-06-20
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D019596 2006
% 212.25/212.40  |- mesh__dateEstablished mesh__D019596 1998-01-01
% 212.25/212.40  |- skos__scopeNote mesh__D019596
% 212.25/212.40       Any of several large carnivorous mammals of the family CANIDAE that usually hunt in packs.%A%    
% 212.25/212.40  |- skos__altLabel mesh__D019596 Gray Wolf
% 212.25/212.40  |- rdf__type mesh__D019596sskos__Concept
% 212.25/212.40  |- mesh__recordOriginator mesh__D019596 PXP
% 212.25/212.40  |- skos__altLabel mesh__D019596 Wolf
% 212.25/212.40  |- skos__hiddenLabel mesh__D019596 Wolf, Ethiopian
% 212.25/212.40  |- skos__broader mesh__D019596smesh__D046028
% 212.25/212.40  |- skos__altLabel mesh__D019596 Red Wolf
% 212.25/212.40  |- skos__altLabel mesh__D019596 Ethiopian Wolf
% 212.25/212.40  |- mesh__recordMaintainer mesh__D019596 ags
% 212.25/212.40  |- mesh__recordAuthorizer mesh__D019596 sjn
% 212.25/212.40  |- mesh__publicMeSHNote mesh__D005576 86   
% 212.25/212.40  |- mesh__recordAuthorizer mesh__D005576 sjn
% 212.25/212.40  |- mesh__recordMaintainer mesh__D005576 CCR
% 212.25/212.40  |- skos__altLabel mesh__D005576 Coleonol
% 212.25/212.40  |- skos__broader mesh__D005576smesh__D004224
% 212.25/212.40  |- skos__historyNote mesh__D005576 Terpenes %28%1966-1973%29%
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D005576 2001
% 212.25/212.40  |- mesh__dateCreated mesh__D005576 1985-03-08
% 212.25/212.40  |- mesh__dateRevised mesh__D005576 2000-06-21
% 212.25/212.40  |- skos__prefLabel mesh__D005576 Forskolin
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D005576 2002
% 212.25/212.40  |- rdf__type mesh__D005576sskos__Concept
% 212.25/212.40  |- mesh__dateEstablished mesh__D005576 1986-01-01
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D005576 2005
% 212.25/212.40  |- skos__scopeNote mesh__D005576
% 212.25/212.40       Potent activator of the adenylate cyclase system and the biosynthesis of cyclic AMP. From the plant Coleus forskohlii. Has antihypertensive, positive ionotropic, platelet aggregation inhibitory, and smooth muscle relaxant activities; also lowers intraocular pressure and promotes release of hormones from the pituitary gland.%A%    
% 212.25/212.40  |- mesh__historyNote mesh__D005576 86   
% 212.25/212.40  |- mesh__recordOriginator mesh__D005576 RLS
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D005576 2003
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D005576 2006
% 212.25/212.40  |- skos__historyNote mesh__D005576 Diterpenes %28%1974-1985%29%
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D005576 2004
% 212.25/212.40  |- mesh__onlineNote mesh__D010710
% 212.25/212.40       use PHOSPHATES to search BLOOD PHOSPHATES 1966-67 %26% PHOSPHATES, INORGANIC 1974-76%A%  
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D010710 1999
% 212.25/212.40  |- skos__broader mesh__D010710smesh__D000838
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D010710 2005
% 212.25/212.40  |- skos__related mesh__D010710smesh__D017674
% 212.25/212.40  |- mesh__dateCreated mesh__D010710 1999-01-01
% 212.25/212.40  |- mesh__activeMeSHYear mesh__D010710 1998
% 212.25/212.40  |- skos__annotation mesh__D010710
% 212.25/212.40       note X ref: inorganic phosphates only; PHOSPHATES, ORGANIC see PHOSPHORIC ACID ESTERS; /physiol permitted; /blood %26% /defic: consider also HYPOPHOSPHATEMIA %26% HYPOPHOSPHATEMIA, FAMILIAL; POLYPHOSPHATES is also available%A%  
% 212.25/212.40  |- skos__broader mesh__D010710smesh__D010756
% 212.26/212.40  |- skos__altLabel mesh__D010710 Inorganic Phosphates
% 212.26/212.40  |- mesh__dateRevised mesh__D010710 1997-06-20
% 212.26/212.40  |- rdf__type mesh__D010710sskos__Concept
% 212.26/212.40  |- mesh__activeMeSHYear mesh__D010710 2002
% 212.26/212.40  |- skos__scopeNote mesh__D010710 Inorganic salts of phosphoric acid.     
% 212.26/212.40  |- mesh__activeMeSHYear mesh__D010710 2001
% 212.26/212.40  |- skos__prefLabel mesh__D010710 Phosphates
% 212.26/212.40  |- mesh__publicMeSHNote mesh__D010710
% 212.26/212.40       /blood was BLOOD PHOSPHATES 1963-67; PHOSPHATES, INORGANIC was see under PHOSPHATES 1974-76%A%  
% 212.26/212.41  |- mesh__recordOriginator mesh__D010710 NLM
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D010710 2004
% 212.26/212.41  |- mesh__recordAuthorizer mesh__D010710 SJN
% 212.26/212.41  |- skos__altLabel mesh__D010710 Phosphates, Inorganic
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D010710 2000
% 212.26/212.41  |- skos__related mesh__D010710smesh__D010755
% 212.26/212.41  |- mesh__historyNote mesh__D010710
% 212.26/212.41       /blood was BLOOD PHOSPHATES 1963-67; PHOSPHATES, INORGANIC was see under PHOSPHATES 1974-76%A%  
% 212.26/212.41  |- mesh__recordMaintainer mesh__D010710 TGC
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D010710 2003
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D010710 2006
% 212.26/212.41  |- mesh__historyNote mesh__D009967 65   
% 212.26/212.41  |- skos__hiddenLabel mesh__D009967 Appliances, Orthodontic
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009967 2004
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009967 1999
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009967 2002
% 212.26/212.41  |- mesh__recordAuthorizer mesh__D009967 PLS
% 212.26/212.41  |- skos__broader mesh__D009967smesh__D009970
% 212.26/212.41  |- mesh__publicMeSHNote mesh__D009967 65   
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009967 1997
% 212.26/212.41  |- rdf__type mesh__D009967sskos__Concept
% 212.26/212.41  |- skos__hiddenLabel mesh__D009967 Appliance, Orthodontic
% 212.26/212.41  |- mesh__dateEstablished mesh__D009967 1965-01-01
% 212.26/212.41  |- skos__scopeNote mesh__D009967
% 212.26/212.41       Devices used for influencing tooth position. Orthodontic appliances may be classified as fixed or removable, active or retaining, and intraoral or extraoral. %28%Boucher%27%s Clinical Dental Terminology, 4th ed, p19%29%%A%    
% 212.26/212.41  |- skos__prefLabel mesh__D009967 Orthodontic Appliances
% 212.26/212.41  |- mesh__dateCreated mesh__D009967 1999-01-01
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009967 2005
% 212.26/212.41  |- skos__hiddenLabel mesh__D009967 Orthodontic Appliance
% 212.26/212.41  |- mesh__dateRevised mesh__D009967 1996-06-10
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009967 2000
% 212.26/212.41  |- skos__related mesh__D009967smesh__D001840
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009967 2006
% 212.26/212.41  |- mesh__recordOriginator mesh__D009967 NLM
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009967 2003
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009967 1998
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009967 2001
% 212.26/212.41  |- mesh__recordMaintainer mesh__D009967 JLS
% 212.26/212.41  |- skos__broader mesh__D001984smesh__D012142
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001984 2002
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001984 2004
% 212.26/212.41  |- mesh__recordOriginator mesh__D001984 NLM
% 212.26/212.41  |- mesh__dateCreated mesh__D001984 1999-01-01
% 212.26/212.41  |- skos__broader mesh__D001984smesh__D001982
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001984 1997
% 212.26/212.41  |- mesh__recordAuthorizer mesh__D001984 PLS
% 212.26/212.41  |- mesh__recordMaintainer mesh__D001984 KEV
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001984 2000
% 212.26/212.41  |- skos__annotation mesh__D001984
% 212.26/212.41       not for bronchial carcinoma %28% = CARCINOMA, BRONCHIAL see CARCINOMA, BRONCHOGENIC + LUNG NEOPLASMS%29%, nor bronchogenic carcinoma %28% = CARCINOMA, BRONCHOGENIC + LUNG NEOPLASMS%29% nor bronchiolar carcinoma %28% = CARCINOMA, BRONCHIOLAR + LUNG NEOPLASMS%29%; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%  
% 212.26/212.41  |- skos__prefLabel mesh__D001984 Bronchial Neoplasms
% 212.26/212.41  |- rdf__type mesh__D001984sskos__Concept
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001984 2005
% 212.26/212.41  |- mesh__dateRevised mesh__D001984 1995-06-08
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001984 2001
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001984 1998
% 212.26/212.41  |- skos__hiddenLabel mesh__D001984 Neoplasm, Bronchial
% 212.26/212.41  |- skos__hiddenLabel mesh__D001984 Bronchial Neoplasm
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001984 2006
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001984 1999
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001984 2003
% 212.26/212.41  |- skos__altLabel mesh__D001984 Neoplasms, Bronchial
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001984 1996
% 212.26/212.41  |- mesh__dateCreated mesh__D009169 1999-01-01
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009169 2006
% 212.26/212.41  |- skos__annotation mesh__D009169
% 212.26/212.41       infection = TUBERCULOSIS or specifics; DF: M TUBERC   
% 212.26/212.41  |- skos__related mesh__D009169smesh__D000995
% 212.26/212.41  |- skos__scopeNote mesh__D009169
% 212.26/212.41       A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation.%A%    
% 212.26/212.41  |- skos__broader mesh__D009169smesh__D009161
% 212.26/212.41  |- mesh__recordOriginator mesh__D009169 NLM
% 212.26/212.41  |- rdf__type mesh__D009169sskos__Concept
% 212.26/212.41  |- mesh__recordAuthorizer mesh__D009169 sjn
% 212.26/212.41  |- mesh__dateRevised mesh__D009169 2005-06-30
% 212.26/212.41  |- skos__prefLabel mesh__D009169 Mycobacterium tuberculosis
% 212.26/212.41  |- mesh__recordMaintainer mesh__D009169 SYSTEM
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001186 2006
% 212.26/212.41  |- skos__hiddenLabel mesh__D001186 Limb Prostheses
% 212.26/212.41  |- skos__hiddenLabel mesh__D001186 Artificial Extremities
% 212.26/212.41  |- mesh__dateCreated mesh__D001186 1999-01-01
% 212.26/212.41  |- skos__broader mesh__D001186smesh__D001187
% 212.26/212.41  |- skos__hiddenLabel mesh__D001186 Prosthesis, Leg
% 212.26/212.41  |- skos__prefLabel mesh__D001186 Artificial Limbs
% 212.26/212.41  |- skos__hiddenLabel mesh__D001186 Prostheses, Limb
% 212.26/212.41  |- skos__hiddenLabel mesh__D001186 Artificial Legs
% 212.26/212.41  |- mesh__recordMaintainer mesh__D001186 jls
% 212.26/212.41  |- skos__altLabel mesh__D001186 Extremities, Artificial
% 212.26/212.41  |- mesh__dateRevised mesh__D001186 2004-07-19
% 212.26/212.41  |- skos__altLabel mesh__D001186 Arm Prosthesis
% 212.26/212.41  |- rdf__type mesh__D001186sskos__Concept
% 212.26/212.41  |- skos__hiddenLabel mesh__D001186 Prostheses, Leg
% 212.26/212.41  |- skos__hiddenLabel mesh__D001186 Arm Prostheses
% 212.26/212.41  |- skos__broader mesh__D001186smesh__D009983
% 212.26/212.41  |- skos__hiddenLabel mesh__D001186 Prosthesis, Limb
% 212.26/212.41  |- skos__altLabel mesh__D001186 Leg, Artificial
% 212.26/212.41  |- skos__hiddenLabel mesh__D001186 Leg Prostheses
% 212.26/212.41  |- skos__hiddenLabel mesh__D001186 Artificial Limb
% 212.26/212.41  |- skos__hiddenLabel mesh__D001186 Prosthesis, Arm
% 212.26/212.41  |- skos__hiddenLabel mesh__D001186 Extremity, Artificial
% 212.26/212.41  |- skos__altLabel mesh__D001186 Limb Prosthesis
% 212.26/212.41  |- skos__hiddenLabel mesh__D001186 Arms, Artificial
% 212.26/212.41  |- skos__hiddenLabel mesh__D001186 Artificial Extremity
% 212.26/212.41  |- skos__hiddenLabel mesh__D001186 Limb, Artificial
% 212.26/212.41  |- skos__scopeNote mesh__D001186
% 212.26/212.41       Prosthetic replacements for arms, legs, and parts thereof.%A%    
% 212.26/212.41  |- skos__annotation mesh__D001186
% 212.26/212.41       coord ARM or LEG %28%NIM%29% if pertinent   
% 212.26/212.41  |- skos__altLabel mesh__D001186 Limbs, Artificial
% 212.26/212.41  |- skos__hiddenLabel mesh__D001186 Legs, Artificial
% 212.26/212.41  |- mesh__recordAuthorizer mesh__D001186 sjn
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001186 2005
% 212.26/212.41  |- skos__altLabel mesh__D001186 Artificial Leg
% 212.26/212.41  |- skos__broader mesh__D001186smesh__D019736
% 212.26/212.41  |- mesh__recordOriginator mesh__D001186 NLM
% 212.26/212.41  |- skos__hiddenLabel mesh__D001186 Prostheses, Arm
% 212.26/212.41  |- skos__hiddenLabel mesh__D001186 Artificial Arms
% 212.26/212.41  |- skos__altLabel mesh__D001186 Arm, Artificial
% 212.26/212.41  |- skos__altLabel mesh__D028323 Porcine parvovirus
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D028323 2002
% 212.26/212.41  |- mesh__historyNote mesh__D028323 2002   
% 212.26/212.41  |- mesh__dateCreated mesh__D028323 2001-07-25
% 212.26/212.41  |- mesh__dateEstablished mesh__D028323 2002-01-01
% 212.26/212.41  |- skos__annotation mesh__D028323
% 212.26/212.41       infection: coord IM with PARVOVIRIDAE INFECTIONS %28%IM%29%   
% 212.26/212.41  |- skos__hiddenLabel mesh__D028323 Porcine Parvoviruses
% 212.26/212.41  |- skos__scopeNote mesh__D028323
% 212.26/212.41       A species of PARVOVIRUS causing reproductive failure in pigs.%A%    
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D028323 2005
% 212.26/212.41  |- skos__broader mesh__D028323smesh__D017992
% 212.26/212.41  |- skos__hiddenLabel mesh__D028323 Parvoviruses, Porcine
% 212.26/212.41  |- skos__prefLabel mesh__D028323 Parvovirus, Porcine
% 212.26/212.41  |- skos__historyNote mesh__D028323 Parvoviridae %28%1973-1993%29%
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D028323 2003
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D028323 2006
% 212.26/212.41  |- mesh__publicMeSHNote mesh__D028323 2002   
% 212.26/212.41  |- skos__historyNote mesh__D028323 Parvovirus %28%1994-2001%29%
% 212.26/212.41  |- rdf__type mesh__D028323sskos__Concept
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D028323 2004
% 212.26/212.41  |- mesh__dateRevised mesh__D020340 2002-07-03
% 212.26/212.41  |- skos__altLabel mesh__D020340 Tobacco Cessation
% 212.26/212.41  |- skos__broader mesh__D020340smesh__D001519
% 212.26/212.41  |- skos__hiddenLabel mesh__D020340 Tobacco Cessations
% 212.26/212.41  |- skos__hiddenLabel mesh__D020340 Tobacco Cessations, Smokeless
% 212.26/212.41  |- skos__hiddenLabel mesh__D020340 Cessations, Tobacco Use
% 212.26/212.41  |- skos__hiddenLabel mesh__D020340 Cessation, Tobacco
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D020340 2005
% 212.26/212.41  |- skos__hiddenLabel mesh__D020340 Smokeless Tobacco Cessations
% 212.26/212.41  |- skos__hiddenLabel mesh__D020340 Cessations, Tobacco
% 212.26/212.41  |- skos__prefLabel mesh__D020340 Tobacco Use Cessation
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D020340 2006
% 212.26/212.41  |- skos__annotation mesh__D020340 SMOKING CESSATION is also available   
% 212.26/212.41  |- rdf__type mesh__D020340sskos__Concept
% 212.26/212.41  |- mesh__publicMeSHNote mesh__D020340 99   
% 212.26/212.41  |- skos__hiddenLabel mesh__D020340 Cessation, Tobacco Use
% 212.26/212.41  |- mesh__dateCreated mesh__D020340 1998-06-11
% 212.26/212.41  |- skos__scopeNote mesh__D020340
% 212.26/212.41       Cessation of the habit of using tobacco products for smoking or chewing, including the use of snuff.%A%    
% 212.26/212.41  |- skos__hiddenLabel mesh__D020340 Cessation, Smokeless Tobacco
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D020340 2003
% 212.26/212.41  |- skos__hiddenLabel mesh__D020340 Cessations, Smokeless Tobacco
% 212.26/212.41  |- skos__hiddenLabel mesh__D020340 Tobacco Cessation, Smokeless
% 212.26/212.41  |- mesh__historyNote mesh__D020340 99   
% 212.26/212.41  |- skos__hiddenLabel mesh__D020340 Use Cessation, Tobacco
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D020340 2004
% 212.26/212.41  |- skos__hiddenLabel mesh__D020340 Tobacco Use Cessations
% 212.26/212.41  |- mesh__dateEstablished mesh__D020340 1999-01-01
% 212.26/212.41  |- skos__hiddenLabel mesh__D020340 Use Cessations, Tobacco
% 212.26/212.41  |- skos__prefLabel mesh__D047288 Asterina
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D047288 2006
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D047288 2005
% 212.26/212.41  |- skos__scopeNote mesh__D047288
% 212.26/212.41       A genus of STARFISH in the family Asterinidae. They externally hold developing embryos %28%EMBRYO, NON-MAMMALIAN%29% among the spines below the oral surface.%A%    
% 212.26/212.41  |- rdf__type mesh__D047288sskos__Concept
% 212.26/212.41  |- skos__historyNote mesh__D047288 Echinodermata %28%1966-1973%29%
% 212.26/212.41  |- mesh__recordOriginator mesh__D047288 ags
% 212.26/212.41  |- mesh__historyNote mesh__D047288 2005   
% 212.26/212.41  |- mesh__recordAuthorizer mesh__D047288 sjn
% 212.26/212.41  |- skos__broader mesh__D047288smesh__D013215
% 212.26/212.41  |- mesh__dateCreated mesh__D047288 2004-07-07
% 212.26/212.41  |- mesh__publicMeSHNote mesh__D047288 2005   
% 212.26/212.41  |- mesh__dateEstablished mesh__D047288 2005-01-01
% 212.26/212.41  |- mesh__recordMaintainer mesh__D047288 ags
% 212.26/212.41  |- skos__historyNote mesh__D047288 Starfish %28%1972-2004%29%
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D014303 1999
% 212.26/212.41  |- mesh__dateCreated mesh__D014303 1999-01-01
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D014303 2006
% 212.26/212.41  |- mesh__recordOriginator mesh__D014303 NLM
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D014303 1995
% 212.26/212.41  |- skos__prefLabel mesh__D014303 Trinitrotoluene
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D014303 1998
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D014303 2001
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D014303 2005
% 212.26/212.41  |- skos__broader mesh__D014303smesh__D014050
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D014303 1994
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D014303 2000
% 212.26/212.41  |- mesh__dateRevised mesh__D014303 1992-05-20
% 212.26/212.41  |- skos__altLabel mesh__D014303 TNT
% 212.26/212.41  |- rdf__type mesh__D014303sskos__Concept
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D014303 1997
% 212.26/212.41  |- mesh__recordMaintainer mesh__D014303 TAP
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D014303 2004
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D014303 2002
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D014303 1993
% 212.26/212.41  |- mesh__recordAuthorizer mesh__D014303 PLS
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D014303 1996
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D014303 2003
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D019597 2005
% 212.26/212.41  |- mesh__recordOriginator mesh__D019597 TGC
% 212.26/212.41  |- skos__scopeNote mesh__D019597
% 212.26/212.41       A plant genus of the family LINACEAE that is cultivated for its fiber %28%manufactured into linen cloth%29%.  It contains a trypsin inhibitor and the seed is the source of LINSEED OIL.%A%    
% 212.26/212.41  |- skos__annotation mesh__D019597
% 212.26/212.41       despite X ref FLAXSEED, coord IM with SEEDS %28%IM%29%; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.26/212.41  |- mesh__recordAuthorizer mesh__D019597 sjn
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D019597 2006
% 212.26/212.41  |- skos__altLabel mesh__D019597 Linseed
% 212.26/212.41  |- skos__altLabel mesh__D019597 Flaxseed
% 212.26/212.41  |- rdf__type mesh__D019597sskos__Concept
% 212.26/212.41  |- mesh__publicMeSHNote mesh__D019597 98   
% 212.26/212.41  |- skos__broader mesh__D019597smesh__D019658
% 212.26/212.41  |- mesh__dateCreated mesh__D019597 1997-06-20
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D019597 2003
% 212.26/212.41  |- mesh__dateEstablished mesh__D019597 1998-01-01
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D019597 2004
% 212.26/212.41  |- mesh__recordMaintainer mesh__D019597 ssb
% 212.26/212.41  |- skos__altLabel mesh__D019597 Linum
% 212.26/212.41  |- mesh__historyNote mesh__D019597 98   
% 212.26/212.41  |- skos__prefLabel mesh__D019597 Flax
% 212.26/212.41  |- mesh__dateRevised mesh__D019597 2002-07-03
% 212.26/212.41  |- mesh__historyNote mesh__D005577
% 212.26/212.41       91%28%82%29%73%28%66 only%29%; was see under ANTIGENS, HETEROPHILE 1983-90; was heading 1973-81; was see under HAPTENS 1965-72 %28%Prov 1966%29%%A%  
% 212.26/212.41  |- rdf__type mesh__D005577sskos__Concept
% 212.26/212.41  |- mesh__onlineNote mesh__D005577
% 212.26/212.41       use HAPTENS to search FORSSMAN ANTIGEN 1966-72 %28%as Prov 1966%29%%A%  
% 212.26/212.41  |- mesh__recordMaintainer mesh__D005577 ssb
% 212.26/212.41  |- mesh__recordOriginator mesh__D005577 NLM
% 212.26/212.41  |- mesh__dateEstablished mesh__D005577 1973-01-01
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D005577 2006
% 212.26/212.41  |- mesh__recordAuthorizer mesh__D005577 sjn
% 212.26/212.41  |- mesh__dateCreated mesh__D005577 1999-01-01
% 212.26/212.41  |- skos__scopeNote mesh__D005577
% 212.26/212.41       A glycolipid, cross-species antigen that induces production of antisheep hemolysin. It is present on the tissue cells of many species but absent in humans. It is found in many infectious agents.%A%    
% 212.26/212.41  |- skos__broader mesh__D005577smesh__D015478
% 212.26/212.41  |- mesh__publicMeSHNote mesh__D005577
% 212.26/212.41       91,73-81; was see under ANTIGENS, HETEROPHILE 1983-90; was heading 1973-81; was see under HAPTENS 1965, 1967-72%A%  
% 212.26/212.41  |- mesh__dateRevised mesh__D005577 2005-06-30
% 212.26/212.41  |- skos__prefLabel mesh__D005577 Forssman Antigen
% 212.26/212.41  |- skos__hiddenLabel mesh__D005577 Antigen, Forssman
% 212.26/212.41  |- rdf__type mesh__D010711sskos__Concept
% 212.26/212.41  |- mesh__publicMeSHNote mesh__D010711
% 212.26/212.41       91; was see under PHOSPHOMONOESTERASES 1979-90   
% 212.26/212.41  |- mesh__dateCreated mesh__D010711 1978-03-13
% 212.26/212.41  |- skos__hiddenLabel mesh__D010711 Phosphatase, Phosphatidic Acid
% 212.26/212.41  |- skos__altLabel mesh__D010711 Phosphatidate Phosphohydrolase
% 212.26/212.41  |- mesh__dateRevised mesh__D010711 2003-07-09
% 212.26/212.41  |- skos__historyNote mesh__D010711 Phosphomonoesterases %28%1975-1978%29%
% 212.26/212.41  |- skos__historyNote mesh__D010711 Phosphatases %28%1966-1974%29%
% 212.26/212.41  |- skos__hiddenLabel mesh__D010711 Phosphohydrolase, Phosphatidic Acid
% 212.26/212.41  |- mesh__recordMaintainer mesh__D010711 ssb
% 212.26/212.41  |- skos__prefLabel mesh__D010711 Phosphatidate Phosphatase
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D010711 2004
% 212.26/212.41  |- mesh__historyNote mesh__D010711
% 212.26/212.41       91%28%79%29%; was see under PHOSPHOMONOESTERASES 1979-90   
% 212.26/212.41  |- skos__historyNote mesh__D010711 Phospholipids %28%1966-1974%29%
% 212.26/212.41  |- skos__hiddenLabel mesh__D010711 Phosphatase, Phosphatidate
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D010711 2006
% 212.26/212.41  |- skos__hiddenLabel mesh__D010711 Phosphohydrolase, Phosphatidate
% 212.26/212.41  |- skos__scopeNote mesh__D010711
% 212.26/212.41       A phosphomonoesterase involved in the synthesis of triacylglycerols. It catalyzes the hydrolysis of phosphatidates with the formation of diacylglycerols and orthophosphate. EC 3.1.3.4.%A%    
% 212.26/212.41  |- mesh__dateEstablished mesh__D010711 1991-01-01
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D010711 2005
% 212.26/212.41  |- skos__broader mesh__D010711smesh__D010744
% 212.26/212.41  |- mesh__recordOriginator mesh__D010711 RLS
% 212.26/212.41  |- skos__altLabel mesh__D010711 Phosphatidic Acid Phosphohydrolase
% 212.26/212.41  |- skos__historyNote mesh__D010711 Phosphatidic Acids %28%1975-1978%29%
% 212.26/212.41  |- skos__altLabel mesh__D010711 Phosphatidic Acid Phosphatase
% 212.26/212.41  |- mesh__recordAuthorizer mesh__D010711 sjn
% 212.26/212.41  |- skos__hiddenLabel mesh__D009968 Appliance, Removable Orthodontic
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009968 2000
% 212.26/212.41  |- skos__broader mesh__D009968smesh__D009967
% 212.26/212.41  |- rdf__type mesh__D009968sskos__Concept
% 212.26/212.41  |- mesh__recordOriginator mesh__D009968 NLM
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009968 1997
% 212.26/212.41  |- skos__hiddenLabel mesh__D009968 Appliances, Removable Orthodontic
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009968 2001
% 212.26/212.41  |- mesh__dateRevised mesh__D009968 1992-05-15
% 212.26/212.41  |- skos__hiddenLabel mesh__D009968 Removable Orthodontic Appliances
% 212.26/212.41  |- skos__hiddenLabel mesh__D009968 Orthodontic Appliance, Removable
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009968 2002
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009968 1994
% 212.26/212.41  |- mesh__recordAuthorizer mesh__D009968 PLS
% 212.26/212.41  |- mesh__dateCreated mesh__D009968 1999-01-01
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009968 2005
% 212.26/212.41  |- mesh__dateEstablished mesh__D009968 1973-01-01
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009968 1995
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009968 2006
% 212.26/212.41  |- skos__historyNote mesh__D009968 Orthodontic Appliances %28%1966-1970%29%
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009968 2003
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009968 1998
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009968 1993
% 212.26/212.41  |- mesh__recordMaintainer mesh__D009968 PLS
% 212.26/212.41  |- skos__hiddenLabel mesh__D009968 Removable Orthodontic Appliance
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009968 2004
% 212.26/212.41  |- skos__prefLabel mesh__D009968 Orthodontic Appliances, Removable
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009968 1999
% 212.26/212.41  |- mesh__historyNote mesh__D009968 73%28%71%29%   
% 212.26/212.41  |- mesh__publicMeSHNote mesh__D009968 73   
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D009968 1996
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Tests, Bronchial Challenge
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Allergen Challenges, Bronchial
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Bronchial Challenge Test
% 212.26/212.41  |- mesh__historyNote mesh__D001985 80   
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001985 2004
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Bronchial Provocation Test
% 212.26/212.41  |- skos__historyNote mesh__D001985 Bronchi %28%1966-1979%29%
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Challenges, Bronchial Allergen
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Challenge Tests, Bronchial
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Test, Endobronchial Challenge
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Provocation Test, Inhalation
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Tests, Inhalation Provocation
% 212.26/212.41  |- mesh__dateEstablished mesh__D001985 1980-01-01
% 212.26/212.41  |- skos__altLabel mesh__D001985 Bronchial Challenge Tests
% 212.26/212.41  |- skos__altLabel mesh__D001985 Provocation Tests, Bronchial
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Provocation Tests, Inhalation
% 212.26/212.41  |- skos__altLabel mesh__D001985 Inhalation Provocation Tests
% 212.26/212.41  |- skos__prefLabel mesh__D001985 Bronchial Provocation Tests
% 212.26/212.41  |- skos__historyNote mesh__D001985
% 212.26/212.41       specific respiratory function test %28%1966-1979%29%
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Tests, Endobronchial Challenge
% 212.26/212.41  |- mesh__dateCreated mesh__D001985 1979-03-08
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Endobronchial Challenge Test
% 212.26/212.41  |- skos__altLabel mesh__D001985 Bronchial Allergen Challenge
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Inhalation Provocation Test
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001985 2003
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Allergen Challenges, Endobronchial
% 212.26/212.41  |- skos__broader mesh__D001985smesh__D012129
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Challenges, Endobronchial Allergen
% 212.26/212.41  |- mesh__recordMaintainer mesh__D001985 nns
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001985 2002
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Allergen Challenge, Bronchial
% 212.26/212.41  |- skos__historyNote mesh__D001985 Asthma %28%1966-1979%29%
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Tests, Bronchial Provocation
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001985 2006
% 212.26/212.41  |- mesh__recordAuthorizer mesh__D001985 sjn
% 212.26/212.41  |- skos__scopeNote mesh__D001985
% 212.26/212.41       Tests involving inhalation of allergens %28%nebulized or in dust form%29%, nebulized pharmacologically active solutions %28%e.g., histamine, methacholine%29%, or control solutions, followed by assessment of respiratory function. These tests are used in the diagnosis of asthma.%A%    
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Test, Bronchial Challenge
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Challenge Test, Bronchial
% 212.26/212.41  |- mesh__publicMeSHNote mesh__D001985 80   
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Provocation Test, Bronchial
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Challenge, Endobronchial Allergen
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Challenge Tests, Endobronchial
% 212.26/212.41  |- skos__historyNote mesh__D001985
% 212.26/212.41       Respiratory Function Tests %28%1966-1979%29%
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Endobronchial Allergen Challenges
% 212.26/212.41  |- mesh__recordOriginator mesh__D001985 SMH
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001985 2005
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Challenge Test, Endobronchial
% 212.26/212.41  |- skos__annotation mesh__D001985 DF: BP TESTS   
% 212.26/212.41  |- skos__altLabel mesh__D001985 Allergen Bronchial Provocation Tests
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001985 2001
% 212.26/212.41  |- skos__historyNote mesh__D001985 Histamine %28%1966-1979%29%
% 212.26/212.41  |- skos__altLabel mesh__D001985 Allergen Challenge, Endobronchial
% 212.26/212.41  |- skos__altLabel mesh__D001985 Antigen Bronchial Provocation Tests
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Challenge, Bronchial Allergen
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Endobronchial Allergen Challenge
% 212.26/212.41  |- skos__historyNote mesh__D001985 Allergens %28%1966-1979%29%
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Test, Bronchial Provocation
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Bronchial Allergen Challenges
% 212.26/212.41  |- rdf__type mesh__D001985sskos__Concept
% 212.26/212.41  |- mesh__dateRevised mesh__D001985 1999-11-03
% 212.26/212.41  |- skos__altLabel mesh__D001985 Endobronchial Challenge Tests
% 212.26/212.41  |- skos__hiddenLabel mesh__D001985 Test, Inhalation Provocation
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001985 2000
% 212.26/212.41  |- mesh__dateRevised mesh__D034361 2005-06-30
% 212.26/212.41  |- mesh__historyNote mesh__D034361 2003   
% 212.26/212.41  |- rdf__type mesh__D034361sskos__Concept
% 212.26/212.41  |- mesh__dateEstablished mesh__D034361 2003-01-01
% 212.26/212.41  |- mesh__recordMaintainer mesh__D034361 SYSTEM
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D034361 2006
% 212.26/212.41  |- mesh__publicMeSHNote mesh__D034361 2003   
% 212.26/212.41  |- mesh__recordAuthorizer mesh__D034361 sjn
% 212.26/212.41  |- skos__broader mesh__D034361smesh__D034363
% 212.26/212.41  |- skos__scopeNote mesh__D034361
% 212.26/212.41       A species of gram-positive, coccoid bacteria commensal in the respiratory tract.%A%    
% 212.26/212.41  |- skos__prefLabel mesh__D034361 Streptococcus mitis
% 212.26/212.41  |- skos__annotation mesh__D034361
% 212.26/212.41       infection: coord IM with STREPTOCOCCAL INFECTIONS %28%IM%29%   
% 212.26/212.41  |- mesh__recordOriginator mesh__D034361 ags
% 212.26/212.41  |- mesh__dateCreated mesh__D034361 2002-07-03
% 212.26/212.41  |- skos__historyNote mesh__D034361 Streptococcus %28%1965-2002%29%
% 212.26/212.41  |- skos__hiddenLabel mesh__D001187 Organ, Artificial
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001187 2000
% 212.26/212.41  |- mesh__recordMaintainer mesh__D001187 PXP
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001187 2004
% 212.26/212.41  |- skos__scopeNote mesh__D001187
% 212.26/212.41       Devices intended to replace non-functioning organs. They may be temporary or permanent. Since they are intended always to function as the natural organs they are replacing, they should be differentiated from PROSTHESES AND IMPLANTS and specific types of prostheses which, though also replacements for body parts, are frequently cosmetic %28%EYE, ARTIFICIAL%29% as well as functional %28%ARTIFICIAL LIMBS%29%.%A%    
% 212.26/212.41  |- mesh__recordOriginator mesh__D001187 NLM
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001187 2006
% 212.26/212.41  |- skos__annotation mesh__D001187
% 212.26/212.41       usually to replace function, as HEART, ARTIFICIAL or KIDNEY, ARTIFICIAL: do not confuse with PROSTHESES AND IMPLANTS which is usually cosmetic; not for injections, like silicones, to replace substance; coord IM with specific organ %28%IM%29% with no qualif but note available precoords%A%  
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001187 1999
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001187 2003
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001187 2005
% 212.26/212.41  |- skos__hiddenLabel mesh__D001187 Artificial Organ
% 212.26/212.41  |- skos__prefLabel mesh__D001187 Artificial Organs
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001187 1998
% 212.26/212.41  |- rdf__type mesh__D001187sskos__Concept
% 212.26/212.41  |- skos__hiddenLabel mesh__D001187 Organs, Artificial
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001187 2002
% 212.26/212.41  |- mesh__dateRevised mesh__D001187 1997-06-20
% 212.26/212.41  |- mesh__activeMeSHYear mesh__D001187 2001
% 212.26/212.41  |- mesh__recordAuthorizer mesh__D001187 SJN
% 212.26/212.42  |- skos__broader mesh__D001187smesh__D013523
% 212.26/212.42  |- mesh__dateCreated mesh__D001187 1999-01-01
% 212.26/212.42  |- skos__hiddenLabel mesh__D020341 Biodegradable Implant
% 212.26/212.42  |- skos__hiddenLabel mesh__D020341 Absorbable Implant
% 212.26/212.42  |- skos__scopeNote mesh__D020341
% 212.26/212.42       Implants constructed of materials designed to be absorbed by the body without producing an immune response. They are usually composed of plastics and are frequently used in orthopedics and orthodontics.%A%    
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D020341 2006
% 212.26/212.42  |- rdf__type mesh__D020341sskos__Concept
% 212.26/212.42  |- mesh__publicMeSHNote mesh__D020341 99   
% 212.26/212.42  |- mesh__dateEstablished mesh__D020341 1999-01-01
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D020341 2000
% 212.26/212.42  |- mesh__historyNote mesh__D020341 99   
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D020341 2003
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D020341 2001
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D020341 1999
% 212.26/212.42  |- skos__altLabel mesh__D020341 Biodegradable Implants
% 212.26/212.42  |- skos__hiddenLabel mesh__D020341 Implants, Bioabsorbable
% 212.26/212.42  |- skos__hiddenLabel mesh__D020341 Implant, Bioabsorbable
% 212.26/212.42  |- skos__hiddenLabel mesh__D020341 Bioabsorbable Implant
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D020341 2004
% 212.26/212.42  |- skos__annotation mesh__D020341 coord with substance if emphasized   
% 212.26/212.42  |- skos__hiddenLabel mesh__D020341 Implant, Absorbable
% 212.26/212.42  |- skos__prefLabel mesh__D020341 Absorbable Implants
% 212.26/212.42  |- skos__altLabel mesh__D020341 Bioabsorbable Implants
% 212.26/212.42  |- mesh__dateCreated mesh__D020341 1998-06-10
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D020341 2002
% 212.26/212.42  |- skos__altLabel mesh__D020341 Implants, Absorbable
% 212.26/212.42  |- skos__broader mesh__D020341smesh__D019736
% 212.26/212.42  |- skos__hiddenLabel mesh__D020341 Implants, Biodegradable
% 212.26/212.42  |- skos__hiddenLabel mesh__D020341 Implant, Biodegradable
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D020341 2005
% 212.26/212.42  |- skos__hiddenLabel mesh__D014304 Trioleate, Glycerol
% 212.26/212.42  |- skos__altLabel mesh__D014304 Trioleoylglycerol
% 212.26/212.42  |- skos__hiddenLabel mesh__D014304 Trioleate Glycerin
% 212.26/212.42  |- skos__altLabel mesh__D014304 Glycerol Trioleate
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D014304 2006
% 212.26/212.42  |- skos__hiddenLabel mesh__D014304 Glycerol, Trioleyl
% 212.26/212.42  |- skos__altLabel mesh__D014304 Trielaidin
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D014304 2005
% 212.26/212.42  |- rdf__type mesh__D014304sskos__Concept
% 212.26/212.42  |- mesh__dateRevised mesh__D014304 2003-07-09
% 212.26/212.42  |- skos__scopeNote mesh__D014304
% 212.26/212.42       %28%Z%29%-9-Octadecenoic acid 1,2,3-propanetriyl ester.     
% 212.26/212.42  |- skos__broader mesh__D014304smesh__D005224
% 212.26/212.42  |- skos__altLabel mesh__D014304 Trioleate-Glycerin
% 212.26/212.42  |- skos__annotation mesh__D014304 a triglyceride   
% 212.26/212.42  |- skos__broader mesh__D014304smesh__D014280
% 212.26/212.42  |- mesh__recordMaintainer mesh__D014304 ssb
% 212.26/212.42  |- skos__altLabel mesh__D014304 Trioleyl Glycerol
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D014304 2004
% 212.26/212.42  |- skos__prefLabel mesh__D014304 Triolein
% 212.26/212.42  |- mesh__dateCreated mesh__D014304 1999-01-01
% 212.26/212.42  |- mesh__recordOriginator mesh__D014304 NLM
% 212.26/212.42  |- mesh__recordAuthorizer mesh__D014304 sjn
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D005578 2005
% 212.26/212.42  |- skos__historyNote mesh__D005578
% 212.26/212.42       Organophosphorus Compounds %28%1973-1974%29%
% 212.26/212.42  |- skos__altLabel mesh__D005578 Phosphomycin
% 212.26/212.42  |- skos__historyNote mesh__D005578 Ethers, Cyclic %28%1971-1974%29%
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D005578 2006
% 212.26/212.42  |- skos__broader mesh__D005578smesh__D010745
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D005578 2004
% 212.26/212.42  |- skos__altLabel mesh__D005578 Phosphonomycin
% 212.26/212.42  |- mesh__recordOriginator mesh__D005578 NLM
% 212.26/212.42  |- mesh__dateRevised mesh__D005578 2003-07-30
% 212.26/212.42  |- mesh__dateCreated mesh__D005578 1974-11-19
% 212.26/212.42  |- mesh__publicMeSHNote mesh__D005578
% 212.26/212.42       86; was see under ANTIBIOTICS 1975-85   
% 212.26/212.42  |- skos__scopeNote mesh__D005578
% 212.26/212.42       An antibiotic produced by Streptomyces fradiae.     
% 212.26/212.42  |- skos__historyNote mesh__D005578 Antibiotics %28%1971-1974%29%
% 212.26/212.42  |- mesh__recordAuthorizer mesh__D005578 NLM
% 212.26/212.42  |- skos__prefLabel mesh__D005578 Fosfomycin
% 212.26/212.42  |- mesh__historyNote mesh__D005578
% 212.26/212.42       86%28%75%29%; was see under ANTIBIOTICS 1975-85   
% 212.26/212.42  |- mesh__recordMaintainer mesh__D005578 SYSTEM
% 212.26/212.42  |- rdf__type mesh__D005578sskos__Concept
% 212.26/212.42  |- mesh__dateEstablished mesh__D005578 1986-01-01
% 212.26/212.42  |- rdf__type mesh__D002280sskos__Concept
% 212.26/212.42  |- skos__hiddenLabel mesh__D002280 Rodent Ulcers
% 212.26/212.42  |- skos__hiddenLabel mesh__D002280 Ulcers, Rodent
% 212.26/212.42  |- skos__altLabel mesh__D002280 Rodent Ulcer
% 212.26/212.42  |- mesh__dateCreated mesh__D002280 1999-01-01
% 212.26/212.42  |- mesh__dateRevised mesh__D002280 1997-06-20
% 212.26/212.42  |- mesh__recordMaintainer mesh__D002280 TGC
% 212.26/212.42  |- skos__annotation mesh__D002280
% 212.26/212.42       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with probably SKIN NEOPLASMS %28%IM%29%; X ref RODENT ULCER: do not coord with ULCER%A%  
% 212.26/212.42  |- skos__broader mesh__D002280smesh__D002277
% 212.26/212.42  |- skos__hiddenLabel mesh__D002280 Basal Cell Epithelioma
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D002280 2002
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D002280 1999
% 212.26/212.42  |- skos__broader mesh__D002280smesh__D018295
% 212.26/212.42  |- skos__scopeNote mesh__D002280
% 212.26/212.42       A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid %28%pagetoid%29%. More than 95%25% of these carcinomas occur in patients over 40. They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85%25% are found on the head and neck area and the remaining 15%25% on the trunk and limbs. %28%From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1471%29%%A%    
% 212.26/212.42  |- skos__hiddenLabel mesh__D002280 Basal Cell Epitheliomas
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D002280 1998
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D002280 2006
% 212.26/212.42  |- skos__prefLabel mesh__D002280 Carcinoma, Basal Cell
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D002280 2004
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D002280 2001
% 212.26/212.42  |- skos__hiddenLabel mesh__D002280 Epitheliomas, Basal Cell
% 212.26/212.42  |- skos__hiddenLabel mesh__D002280 Basal Cell Carcinomas
% 212.26/212.42  |- skos__hiddenLabel mesh__D002280 Basal Cell Carcinoma
% 212.26/212.42  |- skos__hiddenLabel mesh__D002280 Carcinomas, Basal Cell
% 212.26/212.42  |- skos__altLabel mesh__D002280 Ulcer, Rodent
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D002280 2000
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D002280 2005
% 212.26/212.42  |- skos__altLabel mesh__D002280 Carcinoma, Basal Cell, Pigmented
% 212.26/212.42  |- skos__altLabel mesh__D002280 Epithelioma, Basal Cell
% 212.26/212.42  |- mesh__recordOriginator mesh__D002280 NLM
% 212.26/212.42  |- mesh__recordAuthorizer mesh__D002280 SJN
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D002280 2003
% 212.26/212.42  |- skos__hiddenLabel mesh__D010712 Acids, Phosphatidic
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D010712 2004
% 212.26/212.42  |- mesh__publicMeSHNote mesh__D010712 77; see PHOSPHOLIPIDS 1963-76   
% 212.26/212.42  |- mesh__recordAuthorizer mesh__D010712 sjn
% 212.26/212.42  |- mesh__dateEstablished mesh__D010712 1977-01-01
% 212.26/212.42  |- mesh__historyNote mesh__D010712 77%28%63%29%   
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D010712 2006
% 212.26/212.42  |- skos__hiddenLabel mesh__D010712 Phosphatidate, Ammonium
% 212.26/212.42  |- skos__prefLabel mesh__D010712 Phosphatidic Acids
% 212.26/212.42  |- mesh__recordOriginator mesh__D010712 NLM
% 212.26/212.42  |- mesh__recordMaintainer mesh__D010712 ssb
% 212.26/212.42  |- skos__broader mesh__D010712smesh__D005994
% 212.26/212.42  |- mesh__dateCreated mesh__D010712 1999-01-01
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D010712 2005
% 212.26/212.42  |- skos__historyNote mesh__D010712 Phospholipids %28%1966-1974%29%
% 212.26/212.42  |- skos__hiddenLabel mesh__D010712 Acid, Phosphatidic
% 212.26/212.42  |- rdf__type mesh__D010712sskos__Concept
% 212.26/212.42  |- mesh__dateRevised mesh__D010712 2003-07-09
% 212.26/212.42  |- skos__scopeNote mesh__D010712
% 212.26/212.42       Fatty acid derivatives of glycerophosphates. They are composed of glycerol bound in ester linkage with 1 mole of phosphoric acid at the terminal 3-hydroxyl group and with 2 moles of fatty acids at the other two hydroxyl groups.%A%    
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D009969 1994
% 212.26/212.42  |- skos__scopeNote mesh__D009969
% 212.26/212.42       Wires of various dimensions and grades made of stainless steel or precious metal. They are used in orthodontic treatment.%A%    
% 212.26/212.42  |- mesh__dateCreated mesh__D009969 1981-02-24
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D009969 2005
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D009969 1995
% 212.26/212.42  |- skos__hiddenLabel mesh__D009969 Wires, Orthodontic
% 212.26/212.42  |- mesh__dateEstablished mesh__D009969 1991-01-01
% 212.26/212.42  |- mesh__recordOriginator mesh__D009969 RC
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D009969 2006
% 212.26/212.42  |- mesh__historyNote mesh__D009969
% 212.26/212.42       91%28%82%29%; was see under ORTHODONTIC APPLIANCES 1982-90   
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D009969 2003
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D009969 1998
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D009969 1993
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D009969 2000
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D009969 2004
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D009969 1999
% 212.26/212.42  |- skos__prefLabel mesh__D009969 Orthodontic Wires
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D009969 1996
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D009969 2001
% 212.26/212.42  |- skos__broader mesh__D009969smesh__D009967
% 212.26/212.42  |- skos__hiddenLabel mesh__D009969 Orthodontic Wire
% 212.26/212.42  |- mesh__dateRevised mesh__D009969 1992-05-15
% 212.26/212.42  |- mesh__recordMaintainer mesh__D009969 TAP
% 212.26/212.42  |- skos__historyNote mesh__D009969 Orthodontic Appliances %28%1966-1981%29%
% 212.26/212.42  |- skos__hiddenLabel mesh__D009969 Wire, Orthodontic
% 212.26/212.42  |- rdf__type mesh__D009969sskos__Concept
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D009969 1997
% 212.26/212.42  |- mesh__publicMeSHNote mesh__D009969
% 212.26/212.42       91; was see under ORTHODONTIC APPLIANCES 1982-90   
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D009969 2002
% 212.26/212.42  |- mesh__recordAuthorizer mesh__D009969 PLS
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D001986 2000
% 212.26/212.42  |- mesh__historyNote mesh__D001986 64%28%63%29%   
% 212.26/212.42  |- mesh__publicMeSHNote mesh__D001986 64   
% 212.26/212.42  |- skos__hiddenLabel mesh__D001986 Bronchospasms
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D001986 1998
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D001986 1995
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D001986 2006
% 212.26/212.42  |- mesh__dateEstablished mesh__D001986 1964-01-01
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D001986 2001
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D001986 1992
% 212.26/212.42  |- skos__prefLabel mesh__D001986 Bronchial Spasm
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D001986 1999
% 212.26/212.42  |- skos__hiddenLabel mesh__D001986 Bronchial Spasms
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D001986 2003
% 212.26/212.42  |- skos__scopeNote mesh__D001986
% 212.26/212.42       Spasmodic contraction of the smooth muscle of the bronchi.%A%    
% 212.26/212.42  |- skos__hiddenLabel mesh__D001986 Spasm, Bronchial
% 212.26/212.42  |- mesh__recordMaintainer mesh__D001986 TGC
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D001986 1996
% 212.26/212.42  |- skos__altLabel mesh__D001986 Bronchospasm
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D001986 1993
% 212.26/212.42  |- skos__broader mesh__D001986smesh__D001982
% 212.26/212.42  |- skos__hiddenLabel mesh__D001986 Spasms, Bronchial
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D001986 2004
% 212.26/212.42  |- mesh__dateCreated mesh__D001986 1999-01-01
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D001986 1997
% 212.26/212.42  |- mesh__dateRevised mesh__D001986 1991-06-13
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D001986 2002
% 212.26/212.42  |- mesh__recordOriginator mesh__D001986 NLM
% 212.26/212.42  |- mesh__recordAuthorizer mesh__D001986 PLS
% 212.26/212.42  |- rdf__type mesh__D001986sskos__Concept
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D001986 1994
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D001986 2005
% 212.26/212.42  |- skos__broader mesh__D034362smesh__D028083
% 212.26/212.42  |- skos__altLabel mesh__D034362 Witchweed
% 212.26/212.42  |- mesh__dateEstablished mesh__D034362 2003-01-01
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D034362 2004
% 212.26/212.42  |- mesh__dateCreated mesh__D034362 2002-07-03
% 212.26/212.42  |- rdf__type mesh__D034362sskos__Concept
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D034362 2003
% 212.26/212.42  |- mesh__historyNote mesh__D034362 2003   
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D034362 2006
% 212.26/212.42  |- mesh__publicMeSHNote mesh__D034362 2003   
% 212.26/212.42  |- skos__annotation mesh__D034362
% 212.26/212.42       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D034362 2005
% 212.26/212.42  |- skos__scopeNote mesh__D034362
% 212.26/212.42       A plant genus of the family SCROPHULARIACEAE that is parasitic on the roots of other plants. Members contain the flavones, apigenin and luteolin.%A%    
% 212.26/212.42  |- skos__prefLabel mesh__D034362 Striga
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D001188 2006
% 212.26/212.42  |- skos__hiddenLabel mesh__D001188 Artiodactylas
% 212.26/212.42  |- mesh__recordMaintainer mesh__D001188 ags
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D001188 2005
% 212.26/212.42  |- mesh__recordAuthorizer mesh__D001188 sjn
% 212.26/212.42  |- rdf__type mesh__D001188sskos__Concept
% 212.26/212.42  |- skos__prefLabel mesh__D001188 Artiodactyla
% 212.26/212.42  |- skos__annotation mesh__D001188
% 212.26/212.42       GEN or unspecified; prefer specifics; includes giraffe, hippopotamus, peccary; IM; qualif permitted%A%  
% 212.26/212.42  |- mesh__recordOriginator mesh__D001188 NLM
% 212.26/212.42  |- mesh__dateRevised mesh__D001188 2003-07-09
% 212.26/212.42  |- mesh__dateCreated mesh__D001188 1999-01-01
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D001188 2004
% 212.26/212.42  |- skos__broader mesh__D001188smesh__D008322
% 212.26/212.42  |- skos__historyNote mesh__D020342 Models, Theoretical %28%1969-1986%29%
% 212.26/212.42  |- skos__hiddenLabel mesh__D020342 Analyses, Finite Element
% 212.26/212.42  |- skos__broader mesh__D020342smesh__D008433
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D020342 2003
% 212.26/212.42  |- skos__scopeNote mesh__D020342
% 212.26/212.42       A computer based method of simulating or analyzing the behavior of structures or components.%A%    
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D020342 1999
% 212.26/212.42  |- skos__hiddenLabel mesh__D020342 Finite Element Analyses
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D020342 2004
% 212.26/212.42  |- mesh__dateEstablished mesh__D020342 1999-01-01
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D020342 2000
% 212.26/212.42  |- mesh__historyNote mesh__D020342 99   
% 212.26/212.42  |- skos__altLabel mesh__D020342 Analysis, Finite Element
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D020342 2001
% 212.26/212.42  |- skos__annotation mesh__D020342 DF: Finite Element Anal   
% 212.26/212.42  |- skos__hiddenLabel mesh__D020342 Element Analysis, Finite
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D020342 2005
% 212.26/212.42  |- skos__prefLabel mesh__D020342 Finite Element Analysis
% 212.26/212.42  |- mesh__dateCreated mesh__D020342 1998-06-12
% 212.26/212.42  |- skos__historyNote mesh__D020342 Computer Simulation %28%1987-1998%29%
% 212.26/212.42  |- skos__hiddenLabel mesh__D020342 Element Analyses, Finite
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D020342 2006
% 212.26/212.42  |- rdf__type mesh__D020342sskos__Concept
% 212.26/212.42  |- mesh__publicMeSHNote mesh__D020342 99   
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D020342 2002
% 212.26/212.42  |- mesh__publicMeSHNote mesh__D014305
% 212.26/212.42       98; see TRIOSEPHOSPHATE ISOMERASE 1991-97, see CARBOHYDRATE ISOMERASES 1975-90%A%  
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D014305 2005
% 212.26/212.42  |- skos__annotation mesh__D014305
% 212.26/212.42       /defic: consider also ANEMIA, HEMOLYTIC, CONGENITAL NONSPHEROCYTIC%A%  
% 212.26/212.42  |- skos__altLabel mesh__D014305 Triosephosphate Isomerase
% 212.26/212.42  |- skos__altLabel mesh__D014305 Phosphotriose Isomerase
% 212.26/212.42  |- mesh__dateEstablished mesh__D014305 1991-01-01
% 212.26/212.42  |- skos__historyNote mesh__D014305
% 212.26/212.42       Organophosphorus Compounds %28%1973-1974%29%
% 212.26/212.42  |- skos__hiddenLabel mesh__D014305 Isomerase, Triose-Phosphate
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D014305 2006
% 212.26/212.42  |- skos__hiddenLabel mesh__D014305 Isomerase, Triosephosphate
% 212.26/212.42  |- skos__related mesh__D014305smesh__D000746
% 212.26/212.42  |- mesh__recordOriginator mesh__D014305 NLM
% 212.26/212.42  |- mesh__recordAuthorizer mesh__D014305 sjn
% 212.26/212.42  |- skos__broader mesh__D014305smesh__D019747
% 212.26/212.42  |- skos__hiddenLabel mesh__D014305 Triose Phosphate Isomerase
% 212.26/212.42  |- skos__hiddenLabel mesh__D014305 Mutase, Triosephosphate
% 212.26/212.42  |- skos__hiddenLabel mesh__D014305 Isomerase, Phosphotriose
% 212.26/212.42  |- skos__historyNote mesh__D014305 Trioses %28%1973-1974%29%
% 212.26/212.42  |- mesh__dateRevised mesh__D014305 2003-07-09
% 212.26/212.42  |- rdf__type mesh__D014305sskos__Concept
% 212.26/212.42  |- mesh__dateCreated mesh__D014305 1974-11-27
% 212.26/212.42  |- skos__historyNote mesh__D014305
% 212.26/212.42       Carbohydrate Isomerases %28%1973-1974%29%
% 212.26/212.42  |- skos__altLabel mesh__D014305 Triosephosphate Mutase
% 212.26/212.42  |- skos__scopeNote mesh__D014305
% 212.26/212.42       An enzyme that catalyzes reversibly the conversion of D-glyceraldehyde 3-phosphate to dihydroxyacetone phosphate. A deficiency in humans causes nonspherocytic hemolytic disease %28%ANEMIA, HEMOLYTIC, CONGENITAL NONSPHEROCYTIC%29%. EC 5.3.1.1.%A%    
% 212.26/212.42  |- skos__prefLabel mesh__D014305 Triose-Phosphate Isomerase
% 212.26/212.42  |- mesh__recordMaintainer mesh__D014305 ssb
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D014305 2004
% 212.26/212.42  |- mesh__historyNote mesh__D014305 98%28%75%29%   
% 212.26/212.42  |- mesh__dateEstablished mesh__D019599 1998-01-01
% 212.26/212.42  |- skos__broader mesh__D019599smesh__D001369
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D019599 2006
% 212.26/212.42  |- skos__scopeNote mesh__D019599
% 212.26/212.42       Axons of certain cells in the dentate gyrus. They project to the polymorphic layer of the dentate gyrus and to the proximal dendrites of pyramidal cells of the hippocampus. These mossy fibers should not be confused with mossy fibers that are cerebellar afferents %28%see NERVE FIBERS%29%.%A%    
% 212.26/212.42  |- mesh__dateCreated mesh__D019599 1997-06-20
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D019599 2005
% 212.26/212.42  |- skos__historyNote mesh__D019599 Nerve Fibers %28%1978-1997%29%
% 212.26/212.42  |- rdf__type mesh__D019599sskos__Concept
% 212.26/212.42  |- skos__hiddenLabel mesh__D019599 Hippocampal Mossy Fiber
% 212.26/212.42  |- mesh__publicMeSHNote mesh__D019599 98   
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D019599 2002
% 212.26/212.42  |- skos__annotation mesh__D019599
% 212.26/212.42       axons in the dentate gyrus: do not confuse with MOSSY FIBERS, CEREBELLAR see NERVE FIBERS%A%  
% 212.26/212.42  |- skos__prefLabel mesh__D019599 Mossy Fibers, Hippocampal
% 212.26/212.42  |- skos__historyNote mesh__D019599 Hippocampus %28%1967-1997%29%
% 212.26/212.42  |- skos__broader mesh__D019599smesh__D018891
% 212.26/212.42  |- skos__hiddenLabel mesh__D019599 Mossy Fiber, Hippocampal
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D019599 2004
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D019599 2001
% 212.26/212.42  |- skos__broader mesh__D019599smesh__D017729
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D019599 2003
% 212.26/212.42  |- mesh__dateRevised mesh__D019599 2000-06-22
% 212.26/212.42  |- mesh__historyNote mesh__D019599 98   
% 212.26/212.42  |- skos__altLabel mesh__D019599 Hippocampal Mossy Fibers
% 212.26/212.42  |- mesh__historyNote mesh__D005579
% 212.26/212.42       82; was FUELS %28%Cat J heading only%29% 1966-81 %28%Prov 1966-67%29%%A%  
% 212.26/212.42  |- mesh__dateCreated mesh__D005579 1999-01-01
% 212.26/212.42  |- mesh__recordMaintainer mesh__D005579 JLS
% 212.26/212.42  |- mesh__dateEstablished mesh__D005579 1968-01-01
% 212.26/212.42  |- skos__broader mesh__D005579smesh__D004736
% 212.26/212.42  |- rdf__type mesh__D005579sskos__Concept
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D005579 2000
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D005579 2004
% 212.26/212.42  |- skos__hiddenLabel mesh__D005579 Fuel, Fossil
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D005579 2006
% 212.26/212.42  |- skos__prefLabel mesh__D005579 Fossil Fuels
% 212.26/212.42  |- skos__hiddenLabel mesh__D005579 Fossil Fuel
% 212.26/212.42  |- skos__hiddenLabel mesh__D005579 Natural Gas
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D005579 2003
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D005579 1999
% 212.26/212.42  |- mesh__publicMeSHNote mesh__D005579 82; was FUELS 1968-81   
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D005579 2005
% 212.26/212.42  |- mesh__onlineNote mesh__D005579
% 212.26/212.42       use FOSSIL FUELS to search FUELS 1966-81 %28%as Prov 1966-67%29%%A%  
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D005579 2002
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D005579 1998
% 212.26/212.42  |- skos__hiddenLabel mesh__D005579 Fuels, Fossil
% 212.26/212.42  |- mesh__recordOriginator mesh__D005579 NLM
% 212.26/212.42  |- mesh__dateRevised mesh__D005579 1997-06-20
% 212.26/212.42  |- mesh__recordAuthorizer mesh__D005579 SJN
% 212.26/212.42  |- skos__scopeNote mesh__D005579
% 212.26/212.42       Any hydrocarbon deposit that may be used for fuel. Examples are petroleum, coal, and natural gas.%A%    
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D005579 2001
% 212.26/212.42  |- skos__broader mesh__D002281smesh__D002277
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D002281 2000
% 212.26/212.42  |- mesh__recordOriginator mesh__D002281 NLM
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D002281 1999
% 212.26/212.42  |- skos__prefLabel mesh__D002281 Carcinoma, Basosquamous
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D002281 1997
% 212.26/212.42  |- mesh__recordAuthorizer mesh__D002281 PLS
% 212.26/212.42  |- mesh__recordMaintainer mesh__D002281 KEV
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D002281 1998
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D002281 2006
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D002281 1996
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D002281 2002
% 212.26/212.42  |- skos__hiddenLabel mesh__D002281 Basosquamous Carcinomas
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D002281 2004
% 212.26/212.42  |- skos__hiddenLabel mesh__D002281 Carcinomas, Basosquamous
% 212.26/212.42  |- mesh__dateRevised mesh__D002281 1995-06-08
% 212.26/212.42  |- skos__scopeNote mesh__D002281
% 212.26/212.42       A skin carcinoma that histologically exhibits both basal and squamous elements. %28%From Dorland, 27th ed%29%%A%    
% 212.26/212.42  |- skos__annotation mesh__D002281
% 212.26/212.42       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with probably SKIN NEOPLASMS %28%IM%29%%A%  
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D002281 2005
% 212.26/212.42  |- skos__broader mesh__D002281smesh__D018295
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D002281 2003
% 212.26/212.42  |- rdf__type mesh__D002281sskos__Concept
% 212.26/212.42  |- skos__hiddenLabel mesh__D002281 Basosquamous Carcinoma
% 212.26/212.42  |- mesh__activeMeSHYear mesh__D002281 2001
% 212.26/212.42  |- mesh__dateCreated mesh__D002281 1999-01-01
% 212.26/212.42  |- skos__scopeNote mesh__D010713
% 212.26/212.42       Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to a choline moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and choline and 2 moles of fatty acids.%A%    
% 212.26/212.42  |- skos__broader mesh__D010713smesh__D020404
% 212.28/212.42  |- skos__altLabel mesh__D010713 Lecithins
% 212.28/212.42  |- mesh__activeMeSHYear mesh__D010713 2004
% 212.28/212.42  |- mesh__dateCreated mesh__D010713 1999-01-01
% 212.28/212.42  |- mesh__activeMeSHYear mesh__D010713 2005
% 212.28/212.42  |- skos__altLabel mesh__D010713 Choline Glycerophospholipids
% 212.28/212.42  |- mesh__activeMeSHYear mesh__D010713 2006
% 212.28/212.42  |- skos__prefLabel mesh__D010713 Phosphatidylcholines
% 212.28/212.42  |- skos__altLabel mesh__D010713 Lecithin
% 212.28/212.42  |- mesh__recordMaintainer mesh__D010713 ssb
% 212.28/212.42  |- skos__hiddenLabel mesh__D010713 Phosphoglycerides, Choline
% 212.28/212.42  |- mesh__historyNote mesh__D010713
% 212.28/212.42       77; was PHOSPHATIDYL CHOLINE see under LECITHINS 1963-76; LECITHINS was heading 1963-76%A%  
% 212.28/212.42  |- skos__altLabel mesh__D010713 Phosphatidylcholine
% 212.28/212.42  |- mesh__recordAuthorizer mesh__D010713 sjn
% 212.28/212.42  |- skos__hiddenLabel mesh__D010713 Glycerophospholipids, Choline
% 212.28/212.42  |- mesh__recordOriginator mesh__D010713 NLM
% 212.28/212.42  |- rdf__type mesh__D010713sskos__Concept
% 212.28/212.42  |- skos__altLabel mesh__D010713 Choline Phosphoglycerides
% 212.28/212.42  |- mesh__onlineNote mesh__D010713
% 212.28/212.42       use PHOSPHATIDYLCHOLINES to search PHOSPHATIDYL CHOLINE %26% LECITHINS 1966-76%A%  
% 212.28/212.42  |- mesh__publicMeSHNote mesh__D010713
% 212.28/212.42       77; was PHOSPHATIDYL CHOLINE see under LECITHINS 1963-76; LECITHINS was heading 1963-76%A%  
% 212.28/212.42  |- mesh__dateEstablished mesh__D010713 1977-01-01
% 212.28/212.42  |- skos__annotation mesh__D010713 /biosyn /physiol permitted   
% 212.28/212.42  |- mesh__dateRevised mesh__D010713 2003-07-09
% 212.28/212.42  |- mesh__activeMeSHYear mesh__D001987 2006
% 212.28/212.42  |- mesh__recordAuthorizer mesh__D001987 PLS
% 212.28/212.42  |- mesh__activeMeSHYear mesh__D001987 1999
% 212.28/212.42  |- mesh__activeMeSHYear mesh__D001987 2003
% 212.28/212.42  |- skos__annotation mesh__D001987 bronchial dilatation   
% 212.28/212.42  |- mesh__recordMaintainer mesh__D001987 TGC
% 212.28/212.42  |- mesh__activeMeSHYear mesh__D001987 1996
% 212.28/212.42  |- mesh__activeMeSHYear mesh__D001987 2000
% 212.28/212.42  |- skos__hiddenLabel mesh__D001987 Bronchiectases
% 212.28/212.42  |- skos__broader mesh__D001987smesh__D001982
% 212.28/212.42  |- mesh__activeMeSHYear mesh__D001987 2004
% 212.28/212.42  |- mesh__dateCreated mesh__D001987 1999-01-01
% 212.28/212.42  |- mesh__activeMeSHYear mesh__D001987 1997
% 212.28/212.42  |- mesh__activeMeSHYear mesh__D001987 2001
% 212.28/212.42  |- skos__prefLabel mesh__D001987 Bronchiectasis
% 212.28/212.42  |- mesh__dateRevised mesh__D001987 1993-05-25
% 212.28/212.42  |- rdf__type mesh__D001987sskos__Concept
% 212.28/212.42  |- mesh__activeMeSHYear mesh__D001987 1994
% 212.28/212.42  |- mesh__activeMeSHYear mesh__D001987 2005
% 212.28/212.42  |- mesh__activeMeSHYear mesh__D001987 2002
% 212.28/212.42  |- mesh__activeMeSHYear mesh__D001987 1998
% 212.28/212.42  |- skos__scopeNote mesh__D001987
% 212.28/212.42       Persistent abnormal dilatation of the bronchi.     
% 212.28/212.42  |- mesh__recordOriginator mesh__D001987 NLM
% 212.28/212.42  |- mesh__activeMeSHYear mesh__D001987 1995
% 212.28/212.42  |- mesh__recordAuthorizer mesh__D034363 sjn
% 212.28/212.42  |- skos__altLabel mesh__D034363 Streptococcus Viridans Group
% 212.28/212.42  |- skos__scopeNote mesh__D034363
% 212.28/212.42       A large heterogeneous group of mostly alpha-hemolytic streptococci. They colonize the respiratory tract at birth and generally have a low degree of pathogenicity. This group of species includes STREPTOCOCCUS MITIS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS SANGUIS; STREPTOCOCCUS SOBRINUS; and the STREPTOCOCCUS MILLERI GROUP. The latter are often beta-hemolytic and commonly produce invasive pyogenic infections including brain and abdominal abscesses.%A%    
% 212.28/212.42  |- rdf__type mesh__D034363sskos__Concept
% 212.28/212.42  |- skos__broader mesh__D034363smesh__D013291
% 212.28/212.42  |- mesh__recordOriginator mesh__D034363 ags
% 212.28/212.43  |- skos__historyNote mesh__D034363 Streptococcus %28%1967-2002%29%
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D034363 2006
% 212.28/212.43  |- mesh__dateEstablished mesh__D034363 2003-01-01
% 212.28/212.43  |- mesh__publicMeSHNote mesh__D034363 2003   
% 212.28/212.43  |- mesh__recordMaintainer mesh__D034363 SYSTEM
% 212.28/212.43  |- mesh__dateCreated mesh__D034363 2002-07-03
% 212.28/212.43  |- skos__annotation mesh__D034363
% 212.28/212.43       infection: coord IM with STREPTOCOCCAL INFECTIONS %28%IM%29%   
% 212.28/212.43  |- skos__prefLabel mesh__D034363 Viridans Streptococci
% 212.28/212.43  |- mesh__dateRevised mesh__D034363 2005-06-30
% 212.28/212.43  |- mesh__historyNote mesh__D034363 2003   
% 212.28/212.43  |- skos__broader mesh__D013710Q000293smesh__D013710
% 212.28/212.43  |- mesh__preferredCombination mesh__D013710Q000293smesh__D013708
% 212.28/212.43  |- rdf__type mesh__D013710Q000293smesh__CompoundConcept
% 212.28/212.43  |- mesh__dateRevised mesh__D001189 2004-07-07
% 212.28/212.43  |- skos__hiddenLabel mesh__D001189 Monooxygenases, Microsomal
% 212.28/212.43  |- mesh__publicMeSHNote mesh__D001189 75   
% 212.28/212.43  |- skos__prefLabel mesh__D001189 Aryl Hydrocarbon Hydroxylases
% 212.28/212.43  |- skos__hiddenLabel mesh__D001189 Hydroxylases, Aryl Hydrocarbon
% 212.28/212.43  |- skos__altLabel mesh__D001189 Microsomal Monooxygenases
% 212.28/212.43  |- skos__historyNote mesh__D001189 Hydroxylases %28%1971-1974%29%
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001189 2006
% 212.28/212.43  |- mesh__historyNote mesh__D001189 75   
% 212.28/212.43  |- skos__scopeNote mesh__D001189
% 212.28/212.43       A large group of cytochrome P-450 %28%heme-thiolate%29% monooxygenases that complex with NAD%28%P%29%H-FLAVIN OXIDOREDUCTASE in numerous mixed-function oxidations of aromatic compounds. They catalyze hydroxylation of a broad spectrum of substrates and are important in the metabolism of steroids, drugs, and toxins such as PHENOBARBITAL, carcinogens, and insecticides.%A%    
% 212.28/212.43  |- skos__historyNote mesh__D001189 Polycyclic Hydrocarbons %28%1974%29%
% 212.28/212.43  |- mesh__dateCreated mesh__D001189 1974-11-11
% 212.28/212.43  |- mesh__recordAuthorizer mesh__D001189 sjn
% 212.28/212.43  |- skos__broader mesh__D001189smesh__D003577
% 212.28/212.43  |- skos__hiddenLabel mesh__D001189 Monooxygenases, Xenobiotic
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001189 2005
% 212.28/212.43  |- mesh__recordOriginator mesh__D001189 NLM
% 212.28/212.43  |- mesh__dateEstablished mesh__D001189 1975-09-01
% 212.28/212.43  |- mesh__recordMaintainer mesh__D001189 ssb
% 212.28/212.43  |- rdf__type mesh__D001189sskos__Concept
% 212.28/212.43  |- skos__historyNote mesh__D020343
% 212.28/212.43       Hypertension/complications %28%1966-1999%29%
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D020343 2006
% 212.28/212.43  |- mesh__recordAuthorizer mesh__D020343 sjn
% 212.28/212.43  |- mesh__dateRevised mesh__D020343 2004-07-07
% 212.28/212.43  |- mesh__recordMaintainer mesh__D020343 lkt
% 212.28/212.43  |- skos__altLabel mesh__D020343 Encephalopathy, Hypertensive
% 212.28/212.43  |- mesh__historyNote mesh__D020343 2000   
% 212.28/212.43  |- skos__broader mesh__D020343smesh__D019586
% 212.28/212.43  |- mesh__dateCreated mesh__D020343 1999-11-03
% 212.28/212.43  |- mesh__publicMeSHNote mesh__D020343 2000   
% 212.28/212.43  |- mesh__recordOriginator mesh__D020343 KEV
% 212.28/212.43  |- rdf__type mesh__D020343sskos__Concept
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D020343 2005
% 212.28/212.43  |- skos__related mesh__D020343smesh__D006974
% 212.28/212.43  |- skos__prefLabel mesh__D020343 Hypertensive Encephalopathy
% 212.28/212.43  |- skos__scopeNote mesh__D020343
% 212.28/212.43       Brain dysfunction or damage resulting from sustained MALIGNANT HYPERTENSION. When BLOOD PRESSURE exceeds the limits of cerebral autoregulation, cerebral blood flow is impaired %28%BRAIN ISCHEMIA%29%. Clinical manifestations include HEADACHE; NAUSEA; VOMITING; SEIZURES; altered mental status %28%in some cases progressing to COMA%29%; PAPILLEDEMA; and RETINAL HEMORRHAGE.%A%    
% 212.28/212.43  |- mesh__dateEstablished mesh__D020343 2000-01-01
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D014306 2006
% 212.28/212.43  |- skos__annotation mesh__D014306 monosaccharides   
% 212.28/212.43  |- mesh__dateRevised mesh__D014306 2004-07-07
% 212.28/212.43  |- mesh__dateCreated mesh__D014306 1999-01-01
% 212.28/212.43  |- rdf__type mesh__D014306sskos__Concept
% 212.28/212.43  |- skos__broader mesh__D014306smesh__D009005
% 212.28/212.43  |- mesh__recordOriginator mesh__D014306 NLM
% 212.28/212.43  |- mesh__recordAuthorizer mesh__D014306 sjn
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D014306 2005
% 212.28/212.43  |- skos__prefLabel mesh__D014306 Trioses
% 212.28/212.43  |- mesh__recordMaintainer mesh__D014306 ssb
% 212.28/212.43  |- skos__hiddenLabel mesh__D002282 Bronchiolo-Alveolar Adenocarcinomas
% 212.28/212.43  |- mesh__dateRevised mesh__D002282 1995-06-08
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002282 1999
% 212.28/212.43  |- skos__altLabel mesh__D002282 Adenocarcinoma, Alveolar
% 212.28/212.43  |- skos__annotation mesh__D002282
% 212.28/212.43       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with LUNG NEOPLASMS %28%IM%29%%A%  
% 212.28/212.43  |- skos__hiddenLabel mesh__D002282 Bronchiolo-Alveolar Adenocarcinoma
% 212.28/212.43  |- mesh__recordOriginator mesh__D002282 NLM
% 212.28/212.43  |- skos__hiddenLabel mesh__D002282 Alveolar Adenocarcinoma
% 212.28/212.43  |- rdf__type mesh__D002282sskos__Concept
% 212.28/212.43  |- skos__hiddenLabel mesh__D002282 Bronchiolo-Alveolar Carcinoma
% 212.28/212.43  |- skos__altLabel mesh__D002282 Carcinoma, Bronchiolar
% 212.28/212.43  |- skos__hiddenLabel mesh__D002282 Carcinomas, Alveolar
% 212.28/212.43  |- skos__hiddenLabel mesh__D002282 Carcinomas, Bronchiolar
% 212.28/212.43  |- skos__altLabel mesh__D002282 Carcinoma, Alveolar
% 212.28/212.43  |- mesh__publicMeSHNote mesh__D002282
% 212.28/212.43       94; was CARCINOMA, BRONCHIOLAR 1963-93   
% 212.28/212.43  |- skos__hiddenLabel mesh__D002282 Bronchioloalveolar Carcinomas
% 212.28/212.43  |- skos__hiddenLabel mesh__D002282 Bronchiolo-Alveolar Carcinomas
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002282 2002
% 212.28/212.43  |- skos__hiddenLabel mesh__D002282 Carcinoma, Bronchiolo Alveolar
% 212.28/212.43  |- mesh__onlineNote mesh__D002282
% 212.28/212.43       use ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR to search CARCINOMA, BRONCHIOLAR 1966-93%A%  
% 212.28/212.43  |- skos__hiddenLabel mesh__D002282 Bronchiolar Carcinomas
% 212.28/212.43  |- skos__hiddenLabel mesh__D002282 Carcinomas, Bronchioloalveolar
% 212.28/212.43  |- skos__hiddenLabel mesh__D002282 Alveolar Adenocarcinomas
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002282 2003
% 212.28/212.43  |- skos__altLabel mesh__D002282 Carcinoma, Bronchiolo-Alveolar
% 212.28/212.43  |- mesh__recordMaintainer mesh__D002282 KEV
% 212.28/212.43  |- mesh__dateCreated mesh__D002282 1999-01-01
% 212.28/212.43  |- skos__hiddenLabel mesh__D002282 Adenocarcinomas, Alveolar
% 212.28/212.43  |- skos__hiddenLabel mesh__D002282 Bronchiolar Carcinoma
% 212.28/212.43  |- skos__hiddenLabel mesh__D002282 Alveolar Carcinoma
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002282 2004
% 212.28/212.43  |- skos__altLabel mesh__D002282 Carcinoma, Bronchioloalveolar
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002282 1996
% 212.28/212.43  |- mesh__historyNote mesh__D002282
% 212.28/212.43       94; was CARCINOMA, BRONCHIOLAR 1963-93   
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002282 2005
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002282 2000
% 212.28/212.43  |- mesh__recordAuthorizer mesh__D002282 PLS
% 212.28/212.43  |- skos__broader mesh__D002282smesh__D000230
% 212.28/212.43  |- skos__scopeNote mesh__D002282
% 212.28/212.43       A carcinoma thought to be derived from epithelium of terminal bronchioles, in which the neoplastic tissue extends along the alveolar walls and grows in small masses within the alveoli. Involvement may be uniformly diffuse and massive, or nodular, or lobular. The neoplastic cells are cuboidal or columnar and form papillary structures. Mucin may be demonstrated in some of the cells and in the material in the alveoli, which also includes denuded cells. Metastases in regional lymph nodes, and in even more distant sites, are known to occur, but are infrequent. %28%From Stedman, 25th ed%29%%A%    
% 212.28/212.43  |- skos__prefLabel mesh__D002282 Adenocarcinoma, Bronchiolo-Alveolar
% 212.28/212.43  |- skos__hiddenLabel mesh__D002282 Bronchioloalveolar Carcinoma
% 212.28/212.43  |- skos__hiddenLabel mesh__D002282 Carcinomas, Bronchiolo-Alveolar
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002282 1997
% 212.28/212.43  |- skos__hiddenLabel mesh__D002282 Adenocarcinomas, Bronchiolo-Alveolar
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002282 2006
% 212.28/212.43  |- skos__hiddenLabel mesh__D002282 Alveolar Carcinomas
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002282 1998
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002282 2001
% 212.28/212.43  |- skos__hiddenLabel mesh__D002282 Adenocarcinoma, Bronchiolo Alveolar
% 212.28/212.43  |- mesh__historyNote mesh__D010714
% 212.28/212.43       77; was PHOSPHATIDYL ETHANOLAMINE see under CEPHALINS 1963-76; CEPHALINS was heading 1963-76%A%  
% 212.28/212.43  |- mesh__dateEstablished mesh__D010714 1977-01-01
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D010714 2006
% 212.28/212.43  |- skos__altLabel mesh__D010714 Cephalins
% 212.28/212.43  |- skos__altLabel mesh__D010714 Ethanolamineglycerophospholipids
% 212.28/212.43  |- skos__broader mesh__D010714smesh__D020404
% 212.28/212.43  |- skos__hiddenLabel mesh__D010714 Phosphoglycerides, Ethanolamine
% 212.28/212.43  |- rdf__type mesh__D010714sskos__Concept
% 212.28/212.43  |- mesh__recordMaintainer mesh__D010714 ssb
% 212.28/212.43  |- mesh__onlineNote mesh__D010714
% 212.28/212.43       use PHOSPHATIDYLETHANOLAMINES to search PHOSPHATIDYL ETHANOLAMINE %26% CEPHALINS 1966-76%A%  
% 212.28/212.43  |- skos__annotation mesh__D010714 /biosyn /physiol permitted   
% 212.28/212.43  |- mesh__dateRevised mesh__D010714 2003-07-09
% 212.28/212.43  |- skos__altLabel mesh__D010714 Ethanolamine Phosphoglycerides
% 212.28/212.43  |- mesh__recordAuthorizer mesh__D010714 sjn
% 212.28/212.43  |- skos__prefLabel mesh__D010714 Phosphatidylethanolamines
% 212.28/212.43  |- skos__scopeNote mesh__D010714
% 212.28/212.43       Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to an ethanolamine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and ethanolamine and 2 moles of fatty acids.%A%    
% 212.28/212.43  |- mesh__publicMeSHNote mesh__D010714
% 212.28/212.43       77; was PHOSPHATIDYL ETHANOLAMINE see under CEPHALINS 1963-76; CEPHALINS was heading 1963-76%A%  
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D010714 2004
% 212.28/212.43  |- mesh__dateCreated mesh__D010714 1999-01-01
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D010714 2005
% 212.28/212.43  |- mesh__recordOriginator mesh__D010714 NLM
% 212.28/212.43  |- mesh__dateEstablished mesh__D001988 1988-01-01
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001988 2001
% 212.28/212.43  |- skos__scopeNote mesh__D001988 Inflammation of the bronchioles.     
% 212.28/212.43  |- skos__broader mesh__D001988smesh__D001991
% 212.28/212.43  |- mesh__dateCreated mesh__D001988 1987-03-27
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001988 1995
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001988 2006
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001988 1993
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001988 2000
% 212.28/212.43  |- skos__historyNote mesh__D001988 Bronchopneumonia %28%1966-1987%29%
% 212.28/212.43  |- mesh__recordMaintainer mesh__D001988 PLS
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001988 2004
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001988 1999
% 212.28/212.43  |- mesh__historyNote mesh__D001988 88; 64-66 %28%Prov%29%   
% 212.28/212.43  |- skos__hiddenLabel mesh__D001988 Bronchiolitides
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001988 1994
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001988 1997
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001988 1992
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001988 2005
% 212.28/212.43  |- mesh__onlineNote mesh__D001988
% 212.28/212.43       search BRONCHIOLITIS, VIRAL 1966 %28%as Prov%29%   
% 212.28/212.43  |- mesh__recordOriginator mesh__D001988 SCD
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001988 1998
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001988 2003
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001988 1991
% 212.28/212.43  |- mesh__dateRevised mesh__D001988 1990-05-29
% 212.28/212.43  |- skos__annotation mesh__D001988 GEN or unspecified; prefer specifics   
% 212.28/212.43  |- skos__prefLabel mesh__D001988 Bronchiolitis
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001988 1996
% 212.28/212.43  |- skos__historyNote mesh__D001988 Bronchitis %28%1966-1987%29%
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001988 2002
% 212.28/212.43  |- mesh__publicMeSHNote mesh__D001988 88   
% 212.28/212.43  |- rdf__type mesh__D001988sskos__Concept
% 212.28/212.43  |- skos__historyNote mesh__D001988 Bronchiolitis, Viral %28%1966-1987%29%
% 212.28/212.43  |- mesh__recordAuthorizer mesh__D001988 NLM
% 212.28/212.43  |- mesh__publicMeSHNote mesh__D034364 2003   
% 212.28/212.43  |- mesh__dateRevised mesh__D034364 2005-06-30
% 212.28/212.43  |- mesh__historyNote mesh__D034364 2003   
% 212.28/212.43  |- skos__historyNote mesh__D034364 Streptococcus %28%1978-2002%29%
% 212.28/212.43  |- skos__prefLabel mesh__D034364 Streptococcus milleri Group
% 212.28/212.43  |- skos__broader mesh__D034364smesh__D034363
% 212.28/212.43  |- mesh__recordMaintainer mesh__D034364 SYSTEM
% 212.28/212.43  |- skos__annotation mesh__D034364
% 212.28/212.43       infection: coord IM with STREPTOCOCCAL INFECTIONS %28%IM%29%   
% 212.28/212.43  |- mesh__recordAuthorizer mesh__D034364 sjn
% 212.28/212.43  |- mesh__dateEstablished mesh__D034364 2003-01-01
% 212.28/212.43  |- rdf__type mesh__D034364sskos__Concept
% 212.28/212.43  |- mesh__recordOriginator mesh__D034364 ags
% 212.28/212.43  |- skos__scopeNote mesh__D034364
% 212.28/212.43       A subset of VIRIDANS STREPTOCOCCI, but the species in this group differ in their hemolytic pattern and diseases caused. These species are often beta-hemolytic and produce pyogenic infections.%A%    
% 212.28/212.43  |- mesh__dateCreated mesh__D034364 2002-07-03
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D034364 2006
% 212.28/212.43  |- skos__hiddenLabel mesh__D014307 NSC71047
% 212.28/212.43  |- mesh__dateCreated mesh__D014307 1974-11-19
% 212.28/212.43  |- skos__altLabel mesh__D014307 Trioxisalenum
% 212.28/212.43  |- skos__historyNote mesh__D014307 Coumarins %28%1966-1974%29%
% 212.28/212.43  |- skos__altLabel mesh__D014307 ICN Brand of Trioxsalen
% 212.28/212.43  |- skos__historyNote mesh__D014307 Furans %28%1966-1974%29%
% 212.28/212.43  |- skos__broader mesh__D014307smesh__D011564
% 212.28/212.43  |- mesh__recordMaintainer mesh__D014307 ssb
% 212.28/212.43  |- mesh__historyNote mesh__D014307
% 212.28/212.43       91%28%75%29%; was see under PSORALENS 1979-90; was see under COUMARINS 1975-78; TRIOXISALENUM was see TRIOXSALEN 1975-92%A%  
% 212.28/212.43  |- skos__hiddenLabel mesh__D014307 NSC 71047
% 212.28/212.43  |- skos__altLabel mesh__D014307 4,5%27%,8-Trimethylpsoralen
% 212.28/212.43  |- skos__altLabel mesh__D014307
% 212.28/212.43       2,5,9-Trimethyl-7H-furo%28%3,2-g%29%benzopyran-7-one
% 212.28/212.43  |- mesh__onlineNote mesh__D014307
% 212.28/212.43       use TRIOXSALEN to search TRIOXISALENUM 1982-92   
% 212.28/212.43  |- skos__prefLabel mesh__D014307 Trioxsalen
% 212.28/212.43  |- skos__altLabel mesh__D014307 Trioxysalen
% 212.28/212.43  |- skos__scopeNote mesh__D014307
% 212.28/212.43       Pigmenting photosensitizing agent obtained from several plants, mainly Psoralea corylifolia. It is administered either topically or orally in conjunction with ultraviolet light in the treatment of vitiligo.%A%    
% 212.28/212.43  |- mesh__publicMeSHNote mesh__D014307
% 212.28/212.43       91; was see under PSORALENS 1979-90; was see under COUMARINS 1975-78; TRIOXISALENUM was see TRIOXSALEN 1975-92%A%  
% 212.28/212.43  |- mesh__dateRevised mesh__D014307 2005-06-30
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D014307 2006
% 212.28/212.43  |- mesh__dateEstablished mesh__D014307 1991-01-01
% 212.28/212.43  |- mesh__recordOriginator mesh__D014307 NLM
% 212.28/212.43  |- rdf__type mesh__D014307sskos__Concept
% 212.28/212.43  |- mesh__recordAuthorizer mesh__D014307 sjn
% 212.28/212.43  |- mesh__dateRevised mesh__D002283 1995-06-08
% 212.28/212.43  |- skos__hiddenLabel mesh__D002283 Bronchogenic Carcinomas
% 212.28/212.43  |- skos__annotation mesh__D002283
% 212.28/212.43       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with LUNG NEOPLASMS %28%IM%29%, not BRONCHIAL NEOPLASMS; do not confuse X ref CARCINOMA, BRONCHIAL with BRONCHIAL NEOPLASMS%A%  
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002283 2005
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002283 2002
% 212.28/212.43  |- skos__hiddenLabel mesh__D002283 Bronchogenic Carcinoma
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002283 2003
% 212.28/212.43  |- rdf__type mesh__D002283sskos__Concept
% 212.28/212.43  |- skos__altLabel mesh__D002283 Carcinoma, Bronchial
% 212.28/212.43  |- skos__hiddenLabel mesh__D002283 Carcinomas, Bronchogenic
% 212.28/212.43  |- skos__hiddenLabel mesh__D002283 Carcinomas, Bronchial
% 212.28/212.43  |- skos__broader mesh__D002283smesh__D008175
% 212.28/212.43  |- skos__hiddenLabel mesh__D002283 Bronchial Carcinoma
% 212.28/212.43  |- mesh__dateCreated mesh__D002283 1999-01-01
% 212.28/212.43  |- skos__prefLabel mesh__D002283 Carcinoma, Bronchogenic
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002283 2001
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002283 1999
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002283 2000
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002283 1997
% 212.28/212.43  |- mesh__recordOriginator mesh__D002283 NLM
% 212.28/212.43  |- mesh__recordMaintainer mesh__D002283 KEV
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002283 1998
% 212.28/212.43  |- skos__scopeNote mesh__D002283
% 212.28/212.43       A cancer of the lung, so-called because it arises from the epithelium of the bronchial tree. It is not a histologic designation despite the name.%A%    
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002283 2006
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002283 1996
% 212.28/212.43  |- mesh__recordAuthorizer mesh__D002283 PLS
% 212.28/212.43  |- skos__hiddenLabel mesh__D002283 Bronchial Carcinomas
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D002283 2004
% 212.28/212.43  |- mesh__recordMaintainer mesh__D010715 ssb
% 212.28/212.43  |- mesh__recordAuthorizer mesh__D010715 sjn
% 212.28/212.43  |- mesh__dateRevised mesh__D010715 2003-07-09
% 212.28/212.43  |- rdf__type mesh__D010715sskos__Concept
% 212.28/212.43  |- mesh__dateEstablished mesh__D010715 1977-01-01
% 212.28/212.43  |- skos__historyNote mesh__D010715 Glycerophosphates %28%1972-1974%29%
% 212.28/212.43  |- mesh__onlineNote mesh__D010715
% 212.28/212.43       use PHOSPHATIDYLGLYCEROLS to search PHOSPHATIDYL GLYCEROL 1975-76%A%  
% 212.28/212.43  |- mesh__recordOriginator mesh__D010715 NLM
% 212.28/212.43  |- skos__hiddenLabel mesh__D010715 Glycerol, Phosphatidyl
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D010715 2005
% 212.28/212.43  |- mesh__dateCreated mesh__D010715 1974-11-19
% 212.28/212.43  |- skos__annotation mesh__D010715 /biosyn /physiol permitted   
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D010715 2004
% 212.28/212.43  |- skos__historyNote mesh__D010715 Phospholipids %28%1966-1974%29%
% 212.28/212.43  |- mesh__publicMeSHNote mesh__D010715
% 212.28/212.43       77; was PHOSPHATIDYL GLYCEROL see under PHOSPHOLIPIDS 1975-76%A%  
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D010715 2006
% 212.28/212.43  |- skos__scopeNote mesh__D010715
% 212.28/212.43       A nitrogen-free class of lipids present in animal and particularly plant tissues and composed of one mole of glycerol and 1 or 2 moles of phosphatidic acid. Members of this group differ from one another in the nature of the fatty acids released on hydrolysis.%A%    
% 212.28/212.43  |- skos__hiddenLabel mesh__D010715 Phosphoglycerides, Glycerol
% 212.28/212.43  |- skos__altLabel mesh__D010715 Glycerol Phosphoglycerides
% 212.28/212.43  |- skos__broader mesh__D010715smesh__D020404
% 212.28/212.43  |- skos__prefLabel mesh__D010715 Phosphatidylglycerols
% 212.28/212.43  |- mesh__historyNote mesh__D010715
% 212.28/212.43       77; was PHOSPHATIDYL GLYCEROL see under PHOSPHOLIPIDS 1975-76%A%  
% 212.28/212.43  |- mesh__dateCreated mesh__D015400 1988-06-06
% 212.28/212.43  |- mesh__recordOriginator mesh__D015400 EJB
% 212.28/212.43  |- skos__altLabel mesh__D015400 Research, Clinical Nursing
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D015400 2003
% 212.28/212.43  |- skos__historyNote mesh__D015400 Research %28%1966-1988%29%
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D015400 2005
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D015400 2004
% 212.28/212.43  |- skos__historyNote mesh__D015400
% 212.28/212.43       Nursing or specific nursing %28%1966-1988%29%
% 212.28/212.43  |- skos__scopeNote mesh__D015400
% 212.28/212.43       Research carried out by nurses in the clinical setting and designed to provide information that will help improve patient care. Other professional staff may also participate in the research.%A%    
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D015400 2006
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D015400 2000
% 212.28/212.43  |- mesh__recordAuthorizer mesh__D015400 sjn
% 212.28/212.43  |- skos__altLabel mesh__D015400 Research, Nursing Clinical
% 212.28/212.43  |- mesh__recordMaintainer mesh__D015400 kle
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D015400 2001
% 212.28/212.43  |- mesh__publicMeSHNote mesh__D015400
% 212.28/212.43       91; was see under NURSING RESEARCH 1989-90   
% 212.28/212.43  |- mesh__dateEstablished mesh__D015400 1991-01-01
% 212.28/212.43  |- skos__altLabel mesh__D015400 Clinical Practice Nursing Research
% 212.28/212.43  |- skos__altLabel mesh__D015400 Nursing Clinical Research
% 212.28/212.43  |- skos__prefLabel mesh__D015400 Clinical Nursing Research
% 212.28/212.43  |- skos__altLabel mesh__D015400 Clinical Research, Nursing
% 212.28/212.43  |- skos__annotation mesh__D015400
% 212.28/212.43       SPEC: SPEC qualif; DF: CLIN NURS RESEARCH   
% 212.28/212.43  |- skos__altLabel mesh__D015400 Nursing Research, Clinical
% 212.28/212.43  |- rdf__type mesh__D015400sskos__Concept
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D015400 2002
% 212.28/212.43  |- mesh__dateRevised mesh__D015400 1999-11-03
% 212.28/212.43  |- mesh__historyNote mesh__D015400
% 212.28/212.43       91%28%89%29%; was see under NURSING RESEARCH 1989-90   
% 212.28/212.43  |- skos__broader mesh__D015400smesh__D015399
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001989 2006
% 212.28/212.43  |- skos__historyNote mesh__D001989 Bronchopneumonia %28%1966-1987%29%
% 212.28/212.43  |- skos__hiddenLabel mesh__D001989 Exudative Bronchiolitides
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001989 1999
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001989 2004
% 212.28/212.43  |- skos__broader mesh__D001989smesh__D001988
% 212.28/212.43  |- skos__scopeNote mesh__D001989
% 212.28/212.43       Inflammation of the bronchioles with obstruction by fibrous granulation tissue or bronchial exudate. It may follow inhalation of irritating gases or foreign bodies and it complicates pneumonia.%A%    
% 212.28/212.43  |- skos__hiddenLabel mesh__D001989 Proliferative Bronchiolitides
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001989 1994
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001989 1997
% 212.28/212.43  |- skos__historyNote mesh__D001989 Bronchial Diseases %28%1966-1987%29%
% 212.28/212.43  |- skos__hiddenLabel mesh__D001989 Bronchiolitides, Proliferative
% 212.28/212.43  |- mesh__recordAuthorizer mesh__D001989 PLS
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001989 2005
% 212.28/212.43  |- mesh__dateEstablished mesh__D001989 1988-01-01
% 212.28/212.43  |- mesh__recordOriginator mesh__D001989 SCD
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001989 2001
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001989 1998
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001989 2003
% 212.28/212.43  |- mesh__historyNote mesh__D001989 88   
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001989 1996
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001989 2000
% 212.28/212.43  |- skos__historyNote mesh__D001989 Bronchitis %28%1966-1987%29%
% 212.28/212.43  |- skos__hiddenLabel mesh__D001989 Exudative Bronchiolitis
% 212.28/212.43  |- skos__hiddenLabel mesh__D001989 Bronchiolitides, Exudative
% 212.28/212.43  |- skos__altLabel mesh__D001989 Bronchiolitis, Exudative
% 212.28/212.43  |- skos__altLabel mesh__D001989 Bronchiolitis, Proliferative
% 212.28/212.43  |- skos__broader mesh__D001989smesh__D017563
% 212.28/212.43  |- skos__prefLabel mesh__D001989 Bronchiolitis Obliterans
% 212.28/212.43  |- skos__annotation mesh__D001989
% 212.28/212.43       also called acute obliterating bronchiolitis %26% bronchiolitis fibrosa obliterans: do not make diagnoses: use words of text%A%  
% 212.28/212.43  |- mesh__dateRevised mesh__D001989 1993-03-03
% 212.28/212.43  |- mesh__publicMeSHNote mesh__D001989 88   
% 212.28/212.43  |- rdf__type mesh__D001989sskos__Concept
% 212.28/212.43  |- mesh__dateCreated mesh__D001989 1987-04-02
% 212.28/212.43  |- skos__altLabel mesh__D001989 Proliferative Bronchiolitis
% 212.28/212.43  |- mesh__recordMaintainer mesh__D001989 TGC
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001989 2002
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D001989 1995
% 212.28/212.43  |- mesh__recordMaintainer mesh__D034365 SYSTEM
% 212.28/212.43  |- mesh__dateCreated mesh__D034365 2002-07-03
% 212.28/212.43  |- skos__annotation mesh__D034365
% 212.28/212.43       infection: coord IM with STREPTOCOCCAL INFECTIONS %28%IM%29%   
% 212.28/212.43  |- skos__scopeNote mesh__D034365
% 212.28/212.43       A species of gram-positive bacteria in the STREPTOCOCCUS MILLERI GROUP. It is commonly found in the oropharnyx flora and has a proclivity for abscess formation in the upper body and respiratory tract.%A%    
% 212.28/212.43  |- mesh__dateRevised mesh__D034365 2005-06-30
% 212.28/212.43  |- skos__broader mesh__D034365smesh__D034364
% 212.28/212.43  |- mesh__historyNote mesh__D034365 2003   
% 212.28/212.43  |- rdf__type mesh__D034365sskos__Concept
% 212.28/212.43  |- mesh__recordAuthorizer mesh__D034365 sjn
% 212.28/212.43  |- skos__historyNote mesh__D034365 Streptococcus %28%1979-2002%29%
% 212.28/212.43  |- skos__prefLabel mesh__D034365 Streptococcus constellatus
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D034365 2006
% 212.28/212.43  |- mesh__dateEstablished mesh__D034365 2003-01-01
% 212.28/212.43  |- mesh__publicMeSHNote mesh__D034365 2003   
% 212.28/212.43  |- mesh__recordOriginator mesh__D034365 ags
% 212.28/212.43  |- mesh__dateEstablished mesh__D020345 1999-01-01
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D020345 2006
% 212.28/212.43  |- skos__broader mesh__D020345smesh__D004760
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D020345 2004
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D020345 2005
% 212.28/212.43  |- skos__altLabel mesh__D020345 Necrotizing Enterocolitis
% 212.28/212.43  |- mesh__recordOriginator mesh__D020345 ADP
% 212.28/212.43  |- mesh__dateCreated mesh__D020345 1998-06-10
% 212.28/212.43  |- mesh__historyNote mesh__D020345
% 212.28/212.43       99; use ENTEROCOLITIS, PSEUDOMEMBRANOUS 1980-98   
% 212.28/212.43  |- skos__prefLabel mesh__D020345 Enterocolitis, Necrotizing
% 212.28/212.43  |- mesh__recordAuthorizer mesh__D020345 sjn
% 212.28/212.43  |- mesh__dateRevised mesh__D020345 2003-07-09
% 212.28/212.43  |- skos__historyNote mesh__D020345
% 212.28/212.43       Enterocolitis, Pseudomembranous %28%1966-1998%29%
% 212.28/212.43  |- mesh__publicMeSHNote mesh__D020345
% 212.28/212.43       99; see ENTEROCOLITIS, PSEUDOMEMBRANOUS 1980-98   
% 212.28/212.43  |- rdf__type mesh__D020345sskos__Concept
% 212.28/212.43  |- skos__scopeNote mesh__D020345
% 212.28/212.43       ENTEROCOLITIS with extensive ulceration %28%ULCER%29% and NECROSIS. It is observed primarily in LOW BIRTH WEIGHT INFANT.%A%    
% 212.28/212.43  |- mesh__recordMaintainer mesh__D020345 lkt
% 212.28/212.43  |- skos__prefLabel mesh__D014308 Triparanol
% 212.28/212.43  |- mesh__historyNote mesh__D014308 64%28%63%29%   
% 212.28/212.43  |- skos__hiddenLabel mesh__D014308 MER29
% 212.28/212.43  |- skos__scopeNote mesh__D014308
% 212.28/212.43       Antilipemic agent with high ophthalmic toxicity. According to Merck Index, 11th ed, the compound was withdrawn from the market in 1962 because of its association with the formation of irreversible cataracts.%A%    
% 212.28/212.43  |- mesh__recordAuthorizer mesh__D014308 sjn
% 212.28/212.43  |- mesh__recordOriginator mesh__D014308 NLM
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D014308 2005
% 212.28/212.43  |- mesh__recordMaintainer mesh__D014308 CCR
% 212.28/212.43  |- skos__broader mesh__D014308smesh__D001555
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D014308 2001
% 212.28/212.43  |- skos__hiddenLabel mesh__D014308 MER 29
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D014308 2006
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D014308 2002
% 212.28/212.43  |- mesh__dateCreated mesh__D014308 1999-01-01
% 212.28/212.43  |- rdf__type mesh__D014308sskos__Concept
% 212.28/212.43  |- mesh__publicMeSHNote mesh__D014308 64   
% 212.28/212.43  |- mesh__dateEstablished mesh__D014308 1964-01-01
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D014308 2003
% 212.28/212.43  |- mesh__dateRevised mesh__D014308 2000-06-22
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D014308 2004
% 212.28/212.43  |- skos__annotation mesh__D011010
% 212.28/212.43       specifics PNEUMOCYSTIS JIROVECI and PNEUMOCYSTIS CARINII are available; infection = PNEUMOCYSTIS INFECTIONS but consider also PNEUMONIA, PNEUMOCYSTIS%A%  
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D011010 2006
% 212.28/212.43  |- mesh__dateRevised mesh__D011010 2005-07-27
% 212.28/212.43  |- mesh__dateEstablished mesh__D011010 1974-01-01
% 212.28/212.43  |- skos__broader mesh__D011010smesh__D001203
% 212.28/212.43  |- mesh__recordOriginator mesh__D011010 NLM
% 212.28/212.43  |- mesh__dateCreated mesh__D011010 1999-01-01
% 212.28/212.43  |- rdf__type mesh__D011010sskos__Concept
% 212.28/212.43  |- mesh__recordMaintainer mesh__D011010 ags
% 212.28/212.43  |- skos__scopeNote mesh__D011010
% 212.28/212.43       A genus of ascomycetous FUNGI, family Pneumocystidaceae, order Pneumocystidales. It includes various host-specific species causing PNEUMOCYSTIS PNEUMONIA in humans and other MAMMALS.%A%    
% 212.28/212.43  |- skos__prefLabel mesh__D011010 Pneumocystis
% 212.28/212.43  |- mesh__recordAuthorizer mesh__D011010 ags
% 212.28/212.43  |- mesh__publicMeSHNote mesh__D011010
% 212.28/212.43       2002; see PNEUMOCYSTIS CARINII 1974-2003   
% 212.28/212.43  |- mesh__activeMeSHYear mesh__D011010 2006A
% 212.28/212.43  |- mesh__historyNote mesh__D011010 2002 %28%1974%29%   
% 212.28/212.43  |- skos__broader mesh__D002284smesh__D009374
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D002284 2004
% 212.28/212.44  |- mesh__dateCreated mesh__D002284 1999-01-01
% 212.28/212.44  |- mesh__recordOriginator mesh__D002284 NLM
% 212.28/212.44  |- skos__altLabel mesh__D002284 Epithelioma, Brown-Pearce
% 212.28/212.44  |- skos__hiddenLabel mesh__D002284 Brown-Pearce Epithelioma
% 212.28/212.44  |- mesh__dateRevised mesh__D002284 2003-07-30
% 212.28/212.44  |- mesh__recordMaintainer mesh__D002284 ags
% 212.28/212.44  |- rdf__type mesh__D002284sskos__Concept
% 212.28/212.44  |- skos__annotation mesh__D002284
% 212.28/212.44       exper neopl; /blood supply /chem /second /secret /ultrastruct permitted; don%27%t forget check tag ANIMALS%A%  
% 212.28/212.44  |- skos__hiddenLabel mesh__D002284 Carcinoma, Brown Pearce
% 212.28/212.44  |- skos__prefLabel mesh__D002284 Carcinoma, Brown-Pearce
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D002284 2005
% 212.28/212.44  |- skos__hiddenLabel mesh__D002284 Brown-Pearce Carcinoma
% 212.28/212.44  |- skos__hiddenLabel mesh__D002284 Epithelioma, Brown Pearce
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D002284 2006
% 212.28/212.44  |- mesh__recordAuthorizer mesh__D002284 sjn
% 212.28/212.44  |- skos__altLabel mesh__D010716 Phosphatidylinositol
% 212.28/212.44  |- skos__altLabel mesh__D010716 Phosphoinositides
% 212.28/212.44  |- mesh__dateRevised mesh__D010716 2003-07-09
% 212.28/212.44  |- rdf__type mesh__D010716sskos__Concept
% 212.28/212.44  |- skos__hiddenLabel mesh__D010716 Inositol, Phosphatidyl
% 212.28/212.44  |- skos__hiddenLabel mesh__D010716 Phospholipids, Inositide
% 212.28/212.44  |- skos__scopeNote mesh__D010716
% 212.28/212.44       Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to the hexahydroxy alcohol, myo-inositol. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid, myo-inositol, and 2 moles of fatty acids.%A%    
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D010716 2005
% 212.28/212.44  |- skos__altLabel mesh__D010716 Inositol Phospholipids
% 212.28/212.44  |- skos__altLabel mesh__D010716 Inositol Phosphoglycerides
% 212.28/212.44  |- skos__annotation mesh__D010716 /biosyn /physiol permitted   
% 212.28/212.44  |- mesh__recordMaintainer mesh__D010716 ssb
% 212.28/212.44  |- skos__hiddenLabel mesh__D010716 Phospholipids, Inositol
% 212.28/212.44  |- skos__hiddenLabel mesh__D010716 Phosphoglycerides, Inositol
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D010716 2004
% 212.28/212.44  |- mesh__dateCreated mesh__D010716 1999-01-01
% 212.28/212.44  |- mesh__historyNote mesh__D010716
% 212.28/212.44       77; was PHOSPHATIDYL INOSITOL see under PHOSPHOINOSITIDES 1963-76; PHOSPHOINOSITIDES was heading 1963-93%A%  
% 212.28/212.44  |- mesh__recordAuthorizer mesh__D010716 sjn
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D010716 2006
% 212.28/212.44  |- mesh__dateEstablished mesh__D010716 1977-01-01
% 212.28/212.44  |- mesh__recordOriginator mesh__D010716 NLM
% 212.28/212.44  |- mesh__publicMeSHNote mesh__D010716
% 212.28/212.44       77; was PHOSPHATIDYL INOSITOL see under PHOSPHOINOSITIDES 1963-76; PHOSPHOINOSITIDES was heading 1963-93%A%  
% 212.28/212.44  |- skos__altLabel mesh__D010716 Inositide Phospholipids
% 212.28/212.44  |- mesh__onlineNote mesh__D010716
% 212.28/212.44       use PHOSPHATIDYLINOSITOLS to search PHOSPHOINOSITIDES 1966-93 %26% PHOSPHATIDYL INOSITOL 1966-76%A%  
% 212.28/212.44  |- skos__altLabel mesh__D010716 Phosphatidyl Inositol
% 212.28/212.44  |- skos__historyNote mesh__D010716 Phosphoinositides %28%1966-1974%29%
% 212.28/212.44  |- skos__broader mesh__D010716smesh__D020404
% 212.28/212.44  |- skos__altLabel mesh__D010716 PtdIns
% 212.28/212.44  |- skos__prefLabel mesh__D010716 Phosphatidylinositols
% 212.28/212.44  |- mesh__dateEstablished mesh__D029421 2002-01-01
% 212.28/212.44  |- mesh__dateCreated mesh__D029421 2001-07-25
% 212.28/212.44  |- skos__broader mesh__D029421smesh__D019684
% 212.28/212.44  |- rdf__type mesh__D029421sskos__Concept
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D029421 2006
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D029421 2002
% 212.28/212.44  |- skos__prefLabel mesh__D029421 Cactaceae
% 212.28/212.44  |- skos__altLabel mesh__D029421 Cactus
% 212.28/212.44  |- skos__scopeNote mesh__D029421
% 212.28/212.44       The cactus plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. Cacti are succulent perennial plants well adapted to dry regions.%A%    
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D029421 2005
% 212.28/212.44  |- mesh__publicMeSHNote mesh__D029421 2002   
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D029421 2004
% 212.28/212.44  |- skos__annotation mesh__D029421
% 212.28/212.44       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.28/212.44  |- mesh__historyNote mesh__D029421 2002   
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D029421 2003
% 212.28/212.44  |- mesh__dateEstablished mesh__D015401 1991-01-01
% 212.28/212.44  |- rdf__type mesh__D015401sskos__Concept
% 212.28/212.44  |- skos__hiddenLabel mesh__D015401 Researchs, Nursing Administration
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D015401 2001
% 212.28/212.44  |- skos__hiddenLabel mesh__D015401 Administrative Nursing Researchs
% 212.28/212.44  |- skos__hiddenLabel mesh__D015401 Nursing Researchs, Administrative
% 212.28/212.44  |- skos__historyNote mesh__D015401
% 212.28/212.44       Nursing or specific nursing %28%1966-1988%29%
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D015401 2004
% 212.28/212.44  |- skos__prefLabel mesh__D015401 Nursing Administration Research
% 212.28/212.44  |- mesh__recordOriginator mesh__D015401 EJB
% 212.28/212.44  |- skos__historyNote mesh__D015401 Research %28%1966-1988%29%
% 212.28/212.44  |- skos__annotation mesh__D015401
% 212.28/212.44       SPEC: SPEC qualif; DF: NURS ADMIN RESEARCH   
% 212.28/212.44  |- skos__hiddenLabel mesh__D015401 Researchs, Administrative Nursing
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D015401 2000
% 212.28/212.44  |- skos__hiddenLabel mesh__D015401 Nursing Administration Researchs
% 212.28/212.44  |- skos__altLabel mesh__D015401 Research, Nursing Administration
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D015401 2003
% 212.28/212.44  |- mesh__dateRevised mesh__D015401 1999-11-03
% 212.28/212.44  |- skos__scopeNote mesh__D015401
% 212.28/212.44       Research concerned with establishing costs of nursing care, examining the relationships between nursing services and quality patient care, and viewing problems of nursing service delivery within the broader context of policy analysis and delivery of health services %28%from a national study, presented at the 1985 Council on Graduate Education for Administration in Nursing %28%CGEAN%29% meeting%29%.%A%    
% 212.28/212.44  |- skos__altLabel mesh__D015401 Nursing Research, Administrative
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D015401 2006
% 212.28/212.44  |- skos__altLabel mesh__D015401 Administration Research, Nursing
% 212.28/212.44  |- mesh__publicMeSHNote mesh__D015401
% 212.28/212.44       91; was see under NURSING RESEARCH 1989-90   
% 212.28/212.44  |- skos__broader mesh__D015401smesh__D015399
% 212.28/212.44  |- skos__altLabel mesh__D015401 Administrative Nursing Research
% 212.28/212.44  |- mesh__dateCreated mesh__D015401 1988-06-06
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D015401 2002
% 212.28/212.44  |- skos__hiddenLabel mesh__D015401 Administration Researchs, Nursing
% 212.28/212.44  |- mesh__historyNote mesh__D015401
% 212.28/212.44       91%28%89%29%; was see under NURSING RESEARCH 1989-90   
% 212.28/212.44  |- mesh__recordAuthorizer mesh__D015401 sjn
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D015401 2005
% 212.28/212.44  |- mesh__recordMaintainer mesh__D015401 kle
% 212.28/212.44  |- skos__altLabel mesh__D015401 Research, Administrative Nursing
% 212.28/212.44  |- skos__broader mesh__D019927Q000031smesh__D019927
% 212.28/212.44  |- mesh__preferredCombination mesh__D019927Q000031smesh__D016213
% 212.28/212.44  |- rdf__type mesh__D019927Q000031smesh__CompoundConcept
% 212.28/212.44  |- skos__broader mesh__D014566Q000002smesh__D014566
% 212.28/212.44  |- mesh__preferredCombination mesh__D014566Q000002smesh__D014564
% 212.28/212.44  |- rdf__type mesh__D014566Q000002smesh__CompoundConcept
% 212.28/212.44  |- mesh__dateEstablished mesh__D034366 2003-01-01
% 212.28/212.44  |- skos__prefLabel mesh__D034366 Streptococcus anginosus
% 212.28/212.44  |- skos__broader mesh__D034366smesh__D034364
% 212.28/212.44  |- mesh__recordOriginator mesh__D034366 ags
% 212.28/212.44  |- mesh__recordMaintainer mesh__D034366 SYSTEM
% 212.28/212.44  |- mesh__dateCreated mesh__D034366 2002-07-03
% 212.28/212.44  |- rdf__type mesh__D034366sskos__Concept
% 212.28/212.44  |- mesh__dateRevised mesh__D034366 2005-06-30
% 212.28/212.44  |- mesh__historyNote mesh__D034366 2003   
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D034366 2006
% 212.28/212.44  |- mesh__publicMeSHNote mesh__D034366 2003   
% 212.28/212.44  |- skos__scopeNote mesh__D034366
% 212.28/212.44       A species of gram-positive bacteria in the STREPTOCOCCUS MILLERI GROUP. It is the most frequently seen isolate of that group, has a proclivity for abscess formation, and is most often isolated from the blood, gastrointestinal, and urogenital tract.%A%    
% 212.28/212.44  |- skos__annotation mesh__D034366
% 212.28/212.44       infection: coord IM with STREPTOCOCCAL INFECTIONS %28%IM%29%   
% 212.28/212.44  |- mesh__recordAuthorizer mesh__D034366 sjn
% 212.28/212.44  |- skos__broader mesh__D002319Q000601smesh__D002319
% 212.28/212.44  |- mesh__preferredCombination mesh__D002319Q000601smesh__D013504
% 212.28/212.44  |- rdf__type mesh__D002319Q000601smesh__CompoundConcept
% 212.28/212.44  |- mesh__historyNote mesh__D020346 99   
% 212.28/212.44  |- mesh__recordAuthorizer mesh__D020346 sjn
% 212.28/212.44  |- skos__historyNote mesh__D020346 Water/metabolism %28%1976-1998%29%
% 212.28/212.44  |- mesh__publicMeSHNote mesh__D020346 99   
% 212.28/212.44  |- mesh__dateEstablished mesh__D020346 1999-01-01
% 212.28/212.44  |- skos__broader mesh__D020346smesh__D018272
% 212.28/212.44  |- mesh__recordOriginator mesh__D020346 NNS
% 212.28/212.44  |- rdf__type mesh__D020346sskos__Concept
% 212.28/212.44  |- skos__hiddenLabel mesh__D020346 Channels, Water
% 212.28/212.44  |- skos__annotation mesh__D020346 general; prefer specifics   
% 212.28/212.44  |- skos__hiddenLabel mesh__D020346 Proteins, Water Channel
% 212.28/212.44  |- skos__prefLabel mesh__D020346 Aquaporins
% 212.28/212.44  |- skos__scopeNote mesh__D020346
% 212.28/212.44       A class of porins that allow the passage of  WATER and other small molecules across CELL MEMBRANES.%A%    
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D020346 2006
% 212.28/212.44  |- mesh__recordMaintainer mesh__D020346 DRC
% 212.28/212.44  |- skos__hiddenLabel mesh__D020346 Channel Proteins, Water
% 212.28/212.44  |- skos__altLabel mesh__D020346 Water Channel Proteins
% 212.28/212.44  |- skos__altLabel mesh__D020346 Water Channels
% 212.28/212.44  |- mesh__dateCreated mesh__D020346 1998-06-10
% 212.28/212.44  |- mesh__dateRevised mesh__D020346 2005-06-30
% 212.28/212.44  |- skos__historyNote mesh__D020346 Ion Channels %28%1979-1998%29%
% 212.28/212.44  |- skos__historyNote mesh__D020346 Membrane Proteins %28%1977-1998%29%
% 212.28/212.44  |- mesh__dateRevised mesh__D014309 2005-07-08
% 212.28/212.44  |- skos__altLabel mesh__D014309 Chefaro Brand of Tripelennamine
% 212.28/212.44  |- mesh__recordMaintainer mesh__D014309 ags
% 212.28/212.44  |- skos__altLabel mesh__D014309 Tripelennamine Citrate %28%1:1%29%
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D014309 2006A
% 212.28/212.44  |- mesh__dateCreated mesh__D014309 1999-01-01
% 212.28/212.44  |- mesh__recordOriginator mesh__D014309 NLM
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D014309 2006
% 212.28/212.44  |- skos__scopeNote mesh__D014309
% 212.28/212.44       A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.%A%    
% 212.28/212.44  |- skos__broader mesh__D014309smesh__D000631
% 212.28/212.44  |- skos__broader mesh__D014309smesh__D005029
% 212.28/212.44  |- mesh__recordAuthorizer mesh__D014309 ags
% 212.28/212.44  |- rdf__type mesh__D014309sskos__Concept
% 212.28/212.44  |- skos__prefLabel mesh__D014309 Tripelennamine
% 212.28/212.44  |- skos__broader mesh__D011011smesh__D009485
% 212.28/212.44  |- skos__scopeNote mesh__D011011
% 212.28/212.44       Radiographic visualization of the cerebral ventricles by injection of air or other gas.%A%    
% 212.28/212.44  |- mesh__onlineNote mesh__D011011
% 212.28/212.44       search VENTRICULOGRAPHY, CEREBRAL 1966-68   
% 212.28/212.44  |- skos__altLabel mesh__D011011 Pneumoencephalographic Cisternography
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011011 1999
% 212.28/212.44  |- skos__annotation mesh__D011011
% 212.28/212.44       /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: PNEUMOENCEPHALOGR%A%  
% 212.28/212.44  |- skos__hiddenLabel mesh__D011011 Pneumoencephalographies
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011011 2004
% 212.28/212.44  |- skos__hiddenLabel mesh__D011011 Cisternographies, Pneumoencephalographic
% 212.28/212.44  |- mesh__recordMaintainer mesh__D011011 PXP
% 212.28/212.44  |- skos__hiddenLabel mesh__D011011 Pneumoencephalographic Cisternographies
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011011 2001
% 212.28/212.44  |- skos__broader mesh__D011011smesh__D011029
% 212.28/212.44  |- mesh__recordAuthorizer mesh__D011011 SJN
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011011 1998
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011011 2003
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011011 2006
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011011 2000
% 212.28/212.44  |- skos__historyNote mesh__D011011
% 212.28/212.44       Ventriculography, Cerebral %28%1966-1968%29%
% 212.28/212.44  |- mesh__publicMeSHNote mesh__D011011
% 212.28/212.44       72; was see under VENTRICULOGRAPHY 1963-71   
% 212.28/212.44  |- mesh__recordOriginator mesh__D011011 NLM
% 212.28/212.44  |- mesh__dateEstablished mesh__D011011 1972-01-01
% 212.28/212.44  |- skos__prefLabel mesh__D011011 Pneumoencephalography
% 212.28/212.44  |- mesh__dateCreated mesh__D011011 1999-01-01
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011011 2005
% 212.28/212.44  |- mesh__dateRevised mesh__D011011 1997-06-20
% 212.28/212.44  |- rdf__type mesh__D011011sskos__Concept
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011011 2002
% 212.28/212.44  |- mesh__historyNote mesh__D011011
% 212.28/212.44       72%28%69%29%; was see under VENTRICULOGRAPHY 1963-71   
% 212.28/212.44  |- skos__hiddenLabel mesh__D002285 Carcinoma, Noninfiltrating Intraductal
% 212.28/212.44  |- skos__hiddenLabel mesh__D002285 Carcinomas, Noninfiltrating Intraductal
% 212.28/212.44  |- mesh__recordAuthorizer mesh__D002285 SJN
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D002285 2001
% 212.28/212.44  |- rdf__type mesh__D002285sskos__Concept
% 212.28/212.44  |- skos__altLabel mesh__D002285 Carcinoma, Intraductal
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D002285 2002
% 212.28/212.44  |- mesh__dateRevised mesh__D002285 1998-06-10
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D002285 1999
% 212.28/212.44  |- mesh__recordOriginator mesh__D002285 NLM
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D002285 2005
% 212.28/212.44  |- skos__annotation mesh__D002285
% 212.28/212.44       intraductal refers to mammary ducts only; do not confuse X ref CARCINOMA, INTRADUCTAL with CARCINOMA, DUCTAL see CARCINOMA, INFILTRATING DUCT; coord IM with BREAST NEOPLASMS %28%IM%29%%A%  
% 212.28/212.44  |- skos__hiddenLabel mesh__D002285 Carcinomas, Intraductal
% 212.28/212.44  |- skos__broader mesh__D002285smesh__D018299
% 212.28/212.44  |- skos__altLabel mesh__D002285 Intraductal Carcinoma, Noninfiltrating
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D002285 2003
% 212.28/212.44  |- mesh__publicMeSHNote mesh__D002285 94; was CARCINOMA, DUCTAL 1963-93   
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D002285 2006
% 212.28/212.44  |- skos__scopeNote mesh__D002285
% 212.28/212.44       A noninvasive %28%noninfiltrating%29% carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.%A%    
% 212.28/212.44  |- skos__broader mesh__D002285smesh__D000230
% 212.28/212.44  |- mesh__recordMaintainer mesh__D002285 NDW
% 212.28/212.44  |- skos__altLabel mesh__D002285 DCIS
% 212.28/212.44  |- skos__hiddenLabel mesh__D002285 Noninfiltrating Intraductal Carcinomas
% 212.28/212.44  |- skos__hiddenLabel mesh__D002285 Noninfiltrating Intraductal Carcinoma
% 212.28/212.44  |- mesh__historyNote mesh__D002285 94; was CARCINOMA, DUCTAL 1963-93   
% 212.28/212.44  |- skos__hiddenLabel mesh__D002285 Intraductal Carcinomas, Noninfiltrating
% 212.28/212.44  |- skos__prefLabel mesh__D002285 Carcinoma, Intraductal, Noninfiltrating
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D002285 2004
% 212.28/212.44  |- mesh__dateCreated mesh__D002285 1999-01-01
% 212.28/212.44  |- mesh__onlineNote mesh__D002285
% 212.28/212.44       use CARCINOMA, INTRADUCTAL, NONINFILTRATING to search CARCINOMA, DUCTAL 1966-93%A%  
% 212.28/212.44  |- skos__altLabel mesh__D002285 Ductal Carcinoma In Situ
% 212.28/212.44  |- skos__hiddenLabel mesh__D002285 Intraductal Carcinomas
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D002285 2000
% 212.28/212.44  |- skos__hiddenLabel mesh__D002285 Intraductal Carcinoma
% 212.28/212.44  |- mesh__dateRevised mesh__D010717 2003-07-09
% 212.28/212.44  |- skos__altLabel mesh__D010717
% 212.28/212.44       CDP Diacylglycerol-Serine O-Phosphatidyltransferase
% 212.28/212.44  |- skos__historyNote mesh__D010717 Phosphotransferases %28%1972-1974%29%
% 212.28/212.44  |- skos__altLabel mesh__D010717 Phosphatidylserine Synthetase
% 212.28/212.44  |- rdf__type mesh__D010717sskos__Concept
% 212.28/212.44  |- skos__historyNote mesh__D010717 Cytosine Nucleotides %28%1972-1974%29%
% 212.28/212.44  |- skos__hiddenLabel mesh__D010717
% 212.28/212.44       CDP Diglyceride Serine O Phosphatidyltransferase
% 212.28/212.44  |- mesh__recordMaintainer mesh__D010717 ssb
% 212.28/212.44  |- skos__hiddenLabel mesh__D010717
% 212.28/212.44       CDPdiacylglycerol Serine O Phosphatidyltransferase
% 212.28/212.44  |- skos__hiddenLabel mesh__D010717
% 212.28/212.44       Diacylglycerol-Serine O-Phosphatidyltransferase, CDP
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D010717 2004
% 212.28/212.44  |- mesh__publicMeSHNote mesh__D010717
% 212.28/212.44       98; see CDP DIACYLGLYCEROL-SERINE O-PHOSPHATIDYLTRANSFERASE 1994-97, PHOSPHATIDYLSERINE SYNTHETASE 1991-93, %26% PHOSPHOTRANSFERASES 1975-90%A%  
% 212.28/212.44  |- mesh__historyNote mesh__D010717 98%28%75%29%   
% 212.28/212.44  |- skos__hiddenLabel mesh__D010717 Synthase, CDP-DG
% 212.28/212.44  |- skos__hiddenLabel mesh__D010717
% 212.28/212.44       O-Phosphatidyltransferase, CDP Diacylglycerol-Serine
% 212.28/212.44  |- skos__historyNote mesh__D010717 Cephalins %28%1972-1974%29%
% 212.28/212.44  |- skos__hiddenLabel mesh__D010717 Synthase, Phosphatidylserine
% 212.28/212.44  |- skos__hiddenLabel mesh__D010717
% 212.28/212.44       O-Phosphatidyltransferase, CDPdiacylglycerol-Serine
% 212.28/212.44  |- skos__hiddenLabel mesh__D010717
% 212.28/212.44       CDP Diacylglycerol Serine O Phosphatidyltransferase
% 212.28/212.44  |- skos__hiddenLabel mesh__D010717 CDP DG Synthase
% 212.28/212.44  |- skos__altLabel mesh__D010717 CDP-DG Synthase
% 212.28/212.44  |- mesh__dateCreated mesh__D010717 1974-11-19
% 212.28/212.44  |- skos__annotation mesh__D010717 DF: note short X ref   
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D010717 2006
% 212.28/212.44  |- skos__hiddenLabel mesh__D010717 Synthetase, Phosphatidylserine
% 212.28/212.44  |- skos__altLabel mesh__D010717 Phosphatidylserine Synthase
% 212.28/212.44  |- mesh__dateEstablished mesh__D010717 1991-01-01
% 212.28/212.44  |- skos__scopeNote mesh__D010717
% 212.28/212.44       An enzyme that catalyzes the formation of phosphatidylserine and CMP from CDPdiglyceride plus serine. EC 2.7.8.8.%A%    
% 212.28/212.44  |- skos__altLabel mesh__D010717
% 212.28/212.44       CDP Diglyceride Serine O-Phosphatidyltransferase
% 212.28/212.44  |- mesh__recordAuthorizer mesh__D010717 sjn
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D010717 2005
% 212.28/212.44  |- skos__broader mesh__D010717smesh__D017855
% 212.28/212.44  |- mesh__recordOriginator mesh__D010717 NLM
% 212.28/212.44  |- skos__prefLabel mesh__D010717
% 212.28/212.44       CDPdiacylglycerol-Serine O-Phosphatidyltransferase
% 212.28/212.44  |- mesh__dateEstablished mesh__D029422 2002-01-01
% 212.28/212.44  |- skos__scopeNote mesh__D029422
% 212.28/212.44       A plant family of the order Campanulales, subclass Asteridae, class Magnoliopsida%A%    
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D029422 2006
% 212.28/212.44  |- rdf__type mesh__D029422sskos__Concept
% 212.28/212.44  |- mesh__historyNote mesh__D029422 2002   
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D029422 2005
% 212.28/212.44  |- skos__prefLabel mesh__D029422 Campanulaceae
% 212.28/212.44  |- mesh__publicMeSHNote mesh__D029422 2002   
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D029422 2004
% 212.28/212.44  |- mesh__recordAuthorizer mesh__D029422 sjn
% 212.28/212.44  |- mesh__dateRevised mesh__D029422 2003-07-09
% 212.28/212.44  |- skos__broader mesh__D029422smesh__D019684
% 212.28/212.44  |- mesh__recordOriginator mesh__D029422 ssb
% 212.28/212.44  |- mesh__dateCreated mesh__D029422 2001-07-25
% 212.28/212.44  |- skos__annotation mesh__D029422
% 212.28/212.44       GEN or unspecified; prefer specifics; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.28/212.44  |- mesh__recordMaintainer mesh__D029422 ssb
% 212.28/212.44  |- skos__prefLabel mesh__D015402 Nursing Education Research
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D015402 2004
% 212.28/212.44  |- skos__hiddenLabel mesh__D015402 Education Researchs, Nursing
% 212.28/212.44  |- skos__historyNote mesh__D015402 Research %28%1966-1988%29%
% 212.28/212.44  |- skos__altLabel mesh__D015402 Education Research, Nursing
% 212.28/212.44  |- skos__altLabel mesh__D015402 Nursing Research, Educational
% 212.28/212.44  |- skos__altLabel mesh__D015402 Educational Nursing Research
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D015402 2003
% 212.28/212.44  |- skos__hiddenLabel mesh__D015402 Researchs, Educational Nursing
% 212.28/212.44  |- skos__altLabel mesh__D015402 Research, Nursing Education
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D015402 2001
% 212.28/212.44  |- skos__hiddenLabel mesh__D015402 Researchs, Nursing Education
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D015402 2006
% 212.28/212.44  |- skos__broader mesh__D015402smesh__D015399
% 212.28/212.44  |- mesh__publicMeSHNote mesh__D015402
% 212.28/212.44       91; was see under NURSING RESEARCH 1989-90   
% 212.28/212.44  |- skos__scopeNote mesh__D015402
% 212.28/212.44       Investigations into the problems of integrating research findings into nursing curricula, developing problem solving skills, finding approaches to clinical teaching, determining the level of practice by graduates from different basic preparations, etc.%A%    
% 212.28/212.44  |- skos__historyNote mesh__D015402
% 212.28/212.44       Nursing or specific nursing %28%1966-1988%29%
% 212.28/212.44  |- mesh__recordOriginator mesh__D015402 EJB
% 212.28/212.44  |- mesh__dateCreated mesh__D015402 1988-06-06
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D015402 2000
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D015402 2005
% 212.28/212.44  |- skos__hiddenLabel mesh__D015402 Nursing Researchs, Educational
% 212.28/212.44  |- mesh__dateRevised mesh__D015402 1999-11-03
% 212.28/212.44  |- skos__broader mesh__D015402smesh__D004506
% 212.28/212.44  |- skos__altLabel mesh__D015402 Research, Educational Nursing
% 212.28/212.44  |- skos__hiddenLabel mesh__D015402 Nursing Education Researchs
% 212.28/212.44  |- mesh__dateEstablished mesh__D015402 1991-01-01
% 212.28/212.44  |- skos__annotation mesh__D015402
% 212.28/212.44       SPEC: SPEC qualif; DF: NURS EDUC RESEARCH   
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D015402 2002
% 212.28/212.44  |- rdf__type mesh__D015402sskos__Concept
% 212.28/212.44  |- skos__hiddenLabel mesh__D015402 Educational Nursing Researchs
% 212.28/212.44  |- mesh__historyNote mesh__D015402
% 212.28/212.44       91%28%89%29%; was see under NURSING RESEARCH 1989-90   
% 212.28/212.44  |- mesh__recordAuthorizer mesh__D015402 sjn
% 212.28/212.44  |- mesh__recordMaintainer mesh__D015402 kle
% 212.28/212.44  |- skos__broader mesh__D034367smesh__D034364
% 212.28/212.44  |- skos__prefLabel mesh__D034367 Streptococcus intermedius
% 212.28/212.44  |- mesh__recordAuthorizer mesh__D034367 sjn
% 212.28/212.44  |- mesh__dateEstablished mesh__D034367 2003-01-01
% 212.28/212.44  |- mesh__recordMaintainer mesh__D034367 SYSTEM
% 212.28/212.44  |- rdf__type mesh__D034367sskos__Concept
% 212.28/212.44  |- skos__scopeNote mesh__D034367
% 212.28/212.44       A species of gram-positive bacteria in the STREPTOCOCCUS MILLERI GROUP. It is commonly found in the oropharynx flora and has a proclivity for abscess formation, most characteristically in the CENTRAL NERVOUS SYSTEM and LIVER.%A%    
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D034367 2006
% 212.28/212.44  |- mesh__recordOriginator mesh__D034367 ags
% 212.28/212.44  |- mesh__publicMeSHNote mesh__D034367 2003   
% 212.28/212.44  |- mesh__dateCreated mesh__D034367 2002-07-03
% 212.28/212.44  |- skos__historyNote mesh__D034367 Streptococcus %28%1978-2002%29%
% 212.28/212.44  |- skos__annotation mesh__D034367
% 212.28/212.44       infection: coord IM with STREPTOCOCCAL INFECTIONS %28%IM%29%   
% 212.28/212.44  |- mesh__dateRevised mesh__D034367 2005-06-30
% 212.28/212.44  |- mesh__historyNote mesh__D034367 2003   
% 212.28/212.44  |- skos__prefLabel mesh__D006676 History of Nursing
% 212.28/212.44  |- mesh__dateEstablished mesh__D006676 1966-01-01
% 212.28/212.44  |- rdf__type mesh__D006676sskos__Concept
% 212.28/212.44  |- mesh__recordMaintainer mesh__D006676 jls
% 212.28/212.44  |- skos__altLabel mesh__D006676 Nursing, History
% 212.28/212.44  |- mesh__dateCreated mesh__D006676 1999-01-01
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D006676 2005
% 212.28/212.44  |- skos__hiddenLabel mesh__D006676 History Nursing
% 212.28/212.44  |- mesh__recordOriginator mesh__D006676 NLM
% 212.28/212.44  |- mesh__publicMeSHNote mesh__D006676 66   
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D006676 2006
% 212.28/212.44  |- skos__hiddenLabel mesh__D006676 Nursings, History
% 212.28/212.44  |- mesh__recordAuthorizer mesh__D006676 sjn
% 212.28/212.44  |- skos__hiddenLabel mesh__D006676 Nursing Histories
% 212.28/212.44  |- skos__broader mesh__D006676smesh__D006664
% 212.28/212.44  |- mesh__dateRevised mesh__D006676 2004-07-07
% 212.28/212.44  |- skos__hiddenLabel mesh__D006676 Nursing History
% 212.28/212.44  |- mesh__historyNote mesh__D006676 66   
% 212.28/212.44  |- skos__annotation mesh__D006676
% 212.28/212.44       general; prefer /hist with specific nursing term and do not coordinate here or with NURSING; Manual 18.14+, 32.7-.8; DF: HIST NURS%A%  
% 212.28/212.44  |- skos__hiddenLabel mesh__D006676 History Nursings
% 212.28/212.44  |- mesh__recordOriginator mesh__D020347 ADP
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D020347 2000
% 212.28/212.44  |- skos__related mesh__D020347smesh__D002137
% 212.28/212.44  |- mesh__dateRevised mesh__D020347 1999-11-08
% 212.28/212.44  |- mesh__historyNote mesh__D020347 99   
% 212.28/212.44  |- rdf__type mesh__D020347sskos__Concept
% 212.28/212.44  |- mesh__recordAuthorizer mesh__D020347 sjn
% 212.28/212.44  |- skos__scopeNote mesh__D020347
% 212.28/212.44       A condition characterized by the formation of CALCULI and concretions in the hollow organs or ducts of the body. They occur most often in the gallbladder, kidney, and lower urinary tract.%A%    
% 212.28/212.44  |- skos__annotation mesh__D020347
% 212.28/212.44       prefer specifics; coord IM with organ /disease term %28%IM%29%   
% 212.28/212.44  |- mesh__dateEstablished mesh__D020347 1999-01-01
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D020347 2006
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D020347 2002
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D020347 2004
% 212.28/212.44  |- skos__hiddenLabel mesh__D020347 Calculoses
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D020347 2005
% 212.28/212.44  |- skos__altLabel mesh__D020347 Calculosis
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D020347 2003
% 212.28/212.44  |- mesh__recordMaintainer mesh__D020347 KEV
% 212.28/212.44  |- skos__prefLabel mesh__D020347 Lithiasis
% 212.28/212.44  |- skos__hiddenLabel mesh__D020347 Lithiases
% 212.28/212.44  |- mesh__publicMeSHNote mesh__D020347 99   
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D020347 2001
% 212.28/212.44  |- skos__broader mesh__D020347smesh__D010335
% 212.28/212.44  |- mesh__dateCreated mesh__D020347 1998-06-10
% 212.28/212.44  |- skos__broader mesh__D006321Q000502smesh__D006321
% 212.28/212.44  |- rdf__type mesh__D006321Q000502smesh__CompoundConcept
% 212.28/212.44  |- mesh__historyNote mesh__D011810 66   
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011810 1997
% 212.28/212.44  |- mesh__publicMeSHNote mesh__D011810 66   
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011810 2004
% 212.28/212.44  |- mesh__dateRevised mesh__D011810 1992-05-20
% 212.28/212.44  |- mesh__dateCreated mesh__D011810 1999-01-01
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011810 1996
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011810 1999
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011810 2003
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011810 2006
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011810 1998
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011810 1993
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011810 2002
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011810 2005
% 212.28/212.44  |- skos__broader mesh__D011810smesh__D006574
% 212.28/212.44  |- mesh__recordMaintainer mesh__D011810 TAP
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011810 1995
% 212.28/212.44  |- rdf__type mesh__D011810sskos__Concept
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011810 2001
% 212.28/212.44  |- mesh__dateEstablished mesh__D011810 1966-01-01
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011810 1994
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011810 2000
% 212.28/212.44  |- mesh__recordOriginator mesh__D011810 NLM
% 212.28/212.44  |- mesh__recordAuthorizer mesh__D011810 PLS
% 212.28/212.44  |- skos__prefLabel mesh__D011810 Quinoxalines
% 212.28/212.44  |- skos__annotation mesh__D011012
% 212.28/212.44       do not use /util except by MeSH definition   
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011012 1999
% 212.28/212.44  |- skos__prefLabel mesh__D011012 Pneumomediastinum, Diagnostic
% 212.28/212.44  |- skos__hiddenLabel mesh__D011012 Diagnostic Pneumomediastinums
% 212.28/212.44  |- mesh__dateRevised mesh__D011012 1997-06-20
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011012 2004
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011012 2002
% 212.28/212.44  |- skos__hiddenLabel mesh__D011012 Diagnostic Pneumomediastinum
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011012 1998
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011012 2003
% 212.28/212.44  |- skos__scopeNote mesh__D011012
% 212.28/212.44       Deliberate introduction of air or gas into the mediastinum as an aid to examination and diagnosis.%A%    
% 212.28/212.44  |- mesh__activeMeSHYear mesh__D011012 2006
% 212.28/212.44  |- skos__broader mesh__D011012smesh__D003949
% 212.28/212.45  |- mesh__recordMaintainer mesh__D011012 PXP
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D011012 2001
% 212.28/212.45  |- mesh__dateCreated mesh__D011012 1999-01-01
% 212.28/212.45  |- mesh__recordAuthorizer mesh__D011012 SJN
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D011012 2005
% 212.28/212.45  |- rdf__type mesh__D011012sskos__Concept
% 212.28/212.45  |- skos__hiddenLabel mesh__D011012 Pneumomediastinums, Diagnostic
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D011012 2000
% 212.28/212.45  |- mesh__recordOriginator mesh__D011012 NLM
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D002286 2005
% 212.28/212.45  |- skos__hiddenLabel mesh__D002286 Tumor, Ehrlich Ascites
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D002286 2006
% 212.28/212.45  |- skos__annotation mesh__D002286
% 212.28/212.45       exper neopl; /blood supply /chem /second /secret /ultrastruct permitted; note X ref: do not also index under ASCITES; don%27%t forget check tag ANIMALS%A%  
% 212.28/212.45  |- skos__prefLabel mesh__D002286 Carcinoma, Ehrlich Tumor
% 212.28/212.45  |- skos__broader mesh__D002286smesh__D009374
% 212.28/212.45  |- skos__broader mesh__D002286smesh__D002277
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D002286 2004
% 212.28/212.45  |- mesh__recordAuthorizer mesh__D002286 sjn
% 212.28/212.45  |- mesh__dateCreated mesh__D002286 1999-01-01
% 212.28/212.45  |- skos__altLabel mesh__D002286 Ehrlich Ascites Tumor
% 212.28/212.45  |- rdf__type mesh__D002286sskos__Concept
% 212.28/212.45  |- mesh__recordOriginator mesh__D002286 NLM
% 212.28/212.45  |- skos__scopeNote mesh__D002286
% 212.28/212.45       A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.%A%    
% 212.28/212.45  |- mesh__dateRevised mesh__D002286 2003-07-30
% 212.28/212.45  |- mesh__recordMaintainer mesh__D002286 ags
% 212.28/212.45  |- skos__hiddenLabel mesh__D002286 Ascites Tumor, Ehrlich
% 212.28/212.45  |- skos__hiddenLabel mesh__D002286 Ehrlich Tumor Carcinoma
% 212.28/212.45  |- mesh__onlineNote mesh__D010718
% 212.28/212.45       to search PHOSPHATIDYL SERINE use PHOSPHATIDYLSERINES 1975-76 %26% PHOSPHATIDYLETHANOLAMINES 1966-74%A%  
% 212.28/212.45  |- skos__prefLabel mesh__D010718 Phosphatidylserines
% 212.28/212.45  |- mesh__recordAuthorizer mesh__D010718 sjn
% 212.28/212.45  |- rdf__type mesh__D010718sskos__Concept
% 212.28/212.45  |- mesh__publicMeSHNote mesh__D010718
% 212.28/212.45       77; was PHOSPHATIDYL SERINE see under CEPHALINS 1963-76   
% 212.28/212.45  |- skos__broader mesh__D010718smesh__D020404
% 212.28/212.45  |- skos__annotation mesh__D010718 /biosyn /physiol permitted   
% 212.28/212.45  |- mesh__recordOriginator mesh__D010718 NLM
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D010718 2004
% 212.28/212.45  |- skos__hiddenLabel mesh__D010718 Phosphoglycerides, Serine
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D010718 2006
% 212.28/212.45  |- mesh__dateEstablished mesh__D010718 1977-01-01
% 212.28/212.45  |- mesh__historyNote mesh__D010718
% 212.28/212.45       77; was PHOSPHATIDYL SERINE see under CEPHALINS 1963-76   
% 212.28/212.45  |- mesh__recordMaintainer mesh__D010718 ssb
% 212.28/212.45  |- mesh__dateCreated mesh__D010718 1999-01-01
% 212.28/212.45  |- skos__altLabel mesh__D010718 Serine Phosphoglycerides
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D010718 2005
% 212.28/212.45  |- mesh__dateRevised mesh__D010718 2003-07-09
% 212.28/212.45  |- skos__historyNote mesh__D010718
% 212.28/212.45       Phosphatidylethanolamines %28%1966-1974%29%
% 212.28/212.45  |- skos__scopeNote mesh__D010718
% 212.28/212.45       Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to a serine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and serine and 2 moles of fatty acids.%A%    
% 212.28/212.45  |- mesh__dateEstablished mesh__D048388 2005-01-01
% 212.28/212.45  |- skos__broader mesh__D048388smesh__D005399
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D048388 2006
% 212.28/212.45  |- skos__altLabel mesh__D048388 Cods
% 212.28/212.45  |- skos__altLabel mesh__D048388 Grenadiers
% 212.28/212.45  |- rdf__type mesh__D048388sskos__Concept
% 212.28/212.45  |- mesh__recordMaintainer mesh__D048388 ags
% 212.28/212.45  |- mesh__historyNote mesh__D048388 2005   
% 212.28/212.45  |- skos__scopeNote mesh__D048388
% 212.28/212.45       An order of fish including the families Gadidae %28%cods%29%, Macrouridae %28%grenadiers%29%, and hakes. The large Gadidae family includes cod, haddock, whiting, and pollock.%A%    
% 212.28/212.45  |- skos__hiddenLabel mesh__D048388 Hake
% 212.28/212.45  |- mesh__recordOriginator mesh__D048388 ags
% 212.28/212.45  |- skos__prefLabel mesh__D048388 Gadiformes
% 212.28/212.45  |- skos__historyNote mesh__D048388 Fishes %28%1969-2004%29%
% 212.28/212.45  |- mesh__publicMeSHNote mesh__D048388 2005   
% 212.28/212.45  |- mesh__dateCreated mesh__D048388 2004-07-07
% 212.28/212.45  |- mesh__recordAuthorizer mesh__D048388 sjn
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D048388 2005
% 212.28/212.45  |- skos__hiddenLabel mesh__D048388 Grenadier
% 212.28/212.45  |- mesh__dateCreated mesh__D015403 1988-06-06
% 212.28/212.45  |- skos__annotation mesh__D015403
% 212.28/212.45       SPEC: SPEC qualif; DF: NURS EVALUATION RESEARCH   
% 212.28/212.45  |- skos__altLabel mesh__D015403 Program Evaluation, Nursing
% 212.28/212.45  |- skos__hiddenLabel mesh__D015403 Nursing Evaluation Researchs
% 212.28/212.45  |- skos__altLabel mesh__D015403 Evaluation Research, Nursing
% 212.28/212.45  |- skos__hiddenLabel mesh__D015403 Nursing Evaluation Study
% 212.28/212.45  |- skos__hiddenLabel mesh__D015403 Researchs, Nursing Evaluation
% 212.28/212.45  |- skos__altLabel mesh__D015403 Research, Nursing Evaluation
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D015403 2005
% 212.28/212.45  |- skos__scopeNote mesh__D015403
% 212.28/212.45       Research carried out by nurses that uses interviews, data collection, observation, surveys, etc., to evaluate nursing, health, clinical, and nursing education programs and curricula, and which also demonstrates the value of such evaluation.%A%    
% 212.28/212.45  |- skos__altLabel mesh__D015403 Evaluation Studies, Nursing
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D015403 2002
% 212.28/212.45  |- skos__hiddenLabel mesh__D015403 Nursing Evaluation Studies
% 212.28/212.45  |- mesh__historyNote mesh__D015403
% 212.28/212.45       91%28%89%29%; was see under NURSING RESEARCH 1989-90   
% 212.28/212.45  |- mesh__recordAuthorizer mesh__D015403 sjn
% 212.28/212.45  |- skos__hiddenLabel mesh__D015403 Studies, Nursing Evaluation
% 212.28/212.45  |- mesh__recordMaintainer mesh__D015403 jls
% 212.28/212.45  |- skos__hiddenLabel mesh__D015403 Study, Nursing Evaluation
% 212.28/212.45  |- skos__prefLabel mesh__D015403 Nursing Evaluation Research
% 212.28/212.45  |- rdf__type mesh__D015403sskos__Concept
% 212.28/212.45  |- skos__historyNote mesh__D015403
% 212.28/212.45       Nursing or specific nursing %28%1966-1988%29%
% 212.28/212.45  |- skos__hiddenLabel mesh__D015403 Evaluation Study, Nursing
% 212.28/212.45  |- mesh__recordOriginator mesh__D015403 EJB
% 212.28/212.45  |- mesh__dateEstablished mesh__D015403 1991-01-01
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D015403 2004
% 212.28/212.45  |- skos__hiddenLabel mesh__D015403 Program Evaluations, Nursing
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D015403 2001
% 212.28/212.45  |- skos__hiddenLabel mesh__D015403 Evaluation Researchs, Nursing
% 212.28/212.45  |- skos__altLabel mesh__D015403 Evaluation, Nursing Program
% 212.28/212.45  |- skos__hiddenLabel mesh__D015403 Nursing Program Evaluations
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D015403 2003
% 212.28/212.45  |- skos__historyNote mesh__D015403 Research %28%1966-1988%29%
% 212.28/212.45  |- skos__hiddenLabel mesh__D015403 Evaluations, Nursing Program
% 212.28/212.45  |- skos__altLabel mesh__D015403 Nursing Program Evaluation
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D015403 2000
% 212.28/212.45  |- mesh__dateRevised mesh__D015403 1999-11-09
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D015403 2006
% 212.28/212.45  |- skos__broader mesh__D015403smesh__D015399
% 212.28/212.45  |- mesh__publicMeSHNote mesh__D015403
% 212.28/212.45       91; was see under NURSING RESEARCH 1989-90   
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D006677 2005
% 212.28/212.45  |- skos__hiddenLabel mesh__D006677 Histrionic Personality Disorders
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D006677 2006
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D006677 2003
% 212.28/212.45  |- mesh__recordMaintainer mesh__D006677 JLS
% 212.28/212.45  |- skos__altLabel mesh__D006677 Hysterical Personality
% 212.28/212.45  |- mesh__recordAuthorizer mesh__D006677 SJN
% 212.28/212.45  |- mesh__onlineNote mesh__D006677
% 212.28/212.45       use HISTRIONIC PERSONALITY DISORDER to search HYSTERICAL PERSONALITY 1969-80%A%  
% 212.28/212.45  |- skos__historyNote mesh__D006677 Hysteria %28%1966-1968%29%
% 212.28/212.45  |- skos__hiddenLabel mesh__D006677 Personality Disorders, Histrionic
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D006677 1998
% 212.28/212.45  |- mesh__publicMeSHNote mesh__D006677
% 212.28/212.45       81; was HYSTERICAL PERSONALITY 1969-80   
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D006677 2004
% 212.28/212.45  |- skos__broader mesh__D006677smesh__D010554
% 212.28/212.45  |- skos__scopeNote mesh__D006677
% 212.28/212.45       A personality disorder characterized by overly reactive and intensely expressed or overly dramatic behavior, proneness to exaggeration, emotional excitability, and disturbances in interpersonal relationships.%A%    
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D006677 2000
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D006677 1999
% 212.28/212.45  |- mesh__historyNote mesh__D006677
% 212.28/212.45       81; was HYSTERICAL PERSONALITY 1969-80   
% 212.28/212.45  |- skos__hiddenLabel mesh__D006677 Disorders, Histrionic Personality
% 212.28/212.45  |- skos__prefLabel mesh__D006677 Histrionic Personality Disorder
% 212.28/212.45  |- skos__hiddenLabel mesh__D006677 Disorder, Histrionic Personality
% 212.28/212.45  |- mesh__recordOriginator mesh__D006677 NLM
% 212.28/212.45  |- skos__hiddenLabel mesh__D006677 Hysterical Personalities
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D006677 2001
% 212.28/212.45  |- skos__hiddenLabel mesh__D006677 Personalities, Hysterical
% 212.28/212.45  |- skos__altLabel mesh__D006677 Personality, Hysterical
% 212.28/212.45  |- mesh__dateEstablished mesh__D006677 1969-01-01
% 212.28/212.45  |- skos__altLabel mesh__D006677 Personality Disorder, Histrionic
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D006677 2002
% 212.28/212.45  |- mesh__dateRevised mesh__D006677 1997-06-20
% 212.28/212.45  |- rdf__type mesh__D006677sskos__Concept
% 212.28/212.45  |- mesh__dateCreated mesh__D006677 1999-01-01
% 212.28/212.45  |- skos__broader mesh__D006321Q000503smesh__D006321
% 212.28/212.45  |- rdf__type mesh__D006321Q000503smesh__CompoundConcept
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D011811 2006
% 212.28/212.45  |- mesh__recordAuthorizer mesh__D011811 sjn
% 212.28/212.45  |- mesh__dateRevised mesh__D011811 2004-07-07
% 212.28/212.45  |- mesh__recordOriginator mesh__D011811 NLM
% 212.28/212.45  |- skos__hiddenLabel mesh__D011811 Quintuplet
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D011811 2005
% 212.28/212.45  |- skos__broader mesh__D011811smesh__D011272
% 212.28/212.45  |- rdf__type mesh__D011811sskos__Concept
% 212.28/212.45  |- skos__annotation mesh__D011811
% 212.28/212.45       human only; for animals use LITTER SIZE; relation to PREGNANCY: Manual 28.16.4%A%  
% 212.28/212.45  |- skos__prefLabel mesh__D011811 Quintuplets
% 212.28/212.45  |- skos__broader mesh__D011811smesh__D009099
% 212.28/212.45  |- skos__scopeNote mesh__D011811
% 212.28/212.45       Five individuals derived from five FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother.%A%    
% 212.28/212.45  |- mesh__recordMaintainer mesh__D011811 lkt
% 212.28/212.45  |- mesh__dateCreated mesh__D011811 1999-01-01
% 212.28/212.45  |- skos__scopeNote mesh__D011013
% 212.28/212.45       The excision of lung tissue including partial or total lung lobectomy.%A%    
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D011013 2004
% 212.28/212.45  |- skos__hiddenLabel mesh__D011013 Reductions, Lung Volume
% 212.28/212.45  |- skos__hiddenLabel mesh__D011013 Pneumonectomies
% 212.28/212.45  |- mesh__recordOriginator mesh__D011013 NLM
% 212.28/212.45  |- mesh__dateCreated mesh__D011013 1999-01-01
% 212.28/212.45  |- skos__hiddenLabel mesh__D011013 Lung Volume Reductions
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D011013 2005
% 212.28/212.45  |- skos__broader mesh__D011013smesh__D013510
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D011013 2006
% 212.28/212.45  |- skos__hiddenLabel mesh__D011013 Volume Reduction, Lung
% 212.28/212.45  |- skos__hiddenLabel mesh__D011013 Reduction, Lung Volume
% 212.28/212.45  |- rdf__type mesh__D011013sskos__Concept
% 212.28/212.45  |- skos__hiddenLabel mesh__D011013 Volume Reductions, Lung
% 212.28/212.45  |- mesh__dateRevised mesh__D011013 2002-07-03
% 212.28/212.45  |- mesh__recordAuthorizer mesh__D011013 sjn
% 212.28/212.45  |- mesh__recordMaintainer mesh__D011013 lkt
% 212.28/212.45  |- skos__prefLabel mesh__D011013 Pneumonectomy
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D011013 2003
% 212.28/212.45  |- mesh__publicMeSHNote mesh__D029424
% 212.28/212.45       2002; see LUNG DISEASES, OBSTRUCTIVE 1984-2001   
% 212.28/212.45  |- skos__hiddenLabel mesh__D029424 Airflow Obstructions, Chronic
% 212.28/212.45  |- mesh__dateCreated mesh__D029424 2001-07-25
% 212.28/212.45  |- skos__altLabel mesh__D029424 Chronic Airflow Obstruction
% 212.28/212.45  |- mesh__recordAuthorizer mesh__D029424 sjn
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D029424 2004
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D029424 2002
% 212.28/212.45  |- skos__altLabel mesh__D029424 COAD
% 212.28/212.45  |- mesh__dateEstablished mesh__D029424 2002-01-01
% 212.28/212.45  |- skos__prefLabel mesh__D029424 Pulmonary Disease, Chronic Obstructive
% 212.28/212.45  |- skos__scopeNote mesh__D029424
% 212.28/212.45       A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.%A%    
% 212.28/212.45  |- skos__altLabel mesh__D029424 Chronic Obstructive Pulmonary Disease
% 212.28/212.45  |- mesh__historyNote mesh__D029424
% 212.28/212.45       2002; use LUNG DISEASES, OBSTRUCTIVE 1984-2001   
% 212.28/212.45  |- skos__broader mesh__D029424smesh__D008173
% 212.28/212.45  |- skos__altLabel mesh__D029424 Chronic Obstructive Airway Disease
% 212.28/212.45  |- skos__historyNote mesh__D029424 Pulmonary Emphysema %28%1965-1971%29%
% 212.28/212.45  |- skos__altLabel mesh__D029424 COPD
% 212.28/212.45  |- skos__annotation mesh__D029424
% 212.28/212.45       LUNG DISEASES, OBSTRUCTIVE is also available   
% 212.28/212.45  |- skos__historyNote mesh__D029424
% 212.28/212.45       Lung Diseases, Obstructive %28%1971-2001%29%
% 212.28/212.45  |- mesh__recordOriginator mesh__D029424 lkt
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D029424 2005
% 212.28/212.45  |- mesh__recordMaintainer mesh__D029424 lkt
% 212.28/212.45  |- skos__altLabel mesh__D029424 Chronic Obstructive Lung Disease
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D029424 2003
% 212.28/212.45  |- rdf__type mesh__D029424sskos__Concept
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D029424 2006
% 212.28/212.45  |- skos__hiddenLabel mesh__D029424 Chronic Airflow Obstructions
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D002287 2006
% 212.28/212.45  |- skos__broader mesh__D002287smesh__D002277
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D002287 2004
% 212.28/212.45  |- mesh__dateCreated mesh__D002287 1999-01-01
% 212.28/212.45  |- skos__hiddenLabel mesh__D002287 Krebs 2 Carcinoma
% 212.28/212.45  |- rdf__type mesh__D002287sskos__Concept
% 212.28/212.45  |- skos__annotation mesh__D002287
% 212.28/212.45       exper neopl; /blood supply /chem /second /secret /ultrastruct permitted; don%27%t forget check tag ANIMALS%A%  
% 212.28/212.45  |- skos__broader mesh__D002287smesh__D009374
% 212.28/212.45  |- mesh__dateRevised mesh__D002287 2003-07-30
% 212.28/212.45  |- mesh__recordMaintainer mesh__D002287 ags
% 212.28/212.45  |- mesh__recordAuthorizer mesh__D002287 sjn
% 212.28/212.45  |- skos__prefLabel mesh__D002287 Carcinoma, Krebs 2
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D002287 2005
% 212.28/212.45  |- mesh__recordOriginator mesh__D002287 NLM
% 212.28/212.45  |- skos__hiddenLabel mesh__D010719 Phosphene
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D010719 2006
% 212.28/212.45  |- skos__scopeNote mesh__D010719
% 212.28/212.45       Visual sensations arising from mechanical or electrical stimulation of the eyeball.%A%    
% 212.28/212.45  |- mesh__dateCreated mesh__D010719 1974-11-19
% 212.28/212.45  |- mesh__historyNote mesh__D010719
% 212.28/212.45       91%28%75%29%; was see under VISION 1975-90   
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D010719 2005
% 212.28/212.45  |- mesh__recordMaintainer mesh__D010719 nns
% 212.28/212.45  |- mesh__dateEstablished mesh__D010719 1991-01-01
% 212.28/212.45  |- mesh__recordAuthorizer mesh__D010719 sjn
% 212.28/212.45  |- mesh__dateRevised mesh__D010719 2003-07-09
% 212.28/212.45  |- skos__annotation mesh__D010719
% 212.28/212.45       visual sensations of the eyeball; do not confuse with PHOSPHINES%A%  
% 212.28/212.45  |- mesh__recordOriginator mesh__D010719 NLM
% 212.28/212.45  |- skos__prefLabel mesh__D010719 Phosphenes
% 212.28/212.45  |- rdf__type mesh__D010719sskos__Concept
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D010719 2004
% 212.28/212.45  |- skos__broader mesh__D010719smesh__D014785
% 212.28/212.45  |- mesh__publicMeSHNote mesh__D010719 91; was see under VISION 1975-90   
% 212.28/212.45  |- mesh__dateCreated mesh__D007770 1999-01-01
% 212.28/212.45  |- mesh__publicMeSHNote mesh__D007770
% 212.28/212.45       2004; see LACTATE DEHYDROGENASE 1966-2003   
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D007770 2004
% 212.28/212.45  |- mesh__recordMaintainer mesh__D007770 AKE
% 212.28/212.45  |- rdf__type mesh__D007770sskos__Concept
% 212.28/212.45  |- skos__broader mesh__D007770smesh__D045022
% 212.28/212.45  |- skos__hiddenLabel mesh__D007770 L Lactate Dehydrogenase
% 212.28/212.45  |- skos__hiddenLabel mesh__D007770 Dehydrogenase, L-Lactate
% 212.28/212.45  |- mesh__recordOriginator mesh__D007770 NLM
% 212.28/212.45  |- mesh__dateRevised mesh__D007770 2003-07-09
% 212.28/212.45  |- skos__altLabel mesh__D007770 Lactate Dehydrogenase
% 212.28/212.45  |- skos__scopeNote mesh__D007770
% 212.28/212.45       A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits %28%LDH-A, LDH-B and LDH-C%29% exist.%A%    
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D007770 2005
% 212.28/212.45  |- skos__prefLabel mesh__D007770 L-Lactate Dehydrogenase
% 212.28/212.45  |- mesh__recordAuthorizer mesh__D007770 sjn
% 212.28/212.45  |- skos__hiddenLabel mesh__D007770 Dehydrogenase, Lactate
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D007770 2006
% 212.28/212.45  |- mesh__historyNote mesh__D007770 2004%28%1966%29%   
% 212.28/212.45  |- skos__hiddenLabel mesh__D021441 Carcinomas, Pancreas Duct-Cell
% 212.28/212.45  |- skos__annotation mesh__D021441
% 212.28/212.45       coord IM with PANCREATIC NEOPLASMS %28%IM%29%   
% 212.28/212.45  |- mesh__recordOriginator mesh__D021441 jmp
% 212.28/212.45  |- skos__hiddenLabel mesh__D021441 Ductal Carcinomas, Pancreatic
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D021441 2005
% 212.28/212.45  |- skos__broader mesh__D021441smesh__D010190
% 212.28/212.45  |- mesh__recordAuthorizer mesh__D021441 sjn
% 212.28/212.45  |- skos__hiddenLabel mesh__D021441 Pancreatic Ductal Carcinomas
% 212.28/212.45  |- skos__hiddenLabel mesh__D021441 Pancreas Duct-Cell Carcinomas
% 212.28/212.45  |- skos__altLabel mesh__D021441 Ductal Carcinoma of the Pancreas
% 212.28/212.45  |- skos__historyNote mesh__D021441 Pancreatic Neoplasms %28%1966-2000%29%
% 212.28/212.45  |- rdf__type mesh__D021441sskos__Concept
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D021441 2006
% 212.28/212.45  |- mesh__dateRevised mesh__D021441 2004-07-07
% 212.28/212.45  |- mesh__dateCreated mesh__D021441 2000-06-22
% 212.28/212.45  |- skos__hiddenLabel mesh__D021441 Carcinoma, Pancreas Duct-Cell
% 212.28/212.45  |- skos__hiddenLabel mesh__D021441 Carcinomas, Pancreatic Ductal
% 212.28/212.45  |- skos__hiddenLabel mesh__D021441 Duct Cell Carcinoma, Pancreas
% 212.28/212.45  |- skos__altLabel mesh__D021441 Duct-Cell Carcinoma of the Pancreas
% 212.28/212.45  |- skos__hiddenLabel mesh__D021441 Duct-Cell Carcinomas, Pancreas
% 212.28/212.45  |- mesh__publicMeSHNote mesh__D021441 2001   
% 212.28/212.45  |- mesh__dateEstablished mesh__D021441 2001-01-01
% 212.28/212.45  |- mesh__recordMaintainer mesh__D021441 lkt
% 212.28/212.45  |- skos__prefLabel mesh__D021441 Carcinoma, Pancreatic Ductal
% 212.28/212.45  |- mesh__historyNote mesh__D021441 2001   
% 212.28/212.45  |- skos__altLabel mesh__D021441 Pancreatic Ductal Carcinoma
% 212.28/212.45  |- skos__broader mesh__D021441smesh__D044584
% 212.28/212.45  |- skos__hiddenLabel mesh__D021441 Duct Cell Carcinoma of the Pancreas
% 212.28/212.45  |- skos__scopeNote mesh__D021441
% 212.28/212.45       Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.%A%    
% 212.28/212.45  |- skos__altLabel mesh__D021441 Pancreatic Duct Cell Carcinoma
% 212.28/212.45  |- skos__hiddenLabel mesh__D021441 Ductal Carcinoma, Pancreatic
% 212.28/212.45  |- skos__altLabel mesh__D021441 Duct-Cell Carcinoma, Pancreas
% 212.28/212.45  |- skos__hiddenLabel mesh__D021441 Pancreas Duct-Cell Carcinoma
% 212.28/212.45  |- mesh__publicMeSHNote mesh__D048389 2005   
% 212.28/212.45  |- mesh__recordMaintainer mesh__D048389 ags
% 212.28/212.45  |- skos__prefLabel mesh__D048389 Gadus morhua
% 212.28/212.45  |- mesh__recordOriginator mesh__D048389 ags
% 212.28/212.45  |- mesh__recordAuthorizer mesh__D048389 sjn
% 212.28/212.45  |- mesh__dateEstablished mesh__D048389 2005-01-01
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D048389 2006
% 212.28/212.45  |- skos__scopeNote mesh__D048389
% 212.28/212.45       A species of fish in the cod family GADIDAE, known as the Atlantic cod. It is one of the most important commercial FISHES.%A%    
% 212.28/212.45  |- skos__hiddenLabel mesh__D048389 Cod, Atlantic
% 212.28/212.45  |- mesh__historyNote mesh__D048389 2005   
% 212.28/212.45  |- skos__historyNote mesh__D048389 Fishes %28%1968-2004%29%
% 212.28/212.45  |- skos__broader mesh__D048389smesh__D048388
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D048389 2005
% 212.28/212.45  |- rdf__type mesh__D048389sskos__Concept
% 212.28/212.45  |- skos__altLabel mesh__D048389 Atlantic Cod
% 212.28/212.45  |- mesh__dateCreated mesh__D048389 2004-07-07
% 212.28/212.45  |- mesh__recordMaintainer mesh__D015404 sjn
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D015404 2006
% 212.28/212.45  |- mesh__recordAuthorizer mesh__D015404 sjn
% 212.28/212.45  |- mesh__historyNote mesh__D015404
% 212.28/212.45       91%28%89%29%; was see under NURSING RESEARCH 1989-90   
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D015404 2005
% 212.28/212.45  |- skos__altLabel mesh__D015404 Methodology Research, Nursing
% 212.28/212.45  |- rdf__type mesh__D015404sskos__Concept
% 212.28/212.45  |- skos__historyNote mesh__D015404
% 212.28/212.45       Nursing or specific nursing %28%1966-1988%29%
% 212.28/212.45  |- skos__annotation mesh__D015404
% 212.28/212.45       SPEC: SPEC qualif; DF: NURS METHODOL RESEARCH   
% 212.28/212.45  |- mesh__dateEstablished mesh__D015404 1991-01-01
% 212.28/212.45  |- mesh__dateRevised mesh__D015404 2004-07-13
% 212.28/212.45  |- mesh__recordOriginator mesh__D015404 EJB
% 212.28/212.45  |- skos__historyNote mesh__D015404 Research %28%1966-1988%29%
% 212.28/212.45  |- skos__broader mesh__D015404smesh__D015399
% 212.28/212.45  |- mesh__publicMeSHNote mesh__D015404
% 212.28/212.45       91; was see under NURSING RESEARCH 1989-90   
% 212.28/212.45  |- mesh__dateCreated mesh__D015404 1988-06-06
% 212.28/212.45  |- skos__scopeNote mesh__D015404
% 212.28/212.45       Research carried out by nurses concerning techniques and methods to implement projects and to document information, including methods of interviewing patients, collecting data, and forming inferences. The concept includes exploration of methodological issues such as human subjectivity and human experience.%A%    
% 212.28/212.45  |- skos__altLabel mesh__D015404 Research, Nursing Methodology
% 212.28/212.45  |- skos__prefLabel mesh__D015404 Nursing Methodology Research
% 212.28/212.45  |- skos__related mesh__D006678smesh__D015728
% 212.28/212.45  |- mesh__dateEstablished mesh__D006678 1987-01-01
% 212.28/212.45  |- mesh__publicMeSHNote mesh__D006678
% 212.28/212.45       1988; see HTLV-III 1987; for AIDS VIRUS see HIV-1 1990-2004; for HUMAN T-CELL LEUKEMIA VIRUS TYPE III see HIV 1987-1991%A%  
% 212.28/212.45  |- skos__altLabel mesh__D006678 Human T-Cell Lymphotropic Virus Type III
% 212.28/212.45  |- skos__altLabel mesh__D006678 Immunodeficiency Virus, Human
% 212.28/212.45  |- skos__historyNote mesh__D006678
% 212.28/212.45       Human T-Cell Leukemia Virus %28%1984-1986%29%
% 212.28/212.45  |- skos__hiddenLabel mesh__D006678 Lymphadenopathy Associated Virus
% 212.28/212.45  |- skos__hiddenLabel mesh__D006678 Virus, AIDS
% 212.28/212.45  |- skos__broader mesh__D006678smesh__D017958
% 212.28/212.45  |- skos__altLabel mesh__D006678 Human T-Cell Leukemia Virus Type III
% 212.28/212.45  |- skos__altLabel mesh__D006678 Human T Cell Lymphotropic Virus Type III
% 212.28/212.45  |- skos__altLabel mesh__D006678 AIDS Virus
% 212.28/212.45  |- skos__hiddenLabel mesh__D006678 AIDS Viruses
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D006678 2006
% 212.28/212.45  |- skos__altLabel mesh__D006678 Immunodeficiency Viruses, Human
% 212.28/212.45  |- skos__altLabel mesh__D006678 Human Immunodeficiency Virus
% 212.28/212.45  |- skos__altLabel mesh__D006678 Human Immunodeficiency Viruses
% 212.28/212.45  |- skos__hiddenLabel mesh__D006678 Human T Cell Leukemia Virus Type III
% 212.28/212.45  |- mesh__recordAuthorizer mesh__D006678 sjn
% 212.28/212.45  |- skos__altLabel mesh__D006678 Acquired Immunodeficiency Syndrome Virus
% 212.28/212.45  |- skos__annotation mesh__D006678
% 212.28/212.45       infection = HIV INFECTIONS but prefer specifics   
% 212.28/212.45  |- skos__altLabel mesh__D006678 LAV-HTLV-III
% 212.28/212.45  |- skos__related mesh__D006678smesh__D018894
% 212.28/212.45  |- mesh__dateCreated mesh__D006678 1986-06-17
% 212.28/212.45  |- mesh__recordMaintainer mesh__D006678 sjn
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D006678 2005
% 212.28/212.45  |- skos__hiddenLabel mesh__D006678 Lymphadenopathy-Associated Viruses
% 212.28/212.45  |- rdf__type mesh__D006678sskos__Concept
% 212.28/212.45  |- mesh__dateRevised mesh__D006678 2004-07-13
% 212.28/212.45  |- skos__altLabel mesh__D006678 Human T Lymphotropic Virus Type III
% 212.28/212.45  |- skos__hiddenLabel mesh__D006678 Viruses, AIDS
% 212.28/212.45  |- mesh__recordOriginator mesh__D006678 RC
% 212.28/212.45  |- mesh__historyNote mesh__D006678
% 212.28/212.45       1988; use HTLV-III 1987; for AIDS VIRUS use HIV-1 1990-2004; for HUMAN T-CELL LEUKEMIA VIRUS TYPE III see HIV 1987-1991%A%  
% 212.28/212.45  |- skos__altLabel mesh__D006678 Lymphadenopathy-Associated Virus
% 212.28/212.45  |- skos__hiddenLabel mesh__D006678 Viruses, Lymphadenopathy-Associated
% 212.28/212.45  |- skos__scopeNote mesh__D006678
% 212.28/212.45       Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2.  Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus %28%HTLV-III/LAV%29%. From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.%A%    
% 212.28/212.45  |- skos__altLabel mesh__D006678 Virus, Human Immunodeficiency
% 212.28/212.45  |- skos__altLabel mesh__D006678 Acquired Immune Deficiency Syndrome Virus
% 212.28/212.45  |- skos__altLabel mesh__D006678 Viruses, Human Immunodeficiency
% 212.28/212.45  |- skos__altLabel mesh__D006678 HTLV-III
% 212.28/212.45  |- skos__hiddenLabel mesh__D006678 Virus, Lymphadenopathy-Associated
% 212.28/212.45  |- skos__prefLabel mesh__D006678 HIV
% 212.28/212.45  |- skos__altLabel mesh__D006678 Human T-Lymphotropic Virus Type III
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D020349 2005
% 212.28/212.45  |- mesh__dateCreated mesh__D020349 1998-06-11
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D020349 2003
% 212.28/212.45  |- mesh__dateEstablished mesh__D020349 1999-01-01
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D020349 2006
% 212.28/212.45  |- skos__annotation mesh__D020349
% 212.28/212.45       do not confuse with plasmon, extrachromosomal genetic material%A%  
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D020349 2000
% 212.28/212.45  |- mesh__publicMeSHNote mesh__D020349 99   
% 212.28/212.45  |- skos__hiddenLabel mesh__D020349 Resonance, Surface Plasmon
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D020349 2004
% 212.28/212.45  |- skos__broader mesh__D020349smesh__D002623
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D020349 1999
% 212.28/212.45  |- mesh__historyNote mesh__D020349 99   
% 212.28/212.45  |- skos__hiddenLabel mesh__D020349 Plasmon Resonance, Surface
% 212.28/212.45  |- skos__hiddenLabel mesh__D020349 Surface Plasmon Resonances
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D020349 2001
% 212.28/212.45  |- skos__scopeNote mesh__D020349
% 212.28/212.45       A biosensing technique in which biomolecules capable of binding to specific analytes or ligands are first immobilized on one side of a metallic film. Light is then focused on the opposite side of the film to excite the surface plasmons, that is, the oscillations of free electrons propagating along the film%27%s surface. The refractive index of light reflecting off this surface is measured. When the immobilized biomolecules are bound by their ligands, an alteration in surface plasmons on the opposite side of the film is created which is directly proportional to the change in bound, or adsorbed, mass. Binding is measured by changes in the refractive index. The technique is used to study biomolecular interactions, such as antigen-antibody binding.%A%    
% 212.28/212.45  |- skos__prefLabel mesh__D020349 Surface Plasmon Resonance
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D020349 2002
% 212.28/212.45  |- skos__broader mesh__D020349smesh__D015374
% 212.28/212.45  |- skos__hiddenLabel mesh__D020349 Plasmon Resonances, Surface
% 212.28/212.45  |- skos__historyNote mesh__D020349 Biosensing Techniques %28%1991-1998%29%
% 212.28/212.45  |- rdf__type mesh__D020349sskos__Concept
% 212.28/212.45  |- skos__hiddenLabel mesh__D020349 Resonances, Surface Plasmon
% 212.28/212.45  |- rdf__type mesh__D003380sskos__Concept
% 212.28/212.45  |- skos__prefLabel mesh__D003380 Courtship
% 212.28/212.45  |- mesh__recordMaintainer mesh__D003380 lkt
% 212.28/212.45  |- skos__broader mesh__D003380smesh__D012725
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D003380 2005
% 212.28/212.45  |- skos__hiddenLabel mesh__D003380 Courtships
% 212.28/212.45  |- mesh__dateRevised mesh__D003380 2004-07-07
% 212.28/212.45  |- mesh__dateCreated mesh__D003380 1999-01-01
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D003380 2006
% 212.28/212.45  |- mesh__recordAuthorizer mesh__D003380 sjn
% 212.28/212.45  |- skos__annotation mesh__D003380 human %26% animal   
% 212.28/212.45  |- mesh__recordOriginator mesh__D003380 NLM
% 212.28/212.45  |- skos__related mesh__D003380smesh__D008149
% 212.28/212.45  |- skos__scopeNote mesh__D003380
% 212.28/212.45       Activities designed to attract the attention or favors of another.%A%    
% 212.28/212.45  |- rdf__type mesh__D011812sskos__Concept
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D011812 2002
% 212.28/212.45  |- skos__prefLabel mesh__D011812 Quinuclidines
% 212.28/212.45  |- mesh__activeMeSHYear mesh__D011812 1994
% 212.28/212.46  |- mesh__recordMaintainer mesh__D011812 TAP
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011812 2001
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011812 2000
% 212.28/212.46  |- skos__broader mesh__D011812smesh__D006572
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011812 1997
% 212.28/212.46  |- mesh__recordAuthorizer mesh__D011812 PLS
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011812 2004
% 212.28/212.46  |- mesh__recordOriginator mesh__D011812 NLM
% 212.28/212.46  |- mesh__dateCreated mesh__D011812 1999-01-01
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011812 1999
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011812 1996
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011812 2006
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011812 2003
% 212.28/212.46  |- mesh__dateRevised mesh__D011812 1992-05-20
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011812 1993
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011812 1998
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011812 2005
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011812 1995
% 212.28/212.46  |- skos__hiddenLabel mesh__D011014 Inflammations, Lung
% 212.28/212.46  |- mesh__recordAuthorizer mesh__D011014 sjn
% 212.28/212.46  |- skos__annotation mesh__D011014 GEN or unspecified; prefer specifics   
% 212.28/212.46  |- mesh__dateCreated mesh__D011014 1999-01-01
% 212.28/212.46  |- skos__hiddenLabel mesh__D011014 Inflammation, Experimental Lung
% 212.28/212.46  |- skos__altLabel mesh__D011014 Pulmonary Inflammation
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011014 2005
% 212.28/212.46  |- skos__hiddenLabel mesh__D011014 Pulmonary Inflammations
% 212.28/212.46  |- skos__hiddenLabel mesh__D011014 Pneumonitides
% 212.28/212.46  |- skos__hiddenLabel mesh__D011014 Inflammations, Pulmonary
% 212.28/212.46  |- skos__scopeNote mesh__D011014 Inflammation of the lungs.     
% 212.28/212.46  |- skos__hiddenLabel mesh__D011014 Pneumonias
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011014 2001
% 212.28/212.46  |- mesh__dateRevised mesh__D011014 2000-06-22
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011014 2006
% 212.28/212.46  |- mesh__recordMaintainer mesh__D011014 jmp
% 212.28/212.46  |- skos__hiddenLabel mesh__D011014 Experimental Lung Inflammations
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011014 2002
% 212.28/212.46  |- skos__broader mesh__D011014smesh__D008171
% 212.28/212.46  |- mesh__recordOriginator mesh__D011014 NLM
% 212.28/212.46  |- skos__hiddenLabel mesh__D011014 Inflammation, Pulmonary
% 212.28/212.46  |- rdf__type mesh__D011014sskos__Concept
% 212.28/212.46  |- skos__broader mesh__D011014smesh__D012141
% 212.28/212.46  |- skos__prefLabel mesh__D011014 Pneumonia
% 212.28/212.46  |- skos__hiddenLabel mesh__D011014 Lung Inflammation, Experimental
% 212.28/212.46  |- skos__hiddenLabel mesh__D011014 Lung Inflammations, Experimental
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011014 2003
% 212.28/212.46  |- skos__hiddenLabel mesh__D011014 Inflammation, Lung
% 212.28/212.46  |- skos__hiddenLabel mesh__D011014 Lung Inflammations
% 212.28/212.46  |- skos__altLabel mesh__D011014 Lung Inflammation
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011014 2004
% 212.28/212.46  |- skos__altLabel mesh__D011014 Pneumonitis
% 212.28/212.46  |- mesh__recordMaintainer mesh__D035462 ssb
% 212.28/212.46  |- rdf__type mesh__D035462sskos__Concept
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D035462 2003
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D035462 2005
% 212.28/212.46  |- mesh__publicMeSHNote mesh__D035462
% 212.28/212.46       2003; KUTAJA was indexed under ALKALOIDS 1984-2002   
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D035462 2004
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D035462 2006
% 212.28/212.46  |- skos__prefLabel mesh__D035462 Holarrhena
% 212.28/212.46  |- skos__scopeNote mesh__D035462
% 212.28/212.46       A plant genus of the family APOCYNACEAE. Members contain holarrhenine %28%a steroidal alkaloid%29% and TRICHOTHECENES.%A%    
% 212.28/212.46  |- mesh__historyNote mesh__D035462
% 212.28/212.46       2003; for KUTAJA use KUTAJA %28%NM%29% 1984-2002   
% 212.28/212.46  |- skos__annotation mesh__D035462
% 212.28/212.46       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.28/212.46  |- mesh__dateCreated mesh__D035462 2002-07-03
% 212.28/212.46  |- skos__broader mesh__D035462smesh__D029062
% 212.28/212.46  |- mesh__recordOriginator mesh__D035462 ssb
% 212.28/212.46  |- mesh__recordAuthorizer mesh__D035462 sjn
% 212.28/212.46  |- mesh__dateEstablished mesh__D035462 2003-01-01
% 212.28/212.46  |- mesh__publicMeSHNote mesh__D002288
% 212.28/212.46       94; was CARCINOMA, MUCINOUS 1981-93; CARCINOMA, COLLOID was heading 1963-80%A%  
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D002288 2000
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D002288 1996
% 212.28/212.46  |- mesh__dateCreated mesh__D002288 1999-01-01
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D002288 2004
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D002288 1998
% 212.28/212.46  |- mesh__dateRevised mesh__D002288 1995-06-08
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D002288 2006
% 212.28/212.46  |- skos__altLabel mesh__D002288 Carcinoma, Mucinous
% 212.28/212.46  |- skos__hiddenLabel mesh__D002288 Colloid Carcinoma
% 212.28/212.46  |- skos__broader mesh__D002288smesh__D000230
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D002288 2003
% 212.28/212.46  |- mesh__recordOriginator mesh__D002288 NLM
% 212.28/212.46  |- skos__prefLabel mesh__D002288 Adenocarcinoma, Mucinous
% 212.28/212.46  |- mesh__recordMaintainer mesh__D002288 KEV
% 212.28/212.46  |- skos__hiddenLabel mesh__D002288 Mucinous Adenocarcinomas
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D002288 2005
% 212.28/212.46  |- skos__hiddenLabel mesh__D002288 Colloid Carcinomas
% 212.28/212.46  |- skos__hiddenLabel mesh__D002288 Mucinous Adenocarcinoma
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D002288 2002
% 212.28/212.46  |- skos__broader mesh__D002288smesh__D018297
% 212.28/212.46  |- mesh__onlineNote mesh__D002288
% 212.28/212.46       use ADENOCARCINOMA, MUCINOUS to search CARCINOMA, MUCINOUS 1981-93 %26% CARCINOMA, COLLOID 1966-80%A%  
% 212.28/212.46  |- skos__hiddenLabel mesh__D002288 Carcinomas, Mucinous
% 212.28/212.46  |- skos__hiddenLabel mesh__D002288 Adenocarcinomas, Mucinous
% 212.28/212.46  |- rdf__type mesh__D002288sskos__Concept
% 212.28/212.46  |- skos__altLabel mesh__D002288 Carcinoma, Colloid
% 212.28/212.46  |- mesh__recordAuthorizer mesh__D002288 PLS
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D002288 2001
% 212.28/212.46  |- skos__hiddenLabel mesh__D002288 Carcinomas, Colloid
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D002288 1997
% 212.28/212.46  |- skos__hiddenLabel mesh__D002288 Mucinous Carcinoma
% 212.28/212.46  |- skos__hiddenLabel mesh__D002288 Mucinous Carcinomas
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D002288 1999
% 212.28/212.46  |- mesh__historyNote mesh__D002288
% 212.28/212.46       94; was CARCINOMA, MUCINOUS 1981-93; CARCINOMA, COLLOID was heading 1963-80%A%  
% 212.28/212.46  |- skos__annotation mesh__D002288
% 212.28/212.46       also called %22%mucoid%22% or %22%mucous%22% carcinoma; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 212.28/212.46  |- skos__scopeNote mesh__D002288
% 212.28/212.46       An adenocarcinoma producing mucin in significant amounts. %28%From Dorland, 27th ed%29%%A%    
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 Seroconversion, HTLV-III
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 Positivity, HIV Antibody
% 212.28/212.46  |- skos__altLabel mesh__D006679 HIV Seroconversion
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 HIV Seropositivities
% 212.28/212.46  |- skos__historyNote mesh__D006679
% 212.28/212.46       Human T-Cell Leukemia Virus %28%1984-1986%29%
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 AIDS Seroconversions
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 HIV Antibody Positivities
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D006679 2006
% 212.28/212.46  |- skos__scopeNote mesh__D006679
% 212.28/212.46       Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus %28%HIV/HTLV-III/LAV%29%.%A%    
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 Positivities, HIV Antibody
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 Anti HIV Positivity
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 Seropositivity, AIDS
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 HTLV III Seropositivity
% 212.28/212.46  |- skos__altLabel mesh__D006679 Anti-HIV Positivity
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 Seroconversion, HIV
% 212.28/212.46  |- mesh__recordAuthorizer mesh__D006679 sjn
% 212.28/212.46  |- skos__altLabel mesh__D006679 HIV Antibody Positivity
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 Seroconversion, AIDS
% 212.28/212.46  |- skos__historyNote mesh__D006679
% 212.28/212.46       Acquired Immunodeficiency Syndrome %28%1984-1987%29%
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D006679 2005
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 Antibody Positivity, HIV
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 Seroconversions, HIV
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 Seropositivities, AIDS
% 212.28/212.46  |- rdf__type mesh__D006679sskos__Concept
% 212.28/212.46  |- skos__historyNote mesh__D006679 HTLV-III %28%1987%29%
% 212.28/212.46  |- skos__prefLabel mesh__D006679 HIV Seropositivity
% 212.28/212.46  |- mesh__recordMaintainer mesh__D006679 sjn
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 Positivities, Anti-HIV
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 Antibody Positivities, HIV
% 212.28/212.46  |- skos__altLabel mesh__D006679 HTLV-III Seropositivity
% 212.28/212.46  |- skos__altLabel mesh__D006679 AIDS Seropositivity
% 212.28/212.46  |- mesh__dateRevised mesh__D006679 2004-07-13
% 212.28/212.46  |- skos__historyNote mesh__D006679 Antibodies, Viral %28%1983-1987%29%
% 212.28/212.46  |- skos__related mesh__D006679smesh__D018023
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 Seroconversions, AIDS
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 HTLV-III Seroconversions
% 212.28/212.46  |- mesh__dateCreated mesh__D006679 1987-09-28
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 HTLV III Seroconversion
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 AIDS Seropositivities
% 212.28/212.46  |- skos__altLabel mesh__D006679 HTLV-III Seroconversion
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 Seropositivity, HTLV-III
% 212.28/212.46  |- skos__altLabel mesh__D006679 AIDS Seroconversion
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 HTLV-III Seropositivities
% 212.28/212.46  |- skos__annotation mesh__D006679
% 212.28/212.46       note category; HIV SERONEGATIVITY %28%Cat G%29% is also available; /diag /immunol permitted but use caution; coord IM with HIV-1 /immunol %28%IM%29% or HIV-2 /immunol %28%IM%29%; do not confuse with HIV SEROPREVALENCE, an epidemiol concept; DF: HIV SEROPOS%A%  
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 Anti-HIV Positivities
% 212.28/212.46  |- mesh__publicMeSHNote mesh__D006679
% 212.28/212.46       88; ANTI-HIV POSITIVITY was ANTI-HIV POSITIVE 1988-93; HIV ANTIBODY POSITIVITY was HIV ANTIBODY POSITIVE 1988-93%A%  
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 Seroconversions, HTLV-III
% 212.28/212.46  |- mesh__historyNote mesh__D006679
% 212.28/212.46       88; ANTI-HIV POSITIVITY was ANTI-HIV POSITIVE 1988-93; HIV ANTIBODY POSITIVITY was HIV ANTIBODY POSITIVE 1988-93%A%  
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 HIV Seroconversions
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 Seropositivity, HIV
% 212.28/212.46  |- skos__related mesh__D006679smesh__D015528
% 212.28/212.46  |- skos__broader mesh__D006679smesh__D015658
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 Positivity, Anti-HIV
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 Seropositivities, HIV
% 212.28/212.46  |- skos__hiddenLabel mesh__D006679 Seropositivities, HTLV-III
% 212.28/212.46  |- mesh__dateEstablished mesh__D006679 1988-01-01
% 212.28/212.46  |- mesh__recordOriginator mesh__D006679 SCD
% 212.28/212.46  |- skos__scopeNote mesh__D003381
% 212.28/212.46       A genus of gram-negative, rod-shaped bacteria that is widely distributed in TICKS and various mammals throughout the world. Infection with this genus is particularly prevalent in CATTLE, SHEEP, and GOATS.%A%    
% 212.28/212.46  |- skos__broader mesh__D003381smesh__D044125
% 212.28/212.46  |- mesh__recordAuthorizer mesh__D003381 sjn
% 212.28/212.46  |- mesh__recordMaintainer mesh__D003381 SYSTEM
% 212.28/212.46  |- mesh__recordOriginator mesh__D003381 NLM
% 212.28/212.46  |- rdf__type mesh__D003381sskos__Concept
% 212.28/212.46  |- skos__prefLabel mesh__D003381 Coxiella
% 212.28/212.46  |- skos__annotation mesh__D003381
% 212.28/212.46       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D003381 2006
% 212.28/212.46  |- mesh__dateCreated mesh__D003381 1999-01-01
% 212.28/212.46  |- mesh__dateRevised mesh__D003381 2005-06-30
% 212.28/212.46  |- mesh__publicMeSHNote mesh__D011813
% 212.28/212.46       91; was see under QUINUCLIDINES 1980-90   
% 212.28/212.46  |- mesh__recordMaintainer mesh__D011813 CCR
% 212.28/212.46  |- skos__historyNote mesh__D011813 Quinuclidines %28%1966-1979%29%
% 212.28/212.46  |- skos__broader mesh__D011813smesh__D001561
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011813 2002
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011813 2004
% 212.28/212.46  |- skos__historyNote mesh__D011813 Benzilates %28%1966-1979%29%
% 212.28/212.46  |- skos__prefLabel mesh__D011813 Quinuclidinyl Benzilate
% 212.28/212.46  |- skos__hiddenLabel mesh__D011813 Benzilate, Quinuclidinyl
% 212.28/212.46  |- skos__scopeNote mesh__D011813
% 212.28/212.46       A high-affinity muscarinic antagonist commonly used as a tool in animal and tissue studies.%A%    
% 212.28/212.46  |- skos__broader mesh__D011813smesh__D011812
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011813 2001
% 212.28/212.46  |- mesh__dateCreated mesh__D011813 1979-05-30
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011813 2006
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011813 2003
% 212.28/212.46  |- mesh__recordAuthorizer mesh__D011813 sjn
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011813 2005
% 212.28/212.46  |- mesh__recordOriginator mesh__D011813 SH
% 212.28/212.46  |- rdf__type mesh__D011813sskos__Concept
% 212.28/212.46  |- mesh__historyNote mesh__D011813
% 212.28/212.46       91%28%80%29%; was see under QUINUCLIDINES 1980-90   
% 212.28/212.46  |- mesh__dateRevised mesh__D011813 2000-06-22
% 212.28/212.46  |- mesh__dateEstablished mesh__D011813 1991-01-01
% 212.28/212.46  |- mesh__dateEstablished mesh__D011015 1967-01-01
% 212.28/212.46  |- skos__hiddenLabel mesh__D011015 Pneumonias, Aspiration
% 212.28/212.46  |- skos__hiddenLabel mesh__D011015 Syndromes, Acid Aspiration
% 212.28/212.46  |- skos__hiddenLabel mesh__D011015 Syndrome, Acid Aspiration
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011015 2001
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011015 1996
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011015 1995
% 212.28/212.46  |- mesh__publicMeSHNote mesh__D011015 67   
% 212.28/212.46  |- mesh__dateRevised mesh__D011015 2005-07-28
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011015 2005
% 212.28/212.46  |- skos__scopeNote mesh__D011015
% 212.28/212.46       A type of pneumonia resulting from the aspiration of food, liquid, or gastric contents into the upper respiratory tract.%A%    
% 212.28/212.46  |- mesh__historyNote mesh__D011015 67%28%66%29%   
% 212.28/212.46  |- mesh__recordAuthorizer mesh__D011015 ags
% 212.28/212.46  |- mesh__recordOriginator mesh__D011015 NLM
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011015 2002
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011015 1997
% 212.28/212.46  |- rdf__type mesh__D011015sskos__Concept
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011015 2006
% 212.28/212.46  |- skos__altLabel mesh__D011015 Aspiration Pneumonia
% 212.28/212.46  |- skos__hiddenLabel mesh__D011015 Gastric Contents Aspirations
% 212.28/212.46  |- skos__prefLabel mesh__D011015 Pneumonia, Aspiration
% 212.28/212.46  |- skos__broader mesh__D011015smesh__D011014
% 212.28/212.46  |- skos__hiddenLabel mesh__D011015 Acid Aspiration Syndromes
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011015 1998
% 212.28/212.46  |- skos__hiddenLabel mesh__D011015 Aspiration Pneumonias
% 212.28/212.46  |- mesh__recordMaintainer mesh__D011015 ags
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011015 2003
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011015 1999
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011015 2006A
% 212.28/212.46  |- skos__hiddenLabel mesh__D011015 Gastric Contents Aspiration
% 212.28/212.46  |- mesh__dateCreated mesh__D011015 1999-01-01
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011015 2000
% 212.28/212.46  |- skos__annotation mesh__D011015
% 212.28/212.46       lung inflamm from aspiration of food, liquid or gastric contents; /congen: consider also RESPIRATORY DISTRESS SYNDROME, NEWBORN%A%  
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011015 2004
% 212.28/212.46  |- skos__altLabel mesh__D035463 Transcription Factors, TFI
% 212.28/212.46  |- skos__altLabel mesh__D035463 Polymerase 1 Complex Proteins
% 212.28/212.46  |- skos__altLabel mesh__D035463 Polymerase I Complex Transcription Factors
% 212.28/212.46  |- skos__altLabel mesh__D035463 Polymerase I Complex Proteins
% 212.28/212.46  |- skos__prefLabel mesh__D035463
% 212.28/212.46       Pol1 Transcription Initiation Complex Proteins
% 212.28/212.46  |- mesh__recordAuthorizer mesh__D035463 sjn
% 212.28/212.46  |- rdf__type mesh__D035463sskos__Concept
% 212.28/212.46  |- skos__altLabel mesh__D035463 Transcription Factors, RNA Polymerase I
% 212.28/212.46  |- mesh__publicMeSHNote mesh__D035463 2003   
% 212.28/212.46  |- mesh__dateRevised mesh__D035463 2005-06-30
% 212.28/212.46  |- skos__altLabel mesh__D035463
% 212.28/212.46       Pol I Transcription Initiation Complex Proteins
% 212.28/212.46  |- skos__broader mesh__D035463smesh__D035165
% 212.28/212.46  |- skos__scopeNote mesh__D035463
% 212.28/212.46       Factors that form a preinitiation complex at promoters that are specifically transcribed by RNA POLYMERASE I.%A%    
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D035463 2006
% 212.28/212.46  |- mesh__recordOriginator mesh__D035463 jmp
% 212.28/212.46  |- mesh__recordMaintainer mesh__D035463 ags
% 212.28/212.46  |- mesh__historyNote mesh__D035463 2003   
% 212.28/212.46  |- mesh__dateEstablished mesh__D035463 2003-01-01
% 212.28/212.46  |- mesh__dateCreated mesh__D035463 2002-07-03
% 212.28/212.46  |- mesh__recordMaintainer mesh__D002289 nns
% 212.28/212.46  |- mesh__historyNote mesh__D002289
% 212.28/212.46       94; was CARCINOMA, NON-SMALL CELL LUNG 1987-93   
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D002289 2006
% 212.28/212.46  |- skos__related mesh__D002289smesh__D018287
% 212.28/212.46  |- skos__scopeNote mesh__D002289
% 212.28/212.46       A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of the shared properties of poor response to conventional chemotherapy and the potential for cure with surgical resection in a fraction of patients.%A%    
% 212.28/212.46  |- mesh__dateEstablished mesh__D002289 1987-01-01
% 212.28/212.46  |- skos__annotation mesh__D002289
% 212.28/212.46       coordinate IM with LUNG NEOPLASMS %28%IM%29%; do not confuse with CARCINOMA, LARGE CELL or CARCINOMA, SMALL CELL; DF: NSCLC%A%  
% 212.28/212.46  |- mesh__recordAuthorizer mesh__D002289 sjn
% 212.28/212.46  |- skos__related mesh__D002289smesh__D000230
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D002289 2005
% 212.28/212.46  |- skos__related mesh__D002289smesh__D018288
% 212.28/212.46  |- skos__prefLabel mesh__D002289 Carcinoma, Non-Small-Cell Lung
% 212.28/212.46  |- skos__hiddenLabel mesh__D002289 Non-Small-Cell Lung Carcinomas
% 212.28/212.46  |- mesh__dateRevised mesh__D002289 2004-07-07
% 212.28/212.46  |- skos__altLabel mesh__D002289 Non-Small-Cell Lung Carcinoma
% 212.28/212.46  |- skos__hiddenLabel mesh__D002289 Carcinomas, Non-Small-Cell Lung
% 212.28/212.46  |- skos__broader mesh__D002289smesh__D008175
% 212.28/212.46  |- mesh__dateCreated mesh__D002289 1986-06-23
% 212.28/212.46  |- rdf__type mesh__D002289sskos__Concept
% 212.28/212.46  |- skos__hiddenLabel mesh__D002289 Non Small Cell Lung Carcinoma
% 212.28/212.46  |- mesh__publicMeSHNote mesh__D002289
% 212.28/212.46       94; was CARCINOMA, NON-SMALL CELL LUNG 1987-93   
% 212.28/212.46  |- skos__historyNote mesh__D002289 Lung Neoplasms %28%1966-1986%29%
% 212.28/212.46  |- skos__hiddenLabel mesh__D002289 Lung Carcinoma, Non-Small-Cell
% 212.28/212.46  |- skos__hiddenLabel mesh__D002289 Carcinoma, Non Small Cell Lung
% 212.28/212.46  |- mesh__onlineNote mesh__D002289
% 212.28/212.46       use CARCINOMA, NON-SMALL-CELL LUNG to search CARCINOMA, NON-SMALL CELL LUNG 1987-93%A%  
% 212.28/212.46  |- skos__hiddenLabel mesh__D002289 Lung Carcinomas, Non-Small-Cell
% 212.28/212.46  |- mesh__recordOriginator mesh__D002289 VDK
% 212.28/212.46  |- skos__broader mesh__D002289smesh__D002277
% 212.28/212.46  |- skos__related mesh__D002289smesh__D002294
% 212.28/212.46  |- skos__altLabel mesh__D002289 Carcinoma, Non-Small Cell Lung
% 212.28/212.46  |- skos__altLabel mesh__D007772 Riley Virus
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D007772 2005
% 212.28/212.46  |- mesh__recordOriginator mesh__D007772 NLM
% 212.28/212.46  |- mesh__dateEstablished mesh__D007772 1977-01-01
% 212.28/212.46  |- skos__historyNote mesh__D007772 RNA Viruses %28%1966-1974%29%
% 212.28/212.46  |- skos__hiddenLabel mesh__D007772 Lactate dehydrogenase elevating virus
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D007772 2006
% 212.28/212.46  |- skos__hiddenLabel mesh__D007772 Lactic Dehydrogenase Viruses
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D007772 2002
% 212.28/212.46  |- skos__altLabel mesh__D007772 Lactate Dehydrogenase Virus
% 212.28/212.46  |- mesh__recordAuthorizer mesh__D007772 sjn
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D007772 2003
% 212.28/212.46  |- mesh__dateCreated mesh__D007772 1999-01-01
% 212.28/212.46  |- skos__prefLabel mesh__D007772 Lactate dehydrogenase-elevating virus
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D007772 2004
% 212.28/212.46  |- mesh__publicMeSHNote mesh__D007772
% 212.28/212.46       2002; see LACTATE DEHYDROGENASE VIRUS 1977-2001, see RNA VIRUSES 1969-1976; for RILEY VIRUS see RNA VIRUSES 1969-1976, see VERTEBRATE VIRUSES, UNCLASSIFIED 1967-1968; for LACTIC DEHYDROGENASE VIRUSES see LACTATE DEHYDROGENASE VIRUS 1977-1993, was see RILEY VIRUS 1975-1976%A%  
% 212.28/212.46  |- skos__altLabel mesh__D007772 Lactic Dehydrogenase Virus
% 212.28/212.46  |- rdf__type mesh__D007772sskos__Concept
% 212.28/212.46  |- mesh__historyNote mesh__D007772
% 212.28/212.46       2002%28%1969%29%; for LACTIC DEHYDROGENASE VIRUSES use LACTATE DEHYDROGENASE VIRUS 1977-1993, use RILEY VIRUS 1975-1976%A%  
% 212.28/212.46  |- skos__hiddenLabel mesh__D007772 Lactate dehydrogenase-elevating viruses
% 212.28/212.46  |- skos__annotation mesh__D007772
% 212.28/212.46       infection: coord IM with ARTERIVIRUS INFECTIONS %28%IM%29%   
% 212.28/212.46  |- mesh__recordMaintainer mesh__D007772 ags
% 212.28/212.46  |- skos__hiddenLabel mesh__D007772 Lactate Dehydrogenase Viruses
% 212.28/212.46  |- skos__broader mesh__D007772smesh__D018018
% 212.28/212.46  |- skos__scopeNote mesh__D007772
% 212.28/212.46       A species ARTERIVIRUS, occurring in a number of transplantable mouse tumors. Infected mice have permanently elevated serum levels of lactate dehydrogenase.%A%    
% 212.28/212.46  |- mesh__dateRevised mesh__D007772 2001-07-25
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D015406 2000
% 212.28/212.46  |- skos__hiddenLabel mesh__D015406 Single Step-Parents
% 212.28/212.46  |- skos__altLabel mesh__D015406 Parent, Single
% 212.28/212.46  |- skos__annotation mesh__D015406
% 212.28/212.46       never-married, divorced or widowed: read MeSH definition   
% 212.28/212.46  |- skos__related mesh__D015406smesh__D020954
% 212.28/212.46  |- skos__hiddenLabel mesh__D015406 Stepparent, Single
% 212.28/212.46  |- rdf__type mesh__D015406sskos__Concept
% 212.28/212.46  |- skos__broader mesh__D015406smesh__D012847
% 212.28/212.46  |- mesh__dateEstablished mesh__D015406 1989-01-01
% 212.28/212.46  |- skos__scopeNote mesh__D015406
% 212.28/212.46       A natural, adoptive, or substitute parent of a dependent child, who lives with only one parent. The single parent may live with or visit the child. The concept includes the never-married, as well as the divorced and widowed.%A%    
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D015406 2001
% 212.28/212.46  |- skos__altLabel mesh__D015406 Single Step-Parent
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D015406 2003
% 212.28/212.46  |- skos__hiddenLabel mesh__D015406 Step-Parent, Single
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D015406 2002
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D015406 2004
% 212.28/212.46  |- skos__historyNote mesh__D015406 Single Person %28%1968-1988%29%
% 212.28/212.46  |- skos__hiddenLabel mesh__D015406 Stepparents, Single
% 212.28/212.46  |- skos__hiddenLabel mesh__D015406 Parents, Single
% 212.28/212.46  |- skos__hiddenLabel mesh__D015406 Single Stepparents
% 212.28/212.46  |- mesh__publicMeSHNote mesh__D015406 89   
% 212.28/212.46  |- skos__hiddenLabel mesh__D015406 Single Parents
% 212.28/212.46  |- mesh__historyNote mesh__D015406 89   
% 212.28/212.46  |- mesh__recordMaintainer mesh__D015406 jls
% 212.28/212.46  |- skos__prefLabel mesh__D015406 Single Parent
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D015406 2005
% 212.28/212.46  |- skos__hiddenLabel mesh__D015406 Single Step Parent
% 212.28/212.46  |- skos__hiddenLabel mesh__D015406 Step-Parents, Single
% 212.28/212.46  |- mesh__dateCreated mesh__D015406 1988-06-07
% 212.28/212.46  |- mesh__dateRevised mesh__D015406 1999-11-03
% 212.28/212.46  |- mesh__recordAuthorizer mesh__D015406 sjn
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D015406 2006
% 212.28/212.46  |- mesh__recordOriginator mesh__D015406 EJB
% 212.28/212.46  |- skos__broader mesh__D015406smesh__D010290
% 212.28/212.46  |- skos__historyNote mesh__D015406 Parents %28%1969-1988%29%
% 212.28/212.46  |- skos__broader mesh__D010822Q000193smesh__D010822
% 212.28/212.46  |- mesh__preferredCombination mesh__D010822Q000193smesh__D004501
% 212.28/212.46  |- rdf__type mesh__D010822Q000193smesh__CompoundConcept
% 212.28/212.46  |- skos__broader mesh__D011814smesh__D011804
% 212.28/212.46  |- skos__hiddenLabel mesh__D011814 MA1291
% 212.28/212.46  |- mesh__recordAuthorizer mesh__D011814 sjn
% 212.28/212.46  |- mesh__recordMaintainer mesh__D011814 TWD
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011814 2003
% 212.28/212.46  |- mesh__publicMeSHNote mesh__D011814
% 212.28/212.46       91; was see under QUINOLINES 1978-90; QUIPAZINE MALEATE was indexed under QUIPAZINE/analogs %26% derivatives 1982-92%A%  
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011814 2002
% 212.28/212.46  |- skos__broader mesh__D011814smesh__D010879
% 212.28/212.46  |- skos__hiddenLabel mesh__D011814 MA 1291
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011814 2004
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011814 2005
% 212.28/212.46  |- mesh__dateRevised mesh__D011814 2000-06-22
% 212.28/212.46  |- mesh__dateEstablished mesh__D011814 1991-01-01
% 212.28/212.46  |- mesh__onlineNote mesh__D011814
% 212.28/212.46       use QUIPAZINE %28%NM%29% to search QUIPAZINE MALEATE 1982-92   
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011814 2006
% 212.28/212.46  |- skos__prefLabel mesh__D011814 Quipazine
% 212.28/212.46  |- mesh__historyNote mesh__D011814
% 212.28/212.46       91%28%78%29%; was see under QUINOLINES 1978-90; QUIPAZINE MALEATE was NM 1982-92%A%  
% 212.28/212.46  |- mesh__recordOriginator mesh__D011814 SH
% 212.28/212.46  |- skos__historyNote mesh__D011814 Quinolines %28%1966-1977%29%
% 212.28/212.46  |- rdf__type mesh__D011814sskos__Concept
% 212.28/212.46  |- skos__scopeNote mesh__D011814
% 212.28/212.46       A pharmacologic congener of serotonin that contracts smooth muscle and has actions similar to those of tricyclic antidepressants. It has been proposed as an oxytocic.%A%    
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011814 2001
% 212.28/212.46  |- mesh__dateCreated mesh__D011814 1977-04-22
% 212.28/212.46  |- skos__altLabel mesh__D011814 2-%28%1-Piperazinyl%29%quinoline
% 212.28/212.46  |- mesh__recordOriginator mesh__D011016 FPG
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011016 2006
% 212.28/212.46  |- rdf__type mesh__D011016sskos__Concept
% 212.28/212.46  |- mesh__dateRevised mesh__D011016 2004-07-07
% 212.28/212.46  |- skos__altLabel mesh__D011016 Pulmonary Adenomatoses, Bovine
% 212.28/212.46  |- skos__broader mesh__D011016smesh__D048090
% 212.28/212.46  |- skos__hiddenLabel mesh__D011016 Adenomatosis, Bovine Pulmonary
% 212.28/212.46  |- mesh__recordAuthorizer mesh__D011016 sjn
% 212.28/212.46  |- skos__altLabel mesh__D011016 Atypical Interstitial Pneumonia of Cattle
% 212.28/212.46  |- skos__altLabel mesh__D011016 Adenomatosis, Pulmonary, Bovine
% 212.28/212.46  |- mesh__dateCreated mesh__D011016 1975-07-25
% 212.28/212.46  |- skos__altLabel mesh__D011016 Adenomatoses, Bovine Pulmonary
% 212.28/212.46  |- skos__altLabel mesh__D011016 Pulmonary Adenomatosis, Bovine
% 212.28/212.46  |- mesh__dateEstablished mesh__D011016 1976-01-01
% 212.28/212.46  |- mesh__recordMaintainer mesh__D011016 ags
% 212.28/212.46  |- mesh__publicMeSHNote mesh__D011016
% 212.28/212.46       76; was PULMONARY ADENOMATOSIS, BOVINE 1968-75   
% 212.28/212.46  |- skos__annotation mesh__D011016
% 212.28/212.46       don%27%t forget also CATTLE %28%NIM%29% %26% check tag ANIMALS   
% 212.28/212.46  |- mesh__historyNote mesh__D011016
% 212.28/212.46       76; was PULMONARY ADENOMATOSIS, BOVINE 1968-75   
% 212.28/212.46  |- skos__altLabel mesh__D011016 Emphysema, Acute Bovine Pulmonary
% 212.28/212.46  |- skos__altLabel mesh__D011016 Bovine Pulmonary Adenomatoses
% 212.28/212.46  |- skos__hiddenLabel mesh__D011016 Fever, Fog
% 212.28/212.46  |- mesh__onlineNote mesh__D011016
% 212.28/212.46       use PNEUMONIA, ATYPICAL INTERSTITIAL, OF CATTLE to search PULMONARY ADENOMATOSIS, BOVINE 1968-75%A%  
% 212.28/212.46  |- skos__prefLabel mesh__D011016
% 212.28/212.46       Pneumonia, Atypical Interstitial, of Cattle
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D011016 2005
% 212.28/212.46  |- skos__altLabel mesh__D011016 Fog Fever
% 212.28/212.46  |- skos__scopeNote mesh__D011016
% 212.28/212.46       A cattle disease of uncertain cause, probably an allergic reaction.%A%    
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D007773 2002
% 212.28/212.46  |- rdf__type mesh__D007773sskos__Concept
% 212.28/212.46  |- mesh__dateRevised mesh__D007773 1996-06-10
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D007773 1999
% 212.28/212.46  |- skos__prefLabel mesh__D007773 Lactates
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D007773 2006
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D007773 1998
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D007773 1997
% 212.28/212.46  |- mesh__recordAuthorizer mesh__D007773 PLS
% 212.28/212.46  |- skos__scopeNote mesh__D007773
% 212.28/212.46       Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.%A%    
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D007773 2001
% 212.28/212.46  |- mesh__recordOriginator mesh__D007773 NLM
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D007773 2005
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D007773 2004
% 212.28/212.46  |- skos__annotation mesh__D007773
% 212.28/212.46       do not confuse with LACTATE see LACTIC ACID   
% 212.28/212.46  |- skos__broader mesh__D007773smesh__D006880
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D007773 2000
% 212.28/212.46  |- mesh__activeMeSHYear mesh__D007773 2003
% 212.28/212.46  |- mesh__recordMaintainer mesh__D007773 ADP
% 212.28/212.46  |- mesh__dateCreated mesh__D007773 1999-01-01
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011815 2005
% 212.28/212.47  |- mesh__dateEstablished mesh__D011815 1978-01-01
% 212.28/212.47  |- skos__altLabel mesh__D011815 R Plasmids
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011815 2004
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011815 2006
% 212.28/212.47  |- mesh__dateCreated mesh__D011815 1974-11-11
% 212.28/212.47  |- mesh__recordOriginator mesh__D011815 NLM
% 212.28/212.47  |- mesh__recordAuthorizer mesh__D011815 sjn
% 212.28/212.47  |- mesh__recordMaintainer mesh__D011815 nns
% 212.28/212.47  |- skos__hiddenLabel mesh__D011815 Plasmids, R
% 212.28/212.47  |- skos__altLabel mesh__D011815 Resistance Factors
% 212.28/212.47  |- skos__prefLabel mesh__D011815 R Factors
% 212.28/212.47  |- mesh__historyNote mesh__D011815
% 212.28/212.47       78%28%75%29%; was see under DRUG RESISTANCE, MICROBIAL 1975-77   
% 212.28/212.47  |- rdf__type mesh__D011815sskos__Concept
% 212.28/212.47  |- skos__historyNote mesh__D011815
% 212.28/212.47       Drug Resistance, Microbial %28%1967-1974%29%
% 212.28/212.47  |- skos__broader mesh__D011815smesh__D010957
% 212.28/212.47  |- skos__scopeNote mesh__D011815
% 212.28/212.47       A class of plasmids that transfer antibiotic resistance from one bacterium to another by conjugation.%A%    
% 212.28/212.47  |- skos__hiddenLabel mesh__D011815 Factors, Resistance
% 212.28/212.47  |- skos__annotation mesh__D011815 bacterial   
% 212.28/212.47  |- skos__hiddenLabel mesh__D011815 Factors, R
% 212.28/212.47  |- mesh__publicMeSHNote mesh__D011815
% 212.28/212.47       78; was see under DRUG RESISTANCE, MICROBIAL 1975-77   
% 212.28/212.47  |- mesh__dateRevised mesh__D011815 2003-07-09
% 212.28/212.47  |- mesh__publicMeSHNote mesh__D011017
% 212.28/212.47       91; was see under PNEUMONIA, ASPIRATION 1984-90; was heading 1963-83%A%  
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011017 1998
% 212.28/212.47  |- skos__hiddenLabel mesh__D011017 Lipid Pneumonias
% 212.28/212.47  |- mesh__historyNote mesh__D011017
% 212.28/212.47       91%28%84%29%63; was see under PNEUMONIA, ASPIRATION 1984-90; was heading 1963-83%A%  
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011017 2003
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011017 1999
% 212.28/212.47  |- mesh__dateCreated mesh__D011017 1999-01-01
% 212.28/212.47  |- mesh__recordAuthorizer mesh__D011017 PLS
% 212.28/212.47  |- mesh__dateEstablished mesh__D011017 1991-01-01
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011017 2004
% 212.28/212.47  |- skos__prefLabel mesh__D011017 Pneumonia, Lipid
% 212.28/212.47  |- skos__annotation mesh__D011017
% 212.28/212.47       lung inflamm from aspiration or inhalation of oily or fatty substances%A%  
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011017 2000
% 212.28/212.47  |- mesh__recordMaintainer mesh__D011017 PXP
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011017 1995
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011017 1996
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011017 2005
% 212.28/212.47  |- skos__broader mesh__D011017smesh__D011015
% 212.28/212.47  |- skos__scopeNote mesh__D011017
% 212.28/212.47       Pneumonia due to aspiration or inhalation of various oily or fatty substances.%A%    
% 212.28/212.47  |- skos__hiddenLabel mesh__D011017 Lipid Pneumonia
% 212.28/212.47  |- skos__hiddenLabel mesh__D011017 Pneumonias, Lipid
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011017 2001
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011017 1997
% 212.28/212.47  |- rdf__type mesh__D011017sskos__Concept
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011017 2006
% 212.28/212.47  |- mesh__recordOriginator mesh__D011017 NLM
% 212.28/212.47  |- mesh__dateRevised mesh__D011017 1994-05-27
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011017 2002
% 212.28/212.47  |- skos__historyNote mesh__D016500 Phototherapy %28%1972-1991%29%
% 212.28/212.47  |- rdf__type mesh__D016500sskos__Concept
% 212.28/212.47  |- mesh__recordMaintainer mesh__D016500 lkt
% 212.28/212.47  |- mesh__dateEstablished mesh__D016500 1992-01-01
% 212.28/212.47  |- skos__broader mesh__D016500smesh__D010789
% 212.28/212.47  |- skos__annotation mesh__D016500
% 212.28/212.47       treatment of dis with color; coord IM with disease /ther %28%IM%29%%A%  
% 212.28/212.47  |- mesh__dateCreated mesh__D016500 1991-01-02
% 212.28/212.47  |- mesh__historyNote mesh__D016500 92   
% 212.28/212.47  |- skos__prefLabel mesh__D016500 Color Therapy
% 212.28/212.47  |- mesh__recordAuthorizer mesh__D016500 sjn
% 212.28/212.47  |- skos__scopeNote mesh__D016500
% 212.28/212.47       A form of phototherapy using color to influence health and to treat various physical or mental disorders. The color rays may be in the visible or invisible spectrum and can be administered through colored lights or applied mentally through suggestion.%A%    
% 212.28/212.47  |- skos__historyNote mesh__D016500 Color %28%1972-1991%29%
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D016500 2006
% 212.28/212.47  |- mesh__dateRevised mesh__D016500 2005-06-30
% 212.28/212.47  |- skos__altLabel mesh__D016500 Therapy, Color
% 212.28/212.47  |- skos__altLabel mesh__D016500 Chromotherapy
% 212.28/212.47  |- mesh__publicMeSHNote mesh__D016500 92   
% 212.28/212.47  |- mesh__recordOriginator mesh__D016500 TGC
% 212.28/212.47  |- skos__altLabel mesh__D016500 Chromatotherapy
% 212.28/212.47  |- skos__broader mesh__D016500smesh__D026421
% 212.28/212.47  |- skos__broader mesh__D016500smesh__D011613
% 212.28/212.47  |- mesh__recordAuthorizer mesh__D007774 sjn
% 212.28/212.47  |- skos__broader mesh__D007774smesh__D049590
% 212.28/212.47  |- skos__annotation mesh__D007774
% 212.28/212.47       check the tag FEMALE usually but occasionally MALE; %22%postpartum amenorrhea%22% is indexed under PUERPERIUM + AMENORRHEA and not LACTATION unless lactation is particularly discussed; ANIMALS, SUCKLING is available but the suckling of an animal goes here: human suckling goes under BREAST FEEDING%A%  
% 212.28/212.47  |- mesh__publicMeSHNote mesh__D007774
% 212.28/212.47       LACTATION, PROLONGED was heading 1975-96 %28%see under LACTATION 1975-90%29%%A%  
% 212.28/212.47  |- skos__related mesh__D007774smesh__D001942
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D007774 2006
% 212.28/212.47  |- skos__hiddenLabel mesh__D007774 Prolonged Lactation
% 212.28/212.47  |- mesh__recordMaintainer mesh__D007774 sjn
% 212.28/212.47  |- skos__prefLabel mesh__D007774 Lactation
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D007774 2005
% 212.28/212.47  |- skos__hiddenLabel mesh__D007774 Prolonged Lactations
% 212.28/212.47  |- skos__related mesh__D007774smesh__D003126
% 212.28/212.47  |- skos__related mesh__D007774smesh__D008892
% 212.28/212.47  |- mesh__recordOriginator mesh__D007774 NLM
% 212.28/212.47  |- mesh__dateCreated mesh__D007774 1999-01-01
% 212.28/212.47  |- mesh__dateRevised mesh__D007774 2004-07-13
% 212.28/212.47  |- skos__related mesh__D007774smesh__D008895
% 212.28/212.47  |- skos__scopeNote mesh__D007774
% 212.28/212.47       The processes of milk secretion by the maternal MAMMARY GLANDS after PARTURITION. The proliferation of the mammary glandular tissue, milk synthesis, and milk expulsion or let down are regulated by the interactions of several hormones including ESTRADIOL; PROGESTERONE; PROLACTIN; and OXYTOCIN.%A%    
% 212.28/212.47  |- mesh__historyNote mesh__D007774
% 212.28/212.47       LACTATION, PROLONGED was heading 1975-96 %28%see under LACTATION 1975-90%29%%A%  
% 212.28/212.47  |- rdf__type mesh__D007774sskos__Concept
% 212.28/212.47  |- skos__hiddenLabel mesh__D007774 Lactations, Prolonged
% 212.28/212.47  |- skos__broader mesh__D015408smesh__D018273
% 212.28/212.47  |- mesh__publicMeSHNote mesh__D015408
% 212.28/212.47       89; was see ZOLLINGER-ELLISON SYNDROME 1982-88; was see ISLET CELL TUMOR 1981%A%  
% 212.28/212.47  |- skos__hiddenLabel mesh__D015408 Gastrin Producing Tumor
% 212.28/212.47  |- skos__related mesh__D015408smesh__D018761
% 212.28/212.47  |- skos__altLabel mesh__D015408 Islet Cell Tumor, Ulcerogenic
% 212.28/212.47  |- skos__related mesh__D015408smesh__D015043
% 212.28/212.47  |- mesh__recordAuthorizer mesh__D015408 ags
% 212.28/212.47  |- mesh__recordMaintainer mesh__D015408 ags
% 212.28/212.47  |- skos__scopeNote mesh__D015408
% 212.28/212.47       A GASTRIN-secreting neuroendocrine tumor of the non-beta ISLET CELLS, the GASTRIN-SECRETING CELLS. This type of tumor is primarily located in the PANCREAS or the DUODENUM. Majority of gastrinomas are malignant. They metastasize to the LIVER; LYMPH NODES; and BONE but rarely elsewhere. The presence of gastrinoma is one of three requirements to be met for identification of ZOLLINGER-ELLISON SYNDROME, which sometimes occurs in families with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; %28%MEN 1%29%.%A%    
% 212.28/212.47  |- mesh__onlineNote mesh__D015408
% 212.28/212.47       use ZOLLINGER-ELLISON SYNDROME to search GASTRINOMA 1982-88; use ADENOMA, ISLET CELL 1981%A%  
% 212.28/212.47  |- skos__prefLabel mesh__D015408 Gastrinoma
% 212.28/212.47  |- mesh__dateCreated mesh__D015408 1988-06-07
% 212.28/212.47  |- skos__altLabel mesh__D015408 Gastrin-Producing Tumor
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D015408 2006
% 212.28/212.47  |- skos__hiddenLabel mesh__D015408 Gastrinomas
% 212.28/212.47  |- mesh__recordOriginator mesh__D015408 EJB
% 212.28/212.47  |- mesh__dateRevised mesh__D015408 2005-07-20
% 212.28/212.47  |- skos__annotation mesh__D015408
% 212.28/212.47       coord IM with PANCREATIC NEOPLASMS %28%IM%29% or other precoord organ/neopl term %28%IM%29% if not in pancreas%A%  
% 212.28/212.47  |- rdf__type mesh__D015408sskos__Concept
% 212.28/212.47  |- mesh__dateEstablished mesh__D015408 1989-01-01
% 212.28/212.47  |- skos__hiddenLabel mesh__D015408 Tumor, Gastrin-Producing
% 212.28/212.47  |- skos__hiddenLabel mesh__D015408 Tumors, Gastrin-Producing
% 212.28/212.47  |- skos__hiddenLabel mesh__D015408 Gastrin-Producing Tumors
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D015408 2006A
% 212.28/212.47  |- skos__historyNote mesh__D015408
% 212.28/212.47       Zollinger-Ellison Syndrome %28%1982-1988%29%
% 212.28/212.47  |- skos__altLabel mesh__D015408 Ulcerogenic Islet Cell Tumor
% 212.28/212.47  |- mesh__historyNote mesh__D015408
% 212.28/212.47       89; was see ZOLLINGER-ELLISON SYNDROME 1982-88; was see ISLET CELL TUMOR 1981%A%  
% 212.28/212.47  |- skos__historyNote mesh__D015408 Islet Cell Tumor %28%1981%29%
% 212.28/212.47  |- rdf__type mesh__D012110sskos__Concept
% 212.28/212.47  |- skos__scopeNote mesh__D012110
% 212.28/212.47       An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use.%A%    
% 212.28/212.47  |- skos__annotation mesh__D012110
% 212.28/212.47       reserpine derivatives=RESERPINE /analogs   
% 212.28/212.47  |- skos__prefLabel mesh__D012110 Reserpine
% 212.28/212.47  |- mesh__onlineNote mesh__D012110
% 212.28/212.47       use RESERPINE to search RESERPINE DERIVATIVES 1975-77; use YOHIMBANS 1969-74%A%  
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D012110 2006
% 212.28/212.47  |- skos__hiddenLabel mesh__D012110 V Serp
% 212.28/212.47  |- mesh__recordMaintainer mesh__D012110 CCR
% 212.28/212.47  |- skos__altLabel mesh__D012110 Rausedyl
% 212.28/212.47  |- skos__altLabel mesh__D012110 Vangarde Brand of Reserpine
% 212.28/212.47  |- mesh__dateCreated mesh__D012110 1999-01-01
% 212.28/212.47  |- mesh__publicMeSHNote mesh__D012110
% 212.28/212.47       RESERPINE DERIVATIVES was see under RESERPINE 1975-77, was see under YOHIMBANS 1969-74; /adverse effects /poisoning /toxicity were RESERPINE TOXICOLOGY 1963-65%A%  
% 212.28/212.47  |- mesh__historyNote mesh__D012110
% 212.28/212.47       RESERPINE DERIVATIVES was see under RESERPINE 1975-77, was see under YOHIMBANS 1969-74; /adv eff-pois-tox was RESERPINE TOXICOLOGY 1963-65%A%  
% 212.28/212.47  |- skos__altLabel mesh__D012110 Vitarine Brand of Reserpine
% 212.28/212.47  |- mesh__recordAuthorizer mesh__D012110 sjn
% 212.28/212.47  |- mesh__dateRevised mesh__D012110 2005-06-30
% 212.28/212.47  |- skos__broader mesh__D012110smesh__D015016
% 212.28/212.47  |- mesh__recordOriginator mesh__D012110 NLM
% 212.28/212.47  |- skos__broader mesh__D019787Q000031smesh__D019787
% 212.28/212.47  |- mesh__preferredCombination mesh__D019787Q000031smesh__D008041
% 212.28/212.47  |- rdf__type mesh__D019787Q000031smesh__CompoundConcept
% 212.28/212.47  |- skos__hiddenLabel mesh__D003384 Coxsackie Virus Infection
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D003384 2006
% 212.28/212.47  |- mesh__publicMeSHNote mesh__D003384
% 212.28/212.47       79; was COXSACKIE VIRUS INFECTIONS 1963-78   
% 212.28/212.47  |- skos__altLabel mesh__D003384 Infections, Coxsackievirus
% 212.28/212.47  |- skos__altLabel mesh__D003384 Coxsackie Virus Infections
% 212.28/212.47  |- mesh__dateCreated mesh__D003384 1999-01-01
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D003384 2005
% 212.28/212.47  |- skos__altLabel mesh__D003384 Infections, Coxsackie Virus
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D003384 2004
% 212.28/212.47  |- skos__broader mesh__D003384smesh__D004769
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D003384 2002
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D003384 2003
% 212.28/212.47  |- mesh__onlineNote mesh__D003384
% 212.28/212.47       use COXSACKIEVIRUS INFECTIONS to search COXSACKIE VIRUS INFECTIONS 1966-78%A%  
% 212.28/212.47  |- skos__scopeNote mesh__D003384
% 212.28/212.47       A heterogeneous group of infections produced by coxsackieviruses, including HERPANGINA, aseptic meningitis %28%MENINGITIS, ASEPTIC%29%, a common-cold-like syndrome, a non-paralytic poliomyelitis-like syndrome, epidemic pleurodynia %28%PLEURODYNIA, EPIDEMIC%29% and a serious MYOCARDITIS.%A%    
% 212.28/212.47  |- rdf__type mesh__D003384sskos__Concept
% 212.28/212.47  |- mesh__historyNote mesh__D003384
% 212.28/212.47       79; was COXSACKIE VIRUS INFECTIONS 1963-78   
% 212.28/212.47  |- mesh__dateRevised mesh__D003384 2001-07-25
% 212.28/212.47  |- skos__hiddenLabel mesh__D003384 Coxsackievirus Infection
% 212.28/212.47  |- mesh__recordMaintainer mesh__D003384 ags
% 212.28/212.47  |- skos__prefLabel mesh__D003384 Coxsackievirus Infections
% 212.28/212.47  |- mesh__recordAuthorizer mesh__D003384 sjn
% 212.28/212.47  |- mesh__recordOriginator mesh__D003384 NLM
% 212.28/212.47  |- skos__broader mesh__D011018smesh__D018410
% 212.28/212.47  |- skos__hiddenLabel mesh__D011018 Pneumonias, Lobar
% 212.28/212.47  |- rdf__type mesh__D011018sskos__Concept
% 212.28/212.47  |- skos__hiddenLabel mesh__D011018 Pneumonias, Pneumococcal
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011018 2006
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011018 2000
% 212.28/212.47  |- skos__annotation mesh__D011018 caused by Streptococcus pneumoniae   
% 212.28/212.47  |- skos__broader mesh__D011018smesh__D011008
% 212.28/212.47  |- mesh__recordMaintainer mesh__D011018 TGC
% 212.28/212.47  |- skos__hiddenLabel mesh__D011018 Pneumococcal Pneumonia
% 212.28/212.47  |- mesh__dateCreated mesh__D011018 1999-01-01
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011018 2005
% 212.28/212.47  |- mesh__recordOriginator mesh__D011018 NLM
% 212.28/212.47  |- skos__altLabel mesh__D011018 Pneumonia, Lobar
% 212.28/212.47  |- mesh__recordAuthorizer mesh__D011018 SJN
% 212.28/212.47  |- skos__hiddenLabel mesh__D011018 Pneumococcal Pneumonias
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011018 2004
% 212.28/212.47  |- skos__altLabel mesh__D011018 Lobar Pneumonia
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011018 1999
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011018 2003
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011018 1998
% 212.28/212.47  |- skos__prefLabel mesh__D011018 Pneumonia, Pneumococcal
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011018 2002
% 212.28/212.47  |- mesh__dateRevised mesh__D011018 1997-06-20
% 212.28/212.47  |- skos__scopeNote mesh__D011018
% 212.28/212.47       A febrile disease caused by STREPTOCOCCUS PNEUMONIAE. This condition is characterized by inflammation of one or more lobes of the lungs and symptoms include chills, fever, rapid breathing, and cough.%A%    
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011018 2001
% 212.28/212.47  |- mesh__historyNote mesh__D011018
% 212.28/212.47       98; was PNEUMONIA, LOBAR 1963-97; PNEUMONIA, PNEUMOCOCCAL was see PNEUMONIA, LOBAR 1978-97%A%  
% 212.28/212.47  |- skos__hiddenLabel mesh__D011018 Lobar Pneumonias
% 212.28/212.47  |- mesh__publicMeSHNote mesh__D011018
% 212.28/212.47       98; was PNEUMONIA, LOBAR 1963-97; PNEUMONIA, PNEUMOCOCCAL was see PNEUMONIA, LOBAR 1978-97%A%  
% 212.28/212.47  |- mesh__dateCreated mesh__D016501 1991-01-03
% 212.28/212.47  |- mesh__recordOriginator mesh__D016501 TGC
% 212.28/212.47  |- rdf__type mesh__D016501sskos__Concept
% 212.28/212.47  |- skos__broader mesh__D016501smesh__D001369
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D016501 2002
% 212.28/212.47  |- skos__related mesh__D016501smesh__D020439
% 212.28/212.47  |- skos__historyNote mesh__D016501 Neurons %28%1970-1991%29%
% 212.28/212.47  |- mesh__recordMaintainer mesh__D016501 AGS
% 212.28/212.47  |- mesh__historyNote mesh__D016501 92   
% 212.28/212.47  |- skos__broader mesh__D016501smesh__D022081
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D016501 2003
% 212.28/212.47  |- skos__hiddenLabel mesh__D016501 Neurite
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D016501 2005
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D016501 2004
% 212.28/212.47  |- skos__related mesh__D016501smesh__D009414
% 212.28/212.47  |- mesh__dateEstablished mesh__D016501 1992-01-01
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D016501 2006
% 212.28/212.47  |- skos__broader mesh__D016501smesh__D009474
% 212.28/212.47  |- skos__annotation mesh__D016501
% 212.28/212.47       do not confuse with the French %22%nevrite%22% or other vernac %22%nevrit-%22% which means %22%neuritis%22%%A%  
% 212.28/212.47  |- skos__broader mesh__D016501smesh__D003712
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D016501 2001
% 212.28/212.47  |- skos__prefLabel mesh__D016501 Neurites
% 212.28/212.47  |- skos__scopeNote mesh__D016501
% 212.28/212.47       In tissue culture, hairlike projections of neurons stimulated by growth factors and other molecules. These projections may go on to form a branched tree of dendrites or a single axon or they may be reabsorbed at a later stage of development. %22%Neurite%22% may refer to any filamentous or pointed outgrowth of an embryonal or tissue-culture neural cell.%A%    
% 212.28/212.47  |- mesh__recordAuthorizer mesh__D016501 sjn
% 212.28/212.47  |- mesh__dateRevised mesh__D016501 2000-06-22
% 212.28/212.47  |- skos__historyNote mesh__D016501 Axons %28%1967-1991%29%
% 212.28/212.47  |- mesh__publicMeSHNote mesh__D016501 92   
% 212.28/212.47  |- mesh__recordOriginator mesh__D007775 NLM
% 212.28/212.47  |- mesh__dateCreated mesh__D007775 1999-01-01
% 212.28/212.47  |- skos__prefLabel mesh__D007775 Lactation Disorders
% 212.28/212.47  |- skos__hiddenLabel mesh__D007775 Disorder, Lactation
% 212.28/212.47  |- mesh__recordAuthorizer mesh__D007775 sjn
% 212.28/212.47  |- rdf__type mesh__D007775sskos__Concept
% 212.28/212.47  |- skos__related mesh__D007775smesh__D005687
% 212.28/212.47  |- skos__hiddenLabel mesh__D007775 Lactation Disorder
% 212.28/212.47  |- skos__scopeNote mesh__D007775
% 212.28/212.47       Disturbances of MILK secretion in either SEX, not necessarily related to PREGNANCY.%A%    
% 212.28/212.47  |- skos__hiddenLabel mesh__D007775 Hypogalactias
% 212.28/212.47  |- skos__broader mesh__D007775smesh__D001941
% 212.28/212.47  |- mesh__dateRevised mesh__D007775 2005-06-30
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D007775 2006
% 212.28/212.47  |- skos__broader mesh__D007775smesh__D011644
% 212.28/212.47  |- skos__hiddenLabel mesh__D007775 Disorders, Lactation
% 212.28/212.47  |- mesh__recordMaintainer mesh__D007775 lkt
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D015409 1997
% 212.28/212.47  |- skos__hiddenLabel mesh__D015409 Mastectomy, Halsted
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D015409 2001
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D015409 2006
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D015409 2002
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D015409 1998
% 212.28/212.47  |- skos__historyNote mesh__D015409
% 212.28/212.47       Breast Neoplasms/surgery %28%1966-1988%29%
% 212.28/212.47  |- rdf__type mesh__D015409sskos__Concept
% 212.28/212.47  |- mesh__dateRevised mesh__D015409 1996-06-10
% 212.28/212.47  |- skos__hiddenLabel mesh__D015409 Mastectomy, Meyer
% 212.28/212.47  |- mesh__dateEstablished mesh__D015409 1989-01-01
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D015409 1999
% 212.28/212.47  |- mesh__dateCreated mesh__D015409 1988-06-07
% 212.28/212.47  |- skos__prefLabel mesh__D015409 Mastectomy, Radical
% 212.28/212.47  |- mesh__historyNote mesh__D015409 89   
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D015409 2003
% 212.28/212.47  |- skos__scopeNote mesh__D015409
% 212.28/212.47       Removal of the breast, pectoral muscles, axillary lymph nodes, and associated skin and subcutaneous tissue.%A%    
% 212.28/212.47  |- skos__historyNote mesh__D015409 Mastectomy %28%1966-1988%29%
% 212.28/212.47  |- mesh__recordMaintainer mesh__D015409 TGC
% 212.28/212.47  |- mesh__recordOriginator mesh__D015409 EJB
% 212.28/212.47  |- skos__hiddenLabel mesh__D015409 Radical Mastectomy
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D015409 2004
% 212.28/212.47  |- mesh__recordAuthorizer mesh__D015409 PLS
% 212.28/212.47  |- skos__annotation mesh__D015409
% 212.28/212.47       GEN or unspecified; MASTECTOMY, EXTENDED RADICAL %26% MASTECTOMY, MODIFIED RADICAL are also available; do not use /util except by MeSH definition%A%  
% 212.28/212.47  |- skos__historyNote mesh__D015409 Breast/surgery %28%1966-1988%29%
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D015409 2000
% 212.28/212.47  |- skos__broader mesh__D015409smesh__D008408
% 212.28/212.47  |- skos__hiddenLabel mesh__D015409 Mastectomies, Radical
% 212.28/212.47  |- mesh__publicMeSHNote mesh__D015409 89   
% 212.28/212.47  |- skos__hiddenLabel mesh__D015409 Radical Mastectomies
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D015409 2005
% 212.28/212.47  |- skos__broader mesh__D003331Q000530smesh__D003331
% 212.28/212.47  |- mesh__preferredCombination mesh__D003331Q000530smesh__D017023
% 212.28/212.47  |- rdf__type mesh__D003331Q000530smesh__CompoundConcept
% 212.28/212.47  |- skos__scopeNote mesh__D012111
% 212.28/212.47       Elements of residence that characterize a population. They are applicable in determining need for and utilization of health services.%A%    
% 212.28/212.47  |- mesh__recordAuthorizer mesh__D012111 sjn
% 212.28/212.47  |- skos__hiddenLabel mesh__D012111 Selections, Residential
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D012111 2000
% 212.28/212.47  |- skos__broader mesh__D012111smesh__D003710
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D012111 2005
% 212.28/212.47  |- mesh__recordOriginator mesh__D012111 NLM
% 212.28/212.47  |- skos__prefLabel mesh__D012111 Residence Characteristics
% 212.28/212.47  |- mesh__recordMaintainer mesh__D012111 kle
% 212.28/212.47  |- mesh__dateCreated mesh__D012111 1999-01-01
% 212.28/212.47  |- skos__hiddenLabel mesh__D012111 Selection, Residential
% 212.28/212.47  |- skos__hiddenLabel mesh__D012111 Communities
% 212.28/212.47  |- skos__hiddenLabel mesh__D012111 Neighborhoods
% 212.28/212.47  |- skos__hiddenLabel mesh__D012111 Living Arrangement
% 212.28/212.47  |- skos__hiddenLabel mesh__D012111 Arrangement, Living
% 212.28/212.47  |- skos__annotation mesh__D012111 specify geog if pertinent   
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D012111 2002
% 212.28/212.47  |- skos__hiddenLabel mesh__D012111 Domiciles
% 212.28/212.47  |- skos__hiddenLabel mesh__D012111 Characteristic, Residence
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D012111 2004
% 212.28/212.47  |- skos__hiddenLabel mesh__D012111 Characteristics, Residence
% 212.28/212.47  |- mesh__dateRevised mesh__D012111 1999-11-03
% 212.28/212.47  |- rdf__type mesh__D012111sskos__Concept
% 212.28/212.47  |- mesh__dateEstablished mesh__D012111 1968-01-01
% 212.28/212.47  |- skos__hiddenLabel mesh__D012111 Arrangements, Living
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D012111 2003
% 212.28/212.47  |- skos__hiddenLabel mesh__D012111 Residential Selections
% 212.28/212.47  |- mesh__publicMeSHNote mesh__D012111 68   
% 212.28/212.47  |- skos__hiddenLabel mesh__D012111 Birth Place
% 212.28/212.47  |- skos__historyNote mesh__D012111
% 212.28/212.47       Transients and Migrants %28%1966-1967%29%
% 212.28/212.47  |- skos__historyNote mesh__D012111
% 212.28/212.47       Emigration and Immigration %28%1966-1967%29%
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D012111 2001
% 212.28/212.47  |- mesh__historyNote mesh__D012111 68   
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D012111 2006
% 212.28/212.47  |- skos__hiddenLabel mesh__D012111 Residence Characteristic
% 212.28/212.47  |- rdf__type mesh__D011817sskos__Concept
% 212.28/212.47  |- skos__scopeNote mesh__D011817
% 212.28/212.47       The species Oryctolagus cuniculus, in the family Leporidae, order LAGOMORPHA. Rabbits are born in burrows, furless, and with eyes and ears closed.  In contrast with HARES, rabbits have 22 chromosome pairs.%A%    
% 212.28/212.47  |- mesh__dateCreated mesh__D011817 1999-01-01
% 212.28/212.47  |- skos__hiddenLabel mesh__D011817 Domestic Rabbit
% 212.28/212.47  |- mesh__dateRevised mesh__D011817 2003-07-09
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011817 2005
% 212.28/212.47  |- skos__prefLabel mesh__D011817 Rabbits
% 212.28/212.47  |- mesh__recordMaintainer mesh__D011817 ags
% 212.28/212.47  |- skos__broader mesh__D011817smesh__D007793
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011817 2004
% 212.28/212.47  |- skos__annotation mesh__D011817
% 212.28/212.47       check tag: no qualif; when IM, qualif permitted; do not confuse X ref BELGIAN HARE with HARES%A%  
% 212.28/212.47  |- skos__hiddenLabel mesh__D011817 Domestic Rabbits
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011817 2006
% 212.28/212.47  |- skos__hiddenLabel mesh__D011817 Rabbits, Domestic
% 212.28/212.47  |- skos__altLabel mesh__D011817 Oryctolagus cuniculus
% 212.28/212.47  |- skos__altLabel mesh__D011817 Rabbit, Domestic
% 212.28/212.47  |- skos__hiddenLabel mesh__D011817 Hare, Belgian
% 212.28/212.47  |- mesh__recordOriginator mesh__D011817 NLM
% 212.28/212.47  |- mesh__recordAuthorizer mesh__D011817 sjn
% 212.28/212.47  |- skos__hiddenLabel mesh__D011019 Atypical Pneumonia, Primary
% 212.28/212.47  |- mesh__recordAuthorizer mesh__D011019 sjn
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011019 2005
% 212.28/212.47  |- skos__scopeNote mesh__D011019
% 212.28/212.47       Interstitial pneumonia caused by extensive infection of the lungs %28%LUNG%29% and BRONCHI, particularly the lower lobes of the lungs, by MYCOPLASMA PNEUMONIAE in humans. In SHEEP, it is caused by MYCOPLASMA OVIPNEUMONIAE. In CATTLE, it may be caused by MYCOPLASMA DISPAR.%A%    
% 212.28/212.47  |- mesh__dateCreated mesh__D011019 1978-12-21
% 212.28/212.47  |- skos__broader mesh__D011019smesh__D009175
% 212.28/212.47  |- skos__altLabel mesh__D011019 Pneumonia, Primary Atypical
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011019 2004
% 212.28/212.47  |- skos__hiddenLabel mesh__D011019 Primary Atypical Pneumonia
% 212.28/212.47  |- skos__altLabel mesh__D011019 Mycoplasma Pneumonia
% 212.28/212.47  |- skos__hiddenLabel mesh__D011019 Primary Atypical Pneumonias
% 212.28/212.47  |- skos__prefLabel mesh__D011019 Pneumonia, Mycoplasma
% 212.28/212.47  |- skos__historyNote mesh__D011019 Pneumonia %28%1966-1979%29%
% 212.28/212.47  |- skos__historyNote mesh__D011019 Mycoplasma Infections %28%1968-1979%29%
% 212.28/212.47  |- mesh__historyNote mesh__D011019 80   
% 212.28/212.47  |- skos__hiddenLabel mesh__D011019 Atypical Pneumonias, Primary
% 212.28/212.47  |- mesh__dateEstablished mesh__D011019 1980-01-01
% 212.28/212.47  |- skos__historyNote mesh__D011019 Mycoplasma %28%1966-1967%29%
% 212.28/212.47  |- mesh__dateRevised mesh__D011019 2003-07-09
% 212.28/212.47  |- mesh__recordMaintainer mesh__D011019 ags
% 212.28/212.47  |- skos__hiddenLabel mesh__D011019 Pneumonias, Primary Atypical
% 212.28/212.47  |- skos__broader mesh__D011019smesh__D018410
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D011019 2006
% 212.28/212.47  |- rdf__type mesh__D011019sskos__Concept
% 212.28/212.47  |- skos__hiddenLabel mesh__D011019 Pneumonias, Mycoplasma
% 212.28/212.47  |- skos__hiddenLabel mesh__D011019 Mycoplasma Pneumonias
% 212.28/212.47  |- mesh__recordOriginator mesh__D011019 AEP
% 212.28/212.47  |- mesh__publicMeSHNote mesh__D011019 80   
% 212.28/212.47  |- mesh__recordAuthorizer mesh__D008070 sjn
% 212.28/212.47  |- rdf__type mesh__D008070sskos__Concept
% 212.28/212.47  |- skos__broader mesh__D008070smesh__D004731
% 212.28/212.47  |- skos__scopeNote mesh__D008070
% 212.28/212.47       Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains %28%O ANTIGENS%29%. When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. %28%From Dorland, 28th ed%29%%A%    
% 212.28/212.47  |- skos__altLabel mesh__D008070 Lipoglycans
% 212.28/212.47  |- skos__broader mesh__D008070smesh__D011135
% 212.28/212.47  |- skos__broader mesh__D008070smesh__D008055
% 212.28/212.47  |- mesh__recordMaintainer mesh__D008070 ssb
% 212.28/212.47  |- mesh__dateCreated mesh__D008070 1999-01-01
% 212.28/212.47  |- skos__annotation mesh__D008070
% 212.28/212.47       largely bacterial so do not coord with POLYSACCHARIDES, BACTERIAL for bacterial lipopolysaccharides; coord IM with specific bacterium %28%IM%29%; DF: LPS%A%  
% 212.28/212.47  |- skos__prefLabel mesh__D008070 Lipopolysaccharides
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D008070 2006
% 212.28/212.47  |- mesh__dateRevised mesh__D008070 2005-06-30
% 212.28/212.47  |- skos__broader mesh__D008070smesh__D006001
% 212.28/212.47  |- mesh__recordOriginator mesh__D008070 NLM
% 212.28/212.47  |- skos__scopeNote mesh__D012910
% 212.28/212.47       Solutions or mixtures of toxic and nontoxic substances elaborated by snake %28%Ophidia%29% salivary glands for the purpose of killing prey or disabling predators and delivered by grooved or hollow fangs. They usually contain enzymes, toxins, and other factors.%A%    
% 212.28/212.47  |- skos__historyNote mesh__D012910 Venoms %28%1968-1974%29%
% 212.28/212.47  |- skos__broader mesh__D012910smesh__D014688
% 212.28/212.47  |- mesh__dateEstablished mesh__D012910 1976-01-01
% 212.28/212.47  |- rdf__type mesh__D012910sskos__Concept
% 212.28/212.47  |- skos__hiddenLabel mesh__D012910 Venom, Snake
% 212.28/212.47  |- mesh__publicMeSHNote mesh__D012910 76; was see under VENOMS 1975   
% 212.28/212.47  |- skos__annotation mesh__D012910
% 212.28/212.47       GEN or unspecified only: prefer the many specifics: common %26% scientific names of venomous snakes to identify specific SNAKE VENOMS term: TN 241; coord IM with specific available snake family or genus %28%IM%29%; /antag permitted but consider also ANTIVENINS; /enzymol permitted; do not use qualif when coord with ANTIVENINS%A%  
% 212.28/212.47  |- skos__prefLabel mesh__D012910 Snake Venoms
% 212.28/212.47  |- mesh__historyNote mesh__D012910
% 212.28/212.47       76%28%75%29%; was see under VENOMS 1975   
% 212.28/212.47  |- mesh__recordMaintainer mesh__D012910 ssb
% 212.28/212.47  |- mesh__dateRevised mesh__D012910 2005-06-30
% 212.28/212.47  |- skos__related mesh__D012910smesh__D000997
% 212.28/212.47  |- skos__hiddenLabel mesh__D012910 Venoms, Snake
% 212.28/212.47  |- mesh__recordAuthorizer mesh__D012910 sjn
% 212.28/212.47  |- skos__altLabel mesh__D012910 Snake Venom
% 212.28/212.47  |- mesh__recordOriginator mesh__D012910 NLM
% 212.28/212.47  |- mesh__dateCreated mesh__D012910 1999-01-01
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D012910 2006
% 212.28/212.47  |- skos__hiddenLabel mesh__D012112 Facilities, Residential
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D012112 2004
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D012112 2001
% 212.28/212.47  |- mesh__historyNote mesh__D012112 68   
% 212.28/212.47  |- mesh__recordAuthorizer mesh__D012112 sjn
% 212.28/212.47  |- rdf__type mesh__D012112sskos__Concept
% 212.28/212.47  |- mesh__dateEstablished mesh__D012112 1968-01-01
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D012112 2003
% 212.28/212.47  |- mesh__publicMeSHNote mesh__D012112 68   
% 212.28/212.47  |- skos__broader mesh__D012112smesh__D006268
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D012112 2000
% 212.28/212.47  |- mesh__activeMeSHYear mesh__D012112 2006
% 212.28/212.47  |- mesh__recordMaintainer mesh__D012112 kle
% 212.28/212.47  |- mesh__recordOriginator mesh__D012112 NLM
% 212.28/212.47  |- skos__scopeNote mesh__D012112
% 212.28/212.47       Long-term care facilities which provide supervision and assistance in activities of daily living with medical and nursing services when required.%A%    
% 212.28/212.47  |- skos__hiddenLabel mesh__D012112 Facility, Residential
% 212.28/212.47  |- skos__prefLabel mesh__D012112 Residential Facilities
% 212.28/212.47  |- skos__annotation mesh__D012112 IM   
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D012112 2005
% 212.28/212.48  |- mesh__dateCreated mesh__D012112 1999-01-01
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D012112 2002
% 212.28/212.48  |- mesh__dateRevised mesh__D012112 1999-11-03
% 212.28/212.48  |- skos__hiddenLabel mesh__D012112 Residential Facility
% 212.28/212.48  |- skos__annotation mesh__D003386
% 212.28/212.48       as animal %26% food; IM; as food, coord IM with SHELLFISH %28%IM%29%%A%  
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D003386 2004
% 212.28/212.48  |- skos__historyNote mesh__D003386 Crustacea %28%1966-1971%29%
% 212.28/212.48  |- skos__altLabel mesh__D003386 Crabs, True
% 212.28/212.48  |- mesh__historyNote mesh__D003386 2003 %28%1972%29%   
% 212.28/212.48  |- skos__altLabel mesh__D003386 Crab, Green
% 212.28/212.48  |- mesh__dateRevised mesh__D003386 2005-07-30
% 212.28/212.48  |- rdf__type mesh__D003386sskos__Concept
% 212.28/212.48  |- skos__prefLabel mesh__D003386 Brachyura
% 212.28/212.48  |- skos__scopeNote mesh__D003386
% 212.28/212.48       An infraorder of chiefly marine, largely carnivorous CRUSTACEA, in the order DECAPODA, including the genera Cancer, Uca, and Callinectes.%A%    
% 212.28/212.48  |- skos__altLabel mesh__D003386 Crab, Blue
% 212.28/212.48  |- mesh__recordAuthorizer mesh__D003386 jls
% 212.28/212.48  |- skos__altLabel mesh__D003386 Common Shore Crab
% 212.28/212.48  |- skos__altLabel mesh__D003386 Crab, Common Shore
% 212.28/212.48  |- mesh__recordMaintainer mesh__D003386 jls
% 212.28/212.48  |- mesh__recordOriginator mesh__D003386 NLM
% 212.28/212.48  |- mesh__dateCreated mesh__D003386 1999-01-01
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D003386 2005
% 212.28/212.48  |- mesh__dateEstablished mesh__D003386 1972-01-01
% 212.28/212.48  |- skos__altLabel mesh__D003386 Crabs, Short-Tailed
% 212.28/212.48  |- skos__altLabel mesh__D003386 Green Crab
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D003386 2006A
% 212.28/212.48  |- skos__altLabel mesh__D003386 European Shore Crab
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D003386 2006
% 212.28/212.48  |- mesh__publicMeSHNote mesh__D003386 2003; see CRABS 1972-2003   
% 212.28/212.48  |- skos__altLabel mesh__D003386 Blue Crab
% 212.28/212.48  |- skos__broader mesh__D003386smesh__D033364
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D003386 2006B
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D011818 2005
% 212.28/212.48  |- skos__prefLabel mesh__D011818 Rabies
% 212.28/212.48  |- skos__scopeNote mesh__D011818
% 212.28/212.48       An acute infectious disease of the central nervous system affecting almost all mammals, including humans. It is caused by a rhabdovirus and usually spread by contamination with virus-laden saliva of bites inflicted by rabid animals. Important animal vectors include the dog, cat, vampire bat, mongoose, skunk, wolf, raccoon, and fox. %28%From Dorland, 27th ed%29%%A%    
% 212.28/212.48  |- mesh__recordMaintainer mesh__D011818 sjn
% 212.28/212.48  |- rdf__type mesh__D011818sskos__Concept
% 212.28/212.48  |- skos__altLabel mesh__D011818 Hydrophobia
% 212.28/212.48  |- mesh__recordOriginator mesh__D011818 NLM
% 212.28/212.48  |- mesh__recordAuthorizer mesh__D011818 sjn
% 212.28/212.48  |- mesh__dateCreated mesh__D011818 1999-01-01
% 212.28/212.48  |- skos__annotation mesh__D011818
% 212.28/212.48       caused by a rhabdovirus; human %26% animal   
% 212.28/212.48  |- skos__broader mesh__D011818smesh__D018353
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D011818 2006
% 212.28/212.48  |- mesh__dateRevised mesh__D011818 2004-07-13
% 212.28/212.48  |- skos__altLabel mesh__D008071 Lipemia-Clearing Factor
% 212.28/212.48  |- skos__hiddenLabel mesh__D008071 Lipase, Diacylglycerol
% 212.28/212.48  |- mesh__recordOriginator mesh__D008071 NLM
% 212.28/212.48  |- skos__hiddenLabel mesh__D008071 Lipemia Clearing Factor
% 212.28/212.48  |- skos__hiddenLabel mesh__D008071 Heparin Clearing Factor
% 212.28/212.48  |- mesh__recordAuthorizer mesh__D008071 sjn
% 212.28/212.48  |- skos__hiddenLabel mesh__D008071 Lipase, Postheparin Lipoprotein
% 212.28/212.48  |- mesh__dateCreated mesh__D008071 1999-01-01
% 212.28/212.48  |- skos__altLabel mesh__D008071 Heparin-Clearing Factor
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D008071 2005
% 212.28/212.48  |- skos__annotation mesh__D008071
% 212.28/212.48       /defic: consider also LIPOPROTEIN LIPASE DEFICIENCY, FAMILIAL%A%  
% 212.28/212.48  |- mesh__onlineNote mesh__D008071
% 212.28/212.48       use LIPOPROTEIN LIPASE to search HEPARIN-CLEARING FACTOR %26% LIPEMIA-CLEARING FACTOR 1966-80%A%  
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D008071 2006
% 212.28/212.48  |- skos__hiddenLabel mesh__D008071 Lipoprotein Lipase, Postheparin
% 212.28/212.48  |- skos__hiddenLabel mesh__D008071 Lipase, Diglyceride
% 212.28/212.48  |- skos__altLabel mesh__D008071 Post-Heparin Lipase
% 212.28/212.48  |- skos__altLabel mesh__D008071 Postheparin Lipoprotein Lipase
% 212.28/212.48  |- skos__altLabel mesh__D008071 Diglyceride Lipase
% 212.28/212.48  |- mesh__recordMaintainer mesh__D008071 ssb
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D008071 2004
% 212.28/212.48  |- skos__hiddenLabel mesh__D008071 Lipase, Post-Heparin
% 212.28/212.48  |- skos__hiddenLabel mesh__D008071 Factor, Heparin-Clearing
% 212.28/212.48  |- mesh__historyNote mesh__D008071
% 212.28/212.48       HEPARIN-CLEARING FACTOR %26% LIPEMIA-CLEARING FACTOR were see under LIPOPROTEIN LIPASE 1963-80%A%  
% 212.28/212.48  |- skos__hiddenLabel mesh__D008071 Lipase, Lipoprotein
% 212.28/212.48  |- skos__altLabel mesh__D008071 Postheparin Lipase
% 212.28/212.48  |- skos__scopeNote mesh__D008071
% 212.28/212.48       An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. The enzyme hydrolyzes triacylglycerols in chylomicrons, very-low-density lipoproteins, low-density lipoproteins, and diacylglycerols. It occurs on capillary endothelial surfaces, especially in mammary, muscle, and adipose tissue. Genetic deficiency of the enzyme causes familial hyperlipoproteinemia Type I. %28%Dorland, 27th ed%29% EC 3.1.1.34.%A%    
% 212.28/212.48  |- skos__broader mesh__D008071smesh__D002265
% 212.28/212.48  |- mesh__dateRevised mesh__D008071 2003-07-09
% 212.28/212.48  |- skos__hiddenLabel mesh__D008071 Post Heparin Lipase
% 212.28/212.48  |- skos__hiddenLabel mesh__D008071 Lipase, Postheparin
% 212.28/212.48  |- skos__altLabel mesh__D008071 Diacylglycerol Lipase
% 212.28/212.48  |- skos__prefLabel mesh__D008071 Lipoprotein Lipase
% 212.28/212.48  |- rdf__type mesh__D008071sskos__Concept
% 212.28/212.48  |- skos__hiddenLabel mesh__D008071 Factor, Lipemia-Clearing
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D049488 2005
% 212.28/212.48  |- mesh__publicMeSHNote mesh__D049488
% 212.28/212.48       2005; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN was indexed under CARRIER PROTEINS 2000-2004%A%  
% 212.28/212.48  |- mesh__recordMaintainer mesh__D049488 jmp
% 212.28/212.48  |- skos__historyNote mesh__D049488 Carrier Proteins %28%2000-2004%29%
% 212.28/212.48  |- mesh__recordOriginator mesh__D049488 jmp
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D049488 2006
% 212.28/212.48  |- rdf__type mesh__D049488sskos__Concept
% 212.28/212.48  |- skos__scopeNote mesh__D049488
% 212.28/212.48       A ubiquitously found basic protein that binds to phosphatidylethanolamine and NUCLEOTIDES. It is an endogenous inhibitor of RAF KINASES and may play a role in regulating SIGNAL TRANSDUCTION. Phosphatidylethanolamine-binding protein is the precursor of hippocampal cholinergic neurostimulating peptide, which is cleaved from the N-terminal region of the protein.%A%    
% 212.28/212.48  |- skos__broader mesh__D049488smesh__D002352
% 212.28/212.48  |- mesh__historyNote mesh__D049488 2005%28%2000%29%   
% 212.28/212.48  |- skos__altLabel mesh__D049488
% 212.28/212.48       Hippocampal Cholinergic Neurostimulating Peptide Precursor
% 212.28/212.48  |- skos__prefLabel mesh__D049488 Phosphatidylethanolamine Binding Protein
% 212.28/212.48  |- skos__altLabel mesh__D049488 Raf Kinase Inhibitor Protein
% 212.28/212.48  |- skos__broader mesh__D049488smesh__D047908
% 212.28/212.48  |- mesh__dateEstablished mesh__D049488 2005-01-01
% 212.28/212.48  |- mesh__recordAuthorizer mesh__D049488 sjn
% 212.28/212.48  |- skos__altLabel mesh__D049488 Phosphatidylethanolamine-Binding Protein
% 212.28/212.48  |- skos__altLabel mesh__D049488 HCNP Precursor Protein
% 212.28/212.48  |- mesh__dateCreated mesh__D049488 2004-07-07
% 212.28/212.48  |- rdf__type mesh__D016503sskos__Concept
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D016503 2002
% 212.28/212.48  |- skos__scopeNote mesh__D016503
% 212.28/212.48       Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity.%A%    
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D016503 2004
% 212.28/212.48  |- mesh__recordMaintainer mesh__D016503 lkt
% 212.28/212.48  |- skos__altLabel mesh__D016503 Drug Targeting
% 212.28/212.48  |- skos__related mesh__D016503smesh__D004333
% 212.28/212.48  |- mesh__historyNote mesh__D016503 92   
% 212.28/212.48  |- skos__annotation mesh__D016503
% 212.28/212.48       coord IM with drug /admin %28%IM%29%; do not confuse with MEDICATION SYSTEMS, an organizational concept in patient care for providing medication%A%  
% 212.28/212.48  |- skos__hiddenLabel mesh__D016503 Delivery Systems, Drug
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D016503 2003
% 212.28/212.48  |- mesh__dateCreated mesh__D016503 1991-06-21
% 212.28/212.48  |- skos__hiddenLabel mesh__D016503 System, Drug Delivery
% 212.28/212.48  |- mesh__recordAuthorizer mesh__D016503 sjn
% 212.28/212.48  |- skos__hiddenLabel mesh__D016503 Drug Targetings
% 212.28/212.48  |- skos__hiddenLabel mesh__D016503 Systems, Drug Delivery
% 212.28/212.48  |- skos__hiddenLabel mesh__D016503 Drug Delivery System
% 212.28/212.48  |- mesh__recordOriginator mesh__D016503 AGS
% 212.28/212.48  |- skos__prefLabel mesh__D016503 Drug Delivery Systems
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D016503 2006
% 212.28/212.48  |- skos__related mesh__D016503smesh__D004337
% 212.28/212.48  |- mesh__publicMeSHNote mesh__D016503 92   
% 212.28/212.48  |- mesh__dateEstablished mesh__D016503 1992-01-01
% 212.28/212.48  |- skos__related mesh__D016503smesh__D004304
% 212.28/212.48  |- mesh__dateRevised mesh__D016503 2001-07-25
% 212.28/212.48  |- skos__broader mesh__D016503smesh__D004358
% 212.28/212.48  |- skos__hiddenLabel mesh__D016503 Delivery System, Drug
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D016503 2005
% 212.28/212.48  |- skos__hiddenLabel mesh__D016503 Targetings, Drug
% 212.28/212.48  |- skos__hiddenLabel mesh__D016503 Targeting, Drug
% 212.28/212.48  |- skos__historyNote mesh__D007777 Bacteria %28%1966-1974%29%
% 212.28/212.48  |- mesh__dateEstablished mesh__D007777 1975-01-01
% 212.28/212.48  |- mesh__recordMaintainer mesh__D007777 SYSTEM
% 212.28/212.48  |- mesh__historyNote mesh__D007777 75   
% 212.28/212.48  |- rdf__type mesh__D007777sskos__Concept
% 212.28/212.48  |- skos__broader mesh__D007777smesh__D016989
% 212.28/212.48  |- mesh__dateRevised mesh__D007777 2005-06-30
% 212.28/212.48  |- skos__scopeNote mesh__D007777
% 212.28/212.48       A family of gram-positive bacteria found regularly in the mouth and intestinal tract of man and other animals, in food and dairy products, and in fermenting vegetable juices. A few species are highly pathogenic.%A%    
% 212.28/212.48  |- skos__annotation mesh__D007777
% 212.28/212.48       in food, dairy prod, plants, digestive system   
% 212.28/212.48  |- skos__prefLabel mesh__D007777 Lactobacillaceae
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D007777 2006
% 212.28/212.48  |- mesh__dateCreated mesh__D007777 1999-01-01
% 212.28/212.48  |- mesh__recordOriginator mesh__D007777 NLM
% 212.28/212.48  |- mesh__publicMeSHNote mesh__D007777 75   
% 212.28/212.48  |- mesh__recordAuthorizer mesh__D007777 sjn
% 212.28/212.48  |- mesh__recordAuthorizer mesh__D012911 sjn
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D012911 2006
% 212.28/212.48  |- rdf__type mesh__D012911sskos__Concept
% 212.28/212.48  |- skos__related mesh__D012911smesh__D012909
% 212.28/212.48  |- skos__hiddenLabel mesh__D012911 Snake
% 212.28/212.48  |- skos__annotation mesh__D012911
% 212.28/212.48       GEN or unspecified; prefer specific families or genera; IM; qualif permitted; TN 241: common %26% scientific names of venomous snakes to identify specific SNAKE VENOMS terms%A%  
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D012911 2005
% 212.28/212.48  |- mesh__recordOriginator mesh__D012911 NLM
% 212.28/212.48  |- mesh__recordMaintainer mesh__D012911 ags
% 212.28/212.48  |- skos__prefLabel mesh__D012911 Snakes
% 212.28/212.48  |- mesh__dateCreated mesh__D012911 1999-01-01
% 212.28/212.48  |- skos__broader mesh__D012911smesh__D012104
% 212.28/212.48  |- skos__related mesh__D012911smesh__D012910
% 212.28/212.48  |- mesh__dateRevised mesh__D012911 2003-07-09
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D012911 2004
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D012113 2004
% 212.28/212.48  |- skos__historyNote mesh__D012113 Population %28%1966-1967%29%
% 212.28/212.48  |- skos__hiddenLabel mesh__D012113 Mobility, Residential
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D012113 2002
% 212.28/212.48  |- skos__hiddenLabel mesh__D012113 Migration, Rural-Urban
% 212.28/212.48  |- skos__hiddenLabel mesh__D012113 Rural Urban Migration
% 212.28/212.48  |- skos__hiddenLabel mesh__D012113 Mobilities, Residential
% 212.28/212.48  |- mesh__dateRevised mesh__D012113 1999-11-03
% 212.28/212.48  |- rdf__type mesh__D012113sskos__Concept
% 212.28/212.48  |- skos__hiddenLabel mesh__D012113 Migrations, Rural-Urban
% 212.28/212.48  |- mesh__dateEstablished mesh__D012113 1968-01-01
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D012113 2003
% 212.28/212.48  |- mesh__publicMeSHNote mesh__D012113 68   
% 212.28/212.48  |- skos__broader mesh__D012113smesh__D012111
% 212.28/212.48  |- skos__historyNote mesh__D012113
% 212.28/212.48       Emigration and Immigration %28%1966-1967%29%
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D012113 2006
% 212.28/212.48  |- skos__hiddenLabel mesh__D012113 Migrations, Internal
% 212.28/212.48  |- skos__hiddenLabel mesh__D012113 Internal Migrations
% 212.28/212.48  |- skos__historyNote mesh__D012113
% 212.28/212.48       Transients and Migrants %28%1966-1967%29%
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D012113 2001
% 212.28/212.48  |- mesh__historyNote mesh__D012113 68   
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D012113 2005
% 212.28/212.48  |- mesh__recordAuthorizer mesh__D012113 sjn
% 212.28/212.48  |- mesh__dateCreated mesh__D012113 1999-01-01
% 212.28/212.48  |- skos__scopeNote mesh__D012113
% 212.28/212.48       Frequent change of residence, either in the same city or town, or between cities, states or communities.%A%    
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D012113 2000
% 212.28/212.48  |- skos__hiddenLabel mesh__D012113 Rural-Urban Migrations
% 212.28/212.48  |- skos__annotation mesh__D012113 specify geog if pertinent   
% 212.28/212.48  |- mesh__recordMaintainer mesh__D012113 kle
% 212.28/212.48  |- mesh__recordOriginator mesh__D012113 NLM
% 212.28/212.48  |- skos__hiddenLabel mesh__D012113 Internal Migration
% 212.28/212.48  |- skos__prefLabel mesh__D012113 Residential Mobility
% 212.28/212.48  |- skos__hiddenLabel mesh__D012113 Residential Mobilities
% 212.28/212.48  |- skos__broader mesh__D036561smesh__D007887
% 212.28/212.48  |- mesh__publicMeSHNote mesh__D036561 2003   
% 212.28/212.48  |- rdf__type mesh__D036561sskos__Concept
% 212.28/212.48  |- skos__prefLabel mesh__D036561 Cajanus
% 212.28/212.48  |- skos__altLabel mesh__D036561 Pigeonpea Plant
% 212.28/212.48  |- skos__annotation mesh__D036561
% 212.28/212.48       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D036561 2003
% 212.28/212.48  |- mesh__dateCreated mesh__D036561 2002-07-03
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D036561 2005
% 212.28/212.48  |- skos__scopeNote mesh__D036561
% 212.28/212.48       A plant genus of the family FABACEAE that is used for food in NIGERIA.%A%    
% 212.28/212.48  |- mesh__historyNote mesh__D036561 2003   
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D036561 2004
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D036561 2006
% 212.28/212.48  |- skos__altLabel mesh__D036561 Pea Plant, Pigeon
% 212.28/212.48  |- mesh__dateEstablished mesh__D036561 2003-01-01
% 212.28/212.48  |- mesh__dateEstablished mesh__D003387 1991-01-01
% 212.28/212.48  |- skos__broader mesh__D003387smesh__D014082
% 212.28/212.48  |- mesh__historyNote mesh__D003387
% 212.28/212.48       91%28%75%29%; was see under TOOTH FRACTURES 1975-90   
% 212.28/212.48  |- mesh__dateCreated mesh__D003387 1999-01-01
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D003387 2005
% 212.28/212.48  |- mesh__recordMaintainer mesh__D003387 PXP
% 212.28/212.48  |- mesh__recordAuthorizer mesh__D003387 SJN
% 212.28/212.48  |- mesh__publicMeSHNote mesh__D003387
% 212.28/212.48       91; was see under TOOTH FRACTURES 1975-90   
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D003387 2003
% 212.28/212.48  |- skos__scopeNote mesh__D003387
% 212.28/212.48       Incomplete fracture of any part of a tooth, characterized by pain during mastication and sensitivity to heat, cold, sweet or sour tastes, and alcohol; it is often undiagnosed because the tooth is usually X-ray negative and normal to pulp vitality tests.%A%    
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D003387 2006
% 212.28/212.48  |- skos__hiddenLabel mesh__D003387 Syndromes, Cracked Tooth
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D003387 2000
% 212.28/212.48  |- mesh__dateRevised mesh__D003387 1997-06-20
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D003387 2004
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D003387 1998
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D003387 2001
% 212.28/212.48  |- skos__hiddenLabel mesh__D003387 Cracked Tooth Syndromes
% 212.28/212.48  |- skos__annotation mesh__D003387
% 212.28/212.48       incomplete tooth fracture causing sensitivity to heat, cold, sweet, sour, alcohol%A%  
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D003387 2002
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D003387 1999
% 212.28/212.48  |- mesh__onlineNote mesh__D003387 search TOOTH FRACTURES 1970-74   
% 212.28/212.48  |- skos__prefLabel mesh__D003387 Cracked Tooth Syndrome
% 212.28/212.48  |- skos__hiddenLabel mesh__D003387 Syndrome, Cracked Tooth
% 212.28/212.48  |- mesh__recordOriginator mesh__D003387 NLM
% 212.28/212.48  |- rdf__type mesh__D003387sskos__Concept
% 212.28/212.48  |- rdf__type mesh__D011819sskos__Concept
% 212.28/212.48  |- skos__broader mesh__D011819smesh__D014765
% 212.28/212.48  |- mesh__dateCreated mesh__D011819 1999-01-01
% 212.28/212.48  |- mesh__historyNote mesh__D011819 2001 %28%1963%29%   
% 212.28/212.48  |- mesh__recordAuthorizer mesh__D011819 sjn
% 212.28/212.48  |- skos__prefLabel mesh__D011819 Rabies Vaccines
% 212.28/212.48  |- skos__altLabel mesh__D011819 Rabies Human Diploid Cell Vaccine
% 212.28/212.48  |- mesh__recordOriginator mesh__D011819 NLM
% 212.28/212.48  |- skos__hiddenLabel mesh__D011819 Vaccine, Rabies
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D011819 2006
% 212.28/212.48  |- mesh__publicMeSHNote mesh__D011819 2001; see RABIES VACCINE 1963-2000   
% 212.28/212.48  |- skos__altLabel mesh__D011819 Rabies Vaccine
% 212.28/212.48  |- mesh__recordMaintainer mesh__D011819 ssb
% 212.28/212.48  |- skos__scopeNote mesh__D011819
% 212.28/212.48       Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis.%A%    
% 212.28/212.48  |- skos__hiddenLabel mesh__D011819 Vaccines, Rabies
% 212.28/212.48  |- mesh__dateRevised mesh__D011819 2005-06-30
% 212.28/212.48  |- mesh__recordMaintainer mesh__D008870 nns
% 212.28/212.48  |- mesh__dateEstablished mesh__D008870 1972-01-01
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D008870 2004
% 212.28/212.48  |- skos__historyNote mesh__D008870 Organoids %28%1966-1969%29%
% 212.28/212.48  |- rdf__type mesh__D008870sskos__Concept
% 212.28/212.48  |- mesh__dateRevised mesh__D008870 2003-07-09
% 212.28/212.48  |- mesh__historyNote mesh__D008870 72%28%70%29%   
% 212.28/212.48  |- skos__prefLabel mesh__D008870 Microtubules
% 212.28/212.48  |- skos__broader mesh__D008870smesh__D003599
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D008870 2005
% 212.28/212.48  |- mesh__recordAuthorizer mesh__D008870 sjn
% 212.28/212.48  |- skos__hiddenLabel mesh__D008870 Microtubule
% 212.28/212.48  |- mesh__recordOriginator mesh__D008870 NLM
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D008870 2006
% 212.28/212.48  |- mesh__publicMeSHNote mesh__D008870 72   
% 212.28/212.48  |- skos__scopeNote mesh__D008870
% 212.28/212.48       Slender, cylindrical filaments found in the cytoskeleton of plant and animal cells. They are composed of the protein TUBULIN.%A%    
% 212.28/212.48  |- mesh__dateCreated mesh__D008870 1999-01-01
% 212.28/212.48  |- mesh__recordOriginator mesh__D022541 ags
% 212.28/212.48  |- skos__prefLabel mesh__D022541 Streptococcal Vaccines
% 212.28/212.48  |- skos__historyNote mesh__D022541 Bacterial Vaccines %28%1970-2000%29%
% 212.28/212.48  |- mesh__recordMaintainer mesh__D022541 ssb
% 212.28/212.48  |- mesh__recordAuthorizer mesh__D022541 sjn
% 212.28/212.48  |- skos__hiddenLabel mesh__D022541 Vaccines, Streptococcal
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D022541 2006
% 212.28/212.48  |- mesh__dateEstablished mesh__D022541 2001-01-01
% 212.28/212.48  |- mesh__dateCreated mesh__D022541 2000-06-22
% 212.28/212.48  |- mesh__publicMeSHNote mesh__D022541 2001   
% 212.28/212.48  |- skos__annotation mesh__D022541
% 212.28/212.48       coord IM with specific Streptococcus species /immunol %28%IM%29%%A%  
% 212.28/212.48  |- rdf__type mesh__D022541sskos__Concept
% 212.28/212.48  |- skos__scopeNote mesh__D022541
% 212.28/212.48       Vaccines or candidate vaccines used to prevent STREPTOCOCCAL INFECTIONS.%A%    
% 212.28/212.48  |- mesh__historyNote mesh__D022541 2001   
% 212.28/212.48  |- mesh__dateRevised mesh__D022541 2005-06-30
% 212.28/212.48  |- skos__broader mesh__D022541smesh__D001428
% 212.28/212.48  |- skos__altLabel mesh__D008072 Hyperlipoproteinemia Type I
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D008072 2006
% 212.28/212.48  |- skos__hiddenLabel mesh__D008072 Familial Hyperchylomicronemia
% 212.28/212.48  |- skos__hiddenLabel mesh__D008072 Familial Hyperchylomicronemias
% 212.28/212.48  |- skos__hiddenLabel mesh__D008072 Is, Hyperlipoproteinemia Type
% 212.28/212.48  |- skos__hiddenLabel mesh__D008072 I, Hyperlipoproteinemia Type
% 212.28/212.48  |- mesh__dateCreated mesh__D008072 1979-04-23
% 212.28/212.48  |- skos__hiddenLabel mesh__D008072 Hyperlipoproteinemia Type Is
% 212.28/212.48  |- mesh__dateRevised mesh__D008072 2005-06-30
% 212.28/212.48  |- skos__hiddenLabel mesh__D008072 Type Is, Hyperlipoproteinemia
% 212.28/212.48  |- skos__prefLabel mesh__D008072 Lipoprotein Lipase Deficiency, Familial
% 212.28/212.48  |- mesh__recordOriginator mesh__D008072 VDK
% 212.28/212.48  |- mesh__publicMeSHNote mesh__D008072
% 212.28/212.48       91; was see under HYPERLIPOPROTEINEMIA 1980-90   
% 212.28/212.48  |- mesh__recordMaintainer mesh__D008072 lkt
% 212.28/212.48  |- skos__altLabel mesh__D008072 Hyperchylomicronemia, Familial
% 212.28/212.48  |- skos__broader mesh__D008072smesh__D006951
% 212.28/212.48  |- skos__hiddenLabel mesh__D008072 Type I, Hyperlipoproteinemia
% 212.28/212.48  |- rdf__type mesh__D008072sskos__Concept
% 212.28/212.48  |- mesh__historyNote mesh__D008072
% 212.28/212.48       91%28%80%29%; was see under HYPERLIPOPROTEINEMIA 1980-90   
% 212.28/212.48  |- mesh__recordAuthorizer mesh__D008072 sjn
% 212.28/212.48  |- skos__altLabel mesh__D008072 Familial Lipoprotein Lipase Deficiency
% 212.28/212.48  |- mesh__dateEstablished mesh__D008072 1991-01-01
% 212.28/212.48  |- skos__broader mesh__D008072smesh__D008052
% 212.28/212.48  |- skos__annotation mesh__D008072
% 212.28/212.48       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 212.28/212.48  |- skos__hiddenLabel mesh__D008072 Hyperchylomicronemias, Familial
% 212.28/212.48  |- skos__scopeNote mesh__D008072
% 212.28/212.48       A rare familial condition characterized by massive chylomicronemia and decreased levels of other lipoproteins. It is due to deficiency of lipoprotein lipase, an alkaline triglyceride hydrolase which catalyzes an important step in the extrahepatic removal of triglyceride-rich lipoproteins from the blood.%A%    
% 212.28/212.48  |- skos__historyNote mesh__D008072
% 212.28/212.48       Hyperlipidemia/familial %26% genetic %28%1966-1979%29%
% 212.28/212.48  |- mesh__recordAuthorizer mesh__D049489 sjn
% 212.28/212.48  |- rdf__type mesh__D049489sskos__Concept
% 212.28/212.48  |- mesh__publicMeSHNote mesh__D049489 2005   
% 212.28/212.48  |- skos__prefLabel mesh__D049489 Stroboscopy
% 212.28/212.48  |- mesh__recordMaintainer mesh__D049489 nns
% 212.28/212.48  |- skos__scopeNote mesh__D049489
% 212.28/212.48       The observation of successive phases of MOVEMENT by use of a flashing light.%A%    
% 212.28/212.48  |- mesh__dateCreated mesh__D049489 2004-07-07
% 212.28/212.48  |- mesh__historyNote mesh__D049489 2005   
% 212.28/212.48  |- mesh__recordOriginator mesh__D049489 nns
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D049489 2005
% 212.28/212.48  |- skos__broader mesh__D049489smesh__D003952
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D049489 2006
% 212.28/212.48  |- mesh__dateEstablished mesh__D049489 2005-01-01
% 212.28/212.48  |- skos__annotation mesh__D016504
% 212.28/212.48       coord IM with no qualif with disease /diag %28%IM%29% if discussed; DF: BREAST SELF EXAM%A%  
% 212.28/212.48  |- skos__historyNote mesh__D016504 Breast %28%1980-1991%29%
% 212.28/212.48  |- skos__historyNote mesh__D016504 Palpation %28%1966-1991%29%
% 212.28/212.48  |- skos__scopeNote mesh__D016504
% 212.28/212.48       The inspection of one%27%s breasts, usually for signs of disease, especially neoplastic disease.%A%    
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D016504 2004
% 212.28/212.48  |- mesh__recordAuthorizer mesh__D016504 sjn
% 212.28/212.48  |- mesh__historyNote mesh__D016504 92   
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D016504 2003
% 212.28/212.48  |- skos__broader mesh__D016504smesh__D016353
% 212.28/212.48  |- skos__hiddenLabel mesh__D016504 Self-Examinations, Breast
% 212.28/212.48  |- skos__hiddenLabel mesh__D016504 Breast Self-Examinations
% 212.28/212.48  |- mesh__recordOriginator mesh__D016504 JHM
% 212.28/212.48  |- skos__prefLabel mesh__D016504 Breast Self-Examination
% 212.28/212.48  |- mesh__dateRevised mesh__D016504 2002-07-02
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D016504 2006
% 212.28/212.48  |- skos__historyNote mesh__D016504 Breast Neoplasms %28%1966-1991%29%
% 212.28/212.48  |- mesh__publicMeSHNote mesh__D016504 92   
% 212.28/212.48  |- mesh__dateEstablished mesh__D016504 1992-01-01
% 212.28/212.48  |- mesh__recordMaintainer mesh__D016504 PXP
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D016504 2005
% 212.28/212.48  |- skos__hiddenLabel mesh__D016504 Breast Self Examination
% 212.28/212.48  |- mesh__dateCreated mesh__D016504 1991-02-08
% 212.28/212.48  |- rdf__type mesh__D016504sskos__Concept
% 212.28/212.48  |- skos__altLabel mesh__D016504 Self-Examination, Breast
% 212.28/212.48  |- skos__hiddenLabel mesh__D016504 Self Examination, Breast
% 212.28/212.48  |- rdf__type mesh__D007778sskos__Concept
% 212.28/212.48  |- mesh__recordAuthorizer mesh__D007778 sjn
% 212.28/212.48  |- skos__prefLabel mesh__D007778 Lactobacillus
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D007778 2006
% 212.28/212.48  |- skos__scopeNote mesh__D007778
% 212.28/212.48       A genus of gram-positive, microaerophilic, rod-shaped bacteria occurring widely in nature. Its species are also part of the many normal flora of the mouth, intestinal tract, and vagina of many mammals, including humans. Pathogenicity from this genus is rare.%A%    
% 212.28/212.48  |- skos__broader mesh__D007778smesh__D007777
% 212.28/212.48  |- mesh__dateRevised mesh__D007778 2005-06-30
% 212.28/212.48  |- mesh__dateCreated mesh__D007778 1999-01-01
% 212.28/212.48  |- mesh__recordMaintainer mesh__D007778 SYSTEM
% 212.28/212.48  |- mesh__recordOriginator mesh__D007778 NLM
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D004480 2002
% 212.28/212.48  |- mesh__dateRevised mesh__D004480 1999-11-03
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D004480 2005
% 212.28/212.48  |- mesh__recordOriginator mesh__D004480 NLM
% 212.28/212.48  |- mesh__dateCreated mesh__D004480 1999-01-01
% 212.28/212.48  |- skos__scopeNote mesh__D004480
% 212.28/212.48       Gross hypo- or aplasia of one or more long bones of one or more limbs. The concept includes amelia, hemimelia, and phocomelia.%A%    
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D004480 2006
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D004480 2000
% 212.28/212.48  |- skos__broader mesh__D004480smesh__D017880
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D004480 2003
% 212.28/212.48  |- skos__annotation mesh__D004480
% 212.28/212.48       abnorm of arm or leg: see Dorland for definition %26% inclusions; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 212.28/212.48  |- mesh__recordMaintainer mesh__D004480 kle
% 212.28/212.48  |- mesh__recordAuthorizer mesh__D004480 sjn
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D004480 2001
% 212.28/212.48  |- rdf__type mesh__D004480sskos__Concept
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D004480 2004
% 212.28/212.48  |- mesh__onlineNote mesh__D004480
% 212.28/212.48       use ECTROMELIA to search PHOCOMELIA 1966-78 %26% SIRENOMELIA 1967-78%A%  
% 212.28/212.48  |- mesh__dateEstablished mesh__D004480 1967-01-01
% 212.28/212.48  |- mesh__historyNote mesh__D004480
% 212.28/212.48       67%28%63%29%; PHOCOMELIA was see under ECTROMELIA 1967-78, was heading 1963-66; SIRENOMELIA was see under ECTROMELIA 1967-78%A%  
% 212.28/212.48  |- mesh__publicMeSHNote mesh__D004480 67; PHOCOMELIA was heading 1963-66   
% 212.28/212.48  |- skos__prefLabel mesh__D004480 Ectromelia
% 212.28/212.48  |- rdf__type mesh__D012912sskos__Concept
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D012912 2005
% 212.28/212.48  |- mesh__recordAuthorizer mesh__D012912 sjn
% 212.28/212.48  |- skos__hiddenLabel mesh__D012912 Sneezings
% 212.28/212.48  |- mesh__dateCreated mesh__D012912 1999-01-01
% 212.28/212.48  |- skos__broader mesh__D012912smesh__D012818
% 212.28/212.48  |- skos__scopeNote mesh__D012912
% 212.28/212.48       The sudden, forceful, involuntary expulsion of air from the NOSE and MOUTH caused by irritation to the MUCOUS MEMBRANES of the upper RESPIRATORY TRACT.%A%    
% 212.28/212.48  |- mesh__dateRevised mesh__D012912 2003-07-09
% 212.28/212.48  |- mesh__recordOriginator mesh__D012912 NLM
% 212.28/212.48  |- skos__broader mesh__D012912smesh__D044703
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D012912 2004
% 212.28/212.48  |- mesh__recordMaintainer mesh__D012912 nns
% 212.28/212.48  |- skos__prefLabel mesh__D012912 Sneezing
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D012912 2006
% 212.28/212.48  |- skos__hiddenLabel mesh__D012114 Residential Treatments
% 212.28/212.48  |- mesh__dateRevised mesh__D012114 1996-06-10
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D012114 2004
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D012114 2002
% 212.28/212.48  |- rdf__type mesh__D012114sskos__Concept
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D012114 2005
% 212.28/212.48  |- mesh__recordOriginator mesh__D012114 NLM
% 212.28/212.48  |- mesh__dateCreated mesh__D012114 1999-01-01
% 212.28/212.48  |- skos__prefLabel mesh__D012114 Residential Treatment
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D012114 2006
% 212.28/212.48  |- mesh__dateEstablished mesh__D012114 1966-01-01
% 212.28/212.48  |- skos__broader mesh__D012114smesh__D012960
% 212.28/212.48  |- skos__hiddenLabel mesh__D012114 Treatments, Residential
% 212.28/212.48  |- mesh__publicMeSHNote mesh__D012114 66   
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D012114 1997
% 212.28/212.48  |- mesh__historyNote mesh__D012114 66%28%64%29%   
% 212.28/212.48  |- skos__hiddenLabel mesh__D012114 Treatment, Residential
% 212.28/212.48  |- skos__annotation mesh__D012114 SPEC qualif   
% 212.28/212.48  |- mesh__activeMeSHYear mesh__D012114 1998
% 212.28/212.48  |- mesh__recordAuthorizer mesh__D012114 PLS
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012114 2000
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012114 1999
% 212.28/212.49  |- mesh__recordMaintainer mesh__D012114 JLS
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012114 2003
% 212.28/212.49  |- skos__scopeNote mesh__D012114
% 212.28/212.49       A specialized residential treatment program for behavior disorders including substance abuse. It may include therapeutically planned group living and learning situations including teaching of adaptive skills to help patient functioning in the community. %28%From Kahn, A. P. and Fawcett, J. Encyclopedia of Mental Health, 1993, p320.%29%%A%    
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012114 2001
% 212.28/212.49  |- rdf__type mesh__D036562sskos__Concept
% 212.28/212.49  |- mesh__dateCreated mesh__D036562 2002-07-03
% 212.28/212.49  |- skos__prefLabel mesh__D036562 Helichrysum
% 212.28/212.49  |- skos__annotation mesh__D036562
% 212.28/212.49       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.28/212.49  |- mesh__dateEstablished mesh__D036562 2003-01-01
% 212.28/212.49  |- mesh__historyNote mesh__D036562 2003   
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D036562 2003
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D036562 2005
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D036562 2004
% 212.28/212.49  |- skos__scopeNote mesh__D036562
% 212.28/212.49       A plant genus of the family ASTERACEAE. Members contain CHALCONE, helichrysetin, arenarin, and flamin.%A%    
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D036562 2006
% 212.28/212.49  |- skos__broader mesh__D036562smesh__D019659
% 212.28/212.49  |- mesh__publicMeSHNote mesh__D036562 2003   
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D003388 2005
% 212.28/212.49  |- skos__hiddenLabel mesh__D003388 Cranial Fossas, Posterior
% 212.28/212.49  |- skos__hiddenLabel mesh__D003388 Posterior Cranial Fossa
% 212.28/212.49  |- skos__hiddenLabel mesh__D003388 Fossas, Posterior Cranial
% 212.28/212.49  |- mesh__recordAuthorizer mesh__D003388 sjn
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D003388 2006
% 212.28/212.49  |- mesh__recordOriginator mesh__D003388 NLM
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D003388 2003
% 212.28/212.49  |- skos__prefLabel mesh__D003388 Cranial Fossa, Posterior
% 212.28/212.49  |- mesh__historyNote mesh__D003388
% 212.28/212.49       91%28%64%29%; was see under SKULL 1964-90   
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D003388 2004
% 212.28/212.49  |- skos__annotation mesh__D003388
% 212.28/212.49       NIM when merely locational; X ref CLIVUS: restrict to posterior cranial fossa; other clivus sites are indexed under specific cranial bone, as clivus ossis occipitalis goes under OCCIPITAL BONE; neopl: coord IM with SKULL BASE NEOPLASMS %28%IM%29%%A%  
% 212.28/212.49  |- skos__hiddenLabel mesh__D003388 Posterior Cranial Fossas
% 212.28/212.49  |- skos__scopeNote mesh__D003388
% 212.28/212.49       The infratentorial compartment that contains the CEREBELLUM and BRAIN STEM. It is formed by the posterior third of the superior surface of the body of the sphenoid %28%SPHENOID BONE%29%, by the occipital, the petrous, and mastoid portions of the TEMPORAL BONE, and the posterior inferior angle of the PARIETAL BONE.%A%    
% 212.28/212.49  |- skos__broader mesh__D003388smesh__D019291
% 212.28/212.49  |- rdf__type mesh__D003388sskos__Concept
% 212.28/212.49  |- mesh__dateEstablished mesh__D003388 1991-01-01
% 212.28/212.49  |- mesh__dateRevised mesh__D003388 2002-07-03
% 212.28/212.49  |- mesh__publicMeSHNote mesh__D003388 91; was see under SKULL 1964-90   
% 212.28/212.49  |- skos__hiddenLabel mesh__D003388 Fossa, Posterior Cranial
% 212.28/212.49  |- mesh__dateCreated mesh__D003388 1999-01-01
% 212.28/212.49  |- mesh__recordMaintainer mesh__D003388 ags
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D008871 2004
% 212.28/212.49  |- rdf__type mesh__D008871sskos__Concept
% 212.28/212.49  |- skos__historyNote mesh__D008871 Kidney Cortex %28%1973-1977%29%
% 212.28/212.49  |- skos__hiddenLabel mesh__D008871 Border, Striated
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D008871 2001
% 212.28/212.49  |- skos__hiddenLabel mesh__D008871 Microvillus
% 212.28/212.49  |- skos__hiddenLabel mesh__D008871 Brush Borders
% 212.28/212.49  |- skos__hiddenLabel mesh__D008871 Borders, Striated
% 212.28/212.49  |- mesh__recordOriginator mesh__D008871 VDK
% 212.28/212.49  |- skos__hiddenLabel mesh__D008871 Borders, Brush
% 212.28/212.49  |- mesh__dateCreated mesh__D008871 1977-04-27
% 212.28/212.49  |- skos__prefLabel mesh__D008871 Microvilli
% 212.28/212.49  |- skos__annotation mesh__D008871
% 212.28/212.49       NIM: coord with specific cell /ultrastructure %28%IM%29%; IM only if point of article irrespective of identity of cell /ultrastructure %28%NIM%29%; A 11 qualif except /cytol; /genet permitted%A%  
% 212.28/212.49  |- skos__hiddenLabel mesh__D008871 Border, Brush
% 212.28/212.49  |- skos__historyNote mesh__D008871 Intestinal Mucosa %28%1966-1977%29%
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D008871 2005
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D008871 2002
% 212.28/212.49  |- mesh__historyNote mesh__D008871
% 212.28/212.49       84%28%78%29%; was see under CELL MEMBRANE 1978-83   
% 212.28/212.49  |- skos__broader mesh__D008871smesh__D022081
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D008871 2006
% 212.28/212.49  |- skos__historyNote mesh__D008871 Cell Membrane %28%1966-1977%29%
% 212.28/212.49  |- mesh__dateEstablished mesh__D008871 1984-01-01
% 212.28/212.49  |- mesh__dateRevised mesh__D008871 2000-06-22
% 212.28/212.49  |- skos__historyNote mesh__D008871
% 212.28/212.49       Kidney Tubules, Proximal %28%1973-1977%29%
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D008871 2003
% 212.28/212.49  |- mesh__recordMaintainer mesh__D008871 TGC
% 212.28/212.49  |- mesh__publicMeSHNote mesh__D008871
% 212.28/212.49       84; was see under CELL MEMBRANE 1978-83   
% 212.28/212.49  |- skos__altLabel mesh__D008871 Striated Border
% 212.28/212.49  |- skos__scopeNote mesh__D008871
% 212.28/212.49       Minute projections of cell membranes which greatly increase the surface area of the cell.%A%    
% 212.28/212.49  |- mesh__recordAuthorizer mesh__D008871 sjn
% 212.28/212.49  |- skos__hiddenLabel mesh__D008871 Striated Borders
% 212.28/212.49  |- skos__historyNote mesh__D022542 Rubella Vaccine %28%1986-2000%29%
% 212.28/212.49  |- skos__scopeNote mesh__D022542
% 212.28/212.49       A combined vaccine used to prevent MEASLES; MUMPS; and RUBELLA.%A%    
% 212.28/212.49  |- skos__hiddenLabel mesh__D022542 Vaccine, Measles-Mumps-Rubella
% 212.28/212.49  |- mesh__dateRevised mesh__D022542 2005-06-30
% 212.28/212.49  |- skos__broader mesh__D022542smesh__D014765
% 212.28/212.49  |- skos__hiddenLabel mesh__D022542 Vaccine, Mumps-Measles-Rubella
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D022542 2006
% 212.28/212.49  |- mesh__recordOriginator mesh__D022542 ags
% 212.28/212.49  |- skos__broader mesh__D022542smesh__D012411
% 212.28/212.49  |- skos__hiddenLabel mesh__D022542 Mumps Measles Rubella Vaccine
% 212.28/212.49  |- mesh__dateEstablished mesh__D022542 2001-01-01
% 212.28/212.49  |- mesh__recordAuthorizer mesh__D022542 sjn
% 212.28/212.49  |- mesh__recordMaintainer mesh__D022542 ssb
% 212.28/212.49  |- mesh__dateCreated mesh__D022542 2000-06-22
% 212.28/212.49  |- skos__historyNote mesh__D022542 Measles Vaccine %28%1986-2000%29%
% 212.28/212.49  |- mesh__historyNote mesh__D022542
% 212.28/212.49       2001; use MEASLES-MUMPS-RUBELLA VACCINE %28%NM%29%  to search MEASLES, MUMPS, RUBELLA VACCINE 1986-2000%A%  
% 212.28/212.49  |- skos__altLabel mesh__D022542 Mumps-Measles-Rubella Vaccine
% 212.28/212.49  |- skos__historyNote mesh__D022542 Mumps Vaccine %28%1986-2000%29%
% 212.28/212.49  |- rdf__type mesh__D022542sskos__Concept
% 212.28/212.49  |- skos__broader mesh__D022542smesh__D008458
% 212.28/212.49  |- skos__prefLabel mesh__D022542 Measles-Mumps-Rubella Vaccine
% 212.28/212.49  |- skos__hiddenLabel mesh__D022542 Berna, Triviraten
% 212.28/212.49  |- skos__hiddenLabel mesh__D022542 Vaccine, MMR
% 212.28/212.49  |- skos__hiddenLabel mesh__D022542 Measles Mumps Rubella Vaccine
% 212.28/212.49  |- mesh__publicMeSHNote mesh__D022542
% 212.28/212.49       2001; MEASLES, MUMPS, RUBELLA VACCINE was indexed under MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE, %26% VACCINES, COMBINED 1986-2000 and under DRUG COMBINATIONS 1986-1995%A%  
% 212.28/212.49  |- skos__broader mesh__D022542smesh__D017778
% 212.28/212.49  |- skos__historyNote mesh__D022542 Drug Combinations %28%1986-1995%29%
% 212.28/212.49  |- skos__broader mesh__D022542smesh__D009108
% 212.28/212.49  |- skos__altLabel mesh__D022542 Measles, Mumps, Rubella Vaccine
% 212.28/212.49  |- skos__altLabel mesh__D022542 MMR Vaccine
% 212.28/212.49  |- mesh__dateCreated mesh__D008073 1979-05-23
% 212.28/212.49  |- skos__historyNote mesh__D008073 Lipoproteins, LDL %28%1972-1979%29%
% 212.28/212.49  |- skos__altLabel mesh__D008073 LP-X
% 212.28/212.49  |- skos__annotation mesh__D008073 /biosyn /physiol permitted   
% 212.28/212.49  |- mesh__recordOriginator mesh__D008073 RLS
% 212.28/212.49  |- mesh__dateRevised mesh__D008073 2003-07-09
% 212.28/212.49  |- mesh__recordMaintainer mesh__D008073 ssb
% 212.28/212.49  |- skos__scopeNote mesh__D008073
% 212.28/212.49       An abnormal lipoprotein which is present in large amounts in individuals suffering from obstructive liver diseases. It exists as a bilayer vesicle of equimolar phospholipids and unesterified cholesterol containing small amounts of plasma proteins %28%mainly albumin%29% in its internal aqueous compartment together with some apolipoproteins adsorbed on its surface. Separates with LDL by ultracentrifugation.%A%    
% 212.28/212.49  |- rdf__type mesh__D008073sskos__Concept
% 212.28/212.49  |- skos__altLabel mesh__D008073 Lipoprotein X
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D008073 2005
% 212.28/212.49  |- skos__broader mesh__D008073smesh__D008074
% 212.28/212.49  |- mesh__publicMeSHNote mesh__D008073 80   
% 212.28/212.49  |- mesh__historyNote mesh__D008073 80   
% 212.28/212.49  |- skos__hiddenLabel mesh__D008073 X, Lipoprotein
% 212.28/212.49  |- skos__historyNote mesh__D008073 Lipoproteins %28%1966-1979%29%
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D008073 2006
% 212.28/212.49  |- mesh__dateEstablished mesh__D008073 1980-01-01
% 212.28/212.49  |- skos__prefLabel mesh__D008073 Lipoprotein-X
% 212.28/212.49  |- mesh__recordAuthorizer mesh__D008073 sjn
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D008073 2004
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D000090 2001
% 212.28/212.49  |- mesh__recordOriginator mesh__D000090 NLM
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D000090 2004
% 212.28/212.49  |- skos__scopeNote mesh__D000090
% 212.28/212.49       Salts and derivatives of  acetoacetic acid.     
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D000090 2005
% 212.28/212.49  |- mesh__dateRevised mesh__D000090 2000-06-21
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D000090 2003
% 212.28/212.49  |- rdf__type mesh__D000090sskos__Concept
% 212.28/212.49  |- skos__broader mesh__D000090smesh__D007651
% 212.28/212.49  |- skos__prefLabel mesh__D000090 Acetoacetates
% 212.28/212.49  |- skos__broader mesh__D000090smesh__D007657
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D000090 2002
% 212.28/212.49  |- mesh__recordAuthorizer mesh__D000090 sjn
% 212.28/212.49  |- mesh__dateCreated mesh__D000090 1999-01-01
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D000090 2006
% 212.28/212.49  |- mesh__recordMaintainer mesh__D000090 jmp
% 212.28/212.49  |- mesh__dateCreated mesh__D007779 1999-01-01
% 212.28/212.49  |- mesh__recordOriginator mesh__D007779 NLM
% 212.28/212.49  |- mesh__recordAuthorizer mesh__D007779 sjn
% 212.28/212.49  |- skos__scopeNote mesh__D007779
% 212.28/212.49       A species of gram-positive, rod-shaped bacteria isolated from the intestinal tract of humans and animals, the human mouth, and vagina. This organism produces the fermented product, acidophilus milk.%A%    
% 212.28/212.49  |- rdf__type mesh__D007779sskos__Concept
% 212.28/212.49  |- mesh__recordMaintainer mesh__D007779 SYSTEM
% 212.28/212.49  |- skos__prefLabel mesh__D007779 Lactobacillus acidophilus
% 212.28/212.49  |- skos__broader mesh__D007779smesh__D007778
% 212.28/212.49  |- mesh__dateRevised mesh__D007779 2005-06-30
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D007779 2006
% 212.28/212.49  |- skos__altLabel mesh__D004481 Mouse Pox Virus
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D004481 2005
% 212.28/212.49  |- skos__scopeNote mesh__D004481
% 212.28/212.49       A species of ORTHOPOXVIRUS infecting mice and causing a disease that involves internal organs and produces characteristic skin lesions.%A%    
% 212.28/212.49  |- skos__altLabel mesh__D004481 Poxvirus muris
% 212.28/212.49  |- mesh__dateCreated mesh__D004481 1999-01-01
% 212.28/212.49  |- skos__annotation mesh__D004481
% 212.28/212.49       infection = probably ECTROMELIA, INFECTIOUS but see note there%A%  
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D004481 2006
% 212.28/212.49  |- skos__hiddenLabel mesh__D004481 Mouse Pox Viruses
% 212.28/212.49  |- skos__hiddenLabel mesh__D004481 Ectromelia viruses
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D004481 2002
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D004481 2003
% 212.28/212.49  |- skos__prefLabel mesh__D004481 Ectromelia virus
% 212.28/212.49  |- skos__broader mesh__D004481smesh__D018155
% 212.28/212.49  |- mesh__recordOriginator mesh__D004481 NLM
% 212.28/212.49  |- rdf__type mesh__D004481sskos__Concept
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D004481 2004
% 212.28/212.49  |- mesh__recordMaintainer mesh__D004481 ags
% 212.28/212.49  |- mesh__historyNote mesh__D004481
% 212.28/212.49       66; MOUSEPOX VIRUS was MOUSE POX VIRUS 1975-93   
% 212.28/212.49  |- skos__altLabel mesh__D004481 Mousepox virus
% 212.28/212.49  |- mesh__recordAuthorizer mesh__D004481 sjn
% 212.28/212.49  |- mesh__publicMeSHNote mesh__D004481
% 212.28/212.49       66; MOUSEPOX VIRUS was MOUSE POX VIRUS 1975-93   
% 212.28/212.49  |- mesh__dateRevised mesh__D004481 2001-07-25
% 212.28/212.49  |- skos__hiddenLabel mesh__D004481 Mousepox viruses
% 212.28/212.49  |- mesh__dateRevised mesh__D012913 1990-05-29
% 212.28/212.49  |- skos__broader mesh__D012913smesh__D012135
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012913 2001
% 212.28/212.49  |- skos__hiddenLabel mesh__D012913 Snorings
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012913 1994
% 212.28/212.49  |- mesh__recordAuthorizer mesh__D012913 NLM
% 212.28/212.49  |- mesh__historyNote mesh__D012913
% 212.28/212.49       85%28%79%29%; was see under RESPIRATORY SOUNDS 1980-84 %26% MOUTH BREATHING 1979%A%  
% 212.28/212.49  |- mesh__publicMeSHNote mesh__D012913
% 212.28/212.49       85; was see under RESPIRATORY SOUNDS 1980-84 %26% MOUTH BREATHING 1979%A%  
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012913 2000
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012913 1991
% 212.28/212.49  |- skos__prefLabel mesh__D012913 Snoring
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012913 2004
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012913 1997
% 212.28/212.49  |- skos__annotation mesh__D012913 note category   
% 212.28/212.49  |- mesh__dateEstablished mesh__D012913 1985-01-01
% 212.28/212.49  |- skos__scopeNote mesh__D012913
% 212.28/212.49       Rough, noisy breathing during sleep, due to vibration of the uvula and soft palate.%A%    
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012913 2006
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012913 2003
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012913 1999
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012913 1996
% 212.28/212.49  |- rdf__type mesh__D012913sskos__Concept
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012913 1993
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012913 2005
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012913 1998
% 212.28/212.49  |- mesh__recordOriginator mesh__D012913 VDK
% 212.28/212.49  |- mesh__recordMaintainer mesh__D012913 PLS
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012913 2002
% 212.28/212.49  |- mesh__dateCreated mesh__D012913 1978-05-19
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012913 1995
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012913 1992
% 212.28/212.49  |- mesh__recordOriginator mesh__D012115 NLM
% 212.28/212.49  |- rdf__type mesh__D012115sskos__Concept
% 212.28/212.49  |- mesh__dateCreated mesh__D012115 1974-12-12
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012115 2004
% 212.28/212.49  |- skos__scopeNote mesh__D012115
% 212.28/212.49       The volume of air remaining in the LUNGS at the end of a maximal expiration. Common abbreviation is RV.%A%    
% 212.28/212.49  |- skos__annotation mesh__D012115 NIM; in texts as RV   
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012115 2005
% 212.28/212.49  |- mesh__dateRevised mesh__D012115 2003-07-09
% 212.28/212.49  |- skos__broader mesh__D012115smesh__D005652
% 212.28/212.49  |- skos__hiddenLabel mesh__D012115 Volumes, Residual
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012115 2006
% 212.28/212.49  |- mesh__recordMaintainer mesh__D012115 nns
% 212.28/212.49  |- skos__hiddenLabel mesh__D012115 Volume, Residual
% 212.28/212.49  |- mesh__dateEstablished mesh__D012115 1991-01-01
% 212.28/212.49  |- mesh__publicMeSHNote mesh__D012115
% 212.28/212.49       91; was see under LUNG VOLUME MEASUREMENTS 1975-90   
% 212.28/212.49  |- skos__hiddenLabel mesh__D012115 Residual Volumes
% 212.28/212.49  |- mesh__historyNote mesh__D012115
% 212.28/212.49       91%28%75%29%; was see under LUNG VOLUME MEASUREMENTS 1975-90   
% 212.28/212.49  |- skos__prefLabel mesh__D012115 Residual Volume
% 212.28/212.49  |- mesh__recordAuthorizer mesh__D012115 sjn
% 212.28/212.49  |- skos__prefLabel mesh__D036563 Cyclic ADP-Ribose
% 212.28/212.49  |- skos__scopeNote mesh__D036563
% 212.28/212.49       A pyridine nucleotide that mobilizes CALCIUM. It is synthesized from nicotinamide adenine dinucleotide %28%NAD%29% by ADP RIBOSE CYCLASE.%A%    
% 212.28/212.49  |- skos__hiddenLabel mesh__D036563 ADP-Ribose, Cyclic
% 212.28/212.49  |- mesh__recordMaintainer mesh__D036563 ags
% 212.28/212.49  |- skos__hiddenLabel mesh__D036563 cADP Ribose
% 212.28/212.49  |- mesh__dateRevised mesh__D036563 2005-07-07
% 212.28/212.49  |- skos__broader mesh__D036563smesh__D000246
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D036563 2005
% 212.28/212.49  |- skos__altLabel mesh__D036563 cADPR
% 212.28/212.49  |- skos__altLabel mesh__D036563 Cyclic ADPribose
% 212.28/212.49  |- skos__historyNote mesh__D036563
% 212.28/212.49       Adenosine Diphosphate Ribose %28%1989-2002%29%
% 212.28/212.49  |- mesh__dateCreated mesh__D036563 2002-07-03
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D036563 2006B
% 212.28/212.49  |- skos__altLabel mesh__D036563 Cyclic Adenosine Diphosphate Ribose
% 212.28/212.49  |- skos__hiddenLabel mesh__D036563 ADPribose, Cyclic
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D036563 2006
% 212.28/212.49  |- mesh__dateEstablished mesh__D036563 2003-01-01
% 212.28/212.49  |- mesh__recordOriginator mesh__D036563 nns
% 212.28/212.49  |- skos__altLabel mesh__D036563 cADP-Ribose
% 212.28/212.49  |- skos__altLabel mesh__D036563 Adenosine Diphosphate Ribose, Cyclic
% 212.28/212.49  |- mesh__recordAuthorizer mesh__D036563 ags
% 212.28/212.49  |- mesh__historyNote mesh__D036563
% 212.28/212.49       2003; use CYCLIC ADP-RIBOSE %28%NM%29%1989-2002   
% 212.28/212.49  |- rdf__type mesh__D036563sskos__Concept
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D036563 2006A
% 212.28/212.49  |- mesh__publicMeSHNote mesh__D036563
% 212.28/212.49       2003; CYCLIC ADP-RIBOSE %28%NM%29% was indexed under ADENOSINE DIPHOSPHATE RIBOSE 1989-2002%A%  
% 212.28/212.49  |- skos__hiddenLabel mesh__D036563 Cyclic ADP Ribose
% 212.28/212.49  |- rdf__type mesh__D003389sskos__Concept
% 212.28/212.49  |- skos__hiddenLabel mesh__D003389 Palsies, Cranial Nerve
% 212.28/212.49  |- skos__hiddenLabel mesh__D003389 Neuropathies, Multiple Cranial
% 212.28/212.49  |- skos__hiddenLabel mesh__D003389 Multiple Cranial Neuropathy
% 212.28/212.49  |- mesh__recordOriginator mesh__D003389 NLM
% 212.28/212.49  |- mesh__dateCreated mesh__D003389 1999-01-01
% 212.28/212.49  |- mesh__publicMeSHNote mesh__D003389 1981   
% 212.28/212.49  |- skos__broader mesh__D003389smesh__D009422
% 212.28/212.49  |- skos__hiddenLabel mesh__D003389 Palsy, Cranial Nerve
% 212.28/212.49  |- skos__hiddenLabel mesh__D003389 Neuropathy, Multiple Cranial
% 212.28/212.49  |- skos__historyNote mesh__D003389
% 212.28/212.49       Peripheral Nerve Diseases %28%1966-1980%29%
% 212.28/212.49  |- skos__scopeNote mesh__D003389
% 212.28/212.49       Disorders of one or more of the twelve cranial nerves. With the exception of the optic and olfactory nerves, this includes disorders of the brain stem nuclei from which the cranial nerves originate or terminate.%A%    
% 212.28/212.49  |- skos__historyNote mesh__D003389 Cranial Nerves %28%1966-1980%29%
% 212.28/212.49  |- skos__altLabel mesh__D003389 Cranial Nerve Disorders
% 212.28/212.49  |- skos__annotation mesh__D003389 GEN: prefer specifics   
% 212.28/212.49  |- skos__hiddenLabel mesh__D003389 Cranial Nerve Disorder
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D003389 2005
% 212.28/212.49  |- skos__altLabel mesh__D003389 Cranial Neuropathies
% 212.28/212.49  |- mesh__recordMaintainer mesh__D003389 ags
% 212.28/212.49  |- skos__related mesh__D003389smesh__D016919
% 212.28/212.49  |- skos__hiddenLabel mesh__D003389 Cranial Neuropathy
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D003389 2001
% 212.28/212.49  |- skos__hiddenLabel mesh__D003389 Multiple Cranial Neuropathies
% 212.28/212.49  |- skos__hiddenLabel mesh__D003389 Cranial Nerve Palsy
% 212.28/212.49  |- skos__hiddenLabel mesh__D003389 Neuropathy, Cranial
% 212.28/212.49  |- skos__hiddenLabel mesh__D003389 Cranial Neuropathy, Multiple
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D003389 2006
% 212.28/212.49  |- skos__altLabel mesh__D003389 Neuropathies, Cranial
% 212.28/212.49  |- mesh__recordAuthorizer mesh__D003389 sjn
% 212.28/212.49  |- skos__prefLabel mesh__D003389 Cranial Nerve Diseases
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D003389 2003
% 212.28/212.49  |- skos__altLabel mesh__D003389 Nervus Cranialis Disorders
% 212.28/212.49  |- skos__related mesh__D003389smesh__D020953
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D003389 2002
% 212.28/212.49  |- skos__hiddenLabel mesh__D003389 Cranial Nerve Disease
% 212.28/212.49  |- mesh__dateRevised mesh__D003389 2000-06-22
% 212.28/212.49  |- mesh__historyNote mesh__D003389 1981; was NON MESH before 1981   
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D003389 2004
% 212.28/212.49  |- skos__hiddenLabel mesh__D003389 Nervus Cranialis Disorder
% 212.28/212.49  |- mesh__dateEstablished mesh__D003389 1981-01-01
% 212.28/212.49  |- skos__historyNote mesh__D003389 specific cranial nerve %28%1966-1980%29%
% 212.28/212.49  |- skos__hiddenLabel mesh__D008872 Waves, Ultrahigh Frequency
% 212.28/212.49  |- skos__hiddenLabel mesh__D008872 Frequency Wave, Ultrahigh
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D008872 2005
% 212.28/212.49  |- skos__hiddenLabel mesh__D008872 EHF Wave
% 212.28/212.49  |- skos__hiddenLabel mesh__D008872 Wave, EHF
% 212.28/212.49  |- skos__hiddenLabel mesh__D008872 Wave, Ultrahigh Frequency
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D008872 2006
% 212.28/212.49  |- skos__scopeNote mesh__D008872
% 212.28/212.49       That portion of the electromagnetic spectrum from the UHF %28%ultrahigh frequency%29% radio waves and extending into the INFRARED RAYS frequencies.%A%    
% 212.28/212.49  |- mesh__recordAuthorizer mesh__D008872 sjn
% 212.28/212.49  |- mesh__dateCreated mesh__D008872 1999-01-01
% 212.28/212.49  |- mesh__recordOriginator mesh__D008872 NLM
% 212.28/212.49  |- mesh__recordMaintainer mesh__D008872 nns
% 212.28/212.49  |- skos__annotation mesh__D008872
% 212.28/212.49       see Manual for radiation indexing policy   
% 212.28/212.49  |- skos__related mesh__D008872smesh__D003972
% 212.28/212.49  |- skos__broader mesh__D008872smesh__D011846
% 212.28/212.49  |- skos__hiddenLabel mesh__D008872 Frequency Waves, Ultrahigh
% 212.28/212.49  |- skos__hiddenLabel mesh__D008872 Ultrahigh Frequency Wave
% 212.28/212.49  |- mesh__dateRevised mesh__D008872 2004-07-07
% 212.28/212.49  |- rdf__type mesh__D008872sskos__Concept
% 212.28/212.49  |- skos__prefLabel mesh__D008872 Microwaves
% 212.28/212.49  |- skos__hiddenLabel mesh__D008872 Waves, EHF
% 212.28/212.49  |- skos__altLabel mesh__D008872 Extremely High Frequency Radio Waves
% 212.28/212.49  |- skos__hiddenLabel mesh__D008872 Microwave
% 212.28/212.49  |- skos__broader mesh__D008074smesh__D008055
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D008074 2006
% 212.28/212.49  |- mesh__recordOriginator mesh__D008074 NLM
% 212.28/212.49  |- skos__related mesh__D008074smesh__D001053
% 212.28/212.49  |- mesh__recordAuthorizer mesh__D008074 sjn
% 212.28/212.49  |- skos__related mesh__D008074smesh__D007009
% 212.28/212.49  |- mesh__recordMaintainer mesh__D008074 SYSTEM
% 212.28/212.49  |- skos__related mesh__D008074smesh__D011510
% 212.28/212.49  |- skos__broader mesh__D008074smesh__D011506
% 212.28/212.49  |- skos__annotation mesh__D008074
% 212.28/212.49       GEN or unspecified; prefer specifics; /blood: consider also HYPERLIPOPROTEINEMIA; /defic: consider also HYPOLIPOPROTEINEMIA %26% specifics%A%  
% 212.28/212.49  |- skos__related mesh__D008074smesh__D006951
% 212.28/212.49  |- mesh__dateCreated mesh__D008074 1999-01-01
% 212.28/212.49  |- rdf__type mesh__D008074sskos__Concept
% 212.28/212.49  |- skos__related mesh__D008074smesh__D018110
% 212.28/212.49  |- skos__related mesh__D008074smesh__D008065
% 212.28/212.49  |- skos__altLabel mesh__D008074 Lipoprotein
% 212.28/212.49  |- skos__prefLabel mesh__D008074 Lipoproteins
% 212.28/212.49  |- mesh__dateRevised mesh__D008074 2005-06-30
% 212.28/212.49  |- skos__scopeNote mesh__D008074
% 212.28/212.49       Any of the lipid-protein complexes in which lipids are transported in the blood. Lipoprotein particles consist of a spherical hydrophobic core of triglycerides or cholesteryl esters surrounded by an amphipathic monolayer of phospholipids, cholesterol, and apolipoproteins. %28%From Dorland, 27th ed%29%%A%    
% 212.28/212.49  |- mesh__recordMaintainer mesh__D000091 ags
% 212.28/212.49  |- mesh__dateRevised mesh__D000091 2005-06-30
% 212.28/212.49  |- skos__scopeNote mesh__D000091
% 212.28/212.49       A species of gram-negative bacteria of the family ACETOBACTERACEAE found in FLOWERS and FRUIT. Cells are ellipsoidal to rod-shaped and straight or slightly curved.%A%    
% 212.28/212.49  |- rdf__type mesh__D000091sskos__Concept
% 212.28/212.49  |- skos__prefLabel mesh__D000091 Acetobacter
% 212.28/212.49  |- mesh__recordOriginator mesh__D000091 NLM
% 212.28/212.49  |- mesh__historyNote mesh__D000091 1966   
% 212.28/212.49  |- mesh__publicMeSHNote mesh__D000091 1966   
% 212.28/212.49  |- skos__broader mesh__D000091smesh__D016947
% 212.28/212.49  |- mesh__dateCreated mesh__D000091 1999-01-01
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D000091 2006
% 212.28/212.49  |- skos__annotation mesh__D000091 do not confuse with ACETOBACTERIUM   
% 212.28/212.49  |- mesh__recordAuthorizer mesh__D000091 sjn
% 212.28/212.49  |- mesh__dateCreated mesh__D016506 1991-01-03
% 212.28/212.49  |- mesh__recordOriginator mesh__D016506 AGS
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D016506 2006
% 212.28/212.49  |- mesh__dateEstablished mesh__D016506 1992-01-01
% 212.28/212.49  |- skos__broader mesh__D016506smesh__D012873
% 212.28/212.49  |- skos__hiddenLabel mesh__D016506 Benign Familial Pemphigus
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D016506 2005
% 212.28/212.49  |- rdf__type mesh__D016506sskos__Concept
% 212.28/212.49  |- skos__annotation mesh__D016506
% 212.28/212.49       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 212.28/212.49  |- mesh__publicMeSHNote mesh__D016506 92   
% 212.28/212.49  |- skos__prefLabel mesh__D016506 Pemphigus, Benign Familial
% 212.28/212.49  |- mesh__dateRevised mesh__D016506 2001-07-25
% 212.28/212.49  |- skos__hiddenLabel mesh__D016506 Hailey Hailey Disease
% 212.28/212.49  |- mesh__recordMaintainer mesh__D016506 nns
% 212.28/212.49  |- skos__altLabel mesh__D016506 Familial Benign Chronic Pemphigus
% 212.28/212.49  |- skos__broader mesh__D016506smesh__D010392
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D016506 2002
% 212.28/212.49  |- skos__altLabel mesh__D016506 Hailey-Hailey Disease
% 212.28/212.49  |- skos__scopeNote mesh__D016506
% 212.28/212.49       Rare hereditary disease characterized by recurrent eruptions of vesicles and bullae mainly on the neck, axillae, and groin. It exhibits autosomal dominant inheritance and is unrelated to pemphigus vulgaris though it closely resembles that disease.%A%    
% 212.28/212.49  |- skos__hiddenLabel mesh__D016506 Familial Pemphigus, Benign
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D016506 2004
% 212.28/212.49  |- mesh__historyNote mesh__D016506 92   
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D016506 2003
% 212.28/212.49  |- mesh__recordAuthorizer mesh__D016506 sjn
% 212.28/212.49  |- skos__historyNote mesh__D016506 Pemphigus %28%1966-1991%29%
% 212.28/212.49  |- skos__scopeNote mesh__D004482
% 212.28/212.49       A viral infection of mice, causing edema and necrosis followed by limb loss.%A%    
% 212.28/212.49  |- mesh__dateEstablished mesh__D004482 1990-01-01
% 212.28/212.49  |- skos__altLabel mesh__D004482 Mouse Pox
% 212.28/212.49  |- mesh__recordAuthorizer mesh__D004482 sjn
% 212.28/212.49  |- mesh__onlineNote mesh__D004482 search POXVIRUS INFECTIONS 1967-74   
% 212.28/212.49  |- mesh__publicMeSHNote mesh__D004482
% 212.28/212.49       90; was see under POXVIRUS INFECTIONS 1975-89   
% 212.28/212.49  |- skos__broader mesh__D004482smesh__D012376
% 212.28/212.49  |- skos__broader mesh__D004482smesh__D011213
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D004482 2006
% 212.28/212.49  |- skos__annotation mesh__D004482
% 212.28/212.49       caused by a poxvirus; don%27%t forget also MICE %28%NIM%29% %26% check tag ANIMALS%A%  
% 212.28/212.49  |- mesh__dateCreated mesh__D004482 1999-01-01
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D004482 2004
% 212.28/212.49  |- mesh__recordMaintainer mesh__D004482 ags
% 212.28/212.49  |- skos__prefLabel mesh__D004482 Ectromelia, Infectious
% 212.28/212.49  |- skos__altLabel mesh__D004482 Mousepox
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D004482 2005
% 212.28/212.49  |- rdf__type mesh__D004482sskos__Concept
% 212.28/212.49  |- mesh__historyNote mesh__D004482
% 212.28/212.49       90%28%75%29%; was see under POXVIRUS INFECTIONS 1975-89   
% 212.28/212.49  |- mesh__dateRevised mesh__D004482 2003-07-30
% 212.28/212.49  |- mesh__recordOriginator mesh__D004482 NLM
% 212.28/212.49  |- skos__altLabel mesh__D004482 Infectious Ectromelia
% 212.28/212.49  |- skos__broader mesh__D012914smesh__D014867
% 212.28/212.49  |- mesh__recordOriginator mesh__D012914 NLM
% 212.28/212.49  |- mesh__recordMaintainer mesh__D012914 nns
% 212.28/212.49  |- skos__hiddenLabel mesh__D012914 Snows
% 212.28/212.49  |- skos__scopeNote mesh__D012914
% 212.28/212.49       Frozen water crystals that fall from the ATMOSPHERE.     
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012914 2006
% 212.28/212.49  |- rdf__type mesh__D012914sskos__Concept
% 212.28/212.49  |- mesh__dateEstablished mesh__D012914 1991-01-01
% 212.28/212.49  |- mesh__onlineNote mesh__D012914 search WEATHER 1969-74   
% 212.28/212.49  |- mesh__activeMeSHYear mesh__D012914 2005
% 212.28/212.49  |- skos__broader mesh__D012914smesh__D014887
% 212.28/212.49  |- mesh__historyNote mesh__D012914
% 212.28/212.49       91%28%75%29%; was see under WEATHER 1975-90   
% 212.28/212.49  |- mesh__publicMeSHNote mesh__D012914 91; was see under WEATHER 1975-90   
% 212.28/212.49  |- mesh__dateCreated mesh__D012914 1999-01-01
% 212.28/212.49  |- skos__prefLabel mesh__D012914 Snow
% 212.28/212.49  |- mesh__dateRevised mesh__D012914 2004-07-07
% 212.28/212.49  |- mesh__recordAuthorizer mesh__D012914 sjn
% 212.28/212.49  |- mesh__recordAuthorizer mesh__D012116 sjn
% 212.28/212.50  |- skos__prefLabel mesh__D012116 Resins, Plant
% 212.28/212.50  |- skos__scopeNote mesh__D012116
% 212.28/212.50       Flammable, amorphous, vegetable products of secretion or disintegration, usually formed in special cavities of plants. They are generally insoluble in water and soluble in alcohol, carbon tetrachloride, ether, or volatile oils. They are fusible and have a conchoidal fracture. They are the oxidation or polymerization products of the terpenes, and are mixtures of aromatic acids and esters. Most are soft and sticky, but harden after exposure to cold. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed %26% Dorland, 28th ed%29%%A%    
% 212.28/212.50  |- mesh__publicMeSHNote mesh__D012116 2003; see RESINS 1963-2002   
% 212.28/212.50  |- mesh__recordOriginator mesh__D012116 NLM
% 212.28/212.50  |- mesh__dateRevised mesh__D012116 2005-06-30
% 212.28/212.50  |- mesh__historyNote mesh__D012116 2003 %28%1963%29%   
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D012116 2006
% 212.28/212.50  |- skos__hiddenLabel mesh__D012116 Plant Resins
% 212.28/212.50  |- skos__broader mesh__D012116smesh__D010936
% 212.28/212.50  |- skos__broader mesh__D012116smesh__D001704
% 212.28/212.50  |- skos__annotation mesh__D012116 RESINS, SYNTHETIC is also available   
% 212.28/212.50  |- rdf__type mesh__D012116sskos__Concept
% 212.28/212.50  |- mesh__dateCreated mesh__D012116 1999-01-01
% 212.28/212.50  |- mesh__recordMaintainer mesh__D012116 ssb
% 212.28/212.50  |- mesh__recordAuthorizer mesh__D008873 SJN
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D008873 2006
% 212.28/212.50  |- mesh__recordMaintainer mesh__D008873 PXP
% 212.28/212.50  |- skos__broader mesh__D008873smesh__D014481
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D008873 2002
% 212.28/212.50  |- mesh__historyNote mesh__D008873 90; was MID ATLANTIC REGION 1975-89   
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D008873 1999
% 212.28/212.50  |- mesh__dateCreated mesh__D008873 1999-01-01
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D008873 2003
% 212.28/212.50  |- skos__altLabel mesh__D008873 Mid Atlantic Region
% 212.28/212.50  |- mesh__dateEstablished mesh__D008873 1975-01-01
% 212.28/212.50  |- skos__altLabel mesh__D008873 Middle Atlantic States
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D008873 2004
% 212.28/212.50  |- rdf__type mesh__D008873sskos__Concept
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D008873 2000
% 212.28/212.50  |- mesh__recordOriginator mesh__D008873 NLM
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D008873 2001
% 212.28/212.50  |- skos__annotation mesh__D008873
% 212.28/212.50       includes DC, Del, Md, NJ, NY %26% Pa; specify as needed but use MID-ATLANTIC REGION when text uses the term      CATALOG: use for 4 or more states%A%  
% 212.28/212.50  |- mesh__dateRevised mesh__D008873 1997-06-20
% 212.28/212.50  |- mesh__onlineNote mesh__D008873
% 212.28/212.50       use MID-ATLANTIC REGION to search MID ATLANTIC REGION 1975-89%A%  
% 212.28/212.50  |- skos__prefLabel mesh__D008873 Mid-Atlantic Region
% 212.28/212.50  |- skos__scopeNote mesh__D008873
% 212.28/212.50       A geographical area of the United States comprising the District of Columbia, Delaware, Maryland, New Jersey, New York, and Pennsylvania.%A%    
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D008873 2005
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D008873 1998
% 212.28/212.50  |- skos__prefLabel mesh__D000890 Anti-Infective Agents
% 212.28/212.50  |- skos__related mesh__D000890smesh__D000871
% 212.28/212.50  |- skos__hiddenLabel mesh__D000890 Agents, Antimicrobial
% 212.28/212.50  |- skos__hiddenLabel mesh__D000890 Agents, Antiinfective
% 212.28/212.50  |- skos__altLabel mesh__D000890 Anti-Microbial Agents
% 212.28/212.50  |- skos__broader mesh__D000890smesh__D045506
% 212.28/212.50  |- skos__altLabel mesh__D000890 Antiinfective Agents
% 212.28/212.50  |- mesh__dateRevised mesh__D000890 2005-06-30
% 212.28/212.50  |- mesh__dateCreated mesh__D000890 1999-01-01
% 212.28/212.50  |- mesh__recordOriginator mesh__D000890 NLM
% 212.28/212.50  |- skos__scopeNote mesh__D000890
% 212.28/212.50       Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.%A%    
% 212.28/212.50  |- skos__hiddenLabel mesh__D000890 Anti Microbial Agents
% 212.28/212.50  |- skos__hiddenLabel mesh__D000890 Agents, Anti-Microbial
% 212.28/212.50  |- skos__hiddenLabel mesh__D000890 Anti Infective Agents
% 212.28/212.50  |- skos__related mesh__D000890smesh__D000981
% 212.28/212.50  |- mesh__recordMaintainer mesh__D000890 ssb
% 212.28/212.50  |- skos__hiddenLabel mesh__D000890 Agents, Anti-Infective
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D000890 2006
% 212.28/212.50  |- skos__altLabel mesh__D000890 Antimicrobial Agents
% 212.28/212.50  |- rdf__type mesh__D000890sskos__Concept
% 212.28/212.50  |- skos__annotation mesh__D000890
% 212.28/212.50       general or unspecified; prefer specific groups   
% 212.28/212.50  |- mesh__recordAuthorizer mesh__D000890 sjn
% 212.28/212.50  |- skos__broader mesh__D008075smesh__D008074
% 212.28/212.50  |- mesh__dateRevised mesh__D008075 2005-06-30
% 212.28/212.50  |- mesh__publicMeSHNote mesh__D008075 74   
% 212.28/212.50  |- skos__altLabel mesh__D008075 Heavy Lipoproteins
% 212.28/212.50  |- skos__hiddenLabel mesh__D008075 Lipoprotein, alpha-1
% 212.28/212.50  |- skos__hiddenLabel mesh__D008075 alpha 1 Lipoprotein
% 212.28/212.50  |- skos__hiddenLabel mesh__D008075 Lipoproteins, Heavy
% 212.28/212.50  |- mesh__recordMaintainer mesh__D008075 SYSTEM
% 212.28/212.50  |- mesh__recordOriginator mesh__D008075 NLM
% 212.28/212.50  |- skos__hiddenLabel mesh__D008075 Lipoproteins, High-Density
% 212.28/212.50  |- skos__hiddenLabel mesh__D008075 High Density Lipoproteins
% 212.28/212.50  |- mesh__historyNote mesh__D008075 74%28%72%29%   
% 212.28/212.50  |- mesh__dateCreated mesh__D008075 1999-01-01
% 212.28/212.50  |- mesh__recordAuthorizer mesh__D008075 sjn
% 212.28/212.50  |- skos__annotation mesh__D008075
% 212.28/212.50       hyperalphalipoproteinemia = LIPOPROTEINS, HDL /blood %28%IM%29% + HYPERLIPOPROTEINEMIA %28%IM%29%; hypoalphalipoproteinemia = LIPOPROTEINS, HDL /blood %28%IM%29% + HYPOLIPOPROTEINEMIA %28%IM%29%; familial hypoalphalipoproteinemia = TANGIER DISEASE; /defic: consider also HYPOLIPOPROTEINEMIA%A%  
% 212.28/212.50  |- skos__scopeNote mesh__D008075
% 212.28/212.50       A class of lipoproteins frequently divided into HDL2 and HDL3 and the minor variant HDL1. HDL promote transport of cholesterol from extrahepatic tissue to the liver for excretion in the bile. Synthesized by the liver as discoid %22%nascent HDL%22% particles lacking a lipid core, they accumulate a core of cholesterol esters during reverse cholesterol transport and transfer them to the liver directly or indirectly via other lipoproteins. HDL also shuttle apolipoproteins C-II and E to and from triglyceride-rich lipoproteins during catabolism of the lipoproteins. Serum HDL cholesterol has been negatively correlated with premature coronary heart disease. %28%Dorland, 28th ed%29%%A%    
% 212.28/212.50  |- rdf__type mesh__D008075sskos__Concept
% 212.28/212.50  |- skos__altLabel mesh__D008075 alpha-Lipoproteins
% 212.28/212.50  |- skos__historyNote mesh__D008075 Lipoproteins %28%1966-1971%29%
% 212.28/212.50  |- skos__hiddenLabel mesh__D008075 HDL Lipoproteins
% 212.28/212.50  |- skos__altLabel mesh__D008075 High-Density Lipoproteins
% 212.28/212.50  |- skos__prefLabel mesh__D008075 Lipoproteins, HDL
% 212.28/212.50  |- skos__hiddenLabel mesh__D008075 alpha Lipoproteins
% 212.28/212.50  |- mesh__dateEstablished mesh__D008075 1974-01-01
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D008075 2006
% 212.28/212.50  |- skos__related mesh__D008075smesh__D013631
% 212.28/212.50  |- mesh__publicMeSHNote mesh__D000092 66   
% 212.28/212.50  |- skos__hiddenLabel mesh__D000092 Acetohexamide Lilly Brand
% 212.28/212.50  |- skos__altLabel mesh__D000092 Dimelor
% 212.28/212.50  |- skos__altLabel mesh__D000092 Salvat Brand of Acetohexamide
% 212.28/212.50  |- mesh__recordMaintainer mesh__D000092 CCR
% 212.28/212.50  |- mesh__dateEstablished mesh__D000092 1966-01-01
% 212.28/212.50  |- mesh__recordAuthorizer mesh__D000092 sjn
% 212.28/212.50  |- mesh__dateCreated mesh__D000092 1999-01-01
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D000092 2006
% 212.28/212.50  |- mesh__dateRevised mesh__D000092 2005-06-30
% 212.28/212.50  |- skos__scopeNote mesh__D000092
% 212.28/212.50       A sulfonylurea hypoglycemic agent that is metabolized in the liver to 1-hydrohexamide.%A%    
% 212.28/212.50  |- skos__hiddenLabel mesh__D000092 Acetohexamide Salvat Brand
% 212.28/212.50  |- mesh__historyNote mesh__D000092 66%28%64%29%   
% 212.28/212.50  |- skos__broader mesh__D000092smesh__D013453
% 212.28/212.50  |- mesh__recordOriginator mesh__D000092 NLM
% 212.28/212.50  |- rdf__type mesh__D000092sskos__Concept
% 212.28/212.50  |- skos__prefLabel mesh__D000092 Acetohexamide
% 212.28/212.50  |- skos__altLabel mesh__D000092 Lilly Brand of Acetohexamide
% 212.28/212.50  |- skos__annotation mesh__D016507 DF: CARDIOL SERV HOSP   
% 212.28/212.50  |- mesh__recordAuthorizer mesh__D016507 PLS
% 212.28/212.50  |- skos__hiddenLabel mesh__D016507 Hospital Services, Cardiology
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D016507 2006
% 212.28/212.50  |- skos__altLabel mesh__D016507 Service, Cardiology Hospital
% 212.28/212.50  |- skos__related mesh__D016507smesh__D003325
% 212.28/212.50  |- skos__altLabel mesh__D016507 Service, Hospital Cardiology
% 212.28/212.50  |- skos__hiddenLabel mesh__D016507 Services, Cardiology Hospital
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D016507 2000
% 212.28/212.50  |- mesh__dateRevised mesh__D016507 1995-05-22
% 212.28/212.50  |- skos__hiddenLabel mesh__D016507 Cardiology Hospital Service
% 212.28/212.50  |- rdf__type mesh__D016507sskos__Concept
% 212.28/212.50  |- mesh__dateCreated mesh__D016507 1991-02-08
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D016507 1996
% 212.28/212.50  |- mesh__dateEstablished mesh__D016507 1992-01-01
% 212.28/212.50  |- skos__broader mesh__D016507smesh__D006748
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D016507 2001
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D016507 2003
% 212.28/212.50  |- skos__hiddenLabel mesh__D016507 Cardiology Services, Hospital
% 212.28/212.50  |- skos__hiddenLabel mesh__D016507 Cardiology Hospital Services
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D016507 1997
% 212.28/212.50  |- skos__altLabel mesh__D016507 Hospital Cardiology Service
% 212.28/212.50  |- skos__scopeNote mesh__D016507
% 212.28/212.50       The hospital department responsible for the administration and provision of diagnostic and therapeutic services for the cardiac patient.%A%    
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D016507 2002
% 212.28/212.50  |- mesh__recordOriginator mesh__D016507 JHM
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D016507 2004
% 212.28/212.50  |- mesh__publicMeSHNote mesh__D016507 92   
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D016507 1998
% 212.28/212.50  |- mesh__historyNote mesh__D016507 92   
% 212.28/212.50  |- skos__hiddenLabel mesh__D016507 Services, Hospital Cardiology
% 212.28/212.50  |- mesh__recordMaintainer mesh__D016507 KEV
% 212.28/212.50  |- skos__hiddenLabel mesh__D016507 Hospital Cardiology Services
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D016507 2005
% 212.28/212.50  |- skos__hiddenLabel mesh__D016507 Hospital Service, Cardiology
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D016507 1999
% 212.28/212.50  |- skos__prefLabel mesh__D016507 Cardiology Service, Hospital
% 212.28/212.50  |- mesh__recordOriginator mesh__D004483 NLM
% 212.28/212.50  |- skos__scopeNote mesh__D004483
% 212.28/212.50       The turning outward %28%eversion%29% of the edge of the eyelid, resulting in the exposure of the palpebral conjunctiva. %28%Dorland, 27th ed%29%%A%    
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D004483 1995
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D004483 2006
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D004483 2002
% 212.28/212.50  |- mesh__dateCreated mesh__D004483 1999-01-01
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D004483 2004
% 212.28/212.50  |- mesh__recordMaintainer mesh__D004483 TGC
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D004483 1994
% 212.28/212.50  |- mesh__dateRevised mesh__D004483 1993-05-27
% 212.28/212.50  |- mesh__recordAuthorizer mesh__D004483 PLS
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D004483 2005
% 212.28/212.50  |- skos__hiddenLabel mesh__D004483 Ectropions
% 212.28/212.50  |- rdf__type mesh__D004483sskos__Concept
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D004483 1999
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D004483 2003
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D004483 1997
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D004483 2001
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D004483 1998
% 212.28/212.50  |- skos__broader mesh__D004483smesh__D005141
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D004483 1996
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D004483 2000
% 212.28/212.50  |- skos__annotation mesh__D004483
% 212.28/212.50       eversion of eyelid: do not confuse with ENTROPION, inversion%A%  
% 212.28/212.50  |- skos__prefLabel mesh__D004483 Ectropion
% 212.28/212.50  |- skos__hiddenLabel mesh__D012915 Solutions, Soap
% 212.28/212.50  |- mesh__dateEstablished mesh__D012915 1963-01-01
% 212.28/212.50  |- skos__hiddenLabel mesh__D012915 Solution, Soap
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D012915 2005
% 212.28/212.50  |- skos__hiddenLabel mesh__D012915 Soap
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D012915 2004
% 212.28/212.50  |- mesh__recordMaintainer mesh__D012915 ssb
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D012915 2006
% 212.28/212.50  |- mesh__recordAuthorizer mesh__D012915 sjn
% 212.28/212.50  |- skos__hiddenLabel mesh__D012915 Soap Solutions
% 212.28/212.50  |- skos__broader mesh__D012915smesh__D006795
% 212.28/212.50  |- mesh__dateCreated mesh__D012915 1999-01-01
% 212.28/212.50  |- mesh__historyNote mesh__D012915
% 212.28/212.50       91%28%81%29%63; was see under SURFACE-ACTIVE AGENTS 1981-90; was heading 1963-80%A%  
% 212.28/212.50  |- mesh__publicMeSHNote mesh__D012915
% 212.28/212.50       91,63-80; was see under SURFACE-ACTIVE AGENTS 1981-90; was heading 1963-80%A%  
% 212.28/212.50  |- rdf__type mesh__D012915sskos__Concept
% 212.28/212.50  |- skos__annotation mesh__D012915 D25-26 qualif   
% 212.28/212.50  |- skos__prefLabel mesh__D012915 Soaps
% 212.28/212.50  |- mesh__recordOriginator mesh__D012915 NLM
% 212.28/212.50  |- skos__broader mesh__D012915smesh__D003902
% 212.28/212.50  |- mesh__dateRevised mesh__D012915 2003-07-09
% 212.28/212.50  |- skos__scopeNote mesh__D012915
% 212.28/212.50       Sodium or potassium salts of long chain fatty acids. These detergent substances are obtained by boiling natural oils or fats with caustic alkali. Sodium soaps are harder and are used as topical anti-infectives and vehicles in pills and liniments; potassium soaps are soft, used as vehicles for ointments and also as topical antimicrobials.%A%    
% 212.28/212.50  |- mesh__publicMeSHNote mesh__D012117 75   
% 212.28/212.50  |- mesh__dateRevised mesh__D012117 2004-07-07
% 212.28/212.50  |- mesh__dateEstablished mesh__D012117 1975-01-01
% 212.28/212.50  |- skos__hiddenLabel mesh__D012117 Synthetic Resins
% 212.28/212.50  |- rdf__type mesh__D012117sskos__Concept
% 212.28/212.50  |- mesh__recordAuthorizer mesh__D012117 sjn
% 212.28/212.50  |- skos__scopeNote mesh__D012117
% 212.28/212.50       Polymers of high molecular weight which at some stage are capable of being molded and then harden to form useful components.%A%    
% 212.28/212.50  |- mesh__dateCreated mesh__D012117 1999-01-01
% 212.28/212.50  |- skos__prefLabel mesh__D012117 Resins, Synthetic
% 212.28/212.50  |- skos__historyNote mesh__D012117 Plastics %28%1966-1974%29%
% 212.28/212.50  |- mesh__recordOriginator mesh__D012117 NLM
% 212.28/212.50  |- skos__annotation mesh__D012117 D25-26 qualif; DF: RESINS SYN   
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D012117 2005
% 212.28/212.50  |- mesh__historyNote mesh__D012117 75   
% 212.28/212.50  |- mesh__recordMaintainer mesh__D012117 jmp
% 212.28/212.50  |- skos__broader mesh__D012117smesh__D010969
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D012117 2006
% 212.28/212.50  |- mesh__dateRevised mesh__D017600 1995-06-08
% 212.28/212.50  |- skos__hiddenLabel mesh__D017600 Tumors, Retinal Anlage
% 212.28/212.50  |- mesh__recordMaintainer mesh__D017600 KEV
% 212.28/212.50  |- skos__altLabel mesh__D017600 Progonoma, Melanotic
% 212.28/212.50  |- skos__hiddenLabel mesh__D017600 Anlage Tumors, Retinal
% 212.28/212.50  |- skos__hiddenLabel mesh__D017600 Tumor, Retinal Anlage
% 212.28/212.50  |- skos__hiddenLabel mesh__D017600 Anlage Tumor, Retinal
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D017600 2003
% 212.28/212.50  |- skos__hiddenLabel mesh__D017600 Retinal Anlage Tumors
% 212.28/212.50  |- skos__scopeNote mesh__D017600
% 212.28/212.50       A benign, rapidly growing, deeply pigmented tumor of the jaw and occasionally of other sites, consisting of an infiltrating mass of cells arranged in an alveolar pattern, and occurring almost exclusively in infants. Its source of origin is in dispute, the various theories giving rise to its several names. %28%Dorland, 27th ed%29%%A%    
% 212.28/212.50  |- skos__hiddenLabel mesh__D017600 Melanoameloblastomas
% 212.28/212.50  |- skos__altLabel mesh__D017600 Melanoameloblastoma
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D017600 2002
% 212.28/212.50  |- skos__hiddenLabel mesh__D017600 Melanotic Neuroectodermal Tumors
% 212.28/212.50  |- skos__hiddenLabel mesh__D017600 Melanotic Progonoma
% 212.28/212.50  |- skos__hiddenLabel mesh__D017600 Tumor, Melanotic Neuroectodermal
% 212.28/212.50  |- mesh__recordAuthorizer mesh__D017600 PLS
% 212.28/212.50  |- skos__hiddenLabel mesh__D017600 Melanotic Progonomas
% 212.28/212.50  |- mesh__dateEstablished mesh__D017600 1994-01-01
% 212.28/212.50  |- skos__hiddenLabel mesh__D017600 Melanotic Neuroectodermal Tumor
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D017600 1999
% 212.28/212.50  |- skos__broader mesh__D017600smesh__D017599
% 212.28/212.50  |- mesh__publicMeSHNote mesh__D017600 94   
% 212.28/212.50  |- rdf__type mesh__D017600sskos__Concept
% 212.28/212.50  |- skos__annotation mesh__D017600
% 212.28/212.50       /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 212.28/212.50  |- mesh__historyNote mesh__D017600 94   
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D017600 1998
% 212.28/212.50  |- mesh__dateCreated mesh__D017600 1993-06-25
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D017600 2006
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D017600 2001
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D017600 1997
% 212.28/212.50  |- skos__hiddenLabel mesh__D017600 Tumors, Melanotic Neuroectodermal
% 212.28/212.50  |- mesh__recordOriginator mesh__D017600 TGC
% 212.28/212.50  |- skos__historyNote mesh__D017600
% 212.28/212.50       Neoplasms, Germ Cell and Embryonal %28%1966-1993%29%
% 212.28/212.50  |- skos__hiddenLabel mesh__D017600 Progonomas, Melanotic
% 212.28/212.50  |- skos__hiddenLabel mesh__D017600 Neuroectodermal Tumors, Melanotic
% 212.28/212.50  |- skos__prefLabel mesh__D017600 Neuroectodermal Tumor, Melanotic
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D017600 2005
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D017600 2000
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D017600 1996
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D017600 2004
% 212.28/212.50  |- skos__altLabel mesh__D017600 Retinal Anlage Tumor
% 212.28/212.50  |- mesh__recordAuthorizer mesh__D008874 sjn
% 212.28/212.50  |- skos__hiddenLabel mesh__D008874 Hydrochloride, Midazolam
% 212.28/212.50  |- skos__scopeNote mesh__D008874
% 212.28/212.50       A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients.  It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.%A%    
% 212.28/212.50  |- skos__prefLabel mesh__D008874 Midazolam
% 212.28/212.50  |- skos__historyNote mesh__D008874 Azepines %28%1966-1974%29%
% 212.28/212.50  |- mesh__recordMaintainer mesh__D008874 ssb
% 212.28/212.50  |- mesh__dateEstablished mesh__D008874 1987-01-01
% 212.28/212.50  |- skos__hiddenLabel mesh__D008874 Maleate, Midazolam
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D008874 2006
% 212.28/212.50  |- mesh__dateCreated mesh__D008874 1986-04-09
% 212.28/212.50  |- mesh__dateRevised mesh__D008874 2003-07-09
% 212.28/212.50  |- skos__hiddenLabel mesh__D008874 Ro 21 3981
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D008874 2005
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D008874 2004
% 212.28/212.50  |- skos__broader mesh__D008874smesh__D001569
% 212.28/212.50  |- skos__historyNote mesh__D008874 Benzodiazepines %28%1975-1986%29%
% 212.28/212.50  |- skos__hiddenLabel mesh__D008874 Ro 213981
% 212.28/212.50  |- mesh__historyNote mesh__D008874 87   
% 212.28/212.50  |- mesh__recordOriginator mesh__D008874 RLS
% 212.28/212.50  |- rdf__type mesh__D008874sskos__Concept
% 212.28/212.50  |- mesh__publicMeSHNote mesh__D008874 87   
% 212.28/212.50  |- mesh__dateCreated mesh__D000891 1999-01-01
% 212.28/212.50  |- skos__altLabel mesh__D000891 Anti-Infective Agents, Topical
% 212.28/212.50  |- skos__hiddenLabel mesh__D000891 Topical Anti Infective Agents
% 212.28/212.50  |- skos__altLabel mesh__D000891 Antiinfective Agents, Local
% 212.28/212.50  |- skos__altLabel mesh__D000891 Local Antiinfective Agents
% 212.28/212.50  |- mesh__dateEstablished mesh__D000891 1967-01-01
% 212.28/212.50  |- skos__prefLabel mesh__D000891 Anti-Infective Agents, Local
% 212.28/212.50  |- skos__hiddenLabel mesh__D000891 Agents, Topical Anti-Infective
% 212.28/212.50  |- mesh__recordAuthorizer mesh__D000891 sjn
% 212.28/212.50  |- mesh__publicMeSHNote mesh__D000891
% 212.28/212.50       67; ANTISEPTICS %26% ANTISEPTICS, HALOGEN %26% ANTISEPTICS, MERCURIAL %26% ANTISEPTICS, QUATERNARY AMMONIUM were headings 1963-66%A%  
% 212.28/212.50  |- mesh__onlineNote mesh__D000891
% 212.28/212.50       use ANTI-INFECTIVE AGENTS, LOCAL to search ANTISEPTICS 1966; search ANTISEPTICS, HALOGEN %26% ANTISEPTICS, MERCURIAL %26% ANTISEPTICS, QUATERNARY AMMONIUM under ANTI-INFECTIVE AGENTS 1966%A%  
% 212.28/212.50  |- skos__altLabel mesh__D000891 Local Anti-Infective Agents
% 212.28/212.50  |- skos__altLabel mesh__D000891 Topical Anti-Infective Agents
% 212.28/212.50  |- skos__altLabel mesh__D000891 Antiseptics
% 212.28/212.50  |- skos__broader mesh__D000891smesh__D000890
% 212.28/212.50  |- skos__scopeNote mesh__D000891
% 212.28/212.50       Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects.%A%    
% 212.28/212.50  |- skos__hiddenLabel mesh__D000891 Agents, Local Anti-Infective
% 212.28/212.50  |- skos__altLabel mesh__D000891 Topical Antiinfective Agents
% 212.28/212.50  |- skos__altLabel mesh__D000891 Microbicides, Local
% 212.28/212.50  |- skos__hiddenLabel mesh__D000891 Agents, Topical Antiinfective
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D000891 2006
% 212.28/212.50  |- skos__hiddenLabel mesh__D000891 Anti Infective Agents, Topical
% 212.28/212.50  |- mesh__recordOriginator mesh__D000891 NLM
% 212.28/212.50  |- rdf__type mesh__D000891sskos__Concept
% 212.28/212.50  |- mesh__historyNote mesh__D000891
% 212.28/212.50       67; ANTISEPTICS %26% ANTISEPTICS, HALOGEN %26% ANTISEPTICS, MERCURIAL %26% ANTISEPTICS, QUATERNARY AMMONIUM were headings 1963-66%A%  
% 212.28/212.50  |- mesh__dateRevised mesh__D000891 2003-07-09
% 212.28/212.50  |- skos__hiddenLabel mesh__D000891 Agents, Local Antiinfective
% 212.28/212.50  |- skos__related mesh__D000891smesh__D004202
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D000891 2005
% 212.28/212.50  |- skos__hiddenLabel mesh__D000891 Local Anti Infective Agents
% 212.28/212.50  |- skos__hiddenLabel mesh__D000891 Anti Infective Agents, Local
% 212.28/212.50  |- skos__altLabel mesh__D000891 Antiinfective Agents, Topical
% 212.28/212.50  |- mesh__recordMaintainer mesh__D000891 ssb
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D000891 2004
% 212.28/212.50  |- mesh__recordMaintainer mesh__D008076 SYSTEM
% 212.28/212.50  |- skos__prefLabel mesh__D008076 Lipoproteins, HDL Cholesterol
% 212.28/212.50  |- skos__broader mesh__D008076smesh__D002784
% 212.28/212.50  |- skos__altLabel mesh__D008076 High Density Lipoprotein Cholesterol
% 212.28/212.50  |- skos__altLabel mesh__D008076 HDL Cholesterol
% 212.28/212.50  |- mesh__dateEstablished mesh__D008076 1985-01-01
% 212.28/212.50  |- rdf__type mesh__D008076sskos__Concept
% 212.28/212.50  |- skos__hiddenLabel mesh__D008076 Cholesterol, alpha-Lipoprotein
% 212.28/212.50  |- skos__related mesh__D008076smesh__D006938
% 212.28/212.50  |- skos__hiddenLabel mesh__D008076 HDL Cholesterol Lipoproteins
% 212.28/212.50  |- skos__hiddenLabel mesh__D008076 Cholesterol Lipoproteins, HDL
% 212.28/212.50  |- skos__hiddenLabel mesh__D008076 HDL, Cholesterol
% 212.28/212.50  |- skos__hiddenLabel mesh__D008076 HDL Cholesterol Lipoprotein
% 212.28/212.50  |- skos__broader mesh__D008076smesh__D008075
% 212.28/212.50  |- skos__altLabel mesh__D008076 Cholesterol High Density Lipoproteins
% 212.28/212.50  |- skos__hiddenLabel mesh__D008076 alpha Lipoprotein Cholesterol
% 212.28/212.50  |- mesh__dateRevised mesh__D008076 2005-06-30
% 212.28/212.50  |- skos__historyNote mesh__D008076 Cholesterol %28%1966-1984%29%
% 212.28/212.50  |- skos__altLabel mesh__D008076 Lipoprotein, HDL Cholesterol
% 212.28/212.50  |- skos__scopeNote mesh__D008076
% 212.28/212.50       Cholesterol which is contained in or bound to high density lipoproteins %28%HDL%29%. High density lipoproteins transport cholesterol from peripheral tissues to the liver thereby acting as a scavenger to prevent excess accumulation and deposition of cholesterol in blood vessels.%A%    
% 212.28/212.50  |- skos__hiddenLabel mesh__D008076 Cholesterol, HDL
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D008076 2006
% 212.28/212.50  |- mesh__dateCreated mesh__D008076 1984-05-25
% 212.28/212.50  |- mesh__historyNote mesh__D008076 85   
% 212.28/212.50  |- skos__altLabel mesh__D008076 Cholesterol HDL
% 212.28/212.50  |- skos__historyNote mesh__D008076 Lipoproteins, HDL %28%1972-1984%29%
% 212.28/212.50  |- skos__altLabel mesh__D008076 alpha-Lipoprotein Cholesterol
% 212.28/212.50  |- mesh__publicMeSHNote mesh__D008076 85   
% 212.28/212.50  |- mesh__recordOriginator mesh__D008076 RLS
% 212.28/212.50  |- mesh__recordAuthorizer mesh__D008076 sjn
% 212.28/212.50  |- skos__related mesh__D008076smesh__D006937
% 212.28/212.50  |- skos__hiddenLabel mesh__D008076 Cholesterol Lipoprotein, HDL
% 212.28/212.50  |- skos__prefLabel mesh__D000093 Acetoin
% 212.28/212.50  |- skos__historyNote mesh__D000093 Alcohols, Butyl %28%1972-1974%29%
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D000093 2006
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D000093 2004
% 212.28/212.50  |- mesh__historyNote mesh__D000093
% 212.28/212.50       91%28%75%29%; was see under BUTANONES 1975-90   
% 212.28/212.50  |- skos__broader mesh__D000093smesh__D002074
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D000093 2005
% 212.28/212.50  |- skos__altLabel mesh__D000093 Acetylmethylcarbinol
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D000093 2002
% 212.28/212.50  |- mesh__dateCreated mesh__D000093 1974-11-19
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D000093 2003
% 212.28/212.50  |- mesh__recordMaintainer mesh__D000093 CCR
% 212.28/212.50  |- mesh__recordAuthorizer mesh__D000093 sjn
% 212.28/212.50  |- rdf__type mesh__D000093sskos__Concept
% 212.28/212.50  |- mesh__dateRevised mesh__D000093 2000-06-21
% 212.28/212.50  |- mesh__dateEstablished mesh__D000093 1991-01-01
% 212.28/212.50  |- mesh__publicMeSHNote mesh__D000093
% 212.28/212.50       91; was see under BUTANONES 1975-90   
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D000093 2001
% 212.28/212.50  |- mesh__recordOriginator mesh__D000093 NLM
% 212.28/212.50  |- skos__historyNote mesh__D000093 Butanones %28%1970-1974%29%
% 212.28/212.50  |- skos__scopeNote mesh__D000093
% 212.28/212.50       A product of fermentation. It is a component of the butanediol cycle in microorganisms. In mammals it is oxidized to carbon dioxide.%A%    
% 212.28/212.50  |- skos__scopeNote mesh__D016508
% 212.28/212.50       Serologic assay that detects antibodies to Treponema pallidum, the etiologic agent of syphilis. After diluting the patient%27%s serum to remove non-specific antibodies, the serum is mixed on a glass slide with Nichol%27%s strain of Treponema pallidum. An antigen-antibody reaction occurs if the test is positive and the bound antibodies are detected with fluoresceinated antihuman gamma-globulin antibody.%A%    
% 212.28/212.50  |- skos__annotation mesh__D016508
% 212.28/212.50       do not use /util except by MeSH definition; DF: note short X ref%A%  
% 212.28/212.50  |- rdf__type mesh__D016508sskos__Concept
% 212.28/212.50  |- skos__historyNote mesh__D016508 Syphilis Serodiagnosis %28%1966-1991%29%
% 212.28/212.50  |- skos__hiddenLabel mesh__D016508 Test, FTA-ABS
% 212.28/212.50  |- skos__broader mesh__D016508smesh__D013588
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D016508 2003
% 212.28/212.50  |- skos__hiddenLabel mesh__D016508
% 212.28/212.50       Fluorescent Treponemal Antibody Absorption Test
% 212.28/212.50  |- mesh__recordOriginator mesh__D016508 AGS
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D016508 2000
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D016508 2004
% 212.28/212.50  |- skos__altLabel mesh__D016508 FTA-ABS Test
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D016508 1998
% 212.28/212.50  |- mesh__dateCreated mesh__D016508 1991-01-02
% 212.28/212.50  |- mesh__dateEstablished mesh__D016508 1992-01-01
% 212.28/212.50  |- mesh__historyNote mesh__D016508 92   
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D016508 2001
% 212.28/212.50  |- mesh__recordMaintainer mesh__D016508 PXP
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D016508 2005
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D016508 1999
% 212.28/212.50  |- mesh__dateRevised mesh__D016508 1997-06-20
% 212.28/212.50  |- mesh__recordAuthorizer mesh__D016508 SJN
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D016508 2002
% 212.28/212.50  |- skos__hiddenLabel mesh__D016508 FTA-ABS Tests
% 212.28/212.50  |- skos__prefLabel mesh__D016508
% 212.28/212.50       Fluorescent Treponemal Antibody-Absorption Test
% 212.28/212.50  |- skos__hiddenLabel mesh__D016508 FTA ABS Test
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D016508 2006
% 212.28/212.50  |- mesh__publicMeSHNote mesh__D016508 92   
% 212.28/212.50  |- skos__hiddenLabel mesh__D016508 Tests, FTA-ABS
% 212.28/212.50  |- skos__scopeNote mesh__D013210
% 212.28/212.50       A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.%A%    
% 212.28/212.50  |- mesh__recordOriginator mesh__D013210 NLM
% 212.28/212.50  |- mesh__dateCreated mesh__D013210 1999-01-01
% 212.28/212.50  |- skos__prefLabel mesh__D013210 Staphylococcus
% 212.28/212.50  |- mesh__recordMaintainer mesh__D013210 ags
% 212.28/212.50  |- skos__annotation mesh__D013210
% 212.28/212.50       infection = STAPHYLOCOCCAL INFECTIONS on data form; staphylococcal clumping factor = COAGULASE %28%see X refs there%29%; DF: STAPH%A%  
% 212.28/212.50  |- mesh__recordAuthorizer mesh__D013210 ags
% 212.28/212.50  |- skos__broader mesh__D013210smesh__D040141
% 212.28/212.50  |- rdf__type mesh__D013210sskos__Concept
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D013210 2006A
% 212.28/212.50  |- mesh__dateRevised mesh__D013210 2005-08-01
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D013210 2006
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D004484 2001
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D004484 1992
% 212.28/212.50  |- mesh__recordAuthorizer mesh__D004484 ags
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D004484 1999
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D004484 2003
% 212.28/212.50  |- rdf__type mesh__D004484sskos__Concept
% 212.28/212.50  |- mesh__recordMaintainer mesh__D004484 ags
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D004484 1998
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D004484 1997
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D004484 2000
% 212.28/212.50  |- mesh__activeMeSHYear mesh__D004484 1996
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004484 2000A
% 212.28/212.51  |- mesh__recordOriginator mesh__D004484 NLM
% 212.28/212.51  |- skos__broader mesh__D004484smesh__D013020
% 212.28/212.51  |- mesh__dateRevised mesh__D004484 1999-12-01
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004484 2002
% 212.28/212.51  |- skos__prefLabel mesh__D004484 Ecuador
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004484 1995
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004484 2006
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004484 1993
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004484 1994
% 212.28/212.51  |- mesh__dateCreated mesh__D004484 1999-01-01
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004484 2005
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004484 2004
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012916 2004
% 212.28/212.51  |- mesh__recordMaintainer mesh__D012916 TAP
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012916 1997
% 212.28/212.51  |- mesh__publicMeSHNote mesh__D012916 90; was see under SPORTS 1976-89   
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012916 2006
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012916 1999
% 212.28/212.51  |- mesh__dateEstablished mesh__D012916 1990-01-01
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012916 2002
% 212.28/212.51  |- skos__annotation mesh__D012916
% 212.28/212.51       /inj: coord IM with specific inj %28%IM%29%; /physiol permitted; Manual 30.15.1; includes non-North American %22%football%22%; does not include rugby %28%RUGBY see FOOTBALL%29%%A%  
% 212.28/212.51  |- rdf__type mesh__D012916sskos__Concept
% 212.28/212.51  |- skos__prefLabel mesh__D012916 Soccer
% 212.28/212.51  |- skos__scopeNote mesh__D012916
% 212.28/212.51       A game in which a round inflated ball is advanced by kicking or propelling with any part of the body except the hands or arms. The object of the game is to place the ball in opposite goals.%A%    
% 212.28/212.51  |- skos__historyNote mesh__D012916 Sports %28%1966-1975%29%
% 212.28/212.51  |- mesh__historyNote mesh__D012916
% 212.28/212.51       90%28%76%29%; was see under SPORTS 1976-89   
% 212.28/212.51  |- mesh__dateRevised mesh__D012916 1996-06-10
% 212.28/212.51  |- mesh__recordOriginator mesh__D012916 JW
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012916 2000
% 212.28/212.51  |- skos__broader mesh__D012916smesh__D013177
% 212.28/212.51  |- mesh__recordAuthorizer mesh__D012916 PLS
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012916 2003
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012916 2001
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012916 2005
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012916 1998
% 212.28/212.51  |- mesh__dateCreated mesh__D012916 1975-07-23
% 212.28/212.51  |- skos__hiddenLabel mesh__D012916 Soccers
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012118 1999
% 212.28/212.51  |- skos__broader mesh__D012118smesh__D010636
% 212.28/212.51  |- skos__altLabel mesh__D012118 meta-Dihydroxybenzenes
% 212.28/212.51  |- mesh__recordMaintainer mesh__D012118 TPW
% 212.28/212.51  |- skos__prefLabel mesh__D012118 Resorcinols
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012118 2003
% 212.28/212.51  |- rdf__type mesh__D012118sskos__Concept
% 212.28/212.51  |- skos__hiddenLabel mesh__D012118 m Dihydroxybenzenes
% 212.28/212.51  |- mesh__dateRevised mesh__D012118 1994-05-24
% 212.28/212.51  |- mesh__onlineNote mesh__D012118
% 212.28/212.51       use RESORCINOLS to search RESORCINOL 1966-74   
% 212.28/212.51  |- mesh__publicMeSHNote mesh__D012118 75; was RESORCINOL 1963-74   
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012118 2004
% 212.28/212.51  |- mesh__recordAuthorizer mesh__D012118 PLS
% 212.28/212.51  |- mesh__dateCreated mesh__D012118 1999-01-01
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012118 1995
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012118 1996
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012118 2000
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012118 2005
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012118 1997
% 212.28/212.51  |- skos__altLabel mesh__D012118 m-Dihydroxybenzenes
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012118 2001
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012118 2006
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012118 1998
% 212.28/212.51  |- mesh__historyNote mesh__D012118 75; was RESORCINOL 1963-74   
% 212.28/212.51  |- mesh__recordOriginator mesh__D012118 NLM
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012118 2002
% 212.28/212.51  |- skos__hiddenLabel mesh__D012118 meta Dihydroxybenzenes
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017601 2003
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017601 2001
% 212.28/212.51  |- mesh__publicMeSHNote mesh__D017601 98   
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017601 2005
% 212.28/212.51  |- mesh__dateRevised mesh__D017601 1997-06-20
% 212.28/212.51  |- mesh__dateCreated mesh__D017601 1993-06-29
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017601 2004
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017601 1998
% 212.28/212.51  |- rdf__type mesh__D017601sskos__Concept
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017601 2006
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017601 1999
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017601 2002
% 212.28/212.51  |- mesh__recordMaintainer mesh__D017601 ADP
% 212.28/212.51  |- skos__historyNote mesh__D017601 Oxygen %28%1966-1993%29%
% 212.28/212.51  |- mesh__dateEstablished mesh__D017601 1998-01-01
% 212.28/212.51  |- skos__prefLabel mesh__D017601 Oxygen Compounds
% 212.28/212.51  |- skos__scopeNote mesh__D017601
% 212.28/212.51       Inorganic compounds that contain oxygen as an integral part of the molecule.%A%    
% 212.28/212.51  |- skos__broader mesh__D017601smesh__D007287
% 212.28/212.51  |- skos__annotation mesh__D017601
% 212.28/212.51       GEN; prefer specifics; used for mapping supplementary chemicals%A%  
% 212.28/212.51  |- mesh__historyNote mesh__D017601 98; use explode 1994-97   
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017601 2000
% 212.28/212.51  |- mesh__recordOriginator mesh__D017601 TPW
% 212.28/212.51  |- mesh__recordAuthorizer mesh__D017601 SJN
% 212.28/212.51  |- skos__hiddenLabel mesh__D017601 Compounds, Oxygen
% 212.28/212.51  |- mesh__historyNote mesh__D008875
% 212.28/212.51       2004%28%1966%29%; was MIDDLE AGE 1966-2003   
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D008875 2006
% 212.28/212.51  |- mesh__recordOriginator mesh__D008875 NLM
% 212.28/212.51  |- mesh__recordAuthorizer mesh__D008875 sjn
% 212.28/212.51  |- mesh__dateRevised mesh__D008875 2003-07-09
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D008875 2005
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D008875 2004
% 212.28/212.51  |- mesh__recordMaintainer mesh__D008875 jls
% 212.28/212.51  |- mesh__dateCreated mesh__D008875 1999-01-01
% 212.28/212.51  |- skos__prefLabel mesh__D008875 Middle Aged
% 212.28/212.51  |- skos__annotation mesh__D008875
% 212.28/212.51       age 45-64; IM as psychol, sociol entity: Manual 18.5.12; NIM as check tag; Manual 34.10 for indexing examples%A%  
% 212.28/212.51  |- rdf__type mesh__D008875sskos__Concept
% 212.28/212.51  |- skos__broader mesh__D008875smesh__D000328
% 212.28/212.51  |- mesh__recordOriginator mesh__D000892 NLM
% 212.28/212.51  |- skos__hiddenLabel mesh__D000892 Urinary Anti Infective Agents
% 212.28/212.51  |- skos__hiddenLabel mesh__D000892 Anti Infective Agents, Urinary
% 212.28/212.51  |- skos__annotation mesh__D000892
% 212.28/212.51       consider also URINARY TRACT INFECTIONS /drug ther   
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D000892 2006
% 212.28/212.51  |- rdf__type mesh__D000892sskos__Concept
% 212.28/212.51  |- skos__hiddenLabel mesh__D000892 Urinary Antiseptics
% 212.28/212.51  |- mesh__recordMaintainer mesh__D000892 ssb
% 212.28/212.51  |- skos__hiddenLabel mesh__D000892 Agents, Urinary Anti-Infective
% 212.28/212.51  |- mesh__dateEstablished mesh__D000892 1966-01-01
% 212.28/212.51  |- mesh__recordAuthorizer mesh__D000892 sjn
% 212.28/212.51  |- mesh__dateCreated mesh__D000892 1999-01-01
% 212.28/212.51  |- skos__altLabel mesh__D000892 Urinary Antiinfective Agents
% 212.28/212.51  |- skos__altLabel mesh__D000892 Antiinfective Agents, Urinary
% 212.28/212.51  |- skos__hiddenLabel mesh__D000892 Agents, Urinary Antiinfective
% 212.28/212.51  |- mesh__historyNote mesh__D000892 66   
% 212.28/212.51  |- mesh__dateRevised mesh__D000892 2005-06-30
% 212.28/212.51  |- mesh__publicMeSHNote mesh__D000892 66   
% 212.28/212.51  |- skos__broader mesh__D000892smesh__D000890
% 212.28/212.51  |- skos__prefLabel mesh__D000892 Anti-Infective Agents, Urinary
% 212.28/212.51  |- skos__broader mesh__D000892smesh__D012076
% 212.28/212.51  |- skos__scopeNote mesh__D000892
% 212.28/212.51       Substances capable of killing agents causing urinary tract infections or of preventing them from spreading.%A%    
% 212.28/212.51  |- skos__altLabel mesh__D000892 Urinary Anti-Infective Agents
% 212.28/212.51  |- mesh__historyNote mesh__D008077 74%28%72%29%   
% 212.28/212.51  |- mesh__recordAuthorizer mesh__D008077 sjn
% 212.28/212.51  |- skos__hiddenLabel mesh__D008077 Low Density Lipoproteins
% 212.28/212.51  |- skos__altLabel mesh__D008077 Low-Density Lipoproteins
% 212.28/212.51  |- skos__annotation mesh__D008077
% 212.28/212.51       /defic: consider also HYPOBETALIPOPROTEINEMIA   
% 212.28/212.51  |- skos__historyNote mesh__D008077 Lipoproteins %28%1966-1971%29%
% 212.28/212.51  |- skos__related mesh__D008077smesh__D011973
% 212.28/212.51  |- mesh__dateEstablished mesh__D008077 1974-01-01
% 212.28/212.51  |- skos__altLabel mesh__D008077 beta-Lipoproteins
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D008077 2006
% 212.28/212.51  |- skos__scopeNote mesh__D008077
% 212.28/212.51       A class of lipoproteins responsible for transport of cholesterol to extrahepatic tissues. They are formed in the circulation when very-low-density lipoproteins are degraded first to intermediate-density lipoproteins and then to LDL by the gain and loss of specific apolipoproteins and the loss of most of their triglycerides. LDL are taken up and catabolized by both the liver and extrahepatic tissues by specific receptor-mediated endocytosis. %28%Dorland, 28th ed%29%%A%    
% 212.28/212.51  |- skos__broader mesh__D008077smesh__D008074
% 212.28/212.51  |- skos__hiddenLabel mesh__D008077 Lipoproteins, Low-Density
% 212.28/212.51  |- mesh__dateRevised mesh__D008077 2005-06-30
% 212.28/212.51  |- mesh__publicMeSHNote mesh__D008077 74   
% 212.28/212.51  |- skos__altLabel mesh__D008077 LDL%28%2%29%
% 212.28/212.51  |- mesh__dateCreated mesh__D008077 1999-01-01
% 212.28/212.51  |- mesh__recordMaintainer mesh__D008077 SYSTEM
% 212.28/212.51  |- skos__hiddenLabel mesh__D008077 beta Lipoproteins
% 212.28/212.51  |- skos__hiddenLabel mesh__D008077 LDL Lipoproteins
% 212.28/212.51  |- rdf__type mesh__D008077sskos__Concept
% 212.28/212.51  |- mesh__recordOriginator mesh__D008077 NLM
% 212.28/212.51  |- skos__prefLabel mesh__D008077 Lipoproteins, LDL
% 212.28/212.51  |- skos__hiddenLabel mesh__D000094 Dehydrogenase, Acetoin
% 212.28/212.51  |- skos__scopeNote mesh__D000094
% 212.28/212.51       An enzyme that catalyzes the conversion of acetoin to diacetyl in the presence of NAD. EC 1.1.1.5.%A%    
% 212.28/212.51  |- mesh__dateEstablished mesh__D000094 1991-01-01
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D000094 2006
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D000094 2004
% 212.28/212.51  |- mesh__recordOriginator mesh__D000094 NLM
% 212.28/212.51  |- skos__prefLabel mesh__D000094 Acetoin Dehydrogenase
% 212.28/212.51  |- mesh__dateRevised mesh__D000094 2003-07-09
% 212.28/212.51  |- skos__hiddenLabel mesh__D000094 Reductase, Diacetyl
% 212.28/212.51  |- skos__historyNote mesh__D000094 Butanones %28%1972-1974%29%
% 212.28/212.51  |- rdf__type mesh__D000094sskos__Concept
% 212.28/212.51  |- mesh__dateCreated mesh__D000094 1974-11-19
% 212.28/212.51  |- skos__broader mesh__D000094smesh__D000429
% 212.28/212.51  |- mesh__recordMaintainer mesh__D000094 ssb
% 212.28/212.51  |- mesh__publicMeSHNote mesh__D000094
% 212.28/212.51       91; was see under ALCOHOL OXIDOREDUCTASES 1975-90   
% 212.28/212.51  |- skos__altLabel mesh__D000094 Diacetyl Reductase
% 212.28/212.51  |- mesh__historyNote mesh__D000094
% 212.28/212.51       91%28%75%29%; was see under ALCOHOL OXIDOREDUCTASES 1975-90   
% 212.28/212.51  |- mesh__recordAuthorizer mesh__D000094 sjn
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D000094 2005
% 212.28/212.51  |- skos__historyNote mesh__D000094
% 212.28/212.51       Alcohol Oxidoreductases %28%1972-1974%29%
% 212.28/212.51  |- mesh__dateEstablished mesh__D013211 1976-01-01
% 212.28/212.51  |- skos__prefLabel mesh__D013211 Staphylococcus aureus
% 212.28/212.51  |- mesh__historyNote mesh__D013211
% 212.28/212.51       76; was MICROCOCCUS PYOGENES see under STAPHYLOCOCCUS 1963-75; MICROCOCCUS PYOGENES was see STAPHYLOCOCCUS AUREUS 1976-91%A%  
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D013211 2006
% 212.28/212.51  |- skos__broader mesh__D013211smesh__D013210
% 212.28/212.51  |- mesh__onlineNote mesh__D013211
% 212.28/212.51       use STAPHYLOCOCCUS AUREUS to search MICROCOCCUS PYOGENES 1975-91; use STAPHYLOCOCCUS 1966-74%A%  
% 212.28/212.51  |- mesh__recordMaintainer mesh__D013211 SYSTEM
% 212.28/212.51  |- mesh__recordAuthorizer mesh__D013211 sjn
% 212.28/212.51  |- skos__historyNote mesh__D013211 Staphylococcus %28%1966-1974%29%
% 212.28/212.51  |- mesh__recordOriginator mesh__D013211 JW
% 212.28/212.51  |- skos__annotation mesh__D013211
% 212.28/212.51       infection = STAPHYLOCOCCAL INFECTIONS %26% do not bother to coord with S. aureus unless particularly discussed %28%index IM%29%; DF: STAPH AUREUS%A%  
% 212.28/212.51  |- mesh__dateRevised mesh__D013211 2005-06-30
% 212.28/212.51  |- mesh__dateCreated mesh__D013211 1975-07-21
% 212.28/212.51  |- skos__scopeNote mesh__D013211
% 212.28/212.51       Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.%A%    
% 212.28/212.51  |- mesh__publicMeSHNote mesh__D013211
% 212.28/212.51       76; was MICROCOCCUS PYOGENES see under STAPHYLOCOCCUS 1963-75; MICROCOCCUS PYOGENES was see STAPHYLOCOCCUS AUREUS 1976-91%A%  
% 212.28/212.51  |- rdf__type mesh__D013211sskos__Concept
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004485 1998
% 212.28/212.51  |- mesh__recordAuthorizer mesh__D004485 PLS
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004485 1997
% 212.28/212.51  |- skos__hiddenLabel mesh__D004485 Eczematous Dermatitides
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004485 2001
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004485 1996
% 212.28/212.51  |- skos__prefLabel mesh__D004485 Eczema
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004485 2000
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004485 1995
% 212.28/212.51  |- skos__scopeNote mesh__D004485
% 212.28/212.51       A pruritic papulovesicular dermatitis occurring as a reaction to many endogenous and exogenous agents %28%Dorland, 27th ed%29%.%A%    
% 212.28/212.51  |- mesh__dateRevised mesh__D004485 1992-05-08
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004485 2006
% 212.28/212.51  |- skos__broader mesh__D004485smesh__D003872
% 212.28/212.51  |- skos__hiddenLabel mesh__D004485 Eczematous Dermatitis
% 212.28/212.51  |- skos__hiddenLabel mesh__D004485 Dermatitides, Eczematous
% 212.28/212.51  |- mesh__recordOriginator mesh__D004485 NLM
% 212.28/212.51  |- mesh__recordMaintainer mesh__D004485 AGS
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004485 1993
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004485 1994
% 212.28/212.51  |- mesh__dateCreated mesh__D004485 1999-01-01
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004485 2005
% 212.28/212.51  |- skos__annotation mesh__D004485
% 212.28/212.51       an indistinct concept: check text for more specific skin dis; if more specific term is not in text, do not make a diagnosis: index here%A%  
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004485 2004
% 212.28/212.51  |- skos__hiddenLabel mesh__D004485 Eczemas
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004485 2002
% 212.28/212.51  |- skos__altLabel mesh__D004485 Dermatitis, Eczematous
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004485 1999
% 212.28/212.51  |- skos__broader mesh__D004485smesh__D017443
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D004485 2003
% 212.28/212.51  |- rdf__type mesh__D004485sskos__Concept
% 212.28/212.51  |- mesh__dateEstablished mesh__D012917 1969-01-01
% 212.28/212.51  |- skos__scopeNote mesh__D012917
% 212.28/212.51       Adaptation of the person to the social environment. Adjustment may take place by adapting the self to the environment or by changing the environment. %28%From Campbell, Psychiatric Dictionary, 1996%29%%A%    
% 212.28/212.51  |- skos__annotation mesh__D012917 no qualif   
% 212.28/212.51  |- skos__historyNote mesh__D012917
% 212.28/212.51       Adaptation, Psychological %28%1966-1968%29%
% 212.28/212.51  |- skos__altLabel mesh__D012917 Adjustment, Social
% 212.28/212.51  |- mesh__historyNote mesh__D012917 69   
% 212.28/212.51  |- mesh__recordOriginator mesh__D012917 NLM
% 212.28/212.51  |- skos__hiddenLabel mesh__D012917 Adjustments
% 212.28/212.51  |- skos__hiddenLabel mesh__D012917 Social Adjustments
% 212.28/212.51  |- mesh__recordMaintainer mesh__D012917 jls
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012917 2003
% 212.28/212.51  |- skos__broader mesh__D012917smesh__D012919
% 212.28/212.51  |- skos__historyNote mesh__D012917 Behavior %28%1966-1968%29%
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012917 2005
% 212.28/212.51  |- skos__prefLabel mesh__D012917 Social Adjustment
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012917 2004
% 212.28/212.51  |- skos__hiddenLabel mesh__D012917 Adjustments, Social
% 212.28/212.51  |- mesh__publicMeSHNote mesh__D012917 69   
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012917 2006
% 212.28/212.51  |- mesh__dateCreated mesh__D012917 1999-01-01
% 212.28/212.51  |- mesh__dateRevised mesh__D012917 2002-07-02
% 212.28/212.51  |- mesh__recordAuthorizer mesh__D012917 sjn
% 212.28/212.51  |- rdf__type mesh__D012917sskos__Concept
% 212.28/212.51  |- mesh__dateRevised mesh__D012119 2003-07-09
% 212.28/212.51  |- mesh__recordAuthorizer mesh__D012119 sjn
% 212.28/212.51  |- skos__related mesh__D012119smesh__D001945
% 212.28/212.51  |- skos__prefLabel mesh__D012119 Respiration
% 212.28/212.51  |- mesh__dateCreated mesh__D012119 1999-01-01
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012119 2005
% 212.28/212.51  |- skos__related mesh__D012119smesh__D001049
% 212.28/212.51  |- skos__related mesh__D012119smesh__D010101
% 212.28/212.51  |- mesh__recordOriginator mesh__D012119 NLM
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012119 2004
% 212.28/212.51  |- skos__scopeNote mesh__D012119
% 212.28/212.51       The act of breathing with the LUNGS, consisting of INHALATION, or the taking into the lungs of the ambient air, and of EXHALATION, or the expelling of the modified air which contains more CARBON DIOXIDE than the air taken in %28%Blakiston%27%s Gould Medical Dictionary, 4th ed.%29%. This does not include tissue respiration %28%= OXYGEN CONSUMPTION%29% or cell respiration %28%= CELL RESPIRATION%29%.%A%    
% 212.28/212.51  |- skos__related mesh__D012119smesh__D004417
% 212.28/212.51  |- rdf__type mesh__D012119sskos__Concept
% 212.28/212.51  |- skos__broader mesh__D012119smesh__D044703
% 212.28/212.51  |- skos__related mesh__D012119smesh__D009058
% 212.28/212.51  |- skos__annotation mesh__D012119
% 212.28/212.51       lung only: does not refer to tissue respiration %28% = probably OXYGEN CONSUMPTION%29%; TN 145: relation to OXYGEN %26% its qualif%A%  
% 212.28/212.51  |- skos__altLabel mesh__D012119 Breathing
% 212.28/212.51  |- skos__related mesh__D012119smesh__D019069
% 212.28/212.51  |- skos__related mesh__D012119smesh__D001944
% 212.28/212.51  |- mesh__recordMaintainer mesh__D012119 nns
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D012119 2006
% 212.28/212.51  |- skos__annotation mesh__D009170
% 212.28/212.51       note X refs and specific indentions; infection = MYCOBACTERIUM INFECTIONS, ATYPICAL; DF: MYCOBACT ATYPICAL%A%  
% 212.28/212.51  |- skos__altLabel mesh__D009170 Mycobacterium, Atypical
% 212.28/212.51  |- rdf__type mesh__D009170sskos__Concept
% 212.28/212.51  |- skos__altLabel mesh__D009170 Tuberculoid Bacillus
% 212.28/212.51  |- mesh__historyNote mesh__D009170 99   
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D009170 2006A
% 212.28/212.51  |- skos__prefLabel mesh__D009170 Mycobacteria, Atypical
% 212.28/212.51  |- mesh__publicMeSHNote mesh__D009170
% 212.28/212.51       99; see MYCOBACTERIUM, ATYPICAL 1977-98   
% 212.28/212.51  |- mesh__recordAuthorizer mesh__D009170 ags
% 212.28/212.51  |- skos__historyNote mesh__D009170 Mycobacterium %28%1966-1976%29%
% 212.28/212.51  |- mesh__dateEstablished mesh__D009170 1991-01-01
% 212.28/212.51  |- mesh__recordMaintainer mesh__D009170 ags
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D009170 2006
% 212.28/212.51  |- skos__altLabel mesh__D009170 Atypical Mycobacterium
% 212.28/212.51  |- mesh__dateRevised mesh__D009170 2005-07-21
% 212.28/212.51  |- skos__historyNote mesh__D009170
% 212.28/212.51       Mycobacterium, Atypical %28%1977-1998%29%
% 212.28/212.51  |- skos__broader mesh__D009170smesh__D009161
% 212.28/212.51  |- skos__scopeNote mesh__D009170
% 212.28/212.51       So-called atypical species of the genus MYCOBACTERIUM. They are also called tuberculoid bacilli, i.e.: M. buruli, M. chelonae, M. duvalii, M. flavescens, M. fortuitum, M. gilvum, M. gordonae, M. intracellulare %28%see MYCOBACTERIUM AVIUM COMPLEX;%29%, M. kansasii, M. marinum, M. obuense, M. scrofulaceum, M. szulgai, M. terrae, M. ulcerans, M. xenopi.%A%    
% 212.28/212.51  |- mesh__dateCreated mesh__D009170 1976-05-19
% 212.28/212.51  |- skos__altLabel mesh__D009170 Atypical Mycobacteria
% 212.28/212.51  |- mesh__recordOriginator mesh__D009170 FPG
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017602 1996
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017602 2004
% 212.28/212.51  |- skos__annotation mesh__D017602
% 212.28/212.51       do not use /util except by MeSH definition; coord IM with disease /ther, not /surg %28%IM%29%%A%  
% 212.28/212.51  |- skos__altLabel mesh__D017602 Laser-Induced Shockwave Lithotripsy
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017602 2002
% 212.28/212.51  |- skos__hiddenLabel mesh__D017602 Laser Induced Shockwave Lithotripsy
% 212.28/212.51  |- skos__hiddenLabel mesh__D017602 Laser Lithotripsy, Dye
% 212.28/212.51  |- skos__hiddenLabel mesh__D017602 Shockwave Lithotripsies, Laser-Induced
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017602 2003
% 212.28/212.51  |- skos__prefLabel mesh__D017602 Lithotripsy, Laser
% 212.28/212.51  |- skos__hiddenLabel mesh__D017602 Lithotripsy, Dye Laser
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017602 1995
% 212.28/212.51  |- mesh__publicMeSHNote mesh__D017602 94   
% 212.28/212.51  |- skos__hiddenLabel mesh__D017602 Shockwave Lithotripsy, Laser Induced
% 212.28/212.51  |- skos__hiddenLabel mesh__D017602 Lithotripsy, Laser-Induced Shockwave
% 212.28/212.51  |- skos__historyNote mesh__D017602 Lithotripsy %28%1986-1993%29%
% 212.28/212.51  |- skos__scopeNote mesh__D017602
% 212.28/212.51       Fragmentation of calculi, notably urinary or biliary, by laser. It is usually performed with an endoscopically guided pulsed tunable dye laser, a combination of a pulsed laser and a dye laser usually referred to as a pulsed dye laser. It is both safe and effective when extracorporeal shockwave lithotripsy is infeasible or unsuccessful.%A%    
% 212.28/212.51  |- skos__historyNote mesh__D017602 Lasers/therapeutic use %28%1984-1993%29%
% 212.28/212.51  |- mesh__dateEstablished mesh__D017602 1994-01-01
% 212.28/212.51  |- skos__hiddenLabel mesh__D017602 Laser Lithotripsies
% 212.28/212.51  |- skos__hiddenLabel mesh__D017602 Lithotripsies, Laser-Induced Shockwave
% 212.28/212.51  |- skos__broader mesh__D017602smesh__D008096
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017602 1999
% 212.28/212.51  |- skos__hiddenLabel mesh__D017602 Lithotripsies, Laser
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017602 1994
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017602 2001
% 212.28/212.51  |- skos__altLabel mesh__D017602 Laser Lithotripsy, Pulsed Dye
% 212.28/212.51  |- mesh__dateCreated mesh__D017602 1992-12-28
% 212.28/212.51  |- rdf__type mesh__D017602sskos__Concept
% 212.28/212.51  |- skos__hiddenLabel mesh__D017602 Laser-Induced Shockwave Lithotripsies
% 212.28/212.51  |- mesh__historyNote mesh__D017602 94   
% 212.28/212.51  |- skos__hiddenLabel mesh__D017602 Dye Laser Lithotripsies
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017602 1998
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017602 2006
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017602 2000
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017602 1997
% 212.28/212.51  |- skos__altLabel mesh__D017602 Laser Lithotripsy
% 212.28/212.51  |- skos__hiddenLabel mesh__D017602 Lithotripsies, Dye Laser
% 212.28/212.51  |- skos__hiddenLabel mesh__D017602 Laser Lithotripsies, Dye
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D017602 2005
% 212.28/212.51  |- skos__historyNote mesh__D008876 Intubation %28%1966-1982%29%
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D008876 2004
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D008876 1999
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D008876 2005
% 212.28/212.51  |- skos__hiddenLabel mesh__D008876 Ventilations, Middle Ear
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D008876 2000
% 212.28/212.51  |- skos__hiddenLabel mesh__D008876 Tympanostomies
% 212.28/212.51  |- mesh__dateCreated mesh__D008876 1982-04-22
% 212.28/212.51  |- skos__broader mesh__D008876smesh__D013506
% 212.28/212.51  |- skos__hiddenLabel mesh__D008876 Tube Insertions, Tympanostomy
% 212.28/212.51  |- mesh__dateEstablished mesh__D008876 1983-01-01
% 212.28/212.51  |- skos__hiddenLabel mesh__D008876 Insertions, Tympanostomy Tube
% 212.28/212.51  |- rdf__type mesh__D008876sskos__Concept
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D008876 2006
% 212.28/212.51  |- mesh__recordOriginator mesh__D008876 RC
% 212.28/212.51  |- skos__hiddenLabel mesh__D008876 Ear Ventilations, Middle
% 212.28/212.51  |- skos__hiddenLabel mesh__D008876 Insertions, Grommet
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D008876 2001
% 212.28/212.51  |- mesh__recordMaintainer mesh__D008876 PXP
% 212.28/212.51  |- skos__annotation mesh__D008876
% 212.28/212.51       do not use /util except by MeSH definition   
% 212.28/212.51  |- skos__historyNote mesh__D008876 Otitis Media %28%1966-1982%29%
% 212.28/212.51  |- skos__hiddenLabel mesh__D008876 Grommet Insertions
% 212.28/212.51  |- mesh__publicMeSHNote mesh__D008876 83   
% 212.28/212.51  |- skos__broader mesh__D008876smesh__D010030
% 212.28/212.51  |- skos__scopeNote mesh__D008876
% 212.28/212.51       Ventilation of the middle ear in the treatment of secretory %28%serous%29% otitis media, usually by placement of tubes or grommets which pierce the tympanic membrane.%A%    
% 212.28/212.51  |- skos__hiddenLabel mesh__D008876 Insertion, Tympanostomy Tube
% 212.28/212.51  |- mesh__recordAuthorizer mesh__D008876 SJN
% 212.28/212.51  |- skos__hiddenLabel mesh__D008876 Tube Insertion, Tympanostomy
% 212.28/212.51  |- skos__hiddenLabel mesh__D008876 Tympanostomy Tube Insertions
% 212.28/212.51  |- skos__hiddenLabel mesh__D008876 Middle Ear Ventilations
% 212.28/212.51  |- skos__altLabel mesh__D008876 Ventilation, Middle Ear
% 212.28/212.51  |- skos__hiddenLabel mesh__D008876 Ear Ventilation, Middle
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D008876 2002
% 212.28/212.51  |- skos__historyNote mesh__D008876 Tympanic Membrane %28%1966-1982%29%
% 212.28/212.51  |- mesh__dateRevised mesh__D008876 1997-06-20
% 212.28/212.51  |- skos__prefLabel mesh__D008876 Middle Ear Ventilation
% 212.28/212.51  |- skos__hiddenLabel mesh__D008876 Insertion, Grommet
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D008876 1998
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D008876 2003
% 212.28/212.51  |- mesh__historyNote mesh__D008876 83   
% 212.28/212.51  |- skos__broader mesh__D000893smesh__D045506
% 212.28/212.51  |- mesh__dateRevised mesh__D000893 2005-06-30
% 212.28/212.51  |- rdf__type mesh__D000893sskos__Concept
% 212.28/212.51  |- skos__hiddenLabel mesh__D000893 Anti Inflammatory Agents
% 212.28/212.51  |- skos__scopeNote mesh__D000893
% 212.28/212.51       Substances that reduce or suppress INFLAMMATION.     
% 212.28/212.51  |- mesh__recordOriginator mesh__D000893 NLM
% 212.28/212.51  |- skos__hiddenLabel mesh__D000893 Agents, Anti Inflammatory
% 212.28/212.51  |- skos__altLabel mesh__D000893 Agents, Antiinflammatory
% 212.28/212.51  |- skos__altLabel mesh__D000893 Anti-Inflammatories
% 212.28/212.51  |- mesh__dateCreated mesh__D000893 1999-01-01
% 212.28/212.51  |- mesh__historyNote mesh__D000893 66%28%64%29%   
% 212.28/212.51  |- skos__altLabel mesh__D000893 Agents, Anti-Inflammatory
% 212.28/212.51  |- skos__altLabel mesh__D000893 Antiinflammatory Agents
% 212.28/212.51  |- mesh__recordMaintainer mesh__D000893 ssb
% 212.28/212.51  |- skos__hiddenLabel mesh__D000893 Anti Inflammatories
% 212.28/212.51  |- mesh__publicMeSHNote mesh__D000893 66   
% 212.28/212.51  |- mesh__dateEstablished mesh__D000893 1966-01-01
% 212.28/212.51  |- skos__annotation mesh__D000893
% 212.28/212.51       do not confuse with INFLAMMATION MEDIATORS; DF: ANTI INFLAMM AGENTS or ANTIINFLAMM AGENTS%A%  
% 212.28/212.51  |- mesh__recordAuthorizer mesh__D000893 sjn
% 212.28/212.51  |- skos__prefLabel mesh__D000893 Anti-Inflammatory Agents
% 212.28/212.51  |- skos__altLabel mesh__D000893 Antiinflammatories
% 212.28/212.51  |- mesh__activeMeSHYear mesh__D000893 2006
% 212.37/212.51  |- skos__altLabel mesh__D008078 Low Density Lipoprotein Cholesterol
% 212.37/212.51  |- skos__altLabel mesh__D008078 Cholesterol Low Density Lipoproteins
% 212.37/212.51  |- skos__altLabel mesh__D008078 Cholesterol LDL
% 212.37/212.51  |- skos__historyNote mesh__D008078 Cholesterol %28%1966-1984%29%
% 212.37/212.51  |- skos__broader mesh__D008078smesh__D008077
% 212.37/212.51  |- mesh__historyNote mesh__D008078 85   
% 212.37/212.51  |- mesh__publicMeSHNote mesh__D008078 85   
% 212.37/212.51  |- skos__hiddenLabel mesh__D008078 LDL Cholesterol Lipoprotein
% 212.37/212.51  |- skos__related mesh__D008078smesh__D006937
% 212.37/212.51  |- skos__hiddenLabel mesh__D008078 LDL Cholesterol Lipoproteins
% 212.37/212.51  |- mesh__activeMeSHYear mesh__D008078 2006
% 212.37/212.51  |- mesh__recordMaintainer mesh__D008078 SYSTEM
% 212.37/212.51  |- skos__historyNote mesh__D008078 Lipoproteins, LDL %28%1972-1984%29%
% 212.37/212.51  |- skos__hiddenLabel mesh__D008078 beta Lipoprotein Cholesterol
% 212.37/212.51  |- skos__altLabel mesh__D008078 beta-Lipoprotein Cholesterol
% 212.37/212.51  |- skos__altLabel mesh__D008078 Lipoprotein, LDL Cholesterol
% 212.37/212.51  |- skos__altLabel mesh__D008078 LDL Cholesterol
% 212.37/212.51  |- skos__hiddenLabel mesh__D008078 LDL, Cholesteryl Linoleate
% 212.37/212.51  |- skos__hiddenLabel mesh__D008078 Linoleate LDL, Cholesteryl
% 212.37/212.51  |- mesh__recordAuthorizer mesh__D008078 sjn
% 212.37/212.51  |- mesh__dateCreated mesh__D008078 1984-05-24
% 212.37/212.52  |- skos__hiddenLabel mesh__D008078 Cholesterol, LDL
% 212.37/212.52  |- skos__prefLabel mesh__D008078 Lipoproteins, LDL Cholesterol
% 212.37/212.52  |- skos__broader mesh__D008078smesh__D002784
% 212.37/212.52  |- skos__hiddenLabel mesh__D008078 Cholesterol Lipoprotein, LDL
% 212.37/212.52  |- mesh__recordOriginator mesh__D008078 RLS
% 212.37/212.52  |- skos__hiddenLabel mesh__D008078 LDL, Cholesterol
% 212.37/212.52  |- skos__related mesh__D008078smesh__D006938
% 212.37/212.52  |- skos__hiddenLabel mesh__D008078 Cholesterol, beta-Lipoprotein
% 212.37/212.52  |- rdf__type mesh__D008078sskos__Concept
% 212.37/212.52  |- skos__scopeNote mesh__D008078
% 212.37/212.52       Cholesterol which is contained in or bound to low density lipoproteins %28%LDL%29%; LDL transport cholesterol to peripheral tissues and regulate de novo cholesterol synthesis at these sites. Atherosclerosis is caused by the deposit of cholesterol on the walls of blood vessels, because of high concentrations of LDL cholesterol in plasma.%A%    
% 212.37/212.52  |- mesh__dateEstablished mesh__D008078 1985-01-01
% 212.37/212.52  |- mesh__dateRevised mesh__D008078 2005-06-30
% 212.37/212.52  |- skos__hiddenLabel mesh__D008078 Cholesterol Lipoproteins, LDL
% 212.37/212.52  |- mesh__recordMaintainer mesh__D000095 jmp
% 212.37/212.52  |- mesh__dateCreated mesh__D000095 1974-11-11
% 212.37/212.52  |- skos__hiddenLabel mesh__D000095 Synthetase, Acetohydroxy Acid
% 212.37/212.52  |- mesh__publicMeSHNote mesh__D000095
% 212.37/212.52       91; was see under KETOACID-LYASES 1975-90   
% 212.37/212.52  |- mesh__recordAuthorizer mesh__D000095 sjn
% 212.37/212.52  |- skos__broader mesh__D000095smesh__D019880
% 212.37/212.52  |- skos__hiddenLabel mesh__D000095 Synthetase I, Acetohydroxyacid
% 212.37/212.52  |- skos__broader mesh__D000095smesh__D005420
% 212.37/212.52  |- mesh__dateRevised mesh__D000095 2005-06-30
% 212.37/212.52  |- rdf__type mesh__D000095sskos__Concept
% 212.37/212.52  |- skos__scopeNote mesh__D000095
% 212.37/212.52       A flavoprotein enzyme that catalyzes the formation of acetolactate from 2 moles of PYRUVATE in the biosynthesis of VALINE and the formation of acetohydroxybutyrate from pyruvate and alpha-ketobutyrate in the biosynthesis of ISOLEUCINE. This enzyme was formerly listed as EC 4.1.3.18.%A%    
% 212.37/212.52  |- mesh__recordOriginator mesh__D000095 NLM
% 212.37/212.52  |- skos__historyNote mesh__D000095 Ketoacid-Lyases %28%1972-1974%29%
% 212.37/212.52  |- skos__hiddenLabel mesh__D000095 Acid Synthetase, Acetohydroxy
% 212.37/212.52  |- skos__altLabel mesh__D000095 Acetohydroxy Acid Synthetase
% 212.37/212.52  |- skos__altLabel mesh__D000095 Acetohydroxy Acid Synthase
% 212.37/212.52  |- skos__hiddenLabel mesh__D000095 Synthase, Acetolactate
% 212.37/212.52  |- skos__hiddenLabel mesh__D000095 Synthetase, Acetolactate
% 212.37/212.52  |- skos__hiddenLabel mesh__D000095 Acid Synthase, Acetohydroxy
% 212.37/212.52  |- skos__altLabel mesh__D000095 Acetolactate Synthetase
% 212.37/212.52  |- mesh__historyNote mesh__D000095
% 212.37/212.52       91%28%75%29%; was see under KETOACID-LYASES 1975-90   
% 212.37/212.52  |- skos__historyNote mesh__D000095 Pyruvates %28%1972-1974%29%
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D000095 2006
% 212.37/212.52  |- skos__prefLabel mesh__D000095 Acetolactate Synthase
% 212.37/212.52  |- skos__hiddenLabel mesh__D000095 Synthase III, Acetoxyhydroxyacid
% 212.37/212.52  |- skos__hiddenLabel mesh__D000095 Synthase, Acetohydroxy Acid
% 212.37/212.52  |- mesh__dateEstablished mesh__D000095 1991-01-01
% 212.37/212.52  |- mesh__dateCreated mesh__D041701 2003-07-09
% 212.37/212.52  |- skos__hiddenLabel mesh__D041701 3T3 Swiss Albino
% 212.37/212.52  |- skos__broader mesh__D041701smesh__D016475
% 212.37/212.52  |- skos__hiddenLabel mesh__D041701 3T3 Cells, Swiss
% 212.37/212.52  |- rdf__type mesh__D041701sskos__Concept
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D041701 2005
% 212.37/212.52  |- skos__altLabel mesh__D041701 3T3-Swiss Albino
% 212.37/212.52  |- skos__scopeNote mesh__D041701
% 212.37/212.52       A cell line established in 1962 from disaggregated Swiss albino mouse embryos. This fibroblast cell line is extremely popular in research.%A%    
% 212.37/212.52  |- skos__annotation mesh__D041701
% 212.37/212.52       almost always NIM with no subheadings; check ANIMAL %26% MICE; do not routinely add FIBROBLASTS or EMBRYO%A%  
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D041701 2006
% 212.37/212.52  |- mesh__dateEstablished mesh__D041701 2004-01-01
% 212.37/212.52  |- skos__prefLabel mesh__D041701 Swiss 3T3 Cells
% 212.37/212.52  |- mesh__publicMeSHNote mesh__D041701 2004   
% 212.37/212.52  |- skos__historyNote mesh__D041701 Cell Line %28%1973-1991%29%
% 212.37/212.52  |- skos__hiddenLabel mesh__D041701 Cells, Swiss 3T3
% 212.37/212.52  |- skos__historyNote mesh__D041701 3T3 Cells %28%1991-2003%29%
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D041701 2004
% 212.37/212.52  |- mesh__historyNote mesh__D041701 2004   
% 212.37/212.52  |- skos__broader mesh__D013212smesh__D013210
% 212.37/212.52  |- mesh__recordMaintainer mesh__D013212 SYSTEM
% 212.37/212.52  |- skos__historyNote mesh__D013212 Staphylococcus %28%1966-1983%29%
% 212.37/212.52  |- skos__scopeNote mesh__D013212
% 212.37/212.52       A species of STAPHYLOCOCCUS that is a spherical, non-motile, gram-positive, chemoorganotrophic, facultative anaerobe. Mainly found on the skin and mucous membrane of warm-blooded animals, it can be primary pathogen or secondary invader.%A%    
% 212.37/212.52  |- skos__prefLabel mesh__D013212 Staphylococcus epidermidis
% 212.37/212.52  |- mesh__recordAuthorizer mesh__D013212 sjn
% 212.37/212.52  |- mesh__publicMeSHNote mesh__D013212 84   
% 212.37/212.52  |- mesh__dateEstablished mesh__D013212 1984-01-01
% 212.37/212.52  |- mesh__dateCreated mesh__D013212 1983-06-15
% 212.37/212.52  |- rdf__type mesh__D013212sskos__Concept
% 212.37/212.52  |- skos__annotation mesh__D013212
% 212.37/212.52       infection: coord IM with STAPHYLOCOCCAL INFECTIONS %28%IM%29%; DF: STAPH EPIDERMIDIS%A%  
% 212.37/212.52  |- mesh__dateRevised mesh__D013212 2005-06-30
% 212.37/212.52  |- mesh__recordOriginator mesh__D013212 RC
% 212.37/212.52  |- mesh__historyNote mesh__D013212 84   
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D013212 2006
% 212.37/212.52  |- mesh__dateEstablished mesh__D004486 1991-01-01
% 212.37/212.52  |- mesh__recordOriginator mesh__D004486 NLM
% 212.37/212.52  |- skos__scopeNote mesh__D004486
% 212.37/212.52       Basic peptide antibiotic from Bacillus brevis. It exhibits broad-spectrum antibacterial activity and inhibits bacterial DNA synthesis.%A%    
% 212.37/212.52  |- skos__prefLabel mesh__D004486 Edeine
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D004486 2005
% 212.37/212.52  |- skos__broader mesh__D004486smesh__D010455
% 212.37/212.52  |- mesh__dateRevised mesh__D004486 2003-07-09
% 212.37/212.52  |- mesh__publicMeSHNote mesh__D004486
% 212.37/212.52       91; was see under ANTIBIOTICS 1975-90   
% 212.37/212.52  |- mesh__dateCreated mesh__D004486 1974-11-19
% 212.37/212.52  |- mesh__recordAuthorizer mesh__D004486 sjn
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D004486 2006
% 212.37/212.52  |- mesh__recordMaintainer mesh__D004486 ssb
% 212.37/212.52  |- skos__historyNote mesh__D004486 Polyamines %28%1973-1974%29%
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D004486 2004
% 212.37/212.52  |- skos__historyNote mesh__D004486 Antibiotics %28%1971-1974%29%
% 212.37/212.52  |- skos__historyNote mesh__D004486 Peptides %28%1972-1974%29%
% 212.37/212.52  |- mesh__historyNote mesh__D004486
% 212.37/212.52       91%28%75%29%; was see under ANTIBIOTICS 1975-90   
% 212.37/212.52  |- rdf__type mesh__D004486sskos__Concept
% 212.37/212.52  |- skos__prefLabel mesh__D012918 Social Alienation
% 212.37/212.52  |- mesh__recordMaintainer mesh__D012918 JLS
% 212.37/212.52  |- skos__historyNote mesh__D012918
% 212.37/212.52       Interpersonal Relations %28%1966-1967%29%
% 212.37/212.52  |- mesh__publicMeSHNote mesh__D012918
% 212.37/212.52       73; SOCIAL BREAKDOWN was heading 1975-97   
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D012918 2003
% 212.37/212.52  |- skos__historyNote mesh__D012918 Sociology %28%1966-1967%29%
% 212.37/212.52  |- skos__hiddenLabel mesh__D012918 Social Breakdown Syndromes
% 212.37/212.52  |- mesh__dateEstablished mesh__D012918 1973-01-01
% 212.37/212.52  |- skos__hiddenLabel mesh__D012918 Breakdown Syndromes, Social
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D012918 2005
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D012918 2000
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D012918 1998
% 212.37/212.52  |- skos__altLabel mesh__D012918 Alienation, Social
% 212.37/212.52  |- mesh__recordOriginator mesh__D012918 NLM
% 212.37/212.52  |- mesh__historyNote mesh__D012918 73   
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D012918 2004
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D012918 2001
% 212.37/212.52  |- skos__hiddenLabel mesh__D012918 Social Alienations
% 212.37/212.52  |- skos__historyNote mesh__D012918 Social Isolation %28%1968-1972%29%
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D012918 2006
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D012918 1999
% 212.37/212.52  |- skos__scopeNote mesh__D012918
% 212.37/212.52       The state of estrangement individuals feel in cultural settings that they view as foreign, unpredictable, or unacceptable.%A%    
% 212.37/212.52  |- mesh__dateRevised mesh__D012918 1997-07-14
% 212.37/212.52  |- mesh__dateCreated mesh__D012918 1999-01-01
% 212.37/212.52  |- skos__hiddenLabel mesh__D012918 Syndromes, Social Breakdown
% 212.37/212.52  |- skos__hiddenLabel mesh__D012918 Alienations, Social
% 212.37/212.52  |- skos__hiddenLabel mesh__D012918 Syndrome, Social Breakdown
% 212.37/212.52  |- skos__hiddenLabel mesh__D012918 Breakdown Syndrome, Social
% 212.37/212.52  |- rdf__type mesh__D012918sskos__Concept
% 212.37/212.52  |- skos__historyNote mesh__D012918 Social Conditions %28%1966-1967%29%
% 212.37/212.52  |- skos__broader mesh__D012918smesh__D012934
% 212.37/212.52  |- skos__historyNote mesh__D012918 Psychology, Social %28%1966-1967%29%
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D012918 2002
% 212.37/212.52  |- mesh__recordAuthorizer mesh__D012918 SJN
% 212.37/212.52  |- skos__broader mesh__D009171smesh__D006880
% 212.37/212.52  |- mesh__historyNote mesh__D009171 73   
% 212.37/212.52  |- rdf__type mesh__D009171sskos__Concept
% 212.37/212.52  |- mesh__recordOriginator mesh__D009171 NLM
% 212.37/212.52  |- mesh__dateCreated mesh__D009171 1999-01-01
% 212.37/212.52  |- mesh__recordAuthorizer mesh__D009171 sjn
% 212.37/212.52  |- skos__hiddenLabel mesh__D009171 Acid, Mycolic
% 212.37/212.52  |- mesh__recordMaintainer mesh__D009171 ssb
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D009171 2005
% 212.37/212.52  |- skos__hiddenLabel mesh__D009171 Acids, Mycolic
% 212.37/212.52  |- mesh__publicMeSHNote mesh__D009171 73   
% 212.37/212.52  |- skos__broader mesh__D009171smesh__D005227
% 212.37/212.52  |- skos__historyNote mesh__D009171 Fatty Acids %28%1966-1972%29%
% 212.37/212.52  |- skos__prefLabel mesh__D009171 Mycolic Acids
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D009171 2006
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D009171 2004
% 212.37/212.52  |- mesh__dateEstablished mesh__D009171 1973-01-01
% 212.37/212.52  |- mesh__dateRevised mesh__D009171 2003-07-09
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D017603 2004
% 212.37/212.52  |- mesh__dateEstablished mesh__D017603 1994-01-01
% 212.37/212.52  |- skos__historyNote mesh__D017603
% 212.37/212.52       Discrimination %28%Psychology%29% %28%1968-1993%29%
% 212.37/212.52  |- skos__historyNote mesh__D017603 Auditory Perception %28%1967-1993%29%
% 212.37/212.52  |- skos__hiddenLabel mesh__D017603 Detection, Signal %28%Psychology%29%
% 212.37/212.52  |- mesh__recordMaintainer mesh__D017603 ags
% 212.37/212.52  |- mesh__dateCreated mesh__D017603 1992-12-28
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D017603 2000
% 212.37/212.52  |- skos__hiddenLabel mesh__D017603 Analyses, Signal Detection
% 212.37/212.52  |- skos__prefLabel mesh__D017603 Signal Detection %28%Psychology%29%
% 212.37/212.52  |- mesh__recordAuthorizer mesh__D017603 ags
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D017603 2003
% 212.37/212.52  |- mesh__recordOriginator mesh__D017603 TGC
% 212.37/212.52  |- mesh__dateRevised mesh__D017603 1999-12-16
% 212.37/212.52  |- rdf__type mesh__D017603sskos__Concept
% 212.37/212.52  |- skos__hiddenLabel mesh__D017603 Signal Detections %28%Psychology%29%
% 212.37/212.52  |- skos__scopeNote mesh__D017603
% 212.37/212.52       Psychophysical technique that permits the estimation of the bias of the observer as well as detectability of the signal %28%i.e., stimulus%29% in any sensory modality. %28%From APA, Thesaurus of Psychological Index Terms, 8th ed.%29%%A%    
% 212.37/212.52  |- skos__historyNote mesh__D017603 Auditory Threshold %28%1967-1993%29%
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D017603 2006
% 212.37/212.52  |- skos__hiddenLabel mesh__D017603 Signal Detection Analyses
% 212.37/212.52  |- skos__hiddenLabel mesh__D017603 Analysis, Signal Detection
% 212.37/212.52  |- skos__broader mesh__D017603smesh__D011601
% 212.37/212.52  |- skos__hiddenLabel mesh__D017603 Theories, Signal Detection
% 212.37/212.52  |- skos__broader mesh__D017603smesh__D004192
% 212.37/212.52  |- skos__hiddenLabel mesh__D017603 Signal Detection Theories
% 212.37/212.52  |- skos__hiddenLabel mesh__D017603 Detections, Signal %28%Psychology%29%
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D017603 2000A
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D017603 2002
% 212.37/212.52  |- skos__altLabel mesh__D017603 Signal Detection Theory
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D017603 2005
% 212.37/212.52  |- skos__related mesh__D017603smesh__D012684
% 212.37/212.52  |- skos__hiddenLabel mesh__D017603 Theory, Signal Detection
% 212.37/212.52  |- skos__annotation mesh__D017603
% 212.37/212.52       restrict to psychol: do not use for detection of signals in telecommunication %28% = TELECOMMUNICATIONS%29% or in cellular processes %28% = CELL COMMUNICATION or SIGNAL TRANSDUCTION or related concepts%29%; DF: SIGNAL DETECTION%A%  
% 212.37/212.52  |- skos__historyNote mesh__D017603 Attention %28%1966-1993%29%
% 212.37/212.52  |- mesh__publicMeSHNote mesh__D017603 1994   
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D017603 2001
% 212.37/212.52  |- mesh__historyNote mesh__D017603 1994   
% 212.37/212.52  |- skos__broader mesh__D017603smesh__D012684
% 212.37/212.52  |- skos__altLabel mesh__D017603 Signal Detection Analysis
% 212.37/212.52  |- skos__annotation mesh__D008877
% 212.37/212.52       countries from Libya east to Afghanistan, including Turkey%A%  
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D008877 2001
% 212.37/212.52  |- mesh__recordOriginator mesh__D008877 SMH
% 212.37/212.52  |- mesh__historyNote mesh__D008877
% 212.37/212.52       82; NEAR EAST was see ASIA, WESTERN 1994-95   
% 212.37/212.52  |- skos__historyNote mesh__D008877
% 212.37/212.52       specific Middle East country %28%1966-1981%29%
% 212.37/212.52  |- mesh__recordAuthorizer mesh__D008877 PLS
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D008877 2000
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D008877 2006
% 212.37/212.52  |- skos__altLabel mesh__D008877 Gaza Strip %28%Palestine%29%
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D008877 1999
% 212.37/212.52  |- mesh__recordMaintainer mesh__D008877 TGC
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D008877 2004
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D008877 2005
% 212.37/212.52  |- mesh__dateEstablished mesh__D008877 1982-01-01
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D008877 2002
% 212.37/212.52  |- skos__prefLabel mesh__D008877 Middle East
% 212.37/212.52  |- mesh__onlineNote mesh__D008877
% 212.37/212.52       use ASIA, WESTERN to search NEAR EAST 1994-95   
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D008877 1997
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D008877 1998
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D008877 2003
% 212.37/212.52  |- skos__scopeNote mesh__D008877
% 212.37/212.52       The countries of southwest Asia and northeastern Africa usually considered as extending from Libya on the west to Afghanistan on the east. %28%From Webster%27%s New Geographical Dictionary, 1988%29%%A%    
% 212.37/212.52  |- mesh__dateCreated mesh__D008877 1981-02-24
% 212.37/212.52  |- skos__broader mesh__D008877smesh__D017516
% 212.37/212.52  |- mesh__dateRevised mesh__D008877 1995-03-13
% 212.37/212.52  |- skos__broader mesh__D008877smesh__D001211
% 212.37/212.52  |- rdf__type mesh__D008877sskos__Concept
% 212.37/212.52  |- skos__historyNote mesh__D008877 Asia, Western %28%1966-1981%29%
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D008877 1996
% 212.37/212.52  |- skos__historyNote mesh__D000894
% 212.37/212.52       Analgesics, Anti-Inflammatory %28%1966-1986%29%
% 212.37/212.52  |- skos__hiddenLabel mesh__D000894 Nonsteroidal Antiinflammatory Agents
% 212.37/212.52  |- skos__related mesh__D000894smesh__D016861
% 212.37/212.52  |- skos__altLabel mesh__D000894 NSAIDs
% 212.37/212.52  |- skos__hiddenLabel mesh__D000894 Anti Rheumatic Agents, Non Steroidal
% 212.37/212.52  |- skos__hiddenLabel mesh__D000894 Anti-Inflammatory Analgesics
% 212.37/212.52  |- mesh__onlineNote mesh__D000894
% 212.37/212.52       use ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL to search ANALGESICS, ANTI-INFLAMMATORY 1975-89%A%  
% 212.37/212.52  |- skos__altLabel mesh__D000894 Antiinflammatory Agents, Non Steroidal
% 212.37/212.52  |- skos__altLabel mesh__D000894 Antirheumatic Agents, Non-Steroidal
% 212.37/212.52  |- skos__broader mesh__D000894smesh__D018501
% 212.37/212.52  |- skos__hiddenLabel mesh__D000894 Agents, Nonsteroidal Antiinflammatory
% 212.37/212.52  |- skos__prefLabel mesh__D000894 Anti-Inflammatory Agents, Non-Steroidal
% 212.37/212.52  |- mesh__dateEstablished mesh__D000894 1987-01-01
% 212.37/212.52  |- skos__hiddenLabel mesh__D000894 Non-Steroidal Anti-Rheumatic Agents
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D000894 2006
% 212.37/212.52  |- skos__hiddenLabel mesh__D000894 Agents, Nonsteroidal Anti-Inflammatory
% 212.37/212.52  |- mesh__recordMaintainer mesh__D000894 ssb
% 212.37/212.52  |- skos__broader mesh__D000894smesh__D000893
% 212.37/212.52  |- mesh__publicMeSHNote mesh__D000894
% 212.37/212.52       87; ANALGESICS, ANTI-INFLAMMATORY was heading 1975-89   
% 212.37/212.52  |- rdf__type mesh__D000894sskos__Concept
% 212.37/212.52  |- skos__hiddenLabel mesh__D000894 Non Steroidal Anti Inflammatory Agents
% 212.37/212.52  |- skos__hiddenLabel mesh__D000894 Anti Inflammatory Agents, Non Steroidal
% 212.37/212.52  |- skos__hiddenLabel mesh__D000894 Antirheumatic Agents, Non Steroidal
% 212.37/212.52  |- skos__annotation mesh__D000894
% 212.37/212.52       GEN or unspecified: prefer specifics; DF: NSAID   
% 212.37/212.52  |- mesh__dateRevised mesh__D000894 2005-06-30
% 212.37/212.52  |- skos__altLabel mesh__D000894 Non-Steroidal Anti-Inflammatory Agents
% 212.37/212.52  |- skos__altLabel mesh__D000894 Anti Inflammatory Agents, Nonsteroidal
% 212.37/212.52  |- skos__hiddenLabel mesh__D000894 Anti-Inflammatory Agents, Nonsteroidal
% 212.37/212.52  |- mesh__recordAuthorizer mesh__D000894 sjn
% 212.37/212.52  |- skos__hiddenLabel mesh__D000894 Nonsteroidal Anti Inflammatory Agents
% 212.37/212.52  |- skos__hiddenLabel mesh__D000894 Agents, Non-Steroidal Antirheumatic
% 212.37/212.52  |- skos__hiddenLabel mesh__D000894 Non-Steroidal Antirheumatic Agents
% 212.37/212.52  |- skos__hiddenLabel mesh__D000894 Agents, Non-Steroidal Anti-Inflammatory
% 212.37/212.52  |- skos__altLabel mesh__D000894 Antiinflammatory Agents, Nonsteroidal
% 212.37/212.52  |- skos__scopeNote mesh__D000894
% 212.37/212.52       Anti-inflammatory agents that are not steroids. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They are used primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Certain NSAIDs also may inhibit lipoxygenase enzymes or phospholipase C or may modulate T-cell function. %28%AMA Drug Evaluations Annual, 1994, p 1814-5%29%%A%    
% 212.37/212.52  |- skos__altLabel mesh__D000894 Nonsteroidal Anti-Inflammatory Agents
% 212.37/212.52  |- mesh__historyNote mesh__D000894
% 212.37/212.52       87; ANALGESICS, ANTI-INFLAMMATORY was heading 1975-89   
% 212.37/212.52  |- skos__hiddenLabel mesh__D000894 Agents, Aspirin-Like
% 212.37/212.52  |- skos__historyNote mesh__D000894
% 212.37/212.52       Anti-Inflammatory Agents %28%1966-1986%29%
% 212.37/212.52  |- skos__hiddenLabel mesh__D000894 Agents, Non-Steroidal Anti-Rheumatic
% 212.37/212.52  |- mesh__dateCreated mesh__D000894 1986-06-23
% 212.37/212.52  |- mesh__recordOriginator mesh__D000894 SH
% 212.37/212.52  |- skos__hiddenLabel mesh__D000894 Analgesics, Anti Inflammatory
% 212.37/212.52  |- skos__hiddenLabel mesh__D000894 Aspirin Like Agents
% 212.37/212.52  |- skos__broader mesh__D000894smesh__D018712
% 212.37/212.52  |- skos__hiddenLabel mesh__D008079 beta Very Low Density Lipoproteins
% 212.37/212.52  |- mesh__recordMaintainer mesh__D008079 SYSTEM
% 212.37/212.52  |- mesh__publicMeSHNote mesh__D008079
% 212.37/212.52       74; VERY-LOW-DENSITY LIPOPROTEINS was VERY LOW DENSITY LIPOPROTEINS 1974-95%A%  
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D008079 2006
% 212.37/212.52  |- skos__prefLabel mesh__D008079 Lipoproteins, VLDL
% 212.37/212.52  |- skos__hiddenLabel mesh__D008079 alpha2 VLDL Lipoprotein
% 212.37/212.52  |- mesh__historyNote mesh__D008079
% 212.37/212.52       74%28%72%29%; VERY-LOW-DENSITY LIPOPROTEINS was VERY LOW DENSITY LIPOPROTEINS 1972-95%A%  
% 212.37/212.52  |- skos__hiddenLabel mesh__D008079 Lipoprotein, alpha2-VLDL
% 212.37/212.52  |- skos__altLabel mesh__D008079 beta-VLDL Lipoproteins
% 212.37/212.52  |- mesh__dateRevised mesh__D008079 2005-06-30
% 212.37/212.52  |- skos__broader mesh__D008079smesh__D008074
% 212.37/212.52  |- skos__hiddenLabel mesh__D008079 VLDL Lipoproteins
% 212.37/212.52  |- mesh__dateCreated mesh__D008079 1999-01-01
% 212.37/212.52  |- skos__altLabel mesh__D008079 Prebeta-Lipoproteins
% 212.37/212.52  |- skos__hiddenLabel mesh__D008079 beta VLDL
% 212.37/212.52  |- skos__hiddenLabel mesh__D008079 Very Low Density Lipoproteins
% 212.37/212.52  |- skos__hiddenLabel mesh__D008079 Prebeta Lipoproteins
% 212.37/212.52  |- skos__historyNote mesh__D008079 Lipoproteins %28%1966-1971%29%
% 212.37/212.52  |- skos__hiddenLabel mesh__D008079 beta VLDL Lipoproteins
% 212.37/212.52  |- skos__altLabel mesh__D008079 beta-VLDL
% 212.37/212.52  |- skos__scopeNote mesh__D008079
% 212.37/212.52       A class of lipoproteins that transport triglycerides from the intestine and liver to adipose and muscle tissues. Synthesized by the liver, they contain primarily triglycerides in their lipid cores, with some cholesterol esters. As their triglycerides are cleaved by endothelial lipoprotein lipase and transferred to hepatic tissues, the VLDL %28%very-low-density lipoprotein%29% particles lose most of their apolipoprotein C and become intermediate-density lipoproteins. %28%Dorland, 28th ed%29%%A%    
% 212.37/212.52  |- mesh__recordOriginator mesh__D008079 NLM
% 212.37/212.52  |- skos__hiddenLabel mesh__D008079 Lipoproteins, Very-Low-Density
% 212.37/212.52  |- mesh__dateEstablished mesh__D008079 1974-01-01
% 212.37/212.52  |- mesh__recordAuthorizer mesh__D008079 sjn
% 212.37/212.52  |- rdf__type mesh__D008079sskos__Concept
% 212.37/212.52  |- skos__annotation mesh__D008079
% 212.37/212.52       hypoprebetalipoproteinemia = LIPOPROTEINS, VLDL /blood %28%IM%29% + HYPOLIPOPROTEINEMIAS %28%IM%29%; /defic: consider also HYPOLIPOPROTEINEMIAS%A%  
% 212.37/212.52  |- skos__hiddenLabel mesh__D008079 Lipoproteins, beta-VLDL
% 212.37/212.52  |- skos__altLabel mesh__D008079 Very-Low-Density Lipoproteins
% 212.37/212.52  |- skos__hiddenLabel mesh__D008079 Lipoproteins, beta-Very-Low-Density
% 212.37/212.52  |- rdf__type mesh__D000096sskos__Concept
% 212.37/212.52  |- skos__annotation mesh__D000096
% 212.37/212.52       acetonemia %26% acetonuria go under KETONE BODIES   
% 212.37/212.52  |- mesh__dateCreated mesh__D000096 1999-01-01
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D000096 2005
% 212.37/212.52  |- skos__prefLabel mesh__D000096 Acetone
% 212.37/212.52  |- skos__broader mesh__D000096smesh__D007659
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D000096 2003
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D000096 2006
% 212.37/212.52  |- mesh__recordMaintainer mesh__D000096 CCR
% 212.37/212.52  |- mesh__recordAuthorizer mesh__D000096 sjn
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D000096 2004
% 212.37/212.52  |- skos__broader mesh__D000096smesh__D007657
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D000096 2001
% 212.37/212.52  |- skos__scopeNote mesh__D000096
% 212.37/212.52       A colorless liquid used as a solvent and an antiseptic.  It is one of the ketone bodies produced during ketoacidosis.%A%    
% 212.37/212.52  |- mesh__recordOriginator mesh__D000096 NLM
% 212.37/212.52  |- mesh__dateRevised mesh__D000096 2000-06-21
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D000096 2002
% 212.37/212.52  |- skos__hiddenLabel mesh__D041702 Cells, BALB 3T3
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D041702 2004
% 212.37/212.52  |- skos__hiddenLabel mesh__D041702 3T3 Cell, BALB-c
% 212.37/212.52  |- skos__annotation mesh__D041702
% 212.37/212.52       almost always NIM with no subheadings; check ANIMALS %26% MICE; do not routinely add FIBROBLASTS or EMBRYO%A%  
% 212.37/212.52  |- skos__hiddenLabel mesh__D041702 Cells, BALB-c 3T3
% 212.37/212.52  |- skos__hiddenLabel mesh__D041702 BALB-3T3 Cell
% 212.37/212.52  |- skos__altLabel mesh__D041702 BALB-c 3T3 Cells
% 212.37/212.52  |- skos__hiddenLabel mesh__D041702 BALB c 3T3 Cells
% 212.37/212.52  |- skos__hiddenLabel mesh__D041702 3T3 Cell, BALB
% 212.37/212.52  |- skos__hiddenLabel mesh__D041702 BALB 3T3 Cell
% 212.37/212.52  |- mesh__dateEstablished mesh__D041702 2004-01-01
% 212.37/212.52  |- skos__scopeNote mesh__D041702
% 212.37/212.52       Cell lines developed from disaggregated BALB/c mouse embryos. They are extremely sensitive to CONTACT INHIBITION, and highly susceptible to transformation by SV40 VIRUS and murine sarcoma virus %28%SARCOMA VIRUSES, MURINE%29%.%A%    
% 212.37/212.52  |- skos__broader mesh__D041702smesh__D016475
% 212.37/212.52  |- skos__hiddenLabel mesh__D041702 Cell, BALB-c 3T3
% 212.37/212.52  |- skos__altLabel mesh__D041702 BALB-3T3 Cells
% 212.37/212.52  |- skos__historyNote mesh__D041702 3T3 Cells %28%1991-2003%29%
% 212.37/212.52  |- mesh__recordOriginator mesh__D041702 ags
% 212.37/212.52  |- mesh__publicMeSHNote mesh__D041702 2004   
% 212.37/212.52  |- mesh__historyNote mesh__D041702 2004   
% 212.37/212.52  |- rdf__type mesh__D041702sskos__Concept
% 212.37/212.52  |- skos__historyNote mesh__D041702 Cell Line %28%1969-1991%29%
% 212.37/212.52  |- skos__hiddenLabel mesh__D041702 Cells, BALB-3T3
% 212.37/212.52  |- mesh__recordMaintainer mesh__D041702 ags
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D041702 2006
% 212.37/212.52  |- mesh__dateCreated mesh__D041702 2003-07-30
% 212.37/212.52  |- skos__hiddenLabel mesh__D041702 BALB-c 3T3 Cell
% 212.37/212.52  |- skos__hiddenLabel mesh__D041702 Cell, BALB-3T3
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D041702 2005
% 212.37/212.52  |- skos__prefLabel mesh__D041702 BALB 3T3 Cells
% 212.37/212.52  |- skos__altLabel mesh__D041702 3T3 Cells, BALB
% 212.37/212.52  |- skos__hiddenLabel mesh__D041702 Cell, BALB 3T3
% 212.37/212.52  |- skos__hiddenLabel mesh__D041702 3T3 Cells, BALB-c
% 212.37/212.52  |- mesh__recordAuthorizer mesh__D041702 sjn
% 212.37/212.52  |- mesh__recordOriginator mesh__D013213 NLM
% 212.37/212.52  |- skos__broader mesh__D013213smesh__D005936
% 212.37/212.52  |- rdf__type mesh__D013213sskos__Concept
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D013213 2006
% 212.37/212.52  |- skos__scopeNote mesh__D013213
% 212.37/212.52       Any of a group of polysaccharides of the general formula %28%C6-H10-O5%29%n, composed of a long-chain polymer of glucose in the form of amylose and amylopectin. It is the chief storage form of energy reserve %28%carbohydrates%29% in plants.%A%    
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D013213 2005
% 212.37/212.52  |- mesh__dateCreated mesh__D013213 1999-01-01
% 212.37/212.52  |- skos__prefLabel mesh__D013213 Starch
% 212.37/212.52  |- skos__hiddenLabel mesh__D013213 Starch, Amylomaize
% 212.37/212.52  |- mesh__recordMaintainer mesh__D013213 jmp
% 212.37/212.52  |- mesh__dateRevised mesh__D013213 2004-07-07
% 212.37/212.52  |- mesh__recordAuthorizer mesh__D013213 sjn
% 212.37/212.52  |- skos__altLabel mesh__D037661 Lung-Surfactant Proteins
% 212.37/212.52  |- skos__hiddenLabel mesh__D037661
% 212.37/212.52       Surfactant-Associated Proteolipid, Pulmonary
% 212.37/212.52  |- mesh__recordAuthorizer mesh__D037661 sjn
% 212.37/212.52  |- skos__hiddenLabel mesh__D037661
% 212.37/212.52       Pulmonary Surfactant Associated Proteolipid
% 212.37/212.52  |- skos__historyNote mesh__D037661 Proteolipids %28%1981-2002%29%
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D037661 2006
% 212.37/212.52  |- skos__altLabel mesh__D037661 Pulmonary Surfactant-Associated Proteolipid
% 212.37/212.52  |- skos__hiddenLabel mesh__D037661 Pulmonary Surfactant Associated Proteins
% 212.37/212.52  |- skos__hiddenLabel mesh__D037661
% 212.37/212.52       Surfactant-Associated Proteins, Pulmonary
% 212.37/212.52  |- skos__hiddenLabel mesh__D037661 Pulmonary Surfactant Associated Protein
% 212.37/212.52  |- skos__hiddenLabel mesh__D037661 Surfactant-Associated Protein, Pulmonary
% 212.37/212.52  |- mesh__recordOriginator mesh__D037661 jmp
% 212.37/212.52  |- mesh__dateEstablished mesh__D037661 2003-01-01
% 212.37/212.52  |- skos__hiddenLabel mesh__D037661 Proteins, Lung-Surfactant
% 212.37/212.52  |- mesh__dateRevised mesh__D037661 2005-06-30
% 212.37/212.52  |- skos__historyNote mesh__D037661 Pulmonary Surfactants %28%1981-2002%29%
% 212.37/212.52  |- rdf__type mesh__D037661sskos__Concept
% 212.37/212.52  |- skos__scopeNote mesh__D037661
% 212.37/212.52       Proteins found in the LUNG that act as PULMONARY SURFACTANTS.%A%    
% 212.37/212.52  |- skos__altLabel mesh__D037661 PSFAP
% 212.37/212.52  |- mesh__historyNote mesh__D037661
% 212.37/212.52       2003; use PULMONARY SURFACTANT-ASSOCIATED PROTEINS %28%NM%29% 1981-2002%A%  
% 212.37/212.52  |- skos__hiddenLabel mesh__D037661 Lung Surfactant Proteins
% 212.37/212.52  |- skos__prefLabel mesh__D037661 Pulmonary Surfactant-Associated Proteins
% 212.37/212.52  |- skos__altLabel mesh__D037661 Pulmonary Surfactant-Associated Protein
% 212.37/212.52  |- mesh__recordMaintainer mesh__D037661 SYSTEM
% 212.37/212.52  |- skos__broader mesh__D037661smesh__D011506
% 212.37/212.52  |- mesh__dateCreated mesh__D037661 2002-07-03
% 212.37/212.52  |- mesh__publicMeSHNote mesh__D037661
% 212.37/212.52       2003; PULMONARY SURFACTANT-ASSOCIATED PROTEIN %28%now PULMONARY SURFACTANT-ASSOCIATED PROTEINS%29% was indexed under PROTEOLIPIDS %26% PULMONARY SURFACTANTS 1981-2002%A%  
% 212.37/212.52  |- mesh__dateCreated mesh__D004487 1999-01-01
% 212.37/212.52  |- skos__broader mesh__D004487smesh__D012816
% 212.37/212.52  |- skos__scopeNote mesh__D004487
% 212.37/212.52       Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.%A%    
% 212.37/212.52  |- mesh__recordOriginator mesh__D004487 NLM
% 212.37/212.52  |- skos__related mesh__D004487smesh__D010211
% 212.37/212.52  |- skos__related mesh__D004487smesh__D011654
% 212.37/212.52  |- mesh__activeMeSHYear mesh__D004487 2006
% 212.37/212.52  |- skos__related mesh__D004487smesh__D001929
% 212.37/212.52  |- mesh__recordMaintainer mesh__D004487 lkt
% 212.37/212.52  |- skos__prefLabel mesh__D004487 Edema
% 212.37/212.52  |- skos__related mesh__D004487smesh__D008209
% 212.37/212.52  |- mesh__recordAuthorizer mesh__D004487 sjn
% 212.37/212.52  |- rdf__type mesh__D004487sskos__Concept
% 212.37/212.52  |- skos__altLabel mesh__D004487 Dropsy
% 212.37/212.53  |- mesh__dateRevised mesh__D004487 2005-06-30
% 212.37/212.53  |- skos__annotation mesh__D004487
% 212.37/212.53       general: prefer specifics; coordinate IM with organ/diseases term %28%IM%29%; egg-white edema: coordinate IM with OVALBUMIN %28%NIM if indexed at all%29%; EPH %28%Edema, Proteinuria, Hypertension%29% = GESTOSIS, EPH %26% do not index under EDEMA unless it is particularly discussed%A%  
% 212.37/212.53  |- skos__related mesh__D004487smesh__D008269
% 212.37/212.53  |- skos__related mesh__D004487smesh__D007819
% 212.37/212.53  |- skos__altLabel mesh__D004487 Hydrops
% 212.37/212.53  |- skos__related mesh__D004487smesh__D000799
% 212.37/212.53  |- skos__related mesh__D004487smesh__D015160
% 212.37/212.53  |- skos__prefLabel mesh__D012919 Social Behavior
% 212.37/212.53  |- skos__hiddenLabel mesh__D012919 Non-Sexual Harassments
% 212.37/212.53  |- skos__hiddenLabel mesh__D012919 Harassments, Nonsexual
% 212.37/212.53  |- mesh__dateRevised mesh__D012919 2002-07-02
% 212.37/212.53  |- skos__altLabel mesh__D012919 Harassment, Nonsexual
% 212.37/212.53  |- skos__scopeNote mesh__D012919
% 212.37/212.53       Any behavior caused by or affecting another individual, usually of the same species.%A%    
% 212.37/212.53  |- skos__historyNote mesh__D012919 Behavior %28%1966-1968%29%
% 212.37/212.53  |- skos__hiddenLabel mesh__D012919 Nonsexual Harassments
% 212.37/212.53  |- skos__hiddenLabel mesh__D012919 Harassment, Non Sexual
% 212.37/212.53  |- skos__altLabel mesh__D012919 Nonsexual Harassment
% 212.37/212.53  |- skos__hiddenLabel mesh__D012919 Social Behaviors
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D012919 2004
% 212.37/212.53  |- mesh__recordAuthorizer mesh__D012919 sjn
% 212.37/212.53  |- skos__altLabel mesh__D012919 Non-Sexual Harassment
% 212.37/212.53  |- skos__hiddenLabel mesh__D012919 Behavior, Social
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D012919 2003
% 212.37/212.53  |- skos__annotation mesh__D012919
% 212.37/212.53       human %26% animal; no qualif; note X ref HARASSMENT, NONSEXUAL for bullying, repeated mischievous or deleterious acts, etc.%A%  
% 212.37/212.53  |- skos__historyNote mesh__D012919 Psychology, Social %28%1966-1968%29%
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D012919 2006
% 212.37/212.53  |- mesh__recordMaintainer mesh__D012919 JLS
% 212.37/212.53  |- mesh__publicMeSHNote mesh__D012919 69   
% 212.37/212.53  |- skos__broader mesh__D012919smesh__D001519
% 212.37/212.53  |- mesh__historyNote mesh__D012919 69   
% 212.37/212.53  |- mesh__recordOriginator mesh__D012919 NLM
% 212.37/212.53  |- mesh__dateEstablished mesh__D012919 1969-01-01
% 212.37/212.53  |- skos__hiddenLabel mesh__D012919 Non Sexual Harassment
% 212.37/212.53  |- skos__hiddenLabel mesh__D012919 Harassments, Non-Sexual
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D012919 2005
% 212.37/212.53  |- rdf__type mesh__D012919sskos__Concept
% 212.37/212.53  |- mesh__dateCreated mesh__D012919 1999-01-01
% 212.37/212.53  |- skos__hiddenLabel mesh__D012919 Behaviors, Social
% 212.37/212.53  |- mesh__recordMaintainer mesh__D009970 jls
% 212.37/212.53  |- mesh__recordAuthorizer mesh__D009970 sjn
% 212.37/212.53  |- mesh__recordOriginator mesh__D009970 NLM
% 212.37/212.53  |- skos__scopeNote mesh__D009970
% 212.37/212.53       A dental specialty concerned with the prevention and correction of dental and oral anomalies %28%malocclusion%29%.%A%    
% 212.37/212.53  |- mesh__dateRevised mesh__D009970 2001-08-13
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D009970 2006
% 212.37/212.53  |- skos__prefLabel mesh__D009970 Orthodontics
% 212.37/212.53  |- skos__broader mesh__D009970smesh__D003813
% 212.37/212.53  |- rdf__type mesh__D009970sskos__Concept
% 212.37/212.53  |- skos__annotation mesh__D009970
% 212.37/212.53       SPEC: SPEC qualif; orthop%C3%%A9%die dento-faciale in French titles is translated %22%orthodontics%22% %26% indexed here%A%  
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D009970 2005
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D009970 2004
% 212.37/212.53  |- skos__broader mesh__D009970smesh__D013039
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D009970 2002
% 212.37/212.53  |- mesh__dateCreated mesh__D009970 1999-01-01
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D009970 2003
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D023641 2006
% 212.37/212.53  |- mesh__historyNote mesh__D023641 2002   
% 212.37/212.53  |- skos__hiddenLabel mesh__D023641 Viruses, Archaeal
% 212.37/212.53  |- skos__historyNote mesh__D023641 Archaea/virology %28%1996-2001%29%
% 212.37/212.53  |- mesh__dateCreated mesh__D023641 2001-07-25
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D023641 2005
% 212.37/212.53  |- skos__broader mesh__D023641smesh__D014780
% 212.37/212.53  |- rdf__type mesh__D023641sskos__Concept
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D023641 2004
% 212.37/212.53  |- mesh__publicMeSHNote mesh__D023641 2002   
% 212.37/212.53  |- skos__annotation mesh__D023641 coord with specific Archaea /virol   
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D023641 2002
% 212.37/212.53  |- mesh__dateEstablished mesh__D023641 2002-01-01
% 212.37/212.53  |- skos__hiddenLabel mesh__D023641 Archaeal Virus
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D023641 2003
% 212.37/212.53  |- skos__scopeNote mesh__D023641
% 212.37/212.53       Viruses whose hosts are in the domain ARCHAEA.     
% 212.37/212.53  |- skos__prefLabel mesh__D023641 Archaeal Viruses
% 212.37/212.53  |- skos__hiddenLabel mesh__D023641 Virus, Archaeal
% 212.37/212.53  |- mesh__dateCreated mesh__D009172 1999-01-01
% 212.37/212.53  |- mesh__recordMaintainer mesh__D009172 jls
% 212.37/212.53  |- skos__annotation mesh__D009172 SPEC: SPEC qualif; DF: MYCOL   
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D009172 2005
% 212.37/212.53  |- mesh__recordOriginator mesh__D009172 NLM
% 212.37/212.53  |- mesh__recordAuthorizer mesh__D009172 sjn
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D009172 2006
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D009172 2003
% 212.37/212.53  |- skos__broader mesh__D009172smesh__D008829
% 212.37/212.53  |- mesh__dateRevised mesh__D009172 2001-07-25
% 212.37/212.53  |- mesh__publicMeSHNote mesh__D009172 72   
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D009172 2004
% 212.37/212.53  |- skos__historyNote mesh__D009172 Mycoses %28%1966-1971%29%
% 212.37/212.53  |- mesh__dateEstablished mesh__D009172 1972-01-01
% 212.37/212.53  |- mesh__historyNote mesh__D009172 72   
% 212.37/212.53  |- skos__prefLabel mesh__D009172 Mycology
% 212.37/212.53  |- skos__historyNote mesh__D009172 Fungi %28%1966-1971%29%
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D009172 2002
% 212.37/212.53  |- rdf__type mesh__D009172sskos__Concept
% 212.37/212.53  |- mesh__dateEstablished mesh__D017604 1994-01-01
% 212.37/212.53  |- skos__broader mesh__D017604smesh__D002585
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D017604 2004
% 212.37/212.53  |- mesh__recordAuthorizer mesh__D017604 sjn
% 212.37/212.53  |- rdf__type mesh__D017604sskos__Concept
% 212.37/212.53  |- skos__hiddenLabel mesh__D017604 Cesarean Sections, Repeat
% 212.37/212.53  |- skos__hiddenLabel mesh__D017604 Sections, Repeat Cesarean
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D017604 2003
% 212.37/212.53  |- skos__scopeNote mesh__D017604
% 212.37/212.53       Extraction of the fetus by abdominal hysterotomy anytime following a previous cesarean.%A%    
% 212.37/212.53  |- skos__historyNote mesh__D017604 Cesarean Section %28%1971-1993%29%
% 212.37/212.53  |- skos__annotation mesh__D017604
% 212.37/212.53       do not use /util except by MeSH definition; check the tags FEMALE %26% PREGNANCY%A%  
% 212.37/212.53  |- mesh__recordOriginator mesh__D017604 AGS
% 212.37/212.53  |- mesh__dateRevised mesh__D017604 2002-07-03
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D017604 2006
% 212.37/212.53  |- mesh__dateCreated mesh__D017604 1993-02-16
% 212.37/212.53  |- skos__prefLabel mesh__D017604 Cesarean Section, Repeat
% 212.37/212.53  |- mesh__publicMeSHNote mesh__D017604 94   
% 212.37/212.53  |- skos__hiddenLabel mesh__D017604 Repeat Cesarean Sections
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D017604 2005
% 212.37/212.53  |- mesh__recordMaintainer mesh__D017604 PXP
% 212.37/212.53  |- skos__hiddenLabel mesh__D017604 Section, Repeat Cesarean
% 212.37/212.53  |- mesh__historyNote mesh__D017604 94   
% 212.37/212.53  |- skos__altLabel mesh__D017604 Repeat Cesarean Section
% 212.37/212.53  |- skos__hiddenLabel mesh__D008878 Brock Syndrome
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D008878 1994
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D008878 1995
% 212.37/212.53  |- mesh__recordOriginator mesh__D008878 NLM
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D008878 2005
% 212.37/212.53  |- skos__altLabel mesh__D008878 Brock%27%s Syndrome
% 212.37/212.53  |- mesh__recordAuthorizer mesh__D008878 PLS
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D008878 2000
% 212.37/212.53  |- mesh__recordMaintainer mesh__D008878 TGC
% 212.37/212.53  |- mesh__dateCreated mesh__D008878 1999-01-01
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D008878 1998
% 212.37/212.53  |- skos__hiddenLabel mesh__D008878 Syndromes, Middle Lobe
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D008878 2006
% 212.37/212.53  |- skos__scopeNote mesh__D008878
% 212.37/212.53       Atelectasis of the right middle pulmonary lobe, with chronic pneumonitis. %28%Dorland, 27th ed%29%%A%    
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D008878 2003
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D008878 2001
% 212.37/212.53  |- skos__prefLabel mesh__D008878 Middle Lobe Syndrome
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D008878 1999
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D008878 1996
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D008878 2004
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D008878 2002
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D008878 1997
% 212.37/212.53  |- mesh__dateRevised mesh__D008878 1993-06-02
% 212.37/212.53  |- skos__hiddenLabel mesh__D008878 Syndrome, Brock%27%s
% 212.37/212.53  |- skos__hiddenLabel mesh__D008878 Brocks Syndrome
% 212.37/212.53  |- skos__annotation mesh__D008878
% 212.37/212.53       atelectasis of middle lobe of right lung   
% 212.37/212.53  |- skos__broader mesh__D008878smesh__D001261
% 212.37/212.53  |- rdf__type mesh__D008878sskos__Concept
% 212.37/212.53  |- mesh__recordOriginator mesh__D000097 NLM
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D000097 2005
% 212.37/212.53  |- skos__altLabel mesh__D000097 Ethane Nitriles
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D000097 2002
% 212.37/212.53  |- mesh__historyNote mesh__D000097 75   
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D000097 1994
% 212.37/212.53  |- skos__scopeNote mesh__D000097
% 212.37/212.53       Compounds in which a methyl group is attached to the cyano moiety.%A%    
% 212.37/212.53  |- skos__broader mesh__D000097smesh__D009570
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D000097 2003
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D000097 2006
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D000097 1995
% 212.37/212.53  |- mesh__dateRevised mesh__D000097 1992-05-07
% 212.37/212.53  |- mesh__dateCreated mesh__D000097 1974-11-11
% 212.37/212.53  |- mesh__recordMaintainer mesh__D000097 TAP
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D000097 2004
% 212.37/212.53  |- skos__historyNote mesh__D000097 Nitriles %28%1969-1974%29%
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D000097 1998
% 212.37/212.53  |- skos__altLabel mesh__D000097 Methyl Cyanides
% 212.37/212.53  |- skos__prefLabel mesh__D000097 Acetonitriles
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D000097 1993
% 212.37/212.53  |- skos__hiddenLabel mesh__D000097 Cyanides, Methyl
% 212.37/212.53  |- mesh__publicMeSHNote mesh__D000097 75   
% 212.37/212.53  |- skos__hiddenLabel mesh__D000097 Nitriles, Ethane
% 212.37/212.53  |- skos__altLabel mesh__D000097 Cyanomethanes
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D000097 1996
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D000097 1999
% 212.37/212.53  |- mesh__dateEstablished mesh__D000097 1975-09-01
% 212.37/212.53  |- rdf__type mesh__D000097sskos__Concept
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D000097 2000
% 212.37/212.53  |- mesh__recordAuthorizer mesh__D000097 PLS
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D000097 1997
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D000097 2001
% 212.37/212.53  |- mesh__recordAuthorizer mesh__D005580 sjn
% 212.37/212.53  |- mesh__dateEstablished mesh__D005580 1991-01-01
% 212.37/212.53  |- mesh__dateRevised mesh__D005580 2005-06-30
% 212.37/212.53  |- rdf__type mesh__D005580sskos__Concept
% 212.37/212.53  |- skos__prefLabel mesh__D005580 Fossils
% 212.37/212.53  |- skos__hiddenLabel mesh__D005580 Fossil
% 212.37/212.53  |- mesh__publicMeSHNote mesh__D005580
% 212.37/212.53       91; was see under PALEONTOLOGY 1975-90   
% 212.37/212.53  |- skos__scopeNote mesh__D005580
% 212.37/212.53       Remains, impressions, or traces of animals or plants of past geological times which have been preserved in the earth%27%s crust.%A%    
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D005580 2006
% 212.37/212.53  |- mesh__recordMaintainer mesh__D005580 ags
% 212.37/212.53  |- mesh__dateCreated mesh__D005580 1999-01-01
% 212.37/212.53  |- skos__broader mesh__D005580smesh__D010163
% 212.37/212.53  |- mesh__recordOriginator mesh__D005580 NLM
% 212.37/212.53  |- mesh__historyNote mesh__D005580
% 212.37/212.53       91%28%75%29%; was see under PALEONTOLOGY 1975-90   
% 212.37/212.53  |- mesh__onlineNote mesh__D005580 search PALEONTOLOGY 1966-74   
% 212.37/212.53  |- skos__annotation mesh__D013214
% 212.37/212.53       do not confuse with GLYCOGEN %28%STARCH%29% SYNTHASE see GLYCOGEN SYNTHASE%A%  
% 212.37/212.53  |- skos__altLabel mesh__D013214 Granule-Bound Starch Synthase
% 212.37/212.53  |- mesh__publicMeSHNote mesh__D013214
% 212.37/212.53       98; see STARCH %28%BACTERIAL GLYCOGEN%29% SYNTHASE 1991-97; see GLUCOSYLTRANSFERASES 1975-90%A%  
% 212.37/212.53  |- skos__historyNote mesh__D013214 Glucosyltransferases %28%1973-1974%29%
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D013214 2004
% 212.37/212.53  |- skos__broader mesh__D013214smesh__D005964
% 212.37/212.53  |- mesh__recordAuthorizer mesh__D013214 sjn
% 212.37/212.53  |- mesh__recordMaintainer mesh__D013214 ssb
% 212.37/212.53  |- rdf__type mesh__D013214sskos__Concept
% 212.37/212.53  |- skos__hiddenLabel mesh__D013214 Synthase, Granule-Bound Starch
% 212.37/212.53  |- mesh__recordOriginator mesh__D013214 NLM
% 212.37/212.53  |- skos__historyNote mesh__D013214 Adenosine Diphosphate %28%1973-1974%29%
% 212.37/212.53  |- skos__prefLabel mesh__D013214 Starch Synthase
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D013214 2006
% 212.37/212.53  |- skos__scopeNote mesh__D013214
% 212.37/212.53       An enzyme that catalyzes the transfer of glucose from ADPglucose to glucose-containing polysaccharides in 1,4-alpha-linkages. EC 2.4.1.21.%A%    
% 212.37/212.53  |- mesh__dateCreated mesh__D013214 1974-11-19
% 212.37/212.53  |- skos__hiddenLabel mesh__D013214 Granule Bound Starch Synthase
% 212.37/212.53  |- skos__historyNote mesh__D013214
% 212.37/212.53       Nucleoside Diphosphate Sugars %28%1973-1974%29%
% 212.37/212.53  |- skos__hiddenLabel mesh__D013214 Starch Synthase, Granule-Bound
% 212.37/212.53  |- mesh__dateRevised mesh__D013214 2003-07-09
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D013214 2005
% 212.37/212.53  |- skos__altLabel mesh__D013214 GBSS
% 212.37/212.53  |- skos__hiddenLabel mesh__D013214 Synthase, Starch
% 212.37/212.53  |- skos__altLabel mesh__D013214 Starch %28%Bacterial Glycogen%29% Synthase
% 212.37/212.53  |- skos__altLabel mesh__D013214 ADP Glucose Starch Glucosyltransferase
% 212.37/212.53  |- mesh__dateEstablished mesh__D013214 1991-01-01
% 212.37/212.53  |- mesh__historyNote mesh__D013214 98%28%75%29%   
% 212.37/212.53  |- skos__broader mesh__D037662smesh__D037222
% 212.37/212.53  |- skos__altLabel mesh__D037662 SP-A Protein
% 212.37/212.53  |- mesh__dateCreated mesh__D037662 2002-07-03
% 212.37/212.53  |- skos__hiddenLabel mesh__D037662 SP A Protein
% 212.37/212.53  |- mesh__recordAuthorizer mesh__D037662 sjn
% 212.37/212.53  |- mesh__historyNote mesh__D037662
% 212.37/212.53       2003; for SURFACTANT PROTEIN A %26% SP-A PROTEIN use PULMONARY SURFACTANT-ASSOCIATED PROTEINS %28%NM%29% 1991-2002%A%  
% 212.37/212.53  |- skos__prefLabel mesh__D037662 Pulmonary Surfactant-Associated Protein A
% 212.37/212.53  |- mesh__recordMaintainer mesh__D037662 ssb
% 212.37/212.53  |- skos__broader mesh__D037662smesh__D037661
% 212.37/212.53  |- rdf__type mesh__D037662sskos__Concept
% 212.37/212.53  |- mesh__recordOriginator mesh__D037662 jmp
% 212.37/212.53  |- mesh__publicMeSHNote mesh__D037662
% 212.37/212.53       2003; SURFACTANT PROTEIN A %26% SP-A PROTEIN was indexed under PROTEOLIPIDS %26% PULMONARY SURFACTANTS 1991-2002%A%  
% 212.37/212.53  |- mesh__dateEstablished mesh__D037662 2003-01-01
% 212.37/212.53  |- skos__scopeNote mesh__D037662
% 212.37/212.53       An abundant pulmonary surfactant-associated protein that binds to a variety of lung pathogens, resulting in their opsinization. It also stimulates MACROPHAGES to undergo PHAGOCYTOSIS of microorganisms. Surfactant protein A contains a N-terminal collagen-like domain and a C-terminal lectin domain that are characteristic of members of the collectin family of proteins.%A%    
% 212.37/212.53  |- skos__historyNote mesh__D037662 Proteolipids %28%1991-2002%29%
% 212.37/212.53  |- skos__historyNote mesh__D037662 Pulmonary Surfactants %28%1991-2002%29%
% 212.37/212.53  |- mesh__dateRevised mesh__D037662 2005-06-30
% 212.37/212.53  |- skos__altLabel mesh__D037662 Surfactant Protein A
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D037662 2006
% 212.37/212.53  |- skos__annotation mesh__D037662
% 212.37/212.53       see SCR for species-specific terms; DF: SP-A PROTEIN   
% 212.37/212.53  |- skos__hiddenLabel mesh__D037662
% 212.37/212.53       Pulmonary Surfactant Associated Protein A
% 212.37/212.53  |- mesh__recordAuthorizer mesh__D004488 sjn
% 212.37/212.53  |- skos__scopeNote mesh__D004488
% 212.37/212.53       An acute disease of young pigs that is usually associated with weaning. It is characterized clinically by paresis and subcutaneous edema.%A%    
% 212.37/212.53  |- mesh__historyNote mesh__D004488 71   
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D004488 2004
% 212.37/212.53  |- mesh__dateEstablished mesh__D004488 1971-01-01
% 212.37/212.53  |- skos__broader mesh__D004488smesh__D013553
% 212.37/212.53  |- skos__historyNote mesh__D004488
% 212.37/212.53       Gastrointestinal Diseases/veterinary %28%1966-1970%29%
% 212.37/212.53  |- rdf__type mesh__D004488sskos__Concept
% 212.37/212.53  |- skos__annotation mesh__D004488
% 212.37/212.53       don%27%t forget also SWINE %28%NIM%29% %26% check tag ANIMALS   
% 212.37/212.53  |- mesh__recordMaintainer mesh__D004488 ags
% 212.37/212.53  |- skos__hiddenLabel mesh__D004488 Swine Edema Diseases
% 212.37/212.53  |- skos__prefLabel mesh__D004488 Edema Disease of Swine
% 212.37/212.53  |- mesh__dateRevised mesh__D004488 2003-07-30
% 212.37/212.53  |- skos__historyNote mesh__D004488 Edema/veterinary %28%1966-1970%29%
% 212.37/212.53  |- skos__historyNote mesh__D004488 Swine Diseases %28%1966-1970%29%
% 212.37/212.53  |- mesh__recordOriginator mesh__D004488 NLM
% 212.37/212.53  |- mesh__dateCreated mesh__D004488 1999-01-01
% 212.37/212.53  |- mesh__publicMeSHNote mesh__D004488 71   
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D004488 2005
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D004488 2006
% 212.37/212.53  |- skos__hiddenLabel mesh__D004488 Swine Edema Disease
% 212.37/212.53  |- mesh__publicMeSHNote mesh__D009971 65   
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D009971 2005
% 212.37/212.53  |- mesh__dateRevised mesh__D009971 2002-07-03
% 212.37/212.53  |- skos__scopeNote mesh__D009971
% 212.37/212.53       The phase of orthodontics concerned with the correction of malocclusion with proper appliances and prevention of its sequelae %28%Jablonski%27%s Illus. Dictionary of Dentistry%29%.%A%    
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D009971 2006
% 212.37/212.53  |- skos__annotation mesh__D009971
% 212.37/212.53       do not use /util except by MeSH definition   
% 212.37/212.53  |- skos__hiddenLabel mesh__D009971 Corrective Orthodontics
% 212.37/212.53  |- mesh__dateCreated mesh__D009971 1999-01-01
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D009971 2003
% 212.37/212.53  |- rdf__type mesh__D009971sskos__Concept
% 212.37/212.53  |- mesh__dateEstablished mesh__D009971 1965-01-01
% 212.37/212.53  |- mesh__recordOriginator mesh__D009971 NLM
% 212.37/212.53  |- mesh__recordAuthorizer mesh__D009971 sjn
% 212.37/212.53  |- skos__prefLabel mesh__D009971 Orthodontics, Corrective
% 212.37/212.53  |- mesh__historyNote mesh__D009971 65   
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D009971 2004
% 212.37/212.53  |- mesh__recordMaintainer mesh__D009971 mdb
% 212.37/212.53  |- skos__broader mesh__D009971smesh__D009970
% 212.37/212.53  |- skos__related mesh__D009971smesh__D016556
% 212.37/212.53  |- mesh__dateEstablished mesh__D023642 2002-01-01
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D023642 2006
% 212.37/212.53  |- mesh__dateCreated mesh__D023642 2001-07-25
% 212.37/212.53  |- skos__scopeNote mesh__D023642
% 212.37/212.53       Family of rod-shaped DNA viruses infecting ARCHAEA. They lack viral envelopes or lipids.%A%    
% 212.37/212.53  |- skos__altLabel mesh__D023642 Sulfolobus islandicus Rod-Shaped Viruses
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D023642 2003
% 212.37/212.53  |- rdf__type mesh__D023642sskos__Concept
% 212.37/212.53  |- skos__broader mesh__D023642smesh__D023641
% 212.37/212.53  |- mesh__historyNote mesh__D023642 2002   
% 212.37/212.53  |- mesh__publicMeSHNote mesh__D023642 2002   
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D023642 2004
% 212.37/212.53  |- skos__annotation mesh__D023642 coord with specific Archaea /virol   
% 212.37/212.53  |- skos__hiddenLabel mesh__D023642 Sulfolobus virus SIRV 2
% 212.37/212.53  |- skos__altLabel mesh__D023642 SIRV1
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D023642 2002
% 212.37/212.53  |- skos__altLabel mesh__D023642 Sulfolobus virus SIRV-1
% 212.37/212.53  |- skos__altLabel mesh__D023642 SIRV2
% 212.37/212.53  |- skos__altLabel mesh__D023642 Sulfolobus virus SIRV-2
% 212.37/212.53  |- skos__hiddenLabel mesh__D023642 Sulfolobus virus SIRV 1
% 212.37/212.53  |- skos__prefLabel mesh__D023642 Rudiviridae
% 212.37/212.53  |- skos__broader mesh__D023642smesh__D004267
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D023642 2005
% 212.37/212.53  |- skos__hiddenLabel mesh__D023642 Sulfolobus islandicus Rod Shaped Viruses
% 212.37/212.53  |- skos__historyNote mesh__D023642 DNA Viruses %28%1999-2001%29%
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D009173 2006
% 212.37/212.53  |- mesh__recordMaintainer mesh__D009173 ssb
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D009173 2004
% 212.37/212.53  |- mesh__dateEstablished mesh__D009173 1973-01-01
% 212.37/212.53  |- skos__historyNote mesh__D009173 Caproates %28%1967-1971%29%
% 212.37/212.53  |- mesh__dateRevised mesh__D009173 2003-07-09
% 212.37/212.53  |- mesh__publicMeSHNote mesh__D009173 73   
% 212.37/212.53  |- skos__hiddenLabel mesh__D009173 Acid, Mycophenolic
% 212.37/212.53  |- skos__scopeNote mesh__D009173
% 212.37/212.53       An antibiotic substance derived from Penicillium stoloniferum, and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase. Mycophenolic acid is important because of its selective effects on the immune system. It prevents the proliferation of T-cells, lymphocytes, and the formation of antibodies from B-cells. It also may inhibit recruitment of leukocytes to inflammatory sites. %28%From Gilman et al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 9th ed, p1301%29%%A%    
% 212.37/212.53  |- skos__broader mesh__D009173smesh__D002208
% 212.37/212.53  |- mesh__historyNote mesh__D009173 73%28%72%29%   
% 212.37/212.53  |- skos__historyNote mesh__D009173
% 212.37/212.53       Antibiotics, Antineoplastic %28%1967-1971%29%
% 212.37/212.53  |- rdf__type mesh__D009173sskos__Concept
% 212.37/212.53  |- mesh__dateCreated mesh__D009173 1999-01-01
% 212.37/212.53  |- skos__prefLabel mesh__D009173 Mycophenolic Acid
% 212.37/212.53  |- mesh__recordOriginator mesh__D009173 NLM
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D009173 2005
% 212.37/212.53  |- skos__broader mesh__D009173smesh__D005227
% 212.37/212.53  |- mesh__recordAuthorizer mesh__D009173 sjn
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D001190 2002
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D001190 2003
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D001190 1996
% 212.37/212.53  |- rdf__type mesh__D001190sskos__Concept
% 212.37/212.53  |- mesh__dateCreated mesh__D001190 1999-01-01
% 212.37/212.53  |- skos__prefLabel mesh__D001190 Arylsulfonates
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D001190 2004
% 212.37/212.53  |- mesh__recordAuthorizer mesh__D001190 PLS
% 212.37/212.53  |- mesh__dateEstablished mesh__D001190 1974-01-01
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D001190 1997
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D001190 2000
% 212.37/212.53  |- mesh__publicMeSHNote mesh__D001190 94; was ARYL SULFONATES 1974-93   
% 212.37/212.53  |- mesh__historyNote mesh__D001190 94; was ARYL SULFONATES 1974-93   
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D001190 1994
% 212.37/212.53  |- mesh__onlineNote mesh__D001190
% 212.37/212.53       use ARYLSULFONATES to search ARYL SULFONATES 1974-93   
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D001190 2001
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D001190 1995
% 212.37/212.53  |- skos__broader mesh__D001190smesh__D017739
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D001190 2005
% 212.37/212.53  |- mesh__dateRevised mesh__D001190 1993-06-04
% 212.37/212.53  |- mesh__recordMaintainer mesh__D001190 TPW
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D001190 1998
% 212.37/212.53  |- skos__hiddenLabel mesh__D001190 Sulfonates, Aryl
% 212.37/212.53  |- skos__scopeNote mesh__D001190
% 212.37/212.53       Organic sulfonic acid esters or salts which contain an aromatic hydrocarbon radical.%A%    
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D001190 2006
% 212.37/212.53  |- skos__altLabel mesh__D001190 Aryl Sulfonates
% 212.37/212.53  |- mesh__recordOriginator mesh__D001190 NLM
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D001190 1999
% 212.37/212.53  |- skos__prefLabel mesh__D017605 Bromine Compounds
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D017605 2001
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D017605 2003
% 212.37/212.53  |- skos__scopeNote mesh__D017605
% 212.37/212.53       Inorganic compounds that contain bromine as an integral part of the molecule.%A%    
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D017605 2000
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D017605 1999
% 212.37/212.53  |- mesh__dateEstablished mesh__D017605 1994-01-01
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D017605 2006
% 212.37/212.53  |- skos__hiddenLabel mesh__D017605 Compounds, Bromine
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D017605 1998
% 212.37/212.53  |- skos__broader mesh__D017605smesh__D007287
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D017605 2005
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D017605 1995
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D017605 2002
% 212.37/212.53  |- mesh__historyNote mesh__D017605 94   
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D017605 1994
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D017605 1997
% 212.37/212.53  |- mesh__publicMeSHNote mesh__D017605 94   
% 212.37/212.53  |- mesh__dateCreated mesh__D017605 1993-06-04
% 212.37/212.53  |- skos__annotation mesh__D017605
% 212.37/212.53       inorganic; GEN or unspecified; prefer specifics; DF: BROMINE CPDS%A%  
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D017605 2004
% 212.37/212.53  |- skos__historyNote mesh__D017605 Bromine %28%1966-1993%29%
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D017605 1996
% 212.37/212.53  |- rdf__type mesh__D017605sskos__Concept
% 212.37/212.53  |- skos__prefLabel mesh__D008879 Midodrine
% 212.37/212.53  |- mesh__publicMeSHNote mesh__D008879
% 212.37/212.53       96; was MIDODRIN 1975-95 %28%see under ETHANOLAMINES 1975-90%29%%A%  
% 212.37/212.53  |- skos__hiddenLabel mesh__D008879 ST1085
% 212.37/212.53  |- skos__altLabel mesh__D008879 Midodrin
% 212.37/212.53  |- skos__historyNote mesh__D008879 Ethanolamines %28%1973-1974%29%
% 212.37/212.53  |- skos__hiddenLabel mesh__D008879 ST 1085
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D008879 2006
% 212.37/212.53  |- skos__hiddenLabel mesh__D008879 Monohydrochloride, Midodrine
% 212.37/212.53  |- mesh__dateCreated mesh__D008879 1974-11-19
% 212.37/212.53  |- skos__broader mesh__D008879smesh__D004983
% 212.37/212.53  |- skos__altLabel mesh__D008879
% 212.37/212.53       Christiaens Brand of Midodrine Monohydrochloride
% 212.37/212.53  |- mesh__recordAuthorizer mesh__D008879 sjn
% 212.37/212.53  |- skos__historyNote mesh__D008879 Hydroquinones %28%1973-1974%29%
% 212.37/212.53  |- mesh__recordOriginator mesh__D008879 NLM
% 212.37/212.53  |- skos__altLabel mesh__D008879 Midodrine Hydrochloride
% 212.37/212.53  |- skos__altLabel mesh__D008879 Shire Brand of Midodrine Monohydrochloride
% 212.37/212.53  |- mesh__historyNote mesh__D008879
% 212.37/212.53       96; was MIDODRIN 1975-95 %28%see under ETHANOLAMINES 1975-90%29%%A%  
% 212.37/212.53  |- rdf__type mesh__D008879sskos__Concept
% 212.37/212.53  |- skos__altLabel mesh__D008879
% 212.37/212.53       Cahill May Roberts Brand of Midodrine Monohydrochloride
% 212.37/212.53  |- mesh__dateEstablished mesh__D008879 1991-01-01
% 212.37/212.53  |- mesh__recordMaintainer mesh__D008879 CCR
% 212.37/212.53  |- skos__altLabel mesh__D008879 Amatine
% 212.37/212.53  |- skos__historyNote mesh__D008879 Glycine %28%1973-1974%29%
% 212.37/212.53  |- skos__scopeNote mesh__D008879
% 212.37/212.53       An ethanolamine derivative that is an adrenergic alpha agonist. It is used as a vasoconstrictor agent in the treatment of hypotension.%A%    
% 212.37/212.53  |- skos__altLabel mesh__D008879
% 212.37/212.53       Nycomed Brand of Midodrine Monohydrochloride
% 212.37/212.53  |- mesh__dateRevised mesh__D008879 2005-06-30
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D000098 1994
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D000098 2001
% 212.37/212.53  |- skos__broader mesh__D000098smesh__D007659
% 212.37/212.53  |- skos__prefLabel mesh__D000098 Acetophenones
% 212.37/212.53  |- mesh__dateRevised mesh__D000098 1992-05-07
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D000098 2000
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D000098 2004
% 212.37/212.53  |- mesh__recordOriginator mesh__D000098 NLM
% 212.37/212.53  |- mesh__activeMeSHYear mesh__D000098 2006
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D000098 2003
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D000098 1997
% 212.37/212.54  |- mesh__dateCreated mesh__D000098 1999-01-01
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D000098 2005
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D000098 1999
% 212.37/212.54  |- mesh__recordAuthorizer mesh__D000098 PLS
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D000098 1993
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D000098 1996
% 212.37/212.54  |- rdf__type mesh__D000098sskos__Concept
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D000098 1995
% 212.37/212.54  |- mesh__recordMaintainer mesh__D000098 TAP
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D000098 2002
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D000098 1998
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005581 2005
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005581 1998
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005581 2006
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005581 2000
% 212.37/212.54  |- mesh__recordOriginator mesh__D005581 NLM
% 212.37/212.54  |- skos__broader mesh__D005581smesh__D003153
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005581 2003
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005581 1999
% 212.37/212.54  |- mesh__dateCreated mesh__D005581 1999-01-01
% 212.37/212.54  |- mesh__dateRevised mesh__D005581 1997-06-20
% 212.37/212.54  |- skos__annotation mesh__D005581 not restricted to children   
% 212.37/212.54  |- mesh__recordAuthorizer mesh__D005581 SJN
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005581 2001
% 212.37/212.54  |- skos__broader mesh__D005581smesh__D005791
% 212.37/212.54  |- skos__prefLabel mesh__D005581 Foster Home Care
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005581 2004
% 212.37/212.54  |- skos__hiddenLabel mesh__D005581 Care, Foster Home
% 212.37/212.54  |- skos__scopeNote mesh__D005581
% 212.37/212.54       Private families who care for neglected children or patients unable to care for themselves.%A%    
% 212.37/212.54  |- mesh__recordMaintainer mesh__D005581 PXP
% 212.37/212.54  |- skos__hiddenLabel mesh__D005581 Orphan
% 212.37/212.54  |- rdf__type mesh__D005581sskos__Concept
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005581 2002
% 212.37/212.54  |- rdf__type mesh__D013215sskos__Concept
% 212.37/212.54  |- mesh__recordOriginator mesh__D013215 NLM
% 212.37/212.54  |- skos__scopeNote mesh__D013215
% 212.37/212.54       Echinoderms having bodies of usually five radially disposed arms coalescing at the center.%A%    
% 212.37/212.54  |- mesh__historyNote mesh__D013215 72   
% 212.37/212.54  |- mesh__publicMeSHNote mesh__D013215 72   
% 212.37/212.54  |- skos__broader mesh__D013215smesh__D004447
% 212.37/212.54  |- mesh__dateCreated mesh__D013215 1999-01-01
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D013215 2006
% 212.37/212.54  |- skos__annotation mesh__D013215 note specifics   
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D013215 2005
% 212.37/212.54  |- mesh__dateRevised mesh__D013215 2004-07-07
% 212.37/212.54  |- mesh__recordMaintainer mesh__D013215 ags
% 212.37/212.54  |- skos__historyNote mesh__D013215 Echinodermata %28%1966-1971%29%
% 212.37/212.54  |- mesh__dateEstablished mesh__D013215 1972-01-01
% 212.37/212.54  |- skos__prefLabel mesh__D013215 Starfish
% 212.37/212.54  |- mesh__recordAuthorizer mesh__D013215 sjn
% 212.37/212.54  |- mesh__historyNote mesh__D037663
% 212.37/212.54       2003; use PULMONARY SURFACTANT-ASSOCIATED PROTEIN D %28%NM%29% 1990-2002%A%  
% 212.37/212.54  |- skos__hiddenLabel mesh__D037663 Surfactant Associated Glycoprotein D
% 212.37/212.54  |- skos__broader mesh__D037663smesh__D037661
% 212.37/212.54  |- rdf__type mesh__D037663sskos__Concept
% 212.37/212.54  |- mesh__dateRevised mesh__D037663 2005-06-30
% 212.37/212.54  |- skos__altLabel mesh__D037663 SP-D
% 212.37/212.54  |- skos__prefLabel mesh__D037663 Pulmonary Surfactant-Associated Protein D
% 212.37/212.54  |- mesh__dateCreated mesh__D037663 2002-07-03
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D037663 2006
% 212.37/212.54  |- skos__broader mesh__D037663smesh__D037222
% 212.37/212.54  |- skos__scopeNote mesh__D037663
% 212.37/212.54       An abundant pulmonary surfactant-associated protein that binds to a variety of lung pathogens and enhances their opsinization and killing by phagocytic cells. Surfactant protein D contains a N-terminal collagen-like domain and a C-terminal lectin domain that are characteristic of members of the collectin family of proteins.%A%    
% 212.37/212.54  |- mesh__recordAuthorizer mesh__D037663 sjn
% 212.37/212.54  |- skos__altLabel mesh__D037663 Surfactant Protein D
% 212.37/212.54  |- skos__annotation mesh__D037663 DF: SP-D   
% 212.37/212.54  |- skos__altLabel mesh__D037663 Surfactant-Associated Glycoprotein D
% 212.37/212.54  |- mesh__dateEstablished mesh__D037663 2003-01-01
% 212.37/212.54  |- skos__historyNote mesh__D037663 Glycoproteins %28%1990-2002%29%
% 212.37/212.54  |- mesh__recordMaintainer mesh__D037663 ssb
% 212.37/212.54  |- skos__altLabel mesh__D037663 Lung Protein D
% 212.37/212.54  |- mesh__publicMeSHNote mesh__D037663
% 212.37/212.54       2003; SURFACTANT PROTEIN D %28%now PULMONARY SURFACTANT-ASSOCIATED PROTEIN D%29% was indexed under GLYCOPROTEINS %28%1990-2002%29%%A%  
% 212.37/212.54  |- mesh__recordOriginator mesh__D037663 jmp
% 212.37/212.54  |- skos__altLabel mesh__D037663 Pulmonary Surfactant Protein D
% 212.37/212.54  |- skos__hiddenLabel mesh__D037663
% 212.37/212.54       Pulmonary Surfactant Associated Protein D
% 212.37/212.54  |- mesh__recordMaintainer mesh__D004489 TAP
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D004489 1999
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D004489 1996
% 212.37/212.54  |- mesh__onlineNote mesh__D004489
% 212.37/212.54       search HEART FAILURE, CONGESTIVE 1966-74   
% 212.37/212.54  |- rdf__type mesh__D004489sskos__Concept
% 212.37/212.54  |- mesh__historyNote mesh__D004489
% 212.37/212.54       91%28%75%29%; was see under HEART FAILURE, CONGESTIVE 1975-90   
% 212.37/212.54  |- skos__broader mesh__D004489smesh__D006333
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D004489 1997
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D004489 2000
% 212.37/212.54  |- skos__prefLabel mesh__D004489 Edema, Cardiac
% 212.37/212.54  |- skos__hiddenLabel mesh__D004489 Cardiac Edemas
% 212.37/212.54  |- mesh__dateEstablished mesh__D004489 1991-01-01
% 212.37/212.54  |- skos__scopeNote mesh__D004489
% 212.37/212.54       A manifestation of congestive heart failure caused by increased venous and capillary pressures and often associated with the retention of sodium by the kidneys. %28%Dorland, 27th ed%29%%A%    
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D004489 2001
% 212.37/212.54  |- mesh__dateCreated mesh__D004489 1999-01-01
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D004489 1994
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D004489 2005
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D004489 2002
% 212.37/212.54  |- skos__hiddenLabel mesh__D004489 Cardiac Edema
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D004489 1995
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D004489 2006
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D004489 2003
% 212.37/212.54  |- mesh__recordAuthorizer mesh__D004489 PLS
% 212.37/212.54  |- skos__hiddenLabel mesh__D004489 Edemas, Cardiac
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D004489 1998
% 212.37/212.54  |- mesh__recordOriginator mesh__D004489 NLM
% 212.37/212.54  |- skos__annotation mesh__D004489 a manifest of congestive heart failure   
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D004489 2004
% 212.37/212.54  |- mesh__dateRevised mesh__D004489 1993-06-02
% 212.37/212.54  |- mesh__publicMeSHNote mesh__D004489
% 212.37/212.54       91; was see under HEART FAILURE, CONGESTIVE 1975-90   
% 212.37/212.54  |- skos__hiddenLabel mesh__D009972 Interceptive Orthodontics
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D009972 2005
% 212.37/212.54  |- skos__broader mesh__D009972smesh__D009970
% 212.37/212.54  |- mesh__publicMeSHNote mesh__D009972 75   
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D009972 2006
% 212.37/212.54  |- skos__annotation mesh__D009972
% 212.37/212.54       do not use /util except by MeSH definition   
% 212.37/212.54  |- mesh__dateCreated mesh__D009972 1974-11-19
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D009972 2003
% 212.37/212.54  |- rdf__type mesh__D009972sskos__Concept
% 212.37/212.54  |- skos__scopeNote mesh__D009972
% 212.37/212.54       Recognition and elimination of potential irregularities and malpositions in the developing dentofacial complex.%A%    
% 212.37/212.54  |- mesh__dateRevised mesh__D009972 2002-07-03
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D009972 2004
% 212.37/212.54  |- mesh__recordMaintainer mesh__D009972 mdb
% 212.37/212.54  |- mesh__historyNote mesh__D009972 75   
% 212.37/212.54  |- mesh__dateEstablished mesh__D009972 1975-09-01
% 212.37/212.54  |- skos__prefLabel mesh__D009972 Orthodontics, Interceptive
% 212.37/212.54  |- mesh__recordOriginator mesh__D009972 NLM
% 212.37/212.54  |- mesh__recordAuthorizer mesh__D009972 sjn
% 212.37/212.54  |- skos__historyNote mesh__D009972
% 212.37/212.54       Orthodontics, Preventive %28%1966-1974%29%
% 212.37/212.54  |- skos__scopeNote mesh__D023643
% 212.37/212.54       Family of enveloped, lipid-containing filamentous DNA viruses that infect ARCHAEA.%A%    
% 212.37/212.54  |- mesh__dateCreated mesh__D023643 2001-07-25
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D023643 2006
% 212.37/212.54  |- rdf__type mesh__D023643sskos__Concept
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D023643 2003
% 212.37/212.54  |- skos__prefLabel mesh__D023643 Lipothrixviridae
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D023643 2002
% 212.37/212.54  |- skos__broader mesh__D023643smesh__D023641
% 212.37/212.54  |- skos__annotation mesh__D023643 coord with specific Archaea /virol   
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D023643 2004
% 212.37/212.54  |- mesh__publicMeSHNote mesh__D023643 2002   
% 212.37/212.54  |- mesh__historyNote mesh__D023643 2002   
% 212.37/212.54  |- skos__broader mesh__D023643smesh__D004267
% 212.37/212.54  |- mesh__dateEstablished mesh__D023643 2002-01-01
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D023643 2005
% 212.37/212.54  |- skos__scopeNote mesh__D009174
% 212.37/212.54       A genus of gram-negative, mostly facultatively anaerobic bacteria in the family MYCOPLASMATACEAE. The cells are bounded by a PLASMA MEMBRANE and lack a true CELL WALL. Its organisms are pathogens found on the MUCOUS MEMBRANES of humans, ANIMALS, and BIRDS.%A%    
% 212.37/212.54  |- mesh__recordAuthorizer mesh__D009174 sjn
% 212.37/212.54  |- mesh__recordMaintainer mesh__D009174 SYSTEM
% 212.37/212.54  |- mesh__publicMeSHNote mesh__D009174
% 212.37/212.54       1963; for EPERYTHROZOON see EPERYTHROZOON 1966-2003; for HAEMOBARTONELLA see ANAPLASMATACEAE 1997-2003, see HAEMOBARTONELLA 1980-1996; for PLEUROPNEUMONIA-LIKE ORGANISMS see PLEUROPNEUMONIA-LIKE ORGANISMS 1963-1965%A%  
% 212.37/212.54  |- mesh__dateRevised mesh__D009174 2005-06-30
% 212.37/212.54  |- skos__annotation mesh__D009174 infection = MYCOPLASMA INFECTIONS   
% 212.37/212.54  |- skos__prefLabel mesh__D009174 Mycoplasma
% 212.37/212.54  |- rdf__type mesh__D009174sskos__Concept
% 212.37/212.54  |- mesh__dateCreated mesh__D009174 1999-01-01
% 212.37/212.54  |- mesh__historyNote mesh__D009174
% 212.37/212.54       1963; for HAEMOBARTONELLA use ANAPLASMATACEAE 1980-2003   
% 212.37/212.54  |- skos__altLabel mesh__D009174 Pleuropneumonia-Like Organisms
% 212.37/212.54  |- skos__altLabel mesh__D009174 Haemobartonella
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D009174 2006
% 212.37/212.54  |- skos__altLabel mesh__D009174 PPLO
% 212.37/212.54  |- skos__broader mesh__D009174smesh__D009178
% 212.37/212.54  |- skos__altLabel mesh__D009174 Eperythrozoon
% 212.37/212.54  |- mesh__recordOriginator mesh__D009174 NLM
% 212.37/212.54  |- mesh__historyNote mesh__D001191 98%28%80%29%   
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D001191 2006
% 212.37/212.54  |- mesh__publicMeSHNote mesh__D001191
% 212.37/212.54       98%28%80%29%; see ARYLAMINE ACETYLTRANSFERASE 1991-97; see ACETYLTRANSFERASES 1980-90%A%  
% 212.37/212.54  |- mesh__dateRevised mesh__D001191 2005-07-08
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D001191 2006A
% 212.37/212.54  |- skos__hiddenLabel mesh__D001191
% 212.37/212.54       N-Acetyltransferase, Acetyl-CoA Arylamine
% 212.37/212.54  |- skos__hiddenLabel mesh__D001191 Acetylase, Arylamine
% 212.37/212.54  |- rdf__type mesh__D001191sskos__Concept
% 212.37/212.54  |- skos__scopeNote mesh__D001191
% 212.37/212.54       An enzyme that catalyzes the transfer of acetyl groups from ACETYL-COA to arylamines. It can also catalyze acetyl transfer between arylamines without COENZYME A and has a wide specificity for aromatic amines, including SEROTONIN. However, arylamine N-acetyltransferase should not be confused with the enzyme ARYLALKYLAMINE N-ACETYLTRANSFERASE which is also referred to as SEROTONIN ACETYLTRANSFERASE.%A%    
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D001191 2005
% 212.37/212.54  |- skos__hiddenLabel mesh__D001191
% 212.37/212.54       Arylamine N-Acetyltransferase, Acetyl-CoA
% 212.37/212.54  |- skos__hiddenLabel mesh__D001191 Acetyltransferases, Arylamine
% 212.37/212.54  |- skos__prefLabel mesh__D001191 Arylamine N-Acetyltransferase
% 212.37/212.54  |- skos__altLabel mesh__D001191 Arylamine Acetylase
% 212.37/212.54  |- mesh__recordOriginator mesh__D001191 RLS
% 212.37/212.54  |- mesh__dateCreated mesh__D001191 1979-05-23
% 212.37/212.54  |- skos__annotation mesh__D001191
% 212.37/212.54       do not confuse with ARYLALKYLAMINE N-ACETYLTRANSFERASE   
% 212.37/212.54  |- skos__hiddenLabel mesh__D001191 Arylamine N Acetyltransferase
% 212.37/212.54  |- mesh__dateEstablished mesh__D001191 1991-01-01
% 212.37/212.54  |- skos__historyNote mesh__D001191
% 212.37/212.54       Serotonin %28%1966-1974%29% /analogs %26% derivatives %28%1975-1979%29%
% 212.37/212.54  |- skos__hiddenLabel mesh__D001191 Acetylases, Arylamine
% 212.37/212.54  |- mesh__recordMaintainer mesh__D001191 ags
% 212.37/212.54  |- skos__historyNote mesh__D001191 Acyltransferases %28%1966-1972%29%
% 212.37/212.54  |- skos__broader mesh__D001191smesh__D000217
% 212.37/212.54  |- mesh__recordAuthorizer mesh__D001191 ags
% 212.37/212.54  |- skos__hiddenLabel mesh__D001191 N-Acetyltransferase, Arylamine
% 212.37/212.54  |- skos__altLabel mesh__D001191 Acetyl-CoA Arylamine N-Acetyltransferase
% 212.37/212.54  |- skos__hiddenLabel mesh__D001191 Acetyl CoA Arylamine N Acetyltransferase
% 212.37/212.54  |- skos__altLabel mesh__D001191 Arylamine Acetylases
% 212.37/212.54  |- skos__altLabel mesh__D001191 Arylamine Acetyltransferases
% 212.37/212.54  |- skos__historyNote mesh__D001191 Acetyltransferases %28%1973-1979%29%
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D017606 2002
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D017606 1998
% 212.37/212.54  |- mesh__dateCreated mesh__D017606 1993-06-29
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D017606 2005
% 212.37/212.54  |- mesh__dateEstablished mesh__D017606 1998-01-01
% 212.37/212.54  |- mesh__publicMeSHNote mesh__D017606 98   
% 212.37/212.54  |- mesh__recordOriginator mesh__D017606 TPW
% 212.37/212.54  |- skos__prefLabel mesh__D017606 Chlorine Compounds
% 212.37/212.54  |- skos__hiddenLabel mesh__D017606 Compounds, Chlorine
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D017606 2001
% 212.37/212.54  |- skos__annotation mesh__D017606
% 212.37/212.54       GEN; prefer specifics; used for mapping supplementary chemicals%A%  
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D017606 2004
% 212.37/212.54  |- rdf__type mesh__D017606sskos__Concept
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D017606 2000
% 212.37/212.54  |- skos__broader mesh__D017606smesh__D007287
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D017606 2003
% 212.37/212.54  |- mesh__recordAuthorizer mesh__D017606 SJN
% 212.37/212.54  |- mesh__historyNote mesh__D017606 98; use explode 1994-97   
% 212.37/212.54  |- skos__scopeNote mesh__D017606
% 212.37/212.54       Inorganic compounds that contain chlorine as an integral part of the molecule.%A%    
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D017606 1999
% 212.37/212.54  |- mesh__dateRevised mesh__D017606 1997-06-20
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D017606 2006
% 212.37/212.54  |- mesh__recordMaintainer mesh__D017606 ADP
% 212.37/212.54  |- skos__annotation mesh__D000897 restrict to gastrointestinal ulcers   
% 212.37/212.54  |- skos__hiddenLabel mesh__D000897 Drugs, Anti-Ulcer
% 212.37/212.54  |- mesh__dateEstablished mesh__D000897 1977-01-01
% 212.37/212.54  |- mesh__dateCreated mesh__D000897 1976-04-16
% 212.37/212.54  |- mesh__dateRevised mesh__D000897 2005-06-30
% 212.37/212.54  |- skos__hiddenLabel mesh__D000897 Anti Ulcer Drugs
% 212.37/212.54  |- rdf__type mesh__D000897sskos__Concept
% 212.37/212.54  |- skos__prefLabel mesh__D000897 Anti-Ulcer Agents
% 212.37/212.54  |- skos__altLabel mesh__D000897 Anti-Ulcer Drugs
% 212.37/212.54  |- skos__scopeNote mesh__D000897
% 212.37/212.54       Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief.%A%    
% 212.37/212.54  |- skos__historyNote mesh__D000897 Antacids %28%1966-1976%29%
% 212.37/212.54  |- mesh__publicMeSHNote mesh__D000897 77   
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D000897 2006
% 212.37/212.54  |- skos__related mesh__D000897smesh__D000863
% 212.37/212.54  |- skos__related mesh__D000897smesh__D006635
% 212.37/212.54  |- skos__hiddenLabel mesh__D000897 Agents, Anti-Ulcer
% 212.37/212.54  |- mesh__recordAuthorizer mesh__D000897 sjn
% 212.37/212.54  |- skos__historyNote mesh__D000897
% 212.37/212.54       Gastrointestinal Agents %28%1966-1976%29%
% 212.37/212.54  |- mesh__historyNote mesh__D000897 77   
% 212.37/212.54  |- skos__broader mesh__D000897smesh__D005765
% 212.37/212.54  |- skos__hiddenLabel mesh__D000897 Anti Ulcer Agents
% 212.37/212.54  |- mesh__recordOriginator mesh__D000897 SH
% 212.37/212.54  |- mesh__recordMaintainer mesh__D000897 ssb
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D000099 2002
% 212.37/212.54  |- skos__altLabel mesh__D000099 Acetoxyfluorenylacetamide
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D000099 2004
% 212.37/212.54  |- skos__historyNote mesh__D000099 Acetamides %28%1973-1974%29%
% 212.37/212.54  |- mesh__dateRevised mesh__D000099 1999-11-03
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D000099 2001
% 212.37/212.54  |- mesh__recordAuthorizer mesh__D000099 sjn
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D000099 2006
% 212.37/212.54  |- skos__broader mesh__D000099smesh__D015073
% 212.37/212.54  |- skos__historyNote mesh__D000099 Amides %28%1966-1972%29%
% 212.37/212.54  |- skos__hiddenLabel mesh__D000099 N Acetoxy N acetyl 2 aminofluorene
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D000099 2003
% 212.37/212.54  |- skos__scopeNote mesh__D000099
% 212.37/212.54       An alkylating agent that forms DNA ADDUCTS at the C-8 position in GUANINE, resulting in single strand breaks. It has demonstrated carcinogenic action.%A%    
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D000099 2000
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D000099 2005
% 212.37/212.54  |- skos__altLabel mesh__D000099 Acetoxyacetamidofluorene
% 212.37/212.54  |- mesh__dateEstablished mesh__D000099 1991-01-01
% 212.37/212.54  |- skos__historyNote mesh__D000099 Fluorenes %28%1966-1974%29%
% 212.37/212.54  |- skos__altLabel mesh__D000099 N-Acetoxy-2-acetylaminofluorene
% 212.37/212.54  |- skos__prefLabel mesh__D000099 Acetoxyacetylaminofluorene
% 212.37/212.54  |- rdf__type mesh__D000099sskos__Concept
% 212.37/212.54  |- skos__altLabel mesh__D000099 N-Acetoxy-N-acetyl-2-aminofluorene
% 212.37/212.54  |- mesh__publicMeSHNote mesh__D000099
% 212.37/212.54       91; was see under 2-ACETYLAMINOFLUORENE/analogs %26% derivatives 1980-90; was see under FLUORENES 1975-79%A%  
% 212.37/212.54  |- mesh__historyNote mesh__D000099
% 212.37/212.54       91%28%75%29%; was see under 2-ACETYLAMINOFLUORENE/analogs %26% derivatives 1980-90; was see under FLUORENES 1975-79%A%  
% 212.37/212.54  |- mesh__recordOriginator mesh__D000099 NLM
% 212.37/212.54  |- mesh__recordMaintainer mesh__D000099 adp
% 212.37/212.54  |- mesh__dateCreated mesh__D000099 1974-11-11
% 212.37/212.54  |- skos__historyNote mesh__D000099 Acetates %28%1966-1967%29%
% 212.37/212.54  |- skos__hiddenLabel mesh__D000099 N Acetoxy 2 acetylaminofluorene
% 212.37/212.54  |- skos__historyNote mesh__D000099 Acetic Acids %28%1968-1972%29%
% 212.37/212.54  |- skos__prefLabel mesh__D005582 Foundations
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005582 1998
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005582 2006
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005582 2002
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005582 1999
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005582 1993
% 212.37/212.54  |- mesh__dateCreated mesh__D005582 1999-01-01
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005582 2003
% 212.37/212.54  |- skos__scopeNote mesh__D005582
% 212.37/212.54       Organizations established by endowments with provision for future maintenance.%A%    
% 212.37/212.54  |- skos__broader mesh__D005582smesh__D009939
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005582 1996
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005582 2004
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005582 2000
% 212.37/212.54  |- mesh__recordOriginator mesh__D005582 NLM
% 212.37/212.54  |- mesh__dateRevised mesh__D005582 1992-05-15
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005582 1997
% 212.37/212.54  |- skos__broader mesh__D005582smesh__D005378
% 212.37/212.54  |- rdf__type mesh__D005582sskos__Concept
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005582 1994
% 212.37/212.54  |- mesh__recordAuthorizer mesh__D005582 PLS
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005582 2001
% 212.37/212.54  |- skos__hiddenLabel mesh__D005582 Foundation
% 212.37/212.54  |- mesh__recordMaintainer mesh__D005582 TAP
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005582 1995
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D005582 2005
% 212.37/212.54  |- rdf__type mesh__D013216sskos__Concept
% 212.37/212.54  |- skos__prefLabel mesh__D013216 Startle Reaction
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D013216 2002
% 212.37/212.54  |- skos__scopeNote mesh__D013216
% 212.37/212.54       A complex involuntary response to an unexpected strong stimulus usually auditory in nature.%A%    
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D013216 2004
% 212.37/212.54  |- mesh__dateCreated mesh__D013216 1999-01-01
% 212.37/212.54  |- mesh__recordMaintainer mesh__D013216 PXP
% 212.37/212.54  |- skos__broader mesh__D013216smesh__D012018
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D013216 1998
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D013216 2005
% 212.37/212.54  |- mesh__recordAuthorizer mesh__D013216 SJN
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D013216 1999
% 212.37/212.54  |- skos__hiddenLabel mesh__D013216 Reaction, Startle
% 212.37/212.54  |- mesh__recordOriginator mesh__D013216 NLM
% 212.37/212.54  |- skos__hiddenLabel mesh__D013216 Startle Reactions
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D013216 2006
% 212.37/212.54  |- mesh__historyNote mesh__D013216 69%28%65%29%   
% 212.37/212.54  |- skos__hiddenLabel mesh__D013216 Reactions, Startle
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D013216 2000
% 212.37/212.54  |- skos__annotation mesh__D013216 human %26% animal   
% 212.37/212.54  |- mesh__dateEstablished mesh__D013216 1969-01-01
% 212.37/212.54  |- mesh__publicMeSHNote mesh__D013216 69   
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D013216 2001
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D013216 2003
% 212.37/212.54  |- mesh__dateRevised mesh__D013216 1997-06-20
% 212.37/212.54  |- mesh__dateCreated mesh__D009973 1999-01-01
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D009973 2003
% 212.37/212.54  |- mesh__dateEstablished mesh__D009973 1965-01-01
% 212.37/212.54  |- rdf__type mesh__D009973sskos__Concept
% 212.37/212.54  |- mesh__historyNote mesh__D009973 65   
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D009973 2004
% 212.37/212.54  |- mesh__recordOriginator mesh__D009973 NLM
% 212.37/212.54  |- skos__broader mesh__D009973smesh__D009970
% 212.37/212.54  |- mesh__recordAuthorizer mesh__D009973 sjn
% 212.37/212.54  |- mesh__recordMaintainer mesh__D009973 mdb
% 212.37/212.54  |- skos__prefLabel mesh__D009973 Orthodontics, Preventive
% 212.37/212.54  |- skos__hiddenLabel mesh__D009973 Preventive Orthodontics
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D009973 2005
% 212.37/212.54  |- mesh__publicMeSHNote mesh__D009973 65   
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D009973 2006
% 212.37/212.54  |- mesh__dateRevised mesh__D009973 2002-07-03
% 212.37/212.54  |- skos__annotation mesh__D009973
% 212.37/212.54       do not use /util except by MeSH definition   
% 212.37/212.54  |- mesh__historyNote mesh__D001990 67   
% 212.37/212.54  |- skos__hiddenLabel mesh__D001990 Bronchiolitides, Viral
% 212.37/212.54  |- mesh__dateCreated mesh__D001990 1999-01-01
% 212.37/212.54  |- mesh__dateRevised mesh__D001990 2004-07-07
% 212.37/212.54  |- skos__scopeNote mesh__D001990
% 212.37/212.54       An acute inflammatory disease of the upper RESPIRATORY TRACT, caused by paramyxoviruses, occurring primarily in infants and young children; the viruses most commonly implicated are PARAINFLUENZA VIRUS TYPE 3; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; and METAPNEUMOVIRUS.%A%    
% 212.37/212.54  |- mesh__recordOriginator mesh__D001990 NLM
% 212.37/212.54  |- skos__hiddenLabel mesh__D001990 Viral Bronchiolitides
% 212.37/212.54  |- skos__prefLabel mesh__D001990 Bronchiolitis, Viral
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D001990 2005
% 212.37/212.54  |- mesh__recordAuthorizer mesh__D001990 sjn
% 212.37/212.54  |- skos__annotation mesh__D001990
% 212.37/212.54       coord IM with specific virus dis %28%IM%29%   
% 212.37/212.54  |- mesh__recordMaintainer mesh__D001990 ags
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D001990 2006
% 212.37/212.54  |- skos__hiddenLabel mesh__D001990 Viral Bronchiolitis
% 212.37/212.54  |- rdf__type mesh__D001990sskos__Concept
% 212.37/212.54  |- mesh__publicMeSHNote mesh__D001990 67   
% 212.37/212.54  |- mesh__dateEstablished mesh__D001990 1967-01-01
% 212.37/212.54  |- skos__broader mesh__D001990smesh__D014777
% 212.37/212.54  |- skos__broader mesh__D001990smesh__D001988
% 212.37/212.54  |- skos__prefLabel mesh__D023644 Guttaviridae
% 212.37/212.54  |- rdf__type mesh__D023644sskos__Concept
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D023644 2003
% 212.37/212.54  |- skos__broader mesh__D023644smesh__D023641
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D023644 2004
% 212.37/212.54  |- mesh__dateCreated mesh__D023644 2001-07-25
% 212.37/212.54  |- mesh__publicMeSHNote mesh__D023644 2002   
% 212.37/212.54  |- skos__broader mesh__D023644smesh__D004267
% 212.37/212.54  |- skos__hiddenLabel mesh__D023644 SNDV, Sulfolobus virus
% 212.37/212.54  |- skos__scopeNote mesh__D023644
% 212.37/212.54       Family of archaeal viruses with a single genus: Sulfolobus SNDV-like Viruses.%A%    
% 212.37/212.54  |- skos__altLabel mesh__D023644 SNDV
% 212.37/212.54  |- mesh__dateEstablished mesh__D023644 2002-01-01
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D023644 2002
% 212.37/212.54  |- skos__annotation mesh__D023644 coord with specific Archaea /virol   
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D023644 2005
% 212.37/212.54  |- skos__hiddenLabel mesh__D023644 Sulfolobus SNDV like Viruses
% 212.37/212.54  |- mesh__historyNote mesh__D023644 2002   
% 212.37/212.54  |- skos__hiddenLabel mesh__D023644 Viruses, Sulfolobus SNDV-like
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D023644 2006
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D009175 2006
% 212.37/212.54  |- mesh__publicMeSHNote mesh__D009175
% 212.37/212.54       1968; for EPERYTHROZOONOSIS see EPERYTHROZOONOSIS 1991-2003, see ANAPLASMATACEAE INFECTIONS 1977-1990, see BARTONELLA INFECTIONS 1975-1976%A%  
% 212.37/212.54  |- mesh__historyNote mesh__D009175
% 212.37/212.54       1968; for EPERYTHROZOONOSIS use ANAPLASMATACEAE INFECTIONS 1977-1990, use BARTONELLA INFECTIONS 1975-1976%A%  
% 212.37/212.54  |- skos__broader mesh__D009175smesh__D009180
% 212.37/212.54  |- mesh__dateCreated mesh__D009175 1999-01-01
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D009175 2005
% 212.37/212.54  |- mesh__recordMaintainer mesh__D009175 ags
% 212.37/212.54  |- skos__scopeNote mesh__D009175
% 212.37/212.54       Infections with species of the genus MYCOPLASMA.     
% 212.37/212.54  |- skos__hiddenLabel mesh__D009175 Mycoplasma Infection
% 212.37/212.54  |- mesh__recordOriginator mesh__D009175 NLM
% 212.37/212.54  |- skos__altLabel mesh__D009175 Infections, Mycoplasma
% 212.37/212.54  |- mesh__recordAuthorizer mesh__D009175 sjn
% 212.37/212.54  |- rdf__type mesh__D009175sskos__Concept
% 212.37/212.54  |- skos__historyNote mesh__D009175 Mycoplasma %28%1966-1967%29%
% 212.37/212.54  |- mesh__dateRevised mesh__D009175 2003-07-09
% 212.37/212.54  |- mesh__dateEstablished mesh__D009175 1968-01-01
% 212.37/212.54  |- skos__hiddenLabel mesh__D009175 Infection, Mycoplasma
% 212.37/212.54  |- skos__prefLabel mesh__D009175 Mycoplasma Infections
% 212.37/212.54  |- skos__hiddenLabel mesh__D009175 Eperythrozoonoses
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D009175 2004
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D001192 2004
% 212.37/212.54  |- rdf__type mesh__D001192sskos__Concept
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D001192 2005
% 212.37/212.54  |- mesh__recordAuthorizer mesh__D001192 jls
% 212.37/212.54  |- mesh__dateEstablished mesh__D001192 1991-01-01
% 212.37/212.54  |- skos__historyNote mesh__D001192 Phenols %28%1973-1974%29%
% 212.37/212.54  |- mesh__activeMeSHYear mesh__D001192 2006A
% 212.37/212.54  |- mesh__recordMaintainer mesh__D001192 jls
% 212.37/212.54  |- mesh__dateRevised mesh__D001192 2005-07-29
% 212.37/212.54  |- mesh__historyNote mesh__D001192
% 212.37/212.54       91%28%75%29%; was see under SULFATASES 1975-90   
% 212.37/212.54  |- mesh__dateCreated mesh__D001192 1974-11-19
% 212.37/212.54  |- skos__altLabel mesh__D001192 Arylsulphatases
% 212.37/212.54  |- mesh__recordOriginator mesh__D001192 NLM
% 212.37/212.54  |- mesh__publicMeSHNote mesh__D001192
% 212.37/212.54       91; was see under SULFATASES 1975-90   
% 212.37/212.54  |- skos__broader mesh__D001192smesh__D013429
% 212.37/212.54  |- skos__historyNote mesh__D001192 Sulfatases %28%1973-1974%29%
% 212.37/212.54  |- skos__altLabel mesh__D001192 Arylsulfate Sulfohydrolases
% 212.37/212.54  |- skos__prefLabel mesh__D001192 Arylsulfatases
% 212.37/212.54  |- skos__scopeNote mesh__D001192
% 212.37/212.54       Enzymes that catalyze the hydrolysis of a phenol sulfate to yield a phenol and sulfate. Arylsulfatase A, B, and C have been separated. A deficiency of arylsulfatases is one of the causes of metachromatic leukodystrophy %28%LEUKODYSTROPHY, METACHROMATIC%29%. EC 3.1.6.1.%A%    
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D001192 2006
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017607 1995
% 212.37/212.55  |- mesh__historyNote mesh__D017607 94   
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017607 1994
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017607 2002
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017607 1997
% 212.37/212.55  |- skos__prefLabel mesh__D017607 Aluminum Compounds
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017607 2004
% 212.37/212.55  |- rdf__type mesh__D017607sskos__Concept
% 212.37/212.55  |- skos__scopeNote mesh__D017607
% 212.37/212.55       Inorganic compounds that contain aluminum as an integral part of the molecule.%A%    
% 212.37/212.55  |- mesh__dateCreated mesh__D017607 1993-06-04
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017607 1996
% 212.37/212.55  |- skos__hiddenLabel mesh__D017607 Compounds, Aluminum
% 212.37/212.55  |- mesh__publicMeSHNote mesh__D017607 94   
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017607 2003
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017607 2001
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017607 1999
% 212.37/212.55  |- mesh__dateEstablished mesh__D017607 1994-01-01
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017607 2006
% 212.37/212.55  |- skos__historyNote mesh__D017607 Aluminum %28%1966-1993%29%
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017607 2000
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017607 1998
% 212.37/212.55  |- skos__broader mesh__D017607smesh__D007287
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017607 2005
% 212.37/212.55  |- skos__annotation mesh__D017607
% 212.37/212.55       inorganic; GEN or unspecified; prefer specifics; DF: ALUMINUM CPDS%A%  
% 212.37/212.55  |- skos__broader mesh__D000898smesh__D008827
% 212.37/212.55  |- rdf__type mesh__D000898sskos__Concept
% 212.37/212.55  |- skos__altLabel mesh__D000898 Bacterial Interference
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D000898 2005
% 212.37/212.55  |- mesh__dateCreated mesh__D000898 1999-01-01
% 212.37/212.55  |- mesh__recordMaintainer mesh__D000898 PXP
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D000898 2002
% 212.37/212.55  |- mesh__recordOriginator mesh__D000898 NLM
% 212.37/212.55  |- skos__annotation mesh__D000898 micro-organisms only   
% 212.37/212.55  |- skos__prefLabel mesh__D000898 Antibiosis
% 212.37/212.55  |- mesh__historyNote mesh__D000898 72%28%65%29%   
% 212.37/212.55  |- skos__scopeNote mesh__D000898
% 212.37/212.55       A property of microorganisms which enables one microorganism to kill, injure, or inhibit the growth of a different microorganism.%A%    
% 212.37/212.55  |- mesh__dateRevised mesh__D000898 1996-06-10
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D000898 2006
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D000898 1998
% 212.37/212.55  |- mesh__dateEstablished mesh__D000898 1972-01-01
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D000898 2003
% 212.37/212.55  |- skos__altLabel mesh__D000898 Microbial Antagonism
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D000898 2000
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D000898 1999
% 212.37/212.55  |- skos__hiddenLabel mesh__D000898 Microbial Antagonisms
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D000898 2004
% 212.37/212.55  |- skos__hiddenLabel mesh__D000898 Antagonism, Microbial
% 212.37/212.55  |- mesh__publicMeSHNote mesh__D000898 72   
% 212.37/212.55  |- skos__hiddenLabel mesh__D000898 Antagonisms, Microbial
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D000898 2001
% 212.37/212.55  |- skos__hiddenLabel mesh__D000898 Antibioses
% 212.37/212.55  |- mesh__recordAuthorizer mesh__D000898 PLS
% 212.37/212.55  |- skos__hiddenLabel mesh__D000898 Interferences, Bacterial
% 212.37/212.55  |- skos__hiddenLabel mesh__D000898 Bacterial Interferences
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D000898 1997
% 212.37/212.55  |- mesh__dateEstablished mesh__D005583 1973-01-01
% 212.37/212.55  |- mesh__dateRevised mesh__D005583 1995-05-18
% 212.37/212.55  |- skos__altLabel mesh__D005583 Analysis, Cyclic
% 212.37/212.55  |- skos__prefLabel mesh__D005583 Fourier Analysis
% 212.37/212.55  |- skos__annotation mesh__D005583
% 212.37/212.55       a math function; named for Jean Baptiste Fourier %28%1768-1830%29%, French mathematician %26% physicist; no qualif%A%  
% 212.37/212.55  |- mesh__recordMaintainer mesh__D005583 TGC
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005583 2006
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005583 2004
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005583 2001
% 212.37/212.55  |- skos__altLabel mesh__D005583 Analysis, Fourier
% 212.37/212.55  |- skos__hiddenLabel mesh__D005583 Series, Fourier
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005583 1999
% 212.37/212.55  |- skos__broader mesh__D005583smesh__D008433
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005583 2000
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005583 2005
% 212.37/212.55  |- skos__hiddenLabel mesh__D005583 Transform, Fourier
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005583 1997
% 212.37/212.55  |- skos__hiddenLabel mesh__D005583 Analyses, Cyclic
% 212.37/212.55  |- skos__altLabel mesh__D005583 Cyclic Analysis
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005583 2003
% 212.37/212.55  |- mesh__dateCreated mesh__D005583 1999-01-01
% 212.37/212.55  |- mesh__historyNote mesh__D005583 73   
% 212.37/212.55  |- skos__hiddenLabel mesh__D005583 Cyclic Analyses
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005583 1998
% 212.37/212.55  |- mesh__publicMeSHNote mesh__D005583 73   
% 212.37/212.55  |- mesh__recordAuthorizer mesh__D005583 PLS
% 212.37/212.55  |- skos__scopeNote mesh__D005583
% 212.37/212.55       Analysis based on the mathematical function first formulated by Jean-Baptiste-Joseph Fourier in 1807. The function, known as the Fourier transform, describes the sinusoidal pattern of any fluctuating pattern in the physical world in terms of its amplitude and its phase. It has broad applications in biomedicine, e.g., analysis of the x-ray crystallography data pivotal in identifying the double helical nature of DNA and in analysis of other molecules, including viruses, and the modified back-projection algorithm universally used in computerized tomography imaging, etc. %28%From Segen, The Dictionary of Modern Medicine, 1992%29%%A%    
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005583 1996
% 212.37/212.55  |- mesh__recordOriginator mesh__D005583 NLM
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005583 2002
% 212.37/212.55  |- rdf__type mesh__D005583sskos__Concept
% 212.37/212.55  |- skos__annotation mesh__D013217
% 212.37/212.55       TN 80: definition %26% relation to FASTING; refeeding after starvation: index refeeding under FOOD if pertinent%A%  
% 212.37/212.55  |- mesh__recordMaintainer mesh__D013217 lkt
% 212.37/212.55  |- skos__scopeNote mesh__D013217
% 212.37/212.55       Lengthy and continuous deprivation of food. %28%Stedman, 25th ed%29%%A%    
% 212.37/212.55  |- skos__prefLabel mesh__D013217 Starvation
% 212.37/212.55  |- skos__broader mesh__D013217smesh__D044342
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D013217 2005
% 212.37/212.55  |- skos__related mesh__D013217smesh__D006815
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D013217 2006
% 212.37/212.55  |- mesh__dateRevised mesh__D013217 2003-07-09
% 212.37/212.55  |- mesh__recordAuthorizer mesh__D013217 sjn
% 212.37/212.55  |- mesh__recordOriginator mesh__D013217 NLM
% 212.37/212.55  |- skos__hiddenLabel mesh__D013217 Starvations
% 212.37/212.55  |- skos__hiddenLabel mesh__D013217 Famines
% 212.37/212.55  |- rdf__type mesh__D013217sskos__Concept
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D013217 2004
% 212.37/212.55  |- mesh__dateCreated mesh__D013217 1999-01-01
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018700 1998
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018700 1997
% 212.37/212.55  |- skos__historyNote mesh__D018700 Pleura %28%1976-1994%29%
% 212.37/212.55  |- mesh__dateCreated mesh__D018700 1994-05-23
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018700 2003
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018700 1999
% 212.37/212.55  |- skos__prefLabel mesh__D018700 Pleurodesis
% 212.37/212.55  |- skos__annotation mesh__D018700
% 212.37/212.55       instillation of a drug or other agent into pleural space to seal pleural fistula, effusion, etc.; IM; coord with dis /ther %26% specific drug /admin %28%IM%29% if pertinent%A%  
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018700 2005
% 212.37/212.55  |- mesh__historyNote mesh__D018700 95   
% 212.37/212.55  |- skos__scopeNote mesh__D018700
% 212.37/212.55       The production of adhesions between the parietal and visceral pleura. The procedure is used in the treatment of bronchopleural fistulas, malignant pleural effusions, and pneumothorax and often involves instillation of chemicals or other agents into the pleural space causing, in effect, a pleuritis that seals the air leak. %28%From Fishman, Pulmonary Diseases, 2d ed, p2233 %26% Dorland, 27th ed%29%%A%    
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018700 2004
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018700 1995
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018700 2002
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018700 2006
% 212.37/212.55  |- skos__broader mesh__D018700smesh__D004358
% 212.37/212.55  |- rdf__type mesh__D018700sskos__Concept
% 212.37/212.55  |- mesh__publicMeSHNote mesh__D018700 95   
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018700 2000
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018700 1996
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018700 2001
% 212.37/212.55  |- mesh__dateEstablished mesh__D018700 1995-01-01
% 212.37/212.55  |- skos__broader mesh__D019794Q000031smesh__D019794
% 212.37/212.55  |- mesh__preferredCombination mesh__D019794Q000031smesh__D004163
% 212.37/212.55  |- rdf__type mesh__D019794Q000031smesh__CompoundConcept
% 212.37/212.55  |- skos__hiddenLabel mesh__D051336 Membrane, Mitochondrial
% 212.37/212.55  |- mesh__dateCreated mesh__D051336 2005-06-30
% 212.37/212.55  |- skos__scopeNote mesh__D051336
% 212.37/212.55       The two lipoprotein layers in the MITOCHONDRION. The outer membrane encloses the entire mitochondrion and contains channels with TRANSPORT PROTEINS to move molecules and ions in and out of the organelle. The inner membrane folds into cristae and contains many ENZYMES important to cell METABOLISM and energy production %28%MITOCHONDRIAL ATP SYNTHASE%29%.%A%    
% 212.37/212.55  |- skos__hiddenLabel mesh__D051336 Inner Mitochondrial Membranes
% 212.37/212.55  |- skos__broader mesh__D051336smesh__D007425
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D051336 2006
% 212.37/212.55  |- mesh__recordMaintainer mesh__D051336 lkt
% 212.37/212.55  |- skos__prefLabel mesh__D051336 Mitochondrial Membranes
% 212.37/212.55  |- mesh__recordAuthorizer mesh__D051336 sjn
% 212.37/212.55  |- skos__hiddenLabel mesh__D051336 Mitochondrial Membranes, Outer
% 212.37/212.55  |- mesh__dateEstablished mesh__D051336 2006-01-01
% 212.37/212.55  |- skos__altLabel mesh__D051336 Inner Mitochondrial Membrane
% 212.37/212.55  |- skos__hiddenLabel mesh__D051336 Outer Mitochondrial Membranes
% 212.37/212.55  |- skos__hiddenLabel mesh__D051336 Mitochondrial Membranes, Inner
% 212.37/212.55  |- mesh__recordOriginator mesh__D051336 lkt
% 212.37/212.55  |- skos__hiddenLabel mesh__D051336 Mitochondrial Membrane
% 212.37/212.55  |- mesh__publicMeSHNote mesh__D051336 2006   
% 212.37/212.55  |- rdf__type mesh__D051336sskos__Concept
% 212.37/212.55  |- skos__hiddenLabel mesh__D051336 Membranes, Inner Mitochondrial
% 212.37/212.55  |- mesh__historyNote mesh__D051336 2006   
% 212.37/212.55  |- skos__hiddenLabel mesh__D051336 Membrane, Outer Mitochondrial
% 212.37/212.55  |- skos__hiddenLabel mesh__D051336 Membranes, Mitochondrial
% 212.37/212.55  |- skos__altLabel mesh__D051336 Outer Mitochondrial Membrane
% 212.37/212.55  |- skos__hiddenLabel mesh__D051336 Membrane, Inner Mitochondrial
% 212.37/212.55  |- skos__historyNote mesh__D051336 Mitochondria %28%1965-2005%29%
% 212.37/212.55  |- skos__hiddenLabel mesh__D051336 Membranes, Outer Mitochondrial
% 212.37/212.55  |- mesh__recordAuthorizer mesh__D009974 SJN
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D009974 2004
% 212.37/212.55  |- skos__broader mesh__D009974smesh__D004358
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D009974 2000
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D009974 1998
% 212.37/212.55  |- mesh__dateRevised mesh__D009974 1997-06-20
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D009974 2001
% 212.37/212.55  |- skos__hiddenLabel mesh__D009974 Megavitamin Therapies
% 212.37/212.55  |- skos__scopeNote mesh__D009974
% 212.37/212.55       The use of very large doses of vitamins or other naturally occurring substances normally present in the body, frequently for the treatment of mental disorders.%A%    
% 212.37/212.55  |- skos__historyNote mesh__D009974 Ascorbic Acid %28%1974-1976%29%
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D009974 1999
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D009974 2005
% 212.37/212.55  |- skos__hiddenLabel mesh__D009974 Therapies, Megavitamin
% 212.37/212.55  |- mesh__recordMaintainer mesh__D009974 PXP
% 212.37/212.55  |- skos__hiddenLabel mesh__D009974 Orthomolecular Therapies
% 212.37/212.55  |- skos__prefLabel mesh__D009974 Orthomolecular Therapy
% 212.37/212.55  |- mesh__dateEstablished mesh__D009974 1977-01-01
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D009974 2006
% 212.37/212.55  |- skos__historyNote mesh__D009974 Vitamins %28%1974-1976%29%
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D009974 2002
% 212.37/212.55  |- skos__broader mesh__D009974smesh__D013000
% 212.37/212.55  |- skos__altLabel mesh__D009974 Therapy, Orthomolecular
% 212.37/212.55  |- mesh__historyNote mesh__D009974 77   
% 212.37/212.55  |- mesh__dateCreated mesh__D009974 1976-05-19
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D009974 2003
% 212.37/212.55  |- skos__annotation mesh__D009974
% 212.37/212.55       a psychother technique; note X ref: /adv eff permitted; DF: ORTHOMOL THER%A%  
% 212.37/212.55  |- skos__hiddenLabel mesh__D009974 Therapies, Orthomolecular
% 212.37/212.55  |- rdf__type mesh__D009974sskos__Concept
% 212.37/212.55  |- skos__altLabel mesh__D009974 Therapy, Megavitamin
% 212.37/212.55  |- skos__altLabel mesh__D009974 Megavitamin Therapy
% 212.37/212.55  |- mesh__recordOriginator mesh__D009974 EC
% 212.37/212.55  |- mesh__publicMeSHNote mesh__D009974 77   
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D001991 2001
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D001991 1994
% 212.37/212.55  |- skos__annotation mesh__D001991
% 212.37/212.55       tuberc bronchitis: index under TUBERCULOSIS, PULMONARY %26% not also under BRONCHITIS unless particularly discussed; BRONCHIOLITIS is also available%A%  
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D001991 2005
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D001991 1999
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D001991 2000
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D001991 1993
% 212.37/212.55  |- skos__hiddenLabel mesh__D001991 Bronchitides
% 212.37/212.55  |- skos__broader mesh__D001991smesh__D012141
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D001991 2004
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D001991 1998
% 212.37/212.55  |- mesh__dateRevised mesh__D001991 1990-05-29
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D001991 1992
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D001991 2003
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D001991 1997
% 212.37/212.55  |- mesh__recordOriginator mesh__D001991 NLM
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D001991 1991
% 212.37/212.55  |- skos__broader mesh__D001991smesh__D001982
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D001991 2002
% 212.37/212.55  |- skos__broader mesh__D001991smesh__D008173
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D001991 1996
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D001991 1995
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D001991 2006
% 212.37/212.55  |- mesh__dateCreated mesh__D001991 1999-01-01
% 212.37/212.55  |- mesh__recordMaintainer mesh__D001991 PLS
% 212.37/212.55  |- skos__prefLabel mesh__D001991 Bronchitis
% 212.37/212.55  |- mesh__recordAuthorizer mesh__D001991 NLM
% 212.37/212.55  |- rdf__type mesh__D001991sskos__Concept
% 212.37/212.55  |- skos__scopeNote mesh__D009176
% 212.37/212.55       The etiological agent of contagious pleuropneumonia %28%PLEUROPNEUMONIA, CONTAGIOUS%29% of cattle and goats.%A%    
% 212.37/212.55  |- skos__broader mesh__D009176smesh__D009174
% 212.37/212.55  |- mesh__dateEstablished mesh__D009176 1974-01-01
% 212.37/212.55  |- skos__annotation mesh__D009176
% 212.37/212.55       causes pleuropneumonia in cattle %26% goats; infection: coord IM with PLEUROPNEUMONIA, CONTAGIOUS %28%IM%29%%A%  
% 212.37/212.55  |- rdf__type mesh__D009176sskos__Concept
% 212.37/212.55  |- mesh__historyNote mesh__D009176 74%28%72%29%   
% 212.37/212.55  |- mesh__publicMeSHNote mesh__D009176 74   
% 212.37/212.55  |- skos__historyNote mesh__D009176 Mycoplasma %28%1966-1971%29%
% 212.37/212.55  |- mesh__recordOriginator mesh__D009176 NLM
% 212.37/212.55  |- mesh__recordAuthorizer mesh__D009176 sjn
% 212.37/212.55  |- skos__prefLabel mesh__D009176 Mycoplasma mycoides
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D009176 2006
% 212.37/212.55  |- mesh__recordMaintainer mesh__D009176 SYSTEM
% 212.37/212.55  |- mesh__dateCreated mesh__D009176 1999-01-01
% 212.37/212.55  |- mesh__dateRevised mesh__D009176 2005-06-30
% 212.37/212.55  |- skos__hiddenLabel mesh__D001193 Cartilages, Arytenoid
% 212.37/212.55  |- mesh__dateEstablished mesh__D001193 1991-01-01
% 212.37/212.55  |- mesh__recordMaintainer mesh__D001193 ags
% 212.37/212.55  |- mesh__dateRevised mesh__D001193 2005-06-30
% 212.37/212.55  |- mesh__recordOriginator mesh__D001193 RC
% 212.37/212.55  |- skos__prefLabel mesh__D001193 Arytenoid Cartilage
% 212.37/212.55  |- mesh__dateCreated mesh__D001193 1978-12-21
% 212.37/212.55  |- mesh__historyNote mesh__D001193
% 212.37/212.55       91%28%80%29%; was see under LARYNGEAL CARTILAGES 1980-90   
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D001193 2006
% 212.37/212.55  |- skos__historyNote mesh__D001193 Laryngeal Cartilages %28%1966-1979%29%
% 212.37/212.55  |- skos__scopeNote mesh__D001193
% 212.37/212.55       One of a pair of small pyramidal cartilages that articulate with the lamina of the cricoid cartilage. The corresponding vocal ligament and several muscles are attached to it.%A%    
% 212.37/212.55  |- rdf__type mesh__D001193sskos__Concept
% 212.37/212.55  |- mesh__recordAuthorizer mesh__D001193 sjn
% 212.37/212.55  |- skos__hiddenLabel mesh__D001193 Arytenoid Cartilages
% 212.37/212.55  |- skos__hiddenLabel mesh__D001193 Cartilage, Arytenoid
% 212.37/212.55  |- skos__broader mesh__D001193smesh__D007817
% 212.37/212.55  |- mesh__publicMeSHNote mesh__D001193
% 212.37/212.55       91; was see under LARYNGEAL CARTILAGES 1980-90   
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017608 1996
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017608 2001
% 212.37/212.55  |- skos__broader mesh__D017608smesh__D007287
% 212.37/212.55  |- mesh__historyNote mesh__D017608 94   
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017608 2003
% 212.37/212.55  |- skos__hiddenLabel mesh__D017608 Compounds, Chromium
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017608 1997
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017608 2002
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017608 2004
% 212.37/212.55  |- skos__historyNote mesh__D017608 Chromium %28%1966-1993%29%
% 212.37/212.55  |- skos__scopeNote mesh__D017608
% 212.37/212.55       Inorganic compounds that contain chromium as an integral part of the molecule.%A%    
% 212.37/212.55  |- rdf__type mesh__D017608sskos__Concept
% 212.37/212.55  |- mesh__dateCreated mesh__D017608 1993-06-04
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017608 1998
% 212.37/212.55  |- skos__annotation mesh__D017608
% 212.37/212.55       inorganic; GEN or unspecified; prefer specifics; DF: CHROMIUM CPDS%A%  
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017608 2005
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017608 1999
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017608 2006
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017608 2000
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017608 1994
% 212.37/212.55  |- mesh__publicMeSHNote mesh__D017608 94   
% 212.37/212.55  |- skos__prefLabel mesh__D017608 Chromium Compounds
% 212.37/212.55  |- mesh__dateEstablished mesh__D017608 1994-01-01
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D017608 1995
% 212.37/212.55  |- mesh__dateCreated mesh__D042001 2003-07-09
% 212.37/212.55  |- mesh__dateEstablished mesh__D042001 2004-01-01
% 212.37/212.55  |- mesh__dateRevised mesh__D042001 2005-06-30
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D042001 2006
% 212.37/212.55  |- mesh__historyNote mesh__D042001 2004   
% 212.37/212.55  |- skos__scopeNote mesh__D042001
% 212.37/212.55       A family in the order Chromatiales, class GAMMAPROTEOBACTERIA. These are haloalkaliphilic, phototrophic bacteria that deposit elemental sulfur outside their cells.%A%    
% 212.37/212.55  |- mesh__recordMaintainer mesh__D042001 SYSTEM
% 212.37/212.55  |- skos__prefLabel mesh__D042001 Ectothiorhodospiraceae
% 212.37/212.55  |- rdf__type mesh__D042001sskos__Concept
% 212.37/212.55  |- skos__broader mesh__D042001smesh__D016965
% 212.37/212.55  |- skos__broader mesh__D042001smesh__D020563
% 212.37/212.55  |- mesh__recordOriginator mesh__D042001 ags
% 212.37/212.55  |- mesh__recordAuthorizer mesh__D042001 sjn
% 212.37/212.55  |- mesh__publicMeSHNote mesh__D042001 2004   
% 212.37/212.55  |- mesh__recordMaintainer mesh__D014310 lkt
% 212.37/212.55  |- skos__prefLabel mesh__D014310 Triplets
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D014310 2005
% 212.37/212.55  |- mesh__dateCreated mesh__D014310 1999-01-01
% 212.37/212.55  |- mesh__recordOriginator mesh__D014310 NLM
% 212.37/212.55  |- skos__broader mesh__D014310smesh__D009099
% 212.37/212.55  |- mesh__recordAuthorizer mesh__D014310 sjn
% 212.37/212.55  |- skos__scopeNote mesh__D014310
% 212.37/212.55       Three individuals derived from three FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother.%A%    
% 212.37/212.55  |- skos__annotation mesh__D014310
% 212.37/212.55       human only: for animals use LITTER SIZE; relation to PREGNANCY: Manual 28.16.4, 34.14%A%  
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D014310 2006
% 212.37/212.55  |- skos__broader mesh__D014310smesh__D011272
% 212.37/212.55  |- skos__hiddenLabel mesh__D014310 Triplet
% 212.37/212.55  |- mesh__dateRevised mesh__D014310 2004-07-07
% 212.37/212.55  |- rdf__type mesh__D014310sskos__Concept
% 212.37/212.55  |- mesh__recordMaintainer mesh__D000899 jmp
% 212.37/212.55  |- skos__hiddenLabel mesh__D000899 X 5108
% 212.37/212.55  |- mesh__recordOriginator mesh__D000899 SH
% 212.37/212.55  |- skos__altLabel mesh__D000899 X5108
% 212.37/212.55  |- mesh__dateEstablished mesh__D000899 1991-01-01
% 212.37/212.55  |- mesh__historyNote mesh__D000899
% 212.37/212.55       91%28%76%29%; was ANTIBIOTIC X 5108 see under ANTIBIOTICS 1976-90%A%  
% 212.37/212.55  |- skos__altLabel mesh__D000899 Goldinomycin
% 212.37/212.55  |- skos__broader mesh__D000899smesh__D011090
% 212.37/212.55  |- mesh__recordAuthorizer mesh__D000899 sjn
% 212.37/212.55  |- skos__prefLabel mesh__D000899 Aurodox
% 212.37/212.55  |- rdf__type mesh__D000899sskos__Concept
% 212.37/212.55  |- skos__scopeNote mesh__D000899
% 212.37/212.55       Antibiotic obtained from a Streptomyces variant considered as possibly effective against Streptococcus pyogenes infections. It may promote growth in poultry.%A%    
% 212.37/212.55  |- skos__altLabel mesh__D000899 Goldinodox
% 212.37/212.55  |- mesh__dateCreated mesh__D000899 1975-07-21
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D000899 2006
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D000899 2005
% 212.37/212.55  |- mesh__dateRevised mesh__D000899 2004-07-07
% 212.37/212.55  |- skos__historyNote mesh__D000899 Furans %28%1974-1975%29%
% 212.37/212.55  |- skos__altLabel mesh__D000899 X-5108
% 212.37/212.55  |- skos__hiddenLabel mesh__D000899 N Methylkirromycin
% 212.37/212.55  |- mesh__publicMeSHNote mesh__D000899
% 212.37/212.55       91; was ANTIBIOTIC X 5108 see under ANTIBIOTICS 1976-90   
% 212.37/212.55  |- mesh__onlineNote mesh__D000899
% 212.37/212.55       use AURODOX to search ANTIBIOTIC X 5108 1976-90   
% 212.37/212.55  |- skos__altLabel mesh__D000899 N-Methylkirromycin
% 212.37/212.55  |- skos__historyNote mesh__D000899 Pyridones %28%1974-1975%29%
% 212.37/212.55  |- mesh__recordAuthorizer mesh__D005584 PLS
% 212.37/212.55  |- mesh__historyNote mesh__D005584
% 212.37/212.55       91%28%75%29%; was see under MACULA LUTEA 1975-90   
% 212.37/212.55  |- mesh__recordMaintainer mesh__D005584 TGC
% 212.37/212.55  |- mesh__dateRevised mesh__D005584 1995-05-18
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005584 2006
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005584 2002
% 212.37/212.55  |- mesh__recordOriginator mesh__D005584 NLM
% 212.37/212.55  |- mesh__dateEstablished mesh__D005584 1991-01-01
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005584 1999
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005584 2005
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005584 2004
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005584 1998
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005584 2003
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005584 1997
% 212.37/212.55  |- skos__annotation mesh__D005584
% 212.37/212.55       a pit in the macula lutea of the retina   
% 212.37/212.55  |- mesh__dateCreated mesh__D005584 1999-01-01
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005584 2001
% 212.37/212.55  |- skos__prefLabel mesh__D005584 Fovea Centralis
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005584 1996
% 212.37/212.55  |- skos__broader mesh__D005584smesh__D008266
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D005584 2000
% 212.37/212.55  |- skos__scopeNote mesh__D005584
% 212.37/212.55       An area approximately 1.5 millimeters in diameter within the macula lutea where the retina thins out greatly because of the oblique shifting of all layers except the pigment epithelium layer. It includes the sloping walls of the fovea %28%clivus%29% and contains a few rods in its periphery. In its center %28%foveola%29% are the cones most adapted to yield high visual acuity, each cone being connected to only one ganglion cell. %28%Cline et al., Dictionary of Visual Science, 4th ed%29%%A%    
% 212.37/212.55  |- mesh__publicMeSHNote mesh__D005584
% 212.37/212.55       91; was see under MACULA LUTEA 1975-90   
% 212.37/212.55  |- rdf__type mesh__D005584sskos__Concept
% 212.37/212.55  |- mesh__onlineNote mesh__D005584 search MACULA LUTEA 1968-74   
% 212.37/212.55  |- skos__scopeNote mesh__D013218
% 212.37/212.55       Control, direction and financing of the total dental care of the population by a national government.%A%    
% 212.37/212.55  |- mesh__dateRevised mesh__D013218 1999-11-03
% 212.37/212.55  |- mesh__recordOriginator mesh__D013218 NLM
% 212.37/212.55  |- skos__altLabel mesh__D013218 Dentistry, State
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D013218 2000
% 212.37/212.55  |- skos__broader mesh__D013218smesh__D004472
% 212.37/212.55  |- mesh__publicMeSHNote mesh__D013218 65   
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D013218 2003
% 212.37/212.55  |- skos__hiddenLabel mesh__D013218 Socialized Dentistries
% 212.37/212.55  |- rdf__type mesh__D013218sskos__Concept
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D013218 2001
% 212.37/212.55  |- mesh__recordMaintainer mesh__D013218 kle
% 212.37/212.55  |- skos__hiddenLabel mesh__D013218 Dentistries, Socialized
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D013218 2004
% 212.37/212.55  |- mesh__dateCreated mesh__D013218 1999-01-01
% 212.37/212.55  |- skos__hiddenLabel mesh__D013218 State Dentistries
% 212.37/212.55  |- skos__annotation mesh__D013218
% 212.37/212.55       not for dent programs of individual states %28% = specific dent program + specific state%29%; specify country; DF: STATE DENT%A%  
% 212.37/212.55  |- mesh__historyNote mesh__D013218 65   
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D013218 2002
% 212.37/212.55  |- skos__altLabel mesh__D013218 Dentistry, Socialized
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D013218 2005
% 212.37/212.55  |- skos__prefLabel mesh__D013218 State Dentistry
% 212.37/212.55  |- skos__altLabel mesh__D013218 Socialized Dentistry
% 212.37/212.55  |- skos__hiddenLabel mesh__D013218 Dentistries, State
% 212.37/212.55  |- skos__historyNote mesh__D013218 State Medicine
% 212.37/212.55  |- mesh__dateEstablished mesh__D013218 1965-01-01
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D013218 2006
% 212.37/212.55  |- mesh__recordAuthorizer mesh__D013218 sjn
% 212.37/212.55  |- mesh__recordAuthorizer mesh__D018701 ags
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018701 2000
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018701 2005
% 212.37/212.55  |- mesh__historyNote mesh__D018701 95   
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018701 2004
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018701 1995
% 212.37/212.55  |- skos__scopeNote mesh__D018701
% 212.37/212.55       Infections with viruses of the order MONONEGAVIRALES. The concept includes FILOVIRIDAE INFECTIONS; PARAMYXOVIRIDAE INFECTIONS; and RHABDOVIRIDAE INFECTIONS.%A%    
% 212.37/212.55  |- mesh__dateCreated mesh__D018701 1994-04-19
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018701 2001
% 212.37/212.55  |- mesh__dateEstablished mesh__D018701 1995-01-01
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018701 2006
% 212.37/212.55  |- skos__prefLabel mesh__D018701 Mononegavirales Infections
% 212.37/212.55  |- skos__altLabel mesh__D018701 Infections, Mononegavirales
% 212.37/212.55  |- skos__annotation mesh__D018701 GEN or unspecified; prefer specifics   
% 212.37/212.55  |- mesh__dateRevised mesh__D018701 2005-07-14
% 212.37/212.55  |- skos__hiddenLabel mesh__D018701 Infection, Mononegavirales
% 212.37/212.55  |- rdf__type mesh__D018701sskos__Concept
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018701 2002
% 212.37/212.55  |- skos__hiddenLabel mesh__D018701 Mononegavirales Infection
% 212.37/212.55  |- mesh__recordMaintainer mesh__D018701 ags
% 212.37/212.55  |- skos__broader mesh__D018701smesh__D012327
% 212.37/212.55  |- mesh__recordOriginator mesh__D018701 AGS
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018701 1996
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018701 1998
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018701 1997
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018701 2006A
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018701 2003
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D018701 1999
% 212.37/212.55  |- mesh__publicMeSHNote mesh__D018701 95   
% 212.37/212.55  |- mesh__historyNote mesh__D051337 2006   
% 212.37/212.55  |- mesh__activeMeSHYear mesh__D051337 2006
% 212.37/212.56  |- skos__broader mesh__D051337smesh__D002618
% 212.37/212.56  |- skos__prefLabel mesh__D051337 Chemical Terrorism
% 212.37/212.56  |- skos__hiddenLabel mesh__D051337 Terrorism, Chemical
% 212.37/212.56  |- mesh__dateCreated mesh__D051337 2005-06-30
% 212.37/212.56  |- skos__historyNote mesh__D051337 Violence %28%1996-2000%29%
% 212.37/212.56  |- mesh__recordAuthorizer mesh__D051337 sjn
% 212.37/212.56  |- mesh__recordMaintainer mesh__D051337 ags
% 212.37/212.56  |- skos__historyNote mesh__D051337 Chemical Warfare %28%1996-2005%29%
% 212.37/212.56  |- skos__broader mesh__D051337smesh__D023481
% 212.37/212.56  |- mesh__publicMeSHNote mesh__D051337 2006   
% 212.37/212.56  |- rdf__type mesh__D051337sskos__Concept
% 212.37/212.56  |- mesh__dateEstablished mesh__D051337 2006-01-01
% 212.37/212.56  |- skos__historyNote mesh__D051337 Terrorism %28%2000-2005%29%
% 212.37/212.56  |- skos__scopeNote mesh__D051337
% 212.37/212.56       The use of chemical agents in TERRORISM. This includes the malevolent use of nerve agents, blood agents, blister agents, and choking agents %28%NOXAE%29%.%A%    
% 212.37/212.56  |- mesh__recordOriginator mesh__D051337 ags
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D009975 2005
% 212.37/212.56  |- mesh__publicMeSHNote mesh__D009975
% 212.37/212.56       81; was ORTHOMYXOVIRUSES 1977-80; was INFLUENZA VIRUSES 1963-76; was MYXOVIRUSES 1975-76; was MYXOVIRUS 1963-74%A%  
% 212.37/212.56  |- rdf__type mesh__D009975sskos__Concept
% 212.37/212.56  |- mesh__dateCreated mesh__D009975 1976-05-05
% 212.37/212.56  |- mesh__dateRevised mesh__D009975 2004-07-07
% 212.37/212.56  |- skos__scopeNote mesh__D009975
% 212.37/212.56       A family of RNA viruses causing INFLUENZA and other diseases. There are five recognized genera: INFLUENZAVIRUS A; INFLUENZAVIRUS B; INFLUENZAVIRUS C; ISAVIRUS; and THOGOTOVIRUS.%A%    
% 212.37/212.56  |- mesh__dateEstablished mesh__D009975 1977-01-01
% 212.37/212.56  |- mesh__recordMaintainer mesh__D009975 ags
% 212.37/212.56  |- skos__hiddenLabel mesh__D009975 Influenza Virus
% 212.37/212.56  |- skos__altLabel mesh__D009975 Orthomyxoviruses
% 212.37/212.56  |- mesh__onlineNote mesh__D009975
% 212.37/212.56       use ORTHOMYXOVIRIDAE to search ORTHOMYXOVIRUSES 1977-81, INFLUENZA VIRUSES 1966-76, MYXOVIRUSES 1975-76 %26% MYXOVIRUS 1966-74%A%  
% 212.37/212.56  |- mesh__recordOriginator mesh__D009975 FPG
% 212.37/212.56  |- skos__hiddenLabel mesh__D009975 Myxovirus
% 212.37/212.56  |- skos__broader mesh__D009975smesh__D012328
% 212.37/212.56  |- skos__annotation mesh__D009975
% 212.37/212.56       infection = ORTHOMYXOVIRIDAE INFECTIONS   
% 212.37/212.56  |- skos__altLabel mesh__D009975 Influenza Viruses
% 212.37/212.56  |- skos__prefLabel mesh__D009975 Orthomyxoviridae
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D009975 2006
% 212.37/212.56  |- mesh__historyNote mesh__D009975
% 212.37/212.56       81; was ORTHOMYXOVIRUSES 1977-80; was INFLUENZA VIRUSES 1963-76; was MYXOVIRUSES 1975-76; was MYXOVIRUS 1963-74%A%  
% 212.37/212.56  |- mesh__recordAuthorizer mesh__D009975 sjn
% 212.37/212.56  |- skos__hiddenLabel mesh__D009975 Orthomyxovirus
% 212.37/212.56  |- skos__historyNote mesh__D001992 Irrigation %28%1971-1987%29%
% 212.37/212.56  |- mesh__dateRevised mesh__D001992 1999-11-08
% 212.37/212.56  |- skos__hiddenLabel mesh__D001992 Lavage Fluids, Lung
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001992 2005
% 212.37/212.56  |- skos__hiddenLabel mesh__D001992 Lavage Fluid, Bronchoalveolar
% 212.37/212.56  |- skos__prefLabel mesh__D001992 Bronchoalveolar Lavage Fluid
% 212.37/212.56  |- skos__historyNote mesh__D001992 Bronchi %28%1971-1987%29%
% 212.37/212.56  |- skos__hiddenLabel mesh__D001992 Fluids, Lung Lavage
% 212.37/212.56  |- mesh__dateEstablished mesh__D001992 1988-01-01
% 212.37/212.56  |- skos__hiddenLabel mesh__D001992 Lung Lavage Fluids
% 212.37/212.56  |- skos__broader mesh__D001992smesh__D001826
% 212.37/212.56  |- skos__hiddenLabel mesh__D001992 Fluids, Alveolar Lavage
% 212.37/212.56  |- skos__hiddenLabel mesh__D001992 Fluid, Bronchoalveolar Lavage
% 212.37/212.56  |- skos__scopeNote mesh__D001992
% 212.37/212.56       Fluid obtained by washout of the alveolar compartment of the lung. It is used to assess biochemical and inflammatory changes in and effects of therapy on the interstitial lung tissue.%A%    
% 212.37/212.56  |- mesh__publicMeSHNote mesh__D001992 88   
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001992 2006
% 212.37/212.56  |- skos__hiddenLabel mesh__D001992 Lavage Fluid, Alveolar
% 212.37/212.56  |- mesh__recordAuthorizer mesh__D001992 sjn
% 212.37/212.56  |- skos__altLabel mesh__D001992 Lavage Fluid, Bronchial
% 212.37/212.56  |- skos__historyNote mesh__D001992 Pulmonary Alveoli %28%1971-1987%29%
% 212.37/212.56  |- skos__hiddenLabel mesh__D001992 Bronchoalveolar Lavage Fluids
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001992 2000
% 212.37/212.56  |- mesh__recordOriginator mesh__D001992 SCD
% 212.37/212.56  |- skos__hiddenLabel mesh__D001992 Lavage Fluids, Bronchoalveolar
% 212.37/212.56  |- rdf__type mesh__D001992sskos__Concept
% 212.37/212.56  |- skos__historyNote mesh__D001992 Lung %28%1971-1987%29%
% 212.37/212.56  |- skos__hiddenLabel mesh__D001992 Fluid, Lung Lavage
% 212.37/212.56  |- skos__hiddenLabel mesh__D001992 Fluids, Bronchial Lavage
% 212.37/212.56  |- mesh__dateCreated mesh__D001992 1987-04-02
% 212.37/212.56  |- skos__altLabel mesh__D001992 Lung Lavage Fluid
% 212.37/212.56  |- skos__hiddenLabel mesh__D001992 Lavage Fluids, Alveolar
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001992 2001
% 212.37/212.56  |- skos__hiddenLabel mesh__D001992 Alveolar Lavage Fluids
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001992 2003
% 212.37/212.56  |- mesh__historyNote mesh__D001992 88   
% 212.37/212.56  |- skos__hiddenLabel mesh__D001992 Lavage Fluids, Bronchial
% 212.37/212.56  |- skos__annotation mesh__D001992
% 212.37/212.56       do not confuse with BRONCHOALVEOLAR LAVAGE, the irrigation technique; DF: BALF%A%  
% 212.37/212.56  |- skos__altLabel mesh__D001992 Bronchial Lavage Fluid
% 212.37/212.56  |- skos__hiddenLabel mesh__D001992 Fluid, Bronchial Lavage
% 212.37/212.56  |- skos__hiddenLabel mesh__D001992 Fluids, Bronchoalveolar Lavage
% 212.37/212.56  |- skos__hiddenLabel mesh__D001992 Bronchial Lavage Fluids
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001992 2002
% 212.37/212.56  |- mesh__recordMaintainer mesh__D001992 KEV
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001992 2004
% 212.37/212.56  |- skos__altLabel mesh__D001992 Lavage Fluid, Lung
% 212.37/212.56  |- skos__hiddenLabel mesh__D001992 Fluid, Alveolar Lavage
% 212.37/212.56  |- mesh__recordAuthorizer mesh__D009177 sjn
% 212.37/212.56  |- mesh__onlineNote mesh__D009177
% 212.37/212.56       use MYCOPLASMA to search EATON AGENT 1967-91   
% 212.37/212.56  |- skos__scopeNote mesh__D009177
% 212.37/212.56       Short filamentous organism of the genus Mycoplasma, which binds firmly to the cells of the respiratory epithelium. It is one of the etiologic agents of non-viral primary atypical pneumonia in man.%A%    
% 212.37/212.56  |- mesh__publicMeSHNote mesh__D009177
% 212.37/212.56       80; EATON AGENT was see MYCOPLASMA 1967-91   
% 212.37/212.56  |- skos__broader mesh__D009177smesh__D009174
% 212.37/212.56  |- mesh__dateRevised mesh__D009177 2005-06-30
% 212.37/212.56  |- mesh__dateEstablished mesh__D009177 1980-01-01
% 212.37/212.56  |- mesh__historyNote mesh__D009177
% 212.37/212.56       80; EATON AGENT was see MYCOPLASMA 1967-91   
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D009177 2006
% 212.37/212.56  |- mesh__recordOriginator mesh__D009177 AEP
% 212.37/212.56  |- mesh__dateCreated mesh__D009177 1978-12-21
% 212.37/212.56  |- skos__historyNote mesh__D009177 Mycoplasma %28%1966-1979%29%
% 212.37/212.56  |- mesh__recordMaintainer mesh__D009177 SYSTEM
% 212.37/212.56  |- skos__annotation mesh__D009177
% 212.37/212.56       do not confuse with MYCOPLASMA PNEUMONIA, the dis; infection = PNEUMONIA, MYCOPLASMA%A%  
% 212.37/212.56  |- skos__prefLabel mesh__D009177 Mycoplasma pneumoniae
% 212.37/212.56  |- rdf__type mesh__D009177sskos__Concept
% 212.37/212.56  |- skos__altLabel mesh__D009177 Eaton Agent
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001194 2001
% 212.37/212.56  |- mesh__recordAuthorizer mesh__D001194 PLS
% 212.37/212.56  |- mesh__recordMaintainer mesh__D001194 JRT
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001194 2000
% 212.37/212.56  |- mesh__recordOriginator mesh__D001194 NLM
% 212.37/212.56  |- mesh__dateRevised mesh__D001194 1995-05-31
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001194 2006
% 212.37/212.56  |- skos__scopeNote mesh__D001194
% 212.37/212.56       Asbestos. Fibrous incombustible mineral composed of magnesium and calcium silicates with or without other elements. It is relatively inert chemically and used in thermal insulation and fireproofing. Inhalation of dust causes asbestosis and later lung and gastrointestinal neoplasms.%A%    
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001194 1999
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001194 2004
% 212.37/212.56  |- skos__historyNote mesh__D001194 Minerals %28%1966-1968%29%
% 212.37/212.56  |- mesh__historyNote mesh__D001194 70%28%69%29%   
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001194 1997
% 212.37/212.56  |- mesh__publicMeSHNote mesh__D001194 70   
% 212.37/212.56  |- skos__annotation mesh__D001194
% 212.37/212.56       a silicate used in insulation %26% fireproofing; carcinogenic; GEN or unspecified; prefer specifics; /adv eff: consider also ASBESTOSIS; disease coord with ASBESTOS /adv eff is dis /etiol, not dis /chem ind; for emphasis on asbestos fibers, MINERAL FIBERS is available: see note there%A%  
% 212.37/212.56  |- rdf__type mesh__D001194sskos__Concept
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001194 2005
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001194 2002
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001194 1998
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001194 2003
% 212.37/212.56  |- mesh__dateEstablished mesh__D001194 1970-01-01
% 212.37/212.56  |- mesh__dateCreated mesh__D001194 1999-01-01
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001194 1996
% 212.37/212.56  |- skos__prefLabel mesh__D001194 Asbestos
% 212.37/212.56  |- skos__broader mesh__D001194smesh__D017640
% 212.37/212.56  |- skos__scopeNote mesh__D017609
% 212.37/212.56       Inorganic compounds that contain barium as an integral part of the molecule.%A%    
% 212.37/212.56  |- mesh__publicMeSHNote mesh__D017609 94   
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D017609 2004
% 212.37/212.56  |- skos__prefLabel mesh__D017609 Barium Compounds
% 212.37/212.56  |- mesh__dateEstablished mesh__D017609 1994-01-01
% 212.37/212.56  |- rdf__type mesh__D017609sskos__Concept
% 212.37/212.56  |- skos__annotation mesh__D017609
% 212.37/212.56       inorganic; GEN or unspecified; prefer specifics; DF: BARIUM CPDS%A%  
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D017609 2001
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D017609 1998
% 212.37/212.56  |- skos__broader mesh__D017609smesh__D007287
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D017609 2005
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D017609 2002
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D017609 1999
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D017609 2006
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D017609 1994
% 212.37/212.56  |- mesh__dateCreated mesh__D017609 1993-06-04
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D017609 1995
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D017609 1996
% 212.37/212.56  |- skos__hiddenLabel mesh__D017609 Compounds, Barium
% 212.37/212.56  |- mesh__historyNote mesh__D017609 94   
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D017609 2003
% 212.37/212.56  |- skos__historyNote mesh__D017609 Barium %28%1966-1993%29%
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D017609 2000
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D017609 1997
% 212.37/212.56  |- mesh__publicMeSHNote mesh__D042002 2004   
% 212.37/212.56  |- skos__related mesh__D042002smesh__D042421
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D042002 2005
% 212.37/212.56  |- skos__hiddenLabel mesh__D042002 Remodeling, Chromatin
% 212.37/212.56  |- skos__historyNote mesh__D042002 Chromatin/metabolism %28%1978-2003%29%
% 212.37/212.56  |- mesh__recordOriginator mesh__D042002 nns
% 212.37/212.56  |- skos__hiddenLabel mesh__D042002 Chromatin Disassemblies
% 212.37/212.56  |- mesh__dateEstablished mesh__D042002 2004-01-01
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D042002 2006
% 212.37/212.56  |- mesh__recordMaintainer mesh__D042002 nns
% 212.37/212.56  |- mesh__historyNote mesh__D042002 2004   
% 212.37/212.56  |- skos__broader mesh__D042002smesh__D005786
% 212.37/212.56  |- rdf__type mesh__D042002sskos__Concept
% 212.37/212.56  |- skos__altLabel mesh__D042002 Chromatin Modeling
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D042002 2004
% 212.37/212.56  |- skos__prefLabel mesh__D042002 Chromatin Assembly and Disassembly
% 212.37/212.56  |- skos__broader mesh__D042002smesh__D042003
% 212.37/212.56  |- skos__hiddenLabel mesh__D042002 Disassembly, Chromatin
% 212.37/212.56  |- mesh__recordAuthorizer mesh__D042002 sjn
% 212.37/212.56  |- mesh__dateCreated mesh__D042002 2003-07-25
% 212.37/212.56  |- skos__scopeNote mesh__D042002
% 212.37/212.56       The mechanisms effecting establishment, maintenance, and modification of that specific physical conformation of CHROMATIN determining the transcriptional accessibility or inaccessibility of the DNA.%A%    
% 212.37/212.56  |- mesh__publicMeSHNote mesh__D014311
% 212.37/212.56       91; was see under PYRIDINES 1966-90   
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D014311 2006
% 212.37/212.56  |- skos__scopeNote mesh__D014311
% 212.37/212.56       Histamine H1 antagonist used in ALLERGIC RHINITIS; ASTHMA; and URTICARIA. It is a component of COUGH and COLD medicines. It may cause drowsiness.%A%    
% 212.37/212.56  |- skos__altLabel mesh__D014311 Triprolidine Monohydrochloride, Monohydrate
% 212.37/212.56  |- mesh__recordOriginator mesh__D014311 NLM
% 212.37/212.56  |- mesh__recordMaintainer mesh__D014311 ags
% 212.37/212.56  |- mesh__dateEstablished mesh__D014311 1991-01-01
% 212.37/212.56  |- skos__prefLabel mesh__D014311 Triprolidine
% 212.37/212.56  |- mesh__recordAuthorizer mesh__D014311 ags
% 212.37/212.56  |- skos__altLabel mesh__D014311 Wellcome Brand of Triprolidine
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D014311 2006A
% 212.37/212.56  |- rdf__type mesh__D014311sskos__Concept
% 212.37/212.56  |- skos__hiddenLabel mesh__D014311 Hydrochloride, Triprolidine
% 212.37/212.56  |- mesh__dateRevised mesh__D014311 2005-07-07
% 212.37/212.56  |- skos__broader mesh__D014311smesh__D011725
% 212.37/212.56  |- mesh__dateCreated mesh__D014311 1999-01-01
% 212.37/212.56  |- mesh__historyNote mesh__D014311
% 212.37/212.56       91%28%66%29%; was see under PYRIDINES 1966-90   
% 212.37/212.56  |- mesh__recordMaintainer mesh__D005585 ags
% 212.37/212.56  |- mesh__historyNote mesh__D005585 2006 %28%1963%29%   
% 212.37/212.56  |- mesh__dateCreated mesh__D005585 1999-01-01
% 212.37/212.56  |- skos__hiddenLabel mesh__D005585 Avian Influenzas
% 212.37/212.56  |- skos__broader mesh__D005585smesh__D009976
% 212.37/212.56  |- skos__broader mesh__D005585smesh__D001715
% 212.37/212.56  |- skos__scopeNote mesh__D005585
% 212.37/212.56       Infection of domestic and wild fowl and other BIRDS with INFLUENZA A VIRUS. Avian influenza usually does not sicken birds, but can be highly pathogenic and fatal in domestic POULTRY.%A%    
% 212.37/212.56  |- mesh__recordAuthorizer mesh__D005585 ags
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D005585 2006A
% 212.37/212.56  |- skos__altLabel mesh__D005585 Fowl Plague
% 212.37/212.56  |- skos__hiddenLabel mesh__D005585 Flu, Avian
% 212.37/212.56  |- skos__hiddenLabel mesh__D005585 Plague, Fowl
% 212.37/212.56  |- skos__prefLabel mesh__D005585 Influenza in Birds
% 212.37/212.56  |- skos__historyNote mesh__D005585 Poultry Diseases %28%1966-1969%29%
% 212.37/212.56  |- rdf__type mesh__D005585sskos__Concept
% 212.37/212.56  |- mesh__publicMeSHNote mesh__D005585
% 212.37/212.56       2006; see INFLUENZA, AVIAN 2005, see FOWL PLAGUE 1970-2004, see MYXOVIRUS INFECTIONS 1963-1969%A%  
% 212.37/212.56  |- skos__historyNote mesh__D005585
% 212.37/212.56       Orthomyxovirus Infections %28%1966-1969%29%
% 212.37/212.56  |- skos__altLabel mesh__D005585 Avian Flu
% 212.37/212.56  |- skos__annotation mesh__D005585
% 212.37/212.56       coordinate IM with specific virus subtype %28%IM%29% if pertinent; don%27%t forget also BIRDS or POULTRY %28%NIM%29% %26% check tag ANIMALS%A%  
% 212.37/212.56  |- mesh__recordOriginator mesh__D005585 NLM
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D005585 2006
% 212.37/212.56  |- skos__hiddenLabel mesh__D005585 Influenzas, Avian
% 212.37/212.56  |- skos__altLabel mesh__D005585 Avian Influenza
% 212.37/212.56  |- skos__altLabel mesh__D005585 Influenza, Avian
% 212.37/212.56  |- mesh__dateEstablished mesh__D005585 1970-01-01
% 212.37/212.56  |- skos__broader mesh__D005585smesh__D011201
% 212.37/212.56  |- skos__hiddenLabel mesh__D005585 Influenza in Bird
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D005585 2006B
% 212.37/212.56  |- mesh__dateRevised mesh__D005585 2005-11-10
% 212.37/212.56  |- skos__hiddenLabel mesh__D013219 Government, Provincial
% 212.37/212.56  |- skos__annotation mesh__D013219
% 212.37/212.56       not restricted to the U.S.; no qualif; specify state or province%A%  
% 212.37/212.56  |- mesh__publicMeSHNote mesh__D013219
% 212.37/212.56       90; was see under GOVERNMENT 1984-89   
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D013219 2003
% 212.37/212.56  |- mesh__recordAuthorizer mesh__D013219 sjn
% 212.37/212.56  |- skos__prefLabel mesh__D013219 State Government
% 212.37/212.56  |- mesh__dateRevised mesh__D013219 2000-06-22
% 212.37/212.56  |- rdf__type mesh__D013219sskos__Concept
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D013219 2004
% 212.37/212.56  |- skos__altLabel mesh__D013219 Provincial Government
% 212.37/212.56  |- skos__scopeNote mesh__D013219
% 212.37/212.56       The level of governmental organization and function below that of the national or country-wide government.%A%    
% 212.37/212.56  |- skos__altLabel mesh__D013219 Government, State
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D013219 2005
% 212.37/212.56  |- mesh__recordMaintainer mesh__D013219 jls
% 212.37/212.56  |- skos__broader mesh__D013219smesh__D006076
% 212.37/212.56  |- mesh__dateCreated mesh__D013219 1983-06-20
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D013219 2001
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D013219 2006
% 212.37/212.56  |- mesh__dateEstablished mesh__D013219 1990-01-01
% 212.37/212.56  |- mesh__recordOriginator mesh__D013219 EC
% 212.37/212.56  |- skos__hiddenLabel mesh__D013219 State Governments
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D013219 2002
% 212.37/212.56  |- skos__hiddenLabel mesh__D013219 Governments, State
% 212.37/212.56  |- mesh__historyNote mesh__D013219
% 212.37/212.56       90%28%84%29%; was see under GOVERNMENT 1984-89   
% 212.37/212.56  |- rdf__type mesh__D018702sskos__Concept
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D018702 1996
% 212.37/212.56  |- skos__altLabel mesh__D018702 Infections, Filoviridae
% 212.37/212.56  |- mesh__publicMeSHNote mesh__D018702 95   
% 212.37/212.56  |- mesh__dateEstablished mesh__D018702 1995-01-01
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D018702 2000
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D018702 1998
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D018702 1997
% 212.37/212.56  |- skos__hiddenLabel mesh__D018702 Infection, Filoviridae
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D018702 2003
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D018702 2001
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D018702 1999
% 212.37/212.56  |- skos__broader mesh__D018702smesh__D018701
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D018702 2005
% 212.37/212.56  |- skos__hiddenLabel mesh__D018702 Filoviridae Infection
% 212.37/212.56  |- mesh__historyNote mesh__D018702 95   
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D018702 2004
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D018702 1995
% 212.37/212.56  |- mesh__dateCreated mesh__D018702 1994-04-19
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D018702 2006
% 212.37/212.56  |- skos__annotation mesh__D018702 GEN or unspecified; prefer specifics   
% 212.37/212.56  |- skos__scopeNote mesh__D018702
% 212.37/212.56       Infections with viruses of the family FILOVIRIDAE. The infections in humans consist of a variety of clinically similar viral hemorrhagic fevers but the natural reservoir host is unknown.%A%    
% 212.37/212.56  |- skos__prefLabel mesh__D018702 Filoviridae Infections
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D018702 2002
% 212.37/212.56  |- skos__altLabel mesh__D051338 CFL1 Protein
% 212.37/212.56  |- mesh__dateEstablished mesh__D051338 2006-01-01
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D051338 2006
% 212.37/212.56  |- skos__hiddenLabel mesh__D051338 Cofilin, Non-Muscle
% 212.37/212.56  |- skos__altLabel mesh__D051338 Non-Muscle Cofilin
% 212.37/212.56  |- skos__annotation mesh__D051338 see SCR for organism-specific terms   
% 212.37/212.56  |- mesh__recordOriginator mesh__D051338 DRC
% 212.37/212.56  |- mesh__dateCreated mesh__D051338 2005-06-30
% 212.37/212.56  |- skos__scopeNote mesh__D051338
% 212.37/212.56       Cofilin 1 is a member of the cofilin family of proteins that is expressed in non-muscle CELLS. It has ACTIN depolymerization activity that is dependent on HYDROGEN-ION CONCENTRATION.%A%    
% 212.37/212.56  |- skos__broader mesh__D051338smesh__D051339
% 212.37/212.56  |- skos__prefLabel mesh__D051338 Cofilin 1
% 212.37/212.56  |- rdf__type mesh__D051338sskos__Concept
% 212.37/212.56  |- mesh__publicMeSHNote mesh__D051338
% 212.37/212.56       2006; COFILIN 1 was indexed under MICROFILAMENT PROTEINS 2005%A%  
% 212.37/212.56  |- mesh__historyNote mesh__D051338 2006%28%2005%29%   
% 212.37/212.56  |- skos__hiddenLabel mesh__D051338 Non Muscle Cofilin
% 212.37/212.56  |- mesh__recordAuthorizer mesh__D051338 sjn
% 212.37/212.56  |- mesh__recordMaintainer mesh__D051338 DRC
% 212.37/212.56  |- skos__altLabel mesh__D051338 N-Cofilin
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D009976 2003
% 212.37/212.56  |- skos__scopeNote mesh__D009976
% 212.37/212.56       Virus diseases caused by the ORTHOMYXOVIRIDAE.     
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D009976 1995
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D009976 2001
% 212.37/212.56  |- mesh__recordMaintainer mesh__D009976 ags
% 212.37/212.56  |- skos__hiddenLabel mesh__D009976 Infection, Orthomyxovirus
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D009976 1994
% 212.37/212.56  |- mesh__publicMeSHNote mesh__D009976
% 212.37/212.56       94; was ORTHOMYXOVIRUS INFECTIONS 1977-93; was MYXOVIRUS INFECTIONS 1963-76%A%  
% 212.37/212.56  |- skos__hiddenLabel mesh__D009976 Orthomyxovirus Infection
% 212.37/212.56  |- skos__altLabel mesh__D009976 Infections, Orthomyxoviridae
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D009976 2000
% 212.37/212.56  |- skos__prefLabel mesh__D009976 Orthomyxoviridae Infections
% 212.37/212.56  |- skos__altLabel mesh__D009976 Orthomyxovirus Infections
% 212.37/212.56  |- skos__hiddenLabel mesh__D009976 Infection, Orthomyxoviridae
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D009976 1999
% 212.37/212.56  |- mesh__onlineNote mesh__D009976
% 212.37/212.56       use ORTHOMYXOVIRIDAE INFECTIONS to search ORTHOMYXOVIRUS INFECTIONS 1977-93 %26% MYXOVIRUS INFECTIONS 1966-76%A%  
% 212.37/212.56  |- mesh__dateRevised mesh__D009976 2005-11-09
% 212.37/212.56  |- mesh__dateCreated mesh__D009976 1976-04-27
% 212.37/212.56  |- skos__altLabel mesh__D009976 Infections, Orthomyxovirus
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D009976 1998
% 212.37/212.56  |- mesh__dateEstablished mesh__D009976 1977-01-01
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D009976 1997
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D009976 2006
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D009976 2002
% 212.37/212.56  |- skos__annotation mesh__D009976
% 212.37/212.56       coordinate IM with specific influenza virus %28%IM%29% if pertinent; note specific subtypes of INFLUENZA A VIRUS are available%A%  
% 212.37/212.56  |- mesh__recordOriginator mesh__D009976 FPG
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D009976 1996
% 212.37/212.56  |- skos__broader mesh__D009976smesh__D012327
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D009976 2005
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D009976 2004
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D009976 2006A
% 212.37/212.56  |- skos__hiddenLabel mesh__D009976 Orthomyxoviridae Infection
% 212.37/212.56  |- mesh__historyNote mesh__D009976
% 212.37/212.56       94; was ORTHOMYXOVIRUS INFECTIONS 1977-93; was MYXOVIRUS INFECTIONS 1963-76%A%  
% 212.37/212.56  |- rdf__type mesh__D009976sskos__Concept
% 212.37/212.56  |- mesh__recordAuthorizer mesh__D009976 ags
% 212.37/212.56  |- skos__prefLabel mesh__D001993 Bronchodilator Agents
% 212.37/212.56  |- skos__broader mesh__D001993smesh__D001337
% 212.37/212.56  |- mesh__recordMaintainer mesh__D001993 ssb
% 212.37/212.56  |- skos__hiddenLabel mesh__D001993 Agents, Bronchial-Dilating
% 212.37/212.56  |- skos__altLabel mesh__D001993 Bronchial-Dilating Agents
% 212.37/212.56  |- mesh__recordOriginator mesh__D001993 NLM
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001993 2006
% 212.37/212.56  |- mesh__dateCreated mesh__D001993 1999-01-01
% 212.37/212.56  |- mesh__dateEstablished mesh__D001993 1965-01-01
% 212.37/212.56  |- rdf__type mesh__D001993sskos__Concept
% 212.37/212.56  |- skos__broader mesh__D001993smesh__D018927
% 212.37/212.56  |- skos__hiddenLabel mesh__D001993 Bronchial Dilating Agents
% 212.37/212.56  |- mesh__recordAuthorizer mesh__D001993 sjn
% 212.37/212.56  |- mesh__historyNote mesh__D001993 65%28%63%29%   
% 212.37/212.56  |- skos__scopeNote mesh__D001993
% 212.37/212.56       Agents that cause an increase in the expansion of a bronchus or bronchial tubes.%A%    
% 212.37/212.56  |- skos__hiddenLabel mesh__D001993 Agents, Broncholytic
% 212.37/212.56  |- mesh__dateRevised mesh__D001993 2005-06-30
% 212.37/212.56  |- mesh__publicMeSHNote mesh__D001993 65   
% 212.37/212.56  |- skos__annotation mesh__D001993 GEN or unspecified   
% 212.37/212.56  |- skos__altLabel mesh__D001993 Bronchodilators
% 212.37/212.56  |- skos__hiddenLabel mesh__D001993 Agents, Bronchodilator
% 212.37/212.56  |- mesh__recordAuthorizer mesh__D009178 sjn
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D009178 2006
% 212.37/212.56  |- mesh__recordOriginator mesh__D009178 NLM
% 212.37/212.56  |- skos__historyNote mesh__D009178 Bacteria %28%1966-1974%29%
% 212.37/212.56  |- mesh__dateCreated mesh__D009178 1999-01-01
% 212.37/212.56  |- skos__annotation mesh__D009178
% 212.37/212.56       infection: coord IM with MYCOPLASMATALES INFECTIONS %28%IM%29%   
% 212.37/212.56  |- mesh__publicMeSHNote mesh__D009178 75   
% 212.37/212.56  |- skos__prefLabel mesh__D009178 Mycoplasmataceae
% 212.37/212.56  |- mesh__dateEstablished mesh__D009178 1975-01-01
% 212.37/212.56  |- mesh__historyNote mesh__D009178 75   
% 212.37/212.56  |- mesh__dateRevised mesh__D009178 2005-06-30
% 212.37/212.56  |- skos__broader mesh__D009178smesh__D009179
% 212.37/212.56  |- mesh__recordMaintainer mesh__D009178 SYSTEM
% 212.37/212.56  |- rdf__type mesh__D009178sskos__Concept
% 212.37/212.56  |- skos__scopeNote mesh__D009178
% 212.37/212.56       A family of gram-negative, non-motile bacteria from human and animal sources. One saprophytic species is known.%A%    
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001195 2005
% 212.37/212.56  |- mesh__recordAuthorizer mesh__D001195 PLS
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001195 1998
% 212.37/212.56  |- skos__hiddenLabel mesh__D001195 Asbestoses
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001195 2000
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001195 2003
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001195 2006
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001195 2001
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001195 1996
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001195 1999
% 212.37/212.56  |- mesh__dateCreated mesh__D001195 1999-01-01
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001195 2004
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001195 2002
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D001195 1997
% 212.37/212.56  |- skos__broader mesh__D001195smesh__D011009
% 212.37/212.56  |- mesh__recordOriginator mesh__D001195 NLM
% 212.37/212.56  |- rdf__type mesh__D001195sskos__Concept
% 212.37/212.56  |- mesh__dateRevised mesh__D001195 1995-05-31
% 212.37/212.56  |- skos__prefLabel mesh__D001195 Asbestosis
% 212.37/212.56  |- skos__annotation mesh__D001195
% 212.37/212.56       pneumoconiosis from asbestos fibers; do not coord with OCCUPATIONAL DISEASES; for emphasis on presence of asbestos fibers, MINERAL FIBERS is available: see note there%A%  
% 212.37/212.56  |- mesh__recordMaintainer mesh__D001195 TGC
% 212.37/212.56  |- skos__scopeNote mesh__D001195
% 212.37/212.56       A form of lung disease %28%pneumoconiosis%29% caused by inhaling fibers of asbestos and marked by interstitial fibrosis of the lung varying in extent from minor involvement of the basal areas to extensive scarring. It is associated with pleural mesothelioma and bronchogenic carcinoma. %28%Dorland, 27th ed%29%%A%    
% 212.37/212.56  |- mesh__dateCreated mesh__D042003 2003-07-09
% 212.37/212.56  |- mesh__dateEstablished mesh__D042003 2004-01-01
% 212.37/212.56  |- mesh__publicMeSHNote mesh__D042003 2004   
% 212.37/212.56  |- skos__broader mesh__D042003smesh__D002468
% 212.37/212.56  |- skos__scopeNote mesh__D042003
% 212.37/212.56       The folding of an organism%27%s DNA molecule into a compact, orderly structure that fits within the limited space of  a CELL or VIRUS PARTICLE.%A%    
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D042003 2006
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D042003 2004
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D042003 2005
% 212.37/212.56  |- rdf__type mesh__D042003sskos__Concept
% 212.37/212.56  |- skos__broader mesh__D042003smesh__D039361
% 212.37/212.56  |- mesh__historyNote mesh__D042003 2004   
% 212.37/212.56  |- skos__hiddenLabel mesh__D042003 Packaging, DNA
% 212.37/212.56  |- skos__prefLabel mesh__D042003 DNA Packaging
% 212.37/212.56  |- mesh__dateRevised mesh__D014312 2004-07-07
% 212.37/212.56  |- mesh__historyNote mesh__D014312
% 212.37/212.56       86%28%75%29%; was see under OLIGOSACCHARIDES 1966-85   
% 212.37/212.56  |- skos__broader mesh__D014312smesh__D009844
% 212.37/212.56  |- mesh__dateCreated mesh__D014312 1999-01-01
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D014312 2006
% 212.37/212.56  |- mesh__onlineNote mesh__D014312 search OLIGOSACCHARIDES 1966-74   
% 212.37/212.56  |- skos__scopeNote mesh__D014312
% 212.37/212.56       Oligosaccharides containing three monosaccharide units linked by glycosidic bonds.%A%    
% 212.37/212.56  |- mesh__activeMeSHYear mesh__D014312 2005
% 212.37/212.56  |- mesh__recordMaintainer mesh__D014312 ssb
% 212.37/212.56  |- mesh__publicMeSHNote mesh__D014312
% 212.37/212.56       86; was see under OLIGOSACCHARIDES 1966-85   
% 212.37/212.56  |- mesh__recordAuthorizer mesh__D014312 sjn
% 212.37/212.56  |- skos__prefLabel mesh__D014312 Trisaccharides
% 212.37/212.56  |- mesh__dateEstablished mesh__D014312 1986-01-01
% 212.37/212.56  |- mesh__recordOriginator mesh__D014312 NLM
% 212.37/212.56  |- rdf__type mesh__D014312sskos__Concept
% 212.37/212.56  |- skos__broader mesh__D048949Q000517smesh__D048949
% 212.37/212.56  |- mesh__preferredCombination mesh__D048949Q000517smesh__D016362
% 212.37/212.56  |- rdf__type mesh__D048949Q000517smesh__CompoundConcept
% 212.37/212.56  |- mesh__publicMeSHNote mesh__D005586
% 212.37/212.56       94; was FOWL POX 1970-93; BIRDPOX was BIRD POX see FOWL POX 1970-93%A%  
% 212.37/212.56  |- skos__broader mesh__D005586smesh__D011213
% 212.37/212.56  |- skos__hiddenLabel mesh__D005586 Diphtherias, Fowl
% 212.37/212.57  |- skos__hiddenLabel mesh__D005586 Pox, Bird
% 212.37/212.57  |- rdf__type mesh__D005586sskos__Concept
% 212.37/212.57  |- mesh__historyNote mesh__D005586
% 212.37/212.57       94; was FOWL POX 1970-93; BIRDPOX was BIRD POX see FOWL POX 1970-93%A%  
% 212.37/212.57  |- skos__historyNote mesh__D005586 Poxvirus Infections %28%1966-1969%29%
% 212.37/212.57  |- skos__hiddenLabel mesh__D005586 Fowl Diphtherias
% 212.37/212.57  |- skos__altLabel mesh__D005586 Bird Pox
% 212.37/212.57  |- skos__annotation mesh__D005586
% 212.37/212.57       caused by a poxvirus; don%27%t forget also BIRDS or POULTRY %28%NIM%29% %26% check tag ANIMALS%A%  
% 212.37/212.57  |- skos__broader mesh__D005586smesh__D001715
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D005586 2006
% 212.37/212.57  |- skos__scopeNote mesh__D005586
% 212.37/212.57       A poxvirus infection of poultry and other birds characterized by the formation of wart-like nodules on the skin and diphtheritic necrotic masses %28%cankers%29% in the upper digestive and respiratory tracts.%A%    
% 212.37/212.57  |- skos__historyNote mesh__D005586 Poultry Diseases %28%1966-1969%29%
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D005586 2005
% 212.37/212.57  |- mesh__onlineNote mesh__D005586
% 212.37/212.57       use FOWLPOX to search BIRD POX %26% FOWL POX 1970-93   
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D005586 2004
% 212.37/212.57  |- skos__altLabel mesh__D005586 Fowl Pox
% 212.37/212.57  |- mesh__recordOriginator mesh__D005586 NLM
% 212.37/212.57  |- skos__altLabel mesh__D005586 Variola Avium
% 212.37/212.57  |- skos__altLabel mesh__D005586 Fowl Diphtheria
% 212.37/212.57  |- skos__altLabel mesh__D005586 Epithelioma Contagiosum
% 212.37/212.57  |- mesh__dateRevised mesh__D005586 2003-07-30
% 212.37/212.57  |- mesh__recordMaintainer mesh__D005586 ags
% 212.37/212.57  |- skos__hiddenLabel mesh__D005586 Diphtheria, Fowl
% 212.37/212.57  |- mesh__dateCreated mesh__D005586 1999-01-01
% 212.37/212.57  |- mesh__recordAuthorizer mesh__D005586 sjn
% 212.37/212.57  |- skos__hiddenLabel mesh__D005586 Pox, Fowl
% 212.37/212.57  |- mesh__dateEstablished mesh__D005586 1970-01-01
% 212.37/212.57  |- skos__prefLabel mesh__D005586 Fowlpox
% 212.37/212.57  |- skos__broader mesh__D010720smesh__D017553
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D010720 2002
% 212.37/212.57  |- mesh__recordAuthorizer mesh__D010720 PLS
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D010720 1994
% 212.37/212.57  |- mesh__publicMeSHNote mesh__D010720 65   
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D010720 2005
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D010720 2003
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D010720 1998
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D010720 1995
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D010720 1996
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D010720 2006
% 212.37/212.57  |- mesh__dateRevised mesh__D010720 1993-06-04
% 212.37/212.57  |- skos__scopeNote mesh__D010720
% 212.37/212.57       Inorganic or organic compounds derived from phosphine %28%PH3%29% by the replacement of H atoms. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D010720 2004
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D010720 1999
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D010720 1997
% 212.37/212.57  |- skos__prefLabel mesh__D010720 Phosphines
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D010720 2000
% 212.37/212.57  |- mesh__recordOriginator mesh__D010720 NLM
% 212.37/212.57  |- skos__broader mesh__D010720smesh__D009943
% 212.37/212.57  |- skos__annotation mesh__D010720 do not confuse with PHOSPHENES   
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D010720 2001
% 212.37/212.57  |- mesh__historyNote mesh__D010720 65%28%63%29%   
% 212.37/212.57  |- rdf__type mesh__D010720sskos__Concept
% 212.37/212.57  |- mesh__recordMaintainer mesh__D010720 TPW
% 212.37/212.57  |- mesh__dateCreated mesh__D010720 1999-01-01
% 212.37/212.57  |- mesh__dateEstablished mesh__D010720 1965-01-01
% 212.37/212.57  |- skos__scopeNote mesh__D018703
% 212.37/212.57       A phenomenon that is observed when a small subgroup of a larger POPULATION establishes itself as a separate and isolated entity. The subgroup%27%s GENE POOL carries only a fraction of the genetic diversity of the parental population resulting in an increased frequency of certain diseases in the subgroup, especially those diseases known to be autosomal recessive.%A%    
% 212.37/212.57  |- skos__hiddenLabel mesh__D018703 Founder Effects
% 212.37/212.57  |- skos__historyNote mesh__D018703 Genetics, Population %28%1969-1983%29%
% 212.37/212.57  |- skos__hiddenLabel mesh__D018703 Effect, Founder
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D018703 2003
% 212.37/212.57  |- mesh__dateRevised mesh__D018703 2002-07-03
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D018703 2005
% 212.37/212.57  |- mesh__historyNote mesh__D018703 95   
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D018703 2004
% 212.37/212.57  |- skos__annotation mesh__D018703 DF: FOUNDER EFF   
% 212.37/212.57  |- mesh__dateCreated mesh__D018703 1994-04-19
% 212.37/212.57  |- mesh__publicMeSHNote mesh__D018703 95   
% 212.37/212.57  |- mesh__dateEstablished mesh__D018703 1995-01-01
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D018703 2006
% 212.37/212.57  |- skos__hiddenLabel mesh__D018703 Effects, Founder
% 212.37/212.57  |- skos__historyNote mesh__D018703 Pedigree %28%1983-1994%29%
% 212.37/212.57  |- skos__prefLabel mesh__D018703 Founder Effect
% 212.37/212.57  |- skos__broader mesh__D018703smesh__D040341
% 212.37/212.57  |- rdf__type mesh__D018703sskos__Concept
% 212.37/212.57  |- mesh__dateCreated mesh__D051339 2005-06-30
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D051339 2006C
% 212.37/212.57  |- mesh__publicMeSHNote mesh__D051339
% 212.37/212.57       2006; ACTIN DEPOLYMERIZING FACTORS was indexed under MICROFILAMENT PROTEINS 1988-2005, %26% under MUSCLE PROTEINS %26% PROTEINS 1981-1987%A%  
% 212.37/212.57  |- mesh__recordOriginator mesh__D051339 DRC
% 212.37/212.57  |- skos__prefLabel mesh__D051339 Actin Depolymerizing Factors
% 212.37/212.57  |- skos__altLabel mesh__D051339
% 212.37/212.57       ADF Proteins %28%Actin Depolymerizing Factors%29%
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D051339 2006B
% 212.37/212.57  |- rdf__type mesh__D051339sskos__Concept
% 212.37/212.57  |- mesh__dateEstablished mesh__D051339 2006-01-01
% 212.37/212.57  |- skos__altLabel mesh__D051339 Actin Depolymerizing Proteins
% 212.37/212.57  |- mesh__recordMaintainer mesh__D051339 ags
% 212.37/212.57  |- skos__broader mesh__D051339smesh__D008840
% 212.37/212.57  |- skos__hiddenLabel mesh__D051339 Depolymerizing Proteins, Actin
% 212.37/212.57  |- mesh__historyNote mesh__D051339 2006%28%1981%29%   
% 212.37/212.57  |- skos__scopeNote mesh__D051339
% 212.37/212.57       A family of low MOLECULAR WEIGHT actin-binding proteins found throughout eukaryotes. They remodel the actin CYTOSKELETON by severing ACTIN FILAMENTS and increasing the rate of monomer dissociation.%A%    
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D051339 2006A
% 212.37/212.57  |- mesh__dateRevised mesh__D051339 2005-07-13
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D051339 2006
% 212.37/212.57  |- skos__hiddenLabel mesh__D051339 Depolymerizing Factors, Actin
% 212.37/212.57  |- skos__altLabel mesh__D051339 Cofilins
% 212.37/212.57  |- mesh__recordAuthorizer mesh__D051339 ags
% 212.37/212.57  |- skos__altLabel mesh__D051339 Cofilin Proteins
% 212.37/212.57  |- skos__scopeNote mesh__D001994
% 212.37/212.57       A usually spherical cyst, arising as an embryonic out-pouching of the foregut or trachea. It is generally found in the mediastinum or lung and is usually asymptomatic unless it becomes infected.%A%    
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001994 2000
% 212.37/212.57  |- skos__historyNote mesh__D001994 Mediastinal Cyst %28%1966-1986%29%
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001994 1996
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001994 1995
% 212.37/212.57  |- skos__annotation mesh__D001994
% 212.37/212.57       non-neoplastic; /blood supply /chem /secret /ultrastruct permitted%A%  
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001994 2006
% 212.37/212.57  |- rdf__type mesh__D001994sskos__Concept
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001994 2005
% 212.37/212.57  |- skos__hiddenLabel mesh__D001994 Cyst, Bronchial
% 212.37/212.57  |- skos__hiddenLabel mesh__D001994 Bronchial Cysts
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001994 1999
% 212.37/212.57  |- mesh__dateRevised mesh__D001994 1994-05-12
% 212.37/212.57  |- skos__prefLabel mesh__D001994 Bronchogenic Cyst
% 212.37/212.57  |- mesh__recordMaintainer mesh__D001994 PXP
% 212.37/212.57  |- skos__historyNote mesh__D001994 Bronchial Diseases %28%1966-1986%29%
% 212.37/212.57  |- mesh__recordOriginator mesh__D001994 VDK
% 212.37/212.57  |- skos__broader mesh__D001994smesh__D015619
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001994 2004
% 212.37/212.57  |- mesh__dateEstablished mesh__D001994 1987-01-01
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001994 2002
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001994 1998
% 212.37/212.57  |- mesh__publicMeSHNote mesh__D001994 87   
% 212.37/212.57  |- skos__hiddenLabel mesh__D001994 Cysts, Bronchogenic
% 212.37/212.57  |- skos__hiddenLabel mesh__D001994 Cysts, Bronchial
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001994 2003
% 212.37/212.57  |- mesh__dateCreated mesh__D001994 1986-06-23
% 212.37/212.57  |- skos__broader mesh__D001994smesh__D003560
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001994 2001
% 212.37/212.57  |- mesh__recordAuthorizer mesh__D001994 PLS
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001994 1997
% 212.37/212.57  |- mesh__historyNote mesh__D001994 87   
% 212.37/212.57  |- skos__historyNote mesh__D001994 Cysts %28%1966-1986%29%
% 212.37/212.57  |- skos__hiddenLabel mesh__D001994 Bronchogenic Cysts
% 212.37/212.57  |- skos__altLabel mesh__D001994 Bronchial Cyst
% 212.37/212.57  |- skos__hiddenLabel mesh__D001994 Cyst, Bronchogenic
% 212.37/212.57  |- skos__broader mesh__D001994smesh__D001982
% 212.37/212.57  |- mesh__dateEstablished mesh__D009179 1975-01-01
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D009179 2006
% 212.37/212.57  |- skos__prefLabel mesh__D009179 Mycoplasmatales
% 212.37/212.57  |- mesh__historyNote mesh__D009179 75   
% 212.37/212.57  |- skos__annotation mesh__D009179 infection = MYCOPLASMATALES INFECTIONS   
% 212.37/212.57  |- mesh__recordAuthorizer mesh__D009179 sjn
% 212.37/212.57  |- mesh__recordOriginator mesh__D009179 NLM
% 212.37/212.57  |- skos__scopeNote mesh__D009179
% 212.37/212.57       An order of highly pleomorphic, gram-negative bacteria including both pathogenic and saprophytic species.%A%    
% 212.37/212.57  |- rdf__type mesh__D009179sskos__Concept
% 212.37/212.57  |- skos__historyNote mesh__D009179 Bacteria %28%1966-1974%29%
% 212.37/212.57  |- mesh__publicMeSHNote mesh__D009179 75   
% 212.37/212.57  |- skos__broader mesh__D009179smesh__D008973
% 212.37/212.57  |- mesh__dateRevised mesh__D009179 2005-06-30
% 212.37/212.57  |- mesh__dateCreated mesh__D009179 1999-01-01
% 212.37/212.57  |- mesh__recordMaintainer mesh__D009179 SYSTEM
% 212.37/212.57  |- mesh__dateRevised mesh__D001196 2004-07-13
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001196 2006
% 212.37/212.57  |- mesh__dateCreated mesh__D001196 1999-01-01
% 212.37/212.57  |- skos__hiddenLabel mesh__D001196 Ascariases
% 212.37/212.57  |- skos__broader mesh__D001196smesh__D017191
% 212.37/212.57  |- skos__annotation mesh__D001196
% 212.37/212.57       nematode infect caused by ASCARIS; do not confuse with ACARIASIS, mite infestation or ASCARIDIASIS, infection with ASCARIDIA; coord IM with species %28%IM%29%%A%  
% 212.37/212.57  |- rdf__type mesh__D001196sskos__Concept
% 212.37/212.57  |- mesh__recordAuthorizer mesh__D001196 sjn
% 212.37/212.57  |- mesh__recordMaintainer mesh__D001196 sjn
% 212.37/212.57  |- skos__prefLabel mesh__D001196 Ascariasis
% 212.37/212.57  |- mesh__recordOriginator mesh__D001196 NLM
% 212.37/212.57  |- skos__scopeNote mesh__D001196
% 212.37/212.57       Infection by nematodes of the genus ASCARIS. Ingestion of infective eggs causes diarrhea and pneumonitis. Its distribution is more prevalent in areas of poor sanitation and where human feces are used for fertilizer.%A%    
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001196 2005
% 212.37/212.57  |- mesh__recordOriginator mesh__D042802 ags
% 212.37/212.57  |- mesh__historyNote mesh__D042802 2004   
% 212.37/212.57  |- skos__scopeNote mesh__D042802
% 212.37/212.57       A family of gram-negative bacteria in the class BETAPROTEOBACTERIA. There are at least eight genera.%A%    
% 212.37/212.57  |- mesh__dateCreated mesh__D042802 2003-07-09
% 212.37/212.57  |- rdf__type mesh__D042802sskos__Concept
% 212.37/212.57  |- mesh__dateEstablished mesh__D042802 2004-01-01
% 212.37/212.57  |- mesh__recordAuthorizer mesh__D042802 sjn
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D042802 2006
% 212.37/212.57  |- skos__prefLabel mesh__D042802 Oxalobacteraceae
% 212.37/212.57  |- mesh__publicMeSHNote mesh__D042802 2004   
% 212.37/212.57  |- skos__broader mesh__D042802smesh__D020562
% 212.37/212.57  |- mesh__dateRevised mesh__D042802 2005-06-30
% 212.37/212.57  |- mesh__recordMaintainer mesh__D042802 SYSTEM
% 212.37/212.57  |- skos__broader mesh__D042802smesh__D016946
% 212.37/212.57  |- skos__hiddenLabel mesh__D020350 Graft-vs-Tumor Responses
% 212.37/212.57  |- skos__hiddenLabel mesh__D020350 Effects, Graft-vs-Neoplasm
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D020350 2000
% 212.37/212.57  |- mesh__recordOriginator mesh__D020350 NNS
% 212.37/212.57  |- mesh__historyNote mesh__D020350 99   
% 212.37/212.57  |- skos__hiddenLabel mesh__D020350 Response, Graft-vs-Neoplasm
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D020350 2006
% 212.37/212.57  |- mesh__dateCreated mesh__D020350 1998-06-10
% 212.37/212.57  |- rdf__type mesh__D020350sskos__Concept
% 212.37/212.57  |- skos__altLabel mesh__D020350 Graft-vs-Neoplasm Response
% 212.37/212.57  |- skos__hiddenLabel mesh__D020350 Responses, Graft-vs-Tumor
% 212.37/212.57  |- skos__prefLabel mesh__D020350 Graft vs Tumor Effect
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D020350 2005
% 212.37/212.57  |- skos__hiddenLabel mesh__D020350 Effect, Graft-vs-Neoplasm
% 212.37/212.57  |- mesh__recordAuthorizer mesh__D020350 sjn
% 212.37/212.57  |- skos__hiddenLabel mesh__D020350 Graft vs Tumor Response
% 212.37/212.57  |- mesh__recordMaintainer mesh__D020350 nns
% 212.37/212.57  |- skos__hiddenLabel mesh__D020350 Graft-vs-Tumor Effects
% 212.37/212.57  |- skos__hiddenLabel mesh__D020350 Graft-vs-Neoplasm Responses
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D020350 2004
% 212.37/212.57  |- mesh__publicMeSHNote mesh__D020350 99   
% 212.37/212.57  |- skos__scopeNote mesh__D020350
% 212.37/212.57       Immunological rejection of tumor tissue/cells following bone marrow transplantation.%A%    
% 212.37/212.57  |- skos__broader mesh__D020350smesh__D006087
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D020350 2002
% 212.37/212.57  |- skos__altLabel mesh__D020350 Graft-vs-Neoplasm Effect
% 212.37/212.57  |- mesh__dateEstablished mesh__D020350 1999-01-01
% 212.37/212.57  |- skos__hiddenLabel mesh__D020350 Responses, Graft-vs-Neoplasm
% 212.37/212.57  |- skos__hiddenLabel mesh__D020350 Response, Graft-vs-Tumor
% 212.37/212.57  |- skos__hiddenLabel mesh__D020350 Graft vs Neoplasm Response
% 212.37/212.57  |- skos__hiddenLabel mesh__D020350 Effects, Graft-vs-Tumor
% 212.37/212.57  |- skos__hiddenLabel mesh__D020350 Effect, Graft-vs-Tumor
% 212.37/212.57  |- skos__altLabel mesh__D020350 Graft-vs-Tumor Effect
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D020350 2003
% 212.37/212.57  |- skos__historyNote mesh__D020350 Graft vs Host Reaction %28%1973-1998%29%
% 212.37/212.57  |- mesh__dateRevised mesh__D020350 1999-11-03
% 212.37/212.57  |- skos__altLabel mesh__D020350 Graft-vs-Tumor Response
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D020350 2001
% 212.37/212.57  |- skos__hiddenLabel mesh__D020350 Graft-vs-Neoplasm Effects
% 212.37/212.57  |- skos__altLabel mesh__D020350 Graft vs Neoplasm Effect
% 212.37/212.57  |- mesh__recordAuthorizer mesh__D014313 sjn
% 212.37/212.57  |- mesh__recordOriginator mesh__D014313 NLM
% 212.37/212.57  |- mesh__dateCreated mesh__D014313 1999-01-01
% 212.37/212.57  |- skos__broader mesh__D014313smesh__D013035
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D014313 2006
% 212.37/212.57  |- skos__hiddenLabel mesh__D014313 Masseter Muscle Spasms
% 212.37/212.57  |- mesh__recordMaintainer mesh__D014313 ags
% 212.37/212.57  |- skos__altLabel mesh__D014313 Lock Jaw
% 212.37/212.57  |- skos__hiddenLabel mesh__D014313 Muscle Spasms, Masseter
% 212.37/212.57  |- skos__hiddenLabel mesh__D014313 Spasms, Masseter Muscle
% 212.37/212.57  |- skos__hiddenLabel mesh__D014313 Muscle Spasm, Masseter
% 212.37/212.57  |- mesh__dateRevised mesh__D014313 2005-06-30
% 212.37/212.57  |- skos__hiddenLabel mesh__D014313 Spasm, Masseter Muscle
% 212.37/212.57  |- skos__hiddenLabel mesh__D014313 Spasm, Masseter
% 212.37/212.57  |- skos__hiddenLabel mesh__D014313 Masseter Spasms
% 212.37/212.57  |- rdf__type mesh__D014313sskos__Concept
% 212.37/212.57  |- skos__related mesh__D014313smesh__D013742
% 212.37/212.57  |- skos__hiddenLabel mesh__D014313 Spasms, Masseter
% 212.37/212.57  |- skos__scopeNote mesh__D014313
% 212.37/212.57       Spasmodic contraction of the masseter muscle resulting in forceful jaw closure. This may be seen with a variety of diseases, including TETANUS, as a complication of radiation therapy, trauma, or in association with neoplastic conditions.%A%    
% 212.37/212.57  |- skos__prefLabel mesh__D014313 Trismus
% 212.37/212.57  |- skos__altLabel mesh__D014313 Masseter Spasm
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D038761 2003
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D038761 2005
% 212.37/212.57  |- mesh__dateCreated mesh__D038761 2002-07-03
% 212.37/212.57  |- rdf__type mesh__D038761sskos__Concept
% 212.37/212.57  |- skos__broader mesh__D038761smesh__D010777
% 212.37/212.57  |- skos__historyNote mesh__D038761 Photochemistry %28%1972-2002%29%
% 212.37/212.57  |- mesh__historyNote mesh__D038761 2003   
% 212.37/212.57  |- skos__scopeNote mesh__D038761
% 212.37/212.57       Light-induced change in a chromophore, resulting in the loss of its absorption of light of a particular wave length. The photon energy causes a conformational change in the photoreceptor proteins affecting PHOTOTRANSDUCTION. This occurs naturally in the retina %28%ADAPTATION, OCULAR%29% on long exposure to bright light. Photobleaching presents problems when occurring in PHOTODYNAMIC THERAPY, and in FLUORESCENCE MICROSCOPY. On the other hand, this phenomenon is exploited in the technique, FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, allowing measurement of the movements of proteins and LIPIDS in the CELL MEMBRANE.%A%    
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D038761 2004
% 212.37/212.57  |- skos__prefLabel mesh__D038761 Photobleaching
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D038761 2006
% 212.37/212.57  |- mesh__publicMeSHNote mesh__D038761 2003   
% 212.37/212.57  |- mesh__dateEstablished mesh__D038761 2003-01-01
% 212.37/212.57  |- mesh__historyNote mesh__D005587
% 212.37/212.57       94; was FOWL POX VIRUS 1975-93 %28%see under POXVIRIDAE 1981-89, see under POXVIRUSES 1975-80%29%%A%  
% 212.37/212.57  |- mesh__dateRevised mesh__D005587 2001-07-25
% 212.37/212.57  |- mesh__recordOriginator mesh__D005587 NLM
% 212.37/212.57  |- skos__prefLabel mesh__D005587 Fowlpox virus
% 212.37/212.57  |- mesh__dateCreated mesh__D005587 1974-12-12
% 212.37/212.57  |- skos__hiddenLabel mesh__D005587 Fowlpox viruses
% 212.37/212.57  |- rdf__type mesh__D005587sskos__Concept
% 212.37/212.57  |- skos__annotation mesh__D005587 infection = FOWLPOX: see note there   
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D005587 2005
% 212.37/212.57  |- mesh__recordAuthorizer mesh__D005587 sjn
% 212.37/212.57  |- mesh__onlineNote mesh__D005587
% 212.37/212.57       use FOWLPOX VIRUS to search FOWL POX VIRUS 1975-93   
% 212.37/212.57  |- mesh__dateEstablished mesh__D005587 1990-01-01
% 212.37/212.57  |- skos__hiddenLabel mesh__D005587 Fowl Pox Viruses
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D005587 2003
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D005587 2006
% 212.37/212.57  |- mesh__recordMaintainer mesh__D005587 ags
% 212.37/212.57  |- skos__broader mesh__D005587smesh__D018150
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D005587 2004
% 212.37/212.57  |- skos__altLabel mesh__D005587 Fowl Pox Virus
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D005587 2002
% 212.37/212.57  |- mesh__publicMeSHNote mesh__D005587
% 212.37/212.57       94; was FOWL POX VIRUS 1975-93 %28%see under POXVIRIDAE 1981-89, see under POXVIRUSES 1975-80%29%%A%  
% 212.37/212.57  |- skos__scopeNote mesh__D005587
% 212.37/212.57       The type species of the genus AVIPOXVIRUS. It is the etiologic agent of FOWLPOX.%A%    
% 212.37/212.57  |- skos__hiddenLabel mesh__D024741 Hypertrophic Cardiomyopathies, Familial
% 212.37/212.57  |- skos__altLabel mesh__D024741 Cardiomyopathy, Familial Hypertrophic
% 212.37/212.57  |- mesh__dateCreated mesh__D024741 2001-07-25
% 212.37/212.57  |- mesh__recordAuthorizer mesh__D024741 sjn
% 212.37/212.57  |- skos__hiddenLabel mesh__D024741 Familial Ventricular Hypertrophy
% 212.37/212.57  |- mesh__historyNote mesh__D024741 2002   
% 212.37/212.57  |- mesh__publicMeSHNote mesh__D024741 2002   
% 212.37/212.57  |- skos__altLabel mesh__D024741 Familial Hypertrophic Cardiomyopathy
% 212.37/212.57  |- mesh__recordMaintainer mesh__D024741 lkt
% 212.37/212.57  |- skos__broader mesh__D024741smesh__D002312
% 212.37/212.57  |- skos__hiddenLabel mesh__D024741 Familial Hypertrophic Cardiomyopathies
% 212.37/212.57  |- mesh__recordOriginator mesh__D024741 jmp
% 212.37/212.57  |- mesh__dateEstablished mesh__D024741 2002-01-01
% 212.37/212.57  |- skos__scopeNote mesh__D024741
% 212.37/212.57       An autosomal dominant inherited form of HYPERTROPHIC CARDIOMYOPATHY. It results from any of more than 50 mutations involving genes encoding contractile proteins such as VENTRICULAR MYOSINS; cardiac TROPONIN T; ALPHA-TROPOMYOSIN.%A%    
% 212.37/212.57  |- skos__altLabel mesh__D024741 Asymmetric Septal Hypertrophy, Familial
% 212.37/212.57  |- skos__altLabel mesh__D024741 Ventricular Hypertrophy, Familial
% 212.37/212.57  |- skos__prefLabel mesh__D024741 Cardiomyopathy, Hypertrophic, Familial
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D024741 2006
% 212.37/212.57  |- mesh__dateRevised mesh__D024741 2004-07-07
% 212.37/212.57  |- skos__hiddenLabel mesh__D024741 Hypertrophy, Familial Ventricular
% 212.37/212.57  |- skos__historyNote mesh__D024741
% 212.37/212.57       Cardiomyopathy, Hypertrophic/genetics %28%1983-2001%29%
% 212.37/212.57  |- skos__broader mesh__D024741smesh__D030342
% 212.37/212.57  |- rdf__type mesh__D024741sskos__Concept
% 212.37/212.57  |- skos__related mesh__D024741smesh__D020107
% 212.37/212.57  |- skos__related mesh__D024741smesh__D024723
% 212.37/212.57  |- skos__related mesh__D024741smesh__D014335
% 212.37/212.57  |- skos__hiddenLabel mesh__D024741 Hypertrophic Cardiomyopathy, Familial
% 212.37/212.57  |- skos__hiddenLabel mesh__D024741 Cardiomyopathies, Familial Hypertrophic
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D024741 2005
% 212.37/212.57  |- mesh__recordOriginator mesh__D010721 NLM
% 212.37/212.57  |- mesh__dateEstablished mesh__D010721 1965-01-01
% 212.37/212.57  |- skos__broader mesh__D010721smesh__D017976
% 212.37/212.57  |- rdf__type mesh__D010721sskos__Concept
% 212.37/212.57  |- mesh__publicMeSHNote mesh__D010721 65; was PHOSPHINIC ACID 1963-64   
% 212.37/212.57  |- skos__prefLabel mesh__D010721 Phosphinic Acids
% 212.37/212.57  |- mesh__recordMaintainer mesh__D010721 CCR
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D010721 2004
% 212.37/212.57  |- skos__hiddenLabel mesh__D010721 Acids, Hypophosphorous
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D010721 2003
% 212.37/212.57  |- skos__altLabel mesh__D010721 Hypophosphorous Acids
% 212.37/212.57  |- mesh__dateRevised mesh__D010721 2000-06-21
% 212.37/212.57  |- skos__broader mesh__D010721smesh__D009943
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D010721 2006
% 212.37/212.57  |- skos__scopeNote mesh__D010721
% 212.37/212.57       Inorganic or organic derivatives of phosphinic acid, H2PO%28%OH%29%. They include phosphinates and phosphinic acid esters.%A%    
% 212.37/212.57  |- skos__hiddenLabel mesh__D010721 Acid, Phosphinic
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D010721 2002
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D010721 2005
% 212.37/212.57  |- skos__hiddenLabel mesh__D010721 Acids, Phosphinic
% 212.37/212.57  |- mesh__dateCreated mesh__D010721 1999-01-01
% 212.37/212.57  |- mesh__recordAuthorizer mesh__D010721 sjn
% 212.37/212.57  |- mesh__historyNote mesh__D010721 65; was PHOSPHINIC ACID 1963-64   
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D010721 2001
% 212.37/212.57  |- skos__annotation mesh__D010721 do not confuse with PHOSPHONIC ACIDS   
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D018704 1998
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D018704 2002
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D018704 1997
% 212.37/212.57  |- skos__prefLabel mesh__D018704 Orthodontic Retainers
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D018704 1999
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D018704 2003
% 212.37/212.57  |- mesh__historyNote mesh__D018704 95   
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D018704 2000
% 212.37/212.57  |- skos__altLabel mesh__D018704 Retainers, Orthodontic
% 212.37/212.57  |- skos__scopeNote mesh__D018704
% 212.37/212.57       Orthodontic appliances, fixed or removable, used to maintain teeth in corrected positions during the period of functional adaptation following corrective treatment. These appliances are also used to maintain the positions of the teeth and jaws gained by orthodontic procedures. %28%From Zwemer, Boucher%27%s Clinical Dental Terminology, 4th ed, p263%29%%A%    
% 212.37/212.57  |- mesh__publicMeSHNote mesh__D018704 95   
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D018704 2005
% 212.37/212.57  |- skos__hiddenLabel mesh__D018704 Retainer, Orthodontic
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D018704 2004
% 212.37/212.57  |- skos__broader mesh__D018704smesh__D009967
% 212.37/212.57  |- mesh__dateEstablished mesh__D018704 1995-01-01
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D018704 2001
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D018704 1995
% 212.37/212.57  |- mesh__dateCreated mesh__D018704 1994-05-23
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D018704 2006
% 212.37/212.57  |- skos__hiddenLabel mesh__D018704 Orthodontic Retainer
% 212.37/212.57  |- rdf__type mesh__D018704sskos__Concept
% 212.37/212.57  |- skos__historyNote mesh__D018704 Orthodontic Appliances %28%1966-1994%29%
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D018704 1996
% 212.37/212.57  |- mesh__dateCreated mesh__D001995 1999-01-01
% 212.37/212.57  |- rdf__type mesh__D001995sskos__Concept
% 212.37/212.57  |- mesh__dateEstablished mesh__D001995 1964-01-01
% 212.37/212.57  |- mesh__dateRevised mesh__D001995 1997-06-20
% 212.37/212.57  |- mesh__recordAuthorizer mesh__D001995 SJN
% 212.37/212.57  |- mesh__recordOriginator mesh__D001995 NLM
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001995 2006
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001995 1999
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001995 2005
% 212.37/212.57  |- skos__broader mesh__D001995smesh__D003948
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001995 1998
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001995 2002
% 212.37/212.57  |- skos__annotation mesh__D001995
% 212.37/212.57       NIM; do not use /util except by MeSH definition; DF: BRONCHOGR%A%  
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001995 2004
% 212.37/212.57  |- mesh__recordMaintainer mesh__D001995 PXP
% 212.37/212.57  |- skos__broader mesh__D001995smesh__D013902
% 212.37/212.57  |- skos__hiddenLabel mesh__D001995 Bronchographies
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001995 2001
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001995 2003
% 212.37/212.57  |- skos__scopeNote mesh__D001995
% 212.37/212.57       Radiography of the bronchial tree after injection of a contrast medium.%A%    
% 212.37/212.57  |- skos__prefLabel mesh__D001995 Bronchography
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001995 2000
% 212.37/212.57  |- mesh__publicMeSHNote mesh__D001995 64   
% 212.37/212.57  |- mesh__historyNote mesh__D001995 64%28%63%29%   
% 212.37/212.57  |- mesh__recordAuthorizer mesh__D001197 sjn
% 212.37/212.57  |- mesh__dateRevised mesh__D001197 2003-07-09
% 212.37/212.57  |- skos__annotation mesh__D001197
% 212.37/212.57       a genus of nematodes; do not confuse with the order ASCARIDIDA; infection = ASCARIDIASIS %28%do not confuse with ASCARIASIS or ACARIASIS%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 212.37/212.57  |- mesh__recordOriginator mesh__D001197 NLM
% 212.37/212.57  |- skos__historyNote mesh__D001197 Nematoda %28%1966-1971%29%
% 212.37/212.57  |- mesh__historyNote mesh__D001197 72   
% 212.37/212.57  |- mesh__recordMaintainer mesh__D001197 ags
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001197 2005
% 212.37/212.57  |- skos__broader mesh__D001197smesh__D001199
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001197 2006
% 212.37/212.57  |- mesh__dateEstablished mesh__D001197 1972-01-01
% 212.37/212.57  |- mesh__dateCreated mesh__D001197 1999-01-01
% 212.37/212.57  |- skos__prefLabel mesh__D001197 Ascaridia
% 212.37/212.57  |- mesh__publicMeSHNote mesh__D001197 72   
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D001197 2004
% 212.37/212.57  |- skos__scopeNote mesh__D001197
% 212.37/212.57       A genus of nematode worms. A. galli and A. lineata are important intestinal parasites of domestic fowl.%A%    
% 212.37/212.57  |- rdf__type mesh__D001197sskos__Concept
% 212.37/212.57  |- mesh__dateCreated mesh__D042803 2003-07-09
% 212.37/212.57  |- mesh__dateRevised mesh__D042803 2005-06-30
% 212.37/212.57  |- mesh__dateEstablished mesh__D042803 2004-01-01
% 212.37/212.57  |- skos__prefLabel mesh__D042803 Herbaspirillum
% 212.37/212.57  |- skos__broader mesh__D042803smesh__D042802
% 212.37/212.57  |- mesh__publicMeSHNote mesh__D042803 2004   
% 212.37/212.57  |- mesh__recordOriginator mesh__D042803 ags
% 212.37/212.57  |- rdf__type mesh__D042803sskos__Concept
% 212.37/212.57  |- mesh__historyNote mesh__D042803 2004   
% 212.37/212.57  |- mesh__activeMeSHYear mesh__D042803 2006
% 212.37/212.57  |- mesh__recordMaintainer mesh__D042803 SYSTEM
% 212.37/212.57  |- skos__scopeNote mesh__D042803
% 212.37/212.57       A genus of gram-negative bacteria in the family OXALOBACTERACEAE, comprised of vibrioid or sometimes helical cells. They are chemoorganotrophic nitrogen fixers and are found free-living in the soil or in association with the roots of members of the GRAMINEAE. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 212.37/212.57  |- mesh__recordAuthorizer mesh__D042803 sjn
% 212.37/212.57  |- skos__historyNote mesh__D042803 Betaproteobacteria %28%1998-2003%29%
% 212.37/212.57  |- skos__historyNote mesh__D006680 Histocompatibility %28%1970-1972%29%
% 212.37/212.57  |- mesh__recordOriginator mesh__D006680 SH
% 212.37/212.58  |- skos__hiddenLabel mesh__D006680 Antigens, HLA
% 212.37/212.58  |- skos__historyNote mesh__D006680
% 212.37/212.58       Histocompatibility Antigens %28%1973-1974%29%
% 212.37/212.58  |- skos__hiddenLabel mesh__D006680 Antigens, Human Leukocyte
% 212.37/212.58  |- skos__altLabel mesh__D006680 Leukocyte Antigens
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D006680 2006
% 212.37/212.58  |- skos__scopeNote mesh__D006680
% 212.37/212.58       Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases.%A%    
% 212.37/212.58  |- skos__altLabel mesh__D006680 Human Leukocyte Antigens
% 212.37/212.58  |- skos__prefLabel mesh__D006680 HLA Antigens
% 212.37/212.58  |- skos__broader mesh__D006680smesh__D006649
% 212.37/212.58  |- mesh__recordAuthorizer mesh__D006680 sjn
% 212.37/212.58  |- mesh__dateRevised mesh__D006680 2005-06-30
% 212.37/212.58  |- skos__hiddenLabel mesh__D006680 HL A Antigens
% 212.37/212.58  |- skos__hiddenLabel mesh__D006680 Antigens, HL-A
% 212.37/212.58  |- skos__hiddenLabel mesh__D006680 Leukocyte Antigens, Human
% 212.37/212.58  |- skos__altLabel mesh__D006680 HL-A Antigens
% 212.37/212.58  |- skos__annotation mesh__D006680
% 212.37/212.58       human only, standing for Human Leukocyte Antigen; assoc with tissue types in transpl %26% with various dis; GEN or unspecified; prefer specifics; HLA goes here; DF: HLA%A%  
% 212.37/212.58  |- rdf__type mesh__D006680sskos__Concept
% 212.37/212.58  |- skos__hiddenLabel mesh__D006680 Antigens, Leukocyte
% 212.37/212.58  |- mesh__publicMeSHNote mesh__D006680
% 212.37/212.58       82; was HL-A ANTIGENS 1978-81; was HL-A see under HISTOCOMPATIBILITY ANTIGENS 1974-77%A%  
% 212.37/212.58  |- mesh__recordMaintainer mesh__D006680 ssb
% 212.37/212.58  |- mesh__dateEstablished mesh__D006680 1978-01-01
% 212.37/212.58  |- mesh__dateCreated mesh__D006680 1977-03-29
% 212.37/212.58  |- mesh__onlineNote mesh__D006680
% 212.37/212.58       use HLA ANTIGENS to search HL-A ANTIGENS 1978-81 and HL-A 1975-77; use HISTOCOMPATIBILITY ANTIGENS to search HL-A 1974%A%  
% 212.37/212.58  |- mesh__historyNote mesh__D006680
% 212.37/212.58       82; was HL-A ANTIGENS 1978-81; was HL-A see under HISTOCOMPATIBILITY ANTIGENS 1974-77%A%  
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D020351 2005
% 212.37/212.58  |- skos__historyNote mesh__D020351 Oxaloacetates %28%1981-1998%29%
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D020351 2006
% 212.37/212.58  |- skos__scopeNote mesh__D020351
% 212.37/212.58       A class of ketodicarboxylic acids derived from oxalic acid. Oxaloacetic acid is an intermediate in the citric acid cycle and is converted to ASPARTIC ACID by a transamination reaction.%A%    
% 212.37/212.58  |- rdf__type mesh__D020351sskos__Concept
% 212.37/212.58  |- mesh__recordMaintainer mesh__D020351 jmp
% 212.37/212.58  |- skos__broader mesh__D020351smesh__D019816
% 212.37/212.58  |- mesh__dateEstablished mesh__D020351 1999-01-01
% 212.37/212.58  |- skos__prefLabel mesh__D020351 Oxaloacetic Acids
% 212.37/212.58  |- mesh__historyNote mesh__D020351
% 212.37/212.58       99; use OXALOACETIC ACIDS %28%NM%29% 1981-98   
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D020351 2003
% 212.37/212.58  |- skos__altLabel mesh__D020351 Oxalacetic Acid
% 212.37/212.58  |- mesh__recordOriginator mesh__D020351 ADP
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D020351 2004
% 212.37/212.58  |- mesh__publicMeSHNote mesh__D020351
% 212.37/212.58       99; OXALACETIC ACID %28%now OXALOACETIC ACIDS%29% was indexed under OXALOACETATES 1981-98%A%  
% 212.37/212.58  |- mesh__dateCreated mesh__D020351 1998-06-10
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D020351 2002
% 212.37/212.58  |- skos__broader mesh__D020351smesh__D007651
% 212.37/212.58  |- mesh__dateRevised mesh__D020351 2001-07-25
% 212.37/212.58  |- mesh__recordAuthorizer mesh__D020351 sjn
% 212.37/212.58  |- skos__hiddenLabel mesh__D014314 Trisomies
% 212.37/212.58  |- skos__scopeNote mesh__D014314
% 212.37/212.58       The possession of a third chromosome of any one type in an otherwise diploid cell.%A%    
% 212.37/212.58  |- mesh__dateRevised mesh__D014314 2003-07-09
% 212.37/212.58  |- skos__broader mesh__D014314smesh__D000782
% 212.37/212.58  |- skos__prefLabel mesh__D014314 Trisomy
% 212.37/212.58  |- skos__annotation mesh__D014314
% 212.37/212.58       coord IM with specific chromosome number %28%IM%29%; trisomy 21 = DOWN SYNDROME%A%  
% 212.37/212.58  |- mesh__dateEstablished mesh__D014314 1964-01-01
% 212.37/212.58  |- rdf__type mesh__D014314sskos__Concept
% 212.37/212.58  |- mesh__recordAuthorizer mesh__D014314 sjn
% 212.37/212.58  |- mesh__recordOriginator mesh__D014314 NLM
% 212.37/212.58  |- mesh__publicMeSHNote mesh__D014314 64   
% 212.37/212.58  |- mesh__recordMaintainer mesh__D014314 nns
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D014314 2004
% 212.37/212.58  |- mesh__historyNote mesh__D014314 64%28%63%29%   
% 212.37/212.58  |- mesh__dateCreated mesh__D014314 1999-01-01
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D014314 2006
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D014314 2005
% 212.37/212.58  |- mesh__recordMaintainer mesh__D038762 jmp
% 212.37/212.58  |- mesh__dateEstablished mesh__D038762 2003-01-01
% 212.37/212.58  |- mesh__recordOriginator mesh__D038762 jmp
% 212.37/212.58  |- skos__altLabel mesh__D038762 p70s6k
% 212.37/212.58  |- rdf__type mesh__D038762sskos__Concept
% 212.37/212.58  |- mesh__publicMeSHNote mesh__D038762
% 212.37/212.58       2005;  see RIBOSOMAL PROTEIN S6 KINASES, 70 KD 2003-2004; for P70 S6 KINASE %26% P70S6K see RIBOSOMAL PROTEIN S6 KINASES 1998-2002%A%  
% 212.37/212.58  |- mesh__historyNote mesh__D038762
% 212.37/212.58       2005%28%2003%29%; for P70 S6 KINASE %26% P70S6K use RIBOSOMAL PROTEIN S6 KINASES 1998-2002%A%  
% 212.37/212.58  |- skos__historyNote mesh__D038762
% 212.37/212.58       Ribosomal Protein S6 Kinases %28%1990-2002%29%
% 212.37/212.58  |- mesh__dateCreated mesh__D038762 2002-07-03
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D038762 2005
% 212.37/212.58  |- mesh__dateRevised mesh__D038762 2004-07-07
% 212.37/212.58  |- skos__altLabel mesh__D038762 p70 S6 Kinase
% 212.37/212.58  |- mesh__recordAuthorizer mesh__D038762 sjn
% 212.37/212.58  |- skos__scopeNote mesh__D038762
% 212.37/212.58       A family of ribosomal protein S6 kinases that are considered the major physiological kinases for RIBOSOMAL PROTEIN S6. Unlike RIBOSOMAL PROTEIN S6 KINASES, 90KDa the proteins in this family are sensitive to the inhibitory effects of RAPAMYCIN and contain a single kinase domain. They are referred to as 70kDa proteins, however ALTERNATIVE SPLICING of mRNAs for proteins in this class also results in 85kDa variants being formed.%A%    
% 212.37/212.58  |- skos__hiddenLabel mesh__D038762 S6 Kinase, p70
% 212.37/212.58  |- skos__hiddenLabel mesh__D038762 Ribosomal Protein S6 Kinases, 70 kDa
% 212.37/212.58  |- skos__prefLabel mesh__D038762 Ribosomal Protein S6 Kinases, 70-kDa
% 212.37/212.58  |- skos__broader mesh__D038762smesh__D019893
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D038762 2006
% 212.37/212.58  |- rdf__type mesh__D005588sskos__Concept
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D005588 2005
% 212.37/212.58  |- skos__altLabel mesh__D005588 Miliaria, Apocrine
% 212.37/212.58  |- skos__prefLabel mesh__D005588 Fox-Fordyce Disease
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D005588 2006
% 212.37/212.58  |- mesh__dateCreated mesh__D005588 1999-01-01
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D005588 2003
% 212.37/212.58  |- skos__hiddenLabel mesh__D005588 Fox Fordyce Disease
% 212.37/212.58  |- mesh__dateRevised mesh__D005588 2001-07-25
% 212.37/212.58  |- mesh__recordOriginator mesh__D005588 NLM
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D005588 2004
% 212.37/212.58  |- mesh__recordAuthorizer mesh__D005588 sjn
% 212.37/212.58  |- skos__annotation mesh__D005588 pruritic apocrine dis in women   
% 212.37/212.58  |- skos__hiddenLabel mesh__D005588 Disease, Fox-Fordyce
% 212.37/212.58  |- mesh__recordMaintainer mesh__D005588 lkt
% 212.37/212.58  |- skos__broader mesh__D005588smesh__D008883
% 212.37/212.58  |- skos__hiddenLabel mesh__D005588 Apocrine Miliaria
% 212.37/212.58  |- skos__scopeNote mesh__D005588
% 212.37/212.58       Chronic pruritic disease, usually in women, characterized by small follicular papular eruptions in apocrine areas. It is caused by obstruction and rupture of intraepidermal apocrine ducts. %28%From Dorland, 27th ed%29%%A%    
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D005588 2002
% 212.37/212.58  |- skos__hiddenLabel mesh__D024742 High Mobility Group Box Domains
% 212.37/212.58  |- skos__historyNote mesh__D024742
% 212.37/212.58       High Mobility Group Proteins %28%1991-2001%29%
% 212.37/212.58  |- mesh__publicMeSHNote mesh__D024742 2002   
% 212.37/212.58  |- skos__altLabel mesh__D024742 High Mobility Group-Box Domains
% 212.37/212.58  |- mesh__recordOriginator mesh__D024742 nns
% 212.37/212.58  |- mesh__dateEstablished mesh__D024742 2002-01-01
% 212.37/212.58  |- mesh__recordAuthorizer mesh__D024742 sjn
% 212.37/212.58  |- mesh__historyNote mesh__D024742 2002   
% 212.37/212.58  |- skos__hiddenLabel mesh__D024742 HMG-1-Box Domains
% 212.37/212.58  |- skos__hiddenLabel mesh__D024742 Domains, HMG-1-Box
% 212.37/212.58  |- mesh__recordMaintainer mesh__D024742 nns
% 212.37/212.58  |- skos__hiddenLabel mesh__D024742 HMG-Box Domain
% 212.37/212.58  |- mesh__dateCreated mesh__D024742 2001-08-03
% 212.37/212.58  |- skos__hiddenLabel mesh__D024742 HMG 1 Box Domain
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D024742 2006
% 212.37/212.58  |- skos__prefLabel mesh__D024742 HMG-Box Domains
% 212.37/212.58  |- mesh__dateRevised mesh__D024742 2004-07-07
% 212.37/212.58  |- skos__hiddenLabel mesh__D024742 Domain, HMG-Box
% 212.37/212.58  |- skos__hiddenLabel mesh__D024742 Domain, HMG-1-Box
% 212.37/212.58  |- skos__altLabel mesh__D024742 HMG-1-Box Domain
% 212.37/212.58  |- rdf__type mesh__D024742sskos__Concept
% 212.37/212.58  |- skos__scopeNote mesh__D024742
% 212.37/212.58       DNA-binding domains present in proteins of the HMG-box superfamily including the archetypal HMGB PROTEINS, a number of sequence specific TRANSCRIPTION FACTORS, and other DNA-BINDING PROTEINS.  The domains consist of 70-80 amino acids that form an L-shaped fold from three alpha-helical segments. The domain has the capacity to recognize and/or induce specific DNA structures and effect the accessibility of the DNA to other proteins involved in transcription, recombination, or DNA repair. %28%Note that not all HIGH MOBILITY GROUP PROTEINS contain this domain.%29%%A%    
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D024742 2005
% 212.37/212.58  |- skos__annotation mesh__D024742
% 212.37/212.58       HIGH MOBILITY GROUP PROTEINS is also available   
% 212.37/212.58  |- skos__hiddenLabel mesh__D024742 HMG Box Domains
% 212.37/212.58  |- skos__hiddenLabel mesh__D024742 Domains, HMG-Box
% 212.37/212.58  |- skos__broader mesh__D024742smesh__D017434
% 212.37/212.58  |- rdf__type mesh__D001996sskos__Concept
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001996 2005
% 212.37/212.58  |- skos__broader mesh__D001996smesh__D011014
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001996 2001
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001996 1998
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001996 1995
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001996 2006
% 212.37/212.58  |- skos__hiddenLabel mesh__D001996 Bronchopneumonias
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001996 1999
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001996 2003
% 212.37/212.58  |- skos__prefLabel mesh__D001996 Bronchopneumonia
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001996 1996
% 212.37/212.58  |- mesh__dateRevised mesh__D001996 1994-05-27
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001996 2002
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001996 2004
% 212.37/212.58  |- mesh__dateCreated mesh__D001996 1999-01-01
% 212.37/212.58  |- mesh__recordOriginator mesh__D001996 NLM
% 212.37/212.58  |- mesh__recordMaintainer mesh__D001996 PXP
% 212.37/212.58  |- skos__broader mesh__D001996smesh__D001982
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001996 1997
% 212.37/212.58  |- mesh__recordAuthorizer mesh__D001996 PLS
% 212.37/212.58  |- skos__annotation mesh__D001996
% 212.37/212.58       do not make a diagnosis: use term as used by author   
% 212.37/212.58  |- skos__scopeNote mesh__D001996
% 212.37/212.58       Acute inflammation of the walls of the smaller bronchial tubes, with varying amounts of pulmonary consolidation due to spread of the inflammation into peribronchiolar alveoli and the alveolar ducts. %28%Stedman, 25th ed%29%%A%    
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001996 2000
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001198 1994
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001198 2000
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001198 2001
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001198 1995
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001198 2005
% 212.37/212.58  |- mesh__dateRevised mesh__D001198 1993-06-04
% 212.37/212.58  |- mesh__historyNote mesh__D001198
% 212.37/212.58       91%28%75%29%; was see under NEMATODE INFECTIONS 1979-90; was see under ASCARIASIS 1968-78%A%  
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001198 2002
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001198 1998
% 212.37/212.58  |- mesh__recordOriginator mesh__D001198 NLM
% 212.37/212.58  |- skos__hiddenLabel mesh__D001198 Ascaridiases
% 212.37/212.58  |- mesh__publicMeSHNote mesh__D001198
% 212.37/212.58       91; was see under NEMATODE INFECTIONS 1979-90; was see under ASCARIASIS 1968-78%A%  
% 212.37/212.58  |- skos__prefLabel mesh__D001198 Ascaridiasis
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001198 2003
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001198 2006
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001198 1996
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001198 1999
% 212.37/212.58  |- mesh__dateCreated mesh__D001198 1999-01-01
% 212.37/212.58  |- mesh__onlineNote mesh__D001198 search ASCARIASIS 1968-74   
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001198 2004
% 212.37/212.58  |- mesh__recordMaintainer mesh__D001198 JLS
% 212.37/212.58  |- skos__scopeNote mesh__D001198
% 212.37/212.58       Infection with nematodes of the genus ASCARIDIA. This condition usually occurs in fowl, often manifesting diarrhea.%A%    
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001198 1997
% 212.37/212.58  |- rdf__type mesh__D001198sskos__Concept
% 212.37/212.58  |- mesh__dateEstablished mesh__D001198 1991-01-01
% 212.37/212.58  |- skos__broader mesh__D001198smesh__D017191
% 212.37/212.58  |- mesh__recordAuthorizer mesh__D001198 PLS
% 212.37/212.58  |- skos__annotation mesh__D001198
% 212.37/212.58       nematode infect caused by ASCARIDIA; do not confuse with ASCARIASIS %28%caused by ASCARIS%29% or ACARIASIS %28%caused by ACARI or ACARUS%29% or with ASCARIDIDA INFECTIONS%A%  
% 212.37/212.58  |- mesh__dateCreated mesh__D042804 2003-07-09
% 212.37/212.58  |- mesh__recordAuthorizer mesh__D042804 sjn
% 212.37/212.58  |- skos__broader mesh__D042804smesh__D009343
% 212.37/212.58  |- rdf__type mesh__D042804sskos__Concept
% 212.37/212.58  |- skos__prefLabel mesh__D042804 Neisseria cinerea
% 212.37/212.58  |- mesh__publicMeSHNote mesh__D042804 2004   
% 212.37/212.58  |- mesh__dateRevised mesh__D042804 2005-06-30
% 212.37/212.58  |- mesh__dateEstablished mesh__D042804 2004-01-01
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D042804 2006
% 212.37/212.58  |- mesh__recordMaintainer mesh__D042804 SYSTEM
% 212.37/212.58  |- skos__annotation mesh__D042804
% 212.37/212.58       infection: coord IM with NEISSERIACEAE INFECTIONS %28%IM%29%   
% 212.37/212.58  |- mesh__recordOriginator mesh__D042804 ags
% 212.37/212.58  |- skos__historyNote mesh__D042804 Neisseria %28%1980-2003%29%
% 212.37/212.58  |- mesh__historyNote mesh__D042804 2004   
% 212.37/212.58  |- skos__scopeNote mesh__D042804
% 212.37/212.58       A species of gram-negative, aerobic bacteria found in the human NASOPHARYNX.%A%    
% 212.37/212.58  |- skos__hiddenLabel mesh__D006681 Antigens, HLA D
% 212.37/212.58  |- skos__altLabel mesh__D006681 Immune Response Associated Antigens, Human
% 212.37/212.58  |- skos__broader mesh__D006681smesh__D000949
% 212.37/212.58  |- mesh__recordOriginator mesh__D006681 SH
% 212.37/212.58  |- skos__hiddenLabel mesh__D006681 Antigens, HLA-Dw
% 212.37/212.58  |- skos__altLabel mesh__D006681 Antigens, HLA-D
% 212.37/212.58  |- skos__broader mesh__D006681smesh__D006680
% 212.37/212.58  |- skos__altLabel mesh__D006681 Immune-Associated Antigens, Human
% 212.37/212.58  |- skos__scopeNote mesh__D006681
% 212.37/212.58       Human immune-response or Class II antigens found mainly, but not exclusively, on B-lymphocytes and produced from genes of the HLA-D locus. They are extremely polymorphic families of glycopeptides, each consisting of two chains, alpha and beta. This group of antigens includes the -DR, -DQ and -DP designations, of which HLA-DR is most studied; some of these glycoproteins are associated with certain diseases, possibly of immune etiology.%A%    
% 212.37/212.58  |- mesh__recordMaintainer mesh__D006681 ssb
% 212.37/212.58  |- mesh__onlineNote mesh__D006681
% 212.37/212.58       search HISTOCOMPATIBILITY ANTIGENS CLASS II 1981-86   
% 212.37/212.58  |- skos__altLabel mesh__D006681 HLA-Dw
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D006681 2006
% 212.37/212.58  |- skos__hiddenLabel mesh__D006681 Human Ia-Like Antigens
% 212.37/212.58  |- mesh__dateCreated mesh__D006681 1986-06-25
% 212.37/212.58  |- mesh__historyNote mesh__D006681
% 212.37/212.58       87; was see ANTIGENS, IMMUNE RESPONSE 1981-86   
% 212.37/212.58  |- mesh__recordAuthorizer mesh__D006681 sjn
% 212.37/212.58  |- mesh__publicMeSHNote mesh__D006681
% 212.37/212.58       87; was see ANTIGENS, IMMUNE RESPONSE 1981-86   
% 212.37/212.58  |- skos__historyNote mesh__D006681
% 212.37/212.58       Antigens, Immune Response %28%1981-1986%29%
% 212.37/212.58  |- skos__hiddenLabel mesh__D006681 HLA D Antigens
% 212.37/212.58  |- rdf__type mesh__D006681sskos__Concept
% 212.37/212.58  |- skos__altLabel mesh__D006681 Immune-Response Antigens, Human
% 212.37/212.58  |- skos__altLabel mesh__D006681 HLA-D
% 212.37/212.58  |- skos__hiddenLabel mesh__D006681 Human Immune-Response Antigens
% 212.37/212.58  |- mesh__dateEstablished mesh__D006681 1987-01-01
% 212.37/212.58  |- skos__hiddenLabel mesh__D006681 Antigens, Human Immune-Associated
% 212.37/212.58  |- skos__prefLabel mesh__D006681 HLA-D Antigens
% 212.37/212.58  |- skos__altLabel mesh__D006681 Human Class II Antigens
% 212.37/212.58  |- skos__altLabel mesh__D006681 Class II Human Antigens
% 212.37/212.58  |- skos__altLabel mesh__D006681 Ia-Like Antigens, Human
% 212.37/212.58  |- skos__hiddenLabel mesh__D006681 Antigens, Human Immune-Response
% 212.37/212.58  |- skos__hiddenLabel mesh__D006681 Immune Response Antigens, Human
% 212.37/212.58  |- skos__hiddenLabel mesh__D006681 Immune Associated Antigens, Human
% 212.37/212.58  |- mesh__dateRevised mesh__D006681 2005-06-30
% 212.37/212.58  |- skos__altLabel mesh__D006681 HLA-Dw Antigens
% 212.37/212.58  |- skos__annotation mesh__D006681
% 212.37/212.58       assoc with possibly immune dis; GEN; prefer specifics; DF: HLA D%A%  
% 212.37/212.58  |- skos__hiddenLabel mesh__D006681 HLA Dw Antigens
% 212.37/212.58  |- skos__hiddenLabel mesh__D006681 Ia Like Antigens, Human
% 212.37/212.58  |- skos__hiddenLabel mesh__D006681 Antigens, Human Ia-Like
% 212.37/212.58  |- skos__altLabel mesh__D006681 Immune Response-Associated Antigens, Human
% 212.37/212.58  |- skos__hiddenLabel mesh__D006681 Human Immune-Associated Antigens
% 212.37/212.58  |- rdf__type mesh__D020352sskos__Concept
% 212.37/212.58  |- skos__prefLabel mesh__D020352 Oxaloacetate
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D020352 2003
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D020352 1999
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D020352 2000
% 212.37/212.58  |- mesh__historyNote mesh__D020352
% 212.37/212.58       99; use OXALOACETIC ACID %28%NM%29% 1981-98   
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D020352 2004
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D020352 2001
% 212.37/212.58  |- mesh__dateEstablished mesh__D020352 1999-01-01
% 212.37/212.58  |- skos__broader mesh__D020352smesh__D010071
% 212.37/212.58  |- skos__scopeNote mesh__D020352 An anionic form of oxaloacetic acid.     
% 212.37/212.58  |- skos__annotation mesh__D020352 OXALOACETATES is also available   
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D020352 2005
% 212.37/212.58  |- mesh__publicMeSHNote mesh__D020352
% 212.37/212.58       99; OXALOACETATE was indexed under OXALOACETATES 1982-98   
% 212.37/212.58  |- mesh__dateCreated mesh__D020352 1998-06-10
% 212.37/212.58  |- skos__historyNote mesh__D020352 Oxaloacetates %28%1981-1998%29%
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D020352 2002
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D020352 2006
% 212.37/212.58  |- skos__broader mesh__D014315smesh__D013729
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D014315 2002
% 212.37/212.58  |- mesh__historyNote mesh__D014315 74   
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D014315 2005
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D014315 1994
% 212.37/212.58  |- mesh__publicMeSHNote mesh__D014315 74   
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D014315 1997
% 212.37/212.58  |- mesh__dateEstablished mesh__D014315 1974-01-01
% 212.37/212.58  |- mesh__recordOriginator mesh__D014315 NLM
% 212.37/212.58  |- rdf__type mesh__D014315sskos__Concept
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D014315 1996
% 212.37/212.58  |- skos__prefLabel mesh__D014315 Triterpenes
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D014315 2001
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D014315 2004
% 212.37/212.58  |- mesh__dateCreated mesh__D014315 1999-01-01
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D014315 1993
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D014315 2000
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D014315 1999
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D014315 2003
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D014315 1998
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D014315 2006
% 212.37/212.58  |- mesh__recordMaintainer mesh__D014315 TAP
% 212.37/212.58  |- mesh__recordAuthorizer mesh__D014315 PLS
% 212.37/212.58  |- mesh__dateRevised mesh__D014315 1992-05-20
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D014315 1995
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D019000 2005
% 212.37/212.58  |- skos__broader mesh__D019000smesh__D019606
% 212.37/212.58  |- skos__scopeNote mesh__D019000
% 212.37/212.58       An amino acid that occurs in endogenous proteins. Tyrosine phosphorylation and dephosphorylation plays a role in cellular signal transduction and possibly in cell growth control and carcinogenesis.%A%    
% 212.37/212.58  |- skos__hiddenLabel mesh__D019000 Tyrosine O phosphate
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D019000 2004
% 212.37/212.58  |- mesh__recordMaintainer mesh__D019000 nns
% 212.37/212.58  |- skos__broader mesh__D019000smesh__D014443
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D019000 2002
% 212.37/212.58  |- skos__historyNote mesh__D019000
% 212.37/212.58       Tyrosine/analogs %26% derivatives %28%1980-1995%29%
% 212.37/212.58  |- mesh__publicMeSHNote mesh__D019000
% 212.37/212.58       96; PHOSPHOTYROSINE was indexed under TYROSINE/analogs %26% derivatives 1980-95%A%  
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D019000 2003
% 212.37/212.58  |- skos__altLabel mesh__D019000 Tyrosine-O-phosphate
% 212.37/212.58  |- mesh__dateRevised mesh__D019000 2001-07-25
% 212.37/212.58  |- skos__annotation mesh__D019000
% 212.37/212.58       an amino acid; /biosyn /drug eff /physiol permitted   
% 212.37/212.58  |- mesh__recordAuthorizer mesh__D019000 sjn
% 212.37/212.58  |- mesh__historyNote mesh__D019000
% 212.37/212.58       96; was PHOSPHOTYROSINE %28%NM%29% 1980-95   
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D019000 2006
% 212.37/212.58  |- mesh__dateCreated mesh__D019000 1995-06-05
% 212.37/212.58  |- rdf__type mesh__D019000sskos__Concept
% 212.37/212.58  |- mesh__onlineNote mesh__D019000
% 212.37/212.58       use PHOSPHOTYROSINE %28%NM%29% to search PHOSPHOTYROSINE 1980-95%A%  
% 212.37/212.58  |- mesh__dateEstablished mesh__D019000 1996-01-01
% 212.37/212.58  |- mesh__recordOriginator mesh__D019000 TPW
% 212.37/212.58  |- skos__prefLabel mesh__D019000 Phosphotyrosine
% 212.37/212.58  |- mesh__publicMeSHNote mesh__D005589 68   
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D005589 2005A
% 212.37/212.58  |- mesh__dateEstablished mesh__D005589 1968-01-01
% 212.37/212.58  |- mesh__recordAuthorizer mesh__D005589 jls
% 212.37/212.58  |- skos__hiddenLabel mesh__D005589 Fox, Arctic
% 212.37/212.58  |- skos__historyNote mesh__D005589 Carnivora %28%1966-1967%29%
% 212.37/212.58  |- mesh__recordMaintainer mesh__D005589 jls
% 212.37/212.58  |- skos__scopeNote mesh__D005589
% 212.37/212.58       Any of several carnivores in the family CANIDAE, that possess erect ears and long bushy tails and are smaller than WOLVES. They are classified in several genera and found on all continents except Antarctica.%A%    
% 212.37/212.58  |- skos__prefLabel mesh__D005589 Foxes
% 212.37/212.58  |- rdf__type mesh__D005589sskos__Concept
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D005589 2005
% 212.37/212.58  |- skos__broader mesh__D005589smesh__D046028
% 212.37/212.58  |- mesh__historyNote mesh__D005589 68   
% 212.37/212.58  |- mesh__recordOriginator mesh__D005589 NLM
% 212.37/212.58  |- mesh__dateRevised mesh__D005589 2004-07-27
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D005589 2006
% 212.37/212.58  |- mesh__dateCreated mesh__D005589 1999-01-01
% 212.37/212.58  |- skos__altLabel mesh__D005589 Arctic Fox
% 212.37/212.58  |- mesh__dateRevised mesh__D024743 2005-06-30
% 212.37/212.58  |- mesh__dateEstablished mesh__D024743 2002-01-01
% 212.37/212.58  |- mesh__recordAuthorizer mesh__D024743 sjn
% 212.37/212.58  |- mesh__publicMeSHNote mesh__D024743 2002   
% 212.37/212.58  |- skos__hiddenLabel mesh__D024743 Myosin, Atrial
% 212.37/212.58  |- mesh__dateCreated mesh__D024743 2001-07-25
% 212.37/212.58  |- skos__scopeNote mesh__D024743
% 212.37/212.58       Myosin type II isoforms specifically found in the atrial muscle of the heart.%A%    
% 212.37/212.58  |- skos__altLabel mesh__D024743 Myosins, Atrial
% 212.37/212.58  |- skos__altLabel mesh__D024743 Atrial Myosin
% 212.37/212.58  |- rdf__type mesh__D024743sskos__Concept
% 212.37/212.58  |- mesh__recordOriginator mesh__D024743 jmp
% 212.37/212.58  |- mesh__historyNote mesh__D024743 2002   
% 212.37/212.58  |- skos__historyNote mesh__D024743 Myosins %28%1979-2001%29%
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D024743 2006
% 212.37/212.58  |- mesh__recordMaintainer mesh__D024743 DRC
% 212.37/212.58  |- skos__broader mesh__D024743smesh__D024722
% 212.37/212.58  |- skos__prefLabel mesh__D024743 Atrial Myosins
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D002291 2002
% 212.37/212.58  |- mesh__recordOriginator mesh__D002291 NLM
% 212.37/212.58  |- mesh__recordMaintainer mesh__D002291 KEV
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D002291 2003
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D002291 2004
% 212.37/212.58  |- rdf__type mesh__D002291sskos__Concept
% 212.37/212.58  |- skos__scopeNote mesh__D002291
% 212.37/212.58       A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. %28%Stedman, 25th ed%29%%A%    
% 212.37/212.58  |- mesh__dateCreated mesh__D002291 1999-01-01
% 212.37/212.58  |- mesh__dateRevised mesh__D002291 1995-06-08
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D002291 2000
% 212.37/212.58  |- skos__broader mesh__D002291smesh__D002277
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D002291 1998
% 212.37/212.58  |- skos__prefLabel mesh__D002291 Carcinoma, Papillary
% 212.37/212.58  |- skos__broader mesh__D002291smesh__D018307
% 212.37/212.58  |- skos__hiddenLabel mesh__D002291 Papillary Carcinoma
% 212.37/212.58  |- mesh__recordAuthorizer mesh__D002291 PLS
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D002291 2001
% 212.37/212.58  |- skos__annotation mesh__D002291
% 212.37/212.58       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D002291 1999
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D002291 2005
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D002291 1996
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D002291 2006
% 212.37/212.58  |- skos__hiddenLabel mesh__D002291 Papillary Carcinomas
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D002291 1997
% 212.37/212.58  |- skos__hiddenLabel mesh__D002291 Carcinomas, Papillary
% 212.37/212.58  |- skos__hiddenLabel mesh__D010723 Synthase, DAHP
% 212.37/212.58  |- skos__hiddenLabel mesh__D010723
% 212.37/212.58       Synthetase, 3-Deoxyarabinoheptulosonate-7-Phosphate
% 212.37/212.58  |- skos__altLabel mesh__D010723
% 212.37/212.58       3-Deoxyarabinoheptulosonate-7-Phosphate Synthetase
% 212.37/212.58  |- skos__prefLabel mesh__D010723 2-Dehydro-3-Deoxyphosphoheptonate Aldolase
% 212.37/212.58  |- skos__altLabel mesh__D010723 Phospho-2-Keto-3-Deoxyheptonate Aldolase
% 212.37/212.58  |- mesh__dateEstablished mesh__D010723 1991-01-01
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D010723 2005
% 212.37/212.58  |- skos__hiddenLabel mesh__D010723
% 212.37/212.58       2 Dehydro 3 Deoxyphosphoheptonate Aldolase
% 212.37/212.58  |- mesh__dateCreated mesh__D010723 1974-11-19
% 212.37/212.58  |- skos__historyNote mesh__D010723 Tetroses %28%1972-1974%29%
% 212.37/212.58  |- skos__broader mesh__D010723smesh__D000446
% 212.37/212.58  |- skos__hiddenLabel mesh__D010723 Phospho 2 Keto 3 Deoxyheptonate Aldolase
% 212.37/212.58  |- skos__annotation mesh__D010723 DF: note short X ref   
% 212.37/212.58  |- mesh__publicMeSHNote mesh__D010723
% 212.37/212.58       98; see PHOSPHO-2-KETO-3-DEOXYHEPTONATE ALDOLASE 1995-97, see PHOSPHO-2-KETO-3-DEOXY-HEPTONATE ALDOLASE 1991-94, see ALDEHYDE-LYASES 1975-90%A%  
% 212.37/212.58  |- skos__hiddenLabel mesh__D010723
% 212.37/212.58       3 Deoxyarabinoheptulosonate 7 Phosphate Synthetase
% 212.37/212.58  |- mesh__recordAuthorizer mesh__D010723 sjn
% 212.37/212.58  |- mesh__recordMaintainer mesh__D010723 jmp
% 212.37/212.58  |- rdf__type mesh__D010723sskos__Concept
% 212.37/212.58  |- skos__historyNote mesh__D010723 Aldehyde-Lyases %28%1972-1974%29%
% 212.37/212.58  |- mesh__dateRevised mesh__D010723 2004-07-07
% 212.37/212.58  |- mesh__recordOriginator mesh__D010723 NLM
% 212.37/212.58  |- skos__scopeNote mesh__D010723
% 212.37/212.58       An enzyme that catalyzes the formation of 7-phospho-2-keto-3-deoxy-D-arabinoheptonate from phosphoenolpyruvate and D-erythrose-4-phosphate. It is one of the first enzymes in the biosynthesis of tyrosine and phenylalanine. EC 4.1.12.15.%A%    
% 212.37/212.58  |- skos__historyNote mesh__D010723 Phosphoenolpyruvate %28%1973-1974%29%
% 212.37/212.58  |- skos__altLabel mesh__D010723 DAHP Synthase
% 212.37/212.58  |- skos__hiddenLabel mesh__D010723
% 212.37/212.58       Aldolase, 2-Dehydro-3-Deoxyphosphoheptonate
% 212.37/212.58  |- skos__hiddenLabel mesh__D010723
% 212.37/212.58       Aldolase, Phospho-2-Keto-3-Deoxyheptonate
% 212.37/212.58  |- skos__historyNote mesh__D010723 Heptoses %28%1972-1974%29%
% 212.37/212.58  |- mesh__historyNote mesh__D010723 98%28%75%29%   
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D010723 2006
% 212.37/212.58  |- skos__broader mesh__D001997smesh__D008171
% 212.37/212.58  |- skos__annotation mesh__D001997
% 212.37/212.58       check tags  HUMANS %26% INFANT, NEWBORN; DF: BRONCHOPULM DYSPLASIA%A%  
% 212.37/212.58  |- mesh__activeMeSHYear mesh__D001997 2006
% 212.37/212.58  |- mesh__recordAuthorizer mesh__D001997 sjn
% 212.37/212.58  |- mesh__recordOriginator mesh__D001997 VDK
% 212.37/212.58  |- skos__hiddenLabel mesh__D001997 Dysplasia, Bronchopulmonary
% 212.37/212.58  |- skos__historyNote mesh__D001997 Lung Diseases %28%1966-1981%29%
% 212.37/212.58  |- skos__scopeNote mesh__D001997
% 212.37/212.58       A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation %28%VENTILATION, MECHANICAL%29% in certain premature infants %28%INFANT, PREMATURE%29% or newborn infants with respiratory distress syndrome %28%RESPIRATORY DISTRESS SYNDROME, NEWBORN%29%. Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS. Severity of this disease and lung injuries depend on the duration of oxygen supplementation, positive pressure requirement, GESTATIONAL AGE, and BIRTH WEIGHT of the infant.%A%    
% 212.37/212.58  |- mesh__recordMaintainer mesh__D001997 lkt
% 212.37/212.58  |- mesh__dateRevised mesh__D001997 2005-06-30
% 212.37/212.58  |- skos__prefLabel mesh__D001997 Bronchopulmonary Dysplasia
% 212.37/212.58  |- skos__broader mesh__D001997smesh__D007235
% 212.37/212.58  |- mesh__publicMeSHNote mesh__D001997 82   
% 212.37/212.58  |- mesh__dateEstablished mesh__D001997 1982-01-01
% 212.37/212.59  |- mesh__historyNote mesh__D001997 82   
% 212.37/212.59  |- rdf__type mesh__D001997sskos__Concept
% 212.37/212.59  |- skos__historyNote mesh__D001997
% 212.37/212.59       Respiratory Tract Diseases %28%1966-1981%29%
% 212.37/212.59  |- mesh__dateCreated mesh__D001997 1981-05-19
% 212.37/212.59  |- rdf__type mesh__D001199sskos__Concept
% 212.37/212.59  |- skos__broader mesh__D001199smesh__D017162
% 212.37/212.59  |- mesh__dateRevised mesh__D001199 2004-07-19
% 212.37/212.59  |- skos__historyNote mesh__D001199 Nematoda %28%1966-1974%29%
% 212.37/212.59  |- skos__annotation mesh__D001199
% 212.37/212.59       a superfamily of nematodes; do not confuse with ASCARIDIA nor ASCARIS, both nematode genera; infection: coord IM with ASCARIDIDA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 212.37/212.59  |- mesh__onlineNote mesh__D001199
% 212.37/212.59       use ASCARIDOIDEA to search ASCAROIDEA 1975-85   
% 212.37/212.59  |- mesh__dateCreated mesh__D001199 1999-01-01
% 212.37/212.59  |- mesh__recordMaintainer mesh__D001199 jls
% 212.37/212.59  |- skos__prefLabel mesh__D001199 Ascaridoidea
% 212.37/212.59  |- skos__scopeNote mesh__D001199
% 212.37/212.59       A superfamily of polymyarian nematode worms. An important characteristic of this group is the presence of three prominent lips around the mouth of the organism.%A%    
% 212.37/212.59  |- skos__altLabel mesh__D001199 Ascaroidea
% 212.37/212.59  |- mesh__recordAuthorizer mesh__D001199 sjn
% 212.37/212.59  |- mesh__historyNote mesh__D001199 86; was ASCAROIDEA 1975-85   
% 212.37/212.59  |- mesh__activeMeSHYear mesh__D001199 2006
% 212.37/212.59  |- mesh__publicMeSHNote mesh__D001199 86; was ASCAROIDEA 1975-85   
% 212.37/212.59  |- mesh__recordOriginator mesh__D001199 NLM
% 212.37/212.59  |- mesh__activeMeSHYear mesh__D001199 2005
% 212.37/212.59  |- mesh__dateEstablished mesh__D001199 1975-01-01
% 212.37/212.59  |- skos__prefLabel mesh__D042805 Neisseria elongata
% 212.37/212.59  |- mesh__recordOriginator mesh__D042805 ags
% 212.37/212.59  |- mesh__historyNote mesh__D042805 2004   
% 212.37/212.59  |- mesh__activeMeSHYear mesh__D042805 2006
% 212.37/212.59  |- skos__annotation mesh__D042805
% 212.37/212.59       infection: coord IM with NEISSERIACEAE INFECTIONS %28%IM%29%   
% 212.37/212.59  |- mesh__recordMaintainer mesh__D042805 SYSTEM
% 212.37/212.59  |- skos__broader mesh__D042805smesh__D009343
% 212.37/212.59  |- mesh__recordAuthorizer mesh__D042805 sjn
% 212.37/212.59  |- skos__historyNote mesh__D042805 Neisseria %28%1970-2003%29%
% 212.37/212.59  |- mesh__dateCreated mesh__D042805 2003-07-09
% 212.37/212.59  |- mesh__dateEstablished mesh__D042805 2004-01-01
% 212.37/212.59  |- skos__scopeNote mesh__D042805
% 212.37/212.59       A species of gram-negative, aerobic BACTERIA consisting of short chains of rods. It has been isolated from the PHARYNX of healthy individuals and patients with ENDOCARDITIS. There are several recognized subspecies.%A%    
% 212.37/212.59  |- mesh__dateRevised mesh__D042805 2005-06-30
% 212.37/212.59  |- rdf__type mesh__D042805sskos__Concept
% 212.37/212.59  |- mesh__publicMeSHNote mesh__D042805 2004   
% 212.37/212.59  |- skos__hiddenLabel mesh__D006682 Antigens, HLA-PL
% 212.37/212.59  |- skos__altLabel mesh__D006682 HLA-PL
% 212.37/212.59  |- mesh__dateEstablished mesh__D006682 1989-01-01
% 212.37/212.59  |- mesh__recordAuthorizer mesh__D006682 sjn
% 212.37/212.59  |- mesh__dateRevised mesh__D006682 2005-06-30
% 212.37/212.59  |- rdf__type mesh__D006682sskos__Concept
% 212.37/212.59  |- skos__hiddenLabel mesh__D006682 Antigens, HLA-SB
% 212.37/212.59  |- skos__altLabel mesh__D006682 HLA-SB Antigens
% 212.37/212.59  |- skos__broader mesh__D006682smesh__D006681
% 212.37/212.59  |- mesh__recordMaintainer mesh__D006682 ssb
% 212.37/212.59  |- mesh__recordOriginator mesh__D006682 SH
% 212.37/212.59  |- skos__prefLabel mesh__D006682 HLA-DP Antigens
% 212.37/212.59  |- skos__hiddenLabel mesh__D006682 Antigens, HLA-DP
% 212.37/212.59  |- skos__hiddenLabel mesh__D006682 HLA SB Antigens
% 212.37/212.59  |- skos__hiddenLabel mesh__D006682 HLA DP Antigens
% 212.37/212.59  |- mesh__activeMeSHYear mesh__D006682 2006
% 212.37/212.59  |- skos__altLabel mesh__D006682 HLA-DP
% 212.37/212.59  |- skos__hiddenLabel mesh__D006682 HLA PL Antigens
% 212.45/212.59  |- mesh__publicMeSHNote mesh__D006682
% 212.45/212.59       89; was see under HLA-D ANTIGENS 1987-88   
% 212.45/212.59  |- skos__altLabel mesh__D006682 HLA-SB
% 212.45/212.59  |- skos__altLabel mesh__D006682 HLA-PL Antigens
% 212.45/212.59  |- mesh__historyNote mesh__D006682
% 212.45/212.59       89%28%87%29%; was see under HLA-D ANTIGENS 1987-88   
% 212.45/212.59  |- skos__historyNote mesh__D006682
% 212.45/212.59       Antigens, Immune Response %28%1981-1986%29%
% 212.45/212.59  |- skos__scopeNote mesh__D006682
% 212.45/212.59       A group of the D-related HLA antigens %28%human%29% found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases.%A%    
% 212.45/212.59  |- skos__annotation mesh__D006682 assoc with various dis; DF: HLA DP   
% 212.45/212.59  |- mesh__dateCreated mesh__D006682 1986-06-25
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D014316 1997
% 212.45/212.59  |- rdf__type mesh__D014316sskos__Concept
% 212.45/212.59  |- mesh__dateRevised mesh__D014316 1992-06-25
% 212.45/212.59  |- mesh__recordAuthorizer mesh__D014316 PLS
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D014316 1996
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D014316 2002
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D014316 2004
% 212.45/212.59  |- mesh__dateCreated mesh__D014316 1999-01-01
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D014316 1993
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D014316 1999
% 212.45/212.59  |- mesh__recordOriginator mesh__D014316 NLM
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D014316 2003
% 212.45/212.59  |- skos__annotation mesh__D014316 = H3; naturally radioactive   
% 212.45/212.59  |- mesh__recordMaintainer mesh__D014316 PLS
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D014316 1998
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D014316 2001
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D014316 2006
% 212.45/212.59  |- skos__prefLabel mesh__D014316 Tritium
% 212.45/212.59  |- skos__broader mesh__D014316smesh__D006859
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D014316 1995
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D014316 2000
% 212.45/212.59  |- skos__broader mesh__D014316smesh__D011868
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D014316 2005
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D014316 1994
% 212.45/212.59  |- skos__prefLabel mesh__D019001 Nitric Oxide Synthase
% 212.45/212.59  |- mesh__recordAuthorizer mesh__D019001 sjn
% 212.45/212.59  |- mesh__dateEstablished mesh__D019001 1996-01-01
% 212.45/212.59  |- mesh__recordMaintainer mesh__D019001 jmp
% 212.45/212.59  |- skos__altLabel mesh__D019001 Nitric-Oxide Synthetase
% 212.45/212.59  |- skos__hiddenLabel mesh__D019001 Oxide Synthase, Nitric
% 212.45/212.59  |- mesh__dateRevised mesh__D019001 2005-06-30
% 212.45/212.59  |- skos__hiddenLabel mesh__D019001 Synthase, Nitric Oxide
% 212.45/212.59  |- mesh__dateCreated mesh__D019001 1995-06-05
% 212.45/212.59  |- mesh__publicMeSHNote mesh__D019001
% 212.45/212.59       2006; see NITRIC-OXIDE SYNTHASE 1996-2005, NITRIC OXIDE SYNTHASE was indexed under AMINO ACID OXIDOREDUCTASES 1990-1995%A%  
% 212.45/212.59  |- mesh__recordOriginator mesh__D019001 TPW
% 212.45/212.59  |- skos__annotation mesh__D019001 general; prefer specifics   
% 212.45/212.59  |- skos__altLabel mesh__D019001 NO Synthase
% 212.45/212.59  |- skos__scopeNote mesh__D019001
% 212.45/212.59       An NADPH-dependent enzyme that catalyzes the conversion of L-ARGININE and OXYGEN to produce CITRULLINE and NITRIC OXIDE.%A%    
% 212.45/212.59  |- skos__broader mesh__D019001smesh__D000594
% 212.45/212.59  |- mesh__historyNote mesh__D019001 2006%28%1990%29%   
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D019001 2006
% 212.45/212.59  |- skos__altLabel mesh__D019001 Nitric-Oxide Synthase
% 212.45/212.59  |- rdf__type mesh__D019001sskos__Concept
% 212.45/212.59  |- skos__hiddenLabel mesh__D019001 Nitric Oxide Synthetase
% 212.45/212.59  |- skos__broader mesh__D030781smesh__D010944
% 212.45/212.59  |- skos__hiddenLabel mesh__D030781 Organism, GMO
% 212.45/212.59  |- skos__hiddenLabel mesh__D030781 Engineered Organism, Genetically
% 212.45/212.59  |- mesh__dateRevised mesh__D030781 2005-06-30
% 212.45/212.59  |- skos__historyNote mesh__D030781 Genetic Engineering %28%1989-2001%29%
% 212.45/212.59  |- skos__related mesh__D030781smesh__D019076
% 212.45/212.59  |- mesh__recordMaintainer mesh__D030781 jls
% 212.45/212.59  |- skos__hiddenLabel mesh__D030781 Modified Organisms, Genetically
% 212.45/212.59  |- skos__hiddenLabel mesh__D030781 Genetically Engineered Organism
% 212.45/212.59  |- skos__hiddenLabel mesh__D030781 Modified Organism, Genetically
% 212.45/212.59  |- mesh__recordAuthorizer mesh__D030781 sjn
% 212.45/212.59  |- skos__hiddenLabel mesh__D030781 Transgenic Organism
% 212.45/212.59  |- skos__hiddenLabel mesh__D030781 Engineered Organisms, Genetically
% 212.45/212.59  |- skos__altLabel mesh__D030781 GMO Organisms
% 212.45/212.59  |- mesh__dateEstablished mesh__D030781 2002-01-01
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D030781 2006
% 212.45/212.59  |- skos__annotation mesh__D030781
% 212.45/212.59       GEN or unspecified; prefer ANIMALS, GENETICALLY MODIFIED or PLANTS, GENETICALLY MODIFIED or their specifics%A%  
% 212.45/212.59  |- skos__related mesh__D030781smesh__D030841
% 212.45/212.59  |- skos__altLabel mesh__D030781 Transgenic Organisms
% 212.45/212.59  |- skos__hiddenLabel mesh__D030781 GMO Organism
% 212.45/212.59  |- skos__hiddenLabel mesh__D030781 Genetically Modified Organism
% 212.45/212.59  |- skos__hiddenLabel mesh__D030781 Organism, Transgenic
% 212.45/212.59  |- mesh__historyNote mesh__D030781 2002   
% 212.45/212.59  |- skos__hiddenLabel mesh__D030781 Organism, Genetically Engineered
% 212.45/212.59  |- skos__altLabel mesh__D030781 Genetically Modified Organisms
% 212.45/212.59  |- skos__hiddenLabel mesh__D030781 Organisms, GMO
% 212.45/212.59  |- rdf__type mesh__D030781sskos__Concept
% 212.45/212.59  |- skos__scopeNote mesh__D030781
% 212.45/212.59       Organisms whose GENOME has been changed by a GENETIC ENGINEERING technique.%A%    
% 212.45/212.59  |- mesh__dateCreated mesh__D030781 2001-07-25
% 212.45/212.59  |- mesh__recordOriginator mesh__D030781 nns
% 212.45/212.59  |- skos__hiddenLabel mesh__D030781 Organisms, Genetically Engineered
% 212.45/212.59  |- skos__hiddenLabel mesh__D030781 Organism, Genetically Modified
% 212.45/212.59  |- skos__related mesh__D030781smesh__D005818
% 212.45/212.59  |- skos__altLabel mesh__D030781 Genetically Engineered Organisms
% 212.45/212.59  |- skos__broader mesh__D030781smesh__D000828
% 212.45/212.59  |- skos__prefLabel mesh__D030781 Organisms, Genetically Modified
% 212.45/212.59  |- mesh__publicMeSHNote mesh__D030781
% 212.45/212.59       2002; ORGANISMS, TRANSGENIC was heading 1999-2001   
% 212.45/212.59  |- skos__broader mesh__D024744smesh__D024462
% 212.45/212.59  |- mesh__publicMeSHNote mesh__D024744 2002   
% 212.45/212.59  |- skos__altLabel mesh__D024744 Myosins, Skeletal Muscle
% 212.45/212.59  |- skos__scopeNote mesh__D024744
% 212.45/212.59       Myosin type II isoforms found in skeletal muscle.     
% 212.45/212.59  |- mesh__dateCreated mesh__D024744 2001-07-25
% 212.45/212.59  |- skos__historyNote mesh__D024744 Myosins %28%1970-2001%29%
% 212.45/212.59  |- skos__prefLabel mesh__D024744 Skeletal Muscle Myosins
% 212.45/212.59  |- mesh__dateRevised mesh__D024744 2005-06-30
% 212.45/212.59  |- mesh__dateEstablished mesh__D024744 2002-01-01
% 212.45/212.59  |- mesh__recordAuthorizer mesh__D024744 sjn
% 212.45/212.59  |- rdf__type mesh__D024744sskos__Concept
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D024744 2006
% 212.45/212.59  |- skos__historyNote mesh__D024744 Muscle Proteins %28%1966-1970%29%
% 212.45/212.59  |- mesh__recordMaintainer mesh__D024744 DRC
% 212.45/212.59  |- mesh__recordOriginator mesh__D024744 jmp
% 212.45/212.59  |- mesh__historyNote mesh__D024744 2002   
% 212.45/212.59  |- skos__altLabel mesh__D002292 Carcinoma, Hypernephroid
% 212.45/212.59  |- skos__hiddenLabel mesh__D002292
% 212.45/212.59       Duct Carcinomas, Collecting %28%Kidney%29%
% 212.45/212.59  |- skos__hiddenLabel mesh__D002292 Carcinomas, Nephroid
% 212.45/212.59  |- skos__broader mesh__D002292smesh__D007680
% 212.45/212.59  |- skos__hiddenLabel mesh__D002292 Renal Cell Adenocarcinomas
% 212.45/212.59  |- skos__altLabel mesh__D002292 Hypernephroma
% 212.45/212.59  |- skos__altLabel mesh__D002292 Nephroid Carcinoma
% 212.45/212.59  |- skos__historyNote mesh__D002292 Kidney Neoplasms %28%1966-1984%29%
% 212.45/212.59  |- skos__hiddenLabel mesh__D002292 Hypernephromas
% 212.45/212.59  |- skos__broader mesh__D002292smesh__D000230
% 212.45/212.59  |- skos__scopeNote mesh__D002292
% 212.45/212.59       A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells %28%sarcomatoid%29%, or mixed cell-type carcinoma.%A%    
% 212.45/212.59  |- mesh__dateRevised mesh__D002292 2005-06-30
% 212.45/212.59  |- skos__prefLabel mesh__D002292 Carcinoma, Renal Cell
% 212.45/212.59  |- mesh__publicMeSHNote mesh__D002292 85   
% 212.45/212.59  |- skos__altLabel mesh__D002292 Renal Cell Carcinoma
% 212.45/212.59  |- rdf__type mesh__D002292sskos__Concept
% 212.45/212.59  |- skos__hiddenLabel mesh__D002292
% 212.45/212.59       Carcinoma, Collecting Duct %28%Kidney%29%
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D002292 2006
% 212.45/212.59  |- skos__altLabel mesh__D002292 Clear Cell Renal Carcinoma
% 212.45/212.59  |- skos__hiddenLabel mesh__D002292 Adenocarcinomas, Renal Cell
% 212.45/212.59  |- skos__hiddenLabel mesh__D002292 Nephroid Carcinomas
% 212.45/212.59  |- skos__hiddenLabel mesh__D002292
% 212.45/212.59       Carcinomas, Collecting Duct %28%Kidney%29%
% 212.45/212.59  |- mesh__recordAuthorizer mesh__D002292 sjn
% 212.45/212.59  |- skos__hiddenLabel mesh__D002292
% 212.45/212.59       Duct Carcinoma, Collecting %28%Kidney%29%
% 212.45/212.59  |- mesh__historyNote mesh__D002292 85   
% 212.45/212.59  |- skos__hiddenLabel mesh__D002292 Hypernephroid Carcinomas
% 212.45/212.59  |- skos__hiddenLabel mesh__D002292 Carcinomas, Renal Cell
% 212.45/212.59  |- skos__hiddenLabel mesh__D002292 Carcinomas, Hypernephroid
% 212.45/212.59  |- skos__altLabel mesh__D002292 Adenocarcinoma, Renal Cell
% 212.45/212.59  |- skos__hiddenLabel mesh__D002292 Renal Cell Carcinomas
% 212.45/212.59  |- skos__annotation mesh__D002292
% 212.45/212.59       coordinate IM with KIDNEY NEOPLASMS %28%IM%29%   
% 212.45/212.59  |- skos__altLabel mesh__D002292 Grawitz Tumor
% 212.45/212.59  |- skos__historyNote mesh__D002292 Adenocarcinoma %28%1966-1984%29%
% 212.45/212.59  |- skos__hiddenLabel mesh__D002292
% 212.45/212.59       Collecting Duct Carcinomas %28%Kidney%29%
% 212.45/212.59  |- mesh__recordMaintainer mesh__D002292 lkt
% 212.45/212.59  |- skos__hiddenLabel mesh__D002292 Renal Cell Adenocarcinoma
% 212.45/212.59  |- mesh__dateCreated mesh__D002292 1984-05-29
% 212.45/212.59  |- skos__hiddenLabel mesh__D002292 Carcinoma, Nephroid
% 212.45/212.59  |- skos__hiddenLabel mesh__D002292 Hypernephroid Carcinoma
% 212.45/212.59  |- mesh__recordOriginator mesh__D002292 VDK
% 212.45/212.59  |- mesh__dateEstablished mesh__D002292 1985-01-01
% 212.45/212.59  |- skos__hiddenLabel mesh__D002292 Tumor, Grawitz
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D010724 1991
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D010724 1993
% 212.45/212.59  |- mesh__recordMaintainer mesh__D010724 NLM
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D010724 1998
% 212.45/212.59  |- mesh__historyNote mesh__D010724
% 212.45/212.59       91%28%75%29%; was see under ADENINE NUCLEOTIDES 1975-90   
% 212.45/212.59  |- skos__scopeNote mesh__D010724
% 212.45/212.59       3%27%-Phosphoadenosine-5%27%-phosphosulfate. Key intermediate in the formation by living cells of sulfate esters of phenols, alcohols, steroids, sulfated polysaccharides, and simple esters, such as choline sulfate. It is formed from sulfate ion and ATP in a two-step process. This compound also is an important step in the process of sulfur fixation in plants and microorganisms.%A%    
% 212.45/212.59  |- mesh__publicMeSHNote mesh__D010724
% 212.45/212.59       91; was see under ADENINE NUCLEOTIDES 1975-90   
% 212.45/212.59  |- mesh__dateRevised mesh__D010724 1990-04-13
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D010724 1995
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D010724 1992
% 212.45/212.59  |- rdf__type mesh__D010724sskos__Concept
% 212.45/212.59  |- skos__altLabel mesh__D010724
% 212.45/212.59       Adenosine-3%27%-phosphate-5%27%-Phosphosulfate
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D010724 1994
% 212.45/212.59  |- skos__historyNote mesh__D010724
% 212.45/212.59       Adenosine Monophosphate %28%1973-1978%29%
% 212.45/212.59  |- skos__hiddenLabel mesh__D010724 Phosphosulfate, Phosphoadenosine
% 212.45/212.59  |- mesh__dateCreated mesh__D010724 1974-11-19
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D010724 2002
% 212.45/212.59  |- skos__prefLabel mesh__D010724 Phosphoadenosine Phosphosulfate
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D010724 2004
% 212.45/212.59  |- skos__annotation mesh__D010724 DF: PAPS   
% 212.45/212.59  |- skos__historyNote mesh__D010724
% 212.45/212.59       Organophosphorus Compounds %28%1973-1974%29%
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D010724 1997
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D010724 2001
% 212.45/212.59  |- skos__broader mesh__D010724smesh__D000227
% 212.45/212.59  |- skos__historyNote mesh__D010724 Sulfuric Acids %28%1973-1974%29%
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D010724 2006
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D010724 2003
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D010724 2000
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D010724 1999
% 212.45/212.59  |- mesh__recordOriginator mesh__D010724 NLM
% 212.45/212.59  |- mesh__recordAuthorizer mesh__D010724 PLS
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D010724 1996
% 212.45/212.59  |- skos__hiddenLabel mesh__D010724
% 212.45/212.59       Adenosine 3%27% phosphate 5%27% Phosphosulfate
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D010724 2005
% 212.45/212.59  |- mesh__dateEstablished mesh__D010724 1991-01-01
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D018707 1999
% 212.45/212.59  |- mesh__onlineNote mesh__D018707
% 212.45/212.59       use NATURAL DISASTERS to search VOLCANIC ERUPTIONS 1982-94%A%  
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D018707 2000
% 212.45/212.59  |- skos__historyNote mesh__D018707 Natural Disasters %28%1982-1994%29%
% 212.45/212.59  |- mesh__dateCreated mesh__D018707 1994-05-23
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D018707 2003
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D018707 1998
% 212.45/212.59  |- skos__historyNote mesh__D018707
% 212.45/212.59       Air Pollutants, Environmental %28%1982-1994%29%
% 212.45/212.59  |- skos__broader mesh__D018707smesh__D009322
% 212.45/212.59  |- skos__hiddenLabel mesh__D018707 Ash, Volcanic
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D018707 1995
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D018707 2006
% 212.45/212.59  |- skos__historyNote mesh__D018707 Geology %28%1966-1979%29%
% 212.45/212.59  |- rdf__type mesh__D018707sskos__Concept
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D018707 2002
% 212.45/212.59  |- skos__scopeNote mesh__D018707
% 212.45/212.59       The ash, dust, gases, and lava released by volcanic explosion. The gases are volatile matter composed principally of about 90%25% water vapor, and carbon dioxide, sulfur dioxide, hydrogen, carbon monoxide, and nitrogen. The ash or dust is pyroclastic ejecta and lava is molten extrusive material consisting mainly of magnesium silicate. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D018707 1997
% 212.45/212.59  |- skos__annotation mesh__D018707 specify geog   
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D018707 2005
% 212.45/212.59  |- mesh__publicMeSHNote mesh__D018707
% 212.45/212.59       95; was VOLCANIC ERUPTIONS see NATURAL DISASTERS 1982-94   
% 212.45/212.59  |- mesh__dateEstablished mesh__D018707 1995-01-01
% 212.45/212.59  |- skos__hiddenLabel mesh__D018707 Volcanic Eruptions
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D018707 1996
% 212.45/212.59  |- skos__prefLabel mesh__D018707 Volcanic Eruption
% 212.45/212.59  |- skos__hiddenLabel mesh__D018707 Eruption, Volcanic
% 212.45/212.59  |- skos__hiddenLabel mesh__D018707 Gases, Volcanic
% 212.45/212.59  |- mesh__historyNote mesh__D018707
% 212.45/212.59       95; was VOLCANIC ERUPTIONS see NATURAL DISASTERS 1982-94   
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D018707 2001
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D018707 2004
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D001998 2004
% 212.45/212.59  |- mesh__dateCreated mesh__D001998 1999-01-01
% 212.45/212.59  |- skos__altLabel mesh__D001998 Sequestration, Bronchopulmonary
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D001998 2002
% 212.45/212.59  |- skos__broader mesh__D001998smesh__D015619
% 212.45/212.59  |- mesh__recordOriginator mesh__D001998 NLM
% 212.45/212.59  |- mesh__publicMeSHNote mesh__D001998 65   
% 212.45/212.59  |- skos__annotation mesh__D001998
% 212.45/212.59       a lung abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: PULM SEQUESTRATION%A%  
% 212.45/212.59  |- mesh__historyNote mesh__D001998 65%28%64%29%   
% 212.45/212.59  |- mesh__dateEstablished mesh__D001998 1965-01-01
% 212.45/212.59  |- skos__scopeNote mesh__D001998
% 212.45/212.59       A developmental anomaly in which a mass of nonfunctioning lung tissue lacks normal connection with the tracheobroncheal tree and receives an anomalous blood supply originating from the descending thoracic or abdominal aorta. The mass may be extralobar, i.e., completely separated from normally connected lung, or intralobar, i.e., partly surrounded by normal lung.%A%    
% 212.45/212.59  |- skos__prefLabel mesh__D001998 Bronchopulmonary Sequestration
% 212.45/212.59  |- rdf__type mesh__D001998sskos__Concept
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D001998 2005
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D001998 2000
% 212.45/212.59  |- skos__altLabel mesh__D001998 Pulmonary Sequestration
% 212.45/212.59  |- mesh__recordAuthorizer mesh__D001998 sjn
% 212.45/212.59  |- skos__altLabel mesh__D001998 Bronchopulmonary Sequestrations
% 212.45/212.59  |- skos__altLabel mesh__D001998 Sequestrations, Pulmonary
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D001998 2006
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D001998 2001
% 212.45/212.59  |- mesh__dateRevised mesh__D001998 1999-11-03
% 212.45/212.59  |- mesh__recordMaintainer mesh__D001998 kle
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D001998 2003
% 212.45/212.59  |- skos__altLabel mesh__D001998 Pulmonary Sequestrations
% 212.45/212.59  |- skos__altLabel mesh__D001998 Sequestration, Pulmonary
% 212.45/212.59  |- skos__altLabel mesh__D001998 Sequestrations, Bronchopulmonary
% 212.45/212.59  |- mesh__dateRevised mesh__D042806 2005-06-30
% 212.45/212.59  |- skos__annotation mesh__D042806
% 212.45/212.59       infection: coord IM with NEISSERIACEAE INFECTIONS %28%IM%29%   
% 212.45/212.59  |- skos__historyNote mesh__D042806 Neisseria %28%1973-2003%29%
% 212.45/212.59  |- mesh__recordMaintainer mesh__D042806 SYSTEM
% 212.45/212.59  |- skos__scopeNote mesh__D042806
% 212.45/212.59       A species of gram-negative, aerobic BACTERIA commonly found in the NASOPHARYNX of infants and children, but rarely pathogenic. It is the only species to produce acid from LACTOSE.%A%    
% 212.45/212.59  |- mesh__historyNote mesh__D042806 2004   
% 212.45/212.59  |- mesh__recordOriginator mesh__D042806 ags
% 212.45/212.59  |- mesh__dateCreated mesh__D042806 2003-07-09
% 212.45/212.59  |- skos__prefLabel mesh__D042806 Neisseria lactamica
% 212.45/212.59  |- skos__broader mesh__D042806smesh__D009343
% 212.45/212.59  |- mesh__recordAuthorizer mesh__D042806 sjn
% 212.45/212.59  |- mesh__publicMeSHNote mesh__D042806 2004   
% 212.45/212.59  |- rdf__type mesh__D042806sskos__Concept
% 212.45/212.59  |- mesh__dateEstablished mesh__D042806 2004-01-01
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D042806 2006
% 212.45/212.59  |- mesh__publicMeSHNote mesh__D006683
% 212.45/212.59       89; was see under HLA-D ANTIGENS 1987-88   
% 212.45/212.59  |- skos__altLabel mesh__D006683 HLA-MB Antigens
% 212.45/212.59  |- mesh__historyNote mesh__D006683
% 212.45/212.59       89%28%87%29%; was see under HLA-ANTIGENS 1987-88   
% 212.45/212.59  |- skos__historyNote mesh__D006683
% 212.45/212.59       Antigens, Immune Response %28%1981-1986%29%
% 212.45/212.59  |- skos__altLabel mesh__D006683 HLA-DQ
% 212.45/212.59  |- skos__hiddenLabel mesh__D006683 Antigens, HLA-DC
% 212.45/212.59  |- skos__hiddenLabel mesh__D006683 HLA DQ Antigens
% 212.45/212.59  |- skos__altLabel mesh__D006683 HLA-DC
% 212.45/212.59  |- skos__altLabel mesh__D006683 HLA-DS Antigens
% 212.45/212.59  |- skos__hiddenLabel mesh__D006683 HLA LB Antigens
% 212.45/212.59  |- skos__hiddenLabel mesh__D006683 Antigens, HLA-MB
% 212.45/212.59  |- skos__prefLabel mesh__D006683 HLA-DQ Antigens
% 212.45/212.59  |- mesh__recordOriginator mesh__D006683 SH
% 212.45/212.59  |- skos__hiddenLabel mesh__D006683 Antigens, HLA-DQ
% 212.45/212.59  |- mesh__recordAuthorizer mesh__D006683 sjn
% 212.45/212.59  |- mesh__dateRevised mesh__D006683 2005-06-30
% 212.45/212.59  |- skos__scopeNote mesh__D006683
% 212.45/212.59       A group of the D-related HLA antigens found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases.%A%    
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D006683 2006
% 212.45/212.59  |- skos__altLabel mesh__D006683 HLA-LB Antigens
% 212.45/212.59  |- skos__altLabel mesh__D006683 HLA-DS
% 212.45/212.59  |- skos__hiddenLabel mesh__D006683 Antigens, HLA-LB
% 212.45/212.59  |- skos__broader mesh__D006683smesh__D006681
% 212.45/212.59  |- mesh__recordMaintainer mesh__D006683 ssb
% 212.45/212.59  |- skos__annotation mesh__D006683 assoc with various dis; DF: HLA DQ   
% 212.45/212.59  |- skos__hiddenLabel mesh__D006683 Antigens, HLA-DS
% 212.45/212.59  |- mesh__dateCreated mesh__D006683 1986-06-25
% 212.45/212.59  |- skos__hiddenLabel mesh__D006683 HLA DC Antigens
% 212.45/212.59  |- skos__altLabel mesh__D006683 HLA-DC Antigens
% 212.45/212.59  |- skos__hiddenLabel mesh__D006683 HLA DS Antigens
% 212.45/212.59  |- skos__altLabel mesh__D006683 HLA-LB
% 212.45/212.59  |- mesh__dateEstablished mesh__D006683 1989-01-01
% 212.45/212.59  |- skos__altLabel mesh__D006683 HLA-MB
% 212.45/212.59  |- skos__hiddenLabel mesh__D006683 HLA MB Antigens
% 212.45/212.59  |- rdf__type mesh__D006683sskos__Concept
% 212.45/212.59  |- rdf__type mesh__D014317sskos__Concept
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D014317 2001
% 212.45/212.59  |- skos__broader mesh__D014317smesh__D009943
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D014317 2003
% 212.45/212.59  |- mesh__publicMeSHNote mesh__D014317
% 212.45/212.59       91; was see under CRESOLS 1979-90; was TRITOLYL PHOSPHATE see under CRESOLS 1975-78%A%  
% 212.45/212.59  |- mesh__dateRevised mesh__D014317 2000-06-22
% 212.45/212.59  |- skos__hiddenLabel mesh__D014317 Phosphate, Tricresyl
% 212.45/212.59  |- skos__historyNote mesh__D014317
% 212.45/212.59       Organophosphorus Compounds %28%1972-1974%29%
% 212.45/212.59  |- skos__altLabel mesh__D014317 Tricresyl Phosphates
% 212.45/212.59  |- mesh__recordMaintainer mesh__D014317 CCR
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D014317 2002
% 212.45/212.59  |- skos__hiddenLabel mesh__D014317 Phosphates, Tricresyl
% 212.45/212.59  |- skos__historyNote mesh__D014317 Cresols %28%1966-1974%29%
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D014317 2004
% 212.45/212.59  |- mesh__dateCreated mesh__D014317 1974-11-19
% 212.45/212.59  |- mesh__historyNote mesh__D014317
% 212.45/212.59       91%28%79%29%; was see under CRESOLS 1979-90; was TRITOLYL PHOSPHATE see under CRESOLS 1975-78%A%  
% 212.45/212.59  |- skos__hiddenLabel mesh__D014317 Phosphate, Tritolyl
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D014317 2005
% 212.45/212.59  |- mesh__dateEstablished mesh__D014317 1991-01-01
% 212.45/212.59  |- skos__hiddenLabel mesh__D014317 Phosphates, Tritolyl
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D014317 2006
% 212.45/212.59  |- skos__altLabel mesh__D014317 Tricresyl Phosphate
% 212.45/212.59  |- mesh__onlineNote mesh__D014317
% 212.45/212.59       use TRITOLYL PHOSPHATES to search TRITOLYL PHOSPHATE 1975-78%A%  
% 212.45/212.59  |- mesh__recordOriginator mesh__D014317 NLM
% 212.45/212.59  |- mesh__recordAuthorizer mesh__D014317 sjn
% 212.45/212.59  |- skos__prefLabel mesh__D014317 Tritolyl Phosphates
% 212.45/212.59  |- skos__broader mesh__D014317smesh__D003408
% 212.45/212.59  |- skos__altLabel mesh__D014317 Tritolyl Phosphate
% 212.45/212.59  |- skos__scopeNote mesh__D014317
% 212.45/212.59       A mixture of isomeric tritolyl phosphates. Used in the sterilization of certain surgical instruments and in many industrial processes.%A%    
% 212.45/212.59  |- mesh__publicMeSHNote mesh__D019800
% 212.45/212.59       98; PHENOL was indexed under PHENOLS 1969-97   
% 212.45/212.59  |- skos__hiddenLabel mesh__D019800 Sodium Salt Phenol
% 212.45/212.59  |- skos__altLabel mesh__D019800 Carbolic Acid
% 212.45/212.59  |- skos__scopeNote mesh__D019800
% 212.45/212.59       An antiseptic and disinfectant. It is active against a wide range of micro-organisms including some fungi and viruses, but is only slowly effective against spores. It has been used to disinfect skin and to relieve itching. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p801%29%%A%    
% 212.45/212.59  |- mesh__historyNote mesh__D019800 98; use PHENOL %28%NM%29% 1979-97   
% 212.45/212.59  |- mesh__recordOriginator mesh__D019800 KEV
% 212.45/212.59  |- skos__historyNote mesh__D019800 Phenols %28%1969-1997%29%
% 212.45/212.59  |- mesh__dateCreated mesh__D019800 1997-06-20
% 212.45/212.59  |- mesh__dateEstablished mesh__D019800 1998-01-01
% 212.45/212.59  |- skos__prefLabel mesh__D019800 Phenol
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D019800 2004
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D019800 2002
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D019800 2006
% 212.45/212.59  |- mesh__dateRevised mesh__D019800 2000-06-21
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D019800 2003
% 212.45/212.59  |- mesh__activeMeSHYear mesh__D019800 2001
% 212.45/212.59  |- mesh__recordMaintainer mesh__D019800 CCR
% 212.45/212.59  |- skos__broader mesh__D019800smesh__D010636
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D019800 2005
% 212.45/212.60  |- mesh__recordAuthorizer mesh__D019800 sjn
% 212.45/212.60  |- skos__hiddenLabel mesh__D019800 Acid, Carbolic
% 212.45/212.60  |- rdf__type mesh__D019800sskos__Concept
% 212.45/212.60  |- skos__altLabel mesh__D019800 Hydroxybenzene
% 212.45/212.60  |- skos__altLabel mesh__D019002 CD56 Antigen
% 212.45/212.60  |- skos__prefLabel mesh__D019002 Antigens, CD56
% 212.45/212.60  |- skos__annotation mesh__D019002
% 212.45/212.60       for hematodermic CD4/CD56 neoplasm use LYMPHOMA, NON-HODGKIN%A%  
% 212.45/212.60  |- mesh__recordAuthorizer mesh__D019002 sjn
% 212.45/212.60  |- mesh__dateEstablished mesh__D019002 1996-01-01
% 212.45/212.60  |- skos__broader mesh__D019002smesh__D019006
% 212.45/212.60  |- mesh__onlineNote mesh__D019002
% 212.45/212.60       use ANTIGENS, CD56 %28%NM%29% to search NKH-1 ANTIGEN 1988-95   
% 212.45/212.60  |- skos__broader mesh__D019002smesh__D000945
% 212.45/212.60  |- skos__historyNote mesh__D019002
% 212.45/212.60       Antigens, Differentiation, T-Lymphocyte %28%1988-1995%29%
% 212.45/212.60  |- mesh__dateCreated mesh__D019002 1995-05-26
% 212.45/212.60  |- skos__broader mesh__D019002smesh__D015703
% 212.45/212.60  |- skos__altLabel mesh__D019002 NKH-1 Antigen
% 212.45/212.60  |- mesh__dateRevised mesh__D019002 2005-06-30
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D019002 2006
% 212.45/212.60  |- skos__altLabel mesh__D019002 Leu-19 Antigen
% 212.45/212.60  |- rdf__type mesh__D019002sskos__Concept
% 212.45/212.60  |- mesh__publicMeSHNote mesh__D019002
% 212.45/212.60       96; NKH-1 ANTIGEN was indexed under ANTIGENS, CD 1990-95 %26% ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-95%A%  
% 212.45/212.60  |- skos__hiddenLabel mesh__D019002 Leu 19 Antigen
% 212.45/212.60  |- skos__hiddenLabel mesh__D019002 Antigen, Leu-19
% 212.45/212.60  |- skos__hiddenLabel mesh__D019002 Antigen, NKH-1
% 212.45/212.60  |- skos__historyNote mesh__D019002 Antigens, CD %28%1990-1995%29%
% 212.45/212.60  |- mesh__recordMaintainer mesh__D019002 ssb
% 212.45/212.60  |- mesh__historyNote mesh__D019002
% 212.45/212.60       96; was NKH-1 ANTIGEN %28%NM%29% 1988-95   
% 212.45/212.60  |- skos__altLabel mesh__D019002 CD56 Antigens
% 212.45/212.60  |- mesh__recordOriginator mesh__D019002 AGS
% 212.45/212.60  |- skos__hiddenLabel mesh__D019002 Antigen, CD56
% 212.45/212.60  |- skos__scopeNote mesh__D019002
% 212.45/212.60       The 140 kDa isoform of NCAM %28%neural cell adhesion molecule%29% containing a transmembrane domain and short cytoplasmic tail. It is expressed by all lymphocytes mediating non-MHC restricted cytotoxicity and is present on some neural tissues and tumors.%A%    
% 212.45/212.60  |- skos__hiddenLabel mesh__D019002 NKH 1 Antigen
% 212.45/212.60  |- skos__broader mesh__D009420Q000502smesh__D009420
% 212.45/212.60  |- mesh__preferredCombination mesh__D009420Q000502smesh__D009424
% 212.45/212.60  |- rdf__type mesh__D009420Q000502smesh__CompoundConcept
% 212.45/212.60  |- mesh__publicMeSHNote mesh__D024745 2002   
% 212.45/212.60  |- skos__altLabel mesh__D024745 Myosins, Smooth Muscle
% 212.45/212.60  |- mesh__recordMaintainer mesh__D024745 DRC
% 212.45/212.60  |- mesh__recordOriginator mesh__D024745 jmp
% 212.45/212.60  |- mesh__historyNote mesh__D024745 2002   
% 212.45/212.60  |- mesh__dateEstablished mesh__D024745 2002-01-01
% 212.45/212.60  |- rdf__type mesh__D024745sskos__Concept
% 212.45/212.60  |- skos__prefLabel mesh__D024745 Smooth Muscle Myosins
% 212.45/212.60  |- skos__historyNote mesh__D024745 Myosins %28%1971-2001%29%
% 212.45/212.60  |- mesh__dateCreated mesh__D024745 2001-07-25
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D024745 2006
% 212.45/212.60  |- skos__scopeNote mesh__D024745
% 212.45/212.60       Myosin type II isoforms found in smooth muscle.     
% 212.45/212.60  |- skos__historyNote mesh__D024745 Muscle Proteins %28%1966-1970%29%
% 212.45/212.60  |- mesh__dateRevised mesh__D024745 2005-06-30
% 212.45/212.60  |- mesh__recordAuthorizer mesh__D024745 sjn
% 212.45/212.60  |- skos__broader mesh__D024745smesh__D024462
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002293 2002
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002293 2004
% 212.45/212.60  |- mesh__onlineNote mesh__D002293
% 212.45/212.60       use ADENOCARCINOMA, SCIRRHOUS to search CARCINOMA, SCIRRHOUS 1966-93%A%  
% 212.45/212.60  |- mesh__dateRevised mesh__D002293 1995-06-08
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002293 2005
% 212.45/212.60  |- skos__hiddenLabel mesh__D002293 Carcinomas, Scirrhous
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002293 2003
% 212.45/212.60  |- skos__hiddenLabel mesh__D002293 Scirrhous Carcinoma
% 212.45/212.60  |- rdf__type mesh__D002293sskos__Concept
% 212.45/212.60  |- skos__scopeNote mesh__D002293
% 212.45/212.60       An adenocarcinoma with a hard %28%Greek skirrhos, hard%29% structure owing to the formation of dense connective tissue in the stroma. %28%From Dorland, 27th ed%29%%A%    
% 212.45/212.60  |- mesh__publicMeSHNote mesh__D002293
% 212.45/212.60       94; was CARCINOMA, SCIRRHOUS 1963-93   
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002293 2001
% 212.45/212.60  |- mesh__dateCreated mesh__D002293 1999-01-01
% 212.45/212.60  |- mesh__historyNote mesh__D002293 94; was CARCINOMA, SCIRRHOUS 1963-93   
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002293 2000
% 212.45/212.60  |- skos__hiddenLabel mesh__D002293 Scirrhous Carcinomas
% 212.45/212.60  |- mesh__recordOriginator mesh__D002293 NLM
% 212.45/212.60  |- skos__hiddenLabel mesh__D002293 Scirrhous Adenocarcinomas
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002293 1999
% 212.45/212.60  |- skos__altLabel mesh__D002293 Carcinoma, Scirrhous
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002293 1997
% 212.45/212.60  |- mesh__recordAuthorizer mesh__D002293 PLS
% 212.45/212.60  |- skos__annotation mesh__D002293
% 212.45/212.60       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 212.45/212.60  |- mesh__recordMaintainer mesh__D002293 KEV
% 212.45/212.60  |- skos__hiddenLabel mesh__D002293 Adenocarcinomas, Scirrhous
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002293 1998
% 212.45/212.60  |- skos__broader mesh__D002293smesh__D000230
% 212.45/212.60  |- skos__hiddenLabel mesh__D002293 Scirrhous Adenocarcinoma
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002293 2006
% 212.45/212.60  |- skos__prefLabel mesh__D002293 Adenocarcinoma, Scirrhous
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002293 1996
% 212.45/212.60  |- mesh__recordAuthorizer mesh__D010725 sjn
% 212.45/212.60  |- skos__prefLabel mesh__D010725 Phosphocreatine
% 212.45/212.60  |- skos__hiddenLabel mesh__D010725 Disodium Salt Phosphocreatine
% 212.45/212.60  |- skos__hiddenLabel mesh__D010725 Phosphate, Creatine
% 212.45/212.60  |- mesh__recordOriginator mesh__D010725 NLM
% 212.45/212.60  |- rdf__type mesh__D010725sskos__Concept
% 212.45/212.60  |- mesh__historyNote mesh__D010725
% 212.45/212.60       66%28%63%29%; was see under COENZYMES 1963-65   
% 212.45/212.60  |- mesh__publicMeSHNote mesh__D010725
% 212.45/212.60       66; was see under COENZYMES 1963-65   
% 212.45/212.60  |- skos__scopeNote mesh__D010725
% 212.45/212.60       An endogenous substance found mainly in skeletal muscle of vertebrates. It has been tried in the treatment of cardiac disorders and has been added to cardioplegic solutions. %28%Reynolds JEF%28%Ed%29%: Martindale: The Extra Pharmacopoeia %28%electronic version%29%. Micromedex, Inc, Englewood, CO, 1996%29%%A%    
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D010725 2003
% 212.45/212.60  |- skos__broader mesh__D010725smesh__D019606
% 212.45/212.60  |- mesh__recordMaintainer mesh__D010725 CCR
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D010725 2002
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D010725 2004
% 212.45/212.60  |- mesh__dateCreated mesh__D010725 1999-01-01
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D010725 2005
% 212.45/212.60  |- skos__broader mesh__D010725smesh__D003401
% 212.45/212.60  |- mesh__dateEstablished mesh__D010725 1966-01-01
% 212.45/212.60  |- skos__altLabel mesh__D010725 Phosphorylcreatine
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D010725 2006
% 212.45/212.60  |- skos__altLabel mesh__D010725 Creatine Phosphate
% 212.45/212.60  |- mesh__dateRevised mesh__D010725 2001-07-25
% 212.45/212.60  |- skos__broader mesh__D018708smesh__D014713
% 212.45/212.60  |- skos__scopeNote mesh__D018708
% 212.45/212.60       Unclassified, bisegmented, double-stranded RNA virus isolated from the feces of humans and other animals. Some reports associate it with gastroenteritis in humans.%A%    
% 212.45/212.60  |- skos__prefLabel mesh__D018708 Picobirnavirus
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D018708 2001
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D018708 2006
% 212.45/212.60  |- rdf__type mesh__D018708sskos__Concept
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D018708 2000
% 212.45/212.60  |- skos__historyNote mesh__D018708 RNA Viruses %28%1988-1994%29%
% 212.45/212.60  |- mesh__recordMaintainer mesh__D018708 TGC
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D018708 2005
% 212.45/212.60  |- skos__hiddenLabel mesh__D018708 Picotrinaviruses
% 212.45/212.60  |- mesh__dateRevised mesh__D018708 1997-06-20
% 212.45/212.60  |- mesh__dateCreated mesh__D018708 1994-04-19
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D018708 2002
% 212.45/212.60  |- skos__annotation mesh__D018708
% 212.45/212.60       an unclassified RNA virus; from pico %28%tiny%29% + bi%28%segmented%29% + RNA virus; infection: coord IM with RNA VIRUS INFECTIONS %28%IM%29%%A%  
% 212.45/212.60  |- mesh__publicMeSHNote mesh__D018708 95   
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D018708 2004
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D018708 1999
% 212.45/212.60  |- mesh__recordAuthorizer mesh__D018708 SJN
% 212.45/212.60  |- mesh__recordOriginator mesh__D018708 AGS
% 212.45/212.60  |- mesh__dateEstablished mesh__D018708 1995-01-01
% 212.45/212.60  |- mesh__historyNote mesh__D018708 95   
% 212.45/212.60  |- skos__broader mesh__D018708smesh__D012328
% 212.45/212.60  |- skos__hiddenLabel mesh__D018708 Picobirnaviruses
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D018708 2003
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D018708 1998
% 212.45/212.60  |- mesh__dateEstablished mesh__D015410 1989-01-01
% 212.45/212.60  |- skos__historyNote mesh__D015410 Mastectomy %28%1966-1988%29%
% 212.45/212.60  |- skos__historyNote mesh__D015410
% 212.45/212.60       Breast Neoplasms/surgery %28%1966-1988%29%
% 212.45/212.60  |- mesh__publicMeSHNote mesh__D015410 89   
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D015410 2003
% 212.45/212.60  |- skos__prefLabel mesh__D015410 Mastectomy, Extended Radical
% 212.45/212.60  |- mesh__dateCreated mesh__D015410 1988-06-07
% 212.45/212.60  |- skos__hiddenLabel mesh__D015410 Extended Radical Mastectomy
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D015410 2005
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D015410 2000
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D015410 1991
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D015410 2004
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D015410 2001
% 212.45/212.60  |- skos__hiddenLabel mesh__D015410 Extended Radical Mastectomies
% 212.45/212.60  |- skos__hiddenLabel mesh__D015410 Mastectomies, Extended Radical
% 212.45/212.60  |- skos__scopeNote mesh__D015410
% 212.45/212.60       Radical mastectomy with removal of the ipsilateral half of the sternum and a portion of ribs two through five with the underlying pleura and the internal mammary lymph nodes.%A%    
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D015410 2006
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D015410 1996
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D015410 1998
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D015410 1989
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D015410 1992
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D015410 1997
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D015410 1994
% 212.45/212.60  |- skos__hiddenLabel mesh__D015410 Radical Mastectomy, Extended
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D015410 1999
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D015410 2002
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D015410 1993
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D015410 1990
% 212.45/212.60  |- mesh__historyNote mesh__D015410 89   
% 212.45/212.60  |- rdf__type mesh__D015410sskos__Concept
% 212.45/212.60  |- skos__hiddenLabel mesh__D015410 Radical Mastectomies, Extended
% 212.45/212.60  |- skos__historyNote mesh__D015410 Breast/surgery %28%1966-1988%29%
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D015410 1995
% 212.45/212.60  |- skos__annotation mesh__D015410
% 212.45/212.60       do not use /util except by MeSH definition   
% 212.45/212.60  |- skos__broader mesh__D015410smesh__D015409
% 212.45/212.60  |- skos__broader mesh__D001999smesh__D013510
% 212.45/212.60  |- rdf__type mesh__D001999sskos__Concept
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D001999 2005
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D001999 2002
% 212.45/212.60  |- mesh__recordMaintainer mesh__D001999 nns
% 212.45/212.60  |- skos__altLabel mesh__D001999 Surgical Procedures, Bronchoscopic
% 212.45/212.60  |- skos__hiddenLabel mesh__D001999 Surgeries, Bronchoscopic
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D001999 2006
% 212.45/212.60  |- mesh__recordOriginator mesh__D001999 NLM
% 212.45/212.60  |- skos__related mesh__D001999smesh__D002406
% 212.45/212.60  |- skos__altLabel mesh__D001999 Surgery, Bronchoscopic
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D001999 2003
% 212.45/212.60  |- skos__broader mesh__D001999smesh__D004724
% 212.45/212.60  |- skos__hiddenLabel mesh__D001999 Bronchoscopies
% 212.45/212.60  |- skos__hiddenLabel mesh__D001999 Bronchoscopic Surgeries
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D001999 2000
% 212.45/212.60  |- skos__broader mesh__D001999smesh__D003948
% 212.45/212.60  |- mesh__recordAuthorizer mesh__D001999 sjn
% 212.45/212.60  |- skos__altLabel mesh__D001999 Bronchoscopic Surgery
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D001999 2004
% 212.45/212.60  |- mesh__dateCreated mesh__D001999 1999-01-01
% 212.45/212.60  |- skos__scopeNote mesh__D001999
% 212.45/212.60       Endoscopic examination, therapy or surgery of the bronchi.%A%    
% 212.45/212.60  |- skos__prefLabel mesh__D001999 Bronchoscopy
% 212.45/212.60  |- skos__hiddenLabel mesh__D001999 Surgical Procedure, Bronchoscopic
% 212.45/212.60  |- skos__hiddenLabel mesh__D001999 Bronchoscopic Surgical Procedure
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D001999 2001
% 212.45/212.60  |- mesh__dateRevised mesh__D001999 1999-11-03
% 212.45/212.60  |- mesh__recordAuthorizer mesh__D042807 sjn
% 212.45/212.60  |- skos__broader mesh__D042807smesh__D009343
% 212.45/212.60  |- mesh__dateCreated mesh__D042807 2003-07-09
% 212.45/212.60  |- mesh__dateRevised mesh__D042807 2005-06-30
% 212.45/212.60  |- mesh__dateEstablished mesh__D042807 2004-01-01
% 212.45/212.60  |- rdf__type mesh__D042807sskos__Concept
% 212.45/212.60  |- mesh__recordMaintainer mesh__D042807 SYSTEM
% 212.45/212.60  |- mesh__publicMeSHNote mesh__D042807 2004   
% 212.45/212.60  |- skos__scopeNote mesh__D042807
% 212.45/212.60       A species of gram-negative, aerobic BACTERIA, found in the human NASOPHARYNX and in the normal flora of the respiratory tissues in DOLPHINS. It is occasionally pathogenic for humans and pathogenic for MICE. %28%Bergey%27%s Manual of Systemic Bacteriology, 1st edition, p295%29%%A%    
% 212.45/212.60  |- skos__annotation mesh__D042807
% 212.45/212.60       infection: coord IM with NEISSERIACEAE INFECTIONS %28%IM%29%   
% 212.45/212.60  |- skos__historyNote mesh__D042807 Neisseria %28%1970-2003%29%
% 212.45/212.60  |- mesh__historyNote mesh__D042807 2004   
% 212.45/212.60  |- mesh__recordOriginator mesh__D042807 ags
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D042807 2006
% 212.45/212.60  |- skos__prefLabel mesh__D042807 Neisseria mucosa
% 212.45/212.60  |- skos__scopeNote mesh__D006684
% 212.45/212.60       A group of D-related human leukocyte antigens that are polymorphic glycoproteins found on lymphoid cells. They consist of alpha and beta chains and their inheritance differs from that of the DQ and DP antigens; their presence seems to be associated with certain skin diseases like pemphigus vulgaris, dermatitis herpetiformis, and type I diabetes.%A%    
% 212.45/212.60  |- skos__hiddenLabel mesh__D006684 HLA D Related Antigens
% 212.45/212.60  |- skos__prefLabel mesh__D006684 HLA-DR Antigens
% 212.45/212.60  |- skos__altLabel mesh__D006684 HLA-D-Related Antigens
% 212.45/212.60  |- skos__hiddenLabel mesh__D006684 HLA MT Antigens
% 212.45/212.60  |- mesh__historyNote mesh__D006684
% 212.45/212.60       89%28%87%29%; was see under HLA-D ANTIGENS 1987-88   
% 212.45/212.60  |- skos__annotation mesh__D006684
% 212.45/212.60       GEN: prefer specifics; assoc with various skin dis %26% insulin-depend diabetes mellitus; DF: HLA DR%A%  
% 212.45/212.60  |- skos__hiddenLabel mesh__D006684 HLA DR alpha
% 212.45/212.60  |- rdf__type mesh__D006684sskos__Concept
% 212.45/212.60  |- skos__hiddenLabel mesh__D006684 Antigens, HLA-BR
% 212.45/212.60  |- skos__historyNote mesh__D006684
% 212.45/212.60       Antigens, Immune Response %28%1981-1986%29%
% 212.45/212.60  |- skos__altLabel mesh__D006684 HLA-DR
% 212.45/212.60  |- skos__hiddenLabel mesh__D006684 Antigens, HLA-D-Related
% 212.45/212.60  |- skos__altLabel mesh__D006684 HLA-BR
% 212.45/212.60  |- mesh__recordOriginator mesh__D006684 SH
% 212.45/212.60  |- skos__altLabel mesh__D006684 HLA-BR Antigens
% 212.45/212.60  |- skos__altLabel mesh__D006684 HLA-MT Antigens
% 212.45/212.60  |- skos__altLabel mesh__D006684 HLA-MT
% 212.45/212.60  |- skos__broader mesh__D006684smesh__D006681
% 212.45/212.60  |- skos__hiddenLabel mesh__D006684 HLA BR Antigens
% 212.45/212.60  |- mesh__publicMeSHNote mesh__D006684
% 212.45/212.60       89; was see under HLA-D ANTIGENS 1987-88   
% 212.45/212.60  |- skos__hiddenLabel mesh__D006684 Antigens, HLA-MT
% 212.45/212.60  |- skos__hiddenLabel mesh__D006684 HLA DR Antigens
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D006684 2006
% 212.45/212.60  |- mesh__recordMaintainer mesh__D006684 ssb
% 212.45/212.60  |- mesh__dateCreated mesh__D006684 1986-06-25
% 212.45/212.60  |- mesh__recordAuthorizer mesh__D006684 sjn
% 212.45/212.60  |- mesh__dateRevised mesh__D006684 2005-06-30
% 212.45/212.60  |- mesh__dateEstablished mesh__D006684 1989-01-01
% 212.45/212.60  |- skos__hiddenLabel mesh__D006684 Antigens, HLA-DR
% 212.45/212.60  |- skos__hiddenLabel mesh__D006684 HLA DR beta
% 212.45/212.60  |- skos__prefLabel mesh__D020355 Cholates
% 212.45/212.60  |- skos__scopeNote mesh__D020355 Salts and esters of CHOLIC ACID.     
% 212.45/212.60  |- mesh__historyNote mesh__D020355
% 212.45/212.60       99; for CHOLATE use CHOLIC ACIDS %28%NM%29% 1981-98   
% 212.45/212.60  |- mesh__publicMeSHNote mesh__D020355
% 212.45/212.60       99; CHOLATE was indexed under CHOLIC ACIDS 1983-98   
% 212.45/212.60  |- rdf__type mesh__D020355sskos__Concept
% 212.45/212.60  |- mesh__dateCreated mesh__D020355 1998-06-10
% 212.45/212.60  |- skos__annotation mesh__D020355 SODIUM CHOLATE is available   
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D020355 2005
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D020355 2002
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D020355 2006
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D020355 2003
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D020355 1999
% 212.45/212.60  |- skos__broader mesh__D020355smesh__D019826
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D020355 2000
% 212.45/212.60  |- mesh__dateEstablished mesh__D020355 1999-01-01
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D020355 2004
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D020355 2001
% 212.45/212.60  |- mesh__recordOriginator mesh__D014318 NLM
% 212.45/212.60  |- mesh__recordAuthorizer mesh__D014318 sjn
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D014318 2004
% 212.45/212.60  |- skos__historyNote mesh__D014318 Mastigophora %28%1966-1971%29%
% 212.45/212.60  |- skos__annotation mesh__D014318
% 212.45/212.60       infection: coord IM with MASTIGOPHORA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 212.45/212.60  |- mesh__dateEstablished mesh__D014318 1972-01-01
% 212.45/212.60  |- skos__prefLabel mesh__D014318 Tritrichomonas
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D014318 2005
% 212.45/212.60  |- mesh__historyNote mesh__D014318 72   
% 212.45/212.60  |- mesh__recordMaintainer mesh__D014318 ags
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D014318 2006
% 212.45/212.60  |- skos__broader mesh__D014318smesh__D016834
% 212.45/212.60  |- mesh__dateCreated mesh__D014318 1999-01-01
% 212.45/212.60  |- mesh__dateRevised mesh__D014318 2003-07-09
% 212.45/212.60  |- mesh__publicMeSHNote mesh__D014318 72   
% 212.45/212.60  |- rdf__type mesh__D014318sskos__Concept
% 212.45/212.60  |- skos__scopeNote mesh__D014318
% 212.45/212.60       A genus of flagellate protozoans possessing three long anterior flagella.%A%    
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D019003 2005
% 212.45/212.60  |- skos__broader mesh__D019003smesh__D015252
% 212.45/212.60  |- skos__historyNote mesh__D019003
% 212.45/212.60       DNA Restriction Enzymes %28%1980-1988%29%
% 212.45/212.60  |- mesh__dateRevised mesh__D019003 2003-07-09
% 212.45/212.60  |- skos__annotation mesh__D019003
% 212.45/212.60       a DNA restriction enzyme; HpaII stands for Haemophilus parainfluenzae + strain ident; DF: HPAII%A%  
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D019003 2006
% 212.45/212.60  |- rdf__type mesh__D019003sskos__Concept
% 212.45/212.60  |- skos__scopeNote mesh__D019003
% 212.45/212.60       One of the Type II site-specific deoxyribonucleases %28%EC 3.1.21.4%29%. It recognizes and cleaves the sequences C/CGG and GGC/C at the slash. HpaII is from Haemophilus parainfluenzae. Several isoschizomers have been identified. EC 3.1.21.-.%A%    
% 212.45/212.60  |- skos__altLabel mesh__D019003 MspI Endonuclease
% 212.45/212.60  |- mesh__dateCreated mesh__D019003 1995-05-24
% 212.45/212.60  |- skos__altLabel mesh__D019003 Endodeoxyribonuclease HpaII
% 212.45/212.60  |- skos__historyNote mesh__D019003
% 212.45/212.60       Deoxyribonucleases, Type II Site-Specific %28%1989-1995%29%
% 212.45/212.60  |- mesh__historyNote mesh__D019003
% 212.45/212.60       96; was ENDODEOXYRIBONUCLEASE HPAII %28%NM%29% 1980-95   
% 212.45/212.60  |- skos__altLabel mesh__D019003 DNA Restriction Enzyme HpaII
% 212.45/212.60  |- skos__prefLabel mesh__D019003 Deoxyribonuclease HpaII
% 212.45/212.60  |- mesh__dateEstablished mesh__D019003 1996-01-01
% 212.45/212.60  |- skos__hiddenLabel mesh__D019003 Endonuclease, HapII
% 212.45/212.60  |- mesh__onlineNote mesh__D019003
% 212.45/212.60       use DEOXYRIBONUCLEASE HPAII %28%NM%29% to search ENDODEOXYRIBONUCLEASE HPAII 1980-95%A%  
% 212.45/212.60  |- skos__altLabel mesh__D019003 Endonuclease HpaII
% 212.45/212.60  |- mesh__publicMeSHNote mesh__D019003
% 212.45/212.60       96; ENDODEOXYRIBONUCLEASE HPAII was indexed under DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC 1989-95 %26% DNA RESTRICTION ENZYMES 1980-88%A%  
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D019003 2004
% 212.45/212.60  |- skos__altLabel mesh__D011020 Pneumonia, Pneumocystis carinii
% 212.45/212.60  |- mesh__recordMaintainer mesh__D011020 ags
% 212.45/212.60  |- mesh__recordOriginator mesh__D011020 NLM
% 212.45/212.60  |- skos__scopeNote mesh__D011020
% 212.45/212.60       A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECI. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis.%A%    
% 212.45/212.60  |- skos__altLabel mesh__D011020 Pneumocystosis
% 212.45/212.60  |- skos__broader mesh__D011020smesh__D016720
% 212.45/212.60  |- mesh__historyNote mesh__D011020 2004 %28%1963%29%   
% 212.45/212.60  |- mesh__dateRevised mesh__D011020 2003-07-09
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D011020 2005
% 212.45/212.60  |- skos__altLabel mesh__D011020 Pneumonia, Interstitial Plasma Cell
% 212.45/212.60  |- skos__altLabel mesh__D011020 Pneumocystis carinii Pneumonia
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D011020 2004
% 212.45/212.60  |- skos__hiddenLabel mesh__D011020 Pneumocystoses
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D011020 2006
% 212.45/212.60  |- mesh__publicMeSHNote mesh__D011020
% 212.45/212.60       2004; see PNEUMONIA, PNEUMOCYSTIS CARINII 1985-2003, see PNEUMONIA, INTERSTITIAL PLASMA CELL 1963-1984%A%  
% 212.45/212.60  |- skos__hiddenLabel mesh__D011020 Pneumocystis Pneumonias
% 212.45/212.60  |- mesh__dateCreated mesh__D011020 1999-01-01
% 212.45/212.60  |- skos__prefLabel mesh__D011020 Pneumonia, Pneumocystis
% 212.45/212.60  |- skos__broader mesh__D011020smesh__D008172
% 212.45/212.60  |- skos__altLabel mesh__D011020 Pneumocystis Pneumonia
% 212.45/212.60  |- mesh__recordAuthorizer mesh__D011020 sjn
% 212.45/212.60  |- skos__hiddenLabel mesh__D011020 Pneumonias, Pneumocystis carinii
% 212.45/212.60  |- rdf__type mesh__D011020sskos__Concept
% 212.45/212.60  |- skos__broader mesh__D011020smesh__D011014
% 212.45/212.60  |- skos__hiddenLabel mesh__D011020 Pneumonias, Pneumocystis
% 212.45/212.60  |- skos__broader mesh__D014867Q000652smesh__D014867
% 212.45/212.60  |- mesh__preferredCombination mesh__D014867Q000652smesh__D014556
% 212.45/212.60  |- rdf__type mesh__D014867Q000652smesh__CompoundConcept
% 212.45/212.60  |- skos__hiddenLabel mesh__D002294 Carcinomas, Planocellular
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002294 2003
% 212.45/212.60  |- skos__hiddenLabel mesh__D002294 Squamous Cell Carcinoma
% 212.45/212.60  |- mesh__recordMaintainer mesh__D002294 KEV
% 212.45/212.60  |- mesh__dateCreated mesh__D002294 1999-01-01
% 212.45/212.60  |- skos__hiddenLabel mesh__D002294 Planocellular Carcinoma
% 212.45/212.60  |- mesh__publicMeSHNote mesh__D002294
% 212.45/212.60       81; was CARCINOMA, EPIDERMOID 1963-80   
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002294 2004
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002294 1996
% 212.45/212.60  |- skos__hiddenLabel mesh__D002294 Epidermoid Carcinoma
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002294 2005
% 212.45/212.60  |- mesh__onlineNote mesh__D002294
% 212.45/212.60       use CARCINOMA, SQUAMOUS CELL to search CARCINOMA, EPIDERMOID 1966-80%A%  
% 212.45/212.60  |- skos__broader mesh__D002294smesh__D002277
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002294 2000
% 212.45/212.60  |- mesh__dateRevised mesh__D002294 1995-06-08
% 212.45/212.60  |- mesh__recordAuthorizer mesh__D002294 PLS
% 212.45/212.60  |- skos__annotation mesh__D002294
% 212.45/212.60       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 212.45/212.60  |- skos__hiddenLabel mesh__D002294 Epidermoid Carcinomas
% 212.45/212.60  |- mesh__recordOriginator mesh__D002294 NLM
% 212.45/212.60  |- rdf__type mesh__D002294sskos__Concept
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002294 1997
% 212.45/212.60  |- skos__hiddenLabel mesh__D002294 Carcinomas, Squamous Cell
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002294 2006
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002294 1998
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002294 2001
% 212.45/212.60  |- skos__altLabel mesh__D002294 Carcinoma, Squamous
% 212.45/212.60  |- skos__scopeNote mesh__D002294
% 212.45/212.60       A carcinoma derived from stratified squamous epithelium. It may also occur in sites where glandular or columnar epithelium is normally present. %28%From Stedman, 25th ed%29%%A%    
% 212.45/212.60  |- skos__hiddenLabel mesh__D002294 Squamous Carcinoma
% 212.45/212.60  |- skos__hiddenLabel mesh__D002294 Carcinomas, Squamous
% 212.45/212.60  |- skos__prefLabel mesh__D002294 Carcinoma, Squamous Cell
% 212.45/212.60  |- skos__broader mesh__D002294smesh__D018307
% 212.45/212.60  |- skos__hiddenLabel mesh__D002294 Planocellular Carcinomas
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002294 1999
% 212.45/212.60  |- skos__hiddenLabel mesh__D002294 Carcinomas, Epidermoid
% 212.45/212.60  |- skos__altLabel mesh__D002294 Carcinoma, Epidermoid
% 212.45/212.60  |- skos__altLabel mesh__D002294 Carcinoma, Planocellular
% 212.45/212.60  |- skos__hiddenLabel mesh__D002294 Squamous Carcinomas
% 212.45/212.60  |- skos__hiddenLabel mesh__D002294 Squamous Cell Carcinomas
% 212.45/212.60  |- mesh__historyNote mesh__D002294 81; was CARCINOMA, EPIDERMOID 1963-80   
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D002294 2002
% 212.45/212.60  |- mesh__dateRevised mesh__D010726 2003-07-09
% 212.45/212.60  |- skos__prefLabel mesh__D010726 Phosphodiesterase Inhibitors
% 212.45/212.60  |- rdf__type mesh__D010726sskos__Concept
% 212.45/212.60  |- mesh__recordOriginator mesh__D010726 RLS
% 212.45/212.60  |- mesh__recordMaintainer mesh__D010726 ssb
% 212.45/212.60  |- mesh__dateCreated mesh__D010726 1977-05-23
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D010726 2005
% 212.45/212.60  |- mesh__recordAuthorizer mesh__D010726 sjn
% 212.45/212.60  |- skos__altLabel mesh__D010726 Phosphoric Diester Hydrolase Inhibitors
% 212.45/212.60  |- skos__altLabel mesh__D010726 Phosphodiesterase Antagonists
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D010726 2004
% 212.45/212.60  |- skos__annotation mesh__D010726 DF: PHOSPHODIESTERASE INHIB   
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D010726 2006
% 212.45/212.60  |- mesh__dateEstablished mesh__D010726 1978-01-01
% 212.45/212.60  |- skos__historyNote mesh__D010726
% 212.45/212.60       Phosphodiesterases/antagonists %26% inhibitors %28%1972-1977%29%
% 212.45/212.60  |- skos__altLabel mesh__D010726 Antiphosphodiesterases
% 212.45/212.60  |- mesh__publicMeSHNote mesh__D010726 78   
% 212.45/212.60  |- mesh__historyNote mesh__D010726 78   
% 212.45/212.60  |- skos__scopeNote mesh__D010726
% 212.45/212.60       Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases.%A%    
% 212.45/212.60  |- skos__broader mesh__D010726smesh__D004791
% 212.45/212.60  |- skos__hiddenLabel mesh__D018709 Statistics, Non Parametric
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D018709 2005
% 212.45/212.60  |- skos__hiddenLabel mesh__D018709 Rank-Sum Test
% 212.45/212.60  |- skos__hiddenLabel mesh__D018709 Non Parametric Statistics
% 212.45/212.60  |- skos__historyNote mesh__D018709 Statistics %28%1966-1994%29%
% 212.45/212.60  |- mesh__recordAuthorizer mesh__D018709 sjn
% 212.45/212.60  |- skos__prefLabel mesh__D018709 Statistics, Nonparametric
% 212.45/212.60  |- skos__hiddenLabel mesh__D018709 U Test, Mann-Whitney
% 212.45/212.60  |- skos__annotation mesh__D018709
% 212.45/212.60       IM GEN only; coord NIM with specific disease /epidemiol %28%IM%29% or specific non-disease term /statist %28%IM%29%; no qualif%A%  
% 212.45/212.60  |- mesh__publicMeSHNote mesh__D018709 95   
% 212.45/212.60  |- mesh__dateRevised mesh__D018709 2002-07-03
% 212.45/212.60  |- skos__broader mesh__D018709smesh__D013223
% 212.45/212.60  |- mesh__activeMeSHYear mesh__D018709 2006
% 212.45/212.60  |- mesh__recordMaintainer mesh__D018709 mdb
% 212.45/212.60  |- rdf__type mesh__D018709sskos__Concept
% 212.45/212.60  |- skos__altLabel mesh__D018709 Nonparametric Statistics
% 212.45/212.60  |- mesh__dateCreated mesh__D018709 1994-05-23
% 212.45/212.60  |- skos__altLabel mesh__D018709 Statistics, Non-Parametric
% 212.45/212.60  |- mesh__dateEstablished mesh__D018709 1995-01-01
% 212.45/212.60  |- skos__hiddenLabel mesh__D018709 Rank Test, Wilcoxon
% 212.45/212.61  |- skos__hiddenLabel mesh__D018709 Tests, Rank-Sum
% 212.45/212.61  |- skos__hiddenLabel mesh__D018709 Test, Kolmogorov-Smirnov
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D018709 2003
% 212.45/212.61  |- skos__hiddenLabel mesh__D018709 Rank Sum Tests
% 212.45/212.61  |- mesh__recordOriginator mesh__D018709 JLS
% 212.45/212.61  |- skos__hiddenLabel mesh__D018709 Test, Wilcoxon Rank
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D018709 2004
% 212.45/212.61  |- skos__hiddenLabel mesh__D018709 Test, Wilcox
% 212.45/212.61  |- mesh__historyNote mesh__D018709 95   
% 212.45/212.61  |- skos__hiddenLabel mesh__D018709 Kolmogorov Smirnov Test
% 212.45/212.61  |- skos__altLabel mesh__D018709 Non-Parametric Statistics
% 212.45/212.61  |- skos__hiddenLabel mesh__D018709 Mann Whitney U Test
% 212.45/212.61  |- skos__hiddenLabel mesh__D018709 Test, Mann-Whitney U
% 212.45/212.61  |- skos__scopeNote mesh__D018709
% 212.45/212.61       A class of statistical methods applicable to a large set of probability distributions used to test for correlation, location, independence, etc. In most nonparametric statistical tests, the original scores or observations are replaced by another variable containing less information. An important class of nonparametric tests employs the ordinal properties of the data. Another class of tests uses information about whether an observation is above or below some fixed value such as the median, and a third class is based on the frequency of the occurrence of runs in the data. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1284; Corsini, Concise Encyclopedia of Psychology, 1987, p764-5%29%%A%    
% 212.45/212.61  |- skos__hiddenLabel mesh__D018709 Test, Rank-Sum
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D015411 2006
% 212.45/212.61  |- skos__prefLabel mesh__D015411 Mastectomy, Modified Radical
% 212.45/212.61  |- skos__altLabel mesh__D015411 Modified Mastectomy
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D015411 1996
% 212.45/212.61  |- skos__hiddenLabel mesh__D015411 Radical Mastectomies, Modified
% 212.45/212.61  |- skos__hiddenLabel mesh__D015411 Mastectomy, Patey
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D015411 2002
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D015411 1998
% 212.45/212.61  |- skos__scopeNote mesh__D015411
% 212.45/212.61       Total mastectomy with axillary node dissection, but with preservation of the pectoral muscles.%A%    
% 212.45/212.61  |- skos__hiddenLabel mesh__D015411 Modified Radical Mastectomy
% 212.45/212.61  |- skos__historyNote mesh__D015411 Breast/surgery %28%1966-1988%29%
% 212.45/212.61  |- skos__historyNote mesh__D015411
% 212.45/212.61       Breast Neoplasms/surgery %28%1966-1988%29%
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D015411 1997
% 212.45/212.61  |- mesh__historyNote mesh__D015411 89   
% 212.45/212.61  |- skos__hiddenLabel mesh__D015411 Mastectomies, Modified Radical
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D015411 1994
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D015411 1999
% 212.45/212.61  |- mesh__recordAuthorizer mesh__D015411 PLS
% 212.45/212.61  |- skos__hiddenLabel mesh__D015411 Mastectomies, Modified
% 212.45/212.61  |- skos__broader mesh__D015411smesh__D015409
% 212.45/212.61  |- skos__hiddenLabel mesh__D015411 Modified Radical Mastectomies
% 212.45/212.61  |- mesh__dateCreated mesh__D015411 1988-06-07
% 212.45/212.61  |- mesh__recordOriginator mesh__D015411 EJB
% 212.45/212.61  |- rdf__type mesh__D015411sskos__Concept
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D015411 1995
% 212.45/212.61  |- mesh__dateRevised mesh__D015411 1993-06-02
% 212.45/212.61  |- skos__annotation mesh__D015411
% 212.45/212.61       do not use /util except by MeSH definition   
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D015411 2000
% 212.45/212.61  |- skos__hiddenLabel mesh__D015411 Radical Mastectomy, Modified
% 212.45/212.61  |- mesh__dateEstablished mesh__D015411 1989-01-01
% 212.45/212.61  |- skos__hiddenLabel mesh__D015411 Modified Mastectomies
% 212.45/212.61  |- mesh__recordMaintainer mesh__D015411 TGC
% 212.45/212.61  |- mesh__publicMeSHNote mesh__D015411 89   
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D015411 2003
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D015411 2001
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D015411 2005
% 212.45/212.61  |- skos__historyNote mesh__D015411 Mastectomy %28%1966-1988%29%
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D015411 2004
% 212.45/212.61  |- skos__hiddenLabel mesh__D015411 Mastectomy, Modified
% 212.45/212.61  |- skos__prefLabel mesh__D042808 Neisseria sicca
% 212.45/212.61  |- mesh__dateCreated mesh__D042808 2003-07-09
% 212.45/212.61  |- mesh__recordAuthorizer mesh__D042808 sjn
% 212.45/212.61  |- skos__historyNote mesh__D042808 Neisseria %28%1966-2003%29%
% 212.45/212.61  |- skos__broader mesh__D042808smesh__D009343
% 212.45/212.61  |- mesh__recordMaintainer mesh__D042808 SYSTEM
% 212.45/212.61  |- rdf__type mesh__D042808sskos__Concept
% 212.45/212.61  |- skos__annotation mesh__D042808
% 212.45/212.61       infection: coord IM with NEISSERIACEAE INFECTIONS %28%IM%29%   
% 212.45/212.61  |- mesh__publicMeSHNote mesh__D042808 2004   
% 212.45/212.61  |- mesh__dateRevised mesh__D042808 2005-06-30
% 212.45/212.61  |- mesh__dateEstablished mesh__D042808 2004-01-01
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D042808 2006
% 212.45/212.61  |- skos__scopeNote mesh__D042808
% 212.45/212.61       A species of gram-negative, aerobic BACTERIA found in the human NASOPHARYNX; SALIVA; and SPUTUM.%A%    
% 212.45/212.61  |- mesh__recordOriginator mesh__D042808 ags
% 212.45/212.61  |- mesh__historyNote mesh__D042808 2004   
% 212.45/212.61  |- skos__altLabel mesh__D006685 Voice Hoarseness
% 212.45/212.61  |- rdf__type mesh__D006685sskos__Concept
% 212.45/212.61  |- mesh__recordMaintainer mesh__D006685 KEV
% 212.45/212.61  |- skos__hiddenLabel mesh__D006685 Hoarseness, Voice
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D006685 2000
% 212.45/212.61  |- skos__hiddenLabel mesh__D006685 Hoarsenesses
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D006685 2006
% 212.45/212.61  |- mesh__dateCreated mesh__D006685 1999-01-01
% 212.45/212.61  |- skos__prefLabel mesh__D006685 Hoarseness
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D006685 2002
% 212.45/212.61  |- skos__scopeNote mesh__D006685
% 212.45/212.61       An unnaturally deep or rough quality of voice.     
% 212.45/212.61  |- skos__broader mesh__D006685smesh__D012120
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D006685 2005
% 212.45/212.61  |- mesh__dateRevised mesh__D006685 1999-11-08
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D006685 2004
% 212.45/212.61  |- skos__hiddenLabel mesh__D006685 Hoarseness, Neurogenic
% 212.45/212.61  |- skos__broader mesh__D006685smesh__D014832
% 212.45/212.61  |- skos__broader mesh__D006685smesh__D012818
% 212.45/212.61  |- skos__altLabel mesh__D006685 Hoarseness of Voice
% 212.45/212.61  |- skos__hiddenLabel mesh__D006685 Neurogenic Hoarsenesses
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D006685 2003
% 212.45/212.61  |- skos__annotation mesh__D006685
% 212.45/212.61       for other qualities of voice VOICE QUALITY %26% VOICE DISORDERS are available%A%  
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D006685 2001
% 212.45/212.61  |- mesh__recordOriginator mesh__D006685 NLM
% 212.45/212.61  |- mesh__recordAuthorizer mesh__D006685 sjn
% 212.45/212.61  |- skos__hiddenLabel mesh__D039061 Reference Terminology, SNOMED
% 212.45/212.61  |- mesh__dateCreated mesh__D039061 2002-07-03
% 212.45/212.61  |- mesh__historyNote mesh__D039061 2003   
% 212.45/212.61  |- skos__historyNote mesh__D039061 Vocabulary, Controlled %28%1978-2002%29%
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D039061 2004
% 212.45/212.61  |- skos__altLabel mesh__D039061 SNOMED Reference Terminology
% 212.45/212.61  |- skos__hiddenLabel mesh__D039061 Clinical Term, SNOMED
% 212.45/212.61  |- skos__prefLabel mesh__D039061 Systematized Nomenclature of Medicine
% 212.45/212.61  |- skos__scopeNote mesh__D039061
% 212.45/212.61       Controlled vocabulary of clinical terms produced by the College of American Pathologists.%A%    
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D039061 2003
% 212.45/212.61  |- mesh__dateEstablished mesh__D039061 2003-01-01
% 212.45/212.61  |- skos__altLabel mesh__D039061 SNOMED Clinical Terms
% 212.45/212.61  |- skos__annotation mesh__D039061 CATALOG: use NAF entry   
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D039061 2006
% 212.45/212.61  |- skos__hiddenLabel mesh__D039061 SNOMED Clinical Term
% 212.45/212.61  |- skos__broader mesh__D039061smesh__D018875
% 212.45/212.61  |- skos__hiddenLabel mesh__D039061 Clinical Terms, SNOMED
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D039061 2005
% 212.45/212.61  |- rdf__type mesh__D039061sskos__Concept
% 212.45/212.61  |- mesh__publicMeSHNote mesh__D039061 2003   
% 212.45/212.61  |- skos__altLabel mesh__D039061 SNOMED
% 212.45/212.61  |- skos__historyNote mesh__D039061 Terminology %28%1978-2002%29%
% 212.45/212.61  |- mesh__historyNote mesh__D014319 72   
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D014319 2006
% 212.45/212.61  |- mesh__publicMeSHNote mesh__D014319 72   
% 212.45/212.61  |- mesh__recordMaintainer mesh__D014319 ags
% 212.45/212.61  |- mesh__dateCreated mesh__D014319 1999-01-01
% 212.45/212.61  |- rdf__type mesh__D014319sskos__Concept
% 212.45/212.61  |- mesh__recordAuthorizer mesh__D014319 sjn
% 212.45/212.61  |- mesh__dateRevised mesh__D014319 2003-07-09
% 212.45/212.61  |- mesh__recordOriginator mesh__D014319 NLM
% 212.45/212.61  |- mesh__dateEstablished mesh__D014319 1972-01-01
% 212.45/212.61  |- skos__annotation mesh__D014319
% 212.45/212.61       aquatic newt; NIM when exper animal: no qualif; IM; qualif permitted%A%  
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D014319 2004
% 212.45/212.61  |- skos__broader mesh__D014319smesh__D012455
% 212.45/212.61  |- skos__historyNote mesh__D014319 Urodela %28%1966-1971%29%
% 212.45/212.61  |- skos__scopeNote mesh__D014319
% 212.45/212.61       A genus of aquatic newts in the Salamandridae family. During breeding season many Triturus males have a dorsal crest which also serves as an accessory respiratory organ. One of the common Triturus species is Triturus cristatus %28%crested newt%29%.%A%    
% 212.45/212.61  |- skos__prefLabel mesh__D014319 Triturus
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D014319 2005
% 212.45/212.61  |- mesh__dateCreated mesh__D025041 2001-07-25
% 212.45/212.61  |- skos__altLabel mesh__D025041 Migration, Animal
% 212.45/212.61  |- mesh__dateRevised mesh__D025041 2002-07-02
% 212.45/212.61  |- skos__broader mesh__D025041smesh__D001522
% 212.45/212.61  |- skos__prefLabel mesh__D025041 Animal Migration
% 212.45/212.61  |- skos__hiddenLabel mesh__D025041 Animal Migrations
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D025041 2006
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D025041 2004
% 212.45/212.61  |- skos__hiddenLabel mesh__D025041 Migrations, Animal
% 212.45/212.61  |- mesh__historyNote mesh__D025041 2002   
% 212.45/212.61  |- rdf__type mesh__D025041sskos__Concept
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D025041 2005
% 212.45/212.61  |- skos__related mesh__D025041smesh__D006702
% 212.45/212.61  |- skos__scopeNote mesh__D025041
% 212.45/212.61       Periodic movements of animals in response to seasonal changes or reproductive instinct. Hormonal changes are the trigger in at least some animals. Most migrations are made for reasons of climatic change, feeding, or breeding.%A%    
% 212.45/212.61  |- mesh__publicMeSHNote mesh__D025041 2002   
% 212.45/212.61  |- mesh__dateEstablished mesh__D025041 2002-01-01
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D025041 2003
% 212.45/212.61  |- skos__historyNote mesh__D025041 Behavior, Animal %28%1966-2001%29%
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D019802 2005
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D019802 1999
% 212.45/212.61  |- skos__prefLabel mesh__D019802 Succinic Acid
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D019802 2004
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D019802 2001
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D019802 2006
% 212.45/212.61  |- mesh__publicMeSHNote mesh__D019802
% 212.45/212.61       98; SUCCINIC ACID was indexed under SUCCINATES 1981-97   
% 212.45/212.61  |- skos__scopeNote mesh__D019802
% 212.45/212.61       A water-soluble, colorless crystal with an acid taste that is used as a chemical intermediate, in medicine, the manufacture of lacquers, and to make perfume esters. It is also used in foods as a sequestrant, buffer, and a neutralizing agent. %28%Hawley%27%s Condensed Chemical Dictionary, 12th ed, p1099; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1851%29%%A%    
% 212.45/212.61  |- skos__hiddenLabel mesh__D019802 Succinate, Potassium
% 212.45/212.61  |- skos__hiddenLabel mesh__D019802 Acid, Succinic
% 212.45/212.61  |- mesh__dateCreated mesh__D019802 1997-06-20
% 212.45/212.61  |- skos__historyNote mesh__D019802 Succinates %28%1981-1997%29%
% 212.45/212.61  |- rdf__type mesh__D019802sskos__Concept
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D019802 2002
% 212.45/212.61  |- skos__broader mesh__D019802smesh__D019822
% 212.45/212.61  |- mesh__dateEstablished mesh__D019802 1998-01-01
% 212.45/212.61  |- skos__annotation mesh__D019802
% 212.45/212.61       specific compound only; SUCCINIC ACIDS also available   
% 212.45/212.61  |- skos__hiddenLabel mesh__D019802 Acid, Butanedioic
% 212.45/212.61  |- skos__hiddenLabel mesh__D019802 Succinate, Ammonium
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D019802 1998
% 212.45/212.61  |- mesh__historyNote mesh__D019802
% 212.45/212.61       98; use SUCCINIC ACID %28%NM%29% 1981-97   
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D019802 2003
% 212.45/212.61  |- skos__altLabel mesh__D019802 Butanedioic Acid
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D019802 2000
% 212.45/212.61  |- mesh__recordOriginator mesh__D019004 TPW
% 212.45/212.61  |- rdf__type mesh__D019004sskos__Concept
% 212.45/212.61  |- mesh__onlineNote mesh__D019004
% 212.45/212.61       use GALANIN %28%NM%29% to search GALANIN 1984-95   
% 212.45/212.61  |- skos__related mesh__D019004smesh__D044088
% 212.45/212.61  |- mesh__publicMeSHNote mesh__D019004
% 212.45/212.61       96; GALANIN was indexed under PEPTIDES 1984-95   
% 212.45/212.61  |- skos__prefLabel mesh__D019004 Galanin
% 212.45/212.61  |- skos__scopeNote mesh__D019004
% 212.45/212.61       A 29-amino acid peptide that is found in both the central and peripheral nervous systems. It inhibits glucose-induced insulin release, hippocampal acetylcholine release, hippocampal glutamate %28%but not GAMMA-AMINOBUTYRIC ACID%29% release, and it lowers spinal excitability and firing of locus coeruleus neurons. It stimulates food %28%fat%29% intake and growth hormone release upon hypothalamic or i.c.v. injection. %28%Crit Rev Neurobiol 1993;7%28%3-4%29%:229-74%29%%A%    
% 212.45/212.61  |- skos__altLabel mesh__D019004 Galanin %28%1-29%29%
% 212.45/212.61  |- mesh__recordMaintainer mesh__D019004 jmp
% 212.45/212.61  |- mesh__dateEstablished mesh__D019004 1996-01-01
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D019004 2004
% 212.45/212.61  |- skos__historyNote mesh__D019004 Peptides %28%1984-1995%29%
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D019004 2005
% 212.45/212.61  |- mesh__dateRevised mesh__D019004 2003-07-09
% 212.45/212.61  |- skos__broader mesh__D019004smesh__D009479
% 212.45/212.61  |- mesh__historyNote mesh__D019004 96; was GALANIN %28%NM%29% 1984-95   
% 212.45/212.61  |- mesh__recordAuthorizer mesh__D019004 sjn
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D019004 2006
% 212.45/212.61  |- mesh__dateCreated mesh__D019004 1995-05-24
% 212.45/212.61  |- skos__scopeNote mesh__D011021
% 212.45/212.61       Chronic respiratory disease caused by the VISNA-MAEDI VIRUS. It was formerly believed to be identical with jaagsiekte %28%PULMONARY ADENOMATOSIS, OVINE%29% but is now recognized as a separate entity.%A%    
% 212.45/212.61  |- mesh__dateRevised mesh__D011021 2003-07-30
% 212.45/212.61  |- rdf__type mesh__D011021sskos__Concept
% 212.45/212.61  |- mesh__historyNote mesh__D011021
% 212.45/212.61       76; MAEDI was see PULMONARY ADENOMATOSIS, OVINE 1968-74   
% 212.45/212.61  |- mesh__recordAuthorizer mesh__D011021 sjn
% 212.45/212.61  |- mesh__recordMaintainer mesh__D011021 ags
% 212.45/212.61  |- skos__historyNote mesh__D011021
% 212.45/212.61       Pulmonary Adenomatosis, Ovine %28%1968-1975%29%
% 212.45/212.61  |- mesh__recordOriginator mesh__D011021 FPG
% 212.45/212.61  |- skos__broader mesh__D011021smesh__D012897
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D011021 2004
% 212.45/212.61  |- skos__broader mesh__D011021smesh__D016180
% 212.45/212.61  |- mesh__dateCreated mesh__D011021 1975-07-25
% 212.45/212.61  |- mesh__publicMeSHNote mesh__D011021
% 212.45/212.61       76; MAEDI was see PULMONARY ADENOMATOSIS, OVINE 1968-74   
% 212.45/212.61  |- skos__broader mesh__D011021smesh__D012757
% 212.45/212.61  |- skos__altLabel mesh__D011021 Progressive Interstitial Pneumonia of Sheep
% 212.45/212.61  |- skos__annotation mesh__D011021
% 212.45/212.61       caused by a lentivirus; don%27%t forget also SHEEP %28%NIM%29% %26% check tag ANIMALS; DF: note short X ref%A%  
% 212.45/212.61  |- skos__prefLabel mesh__D011021
% 212.45/212.61       Pneumonia, Progressive Interstitial, of Sheep
% 212.45/212.61  |- mesh__onlineNote mesh__D011021
% 212.45/212.61       search PULMONARY ADENOMATOSIS, OVINE 1968-74   
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D011021 2006
% 212.45/212.61  |- skos__altLabel mesh__D011021 Maedi
% 212.45/212.61  |- mesh__dateEstablished mesh__D011021 1976-01-01
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D011021 2005
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D002295 1999
% 212.45/212.61  |- skos__prefLabel mesh__D002295 Carcinoma, Transitional Cell
% 212.45/212.61  |- skos__hiddenLabel mesh__D002295 Cell Carcinomas, Transitional
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D002295 1998
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D002295 2000
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D002295 1997
% 212.45/212.61  |- mesh__recordMaintainer mesh__D002295 KEV
% 212.45/212.61  |- skos__hiddenLabel mesh__D002295 Carcinomas, Transitional Cell
% 212.45/212.61  |- mesh__recordOriginator mesh__D002295 NLM
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D002295 2006
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D002295 1996
% 212.45/212.61  |- skos__annotation mesh__D002295
% 212.45/212.61       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 212.45/212.61  |- mesh__recordAuthorizer mesh__D002295 PLS
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D002295 2005
% 212.45/212.61  |- skos__hiddenLabel mesh__D002295 Cell Carcinoma, Transitional
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D002295 2004
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D002295 2002
% 212.45/212.61  |- mesh__dateRevised mesh__D002295 1995-06-08
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D002295 2003
% 212.45/212.61  |- skos__scopeNote mesh__D002295
% 212.45/212.61       A malignant neoplasm derived from transitional epithelium, occurring chiefly in the urinary bladder, ureters or renal pelves %28%especially if well differentiated%29%, frequently papillary. Transitional cell carcinomas are graded 1 to 3 or 4 according to the degree of anaplasia, grade 1 appearing histologically benign but being liable to recurrence. %28%Stedman, 25th ed%29%%A%    
% 212.45/212.61  |- skos__hiddenLabel mesh__D002295 Transitional Cell Carcinoma
% 212.45/212.61  |- rdf__type mesh__D002295sskos__Concept
% 212.45/212.61  |- skos__broader mesh__D002295smesh__D002277
% 212.45/212.61  |- skos__hiddenLabel mesh__D002295 Transitional Cell Carcinomas
% 212.45/212.61  |- mesh__dateCreated mesh__D002295 1999-01-01
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D002295 2001
% 212.45/212.61  |- skos__broader mesh__D011943Q000037smesh__D011943
% 212.45/212.61  |- mesh__preferredCombination mesh__D011943Q000037smesh__D000319
% 212.45/212.61  |- rdf__type mesh__D011943Q000037smesh__CompoundConcept
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D010727 2004
% 212.45/212.61  |- mesh__dateCreated mesh__D010727 1999-01-01
% 212.45/212.61  |- skos__broader mesh__D010727smesh__D004950
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D010727 2006
% 212.45/212.61  |- mesh__publicMeSHNote mesh__D010727 94; was PHOSPHODIESTERASES 1974-93   
% 212.45/212.61  |- mesh__historyNote mesh__D010727
% 212.45/212.61       94; was PHOSPHODIESTERASES 1972-93 %28%Prov 1972-73%29%   
% 212.45/212.61  |- mesh__dateEstablished mesh__D010727 1973-01-01
% 212.45/212.61  |- skos__historyNote mesh__D010727 Phosphatases %28%1966-1971%29%
% 212.45/212.61  |- skos__altLabel mesh__D010727 Phosphodiesterases
% 212.45/212.61  |- mesh__recordMaintainer mesh__D010727 ssb
% 212.45/212.61  |- mesh__recordAuthorizer mesh__D010727 sjn
% 212.45/212.61  |- mesh__dateRevised mesh__D010727 2003-07-09
% 212.45/212.61  |- rdf__type mesh__D010727sskos__Concept
% 212.45/212.61  |- mesh__onlineNote mesh__D010727
% 212.45/212.61       use PHOSPHORIC DIESTER HYDROLASES to search PHOSPHODIESTERASES 1972-93 %28%as Prov 1972-73%29%%A%  
% 212.45/212.61  |- skos__prefLabel mesh__D010727 Phosphoric Diester Hydrolases
% 212.45/212.61  |- mesh__recordOriginator mesh__D010727 NLM
% 212.45/212.61  |- skos__hiddenLabel mesh__D010727 Hydrolases, Phosphoric Diester
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D010727 2005
% 212.45/212.61  |- skos__scopeNote mesh__D010727
% 212.45/212.61       A class of enzymes that catalyze the hydrolysis of one of the two ester bonds in a phosphodiester compound. EC 3.1.4.%A%    
% 212.45/212.61  |- skos__annotation mesh__D010727
% 212.45/212.61       /antag = PHOSPHORIC DIESTER HYDROLASE INHIBITORS %28%see PHOSPHODIESTERASE INHIBITORS%29%%A%  
% 212.45/212.61  |- skos__hiddenLabel mesh__D015412 Mastectomy, Partial
% 212.45/212.61  |- skos__hiddenLabel mesh__D015412 Local Excision Mastectomies
% 212.45/212.61  |- skos__hiddenLabel mesh__D015412 Mastectomy, Limited Resection
% 212.45/212.61  |- skos__altLabel mesh__D015412 Lumpectomy
% 212.45/212.61  |- mesh__publicMeSHNote mesh__D015412 89   
% 212.45/212.61  |- skos__historyNote mesh__D015412 Mastectomy %28%1966-1988%29%
% 212.45/212.61  |- skos__hiddenLabel mesh__D015412 Mastectomies, Local Excision
% 212.45/212.61  |- skos__hiddenLabel mesh__D015412 Mastectomies, Partial
% 212.45/212.61  |- skos__hiddenLabel mesh__D015412 Excision Mastectomy, Local
% 212.45/212.61  |- skos__hiddenLabel mesh__D015412 Segmental Mastectomies
% 212.45/212.61  |- mesh__dateCreated mesh__D015412 1988-06-07
% 212.45/212.61  |- skos__altLabel mesh__D015412 Segmentectomy
% 212.45/212.61  |- mesh__recordAuthorizer mesh__D015412 sjn
% 212.45/212.61  |- skos__hiddenLabel mesh__D015412 Mastectomies, Limited Resection
% 212.45/212.61  |- skos__hiddenLabel mesh__D015412 Segmentectomies
% 212.45/212.61  |- skos__hiddenLabel mesh__D015412 Excision Mastectomies, Local
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D015412 2006
% 212.45/212.61  |- mesh__recordMaintainer mesh__D015412 jls
% 212.45/212.61  |- mesh__recordOriginator mesh__D015412 EJB
% 212.45/212.61  |- mesh__dateRevised mesh__D015412 2001-07-25
% 212.45/212.61  |- skos__hiddenLabel mesh__D015412 Breast Conserving Surgery
% 212.45/212.61  |- skos__hiddenLabel mesh__D015412 Segmental Mastectomy
% 212.45/212.61  |- skos__broader mesh__D015412smesh__D008408
% 212.45/212.61  |- skos__hiddenLabel mesh__D015412 Resection Mastectomy, Limited
% 212.45/212.61  |- skos__scopeNote mesh__D015412
% 212.45/212.61       Removal of only enough breast tissue to ensure that the margins of the resected surgical specimen are free of tumor.%A%    
% 212.45/212.61  |- skos__altLabel mesh__D015412 Surgery, Breast-Conserving
% 212.45/212.61  |- skos__hiddenLabel mesh__D015412 Resection Mastectomies, Limited
% 212.45/212.61  |- skos__hiddenLabel mesh__D015412 Mastectomies, Segmental
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D015412 2005
% 212.45/212.61  |- skos__hiddenLabel mesh__D015412 Limited Resection Mastectomies
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D015412 2004
% 212.45/212.61  |- skos__prefLabel mesh__D015412 Mastectomy, Segmental
% 212.45/212.61  |- skos__hiddenLabel mesh__D015412 Surgery, Breast Conserving
% 212.45/212.61  |- rdf__type mesh__D015412sskos__Concept
% 212.45/212.61  |- skos__altLabel mesh__D015412 Partial Mastectomy
% 212.45/212.61  |- mesh__historyNote mesh__D015412 89   
% 212.45/212.61  |- skos__historyNote mesh__D015412
% 212.45/212.61       Breast Neoplasms/surgery %28%1966-1988%29%
% 212.45/212.61  |- skos__hiddenLabel mesh__D015412 Surgeries, Breast-Conserving
% 212.45/212.61  |- skos__altLabel mesh__D015412 Local Excision Mastectomy
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D015412 2002
% 212.45/212.61  |- skos__hiddenLabel mesh__D015412 Partial Mastectomies
% 212.45/212.61  |- skos__hiddenLabel mesh__D015412 Breast-Conserving Surgeries
% 212.45/212.61  |- skos__hiddenLabel mesh__D015412 Mastectomy, Local Excision
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D015412 2003
% 212.45/212.61  |- mesh__dateEstablished mesh__D015412 1989-01-01
% 212.45/212.61  |- skos__historyNote mesh__D015412 Breast/surgery %28%1966-1988%29%
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D006686 1993
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D006686 1994
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D006686 2006
% 212.45/212.61  |- skos__hiddenLabel mesh__D006686 Hobby
% 212.45/212.61  |- mesh__dateCreated mesh__D006686 1999-01-01
% 212.45/212.61  |- skos__annotation mesh__D006686
% 212.45/212.61       IM; coord with person pursuing the hobby %28%IM%29%   
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D006686 1999
% 212.45/212.61  |- skos__scopeNote mesh__D006686
% 212.45/212.61       Leisure activities engaged in for pleasure.     
% 212.45/212.61  |- mesh__dateRevised mesh__D006686 1992-05-15
% 212.45/212.61  |- mesh__recordAuthorizer mesh__D006686 PLS
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D006686 2005
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D006686 2004
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D006686 2001
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D006686 1998
% 212.45/212.61  |- mesh__recordOriginator mesh__D006686 NLM
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D006686 1997
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D006686 2003
% 212.45/212.61  |- skos__prefLabel mesh__D006686 Hobbies
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D006686 1996
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D006686 2000
% 212.45/212.61  |- mesh__recordMaintainer mesh__D006686 TGC
% 212.45/212.61  |- rdf__type mesh__D006686sskos__Concept
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D006686 1995
% 212.45/212.61  |- skos__broader mesh__D006686smesh__D011998
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D006686 2002
% 212.45/212.61  |- mesh__publicMeSHNote mesh__D020357 99   
% 212.45/212.61  |- mesh__dateRevised mesh__D020357 2005-06-30
% 212.45/212.61  |- mesh__historyNote mesh__D020357 99   
% 212.45/212.61  |- mesh__recordOriginator mesh__D020357 NDW
% 212.45/212.61  |- mesh__recordAuthorizer mesh__D020357 sjn
% 212.45/212.61  |- rdf__type mesh__D020357sskos__Concept
% 212.45/212.61  |- skos__scopeNote mesh__D020357
% 212.45/212.61       Curved bacteria, usually crescent-shaped rods, with ends often tapered, occurring singly, in pairs, or short chains. They are non-encapsulated, non-sporing, motile, and ferment glucose. Selenomonas are found mainly in the human buccal cavity, the rumen of herbivores, and the cecum of pigs and several rodents. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 212.45/212.61  |- skos__historyNote mesh__D020357
% 212.45/212.61       Gram-Negative Anaerobic Bacteria %28%1978-1998%29%
% 212.45/212.61  |- mesh__dateCreated mesh__D020357 1998-06-11
% 212.45/212.61  |- skos__prefLabel mesh__D020357 Selenomonas
% 212.45/212.61  |- mesh__dateEstablished mesh__D020357 1999-01-01
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D020357 2006
% 212.45/212.61  |- skos__broader mesh__D020357smesh__D045854
% 212.45/212.61  |- skos__historyNote mesh__D020357 Bacteria %28%1967-1975%29%
% 212.45/212.61  |- mesh__recordMaintainer mesh__D020357 SYSTEM
% 212.45/212.61  |- skos__historyNote mesh__D020357 Bacteroides %28%1976-1977%29%
% 212.45/212.61  |- skos__annotation mesh__D020357
% 212.45/212.61       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 212.45/212.61  |- skos__broader mesh__D020357smesh__D016965
% 212.45/212.61  |- mesh__historyNote mesh__D025042 2002   
% 212.45/212.61  |- skos__hiddenLabel mesh__D025042 Cells, Amacrine
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D025042 2006
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D025042 2004
% 212.45/212.61  |- skos__broader mesh__D025042smesh__D007395
% 212.45/212.61  |- skos__historyNote mesh__D025042 Retina/cytology %28%1966-2001%29%
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D025042 2005
% 212.45/212.61  |- rdf__type mesh__D025042sskos__Concept
% 212.45/212.61  |- skos__scopeNote mesh__D025042
% 212.45/212.61       INTERNEURONS of the vertebrate RETINA. They integrate, modulate, and interpose a temporal domain in the visual message presented to the RETINAL GANGLION CELLS, with which they synapse in the inner plexiform layer.%A%    
% 212.45/212.61  |- mesh__publicMeSHNote mesh__D025042 2002   
% 212.45/212.61  |- mesh__dateCreated mesh__D025042 2001-07-25
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D025042 2003
% 212.45/212.61  |- mesh__dateEstablished mesh__D025042 2002-01-01
% 212.45/212.61  |- skos__broader mesh__D025042smesh__D012160
% 212.45/212.61  |- skos__prefLabel mesh__D025042 Amacrine Cells
% 212.45/212.61  |- skos__hiddenLabel mesh__D025042 Cell, Amacrine
% 212.45/212.61  |- skos__hiddenLabel mesh__D025042 Amacrine Cell
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D025042 2002
% 212.45/212.61  |- mesh__recordMaintainer mesh__D019803 jmp
% 212.45/212.61  |- rdf__type mesh__D019803sskos__Concept
% 212.45/212.61  |- skos__broader mesh__D019803smesh__D005978
% 212.45/212.61  |- skos__scopeNote mesh__D019803
% 212.45/212.61       A GLUTATHIONE dimer formed by a disulfide bond between the cysteine sulfhydryl side chains during the course of being oxidized.%A%    
% 212.45/212.61  |- mesh__recordOriginator mesh__D019803 KEV
% 212.45/212.61  |- skos__prefLabel mesh__D019803 Glutathione Disulfide
% 212.45/212.61  |- skos__altLabel mesh__D019803 GSSG
% 212.45/212.61  |- skos__historyNote mesh__D019803
% 212.45/212.61       Glutathione/analogs %26% derivatives %28%1979-1997%29%
% 212.45/212.61  |- mesh__publicMeSHNote mesh__D019803
% 212.45/212.61       98; GLUTATHIONE DISULFATE was indexed under GLUTATHIONE/analogs %26% derivatives %28%80-97%29%%A%  
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D019803 2003
% 212.45/212.61  |- mesh__historyNote mesh__D019803
% 212.45/212.61       98; use GLUTATHIONE DISULFIDE %28%NM%29% 1979-97   
% 212.45/212.61  |- mesh__recordAuthorizer mesh__D019803 sjn
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D019803 2005
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D019803 2004
% 212.45/212.61  |- skos__hiddenLabel mesh__D019803 Oxidized Glutathione
% 212.45/212.61  |- skos__altLabel mesh__D019803 Glutathione, Oxidized
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D019803 2006
% 212.45/212.61  |- mesh__dateRevised mesh__D019803 2001-07-25
% 212.45/212.61  |- mesh__dateCreated mesh__D019803 1997-06-20
% 212.45/212.61  |- mesh__dateEstablished mesh__D019803 1998-01-01
% 212.45/212.61  |- skos__hiddenLabel mesh__D019803 Disulfide, Glutathione
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D019803 2002
% 212.45/212.61  |- mesh__recordMaintainer mesh__D011820 ags
% 212.45/212.61  |- mesh__dateCreated mesh__D011820 1999-01-01
% 212.45/212.61  |- rdf__type mesh__D011820sskos__Concept
% 212.45/212.61  |- mesh__dateRevised mesh__D011820 2001-07-25
% 212.45/212.61  |- skos__scopeNote mesh__D011820
% 212.45/212.61       The type species of LYSSAVIRUS causing rabies in humans and other animals. Transmission is mostly by animal bites through saliva. The virus is neurotropic multiplying in neurons and myotubes of vertebrates.%A%    
% 212.45/212.61  |- skos__annotation mesh__D011820 infection = RABIES   
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D011820 2005
% 212.45/212.61  |- skos__broader mesh__D011820smesh__D018114
% 212.45/212.61  |- skos__hiddenLabel mesh__D011820 Rabies viruses
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D011820 2003
% 212.45/212.61  |- skos__prefLabel mesh__D011820 Rabies virus
% 212.45/212.61  |- mesh__activeMeSHYear mesh__D011820 2006
% 212.45/212.61  |- mesh__recordOriginator mesh__D011820 NLM
% 212.45/212.61  |- mesh__recordAuthorizer mesh__D011820 sjn
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D011820 2004
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D011820 2002
% 212.45/212.62  |- mesh__dateEstablished mesh__D019005 1996-01-01
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D019005 2002
% 212.45/212.62  |- mesh__recordOriginator mesh__D019005 TPW
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D019005 2006
% 212.45/212.62  |- mesh__historyNote mesh__D019005
% 212.45/212.62       96; was CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR %28%NM%29% 1989-95%A%  
% 212.45/212.62  |- skos__altLabel mesh__D019005 CFTR Protein
% 212.45/212.62  |- mesh__publicMeSHNote mesh__D019005
% 212.45/212.62       96; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR was indexed under MEMBRANE PROTEINS 1989-95%A%  
% 212.45/212.62  |- mesh__recordAuthorizer mesh__D019005 sjn
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D019005 2005
% 212.45/212.62  |- rdf__type mesh__D019005sskos__Concept
% 212.45/212.62  |- skos__prefLabel mesh__D019005
% 212.45/212.62       Cystic Fibrosis Transmembrane Conductance Regulator
% 212.45/212.62  |- skos__broader mesh__D019005smesh__D018118
% 212.45/212.62  |- mesh__onlineNote mesh__D019005
% 212.45/212.62       use CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR %28%NM%29% to search CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR 1989-95%A%  
% 212.45/212.62  |- skos__hiddenLabel mesh__D019005 Protein, CFTR
% 212.45/212.62  |- skos__historyNote mesh__D019005 Membrane Proteins %28%1989-1995%29%
% 212.45/212.62  |- mesh__recordMaintainer mesh__D019005 jmp
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D019005 2004
% 212.45/212.62  |- skos__scopeNote mesh__D019005
% 212.45/212.62       A chloride channel that regulates secretion in many exocrine tissues. Abnormalities in the CFTR gene have been shown to cause cystic fibrosis. %28%Hum Genet 1994;93%28%4%29%:364-8%29%%A%    
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D019005 2003
% 212.45/212.62  |- skos__annotation mesh__D019005
% 212.45/212.62       a chloride channel; DF: note short X ref   
% 212.45/212.62  |- mesh__dateRevised mesh__D019005 2001-07-25
% 212.45/212.62  |- mesh__dateCreated mesh__D019005 1995-05-24
% 212.45/212.62  |- mesh__recordMaintainer mesh__D011022 ags
% 212.45/212.62  |- skos__scopeNote mesh__D011022
% 212.45/212.62       Pneumonia caused by infection with bacteria of the family RICKETTSIACEAE.%A%    
% 212.45/212.62  |- mesh__dateRevised mesh__D011022 2003-07-09
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D011022 2004
% 212.45/212.62  |- skos__altLabel mesh__D011022 Rickettsial Pneumonia
% 212.45/212.62  |- mesh__recordAuthorizer mesh__D011022 sjn
% 212.45/212.62  |- skos__broader mesh__D011022smesh__D012288
% 212.45/212.62  |- skos__broader mesh__D011022smesh__D018410
% 212.45/212.62  |- skos__hiddenLabel mesh__D011022 Pneumonias, Rickettsial
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D011022 2006
% 212.45/212.62  |- skos__hiddenLabel mesh__D011022 Rickettsial Pneumonias
% 212.45/212.62  |- mesh__dateCreated mesh__D011022 1999-01-01
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D011022 2005
% 212.45/212.62  |- mesh__recordOriginator mesh__D011022 NLM
% 212.45/212.62  |- rdf__type mesh__D011022sskos__Concept
% 212.45/212.62  |- skos__prefLabel mesh__D011022 Pneumonia, Rickettsial
% 212.45/212.62  |- skos__annotation mesh__D011022
% 212.45/212.62       coord IM with specific rickettsial infection %28%IM%29%   
% 212.45/212.62  |- mesh__historyNote mesh__D049490 2005   
% 212.45/212.62  |- mesh__dateEstablished mesh__D049490 2005-01-01
% 212.45/212.62  |- mesh__recordAuthorizer mesh__D049490 sjn
% 212.45/212.62  |- skos__broader mesh__D049490smesh__D019295
% 212.45/212.62  |- skos__prefLabel mesh__D049490 Systems Biology
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D049490 2005
% 212.45/212.62  |- mesh__recordMaintainer mesh__D049490 nns
% 212.45/212.62  |- mesh__recordOriginator mesh__D049490 nns
% 212.45/212.62  |- skos__scopeNote mesh__D049490
% 212.45/212.62       Comprehensive, methodical analysis of complex biological systems by monitoring responses to perturbations of biological processes. Large scale, computerized collection and analysis of the data are used to develop and test models of biological systems.%A%    
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D049490 2006
% 212.45/212.62  |- rdf__type mesh__D049490sskos__Concept
% 212.45/212.62  |- mesh__dateCreated mesh__D049490 2004-07-07
% 212.45/212.62  |- mesh__publicMeSHNote mesh__D049490 2005   
% 212.45/212.62  |- skos__related mesh__D049490smesh__D013598
% 212.45/212.62  |- skos__hiddenLabel mesh__D049490 Biology, Systems
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002296 1996
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002296 1999
% 212.45/212.62  |- skos__broader mesh__D002296smesh__D018193
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002296 2005
% 212.45/212.62  |- skos__scopeNote mesh__D002296
% 212.45/212.62       A malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. %28%Stedman, 25th ed%29%%A%    
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002296 1997
% 212.45/212.62  |- mesh__recordMaintainer mesh__D002296 KEV
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002296 2000
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002296 2003
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002296 2006
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002296 2001
% 212.45/212.62  |- skos__annotation mesh__D002296
% 212.45/212.62       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 212.45/212.62  |- mesh__recordAuthorizer mesh__D002296 PLS
% 212.45/212.62  |- skos__broader mesh__D002296smesh__D012509
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002296 2004
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002296 2002
% 212.45/212.62  |- mesh__dateCreated mesh__D002296 1999-01-01
% 212.45/212.62  |- mesh__dateRevised mesh__D002296 1995-06-08
% 212.45/212.62  |- mesh__recordOriginator mesh__D002296 NLM
% 212.45/212.62  |- rdf__type mesh__D002296sskos__Concept
% 212.45/212.62  |- skos__hiddenLabel mesh__D002296 Carcinosarcomas
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002296 1998
% 212.45/212.62  |- skos__prefLabel mesh__D002296 Carcinosarcoma
% 212.45/212.62  |- mesh__recordAuthorizer mesh__D043902 sjn
% 212.45/212.62  |- skos__historyNote mesh__D043902 Pyrococcus %28%1998-2003%29%
% 212.45/212.62  |- mesh__publicMeSHNote mesh__D043902 2004   
% 212.45/212.62  |- skos__broader mesh__D043902smesh__D019711
% 212.45/212.62  |- mesh__recordOriginator mesh__D043902 ags
% 212.45/212.62  |- mesh__dateEstablished mesh__D043902 2004-01-01
% 212.45/212.62  |- mesh__dateCreated mesh__D043902 2003-07-09
% 212.45/212.62  |- mesh__dateRevised mesh__D043902 2005-06-30
% 212.45/212.62  |- rdf__type mesh__D043902sskos__Concept
% 212.45/212.62  |- skos__scopeNote mesh__D043902
% 212.45/212.62       Anaerobic hyperthermophilic species of ARCHAEA, isolated from hydrothermal fluid samples. It is obligately heterotrophic with coccoid cells that require TRYPTOPHAN for growth.%A%    
% 212.45/212.62  |- mesh__recordMaintainer mesh__D043902 SYSTEM
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D043902 2006
% 212.45/212.62  |- mesh__historyNote mesh__D043902 2004   
% 212.45/212.62  |- skos__prefLabel mesh__D043902 Pyrococcus horikoshii
% 212.45/212.62  |- mesh__dateRevised mesh__D010728 1979-01-11
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D010728 1999
% 212.45/212.62  |- skos__prefLabel mesh__D010728 Phosphoenolpyruvate
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D010728 1989
% 212.45/212.62  |- mesh__recordOriginator mesh__D010728 NLM
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D010728 1992
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D010728 1994
% 212.45/212.62  |- mesh__recordMaintainer mesh__D010728 HMM
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D010728 2002
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D010728 1993
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D010728 1990
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D010728 1995
% 212.45/212.62  |- mesh__publicMeSHNote mesh__D010728 72   
% 212.45/212.62  |- skos__broader mesh__D010728smesh__D006880
% 212.45/212.62  |- mesh__dateEstablished mesh__D010728 1972-01-01
% 212.45/212.62  |- skos__historyNote mesh__D010728 Phosphoric Acids %28%1968-1971%29%
% 212.45/212.62  |- rdf__type mesh__D010728sskos__Concept
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D010728 2003
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D010728 2005
% 212.45/212.62  |- mesh__recordAuthorizer mesh__D010728 NLM
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D010728 1996
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D010728 2000
% 212.45/212.62  |- mesh__historyNote mesh__D010728 72   
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D010728 1991
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D010728 1998
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D010728 2004
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D010728 2001
% 212.45/212.62  |- mesh__dateCreated mesh__D010728 1999-01-01
% 212.45/212.62  |- skos__historyNote mesh__D010728 Pyruvates %28%1966-1971%29%
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D010728 2006
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D010728 1997
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D015413 2006
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D015413 1997
% 212.45/212.62  |- skos__historyNote mesh__D015413 Mastectomy %28%1966-1988%29%
% 212.45/212.62  |- skos__historyNote mesh__D015413 Breast/surgery %28%1966-1988%29%
% 212.45/212.62  |- mesh__historyNote mesh__D015413 89   
% 212.45/212.62  |- skos__altLabel mesh__D015413 Total Mastectomy
% 212.45/212.62  |- skos__hiddenLabel mesh__D015413 Simple Mastectomy
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D015413 2002
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D015413 1993
% 212.45/212.62  |- mesh__dateCreated mesh__D015413 1988-06-07
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D015413 2005
% 212.45/212.62  |- mesh__recordMaintainer mesh__D015413 TGC
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D015413 1996
% 212.45/212.62  |- skos__historyNote mesh__D015413
% 212.45/212.62       Breast Neoplasms/surgery %28%1966-1988%29%
% 212.45/212.62  |- skos__annotation mesh__D015413
% 212.45/212.62       do not use /util except by MeSH definition   
% 212.45/212.62  |- skos__hiddenLabel mesh__D015413 Simple Mastectomies
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D015413 1999
% 212.45/212.62  |- skos__hiddenLabel mesh__D015413 Mastectomies, Simple
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D015413 1992
% 212.45/212.62  |- mesh__dateEstablished mesh__D015413 1989-01-01
% 212.45/212.62  |- skos__prefLabel mesh__D015413 Mastectomy, Simple
% 212.45/212.62  |- rdf__type mesh__D015413sskos__Concept
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D015413 1995
% 212.45/212.62  |- mesh__publicMeSHNote mesh__D015413 89   
% 212.45/212.62  |- mesh__recordAuthorizer mesh__D015413 PLS
% 212.45/212.62  |- skos__hiddenLabel mesh__D015413 Total Mastectomies
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D015413 1998
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D015413 2001
% 212.45/212.62  |- mesh__dateRevised mesh__D015413 1991-05-15
% 212.45/212.62  |- skos__broader mesh__D015413smesh__D008408
% 212.45/212.62  |- skos__scopeNote mesh__D015413
% 212.45/212.62       Removal of only the breast tissue and nipple and a small portion of the overlying skin.%A%    
% 212.45/212.62  |- skos__hiddenLabel mesh__D015413 Mastectomies, Total
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D015413 2004
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D015413 1994
% 212.45/212.62  |- skos__hiddenLabel mesh__D015413 Mastectomy, Total
% 212.45/212.62  |- mesh__recordOriginator mesh__D015413 EJB
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D015413 2000
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D015413 2003
% 212.45/212.62  |- mesh__dateRevised mesh__D039861 2004-07-30
% 212.45/212.62  |- skos__hiddenLabel mesh__D039861 IF-1, Initiation Factor
% 212.45/212.62  |- skos__hiddenLabel mesh__D039861 Prokaryotic Initiation Factor 1
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D039861 2005A
% 212.45/212.62  |- rdf__type mesh__D039861sskos__Concept
% 212.45/212.62  |- mesh__dateCreated mesh__D039861 2002-07-03
% 212.45/212.62  |- mesh__publicMeSHNote mesh__D039861 2003; for IF-1see EIF-1 1990-2002   
% 212.45/212.62  |- skos__historyNote mesh__D039861
% 212.45/212.62       Eukaryotic Initiation Factor-1 %28%1989-2002%29%
% 212.45/212.62  |- skos__altLabel mesh__D039861 Peptide Initiation Factor-1, Prokaryotic
% 212.45/212.62  |- skos__altLabel mesh__D039861 Peptide Initiation Factor IF-1
% 212.45/212.62  |- skos__hiddenLabel mesh__D039861 Initiation Factor-1, Prokaryotic
% 212.45/212.62  |- mesh__recordAuthorizer mesh__D039861 jls
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D039861 2006
% 212.45/212.62  |- skos__prefLabel mesh__D039861 Prokaryotic Initiation Factor-1
% 212.45/212.62  |- skos__altLabel mesh__D039861 Initiation Factor IF-1
% 212.45/212.62  |- skos__scopeNote mesh__D039861
% 212.45/212.62       The smallest of the three prokaryotic initiation factors with a molecular size of approximately 8 kD. It binds near the A-site of the 30S subunit of RIBOSOMES and may play a role in preventing premature addition of aminoacyl-tRNA-linked PEPTIDE ELONGATION FACTOR TU to the ribosome during the initiation of a peptide chain %28%PEPTIDE CHAIN INITIATION, TRANSLATIONAL%29%.%A%    
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D039861 2005
% 212.45/212.62  |- mesh__historyNote mesh__D039861
% 212.45/212.62       2003; for IF-1 use EUKARYOTIC INITIATION FACTOR-1 1990-2002%A%  
% 212.45/212.62  |- mesh__dateEstablished mesh__D039861 2003-01-01
% 212.45/212.62  |- skos__altLabel mesh__D039861 Prokaryotic Peptide Initiation Factor-1
% 212.45/212.62  |- skos__broader mesh__D039861smesh__D039662
% 212.45/212.62  |- mesh__recordMaintainer mesh__D039861 jls
% 212.45/212.62  |- skos__hiddenLabel mesh__D039861 Peptide Initiation Factor 1, Prokaryotic
% 212.45/212.62  |- skos__historyNote mesh__D039861
% 212.45/212.62       Peptide Initiation Factors %28%1978-2002%29%
% 212.45/212.62  |- skos__hiddenLabel mesh__D039861 Peptide Initiation Factor IF 1
% 212.45/212.62  |- skos__hiddenLabel mesh__D039861 Initiation Factor IF 1
% 212.45/212.62  |- skos__hiddenLabel mesh__D039861 Prokaryotic Peptide Initiation Factor 1
% 212.45/212.62  |- mesh__recordOriginator mesh__D039861 jmp
% 212.45/212.62  |- skos__altLabel mesh__D020358 Sodium Choleate
% 212.45/212.62  |- mesh__dateCreated mesh__D020358 1998-06-11
% 212.45/212.62  |- skos__broader mesh__D020358smesh__D020355
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D020358 2006
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D020358 2001
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D020358 2004
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D020358 1999
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D020358 2000
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D020358 2005
% 212.45/212.62  |- mesh__publicMeSHNote mesh__D020358
% 212.45/212.62       99; SODIUM CHOLATE was indexed under CHOLIC ACIDS 1983-98%A%  
% 212.45/212.62  |- skos__scopeNote mesh__D020358
% 212.45/212.62       A trihydroxy bile salt that is used as a digestive aid in dietary supplements. It is used in culture media and in conjunction with PAPAIN and PANCREATIN.%A%    
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D020358 2003
% 212.45/212.62  |- skos__historyNote mesh__D020358 Cholic Acids %28%1978-1998%29%
% 212.45/212.62  |- mesh__dateEstablished mesh__D020358 1999-01-01
% 212.45/212.62  |- skos__hiddenLabel mesh__D020358 Choleate, Sodium
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D020358 2002
% 212.45/212.62  |- skos__prefLabel mesh__D020358 Sodium Cholate
% 212.45/212.62  |- mesh__historyNote mesh__D020358
% 212.45/212.62       99; use SODIUM CHOLATE %28%NM%29% 1981-98   
% 212.45/212.62  |- rdf__type mesh__D020358sskos__Concept
% 212.45/212.62  |- skos__hiddenLabel mesh__D020358 Cholate, Sodium
% 212.45/212.62  |- skos__annotation mesh__D020358 CHOLATES is available   
% 212.45/212.62  |- mesh__dateEstablished mesh__D025841 2002-01-01
% 212.45/212.62  |- mesh__historyNote mesh__D025841 2002   
% 212.45/212.62  |- skos__broader mesh__D025841smesh__D014452
% 212.45/212.62  |- mesh__dateRevised mesh__D025841 2005-06-30
% 212.45/212.62  |- mesh__recordAuthorizer mesh__D025841 sjn
% 212.45/212.62  |- skos__altLabel mesh__D025841 Sentrin Proteins
% 212.45/212.62  |- skos__scopeNote mesh__D025841
% 212.45/212.62       A class of structurally related proteins of 12-20 kDa in size. They covalently modify specific proteins in a manner analogous to UBIQUITIN.%A%    
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D025841 2006
% 212.45/212.62  |- skos__altLabel mesh__D025841 Sentrins
% 212.45/212.62  |- mesh__publicMeSHNote mesh__D025841 2002   
% 212.45/212.62  |- rdf__type mesh__D025841sskos__Concept
% 212.45/212.62  |- skos__prefLabel mesh__D025841 Small Ubiquitin-Related Modifier Proteins
% 212.45/212.62  |- skos__altLabel mesh__D025841 SUMO Proteins
% 212.45/212.62  |- skos__historyNote mesh__D025841 Ubiquitins %28%1996-2001%29%
% 212.45/212.62  |- mesh__dateCreated mesh__D025841 2001-07-25
% 212.45/212.62  |- mesh__recordOriginator mesh__D025841 jmp
% 212.45/212.62  |- skos__altLabel mesh__D025841 Ubiquitin-Related Modifier Protein, Small
% 212.45/212.62  |- mesh__recordMaintainer mesh__D025841 SYSTEM
% 212.45/212.62  |- skos__hiddenLabel mesh__D025841
% 212.45/212.62       Ubiquitin Related Modifier Protein, Small
% 212.45/212.62  |- skos__hiddenLabel mesh__D025841
% 212.45/212.62       Small Ubiquitin Related Modifier Proteins
% 212.45/212.62  |- skos__altLabel mesh__D019804 Byk Brand of Mesalamine
% 212.45/212.62  |- mesh__publicMeSHNote mesh__D019804
% 212.45/212.62       98; MESALAMINE was indexed under AMINOSALICYLIC ACIDS 1981-97%A%  
% 212.45/212.62  |- skos__historyNote mesh__D019804 Aminosalicylic Acids %28%1981-1997%29%
% 212.45/212.62  |- skos__altLabel mesh__D019804 m-Aminosalicylic Acid
% 212.45/212.62  |- skos__altLabel mesh__D019804 Celltech Brand of Mesalamine
% 212.45/212.62  |- skos__hiddenLabel mesh__D019804 Novo5 ASA
% 212.45/212.62  |- skos__altLabel mesh__D019804 Axcan Brand of Mesalamine
% 212.45/212.62  |- mesh__recordOriginator mesh__D019804 KEV
% 212.45/212.62  |- skos__altLabel mesh__D019804 GlaxoSmithKline Brand of Mesalamine
% 212.45/212.62  |- mesh__recordAuthorizer mesh__D019804 sjn
% 212.45/212.62  |- skos__altLabel mesh__D019804 Salofalk
% 212.45/212.62  |- skos__altLabel mesh__D019804 Falk Brand of Mesalamine
% 212.45/212.62  |- skos__scopeNote mesh__D019804
% 212.45/212.62       An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed%29%%A%    
% 212.45/212.62  |- skos__altLabel mesh__D019804 Provalis Brand of Mesalamine
% 212.45/212.62  |- skos__altLabel mesh__D019804 Schering-Plough Brand of Mesalamine
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D019804 2006
% 212.45/212.62  |- rdf__type mesh__D019804sskos__Concept
% 212.45/212.62  |- skos__hiddenLabel mesh__D019804 meta Aminosalicylic Acid
% 212.45/212.62  |- skos__hiddenLabel mesh__D019804 Schering Plough Brand of Mesalamine
% 212.45/212.62  |- skos__altLabel mesh__D019804 5-Aminosalicylic Acid
% 212.45/212.62  |- skos__hiddenLabel mesh__D019804 m Aminosalicylic Acid
% 212.45/212.62  |- skos__hiddenLabel mesh__D019804 Novo 5 ASA
% 212.45/212.62  |- skos__altLabel mesh__D019804 Farmasa Brand of Mesalamine
% 212.45/212.62  |- skos__altLabel mesh__D019804 Solvay Brand of Mesalamine
% 212.45/212.62  |- mesh__dateCreated mesh__D019804 1997-06-20
% 212.45/212.62  |- skos__altLabel mesh__D019804 SmithKline Brand of Mesalamine
% 212.45/212.62  |- skos__altLabel mesh__D019804 Antigen Brand of Mesalamine
% 212.45/212.62  |- skos__altLabel mesh__D019804 Ferring Brand of Mesalamine
% 212.45/212.62  |- skos__hiddenLabel mesh__D019804 Monosodium Salt, Mesalamine
% 212.45/212.62  |- skos__hiddenLabel mesh__D019804 5 Aminosalicylate
% 212.45/212.62  |- skos__altLabel mesh__D019804 Novopharm Brand of Mesalamine
% 212.45/212.62  |- skos__hiddenLabel mesh__D019804 Hydrochloride, Mesalamine
% 212.45/212.62  |- mesh__recordMaintainer mesh__D019804 CCR
% 212.45/212.62  |- skos__altLabel mesh__D019804 Sanofi Synthelabo Brand of Mesalamine
% 212.45/212.62  |- skos__altLabel mesh__D019804 Henning Berlin Brand of Mesalamine
% 212.45/212.62  |- mesh__dateEstablished mesh__D019804 1998-01-01
% 212.45/212.62  |- skos__broader mesh__D019804smesh__D000636
% 212.45/212.62  |- skos__altLabel mesh__D019804 Mesalazine
% 212.45/212.62  |- skos__prefLabel mesh__D019804 Mesalamine
% 212.45/212.62  |- skos__altLabel mesh__D019804 meta-Aminosalicylic Acid
% 212.45/212.62  |- mesh__dateRevised mesh__D019804 2005-06-30
% 212.45/212.62  |- skos__altLabel mesh__D019804 Procter %26% Gamble Brand of Mesalamine
% 212.45/212.62  |- skos__altLabel mesh__D019804 Yamanouchi Brand of Mesalamine
% 212.45/212.62  |- skos__altLabel mesh__D019804 Merckle Brand of Mesalamine
% 212.45/212.62  |- skos__hiddenLabel mesh__D019804 5 Aminosalicylic Acid
% 212.45/212.62  |- mesh__historyNote mesh__D019804 98; use MESALAMINE %28%NM%29% 1981-97   
% 212.45/212.62  |- skos__altLabel mesh__D019804 Norgine Brand of Mesalamine
% 212.45/212.62  |- skos__altLabel mesh__D019804 Allphar Brand of Mesalamine
% 212.45/212.62  |- skos__historyNote mesh__D011821 Carnivora %28%1966-1967%29%
% 212.45/212.62  |- mesh__recordOriginator mesh__D011821 NLM
% 212.45/212.62  |- mesh__dateEstablished mesh__D011821 1968-01-01
% 212.45/212.62  |- mesh__publicMeSHNote mesh__D011821 68   
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D011821 2006A
% 212.45/212.62  |- skos__annotation mesh__D011821 do not confuse with RACCOON DOGS   
% 212.45/212.62  |- skos__hiddenLabel mesh__D011821 Procyons
% 212.45/212.62  |- skos__prefLabel mesh__D011821 Raccoons
% 212.45/212.62  |- mesh__historyNote mesh__D011821 68   
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D011821 2005
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D011821 2006
% 212.45/212.62  |- skos__altLabel mesh__D011821 Procyon
% 212.45/212.62  |- skos__broader mesh__D011821smesh__D045988
% 212.45/212.62  |- mesh__recordMaintainer mesh__D011821 ags
% 212.45/212.62  |- mesh__dateCreated mesh__D011821 1999-01-01
% 212.45/212.62  |- rdf__type mesh__D011821sskos__Concept
% 212.45/212.62  |- skos__hiddenLabel mesh__D011821 Raccoon
% 212.45/212.62  |- skos__scopeNote mesh__D011821
% 212.45/212.62       Carnivores of the genus Procyon of the family PROCYONIDAE. Two subgenera and seven species are currently recognized. They range from southern Canada to Panama and are found in several of the Caribbean Islands.%A%    
% 212.45/212.62  |- mesh__dateRevised mesh__D011821 2005-07-27
% 212.45/212.62  |- mesh__recordAuthorizer mesh__D011821 ags
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D019006 2006
% 212.45/212.62  |- rdf__type mesh__D019006sskos__Concept
% 212.45/212.62  |- mesh__publicMeSHNote mesh__D019006 96   
% 212.45/212.62  |- mesh__dateEstablished mesh__D019006 1996-01-01
% 212.45/212.62  |- mesh__historyNote mesh__D019006 96   
% 212.45/212.62  |- skos__scopeNote mesh__D019006
% 212.45/212.62       Cell adhesion molecule involved in a diverse range of contact-mediated interactions among neurons, astrocytes, oligodendrocytes, and myotubes. It is widely but transiently expressed in many tissues early in embryogenesis. Four main isoforms exist, including CD56; %28%ANTIGENS, CD56%29%; but there are many other variants resulting from alternative splicing and post-translational modifications. %28%From Pigott %26% Power, The Adhesion Molecule FactsBook, 1993, pp115-119%29%%A%    
% 212.45/212.62  |- skos__altLabel mesh__D019006 Cell Adhesion Molecule, Neural
% 212.45/212.62  |- skos__altLabel mesh__D019006 Cell Adhesion Molecules, Neural
% 212.45/212.62  |- mesh__recordOriginator mesh__D019006 AGS
% 212.45/212.62  |- skos__prefLabel mesh__D019006 Neural Cell Adhesion Molecules
% 212.45/212.62  |- skos__altLabel mesh__D019006 Neural Cell Adhesion Molecule
% 212.45/212.62  |- skos__annotation mesh__D019006
% 212.45/212.62       NCAM: note X ref NEURAL CELL ADHESION MOLECULE but do not confuse this X ref with NEURONAL CELL ADHESION MOLECULES see CELL ADHESION MOLECULES, NEURONAL%A%  
% 212.45/212.62  |- skos__broader mesh__D019006smesh__D015816
% 212.45/212.62  |- mesh__recordAuthorizer mesh__D019006 sjn
% 212.45/212.62  |- mesh__recordMaintainer mesh__D019006 ssb
% 212.45/212.62  |- skos__historyNote mesh__D019006
% 212.45/212.62       Cell Adhesion Molecules, Neuronal %28%1990-1995%29%
% 212.45/212.62  |- mesh__dateRevised mesh__D019006 2005-06-30
% 212.45/212.62  |- skos__altLabel mesh__D019006 NCAM
% 212.45/212.62  |- mesh__dateCreated mesh__D019006 1995-05-26
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D011023 2003
% 212.45/212.62  |- mesh__publicMeSHNote mesh__D011023 68   
% 212.45/212.62  |- skos__broader mesh__D011023smesh__D018410
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D011023 2000
% 212.45/212.62  |- skos__altLabel mesh__D011023 Staphylococcal Pneumonia
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D011023 2006
% 212.45/212.62  |- mesh__recordOriginator mesh__D011023 NLM
% 212.45/212.62  |- skos__hiddenLabel mesh__D011023 Staphylococcal Pneumonias
% 212.45/212.62  |- mesh__dateRevised mesh__D011023 1994-05-27
% 212.45/212.62  |- skos__prefLabel mesh__D011023 Pneumonia, Staphylococcal
% 212.45/212.62  |- skos__broader mesh__D011023smesh__D013203
% 212.45/212.62  |- skos__historyNote mesh__D011023 Pneumonia %28%1966-1967%29%
% 212.45/212.62  |- mesh__dateCreated mesh__D011023 1999-01-01
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D011023 2005
% 212.45/212.62  |- skos__scopeNote mesh__D011023
% 212.45/212.62       Pneumonia caused by STAPHYLOCOCCUS AUREUS. This condition is a frequent complication of viral influenza.%A%    
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D011023 1997
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D011023 2002
% 212.45/212.62  |- rdf__type mesh__D011023sskos__Concept
% 212.45/212.62  |- skos__hiddenLabel mesh__D011023 Pneumonias, Staphylococcal
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D011023 1996
% 212.45/212.62  |- skos__historyNote mesh__D011023
% 212.45/212.62       Staphylococcal Infections %28%1966-1967%29%
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D011023 1999
% 212.45/212.62  |- skos__annotation mesh__D011023
% 212.45/212.62       caused by Staphylococcus aureus; DF: PNEUMONIA STAPH or STAPH PNEUMONIA%A%  
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D011023 2004
% 212.45/212.62  |- mesh__recordMaintainer mesh__D011023 PXP
% 212.45/212.62  |- mesh__dateEstablished mesh__D011023 1968-01-01
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D011023 1995
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D011023 2001
% 212.45/212.62  |- mesh__historyNote mesh__D011023 68   
% 212.45/212.62  |- mesh__recordAuthorizer mesh__D011023 PLS
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D011023 1998
% 212.45/212.62  |- skos__prefLabel mesh__D043903 Pyrococcus abyssi
% 212.45/212.62  |- mesh__recordAuthorizer mesh__D043903 sjn
% 212.45/212.62  |- mesh__dateCreated mesh__D043903 2003-07-09
% 212.45/212.62  |- rdf__type mesh__D043903sskos__Concept
% 212.45/212.62  |- mesh__recordOriginator mesh__D043903 ags
% 212.45/212.62  |- mesh__recordMaintainer mesh__D043903 SYSTEM
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D043903 2006
% 212.45/212.62  |- skos__scopeNote mesh__D043903
% 212.45/212.62       A species of gram-negative hyperthermophilic ARCHAEA  found in deep ocean hydrothermal vents. It is an obligate anaerobe and obligate chemoorganotroph.%A%    
% 212.45/212.62  |- mesh__dateEstablished mesh__D043903 2004-01-01
% 212.45/212.62  |- skos__historyNote mesh__D043903 Archaea %28%1996-1997%29%
% 212.45/212.62  |- mesh__dateRevised mesh__D043903 2005-06-30
% 212.45/212.62  |- skos__historyNote mesh__D043903 Pyrococcus %28%1998-2003%29%
% 212.45/212.62  |- mesh__publicMeSHNote mesh__D043903 2004   
% 212.45/212.62  |- skos__broader mesh__D043903smesh__D019711
% 212.45/212.62  |- mesh__historyNote mesh__D043903 2004   
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002297 1997
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002297 2003
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002297 2006
% 212.45/212.62  |- skos__broader mesh__D002297smesh__D013256
% 212.45/212.62  |- mesh__recordMaintainer mesh__D002297 PLS
% 212.45/212.62  |- mesh__dateEstablished mesh__D002297 1968-01-01
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002297 1994
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002297 2004
% 212.45/212.62  |- mesh__dateCreated mesh__D002297 1999-01-01
% 212.45/212.62  |- mesh__publicMeSHNote mesh__D002297 68   
% 212.45/212.62  |- mesh__historyNote mesh__D002297 68   
% 212.45/212.62  |- skos__annotation mesh__D002297 do not confuse with CARDENOLIDES   
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002297 2000
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002297 1995
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002297 2001
% 212.45/212.62  |- rdf__type mesh__D002297sskos__Concept
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002297 1998
% 212.45/212.62  |- mesh__dateRevised mesh__D002297 1993-06-03
% 212.45/212.62  |- mesh__recordAuthorizer mesh__D002297 PLS
% 212.45/212.62  |- skos__prefLabel mesh__D002297 Cardanolides
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002297 2002
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002297 1996
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002297 1999
% 212.45/212.62  |- mesh__recordOriginator mesh__D002297 NLM
% 212.45/212.62  |- skos__scopeNote mesh__D002297
% 212.45/212.62       The aglycone constituents of CARDIAC GLYCOSIDES. The ring structure is basically a cyclopentanoperhydrophenanthrene nucleus attached to a lactone ring at the C-17 position.%A%    
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D002297 2005
% 212.45/212.62  |- skos__broader mesh__D007780smesh__D007778
% 212.45/212.62  |- skos__scopeNote mesh__D007780
% 212.45/212.62       A rod-shaped bacterium isolated from milk and cheese, dairy products and dairy environments, sour dough, cow dung, silage, and human mouth, human intestinal contents and stools, and the human vagina.%A%    
% 212.45/212.62  |- rdf__type mesh__D007780sskos__Concept
% 212.45/212.62  |- mesh__dateCreated mesh__D007780 1999-01-01
% 212.45/212.62  |- mesh__historyNote mesh__D007780 74%28%72%29%   
% 212.45/212.62  |- skos__annotation mesh__D007780 in milk %26% cheese   
% 212.45/212.62  |- mesh__recordOriginator mesh__D007780 NLM
% 212.45/212.62  |- mesh__activeMeSHYear mesh__D007780 2006
% 212.45/212.62  |- mesh__recordMaintainer mesh__D007780 SYSTEM
% 212.45/212.62  |- mesh__recordAuthorizer mesh__D007780 sjn
% 212.45/212.62  |- mesh__dateEstablished mesh__D007780 1974-01-01
% 212.45/212.62  |- skos__prefLabel mesh__D007780 Lactobacillus casei
% 212.45/212.62  |- mesh__publicMeSHNote mesh__D007780 74   
% 212.45/212.63  |- skos__historyNote mesh__D007780 Lactobacillus %28%1966-1971%29%
% 212.45/212.63  |- mesh__dateRevised mesh__D007780 2005-06-30
% 212.45/212.63  |- skos__broader mesh__D010729smesh__D002262
% 212.45/212.63  |- mesh__dateEstablished mesh__D010729 1974-01-01
% 212.45/212.63  |- skos__scopeNote mesh__D010729
% 212.45/212.63       An enzyme of the lyase class that catalyzes the conversion of GTP and oxaloacetate to GDP, phosphoenolpyruvate, and carbon dioxide. This reaction is part of gluconeogenesis in the liver. The enzyme occurs in both the mitochondria and cytosol of mammalian liver. %28%From Dorland, 27th ed%29% EC 4.1.1.32.%A%    
% 212.45/212.63  |- skos__hiddenLabel mesh__D010729
% 212.45/212.63       Carboxykinase, GTP-Dependent Phosphoenolpyruvate
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D010729 2006
% 212.45/212.63  |- mesh__dateCreated mesh__D010729 1999-01-01
% 212.45/212.63  |- mesh__recordAuthorizer mesh__D010729 sjn
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D010729 2005
% 212.45/212.63  |- mesh__historyNote mesh__D010729 98%28%73%29%   
% 212.45/212.63  |- mesh__recordOriginator mesh__D010729 NLM
% 212.45/212.63  |- mesh__dateRevised mesh__D010729 2003-07-09
% 212.45/212.63  |- skos__hiddenLabel mesh__D010729
% 212.45/212.63       GTP Dependent Phosphoenolpyruvate Carboxykinase
% 212.45/212.63  |- mesh__publicMeSHNote mesh__D010729
% 212.45/212.63       98; see PHOSPHOENOLPYRUVATE CARBOXYKINASES 1975-97, see PHOSPHOENOLPYRUVATE CARBOXYKINASE 1973-74%A%  
% 212.45/212.63  |- skos__annotation mesh__D010729
% 212.45/212.63       do not confuse with PHOSPHOENOLPYRUVATE CARBOXYKINASE %28%ATP%29%; DF: PEP CARBOXYKINASE GTP%A%  
% 212.45/212.63  |- skos__historyNote mesh__D010729 Carboxy-Lyases %28%1966-1972%29%
% 212.45/212.63  |- skos__prefLabel mesh__D010729
% 212.45/212.63       Phosphoenolpyruvate Carboxykinase %28%GTP%29%
% 212.45/212.63  |- rdf__type mesh__D010729sskos__Concept
% 212.45/212.63  |- skos__altLabel mesh__D010729
% 212.45/212.63       GTP-Dependent Phosphoenolpyruvate Carboxykinase
% 212.45/212.63  |- mesh__recordMaintainer mesh__D010729 ssb
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D010729 2004
% 212.45/212.63  |- skos__hiddenLabel mesh__D010729
% 212.45/212.63       Phosphoenolpyruvate Carboxykinase, GTP-Dependent
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D015414 2000
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D015414 2005
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D015414 1996
% 212.45/212.63  |- skos__annotation mesh__D015414
% 212.45/212.63       do not use /util except by MeSH definition   
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D015414 1999
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D015414 1992
% 212.45/212.63  |- rdf__type mesh__D015414sskos__Concept
% 212.45/212.63  |- mesh__dateEstablished mesh__D015414 1989-01-01
% 212.45/212.63  |- skos__scopeNote mesh__D015414
% 212.45/212.63       Excision of breast tissue with preservation of overlying skin, nipple, and areola so that breast form may be reconstructed.%A%    
% 212.45/212.63  |- skos__historyNote mesh__D015414 Breast/surgery %28%1966-1988%29%
% 212.45/212.63  |- skos__hiddenLabel mesh__D015414 Mastectomies, Subcutaneous
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D015414 1990
% 212.45/212.63  |- mesh__historyNote mesh__D015414 89   
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D015414 1995
% 212.45/212.63  |- mesh__publicMeSHNote mesh__D015414 89   
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D015414 2002
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D015414 1998
% 212.45/212.63  |- mesh__dateCreated mesh__D015414 1988-06-07
% 212.45/212.63  |- skos__historyNote mesh__D015414
% 212.45/212.63       Breast Neoplasms/surgery %28%1966-1988%29%
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D015414 2004
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D015414 1994
% 212.45/212.63  |- skos__prefLabel mesh__D015414 Mastectomy, Subcutaneous
% 212.45/212.63  |- skos__hiddenLabel mesh__D015414 Subcutaneous Mastectomies
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D015414 2003
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D015414 2006
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D015414 1989
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D015414 2001
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D015414 1991
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D015414 1997
% 212.45/212.63  |- skos__historyNote mesh__D015414 Mastectomy %28%1966-1988%29%
% 212.45/212.63  |- skos__broader mesh__D015414smesh__D008408
% 212.45/212.63  |- skos__hiddenLabel mesh__D015414 Subcutaneous Mastectomy
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D015414 1993
% 212.45/212.63  |- skos__hiddenLabel mesh__D006688 Hockeys
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D006688 2004
% 212.45/212.63  |- skos__broader mesh__D006688smesh__D013177
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D006688 2002
% 212.45/212.63  |- mesh__publicMeSHNote mesh__D006688 90; was see under SPORTS 1976-89   
% 212.45/212.63  |- mesh__dateCreated mesh__D006688 1975-07-25
% 212.45/212.63  |- skos__hiddenLabel mesh__D006688 Ice Hockeys
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D006688 1997
% 212.45/212.63  |- mesh__historyNote mesh__D006688
% 212.45/212.63       90%28%76%29%; was see under SPORTS 1976-89   
% 212.45/212.63  |- mesh__dateRevised mesh__D006688 1996-06-10
% 212.45/212.63  |- skos__hiddenLabel mesh__D006688 Hockeys, Ice
% 212.45/212.63  |- skos__scopeNote mesh__D006688
% 212.45/212.63       A game in which two parties of players provided with curved or hooked sticks seek to drive a ball or puck through opposite goals. This applies to either ice hockey or field hockey.%A%    
% 212.45/212.63  |- skos__annotation mesh__D006688
% 212.45/212.63       /inj: coord IM with specific inj %28%IM%29%; /physiol permitted; Manual 30.15.1%A%  
% 212.45/212.63  |- mesh__recordAuthorizer mesh__D006688 PLS
% 212.45/212.63  |- skos__prefLabel mesh__D006688 Hockey
% 212.45/212.63  |- skos__hiddenLabel mesh__D006688 Hockey, Ice
% 212.45/212.63  |- mesh__recordOriginator mesh__D006688 JW
% 212.45/212.63  |- rdf__type mesh__D006688sskos__Concept
% 212.45/212.63  |- mesh__dateEstablished mesh__D006688 1990-01-01
% 212.45/212.63  |- mesh__recordMaintainer mesh__D006688 TAP
% 212.45/212.63  |- skos__hiddenLabel mesh__D006688 Hockey, Field
% 212.45/212.63  |- skos__hiddenLabel mesh__D006688 Field Hockeys
% 212.45/212.63  |- skos__historyNote mesh__D006688 Sports %28%1966-1975%29%
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D006688 2005
% 212.45/212.63  |- skos__hiddenLabel mesh__D006688 Hockeys, Field
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D006688 2000
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D006688 1998
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D006688 2006
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D006688 2003
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D006688 2001
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D006688 1999
% 212.45/212.63  |- mesh__historyNote mesh__D031081 2003   
% 212.45/212.63  |- rdf__type mesh__D031081sskos__Concept
% 212.45/212.63  |- mesh__dateCreated mesh__D031081 2002-07-03
% 212.45/212.63  |- skos__altLabel mesh__D031081 Palm, Rattan
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D031081 2003
% 212.45/212.63  |- mesh__dateEstablished mesh__D031081 2003-01-01
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D031081 2004
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D031081 2005
% 212.45/212.63  |- skos__broader mesh__D031081smesh__D028023
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D031081 2006
% 212.45/212.63  |- skos__annotation mesh__D031081
% 212.45/212.63       CALAMUS ROOT see ACORUS is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.45/212.63  |- skos__scopeNote mesh__D031081
% 212.45/212.63       A plant genus of the family ARECACEAE that should not be confused with ACORUS CALAMUS.%A%    
% 212.45/212.63  |- mesh__publicMeSHNote mesh__D031081 2003   
% 212.45/212.63  |- skos__prefLabel mesh__D031081 Calamus
% 212.45/212.63  |- skos__altLabel mesh__D025842 PIC 1 Protein
% 212.45/212.63  |- skos__broader mesh__D025842smesh__D025841
% 212.45/212.63  |- rdf__type mesh__D025842sskos__Concept
% 212.45/212.63  |- skos__scopeNote mesh__D025842
% 212.45/212.63       A 1.5-kDa small ubiquitin-related modifier protein that can covalently bind via an isopeptide link to a number of cellular proteins. It may play a role in intracellular protein transport and a number of other cellular processes.%A%    
% 212.45/212.63  |- skos__hiddenLabel mesh__D025842 Ubiquitin like 1 Gene Product
% 212.45/212.63  |- skos__altLabel mesh__D025842 Gap-modifying Protein 1
% 212.45/212.63  |- skos__altLabel mesh__D025842 UBL1 Protein
% 212.45/212.63  |- skos__historyNote mesh__D025842 Ubiquitins %28%1996-2001%29%
% 212.45/212.63  |- mesh__recordMaintainer mesh__D025842 jmp
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D025842 2005
% 212.45/212.63  |- mesh__publicMeSHNote mesh__D025842
% 212.45/212.63       2002; PIC 1 PROTEIN %28%now SUMO-1 PROTEIN%29% was indexed under UBIQUITIN 1996-2001%A%  
% 212.45/212.63  |- skos__altLabel mesh__D025842 Sentrin
% 212.45/212.63  |- skos__altLabel mesh__D025842 SUMO Protein
% 212.45/212.63  |- mesh__dateRevised mesh__D025842 2004-07-07
% 212.45/212.63  |- skos__hiddenLabel mesh__D025842 PML Interacting Clone Protein
% 212.45/212.63  |- skos__altLabel mesh__D025842 Sentrin 1
% 212.45/212.63  |- skos__hiddenLabel mesh__D025842 Gap modifying Protein 1
% 212.45/212.63  |- skos__altLabel mesh__D025842 PML-Interacting Clone Protein
% 212.45/212.63  |- skos__altLabel mesh__D025842 PIC1 Protein
% 212.45/212.63  |- mesh__recordAuthorizer mesh__D025842 sjn
% 212.45/212.63  |- skos__hiddenLabel mesh__D025842 SUMO 1 Protein
% 212.45/212.63  |- mesh__historyNote mesh__D025842
% 212.45/212.63       2002; use SUMO-1 PROTEIN %28%NM%29% 1996-2001   
% 212.45/212.63  |- skos__prefLabel mesh__D025842 SUMO-1 Protein
% 212.45/212.63  |- skos__altLabel mesh__D025842 SMT3C Protein
% 212.45/212.63  |- skos__hiddenLabel mesh__D025842 GMP1, Protein
% 212.45/212.63  |- skos__altLabel mesh__D025842 Ubiquitin-like 1 Gene Product
% 212.45/212.63  |- mesh__dateEstablished mesh__D025842 2002-01-01
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D025842 2006
% 212.45/212.63  |- mesh__dateCreated mesh__D025842 2001-07-25
% 212.45/212.63  |- mesh__recordOriginator mesh__D025842 jmp
% 212.45/212.63  |- skos__altLabel mesh__D025842 Protein GMP1
% 212.45/212.63  |- skos__broader mesh__D003390smesh__D009423
% 212.45/212.63  |- skos__altLabel mesh__D003390 Cranial Nerve Tumors, Malignant
% 212.45/212.63  |- skos__altLabel mesh__D003390 Malignant Cranial Nerve Neoplasms
% 212.45/212.63  |- skos__hiddenLabel mesh__D003390 Neuromas, Benign Cranial
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D003390 2003
% 212.45/212.63  |- mesh__dateEstablished mesh__D003390 1978-01-01
% 212.45/212.63  |- mesh__dateCreated mesh__D003390 1977-04-27
% 212.45/212.63  |- skos__altLabel mesh__D003390 Neoplasms, Cranial Nerve, Benign
% 212.45/212.63  |- skos__hiddenLabel mesh__D003390 Benign Cranial Neuroma
% 212.45/212.63  |- mesh__dateRevised mesh__D003390 1999-11-03
% 212.45/212.63  |- skos__altLabel mesh__D003390 Cranial Nerve Tumors, Benign
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D003390 2002
% 212.45/212.63  |- skos__altLabel mesh__D003390 Benign Cranial Nerve Tumors
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D003390 2006
% 212.45/212.63  |- skos__annotation mesh__D003390
% 212.45/212.63       coord IM with specific cranial nerve dis %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 212.45/212.63  |- skos__broader mesh__D003390smesh__D003389
% 212.45/212.63  |- mesh__historyNote mesh__D003390 78   
% 212.45/212.63  |- skos__scopeNote mesh__D003390
% 212.45/212.63       Benign and malignant neoplasms that arise from one or more of the twelve cranial nerves.%A%    
% 212.45/212.63  |- skos__broader mesh__D003390smesh__D010524
% 212.45/212.63  |- skos__altLabel mesh__D003390 Tumors, Cranial Nerve, Benign
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D003390 2005
% 212.45/212.63  |- skos__hiddenLabel mesh__D003390 Cranial Nerve Neoplasm
% 212.45/212.63  |- mesh__recordMaintainer mesh__D003390 KEV
% 212.45/212.63  |- rdf__type mesh__D003390sskos__Concept
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D003390 2001
% 212.45/212.63  |- skos__altLabel mesh__D003390 Cranial Nerve Neoplasms, Benign
% 212.45/212.63  |- skos__altLabel mesh__D003390 Neoplasms, Cranial Nerve
% 212.45/212.63  |- skos__hiddenLabel mesh__D003390 Neoplasm, Cranial Nerve
% 212.45/212.63  |- mesh__recordAuthorizer mesh__D003390 sjn
% 212.45/212.63  |- skos__altLabel mesh__D003390 Malignant Cranial Nerve Tumors
% 212.45/212.63  |- skos__hiddenLabel mesh__D003390 Benign Cranial Neuromas
% 212.45/212.63  |- skos__altLabel mesh__D003390 Neoplasms, Cranial Nerve, Malignant
% 212.45/212.63  |- mesh__publicMeSHNote mesh__D003390 78   
% 212.45/212.63  |- skos__altLabel mesh__D003390 Tumors, Cranial Nerve, Malignant
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D003390 2000
% 212.45/212.63  |- skos__hiddenLabel mesh__D003390 Neuroma, Benign Cranial
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D003390 2004
% 212.45/212.63  |- skos__hiddenLabel mesh__D003390 Cranial Neuromas, Benign
% 212.45/212.63  |- skos__prefLabel mesh__D003390 Cranial Nerve Neoplasms
% 212.45/212.63  |- mesh__recordOriginator mesh__D003390 VDK
% 212.45/212.63  |- skos__historyNote mesh__D003390
% 212.45/212.63       Peripheral Nerve Neoplasms %28%1966-1977%29%
% 212.45/212.63  |- mesh__dateCreated mesh__D019805 1997-06-20
% 212.45/212.63  |- skos__broader mesh__D019805smesh__D008781
% 212.45/212.63  |- skos__altLabel mesh__D019805 alpha-Methyl-para-tyrosine
% 212.45/212.63  |- skos__altLabel mesh__D019805 alpha-Methyltyrosine, %28%D,L%29%-Isomer
% 212.45/212.63  |- skos__scopeNote mesh__D019805
% 212.45/212.63       An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. %28%Martindale, The Extra Pharmacopoeia, 30th ed%29%%A%    
% 212.45/212.63  |- skos__hiddenLabel mesh__D019805 alpha Methyl p tyrosine
% 212.45/212.63  |- skos__altLabel mesh__D019805 alpha-MPT
% 212.45/212.63  |- skos__altLabel mesh__D019805 Merck Sharp %26% Dohme Brand of Metyrosine
% 212.45/212.63  |- skos__historyNote mesh__D019805 Methyltyrosines %28%1979-1997%29%
% 212.45/212.63  |- mesh__publicMeSHNote mesh__D019805
% 212.45/212.63       98; ALPHA-METHYLTYROSINE was indexed under METHYLTYROSINES 1979-97%A%  
% 212.45/212.63  |- mesh__historyNote mesh__D019805
% 212.45/212.63       98; use ALPHA-METHYLTYROSINE %28%NM%29% 1979-97   
% 212.45/212.63  |- skos__hiddenLabel mesh__D019805 Metyrosine Merck Brand
% 212.45/212.63  |- skos__hiddenLabel mesh__D019805 alpha-methyl- DL-Tyrosine
% 212.45/212.63  |- skos__altLabel mesh__D019805 alpha-Methyltyrosine, %28%+,-%29%-Isomer
% 212.45/212.63  |- skos__altLabel mesh__D019805 DL-Tyrosine, alpha-methyl-
% 212.45/212.63  |- mesh__recordOriginator mesh__D019805 KEV
% 212.45/212.63  |- skos__hiddenLabel mesh__D019805 Hydrochloride, alpha-Methyltyrosine
% 212.45/212.63  |- skos__hiddenLabel mesh__D019805 alpha Methyltyrosine
% 212.45/212.63  |- skos__altLabel mesh__D019805 alpha-Methyl-p-tyrosine
% 212.45/212.63  |- mesh__recordMaintainer mesh__D019805 CCR
% 212.45/212.63  |- skos__prefLabel mesh__D019805 alpha-Methyltyrosine
% 212.45/212.63  |- skos__altLabel mesh__D019805 alpha-Methyltyrosine, %28%L%29%-Isomer
% 212.45/212.63  |- skos__hiddenLabel mesh__D019805 alpha Methyl para tyrosine
% 212.45/212.63  |- mesh__recordAuthorizer mesh__D019805 sjn
% 212.45/212.63  |- skos__altLabel mesh__D019805 Metirosine
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D019805 2006
% 212.45/212.63  |- skos__hiddenLabel mesh__D019805 alpha Methyltyrosine Hydrochloride
% 212.45/212.63  |- rdf__type mesh__D019805sskos__Concept
% 212.45/212.63  |- skos__hiddenLabel mesh__D019805 alpha MPT
% 212.45/212.63  |- mesh__dateEstablished mesh__D019805 1998-01-01
% 212.45/212.63  |- mesh__dateRevised mesh__D019805 2005-06-30
% 212.45/212.63  |- skos__altLabel mesh__D019805 Merck Brand of Metyrosine
% 212.45/212.63  |- mesh__recordMaintainer mesh__D011822 PLS
% 212.45/212.63  |- skos__related mesh__D011822smesh__D002961
% 212.45/212.63  |- rdf__type mesh__D011822sskos__Concept
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011822 2001
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011822 1995
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011822 2000
% 212.45/212.63  |- skos__annotation mesh__D011822
% 212.45/212.63       coord IM with specific races %28%IM%29% %26% and locale if pertinent; DF: RACE RELAT%A%  
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011822 1994
% 212.45/212.63  |- mesh__recordAuthorizer mesh__D011822 PLS
% 212.45/212.63  |- mesh__recordOriginator mesh__D011822 NLM
% 212.45/212.63  |- skos__historyNote mesh__D011822 Prejudice %28%1966-1967%29%
% 212.45/212.63  |- skos__scopeNote mesh__D011822
% 212.45/212.63       Cultural contacts between people of different races.     
% 212.45/212.63  |- skos__historyNote mesh__D011822
% 212.45/212.63       Interpersonal Relations %28%1966-1967%29%
% 212.45/212.63  |- skos__hiddenLabel mesh__D011822 Relations, Race
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011822 2004
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011822 1997
% 212.45/212.63  |- mesh__dateEstablished mesh__D011822 1968-01-01
% 212.45/212.63  |- skos__prefLabel mesh__D011822 Race Relations
% 212.45/212.63  |- mesh__dateCreated mesh__D011822 1999-01-01
% 212.45/212.63  |- mesh__historyNote mesh__D011822 68   
% 212.45/212.63  |- mesh__publicMeSHNote mesh__D011822 68   
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011822 2006
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011822 2003
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011822 1999
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011822 1996
% 212.45/212.63  |- skos__broader mesh__D011822smesh__D012940
% 212.45/212.63  |- mesh__dateRevised mesh__D011822 1993-11-29
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011822 2002
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011822 2005
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011822 1998
% 212.45/212.63  |- mesh__dateCreated mesh__D019007 1995-06-08
% 212.45/212.63  |- skos__altLabel mesh__D019007 Platelet alpha-Granule Membrane Protein
% 212.45/212.63  |- mesh__recordMaintainer mesh__D019007 ssb
% 212.45/212.63  |- skos__hiddenLabel mesh__D019007 Platelet alpha Granule Membrane Protein
% 212.45/212.63  |- skos__altLabel mesh__D019007 P Selectin
% 212.45/212.63  |- mesh__dateRevised mesh__D019007 2005-06-30
% 212.45/212.63  |- skos__altLabel mesh__D019007 PADGEM
% 212.45/212.63  |- skos__broader mesh__D019007smesh__D015703
% 212.45/212.63  |- mesh__dateEstablished mesh__D019007 1996-01-01
% 212.45/212.63  |- mesh__historyNote mesh__D019007
% 212.45/212.63       96; was PLATELET ALPHA-GRANULE MEMBRANE PROTEIN %28%NM%29% 1985-95%A%  
% 212.45/212.63  |- skos__altLabel mesh__D019007 CD62P Antigens
% 212.45/212.63  |- skos__prefLabel mesh__D019007 P-Selectin
% 212.45/212.63  |- mesh__publicMeSHNote mesh__D019007
% 212.45/212.63       96; PLATELET ALPHA-GRANULE MEMBRANE PROTEIN was indexed under PLATELET MEMBRANE GLYCOPROTEINS 1986-95 %26% MEMBRANE PROTEINS 1985-86%A%  
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D019007 2006
% 212.45/212.63  |- skos__broader mesh__D019007smesh__D019087
% 212.45/212.63  |- rdf__type mesh__D019007sskos__Concept
% 212.45/212.63  |- skos__scopeNote mesh__D019007
% 212.45/212.63       Cell adhesion molecule and CD antigen that mediates the adhesion of neutrophils and monocytes to activated platelets and endothelial cells.%A%    
% 212.45/212.63  |- mesh__onlineNote mesh__D019007
% 212.45/212.63       use P-SELECTIN %28%NM%29% to search PLATELET ALPHA-GRANULE MEMBRANE PROTEIN 1985-95%A%  
% 212.45/212.63  |- skos__historyNote mesh__D019007
% 212.45/212.63       Platelet Membrane Glycoproteins %28%1986-1995%29%
% 212.45/212.63  |- mesh__recordOriginator mesh__D019007 AGS
% 212.45/212.63  |- skos__annotation mesh__D019007
% 212.45/212.63       a cell adhesion molecule %26% CD antigen   
% 212.45/212.63  |- skos__altLabel mesh__D019007 Antigens, CD62P
% 212.45/212.63  |- skos__hiddenLabel mesh__D019007 Antigen, CD62P
% 212.45/212.63  |- skos__altLabel mesh__D019007 CD62P Antigen
% 212.45/212.63  |- skos__historyNote mesh__D019007 Membrane Proteins %28%1985-1986%29%
% 212.45/212.63  |- skos__altLabel mesh__D019007 LECAM-3
% 212.45/212.63  |- mesh__recordAuthorizer mesh__D019007 sjn
% 212.45/212.63  |- skos__broader mesh__D019007smesh__D010980
% 212.45/212.63  |- skos__hiddenLabel mesh__D019007 Selectin, P
% 212.45/212.63  |- skos__altLabel mesh__D019007 GMP-140
% 212.45/212.63  |- skos__hiddenLabel mesh__D011024 Viral Pneumonia
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011024 2001
% 212.45/212.63  |- mesh__dateCreated mesh__D011024 1999-01-01
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011024 2005
% 212.45/212.63  |- mesh__recordAuthorizer mesh__D011024 SJN
% 212.45/212.63  |- skos__hiddenLabel mesh__D011024 Pneumonias, Viral
% 212.45/212.63  |- rdf__type mesh__D011024sskos__Concept
% 212.45/212.63  |- skos__hiddenLabel mesh__D011024 Viral Pneumonias
% 212.45/212.63  |- skos__scopeNote mesh__D011024
% 212.45/212.63       Pneumonia caused by a virus. %28%Dorland, 28th ed%29%     
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011024 2000
% 212.45/212.63  |- skos__prefLabel mesh__D011024 Pneumonia, Viral
% 212.45/212.63  |- mesh__recordOriginator mesh__D011024 NLM
% 212.45/212.63  |- mesh__recordMaintainer mesh__D011024 TGC
% 212.45/212.63  |- skos__broader mesh__D011024smesh__D011014
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011024 1999
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011024 2004
% 212.45/212.63  |- skos__broader mesh__D011024smesh__D014777
% 212.45/212.63  |- mesh__dateRevised mesh__D011024 1997-06-20
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011024 2002
% 212.45/212.63  |- skos__annotation mesh__D011024
% 212.45/212.63       coord IM with specific viral dis %28%IM%29%   
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011024 1998
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011024 2003
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D011024 2006
% 212.45/212.63  |- mesh__dateRevised mesh__D002298 1993-06-03
% 212.45/212.63  |- skos__annotation mesh__D002298
% 212.45/212.63       includes cardadienolides %26% cardatrienolides; do not confuse with CARDANOLIDES%A%  
% 212.45/212.63  |- mesh__recordAuthorizer mesh__D002298 PLS
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D002298 1995
% 212.45/212.63  |- skos__historyNote mesh__D002298 Cardanolides %28%1968-1976%29%
% 212.45/212.63  |- mesh__dateEstablished mesh__D002298 1977-01-01
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D002298 2002
% 212.45/212.63  |- mesh__recordOriginator mesh__D002298 RLS
% 212.45/212.63  |- rdf__type mesh__D002298sskos__Concept
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D002298 1998
% 212.45/212.63  |- mesh__dateCreated mesh__D002298 1976-04-16
% 212.45/212.63  |- mesh__historyNote mesh__D002298 77   
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D002298 1996
% 212.45/212.63  |- skos__broader mesh__D002298smesh__D002297
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D002298 1999
% 212.45/212.63  |- mesh__recordMaintainer mesh__D002298 PLS
% 212.45/212.63  |- skos__scopeNote mesh__D002298
% 212.45/212.63       C%28%23%29%-steroids with methyl groups at C-10 and C-13 and a five-membered lactone at C-17. They are aglycone constituents of CARDIAC GLYCOSIDES and must have at least one double bond in the molecule. The class includes cardadienolides and cardatrienolides. Members include DIGITOXIN and DIGOXIN and their derivatives and the STROPHANTHINS.%A%    
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D002298 2005
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D002298 1997
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D002298 2003
% 212.45/212.63  |- mesh__publicMeSHNote mesh__D002298 77   
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D002298 2006
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D002298 2000
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D002298 1994
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D002298 2004
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D002298 2001
% 212.45/212.63  |- skos__prefLabel mesh__D002298 Cardenolides
% 212.45/212.63  |- mesh__recordAuthorizer mesh__D007781 sjn
% 212.45/212.63  |- rdf__type mesh__D007781sskos__Concept
% 212.45/212.63  |- skos__altLabel mesh__D007781 Lactotransferrin
% 212.45/212.63  |- mesh__recordMaintainer mesh__D007781 ssb
% 212.45/212.63  |- mesh__publicMeSHNote mesh__D007781
% 212.45/212.63       91; was see under LACTOGLOBULINS 1973-90   
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D007781 2005
% 212.45/212.63  |- mesh__dateRevised mesh__D007781 2002-07-03
% 212.45/212.63  |- mesh__historyNote mesh__D007781
% 212.45/212.63       91%28%73%29%; was see under LACTOGLOBULINS 1973-90   
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D007781 2006
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D007781 2003
% 212.45/212.63  |- skos__prefLabel mesh__D007781 Lactoferrin
% 212.45/212.63  |- skos__broader mesh__D007781smesh__D033862
% 212.45/212.63  |- mesh__dateCreated mesh__D007781 1999-01-01
% 212.45/212.63  |- skos__broader mesh__D007781smesh__D007782
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D007781 2004
% 212.45/212.63  |- mesh__recordOriginator mesh__D007781 NLM
% 212.45/212.63  |- skos__scopeNote mesh__D007781
% 212.45/212.63       An iron-binding protein in plasma and secretions %28%milk, mucus, bile%29%, secreted by leukocytes. It is an important component of GRANULOCYTES. It is bacteriostatic, working by depriving bacteria of iron essential for growth.%A%    
% 212.45/212.63  |- skos__broader mesh__D007781smesh__D006023
% 212.45/212.63  |- mesh__dateEstablished mesh__D007781 1991-01-01
% 212.45/212.63  |- skos__broader mesh__D011516Q000172smesh__D011516
% 212.45/212.63  |- mesh__preferredCombination mesh__D011516Q000172smesh__D007020
% 212.45/212.63  |- rdf__type mesh__D011516Q000172smesh__CompoundConcept
% 212.45/212.63  |- skos__altLabel mesh__D015415 Surrogate End Point
% 212.45/212.63  |- mesh__dateCreated mesh__D015415 1988-06-07
% 212.45/212.63  |- mesh__activeMeSHYear mesh__D015415 2006
% 212.45/212.63  |- skos__scopeNote mesh__D015415
% 212.45/212.63       Measurable and quantifiable biological parameters %28%e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances%29% which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.%A%    
% 212.45/212.63  |- skos__altLabel mesh__D015415 Serum Marker
% 212.45/212.63  |- skos__hiddenLabel mesh__D015415 Endpoints, Surrogate
% 212.45/212.63  |- skos__hiddenLabel mesh__D015415 End Point, Surrogate
% 212.45/212.63  |- skos__altLabel mesh__D015415 Immune Marker
% 212.45/212.63  |- skos__altLabel mesh__D015415 Marker, Laboratory
% 212.45/212.63  |- skos__altLabel mesh__D015415 Marker, Clinical
% 212.45/212.63  |- mesh__recordAuthorizer mesh__D015415 sjn
% 212.45/212.63  |- rdf__type mesh__D015415sskos__Concept
% 212.45/212.63  |- skos__prefLabel mesh__D015415 Biological Markers
% 212.45/212.63  |- skos__altLabel mesh__D015415 Surrogate Marker
% 212.45/212.63  |- skos__altLabel mesh__D015415 Markers, Biochemical
% 212.45/212.63  |- skos__altLabel mesh__D015415 Biochemical Markers
% 212.45/212.63  |- skos__altLabel mesh__D015415 Biologic Markers
% 212.45/212.63  |- skos__altLabel mesh__D015415 Viral Marker
% 212.45/212.63  |- skos__altLabel mesh__D015415 Markers, Viral
% 212.45/212.63  |- skos__altLabel mesh__D015415 Markers, Biological
% 212.45/212.63  |- skos__altLabel mesh__D015415 Marker, Serum
% 212.45/212.63  |- skos__altLabel mesh__D015415 Markers, Surrogate
% 212.45/212.63  |- skos__altLabel mesh__D015415 Biologic Marker
% 212.45/212.63  |- skos__altLabel mesh__D015415 Markers, Serum
% 212.45/212.63  |- mesh__dateRevised mesh__D015415 2005-06-30
% 212.45/212.63  |- skos__altLabel mesh__D015415 Clinical Marker
% 212.45/212.63  |- skos__altLabel mesh__D015415 Immune Markers
% 212.45/212.63  |- skos__hiddenLabel mesh__D015415 Endpoint, Surrogate
% 212.45/212.63  |- mesh__recordOriginator mesh__D015415 EJB
% 212.45/212.63  |- mesh__historyNote mesh__D015415 89   
% 212.45/212.63  |- skos__altLabel mesh__D015415 Immunologic Marker
% 212.45/212.63  |- mesh__recordMaintainer mesh__D015415 ssb
% 212.45/212.63  |- skos__hiddenLabel mesh__D015415 Biological Marker
% 212.45/212.63  |- skos__altLabel mesh__D015415 Laboratory Markers
% 212.45/212.63  |- skos__altLabel mesh__D015415 Laboratory Marker
% 212.45/212.63  |- skos__altLabel mesh__D015415 Clinical Markers
% 212.45/212.63  |- mesh__dateEstablished mesh__D015415 1989-01-01
% 212.45/212.63  |- skos__hiddenLabel mesh__D015415 Markers, Immune
% 212.45/212.63  |- skos__altLabel mesh__D015415 Marker, Surrogate
% 212.45/212.63  |- skos__altLabel mesh__D015415 Immunologic Markers
% 212.45/212.63  |- skos__hiddenLabel mesh__D015415 End Points, Surrogate
% 212.45/212.63  |- skos__hiddenLabel mesh__D015415 Markers, Biologic
% 212.45/212.63  |- skos__altLabel mesh__D015415 Marker, Immunologic
% 212.45/212.63  |- skos__altLabel mesh__D015415 Surrogate Endpoint
% 212.45/212.63  |- skos__hiddenLabel mesh__D015415 Marker, Biologic
% 212.45/212.63  |- skos__hiddenLabel mesh__D015415 Marker, Viral
% 212.45/212.63  |- skos__altLabel mesh__D015415 Marker, Biochemical
% 212.45/212.63  |- mesh__publicMeSHNote mesh__D015415 89   
% 212.45/212.63  |- skos__altLabel mesh__D015415 Marker, Biological
% 212.45/212.63  |- skos__hiddenLabel mesh__D015415 Marker, Immune
% 212.45/212.63  |- skos__broader mesh__D015415smesh__D001685
% 212.45/212.63  |- skos__annotation mesh__D015415
% 212.45/212.63       usually NIM; IM GEN only; coord with specific substance %28%IM%29% if pertinent; markers in genetics = probably GENETIC MARKERS; TUMOR MARKERS, BIOLOGICAL is also available; DF: BIOL MARKERS%A%  
% 212.45/212.63  |- skos__altLabel mesh__D015415 Surrogate End Points
% 212.45/212.63  |- skos__related mesh__D015415smesh__D015335
% 212.45/212.63  |- skos__hiddenLabel mesh__D006689 Lymphogranulomas, Malignant
% 212.45/212.63  |- skos__hiddenLabel mesh__D006689 Malignant Granulomas
% 212.45/212.63  |- skos__hiddenLabel mesh__D006689 Disease, Hodgkins
% 212.45/212.63  |- rdf__type mesh__D006689sskos__Concept
% 212.45/212.63  |- skos__hiddenLabel mesh__D006689 Diseases, Hodgkins
% 212.45/212.64  |- skos__altLabel mesh__D006689 Granuloma, Hodgkins
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D006689 1999
% 212.45/212.64  |- skos__altLabel mesh__D006689 Hodgkin%27%s Disease
% 212.45/212.64  |- skos__altLabel mesh__D006689 Granuloma, Hodgkin
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D006689 2001
% 212.45/212.64  |- skos__hiddenLabel mesh__D006689 Malignant Granuloma
% 212.45/212.64  |- skos__altLabel mesh__D006689 Granuloma, Malignant
% 212.45/212.64  |- mesh__recordAuthorizer mesh__D006689 SJN
% 212.45/212.64  |- skos__hiddenLabel mesh__D006689 Disease, Hodgkin%27%s
% 212.45/212.64  |- skos__hiddenLabel mesh__D006689 Hodgkin Granuloma
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D006689 2000
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D006689 1998
% 212.45/212.64  |- skos__altLabel mesh__D006689 Hodgkins Disease
% 212.45/212.64  |- skos__related mesh__D006689smesh__D016539
% 212.45/212.64  |- skos__hiddenLabel mesh__D006689 Hodgkins Granuloma
% 212.45/212.64  |- skos__altLabel mesh__D006689 Lymphogranuloma, Malignant
% 212.45/212.64  |- skos__hiddenLabel mesh__D006689 Hodgkin%27%s Granuloma
% 212.45/212.64  |- skos__annotation mesh__D006689
% 212.45/212.64       neoplastic; do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 212.45/212.64  |- mesh__publicMeSHNote mesh__D006689
% 212.45/212.64       98; see HODGKIN%27%S DISEASE 1966-97   
% 212.45/212.64  |- mesh__recordMaintainer mesh__D006689 TPW
% 212.45/212.64  |- mesh__dateCreated mesh__D006689 1999-01-01
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D006689 2004
% 212.45/212.64  |- skos__hiddenLabel mesh__D006689 Malignant Lymphogranulomas
% 212.45/212.64  |- skos__broader mesh__D006689smesh__D008223
% 212.45/212.64  |- skos__hiddenLabel mesh__D006689 Malignant Lymphogranuloma
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D006689 2003
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D006689 2006
% 212.45/212.64  |- mesh__dateRevised mesh__D006689 1997-06-20
% 212.45/212.64  |- skos__prefLabel mesh__D006689 Hodgkin Disease
% 212.45/212.64  |- skos__hiddenLabel mesh__D006689 Hodgkins Diseases
% 212.45/212.64  |- mesh__recordOriginator mesh__D006689 NLM
% 212.45/212.64  |- skos__hiddenLabel mesh__D006689 Disease, Hodgkin
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D006689 2002
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D006689 2005
% 212.45/212.64  |- skos__scopeNote mesh__D006689
% 212.45/212.64       A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue, and the presence of large, usually multinucleate, cells %28%REED-STERNBERG CELLS%29% of unknown origin.%A%    
% 212.45/212.64  |- mesh__historyNote mesh__D006689 98%28%66%29%   
% 212.45/212.64  |- mesh__dateCreated mesh__D003391 1999-01-01
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D003391 2003
% 212.45/212.64  |- skos__hiddenLabel mesh__D003391 Nerves, Cranial
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D003391 2001
% 212.45/212.64  |- skos__annotation mesh__D003391
% 212.45/212.64       1st cranial nerve = OLFACTORY NERVE, 2d = OPTIC NERVE, 3d = OCULOMOTOR NERVE, 4th = TROCHLEAR NERVE, 5th = TRIGEMINAL NERVE, 6th = ABDUCENS NERVE, 7th = FACIAL NERVE, 8th = VESTIBULOCOCHLEAR NERVE, 9th = GLOSSOPHARYNGEAL NERVE, 10th = VAGUS NERVE, 11th = ACCESSORY NERVE, 12th = HYPOGLOSSAL NERVE%A%  
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D003391 2004
% 212.45/212.64  |- rdf__type mesh__D003391sskos__Concept
% 212.45/212.64  |- mesh__dateRevised mesh__D003391 2002-09-24
% 212.45/212.64  |- skos__broader mesh__D003391smesh__D010525
% 212.45/212.64  |- skos__scopeNote mesh__D003391
% 212.45/212.64       Twelve pairs of nerves that carry general afferent, visceral afferent, special afferent, somatic efferent, and autonomic efferent fibers.%A%    
% 212.45/212.64  |- mesh__recordOriginator mesh__D003391 NLM
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D003391 2002
% 212.45/212.64  |- skos__hiddenLabel mesh__D003391 Cranial Nerve
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D003391 2003A
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D003391 2005
% 212.45/212.64  |- skos__hiddenLabel mesh__D003391 Nerve, Cranial
% 212.45/212.64  |- skos__prefLabel mesh__D003391 Cranial Nerves
% 212.45/212.64  |- mesh__recordMaintainer mesh__D003391 sjn
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D003391 2006
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D003391 2000
% 212.45/212.64  |- mesh__recordAuthorizer mesh__D003391 sjn
% 212.45/212.64  |- skos__hiddenLabel mesh__D019806 BRL 38226
% 212.45/212.64  |- mesh__dateCreated mesh__D019806 1997-06-20
% 212.45/212.64  |- mesh__recordAuthorizer mesh__D019806 sjn
% 212.45/212.64  |- mesh__dateEstablished mesh__D019806 1998-01-01
% 212.45/212.64  |- skos__hiddenLabel mesh__D019806 BRL 38227
% 212.45/212.64  |- mesh__recordMaintainer mesh__D019806 ssb
% 212.45/212.64  |- mesh__publicMeSHNote mesh__D019806
% 212.45/212.64       98; CROMAKALIM was indexed under BENZOPYRANS %26% PYRROLES 1986-97%A%  
% 212.45/212.64  |- mesh__recordOriginator mesh__D019806 KEV
% 212.45/212.64  |- mesh__dateRevised mesh__D019806 2005-06-30
% 212.45/212.64  |- skos__altLabel mesh__D019806 Cromakalim, %28%3S-trans%29%-Isomer
% 212.45/212.64  |- skos__hiddenLabel mesh__D019806 BRL38227
% 212.45/212.64  |- skos__scopeNote mesh__D019806
% 212.45/212.64       A potassium-channel opening vasodilator that has been investigated in the management of hypertension. It has also been tried in patients with asthma. %28%Martindale, The Extra Pharmacopoeia, 30th ed, p352%29%%A%    
% 212.45/212.64  |- mesh__historyNote mesh__D019806 98; use CROMAKALIM %28%NM%29% 1986-97   
% 212.45/212.64  |- skos__broader mesh__D019806smesh__D001578
% 212.45/212.64  |- skos__historyNote mesh__D019806 Pyrroles %28%1986-1997%29%
% 212.45/212.64  |- skos__broader mesh__D019806smesh__D011758
% 212.45/212.64  |- skos__historyNote mesh__D019806 Benzopyrans %28%1986-1997%29%
% 212.45/212.64  |- skos__hiddenLabel mesh__D019806 BRL38226
% 212.45/212.64  |- rdf__type mesh__D019806sskos__Concept
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D019806 2006
% 212.45/212.64  |- skos__prefLabel mesh__D019806 Cromakalim
% 212.45/212.64  |- skos__altLabel mesh__D019008 Antineoplastic Agent Resistance
% 212.45/212.64  |- mesh__recordAuthorizer mesh__D019008 sjn
% 212.45/212.64  |- skos__prefLabel mesh__D019008 Drug Resistance, Neoplasm
% 212.45/212.64  |- mesh__dateCreated mesh__D019008 1995-05-24
% 212.45/212.64  |- mesh__recordMaintainer mesh__D019008 ssb
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D019008 2006
% 212.45/212.64  |- mesh__recordOriginator mesh__D019008 TGC
% 212.45/212.64  |- skos__altLabel mesh__D019008 Drug Resistance, Antineoplastic
% 212.45/212.64  |- skos__altLabel mesh__D019008 Neoplasm Drug Resistance
% 212.45/212.64  |- skos__annotation mesh__D019008 DF: DRUG RESISTANCE NEOPL   
% 212.45/212.64  |- rdf__type mesh__D019008sskos__Concept
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D019008 2005
% 212.45/212.64  |- mesh__dateRevised mesh__D019008 2003-07-09
% 212.45/212.64  |- skos__scopeNote mesh__D019008
% 212.45/212.64       Resistance or diminished response of a neoplasm to an antineoplastic agent in humans, animals, or cell or tissue cultures.%A%    
% 212.45/212.64  |- mesh__dateEstablished mesh__D019008 1996-01-01
% 212.45/212.64  |- mesh__historyNote mesh__D019008 96   
% 212.45/212.64  |- skos__historyNote mesh__D019008 Drug Resistance %28%1972-1995%29%
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D019008 2004
% 212.45/212.64  |- skos__altLabel mesh__D019008 Resistance, Antineoplastic Agent
% 212.45/212.64  |- skos__altLabel mesh__D019008 Resistance, Antineoplastic Drug
% 212.45/212.64  |- mesh__publicMeSHNote mesh__D019008 96   
% 212.45/212.64  |- skos__broader mesh__D019008smesh__D004351
% 212.45/212.64  |- skos__altLabel mesh__D019008 Antineoplastic Drug Resistance
% 212.45/212.64  |- mesh__recordMaintainer mesh__D011025 PXP
% 212.45/212.64  |- skos__prefLabel mesh__D011025 Pneumonolysis
% 212.45/212.64  |- skos__hiddenLabel mesh__D011025 Pneumonolyses
% 212.45/212.64  |- mesh__recordAuthorizer mesh__D011025 SJN
% 212.45/212.64  |- rdf__type mesh__D011025sskos__Concept
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011025 2000
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011025 1998
% 212.45/212.64  |- skos__broader mesh__D011025smesh__D003096
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011025 2003
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011025 2001
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011025 1999
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011025 2004
% 212.45/212.64  |- mesh__dateRevised mesh__D011025 1997-06-20
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011025 2002
% 212.45/212.64  |- mesh__dateCreated mesh__D011025 1999-01-01
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011025 2005
% 212.45/212.64  |- mesh__recordOriginator mesh__D011025 NLM
% 212.45/212.64  |- skos__scopeNote mesh__D011025
% 212.45/212.64       Division of the tissues attaching the lung to the wall of the chest cavity, to permit collapse of the lung. It was formerly used to treat tuberculosis. %28%Dorland, 28th ed%29%%A%    
% 212.45/212.64  |- skos__broader mesh__D011025smesh__D013510
% 212.45/212.64  |- skos__annotation mesh__D011025
% 212.45/212.64       loosing the lung from the chest wall; a form of collapse ther in pulm tuberc; do not use /util except by MeSH definition%A%  
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011025 2006
% 212.45/212.64  |- mesh__recordAuthorizer mesh__D002299 sjn
% 212.45/212.64  |- skos__prefLabel mesh__D002299 Cardia
% 212.45/212.64  |- mesh__recordMaintainer mesh__D002299 lkt
% 212.45/212.64  |- skos__annotation mesh__D002299
% 212.45/212.64       adjective form = %22%cardial%22%: do not confuse with %22%cardiac%22% %28%heart%29%; diseases: coord IM with STOMACH DISEASES %28%IM%29%; neoplasms: coord IM with STOMACH NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 212.45/212.64  |- skos__scopeNote mesh__D002299
% 212.45/212.64       That part of the STOMACH close to the opening from ESOPHAGUS into the stomach %28%cardiac orifice%29%, the ESOPHAGOGASTRIC JUNCTION. The cardia is so named because of its closeness to the HEART. Cardia is characterized by the lack of acid-forming cells %28%GASTRIC PARIETAL CELLS%29%.%A%    
% 212.45/212.64  |- skos__broader mesh__D002299smesh__D013270
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D002299 2005
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D002299 2006
% 212.45/212.64  |- mesh__recordOriginator mesh__D002299 NLM
% 212.45/212.64  |- mesh__dateCreated mesh__D002299 1999-01-01
% 212.45/212.64  |- mesh__dateRevised mesh__D002299 2004-07-07
% 212.45/212.64  |- skos__hiddenLabel mesh__D002299 Cardias
% 212.45/212.64  |- rdf__type mesh__D002299sskos__Concept
% 212.45/212.64  |- skos__prefLabel mesh__D007782 Lactoglobulins
% 212.45/212.64  |- skos__hiddenLabel mesh__D007782 beta Lactoglobulin I
% 212.45/212.64  |- mesh__historyNote mesh__D007782
% 212.45/212.64       67; was LACTOGLOBULIN see under GLOBULINS 1963-66 %28%Prov%29%   
% 212.45/212.64  |- mesh__publicMeSHNote mesh__D007782
% 212.45/212.64       67; was LACTOGLOBULIN see under GLOBULINS 1963-66   
% 212.45/212.64  |- mesh__recordAuthorizer mesh__D007782 sjn
% 212.45/212.64  |- skos__hiddenLabel mesh__D007782 beta Lactoglobulin E
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D007782 2006
% 212.45/212.64  |- skos__hiddenLabel mesh__D007782 beta Lactoglobulin C
% 212.45/212.64  |- skos__hiddenLabel mesh__D007782 B, beta-Lactoglobulin
% 212.45/212.64  |- mesh__dateCreated mesh__D007782 1999-01-01
% 212.45/212.64  |- mesh__dateRevised mesh__D007782 2005-06-30
% 212.45/212.64  |- skos__hiddenLabel mesh__D007782 beta Lactoglobulin B
% 212.45/212.64  |- skos__hiddenLabel mesh__D007782 I, beta-Lactoglobulin
% 212.45/212.64  |- skos__hiddenLabel mesh__D007782 beta Lactoglobulin G
% 212.45/212.64  |- skos__broader mesh__D007782smesh__D008894
% 212.45/212.64  |- skos__annotation mesh__D007782
% 212.45/212.64       milk proteins; /biosyn /physiol permitted   
% 212.45/212.64  |- skos__hiddenLabel mesh__D007782 F, beta-Lactoglobulin
% 212.45/212.64  |- mesh__recordMaintainer mesh__D007782 SYSTEM
% 212.45/212.64  |- mesh__dateEstablished mesh__D007782 1967-01-01
% 212.45/212.64  |- skos__hiddenLabel mesh__D007782 beta Lactoglobulin
% 212.45/212.64  |- skos__broader mesh__D007782smesh__D005916
% 212.45/212.64  |- rdf__type mesh__D007782sskos__Concept
% 212.45/212.64  |- skos__hiddenLabel mesh__D007782 beta Lactoglobulin F
% 212.45/212.64  |- skos__hiddenLabel mesh__D007782 G, beta-Lactoglobulin
% 212.45/212.64  |- skos__hiddenLabel mesh__D007782 C, beta-Lactoglobulin
% 212.45/212.64  |- skos__scopeNote mesh__D007782
% 212.45/212.64       Globulins occurring in milk. %28%From Dorland, 28th ed%29%     
% 212.45/212.64  |- skos__hiddenLabel mesh__D007782 E, beta-Lactoglobulin
% 212.45/212.64  |- skos__hiddenLabel mesh__D007782 A, beta-Lactoglobulin
% 212.45/212.64  |- mesh__onlineNote mesh__D007782
% 212.45/212.64       use LACTOGLOBULINS to search LACTOGLOBULIN 1966 %28%as Prov%29%%A%  
% 212.45/212.64  |- mesh__recordOriginator mesh__D007782 NLM
% 212.45/212.64  |- skos__hiddenLabel mesh__D007782 beta Lactoglobulin A
% 212.45/212.64  |- mesh__recordAuthorizer mesh__D015416 PLS
% 212.45/212.64  |- mesh__dateRevised mesh__D015416 1992-05-14
% 212.45/212.64  |- mesh__publicMeSHNote mesh__D015416 89   
% 212.45/212.64  |- skos__broader mesh__D015416smesh__D002627
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015416 1995
% 212.45/212.64  |- mesh__recordMaintainer mesh__D015416 TAP
% 212.45/212.64  |- skos__prefLabel mesh__D015416 Maillard Reaction
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015416 2001
% 212.45/212.64  |- mesh__recordOriginator mesh__D015416 EJB
% 212.45/212.64  |- skos__hiddenLabel mesh__D015416 Food Brownings
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015416 2004
% 212.45/212.64  |- skos__hiddenLabel mesh__D015416 Reactions, Browning
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015416 1994
% 212.45/212.64  |- skos__historyNote mesh__D015416 Chemistry %28%1966-1988%29%
% 212.45/212.64  |- skos__hiddenLabel mesh__D015416 Brownings, Food
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015416 2000
% 212.45/212.64  |- skos__scopeNote mesh__D015416
% 212.45/212.64       One of a group of nonenzymatic reactions in which aldehydes, ketones, or reducing sugars react with amino acids, peptides, or proteins. Food browning reactions, such as those that occur with cooking of meats, and also food deterioration reactions, resulting in decreased nutritional value and color changes, are attributed to this reaction type. The Maillard reaction is studied by scientists in the agriculture, food, nutrition, and carbohydrate chemistry fields.%A%    
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015416 1997
% 212.45/212.64  |- skos__broader mesh__D015416smesh__D002622
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015416 2003
% 212.45/212.64  |- skos__hiddenLabel mesh__D015416 Reaction, Browning
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015416 1996
% 212.45/212.64  |- skos__hiddenLabel mesh__D015416 Browning Reactions
% 212.45/212.64  |- skos__hiddenLabel mesh__D015416 Reaction, Maillard
% 212.45/212.64  |- skos__hiddenLabel mesh__D015416 Browning, Food
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015416 2006
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015416 1993
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015416 2002
% 212.45/212.64  |- mesh__dateCreated mesh__D015416 1988-06-07
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015416 1999
% 212.45/212.64  |- rdf__type mesh__D015416sskos__Concept
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015416 2005
% 212.45/212.64  |- mesh__historyNote mesh__D015416 89   
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015416 1998
% 212.45/212.64  |- mesh__dateEstablished mesh__D015416 1989-01-01
% 212.45/212.64  |- skos__broader mesh__D031881smesh__D031844
% 212.45/212.64  |- skos__prefLabel mesh__D031881 Nigella sativa
% 212.45/212.64  |- rdf__type mesh__D031881sskos__Concept
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D031881 2005
% 212.45/212.64  |- skos__altLabel mesh__D031881 Black Cumin
% 212.45/212.64  |- skos__scopeNote mesh__D031881
% 212.45/212.64       A plant genus of the family RANUNCULACEAE that contains alpha-hederin, a triterpene saponin in the seeds, and is the source of black seed oil.%A%    
% 212.45/212.64  |- skos__altLabel mesh__D031881 Cumin, Black
% 212.45/212.64  |- mesh__dateCreated mesh__D031881 2002-07-02
% 212.45/212.64  |- skos__altLabel mesh__D031881 Kalonji
% 212.45/212.64  |- skos__annotation mesh__D031881
% 212.45/212.64       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.45/212.64  |- mesh__historyNote mesh__D031881 2003   
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D031881 2006
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D031881 2003
% 212.45/212.64  |- mesh__dateEstablished mesh__D031881 2003-01-01
% 212.45/212.64  |- mesh__publicMeSHNote mesh__D031881 2003   
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D031881 2004
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D003392 2004
% 212.45/212.64  |- rdf__type mesh__D003392sskos__Concept
% 212.45/212.64  |- skos__scopeNote mesh__D003392
% 212.45/212.64       Large endothelium-lined venous channels situated between the two layers of the dura mater; they are devoid of valves.%A%    
% 212.45/212.64  |- mesh__recordAuthorizer mesh__D003392 sjn
% 212.45/212.64  |- skos__broader mesh__D003392smesh__D014680
% 212.45/212.64  |- skos__annotation mesh__D003392 do not confuse with CEREBRAL VEINS   
% 212.45/212.64  |- mesh__dateRevised mesh__D003392 2002-07-03
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D003392 2005
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D003392 2006
% 212.45/212.64  |- mesh__recordOriginator mesh__D003392 NLM
% 212.45/212.64  |- skos__prefLabel mesh__D003392 Cranial Sinuses
% 212.45/212.64  |- skos__hiddenLabel mesh__D003392 Sinuses, Cranial
% 212.45/212.64  |- mesh__dateCreated mesh__D003392 1999-01-01
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D003392 2003
% 212.45/212.64  |- mesh__recordMaintainer mesh__D003392 mdb
% 212.45/212.64  |- skos__scopeNote mesh__D019807
% 212.45/212.64       Iodoacetic acid and its salts and derivatives. Iodoacetic acid reacts with cysteine %28%-SH%29% groups to form a carboxymethylated protein and is used as an enzyme inhibitor in biochemical research.%A%    
% 212.45/212.64  |- skos__historyNote mesh__D019807 Iodoacetates %28%1980-1998%29%
% 212.45/212.64  |- mesh__dateCreated mesh__D019807 1998-06-10
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D019807 2002
% 212.45/212.64  |- mesh__publicMeSHNote mesh__D019807
% 212.45/212.64       99; IODOACETIC ACID was indexed under IODOACETATES 1980-98%A%  
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D019807 2004
% 212.45/212.64  |- skos__broader mesh__D019807smesh__D000088
% 212.45/212.64  |- skos__hiddenLabel mesh__D019807 Acid, Monoiodoacetic
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D019807 1999
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D019807 2001
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D019807 2003
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D019807 2000
% 212.45/212.64  |- skos__prefLabel mesh__D019807 Iodoacetic Acid
% 212.45/212.64  |- skos__altLabel mesh__D019807 Monoiodoacetic Acid
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D019807 2006
% 212.45/212.64  |- rdf__type mesh__D019807sskos__Concept
% 212.45/212.64  |- skos__hiddenLabel mesh__D019807 Acid, Iodoacetic
% 212.45/212.64  |- mesh__dateEstablished mesh__D019807 1999-01-01
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D019807 2005
% 212.45/212.64  |- mesh__historyNote mesh__D019807
% 212.45/212.64       99; use IODOACETIC ACID %28%NM%29% 1980-98   
% 212.45/212.64  |- skos__broader mesh__D019009smesh__D020794
% 212.45/212.64  |- mesh__recordMaintainer mesh__D019009 sjn
% 212.45/212.64  |- skos__hiddenLabel mesh__D019009 p145 c kit
% 212.45/212.64  |- skos__altLabel mesh__D019009 Proto-Oncogene Protein c-kit
% 212.45/212.64  |- skos__hiddenLabel mesh__D019009 Proto-Oncogene Protein, kit
% 212.45/212.64  |- mesh__dateEstablished mesh__D019009 1996-01-01
% 212.45/212.64  |- skos__hiddenLabel mesh__D019009 c kit Protein
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D019009 2006
% 212.45/212.64  |- skos__related mesh__D019009smesh__D016116
% 212.45/212.64  |- skos__altLabel mesh__D019009 CD117 Antigen
% 212.45/212.64  |- mesh__publicMeSHNote mesh__D019009
% 212.45/212.64       2000; see PROTO-ONCOGENE PROTEINS C-KIT 1999-1996; PROTO-ONCOGENE PROTEIN KIT %28%now PROTO-ONCOGENE PROTEIN C-KIT%29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASE 1994-1995; RECEPTORS, COLONY-STIMULATING FACTOR 1991-1995; %26% PROTO-ONCOGENE PROTEINS 1989-1995%A%  
% 212.45/212.64  |- skos__hiddenLabel mesh__D019009 c-kit, Proto-Oncogene Protein
% 212.45/212.64  |- skos__hiddenLabel mesh__D019009 Proto Oncogene Protein c kit
% 212.45/212.64  |- skos__altLabel mesh__D019009 Antigens, CD117
% 212.45/212.64  |- skos__historyNote mesh__D019009
% 212.45/212.64       Receptor Protein-Tyrosine Kinase %28%1994-1995%29%
% 212.45/212.64  |- skos__broader mesh__D019009smesh__D015703
% 212.45/212.64  |- skos__prefLabel mesh__D019009 Proto-Oncogene Proteins c-kit
% 212.45/212.64  |- mesh__recordAuthorizer mesh__D019009 sjn
% 212.45/212.64  |- skos__hiddenLabel mesh__D019009 c-kit, p145
% 212.45/212.64  |- skos__altLabel mesh__D019009 c-kit Receptor
% 212.45/212.64  |- skos__altLabel mesh__D019009 Proto-Oncogene Protein kit
% 212.45/212.64  |- skos__altLabel mesh__D019009 p145c-kit
% 212.45/212.64  |- skos__historyNote mesh__D019009
% 212.45/212.64       Proto-Oncogene Proteins %28%1989-1995%29%
% 212.45/212.64  |- skos__altLabel mesh__D019009 kit Proto-Oncogene Protein
% 212.45/212.64  |- skos__broader mesh__D019009smesh__D011518
% 212.45/212.64  |- skos__historyNote mesh__D019009
% 212.45/212.64       Receptors, Colony-Stimulating Factor %28%1991-1995%29%
% 212.45/212.64  |- skos__hiddenLabel mesh__D019009 Proto Oncogene Protein kit
% 212.45/212.64  |- rdf__type mesh__D019009sskos__Concept
% 212.45/212.64  |- skos__altLabel mesh__D019009 SCF Receptor
% 212.45/212.64  |- mesh__historyNote mesh__D019009
% 212.45/212.64       2000%28%1996%29%; use PROTO-ONCOGENE PROTEIN c-KIT %28%NM%29% 1989-1995%A%  
% 212.45/212.64  |- skos__hiddenLabel mesh__D019009 p145c kit
% 212.45/212.64  |- skos__hiddenLabel mesh__D019009 c-kit, Proto-Oncogene Proteins
% 212.45/212.64  |- skos__broader mesh__D019009smesh__D016184
% 212.45/212.64  |- skos__altLabel mesh__D019009 c-kit Protein
% 212.45/212.64  |- skos__hiddenLabel mesh__D019009 Proto Oncogene Proteins c kit
% 212.45/212.64  |- skos__hiddenLabel mesh__D019009 kit Proto Oncogene Protein
% 212.45/212.64  |- skos__altLabel mesh__D019009 Receptor, Stem Cell Factor
% 212.45/212.64  |- mesh__dateCreated mesh__D019009 1995-05-26
% 212.45/212.64  |- mesh__recordOriginator mesh__D019009 AGS
% 212.45/212.64  |- skos__altLabel mesh__D019009 p145%28%c-kit%29%
% 212.45/212.64  |- mesh__dateRevised mesh__D019009 2005-07-01
% 212.45/212.64  |- skos__altLabel mesh__D019009 Stem Cell Factor Receptor
% 212.45/212.64  |- skos__hiddenLabel mesh__D019009 c kit Receptor
% 212.45/212.64  |- skos__altLabel mesh__D019009 CD117 Antigens
% 212.45/212.64  |- skos__scopeNote mesh__D019009
% 212.45/212.64       A protein-tyrosine kinase receptor that is specific for STEM CELL FACTOR. This interaction is crucial for the development of hematopoietic, gonadal, and pigment stem cells. Genetic mutations that disrupt the expression of PROTO-ONCOGENE PROTEINS C-KIT are associated with PIEBALDISM, while overexpression or constitutive activation of the c-kit protein-tyrosine kinase is associated with tumorigenesis.%A%    
% 212.45/212.64  |- skos__altLabel mesh__D019009 p145 c-kit
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011026 1997
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011026 2006
% 212.45/212.64  |- rdf__type mesh__D011026sskos__Concept
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011026 2000
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011026 1992
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011026 1998
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011026 1991
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011026 2001
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011026 1993
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011026 2003
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011026 1999
% 212.45/212.64  |- mesh__recordAuthorizer mesh__D011026 NLM
% 212.45/212.64  |- skos__hiddenLabel mesh__D011026 Pneumopericardiums
% 212.45/212.64  |- mesh__dateCreated mesh__D011026 1999-01-01
% 212.45/212.64  |- mesh__recordOriginator mesh__D011026 NLM
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011026 1994
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011026 2002
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011026 2004
% 212.45/212.64  |- mesh__recordMaintainer mesh__D011026 PLS
% 212.45/212.64  |- skos__broader mesh__D011026smesh__D006331
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011026 1995
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011026 1996
% 212.45/212.64  |- mesh__dateRevised mesh__D011026 1990-05-29
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D011026 2005
% 212.45/212.64  |- skos__prefLabel mesh__D011026 Pneumopericardium
% 212.45/212.64  |- skos__annotation mesh__D007783
% 212.45/212.64       pyran-2-ones: index PYRONES + LACTONES but BENZOPYRAN-2-ONES is available; for cyclic lactones over 12 atoms consider MACROLIDES%A%  
% 212.45/212.64  |- mesh__dateCreated mesh__D007783 1999-01-01
% 212.45/212.64  |- skos__broader mesh__D007783smesh__D009930
% 212.45/212.64  |- skos__prefLabel mesh__D007783 Lactones
% 212.45/212.64  |- mesh__recordOriginator mesh__D007783 NLM
% 212.45/212.64  |- skos__scopeNote mesh__D007783
% 212.45/212.64       Cyclic esters of hydroxy carboxylic acids, containing a 1-oxacycloalkan-2-one structure. Large cyclic lactones of over a dozen atoms are MACROLIDES.%A%    
% 212.45/212.64  |- rdf__type mesh__D007783sskos__Concept
% 212.45/212.64  |- mesh__recordAuthorizer mesh__D007783 sjn
% 212.45/212.64  |- mesh__recordMaintainer mesh__D007783 ssb
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D007783 2006
% 212.45/212.64  |- mesh__dateRevised mesh__D007783 2005-06-30
% 212.45/212.64  |- skos__annotation mesh__D015417
% 212.45/212.64       do not confuse with HEREDITARY SENSORY AND AUTONOMIC NEUROPATHIES; DF: NEUROPATHIES HEREDITARY MOTOR SENSORY%A%  
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015417 2006B
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015417 2003
% 212.45/212.64  |- skos__historyNote mesh__D015417 Charcot-Marie Disease %28%1975-1988%29%
% 212.45/212.64  |- mesh__dateCreated mesh__D015417 1999-11-08
% 212.45/212.64  |- skos__altLabel mesh__D015417 HMSN Type VII
% 212.45/212.64  |- skos__broader mesh__D015417smesh__D011115
% 212.45/212.64  |- skos__historyNote mesh__D015417 Muscular Atrophy %28%1972-1988%29%
% 212.45/212.64  |- skos__historyNote mesh__D015417 Neuromuscular Diseases %28%1979-1988%29%
% 212.45/212.64  |- skos__broader mesh__D015417smesh__D009421
% 212.45/212.64  |- mesh__recordMaintainer mesh__D015417 ags
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015417 2006
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015417 2006D
% 212.45/212.64  |- skos__hiddenLabel mesh__D015417 Disease, Dejerine-Sottas
% 212.45/212.64  |- skos__hiddenLabel mesh__D015417 Dejerine Sottas Disease
% 212.45/212.64  |- skos__scopeNote mesh__D015417
% 212.45/212.64       A group of slowly progressive inherited disorders affecting motor and sensory peripheral nerves. Subtypes include HMSNs I-VII. HMSN I and II both refer to CHARCOT-MARIE-TOOTH DISEASE. HMSN III refers to hypertrophic neuropathy of infancy. HMSN IV refers to REFSUM DISEASE. HMSN V refers to a condition marked by a hereditary motor and sensory neuropathy associated with spastic paraplegia %28%see SPASTIC PARAPLEGIA, HEREDITARY%29%. HMSN VI refers to HMSN associated with an inherited optic atrophy %28%OPTIC ATROPHIES, HEREDITARY%29%, and HMSN VII refers to HMSN associated with retinitis pigmentosa. %28%From Adams et al., Principles of Neurology, 6th ed, p1343%29%%A%    
% 212.45/212.64  |- skos__altLabel mesh__D015417
% 212.45/212.64       Hereditary, Type III, Motor and Sensory Neuropathy
% 212.45/212.64  |- rdf__type mesh__D015417sskos__Concept
% 212.45/212.64  |- mesh__dateRevised mesh__D015417 2005-07-28
% 212.45/212.64  |- mesh__historyNote mesh__D015417 2000%28%1989%29%   
% 212.45/212.64  |- skos__altLabel mesh__D015417 Neuropathies, Hereditary Motor and Sensory
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015417 2006A
% 212.45/212.64  |- mesh__dateEstablished mesh__D015417 1988-01-01
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015417 2005
% 212.45/212.64  |- skos__altLabel mesh__D015417 HMSN
% 212.45/212.64  |- mesh__recordOriginator mesh__D015417 EC
% 212.45/212.64  |- skos__broader mesh__D015417smesh__D020271
% 212.45/212.64  |- mesh__publicMeSHNote mesh__D015417
% 212.45/212.64       2000; see NEUROPATHIES, HEREDITARY MOTOR AND SENSORY 1988-1999%A%  
% 212.45/212.64  |- skos__altLabel mesh__D015417 Dejerine-Sottas Disease
% 212.45/212.64  |- mesh__recordAuthorizer mesh__D015417 ags
% 212.45/212.64  |- skos__prefLabel mesh__D015417 Hereditary Motor and Sensory Neuropathies
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015417 2002
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015417 2006C
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D015417 2004
% 212.45/212.64  |- rdf__type mesh__D031882sskos__Concept
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D031882 2005
% 212.45/212.64  |- skos__annotation mesh__D031882
% 212.45/212.64       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D031882 2003
% 212.45/212.64  |- mesh__historyNote mesh__D031882 2003   
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D031882 2006
% 212.45/212.64  |- skos__scopeNote mesh__D031882
% 212.45/212.64       A plant genus of the family RANUNCULACEAE. Members contain ACONITINE and other diterpenoid alkaloids.%A%    
% 212.45/212.64  |- mesh__dateEstablished mesh__D031882 2003-01-01
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D031882 2004
% 212.45/212.64  |- skos__altLabel mesh__D031882 Larkspur
% 212.45/212.64  |- mesh__publicMeSHNote mesh__D031882 2003   
% 212.45/212.64  |- skos__broader mesh__D031882smesh__D029626
% 212.45/212.64  |- skos__prefLabel mesh__D031882 Delphinium
% 212.45/212.64  |- mesh__dateCreated mesh__D031882 2002-07-03
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D003393 2004
% 212.45/212.64  |- mesh__activeMeSHYear mesh__D003393 1994
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D003393 2001
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D003393 1992
% 212.45/212.65  |- skos__prefLabel mesh__D003393 Cranial Sutures
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D003393 2000
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D003393 1999
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D003393 2005
% 212.45/212.65  |- skos__historyNote mesh__D003393 specific skull bone %28%1966-1980%29%
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D003393 1997
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D003393 2003
% 212.45/212.65  |- skos__broader mesh__D003393smesh__D012886
% 212.45/212.65  |- rdf__type mesh__D003393sskos__Concept
% 212.45/212.65  |- skos__hiddenLabel mesh__D003393 Sutures, Cranial
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D003393 1998
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D003393 1991
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D003393 1996
% 212.45/212.65  |- mesh__publicMeSHNote mesh__D003393 91; was see under SKULL 1981-90   
% 212.45/212.65  |- skos__hiddenLabel mesh__D003393 Cranial Suture
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D003393 2002
% 212.45/212.65  |- mesh__dateCreated mesh__D003393 1980-04-04
% 212.45/212.65  |- mesh__recordOriginator mesh__D003393 RC
% 212.45/212.65  |- mesh__historyNote mesh__D003393
% 212.45/212.65       91%28%81%29%; was see under SKULL 1981-90   
% 212.45/212.65  |- mesh__recordAuthorizer mesh__D003393 PLS
% 212.45/212.65  |- skos__scopeNote mesh__D003393
% 212.45/212.65       A type of fibrous joint between bones of the head.     
% 212.45/212.65  |- mesh__recordMaintainer mesh__D003393 PLS
% 212.45/212.65  |- mesh__dateEstablished mesh__D003393 1991-01-01
% 212.45/212.65  |- skos__historyNote mesh__D003393 Skull %28%1966-1980%29%
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D003393 1995
% 212.45/212.65  |- skos__annotation mesh__D003393
% 212.45/212.65       note category: a fibrous joint in bones of head; do not confuse with SUTURES %28%E7%29% or SUTURE TECHNIQUES %28%E4%29%%A%  
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D003393 1993
% 212.45/212.65  |- mesh__dateRevised mesh__D003393 1990-02-16
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D003393 2006
% 212.45/212.65  |- skos__hiddenLabel mesh__D003393 Suture, Cranial
% 212.45/212.65  |- skos__altLabel mesh__D019808
% 212.45/212.65       2-Butyl-4-chloro-1-%28%%28%2%27%-%28%1H-etrazol-5-yl%29% %28%1,1%27%-biphenyl%29%-4-yl%29%methyl%29%-1H-imidazole-5-methanol
% 212.45/212.65  |- skos__scopeNote mesh__D019808
% 212.45/212.65       An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.%A%    
% 212.45/212.65  |- skos__altLabel mesh__D019808 MK954
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D019808 2006
% 212.45/212.65  |- mesh__historyNote mesh__D019808 98; use LOSARTAN %28%NM%29% 1990-97   
% 212.45/212.65  |- rdf__type mesh__D019808sskos__Concept
% 212.45/212.65  |- skos__broader mesh__D019808smesh__D001713
% 212.45/212.65  |- skos__altLabel mesh__D019808 Losartan Monopotassium Salt
% 212.45/212.65  |- mesh__dateEstablished mesh__D019808 1998-01-01
% 212.45/212.65  |- mesh__dateCreated mesh__D019808 1997-06-20
% 212.45/212.65  |- skos__historyNote mesh__D019808 Imidazoles %28%1990-1997%29%
% 212.45/212.65  |- mesh__recordAuthorizer mesh__D019808 sjn
% 212.45/212.65  |- skos__hiddenLabel mesh__D019808 MK 954
% 212.45/212.65  |- mesh__recordOriginator mesh__D019808 KEV
% 212.45/212.65  |- mesh__publicMeSHNote mesh__D019808
% 212.45/212.65       98; LOSARTAN was indexed under IMIDAZOLES 1990-97, TETRAZOLES 1990-97, %26% BIPHENYL COMPOUNDS 1990-97%A%  
% 212.45/212.65  |- skos__broader mesh__D019808smesh__D013777
% 212.45/212.65  |- skos__historyNote mesh__D019808 Biphenyl Compounds %28%1990-1997%29%
% 212.45/212.65  |- mesh__recordMaintainer mesh__D019808 ssb
% 212.45/212.65  |- skos__hiddenLabel mesh__D019808 Monopotassium Salt, Losartan
% 212.45/212.65  |- skos__hiddenLabel mesh__D019808 Potassium, Losartan
% 212.45/212.65  |- skos__hiddenLabel mesh__D019808 Salt, Losartan Monopotassium
% 212.45/212.65  |- mesh__dateRevised mesh__D019808 2005-06-30
% 212.45/212.65  |- skos__historyNote mesh__D019808 Tetrazoles %28%1990-1997%29%
% 212.45/212.65  |- skos__broader mesh__D019808smesh__D007093
% 212.45/212.65  |- skos__prefLabel mesh__D019808 Losartan
% 212.45/212.65  |- skos__hiddenLabel mesh__D019808 DuP 753
% 212.45/212.65  |- skos__hiddenLabel mesh__D019808 DuP753
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011825 1996
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011825 2000
% 212.45/212.65  |- skos__scopeNote mesh__D011825
% 212.45/212.65       A system using beamed and reflected radio signals to and from an object in such a way that range, bearing, and other characteristics of the object may be determined.%A%    
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011825 1993
% 212.45/212.65  |- mesh__recordOriginator mesh__D011825 NLM
% 212.45/212.65  |- mesh__recordAuthorizer mesh__D011825 PLS
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011825 2005
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011825 1998
% 212.45/212.65  |- skos__broader mesh__D011825smesh__D013685
% 212.45/212.65  |- rdf__type mesh__D011825sskos__Concept
% 212.45/212.65  |- mesh__dateRevised mesh__D011825 1992-05-18
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011825 1995
% 212.45/212.65  |- skos__annotation mesh__D011825 non-ionizing   
% 212.45/212.65  |- skos__prefLabel mesh__D011825 Radar
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011825 1994
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011825 2002
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011825 2004
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011825 1997
% 212.45/212.65  |- mesh__dateCreated mesh__D011825 1999-01-01
% 212.45/212.65  |- mesh__recordMaintainer mesh__D011825 TAP
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011825 2001
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011825 2006
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011825 2003
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011825 1999
% 212.45/212.65  |- mesh__dateRevised mesh__D011027 2004-07-07
% 212.45/212.65  |- skos__broader mesh__D011027smesh__D010532
% 212.45/212.65  |- mesh__recordAuthorizer mesh__D011027 sjn
% 212.45/212.65  |- mesh__dateCreated mesh__D011027 1999-01-01
% 212.45/212.65  |- skos__annotation mesh__D011027
% 212.45/212.65       a disease; do not confuse with PNEUMOPERITONEUM, ARTIFICIAL, a radiogr technique; RETROPNEUMOPERITONEUM is also available: see note there%A%  
% 212.45/212.65  |- skos__prefLabel mesh__D011027 Pneumoperitoneum
% 212.45/212.65  |- skos__scopeNote mesh__D011027
% 212.45/212.65       A condition with trapped gas or air in the PERITONEAL CAVITY, usually secondary to perforation of the internal organs such as the LUNG and the GASTROINTESTINAL TRACT, or to recent surgery. Pneumoperitoneum may be purposely introduced to aid radiological examination.%A%    
% 212.45/212.65  |- mesh__recordMaintainer mesh__D011027 lkt
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011027 2005
% 212.45/212.65  |- mesh__recordOriginator mesh__D011027 NLM
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011027 2006
% 212.45/212.65  |- rdf__type mesh__D011027sskos__Concept
% 212.45/212.65  |- skos__historyNote mesh__D016510 Cornea/blood supply %28%1978-1991%29%
% 212.45/212.65  |- mesh__recordMaintainer mesh__D016510 lkt
% 212.45/212.65  |- skos__broader mesh__D016510smesh__D003316
% 212.45/212.65  |- rdf__type mesh__D016510sskos__Concept
% 212.45/212.65  |- mesh__dateEstablished mesh__D016510 1992-01-01
% 212.45/212.65  |- skos__prefLabel mesh__D016510 Corneal Neovascularization
% 212.45/212.65  |- mesh__historyNote mesh__D016510 92   
% 212.45/212.65  |- mesh__dateCreated mesh__D016510 1991-01-02
% 212.45/212.65  |- mesh__recordAuthorizer mesh__D016510 sjn
% 212.45/212.65  |- skos__historyNote mesh__D016510 Neovascularization %28%1980-1991%29%
% 212.45/212.65  |- skos__hiddenLabel mesh__D016510 Neovascularization, Corneal
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D016510 2005
% 212.45/212.65  |- skos__scopeNote mesh__D016510
% 212.45/212.65       New blood vessels originating from the corneal veins and extending from the limbus into the adjacent CORNEAL STROMA. Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular anterior segment, such as TRACHOMA, viral interstitial KERATITIS, microbial KERATOCONJUNCTIVITIS, and the immune response elicited by CORNEAL TRANSPLANTATION.%A%    
% 212.45/212.65  |- skos__altLabel mesh__D016510 Corneal Angiogenesis
% 212.45/212.65  |- mesh__dateRevised mesh__D016510 2003-07-09
% 212.45/212.65  |- mesh__publicMeSHNote mesh__D016510 92   
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D016510 2004
% 212.45/212.65  |- skos__hiddenLabel mesh__D016510 Neovascularizations, Corneal
% 212.45/212.65  |- mesh__recordOriginator mesh__D016510 PXP
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D016510 2006
% 212.45/212.65  |- skos__hiddenLabel mesh__D016510 Angiogenesis, Corneal
% 212.45/212.65  |- skos__hiddenLabel mesh__D016510 Corneal Neovascularizations
% 212.45/212.65  |- skos__annotation mesh__D016510 DF: CORNEAL NEOVASC   
% 212.45/212.65  |- skos__scopeNote mesh__D007784
% 212.45/212.65       An enzyme derived from cow%27%s milk. It catalyzes the radioiodination of tyrosine and its derivatives and of peptides containing tyrosine.%A%    
% 212.45/212.65  |- mesh__publicMeSHNote mesh__D007784
% 212.45/212.65       91; was see under PEROXIDASES 1975-90   
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D007784 2004
% 212.45/212.65  |- mesh__recordMaintainer mesh__D007784 ssb
% 212.45/212.65  |- mesh__dateRevised mesh__D007784 2003-07-09
% 212.45/212.65  |- rdf__type mesh__D007784sskos__Concept
% 212.45/212.65  |- skos__historyNote mesh__D007784 Peroxidases %28%1969-1974%29%
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D007784 2005
% 212.45/212.65  |- mesh__dateEstablished mesh__D007784 1991-01-01
% 212.45/212.65  |- mesh__dateCreated mesh__D007784 1974-11-19
% 212.45/212.65  |- skos__broader mesh__D007784smesh__D010544
% 212.45/212.65  |- mesh__recordOriginator mesh__D007784 NLM
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D007784 2006
% 212.45/212.65  |- skos__prefLabel mesh__D007784 Lactoperoxidase
% 212.45/212.65  |- mesh__historyNote mesh__D007784
% 212.45/212.65       91%28%75%29%; was see under PEROXIDASES 1975-90   
% 212.45/212.65  |- mesh__recordAuthorizer mesh__D007784 sjn
% 212.45/212.65  |- mesh__recordMaintainer mesh__D015418 nns
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D015418 2005
% 212.45/212.65  |- skos__broader mesh__D015418smesh__D015785
% 212.45/212.65  |- skos__hiddenLabel mesh__D015418 Atrophies, Hereditary Optic
% 212.45/212.65  |- skos__scopeNote mesh__D015418
% 212.45/212.65       Hereditary conditions that feature progressive visual loss in association with optic atrophy. Relatively common forms include autosomal dominant optic atrophy %28%OPTIC ATROPHY, AUTOSOMAL DOMINANT%29% and Leber hereditary optic atrophy %28%OPTIC ATROPHY, HEREDITARY, LEBER%29%.%A%    
% 212.45/212.65  |- skos__hiddenLabel mesh__D015418 Hereditary Optic Atrophies
% 212.45/212.65  |- mesh__recordAuthorizer mesh__D015418 sjn
% 212.45/212.65  |- skos__altLabel mesh__D015418 Hereditary Optic Atrophy
% 212.45/212.65  |- skos__broader mesh__D015418smesh__D020271
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D015418 2006
% 212.45/212.65  |- skos__prefLabel mesh__D015418 Optic Atrophies, Hereditary
% 212.45/212.65  |- mesh__dateRevised mesh__D015418 2001-07-25
% 212.45/212.65  |- skos__altLabel mesh__D015418 Optic Atrophy, Hereditary
% 212.45/212.65  |- mesh__dateCreated mesh__D015418 1988-06-07
% 212.45/212.65  |- rdf__type mesh__D015418sskos__Concept
% 212.45/212.65  |- mesh__publicMeSHNote mesh__D015418
% 212.45/212.65       2000; see OPTIC ATROPHY, HEREDITARY 1991-1999, see NEUROPATHIES, HEREDITARY MOTOR AND SENSORY 1989-1990%A%  
% 212.45/212.65  |- skos__hiddenLabel mesh__D015418 Atrophy, Hereditary Optic
% 212.45/212.65  |- mesh__historyNote mesh__D015418 2000%28%1989%29%   
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D015418 2003
% 212.45/212.65  |- skos__broader mesh__D015418smesh__D009896
% 212.45/212.65  |- mesh__recordOriginator mesh__D015418 EC
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D015418 2002
% 212.45/212.65  |- mesh__dateEstablished mesh__D015418 1991-01-01
% 212.45/212.65  |- skos__historyNote mesh__D015418 Optic Atrophy/genetics %28%1966-1988%29%
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D015418 2004
% 212.45/212.65  |- mesh__dateRevised mesh__D012120 1997-06-20
% 212.45/212.65  |- skos__hiddenLabel mesh__D012120 Respiration Disorder
% 212.45/212.65  |- skos__prefLabel mesh__D012120 Respiration Disorders
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D012120 2000
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D012120 1998
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D012120 2003
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D012120 2001
% 212.45/212.65  |- skos__hiddenLabel mesh__D012120 Disorder, Respiration
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D012120 2005
% 212.45/212.65  |- mesh__dateCreated mesh__D012120 1999-01-01
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D012120 1999
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D012120 2004
% 212.45/212.65  |- skos__scopeNote mesh__D012120
% 212.45/212.65       Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.%A%    
% 212.45/212.65  |- mesh__publicMeSHNote mesh__D012120
% 212.45/212.65       77; RESPIRATORY DISEASES was a heading 1963-65 superseded by RESPIRATORY TRACT DISEASES in 1966; CHEYNE-STOKES RESPIRATION was see under RESPIRATION 1966-76%A%  
% 212.45/212.65  |- mesh__historyNote mesh__D012120
% 212.45/212.65       77; was NON MESH before 1977; RESPIRATORY DISEASES was a heading 1963-65 superseded by RESPIRATORY TRACT DISEASES in 1966%A%  
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D012120 2006
% 212.45/212.65  |- skos__historyNote mesh__D012120
% 212.45/212.65       Respiratory Insufficiency %28%1966-1976%29%
% 212.45/212.65  |- skos__historyNote mesh__D012120 Respiration %28%1966-1976%29%
% 212.45/212.65  |- mesh__dateEstablished mesh__D012120 1977-01-01
% 212.45/212.65  |- skos__hiddenLabel mesh__D012120 Disorders, Respiration
% 212.45/212.65  |- skos__broader mesh__D012120smesh__D012140
% 212.45/212.65  |- mesh__recordMaintainer mesh__D012120 TGC
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D012120 2002
% 212.45/212.65  |- skos__annotation mesh__D012120 GEN or unspecified; prefer specifics   
% 212.45/212.65  |- rdf__type mesh__D012120sskos__Concept
% 212.45/212.65  |- mesh__recordOriginator mesh__D012120 NLM
% 212.45/212.65  |- mesh__recordAuthorizer mesh__D012120 SJN
% 212.45/212.65  |- skos__prefLabel mesh__D031883 Anemone
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D031883 2005
% 212.45/212.65  |- skos__annotation mesh__D031883
% 212.45/212.65       X ref ANEMONE: venom of Conus anemone use MOLLUSK VENOMS is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D031883 2003
% 212.45/212.65  |- skos__scopeNote mesh__D031883
% 212.45/212.65       A plant genus of the family RANUNCULACEAE that contains triterpene saponins. The root of Anemone raddeana is the source of a Chinese folk medicine, zhu jie xian fu. The common name of liverwort is also used with other plants. This genus is unrelated to SEA ANEMONES.%A%    
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D031883 2006
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D031883 2004
% 212.45/212.65  |- mesh__publicMeSHNote mesh__D031883 2003   
% 212.45/212.65  |- skos__broader mesh__D031883smesh__D029626
% 212.45/212.65  |- mesh__dateCreated mesh__D031883 2002-07-02
% 212.45/212.65  |- mesh__historyNote mesh__D031883 2003   
% 212.45/212.65  |- mesh__dateEstablished mesh__D031883 2003-01-01
% 212.45/212.65  |- rdf__type mesh__D031883sskos__Concept
% 212.45/212.65  |- mesh__dateCreated mesh__D003394 1999-01-01
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D003394 2003
% 212.45/212.65  |- rdf__type mesh__D003394sskos__Concept
% 212.45/212.65  |- skos__altLabel mesh__D003394 Crouzon Disease
% 212.45/212.65  |- skos__annotation mesh__D003394
% 212.45/212.65       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; %22%craniofacial dysmorphism%22% does not go here: index under FACIAL BONES /abnorm + SKULL /abnorm but not also under ABNORMALITIES, MULTIPLE%A%  
% 212.45/212.65  |- skos__altLabel mesh__D003394 Crouzon%27%s Disease
% 212.45/212.65  |- skos__broader mesh__D003394smesh__D019465
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D003394 2001
% 212.45/212.65  |- mesh__recordOriginator mesh__D003394 NLM
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D003394 2000
% 212.45/212.65  |- mesh__recordMaintainer mesh__D003394 KEV
% 212.45/212.65  |- skos__prefLabel mesh__D003394 Craniofacial Dysostosis
% 212.45/212.65  |- mesh__dateRevised mesh__D003394 1999-11-05
% 212.45/212.65  |- skos__scopeNote mesh__D003394
% 212.45/212.65       An autosomal dominant disorder characterized by acrocephaly, exophthalmos, hypertelorism, strabismus, parrot-beaked nose, and hypoplastic maxilla with relative mandibular prognathism. %28%Dorland, 27th ed%29%%A%    
% 212.45/212.65  |- skos__broader mesh__D003394smesh__D004413
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D003394 2006
% 212.45/212.65  |- mesh__recordAuthorizer mesh__D003394 sjn
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D003394 2002
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D003394 2004
% 212.45/212.65  |- skos__hiddenLabel mesh__D003394 Crouzons Disease
% 212.45/212.65  |- skos__hiddenLabel mesh__D003394 Dysostoses, Craniofacial
% 212.45/212.65  |- skos__hiddenLabel mesh__D003394 Disease, Crouzon%27%s
% 212.45/212.65  |- skos__hiddenLabel mesh__D003394 Craniofacial Dysostoses
% 212.45/212.65  |- skos__hiddenLabel mesh__D003394 Disease, Crouzon
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D003394 2005
% 212.45/212.65  |- skos__altLabel mesh__D003394 Dysostosis, Craniofacial
% 212.45/212.65  |- skos__broader mesh__D019809smesh__D001426
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D019809 2006
% 212.45/212.65  |- rdf__type mesh__D019809sskos__Concept
% 212.45/212.65  |- skos__scopeNote mesh__D019809
% 212.45/212.65       A 60-kDa extracellular protein of Streptomyces avidinii with four high-affinity biotin binding sites. Unlike AVIDIN, streptavidin has a near neutral isoelectric point and is free of carbohydrate side chains.%A%    
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D019809 2005
% 212.45/212.65  |- mesh__recordMaintainer mesh__D019809 jmp
% 212.45/212.65  |- mesh__dateRevised mesh__D019809 2004-07-07
% 212.45/212.65  |- mesh__historyNote mesh__D019809
% 212.45/212.65       98; use STREPTAVIDIN %28%NM%29% 1980-97   
% 212.45/212.65  |- mesh__dateEstablished mesh__D019809 1998-01-01
% 212.45/212.65  |- mesh__publicMeSHNote mesh__D019809
% 212.45/212.65       98; STREPTAVIDIN was indexed under BACTERIAL PROTEINS 1980-97%A%  
% 212.45/212.65  |- skos__historyNote mesh__D019809 Bacterial Proteins %28%1980-1997%29%
% 212.45/212.65  |- mesh__dateCreated mesh__D019809 1997-06-20
% 212.45/212.65  |- mesh__recordAuthorizer mesh__D019809 sjn
% 212.45/212.65  |- mesh__recordOriginator mesh__D019809 KEV
% 212.45/212.65  |- skos__altLabel mesh__D019809 Strepavidin
% 212.45/212.65  |- skos__prefLabel mesh__D019809 Streptavidin
% 212.45/212.65  |- skos__scopeNote mesh__D011826
% 212.45/212.65       A major nerve of the upper extremity. In humans the fibers of the radial nerve originate in the lower cervical and upper thoracic spinal cord %28%usually C5 to T1%29%, travel via the posterior cord of the brachial plexus, and supply motor innervation to extensor muscles of the arm and cutaneous sensory fibers to extensor regions of the arm and hand.%A%    
% 212.45/212.65  |- skos__annotation mesh__D011826
% 212.45/212.65       dis = RADIAL NEUROPATHY; neopl = RADIAL NEUROPATHY %28%IM%29% + PERIPHERAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 212.45/212.65  |- skos__hiddenLabel mesh__D011826 Nerve, Radial
% 212.45/212.65  |- skos__hiddenLabel mesh__D011826 Nerves, Radial
% 212.45/212.65  |- skos__prefLabel mesh__D011826 Radial Nerve
% 212.45/212.65  |- rdf__type mesh__D011826sskos__Concept
% 212.45/212.65  |- mesh__dateRevised mesh__D011826 2001-07-25
% 212.45/212.65  |- mesh__dateCreated mesh__D011826 1999-01-01
% 212.45/212.65  |- mesh__recordOriginator mesh__D011826 NLM
% 212.45/212.65  |- mesh__recordMaintainer mesh__D011826 ags
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011826 2003
% 212.45/212.65  |- mesh__recordAuthorizer mesh__D011826 sjn
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011826 2002
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011826 2005
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011826 2004
% 212.45/212.65  |- skos__broader mesh__D011826smesh__D001917
% 212.45/212.65  |- skos__hiddenLabel mesh__D011826 Radial Nerves
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011826 2006
% 212.45/212.65  |- skos__broader mesh__D044202smesh__D011549
% 212.45/212.65  |- skos__scopeNote mesh__D044202
% 212.45/212.65       A species of gram-negative bacteria in the genus PSEUDOMONAS. It cannot utilize FRUCTOSE; GLUCOSE; or MALTOSE for energy.%A%    
% 212.45/212.65  |- mesh__recordAuthorizer mesh__D044202 sjn
% 212.45/212.65  |- mesh__historyNote mesh__D044202 2004   
% 212.45/212.65  |- mesh__recordMaintainer mesh__D044202 SYSTEM
% 212.45/212.65  |- mesh__recordOriginator mesh__D044202 ags
% 212.45/212.65  |- rdf__type mesh__D044202sskos__Concept
% 212.45/212.65  |- mesh__dateCreated mesh__D044202 2003-07-09
% 212.45/212.65  |- mesh__dateEstablished mesh__D044202 2004-01-01
% 212.45/212.65  |- skos__historyNote mesh__D044202 Pseudomonas %28%1968-2003%29%
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D044202 2006
% 212.45/212.65  |- skos__annotation mesh__D044202
% 212.45/212.65       infection: coord IM with PSEUDOMONAS INFECTIONS %28%IM%29%   
% 212.45/212.65  |- skos__prefLabel mesh__D044202 Pseudomonas alcaligenes
% 212.45/212.65  |- mesh__dateRevised mesh__D044202 2005-06-30
% 212.45/212.65  |- mesh__publicMeSHNote mesh__D044202 2004   
% 212.45/212.65  |- mesh__dateCreated mesh__D011028 1999-01-01
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011028 2001
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011028 2004
% 212.45/212.65  |- mesh__dateRevised mesh__D011028 1997-06-20
% 212.45/212.65  |- mesh__recordOriginator mesh__D011028 NLM
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011028 2002
% 212.45/212.65  |- skos__scopeNote mesh__D011028
% 212.45/212.65       Deliberate introduction of air into the peritoneal cavity.%A%    
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011028 2005
% 212.45/212.65  |- skos__hiddenLabel mesh__D011028 Artificial Pneumoperitoneum
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011028 2006
% 212.45/212.65  |- rdf__type mesh__D011028sskos__Concept
% 212.45/212.65  |- skos__broader mesh__D011028smesh__D003949
% 212.45/212.65  |- mesh__recordAuthorizer mesh__D011028 SJN
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011028 1998
% 212.45/212.65  |- skos__prefLabel mesh__D011028 Pneumoperitoneum, Artificial
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011028 2000
% 212.45/212.65  |- mesh__recordMaintainer mesh__D011028 PXP
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011028 2003
% 212.45/212.65  |- skos__annotation mesh__D011028
% 212.45/212.65       do not use /util except by MeSH definition   
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D011028 1999
% 212.45/212.65  |- skos__hiddenLabel mesh__D016511 Lymphocyte Syndromes, Bare
% 212.45/212.65  |- mesh__dateCreated mesh__D016511 1991-01-03
% 212.45/212.65  |- rdf__type mesh__D016511sskos__Concept
% 212.45/212.65  |- skos__broader mesh__D016511smesh__D049914
% 212.45/212.65  |- skos__altLabel mesh__D016511 Immunodeficiency, Severe Combined
% 212.45/212.65  |- mesh__historyNote mesh__D016511 92   
% 212.45/212.65  |- skos__altLabel mesh__D016511 Immunologic Deficiency, Severe Combined
% 212.45/212.65  |- mesh__recordOriginator mesh__D016511 AGS
% 212.45/212.65  |- skos__prefLabel mesh__D016511 Severe Combined Immunodeficiency
% 212.45/212.65  |- skos__hiddenLabel mesh__D016511 Severe Combined Immunodeficiencies
% 212.45/212.65  |- skos__hiddenLabel mesh__D016511 Lymphocyte Syndrome, Bare
% 212.45/212.65  |- skos__hiddenLabel mesh__D016511 Combined Immunodeficiency, Severe
% 212.45/212.65  |- mesh__dateEstablished mesh__D016511 1992-01-01
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D016511 2006
% 212.45/212.65  |- skos__hiddenLabel mesh__D016511 Syndrome, Bare Lymphocyte
% 212.45/212.65  |- skos__hiddenLabel mesh__D016511 Immunodeficiencies, Severe Combined
% 212.45/212.65  |- skos__hiddenLabel mesh__D016511 Bare Lymphocyte Syndromes
% 212.45/212.65  |- skos__broader mesh__D016511smesh__D007153
% 212.45/212.65  |- skos__hiddenLabel mesh__D016511 Syndromes, Bare Lymphocyte
% 212.45/212.65  |- skos__broader mesh__D016511smesh__D007232
% 212.45/212.65  |- mesh__recordAuthorizer mesh__D016511 sjn
% 212.45/212.65  |- skos__altLabel mesh__D016511 Severe Combined Immunodeficiency Syndrome
% 212.45/212.65  |- mesh__recordMaintainer mesh__D016511 nns
% 212.45/212.65  |- skos__altLabel mesh__D016511 SCID
% 212.45/212.65  |- mesh__dateRevised mesh__D016511 2005-06-30
% 212.45/212.65  |- skos__scopeNote mesh__D016511
% 212.45/212.65       Group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. It is inherited as an X-linked or autosomal recessive defect. Mutations occurring in many different genes cause human SCID.%A%    
% 212.45/212.65  |- skos__hiddenLabel mesh__D016511 Combined Immunodeficiencies, Severe
% 212.45/212.65  |- skos__altLabel mesh__D016511 Severe Combined Immunologic Deficiency
% 212.45/212.65  |- skos__altLabel mesh__D016511 Immunodeficiency Syndrome, Severe Combined
% 212.45/212.65  |- skos__historyNote mesh__D016511
% 212.45/212.65       Immunologic Deficiency Syndromes %28%1974-1991%29%
% 212.45/212.65  |- mesh__publicMeSHNote mesh__D016511 92   
% 212.45/212.65  |- mesh__recordOriginator mesh__D007785 NLM
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D007785 2005
% 212.45/212.65  |- skos__prefLabel mesh__D007785 Lactose
% 212.45/212.65  |- skos__scopeNote mesh__D007785
% 212.45/212.65       A disaccharide of GLUCOSE and GALACTOSE in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry.%A%    
% 212.45/212.65  |- mesh__recordAuthorizer mesh__D007785 sjn
% 212.45/212.65  |- mesh__dateCreated mesh__D007785 1999-01-01
% 212.45/212.65  |- skos__broader mesh__D007785smesh__D004187
% 212.45/212.65  |- mesh__recordMaintainer mesh__D007785 sjn
% 212.45/212.65  |- rdf__type mesh__D007785sskos__Concept
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D007785 2006
% 212.45/212.65  |- mesh__dateRevised mesh__D007785 2004-07-13
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D015419 2005
% 212.45/212.65  |- skos__prefLabel mesh__D015419 Spastic Paraplegia, Hereditary
% 212.45/212.65  |- skos__broader mesh__D015419smesh__D015417
% 212.45/212.65  |- rdf__type mesh__D015419sskos__Concept
% 212.45/212.65  |- mesh__publicMeSHNote mesh__D015419
% 212.45/212.65       1991; see NEUROPATHIES, HEREDITARY MOTOR AND SENSORY 1989-1990%A%  
% 212.45/212.65  |- skos__altLabel mesh__D015419
% 212.45/212.65       Spastic Paraplegia, Hereditary, Autosomal Recessive
% 212.45/212.65  |- skos__altLabel mesh__D015419
% 212.45/212.65       Type V Hereditary Motor and Sensory Neuropathy
% 212.45/212.65  |- skos__altLabel mesh__D015419
% 212.45/212.65       Hypertrophic Motor-Sensory Neuropathy-Spastic Paraplegia
% 212.45/212.65  |- mesh__dateEstablished mesh__D015419 1991-01-01
% 212.45/212.65  |- skos__hiddenLabel mesh__D015419
% 212.45/212.65       Spastic Paraplegia Hypertrophic Motor Sensory Neuropathy
% 212.45/212.65  |- skos__hiddenLabel mesh__D015419 Spastic Paraplegias, Hereditary
% 212.45/212.65  |- skos__hiddenLabel mesh__D015419 Paraplegias, Hereditary Spastic
% 212.45/212.65  |- skos__altLabel mesh__D015419
% 212.45/212.65       Hereditary Motor-Sensory Neuropathy with Pyramidal Signs
% 212.45/212.65  |- skos__altLabel mesh__D015419
% 212.45/212.65       Autosomal Recessive Spastic Paraplegia, Hereditary
% 212.45/212.65  |- skos__altLabel mesh__D015419
% 212.45/212.65       Hereditary, Spastic Paraplegia, X-Linked Recessive
% 212.45/212.65  |- skos__hiddenLabel mesh__D015419
% 212.45/212.65       Hereditary Motor Sensory Neuropathy with Pyramidal Signs
% 212.45/212.65  |- skos__altLabel mesh__D015419
% 212.45/212.65       Hereditary Autosomal Recessive Spastic Paraplegia
% 212.45/212.65  |- skos__hiddenLabel mesh__D015419
% 212.45/212.65       X linked Recessive Hereditary Spastic Paraplegia
% 212.45/212.65  |- skos__annotation mesh__D015419
% 212.45/212.65       coord with GENES, DOMINANT or GENES, RECESSIVE if discussed%A%  
% 212.45/212.65  |- skos__altLabel mesh__D015419
% 212.45/212.65       Autosomal Dominant Spastic Paraplegia Hereditary
% 212.45/212.65  |- skos__historyNote mesh__D015419 Paraplegia/genetics %28%1966-1988%29%
% 212.45/212.65  |- skos__hiddenLabel mesh__D015419
% 212.45/212.65       Hereditary X Linked Recessive Spastic Paraplegia
% 212.45/212.65  |- skos__scopeNote mesh__D015419
% 212.45/212.65       A group of inherited diseases that share similar phenotypes but are genetically diverse. Different genetic loci for autosomal recessive, autosomal dominant, and x-linked forms of hereditary spastic paraplegia have been identified. Clinically, patients present with slowly progressive distal limb weakness and lower extremity spasticity. Peripheral sensory neurons may be affected in the later stages of the disease. %28%J Neurol Neurosurg Psychiatry 1998 Jan;64%28%1%29%:61-6; Curr Opin Neurol 1997 Aug;10%28%4%29%:313-8%29%%A%    
% 212.45/212.65  |- skos__altLabel mesh__D015419
% 212.45/212.65       Spastic Paraplegia, Autosomal Recessive, Hereditary
% 212.45/212.65  |- skos__altLabel mesh__D015419
% 212.45/212.65       Hereditary, Spastic Paraplegia, Autosomal Dominant
% 212.45/212.65  |- skos__altLabel mesh__D015419
% 212.45/212.65       Autosomal Dominant Hereditary Spastic Paraplegia
% 212.45/212.65  |- skos__altLabel mesh__D015419
% 212.45/212.65       Spastic Paraplegia-Hypertrophic Motor-Sensory Neuropathy
% 212.45/212.65  |- skos__altLabel mesh__D015419 Paraplegia, Spastic, Hereditary
% 212.45/212.65  |- mesh__recordMaintainer mesh__D015419 jls
% 212.45/212.65  |- mesh__recordOriginator mesh__D015419 EC
% 212.45/212.65  |- mesh__recordAuthorizer mesh__D015419 jls
% 212.45/212.65  |- mesh__dateRevised mesh__D015419 2004-08-02
% 212.45/212.65  |- skos__hiddenLabel mesh__D015419 Hereditary Spastic Paraplegias
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D015419 2005A
% 212.45/212.65  |- mesh__activeMeSHYear mesh__D015419 2006
% 212.45/212.65  |- mesh__dateCreated mesh__D015419 1988-06-07
% 212.45/212.65  |- skos__altLabel mesh__D015419
% 212.45/212.65       Spastic Paraplegia, Hereditary, X-Linked Recessive
% 212.45/212.65  |- skos__altLabel mesh__D015419
% 212.45/212.65       X-linked Recessive Hereditary Spastic Paraplegia
% 212.45/212.65  |- mesh__historyNote mesh__D015419 1991%28%1989%29%   
% 212.45/212.65  |- skos__hiddenLabel mesh__D015419 Type V, HMSN
% 212.45/212.65  |- skos__altLabel mesh__D015419
% 212.45/212.65       Spastic Paraplegia, Hereditary, Autosomal Dominant
% 212.45/212.65  |- skos__altLabel mesh__D015419
% 212.45/212.65       Spastic Paraplegia, X-Linked Recessive, Hereditary
% 212.45/212.65  |- skos__altLabel mesh__D015419
% 212.45/212.65       HMSN V %28%Hereditary Motor and Sensory Neuropathy Type V%29%
% 212.45/212.65  |- skos__hiddenLabel mesh__D015419
% 212.45/212.65       Hypertrophic Motor Sensory Neuropathy Spastic Paraplegia
% 212.45/212.65  |- skos__historyNote mesh__D015419
% 212.45/212.65       Muscle Spasticity/genetics %28%1975-1988%29%
% 212.45/212.65  |- skos__hiddenLabel mesh__D015419 Paraplegia, Hereditary Spastic
% 212.45/212.65  |- skos__altLabel mesh__D015419 HMSN Type V
% 212.45/212.65  |- skos__altLabel mesh__D015419
% 212.45/212.65       Hereditary Spastic Paraplegia, Autosomal Recessive
% 212.45/212.65  |- skos__altLabel mesh__D015419
% 212.45/212.65       Spastic Paraplegia, Autosomal Dominant, Hereditary
% 212.45/212.65  |- skos__altLabel mesh__D015419 Hereditary Spastic Paraplegia
% 212.45/212.65  |- skos__altLabel mesh__D026141 Multidrug Resistance, Fungal
% 212.45/212.65  |- mesh__historyNote mesh__D026141 2002   
% 212.45/212.65  |- skos__broader mesh__D026141smesh__D025141
% 212.45/212.65  |- skos__prefLabel mesh__D026141 Drug Resistance, Multiple, Fungal
% 212.45/212.65  |- mesh__dateRevised mesh__D026141 2003-07-09
% 212.45/212.65  |- mesh__recordMaintainer mesh__D026141 ssb
% 212.45/212.65  |- skos__historyNote mesh__D026141
% 212.45/212.65       Drug Resistance, Microbial %28%1972-2001%29%
% 212.45/212.65  |- mesh__dateEstablished mesh__D026141 2002-01-01
% 212.45/212.65  |- skos__scopeNote mesh__D026141
% 212.45/212.65       The ability of fungi to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance phenotype may be attributed to multiple gene mutations.%A%    
% 212.45/212.65  |- mesh__recordAuthorizer mesh__D026141 sjn
% 212.45/212.65  |- mesh__dateCreated mesh__D026141 2001-07-25
% 212.45/212.65  |- mesh__publicMeSHNote mesh__D026141 2002   
% 212.45/212.66  |- skos__historyNote mesh__D026141
% 212.45/212.66       Drug Resistance, Multiple %28%1994-2001%29%
% 212.45/212.66  |- skos__broader mesh__D026141smesh__D018432
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D026141 2006
% 212.45/212.66  |- mesh__recordOriginator mesh__D026141 lkt
% 212.45/212.66  |- skos__altLabel mesh__D026141 Multiple Antifungal Drug Resistance
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D026141 2004
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D026141 2005
% 212.45/212.66  |- rdf__type mesh__D026141sskos__Concept
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D012121 2003
% 212.45/212.66  |- mesh__recordOriginator mesh__D012121 NLM
% 212.45/212.66  |- skos__prefLabel mesh__D012121 Respiration, Artificial
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D012121 2005
% 212.45/212.66  |- mesh__dateCreated mesh__D012121 1999-01-01
% 212.45/212.66  |- mesh__dateRevised mesh__D012121 2002-07-02
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D012121 2004
% 212.45/212.66  |- skos__annotation mesh__D012121
% 212.45/212.66       /instrum: consider also VENTILATORS, MECHANICAL   
% 212.45/212.66  |- skos__broader mesh__D012121smesh__D012138
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D012121 2006
% 212.45/212.66  |- skos__hiddenLabel mesh__D012121 Mechanical Ventilations
% 212.45/212.66  |- skos__hiddenLabel mesh__D012121 Ventilations, Mechanical
% 212.45/212.66  |- skos__hiddenLabel mesh__D012121 Respirations, Artificial
% 212.45/212.66  |- skos__hiddenLabel mesh__D012121 Artificial Respirations
% 212.45/212.66  |- mesh__recordAuthorizer mesh__D012121 sjn
% 212.45/212.66  |- skos__hiddenLabel mesh__D012121 Artificial Respiration
% 212.45/212.66  |- rdf__type mesh__D012121sskos__Concept
% 212.45/212.66  |- mesh__recordMaintainer mesh__D012121 lkt
% 212.45/212.66  |- skos__related mesh__D012121smesh__D012122
% 212.45/212.66  |- skos__scopeNote mesh__D012121
% 212.45/212.66       Any method of artifical breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen %28%O2 %29% and excretion of carbon dioxide %28%CO2 %29%.%A%    
% 212.45/212.66  |- skos__broader mesh__D012121smesh__D012151
% 212.45/212.66  |- skos__hiddenLabel mesh__D012121 Mechanical Ventilation
% 212.45/212.66  |- skos__altLabel mesh__D031884 Columbine
% 212.45/212.66  |- rdf__type mesh__D031884sskos__Concept
% 212.45/212.66  |- skos__annotation mesh__D031884
% 212.45/212.66       AQUILEGIA ADOXOIDES see SEMIAQUILEGIA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D031884 2004
% 212.45/212.66  |- skos__scopeNote mesh__D031884
% 212.45/212.66       A plant genus of the family RANUNCULACEAE that contains aquiledine, isoaquiledine and cycloartane-type glycosides.%A%    
% 212.45/212.66  |- mesh__dateEstablished mesh__D031884 2003-01-01
% 212.45/212.66  |- skos__broader mesh__D031884smesh__D029626
% 212.45/212.66  |- mesh__publicMeSHNote mesh__D031884 2003   
% 212.45/212.66  |- mesh__dateCreated mesh__D031884 2002-07-02
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D031884 2003
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D031884 2006
% 212.45/212.66  |- skos__prefLabel mesh__D031884 Aquilegia
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D031884 2005
% 212.45/212.66  |- mesh__historyNote mesh__D031884 2003   
% 212.45/212.66  |- skos__annotation mesh__D003395
% 212.45/212.66       specialty; do not confuse with CRANIOMETRY see CEPHALOMETRY; DF: CRANIOL%A%  
% 212.45/212.66  |- skos__prefLabel mesh__D003395 Craniology
% 212.45/212.66  |- mesh__recordAuthorizer mesh__D003395 sjn
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D003395 2006
% 212.45/212.66  |- mesh__dateRevised mesh__D003395 2004-07-07
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D003395 2005
% 212.45/212.66  |- skos__broader mesh__D003395smesh__D000885
% 212.45/212.66  |- skos__scopeNote mesh__D003395
% 212.45/212.66       The scientific study of variations in size, shape, and proportion of the cranium.%A%    
% 212.45/212.66  |- mesh__dateCreated mesh__D003395 1999-01-01
% 212.45/212.66  |- skos__related mesh__D003395smesh__D002508
% 212.45/212.66  |- mesh__recordOriginator mesh__D003395 NLM
% 212.45/212.66  |- rdf__type mesh__D003395sskos__Concept
% 212.45/212.66  |- mesh__recordMaintainer mesh__D003395 nns
% 212.45/212.66  |- skos__related mesh__D011827smesh__D009689
% 212.45/212.66  |- skos__prefLabel mesh__D011827 Radiation
% 212.45/212.66  |- mesh__historyNote mesh__D011827
% 212.45/212.66       RADIATION IMMUNOLOGY was heading 1964-66   
% 212.45/212.66  |- rdf__type mesh__D011827sskos__Concept
% 212.45/212.66  |- skos__scopeNote mesh__D011827
% 212.45/212.66       Emission or propagation of electromagnetic energy %28%waves/rays%29%, or the waves/rays themselves; a stream of electromagnetic particles %28%electrons, neutrons, protons, alpha particles%29% or a mixture of these. The most common source is the sun.%A%    
% 212.45/212.66  |- skos__related mesh__D011827smesh__D011851
% 212.45/212.66  |- mesh__dateCreated mesh__D011827 1999-01-01
% 212.45/212.66  |- mesh__publicMeSHNote mesh__D011827
% 212.45/212.66       RADIATION IMMUNOLOGY was heading 1964-66   
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D011827 2003
% 212.45/212.66  |- skos__hiddenLabel mesh__D011827 Radiations
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D011827 2005
% 212.45/212.66  |- mesh__recordMaintainer mesh__D011827 jls
% 212.45/212.66  |- skos__broader mesh__D011827smesh__D010825
% 212.45/212.66  |- skos__altLabel mesh__D011827 Electromagnetic Radiation
% 212.45/212.66  |- mesh__onlineNote mesh__D011827
% 212.45/212.66       search RADIATION IMMUNOLOGY under RADIATION EFFECTS 1966   
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D011827 2004
% 212.45/212.66  |- skos__altLabel mesh__D011827 Radiation, Electromagnetic
% 212.45/212.66  |- skos__annotation mesh__D011827
% 212.45/212.66       GEN; /adv eff = RADIATION INJURIES but see note there; /diag use = RADIOGRAPHY or RADIONUCLIDE IMAGING; Manual 29.12, 29.13; radiation scattering = SCATTERING, RADIATION; TN 158: how to index x-rays, gamma rays %26% cathode rays; radiation policy: see Manual index under RADIATION %26% entries following; see all RADIATION terms for concepts superior to RADIATION; DF: RAD%A%  
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D011827 2006
% 212.45/212.66  |- mesh__dateRevised mesh__D011827 2001-07-25
% 212.45/212.66  |- mesh__recordOriginator mesh__D011827 NLM
% 212.45/212.66  |- mesh__recordAuthorizer mesh__D011827 sjn
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D011827 2002
% 212.45/212.66  |- skos__altLabel mesh__D011827 Electromagnetic Waves
% 212.45/212.66  |- mesh__recordMaintainer mesh__D044203 SYSTEM
% 212.45/212.66  |- skos__historyNote mesh__D044203 Pseudomonas %28%1981-2003%29%
% 212.45/212.66  |- rdf__type mesh__D044203sskos__Concept
% 212.45/212.66  |- skos__prefLabel mesh__D044203 Pseudomonas mendocina
% 212.45/212.66  |- mesh__dateCreated mesh__D044203 2003-07-09
% 212.45/212.66  |- mesh__dateRevised mesh__D044203 2005-06-30
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D044203 2006
% 212.45/212.66  |- skos__broader mesh__D044203smesh__D011549
% 212.45/212.66  |- skos__annotation mesh__D044203
% 212.45/212.66       infection: coord IM with PSEUDOMONAS INFECTIONS %28%IM%29%   
% 212.45/212.66  |- mesh__recordAuthorizer mesh__D044203 sjn
% 212.45/212.66  |- mesh__historyNote mesh__D044203 2004   
% 212.45/212.66  |- mesh__publicMeSHNote mesh__D044203 2004   
% 212.45/212.66  |- skos__scopeNote mesh__D044203
% 212.45/212.66       A species of gram-negative bacteria in the genus PSEUDOMONAS, which is found in SOIL and WATER.%A%    
% 212.45/212.66  |- mesh__dateEstablished mesh__D044203 2004-01-01
% 212.45/212.66  |- mesh__recordOriginator mesh__D044203 ags
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D008080 2002
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D008080 1999
% 212.45/212.66  |- skos__hiddenLabel mesh__D008080 Liposarcomas, Pleomorphic
% 212.45/212.66  |- mesh__recordAuthorizer mesh__D008080 PLS
% 212.45/212.66  |- skos__hiddenLabel mesh__D008080 Pleomorphic Liposarcomas
% 212.45/212.66  |- mesh__dateRevised mesh__D008080 1995-06-08
% 212.45/212.66  |- skos__hiddenLabel mesh__D008080 Dedifferentiated Liposarcomas
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D008080 1997
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D008080 1998
% 212.45/212.66  |- skos__broader mesh__D008080smesh__D018205
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D008080 2006
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D008080 2001
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D008080 1996
% 212.45/212.66  |- skos__broader mesh__D008080smesh__D012509
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D008080 2004
% 212.45/212.66  |- mesh__dateCreated mesh__D008080 1999-01-01
% 212.45/212.66  |- skos__annotation mesh__D008080
% 212.45/212.66       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D008080 2005
% 212.45/212.66  |- skos__hiddenLabel mesh__D008080 Liposarcomas
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D008080 2000
% 212.45/212.66  |- skos__scopeNote mesh__D008080
% 212.45/212.66       A malignant tumor derived from primitive or embryonal lipoblastic cells. It may be composed of well-differentiated fat cells or may be dedifferentiated: myxoid %28%LIPOSARCOMA, MYXOID%29%, round-celled, or pleomorphic, usually in association with a rich network of capillaries. Recurrences are common and dedifferentiated liposarcomas metastasize to the lungs or serosal surfaces. %28%From Dorland, 27th ed; Stedman, 25th ed%29%%A%    
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D008080 2003
% 212.45/212.66  |- skos__hiddenLabel mesh__D008080 Pleomorphic Liposarcoma
% 212.45/212.66  |- mesh__recordOriginator mesh__D008080 NLM
% 212.45/212.66  |- skos__hiddenLabel mesh__D008080 Liposarcomas, Dedifferentiated
% 212.45/212.66  |- rdf__type mesh__D008080sskos__Concept
% 212.45/212.66  |- skos__hiddenLabel mesh__D008080 Dedifferentiated Liposarcoma
% 212.45/212.66  |- skos__prefLabel mesh__D008080 Liposarcoma
% 212.45/212.66  |- mesh__recordMaintainer mesh__D008080 KEV
% 212.45/212.66  |- skos__altLabel mesh__D011029 Negative Contrast Radiography
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D011029 2000
% 212.45/212.66  |- mesh__recordMaintainer mesh__D011029 PXP
% 212.45/212.66  |- skos__hiddenLabel mesh__D011029 Radiographies, Insufflation
% 212.45/212.66  |- skos__altLabel mesh__D011029 Air Radiography
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D011029 2005
% 212.45/212.66  |- skos__hiddenLabel mesh__D011029 Insufflation Radiographies
% 212.45/212.66  |- mesh__historyNote mesh__D011029 74   
% 212.45/212.66  |- skos__altLabel mesh__D011029 Insufflation Radiography
% 212.45/212.66  |- skos__hiddenLabel mesh__D011029 Radiographies, Negative Contrast
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D011029 2001
% 212.45/212.66  |- skos__annotation mesh__D011029
% 212.45/212.66       %22%radiogr by air, oxygen or some other gas as the contrast medium%22%: nothing to do with LUNG /radiogr; do not use /util except by MeSH definition; DF: PNEUMORADIOGR%A%  
% 212.45/212.66  |- skos__altLabel mesh__D011029 Radiography, Negative Contrast
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D011029 2006
% 212.45/212.66  |- mesh__dateRevised mesh__D011029 1997-06-20
% 212.45/212.66  |- rdf__type mesh__D011029sskos__Concept
% 212.45/212.66  |- skos__hiddenLabel mesh__D011029 Radiographies, Air
% 212.45/212.66  |- mesh__recordOriginator mesh__D011029 NLM
% 212.45/212.66  |- skos__hiddenLabel mesh__D011029 Pneumoradiographies
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D011029 2002
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D011029 1998
% 212.45/212.66  |- skos__altLabel mesh__D011029 Radiography, Air
% 212.45/212.66  |- mesh__publicMeSHNote mesh__D011029 74   
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D011029 2003
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D011029 1999
% 212.45/212.66  |- skos__prefLabel mesh__D011029 Pneumoradiography
% 212.45/212.66  |- skos__altLabel mesh__D011029 Contrast Radiography, Negative
% 212.45/212.66  |- skos__scopeNote mesh__D011029
% 212.45/212.66       Radiography using air, oxygen, or some other gas as a contrast medium.%A%    
% 212.45/212.66  |- skos__hiddenLabel mesh__D011029 Contrast Radiographies, Negative
% 212.45/212.66  |- mesh__dateEstablished mesh__D011029 1974-01-01
% 212.45/212.66  |- mesh__dateCreated mesh__D011029 1999-01-01
% 212.45/212.66  |- skos__broader mesh__D011029smesh__D011859
% 212.45/212.66  |- skos__hiddenLabel mesh__D011029 Negative Contrast Radiographies
% 212.45/212.66  |- mesh__recordAuthorizer mesh__D011029 SJN
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D011029 2004
% 212.45/212.66  |- skos__hiddenLabel mesh__D011029 Air Radiographies
% 212.45/212.66  |- skos__altLabel mesh__D011029 Radiography, Insufflation
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D016512 2005
% 212.45/212.66  |- skos__scopeNote mesh__D016512
% 212.45/212.66       Harm or hurt to the ankle or ankle joint usually inflicted by an external source.%A%    
% 212.45/212.66  |- skos__hiddenLabel mesh__D016512 Injury, Ankle
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D016512 1998
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D016512 2004
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D016512 1997
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D016512 1992
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D016512 2006
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D016512 1994
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D016512 1999
% 212.45/212.66  |- skos__broader mesh__D016512smesh__D007869
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D016512 1993
% 212.45/212.66  |- skos__annotation mesh__D016512 consider also TARSAL BONES /inj   
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D016512 2002
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D016512 1995
% 212.45/212.66  |- mesh__publicMeSHNote mesh__D016512 92; was ANKLE/injuries 1966-91   
% 212.45/212.66  |- skos__hiddenLabel mesh__D016512 Ankle Injury
% 212.45/212.66  |- skos__prefLabel mesh__D016512 Ankle Injuries
% 212.45/212.66  |- rdf__type mesh__D016512sskos__Concept
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D016512 2000
% 212.45/212.66  |- mesh__onlineNote mesh__D016512
% 212.45/212.66       use ANKLE INJURIES to search ANKLE/injuries 1966-91   
% 212.45/212.66  |- mesh__dateEstablished mesh__D016512 1992-01-01
% 212.45/212.66  |- mesh__historyNote mesh__D016512 92; was ANKLE/injuries 1966-91   
% 212.45/212.66  |- skos__altLabel mesh__D016512 Injuries, Ankle
% 212.45/212.66  |- mesh__dateCreated mesh__D016512 1991-05-31
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D016512 2003
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D016512 2001
% 212.45/212.66  |- skos__historyNote mesh__D016512 Ankle/injuries %28%1966-1991%29%
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D016512 1996
% 212.45/212.66  |- skos__prefLabel mesh__D007786 Lactose Factors
% 212.45/212.66  |- skos__historyNote mesh__D007786 Plasmids %28%1975-1977%29%
% 212.45/212.66  |- mesh__historyNote mesh__D007786
% 212.45/212.66       91%28%78%29%; was see under PLASMIDS 1978-90   
% 212.45/212.66  |- mesh__dateRevised mesh__D007786 2003-07-09
% 212.45/212.66  |- skos__hiddenLabel mesh__D007786 Factors, Lactose
% 212.45/212.66  |- rdf__type mesh__D007786sskos__Concept
% 212.45/212.66  |- skos__altLabel mesh__D007786 Lac Factors
% 212.45/212.66  |- skos__historyNote mesh__D007786 Lactose %28%1966-1977%29%
% 212.45/212.66  |- mesh__dateCreated mesh__D007786 1977-05-09
% 212.45/212.66  |- mesh__recordAuthorizer mesh__D007786 sjn
% 212.45/212.66  |- mesh__recordMaintainer mesh__D007786 nns
% 212.45/212.66  |- skos__annotation mesh__D007786
% 212.45/212.66       note category; plasmids determing ability of bact to ferment lactose%A%  
% 212.45/212.66  |- mesh__publicMeSHNote mesh__D007786 91; was see under PLASMIDS 1978-90   
% 212.45/212.66  |- skos__hiddenLabel mesh__D007786 Factors, Lac
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D007786 2006
% 212.45/212.66  |- mesh__dateEstablished mesh__D007786 1991-01-01
% 212.45/212.66  |- mesh__recordOriginator mesh__D007786 AEP
% 212.45/212.66  |- skos__broader mesh__D007786smesh__D010957
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D007786 2005
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D007786 2004
% 212.45/212.66  |- skos__scopeNote mesh__D007786
% 212.45/212.66       Plasmids which determine the ability of a bacterium to ferment lactose.%A%    
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D012920 2006
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D012920 2000
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D012920 1999
% 212.45/212.66  |- mesh__dateRevised mesh__D012920 1997-06-20
% 212.45/212.66  |- skos__broader mesh__D012920smesh__D012940
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D012920 2004
% 212.45/212.66  |- skos__annotation mesh__D012920 human only   
% 212.45/212.66  |- rdf__type mesh__D012920sskos__Concept
% 212.45/212.66  |- mesh__recordAuthorizer mesh__D012920 SJN
% 212.45/212.66  |- skos__scopeNote mesh__D012920
% 212.45/212.66       Behaviors which are at variance with the expected social norm and which affect other individuals.%A%    
% 212.45/212.66  |- skos__hiddenLabel mesh__D012920 Disorders, Social Behavior
% 212.45/212.66  |- skos__related mesh__D012920smesh__D000987
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D012920 2001
% 212.45/212.66  |- mesh__historyNote mesh__D012920 69   
% 212.45/212.66  |- mesh__dateEstablished mesh__D012920 1969-01-01
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D012920 2002
% 212.45/212.66  |- skos__historyNote mesh__D012920
% 212.45/212.66       Child Behavior Disorders %28%1966-1968%29%
% 212.45/212.66  |- skos__prefLabel mesh__D012920 Social Behavior Disorders
% 212.45/212.66  |- skos__hiddenLabel mesh__D012920 Behavior Disorders, Social
% 212.45/212.66  |- mesh__recordMaintainer mesh__D012920 JLS
% 212.45/212.66  |- mesh__dateCreated mesh__D012920 1999-01-01
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D012920 2005
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D012920 1998
% 212.45/212.66  |- mesh__recordOriginator mesh__D012920 NLM
% 212.45/212.66  |- mesh__publicMeSHNote mesh__D012920 69   
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D012920 2003
% 212.45/212.66  |- skos__related mesh__D012122smesh__D021061
% 212.45/212.66  |- skos__broader mesh__D012122smesh__D004864
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D012122 2001
% 212.45/212.66  |- skos__related mesh__D012122smesh__D012121
% 212.45/212.66  |- skos__hiddenLabel mesh__D012122 Ventilator, Mechanical
% 212.45/212.66  |- skos__hiddenLabel mesh__D012122 Respirator
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D012122 2004
% 212.45/212.66  |- skos__scopeNote mesh__D012122
% 212.45/212.66       Mechanical devices used to produce or assist pulmonary ventilation.%A%    
% 212.45/212.66  |- mesh__publicMeSHNote mesh__D012122 89; was RESPIRATORS 1963-88   
% 212.45/212.66  |- skos__altLabel mesh__D012122 Pulmonary Ventilator
% 212.45/212.66  |- skos__altLabel mesh__D012122 Ventilators, Pulmonary
% 212.45/212.66  |- skos__hiddenLabel mesh__D012122 Ventilator
% 212.45/212.66  |- skos__altLabel mesh__D012122 Respirators
% 212.45/212.66  |- skos__altLabel mesh__D012122 Pulmonary Ventilators
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D012122 2003
% 212.45/212.66  |- skos__hiddenLabel mesh__D012122 Mechanical Ventilators
% 212.45/212.66  |- mesh__dateCreated mesh__D012122 1999-01-01
% 212.45/212.66  |- mesh__recordOriginator mesh__D012122 NLM
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D012122 2006
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D012122 2002
% 212.45/212.66  |- skos__altLabel mesh__D012122 Ventilator, Pulmonary
% 212.45/212.66  |- mesh__dateRevised mesh__D012122 2000-06-22
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D012122 2005
% 212.45/212.66  |- mesh__recordAuthorizer mesh__D012122 sjn
% 212.45/212.66  |- rdf__type mesh__D012122sskos__Concept
% 212.45/212.66  |- mesh__onlineNote mesh__D012122
% 212.45/212.66       use VENTILATORS, MECHANICAL to search RESPIRATORS 1966-88%A%  
% 212.45/212.66  |- mesh__recordMaintainer mesh__D012122 nns
% 212.45/212.66  |- mesh__historyNote mesh__D012122 89; was RESPIRATORS 1963-88   
% 212.45/212.66  |- skos__hiddenLabel mesh__D012122 Mechanical Ventilator
% 212.45/212.66  |- skos__prefLabel mesh__D012122 Ventilators, Mechanical
% 212.45/212.66  |- mesh__historyNote mesh__D031885 2003   
% 212.45/212.66  |- skos__scopeNote mesh__D031885
% 212.45/212.66       A plant genus of the family RANUNCULACEAE that contains triterpenoid saponins. Remifemin from C. racemosa is used to suppress LUTEINIZING HORMONE. It is reclassified by some to ACTAEA. The common name of black snakeroot is also used with ASARUM and SANICULA.%A%    
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D031885 2004
% 212.45/212.66  |- skos__altLabel mesh__D031885 Bugbane, Black
% 212.45/212.66  |- skos__altLabel mesh__D031885 Black Cohosh
% 212.45/212.66  |- skos__broader mesh__D031885smesh__D029626
% 212.45/212.66  |- mesh__publicMeSHNote mesh__D031885 2003   
% 212.45/212.66  |- skos__prefLabel mesh__D031885 Cimicifuga
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D031885 2003
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D031885 2006
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D031885 2005
% 212.45/212.66  |- skos__altLabel mesh__D031885 Cohosh, Black
% 212.45/212.66  |- mesh__dateEstablished mesh__D031885 2003-01-01
% 212.45/212.66  |- skos__annotation mesh__D031885
% 212.45/212.66       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.45/212.66  |- mesh__dateCreated mesh__D031885 2002-07-02
% 212.45/212.66  |- rdf__type mesh__D031885sskos__Concept
% 212.45/212.66  |- skos__altLabel mesh__D031885 Actaea racemosa
% 212.45/212.66  |- skos__broader mesh__D011828smesh__D018183
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D011828 2005
% 212.45/212.66  |- skos__altLabel mesh__D011828 Chimera, Radiation
% 212.45/212.66  |- mesh__dateRevised mesh__D011828 2003-07-09
% 212.45/212.66  |- mesh__recordOriginator mesh__D011828 NLM
% 212.45/212.66  |- mesh__recordMaintainer mesh__D011828 ags
% 212.45/212.66  |- mesh__recordAuthorizer mesh__D011828 sjn
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D011828 2004
% 212.45/212.66  |- skos__scopeNote mesh__D011828
% 212.45/212.66       An organism whose body contains cell populations of different genotypes as a result of the TRANSPLANTATION of donor cells after sufficient ionizing radiation to destroy the mature recipient%27%s cells which would otherwise reject the donor cells.%A%    
% 212.45/212.66  |- mesh__historyNote mesh__D011828
% 212.45/212.66       70%28%66%29%; was see under IMMUNITY /radiation effects 1967-69%A%  
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D011828 2006
% 212.45/212.66  |- skos__broader mesh__D011828smesh__D016867
% 212.45/212.66  |- skos__prefLabel mesh__D011828 Radiation Chimera
% 212.45/212.66  |- mesh__dateEstablished mesh__D011828 1970-01-01
% 212.45/212.66  |- mesh__publicMeSHNote mesh__D011828
% 212.45/212.66       70; was see under IMMUNITY /radiation effects 1967-69   
% 212.45/212.66  |- rdf__type mesh__D011828sskos__Concept
% 212.45/212.66  |- skos__hiddenLabel mesh__D011828 Radiation Chimeras
% 212.45/212.66  |- mesh__dateCreated mesh__D011828 1999-01-01
% 212.45/212.66  |- skos__hiddenLabel mesh__D011828 Chimeras, Radiation
% 212.45/212.66  |- rdf__type mesh__D044204sskos__Concept
% 212.45/212.66  |- mesh__dateCreated mesh__D044204 2003-07-09
% 212.45/212.66  |- mesh__dateEstablished mesh__D044204 2004-01-01
% 212.45/212.66  |- mesh__recordOriginator mesh__D044204 ags
% 212.45/212.66  |- skos__historyNote mesh__D044204 Pseudomonas %28%1968-2003%29%
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D044204 2006
% 212.45/212.66  |- skos__scopeNote mesh__D044204
% 212.45/212.66       A species of gram-negative bacteria in the genus PSEUDOMONAS. It is isolated from oil-water emulsions used as lubricants and cooling agents in the cutting and grinding of materials.%A%    
% 212.45/212.66  |- mesh__publicMeSHNote mesh__D044204 2004   
% 212.45/212.66  |- mesh__dateRevised mesh__D044204 2005-06-30
% 212.45/212.66  |- skos__broader mesh__D044204smesh__D011549
% 212.45/212.66  |- mesh__recordAuthorizer mesh__D044204 sjn
% 212.45/212.66  |- mesh__historyNote mesh__D044204 2004   
% 212.45/212.66  |- mesh__recordMaintainer mesh__D044204 SYSTEM
% 212.45/212.66  |- skos__prefLabel mesh__D044204 Pseudomonas oleovorans
% 212.45/212.66  |- skos__broader mesh__D008081smesh__D008567
% 212.45/212.66  |- mesh__recordOriginator mesh__D008081 NLM
% 212.45/212.66  |- mesh__recordAuthorizer mesh__D008081 sjn
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D008081 2006
% 212.45/212.66  |- skos__broader mesh__D008081smesh__D004337
% 212.45/212.66  |- skos__hiddenLabel mesh__D008081 Liposome
% 212.45/212.66  |- skos__annotation mesh__D008081
% 212.45/212.66       when used as a vehicle in drug ther, index specific drug /admin %28%IM%29% + LIPOSOMES %28%NIM without qualif%29%%A%  
% 212.45/212.66  |- mesh__dateCreated mesh__D008081 1999-01-01
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D008081 2005
% 212.45/212.66  |- skos__prefLabel mesh__D008081 Liposomes
% 212.45/212.66  |- skos__historyNote mesh__D008081 Membranes, Artificial %28%1966-1972%29%
% 212.45/212.66  |- mesh__historyNote mesh__D008081 73   
% 212.45/212.66  |- mesh__publicMeSHNote mesh__D008081 73   
% 212.45/212.66  |- mesh__recordMaintainer mesh__D008081 nns
% 212.45/212.66  |- rdf__type mesh__D008081sskos__Concept
% 212.45/212.66  |- skos__scopeNote mesh__D008081
% 212.45/212.66       Artificial, single or multilaminar vesicles %28%made from lecithins or other lipids%29% that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins.%A%    
% 212.45/212.66  |- mesh__dateRevised mesh__D008081 2004-07-07
% 212.45/212.66  |- mesh__dateEstablished mesh__D008081 1973-01-01
% 212.45/212.66  |- skos__scopeNote mesh__D016513
% 212.45/212.66       Mice homozygous for the mutant autosomal recessive gene %22%scid%22% which is located on the centromeric end of chromosome 16. These mice lack mature, functional lymphocytes and are thus highly susceptible to lethal opportunistic infections if not chronically treated with antibiotics. The lack of B- and T-cell immunity resembles severe combined immunodeficiency %28%SCID%29% syndrome in human infants. SCID mice are useful as animal models since they are receptive to implantation of a human immune system producing SCID-human %28%SCID-hu%29% hematochimeric mice.%A%    
% 212.45/212.66  |- skos__altLabel mesh__D016513 Mouse, SCID
% 212.45/212.66  |- mesh__recordOriginator mesh__D016513 AGS
% 212.45/212.66  |- skos__altLabel mesh__D016513 Severe Combined Immunodeficient Mice
% 212.45/212.66  |- mesh__recordMaintainer mesh__D016513 ags
% 212.45/212.66  |- mesh__recordAuthorizer mesh__D016513 sjn
% 212.45/212.66  |- skos__hiddenLabel mesh__D016513 SCID hu Mice
% 212.45/212.66  |- mesh__dateRevised mesh__D016513 2005-06-30
% 212.45/212.66  |- skos__prefLabel mesh__D016513 Mice, SCID
% 212.45/212.66  |- rdf__type mesh__D016513sskos__Concept
% 212.45/212.66  |- skos__altLabel mesh__D016513 SCID Mice
% 212.45/212.66  |- mesh__publicMeSHNote mesh__D016513 92   
% 212.45/212.66  |- mesh__dateCreated mesh__D016513 1991-01-03
% 212.45/212.66  |- skos__altLabel mesh__D016513 SCID-hu Mice
% 212.45/212.66  |- skos__hiddenLabel mesh__D016513 SCID Mouse
% 212.45/212.66  |- skos__hiddenLabel mesh__D016513 Mice, SCID-hu
% 212.45/212.66  |- mesh__historyNote mesh__D016513 92   
% 212.45/212.66  |- skos__hiddenLabel mesh__D016513 SCID-hu Mouse
% 212.45/212.66  |- skos__annotation mesh__D016513
% 212.45/212.66       SCID stands for %22%Severe Combined ImmunoDeficiency%22%; NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE%A%  
% 212.45/212.66  |- skos__broader mesh__D016513smesh__D008817
% 212.45/212.66  |- skos__hiddenLabel mesh__D016513 Mouse, SCID hu
% 212.45/212.66  |- skos__altLabel mesh__D016513 Immunodeficient Mice, Severe Combined
% 212.45/212.66  |- skos__historyNote mesh__D016513 Mice, Mutant Strains %28%1983-1991%29%
% 212.45/212.66  |- mesh__dateEstablished mesh__D016513 1992-01-01
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D016513 2006
% 212.45/212.66  |- skos__broader mesh__D006632Q000819smesh__D006632
% 212.45/212.66  |- mesh__preferredCombination mesh__D006632Q000819smesh__D017442
% 212.45/212.66  |- rdf__type mesh__D006632Q000819smesh__CompoundConcept
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D007787 2006
% 212.45/212.66  |- skos__broader mesh__D007787smesh__D008286
% 212.45/212.66  |- skos__broader mesh__D007787smesh__D002239
% 212.45/212.66  |- skos__scopeNote mesh__D007787
% 212.45/212.66       The condition resulting from the absence or deficiency of LACTASE in the MUCOSA cells of the GASTROINTESTINAL TRACT, and the inability to break down LACTOSE in milk for ABSORPTION. Bacterial fermentation of the unabsorbed lactose leads to symptoms that range from a mild indigestion %28%DYSPEPSIA%29% to severe DIARRHEA. Lactose intolerance may be an inborn error or acquired.%A%    
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D007787 2005
% 212.45/212.66  |- mesh__recordMaintainer mesh__D007787 lkt
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D007787 2004
% 212.45/212.66  |- mesh__recordOriginator mesh__D007787 NLM
% 212.45/212.66  |- mesh__historyNote mesh__D007787 67%28%64%29%   
% 212.45/212.66  |- skos__prefLabel mesh__D007787 Lactose Intolerance
% 212.45/212.66  |- skos__hiddenLabel mesh__D007787 Malabsorption, Lactose
% 212.45/212.66  |- skos__hiddenLabel mesh__D007787 Intolerance, Lactose
% 212.45/212.66  |- mesh__dateRevised mesh__D007787 2003-07-09
% 212.45/212.66  |- mesh__dateEstablished mesh__D007787 1967-01-01
% 212.45/212.66  |- mesh__publicMeSHNote mesh__D007787 67   
% 212.45/212.66  |- mesh__dateCreated mesh__D007787 1999-01-01
% 212.45/212.66  |- skos__altLabel mesh__D007787 Lactose Malabsorption
% 212.45/212.66  |- mesh__recordAuthorizer mesh__D007787 sjn
% 212.45/212.66  |- rdf__type mesh__D007787sskos__Concept
% 212.45/212.66  |- skos__broader mesh__D026941smesh__D002317
% 212.45/212.66  |- skos__prefLabel mesh__D026941 Sodium Channel Blockers
% 212.45/212.66  |- mesh__recordAuthorizer mesh__D026941 sjn
% 212.45/212.66  |- skos__altLabel mesh__D026941 Channel Blockers, Sodium
% 212.45/212.66  |- skos__historyNote mesh__D026941 Ion Channels %28%1982-1988%29%
% 212.45/212.66  |- skos__broader mesh__D026941smesh__D049990
% 212.45/212.66  |- rdf__type mesh__D026941sskos__Concept
% 212.45/212.66  |- mesh__recordOriginator mesh__D026941 ags
% 212.45/212.66  |- mesh__activeMeSHYear mesh__D026941 2006
% 212.45/212.66  |- skos__hiddenLabel mesh__D026941 Diuretics, Potassium Sparing
% 212.45/212.66  |- mesh__recordMaintainer mesh__D026941 ssb
% 212.45/212.66  |- skos__scopeNote mesh__D026941
% 212.45/212.66       A class of drugs that act by inhibition of sodium influx through cell membranes. Blockade of sodium channels slows the rate and amplitude of initial rapid depolarization, reduces cell excitability, and reduces conduction velocity.%A%    
% 212.45/212.66  |- mesh__publicMeSHNote mesh__D026941 2002   
% 212.45/212.66  |- skos__related mesh__D026941smesh__D000889
% 212.45/212.66  |- skos__historyNote mesh__D026941
% 212.45/212.66       Sodium Channels/antagonists %26% inhibitors %28%1988-2001%29%
% 212.45/212.66  |- mesh__dateCreated mesh__D026941 2001-07-25
% 212.45/212.66  |- mesh__dateRevised mesh__D026941 2005-06-30
% 212.45/212.66  |- mesh__historyNote mesh__D026941 2002   
% 212.45/212.66  |- mesh__dateEstablished mesh__D026941 2002-01-01
% 212.45/212.66  |- skos__annotation mesh__D026941
% 212.45/212.66       coordinate with DIURETICS if pertinent; DF: NA CHANNEL BLOCK%A%  
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D012123 2004
% 212.45/212.67  |- mesh__dateEstablished mesh__D012123 1972-01-01
% 212.45/212.67  |- mesh__recordMaintainer mesh__D012123 nns
% 212.45/212.67  |- skos__hiddenLabel mesh__D012123 Ventilation Test
% 212.45/212.67  |- skos__broader mesh__D012123smesh__D044702
% 212.45/212.67  |- skos__scopeNote mesh__D012123
% 212.45/212.67       The total volume of gas, inspired or expired, measured in liters per minute.%A%    
% 212.45/212.67  |- mesh__dateCreated mesh__D012123 1999-01-01
% 212.45/212.67  |- mesh__publicMeSHNote mesh__D012123
% 212.45/212.67       97; was RESPIRATORY AIRFLOW 1972-96; VENTILATION TESTS was see RESPIRATORY FUNCTION TESTS 1990-96%A%  
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D012123 2006
% 212.45/212.67  |- mesh__onlineNote mesh__D012123
% 212.45/212.67       use RESPIRATORY FUNCTION TESTS to search VENTILATION TESTS 1990-96%A%  
% 212.45/212.67  |- mesh__dateRevised mesh__D012123 2003-07-09
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D012123 2005
% 212.45/212.67  |- skos__prefLabel mesh__D012123 Pulmonary Ventilation
% 212.45/212.67  |- rdf__type mesh__D012123sskos__Concept
% 212.45/212.67  |- skos__annotation mesh__D012123
% 212.45/212.67       MAXIMAL VOLUNTARY VENTILATION %26% VENTILATION-PERFUSION RATIO are also available; DF: PULM VENTILATION%A%  
% 212.45/212.67  |- mesh__recordOriginator mesh__D012123 NLM
% 212.45/212.67  |- skos__altLabel mesh__D012123 Ventilation, Pulmonary
% 212.45/212.67  |- skos__broader mesh__D012123smesh__D012129
% 212.45/212.67  |- skos__hiddenLabel mesh__D012123 Airflow, Respiratory
% 212.45/212.67  |- mesh__historyNote mesh__D012123
% 212.45/212.67       97; was RESPIRATORY AIRFLOW 1971-96 %28%Prov 1971%29%; VENTILATION TESTS was see RESPIRATORY FUNCTION TESTS 1990-96%A%  
% 212.45/212.67  |- skos__hiddenLabel mesh__D012123 Test, Ventilation
% 212.45/212.67  |- skos__historyNote mesh__D012123 Respiration %28%1966-1970%29%
% 212.45/212.67  |- skos__hiddenLabel mesh__D012123 Tests, Ventilation
% 212.45/212.67  |- mesh__recordAuthorizer mesh__D012123 sjn
% 212.45/212.67  |- skos__altLabel mesh__D003397 Rathke Pouch Tumor
% 212.45/212.67  |- skos__hiddenLabel mesh__D003397 Craniopharyngiomas
% 212.45/212.67  |- rdf__type mesh__D003397sskos__Concept
% 212.45/212.67  |- skos__hiddenLabel mesh__D003397 Adult Craniopharyngioma
% 212.45/212.67  |- skos__broader mesh__D003397smesh__D017599
% 212.45/212.67  |- skos__altLabel mesh__D003397 Rathke Cleft Neoplasm
% 212.45/212.67  |- skos__hiddenLabel mesh__D003397 Craniopharyngiomas, Adamantinous
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D003397 2000
% 212.45/212.67  |- skos__altLabel mesh__D003397 Rathke%27%s Pouch Tumor
% 212.45/212.67  |- skos__hiddenLabel mesh__D003397 Child Craniopharyngioma
% 212.45/212.67  |- skos__hiddenLabel mesh__D003397 Papillary Craniopharyngiomas
% 212.45/212.67  |- mesh__recordAuthorizer mesh__D003397 sjn
% 212.45/212.67  |- skos__hiddenLabel mesh__D003397 Papillary Craniopharyngioma
% 212.45/212.67  |- skos__altLabel mesh__D003397 Rathke%27%s Cleft Neoplasm
% 212.45/212.67  |- skos__altLabel mesh__D003397 Neoplasm, Rathke%27%s Cleft
% 212.45/212.67  |- skos__hiddenLabel mesh__D003397 Craniopharyngiomas, Child
% 212.45/212.67  |- skos__annotation mesh__D003397
% 212.45/212.67       coord IM with PITUITARY NEOPLASMS %28%IM%29%   
% 212.45/212.67  |- skos__prefLabel mesh__D003397 Craniopharyngioma
% 212.45/212.67  |- skos__hiddenLabel mesh__D003397 Tumor, Rathke%27%s Pouch
% 212.45/212.67  |- skos__hiddenLabel mesh__D003397 Adult Craniopharyngiomas
% 212.45/212.67  |- skos__hiddenLabel mesh__D003397 Rathkes Cleft Neoplasm
% 212.45/212.67  |- skos__hiddenLabel mesh__D003397 Rathkes Pouch Tumor
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D003397 2004
% 212.45/212.67  |- skos__scopeNote mesh__D003397
% 212.45/212.67       A benign pituitary-region neoplasm that originates from Rathke%27%s pouch. The two major histologic and clinical subtypes are adamantinous %28%or classical%29% craniopharyngioma and papillary craniopharyngioma. The adamantinous form presents in children and adolescents as an expanding cystic lesion in the pituitary region. The cystic cavity is filled with a black viscous substance and histologically the tumor is composed of adamantinomatous epithelium and areas of calcification and necrosis. Papillary craniopharyngiomas occur in adults, and histologically feature a squamous epithelium with papillations. %28%From Joynt, Clinical Neurology, 1998, Ch14, p50%29%%A%    
% 212.45/212.67  |- skos__hiddenLabel mesh__D003397 Neoplasm, Rathkes Cleft
% 212.45/212.67  |- mesh__recordOriginator mesh__D003397 NLM
% 212.45/212.67  |- skos__hiddenLabel mesh__D003397 Craniopharyngiomas, Papillary
% 212.45/212.67  |- skos__hiddenLabel mesh__D003397 Child Craniopharyngiomas
% 212.45/212.67  |- mesh__recordMaintainer mesh__D003397 adp
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D003397 2003
% 212.45/212.67  |- skos__hiddenLabel mesh__D003397 Adamantinous Craniopharyngiomas
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D003397 2006
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D003397 2002
% 212.45/212.67  |- skos__hiddenLabel mesh__D003397 Tumor, Rathke Pouch
% 212.45/212.67  |- mesh__dateCreated mesh__D003397 1999-01-01
% 212.45/212.67  |- skos__altLabel mesh__D003397 Neoplasm, Rathke Cleft
% 212.45/212.67  |- mesh__dateRevised mesh__D003397 1999-11-08
% 212.45/212.67  |- skos__hiddenLabel mesh__D003397 Adamantinous Craniopharyngioma
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D003397 2005
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D003397 2001
% 212.45/212.67  |- skos__hiddenLabel mesh__D003397 Craniopharyngiomas, Adult
% 212.45/212.67  |- rdf__type mesh__D008880sskos__Concept
% 212.45/212.67  |- skos__scopeNote mesh__D008880
% 212.45/212.67       The practice of assisting women in childbirth.     
% 212.45/212.67  |- mesh__dateRevised mesh__D008880 1995-05-25
% 212.45/212.67  |- mesh__dateCreated mesh__D008880 1999-01-01
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D008880 1997
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D008880 2003
% 212.45/212.67  |- skos__hiddenLabel mesh__D008880 Traditional Birth Attendants
% 212.45/212.67  |- skos__broader mesh__D008880smesh__D013041
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D008880 1996
% 212.45/212.67  |- skos__related mesh__D008880smesh__D009721
% 212.45/212.67  |- skos__hiddenLabel mesh__D008880 Birth Attendant, Traditional
% 212.45/212.67  |- skos__hiddenLabel mesh__D008880 Birth Attendants, Traditional
% 212.45/212.67  |- skos__annotation mesh__D008880
% 212.45/212.67       SPEC: SPEC qualif; check also tag PREGNANCY   
% 212.45/212.67  |- skos__prefLabel mesh__D008880 Midwifery
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D008880 2006
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D008880 2002
% 212.45/212.67  |- mesh__recordOriginator mesh__D008880 NLM
% 212.45/212.67  |- skos__related mesh__D008880smesh__D006700
% 212.45/212.67  |- mesh__publicMeSHNote mesh__D008880 66; was MIDWIVES 1963-65   
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D008880 1999
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D008880 2005
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D008880 2001
% 212.45/212.67  |- mesh__dateEstablished mesh__D008880 1966-01-01
% 212.45/212.67  |- mesh__historyNote mesh__D008880 66; was MIDWIVES 1963-65   
% 212.45/212.67  |- skos__altLabel mesh__D008880 Midwife
% 212.45/212.67  |- mesh__recordMaintainer mesh__D008880 PLS
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D008880 2004
% 212.45/212.67  |- mesh__recordAuthorizer mesh__D008880 PLS
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D008880 2000
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D008880 1998
% 212.45/212.67  |- skos__related mesh__D011829smesh__D011879
% 212.45/212.67  |- skos__hiddenLabel mesh__D011829 Radiation Dosages
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D011829 2004
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D011829 2001
% 212.45/212.67  |- mesh__recordAuthorizer mesh__D011829 PLS
% 212.45/212.67  |- mesh__activeMeSHYear mesh__D011829 1997
% 212.45/212.67  |- mesh__historyNote mesh__D011829 72   
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D011829 2006
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D011829 1999
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D011829 1992
% 212.52/212.67  |- mesh__publicMeSHNote mesh__D011829 72   
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D011829 1994
% 212.52/212.67  |- skos__annotation mesh__D011829 NIM; no qualif   
% 212.52/212.67  |- mesh__recordOriginator mesh__D011829 NLM
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D011829 1993
% 212.52/212.67  |- skos__prefLabel mesh__D011829 Radiation Dosage
% 212.52/212.67  |- mesh__dateEstablished mesh__D011829 1972-01-01
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D011829 2002
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D011829 1995
% 212.52/212.67  |- mesh__dateRevised mesh__D011829 1991-05-15
% 212.52/212.67  |- rdf__type mesh__D011829sskos__Concept
% 212.52/212.67  |- skos__related mesh__D011829smesh__D004307
% 212.52/212.67  |- skos__hiddenLabel mesh__D011829 Dosages, Radiation
% 212.52/212.67  |- mesh__dateCreated mesh__D011829 1999-01-01
% 212.52/212.67  |- skos__historyNote mesh__D011829 Radiometry %28%1966-1971%29%
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D011829 2003
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D011829 1996
% 212.52/212.67  |- skos__broader mesh__D011829smesh__D011870
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D011829 2005
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D011829 2000
% 212.52/212.67  |- mesh__recordMaintainer mesh__D011829 TGC
% 212.52/212.67  |- skos__altLabel mesh__D011829 Dosage, Radiation
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D011829 1998
% 212.52/212.67  |- skos__broader mesh__D011829smesh__D011874
% 212.52/212.67  |- mesh__dateCreated mesh__D044205 2003-07-09
% 212.52/212.67  |- mesh__recordAuthorizer mesh__D044205 sjn
% 212.52/212.67  |- mesh__historyNote mesh__D044205 2004   
% 212.52/212.67  |- mesh__recordMaintainer mesh__D044205 SYSTEM
% 212.52/212.67  |- rdf__type mesh__D044205sskos__Concept
% 212.52/212.67  |- skos__broader mesh__D044205smesh__D011549
% 212.52/212.67  |- skos__scopeNote mesh__D044205
% 212.52/212.67       A species of gram-negative bacteria in the genus PSEUDOMONAS. All strains can utilize FRUCTOSE for energy. It is occasionally isolated from humans and some strains are pathogenic to WATERMELON.%A%    
% 212.52/212.67  |- skos__prefLabel mesh__D044205 Pseudomonas pseudoalcaligenes
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D044205 2006
% 212.52/212.67  |- mesh__recordOriginator mesh__D044205 ags
% 212.52/212.67  |- skos__annotation mesh__D044205
% 212.52/212.67       infection: coord IM with PSEUDOMONAS INFECTIONS %28%IM%29%   
% 212.52/212.67  |- mesh__publicMeSHNote mesh__D044205 2004   
% 212.52/212.67  |- mesh__dateEstablished mesh__D044205 2004-01-01
% 212.52/212.67  |- skos__historyNote mesh__D044205 Pseudomonas %28%1986-2003%29%
% 212.52/212.67  |- mesh__dateRevised mesh__D044205 2005-06-30
% 212.52/212.67  |- skos__broader mesh__D008082smesh__D005765
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D008082 2006
% 212.52/212.67  |- skos__altLabel mesh__D008082 Lipotropics
% 212.52/212.67  |- mesh__dateRevised mesh__D008082 2005-06-30
% 212.52/212.67  |- skos__hiddenLabel mesh__D008082 Agents, Lipotropic
% 212.52/212.67  |- mesh__recordOriginator mesh__D008082 NLM
% 212.52/212.67  |- skos__hiddenLabel mesh__D008082 Factors, Lipotropic
% 212.52/212.67  |- mesh__publicMeSHNote mesh__D008082 96; was LIPOTROPIC FACTORS 1963-95   
% 212.52/212.67  |- mesh__recordAuthorizer mesh__D008082 sjn
% 212.52/212.67  |- skos__scopeNote mesh__D008082
% 212.52/212.67       Endogenous factors or drugs that act on fat metabolism by hastening the removal of or decreasing the deposit of fat in the liver. %28%From Dorland, 28th ed, p951%29%%A%    
% 212.52/212.67  |- skos__hiddenLabel mesh__D008082 Drugs, Lipotropic
% 212.52/212.67  |- skos__prefLabel mesh__D008082 Lipotropic Agents
% 212.52/212.67  |- rdf__type mesh__D008082sskos__Concept
% 212.52/212.67  |- mesh__historyNote mesh__D008082 96; was LIPOTROPIC FACTORS 1963-95   
% 212.52/212.67  |- skos__broader mesh__D008082smesh__D000960
% 212.52/212.67  |- mesh__recordMaintainer mesh__D008082 ssb
% 212.52/212.67  |- mesh__dateCreated mesh__D008082 1999-01-01
% 212.52/212.67  |- skos__broader mesh__D016514smesh__D016147
% 212.52/212.67  |- skos__altLabel mesh__D016514 nf1 Genes
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D016514 2006
% 212.52/212.67  |- skos__hiddenLabel mesh__D016514 nf 1 Gene
% 212.52/212.67  |- skos__related mesh__D016514smesh__D025542
% 212.52/212.67  |- mesh__recordMaintainer mesh__D016514 nns
% 212.52/212.67  |- skos__hiddenLabel mesh__D016514 nf1 Gene
% 212.52/212.67  |- skos__hiddenLabel mesh__D016514 nf 1 Genes
% 212.52/212.67  |- mesh__dateCreated mesh__D016514 1991-06-21
% 212.52/212.67  |- mesh__recordAuthorizer mesh__D016514 sjn
% 212.52/212.67  |- skos__hiddenLabel mesh__D016514 Gene, nf 1
% 212.52/212.67  |- rdf__type mesh__D016514sskos__Concept
% 212.52/212.67  |- skos__scopeNote mesh__D016514
% 212.52/212.67       Tumor suppressor genes located on the long arm of human chromosome 17 in the region 17q11.2. Mutation of these genes is thought to cause NEUROFIBROMATOSIS 1, Watson syndrome, and LEOPARD syndrome.%A%    
% 212.52/212.67  |- skos__historyNote mesh__D016514
% 212.52/212.67       Neurofibromatosis 1/genetics %28%1987-1991%29%
% 212.52/212.67  |- skos__related mesh__D016514smesh__D009456
% 212.52/212.67  |- mesh__recordOriginator mesh__D016514 AGS
% 212.52/212.67  |- skos__prefLabel mesh__D016514 Genes, Neurofibromatosis 1
% 212.52/212.67  |- skos__hiddenLabel mesh__D016514 Gene, nf1
% 212.52/212.67  |- mesh__dateRevised mesh__D016514 2005-06-30
% 212.52/212.67  |- skos__altLabel mesh__D016514 Neurofibromatosis 1 Genes
% 212.52/212.67  |- skos__hiddenLabel mesh__D016514 Neurofibromatosis 1 Gene
% 212.52/212.67  |- mesh__publicMeSHNote mesh__D016514 92   
% 212.52/212.67  |- skos__altLabel mesh__D016514 Genes, nf 1
% 212.52/212.67  |- mesh__dateEstablished mesh__D016514 1992-01-01
% 212.52/212.67  |- skos__altLabel mesh__D016514 Genes, nf1
% 212.52/212.67  |- mesh__historyNote mesh__D016514 92   
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D007788 2006
% 212.52/212.67  |- mesh__historyNote mesh__D007788
% 212.52/212.67       92: was LACTOSE SYNTHETASE 1972-91 %28%Prov 1972-73%29%   
% 212.52/212.67  |- mesh__publicMeSHNote mesh__D007788 92; was LACTOSE SYNTHETASE 1974-91   
% 212.52/212.67  |- mesh__recordAuthorizer mesh__D007788 sjn
% 212.52/212.67  |- skos__hiddenLabel mesh__D007788 Synthase, Lactose
% 212.52/212.67  |- skos__historyNote mesh__D007788 Glucosyltransferases %28%1966-1971%29%
% 212.52/212.67  |- skos__historyNote mesh__D007788 Lactation %28%1966-1971%29%
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D007788 2004
% 212.52/212.67  |- skos__scopeNote mesh__D007788
% 212.52/212.67       An enzyme of the transferase class that catalyzes the transfer of galactose from UDPgalactose to glucose, forming lactose. The enzyme is a complex of the enzyme N-ACETYLLACTOSAMINE SYNTHASE and alpha-lactalbumin; the latter protein is present in lactating mammary gland cells where it alters the usual specificity of the former to make lactose synthesis the preferred reaction. %28%Dorland, 28th ed%29% EC 2.4.1.22.%A%    
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D007788 2005
% 212.52/212.67  |- mesh__dateEstablished mesh__D007788 1974-01-01
% 212.52/212.67  |- skos__historyNote mesh__D007788 Ligases %28%1966-1971%29%
% 212.52/212.67  |- skos__hiddenLabel mesh__D007788 Synthetase, Lactose
% 212.52/212.67  |- skos__historyNote mesh__D007788 Transferases %28%1966-1971%29%
% 212.52/212.67  |- skos__broader mesh__D007788smesh__D005700
% 212.52/212.67  |- skos__broader mesh__D007788smesh__D009097
% 212.52/212.67  |- mesh__dateRevised mesh__D007788 2003-07-09
% 212.52/212.67  |- mesh__dateCreated mesh__D007788 1999-01-01
% 212.52/212.67  |- skos__altLabel mesh__D007788 Lactose Synthetase
% 212.52/212.67  |- skos__hiddenLabel mesh__D007788
% 212.52/212.67       N Acetylgucosamide 1 4 beta Galactosyl Transferase
% 212.52/212.67  |- skos__prefLabel mesh__D007788 Lactose Synthase
% 212.52/212.67  |- rdf__type mesh__D007788sskos__Concept
% 212.52/212.67  |- mesh__onlineNote mesh__D007788
% 212.52/212.67       use LACTOSE SYNTHASE to search LACTOSE SYNTHETASE 1972-91 %28%as Prov 1972-73%29%%A%  
% 212.52/212.67  |- mesh__recordOriginator mesh__D007788 NLM
% 212.52/212.67  |- mesh__recordMaintainer mesh__D007788 ssb
% 212.52/212.67  |- skos__broader mesh__D032181smesh__D028083
% 212.52/212.67  |- skos__prefLabel mesh__D032181 Craterostigma
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D032181 2003
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D032181 2004
% 212.52/212.67  |- mesh__dateEstablished mesh__D032181 2003-01-01
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D032181 2005
% 212.52/212.67  |- mesh__dateCreated mesh__D032181 2002-07-03
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D032181 2006
% 212.52/212.67  |- mesh__historyNote mesh__D032181 2003   
% 212.52/212.67  |- skos__scopeNote mesh__D032181
% 212.52/212.67       A plant genus of the family SCROPHULARIACEAE.     
% 212.52/212.67  |- mesh__publicMeSHNote mesh__D032181 2003   
% 212.52/212.67  |- rdf__type mesh__D032181sskos__Concept
% 212.52/212.67  |- skos__annotation mesh__D032181
% 212.52/212.67       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.52/212.67  |- skos__altLabel mesh__D032181 Resurrection Plant
% 212.52/212.67  |- skos__historyNote mesh__D026942
% 212.52/212.67       DNA Topoisomerase %28%ATP-Hydrolysing%29% %28%1979-2001%29%
% 212.52/212.67  |- mesh__dateCreated mesh__D026942 2001-07-25
% 212.52/212.67  |- mesh__historyNote mesh__D026942 2002   
% 212.52/212.67  |- skos__scopeNote mesh__D026942
% 212.52/212.67       Enzymes that regulate the topology of DNA by actions such as breaking, relaxing, passing, and rejoining strands of DNA in cells. These enzymes are important components of the DNA replication system. They are classified by their substrate specificities. DNA TOPOISOMERASE I enzymes act on a single strand of DNA. DNA TOPOISOMERASE II enzymes act on double strands of DNA.%A%    
% 212.52/212.67  |- rdf__type mesh__D026942sskos__Concept
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D026942 2006
% 212.52/212.67  |- mesh__recordAuthorizer mesh__D026942 ags
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D026942 2006A
% 212.52/212.67  |- mesh__recordOriginator mesh__D026942 lkt
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D026942 2005
% 212.52/212.67  |- mesh__publicMeSHNote mesh__D026942 2002   
% 212.52/212.67  |- skos__broader mesh__D026942smesh__D007535
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D026942 2004
% 212.52/212.67  |- mesh__dateEstablished mesh__D026942 2002-01-01
% 212.52/212.67  |- skos__prefLabel mesh__D026942 DNA Topoisomerases
% 212.52/212.67  |- mesh__dateRevised mesh__D026942 2005-07-13
% 212.52/212.67  |- skos__historyNote mesh__D026942 DNA Topoisomerase %28%1977-2001%29%
% 212.52/212.67  |- skos__hiddenLabel mesh__D026942 Topoisomerases, DNA
% 212.52/212.67  |- mesh__recordMaintainer mesh__D026942 ags
% 212.52/212.67  |- skos__hiddenLabel mesh__D004490 Aardvark
% 212.52/212.67  |- mesh__publicMeSHNote mesh__D004490 98; was EDENTATA 1963-97   
% 212.52/212.67  |- mesh__recordOriginator mesh__D004490 NLM
% 212.52/212.67  |- mesh__onlineNote mesh__D004490
% 212.52/212.67       use XENARTHRA to search EDENTATA 1966-97   
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D004490 2005
% 212.52/212.67  |- mesh__historyNote mesh__D004490 98; was EDENTATA 1963-97   
% 212.52/212.67  |- skos__altLabel mesh__D004490 Myrmecophagidae
% 212.52/212.67  |- mesh__dateCreated mesh__D004490 1999-01-01
% 212.52/212.67  |- skos__scopeNote mesh__D004490
% 212.52/212.67       An order of New World mammals characterized by the absence of incisors and canines from among their teeth, and comprising the ARMADILLOS, the SLOTHS, and the anteaters. The order is distinguished from all others by what are known as xenarthrous vertebrae %28%xenos, strange; arthron, joint%29%: there are secondary, and sometimes even more, articulations between the vertebrae of the lumbar series. The order was formerly called Edentata. %28%From Random House Unabridged Dictionary, 2d ed; Walker%27%s Mammals of the World, 5th ed, vol. I, p515%29%%A%    
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D004490 2006
% 212.52/212.67  |- mesh__dateRevised mesh__D004490 2004-07-07
% 212.52/212.67  |- mesh__recordAuthorizer mesh__D004490 sjn
% 212.52/212.67  |- mesh__recordMaintainer mesh__D004490 ags
% 212.52/212.67  |- skos__annotation mesh__D004490
% 212.52/212.67       do not confuse X ref AARDVARKS with X ref AARDWOLVES see CARNIVORA; do not confuse X ref ANTEATERS with X ref SPINY ANTEATER see ECHIDNA%A%  
% 212.52/212.67  |- skos__altLabel mesh__D004490 Edentata
% 212.52/212.67  |- rdf__type mesh__D004490sskos__Concept
% 212.52/212.67  |- skos__prefLabel mesh__D004490 Xenarthra
% 212.52/212.67  |- skos__broader mesh__D004490smesh__D008322
% 212.52/212.67  |- skos__broader mesh__D012922smesh__D012959
% 212.52/212.67  |- skos__hiddenLabel mesh__D012922 Community Developments
% 212.52/212.67  |- skos__prefLabel mesh__D012922 Social Change
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D012922 2002
% 212.52/212.67  |- skos__hiddenLabel mesh__D012922 Developments, Social
% 212.52/212.67  |- skos__hiddenLabel mesh__D012922 Impact, Social
% 212.52/212.67  |- skos__hiddenLabel mesh__D012922 Developments, Community
% 212.52/212.67  |- mesh__recordMaintainer mesh__D012922 kle
% 212.52/212.67  |- mesh__dateCreated mesh__D012922 1999-01-01
% 212.52/212.67  |- mesh__publicMeSHNote mesh__D012922 68   
% 212.52/212.67  |- mesh__recordAuthorizer mesh__D012922 sjn
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D012922 2005
% 212.52/212.67  |- skos__annotation mesh__D012922 specify geog if pertinent   
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D012922 2003
% 212.52/212.67  |- skos__hiddenLabel mesh__D012922 Plans, Development
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D012922 2006
% 212.52/212.67  |- mesh__dateEstablished mesh__D012922 1968-01-01
% 212.52/212.67  |- skos__hiddenLabel mesh__D012922 Development Plan
% 212.52/212.67  |- skos__historyNote mesh__D012922 Sociology %28%1966-1967%29%
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D012922 2004
% 212.52/212.67  |- mesh__recordOriginator mesh__D012922 NLM
% 212.52/212.67  |- mesh__historyNote mesh__D012922 68   
% 212.52/212.67  |- rdf__type mesh__D012922sskos__Concept
% 212.52/212.67  |- skos__hiddenLabel mesh__D012922 Development, Social
% 212.52/212.67  |- skos__hiddenLabel mesh__D012922 Social Changes
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D012922 2000
% 212.52/212.67  |- skos__hiddenLabel mesh__D012922 Social Developments
% 212.52/212.67  |- mesh__dateRevised mesh__D012922 1999-11-03
% 212.52/212.67  |- skos__broader mesh__D012922smesh__D012961
% 212.52/212.67  |- skos__hiddenLabel mesh__D012922 Impacts, Social
% 212.52/212.67  |- skos__scopeNote mesh__D012922
% 212.52/212.67       Social process whereby the values, attitudes, or institutions of society, such as education, family, religion, and industry become modified. It includes both the natural process and action programs initiated by members of the community.%A%    
% 212.52/212.67  |- skos__historyNote mesh__D012922 Social Conditions %28%1966-1967%29%
% 212.52/212.67  |- skos__hiddenLabel mesh__D012922 Development, Community
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D012922 2001
% 212.52/212.67  |- skos__hiddenLabel mesh__D012922 Plan, Development
% 212.52/212.67  |- skos__hiddenLabel mesh__D012922 Social Impacts
% 212.52/212.67  |- skos__hiddenLabel mesh__D012922 Changes, Social
% 212.52/212.67  |- skos__hiddenLabel mesh__D012922 Change, Social
% 212.52/212.67  |- skos__scopeNote mesh__D012124
% 212.52/212.67       The hospital unit in which patients with respiratory conditions requiring special attention receive intensive medical care and surveillance.%A%    
% 212.52/212.67  |- skos__historyNote mesh__D012124
% 212.52/212.67       Respiratory Tract Diseases %28%1966-1970%29%
% 212.52/212.67  |- skos__historyNote mesh__D012124 Intensive Care Units %28%1966-1970%29%
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D012124 1998
% 212.52/212.67  |- mesh__recordAuthorizer mesh__D012124 PLS
% 212.52/212.67  |- mesh__dateEstablished mesh__D012124 1973-01-01
% 212.52/212.67  |- mesh__recordOriginator mesh__D012124 NLM
% 212.52/212.67  |- skos__hiddenLabel mesh__D012124 Units, Respiratory Care
% 212.52/212.67  |- skos__hiddenLabel mesh__D012124 Respiratory Care Unit
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D012124 2005
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D012124 1994
% 212.52/212.67  |- rdf__type mesh__D012124sskos__Concept
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D012124 2002
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D012124 1997
% 212.52/212.67  |- skos__hiddenLabel mesh__D012124 Unit, Respiratory Care
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D012124 2004
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D012124 1993
% 212.52/212.67  |- mesh__dateRevised mesh__D012124 1992-05-18
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D012124 2001
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D012124 1996
% 212.52/212.67  |- mesh__historyNote mesh__D012124 73%28%71%29%   
% 212.52/212.67  |- skos__hiddenLabel mesh__D012124 Care Units, Respiratory
% 212.52/212.67  |- skos__broader mesh__D012124smesh__D007362
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D012124 1999
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D012124 2003
% 212.52/212.67  |- mesh__recordMaintainer mesh__D012124 TGC
% 212.52/212.67  |- skos__hiddenLabel mesh__D012124 Care Unit, Respiratory
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D012124 2000
% 212.52/212.67  |- mesh__dateCreated mesh__D012124 1999-01-01
% 212.52/212.67  |- mesh__publicMeSHNote mesh__D012124 73   
% 212.52/212.67  |- skos__prefLabel mesh__D012124 Respiratory Care Units
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D012124 2006
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D012124 1995
% 212.52/212.67  |- mesh__recordMaintainer mesh__D003398 kle
% 212.52/212.67  |- mesh__recordAuthorizer mesh__D003398 sjn
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D003398 2004
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D003398 2000
% 212.52/212.67  |- skos__scopeNote mesh__D003398
% 212.52/212.67       Premature closure of one or more sutures of the skull.     
% 212.52/212.67  |- rdf__type mesh__D003398sskos__Concept
% 212.52/212.67  |- skos__annotation mesh__D003398
% 212.52/212.67       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D003398 2001
% 212.52/212.67  |- mesh__onlineNote mesh__D003398
% 212.52/212.67       use CRANIOSYNOSTOSES to search OXYCEPHALY 1966-78   
% 212.52/212.67  |- skos__broader mesh__D003398smesh__D019465
% 212.52/212.67  |- mesh__publicMeSHNote mesh__D003398
% 212.52/212.67       OXYCEPHALY was see under CRANOPSYNOSTOSES 1963-78   
% 212.52/212.67  |- skos__altLabel mesh__D003398 Craniosynostosis
% 212.52/212.67  |- skos__altLabel mesh__D003398 Oxycephaly
% 212.52/212.67  |- skos__broader mesh__D003398smesh__D013580
% 212.52/212.67  |- mesh__recordOriginator mesh__D003398 NLM
% 212.52/212.67  |- mesh__historyNote mesh__D003398
% 212.52/212.67       OXYCEPHALY was see under CRANIOSYNOSTOSES 1963-78   
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D003398 2002
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D003398 2005
% 212.52/212.67  |- skos__prefLabel mesh__D003398 Craniosynostoses
% 212.52/212.67  |- mesh__dateRevised mesh__D003398 1999-11-03
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D003398 2003
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D003398 2006
% 212.52/212.67  |- mesh__dateCreated mesh__D003398 1999-01-01
% 212.52/212.67  |- skos__annotation mesh__D008881 note many specifics; use word of text   
% 212.52/212.67  |- skos__hiddenLabel mesh__D008881 Migraines, Abdominal
% 212.52/212.67  |- skos__hiddenLabel mesh__D008881 Migraine Variants
% 212.52/212.67  |- mesh__recordOriginator mesh__D008881 NLM
% 212.52/212.67  |- skos__hiddenLabel mesh__D008881 Headache, Sick
% 212.52/212.67  |- skos__hiddenLabel mesh__D008881 Variant, Migraine
% 212.52/212.67  |- skos__hiddenLabel mesh__D008881 Migraine, Acute Confusional
% 212.52/212.67  |- skos__hiddenLabel mesh__D008881 Migraine Syndromes, Cervical
% 212.52/212.67  |- rdf__type mesh__D008881sskos__Concept
% 212.52/212.67  |- skos__hiddenLabel mesh__D008881 Migraines, Hemicrania
% 212.52/212.67  |- skos__hiddenLabel mesh__D008881 Hemicrania Migraines
% 212.52/212.67  |- skos__hiddenLabel mesh__D008881 Headaches, Sick
% 212.52/212.67  |- skos__altLabel mesh__D008881 Migraine
% 212.52/212.67  |- mesh__publicMeSHNote mesh__D008881 2006; see MIGRAINE 1963-2005   
% 212.52/212.67  |- mesh__dateRevised mesh__D008881 2005-07-01
% 212.52/212.67  |- skos__hiddenLabel mesh__D008881 Headaches, Migraine
% 212.52/212.67  |- skos__hiddenLabel mesh__D008881 Migraines, Acute Confusional
% 212.52/212.67  |- mesh__historyNote mesh__D008881 2006 %28%1963%29%   
% 212.52/212.67  |- skos__altLabel mesh__D008881 Migraine Headache
% 212.52/212.67  |- mesh__dateCreated mesh__D008881 1999-01-01
% 212.52/212.67  |- skos__hiddenLabel mesh__D008881 Migraines
% 212.52/212.67  |- skos__hiddenLabel mesh__D008881 Variants, Migraine
% 212.52/212.67  |- mesh__recordMaintainer mesh__D008881 lkt
% 212.52/212.67  |- skos__hiddenLabel mesh__D008881 Abdominal Migraines
% 212.52/212.67  |- mesh__activeMeSHYear mesh__D008881 2006
% 212.52/212.67  |- skos__hiddenLabel mesh__D008881 Disorders, Migraine
% 212.52/212.67  |- skos__hiddenLabel mesh__D008881 Migraine, Hemicrania
% 212.52/212.67  |- skos__hiddenLabel mesh__D008881 Cervical Migraine Syndromes
% 212.52/212.67  |- skos__hiddenLabel mesh__D008881 Migraine Syndrome, Cervical
% 212.52/212.68  |- skos__hiddenLabel mesh__D008881 Migraine, Abdominal
% 212.52/212.68  |- skos__prefLabel mesh__D008881 Migraine Disorders
% 212.52/212.68  |- skos__hiddenLabel mesh__D008881 Acute Confusional Migraines
% 212.52/212.68  |- skos__broader mesh__D008881smesh__D051270
% 212.52/212.68  |- mesh__recordAuthorizer mesh__D008881 sjn
% 212.52/212.68  |- skos__hiddenLabel mesh__D008881 Sick Headaches
% 212.52/212.68  |- skos__hiddenLabel mesh__D008881 Migraine Disorder
% 212.52/212.68  |- skos__hiddenLabel mesh__D008881 Disorder, Migraine
% 212.52/212.68  |- skos__altLabel mesh__D008881 Headache, Migraine
% 212.52/212.68  |- skos__hiddenLabel mesh__D008881 Migraine Headaches
% 212.52/212.68  |- skos__scopeNote mesh__D008881
% 212.52/212.68       A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine %28%without aura%29% and classic migraine %28%with aura or neurological symptoms%29%. %28%International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1%29%%A%    
% 212.52/212.68  |- rdf__type mesh__D044206sskos__Concept
% 212.52/212.68  |- mesh__recordMaintainer mesh__D044206 SYSTEM
% 212.52/212.68  |- mesh__dateEstablished mesh__D044206 2004-01-01
% 212.52/212.68  |- mesh__dateRevised mesh__D044206 2005-06-30
% 212.52/212.68  |- mesh__activeMeSHYear mesh__D044206 2006
% 212.52/212.68  |- mesh__recordAuthorizer mesh__D044206 sjn
% 212.52/212.68  |- mesh__historyNote mesh__D044206 2004   
% 212.52/212.68  |- skos__scopeNote mesh__D044206
% 212.52/212.68       A species of gram-negative, aerobic bacteria in the genus PSEUDOMONAS. It has a characteristic strawberry color and is widely distributed in SOIL and WATER.%A%    
% 212.52/212.68  |- mesh__publicMeSHNote mesh__D044206 2004   
% 212.52/212.68  |- skos__prefLabel mesh__D044206 Pseudomonas fragi
% 212.52/212.68  |- skos__broader mesh__D044206smesh__D011549
% 212.52/212.68  |- skos__historyNote mesh__D044206 Pseudomonas %28%1965-2003%29%
% 212.52/212.68  |- mesh__recordOriginator mesh__D044206 ags
% 212.52/212.68  |- mesh__dateCreated mesh__D044206 2003-07-09
% 212.52/212.68  |- mesh__activeMeSHYear mesh__D008083 2003
% 212.52/212.68  |- skos__hiddenLabel mesh__D008083 beta LPH
% 212.52/212.68  |- skos__annotation mesh__D008083 /biosyn /physiol permitted   
% 212.52/212.68  |- mesh__activeMeSHYear mesh__D008083 2004
% 212.52/212.68  |- skos__scopeNote mesh__D008083
% 212.52/212.68       Lipotropic or pituitary lipotropic hormone. A pituitary hormone mobilizing fat from adipose tissue. Beta-lipotropin is a single-chain peptide of about 90 residues that contains the sequences of endorphins and metenkephalin, and may be a precursor of beta-melanotropin and beta-endorphin. Gamma-lipotropin is shorter and is identical in sequence to the first 58 residues of beta-lipotropin. Both contain sequences common to ACTH and beta-melanotropin. %28%Stedman, 25th ed%29%%A%    
% 212.52/212.68  |- mesh__dateRevised mesh__D008083 2002-07-02
% 212.52/212.68  |- mesh__historyNote mesh__D008083 74%28%65%29%   
% 212.52/212.68  |- rdf__type mesh__D008083sskos__Concept
% 212.52/212.68  |- skos__altLabel mesh__D008083 Adipozin
% 212.52/212.68  |- mesh__recordMaintainer mesh__D008083 KEV
% 212.52/212.68  |- skos__hiddenLabel mesh__D008083 beta Lipotropin
% 212.52/212.68  |- skos__altLabel mesh__D008083 beta-Lipotrophin
% 212.52/212.68  |- mesh__recordOriginator mesh__D008083 NLM
% 212.52/212.68  |- mesh__recordAuthorizer mesh__D008083 sjn
% 212.52/212.68  |- skos__hiddenLabel mesh__D008083 beta Lipotrophin
% 212.52/212.68  |- mesh__dateCreated mesh__D008083 1999-01-01
% 212.52/212.68  |- mesh__activeMeSHYear mesh__D008083 2005
% 212.52/212.68  |- skos__prefLabel mesh__D008083 Lipotropin
% 212.52/212.68  |- mesh__dateEstablished mesh__D008083 1974-01-01
% 212.52/212.68  |- skos__broader mesh__D008083smesh__D011333
% 212.52/212.68  |- skos__hiddenLabel mesh__D008083 gamma Lipotropin
% 212.52/212.68  |- skos__altLabel mesh__D008083 beta-LPH
% 212.52/212.68  |- mesh__activeMeSHYear mesh__D008083 2006
% 212.52/212.68  |- mesh__publicMeSHNote mesh__D008083 74   
% 212.52/212.68  |- skos__hiddenLabel mesh__D016515 Gene, nf 2
% 212.52/212.68  |- skos__prefLabel mesh__D016515 Genes, Neurofibromatosis 2
% 212.52/212.68  |- mesh__publicMeSHNote mesh__D016515 92   
% 212.52/212.68  |- skos__altLabel mesh__D016515 nf2 Genes
% 212.52/212.68  |- mesh__dateEstablished mesh__D016515 1992-01-01
% 212.52/212.68  |- mesh__historyNote mesh__D016515 92   
% 212.52/212.68  |- skos__hiddenLabel mesh__D016515 Gene, nf2
% 212.52/212.68  |- skos__hiddenLabel mesh__D016515 Neurofibromatosis 2 Gene
% 212.52/212.68  |- mesh__recordMaintainer mesh__D016515 nns
% 212.52/212.68  |- skos__historyNote mesh__D016515
% 212.52/212.68       Neuroma, Acoustic/genetics %28%1988-1991%29%
% 212.52/212.68  |- skos__scopeNote mesh__D016515
% 212.52/212.68       Tumor suppressor genes located on the long arm of human chromosome 22. Mutation or loss of these genes causes NEUROFIBROMATOSIS 2.%A%    
% 212.52/212.68  |- mesh__activeMeSHYear mesh__D016515 2006
% 212.52/212.68  |- skos__altLabel mesh__D016515 Neurofibromatosis 2 Genes
% 212.52/212.68  |- skos__altLabel mesh__D016515 Genes, nf2
% 212.52/212.68  |- skos__historyNote mesh__D016515
% 212.52/212.68       Neurofibromatosis 1/genetics %28%1988-1991%29%
% 212.52/212.68  |- skos__hiddenLabel mesh__D016515 Gene, Neurofibromatosis 2
% 212.52/212.68  |- mesh__recordAuthorizer mesh__D016515 sjn
% 212.52/212.68  |- skos__related mesh__D016515smesh__D025581
% 212.53/212.68  |- rdf__type mesh__D016515sskos__Concept
% 212.53/212.68  |- skos__related mesh__D016515smesh__D016518
% 212.53/212.68  |- skos__altLabel mesh__D016515 Genes, nf 2
% 212.53/212.68  |- mesh__recordOriginator mesh__D016515 AGS
% 212.53/212.68  |- skos__hiddenLabel mesh__D016515 nf 2 Genes
% 212.53/212.68  |- mesh__dateCreated mesh__D016515 1991-06-21
% 212.53/212.68  |- skos__hiddenLabel mesh__D016515 nf2 Gene
% 212.53/212.68  |- skos__hiddenLabel mesh__D016515 nf 2 Gene
% 212.53/212.68  |- mesh__dateRevised mesh__D016515 2005-06-30
% 212.53/212.68  |- skos__broader mesh__D016515smesh__D016147
% 212.53/212.68  |- skos__hiddenLabel mesh__D007789 Test, Lactose Tolerance
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D007789 2006
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D007789 2003
% 212.53/212.68  |- skos__annotation mesh__D007789 NIM   
% 212.53/212.68  |- mesh__recordMaintainer mesh__D007789 PXP
% 212.53/212.68  |- mesh__historyNote mesh__D007789 74   
% 212.53/212.68  |- mesh__dateRevised mesh__D007789 1997-06-20
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D007789 2001
% 212.53/212.68  |- skos__hiddenLabel mesh__D007789 Tolerance Tests, Lactose
% 212.53/212.68  |- mesh__dateCreated mesh__D007789 1999-01-01
% 212.53/212.68  |- skos__hiddenLabel mesh__D007789 Lactose Tolerance Tests
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D007789 2004
% 212.53/212.68  |- mesh__recordOriginator mesh__D007789 NLM
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D007789 2002
% 212.53/212.68  |- mesh__dateEstablished mesh__D007789 1974-01-01
% 212.53/212.68  |- skos__hiddenLabel mesh__D007789 Tests, Lactose Tolerance
% 212.53/212.68  |- mesh__recordAuthorizer mesh__D007789 SJN
% 212.53/212.68  |- skos__broader mesh__D007789smesh__D001774
% 212.53/212.68  |- skos__hiddenLabel mesh__D007789 Tolerance Test, Lactose
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D007789 1998
% 212.53/212.68  |- mesh__publicMeSHNote mesh__D007789 74   
% 212.53/212.68  |- rdf__type mesh__D007789sskos__Concept
% 212.53/212.68  |- skos__prefLabel mesh__D007789 Lactose Tolerance Test
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D007789 1999
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D007789 2005
% 212.53/212.68  |- skos__broader mesh__D007789smesh__D003938
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D007789 2000
% 212.53/212.68  |- skos__prefLabel mesh__D004491 Edrophonium
% 212.53/212.68  |- mesh__dateCreated mesh__D004491 1999-01-01
% 212.53/212.68  |- mesh__historyNote mesh__D004491
% 212.53/212.68       83; was see under CURARIFORM ANTAGONISTS 1963-69; EDROPHONIUM CHLORIDE was heading 1964-82 %28%Prov 1964-71%29%%A%  
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D004491 2006
% 212.53/212.68  |- skos__scopeNote mesh__D004491
% 212.53/212.68       A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles.%A%    
% 212.53/212.68  |- mesh__onlineNote mesh__D004491
% 212.53/212.68       search CURARIFORM ANTAGONISTS 1966-69; use EDROPHONIUM to search EDROPHONIUM CHLORIDE 1966-82 %28%as Prov 1966-71%29%%A%  
% 212.53/212.68  |- mesh__publicMeSHNote mesh__D004491
% 212.53/212.68       83; was see under CURARIFORM ANTAGONISTS 1963-69; EDROPHONIUM CHLORIDE was heading 1972-82%A%  
% 212.53/212.68  |- mesh__recordOriginator mesh__D004491 NLM
% 212.53/212.68  |- skos__altLabel mesh__D004491 Edroponium
% 212.53/212.68  |- rdf__type mesh__D004491sskos__Concept
% 212.53/212.68  |- skos__broader mesh__D004491smesh__D000644
% 212.53/212.68  |- mesh__recordMaintainer mesh__D004491 ssb
% 212.53/212.68  |- skos__hiddenLabel mesh__D004491 Chloride, Edrophonium
% 212.53/212.68  |- mesh__recordAuthorizer mesh__D004491 sjn
% 212.53/212.68  |- skos__broader mesh__D004491smesh__D050338
% 212.53/212.68  |- mesh__dateRevised mesh__D004491 2005-06-30
% 212.53/212.68  |- skos__hiddenLabel mesh__D004491 Bromide, Edrophonium
% 212.53/212.68  |- mesh__dateEstablished mesh__D004491 1972-01-01
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012923 2001
% 212.53/212.68  |- mesh__recordMaintainer mesh__D012923 kle
% 212.53/212.68  |- mesh__dateCreated mesh__D012923 1999-01-01
% 212.53/212.68  |- skos__hiddenLabel mesh__D012923 Class Populations, Middle
% 212.53/212.68  |- mesh__dateEstablished mesh__D012923 1968-01-01
% 212.53/212.68  |- skos__scopeNote mesh__D012923
% 212.53/212.68       A stratum of people with similar position and prestige; includes social stratification. Social class is measured by criteria such as education, occupation, and income.%A%    
% 212.53/212.68  |- skos__hiddenLabel mesh__D012923 Population, Middle Class
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012923 2000
% 212.53/212.68  |- mesh__dateRevised mesh__D012923 1999-11-03
% 212.53/212.68  |- skos__hiddenLabel mesh__D012923 Castes
% 212.53/212.68  |- skos__broader mesh__D012923smesh__D012959
% 212.53/212.68  |- skos__hiddenLabel mesh__D012923 Classes, Social
% 212.53/212.68  |- skos__prefLabel mesh__D012923 Social Class
% 212.53/212.68  |- skos__historyNote mesh__D012923 Sociology %28%1966-1967%29%
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012923 2004
% 212.53/212.68  |- mesh__recordAuthorizer mesh__D012923 sjn
% 212.53/212.68  |- skos__hiddenLabel mesh__D012923 Class, Social
% 212.53/212.68  |- skos__hiddenLabel mesh__D012923 Social Classes
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012923 2006
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012923 2003
% 212.53/212.68  |- skos__hiddenLabel mesh__D012923 Middle Class Populations
% 212.53/212.68  |- skos__hiddenLabel mesh__D012923 Class Population, Middle
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012923 2002
% 212.53/212.68  |- skos__broader mesh__D012923smesh__D012961
% 212.53/212.68  |- rdf__type mesh__D012923sskos__Concept
% 212.53/212.68  |- skos__hiddenLabel mesh__D012923 Status, Socioeconomic
% 212.53/212.68  |- skos__annotation mesh__D012923 no qualif   
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012923 2005
% 212.53/212.68  |- skos__hiddenLabel mesh__D012923 Populations, Middle Class
% 212.53/212.68  |- mesh__historyNote mesh__D012923 68   
% 212.53/212.68  |- mesh__recordOriginator mesh__D012923 NLM
% 212.53/212.68  |- mesh__publicMeSHNote mesh__D012923 68   
% 212.53/212.68  |- skos__historyNote mesh__D012923 Social Conditions %28%1966-1967%29%
% 212.53/212.68  |- mesh__historyNote mesh__D012125 72%28%68%29%   
% 212.53/212.68  |- rdf__type mesh__D012125sskos__Concept
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012125 2000
% 212.53/212.68  |- skos__hiddenLabel mesh__D012125 Centers, Respiratory
% 212.53/212.68  |- skos__hiddenLabel mesh__D012125 Center, Respiratory
% 212.53/212.68  |- mesh__recordAuthorizer mesh__D012125 PLS
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012125 1997
% 212.53/212.68  |- mesh__recordOriginator mesh__D012125 NLM
% 212.53/212.68  |- skos__historyNote mesh__D012125 Reticular Formation %28%1966-1967%29%
% 212.53/212.68  |- mesh__recordMaintainer mesh__D012125 TAP
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012125 2004
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012125 1993
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012125 2002
% 212.53/212.68  |- mesh__dateRevised mesh__D012125 1992-05-18
% 212.53/212.68  |- mesh__dateEstablished mesh__D012125 1972-01-01
% 212.53/212.68  |- skos__broader mesh__D012125smesh__D012154
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012125 1996
% 212.53/212.68  |- skos__hiddenLabel mesh__D012125 Respiratory Centers
% 212.53/212.68  |- mesh__publicMeSHNote mesh__D012125 72   
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012125 1999
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012125 2003
% 212.53/212.68  |- mesh__dateCreated mesh__D012125 1999-01-01
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012125 2006
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012125 1995
% 212.53/212.68  |- skos__prefLabel mesh__D012125 Respiratory Center
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012125 1998
% 212.53/212.68  |- skos__historyNote mesh__D012125 Medulla Oblongata %28%1966-1967%29%
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012125 2001
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012125 2005
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012125 1994
% 212.53/212.68  |- skos__broader mesh__D003399smesh__D019635
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D003399 2005
% 212.53/212.68  |- mesh__historyNote mesh__D003399 65%28%64%29%   
% 212.53/212.68  |- skos__prefLabel mesh__D003399 Craniotomy
% 212.53/212.68  |- mesh__publicMeSHNote mesh__D003399 65   
% 212.53/212.68  |- mesh__dateEstablished mesh__D003399 1965-01-01
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D003399 2006
% 212.53/212.68  |- mesh__dateRevised mesh__D003399 1997-06-20
% 212.53/212.68  |- mesh__dateCreated mesh__D003399 1999-01-01
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D003399 2003
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D003399 1998
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D003399 2000
% 212.53/212.68  |- mesh__recordMaintainer mesh__D003399 PXP
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D003399 2004
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D003399 1999
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D003399 2001
% 212.53/212.68  |- skos__annotation mesh__D003399
% 212.53/212.68       do not use /util except by MeSH definition   
% 212.53/212.68  |- mesh__recordAuthorizer mesh__D003399 SJN
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D003399 2002
% 212.53/212.68  |- rdf__type mesh__D003399sskos__Concept
% 212.53/212.68  |- skos__scopeNote mesh__D003399
% 212.53/212.68       Any operation on the cranium or incision into the cranium. %28%Dorland, 28th ed%29%%A%    
% 212.53/212.68  |- mesh__recordOriginator mesh__D003399 NLM
% 212.53/212.68  |- skos__hiddenLabel mesh__D003399 Craniotomies
% 212.53/212.68  |- skos__scopeNote mesh__D008882
% 212.53/212.68       A chronic, benign, and usually painless inflammatory swelling of the lacrimal and salivary glands. It is considered by some to include the glandular enlargement associated with other diseases, such as Sjogren%27%s syndrome, sarcoidosis, lupus erythematosus, etc.%A%    
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D008882 1994
% 212.53/212.68  |- mesh__recordAuthorizer mesh__D008882 PLS
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D008882 2000
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D008882 2005
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D008882 1995
% 212.53/212.68  |- mesh__recordOriginator mesh__D008882 NLM
% 212.53/212.68  |- mesh__dateRevised mesh__D008882 1992-05-22
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D008882 2006
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D008882 1998
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D008882 2001
% 212.53/212.68  |- mesh__dateCreated mesh__D008882 1999-01-01
% 212.53/212.68  |- skos__hiddenLabel mesh__D008882 Disease, Mikulicz%27%
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D008882 1993
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D008882 2003
% 212.53/212.68  |- skos__hiddenLabel mesh__D008882 Disease, Mikulicz
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D008882 1999
% 212.53/212.68  |- skos__prefLabel mesh__D008882 Mikulicz%27% Disease
% 212.53/212.68  |- mesh__recordMaintainer mesh__D008882 PLS
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D008882 2004
% 212.53/212.68  |- skos__annotation mesh__D008882
% 212.53/212.68       an inflamm dis of the lacrimal %26% salivary glands   
% 212.53/212.68  |- skos__altLabel mesh__D008882 Mikulicz Disease
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D008882 1996
% 212.53/212.68  |- rdf__type mesh__D008882sskos__Concept
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D008882 2002
% 212.53/212.68  |- skos__broader mesh__D008882smesh__D012466
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D008882 1997
% 212.53/212.68  |- skos__broader mesh__D004298Q000037smesh__D004298
% 212.53/212.68  |- mesh__preferredCombination mesh__D004298Q000037smesh__D018492
% 212.53/212.68  |- rdf__type mesh__D004298Q000037smesh__CompoundConcept
% 212.53/212.68  |- skos__altLabel mesh__D008084 Lipoxygenases
% 212.53/212.68  |- mesh__recordOriginator mesh__D008084 NLM
% 212.53/212.68  |- skos__prefLabel mesh__D008084 Lipoxygenase
% 212.53/212.68  |- skos__hiddenLabel mesh__D008084 Oxidoreductase, Linoleate-Oxygen
% 212.53/212.68  |- mesh__dateEstablished mesh__D008084 1974-01-01
% 212.53/212.68  |- mesh__recordAuthorizer mesh__D008084 sjn
% 212.53/212.68  |- rdf__type mesh__D008084sskos__Concept
% 212.53/212.68  |- mesh__publicMeSHNote mesh__D008084 92; was LIPOXYGENASES 1974-91   
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D008084 2005
% 212.53/212.68  |- skos__hiddenLabel mesh__D008084 Lipoxygenase 2
% 212.53/212.68  |- skos__altLabel mesh__D008084 Linoleate-Oxygen Oxidoreductase
% 212.53/212.68  |- skos__altLabel mesh__D008084 Lipoxidase
% 212.53/212.68  |- skos__annotation mesh__D008084 coord with ISOENZYMES if discussed   
% 212.53/212.68  |- mesh__dateCreated mesh__D008084 1999-01-01
% 212.53/212.68  |- mesh__historyNote mesh__D008084 92; was LIPOXYGENASES 1974-91   
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D008084 2006
% 212.53/212.68  |- skos__hiddenLabel mesh__D008084 Lipoxygenase 1
% 212.53/212.68  |- skos__scopeNote mesh__D008084
% 212.53/212.68       An enzyme of the oxidoreductase class that catalyzes reactions between linoleate and other fatty acids and oxygen to form hydroperoxy-fatty acid derivatives. Related enzymes in this class include the ARACHIDONATE LIPOXYGENASES; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONATE 12-LIPOXYGENASE; and ARACHIDONATE 15-LIPOXYGENASE. EC 1.13.11.12.%A%    
% 212.53/212.68  |- mesh__recordMaintainer mesh__D008084 ssb
% 212.53/212.68  |- skos__broader mesh__D008084smesh__D049308
% 212.53/212.68  |- skos__broader mesh__D008084smesh__D019159
% 212.53/212.68  |- skos__hiddenLabel mesh__D008084 Linoleate Oxygen Oxidoreductase
% 212.53/212.68  |- mesh__dateRevised mesh__D008084 2004-07-07
% 212.53/212.68  |- mesh__onlineNote mesh__D008084
% 212.53/212.68       use LIPOXYGENASE to search LIPOXYGENASES 1974-91   
% 212.53/212.68  |- mesh__dateCreated mesh__D016516 1991-06-21
% 212.53/212.68  |- skos__broader mesh__D016516smesh__D007109
% 212.53/212.68  |- skos__hiddenLabel mesh__D016516 T4-T8 Ratios
% 212.53/212.68  |- skos__prefLabel mesh__D016516 CD4-CD8 Ratio
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D016516 2006
% 212.53/212.68  |- skos__hiddenLabel mesh__D016516 CD4-CD8 Ratios
% 212.53/212.68  |- mesh__publicMeSHNote mesh__D016516 92   
% 212.53/212.68  |- skos__hiddenLabel mesh__D016516 T4 T8 Ratio
% 212.53/212.68  |- mesh__dateEstablished mesh__D016516 1992-01-01
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D016516 2005
% 212.53/212.68  |- rdf__type mesh__D016516sskos__Concept
% 212.53/212.68  |- skos__altLabel mesh__D016516 T4-T8 Ratio
% 212.53/212.68  |- skos__historyNote mesh__D016516
% 212.53/212.68       Antigens, Differentiation, T-Lymphocyte %28%1986-1991%29%
% 212.53/212.68  |- skos__scopeNote mesh__D016516
% 212.53/212.68       Ratio of T-LYMPHOCYTES that express the CD4 ANTIGEN to those that express the CD8 ANTIGEN. This value is commonly assessed in the diagnosis and staging of diseases affecting the IMMUNE SYSTEM including HIV INFECTIONS.%A%    
% 212.53/212.68  |- skos__historyNote mesh__D016516 Leukocyte Count %28%1986-1991%29%
% 212.53/212.68  |- skos__hiddenLabel mesh__D016516 CD4 CD8 Ratio
% 212.53/212.68  |- mesh__recordMaintainer mesh__D016516 nns
% 212.53/212.68  |- skos__broader mesh__D016516smesh__D018791
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D016516 2004
% 212.53/212.68  |- mesh__dateRevised mesh__D016516 2003-07-09
% 212.53/212.68  |- mesh__recordAuthorizer mesh__D016516 sjn
% 212.53/212.68  |- mesh__historyNote mesh__D016516 92   
% 212.53/212.68  |- mesh__recordOriginator mesh__D016516 AGS
% 212.53/212.68  |- skos__altLabel mesh__D032981 Dehumanisation
% 212.53/212.68  |- mesh__dateEstablished mesh__D032981 2003-01-01
% 212.53/212.68  |- mesh__dateRevised mesh__D032981 2004-07-13
% 212.53/212.68  |- mesh__recordMaintainer mesh__D032981 sjn
% 212.53/212.68  |- skos__prefLabel mesh__D032981 Dehumanization
% 212.53/212.68  |- rdf__type mesh__D032981sskos__Concept
% 212.53/212.68  |- mesh__publicMeSHNote mesh__D032981 2003   
% 212.53/212.68  |- mesh__recordAuthorizer mesh__D032981 sjn
% 212.53/212.68  |- mesh__recordOriginator mesh__D032981 jrf
% 212.53/212.68  |- skos__scopeNote mesh__D032981
% 212.53/212.68       The process by which a person or group of persons comes to be regarded or treated as lacking in human qualities.%A%    
% 212.53/212.68  |- mesh__historyNote mesh__D032981 2003   
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D032981 2005
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D032981 2006
% 212.53/212.68  |- mesh__dateCreated mesh__D032981 2002-07-03
% 212.53/212.68  |- skos__broader mesh__D032981smesh__D012919
% 212.53/212.68  |- skos__altLabel mesh__D004492 Calcium Disodium Edetate
% 212.53/212.68  |- mesh__recordAuthorizer mesh__D004492 sjn
% 212.53/212.68  |- skos__hiddenLabel mesh__D004492 EDTA, Gallium
% 212.53/212.68  |- skos__hiddenLabel mesh__D004492 EDTA, Disodium
% 212.53/212.68  |- skos__hiddenLabel mesh__D004492 EDTA, Copper
% 212.53/212.68  |- skos__scopeNote mesh__D004492
% 212.53/212.68       A chelating agent %28%CHELATING AGENTS%29% that sequesters a variety of polyvalent cations. It is used in pharmaceutical manufacturing and as a food additive.%A%    
% 212.53/212.68  |- skos__hiddenLabel mesh__D004492 EDTA, Potassium
% 212.53/212.68  |- skos__hiddenLabel mesh__D004492 Dinitrilotetraacetate, Ethylene
% 212.53/212.68  |- skos__hiddenLabel mesh__D004492 EDTA, Stannous
% 212.53/212.68  |- skos__altLabel mesh__D004492 Chromium EDTA
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D004492 2006
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D004492 2001
% 212.53/212.68  |- skos__hiddenLabel mesh__D004492 Dinitrilotetraacetate, Disodium Ethylene
% 212.53/212.68  |- skos__altLabel mesh__D004492 Ethylene Dinitrilotetraacetate
% 212.53/212.68  |- skos__hiddenLabel mesh__D004492 EDTA, Chromium
% 212.53/212.68  |- skos__hiddenLabel mesh__D004492 EDTA, Distannous
% 212.53/212.68  |- skos__broader mesh__D004492smesh__D000088
% 212.53/212.68  |- skos__prefLabel mesh__D004492 Edetic Acid
% 212.53/212.68  |- skos__hiddenLabel mesh__D004492 Tetacine, Calcium
% 212.53/212.68  |- skos__altLabel mesh__D004492
% 212.53/212.68       N,N%27%-1,2-Ethanediylbis%28%N-%28%carboxymethyl%29%glycine%29%
% 212.53/212.68  |- skos__hiddenLabel mesh__D004492 Acid, Ethylenedinitrilotetraacetic
% 212.53/212.68  |- skos__altLabel mesh__D004492 Edathamil
% 212.53/212.68  |- mesh__dateCreated mesh__D004492 1999-01-01
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D004492 2005
% 212.53/212.68  |- mesh__recordMaintainer mesh__D004492 jmp
% 212.53/212.68  |- skos__hiddenLabel mesh__D004492 EDTA, Magnesium Disodium
% 212.53/212.68  |- mesh__recordOriginator mesh__D004492 NLM
% 212.53/212.68  |- skos__altLabel mesh__D004492 Potassium EDTA
% 212.53/212.68  |- skos__altLabel mesh__D004492 Edetic Acid, Disodium, Magnesium Salt
% 212.53/212.68  |- rdf__type mesh__D004492sskos__Concept
% 212.53/212.68  |- skos__broader mesh__D004492smesh__D005029
% 212.53/212.68  |- skos__altLabel mesh__D004492 Ethylenediaminetetraacetic Acid
% 212.53/212.68  |- skos__hiddenLabel mesh__D004492 Ethylene Dinitrilotetraacetate, Disodium
% 212.53/212.68  |- skos__hiddenLabel mesh__D004492 Acid, Edetic
% 212.53/212.68  |- skos__altLabel mesh__D004492 Ethylenedinitrilotetraacetic Acid
% 212.53/212.68  |- skos__altLabel mesh__D004492 Disodium Ethylene Dinitrilotetraacetate
% 212.53/212.68  |- mesh__publicMeSHNote mesh__D004492
% 212.53/212.68       92; see EDTA 1966-91, see EDATHAMIL 1963-65   
% 212.53/212.68  |- skos__altLabel mesh__D004492 Disodium EDTA
% 212.53/212.68  |- skos__hiddenLabel mesh__D004492 Acid, Ethylenediaminetetraacetic
% 212.53/212.68  |- mesh__historyNote mesh__D004492 92%28%63%29%   
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D004492 2004
% 212.53/212.68  |- mesh__dateRevised mesh__D004492 2000-06-21
% 212.53/212.68  |- skos__altLabel mesh__D004492 EDTA
% 212.53/212.68  |- mesh__dateEstablished mesh__D004492 1966-01-01
% 212.53/212.68  |- skos__hiddenLabel mesh__D004492 Edetate, Calcium Disodium
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D004492 2002
% 212.53/212.68  |- skos__hiddenLabel mesh__D004492 EDTA, Dicobalt
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D004492 2003
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012924 2002
% 212.53/212.68  |- mesh__recordOriginator mesh__D012924 NLM
% 212.53/212.68  |- skos__broader mesh__D012924smesh__D012959
% 212.53/212.68  |- skos__scopeNote mesh__D012924
% 212.53/212.68       The state of society as it exists or in flux. While it usually refers to society as a whole in a specified geographical or political region, it is applicable also to restricted strata of a society.%A%    
% 212.53/212.68  |- skos__hiddenLabel mesh__D012924 Social Condition
% 212.53/212.68  |- mesh__recordMaintainer mesh__D012924 kle
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012924 2001
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012924 2004
% 212.53/212.68  |- skos__hiddenLabel mesh__D012924 Conditions, Social
% 212.53/212.68  |- skos__prefLabel mesh__D012924 Social Conditions
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012924 2000
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012924 2006
% 212.53/212.68  |- mesh__dateRevised mesh__D012924 1999-11-03
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012924 2003
% 212.53/212.68  |- skos__broader mesh__D012924smesh__D012961
% 212.53/212.68  |- rdf__type mesh__D012924sskos__Concept
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012924 2005
% 212.53/212.68  |- skos__hiddenLabel mesh__D012924 Condition, Social
% 212.53/212.68  |- mesh__recordAuthorizer mesh__D012924 sjn
% 212.53/212.68  |- mesh__dateCreated mesh__D012924 1999-01-01
% 212.53/212.68  |- skos__annotation mesh__D012924 specify geog if pertinent   
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012126 2005
% 212.53/212.68  |- skos__hiddenLabel mesh__D012126 Respiratory Dead Spaces
% 212.53/212.68  |- mesh__recordOriginator mesh__D012126 NLM
% 212.53/212.68  |- skos__hiddenLabel mesh__D012126 Dead Space, Respiratory
% 212.53/212.68  |- skos__hiddenLabel mesh__D012126 Space, Respiratory Dead
% 212.53/212.68  |- mesh__recordMaintainer mesh__D012126 nns
% 212.53/212.68  |- mesh__activeMeSHYear mesh__D012126 2004
% 212.53/212.68  |- mesh__recordAuthorizer mesh__D012126 sjn
% 212.53/212.68  |- mesh__dateEstablished mesh__D012126 1972-01-01
% 212.53/212.68  |- skos__hiddenLabel mesh__D012126 Dead Spaces, Respiratory
% 212.53/212.68  |- mesh__publicMeSHNote mesh__D012126 72   
% 212.53/212.68  |- mesh__dateCreated mesh__D012126 1999-01-01
% 212.53/212.68  |- skos__scopeNote mesh__D012126
% 212.53/212.68       That part of the RESPIRATORY TRACT or the air within the respiratory tract that does not exchange OXYGEN and CARBON DIOXIDE with pulmonary capillary blood.%A%    
% 212.53/212.68  |- skos__historyNote mesh__D012126 Respiration %28%1966-1968%29%
% 212.53/212.68  |- skos__prefLabel mesh__D012126 Respiratory Dead Space
% 212.53/212.69  |- mesh__historyNote mesh__D012126 72%28%69%29%   
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D012126 2006
% 212.53/212.69  |- rdf__type mesh__D012126sskos__Concept
% 212.53/212.69  |- skos__broader mesh__D012126smesh__D044702
% 212.53/212.69  |- skos__hiddenLabel mesh__D012126 Spaces, Respiratory Dead
% 212.53/212.69  |- mesh__dateRevised mesh__D012126 2003-07-09
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008883 2005
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008883 2002
% 212.53/212.69  |- skos__prefLabel mesh__D008883 Miliaria
% 212.53/212.69  |- skos__hiddenLabel mesh__D008883 Heat, Prickly
% 212.53/212.69  |- skos__altLabel mesh__D008883 Prickly Heat
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008883 2006
% 212.53/212.69  |- skos__broader mesh__D008883smesh__D013543
% 212.53/212.69  |- mesh__dateCreated mesh__D008883 1999-01-01
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008883 2003
% 212.53/212.69  |- skos__scopeNote mesh__D008883
% 212.53/212.69       A syndrome of cutaneous changes associated with sweat retention and extravasation of sweat at different levels in the skin. Miliaria rubra, or prickly heat, results from apocrine duct obstruction. The sweat then seeps into the epidermis, producing pruritic erythematous papulovesicles. %28%From Dorland, 27th ed%29%%A%    
% 212.53/212.69  |- mesh__recordAuthorizer mesh__D008883 sjn
% 212.53/212.69  |- mesh__recordOriginator mesh__D008883 NLM
% 212.53/212.69  |- skos__annotation mesh__D008883 a sweat gland dis   
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008883 2004
% 212.53/212.69  |- rdf__type mesh__D008883sskos__Concept
% 212.53/212.69  |- mesh__dateRevised mesh__D008883 2001-07-25
% 212.53/212.69  |- mesh__recordMaintainer mesh__D008883 lkt
% 212.53/212.69  |- rdf__type mesh__D008085sskos__Concept
% 212.53/212.69  |- skos__hiddenLabel mesh__D008085 Speechreadings
% 212.53/212.69  |- mesh__publicMeSHNote mesh__D008085 77; was LIP READING 1963-76   
% 212.53/212.69  |- skos__altLabel mesh__D008085 Lip Reading
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008085 2005
% 212.53/212.69  |- mesh__recordMaintainer mesh__D008085 KEV
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008085 2002
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008085 2003
% 212.53/212.69  |- skos__prefLabel mesh__D008085 Lipreading
% 212.53/212.69  |- mesh__historyNote mesh__D008085 77; was LIP READING 1963-76   
% 212.53/212.69  |- mesh__dateCreated mesh__D008085 1999-01-01
% 212.53/212.69  |- mesh__recordOriginator mesh__D008085 NLM
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008085 2006
% 212.53/212.69  |- mesh__recordAuthorizer mesh__D008085 sjn
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008085 2004
% 212.53/212.69  |- mesh__onlineNote mesh__D008085
% 212.53/212.69       use LIPREADING to search LIP READING 1966-76   
% 212.53/212.69  |- skos__related mesh__D008085smesh__D003638
% 212.53/212.69  |- skos__altLabel mesh__D008085 Speechreading
% 212.53/212.69  |- skos__annotation mesh__D008085 no qualif   
% 212.53/212.69  |- skos__hiddenLabel mesh__D008085 Readings, Lip
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008085 2000
% 212.53/212.69  |- skos__hiddenLabel mesh__D008085 Lip Readings
% 212.53/212.69  |- skos__broader mesh__D008085smesh__D012048
% 212.53/212.69  |- skos__hiddenLabel mesh__D008085 Reading, Lip
% 212.53/212.69  |- mesh__dateRevised mesh__D008085 1999-11-08
% 212.53/212.69  |- skos__scopeNote mesh__D008085
% 212.53/212.69       The process by which an observer comprehends speech by watching the movements of the speaker%27%s lips without hearing the speaker%27%s voice.%A%    
% 212.53/212.69  |- skos__hiddenLabel mesh__D008085 Lipreadings
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008085 2001
% 212.53/212.69  |- skos__broader mesh__D008085smesh__D007803
% 212.53/212.69  |- skos__broader mesh__D032982smesh__D007603
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D032982 2004
% 212.53/212.69  |- skos__prefLabel mesh__D032982 Contracts
% 212.53/212.69  |- mesh__dateEstablished mesh__D032982 2003-01-01
% 212.53/212.69  |- skos__annotation mesh__D032982 CONTRACT SERVICES is also available   
% 212.53/212.69  |- rdf__type mesh__D032982sskos__Concept
% 212.53/212.69  |- mesh__publicMeSHNote mesh__D032982 2003   
% 212.53/212.69  |- mesh__historyNote mesh__D032982 2003   
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D032982 2005
% 212.53/212.69  |- skos__scopeNote mesh__D032982
% 212.53/212.69       Agreements between two or more parties, especially those that are written and enforceable by law %28%American Heritage Dictionary of the English Language, 4th ed%29%. It is sometimes used to characterize the nature of the professional-patient relationship.%A%    
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D032982 2003
% 212.53/212.69  |- skos__hiddenLabel mesh__D032982 Contract
% 212.53/212.69  |- mesh__dateCreated mesh__D032982 2002-07-03
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D032982 2006
% 212.53/212.69  |- skos__related mesh__D032982smesh__D003284
% 212.53/212.69  |- skos__broader mesh__D012137Q000502smesh__D012137
% 212.53/212.69  |- mesh__preferredCombination mesh__D012137Q000502smesh__D012143
% 212.53/212.69  |- rdf__type mesh__D012137Q000502smesh__CompoundConcept
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D004493 2004
% 212.53/212.69  |- skos__related mesh__D004493smesh__D013663
% 212.53/212.69  |- skos__hiddenLabel mesh__D004493 Programs, Training
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D004493 2000
% 212.53/212.69  |- skos__hiddenLabel mesh__D004493 Literacy Program
% 212.53/212.69  |- skos__scopeNote mesh__D004493
% 212.53/212.69       Acquisition of knowledge as a result of instruction in a formal course of study.%A%    
% 212.53/212.69  |- skos__annotation mesh__D004493
% 212.53/212.69       GEN only; prefer /educ: Manual 19.7+, 19.8.28; policy: Manual 30.7+; DF: EDUC%A%  
% 212.53/212.69  |- skos__hiddenLabel mesh__D004493 Workshop
% 212.53/212.69  |- mesh__recordMaintainer mesh__D004493 kle
% 212.53/212.69  |- skos__hiddenLabel mesh__D004493 Program, Literacy
% 212.53/212.69  |- mesh__recordAuthorizer mesh__D004493 sjn
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D004493 2001
% 212.53/212.69  |- skos__related mesh__D004493smesh__D013334
% 212.53/212.69  |- skos__related mesh__D004493smesh__D014146
% 212.53/212.69  |- skos__hiddenLabel mesh__D004493 Training Program
% 212.53/212.69  |- skos__altLabel mesh__D004493 Education, Parenting
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D004493 2005
% 212.53/212.69  |- skos__hiddenLabel mesh__D004493 Programs, Literacy
% 212.53/212.69  |- skos__prefLabel mesh__D004493 Education
% 212.53/212.69  |- mesh__dateCreated mesh__D004493 1999-01-01
% 212.53/212.69  |- mesh__runningHead mesh__D004493 I2 - EDUCATION   
% 212.53/212.69  |- skos__hiddenLabel mesh__D004493 Activity, Educational
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D004493 2006
% 212.53/212.69  |- skos__related mesh__D004493smesh__D007858
% 212.53/212.69  |- skos__hiddenLabel mesh__D004493 Program, Training
% 212.53/212.69  |- skos__related mesh__D004493smesh__D012109
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D004493 2002
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D004493 2003
% 212.53/212.69  |- mesh__dateRevised mesh__D004493 1999-11-03
% 212.53/212.69  |- skos__hiddenLabel mesh__D004493 Educational Activity
% 212.53/212.69  |- mesh__recordOriginator mesh__D004493 NLM
% 212.53/212.69  |- skos__altLabel mesh__D004493 Activities, Educational
% 212.53/212.69  |- rdf__type mesh__D004493sskos__Concept
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D012925 2006
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D012925 2003
% 212.53/212.69  |- mesh__dateRevised mesh__D012925 2002-07-03
% 212.53/212.69  |- skos__hiddenLabel mesh__D012925 Social Conformities
% 212.53/212.69  |- mesh__recordAuthorizer mesh__D012925 sjn
% 212.53/212.69  |- mesh__recordMaintainer mesh__D012925 JLS
% 212.53/212.69  |- rdf__type mesh__D012925sskos__Concept
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D012925 2005
% 212.53/212.69  |- mesh__publicMeSHNote mesh__D012925 68   
% 212.53/212.69  |- skos__historyNote mesh__D012925 Attitude %28%1966-1967%29%
% 212.53/212.69  |- skos__annotation mesh__D012925 no qualif   
% 212.53/212.69  |- mesh__dateCreated mesh__D012925 1999-01-01
% 212.53/212.69  |- mesh__recordOriginator mesh__D012925 NLM
% 212.53/212.69  |- mesh__dateEstablished mesh__D012925 1968-01-01
% 212.53/212.69  |- mesh__historyNote mesh__D012925 68   
% 212.53/212.69  |- skos__scopeNote mesh__D012925
% 212.53/212.69       Behavioral or attitudinal compliance with recognized social patterns or standards.%A%    
% 212.53/212.69  |- skos__related mesh__D012925smesh__D012927
% 212.53/212.69  |- skos__altLabel mesh__D012925 Conformity, Social
% 212.53/212.69  |- skos__historyNote mesh__D012925
% 212.53/212.69       Interpersonal Relations %28%1966-1967%29%
% 212.53/212.69  |- skos__prefLabel mesh__D012925 Social Conformity
% 212.53/212.69  |- skos__hiddenLabel mesh__D012925 Conformities, Social
% 212.53/212.69  |- skos__broader mesh__D012925smesh__D012919
% 212.53/212.69  |- skos__historyNote mesh__D012925 Behavior %28%1966-1967%29%
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D012925 2004
% 212.53/212.69  |- skos__annotation mesh__D012127
% 212.53/212.69       for adults use RESPIRATORY DISTRESS SYNDROME, ADULT; do not confuse with %22%respiratory distress%22% which may be RESPIRATORY INSUFFICIENCY or a specific; do not confuse with SEVERE ACUTE RESPIRATORY SYNDROME%A%  
% 212.53/212.69  |- mesh__dateCreated mesh__D012127 1999-01-01
% 212.53/212.69  |- mesh__historyNote mesh__D012127 2004 %28%1965%29%   
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D012127 2004
% 212.53/212.69  |- skos__scopeNote mesh__D012127
% 212.53/212.69       A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause.%A%    
% 212.53/212.69  |- mesh__recordOriginator mesh__D012127 NLM
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D012127 2005
% 212.53/212.69  |- mesh__dateEstablished mesh__D012127 1965-01-01
% 212.53/212.69  |- skos__broader mesh__D012127smesh__D007235
% 212.53/212.69  |- mesh__recordMaintainer mesh__D012127 ags
% 212.53/212.69  |- mesh__recordAuthorizer mesh__D012127 sjn
% 212.53/212.69  |- skos__broader mesh__D012127smesh__D012120
% 212.53/212.69  |- skos__broader mesh__D012127smesh__D008171
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D012127 2006
% 212.53/212.69  |- rdf__type mesh__D012127sskos__Concept
% 212.53/212.69  |- mesh__publicMeSHNote mesh__D012127
% 212.53/212.69       2004; see RESPIRATORY DISTRESS SYNDROME 1965-2003   
% 212.53/212.69  |- mesh__dateRevised mesh__D012127 2003-07-09
% 212.53/212.69  |- skos__prefLabel mesh__D012127 Respiratory Distress Syndrome, Newborn
% 212.53/212.69  |- skos__hiddenLabel mesh__D017610 Compounds, Calcium
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D017610 2004
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D017610 2002
% 212.53/212.69  |- mesh__dateCreated mesh__D017610 1993-06-04
% 212.53/212.69  |- skos__annotation mesh__D017610
% 212.53/212.69       inorganic; GEN or unspecified; prefer specifics; DF: CALCIUM CPDS%A%  
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D017610 2006
% 212.53/212.69  |- rdf__type mesh__D017610sskos__Concept
% 212.53/212.69  |- mesh__publicMeSHNote mesh__D017610 94   
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D017610 2003
% 212.53/212.69  |- mesh__dateEstablished mesh__D017610 1994-01-01
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D017610 2001
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D017610 1997
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D017610 2005
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D017610 1999
% 212.53/212.69  |- skos__prefLabel mesh__D017610 Calcium Compounds
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D017610 1996
% 212.53/212.69  |- skos__broader mesh__D017610smesh__D007287
% 212.53/212.69  |- skos__scopeNote mesh__D017610
% 212.53/212.69       Inorganic compounds that contain calcium as an integral part of the molecule.%A%    
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D017610 1995
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D017610 2000
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D017610 1998
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D017610 1994
% 212.53/212.69  |- mesh__historyNote mesh__D017610 94   
% 212.53/212.69  |- skos__historyNote mesh__D017610 Calcium %28%1966-1993%29%
% 212.53/212.69  |- skos__prefLabel mesh__D008884 Milieu Therapy
% 212.53/212.69  |- skos__hiddenLabel mesh__D008884 Milieu Therapies
% 212.53/212.69  |- skos__hiddenLabel mesh__D008884 Situational Therapies
% 212.53/212.69  |- mesh__dateRevised mesh__D008884 1995-05-31
% 212.53/212.69  |- skos__altLabel mesh__D008884 Situational Therapy
% 212.53/212.69  |- skos__altLabel mesh__D008884 Therapy, Milieu
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008884 1996
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008884 2004
% 212.53/212.69  |- mesh__recordMaintainer mesh__D008884 TGC
% 212.53/212.69  |- mesh__dateEstablished mesh__D008884 1969-01-01
% 212.53/212.69  |- rdf__type mesh__D008884sskos__Concept
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008884 1997
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008884 2002
% 212.53/212.69  |- skos__historyNote mesh__D008884 Psychotherapy %28%1966%29%
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008884 2005
% 212.53/212.69  |- skos__altLabel mesh__D008884 Therapy, Situational
% 212.53/212.69  |- skos__scopeNote mesh__D008884
% 212.53/212.69       A treatment program based on manipulation of the patient%27%s environment by the medical staff. The patient does not participate in planning the treatment regimen.%A%    
% 212.53/212.69  |- skos__broader mesh__D008884smesh__D012960
% 212.53/212.69  |- mesh__publicMeSHNote mesh__D008884
% 212.53/212.69       69; SITUATIONAL THERAPY was see SOCIOENVIRONMENTAL THERAPY 1979-91, was see under SOCIOENVIRONMENTAL THERAPY 1973-78%A%  
% 212.53/212.69  |- skos__hiddenLabel mesh__D008884 Therapies, Situational
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008884 1998
% 212.53/212.69  |- skos__annotation mesh__D008884
% 212.53/212.69       a form of socioenvir ther; DF: MILIEU THER   
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008884 2006
% 212.53/212.69  |- skos__hiddenLabel mesh__D008884 Therapies, Milieu
% 212.53/212.69  |- mesh__recordAuthorizer mesh__D008884 PLS
% 212.53/212.69  |- mesh__onlineNote mesh__D008884
% 212.53/212.69       use SOCIOENVIRONMENTAL THERAPY to search SITUATIONAL THERAPY 1973-91%A%  
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008884 2000
% 212.53/212.69  |- mesh__recordOriginator mesh__D008884 NLM
% 212.53/212.69  |- mesh__historyNote mesh__D008884
% 212.53/212.69       69%28%67%29%; SITUATIONAL THERAPY was see SOCIOENVIRONMENTAL THERAPY 1979-91, was see under SOCIOENVIRONMENTAL THERAPY 1973-78%A%  
% 212.53/212.69  |- mesh__dateCreated mesh__D008884 1999-01-01
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008884 1999
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008884 2003
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008884 2001
% 212.53/212.69  |- skos__historyNote mesh__D008086 Ammonium Compounds %28%1969-1975%29%
% 212.53/212.69  |- skos__prefLabel mesh__D008086 Lissamine Green Dyes
% 212.53/212.69  |- skos__hiddenLabel mesh__D008086 Dyes, Lissamine Green
% 212.53/212.69  |- rdf__type mesh__D008086sskos__Concept
% 212.53/212.69  |- mesh__dateRevised mesh__D008086 2005-06-30
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D008086 2006
% 212.53/212.69  |- skos__broader mesh__D008086smesh__D001190
% 212.53/212.69  |- mesh__dateEstablished mesh__D008086 1991-01-01
% 212.53/212.69  |- mesh__dateCreated mesh__D008086 1975-07-18
% 212.53/212.69  |- mesh__historyNote mesh__D008086
% 212.53/212.69       91%28%76%29%; was see under AMMONIUM COMPOUNDS 1976-90   
% 212.53/212.69  |- mesh__recordAuthorizer mesh__D008086 sjn
% 212.53/212.69  |- mesh__publicMeSHNote mesh__D008086
% 212.53/212.69       91; was see under AMMONIUM COMPOUNDS 1976-90   
% 212.53/212.69  |- mesh__recordMaintainer mesh__D008086 ssb
% 212.53/212.69  |- skos__scopeNote mesh__D008086
% 212.53/212.69       Green dyes containing ammonium and aryl sulfonate moieties that facilitate the visualization of tissues, if given intravenously. They have mostly been used in the study of kidney physiology.%A%    
% 212.53/212.69  |- skos__hiddenLabel mesh__D008086 Green Dyes, Lissamine
% 212.53/212.69  |- skos__broader mesh__D008086smesh__D000644
% 212.53/212.69  |- mesh__recordOriginator mesh__D008086 SH
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D016518 2006
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Neurofibromatosis, Bilateral Acoustic
% 212.53/212.69  |- skos__historyNote mesh__D016518 Neurofibromatosis 1 %28%1966-1991%29%
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Acoustic Neurofibromatosis, Bilateral
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Neurofibromatosis IIs
% 212.53/212.69  |- skos__historyNote mesh__D016518 Neurilemmoma %28%1966-1976%29%
% 212.53/212.69  |- skos__broader mesh__D016518smesh__D009464
% 212.53/212.69  |- mesh__dateCreated mesh__D016518 1991-06-21
% 212.53/212.69  |- skos__altLabel mesh__D016518 Neurofibromatosis, Type II
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Type 2 Neurofibromatoses
% 212.53/212.69  |- skos__altLabel mesh__D016518 Neurofibromatosis, Central, NF 2
% 212.53/212.69  |- skos__altLabel mesh__D016518 NF2 %28%Neurofibromatosis 2%29%
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 2s, Neurofibromatosis Type
% 212.53/212.69  |- mesh__recordMaintainer mesh__D016518 sjn
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Central NF2 Neurofibromatoses
% 212.53/212.69  |- skos__altLabel mesh__D016518 Neurofibromatosis, Type 2
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Type 2, Neurofibromatosis
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 II, Neurofibromatosis
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Type II Neurofibromatoses
% 212.53/212.69  |- rdf__type mesh__D016518sskos__Concept
% 212.53/212.69  |- skos__related mesh__D016518smesh__D025581
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 2, Neurofibromatosis Type
% 212.53/212.69  |- mesh__dateRevised mesh__D016518 2003-07-25
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Neurofibromatosis Type 2s
% 212.53/212.69  |- skos__altLabel mesh__D016518 Neurofibromatosis Type 2
% 212.53/212.69  |- mesh__onlineNote mesh__D016518
% 212.53/212.69       use NEUROMA, ACOUSTIC to search NEUROFIBROMATOSIS, CENTRAL, NF-2 and NEUROMA, ACOUSTIC, BILATERAL 1989-91%A%  
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Neurofibromatosis Type IIs
% 212.53/212.69  |- skos__annotation mesh__D016518
% 212.53/212.69       do not confuse with NEUROFIBROMATOSIS 1; coord IM with precoord/neopl term %28%IM%29% if relevant%A%  
% 212.53/212.69  |- skos__related mesh__D016518smesh__D016515
% 212.53/212.69  |- skos__altLabel mesh__D016518 Neurofibromatosis, Central, NF2
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 IIs, Neurofibromatosis
% 212.53/212.69  |- skos__historyNote mesh__D016518 Neuroma, Acoustic %28%1978-1991%29%
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D016518 2004
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Type IIs, Neurofibromatosis
% 212.53/212.69  |- mesh__historyNote mesh__D016518
% 212.53/212.69       92; NEUROFIBROMATOSIS, CENTRAL, NF2 was NEUROFIBROMATOSIS, CENTRAL, NF-2 see NEUROMA, ACOUSTIC 1989-91; NEUROMA, ACOUSTIC, BILATERAL was see NEUROMA, ACOUSTIC 1989-91%A%  
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Neurofibromatoses, Type II
% 212.53/212.69  |- skos__altLabel mesh__D016518 Neurofibromatosis II
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Bilateral Acoustic Neurofibromatoses
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Type II, Neurofibromatosis
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Neuroma, Familial Acoustic
% 212.53/212.69  |- mesh__recordOriginator mesh__D016518 AGS
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Neuromas, Familial Acoustic
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Type 2 Neurofibromatosis
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 II Neurofibromatoses, Type
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Acoustic Neurofibromatoses, Bilateral
% 212.53/212.69  |- mesh__publicMeSHNote mesh__D016518
% 212.53/212.69       92; NEUROFIBROMATOSIS, CENTRAL, NF2 was NEUROFIBROMATOSIS, CENTRAL, NF-2 see NEUROMA, ACOUSTIC 1989-91; NEUROMA, ACOUSTIC, BILATERAL was see NEUROMA, ACOUSTIC 1989-91%A%  
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 IIs, Neurofibromatosis Type
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Acoustic Neuromas, Familial
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 2 Neurofibromatosis, Type
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Neurofibromatoses, Bilateral Acoustic
% 212.53/212.69  |- skos__altLabel mesh__D016518 Bilateral Acoustic Neurofibromatosis
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Central NF2 Neurofibromatosis
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Familial Acoustic Neuroma
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D016518 2005
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Neurofibromatoses, Type 2
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 2 Neurofibromatoses, Type
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 NF2s %28%Neurofibromatosis 2%29%
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Acoustic Neuroma, Familial
% 212.53/212.69  |- skos__broader mesh__D016518smesh__D017253
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Type 2s, Neurofibromatosis
% 212.53/212.69  |- mesh__dateEstablished mesh__D016518 1992-01-01
% 212.53/212.69  |- skos__altLabel mesh__D016518 Neurofibromatosis, Acoustic, Bilateral
% 212.53/212.69  |- skos__altLabel mesh__D016518 Neurofibromatosis, Central NF2
% 212.53/212.69  |- skos__altLabel mesh__D016518 Neurofibromatosis Type II
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Neurofibromatoses, Central NF2
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 II Neurofibromatosis, Type
% 212.53/212.69  |- skos__scopeNote mesh__D016518
% 212.53/212.69       An autosomal dominant disorder characterized by a high incidence of bilateral acoustic neuromas as well as schwannomas %28%NEURILEMMOMA%29% of other cranial and peripheral nerves, and other benign intracranial tumors including meningiomas, ependymomas, spinal neurofibromas, and gliomas. The disease has been linked to mutations of the NF2 gene %28%GENES, NEUROFIBROMATOSIS 2%29% on chromosome 22 %28%22q12%29% and usually presents clinically in the first or second decade of life.%A%    
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 II, Neurofibromatosis Type
% 212.53/212.69  |- skos__hiddenLabel mesh__D016518 Type II Neurofibromatosis
% 212.53/212.69  |- skos__prefLabel mesh__D016518 Neurofibromatosis 2
% 212.53/212.69  |- mesh__recordAuthorizer mesh__D016518 sjn
% 212.53/212.69  |- mesh__dateEstablished mesh__D013220 1991-01-01
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D013220 2006
% 212.53/212.69  |- mesh__onlineNote mesh__D013220
% 212.53/212.69       use STATE HEALTH PLANNING AND DEVELOPMENT AGENCIES to search HEALTH PLANNING AGENCIES, UNITED STATES 1980; use HEALTH SYSTEMS AGENCIES to search STATE HEALTH PLANNING AGENCIES, UNITED STATES 1979%A%  
% 212.53/212.69  |- skos__broader mesh__D013220smesh__D006288
% 212.53/212.69  |- mesh__recordMaintainer mesh__D013220 kle
% 212.53/212.69  |- skos__historyNote mesh__D013220
% 212.53/212.69       Regional Health Planning %28%1977-1979%29%
% 212.53/212.69  |- skos__prefLabel mesh__D013220
% 212.53/212.69       State Health Planning and Development Agencies
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D013220 2002
% 212.53/212.69  |- skos__altLabel mesh__D013220 State Health Planning, Development Agencies
% 212.53/212.69  |- skos__annotation mesh__D013220
% 212.53/212.69       U.S. only; Public Law 93-641; specify geog %26% add UNITED STATES also; DF: SHPDA%A%  
% 212.53/212.69  |- skos__scopeNote mesh__D013220
% 212.53/212.69       Agencies established under PL93-641 to coordinate, conduct, and implement state health planning activities. Two primary responsibilities are the preparation of an annual State Health Plan and giving assistance to the Statewide Health Coordinating Council.%A%    
% 212.53/212.69  |- skos__historyNote mesh__D013220 Health Planning %28%1968-1979%29%
% 212.53/212.69  |- mesh__recordOriginator mesh__D013220 EC
% 212.53/212.69  |- mesh__publicMeSHNote mesh__D013220
% 212.53/212.69       91; was see under HEALTH PLANNING ORGANIZATIONS 1980-90; STATE HEALTH PLANNING AGENCIES, UNITED STATES was see HEALTH SYSTEMS AGENCIES 1979%A%  
% 212.53/212.69  |- mesh__historyNote mesh__D013220
% 212.53/212.69       91%28%80%29%; was see under HEALTH PLANNING ORGANIZATIONS 1980-90; STATE HEALTH PLANNING AGENCIES, UNITED STATES was see HEALTH SYSTEMS AGENCIES 1979%A%  
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D013220 2003
% 212.53/212.69  |- mesh__dateRevised mesh__D013220 1999-11-03
% 212.53/212.69  |- mesh__dateCreated mesh__D013220 1979-05-31
% 212.53/212.69  |- mesh__recordAuthorizer mesh__D013220 sjn
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D013220 2005
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D013220 2000
% 212.53/212.69  |- rdf__type mesh__D013220sskos__Concept
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D013220 2004
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D013220 2001
% 212.53/212.69  |- skos__prefLabel mesh__D032983 Setaria Plant
% 212.53/212.69  |- skos__altLabel mesh__D032983 Italian Millet
% 212.53/212.69  |- skos__altLabel mesh__D032983 Bristlegrass
% 212.53/212.69  |- skos__broader mesh__D032983smesh__D006109
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D032983 2005
% 212.53/212.69  |- skos__altLabel mesh__D032983 Millet, Foxtail
% 212.53/212.69  |- mesh__dateEstablished mesh__D032983 2003-01-01
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D032983 2003
% 212.53/212.69  |- mesh__publicMeSHNote mesh__D032983
% 212.53/212.69       2003; for ITALIAN MILLET see PANICUM 1990-2002   
% 212.53/212.69  |- skos__scopeNote mesh__D032983
% 212.53/212.69       A plant genus of the family POACEAE. The small pointed seeds are grown for hay in North America and western Europe and important as food in China and other Asian countries.%A%    
% 212.53/212.69  |- skos__altLabel mesh__D032983 Millet, Italian
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D032983 2006
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D032983 2004
% 212.53/212.69  |- skos__historyNote mesh__D032983 Panicum %28%1990-2002%29%
% 212.53/212.69  |- skos__altLabel mesh__D032983 Millet, German
% 212.53/212.69  |- mesh__historyNote mesh__D032983
% 212.53/212.69       2003; for ITALIAN MILLET use PANICUM 1990-2002   
% 212.53/212.69  |- mesh__dateCreated mesh__D032983 2002-07-02
% 212.53/212.69  |- skos__annotation mesh__D032983
% 212.53/212.69       note X refs: other millet terms are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.53/212.69  |- skos__altLabel mesh__D032983 Chaetochloa italica
% 212.53/212.69  |- rdf__type mesh__D032983sskos__Concept
% 212.53/212.69  |- skos__prefLabel mesh__D004494 Education Department, Hospital
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D004494 1994
% 212.53/212.69  |- skos__hiddenLabel mesh__D004494 Departments, Hospital Education
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D004494 2000
% 212.53/212.69  |- skos__annotation mesh__D004494 DF: EDUC DEP   
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D004494 2005
% 212.53/212.69  |- skos__broader mesh__D004494smesh__D006748
% 212.53/212.69  |- skos__hiddenLabel mesh__D004494 Hospital Education Departments
% 212.53/212.69  |- rdf__type mesh__D004494sskos__Concept
% 212.53/212.69  |- mesh__dateRevised mesh__D004494 1992-05-15
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D004494 1999
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D004494 2003
% 212.53/212.69  |- skos__hiddenLabel mesh__D004494 Department, Hospital Education
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D004494 1997
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D004494 1998
% 212.53/212.69  |- mesh__dateCreated mesh__D004494 1981-02-26
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D004494 1996
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D004494 2002
% 212.53/212.69  |- skos__altLabel mesh__D004494 Hospital Education Department
% 212.53/212.69  |- mesh__dateEstablished mesh__D004494 1991-01-01
% 212.53/212.69  |- mesh__recordAuthorizer mesh__D004494 PLS
% 212.53/212.69  |- mesh__publicMeSHNote mesh__D004494
% 212.53/212.69       91; was see under HOSPITAL DEPARTMENTS 1982-90   
% 212.53/212.69  |- skos__scopeNote mesh__D004494
% 212.53/212.69       Hospital department responsible for administering educational and training activities pertaining to health for patients and staff.%A%    
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D004494 1995
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D004494 2006
% 212.53/212.69  |- skos__altLabel mesh__D004494 Education Departments, Hospital
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D004494 2004
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D004494 1993
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D004494 2001
% 212.53/212.69  |- mesh__historyNote mesh__D004494
% 212.53/212.69       91%28%82%29%; was see under HOSPITAL DEPARTMENTS 1982-90   
% 212.53/212.69  |- mesh__recordMaintainer mesh__D004494 TGC
% 212.53/212.69  |- mesh__recordOriginator mesh__D004494 EC
% 212.53/212.69  |- skos__broader mesh__D012926smesh__D012961
% 212.53/212.69  |- skos__hiddenLabel mesh__D012926 Formal Social Controls
% 212.53/212.69  |- skos__hiddenLabel mesh__D012926 Controls, Social
% 212.53/212.69  |- rdf__type mesh__D012926sskos__Concept
% 212.53/212.69  |- skos__hiddenLabel mesh__D012926 Social Controls
% 212.53/212.69  |- mesh__publicMeSHNote mesh__D012926 68   
% 212.53/212.69  |- skos__broader mesh__D012926smesh__D004472
% 212.53/212.69  |- skos__historyNote mesh__D012926
% 212.53/212.69       specific subject controlled %28%1966-1967%29%
% 212.53/212.69  |- skos__historyNote mesh__D012926 Legislation %28%1966-1967%29%
% 212.53/212.69  |- mesh__dateEstablished mesh__D012926 1968-01-01
% 212.53/212.69  |- mesh__dateRevised mesh__D012926 2002-07-03
% 212.53/212.69  |- mesh__dateCreated mesh__D012926 1999-01-01
% 212.53/212.69  |- mesh__recordAuthorizer mesh__D012926 sjn
% 212.53/212.69  |- skos__annotation mesh__D012926
% 212.53/212.69       X ref REGULATION: not for regulation in biological processes%A%  
% 212.53/212.69  |- skos__historyNote mesh__D012926 specific control %28%1966-1967%29%
% 212.53/212.69  |- skos__prefLabel mesh__D012926 Social Control, Formal
% 212.53/212.69  |- mesh__recordMaintainer mesh__D012926 tjk
% 212.53/212.69  |- skos__hiddenLabel mesh__D012926 Regulations
% 212.53/212.69  |- skos__scopeNote mesh__D012926
% 212.53/212.69       Control which is exerted by the more stable organizations of society, such as established institutions and the law. They are ordinarily embodied in definite codes, usually written.%A%    
% 212.53/212.69  |- skos__related mesh__D012926smesh__D011640
% 212.53/212.69  |- mesh__recordOriginator mesh__D012926 NLM
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D012926 2004
% 212.53/212.69  |- mesh__historyNote mesh__D012926 68   
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D012926 2006
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D012926 2003
% 212.53/212.69  |- skos__hiddenLabel mesh__D012926 Formal Social Control
% 212.53/212.69  |- skos__hiddenLabel mesh__D012926 Control, Social
% 212.53/212.69  |- mesh__activeMeSHYear mesh__D012926 2005
% 212.53/212.69  |- mesh__recordMaintainer mesh__D045302 SYSTEM
% 212.53/212.69  |- skos__scopeNote mesh__D045302
% 212.53/212.69       A genus of gram-negative, anaerobic, metal-reducing bacteria in the family Geobacteraceae. They have the ability to oxidize a variety of organic compounds, including AROMATIC HYDROCARBONS.%A%    
% 212.53/212.69  |- mesh__publicMeSHNote mesh__D045302 2004   
% 212.53/212.69  |- mesh__recordOriginator mesh__D045302 ags
% 212.53/212.70  |- mesh__historyNote mesh__D045302 2004   
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D045302 2006
% 212.53/212.70  |- skos__broader mesh__D045302smesh__D016965
% 212.53/212.70  |- mesh__dateEstablished mesh__D045302 2004-01-01
% 212.53/212.70  |- skos__prefLabel mesh__D045302 Geobacter
% 212.53/212.70  |- mesh__recordAuthorizer mesh__D045302 sjn
% 212.53/212.70  |- skos__broader mesh__D045302smesh__D020564
% 212.53/212.70  |- mesh__dateCreated mesh__D045302 2003-07-09
% 212.53/212.70  |- mesh__dateRevised mesh__D045302 2005-06-30
% 212.53/212.70  |- rdf__type mesh__D045302sskos__Concept
% 212.53/212.70  |- mesh__publicMeSHNote mesh__D012128 77   
% 212.53/212.70  |- mesh__recordAuthorizer mesh__D012128 sjn
% 212.53/212.70  |- skos__hiddenLabel mesh__D012128 Congestive Atelectasis
% 212.53/212.70  |- skos__hiddenLabel mesh__D012128 Human ARDS
% 212.53/212.70  |- skos__hiddenLabel mesh__D012128 Injury, Acute Lung
% 212.53/212.70  |- skos__hiddenLabel mesh__D012128 Lung, Shock
% 212.53/212.70  |- skos__scopeNote mesh__D012128
% 212.53/212.70       A syndrome of life-threatening progressive pulmonary insufficiency in the absence of known pulmonary disease, usually following a systemic insult such as SURGERY or major TRAUMA.%A%    
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012128 2004
% 212.53/212.70  |- skos__altLabel mesh__D012128 Respiratory Distress Syndrome, Acute
% 212.53/212.70  |- mesh__recordOriginator mesh__D012128 VDK
% 212.53/212.70  |- skos__altLabel mesh__D012128 Acute Respiratory Distress Syndrome
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012128 2005
% 212.53/212.70  |- skos__altLabel mesh__D012128 Lung Injury, Acute
% 212.53/212.70  |- skos__altLabel mesh__D012128 Adult Respiratory Distress Syndrome
% 212.53/212.70  |- skos__broader mesh__D012128smesh__D012120
% 212.53/212.70  |- skos__broader mesh__D012128smesh__D008171
% 212.53/212.70  |- mesh__dateCreated mesh__D012128 1976-05-19
% 212.53/212.70  |- mesh__historyNote mesh__D012128 77   
% 212.53/212.70  |- rdf__type mesh__D012128sskos__Concept
% 212.53/212.70  |- skos__hiddenLabel mesh__D012128 Atelectases, Congestive
% 212.53/212.70  |- skos__altLabel mesh__D012128 ARDS, Human
% 212.53/212.70  |- mesh__recordMaintainer mesh__D012128 ags
% 212.53/212.70  |- skos__altLabel mesh__D012128 Shock Lung
% 212.53/212.70  |- skos__hiddenLabel mesh__D012128 ARDSs, Human
% 212.53/212.70  |- skos__hiddenLabel mesh__D012128 Lung Injuries, Acute
% 212.53/212.70  |- skos__hiddenLabel mesh__D012128 Congestive Atelectases
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012128 2006
% 212.53/212.70  |- skos__prefLabel mesh__D012128 Respiratory Distress Syndrome, Adult
% 212.53/212.70  |- mesh__dateRevised mesh__D012128 2003-07-09
% 212.53/212.70  |- mesh__dateEstablished mesh__D012128 1977-01-01
% 212.53/212.70  |- skos__annotation mesh__D012128
% 212.53/212.70       RESPIRATORY DISTRESS SYNDROME, NEWBORN is also available; do not confuse with SEVERE ACUTE RESPIRATORY SYNDROME%A%  
% 212.53/212.70  |- skos__hiddenLabel mesh__D012128 Acute Lung Injuries
% 212.53/212.70  |- skos__hiddenLabel mesh__D012128 Injuries, Acute Lung
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017611 2003
% 212.53/212.70  |- skos__annotation mesh__D017611
% 212.53/212.70       inorganic; GEN or unspecified; prefer specifics; DF: FLUORINE CPDS%A%  
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017611 2005
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017611 2004
% 212.53/212.70  |- skos__scopeNote mesh__D017611
% 212.53/212.70       Inorganic compounds that contain fluorine as an integral part of the molecule.%A%    
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017611 1996
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017611 2002
% 212.53/212.70  |- mesh__dateCreated mesh__D017611 1993-06-04
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017611 2006
% 212.53/212.70  |- rdf__type mesh__D017611sskos__Concept
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017611 1998
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017611 1997
% 212.53/212.70  |- skos__hiddenLabel mesh__D017611 Compounds, Fluorine
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017611 1994
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017611 1999
% 212.53/212.70  |- skos__historyNote mesh__D017611 Fluorine %28%1966-1993%29%
% 212.53/212.70  |- mesh__dateEstablished mesh__D017611 1994-01-01
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017611 1995
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017611 2000
% 212.53/212.70  |- mesh__publicMeSHNote mesh__D017611 94   
% 212.53/212.70  |- skos__broader mesh__D017611smesh__D007287
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017611 2001
% 212.53/212.70  |- mesh__historyNote mesh__D017611 94   
% 212.53/212.70  |- skos__prefLabel mesh__D017611 Fluorine Compounds
% 212.53/212.70  |- mesh__recordAuthorizer mesh__D008885 PLS
% 212.53/212.70  |- rdf__type mesh__D008885sskos__Concept
% 212.53/212.70  |- mesh__publicMeSHNote mesh__D008885 65   
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D008885 2000
% 212.53/212.70  |- mesh__recordOriginator mesh__D008885 NLM
% 212.53/212.70  |- mesh__dateRevised mesh__D008885 1992-05-15
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D008885 2001
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D008885 1997
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D008885 1994
% 212.53/212.70  |- skos__broader mesh__D008885smesh__D003813
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D008885 2005
% 212.53/212.70  |- mesh__recordMaintainer mesh__D008885 TAP
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D008885 1995
% 212.53/212.70  |- mesh__historyNote mesh__D008885 65   
% 212.53/212.70  |- skos__altLabel mesh__D008885 Dentistry, Military
% 212.53/212.70  |- skos__hiddenLabel mesh__D008885 Military Dentistries
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D008885 1998
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D008885 2006
% 212.53/212.70  |- mesh__dateEstablished mesh__D008885 1965-01-01
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D008885 2002
% 212.53/212.70  |- skos__scopeNote mesh__D008885
% 212.53/212.70       The practice of dentistry as applied to special circumstances associated with military operations.%A%    
% 212.53/212.70  |- mesh__dateCreated mesh__D008885 1999-01-01
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D008885 1999
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D008885 2003
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D008885 1993
% 212.53/212.70  |- skos__prefLabel mesh__D008885 Military Dentistry
% 212.53/212.70  |- skos__annotation mesh__D008885
% 212.53/212.70       SPEC: SPEC qualif; specify country; DF: MILITARY DENT   
% 212.53/212.70  |- skos__hiddenLabel mesh__D008885 Dentistries, Military
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D008885 1996
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D008885 2004
% 212.53/212.70  |- skos__historyNote mesh__D008087 Corynebacteriaceae %28%1975%29%
% 212.53/212.70  |- rdf__type mesh__D008087sskos__Concept
% 212.53/212.70  |- mesh__dateCreated mesh__D008087 1975-07-23
% 212.53/212.70  |- skos__scopeNote mesh__D008087
% 212.53/212.70       A genus of bacteria which may be found in the feces of animals and man, on vegetation, and in silage. Its species are parasitic on cold-blooded and warm-blooded animals, including man.%A%    
% 212.53/212.70  |- mesh__dateEstablished mesh__D008087 1976-01-01
% 212.53/212.70  |- skos__historyNote mesh__D008087 Bacteria %28%1966-1974%29%
% 212.53/212.70  |- mesh__recordOriginator mesh__D008087 JW
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D008087 2006
% 212.53/212.70  |- skos__prefLabel mesh__D008087 Listeria
% 212.53/212.70  |- mesh__dateRevised mesh__D008087 2005-06-30
% 212.53/212.70  |- skos__broader mesh__D008087smesh__D016989
% 212.53/212.70  |- mesh__historyNote mesh__D008087 76   
% 212.53/212.70  |- skos__annotation mesh__D008087 in feces, on plants, in silage   
% 212.53/212.70  |- mesh__recordMaintainer mesh__D008087 SYSTEM
% 212.53/212.70  |- mesh__publicMeSHNote mesh__D008087 76   
% 212.53/212.70  |- mesh__recordAuthorizer mesh__D008087 sjn
% 212.53/212.70  |- skos__altLabel mesh__D016519 Religious Hospitals
% 212.53/212.70  |- mesh__publicMeSHNote mesh__D016519
% 212.53/212.70       92; was see HOSPITALS, PRIVATE 1991   
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D016519 2002
% 212.53/212.70  |- skos__scopeNote mesh__D016519
% 212.53/212.70       Private hospitals that are owned or sponsored by religious organizations.%A%    
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D016519 2004
% 212.53/212.70  |- mesh__recordOriginator mesh__D016519 JHM
% 212.53/212.70  |- skos__prefLabel mesh__D016519 Hospitals, Religious
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D016519 2005
% 212.53/212.70  |- skos__broader mesh__D016519smesh__D016304
% 212.53/212.70  |- skos__historyNote mesh__D016519 Hospitals, Voluntary %28%1985-1990%29%
% 212.53/212.70  |- mesh__dateCreated mesh__D016519 1991-02-11
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D016519 2006
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D016519 2000
% 212.53/212.70  |- skos__historyNote mesh__D016519 Hospitals, Private %28%1991%29%
% 212.53/212.70  |- mesh__dateRevised mesh__D016519 1999-11-03
% 212.53/212.70  |- mesh__recordAuthorizer mesh__D016519 sjn
% 212.53/212.70  |- skos__hiddenLabel mesh__D016519 Hospital, Religious
% 212.53/212.70  |- rdf__type mesh__D016519sskos__Concept
% 212.53/212.70  |- skos__hiddenLabel mesh__D016519 Religious Hospital
% 212.53/212.70  |- skos__annotation mesh__D016519
% 212.53/212.70       coord IM with specific religion or religious group %28%NIM%29% or with special hosp %28%e.g., HOSPITALS, CHRONIC DISEASE%29% or med specialty %28%IM%29%; specify geog%A%  
% 212.53/212.70  |- mesh__dateEstablished mesh__D016519 1992-01-01
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D016519 2001
% 212.53/212.70  |- mesh__historyNote mesh__D016519 92; was see HOSPITALS, PRIVATE 1991   
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D016519 2003
% 212.53/212.70  |- mesh__recordMaintainer mesh__D016519 kle
% 212.53/212.70  |- mesh__onlineNote mesh__D016519
% 212.53/212.70       use HOSPITALS, PRIVATE to search HOSPITALS, RELIGIOUS 1991%A%  
% 212.53/212.70  |- mesh__publicMeSHNote mesh__D027241 2002   
% 212.53/212.70  |- rdf__type mesh__D027241sskos__Concept
% 212.53/212.70  |- skos__broader mesh__D027241smesh__D026923
% 212.53/212.70  |- skos__hiddenLabel mesh__D027241 y+L Transporter, System
% 212.53/212.70  |- mesh__dateRevised mesh__D027241 2005-06-30
% 212.53/212.70  |- mesh__recordAuthorizer mesh__D027241 sjn
% 212.53/212.70  |- skos__scopeNote mesh__D027241
% 212.53/212.70       A leucine-sensitive amino acid transport system with high affinity for basic amino acids%28% AMINO ACIDS, BASIC%29%.%A%    
% 212.53/212.70  |- skos__hiddenLabel mesh__D027241 Transporter, System y+L
% 212.53/212.70  |- mesh__dateCreated mesh__D027241 2001-07-25
% 212.53/212.70  |- mesh__dateEstablished mesh__D027241 2002-01-01
% 212.53/212.70  |- skos__historyNote mesh__D027241 Amino Acids/metabolism %28%1992-2001%29%
% 212.53/212.70  |- mesh__recordOriginator mesh__D027241 jmp
% 212.53/212.70  |- skos__altLabel mesh__D027241 System y+L Transporter
% 212.53/212.70  |- skos__prefLabel mesh__D027241 Amino Acid Transport System y+L
% 212.53/212.70  |- skos__altLabel mesh__D027241 Amino Acid Transport System yPlus L
% 212.53/212.70  |- mesh__recordMaintainer mesh__D027241 SYSTEM
% 212.53/212.70  |- mesh__historyNote mesh__D027241 2002   
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D027241 2006
% 212.53/212.70  |- mesh__dateRevised mesh__D013221 1999-11-03
% 212.53/212.70  |- skos__hiddenLabel mesh__D013221 Plan, State Health
% 212.53/212.70  |- mesh__dateCreated mesh__D013221 1979-06-01
% 212.53/212.70  |- mesh__recordAuthorizer mesh__D013221 sjn
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D013221 2000
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D013221 2003
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D013221 2001
% 212.53/212.70  |- skos__annotation mesh__D013221
% 212.53/212.70       Public Law 93-641; specify geog %26% add UNITED STATES also   
% 212.53/212.70  |- skos__hiddenLabel mesh__D013221 State Health Plan
% 212.53/212.70  |- skos__hiddenLabel mesh__D013221 Health Plans, State
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D013221 2005
% 212.53/212.70  |- rdf__type mesh__D013221sskos__Concept
% 212.53/212.70  |- skos__prefLabel mesh__D013221 State Health Plans
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D013221 2004
% 212.53/212.70  |- mesh__publicMeSHNote mesh__D013221 80   
% 212.53/212.70  |- mesh__recordMaintainer mesh__D013221 kle
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D013221 2006
% 212.53/212.70  |- mesh__dateEstablished mesh__D013221 1980-01-01
% 212.53/212.70  |- mesh__historyNote mesh__D013221 80   
% 212.53/212.70  |- mesh__recordOriginator mesh__D013221 EC
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D013221 2002
% 212.53/212.70  |- skos__broader mesh__D013221smesh__D012040
% 212.53/212.70  |- skos__scopeNote mesh__D013221
% 212.53/212.70       State plans prepared by the State Health Planning and Development Agencies which are made up from plans submitted by the Health Systems Agencies and subject to review and revision by the Statewide Health Coordinating Council.%A%    
% 212.53/212.70  |- skos__hiddenLabel mesh__D013221 Plans, State Health
% 212.53/212.70  |- skos__hiddenLabel mesh__D013221 Health Plan, State
% 212.53/212.70  |- skos__related mesh__D032984smesh__D012106
% 212.53/212.70  |- skos__scopeNote mesh__D032984
% 212.53/212.70       The moral obligations governing the conduct of research.  Used for discussions of research ethics as a general topic.%A%    
% 212.53/212.70  |- skos__altLabel mesh__D032984 Research Ethics
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D032984 2005
% 212.53/212.70  |- skos__related mesh__D032984smesh__D032761
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D032984 2003
% 212.53/212.70  |- mesh__historyNote mesh__D032984 2003; use ETHICS 2002   
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D032984 2006
% 212.53/212.70  |- skos__related mesh__D032984smesh__D033042
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D032984 2004
% 212.53/212.70  |- skos__related mesh__D032984smesh__D033041
% 212.53/212.70  |- mesh__dateCreated mesh__D032984 2002-07-03
% 212.53/212.70  |- skos__prefLabel mesh__D032984 Ethics, Research
% 212.53/212.70  |- mesh__dateEstablished mesh__D032984 2003-01-01
% 212.53/212.70  |- skos__related mesh__D032984smesh__D006805
% 212.53/212.70  |- mesh__publicMeSHNote mesh__D032984 2003; see ETHICS 2002   
% 212.53/212.70  |- rdf__type mesh__D032984sskos__Concept
% 212.53/212.70  |- skos__annotation mesh__D032984
% 212.53/212.70       do not use routinely for ethical issues in research, for which prefer specific topics; reserve for discussions of research ethics as a topic in its own right%A%  
% 212.53/212.70  |- skos__broader mesh__D032984smesh__D004989
% 212.53/212.70  |- mesh__recordOriginator mesh__D051340 DRC
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D051340 2006
% 212.53/212.70  |- mesh__publicMeSHNote mesh__D051340
% 212.53/212.70       2006; COFILIN 2 was indexed under MICROFILAMENT PROTEINS 2001-2005%A%  
% 212.53/212.70  |- skos__scopeNote mesh__D051340
% 212.53/212.70       A member of the cofilin family of proteins that is expressed in MUSCLE CELLS.  It has ACTIN depolymerization activity that is dependent on HYDROGEN-ION CONCENTRATION.%A%    
% 212.53/212.70  |- mesh__historyNote mesh__D051340 2006%28%2001%29%   
% 212.53/212.70  |- skos__broader mesh__D051340smesh__D009124
% 212.53/212.70  |- skos__hiddenLabel mesh__D051340 Cofilin, Muscle
% 212.53/212.70  |- skos__altLabel mesh__D051340 CFL2 Protein
% 212.53/212.70  |- mesh__dateCreated mesh__D051340 2005-06-30
% 212.53/212.70  |- mesh__recordMaintainer mesh__D051340 DRC
% 212.53/212.70  |- skos__altLabel mesh__D051340 Cofilin-2
% 212.53/212.70  |- skos__altLabel mesh__D051340 Muscle Cofilin
% 212.53/212.70  |- skos__altLabel mesh__D051340 M-Cofilin
% 212.53/212.70  |- skos__prefLabel mesh__D051340 Cofilin 2
% 212.53/212.70  |- mesh__recordAuthorizer mesh__D051340 sjn
% 212.53/212.70  |- rdf__type mesh__D051340sskos__Concept
% 212.53/212.70  |- mesh__dateEstablished mesh__D051340 2006-01-01
% 212.53/212.70  |- skos__broader mesh__D051340smesh__D051339
% 212.53/212.70  |- mesh__recordAuthorizer mesh__D004495 sjn
% 212.53/212.70  |- mesh__dateEstablished mesh__D004495 1967-01-01
% 212.53/212.70  |- rdf__type mesh__D004495sskos__Concept
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D004495 2001
% 212.53/212.70  |- mesh__publicMeSHNote mesh__D004495
% 212.53/212.70       67; was EDUCATION OF MENTALLY DEFECTIVE 1963-66   
% 212.53/212.70  |- skos__scopeNote mesh__D004495
% 212.53/212.70       The teaching or training of those individuals with subnormal intellectual functioning.%A%    
% 212.53/212.70  |- skos__altLabel mesh__D004495 Mentally Retarded Education
% 212.53/212.70  |- skos__hiddenLabel mesh__D004495 Mentally Defective Education
% 212.53/212.70  |- mesh__onlineNote mesh__D004495
% 212.53/212.70       use EDUCATION OF MENTALLY RETARDED to search EDUCATION OF MENTALLY DEFECTIVE 1966%A%  
% 212.53/212.70  |- skos__annotation mesh__D004495 IM   
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D004495 2000
% 212.53/212.70  |- mesh__historyNote mesh__D004495
% 212.53/212.70       67; was EDUCATION OF MENTALLY DEFECTIVE 1963-66   
% 212.53/212.70  |- skos__altLabel mesh__D004495 Education of Mentally Defective
% 212.53/212.70  |- mesh__dateRevised mesh__D004495 1999-11-03
% 212.53/212.70  |- mesh__recordOriginator mesh__D004495 NLM
% 212.53/212.70  |- skos__broader mesh__D004495smesh__D011588
% 212.53/212.70  |- skos__prefLabel mesh__D004495 Education of Mentally Retarded
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D004495 2006
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D004495 2002
% 212.53/212.70  |- skos__broader mesh__D004495smesh__D004519
% 212.53/212.70  |- mesh__dateCreated mesh__D004495 1999-01-01
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D004495 2005
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D004495 2004
% 212.53/212.70  |- mesh__recordMaintainer mesh__D004495 kle
% 212.53/212.70  |- skos__altLabel mesh__D004495 Education, Mentally Retarded
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D004495 2003
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012927 2000
% 212.53/212.70  |- mesh__recordMaintainer mesh__D012927 PLS
% 212.53/212.70  |- mesh__recordAuthorizer mesh__D012927 PLS
% 212.53/212.70  |- rdf__type mesh__D012927sskos__Concept
% 212.53/212.70  |- mesh__recordOriginator mesh__D012927 NLM
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012927 2001
% 212.53/212.70  |- mesh__historyNote mesh__D012927 68   
% 212.53/212.70  |- mesh__publicMeSHNote mesh__D012927 68   
% 212.53/212.70  |- skos__hiddenLabel mesh__D012927 Controls, Informal Social
% 212.53/212.70  |- skos__hiddenLabel mesh__D012927 Social Controls, Informal
% 212.53/212.70  |- skos__prefLabel mesh__D012927 Social Control, Informal
% 212.53/212.70  |- skos__hiddenLabel mesh__D012927 Control, Informal Social
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012927 2003
% 212.53/212.70  |- mesh__dateRevised mesh__D012927 1996-03-18
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012927 1996
% 212.53/212.70  |- skos__hiddenLabel mesh__D012927 Informal Social Controls
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012927 2002
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012927 2005
% 212.53/212.70  |- skos__hiddenLabel mesh__D012927 Regulation, Self
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012927 1998
% 212.53/212.70  |- skos__broader mesh__D012927smesh__D012961
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012927 2004
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012927 1997
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012927 2006
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012927 1999
% 212.53/212.70  |- skos__scopeNote mesh__D012927
% 212.53/212.70       Those forms of control which are exerted in less concrete and tangible ways, as through folkways, mores, conventions, and public sentiment.%A%    
% 212.53/212.70  |- mesh__dateEstablished mesh__D012927 1968-01-01
% 212.53/212.70  |- mesh__dateCreated mesh__D012927 1999-01-01
% 212.53/212.70  |- skos__hiddenLabel mesh__D012927 Regulations, Self
% 212.53/212.70  |- skos__hiddenLabel mesh__D012927 Self Regulations
% 212.53/212.70  |- skos__altLabel mesh__D012927 Self Regulation
% 212.53/212.70  |- skos__altLabel mesh__D012927 Informal Social Control
% 212.53/212.70  |- skos__historyNote mesh__D045303 Cytochromes %28%1966-1982%29%
% 212.53/212.70  |- skos__broader mesh__D045303smesh__D003573
% 212.53/212.70  |- skos__scopeNote mesh__D045303
% 212.53/212.70       Cytochromes of the b group that have alpha-band absorption of 563-564 nm. They occur as subunits in MITOCHONDRIAL ELECTRON TRANSPORT COMPLEX III.%A%    
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D045303 2006
% 212.53/212.70  |- skos__prefLabel mesh__D045303 Cytochromes b
% 212.53/212.70  |- mesh__recordOriginator mesh__D045303 jmp
% 212.53/212.70  |- mesh__publicMeSHNote mesh__D045303
% 212.53/212.70       2004; see CYTOCHROME B GROUP 1983-2003; APOCYTOCHROME B was indexed under APOPROTEINS %26% CYTOCHROME B 1983-2003 %26% under CYTOCHROMES 1979-1982%A%  
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D045303 2004
% 212.53/212.70  |- skos__annotation mesh__D045303 do not confuse with CYTOCHROME B GROUP   
% 212.53/212.70  |- mesh__historyNote mesh__D045303
% 212.53/212.70       2004; use CYTOCHROME B GROUP 1983-2003; for APOCYTOCHROME B use CYTOCHROMES B %28%NM%29% 1980-2002%A%  
% 212.53/212.70  |- skos__altLabel mesh__D045303 Cytochrome b
% 212.53/212.70  |- mesh__dateEstablished mesh__D045303 2004-01-01
% 212.53/212.70  |- mesh__dateCreated mesh__D045303 2003-07-09
% 212.53/212.70  |- mesh__recordAuthorizer mesh__D045303 sjn
% 212.53/212.70  |- rdf__type mesh__D045303sskos__Concept
% 212.53/212.70  |- mesh__recordMaintainer mesh__D045303 jmp
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D045303 2005
% 212.53/212.70  |- skos__historyNote mesh__D045303 Cytochrome b Group %28%1983-2003%29%
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D009180 2001
% 212.53/212.70  |- rdf__type mesh__D009180sskos__Concept
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D009180 2003
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D009180 1995
% 212.53/212.70  |- mesh__dateRevised mesh__D009180 1993-06-02
% 212.53/212.70  |- skos__hiddenLabel mesh__D009180 Infection, Mycoplasmatales
% 212.53/212.70  |- mesh__publicMeSHNote mesh__D009180 77   
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D009180 2000
% 212.53/212.70  |- skos__hiddenLabel mesh__D009180 Mycoplasmatales Infection
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D009180 1999
% 212.53/212.70  |- mesh__dateCreated mesh__D009180 1976-04-27
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D009180 1994
% 212.53/212.70  |- skos__annotation mesh__D009180 gram-neg bact infect   
% 212.53/212.70  |- mesh__dateEstablished mesh__D009180 1977-01-01
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D009180 1997
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D009180 1998
% 212.53/212.70  |- mesh__recordAuthorizer mesh__D009180 PLS
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D009180 2002
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D009180 1996
% 212.53/212.70  |- skos__scopeNote mesh__D009180
% 212.53/212.70       Infections with bacteria of the order MYCOPLASMATALES.     
% 212.53/212.70  |- skos__altLabel mesh__D009180 Infections, Mycoplasmatales
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D009180 2006
% 212.53/212.70  |- mesh__historyNote mesh__D009180 77   
% 212.53/212.70  |- skos__historyNote mesh__D009180 Bacterial Infections %28%1970-1976%29%
% 212.53/212.70  |- mesh__recordMaintainer mesh__D009180 TAP
% 212.53/212.70  |- skos__prefLabel mesh__D009180 Mycoplasmatales Infections
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D009180 2004
% 212.53/212.70  |- skos__broader mesh__D009180smesh__D016905
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D009180 2005
% 212.53/212.70  |- mesh__recordOriginator mesh__D009180 FPG
% 212.53/212.70  |- skos__hiddenLabel mesh__D012129 Function Tests, Lung
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012129 2002
% 212.53/212.70  |- skos__annotation mesh__D012129
% 212.53/212.70       GEN or unspecified; prefer specifics; NIM   
% 212.53/212.70  |- skos__altLabel mesh__D012129 Function Test, Pulmonary
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012129 2005
% 212.53/212.70  |- mesh__recordOriginator mesh__D012129 NLM
% 212.53/212.70  |- skos__altLabel mesh__D012129 Test, Pulmonary Function
% 212.53/212.70  |- mesh__recordMaintainer mesh__D012129 PXP
% 212.53/212.70  |- rdf__type mesh__D012129sskos__Concept
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012129 2006
% 212.53/212.70  |- skos__hiddenLabel mesh__D012129 Test, Lung Function
% 212.53/212.70  |- skos__hiddenLabel mesh__D012129 Respiratory Function Test
% 212.53/212.70  |- skos__hiddenLabel mesh__D012129 Tests, Respiratory Function
% 212.53/212.70  |- mesh__recordAuthorizer mesh__D012129 SJN
% 212.53/212.70  |- mesh__dateRevised mesh__D012129 1997-06-20
% 212.53/212.70  |- skos__broader mesh__D012129smesh__D003948
% 212.53/212.70  |- skos__scopeNote mesh__D012129
% 212.53/212.70       Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc.%A%    
% 212.53/212.70  |- skos__hiddenLabel mesh__D012129 Function Test, Lung
% 212.53/212.70  |- skos__altLabel mesh__D012129 Pulmonary Function Test
% 212.53/212.70  |- skos__altLabel mesh__D012129 Function Tests, Pulmonary
% 212.53/212.70  |- skos__altLabel mesh__D012129 Lung Function Tests
% 212.53/212.70  |- skos__hiddenLabel mesh__D012129 Tests, Lung Function
% 212.53/212.70  |- mesh__dateCreated mesh__D012129 1999-01-01
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012129 2000
% 212.53/212.70  |- skos__hiddenLabel mesh__D012129 Test, Respiratory Function
% 212.53/212.70  |- skos__altLabel mesh__D012129 Tests, Pulmonary Function
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012129 2003
% 212.53/212.70  |- skos__hiddenLabel mesh__D012129 Function Test, Respiratory
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012129 1998
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012129 2001
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012129 2004
% 212.53/212.70  |- skos__prefLabel mesh__D012129 Respiratory Function Tests
% 212.53/212.70  |- skos__hiddenLabel mesh__D012129 Lung Function Test
% 212.53/212.70  |- skos__hiddenLabel mesh__D012129 Function Tests, Respiratory
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D012129 1999
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017612 2005
% 212.53/212.70  |- skos__historyNote mesh__D017612 Gold %28%1966-1993%29%
% 212.53/212.70  |- mesh__publicMeSHNote mesh__D017612 94   
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017612 2004
% 212.53/212.70  |- skos__broader mesh__D017612smesh__D007287
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017612 1996
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017612 2001
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017612 2006
% 212.53/212.70  |- rdf__type mesh__D017612sskos__Concept
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017612 1998
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017612 1997
% 212.53/212.70  |- skos__annotation mesh__D017612
% 212.53/212.70       inorganic; GEN or unspecified; prefer specifics; DF: GOLD CPDS%A%  
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017612 1994
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017612 1999
% 212.53/212.70  |- skos__prefLabel mesh__D017612 Gold Compounds
% 212.53/212.70  |- skos__scopeNote mesh__D017612
% 212.53/212.70       Inorganic compounds that contain gold as an integral part of the molecule.%A%    
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017612 1995
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017612 2002
% 212.53/212.70  |- mesh__dateCreated mesh__D017612 1993-06-04
% 212.53/212.70  |- skos__hiddenLabel mesh__D017612 Compounds, Gold
% 212.53/212.70  |- mesh__historyNote mesh__D017612 94   
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017612 2003
% 212.53/212.70  |- mesh__dateEstablished mesh__D017612 1994-01-01
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D017612 2000
% 212.53/212.70  |- mesh__recordAuthorizer mesh__D008886 PLS
% 212.53/212.70  |- skos__hiddenLabel mesh__D008886 Hygienes, Military
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D008886 2000
% 212.53/212.70  |- skos__hiddenLabel mesh__D008886 Military Hygienes
% 212.53/212.70  |- mesh__dateCreated mesh__D008886 1999-01-01
% 212.53/212.70  |- skos__annotation mesh__D008886 SPEC: SPEC qualif; specify country   
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D008886 2003
% 212.53/212.70  |- mesh__activeMeSHYear mesh__D008886 1998
% 212.53/212.70  |- mesh__dateRevised mesh__D008886 1992-05-15
% 212.56/212.70  |- mesh__activeMeSHYear mesh__D008886 1997
% 212.56/212.70  |- rdf__type mesh__D008886sskos__Concept
% 212.56/212.70  |- mesh__activeMeSHYear mesh__D008886 1996
% 212.56/212.70  |- mesh__activeMeSHYear mesh__D008886 2002
% 212.56/212.70  |- mesh__recordOriginator mesh__D008886 NLM
% 212.56/212.70  |- mesh__activeMeSHYear mesh__D008886 1995
% 212.56/212.70  |- mesh__recordMaintainer mesh__D008886 TAP
% 212.56/212.70  |- skos__broader mesh__D008886smesh__D006920
% 212.56/212.70  |- mesh__activeMeSHYear mesh__D008886 2006
% 212.56/212.70  |- mesh__activeMeSHYear mesh__D008886 1993
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008886 1994
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008886 2001
% 212.56/212.71  |- skos__hiddenLabel mesh__D008886 Hygiene, Military
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008886 2005
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008886 2004
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008886 1999
% 212.56/212.71  |- skos__prefLabel mesh__D008886 Military Hygiene
% 212.56/212.71  |- skos__broader mesh__D008088smesh__D016908
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008088 1998
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008088 2005
% 212.56/212.71  |- skos__hiddenLabel mesh__D008088 Infection, Listeria
% 212.56/212.71  |- skos__annotation mesh__D008088
% 212.56/212.71       gram-pos bact infect; Listeria monocytogenes infection = LISTERIA INFECTIONS %26% do not bother to coord with LISTERIA MONOCYTOGENES; MENINGITIS, LISTERIA is available%A%  
% 212.56/212.71  |- mesh__recordOriginator mesh__D008088 NLM
% 212.56/212.71  |- skos__hiddenLabel mesh__D008088 Listeria Infection
% 212.56/212.71  |- skos__altLabel mesh__D008088 Infections, Listeria
% 212.56/212.71  |- mesh__dateCreated mesh__D008088 1999-01-01
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008088 2002
% 212.56/212.71  |- skos__prefLabel mesh__D008088 Listeria Infections
% 212.56/212.71  |- rdf__type mesh__D008088sskos__Concept
% 212.56/212.71  |- skos__scopeNote mesh__D008088
% 212.56/212.71       Infections with bacteria of the genus LISTERIA.     
% 212.56/212.71  |- mesh__recordMaintainer mesh__D008088 TGC
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008088 2001
% 212.56/212.71  |- mesh__dateRevised mesh__D008088 1996-06-10
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008088 1997
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008088 2004
% 212.56/212.71  |- mesh__recordAuthorizer mesh__D008088 PLS
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008088 2000
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008088 1999
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008088 2006
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008088 2003
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D013222 2002
% 212.56/212.71  |- skos__altLabel mesh__D013222 Medicine, Socialized
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D013222 2003
% 212.56/212.71  |- mesh__dateRevised mesh__D013222 1999-11-03
% 212.56/212.71  |- rdf__type mesh__D013222sskos__Concept
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D013222 2005
% 212.56/212.71  |- skos__annotation mesh__D013222
% 212.56/212.71       not for med programs of individual states; compulsory system of personal med care under control of a natl govt paying physicians out of public funds; compulsory: do not confuse with NATIONAL HEALTH PROGRAMS; specify country, even GREAT BRITAIN despite X ref below; DF: STATE MED%A%  
% 212.56/212.71  |- skos__scopeNote mesh__D013222
% 212.56/212.71       A system of medical care regulated, controlled and financed by the government, in which the government assumes responsibility for the health needs of the population.%A%    
% 212.56/212.71  |- skos__broader mesh__D013222smesh__D004472
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D013222 2004
% 212.56/212.71  |- mesh__recordAuthorizer mesh__D013222 sjn
% 212.56/212.71  |- skos__altLabel mesh__D013222 Medicine, State
% 212.56/212.71  |- skos__altLabel mesh__D013222 British National Health Service
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D013222 2006
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D013222 2000
% 212.56/212.71  |- mesh__dateCreated mesh__D013222 1999-01-01
% 212.56/212.71  |- mesh__recordOriginator mesh__D013222 NLM
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D013222 2001
% 212.56/212.71  |- skos__altLabel mesh__D013222 British Health Service, National
% 212.56/212.71  |- skos__altLabel mesh__D013222 Service, British National Health
% 212.56/212.71  |- mesh__recordMaintainer mesh__D013222 kle
% 212.56/212.71  |- skos__prefLabel mesh__D013222 State Medicine
% 212.56/212.71  |- skos__altLabel mesh__D013222 Socialized Medicine
% 212.56/212.71  |- skos__related mesh__D051341smesh__D051346
% 212.56/212.71  |- skos__prefLabel mesh__D051341 Dependent Ambulation
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D051341 2006
% 212.56/212.71  |- mesh__historyNote mesh__D051341 2006   
% 212.56/212.71  |- skos__scopeNote mesh__D051341
% 212.56/212.71       To move about or walk on foot with the use of aids.     
% 212.56/212.71  |- skos__broader mesh__D051341smesh__D016138
% 212.56/212.71  |- mesh__recordOriginator mesh__D051341 lkt
% 212.56/212.71  |- mesh__dateCreated mesh__D051341 2005-06-30
% 212.56/212.71  |- mesh__recordAuthorizer mesh__D051341 sjn
% 212.56/212.71  |- mesh__publicMeSHNote mesh__D051341 2006   
% 212.56/212.71  |- rdf__type mesh__D051341sskos__Concept
% 212.56/212.71  |- mesh__recordMaintainer mesh__D051341 lkt
% 212.56/212.71  |- skos__hiddenLabel mesh__D051341 Ambulation, Dependent
% 212.56/212.71  |- mesh__dateEstablished mesh__D051341 2006-01-01
% 212.56/212.71  |- skos__altLabel mesh__D004496 Continuing Education
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D004496 2002
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D004496 2006
% 212.56/212.71  |- mesh__recordMaintainer mesh__D004496 kle
% 212.56/212.71  |- mesh__recordAuthorizer mesh__D004496 sjn
% 212.56/212.71  |- mesh__dateCreated mesh__D004496 1999-01-01
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D004496 2005
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D004496 2004
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D004496 2001
% 212.56/212.71  |- mesh__dateEstablished mesh__D004496 1966-01-01
% 212.56/212.71  |- mesh__publicMeSHNote mesh__D004496 66   
% 212.56/212.71  |- mesh__historyNote mesh__D004496 66   
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D004496 2003
% 212.56/212.71  |- rdf__type mesh__D004496sskos__Concept
% 212.56/212.71  |- skos__broader mesh__D004496smesh__D004517
% 212.56/212.71  |- mesh__dateRevised mesh__D004496 1999-11-03
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D004496 2000
% 212.56/212.71  |- skos__scopeNote mesh__D004496
% 212.56/212.71       Educational programs designed to inform individuals of recent advances in their particular field of interest. They do not lead to any formal advanced standing.%A%    
% 212.56/212.71  |- skos__annotation mesh__D004496
% 212.56/212.71       formal or informal courses to advance or update knowledge: differentiate from EDUCATION, GRADUATE: formal prep for specialty training or advanced study leading to official certification or degree; includes refresher courses; DF: EDUC CONTINUING%A%  
% 212.56/212.71  |- skos__prefLabel mesh__D004496 Education, Continuing
% 212.56/212.71  |- mesh__recordOriginator mesh__D004496 NLM
% 212.56/212.71  |- mesh__historyNote mesh__D012928 65   
% 212.56/212.71  |- mesh__recordAuthorizer mesh__D012928 sjn
% 212.56/212.71  |- skos__broader mesh__D012928smesh__D012919
% 212.56/212.71  |- mesh__publicMeSHNote mesh__D012928 65   
% 212.56/212.71  |- skos__hiddenLabel mesh__D012928 Worth, Social
% 212.56/212.71  |- mesh__recordOriginator mesh__D012928 NLM
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D012928 2003
% 212.56/212.71  |- skos__hiddenLabel mesh__D012928 Desirabilities, Social
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D012928 2005
% 212.56/212.71  |- mesh__recordMaintainer mesh__D012928 AGS
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D012928 2004
% 212.56/212.71  |- skos__prefLabel mesh__D012928 Social Desirability
% 212.56/212.71  |- mesh__dateEstablished mesh__D012928 1965-01-01
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D012928 2006
% 212.56/212.71  |- mesh__dateCreated mesh__D012928 1999-01-01
% 212.56/212.71  |- skos__annotation mesh__D012928 no qualif   
% 212.56/212.71  |- skos__hiddenLabel mesh__D012928 Desirability, Social
% 212.56/212.71  |- skos__scopeNote mesh__D012928
% 212.56/212.71       A personality trait rendering the individual acceptable in social or interpersonal relations. It is related to social acceptance, social approval, popularity, social status, leadership qualities, or any quality making him a socially desirable companion.%A%    
% 212.56/212.71  |- mesh__dateRevised mesh__D012928 2002-07-03
% 212.56/212.71  |- rdf__type mesh__D012928sskos__Concept
% 212.56/212.71  |- skos__hiddenLabel mesh__D012928 Social Desirabilities
% 212.56/212.71  |- skos__altLabel mesh__D045304 Ferricytochrome c
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D045304 2004
% 212.56/212.71  |- skos__scopeNote mesh__D045304
% 212.56/212.71       Cytochromes of the c type that are found in eukaryotic MITOCHONDRIA. They serve as redox intermediates that accept electrons from MITOCHONDRIAL ELECTRON TRANSPORT COMPLEX III and transfer them to MITOCHONDRIAL ELECTRON TRANSPORT COMPLEX IV.%A%    
% 212.56/212.71  |- mesh__historyNote mesh__D045304
% 212.56/212.71       2004; use CYTOCHROME C GROUP 1973-2003; for APOPCYTOCHROME C use CYTOCHROMES C %28%NM%29% 1983-2003%A%  
% 212.56/212.71  |- mesh__recordAuthorizer mesh__D045304 sjn
% 212.56/212.71  |- mesh__dateCreated mesh__D045304 2003-07-09
% 212.56/212.71  |- rdf__type mesh__D045304sskos__Concept
% 212.56/212.71  |- skos__broader mesh__D045304smesh__D003574
% 212.56/212.71  |- skos__historyNote mesh__D045304 Cytochrome c Group %28%1983-2003%29%
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D045304 2005
% 212.56/212.71  |- skos__altLabel mesh__D045304 Cytochrome c
% 212.56/212.71  |- mesh__publicMeSHNote mesh__D045304
% 212.56/212.71       2004; see CYTOCHROME C 1973-2003; APOCYTOCHROME C was indexed under CYTOCHROME C %26% APOPROTEINS 1983-2003%A%  
% 212.56/212.71  |- skos__annotation mesh__D045304 do not confuse with CYTOCHROME C GROUP   
% 212.56/212.71  |- mesh__recordMaintainer mesh__D045304 jmp
% 212.56/212.71  |- mesh__recordOriginator mesh__D045304 jmp
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D045304 2006
% 212.56/212.71  |- mesh__dateEstablished mesh__D045304 2004-01-01
% 212.56/212.71  |- skos__prefLabel mesh__D045304 Cytochromes c
% 212.56/212.71  |- skos__historyNote mesh__D045304 Apoproteins %28%1988-2003%29%
% 212.56/212.71  |- skos__altLabel mesh__D045304 Ferrocytochrome c
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009181 1998
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009181 1997
% 212.56/212.71  |- mesh__recordMaintainer mesh__D009181 TGC
% 212.56/212.71  |- mesh__dateCreated mesh__D009181 1999-01-01
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009181 1992
% 212.56/212.71  |- mesh__recordOriginator mesh__D009181 NLM
% 212.56/212.71  |- skos__altLabel mesh__D009181 Fungus Diseases
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009181 1996
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009181 2006
% 212.56/212.71  |- skos__broader mesh__D009181smesh__D001423
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009181 2001
% 212.56/212.71  |- skos__related mesh__D009181smesh__D000935
% 212.56/212.71  |- skos__annotation mesh__D009181
% 212.56/212.71       GEN: prefer specifics; of skin = DERMATOMYCOSES; /drug ther: consider also ANTIFUNGAL AGENTS%A%  
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009181 2004
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009181 2005
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009181 2000
% 212.56/212.71  |- skos__hiddenLabel mesh__D009181 Disease, Fungus
% 212.56/212.71  |- rdf__type mesh__D009181sskos__Concept
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009181 2003
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009181 1995
% 212.56/212.71  |- mesh__dateRevised mesh__D009181 1991-06-18
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009181 1999
% 212.56/212.71  |- skos__prefLabel mesh__D009181 Mycoses
% 212.56/212.71  |- mesh__recordAuthorizer mesh__D009181 PLS
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009181 1993
% 212.56/212.71  |- skos__hiddenLabel mesh__D009181 Diseases, Fungus
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009181 2002
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009181 1994
% 212.56/212.71  |- skos__hiddenLabel mesh__D009181 Fungus Disease
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D017613 1999
% 212.56/212.71  |- skos__scopeNote mesh__D017613
% 212.56/212.71       Inorganic compounds that contain iodine as an integral part of the molecule.%A%    
% 212.56/212.71  |- mesh__dateEstablished mesh__D017613 1994-01-01
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D017613 1995
% 212.56/212.71  |- skos__historyNote mesh__D017613 Iodine %28%1966-1993%29%
% 212.56/212.71  |- skos__broader mesh__D017613smesh__D007287
% 212.56/212.71  |- mesh__historyNote mesh__D017613 94   
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D017613 2000
% 212.56/212.71  |- skos__prefLabel mesh__D017613 Iodine Compounds
% 212.56/212.71  |- mesh__publicMeSHNote mesh__D017613 94   
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D017613 2003
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D017613 2001
% 212.56/212.71  |- skos__hiddenLabel mesh__D017613 Compounds, Iodine
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D017613 2005
% 212.56/212.71  |- skos__annotation mesh__D017613
% 212.56/212.71       inorganic; GEN or unspecified; prefer specifics; DF: IODINE CPDS%A%  
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D017613 2004
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D017613 1996
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D017613 2006
% 212.56/212.71  |- rdf__type mesh__D017613sskos__Concept
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D017613 1998
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D017613 1997
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D017613 2002
% 212.56/212.71  |- mesh__dateCreated mesh__D017613 1993-06-04
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D017613 1994
% 212.56/212.71  |- skos__broader mesh__D008274Q000172smesh__D008274
% 212.56/212.71  |- mesh__preferredCombination mesh__D008274Q000172smesh__D008275
% 212.56/212.71  |- rdf__type mesh__D008274Q000172smesh__CompoundConcept
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008887 2001
% 212.56/212.71  |- rdf__type mesh__D008887sskos__Concept
% 212.56/212.71  |- skos__prefLabel mesh__D008887 Military Medicine
% 212.56/212.71  |- skos__broader mesh__D008887smesh__D008511
% 212.56/212.71  |- skos__scopeNote mesh__D008887
% 212.56/212.71       The practice of medicine as applied to special circumstances associated with military operations.%A%    
% 212.56/212.71  |- mesh__recordAuthorizer mesh__D008887 PLS
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008887 2000
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008887 2006
% 212.56/212.71  |- skos__altLabel mesh__D008887 Medicine, Military
% 212.56/212.71  |- mesh__recordMaintainer mesh__D008887 TGC
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008887 2002
% 212.56/212.71  |- mesh__recordOriginator mesh__D008887 NLM
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008887 2005
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008887 2004
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008887 1999
% 212.56/212.71  |- skos__annotation mesh__D008887
% 212.56/212.71       SPEC: SPEC qualif; specify country; Manual 23.6, 28.8, 34.15; Uniformed Services University of the Health Sciences %28%USUHS%29%, under US Dept of Defense, goes under SCHOOLS, MEDICAL %28%IM%29% + UNITED STATES %28%NIM%29%; DF: MILITARY MED%A%  
% 212.56/212.71  |- mesh__dateCreated mesh__D008887 1999-01-01
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008887 2003
% 212.56/212.71  |- mesh__dateRevised mesh__D008887 1996-06-10
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008887 1998
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008887 1997
% 212.56/212.71  |- skos__annotation mesh__D008089
% 212.56/212.71       infection = LISTERIA INFECTIONS %26% do not bother to coord with L. monocytogenes%A%  
% 212.56/212.71  |- mesh__dateRevised mesh__D008089 2005-06-30
% 212.56/212.71  |- skos__broader mesh__D008089smesh__D008087
% 212.56/212.71  |- mesh__dateCreated mesh__D008089 1999-01-01
% 212.56/212.71  |- mesh__recordMaintainer mesh__D008089 SYSTEM
% 212.56/212.71  |- mesh__recordOriginator mesh__D008089 NLM
% 212.56/212.71  |- rdf__type mesh__D008089sskos__Concept
% 212.56/212.71  |- mesh__recordAuthorizer mesh__D008089 sjn
% 212.56/212.71  |- skos__scopeNote mesh__D008089
% 212.56/212.71       A species of gram-positive, rod-shaped bacteria widely distributed in nature. It has been isolated from sewage, soil, silage, and from feces of healthy animals and man. Infection with this bacterium leads to encephalitis, meningitis, endocarditis, and abortion.%A%    
% 212.56/212.71  |- skos__prefLabel mesh__D008089 Listeria monocytogenes
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D008089 2006
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Data Correlations
% 212.56/212.71  |- skos__related mesh__D013223smesh__D015201
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Indirect Estimation Technique
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Statistical Studies
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Study, Statistical
% 212.56/212.71  |- skos__altLabel mesh__D013223 Correlation Studies
% 212.56/212.71  |- skos__altLabel mesh__D013223 Service Statistics
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Classification Analysis, Multiple
% 212.56/212.71  |- rdf__type mesh__D013223sskos__Concept
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Data Analyses
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D013223 2003
% 212.56/212.71  |- skos__related mesh__D013223smesh__D012963
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Analysis, Multiple Classification
% 212.56/212.71  |- skos__related mesh__D013223smesh__D015233
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Analyses, Multiple Classification
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Multiple Classification Analyses
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Estimation Technics, Indirect
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D013223 2002
% 212.56/212.71  |- skos__related mesh__D013223smesh__D011594
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Analyses, Area
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Analyses, Data
% 212.56/212.71  |- skos__broader mesh__D013223smesh__D017531
% 212.56/212.71  |- mesh__recordOriginator mesh__D013223 NLM
% 212.56/212.71  |- skos__broader mesh__D013223smesh__D008433
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Techniques, Indirect Estimation
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Charts and Tables
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D013223 2004
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Data Correlation
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Technique, Indirect Estimation
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Estimation Technique
% 212.56/212.71  |- skos__altLabel mesh__D013223 Estimation Technics
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Area Analyses
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Estimation Technique, Indirect
% 212.56/212.71  |- skos__broader mesh__D013223smesh__D004812
% 212.56/212.71  |- skos__scopeNote mesh__D013223
% 212.56/212.71       The science and art of collecting, summarizing, and analyzing data that are subject to random variation. The term is also applied to the data themselves and to the summarization of the data.%A%    
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Study, Correlation
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Techniques, Estimation
% 212.56/212.71  |- skos__related mesh__D013223smesh__D015706
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Technique, Estimation
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Studies, Statistical
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D013223 2000
% 212.56/212.71  |- mesh__recordAuthorizer mesh__D013223 sjn
% 212.56/212.71  |- skos__related mesh__D013223smesh__D001699
% 212.56/212.71  |- skos__prefLabel mesh__D013223 Statistics
% 212.56/212.71  |- mesh__dateRevised mesh__D013223 1999-11-03
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D013223 2005
% 212.56/212.71  |- mesh__recordMaintainer mesh__D013223 kle
% 212.56/212.71  |- skos__annotation mesh__D013223
% 212.56/212.71       IM SPEC only: SPEC qualif; NIM no qualif; prefer /statist with non-disease terms: Manual 19.7+, 19.8.68; statist on dis = /epidemiol; IM for statistical theory or statistical methods; tables in texts are not necessarily /statist; do not confuse with MATHEMATICS; DF: STATIST%A%  
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Estimation Techniques, Indirect
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Studies, Correlation
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Technic, Indirect Estimation
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D013223 2001
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Technic, Estimation
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Estimation Technic, Indirect
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Classification Analyses, Multiple
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Estimation Technic
% 212.56/212.71  |- mesh__dateCreated mesh__D013223 1999-01-01
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D013223 2006
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Analysis, Area
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Analysis, Data
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Technics, Estimation
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Technics, Indirect Estimation
% 212.56/212.71  |- skos__altLabel mesh__D013223 Indirect Estimation Technics
% 212.56/212.71  |- skos__hiddenLabel mesh__D013223 Indirect Estimation Technic
% 212.56/212.71  |- skos__annotation mesh__D004497 DF: EDUC DENT   
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D004497 2006
% 212.56/212.71  |- skos__scopeNote mesh__D004497
% 212.56/212.71       Use for articles concerning dental education in general.%A%    
% 212.56/212.71  |- mesh__recordOriginator mesh__D004497 NLM
% 212.56/212.71  |- mesh__dateCreated mesh__D004497 1999-01-01
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D004497 2005
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D004497 2004
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D004497 2002
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D004497 2003
% 212.56/212.71  |- mesh__recordMaintainer mesh__D004497 kle
% 212.56/212.71  |- rdf__type mesh__D004497sskos__Concept
% 212.56/212.71  |- skos__altLabel mesh__D004497 Dental Education
% 212.56/212.71  |- mesh__recordAuthorizer mesh__D004497 sjn
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D004497 2001
% 212.56/212.71  |- skos__broader mesh__D004497smesh__D004517
% 212.56/212.71  |- skos__prefLabel mesh__D004497 Education, Dental
% 212.56/212.71  |- mesh__dateRevised mesh__D004497 1999-11-03
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D004497 2000
% 212.56/212.71  |- mesh__historyNote mesh__D009980 1997 %28%1977%29%   
% 212.56/212.71  |- skos__altLabel mesh__D009980 Avian Orthomyxovirus Type A
% 212.56/212.71  |- skos__hiddenLabel mesh__D009980 Myxovirus influenzae A hominis
% 212.56/212.71  |- mesh__recordOriginator mesh__D009980 FPG
% 212.56/212.71  |- skos__annotation mesh__D009980
% 212.56/212.71       infection: coordinate IM with INFLUENZA, HUMAN %28%IM%29% in humans or ORTHOMYXOVIRIDAE INFECTIONS %28%IM%29% in animals other than birds; infection in birds = INFLUENZA IN BIRDS; INFLUENZAVIRUS A is also available%A%  
% 212.56/212.71  |- skos__prefLabel mesh__D009980 Influenza A virus
% 212.56/212.71  |- mesh__dateCreated mesh__D009980 1976-04-27
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009980 2006A
% 212.56/212.71  |- mesh__dateRevised mesh__D009980 2005-11-18
% 212.56/212.71  |- skos__altLabel mesh__D009980 Myxovirus pestis galli
% 212.56/212.71  |- skos__hiddenLabel mesh__D009980 Influenza Viruses, Swine
% 212.56/212.71  |- skos__hiddenLabel mesh__D009980 Myxoviruses, Pestis galli
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009980 2003
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009980 2006E
% 212.56/212.71  |- skos__historyNote mesh__D009980 Orthomyxoviridae %28%1968-1976%29%
% 212.56/212.71  |- skos__hiddenLabel mesh__D009980 Viruses, Swine Influenza
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009980 2006B
% 212.56/212.71  |- skos__altLabel mesh__D009980 Influenza Viruses Type A
% 212.56/212.71  |- skos__altLabel mesh__D009980 Swine Influenza Virus
% 212.56/212.71  |- skos__hiddenLabel mesh__D009980 Influenza Virus, Swine
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009980 2002
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009980 2004
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009980 2006D
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009980 2006F
% 212.56/212.71  |- mesh__publicMeSHNote mesh__D009980
% 212.56/212.71       1997; see ORTHOMYXOVIRUSES TYPE A 1977-1996; for ORTHOMYXOVIRUS TYPE A, HUMAN see INFLUENZA A VIRUS, HUMAN 1997-2005; for MYXOVIRUS INFLUENZAE-A HOMINIS see INFLUENZA A VIRUS 1974-2005; for ORTHOMYXOVIRUS TYPE A, AVIAN see INFLUENZA  A VIRUS, AVIAN 1997-2005; for ORTHOMYXOVIRUS TYPE A, PORCINE see INFLUENZA A VIRUS, PORCINE 1995-2005%A%  
% 212.56/212.71  |- skos__hiddenLabel mesh__D009980 Pestis galli Myxoviruses
% 212.56/212.71  |- skos__hiddenLabel mesh__D009980 influenzae-A hominis, Myxovirus
% 212.56/212.71  |- skos__hiddenLabel mesh__D009980 Influenza A viruses
% 212.56/212.71  |- skos__hiddenLabel mesh__D009980 influenzae-A suis, Myxovirus
% 212.56/212.71  |- skos__altLabel mesh__D009980 Orthomyxovirus Type A
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009980 2006C
% 212.56/212.71  |- skos__hiddenLabel mesh__D009980 Myxovirus influenzae A suis
% 212.56/212.71  |- skos__hiddenLabel mesh__D009980 Virus, Fowl Plague
% 212.56/212.71  |- skos__hiddenLabel mesh__D009980 Virus, Swine Influenza
% 212.56/212.71  |- skos__scopeNote mesh__D009980
% 212.56/212.71       The type species of the genus INFLUENZAVIRUS A that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol %28%human and most non-aquatic hosts%29% or waterborne %28%ducks%29%. Infected birds shed the virus in their saliva, nasal secretions, and feces.%A%    
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009980 2005
% 212.56/212.71  |- skos__hiddenLabel mesh__D009980 Swine Influenza Viruses
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009980 2006G
% 212.56/212.71  |- skos__altLabel mesh__D009980 Myxovirus influenzae-A suis
% 212.56/212.71  |- skos__hiddenLabel mesh__D009980 Plague Virus, Fowl
% 212.56/212.71  |- mesh__dateEstablished mesh__D009980 1977-01-01
% 212.56/212.71  |- skos__hiddenLabel mesh__D009980 Myxovirus, Pestis galli
% 212.56/212.71  |- mesh__recordAuthorizer mesh__D009980 ags
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009980 2006
% 212.56/212.71  |- skos__hiddenLabel mesh__D009980 Fowl Plague Viruses
% 212.56/212.71  |- rdf__type mesh__D009980sskos__Concept
% 212.56/212.71  |- skos__hiddenLabel mesh__D009980 Plague Viruses, Fowl
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D009980 2006H
% 212.56/212.71  |- skos__broader mesh__D009980smesh__D029521
% 212.56/212.71  |- skos__hiddenLabel mesh__D009980 Viruses, Fowl Plague
% 212.56/212.71  |- skos__hiddenLabel mesh__D009980 pestis galli, Myxovirus
% 212.56/212.71  |- mesh__recordMaintainer mesh__D009980 ags
% 212.56/212.71  |- skos__altLabel mesh__D009980 Pestis galli Myxovirus
% 212.56/212.71  |- skos__altLabel mesh__D009980 Myxovirus influenzae-A hominis
% 212.56/212.71  |- skos__altLabel mesh__D009980 Fowl Plague Virus
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D012929 2005
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D012929 2004
% 212.56/212.71  |- skos__historyNote mesh__D012929 Psychology, Social %28%1966-1968%29%
% 212.56/212.71  |- mesh__publicMeSHNote mesh__D012929 69   
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D012929 2006
% 212.56/212.71  |- mesh__dateRevised mesh__D012929 2002-07-03
% 212.56/212.71  |- skos__broader mesh__D012929smesh__D006126
% 212.56/212.71  |- mesh__dateCreated mesh__D012929 1999-01-01
% 212.56/212.71  |- mesh__recordAuthorizer mesh__D012929 sjn
% 212.56/212.71  |- mesh__recordMaintainer mesh__D012929 JLS
% 212.56/212.71  |- rdf__type mesh__D012929sskos__Concept
% 212.56/212.71  |- mesh__dateEstablished mesh__D012929 1969-01-01
% 212.56/212.71  |- skos__prefLabel mesh__D012929 Social Distance
% 212.56/212.71  |- skos__annotation mesh__D012929 no qualif   
% 212.56/212.71  |- skos__hiddenLabel mesh__D012929 Distance, Social
% 212.56/212.71  |- mesh__historyNote mesh__D012929 69   
% 212.56/212.71  |- skos__scopeNote mesh__D012929
% 212.56/212.71       The degree of closeness or acceptance an individual or group feels toward another individual or group.%A%    
% 212.56/212.71  |- mesh__recordOriginator mesh__D012929 NLM
% 212.56/212.71  |- skos__hiddenLabel mesh__D012929 Social Distances
% 212.56/212.71  |- mesh__activeMeSHYear mesh__D012929 2003
% 212.56/212.71  |- skos__broader mesh__D012929smesh__D012919
% 212.56/212.71  |- skos__historyNote mesh__D012929
% 212.56/212.71       Interpersonal Relations %28%1966-1968%29%
% 212.56/212.71  |- skos__hiddenLabel mesh__D012929 Distances, Social
% 212.56/212.71  |- mesh__dateEstablished mesh__D045305 2004-01-01
% 212.56/212.71  |- mesh__dateCreated mesh__D045305 2003-07-09
% 212.56/212.71  |- skos__historyNote mesh__D045305 Cytochrome c Group %28%1981-2003%29%
% 212.56/212.71  |- skos__altLabel mesh__D045305 Ferricytochrome c%27%
% 212.56/212.71  |- rdf__type mesh__D045305sskos__Concept
% 212.56/212.72  |- skos__scopeNote mesh__D045305
% 212.56/212.72       A widely occurring subclass of c type cytochromes which function as electron carriers in the electron transport chain in photosynthetic and denitrifying BACTERIA.%A%    
% 212.56/212.72  |- skos__broader mesh__D045305smesh__D003574
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D045305 2005
% 212.56/212.72  |- skos__altLabel mesh__D045305 Cytochromes c Prime
% 212.56/212.72  |- mesh__recordAuthorizer mesh__D045305 sjn
% 212.56/212.72  |- mesh__publicMeSHNote mesh__D045305 2004; see CYTOCHROME C 1982-2003   
% 212.56/212.72  |- skos__altLabel mesh__D045305 Cytochrome c%27%
% 212.56/212.72  |- mesh__recordMaintainer mesh__D045305 jls
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D045305 2006
% 212.56/212.72  |- mesh__dateRevised mesh__D045305 2004-07-19
% 212.56/212.72  |- mesh__historyNote mesh__D045305
% 212.56/212.72       2004; use CYTOCHROME C GROUP 1982-2003   
% 212.56/212.72  |- mesh__recordOriginator mesh__D045305 jmp
% 212.56/212.72  |- skos__prefLabel mesh__D045305 Cytochromes c%27%
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D009182 1996
% 212.56/212.72  |- mesh__recordAuthorizer mesh__D009182 PLS
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D009182 2006
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D009182 2002
% 212.56/212.72  |- skos__annotation mesh__D009182
% 212.56/212.72       a type of malignant T-cell lymphoma of the skin; coord IM with SKIN NEOPLASMS %28%IM%29%%A%  
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D009182 2004
% 212.56/212.72  |- mesh__recordOriginator mesh__D009182 NLM
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D009182 2005
% 212.56/212.72  |- mesh__dateRevised mesh__D009182 1995-06-08
% 212.56/212.72  |- rdf__type mesh__D009182sskos__Concept
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D009182 2003
% 212.56/212.72  |- skos__scopeNote mesh__D009182
% 212.56/212.72       A chronic malignant T-cell lymphoma of the skin. In the late stages the lymph nodes and viscera are affected.%A%    
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D009182 2001
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D009182 1999
% 212.56/212.72  |- mesh__recordMaintainer mesh__D009182 KEV
% 212.56/212.72  |- skos__prefLabel mesh__D009182 Mycosis Fungoides
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D009182 2000
% 212.56/212.72  |- skos__broader mesh__D009182smesh__D016410
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D009182 1997
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D009182 1998
% 212.56/212.72  |- mesh__dateCreated mesh__D009182 1999-01-01
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017614 2002
% 212.56/212.72  |- mesh__historyNote mesh__D017614 94   
% 212.56/212.72  |- mesh__dateCreated mesh__D017614 1993-06-04
% 212.56/212.72  |- skos__prefLabel mesh__D017614 Iron Compounds
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017614 2003
% 212.56/212.72  |- mesh__dateEstablished mesh__D017614 1994-01-01
% 212.56/212.72  |- skos__historyNote mesh__D017614 Iron %28%1966-1993%29%
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017614 2005
% 212.56/212.72  |- skos__annotation mesh__D017614
% 212.56/212.72       inorganic; GEN or unspecified; prefer specifics; DF: IRON CPDS%A%  
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017614 2004
% 212.56/212.72  |- skos__broader mesh__D017614smesh__D007287
% 212.56/212.72  |- skos__scopeNote mesh__D017614
% 212.56/212.72       Inorganic compounds that contain iron as an integral part of the molecule.%A%    
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017614 1996
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017614 2006
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017614 2000
% 212.56/212.72  |- rdf__type mesh__D017614sskos__Concept
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017614 1998
% 212.56/212.72  |- mesh__publicMeSHNote mesh__D017614 94   
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017614 1997
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017614 2001
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017614 1994
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017614 1999
% 212.56/212.72  |- skos__hiddenLabel mesh__D017614 Compounds, Iron
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017614 1995
% 212.56/212.72  |- mesh__recordAuthorizer mesh__D008888 sjn
% 212.56/212.72  |- mesh__recordOriginator mesh__D008888 NLM
% 212.56/212.72  |- skos__altLabel mesh__D008888 Nursing, Military
% 212.56/212.72  |- skos__prefLabel mesh__D008888 Military Nursing
% 212.56/212.72  |- skos__altLabel mesh__D008888 Military and Naval Nursing
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D008888 2006
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D008888 2004
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D008888 2005
% 212.56/212.72  |- skos__scopeNote mesh__D008888
% 212.56/212.72       The practice of nursing in military environments.     
% 212.56/212.72  |- skos__hiddenLabel mesh__D008888 Nursings, Military
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D008888 2001
% 212.56/212.72  |- skos__hiddenLabel mesh__D008888 Military Nursings
% 212.56/212.72  |- mesh__dateCreated mesh__D008888 1999-01-01
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D008888 2003
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D008888 2000
% 212.56/212.72  |- mesh__recordMaintainer mesh__D008888 kle
% 212.56/212.72  |- rdf__type mesh__D008888sskos__Concept
% 212.56/212.72  |- skos__broader mesh__D008888smesh__D013041
% 212.56/212.72  |- skos__annotation mesh__D008888 SPEC: SPEC qualif; specify country   
% 212.56/212.72  |- mesh__dateRevised mesh__D008888 1999-11-03
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D008888 2002
% 212.56/212.72  |- skos__prefLabel mesh__D033281 Nontherapeutic Human Experimentation
% 212.56/212.72  |- skos__altLabel mesh__D033281 Human Experimentation, Nontherapeutic
% 212.56/212.72  |- mesh__publicMeSHNote mesh__D033281 2003   
% 212.56/212.72  |- rdf__type mesh__D033281sskos__Concept
% 212.56/212.72  |- skos__altLabel mesh__D033281 Research, Nontherapeutic
% 212.56/212.72  |- mesh__dateRevised mesh__D033281 2004-07-13
% 212.56/212.72  |- skos__annotation mesh__D033281
% 212.56/212.72       use only when the issue of nontherapeutic research is discussed, including its ethical, legal, psychological, or social implications%A%  
% 212.56/212.72  |- skos__historyNote mesh__D033281 Human Experimentation %28%1978-2002%29%
% 212.56/212.72  |- skos__related mesh__D033281smesh__D036302
% 212.56/212.72  |- mesh__historyNote mesh__D033281 2003   
% 212.56/212.72  |- skos__hiddenLabel mesh__D033281 Experimentation, Nontherapeutic Human
% 212.56/212.72  |- mesh__recordAuthorizer mesh__D033281 sjn
% 212.56/212.72  |- skos__broader mesh__D033281smesh__D006805
% 212.56/212.72  |- skos__scopeNote mesh__D033281
% 212.56/212.72       Human experimentation that is not intended to benefit the subjects on whom it is performed. Phase I drug studies %28%CLINICAL TRIALS, PHASE I%29% and research involving healthy volunteers are examples of nontherapeutic human experimentation.%A%    
% 212.56/212.72  |- skos__altLabel mesh__D033281 Nontherapeutic Research
% 212.56/212.72  |- mesh__dateEstablished mesh__D033281 2003-01-01
% 212.56/212.72  |- mesh__recordOriginator mesh__D033281 jrf
% 212.56/212.72  |- mesh__recordMaintainer mesh__D033281 sjn
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D033281 2005
% 212.56/212.72  |- skos__related mesh__D033281smesh__D017321
% 212.56/212.72  |- mesh__dateCreated mesh__D033281 2002-07-03
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D033281 2006
% 212.56/212.72  |- mesh__historyNote mesh__D005590
% 212.56/212.72       91%28%75%29%; was see under PRECIPITATION 1975-90   
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D005590 2001
% 212.56/212.72  |- rdf__type mesh__D005590sskos__Concept
% 212.56/212.72  |- mesh__publicMeSHNote mesh__D005590
% 212.56/212.72       91; was see under PRECIPITATION 1975-90   
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D005590 1996
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D005590 2000
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D005590 1995
% 212.56/212.72  |- mesh__dateRevised mesh__D005590 1990-04-13
% 212.56/212.72  |- skos__hiddenLabel mesh__D005590 Fractional Precipitations
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D005590 2006
% 212.56/212.72  |- skos__hiddenLabel mesh__D005590 Precipitations, Fractional
% 212.56/212.72  |- mesh__recordAuthorizer mesh__D005590 PLS
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D005590 1994
% 212.56/212.72  |- skos__hiddenLabel mesh__D005590 Precipitation, Fractional
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D005590 2005
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D005590 1993
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D005590 1999
% 212.56/212.72  |- mesh__dateEstablished mesh__D005590 1991-01-01
% 212.56/212.72  |- skos__annotation mesh__D005590 NIM; no qualif   
% 212.56/212.72  |- skos__broader mesh__D005590smesh__D011232
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D005590 2004
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D005590 1991
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D005590 1992
% 212.56/212.72  |- mesh__recordOriginator mesh__D005590 NLM
% 212.56/212.72  |- mesh__recordMaintainer mesh__D005590 NLM
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D005590 1998
% 212.56/212.72  |- mesh__onlineNote mesh__D005590 search PRECIPITATION 1966-74   
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D005590 2002
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D005590 2003
% 212.56/212.72  |- skos__prefLabel mesh__D005590 Fractional Precipitation
% 212.56/212.72  |- mesh__dateCreated mesh__D005590 1999-01-01
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D005590 1997
% 212.56/212.72  |- skos__hiddenLabel mesh__D013224 Asthmatic Shocks
% 212.56/212.72  |- skos__hiddenLabel mesh__D013224 Asthmaticus, Status
% 212.56/212.72  |- mesh__recordOriginator mesh__D013224 VDK
% 212.56/212.72  |- skos__hiddenLabel mesh__D013224 Shocks, Asthmatic
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D013224 2004
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D013224 1997
% 212.56/212.72  |- skos__scopeNote mesh__D013224
% 212.56/212.72       A sudden intense and continuous aggravation of a state of asthma, marked by dyspnea to the point of exhaustion and collapse and not responding to the usual therapeutic efforts.%A%    
% 212.56/212.72  |- mesh__historyNote mesh__D013224
% 212.56/212.72       91%28%85%29%; was see under ASTHMA 1985-90   
% 212.56/212.72  |- mesh__dateCreated mesh__D013224 1984-05-29
% 212.56/212.72  |- rdf__type mesh__D013224sskos__Concept
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D013224 2003
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D013224 1996
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D013224 2001
% 212.56/212.72  |- skos__hiddenLabel mesh__D013224 Shock, Asthmatic
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D013224 2006
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D013224 1999
% 212.56/212.72  |- skos__annotation mesh__D013224 sudden intense aggravation of asthma   
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D013224 2000
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D013224 1995
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D013224 2005
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D013224 1998
% 212.56/212.72  |- skos__broader mesh__D013224smesh__D001249
% 212.56/212.72  |- mesh__dateEstablished mesh__D013224 1991-01-01
% 212.56/212.72  |- skos__altLabel mesh__D013224 Asthmatic Shock
% 212.56/212.72  |- skos__hiddenLabel mesh__D013224 Crises, Asthmatic
% 212.56/212.72  |- skos__hiddenLabel mesh__D013224 Asthmatic Crises
% 212.56/212.72  |- skos__altLabel mesh__D013224 Asthmatic Crisis
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D013224 1994
% 212.56/212.72  |- mesh__recordAuthorizer mesh__D013224 PLS
% 212.56/212.72  |- skos__prefLabel mesh__D013224 Status Asthmaticus
% 212.56/212.72  |- skos__hiddenLabel mesh__D013224 Crisis, Asthmatic
% 212.56/212.72  |- skos__historyNote mesh__D013224 Asthma %28%1966-1984%29%
% 212.56/212.72  |- mesh__recordMaintainer mesh__D013224 TGC
% 212.56/212.72  |- mesh__dateRevised mesh__D013224 1993-06-03
% 212.56/212.72  |- mesh__publicMeSHNote mesh__D013224 91; was see under ASTHMA 1985-90   
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D013224 2002
% 212.56/212.72  |- mesh__recordAuthorizer mesh__D004498 sjn
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D004498 2003
% 212.56/212.72  |- skos__altLabel mesh__D004498 Continuing Dental Education
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D004498 2006
% 212.56/212.72  |- skos__broader mesh__D004498smesh__D004496
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D004498 2001
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D004498 2004
% 212.56/212.72  |- skos__hiddenLabel mesh__D004498 Dental Educations, Continuing
% 212.56/212.72  |- skos__hiddenLabel mesh__D004498 Educations, Continuing Dental
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D004498 2002
% 212.56/212.72  |- skos__hiddenLabel mesh__D004498 Continuing Dental Educations
% 212.56/212.72  |- rdf__type mesh__D004498sskos__Concept
% 212.56/212.72  |- mesh__dateRevised mesh__D004498 1999-11-03
% 212.56/212.72  |- mesh__recordOriginator mesh__D004498 NLM
% 212.56/212.72  |- mesh__onlineNote mesh__D004498
% 212.56/212.72       use EDUCATION, DENTAL, CONTINUING %26% EDUCATION, DENTAL, GRADUATE to search EDUCATION, DENTAL, POSTGRADUATE 1966-74%A%  
% 212.56/212.72  |- skos__prefLabel mesh__D004498 Education, Dental, Continuing
% 212.56/212.72  |- mesh__publicMeSHNote mesh__D004498
% 212.56/212.72       66; EDUCATION, DENTAL, POSTGRADUATE was see under EDUCATION, DENTAL, CONTINUING %26% EDUCATION, DENTAL, GRADUATE 1966-74, was heading 1965%A%  
% 212.56/212.72  |- skos__altLabel mesh__D004498 Dental Education, Continuing
% 212.56/212.72  |- skos__scopeNote mesh__D004498
% 212.56/212.72       Educational programs designed to inform dentists of recent advances in their fields.%A%    
% 212.56/212.72  |- mesh__historyNote mesh__D004498
% 212.56/212.72       66; EDUCATION, DENTAL, POSTGRADUATE was see under EDUCATION, DENTAL, CONTINUING %26% EDUCATION, DENTAL, GRADUATE 1966-74, was heading 1965%A%  
% 212.56/212.72  |- skos__hiddenLabel mesh__D004498 Education, Continuing Dental
% 212.56/212.72  |- mesh__dateCreated mesh__D004498 1999-01-01
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D004498 2005
% 212.56/212.72  |- mesh__recordMaintainer mesh__D004498 kle
% 212.56/212.72  |- skos__annotation mesh__D004498
% 212.56/212.72       differentiate from EDUCATION, DENTAL, GRADUATE: see note on EDUCATION, CONTINUING; DF: EDUC DENT CONTINUING%A%  
% 212.56/212.72  |- mesh__dateEstablished mesh__D004498 1966-01-01
% 212.56/212.72  |- skos__broader mesh__D004498smesh__D004497
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D004498 2000
% 212.56/212.72  |- mesh__dateEstablished mesh__D009981 1985-01-01
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D009981 2006A
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D009981 2006
% 212.56/212.72  |- skos__hiddenLabel mesh__D009981 Influenza B viruses
% 212.56/212.72  |- mesh__historyNote mesh__D009981
% 212.56/212.72       97; was ORTHOMYXOVIRUSES TYPE B 1985-96   
% 212.56/212.72  |- skos__prefLabel mesh__D009981 Influenza B virus
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D009981 2002
% 212.56/212.72  |- mesh__dateRevised mesh__D009981 2005-11-10
% 212.56/212.72  |- skos__annotation mesh__D009981
% 212.56/212.72       infection: coordinate IM with INFLUENZA, HUMAN %28%IM%29% in humans or ORTHOMYXOVIRIDAE INFECTIONS %28%IM%29% in animals; INFLUENZAVIRUS B is also available%A%  
% 212.56/212.72  |- skos__historyNote mesh__D009981 Orthomyxoviridae %28%1981-1984%29%
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D009981 2005
% 212.56/212.72  |- rdf__type mesh__D009981sskos__Concept
% 212.56/212.72  |- skos__altLabel mesh__D009981 Influenza Viruses Type B
% 212.56/212.72  |- mesh__recordOriginator mesh__D009981 RC
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D009981 2004
% 212.56/212.72  |- mesh__recordAuthorizer mesh__D009981 ags
% 212.56/212.72  |- skos__scopeNote mesh__D009981
% 212.56/212.72       Species of the genus INFLUENZAVIRUS B that cause HUMAN INFLUENZA and other diseases primarily in humans. Antigenic variation is less extensive than in type A viruses %28%INFLUENZA A VIRUS%29% and consequently there is no basis for distinct subtypes or variants. Epidemics are less likely than with INFLUENZA A VIRUS and there have been no pandemics. Previously only found in humans, Influenza B virus has been isolated from seals which may constitute the animal reservoir from which humans are exposed.%A%    
% 212.56/212.72  |- mesh__publicMeSHNote mesh__D009981
% 212.56/212.72       97; was ORTHOMYXOVIRUSES TYPE B 1985-96   
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D009981 2003
% 212.56/212.72  |- skos__altLabel mesh__D009981 Orthomyxoviruses Type B
% 212.56/212.72  |- skos__broader mesh__D009981smesh__D029524
% 212.56/212.72  |- mesh__recordMaintainer mesh__D009981 ags
% 212.56/212.72  |- mesh__dateCreated mesh__D009981 1984-04-06
% 212.56/212.72  |- skos__prefLabel mesh__D009183 Mycotoxins
% 212.56/212.72  |- skos__annotation mesh__D009183
% 212.56/212.72       /antag permitted but consider also ANTITOXINS   
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D009183 2006
% 212.56/212.72  |- mesh__dateRevised mesh__D009183 2005-06-30
% 212.56/212.72  |- skos__historyNote mesh__D009183 Carcinogens %28%1966%29%
% 212.56/212.72  |- skos__broader mesh__D009183smesh__D014118
% 212.56/212.72  |- skos__scopeNote mesh__D009183 Toxic compounds produced by FUNGI.     
% 212.56/212.72  |- mesh__dateEstablished mesh__D009183 1967-01-01
% 212.56/212.72  |- rdf__type mesh__D009183sskos__Concept
% 212.56/212.72  |- mesh__dateCreated mesh__D009183 1999-01-01
% 212.56/212.72  |- skos__altLabel mesh__D009183 Fungal Toxins
% 212.56/212.72  |- skos__related mesh__D009183smesh__D004881
% 212.56/212.72  |- mesh__recordAuthorizer mesh__D009183 sjn
% 212.56/212.72  |- mesh__historyNote mesh__D009183 67   
% 212.56/212.72  |- mesh__recordOriginator mesh__D009183 NLM
% 212.56/212.72  |- mesh__recordMaintainer mesh__D009183 ssb
% 212.56/212.72  |- mesh__publicMeSHNote mesh__D009183
% 212.56/212.72       67; GLIOTOXINS was GLIOTOXIN see under ANTIBIOTICS 1975-80%A%  
% 212.56/212.72  |- skos__historyNote mesh__D009183 Toxins %28%1966%29%
% 212.56/212.72  |- skos__historyNote mesh__D009183 Fungi %28%1966%29%
% 212.56/212.72  |- skos__hiddenLabel mesh__D009183 Toxins, Fungal
% 212.56/212.72  |- skos__related mesh__D009183smesh__D009145
% 212.56/212.72  |- skos__broader mesh__D017615smesh__D001341
% 212.56/212.72  |- mesh__dateCreated mesh__D017615 1993-06-18
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017615 2002
% 212.56/212.72  |- skos__scopeNote mesh__D017615
% 212.56/212.72       Two ganglionated neural plexuses in the gut wall which form one of the three major divisions of the autonomic nervous system. The enteric nervous system innervates the gastrointestinal tract, the pancreas, and the gallbladder. It contains sensory neurons, interneurons, and motor neurons. Thus the circuitry can autonomously sense the tension and the chemical environment in the gut and regulate blood vessel tone, motility, secretions, and fluid transport. The system is itself governed by the central nervous system and receives both parasympathetic and sympathetic innervation. %28%From Kandel, Schwartz, and Jessel, Principles of Neural Science, 3d ed, p766%29%%A%    
% 212.56/212.72  |- mesh__historyNote mesh__D017615 94   
% 212.56/212.72  |- mesh__recordAuthorizer mesh__D017615 PLS
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017615 2003
% 212.56/212.72  |- mesh__dateEstablished mesh__D017615 1994-01-01
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017615 1996
% 212.56/212.72  |- skos__prefLabel mesh__D017615 Enteric Nervous System
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017615 2000
% 212.56/212.72  |- mesh__dateRevised mesh__D017615 1995-06-08
% 212.56/212.72  |- skos__annotation mesh__D017615
% 212.56/212.72       a major division of the autonomic nerv syst   
% 212.56/212.72  |- rdf__type mesh__D017615sskos__Concept
% 212.56/212.72  |- mesh__recordMaintainer mesh__D017615 TAP
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017615 2005
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017615 1998
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017615 2004
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017615 1997
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017615 2001
% 212.56/212.72  |- mesh__publicMeSHNote mesh__D017615 94   
% 212.56/212.72  |- skos__hiddenLabel mesh__D017615 Systems, Enteric Nervous
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017615 2006
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D017615 1999
% 212.56/212.72  |- skos__hiddenLabel mesh__D017615 Nervous System, Enteric
% 212.56/212.72  |- skos__hiddenLabel mesh__D017615 System, Enteric Nervous
% 212.56/212.72  |- mesh__recordOriginator mesh__D017615 RAZ
% 212.56/212.72  |- skos__hiddenLabel mesh__D017615 Enteric Nervous Systems
% 212.56/212.72  |- skos__hiddenLabel mesh__D017615 Nervous Systems, Enteric
% 212.56/212.72  |- skos__hiddenLabel mesh__D008889 Personnel, Navy
% 212.56/212.72  |- mesh__dateRevised mesh__D008889 2001-07-25
% 212.56/212.72  |- skos__altLabel mesh__D008889 Armed Forces Personnel
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D008889 2004
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D008889 2005
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D008889 2002
% 212.56/212.72  |- skos__altLabel mesh__D008889 Military
% 212.56/212.72  |- mesh__recordAuthorizer mesh__D008889 sjn
% 212.56/212.72  |- mesh__dateCreated mesh__D008889 1999-01-01
% 212.56/212.72  |- mesh__recordOriginator mesh__D008889 NLM
% 212.56/212.72  |- skos__hiddenLabel mesh__D008889 Personnel, Military
% 212.56/212.72  |- mesh__recordMaintainer mesh__D008889 tpw
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D008889 2003
% 212.56/212.72  |- skos__annotation mesh__D008889
% 212.56/212.72       their physiol %26% diseases go here: reserve MILITARY MEDICINE for the specialty; includes all uniformed personnel: note X refs; /psychol: consider also the specialties PSYCHOLOGY, MILITARY %26% MILITARY PSYCHIATRY; specify country; Manual 28.8, 34.15%A%  
% 212.56/212.72  |- skos__prefLabel mesh__D008889 Military Personnel
% 212.56/212.72  |- skos__hiddenLabel mesh__D008889 Personnel, Air Force
% 212.56/212.72  |- skos__hiddenLabel mesh__D008889 Personnel, Army
% 212.56/212.72  |- rdf__type mesh__D008889sskos__Concept
% 212.56/212.72  |- skos__hiddenLabel mesh__D008889 Force Personnel, Air
% 212.56/212.72  |- skos__hiddenLabel mesh__D008889 Sailor
% 212.56/212.72  |- skos__related mesh__D008889smesh__D014728
% 212.56/212.72  |- skos__hiddenLabel mesh__D008889 Soldier
% 212.56/212.72  |- skos__hiddenLabel mesh__D008889 Submariner
% 212.56/212.72  |- skos__broader mesh__D008889smesh__D009274
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D008889 2006
% 212.56/212.72  |- skos__scopeNote mesh__D008889
% 212.56/212.72       Persons including soldiers involved with the armed forces.%A%    
% 212.56/212.72  |- skos__hiddenLabel mesh__D008889 Personnel, Armed Forces
% 212.56/212.72  |- skos__broader mesh__D004194Q000401smesh__D004194
% 212.56/212.72  |- mesh__preferredCombination mesh__D004194Q000401smesh__D009026
% 212.56/212.72  |- rdf__type mesh__D004194Q000401smesh__CompoundConcept
% 212.56/212.72  |- mesh__recordAuthorizer mesh__D033282 jls
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D033282 2003A
% 212.56/212.72  |- rdf__type mesh__D033282sskos__Concept
% 212.56/212.72  |- mesh__dateCreated mesh__D033282 2002-07-03
% 212.56/212.72  |- skos__scopeNote mesh__D033282
% 212.56/212.72       Informed consent given by a parent on behalf of a minor or otherwise incompetent child.%A%    
% 212.56/212.72  |- mesh__historyNote mesh__D033282
% 212.56/212.72       2003; use THIRD-PARTY CONSENT 1999-2002   
% 212.56/212.72  |- skos__broader mesh__D033282smesh__D020458
% 212.56/212.72  |- skos__prefLabel mesh__D033282 Parental Consent
% 212.56/212.72  |- skos__historyNote mesh__D033282 Informed Consent %28%1974-1998%29%
% 212.56/212.72  |- skos__related mesh__D033282smesh__D010290
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D033282 2003
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D033282 2005
% 212.56/212.72  |- mesh__publicMeSHNote mesh__D033282
% 212.56/212.72       2003; see THIRD-PARTY CONSENT 1999-2002   
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D033282 2004
% 212.56/212.72  |- mesh__recordMaintainer mesh__D033282 jls
% 212.56/212.72  |- skos__hiddenLabel mesh__D033282 Consent, Parental
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D033282 2006
% 212.56/212.72  |- mesh__dateRevised mesh__D033282 2002-10-31
% 212.56/212.72  |- mesh__dateEstablished mesh__D033282 2003-01-01
% 212.56/212.72  |- skos__related mesh__D033282smesh__D035622
% 212.56/212.72  |- skos__historyNote mesh__D033282 Third-Party Consent %28%1999-2002%29%
% 212.56/212.72  |- mesh__recordOriginator mesh__D033282 jrf
% 212.56/212.72  |- mesh__dateEstablished mesh__D005591 1991-01-01
% 212.56/212.72  |- rdf__type mesh__D005591sskos__Concept
% 212.56/212.72  |- skos__hiddenLabel mesh__D005591 Chemical Fractionations
% 212.56/212.72  |- skos__broader mesh__D005591smesh__D002623
% 212.56/212.72  |- mesh__recordOriginator mesh__D005591 NLM
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D005591 2005
% 212.56/212.72  |- mesh__dateRevised mesh__D005591 2003-07-09
% 212.56/212.72  |- mesh__recordAuthorizer mesh__D005591 sjn
% 212.56/212.72  |- skos__scopeNote mesh__D005591
% 212.56/212.72       Separation of a mixture in successive stages, each stage removing from the mixture some proportion of one of the substances, for example by differential solubility in water-solvent mixtures. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D005591 2006
% 212.56/212.72  |- skos__prefLabel mesh__D005591 Chemical Fractionation
% 212.56/212.72  |- mesh__publicMeSHNote mesh__D005591
% 212.56/212.72       2003; see FRACTIONATION 1991-2002; see CHEMISTRY, ANALYTICAL 1967-1990%A%  
% 212.56/212.72  |- mesh__historyNote mesh__D005591 2003%28%1964%29%   
% 212.56/212.72  |- mesh__dateCreated mesh__D005591 1999-01-01
% 212.56/212.72  |- skos__hiddenLabel mesh__D005591 Fractionations, Chemical
% 212.56/212.72  |- skos__annotation mesh__D005591
% 212.56/212.72       DOSE FRACTIONATION; CELL FRACTIONATION and FRACTIONATION, FIELD FLOW are also available%A%  
% 212.56/212.72  |- mesh__activeMeSHYear mesh__D005591 2004
% 212.56/212.72  |- skos__altLabel mesh__D005591 Fractionation, Chemical
% 212.56/212.72  |- mesh__recordMaintainer mesh__D005591 ssb
% 212.56/212.72  |- skos__broader mesh__D051344smesh__D008840
% 212.56/212.72  |- skos__scopeNote mesh__D051344
% 212.56/212.72       Actin capping proteins are cytoskeletal proteins that bind to the ends of ACTIN FILAMENTS to regulate actin polymerization.%A%    
% 212.56/212.72  |- mesh__recordMaintainer mesh__D051344 DRC
% 212.56/212.72  |- mesh__recordOriginator mesh__D051344 DRC
% 212.56/212.72  |- skos__altLabel mesh__D051344 Capping Protein, Actin
% 212.58/212.72  |- skos__prefLabel mesh__D051344 Actin Capping Proteins
% 212.58/212.72  |- mesh__publicMeSHNote mesh__D051344
% 212.58/212.72       2006; ACTIN CAPPING PROTEINS was indexed under MICROFILAMENT PROTEINS 1988-2005, %26% under MUSCLE PROTEINS %26% PROTEINS 1981-1987%A%  
% 212.58/212.72  |- mesh__dateCreated mesh__D051344 2005-06-30
% 212.58/212.72  |- mesh__activeMeSHYear mesh__D051344 2006
% 212.58/212.72  |- mesh__recordAuthorizer mesh__D051344 sjn
% 212.58/212.72  |- mesh__dateEstablished mesh__D051344 2006-01-01
% 212.58/212.72  |- skos__hiddenLabel mesh__D051344 Actin Capping Protein
% 212.58/212.72  |- skos__hiddenLabel mesh__D051344 Capping Proteins, Actin
% 212.58/212.72  |- skos__altLabel mesh__D051344 Actin-Capping Proteins
% 212.58/212.72  |- skos__altLabel mesh__D051344 Actin Filament Capping Proteins
% 212.58/212.72  |- mesh__historyNote mesh__D051344 2006%28%1981%29%   
% 212.58/212.72  |- rdf__type mesh__D051344sskos__Concept
% 212.58/212.72  |- mesh__activeMeSHYear mesh__D004499 2004
% 212.58/212.72  |- mesh__recordMaintainer mesh__D004499 kle
% 212.58/212.72  |- skos__prefLabel mesh__D004499 Education, Dental, Graduate
% 212.58/212.72  |- mesh__dateEstablished mesh__D004499 1966-01-01
% 212.58/212.72  |- mesh__activeMeSHYear mesh__D004499 2000
% 212.58/212.72  |- mesh__recordAuthorizer mesh__D004499 sjn
% 212.58/212.72  |- rdf__type mesh__D004499sskos__Concept
% 212.58/212.72  |- mesh__activeMeSHYear mesh__D004499 2001
% 212.58/212.72  |- skos__altLabel mesh__D004499 Graduate Dental Education
% 212.58/212.72  |- mesh__onlineNote mesh__D004499
% 212.58/212.72       use EDUCATION, DENTAL, GRADUATE %26% EDUCATION, DENTAL, CONTINUING to search EDUCATION, DENTAL, POSTGRADUATE 1966-74%A%  
% 212.58/212.72  |- mesh__activeMeSHYear mesh__D004499 2002
% 212.58/212.72  |- skos__annotation mesh__D004499
% 212.58/212.72       differentiate from EDUCATION, DENTAL, CONTINUING: see note on EDUCATION, CONTINUING; DF: EDUC DENT GRAD%A%  
% 212.58/212.72  |- mesh__dateCreated mesh__D004499 1999-01-01
% 212.58/212.72  |- mesh__activeMeSHYear mesh__D004499 2005
% 212.58/212.72  |- skos__broader mesh__D004499smesh__D004500
% 212.58/212.72  |- skos__broader mesh__D004499smesh__D004497
% 212.58/212.72  |- skos__scopeNote mesh__D004499
% 212.58/212.72       Educational programs for dental graduates entering a specialty. They include formal specialty training as well as academic work in the clinical and basic dental sciences, and may lead to board certification or an advanced dental degree.%A%    
% 212.58/212.72  |- mesh__dateRevised mesh__D004499 1999-11-03
% 212.58/212.72  |- mesh__publicMeSHNote mesh__D004499
% 212.58/212.72       66; EDUCATION, DENTAL, POSTGRADUATE was see under EDUCATION, DENTAL, CONTINUING %26% EDUCATION, DENTAL, GRADUATE 1966-74; was heading 1965%A%  
% 212.58/212.72  |- mesh__recordOriginator mesh__D004499 NLM
% 212.58/212.72  |- mesh__activeMeSHYear mesh__D004499 2006
% 212.58/212.72  |- mesh__activeMeSHYear mesh__D004499 2003
% 212.58/212.72  |- mesh__historyNote mesh__D004499
% 212.58/212.72       66; EDUCATION, DENTAL, POSTGRADUATE was see under EDUCATION, DENTAL, CONTINUING %26% EDUCATION, DENTAL, GRADUATE 1966-74; was heading 1965%A%  
% 212.58/212.72  |- skos__altLabel mesh__D004499 Dental Education, Graduate
% 212.58/212.72  |- skos__broader mesh__D009982smesh__D009975
% 212.58/212.72  |- mesh__dateRevised mesh__D009982 2005-11-10
% 212.58/212.72  |- mesh__activeMeSHYear mesh__D009982 1997
% 212.58/212.72  |- skos__altLabel mesh__D009982 Influenza Viruses Type C
% 212.58/212.72  |- mesh__activeMeSHYear mesh__D009982 2005
% 212.58/212.72  |- rdf__type mesh__D009982sskos__Concept
% 212.58/212.72  |- skos__hiddenLabel mesh__D009982 Viruses, Influenza C
% 212.58/212.72  |- skos__prefLabel mesh__D009982 Influenzavirus C
% 212.58/212.72  |- mesh__recordOriginator mesh__D009982 RC
% 212.58/212.72  |- mesh__activeMeSHYear mesh__D009982 2004
% 212.58/212.72  |- mesh__activeMeSHYear mesh__D009982 2006A
% 212.58/212.72  |- mesh__recordAuthorizer mesh__D009982 ags
% 212.58/212.72  |- mesh__dateEstablished mesh__D009982 1991-01-01
% 212.58/212.72  |- mesh__activeMeSHYear mesh__D009982 2002
% 212.58/212.72  |- mesh__dateCreated mesh__D009982 1985-05-07
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009982 2003
% 212.58/212.73  |- mesh__historyNote mesh__D009982
% 212.58/212.73       97; was ORTHOMYXOVIRUSES TYPE C 1986-96 %28%see under ORTHOMYXOVIRIDAE 1986-90%29%%A%  
% 212.58/212.73  |- skos__hiddenLabel mesh__D009982 Influenza C Viruses
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009982 2001
% 212.58/212.73  |- skos__annotation mesh__D009982
% 212.58/212.73       infection: coordinate IM with INFLUENZA, HUMAN %28%IM%29% in humans or ORTHOMYXOVIRIDAE INFECTIONS %28%IM%29% in animals; INFLUENZA C VIRUS is also available%A%  
% 212.58/212.73  |- skos__hiddenLabel mesh__D009982 Virus, Influenza C
% 212.58/212.73  |- skos__historyNote mesh__D009982 Orthomyxoviridae %28%1981-1985%29%
% 212.58/212.73  |- mesh__recordMaintainer mesh__D009982 ags
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009982 1999
% 212.58/212.73  |- mesh__publicMeSHNote mesh__D009982
% 212.58/212.73       97; was ORTHOMYXOVIRUSES TYPE C 1986-96 %28%see under ORTHOMYXOVIRIDAE 1986-90%29%%A%  
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009982 2000
% 212.58/212.73  |- skos__scopeNote mesh__D009982
% 212.58/212.73       A genus of the family ORTHOMYXOVIRIDAE comprising viruses similar to types A and B but less common, more stable, more homogeneous, and lacking the neuraminidase protein. They have not been associated with epidemics but may cause mild influenza. Influenza C virus is the type species.%A%    
% 212.58/212.73  |- skos__altLabel mesh__D009982 Orthomyxoviruses Type C
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009982 1998
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009982 2006
% 212.58/212.73  |- skos__broader mesh__D004044Q000737smesh__D004044
% 212.58/212.73  |- mesh__preferredCombination mesh__D004044Q000737smesh__D011506
% 212.58/212.73  |- rdf__type mesh__D004044Q000737smesh__CompoundConcept
% 212.58/212.73  |- mesh__recordMaintainer mesh__D009184 ssb
% 212.58/212.73  |- skos__prefLabel mesh__D009184 Mydriatics
% 212.58/212.73  |- mesh__dateRevised mesh__D009184 2005-06-30
% 212.58/212.73  |- mesh__onlineNote mesh__D009184
% 212.58/212.73       use MYDRIATICS to search CYCLOPLEGICS 1966-78   
% 212.58/212.73  |- rdf__type mesh__D009184sskos__Concept
% 212.58/212.73  |- mesh__dateCreated mesh__D009184 1999-01-01
% 212.58/212.73  |- mesh__dateEstablished mesh__D009184 1964-01-01
% 212.58/212.73  |- skos__scopeNote mesh__D009184
% 212.58/212.73       Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. The latter cause cycloplegia or paralysis of accommodation at high doses and may precipitate glaucoma. Mydriatics are used in eye diseases and to facilitate eye examination.%A%    
% 212.58/212.73  |- mesh__publicMeSHNote mesh__D009184 CYCLOPLEGICS was heading 1963-78   
% 212.58/212.73  |- mesh__historyNote mesh__D009184 CYCLOPLEGICS was heading 1963-78   
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009184 2006
% 212.58/212.73  |- mesh__recordOriginator mesh__D009184 NLM
% 212.58/212.73  |- mesh__recordAuthorizer mesh__D009184 sjn
% 212.58/212.73  |- skos__annotation mesh__D009184
% 212.58/212.73       GEN or unspecified; prefer specifics; consider also PUPIL /drug eff; for CYCLOPLEGICS consider also CILIARY BODY /drug eff%A%  
% 212.58/212.73  |- skos__broader mesh__D009184smesh__D001337
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D017616 1999
% 212.58/212.73  |- mesh__dateCreated mesh__D017616 1993-06-04
% 212.58/212.73  |- mesh__publicMeSHNote mesh__D017616 94   
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D017616 2005
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D017616 1998
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D017616 2001
% 212.58/212.73  |- skos__historyNote mesh__D017616 Magnesium %28%1966-1993%29%
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D017616 1995
% 212.58/212.73  |- mesh__historyNote mesh__D017616 94   
% 212.58/212.73  |- skos__prefLabel mesh__D017616 Magnesium Compounds
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D017616 2000
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D017616 1994
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D017616 2004
% 212.58/212.73  |- mesh__dateEstablished mesh__D017616 1994-01-01
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D017616 1997
% 212.58/212.73  |- skos__annotation mesh__D017616
% 212.58/212.73       inorganic; GEN or unspecified; prefer specifics; DF: MAGNESIUM CPDS%A%  
% 212.58/212.73  |- skos__scopeNote mesh__D017616
% 212.58/212.73       Inorganic compounds that contain magnesium as an integral part of the molecule.%A%    
% 212.58/212.73  |- rdf__type mesh__D017616sskos__Concept
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D017616 2003
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D017616 1996
% 212.58/212.73  |- skos__hiddenLabel mesh__D017616 Compounds, Magnesium
% 212.58/212.73  |- skos__broader mesh__D017616smesh__D007287
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D017616 2002
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D017616 2006
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D033283 2003
% 212.58/212.73  |- skos__related mesh__D033283smesh__D030881
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D033283 2005
% 212.58/212.73  |- skos__historyNote mesh__D033283 Patient Rights %28%2000-2002%29%
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D033283 2004
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D033283 2006
% 212.58/212.73  |- skos__scopeNote mesh__D033283
% 212.58/212.73       The freedom of patients to review their own medical, genetic, or other health-related records.%A%    
% 212.58/212.73  |- skos__historyNote mesh__D033283 Patient Advocacy %28%1974-2002%29%
% 212.58/212.73  |- mesh__historyNote mesh__D033283
% 212.58/212.73       2003; use PATIENT RIGHTS 2002, use PATIENT ADVOCACY 1992-2001%A%  
% 212.58/212.73  |- mesh__dateCreated mesh__D033283 2002-07-03
% 212.58/212.73  |- skos__broader mesh__D033283smesh__D028701
% 212.58/212.73  |- mesh__publicMeSHNote mesh__D033283
% 212.58/212.73       2003; see PATIENT RIGHTS 2002, see PATIENT ADVOCACY 1992-2001%A%  
% 212.58/212.73  |- rdf__type mesh__D033283sskos__Concept
% 212.58/212.73  |- skos__prefLabel mesh__D033283 Patient Access to Records
% 212.58/212.73  |- skos__broader mesh__D033283smesh__D022126
% 212.58/212.73  |- mesh__dateEstablished mesh__D033283 2003-01-01
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D005592 2002
% 212.58/212.73  |- skos__hiddenLabel mesh__D005592 Fixation, Skeletal
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D005592 2006
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D005592 1998
% 212.58/212.73  |- skos__scopeNote mesh__D005592
% 212.58/212.73       The use of metallic devices inserted into or through bone to hold a fracture in a set position and alignment while it heals.%A%    
% 212.58/212.73  |- skos__prefLabel mesh__D005592 Fracture Fixation
% 212.58/212.73  |- mesh__dateCreated mesh__D005592 1999-01-01
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D005592 2003
% 212.58/212.73  |- skos__broader mesh__D005592smesh__D019637
% 212.58/212.73  |- skos__hiddenLabel mesh__D005592 Fixations, Skeletal
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D005592 1999
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D005592 2000
% 212.58/212.73  |- mesh__recordOriginator mesh__D005592 NLM
% 212.58/212.73  |- skos__altLabel mesh__D005592 Skeletal Fixation
% 212.58/212.73  |- skos__related mesh__D005592smesh__D009984
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D005592 2004
% 212.58/212.73  |- skos__related mesh__D005592smesh__D016267
% 212.58/212.73  |- mesh__dateRevised mesh__D005592 1997-06-20
% 212.58/212.73  |- mesh__recordAuthorizer mesh__D005592 SJN
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D005592 2001
% 212.58/212.73  |- skos__hiddenLabel mesh__D005592 Fixations, Fracture
% 212.58/212.73  |- skos__annotation mesh__D005592
% 212.58/212.73       TN 87: various types of fracture surg %26% related MeSH terms; osteosynthesis in fract surg goes under FRACTURE FIXATION, INTERNAL or FRACTURE FIXATION, INTRAMEDULLARY%A%  
% 212.58/212.73  |- mesh__recordMaintainer mesh__D005592 PXP
% 212.58/212.73  |- rdf__type mesh__D005592sskos__Concept
% 212.58/212.73  |- skos__hiddenLabel mesh__D005592 Fracture Fixations
% 212.58/212.73  |- skos__hiddenLabel mesh__D005592 Skeletal Fixations
% 212.58/212.73  |- skos__hiddenLabel mesh__D005592 Fixation, Fracture
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D005592 2005
% 212.58/212.73  |- skos__altLabel mesh__D013226 Absence Status
% 212.58/212.73  |- skos__annotation mesh__D013226
% 212.58/212.73       note X ref petit mal status: do not confuse with PETIT MAL EPILEPSY see EPILEPSY, ABSENCE%A%  
% 212.58/212.73  |- skos__altLabel mesh__D013226 Status Epilepticus, Electrographic
% 212.58/212.73  |- skos__altLabel mesh__D013226 Status Epilepticus, Complex Partial
% 212.58/212.73  |- mesh__recordAuthorizer mesh__D013226 ags
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013226 2006
% 212.58/212.73  |- mesh__dateEstablished mesh__D013226 1977-01-01
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013226 2006A
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013226 2000A
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013226 2002
% 212.58/212.73  |- mesh__dateRevised mesh__D013226 2005-07-22
% 212.58/212.73  |- skos__altLabel mesh__D013226 Status Epilepticus, Grand Mal
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013226 2005
% 212.58/212.73  |- skos__prefLabel mesh__D013226 Status Epilepticus
% 212.58/212.73  |- mesh__historyNote mesh__D013226 1977   
% 212.58/212.73  |- mesh__recordMaintainer mesh__D013226 ags
% 212.58/212.73  |- skos__scopeNote mesh__D013226
% 212.58/212.73       A prolonged seizure or seizures repeated frequently enough to prevent recovery between episodes occurring over a period of 20-30 minutes. The most common subtype is generalized tonic-clonic status epilepticus, a potentially fatal condition associated with neuronal injury and respiratory and metabolic dysfunction. Nonconvulsive forms include petit mal status and complex partial status, which may manifest as behavioral disturbances. Simple partial status epilepticus consists of persistent motor, sensory, or autonomic seizures that do not impair cognition %28%see also EPILEPSIA PARTIALIS CONTINUA%29%. Subclinical status epilepticus generally refers to seizures occurring in an unresponsive or comatose individual in the absence of overt signs of seizure activity. %28%From N Engl J Med 1998 Apr 2;338%28%14%29%:970-6; Neurologia 1997 Dec;12 Suppl 6:25-30%29%%A%    
% 212.58/212.73  |- mesh__dateCreated mesh__D013226 1976-04-27
% 212.58/212.73  |- skos__altLabel mesh__D013226 Generalized Convulsive Status Epilepticus
% 212.58/212.73  |- skos__altLabel mesh__D013226 Status Epilepticus, Generalized Convulsive
% 212.58/212.73  |- skos__altLabel mesh__D013226 Status Epilepticus, Generalized
% 212.58/212.73  |- rdf__type mesh__D013226sskos__Concept
% 212.58/212.73  |- skos__hiddenLabel mesh__D013226 Subclinical Status Epilepticus
% 212.58/212.73  |- skos__hiddenLabel mesh__D013226 Status Epilepticus, Non Convulsive
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013226 2001
% 212.58/212.73  |- skos__hiddenLabel mesh__D013226 Status, Absence
% 212.58/212.73  |- skos__altLabel mesh__D013226 Status Epilepticus, Non-Convulsive
% 212.58/212.73  |- mesh__recordOriginator mesh__D013226 MM
% 212.58/212.73  |- skos__hiddenLabel mesh__D013226 Status, Petit Mal
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013226 2004
% 212.58/212.73  |- mesh__publicMeSHNote mesh__D013226 1977   
% 212.58/212.73  |- skos__historyNote mesh__D013226 Epilepsy %28%1966-1976%29%
% 212.58/212.73  |- skos__altLabel mesh__D013226 Status Epilepticus, Simple Partial
% 212.58/212.73  |- skos__broader mesh__D013226smesh__D004827
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013226 2000
% 212.58/212.73  |- skos__hiddenLabel mesh__D013226 Generalized Status Epilepticus
% 212.58/212.73  |- skos__hiddenLabel mesh__D013226 Electrographic Status Epilepticus
% 212.58/212.73  |- skos__hiddenLabel mesh__D013226 Non Convulsive Status Epilepticus
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013226 2003
% 212.58/212.73  |- skos__scopeNote mesh__D051345
% 212.58/212.73       A member of the actin depolymerizing factors. Its depolymerizing activity is independent of HYDROGEN-ION CONCENTRATION.%A%    
% 212.58/212.73  |- skos__broader mesh__D051345smesh__D051339
% 212.58/212.73  |- mesh__dateEstablished mesh__D051345 2006-01-01
% 212.58/212.73  |- mesh__publicMeSHNote mesh__D051345
% 212.58/212.73       2006; DESTRIN was indexed under MICROFILAMENT PROTEINS 1988-2005, %26% under MUSCLE PROTEINS %26% PROTEINS 1981-1987%A%  
% 212.58/212.73  |- skos__altLabel mesh__D051345
% 212.58/212.73       ADF Protein %28%Actin Depolymerizing Factor%29%
% 212.58/212.73  |- mesh__historyNote mesh__D051345 2006%28%1981%29%   
% 212.58/212.73  |- mesh__recordMaintainer mesh__D051345 DRC
% 212.58/212.73  |- skos__altLabel mesh__D051345 Actin Depolymerizing Factor
% 212.58/212.73  |- skos__hiddenLabel mesh__D051345 Depolymerizing Factor, Actin
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D051345 2006
% 212.58/212.73  |- skos__altLabel mesh__D051345 DSTN Protein
% 212.58/212.73  |- skos__prefLabel mesh__D051345 Destrin
% 212.58/212.73  |- mesh__dateCreated mesh__D051345 2005-06-30
% 212.58/212.73  |- mesh__recordOriginator mesh__D051345 DRC
% 212.58/212.73  |- mesh__recordAuthorizer mesh__D051345 sjn
% 212.58/212.73  |- rdf__type mesh__D051345sskos__Concept
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009983 2001
% 212.58/212.73  |- mesh__dateCreated mesh__D009983 1999-01-01
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009983 2003
% 212.58/212.73  |- skos__hiddenLabel mesh__D009983 Equipments, Orthopedic
% 212.58/212.73  |- rdf__type mesh__D009983sskos__Concept
% 212.58/212.73  |- mesh__recordMaintainer mesh__D009983 PXP
% 212.58/212.73  |- mesh__recordOriginator mesh__D009983 NLM
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009983 2004
% 212.58/212.73  |- skos__scopeNote mesh__D009983
% 212.58/212.73       Nonexpendable items used in the performance of orthopedic surgery and related therapy. They are differentiated from ORTHOTIC DEVICES, apparatus used to prevent or correct deformities in patients.%A%    
% 212.58/212.73  |- skos__broader mesh__D009983smesh__D013523
% 212.58/212.73  |- skos__annotation mesh__D009983
% 212.58/212.73       nonexpendable %26% used by the orthopedic surgeon; do not confuse with ORTHOTIC DEVICES used on the patient%A%  
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009983 2002
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009983 1998
% 212.58/212.73  |- skos__hiddenLabel mesh__D009983 Orthopedic Equipments
% 212.58/212.73  |- skos__prefLabel mesh__D009983 Orthopedic Equipment
% 212.58/212.73  |- mesh__recordAuthorizer mesh__D009983 SJN
% 212.58/212.73  |- skos__hiddenLabel mesh__D009983 Equipment, Orthopedic
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009983 1999
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009983 2000
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009983 2005
% 212.58/212.73  |- mesh__dateRevised mesh__D009983 1997-06-20
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009983 2006
% 212.58/212.73  |- skos__hiddenLabel mesh__D009185 Proteins, Myelin
% 212.58/212.73  |- skos__annotation mesh__D009185
% 212.58/212.73       GEN or unspecified; prefer specifics; not a synonym for MYELIN see MYELIN SHEATH; do not routinely coord with MYELIN SHEATH unless this is particularly discussed; /biosyn /drug eff /physiol /ultrastruct permitted%A%  
% 212.58/212.73  |- skos__prefLabel mesh__D009185 Myelin Proteins
% 212.58/212.73  |- skos__historyNote mesh__D009185 Myelin Sheath %28%1966-1976%29%
% 212.58/212.73  |- mesh__recordAuthorizer mesh__D009185 sjn
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009185 2006
% 212.58/212.73  |- skos__scopeNote mesh__D009185
% 212.58/212.73       Proteins found in the myelin sheath. The major proteins of central nervous system myelin include: MYELIN PROTEOLIPID PROTEIN; MYELIN BASIC PROTEINS; and MYELIN-ASSOCIATED GLYCOPROTEIN. The major proteins of peripheral nervous system myelin include: MYELIN BASIC PROTEINS %28%myelin P1 protein and MYELIN P2 PROTEIN%29%; MYELIN P0 PROTEIN; and MYELIN-ASSOCIATED GLYCOPROTEIN.%A%    
% 212.58/212.73  |- mesh__recordOriginator mesh__D009185 RLS
% 212.58/212.73  |- mesh__publicMeSHNote mesh__D009185 77   
% 212.58/212.73  |- skos__historyNote mesh__D009185 Nerve Tissue Proteins %28%1966-1976%29%
% 212.58/212.73  |- skos__broader mesh__D009185smesh__D008565
% 212.58/212.73  |- mesh__dateRevised mesh__D009185 2005-06-30
% 212.58/212.73  |- skos__broader mesh__D009185smesh__D009419
% 212.58/212.73  |- mesh__dateEstablished mesh__D009185 1977-01-01
% 212.58/212.73  |- mesh__recordMaintainer mesh__D009185 SYSTEM
% 212.58/212.73  |- mesh__historyNote mesh__D009185 77   
% 212.58/212.73  |- mesh__dateCreated mesh__D009185 1976-05-19
% 212.58/212.73  |- rdf__type mesh__D009185sskos__Concept
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D005593 1999
% 212.58/212.73  |- skos__annotation mesh__D005593
% 212.58/212.73       do not use /util except by MeSH definition; TN 87; osteosynthesis in fracture surg goes here or under FRACTURE FIXATION, INTRAMEDULLARY%A%  
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D005593 2001
% 212.58/212.73  |- skos__hiddenLabel mesh__D005593 Internal Fracture Fixation
% 212.58/212.73  |- skos__hiddenLabel mesh__D005593 Fixation, Internal Fracture
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D005593 2004
% 212.58/212.73  |- mesh__dateEstablished mesh__D005593 1972-01-01
% 212.58/212.73  |- skos__hiddenLabel mesh__D005593 Fixations, Internal Fracture
% 212.58/212.73  |- skos__hiddenLabel mesh__D005593 Fracture Osteosynthesis
% 212.58/212.73  |- mesh__recordMaintainer mesh__D005593 PXP
% 212.58/212.73  |- mesh__publicMeSHNote mesh__D005593 72   
% 212.58/212.73  |- skos__prefLabel mesh__D005593 Fracture Fixation, Internal
% 212.58/212.73  |- mesh__historyNote mesh__D005593 72%28%70%29%   
% 212.58/212.73  |- rdf__type mesh__D005593sskos__Concept
% 212.58/212.73  |- skos__hiddenLabel mesh__D005593 Osteosyntheses, Fracture
% 212.58/212.73  |- skos__scopeNote mesh__D005593
% 212.58/212.73       The use of internal devices %28%metal plates, nails, rods, etc.%29% to hold the position of a fracture in proper alignment.%A%    
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D005593 2002
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D005593 2005
% 212.58/212.73  |- skos__hiddenLabel mesh__D005593 Fracture Fixations, Internal
% 212.58/212.73  |- skos__altLabel mesh__D005593 Osteosynthesis, Fracture
% 212.58/212.73  |- skos__hiddenLabel mesh__D005593 Fracture Osteosyntheses
% 212.58/212.73  |- mesh__recordOriginator mesh__D005593 NLM
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D005593 2006
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D005593 2000
% 212.58/212.73  |- skos__broader mesh__D005593smesh__D005592
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D005593 1998
% 212.58/212.73  |- skos__hiddenLabel mesh__D005593 Internal Fracture Fixations
% 212.58/212.73  |- skos__historyNote mesh__D005593 Fracture Fixation %28%1966-1969%29%
% 212.58/212.73  |- mesh__dateCreated mesh__D005593 1999-01-01
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D005593 2003
% 212.58/212.73  |- mesh__dateRevised mesh__D005593 1997-06-20
% 212.58/212.73  |- mesh__recordAuthorizer mesh__D005593 SJN
% 212.58/212.73  |- skos__related mesh__D005593smesh__D016268
% 212.58/212.73  |- mesh__dateCreated mesh__D013227 1999-01-01
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013227 2006
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013227 1998
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013227 2000
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013227 2005
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013227 1995
% 212.58/212.73  |- mesh__recordAuthorizer mesh__D013227 PLS
% 212.58/212.73  |- skos__hiddenLabel mesh__D013227 Steams
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013227 1994
% 212.58/212.73  |- skos__broader mesh__D013227smesh__D014867
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013227 1997
% 212.58/212.73  |- mesh__recordMaintainer mesh__D013227 TAP
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013227 2002
% 212.58/212.73  |- rdf__type mesh__D013227sskos__Concept
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013227 2004
% 212.58/212.73  |- mesh__recordOriginator mesh__D013227 NLM
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013227 1996
% 212.58/212.73  |- mesh__dateRevised mesh__D013227 1992-05-18
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013227 2003
% 212.58/212.73  |- skos__prefLabel mesh__D013227 Steam
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013227 1993
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013227 1999
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D013227 2001
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Unit, Pain Relief
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Service, Acute Pain
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D018710 2001
% 212.58/212.73  |- rdf__type mesh__D018710sskos__Concept
% 212.58/212.73  |- skos__broader mesh__D018710smesh__D010044
% 212.58/212.73  |- mesh__dateRevised mesh__D018710 1995-05-22
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Clinics, Multidisciplinary Pain
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D018710 2005
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Centers, Pain
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Multidisciplinary Pain Clinic
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Clinics, Pain
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D018710 1999
% 212.58/212.73  |- skos__broader mesh__D018710smesh__D000554
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D018710 1996
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D018710 2002
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Pain Services, Acute
% 212.58/212.73  |- skos__altLabel mesh__D018710 Pain Relief Units
% 212.58/212.73  |- mesh__recordOriginator mesh__D018710 JLS
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D018710 2006
% 212.58/212.73  |- skos__scopeNote mesh__D018710
% 212.58/212.73       Facilities providing diagnostic, therapeutic, and palliative services for patients with severe chronic pain. These may be free-standing clinics or hospital-based and serve ambulatory or inpatient populations. The approach is usually multidisciplinary. These clinics are often referred to as %22%acute pain services%22%. %28%From Br Med Bull 1991 Jul;47%28%3%29%:762-85%29%%A%    
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Center, Pain
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Centers, Multidisciplinary Pain
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D018710 2003
% 212.58/212.73  |- skos__prefLabel mesh__D018710 Pain Clinics
% 212.58/212.73  |- mesh__historyNote mesh__D018710 95   
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D018710 1997
% 212.58/212.73  |- mesh__recordMaintainer mesh__D018710 KEV
% 212.58/212.73  |- mesh__dateCreated mesh__D018710 1994-05-23
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Pain Clinic, Multidisciplinary
% 212.58/212.73  |- skos__altLabel mesh__D018710 Pain Centers
% 212.58/212.73  |- mesh__recordAuthorizer mesh__D018710 PLS
% 212.58/212.73  |- skos__altLabel mesh__D018710 Pain Service, Acute
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Multidisciplinary Pain Center
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D018710 2004
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Services, Acute Pain
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Pain Center
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Clinic, Pain
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Pain Clinics, Multidisciplinary
% 212.58/212.73  |- skos__annotation mesh__D018710
% 212.58/212.73       for diag %26% ther; coord IM with specific dis %28%IM%29% if pertinent%A%  
% 212.58/212.73  |- mesh__dateEstablished mesh__D018710 1995-01-01
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Center, Multidisciplinary Pain
% 212.58/212.73  |- skos__historyNote mesh__D018710 Pain %28%1966-1994%29%
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Pain Clinic
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Pain Relief Unit
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D018710 2000
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Clinic, Multidisciplinary Pain
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Acute Pain Services
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Pain Centers, Multidisciplinary
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Pain Center, Multidisciplinary
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D018710 1998
% 212.58/212.73  |- skos__hiddenLabel mesh__D018710 Units, Pain Relief
% 212.58/212.73  |- mesh__publicMeSHNote mesh__D018710 95   
% 212.58/212.73  |- skos__hiddenLabel mesh__D051346 Limitation, Mobility
% 212.58/212.73  |- skos__broader mesh__D051346smesh__D012816
% 212.58/212.73  |- mesh__recordAuthorizer mesh__D051346 sjn
% 212.58/212.73  |- skos__altLabel mesh__D051346 Difficulty Walking
% 212.58/212.73  |- skos__hiddenLabel mesh__D051346 Mobility Limitations
% 212.58/212.73  |- skos__scopeNote mesh__D051346
% 212.58/212.73       Difficulty in walking from place to place.     
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D051346 2006
% 212.58/212.73  |- skos__related mesh__D051346smesh__D051341
% 212.58/212.73  |- mesh__recordMaintainer mesh__D051346 lkt
% 212.58/212.73  |- mesh__dateEstablished mesh__D051346 2006-01-01
% 212.58/212.73  |- skos__prefLabel mesh__D051346 Mobility Limitation
% 212.58/212.73  |- skos__altLabel mesh__D051346 Ambulatory Difficulty
% 212.58/212.73  |- mesh__recordOriginator mesh__D051346 lkt
% 212.58/212.73  |- mesh__historyNote mesh__D051346 2006   
% 212.58/212.73  |- mesh__publicMeSHNote mesh__D051346 2006   
% 212.58/212.73  |- rdf__type mesh__D051346sskos__Concept
% 212.58/212.73  |- skos__altLabel mesh__D051346 Difficulty Ambulation
% 212.58/212.73  |- mesh__dateCreated mesh__D051346 2005-06-30
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009984 2000
% 212.58/212.73  |- rdf__type mesh__D009984sskos__Concept
% 212.58/212.73  |- skos__historyNote mesh__D009984
% 212.58/212.73       Fracture Fixation/instrumentation %28%1966-1970%29%
% 212.58/212.73  |- skos__hiddenLabel mesh__D009984 Fixation Devices, Orthopedic
% 212.58/212.73  |- skos__annotation mesh__D009984 TN 124: /adv eff   
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009984 2004
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009984 1995
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009984 2001
% 212.58/212.73  |- skos__scopeNote mesh__D009984
% 212.58/212.73       Devices which are used in the treatment of orthopedic injuries and diseases.%A%    
% 212.58/212.73  |- skos__broader mesh__D009984smesh__D009983
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009984 1998
% 212.58/212.73  |- skos__hiddenLabel mesh__D009984 Device, Orthopedic Fixation
% 212.58/212.73  |- skos__hiddenLabel mesh__D009984 Fixation Device, Orthopedic
% 212.58/212.73  |- mesh__recordOriginator mesh__D009984 NLM
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009984 1999
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009984 2005
% 212.58/212.73  |- mesh__publicMeSHNote mesh__D009984 72   
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009984 1993
% 212.58/212.73  |- skos__hiddenLabel mesh__D009984 Orthopedic Fixation Device
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009984 2002
% 212.58/212.73  |- skos__historyNote mesh__D009984
% 212.58/212.73       Fracture Fixation, Intramedullary/instrumentation %28%1970%29%
% 212.58/212.73  |- mesh__dateRevised mesh__D009984 1992-05-15
% 212.58/212.73  |- mesh__recordAuthorizer mesh__D009984 PLS
% 212.58/212.73  |- mesh__historyNote mesh__D009984 72%28%71%29%   
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009984 1996
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009984 2006
% 212.58/212.73  |- skos__hiddenLabel mesh__D009984 Devices, Orthopedic Fixation
% 212.58/212.73  |- skos__prefLabel mesh__D009984 Orthopedic Fixation Devices
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009984 2003
% 212.58/212.73  |- mesh__dateCreated mesh__D009984 1999-01-01
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009984 1997
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009984 1994
% 212.58/212.73  |- mesh__recordMaintainer mesh__D009984 TAP
% 212.58/212.73  |- mesh__dateEstablished mesh__D009984 1972-01-01
% 212.58/212.73  |- skos__historyNote mesh__D009984 Orthopedic Equipment %28%1966-1970%29%
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009186 2005
% 212.58/212.73  |- mesh__recordMaintainer mesh__D009186 lkt
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009186 2003
% 212.58/212.73  |- skos__prefLabel mesh__D009186 Myelin Sheath
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009186 2006
% 212.58/212.73  |- mesh__activeMeSHYear mesh__D009186 2004
% 212.58/212.73  |- skos__annotation mesh__D009186
% 212.58/212.73       X ref MYELIN is the substance of the myelin sheath: do not confuse with MYELIN BASIC PROTEINS; myelination: index under MYELIN SHEATH /physiol%A%  
% 212.58/212.73  |- skos__broader mesh__D009186smesh__D009417
% 212.58/212.73  |- mesh__dateRevised mesh__D009186 2002-07-03
% 212.58/212.73  |- skos__hiddenLabel mesh__D009186 Myelin Sheaths
% 212.58/212.73  |- skos__broader mesh__D009186smesh__D009836
% 212.58/212.73  |- mesh__recordOriginator mesh__D009186 NLM
% 212.58/212.73  |- skos__hiddenLabel mesh__D009186 Sheaths, Myelin
% 212.58/212.73  |- mesh__recordAuthorizer mesh__D009186 sjn
% 212.58/212.73  |- skos__broader mesh__D009186smesh__D021961
% 212.58/212.73  |- rdf__type mesh__D009186sskos__Concept
% 212.58/212.73  |- skos__hiddenLabel mesh__D009186 Sheath, Myelin
% 212.58/212.73  |- skos__broader mesh__D009186smesh__D009413
% 212.58/212.73  |- mesh__dateCreated mesh__D009186 1999-01-01
% 212.58/212.73  |- skos__scopeNote mesh__D009186
% 212.58/212.73       The lipid-rich sheath surrounding AXONS in both the central and peripheral nervous systems. The myelin sheath is an electrical insulator and allows faster and more energetically efficient conduction of impulses. The sheath is formed by the cell membranes of glial cells %28%SCHWANN CELLS in the peripheral and OLIGODENDROGLIA in the central nervous system%29%. Deterioration of the sheath in DEMYELINATING DISEASES is a serious clinical problem.%A%    
% 212.58/212.73  |- skos__broader mesh__D009186smesh__D012583
% 212.58/212.73  |- skos__broader mesh__D014320smesh__D001555
% 212.58/212.73  |- mesh__recordOriginator mesh__D014320 NLM
% 212.58/212.73  |- mesh__historyNote mesh__D014320 74   
% 212.58/212.74  |- rdf__type mesh__D014320sskos__Concept
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D014320 1996
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D014320 2003
% 212.58/212.74  |- mesh__recordAuthorizer mesh__D014320 PLS
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D014320 1998
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D014320 2005
% 212.58/212.74  |- skos__prefLabel mesh__D014320 Trityl Compounds
% 212.58/212.74  |- mesh__dateCreated mesh__D014320 1999-01-01
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D014320 2004
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D014320 1997
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D014320 1994
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D014320 2002
% 212.58/212.74  |- skos__altLabel mesh__D014320 Triphenylmethyl Compounds
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D014320 1999
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D014320 2006
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D014320 1993
% 212.58/212.74  |- mesh__dateEstablished mesh__D014320 1974-01-01
% 212.58/212.74  |- skos__hiddenLabel mesh__D014320 Compounds, Triphenylmethyl
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D014320 1995
% 212.58/212.74  |- mesh__dateRevised mesh__D014320 1992-05-20
% 212.58/212.74  |- mesh__publicMeSHNote mesh__D014320 74   
% 212.58/212.74  |- mesh__recordMaintainer mesh__D014320 TAP
% 212.58/212.74  |- skos__annotation mesh__D014320 benzene derivatives; DF: TRITYL CPDS   
% 212.58/212.74  |- skos__hiddenLabel mesh__D014320 Compounds, Trityl
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D014320 2000
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D014320 2001
% 212.58/212.74  |- skos__prefLabel mesh__D000300 Adoption
% 212.58/212.74  |- skos__scopeNote mesh__D000300
% 212.58/212.74       Voluntary acceptance of a child of other parents to be as one%27%s own child, usually with legal confirmation.%A%    
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D000300 2003
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D000300 2001
% 212.58/212.74  |- mesh__recordAuthorizer mesh__D000300 SJN
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D000300 2000
% 212.58/212.74  |- skos__hiddenLabel mesh__D000300 Adoptions
% 212.58/212.74  |- skos__broader mesh__D000300smesh__D005190
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D000300 2006
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D000300 1999
% 212.58/212.74  |- mesh__dateRevised mesh__D000300 1997-06-20
% 212.58/212.74  |- mesh__recordMaintainer mesh__D000300 TPW
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D000300 2005
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D000300 1998
% 212.58/212.74  |- mesh__dateCreated mesh__D000300 1999-01-01
% 212.58/212.74  |- mesh__recordOriginator mesh__D000300 NLM
% 212.58/212.74  |- rdf__type mesh__D000300sskos__Concept
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D000300 2004
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D000300 2002
% 212.58/212.74  |- skos__historyNote mesh__D005594
% 212.58/212.74       specific fracture/surgery %28%1966-1969%29%
% 212.58/212.74  |- mesh__recordAuthorizer mesh__D005594 SJN
% 212.58/212.74  |- mesh__historyNote mesh__D005594 70   
% 212.58/212.74  |- mesh__dateRevised mesh__D005594 1997-06-20
% 212.58/212.74  |- skos__annotation mesh__D005594
% 212.58/212.74       do not use /util except by MeSH definition; TN 87: definition%A%  
% 212.58/212.74  |- mesh__publicMeSHNote mesh__D005594 70   
% 212.58/212.74  |- rdf__type mesh__D005594sskos__Concept
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D005594 2001
% 212.58/212.74  |- skos__hiddenLabel mesh__D005594 Nailings, Intramedullary
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D005594 2005
% 212.58/212.74  |- mesh__recordMaintainer mesh__D005594 PXP
% 212.58/212.74  |- skos__hiddenLabel mesh__D005594 Intramedullary Fracture Fixations
% 212.58/212.74  |- skos__hiddenLabel mesh__D005594 Fixations, Intramedullary Fracture
% 212.58/212.74  |- skos__broader mesh__D005594smesh__D005593
% 212.58/212.74  |- skos__hiddenLabel mesh__D005594 Fixation, Intramedullary Fracture
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D005594 2006
% 212.58/212.74  |- skos__altLabel mesh__D005594 Osteosynthesis, Fracture, Intramedullary
% 212.58/212.74  |- skos__altLabel mesh__D005594 Nailing, Intramedullary
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D005594 1998
% 212.58/212.74  |- skos__hiddenLabel mesh__D005594 Fracture Fixations, Intramedullary
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D005594 2002
% 212.58/212.74  |- mesh__dateEstablished mesh__D005594 1970-01-01
% 212.58/212.74  |- skos__historyNote mesh__D005594 Fracture Fixation %28%1966-1969%29%
% 212.58/212.74  |- mesh__dateCreated mesh__D005594 1999-01-01
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D005594 2003
% 212.58/212.74  |- skos__related mesh__D005594smesh__D016268
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D005594 1999
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D005594 2004
% 212.58/212.74  |- skos__hiddenLabel mesh__D005594 Intramedullary Nailings
% 212.58/212.74  |- skos__hiddenLabel mesh__D005594 Intramedullary Fracture Fixation
% 212.58/212.74  |- mesh__recordOriginator mesh__D005594 NLM
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D005594 2000
% 212.58/212.74  |- skos__prefLabel mesh__D005594 Fracture Fixation, Intramedullary
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D013228 2006
% 212.58/212.74  |- skos__historyNote mesh__D013228 Stearic Acids %28%1966-1974%29%
% 212.58/212.74  |- mesh__dateRevised mesh__D013228 2003-07-09
% 212.58/212.74  |- mesh__historyNote mesh__D013228
% 212.58/212.74       91%28%75%29%; was see under STEARIC ACIDS 1975-90   
% 212.58/212.74  |- mesh__publicMeSHNote mesh__D013228
% 212.58/212.74       91; was see under STEARIC ACIDS 1975-90   
% 212.58/212.74  |- skos__broader mesh__D013228smesh__D013229
% 212.58/212.74  |- skos__scopeNote mesh__D013228
% 212.58/212.74       Salts and esters of the 18-carbon saturated, monocarboxylic acid--stearic acid.%A%    
% 212.58/212.74  |- skos__prefLabel mesh__D013228 Stearates
% 212.58/212.74  |- mesh__recordMaintainer mesh__D013228 ssb
% 212.58/212.74  |- rdf__type mesh__D013228sskos__Concept
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D013228 2004
% 212.58/212.74  |- mesh__dateEstablished mesh__D013228 1991-01-01
% 212.58/212.74  |- mesh__dateCreated mesh__D013228 1974-11-11
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D013228 2005
% 212.58/212.74  |- mesh__recordAuthorizer mesh__D013228 sjn
% 212.58/212.74  |- skos__altLabel mesh__D013228 Octadecanoates
% 212.58/212.74  |- mesh__recordOriginator mesh__D013228 NLM
% 212.58/212.74  |- skos__altLabel mesh__D051347 Cap Z Protein
% 212.58/212.74  |- skos__prefLabel mesh__D051347 CapZ Actin Capping Protein
% 212.58/212.74  |- mesh__recordOriginator mesh__D051347 DRC
% 212.58/212.74  |- mesh__historyNote mesh__D051347 2006%28%1991%29%   
% 212.58/212.74  |- rdf__type mesh__D051347sskos__Concept
% 212.58/212.74  |- mesh__dateCreated mesh__D051347 2005-06-30
% 212.58/212.74  |- skos__altLabel mesh__D051347 CapZ Protein, alpha Subunit
% 212.58/212.74  |- mesh__publicMeSHNote mesh__D051347
% 212.58/212.74       2006; CAPZ PROTEIN was indexed under MICROFILAMENT PROTEINS %26% MUSCLE PROTEINS 1991-2005%A%  
% 212.58/212.74  |- mesh__recordAuthorizer mesh__D051347 sjn
% 212.58/212.74  |- mesh__dateEstablished mesh__D051347 2006-01-01
% 212.58/212.74  |- skos__broader mesh__D051347smesh__D009124
% 212.58/212.74  |- skos__scopeNote mesh__D051347
% 212.58/212.74       An actin capping protein that binds to the barbed-ends of ACTIN filaments. It is a heterodimer consisting of an alpha and a beta subunit. It regulates actin assembly by stabilizing actin oligomers for elongation. In SKELETAL MUSCLE, CapZ is localized to the Z-disk.%A%    
% 212.58/212.74  |- skos__altLabel mesh__D051347 CapZ Protein
% 212.58/212.74  |- mesh__recordMaintainer mesh__D051347 DRC
% 212.58/212.74  |- skos__altLabel mesh__D051347 CapZ Protein, beta Subunit
% 212.58/212.74  |- skos__broader mesh__D051347smesh__D051344
% 212.58/212.74  |- skos__altLabel mesh__D051347 CapZ beta Protein
% 212.58/212.74  |- skos__altLabel mesh__D051347 CapZ alpha Protein
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D051347 2006
% 212.58/212.74  |- skos__annotation mesh__D009985
% 212.58/212.74       SPEC: SPEC qualif; Manual 26.19+; orthopedie dento-faciale in French titles is translated %22%orthodontics%22% %26% is indexed under ORTHODONTICS%A%  
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D009985 1999
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D009985 2005
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D009985 2006
% 212.58/212.74  |- mesh__recordAuthorizer mesh__D009985 SJN
% 212.58/212.74  |- skos__related mesh__D009985smesh__D019637
% 212.58/212.74  |- skos__scopeNote mesh__D009985
% 212.58/212.74       A surgical specialty which utilizes medical, surgical, and physical methods to treat and correct deformities, diseases, and injuries to the skeletal system, its articulations, and associated structures.%A%    
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D009985 2000
% 212.58/212.74  |- skos__hiddenLabel mesh__D009985 Surgeries, Orthopedic
% 212.58/212.74  |- mesh__dateCreated mesh__D009985 1999-01-01
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D009985 2003
% 212.58/212.74  |- mesh__dateRevised mesh__D009985 1997-06-20
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D009985 2001
% 212.58/212.74  |- skos__broader mesh__D009985smesh__D013043
% 212.58/212.74  |- rdf__type mesh__D009985sskos__Concept
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D009985 2004
% 212.58/212.74  |- mesh__recordMaintainer mesh__D009985 PXP
% 212.58/212.74  |- skos__altLabel mesh__D009985 Surgery, Orthopedic
% 212.58/212.74  |- mesh__recordOriginator mesh__D009985 NLM
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D009985 1998
% 212.58/212.74  |- skos__hiddenLabel mesh__D009985 Orthopedic Surgeries
% 212.58/212.74  |- skos__hiddenLabel mesh__D009985 Orthopedic
% 212.58/212.74  |- skos__prefLabel mesh__D009985 Orthopedics
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D009985 2002
% 212.58/212.74  |- skos__broader mesh__D009187smesh__D013118
% 212.58/212.74  |- rdf__type mesh__D009187sskos__Concept
% 212.58/212.74  |- skos__annotation mesh__D009187
% 212.58/212.74       do not confuse with inflamm of the bone marrow %28% = OSTEOMYELITIS%29%; SMON %28%subacute-myelo-optico-neuropathy%29% is indexed here + OPTIC NEURITIS + SYNDROME; coord IM with specific cause %28%IM%29% if pertinent%A%  
% 212.58/212.74  |- mesh__dateRevised mesh__D009187 2003-07-25
% 212.58/212.74  |- mesh__recordMaintainer mesh__D009187 sjn
% 212.58/212.74  |- skos__hiddenLabel mesh__D009187 Inflammatory Myelopathies
% 212.58/212.74  |- skos__altLabel mesh__D009187 Inflammation, Spinal Cord
% 212.58/212.74  |- skos__broader mesh__D009187smesh__D020805
% 212.58/212.74  |- skos__scopeNote mesh__D009187
% 212.58/212.74       Inflammation of the spinal cord. Relatively common etiologies include infections; AUTOIMMUNE DISEASES; SPINAL CORD; and ischemia %28%see also SPINAL CORD VASCULAR DISEASES%29%. Clinical features generally include weakness, sensory loss, localized pain, incontinence, and other signs of autonomic dysfunction.%A%    
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D009187 2004
% 212.58/212.74  |- skos__hiddenLabel mesh__D009187 Inflammatory Myelopathy
% 212.58/212.74  |- skos__broader mesh__D009187smesh__D002494
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D009187 2006
% 212.58/212.74  |- skos__hiddenLabel mesh__D009187 Myelopathies, Inflammatory
% 212.58/212.74  |- skos__hiddenLabel mesh__D009187 Spinal Cord Inflammations
% 212.58/212.74  |- skos__hiddenLabel mesh__D009187 Myelitis, Subacute Necrotising
% 212.58/212.74  |- mesh__dateCreated mesh__D009187 1999-01-01
% 212.58/212.74  |- skos__hiddenLabel mesh__D009187 Inflammations, Spinal Cord
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D009187 2005
% 212.58/212.74  |- skos__hiddenLabel mesh__D009187 Myelitides
% 212.58/212.74  |- skos__hiddenLabel mesh__D009187 Myelitis, Infectious
% 212.58/212.74  |- skos__prefLabel mesh__D009187 Myelitis
% 212.58/212.74  |- skos__hiddenLabel mesh__D009187 Necrotising Myelitis, Subacute
% 212.58/212.74  |- skos__altLabel mesh__D009187 Myelopathy, Inflammatory
% 212.58/212.74  |- mesh__recordAuthorizer mesh__D009187 sjn
% 212.58/212.74  |- mesh__recordOriginator mesh__D009187 NLM
% 212.58/212.74  |- skos__altLabel mesh__D009187 Spinal Cord Inflammation
% 212.58/212.74  |- skos__hiddenLabel mesh__D042810 Tyrosine Kinase, TIE1
% 212.58/212.74  |- skos__historyNote mesh__D042810
% 212.58/212.74       Receptor Protein-Tyrosine Kinase %28%1994-2003%29%
% 212.58/212.74  |- skos__annotation mesh__D042810 see SCR for organism-specific terms   
% 212.58/212.74  |- skos__altLabel mesh__D042810 TIE-1 Receptor Tyrosine Kinase
% 212.58/212.74  |- skos__altLabel mesh__D042810 TIE1 Tyrosine Kinase
% 212.58/212.74  |- mesh__dateRevised mesh__D042810 2005-06-30
% 212.58/212.74  |- skos__hiddenLabel mesh__D042810 TIE-1 Receptor
% 212.58/212.74  |- skos__hiddenLabel mesh__D042810 Receptor, TIE 1
% 212.58/212.74  |- mesh__publicMeSHNote mesh__D042810
% 212.58/212.74       2004; TIE-1 RECEPTOR TYROSINE KINASE %26% TIE1 TYROSINE KINASE were indexed under RECEPTORS, CELL SURFACE %26% RECEPTOR PROTEIN-TYROSINE KINASES 1993-2003%A%  
% 212.58/212.74  |- skos__hiddenLabel mesh__D042810 TIE 1 Receptor Tyrosine Kinase
% 212.58/212.74  |- mesh__recordOriginator mesh__D042810 jmp
% 212.58/212.74  |- skos__broader mesh__D042810smesh__D042764
% 212.58/212.74  |- skos__historyNote mesh__D042810
% 212.58/212.74       Protein-Tyrosine Kinase %28%1992-1993%29%
% 212.58/212.74  |- mesh__dateCreated mesh__D042810 2003-07-09
% 212.58/212.74  |- skos__historyNote mesh__D042810
% 212.58/212.74       Receptors, Cell Surface %28%1994-2003%29%
% 212.58/212.74  |- rdf__type mesh__D042810sskos__Concept
% 212.58/212.74  |- skos__scopeNote mesh__D042810
% 212.58/212.74       A TIE receptor found predominantly on ENDOTHELIAL CELLS. It is considered essential for vascular development and can form a heterodimer with the TIE-2 RECEPTOR. The TIE-1 receptor may play a role in regulating BLOOD VESSEL stability and maturation.%A%    
% 212.58/212.74  |- mesh__recordAuthorizer mesh__D042810 sjn
% 212.58/212.74  |- mesh__dateEstablished mesh__D042810 2004-01-01
% 212.58/212.74  |- mesh__recordMaintainer mesh__D042810 jmp
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D042810 2006
% 212.58/212.74  |- skos__prefLabel mesh__D042810 Receptor, TIE-1
% 212.58/212.74  |- mesh__historyNote mesh__D042810
% 212.58/212.74       2004; for TIE-1 RECEPTOR TYROSINE KINASE %26% TIE1 TYROSINE KINASE use RECEPTOR, TIE-1 %28%NM%29% 1993-2003%A%  
% 212.58/212.74  |- skos__hiddenLabel mesh__D017619 Irradiations, Hemibody
% 212.58/212.74  |- mesh__dateEstablished mesh__D017619 1994-01-01
% 212.58/212.74  |- skos__altLabel mesh__D017619 Half-Body Irradiation
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D017619 2006
% 212.58/212.74  |- mesh__recordMaintainer mesh__D017619 lkt
% 212.58/212.74  |- skos__hiddenLabel mesh__D017619 Irradiations, Systemic Hemibody
% 212.58/212.74  |- skos__historyNote mesh__D017619 Whole-Body Irradiation %28%1981-1993%29%
% 212.58/212.74  |- skos__hiddenLabel mesh__D017619 Hemibody Irradiation, Systemic
% 212.58/212.74  |- skos__hiddenLabel mesh__D017619 Sequential Hemibody Irradiations
% 212.58/212.74  |- skos__related mesh__D017619smesh__D014916
% 212.58/212.74  |- skos__hiddenLabel mesh__D017619 Hemi-Body Irradiations
% 212.58/212.74  |- skos__altLabel mesh__D017619 Hemi-Body Irradiation
% 212.58/212.74  |- skos__altLabel mesh__D017619 Irradiation, Hemibody
% 212.58/212.74  |- skos__hiddenLabel mesh__D017619 Irradiations, Half-Body
% 212.58/212.74  |- mesh__historyNote mesh__D017619 94   
% 212.58/212.74  |- skos__hiddenLabel mesh__D017619 Half-Body Irradiations
% 212.58/212.74  |- mesh__dateCreated mesh__D017619 1992-12-28
% 212.58/212.74  |- mesh__recordAuthorizer mesh__D017619 sjn
% 212.58/212.74  |- skos__altLabel mesh__D017619 Systemic Hemibody Irradiation
% 212.58/212.74  |- skos__annotation mesh__D017619
% 212.58/212.74       in radiother coord IM with disease /radiother %28%IM%29%; for hemibody irrad experiments, see note on WHOLE-BODY IRRADIATION; DF: HEMIBODY IRRAD%A%  
% 212.58/212.74  |- skos__historyNote mesh__D017619 Radiotherapy Dosage %28%1980-1993%29%
% 212.58/212.74  |- skos__scopeNote mesh__D017619
% 212.58/212.74       Irradiation of one half or both halves of the body in the treatment of disseminated cancer or widespread metastases. It is used to treat diffuse metastases in one session as opposed to multiple fields over an extended period. The more frequent treatment modalities are upper hemibody irradiation %28%UHBI%29% or lower hemibody irradiation %28%LHBI%29%. Less common is mid-body irradiation %28%MBI%29%. In the treatment of both halves of the body sequentially, hemibody irradiation permits radiotherapy of the whole body with larger doses of radiation than could be accomplished with WHOLE-BODY IRRADIATION. It is sometimes called %22%systemic%22% hemibody irradiation with reference to its use in widespread cancer or metastases. %28%P. Rubin et al. Cancer, Vol 55, p2210, 1985%29%%A%    
% 212.58/212.74  |- skos__hiddenLabel mesh__D017619 Irradiations, Hemi-Body
% 212.58/212.74  |- skos__hiddenLabel mesh__D017619 Irradiation, Hemi-Body
% 212.58/212.74  |- mesh__recordOriginator mesh__D017619 TGC
% 212.58/212.74  |- rdf__type mesh__D017619sskos__Concept
% 212.58/212.74  |- skos__hiddenLabel mesh__D017619 Half Body Irradiation
% 212.58/212.74  |- skos__hiddenLabel mesh__D017619 Hemibody Irradiations, Sequential
% 212.58/212.74  |- skos__hiddenLabel mesh__D017619 Hemi Body Irradiation
% 212.58/212.74  |- skos__altLabel mesh__D017619 Irradiation, Half-Body
% 212.58/212.74  |- skos__hiddenLabel mesh__D017619 Irradiation, Half Body
% 212.58/212.74  |- skos__hiddenLabel mesh__D017619 Systemic Hemibody Irradiations
% 212.58/212.74  |- skos__hiddenLabel mesh__D017619 Irradiation, Systemic Hemibody
% 212.58/212.74  |- mesh__publicMeSHNote mesh__D017619 94   
% 212.58/212.74  |- mesh__dateRevised mesh__D017619 2005-06-30
% 212.58/212.74  |- skos__prefLabel mesh__D017619 Hemibody Irradiation
% 212.58/212.74  |- skos__hiddenLabel mesh__D017619 Irradiations, Sequential Hemibody
% 212.58/212.74  |- skos__hiddenLabel mesh__D017619 Hemibody Irradiation, Sequential
% 212.58/212.74  |- skos__hiddenLabel mesh__D017619 Hemibody Irradiations, Systemic
% 212.58/212.74  |- skos__hiddenLabel mesh__D017619 Irradiation, Sequential Hemibody
% 212.58/212.74  |- skos__historyNote mesh__D017619 Radiotherapy %28%1980-1993%29%
% 212.58/212.74  |- skos__altLabel mesh__D017619 Sequential Hemibody Irradiation
% 212.58/212.74  |- skos__hiddenLabel mesh__D017619 Hemibody Irradiations
% 212.58/212.74  |- skos__broader mesh__D017619smesh__D011878
% 212.58/212.74  |- skos__broader mesh__D028341smesh__D036361
% 212.58/212.74  |- skos__scopeNote mesh__D028341
% 212.58/212.74       Activins are produced in the pituitary, gonads, and other tissues. By acting locally, they stimulate pituitary FSH secretion and have diverse effects on cell differentiation and embryonic development. Activins are glycoproteins that are hetero- or homodimers of INHIBIN-BETA SUBUNITS.%A%    
% 212.58/212.74  |- skos__hiddenLabel mesh__D028341 FSH Releasing Protein
% 212.58/212.74  |- mesh__dateEstablished mesh__D028341 2002-01-01
% 212.58/212.74  |- skos__altLabel mesh__D028341 Activin
% 212.58/212.74  |- mesh__dateCreated mesh__D028341 2001-07-25
% 212.58/212.74  |- skos__prefLabel mesh__D028341 Activins
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D028341 2005
% 212.58/212.74  |- skos__broader mesh__D028341smesh__D042341
% 212.58/212.74  |- mesh__historyNote mesh__D028341
% 212.58/212.74       2002; use ACTIVINS %28%NM%29% 1987-2001   
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D028341 2006
% 212.58/212.74  |- rdf__type mesh__D028341sskos__Concept
% 212.58/212.74  |- skos__altLabel mesh__D028341 FSH-Releasing Protein
% 212.58/212.74  |- mesh__dateRevised mesh__D028341 2003-07-09
% 212.58/212.74  |- skos__historyNote mesh__D028341 Inhibin %28%1986-2001%29%
% 212.58/212.74  |- mesh__publicMeSHNote mesh__D028341
% 212.58/212.74       2002; ACTIVIN was indexed under INHIBIN 1987-2001   
% 212.58/212.74  |- skos__hiddenLabel mesh__D028341 Protein, FSH-Releasing
% 212.58/212.74  |- skos__broader mesh__D028341smesh__D006023
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D028341 2004
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D014321 2005
% 212.58/212.74  |- mesh__dateCreated mesh__D014321 1999-01-01
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D014321 2000
% 212.58/212.74  |- skos__scopeNote mesh__D014321
% 212.58/212.74       The 4th cranial nerve. The trochlear nerve carries the motor innervation of the superior oblique muscles of the eye.%A%    
% 212.58/212.74  |- skos__hiddenLabel mesh__D014321 Trochlear Nerves
% 212.58/212.74  |- skos__hiddenLabel mesh__D014321 Nerve IV, Cranial
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D014321 2004
% 212.58/212.74  |- mesh__dateRevised mesh__D014321 1999-11-03
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D014321 2001
% 212.58/212.74  |- skos__hiddenLabel mesh__D014321 Nerves, Fourth Cranial
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D014321 2006
% 212.58/212.74  |- mesh__recordOriginator mesh__D014321 NLM
% 212.58/212.74  |- mesh__recordAuthorizer mesh__D014321 sjn
% 212.58/212.74  |- mesh__recordMaintainer mesh__D014321 ags
% 212.58/212.74  |- skos__annotation mesh__D014321
% 212.58/212.74       neopl = TROCHLEAR NERVE DISEASES %28%IM%29% + CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 212.58/212.74  |- skos__prefLabel mesh__D014321 Trochlear Nerve
% 212.58/212.74  |- skos__hiddenLabel mesh__D014321 Fourth Cranial Nerves
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D014321 2002
% 212.58/212.74  |- skos__hiddenLabel mesh__D014321 IV, Cranial Nerve
% 212.58/212.74  |- skos__altLabel mesh__D014321 Fourth Cranial Nerve
% 212.58/212.74  |- skos__hiddenLabel mesh__D014321 Nerve, Fourth Cranial
% 212.58/212.74  |- skos__hiddenLabel mesh__D014321 Cranial Nerves, Fourth
% 212.58/212.74  |- skos__hiddenLabel mesh__D014321 Cranial Nerve, Fourth
% 212.58/212.74  |- skos__broader mesh__D014321smesh__D003391
% 212.58/212.74  |- rdf__type mesh__D014321sskos__Concept
% 212.58/212.74  |- skos__hiddenLabel mesh__D014321 Nerve, Trochlear
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D014321 2003
% 212.58/212.74  |- skos__hiddenLabel mesh__D014321 Nerves, Trochlear
% 212.58/212.74  |- skos__altLabel mesh__D014321 Cranial Nerve IV
% 212.58/212.74  |- mesh__publicMeSHNote mesh__D000301
% 212.58/212.74       91; was see under CHOLESTEROL 1989-90; was see under STEROLS 1979-88%A%  
% 212.58/212.74  |- skos__hiddenLabel mesh__D000301 NCL 6
% 212.58/212.74  |- skos__hiddenLabel mesh__D000301 NCL6
% 212.58/212.74  |- mesh__recordAuthorizer mesh__D000301 sjn
% 212.58/212.74  |- skos__historyNote mesh__D000301 Sterols %28%1966-1978%29%
% 212.58/212.74  |- mesh__historyNote mesh__D000301
% 212.58/212.74       91%28%79%29%; was see under CHOLESTEROL 1989-90; was see under STEROLS 1979-88%A%  
% 212.58/212.74  |- skos__historyNote mesh__D000301 Iodine Radioisotopes %28%1966-1978%29%
% 212.58/212.74  |- mesh__dateCreated mesh__D000301 1978-05-16
% 212.58/212.74  |- skos__prefLabel mesh__D000301 Adosterol
% 212.58/212.74  |- skos__broader mesh__D000301smesh__D013261
% 212.58/212.74  |- mesh__dateEstablished mesh__D000301 1991-01-01
% 212.58/212.74  |- skos__historyNote mesh__D000301 Cholestenes %28%1973-1978%29%
% 212.58/212.74  |- skos__scopeNote mesh__D000301
% 212.58/212.74       A sterol usually substituted with radioactive iodine. It is an adrenal cortex scanning agent with demonstrated high adrenal concentration and superior adrenal imaging.%A%    
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D000301 2006
% 212.58/212.74  |- skos__altLabel mesh__D000301 6-Iodomethylnorcholesterol
% 212.58/212.74  |- skos__hiddenLabel mesh__D000301 6 Iodomethylnorcholesterol
% 212.58/212.74  |- rdf__type mesh__D000301sskos__Concept
% 212.58/212.74  |- mesh__dateRevised mesh__D000301 2004-07-07
% 212.58/212.74  |- mesh__recordMaintainer mesh__D000301 jmp
% 212.58/212.74  |- skos__hiddenLabel mesh__D000301 NP59
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D000301 2005
% 212.58/212.74  |- mesh__recordOriginator mesh__D000301 RLS
% 212.58/212.74  |- skos__altLabel mesh__D013229 Octadecanoic Acids
% 212.58/212.74  |- skos__hiddenLabel mesh__D013229 Acids, Octadecanoic
% 212.58/212.74  |- mesh__historyNote mesh__D013229 75; was STEARIC ACID 1963-74   
% 212.58/212.74  |- mesh__recordAuthorizer mesh__D013229 sjn
% 212.58/212.74  |- skos__broader mesh__D013229smesh__D005227
% 212.58/212.74  |- mesh__recordOriginator mesh__D013229 NLM
% 212.58/212.74  |- skos__altLabel mesh__D013229 Tetrahydrolinoleic Acids
% 212.58/212.74  |- skos__hiddenLabel mesh__D013229 Acids, Stearic
% 212.58/212.74  |- rdf__type mesh__D013229sskos__Concept
% 212.58/212.74  |- skos__prefLabel mesh__D013229 Stearic Acids
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D013229 2004
% 212.58/212.74  |- mesh__dateCreated mesh__D013229 1999-01-01
% 212.58/212.74  |- mesh__onlineNote mesh__D013229
% 212.58/212.74       use STEARIC ACIDS to search STEARIC ACID 1966-74   
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D013229 2005
% 212.58/212.74  |- skos__hiddenLabel mesh__D013229 Acids, Tetrahydrolinoleic
% 212.58/212.74  |- mesh__publicMeSHNote mesh__D013229 75; was STEARIC ACID 1963-74   
% 212.58/212.74  |- skos__hiddenLabel mesh__D013229 Acids, Dihydrooleic
% 212.58/212.74  |- mesh__recordMaintainer mesh__D013229 ssb
% 212.58/212.74  |- skos__scopeNote mesh__D013229
% 212.58/212.74       A group of compounds that are derivatives of octadecanoic acid which is one of the most abundant fatty acids found in animal lipids. %28%Stedman, 25th ed%29%%A%    
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D013229 2006
% 212.58/212.74  |- skos__annotation mesh__D013229
% 212.58/212.74       do not confuse X ref OCTADECANOIC ACIDS with OCTADECENOIC ACIDS see OLEIC ACIDS%A%  
% 212.58/212.74  |- skos__altLabel mesh__D013229 Dihydrooleic Acids
% 212.58/212.74  |- mesh__dateRevised mesh__D013229 2003-07-09
% 212.58/212.74  |- mesh__dateCreated mesh__D018712 1994-06-03
% 212.58/212.74  |- skos__historyNote mesh__D018712 Analgesics %28%1966-1994%29%
% 212.58/212.74  |- mesh__recordMaintainer mesh__D018712 ssb
% 212.58/212.74  |- skos__altLabel mesh__D018712 Analgesics, Nonopioid
% 212.58/212.74  |- skos__hiddenLabel mesh__D018712 Nonnarcotic Analgesics
% 212.58/212.74  |- mesh__recordOriginator mesh__D018712 RAZ
% 212.58/212.74  |- rdf__type mesh__D018712sskos__Concept
% 212.58/212.74  |- mesh__recordAuthorizer mesh__D018712 sjn
% 212.58/212.74  |- mesh__historyNote mesh__D018712
% 212.58/212.74       95; ANTIPYRETICS was see ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL 1990-94; was see ANALGESICS, ANTI-INFAMMATORY 1978-89; was see ANALGESICS AND ANTIPYRETICS 1975-77; was see under ANALGESICS AND ANTIPYRETICS  1963-74%A%  
% 212.58/212.74  |- skos__hiddenLabel mesh__D018712 Analgesics, Non Narcotic
% 212.58/212.74  |- skos__scopeNote mesh__D018712
% 212.58/212.74       Drugs that have principally analgesic, antipyretic, and anti-inflammatory actions. They do not bind to opioid receptors and are not classified under the Controlled Substances Act. %28%From Drug Evaluations Annual, 1992, p109%29%%A%    
% 212.58/212.74  |- mesh__dateEstablished mesh__D018712 1995-01-01
% 212.58/212.74  |- mesh__publicMeSHNote mesh__D018712
% 212.58/212.74       95; ANTIPYRETICS was see ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL 1990-94; was see ANALGESICS, ANTI-INFAMMATORY 1978-89; was see ANALGESICS AND ANTIPYRETICS 1975-77; was see under ANALGESICS AND ANTIPYRETICS  1963-74%A%  
% 212.58/212.74  |- mesh__onlineNote mesh__D018712
% 212.58/212.74       use ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL to search ANTIPYRETICS 1978-94; use ANALGESICS 1966-77%A%  
% 212.58/212.74  |- mesh__dateRevised mesh__D018712 2005-06-30
% 212.58/212.74  |- skos__hiddenLabel mesh__D018712 Non-Narcotic Analgesics
% 212.58/212.74  |- skos__broader mesh__D018712smesh__D000700
% 212.58/212.74  |- skos__annotation mesh__D018712 GEN or unspecified: prefer specifics   
% 212.58/212.74  |- skos__prefLabel mesh__D018712 Analgesics, Non-Narcotic
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D018712 2006
% 212.58/212.74  |- skos__altLabel mesh__D018712 Nonopioid Analgesics
% 212.58/212.74  |- skos__altLabel mesh__D018712 Analgesics, Nonnarcotic
% 212.58/212.74  |- mesh__recordOriginator mesh__D051348 DRC
% 212.58/212.74  |- skos__broader mesh__D051348smesh__D051344
% 212.58/212.74  |- rdf__type mesh__D051348sskos__Concept
% 212.58/212.74  |- mesh__historyNote mesh__D051348 2006%28%1992%29%   
% 212.58/212.74  |- mesh__dateCreated mesh__D051348 2005-06-30
% 212.58/212.74  |- skos__prefLabel mesh__D051348 Tropomodulin
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D051348 2006
% 212.58/212.74  |- skos__scopeNote mesh__D051348
% 212.58/212.74       An actin capping protein that binds to the pointed-end of ACTIN. It functions in the presence of TROPOMYOSIN to inhibit microfilament elongation.%A%    
% 212.58/212.74  |- mesh__recordAuthorizer mesh__D051348 sjn
% 212.58/212.74  |- mesh__dateEstablished mesh__D051348 2006-01-01
% 212.58/212.74  |- skos__broader mesh__D051348smesh__D009124
% 212.58/212.74  |- mesh__publicMeSHNote mesh__D051348
% 212.58/212.74       2006; TROPOMODULIN was indexed under MICROFILAMENT PROTEINS %26% CARRIER PROTEINS 1992-2005%A%  
% 212.58/212.74  |- mesh__recordMaintainer mesh__D051348 DRC
% 212.58/212.74  |- mesh__dateEstablished mesh__D009986 1974-01-01
% 212.58/212.74  |- mesh__publicMeSHNote mesh__D009986 74   
% 212.58/212.74  |- mesh__recordOriginator mesh__D009986 NLM
% 212.58/212.74  |- mesh__recordAuthorizer mesh__D009986 sjn
% 212.58/212.74  |- mesh__historyNote mesh__D009986 74   
% 212.58/212.74  |- mesh__dateRevised mesh__D009986 2004-07-13
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D009986 2006
% 212.58/212.74  |- skos__broader mesh__D009986smesh__D011570
% 212.58/212.74  |- mesh__recordMaintainer mesh__D009986 sjn
% 212.58/212.74  |- mesh__dateCreated mesh__D009986 1999-01-01
% 212.58/212.74  |- rdf__type mesh__D009986sskos__Concept
% 212.58/212.74  |- skos__scopeNote mesh__D009986
% 212.58/212.74       The study and treatment of human behavior problems utilizing principles derived from the behavioral, medical, and social science with emphasis on promotion of mental health.%A%    
% 212.58/212.74  |- skos__related mesh__D009986smesh__D008603
% 212.58/212.74  |- skos__annotation mesh__D009986
% 212.58/212.74       SPEC; SPEC qualif; MDs, psychologists, social workers, etc.%A%  
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D009986 2005
% 212.58/212.74  |- skos__prefLabel mesh__D009986 Orthopsychiatry
% 212.58/212.74  |- skos__altLabel mesh__D009188 Postinfectious Myelitis
% 212.58/212.74  |- skos__altLabel mesh__D009188 Transverse Myelopathy Syndrome
% 212.58/212.74  |- skos__related mesh__D009188smesh__D009103
% 212.58/212.74  |- skos__hiddenLabel mesh__D009188 Myelitides, Subacute Transverse
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D009188 2002
% 212.58/212.74  |- skos__related mesh__D009188smesh__D020529
% 212.58/212.74  |- mesh__recordAuthorizer mesh__D009188 sjn
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D009188 2004
% 212.58/212.74  |- mesh__publicMeSHNote mesh__D009188 1991; see MYELITIS 1971-1990   
% 212.58/212.74  |- skos__historyNote mesh__D009188 Myelitis %28%1966-1970%29%
% 212.58/212.74  |- mesh__recordOriginator mesh__D009188 NLM
% 212.58/212.74  |- skos__broader mesh__D009188smesh__D020278
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D009188 2006
% 212.58/212.74  |- skos__historyNote mesh__D009188 Demyelinating Diseases %28%1966-1970%29%
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D009188 2003
% 212.58/212.74  |- skos__hiddenLabel mesh__D009188 Transverse Myelitis, Acute
% 212.58/212.74  |- skos__altLabel mesh__D009188 Transverse Myelitis
% 212.58/212.74  |- mesh__dateCreated mesh__D009188 1999-01-01
% 212.58/212.74  |- skos__broader mesh__D009188smesh__D009187
% 212.58/212.74  |- skos__hiddenLabel mesh__D009188 Subacute Transverse Myelitis
% 212.58/212.74  |- skos__hiddenLabel mesh__D009188 Postvaccinal Myelitis
% 212.58/212.74  |- mesh__activeMeSHYear mesh__D009188 2005
% 212.58/212.74  |- skos__broader mesh__D009188smesh__D020361
% 212.58/212.74  |- skos__prefLabel mesh__D009188 Myelitis, Transverse
% 212.58/212.74  |- skos__hiddenLabel mesh__D009188 Acute Transverse Myelitis
% 212.58/212.74  |- mesh__dateRevised mesh__D009188 2001-07-25
% 212.58/212.74  |- mesh__recordMaintainer mesh__D009188 ags
% 212.58/212.75  |- skos__hiddenLabel mesh__D009188 Transverse Myelitis, Subacute
% 212.58/212.75  |- skos__hiddenLabel mesh__D009188 Myelitis, Demyelinative
% 212.58/212.75  |- rdf__type mesh__D009188sskos__Concept
% 212.58/212.75  |- skos__hiddenLabel mesh__D009188 Paraneoplastic Myelitis
% 212.58/212.75  |- skos__scopeNote mesh__D009188
% 212.58/212.75       Inflammation of a transverse portion of the spinal cord characterized by acute or subacute segmental demyelination or necrosis. The condition may occur sporadically, follow an infection or vaccination, or present as a paraneoplastic syndrome %28%see also ENCEPHALOMYELITIS, ACUTE DISSEMINATED%29%. Clinical manifestations include motor weakness, sensory loss, and incontinence. %28%Adams et al., Principles of Neurology, 6th ed, pp1242-6%29%%A%    
% 212.58/212.75  |- mesh__historyNote mesh__D009188
% 212.58/212.75       1991%28%1971%29%; see MYELITIS 1971-1990   
% 212.58/212.75  |- skos__hiddenLabel mesh__D009188 Necrotizing Myelitis
% 212.58/212.75  |- mesh__dateEstablished mesh__D009188 1991-01-01
% 212.58/212.75  |- skos__annotation mesh__D009188
% 212.58/212.75       post-vaccinal or postinfectious inflammation of the spinal cord only goes here, in central nervous system or brain see X refs at ENCEPHALOMYELITIS, ACUTE DISSEMINATED%A%  
% 212.58/212.75  |- skos__hiddenLabel mesh__D009188 Transverse Myelopathy Syndromes
% 212.58/212.75  |- mesh__recordMaintainer mesh__D014322 ags
% 212.58/212.75  |- skos__prefLabel mesh__D014322 Troglotrematidae
% 212.58/212.75  |- mesh__dateCreated mesh__D014322 1981-05-15
% 212.58/212.75  |- mesh__historyNote mesh__D014322 98; use explode 1982-97   
% 212.58/212.75  |- mesh__dateEstablished mesh__D014322 1998-01-01
% 212.58/212.75  |- skos__annotation mesh__D014322
% 212.58/212.75       a family of trematodes; infection: coord IM with TREMATODE INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 212.58/212.75  |- mesh__dateRevised mesh__D014322 2003-07-09
% 212.58/212.75  |- skos__historyNote mesh__D014322 Trematoda %28%1966-1997%29%
% 212.58/212.75  |- rdf__type mesh__D014322sskos__Concept
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D014322 2005
% 212.58/212.75  |- mesh__recordAuthorizer mesh__D014322 sjn
% 212.58/212.75  |- mesh__publicMeSHNote mesh__D014322 98   
% 212.58/212.75  |- skos__scopeNote mesh__D014322
% 212.58/212.75       A family of flukes %28%TREMATODA%29% usually under 10 mm in length, some being only 1 or 2 mm long. In general they are thick, spinous, or scaly flukes having an oval outline and living in various organs and sinuses of birds and mammals. The genus with the greatest interest is PARAGONIMUS. %28%From Noble et al., Parasitology: the Biology of Animal Parasites, 6th ed, p191%29%%A%    
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D014322 2004
% 212.58/212.75  |- skos__broader mesh__D014322smesh__D014200
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D014322 2006
% 212.58/212.75  |- mesh__recordOriginator mesh__D014322 EC
% 212.58/212.75  |- mesh__publicMeSHNote mesh__D000302
% 212.58/212.75       78,63-67; was see under ADRENAL GLANDS 1968-77   
% 212.58/212.75  |- mesh__onlineNote mesh__D000302 search ADRENAL GLANDS 1966-74   
% 212.58/212.75  |- skos__annotation mesh__D000302 PITUITARY-ADRENAL SYSTEM is available   
% 212.58/212.75  |- mesh__recordOriginator mesh__D000302 NLM
% 212.58/212.75  |- mesh__recordMaintainer mesh__D000302 lkt
% 212.58/212.75  |- mesh__dateCreated mesh__D000302 1999-01-01
% 212.58/212.75  |- skos__prefLabel mesh__D000302 Adrenal Cortex
% 212.58/212.75  |- mesh__dateRevised mesh__D000302 2004-07-07
% 212.58/212.75  |- mesh__recordAuthorizer mesh__D000302 sjn
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D000302 2005
% 212.58/212.75  |- skos__hiddenLabel mesh__D000302 Cortex, Adrenal
% 212.58/212.75  |- mesh__historyNote mesh__D000302
% 212.58/212.75       78%28%75%29%63-67; was see under ADRENAL GLANDS 1968-77   
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D000302 2006
% 212.58/212.75  |- mesh__dateEstablished mesh__D000302 1978-01-01
% 212.58/212.75  |- skos__historyNote mesh__D000302 Adrenal Glands %28%1966-1974%29%
% 212.58/212.75  |- skos__broader mesh__D000302smesh__D000311
% 212.58/212.75  |- rdf__type mesh__D000302sskos__Concept
% 212.58/212.75  |- skos__scopeNote mesh__D000302
% 212.58/212.75       The outer layer of the adrenal gland. It is derived from MESODERM and comprised of three zones %28%outer ZONA GLOMERULOSA, middle ZONA FASCICULATA, and inner ZONA RETICULARIS%29% with each producing various steroids preferentially, such as ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and ANDROSTENEDIONE. Adrenal cortex function is regulated by pituitary ADRENOCORTICOTROPIN.%A%    
% 212.58/212.75  |- skos__hiddenLabel mesh__D005596 Fracture, Closed
% 212.58/212.75  |- skos__broader mesh__D005596smesh__D050723
% 212.58/212.75  |- mesh__recordMaintainer mesh__D005596 ssb
% 212.58/212.75  |- skos__annotation mesh__D005596
% 212.58/212.75       fract not causing an open wound; IM; coord with precoord organ/fract term %28%IM%29%, as %22%closed fract of tibia%22% = FRACTURES, CLOSED %28%IM%29% + TIBIAL FRACTURES %28%IM%29%; if no precoord organ/fract term is available, coord IM with organ /inj %28%IM%29%, as %22%closed fract of fibula%22% = FRACTURES, CLOSED %28%IM%29% + FIBULA /inj %28%IM%29%%A%  
% 212.58/212.75  |- skos__hiddenLabel mesh__D005596 Closed Fractures
% 212.58/212.75  |- mesh__dateRevised mesh__D005596 2005-06-30
% 212.58/212.75  |- skos__prefLabel mesh__D005596 Fractures, Closed
% 212.58/212.75  |- skos__hiddenLabel mesh__D005596 Occult Fractures
% 212.58/212.75  |- skos__hiddenLabel mesh__D005596 Occult Fracture
% 212.58/212.75  |- rdf__type mesh__D005596sskos__Concept
% 212.58/212.75  |- skos__scopeNote mesh__D005596
% 212.58/212.75       Fractures in which the break in bone is not accompanied by an external wound.%A%    
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D005596 2006
% 212.58/212.75  |- mesh__recordOriginator mesh__D005596 NLM
% 212.58/212.75  |- mesh__dateEstablished mesh__D005596 1986-01-01
% 212.58/212.75  |- skos__hiddenLabel mesh__D005596 Closed Fracture
% 212.58/212.75  |- mesh__publicMeSHNote mesh__D005596
% 212.58/212.75       86; was see under FRACTURES 1975-85   
% 212.58/212.75  |- mesh__recordAuthorizer mesh__D005596 sjn
% 212.58/212.75  |- skos__hiddenLabel mesh__D005596 Fracture, Occult
% 212.58/212.75  |- mesh__dateCreated mesh__D005596 1999-01-01
% 212.58/212.75  |- mesh__historyNote mesh__D005596
% 212.58/212.75       86%28%73%29%; was see under FRACTURES 1975-85, was Prov 1973-74%A%  
% 212.58/212.75  |- rdf__type mesh__D018713sskos__Concept
% 212.58/212.75  |- mesh__dateCreated mesh__D018713 1994-04-16
% 212.58/212.75  |- mesh__recordMaintainer mesh__D018713 SYSTEM
% 212.58/212.75  |- mesh__recordOriginator mesh__D018713 PXP
% 212.58/212.75  |- skos__prefLabel mesh__D018713 Prevotella intermedia
% 212.58/212.75  |- skos__historyNote mesh__D018713 Bacteroides %28%1979-1994%29%
% 212.58/212.75  |- mesh__publicMeSHNote mesh__D018713 95   
% 212.58/212.75  |- mesh__recordAuthorizer mesh__D018713 sjn
% 212.58/212.75  |- skos__annotation mesh__D018713
% 212.58/212.75       infection: coord IM with BACTEROIDACEAE INFECTIONS %28%IM%29%   
% 212.58/212.75  |- mesh__historyNote mesh__D018713 95   
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D018713 2006
% 212.58/212.75  |- mesh__dateEstablished mesh__D018713 1995-01-01
% 212.58/212.75  |- skos__broader mesh__D018713smesh__D018720
% 212.58/212.75  |- skos__scopeNote mesh__D018713
% 212.58/212.75       A species of gram-negative, anaerobic, rod-shaped bacteria originally classified within the BACTEROIDES genus. This bacterium is a common commensal in the gingival crevice and is often isolated from cases of gingivitis and other purulent lesions related to the mouth.%A%    
% 212.58/212.75  |- mesh__dateRevised mesh__D018713 2005-06-30
% 212.58/212.75  |- skos__altLabel mesh__D018713 Bacteroides intermedius
% 212.58/212.75  |- mesh__recordMaintainer mesh__D010730 ssb
% 212.58/212.75  |- mesh__dateEstablished mesh__D010730 1991-01-01
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D010730 2005
% 212.58/212.75  |- skos__prefLabel mesh__D010730 Phosphoenolpyruvate Carboxylase
% 212.58/212.75  |- skos__historyNote mesh__D010730 Phosphoenolpyruvate %28%1972-1978%29%
% 212.58/212.75  |- mesh__recordAuthorizer mesh__D010730 sjn
% 212.58/212.75  |- mesh__historyNote mesh__D010730
% 212.58/212.75       91%28%79%29%; was see under CARBOXY-LYASES 1979-90   
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D010730 2006
% 212.58/212.75  |- skos__historyNote mesh__D010730 Carboxy-Lyases %28%1966-1978%29%
% 212.58/212.75  |- mesh__publicMeSHNote mesh__D010730
% 212.58/212.75       91; was see under CARBOXY-LYASES 1979-90   
% 212.58/212.75  |- mesh__dateCreated mesh__D010730 1978-03-13
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D010730 2004
% 212.58/212.75  |- mesh__recordOriginator mesh__D010730 RLS
% 212.58/212.75  |- skos__annotation mesh__D010730
% 212.58/212.75       do not confuse with PHOSPHOENOLPYRUVATE CARBOXYKINASE %28%ATP%29% or PHOSPHOENOLPYRUVATE CARBOXYKINASE %28%GTP%29%%A%  
% 212.58/212.75  |- mesh__dateRevised mesh__D010730 2003-07-09
% 212.58/212.75  |- skos__broader mesh__D010730smesh__D002262
% 212.58/212.75  |- skos__scopeNote mesh__D010730
% 212.58/212.75       An enzyme with high affinity for carbon dioxide. It catalyzes irreversibly the formation of oxaloacetate from phosphoenolpyruvate and carbon dioxide. This fixation of carbon dioxide in several bacteria and some plants is the first step in the biosynthesis of glucose. EC 4.1.1.31.%A%    
% 212.58/212.75  |- skos__hiddenLabel mesh__D010730 Carboxylase, Phosphoenolpyruvate
% 212.58/212.75  |- rdf__type mesh__D010730sskos__Concept
% 212.58/212.75  |- skos__broader mesh__D019818Q000031smesh__D019818
% 212.58/212.75  |- mesh__preferredCombination mesh__D019818Q000031smesh__D002969
% 212.58/212.75  |- rdf__type mesh__D019818Q000031smesh__CompoundConcept
% 212.58/212.75  |- skos__prefLabel mesh__D009987 Orthoptera
% 212.58/212.75  |- mesh__dateRevised mesh__D009987 2003-07-09
% 212.58/212.75  |- skos__annotation mesh__D009987
% 212.58/212.75       do not use /drug eff for insecticides: TN 111   
% 212.58/212.75  |- skos__scopeNote mesh__D009987
% 212.58/212.75       An order of insects comprising two suborders: Caelifera and Ensifera. They consist of GRASSHOPPERS, locusts, and crickets %28%GRYLLIDAE%29%.%A%    
% 212.58/212.75  |- mesh__dateEstablished mesh__D009987 1975-01-01
% 212.58/212.75  |- skos__historyNote mesh__D009987 Insects %28%1966-1974%29%
% 212.58/212.75  |- skos__broader mesh__D009987smesh__D007313
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D009987 2006
% 212.58/212.75  |- mesh__recordOriginator mesh__D009987 NLM
% 212.58/212.75  |- mesh__recordAuthorizer mesh__D009987 sjn
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D009987 2005
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D009987 2004
% 212.58/212.75  |- rdf__type mesh__D009987sskos__Concept
% 212.58/212.75  |- mesh__dateCreated mesh__D009987 1999-01-01
% 212.58/212.75  |- mesh__historyNote mesh__D009987 75   
% 212.58/212.75  |- mesh__recordMaintainer mesh__D009987 ags
% 212.58/212.75  |- mesh__publicMeSHNote mesh__D009987 75   
% 212.58/212.75  |- mesh__dateRevised mesh__D009189 2001-07-25
% 212.58/212.75  |- mesh__dateCreated mesh__D009189 1999-01-01
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D009189 2005
% 212.58/212.75  |- skos__prefLabel mesh__D009189 Myeloblastosis Virus, Avian
% 212.58/212.75  |- skos__hiddenLabel mesh__D009189 Avian Myeloblastosis Viruses
% 212.58/212.75  |- skos__hiddenLabel mesh__D009189 Myeloblastosis Viruses, Avian
% 212.58/212.75  |- mesh__publicMeSHNote mesh__D009189
% 212.58/212.75       91; was see under AVIAN LEUKOSIS VIRUSES 1975-90; was see under AVIAN LEUKOSIS VIRUS 1963-74%A%  
% 212.58/212.75  |- skos__hiddenLabel mesh__D009189 Viruses, Avian Myeloblastosis
% 212.58/212.75  |- rdf__type mesh__D009189sskos__Concept
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D009189 2002
% 212.58/212.75  |- skos__annotation mesh__D009189
% 212.58/212.75       infection: coord IM with AVIAN LEUKOSIS %28%IM%29%   
% 212.58/212.75  |- mesh__recordMaintainer mesh__D009189 ags
% 212.58/212.75  |- mesh__recordAuthorizer mesh__D009189 sjn
% 212.58/212.75  |- mesh__historyNote mesh__D009189
% 212.58/212.75       91%28%75%29%; was see under AVIAN LEUKOSIS VIRUSES 1975-90; was see under AVIAN LEUKOSIS VIRUS 1963-74%A%  
% 212.58/212.75  |- mesh__recordOriginator mesh__D009189 NLM
% 212.58/212.75  |- skos__hiddenLabel mesh__D009189 Virus, Avian Myeloblastosis
% 212.58/212.75  |- skos__broader mesh__D009189smesh__D001355
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D009189 2004
% 212.58/212.75  |- mesh__dateEstablished mesh__D009189 1991-01-01
% 212.58/212.75  |- skos__scopeNote mesh__D009189
% 212.58/212.75       A species of ALPHARETROVIRUS causing anemia in fowl.     
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D009189 2006
% 212.58/212.75  |- mesh__onlineNote mesh__D009189
% 212.58/212.75       use AVIAN LEUKOSIS VIRUSES to search MYELOBLASTOSIS, VIRUS AVIAN 1966-90%A%  
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D009189 2003
% 212.58/212.75  |- skos__altLabel mesh__D009189 Avian myeloblastosis virus
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D020360 2000
% 212.58/212.75  |- mesh__historyNote mesh__D020360 99   
% 212.58/212.75  |- skos__altLabel mesh__D020360 Neoadjuvant Treatment
% 212.58/212.75  |- skos__scopeNote mesh__D020360
% 212.58/212.75       Preliminary cancer therapy %28%chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.%29% that precedes a necessary second modality of treatment.%A%    
% 212.58/212.75  |- rdf__type mesh__D020360sskos__Concept
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D020360 2006
% 212.58/212.75  |- skos__hiddenLabel mesh__D020360 Treatment, Neoadjuvant
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D020360 1999
% 212.58/212.75  |- skos__hiddenLabel mesh__D020360 Neoadjuvant Therapies
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D020360 2005
% 212.58/212.75  |- mesh__dateCreated mesh__D020360 1998-06-10
% 212.58/212.75  |- skos__hiddenLabel mesh__D020360 Neoadjuvant Treatments
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D020360 2002
% 212.58/212.75  |- skos__hiddenLabel mesh__D020360 Therapies, Neoadjuvant
% 212.58/212.75  |- skos__hiddenLabel mesh__D020360 Therapy, Neoadjuvant
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D020360 2004
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D020360 2001
% 212.58/212.75  |- mesh__publicMeSHNote mesh__D020360 99   
% 212.58/212.75  |- skos__hiddenLabel mesh__D020360 Treatments, Neoadjuvant
% 212.58/212.75  |- skos__prefLabel mesh__D020360 Neoadjuvant Therapy
% 212.58/212.75  |- skos__historyNote mesh__D020360
% 212.58/212.75       Combined Modality Therapy %28%1984-1998%29%
% 212.58/212.75  |- mesh__dateEstablished mesh__D020360 1999-01-01
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D020360 2003
% 212.58/212.75  |- skos__broader mesh__D020360smesh__D003131
% 212.58/212.75  |- mesh__dateEstablished mesh__D014323 1991-01-01
% 212.58/212.75  |- skos__prefLabel mesh__D014323 Trombiculiasis
% 212.58/212.75  |- mesh__historyNote mesh__D014323
% 212.58/212.75       91%28%75%29%; was see under MITE INFESTATIONS 1975-90   
% 212.58/212.75  |- rdf__type mesh__D014323sskos__Concept
% 212.58/212.75  |- skos__broader mesh__D014323smesh__D008924
% 212.58/212.75  |- mesh__publicMeSHNote mesh__D014323
% 212.58/212.75       91; was see under MITE INFESTATIONS 1975-90   
% 212.58/212.75  |- mesh__dateCreated mesh__D014323 1999-01-01
% 212.58/212.75  |- mesh__dateRevised mesh__D014323 2005-06-30
% 212.58/212.75  |- skos__scopeNote mesh__D014323
% 212.58/212.75       Infestation with mites of the genus Trombicula, whose larvae carry the rickettsial agent of scrub typhus.%A%    
% 212.58/212.75  |- skos__hiddenLabel mesh__D014323 Trombiculiases
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D014323 2006
% 212.58/212.75  |- mesh__recordAuthorizer mesh__D014323 sjn
% 212.58/212.75  |- mesh__recordOriginator mesh__D014323 NLM
% 212.58/212.75  |- skos__annotation mesh__D014323 mite infestation   
% 212.58/212.75  |- mesh__onlineNote mesh__D014323 search MITE INFESTATIONS 1968-74   
% 212.58/212.75  |- mesh__recordMaintainer mesh__D014323 ags
% 212.58/212.75  |- mesh__historyNote mesh__D000303
% 212.58/212.75       79%28%75%29%63-67; was see under ADRENAL GLAND DISEASES 1975-78%A%  
% 212.58/212.75  |- skos__hiddenLabel mesh__D000303 Diseases, Adrenal Cortex
% 212.58/212.75  |- mesh__dateEstablished mesh__D000303 1979-01-01
% 212.58/212.75  |- mesh__dateCreated mesh__D000303 1999-01-01
% 212.58/212.75  |- skos__broader mesh__D000303smesh__D000307
% 212.58/212.75  |- mesh__dateRevised mesh__D000303 2004-07-07
% 212.58/212.75  |- skos__hiddenLabel mesh__D000303 Cortex Disease, Adrenal
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D000303 2005
% 212.58/212.75  |- mesh__recordOriginator mesh__D000303 NLM
% 212.58/212.75  |- mesh__onlineNote mesh__D000303 search ADRENAL GLAND DISEASES 1966-74   
% 212.58/212.75  |- mesh__recordMaintainer mesh__D000303 lkt
% 212.58/212.75  |- skos__hiddenLabel mesh__D000303 Adrenal Cortex Disease
% 212.58/212.75  |- skos__scopeNote mesh__D000303
% 212.58/212.75       Pathological processes of the ADRENAL CORTEX.     
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D000303 2006
% 212.58/212.75  |- rdf__type mesh__D000303sskos__Concept
% 212.58/212.75  |- mesh__recordAuthorizer mesh__D000303 sjn
% 212.58/212.75  |- skos__prefLabel mesh__D000303 Adrenal Cortex Diseases
% 212.58/212.75  |- mesh__publicMeSHNote mesh__D000303
% 212.58/212.75       79,63-67; was see under ADRENAL GLAND DISEASES 1975-78   
% 212.58/212.75  |- skos__hiddenLabel mesh__D000303 Disease, Adrenal Cortex
% 212.58/212.75  |- skos__historyNote mesh__D000303 Adrenal Gland Diseases %28%1966-1974%29%
% 212.58/212.75  |- skos__hiddenLabel mesh__D000303 Cortex Diseases, Adrenal
% 212.58/212.75  |- skos__hiddenLabel mesh__D005597 Fracture, Open
% 212.58/212.75  |- skos__hiddenLabel mesh__D005597 Compound Fractures
% 212.58/212.75  |- skos__annotation mesh__D005597
% 212.58/212.75       fract causing an open wound; IM; coord with specific organ/inj or precoord organ/fract term %28%IM%29%%A%  
% 212.58/212.75  |- mesh__recordAuthorizer mesh__D005597 sjn
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D005597 2006
% 212.58/212.75  |- mesh__historyNote mesh__D005597 78%28%73%29%   
% 212.58/212.75  |- skos__hiddenLabel mesh__D005597 Compound Fracture
% 212.58/212.75  |- skos__altLabel mesh__D005597 Fractures, Compound
% 212.58/212.75  |- mesh__recordMaintainer mesh__D005597 ssb
% 212.58/212.75  |- skos__hiddenLabel mesh__D005597 Fracture, Compound
% 212.58/212.75  |- skos__scopeNote mesh__D005597
% 212.58/212.75       Fractures in which there is an external wound communicating with the break of the bone.%A%    
% 212.58/212.75  |- mesh__dateRevised mesh__D005597 2005-06-30
% 212.58/212.75  |- skos__hiddenLabel mesh__D005597 Open Fracture
% 212.58/212.75  |- mesh__dateCreated mesh__D005597 1999-01-01
% 212.58/212.75  |- skos__prefLabel mesh__D005597 Fractures, Open
% 212.58/212.75  |- skos__hiddenLabel mesh__D005597 Open Fractures
% 212.58/212.75  |- mesh__publicMeSHNote mesh__D005597 78   
% 212.58/212.75  |- skos__historyNote mesh__D005597 Fractures %28%1966-1972%29%
% 212.58/212.75  |- skos__broader mesh__D005597smesh__D050723
% 212.58/212.75  |- mesh__dateEstablished mesh__D005597 1978-01-01
% 212.58/212.75  |- rdf__type mesh__D005597sskos__Concept
% 212.58/212.75  |- mesh__recordOriginator mesh__D005597 NLM
% 212.58/212.75  |- skos__historyNote mesh__D018714
% 212.58/212.75       Combined Modality Therapy %28%1985-1994%29%
% 212.58/212.75  |- skos__broader mesh__D018714smesh__D003131
% 212.58/212.75  |- mesh__historyNote mesh__D018714 95   
% 212.58/212.75  |- skos__scopeNote mesh__D018714
% 212.58/212.75       Radiotherapy given to augment some other form of treatment such as surgery or chemotherapy. Adjuvant radiotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.%A%    
% 212.58/212.75  |- mesh__dateCreated mesh__D018714 1994-05-23
% 212.58/212.75  |- mesh__dateRevised mesh__D018714 2005-06-30
% 212.58/212.75  |- skos__altLabel mesh__D018714 Adjuvant Radiotherapy
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D018714 2006
% 212.58/212.75  |- skos__prefLabel mesh__D018714 Radiotherapy, Adjuvant
% 212.58/212.75  |- mesh__recordMaintainer mesh__D018714 lkt
% 212.58/212.75  |- skos__hiddenLabel mesh__D018714 Adjuvant Radiotherapies
% 212.58/212.75  |- rdf__type mesh__D018714sskos__Concept
% 212.58/212.75  |- skos__historyNote mesh__D018714
% 212.58/212.75       specific neoplasms/radiotherapy %28%1966-1994%29%
% 212.58/212.75  |- skos__hiddenLabel mesh__D018714 Radiotherapies, Adjuvant
% 212.58/212.75  |- mesh__recordOriginator mesh__D018714 JLS
% 212.58/212.75  |- skos__annotation mesh__D018714
% 212.58/212.75       almost never IM; coord with dis /radiother %28%IM%29% + specific radiother %28%IM%29% + specific surg or chemother to which this is adjuvant %28%IM%29%; DF: RADIOTHER ADJUVANT%A%  
% 212.58/212.75  |- mesh__dateEstablished mesh__D018714 1995-01-01
% 212.58/212.75  |- mesh__publicMeSHNote mesh__D018714 95   
% 212.58/212.75  |- mesh__recordAuthorizer mesh__D018714 sjn
% 212.58/212.75  |- skos__broader mesh__D018714smesh__D011878
% 212.58/212.75  |- skos__historyNote mesh__D010731 Phosphotransferases %28%1966-1979%29%
% 212.58/212.75  |- skos__hiddenLabel mesh__D010731
% 212.58/212.75       System, Phosphoenolpyruvate-Glycose Phosphotransferase
% 212.58/212.75  |- mesh__publicMeSHNote mesh__D010731 80   
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D010731 2006
% 212.58/212.75  |- skos__broader mesh__D010731smesh__D017853
% 212.58/212.75  |- skos__historyNote mesh__D010731 Phosphoric Acids %28%1968-1971%29%
% 212.58/212.75  |- mesh__historyNote mesh__D010731 80   
% 212.58/212.75  |- mesh__dateCreated mesh__D010731 1979-05-23
% 212.58/212.75  |- skos__hiddenLabel mesh__D010731
% 212.58/212.75       Phosphoenolpyruvate Glycose Phosphotransferase System
% 212.58/212.75  |- mesh__dateEstablished mesh__D010731 1980-01-01
% 212.58/212.75  |- skos__hiddenLabel mesh__D010731
% 212.58/212.75       Phosphotransferases, Phosphoenolpyruvate Hexose
% 212.58/212.75  |- skos__historyNote mesh__D010731 Phosphoenolpyruvate %28%1972-1979%29%
% 212.58/212.75  |- mesh__recordMaintainer mesh__D010731 jmp
% 212.58/212.75  |- skos__prefLabel mesh__D010731
% 212.58/212.75       Phosphoenolpyruvate Sugar Phosphotransferase System
% 212.58/212.75  |- skos__broader mesh__D010731smesh__D009097
% 212.58/212.75  |- skos__scopeNote mesh__D010731
% 212.58/212.75       The bacterial sugar phosphotransferase system %28%PTS%29% that catalyzes the transfer of the phosphoryl group from phosphoenolpyruvate to its sugar substrates %28%the PTS sugars%29% concomitant with the translocation of these sugars across the bacterial membrane. The phosphorylation of a given sugar requires four proteins, two general proteins, Enzyme I and HPr and a pair of sugar-specific proteins designated as the Enzyme II complex. The PTS has also been implicated in the induction of synthesis of some catabolic enzyme systems required for the utilization of sugars that are not substrates of the PTS as well as the regulation of the activity of adenylate cyclase. EC 2.7.1.-.%A%    
% 212.58/212.75  |- rdf__type mesh__D010731sskos__Concept
% 212.58/212.75  |- skos__annotation mesh__D010731 DF: PEPPTS   
% 212.58/212.75  |- mesh__dateRevised mesh__D010731 2004-07-07
% 212.58/212.75  |- skos__hiddenLabel mesh__D010731
% 212.58/212.75       Phosphotransferase System, Phosphoenolpyruvate-Glycose
% 212.58/212.75  |- skos__hiddenLabel mesh__D010731
% 212.58/212.75       Hexose Phosphotransferases, Phosphoenolpyruvate
% 212.58/212.75  |- mesh__recordAuthorizer mesh__D010731 sjn
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D010731 2005
% 212.58/212.75  |- mesh__recordOriginator mesh__D010731 RLS
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D009988 2006
% 212.58/212.75  |- skos__related mesh__D009988smesh__D013285
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D009988 2002
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D009988 2004
% 212.58/212.75  |- skos__broader mesh__D009988smesh__D006281
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D009988 2005
% 212.58/212.75  |- mesh__dateCreated mesh__D009988 1999-01-01
% 212.58/212.75  |- rdf__type mesh__D009988sskos__Concept
% 212.58/212.75  |- skos__broader mesh__D009988smesh__D013812
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D009988 2003
% 212.58/212.75  |- skos__altLabel mesh__D009988 Pleoptics
% 212.58/212.75  |- skos__annotation mesh__D009988
% 212.58/212.75       SPEC: SPEC qualif; X ref PLEOPTICS is seen in foreign lit%A%  
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D009988 2001
% 212.58/212.75  |- mesh__recordAuthorizer mesh__D009988 sjn
% 212.58/212.75  |- mesh__recordOriginator mesh__D009988 NLM
% 212.58/212.75  |- skos__hiddenLabel mesh__D009988 Pleoptic
% 212.58/212.75  |- skos__hiddenLabel mesh__D009988 Orthoptic
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D009988 2000
% 212.58/212.75  |- skos__prefLabel mesh__D009988 Orthoptics
% 212.58/212.75  |- skos__scopeNote mesh__D009988
% 212.58/212.75       The study and treatment of defects in binocular vision resulting from defects in the optic musculature or of faulty visual habits. It involves a technique of eye exercises designed to correct the visual axes of eyes not properly coordinated for binocular vision.%A%    
% 212.58/212.75  |- mesh__recordMaintainer mesh__D009988 KEV
% 212.58/212.75  |- mesh__dateRevised mesh__D009988 1999-11-08
% 212.58/212.75  |- skos__broader mesh__D034381smesh__D006311
% 212.58/212.75  |- skos__altLabel mesh__D034381 Hypoacusis
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D034381 2006
% 212.58/212.75  |- mesh__recordAuthorizer mesh__D034381 sjn
% 212.58/212.75  |- mesh__dateRevised mesh__D034381 2004-07-07
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D034381 2005
% 212.58/212.75  |- mesh__publicMeSHNote mesh__D034381
% 212.58/212.75       2003; see DEAFNESS 2000-2002; for HYPOACUSIS see HEARING LOSS, PARTIAL 2000-2002%A%  
% 212.58/212.75  |- skos__altLabel mesh__D034381 Hearing Impairment
% 212.58/212.75  |- skos__annotation mesh__D034381 GEN or unspecified; prefer specifics   
% 212.58/212.75  |- skos__scopeNote mesh__D034381
% 212.58/212.75       A general term for the complete or partial loss of the ability to hear from one or both ears.%A%    
% 212.58/212.75  |- mesh__historyNote mesh__D034381 2003; use DEAFNESS 2000-2002   
% 212.58/212.75  |- skos__hiddenLabel mesh__D034381 Loss, Hearing
% 212.58/212.75  |- mesh__recordMaintainer mesh__D034381 lkt
% 212.58/212.75  |- mesh__recordOriginator mesh__D034381 lkt
% 212.58/212.75  |- mesh__dateCreated mesh__D034381 2002-07-03
% 212.58/212.75  |- mesh__dateEstablished mesh__D034381 2003-01-01
% 212.58/212.75  |- skos__prefLabel mesh__D034381 Hearing Loss
% 212.58/212.75  |- rdf__type mesh__D034381sskos__Concept
% 212.58/212.75  |- skos__hiddenLabel mesh__D034381 Hypoacuses
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D006690 2006
% 212.58/212.75  |- skos__scopeNote mesh__D006690
% 212.58/212.75       A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.%A%    
% 212.58/212.75  |- skos__altLabel mesh__D006690 Hoe-33258
% 212.58/212.75  |- skos__altLabel mesh__D006690 Pibenzimol
% 212.58/212.75  |- mesh__recordAuthorizer mesh__D006690 sjn
% 212.58/212.75  |- skos__hiddenLabel mesh__D006690 NSC322921
% 212.58/212.75  |- skos__broader mesh__D006690smesh__D001562
% 212.58/212.75  |- mesh__dateRevised mesh__D006690 2005-06-30
% 212.58/212.75  |- rdf__type mesh__D006690sskos__Concept
% 212.58/212.75  |- mesh__publicMeSHNote mesh__D006690
% 212.58/212.75       91; was see under BENZIMIDAZOLES 1977-90   
% 212.58/212.75  |- mesh__recordMaintainer mesh__D006690 ags
% 212.58/212.75  |- skos__historyNote mesh__D006690 Benzimidazoles %28%1971-1976%29%
% 212.58/212.75  |- skos__historyNote mesh__D006690 Phenols %28%1972-1975%29%
% 212.58/212.75  |- skos__hiddenLabel mesh__D006690 33258, Hoechst
% 212.58/212.75  |- mesh__recordOriginator mesh__D006690 SH
% 212.58/212.75  |- skos__historyNote mesh__D006690 Piperazines %28%1971-1975%29%
% 212.58/212.75  |- mesh__dateEstablished mesh__D006690 1991-01-01
% 212.58/212.75  |- skos__hiddenLabel mesh__D006690 NSC 322921
% 212.58/212.75  |- mesh__dateCreated mesh__D006690 1976-04-13
% 212.58/212.75  |- mesh__historyNote mesh__D006690
% 212.58/212.75       91%28%77%29%; was see under BENZIMIDAZOLES 1977-90   
% 212.58/212.75  |- skos__prefLabel mesh__D006690 Bisbenzimide
% 212.58/212.75  |- skos__hiddenLabel mesh__D020361 Opsoclonus-Myoclonus Syndromes
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D020361 2005
% 212.58/212.75  |- skos__historyNote mesh__D020361 Neoplasms %28%1966-1999%29%
% 212.58/212.75  |- skos__hiddenLabel mesh__D020361 Syndromes, Opsoclonus-Myoclonus
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D020361 2001
% 212.58/212.75  |- skos__hiddenLabel mesh__D020361 Syndrome, Opsoclonus-Myoclonus
% 212.58/212.75  |- skos__hiddenLabel mesh__D020361 Autonomic Dysfunctions, Paraneoplastic
% 212.58/212.75  |- skos__prefLabel mesh__D020361 Paraneoplastic Syndromes, Nervous System
% 212.58/212.75  |- skos__broader mesh__D020361smesh__D010257
% 212.58/212.75  |- skos__altLabel mesh__D020361 Nervous System Paraneoplastic Syndromes
% 212.58/212.75  |- skos__annotation mesh__D020361 DF: PARANEOPL ENCEPH   
% 212.58/212.75  |- mesh__dateCreated mesh__D020361 1999-11-03
% 212.58/212.75  |- skos__historyNote mesh__D020361
% 212.58/212.75       Neurologic Manifestations %28%1966-1999%29%
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D020361 2004
% 212.58/212.75  |- skos__hiddenLabel mesh__D020361 Paraneoplastic Encephalomyelitides
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D020361 2000
% 212.58/212.75  |- skos__hiddenLabel mesh__D020361 Opsoclonus Myoclonus Syndrome
% 212.58/212.75  |- skos__broader mesh__D020361smesh__D009423
% 212.58/212.75  |- skos__altLabel mesh__D020361 Autonomic Dysfunction, Paraneoplastic
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D020361 2003
% 212.58/212.75  |- mesh__dateEstablished mesh__D020361 2000-01-01
% 212.58/212.75  |- skos__broader mesh__D020361smesh__D019636
% 212.58/212.75  |- mesh__historyNote mesh__D020361 2000   
% 212.58/212.75  |- skos__hiddenLabel mesh__D020361 Paraneoplastic Autonomic Dysfunctions
% 212.58/212.75  |- skos__scopeNote mesh__D020361
% 212.58/212.75       Degenerative or inflammatory conditions affecting the central or peripheral nervous system that develop in association with a systemic neoplasm without direct invasion by tumor. They may be associated with circulating antibodies that react with the affected neural tissue. %28%Intern Med 1996 Dec;35%28%12%29%:925-9%29%%A%    
% 212.58/212.75  |- skos__hiddenLabel mesh__D020361 Encephalomyelitis, Paraneoplastic
% 212.58/212.75  |- rdf__type mesh__D020361sskos__Concept
% 212.58/212.75  |- mesh__publicMeSHNote mesh__D020361 2000   
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D020361 2006
% 212.58/212.75  |- skos__historyNote mesh__D020361
% 212.58/212.75       Paraneoplastic Syndromes %28%1980-1999%29%
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D020361 2002
% 212.58/212.75  |- mesh__publicMeSHNote mesh__D014324 91; was see under MITES 1975-90   
% 212.58/212.75  |- mesh__recordMaintainer mesh__D014324 ags
% 212.58/212.75  |- mesh__historyNote mesh__D014324
% 212.58/212.75       91%28%75%29%; was see under MITES 1975-90   
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D014324 2005
% 212.58/212.75  |- skos__annotation mesh__D014324 infection = TROMBICULIASIS   
% 212.58/212.75  |- mesh__dateCreated mesh__D014324 1974-12-12
% 212.58/212.75  |- skos__altLabel mesh__D014324 Chiggers
% 212.58/212.75  |- mesh__dateRevised mesh__D014324 2003-07-09
% 212.58/212.75  |- mesh__recordOriginator mesh__D014324 NLM
% 212.58/212.75  |- mesh__recordAuthorizer mesh__D014324 sjn
% 212.58/212.75  |- skos__prefLabel mesh__D014324 Trombiculidae
% 212.58/212.75  |- rdf__type mesh__D014324sskos__Concept
% 212.58/212.75  |- skos__altLabel mesh__D014324 Harvest Mites
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D014324 2004
% 212.58/212.75  |- mesh__dateEstablished mesh__D014324 1991-01-01
% 212.58/212.75  |- skos__scopeNote mesh__D014324
% 212.58/212.75       Family of MITES in the superfamily Trombiculoidea, suborder Prostigmata, which attack humans and other vertebrates, causing DERMATITIS and severe allergic reactions. Chiggers, red bugs, and harvest mites commonly refer to the larval stage of Trombiculid mites, the only parasitic stage of the mite%27%s life cycle.%A%    
% 212.58/212.75  |- skos__altLabel mesh__D014324 Red Bugs
% 212.58/212.75  |- skos__altLabel mesh__D014324 Trombiculid Mites
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D014324 2006
% 212.58/212.75  |- skos__broader mesh__D014324smesh__D008925
% 212.58/212.75  |- mesh__dateRevised mesh__D000304 1997-06-20
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D000304 2006
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D000304 2001
% 212.58/212.75  |- rdf__type mesh__D000304sskos__Concept
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D000304 2003
% 212.58/212.75  |- mesh__publicMeSHNote mesh__D000304
% 212.58/212.75       91,63-67; was see under PITUITARY-ADRENAL FUNCTION TESTS 1975-90; was heading 1963-67%A%  
% 212.58/212.75  |- skos__prefLabel mesh__D000304 Adrenal Cortex Function Tests
% 212.58/212.75  |- mesh__historyNote mesh__D000304
% 212.58/212.75       91%28%75%29%63-67; was see under PITUITARY-ADRENAL FUNCTION TESTS 1975-90; was heading 1963-67%A%  
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D000304 2004
% 212.58/212.75  |- mesh__dateEstablished mesh__D000304 1991-01-01
% 212.58/212.75  |- mesh__onlineNote mesh__D000304
% 212.58/212.75       search PITUITARY-ADRENAL FUNCTION TESTS 1966-74   
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D000304 2002
% 212.58/212.75  |- mesh__recordMaintainer mesh__D000304 PXP
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D000304 1998
% 212.58/212.75  |- mesh__dateCreated mesh__D000304 1999-01-01
% 212.58/212.75  |- mesh__recordOriginator mesh__D000304 NLM
% 212.58/212.75  |- skos__broader mesh__D000304smesh__D003940
% 212.58/212.75  |- mesh__activeMeSHYear mesh__D000304 2005
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D000304 2000
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D000304 1999
% 212.58/212.76  |- mesh__recordAuthorizer mesh__D000304 SJN
% 212.58/212.76  |- skos__prefLabel mesh__D005598 Fractures, Spontaneous
% 212.58/212.76  |- skos__altLabel mesh__D005598 Fracture, Pathological
% 212.58/212.76  |- mesh__recordOriginator mesh__D005598 NLM
% 212.58/212.76  |- skos__scopeNote mesh__D005598
% 212.58/212.76       Fractures occurring as a result of disease of a bone or from some undiscoverable cause, and not due to trauma. %28%Dorland, 27th ed%29%%A%    
% 212.58/212.76  |- skos__hiddenLabel mesh__D005598 Pathologic Fracture
% 212.58/212.76  |- skos__altLabel mesh__D005598 Pathological Fractures
% 212.58/212.76  |- mesh__dateCreated mesh__D005598 1999-01-01
% 212.58/212.76  |- mesh__recordAuthorizer mesh__D005598 sjn
% 212.58/212.76  |- skos__hiddenLabel mesh__D005598 Fracture, Spontaneous
% 212.58/212.76  |- skos__altLabel mesh__D005598 Fracture, Pathologic
% 212.58/212.76  |- skos__broader mesh__D005598smesh__D050723
% 212.58/212.76  |- skos__altLabel mesh__D005598 Fractures, Pathological
% 212.58/212.76  |- mesh__recordMaintainer mesh__D005598 ssb
% 212.58/212.76  |- skos__hiddenLabel mesh__D005598 Spontaneous Fractures
% 212.58/212.76  |- skos__altLabel mesh__D005598 Pathological Fracture
% 212.58/212.76  |- skos__annotation mesh__D005598
% 212.58/212.76       fract not caused by trauma; IM; coord with specific organ /inj or organ/fract term %28%IM%29%%A%  
% 212.58/212.76  |- mesh__dateRevised mesh__D005598 2005-06-30
% 212.58/212.76  |- skos__hiddenLabel mesh__D005598 Spontaneous Fracture
% 212.58/212.76  |- rdf__type mesh__D005598sskos__Concept
% 212.58/212.76  |- skos__altLabel mesh__D005598 Fractures, Pathologic
% 212.58/212.76  |- skos__hiddenLabel mesh__D005598 Pathologic Fractures
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D005598 2006
% 212.58/212.76  |- skos__altLabel mesh__D018715 Video Microscopy
% 212.58/212.76  |- skos__scopeNote mesh__D018715
% 212.58/212.76       Microscopy in which television cameras are used to brighten magnified images that are otherwise too dark to be seen with the naked eye. It is used frequently in TELEPATHOLOGY.%A%    
% 212.58/212.76  |- skos__hiddenLabel mesh__D018715 Video Microscopies
% 212.58/212.76  |- mesh__historyNote mesh__D018715 95   
% 212.58/212.76  |- skos__prefLabel mesh__D018715 Microscopy, Video
% 212.58/212.76  |- skos__hiddenLabel mesh__D018715 Videomicrographies
% 212.58/212.76  |- skos__hiddenLabel mesh__D018715 Microscopies, Video
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D018715 2005
% 212.58/212.76  |- skos__broader mesh__D018715smesh__D008853
% 212.58/212.76  |- skos__historyNote mesh__D018715 Microscopy %28%1974-1994%29%
% 212.58/212.76  |- mesh__dateRevised mesh__D018715 2004-07-07
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D018715 2006
% 212.58/212.76  |- rdf__type mesh__D018715sskos__Concept
% 212.58/212.76  |- skos__annotation mesh__D018715 NIM   
% 212.58/212.76  |- skos__broader mesh__D018715smesh__D013690
% 212.58/212.76  |- skos__altLabel mesh__D018715 Videomicrography
% 212.58/212.76  |- mesh__recordMaintainer mesh__D018715 nns
% 212.58/212.76  |- mesh__dateCreated mesh__D018715 1994-04-16
% 212.58/212.76  |- mesh__recordAuthorizer mesh__D018715 sjn
% 212.58/212.76  |- skos__altLabel mesh__D018715 Videomicroscopy
% 212.58/212.76  |- mesh__publicMeSHNote mesh__D018715 95   
% 212.58/212.76  |- skos__hiddenLabel mesh__D018715 Videomicroscopies
% 212.58/212.76  |- mesh__recordOriginator mesh__D018715 PXP
% 212.58/212.76  |- mesh__dateEstablished mesh__D018715 1995-01-01
% 212.58/212.76  |- mesh__dateRevised mesh__D010732 2005-07-08
% 212.58/212.76  |- skos__altLabel mesh__D010732 Fructose-6-P 1-Kinase
% 212.58/212.76  |- skos__annotation mesh__D010732 GEN or unspecified; prefer specifics   
% 212.58/212.76  |- skos__hiddenLabel mesh__D010732 6 Phosphofructokinase
% 212.58/212.76  |- mesh__recordOriginator mesh__D010732 NLM
% 212.58/212.76  |- mesh__recordMaintainer mesh__D010732 ags
% 212.58/212.76  |- skos__altLabel mesh__D010732 Fructose-6-phosphate 1-Phosphotransferase
% 212.58/212.76  |- skos__related mesh__D010732smesh__D006014
% 212.58/212.76  |- rdf__type mesh__D010732sskos__Concept
% 212.58/212.76  |- skos__altLabel mesh__D010732 6-Phosphofructo-1-kinase
% 212.58/212.76  |- mesh__dateCreated mesh__D010732 1999-01-01
% 212.58/212.76  |- mesh__dateEstablished mesh__D010732 1965-01-01
% 212.58/212.76  |- mesh__recordAuthorizer mesh__D010732 ags
% 212.58/212.76  |- mesh__publicMeSHNote mesh__D010732
% 212.58/212.76       2002; see 6-PHOSPHOFRUCTOKINASE 1993-2001, see PHOSPHOFRUCTOKINASE 1965-1992%A%  
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D010732 2006A
% 212.58/212.76  |- skos__altLabel mesh__D010732 6-Phosphofructokinase
% 212.58/212.76  |- skos__scopeNote mesh__D010732
% 212.58/212.76       An allosteric enzyme that regulates glycolysis by catalyzing the transfer of a phosphate group from ATP to fructose-6-phosphate to yield fructose-1,6-bisphosphate. D-tagatose- 6-phosphate and sedoheptulose-7-phosphate also are acceptors. UTP, CTP, and ITP also are donors. In human phosphofructokinase-1, three types of subunits have been identified. They are PHOSPHOFRUCTOKINASE-1, MUSCLE TYPE; PHOSPHOFRUCTOKINASE-1, LIVER TYPE; and PHOSPHOFRUCTOKINASE-1, C TYPE; found in platelets, brain, and other tissues.%A%    
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D010732 2005
% 212.58/212.76  |- skos__broader mesh__D010732smesh__D025221
% 212.58/212.76  |- skos__prefLabel mesh__D010732 Phosphofructokinase-1
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D010732 2006
% 212.58/212.76  |- skos__related mesh__D010732smesh__D025481
% 212.58/212.76  |- skos__hiddenLabel mesh__D010732 Phosphofructokinase 1
% 212.58/212.76  |- mesh__historyNote mesh__D010732 2002   
% 212.58/212.76  |- rdf__type mesh__D009989sskos__Concept
% 212.58/212.76  |- mesh__dateCreated mesh__D009989 1999-01-01
% 212.58/212.76  |- skos__prefLabel mesh__D009989 Orthotic Devices
% 212.58/212.76  |- mesh__recordOriginator mesh__D009989 NLM
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D009989 2003
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D009989 1995
% 212.58/212.76  |- skos__hiddenLabel mesh__D009989 Device, Orthotic
% 212.58/212.76  |- skos__hiddenLabel mesh__D009989 Devices, Orthotic
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D009989 2000
% 212.58/212.76  |- skos__hiddenLabel mesh__D009989 Orthotic Device
% 212.58/212.76  |- mesh__publicMeSHNote mesh__D009989 74   
% 212.58/212.76  |- mesh__historyNote mesh__D009989 74%28%72%29%   
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D009989 1993
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D009989 1994
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D009989 1999
% 212.58/212.76  |- skos__altLabel mesh__D009989 Orthosis
% 212.58/212.76  |- skos__scopeNote mesh__D009989
% 212.58/212.76       Apparatus used to support, align, prevent, or correct deformities or to improve the function of movable parts of the body.%A%    
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D009989 2002
% 212.58/212.76  |- mesh__recordMaintainer mesh__D009989 TAP
% 212.58/212.76  |- skos__broader mesh__D009989smesh__D009983
% 212.58/212.76  |- mesh__dateEstablished mesh__D009989 1974-01-01
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D009989 1997
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D009989 1998
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D009989 2006
% 212.58/212.76  |- mesh__dateRevised mesh__D009989 1992-05-15
% 212.58/212.76  |- mesh__recordAuthorizer mesh__D009989 PLS
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D009989 1996
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D009989 2004
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D009989 2005
% 212.58/212.76  |- skos__historyNote mesh__D009989 Orthopedic Equipment %28%1966-1971%29%
% 212.58/212.76  |- skos__annotation mesh__D009989 includes slings, BRACES, etc.   
% 212.58/212.76  |- skos__altLabel mesh__D009989 Orthoses
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D009989 2001
% 212.58/212.76  |- skos__broader mesh__D006691smesh__D013553
% 212.58/212.76  |- skos__scopeNote mesh__D006691
% 212.58/212.76       An acute, highly contagious disease affecting swine of all ages and caused by the CLASSICAL SWINE FEVER VIRUS. It has a sudden onset with high morbidity and mortality.%A%    
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D006691 2004
% 212.58/212.76  |- mesh__dateRevised mesh__D006691 2003-07-09
% 212.58/212.76  |- rdf__type mesh__D006691sskos__Concept
% 212.58/212.76  |- mesh__recordMaintainer mesh__D006691 ags
% 212.58/212.76  |- skos__hiddenLabel mesh__D006691 Cholera, Hog
% 212.58/212.76  |- skos__altLabel mesh__D006691 Hog Cholera
% 212.58/212.76  |- mesh__publicMeSHNote mesh__D006691 2002; see HOG CHOLERA 1963-2001   
% 212.58/212.76  |- skos__annotation mesh__D006691
% 212.58/212.76       do not confuse X ref SWINE FEVER with AFRICAN SWINE FEVER; don%27%t forget also SWINE %28%NIM%29%%A%  
% 212.58/212.76  |- mesh__recordAuthorizer mesh__D006691 sjn
% 212.58/212.76  |- skos__prefLabel mesh__D006691 Classical Swine Fever
% 212.58/212.76  |- mesh__recordOriginator mesh__D006691 NLM
% 212.58/212.76  |- skos__broader mesh__D006691smesh__D018182
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D006691 2006
% 212.58/212.76  |- skos__altLabel mesh__D006691 Swine Fever
% 212.58/212.76  |- mesh__dateCreated mesh__D006691 1999-01-01
% 212.58/212.76  |- mesh__historyNote mesh__D006691 2002 %28%1963%29%   
% 212.58/212.76  |- skos__altLabel mesh__D006691 Swine Fever, Classical
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D006691 2005
% 212.58/212.76  |- skos__scopeNote mesh__D020362
% 212.58/212.76       Cerebellar degeneration associated with a remote neoplasm. Clinical manifestations include progressive limb and GAIT ATAXIA; DYSARTHRIA; and NYSTAGMUS, PATHOLOGIC. The histologic type of the associated neoplasm is usually carcinoma or lymphoma. Pathologically the cerebellar cortex and subcortical nuclei demonstrate diffuse degenerative changes. Anti-Purkinje cell antibodies %28%anti-Yo%29% are found in the serum of approximately 50%25% of affected individuals. %28%Adams et al., Principles of Neurology, 6th ed, p686%29%%A%    
% 212.58/212.76  |- skos__broader mesh__D020362smesh__D020361
% 212.58/212.76  |- mesh__publicMeSHNote mesh__D020362 2000   
% 212.58/212.76  |- skos__historyNote mesh__D020362
% 212.58/212.76       Paraneoplastic Syndromes %28%1980-1999%29%
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D020362 2004
% 212.58/212.76  |- mesh__recordMaintainer mesh__D020362 ags
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D020362 2002
% 212.58/212.76  |- skos__altLabel mesh__D020362
% 212.58/212.76       Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration
% 212.58/212.76  |- skos__historyNote mesh__D020362 Cerebellar Ataxia %28%1975-1999%29%
% 212.58/212.76  |- skos__broader mesh__D020362smesh__D002526
% 212.58/212.76  |- skos__prefLabel mesh__D020362 Paraneoplastic Cerebellar Degeneration
% 212.58/212.76  |- mesh__recordOriginator mesh__D020362 KEV
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D020362 2003
% 212.58/212.76  |- mesh__dateEstablished mesh__D020362 2000-01-01
% 212.58/212.76  |- skos__hiddenLabel mesh__D020362 Cerebellar Syndromes, Paraneoplastic
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D020362 2001
% 212.58/212.76  |- skos__altLabel mesh__D020362 Paraneoplastic Cerebellar Syndrome
% 212.58/212.76  |- skos__hiddenLabel mesh__D020362 Paraneoplastic Cerebellar Syndromes
% 212.58/212.76  |- mesh__historyNote mesh__D020362 2000   
% 212.58/212.76  |- skos__hiddenLabel mesh__D020362 Degeneration, Paraneoplastic Cerebellar
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D020362 2000
% 212.58/212.76  |- rdf__type mesh__D020362sskos__Concept
% 212.58/212.76  |- mesh__dateCreated mesh__D020362 1999-11-04
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D020362 2006
% 212.58/212.76  |- skos__annotation mesh__D020362
% 212.58/212.76       coord with precoord organ/neopl term + histol type   
% 212.58/212.76  |- skos__altLabel mesh__D020362 Cerebellar Degeneration, Paraneoplastic
% 212.58/212.76  |- mesh__recordAuthorizer mesh__D020362 ags
% 212.58/212.76  |- skos__altLabel mesh__D020362 Cerebellar Syndrome, Paraneoplastic
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D020362 2005
% 212.58/212.76  |- mesh__dateRevised mesh__D020362 2005-07-21
% 212.58/212.76  |- skos__hiddenLabel mesh__D020362
% 212.58/212.76       Paraneoplastic Cerebellar Degeneration, Anti Yo Associated
% 212.58/212.76  |- skos__hiddenLabel mesh__D020362
% 212.58/212.76       Anti Yo Associated Paraneoplastic Cerebellar Degeneration
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D020362 2006A
% 212.58/212.76  |- skos__altLabel mesh__D014325 Tris Buffer
% 212.58/212.76  |- skos__altLabel mesh__D014325 Tris-Mg%28%II%29%-KCl Buffer
% 212.58/212.76  |- skos__scopeNote mesh__D014325
% 212.58/212.76       An organic amine proton acceptor. It is used in the synthesis of surface-active agents and pharmaceuticals; as an emulsifying agent for cosmetic creams and lotions, mineral oil and paraffin wax emulsions, as a biological buffer, and used as an alkalizer. %28%From Merck, 11th ed; Martindale, The Extra Pharmacopoeia, 30th ed, p1424%29%%A%    
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D014325 2002
% 212.58/212.76  |- skos__prefLabel mesh__D014325 Tromethamine
% 212.58/212.76  |- mesh__recordMaintainer mesh__D014325 ssb
% 212.58/212.76  |- rdf__type mesh__D014325sskos__Concept
% 212.58/212.76  |- skos__altLabel mesh__D014325 Tri%28%hydroxymethyl%29%aminomethane
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D014325 2004
% 212.58/212.76  |- mesh__dateEstablished mesh__D014325 1965-01-01
% 212.58/212.76  |- mesh__recordOriginator mesh__D014325 NLM
% 212.58/212.76  |- mesh__recordAuthorizer mesh__D014325 sjn
% 212.58/212.76  |- mesh__publicMeSHNote mesh__D014325 65   
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D014325 2003
% 212.58/212.76  |- mesh__dateCreated mesh__D014325 1999-01-01
% 212.58/212.76  |- skos__altLabel mesh__D014325 Trisamine
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D014325 2006
% 212.58/212.76  |- skos__altLabel mesh__D014325 Trometamol
% 212.58/212.76  |- skos__altLabel mesh__D014325 Tris%28%hydroxymethyl%29%aminomethane
% 212.58/212.76  |- skos__altLabel mesh__D014325 THAM
% 212.58/212.76  |- mesh__dateRevised mesh__D014325 2001-07-25
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D014325 2005
% 212.58/212.76  |- skos__broader mesh__D014325smesh__D011409
% 212.58/212.76  |- mesh__historyNote mesh__D014325 65   
% 212.58/212.76  |- rdf__type mesh__D000305sskos__Concept
% 212.58/212.76  |- mesh__recordMaintainer mesh__D000305 NLM
% 212.58/212.76  |- skos__related mesh__D000305smesh__D000308
% 212.58/212.76  |- skos__hiddenLabel mesh__D000305 Hormones, Adrenal Cortex
% 212.58/212.76  |- skos__broader mesh__D000305smesh__D006728
% 212.58/212.76  |- skos__annotation mesh__D000305
% 212.58/212.76       GEN only; avoid: prefer specifics; /defic: consider also ADRENAL GLAND HYPOFUNCTION%A%  
% 212.58/212.76  |- mesh__dateCreated mesh__D000305 1999-01-01
% 212.58/212.76  |- mesh__dateRevised mesh__D000305 2004-07-20
% 212.58/212.76  |- mesh__recordAuthorizer mesh__D000305 NLM
% 212.58/212.76  |- skos__prefLabel mesh__D000305 Adrenal Cortex Hormones
% 212.58/212.76  |- skos__related mesh__D000305smesh__D011965
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D000305 2005
% 212.58/212.76  |- skos__altLabel mesh__D000305 Corticoids
% 212.58/212.76  |- skos__related mesh__D000305smesh__D000309
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D000305 2006
% 212.58/212.76  |- skos__altLabel mesh__D000305 Corticosteroids
% 212.58/212.76  |- mesh__recordOriginator mesh__D000305 NLM
% 212.58/212.76  |- skos__altLabel mesh__D019010 Vascular Cell Adhesion Molecule
% 212.58/212.76  |- skos__scopeNote mesh__D019010
% 212.58/212.76       Cytokine-induced cell adhesion molecule present on activated endothelial cells, tissue macrophages, dendritic cells, bone marrow fibroblasts, myoblasts, and myotubes. It is important for the recruitment of leukocytes to sites of inflammation. %28%From Pigott %26% Power, The Adhesion Molecule FactsBook, 1993, p154%29%%A%    
% 212.58/212.76  |- skos__altLabel mesh__D019010 CD106 Antigens
% 212.58/212.76  |- skos__altLabel mesh__D019010 Antigens, CD106
% 212.58/212.76  |- skos__historyNote mesh__D019010
% 212.58/212.76       Cell Adhesion Molecules %28%1990-1995%29%
% 212.58/212.76  |- mesh__onlineNote mesh__D019010
% 212.58/212.76       use VASCULAR CELL ADHESION MOLECULE-1 %28%NM%29% to search VASCULAR CELL ADHESION MOLECULE %26% INDUCIBLE CELL ADHESION MOLECULE 110 1990-95%A%  
% 212.58/212.76  |- mesh__historyNote mesh__D019010
% 212.58/212.76       96; was VASCULAR CELL ADHESION MOLECULE %28%NM%29% %26% INDUCIBLE CELL ADHESION MOLECULE 110 %28%NM%29% 1990-95%A%  
% 212.58/212.76  |- skos__altLabel mesh__D019010 INCAM-110
% 212.58/212.76  |- skos__altLabel mesh__D019010 VCAM-1
% 212.58/212.76  |- skos__annotation mesh__D019010
% 212.58/212.76       a cell adhesion molecule %26% CD antigen; DF: note short X refs%A%  
% 212.58/212.76  |- skos__prefLabel mesh__D019010 Vascular Cell Adhesion Molecule-1
% 212.58/212.76  |- skos__broader mesh__D019010smesh__D015815
% 212.58/212.76  |- mesh__recordOriginator mesh__D019010 AGS
% 212.58/212.76  |- mesh__recordMaintainer mesh__D019010 ssb
% 212.58/212.76  |- mesh__recordAuthorizer mesh__D019010 sjn
% 212.58/212.76  |- skos__altLabel mesh__D019010 CD106 Antigen
% 212.58/212.76  |- skos__hiddenLabel mesh__D019010 Antigen, CD106
% 212.58/212.76  |- skos__hiddenLabel mesh__D019010 Vascular Cell Adhesion Molecule 1
% 212.58/212.76  |- skos__altLabel mesh__D019010 Inducible Cell Adhesion Molecule 110
% 212.58/212.76  |- mesh__dateCreated mesh__D019010 1995-05-26
% 212.58/212.76  |- skos__broader mesh__D019010smesh__D015703
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D019010 2006
% 212.58/212.76  |- mesh__dateRevised mesh__D019010 2005-06-30
% 212.58/212.76  |- mesh__dateEstablished mesh__D019010 1996-01-01
% 212.58/212.76  |- rdf__type mesh__D019010sskos__Concept
% 212.58/212.76  |- mesh__publicMeSHNote mesh__D019010
% 212.58/212.76       96; VASCULAR CELL ADHESION MOLECULE %26% INDUCIBLE CELL ADHESION MOLECULE 110 were indexed under CELL ADHESION MOLECULES 1990-95%A%  
% 212.58/212.76  |- skos__scopeNote mesh__D005599
% 212.58/212.76       A fracture in which union fails to occur, the ends of the bone becoming rounded and eburnated, and a false joint occurs. %28%Stedman, 25th ed%29%%A%    
% 212.58/212.76  |- mesh__dateRevised mesh__D005599 2005-06-30
% 212.58/212.76  |- skos__hiddenLabel mesh__D005599 Fracture, Ununited
% 212.58/212.76  |- skos__prefLabel mesh__D005599 Fractures, Ununited
% 212.58/212.76  |- skos__broader mesh__D005599smesh__D050723
% 212.58/212.76  |- skos__hiddenLabel mesh__D005599 Ununited Fractures
% 212.58/212.76  |- mesh__recordOriginator mesh__D005599 NLM
% 212.58/212.76  |- mesh__recordMaintainer mesh__D005599 ssb
% 212.58/212.76  |- rdf__type mesh__D005599sskos__Concept
% 212.58/212.76  |- mesh__recordAuthorizer mesh__D005599 sjn
% 212.58/212.76  |- skos__hiddenLabel mesh__D005599 Ununited Fracture
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D005599 2006
% 212.58/212.76  |- mesh__dateCreated mesh__D005599 1999-01-01
% 212.58/212.76  |- skos__annotation mesh__D005599
% 212.58/212.76       fract where union does not occur; do not confuse with FRACTURES, MALUNITED; IM; coord with specific organ/inj or precoord organ/fract term %28%IM%29%%A%  
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D018716 2005
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D018716 2004
% 212.58/212.76  |- mesh__publicMeSHNote mesh__D018716 95   
% 212.58/212.76  |- skos__hiddenLabel mesh__D018716 Mimicries, Molecular
% 212.58/212.76  |- skos__hiddenLabel mesh__D018716 Mimicries, Antigenic
% 212.58/212.76  |- mesh__dateEstablished mesh__D018716 1995-01-01
% 212.58/212.76  |- skos__hiddenLabel mesh__D018716 Molecular Mimicries
% 212.58/212.76  |- skos__hiddenLabel mesh__D018716 Mimicries, Antigen
% 212.58/212.76  |- mesh__dateRevised mesh__D018716 2002-07-02
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D018716 2006
% 212.58/212.76  |- mesh__dateCreated mesh__D018716 1994-05-23
% 212.58/212.76  |- skos__altLabel mesh__D018716 Antigen Mimicry
% 212.58/212.76  |- rdf__type mesh__D018716sskos__Concept
% 212.58/212.76  |- skos__hiddenLabel mesh__D018716 Mimicries, DNA
% 212.58/212.76  |- skos__hiddenLabel mesh__D018716 DNA Mimicries
% 212.58/212.76  |- skos__prefLabel mesh__D018716 Molecular Mimicry
% 212.58/212.76  |- skos__hiddenLabel mesh__D018716 Mimicry, Antigenic
% 212.58/212.76  |- skos__hiddenLabel mesh__D018716 Mimicry, DNA
% 212.58/212.76  |- skos__hiddenLabel mesh__D018716 Antigenic Mimicries
% 212.58/212.76  |- skos__altLabel mesh__D018716 Mimicry, Molecular
% 212.58/212.76  |- skos__broader mesh__D018716smesh__D001669
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D018716 2003
% 212.58/212.76  |- skos__hiddenLabel mesh__D018716 Mimicry, Antigen
% 212.58/212.76  |- skos__historyNote mesh__D018716 Amino Acid Sequence %28%1980-1994%29%
% 212.58/212.76  |- skos__scopeNote mesh__D018716
% 212.58/212.76       The process in which structural properties of an introduced molecule imitate or simulate molecules of the host. Direct mimicry of a molecule enables a viral protein to bind directly to a normal substrate as a substitute for the homologous normal ligand. Immunologic molecular mimicry generally refers to what can be described as antigenic mimicry and is defined by the properties of ANTIBODIES raised against various facets of EPITOPES on the viral protein. %28%From Immunology Letters 1991 May;28%28%2%29%:91-9%29%%A%    
% 212.58/212.76  |- skos__hiddenLabel mesh__D018716 Antigen Mimicries
% 212.58/212.76  |- mesh__historyNote mesh__D018716 95   
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D010733 2006
% 212.58/212.76  |- skos__hiddenLabel mesh__D010733 Phosphomutase, Glucose
% 212.58/212.76  |- skos__broader mesh__D010733smesh__D017875
% 212.58/212.76  |- skos__scopeNote mesh__D010733
% 212.58/212.76       An enzyme that catalyzes the conversion of alpha D-glucose 1-phosphate to alpha D-glucose 6-phosphate. EC 5.4.2.2.%A%    
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D010733 2005
% 212.58/212.76  |- mesh__recordAuthorizer mesh__D010733 sjn
% 212.58/212.76  |- mesh__dateCreated mesh__D010733 1999-01-01
% 212.58/212.76  |- rdf__type mesh__D010733sskos__Concept
% 212.58/212.76  |- mesh__recordMaintainer mesh__D010733 ssb
% 212.58/212.76  |- mesh__recordOriginator mesh__D010733 NLM
% 212.58/212.76  |- skos__altLabel mesh__D010733 Glucose Phosphomutase
% 212.58/212.76  |- mesh__dateRevised mesh__D010733 2003-07-09
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D010733 2004
% 212.58/212.76  |- skos__prefLabel mesh__D010733 Phosphoglucomutase
% 212.58/212.76  |- mesh__recordAuthorizer mesh__D006692 sjn
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D006692 2004
% 212.58/212.76  |- mesh__recordMaintainer mesh__D006692 ags
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D006692 2002
% 212.58/212.76  |- rdf__type mesh__D006692sskos__Concept
% 212.58/212.76  |- skos__altLabel mesh__D006692 Hog Cholera Virus
% 212.58/212.76  |- mesh__recordOriginator mesh__D006692 AEP
% 212.58/212.76  |- skos__hiddenLabel mesh__D006692 Cholera Virus, Hog
% 212.58/212.76  |- skos__annotation mesh__D006692
% 212.58/212.76       do not confuse X ref SWINE FEVER VIRUS with AFRICAN SWINE FEVER VIRUS; infection = CLASSICAL SWINE FEVER: see note there%A%  
% 212.58/212.76  |- skos__scopeNote mesh__D006692
% 212.58/212.76       A species of the PESTIVIRUS genus causing exceedingly contagious and fatal hemorrhagic disease of swine.%A%    
% 212.58/212.76  |- skos__broader mesh__D006692smesh__D010576
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D006692 2005
% 212.58/212.76  |- mesh__dateRevised mesh__D006692 2001-07-25
% 212.58/212.76  |- mesh__publicMeSHNote mesh__D006692
% 212.58/212.76       2002; see HOG CHOLERA VIRUS 1979-2001   
% 212.58/212.76  |- mesh__historyNote mesh__D006692 2002 %28%1979%29%   
% 212.58/212.76  |- skos__altLabel mesh__D006692 Swine Fever Virus
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D006692 2006
% 212.58/212.76  |- mesh__dateCreated mesh__D006692 1977-12-05
% 212.58/212.76  |- skos__historyNote mesh__D006692 RNA Viruses %28%1966-1978%29%
% 212.58/212.76  |- skos__historyNote mesh__D006692 Hog Cholera %28%1966-1978%29%
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D006692 2003
% 212.58/212.76  |- skos__prefLabel mesh__D006692 Classical swine fever virus
% 212.58/212.76  |- skos__altLabel mesh__D006692 Swine Fever Virus, Classical
% 212.58/212.76  |- mesh__dateEstablished mesh__D006692 1979-01-01
% 212.58/212.76  |- skos__broader mesh__D020363smesh__D020361
% 212.58/212.76  |- skos__annotation mesh__D020363 DF: LIMBIC ENCEPH   
% 212.58/212.76  |- mesh__dateCreated mesh__D020363 1999-11-03
% 212.58/212.76  |- mesh__publicMeSHNote mesh__D020363 2000   
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D020363 2004
% 212.58/212.76  |- mesh__historyNote mesh__D020363 2000   
% 212.58/212.76  |- skos__altLabel mesh__D020363 Encephalitis, Limbic
% 212.58/212.76  |- skos__scopeNote mesh__D020363
% 212.58/212.76       A paraneoplastic syndrome marked by degeneration of neurons in the medial temporal lobe. Clinical features include behavioral changes, HALLUCINATIONS, loss of short term memory, anosmia, AGEUSIA, and DEMENTIA. Circulating anti-neuronal antibodies %28%anti-Hu; also called ANNA 1%29% and small cell lung carcinomas are frequently associated with this condition. %28%From Pathologe 1997 Sep;18%28%5%29%:406-10; J Int Neuropsychol Soc 1996 Sep;2%28%5%29%:460-6; Brain 1997 Jun;120%28%Pt 6%29%:923-8%29%%A%    
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D020363 2002
% 212.58/212.76  |- skos__hiddenLabel mesh__D020363 Limbic Encephalitis, Paraneoplastic
% 212.58/212.76  |- skos__hiddenLabel mesh__D020363 Encephalitis, Paraneoplastic Limbic
% 212.58/212.76  |- skos__hiddenLabel mesh__D020363 Encephalitides, Paraneoplastic Limbic
% 212.58/212.76  |- skos__historyNote mesh__D020363
% 212.58/212.76       Paraneoplastic Syndromes %28%1980-1999%29%
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D020363 2005
% 212.58/212.76  |- skos__historyNote mesh__D020363 Dementia/etiology %28%1968-1999%29%
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D020363 2000
% 212.58/212.76  |- rdf__type mesh__D020363sskos__Concept
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D020363 2006
% 212.58/212.76  |- skos__historyNote mesh__D020363
% 212.58/212.76       Encephalitis/complications %28%1969-1999%29%
% 212.58/212.76  |- mesh__dateEstablished mesh__D020363 2000-01-01
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D020363 2001
% 212.58/212.76  |- skos__broader mesh__D020363smesh__D004660
% 212.58/212.76  |- skos__historyNote mesh__D020363
% 212.58/212.76       Limbic System/pathology %28%1968-1999%29%
% 212.58/212.76  |- skos__altLabel mesh__D020363 Paraneoplastic Limbic Encephalitis
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D020363 2003
% 212.58/212.76  |- skos__prefLabel mesh__D020363 Limbic Encephalitis
% 212.58/212.76  |- skos__historyNote mesh__D020363
% 212.58/212.76       Carcinoma, Small Cell/complications %28%1982-1999%29%
% 212.58/212.76  |- skos__historyNote mesh__D014326 Nortropanes %28%1966-1968%29%
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D014326 2002
% 212.58/212.76  |- rdf__type mesh__D014326sskos__Concept
% 212.58/212.76  |- mesh__historyNote mesh__D014326 69; was see under NORTROPANES 1963-68   
% 212.58/212.76  |- mesh__onlineNote mesh__D014326 search NORTROPANES 1966-68   
% 212.58/212.76  |- mesh__dateEstablished mesh__D014326 1969-01-01
% 212.58/212.76  |- mesh__recordOriginator mesh__D014326 NLM
% 212.58/212.76  |- mesh__recordAuthorizer mesh__D014326 sjn
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D014326 2004
% 212.58/212.76  |- mesh__dateCreated mesh__D014326 1999-01-01
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D014326 2001
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D014326 2003
% 212.58/212.76  |- mesh__publicMeSHNote mesh__D014326
% 212.58/212.76       69; was see under NORTROPANES 1963-68; HOMATROPINE was see under BELLADONNA 1963-68%A%  
% 212.58/212.76  |- skos__historyNote mesh__D014326 Cocaine %28%1966-1968%29%
% 212.58/212.76  |- mesh__dateRevised mesh__D014326 2000-06-22
% 212.58/212.76  |- skos__broader mesh__D014326smesh__D006572
% 212.58/212.76  |- skos__broader mesh__D014326smesh__D000470
% 212.58/212.76  |- skos__historyNote mesh__D014326 Atropine %28%1966-1968%29%
% 212.58/212.76  |- skos__prefLabel mesh__D014326 Tropanes
% 212.58/212.76  |- skos__historyNote mesh__D014326 Belladonna %28%1966-1968%29%
% 212.58/212.76  |- mesh__recordMaintainer mesh__D014326 TWD
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D014326 2006
% 212.58/212.76  |- skos__historyNote mesh__D014326 Scopolamine %28%1966-1968%29%
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D014326 2005
% 212.58/212.76  |- skos__hiddenLabel mesh__D000306 Adrenocortical Cancers
% 212.58/212.76  |- skos__hiddenLabel mesh__D000306 Cancer, Adrenocortical
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D000306 2006
% 212.58/212.76  |- skos__scopeNote mesh__D000306
% 212.58/212.76       Tumors or cancers of the ADRENAL CORTEX.     
% 212.58/212.76  |- mesh__onlineNote mesh__D000306 search ADRENAL GLAND NEOPLASMS 1966-74   
% 212.58/212.76  |- skos__annotation mesh__D000306
% 212.58/212.76       coord IM with histol type of neopl %28%IM%29%   
% 212.58/212.76  |- skos__prefLabel mesh__D000306 Adrenal Cortex Neoplasms
% 212.58/212.76  |- skos__altLabel mesh__D000306 Adrenal Cortex Cancer
% 212.58/212.76  |- skos__hiddenLabel mesh__D000306 Neoplasm, Adrenal Cortex
% 212.58/212.76  |- skos__hiddenLabel mesh__D000306 Cancers, Adrenocortical
% 212.58/212.76  |- mesh__historyNote mesh__D000306
% 212.58/212.76       79%28%75%29%63-67; was see under ADRENAL GLAND NEOPLASMS 1975-78%A%  
% 212.58/212.76  |- skos__altLabel mesh__D000306 Cancer of Adrenal Cortex
% 212.58/212.76  |- rdf__type mesh__D000306sskos__Concept
% 212.58/212.76  |- skos__historyNote mesh__D000306
% 212.58/212.76       Adrenal Gland Neoplasms %28%1966-1974%29%
% 212.58/212.76  |- mesh__publicMeSHNote mesh__D000306
% 212.58/212.76       79,63-67; was see under ADRENAL GLAND NEOPLASMS 1975-78   
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D000306 2005
% 212.58/212.76  |- skos__hiddenLabel mesh__D000306 Adrenal Cortex Neoplasm
% 212.58/212.76  |- mesh__recordOriginator mesh__D000306 NLM
% 212.58/212.76  |- mesh__recordMaintainer mesh__D000306 lkt
% 212.58/212.76  |- skos__altLabel mesh__D000306 Cancer of the Adrenal Cortex
% 212.58/212.76  |- mesh__dateEstablished mesh__D000306 1979-01-01
% 212.58/212.76  |- skos__hiddenLabel mesh__D000306 Adrenal Cortex Cancers
% 212.58/212.76  |- skos__broader mesh__D000306smesh__D000303
% 212.58/212.76  |- mesh__recordAuthorizer mesh__D000306 sjn
% 212.58/212.76  |- skos__hiddenLabel mesh__D000306 Cancer, Adrenal Cortex
% 212.58/212.76  |- skos__hiddenLabel mesh__D000306 Cancers, Adrenal Cortex
% 212.58/212.76  |- skos__broader mesh__D000306smesh__D000310
% 212.58/212.76  |- mesh__dateCreated mesh__D000306 1999-01-01
% 212.58/212.76  |- mesh__dateRevised mesh__D000306 2004-07-07
% 212.58/212.76  |- skos__altLabel mesh__D000306 Neoplasms, Adrenal Cortex
% 212.58/212.76  |- mesh__dateEstablished mesh__D019011 1996-01-01
% 212.58/212.76  |- mesh__historyNote mesh__D019011
% 212.58/212.76       96; was CD7 ANTIGEN %28%NM%29% 1988-95   
% 212.58/212.76  |- mesh__publicMeSHNote mesh__D019011
% 212.58/212.76       96; CD7 ANTIGEN was indexed under ANTIGENS, CD 1990-95 %26% ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-95%A%  
% 212.58/212.76  |- skos__historyNote mesh__D019011 Antigens, CD %28%1990-1995%29%
% 212.58/212.76  |- skos__broader mesh__D019011smesh__D015703
% 212.58/212.76  |- mesh__dateRevised mesh__D019011 2005-06-30
% 212.58/212.76  |- skos__altLabel mesh__D019011 CD7 Antigens
% 212.58/212.76  |- mesh__dateCreated mesh__D019011 1995-05-26
% 212.58/212.76  |- skos__broader mesh__D019011smesh__D000945
% 212.58/212.76  |- mesh__activeMeSHYear mesh__D019011 2006
% 212.58/212.76  |- skos__hiddenLabel mesh__D019011 Antigen, CD7
% 212.58/212.76  |- skos__scopeNote mesh__D019011
% 212.58/212.76       Differentiation antigens expressed on pluripotential hematopoietic cells, most human thymocytes, and a major subset of peripheral blood T-lymphocytes. They have been implicated in integrin-mediated cellular adhesion and as signalling receptors on T-cells.%A%    
% 212.58/212.76  |- rdf__type mesh__D019011sskos__Concept
% 212.58/212.76  |- skos__prefLabel mesh__D019011 Antigens, CD7
% 212.58/212.76  |- skos__altLabel mesh__D019011 CD7 Antigen
% 212.58/212.76  |- skos__historyNote mesh__D019011
% 212.58/212.76       Antigens, Differentiation, T-Lymphocyte %28%1988-1995%29%
% 212.58/212.76  |- mesh__recordMaintainer mesh__D019011 ssb
% 212.58/212.76  |- skos__annotation mesh__D019011 T-lymphocyte differentiation antigens   
% 212.58/212.76  |- mesh__recordAuthorizer mesh__D019011 sjn
% 212.58/212.76  |- mesh__onlineNote mesh__D019011
% 212.58/212.76       use ANTIGENS, CD7 %28%NM%29% to search CD7 ANTIGEN 1988-95   
% 212.58/212.76  |- mesh__recordOriginator mesh__D019011 AGS
% 212.58/212.76  |- mesh__recordOriginator mesh__D046408 ags
% 212.58/212.76  |- skos__prefLabel mesh__D046408 Melopsittacus
% 212.58/212.77  |- skos__historyNote mesh__D046408 Parrots %28%1975-2004%29%
% 212.58/212.77  |- mesh__dateEstablished mesh__D046408 2005-01-01
% 212.58/212.77  |- skos__hiddenLabel mesh__D046408 Budgerigar
% 212.58/212.77  |- mesh__recordMaintainer mesh__D046408 ags
% 212.58/212.77  |- mesh__publicMeSHNote mesh__D046408 2005; see PARROTS 1995-2004   
% 212.58/212.77  |- skos__broader mesh__D046408smesh__D010240
% 212.58/212.77  |- skos__historyNote mesh__D046408 Birds %28%1965-2002%29%
% 212.58/212.77  |- mesh__recordAuthorizer mesh__D046408 sjn
% 212.58/212.77  |- rdf__type mesh__D046408sskos__Concept
% 212.58/212.77  |- mesh__historyNote mesh__D046408 2005; use PARROTS 1995-2004   
% 212.58/212.77  |- skos__historyNote mesh__D046408 Psittaciformes %28%1975-2004%29%
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D046408 2006
% 212.58/212.77  |- skos__altLabel mesh__D046408 Budgerigars
% 212.58/212.77  |- skos__scopeNote mesh__D046408
% 212.58/212.77       A genus, commonly called budgerigars, in the family PSITTACIDAE. In the United States they are considered one of the five species of PARAKEETS.%A%    
% 212.58/212.77  |- mesh__dateCreated mesh__D046408 2004-07-07
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D046408 2005
% 212.58/212.77  |- skos__broader mesh__D006262Q000364smesh__D006262
% 212.58/212.77  |- mesh__preferredCombination mesh__D006262Q000364smesh__D006280
% 212.58/212.77  |- rdf__type mesh__D006262Q000364smesh__CompoundConcept
% 212.58/212.77  |- skos__historyNote mesh__D018717 Bacteriorhodopsin %28%1976-1994%29%
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D018717 2004
% 212.58/212.77  |- skos__hiddenLabel mesh__D018717 Membrane, Purple
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D018717 2003
% 212.58/212.77  |- skos__historyNote mesh__D018717 Cell Membrane %28%1971-1978%29%
% 212.58/212.77  |- skos__hiddenLabel mesh__D018717 Purple Membranes
% 212.58/212.77  |- mesh__recordMaintainer mesh__D018717 sjn
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D018717 2002
% 212.58/212.77  |- mesh__recordAuthorizer mesh__D018717 sjn
% 212.58/212.77  |- mesh__publicMeSHNote mesh__D018717
% 212.58/212.77       95; was see BACTERIORHODOPSIN 1976-94   
% 212.58/212.77  |- mesh__historyNote mesh__D018717 95; was see BACTERIORHODOPSIN 1976-94   
% 212.58/212.77  |- skos__hiddenLabel mesh__D018717 Membranes, Purple
% 212.58/212.77  |- mesh__onlineNote mesh__D018717
% 212.58/212.77       use BACTERIORHODOPSIN to search PURPLE MEMBRANE 1976-94   
% 212.58/212.77  |- skos__broader mesh__D018717smesh__D002462
% 212.58/212.77  |- mesh__recordOriginator mesh__D018717 AGS
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D018717 2006
% 212.58/212.77  |- skos__annotation mesh__D018717
% 212.58/212.77       purple regions of cytoplasmic membrane of strains of Halobacterium halobium; A 11 qualif except /cytol%A%  
% 212.58/212.77  |- rdf__type mesh__D018717sskos__Concept
% 212.58/212.77  |- skos__related mesh__D018717smesh__D001436
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D018717 2005
% 212.58/212.77  |- skos__prefLabel mesh__D018717 Purple Membrane
% 212.58/212.77  |- mesh__dateEstablished mesh__D018717 1995-01-01
% 212.58/212.77  |- mesh__dateRevised mesh__D018717 2001-08-03
% 212.58/212.77  |- mesh__dateCreated mesh__D018717 1994-04-19
% 212.58/212.77  |- skos__scopeNote mesh__D018717
% 212.58/212.77       Functionally and structurally differentiated, purple-pigmented regions of the cytoplasmic membrane of some strains of Halobacterium halobium. The membrane develops under anaerobic conditions and is made almost entirely of the purple pigment BACTERIORHODOPSINS. %28%From Singleton %26% Sainsbury Dictionary of Microbiology and Molecular Biology, 2d ed%29%%A%    
% 212.58/212.77  |- skos__hiddenLabel mesh__D010734 Dehydrogenase, 6-Phosphogluconate
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D010734 2005
% 212.58/212.77  |- skos__altLabel mesh__D010734 6-Phosphogluconate Dehydrogenase
% 212.58/212.77  |- mesh__dateCreated mesh__D010734 1999-01-01
% 212.58/212.77  |- rdf__type mesh__D010734sskos__Concept
% 212.58/212.77  |- mesh__historyNote mesh__D010734 65   
% 212.58/212.77  |- skos__prefLabel mesh__D010734 Phosphogluconate Dehydrogenase
% 212.58/212.77  |- skos__broader mesh__D010734smesh__D002237
% 212.58/212.77  |- mesh__recordAuthorizer mesh__D010734 sjn
% 212.58/212.77  |- mesh__dateRevised mesh__D010734 2003-07-09
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D010734 2004
% 212.58/212.77  |- skos__hiddenLabel mesh__D010734 Dehydrogenase, Phosphogluconate
% 212.58/212.77  |- mesh__recordMaintainer mesh__D010734 ssb
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D010734 2006
% 212.58/212.77  |- mesh__recordOriginator mesh__D010734 NLM
% 212.58/212.77  |- mesh__dateEstablished mesh__D010734 1965-01-01
% 212.58/212.77  |- mesh__publicMeSHNote mesh__D010734 65   
% 212.58/212.77  |- skos__hiddenLabel mesh__D010734 6 Phosphogluconate Dehydrogenase
% 212.58/212.77  |- skos__scopeNote mesh__D010734
% 212.58/212.77       An enzyme of the oxidoreductase class that catalyzes the reaction 6-phospho-D-gluconate and NADP+ to yield D-ribulose 5-phosphate, carbon dioxide, and NADPH. The reaction is a step in the pentose phosphate pathway of glucose metabolism. %28%From Dorland, 27th ed%29% EC 1.1.1.43.%A%    
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D006693 1997
% 212.58/212.77  |- skos__hiddenLabel mesh__D006693 Holiday
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D006693 2001
% 212.58/212.77  |- rdf__type mesh__D006693sskos__Concept
% 212.58/212.77  |- skos__scopeNote mesh__D006693
% 212.58/212.77       Days commemorating events. Holidays also include vacation periods.%A%    
% 212.58/212.77  |- mesh__recordMaintainer mesh__D006693 TGC
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D006693 1994
% 212.58/212.77  |- skos__prefLabel mesh__D006693 Holidays
% 212.58/212.77  |- mesh__recordOriginator mesh__D006693 NLM
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D006693 1995
% 212.58/212.77  |- mesh__dateCreated mesh__D006693 1999-01-01
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D006693 2005
% 212.58/212.77  |- mesh__recordAuthorizer mesh__D006693 PLS
% 212.58/212.77  |- mesh__onlineNote mesh__D006693
% 212.58/212.77       use HOLIDAYS to search FESTIVALS 1966-82   
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D006693 2002
% 212.58/212.77  |- mesh__dateRevised mesh__D006693 1992-05-15
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D006693 1998
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D006693 2006
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D006693 1993
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D006693 1999
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D006693 2003
% 212.58/212.77  |- mesh__historyNote mesh__D006693
% 212.58/212.77       FESTIVALS was see under HOLIDAYS 1963-82   
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D006693 2000
% 212.58/212.77  |- skos__broader mesh__D006693smesh__D007899
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D006693 1996
% 212.58/212.77  |- skos__hiddenLabel mesh__D006693 Festival
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D006693 2004
% 212.58/212.77  |- skos__prefLabel mesh__D020364 Paraneoplastic Polyneuropathy
% 212.58/212.77  |- skos__hiddenLabel mesh__D020364 Neuropathies, Paraneoplastic Peripheral
% 212.58/212.77  |- mesh__recordOriginator mesh__D020364 KEV
% 212.58/212.77  |- skos__altLabel mesh__D020364 Paraneoplastic Neuropathy
% 212.58/212.77  |- skos__altLabel mesh__D020364 Polyneuropathy, Paraneoplastic
% 212.58/212.77  |- skos__hiddenLabel mesh__D020364 Paraneoplastic Polyneuropathies
% 212.58/212.77  |- mesh__publicMeSHNote mesh__D020364 2000   
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D020364 2005
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D020364 2002
% 212.58/212.77  |- rdf__type mesh__D020364sskos__Concept
% 212.58/212.77  |- skos__hiddenLabel mesh__D020364 Paraneoplastic Peripheral Neuropathies
% 212.58/212.77  |- skos__hiddenLabel mesh__D020364 Paraneoplastic Neuropathies
% 212.58/212.77  |- skos__hiddenLabel mesh__D020364 Neuropathy, Paraneoplastic Peripheral
% 212.58/212.77  |- skos__altLabel mesh__D020364 Paraneoplastic Peripheral Neuropathy
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D020364 2006
% 212.58/212.77  |- skos__historyNote mesh__D020364
% 212.58/212.77       Paraneoplastic Syndromes %28%1980-1999%29%
% 212.58/212.77  |- skos__hiddenLabel mesh__D020364 Neuropathies, Paraneoplastic
% 212.58/212.77  |- skos__hiddenLabel mesh__D020364 Peripheral Neuropathies, Paraneoplastic
% 212.58/212.77  |- mesh__dateEstablished mesh__D020364 2000-01-01
% 212.58/212.77  |- mesh__recordAuthorizer mesh__D020364 sjn
% 212.58/212.77  |- mesh__dateRevised mesh__D020364 2000-06-22
% 212.58/212.77  |- skos__broader mesh__D020364smesh__D011115
% 212.58/212.77  |- skos__historyNote mesh__D020364
% 212.58/212.77       Neoplasms/complications %28%1967-1999%29%
% 212.58/212.77  |- mesh__recordMaintainer mesh__D020364 ags
% 212.58/212.77  |- skos__altLabel mesh__D020364 Neuropathy, Paraneoplastic
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D020364 2003
% 212.58/212.77  |- skos__broader mesh__D020364smesh__D020361
% 212.58/212.77  |- skos__hiddenLabel mesh__D020364 Polyneuropathies, Paraneoplastic
% 212.58/212.77  |- skos__scopeNote mesh__D020364
% 212.58/212.77       A diffuse or multifocal peripheral neuropathy related to the remote effects of a neoplasm, most often carcinoma or lymphoma. Pathologically, there are inflammatory changes in peripheral nerves. The most common clinical presentation is a symmetric distal mixed sensorimotor polyneuropathy. %28%Adams et al., Principles of Neurology, 6th ed, p1334%29%%A%    
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D020364 2004
% 212.58/212.77  |- mesh__historyNote mesh__D020364 2000   
% 212.58/212.77  |- mesh__dateCreated mesh__D020364 1999-11-08
% 212.58/212.77  |- skos__annotation mesh__D020364 DF: PARANEOPL POLYNEUROPATHY   
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D020364 2001
% 212.58/212.77  |- skos__historyNote mesh__D020364
% 212.58/212.77       Peripheral Nervous System Diseases/etiology %28%1968-1999%29%
% 212.58/212.77  |- skos__altLabel mesh__D020364 Peripheral Neuropathy, Paraneoplastic
% 212.58/212.77  |- mesh__dateCreated mesh__D014327 1999-01-01
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D014327 2003
% 212.58/212.77  |- skos__scopeNote mesh__D014327
% 212.58/212.77       Cells lining the outside of the BLASTOCYST. After binding to the ENDOMETRIUM, trophoblasts develop into two distinct layers, an inner layer of mononuclear cytotrophoblasts and an outer layer of continuous multinuclear cytoplasm, the syncytiotrophoblasts, which form the early fetal-maternal interface %28%PLACENTA%29%.%A%    
% 212.58/212.77  |- mesh__dateEstablished mesh__D014327 1968-01-01
% 212.58/212.77  |- mesh__dateRevised mesh__D014327 2002-07-03
% 212.58/212.77  |- mesh__historyNote mesh__D014327 68%28%64%29%   
% 212.58/212.77  |- mesh__publicMeSHNote mesh__D014327 68   
% 212.58/212.77  |- skos__hiddenLabel mesh__D014327 Cytotrophoblast
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D014327 2006
% 212.58/212.77  |- skos__broader mesh__D014327smesh__D002477
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D014327 2005
% 212.58/212.77  |- mesh__recordOriginator mesh__D014327 NLM
% 212.58/212.77  |- skos__broader mesh__D014327smesh__D010920
% 212.58/212.77  |- mesh__recordAuthorizer mesh__D014327 sjn
% 212.58/212.77  |- mesh__recordMaintainer mesh__D014327 lkt
% 212.58/212.77  |- rdf__type mesh__D014327sskos__Concept
% 212.58/212.77  |- skos__altLabel mesh__D014327 Trophoblast
% 212.58/212.77  |- skos__broader mesh__D014327smesh__D001755
% 212.58/212.77  |- skos__hiddenLabel mesh__D014327 Syncytiotrophoblast
% 212.58/212.77  |- skos__prefLabel mesh__D014327 Trophoblasts
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D014327 2004
% 212.58/212.77  |- skos__historyNote mesh__D019810 Azides %28%1977-1997%29%
% 212.58/212.77  |- mesh__dateCreated mesh__D019810 1997-06-20
% 212.58/212.77  |- skos__broader mesh__D019810smesh__D017670
% 212.58/212.77  |- skos__historyNote mesh__D019810 Nitrogen %28%1975-1976%29%
% 212.58/212.77  |- mesh__publicMeSHNote mesh__D019810
% 212.58/212.77       98; SODIUM AZIDE was indexed under AZIDES 1977-97 %26% NITROGEN 1975-76%A%  
% 212.58/212.77  |- mesh__recordOriginator mesh__D019810 KEV
% 212.58/212.77  |- mesh__recordAuthorizer mesh__D019810 SJN
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D019810 2002
% 212.58/212.77  |- skos__hiddenLabel mesh__D019810 Azide, Sodium
% 212.58/212.77  |- skos__prefLabel mesh__D019810 Sodium Azide
% 212.58/212.77  |- mesh__dateEstablished mesh__D019810 1998-01-01
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D019810 2004
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D019810 2001
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D019810 1999
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D019810 2006
% 212.58/212.77  |- mesh__dateRevised mesh__D019810 1998-06-11
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D019810 2003
% 212.58/212.77  |- mesh__recordMaintainer mesh__D019810 TPW
% 212.58/212.77  |- skos__altLabel mesh__D019810 NaN3
% 212.58/212.77  |- skos__broader mesh__D019810smesh__D001386
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D019810 2005
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D019810 2000
% 212.58/212.77  |- rdf__type mesh__D019810sskos__Concept
% 212.58/212.77  |- skos__scopeNote mesh__D019810
% 212.58/212.77       A cytochrome oxidase inhibitor which is a nitridizing agent and an inhibitor of terminal oxidation. %28%From Merck Index, 12th ed%29%%A%    
% 212.58/212.77  |- mesh__historyNote mesh__D019810
% 212.58/212.77       98; use SODIUM AZIDE %28%NM%29% 1979-97   
% 212.58/212.77  |- rdf__type mesh__D000307sskos__Concept
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D000307 2005
% 212.58/212.77  |- skos__annotation mesh__D000307
% 212.58/212.77       general; prefer specifics; coordinate IM with ADRENAL MEDULLA %28%IM%29% for diseases of adrenal medulla; for adrenal hyperplasia see note at ADRENAL GLANDS%A%  
% 212.58/212.77  |- skos__prefLabel mesh__D000307 Adrenal Gland Diseases
% 212.58/212.77  |- skos__hiddenLabel mesh__D000307 Gland Disease, Adrenal
% 212.58/212.77  |- skos__hiddenLabel mesh__D000307 Diseases, Adrenal Gland
% 212.58/212.77  |- skos__hiddenLabel mesh__D000307 Disease, Adrenal Gland
% 212.58/212.77  |- mesh__recordOriginator mesh__D000307 NLM
% 212.58/212.77  |- mesh__recordMaintainer mesh__D000307 lkt
% 212.58/212.77  |- skos__hiddenLabel mesh__D000307 Gland Diseases, Adrenal
% 212.58/212.77  |- mesh__dateCreated mesh__D000307 1999-01-01
% 212.58/212.77  |- skos__hiddenLabel mesh__D000307 Adrenal Gland Disease
% 212.58/212.77  |- mesh__dateRevised mesh__D000307 2004-07-07
% 212.58/212.77  |- skos__broader mesh__D000307smesh__D004700
% 212.58/212.77  |- mesh__recordAuthorizer mesh__D000307 sjn
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D000307 2006
% 212.58/212.77  |- skos__scopeNote mesh__D000307
% 212.58/212.77       Pathological processes of the ADRENAL GLANDS.     
% 212.58/212.77  |- skos__related mesh__D019012smesh__D016029
% 212.58/212.77  |- skos__historyNote mesh__D019012 Antigens, CD %28%1990-1995%29%
% 212.58/212.77  |- skos__altLabel mesh__D019012 Integrin beta1
% 212.58/212.77  |- skos__prefLabel mesh__D019012 Antigens, CD29
% 212.58/212.77  |- skos__altLabel mesh__D019012 4B4 Antigen
% 212.58/212.77  |- skos__broader mesh__D019012smesh__D000943
% 212.58/212.77  |- skos__altLabel mesh__D019012 CDw29 Antigen
% 212.58/212.77  |- mesh__recordMaintainer mesh__D019012 ssb
% 212.58/212.77  |- mesh__recordAuthorizer mesh__D019012 sjn
% 212.58/212.77  |- skos__hiddenLabel mesh__D019012 Integrin, beta1
% 212.58/212.77  |- mesh__recordOriginator mesh__D019012 AGS
% 212.58/212.77  |- mesh__dateCreated mesh__D019012 1995-05-26
% 212.58/212.77  |- skos__altLabel mesh__D019012 CD29 Antigen
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D019012 2006
% 212.58/212.77  |- skos__broader mesh__D019012smesh__D039641
% 212.58/212.77  |- skos__scopeNote mesh__D019012
% 212.58/212.77       Integrin beta-1 chains which are expressed as heterodimers that are noncovalently associated with specific alpha-chains of the CD49 family %28%CD49a-f%29%. CD29 is expressed on resting and activated leukocytes and is a marker for all of the very late activation antigens on cells. %28%from: Barclay et al., The Leukocyte Antigen FactsBook, 1993, p164%29%%A%    
% 212.58/212.77  |- mesh__dateEstablished mesh__D019012 1996-01-01
% 212.58/212.77  |- rdf__type mesh__D019012sskos__Concept
% 212.58/212.77  |- skos__broader mesh__D019012smesh__D015703
% 212.58/212.77  |- mesh__dateRevised mesh__D019012 2005-06-30
% 212.58/212.77  |- skos__related mesh__D019012smesh__D017469
% 212.58/212.77  |- skos__altLabel mesh__D019012 beta1 Integrin
% 212.58/212.77  |- mesh__publicMeSHNote mesh__D019012
% 212.58/212.77       96; INTEGRIN BETA1 was indexed under INTEGRINS 1991-95; CD29 ANTIGEN was indexed under ANTIGENS, CD %26% INTEGRINS 1990-95; %26% ANTIGENS, DIFFERENTIATION 1990-91; CDW29 ANTIGEN was indexed under ANTIGENS, CD 1990-95 %26% ANTIGENS, DIFFERENTIATION 1988-91%A%  
% 212.58/212.77  |- mesh__historyNote mesh__D019012
% 212.58/212.77       96; was INTEGRIN BETA1 %28%NM%29% 1991-95, CD29 ANTIGEN %28%NM%29% 1990-95, %26% CDW29 ANTIGEN %28%NM%29% 1988-95%A%  
% 212.58/212.77  |- skos__hiddenLabel mesh__D019012 Antigen, CD29
% 212.58/212.77  |- skos__historyNote mesh__D019012 Integrins %28%1990-1995%29%
% 212.58/212.77  |- skos__hiddenLabel mesh__D019012 Antigen, 4B4
% 212.58/212.77  |- skos__altLabel mesh__D019012 CD29 Antigens
% 212.58/212.77  |- skos__hiddenLabel mesh__D019012 Antigen, CDw29
% 212.58/212.77  |- mesh__onlineNote mesh__D019012
% 212.58/212.77       use ANTIGENS, CD29 %28%NM%29% to search INTEGRIN BETA1 1991-95, CD29 ANTIGEN 1990-95, %26% CDW29 ANTIGEN 1988-95%A%  
% 212.58/212.77  |- skos__broader mesh__D046409smesh__D010240
% 212.58/212.77  |- rdf__type mesh__D046409sskos__Concept
% 212.58/212.77  |- mesh__recordMaintainer mesh__D046409 ags
% 212.58/212.77  |- mesh__historyNote mesh__D046409 2005   
% 212.58/212.77  |- skos__prefLabel mesh__D046409 Psittacula
% 212.58/212.77  |- skos__scopeNote mesh__D046409
% 212.58/212.77       A genus in the family PSITTACIDAE containing three species of PARAKEETS: the Derbyan, the Alexandrine, and the rose-ringed.%A%    
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D046409 2006
% 212.58/212.77  |- mesh__recordOriginator mesh__D046409 ags
% 212.58/212.77  |- mesh__dateEstablished mesh__D046409 2005-01-01
% 212.58/212.77  |- mesh__dateCreated mesh__D046409 2004-07-07
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D046409 2005
% 212.58/212.77  |- skos__altLabel mesh__D046409 Parakeet, Rose-ringed
% 212.58/212.77  |- skos__hiddenLabel mesh__D046409 Rose-ringed Parakeet
% 212.58/212.77  |- mesh__publicMeSHNote mesh__D046409 2005   
% 212.58/212.77  |- skos__hiddenLabel mesh__D046409 Parakeets, Rose-ringed
% 212.58/212.77  |- skos__hiddenLabel mesh__D046409 Parakeet, Rose ringed
% 212.58/212.77  |- mesh__recordAuthorizer mesh__D046409 sjn
% 212.58/212.77  |- skos__historyNote mesh__D046409 Parakeets %28%1975-2004%29%
% 212.58/212.77  |- skos__hiddenLabel mesh__D046409 Rose-ringed Parakeets
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D018718 2003
% 212.58/212.77  |- mesh__historyNote mesh__D018718 95   
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D018718 2001
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D018718 1998
% 212.58/212.77  |- skos__altLabel mesh__D018718 Infusion Therapies, Home
% 212.58/212.77  |- skos__annotation mesh__D018718
% 212.58/212.77       IM; coord with specific type of infusion or infusion ther %28%IM%29%; DF: HOME INFUSION THER%A%  
% 212.58/212.77  |- skos__prefLabel mesh__D018718 Home Infusion Therapy
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D018718 2000
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D018718 1995
% 212.58/212.77  |- skos__altLabel mesh__D018718 Outpatient Infusion Therapies
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D018718 2006
% 212.58/212.77  |- skos__altLabel mesh__D018718 Therapy, Home Infusion
% 212.58/212.77  |- rdf__type mesh__D018718sskos__Concept
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D018718 1997
% 212.58/212.77  |- skos__altLabel mesh__D018718 Infusion Therapies, Outpatient
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D018718 2005
% 212.58/212.77  |- skos__broader mesh__D018718smesh__D006699
% 212.58/212.77  |- skos__scopeNote mesh__D018718
% 212.58/212.77       Use of any infusion therapy on an ambulatory, outpatient, or other non-institutionalized basis.%A%    
% 212.58/212.77  |- skos__altLabel mesh__D018718 Therapies, Home Infusion
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D018718 1996
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D018718 2002
% 212.58/212.77  |- skos__related mesh__D018718smesh__D016331
% 212.58/212.77  |- mesh__dateCreated mesh__D018718 1994-06-03
% 212.58/212.77  |- mesh__publicMeSHNote mesh__D018718 95   
% 212.58/212.77  |- skos__broader mesh__D018718smesh__D004358
% 212.58/212.77  |- skos__altLabel mesh__D018718 Home Infusion Therapies
% 212.58/212.77  |- skos__altLabel mesh__D018718 Therapy, Outpatient Infusion
% 212.58/212.77  |- skos__altLabel mesh__D018718 Infusion Therapy, Home
% 212.58/212.77  |- skos__altLabel mesh__D018718 Infusion Therapy, Outpatient
% 212.58/212.77  |- skos__altLabel mesh__D018718 Therapies, Outpatient Infusion
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D018718 2004
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D018718 1999
% 212.58/212.77  |- mesh__dateEstablished mesh__D018718 1995-01-01
% 212.58/212.77  |- mesh__historyNote mesh__D010735 65   
% 212.58/212.77  |- mesh__dateEstablished mesh__D010735 1965-01-01
% 212.58/212.77  |- skos__broader mesh__D010735smesh__D017851
% 212.58/212.77  |- mesh__recordMaintainer mesh__D010735 ssb
% 212.58/212.77  |- mesh__dateRevised mesh__D010735 2003-07-09
% 212.58/212.77  |- mesh__recordOriginator mesh__D010735 NLM
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D010735 2004
% 212.58/212.77  |- mesh__publicMeSHNote mesh__D010735 65   
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D010735 2006
% 212.58/212.77  |- skos__prefLabel mesh__D010735 Phosphoglycerate Kinase
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D010735 2005
% 212.58/212.77  |- skos__scopeNote mesh__D010735
% 212.58/212.77       An enzyme catalyzing the transfer of a phosphate group from 3-phospho-D-glycerate in the presence of ATP to yield 3-phospho-D-glyceroyl phosphate and ADP. EC 2.7.2.3.%A%    
% 212.58/212.77  |- mesh__dateCreated mesh__D010735 1999-01-01
% 212.58/212.77  |- rdf__type mesh__D010735sskos__Concept
% 212.58/212.77  |- mesh__recordAuthorizer mesh__D010735 sjn
% 212.58/212.77  |- skos__hiddenLabel mesh__D010735 Kinase, Phosphoglycerate
% 212.58/212.77  |- skos__broader mesh__D001400smesh__D008667
% 212.58/212.77  |- mesh__recordMaintainer mesh__D001400 TAP
% 212.58/212.77  |- skos__historyNote mesh__D001400 Copper %28%1970-1974%29%
% 212.58/212.77  |- mesh__recordOriginator mesh__D001400 NLM
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D001400 2005
% 212.58/212.77  |- skos__historyNote mesh__D001400 Bacterial Proteins %28%1970-1974%29%
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D001400 2001
% 212.58/212.77  |- mesh__dateCreated mesh__D001400 1974-11-19
% 212.58/212.77  |- skos__prefLabel mesh__D001400 Azurin
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D001400 1994
% 212.58/212.77  |- mesh__publicMeSHNote mesh__D001400
% 212.58/212.77       91; was see under BACTERIAL PROTEINS 1975-90   
% 212.58/212.77  |- rdf__type mesh__D001400sskos__Concept
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D001400 1999
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D001400 2004
% 212.58/212.77  |- skos__scopeNote mesh__D001400
% 212.58/212.77       A bacterial protein from Pseudomonas, Bordetella, or Alcaligenes which operates as an electron transfer unit associated with the cytochrome chain. The protein has a molecular weight of approximately 16,000, contains a single copper atom, is intensively blue, and has a fluorescence emission band centered at 308nm.%A%    
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D001400 2000
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D001400 1993
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D001400 1998
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D001400 2003
% 212.58/212.77  |- skos__annotation mesh__D001400
% 212.58/212.77       a bact protein; /drug eff /ultrastruct permitted   
% 212.58/212.77  |- mesh__dateRevised mesh__D001400 1992-05-07
% 212.58/212.77  |- skos__historyNote mesh__D001400 Metalloproteins %28%1973-1974%29%
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D001400 1997
% 212.58/212.77  |- skos__broader mesh__D001400smesh__D001426
% 212.58/212.77  |- mesh__recordAuthorizer mesh__D001400 PLS
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D001400 2006
% 212.58/212.77  |- mesh__historyNote mesh__D001400
% 212.58/212.77       91%28%75%29%; was see under BACTERIAL PROTEINS 1975-90   
% 212.58/212.77  |- mesh__dateEstablished mesh__D001400 1991-01-01
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D001400 2002
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D001400 1996
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D001400 1995
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D006694 2005
% 212.58/212.77  |- mesh__recordOriginator mesh__D006694 EC
% 212.58/212.77  |- skos__broader mesh__D006694smesh__D010686
% 212.58/212.77  |- skos__broader mesh__D006694smesh__D006262
% 212.58/212.77  |- skos__altLabel mesh__D006694 Wholistic Health
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D006694 2006
% 212.58/212.77  |- skos__altLabel mesh__D006694 Wholistic Therapies
% 212.58/212.77  |- mesh__dateRevised mesh__D006694 2001-07-25
% 212.58/212.77  |- skos__scopeNote mesh__D006694
% 212.58/212.77       Health as viewed from the perspective that humans and other organisms function as complete, integrated units rather than as aggregates of separate parts.%A%    
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D006694 2003
% 212.58/212.77  |- mesh__publicMeSHNote mesh__D006694 80   
% 212.58/212.77  |- skos__altLabel mesh__D006694 Wholistic Medicine
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D006694 2004
% 212.58/212.77  |- skos__altLabel mesh__D006694 Holistic Medicine
% 212.58/212.77  |- mesh__dateCreated mesh__D006694 1979-06-01
% 212.58/212.77  |- mesh__recordAuthorizer mesh__D006694 sjn
% 212.58/212.77  |- skos__annotation mesh__D006694
% 212.58/212.77       coord with specific complementary therapy if pertinent   
% 212.58/212.77  |- skos__prefLabel mesh__D006694 Holistic Health
% 212.58/212.77  |- skos__hiddenLabel mesh__D006694 Health, Holistic
% 212.58/212.77  |- skos__hiddenLabel mesh__D006694 Health, Wholistic
% 212.58/212.77  |- rdf__type mesh__D006694sskos__Concept
% 212.58/212.77  |- mesh__dateEstablished mesh__D006694 1980-01-01
% 212.58/212.77  |- skos__altLabel mesh__D006694 Medicine, Wholistic
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D006694 2002
% 212.58/212.77  |- mesh__historyNote mesh__D006694 80   
% 212.58/212.77  |- skos__broader mesh__D006694smesh__D000529
% 212.58/212.77  |- mesh__recordMaintainer mesh__D006694 ssb
% 212.58/212.77  |- mesh__dateCreated mesh__D020365 1998-06-11
% 212.58/212.77  |- mesh__publicMeSHNote mesh__D020365
% 212.58/212.77       99; RNA HELICASE was indexed under RNA NUCLEOTIDYLTRANSFERASES 1992-98%A%  
% 212.58/212.77  |- skos__historyNote mesh__D020365
% 212.58/212.77       RNA Nucleotidyltransferases %28%1989-1998%29%
% 212.58/212.77  |- skos__altLabel mesh__D020365 RNA Helicase
% 212.58/212.77  |- skos__hiddenLabel mesh__D020365 Helicases, RNA
% 212.58/212.77  |- rdf__type mesh__D020365sskos__Concept
% 212.58/212.77  |- skos__broader mesh__D020365smesh__D012316
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D020365 2005
% 212.58/212.77  |- skos__prefLabel mesh__D020365 RNA Helicases
% 212.58/212.77  |- skos__scopeNote mesh__D020365
% 212.58/212.77       A family of proteins that promote unwinding of RNA during splicing and translation. EC 2.7.7.-.%A%    
% 212.58/212.77  |- mesh__dateRevised mesh__D020365 2003-07-09
% 212.58/212.77  |- mesh__historyNote mesh__D020365
% 212.58/212.77       99; for RNA HELICASE use RNA HELICASES 1989-98   
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D020365 2006
% 212.58/212.77  |- skos__hiddenLabel mesh__D020365 Helicase, RNA
% 212.58/212.77  |- mesh__dateEstablished mesh__D020365 1999-01-01
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D020365 2004
% 212.58/212.77  |- skos__broader mesh__D000661Q000031smesh__D000661
% 212.58/212.77  |- mesh__preferredCombination mesh__D000661Q000031smesh__D000662
% 212.58/212.77  |- rdf__type mesh__D000661Q000031smesh__CompoundConcept
% 212.58/212.77  |- mesh__recordOriginator mesh__D014328 NLM
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D014328 2002
% 212.58/212.77  |- skos__hiddenLabel mesh__D014328 Trophoblast Neoplasm
% 212.58/212.77  |- skos__broader mesh__D014328smesh__D009373
% 212.58/212.77  |- skos__hiddenLabel mesh__D014328 Trophoblastic Tumors
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D014328 2003
% 212.58/212.77  |- skos__hiddenLabel mesh__D014328 Cancers, Trophoblast
% 212.58/212.77  |- skos__hiddenLabel mesh__D014328 Trophoblastic Neoplasm
% 212.58/212.77  |- mesh__recordMaintainer mesh__D014328 nns
% 212.58/212.77  |- skos__hiddenLabel mesh__D014328 Tumor, Trophoblast
% 212.58/212.77  |- skos__scopeNote mesh__D014328
% 212.58/212.77       Trophoblastic growth, which may be gestational or nongestational in origin. Trophoblastic neoplasia resulting from pregnancy is often described as gestational trophoblastic disease to distinguish it from germ cell tumors which frequently show trophoblastic elements, and from the trophoblastic differentiation which sometimes occurs in a wide variety of epithelial cancers. Gestational trophoblastic growth has several forms, including HYDATIDIFORM MOLE and CHORIOCARCINOMA. %28%From Holland et al., Cancer Medicine, 3d ed, p1691%29%%A%    
% 212.58/212.77  |- skos__altLabel mesh__D014328 Trophoblast Tumor
% 212.58/212.77  |- skos__annotation mesh__D014328
% 212.58/212.77       = %22%trophoblastic disease%22%; coord IM with UTERINE NEOPLASMS %28%IM%29%; check the tags FEMALE %26% PREGNANCY if needed%A%  
% 212.58/212.77  |- skos__hiddenLabel mesh__D014328 Trophoblast Tumors
% 212.58/212.77  |- skos__hiddenLabel mesh__D014328 Neoplasm, Trophoblast
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D014328 2004
% 212.58/212.77  |- skos__hiddenLabel mesh__D014328 Tumor, Trophoblastic
% 212.58/212.77  |- mesh__dateRevised mesh__D014328 1999-11-03
% 212.58/212.77  |- skos__altLabel mesh__D014328 Neoplasms, Trophoblastic
% 212.58/212.77  |- skos__prefLabel mesh__D014328 Trophoblastic Neoplasms
% 212.58/212.77  |- mesh__recordAuthorizer mesh__D014328 sjn
% 212.58/212.77  |- skos__broader mesh__D014328smesh__D011252
% 212.58/212.77  |- rdf__type mesh__D014328sskos__Concept
% 212.58/212.77  |- skos__altLabel mesh__D014328 Trophoblast Neoplasms
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D014328 2000
% 212.58/212.77  |- skos__hiddenLabel mesh__D014328 Cancers, Trophoblastic
% 212.58/212.77  |- skos__hiddenLabel mesh__D014328 Neoplasm, Trophoblastic
% 212.58/212.77  |- skos__hiddenLabel mesh__D014328 Neoplasms, Trophoblast
% 212.58/212.77  |- skos__hiddenLabel mesh__D014328 Trophoblastic Cancers
% 212.58/212.77  |- skos__hiddenLabel mesh__D014328 Tumors, Trophoblastic
% 212.58/212.77  |- skos__hiddenLabel mesh__D014328 Trophoblast Cancers
% 212.58/212.77  |- skos__hiddenLabel mesh__D014328 Tumors, Trophoblast
% 212.58/212.77  |- mesh__onlineNote mesh__D014328
% 212.58/212.77       use TROPHOBLASTIC NEOPLASMS to search TROPHOBLASTIC TUMOR 1966-93%A%  
% 212.58/212.77  |- skos__altLabel mesh__D014328 Trophoblast Cancer
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D014328 2001
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D014328 2005
% 212.58/212.77  |- mesh__dateCreated mesh__D014328 1999-01-01
% 212.58/212.77  |- skos__hiddenLabel mesh__D014328 Cancer, Trophoblast
% 212.58/212.77  |- mesh__publicMeSHNote mesh__D014328
% 212.58/212.77       94; was TROPHOBLASTIC TUMOR 1963-93   
% 212.58/212.77  |- skos__hiddenLabel mesh__D014328 Cancer, Trophoblastic
% 212.58/212.77  |- skos__altLabel mesh__D014328 Trophoblastic Tumor
% 212.58/212.77  |- mesh__activeMeSHYear mesh__D014328 2006
% 212.58/212.78  |- mesh__historyNote mesh__D014328 94; was TROPHOBLASTIC TUMOR 1963-93   
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D019811 2000
% 212.58/212.78  |- mesh__publicMeSHNote mesh__D019811
% 212.58/212.78       98; HYDROXYLAMINE was indexed under HYDROXYLAMINES 1976-97%A%  
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D019811 2006
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D019811 2003
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D019811 1998
% 212.58/212.78  |- skos__scopeNote mesh__D019811
% 212.58/212.78       A colorless inorganic compound %28%HONH2%29% used in organic synthesis and as a reducing agent, due to its ability to donate nitric oxide.%A%    
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D019811 2005
% 212.58/212.78  |- rdf__type mesh__D019811sskos__Concept
% 212.58/212.78  |- mesh__dateCreated mesh__D019811 1997-06-20
% 212.58/212.78  |- mesh__dateEstablished mesh__D019811 1998-01-01
% 212.58/212.78  |- skos__broader mesh__D019811smesh__D000644
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D019811 2002
% 212.58/212.78  |- skos__prefLabel mesh__D019811 Hydroxylamine
% 212.58/212.78  |- skos__historyNote mesh__D019811 Hydroxylamines %28%1976-1997%29%
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D019811 2001
% 212.58/212.78  |- skos__hiddenLabel mesh__D019811 Hydrochloride, Hydroxylamine
% 212.58/212.78  |- skos__hiddenLabel mesh__D019811 Chloride, Hydroxylammonium
% 212.58/212.78  |- mesh__historyNote mesh__D019811
% 212.58/212.78       98; use HYDROXYLAMINE %28%NM%29% 1980-97   
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D019811 2004
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D019811 1999
% 212.58/212.78  |- skos__broader mesh__D000308smesh__D000307
% 212.58/212.78  |- skos__altLabel mesh__D000308 Hypercorticism
% 212.58/212.78  |- skos__altLabel mesh__D000308 Hyperadrenocorticism
% 212.58/212.78  |- skos__altLabel mesh__D000308 Hyperadrenalism
% 212.58/212.78  |- mesh__publicMeSHNote mesh__D000308
% 212.58/212.78       2005; see ADRENAL GLAND HYPERFUNCTION 1968-2004   
% 212.58/212.78  |- mesh__recordAuthorizer mesh__D000308 sjn
% 212.58/212.78  |- mesh__dateCreated mesh__D000308 1999-01-01
% 212.58/212.78  |- skos__annotation mesh__D000308
% 212.58/212.78       do not confuse with ADRENAL GLAND HYPOFUNCTION; non-congenital adrenal hyperplasia: index under ADRENAL GLANDS /pathol %28%IM%29% + HYPERPLASIA %28%NIM%29%%A%  
% 212.58/212.78  |- mesh__dateRevised mesh__D000308 2004-07-07
% 212.58/212.78  |- mesh__dateEstablished mesh__D000308 1968-01-01
% 212.58/212.78  |- skos__hiddenLabel mesh__D000308 Hyperfunction, Adrenal Gland
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D000308 2006
% 212.58/212.78  |- skos__prefLabel mesh__D000308 Adrenocortical Hyperfunction
% 212.58/212.78  |- mesh__historyNote mesh__D000308 2005 %28%1968%29%   
% 212.58/212.78  |- rdf__type mesh__D000308sskos__Concept
% 212.58/212.78  |- skos__related mesh__D000308smesh__D017588
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D000308 2005
% 212.58/212.78  |- skos__scopeNote mesh__D000308
% 212.58/212.78       Excess production of ADRENAL CORTEX HORMONES such as ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE. Hyperadrenal syndromes include CUSHING SYNDROME; HYPERALDOSTERONISM; and VIRILISM.%A%    
% 212.58/212.78  |- mesh__recordMaintainer mesh__D000308 lkt
% 212.58/212.78  |- skos__hiddenLabel mesh__D000308 Hyperfunction, Adrenocortical
% 212.58/212.78  |- skos__altLabel mesh__D000308 Adrenal Gland Hyperfunction
% 212.58/212.78  |- mesh__recordOriginator mesh__D000308 NLM
% 212.58/212.78  |- skos__related mesh__D019013smesh__D023201
% 212.58/212.78  |- mesh__recordMaintainer mesh__D019013 ssb
% 212.58/212.78  |- skos__historyNote mesh__D019013
% 212.58/212.78       Antigens, Differentiation, B-Lymphocyte %28%1988-1995%29%
% 212.58/212.78  |- mesh__recordOriginator mesh__D019013 AGS
% 212.58/212.78  |- mesh__dateCreated mesh__D019013 1995-05-26
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D019013 2006
% 212.58/212.78  |- rdf__type mesh__D019013sskos__Concept
% 212.58/212.78  |- skos__hiddenLabel mesh__D019013 Antigen, CDw40
% 212.58/212.78  |- mesh__publicMeSHNote mesh__D019013
% 212.58/212.78       96; CD40 ANTIGEN was indexed under ANTIGENS, CD 1990-95 %26% ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1989-95; CDW40 ANTIGEN was indexed under ANTIGENS, CD 1990-95 %26% ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1988-95%A%  
% 212.58/212.78  |- skos__hiddenLabel mesh__D019013 Receptor, TNFRSF5
% 212.58/212.78  |- skos__historyNote mesh__D019013 Antigens, CD %28%1990-1995%29%
% 212.58/212.78  |- skos__broader mesh__D019013smesh__D018124
% 212.58/212.78  |- mesh__onlineNote mesh__D019013
% 212.58/212.78       use ANTIGENS, CD40 %28%NM%29% to search CD40 ANTIGEN 1989-95 %26% CDW4O ANTIGEN 1988-95%A%  
% 212.58/212.78  |- mesh__recordAuthorizer mesh__D019013 sjn
% 212.58/212.78  |- skos__altLabel mesh__D019013 CD40 Antigens
% 212.58/212.78  |- mesh__dateEstablished mesh__D019013 1996-01-01
% 212.58/212.78  |- skos__prefLabel mesh__D019013 Antigens, CD40
% 212.58/212.78  |- mesh__historyNote mesh__D019013
% 212.58/212.78       96; was CD40 ANTIGEN %28%NM%29% 1989-95 %26% CDW40 ANTIGEN %28%NM%29% 1988-95%A%  
% 212.58/212.78  |- skos__hiddenLabel mesh__D019013 Antigen, CD40
% 212.58/212.78  |- skos__altLabel mesh__D019013
% 212.58/212.78       Tumor Necrosis Factor Receptor Superfamily, Member 5
% 212.58/212.78  |- skos__altLabel mesh__D019013 CD40 Antigen
% 212.58/212.78  |- skos__broader mesh__D019013smesh__D015703
% 212.58/212.78  |- skos__altLabel mesh__D019013 TNFRSF5 Receptor
% 212.58/212.78  |- skos__scopeNote mesh__D019013
% 212.58/212.78       A member of the tumor necrosis factor receptor superfamily found on mature B-LYMPHOCYTES and some EPITHELIAL CELLS, and lymphoid DENDRITIC CELLS. Evidence suggests that CD40-dependent activation of B-cells is important for generation of memory B-cells within the germinal centers.%A%    
% 212.58/212.78  |- mesh__dateRevised mesh__D019013 2005-06-30
% 212.58/212.78  |- skos__broader mesh__D019013smesh__D000944
% 212.58/212.78  |- skos__altLabel mesh__D019013 CDw40 Antigen
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011030 2002
% 212.58/212.78  |- rdf__type mesh__D011030sskos__Concept
% 212.58/212.78  |- mesh__recordOriginator mesh__D011030 NLM
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011030 1998
% 212.58/212.78  |- skos__prefLabel mesh__D011030 Pneumothorax
% 212.58/212.78  |- skos__related mesh__D011030smesh__D006468
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011030 1997
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011030 1994
% 212.58/212.78  |- skos__scopeNote mesh__D011030
% 212.58/212.78       An accumulation of air or gas in the pleural space, which may occur spontaneously or as a result of trauma or a pathological process, or be introduced deliberately %28% = PNEUMOTHORAX, ARTIFICIAL%29%. %28%Dorland, 27th ed%29%%A%    
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011030 1999
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011030 2003
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011030 2005
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011030 2000
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011030 1995
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011030 2004
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011030 2001
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011030 2003A
% 212.58/212.78  |- skos__related mesh__D011030smesh__D006872
% 212.58/212.78  |- mesh__recordAuthorizer mesh__D011030 sjn
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011030 2006
% 212.58/212.78  |- mesh__dateCreated mesh__D011030 1999-01-01
% 212.58/212.78  |- mesh__dateRevised mesh__D011030 2002-10-23
% 212.58/212.78  |- mesh__recordMaintainer mesh__D011030 sjn
% 212.58/212.78  |- skos__annotation mesh__D011030
% 212.58/212.78       accumul of air or gas in pleural cavity: a disease; do not confuse with PNEUMOTHORAX, ARTIFICIAL, a surg procedure%A%  
% 212.58/212.78  |- skos__broader mesh__D011030smesh__D010995
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011030 1996
% 212.58/212.78  |- skos__altLabel mesh__D018719 erbB-2 Proto-Oncogene Protein
% 212.58/212.78  |- mesh__historyNote mesh__D018719
% 212.58/212.78       2000%28%1995%29%; use RECEPTOR, ERBB-2 %28%NM%29% 1985-1994   
% 212.58/212.78  |- skos__hiddenLabel mesh__D018719 Receptors, erbB 2
% 212.58/212.78  |- skos__hiddenLabel mesh__D018719 Proto Oncogene Protein HER 2
% 212.58/212.78  |- skos__altLabel mesh__D018719 Receptors, erbB-2
% 212.58/212.78  |- skos__altLabel mesh__D018719 neu Receptor
% 212.58/212.78  |- skos__broader mesh__D018719smesh__D017978
% 212.58/212.78  |- skos__hiddenLabel mesh__D018719 Proto-Oncogene Protein, HER-2
% 212.58/212.78  |- mesh__recordAuthorizer mesh__D018719 sjn
% 212.58/212.78  |- skos__historyNote mesh__D018719
% 212.58/212.78       Proto-Oncogene Proteins %28%1986-1994%29%
% 212.58/212.78  |- skos__altLabel mesh__D018719 c-erbB-2 Protein
% 212.58/212.78  |- skos__hiddenLabel mesh__D018719 Oncogene Protein HER 2
% 212.58/212.78  |- skos__scopeNote mesh__D018719
% 212.58/212.78       A cell surface protein-tyrosine kinase receptor that is found to be overexpressed in a significant number of adenocarcinomas. It has extensive homology to and can heterodimerize with the EGF receptor %28%RECEPTOR, EPIDERMAL GROWTH FACTOR%29%, the erbB-3 receptor %28%RECEPTOR, ERBB-3%29% and the erbB-4 receptor. Activation of the erbB-2 receptor occurs during heterodimer formation with a ligand-bound erbB receptor family members.%A%    
% 212.58/212.78  |- mesh__recordOriginator mesh__D018719 AGS
% 212.58/212.78  |- skos__hiddenLabel mesh__D018719 neu Proto Oncogene Protein
% 212.58/212.78  |- skos__hiddenLabel mesh__D018719 c erbB 2 Protein
% 212.58/212.78  |- mesh__dateEstablished mesh__D018719 1995-01-01
% 212.58/212.78  |- skos__altLabel mesh__D018719 erbB-2 Receptor Protein-Tyrosine Kinase
% 212.58/212.78  |- skos__hiddenLabel mesh__D018719 HER 2 Proto Oncogene Protein
% 212.58/212.78  |- skos__hiddenLabel mesh__D018719 Proto-Oncogene Protein, neu
% 212.58/212.78  |- skos__historyNote mesh__D018719 Phosphoproteins %28%1985%29%
% 212.58/212.78  |- rdf__type mesh__D018719sskos__Concept
% 212.58/212.78  |- skos__altLabel mesh__D018719 HER-2 Proto-Oncogene Protein
% 212.58/212.78  |- skos__prefLabel mesh__D018719 Receptor, erbB-2
% 212.58/212.78  |- skos__hiddenLabel mesh__D018719 erbB 2 Receptor Protein Tyrosine Kinase
% 212.58/212.78  |- skos__broader mesh__D018719smesh__D014408
% 212.58/212.78  |- skos__hiddenLabel mesh__D018719 erbB 2 Proto Oncogene Protein
% 212.58/212.78  |- skos__altLabel mesh__D018719 Receptor, neu
% 212.58/212.78  |- mesh__dateCreated mesh__D018719 1999-11-04
% 212.58/212.78  |- skos__historyNote mesh__D018719
% 212.58/212.78       Epidermal Growth Factor Receptor Protein-Tyrosine Kinase %28%1994%29%
% 212.58/212.78  |- skos__broader mesh__D018719smesh__D020794
% 212.58/212.78  |- skos__broader mesh__D018719smesh__D011518
% 212.58/212.78  |- skos__altLabel mesh__D018719 neu Proto-Oncogene Protein
% 212.58/212.78  |- skos__hiddenLabel mesh__D018719 Proto Oncogene Proteins c erbB 2
% 212.58/212.78  |- skos__altLabel mesh__D018719 Proto-Oncogene Protein p185%28%neu%29%
% 212.58/212.78  |- skos__altLabel mesh__D018719 Proto-Oncogene Protein HER-2
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D018719 2006
% 212.58/212.78  |- mesh__dateRevised mesh__D018719 2005-06-30
% 212.58/212.78  |- skos__hiddenLabel mesh__D018719 Proto-Oncogene Protein, erbB-2
% 212.58/212.78  |- skos__altLabel mesh__D018719 Proto-Oncogene Proteins c-erbB-2
% 212.58/212.78  |- skos__hiddenLabel mesh__D018719 erbB-2 Receptor
% 212.58/212.78  |- skos__hiddenLabel mesh__D018719 Receptor, erbB 2
% 212.58/212.78  |- skos__altLabel mesh__D018719 Oncogene Protein HER-2
% 212.58/212.78  |- mesh__recordMaintainer mesh__D018719 jmp
% 212.58/212.78  |- skos__hiddenLabel mesh__D018719 erbB-2 Receptors
% 212.58/212.78  |- mesh__publicMeSHNote mesh__D018719
% 212.58/212.78       2000; see PROTO-ONCOGENE PROTEINS C-ERBB-2 1995-1999; for PROTO-ONCOGENE PROTEIN ERBB-2 see EPIDERMAL GROWTH FACTOR RECEPTOR PROTEIN-TYROSINE KINASE 1994, PROTO-ONCOGENE PROTEINS 1986-1994, %26% PHOSPHOPROTEINS 1985;%A%  
% 212.58/212.78  |- skos__altLabel mesh__D018719 p185%28%c-neu%29%
% 212.58/212.78  |- skos__related mesh__D018719smesh__D018734
% 212.58/212.78  |- skos__scopeNote mesh__D010736
% 212.58/212.78       An enzyme that catalyzes the conversion of 2-phospho-D-glycerate to 3-phospho-D-glycerate. EC 5.4.2.1.%A%    
% 212.58/212.78  |- mesh__dateCreated mesh__D010736 1974-11-19
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D010736 2004
% 212.58/212.78  |- skos__hiddenLabel mesh__D010736 Phosphomutase, Phosphoglycerate
% 212.58/212.78  |- skos__altLabel mesh__D010736 Glycerate %28%3-2%29%-Phosphomutase
% 212.58/212.78  |- skos__hiddenLabel mesh__D010736 Mutase, Phosphoglycerate
% 212.58/212.78  |- mesh__recordAuthorizer mesh__D010736 sjn
% 212.58/212.78  |- skos__altLabel mesh__D010736 Phosphoglycerate Phosphomutase
% 212.58/212.78  |- skos__broader mesh__D010736smesh__D017875
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D010736 2006
% 212.58/212.78  |- mesh__publicMeSHNote mesh__D010736
% 212.58/212.78       94; was PHOSPHOGLYCEROMUTASE 1975-93 %28%see under PHOSPHOTRANSFERASES 1975-90%29%; PHOSPHOGLYCERATE PHOSPHOMUTASE was indexed under ISOMERASES 1983-93, GLYCERIC ACIDS 1973-82 %26% ORGANOPHOSPHORUS COMPOUNDS 1973-82%A%  
% 212.58/212.78  |- mesh__historyNote mesh__D010736
% 212.58/212.78       94; was PHOSPHOGLYCEROMUTASE 1975-93 %28%see under PHOSPHOTRANSFERASES 1975-90%29%; PHOSPHOGLYCERATE PHOSPHOMUTASE was %28%NM%29% 1973-93%A%  
% 212.58/212.78  |- mesh__recordMaintainer mesh__D010736 ssb
% 212.58/212.78  |- mesh__recordOriginator mesh__D010736 NLM
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D010736 2005
% 212.58/212.78  |- mesh__dateEstablished mesh__D010736 1991-01-01
% 212.58/212.78  |- mesh__onlineNote mesh__D010736
% 212.58/212.78       use PHOSPHOGLYCERATE MUTASE to search PHOSPHOGLYCEROMUTASE 1975-93; use PHOSPHOGLYCERATE MUTASE %28%NM%29% to search PHOSPHOGLYCERATE PHOSPHOMUTASE 1980-93%A%  
% 212.58/212.78  |- skos__altLabel mesh__D010736 Phosphoglyceromutase
% 212.58/212.78  |- skos__historyNote mesh__D010736 Phosphotransferases %28%1973-1974%29%
% 212.58/212.78  |- rdf__type mesh__D010736sskos__Concept
% 212.58/212.78  |- skos__prefLabel mesh__D010736 Phosphoglycerate Mutase
% 212.58/212.78  |- skos__historyNote mesh__D010736
% 212.58/212.78       Diphosphoglyceric Acids %28%1973-1974%29%
% 212.58/212.78  |- mesh__dateRevised mesh__D010736 2003-07-09
% 212.58/212.78  |- mesh__dateEstablished mesh__D029441 2002-01-01
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D029441 2006
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D029441 2003
% 212.58/212.78  |- skos__broader mesh__D029441smesh__D031241
% 212.58/212.78  |- mesh__publicMeSHNote mesh__D029441 2002   
% 212.58/212.78  |- mesh__dateCreated mesh__D029441 2001-07-25
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D029441 2004
% 212.58/212.78  |- skos__annotation mesh__D029441
% 212.58/212.78       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.58/212.78  |- mesh__historyNote mesh__D029441 2002   
% 212.58/212.78  |- mesh__dateRevised mesh__D029441 2002-07-03
% 212.58/212.78  |- skos__prefLabel mesh__D029441 Carica
% 212.58/212.78  |- skos__scopeNote mesh__D029441
% 212.58/212.78       A plant genus of the family Caricaceae, order Violales, subclass Dilleniidae, class Magnoliopsida. It is the source of edible fruit and PAPAIN.%A%    
% 212.58/212.78  |- rdf__type mesh__D029441sskos__Concept
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D029441 2005
% 212.58/212.78  |- skos__prefLabel mesh__D001401 Azygos Vein
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D001401 2006
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D001401 2001
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D001401 1995
% 212.58/212.78  |- skos__broader mesh__D001401smesh__D014680
% 212.58/212.78  |- rdf__type mesh__D001401sskos__Concept
% 212.58/212.78  |- skos__hiddenLabel mesh__D001401 Veins, Azygos
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D001401 2005
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D001401 2000
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D001401 1999
% 212.58/212.78  |- skos__hiddenLabel mesh__D001401 Vein, Azygos
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D001401 1994
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D001401 2004
% 212.58/212.78  |- mesh__dateCreated mesh__D001401 1999-01-01
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D001401 1998
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D001401 1993
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D001401 2003
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D001401 1997
% 212.58/212.78  |- mesh__recordAuthorizer mesh__D001401 PLS
% 212.58/212.78  |- skos__scopeNote mesh__D001401
% 212.58/212.78       A vein which arises from the right ascending lumbar vein or the vena cava, enters the thorax through the aortic orifice in the diaphragm, and terminates in the superior vena cava.%A%    
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D001401 1996
% 212.58/212.78  |- skos__hiddenLabel mesh__D001401 Azygos Veins
% 212.58/212.78  |- mesh__recordOriginator mesh__D001401 NLM
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D001401 2002
% 212.58/212.78  |- mesh__dateRevised mesh__D001401 1992-03-25
% 212.58/212.78  |- mesh__recordMaintainer mesh__D001401 TAP
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D006695 2002
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D006695 2003
% 212.58/212.78  |- mesh__dateRevised mesh__D006695 2001-07-25
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D006695 2004
% 212.58/212.78  |- skos__scopeNote mesh__D006695
% 212.58/212.78       Holmium. An element of the rare earth family of metals. It has the atomic symbol Ho, atomic number 67, and atomic weight 164.93.%A%    
% 212.58/212.78  |- skos__prefLabel mesh__D006695 Holmium
% 212.58/212.78  |- rdf__type mesh__D006695sskos__Concept
% 212.58/212.78  |- skos__broader mesh__D006695smesh__D028581
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D006695 2005
% 212.58/212.78  |- mesh__recordMaintainer mesh__D006695 jmp
% 212.58/212.78  |- skos__annotation mesh__D006695
% 212.58/212.78       a rare earth metal; Ho-165; Ho-151-170, except Ho-165 = HOLMIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 212.58/212.78  |- mesh__dateCreated mesh__D006695 1999-01-01
% 212.58/212.78  |- mesh__recordAuthorizer mesh__D006695 sjn
% 212.58/212.78  |- mesh__recordOriginator mesh__D006695 NLM
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D006695 2006
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D020366 2005
% 212.58/212.78  |- skos__hiddenLabel mesh__D020366 Monomer, Methacrylate Methyl
% 212.58/212.78  |- mesh__dateEstablished mesh__D020366 1999-01-01
% 212.58/212.78  |- mesh__recordMaintainer mesh__D020366 jmp
% 212.58/212.78  |- skos__broader mesh__D020366smesh__D008768
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D020366 2006
% 212.58/212.78  |- skos__prefLabel mesh__D020366 Methylmethacrylate
% 212.58/212.78  |- skos__scopeNote mesh__D020366
% 212.58/212.78       The methyl ester of methacrylic acid. It polymerizes easily to form POLYMETHYL METHACRYLATE. It is used as a bone cement.%A%    
% 212.58/212.78  |- skos__hiddenLabel mesh__D020366 Monomer, Methylmethacrylate Methyl
% 212.58/212.78  |- mesh__dateRevised mesh__D020366 2004-07-07
% 212.58/212.78  |- mesh__recordOriginator mesh__D020366 ADP
% 212.58/212.78  |- skos__altLabel mesh__D020366 Methacrylate Methyl Monomer
% 212.58/212.78  |- skos__altLabel mesh__D020366 Methylmethacrylate Methyl Monomer
% 212.58/212.78  |- skos__hiddenLabel mesh__D020366 A, Kallocryl
% 212.58/212.78  |- skos__annotation mesh__D020366 POLYMETHYL METHACRYLATE is available   
% 212.58/212.78  |- mesh__publicMeSHNote mesh__D020366
% 212.58/212.78       99; METHYLMETHACRYLATE was indexed under METHYLMETHACRYLATES 1974-98%A%  
% 212.58/212.78  |- mesh__historyNote mesh__D020366
% 212.58/212.78       99; use METHYLMETHACRYLATE %28%NM%29% 1980-98   
% 212.58/212.78  |- skos__hiddenLabel mesh__D020366 Bone Cement, Zimmer
% 212.58/212.78  |- mesh__recordAuthorizer mesh__D020366 sjn
% 212.58/212.78  |- rdf__type mesh__D020366sskos__Concept
% 212.58/212.78  |- skos__hiddenLabel mesh__D020366 P, Simplex
% 212.58/212.78  |- skos__hiddenLabel mesh__D020366 Cement, Zimmer Bone
% 212.58/212.78  |- skos__hiddenLabel mesh__D020366 Methyl Monomer, Methacrylate
% 212.58/212.78  |- mesh__dateCreated mesh__D020366 1998-06-10
% 212.58/212.78  |- skos__historyNote mesh__D020366 Methylmethacrylates %28%1974-1998%29%
% 212.58/212.78  |- skos__hiddenLabel mesh__D020366 Methyl Monomer, Methylmethacrylate
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D014329 2005
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D014329 2006
% 212.58/212.78  |- mesh__recordMaintainer mesh__D014329 kle
% 212.58/212.78  |- mesh__recordOriginator mesh__D014329 NLM
% 212.58/212.78  |- skos__hiddenLabel mesh__D014329 Climates, Tropical
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D014329 2000
% 212.58/212.78  |- skos__prefLabel mesh__D014329 Tropical Climate
% 212.58/212.78  |- mesh__recordAuthorizer mesh__D014329 sjn
% 212.58/212.78  |- mesh__dateRevised mesh__D014329 1999-11-03
% 212.58/212.78  |- mesh__dateCreated mesh__D014329 1999-01-01
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D014329 2001
% 212.58/212.78  |- rdf__type mesh__D014329sskos__Concept
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D014329 2003
% 212.58/212.78  |- skos__hiddenLabel mesh__D014329 Tropical Climates
% 212.58/212.78  |- skos__hiddenLabel mesh__D014329 Climate, Tropical
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D014329 2002
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D014329 2004
% 212.58/212.78  |- skos__annotation mesh__D014329 specify geog if pertinent   
% 212.58/212.78  |- skos__scopeNote mesh__D014329
% 212.58/212.78       A climate which is typical of equatorial and tropical regions, i.e., one with continually high temperatures with considerable precipitation, at least during part of the year. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 212.58/212.78  |- skos__broader mesh__D014329smesh__D002980
% 212.58/212.78  |- skos__hiddenLabel mesh__D019812 Proteoglycan, Heparan Sulfate
% 212.58/212.78  |- mesh__publicMeSHNote mesh__D019812
% 212.58/212.78       98; HEPARAN SULFATE PROTEOGLYCAN was indexed under PROTEOGLYCANS 1982-97, HEPARITIN SULFATE 1982-97, %26% PROTEOCHONDROITIN SULFATES 1982-92%A%  
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D019812 2005
% 212.58/212.78  |- mesh__recordAuthorizer mesh__D019812 sjn
% 212.58/212.78  |- rdf__type mesh__D019812sskos__Concept
% 212.58/212.78  |- skos__altLabel mesh__D019812 Proteoheparan Sulfate
% 212.58/212.78  |- skos__altLabel mesh__D019812 HSPG
% 212.58/212.78  |- skos__historyNote mesh__D019812 Proteoglycans %28%1982-1997%29%
% 212.58/212.78  |- skos__broader mesh__D019812smesh__D006497
% 212.58/212.78  |- mesh__dateRevised mesh__D019812 2004-07-07
% 212.58/212.78  |- skos__scopeNote mesh__D019812
% 212.58/212.78       Ubiquitous macromolecules associated with the cell surface and extracellular matrix of a wide range of cells of vertebrate and invertebrate tissues. They are essential cofactors in cell-matrix adhesion processes, in cell-cell recognition systems, and in receptor-growth factor interactions. %28%From Cancer Metastasis Rev 1996; 15%28%2%29%: 177-86; Hepatology 1996; 24%28%3%29%: 524-32%29%%A%    
% 212.58/212.78  |- mesh__recordOriginator mesh__D019812 KEV
% 212.58/212.78  |- mesh__dateCreated mesh__D019812 1997-06-20
% 212.58/212.78  |- skos__broader mesh__D019812smesh__D011509
% 212.58/212.78  |- skos__hiddenLabel mesh__D019812 Sulfate, Proteoheparan
% 212.58/212.78  |- mesh__dateEstablished mesh__D019812 1998-01-01
% 212.58/212.78  |- skos__prefLabel mesh__D019812 Heparan Sulfate Proteoglycan
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D019812 2006
% 212.58/212.78  |- skos__hiddenLabel mesh__D019812 Sulfate Proteoglycan, Heparan
% 212.58/212.78  |- mesh__recordMaintainer mesh__D019812 ssb
% 212.58/212.78  |- skos__annotation mesh__D019812
% 212.58/212.78       do not confuse with HEPARAN SULFATE see HEPARITIN SULFATE%A%  
% 212.58/212.78  |- mesh__historyNote mesh__D019812
% 212.58/212.78       98; use HEPARAN SULFATE PROTEOGLYCAN %28%NM%29% 1982-97   
% 212.58/212.78  |- skos__historyNote mesh__D019812
% 212.58/212.78       Proteochondroitin Sulfates %28%1982-1992%29%
% 212.58/212.78  |- skos__historyNote mesh__D019812 Heparitin Sulfate %28%1982-1997%29%
% 212.58/212.78  |- mesh__recordMaintainer mesh__D000309 lkt
% 212.58/212.78  |- skos__hiddenLabel mesh__D000309 Hypofunction, Adrenal Gland
% 212.58/212.78  |- skos__hiddenLabel mesh__D000309 Adrenal Insufficiencies
% 212.58/212.78  |- mesh__publicMeSHNote mesh__D000309
% 212.58/212.78       2005; see ADRENAL GLAND HYPOFUNCTION 1968-2004   
% 212.58/212.78  |- mesh__dateCreated mesh__D000309 1999-01-01
% 212.58/212.78  |- skos__related mesh__D000309smesh__D000305
% 212.58/212.78  |- skos__altLabel mesh__D000309 Hypoadrenalism
% 212.58/212.78  |- mesh__recordOriginator mesh__D000309 NLM
% 212.58/212.78  |- mesh__dateEstablished mesh__D000309 1968-01-01
% 212.58/212.78  |- mesh__dateRevised mesh__D000309 2004-07-07
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D000309 2006
% 212.58/212.78  |- skos__prefLabel mesh__D000309 Adrenal Insufficiency
% 212.58/212.78  |- skos__broader mesh__D000309smesh__D000307
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D000309 2005
% 212.58/212.78  |- mesh__recordAuthorizer mesh__D000309 sjn
% 212.58/212.78  |- rdf__type mesh__D000309sskos__Concept
% 212.58/212.78  |- skos__annotation mesh__D000309
% 212.58/212.78       do not confuse with ADRENAL GLAND HYPERFUNCTION   
% 212.58/212.78  |- skos__altLabel mesh__D000309 Adrenal Gland Hypofunction
% 212.58/212.78  |- mesh__historyNote mesh__D000309 2005 %28%1968%29%   
% 212.58/212.78  |- skos__scopeNote mesh__D000309
% 212.58/212.78       Conditions in which the production of adrenal CORTICOSTEROIDS falls below the requirement of the body. Adrenal insufficiency can be caused by defects in the ADRENAL GLANDS, the PITUITARY GLAND, or the HYPOTHALAMUS.%A%    
% 212.58/212.78  |- mesh__dateCreated mesh__D019014 1995-05-26
% 212.58/212.78  |- skos__broader mesh__D019014smesh__D015703
% 212.58/212.78  |- skos__historyNote mesh__D019014 Antigens, Surface %28%1989-1995%29%
% 212.58/212.78  |- skos__altLabel mesh__D019014 fas Antigens
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D019014 2006
% 212.58/212.78  |- mesh__dateRevised mesh__D019014 2005-06-30
% 212.58/212.78  |- skos__hiddenLabel mesh__D019014 Receptor, fas
% 212.58/212.78  |- rdf__type mesh__D019014sskos__Concept
% 212.58/212.78  |- skos__hiddenLabel mesh__D019014 APO 1 Antigen
% 212.58/212.78  |- skos__altLabel mesh__D019014 TNFRSF6 Receptor
% 212.58/212.78  |- skos__broader mesh__D019014smesh__D018124
% 212.58/212.78  |- skos__altLabel mesh__D019014 CD95 Antigen
% 212.58/212.78  |- mesh__recordMaintainer mesh__D019014 ssb
% 212.58/212.78  |- mesh__recordOriginator mesh__D019014 AGS
% 212.58/212.78  |- skos__altLabel mesh__D019014 Receptors, fas
% 212.58/212.78  |- mesh__historyNote mesh__D019014
% 212.58/212.78       1996; use ANTIGENS, CD95 %28%NM%29% 1989-1995; for FAS RECEPTOR use ANTIGENS, CD95 1998-1999%A%  
% 212.58/212.78  |- skos__altLabel mesh__D019014 APO-1 Antigen
% 212.58/212.78  |- skos__altLabel mesh__D019014 fas Antigen
% 212.58/212.78  |- skos__prefLabel mesh__D019014 Antigens, CD95
% 212.58/212.78  |- mesh__recordAuthorizer mesh__D019014 sjn
% 212.58/212.78  |- mesh__dateEstablished mesh__D019014 1996-01-01
% 212.58/212.78  |- skos__altLabel mesh__D019014 fas Receptor
% 212.58/212.78  |- skos__scopeNote mesh__D019014
% 212.58/212.78       Differentiation antigens expressed on a variety of cell lines including myeloid and lymphoblastoid cell lines. They are members of the tumor necrosis receptor superfamily involved in the regulation of peripheral immune responses and APOPTOSIS.%A%    
% 212.58/212.78  |- skos__altLabel mesh__D019014 fas Receptors
% 212.58/212.78  |- skos__altLabel mesh__D019014 CD95 Antigens
% 212.58/212.78  |- mesh__publicMeSHNote mesh__D019014
% 212.58/212.78       1996; FAS ANTIGEN %28%now ANTIGENS, CD95%29% was indexed under ANTIGENS, SURFACE 1989-1995; FAS RECEPTOR was indexed under RECEPTORS, TUMOR NECROSIS FACTOR 1998-1999%A%  
% 212.58/212.78  |- skos__altLabel mesh__D019014
% 212.58/212.78       Tumor Necrosis Factor Receptor Superfamily, Member 6
% 212.58/212.78  |- skos__hiddenLabel mesh__D019014 Receptor, TNFRSF6
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011031 2005
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011031 2004
% 212.58/212.78  |- skos__annotation mesh__D011031
% 212.58/212.78       a form of collapse ther; do not use /util except by MeSH definition; in treating dis, coord Cat C term with /surg%A%  
% 212.58/212.78  |- mesh__dateRevised mesh__D011031 1997-06-20
% 212.58/212.78  |- skos__hiddenLabel mesh__D011031 Artificial Pneumothoraxs
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011031 2006
% 212.58/212.78  |- mesh__dateCreated mesh__D011031 1999-01-01
% 212.58/212.78  |- skos__hiddenLabel mesh__D011031 Pneumothoraxs, Artificial
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011031 2002
% 212.58/212.78  |- mesh__recordOriginator mesh__D011031 NLM
% 212.58/212.78  |- skos__scopeNote mesh__D011031
% 212.58/212.78       Injection of air or a more slowly absorbed gas such as nitrogen, into the pleural space to collapse the lung. It was formerly used to treat pulmonary tuberculosis. %28%From Stedman, 26th ed %26% Dorland, 28th ed%29%%A%    
% 212.58/212.78  |- rdf__type mesh__D011031sskos__Concept
% 212.58/212.78  |- mesh__recordMaintainer mesh__D011031 PXP
% 212.58/212.78  |- skos__prefLabel mesh__D011031 Pneumothorax, Artificial
% 212.58/212.78  |- skos__broader mesh__D011031smesh__D003096
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011031 1998
% 212.58/212.78  |- mesh__recordAuthorizer mesh__D011031 SJN
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011031 2000
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011031 1999
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011031 2003
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D011031 2001
% 212.58/212.78  |- skos__hiddenLabel mesh__D011031 Artificial Pneumothorax
% 212.58/212.78  |- skos__annotation mesh__D015422 inflamm dis = SCLERITIS   
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D015422 1998
% 212.58/212.78  |- skos__hiddenLabel mesh__D015422 Disease, Sclera
% 212.58/212.78  |- skos__broader mesh__D015422smesh__D005128
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D015422 1997
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D015422 1992
% 212.58/212.78  |- mesh__recordMaintainer mesh__D015422 PLS
% 212.58/212.78  |- skos__hiddenLabel mesh__D015422 Disease, Scleral
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D015422 1994
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D015422 1999
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D015422 2002
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D015422 1993
% 212.58/212.78  |- skos__altLabel mesh__D015422 Sclera Diseases
% 212.58/212.78  |- mesh__recordOriginator mesh__D015422 WDJ
% 212.58/212.78  |- skos__hiddenLabel mesh__D015422 Diseases, Sclera
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D015422 1995
% 212.58/212.78  |- rdf__type mesh__D015422sskos__Concept
% 212.58/212.78  |- mesh__historyNote mesh__D015422 89   
% 212.58/212.78  |- skos__historyNote mesh__D015422 Eye Diseases %28%1966-1988%29%
% 212.58/212.78  |- mesh__recordAuthorizer mesh__D015422 PLS
% 212.58/212.78  |- skos__scopeNote mesh__D015422
% 212.58/212.78       General disorders of the sclera or white of the eye. They may include anatomic, embryologic, degenerative, or pigmentation defects.%A%    
% 212.58/212.78  |- mesh__dateEstablished mesh__D015422 1989-01-01
% 212.58/212.78  |- skos__hiddenLabel mesh__D015422 Diseases, Scleral
% 212.58/212.78  |- skos__prefLabel mesh__D015422 Scleral Diseases
% 212.58/212.78  |- skos__historyNote mesh__D015422 Sclera %28%1966-1988%29%
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D015422 2003
% 212.58/212.78  |- mesh__publicMeSHNote mesh__D015422 89   
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D015422 2000
% 212.58/212.78  |- mesh__dateCreated mesh__D015422 1988-06-07
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D015422 2005
% 212.58/212.78  |- skos__hiddenLabel mesh__D015422 Scleral Disease
% 212.58/212.78  |- mesh__dateRevised mesh__D015422 1991-06-19
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D015422 2004
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D015422 2001
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D015422 2006
% 212.58/212.78  |- skos__hiddenLabel mesh__D015422 Sclera Disease
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D015422 1996
% 212.58/212.78  |- skos__hiddenLabel mesh__D001402 B Cells
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D001402 2005
% 212.58/212.78  |- skos__hiddenLabel mesh__D001402 Lymphocytes, Bursa-Dependent
% 212.58/212.78  |- mesh__recordOriginator mesh__D001402 NLM
% 212.58/212.78  |- skos__historyNote mesh__D001402 Lymphocytes %28%1966-1972%29%
% 212.58/212.78  |- skos__hiddenLabel mesh__D001402 B-Cell
% 212.58/212.78  |- mesh__activeMeSHYear mesh__D001402 2004
% 212.58/212.78  |- mesh__dateCreated mesh__D001402 1999-01-01
% 212.58/212.78  |- skos__broader mesh__D001402smesh__D000921
% 212.58/212.78  |- skos__prefLabel mesh__D001402 B-Lymphocytes
% 212.58/212.78  |- skos__hiddenLabel mesh__D001402 Bursa Dependent Lymphocytes
% 212.58/212.78  |- mesh__recordMaintainer mesh__D001402 jmp
% 212.58/212.78  |- skos__hiddenLabel mesh__D001402 Lymphocyte, Bursa-Dependent
% 212.58/212.79  |- skos__hiddenLabel mesh__D001402 Bursa-Dependent Lymphocyte
% 212.58/212.79  |- skos__hiddenLabel mesh__D001402 B-Lymphocyte
% 212.58/212.79  |- skos__altLabel mesh__D001402 B-Cells
% 212.58/212.79  |- skos__hiddenLabel mesh__D001402 B Lymphocytes
% 212.58/212.79  |- mesh__dateRevised mesh__D001402 2003-07-09
% 212.58/212.79  |- mesh__recordAuthorizer mesh__D001402 sjn
% 212.58/212.79  |- mesh__publicMeSHNote mesh__D001402 90; was B LYMPHOCYTES 1973-89   
% 212.58/212.79  |- skos__annotation mesh__D001402
% 212.58/212.79       involved in antibody formation; do not confuse X ref B-CELLS with pancreatic B cells or beta cells %28%index under ISLANDS OF LANGERHANS%29%; A 11 qualif; subpopulations = B-LYMPHOCYTE SUBSETS%A%  
% 212.58/212.79  |- skos__altLabel mesh__D001402 Bursa-Dependent Lymphocytes
% 212.58/212.79  |- skos__broader mesh__D001402smesh__D008214
% 212.58/212.79  |- mesh__historyNote mesh__D001402 90; was B LYMPHOCYTES 1973-89   
% 212.58/212.79  |- skos__scopeNote mesh__D001402
% 212.58/212.79       Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.%A%    
% 212.58/212.79  |- skos__related mesh__D001402smesh__D008211
% 212.58/212.79  |- mesh__activeMeSHYear mesh__D001402 2006
% 212.58/212.79  |- mesh__dateEstablished mesh__D001402 1973-01-01
% 212.58/212.79  |- skos__related mesh__D001402smesh__D018858
% 212.58/212.79  |- rdf__type mesh__D001402sskos__Concept
% 212.58/212.79  |- mesh__dateRevised mesh__D006696 2000-06-22
% 212.58/212.79  |- skos__prefLabel mesh__D006696 Holography
% 212.58/212.79  |- mesh__activeMeSHYear mesh__D006696 2006
% 212.58/212.79  |- mesh__dateCreated mesh__D006696 1999-01-01
% 212.58/212.79  |- mesh__activeMeSHYear mesh__D006696 2001
% 212.58/212.79  |- mesh__recordAuthorizer mesh__D006696 sjn
% 212.58/212.79  |- skos__historyNote mesh__D006696 Photography %28%1966-1968%29%
% 212.58/212.79  |- mesh__recordOriginator mesh__D006696 NLM
% 212.58/212.79  |- mesh__activeMeSHYear mesh__D006696 2005
% 212.58/212.79  |- mesh__activeMeSHYear mesh__D006696 2004
% 212.58/212.79  |- mesh__activeMeSHYear mesh__D006696 2003
% 212.58/212.79  |- mesh__recordMaintainer mesh__D006696 PXP
% 212.58/212.79  |- skos__annotation mesh__D006696 DF: HOLOGR   
% 212.58/212.79  |- mesh__historyNote mesh__D006696 74%28%69%29%   
% 212.58/212.79  |- mesh__dateEstablished mesh__D006696 1974-01-01
% 212.58/212.79  |- skos__historyNote mesh__D006696 Lasers %28%1966-1968%29%
% 212.58/212.79  |- skos__broader mesh__D006696smesh__D021621
% 212.58/212.79  |- rdf__type mesh__D006696sskos__Concept
% 212.58/212.79  |- mesh__publicMeSHNote mesh__D006696 74   
% 212.58/212.79  |- mesh__activeMeSHYear mesh__D006696 2002
% 212.58/212.79  |- skos__scopeNote mesh__D006696
% 212.58/212.79       The recording of images in three-dimensional form on a photographic film by exposing it to a laser beam reflected from the object under study.%A%    
% 212.58/212.79  |- skos__broader mesh__D006696smesh__D010781
% 212.58/212.79  |- mesh__recordAuthorizer mesh__D020367 sjn
% 212.58/212.79  |- skos__broader mesh__D020367smesh__D000662
% 212.58/212.79  |- mesh__activeMeSHYear mesh__D020367 2006
% 212.58/212.79  |- skos__altLabel mesh__D020367
% 212.58/212.79       N-Isopropyl-p-iodoamphetamine %28%I123%29% Hydrochloride
% 212.58/212.79  |- skos__altLabel mesh__D020367 N-Isopropyl-p-iodoamphetamine
% 212.58/212.79  |- mesh__dateCreated mesh__D020367 1998-06-10
% 212.58/212.79  |- mesh__dateRevised mesh__D020367 2000-06-22
% 212.58/212.79  |- mesh__publicMeSHNote mesh__D020367
% 212.58/212.79       99; IOFETAMINE was indexed under AMPHETAMINES 1980-98   
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D020367 2003
% 212.67/212.88  |- skos__prefLabel mesh__D020367 Iofetamine
% 212.67/212.88  |- skos__hiddenLabel mesh__D020367 Iofetamine Hydrochloride, I 123
% 212.67/212.88  |- mesh__dateEstablished mesh__D020367 1999-01-01
% 212.67/212.88  |- mesh__recordMaintainer mesh__D020367 CCR
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D020367 2004
% 212.67/212.88  |- skos__altLabel mesh__D020367
% 212.67/212.88       N-Isopropyl-p-%28%Iodine-123%29%-Iodoamphetamine
% 212.67/212.88  |- skos__historyNote mesh__D020367 Amphetamines %28%1980-1998%29%
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D020367 2001
% 212.67/212.88  |- skos__hiddenLabel mesh__D020367 Hydrochloride, I-123 Iofetamine
% 212.67/212.88  |- skos__hiddenLabel mesh__D020367 I-123, Iofetamine
% 212.67/212.88  |- mesh__historyNote mesh__D020367 99; use IOFETAMINE %28%NM%29% 1980-98   
% 212.67/212.88  |- skos__scopeNote mesh__D020367
% 212.67/212.88       An amphetamine analog that is rapidly taken up by the lungs and from there redistributed primarily to the brain and liver. It is used in brain radionuclide scanning with I-123.%A%    
% 212.67/212.88  |- mesh__recordOriginator mesh__D020367 ADP
% 212.67/212.88  |- rdf__type mesh__D020367sskos__Concept
% 212.67/212.88  |- skos__altLabel mesh__D020367 Iofetamine I-123
% 212.67/212.88  |- skos__hiddenLabel mesh__D020367 Iodine 123 IMP
% 212.67/212.88  |- skos__hiddenLabel mesh__D020367 I-123 Iofetamine Hydrochloride
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D020367 2005
% 212.67/212.88  |- skos__hiddenLabel mesh__D020367 N Isopropyl p iodoamphetamine
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D020367 2002
% 212.67/212.88  |- skos__hiddenLabel mesh__D020367 Iofetamine I 123
% 212.67/212.88  |- rdf__type mesh__D019813sskos__Concept
% 212.67/212.88  |- skos__hiddenLabel mesh__D019813 sym Dimethylhydrazine
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019813 2000
% 212.67/212.88  |- skos__broader mesh__D019813smesh__D004127
% 212.67/212.88  |- skos__altLabel mesh__D019813 1,2-Dimethyl-hydrazine
% 212.67/212.88  |- skos__hiddenLabel mesh__D019813 1,2 Dimethylhydrazine
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019813 2001
% 212.67/212.88  |- mesh__publicMeSHNote mesh__D019813
% 212.67/212.88       98; 1,2-DIMETHYLHYDRAZINE was indexed under DIMETHYLHYDRAZINES 1980-97%A%  
% 212.67/212.88  |- skos__historyNote mesh__D019813 Dimethylhydrazines %28%1977-1997%29%
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019813 2003
% 212.67/212.88  |- mesh__historyNote mesh__D019813
% 212.67/212.88       98; use 1,2-DIMETHYLHYDRAZINE %28%NM%29% 1980-97   
% 212.67/212.88  |- mesh__dateCreated mesh__D019813 1997-06-20
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019813 1998
% 212.67/212.88  |- skos__altLabel mesh__D019813 N,N%27%-Dimethylhydrazine
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019813 2005
% 212.67/212.88  |- skos__scopeNote mesh__D019813
% 212.67/212.88       A DNA alkylating agent that has been shown to be a potent carcinogen and is widely used to induce colon tumors in experimental animals.%A%    
% 212.67/212.88  |- skos__prefLabel mesh__D019813 1,2-Dimethylhydrazine
% 212.67/212.88  |- skos__altLabel mesh__D019813 SDMH
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019813 2004
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019813 1999
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019813 2002
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019813 2006
% 212.67/212.88  |- skos__hiddenLabel mesh__D019813 1,2 Dimethyl hydrazine
% 212.67/212.88  |- mesh__dateEstablished mesh__D019813 1998-01-01
% 212.67/212.88  |- skos__hiddenLabel mesh__D019813 N,N%27% Dimethylhydrazine
% 212.67/212.88  |- skos__hiddenLabel mesh__D011830 Radiation Effect
% 212.67/212.88  |- mesh__recordMaintainer mesh__D011830 nns
% 212.67/212.88  |- mesh__dateCreated mesh__D011830 1999-01-01
% 212.67/212.88  |- mesh__publicMeSHNote mesh__D011830
% 212.67/212.88       RADIATION IMMUNOLOGY was heading 1964-66   
% 212.67/212.88  |- mesh__onlineNote mesh__D011830
% 212.67/212.88       use RADIATION EFFECTS to search RADIATION IMMUNOLOGY 1966%A%  
% 212.67/212.88  |- rdf__type mesh__D011830sskos__Concept
% 212.67/212.88  |- skos__scopeNote mesh__D011830
% 212.67/212.88       The effects of ionizing and nonionizing radiation upon living organisms, organs and tissues, and their constituents, and upon physiologic processes. It includes the effect of irradiation on drugs and chemicals.%A%    
% 212.67/212.88  |- skos__annotation mesh__D011830
% 212.67/212.88       GEN only: prefer /rad eff: Manual 19.7+, 19.8.60; do not coord with specific term /rad eff; no qualif; TN 158: ionizing vs non-ionizing; indexing policy: Manual 28.11-28.11.5; radiations causing neopl = NEOPLASMS, RADIATION-INDUCED or LEUKEMIA, RADIATION-INDUCED, causing abnorm = ABNORMALITIES, RADIATION-INDUCED; DF: RAD EFF%A%  
% 212.67/212.88  |- skos__prefLabel mesh__D011830 Radiation Effects
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011830 2005
% 212.67/212.88  |- skos__related mesh__D011830smesh__D011831
% 212.67/212.88  |- mesh__historyNote mesh__D011830
% 212.67/212.88       RADIATION IMMUNOLOGY was heading 1964-66   
% 212.67/212.88  |- mesh__recordOriginator mesh__D011830 NLM
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011830 2003
% 212.67/212.88  |- mesh__recordAuthorizer mesh__D011830 sjn
% 212.67/212.88  |- skos__hiddenLabel mesh__D011830 Effect, Radiation
% 212.67/212.88  |- mesh__dateRevised mesh__D011830 2002-07-03
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011830 2006
% 212.67/212.88  |- skos__broader mesh__D011830smesh__D011870
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011830 2004
% 212.67/212.88  |- skos__altLabel mesh__D011830 Effects, Radiation
% 212.67/212.88  |- skos__hiddenLabel mesh__D019015 Sediment, Marine
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019015 1997
% 212.67/212.88  |- skos__altLabel mesh__D019015 Sediment, Geologic
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019015 2003
% 212.67/212.88  |- skos__prefLabel mesh__D019015 Geologic Sediments
% 212.67/212.88  |- skos__broader mesh__D019015smesh__D005844
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019015 1998
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019015 2000
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019015 2004
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019015 2001
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019015 1999
% 212.67/212.88  |- skos__scopeNote mesh__D019015
% 212.67/212.88       A mass of organic or inorganic solid fragmented material, or the solid fragment itself, that comes from the weathering of rock and is carried by, suspended in, or dropped by air, water, or ice. It refers also to a mass that is accumulated by any other natural agent and that forms in layers on the earth%27%s surface, such as sand, gravel, silt, mud, fill, or loess. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1689%29%%A%    
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019015 2005
% 212.67/212.88  |- mesh__publicMeSHNote mesh__D019015 96   
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019015 2002
% 212.67/212.88  |- skos__hiddenLabel mesh__D019015 Marine Sediment
% 212.67/212.88  |- skos__annotation mesh__D019015
% 212.67/212.88       not restricted to water, marine or fresh: read MeSH definition; DF: GEOL SEDIMENTS%A%  
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019015 2006
% 212.67/212.88  |- mesh__dateCreated mesh__D019015 1995-05-24
% 212.67/212.88  |- skos__broader mesh__D019015smesh__D009791
% 212.67/212.88  |- skos__altLabel mesh__D019015 Sediments, Geologic
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019015 1996
% 212.67/212.88  |- rdf__type mesh__D019015sskos__Concept
% 212.67/212.88  |- skos__altLabel mesh__D019015 Geologic Sediment
% 212.67/212.88  |- mesh__dateEstablished mesh__D019015 1996-01-01
% 212.67/212.88  |- skos__hiddenLabel mesh__D019015 Marine Sediments
% 212.67/212.88  |- mesh__historyNote mesh__D019015 96   
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011032 2006
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011032 2000
% 212.67/212.88  |- skos__related mesh__D011032smesh__D005534
% 212.67/212.88  |- mesh__dateCreated mesh__D011032 1999-01-01
% 212.67/212.88  |- mesh__recordMaintainer mesh__D011032 PLS
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011032 2001
% 212.67/212.88  |- rdf__type mesh__D011032sskos__Concept
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011032 1996
% 212.67/212.88  |- skos__annotation mesh__D011032
% 212.67/212.88       SPEC: SPEC qualif; for /educ, coord with med educ terms permitted%A%  
% 212.67/212.88  |- skos__prefLabel mesh__D011032 Podiatry
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011032 1998
% 212.67/212.88  |- skos__scopeNote mesh__D011032
% 212.67/212.88       A specialty concerned with the diagnosis and treatment of foot disorders and injuries and anatomic defects of the foot.%A%    
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011032 1992
% 212.67/212.88  |- mesh__dateRevised mesh__D011032 1991-05-28
% 212.67/212.88  |- skos__broader mesh__D011032smesh__D006281
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011032 2002
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011032 1997
% 212.67/212.88  |- skos__altLabel mesh__D011032 Chiropody
% 212.67/212.88  |- mesh__recordOriginator mesh__D011032 NLM
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011032 1994
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011032 1999
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011032 2003
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011032 1993
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011032 2005
% 212.67/212.88  |- mesh__recordAuthorizer mesh__D011032 PLS
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011032 1995
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011032 2004
% 212.67/212.88  |- mesh__historyNote mesh__D010738
% 212.67/212.88       86%28%80%29%; was see under PHOSPHOLIPASES 1980-85   
% 212.67/212.88  |- mesh__dateEstablished mesh__D010738 1986-01-01
% 212.67/212.88  |- skos__scopeNote mesh__D010738
% 212.67/212.88       An enzyme found in the alpha-toxin of Clostridium welchii and other strains of clostridia and bacilli. It hydrolyzes glycerophosphatidates with the formation of 1,2-diacylglycerol and a phosphorylated nitrogenous base such as choline. EC 3.1.4.3.%A%    
% 212.67/212.88  |- skos__altLabel mesh__D010738 Lecithinase C
% 212.67/212.88  |- mesh__publicMeSHNote mesh__D010738
% 212.67/212.88       86; was see under PHOSPHOLIPASES 1980-85   
% 212.67/212.88  |- skos__annotation mesh__D010738
% 212.67/212.88       note specific phospholipase C terms at PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE%A%  
% 212.67/212.88  |- skos__hiddenLabel mesh__D010738 alpha Toxin
% 212.67/212.88  |- mesh__dateCreated mesh__D010738 1979-02-22
% 212.67/212.88  |- rdf__type mesh__D010738sskos__Concept
% 212.67/212.88  |- skos__historyNote mesh__D010738 Phospholipases %28%1966-1979%29%
% 212.67/212.88  |- mesh__recordOriginator mesh__D010738 RLS
% 212.67/212.88  |- mesh__dateRevised mesh__D010738 2003-07-09
% 212.67/212.88  |- mesh__recordMaintainer mesh__D010738 ssb
% 212.67/212.88  |- skos__broader mesh__D010738smesh__D010740
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D010738 2005
% 212.67/212.88  |- mesh__recordAuthorizer mesh__D010738 sjn
% 212.67/212.88  |- skos__prefLabel mesh__D010738 Phospholipase C
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D010738 2004
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D010738 2006
% 212.67/212.88  |- skos__hiddenLabel mesh__D015423 Scleritis, Necrotizing
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D015423 2000
% 212.67/212.88  |- mesh__dateEstablished mesh__D015423 1989-01-01
% 212.67/212.88  |- mesh__recordMaintainer mesh__D015423 TGC
% 212.67/212.88  |- skos__hiddenLabel mesh__D015423 Episcleritides
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D015423 2003
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D015423 2001
% 212.67/212.88  |- mesh__publicMeSHNote mesh__D015423 89   
% 212.67/212.88  |- skos__annotation mesh__D015423
% 212.67/212.88       inflamm of sclera; note X ref EPISCLERITIS   
% 212.67/212.88  |- mesh__dateRevised mesh__D015423 1993-06-03
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D015423 2005
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D015423 2004
% 212.67/212.88  |- skos__hiddenLabel mesh__D015423 Scleritides, Necrotizing
% 212.67/212.88  |- skos__broader mesh__D015423smesh__D015422
% 212.67/212.88  |- skos__historyNote mesh__D015423 Sclera %28%1966-1988%29%
% 212.67/212.88  |- skos__hiddenLabel mesh__D015423 Necrotizing Scleritides
% 212.67/212.88  |- skos__scopeNote mesh__D015423
% 212.67/212.88       Refers to any inflammation of the sclera including episcleritis, a benign condition affecting only the episclera, which is generally short-lived and easily treated. Classic scleritis, on the other hand, affects deeper tissue and is characterized by higher rates of visual acuity loss and even mortality, particularly in necrotizing form. Its characteristic symptom is severe and general head pain. Scleritis has also been associated with systemic collagen disease. Etiology is unknown but is thought to involve a local immune response. Treatment is difficult and includes administration of anti-inflammatory and immunosuppressive agents such as corticosteroids. Inflammation of the sclera may also be secondary to inflammation of adjacent tissues, such as the conjunctiva.%A%    
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D015423 2006
% 212.67/212.88  |- mesh__recordOriginator mesh__D015423 WDJ
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D015423 1996
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D015423 2002
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D015423 1998
% 212.67/212.88  |- skos__historyNote mesh__D015423 Inflammation %28%1966-1988%29%
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D015423 1997
% 212.67/212.88  |- mesh__historyNote mesh__D015423 89   
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D015423 1994
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D015423 1999
% 212.67/212.88  |- mesh__recordAuthorizer mesh__D015423 PLS
% 212.67/212.88  |- mesh__dateCreated mesh__D015423 1988-06-07
% 212.67/212.88  |- skos__prefLabel mesh__D015423 Scleritis
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D015423 1995
% 212.67/212.88  |- skos__hiddenLabel mesh__D015423 Scleritides
% 212.67/212.88  |- rdf__type mesh__D015423sskos__Concept
% 212.67/212.88  |- skos__scopeNote mesh__D001403
% 212.67/212.88       A genus of tick-borne protozoan parasites that infests the red blood cells of mammals, including humans. There are many recognized species, and the distribution is world-wide.%A%    
% 212.67/212.88  |- skos__prefLabel mesh__D001403 Babesia
% 212.67/212.88  |- mesh__dateEstablished mesh__D001403 1974-01-01
% 212.67/212.88  |- skos__altLabel mesh__D001403 Piroplasma
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D001403 2004
% 212.67/212.88  |- skos__annotation mesh__D001403
% 212.67/212.88       infection = BABESIOSIS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 212.67/212.88  |- mesh__recordMaintainer mesh__D001403 ags
% 212.67/212.88  |- skos__broader mesh__D001403smesh__D016792
% 212.67/212.88  |- mesh__recordOriginator mesh__D001403 NLM
% 212.67/212.88  |- mesh__publicMeSHNote mesh__D001403 74   
% 212.67/212.88  |- mesh__dateRevised mesh__D001403 2003-07-09
% 212.67/212.88  |- mesh__historyNote mesh__D001403 74   
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D001403 2005
% 212.67/212.88  |- mesh__dateCreated mesh__D001403 1999-01-01
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D001403 2006
% 212.67/212.88  |- mesh__recordAuthorizer mesh__D001403 sjn
% 212.67/212.88  |- rdf__type mesh__D001403sskos__Concept
% 212.67/212.88  |- skos__broader mesh__D006697smesh__D008387
% 212.67/212.88  |- mesh__publicMeSHNote mesh__D006697 91; was see under SAPONINS 1975-90   
% 212.67/212.88  |- skos__historyNote mesh__D006697 Saponins %28%1970-1974%29%
% 212.67/212.88  |- skos__annotation mesh__D006697
% 212.67/212.88       /antag permitted but consider also ANTITOXINS   
% 212.67/212.88  |- skos__prefLabel mesh__D006697 Holothurin
% 212.67/212.88  |- mesh__recordMaintainer mesh__D006697 ssb
% 212.67/212.88  |- mesh__dateCreated mesh__D006697 1974-11-19
% 212.67/212.88  |- mesh__recordAuthorizer mesh__D006697 sjn
% 212.67/212.88  |- mesh__recordOriginator mesh__D006697 NLM
% 212.67/212.88  |- mesh__dateRevised mesh__D006697 2005-06-30
% 212.67/212.88  |- rdf__type mesh__D006697sskos__Concept
% 212.67/212.88  |- skos__scopeNote mesh__D006697
% 212.67/212.88       A highly toxic saponin occurring in HOLOTHUROIDEA. This marine toxin is an anionic surfactant, hemolyzing ERYTHROCYTES.%A%    
% 212.67/212.88  |- skos__historyNote mesh__D006697 Toxins %28%1970-1974%29%
% 212.67/212.88  |- mesh__dateEstablished mesh__D006697 1991-01-01
% 212.67/212.88  |- mesh__historyNote mesh__D006697
% 212.67/212.88       91%28%75%29%; was see under SAPONINS 1975-90   
% 212.67/212.88  |- skos__historyNote mesh__D006697 Steroids %28%1972-1974%29%
% 212.67/212.88  |- skos__broader mesh__D006697smesh__D012503
% 212.67/212.88  |- skos__historyNote mesh__D006697 Echinodermata %28%1970-1974%29%
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D006697 2006
% 212.67/212.88  |- mesh__dateEstablished mesh__D019814 1998-01-01
% 212.67/212.88  |- mesh__publicMeSHNote mesh__D019814
% 212.67/212.88       98; MYRISTIC ACID was indexed under MYRISTIC ACIDS 1982-97%A%  
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019814 2005A
% 212.67/212.88  |- mesh__dateRevised mesh__D019814 2004-07-29
% 212.67/212.88  |- skos__hiddenLabel mesh__D019814 Acid, Myristic
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019814 2005
% 212.67/212.88  |- mesh__recordAuthorizer mesh__D019814 jls
% 212.67/212.88  |- skos__altLabel mesh__D019814 Tetradecanoic Acid
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019814 2004
% 212.67/212.88  |- skos__hiddenLabel mesh__D019814 Acid, Tetradecanoic
% 212.67/212.88  |- skos__prefLabel mesh__D019814 Myristic Acid
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019814 2006
% 212.67/212.88  |- mesh__recordOriginator mesh__D019814 ADP
% 212.67/212.88  |- skos__historyNote mesh__D019814 Myristic Acids %28%1982-1997%29%
% 212.67/212.88  |- mesh__recordMaintainer mesh__D019814 jls
% 212.67/212.88  |- mesh__dateCreated mesh__D019814 1997-06-20
% 212.67/212.88  |- rdf__type mesh__D019814sskos__Concept
% 212.67/212.88  |- skos__broader mesh__D019814smesh__D009227
% 212.67/212.88  |- mesh__historyNote mesh__D019814
% 212.67/212.88       98; use MYRISTIC ACID %28%NM%29% 1982-97   
% 212.67/212.88  |- skos__scopeNote mesh__D019814
% 212.67/212.88       A saturated 14-carbon fatty acid occurring in most animal and vegetable fats, particularly butterfat and coconut, palm, and nutmeg oils. It is used to synthesize flavor and as an ingredient in soaps and cosmetics. %28%From Dorland, 28th ed%29%%A%    
% 212.67/212.88  |- mesh__dateRevised mesh__D011831 2002-07-03
% 212.67/212.88  |- skos__prefLabel mesh__D011831 Radiation Genetics
% 212.67/212.88  |- mesh__recordMaintainer mesh__D011831 nns
% 212.67/212.88  |- skos__annotation mesh__D011831
% 212.67/212.88       SPEC or GEN; prefer specifics: Manual 28.22.5   
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011831 2005
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011831 2003
% 212.67/212.88  |- skos__altLabel mesh__D011831 Genetics, Radiation
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011831 2006
% 212.67/212.88  |- skos__broader mesh__D011831smesh__D011870
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011831 2004
% 212.67/212.88  |- skos__scopeNote mesh__D011831
% 212.67/212.88       A subdiscipline of genetics that studies RADIATION EFFECTS on the components and processes of biological inheritance.%A%    
% 212.67/212.88  |- mesh__recordOriginator mesh__D011831 NLM
% 212.67/212.88  |- skos__broader mesh__D011831smesh__D005823
% 212.67/212.88  |- mesh__dateCreated mesh__D011831 1999-01-01
% 212.67/212.88  |- skos__related mesh__D011831smesh__D011830
% 212.67/212.88  |- mesh__recordAuthorizer mesh__D011831 sjn
% 212.67/212.88  |- rdf__type mesh__D011831sskos__Concept
% 212.67/212.88  |- mesh__recordOriginator mesh__D019016 TGC
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019016 2006A
% 212.67/212.88  |- mesh__dateEstablished mesh__D019016 1996-01-01
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019016 2004
% 212.67/212.88  |- skos__scopeNote mesh__D019016
% 212.67/212.88       Long, pliable, cohesive natural or manufactured filaments of various lengths. They form the structure of some minerals. The medical significance lies in their potential ability to cause various types of PNEUMOCONIOSIS %28%e.g., ASBESTOSIS%29% after occupational or environmental exposure. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p708%29%%A%    
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019016 2005
% 212.67/212.88  |- skos__prefLabel mesh__D019016 Mineral Fibers
% 212.67/212.88  |- mesh__dateCreated mesh__D019016 1995-06-29
% 212.67/212.88  |- mesh__recordAuthorizer mesh__D019016 ags
% 212.67/212.88  |- skos__broader mesh__D019016smesh__D008903
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019016 2006
% 212.67/212.88  |- skos__annotation mesh__D019016
% 212.67/212.88       restrict to minerals; emphasis is on the filamentous structure; IM GEN or unspecified only; coord NIM with specific mineral or material %28%IM%29%, as asbestos fibers = MINERAL FIBERS %28%NIM%29% + ASBESTOS %28%IM%29%; not for textile fibers %28% = TEXTILES or specific textile such as COTTON FIBER; WOOL; or NYLON%29%; not for fiberglass %28% = GLASS%29%; /adv eff: consider also specific pneumoconioses, such as ASBESTOSIS%A%  
% 212.67/212.88  |- skos__related mesh__D019016smesh__D011009
% 212.67/212.88  |- rdf__type mesh__D019016sskos__Concept
% 212.67/212.88  |- mesh__publicMeSHNote mesh__D019016 96   
% 212.67/212.88  |- skos__historyNote mesh__D019016 Minerals %28%1966-1995%29%
% 212.67/212.88  |- skos__altLabel mesh__D019016 Mineral Fiber
% 212.67/212.88  |- mesh__historyNote mesh__D019016 96   
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019016 2002
% 212.67/212.88  |- skos__hiddenLabel mesh__D019016 Fibers, Mineral
% 212.67/212.88  |- skos__hiddenLabel mesh__D019016 Fiber, Mineral
% 212.67/212.88  |- mesh__recordMaintainer mesh__D019016 ags
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D019016 2003
% 212.67/212.88  |- mesh__dateRevised mesh__D019016 2005-07-12
% 212.67/212.88  |- mesh__recordOriginator mesh__D011033 NLM
% 212.67/212.88  |- skos__broader mesh__D011033smesh__D010936
% 212.67/212.88  |- mesh__onlineNote mesh__D011033 search PODOPHYLLUM 1966-71   
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D011033 2006
% 212.67/212.88  |- mesh__dateEstablished mesh__D011033 1972-01-01
% 212.67/212.88  |- skos__hiddenLabel mesh__D011033 Resin, Podophyllum
% 212.67/212.88  |- mesh__dateCreated mesh__D011033 1999-01-01
% 212.67/212.88  |- mesh__historyNote mesh__D011033
% 212.67/212.88       72%28%64%29%; was see under PODOPHYLLUM 1963-71   
% 212.67/212.88  |- mesh__recordAuthorizer mesh__D011033 sjn
% 212.67/212.88  |- rdf__type mesh__D011033sskos__Concept
% 212.67/212.88  |- skos__altLabel mesh__D011033 Podophyllum Resin
% 212.67/212.88  |- mesh__dateRevised mesh__D011033 2005-06-30
% 212.67/212.88  |- skos__prefLabel mesh__D011033 Podophyllin
% 212.67/212.88  |- mesh__recordMaintainer mesh__D011033 ssb
% 212.67/212.88  |- skos__scopeNote mesh__D011033
% 212.67/212.88       Caustic extract from the roots of Podophyllum peltatum and P. emodi. It contains PODOPHYLLOTOXIN and its congeners and is very irritating to mucous membranes and skin. Podophyllin is a violent purgative that may cause CNS damage and teratogenesis. It is used as a paint for warts, skin neoplasms, and senile keratoses.%A%    
% 212.67/212.88  |- mesh__publicMeSHNote mesh__D011033
% 212.67/212.88       72; was see under PODOPHYLLUM 1963-71   
% 212.67/212.88  |- skos__related mesh__D035481smesh__D028781
% 212.67/212.88  |- skos__related mesh__D035481smesh__D028743
% 212.67/212.88  |- skos__broader mesh__D035481smesh__D026689
% 212.67/212.88  |- skos__scopeNote mesh__D035481
% 212.67/212.88       The application of current standards of morality to past actions, institutions, or persons.%A%    
% 212.67/212.88  |- skos__historyNote mesh__D035481 Morals %28%1997-2002%29%
% 212.67/212.88  |- mesh__dateEstablished mesh__D035481 2003-01-01
% 212.67/212.88  |- mesh__dateCreated mesh__D035481 2002-07-03
% 212.67/212.88  |- rdf__type mesh__D035481sskos__Concept
% 212.67/212.88  |- mesh__historyNote mesh__D035481 2003   
% 212.67/212.88  |- skos__prefLabel mesh__D035481 Retrospective Moral Judgment
% 212.67/212.88  |- skos__hiddenLabel mesh__D035481 Retrospective Moral Judgments
% 212.67/212.88  |- skos__hiddenLabel mesh__D035481 Judgment, Retrospective Moral
% 212.67/212.88  |- mesh__publicMeSHNote mesh__D035481 2003   
% 212.67/212.88  |- skos__altLabel mesh__D035481 Moral Judgment, Retrospective
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D035481 2004
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D035481 2006
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D035481 2003
% 212.67/212.88  |- skos__hiddenLabel mesh__D035481 Moral Judgments, Retrospective
% 212.67/212.88  |- skos__hiddenLabel mesh__D035481 Judgments, Retrospective Moral
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D035481 2005
% 212.67/212.88  |- skos__related mesh__D035481smesh__D009014
% 212.67/212.88  |- mesh__dateRevised mesh__D007790 2004-07-07
% 212.67/212.88  |- rdf__type mesh__D007790sskos__Concept
% 212.67/212.88  |- mesh__recordMaintainer mesh__D007790 ssb
% 212.67/212.88  |- skos__prefLabel mesh__D007790 Lactosylceramides
% 212.67/212.88  |- skos__historyNote mesh__D007790 Cerebrosides %28%1966-1978%29%
% 212.67/212.88  |- skos__hiddenLabel mesh__D007790 Ceramides, Lactosyl
% 212.67/212.88  |- skos__altLabel mesh__D007790 Lactosyl Ceramides
% 212.67/212.88  |- mesh__publicMeSHNote mesh__D007790
% 212.67/212.88       91; was see under GLYCOSPHINGOLIPIDS 1979-90   
% 212.67/212.88  |- skos__historyNote mesh__D007790 Ceramides %28%1972-1978%29%
% 212.67/212.88  |- skos__scopeNote mesh__D007790
% 212.67/212.88       Glycosphingolipids which contain as their polar head group a lactose moiety bound in glycosidic linkage to the hydroxyl group of ceramide. Their accumulation in tissue, due to a defect in lactosylceramide beta-galactosidase, is the cause of lactosylceramidosis.%A%    
% 212.67/212.88  |- mesh__recordOriginator mesh__D007790 RLS
% 212.67/212.88  |- mesh__recordAuthorizer mesh__D007790 sjn
% 212.67/212.88  |- mesh__dateEstablished mesh__D007790 1991-01-01
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D007790 2006
% 212.67/212.88  |- skos__broader mesh__D007790smesh__D002518
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D007790 2005
% 212.67/212.88  |- mesh__dateCreated mesh__D007790 1978-05-16
% 212.67/212.88  |- skos__historyNote mesh__D007790 Glycosphingolipids %28%1975-1978%29%
% 212.67/212.88  |- skos__annotation mesh__D007790 /biosyn /physiol permitted   
% 212.67/212.88  |- mesh__historyNote mesh__D007790
% 212.67/212.88       91%28%79%29%; was see under GLYCOSPHINGOLIPIDS 1979-90   
% 212.67/212.88  |- mesh__recordMaintainer mesh__D010739 ssb
% 212.67/212.88  |- rdf__type mesh__D010739sskos__Concept
% 212.67/212.88  |- skos__broader mesh__D010739smesh__D010740
% 212.67/212.88  |- mesh__recordAuthorizer mesh__D010739 sjn
% 212.67/212.88  |- mesh__publicMeSHNote mesh__D010739
% 212.67/212.88       91; was see under PHOSPHOLIPASES 1980-90   
% 212.67/212.88  |- mesh__historyNote mesh__D010739
% 212.67/212.88       91%28%80%29%; was see under PHOSPHOLIPASES 1980-90   
% 212.67/212.88  |- skos__prefLabel mesh__D010739 Phospholipase D
% 212.67/212.88  |- mesh__dateRevised mesh__D010739 2003-07-09
% 212.67/212.88  |- skos__historyNote mesh__D010739 Phospholipases %28%1966-1979%29%
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D010739 2005
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D010739 2004
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D010739 2006
% 212.67/212.88  |- mesh__dateEstablished mesh__D010739 1991-01-01
% 212.67/212.88  |- skos__altLabel mesh__D010739 Phosphatidylcholine Phosphohydrolase
% 212.67/212.88  |- mesh__recordOriginator mesh__D010739 RLS
% 212.67/212.88  |- skos__altLabel mesh__D010739 Lecithinase D
% 212.67/212.88  |- skos__scopeNote mesh__D010739
% 212.67/212.88       An enzyme found mostly in plant tissue. It hydrolyzes glycerophosphatidates with the formation of a phosphatidic acid and a nitrogenous base such as choline. This enzyme also catalyzes transphosphatidylation reactions. EC 3.1.4.4.%A%    
% 212.67/212.88  |- mesh__dateCreated mesh__D010739 1979-02-22
% 212.67/212.88  |- mesh__historyNote mesh__D021461 2001   
% 212.67/212.88  |- skos__altLabel mesh__D021461 Outbred Animal Strains
% 212.67/212.88  |- skos__hiddenLabel mesh__D021461 Outbred Strain, Animals
% 212.67/212.88  |- skos__altLabel mesh__D021461 Outbred Strains of Animals
% 212.67/212.88  |- skos__hiddenLabel mesh__D021461 Strain, Animals Outbred
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D021461 2006
% 212.67/212.88  |- rdf__type mesh__D021461sskos__Concept
% 212.67/212.88  |- skos__scopeNote mesh__D021461
% 212.67/212.88       Animals that are generated from breeding two genetically dissimilar strains of the same species.%A%    
% 212.67/212.88  |- skos__prefLabel mesh__D021461 Animals, Outbred Strains
% 212.67/212.88  |- skos__hiddenLabel mesh__D021461 Strains Animals, Outbred
% 212.67/212.88  |- skos__hiddenLabel mesh__D021461 Animal Outbred Strain
% 212.67/212.88  |- skos__hiddenLabel mesh__D021461 Animal Strains, Outbred
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D021461 2005
% 212.67/212.88  |- skos__annotation mesh__D021461
% 212.67/212.88       IM GEN or unspecified; coord NIM with specific animal probably NIM%A%  
% 212.67/212.88  |- skos__hiddenLabel mesh__D021461 Animals Outbred Strain
% 212.67/212.88  |- mesh__dateCreated mesh__D021461 2000-06-21
% 212.67/212.88  |- mesh__dateEstablished mesh__D021461 2001-01-01
% 212.67/212.88  |- skos__hiddenLabel mesh__D021461 Outbred Strains Animals
% 212.67/212.88  |- skos__altLabel mesh__D021461 Outbred Strain of Animal
% 212.67/212.88  |- skos__hiddenLabel mesh__D021461 Strains, Outbred Animal
% 212.67/212.88  |- mesh__activeMeSHYear mesh__D021461 2004
% 212.67/212.88  |- skos__hiddenLabel mesh__D021461 Strain, Outbred Animal
% 212.67/212.88  |- skos__hiddenLabel mesh__D021461 Animal Outbred Strains
% 212.67/212.88  |- mesh__dateRevised mesh__D021461 2003-07-09
% 212.67/212.88  |- skos__hiddenLabel mesh__D021461 Animal Strain, Outbred
% 212.67/212.88  |- skos__broader mesh__D021461smesh__D000828
% 212.67/212.88  |- skos__hiddenLabel mesh__D021461 Animal, Outbred Strains
% 212.67/212.88  |- mesh__publicMeSHNote mesh__D021461 2001   
% 212.67/212.88  |- skos__hiddenLabel mesh__D021461 Outbred Animal Strain
% 212.67/212.88  |- skos__hiddenLabel mesh__D021461 Strains, Animals Outbred
% 212.67/212.89  |- skos__hiddenLabel mesh__D021461 Strains Animal, Outbred
% 212.67/212.89  |- skos__hiddenLabel mesh__D021461 Animals Outbred Strains
% 212.67/212.89  |- skos__hiddenLabel mesh__D021461 Outbred Strains Animal
% 212.67/212.89  |- skos__altLabel mesh__D021461 Outbred Strains, Animals
% 212.67/212.89  |- skos__historyNote mesh__D015424 Ischemia %28%1969-1988%29%
% 212.67/212.89  |- mesh__activeMeSHYear mesh__D015424 2003
% 212.67/212.89  |- mesh__publicMeSHNote mesh__D015424 89   
% 212.67/212.89  |- skos__prefLabel mesh__D015424 Reperfusion
% 212.67/212.89  |- mesh__recordAuthorizer mesh__D015424 SJN
% 212.67/212.89  |- mesh__dateCreated mesh__D015424 1988-06-07
% 212.67/212.89  |- mesh__activeMeSHYear mesh__D015424 2005
% 212.67/212.89  |- skos__hiddenLabel mesh__D015424 Reperfusions
% 212.67/212.89  |- mesh__recordMaintainer mesh__D015424 PXP
% 212.67/212.89  |- skos__historyNote mesh__D015424
% 212.67/212.89       specific organ/blood supply %28%1976-1988%29%
% 212.67/212.89  |- mesh__activeMeSHYear mesh__D015424 2004
% 212.67/212.89  |- mesh__activeMeSHYear mesh__D015424 2006
% 212.67/212.89  |- mesh__activeMeSHYear mesh__D015424 2000
% 212.67/212.89  |- skos__broader mesh__D015424smesh__D013504
% 212.67/212.89  |- skos__scopeNote mesh__D015424
% 212.67/212.89       Restoration of blood supply to tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. It is primarily a procedure for treating infarction or other ischemia, by enabling viable ischemic tissue to recover, thus limiting further necrosis. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing REPERFUSION INJURY.%A%    
% 212.67/212.89  |- mesh__activeMeSHYear mesh__D015424 2001
% 212.67/212.89  |- mesh__activeMeSHYear mesh__D015424 1998
% 212.67/212.89  |- skos__broader mesh__D015424smesh__D010477
% 212.67/212.89  |- skos__historyNote mesh__D015424 Perfusion %28%1968-1988%29%
% 212.67/212.89  |- mesh__activeMeSHYear mesh__D015424 1999
% 212.67/212.89  |- mesh__recordOriginator mesh__D015424 WDJ
% 212.67/212.89  |- rdf__type mesh__D015424sskos__Concept
% 212.67/212.89  |- mesh__activeMeSHYear mesh__D015424 2002
% 212.67/212.89  |- skos__annotation mesh__D015424
% 212.67/212.89       note category: a technique; /adv eff permitted but consider also REPERFUSION INJURY; MYOCARDIAL REPERFUSION is also available%A%  
% 212.67/212.89  |- mesh__dateEstablished mesh__D015424 1989-01-01
% 212.67/212.89  |- mesh__dateRevised mesh__D015424 1997-06-20
% 212.67/212.89  |- mesh__historyNote mesh__D015424 89   
% 212.67/212.89  |- skos__historyNote mesh__D001404 Protozoan Infections %28%1966-1967%29%
% 212.67/212.89  |- mesh__recordMaintainer mesh__D001404 ags
% 212.67/212.89  |- mesh__recordAuthorizer mesh__D001404 sjn
% 212.67/212.89  |- mesh__publicMeSHNote mesh__D001404 82; was BABESIASIS 1968-81   
% 212.67/212.89  |- mesh__dateRevised mesh__D001404 2003-07-09
% 212.67/212.89  |- mesh__onlineNote mesh__D001404
% 212.67/212.89       use BABESIOSIS to search BABESIASIS 1968-81   
% 212.67/212.89  |- skos__hiddenLabel mesh__D001404 Babesioses
% 212.67/212.89  |- skos__hiddenLabel mesh__D001404 Babesiases
% 212.67/212.89  |- skos__broader mesh__D001404smesh__D010273
% 212.67/212.89  |- mesh__activeMeSHYear mesh__D001404 2005
% 212.67/212.89  |- mesh__historyNote mesh__D001404 82; was BABESIASIS 1968-81   
% 212.67/212.89  |- mesh__dateCreated mesh__D001404 1999-01-01
% 212.67/212.89  |- skos__scopeNote mesh__D001404
% 212.67/212.89       A group of tick-borne diseases of mammals including ZOONOSES in humans. They are caused by PROTOZOANS of the genus BABESIA, which parasitize erythrocytes, producing hemolysis. In the U.S., the organism%27%s natural host is mice and transmission is by the deer tick IXODES SCAPULARIS.%A%    
% 212.67/212.89  |- mesh__activeMeSHYear mesh__D001404 2006
% 212.67/212.89  |- mesh__recordOriginator mesh__D001404 NLM
% 212.67/212.89  |- skos__prefLabel mesh__D001404 Babesiosis
% 212.67/212.89  |- rdf__type mesh__D001404sskos__Concept
% 212.67/212.89  |- skos__hiddenLabel mesh__D001404 Piroplasmoses
% 212.67/212.89  |- skos__broader mesh__D001404smesh__D011529
% 212.67/212.89  |- skos__altLabel mesh__D001404 Babesiasis
% 212.67/212.89  |- skos__altLabel mesh__D001404 Piroplasmosis
% 212.67/212.89  |- skos__broader mesh__D001404smesh__D017282
% 212.67/212.89  |- mesh__activeMeSHYear mesh__D001404 2004
% 212.67/212.89  |- mesh__dateEstablished mesh__D001404 1968-01-01
% 212.67/212.89  |- skos__historyNote mesh__D006698 Ink Blot Tests %28%1966-1970%29%
% 212.67/212.89  |- mesh__activeMeSHYear mesh__D006698 1996
% 212.67/212.89  |- mesh__activeMeSHYear mesh__D006698 2000
% 212.67/212.89  |- skos__broader mesh__D006698smesh__D007282
% 212.67/212.89  |- skos__scopeNote mesh__D006698
% 212.67/212.89       Personality evaluation based on the scoring of several variables as a result of the subject%27%s responses in perceiving 47 inkblot plates.%A%    
% 212.67/212.89  |- rdf__type mesh__D006698sskos__Concept
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D006698 1995
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D006698 2002
% 212.75/212.89  |- mesh__recordMaintainer mesh__D006698 TAP
% 212.75/212.89  |- mesh__publicMeSHNote mesh__D006698
% 212.75/212.89       91; was see under INK BLOT TESTS 1971-90   
% 212.75/212.89  |- skos__hiddenLabel mesh__D006698 Test, Holtzman Inkblot
% 212.75/212.89  |- mesh__dateEstablished mesh__D006698 1991-01-01
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D006698 1994
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D006698 1993
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D006698 2006
% 212.75/212.89  |- mesh__dateCreated mesh__D006698 1999-01-01
% 212.75/212.89  |- skos__hiddenLabel mesh__D006698 Inkblot Test, Holtzman
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D006698 1999
% 212.75/212.89  |- mesh__historyNote mesh__D006698
% 212.75/212.89       91%28%71%29%; was see under INK BLOT TESTS 1971-90   
% 212.75/212.89  |- skos__prefLabel mesh__D006698 Holtzman Inkblot Test
% 212.75/212.89  |- mesh__dateRevised mesh__D006698 1992-05-15
% 212.75/212.89  |- mesh__recordAuthorizer mesh__D006698 PLS
% 212.75/212.89  |- mesh__onlineNote mesh__D006698 search INK BLOT TESTS 1969-70   
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D006698 2005
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D006698 2004
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D006698 2001
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D006698 1998
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D006698 1997
% 212.75/212.89  |- mesh__recordOriginator mesh__D006698 NLM
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D006698 2003
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D020369 2006
% 212.75/212.89  |- mesh__dateEstablished mesh__D020369 1999-01-01
% 212.75/212.89  |- skos__broader mesh__D020369smesh__D016946
% 212.75/212.89  |- skos__historyNote mesh__D020369 Rhizobium %28%1985-1998%29%
% 212.75/212.89  |- skos__historyNote mesh__D020369 Rhizobiaceae %28%1985-1998%29%
% 212.75/212.89  |- mesh__recordMaintainer mesh__D020369 SYSTEM
% 212.75/212.89  |- mesh__historyNote mesh__D020369 99   
% 212.75/212.89  |- mesh__publicMeSHNote mesh__D020369 99   
% 212.75/212.89  |- mesh__recordAuthorizer mesh__D020369 sjn
% 212.75/212.89  |- mesh__dateCreated mesh__D020369 1998-06-10
% 212.75/212.89  |- mesh__dateRevised mesh__D020369 2005-06-30
% 212.75/212.89  |- rdf__type mesh__D020369sskos__Concept
% 212.75/212.89  |- mesh__recordOriginator mesh__D020369 AGS
% 212.75/212.89  |- skos__prefLabel mesh__D020369 Bradyrhizobium
% 212.75/212.89  |- skos__broader mesh__D020369smesh__D041841
% 212.75/212.89  |- skos__scopeNote mesh__D020369
% 212.75/212.89       A genus of gram-negative, aerobic, rod-shaped bacteria usually containing granules of poly-beta-hydroxybutyrate. They characteristically invade the root hairs of leguminous plants and act as intracellular symbionts.%A%    
% 212.75/212.89  |- skos__prefLabel mesh__D019815 Oxalic Acid
% 212.75/212.89  |- skos__scopeNote mesh__D019815
% 212.75/212.89       A strong dicarboxylic acid occurring in many plants and vegetables. It is produced in the body by metabolism of glyoxylic acid or ascorbic acid. It is not metabolized but excreted in the urine. It is used as an analytical reagent and general reducing agent.%A%    
% 212.75/212.89  |- mesh__dateEstablished mesh__D019815 1999-01-01
% 212.75/212.89  |- skos__historyNote mesh__D019815 Oxalates %28%1979-1998%29%
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019815 2000
% 212.75/212.89  |- mesh__dateCreated mesh__D019815 1998-06-10
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019815 2003
% 212.75/212.89  |- mesh__historyNote mesh__D019815
% 212.75/212.89       99; use OXALIC ACID %28%NM%29% 1981-98   
% 212.75/212.89  |- skos__broader mesh__D019815smesh__D019816
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019815 2001
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019815 1999
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019815 2005
% 212.75/212.89  |- skos__hiddenLabel mesh__D019815 Acid, Oxalic
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019815 2004
% 212.75/212.89  |- rdf__type mesh__D019815sskos__Concept
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019815 2006
% 212.75/212.89  |- mesh__publicMeSHNote mesh__D019815
% 212.75/212.89       99; OXALIC ACID was indexed under OXALATES 1981-98   
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019815 2002
% 212.75/212.89  |- skos__hiddenLabel mesh__D011832 Radiation Sicknesses
% 212.75/212.89  |- skos__prefLabel mesh__D011832 Radiation Injuries
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D011832 2005
% 212.75/212.89  |- skos__broader mesh__D011832smesh__D014947
% 212.75/212.89  |- skos__hiddenLabel mesh__D011832 Radiation Injury
% 212.75/212.89  |- skos__scopeNote mesh__D011832
% 212.75/212.89       Harmful effects of non-experimental exposure to ionizing or non-ionizing radiation in chordates.%A%    
% 212.75/212.89  |- skos__hiddenLabel mesh__D011832 Sicknesses, Radiation
% 212.75/212.89  |- skos__hiddenLabel mesh__D011832 Radiation Syndromes
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D011832 2006
% 212.75/212.89  |- mesh__recordOriginator mesh__D011832 NLM
% 212.75/212.89  |- mesh__recordAuthorizer mesh__D011832 sjn
% 212.75/212.89  |- skos__broader mesh__D011832smesh__D011830
% 212.75/212.89  |- skos__hiddenLabel mesh__D011832 Syndrome, Radiation
% 212.75/212.89  |- skos__hiddenLabel mesh__D011832 Injury, Radiation
% 212.75/212.89  |- skos__related mesh__D011832smesh__D018788
% 212.75/212.89  |- mesh__dateRevised mesh__D011832 2004-07-13
% 212.75/212.89  |- mesh__dateCreated mesh__D011832 1999-01-01
% 212.75/212.89  |- rdf__type mesh__D011832sskos__Concept
% 212.75/212.89  |- skos__altLabel mesh__D011832 Injuries, Radiation
% 212.75/212.89  |- skos__annotation mesh__D011832
% 212.75/212.89       only Cat C qualif; human %26% vet animals only; exper animals = RADIATION INJURIES, EXPERIMENTAL, but only if B2: see note on RADIATION INJURIES, EXPERIMENTAL; Manual 28.12; radiations causing neopl = NEOPLASMS, RADIATION-INDUCED or LEUKEMIA, RADIATION-INDUCED, causing abnorm = ABNORMALITIES, RADIATION-INDUCED; OSTEORADIONECROSIS is available%A%  
% 212.75/212.89  |- mesh__dateEstablished mesh__D011832 1973-01-01
% 212.75/212.89  |- mesh__onlineNote mesh__D011832
% 212.75/212.89       use RADIATION INJURIES to search RADIATION INJURY 1966-72%A%  
% 212.75/212.89  |- mesh__recordMaintainer mesh__D011832 sjn
% 212.75/212.89  |- mesh__publicMeSHNote mesh__D011832 73; was RADIATION INJURY 1963-72   
% 212.75/212.89  |- skos__hiddenLabel mesh__D011832 Syndromes, Radiation
% 212.75/212.89  |- mesh__historyNote mesh__D011832 73; was RADIATION INJURY 1963-72   
% 212.75/212.89  |- skos__hiddenLabel mesh__D011832 Sickness, Radiation
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019017 1996
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019017 2004
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019017 2003
% 212.75/212.89  |- skos__scopeNote mesh__D019017
% 212.75/212.89       A country of eastern Africa, west of the Red Sea. In ancient times, it formed a part of many kingdoms at different periods. Its capital is Asmara. Under Italian rule from 1869 to 1890 and under the British as a protectorate until 1952, it was federated with Ethiopia in 1952 and was made one of its provinces in 1962. In 1991 Eritrea was established as a de facto independent state and became fully independent in 1993. The name Eritrea alludes to its location near the Red Sea since it comes from the Greek erythros, red. %28%From Webster%27%s New Geographical Dictionary, p376 %26% Information Section, Embassy of Eritrea, Washington, D.C., 1995; from Room, Brewer%27%s Dictionary of Names, 1992, p174%29%%A%    
% 212.75/212.89  |- skos__historyNote mesh__D019017 Ethiopia %28%1966-1995%29%
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019017 1999
% 212.75/212.89  |- skos__prefLabel mesh__D019017 Eritrea
% 212.75/212.89  |- mesh__dateEstablished mesh__D019017 1996-01-01
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019017 2002
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019017 1998
% 212.75/212.89  |- skos__annotation mesh__D019017
% 212.75/212.89       a country of eastern Africa, formerly a province of Ethiopia%A%  
% 212.75/212.89  |- mesh__dateCreated mesh__D019017 1995-05-26
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019017 2006
% 212.75/212.89  |- mesh__onlineNote mesh__D019017 use ETHIOPIA to search ERITREA 1975-95   
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019017 2001
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019017 1997
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019017 2005
% 212.75/212.89  |- rdf__type mesh__D019017sskos__Concept
% 212.75/212.89  |- mesh__historyNote mesh__D019017 96; was see ETHIOPIA 1975-95   
% 212.75/212.89  |- skos__broader mesh__D019017smesh__D000351
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019017 2000
% 212.75/212.89  |- mesh__onlineNote mesh__D011034
% 212.75/212.89       use PODOPHYLLOTOXIN to search EPIPODOPHYLLOTOXIN 1975   
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D011034 2006
% 212.75/212.89  |- skos__altLabel mesh__D011034 Podofilm
% 212.75/212.89  |- mesh__historyNote mesh__D011034
% 212.75/212.89       73; EPIPODOPHYLLOTOXIN was see under PODOPHYLLOTOXIN 1975%A%  
% 212.75/212.89  |- skos__altLabel mesh__D011034 Ardern Brand of Podophyllotoxin
% 212.75/212.89  |- mesh__dateCreated mesh__D011034 1999-01-01
% 212.75/212.89  |- skos__altLabel mesh__D011034 Canderm Brand of Podophyllotoxin
% 212.75/212.89  |- mesh__recordOriginator mesh__D011034 NLM
% 212.75/212.89  |- skos__altLabel mesh__D011034 Oclassen Brand of Podophyllotoxin
% 212.75/212.89  |- skos__broader mesh__D011034smesh__D017705
% 212.75/212.89  |- skos__altLabel mesh__D011034 Yamanouchi Brand of Podophyllotoxin
% 212.75/212.89  |- skos__altLabel mesh__D011034 Warticon
% 212.75/212.89  |- rdf__type mesh__D011034sskos__Concept
% 212.75/212.89  |- mesh__dateEstablished mesh__D011034 1973-01-01
% 212.75/212.89  |- skos__altLabel mesh__D011034 Hamilton Brand of Podophyllotoxin
% 212.75/212.89  |- skos__broader mesh__D011034smesh__D013764
% 212.75/212.89  |- skos__altLabel mesh__D011034 Fides Ecopharma Brand of Podophyllotoxin
% 212.75/212.89  |- skos__altLabel mesh__D011034 Wolff Brand of Podophyllotoxin
% 212.75/212.89  |- skos__historyNote mesh__D011034 Antineoplastic Agents %28%1966-1972%29%
% 212.75/212.89  |- skos__scopeNote mesh__D011034
% 212.75/212.89       A lignan %28%LIGNANS%29% found in PODOPHYLLIN resin from the roots of PODOPHYLLUM plants. It is a potent spindle poison, toxic if taken internally, and has been used as a cathartic. It is very irritating to skin and mucous membranes, has keratolytic actions, has been used to treat warts and keratoses, and may have antineoplastic properties, as do some of its congeners and derivatives.%A%    
% 212.75/212.89  |- skos__annotation mesh__D011034 /biosyn permitted if by plant   
% 212.75/212.89  |- mesh__publicMeSHNote mesh__D011034
% 212.75/212.89       73; EPIPODOPHYLLOTOXIN was see under PODOPHYLLOTOXIN 1975%A%  
% 212.75/212.89  |- skos__prefLabel mesh__D011034 Podophyllotoxin
% 212.75/212.89  |- mesh__recordAuthorizer mesh__D011034 sjn
% 212.75/212.89  |- skos__altLabel mesh__D011034 Podofilox
% 212.75/212.89  |- skos__altLabel mesh__D011034 Stiefel Brand of Podophyllotoxin
% 212.75/212.89  |- skos__altLabel mesh__D011034 Paddock Brand of Podophyllotoxin
% 212.75/212.89  |- skos__altLabel mesh__D011034 Newport Brand of Podophyllotoxin
% 212.75/212.89  |- skos__altLabel mesh__D011034 Paladin Brand of Podophyllotoxin
% 212.75/212.89  |- mesh__recordMaintainer mesh__D011034 lkw
% 212.75/212.89  |- skos__historyNote mesh__D011034 Alkaloids %28%1966-1972%29%
% 212.75/212.89  |- mesh__dateRevised mesh__D011034 2005-06-30
% 212.75/212.89  |- skos__hiddenLabel mesh__D007791 Glutathione Lyase, Lactoyl
% 212.75/212.89  |- skos__hiddenLabel mesh__D007791 Lyase, Lactoyl Glutathione
% 212.75/212.89  |- mesh__dateCreated mesh__D007791 1974-11-19
% 212.75/212.89  |- skos__altLabel mesh__D007791 Glyoxalase I
% 212.75/212.89  |- skos__altLabel mesh__D007791 Lactoyl Glutathione Lyase
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D007791 2006
% 212.75/212.89  |- skos__historyNote mesh__D007791 Glutathione %28%1973-1974%29%
% 212.75/212.89  |- mesh__publicMeSHNote mesh__D007791
% 212.75/212.89       98; see LACTOYL GLUTATHIONE LYASE 1991-97, see LYASES 1975-90%A%  
% 212.75/212.89  |- skos__altLabel mesh__D007791 Methylglyoxalase
% 212.75/212.89  |- mesh__dateEstablished mesh__D007791 1991-01-01
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D007791 2005
% 212.75/212.89  |- skos__prefLabel mesh__D007791 Lactoylglutathione Lyase
% 212.75/212.89  |- mesh__historyNote mesh__D007791 98%28%75%29%   
% 212.75/212.89  |- skos__broader mesh__D007791smesh__D013437
% 212.75/212.89  |- mesh__recordMaintainer mesh__D007791 ssb
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D007791 2004
% 212.75/212.89  |- skos__hiddenLabel mesh__D007791 I, Glyoxalase
% 212.75/212.89  |- skos__historyNote mesh__D007791 Lyases %28%1973-1974%29%
% 212.75/212.89  |- rdf__type mesh__D007791sskos__Concept
% 212.75/212.89  |- skos__scopeNote mesh__D007791
% 212.75/212.89       An enzyme that catalyzes the interconversion of methylglyoxal and lactate, with glutathione serving as a coenzyme. EC 4.4.1.5.%A%    
% 212.75/212.89  |- mesh__recordOriginator mesh__D007791 NLM
% 212.75/212.89  |- skos__historyNote mesh__D007791 Glyoxal %28%1974%29%
% 212.75/212.89  |- mesh__recordAuthorizer mesh__D007791 sjn
% 212.75/212.89  |- mesh__dateRevised mesh__D007791 2003-07-09
% 212.75/212.89  |- skos__hiddenLabel mesh__D007791 Lyase, Lactoylglutathione
% 212.75/212.89  |- skos__scopeNote mesh__D015425
% 212.75/212.89       Generally, restoration of blood supply to heart tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. Reperfusion can be induced to treat ischemia. Methods include chemical dissolution of an occluding thrombus, administration of vasodilator drugs, angioplasty, catheterization, and artery bypass graft surgery. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing MYOCARDIAL REPERFUSION INJURY.%A%    
% 212.75/212.89  |- skos__related mesh__D015425smesh__D019157
% 212.75/212.89  |- mesh__publicMeSHNote mesh__D015425 89   
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D015425 1998
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D015425 2001
% 212.75/212.89  |- mesh__recordAuthorizer mesh__D015425 SJN
% 212.75/212.89  |- skos__historyNote mesh__D015425 Myocardium/metabolism %28%1974-1988%29%
% 212.75/212.89  |- mesh__recordMaintainer mesh__D015425 PXP
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D015425 2004
% 212.75/212.89  |- skos__broader mesh__D015425smesh__D015424
% 212.75/212.89  |- mesh__recordOriginator mesh__D015425 WDJ
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D015425 2000
% 212.75/212.89  |- skos__hiddenLabel mesh__D015425 Reperfusions, Coronary
% 212.75/212.89  |- skos__altLabel mesh__D015425 Coronary Reperfusion
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D015425 2003
% 212.75/212.89  |- skos__historyNote mesh__D015425 Coronary Disease %28%1973-1988%29%
% 212.75/212.89  |- skos__historyNote mesh__D015425 Perfusion %28%1968-1988%29%
% 212.75/212.89  |- skos__hiddenLabel mesh__D015425 Reperfusions, Myocardial
% 212.75/212.89  |- skos__hiddenLabel mesh__D015425 Coronary Reperfusions
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D015425 2006
% 212.75/212.89  |- skos__historyNote mesh__D015425 Coronary Circulation %28%1973-1988%29%
% 212.75/212.89  |- skos__historyNote mesh__D015425 Myocardial Infarction %28%1972-1988%29%
% 212.75/212.89  |- mesh__historyNote mesh__D015425 89   
% 212.75/212.89  |- skos__prefLabel mesh__D015425 Myocardial Reperfusion
% 212.75/212.89  |- skos__hiddenLabel mesh__D015425 Reperfusion, Coronary
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D015425 2002
% 212.75/212.89  |- skos__historyNote mesh__D015425 Ischemia %28%1969-1988%29%
% 212.75/212.89  |- mesh__dateCreated mesh__D015425 1988-06-07
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D015425 2005
% 212.75/212.89  |- skos__related mesh__D015425smesh__D017682
% 212.75/212.89  |- skos__annotation mesh__D015425
% 212.75/212.89       note category: a technique; /adv eff permitted but consider also MYOCARDIAL REPERFUSION INJURY%A%  
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D015425 1999
% 212.75/212.89  |- skos__hiddenLabel mesh__D015425 Myocardial Reperfusions
% 212.75/212.89  |- mesh__dateEstablished mesh__D015425 1989-01-01
% 212.75/212.89  |- mesh__dateRevised mesh__D015425 1997-06-20
% 212.75/212.89  |- skos__altLabel mesh__D015425 Reperfusion, Myocardial
% 212.75/212.89  |- rdf__type mesh__D015425sskos__Concept
% 212.75/212.89  |- skos__altLabel mesh__D001405 Extensor Plantar Response
% 212.75/212.89  |- skos__hiddenLabel mesh__D001405 Babinski Signs
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D001405 2005
% 212.75/212.89  |- skos__hiddenLabel mesh__D001405 Responses, Extensor Plantar
% 212.75/212.89  |- skos__altLabel mesh__D001405 Great Toe Paradoxical Extensor Reflex
% 212.75/212.89  |- skos__altLabel mesh__D001405 Babinski Sign Positive
% 212.75/212.89  |- mesh__recordOriginator mesh__D001405 NLM
% 212.75/212.89  |- skos__hiddenLabel mesh__D001405 Reflex, Babinski%27%s
% 212.75/212.89  |- mesh__dateCreated mesh__D001405 1999-01-01
% 212.75/212.89  |- skos__hiddenLabel mesh__D001405 Reflex, Extensor Plantar
% 212.75/212.89  |- skos__altLabel mesh__D001405 Reflexes, Babinski
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D001405 2006
% 212.75/212.89  |- skos__hiddenLabel mesh__D001405 Extensor Plantar Responses
% 212.75/212.89  |- skos__broader mesh__D001405smesh__D012021
% 212.75/212.89  |- skos__altLabel mesh__D001405 Paradoxical Extensor Reflex, Great Toe
% 212.75/212.89  |- mesh__historyNote mesh__D001405 1991%28%1975%29%   
% 212.75/212.89  |- rdf__type mesh__D001405sskos__Concept
% 212.75/212.89  |- skos__altLabel mesh__D001405 Extensor Plantar Reflex
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D001405 2003
% 212.75/212.89  |- skos__hiddenLabel mesh__D001405 Plantar Response, Extensor
% 212.75/212.89  |- skos__hiddenLabel mesh__D001405 Plantar Reflex, Extensor
% 212.75/212.89  |- skos__altLabel mesh__D001405 Babinski%27%s Sign
% 212.75/212.89  |- mesh__recordAuthorizer mesh__D001405 sjn
% 212.75/212.89  |- skos__hiddenLabel mesh__D001405 Plantar Responses, Extensor
% 212.75/212.89  |- mesh__publicMeSHNote mesh__D001405
% 212.75/212.89       1991; see REFLEX 1990, see REFLEX, ABNORMAL 1975-1989   
% 212.75/212.89  |- skos__hiddenLabel mesh__D001405 Response, Extensor Plantar
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D001405 2004
% 212.75/212.89  |- mesh__dateEstablished mesh__D001405 1991-01-01
% 212.75/212.89  |- skos__altLabel mesh__D001405 Babinski Reflex
% 212.75/212.89  |- skos__scopeNote mesh__D001405
% 212.75/212.89       An abnormal reflex consisting of dorsiflexion of the great toe and abduction of the other toes in response to cutaneous stimulation of the plantar surface of the foot.%A%    
% 212.75/212.89  |- skos__hiddenLabel mesh__D001405 Babinski%27%s Signs
% 212.75/212.89  |- skos__altLabel mesh__D001405 Babinski Sign
% 212.75/212.89  |- skos__hiddenLabel mesh__D001405 Signs, Babinski%27%s
% 212.75/212.89  |- skos__altLabel mesh__D001405 Babinski Sign Negative
% 212.75/212.89  |- skos__altLabel mesh__D001405 Babinski Reflexes
% 212.75/212.89  |- skos__prefLabel mesh__D001405 Reflex, Babinski
% 212.75/212.89  |- mesh__recordMaintainer mesh__D001405 mdb
% 212.75/212.89  |- skos__altLabel mesh__D001405 Babinski%27%s Reflex
% 212.75/212.89  |- mesh__dateRevised mesh__D001405 2002-07-02
% 212.75/212.89  |- skos__prefLabel mesh__D006699 Home Care Services
% 212.75/212.89  |- mesh__dateCreated mesh__D006699 1977-12-07
% 212.75/212.89  |- mesh__recordAuthorizer mesh__D006699 sjn
% 212.75/212.89  |- mesh__recordMaintainer mesh__D006699 lkt
% 212.75/212.89  |- mesh__historyNote mesh__D006699 67; was HOME CARE SERVICE 1966   
% 212.75/212.89  |- skos__altLabel mesh__D006699 Services, Home Care
% 212.75/212.89  |- mesh__publicMeSHNote mesh__D006699 67; was HOME CARE SERVICE 1966   
% 212.75/212.89  |- skos__scopeNote mesh__D006699
% 212.75/212.89       Community health and NURSING SERVICES providing coordinated multiple services to the patient at the patient%27%s homes. These home-care services are provided by a visiting nurse, home health agencies, HOSPITALS, or organized community groups using professional staff for care delivery. It differs from HOME NURSING which is provided by non-professionals.%A%    
% 212.75/212.89  |- skos__hiddenLabel mesh__D006699 Service, Home Care
% 212.75/212.89  |- skos__hiddenLabel mesh__D006699 Care, Home
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D006699 2006
% 212.75/212.89  |- skos__broader mesh__D006699smesh__D009739
% 212.75/212.89  |- mesh__onlineNote mesh__D006699
% 212.75/212.89       use HOME CARE SERVICES to search HOME CARE SERVICE 1966   
% 212.75/212.89  |- mesh__dateRevised mesh__D006699 2003-07-09
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D006699 2004
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D006699 2005
% 212.75/212.89  |- skos__annotation mesh__D006699
% 212.75/212.89       IM; coord with specific home care %28%IM%29%; DF: HOME CARE SERV%A%  
% 212.75/212.89  |- skos__hiddenLabel mesh__D006699 Home Care Service
% 212.75/212.89  |- mesh__dateEstablished mesh__D006699 1966-01-01
% 212.75/212.89  |- mesh__recordOriginator mesh__D006699 EC
% 212.75/212.89  |- skos__broader mesh__D006699smesh__D003153
% 212.75/212.89  |- skos__hiddenLabel mesh__D006699 Care, Domiciliary
% 212.75/212.89  |- rdf__type mesh__D006699sskos__Concept
% 212.75/212.89  |- skos__altLabel mesh__D006699 Care Services, Home
% 212.75/212.89  |- skos__altLabel mesh__D006699 Domiciliary Care
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019816 2003
% 212.75/212.89  |- skos__scopeNote mesh__D019816
% 212.75/212.89       Acids, salts, and derivatives of OXALIC ACID.     
% 212.75/212.89  |- skos__historyNote mesh__D019816 Oxalates %28%1966-1998%29%
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019816 1999
% 212.75/212.89  |- mesh__historyNote mesh__D019816 99   
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019816 2005
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019816 2004
% 212.75/212.89  |- rdf__type mesh__D019816sskos__Concept
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019816 2002
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019816 2006
% 212.75/212.89  |- mesh__dateEstablished mesh__D019816 1999-01-01
% 212.75/212.89  |- skos__hiddenLabel mesh__D019816 Acids, Ethanedioic
% 212.75/212.89  |- skos__prefLabel mesh__D019816 Oxalic Acids
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019816 2000
% 212.75/212.89  |- mesh__dateCreated mesh__D019816 1998-06-10
% 212.75/212.89  |- mesh__publicMeSHNote mesh__D019816 99   
% 212.75/212.89  |- skos__hiddenLabel mesh__D019816 Acids, Oxalic
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019816 2001
% 212.75/212.89  |- skos__altLabel mesh__D019816 Ethanedioic Acids
% 212.75/212.89  |- skos__annotation mesh__D019816 OXALIC ACID is also available.   
% 212.75/212.89  |- skos__broader mesh__D019816smesh__D003998
% 212.75/212.89  |- mesh__recordMaintainer mesh__D011833 lkt
% 212.75/212.89  |- mesh__historyNote mesh__D011833
% 212.75/212.89       73; was RADIATION INJURY, EXPERIMENTAL 1963-72   
% 212.75/212.89  |- skos__hiddenLabel mesh__D011833 Experimental Radiation Injury
% 212.75/212.89  |- skos__broader mesh__D011833smesh__D011832
% 212.75/212.89  |- mesh__dateCreated mesh__D011833 1999-01-01
% 212.75/212.89  |- rdf__type mesh__D011833sskos__Concept
% 212.75/212.89  |- skos__altLabel mesh__D011833 Experimental Radiation Injuries
% 212.75/212.89  |- mesh__recordAuthorizer mesh__D011833 sjn
% 212.75/212.89  |- mesh__recordOriginator mesh__D011833 NLM
% 212.75/212.89  |- skos__hiddenLabel mesh__D011833 Radiation Injury, Experimental
% 212.75/212.89  |- skos__altLabel mesh__D011833 Injuries, Experimental Radiation
% 212.75/212.89  |- skos__broader mesh__D011833smesh__D004195
% 212.75/212.89  |- mesh__onlineNote mesh__D011833
% 212.75/212.89       use RADIATION INJURIES, EXPERIMENTAL to search RADIATION INJURY, EXPERIMENTAL 1966-72%A%  
% 212.75/212.89  |- skos__scopeNote mesh__D011833
% 212.75/212.89       Experimentally produced harmful effects of ionizing or non-ionizing RADIATION in CHORDATA animals.%A%    
% 212.75/212.89  |- skos__annotation mesh__D011833
% 212.75/212.89       for vertebrate animals only; %22%injuries%22% to insects, parasites, bacteria, viruses = RADIATION EFFECTS %28%general only%29% or specific organism /rad eff; Manual 28.12; radiations causing neoplasms = NEOPLASMS, RADIATION-INDUCED or LEUKEMIA, RADIATION-INDUCED, causing abnormalities = ABNORMALITIES, RADIATION-INDUCED; DF: RAD INJ EXPER%A%  
% 212.75/212.89  |- mesh__publicMeSHNote mesh__D011833
% 212.75/212.89       73; was RADIATION INJURY, EXPERIMENTAL 1963-72   
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D011833 2005
% 212.75/212.89  |- mesh__dateEstablished mesh__D011833 1973-01-01
% 212.75/212.89  |- skos__prefLabel mesh__D011833 Radiation Injuries, Experimental
% 212.75/212.89  |- mesh__dateRevised mesh__D011833 2004-07-07
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D011833 2006
% 212.75/212.89  |- mesh__dateRevised mesh__D019018 2004-07-13
% 212.75/212.89  |- mesh__recordAuthorizer mesh__D019018 sjn
% 212.75/212.89  |- skos__altLabel mesh__D019018 Imagery
% 212.75/212.89  |- mesh__recordOriginator mesh__D019018 TGC
% 212.75/212.89  |- skos__hiddenLabel mesh__D019018 Imageries %28%Psychotherapy%29%
% 212.75/212.89  |- mesh__recordMaintainer mesh__D019018 sjn
% 212.75/212.89  |- mesh__activeMeSHYear mesh__D019018 2006
% 212.75/212.89  |- skos__broader mesh__D019018smesh__D011613
% 212.75/212.89  |- skos__scopeNote mesh__D019018
% 212.75/212.89       The use of mental images produced by the imagination as a form of psychotherapy. It can be classified by the modality of its content: visual, verbal, auditory, olfactory, tactile, gustatory, or kinesthetic. Common themes derive from nature imagery %28%e.g., forests and mountains%29%, water imagery %28%e.g., brooks and oceans%29%, travel imagery, etc. Imagery is used in the treatment of mental disorders and in helping patients cope with other diseases. Imagery often forms a part of HYPNOSIS, of AUTOGENIC TRAINING, of RELAXATION TECHNIQUES, and of BEHAVIOR THERAPY. %28%From Encyclopedia of Human Behavior, vol. 4, pp29-30, 1994%29%%A%    
% 212.75/212.89  |- skos__prefLabel mesh__D019018 Imagery %28%Psychotherapy%29%
% 212.75/212.90  |- skos__altLabel mesh__D019018 Imagery, Guided
% 212.75/212.90  |- skos__broader mesh__D019018smesh__D026441
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D019018 2005
% 212.75/212.90  |- rdf__type mesh__D019018sskos__Concept
% 212.75/212.90  |- skos__hiddenLabel mesh__D019018 Directed Reverie Therapies
% 212.75/212.90  |- skos__altLabel mesh__D019018 Guided Imagery
% 212.75/212.90  |- skos__annotation mesh__D019018
% 212.75/212.90       a psychother technique; do not confuse with the imagery or mental images produced by the imagination %28% = IMAGINATION%29%; DF: IMAGERY%A%  
% 212.75/212.90  |- skos__hiddenLabel mesh__D019018 Therapy, Directed Reverie
% 212.75/212.90  |- mesh__dateEstablished mesh__D019018 1996-01-01
% 212.75/212.90  |- skos__hiddenLabel mesh__D019018 Reverie Therapies, Directed
% 212.75/212.90  |- mesh__publicMeSHNote mesh__D019018 96   
% 212.75/212.90  |- mesh__historyNote mesh__D019018 96   
% 212.75/212.90  |- mesh__dateCreated mesh__D019018 1995-06-08
% 212.75/212.90  |- skos__hiddenLabel mesh__D019018 Reverie Therapy, Directed
% 212.75/212.90  |- skos__historyNote mesh__D019018 Relaxation Techniques %28%1980-1995%29%
% 212.75/212.90  |- skos__hiddenLabel mesh__D019018 Therapies, Directed Reverie
% 212.75/212.90  |- rdf__type mesh__D011035sskos__Concept
% 212.75/212.90  |- skos__annotation mesh__D011035
% 212.75/212.90       plant only with PODOPHYLLIN the probable Cat D term;  prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.75/212.90  |- mesh__recordAuthorizer mesh__D011035 sjn
% 212.75/212.90  |- mesh__historyNote mesh__D011035
% 212.75/212.90       91%28%86%29%63; was see under PLANTS, TOXIC 1986-90; was heading 1963-85; was in Cat B %26% D 1963-77%A%  
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011035 2004
% 212.75/212.90  |- skos__related mesh__D011035smesh__D026781
% 212.75/212.90  |- mesh__recordMaintainer mesh__D011035 ssb
% 212.75/212.90  |- mesh__publicMeSHNote mesh__D011035
% 212.75/212.90       91; was see under PLANTS, TOXIC 1986-90; was heading 1963-85; was in Cat B %26% D 1963-77%A%  
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011035 2003
% 212.75/212.90  |- skos__broader mesh__D011035smesh__D028141
% 212.75/212.90  |- mesh__recordOriginator mesh__D011035 NLM
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011035 2006
% 212.75/212.90  |- mesh__dateRevised mesh__D011035 2001-07-25
% 212.75/212.90  |- skos__scopeNote mesh__D011035
% 212.75/212.90       A genus of poisonous American herbs, family BERBERIDACEAE. The roots yield PODOPHYLLOTOXIN and other pharmacologically important agents. The plant was formerly used as a cholagogue and cathartic. It is different from the European mandrake, MANDRAGORA.%A%    
% 212.75/212.90  |- mesh__dateCreated mesh__D011035 1999-01-01
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011035 2005
% 212.75/212.90  |- skos__prefLabel mesh__D011035 Podophyllum
% 212.75/212.90  |- mesh__dateEstablished mesh__D011035 1991-01-01
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011035 2002
% 212.75/212.90  |- mesh__recordAuthorizer mesh__D007792 sjn
% 212.75/212.90  |- mesh__dateEstablished mesh__D007792 1991-01-01
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D007792 2005
% 212.75/212.90  |- mesh__historyNote mesh__D007792
% 212.75/212.90       91%28%73%29%; was see under DISACCHARIDES 1973-90   
% 212.75/212.90  |- skos__annotation mesh__D007792 do not confuse with LACTOSE   
% 212.75/212.90  |- mesh__dateRevised mesh__D007792 2004-07-07
% 212.75/212.90  |- rdf__type mesh__D007792sskos__Concept
% 212.75/212.90  |- skos__scopeNote mesh__D007792
% 212.75/212.90       A synthetic disaccharide used in the treatment of constipation and hepatic encephalopathy. It has also been used in the diagnosis of gastrointestinal disorders. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p887%29%%A%    
% 212.75/212.90  |- mesh__recordMaintainer mesh__D007792 ssb
% 212.75/212.90  |- mesh__dateCreated mesh__D007792 1999-01-01
% 212.75/212.90  |- skos__prefLabel mesh__D007792 Lactulose
% 212.75/212.90  |- mesh__publicMeSHNote mesh__D007792
% 212.75/212.90       91; was see under DISACCHARIDES 1973-90   
% 212.75/212.90  |- skos__broader mesh__D007792smesh__D004187
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D007792 2006
% 212.75/212.90  |- mesh__recordOriginator mesh__D007792 NLM
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D001406 2006
% 212.75/212.90  |- skos__scopeNote mesh__D001406
% 212.75/212.90       A family of bacteria which produce endospores. They are mostly saprophytes from soil, but a few are insect or animal parasites or pathogens.%A%    
% 212.75/212.90  |- skos__prefLabel mesh__D001406 Bacillaceae
% 212.75/212.90  |- rdf__type mesh__D001406sskos__Concept
% 212.75/212.90  |- mesh__publicMeSHNote mesh__D001406 75   
% 212.75/212.90  |- mesh__recordOriginator mesh__D001406 NLM
% 212.75/212.90  |- mesh__dateRevised mesh__D001406 2005-06-30
% 212.75/212.90  |- skos__annotation mesh__D001406 pathogenic %26% non-pathogenic   
% 212.75/212.90  |- mesh__historyNote mesh__D001406 75   
% 212.75/212.90  |- mesh__recordAuthorizer mesh__D001406 sjn
% 212.75/212.90  |- skos__historyNote mesh__D001406 Bacteria %28%1966-1974%29%
% 212.75/212.90  |- skos__broader mesh__D001406smesh__D016937
% 212.75/212.90  |- mesh__dateEstablished mesh__D001406 1975-01-01
% 212.75/212.90  |- mesh__recordMaintainer mesh__D001406 SYSTEM
% 212.75/212.90  |- mesh__dateCreated mesh__D001406 1999-01-01
% 212.75/212.90  |- skos__prefLabel mesh__D047508 Massive Hepatic Necrosis
% 212.75/212.90  |- mesh__historyNote mesh__D047508 2005; use LIVER DISEASES 1997-2004   
% 212.75/212.90  |- skos__hiddenLabel mesh__D047508 Acute Yellow Atrophies
% 212.75/212.90  |- skos__hiddenLabel mesh__D047508 Yellow Atrophy, Acute
% 212.75/212.90  |- mesh__recordMaintainer mesh__D047508 lkt
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D047508 2006
% 212.75/212.90  |- skos__broader mesh__D047508smesh__D017114
% 212.75/212.90  |- skos__historyNote mesh__D047508 Liver Diseases %28%1968-2004%29%
% 212.75/212.90  |- rdf__type mesh__D047508sskos__Concept
% 212.75/212.90  |- mesh__dateCreated mesh__D047508 2004-07-07
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D047508 2005
% 212.75/212.90  |- skos__altLabel mesh__D047508 Acute Yellow Atrophy of Liver
% 212.75/212.90  |- mesh__recordOriginator mesh__D047508 lkt
% 212.75/212.90  |- skos__scopeNote mesh__D047508
% 212.75/212.90       Extensive and rapid death of parenchymal cells in the LIVER, often due to exposure to toxic materials. It is characterized by a soft, flabby, yellow-brown wrinkled, and shrunken liver. It was called %22%acute yellow atrophy%22%.%A%    
% 212.75/212.90  |- skos__hiddenLabel mesh__D047508 Hepatic Necrosis, Massive
% 212.75/212.90  |- mesh__recordAuthorizer mesh__D047508 sjn
% 212.75/212.90  |- mesh__publicMeSHNote mesh__D047508 2005; see LIVER DISEASES 1997-2004   
% 212.75/212.90  |- mesh__dateEstablished mesh__D047508 2005-01-01
% 212.75/212.90  |- skos__altLabel mesh__D047508 Acute Yellow Atrophy
% 212.75/212.90  |- skos__historyNote mesh__D047508 Necrosis %28%1968-2004%29%
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D019817 2005
% 212.75/212.90  |- mesh__publicMeSHNote mesh__D019817
% 212.75/212.90       99; BENZOIC ACID was indexed under BENZOATES 1980-98   
% 212.75/212.90  |- rdf__type mesh__D019817sskos__Concept
% 212.75/212.90  |- mesh__recordAuthorizer mesh__D019817 sjn
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D019817 2006
% 212.75/212.90  |- mesh__dateRevised mesh__D019817 2004-07-07
% 212.75/212.90  |- mesh__recordOriginator mesh__D019817 ADP
% 212.75/212.90  |- mesh__recordMaintainer mesh__D019817 mdb
% 212.75/212.90  |- mesh__historyNote mesh__D019817
% 212.75/212.90       99; use BENZOIC ACID %28%NM%29% 1980-98   
% 212.75/212.90  |- skos__scopeNote mesh__D019817
% 212.75/212.90       A fungistatic compound that is widely used as a food preservative. It is conjugated to GLYCINE in the liver and excreted as hippuric acid.%A%    
% 212.75/212.90  |- skos__prefLabel mesh__D019817 Benzoic Acid
% 212.75/212.90  |- mesh__dateEstablished mesh__D019817 1999-01-01
% 212.75/212.90  |- skos__annotation mesh__D019817 BENZOIC ACIDS is also available   
% 212.75/212.90  |- skos__broader mesh__D019817smesh__D020185
% 212.75/212.90  |- skos__altLabel mesh__D019817 Kendall Brand of Benzoic Acid Sodium Salt
% 212.75/212.90  |- skos__historyNote mesh__D019817 Benzoates %28%1966-1998%29%
% 212.75/212.90  |- mesh__dateCreated mesh__D019817 1998-06-10
% 212.75/212.90  |- skos__hiddenLabel mesh__D019817 Acid, Benzoic
% 212.75/212.90  |- skos__scopeNote mesh__D011834
% 212.75/212.90       The observation, either continuously or at intervals, of the levels of radiation in a given area, generally for the purpose of assuring that they have not exceeded prescribed amounts or, in case of radiation already present in the area, assuring that the levels have returned to those meeting acceptable safety standards.%A%    
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011834 2004
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011834 1997
% 212.75/212.90  |- mesh__dateCreated mesh__D011834 1999-01-01
% 212.75/212.90  |- mesh__publicMeSHNote mesh__D011834 64; was see under RADIOMETRY 1963   
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011834 2006
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011834 2003
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011834 1999
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011834 1996
% 212.75/212.90  |- mesh__historyNote mesh__D011834 64; was see under RADIOMETRY 1963   
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011834 2002
% 212.75/212.90  |- mesh__dateEstablished mesh__D011834 1964-01-01
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011834 2005
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011834 1993
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011834 1998
% 212.75/212.90  |- skos__broader mesh__D011834smesh__D011870
% 212.75/212.90  |- mesh__recordMaintainer mesh__D011834 PLS
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011834 2001
% 212.75/212.90  |- mesh__dateRevised mesh__D011834 1992-05-18
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011834 1995
% 212.75/212.90  |- skos__broader mesh__D011834smesh__D011874
% 212.75/212.90  |- rdf__type mesh__D011834sskos__Concept
% 212.75/212.90  |- skos__prefLabel mesh__D011834 Radiation Monitoring
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011834 2000
% 212.75/212.90  |- skos__altLabel mesh__D011834 Monitoring, Radiation
% 212.75/212.90  |- skos__broader mesh__D011834smesh__D004784
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011834 1994
% 212.75/212.90  |- mesh__recordAuthorizer mesh__D011834 PLS
% 212.75/212.90  |- mesh__recordOriginator mesh__D011834 NLM
% 212.75/212.90  |- skos__hiddenLabel mesh__D011036 Mollies
% 212.75/212.90  |- skos__prefLabel mesh__D011036 Poecilia
% 212.75/212.90  |- mesh__recordMaintainer mesh__D011036 ags
% 212.75/212.90  |- mesh__dateRevised mesh__D011036 2003-07-09
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011036 2004
% 212.75/212.90  |- mesh__dateCreated mesh__D011036 1986-04-15
% 212.75/212.90  |- mesh__historyNote mesh__D011036
% 212.75/212.90       91%28%87%29%; was see under CYPRINODONTIFORMES 1987-90   
% 212.75/212.90  |- skos__hiddenLabel mesh__D011036 Guppies
% 212.75/212.90  |- mesh__recordAuthorizer mesh__D011036 sjn
% 212.75/212.90  |- skos__broader mesh__D011036smesh__D003532
% 212.75/212.90  |- skos__altLabel mesh__D011036 Guppy
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011036 2006
% 212.75/212.90  |- skos__scopeNote mesh__D011036
% 212.75/212.90       A genus of livebearing cyprinodont fish comprising the guppy and molly. Some species are virtually all female and depend on sperm from other species to stimulate egg development. Poecilia is used in carcinogenicity studies as well as neurologic and physiologic research.%A%    
% 212.75/212.90  |- skos__historyNote mesh__D011036 Fishes %28%1966-1986%29%
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011036 2005
% 212.75/212.90  |- mesh__dateEstablished mesh__D011036 1991-01-01
% 212.75/212.90  |- rdf__type mesh__D011036sskos__Concept
% 212.75/212.90  |- mesh__publicMeSHNote mesh__D011036
% 212.75/212.90       91; was see under CYPRINODONTIFORMES 1987-90   
% 212.75/212.90  |- mesh__recordOriginator mesh__D011036 EC
% 212.75/212.90  |- skos__hiddenLabel mesh__D011036 Poecilias
% 212.75/212.90  |- skos__annotation mesh__D011036
% 212.75/212.90       note X refs; NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 212.75/212.90  |- mesh__publicMeSHNote mesh__D007793
% 212.75/212.90       91; was see under MAMMALS 1975-90; was see under RABBITS 1963-74%A%  
% 212.75/212.90  |- skos__altLabel mesh__D007793 Lagomorphs
% 212.75/212.90  |- skos__broader mesh__D007793smesh__D008322
% 212.75/212.90  |- skos__annotation mesh__D007793
% 212.75/212.90       HARES and RABBITS are available; note X refs   
% 212.75/212.90  |- skos__altLabel mesh__D007793 Ochotonidae
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D007793 2004
% 212.75/212.90  |- mesh__onlineNote mesh__D007793
% 212.75/212.90       use RABBITS to search LAGOMORPHA 1966-74   
% 212.75/212.90  |- mesh__recordMaintainer mesh__D007793 ags
% 212.75/212.90  |- mesh__recordOriginator mesh__D007793 NLM
% 212.75/212.90  |- mesh__dateCreated mesh__D007793 1999-01-01
% 212.75/212.90  |- rdf__type mesh__D007793sskos__Concept
% 212.75/212.90  |- mesh__recordAuthorizer mesh__D007793 sjn
% 212.75/212.90  |- mesh__dateEstablished mesh__D007793 1991-01-01
% 212.75/212.90  |- mesh__historyNote mesh__D007793
% 212.75/212.90       91%28%75%29%; was see under MAMMALS 1975-90; was see under RABBITS 1963-74%A%  
% 212.75/212.90  |- skos__hiddenLabel mesh__D007793 Lagomorph
% 212.75/212.90  |- skos__scopeNote mesh__D007793
% 212.75/212.90       An order of small mammals comprising two families, Ochotonidae %28%pikas%29% and Leporidae %28%RABBITS and HARES%29%. Head and body length ranges from about 125 mm to 750 mm. Hares and rabbits have a short tail, and the pikas lack a tail. Rabbits are born furless and with both eyes and ears closed. HARES are born fully haired with eyes and ears open. All are vegetarians. %28%From Nowak, Walker%27%s Mammals of the World, 5th ed, p539-41%29%%A%    
% 212.75/212.90  |- mesh__dateRevised mesh__D007793 2003-07-09
% 212.75/212.90  |- skos__prefLabel mesh__D007793 Lagomorpha
% 212.75/212.90  |- skos__hiddenLabel mesh__D007793 Pika
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D007793 2005
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D007793 2006
% 212.75/212.90  |- skos__hiddenLabel mesh__D015427 Reperfusion Damages
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D015427 2004
% 212.75/212.90  |- skos__hiddenLabel mesh__D015427 Injuries, Reperfusion
% 212.75/212.90  |- skos__hiddenLabel mesh__D015427 Damage, Reperfusion
% 212.75/212.90  |- skos__altLabel mesh__D015427 Injury, Reperfusion
% 212.75/212.90  |- skos__hiddenLabel mesh__D015427 Injuries, Ischemia-Reperfusion
% 212.75/212.90  |- skos__broader mesh__D015427smesh__D007511
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D015427 2003
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D015427 2001
% 212.75/212.90  |- mesh__dateCreated mesh__D015427 1988-06-08
% 212.75/212.90  |- mesh__recordMaintainer mesh__D015427 KEV
% 212.75/212.90  |- skos__altLabel mesh__D015427 Ischemia-Reperfusion Injury
% 212.75/212.90  |- skos__hiddenLabel mesh__D015427 Damages, Reperfusion
% 212.75/212.90  |- skos__historyNote mesh__D015427 Ischemia %28%1971-1988%29%
% 212.75/212.90  |- skos__broader mesh__D015427smesh__D011183
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D015427 2000
% 212.75/212.90  |- mesh__recordOriginator mesh__D015427 WDJ
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D015427 2006
% 212.75/212.90  |- skos__prefLabel mesh__D015427 Reperfusion Injury
% 212.75/212.90  |- skos__hiddenLabel mesh__D015427 Ischemia Reperfusion Injury
% 212.75/212.90  |- skos__scopeNote mesh__D015427
% 212.75/212.90       Functional, metabolic, or structural changes, including necrosis, in ischemic tissues thought to result from REPERFUSION to ischemic areas of the tissue. The most common instance is MYOCARDIAL REPERFUSION INJURY.%A%    
% 212.75/212.90  |- rdf__type mesh__D015427sskos__Concept
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D015427 2005
% 212.75/212.90  |- skos__altLabel mesh__D015427 Injury, Ischemia-Reperfusion
% 212.75/212.90  |- skos__hiddenLabel mesh__D015427 Ischemia-Reperfusion Injuries
% 212.75/212.90  |- skos__historyNote mesh__D015427 Perfusion %28%1971-1988%29%
% 212.75/212.90  |- mesh__dateRevised mesh__D015427 1999-11-03
% 212.75/212.90  |- mesh__recordAuthorizer mesh__D015427 sjn
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D015427 2002
% 212.75/212.90  |- mesh__dateEstablished mesh__D015427 1989-01-01
% 212.75/212.90  |- skos__altLabel mesh__D015427 Reperfusion Damage
% 212.75/212.90  |- skos__hiddenLabel mesh__D015427 Injury, Ischemia Reperfusion
% 212.75/212.90  |- mesh__historyNote mesh__D015427 89   
% 212.75/212.90  |- mesh__publicMeSHNote mesh__D015427 89   
% 212.75/212.90  |- skos__hiddenLabel mesh__D015427 Reperfusion Injuries
% 212.75/212.90  |- mesh__recordAuthorizer mesh__D001407 sjn
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D001407 2006
% 212.75/212.90  |- skos__annotation mesh__D001407
% 212.75/212.90       specific genus: do not confuse with %22%bacillus%22% as %22%bacterium%22%; Bacillus mesentericus goes here%A%  
% 212.75/212.90  |- rdf__type mesh__D001407sskos__Concept
% 212.75/212.90  |- mesh__dateCreated mesh__D001407 1999-01-01
% 212.75/212.90  |- mesh__recordMaintainer mesh__D001407 SYSTEM
% 212.75/212.90  |- mesh__recordOriginator mesh__D001407 NLM
% 212.75/212.90  |- skos__scopeNote mesh__D001407
% 212.75/212.90       A genus of BACILLACEAE that are spore-forming, rod-shaped cells. Most species are saprophytic soil forms with only a few species being pathogenic.%A%    
% 212.75/212.90  |- skos__broader mesh__D001407smesh__D001406
% 212.75/212.90  |- skos__prefLabel mesh__D001407 Bacillus
% 212.75/212.90  |- mesh__dateRevised mesh__D001407 2005-06-30
% 212.75/212.90  |- skos__hiddenLabel mesh__D019818 Clavulanate, Potassium
% 212.75/212.90  |- mesh__historyNote mesh__D019818
% 212.75/212.90       98; use CLAVULANIC ACID %28%NM%29% 1980-97   
% 212.75/212.90  |- rdf__type mesh__D019818sskos__Concept
% 212.75/212.90  |- skos__historyNote mesh__D019818 Lactams %28%1976-1982%29%
% 212.75/212.90  |- mesh__dateCreated mesh__D019818 1997-06-20
% 212.75/212.90  |- skos__scopeNote mesh__D019818
% 212.75/212.90       Clavulanic acid and its salts and esters. The acid is a suicide inhibitor of bacterial beta-lactamase enzymes from Streptomyces clavuligerus. Administered alone, it has only weak antibacterial activity against most organisms, but given in combination with beta-lactam antibiotics prevents antibiotic inactivation by microbial lactamase.%A%    
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D019818 2006
% 212.75/212.90  |- mesh__publicMeSHNote mesh__D019818
% 212.75/212.90       98; CLAVULANIC ACID was indexed under CLAVULANIC ACIDS 1978-97 %26% LACTAMS 1976-82%A%  
% 212.75/212.90  |- skos__hiddenLabel mesh__D019818 Clavulanate, Sodium
% 212.75/212.90  |- mesh__recordAuthorizer mesh__D019818 sjn
% 212.75/212.90  |- mesh__dateEstablished mesh__D019818 1998-01-01
% 212.75/212.90  |- skos__altLabel mesh__D019818 Sodium Clavulanate
% 212.75/212.90  |- skos__altLabel mesh__D019818 Potassium Clavulanate
% 212.75/212.90  |- mesh__recordMaintainer mesh__D019818 ssb
% 212.75/212.90  |- mesh__dateRevised mesh__D019818 2004-07-07
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D019818 2005
% 212.75/212.90  |- mesh__recordOriginator mesh__D019818 ADP
% 212.75/212.90  |- skos__historyNote mesh__D019818 Clavulanic Acids %28%1978-1997%29%
% 212.75/212.90  |- skos__broader mesh__D019818smesh__D002969
% 212.75/212.90  |- skos__prefLabel mesh__D019818 Clavulanic Acid
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011835 2006
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011835 2003
% 212.75/212.90  |- mesh__recordAuthorizer mesh__D011835 PLS
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011835 1999
% 212.75/212.90  |- mesh__recordOriginator mesh__D011835 NLM
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011835 1996
% 212.75/212.90  |- skos__hiddenLabel mesh__D011835 Protections, Radiation
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011835 2005
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011835 1993
% 212.75/212.90  |- skos__broader mesh__D011835smesh__D011870
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011835 1998
% 212.75/212.90  |- skos__prefLabel mesh__D011835 Radiation Protection
% 212.75/212.90  |- mesh__dateRevised mesh__D011835 1992-05-18
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011835 1995
% 212.75/212.90  |- rdf__type mesh__D011835sskos__Concept
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011835 2002
% 212.75/212.90  |- skos__hiddenLabel mesh__D011835 Radiation Protections
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011835 1994
% 212.75/212.90  |- skos__annotation mesh__D011835 includes %22%shielding%22%   
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011835 2001
% 212.75/212.90  |- mesh__recordMaintainer mesh__D011835 TAP
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011835 2004
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011835 1997
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011835 2000
% 212.75/212.90  |- mesh__dateCreated mesh__D011835 1999-01-01
% 212.75/212.90  |- skos__altLabel mesh__D011835 Protection, Radiation
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011037 1999
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011037 2002
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011037 2004
% 212.75/212.90  |- skos__prefLabel mesh__D011037 Poetry
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011037 1998
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011037 2003
% 212.75/212.90  |- mesh__dateRevised mesh__D011037 1992-05-18
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011037 1995
% 212.75/212.90  |- skos__broader mesh__D011037smesh__D008091
% 212.75/212.90  |- mesh__recordAuthorizer mesh__D011037 PLS
% 212.75/212.90  |- mesh__dateCreated mesh__D011037 1999-01-01
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011037 2001
% 212.75/212.90  |- mesh__recordMaintainer mesh__D011037 TAP
% 212.75/212.90  |- skos__hiddenLabel mesh__D011037 Poetries
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011037 1994
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011037 2006
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011037 1997
% 212.75/212.90  |- mesh__recordOriginator mesh__D011037 NLM
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011037 2000
% 212.75/212.90  |- rdf__type mesh__D011037sskos__Concept
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011037 2005
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011037 1996
% 212.75/212.90  |- skos__annotation mesh__D011037
% 212.75/212.90       coord IM with LITERATURE, MEDIEVAL %28%IM%29% or LITERATURE, MODERN %28%IM%29%%A%  
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D011037 1993
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D016520 2002
% 212.75/212.90  |- mesh__dateCreated mesh__D016520 1991-02-11
% 212.75/212.90  |- skos__prefLabel mesh__D016520 Entrepreneurship
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D016520 2001
% 212.75/212.90  |- skos__historyNote mesh__D016520
% 212.75/212.90       Organization and Administration %28%1985-1991%29%
% 212.75/212.90  |- mesh__historyNote mesh__D016520 92   
% 212.75/212.90  |- skos__broader mesh__D016520smesh__D003132
% 212.75/212.90  |- mesh__dateRevised mesh__D016520 2000-06-22
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D016520 2004
% 212.75/212.90  |- mesh__recordMaintainer mesh__D016520 jls
% 212.75/212.90  |- mesh__recordAuthorizer mesh__D016520 sjn
% 212.75/212.90  |- mesh__publicMeSHNote mesh__D016520 92   
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D016520 2006
% 212.75/212.90  |- mesh__dateEstablished mesh__D016520 1992-01-01
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D016520 2003
% 212.75/212.90  |- skos__historyNote mesh__D016520 Commerce %28%1985-1991%29%
% 212.75/212.90  |- skos__annotation mesh__D016520 use qualif discreetly   
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D016520 2005
% 212.75/212.90  |- skos__scopeNote mesh__D016520
% 212.75/212.90       The organization, management, and assumption of risks of a business or enterprise, usually implying an element of change or challenge and a new opportunity.%A%    
% 212.75/212.90  |- skos__broader mesh__D016520smesh__D009936
% 212.75/212.90  |- skos__historyNote mesh__D016520
% 212.75/212.90       Organizational Innovation %28%1985-1991%29%
% 212.75/212.90  |- mesh__recordOriginator mesh__D016520 JHM
% 212.75/212.90  |- rdf__type mesh__D016520sskos__Concept
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D002500 2004
% 212.75/212.90  |- mesh__onlineNote mesh__D002500
% 212.75/212.90       search CENTRIFUGATION, DENSITY GRADIENT 1968-74   
% 212.75/212.90  |- skos__broader mesh__D002500smesh__D002499
% 212.75/212.90  |- rdf__type mesh__D002500sskos__Concept
% 212.75/212.90  |- mesh__dateRevised mesh__D002500 2002-07-03
% 212.75/212.90  |- mesh__recordMaintainer mesh__D002500 lkt
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D002500 2003
% 212.75/212.90  |- mesh__publicMeSHNote mesh__D002500
% 212.75/212.90       91; was see under CENTRIFUGATION, DENSITY GRADIENT 1975-90%A%  
% 212.75/212.90  |- mesh__dateCreated mesh__D002500 1999-01-01
% 212.75/212.90  |- mesh__recordOriginator mesh__D002500 NLM
% 212.75/212.90  |- skos__hiddenLabel mesh__D002500 Isopycnic Centrifugation
% 212.75/212.90  |- mesh__dateEstablished mesh__D002500 1991-01-01
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D002500 2006
% 212.75/212.90  |- mesh__recordAuthorizer mesh__D002500 sjn
% 212.75/212.90  |- skos__prefLabel mesh__D002500 Centrifugation, Isopycnic
% 212.75/212.90  |- mesh__historyNote mesh__D002500
% 212.75/212.90       91%28%75%29%; was see under CENTRIFUGATION, DENSITY GRADIENT 1975-90%A%  
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D002500 2005
% 212.75/212.90  |- skos__scopeNote mesh__D002500
% 212.75/212.90       A technique used to separate particles according to their densities in a continuous density gradient. The sample is usually mixed with a solution of known gradient materials and subjected to centrifugation. Each particle sediments to the position at which the gradient density is equal to its own. The range of the density gradient is usually greater than that of the sample particles. It is used in purifying biological materials such as proteins, nucleic acids, organelles, and cell types.%A%    
% 212.75/212.90  |- skos__broader mesh__D014180Q000276smesh__D014180
% 212.75/212.90  |- mesh__preferredCombination mesh__D014180Q000276smesh__D014181
% 212.75/212.90  |- rdf__type mesh__D014180Q000276smesh__CompoundConcept
% 212.75/212.90  |- mesh__recordOriginator mesh__D007794 FPG
% 212.75/212.90  |- skos__hiddenLabel mesh__D007794 Lamenesses, Animal
% 212.75/212.90  |- skos__hiddenLabel mesh__D007794 Animal Lameness
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D007794 2004
% 212.75/212.90  |- mesh__recordMaintainer mesh__D007794 ags
% 212.75/212.90  |- skos__hiddenLabel mesh__D007794 Animal Lamenesses
% 212.75/212.90  |- skos__hiddenLabel mesh__D007794 Gait Disorder, Animal
% 212.75/212.90  |- skos__altLabel mesh__D007794 Gait Disorders, Animal
% 212.75/212.90  |- mesh__historyNote mesh__D007794 76   
% 212.75/212.90  |- skos__broader mesh__D007794smesh__D000820
% 212.75/212.90  |- rdf__type mesh__D007794sskos__Concept
% 212.75/212.90  |- skos__historyNote mesh__D007794 Gait %28%1966-1975%29%
% 212.75/212.90  |- skos__annotation mesh__D007794
% 212.75/212.90       coord IM with precoord animal/dis term %28%IM%29% + animal %28%NIM%29%; don%27%t forget also check tag ANIMALS%A%  
% 212.75/212.90  |- skos__scopeNote mesh__D007794
% 212.75/212.90       A departure from the normal gait in animals.     
% 212.75/212.90  |- skos__hiddenLabel mesh__D007794 Disorder, Animal Gait
% 212.75/212.90  |- skos__prefLabel mesh__D007794 Lameness, Animal
% 212.75/212.90  |- skos__hiddenLabel mesh__D007794 Disorders, Animal Gait
% 212.75/212.90  |- mesh__dateRevised mesh__D007794 2003-07-30
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D007794 2005
% 212.75/212.90  |- skos__hiddenLabel mesh__D007794 Animal Gait Disorders
% 212.75/212.90  |- mesh__recordAuthorizer mesh__D007794 sjn
% 212.75/212.90  |- mesh__dateEstablished mesh__D007794 1976-01-01
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D007794 2006
% 212.75/212.90  |- mesh__dateCreated mesh__D007794 1975-07-25
% 212.75/212.90  |- skos__hiddenLabel mesh__D007794 Animal Gait Disorder
% 212.75/212.90  |- mesh__publicMeSHNote mesh__D007794 76   
% 212.75/212.90  |- skos__broader mesh__D015428smesh__D009202
% 212.75/212.90  |- skos__prefLabel mesh__D015428 Myocardial Reperfusion Injury
% 212.75/212.90  |- skos__hiddenLabel mesh__D015428 Myocardial Reperfusion Injuries
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D015428 2006
% 212.75/212.90  |- skos__related mesh__D015428smesh__D017682
% 212.75/212.90  |- skos__historyNote mesh__D015428 Coronary Disease %28%1971-1988%29%
% 212.75/212.90  |- skos__historyNote mesh__D015428 Coronary Circulation %28%1975-1988%29%
% 212.75/212.90  |- mesh__recordAuthorizer mesh__D015428 sjn
% 212.75/212.90  |- rdf__type mesh__D015428sskos__Concept
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D015428 2005
% 212.75/212.90  |- mesh__recordMaintainer mesh__D015428 lkt
% 212.75/212.90  |- mesh__historyNote mesh__D015428 89   
% 212.75/212.90  |- mesh__dateRevised mesh__D015428 2004-07-07
% 212.75/212.90  |- skos__scopeNote mesh__D015428
% 212.75/212.90       Damage to the MYOCARDIUM resulting from reperfusion of ischemic areas of the HEART. Reperfusion takes place when there is spontaneous thrombolysis, THROMBOLYTIC THERAPY, collateral flow from other coronary vascular beds, or reversal of vasospasm. Reperfusion can cause EDEMA, injuries to cardiac myocytes %28%MYOCYTES, CARDIAC%29% and the conducting tissue with resultant ARRHYTHMIA. Degree of injury depends on the duration and extent of MYOCARDIAL ISCHEMIA before reperfusion, cytosolic calcium overload, and oxygen FREE RADICALS.%A%    
% 212.75/212.90  |- mesh__dateCreated mesh__D015428 1988-06-08
% 212.75/212.90  |- mesh__dateEstablished mesh__D015428 1989-01-01
% 212.75/212.90  |- skos__altLabel mesh__D015428 Injury, Myocardial Reperfusion
% 212.75/212.90  |- skos__hiddenLabel mesh__D015428 Reperfusion Injuries, Myocardial
% 212.75/212.90  |- skos__historyNote mesh__D015428 Perfusion %28%1971-1988%29%
% 212.75/212.90  |- mesh__publicMeSHNote mesh__D015428 89   
% 212.75/212.90  |- skos__altLabel mesh__D015428 Myocardial Ischemic Reperfusion Injury
% 212.75/212.90  |- mesh__recordOriginator mesh__D015428 WDJ
% 212.75/212.90  |- skos__broader mesh__D015428smesh__D015427
% 212.75/212.90  |- skos__hiddenLabel mesh__D015428 Injuries, Myocardial Reperfusion
% 212.75/212.90  |- skos__historyNote mesh__D015428 Myocardial Infarction %28%1973-1988%29%
% 212.75/212.90  |- skos__altLabel mesh__D015428 Reperfusion Injury, Myocardial
% 212.75/212.90  |- skos__historyNote mesh__D015428 Ischemia %28%1971-1988%29%
% 212.75/212.90  |- mesh__activeMeSHYear mesh__D001408 2006
% 212.75/212.90  |- mesh__dateRevised mesh__D001408 2005-06-30
% 212.75/212.90  |- mesh__dateCreated mesh__D001408 1999-01-01
% 212.75/212.90  |- rdf__type mesh__D001408sskos__Concept
% 212.75/212.90  |- mesh__recordMaintainer mesh__D001408 SYSTEM
% 212.75/212.90  |- mesh__recordAuthorizer mesh__D001408 sjn
% 212.75/212.90  |- skos__prefLabel mesh__D001408 Bacillus anthracis
% 212.75/212.90  |- skos__scopeNote mesh__D001408
% 212.75/212.90       A species of bacteria that causes ANTHRAX in humans and animals.%A%    
% 212.75/212.90  |- skos__broader mesh__D001408smesh__D001407
% 212.75/212.90  |- skos__annotation mesh__D001408 infection = ANTHRAX   
% 212.75/212.91  |- mesh__recordOriginator mesh__D001408 NLM
% 212.75/212.91  |- mesh__recordAuthorizer mesh__D012130 sjn
% 212.75/212.91  |- skos__altLabel mesh__D012130 Hypersensitivity, Respiratory
% 212.75/212.91  |- skos__prefLabel mesh__D012130 Respiratory Hypersensitivity
% 212.75/212.91  |- skos__annotation mesh__D012130 %22%respiratory allergy%22%   
% 212.75/212.91  |- skos__broader mesh__D012130smesh__D006969
% 212.75/212.91  |- mesh__publicMeSHNote mesh__D012130
% 212.75/212.91       66; was RESPIRATORY ALLERGY 1963-65   
% 212.75/212.91  |- mesh__dateCreated mesh__D012130 1999-01-01
% 212.75/212.91  |- mesh__dateRevised mesh__D012130 2005-07-01
% 212.75/212.91  |- skos__hiddenLabel mesh__D012130 Respiratory Hypersensitivities
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D012130 2006
% 212.75/212.91  |- mesh__recordMaintainer mesh__D012130 sjn
% 212.75/212.91  |- skos__scopeNote mesh__D012130
% 212.75/212.91       A form of hypersensitivity affecting the respiratory tract. It includes ASTHMA and RHINITIS, ALLERGIC, SEASONAL.%A%    
% 212.75/212.91  |- skos__hiddenLabel mesh__D012130 Hypersensitivities, Respiratory
% 212.75/212.91  |- skos__broader mesh__D012130smesh__D012140
% 212.75/212.91  |- mesh__recordOriginator mesh__D012130 NLM
% 212.75/212.91  |- mesh__dateEstablished mesh__D012130 1966-01-01
% 212.75/212.91  |- mesh__historyNote mesh__D012130 66; was RESPIRATORY ALLERGY 1963-65   
% 212.75/212.91  |- rdf__type mesh__D012130sskos__Concept
% 212.75/212.91  |- skos__broader mesh__D006321Q000528smesh__D006321
% 212.75/212.91  |- rdf__type mesh__D006321Q000528smesh__CompoundConcept
% 212.75/212.91  |- mesh__dateRevised mesh__D019819 2003-07-09
% 212.75/212.91  |- rdf__type mesh__D019819sskos__Concept
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D019819 2006
% 212.75/212.91  |- skos__prefLabel mesh__D019819 Budesonide
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D019819 2005
% 212.75/212.91  |- skos__scopeNote mesh__D019819
% 212.75/212.91       A glucocorticoid used in the management of ASTHMA, the treatment of various skin disorders, and allergic RHINITIS.%A%    
% 212.75/212.91  |- skos__historyNote mesh__D019819 Pregnenediones %28%1979-1997%29%
% 212.75/212.91  |- mesh__dateCreated mesh__D019819 1997-06-20
% 212.75/212.91  |- skos__broader mesh__D019819smesh__D011282
% 212.75/212.91  |- mesh__recordAuthorizer mesh__D019819 sjn
% 212.75/212.91  |- mesh__dateEstablished mesh__D019819 1998-01-01
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D019819 2004
% 212.75/212.91  |- mesh__recordMaintainer mesh__D019819 ssb
% 212.75/212.91  |- mesh__recordOriginator mesh__D019819 ADP
% 212.75/212.91  |- mesh__publicMeSHNote mesh__D019819
% 212.75/212.91       98; BUDESONIDE was indexed under PREGNENEDIONES 1979-97   
% 212.75/212.91  |- mesh__historyNote mesh__D019819 98; use BUDESONIDE %28%NM%29% 1979-97   
% 212.75/212.91  |- rdf__type mesh__D011836sskos__Concept
% 212.75/212.91  |- skos__altLabel mesh__D011836 Radiation Sensitivity
% 212.75/212.91  |- skos__related mesh__D011836smesh__D011838
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D011836 2001
% 212.75/212.91  |- skos__prefLabel mesh__D011836 Radiation Tolerance
% 212.75/212.91  |- mesh__dateCreated mesh__D011836 1976-04-13
% 212.75/212.91  |- skos__altLabel mesh__D011836 Sensitivity, Radiation
% 212.75/212.91  |- skos__altLabel mesh__D011836 Tolerance, Radiation
% 212.75/212.91  |- skos__hiddenLabel mesh__D011836 Sensitivities, Radiation
% 212.75/212.91  |- skos__hiddenLabel mesh__D011836 Radiation Sensitivities
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D011836 2000
% 212.75/212.91  |- skos__hiddenLabel mesh__D011836 Radiation Tolerances
% 212.75/212.91  |- skos__historyNote mesh__D011836 Radiation Dosage %28%1972-1976%29%
% 212.75/212.91  |- skos__hiddenLabel mesh__D011836 Tolerances, Radiation
% 212.75/212.91  |- mesh__recordMaintainer mesh__D011836 TGC
% 212.75/212.91  |- skos__historyNote mesh__D011836 Radiotherapy Dosage %28%1966-1976%29%
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D011836 2004
% 212.75/212.91  |- skos__related mesh__D011836smesh__D011837
% 212.75/212.91  |- skos__broader mesh__D011836smesh__D011827
% 212.75/212.91  |- mesh__historyNote mesh__D011836 77   
% 212.75/212.91  |- skos__scopeNote mesh__D011836
% 212.75/212.91       The ability of some cells or tissues to withstand ionizing radiation without serious injury. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS.%A%    
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D011836 2006
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D011836 2003
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D011836 1999
% 212.75/212.91  |- skos__hiddenLabel mesh__D011836 Radiosensitivities
% 212.75/212.91  |- mesh__publicMeSHNote mesh__D011836 77   
% 212.75/212.91  |- mesh__dateEstablished mesh__D011836 1977-01-01
% 212.75/212.91  |- skos__annotation mesh__D011836
% 212.75/212.91       to ionizing radiations only; DF: RAD TOLERANCE   
% 212.75/212.91  |- mesh__recordAuthorizer mesh__D011836 SJN
% 212.75/212.91  |- mesh__dateRevised mesh__D011836 1997-06-20
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D011836 2005
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D011836 1998
% 212.75/212.91  |- skos__historyNote mesh__D011836 Radiation Effects %28%1966-1976%29%
% 212.75/212.91  |- skos__altLabel mesh__D011836 Radiosensitivity
% 212.75/212.91  |- mesh__recordOriginator mesh__D011836 SH
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D011836 2002
% 212.75/212.91  |- mesh__dateRevised mesh__D011038 2005-06-30
% 212.75/212.91  |- mesh__recordOriginator mesh__D011038 NLM
% 212.75/212.91  |- mesh__dateCreated mesh__D011038 1999-01-01
% 212.75/212.91  |- skos__altLabel mesh__D011038 Poikiloderma Congenitale
% 212.75/212.91  |- skos__hiddenLabel mesh__D011038 Rothmund Thomson Syndrome
% 212.75/212.91  |- skos__prefLabel mesh__D011038 Rothmund-Thomson Syndrome
% 212.75/212.91  |- skos__broader mesh__D011038smesh__D007232
% 212.75/212.91  |- skos__broader mesh__D011038smesh__D012873
% 212.75/212.91  |- mesh__publicMeSHNote mesh__D011038
% 212.75/212.91       2006; see POIKILODERMA CONGENITALE 1991-2005, see SKIN DISEASES 1964-1990%A%  
% 212.75/212.91  |- skos__scopeNote mesh__D011038
% 212.75/212.91       An autosomal recessive syndrome occurring principally in females, characterized by the presence of reticulated, atrophic, hyperpigmented, telangiectatic cutaneous plaques, often accompanied by juvenile cataracts, saddle nose, congenital bone defects, disturbances in the growth of HAIR; NAILS; and TEETH; and HYPOGONADISM.%A%    
% 212.75/212.91  |- skos__hiddenLabel mesh__D011038 Syndrome, Rothmund-Thomson
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D011038 2006
% 212.75/212.91  |- skos__broader mesh__D011038smesh__D012868
% 212.75/212.91  |- mesh__recordAuthorizer mesh__D011038 sjn
% 212.75/212.91  |- skos__broader mesh__D011038smesh__D049914
% 212.75/212.91  |- rdf__type mesh__D011038sskos__Concept
% 212.75/212.91  |- mesh__recordMaintainer mesh__D011038 nns
% 212.75/212.91  |- mesh__historyNote mesh__D011038 2006 %28%1964%29%   
% 212.75/212.91  |- mesh__dateEstablished mesh__D011038 1991-01-01
% 212.75/212.91  |- mesh__dateRevised mesh__D016521 2002-07-03
% 212.75/212.91  |- skos__altLabel mesh__D016521 Pulsed-Field Gel Electrophoresis
% 212.75/212.91  |- mesh__dateCreated mesh__D016521 1991-01-02
% 212.75/212.91  |- mesh__historyNote mesh__D016521 92   
% 212.75/212.91  |- skos__historyNote mesh__D016521 Electrophoresis %28%1986-1991%29%
% 212.75/212.91  |- skos__altLabel mesh__D016521 Gel Electrophoresis, Pulsed-Field
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D016521 2004
% 212.75/212.91  |- skos__altLabel mesh__D016521 Electrophoresis, Gel, Pulsed Field
% 212.75/212.91  |- skos__prefLabel mesh__D016521 Electrophoresis, Gel, Pulsed-Field
% 212.75/212.91  |- skos__broader mesh__D016521smesh__D004586
% 212.75/212.91  |- skos__hiddenLabel mesh__D016521 Pulsed Field Gel Electrophoresis
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D016521 2006
% 212.75/212.91  |- mesh__recordMaintainer mesh__D016521 lkt
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D016521 2003
% 212.75/212.91  |- skos__altLabel mesh__D016521 Pulsed Field Gradient Gel Electrophoresis
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D016521 2005
% 212.75/212.91  |- skos__hiddenLabel mesh__D016521 Electrophoresis, Pulsed-Field Gel
% 212.75/212.91  |- skos__altLabel mesh__D016521 Pulsed-Field Gradient Gel Electrophoresis
% 212.75/212.91  |- mesh__recordAuthorizer mesh__D016521 sjn
% 212.75/212.91  |- mesh__publicMeSHNote mesh__D016521 92   
% 212.75/212.91  |- rdf__type mesh__D016521sskos__Concept
% 212.75/212.91  |- mesh__dateEstablished mesh__D016521 1992-01-01
% 212.75/212.91  |- skos__altLabel mesh__D016521 Electrophoresis, Pulsed Field Gel
% 212.75/212.91  |- skos__altLabel mesh__D016521 Electrophoresis, Gel, Pulsed-Field Gradient
% 212.75/212.91  |- skos__hiddenLabel mesh__D016521 Gel Electrophoresis, Pulsed Field
% 212.75/212.91  |- mesh__recordOriginator mesh__D016521 PXP
% 212.75/212.91  |- skos__scopeNote mesh__D016521
% 212.75/212.91       Electrophoresis in which the direction of the electric field is changed periodically. This technique is similar to other electrophoretic methods normally used to separate double-stranded DNA molecules ranging in size up to tens of thousands of base-pairs. However, by alternating the electric field direction one is able to separate DNA molecules up to several million base-pairs in length.%A%    
% 212.75/212.91  |- skos__annotation mesh__D016521 NIM; DF: PFGE   
% 212.75/212.91  |- skos__annotation mesh__D002501
% 212.75/212.91       a type of density gradient centrif; NIM   
% 212.75/212.91  |- rdf__type mesh__D002501sskos__Concept
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D002501 2004
% 212.75/212.91  |- skos__prefLabel mesh__D002501 Centrifugation, Zonal
% 212.75/212.91  |- mesh__publicMeSHNote mesh__D002501 68   
% 212.75/212.91  |- skos__scopeNote mesh__D002501
% 212.75/212.91       Centrifugation using a rotating chamber of large capacity in which to separate cell organelles by density-gradient centrifugation. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 212.75/212.91  |- skos__hiddenLabel mesh__D002501 Zonal Centrifugations
% 212.75/212.91  |- mesh__recordMaintainer mesh__D002501 lkt
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D002501 2003
% 212.75/212.91  |- mesh__recordOriginator mesh__D002501 NLM
% 212.75/212.91  |- skos__broader mesh__D002501smesh__D002499
% 212.75/212.91  |- mesh__dateCreated mesh__D002501 1999-01-01
% 212.75/212.91  |- mesh__dateRevised mesh__D002501 2002-07-03
% 212.75/212.91  |- skos__hiddenLabel mesh__D002501 Zonal Centrifugation
% 212.75/212.91  |- mesh__dateEstablished mesh__D002501 1968-01-01
% 212.75/212.91  |- mesh__recordAuthorizer mesh__D002501 sjn
% 212.75/212.91  |- mesh__historyNote mesh__D002501 68%28%66%29%   
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D002501 2006
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D002501 2005
% 212.75/212.91  |- skos__hiddenLabel mesh__D002501 Centrifugations, Zonal
% 212.75/212.91  |- skos__annotation mesh__D007795
% 212.75/212.91       for dried Laminaria for cervical dilat %26% %22%laminaria tent%22% %28%note X ref %26% read MeSH definition%29%, use no qualif%A%  
% 212.75/212.91  |- skos__broader mesh__D007795smesh__D000459
% 212.75/212.91  |- mesh__recordMaintainer mesh__D007795 SYSTEM
% 212.75/212.91  |- mesh__recordAuthorizer mesh__D007795 sjn
% 212.75/212.91  |- mesh__dateEstablished mesh__D007795 1991-01-01
% 212.75/212.91  |- skos__prefLabel mesh__D007795 Laminaria
% 212.75/212.91  |- mesh__recordOriginator mesh__D007795 AEP
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D007795 2006
% 212.75/212.91  |- mesh__historyNote mesh__D007795
% 212.75/212.91       91%28%80%29%; was see under SEAWEED 1980-90   
% 212.75/212.91  |- mesh__dateRevised mesh__D007795 2005-06-30
% 212.75/212.91  |- skos__scopeNote mesh__D007795
% 212.75/212.91       A genus of BROWN ALGAE in the family Laminariaceae. Dried pencil-like pieces may be inserted in the cervix where they swell as they absorb moisture, serving as osmotic dilators.%A%    
% 212.75/212.91  |- skos__altLabel mesh__D007795 Kombu
% 212.75/212.91  |- skos__historyNote mesh__D007795 Seaweed %28%1966-1979%29%
% 212.75/212.91  |- mesh__publicMeSHNote mesh__D007795 91; was see under SEAWEED 1980-90   
% 212.75/212.91  |- rdf__type mesh__D007795sskos__Concept
% 212.75/212.91  |- mesh__dateCreated mesh__D007795 1978-12-21
% 212.75/212.91  |- skos__broader mesh__D001409smesh__D001407
% 212.75/212.91  |- mesh__recordOriginator mesh__D001409 NLM
% 212.75/212.91  |- skos__annotation mesh__D001409 in soil, dust, plants   
% 212.75/212.91  |- mesh__dateRevised mesh__D001409 2005-06-30
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D001409 2006
% 212.75/212.91  |- skos__prefLabel mesh__D001409 Bacillus cereus
% 212.75/212.91  |- mesh__recordAuthorizer mesh__D001409 sjn
% 212.75/212.91  |- mesh__dateCreated mesh__D001409 1999-01-01
% 212.75/212.91  |- rdf__type mesh__D001409sskos__Concept
% 212.75/212.91  |- skos__scopeNote mesh__D001409
% 212.75/212.91       A species of rod-shaped bacteria that is a common soil saprophyte. Its spores are widespread and multiplication has been observed chiefly in foods. Contamination may lead to food poisoning.%A%    
% 212.75/212.91  |- mesh__recordMaintainer mesh__D001409 SYSTEM
% 212.75/212.91  |- mesh__recordOriginator mesh__D012131 NLM
% 212.75/212.91  |- mesh__dateRevised mesh__D012131 2003-07-25
% 212.75/212.91  |- skos__altLabel mesh__D012131 Ventilatory Depression
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D012131 2005
% 212.75/212.91  |- mesh__dateCreated mesh__D012131 1999-01-01
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D012131 2004
% 212.75/212.91  |- mesh__recordAuthorizer mesh__D012131 sjn
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D012131 2006
% 212.75/212.91  |- skos__hiddenLabel mesh__D012131 Depressions, Ventilatory
% 212.75/212.91  |- skos__prefLabel mesh__D012131 Respiratory Insufficiency
% 212.75/212.91  |- skos__annotation mesh__D012131
% 212.75/212.91       do not confuse with RESPIRATORY DISTRESS SYNDROME, NEWBORN in newborn inf%A%  
% 212.75/212.91  |- skos__broader mesh__D012131smesh__D012120
% 212.75/212.91  |- rdf__type mesh__D012131sskos__Concept
% 212.75/212.91  |- skos__scopeNote mesh__D012131
% 212.75/212.91       Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. %28%Stedman, 25th ed%29%%A%    
% 212.75/212.91  |- mesh__recordMaintainer mesh__D012131 sjn
% 212.75/212.91  |- skos__altLabel mesh__D011837 Radiation-Protective Drugs
% 212.75/212.91  |- skos__altLabel mesh__D011837 Radioprotective Drugs
% 212.75/212.91  |- skos__hiddenLabel mesh__D011837 Protective Agents, Radiation
% 212.75/212.91  |- mesh__dateRevised mesh__D011837 2003-07-09
% 212.75/212.91  |- skos__prefLabel mesh__D011837 Radiation-Protective Agents
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D011837 2004
% 212.75/212.91  |- skos__broader mesh__D011837smesh__D020011
% 212.75/212.91  |- skos__scopeNote mesh__D011837
% 212.75/212.91       Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other, e.g. military, purposes.%A%    
% 212.75/212.91  |- skos__hiddenLabel mesh__D011837 Drugs, Radiation-Protective
% 212.75/212.91  |- mesh__dateCreated mesh__D011837 1999-01-01
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D011837 2006
% 212.75/212.91  |- skos__altLabel mesh__D011837 Agents, Radiation-Protective
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D011837 2005
% 212.75/212.91  |- skos__altLabel mesh__D011837 Radiation Protective Agents
% 212.75/212.91  |- skos__hiddenLabel mesh__D011837 Protectants, Radiation
% 212.75/212.91  |- skos__hiddenLabel mesh__D011837 Agents, Radioprotective
% 212.75/212.91  |- mesh__recordOriginator mesh__D011837 NLM
% 212.75/212.91  |- mesh__recordAuthorizer mesh__D011837 sjn
% 212.75/212.91  |- mesh__recordMaintainer mesh__D011837 ssb
% 212.75/212.91  |- skos__altLabel mesh__D011837 Radiation Protectants
% 212.75/212.91  |- rdf__type mesh__D011837sskos__Concept
% 212.75/212.91  |- skos__hiddenLabel mesh__D011837 Drugs, Radioprotective
% 212.75/212.91  |- skos__hiddenLabel mesh__D011837 Radiation Protective Drugs
% 212.75/212.91  |- skos__hiddenLabel mesh__D011837 Agents, Radiation Protective
% 212.75/212.91  |- skos__altLabel mesh__D011837 Radioprotective Agents
% 212.75/212.91  |- skos__annotation mesh__D011837
% 212.75/212.91       D25-26 qualif; protective against ionizing rad; not for SUNSCREENING AGENTS %26% not for shields %26% shielding in diag x-ray %28% = RADIATION PROTECTION%29%; DF: RAD PROTECTIVE AGENTS%A%  
% 212.75/212.91  |- mesh__historyNote mesh__D008090
% 212.75/212.91       91%28%79%29%; was see under ERGOLINES 1979-90   
% 212.75/212.91  |- skos__broader mesh__D008090smesh__D004873
% 212.75/212.91  |- skos__historyNote mesh__D008090 Ergolines %28%1969-1978%29%
% 212.75/212.91  |- mesh__dateCreated mesh__D008090 1978-02-08
% 212.75/212.91  |- rdf__type mesh__D008090sskos__Concept
% 212.75/212.91  |- skos__altLabel mesh__D008090 Schering Brand 1 of Lisuride Maleate
% 212.75/212.91  |- skos__altLabel mesh__D008090 Roche Brand of Lisuride Maleate
% 212.75/212.91  |- skos__scopeNote mesh__D008090
% 212.75/212.91       An ergot derivative that acts as an agonist at dopamine D2 receptors %28%DOPAMINE AGONISTS%29%. It may also act as an antagonist at dopamine D1 receptors, and as an agonist at some serotonin receptors %28%SEROTONIN AGONISTS%29%.%A%    
% 212.75/212.91  |- mesh__publicMeSHNote mesh__D008090
% 212.75/212.91       91; was see under ERGOLINES 1979-90   
% 212.75/212.91  |- skos__altLabel mesh__D008090 Lysurid
% 212.75/212.91  |- mesh__dateRevised mesh__D008090 2004-07-07
% 212.75/212.91  |- skos__altLabel mesh__D008090 Methylergol Carbamide
% 212.75/212.91  |- skos__historyNote mesh__D008090 Ergot Alkaloids %28%1966-1968%29%
% 212.75/212.91  |- skos__hiddenLabel mesh__D008090 Hydrogen Maleate, Lysuride
% 212.75/212.91  |- skos__altLabel mesh__D008090 Dopergin
% 212.75/212.91  |- skos__altLabel mesh__D008090 IPRAD Brand of Lisuride Maleate
% 212.75/212.91  |- skos__hiddenLabel mesh__D008090 Hydrochloride, Lisuride
% 212.75/212.91  |- mesh__dateEstablished mesh__D008090 1991-01-01
% 212.75/212.91  |- skos__hiddenLabel mesh__D008090 Carbamide, Methylergol
% 212.75/212.91  |- skos__altLabel mesh__D008090 Schering Brand 2 of Lisuride Maleate
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D008090 2006
% 212.75/212.91  |- skos__altLabel mesh__D008090 Lysuride Hydrogen Maleate
% 212.75/212.91  |- skos__prefLabel mesh__D008090 Lisuride
% 212.75/212.91  |- skos__hiddenLabel mesh__D008090 Mesylate, Lisuride
% 212.75/212.91  |- skos__hiddenLabel mesh__D008090 Maleate, Lisuride
% 212.75/212.91  |- mesh__recordOriginator mesh__D008090 SH
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D008090 2005
% 212.75/212.91  |- mesh__recordMaintainer mesh__D008090 CCR
% 212.75/212.91  |- mesh__recordAuthorizer mesh__D008090 sjn
% 212.75/212.91  |- skos__altLabel mesh__D008090 Lisuride Maleate %28%1:1%29%
% 212.75/212.91  |- skos__scopeNote mesh__D011039
% 212.75/212.91       Facilities which provide information concerning poisons and treatment of poisoning in emergencies.%A%    
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D011039 2001
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D011039 2005
% 212.75/212.91  |- skos__hiddenLabel mesh__D011039 Center, Poison Control
% 212.75/212.91  |- mesh__recordOriginator mesh__D011039 NLM
% 212.75/212.91  |- mesh__dateRevised mesh__D011039 1999-11-03
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D011039 2002
% 212.75/212.91  |- mesh__recordMaintainer mesh__D011039 kle
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D011039 2006
% 212.75/212.91  |- skos__broader mesh__D011039smesh__D004632
% 212.75/212.91  |- skos__prefLabel mesh__D011039 Poison Control Centers
% 212.75/212.91  |- rdf__type mesh__D011039sskos__Concept
% 212.75/212.91  |- skos__altLabel mesh__D011039 Centers, Poison Control
% 212.75/212.91  |- skos__hiddenLabel mesh__D011039 Control Centers, Poison
% 212.75/212.91  |- mesh__publicMeSHNote mesh__D011039 66   
% 212.75/212.91  |- mesh__dateEstablished mesh__D011039 1966-01-01
% 212.75/212.91  |- skos__broader mesh__D011039smesh__D006268
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D011039 2003
% 212.75/212.91  |- mesh__recordAuthorizer mesh__D011039 sjn
% 212.75/212.91  |- mesh__historyNote mesh__D011039 66%28%64%29%   
% 212.75/212.91  |- mesh__dateCreated mesh__D011039 1999-01-01
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D011039 2000
% 212.75/212.91  |- skos__hiddenLabel mesh__D011039 Poison Control Center
% 212.75/212.91  |- skos__annotation mesh__D011039 specify geog if pertinent   
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D011039 2004
% 212.75/212.91  |- mesh__historyNote mesh__D016522
% 212.75/212.91       92; CANCER CARE UNITS was see HOSPITAL UNITS 1986-91   
% 212.75/212.91  |- skos__scopeNote mesh__D016522
% 212.75/212.91       The hospital department responsible for the administration and provision of diagnostic and therapeutic services for the cancer patient.%A%    
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D016522 2005
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D016522 1996
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D016522 2004
% 212.75/212.91  |- skos__hiddenLabel mesh__D016522 Cancer Care Unit
% 212.75/212.91  |- skos__altLabel mesh__D016522 Hospital Oncology Service
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D016522 1998
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D016522 2002
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D016522 2006
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D016522 1997
% 212.75/212.91  |- skos__hiddenLabel mesh__D016522 Services, Hospital Oncology
% 212.75/212.91  |- mesh__onlineNote mesh__D016522
% 212.75/212.91       use HOSPITAL UNITS to search CANCER CARE UNITS 1986-91   
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D016522 1999
% 212.75/212.91  |- skos__altLabel mesh__D016522 Oncology Services, Hospital
% 212.75/212.91  |- mesh__recordMaintainer mesh__D016522 KEV
% 212.75/212.91  |- mesh__recordOriginator mesh__D016522 JHM
% 212.75/212.91  |- mesh__recordAuthorizer mesh__D016522 PLS
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D016522 2000
% 212.75/212.91  |- mesh__dateCreated mesh__D016522 1991-02-11
% 212.75/212.91  |- rdf__type mesh__D016522sskos__Concept
% 212.75/212.91  |- mesh__dateRevised mesh__D016522 1995-05-22
% 212.75/212.91  |- skos__annotation mesh__D016522 DF: ONCOL SERV HOSP   
% 212.75/212.91  |- mesh__publicMeSHNote mesh__D016522
% 212.75/212.91       92; CANCER CARE UNITS was see HOSPITAL UNITS 1986-91   
% 212.75/212.91  |- skos__broader mesh__D016522smesh__D006748
% 212.75/212.91  |- skos__altLabel mesh__D016522 Service, Hospital Oncology
% 212.75/212.91  |- skos__hiddenLabel mesh__D016522 Units, Cancer Care
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D016522 2001
% 212.75/212.91  |- skos__hiddenLabel mesh__D016522 Unit, Cancer Care
% 212.75/212.91  |- skos__hiddenLabel mesh__D016522 Hospital Oncology Services
% 212.75/212.91  |- mesh__dateEstablished mesh__D016522 1992-01-01
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D016522 2003
% 212.75/212.91  |- skos__prefLabel mesh__D016522 Oncology Service, Hospital
% 212.75/212.91  |- mesh__dateCreated mesh__D002502 1978-03-10
% 212.75/212.91  |- mesh__recordMaintainer mesh__D002502 nns
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D002502 2006
% 212.75/212.91  |- skos__broader mesh__D002502smesh__D018385
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D002502 2005
% 212.75/212.91  |- rdf__type mesh__D002502sskos__Concept
% 212.75/212.91  |- skos__scopeNote mesh__D002502
% 212.75/212.91       Self-replicating, short, fibrous, rod-shaped organelles. Each centriole is a short cylinder containing nine pairs of peripheral microtubules, arranged so as to form the wall of the cylinder.%A%    
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D002502 2004
% 212.75/212.91  |- skos__prefLabel mesh__D002502 Centrioles
% 212.75/212.91  |- skos__historyNote mesh__D002502 Mitosis %28%1968-1978%29%
% 212.75/212.91  |- skos__annotation mesh__D002502
% 212.75/212.91       A 11 qualif except /cytol; /genet permitted   
% 212.75/212.91  |- skos__hiddenLabel mesh__D002502 Centriole
% 212.75/212.91  |- mesh__publicMeSHNote mesh__D002502
% 212.75/212.91       85; was see under ORGANOIDS 1979-84   
% 212.75/212.91  |- mesh__recordOriginator mesh__D002502 VDK
% 212.75/212.91  |- mesh__dateEstablished mesh__D002502 1985-01-01
% 212.75/212.91  |- mesh__dateRevised mesh__D002502 2003-07-09
% 212.75/212.91  |- mesh__historyNote mesh__D002502
% 212.75/212.91       85%28%79%29%; was see under ORGANOIDS 1979-84   
% 212.75/212.91  |- skos__historyNote mesh__D002502 Organoids %28%1966-1978%29%
% 212.75/212.91  |- mesh__recordAuthorizer mesh__D002502 sjn
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D007796 1999
% 212.75/212.91  |- skos__prefLabel mesh__D007796 Laminectomy
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D007796 2006
% 212.75/212.91  |- mesh__recordAuthorizer mesh__D007796 SJN
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D007796 2002
% 212.75/212.91  |- mesh__recordOriginator mesh__D007796 NLM
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D007796 2003
% 212.75/212.91  |- skos__annotation mesh__D007796
% 212.75/212.91       do not use /util except by MeSH definition   
% 212.75/212.91  |- skos__broader mesh__D007796smesh__D019635
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D007796 2004
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D007796 2000
% 212.75/212.91  |- mesh__dateEstablished mesh__D007796 1967-01-01
% 212.75/212.91  |- mesh__dateCreated mesh__D007796 1999-01-01
% 212.75/212.91  |- mesh__publicMeSHNote mesh__D007796 67   
% 212.75/212.91  |- mesh__recordMaintainer mesh__D007796 PXP
% 212.75/212.91  |- rdf__type mesh__D007796sskos__Concept
% 212.75/212.91  |- skos__scopeNote mesh__D007796
% 212.75/212.91       Excision of the posterior arch of a vertebra. %28%Dorland, 28th ed%29%%A%    
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D007796 2001
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D007796 1998
% 212.75/212.91  |- mesh__dateRevised mesh__D007796 1997-06-20
% 212.75/212.91  |- skos__hiddenLabel mesh__D007796 Laminectomies
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D007796 2005
% 212.75/212.91  |- mesh__historyNote mesh__D007796 67%28%64%29%   
% 212.75/212.91  |- mesh__publicMeSHNote mesh__D012930 69; was DOMINANCE, SOCIAL 1968   
% 212.75/212.91  |- skos__altLabel mesh__D012930 Dominance, Social
% 212.75/212.91  |- skos__hiddenLabel mesh__D012930 Hierarchy, Dominance
% 212.75/212.91  |- mesh__dateEstablished mesh__D012930 1969-01-01
% 212.75/212.91  |- skos__broader mesh__D012930smesh__D012919
% 212.75/212.91  |- mesh__historyNote mesh__D012930 69; was DOMINANCE, SOCIAL 1968   
% 212.75/212.91  |- mesh__dateRevised mesh__D012930 2002-07-03
% 212.75/212.91  |- skos__annotation mesh__D012930 human %26% animal   
% 212.75/212.91  |- mesh__recordAuthorizer mesh__D012930 sjn
% 212.75/212.91  |- skos__hiddenLabel mesh__D012930 Dominance Hierarchies
% 212.75/212.91  |- mesh__recordMaintainer mesh__D012930 jls
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D012930 2006
% 212.75/212.91  |- skos__scopeNote mesh__D012930
% 212.75/212.91       Social structure of a group as it relates to the relative social rank of dominance status of its members. %28%APA, Thesaurus of Psychological Index Terms, 8th ed.%29%%A%    
% 212.75/212.91  |- mesh__recordOriginator mesh__D012930 NLM
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D012930 2004
% 212.75/212.91  |- mesh__dateCreated mesh__D012930 1999-01-01
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D012930 2005
% 212.75/212.91  |- rdf__type mesh__D012930sskos__Concept
% 212.75/212.91  |- mesh__onlineNote mesh__D012930
% 212.75/212.91       use SOCIAL DOMINANCE to search DOMINANCE, SOCIAL 1968   
% 212.75/212.91  |- skos__altLabel mesh__D012930 Dominance Hierarchy
% 212.75/212.91  |- skos__prefLabel mesh__D012930 Social Dominance
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D012930 2003
% 212.75/212.91  |- skos__broader mesh__D011970Q000819smesh__D011970
% 212.75/212.91  |- mesh__preferredCombination mesh__D011970Q000819smesh__D017442
% 212.75/212.91  |- rdf__type mesh__D011970Q000819smesh__CompoundConcept
% 212.75/212.91  |- mesh__activeMeSHYear mesh__D012132 2006
% 212.75/212.91  |- skos__hiddenLabel mesh__D012132 Muscle, Respiratory
% 212.75/212.91  |- mesh__dateEstablished mesh__D012132 1987-01-01
% 212.75/212.91  |- skos__historyNote mesh__D012132 Muscles %28%1966-1986%29%
% 212.75/212.91  |- skos__altLabel mesh__D012132 Respiratory Muscle
% 212.75/212.91  |- skos__historyNote mesh__D012132 Intercostal Muscles %28%1966-1986%29%
% 212.75/212.91  |- skos__hiddenLabel mesh__D012132 Muscle, Ventilatory
% 212.75/212.91  |- rdf__type mesh__D012132sskos__Concept
% 212.75/212.91  |- mesh__dateRevised mesh__D012132 2003-07-09
% 212.75/212.91  |- skos__hiddenLabel mesh__D012132 Muscles, Ventilatory
% 212.75/212.91  |- skos__annotation mesh__D012132
% 212.75/212.91       /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 212.75/212.91  |- skos__altLabel mesh__D012132 Ventilatory Muscles
% 212.75/212.91  |- skos__historyNote mesh__D012132 Respiration %28%1966-1986%29%
% 212.75/212.91  |- skos__broader mesh__D012132smesh__D018482
% 212.75/212.91  |- skos__historyNote mesh__D012132 Diaphragm %28%1966-1986%29%
% 212.75/212.92  |- skos__hiddenLabel mesh__D012132 Muscles, Respiratory
% 212.75/212.92  |- skos__hiddenLabel mesh__D012132 Ventilatory Muscle
% 212.75/212.92  |- mesh__recordAuthorizer mesh__D012132 sjn
% 212.75/212.92  |- mesh__dateCreated mesh__D012132 1986-04-02
% 212.75/212.92  |- mesh__historyNote mesh__D012132 87   
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D012132 2005
% 212.75/212.92  |- mesh__publicMeSHNote mesh__D012132 87   
% 212.75/212.92  |- skos__scopeNote mesh__D012132
% 212.75/212.92       These include the muscles of the DIAPHRAGM and the INTERCOSTAL MUSCLES.%A%    
% 212.75/212.92  |- mesh__recordMaintainer mesh__D012132 nns
% 212.75/212.92  |- mesh__recordOriginator mesh__D012132 RC
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D012132 2004
% 212.75/212.92  |- skos__prefLabel mesh__D012132 Respiratory Muscles
% 212.75/212.92  |- skos__broader mesh__D014730Q000331smesh__D014730
% 212.75/212.92  |- mesh__preferredCombination mesh__D014730Q000331smesh__D007886
% 212.75/212.92  |- rdf__type mesh__D014730Q000331smesh__CompoundConcept
% 212.75/212.92  |- mesh__dateCreated mesh__D011838 1999-01-01
% 212.75/212.92  |- mesh__recordAuthorizer mesh__D011838 sjn
% 212.75/212.92  |- mesh__recordOriginator mesh__D011838 NLM
% 212.75/212.92  |- skos__hiddenLabel mesh__D011838 Drugs, Radiosensitizing
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D011838 2005
% 212.75/212.92  |- mesh__dateRevised mesh__D011838 2003-07-09
% 212.75/212.92  |- skos__altLabel mesh__D011838 Radiation Sensitizers
% 212.75/212.92  |- mesh__publicMeSHNote mesh__D011838 66   
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D011838 2004
% 212.75/212.92  |- skos__altLabel mesh__D011838 Radiation-Sensitizing Drugs
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D011838 2006
% 212.75/212.92  |- skos__prefLabel mesh__D011838 Radiation-Sensitizing Agents
% 212.75/212.92  |- mesh__historyNote mesh__D011838 66%28%65%29%   
% 212.75/212.92  |- skos__hiddenLabel mesh__D011838 Sensitizers, Radiation
% 212.75/212.92  |- skos__hiddenLabel mesh__D011838 Sensitizing Agents, Radiation
% 212.75/212.92  |- mesh__dateEstablished mesh__D011838 1966-01-01
% 212.75/212.92  |- skos__altLabel mesh__D011838 Agents, Radiation-Sensitizing
% 212.75/212.92  |- skos__hiddenLabel mesh__D011838 Agents, Radiosensitizing
% 212.75/212.92  |- skos__scopeNote mesh__D011838
% 212.75/212.92       Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.%A%    
% 212.75/212.92  |- mesh__recordMaintainer mesh__D011838 ssb
% 212.75/212.92  |- skos__altLabel mesh__D011838 Radiosensitizing Drugs
% 212.75/212.92  |- rdf__type mesh__D011838sskos__Concept
% 212.75/212.92  |- skos__annotation mesh__D011838
% 212.75/212.92       D25-26 qualif; do not use /ther use when coordinating with disease /radiother but /ther use permitted with specific radiation-sensitizing agents in radiother; DF: RAD SENSITIZING AGENTS%A%  
% 212.75/212.92  |- skos__hiddenLabel mesh__D011838 Radiation Sensitizing Drugs
% 212.75/212.92  |- skos__altLabel mesh__D011838 Radiation Sensitizing Agents
% 212.75/212.92  |- skos__broader mesh__D011838smesh__D045505
% 212.75/212.92  |- skos__hiddenLabel mesh__D011838 Agents, Radiation Sensitizing
% 212.75/212.92  |- skos__altLabel mesh__D011838 Radiosensitizing Agents
% 212.75/212.92  |- skos__hiddenLabel mesh__D011838 Drugs, Radiation-Sensitizing
% 212.75/212.92  |- mesh__recordAuthorizer mesh__D008091 sjn
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008091 2002
% 212.75/212.92  |- skos__scopeNote mesh__D008091
% 212.75/212.92       Writings having excellence of form or expression and expressing ideas of permanent or universal interest. The body of written works produced in a particular language, country, or age. %28%Webster, 3d ed%29%%A%    
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008091 2006
% 212.75/212.92  |- skos__annotation mesh__D008091
% 212.75/212.92       the body of literary works; TN 121: differentiate from BIBLIOGRAPHY; relation to BOOKS: Manual 33.11%A%  
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008091 2004
% 212.75/212.92  |- mesh__dateCreated mesh__D008091 1999-01-01
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008091 2005
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008091 2001
% 212.75/212.92  |- mesh__dateRevised mesh__D008091 1999-11-03
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008091 2003
% 212.75/212.92  |- skos__related mesh__D008091smesh__D008513
% 212.75/212.92  |- skos__broader mesh__D008091smesh__D006809
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008091 2000
% 212.75/212.92  |- skos__prefLabel mesh__D008091 Literature
% 212.75/212.92  |- skos__hiddenLabel mesh__D008091 Literatures
% 212.75/212.92  |- mesh__recordMaintainer mesh__D008091 kle
% 212.75/212.92  |- rdf__type mesh__D008091sskos__Concept
% 212.75/212.92  |- mesh__recordOriginator mesh__D008091 NLM
% 212.75/212.92  |- mesh__recordOriginator mesh__D016523 AGS
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D016523 2001
% 212.75/212.92  |- skos__historyNote mesh__D016523 Foot Diseases %28%1966-1991%29%
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D016523 2006
% 212.75/212.92  |- skos__annotation mesh__D016523 DIABETIC FOOT is also available   
% 212.75/212.92  |- skos__historyNote mesh__D016523 Skin Ulcer %28%1966-1991%29%
% 212.75/212.92  |- skos__hiddenLabel mesh__D016523 Foot Ulcers
% 212.75/212.92  |- mesh__dateEstablished mesh__D016523 1992-01-01
% 212.75/212.92  |- mesh__recordAuthorizer mesh__D016523 sjn
% 212.75/212.92  |- skos__hiddenLabel mesh__D016523 Plantar Ulcers
% 212.75/212.92  |- mesh__publicMeSHNote mesh__D016523 92   
% 212.75/212.92  |- skos__broader mesh__D016523smesh__D005534
% 212.75/212.92  |- skos__hiddenLabel mesh__D016523 Ulcer, Foot
% 212.75/212.92  |- skos__hiddenLabel mesh__D016523 Ulcer, Plantar
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D016523 2002
% 212.75/212.92  |- rdf__type mesh__D016523sskos__Concept
% 212.75/212.92  |- skos__hiddenLabel mesh__D016523 Ulcers, Foot
% 212.75/212.92  |- skos__scopeNote mesh__D016523
% 212.75/212.92       Lesion on the surface of the skin of the foot, usually accompanied by inflammation. The lesion may become infected or necrotic and is frequently associated with diabetes or leprosy.%A%    
% 212.75/212.92  |- mesh__recordMaintainer mesh__D016523 PXP
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D016523 2003
% 212.75/212.92  |- skos__prefLabel mesh__D016523 Foot Ulcer
% 212.75/212.92  |- mesh__dateRevised mesh__D016523 1999-11-03
% 212.75/212.92  |- skos__hiddenLabel mesh__D016523 Ulcers, Plantar
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D016523 2000
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D016523 2005
% 212.75/212.92  |- mesh__dateCreated mesh__D016523 1991-01-02
% 212.75/212.92  |- mesh__historyNote mesh__D016523 92   
% 212.75/212.92  |- skos__broader mesh__D016523smesh__D007871
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D016523 2004
% 212.75/212.92  |- mesh__recordOriginator mesh__D002503 VDK
% 212.75/212.92  |- mesh__recordAuthorizer mesh__D002503 sjn
% 212.75/212.92  |- mesh__dateCreated mesh__D002503 1977-04-29
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D002503 2006
% 212.75/212.92  |- skos__historyNote mesh__D002503 Chromosomes %28%1966-1977%29%
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D002503 2005
% 212.75/212.92  |- mesh__publicMeSHNote mesh__D002503
% 212.75/212.92       91; was see under CHROMOSOMES 1978-90   
% 212.75/212.92  |- mesh__recordMaintainer mesh__D002503 nns
% 212.75/212.92  |- rdf__type mesh__D002503sskos__Concept
% 212.75/212.92  |- skos__prefLabel mesh__D002503 Centromere
% 212.75/212.92  |- skos__scopeNote mesh__D002503
% 212.75/212.92       The clear constricted portion of the chromosome at which the chromatids are joined and by which the chromosome is attached to the spindle during cell division.%A%    
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D002503 2004
% 212.75/212.92  |- skos__broader mesh__D002503smesh__D022004
% 212.75/212.92  |- mesh__dateRevised mesh__D002503 2003-07-09
% 212.75/212.92  |- mesh__historyNote mesh__D002503
% 212.75/212.92       91%28%78%29%; was see under CHROMOSOMES 1978-90   
% 212.75/212.92  |- skos__related mesh__D002503smesh__D004276
% 212.75/212.92  |- mesh__dateEstablished mesh__D002503 1991-01-01
% 212.75/212.92  |- skos__hiddenLabel mesh__D002503 Centromeres
% 212.75/212.92  |- skos__hiddenLabel mesh__D007797 Glycoprotein GP 2
% 212.75/212.92  |- skos__altLabel mesh__D007797 Glycoprotein GP-2
% 212.75/212.92  |- skos__historyNote mesh__D007797 Membrane Proteins %28%1977-1983%29%
% 212.75/212.92  |- mesh__publicMeSHNote mesh__D007797 84   
% 212.75/212.92  |- skos__prefLabel mesh__D007797 Laminin
% 212.75/212.92  |- mesh__dateRevised mesh__D007797 1996-06-10
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D007797 1999
% 212.75/212.92  |- skos__annotation mesh__D007797
% 212.75/212.92       an extracellular matrix protein; /biosyn /physiol permitted%A%  
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D007797 2006
% 212.75/212.92  |- skos__historyNote mesh__D007797 Glycoproteins %28%1966-1983%29%
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D007797 2001
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D007797 1998
% 212.75/212.92  |- mesh__historyNote mesh__D007797 84   
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D007797 1997
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D007797 2005
% 212.75/212.92  |- mesh__recordAuthorizer mesh__D007797 PLS
% 212.75/212.92  |- skos__broader mesh__D007797smesh__D008562
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D007797 2004
% 212.75/212.92  |- mesh__dateCreated mesh__D007797 1983-05-31
% 212.75/212.92  |- skos__broader mesh__D007797smesh__D016326
% 212.75/212.92  |- mesh__dateEstablished mesh__D007797 1984-01-01
% 212.75/212.92  |- skos__hiddenLabel mesh__D007797 Chain, Laminin M
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D007797 2000
% 212.75/212.92  |- skos__historyNote mesh__D007797 Neoplasm Proteins %28%1966-1983%29%
% 212.75/212.92  |- skos__related mesh__D007797smesh__D017474
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D007797 2003
% 212.75/212.92  |- mesh__recordOriginator mesh__D007797 RLS
% 212.75/212.92  |- skos__hiddenLabel mesh__D007797 M Chain, Laminin
% 212.75/212.92  |- mesh__recordMaintainer mesh__D007797 TPW
% 212.75/212.92  |- rdf__type mesh__D007797sskos__Concept
% 212.75/212.92  |- skos__scopeNote mesh__D007797
% 212.75/212.92       Large, noncollagenous glycoprotein with antigenic properties. It is localized in the basement membrane lamina lucida and functions to bind epithelial cells to the basement membrane. Evidence suggests that the protein plays a role in tumor invasion.%A%    
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D007797 2002
% 212.75/212.92  |- skos__historyNote mesh__D012931 Social Conditions %28%1966-1971%29%
% 212.75/212.92  |- skos__historyNote mesh__D012931 Social Planning %28%1968-1971%29%
% 212.75/212.92  |- skos__historyNote mesh__D012931 Environment %28%1966-1971%29%
% 212.75/212.92  |- mesh__recordOriginator mesh__D012931 NLM
% 212.75/212.92  |- skos__annotation mesh__D012931
% 212.75/212.92       human %26% animal; no qualif; DF: SOCIAL ENVIR   
% 212.75/212.92  |- skos__prefLabel mesh__D012931 Social Environment
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D012931 2000
% 212.75/212.92  |- skos__related mesh__D012931smesh__D008019
% 212.75/212.92  |- skos__historyNote mesh__D012931 Socioeconomic Factors %28%1968-1971%29%
% 212.75/212.92  |- mesh__dateCreated mesh__D012931 1999-01-01
% 212.75/212.92  |- mesh__dateEstablished mesh__D012931 1973-01-01
% 212.75/212.92  |- skos__historyNote mesh__D012931 Social Behavior %28%1969-1971%29%
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D012931 2005
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D012931 2001
% 212.75/212.92  |- mesh__dateRevised mesh__D012931 1999-11-03
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D012931 2003
% 212.75/212.92  |- skos__historyNote mesh__D012931 Social Adjustment %28%1969-1971%29%
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D012931 2006
% 212.75/212.92  |- skos__historyNote mesh__D012931
% 212.75/212.92       Adaptation, Psychological %28%1966-1968%29%
% 212.75/212.92  |- skos__hiddenLabel mesh__D012931 Environments, Social
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D012931 2002
% 212.75/212.92  |- mesh__historyNote mesh__D012931 73%28%72%29%   
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D012931 2004
% 212.75/212.92  |- mesh__recordMaintainer mesh__D012931 kle
% 212.75/212.92  |- mesh__publicMeSHNote mesh__D012931 73   
% 212.75/212.92  |- skos__historyNote mesh__D012931 Social Isolation %28%1969-1971%29%
% 212.75/212.92  |- rdf__type mesh__D012931sskos__Concept
% 212.75/212.92  |- mesh__recordAuthorizer mesh__D012931 sjn
% 212.75/212.92  |- skos__altLabel mesh__D012931 Environment, Social
% 212.75/212.92  |- skos__hiddenLabel mesh__D012931 Social Environments
% 212.75/212.92  |- skos__scopeNote mesh__D012931
% 212.75/212.92       The aggregate of social and cultural institutions, forms, patterns, and processes that influence the life of an individual or community.%A%    
% 212.75/212.92  |- skos__broader mesh__D012931smesh__D012961
% 212.75/212.92  |- skos__hiddenLabel mesh__D012133 Respiratory Muscle Paralysis
% 212.75/212.92  |- mesh__recordAuthorizer mesh__D012133 ags
% 212.75/212.92  |- skos__hiddenLabel mesh__D012133 Paralysis, Diaphragmatic
% 212.75/212.92  |- mesh__recordMaintainer mesh__D012133 ags
% 212.75/212.92  |- rdf__type mesh__D012133sskos__Concept
% 212.75/212.92  |- mesh__publicMeSHNote mesh__D012133 73   
% 212.75/212.92  |- skos__hiddenLabel mesh__D012133 Muscle Paralyses, Respiratory
% 212.75/212.92  |- mesh__dateEstablished mesh__D012133 1973-01-01
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D012133 2002
% 212.75/212.92  |- skos__historyNote mesh__D012133
% 212.75/212.92       Respiratory Insufficiency %28%1966-1967%29%
% 212.75/212.92  |- skos__prefLabel mesh__D012133 Respiratory Paralysis
% 212.75/212.92  |- skos__broader mesh__D012133smesh__D012131
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D012133 2006A
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D012133 2003
% 212.75/212.92  |- mesh__dateRevised mesh__D012133 2005-07-22
% 212.75/212.92  |- mesh__dateCreated mesh__D012133 1999-01-01
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D012133 2005
% 212.75/212.92  |- mesh__recordOriginator mesh__D012133 NLM
% 212.75/212.92  |- skos__historyNote mesh__D012133 Paralysis %28%1966-1967%29%
% 212.75/212.92  |- skos__altLabel mesh__D012133 Diaphragmatic Paralysis
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D012133 2004
% 212.75/212.92  |- skos__scopeNote mesh__D012133
% 212.75/212.92       Complete or severe weakness of the muscles of respiration. This condition may be associated with MOTOR NEURON DISEASES; PERIPHERAL NERVE DISEASES; NEUROMUSCULAR JUNCTION DISEASES; SPINAL CORD DISEASES; injury to the PHRENIC NERVE; and other disorders.%A%    
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D012133 2006
% 212.75/212.92  |- mesh__historyNote mesh__D012133 73%28%68%29%   
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D012133 2000
% 212.75/212.92  |- skos__broader mesh__D012133smesh__D010243
% 212.75/212.92  |- skos__hiddenLabel mesh__D012133 Muscle Paralysis, Respiratory
% 212.75/212.92  |- skos__altLabel mesh__D012133 Paralysis, Respiratory Muscle
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D012133 2001
% 212.75/212.92  |- skos__hiddenLabel mesh__D012133 Paralysis, Respiratory
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D036581 2005
% 212.75/212.92  |- skos__broader mesh__D036581smesh__D019659
% 212.75/212.92  |- mesh__publicMeSHNote mesh__D036581 2003   
% 212.75/212.92  |- rdf__type mesh__D036581sskos__Concept
% 212.75/212.92  |- skos__prefLabel mesh__D036581 Ratibida
% 212.75/212.92  |- skos__scopeNote mesh__D036581
% 212.75/212.92       A plant genus of the family ASTERACEAE. Members contain sesquiterpene lactones.%A%    
% 212.75/212.92  |- mesh__dateEstablished mesh__D036581 2003-01-01
% 212.75/212.92  |- mesh__dateCreated mesh__D036581 2002-07-03
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D036581 2004
% 212.75/212.92  |- mesh__historyNote mesh__D036581 2003   
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D036581 2006
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D036581 2003
% 212.75/212.92  |- skos__altLabel mesh__D036581 Coneflower, Prairie
% 212.75/212.92  |- skos__annotation mesh__D036581
% 212.75/212.92       X ref CONEFLOWER, PRAIRIE: CONEFLOWER, PURPLE see ECHINACEA and CONEFLOWER, ORANGE see RUDBECKIA are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008890 2004
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008890 1998
% 212.75/212.92  |- skos__scopeNote mesh__D008890
% 212.75/212.92       Branch of psychiatry concerned with problems related to the prevention, diagnosis, etiology, and treatment of mental or emotional disorders of Armed Forces personnel.%A%    
% 212.75/212.92  |- rdf__type mesh__D008890sskos__Concept
% 212.75/212.92  |- mesh__dateCreated mesh__D008890 1999-01-01
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008890 2003
% 212.75/212.92  |- mesh__historyNote mesh__D008890 80; was PSYCHIATRY, MILITARY 1963-79   
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008890 1997
% 212.75/212.92  |- skos__annotation mesh__D008890
% 212.75/212.92       SPEC only: SPEC qualif; not for MENTAL DISORDERS in soldiers, etc.%A%  
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008890 1996
% 212.75/212.92  |- skos__broader mesh__D008890smesh__D011570
% 212.75/212.92  |- skos__altLabel mesh__D008890 Psychiatry, Military
% 212.75/212.92  |- mesh__recordOriginator mesh__D008890 NLM
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008890 2002
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008890 2006
% 212.75/212.92  |- mesh__publicMeSHNote mesh__D008890
% 212.75/212.92       80; was PSYCHIATRY, MILITARY 1963-79   
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008890 2001
% 212.75/212.92  |- skos__prefLabel mesh__D008890 Military Psychiatry
% 212.75/212.92  |- mesh__recordAuthorizer mesh__D008890 PLS
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008890 2005
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008890 2000
% 212.75/212.92  |- mesh__dateRevised mesh__D008890 1995-05-18
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008890 1999
% 212.75/212.92  |- mesh__onlineNote mesh__D008890
% 212.75/212.92       use MILITARY PSYCHIATRY to search PSYCHIATRY, MILITARY 1966-79%A%  
% 212.75/212.92  |- mesh__recordMaintainer mesh__D008890 TAP
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D011839 1998
% 212.75/212.92  |- skos__altLabel mesh__D011839 Radiation, Ionizing Electromagnetic
% 212.75/212.92  |- skos__annotation mesh__D011839
% 212.75/212.92       as NIM: Manual 19.8.60, 28.11.1; when not to use: Manual 21.16; no qualif; /adv eff = RADIATION INJURIES but see note there%A%  
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D011839 2004
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D011839 1997
% 212.75/212.92  |- mesh__publicMeSHNote mesh__D011839 76   
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D011839 2006
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D011839 1999
% 212.75/212.92  |- skos__prefLabel mesh__D011839 Radiation, Ionizing
% 212.75/212.92  |- skos__scopeNote mesh__D011839
% 212.75/212.92       Electromagnetic or corpuscular radiation capable of producing ions, directly or indirectly, in its passage through matter. The wavelengths are equal to or smaller than those of short %28%far%29% ultraviolet radiation and include gamma and X-rays and high-energy elementary particles.%A%    
% 212.75/212.92  |- skos__altLabel mesh__D011839 Electromagnetic Radiation, Ionizing
% 212.75/212.92  |- skos__hiddenLabel mesh__D011839 Ionizing Radiations
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D011839 2002
% 212.75/212.92  |- skos__broader mesh__D011839smesh__D011827
% 212.75/212.92  |- mesh__dateRevised mesh__D011839 1995-03-13
% 212.75/212.92  |- mesh__historyNote mesh__D011839 76; was NON MESH before 1976   
% 212.75/212.92  |- skos__hiddenLabel mesh__D011839 Electromagnetic Radiations, Ionizing
% 212.75/212.92  |- skos__altLabel mesh__D011839 Ionizing Radiation
% 212.75/212.92  |- skos__hiddenLabel mesh__D011839 Radiations, Ionizing Electromagnetic
% 212.75/212.92  |- rdf__type mesh__D011839sskos__Concept
% 212.75/212.92  |- skos__hiddenLabel mesh__D011839 Radiations, Ionizing
% 212.75/212.92  |- skos__hiddenLabel mesh__D011839 Ionizing Electromagnetic Radiations
% 212.75/212.92  |- mesh__dateCreated mesh__D011839 1975-07-23
% 212.75/212.92  |- skos__altLabel mesh__D011839 Ionizing Electromagnetic Radiation
% 212.75/212.92  |- mesh__recordMaintainer mesh__D011839 TGC
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D011839 2000
% 212.75/212.92  |- mesh__dateEstablished mesh__D011839 1976-01-01
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D011839 2003
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D011839 2001
% 212.75/212.92  |- mesh__recordOriginator mesh__D011839 JW
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D011839 1996
% 212.75/212.92  |- mesh__recordAuthorizer mesh__D011839 PLS
% 212.75/212.92  |- skos__historyNote mesh__D011839 Radiation %28%1966-1975%29%
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D011839 2005
% 212.75/212.92  |- skos__scopeNote mesh__D022561
% 212.75/212.92       The use of sophisticated methods and equipment to treat cardiopulmonary arrest. Advanced Cardiac Life Support %28%ACLS%29% includes the use of specialized equipment to maintain the airway, early defibrillation and pharmacological therapy.%A%    
% 212.75/212.92  |- skos__altLabel mesh__D022561 Cardiac Life Support, Advanced
% 212.75/212.92  |- skos__related mesh__D022561smesh__D006323
% 212.75/212.92  |- mesh__recordAuthorizer mesh__D022561 sjn
% 212.75/212.92  |- skos__prefLabel mesh__D022561 Advanced Cardiac Life Support
% 212.75/212.92  |- skos__historyNote mesh__D022561 Resuscitation %28%1971-1991%29%
% 212.75/212.92  |- mesh__historyNote mesh__D022561 2001   
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D022561 2006
% 212.75/212.92  |- mesh__recordMaintainer mesh__D022561 jls
% 212.75/212.92  |- mesh__dateEstablished mesh__D022561 2001-01-01
% 212.75/212.92  |- skos__historyNote mesh__D022561
% 212.75/212.92       Cardiopulmonary Resuscitation %28%1992-2000%29%
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D022561 2005
% 212.75/212.92  |- skos__broader mesh__D022561smesh__D016887
% 212.75/212.92  |- rdf__type mesh__D022561sskos__Concept
% 212.75/212.92  |- mesh__dateCreated mesh__D022561 2000-06-21
% 212.75/212.92  |- mesh__recordOriginator mesh__D022561 jmp
% 212.75/212.92  |- mesh__publicMeSHNote mesh__D022561 2001   
% 212.75/212.92  |- mesh__dateRevised mesh__D022561 2004-07-19
% 212.75/212.92  |- skos__altLabel mesh__D022561 Life Support, Advanced Cardiac
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008092 2004
% 212.75/212.92  |- mesh__dateCreated mesh__D008092 1999-01-01
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008092 2005
% 212.75/212.92  |- skos__altLabel mesh__D008092 Medieval Literature
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008092 2000
% 212.75/212.92  |- mesh__recordMaintainer mesh__D008092 kle
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008092 2003
% 212.75/212.92  |- mesh__recordOriginator mesh__D008092 NLM
% 212.75/212.92  |- mesh__recordAuthorizer mesh__D008092 sjn
% 212.75/212.92  |- rdf__type mesh__D008092sskos__Concept
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008092 2002
% 212.75/212.92  |- mesh__dateRevised mesh__D008092 1999-11-03
% 212.75/212.92  |- skos__annotation mesh__D008092
% 212.75/212.92       coord IM with POETRY %28%IM%29% or DRAMA %28%IM%29%; DF: LIT MEDIEVAL%A%  
% 212.75/212.92  |- skos__broader mesh__D008092smesh__D008091
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008092 2006
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D008092 2001
% 212.75/212.92  |- skos__prefLabel mesh__D008092 Literature, Medieval
% 212.75/212.92  |- skos__hiddenLabel mesh__D016524 Leave, Paternity
% 212.75/212.92  |- skos__historyNote mesh__D016524 Pregnancy %28%1978-1990%29%
% 212.75/212.92  |- rdf__type mesh__D016524sskos__Concept
% 212.75/212.92  |- skos__annotation mesh__D016524
% 212.75/212.92       prenatal %26% postnatal leave, leave for illness of a child or leave for adoption procedures; do not confuse with FAMILY LEAVE: see MeSH definition%A%  
% 212.75/212.92  |- skos__hiddenLabel mesh__D016524 Leave, Parental
% 212.75/212.92  |- skos__prefLabel mesh__D016524 Parental Leave
% 212.75/212.92  |- mesh__recordOriginator mesh__D016524 JHM
% 212.75/212.92  |- mesh__recordAuthorizer mesh__D016524 PLS
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D016524 2000
% 212.75/212.92  |- mesh__dateCreated mesh__D016524 1991-02-11
% 212.75/212.92  |- mesh__dateRevised mesh__D016524 1994-05-05
% 212.75/212.92  |- mesh__dateEstablished mesh__D016524 1992-01-01
% 212.75/212.92  |- skos__historyNote mesh__D016524
% 212.75/212.92       Salaries and Fringe Benefits %28%1981-1990%29%
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D016524 2003
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D016524 2001
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D016524 2005
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D016524 1996
% 212.75/212.92  |- mesh__historyNote mesh__D016524 92   
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D016524 2004
% 212.75/212.92  |- skos__hiddenLabel mesh__D016524 Leave, Maternity
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D016524 1998
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D016524 2006
% 212.75/212.92  |- mesh__publicMeSHNote mesh__D016524 92   
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D016524 1997
% 212.75/212.92  |- skos__broader mesh__D016524smesh__D017407
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D016524 1999
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D016524 2002
% 212.75/212.92  |- skos__scopeNote mesh__D016524
% 212.75/212.92       The authorized absence from work of either parent prior to and after the birth of their child. It includes also absence because of the illness of a child or at the time of the adoption of a child. It does not include leave for care of siblings, parents, or other family members: for this FAMILY LEAVE is available.%A%    
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D016524 1995
% 212.75/212.92  |- mesh__recordMaintainer mesh__D016524 TGC
% 212.75/212.92  |- skos__altLabel mesh__D002504
% 212.75/212.92       Alpharma Brand of Meclofenoxate Hydrochloride
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D002504 2006
% 212.75/212.92  |- mesh__recordOriginator mesh__D002504 NLM
% 212.75/212.92  |- skos__scopeNote mesh__D002504
% 212.75/212.92       A drug composed of DIMETHYLAMINOETHANOL and parachlorphenoxyacetic acid %28%PCPA%29%.%A%    
% 212.75/212.92  |- mesh__dateCreated mesh__D002504 1999-01-01
% 212.75/212.92  |- mesh__dateEstablished mesh__D002504 1991-01-01
% 212.75/212.92  |- skos__altLabel mesh__D002504 Centrophenoxine
% 212.75/212.92  |- skos__prefLabel mesh__D002504 Meclofenoxate
% 212.75/212.92  |- rdf__type mesh__D002504sskos__Concept
% 212.75/212.92  |- skos__broader mesh__D002504smesh__D006016
% 212.75/212.92  |- mesh__recordAuthorizer mesh__D002504 sjn
% 212.75/212.92  |- mesh__historyNote mesh__D002504
% 212.75/212.92       91%28%65%29%; was CENTROPHENOXINE see under GLYCOLATES 1975-90 %26% see under ACETIC ACIDS 1965-74 %28%Prov 1965-67%29%; MECLOFENOXATE was see CENTROPHENOXINE 1977-90%A%  
% 212.75/212.92  |- mesh__onlineNote mesh__D002504
% 212.75/212.92       use MECLOFENOXATE to search CENTROPHENOXINE 1975-90; use ACETIC ACIDS 1966-74 %28%as Prov 1966-67%29%%A%  
% 212.75/212.92  |- mesh__dateRevised mesh__D002504 2005-06-30
% 212.75/212.92  |- skos__altLabel mesh__D002504
% 212.75/212.92       Lundbeck Brand of Meclofenoxate Hydrochloride
% 212.75/212.92  |- mesh__recordMaintainer mesh__D002504 ags
% 212.75/212.92  |- mesh__publicMeSHNote mesh__D002504
% 212.75/212.92       91; was CENTROPHENOXINE see under GLYCOLATES 1975-90 %26% see under ACETIC ACIDS 1968-74; MECLOFENOXATE was see CENTROPHENOXINE 1977-90%A%  
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D007798 2006
% 212.75/212.92  |- mesh__onlineNote mesh__D007798 search CYCLOSTOMES 1968-74   
% 212.75/212.92  |- skos__prefLabel mesh__D007798 Lampreys
% 212.75/212.92  |- skos__scopeNote mesh__D007798
% 212.75/212.92       Common name for the only family %28%Petromyzontidae%29% of eellike fish in the order Petromyzontiformes. They are jawless but have a sucking mouth with horny teeth.%A%    
% 212.75/212.92  |- mesh__dateEstablished mesh__D007798 1991-01-01
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D007798 2005
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D007798 2004
% 212.75/212.92  |- skos__altLabel mesh__D007798 Eels, Lamprey
% 212.75/212.92  |- skos__hiddenLabel mesh__D007798 Lamprey Eels
% 212.75/212.92  |- mesh__recordMaintainer mesh__D007798 ags
% 212.75/212.92  |- skos__hiddenLabel mesh__D007798 Lamprey
% 212.75/212.92  |- skos__hiddenLabel mesh__D007798 Eel, Lamprey
% 212.75/212.92  |- mesh__dateRevised mesh__D007798 2003-07-09
% 212.75/212.92  |- rdf__type mesh__D007798sskos__Concept
% 212.75/212.92  |- skos__altLabel mesh__D007798 Petromyzontidae
% 212.75/212.92  |- skos__hiddenLabel mesh__D007798 Lamprey Eel
% 212.75/212.92  |- mesh__recordOriginator mesh__D007798 NLM
% 212.75/212.92  |- skos__broader mesh__D007798smesh__D005399
% 212.75/212.92  |- mesh__historyNote mesh__D007798
% 212.75/212.92       91%28%75%29%; was see under CYCLOSTOMES 1975-90   
% 212.75/212.92  |- mesh__dateCreated mesh__D007798 1999-01-01
% 212.75/212.92  |- mesh__publicMeSHNote mesh__D007798
% 212.75/212.92       91; was see under CYCLOSTOMES 1975-90   
% 212.75/212.92  |- mesh__recordAuthorizer mesh__D007798 sjn
% 212.75/212.92  |- skos__scopeNote mesh__D012932
% 212.75/212.92       Any enhancement of a motivated behavior in which individuals do the same thing with some degree of mutual stimulation and consequent coordination.%A%    
% 212.75/212.92  |- skos__hiddenLabel mesh__D012932 Social Facilitations
% 212.75/212.92  |- mesh__dateRevised mesh__D012932 2002-07-03
% 212.75/212.92  |- mesh__recordAuthorizer mesh__D012932 sjn
% 212.75/212.92  |- mesh__dateCreated mesh__D012932 1999-01-01
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D012932 2005
% 212.75/212.92  |- mesh__publicMeSHNote mesh__D012932 68   
% 212.75/212.92  |- mesh__recordOriginator mesh__D012932 NLM
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D012932 2003
% 212.75/212.92  |- mesh__historyNote mesh__D012932 68   
% 212.75/212.92  |- skos__hiddenLabel mesh__D012932 Facilitations, Social
% 212.75/212.92  |- skos__annotation mesh__D012932 human %26% animal; no qualif   
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D012932 2006
% 212.75/212.92  |- mesh__dateEstablished mesh__D012932 1968-01-01
% 212.75/212.92  |- mesh__activeMeSHYear mesh__D012932 2004
% 212.75/212.92  |- rdf__type mesh__D012932sskos__Concept
% 212.75/212.92  |- skos__hiddenLabel mesh__D012932 Facilitation, Social
% 212.75/212.92  |- skos__prefLabel mesh__D012932 Social Facilitation
% 212.75/212.92  |- mesh__recordMaintainer mesh__D012932 AGS
% 212.75/212.92  |- skos__broader mesh__D012932smesh__D012919
% 212.75/212.92  |- skos__hiddenLabel mesh__D012134 Air-Purifying Respirator
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D012134 2006
% 212.75/212.93  |- mesh__recordOriginator mesh__D012134 NLM
% 212.75/212.93  |- skos__hiddenLabel mesh__D012134 Respirator, Industrial
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D012134 1998
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D012134 2002
% 212.75/212.93  |- mesh__recordMaintainer mesh__D012134 PXP
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D012134 2005
% 212.75/212.93  |- skos__prefLabel mesh__D012134 Respiratory Protective Devices
% 212.75/212.93  |- rdf__type mesh__D012134sskos__Concept
% 212.75/212.93  |- skos__hiddenLabel mesh__D012134 Air-Purifying Respirators
% 212.75/212.93  |- skos__hiddenLabel mesh__D012134 Protective Devices, Respiratory
% 212.75/212.93  |- mesh__dateEstablished mesh__D012134 1991-01-01
% 212.75/212.93  |- skos__hiddenLabel mesh__D012134 Devices, Respiratory Protective
% 212.75/212.93  |- skos__hiddenLabel mesh__D012134 Respirator, Air-Purifying
% 212.75/212.93  |- mesh__dateCreated mesh__D012134 1974-12-12
% 212.75/212.93  |- skos__altLabel mesh__D012134 Industrial Respirators
% 212.75/212.93  |- mesh__historyNote mesh__D012134 91%28%63%29%   
% 212.75/212.93  |- skos__hiddenLabel mesh__D012134 Respirators, Air Purifying
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D012134 2001
% 212.75/212.93  |- skos__hiddenLabel mesh__D012134 Protective Device, Respiratory
% 212.75/212.93  |- skos__hiddenLabel mesh__D012134 Respiratory Protective Device
% 212.75/212.93  |- skos__hiddenLabel mesh__D012134 Mask, Gas
% 212.75/212.93  |- skos__hiddenLabel mesh__D012134 Gas Mask
% 212.75/212.93  |- mesh__recordAuthorizer mesh__D012134 SJN
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D012134 2004
% 212.75/212.93  |- mesh__dateRevised mesh__D012134 1997-06-20
% 212.75/212.93  |- skos__broader mesh__D012134smesh__D011482
% 212.75/212.93  |- mesh__publicMeSHNote mesh__D012134
% 212.75/212.93       91; see PROTECTIVE DEVICES 1975-90; for GAS MASKS see MASKS 1968-74, see GAS MASKS 1963-67%A%  
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D012134 2000
% 212.75/212.93  |- skos__hiddenLabel mesh__D012134 Masks, Gas
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D012134 1999
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D012134 2003
% 212.75/212.93  |- skos__scopeNote mesh__D012134
% 212.75/212.93       Respirators to protect individuals from breathing air contaminated with harmful dusts, fogs, fumes, mists, gases, smokes, sprays, or vapors.%A%    
% 212.75/212.93  |- skos__hiddenLabel mesh__D012134 Device, Respiratory Protective
% 212.75/212.93  |- skos__hiddenLabel mesh__D012134 Industrial Respirator
% 212.75/212.93  |- skos__annotation mesh__D036582
% 212.75/212.93       X ref CONEFLOWER, ORANGE: CONEFLOWER, PURPLE see ECHINACEA and CONEFLOWER, PRAIRIE see RATIBIDA are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.75/212.93  |- mesh__historyNote mesh__D036582 2003   
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D036582 2004
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D036582 2006
% 212.75/212.93  |- mesh__dateEstablished mesh__D036582 2003-01-01
% 212.75/212.93  |- skos__prefLabel mesh__D036582 Rudbeckia
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D036582 2003
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D036582 2005
% 212.75/212.93  |- mesh__publicMeSHNote mesh__D036582 2003   
% 212.75/212.93  |- skos__broader mesh__D036582smesh__D019659
% 212.75/212.93  |- skos__altLabel mesh__D036582 Coneflower, Orange
% 212.75/212.93  |- mesh__dateCreated mesh__D036582 2002-07-03
% 212.75/212.93  |- rdf__type mesh__D036582sskos__Concept
% 212.75/212.93  |- skos__scopeNote mesh__D036582
% 212.75/212.93       A plant genus of the family ASTERACEAE. Some Rudbeckia species have been reclassified to ECHINACEA; RATIBIDA; or HELIANTHUS.%A%    
% 212.75/212.93  |- mesh__recordAuthorizer mesh__D008891 PLS
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008891 2000
% 212.75/212.93  |- skos__hiddenLabel mesh__D008891 Sciences, Naval
% 212.75/212.93  |- mesh__publicMeSHNote mesh__D008891 NAVAL SCIENCE was heading 1963-82   
% 212.75/212.93  |- mesh__historyNote mesh__D008891 NAVAL SCIENCE was heading 1963-82   
% 212.75/212.93  |- skos__hiddenLabel mesh__D008891 Naval Sciences
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008891 1996
% 212.75/212.93  |- skos__broader mesh__D008891smesh__D013676
% 212.75/212.93  |- mesh__dateRevised mesh__D008891 1992-05-15
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008891 1995
% 212.75/212.93  |- skos__hiddenLabel mesh__D008891 Science, Military
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008891 2006
% 212.75/212.93  |- skos__hiddenLabel mesh__D008891 Sciences, Military
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008891 1994
% 212.75/212.93  |- skos__hiddenLabel mesh__D008891 Science, Naval
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008891 1993
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008891 1999
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008891 2005
% 212.75/212.93  |- mesh__recordMaintainer mesh__D008891 TGC
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008891 2002
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008891 2004
% 212.75/212.93  |- mesh__recordOriginator mesh__D008891 NLM
% 212.75/212.93  |- skos__prefLabel mesh__D008891 Military Science
% 212.75/212.93  |- skos__hiddenLabel mesh__D008891 Military Sciences
% 212.75/212.93  |- skos__annotation mesh__D008891 specify country   
% 212.75/212.93  |- mesh__onlineNote mesh__D008891
% 212.75/212.93       use MILITARY SCIENCE to search NAVAL SCIENCE 1966-82   
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008891 1998
% 212.75/212.93  |- rdf__type mesh__D008891sskos__Concept
% 212.75/212.93  |- mesh__dateCreated mesh__D008891 1999-01-01
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008891 2001
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008891 1997
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008891 2003
% 212.75/212.93  |- mesh__dateRevised mesh__D022562 2005-06-30
% 212.75/212.93  |- skos__historyNote mesh__D022562 Bacterial Vaccines %28%1968-2000%29%
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D022562 2006
% 212.75/212.93  |- mesh__publicMeSHNote mesh__D022562 2001   
% 212.75/212.93  |- mesh__dateEstablished mesh__D022562 2001-01-01
% 212.75/212.93  |- mesh__recordOriginator mesh__D022562 ags
% 212.75/212.93  |- mesh__recordAuthorizer mesh__D022562 sjn
% 212.75/212.93  |- skos__prefLabel mesh__D022562 Salmonella Vaccines
% 212.75/212.93  |- skos__broader mesh__D022562smesh__D001428
% 212.75/212.93  |- skos__scopeNote mesh__D022562
% 212.75/212.93       Vaccines or candidate vaccines used to prevent infection with SALMONELLA. This includes vaccines used to prevent TYPHOID FEVER or PARATYPHOID FEVER; %28%TYPHOID-PARATYPHOID VACCINES%29%, and vaccines used to prevent nontyphoid salmonellosis.%A%    
% 212.75/212.93  |- rdf__type mesh__D022562sskos__Concept
% 212.75/212.93  |- skos__altLabel mesh__D022562 Salmonellosis Vaccines
% 212.75/212.93  |- mesh__recordMaintainer mesh__D022562 ssb
% 212.75/212.93  |- skos__annotation mesh__D022562
% 212.75/212.93       coord IM with specific Salmonella species /immunol %28%IM%29% but note TYPHOID-PARATYPHOID VACCINES is also available%A%  
% 212.75/212.93  |- mesh__dateCreated mesh__D022562 2000-06-22
% 212.75/212.93  |- skos__hiddenLabel mesh__D022562 Vaccines, Salmonellosis
% 212.75/212.93  |- mesh__historyNote mesh__D022562 2001   
% 212.75/212.93  |- skos__altLabel mesh__D022562 Vaccines, Salmonella
% 212.75/212.93  |- mesh__dateRevised mesh__D008093 1999-11-03
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008093 2003
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008093 2001
% 212.75/212.93  |- rdf__type mesh__D008093sskos__Concept
% 212.75/212.93  |- skos__altLabel mesh__D008093 Modern Literature
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008093 2000
% 212.75/212.93  |- mesh__recordMaintainer mesh__D008093 kle
% 212.75/212.93  |- mesh__recordOriginator mesh__D008093 NLM
% 212.75/212.93  |- skos__broader mesh__D008093smesh__D008091
% 212.75/212.93  |- mesh__recordAuthorizer mesh__D008093 sjn
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008093 2006
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008093 2002
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008093 2004
% 212.75/212.93  |- mesh__dateCreated mesh__D008093 1999-01-01
% 212.75/212.93  |- skos__annotation mesh__D008093
% 212.75/212.93       starts with 15th cent; coord IM with POETRY %28%IM%29% or DRAMA %28%IM%29%; DF: LIT MODERN%A%  
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008093 2005
% 212.75/212.93  |- skos__prefLabel mesh__D008093 Literature, Modern
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016525 2002
% 212.75/212.93  |- skos__broader mesh__D016525smesh__D000937
% 212.75/212.93  |- skos__historyNote mesh__D016525
% 212.75/212.93       Antigens, Surface/analysis %28%1979-1991%29%
% 212.75/212.93  |- skos__hiddenLabel mesh__D016525 Modulations, Antigenic
% 212.75/212.93  |- skos__hiddenLabel mesh__D016525 Antigenic Modulations
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016525 2003
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016525 2005
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016525 1996
% 212.75/212.93  |- mesh__historyNote mesh__D016525 92   
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016525 2004
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016525 1998
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016525 2006
% 212.75/212.93  |- mesh__recordAuthorizer mesh__D016525 PLS
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016525 2000
% 212.75/212.93  |- skos__prefLabel mesh__D016525 Antigenic Modulation
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016525 1997
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016525 1994
% 212.75/212.93  |- mesh__dateEstablished mesh__D016525 1992-01-01
% 212.75/212.93  |- mesh__recordOriginator mesh__D016525 AGS
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016525 1999
% 212.75/212.93  |- mesh__dateCreated mesh__D016525 1991-06-21
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016525 2001
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016525 1993
% 212.75/212.93  |- skos__scopeNote mesh__D016525
% 212.75/212.93       Loss of detectable antigen from the surface of a cell after incubation with antibodies. This is one method in which some tumors escape detection by the immune system. Antigenic modulation of target antigens also reduces the therapeutic effectiveness of treatment by monoclonal antibodies.%A%    
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016525 1995
% 212.75/212.93  |- mesh__dateRevised mesh__D016525 1992-03-25
% 212.75/212.93  |- skos__historyNote mesh__D016525
% 212.75/212.93       Antigen-Antibody Reactions %28%1968-1989%29%
% 212.75/212.93  |- skos__hiddenLabel mesh__D016525 Modulation, Antigenic
% 212.75/212.93  |- rdf__type mesh__D016525sskos__Concept
% 212.75/212.93  |- mesh__publicMeSHNote mesh__D016525 92   
% 212.75/212.93  |- skos__historyNote mesh__D016525
% 212.75/212.93       Antigens, Surface/immunology %28%1979-1988%29%
% 212.75/212.93  |- mesh__recordMaintainer mesh__D016525 TAP
% 212.75/212.93  |- mesh__dateCreated mesh__D002505 1974-11-19
% 212.75/212.93  |- mesh__dateEstablished mesh__D002505 1991-01-01
% 212.75/212.93  |- mesh__recordMaintainer mesh__D002505 ssb
% 212.75/212.93  |- skos__broader mesh__D002505smesh__D002511
% 212.75/212.93  |- skos__hiddenLabel mesh__D002505 Sodium, Cephacetrile
% 212.75/212.93  |- skos__prefLabel mesh__D002505 Cephacetrile
% 212.75/212.93  |- skos__hiddenLabel mesh__D002505 C 36278 Ba
% 212.75/212.93  |- rdf__type mesh__D002505sskos__Concept
% 212.75/212.93  |- skos__historyNote mesh__D002505 Nitriles %28%1973-1974%29%
% 212.75/212.93  |- skos__altLabel mesh__D002505 Cefacetrile
% 212.75/212.93  |- skos__hiddenLabel mesh__D002505 C36278Ba
% 212.75/212.93  |- mesh__recordOriginator mesh__D002505 NLM
% 212.75/212.93  |- skos__historyNote mesh__D002505 Cephalosporins %28%1973-1974%29%
% 212.75/212.93  |- mesh__publicMeSHNote mesh__D002505
% 212.75/212.93       91; was see under CEPHALOSPORINS 1975-90   
% 212.75/212.93  |- mesh__recordAuthorizer mesh__D002505 sjn
% 212.75/212.93  |- skos__scopeNote mesh__D002505
% 212.75/212.93       A derivative of 7-aminocephalosporanic acid.     
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D002505 2005
% 212.75/212.93  |- skos__historyNote mesh__D002505 Acetamides %28%1973-1974%29%
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D002505 2006
% 212.75/212.93  |- mesh__historyNote mesh__D002505
% 212.75/212.93       91%28%75%29%; was see under CEPHALOSPORINS 1975-90   
% 212.75/212.93  |- mesh__dateRevised mesh__D002505 2004-07-07
% 212.75/212.93  |- mesh__dateRevised mesh__D007799 2004-07-07
% 212.75/212.93  |- skos__altLabel mesh__D007799 Digilanides
% 212.75/212.93  |- skos__broader mesh__D007799smesh__D004071
% 212.75/212.93  |- mesh__recordMaintainer mesh__D007799 ssb
% 212.75/212.93  |- skos__scopeNote mesh__D007799
% 212.75/212.93       Glycosides from DIGITALIS lanata leaf. Lanatoside C has actions similar to DIGOXIN. Mixtures of lanatosides A, B, and C have also been used. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p670%29%%A%    
% 212.75/212.93  |- mesh__recordOriginator mesh__D007799 NLM
% 212.75/212.93  |- rdf__type mesh__D007799sskos__Concept
% 212.75/212.93  |- skos__prefLabel mesh__D007799 Lanatosides
% 212.75/212.93  |- mesh__recordAuthorizer mesh__D007799 sjn
% 212.75/212.93  |- mesh__dateCreated mesh__D007799 1999-01-01
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D007799 2006
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D007799 2005
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D012933 2003
% 212.75/212.93  |- skos__hiddenLabel mesh__D012933 Identification, Group
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D012933 2006
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D012933 2004
% 212.75/212.93  |- skos__hiddenLabel mesh__D012933 Identifications, Social
% 212.75/212.93  |- mesh__recordMaintainer mesh__D012933 jls
% 212.75/212.93  |- rdf__type mesh__D012933sskos__Concept
% 212.75/212.93  |- skos__prefLabel mesh__D012933 Social Identification
% 212.75/212.93  |- mesh__recordOriginator mesh__D012933 EC
% 212.75/212.93  |- mesh__dateRevised mesh__D012933 2002-07-03
% 212.75/212.93  |- skos__hiddenLabel mesh__D012933 Social Identities
% 212.75/212.93  |- skos__hiddenLabel mesh__D012933 Social Identifications
% 212.75/212.93  |- mesh__recordAuthorizer mesh__D012933 sjn
% 212.75/212.93  |- skos__annotation mesh__D012933 no qualif   
% 212.75/212.93  |- skos__scopeNote mesh__D012933
% 212.75/212.93       The process by which an aspect of self image is developed based on in-group preference or ethnocentrism and a perception of belonging to a social or cultural group. %28%From APA, Thesaurus of Psychological Index Terms, 8th ed.%29%%A%    
% 212.75/212.93  |- skos__hiddenLabel mesh__D012933 Group Identifications
% 212.75/212.93  |- mesh__dateCreated mesh__D012933 1977-04-22
% 212.75/212.93  |- skos__broader mesh__D012933smesh__D012919
% 212.75/212.93  |- mesh__publicMeSHNote mesh__D012933
% 212.75/212.93       91; was see under SOCIAL BEHAVIOR 1978-90   
% 212.75/212.93  |- skos__historyNote mesh__D012933 Social Behavior %28%1969-1977%29%
% 212.75/212.93  |- skos__altLabel mesh__D012933 Identification, Social
% 212.75/212.93  |- skos__hiddenLabel mesh__D012933 Identity, Social
% 212.75/212.93  |- mesh__dateEstablished mesh__D012933 1991-01-01
% 212.75/212.93  |- skos__hiddenLabel mesh__D012933 Identities, Social
% 212.75/212.93  |- skos__hiddenLabel mesh__D012933 Identifications, Group
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D012933 2005
% 212.75/212.93  |- skos__altLabel mesh__D012933 Social Identity
% 212.75/212.93  |- mesh__historyNote mesh__D012933
% 212.75/212.93       91%28%78%29%; was see under SOCIAL BEHAVIOR 1978-90   
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D012135 2005
% 212.75/212.93  |- skos__hiddenLabel mesh__D012135 Wheezings
% 212.75/212.93  |- rdf__type mesh__D012135sskos__Concept
% 212.75/212.93  |- skos__hiddenLabel mesh__D012135 Rhonchus
% 212.75/212.93  |- skos__hiddenLabel mesh__D012135 Rub, Pleural
% 212.75/212.93  |- skos__broader mesh__D012135smesh__D003948
% 212.75/212.93  |- skos__altLabel mesh__D012135 Lung Sounds
% 212.75/212.93  |- mesh__dateEstablished mesh__D012135 1980-01-01
% 212.75/212.93  |- skos__prefLabel mesh__D012135 Respiratory Sounds
% 212.75/212.93  |- skos__broader mesh__D012135smesh__D012818
% 212.75/212.93  |- mesh__recordAuthorizer mesh__D012135 sjn
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D012135 2004
% 212.75/212.93  |- skos__hiddenLabel mesh__D012135 Sound, Lung
% 212.75/212.93  |- skos__hiddenLabel mesh__D012135 Sound, Breathing
% 212.75/212.93  |- skos__hiddenLabel mesh__D012135 Respiratory Sound
% 212.75/212.93  |- mesh__recordMaintainer mesh__D012135 nns
% 212.75/212.93  |- mesh__historyNote mesh__D012135 80   
% 212.75/212.93  |- skos__hiddenLabel mesh__D012135 Lung Sound
% 212.75/212.93  |- skos__hiddenLabel mesh__D012135 Sound, Respiratory
% 212.75/212.93  |- skos__hiddenLabel mesh__D012135 Rale
% 212.75/212.93  |- skos__altLabel mesh__D012135 Breathing Sounds
% 212.75/212.93  |- mesh__publicMeSHNote mesh__D012135 80   
% 212.75/212.93  |- skos__hiddenLabel mesh__D012135 Sounds, Breathing
% 212.75/212.93  |- skos__broader mesh__D012135smesh__D044702
% 212.75/212.93  |- skos__scopeNote mesh__D012135
% 212.75/212.93       Noises, normal and abnormal, heard on auscultation over any part of the RESPIRATORY TRACT.%A%    
% 212.75/212.93  |- skos__hiddenLabel mesh__D012135 Crackle
% 212.75/212.93  |- mesh__recordOriginator mesh__D012135 VDK
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D012135 2006
% 212.75/212.93  |- mesh__dateCreated mesh__D012135 1979-05-25
% 212.75/212.93  |- skos__altLabel mesh__D012135 Crackles
% 212.75/212.93  |- skos__hiddenLabel mesh__D012135 Stridors
% 212.75/212.93  |- skos__hiddenLabel mesh__D012135 Breathing Sound
% 212.75/212.93  |- mesh__dateRevised mesh__D012135 2003-07-09
% 212.75/212.93  |- skos__hiddenLabel mesh__D012135 Sounds, Lung
% 212.75/212.93  |- skos__hiddenLabel mesh__D012135 Pleural Rubs
% 212.75/212.93  |- skos__broader mesh__D005164Q000172smesh__D005164
% 212.75/212.93  |- mesh__preferredCombination mesh__D005164Q000172smesh__D002836
% 212.75/212.93  |- rdf__type mesh__D005164Q000172smesh__CompoundConcept
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008892 2006
% 212.75/212.93  |- mesh__recordMaintainer mesh__D008892 ssb
% 212.75/212.93  |- skos__broader mesh__D008892smesh__D003611
% 212.75/212.93  |- mesh__recordAuthorizer mesh__D008892 sjn
% 212.75/212.93  |- skos__scopeNote mesh__D008892
% 212.75/212.93       The white liquid secreted by the mammary glands. It contains proteins, sugar, lipids, vitamins, and minerals.%A%    
% 212.75/212.93  |- mesh__recordOriginator mesh__D008892 NLM
% 212.75/212.93  |- skos__annotation mesh__D008892
% 212.75/212.93       assume to be cow%27%s milk %26% do not coord with CATTLE; coord IM with other animal source %28%NIM%29%, as goat%27%s milk = MILK %28%IM%29% + GOATS %28%NIM%29%; /secret: consider also LACTATION; /adv eff; consider also MILK HYPERSENSITIVITY%A%  
% 212.75/212.93  |- skos__prefLabel mesh__D008892 Milk
% 212.75/212.93  |- skos__broader mesh__D008892smesh__D012634
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008892 2005
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008892 2004
% 212.75/212.93  |- rdf__type mesh__D008892sskos__Concept
% 212.75/212.93  |- mesh__dateCreated mesh__D008892 1999-01-01
% 212.75/212.93  |- mesh__dateRevised mesh__D008892 2003-07-09
% 212.75/212.93  |- skos__broader mesh__D008892smesh__D001628
% 212.75/212.93  |- skos__related mesh__D008892smesh__D007774
% 212.75/212.93  |- rdf__type mesh__D008094sskos__Concept
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008094 1998
% 212.75/212.93  |- mesh__dateRevised mesh__D008094 1997-06-20
% 212.75/212.93  |- mesh__recordAuthorizer mesh__D008094 SJN
% 212.75/212.93  |- mesh__recordMaintainer mesh__D008094 ADP
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008094 2000
% 212.75/212.93  |- skos__annotation mesh__D008094
% 212.75/212.93       an alkali metal; a tranquilizer in the form of its salts; Li-7; Li-6 = LITHIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Li-5, 8, 9 = LITHIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008094 1999
% 212.75/212.93  |- mesh__dateCreated mesh__D008094 1999-01-01
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008094 2005
% 212.75/212.93  |- skos__scopeNote mesh__D008094
% 212.75/212.93       Lithium. An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight 6.94. Salts of lithium are used in treating manic-depressive disorders.%A%    
% 212.75/212.93  |- skos__prefLabel mesh__D008094 Lithium
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008094 2001
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008094 2006
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008094 2003
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008094 2002
% 212.75/212.93  |- skos__broader mesh__D008094smesh__D008672
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D008094 2004
% 212.75/212.93  |- mesh__recordOriginator mesh__D008094 NLM
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016526 1993
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016526 2006
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016526 1998
% 212.75/212.93  |- skos__hiddenLabel mesh__D016526 Workloads
% 212.75/212.93  |- mesh__recordMaintainer mesh__D016526 TGC
% 212.75/212.93  |- mesh__dateEstablished mesh__D016526 1992-01-01
% 212.75/212.93  |- skos__hiddenLabel mesh__D016526 Work Loads, Staff
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016526 1997
% 212.75/212.93  |- skos__historyNote mesh__D016526
% 212.75/212.93       Task Performance and Analysis %28%1971-1991%29%
% 212.75/212.93  |- skos__historyNote mesh__D016526
% 212.75/212.93       Personnel Staffing and Scheduling %28%1981-1991%29%
% 212.75/212.93  |- skos__altLabel mesh__D016526 Employee Work Load
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016526 2005
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016526 2004
% 212.75/212.93  |- rdf__type mesh__D016526sskos__Concept
% 212.75/212.93  |- skos__hiddenLabel mesh__D016526 Work Load, Staff
% 212.75/212.93  |- skos__hiddenLabel mesh__D016526 Workloads, Staff
% 212.75/212.93  |- skos__hiddenLabel mesh__D016526 Work Loads
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016526 1996
% 212.75/212.93  |- mesh__recordOriginator mesh__D016526 JHM
% 212.75/212.93  |- skos__hiddenLabel mesh__D016526 Work Loads, Employee
% 212.75/212.93  |- skos__hiddenLabel mesh__D016526 Employee Workloads
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016526 2002
% 212.75/212.93  |- skos__altLabel mesh__D016526 Staff Work Load
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016526 2003
% 212.75/212.93  |- mesh__dateRevised mesh__D016526 1992-05-18
% 212.75/212.93  |- skos__broader mesh__D016526smesh__D010559
% 212.75/212.93  |- mesh__historyNote mesh__D016526 92   
% 212.75/212.93  |- skos__hiddenLabel mesh__D016526 Staff Workloads
% 212.75/212.93  |- skos__hiddenLabel mesh__D016526 Workload, Employee
% 212.75/212.93  |- mesh__recordAuthorizer mesh__D016526 PLS
% 212.75/212.93  |- skos__hiddenLabel mesh__D016526 Staff Work Loads
% 212.75/212.93  |- skos__scopeNote mesh__D016526
% 212.75/212.93       The total amount of work to be performed by an individual, a department, or other group of workers in a period of time.%A%    
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016526 1995
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016526 2001
% 212.75/212.93  |- skos__hiddenLabel mesh__D016526 Work Load, Employee
% 212.75/212.93  |- skos__hiddenLabel mesh__D016526 Workloads, Employee
% 212.75/212.93  |- skos__hiddenLabel mesh__D016526 Workload, Staff
% 212.75/212.93  |- skos__prefLabel mesh__D016526 Workload
% 212.75/212.93  |- skos__altLabel mesh__D016526 Work Load
% 212.75/212.93  |- skos__historyNote mesh__D016526 Personnel Management %28%1967-1991%29%
% 212.75/212.93  |- mesh__publicMeSHNote mesh__D016526 92   
% 212.75/212.93  |- mesh__dateCreated mesh__D016526 1991-02-11
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016526 1999
% 212.75/212.93  |- skos__hiddenLabel mesh__D016526 Employee Work Loads
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016526 1994
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D016526 2000
% 212.75/212.93  |- mesh__publicMeSHNote mesh__D002506 73   
% 212.75/212.93  |- skos__hiddenLabel mesh__D002506 Monohydrate Cephalexin Monohydrochloride
% 212.75/212.93  |- skos__hiddenLabel mesh__D002506 Monohydrate, Cephalexin
% 212.75/212.93  |- skos__hiddenLabel mesh__D002506 Dihydride, Cephalexin
% 212.75/212.93  |- skos__hiddenLabel mesh__D002506 Hemihydrate, Cephalexin
% 212.75/212.93  |- mesh__recordAuthorizer mesh__D002506 jls
% 212.75/212.93  |- skos__historyNote mesh__D002506 Cephalosporins %28%1966-1971%29%
% 212.75/212.93  |- skos__hiddenLabel mesh__D002506 Hydrochloride, Cephalexin
% 212.75/212.93  |- mesh__recordMaintainer mesh__D002506 jls
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D002506 2005
% 212.75/212.93  |- skos__hiddenLabel mesh__D002506 Monosodium Salt Cephalexin
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D002506 2006
% 212.75/212.93  |- skos__scopeNote mesh__D002506
% 212.75/212.93       A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms.%A%    
% 212.75/212.93  |- skos__hiddenLabel mesh__D002506
% 212.75/212.93       Monohydrochloride, Monohydrate Cephalexin
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D002506 2006A
% 212.75/212.93  |- mesh__historyNote mesh__D002506 73%28%72%29%   
% 212.75/212.93  |- mesh__dateCreated mesh__D002506 1999-01-01
% 212.75/212.93  |- skos__hiddenLabel mesh__D002506 Monohydrochloride, Cephalexin
% 212.75/212.93  |- mesh__dateRevised mesh__D002506 2005-07-30
% 212.75/212.93  |- skos__broader mesh__D002506smesh__D002511
% 212.75/212.93  |- rdf__type mesh__D002506sskos__Concept
% 212.75/212.93  |- mesh__dateEstablished mesh__D002506 1973-01-01
% 212.75/212.93  |- skos__prefLabel mesh__D002506 Cephalexin
% 212.75/212.93  |- mesh__recordOriginator mesh__D002506 NLM
% 212.75/212.93  |- skos__altLabel mesh__D002506 Cephalexin Hydrochloride
% 212.75/212.93  |- skos__altLabel mesh__D002506 Cefalexin
% 212.75/212.93  |- skos__prefLabel mesh__D048608 Rupicapra
% 212.75/212.93  |- mesh__dateEstablished mesh__D048608 2005-01-01
% 212.75/212.93  |- mesh__dateCreated mesh__D048608 2004-07-07
% 212.75/212.93  |- rdf__type mesh__D048608sskos__Concept
% 212.75/212.93  |- mesh__activeMeSHYear mesh__D048608 2006
% 212.75/212.93  |- mesh__historyNote mesh__D048608 2005   
% 212.75/212.93  |- skos__broader mesh__D048608smesh__D006041
% 212.75/212.93  |- mesh__recordMaintainer mesh__D048608 ags
% 212.75/212.93  |- skos__hiddenLabel mesh__D048608 Pyrenean Chamois
% 212.75/212.93  |- skos__altLabel mesh__D048608 Rupicapra pyrenaica
% 212.75/212.94  |- skos__scopeNote mesh__D048608
% 212.75/212.94       A genus of ruminants in the family Bovidae. The common name chamois usually refers to the species Rupicapra rupicapra. Rupicapra pyrenaica, found in the Pyrenees, is more properly referred to as the Pyrenean chamois.%A%    
% 212.75/212.94  |- mesh__publicMeSHNote mesh__D048608 2005   
% 212.75/212.94  |- mesh__recordAuthorizer mesh__D048608 sjn
% 212.75/212.94  |- mesh__recordOriginator mesh__D048608 ags
% 212.75/212.94  |- skos__hiddenLabel mesh__D048608 Rupicapras
% 212.75/212.94  |- skos__altLabel mesh__D048608 Rupicapra rupicapra
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D048608 2005
% 212.75/212.94  |- skos__historyNote mesh__D048608 Goats %28%1973-2004%29%
% 212.75/212.94  |- mesh__recordOriginator mesh__D012934 NLM
% 212.75/212.94  |- rdf__type mesh__D012934sskos__Concept
% 212.75/212.94  |- skos__hiddenLabel mesh__D012934 Social Isolations
% 212.75/212.94  |- skos__prefLabel mesh__D012934 Social Isolation
% 212.75/212.94  |- mesh__onlineNote mesh__D012934
% 212.75/212.94       use SOCIAL ISOLATION to search ISOLATION, SOCIAL 1968   
% 212.75/212.94  |- skos__altLabel mesh__D012934 Isolation, Social
% 212.75/212.94  |- mesh__historyNote mesh__D012934 69; was ISOLATION, SOCIAL 1968   
% 212.75/212.94  |- skos__broader mesh__D012934smesh__D012961
% 212.75/212.94  |- skos__hiddenLabel mesh__D012934 Isolations, Social
% 212.75/212.94  |- skos__annotation mesh__D012934 human %26% animal   
% 212.75/212.94  |- mesh__dateEstablished mesh__D012934 1969-01-01
% 212.75/212.94  |- skos__broader mesh__D012934smesh__D012919
% 212.75/212.94  |- mesh__dateRevised mesh__D012934 2002-07-03
% 212.75/212.94  |- mesh__dateCreated mesh__D012934 1999-01-01
% 212.75/212.94  |- mesh__recordAuthorizer mesh__D012934 sjn
% 212.75/212.94  |- mesh__publicMeSHNote mesh__D012934 69; was ISOLATION, SOCIAL 1968   
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012934 2005
% 212.75/212.94  |- mesh__recordMaintainer mesh__D012934 JLS
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012934 2003
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012934 2006
% 212.75/212.94  |- skos__scopeNote mesh__D012934
% 212.75/212.94       The separation of individuals or groups resulting in the lack of or minimizing of social contact and/or communication. This separation may be accomplished by physical separation, by social barriers and by psychological mechanisms. In the latter, there may be interaction but no real communication.%A%    
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012934 2004
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012136 2004
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012136 2001
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012136 1996
% 212.75/212.94  |- mesh__publicMeSHNote mesh__D012136
% 212.75/212.94       77; was RESPIRATORY SYNCYTIAL VIRUS 1966-76   
% 212.75/212.94  |- mesh__dateRevised mesh__D012136 1993-06-04
% 212.75/212.94  |- mesh__historyNote mesh__D012136
% 212.75/212.94       77; was RESPIRATORY SYNCYTIAL VIRUS 1964-76 %28%Prov 1964-65%29%%A%  
% 212.75/212.94  |- skos__hiddenLabel mesh__D012136 Virus, Respiratory Syncytial
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012136 1999
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012136 2003
% 212.75/212.94  |- skos__hiddenLabel mesh__D012136 Coryza Agent, Chimpanzee
% 212.75/212.94  |- mesh__onlineNote mesh__D012136
% 212.75/212.94       use RESPIRATORY SYNCYTIAL VIRUSES to search RESPIRATORY SYNCYTIAL VIRUS 1966-76%A%  
% 212.75/212.94  |- skos__broader mesh__D012136smesh__D018111
% 212.75/212.94  |- mesh__dateCreated mesh__D012136 1999-01-01
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012136 2000
% 212.75/212.94  |- skos__hiddenLabel mesh__D012136 Syncytial Virus, Respiratory
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012136 2006
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012136 1995
% 212.75/212.94  |- skos__annotation mesh__D012136
% 212.75/212.94       a group of viruses of the genus Pneumovirus; infection = RESPIRATORY SYNCYTIAL VIRUS INFECTIONS%A%  
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012136 1998
% 212.75/212.94  |- mesh__recordAuthorizer mesh__D012136 PLS
% 212.75/212.94  |- skos__hiddenLabel mesh__D012136 Chimpanzee Coryza Agents
% 212.75/212.94  |- mesh__recordOriginator mesh__D012136 NLM
% 212.75/212.94  |- skos__hiddenLabel mesh__D012136 Coryza Agents, Chimpanzee
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012136 2005
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012136 1994
% 212.75/212.94  |- skos__hiddenLabel mesh__D012136 Syncytial Viruses, Respiratory
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012136 2002
% 212.75/212.94  |- rdf__type mesh__D012136sskos__Concept
% 212.75/212.94  |- skos__prefLabel mesh__D012136 Respiratory Syncytial Viruses
% 212.75/212.94  |- mesh__dateEstablished mesh__D012136 1966-01-01
% 212.75/212.94  |- mesh__recordMaintainer mesh__D012136 AGS
% 212.75/212.94  |- skos__scopeNote mesh__D012136
% 212.75/212.94       A group of viruses in the PNEUMOVIRUS genus causing respiratory infections in various mammals. Humans and cattle are most affected but infections in goats and sheep have also been reported.%A%    
% 212.75/212.94  |- skos__hiddenLabel mesh__D012136 Viruses, Respiratory Syncytial
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012136 1997
% 212.75/212.94  |- skos__hiddenLabel mesh__D012136 Respiratory Syncytial Virus
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D008893 2005
% 212.75/212.94  |- skos__prefLabel mesh__D008893 Milk Ejection
% 212.75/212.94  |- skos__hiddenLabel mesh__D008893 Milk Let down
% 212.75/212.94  |- rdf__type mesh__D008893sskos__Concept
% 212.75/212.94  |- mesh__recordAuthorizer mesh__D008893 sjn
% 212.75/212.94  |- mesh__recordOriginator mesh__D008893 NLM
% 212.75/212.94  |- skos__broader mesh__D008893smesh__D007774
% 212.75/212.94  |- skos__altLabel mesh__D008893 Milk Let-down
% 212.75/212.94  |- skos__scopeNote mesh__D008893
% 212.75/212.94       Expulsion of milk from the mammary alveolar lumen, which is surrounded by a layer of milk-secreting EPITHELIAL CELLS and a network of myoepithelial cells. Contraction of the myoepithelial cells is regulated by neuroendocrine signals.%A%    
% 212.75/212.94  |- skos__annotation mesh__D008893 human %26% animal   
% 212.75/212.94  |- mesh__recordMaintainer mesh__D008893 lkt
% 212.75/212.94  |- mesh__dateRevised mesh__D008893 2004-07-07
% 212.75/212.94  |- mesh__historyNote mesh__D008893
% 212.75/212.94       91%28%75%29%; was see under LACTATION 1975-90   
% 212.75/212.94  |- skos__hiddenLabel mesh__D008893 Ejection, Milk
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D008893 2006
% 212.75/212.94  |- mesh__dateCreated mesh__D008893 1974-11-11
% 212.75/212.94  |- mesh__dateEstablished mesh__D008893 1991-01-01
% 212.75/212.94  |- mesh__publicMeSHNote mesh__D008893
% 212.75/212.94       91; was see under LACTATION 1975-90   
% 212.75/212.94  |- skos__scopeNote mesh__D008095
% 212.75/212.94       A bile acid formed from chenodeoxycholate by bacterial action, usually conjugated with glycine or taurine. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as cholagogue and choleretic.%A%    
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D008095 2002
% 212.75/212.94  |- mesh__recordOriginator mesh__D008095 NLM
% 212.75/212.94  |- rdf__type mesh__D008095sskos__Concept
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D008095 2005
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D008095 2003
% 212.75/212.94  |- mesh__recordAuthorizer mesh__D008095 sjn
% 212.75/212.94  |- mesh__dateCreated mesh__D008095 1999-01-01
% 212.75/212.94  |- skos__broader mesh__D008095smesh__D002793
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D008095 2006
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D008095 2004
% 212.75/212.94  |- mesh__recordMaintainer mesh__D008095 adp
% 212.75/212.94  |- skos__hiddenLabel mesh__D008095 Acid, Isolithocholic
% 212.75/212.94  |- mesh__publicMeSHNote mesh__D008095 78   
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D008095 2000
% 212.75/212.94  |- skos__prefLabel mesh__D008095 Lithocholic Acid
% 212.75/212.94  |- mesh__dateRevised mesh__D008095 1999-11-03
% 212.75/212.94  |- skos__hiddenLabel mesh__D008095 Acid, Lithocholic
% 212.75/212.94  |- mesh__historyNote mesh__D008095 78%28%73%29%   
% 212.75/212.94  |- mesh__dateEstablished mesh__D008095 1978-01-01
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D008095 2001
% 212.75/212.94  |- skos__annotation mesh__D008095
% 212.75/212.94       a bile acid; /biosyn /physiol permitted   
% 212.75/212.94  |- skos__altLabel mesh__D008095 Isolithocholic Acid
% 212.75/212.94  |- skos__broader mesh__D016527smesh__D017048
% 212.75/212.94  |- rdf__type mesh__D016527sskos__Concept
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016527 2005
% 212.75/212.94  |- mesh__recordMaintainer mesh__D016527 PLS
% 212.75/212.94  |- mesh__dateRevised mesh__D016527 1993-09-16
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016527 1995
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016527 2001
% 212.75/212.94  |- skos__hiddenLabel mesh__D016527 Cost, Drug
% 212.75/212.94  |- mesh__recordAuthorizer mesh__D016527 NLM
% 212.75/212.94  |- skos__historyNote mesh__D016527 Cost Control %28%1979-1991%29%
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016527 2000
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016527 1997
% 212.75/212.94  |- mesh__dateCreated mesh__D016527 1991-06-21
% 212.75/212.94  |- mesh__publicMeSHNote mesh__D016527 92   
% 212.75/212.94  |- skos__hiddenLabel mesh__D016527 Costs, Drug
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016527 2004
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016527 1996
% 212.75/212.94  |- skos__historyNote mesh__D016527
% 212.75/212.94       Costs and Cost Analysis %28%1966-1991%29%
% 212.75/212.94  |- mesh__recordOriginator mesh__D016527 JHM
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016527 2003
% 212.75/212.94  |- skos__scopeNote mesh__D016527
% 212.75/212.94       The amount that a health care institution or organization pays for its drugs. It is one component of the final price that is charged to the consumer %28%FEES, PHARMACEUTICAL or PRESCRIPTION FEES%29%.%A%    
% 212.75/212.94  |- mesh__dateEstablished mesh__D016527 1992-01-01
% 212.75/212.94  |- mesh__historyNote mesh__D016527 92   
% 212.75/212.94  |- skos__historyNote mesh__D016527 Fees, Pharmaceutical %28%1968-1977%29%
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016527 2002
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016527 1999
% 212.75/212.94  |- skos__hiddenLabel mesh__D016527 Drug Cost
% 212.75/212.94  |- skos__annotation mesh__D016527
% 212.75/212.94       costs to a health care facility or organiz: do not confuse with FEES, PHARMACEUTICAL or PRESCRIPTION FEES which are costs to the patient%A%  
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016527 2006
% 212.75/212.94  |- skos__prefLabel mesh__D016527 Drug Costs
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016527 1998
% 212.75/212.94  |- skos__altLabel mesh__D002507 Cefaloglycin
% 212.75/212.94  |- mesh__recordOriginator mesh__D002507 NLM
% 212.75/212.94  |- mesh__dateEstablished mesh__D002507 1973-01-01
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D002507 2005
% 212.75/212.94  |- mesh__publicMeSHNote mesh__D002507 73   
% 212.75/212.94  |- mesh__recordAuthorizer mesh__D002507 sjn
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D002507 2006
% 212.75/212.94  |- mesh__dateRevised mesh__D002507 2004-07-07
% 212.75/212.94  |- skos__broader mesh__D002507smesh__D002506
% 212.75/212.94  |- mesh__dateCreated mesh__D002507 1999-01-01
% 212.75/212.94  |- skos__scopeNote mesh__D002507 A cephalorsporin antibiotic.     
% 212.75/212.94  |- rdf__type mesh__D002507sskos__Concept
% 212.75/212.94  |- skos__altLabel mesh__D002507 Cephaloglycine
% 212.75/212.94  |- skos__prefLabel mesh__D002507 Cephaloglycin
% 212.75/212.94  |- mesh__recordMaintainer mesh__D002507 ssb
% 212.75/212.94  |- mesh__historyNote mesh__D002507 73%28%72%29%   
% 212.75/212.94  |- skos__hiddenLabel mesh__D002507 Dihydrate, Cephaloglycin
% 212.75/212.94  |- mesh__recordOriginator mesh__D012935 EC
% 212.75/212.94  |- mesh__recordAuthorizer mesh__D012935 sjn
% 212.75/212.94  |- mesh__historyNote mesh__D012935
% 212.75/212.94       91%28%78%29%; was see under HUMAN RIGHTS 1978-90   
% 212.75/212.94  |- skos__related mesh__D012935smesh__D006806
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012935 2006
% 212.75/212.94  |- mesh__dateEstablished mesh__D012935 1991-01-01
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012935 2003
% 212.75/212.94  |- skos__broader mesh__D012935smesh__D006806
% 212.75/212.94  |- skos__hiddenLabel mesh__D012935 Justice, Social
% 212.75/212.94  |- rdf__type mesh__D012935sskos__Concept
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012935 2005
% 212.75/212.94  |- mesh__dateCreated mesh__D012935 1977-04-22
% 212.75/212.94  |- skos__related mesh__D012935smesh__D002961
% 212.75/212.94  |- skos__scopeNote mesh__D012935
% 212.75/212.94       An interactive process whereby members of a community are concerned for the equality and rights of all.%A%    
% 212.75/212.94  |- skos__broader mesh__D012935smesh__D028662
% 212.75/212.94  |- mesh__publicMeSHNote mesh__D012935
% 212.75/212.94       91; was see under HUMAN RIGHTS 1978-90   
% 212.75/212.94  |- mesh__recordMaintainer mesh__D012935 hjn
% 212.75/212.94  |- skos__annotation mesh__D012935 specify geog   
% 212.75/212.94  |- skos__hiddenLabel mesh__D012935 Good, Common
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012935 2004
% 212.75/212.94  |- mesh__dateRevised mesh__D012935 2002-07-03
% 212.75/212.94  |- skos__prefLabel mesh__D012935 Social Justice
% 212.75/212.94  |- skos__hiddenLabel mesh__D012137 Tract, Respiratory
% 212.75/212.94  |- skos__annotation mesh__D012137
% 212.75/212.94       GEN: prefer specifics; /abnorm: RESPIRATORY SYSTEM ABNORMALITIES is available but consider also specific part of resp syst with /abnorm or specific abnorm%A%  
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012137 2001
% 212.75/212.94  |- skos__hiddenLabel mesh__D012137 Tracts, Respiratory
% 212.75/212.94  |- mesh__recordAuthorizer mesh__D012137 SJN
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012137 2004
% 212.75/212.94  |- mesh__dateRevised mesh__D012137 1998-06-15
% 212.75/212.94  |- mesh__dateCreated mesh__D012137 1999-01-01
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012137 2000
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012137 1999
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012137 2003
% 212.75/212.94  |- mesh__recordOriginator mesh__D012137 NLM
% 212.75/212.94  |- mesh__runningHead mesh__D012137 A4 - ANATOMY-RESPIRATORY SYSTEM   
% 212.75/212.94  |- skos__scopeNote mesh__D012137
% 212.75/212.94       The tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.%A%    
% 212.75/212.94  |- skos__hiddenLabel mesh__D012137 Systems, Respiratory
% 212.75/212.94  |- skos__hiddenLabel mesh__D012137 System, Respiratory
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012137 2006
% 212.75/212.94  |- rdf__type mesh__D012137sskos__Concept
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012137 2002
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012137 2005
% 212.75/212.94  |- skos__hiddenLabel mesh__D012137 Respiratory Tracts
% 212.75/212.94  |- skos__prefLabel mesh__D012137 Respiratory System
% 212.75/212.94  |- skos__hiddenLabel mesh__D012137 Respiratory Systems
% 212.75/212.94  |- mesh__recordMaintainer mesh__D012137 NNS
% 212.75/212.94  |- mesh__dateCreated mesh__D003600 1999-01-01
% 212.75/212.94  |- mesh__historyNote mesh__D003600 73   
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D003600 2004
% 212.75/212.94  |- skos__scopeNote mesh__D003600
% 212.75/212.94       Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components.%A%    
% 212.75/212.94  |- rdf__type mesh__D003600sskos__Concept
% 212.75/212.94  |- mesh__recordAuthorizer mesh__D003600 sjn
% 212.75/212.94  |- skos__historyNote mesh__D003600 Subcellular Fractions %28%1972%29%
% 212.75/212.94  |- mesh__dateRevised mesh__D003600 2003-07-09
% 212.75/212.94  |- skos__prefLabel mesh__D003600 Cytosol
% 212.75/212.94  |- mesh__recordMaintainer mesh__D003600 nns
% 212.75/212.94  |- skos__broader mesh__D003600smesh__D003593
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D003600 2006
% 212.75/212.94  |- mesh__recordOriginator mesh__D003600 NLM
% 212.75/212.94  |- mesh__dateEstablished mesh__D003600 1973-01-01
% 212.75/212.94  |- mesh__publicMeSHNote mesh__D003600 73   
% 212.75/212.94  |- skos__broader mesh__D003600smesh__D007424
% 212.75/212.94  |- skos__hiddenLabel mesh__D003600 Cytosols
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D003600 2005
% 212.75/212.94  |- skos__annotation mesh__D003600 A 11 qualif except /cytol   
% 212.75/212.94  |- skos__broader mesh__D050256smesh__D050258
% 212.75/212.94  |- skos__altLabel mesh__D050256 Antimitotic Drugs
% 212.75/212.94  |- mesh__recordAuthorizer mesh__D050256 sjn
% 212.75/212.94  |- mesh__dateEstablished mesh__D050256 2006-01-01
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D050256 2006
% 212.75/212.94  |- mesh__recordOriginator mesh__D050256 ssb
% 212.75/212.94  |- mesh__historyNote mesh__D050256
% 212.75/212.94       2006; use ANTINEOPLASTIC AGENTS 1988-2005   
% 212.75/212.94  |- mesh__recordMaintainer mesh__D050256 ssb
% 212.75/212.94  |- skos__broader mesh__D050256smesh__D000970
% 212.75/212.94  |- skos__prefLabel mesh__D050256 Antimitotic Agents
% 212.75/212.94  |- skos__altLabel mesh__D050256 Antimitotics
% 212.75/212.94  |- skos__hiddenLabel mesh__D050256 Agents, Antimitotic
% 212.75/212.94  |- skos__scopeNote mesh__D050256
% 212.75/212.94       Agents that arrest cells in MITOSIS, most notably TUBULIN MODULATORS.%A%    
% 212.75/212.94  |- mesh__publicMeSHNote mesh__D050256
% 212.75/212.94       2006; see ANTINEOPLASTIC AGENTS 1988-2005   
% 212.75/212.94  |- skos__hiddenLabel mesh__D050256 Drugs, Antimitotic
% 212.75/212.94  |- rdf__type mesh__D050256sskos__Concept
% 212.75/212.94  |- mesh__dateCreated mesh__D050256 2005-06-30
% 212.75/212.94  |- skos__historyNote mesh__D050256 Antineoplastic Agents %28%1988-2005%29%
% 212.75/212.94  |- skos__annotation mesh__D008894 do not use /analogs /defic /physiol   
% 212.75/212.94  |- skos__scopeNote mesh__D008894
% 212.75/212.94       The major protein constituents of milk are CASEINS and whey proteins such as LACTALBUMIN and LACTOGLOBULINS. Immunoglobulins occur in high concentrations in colostrum and in relatively lower concentrations in milk. %28%Singleton and Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed, p554%29%%A%    
% 212.75/212.94  |- skos__hiddenLabel mesh__D008894 Proteins, Milk
% 212.75/212.94  |- rdf__type mesh__D008894sskos__Concept
% 212.75/212.94  |- skos__altLabel mesh__D008894 Milk Protein
% 212.75/212.94  |- skos__historyNote mesh__D008894 Albumins %28%1966-1972%29%
% 212.75/212.94  |- mesh__dateRevised mesh__D008894 2005-06-30
% 212.75/212.94  |- skos__historyNote mesh__D008894 Caseins %28%1966-1972%29%
% 212.75/212.94  |- mesh__publicMeSHNote mesh__D008894 73   
% 212.75/212.94  |- skos__hiddenLabel mesh__D008894 Protein, Milk
% 212.75/212.94  |- mesh__recordAuthorizer mesh__D008894 sjn
% 212.75/212.94  |- skos__prefLabel mesh__D008894 Milk Proteins
% 212.75/212.94  |- mesh__recordOriginator mesh__D008894 NLM
% 212.75/212.94  |- skos__broader mesh__D008894smesh__D004044
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D008894 2006
% 212.75/212.94  |- mesh__recordMaintainer mesh__D008894 SYSTEM
% 212.75/212.94  |- skos__historyNote mesh__D008894 Lactoglobulins %28%1966-1972%29%
% 212.75/212.94  |- mesh__historyNote mesh__D008894 73   
% 212.75/212.94  |- mesh__dateCreated mesh__D008894 1999-01-01
% 212.75/212.94  |- mesh__dateEstablished mesh__D008894 1973-01-01
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096 Shockwave Lithotripsy, Extracorporeal
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096
% 212.75/212.94       ESWLs %28%Extracorporeal Shockwave Lithotripsy%29%
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096 Ultrasonic Lithotripsy, Percutaneous
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D008096 2003
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096 Lithotripsies, Extracorporeal Shockwave
% 212.75/212.94  |- skos__historyNote mesh__D008096 Ultrasonic Therapy %28%1966-1985%29%
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096 Lithotripsy, Electrohydraulic Shockwave
% 212.75/212.94  |- mesh__publicMeSHNote mesh__D008096 86   
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096
% 212.75/212.94       Lithotripsies, Electrohydraulic Shockwave
% 212.75/212.94  |- skos__historyNote mesh__D008096 Physical Therapy %28%1966-1985%29%
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D008096 2006
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096 Lithotripsies
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D008096 1998
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D008096 2001
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096 Shockwave Lithotripsies, Extracorporeal
% 212.75/212.94  |- skos__historyNote mesh__D008096 Electrotherapy %28%1966-1985%29%
% 212.75/212.94  |- mesh__dateEstablished mesh__D008096 1986-01-01
% 212.75/212.94  |- skos__altLabel mesh__D008096 Litholapaxy
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096 Extracorporeal Shockwave Lithotripsies
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096 Ultrasonic Lithotripsies, Percutaneous
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096 Noninvasive Litholapaxies
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096 Lithotripsies, Ultrasonic
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096 Lithotripsy, Percutaneous Ultrasonic
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096 Electrohydraulic Shockwave Lithotripsies
% 212.75/212.94  |- skos__altLabel mesh__D008096
% 212.75/212.94       ESWL %28%Extracorporeal Shockwave Lithotripsy%29%
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D008096 2005
% 212.75/212.94  |- skos__altLabel mesh__D008096 Ultrasonic Lithotripsy
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D008096 2000
% 212.75/212.94  |- skos__related mesh__D008096smesh__D019220
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096 Litholapaxies, Noninvasive
% 212.75/212.94  |- mesh__recordOriginator mesh__D008096 SH
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096 Shockwave Lithotripsy, Electrohydraulic
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096 Litholapaxies
% 212.75/212.94  |- mesh__recordMaintainer mesh__D008096 JLS
% 212.75/212.94  |- mesh__recordAuthorizer mesh__D008096 PLS
% 212.75/212.94  |- mesh__dateRevised mesh__D008096 1996-06-13
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096 Lithotripsies, Percutaneous Ultrasonic
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096 Ultrasonic Lithotripsies
% 212.75/212.94  |- mesh__historyNote mesh__D008096 86   
% 212.75/212.94  |- skos__altLabel mesh__D008096 Electrohydraulic Shockwave Lithotripsy
% 212.75/212.94  |- rdf__type mesh__D008096sskos__Concept
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096 Litholapaxy, Noninvasive
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096 Lithotripsy, Ultrasonic
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D008096 1997
% 212.75/212.94  |- skos__broader mesh__D008096smesh__D013812
% 212.75/212.94  |- mesh__dateCreated mesh__D008096 1985-06-07
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096
% 212.75/212.94       Shockwave Lithotripsies, Electrohydraulic
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096 Lithotripsy, Extracorporeal Shockwave
% 212.75/212.94  |- skos__hiddenLabel mesh__D008096 Percutaneous Ultrasonic Lithotripsies
% 212.75/212.94  |- skos__annotation mesh__D008096
% 212.75/212.94       do not use /util except by MeSH definition; litholysis %28%dissolving calculi by acid%29% is disease /ther, not LITHOTRIPSY; DF: ESWL%A%  
% 212.75/212.94  |- skos__scopeNote mesh__D008096
% 212.75/212.94       The destruction of a calculus of the kidney, ureter, bladder, or gallbladder by physical forces, including crushing with a lithotriptor through a catheter. Focused percutaneous ultrasound and focused hydraulic shock waves may be used without surgery. Lithotripsy does not include the dissolving of stones by acids or litholysis. Lithotripsy by laser is LITHOTRIPSY, LASER.%A%    
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D008096 2004
% 212.75/212.94  |- skos__prefLabel mesh__D008096 Lithotripsy
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D008096 2002
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D008096 1999
% 212.75/212.94  |- skos__altLabel mesh__D016528 Recovery Room Nursing
% 212.75/212.94  |- skos__altLabel mesh__D016528 Nursing, Post-Surgical
% 212.75/212.94  |- mesh__dateCreated mesh__D016528 1991-02-11
% 212.75/212.94  |- skos__hiddenLabel mesh__D016528 Post Anesthesia Nursing
% 212.75/212.94  |- skos__hiddenLabel mesh__D016528 Nursing, Post Anesthesia
% 212.75/212.94  |- mesh__dateRevised mesh__D016528 1995-03-13
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016528 1997
% 212.75/212.94  |- skos__hiddenLabel mesh__D016528 Nursing, Post Surgical
% 212.75/212.94  |- skos__altLabel mesh__D016528 Nursing, Post-Anesthesia
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016528 2004
% 212.75/212.94  |- mesh__publicMeSHNote mesh__D016528
% 212.75/212.94       93; was POST-ANESTHESIA NURSING 1992   
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016528 1996
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016528 2001
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016528 2003
% 212.75/212.94  |- skos__historyNote mesh__D016528 Surgical Nursing %28%1975-1991%29%
% 212.75/212.94  |- skos__historyNote mesh__D016528 Recovery Room %28%1975-1991%29%
% 212.75/212.94  |- mesh__recordMaintainer mesh__D016528 TGC
% 212.75/212.94  |- skos__broader mesh__D016528smesh__D013527
% 212.75/212.94  |- mesh__recordAuthorizer mesh__D016528 PLS
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016528 2000
% 212.75/212.94  |- skos__scopeNote mesh__D016528
% 212.75/212.94       The specialty or practice of nursing in the care of patients in the recovery room following surgery and/or anesthesia.%A%    
% 212.75/212.94  |- skos__altLabel mesh__D016528 Post-Anesthesia Nursing
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016528 1999
% 212.75/212.94  |- skos__altLabel mesh__D016528 Nursing, Postanesthesia
% 212.75/212.94  |- mesh__onlineNote mesh__D016528
% 212.75/212.94       use POSTANESTHESIA NURSING to search POST-ANESTHESIA NURSING 1992%A%  
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016528 2006
% 212.75/212.94  |- skos__annotation mesh__D016528 SPEC: SPEC qualif   
% 212.75/212.94  |- skos__prefLabel mesh__D016528 Postanesthesia Nursing
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016528 1998
% 212.75/212.94  |- mesh__recordOriginator mesh__D016528 JHM
% 212.75/212.94  |- rdf__type mesh__D016528sskos__Concept
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016528 2005
% 212.75/212.94  |- skos__altLabel mesh__D016528 Post-Surgical Nursing
% 212.75/212.94  |- mesh__dateEstablished mesh__D016528 1992-01-01
% 212.75/212.94  |- skos__altLabel mesh__D016528 Nursing, Recovery Room
% 212.75/212.94  |- mesh__historyNote mesh__D016528 93; was POST-ANESTHESIA NURSING 1992   
% 212.75/212.94  |- skos__hiddenLabel mesh__D016528 Post Surgical Nursing
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D016528 2002
% 212.75/212.94  |- skos__broader mesh__D002508smesh__D000886
% 212.75/212.94  |- skos__prefLabel mesh__D002508 Cephalometry
% 212.75/212.94  |- mesh__publicMeSHNote mesh__D002508
% 212.75/212.94       1965; for CRANIOMETRY see CRANIOMETRY 1966-2004   
% 212.75/212.94  |- mesh__recordMaintainer mesh__D002508 nns
% 212.75/212.94  |- mesh__historyNote mesh__D002508 1965   
% 212.75/212.94  |- mesh__recordOriginator mesh__D002508 NLM
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D002508 2006
% 212.75/212.94  |- mesh__recordAuthorizer mesh__D002508 sjn
% 212.75/212.94  |- mesh__dateRevised mesh__D002508 2004-07-07
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D002508 2005
% 212.75/212.94  |- mesh__dateEstablished mesh__D002508 1965-01-01
% 212.75/212.94  |- rdf__type mesh__D002508sskos__Concept
% 212.75/212.94  |- mesh__dateCreated mesh__D002508 1999-01-01
% 212.75/212.94  |- skos__scopeNote mesh__D002508
% 212.75/212.94       The measurement of the dimensions of the HEAD.     
% 212.75/212.94  |- skos__hiddenLabel mesh__D013230 Desaturase, delta-9
% 212.75/212.94  |- mesh__dateCreated mesh__D013230 1974-11-19
% 212.75/212.94  |- skos__altLabel mesh__D013230 Stearate Desaturase
% 212.75/212.94  |- skos__hiddenLabel mesh__D013230 delta 9 Desaturase
% 212.75/212.94  |- skos__altLabel mesh__D013230 Stearyl-CoA Desaturase
% 212.75/212.94  |- mesh__dateRevised mesh__D013230 2004-07-07
% 212.75/212.94  |- skos__hiddenLabel mesh__D013230 Desaturase, Stearate
% 212.75/212.94  |- skos__hiddenLabel mesh__D013230 Stearoyl CoA Desaturase
% 212.75/212.94  |- skos__altLabel mesh__D013230 delta-9 Desaturase
% 212.75/212.94  |- mesh__dateEstablished mesh__D013230 1991-01-01
% 212.75/212.94  |- mesh__publicMeSHNote mesh__D013230
% 212.75/212.94       95; was STEARYL-COA DESATURASE 1975-94 %28%see under FATTY ACID DESATURASES 1975-90%29%%A%  
% 212.75/212.94  |- rdf__type mesh__D013230sskos__Concept
% 212.75/212.94  |- mesh__recordMaintainer mesh__D013230 ssb
% 212.75/212.94  |- skos__hiddenLabel mesh__D013230 Stearyl CoA Desaturase
% 212.75/212.94  |- skos__historyNote mesh__D013230 Coenzyme A %28%1973-1974%29%
% 212.75/212.94  |- mesh__historyNote mesh__D013230
% 212.75/212.94       95; was STEARYL-COA DESATURASE 1975-94 %28%see under FATTY ACID DESATURASES 1975-90%29%%A%  
% 212.75/212.94  |- skos__hiddenLabel mesh__D013230 Desaturase, Stearyl-CoA
% 212.75/212.94  |- skos__broader mesh__D013230smesh__D044943
% 212.75/212.94  |- skos__historyNote mesh__D013230 Hydroxylases %28%1973-1974%29%
% 212.75/212.94  |- mesh__recordAuthorizer mesh__D013230 sjn
% 212.75/212.94  |- skos__scopeNote mesh__D013230
% 212.75/212.94       An enzyme that catalyzes the formation of oleoyl-CoA, A, and water from stearoyl-CoA, AH2, and oxygen where AH2 is an unspecified hydrogen donor. EC 1.14.99.5.%A%    
% 212.75/212.94  |- skos__prefLabel mesh__D013230 Stearoyl-CoA Desaturase
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D013230 2006
% 212.75/212.94  |- mesh__onlineNote mesh__D013230
% 212.75/212.94       use STEAROYL-COA DESATURASE to search STEARYL-COA DESATURASE 1975-94%A%  
% 212.75/212.94  |- skos__hiddenLabel mesh__D013230 Desaturase, Stearoyl-CoA
% 212.75/212.94  |- skos__historyNote mesh__D013230 Stearic Acids %28%1973-1974%29%
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D013230 2005
% 212.75/212.94  |- mesh__recordOriginator mesh__D013230 NLM
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012936 1999
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012936 1996
% 212.75/212.94  |- skos__broader mesh__D012936smesh__D008511
% 212.75/212.94  |- rdf__type mesh__D012936sskos__Concept
% 212.75/212.94  |- skos__prefLabel mesh__D012936 Social Medicine
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012936 2005
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012936 1993
% 212.75/212.94  |- mesh__dateRevised mesh__D012936 1990-05-17
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012936 1998
% 212.75/212.94  |- mesh__dateCreated mesh__D012936 1999-01-01
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012936 1995
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012936 1992
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012936 2002
% 212.75/212.94  |- mesh__recordOriginator mesh__D012936 NLM
% 212.75/212.94  |- skos__altLabel mesh__D012936 Medicine, Social
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012936 1994
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012936 2001
% 212.75/212.94  |- skos__annotation mesh__D012936 SPEC: SPEC qualif; DF: SOCIAL MED   
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012936 2004
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012936 2000
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012936 1997
% 212.75/212.94  |- mesh__recordAuthorizer mesh__D012936 PLS
% 212.75/212.94  |- skos__scopeNote mesh__D012936
% 212.75/212.94       A branch of medicine concerned with the role of socio-environmental factors in the occurrence, prevention and treatment of disease.%A%    
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012936 2006
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012936 1991
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012936 2003
% 212.75/212.94  |- mesh__recordMaintainer mesh__D012936 TAP
% 212.75/212.94  |- skos__annotation mesh__D012138
% 212.75/212.94       do not use /util except by MeSH definition; do not confuse with ADMINISTRATION, INHALATION%A%  
% 212.75/212.94  |- skos__hiddenLabel mesh__D012138 Respiratory Therapies
% 212.75/212.94  |- mesh__dateCreated mesh__D012138 1999-01-01
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012138 1999
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012138 2003
% 212.75/212.94  |- skos__hiddenLabel mesh__D012138 Therapies, Inhalation
% 212.75/212.94  |- mesh__dateRevised mesh__D012138 1995-05-31
% 212.75/212.94  |- mesh__publicMeSHNote mesh__D012138 78; was INHALATION THERAPY 1963-77   
% 212.75/212.94  |- skos__hiddenLabel mesh__D012138 Inhalation Therapies
% 212.75/212.94  |- skos__broader mesh__D012138smesh__D013812
% 212.75/212.94  |- skos__altLabel mesh__D012138 Therapy, Respiratory
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012138 1998
% 212.75/212.94  |- skos__altLabel mesh__D012138 Therapy, Inhalation
% 212.75/212.94  |- skos__scopeNote mesh__D012138
% 212.75/212.94       Care of patients with deficiencies and abnormalities associated with the cardiopulmonary system. It includes the therapeutic use of medical gases and their administrative apparatus, environmental control systems, humidification, aerosols, ventilatory support, bronchopulmonary drainage and exercise, respiratory rehabilitation, assistance with cardiopulmonary resuscitation, and maintenance of natural, artificial, and mechanical airways.%A%    
% 212.75/212.94  |- mesh__recordMaintainer mesh__D012138 PLS
% 212.75/212.94  |- skos__hiddenLabel mesh__D012138 Therapies, Respiratory
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012138 2001
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012138 2006
% 212.75/212.94  |- rdf__type mesh__D012138sskos__Concept
% 212.75/212.94  |- mesh__historyNote mesh__D012138 78; was INHALATION THERAPY 1963-77   
% 212.75/212.94  |- mesh__activeMeSHYear mesh__D012138 2000
% 212.75/212.95  |- skos__prefLabel mesh__D012138 Respiratory Therapy
% 212.75/212.95  |- mesh__onlineNote mesh__D012138
% 212.75/212.95       use RESPIRATORY THERAPY to search INHALATION THERAPY 1966-77%A%  
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012138 2005
% 212.75/212.95  |- mesh__recordAuthorizer mesh__D012138 PLS
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012138 1997
% 212.75/212.95  |- mesh__recordOriginator mesh__D012138 NLM
% 212.75/212.95  |- skos__related mesh__D012138smesh__D001945
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012138 1996
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012138 2002
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012138 2004
% 212.75/212.95  |- skos__broader mesh__D000842Q000293smesh__D000842
% 212.75/212.95  |- mesh__preferredCombination mesh__D000842Q000293smesh__D016512
% 212.75/212.95  |- rdf__type mesh__D000842Q000293smesh__CompoundConcept
% 212.75/212.95  |- skos__hiddenLabel mesh__D003601 Immunological Cytotoxicity Tests
% 212.75/212.95  |- skos__altLabel mesh__D003601 Immunologic Cytotoxicity Tests
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003601 2001
% 212.75/212.95  |- skos__altLabel mesh__D003601
% 212.75/212.95       Antiglobulin-Augmented Lymphocytotoxicity Tests
% 212.75/212.95  |- rdf__type mesh__D003601sskos__Concept
% 212.75/212.95  |- mesh__recordOriginator mesh__D003601 NLM
% 212.75/212.95  |- skos__altLabel mesh__D003601
% 212.75/212.95       Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent
% 212.75/212.95  |- skos__hiddenLabel mesh__D003601 Immunological Cytotoxicity Test
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003601 2003
% 212.75/212.95  |- skos__altLabel mesh__D003601
% 212.75/212.95       Anti Human Globulin Complement Dependent Cytotoxicity Tests
% 212.75/212.95  |- skos__altLabel mesh__D003601 Microcytotoxicity Tests
% 212.75/212.95  |- skos__hiddenLabel mesh__D003601 AHG CDC Tests
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003601 2002
% 212.75/212.95  |- skos__historyNote mesh__D003601
% 212.75/212.95       specific cell/immunology %28%1966-1970%29%
% 212.75/212.95  |- skos__hiddenLabel mesh__D003601 Cytotoxicity Test, Immunological
% 212.75/212.95  |- mesh__historyNote mesh__D003601 73%28%71%29%   
% 212.75/212.95  |- mesh__publicMeSHNote mesh__D003601 73   
% 212.75/212.95  |- mesh__dateCreated mesh__D003601 1999-01-01
% 212.75/212.95  |- skos__altLabel mesh__D003601 Cytotoxicity Test, Immunologic
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003601 1998
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003601 2004
% 212.75/212.95  |- skos__annotation mesh__D003601
% 212.75/212.95       note category: do not confuse with CYTOTOXICITY, IMMUNOLOGIC %28%Cat G%29%; DF: CYTOTOX TESTS IMMUNOL%A%  
% 212.75/212.95  |- mesh__recordMaintainer mesh__D003601 jls
% 212.75/212.95  |- skos__hiddenLabel mesh__D003601 AHG-CDC Test
% 212.75/212.95  |- skos__prefLabel mesh__D003601 Cytotoxicity Tests, Immunologic
% 212.75/212.95  |- skos__broader mesh__D003601smesh__D007158
% 212.75/212.95  |- mesh__dateRevised mesh__D003601 2005-07-30
% 212.75/212.95  |- skos__altLabel mesh__D003601
% 212.75/212.95       Anti-Human Globulin Complement-Dependent Cytotoxicity Test
% 212.75/212.95  |- skos__hiddenLabel mesh__D003601
% 212.75/212.95       Antiglobulin Augmented Lymphocytotoxicity Tests
% 212.75/212.95  |- skos__broader mesh__D003601smesh__D007159
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003601 1999
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003601 2005
% 212.75/212.95  |- skos__broader mesh__D003601smesh__D018675
% 212.75/212.95  |- mesh__dateEstablished mesh__D003601 1973-01-01
% 212.75/212.95  |- skos__altLabel mesh__D003601
% 212.75/212.95       Antiglobulin-Augmented Lymphocytotoxicity Test
% 212.75/212.95  |- skos__hiddenLabel mesh__D003601
% 212.75/212.95       Cytotoxicity Tests, Anti Human Globulin Complement Dependent
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003601 2006A
% 212.75/212.95  |- skos__hiddenLabel mesh__D003601
% 212.75/212.95       Anti Human Globulin Complement Dependent Cytotoxicity Test
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003601 2000
% 212.75/212.95  |- skos__hiddenLabel mesh__D003601
% 212.75/212.95       Lymphocytotoxicity Test, Antiglobulin Augmented
% 212.75/212.95  |- skos__historyNote mesh__D003601 specific immune factor %28%1966-1970%29%
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003601 2006
% 212.75/212.95  |- skos__altLabel mesh__D003601 Immunologic Cytotoxicity Test
% 212.75/212.95  |- skos__scopeNote mesh__D003601
% 212.75/212.95       The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement.%A%    
% 212.75/212.95  |- skos__altLabel mesh__D003601
% 212.75/212.95       Lymphocytotoxicity Test, Antiglobulin-Augmented
% 212.75/212.95  |- skos__altLabel mesh__D003601 AHG-CDC Tests
% 212.75/212.95  |- skos__hiddenLabel mesh__D003601
% 212.75/212.95       Antiglobulin Augmented Lymphocytotoxicity Test
% 212.75/212.95  |- mesh__recordAuthorizer mesh__D003601 jls
% 212.75/212.95  |- skos__hiddenLabel mesh__D003601
% 212.75/212.95       Lymphocytotoxicity Tests, Antiglobulin Augmented
% 212.75/212.95  |- skos__altLabel mesh__D003601 Cytotoxicity Tests, Immunological
% 212.75/212.95  |- skos__broader mesh__D050257smesh__D050256
% 212.75/212.95  |- skos__hiddenLabel mesh__D050257 Inhibitors, Tubulin Polymerization
% 212.75/212.95  |- mesh__dateCreated mesh__D050257 2005-06-30
% 212.75/212.95  |- mesh__historyNote mesh__D050257 2006   
% 212.75/212.95  |- skos__altLabel mesh__D050257 Tubulin Polymerization Inhibitors
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D050257 2006
% 212.75/212.95  |- skos__historyNote mesh__D050257 Tubulin %28%1980-2005%29%
% 212.75/212.95  |- mesh__recordOriginator mesh__D050257 ssb
% 212.75/212.95  |- mesh__publicMeSHNote mesh__D050257 2006   
% 212.75/212.95  |- skos__hiddenLabel mesh__D050257 Polymerization Inhibitors, Tubulin
% 212.75/212.95  |- skos__hiddenLabel mesh__D050257 Modulators, Microtubule
% 212.75/212.95  |- mesh__recordAuthorizer mesh__D050257 sjn
% 212.75/212.95  |- mesh__dateEstablished mesh__D050257 2006-01-01
% 212.75/212.95  |- skos__scopeNote mesh__D050257
% 212.75/212.95       Agents that interact with TUBULIN to inhibit or promote polymerization.%A%    
% 212.75/212.95  |- skos__hiddenLabel mesh__D050257 Polymerization Promoters, Tubulin
% 212.75/212.95  |- skos__hiddenLabel mesh__D050257 Promoters, Tubulin
% 212.75/212.95  |- skos__prefLabel mesh__D050257 Tubulin Modulators
% 212.75/212.95  |- skos__altLabel mesh__D050257 Microtubule Modulators
% 212.75/212.95  |- rdf__type mesh__D050257sskos__Concept
% 212.75/212.95  |- skos__altLabel mesh__D050257 Tubulin Polymerization Promoters
% 212.75/212.95  |- mesh__recordMaintainer mesh__D050257 ssb
% 212.75/212.95  |- skos__hiddenLabel mesh__D050257 Inhibitors, Tubulin
% 212.75/212.95  |- skos__hiddenLabel mesh__D050257 Modulators, Tubulin
% 212.75/212.95  |- skos__hiddenLabel mesh__D050257 Promoters, Tubulin Polymerization
% 212.75/212.95  |- skos__related mesh__D008895smesh__D007774
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008895 2004
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008895 2001
% 212.75/212.95  |- skos__broader mesh__D008895smesh__D012634
% 212.75/212.95  |- rdf__type mesh__D008895sskos__Concept
% 212.75/212.95  |- skos__related mesh__D008895smesh__D001942
% 212.75/212.95  |- skos__hiddenLabel mesh__D008895 Breast Milks
% 212.75/212.95  |- mesh__recordMaintainer mesh__D008895 JLS
% 212.75/212.95  |- mesh__dateRevised mesh__D008895 1997-06-20
% 212.75/212.95  |- skos__annotation mesh__D008895 /secret: consider also LACTATION   
% 212.75/212.95  |- skos__altLabel mesh__D008895 Human Milk
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008895 2005
% 212.75/212.95  |- skos__hiddenLabel mesh__D008895 Milk, Breast
% 212.75/212.95  |- mesh__recordAuthorizer mesh__D008895 SJN
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008895 2002
% 212.75/212.95  |- skos__related mesh__D008895smesh__D017784
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008895 1998
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008895 2006
% 212.75/212.95  |- skos__prefLabel mesh__D008895 Milk, Human
% 212.75/212.95  |- skos__altLabel mesh__D008895 Breast Milk
% 212.75/212.95  |- mesh__dateCreated mesh__D008895 1999-01-01
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008895 1999
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008895 2003
% 212.75/212.95  |- skos__broader mesh__D008895smesh__D008892
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008895 2000
% 212.75/212.95  |- mesh__recordOriginator mesh__D008895 NLM
% 212.75/212.95  |- skos__broader mesh__D008097smesh__D001454
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008097 2000
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008097 2001
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008097 1995
% 212.75/212.95  |- rdf__type mesh__D008097sskos__Concept
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008097 1998
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008097 2005
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008097 2002
% 212.75/212.95  |- mesh__recordOriginator mesh__D008097 NLM
% 212.75/212.95  |- mesh__recordAuthorizer mesh__D008097 PLS
% 212.75/212.95  |- mesh__recordMaintainer mesh__D008097 PLS
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008097 1996
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008097 2003
% 212.75/212.95  |- skos__prefLabel mesh__D008097 Lithuania
% 212.75/212.95  |- mesh__dateCreated mesh__D008097 1999-01-01
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008097 1999
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008097 2006
% 212.75/212.95  |- mesh__dateRevised mesh__D008097 1994-03-17
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008097 1997
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008097 2004
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D016529 2003
% 212.75/212.95  |- mesh__publicMeSHNote mesh__D016529 92   
% 212.75/212.95  |- skos__altLabel mesh__D016529 Nursing, Emergency
% 212.75/212.95  |- mesh__dateEstablished mesh__D016529 1992-01-01
% 212.75/212.95  |- mesh__historyNote mesh__D016529 92   
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D016529 1993
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D016529 1999
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D016529 2006
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D016529 1992
% 212.75/212.95  |- skos__broader mesh__D016529smesh__D013041
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D016529 1998
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D016529 2002
% 212.75/212.95  |- rdf__type mesh__D016529sskos__Concept
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D016529 2005
% 212.75/212.95  |- mesh__dateCreated mesh__D016529 1991-02-11
% 212.75/212.95  |- skos__altLabel mesh__D016529 Emergency Room Nursing
% 212.75/212.95  |- skos__prefLabel mesh__D016529 Emergency Nursing
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D016529 1995
% 212.75/212.95  |- skos__broader mesh__D016529smesh__D009732
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D016529 1994
% 212.75/212.95  |- skos__scopeNote mesh__D016529
% 212.75/212.95       The specialty or practice of nursing in the care of patients admitted to the emergency department.%A%    
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D016529 1997
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D016529 2001
% 212.75/212.95  |- skos__historyNote mesh__D016529 Emergencies/nursing %28%1966-1991%29%
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D016529 2004
% 212.75/212.95  |- skos__historyNote mesh__D016529 Specialties, Nursing %28%1973-1991%29%
% 212.75/212.95  |- skos__annotation mesh__D016529 SPEC: SPEC qualif   
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D016529 1996
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D016529 2000
% 212.75/212.95  |- skos__historyNote mesh__D016529
% 212.75/212.95       Emergency Service, Hospital %28%1966-1991%29%
% 212.75/212.95  |- skos__altLabel mesh__D016529 Nursing, Emergency Room
% 212.75/212.95  |- mesh__recordMaintainer mesh__D002509 ssb
% 212.75/212.95  |- mesh__dateEstablished mesh__D002509 1968-01-01
% 212.75/212.95  |- skos__altLabel mesh__D002509 Cephalomycine
% 212.75/212.95  |- skos__prefLabel mesh__D002509 Cephaloridine
% 212.75/212.95  |- skos__altLabel mesh__D002509 Cefaloridine
% 212.75/212.95  |- skos__scopeNote mesh__D002509 A cephalosporin antibiotic.     
% 212.75/212.95  |- mesh__historyNote mesh__D002509 68%28%66%29%   
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D002509 2006
% 212.75/212.95  |- skos__broader mesh__D002509smesh__D002511
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D002509 2005
% 212.75/212.95  |- mesh__dateRevised mesh__D002509 2004-07-07
% 212.75/212.95  |- skos__altLabel mesh__D002509 Cephaloridin
% 212.75/212.95  |- mesh__recordOriginator mesh__D002509 NLM
% 212.75/212.95  |- mesh__dateCreated mesh__D002509 1999-01-01
% 212.75/212.95  |- rdf__type mesh__D002509sskos__Concept
% 212.75/212.95  |- mesh__publicMeSHNote mesh__D002509 68   
% 212.75/212.95  |- mesh__recordAuthorizer mesh__D002509 sjn
% 212.75/212.95  |- mesh__dateCreated mesh__D013231 1999-01-01
% 212.75/212.95  |- skos__prefLabel mesh__D013231 Steatitis
% 212.75/212.95  |- mesh__recordMaintainer mesh__D013231 sjn
% 212.75/212.95  |- mesh__recordAuthorizer mesh__D013231 sjn
% 212.75/212.95  |- skos__broader mesh__D013231smesh__D000820
% 212.75/212.95  |- skos__broader mesh__D013231smesh__D014811
% 212.75/212.95  |- skos__historyNote mesh__D013231 Selenium %28%1966-1970%29%
% 212.75/212.95  |- skos__historyNote mesh__D013231 Swine Diseases %28%1966-1970%29%
% 212.75/212.95  |- skos__annotation mesh__D013231
% 212.75/212.95       inflamm of adipose tissue in cats %26% minks; coord IM with CAT DISEASES %28%IM%29% or MINKS %28%IM%29%; check tags CATS if cat %26% ANIMALS for cat or mink%A%  
% 212.75/212.95  |- mesh__publicMeSHNote mesh__D013231 71   
% 212.75/212.95  |- mesh__recordOriginator mesh__D013231 NLM
% 212.75/212.95  |- mesh__dateEstablished mesh__D013231 1971-01-01
% 212.75/212.95  |- rdf__type mesh__D013231sskos__Concept
% 212.75/212.95  |- skos__historyNote mesh__D013231
% 212.75/212.95       Vitamin E Deficiency/VE %28%1966-1970%29%
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D013231 2005
% 212.75/212.95  |- skos__hiddenLabel mesh__D013231 Steatitides
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D013231 2004
% 212.75/212.95  |- mesh__historyNote mesh__D013231 71   
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D013231 2006
% 212.75/212.95  |- skos__scopeNote mesh__D013231
% 212.75/212.95       A disease of cats and mink characterized by a marked inflammation of adipose tissue and the deposition of %22%ceroid%22% pigment in the interstices of the adipose cells. It is believed to be caused by feeding diets containing too much unsaturated fatty acid and too little vitamin E. %28%Merck Veterinary Manual, 5th ed; Stedman, 25th ed%29%%A%    
% 212.75/212.95  |- mesh__dateRevised mesh__D013231 2003-07-30
% 212.75/212.95  |- skos__hiddenLabel mesh__D012937 Mobility, Social
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012937 2001
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012937 1992
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012937 1994
% 212.75/212.95  |- mesh__historyNote mesh__D012937 68   
% 212.75/212.95  |- skos__historyNote mesh__D012937 Sociology %28%1966-1967%29%
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012937 2000
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012937 1991
% 212.75/212.95  |- mesh__dateRevised mesh__D012937 1990-08-30
% 212.75/212.95  |- mesh__recordAuthorizer mesh__D012937 PLS
% 212.75/212.95  |- skos__hiddenLabel mesh__D012937 Social Mobilities
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012937 2004
% 212.75/212.95  |- skos__prefLabel mesh__D012937 Social Mobility
% 212.75/212.95  |- skos__broader mesh__D012937smesh__D012923
% 212.75/212.95  |- skos__scopeNote mesh__D012937
% 212.75/212.95       The movement or shifting of membership between or within social classes by individuals or by groups.%A%    
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012937 2006
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012937 1997
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012937 2003
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012937 1999
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012937 2005
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012937 1996
% 212.75/212.95  |- skos__hiddenLabel mesh__D012937 Mobilities, Social
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012937 1998
% 212.75/212.95  |- rdf__type mesh__D012937sskos__Concept
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012937 2002
% 212.75/212.95  |- skos__annotation mesh__D012937 no qualif   
% 212.75/212.95  |- mesh__recordMaintainer mesh__D012937 PLS
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012937 1993
% 212.75/212.95  |- mesh__publicMeSHNote mesh__D012937 68   
% 212.75/212.95  |- mesh__dateEstablished mesh__D012937 1968-01-01
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012937 1995
% 212.75/212.95  |- mesh__recordOriginator mesh__D012937 NLM
% 212.75/212.95  |- mesh__dateCreated mesh__D012937 1999-01-01
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012139 1993
% 212.75/212.95  |- mesh__publicMeSHNote mesh__D012139
% 212.75/212.95       91; was see under HOSPITAL DEPARTMENTS Aug 1977-90   
% 212.75/212.95  |- skos__historyNote mesh__D012139
% 212.75/212.95       Respiratory Therapy %28%1966-Jul 1977%29%
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012139 1999
% 212.75/212.95  |- skos__prefLabel mesh__D012139 Respiratory Therapy Department, Hospital
% 212.75/212.95  |- mesh__dateCreated mesh__D012139 1977-05-19
% 212.75/212.95  |- mesh__historyNote mesh__D012139
% 212.75/212.95       91%28%Aug 77%29%; was see under HOSPITAL DEPARTMENTS 1977-90   
% 212.75/212.95  |- skos__altLabel mesh__D012139 Hospital Respiratory Therapy Department
% 212.75/212.95  |- mesh__recordMaintainer mesh__D012139 TGC
% 212.75/212.95  |- mesh__dateEstablished mesh__D012139 1991-01-01
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012139 2005
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012139 1994
% 212.75/212.95  |- mesh__recordOriginator mesh__D012139 EC
% 212.75/212.95  |- rdf__type mesh__D012139sskos__Concept
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012139 2006
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012139 1995
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012139 1996
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012139 2000
% 212.75/212.95  |- skos__historyNote mesh__D012139
% 212.75/212.95       Hospital Departments %28%1968-Jul 1977%29%
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012139 1997
% 212.75/212.95  |- mesh__recordAuthorizer mesh__D012139 PLS
% 212.75/212.95  |- skos__altLabel mesh__D012139 Respiratory Therapy Departments, Hospital
% 212.75/212.95  |- mesh__dateRevised mesh__D012139 1992-05-18
% 212.75/212.95  |- skos__scopeNote mesh__D012139
% 212.75/212.95       Hospital department which is responsible for the administration of diagnostic pulmonary function tests and of procedures to restore optimum pulmonary ventilation.%A%    
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012139 2001
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012139 2003
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012139 1998
% 212.75/212.95  |- skos__annotation mesh__D012139 DF: RESP THER DEP   
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012139 2002
% 212.75/212.95  |- skos__broader mesh__D012139smesh__D006748
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D012139 2004
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D009190 2004
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D009190 1992
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D009190 1999
% 212.75/212.95  |- skos__altLabel mesh__D009190 Dysmyelopoietic Syndromes
% 212.75/212.95  |- mesh__recordMaintainer mesh__D009190 TGC
% 212.75/212.95  |- skos__historyNote mesh__D009190
% 212.75/212.95       Myeloproliferative Disorders %28%1966-1985%29%
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D009190 2002
% 212.75/212.95  |- skos__annotation mesh__D009190
% 212.75/212.95       myelo- here = bone marrow, not spinal cord   
% 212.75/212.95  |- skos__hiddenLabel mesh__D009190 Syndrome, Dysmyelopoietic
% 212.75/212.95  |- mesh__historyNote mesh__D009190 86   
% 212.75/212.95  |- skos__hiddenLabel mesh__D009190 Syndrome, Myelodysplastic
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D009190 2003
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D009190 1995
% 212.75/212.95  |- skos__broader mesh__D009190smesh__D001855
% 212.75/212.95  |- skos__historyNote mesh__D009190 Bone Marrow Diseases %28%1966-1985%29%
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D009190 1998
% 212.75/212.95  |- skos__hiddenLabel mesh__D009190 Syndromes, Dysmyelopoietic
% 212.75/212.95  |- rdf__type mesh__D009190sskos__Concept
% 212.75/212.95  |- skos__prefLabel mesh__D009190 Myelodysplastic Syndromes
% 212.75/212.95  |- mesh__recordOriginator mesh__D009190 VDK
% 212.75/212.95  |- skos__historyNote mesh__D009190 Leukemia, Myelocytic %28%1966-1985%29%
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D009190 2006
% 212.75/212.95  |- skos__scopeNote mesh__D009190
% 212.75/212.95       Conditions in which the bone marrow shows qualitative and quantitative changes suggestive of a preleukemic process, but having a chronic course that does not necessarily terminate as acute leukemia.%A%    
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D009190 1994
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D009190 2001
% 212.75/212.95  |- skos__historyNote mesh__D009190 Anemia, Aplastic %28%1966-1985%29%
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D009190 2005
% 212.75/212.95  |- skos__hiddenLabel mesh__D009190 Syndromes, Myelodysplastic
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D009190 1997
% 212.75/212.95  |- skos__hiddenLabel mesh__D009190 Dysmyelopoietic Syndrome
% 212.75/212.95  |- mesh__dateRevised mesh__D009190 1991-06-18
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D009190 2000
% 212.75/212.95  |- mesh__publicMeSHNote mesh__D009190 86   
% 212.75/212.95  |- mesh__dateEstablished mesh__D009190 1986-01-01
% 212.75/212.95  |- mesh__recordAuthorizer mesh__D009190 PLS
% 212.75/212.95  |- mesh__dateCreated mesh__D009190 1985-06-06
% 212.75/212.95  |- skos__historyNote mesh__D009190 Preleukemia %28%1977-1985%29%
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D009190 1993
% 212.75/212.95  |- skos__hiddenLabel mesh__D009190 Myelodysplastic Syndrome
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D009190 1996
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D017622 1997
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D017622 2001
% 212.75/212.95  |- mesh__dateEstablished mesh__D017622 1994-01-01
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D017622 2005
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D017622 1999
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D017622 1996
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D017622 1995
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D017622 2000
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D017622 1998
% 212.75/212.95  |- skos__historyNote mesh__D017622 Periodontal Diseases %28%1976-1993%29%
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D017622 1994
% 212.75/212.95  |- mesh__historyNote mesh__D017622 94   
% 212.75/212.95  |- skos__broader mesh__D017622smesh__D010510
% 212.75/212.95  |- skos__historyNote mesh__D017622 Periodontitis %28%1976-1993%29%
% 212.75/212.95  |- skos__altLabel mesh__D017622 Attachment Loss, Periodontal
% 212.75/212.95  |- skos__hiddenLabel mesh__D017622 Loss, Periodontal Attachment
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D017622 2004
% 212.75/212.95  |- skos__annotation mesh__D017622
% 212.75/212.95       attachment refers to the periodontal ligament   
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D017622 2002
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D017622 2006
% 212.75/212.95  |- skos__prefLabel mesh__D017622 Periodontal Attachment Loss
% 212.75/212.95  |- rdf__type mesh__D017622sskos__Concept
% 212.75/212.95  |- skos__scopeNote mesh__D017622
% 212.75/212.95       Loss or destruction of periodontal tissue caused by periodontitis or other destructive periodontal diseases or by injury during instrumentation. Attachment refers to the periodontal ligament which attaches to the alveolar bone. It has been hypothesized that treatment of the underlying periodontal disease and the seeding of periodontal ligament cells enable the creating of new attachment.%A%    
% 212.75/212.95  |- mesh__dateCreated mesh__D017622 1992-12-28
% 212.75/212.95  |- mesh__publicMeSHNote mesh__D017622 94   
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D017622 2003
% 212.75/212.95  |- mesh__dateRevised mesh__D003602 1994-05-23
% 212.75/212.95  |- skos__historyNote mesh__D003602
% 212.75/212.95       Cytotoxicity Tests, Immunologic %28%1971-1977%29%
% 212.75/212.95  |- skos__related mesh__D003602smesh__D015938
% 212.75/212.95  |- skos__related mesh__D003602smesh__D018033
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003602 2000
% 212.75/212.95  |- skos__related mesh__D003602smesh__D015979
% 212.75/212.95  |- skos__altLabel mesh__D003602 Tumoricidal Activity, Immunologic
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003602 2003
% 212.75/212.95  |- skos__related mesh__D003602smesh__D007694
% 212.75/212.95  |- mesh__historyNote mesh__D003602 78   
% 212.75/212.95  |- mesh__publicMeSHNote mesh__D003602 78   
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003602 1995
% 212.75/212.95  |- skos__broader mesh__D003602smesh__D007109
% 212.75/212.95  |- skos__related mesh__D003602smesh__D013602
% 212.75/212.95  |- mesh__dateCreated mesh__D003602 1977-03-01
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003602 1999
% 212.75/212.95  |- skos__prefLabel mesh__D003602 Cytotoxicity, Immunologic
% 212.75/212.95  |- mesh__dateEstablished mesh__D003602 1978-01-01
% 212.75/212.95  |- skos__historyNote mesh__D003602 Immunity, Cellular %28%1970-1977%29%
% 212.75/212.95  |- mesh__recordMaintainer mesh__D003602 AGS
% 212.75/212.95  |- skos__historyNote mesh__D003602 T Lymphocytes %28%1973-1979%29%
% 212.75/212.95  |- skos__historyNote mesh__D003602 Lymphocytes %28%1966-1977%29%
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003602 1998
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003602 2006
% 212.75/212.95  |- skos__altLabel mesh__D003602 Tumoricidal Activities, Immunologic
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003602 2002
% 212.75/212.95  |- skos__altLabel mesh__D003602 Immunologic Tumoricidal Activity
% 212.75/212.95  |- skos__scopeNote mesh__D003602
% 212.75/212.95       The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid %22%killer%22% cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement.%A%    
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003602 1997
% 212.75/212.95  |- mesh__recordAuthorizer mesh__D003602 PLS
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003602 2005
% 212.75/212.95  |- mesh__recordOriginator mesh__D003602 AEP
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003602 2001
% 212.75/212.95  |- rdf__type mesh__D003602sskos__Concept
% 212.75/212.95  |- skos__altLabel mesh__D003602 Immunologic Cytotoxicity
% 212.75/212.95  |- skos__annotation mesh__D003602
% 212.75/212.95       note category: reserve for process: do not confuse with CYTOTOXICITY TESTS, IMMUNOLOGIC; DF: CYTOTOX IMMUNOL%A%  
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003602 1996
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D003602 2004
% 212.75/212.95  |- mesh__recordOriginator mesh__D050258 ssb
% 212.75/212.95  |- mesh__recordMaintainer mesh__D050258 ssb
% 212.75/212.95  |- rdf__type mesh__D050258sskos__Concept
% 212.75/212.95  |- skos__historyNote mesh__D050258 Mitosis %28%1973-2005%29%
% 212.75/212.95  |- skos__scopeNote mesh__D050258 Agents that affect MITOSIS of CELLS.     
% 212.75/212.95  |- mesh__dateCreated mesh__D050258 2005-06-30
% 212.75/212.95  |- mesh__historyNote mesh__D050258 2006   
% 212.75/212.95  |- mesh__dateEstablished mesh__D050258 2006-01-01
% 212.75/212.95  |- skos__broader mesh__D050258smesh__D045504
% 212.75/212.95  |- skos__prefLabel mesh__D050258 Mitosis Modulators
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D050258 2006
% 212.75/212.95  |- mesh__recordAuthorizer mesh__D050258 sjn
% 212.75/212.95  |- skos__hiddenLabel mesh__D050258 Modulators, Mitosis
% 212.75/212.95  |- mesh__publicMeSHNote mesh__D050258 2006   
% 212.75/212.95  |- mesh__activeMeSHYear mesh__D008098 2006
% 212.75/212.95  |- mesh__recordOriginator mesh__D008098 NLM
% 212.75/212.95  |- skos__related mesh__D008098smesh__D011247
% 212.75/212.95  |- mesh__recordMaintainer mesh__D008098 ags
% 212.75/212.95  |- mesh__historyNote mesh__D008098
% 212.75/212.95       76%28%75%29%; was see under ANIMALS, NEWBORN 1975   
% 212.75/212.95  |- skos__hiddenLabel mesh__D008098 Sizes, Litter
% 212.75/212.95  |- skos__historyNote mesh__D008098 Animals, Newborn %28%1966-1974%29%
% 212.75/212.95  |- mesh__recordAuthorizer mesh__D008098 sjn
% 212.75/212.95  |- skos__annotation mesh__D008098
% 212.75/212.95       viviparous animals only: see also note under TWINS; for oviparous or ovoviviparous animals use CLUTCH SIZE; relation to PREGNANCY: Manual 28.16.4%A%  
% 212.75/212.95  |- skos__prefLabel mesh__D008098 Litter Size
% 212.75/212.95  |- mesh__dateEstablished mesh__D008098 1976-01-01
% 212.75/212.95  |- skos__related mesh__D008098smesh__D052286
% 212.75/212.95  |- skos__hiddenLabel mesh__D008098 Size, Litter
% 212.75/212.95  |- rdf__type mesh__D008098sskos__Concept
% 212.75/212.96  |- skos__broader mesh__D008098smesh__D011270
% 212.75/212.96  |- mesh__dateRevised mesh__D008098 2005-06-30
% 212.75/212.96  |- mesh__dateCreated mesh__D008098 1974-11-11
% 212.75/212.96  |- skos__scopeNote mesh__D008098
% 212.75/212.96       The number of offspring produced at one birth by a viviparous animal.%A%    
% 212.75/212.96  |- mesh__publicMeSHNote mesh__D008098
% 212.75/212.96       76; was see under ANIMALS, NEWBORN 1975   
% 212.75/212.96  |- skos__hiddenLabel mesh__D008098 Litter Sizes
% 212.75/212.96  |- rdf__type mesh__D041721sskos__Concept
% 212.75/212.96  |- skos__annotation mesh__D041721
% 212.75/212.96       check ANIMALS %26% MICE but do not add FIBROBLASTS nor EMBRYO%A%  
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D041721 2006
% 212.75/212.96  |- skos__hiddenLabel mesh__D041721 3T3 L1 Cells
% 212.75/212.96  |- skos__historyNote mesh__D041721 Cell Line %28%1977-1991%29%
% 212.75/212.96  |- mesh__dateEstablished mesh__D041721 2004-01-01
% 212.75/212.96  |- mesh__recordAuthorizer mesh__D041721 sjn
% 212.75/212.96  |- mesh__dateCreated mesh__D041721 2003-07-30
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D041721 2005
% 212.75/212.96  |- skos__prefLabel mesh__D041721 3T3-L1 Cells
% 212.75/212.96  |- skos__hiddenLabel mesh__D041721 Cells, 3T3-L1
% 212.75/212.96  |- skos__hiddenLabel mesh__D041721 Cell, 3T3-L1
% 212.75/212.96  |- mesh__publicMeSHNote mesh__D041721 2004   
% 212.75/212.96  |- skos__hiddenLabel mesh__D041721 3T3-L1 Cell
% 212.75/212.96  |- skos__historyNote mesh__D041721 Cell Line %28%1991-2003%29%
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D041721 2004
% 212.75/212.96  |- mesh__historyNote mesh__D041721 2004   
% 212.75/212.96  |- mesh__recordMaintainer mesh__D041721 ags
% 212.75/212.96  |- skos__scopeNote mesh__D041721
% 212.75/212.96       A continuous cell line that is a substrain of  SWISS 3T3 CELLS developed though clonal isolation. The mouse fibroblast cells undergo an adipose-like conversion as they move to a confluent and contact-inhibited state.%A%    
% 212.75/212.96  |- skos__broader mesh__D041721smesh__D041701
% 212.75/212.96  |- mesh__recordOriginator mesh__D041721 ags
% 212.75/212.96  |- mesh__onlineNote mesh__D013232
% 212.75/212.96       use ALLOYS to search STEEL 1968-74 %26% METALS 1966-67   
% 212.75/212.96  |- mesh__publicMeSHNote mesh__D013232
% 212.75/212.96       91; was see under ALLOYS 1968-90; was see under METALS 1963-67%A%  
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D013232 2003
% 212.75/212.96  |- mesh__dateRevised mesh__D013232 1999-11-03
% 212.75/212.96  |- rdf__type mesh__D013232sskos__Concept
% 212.75/212.96  |- mesh__recordAuthorizer mesh__D013232 sjn
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D013232 2005
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D013232 2000
% 212.75/212.96  |- skos__scopeNote mesh__D013232
% 212.75/212.96       A tough, malleable, iron-based alloy containing up to, but no more than, two percent carbon and often other metals. It is used in medicine and dentistry in implants and instrumentation.%A%    
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D013232 2004
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D013232 2001
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D013232 2006
% 212.75/212.96  |- mesh__recordOriginator mesh__D013232 NLM
% 212.75/212.96  |- mesh__dateEstablished mesh__D013232 1991-01-01
% 212.75/212.96  |- mesh__historyNote mesh__D013232
% 212.75/212.96       91%28%75%29%; was see under ALLOYS 1968-90; was see under METALS 1963-67%A%  
% 212.75/212.96  |- skos__prefLabel mesh__D013232 Steel
% 212.75/212.96  |- skos__annotation mesh__D013232 D25-26 qualif   
% 212.75/212.96  |- skos__broader mesh__D013232smesh__D017614
% 212.75/212.96  |- mesh__recordMaintainer mesh__D013232 adp
% 212.75/212.96  |- mesh__dateCreated mesh__D013232 1999-01-01
% 212.75/212.96  |- skos__broader mesh__D013232smesh__D000497
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D013232 2002
% 212.75/212.96  |- mesh__recordMaintainer mesh__D012938 TGC
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012938 2002
% 212.75/212.96  |- skos__related mesh__D012938smesh__D013240
% 212.75/212.96  |- skos__scopeNote mesh__D012938
% 212.75/212.96       The perceiving of attributes, characteristics, and behaviors of one%27%s associates or social groups.%A%    
% 212.75/212.96  |- mesh__recordOriginator mesh__D012938 NLM
% 212.75/212.96  |- skos__altLabel mesh__D012938 Perception, Social
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012938 2004
% 212.75/212.96  |- mesh__historyNote mesh__D012938 69   
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012938 2001
% 212.75/212.96  |- skos__hiddenLabel mesh__D012938 Perceptions, Social
% 212.75/212.96  |- mesh__dateRevised mesh__D012938 1991-06-11
% 212.75/212.96  |- mesh__publicMeSHNote mesh__D012938 69   
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012938 2006
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012938 1997
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012938 2003
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012938 1999
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012938 2005
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012938 2000
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012938 1996
% 212.75/212.96  |- mesh__recordAuthorizer mesh__D012938 PLS
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012938 1998
% 212.75/212.96  |- mesh__dateEstablished mesh__D012938 1969-01-01
% 212.75/212.96  |- skos__broader mesh__D012938smesh__D010465
% 212.75/212.96  |- rdf__type mesh__D012938sskos__Concept
% 212.75/212.96  |- skos__prefLabel mesh__D012938 Social Perception
% 212.75/212.96  |- skos__historyNote mesh__D012938 Perception %28%1966-1968%29%
% 212.75/212.96  |- skos__annotation mesh__D012938 no qualif   
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012938 1993
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012938 1995
% 212.75/212.96  |- skos__hiddenLabel mesh__D012938 Social Perceptions
% 212.75/212.96  |- mesh__dateCreated mesh__D012938 1999-01-01
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012938 1992
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012938 1994
% 212.75/212.96  |- mesh__recordMaintainer mesh__D009191 TGC
% 212.75/212.96  |- mesh__recordOriginator mesh__D009191 NLM
% 212.75/212.96  |- skos__hiddenLabel mesh__D009191 Myelofibroses
% 212.75/212.96  |- skos__hiddenLabel mesh__D009191 Fibroses, Bone Marrow
% 212.75/212.96  |- skos__altLabel mesh__D009191 Myelosclerosis
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009191 1997
% 212.75/212.96  |- skos__altLabel mesh__D009191 Bone Marrow Fibrosis
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009191 1998
% 212.75/212.96  |- mesh__dateCreated mesh__D009191 1999-01-01
% 212.75/212.96  |- skos__broader mesh__D009191smesh__D009196
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009191 2001
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009191 1996
% 212.75/212.96  |- skos__altLabel mesh__D009191 Fibrosis, Bone Marrow
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009191 2006
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009191 2000
% 212.75/212.96  |- skos__prefLabel mesh__D009191 Myelofibrosis
% 212.75/212.96  |- skos__hiddenLabel mesh__D009191 Myeloscleroses
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009191 2004
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009191 2005
% 212.75/212.96  |- skos__scopeNote mesh__D009191
% 212.75/212.96       Replacement of the bone marrow by fibrous tissue, occurring in association with a myeloproliferative disorder or secondary to another, unrelated condition. %28%Dorland, 27th ed%29%%A%    
% 212.75/212.96  |- skos__annotation mesh__D009191
% 212.75/212.96       myelo- here = bone marrow, not spinal cord: note X refs   
% 212.75/212.96  |- mesh__dateRevised mesh__D009191 1994-05-24
% 212.75/212.96  |- mesh__recordAuthorizer mesh__D009191 PLS
% 212.75/212.96  |- rdf__type mesh__D009191sskos__Concept
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009191 2003
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009191 2002
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009191 1995
% 212.75/212.96  |- skos__hiddenLabel mesh__D009191 Bone Marrow Fibroses
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009191 1999
% 212.75/212.96  |- mesh__dateEstablished mesh__D003603 1978-01-01
% 212.75/212.96  |- mesh__recordOriginator mesh__D003603 SH
% 212.75/212.96  |- skos__prefLabel mesh__D003603 Cytotoxins
% 212.75/212.96  |- skos__historyNote mesh__D003603 Toxins %28%1966-1977%29%
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D003603 2006
% 212.75/212.96  |- skos__broader mesh__D003603smesh__D009676
% 212.75/212.96  |- skos__historyNote mesh__D003603 specific cell %28%1966-1977%29%
% 212.75/212.96  |- mesh__dateCreated mesh__D003603 1977-04-22
% 212.75/212.96  |- skos__scopeNote mesh__D003603
% 212.75/212.96       Substances elaborated by microorganisms, plants or animals that are specifically toxic to individual cells; they may be involved in immunity or may be contained in venoms. Some of them are used as CYTOTOXIC ANTIBIOTICS.%A%    
% 212.75/212.96  |- rdf__type mesh__D003603sskos__Concept
% 212.75/212.96  |- mesh__historyNote mesh__D003603 78   
% 212.75/212.96  |- mesh__recordAuthorizer mesh__D003603 sjn
% 212.75/212.96  |- mesh__recordMaintainer mesh__D003603 ssb
% 212.75/212.96  |- mesh__dateRevised mesh__D003603 2005-06-30
% 212.75/212.96  |- mesh__publicMeSHNote mesh__D003603 78   
% 212.75/212.96  |- skos__historyNote mesh__D003603
% 212.75/212.96       Cytotoxicity Tests, Immunologic %28%1973-1977%29%
% 212.75/212.96  |- skos__annotation mesh__D003603
% 212.75/212.96       /antag permitted but consider also ANTITOXINS; coordinate IM with source of cytotoxin %28%IM or NIM%29%; cytotoxins are biological matter: do not confuse with antineoplastic agents called %22%cytotoxic drugs%22%%A%  
% 212.75/212.96  |- mesh__recordAuthorizer mesh__D050259 sjn
% 212.75/212.96  |- mesh__recordMaintainer mesh__D050259 nns
% 212.75/212.96  |- rdf__type mesh__D050259sskos__Concept
% 212.75/212.96  |- skos__broader mesh__D050259smesh__D005111
% 212.75/212.96  |- skos__related mesh__D050259smesh__D004272
% 212.75/212.96  |- skos__hiddenLabel mesh__D050259 Inheritance, Mitochondrial
% 212.75/212.96  |- mesh__historyNote mesh__D050259
% 212.75/212.96       2006; for MITOCHONDRIAL INHERITANCE use EXTRACHROMOSOMAL INHERITANCE 2001-2005%A%  
% 212.75/212.96  |- skos__hiddenLabel mesh__D050259 Gene, Mitochondrial
% 212.75/212.96  |- skos__prefLabel mesh__D050259 Genes, Mitochondrial
% 212.75/212.96  |- mesh__recordOriginator mesh__D050259 nns
% 212.75/212.96  |- skos__scopeNote mesh__D050259
% 212.75/212.96       Genes that are located on the MITOCHONDRIAL DNA. Mitochondrial inheritance is often referred to as maternal inheritance but should be differentiated from maternal inheritance that is transmitted chromosomally.%A%    
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D050259 2006
% 212.75/212.96  |- mesh__dateCreated mesh__D050259 2005-06-30
% 212.75/212.96  |- mesh__dateEstablished mesh__D050259 2006-01-01
% 212.75/212.96  |- skos__hiddenLabel mesh__D050259 Mitochondrial Gene
% 212.75/212.96  |- mesh__publicMeSHNote mesh__D050259
% 212.75/212.96       2006; for MITOCHONDRIAL INHERITANCE see EXTRACHROMOSOMAL INHERITANCE 2001-2005%A%  
% 212.75/212.96  |- skos__broader mesh__D050259smesh__D005796
% 212.75/212.96  |- skos__altLabel mesh__D050259 Mitochondrial Genes
% 212.75/212.96  |- skos__broader mesh__D008897smesh__D006109
% 212.75/212.96  |- skos__altLabel mesh__D008897 Millet, Broomcorn
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D008897 2006
% 212.75/212.96  |- skos__broader mesh__D008897smesh__D002523
% 212.75/212.96  |- skos__annotation mesh__D008897
% 212.75/212.96       other millet plants are available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.75/212.96  |- skos__hiddenLabel mesh__D008897 Common Millet
% 212.75/212.96  |- mesh__recordMaintainer mesh__D008897 ssb
% 212.75/212.96  |- skos__scopeNote mesh__D008897
% 212.75/212.96       A plant genus of the family POACEAE. The seed is one of the millets used in CEREALS and in feed for birds and livestock %28%ANIMAL FEED%29%. It contains diosgenin %28%SAPONINS%29%.%A%    
% 212.75/212.96  |- mesh__dateCreated mesh__D008897 1999-01-01
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D008897 2003
% 212.75/212.96  |- mesh__historyNote mesh__D008897 2003%28%1963%29%   
% 212.75/212.96  |- skos__altLabel mesh__D008897 Millet, Common
% 212.75/212.96  |- skos__broader mesh__D008897smesh__D000821
% 212.75/212.96  |- skos__hiddenLabel mesh__D008897 Little Millet
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D008897 2004
% 212.75/212.96  |- skos__hiddenLabel mesh__D008897 Broomcorn Millet
% 212.75/212.96  |- rdf__type mesh__D008897sskos__Concept
% 212.75/212.96  |- skos__altLabel mesh__D008897 Millet, Little
% 212.75/212.96  |- mesh__recordOriginator mesh__D008897 NLM
% 212.75/212.96  |- mesh__recordAuthorizer mesh__D008897 sjn
% 212.75/212.96  |- skos__prefLabel mesh__D008897 Panicum
% 212.75/212.96  |- mesh__publicMeSHNote mesh__D008897
% 212.75/212.96       2003; see MILLET 1991-2002, see CEREALS 1985-1990, see GRAIN 1963-1984%A%  
% 212.75/212.96  |- mesh__dateRevised mesh__D008897 2002-07-02
% 212.75/212.96  |- skos__hiddenLabel mesh__D008897 Millets
% 212.75/212.96  |- skos__altLabel mesh__D008897 Panicgrass
% 212.75/212.96  |- mesh__dateEstablished mesh__D008897 1991-01-01
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D008897 2005
% 212.75/212.96  |- skos__prefLabel mesh__D008099 Liver
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D008099 2005
% 212.75/212.96  |- mesh__dateRevised mesh__D008099 2004-07-07
% 212.75/212.96  |- skos__annotation mesh__D008099
% 212.75/212.96       /blood supply: consider also LIVER CIRCULATION; /cytol: consider also KUPFFER CELLS; /surg: consider also HEPATECTOMY %26% LIVER TRANSPLANTATION; inflammation = HEPATITIS %26% its specifics; specialty is HEPATOLOGY see GASTROENTEROLOGY; be careful: do not confuse %22%hepatic%22% with %22%intrahepatic%22%: %22%intrahepatic%22% may refer to BILE DUCTS, INTRAHEPATIC %26% its dis, not LIVER%A%  
% 212.75/212.96  |- skos__broader mesh__D008099smesh__D004064
% 212.75/212.96  |- mesh__recordOriginator mesh__D008099 NLM
% 212.75/212.96  |- mesh__dateCreated mesh__D008099 1999-01-01
% 212.75/212.96  |- mesh__recordAuthorizer mesh__D008099 sjn
% 212.75/212.96  |- skos__altLabel mesh__D008099 Livers
% 212.75/212.96  |- rdf__type mesh__D008099sskos__Concept
% 212.75/212.96  |- mesh__publicMeSHNote mesh__D008099
% 212.75/212.96       /cytology was LIVER CYTOLOGY 1964-65; /enzymology was LIVER ENZYMOLOGY 1964-65; /physiology was LIVER FUNCTION 1964-65%A%  
% 212.75/212.96  |- mesh__considerAlso mesh__D008099 consider also terms at HEPAT-   
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D008099 2006
% 212.75/212.96  |- mesh__historyNote mesh__D008099
% 212.75/212.96       /cytology was LIVER CYTOLOGY 1964-65; /enzymology was LIVER ENZYMOLOGY 1964-65; /physiology was LIVER FUNCTION 1964-65%A%  
% 212.75/212.96  |- skos__related mesh__D008099smesh__D006498
% 212.75/212.96  |- mesh__recordMaintainer mesh__D008099 ags
% 212.75/212.96  |- skos__hiddenLabel mesh__D041722 Suicide Gene, Transgenic
% 212.75/212.96  |- rdf__type mesh__D041722sskos__Concept
% 212.75/212.96  |- skos__hiddenLabel mesh__D041722 Transgenes, Apoptosis-Inducing
% 212.75/212.96  |- mesh__historyNote mesh__D041722 2004   
% 212.75/212.96  |- skos__hiddenLabel mesh__D041722 Transgenic Apoptosis-Inducing Genes
% 212.75/212.96  |- skos__hiddenLabel mesh__D041722 Transduced Suicide Gene
% 212.75/212.96  |- mesh__dateCreated mesh__D041722 2003-07-25
% 212.75/212.96  |- skos__related mesh__D041722smesh__D015316
% 212.75/212.96  |- mesh__dateEstablished mesh__D041722 2004-01-01
% 212.75/212.96  |- skos__hiddenLabel mesh__D041722 Apoptosis-Inducing Genes, Transgenic
% 212.75/212.96  |- skos__broader mesh__D041722smesh__D019076
% 212.75/212.96  |- skos__hiddenLabel mesh__D041722 Suicide Transgene
% 212.75/212.96  |- skos__altLabel mesh__D041722 Suicide Genes, Transduced
% 212.75/212.96  |- skos__altLabel mesh__D041722 Transgenic Metabolic Suicide Genes
% 212.75/212.96  |- skos__hiddenLabel mesh__D041722 Suicide Gene, Transduced
% 212.75/212.96  |- mesh__publicMeSHNote mesh__D041722 2004   
% 212.75/212.96  |- skos__hiddenLabel mesh__D041722 Genes, Transgenic Apoptosis Inducing
% 212.75/212.96  |- skos__hiddenLabel mesh__D041722 Transgene, Suicide
% 212.75/212.96  |- skos__hiddenLabel mesh__D041722 Apoptosis Inducing Transgenes
% 212.75/212.96  |- skos__hiddenLabel mesh__D041722 Apoptosis-Inducing Transgene
% 212.75/212.96  |- skos__hiddenLabel mesh__D041722 Genes, Transgenic Suicide
% 212.75/212.96  |- skos__hiddenLabel mesh__D041722 Transgenic Apoptosis-Inducing Gene
% 212.75/212.96  |- skos__hiddenLabel mesh__D041722 Transgenic Suicide Gene
% 212.75/212.96  |- skos__prefLabel mesh__D041722 Genes, Transgenic, Suicide
% 212.75/212.96  |- mesh__dateRevised mesh__D041722 2005-06-30
% 212.75/212.96  |- skos__hiddenLabel mesh__D041722 Gene, Transgenic Suicide
% 212.75/212.96  |- skos__hiddenLabel mesh__D041722 Gene, Transduced Suicide
% 212.75/212.96  |- skos__hiddenLabel mesh__D041722 Transgene, Apoptosis-Inducing
% 212.75/212.96  |- skos__altLabel mesh__D041722 Suicide Transgenes
% 212.75/212.96  |- skos__altLabel mesh__D041722 Transduced Suicide Genes
% 212.75/212.96  |- skos__altLabel mesh__D041722 Suicide Genes, Transgenic
% 212.75/212.96  |- skos__hiddenLabel mesh__D041722 Genes, Transduced Suicide
% 212.75/212.96  |- skos__hiddenLabel mesh__D041722 Gene, Transgenic Apoptosis-Inducing
% 212.75/212.96  |- skos__related mesh__D041722smesh__D017209
% 212.75/212.96  |- skos__scopeNote mesh__D041722
% 212.75/212.96       Genes that are used transgenically, i.e., via GENE TRANSFER TECHNIQUES to induce CELL DEATH.%A%    
% 212.75/212.96  |- mesh__recordOriginator mesh__D041722 nns
% 212.75/212.96  |- skos__hiddenLabel mesh__D041722 Apoptosis-Inducing Gene, Transgenic
% 212.75/212.96  |- mesh__recordAuthorizer mesh__D041722 sjn
% 212.75/212.96  |- mesh__recordMaintainer mesh__D041722 nns
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D041722 2006
% 212.75/212.96  |- skos__altLabel mesh__D041722 Apoptosis-Inducing Transgenes
% 212.75/212.96  |- skos__hiddenLabel mesh__D041722 Transgenes, Suicide
% 212.75/212.96  |- skos__altLabel mesh__D041722 Transgenic Suicide Genes
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D013233 2004
% 212.75/212.96  |- skos__broader mesh__D013233smesh__D005728
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D013233 1998
% 212.75/212.96  |- mesh__recordAuthorizer mesh__D013233 PLS
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D013233 2006
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D013233 1997
% 212.75/212.96  |- skos__hiddenLabel mesh__D013233 Ganglias, Stellate
% 212.75/212.96  |- skos__altLabel mesh__D013233 Cervicothoracic Ganglion
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D013233 1999
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D013233 2002
% 212.75/212.96  |- skos__hiddenLabel mesh__D013233 Stellate Ganglias
% 212.75/212.96  |- skos__scopeNote mesh__D013233
% 212.75/212.96       A paravertebral sympathetic ganglion formed by the fusion of the inferior cervical and first thoracic ganglia.%A%    
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D013233 1995
% 212.75/212.96  |- mesh__dateCreated mesh__D013233 1999-01-01
% 212.75/212.96  |- skos__hiddenLabel mesh__D013233 Ganglia, Cervicothoracic
% 212.75/212.96  |- skos__hiddenLabel mesh__D013233 Ganglia, Stellate
% 212.75/212.96  |- skos__altLabel mesh__D013233 Stellate Ganglia
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D013233 2000
% 212.75/212.96  |- skos__prefLabel mesh__D013233 Stellate Ganglion
% 212.75/212.96  |- skos__annotation mesh__D013233 a sympath ganglion   
% 212.75/212.96  |- rdf__type mesh__D013233sskos__Concept
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D013233 2003
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D013233 2001
% 212.75/212.96  |- skos__hiddenLabel mesh__D013233 Ganglion, Cervicothoracic
% 212.75/212.96  |- mesh__dateRevised mesh__D013233 1994-04-11
% 212.75/212.96  |- skos__hiddenLabel mesh__D013233 Ganglion, Stellate
% 212.75/212.96  |- skos__altLabel mesh__D013233 Cervicothoracic Ganglia
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D013233 2005
% 212.75/212.96  |- mesh__recordMaintainer mesh__D013233 TGC
% 212.75/212.96  |- mesh__recordOriginator mesh__D013233 NLM
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D013233 1996
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012939 2003
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012939 2002
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012939 2005
% 212.75/212.96  |- skos__broader mesh__D012939smesh__D012961
% 212.75/212.96  |- skos__hiddenLabel mesh__D012939 Rural Developments
% 212.75/212.96  |- skos__hiddenLabel mesh__D012939 Plannings, Social
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012939 2004
% 212.75/212.96  |- skos__hiddenLabel mesh__D012939 Plans, Five-Year
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012939 2006
% 212.75/212.96  |- mesh__dateEstablished mesh__D012939 1968-01-01
% 212.75/212.96  |- mesh__recordAuthorizer mesh__D012939 sjn
% 212.75/212.96  |- skos__prefLabel mesh__D012939 Social Planning
% 212.75/212.96  |- skos__scopeNote mesh__D012939
% 212.75/212.96       Interactional process combining investigation, discussion, and agreement by a number of people in the preparation and carrying out of a program to ameliorate conditions of need or social pathology in the community. It usually involves the action of a formal political, legal, or recognized voluntary body.%A%    
% 212.75/212.96  |- mesh__dateCreated mesh__D012939 1999-01-01
% 212.75/212.96  |- skos__annotation mesh__D012939 no qualif   
% 212.75/212.96  |- skos__hiddenLabel mesh__D012939 Five Year Plans
% 212.75/212.96  |- skos__hiddenLabel mesh__D012939 Plan, Five-Year
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012939 2000
% 212.75/212.96  |- skos__hiddenLabel mesh__D012939 Planning, Development
% 212.75/212.96  |- skos__hiddenLabel mesh__D012939 Social Plannings
% 212.75/212.96  |- mesh__recordOriginator mesh__D012939 NLM
% 212.75/212.96  |- skos__historyNote mesh__D012939 Social Conditions %28%1966-1967%29%
% 212.75/212.96  |- skos__hiddenLabel mesh__D012939 Development Plannings
% 212.75/212.96  |- rdf__type mesh__D012939sskos__Concept
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D012939 2001
% 212.75/212.96  |- mesh__publicMeSHNote mesh__D012939 68   
% 212.75/212.96  |- skos__historyNote mesh__D012939 Sociology %28%1966-1967%29%
% 212.75/212.96  |- mesh__historyNote mesh__D012939 68   
% 212.75/212.96  |- mesh__recordMaintainer mesh__D012939 kle
% 212.75/212.96  |- skos__hiddenLabel mesh__D012939 Five-Year Plan
% 212.75/212.96  |- skos__historyNote mesh__D012939 Housing %28%1966-1967%29%
% 212.75/212.96  |- mesh__dateRevised mesh__D012939 1999-11-03
% 212.75/212.96  |- skos__hiddenLabel mesh__D012939 Developments, Rural
% 212.75/212.96  |- skos__hiddenLabel mesh__D012939 Planning, Social
% 212.75/212.96  |- skos__hiddenLabel mesh__D012939 Development, Rural
% 212.75/212.96  |- skos__hiddenLabel mesh__D012939 Plannings, Development
% 212.75/212.96  |- skos__hiddenLabel mesh__D009990 Medakas
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009990 2006
% 212.75/212.96  |- skos__broader mesh__D009990smesh__D023761
% 212.75/212.96  |- skos__altLabel mesh__D009990 Japanese Rice Fish
% 212.75/212.96  |- mesh__recordOriginator mesh__D009990 EC
% 212.75/212.96  |- mesh__recordAuthorizer mesh__D009990 sjn
% 212.75/212.96  |- mesh__dateEstablished mesh__D009990 1991-01-01
% 212.75/212.96  |- mesh__recordMaintainer mesh__D009990 ags
% 212.75/212.96  |- rdf__type mesh__D009990sskos__Concept
% 212.75/212.96  |- skos__hiddenLabel mesh__D009990 Killifish, Medaka
% 212.75/212.96  |- skos__annotation mesh__D009990
% 212.75/212.96       note X refs JAPANESE KILLIFISH and MEDAKA KILLIFISH; KILLIFISHES is also available%A%  
% 212.75/212.96  |- skos__historyNote mesh__D009990 Fishes %28%1966-1986%29%
% 212.75/212.96  |- skos__prefLabel mesh__D009990 Oryzias
% 212.75/212.96  |- skos__altLabel mesh__D009990 Oryzias latipes
% 212.75/212.96  |- skos__altLabel mesh__D009990 Medaka Killifish
% 212.75/212.96  |- skos__altLabel mesh__D009990 Killifish, Japanese
% 212.75/212.96  |- mesh__publicMeSHNote mesh__D009990
% 212.75/212.96       91; was see under CYPRINODONTIFORMES 1987-90   
% 212.75/212.96  |- skos__scopeNote mesh__D009990
% 212.75/212.96       The only genus in the family Oryziinae, order BELONIFORMES. Oryzias are egg-layers; other fish of the same order are livebearers. Oryzias are used extensively in testing carcinogens.%A%    
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009990 2004
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009990 2005
% 212.75/212.96  |- mesh__dateCreated mesh__D009990 1986-04-15
% 212.75/212.96  |- mesh__dateRevised mesh__D009990 2003-07-09
% 212.75/212.96  |- skos__altLabel mesh__D009990 Japanese Killifish
% 212.75/212.96  |- mesh__historyNote mesh__D009990
% 212.75/212.96       91%28%87%29%; was see under CYPRINODONTIFORMES 1987-90   
% 212.75/212.96  |- skos__altLabel mesh__D009990 Oryziinae
% 212.75/212.96  |- mesh__dateEstablished mesh__D023661 2002-01-01
% 212.75/212.96  |- mesh__publicMeSHNote mesh__D023661 2002   
% 212.75/212.96  |- mesh__dateCreated mesh__D023661 2001-07-25
% 212.75/212.96  |- mesh__recordAuthorizer mesh__D023661 jls
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D023661 2006
% 212.75/212.96  |- skos__broader mesh__D023661smesh__D005399
% 212.75/212.96  |- mesh__recordMaintainer mesh__D023661 jls
% 212.75/212.96  |- rdf__type mesh__D023661sskos__Concept
% 212.75/212.96  |- skos__scopeNote mesh__D023661
% 212.75/212.96       An order of fishes native to North America and Northern Eurasia, consisting of two families: ESOCIDAE %28%pikes%29% and UMBRIDAE %28%mudminnows%29%.%A%    
% 212.75/212.96  |- mesh__dateRevised mesh__D023661 2004-07-27
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D023661 2005A
% 212.75/212.96  |- skos__prefLabel mesh__D023661 Esociformes
% 212.75/212.96  |- mesh__historyNote mesh__D023661 2002   
% 212.75/212.96  |- mesh__recordOriginator mesh__D023661 ags
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D023661 2004
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D023661 2005
% 212.75/212.96  |- mesh__dateCreated mesh__D009192 1999-01-01
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009192 2002
% 212.75/212.96  |- skos__altLabel mesh__D009192 Myelographic Cisternography
% 212.75/212.96  |- skos__hiddenLabel mesh__D009192 Myelographies
% 212.75/212.96  |- skos__scopeNote mesh__D009192
% 212.75/212.96       X-ray visualization of the spinal cord following injection of contrast medium into the spinal arachnoid space.%A%    
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009192 2006
% 212.75/212.96  |- skos__hiddenLabel mesh__D009192 Myelographic Cisternographies
% 212.75/212.96  |- mesh__recordOriginator mesh__D009192 NLM
% 212.75/212.96  |- mesh__publicMeSHNote mesh__D009192 66   
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009192 2004
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009192 2005
% 212.75/212.96  |- skos__prefLabel mesh__D009192 Myelography
% 212.75/212.96  |- skos__broader mesh__D009192smesh__D009485
% 212.75/212.96  |- skos__annotation mesh__D009192
% 212.75/212.96       myelo- here = spinal cord, not bone marrow; NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: MYELOGR%A%  
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009192 2001
% 212.75/212.96  |- mesh__historyNote mesh__D009192 66%28%64%29%   
% 212.75/212.96  |- skos__hiddenLabel mesh__D009192 Cisternographies, Myelographic
% 212.75/212.96  |- mesh__dateEstablished mesh__D009192 1966-01-01
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009192 2003
% 212.75/212.96  |- rdf__type mesh__D009192sskos__Concept
% 212.75/212.96  |- mesh__recordMaintainer mesh__D009192 PXP
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009192 2000
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009192 1999
% 212.75/212.96  |- mesh__dateRevised mesh__D009192 1997-06-20
% 212.75/212.96  |- mesh__recordAuthorizer mesh__D009192 SJN
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D009192 1998
% 212.75/212.96  |- skos__scopeNote mesh__D017624
% 212.75/212.96       A contiguous gene syndrome associated with hemizygous deletions of chromosome region 11p13. The condition is marked by the combination of WILMS TUMOR; ANIRIDIA; GENITOURINARY ABNORMALITIES; and MENTAL RETARDATION.%A%    
% 212.75/212.96  |- skos__broader mesh__D017624smesh__D025063
% 212.75/212.96  |- mesh__recordOriginator mesh__D017624 TGC
% 212.75/212.96  |- skos__broader mesh__D017624smesh__D014564
% 212.75/212.96  |- skos__altLabel mesh__D017624 WAGR Contiguous Gene Syndrome
% 212.75/212.96  |- skos__hiddenLabel mesh__D017624 Complices, WAGR
% 212.75/212.96  |- mesh__historyNote mesh__D017624 94   
% 212.75/212.96  |- mesh__recordAuthorizer mesh__D017624 sjn
% 212.75/212.96  |- skos__hiddenLabel mesh__D017624 Syndrome, WAGR
% 212.75/212.96  |- mesh__dateCreated mesh__D017624 1993-06-03
% 212.75/212.96  |- skos__related mesh__D017624smesh__D016162
% 212.75/212.96  |- skos__hiddenLabel mesh__D017624
% 212.75/212.96       Wilms Tumor Aniridia Genitourinary Anomalies MR Syndrome
% 212.75/212.96  |- skos__historyNote mesh__D017624
% 212.75/212.96       Chromosomes, Human, Pair 11 %28%1986-1993%29%
% 212.75/212.96  |- skos__historyNote mesh__D017624 Iris/abnormalities %28%1980-1993%29%
% 212.75/212.96  |- skos__altLabel mesh__D017624 Contiguous Gene Syndrome, WAGR
% 212.75/212.96  |- mesh__dateEstablished mesh__D017624 1994-01-01
% 212.75/212.96  |- skos__hiddenLabel mesh__D017624 WAGR Complices
% 212.75/212.96  |- skos__altLabel mesh__D017624
% 212.75/212.96       Wilms Tumor-Aniridia-Genitourinary Anomalies-MR Syndrome
% 212.75/212.96  |- mesh__publicMeSHNote mesh__D017624 94   
% 212.75/212.96  |- skos__broader mesh__D017624smesh__D009396
% 212.75/212.96  |- skos__broader mesh__D017624smesh__D008607
% 212.75/212.96  |- skos__historyNote mesh__D017624
% 212.75/212.96       Chromosomes, Human, 6-12 %28%1980-1985%29%
% 212.75/212.96  |- mesh__activeMeSHYear mesh__D017624 2006
% 212.75/212.96  |- rdf__type mesh__D017624sskos__Concept
% 212.75/212.96  |- skos__historyNote mesh__D017624
% 212.75/212.96       Urogenital System/abnormalities %28%1984-1993%29%
% 212.75/212.96  |- skos__hiddenLabel mesh__D017624 Syndromes, WAGR
% 212.75/212.96  |- mesh__dateRevised mesh__D017624 2005-06-30
% 212.75/212.96  |- skos__broader mesh__D017624smesh__D015783
% 212.75/212.96  |- skos__hiddenLabel mesh__D017624 WAGR Syndromes
% 212.75/212.96  |- mesh__recordMaintainer mesh__D017624 lkt
% 212.75/212.96  |- skos__historyNote mesh__D017624 Nephroblastoma %28%1980-1993%29%
% 212.75/212.97  |- skos__altLabel mesh__D017624 WAGR Complex
% 212.75/212.97  |- skos__historyNote mesh__D017624 Mental Retardation %28%1984-1993%29%
% 212.75/212.97  |- skos__prefLabel mesh__D017624 WAGR Syndrome
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D003604 1998
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D003604 2006
% 212.75/212.97  |- skos__scopeNote mesh__D003604
% 212.75/212.97       Created as a republic in 1918 by Czechs and Slovaks from territories formerly part of the Austro-Hungarian Empire. The country split into the Czech Republic and Slovakia 1 January 1993.%A%    
% 212.75/212.97  |- mesh__dateCreated mesh__D003604 1999-01-01
% 212.75/212.97  |- skos__annotation mesh__D003604
% 212.75/212.97       in translations of historical articles use spelling People%27%s Republic, not Peoples%27% nor Peoples%A%  
% 212.75/212.97  |- skos__broader mesh__D003604smesh__D017516
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D003604 1997
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D003604 2005
% 212.75/212.97  |- mesh__recordMaintainer mesh__D003604 TGC
% 212.75/212.97  |- mesh__dateRevised mesh__D003604 1993-05-26
% 212.75/212.97  |- rdf__type mesh__D003604sskos__Concept
% 212.75/212.97  |- mesh__recordOriginator mesh__D003604 NLM
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D003604 2002
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D003604 1996
% 212.75/212.97  |- mesh__recordAuthorizer mesh__D003604 PLS
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D003604 2004
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D003604 2001
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D003604 2003
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D003604 2000
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D003604 1995
% 212.75/212.97  |- skos__prefLabel mesh__D003604 Czechoslovakia
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D003604 1999
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D003604 1994
% 212.75/212.97  |- skos__historyNote mesh__D008898 Pyridones %28%1969-1974%29%
% 212.75/212.97  |- skos__altLabel mesh__D008898 Leucenine
% 212.75/212.97  |- skos__broader mesh__D008898smesh__D000409
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D008898 1995
% 212.75/212.97  |- skos__scopeNote mesh__D008898
% 212.75/212.97       3-Hydroxy-4-oxo-1%28%4H%29%-pyridinealanine. An antineoplastic alanine-substituted pyridine derivative isolated from Leucena glauca.%A%    
% 212.75/212.97  |- mesh__publicMeSHNote mesh__D008898
% 212.75/212.97       91; was see under PYRIDONES 1975-90   
% 212.75/212.97  |- mesh__dateEstablished mesh__D008898 1991-01-01
% 212.75/212.97  |- skos__annotation mesh__D008898 an antineoplastic   
% 212.75/212.97  |- skos__historyNote mesh__D008898 Alanine %28%1972-1974%29%
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D008898 2006
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D008898 1994
% 212.75/212.97  |- mesh__recordMaintainer mesh__D008898 TAP
% 212.75/212.97  |- mesh__dateCreated mesh__D008898 1974-11-19
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D008898 2001
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D008898 1993
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D008898 2005
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D008898 2004
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D008898 1999
% 212.75/212.97  |- skos__prefLabel mesh__D008898 Mimosine
% 212.75/212.97  |- mesh__recordAuthorizer mesh__D008898 PLS
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D008898 2000
% 212.75/212.97  |- skos__broader mesh__D008898smesh__D011728
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D008898 2003
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D008898 1998
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D008898 1997
% 212.75/212.97  |- mesh__historyNote mesh__D008898
% 212.75/212.97       91%28%75%29%; was see under PYRIDONES 1975-90   
% 212.75/212.97  |- mesh__dateRevised mesh__D008898 1992-05-18
% 212.75/212.97  |- rdf__type mesh__D008898sskos__Concept
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D008898 1996
% 212.75/212.97  |- skos__altLabel mesh__D008898 Leucenol
% 212.75/212.97  |- skos__altLabel mesh__D008898 Leucaenol
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D008898 2002
% 212.75/212.97  |- mesh__recordOriginator mesh__D008898 NLM
% 212.75/212.97  |- skos__altLabel mesh__D008898 Leucaenine
% 212.75/212.97  |- skos__scopeNote mesh__D013234
% 212.75/212.97       Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells.%A%    
% 212.75/212.97  |- skos__prefLabel mesh__D013234 Stem Cells
% 212.75/212.97  |- skos__altLabel mesh__D013234 Progenitor Cells
% 212.75/212.97  |- mesh__recordOriginator mesh__D013234 AEP
% 212.75/212.97  |- skos__historyNote mesh__D013234 Cell Differentiation %28%1966-1983%29%
% 212.75/212.97  |- skos__hiddenLabel mesh__D013234 Colony Forming Units
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D013234 2003A
% 212.75/212.97  |- skos__hiddenLabel mesh__D013234 Cells, Mother
% 212.75/212.97  |- skos__altLabel mesh__D013234 Mother Cells
% 212.75/212.97  |- skos__hiddenLabel mesh__D013234 Stem Cell
% 212.75/212.97  |- skos__hiddenLabel mesh__D013234 Cells, Stem
% 212.75/212.97  |- skos__hiddenLabel mesh__D013234 Cell, Stem
% 212.75/212.97  |- mesh__dateRevised mesh__D013234 2002-09-24
% 212.75/212.97  |- skos__historyNote mesh__D013234
% 212.75/212.97       Colony-Forming Units Assay %28%1979-1983%29%
% 212.75/212.97  |- mesh__dateEstablished mesh__D013234 1984-01-01
% 212.75/212.97  |- skos__hiddenLabel mesh__D013234 Units, Colony-Forming
% 212.75/212.97  |- skos__hiddenLabel mesh__D013234 Progenitor Cell
% 212.75/212.97  |- skos__hiddenLabel mesh__D013234 Colony Forming Unit
% 212.75/212.97  |- mesh__historyNote mesh__D013234 84   
% 212.75/212.97  |- mesh__publicMeSHNote mesh__D013234 84   
% 212.75/212.97  |- skos__hiddenLabel mesh__D013234 Cell, Progenitor
% 212.75/212.97  |- rdf__type mesh__D013234sskos__Concept
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D013234 2003
% 212.75/212.97  |- skos__altLabel mesh__D013234 Colony-Forming Units
% 212.75/212.97  |- skos__hiddenLabel mesh__D013234 Unit, Colony-Forming
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D013234 2005
% 212.75/212.97  |- mesh__recordMaintainer mesh__D013234 sjn
% 212.75/212.97  |- skos__broader mesh__D013234smesh__D002477
% 212.75/212.97  |- skos__historyNote mesh__D013234 Cell Line %28%1969-1983%29%
% 212.75/212.97  |- mesh__dateCreated mesh__D013234 1983-02-24
% 212.75/212.97  |- skos__hiddenLabel mesh__D013234 Cell, Mother
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D013234 2004
% 212.75/212.97  |- mesh__recordAuthorizer mesh__D013234 sjn
% 212.75/212.97  |- skos__hiddenLabel mesh__D013234 Cells, Progenitor
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D013234 2006
% 212.75/212.97  |- skos__hiddenLabel mesh__D013234 Mother Cell
% 212.75/212.97  |- skos__historyNote mesh__D013234 Cells, Cultured %28%1972-1983%29%
% 212.75/212.97  |- mesh__recordAuthorizer mesh__D009991 PLS
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009991 1999
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009991 2002
% 212.75/212.97  |- mesh__recordMaintainer mesh__D009991 TGC
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009991 2006
% 212.75/212.97  |- skos__prefLabel mesh__D009991 Oscillometry
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009991 1998
% 212.75/212.97  |- skos__annotation mesh__D009991 NIM   
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009991 2001
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009991 1997
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009991 2000
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009991 2005
% 212.75/212.97  |- skos__scopeNote mesh__D009991
% 212.75/212.97       Measurement of oscillations of any kind. In medicine it is used in studying cardiovascular and respiratory physiology. %28%Dorland, 28th ed%29%%A%    
% 212.75/212.97  |- mesh__recordOriginator mesh__D009991 NLM
% 212.75/212.97  |- rdf__type mesh__D009991sskos__Concept
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009991 2004
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009991 1996
% 212.75/212.97  |- mesh__dateCreated mesh__D009991 1999-01-01
% 212.75/212.97  |- skos__hiddenLabel mesh__D009991 Oscillometries
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009991 2003
% 212.75/212.97  |- skos__broader mesh__D009991smesh__D010825
% 212.75/212.97  |- mesh__dateRevised mesh__D009991 1995-03-13
% 212.75/212.97  |- skos__broader mesh__D009991smesh__D008919
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009193 2004
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009193 2005
% 212.75/212.97  |- skos__hiddenLabel mesh__D009193 Nonleukemic Myeloses
% 212.75/212.97  |- skos__hiddenLabel mesh__D009193 Myeloid Metaplasias
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009193 2000
% 212.75/212.97  |- skos__hiddenLabel mesh__D009193 Metaplasia, Agnogenic Myeloid
% 212.75/212.97  |- skos__hiddenLabel mesh__D009193 Myeloid Metaplasias, Agnogenic
% 212.75/212.97  |- rdf__type mesh__D009193sskos__Concept
% 212.75/212.97  |- skos__hiddenLabel mesh__D009193 Myeloid Metaplasia, Agnogenic
% 212.75/212.97  |- skos__hiddenLabel mesh__D009193 Metaplasia, Myeloid
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009193 2003
% 212.75/212.97  |- mesh__dateEstablished mesh__D009193 1964-01-01
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009193 1995
% 212.75/212.97  |- mesh__publicMeSHNote mesh__D009193 64   
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009193 1999
% 212.75/212.97  |- mesh__dateRevised mesh__D009193 2004-07-29
% 212.75/212.97  |- skos__hiddenLabel mesh__D009193 Metaplasias, Myeloid
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009193 2002
% 212.75/212.97  |- mesh__recordMaintainer mesh__D009193 jls
% 212.75/212.97  |- mesh__historyNote mesh__D009193 64   
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009193 2005A
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009193 1997
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009193 1998
% 212.75/212.97  |- skos__annotation mesh__D009193
% 212.75/212.97       myeloid here = bone marrow, not spinal cord   
% 212.75/212.97  |- mesh__dateCreated mesh__D009193 1999-01-01
% 212.75/212.97  |- mesh__recordOriginator mesh__D009193 NLM
% 212.75/212.97  |- skos__broader mesh__D009193smesh__D009196
% 212.75/212.97  |- skos__broader mesh__D009193smesh__D013158
% 212.75/212.97  |- skos__hiddenLabel mesh__D009193 Agnogenic Myeloid Metaplasias
% 212.75/212.97  |- skos__altLabel mesh__D009193 Agnogenic Myeloid Metaplasia
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009193 1996
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009193 2006
% 212.75/212.97  |- skos__hiddenLabel mesh__D009193 Myeloses, Nonleukemic
% 212.75/212.97  |- skos__prefLabel mesh__D009193 Myeloid Metaplasia
% 212.75/212.97  |- mesh__recordAuthorizer mesh__D009193 jls
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009193 2001
% 212.75/212.97  |- skos__scopeNote mesh__D009193
% 212.75/212.97       The occurrence of myeloid tissue in extramedullary sites. Specifically it is a syndrome characterized by splenomegaly, anemia, the presence of nucleated erythrocytes and immature granulocytes in the circulating blood, and extramedullary hematopoiesis in the liver and spleen. The primary form is also known as agnogenic myeloid metaplasia, myelosclerosis, and myelofibrosis. The secondary or symptomatic form may be associated with various diseases, including carcinomatosis, tuberculosis, leukemia, and polycythemia vera. %28%Dorland, 27th ed%29%%A%    
% 212.75/212.97  |- skos__hiddenLabel mesh__D009193 Metaplasias, Agnogenic Myeloid
% 212.75/212.97  |- skos__hiddenLabel mesh__D009193 Nonleukemic Myelosis
% 212.75/212.97  |- skos__hiddenLabel mesh__D003605 D Amino Acid Dehydrogenase
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D003605 2006
% 212.75/212.97  |- skos__hiddenLabel mesh__D003605 dextro Amino Acid Oxidase
% 212.75/212.97  |- skos__hiddenLabel mesh__D003605 Acid Dehydrogenase, D-Amino
% 212.75/212.97  |- skos__altLabel mesh__D003605 dextro-Amino Acid Oxidase
% 212.75/212.97  |- mesh__recordAuthorizer mesh__D003605 sjn
% 212.75/212.97  |- skos__broader mesh__D003605smesh__D000594
% 212.75/212.97  |- rdf__type mesh__D003605sskos__Concept
% 212.75/212.97  |- mesh__recordMaintainer mesh__D003605 jmp
% 212.75/212.97  |- skos__hiddenLabel mesh__D003605 D Amino Acid Oxidase
% 212.75/212.97  |- mesh__dateRevised mesh__D003605 2005-06-30
% 212.75/212.97  |- skos__altLabel mesh__D003605 D-Amino Acid Dehydrogenase
% 212.75/212.97  |- mesh__onlineNote mesh__D003605
% 212.75/212.97       use D-AMINO-ACID OXIDASE to search D-AMINO ACID OXIDASE 1974-94 %26% D-AMINOACID OXIDASE 1966-73%A%  
% 212.75/212.97  |- skos__hiddenLabel mesh__D003605 Acid Oxidase, dextro-Amino
% 212.75/212.97  |- mesh__publicMeSHNote mesh__D003605
% 212.75/212.97       95; was D-AMINO ACID OXIDASE 1974-94, was D-AMINOACID OXIDASE 1966-73%A%  
% 212.75/212.97  |- mesh__dateCreated mesh__D003605 1999-01-01
% 212.75/212.97  |- skos__hiddenLabel mesh__D003605 Dehydrogenase, D-Amino Acid
% 212.75/212.97  |- mesh__recordOriginator mesh__D003605 NLM
% 212.75/212.97  |- skos__hiddenLabel mesh__D003605 Oxidase, dextro-Amino Acid
% 212.75/212.97  |- skos__hiddenLabel mesh__D003605 Oxidase, D-Amino-Acid
% 212.75/212.97  |- mesh__historyNote mesh__D003605
% 212.75/212.97       95; was D-AMINO ACID OXIDASE 1974-94, was D-AMINOACID OXIDASE 1963-73 %28%Prov 1963-65%29%%A%  
% 212.75/212.97  |- skos__prefLabel mesh__D003605 D-Amino-Acid Oxidase
% 212.75/212.97  |- mesh__dateEstablished mesh__D003605 1966-01-01
% 212.75/212.97  |- skos__hiddenLabel mesh__D008899 Liquid Petrolatum
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D008899 2006
% 212.75/212.97  |- mesh__historyNote mesh__D008899
% 212.75/212.97       66; was in Cat D only 1966-82, was PETROLATUM LIQUID in Cat D only 1963-65%A%  
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D008899 2002
% 212.75/212.97  |- skos__altLabel mesh__D008899 Petrolatum, Liquid
% 212.75/212.97  |- skos__altLabel mesh__D008899 Liquid Paraffin
% 212.75/212.97  |- mesh__recordAuthorizer mesh__D008899 sjn
% 212.75/212.97  |- mesh__dateRevised mesh__D008899 1999-11-03
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D008899 2004
% 212.75/212.97  |- mesh__recordOriginator mesh__D008899 NLM
% 212.75/212.97  |- skos__hiddenLabel mesh__D008899 Oil, Mineral
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D008899 2005
% 212.75/212.97  |- mesh__dateCreated mesh__D008899 1999-01-01
% 212.75/212.97  |- skos__prefLabel mesh__D008899 Mineral Oil
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D008899 2003
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D008899 2001
% 212.75/212.97  |- rdf__type mesh__D008899sskos__Concept
% 212.75/212.97  |- mesh__dateEstablished mesh__D008899 1966-01-01
% 212.75/212.97  |- mesh__publicMeSHNote mesh__D008899 66; was PETROLATUM, LIQUID 1963-65   
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D008899 2000
% 212.75/212.97  |- mesh__recordMaintainer mesh__D008899 adp
% 212.75/212.97  |- skos__broader mesh__D008899smesh__D010577
% 212.75/212.97  |- skos__scopeNote mesh__D008899
% 212.75/212.97       A mixture of liquid hydrocarbons obtained from petroleum. It is used as laxative, lubricant, ointment base, and emollient.%A%    
% 212.75/212.97  |- skos__hiddenLabel mesh__D008899 Oil, Vaseline
% 212.75/212.97  |- skos__hiddenLabel mesh__D008899 Paraffin, Liquid
% 212.75/212.97  |- skos__annotation mesh__D008899 D25-26 qualif   
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009992 2006
% 212.75/212.97  |- skos__broader mesh__D009992smesh__D019216
% 212.75/212.97  |- mesh__dateRevised mesh__D009992 2001-07-25
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009992 2005
% 212.75/212.97  |- rdf__type mesh__D009992sskos__Concept
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009992 2002
% 212.75/212.97  |- skos__scopeNote mesh__D009992
% 212.75/212.97       Osmium. A very hard, gray, toxic, and nearly infusible metal element, atomic number 76, atomic weight 190.2, symbol Os. %28%From Dorland, 28th ed%29%%A%    
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009992 2004
% 212.75/212.97  |- skos__broader mesh__D009992smesh__D028561
% 212.75/212.97  |- mesh__dateCreated mesh__D009992 1999-01-01
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009992 2003
% 212.75/212.97  |- mesh__recordAuthorizer mesh__D009992 sjn
% 212.75/212.97  |- mesh__recordOriginator mesh__D009992 NLM
% 212.75/212.97  |- mesh__recordMaintainer mesh__D009992 jmp
% 212.75/212.97  |- skos__annotation mesh__D009992
% 212.75/212.97       Os-192; Os-184, 186-190, = OSMIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Os-181-183, 185, 191, 193-195 = OSMIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 212.75/212.97  |- skos__prefLabel mesh__D009992 Osmium
% 212.75/212.97  |- rdf__type mesh__D009194sskos__Concept
% 212.75/212.97  |- mesh__dateEstablished mesh__D009194 1972-01-01
% 212.75/212.97  |- skos__historyNote mesh__D009194 Serum Globulins %28%1966-1971%29%
% 212.75/212.97  |- mesh__publicMeSHNote mesh__D009194 72   
% 212.75/212.97  |- mesh__recordMaintainer mesh__D009194 ssb
% 212.75/212.97  |- skos__broader mesh__D009194smesh__D009363
% 212.75/212.97  |- skos__broader mesh__D009194smesh__D010266
% 212.75/212.97  |- skos__altLabel mesh__D009194 M Components
% 212.75/212.97  |- mesh__dateRevised mesh__D009194 2005-06-30
% 212.75/212.97  |- mesh__dateCreated mesh__D009194 1999-01-01
% 212.75/212.97  |- skos__historyNote mesh__D009194 Multiple Myeloma %28%1966-1971%29%
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009194 2006
% 212.75/212.97  |- mesh__historyNote mesh__D009194 72   
% 212.75/212.97  |- mesh__recordAuthorizer mesh__D009194 sjn
% 212.75/212.97  |- skos__prefLabel mesh__D009194 Myeloma Proteins
% 212.75/212.97  |- skos__hiddenLabel mesh__D009194 Proteins, Myeloma
% 212.75/212.97  |- mesh__recordOriginator mesh__D009194 NLM
% 212.75/212.97  |- skos__historyNote mesh__D009194 Neoplasm Proteins %28%1966-1971%29%
% 212.75/212.97  |- skos__scopeNote mesh__D009194
% 212.75/212.97       Abnormal immunoglobulins characteristic of MULTIPLE MYELOMA.%A%    
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D017626 2003
% 212.75/212.97  |- mesh__dateRevised mesh__D017626 1999-11-03
% 212.75/212.97  |- skos__scopeNote mesh__D017626
% 212.75/212.97       The brain stem nucleus that receives the central input from the cochlear nerve. The cochlear nucleus is located lateral and dorsolateral to the inferior cerebellar peduncles and is functionally divided into dorsal and ventral parts. It is tonotopically organized, performs the first stage of central auditory processing, and projects %28%directly or indirectly%29% to higher auditory areas including the superior olivary nuclei, the medial geniculi, the inferior colliculi, and the auditory cortex.%A%    
% 212.75/212.97  |- rdf__type mesh__D017626sskos__Concept
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D017626 2005
% 212.75/212.97  |- skos__historyNote mesh__D017626 Brain Stem %28%1966-1993%29%
% 212.75/212.97  |- mesh__recordOriginator mesh__D017626 RAZ
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D017626 2004
% 212.75/212.97  |- mesh__recordMaintainer mesh__D017626 ags
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D017626 2002
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D017626 2006
% 212.75/212.97  |- skos__altLabel mesh__D017626 Cochlear Nuclei
% 212.75/212.97  |- skos__broader mesh__D017626smesh__D011149
% 212.75/212.97  |- mesh__recordAuthorizer mesh__D017626 sjn
% 212.75/212.97  |- skos__hiddenLabel mesh__D017626 Nucleus, Cochlear
% 212.75/212.97  |- mesh__dateEstablished mesh__D017626 1994-01-01
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D017626 2000
% 212.75/212.97  |- mesh__dateCreated mesh__D017626 1993-06-18
% 212.75/212.97  |- skos__prefLabel mesh__D017626 Cochlear Nucleus
% 212.75/212.97  |- skos__hiddenLabel mesh__D017626 Nuclei, Cochlear
% 212.75/212.97  |- mesh__historyNote mesh__D017626 94   
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D017626 2001
% 212.75/212.97  |- mesh__publicMeSHNote mesh__D017626 94   
% 212.75/212.97  |- skos__broader mesh__D003606smesh__D014226
% 212.75/212.97  |- skos__altLabel mesh__D003606 ICDT
% 212.75/212.97  |- skos__altLabel mesh__D003606
% 212.75/212.97       5-%28%3,3-Dimethyl-1-triazeno%29%imidazole-4-carboxamide
% 212.75/212.97  |- skos__hiddenLabel mesh__D003606 DTICDome
% 212.75/212.97  |- skos__altLabel mesh__D003606 Dimethyl Imidazole Carboxamide
% 212.75/212.97  |- mesh__dateEstablished mesh__D003606 1980-01-01
% 212.75/212.97  |- mesh__historyNote mesh__D003606 80%28%75%29%   
% 212.75/212.97  |- skos__historyNote mesh__D003606 Azo Compounds %28%1966-1972%29%
% 212.75/212.97  |- rdf__type mesh__D003606sskos__Concept
% 212.75/212.97  |- mesh__recordMaintainer mesh__D003606 ssb
% 212.75/212.97  |- skos__hiddenLabel mesh__D003606 Imidazole Carboxamide, Dimethyl
% 212.75/212.97  |- mesh__publicMeSHNote mesh__D003606 80; see TRIAZENES 1975-79   
% 212.75/212.97  |- skos__altLabel mesh__D003606 Dimethyl Triazeno Imidazole Carboxamide
% 212.75/212.97  |- skos__scopeNote mesh__D003606
% 212.75/212.97       An antineoplastic agent. It has significant activity against melanomas. %28%from Martindale, The Extra Pharmacopoeia, 31st ed, p564%29%%A%    
% 212.75/212.97  |- skos__historyNote mesh__D003606 Imidazoles %28%1966-1974%29%
% 212.75/212.97  |- skos__historyNote mesh__D003606 Amides %28%1966-1974%29%
% 212.75/212.97  |- mesh__dateCreated mesh__D003606 1974-11-11
% 212.75/212.97  |- skos__hiddenLabel mesh__D003606 NSC 45388
% 212.75/212.97  |- skos__hiddenLabel mesh__D003606 DTIC Dome
% 212.75/212.97  |- mesh__recordAuthorizer mesh__D003606 sjn
% 212.75/212.97  |- skos__broader mesh__D003606smesh__D007093
% 212.75/212.97  |- mesh__dateRevised mesh__D003606 2005-06-30
% 212.75/212.97  |- skos__hiddenLabel mesh__D003606 Carboxamide, Dimethyl Imidazole
% 212.75/212.97  |- skos__historyNote mesh__D003606 Triazenes %28%1972-1974%29%
% 212.75/212.97  |- skos__hiddenLabel mesh__D003606 NSC45388
% 212.75/212.97  |- skos__altLabel mesh__D003606 DTIC
% 212.75/212.97  |- skos__altLabel mesh__D003606 Decarbazine
% 212.75/212.97  |- skos__altLabel mesh__D003606 DIC
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D003606 2006
% 212.75/212.97  |- skos__prefLabel mesh__D003606 Dacarbazine
% 212.75/212.97  |- mesh__recordOriginator mesh__D003606 NLM
% 212.75/212.97  |- skos__broader mesh__D020022Q000175smesh__D020022
% 212.75/212.97  |- mesh__preferredCombination mesh__D020022Q000175smesh__D005820
% 212.75/212.97  |- rdf__type mesh__D020022Q000175smesh__CompoundConcept
% 212.75/212.97  |- skos__broader mesh__D018987Q000530smesh__D018987
% 212.75/212.97  |- mesh__preferredCombination mesh__D018987Q000530smesh__D012796
% 212.75/212.97  |- rdf__type mesh__D018987Q000530smesh__CompoundConcept
% 212.75/212.97  |- mesh__recordOriginator mesh__D046410 ags
% 212.75/212.97  |- rdf__type mesh__D046410sskos__Concept
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D046410 2006
% 212.75/212.97  |- skos__hiddenLabel mesh__D046410 Cockatiel
% 212.75/212.97  |- skos__scopeNote mesh__D046410
% 212.75/212.97       Large crested BIRDS in the family Cacatuidae, found in Australia, New Guinea, and islands adjacent to the Philippines. The cockatiel %28%species Nymphicus hollandicus%29% is much smaller.%A%    
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D046410 2005
% 212.75/212.97  |- mesh__recordAuthorizer mesh__D046410 sjn
% 212.75/212.97  |- mesh__recordMaintainer mesh__D046410 ags
% 212.75/212.97  |- mesh__publicMeSHNote mesh__D046410 2005   
% 212.75/212.97  |- skos__historyNote mesh__D046410 Psittaciformes %28%1974-2004%29%
% 212.75/212.97  |- mesh__historyNote mesh__D046410 2005   
% 212.75/212.97  |- mesh__dateCreated mesh__D046410 2004-07-07
% 212.75/212.97  |- skos__broader mesh__D046410smesh__D011563
% 212.75/212.97  |- skos__prefLabel mesh__D046410 Cockatoos
% 212.75/212.97  |- skos__altLabel mesh__D046410 Nymphicus hollandicus
% 212.75/212.97  |- skos__altLabel mesh__D046410 Cacatuidae
% 212.75/212.97  |- skos__historyNote mesh__D046410 Birds %28%1966-1986%29%
% 212.75/212.97  |- skos__hiddenLabel mesh__D046410 Cockatoo
% 212.75/212.97  |- mesh__dateEstablished mesh__D046410 2005-01-01
% 212.75/212.97  |- mesh__publicMeSHNote mesh__D013236 73   
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D013236 1999
% 212.75/212.97  |- mesh__historyNote mesh__D013236 73   
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D013236 2000
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D013236 2005
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D013236 1995
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D013236 1998
% 212.75/212.97  |- skos__broader mesh__D013236smesh__D005556
% 212.75/212.97  |- skos__historyNote mesh__D013236 Form Perception %28%1966-1972%29%
% 212.75/212.97  |- mesh__dateCreated mesh__D013236 1999-01-01
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D013236 1994
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D013236 2002
% 212.75/212.97  |- mesh__recordMaintainer mesh__D013236 TAP
% 212.75/212.97  |- mesh__recordAuthorizer mesh__D013236 PLS
% 212.75/212.97  |- mesh__dateRevised mesh__D013236 1992-05-18
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D013236 2004
% 212.75/212.97  |- rdf__type mesh__D013236sskos__Concept
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D013236 1997
% 212.75/212.97  |- skos__scopeNote mesh__D013236
% 212.75/212.97       Perception of shape and form of objects by touch.     
% 212.75/212.97  |- mesh__recordOriginator mesh__D013236 NLM
% 212.75/212.97  |- mesh__dateEstablished mesh__D013236 1973-01-01
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D013236 2003
% 212.75/212.97  |- skos__prefLabel mesh__D013236 Stereognosis
% 212.75/212.97  |- skos__broader mesh__D013236smesh__D014110
% 212.75/212.97  |- skos__historyNote mesh__D013236 Touch %28%1966-1972%29%
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D013236 1993
% 212.75/212.97  |- skos__hiddenLabel mesh__D013236 Stereognoses
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D013236 2001
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D013236 2006
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D013236 1996
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009993 2000
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009993 1996
% 212.75/212.97  |- skos__broader mesh__D009993smesh__D017892
% 212.75/212.97  |- skos__broader mesh__D009993smesh__D010087
% 212.75/212.97  |- skos__hiddenLabel mesh__D009993 Acid, Osmic
% 212.75/212.97  |- mesh__dateEstablished mesh__D009993 1991-01-01
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009993 1995
% 212.75/212.97  |- skos__annotation mesh__D009993 indust %26% histol uses   
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009993 2003
% 212.75/212.97  |- skos__prefLabel mesh__D009993 Osmium Tetroxide
% 212.75/212.97  |- mesh__publicMeSHNote mesh__D009993 91; was see under OSMIUM 1979-90   
% 212.75/212.97  |- skos__historyNote mesh__D009993 Oxides %28%1966-1978%29%
% 212.75/212.97  |- mesh__dateCreated mesh__D009993 1978-03-20
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009993 1994
% 212.75/212.97  |- skos__historyNote mesh__D009993 Osmium %28%1966-1978%29%
% 212.75/212.97  |- skos__altLabel mesh__D009993 Osmic Acid
% 212.75/212.97  |- mesh__activeMeSHYear mesh__D009993 1999
% 212.75/212.98  |- mesh__dateRevised mesh__D009993 1993-06-02
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009993 2006
% 212.75/212.98  |- mesh__recordAuthorizer mesh__D009993 PLS
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009993 2002
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009993 1998
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009993 1997
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009993 2005
% 212.75/212.98  |- mesh__recordOriginator mesh__D009993 SH
% 212.75/212.98  |- mesh__recordMaintainer mesh__D009993 TPW
% 212.75/212.98  |- skos__scopeNote mesh__D009993
% 212.75/212.98       %28%T-4%29%-Osmium oxide %28%OsO4%29%. A highly toxic and volatile oxide of osmium used in industry as an oxidizing agent. It is also used as a histological fixative and stain and as a synovectomy agent in arthritic joints. Its vapor can cause eye, skin, and lung damage.%A%    
% 212.75/212.98  |- rdf__type mesh__D009993sskos__Concept
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009993 2001
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009993 2004
% 212.75/212.98  |- skos__hiddenLabel mesh__D009993 Tetroxide, Osmium
% 212.75/212.98  |- mesh__historyNote mesh__D009993
% 212.75/212.98       91%28%79%29%; was see under OSMIUM 1979-90   
% 212.75/212.98  |- skos__prefLabel mesh__D009195 Peroxidase
% 212.75/212.98  |- rdf__type mesh__D009195sskos__Concept
% 212.75/212.98  |- mesh__onlineNote mesh__D009195
% 212.75/212.98       use PEROXIDASE to search MYELOPEROXIDASE 1975-93 and GUAIACOL PEROXIDASE %26% HYDROPEROXIDASE II 1989-93%A%  
% 212.75/212.98  |- mesh__recordAuthorizer mesh__D009195 sjn
% 212.75/212.98  |- mesh__recordOriginator mesh__D009195 NLM
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009195 2005
% 212.75/212.98  |- mesh__recordMaintainer mesh__D009195 ssb
% 212.75/212.98  |- skos__broader mesh__D009195smesh__D010544
% 212.75/212.98  |- skos__altLabel mesh__D009195 Myeloperoxidase
% 212.75/212.98  |- mesh__historyNote mesh__D009195
% 212.75/212.98       94; was MYELOPEROXIDASE 1975-93 %28%see under PEROXIDASES 1975-85%29%; GUAIACOL PEROXIDASE %26% HYDROPEROXIDASE II were see MYELOPEROXIDASE 1989-93%A%  
% 212.75/212.98  |- skos__scopeNote mesh__D009195
% 212.75/212.98       A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7.%A%    
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009195 2006
% 212.75/212.98  |- skos__altLabel mesh__D009195 Hemi-Myeloperoxidase
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009195 2004
% 212.75/212.98  |- mesh__dateCreated mesh__D009195 1974-11-19
% 212.75/212.98  |- skos__hiddenLabel mesh__D009195 Hemi Myeloperoxidase
% 212.75/212.98  |- skos__historyNote mesh__D009195 Peroxidases %28%1970-1974%29%
% 212.75/212.98  |- skos__annotation mesh__D009195
% 212.75/212.98       a hemeprotein synthesized by leukocytes: do not confuse with PEROXIDASES, a subclass of oxidoreductases%A%  
% 212.75/212.98  |- mesh__publicMeSHNote mesh__D009195
% 212.75/212.98       94; was MYELOPEROXIDASE 1975-93 %28%see under PEROXIDASES 1975-85%29%; GUAIACOL PEROXIDASE %26% HYDROPEROXIDASE II were see MYELOPEROXIDASE 1989-93%A%  
% 212.75/212.98  |- mesh__dateRevised mesh__D009195 2003-07-09
% 212.75/212.98  |- mesh__dateEstablished mesh__D009195 1986-01-01
% 212.75/212.98  |- skos__prefLabel mesh__D003607 Dacryocystitis
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D003607 1998
% 212.75/212.98  |- skos__hiddenLabel mesh__D003607 Dacryocystitides
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D003607 1995
% 212.75/212.98  |- mesh__dateCreated mesh__D003607 1999-01-01
% 212.75/212.98  |- mesh__dateRevised mesh__D003607 1994-01-25
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D003607 1999
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D003607 2000
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D003607 2005
% 212.75/212.98  |- skos__scopeNote mesh__D003607
% 212.75/212.98       Inflammation of the lacrimal sac. %28%Dorland, 27th ed%29%     
% 212.75/212.98  |- mesh__recordOriginator mesh__D003607 NLM
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D003607 1996
% 212.75/212.98  |- skos__hiddenLabel mesh__D003607 Dacryoadenitides
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D003607 2006
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D003607 2001
% 212.75/212.98  |- skos__annotation mesh__D003607 inflamm of lacrimal sac   
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D003607 1997
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D003607 2003
% 212.75/212.98  |- mesh__recordMaintainer mesh__D003607 TGC
% 212.75/212.98  |- skos__broader mesh__D003607smesh__D007766
% 212.75/212.98  |- rdf__type mesh__D003607sskos__Concept
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D003607 2004
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D003607 2002
% 212.75/212.98  |- mesh__recordAuthorizer mesh__D003607 PLS
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D013237 2000
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D013237 1999
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D013237 2006
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D013237 1998
% 212.75/212.98  |- mesh__publicMeSHNote mesh__D013237 97; was STEREOISOMERS 1974-96   
% 212.75/212.98  |- mesh__dateCreated mesh__D013237 1999-01-01
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D013237 2005
% 212.75/212.98  |- mesh__dateRevised mesh__D013237 1996-06-10
% 212.75/212.98  |- mesh__historyNote mesh__D013237
% 212.75/212.98       97; was STEREOISOMERS 1974-96 %28%Prov 1968-73%29%   
% 212.75/212.98  |- mesh__dateEstablished mesh__D013237 1974-01-01
% 212.75/212.98  |- skos__broader mesh__D013237smesh__D007536
% 212.75/212.98  |- skos__scopeNote mesh__D013237
% 212.75/212.98       The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%    
% 212.75/212.98  |- mesh__recordAuthorizer mesh__D013237 PLS
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D013237 2002
% 212.75/212.98  |- rdf__type mesh__D013237sskos__Concept
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D013237 1997
% 212.75/212.98  |- skos__hiddenLabel mesh__D013237 Stereoisomer
% 212.75/212.98  |- mesh__recordMaintainer mesh__D013237 TPW
% 212.75/212.98  |- mesh__recordOriginator mesh__D013237 NLM
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D013237 2004
% 212.75/212.98  |- skos__annotation mesh__D013237
% 212.75/212.98       NIM; no qualif; policy: Manual 25.5.5.1   
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D013237 2003
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D013237 2001
% 212.75/212.98  |- skos__prefLabel mesh__D013237 Stereoisomerism
% 212.75/212.98  |- mesh__recordMaintainer mesh__D018720 SYSTEM
% 212.75/212.98  |- skos__annotation mesh__D018720
% 212.75/212.98       infection: coord IM with BACTEROIDACEAE INFECTIONS %28%IM%29%; named for the French microbiologist A. R. Pr%C3%%A9%vot, pioneer in anaerobic microbiol%A%  
% 212.75/212.98  |- mesh__dateRevised mesh__D018720 2005-06-30
% 212.75/212.98  |- mesh__historyNote mesh__D018720 95   
% 212.75/212.98  |- mesh__dateCreated mesh__D018720 1994-07-06
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D018720 2006
% 212.75/212.98  |- mesh__recordOriginator mesh__D018720 PXP
% 212.75/212.98  |- skos__scopeNote mesh__D018720
% 212.75/212.98       A genus of gram-negative, anaerobic, nonsporeforming, nonmotile rods. Organisms of this genus had originally been classified as members of the BACTEROIDES genus but overwhelming biochemical and chemical findings in 1990 indicated the need to separate them from other Bacteroides species, and hence, this new genus was established.%A%    
% 212.75/212.98  |- skos__prefLabel mesh__D018720 Prevotella
% 212.75/212.98  |- mesh__publicMeSHNote mesh__D018720 95   
% 212.75/212.98  |- rdf__type mesh__D018720sskos__Concept
% 212.75/212.98  |- mesh__recordAuthorizer mesh__D018720 sjn
% 212.75/212.98  |- skos__historyNote mesh__D018720 Bacteroides %28%1990-1994%29%
% 212.75/212.98  |- mesh__dateEstablished mesh__D018720 1995-01-01
% 212.75/212.98  |- skos__broader mesh__D018720smesh__D001438
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D004700 2006
% 212.75/212.98  |- skos__prefLabel mesh__D004700 Endocrine System Diseases
% 212.75/212.98  |- skos__annotation mesh__D004700
% 212.75/212.98       general; prefer specific disease: Manual 23.25.3; /diag: consider also DIAGNOSTIC TECHNIQUES, ENDOCRINE%A%  
% 212.75/212.98  |- skos__scopeNote mesh__D004700
% 212.75/212.98       Pathological processes of the ENDOCRINE GLANDS, and diseases resulting from abnormal level of available HORMONES.%A%    
% 212.75/212.98  |- skos__hiddenLabel mesh__D004700 Diseases, Endocrine System
% 212.75/212.98  |- mesh__dateRevised mesh__D004700 2004-07-07
% 212.75/212.98  |- skos__related mesh__D004700smesh__D004704
% 212.75/212.98  |- skos__hiddenLabel mesh__D004700 System Disease, Endocrine
% 212.75/212.98  |- mesh__recordOriginator mesh__D004700 NLM
% 212.75/212.98  |- skos__hiddenLabel mesh__D004700 System Diseases, Endocrine
% 212.75/212.98  |- skos__hiddenLabel mesh__D004700 Diseases, Endocrine
% 212.75/212.98  |- skos__hiddenLabel mesh__D004700 Endocrine Disease
% 212.75/212.98  |- mesh__recordMaintainer mesh__D004700 lkt
% 212.75/212.98  |- mesh__publicMeSHNote mesh__D004700
% 212.75/212.98       2005; see ENDOCRINE DISEASES 1965-2004   
% 212.75/212.98  |- skos__hiddenLabel mesh__D004700 Disease, Endocrine
% 212.75/212.98  |- rdf__type mesh__D004700sskos__Concept
% 212.75/212.98  |- mesh__runningHead mesh__D004700 C19 - DISEASES-ENDOCRINE   
% 212.75/212.98  |- skos__altLabel mesh__D004700 Endocrine Diseases
% 212.75/212.98  |- skos__hiddenLabel mesh__D004700 Endocrine System Disease
% 212.75/212.98  |- mesh__dateEstablished mesh__D004700 1965-01-01
% 212.75/212.98  |- skos__hiddenLabel mesh__D004700 Disease, Endocrine System
% 212.75/212.98  |- mesh__dateCreated mesh__D004700 1999-01-01
% 212.75/212.98  |- mesh__recordAuthorizer mesh__D004700 sjn
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D004700 2005
% 212.75/212.98  |- mesh__historyNote mesh__D004700 2005 %28%1965%29%   
% 212.75/212.98  |- skos__altLabel mesh__D004700 Diseases of Endocrine System
% 212.75/212.98  |- mesh__dateRevised mesh__D051356 2005-07-27
% 212.75/212.98  |- skos__prefLabel mesh__D051356 Cortactin
% 212.75/212.98  |- mesh__recordOriginator mesh__D051356 DRC
% 212.75/212.98  |- skos__broader mesh__D051356smesh__D010750
% 212.75/212.98  |- mesh__historyNote mesh__D051356 2006%28%1983%29%   
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D051356 2006
% 212.75/212.98  |- skos__broader mesh__D051356smesh__D008840
% 212.75/212.98  |- mesh__dateCreated mesh__D051356 2005-06-30
% 212.75/212.98  |- mesh__dateEstablished mesh__D051356 2006-01-01
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D051356 2006B
% 212.75/212.98  |- mesh__recordMaintainer mesh__D051356 ags
% 212.75/212.98  |- mesh__recordAuthorizer mesh__D051356 ags
% 212.75/212.98  |- skos__scopeNote mesh__D051356
% 212.75/212.98       A microfilament protein that interacts with F-ACTIN and regulates cortical actin assembly and organization. It is also an SH3 DOMAIN containing phosphoprotein, and it mediates tyrosine PHOSPHORYLATION based SIGNAL TRANSDUCTION by PROTO-ONCOGENE PROTEIN PP60%28%C-SRC%29%.%A%    
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D051356 2006A
% 212.75/212.98  |- skos__broader mesh__D051356smesh__D048868
% 212.75/212.98  |- rdf__type mesh__D051356sskos__Concept
% 212.75/212.98  |- mesh__publicMeSHNote mesh__D051356
% 212.75/212.98       2006; CORTACTIN was indexed under MICROFILAMENT PROTEINS 1993-2005%A%  
% 212.75/212.98  |- skos__historyNote mesh__D009994 Osmosis %28%1966-1967%29%
% 212.75/212.98  |- skos__hiddenLabel mesh__D009994 Concentration, Osmolar
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009994 2001
% 212.75/212.98  |- skos__scopeNote mesh__D009994
% 212.75/212.98       The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent.%A%    
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009994 1994
% 212.75/212.98  |- skos__hiddenLabel mesh__D009994 Ionic Strengths
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009994 2000
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009994 1993
% 212.75/212.98  |- mesh__recordOriginator mesh__D009994 NLM
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009994 1999
% 212.75/212.98  |- skos__historyNote mesh__D009994
% 212.75/212.98       Water-Electrolyte Balance %28%1966-1967%29%
% 212.75/212.98  |- mesh__dateRevised mesh__D009994 1991-01-08
% 212.75/212.98  |- mesh__publicMeSHNote mesh__D009994 70   
% 212.75/212.98  |- skos__hiddenLabel mesh__D009994 Osmolarities
% 212.75/212.98  |- skos__hiddenLabel mesh__D009994 Osmolar Concentrations
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009994 2006
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009994 1992
% 212.75/212.98  |- skos__altLabel mesh__D009994 Osmolarity
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009994 1998
% 212.75/212.98  |- mesh__recordMaintainer mesh__D009994 TGC
% 212.75/212.98  |- skos__prefLabel mesh__D009994 Osmolar Concentration
% 212.75/212.98  |- mesh__dateEstablished mesh__D009994 1970-01-01
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009994 1997
% 212.75/212.98  |- skos__hiddenLabel mesh__D009994 Osmolalities
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009994 2005
% 212.75/212.98  |- rdf__type mesh__D009994sskos__Concept
% 212.75/212.98  |- skos__broader mesh__D009994smesh__D002627
% 212.75/212.98  |- skos__hiddenLabel mesh__D009994 Strengths, Ionic
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009994 2004
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009994 1996
% 212.75/212.98  |- mesh__recordAuthorizer mesh__D009994 PLS
% 212.75/212.98  |- skos__annotation mesh__D009994 NIM; no qualif   
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009994 2002
% 212.75/212.98  |- mesh__dateCreated mesh__D009994 1999-01-01
% 212.75/212.98  |- skos__hiddenLabel mesh__D009994 Strength, Ionic
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009994 1995
% 212.75/212.98  |- mesh__historyNote mesh__D009994 70%28%68%29%   
% 212.75/212.98  |- skos__hiddenLabel mesh__D009994 Concentrations, Osmolar
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009994 2003
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009196 1996
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009196 2002
% 212.75/212.98  |- skos__annotation mesh__D009196
% 212.75/212.98       myelo- here = bone marrow, not spinal cord; GEN; prefer specifics%A%  
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009196 1999
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009196 2005
% 212.75/212.98  |- skos__hiddenLabel mesh__D009196 Myeloproliferative Disorder
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009196 1997
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009196 2003
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009196 2006
% 212.75/212.98  |- skos__hiddenLabel mesh__D009196 Disorders, Myeloproliferative
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009196 2004
% 212.75/212.98  |- skos__prefLabel mesh__D009196 Myeloproliferative Disorders
% 212.75/212.98  |- mesh__recordOriginator mesh__D009196 NLM
% 212.75/212.98  |- mesh__historyNote mesh__D009196 70%28%66%29%   
% 212.75/212.98  |- skos__scopeNote mesh__D009196
% 212.75/212.98       Disorders in which one or more stimuli cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential.%A%    
% 212.75/212.98  |- skos__hiddenLabel mesh__D009196 Disorder, Myeloproliferative
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009196 1994
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009196 2000
% 212.75/212.98  |- skos__broader mesh__D009196smesh__D001855
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009196 1992
% 212.75/212.98  |- mesh__publicMeSHNote mesh__D009196 70   
% 212.75/212.98  |- mesh__dateRevised mesh__D009196 1991-06-18
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009196 1995
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009196 2001
% 212.75/212.98  |- mesh__dateEstablished mesh__D009196 1970-01-01
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009196 1993
% 212.75/212.98  |- mesh__recordAuthorizer mesh__D009196 PLS
% 212.75/212.98  |- mesh__dateCreated mesh__D009196 1999-01-01
% 212.75/212.98  |- rdf__type mesh__D009196sskos__Concept
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D009196 1998
% 212.75/212.98  |- skos__related mesh__D009196smesh__D007938
% 212.75/212.98  |- mesh__recordMaintainer mesh__D009196 TGC
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D017628 1994
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D017628 2004
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D017628 1997
% 212.75/212.98  |- mesh__dateEstablished mesh__D017628 1994-01-01
% 212.75/212.98  |- rdf__type mesh__D017628sskos__Concept
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D017628 2003
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D017628 1996
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D017628 2002
% 212.75/212.98  |- skos__scopeNote mesh__D017628
% 212.75/212.98       The third type of glial cell, along with astrocytes and oligodendrocytes %28%which together form the macroglia%29%. Microglia vary in appearance depending on developmental stage, functional state, and anatomical location; subtype terms include ramified, perivascular, ameboid, resting, and activated. Microglia clearly are capable of phagocytosis and play an important role in a wide spectrum of neuropathologies. They have also been suggested to act in several other roles including in secretion %28%e.g., of cytokines and neural growth factors%29%, in immunological processing %28%e.g., antigen presentation%29%, and in central nervous system development and remodeling.%A%    
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D017628 2006
% 212.75/212.98  |- skos__prefLabel mesh__D017628 Microglia
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D017628 1999
% 212.75/212.98  |- mesh__dateCreated mesh__D017628 1993-06-18
% 212.75/212.98  |- mesh__publicMeSHNote mesh__D017628 94   
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D017628 2005
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D017628 1998
% 212.75/212.98  |- skos__annotation mesh__D017628 a type of neuroglia; A 11 qualif   
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D017628 2001
% 212.75/212.98  |- skos__broader mesh__D017628smesh__D009457
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D017628 1995
% 212.75/212.98  |- mesh__historyNote mesh__D017628 94   
% 212.75/212.98  |- skos__historyNote mesh__D017628 Neuroglia %28%1966-1993%29%
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D017628 2000
% 212.75/212.98  |- skos__annotation mesh__D042021
% 212.75/212.98       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 212.75/212.98  |- mesh__publicMeSHNote mesh__D042021
% 212.75/212.98       2004; see BRUCELLA 1992-2003, see GRAM-POSITIVE AEROBIC BACTERIA 1976-1991, see BRUCELLACEAE 1975%A%  
% 212.75/212.98  |- rdf__type mesh__D042021sskos__Concept
% 212.75/212.98  |- skos__scopeNote mesh__D042021
% 212.75/212.98       A family of gram-negative coccoid to rod-shaped bacteria in the order Rhizobiales. They are obligate parasites chiefly of warm-blooded VERTEBRATES. Many are pathogenic.%A%    
% 212.75/212.98  |- skos__prefLabel mesh__D042021 Brucellaceae
% 212.75/212.98  |- mesh__historyNote mesh__D042021
% 212.75/212.98       2004, 1975-1991; use BRUCELLA 1992-2003   
% 212.75/212.98  |- mesh__dateCreated mesh__D042021 2003-07-09
% 212.75/212.98  |- mesh__recordAuthorizer mesh__D042021 sjn
% 212.75/212.98  |- mesh__recordMaintainer mesh__D042021 SYSTEM
% 212.75/212.98  |- mesh__recordOriginator mesh__D042021 ags
% 212.75/212.98  |- mesh__dateRevised mesh__D042021 2005-06-30
% 212.75/212.98  |- skos__broader mesh__D042021smesh__D016946
% 212.75/212.98  |- skos__historyNote mesh__D042021 Brucella %28%1972-2003%29%
% 212.75/212.98  |- skos__broader mesh__D042021smesh__D020561
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D042021 2006
% 212.75/212.98  |- mesh__dateEstablished mesh__D042021 2004-01-01
% 212.75/212.98  |- skos__hiddenLabel mesh__D003608 Dacryocystostomies
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D003608 1999
% 212.75/212.98  |- skos__historyNote mesh__D003608
% 212.75/212.98       Lacrimal Duct Obstruction/surgery %28%1966-1987%29%
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D003608 2005
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D003608 2002
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D003608 2006
% 212.75/212.98  |- skos__hiddenLabel mesh__D003608 Dacryocystorhinostomies
% 212.75/212.98  |- mesh__publicMeSHNote mesh__D003608 88   
% 212.75/212.98  |- skos__broader mesh__D003608smesh__D013508
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D003608 2003
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D003608 2000
% 212.75/212.98  |- rdf__type mesh__D003608sskos__Concept
% 212.75/212.98  |- mesh__dateRevised mesh__D003608 1997-06-20
% 212.75/212.98  |- mesh__historyNote mesh__D003608 88   
% 212.75/212.98  |- mesh__dateEstablished mesh__D003608 1988-01-01
% 212.75/212.98  |- mesh__recordOriginator mesh__D003608 SCD
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D003608 2004
% 212.75/212.98  |- skos__historyNote mesh__D003608
% 212.75/212.98       Lacrimal Apparatus/surgery %28%1966-1987%29%
% 212.75/212.98  |- skos__historyNote mesh__D003608 Dacryocystitis/surgery %28%1966-1987%29%
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D003608 2001
% 212.75/212.98  |- mesh__recordAuthorizer mesh__D003608 SJN
% 212.75/212.98  |- skos__scopeNote mesh__D003608
% 212.75/212.98       Surgical fistulization of the lacrimal sac for external drainage of an obstructed nasolacrimal duct.%A%    
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D003608 1998
% 212.75/212.98  |- mesh__recordMaintainer mesh__D003608 PXP
% 212.75/212.98  |- skos__prefLabel mesh__D003608 Dacryocystorhinostomy
% 212.75/212.98  |- mesh__dateCreated mesh__D003608 1987-03-18
% 212.75/212.98  |- skos__broader mesh__D003608smesh__D010030
% 212.75/212.98  |- skos__annotation mesh__D003608
% 212.75/212.98       do not use /util except by MeSH definition   
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D014330 1997
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D014330 2004
% 212.75/212.98  |- skos__scopeNote mesh__D014330
% 212.75/212.98       The branch of medicine concerned with diseases, mainly of parasitic origin, common in tropical and subtropical regions.%A%    
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D014330 2000
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D014330 1999
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D014330 2006
% 212.75/212.98  |- skos__altLabel mesh__D014330 Medicine, Tropical
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D014330 2003
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D014330 1996
% 212.75/212.98  |- skos__prefLabel mesh__D014330 Tropical Medicine
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D014330 1993
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D014330 1995
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D014330 1998
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D014330 2005
% 212.75/212.98  |- mesh__dateCreated mesh__D014330 1999-01-01
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D014330 1992
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D014330 1994
% 212.75/212.98  |- mesh__recordAuthorizer mesh__D014330 PLS
% 212.75/212.98  |- skos__broader mesh__D014330smesh__D008511
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D014330 2002
% 212.75/212.98  |- mesh__recordMaintainer mesh__D014330 TGC
% 212.75/212.98  |- rdf__type mesh__D014330sskos__Concept
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D014330 2001
% 212.75/212.98  |- skos__annotation mesh__D014330
% 212.75/212.98       SPEC: SPEC qualif; = %22%tropical diseases%22% when very general but avoid: prefer specific diseases; DF: TROPICAL MED%A%  
% 212.75/212.98  |- mesh__dateRevised mesh__D014330 1991-08-23
% 212.75/212.98  |- mesh__recordOriginator mesh__D014330 NLM
% 212.75/212.98  |- skos__altLabel mesh__D000310 Cancer of the Adrenal Gland
% 212.75/212.98  |- rdf__type mesh__D000310sskos__Concept
% 212.75/212.98  |- mesh__recordAuthorizer mesh__D000310 sjn
% 212.75/212.98  |- skos__annotation mesh__D000310
% 212.75/212.98       coord IM with histol type of neopl %28%IM%29%   
% 212.75/212.98  |- skos__hiddenLabel mesh__D000310 Adrenal Gland Neoplasm
% 212.75/212.98  |- skos__broader mesh__D000310smesh__D004701
% 212.75/212.98  |- skos__hiddenLabel mesh__D000310 Adrenal Gland Cancers
% 212.75/212.98  |- skos__hiddenLabel mesh__D000310 Cancer, Adrenal
% 212.75/212.98  |- skos__altLabel mesh__D000310 Neoplasms, Adrenal Gland
% 212.75/212.98  |- skos__altLabel mesh__D000310 Adrenal Gland Cancer
% 212.75/212.98  |- skos__scopeNote mesh__D000310
% 212.75/212.98       Tumors or cancer of the ADRENAL GLANDS.     
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D000310 2006
% 212.75/212.98  |- skos__prefLabel mesh__D000310 Adrenal Gland Neoplasms
% 212.75/212.98  |- mesh__recordMaintainer mesh__D000310 lkt
% 212.75/212.98  |- skos__hiddenLabel mesh__D000310 Neoplasm, Adrenal Gland
% 212.75/212.98  |- skos__hiddenLabel mesh__D000310 Cancers, Adrenal Gland
% 212.75/212.98  |- skos__broader mesh__D000310smesh__D000307
% 212.75/212.98  |- skos__hiddenLabel mesh__D000310 Cancers, Adrenal
% 212.75/212.98  |- skos__hiddenLabel mesh__D000310 Adrenal Cancers
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D000310 2005
% 212.75/212.98  |- mesh__recordOriginator mesh__D000310 NLM
% 212.75/212.98  |- mesh__dateCreated mesh__D000310 1999-01-01
% 212.75/212.98  |- mesh__dateRevised mesh__D000310 2004-07-07
% 212.75/212.98  |- skos__hiddenLabel mesh__D000310 Cancer, Adrenal Gland
% 212.75/212.98  |- mesh__recordOriginator mesh__D013238 NLM
% 212.75/212.98  |- skos__related mesh__D013238smesh__D001931
% 212.75/212.98  |- skos__prefLabel mesh__D013238 Stereotaxic Techniques
% 212.75/212.98  |- skos__broader mesh__D013238smesh__D008919
% 212.75/212.98  |- rdf__type mesh__D013238sskos__Concept
% 212.75/212.98  |- skos__hiddenLabel mesh__D013238 Technique, Stereotaxic
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D013238 2001
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D013238 2004
% 212.75/212.98  |- skos__hiddenLabel mesh__D013238 Technic, Stereotaxic
% 212.75/212.98  |- mesh__recordMaintainer mesh__D013238 kle
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D013238 2000
% 212.75/212.98  |- skos__hiddenLabel mesh__D013238 Technics, Stereotaxic
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D013238 2003
% 212.75/212.98  |- mesh__onlineNote mesh__D013238
% 212.75/212.98       use STEREOTAXIC TECHNIQUES to search STEREOTAXIC TECHNICS 1966-90%A%  
% 212.75/212.98  |- skos__annotation mesh__D013238
% 212.75/212.98       do not use /util except by MeSH definition   
% 212.75/212.98  |- skos__hiddenLabel mesh__D013238 Techniques, Stereotaxic
% 212.75/212.98  |- mesh__historyNote mesh__D013238 91; was STEREOTAXIC TECHNICS 1965-90   
% 212.75/212.98  |- skos__altLabel mesh__D013238 Stereotaxic Technics
% 212.75/212.98  |- skos__broader mesh__D013238smesh__D019635
% 212.75/212.98  |- mesh__publicMeSHNote mesh__D013238
% 212.75/212.98       91; was STEREOTAXIC TECHNICS 1965-90   
% 212.75/212.98  |- skos__hiddenLabel mesh__D013238 Stereotaxic Technic
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D013238 2006
% 212.75/212.98  |- mesh__recordAuthorizer mesh__D013238 sjn
% 212.75/212.98  |- mesh__dateRevised mesh__D013238 1999-11-03
% 212.75/212.98  |- skos__scopeNote mesh__D013238
% 212.75/212.98       Techniques during brain surgery that use a system of three-dimensional coordinates to locate the site to be operated on. %28%From Dorland, 28th ed%29%%A%    
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D013238 2002
% 212.75/212.98  |- mesh__dateCreated mesh__D013238 1999-01-01
% 212.75/212.98  |- mesh__dateEstablished mesh__D013238 1965-01-01
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D013238 2005
% 212.75/212.98  |- skos__hiddenLabel mesh__D013238 Stereotaxic Technique
% 212.75/212.98  |- mesh__recordMaintainer mesh__D018721 ssb
% 212.75/212.98  |- mesh__activeMeSHYear mesh__D018721 2006
% 212.75/212.98  |- mesh__dateEstablished mesh__D018721 1995-01-01
% 212.75/212.98  |- skos__altLabel mesh__D018721 Cholinergic Agonists, Muscarinic
% 212.75/212.98  |- skos__altLabel mesh__D018721 Cholinergic Agonist, Muscarinic
% 212.75/212.99  |- mesh__dateCreated mesh__D018721 1994-06-01
% 212.75/212.99  |- mesh__dateRevised mesh__D018721 2005-06-30
% 212.75/212.99  |- skos__hiddenLabel mesh__D018721 Agonists, Muscarinic Cholinergic
% 212.75/212.99  |- skos__scopeNote mesh__D018721
% 212.75/212.99       Drugs that bind to and activate muscarinic cholinergic receptors %28%RECEPTORS, MUSCARINIC%29%. Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate.%A%    
% 212.75/212.99  |- skos__hiddenLabel mesh__D018721 Agonist, Muscarinic Cholinergic
% 212.75/212.99  |- skos__hiddenLabel mesh__D018721 Muscarinic Cholinergic Agonist
% 212.75/212.99  |- skos__prefLabel mesh__D018721 Muscarinic Agonists
% 212.75/212.99  |- rdf__type mesh__D018721sskos__Concept
% 212.75/212.99  |- skos__broader mesh__D018721smesh__D018679
% 212.75/212.99  |- skos__annotation mesh__D018721
% 212.75/212.99       GEN or unspecified; prefer specifics; DF: MUSCARINIC AGON or MUSCARINIC AG%A%  
% 212.75/212.99  |- skos__hiddenLabel mesh__D018721 Agonist, Muscarinic
% 212.75/212.99  |- mesh__recordOriginator mesh__D018721 RAZ
% 212.75/212.99  |- skos__altLabel mesh__D018721 Muscarinic Agonist
% 212.75/212.99  |- mesh__publicMeSHNote mesh__D018721 95   
% 212.75/212.99  |- skos__hiddenLabel mesh__D018721 Agonists, Muscarinic
% 212.75/212.99  |- mesh__recordAuthorizer mesh__D018721 sjn
% 212.75/212.99  |- skos__hiddenLabel mesh__D018721 Muscarinic Cholinergic Agonists
% 212.75/212.99  |- mesh__historyNote mesh__D018721 95   
% 212.75/212.99  |- skos__altLabel mesh__D004701 Endocrine Cancer
% 212.75/212.99  |- skos__hiddenLabel mesh__D004701 Endocrine Cancers
% 212.75/212.99  |- mesh__recordOriginator mesh__D004701 NLM
% 212.75/212.99  |- skos__prefLabel mesh__D004701 Endocrine Gland Neoplasms
% 212.75/212.99  |- skos__altLabel mesh__D004701 Endocrine Gland Carcinoma
% 212.75/212.99  |- mesh__dateRevised mesh__D004701 2005-06-30
% 212.75/212.99  |- mesh__activeMeSHYear mesh__D004701 2006
% 212.75/212.99  |- skos__altLabel mesh__D004701 Endocrine Gland Cancer
% 212.75/212.99  |- mesh__historyNote mesh__D004701
% 212.75/212.99       92; was ENDOCRINE GLAND NEOPLASMS %28%NON MESH%29% 1971-91   
% 212.75/212.99  |- skos__broader mesh__D004701smesh__D009371
% 212.75/212.99  |- skos__annotation mesh__D004701
% 212.75/212.99       general; prefer specifics; coordinate IM with histological type of neoplasm %28%IM%29%%A%  
% 212.75/212.99  |- skos__hiddenLabel mesh__D004701 Endocrine Gland Neoplasm
% 212.75/212.99  |- mesh__recordMaintainer mesh__D004701 lkt
% 212.75/212.99  |- skos__hiddenLabel mesh__D004701 Carcinoma, Endocrine Gland
% 212.75/212.99  |- skos__altLabel mesh__D004701 Cancer of the Endocrine Gland
% 212.75/212.99  |- skos__altLabel mesh__D004701 Cancer of Endocrine Gland
% 212.75/212.99  |- rdf__type mesh__D004701sskos__Concept
% 212.75/212.99  |- skos__hiddenLabel mesh__D004701 Cancers, Endocrine
% 212.75/212.99  |- skos__scopeNote mesh__D004701
% 212.75/212.99       Tumors or cancer of the ENDOCRINE GLANDS.     
% 212.75/212.99  |- skos__broader mesh__D004701smesh__D004700
% 212.75/212.99  |- mesh__dateEstablished mesh__D004701 1992-01-01
% 212.75/212.99  |- skos__hiddenLabel mesh__D004701 Neoplasm, Endocrine Gland
% 212.75/212.99  |- mesh__publicMeSHNote mesh__D004701 92   
% 212.75/212.99  |- mesh__dateCreated mesh__D004701 1999-01-01
% 212.75/212.99  |- mesh__recordAuthorizer mesh__D004701 sjn
% 212.84/212.99  |- skos__hiddenLabel mesh__D004701 Cancer, Endocrine Gland
% 212.84/212.99  |- skos__historyNote mesh__D004701 Endocrine Diseases %28%1966-1991%29%
% 212.84/212.99  |- skos__hiddenLabel mesh__D004701 Cancer, Endocrine
% 212.84/212.99  |- skos__altLabel mesh__D004701 Neoplasms, Endocrine Gland
% 212.84/212.99  |- skos__hiddenLabel mesh__D051357 Cyclin Dependent Kinase 2
% 212.84/212.99  |- skos__altLabel mesh__D051357 Cdk2 Protein Kinase
% 212.84/212.99  |- mesh__recordMaintainer mesh__D051357 DRC
% 212.84/212.99  |- mesh__dateEstablished mesh__D051357 2006-01-01
% 212.84/212.99  |- skos__scopeNote mesh__D051357
% 212.84/212.99       A key regulator of CELL CYCLE progression. It partners with CYCLIN E to regulate entry into S PHASE and also interacts with CYCLIN A to phosphorylate RETINOBLASTOMA PROTEIN. Its activity is inhibited by CYCLIN-DEPENDENT KINASE INHIBITOR P27 and CYCLIN-DEPENDENT KINASE INHIBITOR P21.%A%    
% 212.84/212.99  |- skos__altLabel mesh__D051357 Cdc2-Related Protein Kinase
% 212.84/212.99  |- mesh__recordAuthorizer mesh__D051357 sjn
% 212.84/212.99  |- skos__prefLabel mesh__D051357 Cyclin-Dependent Kinase 2
% 212.84/212.99  |- mesh__publicMeSHNote mesh__D051357
% 212.84/212.99       2006; CYCLIN-DEPENDENT KINASE 2 was indexed under CDC2-CDC28 KINASES 2004-2005, %26% under CYCLIN-DEPENDENT KINASES 1991-2003, %26% under PROTEIN KINASES 1991-1994%A%  
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D051357 2006
% 212.84/212.99  |- skos__altLabel mesh__D051357 p33cdk2 Kinase
% 212.84/212.99  |- skos__altLabel mesh__D051357 CDK2 Protein
% 212.84/212.99  |- mesh__historyNote mesh__D051357 2006%28%1991%29%   
% 212.84/212.99  |- skos__broader mesh__D051357smesh__D018844
% 212.84/212.99  |- mesh__recordOriginator mesh__D051357 DRC
% 212.84/212.99  |- skos__hiddenLabel mesh__D051357 Cdc2 Related Protein Kinase
% 212.84/212.99  |- rdf__type mesh__D051357sskos__Concept
% 212.84/212.99  |- mesh__dateCreated mesh__D051357 2005-06-30
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009995 1998
% 212.84/212.99  |- skos__broader mesh__D009995smesh__D010539
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009995 2005
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009995 1999
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009995 1993
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009995 2000
% 212.84/212.99  |- mesh__recordMaintainer mesh__D009995 TGC
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009995 2006
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009995 2001
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009995 1996
% 212.84/212.99  |- skos__annotation mesh__D009995
% 212.84/212.99       NIM; coord NIM with substance /pharmacokin %28%IM%29% or tissue /metab %28%IM%29%; osmotic shock: index under OSMOTIC PRESSURE%A%  
% 212.84/212.99  |- skos__hiddenLabel mesh__D009995 Osmoses
% 212.84/212.99  |- mesh__dateCreated mesh__D009995 1999-01-01
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009995 2003
% 212.84/212.99  |- skos__scopeNote mesh__D009995
% 212.84/212.99       Tendency of fluids %28%e.g., water%29% to move from the less concentrated to the more concentrated side of a semipermeable membrane.%A%    
% 212.84/212.99  |- skos__broader mesh__D009995smesh__D001669
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009995 1997
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009995 1994
% 212.84/212.99  |- mesh__recordOriginator mesh__D009995 NLM
% 212.84/212.99  |- rdf__type mesh__D009995sskos__Concept
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009995 2004
% 212.84/212.99  |- skos__prefLabel mesh__D009995 Osmosis
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009995 2002
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009995 1995
% 212.84/212.99  |- mesh__dateRevised mesh__D009995 1992-05-15
% 212.84/212.99  |- mesh__recordAuthorizer mesh__D009995 PLS
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009197 2000
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009197 2004
% 212.84/212.99  |- skos__prefLabel mesh__D009197 Myenteric Plexus
% 212.84/212.99  |- skos__hiddenLabel mesh__D009197 Auerbachs Plexus
% 212.84/212.99  |- mesh__recordMaintainer mesh__D009197 RAZ
% 212.84/212.99  |- skos__broader mesh__D009197smesh__D017615
% 212.84/212.99  |- mesh__publicMeSHNote mesh__D009197 65   
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009197 1994
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009197 2001
% 212.84/212.99  |- skos__scopeNote mesh__D009197
% 212.84/212.99       One of two ganglionated neural networks which together form the ENTERIC NERVOUS SYSTEM. The myenteric %28%Auerbach%27%s%29% plexus is located between the longitudinal and circular muscle layers of the gut. Its neurons project to the circular muscle, to other myenteric ganglia, to submucosal ganglia, or directly to the epithelium, and play an important role in regulating and patterning gut motility. %28%From FASEB J 1989;3:127-38%29%%A%    
% 212.84/212.99  |- mesh__recordAuthorizer mesh__D009197 PLS
% 212.84/212.99  |- skos__hiddenLabel mesh__D009197 Auerbach Plexus
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009197 1995
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009197 2002
% 212.84/212.99  |- mesh__dateEstablished mesh__D009197 1965-01-01
% 212.84/212.99  |- rdf__type mesh__D009197sskos__Concept
% 212.84/212.99  |- mesh__dateCreated mesh__D009197 1999-01-01
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009197 1998
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009197 1996
% 212.84/212.99  |- skos__hiddenLabel mesh__D009197 Plexus, Myenteric
% 212.84/212.99  |- mesh__historyNote mesh__D009197 65   
% 212.84/212.99  |- skos__hiddenLabel mesh__D009197 Plexus, Auerbach%27%s
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009197 2005
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009197 1999
% 212.84/212.99  |- skos__annotation mesh__D009197
% 212.84/212.99       a neural network in the enteric nerv syst   
% 212.84/212.99  |- skos__altLabel mesh__D009197 Auerbach%27%s Plexus
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009197 2003
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009197 1997
% 212.84/212.99  |- mesh__recordOriginator mesh__D009197 NLM
% 212.84/212.99  |- mesh__dateRevised mesh__D009197 1993-06-18
% 212.84/212.99  |- skos__broader mesh__D009197smesh__D017776
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009197 2006
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D017629 2001
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D017629 2003
% 212.84/212.99  |- rdf__type mesh__D017629sskos__Concept
% 212.84/212.99  |- skos__broader mesh__D017629smesh__D007365
% 212.84/212.99  |- mesh__recordMaintainer mesh__D017629 jls
% 212.84/212.99  |- mesh__recordOriginator mesh__D017629 RAZ
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D017629 2006
% 212.84/212.99  |- mesh__dateEstablished mesh__D017629 1994-01-01
% 212.84/212.99  |- mesh__recordAuthorizer mesh__D017629 sjn
% 212.84/212.99  |- mesh__dateCreated mesh__D017629 1993-08-06
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D017629 2005
% 212.84/212.99  |- skos__historyNote mesh__D017629
% 212.84/212.99       Intercellular Junctions %28%1971-1993%29%
% 212.84/212.99  |- skos__hiddenLabel mesh__D017629 Gap Junction
% 212.84/212.99  |- mesh__dateRevised mesh__D017629 2000-06-22
% 212.84/212.99  |- skos__prefLabel mesh__D017629 Gap Junctions
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D017629 2002
% 212.84/212.99  |- skos__hiddenLabel mesh__D017629 Junctions, Gap
% 212.84/212.99  |- mesh__historyNote mesh__D017629 94   
% 212.84/212.99  |- skos__related mesh__D017629smesh__D017630
% 212.84/212.99  |- skos__annotation mesh__D017629
% 212.84/212.99       intercellular junctions; A 11 qualif except /cytol /transpl; /genet permitted%A%  
% 212.84/212.99  |- skos__scopeNote mesh__D017629
% 212.84/212.99       Connections between cells which allow passage of small molecules and electric current. Gap junctions were first described anatomically as regions of close apposition between cells with a narrow %28%1-2 nm%29% gap between cell membranes. The variety in the properties of gap junctions is reflected in the number of CONNEXINS, the family of proteins which form the junctions.%A%    
% 212.84/212.99  |- mesh__publicMeSHNote mesh__D017629 94   
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D017629 2004
% 212.84/212.99  |- skos__hiddenLabel mesh__D017629 Junction, Gap
% 212.84/212.99  |- mesh__historyNote mesh__D003609 66; ACTINOMYCIN was heading 1963-95   
% 212.84/212.99  |- skos__altLabel mesh__D003609 Lemery Brand of Dactinomycin
% 212.84/212.99  |- skos__altLabel mesh__D003609
% 212.84/212.99       Merck Sharp %26% Dohme Brand of Dactinomycin
% 212.84/212.99  |- skos__altLabel mesh__D003609 Meractinomycin
% 212.84/212.99  |- skos__broader mesh__D003609smesh__D010456
% 212.84/212.99  |- skos__hiddenLabel mesh__D003609 Lyovac, Cosmegen
% 212.84/212.99  |- skos__altLabel mesh__D003609 Lyovac-Cosmegen
% 212.84/212.99  |- skos__altLabel mesh__D003609 Actinomycin D
% 212.84/212.99  |- mesh__dateCreated mesh__D003609 1999-01-01
% 212.84/212.99  |- skos__broader mesh__D003609smesh__D006575
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D003609 2006
% 212.84/212.99  |- mesh__recordAuthorizer mesh__D003609 sjn
% 212.84/212.99  |- skos__altLabel mesh__D003609 MSD Brand of Dactinomycin
% 212.84/212.99  |- mesh__recordMaintainer mesh__D003609 exl
% 212.84/212.99  |- mesh__dateEstablished mesh__D003609 1966-01-01
% 212.84/212.99  |- mesh__dateRevised mesh__D003609 2005-06-30
% 212.84/212.99  |- skos__altLabel mesh__D003609 Merck Brand of Dactinomycin
% 212.84/212.99  |- skos__scopeNote mesh__D003609
% 212.84/212.99       A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis %28%transcription%29%, with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. %28%From AMA Drug Evaluations Annual, 1993, p2015%29%%A%    
% 212.84/212.99  |- mesh__publicMeSHNote mesh__D003609
% 212.84/212.99       66; ACTINOMYCIN was heading 1963-95   
% 212.84/212.99  |- rdf__type mesh__D003609sskos__Concept
% 212.84/212.99  |- skos__altLabel mesh__D003609 Cosmegen Lyovac
% 212.84/212.99  |- skos__prefLabel mesh__D003609 Dactinomycin
% 212.84/212.99  |- skos__altLabel mesh__D003609 Merck Frosst Brand of Dactinomycin
% 212.84/212.99  |- mesh__recordOriginator mesh__D003609 NLM
% 212.84/212.99  |- skos__altLabel mesh__D014331 N-Ethyl-N-%28%4-pyridylmethyl%29%tropamide
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D014331 2003
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D014331 2005
% 212.84/212.99  |- mesh__recordOriginator mesh__D014331 SH
% 212.84/212.99  |- mesh__recordAuthorizer mesh__D014331 sjn
% 212.84/212.99  |- skos__historyNote mesh__D014331 Pyridines %28%1966-1978%29%
% 212.84/212.99  |- mesh__dateRevised mesh__D014331 2001-07-25
% 212.84/212.99  |- mesh__dateCreated mesh__D014331 1978-02-08
% 212.84/212.99  |- skos__altLabel mesh__D014331
% 212.84/212.99       N-Ethyl-alpha-%28%hydroxymethyl%29%-N-%28%4-pyridinylmethyl%29%benzeneacetamide
% 212.84/212.99  |- mesh__publicMeSHNote mesh__D014331
% 212.84/212.99       91; was see under PYRIDINES 1979-90   
% 212.84/212.99  |- rdf__type mesh__D014331sskos__Concept
% 212.84/212.99  |- skos__scopeNote mesh__D014331
% 212.84/212.99       One of the MUSCARINIC ANTAGONISTS with pharmacologic action similar to ATROPINE and used mainly as an ophthalmic parasympatholytic or mydriatic.%A%    
% 212.84/212.99  |- skos__broader mesh__D014331smesh__D011725
% 212.84/212.99  |- mesh__recordMaintainer mesh__D014331 ssb
% 212.84/212.99  |- mesh__historyNote mesh__D014331
% 212.84/212.99       91%28%79%29%; was see under PYRIDINES 1979-90   
% 212.84/212.99  |- mesh__dateEstablished mesh__D014331 1991-01-01
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D014331 2004
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D014331 2002
% 212.84/212.99  |- skos__prefLabel mesh__D014331 Tropicamide
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D014331 2006
% 212.84/212.99  |- skos__hiddenLabel mesh__D000311 Glands, Adrenal
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D000311 2006
% 212.84/212.99  |- mesh__recordOriginator mesh__D000311 NLM
% 212.84/212.99  |- skos__related mesh__D000311smesh__D000315
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D000311 2005
% 212.84/212.99  |- skos__hiddenLabel mesh__D000311 Adrenal Gland
% 212.84/212.99  |- mesh__recordAuthorizer mesh__D000311 sjn
% 212.84/212.99  |- mesh__dateRevised mesh__D000311 2004-07-07
% 212.84/212.99  |- mesh__dateCreated mesh__D000311 1999-01-01
% 212.84/212.99  |- skos__prefLabel mesh__D000311 Adrenal Glands
% 212.84/212.99  |- skos__hiddenLabel mesh__D000311 Gland, Adrenal
% 212.84/212.99  |- skos__scopeNote mesh__D000311
% 212.84/212.99       A pair of glands located at the cranial pole of each of the two KIDNEYS. Each adrenal gland is composed of two distinct endocrine tissues with separate embryonic origins, the ADRENAL CORTEX producing STEROIDS and the ADRENAL MEDULLA producing NEUROTRANSMITTERS.%A%    
% 212.84/212.99  |- rdf__type mesh__D000311sskos__Concept
% 212.84/212.99  |- skos__annotation mesh__D000311
% 212.84/212.99       /surg = probably ADRENALECTOMY; hypothalamo-pituitary-adrenal axis: coord HYPOTHALAMO-HYPOPHYSEAL SYSTEM + PITUITARY-ADRENAL SYSTEM; hyperplasia = ADRENAL GLANDS /pathol %28%IM%29% + HYPERPLASIA %28%NIM%29%; congenital adrenal hyperplasia %28%CAH%29% = ADRENAL HYPERPLASIA, CONGENITAL%A%  
% 212.84/212.99  |- skos__broader mesh__D000311smesh__D004702
% 212.84/212.99  |- mesh__recordMaintainer mesh__D000311 lkt
% 212.84/212.99  |- skos__broader mesh__D013239smesh__D001519
% 212.84/212.99  |- mesh__recordMaintainer mesh__D013239 JLS
% 212.84/212.99  |- skos__hiddenLabel mesh__D013239 Behavior, Stereotyped
% 212.84/212.99  |- skos__hiddenLabel mesh__D013239 Stereotyped Behaviors
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D013239 2004
% 212.84/212.99  |- mesh__historyNote mesh__D013239
% 212.84/212.99       81%28%73%29%; was see under BEHAVIOR 1975-80   
% 212.84/212.99  |- skos__historyNote mesh__D013239 Behavior %28%1966-1972%29%
% 212.84/212.99  |- mesh__publicMeSHNote mesh__D013239 81; was see under BEHAVIOR 1975-80   
% 212.84/212.99  |- skos__annotation mesh__D013239 human %26% animal   
% 212.84/212.99  |- mesh__recordOriginator mesh__D013239 NLM
% 212.84/212.99  |- skos__prefLabel mesh__D013239 Stereotyped Behavior
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D013239 2003
% 212.84/212.99  |- skos__hiddenLabel mesh__D013239 Behaviors, Stereotyped
% 212.84/212.99  |- skos__scopeNote mesh__D013239
% 212.84/212.99       Relatively invariant mode of behavior elicited or determined by a particular situation; may be verbal, postural, or expressive.%A%    
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D013239 2006
% 212.84/212.99  |- mesh__dateEstablished mesh__D013239 1981-01-01
% 212.84/212.99  |- mesh__dateCreated mesh__D013239 1999-01-01
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D013239 2005
% 212.84/212.99  |- mesh__dateRevised mesh__D013239 2002-07-02
% 212.84/212.99  |- rdf__type mesh__D013239sskos__Concept
% 212.84/212.99  |- mesh__recordAuthorizer mesh__D013239 sjn
% 212.84/212.99  |- skos__historyNote mesh__D013239 Behavior, Animal %28%1966-1972%29%
% 212.84/212.99  |- skos__related mesh__D013239smesh__D019956
% 212.84/212.99  |- rdf__type mesh__D018722sskos__Concept
% 212.84/212.99  |- skos__hiddenLabel mesh__D018722 Nicotinic Cholinergic Agonist
% 212.84/212.99  |- skos__hiddenLabel mesh__D018722 Agonist, Nicotinic Cholinergic
% 212.84/212.99  |- mesh__publicMeSHNote mesh__D018722 95   
% 212.84/212.99  |- skos__altLabel mesh__D018722 Nicotinic Agonist
% 212.84/212.99  |- skos__hiddenLabel mesh__D018722 Agonists, Nicotinic Cholinergic
% 212.84/212.99  |- mesh__recordOriginator mesh__D018722 RAZ
% 212.84/212.99  |- mesh__recordAuthorizer mesh__D018722 sjn
% 212.84/212.99  |- skos__broader mesh__D018722smesh__D018679
% 212.84/212.99  |- mesh__dateEstablished mesh__D018722 1995-01-01
% 212.84/212.99  |- skos__hiddenLabel mesh__D018722 Agonist, Nicotinic
% 212.84/212.99  |- skos__altLabel mesh__D018722 Cholinergic Agonists, Nicotinic
% 212.84/212.99  |- skos__prefLabel mesh__D018722 Nicotinic Agonists
% 212.84/212.99  |- mesh__recordMaintainer mesh__D018722 ssb
% 212.84/212.99  |- skos__annotation mesh__D018722
% 212.84/212.99       GEN or unspecified; prefer specifics; DF: NICOTINIC AGON or NICOTINIC AG%A%  
% 212.84/212.99  |- skos__hiddenLabel mesh__D018722 Nicotinic Cholinergic Agonists
% 212.84/212.99  |- mesh__historyNote mesh__D018722 95   
% 212.84/212.99  |- mesh__dateCreated mesh__D018722 1994-06-01
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D018722 2006
% 212.84/212.99  |- skos__scopeNote mesh__D018722
% 212.84/212.99       Drugs that bind to and activate nicotinic cholinergic receptors %28%RECEPTORS, NICOTINIC%29%. Nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the central nervous system. Agents that function as neuromuscular depolarizing blocking agents are included here because they activate nicotinic receptors, although they are used clinically to block nicotinic transmission.%A%    
% 212.84/212.99  |- mesh__dateRevised mesh__D018722 2005-06-30
% 212.84/212.99  |- skos__altLabel mesh__D018722 Cholinergic Agonist, Nicotinic
% 212.84/212.99  |- skos__hiddenLabel mesh__D018722 Agonists, Nicotinic
% 212.84/212.99  |- skos__hiddenLabel mesh__D004702 Endocrine Gland
% 212.84/212.99  |- mesh__recordMaintainer mesh__D004702 sjn
% 212.84/212.99  |- mesh__recordAuthorizer mesh__D004702 sjn
% 212.84/212.99  |- skos__broader mesh__D004702smesh__D004703
% 212.84/212.99  |- skos__annotation mesh__D004702
% 212.84/212.99       general; prefer specifics, /surg: consider also ENDOCRINE SURGICAL PROCEDURES; endocrine deficiency: probably specific ENDOCRINE SYSTEM DISEASE in Category C19: Manual 23.25.3; %22%endocrine cells%22% in Russian literature is probably ENTEROENDOCRINE CELLS%A%  
% 212.84/212.99  |- skos__related mesh__D004702smesh__D006728
% 212.84/212.99  |- mesh__dateRevised mesh__D004702 2005-07-01
% 212.84/212.99  |- skos__scopeNote mesh__D004702
% 212.84/212.99       Ductless glands that secrete HORMONES directly into the BLOOD CIRCULATION. These hormones influence the METABOLISM and other functions of cells in the body.%A%    
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D004702 2006
% 212.84/212.99  |- mesh__recordOriginator mesh__D004702 NLM
% 212.84/212.99  |- mesh__dateCreated mesh__D004702 1999-01-01
% 212.84/212.99  |- skos__prefLabel mesh__D004702 Endocrine Glands
% 212.84/212.99  |- rdf__type mesh__D004702sskos__Concept
% 212.84/212.99  |- skos__hiddenLabel mesh__D004702 Gland, Endocrine
% 212.84/212.99  |- skos__altLabel mesh__D051358 Cdk4 Protein
% 212.84/212.99  |- skos__altLabel mesh__D051358 p34PSK-J3 Kinase
% 212.84/212.99  |- skos__hiddenLabel mesh__D051358 Protein Kinase, Cdk4
% 212.84/212.99  |- mesh__publicMeSHNote mesh__D051358
% 212.84/212.99       2006; CYCLIN-DEPENDENT KINASE 4 was indexed under CYCLIN-DEPENDENT KINASES %26% PROTO-ONCOGENE PROTEINS 2005, CELL CYCLE PROTEINS 1992-2004, PROTEIN SERINE THREONINE KINASES 1995, %26% under PROTEIN KINASES 1992-1994%A%  
% 212.84/212.99  |- mesh__dateCreated mesh__D051358 2005-06-30
% 212.84/212.99  |- skos__altLabel mesh__D051358 PSK-J3 Kinase
% 212.84/212.99  |- skos__altLabel mesh__D051358 Cdk4 Protein Kinase
% 212.84/212.99  |- skos__hiddenLabel mesh__D051358 Cyclin Dependent Kinase 4
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D051358 2006
% 212.84/212.99  |- mesh__recordMaintainer mesh__D051358 DRC
% 212.84/212.99  |- skos__hiddenLabel mesh__D051358 Cdk4 Cyclin Dependent Kinase
% 212.84/212.99  |- skos__altLabel mesh__D051358 Cell Division Protein Kinase 4
% 212.84/212.99  |- mesh__dateEstablished mesh__D051358 2006-01-01
% 212.84/212.99  |- skos__broader mesh__D051358smesh__D018844
% 212.84/212.99  |- skos__prefLabel mesh__D051358 Cyclin-Dependent Kinase 4
% 212.84/212.99  |- skos__hiddenLabel mesh__D051358 p34PSK J3 Kinase
% 212.84/212.99  |- mesh__recordOriginator mesh__D051358 DRC
% 212.84/212.99  |- skos__hiddenLabel mesh__D051358 Cyclin-Dependent Kinase, Cdk4
% 212.84/212.99  |- mesh__recordAuthorizer mesh__D051358 sjn
% 212.84/212.99  |- mesh__historyNote mesh__D051358 2006%28%1992%29%   
% 212.84/212.99  |- rdf__type mesh__D051358sskos__Concept
% 212.84/212.99  |- skos__scopeNote mesh__D051358
% 212.84/212.99       Cyclin-dependent kinase 4 is a key regulator of G1 PHASE of the CELL CYCLE. It partners with CYCLIN D to phosphorylate RETINOBLASTOMA PROTEIN. CDK4 activity is inhibited by CYCLIN-DEPENDENT KINASE INHIBITOR P16.%A%    
% 212.84/212.99  |- skos__altLabel mesh__D051358 Cdk4 Cyclin-Dependent Kinase
% 212.84/212.99  |- skos__hiddenLabel mesh__D051358 Cyclin D Dependent Kinase CDK4
% 212.84/212.99  |- skos__altLabel mesh__D051358 Cyclin D-Dependent Kinase CDK4
% 212.84/212.99  |- skos__hiddenLabel mesh__D051358 PSK J3 Kinase
% 212.84/212.99  |- skos__annotation mesh__D009996
% 212.84/212.99       do not coord with ERYTHROCYTES since this is defined in terms of erythrocytes; NIM%A%  
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009996 2006
% 212.84/212.99  |- mesh__dateRevised mesh__D009996 2003-07-09
% 212.84/212.99  |- mesh__dateCreated mesh__D009996 1999-01-01
% 212.84/212.99  |- skos__hiddenLabel mesh__D009996 Fragility, Saline
% 212.84/212.99  |- rdf__type mesh__D009996sskos__Concept
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009996 2004
% 212.84/212.99  |- mesh__historyNote mesh__D009996 70%28%65%29%   
% 212.84/212.99  |- mesh__recordMaintainer mesh__D009996 nns
% 212.84/212.99  |- skos__broader mesh__D009996smesh__D045122
% 212.84/212.99  |- skos__hiddenLabel mesh__D009996 Fragility, Osmotic
% 212.84/212.99  |- mesh__publicMeSHNote mesh__D009996 70   
% 212.84/212.99  |- skos__broader mesh__D009996smesh__D006403
% 212.84/212.99  |- mesh__recordOriginator mesh__D009996 NLM
% 212.84/212.99  |- mesh__dateEstablished mesh__D009996 1970-01-01
% 212.84/212.99  |- mesh__recordAuthorizer mesh__D009996 sjn
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009996 2005
% 212.84/212.99  |- skos__scopeNote mesh__D009996
% 212.84/212.99       RED BLOOD CELL sensitivity to change in OSMOTIC PRESSURE. When exposed to a hypotonic concentration of sodium in a solution, red cells take in more water, swell until the capacity of the cell membrane is exceeded, and burst.%A%    
% 212.84/212.99  |- skos__prefLabel mesh__D009996 Osmotic Fragility
% 212.84/212.99  |- skos__hiddenLabel mesh__D009198 Maggot Infestation
% 212.84/212.99  |- mesh__recordAuthorizer mesh__D009198 sjn
% 212.84/212.99  |- mesh__recordOriginator mesh__D009198 NLM
% 212.84/212.99  |- skos__hiddenLabel mesh__D009198 Myiases
% 212.84/212.99  |- skos__altLabel mesh__D009198 Maggot Infestations
% 212.84/212.99  |- skos__scopeNote mesh__D009198
% 212.84/212.99       The invasion of living tissues of man and other mammals by dipterous larvae.%A%    
% 212.84/212.99  |- rdf__type mesh__D009198sskos__Concept
% 212.84/212.99  |- mesh__dateCreated mesh__D009198 1999-01-01
% 212.84/212.99  |- skos__prefLabel mesh__D009198 Myiasis
% 212.84/212.99  |- mesh__dateRevised mesh__D009198 2005-06-30
% 212.84/212.99  |- skos__broader mesh__D009198smesh__D004478
% 212.84/212.99  |- skos__annotation mesh__D009198 infestation by fly maggots   
% 212.84/212.99  |- skos__hiddenLabel mesh__D009198 Infestation, Maggot
% 212.84/212.99  |- skos__hiddenLabel mesh__D009198 Infestations, Maggot
% 212.84/212.99  |- mesh__recordMaintainer mesh__D009198 ags
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D009198 2006
% 212.84/212.99  |- skos__historyNote mesh__D014332 Collagen %28%1966-1971%29%
% 212.84/212.99  |- skos__broader mesh__D014332smesh__D003094
% 212.84/212.99  |- mesh__historyNote mesh__D014332 72   
% 212.84/212.99  |- skos__scopeNote mesh__D014332
% 212.84/212.99       The molecular unit of collagen fibrils that consist of repeating three-stranded polypeptide units arranged head to tail in parallel bundles. It is a right-handed triple helix composed of 2 polypeptide chains. It is rich in glycine, proline, hydroxyproline, and hydroxylysine.%A%    
% 212.84/212.99  |- skos__prefLabel mesh__D014332 Tropocollagen
% 212.84/212.99  |- mesh__dateRevised mesh__D014332 2004-07-07
% 212.84/212.99  |- mesh__recordOriginator mesh__D014332 NLM
% 212.84/212.99  |- mesh__recordAuthorizer mesh__D014332 sjn
% 212.84/212.99  |- rdf__type mesh__D014332sskos__Concept
% 212.84/212.99  |- mesh__dateEstablished mesh__D014332 1972-01-01
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D014332 2005
% 212.84/212.99  |- mesh__dateCreated mesh__D014332 1999-01-01
% 212.84/212.99  |- mesh__recordMaintainer mesh__D014332 jmp
% 212.84/212.99  |- mesh__publicMeSHNote mesh__D014332 72   
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D014332 2006
% 212.84/212.99  |- mesh__recordOriginator mesh__D000312 NLM
% 212.84/212.99  |- mesh__publicMeSHNote mesh__D000312
% 212.84/212.99       80; was ADRENOGENITAL SYNDROME 1963-79   
% 212.84/212.99  |- skos__related mesh__D000312smesh__D011629
% 212.84/212.99  |- skos__related mesh__D000312smesh__D013252
% 212.84/212.99  |- skos__broader mesh__D000312smesh__D000307
% 212.84/212.99  |- mesh__recordAuthorizer mesh__D000312 sjn
% 212.84/212.99  |- mesh__dateCreated mesh__D000312 1999-01-01
% 212.84/212.99  |- mesh__onlineNote mesh__D000312
% 212.84/212.99       use ADRENAL HYPERPLASIA, CONGENITAL to search ADRENOGENITAL SYNDROME 1966-79%A%  
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D000312 2006
% 212.84/212.99  |- skos__altLabel mesh__D000312 Congenital Adrenal Hyperplasia
% 212.84/212.99  |- skos__broader mesh__D000312smesh__D043202
% 212.84/212.99  |- mesh__historyNote mesh__D000312
% 212.84/212.99       80; was ADRENOGENITAL SYNDROME 1963-79   
% 212.84/212.99  |- skos__hiddenLabel mesh__D000312 Congenital Adrenal Hyperplasias
% 212.84/212.99  |- mesh__activeMeSHYear mesh__D000312 2005
% 212.84/212.99  |- mesh__dateRevised mesh__D000312 2004-07-07
% 212.84/212.99  |- rdf__type mesh__D000312sskos__Concept
% 212.84/212.99  |- skos__related mesh__D000312smesh__D013254
% 212.84/212.99  |- skos__altLabel mesh__D000312 Hyperplasia, Congenital Adrenal
% 212.84/212.99  |- skos__related mesh__D000312smesh__D013255
% 212.84/212.99  |- skos__broader mesh__D000312smesh__D030342
% 212.84/212.99  |- skos__hiddenLabel mesh__D000312 Adrenal Hyperplasias, Congenital
% 212.84/212.99  |- skos__related mesh__D000312smesh__D014770
% 212.84/212.99  |- mesh__recordMaintainer mesh__D000312 lkt
% 212.84/212.99  |- skos__related mesh__D000312smesh__D047808
% 212.84/212.99  |- skos__prefLabel mesh__D000312 Adrenal Hyperplasia, Congenital
% 212.84/212.99  |- skos__scopeNote mesh__D000312
% 212.84/212.99       A group of inherited disorders of the ADRENAL GLANDS, caused by enzyme defects in the synthesis of cortisol %28%HYDROCORTISONE%29% and/or ALDOSTERONE leading to accumulation of precursors for ANDROGENS. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. The most common defect is in STEROID 21-HYDROXYLASE. Other defects occur in STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; or 3-beta-hydroxysteroid dehydrogenase %28%3-HYDROXYSTEROID DEHYDROGENASES%29%.%A%    
% 212.84/212.99  |- skos__hiddenLabel mesh__D000312 Hyperplasias, Congenital Adrenal
% 212.84/212.99  |- skos__broader mesh__D020106Q000031smesh__D020106
% 212.84/212.99  |- mesh__preferredCombination mesh__D020106Q000031smesh__D000178
% 212.84/213.00  |- rdf__type mesh__D020106Q000031smesh__CompoundConcept
% 212.84/213.00  |- skos__hiddenLabel mesh__D018723 PMSBethanechol Chloride
% 212.84/213.00  |- skos__broader mesh__D018723smesh__D001626
% 212.84/213.00  |- skos__altLabel mesh__D018723 Roberts Brand of Bethanechol Chloride
% 212.84/213.00  |- skos__altLabel mesh__D018723 Organon Brand of Bethanechol Chloride
% 212.84/213.00  |- skos__hiddenLabel mesh__D018723 Chloride, Bethanechol
% 212.84/213.00  |- skos__hiddenLabel mesh__D018723 Hermes, Myo
% 212.84/213.00  |- mesh__publicMeSHNote mesh__D018723
% 212.84/213.00       95; BETHANECHOL was indexed under BETHANECHOL COMPOUNDS 1981-94%A%  
% 212.84/213.00  |- mesh__activeMeSHYear mesh__D018723 2006
% 212.84/213.00  |- mesh__recordOriginator mesh__D018723 RAZ
% 212.84/213.00  |- mesh__recordAuthorizer mesh__D018723 sjn
% 212.84/213.00  |- skos__hiddenLabel mesh__D018723 PMS Bethanechol Chloride
% 212.84/213.00  |- skos__altLabel mesh__D018723 Myotonine
% 212.84/213.00  |- mesh__dateEstablished mesh__D018723 1995-01-01
% 212.84/213.00  |- skos__altLabel mesh__D018723 Myotonachol
% 212.84/213.00  |- mesh__onlineNote mesh__D018723
% 212.84/213.00       use BETHANECHOL %28%NM%29% to search BETHANECHOL 1981-94; use BETHANECHOL COMPOUNDS to search BETHANECHOL 1966-67 %28%as Prov 1966-67%29%%A%  
% 212.84/213.00  |- mesh__recordMaintainer mesh__D018723 ssb
% 212.84/213.00  |- skos__prefLabel mesh__D018723 Bethanechol
% 212.85/213.00  |- skos__altLabel mesh__D018723 Hamilton Brand of Bethanechol Chloride
% 212.85/213.00  |- skos__altLabel mesh__D018723 Pharmascience Brand of Bethanechol Chloride
% 212.85/213.00  |- mesh__dateCreated mesh__D018723 1994-06-01
% 212.85/213.00  |- rdf__type mesh__D018723sskos__Concept
% 212.85/213.00  |- mesh__historyNote mesh__D018723
% 212.85/213.00       95; was BETHANECHOL %28%NM%29% 1981-94; was heading 1964-67 %28%Prov%29%%A%  
% 212.85/213.00  |- skos__altLabel mesh__D018723 Glenwood Brand of Bethanechol Chloride
% 212.85/213.00  |- mesh__dateRevised mesh__D018723 2005-06-30
% 212.85/213.00  |- skos__scopeNote mesh__D018723
% 212.85/213.00       A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, cardiac rate changes, and bronchial spasms.%A%    
% 212.85/213.00  |- skos__altLabel mesh__D018723 Bethanecol
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D010740 2006
% 212.85/213.00  |- mesh__publicMeSHNote mesh__D010740 80; was PHOSPHOLIPASE 1963-79   
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D010740 2004
% 212.85/213.00  |- mesh__dateCreated mesh__D010740 1999-01-01
% 212.85/213.00  |- mesh__recordMaintainer mesh__D010740 ssb
% 212.85/213.00  |- mesh__recordAuthorizer mesh__D010740 sjn
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D010740 2005
% 212.85/213.00  |- mesh__onlineNote mesh__D010740
% 212.85/213.00       use PHOSPHOLIPASES to search PHOSPHOLIPASE %26% LECITHINASE 1966-79%A%  
% 212.85/213.00  |- skos__altLabel mesh__D010740 Phospholipase
% 212.85/213.00  |- skos__altLabel mesh__D010740 Lecithinases
% 212.85/213.00  |- rdf__type mesh__D010740sskos__Concept
% 212.85/213.00  |- mesh__dateRevised mesh__D010740 2003-07-09
% 212.85/213.00  |- mesh__recordOriginator mesh__D010740 NLM
% 212.85/213.00  |- skos__prefLabel mesh__D010740 Phospholipases
% 212.85/213.00  |- mesh__historyNote mesh__D010740
% 212.85/213.00       80; was PHOSPHOLIPASE 1963-79; LECITHINASES was LECITHINASE see under PHOSPHOLIPASE 1963-79%A%  
% 212.85/213.00  |- skos__broader mesh__D010740smesh__D002265
% 212.85/213.00  |- skos__broader mesh__D010740smesh__D010727
% 212.85/213.00  |- skos__scopeNote mesh__D010740
% 212.85/213.00       A class of enzymes that catalyze the hydrolysis of phosphoglycerides or glycerophosphatidates. EC 3.1.-.%A%    
% 212.85/213.00  |- skos__altLabel mesh__D010740 Lecithinase
% 212.85/213.00  |- mesh__recordAuthorizer mesh__D004703 ags
% 212.85/213.00  |- skos__hiddenLabel mesh__D004703 System, Endocrine
% 212.85/213.00  |- skos__hiddenLabel mesh__D004703 Endocrine Systems
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D004703 2006
% 212.85/213.00  |- mesh__dateCreated mesh__D004703 1999-01-01
% 212.85/213.00  |- skos__annotation mesh__D004703
% 212.85/213.00       avoid: too general; prefer ENDOCRINE GLANDS; CHROMAFFIN SYSTEM; or NEUROSECRETORY SYSTEMS %26% their specifics%A%  
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D004703 2002
% 212.85/213.00  |- mesh__recordMaintainer mesh__D004703 ags
% 212.85/213.00  |- skos__hiddenLabel mesh__D004703 Systems, Endocrine
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D004703 2005
% 212.85/213.00  |- mesh__dateEstablished mesh__D004703 1998-01-01
% 212.85/213.00  |- rdf__type mesh__D004703sskos__Concept
% 212.85/213.00  |- mesh__runningHead mesh__D004703 A6 - ANATOMY-ENDOCRINE SYSTEM   
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D004703 2001
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D004703 1999
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D004703 2004
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D004703 2000
% 212.85/213.00  |- mesh__recordOriginator mesh__D004703 NLM
% 212.85/213.00  |- mesh__publicMeSHNote mesh__D004703 98   
% 212.85/213.00  |- mesh__historyNote mesh__D004703 98; use explode 1967-97   
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D004703 1998
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D004703 2003
% 212.85/213.00  |- skos__historyNote mesh__D004703 Endocrine Glands %28%1966-1997%29%
% 212.85/213.00  |- mesh__dateRevised mesh__D004703 2005-07-13
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D004703 2006A
% 212.85/213.00  |- skos__scopeNote mesh__D004703
% 212.85/213.00       The system of glands that release their secretions %28%hormones%29% directly into the circulatory system. In addition to the ENDOCRINE GLANDS, included are the CHROMAFFIN SYSTEM and the NEUROSECRETORY SYSTEMS.%A%    
% 212.85/213.00  |- skos__prefLabel mesh__D004703 Endocrine System
% 212.85/213.00  |- skos__hiddenLabel mesh__D051359 Familial Hemophagocytic Lymphocytoses
% 212.85/213.00  |- skos__hiddenLabel mesh__D051359 Hemophagocytic Lymphohistiocytoses
% 212.85/213.00  |- skos__scopeNote mesh__D051359
% 212.85/213.00       A group of related disorders characterized by LYMPHOCYTOSIS; HISTIOCYTOSIS; and hemophagocytosis. The two major forms are familial and reactive.%A%    
% 212.85/213.00  |- skos__altLabel mesh__D051359 Hemophagocytic Syndromes
% 212.85/213.00  |- skos__altLabel mesh__D051359 Hemophagocytic Syndrome, Reactive
% 212.85/213.00  |- mesh__recordMaintainer mesh__D051359 ags
% 212.85/213.00  |- skos__hiddenLabel mesh__D051359
% 212.85/213.00       Lymphohistiocytoses, Familial Hemophagocytic
% 212.85/213.00  |- mesh__publicMeSHNote mesh__D051359
% 212.85/213.00       2006; see HISTIOCYTOSIS, NON-LANGERHANS CELL 1990-2005   
% 212.85/213.00  |- skos__hiddenLabel mesh__D051359
% 212.85/213.00       Primary Hemophagocytic Lymphohistiocytoses
% 212.85/213.00  |- skos__hiddenLabel mesh__D051359
% 212.85/213.00       Lymphohistiocytosis, Familial Hemophagocytic
% 212.85/213.00  |- rdf__type mesh__D051359sskos__Concept
% 212.85/213.00  |- skos__hiddenLabel mesh__D051359 Lymphocytoses, Familial Hemophagocytic
% 212.85/213.00  |- skos__hiddenLabel mesh__D051359
% 212.85/213.00       Lymphohistiocytoses, Primary Hemophagocytic
% 212.85/213.00  |- skos__hiddenLabel mesh__D051359
% 212.85/213.00       Hemophagocytic Lymphohistiocytosis, Primary
% 212.85/213.00  |- mesh__recordOriginator mesh__D051359 ags
% 212.85/213.00  |- skos__hiddenLabel mesh__D051359
% 212.85/213.00       Hemophagocytic Lymphohistiocytoses, Primary
% 212.85/213.00  |- skos__altLabel mesh__D051359
% 212.85/213.00       Hemophagocytic Lymphohistiocytosis, Familial
% 212.85/213.00  |- skos__broader mesh__D051359smesh__D015616
% 212.85/213.00  |- skos__historyNote mesh__D051359
% 212.85/213.00       Histiocytosis, Non-Langerhans-Cell %28%1989-2005%29%
% 212.85/213.00  |- skos__hiddenLabel mesh__D051359
% 212.85/213.00       Lymphohistiocytosis, Primary Hemophagocytic
% 212.85/213.00  |- skos__altLabel mesh__D051359 Primary Hemophagocytic Lymphohistiocytosis
% 212.85/213.00  |- skos__hiddenLabel mesh__D051359 Lymphohistiocytoses, Hemophagocytic
% 212.85/213.00  |- skos__hiddenLabel mesh__D051359 Hemophagocytic Lymphocytoses, Familial
% 212.85/213.00  |- mesh__dateCreated mesh__D051359 2005-06-30
% 212.85/213.00  |- skos__hiddenLabel mesh__D051359
% 212.85/213.00       Hemophagocytic Syndrome, Infection Associated
% 212.85/213.00  |- skos__hiddenLabel mesh__D051359
% 212.85/213.00       Hemophagocytic Lymphohistiocytoses, Familial
% 212.85/213.00  |- skos__hiddenLabel mesh__D051359
% 212.85/213.00       Familial Hemophagocytic Lymphohistiocytoses
% 212.85/213.00  |- mesh__dateEstablished mesh__D051359 2006-01-01
% 212.85/213.00  |- skos__hiddenLabel mesh__D051359
% 212.85/213.00       Familial Hemophagocytic Lymphohistiocytosis
% 212.85/213.00  |- skos__hiddenLabel mesh__D051359 Lymphocytosis, Familial Hemophagocytic
% 212.85/213.00  |- skos__hiddenLabel mesh__D051359 Hemophagocytic Lymphocytosis, Familial
% 212.85/213.00  |- skos__altLabel mesh__D051359
% 212.85/213.00       Hemophagocytic Syndrome, Infection-Associated
% 212.85/213.00  |- skos__hiddenLabel mesh__D051359
% 212.85/213.00       Infection-Associated Hemophagocytic Syndrome
% 212.85/213.00  |- skos__hiddenLabel mesh__D051359 Hemophagocytic Lymphohistiocytosis
% 212.85/213.00  |- skos__hiddenLabel mesh__D051359 Hemophagocytic Syndrome
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D051359 2006
% 212.85/213.00  |- skos__prefLabel mesh__D051359 Lymphohistiocytosis, Hemophagocytic
% 212.85/213.00  |- mesh__recordAuthorizer mesh__D051359 sjn
% 212.85/213.00  |- mesh__historyNote mesh__D051359
% 212.85/213.00       2006; use HISTIOCYTOSIS, NON-LANGERHANS CELL 1990-2005   
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D009997 2003
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D009997 2001
% 212.85/213.00  |- mesh__dateRevised mesh__D009997 1997-06-20
% 212.85/213.00  |- skos__historyNote mesh__D009997 Osmosis %28%1966-1967%29%
% 212.85/213.00  |- skos__hiddenLabel mesh__D009997 Osmotic Pressures
% 212.85/213.00  |- rdf__type mesh__D009997sskos__Concept
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D009997 2004
% 212.85/213.00  |- mesh__dateEstablished mesh__D009997 1974-01-01
% 212.85/213.00  |- mesh__publicMeSHNote mesh__D009997 74   
% 212.85/213.00  |- mesh__recordOriginator mesh__D009997 NLM
% 212.85/213.00  |- skos__hiddenLabel mesh__D009997 Shock, Osmotic
% 212.85/213.00  |- skos__prefLabel mesh__D009997 Osmotic Pressure
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D009997 1998
% 212.85/213.00  |- skos__hiddenLabel mesh__D009997 Osmotic Shocks
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D009997 2002
% 212.85/213.00  |- skos__hiddenLabel mesh__D009997 Shocks, Osmotic
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D009997 2005
% 212.85/213.00  |- skos__broader mesh__D009997smesh__D010539
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D009997 1999
% 212.85/213.00  |- mesh__historyNote mesh__D009997 74%28%68%29%   
% 212.85/213.00  |- skos__hiddenLabel mesh__D009997 Pressure, Osmotic
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D009997 2006
% 212.85/213.00  |- skos__annotation mesh__D009997 NIM   
% 212.85/213.00  |- mesh__recordAuthorizer mesh__D009997 SJN
% 212.85/213.00  |- mesh__recordMaintainer mesh__D009997 TGC
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D009997 2000
% 212.85/213.00  |- skos__scopeNote mesh__D009997
% 212.85/213.00       The pressure required to stop osmosis through a semipermeable membrane between a solution and pure solvent. It is proportional to the osmolality of the solution. Osmotic shock is a sudden change in the osmotic pressure to which a cell is subjected, usually in order to cause it to lyse and lose its contents. %28%Dorland, 28th ed; Stedman, 26th ed%29%%A%    
% 212.85/213.00  |- skos__hiddenLabel mesh__D009997 Pressures, Osmotic
% 212.85/213.00  |- mesh__dateCreated mesh__D009997 1999-01-01
% 212.85/213.00  |- skos__broader mesh__D009997smesh__D011312
% 212.85/213.00  |- skos__hiddenLabel mesh__D042822 Instability, Genomic
% 212.85/213.00  |- skos__altLabel mesh__D042822 Genome Instability
% 212.85/213.00  |- mesh__dateCreated mesh__D042822 2003-07-09
% 212.85/213.00  |- rdf__type mesh__D042822sskos__Concept
% 212.85/213.00  |- skos__hiddenLabel mesh__D042822 Stabilities, Genome
% 212.85/213.00  |- skos__hiddenLabel mesh__D042822 Instabilities, Genomic
% 212.85/213.00  |- skos__hiddenLabel mesh__D042822 Genomic Instabilities
% 212.85/213.00  |- skos__hiddenLabel mesh__D042822 Instability, Genome
% 212.85/213.00  |- skos__prefLabel mesh__D042822 Genomic Instability
% 212.85/213.00  |- skos__broader mesh__D042822smesh__D040341
% 212.85/213.00  |- skos__hiddenLabel mesh__D042822 Stability, Genomic
% 212.85/213.00  |- mesh__dateEstablished mesh__D042822 2004-01-01
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D042822 2006
% 212.85/213.00  |- skos__hiddenLabel mesh__D042822 Stabilities, Genomic
% 212.85/213.00  |- skos__broader mesh__D042822smesh__D009154
% 212.85/213.00  |- skos__related mesh__D042822smesh__D043243
% 212.85/213.00  |- skos__hiddenLabel mesh__D042822 Instabilities, Genome
% 212.85/213.00  |- skos__broader mesh__D042822smesh__D010335
% 212.85/213.00  |- skos__scopeNote mesh__D042822
% 212.85/213.00       An increased tendency of the GENOME to acquire MUTATIONS when various processes involved in maintaining and replicating the genome are dysfunctional.%A%    
% 212.85/213.00  |- skos__hiddenLabel mesh__D042822 Stability, Genome
% 212.85/213.00  |- mesh__publicMeSHNote mesh__D042822 2004   
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D042822 2005
% 212.85/213.00  |- skos__hiddenLabel mesh__D042822 Genome Instabilities
% 212.85/213.00  |- skos__hiddenLabel mesh__D042822 Genomic Stabilities
% 212.85/213.00  |- skos__altLabel mesh__D042822 Genome Stability
% 212.85/213.00  |- mesh__historyNote mesh__D042822 2004   
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D042822 2004
% 212.85/213.00  |- skos__hiddenLabel mesh__D042822 Genome Stabilities
% 212.85/213.00  |- mesh__historyNote mesh__D020370 99   
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D020370 2002
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D020370 2003
% 212.85/213.00  |- skos__hiddenLabel mesh__D020370 Knee Osteoarthritides
% 212.85/213.00  |- skos__historyNote mesh__D020370 Osteoarthritis %28%1965-1998%29%
% 212.85/213.00  |- mesh__dateCreated mesh__D020370 1998-06-10
% 212.85/213.00  |- skos__prefLabel mesh__D020370 Osteoarthritis, Knee
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D020370 2004
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D020370 2005
% 212.85/213.00  |- mesh__dateEstablished mesh__D020370 1999-01-01
% 212.85/213.00  |- skos__scopeNote mesh__D020370
% 212.85/213.00       Noninflammatory degenerative disease of the knee joint consisting of three large categories: conditions that block normal synchronous movement, conditions that produce abnormal pathways of motion, and conditions that cause stress concentration resulting in changes to articular cartilage. %28%Crenshaw, Campbell%27%s Operative Orthopaedics, 8th ed, p2019%29%%A%    
% 212.85/213.00  |- rdf__type mesh__D020370sskos__Concept
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D020370 2006
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D020370 2000
% 212.85/213.00  |- skos__historyNote mesh__D020370 Knee Joint %28%1965-1998%29%
% 212.85/213.00  |- skos__hiddenLabel mesh__D020370 Knee Osteoarthritis
% 212.85/213.00  |- skos__hiddenLabel mesh__D020370 Osteoarthritides, Knee
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D020370 1999
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D020370 2001
% 212.85/213.00  |- mesh__publicMeSHNote mesh__D020370 99   
% 212.85/213.00  |- skos__broader mesh__D020370smesh__D010003
% 212.85/213.00  |- skos__historyNote mesh__D014333 Protein Precursors %28%1973-1976%29%
% 212.85/213.00  |- mesh__dateCreated mesh__D014333 1976-04-27
% 212.85/213.00  |- skos__historyNote mesh__D014333 Elastin %28%1966-1976%29%
% 212.85/213.00  |- mesh__dateRevised mesh__D014333 2004-07-07
% 212.85/213.00  |- mesh__publicMeSHNote mesh__D014333 91; was see under ELASTIN 1977-90   
% 212.85/213.00  |- rdf__type mesh__D014333sskos__Concept
% 212.85/213.00  |- skos__scopeNote mesh__D014333
% 212.85/213.00       A salt-soluble precursor of elastin. Lysyl oxidase is instrumental in converting it to elastin in connective tissue.%A%    
% 212.85/213.00  |- mesh__recordOriginator mesh__D014333 RLS
% 212.85/213.00  |- mesh__historyNote mesh__D014333
% 212.85/213.00       91%28%77%29%; was see under ELASTIN 1977-90   
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D014333 2005
% 212.85/213.00  |- mesh__recordMaintainer mesh__D014333 jmp
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D014333 2006
% 212.85/213.00  |- skos__broader mesh__D014333smesh__D011498
% 212.85/213.00  |- mesh__recordAuthorizer mesh__D014333 sjn
% 212.85/213.00  |- skos__prefLabel mesh__D014333 Tropoelastin
% 212.85/213.00  |- skos__annotation mesh__D014333
% 212.85/213.00       a protein precursor; /biosyn /physiol permitted   
% 212.85/213.00  |- skos__broader mesh__D014333smesh__D004549
% 212.85/213.00  |- mesh__dateEstablished mesh__D014333 1991-01-01
% 212.85/213.00  |- mesh__recordMaintainer mesh__D000313 lkt
% 212.85/213.00  |- mesh__dateCreated mesh__D000313 1999-01-01
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D000313 2006
% 212.85/213.00  |- skos__hiddenLabel mesh__D000313 Medulla, Adrenal
% 212.85/213.00  |- mesh__recordOriginator mesh__D000313 NLM
% 212.85/213.00  |- skos__broader mesh__D000313smesh__D000311
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D000313 2005
% 212.85/213.00  |- mesh__dateRevised mesh__D000313 2004-07-07
% 212.85/213.00  |- rdf__type mesh__D000313sskos__Concept
% 212.85/213.00  |- skos__hiddenLabel mesh__D000313 Adrenal Medullas
% 212.85/213.00  |- mesh__recordAuthorizer mesh__D000313 sjn
% 212.85/213.00  |- skos__annotation mesh__D000313
% 212.85/213.00       dis = ADRENAL MEDULLA %28%IM%29% + ADRENAL GLAND DISEASES %28%IM%29%; medulla enucleation: for physiol studies, ADRENAL MEDULLA /physiol, for surg ther, ADRENAL MEDULLA /surg%A%  
% 212.85/213.00  |- skos__prefLabel mesh__D000313 Adrenal Medulla
% 212.85/213.00  |- skos__scopeNote mesh__D000313
% 212.85/213.00       The inner portion of the adrenal gland. Derived from ECTODERM, adrenal medulla consists mainly of CHROMAFFIN CELLS that produces and stores a number of NEUROTRANSMITTERS, mainly adrenaline %28%EPINEPHRINE%29% and NOREPINEPHRINE. The activity of the adrenal medulla is regulated by the SYMPATHETIC NERVOUS SYSTEM.%A%    
% 212.85/213.00  |- skos__hiddenLabel mesh__D000313 Medullas, Adrenal
% 212.85/213.00  |- mesh__historyNote mesh__D038781 2003   
% 212.85/213.00  |- mesh__recordAuthorizer mesh__D038781 sjn
% 212.85/213.00  |- skos__historyNote mesh__D038781
% 212.85/213.00       Diagnostic Techniques, Otological %28%1978-2002%29%
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D038781 2005
% 212.85/213.00  |- skos__scopeNote mesh__D038781
% 212.85/213.00       Examination of the EAR CANAL and eardrum with an OTOSCOPE.%A%    
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D038781 2003
% 212.85/213.00  |- mesh__recordOriginator mesh__D038781 ags
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D038781 2006
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D038781 2003A
% 212.85/213.00  |- mesh__dateCreated mesh__D038781 2002-07-03
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D038781 2004
% 212.85/213.00  |- mesh__recordMaintainer mesh__D038781 sjn
% 212.85/213.00  |- mesh__publicMeSHNote mesh__D038781 2003   
% 212.85/213.00  |- mesh__dateRevised mesh__D038781 2002-09-24
% 212.85/213.00  |- skos__historyNote mesh__D038781 Endoscopy %28%1973-2002%29%
% 212.85/213.00  |- skos__broader mesh__D038781smesh__D003939
% 212.85/213.00  |- rdf__type mesh__D038781sskos__Concept
% 212.85/213.00  |- skos__related mesh__D038781smesh__D019720
% 212.85/213.00  |- skos__prefLabel mesh__D038781 Otoscopy
% 212.85/213.00  |- mesh__dateEstablished mesh__D038781 2003-01-01
% 212.85/213.00  |- skos__broader mesh__D024761smesh__D020816
% 212.85/213.00  |- skos__historyNote mesh__D024761 DNA-Binding Proteins %28%1994-2001%29%
% 212.85/213.00  |- skos__hiddenLabel mesh__D024761 Motifs, AT Hook
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D024761 2005
% 212.85/213.00  |- mesh__dateRevised mesh__D024761 2005-07-18
% 212.85/213.00  |- mesh__dateEstablished mesh__D024761 2002-01-01
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D024761 2006A
% 212.85/213.00  |- mesh__recordAuthorizer mesh__D024761 ags
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D024761 2006
% 212.85/213.00  |- skos__hiddenLabel mesh__D024761 AT-Hook Motif
% 212.85/213.00  |- skos__prefLabel mesh__D024761 AT-Hook Motifs
% 212.85/213.00  |- mesh__recordMaintainer mesh__D024761 ags
% 212.85/213.00  |- mesh__dateCreated mesh__D024761 2001-07-25
% 212.85/213.00  |- rdf__type mesh__D024761sskos__Concept
% 212.85/213.00  |- mesh__publicMeSHNote mesh__D024761 2002   
% 212.85/213.00  |- skos__hiddenLabel mesh__D024761 Motif, AT-Hook
% 212.85/213.00  |- skos__hiddenLabel mesh__D024761 Hook, AT
% 212.85/213.00  |- skos__hiddenLabel mesh__D024761 Motifs, AT-Hook
% 212.85/213.00  |- skos__hiddenLabel mesh__D024761 Motif, AT Hook
% 212.85/213.00  |- skos__hiddenLabel mesh__D024761 AT Hook Motifs
% 212.85/213.00  |- skos__altLabel mesh__D024761 AT Hooks
% 212.85/213.00  |- skos__hiddenLabel mesh__D024761 AT Hook
% 212.85/213.00  |- skos__altLabel mesh__D024761 AT Hook Motif
% 212.85/213.00  |- skos__hiddenLabel mesh__D024761 Hooks, AT
% 212.85/213.00  |- skos__scopeNote mesh__D024761
% 212.85/213.00       DNA-binding motifs, first described in one of the HMGA PROTEINS: HMG-I%28%Y%29% PROTEIN. They consist of positively charged sequences of nine amino acids centered on the invariant tripeptide glycine-arginine-proline. They act to fasten the protein to an AT RICH SEQUENCE in the DNA.%A%    
% 212.85/213.00  |- mesh__historyNote mesh__D024761 2002   
% 212.85/213.00  |- mesh__recordOriginator mesh__D024761 nns
% 212.85/213.00  |- mesh__dateEstablished mesh__D018724 1995-01-01
% 212.85/213.00  |- skos__prefLabel mesh__D018724 Spinacia oleracea
% 212.85/213.00  |- mesh__dateCreated mesh__D018724 1994-02-28
% 212.85/213.00  |- skos__historyNote mesh__D018724 Plants %28%1966-1994%29%
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D018724 2005
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D018724 2006
% 212.85/213.00  |- mesh__historyNote mesh__D018724 2005%28%1995%29%   
% 212.85/213.00  |- mesh__dateRevised mesh__D018724 2004-07-07
% 212.85/213.00  |- mesh__recordMaintainer mesh__D018724 ssb
% 212.85/213.00  |- mesh__publicMeSHNote mesh__D018724 2005; see SPINACH 1995-2004   
% 212.85/213.00  |- skos__historyNote mesh__D018724 Vegetables %28%1966-1994%29%
% 212.85/213.00  |- skos__historyNote mesh__D018724 Plants, Edible %28%1966-1994%29%
% 212.85/213.00  |- skos__annotation mesh__D018724 as plant %26% food;   
% 212.85/213.00  |- rdf__type mesh__D018724sskos__Concept
% 212.85/213.00  |- mesh__recordAuthorizer mesh__D018724 sjn
% 212.85/213.00  |- mesh__recordOriginator mesh__D018724 JLS
% 212.85/213.00  |- skos__broader mesh__D018724smesh__D019663
% 212.85/213.00  |- skos__broader mesh__D018724smesh__D014675
% 212.85/213.00  |- skos__scopeNote mesh__D018724
% 212.85/213.00       A widely cultivated plant, native to Asia, having succulent, edible leaves eaten as a vegetable. %28%From American Heritage Dictionary, 1982%29%%A%    
% 212.85/213.00  |- skos__altLabel mesh__D010741 Lecithinase A1
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D010741 2006
% 212.85/213.00  |- skos__hiddenLabel mesh__D010741 A2, Phospholipase
% 212.85/213.00  |- mesh__historyNote mesh__D010741
% 212.85/213.00       91%28%80%29%; was see under PHOSPHOLIPASES 1980-90   
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D010741 2004
% 212.85/213.00  |- skos__hiddenLabel mesh__D010741 A2, Lecithinase
% 212.85/213.00  |- skos__hiddenLabel mesh__D010741 A1, Phospholipase
% 212.85/213.00  |- skos__hiddenLabel mesh__D010741 A, Phospholipases
% 212.85/213.00  |- skos__historyNote mesh__D010741 Phospholipases %28%1966-1979%29%
% 212.85/213.00  |- skos__hiddenLabel mesh__D010741 1-Acylhydrolase, Phosphatidate
% 212.85/213.00  |- mesh__publicMeSHNote mesh__D010741
% 212.85/213.00       91; was see under PHOSPHOLIPASES 1980-90   
% 212.85/213.00  |- mesh__recordMaintainer mesh__D010741 jmp
% 212.85/213.00  |- skos__broader mesh__D010741smesh__D010740
% 212.85/213.00  |- skos__altLabel mesh__D010741 Lecithinase A2
% 212.85/213.00  |- rdf__type mesh__D010741sskos__Concept
% 212.85/213.00  |- mesh__dateRevised mesh__D010741 2003-07-09
% 212.85/213.00  |- skos__scopeNote mesh__D010741
% 212.85/213.00       Phospholipases that hydrolyze one of the acyl groups of phosphoglycerides or glycerophosphatidates. Phospholipase A1%28%EC 3.1.1.32%29% hydrolyzes the acyl group attached to the 1-position  and phospholipase A2 %28%EC 3.1.1.4%29% hydrolyzes the acyl group attached to the 2-position.%A%    
% 212.85/213.00  |- skos__hiddenLabel mesh__D010741 A1, Lecithinase
% 212.85/213.00  |- skos__altLabel mesh__D010741 Phosphatidate 1-Acylhydrolase
% 212.85/213.00  |- mesh__recordAuthorizer mesh__D010741 sjn
% 212.85/213.00  |- skos__prefLabel mesh__D010741 Phospholipases A
% 212.85/213.00  |- skos__hiddenLabel mesh__D010741 Phosphatidate 1 Acylhydrolase
% 212.85/213.00  |- mesh__recordOriginator mesh__D010741 RLS
% 212.85/213.00  |- mesh__dateEstablished mesh__D010741 1991-01-01
% 212.85/213.00  |- mesh__dateCreated mesh__D010741 1979-02-22
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D010741 2005
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D004704 2005
% 212.85/213.00  |- mesh__recordOriginator mesh__D004704 NLM
% 212.85/213.00  |- rdf__type mesh__D004704sskos__Concept
% 212.85/213.00  |- skos__prefLabel mesh__D004704 Endocrinology
% 212.85/213.00  |- skos__annotation mesh__D004704 SPEC: SPEC qualif; DF: ENDOCRINOL   
% 212.85/213.00  |- skos__altLabel mesh__D004704
% 212.85/213.00       Metabolism and Endocrinology %28%Specialty%29%
% 212.85/213.00  |- skos__broader mesh__D004704smesh__D010827
% 212.85/213.00  |- mesh__dateRevised mesh__D004704 2004-07-20
% 212.85/213.00  |- skos__broader mesh__D004704smesh__D007388
% 212.85/213.00  |- mesh__recordMaintainer mesh__D004704 NLM
% 212.85/213.00  |- skos__related mesh__D004704smesh__D004700
% 212.85/213.00  |- mesh__recordAuthorizer mesh__D004704 NLM
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D004704 2006
% 212.85/213.00  |- skos__scopeNote mesh__D004704
% 212.85/213.00       A subspecialty of internal medicine concerned with the metabolism, physiology, and disorders of the endocrine system.%A%    
% 212.85/213.00  |- mesh__dateCreated mesh__D004704 1999-01-01
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D009998 2004
% 212.85/213.00  |- skos__hiddenLabel mesh__D009998 Implants, Middle Ear
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D009998 2003A
% 212.85/213.00  |- skos__related mesh__D009998smesh__D019933
% 212.85/213.00  |- skos__altLabel mesh__D009998 Replacement Prostheses, Ossicular
% 212.85/213.00  |- rdf__type mesh__D009998sskos__Concept
% 212.85/213.00  |- skos__prefLabel mesh__D009998 Ossicular Prosthesis
% 212.85/213.00  |- skos__hiddenLabel mesh__D009998 Ossicular Prostheses
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D009998 2002
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D009998 2003
% 212.85/213.00  |- skos__altLabel mesh__D009998 Replacement Prosthesis, Ossicular
% 212.85/213.00  |- skos__historyNote mesh__D009998 Prosthesis %28%1966-1986%29%
% 212.85/213.00  |- skos__hiddenLabel mesh__D009998 Prosthesis, Ossicular
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D009998 2006
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D009998 1999
% 212.85/213.00  |- skos__altLabel mesh__D009998 Replacement Implant, Ossicular
% 212.85/213.00  |- skos__altLabel mesh__D009998 Ossicular Replacement Prosthesis
% 212.85/213.00  |- mesh__recordAuthorizer mesh__D009998 sjn
% 212.85/213.00  |- skos__historyNote mesh__D009998 Ear Ossicles %28%1966-1986%29%
% 212.85/213.00  |- skos__altLabel mesh__D009998 Ossicular Replacement Implant
% 212.85/213.00  |- skos__scopeNote mesh__D009998
% 212.85/213.00       An implant used to replace one or more of the ear ossicles. They are usually made of plastic, Gelfoam, ceramic, or stainless steel.%A%    
% 212.85/213.00  |- mesh__recordOriginator mesh__D009998 RC
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D009998 2001
% 212.85/213.00  |- skos__altLabel mesh__D009998 Prosthesis, Ossicular Replacement
% 212.85/213.00  |- mesh__dateEstablished mesh__D009998 1987-01-01
% 212.85/213.00  |- skos__hiddenLabel mesh__D009998 Replacement Implants, Ossicular
% 212.85/213.00  |- mesh__historyNote mesh__D009998 98%28%87%29%   
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D009998 2005
% 212.85/213.00  |- skos__hiddenLabel mesh__D009998 Ossicular Replacement Implants
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D009998 1998
% 212.85/213.00  |- skos__altLabel mesh__D009998 Ossicular Replacement Prostheses
% 212.85/213.00  |- mesh__publicMeSHNote mesh__D009998
% 212.85/213.00       98; see OSSICULAR REPLACEMENT PROSTHESIS 1987-97   
% 212.85/213.00  |- skos__altLabel mesh__D009998 Prostheses, Ossicular Replacement
% 212.85/213.00  |- skos__broader mesh__D009998smesh__D019736
% 212.85/213.00  |- skos__hiddenLabel mesh__D009998 Ossicular Replacement Prosthese
% 212.85/213.00  |- skos__hiddenLabel mesh__D009998 Prostheses, Ossicular
% 212.85/213.00  |- mesh__activeMeSHYear mesh__D009998 2000
% 212.85/213.00  |- skos__annotation mesh__D009998
% 212.85/213.00       note short X refs TORP %26% PORP standing for Total Ossic Replace Prosth %28% = drum-to-foot plate%29% %26% Partial Ossic Replace Prosth %28% = drum-to-stapes%29%%A%  
% 212.85/213.00  |- mesh__dateCreated mesh__D009998 1986-03-27
% 212.85/213.00  |- skos__hiddenLabel mesh__D009998 Ear Implant, Middle
% 212.85/213.00  |- skos__altLabel mesh__D009998 Middle Ear Implant
% 212.85/213.01  |- skos__historyNote mesh__D009998 Tympanoplasty %28%1966-1986%29%
% 212.85/213.01  |- mesh__recordMaintainer mesh__D009998 sjn
% 212.85/213.01  |- mesh__dateRevised mesh__D009998 2002-10-23
% 212.85/213.01  |- skos__altLabel mesh__D009998 Implant, Ossicular Replacement
% 212.85/213.01  |- skos__hiddenLabel mesh__D009998 Implants, Ossicular Replacement
% 212.85/213.01  |- skos__hiddenLabel mesh__D009998 Middle Ear Implants
% 212.85/213.01  |- skos__hiddenLabel mesh__D009998 Ear Implants, Middle
% 212.85/213.01  |- skos__historyNote mesh__D020371
% 212.85/213.01       Diffuse Cerebral Sclerosis of Schilder %28%1966-1999%29%
% 212.85/213.01  |- skos__hiddenLabel mesh__D020371 Pelizaeus Merzbacher Disease
% 212.85/213.01  |- skos__scopeNote mesh__D020371
% 212.85/213.01       A rare, slowly progressive disorder of myelin formation. Subtypes are referred to as classic, congenital, transitional, and adult forms of this disease. The classic form is X-chromosome linked, has its onset in infancy and is associated with a mutation of the proteolipid protein gene. Clinical manifestations include TREMOR, spasmus nutans, roving eye movements, ATAXIA, spasticity, and NYSTAGMUS, CONGENITAL. Death occurs by the third decade of life. The congenital form has similar characteristics but presents early in infancy and features rapid disease progression. Transitional and adult subtypes have a later onset and less severe symptomatology. Pathologic features include patchy areas of demyelination with preservation of perivascular islands %28%trigoid appearance%29%. %28%From Menkes, Textbook of Child Neurology, 5th ed, p190%29%%A%    
% 212.85/213.01  |- mesh__dateRevised mesh__D020371 2005-07-21
% 212.85/213.01  |- skos__hiddenLabel mesh__D020371 Diseases, Atypical Pelizaeus-Merzbacher
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D020371 2003
% 212.85/213.01  |- skos__hiddenLabel mesh__D020371 Cockayne Pelizaeus Merzbacher Disease
% 212.85/213.01  |- skos__broader mesh__D020371smesh__D040181
% 212.85/213.01  |- skos__hiddenLabel mesh__D020371
% 212.85/213.01       Transitional Pelizaeus Merzbacher Disease
% 212.85/213.01  |- skos__hiddenLabel mesh__D020371 Pelizaeus-Merzbacher Diseases, Adult
% 212.85/213.01  |- skos__hiddenLabel mesh__D020371 Pelizaeus-Merzbacher Diseases, Atypical
% 212.85/213.01  |- skos__hiddenLabel mesh__D020371 Pelizaeus Merzbacher Disease, Atypical
% 212.85/213.01  |- skos__altLabel mesh__D020371 Transitional Pelizaeus-Merzbacher Disease
% 212.85/213.01  |- skos__prefLabel mesh__D020371 Pelizaeus-Merzbacher Disease
% 212.85/213.01  |- mesh__recordAuthorizer mesh__D020371 ags
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D020371 2004
% 212.85/213.01  |- skos__altLabel mesh__D020371 Pelizaeus-Merzbacher Disease, Adult
% 212.85/213.01  |- mesh__dateEstablished mesh__D020371 2000-01-01
% 212.85/213.01  |- skos__altLabel mesh__D020371 Atypical Pelizaeus-Merzbacher Disease
% 212.85/213.01  |- skos__altLabel mesh__D020371 Pelizaeus-Merzbacher Disease, Classic
% 212.85/213.01  |- skos__hiddenLabel mesh__D020371 Diseases, Adult Pelizaeus-Merzbacher
% 212.85/213.01  |- skos__hiddenLabel mesh__D020371
% 212.85/213.01       Pelizaeus Merzbacher Disease, Transitional
% 212.85/213.01  |- skos__hiddenLabel mesh__D020371 Adult Pelizaeus Merzbacher Disease
% 212.85/213.01  |- skos__historyNote mesh__D020371 Multiple Sclerosis %28%1966-1999%29%
% 212.85/213.01  |- mesh__recordOriginator mesh__D020371 KEV
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D020371 2006A
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D020371 2005
% 212.85/213.01  |- mesh__historyNote mesh__D020371
% 212.85/213.01       2000; use CEREBRAL SCLEROSIS, DIFFUSE 1979-1999   
% 212.85/213.01  |- mesh__dateCreated mesh__D020371 1999-11-04
% 212.85/213.01  |- rdf__type mesh__D020371sskos__Concept
% 212.85/213.01  |- skos__related mesh__D020371smesh__D018991
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D020371 2006
% 212.85/213.01  |- skos__hiddenLabel mesh__D020371 Atypical Pelizaeus Merzbacher Disease
% 212.85/213.01  |- mesh__recordMaintainer mesh__D020371 ags
% 212.85/213.01  |- mesh__publicMeSHNote mesh__D020371
% 212.85/213.01       2000; see CEREBRAL SCLEROSIS, DIFFUSE 1979-1999   
% 212.85/213.01  |- skos__broader mesh__D020371smesh__D020279
% 212.85/213.01  |- skos__hiddenLabel mesh__D020371 Pelizaeus Merzbacher Disease, Classic
% 212.85/213.01  |- skos__hiddenLabel mesh__D020371 Adult Pelizaeus-Merzbacher Diseases
% 212.85/213.01  |- skos__hiddenLabel mesh__D020371 Pelizaeus Merzbacher Disease, Adult
% 212.85/213.01  |- skos__hiddenLabel mesh__D020371 Classic Pelizaeus Merzbacher Disease
% 212.85/213.01  |- skos__hiddenLabel mesh__D020371 Atypical Pelizaeus-Merzbacher Diseases
% 212.85/213.01  |- rdf__type mesh__D014334sskos__Concept
% 212.85/213.01  |- skos__broader mesh__D014334smesh__D003508
% 212.85/213.01  |- mesh__historyNote mesh__D014334
% 212.85/213.01       91%28%75%29%; was see under CYCLOHEPTANES 1975-90   
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D014334 2005
% 212.85/213.01  |- mesh__recordAuthorizer mesh__D014334 sjn
% 212.85/213.01  |- mesh__recordOriginator mesh__D014334 NLM
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D014334 2006
% 212.85/213.01  |- mesh__recordMaintainer mesh__D014334 ssb
% 212.85/213.01  |- skos__historyNote mesh__D014334 Alcohols %28%1972-1974%29%
% 212.85/213.01  |- mesh__dateCreated mesh__D014334 1974-11-19
% 212.85/213.01  |- skos__prefLabel mesh__D014334 Tropolone
% 212.85/213.01  |- skos__scopeNote mesh__D014334
% 212.85/213.01       A seven-membered aromatic ring compound. It is structurally related to a number of naturally occurring antifungal compounds %28%ANTIBIOTICS, ANTIFUNGAL%29%.%A%    
% 212.85/213.01  |- skos__historyNote mesh__D014334 Cycloheptanes %28%1970-1974%29%
% 212.85/213.01  |- mesh__dateEstablished mesh__D014334 1991-01-01
% 212.85/213.01  |- mesh__publicMeSHNote mesh__D014334
% 212.85/213.01       91; was see under CYCLOHEPTANES 1975-90   
% 212.85/213.01  |- mesh__dateRevised mesh__D014334 2004-07-07
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D000314 2006
% 212.85/213.01  |- skos__hiddenLabel mesh__D000314 Tumors, Adrenal Rest
% 212.85/213.01  |- skos__broader mesh__D000314smesh__D000236
% 212.85/213.01  |- mesh__publicMeSHNote mesh__D000314
% 212.85/213.01       82; was ADRENAL CORTICAL REST TUMOR 1963-81   
% 212.85/213.01  |- rdf__type mesh__D000314sskos__Concept
% 212.85/213.01  |- skos__prefLabel mesh__D000314 Adrenal Rest Tumor
% 212.85/213.01  |- skos__hiddenLabel mesh__D000314 Rest Tumor, Adrenal
% 212.85/213.01  |- mesh__recordMaintainer mesh__D000314 lkt
% 212.85/213.01  |- mesh__recordOriginator mesh__D000314 NLM
% 212.85/213.01  |- skos__hiddenLabel mesh__D000314 Adrenal Rest Tumors
% 212.85/213.01  |- skos__hiddenLabel mesh__D000314 Rest Tumors, Adrenal
% 212.85/213.01  |- mesh__onlineNote mesh__D000314
% 212.85/213.01       use ADRENAL REST TUMOR to search ADRENAL CORTICAL REST TUMOR 1966-81%A%  
% 212.85/213.01  |- mesh__dateCreated mesh__D000314 1999-01-01
% 212.85/213.01  |- skos__altLabel mesh__D000314 Adrenal Cortical Rest Tumor
% 212.85/213.01  |- skos__annotation mesh__D000314
% 212.85/213.01       coordinate IM with tissue-specific neoplasms such as TESTICULAR NEOPLASMS %28%IM%29%%A%  
% 212.85/213.01  |- skos__hiddenLabel mesh__D000314 Tumor, Adrenal Rest
% 212.85/213.01  |- mesh__historyNote mesh__D000314
% 212.85/213.01       82; was ADRENAL CORTICAL REST TUMOR 1963-81   
% 212.85/213.01  |- mesh__recordAuthorizer mesh__D000314 sjn
% 212.85/213.01  |- mesh__dateRevised mesh__D000314 2004-07-07
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D000314 2005
% 212.85/213.01  |- skos__scopeNote mesh__D000314
% 212.85/213.01       Neoplasm derived from displaced cells %28%rest cells%29% of the primordial ADRENAL GLANDS, generally in patients with CONGENITAL ADRENAL HYPERPLASIA. Adrenal rest tumors have been identified in TESTES; LIVER; and other tissues. They are dependent on ADRENOCORTICOTROPIN for growth and adrenal steroid secretion.%A%    
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D018725 2005
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D018725 2004
% 212.85/213.01  |- mesh__historyNote mesh__D018725 95   
% 212.85/213.01  |- skos__scopeNote mesh__D018725
% 212.85/213.01       A cold infusion of tar in water, formerly regarded as a cure-all. %28%Webster, 3d ed%29%%A%    
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D018725 2006
% 212.85/213.01  |- mesh__dateCreated mesh__D018725 1994-04-19
% 212.85/213.01  |- mesh__dateEstablished mesh__D018725 1995-01-01
% 212.85/213.01  |- skos__broader mesh__D018725smesh__D013638
% 212.85/213.01  |- skos__hiddenLabel mesh__D018725 Tar Water
% 212.85/213.01  |- skos__prefLabel mesh__D018725 Tar-Water
% 212.85/213.01  |- mesh__dateRevised mesh__D018725 2003-07-09
% 212.85/213.01  |- skos__annotation mesh__D018725
% 212.85/213.01       infusion of tar in water; in hist articles   
% 212.85/213.01  |- rdf__type mesh__D018725sskos__Concept
% 212.85/213.01  |- mesh__publicMeSHNote mesh__D018725 95   
% 212.85/213.01  |- skos__historyNote mesh__D010742 Ethers %28%1966-1987%29%
% 212.85/213.01  |- mesh__recordOriginator mesh__D010742 RLS
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D010742 2004
% 212.85/213.01  |- skos__hiddenLabel mesh__D010742 Phosphate Ethers, Glycerol
% 212.85/213.01  |- skos__altLabel mesh__D010742 Ether Phospholipids
% 212.85/213.01  |- skos__altLabel mesh__D010742 Ether Phosphatidates
% 212.85/213.01  |- skos__historyNote mesh__D010742 Phospholipids %28%1966-1987%29%
% 212.85/213.01  |- skos__scopeNote mesh__D010742
% 212.85/213.01       Phospholipids which have an alcohol moiety in ethereal linkage with a saturated or unsaturated aliphatic alcohol. They are usually derivatives of phosphoglycerols or phosphatidates. The other two alcohol groups of the glycerol backbone are usually in ester linkage. These compounds are widely distributed in animal tissues.%A%    
% 212.85/213.01  |- skos__hiddenLabel mesh__D010742 1 Alkyl 2 Acylphosphatidates
% 212.85/213.01  |- skos__broader mesh__D010742smesh__D005995
% 212.85/213.01  |- mesh__dateEstablished mesh__D010742 1988-01-01
% 212.85/213.01  |- skos__hiddenLabel mesh__D010742 Ethers, Glycerol Phosphate
% 212.85/213.01  |- mesh__publicMeSHNote mesh__D010742 88   
% 212.85/213.01  |- rdf__type mesh__D010742sskos__Concept
% 212.85/213.01  |- mesh__dateRevised mesh__D010742 2003-07-09
% 212.85/213.01  |- skos__prefLabel mesh__D010742 Phospholipid Ethers
% 212.85/213.01  |- skos__hiddenLabel mesh__D010742 Phospholipids, Ether
% 212.85/213.01  |- skos__hiddenLabel mesh__D010742 Ethers, Glycerophosphate
% 212.85/213.01  |- mesh__recordMaintainer mesh__D010742 ssb
% 212.85/213.01  |- skos__historyNote mesh__D010742
% 212.85/213.01       Phosphatidic Acids or derivatives %28%1975-1987%29%
% 212.85/213.01  |- skos__hiddenLabel mesh__D010742 Phosphatidates, Ether
% 212.85/213.01  |- skos__hiddenLabel mesh__D010742 Ethers, Phospholipid
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D010742 2005
% 212.85/213.01  |- mesh__historyNote mesh__D010742 88   
% 212.85/213.01  |- mesh__dateCreated mesh__D010742 1987-03-25
% 212.85/213.01  |- skos__altLabel mesh__D010742 Glycerol Phosphate Ethers
% 212.85/213.01  |- mesh__recordAuthorizer mesh__D010742 sjn
% 212.85/213.01  |- skos__altLabel mesh__D010742 Glycerophosphate Ethers
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D010742 2006
% 212.85/213.01  |- skos__broader mesh__D010742smesh__D020404
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D004705 2001
% 212.85/213.01  |- mesh__publicMeSHNote mesh__D004705
% 212.85/213.01       76; was see under PHAGOCYTOSIS 1975   
% 212.85/213.01  |- skos__hiddenLabel mesh__D004705 Endocytoses
% 212.85/213.01  |- mesh__dateEstablished mesh__D004705 1976-01-01
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D004705 1998
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D004705 2003
% 212.85/213.01  |- skos__broader mesh__D004705smesh__D002468
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D004705 2000
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D004705 1997
% 212.85/213.01  |- mesh__recordOriginator mesh__D004705 NLM
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D004705 1996
% 212.85/213.01  |- mesh__recordMaintainer mesh__D004705 PXP
% 212.85/213.01  |- mesh__dateRevised mesh__D004705 1994-06-03
% 212.85/213.01  |- skos__historyNote mesh__D004705 Cells/physiology %28%1966-1972%29%
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D004705 2006
% 212.85/213.01  |- skos__related mesh__D004705smesh__D011992
% 212.85/213.01  |- mesh__dateCreated mesh__D004705 1999-01-01
% 212.85/213.01  |- mesh__recordAuthorizer mesh__D004705 PLS
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D004705 1995
% 212.85/213.01  |- mesh__historyNote mesh__D004705
% 212.85/213.01       76%28%73%29%; was see under PHAGOCYTOSIS 1975   
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D004705 2005
% 212.85/213.01  |- rdf__type mesh__D004705sskos__Concept
% 212.85/213.01  |- skos__scopeNote mesh__D004705
% 212.85/213.01       Cellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles. ENDOSOMES play a central role in endocytosis.%A%    
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D004705 2002
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D004705 1999
% 212.85/213.01  |- skos__prefLabel mesh__D004705 Endocytosis
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D004705 2004
% 212.85/213.01  |- skos__hiddenLabel mesh__D009999 Heterotopic Ossification
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D009999 2000
% 212.85/213.01  |- mesh__dateCreated mesh__D009999 1999-01-01
% 212.85/213.01  |- skos__altLabel mesh__D009999 Ossification, Ectopic
% 212.85/213.01  |- rdf__type mesh__D009999sskos__Concept
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D009999 2003
% 212.85/213.01  |- skos__altLabel mesh__D009999 Ossification, Pathological
% 212.85/213.01  |- skos__altLabel mesh__D009999 Pathologic Ossification
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D009999 2002
% 212.85/213.01  |- skos__scopeNote mesh__D009999
% 212.85/213.01       The development of bony substance in normally soft structures.%A%    
% 212.85/213.01  |- skos__hiddenLabel mesh__D009999 Pathological Ossification
% 212.85/213.01  |- mesh__publicMeSHNote mesh__D009999
% 212.85/213.01       92; was OSSIFICATION, PATHOLOGIC 1965-91; OSSIFICATION was heading 1963-64%A%  
% 212.85/213.01  |- skos__altLabel mesh__D009999 Ossification, Pathologic
% 212.85/213.01  |- mesh__recordMaintainer mesh__D009999 KEV
% 212.85/213.01  |- mesh__dateRevised mesh__D009999 1999-11-03
% 212.85/213.01  |- mesh__onlineNote mesh__D009999
% 212.85/213.01       use OSSIFICATION, HETEROTOPIC to search OSSIFICATION, PATHOLOGIC 1966-91%A%  
% 212.85/213.01  |- skos__prefLabel mesh__D009999 Ossification, Heterotopic
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D009999 2006
% 212.85/213.01  |- skos__broader mesh__D009999smesh__D010335
% 212.85/213.01  |- skos__related mesh__D009999smesh__D013580
% 212.85/213.01  |- mesh__dateEstablished mesh__D009999 1965-01-01
% 212.85/213.01  |- skos__hiddenLabel mesh__D009999 Ectopic Ossification
% 212.85/213.01  |- mesh__historyNote mesh__D009999
% 212.85/213.01       92; was OSSIFICATION, PATHOLOGIC 1965-91; OSSIFICATION was heading 1963-64%A%  
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D009999 2001
% 212.85/213.01  |- mesh__recordAuthorizer mesh__D009999 sjn
% 212.85/213.01  |- mesh__recordOriginator mesh__D009999 NLM
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D009999 2004
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D009999 2005
% 212.85/213.01  |- mesh__publicMeSHNote mesh__D020372 99   
% 212.85/213.01  |- mesh__dateEstablished mesh__D020372 1999-01-01
% 212.85/213.01  |- mesh__recordMaintainer mesh__D020372 exl
% 212.85/213.01  |- mesh__historyNote mesh__D020372 99   
% 212.85/213.01  |- mesh__recordOriginator mesh__D020372 ADP
% 212.85/213.01  |- skos__altLabel mesh__D020372
% 212.85/213.01       Wyeth Brand of Dexfenfluramine Hydrochloride
% 212.85/213.01  |- skos__hiddenLabel mesh__D020372 Hydrochloride, Dexfenfluramine
% 212.85/213.01  |- rdf__type mesh__D020372sskos__Concept
% 212.85/213.01  |- skos__historyNote mesh__D020372 Fenfluramine %28%1986-1998%29%
% 212.85/213.01  |- skos__prefLabel mesh__D020372 Dexfenfluramine
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D020372 2006
% 212.85/213.01  |- mesh__dateRevised mesh__D020372 2005-06-30
% 212.85/213.01  |- skos__broader mesh__D020372smesh__D010627
% 212.85/213.01  |- skos__scopeNote mesh__D020372
% 212.85/213.01       The S-isomer of FENFLURAMINE. It is a serotonin agonist and is used as an anorectic. Unlike fenfluramine, it does not possess any catecholamine agonist activity.%A%    
% 212.85/213.01  |- mesh__recordAuthorizer mesh__D020372 sjn
% 212.85/213.01  |- mesh__dateCreated mesh__D020372 1998-06-10
% 212.85/213.01  |- mesh__publicMeSHNote mesh__D014335 74   
% 212.85/213.01  |- skos__hiddenLabel mesh__D014335 Mg, Tropomyosin
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D014335 2006
% 212.85/213.01  |- mesh__historyNote mesh__D014335 74%28%71%29%   
% 212.85/213.01  |- skos__broader mesh__D014335smesh__D008840
% 212.85/213.01  |- skos__annotation mesh__D014335
% 212.85/213.01       a muscle protein; /biosyn /physiol permitted   
% 212.85/213.01  |- mesh__recordMaintainer mesh__D014335 DRC
% 212.85/213.01  |- skos__hiddenLabel mesh__D014335 gamma Tropomyosin
% 212.85/213.01  |- mesh__recordAuthorizer mesh__D014335 sjn
% 212.85/213.01  |- skos__hiddenLabel mesh__D014335 beta Tropomyosin
% 212.85/213.01  |- mesh__recordOriginator mesh__D014335 NLM
% 212.85/213.01  |- skos__scopeNote mesh__D014335
% 212.85/213.01       A protein found in the thin filaments of muscle fibers. It inhibits contraction of the muscle unless its position is modified by TROPONIN.%A%    
% 212.85/213.01  |- skos__prefLabel mesh__D014335 Tropomyosin
% 212.85/213.01  |- skos__related mesh__D014335smesh__D024741
% 212.85/213.01  |- skos__historyNote mesh__D014335 Muscle Proteins %28%1966-1970%29%
% 212.85/213.01  |- skos__broader mesh__D014335smesh__D009124
% 212.85/213.01  |- skos__altLabel mesh__D014335 Paratropomyosin
% 212.85/213.01  |- skos__hiddenLabel mesh__D014335 alpha Tropomyosin
% 212.85/213.01  |- mesh__dateEstablished mesh__D014335 1974-01-01
% 212.85/213.01  |- rdf__type mesh__D014335sskos__Concept
% 212.85/213.01  |- mesh__dateCreated mesh__D014335 1999-01-01
% 212.85/213.01  |- mesh__dateRevised mesh__D014335 2005-06-30
% 212.85/213.01  |- skos__scopeNote mesh__D000315
% 212.85/213.01       Excision of one or both adrenal glands. %28%From Dorland, 28th ed%29%%A%    
% 212.85/213.01  |- mesh__recordAuthorizer mesh__D000315 SJN
% 212.85/213.01  |- skos__hiddenLabel mesh__D000315 Adrenalectomies
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D000315 2003
% 212.85/213.01  |- rdf__type mesh__D000315sskos__Concept
% 212.85/213.01  |- skos__prefLabel mesh__D000315 Adrenalectomy
% 212.85/213.01  |- mesh__dateRevised mesh__D000315 1997-06-20
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D000315 2001
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D000315 2004
% 212.85/213.01  |- skos__annotation mesh__D000315
% 212.85/213.01       excision of entire adrenal; enucleation: see note under ADRENAL MEDULLA%A%  
% 212.85/213.01  |- skos__broader mesh__D000315smesh__D013507
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D000315 1998
% 212.85/213.01  |- mesh__dateCreated mesh__D000315 1999-01-01
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D000315 2002
% 212.85/213.01  |- mesh__recordMaintainer mesh__D000315 PXP
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D000315 2005
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D000315 1999
% 212.85/213.01  |- mesh__recordOriginator mesh__D000315 NLM
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D000315 2006
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D000315 2000
% 212.85/213.01  |- skos__annotation mesh__D019020 DF: DIRECTED MOL EVOLUTION   
% 212.85/213.01  |- skos__hiddenLabel mesh__D019020 Evolutions, Directed Molecular
% 212.85/213.01  |- skos__altLabel mesh__D019020 Molecular Evolution, Directed
% 212.85/213.01  |- skos__hiddenLabel mesh__D019020 Directed Molecular Evolutions
% 212.85/213.01  |- mesh__dateCreated mesh__D019020 1995-06-05
% 212.85/213.01  |- skos__scopeNote mesh__D019020
% 212.85/213.01       The techniques used to produce molecules exhibiting properties that conform to the demands of the experimenter. These techniques combine methods of generating structural changes with methods of selection. They are also used to examine proposed mechanisms of evolution under in vitro selection conditions.%A%    
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D019020 2005
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D019020 2004
% 212.85/213.01  |- skos__related mesh__D019020smesh__D019143
% 212.85/213.01  |- skos__hiddenLabel mesh__D019020 Laboratory Molecular Evolutions
% 212.85/213.01  |- skos__prefLabel mesh__D019020 Directed Molecular Evolution
% 212.85/213.01  |- mesh__dateEstablished mesh__D019020 1996-01-01
% 212.85/213.01  |- rdf__type mesh__D019020sskos__Concept
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D019020 2006
% 212.85/213.01  |- skos__hiddenLabel mesh__D019020 Evolution, Laboratory Molecular
% 212.85/213.01  |- skos__hiddenLabel mesh__D019020 Molecular Evolutions, Directed
% 212.85/213.01  |- skos__hiddenLabel mesh__D019020 Evolutions, Laboratory Molecular
% 212.85/213.01  |- skos__hiddenLabel mesh__D019020 Evolution, Directed Molecular
% 212.85/213.01  |- mesh__recordAuthorizer mesh__D019020 sjn
% 212.85/213.01  |- skos__altLabel mesh__D019020 Evolution, Molecular, Directed
% 212.85/213.01  |- skos__historyNote mesh__D019020 Evolution %28%1978-1995%29%
% 212.85/213.01  |- mesh__recordMaintainer mesh__D019020 nns
% 212.85/213.01  |- skos__related mesh__D019020smesh__D015202
% 212.85/213.01  |- skos__altLabel mesh__D019020 Laboratory Molecular Evolution
% 212.85/213.01  |- mesh__historyNote mesh__D019020 96   
% 212.85/213.01  |- skos__broader mesh__D019020smesh__D005818
% 212.85/213.01  |- skos__hiddenLabel mesh__D019020 Molecular Evolutions, Laboratory
% 212.85/213.01  |- mesh__publicMeSHNote mesh__D019020 96   
% 212.85/213.01  |- mesh__dateRevised mesh__D019020 2002-07-03
% 212.85/213.01  |- mesh__recordOriginator mesh__D019020 PXP
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D019020 2003
% 212.85/213.01  |- skos__hiddenLabel mesh__D019020 Molecular Evolution, Laboratory
% 212.85/213.01  |- skos__hiddenLabel mesh__D005000 Trecator SC
% 212.85/213.01  |- skos__altLabel mesh__D005000 Trecator
% 212.85/213.01  |- mesh__recordAuthorizer mesh__D005000 sjn
% 212.85/213.01  |- rdf__type mesh__D005000sskos__Concept
% 212.85/213.01  |- mesh__recordMaintainer mesh__D005000 CCR
% 212.85/213.01  |- skos__altLabel mesh__D005000 Amidazine
% 212.85/213.01  |- mesh__dateRevised mesh__D005000 2005-06-30
% 212.85/213.01  |- mesh__publicMeSHNote mesh__D005000 64; was ETHIONIAMIDE 1963   
% 212.85/213.01  |- skos__scopeNote mesh__D005000
% 212.85/213.01       A second-line antitubercular agent that inhibits mycolic acid synthesis. It also may be used for treatment of leprosy. %28%From Smith and Reynard, Textbook of Pharmacology, 1992, p868%29%%A%    
% 212.85/213.01  |- skos__altLabel mesh__D005000 Ethioniamide
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D005000 2006
% 212.85/213.01  |- skos__altLabel mesh__D005000 Wyeth Brand of Ethionamide
% 212.85/213.01  |- mesh__dateCreated mesh__D005000 1999-01-01
% 212.85/213.01  |- skos__broader mesh__D005000smesh__D007539
% 212.85/213.01  |- skos__prefLabel mesh__D005000 Ethionamide
% 212.85/213.01  |- mesh__recordOriginator mesh__D005000 NLM
% 212.85/213.01  |- mesh__historyNote mesh__D005000 64; was ETHIONIAMIDE 1963   
% 212.85/213.01  |- mesh__recordMaintainer mesh__D024763 lkt
% 212.85/213.01  |- skos__historyNote mesh__D024763 Bloodletting %28%1965-2001%29%
% 212.85/213.01  |- skos__scopeNote mesh__D024763
% 212.85/213.01       The application of LEECHES to the body to draw blood for therapeutic purposes. Such medicinal leeching, an ancient medical practice, is still being used in microsurgery and the treatment of venous congestion or occlusion.%A%    
% 212.85/213.01  |- skos__prefLabel mesh__D024763 Leeching
% 212.85/213.01  |- mesh__dateRevised mesh__D024763 2005-06-30
% 212.85/213.01  |- mesh__recordOriginator mesh__D024763 lkt
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D024763 2006
% 212.85/213.01  |- skos__historyNote mesh__D024763 Leeches %28%1965-2001%29%
% 212.85/213.01  |- rdf__type mesh__D024763sskos__Concept
% 212.85/213.01  |- skos__related mesh__D024763smesh__D007865
% 212.85/213.01  |- mesh__recordAuthorizer mesh__D024763 sjn
% 212.85/213.01  |- mesh__historyNote mesh__D024763 2002   
% 212.85/213.01  |- skos__related mesh__D024763smesh__D024764
% 212.85/213.01  |- mesh__dateCreated mesh__D024763 2001-07-25
% 212.85/213.01  |- skos__related mesh__D024763smesh__D001815
% 212.85/213.01  |- skos__altLabel mesh__D024763 Leech Therapy
% 212.85/213.01  |- skos__broader mesh__D024763smesh__D013812
% 212.85/213.01  |- mesh__dateEstablished mesh__D024763 2002-01-01
% 212.85/213.01  |- mesh__publicMeSHNote mesh__D024763 2002   
% 212.85/213.01  |- mesh__historyNote mesh__D018726 95   
% 212.85/213.01  |- skos__historyNote mesh__D018726 Antiparkinson Agents %28%1976-1994%29%
% 212.85/213.01  |- mesh__dateEstablished mesh__D018726 1995-01-01
% 212.85/213.01  |- skos__hiddenLabel mesh__D018726 Anti Dyskinesia Agents
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D018726 2006
% 212.85/213.01  |- skos__broader mesh__D018726smesh__D002491
% 212.85/213.01  |- skos__altLabel mesh__D018726 Movement Disorder Agents
% 212.85/213.01  |- mesh__recordOriginator mesh__D018726 TPW
% 212.85/213.01  |- rdf__type mesh__D018726sskos__Concept
% 212.85/213.01  |- mesh__dateRevised mesh__D018726 2005-06-30
% 212.85/213.01  |- skos__prefLabel mesh__D018726 Anti-Dyskinesia Agents
% 212.85/213.01  |- mesh__dateCreated mesh__D018726 1994-06-03
% 212.85/213.01  |- mesh__recordMaintainer mesh__D018726 ssb
% 212.85/213.01  |- skos__hiddenLabel mesh__D018726 Agents, Anti-Dyskinesia
% 212.85/213.01  |- skos__hiddenLabel mesh__D018726 Disorder Agents, Movement
% 212.85/213.01  |- mesh__recordAuthorizer mesh__D018726 sjn
% 212.85/213.01  |- mesh__publicMeSHNote mesh__D018726 95   
% 212.85/213.01  |- skos__scopeNote mesh__D018726
% 212.85/213.01       Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of Parkinson disease %28%ANTIPARKINSON AGENTS%29% and those for the tardive dyskinesias.%A%    
% 212.85/213.01  |- skos__hiddenLabel mesh__D018726 Agents, Movement Disorder
% 212.85/213.01  |- skos__prefLabel mesh__D010743 Phospholipids
% 212.85/213.01  |- skos__scopeNote mesh__D010743
% 212.85/213.01       Lipids containing one or more phosphate groups, particularly those derived from either glycerol %28%phosphoglycerides see GLYCEROPHOSPHOLIPIDS%29% or sphingosine %28%SPHINGOLIPIDS%29%. They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system.%A%    
% 212.85/213.01  |- skos__broader mesh__D010743smesh__D008563
% 212.85/213.01  |- mesh__dateCreated mesh__D010743 1999-01-01
% 212.85/213.01  |- skos__related mesh__D010743smesh__D017152
% 212.85/213.01  |- mesh__recordAuthorizer mesh__D010743 sjn
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D010743 2005
% 212.85/213.01  |- mesh__historyNote mesh__D010743
% 212.85/213.01       /metabolism was PHOSPHOLIPID METABOLISM 1965   
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D010743 2006
% 212.85/213.01  |- mesh__recordOriginator mesh__D010743 NLM
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D010743 2004
% 212.85/213.01  |- mesh__publicMeSHNote mesh__D010743
% 212.85/213.01       /metabolism was PHOSPHOLIPID METABOLISM 1965   
% 212.85/213.01  |- skos__related mesh__D010743smesh__D016736
% 212.85/213.01  |- skos__broader mesh__D010743smesh__D008055
% 212.85/213.01  |- mesh__recordMaintainer mesh__D010743 ssb
% 212.85/213.01  |- skos__altLabel mesh__D010743 Phosphatides
% 212.85/213.01  |- rdf__type mesh__D010743sskos__Concept
% 212.85/213.01  |- mesh__dateRevised mesh__D010743 2003-07-09
% 212.85/213.01  |- mesh__dateRevised mesh__D004706 2003-07-09
% 212.85/213.01  |- skos__historyNote mesh__D004706 Phosphatases %28%1966-1972%29%
% 212.85/213.01  |- mesh__historyNote mesh__D004706 83   
% 212.85/213.01  |- skos__historyNote mesh__D004706 Deoxyribonucleases %28%1966-1982%29%
% 212.85/213.01  |- mesh__recordAuthorizer mesh__D004706 sjn
% 212.85/213.01  |- mesh__publicMeSHNote mesh__D004706 83   
% 212.85/213.01  |- skos__broader mesh__D004706smesh__D004720
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D004706 2005
% 212.85/213.01  |- mesh__dateEstablished mesh__D004706 1983-01-01
% 212.85/213.01  |- skos__historyNote mesh__D004706 Endonucleases %28%1973-1982%29%
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D004706 2006
% 212.85/213.01  |- mesh__dateCreated mesh__D004706 1982-04-30
% 212.85/213.01  |- skos__scopeNote mesh__D004706
% 212.85/213.01       A group of enzymes catalyzing the endonucleolytic cleavage of DNA. They include members of EC 3.1.21.-, EC 3.1.22.-, EC 3.1.23.- %28%DNA RESTRICTION ENZYMES%29%, EC 3.1.24.- %28%DNA RESTRICTION ENZYMES%29%, and EC 3.1.25.-.%A%    
% 212.85/213.01  |- mesh__recordMaintainer mesh__D004706 ssb
% 212.85/213.01  |- skos__prefLabel mesh__D004706 Endodeoxyribonucleases
% 212.85/213.01  |- mesh__recordOriginator mesh__D004706 RLS
% 212.85/213.01  |- skos__broader mesh__D004706smesh__D003851
% 212.85/213.01  |- rdf__type mesh__D004706sskos__Concept
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D004706 2004
% 212.85/213.01  |- mesh__publicMeSHNote mesh__D014336
% 212.85/213.01       84; was see under MUSCLE PROTEINS 1975-83   
% 212.85/213.01  |- rdf__type mesh__D014336sskos__Concept
% 212.85/213.01  |- mesh__historyNote mesh__D014336
% 212.85/213.01       84%28%75%29%; was see under MUSCLE PROTEINS 1975-83   
% 212.85/213.01  |- skos__annotation mesh__D014336
% 212.85/213.01       a muscle protein; /biosyn /physiol permitted; TROPONIN C; TROPONIN I; %26% TROPONIN T are also available%A%  
% 212.85/213.01  |- mesh__dateEstablished mesh__D014336 1984-01-01
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D014336 2006
% 212.85/213.01  |- mesh__dateRevised mesh__D014336 2005-06-30
% 212.85/213.01  |- skos__broader mesh__D014336smesh__D008840
% 212.85/213.01  |- mesh__recordMaintainer mesh__D014336 DRC
% 212.85/213.01  |- skos__prefLabel mesh__D014336 Troponin
% 212.85/213.01  |- skos__broader mesh__D014336smesh__D009124
% 212.85/213.01  |- skos__historyNote mesh__D014336 Muscle Proteins %28%1973-1974%29%
% 212.85/213.01  |- mesh__dateCreated mesh__D014336 1974-11-19
% 212.85/213.01  |- skos__scopeNote mesh__D014336
% 212.85/213.01       One of the minor protein components of skeletal muscle. Its function is to serve as the calcium-binding component in the troponin-tropomyosin B-actin-myosin complex by conferring calcium sensitivity to the cross-linked actin and myosin filaments.%A%    
% 212.85/213.01  |- mesh__recordAuthorizer mesh__D014336 sjn
% 212.85/213.01  |- mesh__recordOriginator mesh__D014336 NLM
% 212.85/213.01  |- rdf__type mesh__D000316sskos__Concept
% 212.85/213.01  |- mesh__activeMeSHYear mesh__D000316 2006
% 212.85/213.01  |- skos__hiddenLabel mesh__D000316 Agonists, alpha-Adrenergic
% 212.85/213.01  |- skos__altLabel mesh__D000316 Adrenergic alpha-Receptor Agonists
% 212.85/213.01  |- mesh__recordMaintainer mesh__D000316 ssb
% 212.85/213.01  |- skos__hiddenLabel mesh__D000316 alpha-Agonists, Adrenergic
% 212.85/213.01  |- skos__hiddenLabel mesh__D000316 Receptor Agonist, alpha-Adrenergic
% 212.85/213.01  |- skos__hiddenLabel mesh__D000316 Agonist, Adrenergic alpha-Receptor
% 212.85/213.01  |- skos__altLabel mesh__D000316 Adrenergic alpha-Receptor Agonist
% 212.85/213.01  |- skos__broader mesh__D000316smesh__D000322
% 212.85/213.01  |- skos__altLabel mesh__D000316 alpha-Adrenergic Agonist
% 212.85/213.01  |- mesh__dateRevised mesh__D000316 2005-06-30
% 212.85/213.01  |- mesh__publicMeSHNote mesh__D000316
% 212.85/213.01       95; was ADRENERGIC ALPHA RECEPTOR AGONISTS 1973-94   
% 212.85/213.01  |- skos__altLabel mesh__D000316 Receptor Agonists, Adrenergic alpha
% 212.85/213.02  |- skos__hiddenLabel mesh__D000316 alpha Adrenergic Receptor Agonists
% 212.85/213.02  |- skos__hiddenLabel mesh__D000316 alpha-Agonist, Adrenergic
% 212.85/213.02  |- skos__historyNote mesh__D000316 Sympathomimetics %28%1966-1968%29%
% 212.85/213.02  |- skos__prefLabel mesh__D000316 Adrenergic alpha-Agonists
% 212.85/213.02  |- mesh__recordOriginator mesh__D000316 NLM
% 212.85/213.02  |- skos__hiddenLabel mesh__D000316 alpha Adrenergic Agonist
% 212.85/213.02  |- skos__scopeNote mesh__D000316
% 212.85/213.02       Drugs that selectively bind to and activate alpha adrenergic receptors.%A%    
% 212.85/213.02  |- skos__hiddenLabel mesh__D000316 alpha-Receptor Agonists, Adrenergic
% 212.85/213.02  |- skos__altLabel mesh__D000316 Adrenergic alpha-Agonist
% 212.85/213.02  |- mesh__dateEstablished mesh__D000316 1973-01-01
% 212.85/213.02  |- mesh__dateCreated mesh__D000316 1999-01-01
% 212.85/213.02  |- mesh__onlineNote mesh__D000316
% 212.85/213.02       use ADRENERGIC ALPHA-AGONISTS to search ADRENERGIC ALPHA RECEPTOR AGONISTS 1969-94 %28%as Prov 1969-72%29%%A%  
% 212.85/213.02  |- mesh__recordAuthorizer mesh__D000316 sjn
% 212.85/213.02  |- skos__hiddenLabel mesh__D000316 alpha Adrenergic Receptor Agonist
% 212.85/213.02  |- skos__altLabel mesh__D000316 alpha-Adrenergic Agonists
% 212.85/213.02  |- skos__hiddenLabel mesh__D000316 Agonists, Adrenergic alpha-Receptor
% 212.85/213.02  |- skos__hiddenLabel mesh__D000316 Agonist, alpha-Adrenergic
% 212.85/213.02  |- skos__hiddenLabel mesh__D000316 alpha-Receptor Agonist, Adrenergic
% 212.85/213.02  |- skos__hiddenLabel mesh__D000316 Agonist, alpha-Adrenergic Receptor
% 212.85/213.02  |- skos__hiddenLabel mesh__D000316 Adrenergic alpha Agonist
% 212.85/213.02  |- skos__hiddenLabel mesh__D000316 alpha Adrenergic Agonists
% 212.85/213.02  |- skos__altLabel mesh__D000316 alpha-Adrenergic Receptor Agonists
% 212.85/213.02  |- skos__altLabel mesh__D000316 Receptor Agonists, alpha-Adrenergic
% 212.85/213.02  |- skos__annotation mesh__D000316
% 212.85/213.02       GEN or unspecified; prefer specifics; do not confuse with ADRENERGIC ALPHA-ANTAGONISTS; DF: ADREN ALPHA AGON or ADREN ALPHA AG%A%  
% 212.85/213.02  |- skos__hiddenLabel mesh__D000316 Receptor Agonists, alpha Adrenergic
% 212.85/213.02  |- skos__altLabel mesh__D000316 alpha-Adrenergic Receptor Agonist
% 212.85/213.02  |- skos__hiddenLabel mesh__D000316 Adrenergic alpha Agonists
% 212.85/213.02  |- skos__hiddenLabel mesh__D000316 Agonists, alpha-Adrenergic Receptor
% 212.85/213.02  |- skos__hiddenLabel mesh__D000316 Adrenergic alpha Receptor Agonists
% 212.85/213.02  |- skos__hiddenLabel mesh__D000316 Adrenergic alpha Receptor Agonist
% 212.85/213.02  |- mesh__historyNote mesh__D000316
% 212.85/213.02       95; was ADRENERGIC ALPHA RECEPTOR AGONISTS 1969-94 %28%Prov 1969-72%29%%A%  
% 212.85/213.02  |- mesh__dateRevised mesh__D019021 2004-07-07
% 212.85/213.02  |- skos__historyNote mesh__D019021 Science %28%1976-1984%29%
% 212.85/213.02  |- skos__scopeNote mesh__D019021
% 212.85/213.02       A former branch of knowledge embracing the study, description, and classification of natural objects %28%as animals, plants, and minerals%29% and thus including the modern sciences of zoology, botany, and mineralogy insofar as they existed at that time. In the 17th, 18th, and 19th centuries it was much used for the generalized pursuit of certain areas of science. %28%Webster, 3d ed; from Dr. James H. Cassedy, NLM History of Medicine Division%29%%A%    
% 212.85/213.02  |- skos__annotation mesh__D019021
% 212.85/213.02       restrict to the hist science: not for the %22%natural history%22% or natural course or develop of a dis; DF: NATURAL HIST%A%  
% 212.85/213.02  |- mesh__publicMeSHNote mesh__D019021 96   
% 212.85/213.02  |- skos__broader mesh__D019021smesh__D012586
% 212.85/213.02  |- skos__historyNote mesh__D019021 Biology %28%1966-1995%29%
% 212.85/213.02  |- mesh__dateEstablished mesh__D019021 1996-01-01
% 212.85/213.02  |- mesh__dateCreated mesh__D019021 1995-05-26
% 212.85/213.02  |- mesh__recordOriginator mesh__D019021 TGC
% 212.85/213.02  |- rdf__type mesh__D019021sskos__Concept
% 212.85/213.02  |- skos__broader mesh__D019021smesh__D001695
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D019021 2006
% 212.85/213.02  |- skos__broader mesh__D019021smesh__D006664
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D019021 2005
% 212.85/213.02  |- mesh__recordMaintainer mesh__D019021 jls
% 212.85/213.02  |- mesh__recordAuthorizer mesh__D019021 sjn
% 212.85/213.02  |- skos__prefLabel mesh__D019021 Natural History
% 212.85/213.02  |- mesh__historyNote mesh__D019021 96   
% 212.85/213.02  |- skos__hiddenLabel mesh__D019021 History, Natural
% 212.85/213.02  |- mesh__recordOriginator mesh__D005001 NLM
% 212.85/213.02  |- mesh__recordMaintainer mesh__D005001 ssb
% 212.85/213.02  |- mesh__recordAuthorizer mesh__D005001 sjn
% 212.85/213.02  |- skos__annotation mesh__D005001
% 212.85/213.02       a carcinogen %26% antimetabolite; /biosyn /defic /physiol permitted%A%  
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D005001 2006
% 212.85/213.02  |- skos__broader mesh__D005001smesh__D000603
% 212.85/213.02  |- mesh__dateRevised mesh__D005001 2005-06-30
% 212.85/213.02  |- mesh__dateCreated mesh__D005001 1999-01-01
% 212.85/213.02  |- skos__scopeNote mesh__D005001
% 212.85/213.02       2-Amino-4-%28%ethylthio%29%butyric acid. An antimetabolite and methionine antagonist that interferes with amino acid incorporation into proteins and with cellular ATP utilization. It also produces liver neoplasms.%A%    
% 212.85/213.02  |- rdf__type mesh__D005001sskos__Concept
% 212.85/213.02  |- skos__prefLabel mesh__D005001 Ethionine
% 212.85/213.02  |- skos__broader mesh__D024764smesh__D015912
% 212.85/213.02  |- mesh__recordOriginator mesh__D024764 lkt
% 212.85/213.02  |- skos__related mesh__D024764smesh__D006629
% 212.85/213.02  |- skos__related mesh__D024764smesh__D024763
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D024764 2006
% 212.85/213.02  |- rdf__type mesh__D024764sskos__Concept
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D024764 2005
% 212.85/213.02  |- mesh__dateRevised mesh__D024764 2004-07-13
% 212.85/213.02  |- skos__scopeNote mesh__D024764
% 212.85/213.02        Use of  HIRUDINS as an anticoagulant in the treatment of cardiological and hematological disorders.%A%    
% 212.85/213.02  |- skos__historyNote mesh__D024764 Hirudin %28%1968-2001%29%
% 212.85/213.02  |- mesh__recordMaintainer mesh__D024764 sjn
% 212.85/213.02  |- mesh__recordAuthorizer mesh__D024764 sjn
% 212.85/213.02  |- mesh__dateEstablished mesh__D024764 2002-01-01
% 212.85/213.02  |- mesh__historyNote mesh__D024764 2002   
% 212.85/213.02  |- mesh__publicMeSHNote mesh__D024764 2002   
% 212.85/213.02  |- skos__annotation mesh__D024764
% 212.85/213.02       coord IM with disease/drug ther %28%IM%29%   
% 212.85/213.02  |- mesh__dateCreated mesh__D024764 2001-08-03
% 212.85/213.02  |- skos__prefLabel mesh__D024764 Hirudin Therapy
% 212.85/213.02  |- mesh__recordMaintainer mesh__D018727 ssb
% 212.85/213.02  |- rdf__type mesh__D018727sskos__Concept
% 212.85/213.02  |- skos__hiddenLabel mesh__D018727 Agents, Antimuscarinic
% 212.85/213.02  |- skos__altLabel mesh__D018727 Antimuscarinic Agents
% 212.85/213.02  |- mesh__recordAuthorizer mesh__D018727 sjn
% 212.85/213.02  |- mesh__dateCreated mesh__D018727 1994-06-01
% 212.85/213.02  |- mesh__recordOriginator mesh__D018727 RAZ
% 212.85/213.02  |- skos__prefLabel mesh__D018727 Muscarinic Antagonists
% 212.85/213.02  |- skos__broader mesh__D018727smesh__D018680
% 212.85/213.02  |- mesh__dateEstablished mesh__D018727 1995-01-01
% 212.85/213.02  |- mesh__historyNote mesh__D018727
% 212.85/213.02       95; ANTIMUSCARINIC AGENTS was see PARASYMPATHOLYTICS 1969-94%A%  
% 212.85/213.02  |- skos__related mesh__D018727smesh__D010276
% 212.85/213.02  |- skos__annotation mesh__D018727
% 212.85/213.02       GEN or unspecified; prefer specifics; DF: MUSCARINIC ANTAG%A%  
% 212.85/213.02  |- skos__historyNote mesh__D018727 Parasympatholytics %28%1966-1994%29%
% 212.85/213.02  |- skos__scopeNote mesh__D018727
% 212.85/213.02       Drugs that bind to but do not activate muscarinic cholinergic receptors %28%RECEPTORS, MUSCARINIC%29%, thereby blocking the actions of endogenous acetylcholine or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. Antagonists that discriminate among the various muscarinic receptor subtypes and might allow better control of peripheral and central actions are under development.%A%    
% 212.85/213.02  |- skos__hiddenLabel mesh__D018727 Antagonists, Muscarinic
% 212.85/213.02  |- mesh__dateRevised mesh__D018727 2005-06-30
% 212.85/213.02  |- mesh__publicMeSHNote mesh__D018727
% 212.85/213.02       95; ANTIMUSCARINIC AGENTS was see PARASYMPATHOLYTICS 1969-94%A%  
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D018727 2006
% 212.85/213.02  |- mesh__onlineNote mesh__D018727
% 212.85/213.02       use PARASYMPATHOLYTICS to search ANTIMUSCARINIC AGENTS 1969-94%A%  
% 212.85/213.02  |- mesh__dateCreated mesh__D010744 1999-01-01
% 212.85/213.02  |- mesh__recordMaintainer mesh__D010744 ssb
% 212.85/213.02  |- skos__altLabel mesh__D010744 Phosphomonoesterases
% 212.85/213.02  |- skos__scopeNote mesh__D010744
% 212.85/213.02       A group of hydrolases which catalyze the hydrolysis of monophosphoric esters with the production of one mole of orthophosphate. EC 3.1.3.%A%    
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D010744 2005
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D010744 2006
% 212.85/213.02  |- skos__prefLabel mesh__D010744 Phosphoric Monoester Hydrolases
% 212.85/213.02  |- skos__broader mesh__D010744smesh__D004950
% 212.85/213.02  |- mesh__historyNote mesh__D010744
% 212.85/213.02       94; was PHOSPHOMONOESTERASES 1975-93; PHOSPHORIC MONOESTER HYDROLASES was see PHOSPHOMONOESTERASES 1975-93; PHOSPHATASES was heading 1963-93; PHOSPHOHYDROLASES was see PHOSPHATASES 1963-93%A%  
% 212.85/213.02  |- mesh__publicMeSHNote mesh__D010744
% 212.85/213.02       94; was PHOSPHOMONOESTERASES 1975-93; PHOSPHORIC MONOESTER HYDROLASES was see PHOSPHOMONOESTERASES 1975-93; PHOSPHATASES was heading 1963-93; PHOSPHOHYDROLASES was see PHOSPHATASES 1963-93%A%  
% 212.85/213.02  |- mesh__onlineNote mesh__D010744
% 212.85/213.02       use PHOSPHORIC MONOESTER HYDROLASES to search PHOSPHOMONOESTERASES 1975-93 %26% PHOSPHATASES %26% PHOSPHOHYDROLASES 1966-93%A%  
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D010744 2004
% 212.85/213.02  |- skos__altLabel mesh__D010744 Phosphatases
% 212.85/213.02  |- skos__annotation mesh__D010744 DF: note short X ref   
% 212.85/213.02  |- mesh__recordAuthorizer mesh__D010744 sjn
% 212.85/213.02  |- mesh__dateEstablished mesh__D010744 1975-01-01
% 212.85/213.02  |- skos__historyNote mesh__D010744 Phosphatases %28%1966-1974%29%
% 212.85/213.02  |- rdf__type mesh__D010744sskos__Concept
% 212.85/213.02  |- skos__hiddenLabel mesh__D010744 Hydrolases, Phosphoric Monoester
% 212.85/213.02  |- mesh__dateRevised mesh__D010744 2003-07-09
% 212.85/213.02  |- mesh__recordOriginator mesh__D010744 NLM
% 212.85/213.02  |- skos__altLabel mesh__D010744 Phosphohydrolases
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D004707 1997
% 212.85/213.02  |- skos__annotation mesh__D004707
% 212.85/213.02       A 11 qualif; ENDODERMAL SINUS TUMOR is also available: see note there%A%  
% 212.85/213.02  |- skos__broader mesh__D004707smesh__D005855
% 212.85/213.02  |- mesh__dateCreated mesh__D004707 1999-01-01
% 212.85/213.02  |- mesh__recordMaintainer mesh__D004707 TGC
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D004707 2002
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D004707 2005
% 212.85/213.02  |- skos__scopeNote mesh__D004707
% 212.85/213.02       The inner of the three germ layers of the embryo.     
% 212.85/213.02  |- skos__hiddenLabel mesh__D004707 Endoderms
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D004707 2006
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D004707 2000
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D004707 1998
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D004707 2003
% 212.85/213.02  |- rdf__type mesh__D004707sskos__Concept
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D004707 2001
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D004707 1999
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D004707 2004
% 212.85/213.02  |- mesh__dateRevised mesh__D004707 1996-06-10
% 212.85/213.02  |- skos__prefLabel mesh__D004707 Endoderm
% 212.85/213.02  |- mesh__recordOriginator mesh__D004707 SMH
% 212.85/213.02  |- mesh__recordAuthorizer mesh__D004707 PLS
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D020374 2000
% 212.85/213.02  |- mesh__historyNote mesh__D020374 99   
% 212.85/213.02  |- rdf__type mesh__D020374sskos__Concept
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D020374 2006
% 212.85/213.02  |- skos__annotation mesh__D020374
% 212.85/213.02       do not confuse with capillary gas chromatography %28%= CHROMATOGRAPHY, GAS%29%%A%  
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D020374 1999
% 212.85/213.02  |- skos__historyNote mesh__D020374 Electrophoresis %28%1991-1995%29%
% 212.85/213.02  |- skos__prefLabel mesh__D020374
% 212.85/213.02       Chromatography, Micellar Electrokinetic Capillary
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D020374 2005
% 212.85/213.02  |- skos__altLabel mesh__D020374
% 212.85/213.02       Micellar Electrokinetic Capillary Chromatography
% 212.85/213.02  |- skos__historyNote mesh__D020374
% 212.85/213.02       Electrophoresis, Capillary %28%1996-1998%29%
% 212.85/213.02  |- skos__scopeNote mesh__D020374
% 212.85/213.02       A hybrid separation technique combining both chromatographic and electrophoretic separation principles. While the method was invented to separate neutral species, it can also be applied to charged molecules such as small peptides.%A%    
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D020374 2004
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D020374 2002
% 212.85/213.02  |- mesh__publicMeSHNote mesh__D020374 99   
% 212.85/213.02  |- skos__historyNote mesh__D020374 Chromatography, Liquid %28%1985-1998%29%
% 212.85/213.02  |- mesh__dateEstablished mesh__D020374 1999-01-01
% 212.85/213.02  |- skos__broader mesh__D020374smesh__D002845
% 212.85/213.02  |- skos__altLabel mesh__D020374 MECC
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D020374 2003
% 212.85/213.02  |- mesh__dateCreated mesh__D020374 1998-06-18
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D020374 2001
% 212.85/213.02  |- skos__historyNote mesh__D020374 Chromatography %28%1987-1998%29%
% 212.85/213.02  |- skos__altLabel mesh__D020374 MEKC
% 212.85/213.02  |- skos__related mesh__D020374smesh__D019075
% 212.85/213.02  |- skos__scopeNote mesh__D014337
% 212.85/213.02       Various fish of the family SALMONIDAE, usually smaller than salmon. They are mostly restricted to cool clear freshwater. Some are anadromous. They are highly regarded for their handsome colors, rich well-flavored flesh, and gameness as an angling fish. The genera Salvelinus, Salmo, and ONCORHYNCHUS have been introduced virtually throughout the world.%A%    
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D014337 2004
% 212.85/213.02  |- mesh__historyNote mesh__D014337
% 212.85/213.02       1991%28%1975%29%; use SALMONIDAE 1968-1974   
% 212.85/213.02  |- mesh__dateCreated mesh__D014337 1999-01-01
% 212.85/213.02  |- mesh__publicMeSHNote mesh__D014337 1991; see SALMONIDAE 1968-1990   
% 212.85/213.02  |- skos__hiddenLabel mesh__D014337 Char
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D014337 2006
% 212.85/213.02  |- skos__broader mesh__D014337smesh__D012487
% 212.85/213.02  |- mesh__recordMaintainer mesh__D014337 ags
% 212.85/213.02  |- mesh__recordOriginator mesh__D014337 NLM
% 212.85/213.02  |- mesh__recordAuthorizer mesh__D014337 sjn
% 212.85/213.02  |- skos__altLabel mesh__D014337 Chars
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D014337 2005
% 212.85/213.02  |- skos__prefLabel mesh__D014337 Trout
% 212.85/213.02  |- mesh__dateRevised mesh__D014337 2003-07-09
% 212.85/213.02  |- mesh__dateEstablished mesh__D014337 1991-01-01
% 212.85/213.02  |- rdf__type mesh__D014337sskos__Concept
% 212.85/213.02  |- skos__annotation mesh__D014337
% 212.85/213.02       genera Oncorhynchus and Salmo may be either salmon or trout; check text%A%  
% 212.85/213.02  |- mesh__publicMeSHNote mesh__D019820
% 212.85/213.02       98; XANTHINE was indexed under XANTHINES 1981-97   
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D019820 2004
% 212.85/213.02  |- rdf__type mesh__D019820sskos__Concept
% 212.85/213.02  |- skos__scopeNote mesh__D019820
% 212.85/213.02       A purine base found in most body tissues and fluids, certain plants, and some urinary calculi. It is an intermediate in the degradation of adenosine monophosphate to uric acid, being formed by oxidation of hypoxanthine. The methylated xanthine compounds caffeine, theobromine, and theophylline and their derivatives are used in medicine for their bronchodilator effects. %28%Dorland, 28th ed%29%%A%    
% 212.85/213.02  |- skos__historyNote mesh__D019820 Xanthines %28%1980-1997%29%
% 212.85/213.02  |- skos__broader mesh__D019820smesh__D014970
% 212.85/213.02  |- mesh__dateEstablished mesh__D019820 1998-01-01
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D019820 2000
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D019820 2001
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D019820 1998
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D019820 2005
% 212.85/213.02  |- skos__annotation mesh__D019820
% 212.85/213.02       a specific chem: do not confuse with XANTHINES or XANTHENES%A%  
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D019820 2002
% 212.85/213.02  |- skos__prefLabel mesh__D019820 Xanthine
% 212.85/213.02  |- mesh__dateCreated mesh__D019820 1997-06-20
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D019820 1999
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D019820 2003
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D019820 2006
% 212.85/213.02  |- mesh__historyNote mesh__D019820 98; use XANTHINE %28%NM%29% 1980-97   
% 212.85/213.02  |- skos__annotation mesh__D000317
% 212.85/213.02       GEN or unspecified; prefer specifics; do not confuse with ADRENERGIC ALPHA-AGONISTS; DF: ADREN ALPHA ANTAG%A%  
% 212.85/213.02  |- skos__altLabel mesh__D000317 alpha-Adrenergic Blockers
% 212.85/213.02  |- skos__prefLabel mesh__D000317 Adrenergic alpha-Antagonists
% 212.85/213.02  |- mesh__dateRevised mesh__D000317 2005-06-30
% 212.85/213.02  |- mesh__dateEstablished mesh__D000317 1973-01-01
% 212.85/213.02  |- skos__altLabel mesh__D000317 alpha-Adrenergic Blocking Agents
% 212.85/213.02  |- skos__broader mesh__D000317smesh__D018674
% 212.85/213.02  |- skos__hiddenLabel mesh__D000317 Adrenergic alpha Blockers
% 212.85/213.02  |- skos__historyNote mesh__D000317 Sympatholytics %28%1966-1968%29%
% 212.85/213.02  |- mesh__recordMaintainer mesh__D000317 ssb
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D000317 2006
% 212.85/213.02  |- skos__altLabel mesh__D000317 alpha-Adrenergic Receptor Blockaders
% 212.85/213.02  |- skos__hiddenLabel mesh__D000317 alpha Adrenergic Blockers
% 212.85/213.02  |- rdf__type mesh__D000317sskos__Concept
% 212.85/213.02  |- skos__hiddenLabel mesh__D000317 alpha Blockers, Adrenergic
% 212.85/213.02  |- mesh__onlineNote mesh__D000317
% 212.85/213.02       use ADRENERGIC ALPHA-ANTAGONISTS to search ADRENERGIC ALPHA RECEPTOR BLOCKADERS 1969-94 %28%as Prov 1969-72%29%%A%  
% 212.85/213.02  |- skos__altLabel mesh__D000317 Adrenergic alpha-Blockers
% 212.85/213.02  |- skos__hiddenLabel mesh__D000317 alpha Adrenergic Receptor Blockaders
% 212.85/213.02  |- mesh__recordOriginator mesh__D000317 NLM
% 212.85/213.02  |- skos__hiddenLabel mesh__D000317 Receptor Blockaders, alpha-Adrenergic
% 212.85/213.02  |- skos__hiddenLabel mesh__D000317 Blockers, alpha-Adrenergic
% 212.85/213.02  |- skos__hiddenLabel mesh__D000317 Blockaders, alpha-Adrenergic Receptor
% 212.85/213.02  |- skos__hiddenLabel mesh__D000317 Adrenergic alpha Antagonists
% 212.85/213.02  |- skos__hiddenLabel mesh__D000317 alpha-Antagonists, Adrenergic
% 212.85/213.02  |- skos__scopeNote mesh__D000317
% 212.85/213.02       Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.%A%    
% 212.85/213.02  |- skos__hiddenLabel mesh__D000317 alpha-Receptor Blockaders, Adrenergic
% 212.85/213.02  |- mesh__recordAuthorizer mesh__D000317 sjn
% 212.85/213.02  |- skos__altLabel mesh__D000317 Adrenergic alpha-Receptor Blockaders
% 212.85/213.02  |- skos__altLabel mesh__D000317 alpha-Blockers, Adrenergic
% 212.85/213.02  |- mesh__historyNote mesh__D000317
% 212.85/213.02       95; was ADRENERGIC ALPHA RECEPTOR BLOCKADERS 1969-94 %28%Prov 1969-72%29%%A%  
% 212.85/213.02  |- skos__hiddenLabel mesh__D000317 alpha Adrenergic Blocking Agents
% 212.85/213.02  |- skos__hiddenLabel mesh__D000317 Blocking Agents, alpha-Adrenergic
% 212.85/213.02  |- skos__hiddenLabel mesh__D000317 Agents, alpha-Adrenergic Blocking
% 212.85/213.02  |- skos__hiddenLabel mesh__D000317 Adrenergic alpha Receptor Blockaders
% 212.85/213.02  |- skos__hiddenLabel mesh__D000317 Blockaders, Adrenergic alpha-Receptor
% 212.85/213.02  |- mesh__dateCreated mesh__D000317 1999-01-01
% 212.85/213.02  |- mesh__publicMeSHNote mesh__D000317
% 212.85/213.02       95; was ADRENERGIC ALPHA RECEPTOR BLOCKADERS 1973-94   
% 212.85/213.02  |- skos__broader mesh__D019022smesh__D002608
% 212.85/213.02  |- skos__hiddenLabel mesh__D019022 Almshouse
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D019022 2003
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D019022 1999
% 212.85/213.02  |- mesh__dateCreated mesh__D019022 1995-05-26
% 212.85/213.02  |- skos__altLabel mesh__D019022 Poorhouses
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D019022 2001
% 212.85/213.02  |- rdf__type mesh__D019022sskos__Concept
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D019022 2006
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D019022 1998
% 212.85/213.02  |- mesh__publicMeSHNote mesh__D019022 96   
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D019022 2000
% 212.85/213.02  |- skos__hiddenLabel mesh__D019022 Poorhouse
% 212.85/213.02  |- mesh__dateRevised mesh__D019022 1996-06-10
% 212.85/213.02  |- skos__prefLabel mesh__D019022 Almshouses
% 212.85/213.02  |- mesh__dateEstablished mesh__D019022 1996-01-01
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D019022 2005
% 212.85/213.02  |- mesh__recordOriginator mesh__D019022 TGC
% 212.85/213.02  |- skos__annotation mesh__D019022 in hist contexts only; check hist tags   
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D019022 1997
% 212.85/213.02  |- mesh__historyNote mesh__D019022 96   
% 212.85/213.02  |- skos__scopeNote mesh__D019022
% 212.85/213.02       Privately endowed or public charities or institutions receiving and supporting the aged or infirm poor. They sometimes functioned as centers of health care before the establishment of formal hospitals. %28%From Random House Unabridged Dictionary, 2d ed %26% Dr. James H. Cassedy, NLM History of Medicine Division%29%%A%    
% 212.85/213.02  |- mesh__recordMaintainer mesh__D019022 TGC
% 212.85/213.02  |- mesh__recordAuthorizer mesh__D019022 PLS
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D019022 2002
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D019022 2004
% 212.85/213.02  |- skos__prefLabel mesh__D005800 Genes, Fungal
% 212.85/213.02  |- mesh__publicMeSHNote mesh__D005800 1984   
% 212.85/213.02  |- mesh__recordOriginator mesh__D005800 AEP
% 212.85/213.02  |- mesh__recordMaintainer mesh__D005800 nns
% 212.85/213.02  |- skos__altLabel mesh__D005800 Fungal Genes
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D005800 2006
% 212.85/213.02  |- skos__historyNote mesh__D005800 DNA, Fungal %28%1980-1983%29%
% 212.85/213.02  |- skos__scopeNote mesh__D005800
% 212.85/213.02       The functional hereditary units of FUNGI.     
% 212.85/213.02  |- mesh__recordAuthorizer mesh__D005800 sjn
% 212.85/213.02  |- skos__historyNote mesh__D005800
% 212.85/213.02       specific fungus/genetics %28%1978-1979%29%
% 212.85/213.02  |- mesh__dateRevised mesh__D005800 2005-06-30
% 212.85/213.02  |- skos__annotation mesh__D005800 coordinate with specific fungus /genet   
% 212.85/213.02  |- skos__broader mesh__D005800smesh__D016681
% 212.85/213.02  |- mesh__dateCreated mesh__D005800 1983-02-24
% 212.85/213.02  |- rdf__type mesh__D005800sskos__Concept
% 212.85/213.02  |- skos__hiddenLabel mesh__D005800 Gene, Fungal
% 212.85/213.02  |- skos__broader mesh__D005800smesh__D005796
% 212.85/213.02  |- mesh__dateEstablished mesh__D005800 1984-01-01
% 212.85/213.02  |- skos__historyNote mesh__D005800 Genes %28%1966-1977%29%
% 212.85/213.02  |- skos__hiddenLabel mesh__D005800 Fungal Gene
% 212.85/213.02  |- mesh__historyNote mesh__D005800 1984   
% 212.85/213.02  |- mesh__dateCreated mesh__D005002 1999-01-01
% 212.85/213.02  |- mesh__dateRevised mesh__D005002 2003-07-09
% 212.85/213.02  |- rdf__type mesh__D005002sskos__Concept
% 212.85/213.02  |- skos__prefLabel mesh__D005002 Ethiopia
% 212.85/213.02  |- skos__broader mesh__D005002smesh__D000351
% 212.85/213.02  |- mesh__recordOriginator mesh__D005002 NLM
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D005002 2006
% 212.85/213.02  |- mesh__recordAuthorizer mesh__D005002 sjn
% 212.85/213.02  |- mesh__recordMaintainer mesh__D005002 jls
% 212.85/213.02  |- skos__annotation mesh__D005002
% 212.85/213.02       a country in eastern Africa on the Red Sea   
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D005002 2005
% 212.85/213.02  |- skos__scopeNote mesh__D005002
% 212.85/213.02       An independent state in eastern Africa, east of SUDAN and bounded on the north by the Red Sea. Its capital is Addis Ababa. It gained independence in 1941. In 1952 it became federated with ERITREA which became a separate nation in 1993. %28%Webster%27%s New Geographical Dictionary, 1997, p366%29%%A%    
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D005002 2004
% 212.85/213.02  |- skos__hiddenLabel mesh__D018728 Area, Entorhinal
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D018728 2002
% 212.85/213.02  |- skos__hiddenLabel mesh__D018728 Cortices, Entorhinal
% 212.85/213.02  |- mesh__recordOriginator mesh__D018728 PXP
% 212.85/213.02  |- skos__altLabel mesh__D018728 Entorhinal Area
% 212.85/213.02  |- skos__scopeNote mesh__D018728
% 212.85/213.02       The cytoarchitecturally well-defined area of multilaminate cerebral cortex on the medial aspect of the parahippocampal gyrus, immediately caudal to the olfactory cortex of the uncus. The entorhinal cortex is the origin of the major neural fiber system afferent to the hippocampus, the so-called PERFORANT PATHWAY. %28%Stedman, 25th ed%29%%A%    
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D018728 2003
% 212.85/213.02  |- mesh__recordMaintainer mesh__D018728 jls
% 212.85/213.02  |- skos__hiddenLabel mesh__D018728 Cortex, Entorhinal
% 212.85/213.02  |- mesh__dateCreated mesh__D018728 1994-04-19
% 212.85/213.02  |- skos__prefLabel mesh__D018728 Entorhinal Cortex
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D018728 2000
% 212.85/213.02  |- skos__altLabel mesh__D018728 Entorhinal Cortices
% 212.85/213.02  |- mesh__recordAuthorizer mesh__D018728 sjn
% 212.85/213.02  |- mesh__historyNote mesh__D018728 95   
% 212.85/213.02  |- mesh__dateRevised mesh__D018728 1999-11-08
% 212.85/213.02  |- mesh__publicMeSHNote mesh__D018728 95   
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D018728 2005
% 212.85/213.02  |- skos__hiddenLabel mesh__D018728 Areas, Entorhinal
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D018728 2004
% 212.85/213.02  |- skos__historyNote mesh__D018728 Hippocampus %28%1972-1994%29%
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D018728 2001
% 212.85/213.02  |- mesh__dateEstablished mesh__D018728 1995-01-01
% 212.85/213.02  |- mesh__activeMeSHYear mesh__D018728 2006
% 212.85/213.02  |- skos__historyNote mesh__D018728 Limbic System %28%1969-1994%29%
% 212.85/213.02  |- skos__historyNote mesh__D018728 Cerebral Cortex %28%1968-1994%29%
% 212.85/213.02  |- skos__hiddenLabel mesh__D018728 Entorhinal Areas
% 212.85/213.02  |- rdf__type mesh__D018728sskos__Concept
% 212.88/213.02  |- skos__related mesh__D018728smesh__D019580
% 212.88/213.02  |- skos__broader mesh__D018728smesh__D020534
% 212.88/213.02  |- rdf__type mesh__D010745sskos__Concept
% 212.88/213.02  |- mesh__historyNote mesh__D010745 65   
% 212.88/213.02  |- mesh__recordMaintainer mesh__D010745 ssb
% 212.88/213.02  |- mesh__dateRevised mesh__D010745 2004-07-07
% 212.88/213.02  |- skos__broader mesh__D010745smesh__D017976
% 212.88/213.02  |- mesh__dateEstablished mesh__D010745 1965-01-01
% 212.88/213.02  |- mesh__recordOriginator mesh__D010745 NLM
% 212.88/213.02  |- mesh__publicMeSHNote mesh__D010745 65   
% 212.88/213.02  |- skos__hiddenLabel mesh__D010745 Acids, Phosphonic
% 212.88/213.02  |- mesh__activeMeSHYear mesh__D010745 2006
% 212.88/213.02  |- skos__scopeNote mesh__D010745
% 212.88/213.02       Inorganic or organic derivatives of phosphonic acid with the general formula ROP%28%OH%29%2 or RP%28%=O%29%%28%OH%29%2. The tautomeric form of this compound %28%P%28%OH%29%3%29% is PHOSPHOROUS ACIDS. Nucleoside phosphonates have a phosphate-carbon bond that is more resistant to enzymatic cleavage than the normal phosphate-oxygen bond.%A%    
% 212.88/213.02  |- skos__prefLabel mesh__D010745 Phosphonic Acids
% 212.88/213.02  |- skos__hiddenLabel mesh__D010745 Acid Esters, Phosphonic
% 212.88/213.02  |- skos__annotation mesh__D010745
% 212.88/213.02       do not confuse with PHOSPHINIC ACIDS; for nucleoside phosphonates coordinate with PURINES or PYRIMIDINES%A%  
% 212.88/213.02  |- mesh__activeMeSHYear mesh__D010745 2005
% 212.88/213.02  |- skos__broader mesh__D010745smesh__D009943
% 212.88/213.02  |- mesh__recordAuthorizer mesh__D010745 sjn
% 212.88/213.02  |- mesh__dateCreated mesh__D010745 1999-01-01
% 212.88/213.02  |- skos__hiddenLabel mesh__D010745 Esters, Phosphonic Acid
% 212.88/213.02  |- mesh__activeMeSHYear mesh__D004708 2006
% 212.88/213.02  |- mesh__activeMeSHYear mesh__D004708 1994
% 212.88/213.02  |- mesh__recordMaintainer mesh__D004708 TAP
% 212.88/213.02  |- mesh__activeMeSHYear mesh__D004708 2001
% 212.88/213.02  |- mesh__activeMeSHYear mesh__D004708 1998
% 212.88/213.02  |- mesh__activeMeSHYear mesh__D004708 2003
% 212.88/213.02  |- mesh__activeMeSHYear mesh__D004708 1995
% 212.88/213.02  |- rdf__type mesh__D004708sskos__Concept
% 212.88/213.02  |- skos__scopeNote mesh__D004708
% 212.88/213.02       A dental specialty concerned with the maintenance of the dental pulp in a state of health and the treatment of the pulp cavity %28%pulp chamber and pulp canal%29%.%A%    
% 212.88/213.02  |- mesh__recordOriginator mesh__D004708 NLM
% 212.88/213.02  |- mesh__activeMeSHYear mesh__D004708 1992
% 212.88/213.02  |- mesh__activeMeSHYear mesh__D004708 1999
% 212.88/213.02  |- mesh__activeMeSHYear mesh__D004708 2004
% 212.88/213.02  |- mesh__recordAuthorizer mesh__D004708 PLS
% 212.88/213.02  |- mesh__activeMeSHYear mesh__D004708 1993
% 212.88/213.02  |- mesh__activeMeSHYear mesh__D004708 1996
% 212.88/213.02  |- mesh__activeMeSHYear mesh__D004708 2002
% 212.88/213.02  |- skos__annotation mesh__D004708
% 212.88/213.02       SPEC: SPEC qualif; ENDODONTICS = the specialty, ROOT CANAL THERAPY = the patient%A%  
% 212.88/213.02  |- mesh__activeMeSHYear mesh__D004708 1991
% 212.88/213.02  |- mesh__activeMeSHYear mesh__D004708 1997
% 212.88/213.02  |- skos__broader mesh__D004708smesh__D013039
% 212.88/213.02  |- skos__broader mesh__D004708smesh__D003813
% 212.88/213.02  |- mesh__dateCreated mesh__D004708 1999-01-01
% 212.88/213.02  |- skos__related mesh__D004708smesh__D003788
% 212.88/213.02  |- mesh__activeMeSHYear mesh__D004708 2000
% 212.88/213.02  |- mesh__activeMeSHYear mesh__D004708 2005
% 212.88/213.02  |- skos__prefLabel mesh__D004708 Endodontics
% 212.88/213.02  |- skos__related mesh__D004708smesh__D003791
% 212.88/213.02  |- mesh__dateRevised mesh__D004708 1990-05-29
% 212.88/213.02  |- mesh__recordAuthorizer mesh__D015430 sjn
% 212.88/213.02  |- mesh__activeMeSHYear mesh__D015430 2006
% 212.88/213.02  |- mesh__recordMaintainer mesh__D015430 lkt
% 212.88/213.02  |- skos__prefLabel mesh__D015430 Weight Gain
% 212.88/213.02  |- mesh__dateCreated mesh__D015430 1988-06-08
% 212.88/213.02  |- mesh__onlineNote mesh__D015430 search BODY WEIGHT 1966-88   
% 212.88/213.02  |- skos__related mesh__D015430smesh__D009765
% 212.88/213.02  |- skos__hiddenLabel mesh__D015430 Gains, Weight
% 212.88/213.02  |- mesh__activeMeSHYear mesh__D015430 2005
% 212.88/213.02  |- skos__hiddenLabel mesh__D015430 Weight Gains
% 212.88/213.02  |- mesh__recordOriginator mesh__D015430 WDJ
% 212.88/213.03  |- skos__hiddenLabel mesh__D015430 Gain, Weight
% 212.88/213.03  |- rdf__type mesh__D015430sskos__Concept
% 212.88/213.03  |- mesh__publicMeSHNote mesh__D015430 89; was see BODY WEIGHT 1966-88   
% 212.88/213.03  |- mesh__dateRevised mesh__D015430 2004-07-07
% 212.88/213.03  |- skos__scopeNote mesh__D015430
% 212.88/213.03       Increase in BODY WEIGHT over existing weight.     
% 212.88/213.03  |- mesh__dateEstablished mesh__D015430 1989-01-01
% 212.88/213.03  |- skos__historyNote mesh__D015430 Body Weight %28%1966-1988%29%
% 212.88/213.03  |- mesh__historyNote mesh__D015430 89; was see BODY WEIGHT 1966-88   
% 212.88/213.03  |- skos__broader mesh__D015430smesh__D001836
% 212.88/213.03  |- mesh__recordMaintainer mesh__D001410 SYSTEM
% 212.88/213.03  |- mesh__recordAuthorizer mesh__D001410 sjn
% 212.88/213.03  |- skos__prefLabel mesh__D001410 Bacillus megaterium
% 212.88/213.03  |- rdf__type mesh__D001410sskos__Concept
% 212.88/213.03  |- mesh__dateCreated mesh__D001410 1999-01-01
% 212.88/213.03  |- skos__broader mesh__D001410smesh__D001407
% 212.88/213.03  |- skos__scopeNote mesh__D001410
% 212.88/213.03       A species of bacteria whose spores vary from round to elongate. It is a common soil saprophyte.%A%    
% 212.88/213.03  |- skos__annotation mesh__D001410
% 212.88/213.03       same as B. megatherium; in soil, water, dust, decomposing material%A%  
% 212.88/213.03  |- skos__altLabel mesh__D001410 Bacillus megatherium
% 212.88/213.03  |- mesh__recordOriginator mesh__D001410 NLM
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D001410 2006
% 212.88/213.03  |- mesh__dateRevised mesh__D001410 2005-06-30
% 212.88/213.03  |- skos__prefLabel mesh__D020375 Education, Distance
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D020375 2000
% 212.88/213.03  |- rdf__type mesh__D020375sskos__Concept
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D020375 2006
% 212.88/213.03  |- skos__hiddenLabel mesh__D020375 Learning, Distance
% 212.88/213.03  |- skos__annotation mesh__D020375
% 212.88/213.03       do not confuse with COMPUTER-ASSISTED INSTRUCTION   
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D020375 2001
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D020375 1999
% 212.88/213.03  |- mesh__publicMeSHNote mesh__D020375
% 212.88/213.03       99; for CORRESPONDENCE COURSES see EDUCATION 1978-98   
% 212.88/213.03  |- skos__broader mesh__D020375smesh__D004493
% 212.88/213.03  |- skos__related mesh__D020375smesh__D003195
% 212.88/213.03  |- mesh__historyNote mesh__D020375
% 212.88/213.03       99; for CORRESPONDENCE COURSES see EDUCATION 1978-98   
% 212.88/213.03  |- mesh__dateEstablished mesh__D020375 1999-01-01
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D020375 2003
% 212.88/213.03  |- skos__hiddenLabel mesh__D020375 Correspondence Course
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D020375 2004
% 212.88/213.03  |- skos__scopeNote mesh__D020375
% 212.88/213.03       Education via communication media %28%correspondence, radio, television, computer networks%29% with little or no in-person face-to-face contact between students and teachers. %28%ERIC Thesaurus, 1997%29%%A%    
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D020375 2002
% 212.88/213.03  |- skos__altLabel mesh__D020375 Distance Education
% 212.88/213.03  |- mesh__dateCreated mesh__D020375 1998-06-10
% 212.88/213.03  |- skos__hiddenLabel mesh__D020375 Course, Correspondence
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D020375 2005
% 212.88/213.03  |- skos__broader mesh__D006321Q000530smesh__D006321
% 212.88/213.03  |- rdf__type mesh__D006321Q000530smesh__CompoundConcept
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D014338 2003
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D014338 2001
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D014338 1993
% 212.88/213.03  |- skos__scopeNote mesh__D014338
% 212.88/213.03       The embryonic arterial trunk arising from the heart which then divides into the aorta and the main pulmonary artery.%A%    
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D014338 1999
% 212.88/213.03  |- skos__hiddenLabel mesh__D014338 Arteriosus, Truncus
% 212.88/213.03  |- skos__historyNote mesh__D014338 Aorta %28%1966-1976%29%
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D014338 2000
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D014338 1998
% 212.88/213.03  |- mesh__dateEstablished mesh__D014338 1977-01-01
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D014338 2006
% 212.88/213.03  |- skos__broader mesh__D014338smesh__D005318
% 212.88/213.03  |- skos__prefLabel mesh__D014338 Truncus Arteriosus
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D014338 1995
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D014338 2005
% 212.88/213.03  |- mesh__publicMeSHNote mesh__D014338 77   
% 212.88/213.03  |- mesh__recordAuthorizer mesh__D014338 PLS
% 212.88/213.03  |- mesh__dateRevised mesh__D014338 1992-05-18
% 212.88/213.03  |- mesh__dateCreated mesh__D014338 1976-05-19
% 212.88/213.03  |- mesh__recordMaintainer mesh__D014338 TAP
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D014338 1994
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D014338 2002
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D014338 1997
% 212.88/213.03  |- skos__historyNote mesh__D014338 Pulmonary Artery %28%1966-1976%29%
% 212.88/213.03  |- rdf__type mesh__D014338sskos__Concept
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D014338 1996
% 212.88/213.03  |- mesh__recordOriginator mesh__D014338 VDK
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D014338 2004
% 212.88/213.03  |- mesh__historyNote mesh__D014338 77   
% 212.88/213.03  |- skos__annotation mesh__D014338
% 212.88/213.03       normal; abnormal is probably TRUNCUS ARTERIOSUS, PERSISTENT; pseudotruncus arteriosus = TETRALOGY OF FALLOT%A%  
% 212.88/213.03  |- skos__historyNote mesh__D019821 Naphthalenes %28%1986-1987%29%
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D019821 2004
% 212.88/213.03  |- mesh__historyNote mesh__D019821
% 212.88/213.03       98; use SIMVASTATIN %28%NM%29% 1986-97   
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D019821 2006
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D019821 2003
% 212.88/213.03  |- mesh__dateRevised mesh__D019821 2000-06-22
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D019821 2005
% 212.88/213.03  |- mesh__dateCreated mesh__D019821 1997-06-20
% 212.88/213.03  |- rdf__type mesh__D019821sskos__Concept
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D019821 2002
% 212.88/213.03  |- skos__historyNote mesh__D019821
% 212.88/213.03       Lovastatin/analogs %26% derivatives %28%1988-1997%29%
% 212.88/213.03  |- skos__hiddenLabel mesh__D019821 MK 733
% 212.88/213.03  |- skos__broader mesh__D019821smesh__D008148
% 212.88/213.03  |- mesh__dateEstablished mesh__D019821 1998-01-01
% 212.88/213.03  |- mesh__recordMaintainer mesh__D019821 TWD
% 212.88/213.03  |- skos__scopeNote mesh__D019821
% 212.88/213.03       A derivative of LOVASTATIN and potent competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase %28%HYDROXYMETHYLGLUTARYL COA REDUCTASES%29%, which is the rate-limiting enzyme in cholesterol biosynthesis. It may also interfere with steroid hormone production. Due to the induction of hepatic LDL RECEPTORS, it increases breakdown of LDL-cholesterol %28%LIPOPROTEINS, LDL CHOLESTEROL%29%.%A%    
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D019821 2001
% 212.88/213.03  |- skos__prefLabel mesh__D019821 Simvastatin
% 212.88/213.03  |- mesh__publicMeSHNote mesh__D019821
% 212.88/213.03       98; SIMVASTATIN was indexed under LOVASTATIN/analogs %26% derivatives 1988-97 %26% NAPHTHALENES 1986-87%A%  
% 212.88/213.03  |- skos__hiddenLabel mesh__D019821 MK733
% 212.88/213.03  |- mesh__recordAuthorizer mesh__D019821 sjn
% 212.88/213.03  |- mesh__recordOriginator mesh__D019821 ADP
% 212.88/213.03  |- skos__altLabel mesh__D019821 Synvinolin
% 212.88/213.03  |- mesh__recordOriginator mesh__D019023 TGC
% 212.88/213.03  |- mesh__dateRevised mesh__D019023 1999-11-03
% 212.88/213.03  |- skos__prefLabel mesh__D019023 Stethoscopes
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D019023 2005
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D019023 2002
% 212.88/213.03  |- skos__historyNote mesh__D019023
% 212.88/213.03       Heart Auscultation/instrumentation %28%1966-1995%29%
% 212.88/213.03  |- mesh__historyNote mesh__D019023 96   
% 212.88/213.03  |- skos__historyNote mesh__D019023
% 212.88/213.03       Auscultation/instrumentation %28%1966-1995%29%
% 212.88/213.03  |- mesh__recordAuthorizer mesh__D019023 sjn
% 212.88/213.03  |- skos__hiddenLabel mesh__D019023 Stethoscope
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D019023 2004
% 212.88/213.03  |- skos__scopeNote mesh__D019023
% 212.88/213.03       Instruments intended to detect and study sound produced by the heart, lungs, or other parts of the body. %28%from UMDNS, 1999%29%%A%    
% 212.88/213.03  |- mesh__dateEstablished mesh__D019023 1996-01-01
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D019023 2001
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D019023 2003
% 212.88/213.03  |- mesh__dateCreated mesh__D019023 1995-05-26
% 212.88/213.03  |- skos__broader mesh__D019023smesh__D019719
% 212.88/213.03  |- mesh__publicMeSHNote mesh__D019023 96   
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D019023 2000
% 212.88/213.03  |- mesh__recordMaintainer mesh__D019023 kle
% 212.88/213.03  |- rdf__type mesh__D019023sskos__Concept
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D019023 2006
% 212.88/213.03  |- skos__hiddenLabel mesh__D000318 beta-Receptor Agonist, Adrenergic
% 212.88/213.03  |- mesh__dateEstablished mesh__D000318 1973-01-01
% 212.88/213.03  |- skos__hiddenLabel mesh__D000318 Agonist, Adrenergic beta-Receptor
% 212.88/213.03  |- skos__hiddenLabel mesh__D000318 beta Adrenergic Receptor Agonist
% 212.88/213.03  |- skos__hiddenLabel mesh__D000318 Adrenergic beta Receptor Agonist
% 212.88/213.03  |- skos__altLabel mesh__D000318 Receptor Agonists, beta-Adrenergic
% 212.88/213.03  |- skos__hiddenLabel mesh__D000318 Agonist, beta-Adrenergic Receptor
% 212.88/213.03  |- skos__hiddenLabel mesh__D000318 beta-Agonist, Adrenergic
% 212.88/213.03  |- skos__hiddenLabel mesh__D000318 beta Adrenergic Receptor Agonists
% 212.88/213.03  |- skos__hiddenLabel mesh__D000318 Agonist, beta-Adrenergic
% 212.88/213.03  |- skos__altLabel mesh__D000318 beta-Adrenergic Agonists
% 212.88/213.03  |- skos__hiddenLabel mesh__D000318 beta-Agonists, Adrenergic
% 212.88/213.03  |- mesh__dateRevised mesh__D000318 2005-06-30
% 212.88/213.03  |- skos__scopeNote mesh__D000318
% 212.88/213.03       Drugs that selectively bind to and activate beta-adrenergic receptors.%A%    
% 212.88/213.03  |- skos__historyNote mesh__D000318 Sympathomimetics %28%1966-1968%29%
% 212.88/213.03  |- skos__prefLabel mesh__D000318 Adrenergic beta-Agonists
% 212.88/213.03  |- skos__hiddenLabel mesh__D000318 Agonists, beta-Adrenergic
% 212.88/213.03  |- skos__hiddenLabel mesh__D000318 Receptor Agonists, beta Adrenergic
% 212.88/213.03  |- mesh__recordOriginator mesh__D000318 NLM
% 212.88/213.03  |- skos__hiddenLabel mesh__D000318 beta Adrenergic Agonist
% 212.88/213.03  |- skos__altLabel mesh__D000318 Adrenergic beta-Receptor Agonist
% 212.88/213.03  |- mesh__recordMaintainer mesh__D000318 ssb
% 212.88/213.03  |- skos__hiddenLabel mesh__D000318 Adrenergic beta Receptor Agonists
% 212.88/213.03  |- skos__altLabel mesh__D000318 beta-Adrenergic Agonist
% 212.88/213.03  |- mesh__recordAuthorizer mesh__D000318 sjn
% 212.88/213.03  |- rdf__type mesh__D000318sskos__Concept
% 212.88/213.03  |- skos__broader mesh__D000318smesh__D000322
% 212.88/213.03  |- skos__altLabel mesh__D000318 beta-Adrenergic Receptor Agonist
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D000318 2006
% 212.88/213.03  |- skos__altLabel mesh__D000318 beta-Adrenergic Receptor Agonists
% 212.88/213.03  |- skos__hiddenLabel mesh__D000318 Agonists, beta-Adrenergic Receptor
% 212.88/213.03  |- skos__altLabel mesh__D000318 Adrenergic beta-Agonist
% 212.88/213.03  |- skos__hiddenLabel mesh__D000318 Agonists, Adrenergic beta-Receptor
% 212.88/213.03  |- skos__annotation mesh__D000318
% 212.88/213.03       GEN or unspecified; prefer specifics; do not confuse with ADRENERGIC BETA-ANTAGONISTS; DF: ADREN BETA AGON or ADREN BETA AG%A%  
% 212.88/213.03  |- mesh__historyNote mesh__D000318
% 212.88/213.03       95; was ADRENERGIC BETA RECEPTOR AGONISTS 1969-94 %28%Prov 1969-72%29%%A%  
% 212.88/213.03  |- skos__altLabel mesh__D000318 Receptors Agonists, Adrenergic beta
% 212.88/213.03  |- mesh__dateCreated mesh__D000318 1999-01-01
% 212.88/213.03  |- mesh__publicMeSHNote mesh__D000318
% 212.88/213.03       95; was ADRENERGIC BETA RECEPTOR AGONISTS 1973-94   
% 212.88/213.03  |- mesh__onlineNote mesh__D000318
% 212.88/213.03       use ADRENERGIC BETA-AGONISTS to search ADRENERGIC BETA RECEPTOR AGONISTS 1969-94 %28%as Prov 1969-72%29%%A%  
% 212.88/213.03  |- skos__hiddenLabel mesh__D000318 Adrenergic beta Agonists
% 212.88/213.03  |- skos__hiddenLabel mesh__D000318 Receptor Agonist, beta-Adrenergic
% 212.88/213.03  |- skos__hiddenLabel mesh__D000318 beta Adrenergic Agonists
% 212.88/213.03  |- skos__altLabel mesh__D000318 Adrenergic beta-Receptor Agonists
% 212.88/213.03  |- skos__hiddenLabel mesh__D000318 Adrenergic beta Agonist
% 212.88/213.03  |- skos__hiddenLabel mesh__D000318 beta-Receptor Agonists, Adrenergic
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D011040 1996
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D011040 1993
% 212.88/213.03  |- skos__hiddenLabel mesh__D011040 Dermatitides, Toxicodendron
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D011040 1995
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D011040 1998
% 212.88/213.03  |- skos__scopeNote mesh__D011040
% 212.88/213.03       An allergic contact dermatitis caused by exposure to plants of the genus Toxicodendron %28%formerly Rhus%29%. These include poison ivy, poison oak, and poison sumac, all plants that contain the substance urushiol, a potent skin sensitizing agent. %28%From Dorland, 27th ed%29%%A%    
% 212.88/213.03  |- skos__hiddenLabel mesh__D011040 Dermatitides, Rhus
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D011040 2004
% 212.88/213.03  |- skos__hiddenLabel mesh__D011040 Poison Ivy Dermatitides
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D011040 2002
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D011040 1994
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D011040 2006
% 212.88/213.03  |- mesh__onlineNote mesh__D011040
% 212.88/213.03       use DERMATITIS, TOXICODENDRON to search POISON IVY DERMATITIS 1966-92%A%  
% 212.88/213.03  |- skos__hiddenLabel mesh__D011040 Dermatitides, Poison Ivy
% 212.88/213.03  |- skos__altLabel mesh__D011040 Poison Ivy Dermatitis
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D011040 2003
% 212.88/213.03  |- skos__altLabel mesh__D011040 Rhus Dermatitis
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D011040 2001
% 212.88/213.03  |- mesh__recordMaintainer mesh__D011040 PLS
% 212.88/213.03  |- skos__prefLabel mesh__D011040 Dermatitis, Toxicodendron
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D011040 2005
% 212.88/213.03  |- mesh__recordAuthorizer mesh__D011040 PLS
% 212.88/213.03  |- skos__hiddenLabel mesh__D011040 Dermatitis, Rhus
% 212.88/213.03  |- skos__hiddenLabel mesh__D011040 Rhus Dermatitides
% 212.88/213.03  |- mesh__publicMeSHNote mesh__D011040
% 212.88/213.03       93; was POISON IVY DERMATITIS 1963-92   
% 212.88/213.03  |- mesh__dateRevised mesh__D011040 1992-05-20
% 212.88/213.03  |- skos__altLabel mesh__D011040 Toxicodendron Dermatitis
% 212.88/213.03  |- skos__hiddenLabel mesh__D011040 Toxicodendron Dermatitides
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D011040 2000
% 212.88/213.03  |- mesh__dateCreated mesh__D011040 1999-01-01
% 212.88/213.03  |- rdf__type mesh__D011040sskos__Concept
% 212.88/213.03  |- skos__broader mesh__D011040smesh__D017449
% 212.88/213.03  |- skos__annotation mesh__D011040
% 212.88/213.03       Toxicodendron or Rhus is the genus name for poison ivy; includes poison oak %26% poison sumac%A%  
% 212.88/213.03  |- mesh__historyNote mesh__D011040 93; was POISON IVY DERMATITIS 1963-92   
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D011040 1997
% 212.88/213.03  |- mesh__recordOriginator mesh__D011040 NLM
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D011040 1999
% 212.88/213.03  |- skos__altLabel mesh__D005801 Genes, Homeo Box
% 212.88/213.03  |- mesh__onlineNote mesh__D005801
% 212.88/213.03       use GENES, HOMEOBOX to search GENES, HOMEO BOX 1987-94   
% 212.88/213.03  |- mesh__publicMeSHNote mesh__D005801 95; was GENES, HOMEO BOX 1987-94   
% 212.88/213.03  |- skos__hiddenLabel mesh__D005801 Homeobox Gene
% 212.88/213.03  |- skos__historyNote mesh__D005801 Alleles %28%1968-1975%29%
% 212.88/213.03  |- skos__altLabel mesh__D005801 Homeoboxes
% 212.88/213.03  |- skos__hiddenLabel mesh__D005801 Sequences, Homeobox
% 212.88/213.03  |- skos__altLabel mesh__D005801 Homeo Boxes
% 212.88/213.03  |- skos__hiddenLabel mesh__D005801 Homeo Box Genes
% 212.88/213.03  |- mesh__recordAuthorizer mesh__D005801 sjn
% 212.88/213.03  |- skos__hiddenLabel mesh__D005801 Sequence, Homeobox
% 212.88/213.03  |- skos__broader mesh__D005801smesh__D050437
% 212.88/213.03  |- skos__hiddenLabel mesh__D005801 Homeotic Gene
% 212.88/213.03  |- skos__hiddenLabel mesh__D005801 Gene, Homeo Box
% 212.88/213.03  |- mesh__dateEstablished mesh__D005801 1987-01-01
% 212.88/213.03  |- skos__historyNote mesh__D005801 Morphogenesis %28%1983-1986%29%
% 212.88/213.03  |- mesh__recordMaintainer mesh__D005801 nns
% 212.88/213.03  |- skos__hiddenLabel mesh__D005801 Sequences, Homeo Box
% 212.88/213.03  |- skos__hiddenLabel mesh__D005801 Homeobox Sequences
% 212.88/213.03  |- skos__altLabel mesh__D005801 Homeobox
% 212.88/213.03  |- skos__altLabel mesh__D005801 Homeo Box
% 212.88/213.03  |- skos__hiddenLabel mesh__D005801 Homeobox Genes
% 212.88/213.03  |- skos__hiddenLabel mesh__D005801 Homeo Box Gene
% 212.88/213.03  |- skos__hiddenLabel mesh__D005801 Gene, Homeobox
% 212.88/213.03  |- rdf__type mesh__D005801sskos__Concept
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D005801 2006
% 212.88/213.03  |- skos__altLabel mesh__D005801 Genes, Homeotic
% 212.88/213.03  |- skos__historyNote mesh__D005801
% 212.88/213.03       Drosophila Melanogaster %28%1972-1986%29%
% 212.88/213.03  |- skos__altLabel mesh__D005801 Homeobox Sequence
% 212.88/213.03  |- mesh__dateRevised mesh__D005801 2005-06-30
% 212.88/213.03  |- skos__hiddenLabel mesh__D005801 Homeo Box Sequences
% 212.88/213.03  |- skos__hiddenLabel mesh__D005801 Gene, Homeotic
% 212.88/213.03  |- skos__scopeNote mesh__D005801
% 212.88/213.03       Genes that encode highly conserved TRANSCRIPTION FACTORS that control positional identity of cells %28%BODY PATTERNING%29% and MORPHOGENESIS throughout development. Their sequences contain a 180 nucleotide sequence designated the homeobox, so called because mutations of these genes often results in homeotic transformations, in which one body structure replaces another. The proteins encoded by homeobox genes are called HOMEODOMAIN PROTEINS.%A%    
% 212.88/213.03  |- skos__prefLabel mesh__D005801 Genes, Homeobox
% 212.88/213.03  |- skos__related mesh__D005801smesh__D018398
% 212.88/213.03  |- skos__altLabel mesh__D005801 Homeotic Genes
% 212.88/213.03  |- mesh__dateCreated mesh__D005801 1986-06-18
% 212.88/213.03  |- mesh__historyNote mesh__D005801 95; was GENES, HOMEO BOX 1987-94   
% 212.88/213.03  |- skos__historyNote mesh__D005801 Genes, Structural %28%1983-1986%29%
% 212.88/213.03  |- mesh__recordOriginator mesh__D005801 SCD
% 212.88/213.03  |- skos__altLabel mesh__D005801 Sequence, Homeo Box
% 212.88/213.03  |- skos__altLabel mesh__D005003 Anhydrohydroxyprogesterone
% 212.88/213.03  |- skos__scopeNote mesh__D005003
% 212.88/213.03       17 alpha-Hydroxypregn-4-en-20-yn-3-one. A synthetic steroid hormone with progestational effects.%A%    
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D005003 2006
% 212.88/213.03  |- mesh__historyNote mesh__D005003 65   
% 212.88/213.03  |- skos__hiddenLabel mesh__D005003 17 alpha Ethynyltestosterone
% 212.88/213.03  |- skos__altLabel mesh__D005003 Pregneninolone
% 212.88/213.03  |- mesh__dateEstablished mesh__D005003 1965-01-01
% 212.88/213.03  |- skos__prefLabel mesh__D005003 Ethisterone
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D005003 2005
% 212.88/213.03  |- skos__broader mesh__D005003smesh__D011283
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D005003 2004
% 212.88/213.03  |- mesh__recordOriginator mesh__D005003 NLM
% 212.88/213.03  |- mesh__recordMaintainer mesh__D005003 lkt
% 212.88/213.03  |- mesh__dateCreated mesh__D005003 1999-01-01
% 212.88/213.03  |- mesh__recordAuthorizer mesh__D005003 sjn
% 212.88/213.03  |- mesh__publicMeSHNote mesh__D005003 65   
% 212.88/213.03  |- mesh__dateRevised mesh__D005003 2003-07-09
% 212.88/213.03  |- skos__altLabel mesh__D005003 17 alpha-Ethynyltestosterone
% 212.88/213.03  |- rdf__type mesh__D005003sskos__Concept
% 212.88/213.03  |- skos__hiddenLabel mesh__D018729 Hemi Fontan Procedure
% 212.88/213.03  |- skos__scopeNote mesh__D018729
% 212.88/213.03       A procedure in which total right atrial or total caval blood flow is channeled directly into the pulmonary artery or into a small right ventricle that serves only as a conduit. The principal congenital malformations for which this operation is useful are TRICUSPID ATRESIA and single ventricle with pulmonary stenosis.%A%    
% 212.88/213.03  |- mesh__recordAuthorizer mesh__D018729 SJN
% 212.88/213.03  |- rdf__type mesh__D018729sskos__Concept
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D018729 2005
% 212.88/213.03  |- skos__hiddenLabel mesh__D018729 Procedure, Hemi-Fontan
% 212.88/213.03  |- mesh__recordMaintainer mesh__D018729 NDW
% 212.88/213.03  |- skos__prefLabel mesh__D018729 Fontan Procedure
% 212.88/213.03  |- skos__hiddenLabel mesh__D018729 Operation, Fontan
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D018729 2001
% 212.88/213.03  |- mesh__dateEstablished mesh__D018729 1995-01-01
% 212.88/213.03  |- mesh__dateCreated mesh__D018729 1994-04-19
% 212.88/213.03  |- mesh__recordOriginator mesh__D018729 PXP
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D018729 2000
% 212.88/213.03  |- skos__altLabel mesh__D018729 Fontan Operation
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D018729 2004
% 212.88/213.03  |- skos__broader mesh__D018729smesh__D018610
% 212.88/213.03  |- skos__historyNote mesh__D018729
% 212.88/213.03       Heart Defects, Congenital/surgery %28%1977-1994%29%
% 212.88/213.03  |- mesh__dateRevised mesh__D018729 1998-06-10
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D018729 1999
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D018729 2003
% 212.88/213.03  |- mesh__historyNote mesh__D018729 95   
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D018729 2002
% 212.88/213.03  |- mesh__publicMeSHNote mesh__D018729 95   
% 212.88/213.03  |- skos__hiddenLabel mesh__D018729 Procedure, Fontan
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D018729 2006
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D010746 2001
% 212.88/213.03  |- mesh__dateEstablished mesh__D010746 1990-01-01
% 212.88/213.03  |- mesh__recordAuthorizer mesh__D010746 SJN
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D010746 2004
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D010746 2000
% 212.88/213.03  |- mesh__historyNote mesh__D010746
% 212.88/213.03       90%28%78%29%; was see under ORGANOPHOSPHORUS COMPOUNDS 1978-89   
% 212.88/213.03  |- mesh__recordOriginator mesh__D010746 SH
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D010746 2006
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D010746 2003
% 212.88/213.03  |- mesh__publicMeSHNote mesh__D010746
% 212.88/213.03       90; was see under ORGANOPHOSPHORUS COMPOUNDS 1978-89   
% 212.88/213.03  |- mesh__dateCreated mesh__D010746 1977-04-22
% 212.88/213.03  |- skos__broader mesh__D010746smesh__D000088
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D010746 1999
% 212.88/213.03  |- skos__scopeNote mesh__D010746
% 212.88/213.03       A simple organophosphorus compound that inhibits DNA polymerase, especially in viruses and is used as an antiviral agent.%A%    
% 212.88/213.03  |- skos__hiddenLabel mesh__D010746 Sodium, Fosfonet
% 212.88/213.03  |- skos__altLabel mesh__D010746 Phosphonacetic Acid
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D010746 2005
% 212.88/213.03  |- skos__broader mesh__D010746smesh__D010745
% 212.88/213.03  |- mesh__recordMaintainer mesh__D010746 ADP
% 212.88/213.03  |- skos__hiddenLabel mesh__D010746 Acid, Phosphonoacetic
% 212.88/213.03  |- mesh__dateRevised mesh__D010746 1998-06-10
% 212.88/213.03  |- rdf__type mesh__D010746sskos__Concept
% 212.88/213.03  |- skos__prefLabel mesh__D010746 Phosphonoacetic Acid
% 212.88/213.03  |- skos__hiddenLabel mesh__D010746 Acid, Phosphonacetic
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D010746 2002
% 212.88/213.03  |- skos__hiddenLabel mesh__D010746 Phosphonoacetate, Disodium
% 212.88/213.03  |- skos__historyNote mesh__D010746
% 212.88/213.03       Organophosphorus Compounds %28%1972-1977%29%
% 212.88/213.03  |- mesh__dateEstablished mesh__D004709 1991-01-01
% 212.88/213.03  |- mesh__recordAuthorizer mesh__D004709 sjn
% 212.88/213.03  |- rdf__type mesh__D004709sskos__Concept
% 212.88/213.03  |- mesh__recordMaintainer mesh__D004709 ags
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D004709 2004
% 212.88/213.03  |- mesh__dateRevised mesh__D004709 2003-07-09
% 212.88/213.03  |- skos__annotation mesh__D004709
% 212.88/213.03       infection: coord IM with AMEBIASIS %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 212.88/213.03  |- mesh__publicMeSHNote mesh__D004709
% 212.88/213.03       91; was see under AMOEBA 1977-90; was see under SARCODINA 1963-76%A%  
% 212.88/213.03  |- mesh__recordOriginator mesh__D004709 NLM
% 212.88/213.03  |- mesh__dateCreated mesh__D004709 1999-01-01
% 212.88/213.03  |- skos__prefLabel mesh__D004709 Endolimax
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D004709 2005
% 212.88/213.03  |- mesh__historyNote mesh__D004709
% 212.88/213.03       91%28%75%29%; was see under AMOEBA 1977-90; was see under SARCODINA 1963-76%A%  
% 212.88/213.03  |- mesh__onlineNote mesh__D004709 search SARCODINA 1966-74   
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D004709 2006
% 212.88/213.03  |- skos__broader mesh__D004709smesh__D016846
% 212.88/213.03  |- skos__scopeNote mesh__D004709
% 212.88/213.03       A genus of ameboid protozoa found in the intestines of vertebrates and invertebrates.%A%    
% 212.88/213.03  |- mesh__historyNote mesh__D015431 89; was see BODY WEIGHT 1966-88   
% 212.88/213.03  |- skos__hiddenLabel mesh__D015431 Reductions, Weight
% 212.88/213.03  |- skos__hiddenLabel mesh__D015431 Weight Reductions
% 212.88/213.03  |- skos__hiddenLabel mesh__D015431 Losses, Weight
% 212.88/213.03  |- skos__altLabel mesh__D015431 Weight Reduction
% 212.88/213.03  |- skos__hiddenLabel mesh__D015431 Loss, Weight
% 212.88/213.03  |- skos__broader mesh__D015431smesh__D001836
% 212.88/213.03  |- rdf__type mesh__D015431sskos__Concept
% 212.88/213.03  |- mesh__recordMaintainer mesh__D015431 lkt
% 212.88/213.03  |- skos__hiddenLabel mesh__D015431 Weight Losses
% 212.88/213.03  |- skos__prefLabel mesh__D015431 Weight Loss
% 212.88/213.03  |- mesh__dateRevised mesh__D015431 2004-07-07
% 212.88/213.03  |- mesh__recordAuthorizer mesh__D015431 sjn
% 212.88/213.03  |- mesh__dateCreated mesh__D015431 1988-06-08
% 212.88/213.03  |- mesh__dateEstablished mesh__D015431 1989-01-01
% 212.88/213.03  |- mesh__publicMeSHNote mesh__D015431 89; was see BODY WEIGHT 1966-88   
% 212.88/213.03  |- skos__related mesh__D015431smesh__D013851
% 212.88/213.03  |- skos__historyNote mesh__D015431 Body Weight %28%1966-1988%29%
% 212.88/213.03  |- skos__scopeNote mesh__D015431 Decrease in existing BODY WEIGHT.     
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D015431 2006
% 212.88/213.03  |- mesh__recordOriginator mesh__D015431 WDJ
% 212.88/213.03  |- mesh__onlineNote mesh__D015431 search BODY WEIGHT 1966-88   
% 212.88/213.03  |- skos__hiddenLabel mesh__D015431 Reduction, Weight
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D015431 2005
% 212.88/213.03  |- mesh__recordOriginator mesh__D001411 NLM
% 212.88/213.03  |- mesh__dateRevised mesh__D001411 2005-06-30
% 212.88/213.03  |- rdf__type mesh__D001411sskos__Concept
% 212.88/213.03  |- skos__annotation mesh__D001411 in soil %26% spoiled food   
% 212.88/213.03  |- mesh__publicMeSHNote mesh__D001411 75   
% 212.88/213.03  |- mesh__dateCreated mesh__D001411 1974-11-19
% 212.88/213.03  |- skos__scopeNote mesh__D001411
% 212.88/213.03       A species of gram-positive bacteria found in soil, hot springs, Arctic waters, ocean sediments, and spoiled food products.%A%    
% 212.88/213.03  |- mesh__dateEstablished mesh__D001411 1975-09-01
% 212.88/213.03  |- mesh__recordAuthorizer mesh__D001411 sjn
% 212.88/213.03  |- skos__historyNote mesh__D001411 Bacillus %28%1966-1974%29%
% 212.88/213.03  |- mesh__historyNote mesh__D001411 75   
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D001411 2006
% 212.88/213.03  |- skos__broader mesh__D001411smesh__D001407
% 212.88/213.03  |- skos__prefLabel mesh__D001411 Bacillus stearothermophilus
% 212.88/213.03  |- mesh__recordMaintainer mesh__D001411 SYSTEM
% 212.88/213.03  |- skos__broader mesh__D039081smesh__D017469
% 212.88/213.03  |- skos__altLabel mesh__D039081 Fibronectin Receptor
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D039081 2004
% 212.88/213.03  |- skos__hiddenLabel mesh__D039081 Integrin alpha 5 beta 1
% 212.88/213.03  |- skos__prefLabel mesh__D039081 Integrin alpha5beta1
% 212.88/213.03  |- mesh__activeMeSHYear mesh__D039081 2006
% 212.88/213.03  |- skos__hiddenLabel mesh__D039081 VLA 5 Receptors
% 212.88/213.03  |- skos__hiddenLabel mesh__D039081 beta-1, Integrin alpha-5
% 212.88/213.03  |- skos__hiddenLabel mesh__D039081 Receptor, Fibronectin
% 212.88/213.03  |- mesh__dateCreated mesh__D039081 2002-07-02
% 212.88/213.03  |- skos__broader mesh__D039081smesh__D017474
% 212.88/213.03  |- skos__historyNote mesh__D039081 Receptors, Fibronectin %28%1992-2002%29%
% 212.88/213.03  |- skos__altLabel mesh__D039081 Receptors, VLA-5
% 212.88/213.03  |- rdf__type mesh__D039081sskos__Concept
% 212.88/213.04  |- skos__scopeNote mesh__D039081
% 212.88/213.04       An integrin found in FIBROBLASTS; PLATELETS; MONOCYTES, and LYMPHOCYTES. Integrin alpha5beta1 is the classical receptor for FIBRONECTIN, but it also functions as a receptor for LAMININ and several other EXTRACELLULAR MATRIX PROTEINS.%A%    
% 212.88/213.04  |- skos__annotation mesh__D039081
% 212.88/213.04       do not confuse X ref FIBRONECTIN RECEPTOR with RECEPTORS, FIBRONECTIN%A%  
% 212.88/213.04  |- skos__hiddenLabel mesh__D039081 Receptors, VLA 5
% 212.88/213.04  |- skos__broader mesh__D039081smesh__D010980
% 212.88/213.04  |- skos__hiddenLabel mesh__D039081 Ic/IIa, Platelet Glycoprotein
% 212.88/213.04  |- mesh__publicMeSHNote mesh__D039081
% 212.88/213.04       2003; see RECEPTORS, FIBRONECTIN 1992-2002   
% 212.88/213.04  |- skos__hiddenLabel mesh__D039081 alpha5beta1, Integrin
% 212.88/213.04  |- mesh__historyNote mesh__D039081
% 212.88/213.04       2003; use RECEPTORS, FIBRONECTIN 1992-2002   
% 212.88/213.04  |- mesh__dateRevised mesh__D039081 2003-07-09
% 212.88/213.04  |- skos__altLabel mesh__D039081 VLA-5 Receptors
% 212.88/213.04  |- skos__altLabel mesh__D039081 Platelet Glycoprotein Ic/IIa
% 212.88/213.04  |- skos__broader mesh__D039081smesh__D016029
% 212.88/213.04  |- skos__hiddenLabel mesh__D039081 alpha-5 beta-1, Integrin
% 212.88/213.04  |- skos__altLabel mesh__D039081 VLA-5
% 212.88/213.04  |- mesh__dateEstablished mesh__D039081 2003-01-01
% 212.88/213.04  |- skos__altLabel mesh__D039081 Integrin alpha-5 beta-1
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D039081 2005
% 212.88/213.04  |- skos__hiddenLabel mesh__D039081 Glycoprotein Ic/IIa, Platelet
% 212.88/213.04  |- rdf__type mesh__D020376sskos__Concept
% 212.88/213.04  |- mesh__recordOriginator mesh__D020376 NDW
% 212.88/213.04  |- mesh__dateEstablished mesh__D020376 1999-01-01
% 212.88/213.04  |- skos__prefLabel mesh__D020376 Dichelobacter nodosus
% 212.88/213.04  |- mesh__historyNote mesh__D020376 99   
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D020376 2006
% 212.88/213.04  |- mesh__recordMaintainer mesh__D020376 SYSTEM
% 212.88/213.04  |- mesh__publicMeSHNote mesh__D020376 99   
% 212.88/213.04  |- skos__broader mesh__D020376smesh__D044065
% 212.88/213.04  |- skos__broader mesh__D020376smesh__D016965
% 212.88/213.04  |- skos__historyNote mesh__D020376 Bacteroides %28%1991-1998%29%
% 212.88/213.04  |- skos__annotation mesh__D020376
% 212.88/213.04       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29% and also FOOT ROT %28%IM%29% if pertinent%A%  
% 212.88/213.04  |- mesh__recordAuthorizer mesh__D020376 sjn
% 212.88/213.04  |- skos__related mesh__D020376smesh__D005535
% 212.88/213.04  |- skos__scopeNote mesh__D020376
% 212.88/213.04       A gram-negative, obligate anaerobe of the family Cardiobacteriaceae. It has polar fimbriae and is the causative agent of ovine FOOT ROT. It is the lone species in the genus Dichelobacter.%A%    
% 212.88/213.04  |- skos__altLabel mesh__D020376 Bacteroides nodosus
% 212.88/213.04  |- mesh__dateCreated mesh__D020376 1998-06-10
% 212.88/213.04  |- mesh__dateRevised mesh__D020376 2005-06-30
% 212.88/213.04  |- skos__broader mesh__D006321Q000531smesh__D006321
% 212.88/213.04  |- rdf__type mesh__D006321Q000531smesh__CompoundConcept
% 212.88/213.04  |- mesh__recordOriginator mesh__D014339 VDK
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D014339 2002
% 212.88/213.04  |- skos__broader mesh__D014339smesh__D006330
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D014339 2005
% 212.88/213.04  |- mesh__publicMeSHNote mesh__D014339 77   
% 212.88/213.04  |- mesh__recordMaintainer mesh__D014339 kle
% 212.88/213.04  |- mesh__dateRevised mesh__D014339 1999-11-03
% 212.88/213.04  |- mesh__recordAuthorizer mesh__D014339 sjn
% 212.88/213.04  |- mesh__historyNote mesh__D014339 77   
% 212.88/213.04  |- rdf__type mesh__D014339sskos__Concept
% 212.88/213.04  |- skos__historyNote mesh__D014339
% 212.88/213.04       Heart Defects, Congenital %28%1966-1976%29%
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D014339 2001
% 212.88/213.04  |- skos__hiddenLabel mesh__D014339 Arteriosus, Persistent Truncus
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D014339 2004
% 212.88/213.04  |- mesh__dateEstablished mesh__D014339 1977-01-01
% 212.88/213.04  |- skos__scopeNote mesh__D014339
% 212.88/213.04       A congenital anomaly resulting from the failure of the aorticopulmonary system to develop and divide the truncus arteriosus into the aorta and the pulmonary trunk.%A%    
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D014339 2000
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D014339 2003
% 212.88/213.04  |- skos__annotation mesh__D014339
% 212.88/213.04       abnormal; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 212.88/213.04  |- mesh__dateCreated mesh__D014339 1976-05-19
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D014339 2006
% 212.88/213.04  |- skos__prefLabel mesh__D014339 Truncus Arteriosus, Persistent
% 212.88/213.04  |- skos__hiddenLabel mesh__D014339 Persistent Truncus Arteriosus
% 212.88/213.04  |- mesh__dateEstablished mesh__D025061 2002-01-01
% 212.88/213.04  |- skos__scopeNote mesh__D025061
% 212.88/213.04       General name for two extinct orders of reptiles from the Mesozoic era: Saurischia and Ornithischia.%A%    
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D025061 2006
% 212.88/213.04  |- mesh__dateCreated mesh__D025061 2001-07-25
% 212.88/213.04  |- mesh__publicMeSHNote mesh__D025061 2002   
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D025061 2004
% 212.88/213.04  |- rdf__type mesh__D025061sskos__Concept
% 212.88/213.04  |- skos__historyNote mesh__D025061 Reptiles %28%1966-2001%29%
% 212.88/213.04  |- skos__hiddenLabel mesh__D025061 Dinosaur
% 212.88/213.04  |- mesh__historyNote mesh__D025061 2002   
% 212.88/213.04  |- mesh__dateRevised mesh__D025061 2003-07-09
% 212.88/213.04  |- skos__historyNote mesh__D025061 Fossils %28%1975-2001%29%
% 212.88/213.04  |- skos__broader mesh__D025061smesh__D012104
% 212.88/213.04  |- skos__prefLabel mesh__D025061 Dinosaurs
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D025061 2005
% 212.88/213.04  |- skos__related mesh__D019822smesh__D013388
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D019822 2003
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D019822 1998
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D019822 2000
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D019822 2005
% 212.88/213.04  |- rdf__type mesh__D019822sskos__Concept
% 212.88/213.04  |- mesh__publicMeSHNote mesh__D019822 98   
% 212.88/213.04  |- mesh__historyNote mesh__D019822 98   
% 212.88/213.04  |- skos__hiddenLabel mesh__D019822 Acids, Succinic
% 212.88/213.04  |- skos__annotation mesh__D019822 SUCCINIC ACID also available   
% 212.88/213.04  |- mesh__dateCreated mesh__D019822 1997-06-20
% 212.88/213.04  |- skos__prefLabel mesh__D019822 Succinic Acids
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D019822 2002
% 212.88/213.04  |- mesh__dateEstablished mesh__D019822 1998-01-01
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D019822 2004
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D019822 1999
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D019822 2001
% 212.88/213.04  |- skos__scopeNote mesh__D019822
% 212.88/213.04       A class of dicarboxylic acids with the general structure of butanedioic acid %28%succinic acid%29%. They are used in perfumery and as a chemical intermediate in medicine.%A%    
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D019822 2006
% 212.88/213.04  |- skos__broader mesh__D019822smesh__D003998
% 212.88/213.04  |- mesh__publicMeSHNote mesh__D019024 96   
% 212.88/213.04  |- mesh__historyNote mesh__D019024 96   
% 212.88/213.04  |- mesh__dateRevised mesh__D019024 2004-07-07
% 212.88/213.04  |- skos__altLabel mesh__D019024 Surgeons, Barber
% 212.88/213.04  |- mesh__recordOriginator mesh__D019024 TGC
% 212.88/213.04  |- skos__prefLabel mesh__D019024 Barber Surgeons
% 212.88/213.04  |- skos__broader mesh__D019024smesh__D006666
% 212.88/213.04  |- skos__historyNote mesh__D019024 Barbering/history %28%1966-1995%29%
% 212.88/213.04  |- mesh__recordMaintainer mesh__D019024 jls
% 212.88/213.04  |- mesh__dateCreated mesh__D019024 1995-05-26
% 212.88/213.04  |- mesh__recordAuthorizer mesh__D019024 sjn
% 212.88/213.04  |- skos__scopeNote mesh__D019024
% 212.88/213.04       In the late Middle Ages barbers who also let blood, sold unguents, pulled teeth, applied cups, and gave enemas. They generally had the right to practice surgery. They began to acquire importance about 1100, when the monks, who required the barber%27%s services for the tonsure, also had recourse to them for blood-letting, a practice required by ecclesiastic law. By the 18th century barbers continued to practice minor surgery and dentistry and many famous surgeons acquired their skill in the shops of barbers. %28%From Castiglioni, A History of Medicine, 2d ed, pp402, 568, 658%29%%A%    
% 212.88/213.04  |- skos__annotation mesh__D019024
% 212.88/213.04       usually in hist texts; check hist tags; DF: BARBER SURG   
% 212.88/213.04  |- rdf__type mesh__D019024sskos__Concept
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D019024 2006
% 212.88/213.04  |- skos__hiddenLabel mesh__D019024 Surgeon, Barber
% 212.88/213.04  |- skos__historyNote mesh__D019024 Surgery/history %28%1966-1995%29%
% 212.88/213.04  |- skos__hiddenLabel mesh__D019024 Barber Surgeon
% 212.88/213.04  |- mesh__dateEstablished mesh__D019024 1996-01-01
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D019024 2005
% 212.88/213.04  |- mesh__historyNote mesh__D000319
% 212.88/213.04       95: was ADRENERGIC BETA RECEPTOR BLOCKADERS 1969-94 %28%Prov 1969-72%29%%A%  
% 212.88/213.04  |- skos__hiddenLabel mesh__D000319 Adrenergic beta-Blockers
% 212.88/213.04  |- mesh__recordOriginator mesh__D000319 NLM
% 212.88/213.04  |- mesh__dateEstablished mesh__D000319 1973-01-01
% 212.88/213.04  |- mesh__publicMeSHNote mesh__D000319
% 212.88/213.04       95: was ADRENERGIC BETA RECEPTOR BLOCKADERS 1973-94   
% 212.88/213.04  |- mesh__dateCreated mesh__D000319 1999-01-01
% 212.88/213.04  |- skos__altLabel mesh__D000319 beta-Adrenergic Receptor Blockaders
% 212.88/213.04  |- mesh__onlineNote mesh__D000319
% 212.88/213.04       use ADRENERGIC BETA-ANTAGONISTS to search ADRENERGIC BETA RECEPTOR BLOCKADERS 1973-94 %28%as Prov 1969-72%29%%A%  
% 212.88/213.04  |- skos__altLabel mesh__D000319 beta-Adrenergic Blockers
% 212.88/213.04  |- skos__hiddenLabel mesh__D000319 Blocking Agents, beta-Adrenergic
% 212.88/213.04  |- mesh__recordAuthorizer mesh__D000319 sjn
% 212.88/213.04  |- skos__altLabel mesh__D000319 beta-Blockers, Adrenergic
% 212.88/213.04  |- skos__altLabel mesh__D000319 Adrenergic beta-Receptor Blockaders
% 212.88/213.04  |- skos__scopeNote mesh__D000319
% 212.88/213.04       Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.%A%    
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D000319 2006
% 212.88/213.04  |- skos__broader mesh__D000319smesh__D018674
% 212.88/213.04  |- rdf__type mesh__D000319sskos__Concept
% 212.88/213.04  |- skos__prefLabel mesh__D000319 Adrenergic beta-Antagonists
% 212.88/213.04  |- skos__annotation mesh__D000319
% 212.88/213.04       GEN or unspecified; prefer specifics; do not confuse with ADRENERGIC BETA-AGONISTS; DF: ADREN BETA ANTAG%A%  
% 212.88/213.04  |- skos__hiddenLabel mesh__D000319 beta-Antagonists, Adrenergic
% 212.88/213.04  |- skos__hiddenLabel mesh__D000319 Blockers, beta-Adrenergic
% 212.88/213.04  |- mesh__recordMaintainer mesh__D000319 ssb
% 212.88/213.04  |- skos__hiddenLabel mesh__D000319 Receptor Blockaders, beta-Adrenergic
% 212.88/213.04  |- skos__hiddenLabel mesh__D000319 Blockaders, beta-Adrenergic Receptor
% 212.88/213.04  |- skos__hiddenLabel mesh__D000319 beta Adrenergic Receptor Blockaders
% 212.88/213.04  |- skos__hiddenLabel mesh__D000319 Agents, beta-Adrenergic Blocking
% 212.88/213.04  |- mesh__dateRevised mesh__D000319 2005-06-30
% 212.88/213.04  |- skos__hiddenLabel mesh__D000319 Adrenergic beta Antagonists
% 212.88/213.04  |- skos__hiddenLabel mesh__D000319 Adrenergic beta Receptor Blockaders
% 212.88/213.04  |- skos__hiddenLabel mesh__D000319 beta Blockers, Adrenergic
% 212.88/213.04  |- skos__altLabel mesh__D000319 beta-Adrenergic Blocking Agents
% 212.88/213.04  |- skos__hiddenLabel mesh__D000319 beta-Receptor Blockaders, Adrenergic
% 212.88/213.04  |- skos__hiddenLabel mesh__D000319 beta Adrenergic Blocking Agents
% 212.88/213.04  |- skos__hiddenLabel mesh__D000319 beta Adrenergic Blockers
% 212.88/213.04  |- skos__hiddenLabel mesh__D000319 Blockaders, Adrenergic beta-Receptor
% 212.88/213.04  |- skos__historyNote mesh__D000319 Sympatholytics %28%1966-1968%29%
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D011041 2003
% 212.88/213.04  |- skos__related mesh__D011041smesh__D000931
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D011041 2005
% 212.88/213.04  |- skos__prefLabel mesh__D011041 Poisoning
% 212.88/213.04  |- skos__annotation mesh__D011041
% 212.88/213.04       a dis concept: the field = TOXICOLOGY; IM; GEN only; prefer /pois with Cat D %26% J terms: Manual 19.7+, 19.8.57, 19.9+, 25.11.4; /drug ther: consider also ANTIDOTES; sometimes called %22%toxicoses%22% %26% often called %22%intoxication%22% in foreign lit; DF: POIS%A%  
% 212.88/213.04  |- skos__scopeNote mesh__D011041
% 212.88/213.04       A condition or physical state produced by the ingestion, injection or inhalation of, or exposure to a deleterious agent.%A%    
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D011041 2004
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D011041 2002
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D011041 2006
% 212.88/213.04  |- mesh__dateCreated mesh__D011041 1999-01-01
% 212.88/213.04  |- mesh__recordOriginator mesh__D011041 NLM
% 212.88/213.04  |- skos__broader mesh__D011041smesh__D007280
% 212.88/213.04  |- skos__hiddenLabel mesh__D011041 Poisonings
% 212.88/213.04  |- mesh__recordMaintainer mesh__D011041 KEV
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D011041 2000
% 212.88/213.04  |- rdf__type mesh__D011041sskos__Concept
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D011041 2001
% 212.88/213.04  |- skos__hiddenLabel mesh__D011041 Intoxications
% 212.88/213.04  |- mesh__recordAuthorizer mesh__D011041 sjn
% 212.88/213.04  |- mesh__dateRevised mesh__D011041 1999-11-04
% 212.88/213.04  |- mesh__onlineNote mesh__D005802
% 212.88/213.04       use GENES, MHC CLASS II to search GENES, IMMUNE RESPONSE 1978-91%A%  
% 212.88/213.04  |- skos__annotation mesh__D005802
% 212.88/213.04       MHC stands for %22%Major Histocompatibility Complex%22%; DF: note short X ref%A%  
% 212.88/213.04  |- skos__altLabel mesh__D005802 MHC Class II Genes
% 212.88/213.04  |- skos__altLabel mesh__D005802 Genes, Immune Response
% 212.88/213.04  |- skos__hiddenLabel mesh__D005802 Gene, Immune Response
% 212.88/213.04  |- skos__historyNote mesh__D005802 Genes %28%1966-1977%29%
% 212.88/213.04  |- skos__hiddenLabel mesh__D005802 Gene, Class II
% 212.88/213.04  |- skos__scopeNote mesh__D005802
% 212.88/213.04       Genetic loci in the vertebrate major histocompatibility complex that encode polymorphic products which control the immune response to specific antigens. The genes are found in the HLA-D region in humans and in the I region in mice.%A%    
% 212.88/213.04  |- skos__hiddenLabel mesh__D005802 Gene, Ir
% 212.88/213.04  |- skos__altLabel mesh__D005802 Class II Genes
% 212.88/213.04  |- skos__hiddenLabel mesh__D005802 Immune Response Gene
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D005802 2006
% 212.88/213.04  |- skos__hiddenLabel mesh__D005802 Genes, Ir
% 212.88/213.04  |- rdf__type mesh__D005802sskos__Concept
% 212.88/213.04  |- mesh__recordOriginator mesh__D005802 AEP
% 212.88/213.04  |- skos__hiddenLabel mesh__D005802 Ir Gene
% 212.88/213.04  |- mesh__recordMaintainer mesh__D005802 nns
% 212.88/213.04  |- skos__historyNote mesh__D005802 Genes, Structural %28%1968-1977%29%
% 212.88/213.04  |- mesh__recordAuthorizer mesh__D005802 sjn
% 212.88/213.04  |- skos__altLabel mesh__D005802 Genes, Class II
% 212.88/213.04  |- skos__altLabel mesh__D005802 Genes, HLA Class II
% 212.88/213.04  |- mesh__historyNote mesh__D005802
% 212.88/213.04       92; was GENES, IMMUNE RESPONSE 1978-91   
% 212.88/213.04  |- mesh__dateRevised mesh__D005802 2005-06-30
% 212.88/213.04  |- mesh__dateCreated mesh__D005802 1977-05-04
% 212.88/213.04  |- mesh__dateEstablished mesh__D005802 1978-01-01
% 212.88/213.04  |- skos__hiddenLabel mesh__D005802 Class II Gene
% 212.88/213.04  |- skos__broader mesh__D005802smesh__D008285
% 212.88/213.04  |- skos__prefLabel mesh__D005802 Genes, MHC Class II
% 212.88/213.04  |- skos__altLabel mesh__D005802 Immune Response Genes
% 212.88/213.04  |- mesh__publicMeSHNote mesh__D005802
% 212.88/213.04       92; was GENES, IMMUNE RESPONSE 1978-91   
% 212.88/213.04  |- skos__hiddenLabel mesh__D005004 Plate, Cribriform
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D005004 2006
% 212.88/213.04  |- mesh__dateRevised mesh__D005004 1991-01-07
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D005004 1995
% 212.88/213.04  |- skos__hiddenLabel mesh__D005004 Bones, Ethmoid
% 212.88/213.04  |- skos__hiddenLabel mesh__D005004 Cribriform Plates
% 212.88/213.04  |- mesh__onlineNote mesh__D005004
% 212.88/213.04       use ETHMOID BONE to search CRIBRIFORM PLATE 1966-78   
% 212.88/213.04  |- mesh__recordOriginator mesh__D005004 NLM
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D005004 2005
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D005004 2004
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D005004 1993
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D005004 1994
% 212.88/213.04  |- mesh__recordMaintainer mesh__D005004 TGC
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D005004 2001
% 212.88/213.04  |- skos__hiddenLabel mesh__D005004 Bone, Ethmoid
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D005004 2003
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D005004 1999
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D005004 1992
% 212.88/213.04  |- mesh__recordAuthorizer mesh__D005004 PLS
% 212.88/213.04  |- skos__prefLabel mesh__D005004 Ethmoid Bone
% 212.88/213.04  |- mesh__dateCreated mesh__D005004 1999-01-01
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D005004 2000
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D005004 1998
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D005004 1997
% 212.88/213.04  |- rdf__type mesh__D005004sskos__Concept
% 212.88/213.04  |- skos__annotation mesh__D005004
% 212.88/213.04       fractures: coord ETHMOID BONE /inj %28%IM%29% + SKULL FRACTURES %28%IM%29%; neopl:  coord IM with SKULL NEOPLASMS %28%IM%29%%A%  
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D005004 1996
% 212.88/213.04  |- mesh__historyNote mesh__D005004
% 212.88/213.04       CRIBRIFORM PLATE was see under ETHMOID BONE 1963-78   
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D005004 2002
% 212.88/213.04  |- skos__hiddenLabel mesh__D005004 Plates, Cribriform
% 212.88/213.04  |- skos__hiddenLabel mesh__D005004 Ethmoid Bones
% 212.88/213.04  |- skos__broader mesh__D005004smesh__D012886
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D015432 2006
% 212.88/213.04  |- mesh__dateRevised mesh__D015432 1993-05-28
% 212.88/213.04  |- mesh__publicMeSHNote mesh__D015432 89   
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D015432 2002
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D015432 2003
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D015432 1997
% 212.88/213.04  |- skos__broader mesh__D015432smesh__D007154
% 212.88/213.04  |- skos__hiddenLabel mesh__D015432 Hypocomplementemic Glomerulonephritis
% 212.88/213.04  |- skos__altLabel mesh__D015432 MPGN
% 212.88/213.04  |- skos__altLabel mesh__D015432 Glomerulonephritis, Mesangiocapillary
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D015432 2004
% 212.88/213.04  |- mesh__historyNote mesh__D015432 89   
% 212.88/213.04  |- skos__annotation mesh__D015432
% 212.88/213.04       do not confuse with GLOMERULONEPHRITIS, MEMBRANOUS; do not make diagnoses: use the term used by the author; DF: note short X ref%A%  
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D015432 1994
% 212.88/213.04  |- skos__hiddenLabel mesh__D015432 Hypocomplementemic Glomerulonephritides
% 212.88/213.04  |- mesh__recordOriginator mesh__D015432 WDJ
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D015432 1998
% 212.88/213.04  |- skos__broader mesh__D015432smesh__D005921
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D015432 1995
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D015432 2000
% 212.88/213.04  |- mesh__recordMaintainer mesh__D015432 TGC
% 212.88/213.04  |- rdf__type mesh__D015432sskos__Concept
% 212.88/213.04  |- skos__altLabel mesh__D015432 Membranoproliferative Glomerulonephritis
% 212.88/213.04  |- skos__hiddenLabel mesh__D015432 Glomerulonephritides, Hypocomplementemic
% 212.88/213.04  |- skos__historyNote mesh__D015432 Glomerulonephritis %28%1969-1988%29%
% 212.88/213.04  |- skos__altLabel mesh__D015432 Mesangiocapillary Glomerulonephritis
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D015432 2005
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D015432 1999
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D015432 2001
% 212.88/213.04  |- mesh__dateEstablished mesh__D015432 1989-01-01
% 212.88/213.04  |- skos__hiddenLabel mesh__D015432 Mesangiocapillary Glomerulonephritides
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D015432 1996
% 212.88/213.04  |- mesh__recordAuthorizer mesh__D015432 PLS
% 212.88/213.04  |- skos__scopeNote mesh__D015432
% 212.88/213.04       Chronic glomerulonephritis characterized histologically by proliferation of mesangial cells, increase in the mesangial matrix, and a thickening of the glomerular capillary walls. The wall thickening is sometimes said to be a result of the interposition of mesangial cytoplasm or matrix between the basement membrane and the endothelium of the capillary wall. It is often divided into types I and II, and sometimes III. Pathogenesis is not well understood, but some types are thought to involve the immune system, with the complement system, in particular, being implicated.%A%    
% 212.88/213.04  |- skos__hiddenLabel mesh__D015432 Glomerulonephritides, Mesangiocapillary
% 212.88/213.04  |- skos__hiddenLabel mesh__D015432
% 212.88/213.04       Membranoproliferative Glomerulonephritides
% 212.88/213.04  |- skos__altLabel mesh__D015432 Glomerulonephritis, Hypocomplementemic
% 212.88/213.04  |- mesh__dateCreated mesh__D015432 1988-06-08
% 212.88/213.04  |- skos__prefLabel mesh__D015432 Glomerulonephritis, Membranoproliferative
% 212.88/213.04  |- skos__hiddenLabel mesh__D015432
% 212.88/213.04       Glomerulonephritides, Membranoproliferative
% 212.88/213.04  |- mesh__recordMaintainer mesh__D001412 SYSTEM
% 212.88/213.04  |- rdf__type mesh__D001412sskos__Concept
% 212.88/213.04  |- mesh__dateRevised mesh__D001412 2005-06-30
% 212.88/213.04  |- skos__scopeNote mesh__D001412
% 212.88/213.04       A species of gram-positive bacteria that is a common soil and water saprophyte.%A%    
% 212.88/213.04  |- mesh__dateCreated mesh__D001412 1999-01-01
% 212.88/213.04  |- skos__altLabel mesh__D001412 Bacillus subtilis %28%natto%29%
% 212.88/213.04  |- mesh__recordAuthorizer mesh__D001412 sjn
% 212.88/213.04  |- skos__prefLabel mesh__D001412 Bacillus subtilis
% 212.88/213.04  |- skos__altLabel mesh__D001412 Bacillus subtilis var. natto
% 212.88/213.04  |- skos__broader mesh__D001412smesh__D001407
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D001412 2006
% 212.88/213.04  |- mesh__recordOriginator mesh__D001412 NLM
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D020377 1999
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D020377 2006
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D020377 2000
% 212.88/213.04  |- skos__broader mesh__D020377smesh__D012649
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D020377 2003
% 212.88/213.04  |- mesh__publicMeSHNote mesh__D020377 99   
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D020377 2001
% 212.88/213.04  |- mesh__dateEstablished mesh__D020377 1999-01-01
% 212.88/213.04  |- skos__historyNote mesh__D020377 Self Concept %28%1969-1998%29%
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D020377 2004
% 212.88/213.04  |- mesh__historyNote mesh__D020377 99   
% 212.88/213.04  |- mesh__dateCreated mesh__D020377 1998-06-11
% 212.88/213.04  |- skos__prefLabel mesh__D020377 Self Efficacy
% 212.88/213.04  |- rdf__type mesh__D020377sskos__Concept
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D020377 2002
% 212.88/213.04  |- skos__hiddenLabel mesh__D020377 Efficacy, Self
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D020377 2005
% 212.88/213.04  |- skos__scopeNote mesh__D020377
% 212.88/213.04       Cognitive mechanism based on expectations or beliefs about one%27%s ability to perform actions necessary to produce a given effect. It is also a theoretical component of behavior change in various therapeutic treatments. %28%APA, Thesaurus of Psychological Index Terms, 1994%29%%A%    
% 212.88/213.04  |- rdf__type mesh__D025062sskos__Concept
% 212.88/213.04  |- skos__scopeNote mesh__D025062
% 212.88/213.04       A genus of ascomycetous yeast in the family Dipodascaceae, order SACCHAROMYCETALES.%A%    
% 212.88/213.04  |- mesh__recordAuthorizer mesh__D025062 sjn
% 212.88/213.04  |- mesh__dateRevised mesh__D025062 2005-06-30
% 212.88/213.04  |- mesh__recordOriginator mesh__D025062 ags
% 212.88/213.04  |- mesh__dateCreated mesh__D025062 2001-07-25
% 212.88/213.04  |- mesh__recordMaintainer mesh__D025062 SYSTEM
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D025062 2006
% 212.88/213.04  |- skos__historyNote mesh__D025062 Yeasts %28%1980-2001%29%
% 212.88/213.04  |- mesh__dateEstablished mesh__D025062 2002-01-01
% 212.88/213.04  |- skos__prefLabel mesh__D025062 Yarrowia
% 212.88/213.04  |- skos__broader mesh__D025062smesh__D015003
% 212.88/213.04  |- mesh__historyNote mesh__D025062 2002   
% 212.88/213.04  |- mesh__publicMeSHNote mesh__D025062 2002   
% 212.88/213.04  |- skos__broader mesh__D025062smesh__D004718
% 212.88/213.04  |- skos__scopeNote mesh__D011840
% 212.88/213.04       Electromagnetic radiation which does not produce ions in matter through which it passes. Its wavelengths are generally greater than those of far ultraviolet radiation and range through the longest radio waves.%A%    
% 212.88/213.04  |- mesh__dateRevised mesh__D011840 1996-06-10
% 212.88/213.04  |- mesh__recordOriginator mesh__D011840 JW
% 212.88/213.04  |- rdf__type mesh__D011840sskos__Concept
% 212.88/213.04  |- skos__hiddenLabel mesh__D011840 Radiation, Non-Ionizing
% 212.88/213.04  |- skos__hiddenLabel mesh__D011840 Electromagnetic Radiations, Non-Ionizing
% 212.88/213.04  |- skos__altLabel mesh__D011840 Non-Ionizing Radiation
% 212.88/213.04  |- skos__hiddenLabel mesh__D011840 Electromagnetic Radiation, Non Ionizing
% 212.88/213.04  |- skos__hiddenLabel mesh__D011840 Radiations, Non-Ionizing
% 212.88/213.04  |- skos__altLabel mesh__D011840 Radiation, Nonionizing Electromagnetic
% 212.88/213.04  |- skos__altLabel mesh__D011840 Nonionizing Electromagnetic Radiation
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D011840 2002
% 212.88/213.04  |- skos__hiddenLabel mesh__D011840 Radiation, Non Ionizing Electromagnetic
% 212.88/213.04  |- skos__hiddenLabel mesh__D011840 Nonionizing Radiations
% 212.88/213.04  |- skos__hiddenLabel mesh__D011840 Radiations, Nonionizing
% 212.88/213.04  |- skos__altLabel mesh__D011840 Radiation, Non-Ionizing Electromagnetic
% 212.88/213.04  |- skos__prefLabel mesh__D011840 Radiation, Nonionizing
% 212.88/213.04  |- skos__altLabel mesh__D011840 Non-Ionizing Electromagnetic Radiation
% 212.88/213.04  |- mesh__recordMaintainer mesh__D011840 TGC
% 212.88/213.04  |- skos__hiddenLabel mesh__D011840 Non Ionizing Radiation
% 212.88/213.04  |- mesh__dateEstablished mesh__D011840 1976-01-01
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D011840 2003
% 212.88/213.04  |- skos__hiddenLabel mesh__D011840 Non-Ionizing Electromagnetic Radiations
% 212.88/213.04  |- skos__hiddenLabel mesh__D011840 Electromagnetic Radiations, Nonionizing
% 212.88/213.04  |- skos__hiddenLabel mesh__D011840 Non-Ionizing Radiations
% 212.88/213.04  |- skos__hiddenLabel mesh__D011840 Nonionizing Electromagnetic Radiations
% 212.88/213.04  |- skos__historyNote mesh__D011840 Radiation %28%1966-1975%29%
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D011840 1997
% 212.88/213.04  |- skos__hiddenLabel mesh__D011840 Radiations, Nonionizing Electromagnetic
% 212.88/213.04  |- mesh__historyNote mesh__D011840 76; was NON MESH before 1976   
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D011840 1998
% 212.88/213.04  |- mesh__dateCreated mesh__D011840 1975-07-21
% 212.88/213.04  |- skos__altLabel mesh__D011840 Nonionizing Radiation
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D011840 2004
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D011840 2000
% 212.88/213.04  |- skos__hiddenLabel mesh__D011840 Non Ionizing Electromagnetic Radiation
% 212.88/213.04  |- mesh__publicMeSHNote mesh__D011840 76   
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D011840 2005
% 212.88/213.04  |- skos__annotation mesh__D011840
% 212.88/213.04       as NIM: Manual 19.8.60, 28.11.1; when not to use: Manual 21.16; no qualif except /adv eff; DF: RAD NONIONIZING%A%  
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D011840 1999
% 212.88/213.04  |- skos__hiddenLabel mesh__D011840 Radiations, Non-Ionizing Electromagnetic
% 212.88/213.04  |- skos__altLabel mesh__D011840 Electromagnetic Radiation, Nonionizing
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D011840 2001
% 212.88/213.04  |- skos__altLabel mesh__D011840 Electromagnetic Radiation, Non-Ionizing
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D011840 2006
% 212.88/213.04  |- mesh__recordAuthorizer mesh__D011840 PLS
% 212.88/213.04  |- skos__broader mesh__D011840smesh__D011827
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D011042 2004
% 212.88/213.04  |- mesh__recordAuthorizer mesh__D011042 sjn
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D011042 2006
% 212.88/213.04  |- skos__scopeNote mesh__D011042
% 212.88/213.04       Substances which, when ingested, inhaled, or absorbed, or when applied to, injected into, or developed within the body in relatively small amounts may, by their chemical action, cause damage to structure or disturbance of function. %28%From Dorland, 27th ed%29%%A%    
% 212.88/213.04  |- mesh__dateCreated mesh__D011042 1999-01-01
% 212.88/213.04  |- skos__broader mesh__D011042smesh__D020313
% 212.88/213.04  |- rdf__type mesh__D011042sskos__Concept
% 212.88/213.04  |- skos__broader mesh__D011042smesh__D009676
% 212.88/213.04  |- mesh__recordOriginator mesh__D011042 NLM
% 212.88/213.04  |- skos__prefLabel mesh__D011042 Poisons
% 212.88/213.04  |- mesh__recordMaintainer mesh__D011042 ssb
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D011042 2005
% 212.88/213.04  |- skos__annotation mesh__D011042 IM   
% 212.88/213.04  |- mesh__dateRevised mesh__D011042 2003-07-09
% 212.88/213.04  |- skos__scopeNote mesh__D005803
% 212.88/213.04       Genes encoding the different subunits of the IMMUNOGLOBULINS, for example the IMMUNOGLOBULIN LIGHT CHAIN GENES and the IMMUNOGLOBULIN HEAVY CHAIN GENES. The heavy and light immunoglobulin genes are present as gene segments in the germline cells. The completed genes are created when the segments are shuffled and assembled %28%B-LYMPHOCYTE GENE REARRANGEMENT%29% during B-LYMPHOCYTE maturation. The gene segments of the human light and heavy chain germline genes are symbolized V %28%variable%29%, J %28%joining%29% and C %28%constant%29%. The heavy chain germline genes have an additional segment D %28%diversity%29%.%A%    
% 212.88/213.04  |- skos__hiddenLabel mesh__D005803 Gene, Immunoglobulin
% 212.88/213.04  |- skos__related mesh__D005803smesh__D007136
% 212.88/213.04  |- skos__prefLabel mesh__D005803 Genes, Immunoglobulin
% 212.88/213.04  |- skos__hiddenLabel mesh__D005803 Ig Gene
% 212.88/213.04  |- mesh__recordMaintainer mesh__D005803 nns
% 212.88/213.04  |- mesh__recordOriginator mesh__D005803 SCD
% 212.88/213.04  |- mesh__dateRevised mesh__D005803 2005-06-30
% 212.88/213.04  |- skos__related mesh__D005803smesh__D050440
% 212.88/213.04  |- skos__altLabel mesh__D005803 Immunoglobulin Genes
% 212.88/213.04  |- skos__historyNote mesh__D005803
% 212.88/213.04       specific immunoglobulin chain or region %28%1975-1987%29%
% 212.88/213.04  |- skos__hiddenLabel mesh__D005803 Immunoglobulin Gene
% 212.88/213.04  |- skos__broader mesh__D005803smesh__D005796
% 212.88/213.04  |- mesh__dateCreated mesh__D005803 1987-05-11
% 212.88/213.04  |- skos__historyNote mesh__D005803 Genes, Structural %28%1972-1987%29%
% 212.88/213.04  |- mesh__activeMeSHYear mesh__D005803 2006
% 212.88/213.04  |- rdf__type mesh__D005803sskos__Concept
% 212.88/213.04  |- skos__related mesh__D005803smesh__D007125
% 212.88/213.04  |- skos__altLabel mesh__D005803 Genes, Ig
% 212.88/213.04  |- skos__historyNote mesh__D005803 Immunoglobulins %28%1972-1987%29%
% 212.88/213.04  |- skos__broader mesh__D005803smesh__D007125
% 212.88/213.05  |- mesh__publicMeSHNote mesh__D005803 88   
% 212.88/213.05  |- skos__hiddenLabel mesh__D005803 Ig Genes
% 212.88/213.05  |- skos__hiddenLabel mesh__D005803 Gene, Ig
% 212.88/213.05  |- skos__related mesh__D005803smesh__D007126
% 212.88/213.05  |- mesh__dateEstablished mesh__D005803 1988-01-01
% 212.88/213.05  |- mesh__historyNote mesh__D005803 88   
% 212.88/213.05  |- mesh__recordAuthorizer mesh__D005803 sjn
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D005005 2005
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D005005 2002
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D005005 1999
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D005005 2003
% 212.88/213.05  |- mesh__dateCreated mesh__D005005 1999-01-01
% 212.88/213.05  |- skos__hiddenLabel mesh__D005005 Sinus, Ethmoid
% 212.88/213.05  |- skos__scopeNote mesh__D005005
% 212.88/213.05       Numerous small thin-walled spaces or air cells in the ethmoid bone, where they form an ethmoidal labyrinth.%A%    
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D005005 1997
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D005005 1998
% 212.88/213.05  |- mesh__recordOriginator mesh__D005005 VDK
% 212.88/213.05  |- rdf__type mesh__D005005sskos__Concept
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D005005 2001
% 212.88/213.05  |- skos__prefLabel mesh__D005005 Ethmoid Sinus
% 212.88/213.05  |- mesh__dateRevised mesh__D005005 1994-05-12
% 212.88/213.05  |- mesh__recordAuthorizer mesh__D005005 PLS
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D005005 1996
% 212.88/213.05  |- skos__annotation mesh__D005005
% 212.88/213.05       inflammation or sinusitis = ETHMOID SINUSITIS; fractures: coord ETHMOID SINUS /inj %28%IM%29% + SKULL FRACTURES %28%IM%29%; neopl: coord IM with PARANASAL SINUS NEOPLASMS %28%IM%29%%A%  
% 212.88/213.05  |- skos__broader mesh__D005005smesh__D010256
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D005005 2000
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D005005 2006
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D005005 1995
% 212.88/213.05  |- mesh__recordMaintainer mesh__D005005 PXP
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D005005 2004
% 212.88/213.05  |- mesh__publicMeSHNote mesh__D043922
% 212.88/213.05       2004; see PHARMACOGENETICS 2003; for TOXICOGENOMICS see PHARMACOGENETICS 2003%A%  
% 212.88/213.05  |- skos__broader mesh__D043922smesh__D010597
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D043922 2006
% 212.88/213.05  |- skos__prefLabel mesh__D043922 Toxicogenetics
% 212.88/213.05  |- skos__broader mesh__D043922smesh__D014116
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D043922 2005
% 212.88/213.05  |- skos__historyNote mesh__D043922 Pharmacogenetics %28%1993-2003%29%
% 212.88/213.05  |- skos__scopeNote mesh__D043922
% 212.88/213.05       The study of existing genetic knowledge, and the generation of new genetic data, to understand and thus avoid DRUG TOXICITY and adverse effects from toxic substances from the environment.%A%    
% 212.88/213.05  |- mesh__historyNote mesh__D043922
% 212.88/213.05       2004; use PHARMACOGENETICS 2003; for TOXICOGENOMICS use PHARMACOGENETICS 2003%A%  
% 212.88/213.05  |- mesh__dateEstablished mesh__D043922 2004-01-01
% 212.88/213.05  |- mesh__recordOriginator mesh__D043922 nns
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D043922 2004
% 212.88/213.05  |- mesh__dateCreated mesh__D043922 2003-07-09
% 212.88/213.05  |- mesh__recordAuthorizer mesh__D043922 sjn
% 212.88/213.05  |- rdf__type mesh__D043922sskos__Concept
% 212.88/213.05  |- skos__historyNote mesh__D043922 Toxicology %28%1993-2003%29%
% 212.88/213.05  |- skos__annotation mesh__D043922
% 212.88/213.05       SPEC or GEN; prefer specific drug or toxic substance and specific genetic aspect%A%  
% 212.88/213.05  |- mesh__recordMaintainer mesh__D043922 nns
% 212.88/213.05  |- mesh__recordOriginator mesh__D010748 NLM
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D010748 1998
% 212.88/213.05  |- mesh__recordAuthorizer mesh__D010748 PLS
% 212.88/213.05  |- skos__broader mesh__D010748smesh__D010455
% 212.88/213.05  |- mesh__dateCreated mesh__D010748 1999-01-01
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D010748 1993
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D010748 1995
% 212.88/213.05  |- rdf__type mesh__D010748sskos__Concept
% 212.88/213.05  |- mesh__dateRevised mesh__D010748 1992-05-19
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D010748 1994
% 212.88/213.05  |- skos__prefLabel mesh__D010748 Phosphopeptides
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D010748 2002
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D010748 2004
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D010748 2001
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D010748 2006
% 212.88/213.05  |- mesh__recordMaintainer mesh__D010748 TAP
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D010748 2003
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D010748 1997
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D010748 2005
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D010748 1999
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D010748 2000
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D010748 1996
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D015433 1996
% 212.88/213.05  |- skos__altLabel mesh__D015433 Extramembranous Glomerulopathy
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433 Extramembranous Glomerulopathies
% 212.88/213.05  |- skos__altLabel mesh__D015433 Nephropathy, Membranous
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433 Nephropathies, Membranous
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433 Glomerulopathies, Extramembranous
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433 Membranous Glomerulonephritides
% 212.88/213.05  |- mesh__recordAuthorizer mesh__D015433 PLS
% 212.88/213.05  |- skos__broader mesh__D015433smesh__D001327
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433 Idiopathic Membranous Nephropathies
% 212.88/213.05  |- mesh__historyNote mesh__D015433 89   
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D015433 2003
% 212.88/213.05  |- mesh__recordOriginator mesh__D015433 WDJ
% 212.88/213.05  |- skos__historyNote mesh__D015433 Glomerulonephritis %28%1966-1988%29%
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D015433 2002
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433 Glomerulopathy, Membranous
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433
% 212.88/213.05       Idiopathic Membranous Glomerulonephritides
% 212.88/213.05  |- skos__altLabel mesh__D015433 Idiopathic Membranous Nephropathy
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433
% 212.88/213.05       Glomerulonephritis, Idiopathic Membranous
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D015433 1995
% 212.88/213.05  |- skos__broader mesh__D015433smesh__D005921
% 212.88/213.05  |- skos__altLabel mesh__D015433 MGN
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433 Glomerulonephritides, Membranous
% 212.88/213.05  |- rdf__type mesh__D015433sskos__Concept
% 212.88/213.05  |- skos__scopeNote mesh__D015433
% 212.88/213.05       A disease of the glomerulus manifested clinically by proteinuria, and sometimes by other features of the nephrotic syndrome. It is histologically characterized by deposits in the glomerular capillary wall between the epithelial cell and the basement membrane and a thickening of the membrane. Also characteristic are outward projections of the membrane between the epithelial deposits in the form of %22%spikes%22%. There is some agreement that the deposits are antigen-antibody complexes.%A%    
% 212.88/213.05  |- skos__annotation mesh__D015433
% 212.88/213.05       do not confuse with GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; do not make diagnoses: use the term used by the author; DF: note short X ref%A%  
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433
% 212.88/213.05       Membranous Glomerulonephritides, Idiopathic
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433
% 212.88/213.05       Glomerulonephritides, Idiopathic Membranous
% 212.88/213.05  |- mesh__recordMaintainer mesh__D015433 PLS
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433 Membranous Glomerulonephritis
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D015433 1999
% 212.88/213.05  |- skos__altLabel mesh__D015433 Membranous Glomerulonephropathy
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433 Membranous Nephropathy, Idiopathic
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D015433 1994
% 212.88/213.05  |- mesh__dateEstablished mesh__D015433 1989-01-01
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433 Glomerulonephropathy, Membranous
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D015433 2001
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433
% 212.88/213.05       Membranous Glomerulonephritis, Idiopathic
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433 Membranous Nephropathies
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433 Membranous Nephropathies, Idiopathic
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433 Glomerulopathy, Extramembranous
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433 Nephropathies, Idiopathic Membranous
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D015433 2006
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D015433 1998
% 212.88/213.05  |- mesh__dateRevised mesh__D015433 1993-05-28
% 212.88/213.05  |- mesh__publicMeSHNote mesh__D015433 89   
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D015433 1997
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433 Glomerulonephropathies, Membranous
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433 Glomerulopathies, Membranous
% 212.88/213.05  |- skos__prefLabel mesh__D015433 Glomerulonephritis, Membranous
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D015433 2000
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433 Nephropathy, Idiopathic Membranous
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433 Membranous Glomerulonephropathies
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D015433 2005
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433 Membranous Glomerulopathies
% 212.88/213.05  |- skos__hiddenLabel mesh__D015433 Membranous Nephropathy
% 212.88/213.05  |- skos__altLabel mesh__D015433 Membranous Glomerulopathy
% 212.88/213.05  |- mesh__dateCreated mesh__D015433 1988-06-08
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D015433 2004
% 212.88/213.05  |- skos__prefLabel mesh__D001413 Bacillus thuringiensis
% 212.88/213.05  |- mesh__historyNote mesh__D001413 75   
% 212.88/213.05  |- mesh__dateEstablished mesh__D001413 1975-09-01
% 212.88/213.05  |- skos__broader mesh__D001413smesh__D001407
% 212.88/213.05  |- skos__historyNote mesh__D001413 Bacillus %28%1966-1974%29%
% 212.88/213.05  |- mesh__recordOriginator mesh__D001413 NLM
% 212.88/213.05  |- mesh__publicMeSHNote mesh__D001413 75   
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D001413 2006
% 212.88/213.05  |- mesh__dateCreated mesh__D001413 1974-11-19
% 212.88/213.05  |- mesh__dateRevised mesh__D001413 2005-06-30
% 212.88/213.05  |- rdf__type mesh__D001413sskos__Concept
% 212.88/213.05  |- skos__scopeNote mesh__D001413
% 212.88/213.05       A species of gram-positive bacteria which may be pathogenic for certain insects. It is used for the biological control of the Gypsy moth.%A%    
% 212.88/213.05  |- mesh__recordMaintainer mesh__D001413 SYSTEM
% 212.88/213.05  |- mesh__recordAuthorizer mesh__D001413 sjn
% 212.88/213.05  |- skos__annotation mesh__D001413 pathogenic for insects   
% 212.88/213.05  |- skos__altLabel mesh__D039881 Peptide Initiation Factor 2
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D039881 2004
% 212.88/213.05  |- skos__broader mesh__D039881smesh__D039662
% 212.88/213.05  |- skos__altLabel mesh__D039881 infB Protein
% 212.88/213.05  |- skos__prefLabel mesh__D039881 Prokaryotic Initiation Factor-2
% 212.88/213.05  |- skos__scopeNote mesh__D039881
% 212.88/213.05       The largest of the three prokaryotic initiation factors with a molecular size of approximately 80 kD. It functions in the transcription initiation process by promoting the binding of formylmethionine-tRNA to the P-site of the 30S ribosome and by preventing the incorrect binding of elongator tRNA to the translation initiation site.%A%    
% 212.88/213.05  |- mesh__recordOriginator mesh__D039881 jmp
% 212.88/213.05  |- mesh__dateCreated mesh__D039881 2002-07-03
% 212.88/213.05  |- skos__hiddenLabel mesh__D039881 Prokaryotic Initiation Factor 2
% 212.88/213.05  |- mesh__recordMaintainer mesh__D039881 jmp
% 212.88/213.05  |- mesh__publicMeSHNote mesh__D039881
% 212.88/213.05       2003; PROKARYOTIC INITIATION FACTOR-2 was indexed under PEPTIDE INTIATION FACTORS 1990-2002; TRANSLATIONAL INITIATION FACTOR 2 was indexed under PEPTIDE INITIATION FACTORS 1997-2002%A%  
% 212.88/213.05  |- skos__hiddenLabel mesh__D039881 Peptide Initiation Factor IF 2
% 212.88/213.05  |- skos__hiddenLabel mesh__D039881 Initiation Factor-2, Prokaryotic
% 212.88/213.05  |- rdf__type mesh__D039881sskos__Concept
% 212.88/213.05  |- mesh__dateEstablished mesh__D039881 2003-01-01
% 212.88/213.05  |- skos__altLabel mesh__D039881 IF2 Protein
% 212.88/213.05  |- skos__altLabel mesh__D039881 Initiation Factor-2
% 212.88/213.05  |- skos__altLabel mesh__D039881 Translational Initiation Factor 2
% 212.88/213.05  |- skos__altLabel mesh__D039881 infB Gene Product
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D039881 2005
% 212.88/213.05  |- skos__altLabel mesh__D039881 Peptide Initiation Factor IF-2
% 212.88/213.05  |- mesh__recordAuthorizer mesh__D039881 sjn
% 212.88/213.05  |- skos__hiddenLabel mesh__D039881 Initiation Factor 2
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D039881 2003
% 212.88/213.05  |- skos__historyNote mesh__D039881
% 212.88/213.05       Peptide Initiation Factors %28%1990-2002%29%
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D039881 2006
% 212.88/213.05  |- mesh__historyNote mesh__D039881
% 212.88/213.05       2003; use PROKARYOTIC INITIATION FACTOR-2 %28%NM%29% 1990-2002   
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D020378 2004
% 212.88/213.05  |- skos__related mesh__D020378smesh__D014691
% 212.88/213.05  |- skos__related mesh__D020378smesh__D018504
% 212.88/213.05  |- skos__hiddenLabel mesh__D020378 Spaces, Confined
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D020378 2002
% 212.88/213.05  |- skos__scopeNote mesh__D020378
% 212.88/213.05       A space which has limited openings for entry and exit combined with unfavorable natural ventilation such as caves, refrigerators, deep tunnels, pipelines, sewers, silos, tanks, vats, mines, deep trenches or pits, vaults, manholes, chimneys, etc.%A%    
% 212.88/213.05  |- mesh__dateCreated mesh__D020378 1998-06-10
% 212.88/213.05  |- rdf__type mesh__D020378sskos__Concept
% 212.88/213.05  |- skos__hiddenLabel mesh__D020378 Unventilated Space
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D020378 2005
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D020378 2000
% 212.88/213.05  |- skos__prefLabel mesh__D020378 Confined Spaces
% 212.88/213.05  |- mesh__dateEstablished mesh__D020378 1999-01-01
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D020378 1999
% 212.88/213.05  |- skos__hiddenLabel mesh__D020378 Spaces, Unventilated
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D020378 2006
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D020378 2001
% 212.88/213.05  |- skos__annotation mesh__D020378 do not use with claustrophobia   
% 212.88/213.05  |- skos__broader mesh__D020378smesh__D004777
% 212.88/213.05  |- skos__hiddenLabel mesh__D020378 Confined Space
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D020378 2003
% 212.88/213.05  |- mesh__publicMeSHNote mesh__D020378 99   
% 212.88/213.05  |- skos__hiddenLabel mesh__D020378 Space, Confined
% 212.88/213.05  |- mesh__historyNote mesh__D020378 99   
% 212.88/213.05  |- skos__related mesh__D020378smesh__D000395
% 212.88/213.05  |- skos__hiddenLabel mesh__D020378 Space, Unventilated
% 212.88/213.05  |- rdf__type mesh__D025861sskos__Concept
% 212.88/213.05  |- skos__hiddenLabel mesh__D025861 Coagulation Disorder, Inherited
% 212.88/213.05  |- skos__hiddenLabel mesh__D025861 Inherited Coagulation Disorder
% 212.88/213.05  |- skos__hiddenLabel mesh__D025861 Hereditary Coagulation Disorder
% 212.88/213.05  |- skos__altLabel mesh__D025861 Hereditary Coagulation Disorders
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D025861 2003
% 212.88/213.05  |- skos__altLabel mesh__D025861 Coagulation Disorders, Inherited
% 212.88/213.05  |- skos__hiddenLabel mesh__D025861 Coagulation Disorders, Hereditary
% 212.88/213.05  |- skos__broader mesh__D025861smesh__D030342
% 212.88/213.05  |- mesh__publicMeSHNote mesh__D025861 2002   
% 212.88/213.05  |- skos__altLabel mesh__D025861 Inherited Coagulation Disorders
% 212.88/213.05  |- skos__prefLabel mesh__D025861 Blood Coagulation Disorders, Inherited
% 212.88/213.05  |- skos__broader mesh__D025861smesh__D001778
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D025861 2004
% 212.88/213.05  |- skos__altLabel mesh__D025861 Inherited Blood Coagulation Disorders
% 212.88/213.05  |- mesh__dateCreated mesh__D025861 2001-07-25
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D025861 2005
% 212.88/213.05  |- mesh__dateEstablished mesh__D025861 2002-01-01
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D025861 2006
% 212.88/213.05  |- skos__historyNote mesh__D025861
% 212.88/213.05       Blood Coagulation Disorders %28%1995-2001%29%
% 212.88/213.05  |- skos__altLabel mesh__D025861 Hereditary Blood Coagulation Disorders
% 212.88/213.05  |- skos__hiddenLabel mesh__D025861 Coagulation Disorder, Hereditary
% 212.88/213.05  |- mesh__historyNote mesh__D025861 2002   
% 212.88/213.05  |- skos__scopeNote mesh__D025861
% 212.88/213.05       Hemorrhagic and thrombotic disorders that occur as a consequence of inherited abnormalities in blood coagulation.%A%    
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D025861 2002
% 212.88/213.05  |- skos__broader mesh__D025063smesh__D000013
% 212.88/213.05  |- mesh__historyNote mesh__D025063
% 212.88/213.05       2002; see CHROMOSOMAL ABNORMALITIES 1978-1995   
% 212.88/213.05  |- skos__related mesh__D025063smesh__D005826
% 212.88/213.05  |- skos__hiddenLabel mesh__D025063 Disorder, Chromosome Abnormality
% 212.88/213.05  |- skos__hiddenLabel mesh__D025063 Chromosomal Disorder
% 212.88/213.05  |- skos__hiddenLabel mesh__D025063 Chromosome Disorder, Autosomal
% 212.88/213.05  |- skos__hiddenLabel mesh__D025063 Disorders, Chromosomal
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D025063 2005
% 212.88/213.05  |- skos__related mesh__D025063smesh__D003582
% 212.88/213.05  |- skos__hiddenLabel mesh__D025063 Disorder, Chromosomal
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D025063 2006
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D025063 2002
% 212.88/213.05  |- skos__broader mesh__D025063smesh__D030342
% 212.88/213.05  |- skos__hiddenLabel mesh__D025063 Disorders, Chromosome
% 212.88/213.05  |- mesh__dateEstablished mesh__D025063 2002-01-01
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D025063 2003
% 212.88/213.05  |- skos__hiddenLabel mesh__D025063 Disorder, Chromosome
% 212.88/213.05  |- mesh__publicMeSHNote mesh__D025063 2002   
% 212.88/213.05  |- skos__altLabel mesh__D025063 Chromosome Abnormality Disorders
% 212.88/213.05  |- rdf__type mesh__D025063sskos__Concept
% 212.88/213.05  |- skos__annotation mesh__D025063
% 212.88/213.05       GEN or unspecified; prefer specifics; coord IM with specific numbered chromosome %28%IM%29%%A%  
% 212.88/213.05  |- mesh__dateCreated mesh__D025063 2001-07-25
% 212.88/213.05  |- skos__hiddenLabel mesh__D025063 Autosomal Chromosome Disorder
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D025063 2004
% 212.88/213.05  |- skos__historyNote mesh__D025063
% 212.88/213.05       Chromosome Abnormalities %28%1964-2001%29%
% 212.88/213.05  |- skos__prefLabel mesh__D025063 Chromosome Disorders
% 212.88/213.05  |- skos__scopeNote mesh__D025063
% 212.88/213.05       Clinical conditions caused by an abnormal chromosome constitution in which there is extra or missing chromosome material %28%either a whole chromosome or a chromosome segment%29%. %28%from Thompson et al., Genetics in Medicine, 5th ed, p429%29%%A%    
% 212.88/213.05  |- skos__hiddenLabel mesh__D025063 Chromosome Abnormality Disorder
% 212.88/213.05  |- skos__hiddenLabel mesh__D025063 Chromosome Disorders, Autosomal
% 212.88/213.05  |- skos__altLabel mesh__D025063 Chromosomal Disorders
% 212.88/213.05  |- skos__hiddenLabel mesh__D025063 Chromosome Disorder
% 212.88/213.05  |- skos__altLabel mesh__D019824 beta-Melanotropin
% 212.88/213.05  |- mesh__dateEstablished mesh__D019824 2000-01-01
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D019824 2006
% 212.88/213.05  |- skos__hiddenLabel mesh__D019824 beta Melanotropin
% 212.88/213.05  |- mesh__recordMaintainer mesh__D019824 ssb
% 212.88/213.05  |- skos__prefLabel mesh__D019824 beta-MSH
% 212.88/213.05  |- mesh__dateCreated mesh__D019824 1999-11-03
% 212.88/213.05  |- mesh__dateRevised mesh__D019824 2005-06-30
% 212.88/213.05  |- mesh__historyNote mesh__D019824 1998   
% 212.88/213.05  |- mesh__recordAuthorizer mesh__D019824 sjn
% 212.88/213.05  |- skos__hiddenLabel mesh__D019824 beta MSH
% 212.88/213.05  |- rdf__type mesh__D019824sskos__Concept
% 212.88/213.05  |- mesh__publicMeSHNote mesh__D019824 1998   
% 212.88/213.05  |- skos__altLabel mesh__D019824 beta-Melanocyte-Stimulating Hormone
% 212.88/213.05  |- skos__broader mesh__D019824smesh__D009074
% 212.88/213.05  |- skos__altLabel mesh__D019824 MSH, beta
% 212.88/213.05  |- skos__scopeNote mesh__D019824
% 212.88/213.05       A peptide hormone of about 22 amino acids. It is derived from PRO-OPIOMELANOCORTIN and has natriuretic activity.%A%    
% 212.88/213.05  |- skos__hiddenLabel mesh__D019824 beta Melanocyte Stimulating Hormone
% 212.88/213.05  |- mesh__recordOriginator mesh__D019824 adp
% 212.88/213.05  |- skos__altLabel mesh__D019026 Chests, Medicine
% 212.88/213.05  |- mesh__recordAuthorizer mesh__D019026 jls
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D019026 1998
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D019026 2004
% 212.88/213.05  |- mesh__dateEstablished mesh__D019026 1996-01-01
% 212.88/213.05  |- skos__altLabel mesh__D019026 Chest, Medicine
% 212.88/213.05  |- mesh__dateRevised mesh__D019026 2004-07-28
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D019026 2005A
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D019026 2005
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D019026 1999
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D019026 2000
% 212.88/213.05  |- skos__scopeNote mesh__D019026
% 212.88/213.05       Boxes in which physicians kept their drugs and other medications, medical instruments and supplies, manuals, etc. As a carrying case or convenient storage receptacle, or a kind of portable pharmacy, the medicine chest was indispensable to the itinerant physician. The chest was usually larger and sturdier than a doctor%27%s kit or bag.%A%    
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D019026 2001
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D019026 2006
% 212.88/213.05  |- mesh__publicMeSHNote mesh__D019026 96   
% 212.88/213.05  |- rdf__type mesh__D019026sskos__Concept
% 212.88/213.05  |- mesh__dateCreated mesh__D019026 1995-06-08
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D019026 2002
% 212.88/213.05  |- skos__broader mesh__D019026smesh__D004864
% 212.88/213.05  |- skos__prefLabel mesh__D019026 Medicine Chests
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D019026 1996
% 212.88/213.05  |- mesh__historyNote mesh__D019026 96   
% 212.88/213.05  |- skos__annotation mesh__D019026
% 212.88/213.05       do not confuse with the modern medicine cabinet: read MeSH definition; may be used for doctor%27%s bags; often in hist contexts so check hist tags; DF: MED CHESTS%A%  
% 212.88/213.05  |- skos__altLabel mesh__D019026 Medicine Chest
% 212.88/213.05  |- mesh__recordMaintainer mesh__D019026 jls
% 212.88/213.05  |- mesh__recordOriginator mesh__D019026 TGC
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D019026 2003
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D019026 1997
% 212.88/213.05  |- skos__broader mesh__D011043smesh__D037121
% 212.88/213.05  |- mesh__publicMeSHNote mesh__D011043 79   
% 212.88/213.05  |- rdf__type mesh__D011043sskos__Concept
% 212.88/213.05  |- skos__hiddenLabel mesh__D011043 Mitogen Isolectin, Pokeweed
% 212.88/213.05  |- mesh__dateCreated mesh__D011043 1978-05-03
% 212.88/213.05  |- mesh__recordMaintainer mesh__D011043 ssb
% 212.88/213.05  |- skos__prefLabel mesh__D011043 Pokeweed Mitogens
% 212.88/213.05  |- skos__hiddenLabel mesh__D011043 Mitogens, Pokeweed
% 212.88/213.05  |- mesh__recordOriginator mesh__D011043 SH
% 212.88/213.05  |- mesh__recordAuthorizer mesh__D011043 sjn
% 212.88/213.05  |- mesh__dateEstablished mesh__D011043 1979-01-01
% 212.88/213.05  |- skos__historyNote mesh__D011043 Mitogens %28%1966-1972%29%
% 212.88/213.05  |- skos__scopeNote mesh__D011043
% 212.88/213.05       Proteins isolated from the roots of the pokeweed, Phytolacca americana, that agglutinate some erythrocytes, stimulate mitosis and antibody synthesis in lymphocytes, and induce activation of plasma cells.%A%    
% 212.88/213.05  |- mesh__dateRevised mesh__D011043 2005-06-30
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D011043 2006
% 212.88/213.05  |- skos__altLabel mesh__D011043 Pokeweed Lectins
% 212.88/213.05  |- skos__historyNote mesh__D011043 Lectins %28%1966-1978%29%
% 212.88/213.05  |- skos__hiddenLabel mesh__D011043 Isolectin, Pokeweed Mitogen
% 212.88/213.05  |- skos__altLabel mesh__D011043 Lectins, Pokeweed
% 212.88/213.05  |- mesh__historyNote mesh__D011043 79   
% 212.88/213.05  |- mesh__publicMeSHNote mesh__D005804 68   
% 212.88/213.05  |- mesh__recordOriginator mesh__D005804 NLM
% 212.88/213.05  |- mesh__dateCreated mesh__D005804 1999-01-01
% 212.88/213.05  |- skos__hiddenLabel mesh__D005804 Lethal Genes
% 212.88/213.05  |- mesh__recordAuthorizer mesh__D005804 sjn
% 212.88/213.05  |- skos__hiddenLabel mesh__D005804 Gene, Lethal
% 212.88/213.05  |- skos__broader mesh__D005804smesh__D005796
% 212.88/213.05  |- mesh__historyNote mesh__D005804 68   
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D005804 2006
% 212.88/213.05  |- mesh__recordMaintainer mesh__D005804 nns
% 212.88/213.05  |- rdf__type mesh__D005804sskos__Concept
% 212.88/213.05  |- mesh__dateRevised mesh__D005804 2005-06-30
% 212.88/213.05  |- skos__historyNote mesh__D005804 Genes %28%1966-1967%29%
% 212.88/213.05  |- skos__annotation mesh__D005804 lethal genotype goes here   
% 212.88/213.05  |- skos__hiddenLabel mesh__D005804 Lethal Gene
% 212.88/213.05  |- mesh__dateEstablished mesh__D005804 1968-01-01
% 212.88/213.05  |- skos__prefLabel mesh__D005804 Genes, Lethal
% 212.88/213.05  |- skos__scopeNote mesh__D005804
% 212.88/213.05       Genes which result in the premature death of the organism; dominant lethal genes kill heterozygotes, whereas recessive lethal genes kill only homozygotes.%A%    
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D005006 2004B
% 212.88/213.05  |- mesh__recordAuthorizer mesh__D005006 jls
% 212.88/213.05  |- mesh__dateEstablished mesh__D005006 1968-01-01
% 212.88/213.05  |- skos__prefLabel mesh__D005006 Ethnic Groups
% 212.88/213.05  |- mesh__publicMeSHNote mesh__D005006 68   
% 212.88/213.05  |- skos__annotation mesh__D005006
% 212.88/213.05       do not confuse ethnicity with CONTINENTAL POPULATION GROUPS%A%  
% 212.88/213.05  |- skos__hiddenLabel mesh__D005006 Nationalities
% 212.88/213.05  |- skos__hiddenLabel mesh__D005006 Ethnic Group
% 212.88/213.05  |- mesh__dateRevised mesh__D005006 2003-10-30
% 212.88/213.05  |- rdf__type mesh__D005006sskos__Concept
% 212.88/213.05  |- skos__hiddenLabel mesh__D005006 Groups, Ethnic
% 212.88/213.05  |- mesh__recordMaintainer mesh__D005006 jls
% 212.88/213.05  |- mesh__historyNote mesh__D005006 68   
% 212.88/213.05  |- skos__broader mesh__D005006smesh__D003710
% 212.88/213.05  |- skos__historyNote mesh__D005006 Ethnology %28%1966-1967%29%
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D005006 2005
% 212.88/213.05  |- skos__scopeNote mesh__D005006
% 212.88/213.05       A group of people with a common cultural heritage that sets them apart from others in a variety of social relationships.%A%    
% 212.88/213.05  |- mesh__recordOriginator mesh__D005006 NLM
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D005006 2006
% 212.88/213.05  |- skos__broader mesh__D005006smesh__D044382
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D005006 2004A
% 212.88/213.05  |- mesh__dateCreated mesh__D005006 1999-01-01
% 212.88/213.05  |- skos__hiddenLabel mesh__D005006 Group, Ethnic
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D005006 2004
% 212.88/213.05  |- skos__hiddenLabel mesh__D010749 Protein Phosphatase 2A
% 212.88/213.05  |- skos__hiddenLabel mesh__D010749 Phosphatase-1G, Protein
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D010749 2006
% 212.88/213.05  |- skos__hiddenLabel mesh__D010749 Phosphohydrolase, Phosphoprotein
% 212.88/213.05  |- skos__hiddenLabel mesh__D010749 Phosphoprotein Phosphatase 1 delta
% 212.88/213.05  |- skos__hiddenLabel mesh__D010749 Phosphoprotein Phosphatase 2C
% 212.88/213.05  |- skos__prefLabel mesh__D010749 Phosphoprotein Phosphatase
% 212.88/213.05  |- skos__scopeNote mesh__D010749
% 212.88/213.05       A group of enzymes removing the serine- or threonine-bound phosphate groups from a wide range of phosphoproteins, including a number of enzymes which have been phosphorylated under the action of a kinase. %28%Enzyme Nomenclature, 1992%29% EC 3.1.3.16.%A%    
% 212.88/213.05  |- skos__historyNote mesh__D010749 Phosphoproteins %28%1971-1977%29%
% 212.88/213.05  |- skos__hiddenLabel mesh__D010749 Protein Phosphatase C I
% 212.88/213.05  |- skos__hiddenLabel mesh__D010749 Phosphoseryl Protein Phosphatase
% 212.88/213.05  |- skos__altLabel mesh__D010749 Protein Phosphatase-2A
% 212.88/213.05  |- skos__hiddenLabel mesh__D010749 Protein Phosphatase 1 alpha
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D010749 2005
% 212.88/213.05  |- skos__hiddenLabel mesh__D010749 Phosphatase-1 delta, Phosphoprotein
% 212.88/213.05  |- skos__hiddenLabel mesh__D010749 Phosphatase-1, Protein
% 212.88/213.05  |- skos__hiddenLabel mesh__D010749 Phosphoprotein Phosphatase 1 gamma 1
% 212.88/213.05  |- mesh__activeMeSHYear mesh__D010749 2004
% 212.88/213.05  |- mesh__recordOriginator mesh__D010749 RLS
% 212.88/213.05  |- skos__hiddenLabel mesh__D010749 Protein Phosphatase H II
% 212.88/213.05  |- mesh__dateEstablished mesh__D010749 1978-01-01
% 212.88/213.05  |- skos__hiddenLabel mesh__D010749 Phosphatase, Phosphohistone
% 212.88/213.05  |- mesh__publicMeSHNote mesh__D010749
% 212.88/213.05       94; was PHOSPHOPROTEIN PHOSPHATASES 1978-93; PHOSPHOPROTEIN PHOSPHOHYDROLASE was PHOSPHOPROTEIN PHOSPHOHYDROLASES 1978-93%A%  
% 212.88/213.05  |- skos__hiddenLabel mesh__D010749 alpha, Protein Phosphatase-1
% 212.88/213.05  |- skos__hiddenLabel mesh__D010749 Phosphatase, Nuclear Protein
% 212.88/213.05  |- skos__hiddenLabel mesh__D010749 Phosphatase C-I, Protein
% 212.88/213.05  |- skos__hiddenLabel mesh__D010749 Protein Phosphatase, Nuclear
% 212.88/213.05  |- mesh__historyNote mesh__D010749
% 212.88/213.05       94; was PHOSPHOPROTEIN PHOSPHATASES 1978-93; PHOSPHOPROTEIN PHOSPHOHYDROLASE was PHOSPHOPROTEIN PHOSPHOHYDROLASES 1978-93%A%  
% 212.88/213.05  |- skos__historyNote mesh__D010749 Phosphomonoesterases %28%1975-1977%29%
% 212.88/213.05  |- skos__altLabel mesh__D010749 Protein Phosphatases
% 212.88/213.05  |- skos__hiddenLabel mesh__D010749 Phosphatase, Phosphoprotein
% 212.88/213.05  |- skos__hiddenLabel mesh__D010749 Phosphatases, Phosphoprotein
% 212.88/213.05  |- skos__hiddenLabel mesh__D010749 Protein Phosphatase 1 gamma 2
% 212.88/213.06  |- skos__hiddenLabel mesh__D010749 Phosphatase C, Protein
% 212.88/213.06  |- skos__hiddenLabel mesh__D010749 Protein Phosphatase C II
% 212.88/213.06  |- skos__hiddenLabel mesh__D010749 Phosphatases, Protein
% 212.88/213.06  |- skos__hiddenLabel mesh__D010749 Protein Phosphatase 1G
% 212.88/213.06  |- mesh__dateCreated mesh__D010749 1977-04-15
% 212.88/213.06  |- mesh__recordAuthorizer mesh__D010749 sjn
% 212.88/213.06  |- skos__hiddenLabel mesh__D010749 Phosphatase C-II, Protein
% 212.88/213.06  |- skos__altLabel mesh__D010749 Phosphoprotein Phosphatases
% 212.88/213.06  |- skos__altLabel mesh__D010749 Phosphoprotein Phosphohydrolase
% 212.88/213.06  |- skos__altLabel mesh__D010749 Protein Phosphatase-1
% 212.88/213.06  |- skos__hiddenLabel mesh__D010749 Phosphatase, Ecto-Phosphoprotein
% 212.88/213.06  |- skos__hiddenLabel mesh__D010749 Phosphatase-1 alpha, Protein
% 212.88/213.06  |- mesh__recordMaintainer mesh__D010749 ssb
% 212.88/213.06  |- skos__hiddenLabel mesh__D010749 Phosphatase, Phosphoseryl-Protein
% 212.88/213.06  |- skos__hiddenLabel mesh__D010749 delta, Phosphoprotein Phosphatase-1
% 212.88/213.06  |- mesh__dateRevised mesh__D010749 2003-07-09
% 212.88/213.06  |- skos__hiddenLabel mesh__D010749 Protein Phosphatase 1
% 212.88/213.06  |- skos__hiddenLabel mesh__D010749 Phosphatase, Casein
% 212.88/213.06  |- skos__hiddenLabel mesh__D010749 Phosphatase H-II, Protein
% 212.88/213.06  |- skos__hiddenLabel mesh__D010749 Phosphatase-2C, Phosphoprotein
% 212.88/213.06  |- mesh__onlineNote mesh__D010749
% 212.88/213.06       use PHOSPHOPROTEIN PHOSPHATASE to search PHOSPHOPROTEIN PHOSPHATASES 1978-93%A%  
% 212.88/213.06  |- skos__altLabel mesh__D010749 Phosphoprotein Phosphatase-2C
% 212.88/213.06  |- rdf__type mesh__D010749sskos__Concept
% 212.88/213.06  |- skos__altLabel mesh__D010749 Protein Phosphatase C
% 212.88/213.06  |- skos__hiddenLabel mesh__D010749 Ecto Phosphoprotein Phosphatase
% 212.88/213.06  |- skos__hiddenLabel mesh__D010749 Phosphatase-2A, Protein
% 212.88/213.06  |- skos__broader mesh__D010749smesh__D010744
% 212.88/213.06  |- mesh__historyNote mesh__D015434 89; was heading 1963-64   
% 212.88/213.06  |- mesh__dateCreated mesh__D015434 1988-06-08
% 212.88/213.06  |- skos__hiddenLabel mesh__D015434 Panniculitides, Cold
% 212.88/213.06  |- mesh__dateRevised mesh__D015434 1993-06-02
% 212.88/213.06  |- mesh__dateEstablished mesh__D015434 1989-01-01
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015434 2003
% 212.88/213.06  |- skos__hiddenLabel mesh__D015434 Panniculitides
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015434 2000
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015434 2005
% 212.88/213.06  |- skos__prefLabel mesh__D015434 Panniculitis
% 212.88/213.06  |- skos__scopeNote mesh__D015434
% 212.88/213.06       General term for inflammation of adipose tissue, usually of the skin, characterized by reddened subcutaneous nodules.%A%    
% 212.88/213.06  |- skos__historyNote mesh__D015434
% 212.88/213.06       Panniculitis, Nodular Nonsuppurative %28%1966-1988%29%
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015434 2004
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015434 2001
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015434 2006
% 212.88/213.06  |- skos__broader mesh__D015434smesh__D003240
% 212.88/213.06  |- skos__broader mesh__D015434smesh__D012871
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015434 1996
% 212.88/213.06  |- skos__annotation mesh__D015434
% 212.88/213.06       inflamm of adipose tissue; GEN or unspecified; prefer specifics%A%  
% 212.88/213.06  |- skos__historyNote mesh__D015434 Adipose Tissue %28%1966-1988%29%
% 212.88/213.06  |- skos__hiddenLabel mesh__D015434 Panniculitis, Cold
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015434 1998
% 212.88/213.06  |- mesh__recordMaintainer mesh__D015434 TAP
% 212.88/213.06  |- mesh__publicMeSHNote mesh__D015434 89; was heading 1963-64   
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015434 1997
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015434 2002
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015434 1994
% 212.88/213.06  |- skos__hiddenLabel mesh__D015434 Cold Panniculitides
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015434 1999
% 212.88/213.06  |- mesh__recordOriginator mesh__D015434 WDJ
% 212.88/213.06  |- rdf__type mesh__D015434sskos__Concept
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015434 1995
% 212.88/213.06  |- mesh__recordAuthorizer mesh__D015434 PLS
% 212.88/213.06  |- skos__hiddenLabel mesh__D001414 Ocu Tracin
% 212.88/213.06  |- skos__hiddenLabel mesh__D001414 Zinc, Bacitracin
% 212.88/213.06  |- mesh__recordAuthorizer mesh__D001414 sjn
% 212.88/213.06  |- skos__altLabel mesh__D001414 Dioptic Brand of Bacitracin
% 212.88/213.06  |- skos__hiddenLabel mesh__D001414 Bacitracin McNeil Brand
% 212.88/213.06  |- skos__hiddenLabel mesh__D001414 OcuTracin
% 212.88/213.06  |- skos__hiddenLabel mesh__D001414 Zeba Rx
% 212.88/213.06  |- skos__hiddenLabel mesh__D001414 Martinet, Bacitracine
% 212.88/213.06  |- skos__altLabel mesh__D001414 Ciba Vision Brand of Bacitracin
% 212.88/213.06  |- skos__hiddenLabel mesh__D001414 Baci IM
% 212.88/213.06  |- skos__altLabel mesh__D001414 Reed %26% Carnrick Brand of Bacitracin
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D001414 2006
% 212.88/213.06  |- mesh__recordMaintainer mesh__D001414 CCR
% 212.88/213.06  |- skos__hiddenLabel mesh__D001414 Bacitracin Pharmascience Brand
% 212.88/213.06  |- skos__altLabel mesh__D001414 Zinc Bacitracin
% 212.88/213.06  |- skos__altLabel mesh__D001414 McNeil Brand of Bacitracin
% 212.88/213.06  |- skos__broader mesh__D001414smesh__D010456
% 212.88/213.06  |- rdf__type mesh__D001414sskos__Concept
% 212.88/213.06  |- skos__altLabel mesh__D001414 Ocumed Brand of Bacitracin
% 212.88/213.06  |- skos__altLabel mesh__D001414 Baci-Rx
% 212.88/213.06  |- skos__hiddenLabel mesh__D001414 Baci Rx
% 212.88/213.06  |- skos__altLabel mesh__D001414 Pharmascience Brand of Bacitracin
% 212.88/213.06  |- mesh__recordOriginator mesh__D001414 NLM
% 212.88/213.06  |- skos__scopeNote mesh__D001414
% 212.88/213.06       A complex of cyclic peptide antibiotics produced by the Tracy-I strain of Bacillus subtilis. The commercial preparation is a mixture of at least nine bacitracins with bacitracin A as the major constituent. It is used topically to treat open infections such as infected eczema and infected dermal ulcers. %28%From Goodman and Gilman, The Pharmacological Basis of Therapeutics, 8th ed, p1140%29%%A%    
% 212.88/213.06  |- skos__hiddenLabel mesh__D001414 Bacitracin Akorn Brand
% 212.88/213.06  |- skos__hiddenLabel mesh__D001414 Bacitracin, Zinc
% 212.88/213.06  |- skos__hiddenLabel mesh__D001414 Bacitracin Dioptic Brand
% 212.88/213.06  |- mesh__dateCreated mesh__D001414 1999-01-01
% 212.88/213.06  |- skos__altLabel mesh__D001414 Zeba-Rx
% 212.88/213.06  |- skos__hiddenLabel mesh__D001414 Ak Tracin
% 212.88/213.06  |- skos__hiddenLabel mesh__D001414 Bacitracin Lee Brand
% 212.88/213.06  |- skos__altLabel mesh__D001414 Bacitracin Zinc
% 212.88/213.06  |- skos__altLabel mesh__D001414 A.L. Labs Brand of Bacitracin Zinc Salt
% 212.88/213.06  |- skos__prefLabel mesh__D001414 Bacitracin
% 212.88/213.06  |- mesh__dateRevised mesh__D001414 2005-06-30
% 212.88/213.06  |- skos__altLabel mesh__D001414 Akorn Brand of Bacitracin
% 212.88/213.06  |- skos__altLabel mesh__D001414 Pharma Tek Brand of Bacitracin
% 212.88/213.06  |- skos__altLabel mesh__D001414 Lee Brand of Bacitracin
% 212.88/213.06  |- mesh__historyNote mesh__D020379 99   
% 212.88/213.06  |- rdf__type mesh__D020379sskos__Concept
% 212.88/213.06  |- skos__scopeNote mesh__D020379
% 212.88/213.06       The use of severity-of-illness measures, such as age, to estimate the risk %28%measurable or predictable chance of loss, injury or death%29% to which a patient is subject before receiving some health care intervention. This adjustment allows comparison of performance and quality across organizations, practitioners, and communities. %28%from JCAHO, Lexikon, 1994%29%%A%    
% 212.88/213.06  |- skos__hiddenLabel mesh__D020379 Case-Mix Adjustments
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D020379 2005
% 212.88/213.06  |- skos__prefLabel mesh__D020379 Risk Adjustment
% 212.88/213.06  |- skos__hiddenLabel mesh__D020379 Adjustments, Case-Mix
% 212.88/213.06  |- skos__hiddenLabel mesh__D020379 Adjustment, Case-Mix
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D020379 2002
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D020379 1999
% 212.88/213.06  |- skos__broader mesh__D020379smesh__D019984
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D020379 2006
% 212.88/213.06  |- skos__hiddenLabel mesh__D020379 Case Mix Adjustment
% 212.88/213.06  |- skos__broader mesh__D020379smesh__D018570
% 212.88/213.06  |- skos__hiddenLabel mesh__D020379 Risk Adjustments
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D020379 2003
% 212.88/213.06  |- mesh__publicMeSHNote mesh__D020379 99   
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D020379 2000
% 212.88/213.06  |- skos__hiddenLabel mesh__D020379 Adjustment, Risk
% 212.88/213.06  |- mesh__dateEstablished mesh__D020379 1999-01-01
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D020379 2004
% 212.88/213.06  |- mesh__dateCreated mesh__D020379 1998-06-11
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D020379 2001
% 212.88/213.06  |- skos__hiddenLabel mesh__D020379 Adjustments, Risk
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D025064 2003
% 212.88/213.06  |- skos__broader mesh__D025064smesh__D025063
% 212.88/213.06  |- rdf__type mesh__D025064sskos__Concept
% 212.88/213.06  |- mesh__dateEstablished mesh__D025064 2002-01-01
% 212.88/213.06  |- skos__annotation mesh__D025064
% 212.88/213.06       GEN or unspecified; prefer specifics; coord IM with specific sex chromosome %28%IM%29%%A%  
% 212.88/213.06  |- skos__hiddenLabel mesh__D025064 Chromosome Disorder, Sex
% 212.88/213.06  |- skos__related mesh__D025064smesh__D005826
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D025064 2002
% 212.88/213.06  |- skos__historyNote mesh__D025064
% 212.88/213.06       Sex Chromosome Abnormalities %28%1971-2001%29%
% 212.88/213.06  |- skos__altLabel mesh__D025064 Disorders, Sex Chromosome
% 212.88/213.06  |- skos__related mesh__D025064smesh__D012729
% 212.88/213.06  |- skos__altLabel mesh__D025064 Disorders, Sex Chromosome Abnormality
% 212.88/213.06  |- mesh__historyNote mesh__D025064 2002   
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D025064 2006
% 212.88/213.06  |- skos__scopeNote mesh__D025064
% 212.88/213.06       Clinical conditions caused by an abnormal sex chromosome constitution %28%SEX CHROMOSOME ABERRATIONS%29% in which there is extra or missing sex chromosome material %28%either a whole chromosome or a chromosome segment%29%.%A%    
% 212.88/213.06  |- skos__altLabel mesh__D025064 Sex Chromosome Abnormality Disorders
% 212.88/213.06  |- mesh__dateCreated mesh__D025064 2001-07-25
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D025064 2004
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D025064 2005
% 212.88/213.06  |- skos__hiddenLabel mesh__D025064 Chromosome Disorders, Sex
% 212.88/213.06  |- mesh__publicMeSHNote mesh__D025064 2002   
% 212.88/213.06  |- skos__hiddenLabel mesh__D025064 Sex Chromosome Disorder
% 212.88/213.06  |- skos__prefLabel mesh__D025064 Sex Chromosome Disorders
% 212.88/213.06  |- skos__related mesh__D025064smesh__D003582
% 212.88/213.06  |- mesh__dateCreated mesh__D019825 1999-11-03
% 212.88/213.06  |- skos__scopeNote mesh__D019825
% 212.88/213.06       A peptide hormone of about 11 amino acids derived from PRO-OPIOMELANOCORTIN that has natriuretic activity.%A%    
% 212.88/213.06  |- skos__altLabel mesh__D019825 MSH, gamma
% 212.88/213.06  |- skos__prefLabel mesh__D019825 gamma-MSH
% 212.88/213.06  |- skos__broader mesh__D019825smesh__D009074
% 212.88/213.06  |- skos__hiddenLabel mesh__D019825 gamma3 MSH
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D019825 2006
% 212.88/213.06  |- mesh__recordMaintainer mesh__D019825 ssb
% 212.88/213.06  |- rdf__type mesh__D019825sskos__Concept
% 212.88/213.06  |- skos__hiddenLabel mesh__D019825 gamma2 MSH
% 212.88/213.06  |- skos__hiddenLabel mesh__D019825 gamma Melanocyte Stimulating Hormone
% 212.88/213.06  |- mesh__publicMeSHNote mesh__D019825 1998   
% 212.88/213.06  |- skos__altLabel mesh__D019825 gamma-Melanotropin
% 212.88/213.06  |- skos__hiddenLabel mesh__D019825 gamma1 MSH
% 212.88/213.06  |- mesh__dateEstablished mesh__D019825 2000-01-01
% 212.88/213.06  |- skos__altLabel mesh__D019825 gamma-Melanocyte-Stimulating Hormone
% 212.88/213.06  |- skos__hiddenLabel mesh__D019825 gamma Melanotropin
% 212.88/213.06  |- mesh__dateRevised mesh__D019825 2005-06-30
% 212.88/213.06  |- mesh__historyNote mesh__D019825 1998   
% 212.88/213.06  |- skos__hiddenLabel mesh__D019825 gamma MSH
% 212.88/213.06  |- mesh__recordAuthorizer mesh__D019825 sjn
% 212.88/213.06  |- mesh__recordOriginator mesh__D019825 adp
% 212.88/213.06  |- skos__hiddenLabel mesh__D011842 Cysts, Periapical
% 212.88/213.06  |- mesh__dateEstablished mesh__D011842 1965-01-01
% 212.88/213.06  |- skos__altLabel mesh__D011842 Periodontal Cyst, Apical
% 212.88/213.06  |- skos__hiddenLabel mesh__D011842 Apical Periodontal Cyst
% 212.88/213.06  |- skos__scopeNote mesh__D011842
% 212.88/213.06       Slow-growing fluid-filled epithelial sac at the apex of a tooth with a nonvital pulp or defective root canal filling.%A%    
% 212.88/213.06  |- skos__broader mesh__D011842smesh__D010509
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011842 1997
% 212.88/213.06  |- mesh__recordAuthorizer mesh__D011842 PLS
% 212.88/213.06  |- mesh__recordMaintainer mesh__D011842 TGC
% 212.88/213.06  |- skos__prefLabel mesh__D011842 Radicular Cyst
% 212.88/213.06  |- mesh__publicMeSHNote mesh__D011842 65   
% 212.88/213.06  |- skos__hiddenLabel mesh__D011842 Radicular Cysts
% 212.88/213.06  |- skos__annotation mesh__D011842
% 212.88/213.06       non-neoplastic periodontal cyst; /blood supply /chem /secret /ultrastruct permitted; coord IM with organ/dis %28%IM%29%, not organ/neopl%A%  
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011842 2004
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011842 1996
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011842 1999
% 212.88/213.06  |- mesh__dateRevised mesh__D011842 1993-06-02
% 212.88/213.06  |- skos__hiddenLabel mesh__D011842 Cysts, Radicular
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011842 2003
% 212.88/213.06  |- skos__hiddenLabel mesh__D011842 Apical Periodontal Cysts
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011842 2002
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011842 2006
% 212.88/213.06  |- skos__hiddenLabel mesh__D011842 Cyst, Periapical
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011842 1995
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011842 1998
% 212.88/213.06  |- skos__broader mesh__D011842smesh__D010483
% 212.88/213.06  |- skos__hiddenLabel mesh__D011842 Cyst, Apical Periodontal
% 212.88/213.06  |- skos__hiddenLabel mesh__D011842 Periodontal Cysts, Apical
% 212.88/213.06  |- rdf__type mesh__D011842sskos__Concept
% 212.88/213.06  |- skos__hiddenLabel mesh__D011842 Periapical Cysts
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011842 2001
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011842 2005
% 212.88/213.06  |- mesh__dateCreated mesh__D011842 1999-01-01
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011842 1994
% 212.88/213.06  |- skos__altLabel mesh__D011842 Periapical Cyst
% 212.88/213.06  |- skos__hiddenLabel mesh__D011842 Cysts, Apical Periodontal
% 212.88/213.06  |- mesh__recordOriginator mesh__D011842 NLM
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011842 2000
% 212.88/213.06  |- mesh__historyNote mesh__D011842 65   
% 212.88/213.06  |- skos__hiddenLabel mesh__D011842 Cyst, Radicular
% 212.88/213.06  |- skos__annotation mesh__D011044
% 212.88/213.06       in translations of historical articles use spelling People%27%s Republic, not Peoples%27% nor Peoples%A%  
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011044 2002
% 212.88/213.06  |- mesh__dateRevised mesh__D011044 1993-06-03
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011044 1997
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011044 1994
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011044 1999
% 212.88/213.06  |- mesh__recordOriginator mesh__D011044 NLM
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011044 2003
% 212.88/213.06  |- mesh__recordAuthorizer mesh__D011044 PLS
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011044 1995
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011044 2005
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011044 2004
% 212.88/213.06  |- skos__prefLabel mesh__D011044 Poland
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011044 2006
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011044 2000
% 212.88/213.06  |- mesh__dateCreated mesh__D011044 1999-01-01
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011044 2001
% 212.88/213.06  |- mesh__recordMaintainer mesh__D011044 PLS
% 212.88/213.06  |- skos__broader mesh__D011044smesh__D005061
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011044 1996
% 212.88/213.06  |- rdf__type mesh__D011044sskos__Concept
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D011044 1998
% 212.88/213.06  |- skos__altLabel mesh__D005805 Class I Genes
% 212.88/213.06  |- skos__hiddenLabel mesh__D005805 Genes, H 2 Class I
% 212.88/213.06  |- skos__scopeNote mesh__D005805
% 212.88/213.06       Genetic loci in the vertebrate major histocompatibility complex which encode polymorphic characteristics not related to immune responsiveness or complement activity, e.g., B loci %28%chicken%29%, DLA %28%dog%29%, GPLA %28%guinea pig%29%, H-2 %28%mouse%29%, RT-1 %28%rat%29%, HLA-A, -B, and -C class I genes of man.%A%    
% 212.88/213.06  |- skos__hiddenLabel mesh__D005805 Class I Gene
% 212.88/213.06  |- skos__historyNote mesh__D005805 H-2 Antigens/genetics %28%1980-1987%29%
% 212.88/213.06  |- skos__historyNote mesh__D005805
% 212.88/213.06       Major Histocompatibility Complex %28%1980-1987%29%
% 212.88/213.06  |- skos__prefLabel mesh__D005805 Genes, MHC Class I
% 212.88/213.06  |- skos__altLabel mesh__D005805 Genes, HLA Class I
% 212.88/213.06  |- mesh__publicMeSHNote mesh__D005805 88   
% 212.88/213.06  |- skos__hiddenLabel mesh__D005805 Gene, Class I
% 212.88/213.06  |- mesh__dateEstablished mesh__D005805 1988-01-01
% 212.88/213.06  |- skos__broader mesh__D005805smesh__D008285
% 212.88/213.06  |- mesh__historyNote mesh__D005805 88   
% 212.88/213.06  |- mesh__recordAuthorizer mesh__D005805 sjn
% 212.88/213.06  |- skos__annotation mesh__D005805
% 212.88/213.06       MHC stands for %22%Major Histocompatibility Complex%22%; DF: note short X ref%A%  
% 212.88/213.06  |- mesh__recordOriginator mesh__D005805 SCD
% 212.88/213.06  |- mesh__recordMaintainer mesh__D005805 nns
% 212.88/213.06  |- skos__historyNote mesh__D005805 HLA Antigens/genetics %28%1981-1987%29%
% 212.88/213.06  |- skos__altLabel mesh__D005805 MHC Class I Genes
% 212.88/213.06  |- mesh__dateRevised mesh__D005805 2005-06-30
% 212.88/213.06  |- skos__altLabel mesh__D005805 Genes, Class I
% 212.88/213.06  |- skos__altLabel mesh__D005805 H-2 Class I Genes
% 212.88/213.06  |- mesh__dateCreated mesh__D005805 1987-05-11
% 212.88/213.06  |- rdf__type mesh__D005805sskos__Concept
% 212.88/213.06  |- skos__hiddenLabel mesh__D005805 H 2 Class I Genes
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D005805 2006
% 212.88/213.06  |- skos__broader mesh__D015289Q000037smesh__D015289
% 212.88/213.06  |- mesh__preferredCombination mesh__D015289Q000037smesh__D020024
% 212.88/213.06  |- rdf__type mesh__D015289Q000037smesh__CompoundConcept
% 212.88/213.06  |- skos__broader mesh__D005007smesh__D003469
% 212.88/213.06  |- mesh__recordMaintainer mesh__D005007 TAP
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D005007 2001
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D005007 1997
% 212.88/213.06  |- rdf__type mesh__D005007sskos__Concept
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D005007 2002
% 212.88/213.06  |- skos__annotation mesh__D005007
% 212.88/213.06       do not confuse with ETHOLOGY, the study of animal behavior; prefer /ethnol: Manual 19.7+; IM as SPEC; SPEC qualif; Manual 30.6; don%27%t forget /ethnol with Cat Z: Manual 19.8.32; note other categories with /ethnology; DF: ETHNOL%A%  
% 212.88/213.06  |- skos__hiddenLabel mesh__D005007 Society, Primitive
% 212.88/213.06  |- skos__prefLabel mesh__D005007 Ethnology
% 212.88/213.06  |- skos__hiddenLabel mesh__D005007 Societies, Primitive
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D005007 2005
% 212.88/213.06  |- mesh__dateRevised mesh__D005007 1996-06-10
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D005007 2006
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D005007 2003
% 212.88/213.06  |- mesh__dateCreated mesh__D005007 1999-01-01
% 212.88/213.06  |- skos__scopeNote mesh__D005007
% 212.88/213.06       The comparative and theoretical study of culture, often synonymous with cultural anthropology.%A%    
% 212.88/213.06  |- skos__hiddenLabel mesh__D005007 Primitive Society
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D005007 2004
% 212.88/213.06  |- mesh__recordAuthorizer mesh__D005007 PLS
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D005007 1998
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D005007 2000
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D005007 1999
% 212.88/213.06  |- mesh__recordOriginator mesh__D005007 NLM
% 212.88/213.06  |- skos__historyNote mesh__D043924
% 212.88/213.06       Angiogenesis Inhibitors %28%2000-2003%29%
% 212.88/213.06  |- skos__scopeNote mesh__D043924
% 212.88/213.06       Agents that modulate the PHYSIOLOGIC ANGIOGENESIS process. This is accomplished by endogenous ANGIOGENIC PROTEINS and a variety of other chemicals and pharmaceutical agents.%A%    
% 212.88/213.06  |- skos__historyNote mesh__D043924 Angiogenesis Factor %28%1973-2003%29%
% 212.88/213.06  |- mesh__dateEstablished mesh__D043924 2004-01-01
% 212.88/213.06  |- skos__altLabel mesh__D043924 Angiogenesis Modulators
% 212.88/213.06  |- mesh__dateCreated mesh__D043924 2003-07-09
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D043924 2004
% 212.88/213.06  |- skos__prefLabel mesh__D043924 Angiogenesis Modulating Agents
% 212.88/213.06  |- mesh__historyNote mesh__D043924 2004   
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D043924 2005
% 212.88/213.06  |- rdf__type mesh__D043924sskos__Concept
% 212.88/213.06  |- skos__annotation mesh__D043924
% 212.88/213.06       GEN: prefer specifics; coord with specific agents   
% 212.88/213.06  |- skos__broader mesh__D043924smesh__D006133
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D043924 2006
% 212.88/213.06  |- mesh__publicMeSHNote mesh__D043924 2004   
% 212.88/213.06  |- skos__hiddenLabel mesh__D043924 Modulators, Angiogenesis
% 212.88/213.06  |- skos__hiddenLabel mesh__D015435 Panniculitis, Lupus
% 212.88/213.06  |- mesh__recordAuthorizer mesh__D015435 PLS
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015435 2005
% 212.88/213.06  |- skos__altLabel mesh__D015435 Lupus Panniculitis
% 212.88/213.06  |- skos__hiddenLabel mesh__D015435 Panniculitides, Lupus Erythematosus
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015435 2004
% 212.88/213.06  |- mesh__dateCreated mesh__D015435 1988-06-08
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015435 1996
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015435 2002
% 212.88/213.06  |- skos__altLabel mesh__D015435 Lupus Profundus
% 212.88/213.06  |- skos__historyNote mesh__D015435
% 212.88/213.06       Panniculitis, Nodular Nonsuppurative %28%1966-1988%29%
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015435 2003
% 212.88/213.06  |- mesh__recordOriginator mesh__D015435 WDJ
% 212.88/213.06  |- skos__annotation mesh__D015435 DF: PANNICULITIS LE   
% 212.88/213.06  |- skos__hiddenLabel mesh__D015435 Lupus Erythematosus Panniculitides
% 212.88/213.06  |- skos__broader mesh__D015435smesh__D008179
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015435 1995
% 212.88/213.06  |- mesh__dateEstablished mesh__D015435 1991-01-01
% 212.88/213.06  |- rdf__type mesh__D015435sskos__Concept
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015435 2001
% 212.88/213.06  |- skos__broader mesh__D015435smesh__D015434
% 212.88/213.06  |- mesh__publicMeSHNote mesh__D015435
% 212.88/213.06       91; was see under PANNICULITIS 1989-90   
% 212.88/213.06  |- mesh__recordMaintainer mesh__D015435 PLS
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015435 1999
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015435 1994
% 212.88/213.06  |- skos__altLabel mesh__D015435 Lupus Erythematosus Profundus
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015435 1993
% 212.88/213.06  |- mesh__historyNote mesh__D015435
% 212.88/213.06       91%28%89%29%; was see under PANNICULITIS 1989-90   
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015435 2000
% 212.88/213.06  |- skos__altLabel mesh__D015435 Lupus Erythematosus Panniculitis
% 212.88/213.06  |- mesh__dateRevised mesh__D015435 1992-05-22
% 212.88/213.06  |- skos__hiddenLabel mesh__D015435 Panniculitides, Lupus
% 212.88/213.06  |- skos__hiddenLabel mesh__D015435 Lupus Panniculitides
% 212.88/213.06  |- skos__prefLabel mesh__D015435 Panniculitis, Lupus Erythematosus
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015435 2006
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015435 1998
% 212.88/213.06  |- skos__scopeNote mesh__D015435
% 212.88/213.06       A type of lupus erythematosus characterized by deep dermal or subcutaneous nodules, most often on the head, face, or upper arms. It is generally chronic and occurs most often in women between the ages of 20 and 45.%A%    
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D015435 1997
% 212.88/213.06  |- skos__historyNote mesh__D015435
% 212.88/213.06       Lupus Erythematosus, Systemic %28%1966-1988%29%
% 212.88/213.06  |- skos__historyNote mesh__D015435
% 212.88/213.06       Lupus Erythematosus, Discoid %28%1966-1988%29%
% 212.88/213.06  |- skos__prefLabel mesh__D001415 Back
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D001415 2005
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D001415 2001
% 212.88/213.06  |- skos__broader mesh__D001415smesh__D001829
% 212.88/213.06  |- mesh__dateCreated mesh__D001415 1999-01-01
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D001415 2006
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D001415 1998
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D001415 2003
% 212.88/213.06  |- rdf__type mesh__D001415sskos__Concept
% 212.88/213.06  |- skos__hiddenLabel mesh__D001415 Backs
% 212.88/213.06  |- skos__annotation mesh__D001415
% 212.88/213.06       a region; in humans, the posterior trunk from the neck to the pelvis; prefer a more specific term if possible%A%  
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D001415 2002
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D001415 1999
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D001415 2004
% 212.88/213.06  |- mesh__recordMaintainer mesh__D001415 TGC
% 212.88/213.06  |- mesh__recordAuthorizer mesh__D001415 SJN
% 212.88/213.06  |- mesh__dateRevised mesh__D001415 1997-06-20
% 212.88/213.06  |- mesh__recordOriginator mesh__D001415 NLM
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D001415 2000
% 212.88/213.06  |- skos__prefLabel mesh__D006100 Granuloma Inguinale
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D006100 2003
% 212.88/213.06  |- skos__broader mesh__D006100smesh__D004756
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D006100 2004
% 212.88/213.06  |- mesh__dateRevised mesh__D006100 2001-07-25
% 212.88/213.06  |- skos__broader mesh__D006100smesh__D015231
% 212.88/213.06  |- rdf__type mesh__D006100sskos__Concept
% 212.88/213.06  |- skos__scopeNote mesh__D006100
% 212.88/213.06       Anogenital ulcers caused by Calymmatobacterium granulomatis as distinguished from lymphogranuloma inguinale %28%see LYMPHOGRANULOMA VENEREUM%29% caused by CHLAMYDIA TRACHOMATIS. Diagnosis is made by demonstration of typical intracellular Donovan bodies in crushed-tissue smears.%A%    
% 212.88/213.06  |- mesh__recordAuthorizer mesh__D006100 sjn
% 212.88/213.06  |- skos__annotation mesh__D006100
% 212.88/213.06       non-neoplastic; gram-neg bact infect; sexually transmitted%A%  
% 212.88/213.06  |- skos__altLabel mesh__D006100 Granuloma Venereum
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D006100 2005
% 212.88/213.06  |- mesh__dateCreated mesh__D006100 1999-01-01
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D006100 2002
% 212.88/213.06  |- mesh__recordMaintainer mesh__D006100 ags
% 212.88/213.06  |- skos__broader mesh__D006100smesh__D017192
% 212.88/213.06  |- mesh__recordOriginator mesh__D006100 NLM
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D006100 2006
% 212.88/213.06  |- skos__altLabel mesh__D006100 Donovanosis
% 212.88/213.06  |- mesh__dateCreated mesh__D025065 2001-07-25
% 212.88/213.06  |- mesh__dateRevised mesh__D025065 2005-06-30
% 212.88/213.06  |- skos__scopeNote mesh__D025065
% 212.88/213.06       A specific species of bacteria, part of the BORRELIA BURGDORFERI GROUP, whose common name is Lyme disease spirochete.%A%    
% 212.88/213.06  |- mesh__recordOriginator mesh__D025065 ags
% 212.88/213.06  |- skos__broader mesh__D025065smesh__D015748
% 212.88/213.06  |- skos__historyNote mesh__D025065
% 212.88/213.06       Borrelia burgdorferi Group %28%1990-2001%29%
% 212.88/213.06  |- skos__prefLabel mesh__D025065 Borrelia burgdorferi
% 212.88/213.06  |- skos__annotation mesh__D025065
% 212.88/213.06       infection: coord IM with LYME DISEASE or specifics %28%IM%29%; BORRELIA BURGDORFERI GROUP is also available%A%  
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D025065 2006
% 212.88/213.06  |- mesh__recordMaintainer mesh__D025065 SYSTEM
% 212.88/213.06  |- skos__altLabel mesh__D025065 Lyme Disease Spirochete
% 212.88/213.06  |- mesh__historyNote mesh__D025065 2002   
% 212.88/213.06  |- mesh__publicMeSHNote mesh__D025065 2002   
% 212.88/213.06  |- skos__altLabel mesh__D025065 Borrelia burgdorferi sensu stricto
% 212.88/213.06  |- mesh__dateEstablished mesh__D025065 2002-01-01
% 212.88/213.06  |- rdf__type mesh__D025065sskos__Concept
% 212.88/213.06  |- mesh__recordAuthorizer mesh__D025065 sjn
% 212.88/213.06  |- skos__broader mesh__D002477Q000502smesh__D002477
% 212.88/213.06  |- mesh__preferredCombination mesh__D002477Q000502smesh__D002468
% 212.88/213.06  |- rdf__type mesh__D002477Q000502smesh__CompoundConcept
% 212.88/213.06  |- mesh__activeMeSHYear mesh__D019826 2003
% 212.88/213.06  |- skos__annotation mesh__D019826 CHOLIC ACIDS is available   
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019826 1999
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019826 2002
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019826 2005
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019826 2004
% 212.88/213.07  |- skos__prefLabel mesh__D019826 Cholic Acid
% 212.88/213.07  |- skos__hiddenLabel mesh__D019826 Acid, Cholic
% 212.88/213.07  |- rdf__type mesh__D019826sskos__Concept
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019826 2006
% 212.88/213.07  |- mesh__dateEstablished mesh__D019826 1999-01-01
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019826 2000
% 212.88/213.07  |- mesh__publicMeSHNote mesh__D019826
% 212.88/213.07       99; CHOLIC ACID was indexed under CHOLIC ACIDS 1983-98   
% 212.88/213.07  |- skos__broader mesh__D019826smesh__D002793
% 212.88/213.07  |- mesh__dateCreated mesh__D019826 1998-06-10
% 212.88/213.07  |- skos__historyNote mesh__D019826 Cholic Acids %28%1978-1998%29%
% 212.88/213.07  |- skos__scopeNote mesh__D019826
% 212.88/213.07       A major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion.%A%    
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019826 2001
% 212.88/213.07  |- mesh__historyNote mesh__D019826
% 212.88/213.07       99; use CHOLIC ACID %28%NM%29% 1981-98   
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D011843 2006
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D011843 2000
% 212.88/213.07  |- mesh__dateEstablished mesh__D011843 1971-01-01
% 212.88/213.07  |- skos__scopeNote mesh__D011843
% 212.88/213.07       Disease involving a spinal nerve root %28%see SPINAL NERVE ROOTS%29% which may result from compression related to INTERVERTEBRAL DISK DISPLACEMENT; SPINAL CORD INJURIES; SPINAL DISEASES; and other conditions. Clinical manifestations include radicular pain, weakness, and sensory loss referable to structures innervated by the involved nerve root.%A%    
% 212.88/213.07  |- skos__hiddenLabel mesh__D011843 Compressions, Nerve Root
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D011843 2004
% 212.88/213.07  |- skos__historyNote mesh__D011843 Polyradiculitis %28%1966-1970%29%
% 212.88/213.07  |- skos__altLabel mesh__D011843 Nerve Root Inflammation
% 212.88/213.07  |- skos__hiddenLabel mesh__D011843 Cervical Radiculopathies
% 212.88/213.07  |- skos__annotation mesh__D011843
% 212.88/213.07       disease of a single spinal nerve root; do not confuse with POLYRADICULOPATHY %28%dis of several spinal nerve roots%29% nor with POLYRADICULONEUROPATHY %28%dis of both spinal nerve roots %26% peripheral nerves%29%%A%  
% 212.88/213.07  |- skos__hiddenLabel mesh__D011843 Cervical Radiculopathy
% 212.88/213.07  |- skos__hiddenLabel mesh__D011843 Nerve Root Compressions
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D011843 2001
% 212.88/213.07  |- mesh__recordOriginator mesh__D011843 NLM
% 212.88/213.07  |- mesh__dateCreated mesh__D011843 1999-01-01
% 212.88/213.07  |- skos__hiddenLabel mesh__D011843 Nerve Root Inflammations
% 212.88/213.07  |- mesh__recordAuthorizer mesh__D011843 sjn
% 212.88/213.07  |- rdf__type mesh__D011843sskos__Concept
% 212.88/213.07  |- skos__prefLabel mesh__D011843 Radiculopathy
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D011843 2002
% 212.88/213.07  |- skos__hiddenLabel mesh__D011843 Nerve Root Disorders
% 212.88/213.07  |- skos__hiddenLabel mesh__D011843 Radiculitides
% 212.88/213.07  |- skos__broader mesh__D011843smesh__D011128
% 212.88/213.07  |- skos__hiddenLabel mesh__D011843 Nerve Root Avulsions
% 212.88/213.07  |- skos__hiddenLabel mesh__D011843 Avulsion, Nerve Root
% 212.88/213.07  |- skos__hiddenLabel mesh__D011843 Radiculopathies
% 212.88/213.07  |- skos__hiddenLabel mesh__D011843 Avulsions, Nerve Root
% 212.88/213.07  |- skos__hiddenLabel mesh__D011843 Inflammation, Nerve Root
% 212.88/213.07  |- skos__hiddenLabel mesh__D011843 Compression, Nerve Root
% 212.88/213.07  |- mesh__historyNote mesh__D011843 2000%28%1971%29%   
% 212.88/213.07  |- mesh__recordMaintainer mesh__D011843 KEV
% 212.88/213.07  |- skos__hiddenLabel mesh__D011843 Radiculopathies, Cervical
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D011843 2005
% 212.88/213.07  |- mesh__publicMeSHNote mesh__D011843 2000; see RADICULITIS 1971-1999   
% 212.88/213.07  |- mesh__dateRevised mesh__D011843 1999-11-04
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D011843 2003
% 212.88/213.07  |- rdf__type mesh__D019028sskos__Concept
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019028 2001
% 212.88/213.07  |- skos__scopeNote mesh__D019028
% 212.88/213.07       A type of imaging technique used primarily in the field of cardiology. By coordinating the fast gradient-echo MRI sequence with retrospective ECG-gating, numerous short time frames evenly spaced in the cardiac cycle are produced. These images are laced together in a cinematic display so that wall motion of the ventricles, valve motion, and blood flow patterns in the heart and great vessels can be visualized.%A%    
% 212.88/213.07  |- skos__prefLabel mesh__D019028 Magnetic Resonance Imaging, Cine
% 212.88/213.07  |- skos__altLabel mesh__D019028 Cine Magnetic Resonance Imaging
% 212.88/213.07  |- mesh__publicMeSHNote mesh__D019028 96   
% 212.88/213.07  |- skos__altLabel mesh__D019028 Cine MRI
% 212.88/213.07  |- skos__hiddenLabel mesh__D019028 Cine MRIs
% 212.88/213.07  |- mesh__recordAuthorizer mesh__D019028 SJN
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019028 2002
% 212.88/213.07  |- mesh__historyNote mesh__D019028 96   
% 212.88/213.07  |- mesh__recordOriginator mesh__D019028 PXP
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019028 2003
% 212.88/213.07  |- skos__hiddenLabel mesh__D019028 MRI, Cine
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019028 1998
% 212.88/213.07  |- skos__hiddenLabel mesh__D019028 MRIs, Cine
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019028 2004
% 212.88/213.07  |- mesh__dateEstablished mesh__D019028 1996-01-01
% 212.88/213.07  |- skos__broader mesh__D019028smesh__D008279
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019028 2005
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019028 1999
% 212.88/213.07  |- skos__historyNote mesh__D019028
% 212.88/213.07       Magnetic Resonance Imaging %28%1988-1995%29%
% 212.88/213.07  |- mesh__recordMaintainer mesh__D019028 PXP
% 212.88/213.07  |- mesh__dateCreated mesh__D019028 1995-05-26
% 212.88/213.07  |- mesh__dateRevised mesh__D019028 1997-06-20
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019028 2006
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019028 2000
% 212.88/213.07  |- skos__annotation mesh__D019028
% 212.88/213.07       for dis %26% organ coords see note on MAGNETIC RESONANCE IMAGING; DF: MRI CINE or short X ref%A%  
% 212.88/213.07  |- skos__hiddenLabel mesh__D011045 Syndrome, Poland
% 212.88/213.07  |- mesh__recordOriginator mesh__D011045 RC
% 212.88/213.07  |- mesh__recordAuthorizer mesh__D011045 sjn
% 212.88/213.07  |- rdf__type mesh__D011045sskos__Concept
% 212.88/213.07  |- mesh__dateCreated mesh__D011045 1984-04-05
% 212.88/213.07  |- mesh__publicMeSHNote mesh__D011045
% 212.88/213.07       91; was see under SYNDACTYLIA 1985-90   
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D011045 2001
% 212.88/213.07  |- mesh__dateRevised mesh__D011045 1999-11-03
% 212.88/213.07  |- skos__annotation mesh__D011045
% 212.88/213.07       abnorm of pectoralis musc with syndactyly, named for A. Poland, 19th cent physician; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D011045 2004
% 212.88/213.07  |- mesh__historyNote mesh__D011045
% 212.88/213.07       91%28%85%29%; was see under SYNDACTYLIA 1985-90   
% 212.88/213.07  |- mesh__recordMaintainer mesh__D011045 kle
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D011045 2000
% 212.88/213.07  |- skos__scopeNote mesh__D011045
% 212.88/213.07       A syndrome which is characterized by symbrachydactyly and aplasia of the sternal head of pectoralis major.%A%    
% 212.88/213.07  |- skos__historyNote mesh__D011045 Syndactylia %28%1967-1984%29%
% 212.88/213.07  |- skos__historyNote mesh__D011045 Pectoralis Muscles %28%1966-1984%29%
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D011045 2003
% 212.88/213.07  |- skos__historyNote mesh__D011045 Hand %28%1966-1984%29%
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D011045 2006
% 212.88/213.07  |- mesh__dateEstablished mesh__D011045 1991-01-01
% 212.88/213.07  |- skos__prefLabel mesh__D011045 Poland Syndrome
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D011045 2002
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D011045 2005
% 212.88/213.07  |- skos__broader mesh__D011045smesh__D013576
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D005008 2005
% 212.88/213.07  |- skos__prefLabel mesh__D005008 Ethnopsychology
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D005008 2006
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D005008 2003
% 212.88/213.07  |- mesh__dateCreated mesh__D005008 1999-01-01
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D005008 2000
% 212.88/213.07  |- mesh__recordOriginator mesh__D005008 NLM
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D005008 2004
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D005008 1998
% 212.88/213.07  |- skos__broader mesh__D005008smesh__D011584
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D005008 2001
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D005008 1999
% 212.88/213.07  |- skos__annotation mesh__D005008
% 212.88/213.07       IM, GEN only; SPEC qualif; for psychol of specific ethnic group, index under ethnic group or race /psychol %28%IM%29%, as %22%psychol of Italo-Americans%22% = ETHNIC GROUPS /psychol %28%IM%29% + ITALY /ethnol %28%NIM%29% + UNITED STATES %28%NIM%29%; Manual 27.15; DF: ETHNOPSYCHOL%A%  
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D005008 2002
% 212.88/213.07  |- skos__scopeNote mesh__D005008
% 212.88/213.07       Comparative psychology of races and peoples.     
% 212.88/213.07  |- rdf__type mesh__D005008sskos__Concept
% 212.88/213.07  |- mesh__recordAuthorizer mesh__D005008 SJN
% 212.88/213.07  |- mesh__dateRevised mesh__D005008 1997-06-20
% 212.88/213.07  |- mesh__recordMaintainer mesh__D005008 TPW
% 212.88/213.07  |- skos__hiddenLabel mesh__D043925 Inducers, Angiogenesis
% 212.88/213.07  |- mesh__recordOriginator mesh__D043925 ssb
% 212.88/213.07  |- skos__annotation mesh__D043925 coord with specific agents   
% 212.88/213.07  |- skos__hiddenLabel mesh__D043925 Agents, Angiogenesis Stimulating
% 212.88/213.07  |- skos__altLabel mesh__D043925 Angiogenic Factor
% 212.88/213.07  |- skos__altLabel mesh__D043925 Angiogenesis Stimulators
% 212.88/213.07  |- skos__historyNote mesh__D043925 Angiogenesis Factor %28%1973-2003%29%
% 212.88/213.07  |- skos__hiddenLabel mesh__D043925 Inducing Agents, Angiogenesis
% 212.88/213.07  |- skos__hiddenLabel mesh__D043925 Factor, Angiogenesis
% 212.88/213.07  |- skos__scopeNote mesh__D043925
% 212.88/213.07       Agents that induce or stimulate the PHYSIOLOGIC ANGIOGENESIS process. This is caused by a number of ANGIOGENIC PROTEINS.%A%    
% 212.88/213.07  |- skos__hiddenLabel mesh__D043925 Stimulators, Angiogenesis
% 212.88/213.07  |- skos__altLabel mesh__D043925 Angiogenesis Stimulating Agents
% 212.88/213.07  |- mesh__dateCreated mesh__D043925 2003-07-09
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D043925 2004
% 212.88/213.07  |- skos__hiddenLabel mesh__D043925 Stimulating Agents, Angiogenesis
% 212.88/213.07  |- skos__broader mesh__D043925smesh__D043924
% 212.88/213.07  |- skos__hiddenLabel mesh__D043925 Angiogenic Factor, Tumor
% 212.88/213.07  |- skos__hiddenLabel mesh__D043925 Factor, Angiogenic
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D043925 2005
% 212.88/213.07  |- rdf__type mesh__D043925sskos__Concept
% 212.88/213.07  |- skos__hiddenLabel mesh__D043925 Agents, Angiogenesis Inducing
% 212.88/213.07  |- mesh__recordAuthorizer mesh__D043925 sjn
% 212.88/213.07  |- mesh__dateEstablished mesh__D043925 2004-01-01
% 212.88/213.07  |- skos__altLabel mesh__D043925 Angiogenesis Inducers
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D043925 2006
% 212.88/213.07  |- mesh__publicMeSHNote mesh__D043925 2004   
% 212.88/213.07  |- mesh__recordMaintainer mesh__D043925 ssb
% 212.88/213.07  |- skos__prefLabel mesh__D043925 Angiogenesis Inducing Agents
% 212.88/213.07  |- mesh__historyNote mesh__D043925 2004   
% 212.88/213.07  |- skos__hiddenLabel mesh__D043925 Factor, Tumor Angiogenic
% 212.88/213.07  |- skos__hiddenLabel mesh__D015436 Mesenteritis, Sclerosing
% 212.88/213.07  |- skos__hiddenLabel mesh__D015436 Peritoneal Panniculitis
% 212.88/213.07  |- mesh__recordAuthorizer mesh__D015436 jls
% 212.88/213.07  |- skos__broader mesh__D015436smesh__D010532
% 212.88/213.07  |- skos__hiddenLabel mesh__D015436 Mesenteritis, Liposclerotic
% 212.88/213.07  |- skos__hiddenLabel mesh__D015436 Lipodystrophy, Mesenteric
% 212.88/213.07  |- mesh__dateRevised mesh__D015436 2004-07-30
% 212.88/213.07  |- mesh__recordOriginator mesh__D015436 WDJ
% 212.88/213.07  |- mesh__recordMaintainer mesh__D015436 jls
% 212.88/213.07  |- rdf__type mesh__D015436sskos__Concept
% 212.88/213.07  |- skos__hiddenLabel mesh__D015436 Mesenteric Weber Christian Disease
% 212.88/213.07  |- skos__altLabel mesh__D015436 Mesenteric Lipodystrophy
% 212.88/213.07  |- skos__altLabel mesh__D015436 Mesenteric Weber-Christian Disease
% 212.88/213.07  |- mesh__historyNote mesh__D015436 89   
% 212.88/213.07  |- mesh__dateCreated mesh__D015436 1988-06-08
% 212.88/213.07  |- skos__hiddenLabel mesh__D015436 Panniculitis, Omental
% 212.88/213.07  |- mesh__dateEstablished mesh__D015436 1989-01-01
% 212.88/213.07  |- skos__historyNote mesh__D015436 Mesentery %28%1966-1988%29%
% 212.88/213.07  |- skos__altLabel mesh__D015436 Sclerosing Mesenteritis
% 212.88/213.07  |- mesh__publicMeSHNote mesh__D015436 89   
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D015436 2005
% 212.88/213.07  |- skos__scopeNote mesh__D015436
% 212.88/213.07       INFLAMMATION of the underlying layer of ADIPOSE TISSUE %28%panniculus%29% of the PERITONEUM, usually of the MESENTERY or the OMENTUM. There are several forms with various names and are usually characterized by infiltration of LYMPHOCYTES and NEUTROPHILS, fat NECROSIS, and FIBROSIS.%A%    
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D015436 2005A
% 212.88/213.07  |- skos__broader mesh__D015436smesh__D015434
% 212.88/213.07  |- skos__hiddenLabel mesh__D015436 Mesenteritis, Retractile
% 212.88/213.07  |- skos__hiddenLabel mesh__D015436 Panniculitis, Mesenteric
% 212.88/213.07  |- skos__prefLabel mesh__D015436 Panniculitis, Peritoneal
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D015436 2006
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D015436 2005B
% 212.88/213.07  |- skos__historyNote mesh__D015436
% 212.88/213.07       Panniculitis, Nodular Nonsuppurative %28%1966-1988%29%
% 212.88/213.07  |- skos__historyNote mesh__D015436 Peritoneal Diseases %28%1966-1988%29%
% 212.88/213.07  |- skos__altLabel mesh__D015436 Liposclerotic Mesenteritis
% 212.88/213.07  |- skos__hiddenLabel mesh__D001416 Back Pains
% 212.88/213.07  |- mesh__dateCreated mesh__D001416 1999-01-01
% 212.88/213.07  |- skos__hiddenLabel mesh__D001416 Pain Syndrome, Vertebrogenic
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D001416 2006
% 212.88/213.07  |- mesh__recordOriginator mesh__D001416 NLM
% 212.88/213.07  |- skos__hiddenLabel mesh__D001416 Pain Syndromes, Vertebrogenic
% 212.88/213.07  |- skos__altLabel mesh__D001416 Backache
% 212.88/213.07  |- skos__broader mesh__D001416smesh__D010146
% 212.88/213.07  |- rdf__type mesh__D001416sskos__Concept
% 212.88/213.07  |- skos__annotation mesh__D001416
% 212.88/213.07       GEN or unspecified; %22%lombo-sciatique%22% in French texts is indexed under LOW BACK PAIN %28%IM%29% + SCIATICA %28%IM%29%; for lower back pain or pain in the lumbar region, LOW BACK PAIN is available%A%  
% 212.88/213.07  |- skos__hiddenLabel mesh__D001416 Syndrome, Vertebrogenic Pain
% 212.88/213.07  |- mesh__historyNote mesh__D001416 93; was BACKACHE 1963-92   
% 212.88/213.07  |- skos__hiddenLabel mesh__D001416 Aches, Back
% 212.88/213.07  |- skos__hiddenLabel mesh__D001416 Backaches
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D001416 2004
% 212.88/213.07  |- skos__hiddenLabel mesh__D001416 Pain, Back
% 212.88/213.07  |- skos__hiddenLabel mesh__D001416 Syndromes, Vertebrogenic Pain
% 212.88/213.07  |- skos__hiddenLabel mesh__D001416 Pains, Back
% 212.88/213.07  |- skos__related mesh__D001416smesh__D017116
% 212.88/213.07  |- mesh__recordAuthorizer mesh__D001416 sjn
% 212.88/213.07  |- skos__hiddenLabel mesh__D001416 Vertebrogenic Pain Syndromes
% 212.88/213.07  |- skos__altLabel mesh__D001416 Back Ache
% 212.88/213.07  |- mesh__recordMaintainer mesh__D001416 lkt
% 212.88/213.07  |- skos__prefLabel mesh__D001416 Back Pain
% 212.88/213.07  |- skos__hiddenLabel mesh__D001416 Back Aches
% 212.88/213.07  |- mesh__onlineNote mesh__D001416
% 212.88/213.07       use BACK PAIN to search BACKACHE 1966-92   
% 212.88/213.07  |- mesh__dateRevised mesh__D001416 2003-07-09
% 212.88/213.07  |- skos__hiddenLabel mesh__D001416 Ache, Back
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D001416 2005
% 212.88/213.07  |- skos__scopeNote mesh__D001416
% 212.88/213.07       Acute or chronic pain located in the posterior regions of the THORAX; LUMBOSACRAL REGION; or the adjacent regions.%A%    
% 212.88/213.07  |- mesh__publicMeSHNote mesh__D001416 93; was BACKACHE 1963-92   
% 212.88/213.07  |- skos__broader mesh__D008168Q000637smesh__D008168
% 212.88/213.07  |- mesh__preferredCombination mesh__D008168Q000637smesh__D016040
% 212.88/213.07  |- rdf__type mesh__D008168Q000637smesh__CompoundConcept
% 212.88/213.07  |- rdf__type mesh__D006101sskos__Concept
% 212.88/213.07  |- skos__hiddenLabel mesh__D006101 Giant Cell Granulomas
% 212.88/213.07  |- skos__altLabel mesh__D006101 Peripheral Giant Cell Granuloma
% 212.88/213.07  |- skos__broader mesh__D006101smesh__D006099
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D006101 2002
% 212.88/213.07  |- skos__hiddenLabel mesh__D006101 Giant Cell Epulis
% 212.88/213.07  |- skos__annotation mesh__D006101
% 212.88/213.07       do not confuse with GIANT CELL TUMORS, benign or malignant neopl; coord IM with organ/dis %28%IM%29%, not organ/neopl; peripheral or epulis involves gingiva, central refers to jaw%A%  
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D006101 2005
% 212.88/213.07  |- skos__hiddenLabel mesh__D006101 Giant Cell Epulides
% 212.88/213.07  |- mesh__dateEstablished mesh__D006101 1965-01-01
% 212.88/213.07  |- mesh__recordOriginator mesh__D006101 NLM
% 212.88/213.07  |- skos__hiddenLabel mesh__D006101 Granulomas, Giant Cell
% 212.88/213.07  |- skos__scopeNote mesh__D006101
% 212.88/213.07       A non-neoplastic inflammatory lesion, usually of the jaw or gingiva, containing large, multinucleated cells. It includes reparative giant cell granuloma. Peripheral giant cell granuloma refers to the gingiva %28%giant cell epulis%29%; central refers to the jaw.%A%    
% 212.88/213.07  |- mesh__dateCreated mesh__D006101 1999-01-01
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D006101 2006
% 212.88/213.07  |- skos__altLabel mesh__D006101 Epulides, Giant Cell
% 212.88/213.07  |- mesh__dateRevised mesh__D006101 2001-07-25
% 212.88/213.07  |- mesh__onlineNote mesh__D006101
% 212.88/213.07       use GRANULOMA, GIANT CELL to search GRANULOMA, REPARATIVE GIANT CELL 1966-73%A%  
% 212.88/213.07  |- mesh__recordMaintainer mesh__D006101 ags
% 212.88/213.07  |- skos__altLabel mesh__D006101 Giant Cell Granuloma
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D006101 2003
% 212.88/213.07  |- skos__prefLabel mesh__D006101 Granuloma, Giant Cell
% 212.88/213.07  |- skos__broader mesh__D006101smesh__D007571
% 212.88/213.07  |- mesh__publicMeSHNote mesh__D006101
% 212.88/213.07       74; was GRANULOMA, REPARATIVE GIANT CELL 1965-73   
% 212.88/213.07  |- mesh__historyNote mesh__D006101
% 212.88/213.07       74; was GRANULOMA, REPARATIVE GIANT CELL 1965-73   
% 212.88/213.07  |- mesh__recordAuthorizer mesh__D006101 sjn
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D006101 2004
% 212.88/213.07  |- skos__broader mesh__D006101smesh__D005882
% 212.88/213.07  |- mesh__dateRevised mesh__D011844 2001-07-25
% 212.88/213.07  |- mesh__historyNote mesh__D011844 67,63-65   
% 212.88/213.07  |- skos__broader mesh__D011844smesh__D026443
% 212.88/213.07  |- rdf__type mesh__D011844sskos__Concept
% 212.88/213.07  |- mesh__recordMaintainer mesh__D011844 ssb
% 212.88/213.07  |- skos__prefLabel mesh__D011844 Radiesthesia
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D011844 2005
% 212.88/213.07  |- skos__scopeNote mesh__D011844
% 212.88/213.07       Therapeutic cult concerned with intangible energies surrounding the living body and based on the detection of these intrinsic radiations by dowsing, or divining, or the use of more elaborate instruments %28%radionics%29%.%A%    
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D011844 2003
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D011844 2006
% 212.88/213.07  |- skos__annotation mesh__D011844
% 212.88/213.07       do not use /util except by MeSH definition   
% 212.88/213.07  |- mesh__recordAuthorizer mesh__D011844 sjn
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D011844 2004
% 212.88/213.07  |- mesh__recordOriginator mesh__D011844 NLM
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D011844 2002
% 212.88/213.07  |- mesh__dateCreated mesh__D011844 1999-01-01
% 212.88/213.07  |- mesh__publicMeSHNote mesh__D011844 67,63-65   
% 212.88/213.07  |- mesh__dateCreated mesh__D019029 1995-05-26
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019029 2002
% 212.88/213.07  |- mesh__dateEstablished mesh__D019029 1996-01-01
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019029 1998
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019029 2006
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019029 2001
% 212.88/213.07  |- skos__historyNote mesh__D019029 Micronesia %28%1970-1995%29%
% 212.88/213.07  |- rdf__type mesh__D019029sskos__Concept
% 212.88/213.07  |- mesh__recordMaintainer mesh__D019029 PLS
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019029 2005
% 212.88/213.07  |- skos__scopeNote mesh__D019029
% 212.88/213.07       A republic consisting of a group of about 100 islands and islets in the western Pacific Ocean. Its capital is Koror. Under Spain it was administered as a part of the Caroline Islands but was sold to Germany in 1899. Seized by Japan in 1914, it was taken by the Allies in World War II in 1944. In 1947 it became part of the U.S. Trust Territory of the Pacific Islands, became internally self-governing in 1980, obtained independent control over its foreign policy %28%except defense%29% in 1986, and achieved total independence October 1, 1994. %28%Webster%27%s New Geographical Dictionary, 1988, p915; telephone communication with Randy Flynn, Board on Geographic Names, 17 January 1995%29%%A%    
% 212.88/213.07  |- mesh__recordAuthorizer mesh__D019029 PLS
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019029 1997
% 212.88/213.07  |- skos__broader mesh__D019029smesh__D008849
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019029 2000
% 212.88/213.07  |- mesh__onlineNote mesh__D019029
% 212.88/213.07       use MICRONESIA to search PALAU 1995 %26% PAULAU 1994   
% 212.88/213.07  |- mesh__dateRevised mesh__D019029 1995-07-18
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019029 1996
% 212.88/213.07  |- skos__prefLabel mesh__D019029 Palau
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019029 2004
% 212.88/213.07  |- mesh__recordOriginator mesh__D019029 TGC
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019029 2003
% 212.88/213.07  |- mesh__historyNote mesh__D019029
% 212.88/213.07       96; was see MICRONESIA 1995; was PAULAU see MICRONESIA 1994%A%  
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D019029 1999
% 212.88/213.07  |- mesh__recordMaintainer mesh__D005807 nns
% 212.88/213.07  |- mesh__recordAuthorizer mesh__D005807 sjn
% 212.88/213.07  |- skos__scopeNote mesh__D005807
% 212.88/213.07       Genes whose nucleotide sequences overlap to some degree. The overlapped sequences may involve structural or regulatory genes of eukaryotic or prokaryotic cells.%A%    
% 212.88/213.07  |- skos__broader mesh__D005807smesh__D005796
% 212.88/213.07  |- skos__altLabel mesh__D005807 Overlapping Genes
% 212.88/213.07  |- mesh__dateRevised mesh__D005807 2005-06-30
% 212.88/213.07  |- mesh__recordOriginator mesh__D005807 SCD
% 212.88/213.07  |- mesh__publicMeSHNote mesh__D005807 91; was see under GENES 1988-90   
% 212.88/213.07  |- mesh__historyNote mesh__D005807
% 212.88/213.07       91%28%88%29%; was see under GENES 1988-90   
% 212.88/213.07  |- skos__historyNote mesh__D005807
% 212.88/213.07       specific microbial gene heading %28%1978-1987%29%
% 212.88/213.07  |- mesh__dateEstablished mesh__D005807 1991-01-01
% 212.88/213.07  |- skos__prefLabel mesh__D005807 Genes, Overlapping
% 212.88/213.07  |- skos__historyNote mesh__D005807 Genes, Structural %28%1975-1987%29%
% 212.88/213.07  |- skos__hiddenLabel mesh__D005807 Gene, Overlapping
% 212.88/213.07  |- skos__hiddenLabel mesh__D005807 Overlapping Gene
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D005807 2006
% 212.88/213.07  |- rdf__type mesh__D005807sskos__Concept
% 212.88/213.07  |- skos__historyNote mesh__D005807 Base Sequence %28%1975-1987%29%
% 212.88/213.07  |- mesh__dateCreated mesh__D005807 1987-05-08
% 212.88/213.07  |- mesh__publicMeSHNote mesh__D005009
% 212.88/213.07       91; was see under ETHERS 1975-90; was see under ALKYLATING AGENTS 1967-74%A%  
% 212.88/213.07  |- skos__scopeNote mesh__D005009
% 212.88/213.07       Alkylating antineoplastic agent used especially in bladder neoplasms. It is toxic to hair follicles, gastro-intestinal tract, and vasculature.%A%    
% 212.88/213.07  |- mesh__historyNote mesh__D005009
% 212.88/213.07       91%28%65%29%; was see under ETHERS 1975-90; was see under ALKYLATING AGENTS 1967-74%A%  
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D005009 2005
% 212.88/213.07  |- mesh__dateCreated mesh__D005009 1999-01-01
% 212.88/213.07  |- mesh__recordOriginator mesh__D005009 NLM
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D005009 2003
% 212.88/213.07  |- mesh__recordAuthorizer mesh__D005009 sjn
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D005009 2006
% 212.88/213.07  |- skos__altLabel mesh__D005009 Etoglucid
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D005009 2001
% 212.88/213.07  |- skos__prefLabel mesh__D005009 Ethoglucid
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D005009 2004
% 212.88/213.07  |- mesh__recordMaintainer mesh__D005009 CCR
% 212.88/213.07  |- skos__broader mesh__D005009smesh__D004987
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D005009 2002
% 212.88/213.07  |- rdf__type mesh__D005009sskos__Concept
% 212.88/213.07  |- mesh__dateRevised mesh__D005009 2000-06-22
% 212.88/213.07  |- mesh__dateEstablished mesh__D005009 1991-01-01
% 212.88/213.07  |- skos__broader mesh__D006632Q000037smesh__D006632
% 212.88/213.07  |- mesh__preferredCombination mesh__D006632Q000037smesh__D006633
% 212.88/213.07  |- rdf__type mesh__D006632Q000037smesh__CompoundConcept
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D001417 1999
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D001417 2004
% 212.88/213.07  |- mesh__dateEstablished mesh__D001417 1991-01-01
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D001417 1993
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D001417 1996
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D001417 2002
% 212.88/213.07  |- skos__broader mesh__D001417smesh__D011839
% 212.88/213.07  |- mesh__publicMeSHNote mesh__D001417
% 212.88/213.07       91; was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1975%A%  
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D001417 1997
% 212.88/213.07  |- skos__prefLabel mesh__D001417 Background Radiation
% 212.88/213.07  |- mesh__historyNote mesh__D001417
% 212.88/213.07       91%28%71%29%; was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1975%A%  
% 212.88/213.07  |- skos__altLabel mesh__D001417 Natural Radiation
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D001417 2000
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D001417 2005
% 212.88/213.07  |- mesh__recordOriginator mesh__D001417 NLM
% 212.88/213.07  |- mesh__dateRevised mesh__D001417 1992-03-25
% 212.88/213.07  |- skos__hiddenLabel mesh__D001417 Background Radiations
% 212.88/213.07  |- mesh__dateCreated mesh__D001417 1999-01-01
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D001417 2006
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D001417 1994
% 212.88/213.07  |- mesh__recordMaintainer mesh__D001417 TAP
% 212.88/213.07  |- skos__hiddenLabel mesh__D001417 Radiations, Natural
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D001417 2001
% 212.88/213.07  |- rdf__type mesh__D001417sskos__Concept
% 212.88/213.07  |- skos__altLabel mesh__D001417 Radiation, Background
% 212.88/213.07  |- skos__historyNote mesh__D001417 Radiation %28%1966-1970%29%
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D001417 1998
% 212.88/213.07  |- skos__scopeNote mesh__D001417
% 212.88/213.07       Radiation from sources other than the source of interest. It is due to cosmic rays and natural radioactivity in the environment.%A%    
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D001417 1995
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D001417 2003
% 212.88/213.07  |- skos__altLabel mesh__D001417 Radiation, Natural
% 212.88/213.07  |- skos__hiddenLabel mesh__D001417 Radiations, Background
% 212.88/213.07  |- mesh__recordAuthorizer mesh__D001417 PLS
% 212.88/213.07  |- skos__hiddenLabel mesh__D001417 Natural Radiations
% 212.88/213.07  |- skos__historyNote mesh__D001417 Radioactivity %28%1966-1970%29%
% 212.88/213.07  |- skos__prefLabel mesh__D006900 Hydroxylation
% 212.88/213.07  |- skos__annotation mesh__D006900
% 212.88/213.07       almost never IM; enzymatic hydroxylation: coord NIM with MIXED FUNCTION OXYGENASES %28%IM%29% + substrate %28%NIM%29% or specific hydroxylase %28%IM%29%%A%  
% 212.88/213.07  |- skos__historyNote mesh__D006900 Chemistry, Organic %28%1966-1970%29%
% 212.88/213.07  |- mesh__dateEstablished mesh__D006900 1991-01-01
% 212.88/213.07  |- skos__broader mesh__D006900smesh__D002625
% 212.88/213.07  |- skos__hiddenLabel mesh__D006900 Hydroxylations
% 212.88/213.07  |- skos__scopeNote mesh__D006900
% 212.88/213.07       Placing of a hydroxyl group on a compound in a position where one did not exist before. %28%Stedman, 26th ed%29%%A%    
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D006900 2003
% 212.88/213.07  |- mesh__dateCreated mesh__D006900 1999-01-01
% 212.88/213.07  |- mesh__dateRevised mesh__D006900 2002-07-03
% 212.88/213.07  |- mesh__recordOriginator mesh__D006900 NLM
% 212.88/213.07  |- skos__broader mesh__D006900smesh__D008660
% 212.88/213.07  |- mesh__publicMeSHNote mesh__D006900
% 212.88/213.07       91; was see under CHEMISTRY, ORGANIC 1971-90   
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D006900 2004
% 212.88/213.07  |- mesh__historyNote mesh__D006900
% 212.88/213.07       91%28%71%29%; was see under CHEMISTRY, ORGANIC 1971-90   
% 212.88/213.07  |- mesh__recordMaintainer mesh__D006900 sjn
% 212.88/213.07  |- rdf__type mesh__D006900sskos__Concept
% 212.88/213.07  |- mesh__recordAuthorizer mesh__D006900 sjn
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D006900 2005
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D006900 2006
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D006102 2005
% 212.88/213.07  |- mesh__recordAuthorizer mesh__D006102 sjn
% 212.88/213.07  |- mesh__publicMeSHNote mesh__D006102
% 212.88/213.07       91; was see under LARYNGEAL DISEASES 1979-90   
% 212.88/213.07  |- mesh__dateRevised mesh__D006102 1999-11-08
% 212.88/213.07  |- mesh__dateEstablished mesh__D006102 1991-01-01
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D006102 2006
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D006102 2002
% 212.88/213.07  |- mesh__dateCreated mesh__D006102 1978-05-19
% 212.88/213.07  |- mesh__activeMeSHYear mesh__D006102 2003
% 212.88/213.07  |- skos__broader mesh__D006102smesh__D015769
% 212.88/213.07  |- skos__broader mesh__D006102smesh__D007818
% 212.88/213.07  |- mesh__historyNote mesh__D006102
% 212.88/213.07       91%28%79%29%; was see under LARYNGEAL DISEASES 1979-90   
% 212.88/213.08  |- skos__broader mesh__D006102smesh__D012131
% 212.88/213.08  |- mesh__recordMaintainer mesh__D006102 KEV
% 212.88/213.08  |- skos__annotation mesh__D006102 non-neoplastic   
% 212.88/213.08  |- skos__scopeNote mesh__D006102
% 212.88/213.08       A polypoid granulomatous projection into the lumen of the larynx.%A%    
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D006102 2004
% 212.88/213.08  |- mesh__recordOriginator mesh__D006102 RC
% 212.88/213.08  |- skos__altLabel mesh__D006102 Laryngeal Granuloma
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D006102 2000
% 212.88/213.08  |- rdf__type mesh__D006102sskos__Concept
% 212.88/213.08  |- skos__hiddenLabel mesh__D006102 Laryngeal Granulomas
% 212.88/213.08  |- skos__prefLabel mesh__D006102 Granuloma, Laryngeal
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D006102 2001
% 212.88/213.08  |- skos__hiddenLabel mesh__D006102 Granulomas, Laryngeal
% 212.88/213.08  |- skos__hiddenLabel mesh__D011845 Radios
% 212.88/213.08  |- mesh__recordOriginator mesh__D011845 NLM
% 212.88/213.08  |- skos__prefLabel mesh__D011845 Radio
% 212.88/213.08  |- skos__broader mesh__D011845smesh__D001296
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D011845 2005
% 212.88/213.08  |- skos__scopeNote mesh__D011845
% 212.88/213.08       The transmission and reception of electric impulses or signals by means of electric waves without a connecting wire, or the use of these waves for the wireless transmission of electric impulses into which sound is converted. %28%From Webster%27%s 3d%29%%A%    
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D011845 2006
% 212.88/213.08  |- mesh__dateRevised mesh__D011845 2004-07-07
% 212.88/213.08  |- skos__broader mesh__D011845smesh__D008402
% 212.88/213.08  |- mesh__dateCreated mesh__D011845 1999-01-01
% 212.88/213.08  |- skos__broader mesh__D011845smesh__D013685
% 212.88/213.08  |- mesh__recordMaintainer mesh__D011845 ags
% 212.88/213.08  |- rdf__type mesh__D011845sskos__Concept
% 212.88/213.08  |- mesh__recordAuthorizer mesh__D011845 sjn
% 212.88/213.08  |- skos__broader mesh__D005808smesh__D005796
% 212.88/213.08  |- mesh__publicMeSHNote mesh__D005808 68   
% 212.88/213.08  |- skos__altLabel mesh__D005808 Recessive Genetic Conditions
% 212.88/213.08  |- mesh__recordOriginator mesh__D005808 NLM
% 212.88/213.08  |- mesh__recordMaintainer mesh__D005808 nns
% 212.88/213.08  |- skos__hiddenLabel mesh__D005808 Genetic Condition, Recessive
% 212.88/213.08  |- skos__hiddenLabel mesh__D005808 Condition, Recessive Genetic
% 212.88/213.08  |- mesh__recordAuthorizer mesh__D005808 sjn
% 212.88/213.08  |- skos__prefLabel mesh__D005808 Genes, Recessive
% 212.88/213.08  |- skos__scopeNote mesh__D005808
% 212.88/213.08       Genes that influence the PHENOTYPE only in the homozygous state.%A%    
% 212.88/213.08  |- skos__hiddenLabel mesh__D005808 Gene, Recessive
% 212.88/213.08  |- mesh__historyNote mesh__D005808 68   
% 212.88/213.08  |- skos__broader mesh__D005808smesh__D040582
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D005808 2006
% 212.88/213.08  |- rdf__type mesh__D005808sskos__Concept
% 212.88/213.08  |- mesh__dateEstablished mesh__D005808 1968-01-01
% 212.88/213.08  |- mesh__dateRevised mesh__D005808 2005-06-30
% 212.88/213.08  |- skos__historyNote mesh__D005808 Genes %28%1966-1967%29%
% 212.88/213.08  |- skos__hiddenLabel mesh__D005808 Recessive Gene
% 212.88/213.08  |- skos__altLabel mesh__D005808 Genetic Conditions, Recessive
% 212.88/213.08  |- skos__hiddenLabel mesh__D005808 Recessive Genes
% 212.88/213.08  |- skos__hiddenLabel mesh__D005808 Recessive Genetic Condition
% 212.88/213.08  |- mesh__dateCreated mesh__D005808 1999-01-01
% 212.88/213.08  |- mesh__dateCreated mesh__D016530 1991-02-11
% 212.88/213.08  |- skos__historyNote mesh__D016530 Orthopedics/nursing %28%1970-1991%29%
% 212.88/213.08  |- rdf__type mesh__D016530sskos__Concept
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D016530 2001
% 212.88/213.08  |- skos__broader mesh__D016530smesh__D009732
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D016530 2000
% 212.88/213.08  |- mesh__publicMeSHNote mesh__D016530 92   
% 212.88/213.08  |- mesh__historyNote mesh__D016530 92   
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D016530 2004
% 212.88/213.08  |- skos__scopeNote mesh__D016530
% 212.88/213.08       The specialty or practice of nursing in the care of the orthopedic patient.%A%    
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D016530 2006
% 212.88/213.08  |- skos__annotation mesh__D016530 SPEC: SPEC qualif   
% 212.88/213.08  |- skos__prefLabel mesh__D016530 Orthopedic Nursing
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D016530 1997
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D016530 2003
% 212.88/213.08  |- mesh__dateEstablished mesh__D016530 1992-01-01
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D016530 1999
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D016530 2005
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D016530 1996
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D016530 1993
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D016530 1995
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D016530 1998
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D016530 2002
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D016530 1992
% 212.88/213.08  |- skos__altLabel mesh__D016530 Nursing, Orthopedic
% 212.88/213.08  |- skos__broader mesh__D016530smesh__D013041
% 212.88/213.08  |- skos__historyNote mesh__D016530 Specialties, Nursing %28%1972-1991%29%
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D016530 1994
% 212.88/213.08  |- mesh__recordAuthorizer mesh__D030201 sjn
% 212.88/213.08  |- mesh__publicMeSHNote mesh__D030201
% 212.88/213.08       2002; ACTIVIN RECEPTOR TYPE I was indexed under RECEPTORS, GROWTH FACTOR 1997-2001%A%  
% 212.88/213.08  |- skos__prefLabel mesh__D030201 Activin Receptors, Type I
% 212.88/213.08  |- mesh__recordMaintainer mesh__D030201 ssb
% 212.88/213.08  |- skos__broader mesh__D030201smesh__D029404
% 212.88/213.08  |- skos__historyNote mesh__D030201
% 212.88/213.08       Receptors, Growth Factor %28%1995-2001%29%
% 212.88/213.08  |- skos__hiddenLabel mesh__D030201 Activin Receptor Like Kinases, Type I
% 212.88/213.08  |- mesh__dateEstablished mesh__D030201 2002-01-01
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D030201 2005
% 212.88/213.08  |- mesh__recordOriginator mesh__D030201 lkt
% 212.88/213.08  |- skos__scopeNote mesh__D030201
% 212.88/213.08       One of the two types of ACTIVIN RECEPTORS or activin receptor-like kinases %28%ALK%27%S%29%. There are several type I activin receptors. The major active ones are ALK-2 %28%ActR-IA%29% and ALK-4 %28%ActR-IB%29%.%A%    
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D030201 2006
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D030201 2004
% 212.88/213.08  |- mesh__historyNote mesh__D030201
% 212.88/213.08       2002; use ACTIVIN RECEPTORS, TYPE I %28%NM%29% 1997-2001   
% 212.88/213.08  |- skos__altLabel mesh__D030201 Activin Receptor-Like Kinases, Type I
% 212.88/213.08  |- rdf__type mesh__D030201sskos__Concept
% 212.88/213.08  |- mesh__dateRevised mesh__D030201 2003-07-09
% 212.88/213.08  |- mesh__dateCreated mesh__D030201 2001-07-25
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D002510 2006
% 212.88/213.08  |- skos__hiddenLabel mesh__D002510 beta Lactamase II
% 212.88/213.08  |- skos__hiddenLabel mesh__D002510
% 212.88/213.08       Amido-beta-Lactam Hydrolase, Cephalosporin
% 212.88/213.08  |- skos__hiddenLabel mesh__D002510 Cephalosporin beta Lactamase
% 212.88/213.08  |- skos__altLabel mesh__D002510 beta-Lactamase II
% 212.88/213.08  |- mesh__dateCreated mesh__D002510 1999-01-01
% 212.88/213.08  |- mesh__publicMeSHNote mesh__D002510
% 212.88/213.08       91; was see under BETA-LACTAMASES 1979-90; was see under AMIDOHYDROLASES 1968-78%A%  
% 212.88/213.08  |- mesh__recordOriginator mesh__D002510 NLM
% 212.88/213.08  |- mesh__dateRevised mesh__D002510 2003-07-09
% 212.88/213.08  |- skos__altLabel mesh__D002510 Cephalosporin Amido-beta-Lactam Hydrolase
% 212.88/213.08  |- skos__hiddenLabel mesh__D002510 Amidase, Cephalexin
% 212.88/213.08  |- mesh__onlineNote mesh__D002510 search AMIDOHYDROLASES 1968-74   
% 212.88/213.08  |- mesh__historyNote mesh__D002510
% 212.88/213.08       91%28%75%29%; was see under BETA-LACTAMASES 1979-90; was see under AMIDOHYDROLASES 1968-78%A%  
% 212.88/213.08  |- mesh__recordAuthorizer mesh__D002510 sjn
% 212.88/213.08  |- skos__prefLabel mesh__D002510 Cephalosporinase
% 212.88/213.08  |- skos__altLabel mesh__D002510 Cephalosporin beta-Lactamase
% 212.88/213.08  |- rdf__type mesh__D002510sskos__Concept
% 212.88/213.08  |- skos__hiddenLabel mesh__D002510
% 212.88/213.08       Hydrolase, Cephalosporin Amido-beta-Lactam
% 212.88/213.08  |- skos__broader mesh__D002510smesh__D001618
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D002510 2004
% 212.88/213.08  |- mesh__dateEstablished mesh__D002510 1991-01-01
% 212.88/213.08  |- mesh__recordMaintainer mesh__D002510 ssb
% 212.88/213.08  |- skos__hiddenLabel mesh__D002510
% 212.88/213.08       Cephalosporin Amido beta Lactam Hydrolase
% 212.88/213.08  |- skos__hiddenLabel mesh__D002510 beta-Lactamase, Cephalosporin
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D002510 2005
% 212.88/213.08  |- mesh__recordOriginator mesh__D015438 EC
% 212.88/213.08  |- mesh__recordAuthorizer mesh__D015438 sjn
% 212.88/213.08  |- mesh__dateRevised mesh__D015438 2002-07-02
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D015438 2006
% 212.88/213.08  |- mesh__historyNote mesh__D015438 89   
% 212.88/213.08  |- mesh__recordMaintainer mesh__D015438 jls
% 212.88/213.08  |- skos__scopeNote mesh__D015438
% 212.88/213.08       Behaviors expressed by individuals to protect, maintain or promote their health status. For example, proper diet, and appropriate exercise are activities perceived to influence health status. Life style is closely associated with health behavior and factors influencing life style are socioeconomic, educational, and cultural.%A%    
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D015438 2005
% 212.88/213.08  |- skos__historyNote mesh__D015438 Attitude to Health %28%1969-1988%29%
% 212.88/213.08  |- skos__hiddenLabel mesh__D015438 Behaviors, Health
% 212.88/213.08  |- rdf__type mesh__D015438sskos__Concept
% 212.88/213.08  |- skos__broader mesh__D015438smesh__D001519
% 212.88/213.08  |- skos__hiddenLabel mesh__D015438 Behavior, Health
% 212.88/213.08  |- mesh__dateCreated mesh__D015438 1988-06-08
% 212.88/213.08  |- mesh__dateEstablished mesh__D015438 1989-01-01
% 212.88/213.08  |- mesh__publicMeSHNote mesh__D015438 89   
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D015438 2004
% 212.88/213.08  |- skos__prefLabel mesh__D015438 Health Behavior
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D015438 2003
% 212.88/213.08  |- skos__hiddenLabel mesh__D015438 Health Behaviors
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 PMSBaclofen
% 212.88/213.08  |- skos__altLabel mesh__D001418 Genpharm
% 212.88/213.08  |- skos__altLabel mesh__D001418 PCP-GABA
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D001418 2005
% 212.88/213.08  |- skos__altLabel mesh__D001418 Ciba-Geigy Brand of Baclofen
% 212.88/213.08  |- skos__prefLabel mesh__D001418 Baclofen
% 212.88/213.08  |- skos__altLabel mesh__D001418 Apotex Brand of Baclofen
% 212.88/213.08  |- rdf__type mesh__D001418sskos__Concept
% 212.88/213.08  |- skos__altLabel mesh__D001418 Nu-Pharm Brand of Baclofen
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 Baclofen Athena Brand
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 Baclofen Apotex Brand
% 212.88/213.08  |- skos__altLabel mesh__D001418 ASTA Medica Brand of Baclofen
% 212.88/213.08  |- skos__scopeNote mesh__D001418
% 212.88/213.08       A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist at GABA-B receptors %28%RECEPTORS, GABA-B%29%. It is used in the treatment of spasticity, especially that due to spinal cord damage. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.%A%    
% 212.88/213.08  |- skos__historyNote mesh__D001418 Chlorobenzenes %28%1974%29%
% 212.88/213.08  |- mesh__dateCreated mesh__D001418 1974-11-11
% 212.88/213.08  |- skos__altLabel mesh__D001418 Ashbourne Brand of Baclofen
% 212.88/213.08  |- mesh__dateEstablished mesh__D001418 1980-01-01
% 212.88/213.08  |- skos__altLabel mesh__D001418 Pharmascience Brand of Baclofen
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 GABA, Chlorophenyl
% 212.88/213.08  |- mesh__recordOriginator mesh__D001418 NLM
% 212.88/213.08  |- skos__altLabel mesh__D001418 CIBA-34,647-BA
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 Baclofen Alphapharm Brand
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 Ba34,647
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 Baclofen Irex Brand
% 212.88/213.08  |- mesh__publicMeSHNote mesh__D001418
% 212.88/213.08       80; was see under AMINOBUTYRIC ACIDS 1975-79   
% 212.88/213.08  |- skos__broader mesh__D001418smesh__D005680
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 Gen Baclofen
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 Nu Baclo
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 Ba34647
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 Baclofen Ciba-Geigy Brand
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 Baclofen Medtronic Brand
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 GenBaclofen
% 212.88/213.08  |- mesh__recordAuthorizer mesh__D001418 sjn
% 212.88/213.08  |- skos__altLabel mesh__D001418
% 212.88/213.08       beta-%28%p-Chlorophenyl%29%-gamma-aminobutyric Acid
% 212.88/213.08  |- skos__altLabel mesh__D001418 Irex Brand of Baclofen
% 212.88/213.08  |- skos__altLabel mesh__D001418 Medtronic Brand of Baclofen
% 212.88/213.08  |- skos__altLabel mesh__D001418 Isis Brand of Baclofen
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 CIBA34,647BA
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 Baclofen Pharmascience Brand
% 212.88/213.08  |- skos__altLabel mesh__D001418 Athena Brand of Baclofen
% 212.88/213.08  |- skos__altLabel mesh__D001418 Lior%C3%%A9%sal
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 Ciba Geigy Brand of Baclofen
% 212.88/213.08  |- skos__altLabel mesh__D001418 Novartis Brand of Baclofen
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 Baclofen Ashbourne Brand
% 212.88/213.08  |- skos__altLabel mesh__D001418 Ba-34647
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 Baclof%C3%%A8%neIrex
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 Baclofen Nu-Pharm Brand
% 212.88/213.08  |- skos__altLabel mesh__D001418 Chlorophenyl GABA
% 212.88/213.08  |- mesh__dateRevised mesh__D001418 2004-07-07
% 212.88/213.08  |- skos__altLabel mesh__D001418 Alphapharm Brand of Baclofen
% 212.88/213.08  |- mesh__recordMaintainer mesh__D001418 mdb
% 212.88/213.08  |- skos__altLabel mesh__D001418
% 212.88/213.08       beta-%28%Aminomethyl%29%-4-chlorobenzenepropanoic Acid
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 Baclofen Isis Brand
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 Baclof%C3%%A8%ne Irex
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 Apo Baclofen
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 Nu Pharm Brand of Baclofen
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 PMS Baclofen
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 AWD, Baclofen
% 212.88/213.08  |- skos__altLabel mesh__D001418 Baclophen
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 NuBaclo
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 ApoBaclofen
% 212.88/213.08  |- skos__historyNote mesh__D001418 Aminobutyric Acids %28%1972-1974%29%
% 212.88/213.08  |- mesh__historyNote mesh__D001418
% 212.88/213.08       80%28%75%29%; was see under AMINOBUTYRIC ACIDS 1975-79   
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D001418 2006
% 212.88/213.08  |- skos__hiddenLabel mesh__D001418 Baclofen Novartis Brand
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D012140 2001
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D012140 2004
% 212.88/213.08  |- mesh__recordAuthorizer mesh__D012140 SJN
% 212.88/213.08  |- mesh__runningHead mesh__D012140 C8 - DISEASES-RESPIRATORY   
% 212.88/213.08  |- mesh__dateRevised mesh__D012140 1997-06-20
% 212.88/213.08  |- skos__annotation mesh__D012140
% 212.88/213.08       GEN or unspecified; prefer specifics; /diag: consider also DIAGNOSTIC TECHNIQUES, RESPIRATORY SYSTEM; DF: RESPIRATORY TRACT DIS%A%  
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D012140 1999
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D012140 2000
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D012140 2006
% 212.88/213.08  |- skos__hiddenLabel mesh__D012140 Tract Diseases, Respiratory
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D012140 2003
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D012140 1998
% 212.88/213.08  |- mesh__onlineNote mesh__D012140
% 212.88/213.08       pre-explosion = RESPIRATORY TRACT DISEASES %28%PX%29%   
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D012140 2005
% 212.88/213.08  |- mesh__dateCreated mesh__D012140 1999-01-01
% 212.88/213.08  |- skos__hiddenLabel mesh__D012140 Respiratory Tract Disease
% 212.88/213.08  |- skos__prefLabel mesh__D012140 Respiratory Tract Diseases
% 212.88/213.08  |- skos__hiddenLabel mesh__D012140 Diseases, Respiratory Tract
% 212.88/213.08  |- mesh__recordMaintainer mesh__D012140 TGC
% 212.88/213.08  |- mesh__publicMeSHNote mesh__D012140
% 212.88/213.08       66; was RESPIRATORY DISEASES 1963-65   
% 212.88/213.08  |- mesh__historyNote mesh__D012140 66; was RESPIRATORY DISEASES 1963-65   
% 212.88/213.08  |- mesh__recordOriginator mesh__D012140 NLM
% 212.88/213.08  |- rdf__type mesh__D012140sskos__Concept
% 212.88/213.08  |- skos__hiddenLabel mesh__D012140 Tract Disease, Respiratory
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D012140 2002
% 212.88/213.08  |- skos__hiddenLabel mesh__D012140 Disease, Respiratory Tract
% 212.88/213.08  |- mesh__dateEstablished mesh__D012140 1966-01-01
% 212.88/213.08  |- skos__prefLabel mesh__D006901 Hydroxylysine
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D006901 2002
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D006901 2006
% 212.88/213.08  |- skos__broader mesh__D006901smesh__D008239
% 212.88/213.08  |- mesh__dateCreated mesh__D006901 1999-01-01
% 212.88/213.08  |- mesh__dateRevised mesh__D006901 2001-07-25
% 212.88/213.08  |- mesh__recordOriginator mesh__D006901 NLM
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D006901 2003
% 212.88/213.08  |- skos__historyNote mesh__D006901 Lysine %28%1966-1970%29%
% 212.88/213.08  |- rdf__type mesh__D006901sskos__Concept
% 212.88/213.08  |- mesh__recordAuthorizer mesh__D006901 sjn
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D006901 2004
% 212.88/213.08  |- mesh__historyNote mesh__D006901 73%28%71%29%   
% 212.88/213.08  |- skos__scopeNote mesh__D006901
% 212.88/213.08       A hydroxylated derivative of the amino acid LYSINE that is present in certain collagens.%A%    
% 212.88/213.08  |- mesh__dateEstablished mesh__D006901 1973-01-01
% 212.88/213.08  |- mesh__publicMeSHNote mesh__D006901 73   
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D006901 2005
% 212.88/213.08  |- mesh__recordMaintainer mesh__D006901 nns
% 212.88/213.08  |- rdf__type mesh__D006103sskos__Concept
% 212.88/213.08  |- skos__scopeNote mesh__D006103
% 212.88/213.08       A non-neoplastic disease of unknown etiology beginning with inflammation, ulceration, and perforation of nose and palate and progressing to gradual destruction of midline facial structures.%A%    
% 212.88/213.08  |- skos__altLabel mesh__D006103 Lethal Midline Granuloma
% 212.88/213.08  |- mesh__dateEstablished mesh__D006103 1965-01-01
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D006103 2002
% 212.88/213.08  |- skos__hiddenLabel mesh__D006103 Granulomas, Lethal Midline
% 212.88/213.08  |- skos__broader mesh__D006103smesh__D006099
% 212.88/213.08  |- skos__prefLabel mesh__D006103 Granuloma, Lethal Midline
% 212.88/213.08  |- skos__hiddenLabel mesh__D006103 Midline Granuloma, Lethal
% 212.88/213.08  |- mesh__publicMeSHNote mesh__D006103
% 212.88/213.08       65; GRANULOMA GANGRAENESCENS %26% LETHAL MIDLINE GRANULOMA were see under WEGENER%27%S GRANULOMATOSIS 1963-64%A%  
% 212.88/213.08  |- skos__broader mesh__D006103smesh__D009668
% 212.88/213.08  |- mesh__recordAuthorizer mesh__D006103 sjn
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D006103 2006
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D006103 2001
% 212.88/213.08  |- mesh__recordMaintainer mesh__D006103 KEV
% 212.88/213.08  |- mesh__historyNote mesh__D006103
% 212.88/213.08       65; GRANULOMA GANGRAENESCENS %26% LETHAL MIDLINE GRANULOMA were see under WEGENER%27%S GRANULOMATOSIS 1963-64%A%  
% 212.88/213.08  |- mesh__dateCreated mesh__D006103 1999-01-01
% 212.88/213.08  |- mesh__dateRevised mesh__D006103 1999-11-03
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D006103 2005
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D006103 2004
% 212.88/213.08  |- skos__hiddenLabel mesh__D006103 Midline Granulomas, Lethal
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D006103 2000
% 212.88/213.08  |- skos__hiddenLabel mesh__D006103 Lethal Midline Granulomas
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D006103 2003
% 212.88/213.08  |- mesh__recordOriginator mesh__D006103 NLM
% 212.88/213.08  |- mesh__recordOriginator mesh__D019829 AGS
% 212.88/213.08  |- skos__altLabel mesh__D019829 Cahill May Roberts Brand of Nevirapine
% 212.88/213.08  |- skos__altLabel mesh__D019829 Promeco Brand of Nevirapine
% 212.88/213.08  |- skos__broader mesh__D019829smesh__D011725
% 212.88/213.08  |- skos__hiddenLabel mesh__D019829 BI RG 587
% 212.88/213.08  |- mesh__dateCreated mesh__D019829 1997-07-22
% 212.88/213.08  |- skos__scopeNote mesh__D019829
% 212.88/213.08       A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV infection and AIDS.%A%    
% 212.88/213.08  |- skos__hiddenLabel mesh__D019829 BIRG587
% 212.88/213.08  |- mesh__recordAuthorizer mesh__D019829 sjn
% 212.88/213.08  |- rdf__type mesh__D019829sskos__Concept
% 212.88/213.08  |- mesh__historyNote mesh__D019829 98   
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D019829 2006
% 212.88/213.08  |- skos__prefLabel mesh__D019829 Nevirapine
% 212.88/213.08  |- mesh__dateRevised mesh__D019829 2005-06-30
% 212.88/213.08  |- skos__historyNote mesh__D019829 Pyridines %28%1993-1997%29%
% 212.88/213.08  |- mesh__dateEstablished mesh__D019829 1998-01-01
% 212.88/213.08  |- skos__historyNote mesh__D019829 Azepines %28%1991-1992%29%
% 212.88/213.08  |- mesh__publicMeSHNote mesh__D019829 98   
% 212.88/213.08  |- mesh__recordMaintainer mesh__D019829 lkw
% 212.88/213.08  |- mesh__dateRevised mesh__D011846 2004-07-07
% 212.88/213.08  |- skos__altLabel mesh__D011846 Hertzian Waves
% 212.88/213.08  |- skos__hiddenLabel mesh__D011846 Wave, Short
% 212.88/213.08  |- mesh__recordMaintainer mesh__D011846 nns
% 212.88/213.08  |- skos__prefLabel mesh__D011846 Radio Waves
% 212.88/213.08  |- skos__hiddenLabel mesh__D011846 Frequency Wave, High
% 212.88/213.08  |- skos__hiddenLabel mesh__D011846 Short Wave
% 212.88/213.08  |- mesh__recordAuthorizer mesh__D011846 sjn
% 212.88/213.08  |- skos__hiddenLabel mesh__D011846 Waves, Radio
% 212.88/213.08  |- skos__hiddenLabel mesh__D011846 High Frequency Wave
% 212.88/213.08  |- skos__broader mesh__D011846smesh__D011840
% 212.88/213.08  |- mesh__dateCreated mesh__D011846 1999-01-01
% 212.88/213.08  |- mesh__recordOriginator mesh__D011846 NLM
% 212.88/213.08  |- skos__hiddenLabel mesh__D011846 Radio Wave
% 212.88/213.08  |- skos__hiddenLabel mesh__D011846 Waves, Short
% 212.88/213.08  |- skos__annotation mesh__D011846
% 212.88/213.08       radiation policy: see Manual index under RADIATION %26% entries following%A%  
% 212.88/213.08  |- skos__hiddenLabel mesh__D011846 Frequency Waves, High
% 212.88/213.08  |- skos__scopeNote mesh__D011846
% 212.88/213.08       Electromagnetic waves with frequencies between about 3 kilohertz %28%very low frequency - VLF%29% and 300,000 megahertz %28%extremely high frequency - EHF%29%. They are used in television and radio broadcasting, land and satellite communications systems, radionavigation, radiolocation, and DIATHERMY. The highest frequency radio waves are MICROWAVES.%A%    
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D011846 2006
% 212.88/213.08  |- skos__hiddenLabel mesh__D011846 Wave, High Frequency
% 212.88/213.08  |- skos__hiddenLabel mesh__D011846 Waves, High Frequency
% 212.88/213.08  |- skos__hiddenLabel mesh__D011846 Waves, Hertzian
% 212.88/213.08  |- skos__hiddenLabel mesh__D011846 Wave, Radio
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D011846 2005
% 212.88/213.08  |- rdf__type mesh__D011846sskos__Concept
% 212.88/213.08  |- skos__related mesh__D011846smesh__D011825
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D044222 2006
% 212.88/213.08  |- mesh__recordMaintainer mesh__D044222 SYSTEM
% 212.88/213.08  |- mesh__dateCreated mesh__D044222 2003-07-09
% 212.88/213.08  |- mesh__dateRevised mesh__D044222 2005-06-30
% 212.88/213.08  |- skos__prefLabel mesh__D044222 Halothiobacillus
% 212.88/213.08  |- skos__scopeNote mesh__D044222
% 212.88/213.08       A genus of gram-negative, chemolithoautotrophic bacteria in the family CHROMATIACEAE. Several of its species were reclassified to this genus from THIOBACILLUS.%A%    
% 212.88/213.08  |- rdf__type mesh__D044222sskos__Concept
% 212.88/213.08  |- mesh__historyNote mesh__D044222 2004   
% 212.88/213.08  |- mesh__publicMeSHNote mesh__D044222 2004   
% 212.88/213.08  |- mesh__recordAuthorizer mesh__D044222 sjn
% 212.88/213.08  |- skos__broader mesh__D044222smesh__D002841
% 212.88/213.08  |- skos__broader mesh__D044222smesh__D016946
% 212.88/213.08  |- mesh__dateEstablished mesh__D044222 2004-01-01
% 212.88/213.08  |- skos__altLabel mesh__D044222 Thiobacillus neapolitanus
% 212.88/213.08  |- mesh__recordOriginator mesh__D044222 ags
% 212.88/213.08  |- skos__hiddenLabel mesh__D011048 Polarography, DC
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D011048 2003
% 212.88/213.08  |- skos__broader mesh__D011048smesh__D002623
% 212.88/213.08  |- mesh__dateCreated mesh__D011048 1999-01-01
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D011048 2006
% 212.88/213.08  |- skos__annotation mesh__D011048 DF: POLAROGR   
% 212.88/213.08  |- skos__broader mesh__D011048smesh__D004563
% 212.88/213.08  |- skos__prefLabel mesh__D011048 Polarography
% 212.88/213.08  |- rdf__type mesh__D011048sskos__Concept
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D011048 2005
% 212.88/213.08  |- mesh__recordAuthorizer mesh__D011048 sjn
% 212.88/213.08  |- mesh__recordMaintainer mesh__D011048 lkt
% 212.88/213.08  |- skos__scopeNote mesh__D011048
% 212.88/213.08       An electrochemical technique for measuring the current that flows in solution as a function of an applied voltage. The observed polarographic wave, resulting from the electrochemical response, depends on the way voltage is applied %28%linear sweep or differential pulse%29% and the type of electrode used. Usually a mercury drop electrode is used.%A%    
% 212.88/213.08  |- skos__hiddenLabel mesh__D011048 Polarography, Pulse
% 212.88/213.08  |- mesh__dateRevised mesh__D011048 2002-07-03
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D011048 2004
% 212.88/213.08  |- mesh__recordOriginator mesh__D011048 NLM
% 212.88/213.08  |- skos__related mesh__D005809smesh__D015533
% 212.88/213.08  |- mesh__dateRevised mesh__D005809 2005-06-30
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D005809 2006
% 212.88/213.08  |- mesh__dateEstablished mesh__D005809 1968-01-01
% 212.88/213.08  |- rdf__type mesh__D005809sskos__Concept
% 212.88/213.08  |- mesh__recordMaintainer mesh__D005809 nns
% 212.88/213.08  |- skos__scopeNote mesh__D005809
% 212.88/213.08       Genes which regulate or circumscribe the activity of other genes; specifically, genes which code for PROTEINS or RNAs which have GENE EXPRESSION REGULATION functions.%A%    
% 212.88/213.08  |- skos__prefLabel mesh__D005809 Genes, Regulator
% 212.88/213.08  |- mesh__dateCreated mesh__D005809 1999-01-01
% 212.88/213.08  |- mesh__recordOriginator mesh__D005809 NLM
% 212.88/213.08  |- skos__related mesh__D005809smesh__D018085
% 212.88/213.08  |- skos__altLabel mesh__D005809 Regulator Genes
% 212.88/213.08  |- skos__altLabel mesh__D005809 Gene, Regulator
% 212.88/213.08  |- skos__broader mesh__D005809smesh__D005796
% 212.88/213.08  |- mesh__recordAuthorizer mesh__D005809 sjn
% 212.88/213.08  |- skos__historyNote mesh__D005809 Genes %28%1966-1967%29%
% 212.88/213.08  |- mesh__publicMeSHNote mesh__D005809 68   
% 212.88/213.08  |- skos__annotation mesh__D005809
% 212.88/213.08       regulatory proteins go under TRANSCRIPTION FACTORS or REPRESSOR PROTEINS or TRANS-ACTIVATORS; DF: GENES REG%A%  
% 212.88/213.08  |- skos__altLabel mesh__D005809 Regulator Gene
% 212.88/213.08  |- mesh__historyNote mesh__D005809 68   
% 212.88/213.08  |- skos__broader mesh__D002511smesh__D047090
% 212.88/213.08  |- mesh__dateCreated mesh__D002511 1999-01-01
% 212.88/213.08  |- skos__altLabel mesh__D002511 Antibiotics, Cephalosporin
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D002511 2006
% 212.88/213.08  |- mesh__historyNote mesh__D002511 66%28%65%29%   
% 212.88/213.08  |- skos__hiddenLabel mesh__D002511 Acids, Cephalosporanic
% 212.88/213.08  |- mesh__dateEstablished mesh__D002511 1966-01-01
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D002511 2005
% 212.88/213.08  |- skos__hiddenLabel mesh__D002511 Cephalosporin Antibiotics
% 212.88/213.08  |- skos__prefLabel mesh__D002511 Cephalosporins
% 212.88/213.08  |- mesh__recordOriginator mesh__D002511 NLM
% 212.88/213.08  |- mesh__recordMaintainer mesh__D002511 ssb
% 212.88/213.08  |- mesh__dateRevised mesh__D002511 2004-07-07
% 212.88/213.08  |- skos__scopeNote mesh__D002511
% 212.88/213.08       A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid.%A%    
% 212.88/213.08  |- rdf__type mesh__D002511sskos__Concept
% 212.88/213.08  |- mesh__publicMeSHNote mesh__D002511 66   
% 212.88/213.08  |- mesh__recordAuthorizer mesh__D002511 sjn
% 212.88/213.08  |- skos__hiddenLabel mesh__D015439 Dimorphous Leprosies
% 212.88/213.08  |- skos__hiddenLabel mesh__D015439 Borderline Leprosy
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D015439 1993
% 212.88/213.08  |- mesh__recordMaintainer mesh__D015439 PXP
% 212.88/213.08  |- mesh__activeMeSHYear mesh__D015439 2005
% 212.88/213.09  |- rdf__type mesh__D015439sskos__Concept
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D015439 1999
% 212.88/213.09  |- mesh__recordOriginator mesh__D015439 EC
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D015439 1992
% 212.88/213.09  |- skos__hiddenLabel mesh__D015439 Leprosies, Dimorphous
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D015439 2002
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D015439 1998
% 212.88/213.09  |- mesh__historyNote mesh__D015439 89   
% 212.88/213.09  |- mesh__dateEstablished mesh__D015439 1989-01-01
% 212.88/213.09  |- mesh__publicMeSHNote mesh__D015439 89   
% 212.88/213.09  |- skos__scopeNote mesh__D015439
% 212.88/213.09       A form of LEPROSY in which there are clinical manifestations of both principal types %28%lepromatous and tuberculoid%29%. The disease may shift toward one of these two polar or principal forms.%A%    
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D015439 1995
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D015439 2004
% 212.88/213.09  |- mesh__recordAuthorizer mesh__D015439 PLS
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D015439 1994
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D015439 2001
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D015439 2003
% 212.88/213.09  |- mesh__dateRevised mesh__D015439 1991-06-12
% 212.88/213.09  |- skos__hiddenLabel mesh__D015439 Borderline Leprosies
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D015439 1997
% 212.88/213.09  |- mesh__dateCreated mesh__D015439 1988-06-08
% 212.88/213.09  |- skos__hiddenLabel mesh__D015439 Dimorphous Leprosy
% 212.88/213.09  |- skos__hiddenLabel mesh__D015439 Leprosies, Borderline
% 212.88/213.09  |- skos__broader mesh__D015439smesh__D007918
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D015439 2000
% 212.88/213.09  |- skos__prefLabel mesh__D015439 Leprosy, Borderline
% 212.88/213.09  |- skos__historyNote mesh__D015439 Leprosy %28%1966-1988%29%
% 212.88/213.09  |- skos__altLabel mesh__D015439 Leprosy, Dimorphous
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D015439 1996
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D015439 2006
% 212.88/213.09  |- skos__prefLabel mesh__D026161 MADS Domain Proteins
% 212.88/213.09  |- mesh__publicMeSHNote mesh__D026161
% 212.88/213.09       2002; DEFICIENS-AGAMOUS-LIKE PROTEINS was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1995-2001%A%  
% 212.88/213.09  |- mesh__recordMaintainer mesh__D026161 ags
% 212.88/213.09  |- skos__hiddenLabel mesh__D026161 Proteins, Agamous-Related
% 212.88/213.09  |- skos__hiddenLabel mesh__D026161 Deficiens Agamous Like Proteins
% 212.88/213.09  |- skos__hiddenLabel mesh__D026161 Agamous Like Proteins
% 212.88/213.09  |- skos__hiddenLabel mesh__D026161 Agamous Related Proteins
% 212.88/213.09  |- mesh__dateRevised mesh__D026161 2005-07-19
% 212.88/213.09  |- mesh__dateEstablished mesh__D026161 2002-01-01
% 212.88/213.09  |- skos__altLabel mesh__D026161 Agamous-Related Proteins
% 212.88/213.09  |- mesh__recordAuthorizer mesh__D026161 ags
% 212.88/213.09  |- skos__altLabel mesh__D026161 Deficiens-Agamous-Related Proteins
% 212.88/213.09  |- mesh__dateCreated mesh__D026161 2001-07-25
% 212.88/213.09  |- skos__annotation mesh__D026161
% 212.88/213.09       note X refs; AGAMOUS PROTEIN, ARABIDOPSIS and DEFICIENS PROTEIN are also available%A%  
% 212.88/213.09  |- skos__hiddenLabel mesh__D026161 Deficiens Agamous Related Proteins
% 212.88/213.09  |- skos__historyNote mesh__D026161 DNA-Binding Proteins %28%1995-2001%29%
% 212.88/213.09  |- skos__broader mesh__D026161smesh__D018398
% 212.88/213.09  |- skos__historyNote mesh__D026161 Transcription Factors %28%1995-2001%29%
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D026161 2006
% 212.88/213.09  |- mesh__recordOriginator mesh__D026161 jmp
% 212.88/213.09  |- skos__broader mesh__D026161smesh__D014157
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D026161 2006A
% 212.88/213.09  |- mesh__historyNote mesh__D026161
% 212.88/213.09       2002; for DEFICIENS-AGAMOUS-LIKE PROTEINS use MADS DOMAIN PROTEINS 1995-2001%A%  
% 212.88/213.09  |- skos__scopeNote mesh__D026161
% 212.88/213.09       A superfamily of proteins that share a highly conserved MADS domain sequence motif. The term MADS refers to the first four members which were MCM1 PROTEIN; AGAMOUS PROTEIN; DEFICIENS PROTEIN; and SERUM RESPONSE FACTOR.  Many MADS domain proteins have been found in species from all eukaryotic kingdoms. They play an important role in development, especially in plants where they have an important role in flower development.%A%    
% 212.88/213.09  |- rdf__type mesh__D026161sskos__Concept
% 212.88/213.09  |- mesh__dateRevised mesh__D001419 2005-07-30
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D001419 2006B
% 212.88/213.09  |- mesh__publicMeSHNote mesh__D001419 1963   
% 212.88/213.09  |- mesh__historyNote mesh__D001419 1963   
% 212.88/213.09  |- mesh__recordOriginator mesh__D001419 NLM
% 212.88/213.09  |- skos__annotation mesh__D001419
% 212.88/213.09       GEN; prefer specifics; relation to bact disease: Manual 22.12-22.16; presence of bacteria in organs vs infection: Manual 22.11; note many precoord BACT- terms %28%BACTERIAL PROTEINS; ANTIBODIES, BACTERIAL; etc%29%; %22%coliform bacteria%22% = COLIFORM BACILLI see ENTEROBACTERIACEAE; presence of bacteria in blood = BACTEREMIA: see note there; DF: BACT%A%  
% 212.88/213.09  |- skos__prefLabel mesh__D001419 Bacteria
% 212.88/213.09  |- mesh__recordAuthorizer mesh__D001419 jls
% 212.88/213.09  |- mesh__recordMaintainer mesh__D001419 jls
% 212.88/213.09  |- skos__related mesh__D001419smesh__D018933
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D001419 2006A
% 212.88/213.09  |- skos__altLabel mesh__D001419 Eubacteria
% 212.88/213.09  |- mesh__runningHead mesh__D001419 B3 - ORGANISMS-BACTERIA   
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D001419 2006
% 212.88/213.09  |- mesh__dateCreated mesh__D001419 1999-01-01
% 212.88/213.09  |- skos__scopeNote mesh__D001419
% 212.88/213.09       One of the three domains of life %28%the others being Eukarya and ARCHAEA%29%, also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophic %28%via chemical reaction%29% or phototrophic %28%via light reaction%29%; for chemotrophs by their source of chemical energy: lithotrophic %28%from inorganic compounds%29% or organotrophic %28%from organic compounds%29%; and by where they get their CARBON: heterotrophic %28%from organic sources%29% or autotrophic %28%from CARBON DIOXIDE%29%. They can also be classified by whether or not they stain %28%based on the structure of their CELL WALLS%29% with CRYSTAL VIOLET dye: gram-negative or gram-positive.%A%    
% 212.88/213.09  |- rdf__type mesh__D001419sskos__Concept
% 212.88/213.09  |- skos__related mesh__D001419smesh__D010861
% 212.88/213.09  |- skos__altLabel mesh__D012141 Infections, Respiratory
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012141 2004
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012141 2002
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012141 1999
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012141 2006
% 212.88/213.09  |- skos__hiddenLabel mesh__D012141 Infection, Upper Respiratory
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012141 2003
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012141 2001
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012141 1998
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012141 2005
% 212.88/213.09  |- mesh__dateCreated mesh__D012141 1999-01-01
% 212.88/213.09  |- skos__broader mesh__D012141smesh__D012140
% 212.88/213.09  |- skos__altLabel mesh__D012141 Infections, Respiratory Tract
% 212.88/213.09  |- mesh__recordMaintainer mesh__D012141 TGC
% 212.88/213.09  |- mesh__recordAuthorizer mesh__D012141 SJN
% 212.88/213.09  |- skos__hiddenLabel mesh__D012141 Respiratory Infection, Upper
% 212.88/213.09  |- mesh__dateRevised mesh__D012141 1997-06-20
% 212.88/213.09  |- rdf__type mesh__D012141sskos__Concept
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012141 2000
% 212.88/213.09  |- skos__prefLabel mesh__D012141 Respiratory Tract Infections
% 212.88/213.09  |- skos__hiddenLabel mesh__D012141 Infection, Respiratory Tract
% 212.88/213.09  |- skos__hiddenLabel mesh__D012141 Upper Respiratory Infection
% 212.88/213.09  |- skos__hiddenLabel mesh__D012141 Infection, Respiratory
% 212.88/213.09  |- skos__hiddenLabel mesh__D012141 Respiratory Infection
% 212.88/213.09  |- skos__hiddenLabel mesh__D012141 Respiratory Infections, Upper
% 212.88/213.09  |- skos__broader mesh__D012141smesh__D007239
% 212.88/213.09  |- skos__annotation mesh__D012141
% 212.88/213.09       GEN: prefer specifics; DF: RESPIRATORY TRACT INFECT   
% 212.88/213.09  |- skos__hiddenLabel mesh__D012141 Respiratory Tract Infection
% 212.88/213.09  |- mesh__recordOriginator mesh__D012141 NLM
% 212.88/213.09  |- skos__altLabel mesh__D012141 Respiratory Infections
% 212.88/213.09  |- skos__altLabel mesh__D012141 Upper Respiratory Infections
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D006902 2000
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D006902 2003
% 212.88/213.09  |- rdf__type mesh__D006902sskos__Concept
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D006902 2001
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D006902 2004
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D006902 2002
% 212.88/213.09  |- mesh__historyNote mesh__D006902 72   
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D006902 2005
% 212.88/213.09  |- skos__prefLabel mesh__D006902 Hydroxymercuribenzoates
% 212.88/213.09  |- skos__historyNote mesh__D006902 Benzoates %28%1966-1971%29%
% 212.88/213.09  |- mesh__publicMeSHNote mesh__D006902 72   
% 212.88/213.09  |- skos__broader mesh__D006902smesh__D008626
% 212.88/213.09  |- skos__historyNote mesh__D006902
% 212.88/213.09       Organometallic Compounds %28%1968-1971%29%
% 212.88/213.09  |- skos__scopeNote mesh__D006902
% 212.88/213.09       Hydroxylated benzoic acid derivatives that contain mercury. Some of these are used as sulfhydryl reagents in biochemical studies.%A%    
% 212.88/213.09  |- mesh__dateRevised mesh__D006902 1998-06-10
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D006902 2006
% 212.88/213.09  |- skos__broader mesh__D006902smesh__D006883
% 212.88/213.09  |- skos__historyNote mesh__D006902 Mercury %28%1966-1971%29%
% 212.88/213.09  |- mesh__recordOriginator mesh__D006902 NLM
% 212.88/213.09  |- mesh__dateEstablished mesh__D006902 1972-01-01
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D006902 1999
% 212.88/213.09  |- mesh__recordAuthorizer mesh__D006902 SJN
% 212.88/213.09  |- mesh__recordMaintainer mesh__D006902 ADP
% 212.88/213.09  |- mesh__dateCreated mesh__D006902 1999-01-01
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D006104 2000
% 212.88/213.09  |- skos__hiddenLabel mesh__D006104 Plasma Cell Granulomas
% 212.88/213.09  |- skos__hiddenLabel mesh__D006104 Inflammatory Pseudotumors
% 212.88/213.09  |- skos__historyNote mesh__D006104 Granuloma %28%1966-1983%29%
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D006104 2006
% 212.88/213.09  |- mesh__onlineNote mesh__D006104
% 212.88/213.09       use FIBROMA to search PSEUDOTUMOR, INFLAMMATORY 1990-91   
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D006104 2002
% 212.88/213.09  |- mesh__recordMaintainer mesh__D006104 KEV
% 212.88/213.09  |- skos__broader mesh__D006104smesh__D006099
% 212.88/213.09  |- mesh__historyNote mesh__D006104
% 212.88/213.09       91%28%84%29%; was see under GRANULOMA 1984-90; PSEUDOTUMOR, INFLAMMATORY was see FIBROMA 1990-91%A%  
% 212.88/213.09  |- skos__hiddenLabel mesh__D006104 Pseudotumors, Inflammatory
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D006104 2005
% 212.88/213.09  |- mesh__dateEstablished mesh__D006104 1991-01-01
% 212.88/213.09  |- skos__scopeNote mesh__D006104
% 212.88/213.09       A slow-growing benign pseudotumor in which plasma cells greatly outnumber the inflammatory cells.%A%    
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D006104 2004
% 212.88/213.09  |- skos__prefLabel mesh__D006104 Granuloma, Plasma Cell
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D006104 2003
% 212.88/213.09  |- mesh__recordAuthorizer mesh__D006104 sjn
% 212.88/213.09  |- mesh__recordOriginator mesh__D006104 VDK
% 212.88/213.09  |- skos__historyNote mesh__D006104 Plasma Cells %28%1966-1983%29%
% 212.88/213.09  |- mesh__publicMeSHNote mesh__D006104
% 212.88/213.09       91; was see under GRANULOMA 1984-90; PSEUDOTUMOR, INFLAMMATORY was see FIBROMA 1990-1991%A%  
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D006104 2001
% 212.88/213.09  |- skos__altLabel mesh__D006104 Pseudotumor, Inflammatory
% 212.88/213.09  |- mesh__dateCreated mesh__D006104 1983-05-31
% 212.88/213.09  |- skos__annotation mesh__D006104
% 212.88/213.09       GEN or unspecified; prefer specifics; non-neoplastic; IM; coord with organ/dis %28%IM%29%, not organ/neopl%A%  
% 212.88/213.09  |- rdf__type mesh__D006104sskos__Concept
% 212.88/213.09  |- mesh__dateRevised mesh__D006104 1999-11-03
% 212.88/213.09  |- skos__altLabel mesh__D006104 Plasma Cell Granuloma
% 212.88/213.09  |- skos__hiddenLabel mesh__D006104 Granulomas, Plasma Cell
% 212.88/213.09  |- skos__broader mesh__D020113Q000031smesh__D020113
% 212.88/213.09  |- mesh__preferredCombination mesh__D020113Q000031smesh__D010635
% 212.88/213.09  |- rdf__type mesh__D020113Q000031smesh__CompoundConcept
% 212.88/213.09  |- skos__historyNote mesh__D050260
% 212.88/213.09       Carbohydrates/metabolism %28%1964-2005%29%
% 212.88/213.09  |- mesh__recordOriginator mesh__D050260 lkt
% 212.88/213.09  |- skos__scopeNote mesh__D050260
% 212.88/213.09       Cellular processes in biosynthesis %28%anabolism%29% and degradation %28%catabolism%29% of CARBOHYDRATES.%A%    
% 212.88/213.09  |- skos__annotation mesh__D050260
% 212.88/213.09       general; prefer specific carbohydrate/metab   
% 212.88/213.09  |- skos__broader mesh__D050260smesh__D008660
% 212.88/213.09  |- skos__altLabel mesh__D050260 Metabolism, Carbohydrate
% 212.88/213.09  |- mesh__historyNote mesh__D050260 2006   
% 212.88/213.09  |- mesh__dateEstablished mesh__D050260 2006-01-01
% 212.88/213.09  |- mesh__dateCreated mesh__D050260 2005-06-30
% 212.88/213.09  |- rdf__type mesh__D050260sskos__Concept
% 212.88/213.09  |- mesh__publicMeSHNote mesh__D050260 2006   
% 212.88/213.09  |- mesh__recordAuthorizer mesh__D050260 sjn
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D050260 2006
% 212.88/213.09  |- skos__prefLabel mesh__D050260 Carbohydrate Metabolism
% 212.88/213.09  |- mesh__recordMaintainer mesh__D050260 lkt
% 212.88/213.09  |- skos__prefLabel mesh__D011847 Radioactive Fallout
% 212.88/213.09  |- skos__broader mesh__D011847smesh__D011848
% 212.88/213.09  |- skos__scopeNote mesh__D011847
% 212.88/213.09       The material that descends to the earth or water well beyond the site of a surface or subsurface nuclear explosion. %28%McGraw-Hill Dictionary of Chemical and Technical Terms, 4th ed%29%%A%    
% 212.88/213.09  |- skos__hiddenLabel mesh__D011847 Fallout, Radioactive
% 212.88/213.09  |- skos__hiddenLabel mesh__D011847 Fallouts, Radioactive
% 212.88/213.09  |- mesh__dateCreated mesh__D011847 1999-01-01
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D011847 2004
% 212.88/213.09  |- mesh__dateRevised mesh__D011847 2003-07-09
% 212.88/213.09  |- mesh__recordMaintainer mesh__D011847 ssb
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D011847 2006
% 212.88/213.09  |- mesh__recordAuthorizer mesh__D011847 sjn
% 212.88/213.09  |- mesh__recordOriginator mesh__D011847 NLM
% 212.88/213.09  |- skos__annotation mesh__D011847 IM; specify geog if pertinent   
% 212.88/213.09  |- skos__broader mesh__D011847smesh__D011870
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D011847 2005
% 212.88/213.09  |- rdf__type mesh__D011847sskos__Concept
% 212.88/213.09  |- skos__hiddenLabel mesh__D011847 Radioactive Fallouts
% 212.88/213.09  |- rdf__type mesh__D044223sskos__Concept
% 212.88/213.09  |- mesh__recordOriginator mesh__D044223 ags
% 212.88/213.09  |- skos__scopeNote mesh__D044223
% 212.88/213.09       A species of gram-negative bacteria in the genus PSEUDOMONAS, containing multiple genomovars. It is distinguishable from other pseudomonad species by its ability to use MALTOSE and STARCH as sole carbon and energy sources. It can degrade ENVIRONMENTAL POLLUTANTS and has been used as a model organism to study denitrification.%A%    
% 212.88/213.09  |- skos__historyNote mesh__D044223 Pseudomonas %28%1966-2003%29%
% 212.88/213.09  |- mesh__publicMeSHNote mesh__D044223 2004   
% 212.88/213.09  |- skos__prefLabel mesh__D044223 Pseudomonas stutzeri
% 212.88/213.09  |- skos__broader mesh__D044223smesh__D011549
% 212.88/213.09  |- mesh__dateRevised mesh__D044223 2005-06-30
% 212.88/213.09  |- skos__annotation mesh__D044223
% 212.88/213.09       infection: coord IM with PSEUDOMONAS INFECTIONS %28%IM%29%   
% 212.88/213.09  |- mesh__historyNote mesh__D044223 2004   
% 212.88/213.09  |- mesh__recordAuthorizer mesh__D044223 sjn
% 212.88/213.09  |- mesh__dateEstablished mesh__D044223 2004-01-01
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D044223 2006
% 212.88/213.09  |- mesh__recordMaintainer mesh__D044223 SYSTEM
% 212.88/213.09  |- mesh__dateCreated mesh__D044223 2003-07-09
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D011049 2001
% 212.88/213.09  |- mesh__dateRevised mesh__D011049 1999-11-03
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D011049 2006
% 212.88/213.09  |- skos__hiddenLabel mesh__D011049 Social Control Policy
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D011049 2000
% 212.88/213.09  |- skos__hiddenLabel mesh__D011049 Control Policies, Social
% 212.88/213.09  |- skos__prefLabel mesh__D011049 Social Control Policies
% 212.88/213.09  |- rdf__type mesh__D011049sskos__Concept
% 212.88/213.09  |- skos__scopeNote mesh__D011049
% 212.88/213.09       Decisions for determining and guiding present and future objectives from among alternatives.%A%    
% 212.88/213.09  |- mesh__recordMaintainer mesh__D011049 kle
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D011049 2005
% 212.88/213.09  |- mesh__recordOriginator mesh__D011049 EC
% 212.88/213.09  |- mesh__dateCreated mesh__D011049 1979-06-01
% 212.88/213.09  |- mesh__dateEstablished mesh__D011049 1998-01-01
% 212.88/213.09  |- skos__annotation mesh__D011049
% 212.88/213.09       GEN or unspecified; prefer specifics; coord IM with subject of policy %28%IM%29%; specify state or country or other body if pertinent%A%  
% 212.88/213.09  |- skos__broader mesh__D011049smesh__D012926
% 212.88/213.09  |- skos__hiddenLabel mesh__D011049 Policy, Social Control
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D011049 2002
% 212.88/213.09  |- mesh__publicMeSHNote mesh__D011049 98   
% 212.88/213.09  |- mesh__historyNote mesh__D011049 98; use explode 1980-97   
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D011049 2004
% 212.88/213.09  |- mesh__recordAuthorizer mesh__D011049 sjn
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D011049 2003
% 212.88/213.09  |- skos__hiddenLabel mesh__D011049 Control Policy, Social
% 212.88/213.09  |- skos__hiddenLabel mesh__D011049 Policies, Social Control
% 212.88/213.09  |- skos__prefLabel mesh__D016532 Mucopolysaccharidosis II
% 212.88/213.09  |- skos__broader mesh__D016532smesh__D009083
% 212.88/213.09  |- mesh__recordOriginator mesh__D016532 AGS
% 212.88/213.09  |- skos__related mesh__D016532smesh__D008059
% 212.88/213.09  |- mesh__dateEstablished mesh__D016532 1992-01-01
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D016532 2003
% 212.88/213.09  |- mesh__historyNote mesh__D016532
% 212.88/213.09       92; MUCOPOLYSACCHARIDOSIS 2 and HUNTER%27%S SYNDROME were see LIPOCHONDRODYSTROPHY 1976-91%A%  
% 212.88/213.09  |- skos__historyNote mesh__D016532
% 212.88/213.09       Mucopolysaccharidosis I %28%1966-1991%29%
% 212.88/213.09  |- mesh__recordMaintainer mesh__D016532 nns
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D016532 2005
% 212.88/213.09  |- skos__altLabel mesh__D016532 Hunter Syndrome Gargoylism
% 212.88/213.09  |- skos__hiddenLabel mesh__D016532 Mucopolysaccharidosis IIs
% 212.88/213.09  |- skos__altLabel mesh__D016532 Gargoylism, Hunter Syndrome
% 212.88/213.09  |- mesh__dateRevised mesh__D016532 2002-07-03
% 212.88/213.09  |- mesh__publicMeSHNote mesh__D016532
% 212.88/213.09       92; MUCOPOLYSACCHARIDOSIS 2 and HUNTER%27%S SYNDROME were see LIPOCHONDRODYSTROPHY 1976-91%A%  
% 212.88/213.09  |- rdf__type mesh__D016532sskos__Concept
% 212.88/213.09  |- skos__hiddenLabel mesh__D016532 Syndrome, Hunter%27%s
% 212.88/213.09  |- skos__broader mesh__D016532smesh__D038901
% 212.88/213.09  |- skos__hiddenLabel mesh__D016532 Hunter Syndrome Gargoylisms
% 212.88/213.09  |- skos__altLabel mesh__D016532 Hunter%27%s Syndrome
% 212.88/213.09  |- skos__hiddenLabel mesh__D016532 Hunters Syndrome
% 212.88/213.09  |- mesh__dateCreated mesh__D016532 1991-06-21
% 212.88/213.09  |- skos__scopeNote mesh__D016532
% 212.88/213.09       Systemic lysosomal storage disease marked by progressive physical deterioration and caused by a deficiency of L-sulfoiduronate sulfatase. This disease differs from MUCOPOLYSACCHARIDOSIS I by slower progression, lack of corneal clouding, and X-linked rather than autosomal recessive inheritance. The mild form produces near-normal intelligence and life span. The severe form usually causes death by age 15.%A%    
% 212.88/213.09  |- skos__hiddenLabel mesh__D016532 Hunter Syndrome
% 212.88/213.09  |- skos__hiddenLabel mesh__D016532 Gargoylisms, Hunter Syndrome
% 212.88/213.09  |- skos__altLabel mesh__D016532 Mucopolysaccharidosis 2
% 212.88/213.09  |- skos__annotation mesh__D016532 DF: MPS II   
% 212.88/213.09  |- mesh__onlineNote mesh__D016532
% 212.88/213.09       use MUCOPOLYSACCHARIDOSIS II to search MUCOPOLYSACCHARIDOSIS 2 %26% HUNTER%27%S SYNDROME 1976-91%A%  
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D016532 2004
% 212.88/213.09  |- mesh__recordAuthorizer mesh__D016532 sjn
% 212.88/213.09  |- skos__hiddenLabel mesh__D016532 IIs, Mucopolysaccharidosis
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D016532 2006
% 212.88/213.09  |- skos__altLabel mesh__D002512 Normon Brand of Cephalothin Sodium
% 212.88/213.09  |- mesh__publicMeSHNote mesh__D002512 66   
% 212.88/213.09  |- skos__prefLabel mesh__D002512 Cephalothin
% 212.88/213.09  |- skos__altLabel mesh__D002512 Cefalotin
% 212.88/213.09  |- mesh__dateRevised mesh__D002512 2005-06-30
% 212.88/213.09  |- mesh__dateEstablished mesh__D002512 1966-01-01
% 212.88/213.09  |- skos__hiddenLabel mesh__D002512 Salt, Cephalothin Monosodium
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D002512 2006
% 212.88/213.09  |- skos__altLabel mesh__D002512 Cephalothin Monosodium Salt
% 212.88/213.09  |- mesh__recordOriginator mesh__D002512 NLM
% 212.88/213.09  |- mesh__historyNote mesh__D002512 66%28%63%29%   
% 212.88/213.09  |- skos__scopeNote mesh__D002512 A cephalosporin antibiotic.     
% 212.88/213.09  |- rdf__type mesh__D002512sskos__Concept
% 212.88/213.09  |- skos__broader mesh__D002512smesh__D002505
% 212.88/213.09  |- skos__altLabel mesh__D002512 Lilly Brand of Cephalothin Sodium
% 212.88/213.09  |- mesh__recordAuthorizer mesh__D002512 sjn
% 212.88/213.09  |- skos__altLabel mesh__D002512 Spaly Brand of Cephalothin Sodium
% 212.88/213.09  |- skos__altLabel mesh__D002512 Galen Brand of Cephalothin Sodium
% 212.88/213.09  |- skos__hiddenLabel mesh__D002512 Cephalothin, Sodium
% 212.88/213.09  |- skos__hiddenLabel mesh__D002512 Monosodium Salt, Cephalothin
% 212.88/213.09  |- mesh__recordMaintainer mesh__D002512 lkw
% 212.88/213.09  |- mesh__dateCreated mesh__D002512 1999-01-01
% 212.88/213.09  |- rdf__type mesh__D012940sskos__Concept
% 212.88/213.09  |- mesh__dateRevised mesh__D012940 1999-11-03
% 212.88/213.09  |- skos__related mesh__D012940smesh__D013332
% 212.88/213.09  |- skos__historyNote mesh__D012940 Prostitution %28%1966-1967%29%
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012940 2001
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012940 2003
% 212.88/213.09  |- skos__historyNote mesh__D012940 Juvenile Delinquency %28%1966-1967%29%
% 212.88/213.09  |- skos__scopeNote mesh__D012940
% 212.88/213.09       Situations affecting a significant number of people, that are believed to be sources of difficulty or threaten the stability of the community, and that require programs of amelioration.%A%    
% 212.88/213.09  |- mesh__dateEstablished mesh__D012940 1968-01-01
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012940 2000
% 212.88/213.09  |- skos__related mesh__D012940smesh__D000437
% 212.88/213.09  |- skos__broader mesh__D012940smesh__D012961
% 212.88/213.09  |- mesh__recordAuthorizer mesh__D012940 sjn
% 212.88/213.09  |- skos__related mesh__D012940smesh__D019966
% 212.88/213.09  |- mesh__recordMaintainer mesh__D012940 kle
% 212.88/213.09  |- skos__historyNote mesh__D012940
% 212.88/213.09       Antisocial Personality Disorder %28%1966-1967%29%
% 212.88/213.09  |- skos__hiddenLabel mesh__D012940 Problems, Social
% 212.88/213.09  |- mesh__publicMeSHNote mesh__D012940 68   
% 212.88/213.09  |- skos__historyNote mesh__D012940 Alcoholism %28%1966-1967%29%
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012940 2002
% 212.88/213.09  |- mesh__recordOriginator mesh__D012940 NLM
% 212.88/213.09  |- skos__annotation mesh__D012940 specify geog if pertinent   
% 212.88/213.09  |- skos__hiddenLabel mesh__D012940 Social Problem
% 212.88/213.09  |- skos__hiddenLabel mesh__D012940 Slave
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012940 2006
% 212.88/213.09  |- mesh__historyNote mesh__D012940 68   
% 212.88/213.09  |- skos__prefLabel mesh__D012940 Social Problems
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012940 2004
% 212.88/213.09  |- skos__hiddenLabel mesh__D012940 Problem, Social
% 212.88/213.09  |- mesh__dateCreated mesh__D012940 1999-01-01
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012940 2005
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012142 2004
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012142 1999
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012142 2002
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012142 2006
% 212.88/213.09  |- mesh__recordMaintainer mesh__D012142 KEV
% 212.88/213.09  |- skos__broader mesh__D012142smesh__D013899
% 212.88/213.09  |- skos__prefLabel mesh__D012142 Respiratory Tract Neoplasms
% 212.88/213.09  |- mesh__recordOriginator mesh__D012142 NLM
% 212.88/213.09  |- skos__broader mesh__D012142smesh__D012140
% 212.88/213.09  |- skos__hiddenLabel mesh__D012142 Tract Neoplasms, Respiratory
% 212.88/213.09  |- rdf__type mesh__D012142sskos__Concept
% 212.88/213.09  |- skos__hiddenLabel mesh__D012142 Tract Neoplasm, Respiratory
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012142 2000
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012142 2001
% 212.88/213.09  |- mesh__recordAuthorizer mesh__D012142 PLS
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012142 1996
% 212.88/213.09  |- mesh__dateRevised mesh__D012142 1995-06-08
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012142 2003
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012142 1998
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012142 2005
% 212.88/213.09  |- skos__hiddenLabel mesh__D012142 Neoplasms, Respiratory Tract
% 212.88/213.09  |- mesh__dateCreated mesh__D012142 1999-01-01
% 212.88/213.09  |- skos__hiddenLabel mesh__D012142 Respiratory Tract Neoplasm
% 212.88/213.09  |- skos__annotation mesh__D012142
% 212.88/213.09       GEN: prefer specific precoord; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%  
% 212.88/213.09  |- skos__hiddenLabel mesh__D012142 Neoplasm, Respiratory Tract
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D012142 1997
% 212.88/213.09  |- mesh__dateRevised mesh__D006903 2003-07-09
% 212.88/213.09  |- skos__prefLabel mesh__D006903 Hydroxymethylglutaryl CoA Reductases
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D006903 2004
% 212.88/213.09  |- mesh__recordAuthorizer mesh__D006903 sjn
% 212.88/213.09  |- skos__broader mesh__D006903smesh__D015094
% 212.88/213.09  |- skos__hiddenLabel mesh__D006903
% 212.88/213.09       Reductase, 3-Hydroxy-3-methylglutaryl CoA
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D006903 2005
% 212.88/213.09  |- skos__scopeNote mesh__D006903
% 212.88/213.09       Enzymes that catalyze the reversible reduction of alpha-carboxyl group of 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A to yield MEVALONIC ACID.%A%    
% 212.88/213.09  |- skos__hiddenLabel mesh__D006903
% 212.88/213.09       CoA Reductase, 3-Hydroxy-3-methylglutaryl
% 212.88/213.09  |- mesh__dateCreated mesh__D006903 1974-11-11
% 212.88/213.09  |- mesh__historyNote mesh__D006903
% 212.88/213.09       78%28%75%29%; was see under ALCOHOL OXIDOREDUCTASES 1975-77   
% 212.88/213.09  |- skos__historyNote mesh__D006903 Glutarates %28%1966-1974%29%
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D006903 2006
% 212.88/213.09  |- skos__altLabel mesh__D006903 HMG CoA Reductase
% 212.88/213.09  |- skos__related mesh__D006903smesh__D019161
% 212.88/213.09  |- mesh__publicMeSHNote mesh__D006903
% 212.88/213.09       78; was see under ALCOHOL OXIDOREDUCTASES 1975-77   
% 212.88/213.09  |- skos__altLabel mesh__D006903 Hydroxymethylglutaryl CoA Reductase
% 212.88/213.09  |- skos__altLabel mesh__D006903 3-Hydroxy-3-methylglutaryl CoA Reductase
% 212.88/213.09  |- skos__altLabel mesh__D006903 HMG CoA Reductases
% 212.88/213.09  |- skos__hiddenLabel mesh__D006903 3 Hydroxy 3 methylglutaryl CoA Reductase
% 212.88/213.09  |- mesh__dateEstablished mesh__D006903 1978-01-01
% 212.88/213.09  |- skos__historyNote mesh__D006903 Mevalonic Acid %28%1966-1974%29%
% 212.88/213.09  |- mesh__recordMaintainer mesh__D006903 ssb
% 212.88/213.09  |- rdf__type mesh__D006903sskos__Concept
% 212.88/213.09  |- skos__historyNote mesh__D006903
% 212.88/213.09       Alcohol Oxidoreductases %28%1966-1977%29%
% 212.88/213.09  |- mesh__recordOriginator mesh__D006903 NLM
% 212.88/213.09  |- mesh__dateCreated mesh__D006105 1999-01-01
% 212.88/213.09  |- mesh__recordAuthorizer mesh__D006105 sjn
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D006105 2004
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D006105 2005
% 212.88/213.09  |- skos__hiddenLabel mesh__D006105 Granulomatous Diseases, Chronic
% 212.88/213.09  |- mesh__historyNote mesh__D006105
% 212.88/213.09       78%28%75%29%; was see under PHAGOCYTE BACTERICIDAL DYSFUNCTION 1972-77%A%  
% 212.88/213.09  |- mesh__activeMeSHYear mesh__D006105 2003
% 212.88/213.09  |- skos__annotation mesh__D006105
% 212.88/213.09       also called granulomatous disease of childhood   
% 212.88/213.09  |- skos__hiddenLabel mesh__D006105 Diseases, Chronic Granulomatous
% 212.88/213.09  |- skos__prefLabel mesh__D006105 Granulomatous Disease, Chronic
% 212.88/213.09  |- rdf__type mesh__D006105sskos__Concept
% 212.88/213.09  |- skos__broader mesh__D006105smesh__D010585
% 212.88/213.09  |- skos__scopeNote mesh__D006105
% 212.88/213.09       A recessive X-linked defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation.%A%    
% 212.88/213.09  |- skos__hiddenLabel mesh__D006105 Disease, Chronic Granulomatous
% 212.88/213.09  |- mesh__recordOriginator mesh__D006105 NLM
% 212.88/213.09  |- skos__broader mesh__D006105smesh__D040181
% 212.88/213.09  |- skos__historyNote mesh__D006105
% 212.88/213.09       Immunologic Deficiency Syndromes %28%1968-1971%29%
% 212.88/213.09  |- mesh__recordMaintainer mesh__D006105 PLS
% 212.88/213.09  |- mesh__publicMeSHNote mesh__D006105
% 212.88/213.09       78; was see under PHAGOCYTE BACTERICIDAL DYSFUNCTION 1972-77%A%  
% 212.88/213.09  |- skos__historyNote mesh__D006105 Granuloma %28%1966-1971%29%
% 212.88/213.09  |- skos__historyNote mesh__D006105 Phagocytosis %28%1966-1971%29%
% 212.88/213.09  |- mesh__dateEstablished mesh__D006105 1978-01-01
% 212.88/213.09  |- skos__hiddenLabel mesh__D006105 Chronic Granulomatous Disease
% 212.88/213.09  |- mesh__onlineNote mesh__D006105
% 212.88/213.09       search PHAGOCYTE BACTERICIDAL DYSFUNCTION 1972-74   
% 212.88/213.09  |- mesh__dateRevised mesh__D006105 2002-07-03
% 212.88/213.09  |- skos__historyNote mesh__D006105
% 212.88/213.09       Phagocyte Bactericidal Dysfunction %28%1972-1977%29%
% 212.88/213.09  |- skos__hiddenLabel mesh__D006105 Chronic Granulomatous Diseases
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D006105 2006
% 212.88/213.10  |- mesh__recordAuthorizer mesh__D050261 sjn
% 212.88/213.10  |- skos__hiddenLabel mesh__D050261 Glycogenolyses
% 212.88/213.10  |- mesh__recordMaintainer mesh__D050261 lkt
% 212.88/213.10  |- skos__prefLabel mesh__D050261 Glycogenolysis
% 212.88/213.10  |- rdf__type mesh__D050261sskos__Concept
% 212.88/213.10  |- mesh__publicMeSHNote mesh__D050261 2006   
% 212.88/213.10  |- skos__broader mesh__D050261smesh__D050260
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D050261 2006
% 212.88/213.10  |- skos__historyNote mesh__D050261 Glycogen/metabolism %28%1965-2005%29%
% 212.88/213.10  |- mesh__recordOriginator mesh__D050261 lkt
% 212.88/213.10  |- mesh__historyNote mesh__D050261 2006   
% 212.88/213.10  |- mesh__dateEstablished mesh__D050261 2006-01-01
% 212.88/213.10  |- skos__scopeNote mesh__D050261
% 212.88/213.10       The release of GLUCOSE from GLYCOGEN by GLYCOGEN PHOSPHORYLASE %28%phosphorolysis%29%. The released glucose-1-phosphate is then converted to GLUCOSE-6-PHOSPHATE by PHOSPHOGLUCOMUTASE before entering GLYCOLYSIS. Glycogenolysis is stimulated by GLUCAGON or EPINEPHRINE via the activation of PHOSPHORYLASE KINASE.%A%    
% 212.88/213.10  |- mesh__dateCreated mesh__D050261 2005-06-30
% 212.88/213.10  |- mesh__recordMaintainer mesh__D011848 ssb
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D011848 2006
% 212.88/213.10  |- mesh__recordOriginator mesh__D011848 NLM
% 212.88/213.10  |- skos__historyNote mesh__D011848 Radioactivity %28%1966-1974%29%
% 212.88/213.10  |- skos__prefLabel mesh__D011848 Radioactive Pollutants
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D011848 2005
% 212.88/213.10  |- mesh__publicMeSHNote mesh__D011848 75   
% 212.88/213.10  |- rdf__type mesh__D011848sskos__Concept
% 212.88/213.10  |- skos__hiddenLabel mesh__D011848 Pollutants, Radioactive
% 212.88/213.10  |- skos__scopeNote mesh__D011848
% 212.88/213.10       Radioactive substances which act as pollutants. They include chemicals whose radiation is released via radioactive waste, nuclear accidents, fallout from nuclear explosions, and the like.%A%    
% 212.88/213.10  |- skos__historyNote mesh__D011848
% 212.88/213.10       Environmental Pollution %28%1971-1974%29%
% 212.88/213.10  |- skos__broader mesh__D011848smesh__D045424
% 212.88/213.10  |- mesh__historyNote mesh__D011848 75   
% 212.88/213.10  |- skos__annotation mesh__D011848
% 212.88/213.10       specify radiopollutant if pertinent %28%IM or NIM%29%   
% 212.88/213.10  |- mesh__dateCreated mesh__D011848 1999-01-01
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D011848 2004
% 212.88/213.10  |- mesh__dateRevised mesh__D011848 2003-07-09
% 212.88/213.10  |- mesh__dateEstablished mesh__D011848 1975-09-01
% 212.88/213.10  |- mesh__recordAuthorizer mesh__D011848 sjn
% 212.88/213.10  |- mesh__recordOriginator mesh__D044224 ags
% 212.88/213.10  |- skos__historyNote mesh__D044224 Pseudomonas %28%1966-2003%29%
% 212.88/213.10  |- mesh__publicMeSHNote mesh__D044224 2004   
% 212.88/213.10  |- skos__scopeNote mesh__D044224
% 212.88/213.10       A species of gram-negative, fluorescent, phytopathogenic bacteria in the genus PSEUDOMONAS. It is differentiated into approximately 50 pathovars with different plant pathogenicities and host specificities.%A%    
% 212.88/213.10  |- mesh__dateRevised mesh__D044224 2005-06-30
% 212.88/213.10  |- skos__broader mesh__D044224smesh__D011549
% 212.88/213.10  |- mesh__recordAuthorizer mesh__D044224 sjn
% 212.88/213.10  |- mesh__historyNote mesh__D044224 2004   
% 212.88/213.10  |- skos__prefLabel mesh__D044224 Pseudomonas syringae
% 212.88/213.10  |- rdf__type mesh__D044224sskos__Concept
% 212.88/213.10  |- mesh__dateCreated mesh__D044224 2003-07-09
% 212.88/213.10  |- mesh__dateEstablished mesh__D044224 2004-01-01
% 212.88/213.10  |- mesh__recordMaintainer mesh__D044224 SYSTEM
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D044224 2006
% 212.88/213.10  |- skos__altLabel mesh__D016533 Mycological Typing Technique
% 212.88/213.10  |- mesh__dateRevised mesh__D016533 2000-06-22
% 212.88/213.10  |- mesh__historyNote mesh__D016533 92   
% 212.88/213.10  |- skos__altLabel mesh__D016533 Technics, Mycological Typing
% 212.88/213.10  |- skos__altLabel mesh__D016533 Typing Techniques, Mycological
% 212.88/213.10  |- skos__hiddenLabel mesh__D016533 Typing Technique, Fungal
% 212.88/213.10  |- skos__altLabel mesh__D016533 Typing Technic, Mycological
% 212.88/213.10  |- skos__altLabel mesh__D016533 Typing Technique, Mycological
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D016533 2004
% 212.88/213.10  |- skos__hiddenLabel mesh__D016533 Typing Technic, Fungal
% 212.88/213.10  |- skos__hiddenLabel mesh__D016533 Fungal Typing Technic
% 212.88/213.10  |- mesh__dateCreated mesh__D016533 1991-01-03
% 212.88/213.10  |- mesh__dateEstablished mesh__D016533 1992-01-01
% 212.88/213.10  |- skos__altLabel mesh__D016533 Mycological Typing Technics
% 212.88/213.10  |- skos__annotation mesh__D016533
% 212.88/213.10       NIM; coord with fungus /class %28%IM%29%; DF: MYCOL TYPING TECHNIQUES%A%  
% 212.88/213.10  |- skos__hiddenLabel mesh__D016533 Fungal Typing Technique
% 212.88/213.10  |- skos__historyNote mesh__D016533
% 212.88/213.10       specific fungus/classification %28%1978-1991%29%
% 212.88/213.10  |- skos__altLabel mesh__D016533 Typing Technics, Mycological
% 212.88/213.10  |- mesh__publicMeSHNote mesh__D016533 92   
% 212.88/213.10  |- skos__hiddenLabel mesh__D016533 Typing Technics, Fungal
% 212.88/213.10  |- skos__scopeNote mesh__D016533
% 212.88/213.10       Procedures for identifying types and strains of fungi.     
% 212.88/213.10  |- skos__prefLabel mesh__D016533 Mycological Typing Techniques
% 212.88/213.10  |- skos__broader mesh__D016533smesh__D008828
% 212.88/213.10  |- skos__altLabel mesh__D016533 Fungal Typing Techniques
% 212.88/213.10  |- skos__altLabel mesh__D016533 Mycological Typing Technic
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D016533 2005
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D016533 2001
% 212.88/213.10  |- skos__altLabel mesh__D016533 Mycological Biotyping
% 212.88/213.10  |- skos__hiddenLabel mesh__D016533 Typing Techniques, Fungal
% 212.88/213.10  |- skos__hiddenLabel mesh__D016533 Techniques, Fungal Typing
% 212.88/213.10  |- skos__hiddenLabel mesh__D016533 Technic, Fungal Typing
% 212.88/213.10  |- mesh__recordAuthorizer mesh__D016533 sjn
% 212.88/213.10  |- skos__altLabel mesh__D016533 Techniques, Mycological Typing
% 212.88/213.10  |- skos__hiddenLabel mesh__D016533 Technique, Fungal Typing
% 212.88/213.10  |- rdf__type mesh__D016533sskos__Concept
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D016533 2006
% 212.88/213.10  |- skos__altLabel mesh__D016533 Technique, Mycological Typing
% 212.88/213.10  |- skos__altLabel mesh__D016533 Fungal Typing Technics
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D016533 2002
% 212.88/213.10  |- skos__hiddenLabel mesh__D016533 Fungal Typing
% 212.88/213.10  |- mesh__recordOriginator mesh__D016533 PXP
% 212.88/213.10  |- skos__hiddenLabel mesh__D016533 Technics, Fungal Typing
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D016533 2003
% 212.88/213.10  |- mesh__recordMaintainer mesh__D016533 TGC
% 212.88/213.10  |- skos__altLabel mesh__D016533 Technic, Mycological Typing
% 212.88/213.10  |- mesh__recordAuthorizer mesh__D002513 sjn
% 212.88/213.10  |- mesh__historyNote mesh__D002513
% 212.88/213.10       84%28%75%29%; was see under CEPHALOSPORINS 1975-83   
% 212.88/213.10  |- skos__altLabel mesh__D002513 Antibiotics, Cephamycin
% 212.88/213.10  |- skos__historyNote mesh__D002513 Cephalosporins %28%1974%29%
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D002513 2006
% 212.88/213.10  |- skos__prefLabel mesh__D002513 Cephamycins
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D002513 2005
% 212.88/213.10  |- skos__scopeNote mesh__D002513
% 212.88/213.10       Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms.%A%    
% 212.88/213.10  |- skos__broader mesh__D002513smesh__D002511
% 212.88/213.10  |- mesh__publicMeSHNote mesh__D002513
% 212.88/213.10       84; was see under CEPHALOSPORINS 1975-83   
% 212.88/213.10  |- skos__hiddenLabel mesh__D002513 Cephamycin Antibiotics
% 212.88/213.10  |- skos__historyNote mesh__D002513 Methyl Ethers %28%1974%29%
% 212.88/213.10  |- rdf__type mesh__D002513sskos__Concept
% 212.88/213.10  |- mesh__dateRevised mesh__D002513 2004-07-07
% 212.88/213.10  |- mesh__recordOriginator mesh__D002513 NLM
% 212.88/213.10  |- mesh__dateCreated mesh__D002513 1974-11-19
% 212.88/213.10  |- mesh__dateEstablished mesh__D002513 1984-01-01
% 212.88/213.10  |- mesh__recordMaintainer mesh__D002513 ssb
% 212.88/213.10  |- mesh__recordOriginator mesh__D012941 EC
% 212.88/213.10  |- skos__hiddenLabel mesh__D012941 Future Generation
% 212.88/213.10  |- skos__hiddenLabel mesh__D012941 Social Obligation
% 212.88/213.10  |- skos__hiddenLabel mesh__D012941 Responsibilities, Social
% 212.88/213.10  |- skos__hiddenLabel mesh__D012941 Generations, Future
% 212.88/213.10  |- skos__prefLabel mesh__D012941 Social Responsibility
% 212.88/213.10  |- mesh__publicMeSHNote mesh__D012941 78   
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012941 2006
% 212.88/213.10  |- skos__hiddenLabel mesh__D012941 Society, Obligations to
% 212.88/213.10  |- skos__hiddenLabel mesh__D012941 Obligations, Social
% 212.88/213.10  |- skos__altLabel mesh__D012941 Responsibility, Social
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012941 2004
% 212.88/213.10  |- skos__hiddenLabel mesh__D012941 Generation, Future
% 212.88/213.10  |- skos__hiddenLabel mesh__D012941 Social Responsibilities
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012941 2005
% 212.88/213.10  |- mesh__dateRevised mesh__D012941 2003-07-25
% 212.88/213.10  |- rdf__type mesh__D012941sskos__Concept
% 212.88/213.10  |- mesh__historyNote mesh__D012941 78   
% 212.88/213.10  |- skos__annotation mesh__D012941 no qualif   
% 212.88/213.10  |- mesh__recordMaintainer mesh__D012941 sjn
% 212.88/213.10  |- mesh__recordAuthorizer mesh__D012941 sjn
% 212.88/213.10  |- skos__scopeNote mesh__D012941
% 212.88/213.10       The obligations and accountability assumed in carrying out actions or ideas on behalf of others.%A%    
% 212.88/213.10  |- mesh__dateEstablished mesh__D012941 1978-01-01
% 212.88/213.10  |- skos__broader mesh__D012941smesh__D009014
% 212.88/213.10  |- skos__hiddenLabel mesh__D012941 Social Obligations
% 212.88/213.10  |- skos__hiddenLabel mesh__D012941 Accountability, Social
% 212.88/213.10  |- mesh__dateCreated mesh__D012941 1977-04-22
% 212.88/213.10  |- skos__broader mesh__D012143smesh__D002943
% 212.88/213.10  |- skos__scopeNote mesh__D012143
% 212.88/213.10       Functions, activities, and phenomena of the RESPIRATORY SYSTEM as a whole or of any of its parts.%A%    
% 212.88/213.10  |- mesh__recordMaintainer mesh__D012143 nns
% 212.88/213.10  |- rdf__type mesh__D012143sskos__Concept
% 212.88/213.10  |- skos__hiddenLabel mesh__D012143 Physiologies, Respiratory
% 212.88/213.10  |- mesh__dateRevised mesh__D012143 2003-07-09
% 212.88/213.10  |- mesh__recordOriginator mesh__D012143 NLM
% 212.88/213.10  |- mesh__publicMeSHNote mesh__D012143 98   
% 212.88/213.10  |- skos__historyNote mesh__D012143
% 212.88/213.10       Respiratory System/physiology %28%1966-1997%29%
% 212.88/213.10  |- skos__hiddenLabel mesh__D012143 Respiratory Physiologies
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012143 2005
% 212.88/213.10  |- mesh__dateCreated mesh__D012143 1999-01-01
% 212.88/213.10  |- skos__annotation mesh__D012143
% 212.88/213.10       GEN or unspecified; prefer specifics; DF: RESPIRATORY PHYSIOL%A%  
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012143 2004
% 212.88/213.10  |- mesh__recordAuthorizer mesh__D012143 sjn
% 212.88/213.10  |- skos__altLabel mesh__D012143 Physiology, Respiratory
% 212.88/213.10  |- mesh__historyNote mesh__D012143 98; use explode 1970-97   
% 212.88/213.10  |- skos__prefLabel mesh__D012143 Respiratory Physiology
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012143 2006
% 212.88/213.10  |- mesh__dateEstablished mesh__D012143 1998-01-01
% 212.88/213.10  |- mesh__recordMaintainer mesh__D006904 jmp
% 212.88/213.10  |- skos__broader mesh__D006904smesh__D000217
% 212.88/213.10  |- rdf__type mesh__D006904sskos__Concept
% 212.88/213.10  |- skos__hiddenLabel mesh__D006904 Synthase, Hydroxymethylglutaryl-CoA
% 212.88/213.10  |- mesh__recordOriginator mesh__D006904 NLM
% 212.88/213.10  |- skos__prefLabel mesh__D006904 Hydroxymethylglutaryl-CoA Synthase
% 212.88/213.10  |- skos__historyNote mesh__D006904 Glutarates %28%1973-1974%29%
% 212.88/213.10  |- mesh__recordAuthorizer mesh__D006904 sjn
% 212.88/213.10  |- mesh__dateCreated mesh__D006904 1974-11-19
% 212.88/213.10  |- mesh__historyNote mesh__D006904
% 212.88/213.10       91%28%75%29%; was see under KETOACID-LYASES 1975-90   
% 212.88/213.10  |- skos__hiddenLabel mesh__D006904 Hydroxymethylglutaryl CoA Synthase
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D006904 2006
% 212.88/213.10  |- skos__historyNote mesh__D006904 Coenzyme A %28%1973-1974%29%
% 212.88/213.10  |- mesh__publicMeSHNote mesh__D006904
% 212.88/213.10       91; was see under KETOACID-LYASES 1975-90   
% 212.88/213.10  |- skos__scopeNote mesh__D006904
% 212.88/213.10       An enzyme that catalyzes the synthesis of hydroxymethylglutaryl-CoA from acetyl-CoA and acetoacetyl-CoA. This is a key enzyme in steroid biosynthesis. This enzyme was formerly listed as EC 4.1.3.5.%A%    
% 212.88/213.10  |- skos__historyNote mesh__D006904 Ketoacid-Lyases %28%1973-1974%29%
% 212.88/213.10  |- skos__annotation mesh__D006904 DF: HMG COA SYNTHASE   
% 212.88/213.10  |- mesh__dateRevised mesh__D006904 2005-06-30
% 212.88/213.10  |- mesh__dateEstablished mesh__D006904 1991-01-01
% 212.88/213.10  |- skos__hiddenLabel mesh__D006106 Granulosa Cell Cancers
% 212.88/213.10  |- skos__broader mesh__D006106smesh__D010051
% 212.88/213.10  |- skos__annotation mesh__D006106
% 212.88/213.10       coordinate IM with probably OVARIAN NEOPLASMS %28%IM%29%; do not confuse with GRANULAR CELL TUMOR, a myoblastoma%A%  
% 212.88/213.10  |- skos__hiddenLabel mesh__D006106 Granulosa Cells Cancer
% 212.88/213.10  |- skos__prefLabel mesh__D006106 Granulosa Cell Tumor
% 212.88/213.10  |- skos__broader mesh__D006106smesh__D018312
% 212.88/213.10  |- skos__hiddenLabel mesh__D006106 Cells Cancers, Granulosa
% 212.88/213.10  |- rdf__type mesh__D006106sskos__Concept
% 212.88/213.10  |- mesh__recordAuthorizer mesh__D006106 sjn
% 212.88/213.10  |- skos__hiddenLabel mesh__D006106 Cell Cancers, Granulosa
% 212.88/213.10  |- skos__hiddenLabel mesh__D006106 Cancers, Granulosa Cell
% 212.88/213.10  |- skos__hiddenLabel mesh__D006106 Cancer, Granulosa Cell
% 212.88/213.10  |- mesh__dateRevised mesh__D006106 2005-06-30
% 212.88/213.10  |- skos__hiddenLabel mesh__D006106 Tumors, Granulosa Cell
% 212.88/213.10  |- skos__hiddenLabel mesh__D006106 Cells Cancer, Granulosa
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D006106 2006
% 212.88/213.10  |- skos__altLabel mesh__D006106 Cancer of Granulosa Cells
% 212.88/213.10  |- mesh__recordOriginator mesh__D006106 NLM
% 212.88/213.10  |- mesh__dateCreated mesh__D006106 1999-01-01
% 212.88/213.10  |- skos__scopeNote mesh__D006106
% 212.88/213.10       A neoplasm composed entirely of GRANULOSA CELLS, occurring mostly in the OVARY. In the adult form, it may contain some THECA CELLS. This tumor often produces ESTRADIOL and INHIBIN. The excess estrogen exposure can lead to other malignancies in women and PRECOCIOUS PUBERTY in girls. In rare cases, granulosa cell tumors have been identified in the TESTES.%A%    
% 212.88/213.10  |- skos__hiddenLabel mesh__D006106 Tumor, Granulosa Cell
% 212.88/213.10  |- skos__hiddenLabel mesh__D006106 Cell Cancer, Granulosa
% 212.88/213.10  |- mesh__recordMaintainer mesh__D006106 lkt
% 212.88/213.10  |- skos__hiddenLabel mesh__D006106 Granulosa Cell Tumors
% 212.88/213.10  |- skos__hiddenLabel mesh__D006106 Granulosa Cells Cancers
% 212.88/213.10  |- skos__broader mesh__D011449Q000031smesh__D011449
% 212.88/213.10  |- mesh__preferredCombination mesh__D011449Q000031smesh__D011450
% 212.88/213.10  |- rdf__type mesh__D011449Q000031smesh__CompoundConcept
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D050262 2006A
% 212.88/213.10  |- rdf__type mesh__D050262sskos__Concept
% 212.88/213.10  |- mesh__publicMeSHNote mesh__D050262 2006   
% 212.88/213.10  |- mesh__dateRevised mesh__D050262 2005-07-22
% 212.88/213.10  |- mesh__dateCreated mesh__D050262 2005-06-30
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D050262 2006B
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D050262 2006
% 212.88/213.10  |- mesh__recordMaintainer mesh__D050262 ags
% 212.88/213.10  |- skos__broader mesh__D050262smesh__D050175
% 212.88/213.10  |- skos__historyNote mesh__D050262 Microsporidia %28%2000-2005%29%
% 212.88/213.10  |- skos__scopeNote mesh__D050262
% 212.88/213.10       A genus of FUNGI, in the family Glugeidae, a parasite of ATLANTIC SALMON and other FISHES.%A%    
% 212.88/213.10  |- mesh__recordOriginator mesh__D050262 ags
% 212.88/213.10  |- skos__prefLabel mesh__D050262 Loma
% 212.88/213.10  |- mesh__recordAuthorizer mesh__D050262 ags
% 212.88/213.10  |- skos__annotation mesh__D050262
% 212.88/213.10       infection: coordinate IM with MICROSPORIDIOSIS %28%IM%29%; coordinate with specific fungal terms %28%ANTIGENS, FUNGAL, etc%29% if pertinent%A%  
% 212.88/213.10  |- mesh__historyNote mesh__D050262 2006   
% 212.88/213.10  |- mesh__dateEstablished mesh__D050262 2006-01-01
% 212.88/213.10  |- mesh__recordAuthorizer mesh__D011849 PLS
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D011849 2005
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D011849 2000
% 212.88/213.10  |- mesh__onlineNote mesh__D011849 search RADIOISOTOPES 1974   
% 212.88/213.10  |- mesh__publicMeSHNote mesh__D011849
% 212.88/213.10       91; was see under RADIOISOTOPES 1975-90   
% 212.88/213.10  |- skos__scopeNote mesh__D011849
% 212.88/213.10       Radioactive substances added in minute amounts to the reacting elements or compounds in a chemical process and traced through the process by appropriate detection methods, e.g., Geiger counter. Compounds containing tracers are often said to be tagged or labeled. %28%Hawley%27%s Condensed Chemical Dictionary, 12th ed%29%%A%    
% 212.88/213.10  |- skos__prefLabel mesh__D011849 Radioactive Tracers
% 212.88/213.10  |- rdf__type mesh__D011849sskos__Concept
% 212.88/213.10  |- mesh__recordOriginator mesh__D011849 NLM
% 212.88/213.10  |- mesh__recordMaintainer mesh__D011849 PLS
% 212.88/213.10  |- mesh__dateEstablished mesh__D011849 1991-01-01
% 212.88/213.10  |- skos__hiddenLabel mesh__D011849 Tracers, Radioactive
% 212.88/213.10  |- skos__annotation mesh__D011849 IM for general only; no qualif   
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D011849 1997
% 212.88/213.10  |- mesh__dateRevised mesh__D011849 1995-03-20
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D011849 2002
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D011849 1999
% 212.88/213.10  |- skos__broader mesh__D011849smesh__D011868
% 212.88/213.10  |- mesh__dateCreated mesh__D011849 1999-01-01
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D011849 1996
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D011849 2004
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D011849 2001
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D011849 1998
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D011849 2006
% 212.88/213.10  |- mesh__historyNote mesh__D011849
% 212.88/213.10       91%28%75%29%; was see under RADIOISOTOPES 1975-90   
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D011849 2003
% 212.88/213.10  |- skos__hiddenLabel mesh__D044225 Piscirickettsiaceae Infection
% 212.88/213.10  |- mesh__publicMeSHNote mesh__D044225 2004   
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D044225 2004
% 212.88/213.10  |- skos__historyNote mesh__D044225 Fish Diseases %28%1997-2003%29%
% 212.88/213.10  |- skos__scopeNote mesh__D044225
% 212.88/213.10       Infections with bacteria of the family PISCIRICKETTSIACEAE, causing septicemic disease of salmonid fish %28%SALMONIDAE%29%. Piscirickettsia-like bacteria are also associated with disease syndromes in non-salmonid fish.%A%    
% 212.88/213.10  |- mesh__dateEstablished mesh__D044225 2004-01-01
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D044225 2005
% 212.88/213.10  |- skos__broader mesh__D044225smesh__D016905
% 212.88/213.10  |- skos__altLabel mesh__D044225 Piscirickettsiosis
% 212.88/213.10  |- rdf__type mesh__D044225sskos__Concept
% 212.88/213.10  |- skos__prefLabel mesh__D044225 Piscirickettsiaceae Infections
% 212.88/213.10  |- skos__hiddenLabel mesh__D044225 Piscirickettsioses
% 212.88/213.10  |- mesh__dateCreated mesh__D044225 2003-07-09
% 212.88/213.10  |- mesh__historyNote mesh__D044225 2004   
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D044225 2006
% 212.88/213.10  |- skos__broader mesh__D016534smesh__D006331
% 212.88/213.10  |- mesh__recordAuthorizer mesh__D016534 PLS
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D016534 2000
% 212.88/213.10  |- skos__scopeNote mesh__D016534
% 212.88/213.10       A state of elevated cardiac output. Conditions that lower peripheral vascular resistance, such as anemia, arteriovenous fistulas, thyrotoxicosis, and pregnancy, are among the most important factors augmenting the venous return and therefore elevating cardiac output. Increased cardiac output also occurs in muscular exercise, fever, and severe anoxia.%A%    
% 212.88/213.10  |- rdf__type mesh__D016534sskos__Concept
% 212.88/213.10  |- skos__hiddenLabel mesh__D016534 Cardiac Outputs, High
% 212.88/213.10  |- mesh__dateRevised mesh__D016534 1996-06-10
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D016534 2001
% 212.88/213.10  |- skos__prefLabel mesh__D016534 Cardiac Output, High
% 212.88/213.10  |- skos__annotation mesh__D016534
% 212.88/213.10       note category: do not confuse with CARDIAC OUTPUT, a physiol concept%A%  
% 212.88/213.10  |- skos__hiddenLabel mesh__D016534 Outputs, High Cardiac
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D016534 2003
% 212.88/213.10  |- mesh__dateEstablished mesh__D016534 1992-01-01
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D016534 2005
% 212.88/213.10  |- mesh__publicMeSHNote mesh__D016534 92   
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D016534 2004
% 212.88/213.10  |- mesh__dateCreated mesh__D016534 1991-01-02
% 212.88/213.10  |- mesh__historyNote mesh__D016534 92   
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D016534 1998
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D016534 2002
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D016534 2006
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D016534 1997
% 212.88/213.10  |- mesh__recordOriginator mesh__D016534 PXP
% 212.88/213.10  |- skos__altLabel mesh__D016534 High Cardiac Output
% 212.88/213.10  |- mesh__recordMaintainer mesh__D016534 TGC
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D016534 1999
% 212.88/213.10  |- skos__hiddenLabel mesh__D016534 Output, High Cardiac
% 212.88/213.10  |- skos__hiddenLabel mesh__D016534 High Cardiac Outputs
% 212.88/213.10  |- skos__historyNote mesh__D016534 Cardiac Output %28%1967-1991%29%
% 212.88/213.10  |- mesh__dateCreated mesh__D002514 1974-11-19
% 212.88/213.10  |- skos__historyNote mesh__D002514 Sulfides %28%1972-1974%29%
% 212.88/213.10  |- skos__hiddenLabel mesh__D002514 Salt, Cephapirin Monosodium
% 212.88/213.10  |- skos__hiddenLabel mesh__D002514 Monosodium Salt, Cephapirin
% 212.88/213.10  |- mesh__historyNote mesh__D002514
% 212.88/213.10       91%28%75%29%; was see under CEPHALOSPORINS 1975-90   
% 212.88/213.10  |- rdf__type mesh__D002514sskos__Concept
% 212.88/213.10  |- mesh__recordOriginator mesh__D002514 NLM
% 212.88/213.10  |- skos__hiddenLabel mesh__D002514 BLP 1322
% 212.88/213.10  |- skos__altLabel mesh__D002514 Cefapirin
% 212.88/213.10  |- skos__scopeNote mesh__D002514
% 212.88/213.10       Cephalosporin antibiotic, partly plasma-bound, that is effective against gram-negative and gram-positive organisms.%A%    
% 212.88/213.10  |- skos__historyNote mesh__D002514 Cephalosporins %28%1972-1974%29%
% 212.88/213.10  |- skos__prefLabel mesh__D002514 Cephapirin
% 212.88/213.10  |- skos__hiddenLabel mesh__D002514 BL P 1322
% 212.88/213.10  |- skos__altLabel mesh__D002514 Sodium Cephapirin
% 212.88/213.10  |- mesh__recordMaintainer mesh__D002514 lkw
% 212.88/213.10  |- skos__broader mesh__D002514smesh__D002505
% 212.88/213.10  |- mesh__recordAuthorizer mesh__D002514 sjn
% 212.88/213.10  |- mesh__publicMeSHNote mesh__D002514
% 212.88/213.10       91; was see under CEPHALOSPORINS 1975-90   
% 212.88/213.10  |- mesh__dateEstablished mesh__D002514 1991-01-01
% 212.88/213.10  |- skos__hiddenLabel mesh__D002514 Cephapirin, Sodium
% 212.88/213.10  |- skos__historyNote mesh__D002514 Pyridines %28%1972-1974%29%
% 212.88/213.10  |- mesh__dateRevised mesh__D002514 2005-06-30
% 212.88/213.10  |- skos__altLabel mesh__D002514 Cephapirin Monosodium Salt
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D002514 2006
% 212.88/213.10  |- skos__historyNote mesh__D002514 Acetamides %28%1972-1974%29%
% 212.88/213.10  |- skos__altLabel mesh__D002514
% 212.88/213.10       Bristol-Myers Squibb Brand of Cephapirin Sodium
% 212.88/213.10  |- skos__altLabel mesh__D002514 Apothecon Brand of Cephapirin Sodium
% 212.88/213.10  |- skos__altLabel mesh__D002514 Bristol-Myers Brand of Cephapirin Sodium
% 212.88/213.10  |- mesh__dateRevised mesh__D026962 2005-07-07
% 212.88/213.10  |- mesh__recordMaintainer mesh__D026962 ags
% 212.88/213.10  |- skos__altLabel mesh__D026962 Amino Acid Transporter ASC
% 212.88/213.10  |- skos__altLabel mesh__D026962 System ASC Transporter
% 212.88/213.10  |- mesh__recordOriginator mesh__D026962 jmp
% 212.88/213.10  |- mesh__dateCreated mesh__D026962 2001-07-25
% 212.88/213.10  |- skos__historyNote mesh__D026962 Amino Acids/metabolism %28%1980-2001%29%
% 212.88/213.10  |- skos__historyNote mesh__D026962 Biological Transport %28%1980-2001%29%
% 212.88/213.10  |- mesh__dateEstablished mesh__D026962 2002-01-01
% 212.88/213.10  |- mesh__publicMeSHNote mesh__D026962 2002   
% 212.88/213.10  |- skos__altLabel mesh__D026962 System ASC Transporter Proteins
% 212.88/213.10  |- skos__altLabel mesh__D026962 Amino Acid Transport System ASC Proteins
% 212.88/213.10  |- skos__prefLabel mesh__D026962 Amino Acid Transport System ASC
% 212.88/213.10  |- skos__scopeNote mesh__D026962
% 212.88/213.10       A ubiquitous sodium-dependent neutral amino acid transporter. The preferred substrates for this transporter system include ALANINE; SERINE; and CYSTEINE.%A%    
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D026962 2006
% 212.88/213.10  |- skos__broader mesh__D026962smesh__D026921
% 212.88/213.10  |- rdf__type mesh__D026962sskos__Concept
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D026962 2006A
% 212.88/213.10  |- mesh__historyNote mesh__D026962 2002   
% 212.88/213.10  |- mesh__recordAuthorizer mesh__D026962 ags
% 212.88/213.10  |- mesh__recordMaintainer mesh__D012942 kle
% 212.88/213.10  |- mesh__recordAuthorizer mesh__D012942 sjn
% 212.88/213.10  |- skos__hiddenLabel mesh__D012942 Sciences, Social
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012942 2006
% 212.88/213.10  |- mesh__recordOriginator mesh__D012942 NLM
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012942 2002
% 212.88/213.10  |- skos__prefLabel mesh__D012942 Social Sciences
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012942 2004
% 212.88/213.10  |- mesh__dateCreated mesh__D012942 1999-01-01
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012942 2005
% 212.88/213.10  |- rdf__type mesh__D012942sskos__Concept
% 212.88/213.10  |- mesh__dateRevised mesh__D012942 1999-11-03
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012942 2003
% 212.88/213.10  |- skos__hiddenLabel mesh__D012942 Social Science
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012942 2001
% 212.88/213.10  |- skos__annotation mesh__D012942 SPEC: SPEC qualif   
% 212.88/213.10  |- skos__scopeNote mesh__D012942
% 212.88/213.10       Disciplines concerned with the interrelationships of individuals in a social environment including social organizations and institutions. Includes Sociology and Anthropology.%A%    
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012942 2000
% 212.88/213.10  |- mesh__runningHead mesh__D012942 I1 - SOCIAL SCIENCES   
% 212.88/213.10  |- skos__hiddenLabel mesh__D012942 Science, Social
% 212.88/213.10  |- mesh__dateRevised mesh__D012144 1997-06-20
% 212.88/213.10  |- skos__broader mesh__D012144smesh__D006701
% 212.88/213.10  |- skos__scopeNote mesh__D012144
% 212.88/213.10       Patient care provided in the home or institution intermittently in order to provide temporary relief to the family home care giver.%A%    
% 212.88/213.10  |- skos__annotation mesh__D012144
% 212.88/213.10       %22%in the home or institution intermittently in order to provide temporary relief to the family home care giver%22%%A%  
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012144 2000
% 212.88/213.10  |- skos__historyNote mesh__D012144 Home Care Services %28%1967-1984%29%
% 212.88/213.10  |- skos__hiddenLabel mesh__D012144 Respite Cares
% 212.88/213.10  |- skos__hiddenLabel mesh__D012144 Care, Respite
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012144 2003
% 212.88/213.10  |- mesh__dateEstablished mesh__D012144 1985-01-01
% 212.88/213.10  |- mesh__dateCreated mesh__D012144 1984-04-11
% 212.88/213.10  |- mesh__historyNote mesh__D012144 85   
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012144 2001
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012144 1998
% 212.88/213.10  |- skos__historyNote mesh__D012144 Home Nursing %28%1966-1984%29%
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012144 2005
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012144 2004
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012144 1999
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012144 2006
% 212.88/213.10  |- mesh__recordMaintainer mesh__D012144 PXP
% 212.88/213.10  |- skos__prefLabel mesh__D012144 Respite Care
% 212.88/213.10  |- mesh__publicMeSHNote mesh__D012144 85   
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D012144 2002
% 212.88/213.10  |- mesh__recordOriginator mesh__D012144 EC
% 212.88/213.10  |- rdf__type mesh__D012144sskos__Concept
% 212.88/213.10  |- skos__hiddenLabel mesh__D012144 Cares, Respite
% 212.88/213.10  |- mesh__recordAuthorizer mesh__D012144 SJN
% 212.88/213.10  |- mesh__historyNote mesh__D006107
% 212.88/213.10       78%28%75%29%; was see under GRAAFIAN FOLLICLE 1975-77   
% 212.88/213.10  |- skos__hiddenLabel mesh__D006107 Cell, Granulosa
% 212.88/213.10  |- mesh__recordOriginator mesh__D006107 NLM
% 212.88/213.10  |- mesh__dateEstablished mesh__D006107 1978-01-01
% 212.88/213.10  |- rdf__type mesh__D006107sskos__Concept
% 212.88/213.10  |- skos__hiddenLabel mesh__D006107 Granulosa Cell
% 212.88/213.10  |- mesh__publicMeSHNote mesh__D006107
% 212.88/213.10       78; was see under GRAAFIAN FOLLICLE 1975-77   
% 212.88/213.10  |- mesh__dateRevised mesh__D006107 2002-07-03
% 212.88/213.10  |- mesh__recordMaintainer mesh__D006107 lkt
% 212.88/213.10  |- skos__prefLabel mesh__D006107 Granulosa Cells
% 212.88/213.10  |- mesh__activeMeSHYear mesh__D006107 2005
% 212.88/213.10  |- skos__broader mesh__D006107smesh__D004847
% 212.88/213.10  |- mesh__dateCreated mesh__D006107 1974-11-11
% 212.88/213.11  |- mesh__recordAuthorizer mesh__D006107 sjn
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006107 2006
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006107 2003
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006107 2004
% 212.88/213.11  |- skos__broader mesh__D006107smesh__D006080
% 212.88/213.11  |- skos__hiddenLabel mesh__D006107 Cells, Granulosa
% 212.88/213.11  |- skos__scopeNote mesh__D006107
% 212.88/213.11       Supporting cells for the developing female gamete in the OVARY. They are derived from the coelomic epithelial cells of the gonadal ridge. Granulosa cells form a single layer around the OOCYTE in the primordial ovarian follicle and advance to form a multilayered cumulus oophorus surrounding the OVUM in the Graafian follicle. The major functions of granulosa cells include the production of steroids and LH receptors %28%RECEPTORS, LH%29%.%A%    
% 212.88/213.11  |- mesh__dateEstablished mesh__D050263 2006-01-01
% 212.88/213.11  |- mesh__publicMeSHNote mesh__D050263 2006   
% 212.88/213.11  |- mesh__recordAuthorizer mesh__D050263 sjn
% 212.88/213.11  |- mesh__dateCreated mesh__D050263 2005-06-30
% 212.88/213.11  |- skos__broader mesh__D050263smesh__D050175
% 212.88/213.11  |- mesh__recordMaintainer mesh__D050263 ags
% 212.88/213.11  |- skos__historyNote mesh__D050263 Protozoa %28%1965-2005%29%
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D050263 2006
% 212.88/213.11  |- mesh__recordOriginator mesh__D050263 ags
% 212.88/213.11  |- skos__scopeNote mesh__D050263
% 212.88/213.11       A genus of FUNGI, in the family Thelohaniidae, a parasite of red imported fire ants, MOSQUITOES, and other organisms.%A%    
% 212.88/213.11  |- skos__annotation mesh__D050263
% 212.88/213.11       coordinate with specific fungal terms %28%ANTIGENS, FUNGAL, etc%29% if pertinent%A%  
% 212.88/213.11  |- skos__prefLabel mesh__D050263 Thelohania
% 212.88/213.11  |- mesh__historyNote mesh__D050263 2006   
% 212.88/213.11  |- rdf__type mesh__D050263sskos__Concept
% 212.88/213.11  |- skos__historyNote mesh__D016535 Bronchi %28%1970-1991%29%
% 212.88/213.11  |- rdf__type mesh__D016535sskos__Concept
% 212.88/213.11  |- skos__hiddenLabel mesh__D016535 Hyperreactivities, Bronchial
% 212.88/213.11  |- skos__annotation mesh__D016535
% 212.88/213.11       note category; if present in asthma, coord IM with ASTHMA /physiopathol %28%IM%29%%A%  
% 212.88/213.11  |- skos__prefLabel mesh__D016535 Bronchial Hyperreactivity
% 212.88/213.11  |- skos__hiddenLabel mesh__D016535 Hyperreactivity, Bronchial
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016535 2003
% 212.88/213.11  |- skos__historyNote mesh__D016535
% 212.88/213.11       Respiratory Hypersensitivity %28%1970-1991%29%
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016535 2000
% 212.88/213.11  |- skos__scopeNote mesh__D016535
% 212.88/213.11       Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory.%A%    
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016535 2005
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016535 1996
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016535 2004
% 212.88/213.11  |- mesh__dateCreated mesh__D016535 1991-01-02
% 212.88/213.11  |- mesh__historyNote mesh__D016535 92   
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016535 1998
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016535 2001
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016535 2006
% 212.88/213.11  |- skos__hiddenLabel mesh__D016535 Bronchial Hyperreactivities
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016535 1997
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016535 1992
% 212.88/213.11  |- skos__broader mesh__D016535smesh__D001982
% 212.88/213.11  |- skos__historyNote mesh__D016535 Asthma %28%1970-1991%29%
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016535 1994
% 212.88/213.11  |- skos__related mesh__D016535smesh__D001249
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016535 1999
% 212.88/213.11  |- mesh__dateEstablished mesh__D016535 1992-01-01
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016535 1993
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016535 1995
% 212.88/213.11  |- mesh__publicMeSHNote mesh__D016535 92   
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016535 2002
% 212.88/213.11  |- skos__hiddenLabel mesh__D002515 Dihydrate, Cephradine
% 212.88/213.11  |- skos__altLabel mesh__D002515 Bouchara Brand of Cephradine
% 212.88/213.11  |- mesh__dateCreated mesh__D002515 1974-11-19
% 212.88/213.11  |- skos__hiddenLabel mesh__D002515 Non-Stoichiometric Hydrate Cephradine
% 212.88/213.11  |- skos__hiddenLabel mesh__D002515 Cephradine, Non Stoichiometric Hydrate
% 212.88/213.11  |- skos__altLabel mesh__D002515 Dexo Brand of Cephradine
% 212.88/213.11  |- skos__historyNote mesh__D002515 Cyclohexane %28%1972-1974%29%
% 212.88/213.11  |- skos__altLabel mesh__D002515 Squibb Brand of Cephradine
% 212.88/213.11  |- skos__altLabel mesh__D002515 Reig Jofre Brand of Cephradine
% 212.88/213.11  |- skos__altLabel mesh__D002515 Galen Brand of Cephradine
% 212.88/213.11  |- mesh__recordOriginator mesh__D002515 NLM
% 212.88/213.11  |- mesh__dateEstablished mesh__D002515 1991-01-01
% 212.88/213.11  |- skos__prefLabel mesh__D002515 Cephradine
% 212.88/213.11  |- skos__altLabel mesh__D002515 Septa Brand of Cephradine
% 212.88/213.11  |- skos__historyNote mesh__D002515 Cephalosporins %28%1972-1974%29%
% 212.88/213.11  |- mesh__recordMaintainer mesh__D002515 lkw
% 212.88/213.11  |- mesh__recordAuthorizer mesh__D002515 sjn
% 212.88/213.11  |- mesh__publicMeSHNote mesh__D002515
% 212.88/213.11       91; was see under CEPHALOSPORINS 1975-90   
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D002515 2006
% 212.88/213.11  |- skos__altLabel mesh__D002515 Cefradine
% 212.88/213.11  |- skos__altLabel mesh__D002515 Alpharma Brand of Cephradine
% 212.88/213.11  |- skos__broader mesh__D002515smesh__D002506
% 212.88/213.11  |- skos__hiddenLabel mesh__D002515 SQ11436
% 212.88/213.11  |- skos__hiddenLabel mesh__D002515 SQ 11436
% 212.88/213.11  |- skos__altLabel mesh__D002515 Bristol-Myers Squibb Brand of Cefradine
% 212.88/213.11  |- mesh__historyNote mesh__D002515
% 212.88/213.11       91%28%75%29%; was see under CEPHALOSPORINS 1975-90   
% 212.88/213.11  |- skos__altLabel mesh__D002515 Yamanouchi Brand of Cephradine
% 212.88/213.11  |- rdf__type mesh__D002515sskos__Concept
% 212.88/213.11  |- skos__scopeNote mesh__D002515
% 212.88/213.11       A semi-synthetic cephalosporin antibiotic.     
% 212.88/213.11  |- mesh__dateRevised mesh__D002515 2005-06-30
% 212.88/213.11  |- skos__broader mesh__D009206Q000166smesh__D009206
% 212.88/213.11  |- rdf__type mesh__D009206Q000166smesh__CompoundConcept
% 212.88/213.11  |- mesh__dateCreated mesh__D007200 1999-01-01
% 212.88/213.11  |- skos__broader mesh__D007200smesh__D007211
% 212.88/213.11  |- skos__scopeNote mesh__D007200
% 212.88/213.11       A substance occurring in the urine of mammals and also in blood plasma as the normal metabolite of tryptophan. An increased urinary excretion of indican is seen in Hartnup disease from the bacterial degradation of unabsorbed tryptophan.%A%    
% 212.88/213.11  |- mesh__dateRevised mesh__D007200 2000-06-22
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D007200 2006
% 212.88/213.11  |- mesh__recordOriginator mesh__D007200 NLM
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D007200 2001
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D007200 2003
% 212.88/213.11  |- skos__hiddenLabel mesh__D007200 Sulfate, Indoxyl
% 212.88/213.11  |- skos__hiddenLabel mesh__D007200 Monosodium Salt, Indican
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D007200 2004
% 212.88/213.11  |- skos__altLabel mesh__D007200 Indoxyl Sulfate
% 212.88/213.11  |- rdf__type mesh__D007200sskos__Concept
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D007200 2002
% 212.88/213.11  |- skos__related mesh__D007200smesh__D006250
% 212.88/213.11  |- skos__altLabel mesh__D007200 1H-Indol-3-ol Hydrogen Sulfate Ester
% 212.88/213.11  |- skos__prefLabel mesh__D007200 Indican
% 212.88/213.11  |- mesh__recordAuthorizer mesh__D007200 sjn
% 212.88/213.11  |- mesh__recordMaintainer mesh__D007200 TWD
% 212.88/213.11  |- skos__hiddenLabel mesh__D007200 Monopotassium Salt, Indican
% 212.88/213.11  |- skos__annotation mesh__D007200
% 212.88/213.11       do not confuse with indican, a glycoside from plants yielding indigo %28%index under GLYCOSIDES%29%%A%  
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D007200 2005
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012943 2005
% 212.88/213.11  |- mesh__dateRevised mesh__D012943 1999-11-03
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012943 2001
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012943 2003
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012943 2006
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012943 2002
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012943 2004
% 212.88/213.11  |- skos__altLabel mesh__D012943 Social Insurance
% 212.88/213.11  |- mesh__recordMaintainer mesh__D012943 kle
% 212.88/213.11  |- mesh__recordAuthorizer mesh__D012943 sjn
% 212.88/213.11  |- rdf__type mesh__D012943sskos__Concept
% 212.88/213.11  |- skos__hiddenLabel mesh__D012943 Security, Social
% 212.88/213.11  |- skos__scopeNote mesh__D012943
% 212.88/213.11       Government sponsored social insurance programs.     
% 212.88/213.11  |- mesh__onlineNote mesh__D012943
% 212.88/213.11       use SOCIAL SECURITY to search AID TO THE BLIND %26% AID TO THE TOTALLY DISABLED 1975-76; use PUBLIC ASSISTANCE 1968-74%A%  
% 212.88/213.11  |- skos__broader mesh__D012943smesh__D007341
% 212.88/213.11  |- mesh__historyNote mesh__D012943
% 212.88/213.11       AID TO THE BLIND %26% AID TO THE TOTALLY DISABLED were see under PUBLIC ASSISTANCE 1968-77%A%  
% 212.88/213.11  |- mesh__recordOriginator mesh__D012943 NLM
% 212.88/213.11  |- mesh__publicMeSHNote mesh__D012943
% 212.88/213.11       AID TO THE BLIND %26% AID TO THE TOTALLY DISABLED were see under PUBLIC ASSISTANCE 1968-77%A%  
% 212.88/213.11  |- skos__annotation mesh__D012943 specify country, including U.S.   
% 212.88/213.11  |- skos__prefLabel mesh__D012943 Social Security
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012943 2000
% 212.88/213.11  |- skos__broader mesh__D012943smesh__D011632
% 212.88/213.11  |- mesh__dateCreated mesh__D012943 1999-01-01
% 212.88/213.11  |- skos__hiddenLabel mesh__D012943 Insurance, Social
% 212.88/213.11  |- mesh__recordOriginator mesh__D006906 NLM
% 212.88/213.11  |- mesh__recordMaintainer mesh__D006906 TPW
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006906 2006
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006906 2001
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006906 1999
% 212.88/213.11  |- skos__historyNote mesh__D006906 Azo Compounds %28%1972-1974%29%
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006906 2000
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006906 2005
% 212.88/213.11  |- mesh__dateRevised mesh__D006906 1996-06-10
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006906 2004
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006906 1998
% 212.88/213.11  |- skos__prefLabel mesh__D006906 Hydroxyphenylazouracil
% 212.88/213.11  |- skos__historyNote mesh__D006906 Phenols %28%1972-1974%29%
% 212.88/213.11  |- rdf__type mesh__D006906sskos__Concept
% 212.88/213.11  |- mesh__dateEstablished mesh__D006906 1991-01-01
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006906 1997
% 212.88/213.11  |- skos__broader mesh__D006906smesh__D014498
% 212.88/213.11  |- mesh__publicMeSHNote mesh__D006906 91; was see under URACIL 1975-90   
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006906 2003
% 212.88/213.11  |- skos__altLabel mesh__D006906 6-%28%4-Hydroxyphenylazo%29%uracil
% 212.88/213.11  |- skos__scopeNote mesh__D006906
% 212.88/213.11       Inhibitor of DNA replication in gram-positive bacteria.%A%    
% 212.88/213.11  |- mesh__recordAuthorizer mesh__D006906 PLS
% 212.88/213.11  |- mesh__historyNote mesh__D006906
% 212.88/213.11       91%28%75%29%; was see under URACIL 1975-90   
% 212.88/213.11  |- skos__historyNote mesh__D006906 Uracil %28%1972-1974%29%
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006906 2002
% 212.88/213.11  |- mesh__dateCreated mesh__D006906 1974-11-19
% 212.88/213.11  |- mesh__recordMaintainer mesh__D006108 TPW
% 212.88/213.11  |- mesh__dateRevised mesh__D006108 1993-06-04
% 212.88/213.11  |- mesh__publicMeSHNote mesh__D006108 91; was see under CARBON 1975-90   
% 212.88/213.11  |- skos__broader mesh__D006108smesh__D002244
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006108 2002
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006108 1999
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006108 1996
% 212.88/213.11  |- mesh__historyNote mesh__D006108
% 212.88/213.11       91%28%75%29%; was see under CARBON 1975-90   
% 212.88/213.11  |- skos__prefLabel mesh__D006108 Graphite
% 212.88/213.11  |- mesh__recordAuthorizer mesh__D006108 PLS
% 212.88/213.11  |- mesh__dateCreated mesh__D006108 1999-01-01
% 212.88/213.11  |- mesh__dateEstablished mesh__D006108 1991-01-01
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006108 2005
% 212.88/213.11  |- mesh__recordOriginator mesh__D006108 NLM
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006108 1997
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006108 2006
% 212.88/213.11  |- skos__broader mesh__D006108smesh__D008903
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006108 2003
% 212.88/213.11  |- skos__scopeNote mesh__D006108
% 212.88/213.11       Graphite. An allotropic form of carbon that is used in pencils, as a lubricant, and in matches and explosives. It is obtained by mining and its dust can cause lung irritation.%A%    
% 212.88/213.11  |- skos__annotation mesh__D006108 a form of carbon   
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006108 1994
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006108 2004
% 212.88/213.11  |- mesh__onlineNote mesh__D006108 search CARBON 1966-74   
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006108 2000
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006108 1995
% 212.88/213.11  |- rdf__type mesh__D006108sskos__Concept
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006108 2001
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006108 1998
% 212.88/213.11  |- skos__hiddenLabel mesh__D016536 Plan, Competitive Medical
% 212.88/213.11  |- skos__prefLabel mesh__D016536 Competitive Medical Plans
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016536 2004
% 212.88/213.11  |- mesh__historyNote mesh__D016536 92   
% 212.88/213.11  |- mesh__recordAuthorizer mesh__D016536 sjn
% 212.88/213.11  |- skos__hiddenLabel mesh__D016536 Plans, Competitive Medical
% 212.88/213.11  |- skos__annotation mesh__D016536 DF: COMPETITIVE MED PLANS   
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016536 2006
% 212.88/213.11  |- skos__altLabel mesh__D016536 Medical Plan, Competitive
% 212.88/213.11  |- mesh__publicMeSHNote mesh__D016536 92   
% 212.88/213.11  |- skos__historyNote mesh__D016536
% 212.88/213.11       Health Maintenance Organizations %28%1984-1991%29%
% 212.88/213.11  |- mesh__recordMaintainer mesh__D016536 kle
% 212.88/213.11  |- skos__scopeNote mesh__D016536
% 212.88/213.11       Alternative health care delivery mechanisms, such as PREFERRED PROVIDER ORGANIZATIONS or other health insurance services or prepaid plans %28%other than HEALTH MAINTENANCE ORGANIZATIONS%29%, that meet Medicare qualifications for a risk-sharing contract. %28%From Facts on File Dictionary of Health Care Management, 1988%29%%A%    
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016536 2002
% 212.88/213.11  |- skos__broader mesh__D016536smesh__D008329
% 212.88/213.11  |- mesh__dateRevised mesh__D016536 1999-11-03
% 212.88/213.11  |- skos__altLabel mesh__D016536 Medical Plans, Competitive
% 212.88/213.11  |- skos__altLabel mesh__D016536 Competitive Health Plan
% 212.88/213.11  |- rdf__type mesh__D016536sskos__Concept
% 212.88/213.11  |- skos__hiddenLabel mesh__D016536 Health Plan, Competitive
% 212.88/213.11  |- skos__hiddenLabel mesh__D016536 Health Plans, Competitive
% 212.88/213.11  |- mesh__recordOriginator mesh__D016536 JHM
% 212.88/213.11  |- skos__related mesh__D016536smesh__D011243
% 212.88/213.11  |- skos__hiddenLabel mesh__D016536 Plans, Competitive Health
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016536 2000
% 212.88/213.11  |- skos__altLabel mesh__D016536 Competitive Medical Plan
% 212.88/213.11  |- skos__hiddenLabel mesh__D016536 Plan, Competitive Health
% 212.88/213.11  |- skos__hiddenLabel mesh__D016536 Competitive Health Plans
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016536 2003
% 212.88/213.11  |- mesh__dateCreated mesh__D016536 1991-06-21
% 212.88/213.11  |- mesh__dateEstablished mesh__D016536 1992-01-01
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016536 2001
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D016536 2005
% 212.88/213.11  |- skos__broader mesh__D004622Q000637smesh__D004622
% 212.88/213.11  |- mesh__preferredCombination mesh__D004622Q000637smesh__D004624
% 212.88/213.11  |- rdf__type mesh__D004622Q000637smesh__CompoundConcept
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D002516 1999
% 212.88/213.11  |- mesh__historyNote mesh__D002516 73%28%67%29%   
% 212.88/213.11  |- skos__historyNote mesh__D002516 Minerals %28%1966%29%
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D002516 1996
% 212.88/213.11  |- skos__broader mesh__D002516smesh__D008420
% 212.88/213.11  |- skos__historyNote mesh__D002516 Chemical Industry %28%1966%29%
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D002516 2000
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D002516 1997
% 212.88/213.11  |- mesh__recordAuthorizer mesh__D002516 PLS
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D002516 2005
% 212.88/213.11  |- skos__scopeNote mesh__D002516
% 212.88/213.11       Products made by baking or firing nonmetallic minerals %28%clay and similar materials%29%. In making dental restorations or parts of restorations the material is fused porcelain. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed %26% Boucher%27%s Clinical Dental Terminology, 4th ed%29%%A%    
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D002516 2001
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D002516 2006
% 212.88/213.11  |- mesh__recordMaintainer mesh__D002516 TGC
% 212.88/213.11  |- skos__broader mesh__D002516smesh__D001697
% 212.88/213.11  |- skos__annotation mesh__D002516
% 212.88/213.11       not restricted to dentistry; D25-26 qualif   
% 212.88/213.11  |- mesh__dateCreated mesh__D002516 1999-01-01
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D002516 2003
% 212.88/213.11  |- mesh__recordOriginator mesh__D002516 NLM
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D002516 1998
% 212.88/213.11  |- skos__prefLabel mesh__D002516 Ceramics
% 212.88/213.11  |- rdf__type mesh__D002516sskos__Concept
% 212.88/213.11  |- skos__hiddenLabel mesh__D002516 Ceramic
% 212.88/213.11  |- skos__historyNote mesh__D002516 Dental Materials %28%1966%29%
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D002516 2002
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D002516 2004
% 212.88/213.11  |- mesh__dateEstablished mesh__D002516 1973-01-01
% 212.88/213.11  |- mesh__dateRevised mesh__D002516 1995-03-16
% 212.88/213.11  |- mesh__publicMeSHNote mesh__D002516 73   
% 212.88/213.11  |- skos__broader mesh__D007201smesh__D008919
% 212.88/213.11  |- skos__hiddenLabel mesh__D007201 Indicator Dilution Technic
% 212.88/213.11  |- skos__hiddenLabel mesh__D007201 Techniques, Indicator Dilution
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D007201 2000
% 212.88/213.11  |- skos__hiddenLabel mesh__D007201 Techniques, Dilution
% 212.88/213.11  |- mesh__dateEstablished mesh__D007201 1967-01-01
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D007201 2004
% 212.88/213.11  |- skos__hiddenLabel mesh__D007201 Indicator Dilution Technique
% 212.88/213.11  |- mesh__recordAuthorizer mesh__D007201 sjn
% 212.88/213.11  |- rdf__type mesh__D007201sskos__Concept
% 212.88/213.11  |- skos__prefLabel mesh__D007201 Indicator Dilution Techniques
% 212.88/213.11  |- skos__hiddenLabel mesh__D007201 Technics, Dilution
% 212.88/213.11  |- skos__hiddenLabel mesh__D007201 Dilution Technics, Indicator
% 212.88/213.11  |- skos__altLabel mesh__D007201 Dilution Techniques
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D007201 2003
% 212.88/213.11  |- mesh__publicMeSHNote mesh__D007201
% 212.88/213.11       91; was INDICATOR DILUTION TECHNICS 1967-90   
% 212.88/213.11  |- skos__hiddenLabel mesh__D007201 Dilution Technic, Indicator
% 212.88/213.11  |- skos__hiddenLabel mesh__D007201 Dilution Technique
% 212.88/213.11  |- skos__hiddenLabel mesh__D007201 Technics, Indicator Dilution
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D007201 2002
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D007201 2006
% 212.88/213.11  |- mesh__onlineNote mesh__D007201
% 212.88/213.11       use INDICATOR DILUTION TECHNIQUES to search INDICATOR DILUTION TECHNICS 1967-90%A%  
% 212.88/213.11  |- mesh__historyNote mesh__D007201
% 212.88/213.11       91; was INDICATOR DILUTION TECHNICS 1967-90   
% 212.88/213.11  |- skos__annotation mesh__D007201
% 212.88/213.11       NIM; do not use /util except by MeSH definition; DYE DILUTION TECHNIQUE and RADIOISOTOPE DILUTION TECHNIQUE are also available%A%  
% 212.88/213.11  |- mesh__dateCreated mesh__D007201 1999-01-01
% 212.88/213.11  |- skos__hiddenLabel mesh__D007201 Dilution Technique, Indicator
% 212.88/213.11  |- mesh__recordMaintainer mesh__D007201 kle
% 212.88/213.11  |- mesh__dateRevised mesh__D007201 1999-11-03
% 212.88/213.11  |- skos__hiddenLabel mesh__D007201 Dilution Techniques, Indicator
% 212.88/213.11  |- skos__altLabel mesh__D007201 Indicator Dilution Technics
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D007201 2005
% 212.88/213.11  |- skos__scopeNote mesh__D007201
% 212.88/213.11       Methods for assessing flow through a system by injection of a known quantity of an indicator, such as a dye, radionuclide, or chilled liquid, into the system and monitoring its concentration over time at a specific point in the system. %28%From Dorland, 28th ed%29%%A%    
% 212.88/213.11  |- skos__hiddenLabel mesh__D007201 Technic, Dilution
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D007201 2001
% 212.88/213.11  |- skos__hiddenLabel mesh__D007201 Technique, Indicator Dilution
% 212.88/213.11  |- skos__hiddenLabel mesh__D007201 Dilution Technic
% 212.88/213.11  |- skos__historyNote mesh__D007201 Dye Dilution Technique %28%1966%29%
% 212.88/213.11  |- skos__hiddenLabel mesh__D007201 Technic, Indicator Dilution
% 212.88/213.11  |- skos__hiddenLabel mesh__D007201 Technique, Dilution
% 212.88/213.11  |- mesh__recordOriginator mesh__D007201 NLM
% 212.88/213.11  |- skos__prefLabel mesh__D012944 Social Support
% 212.88/213.11  |- skos__broader mesh__D012944smesh__D012931
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012944 2004
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012944 1999
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012944 1997
% 212.88/213.11  |- rdf__type mesh__D012944sskos__Concept
% 212.88/213.11  |- skos__hiddenLabel mesh__D012944 System, Psychosocial Support
% 212.88/213.11  |- skos__hiddenLabel mesh__D012944 Support Systems, Psychosocial
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012944 2001
% 212.88/213.11  |- skos__hiddenLabel mesh__D012944 Systems, Psychosocial Support
% 212.88/213.11  |- skos__historyNote mesh__D012944 Social Environment %28%1973-1982%29%
% 212.88/213.11  |- skos__hiddenLabel mesh__D012944 Network, Social
% 212.88/213.11  |- skos__hiddenLabel mesh__D012944 Support System, Psychosocial
% 212.88/213.11  |- skos__hiddenLabel mesh__D012944 Social Network
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012944 2002
% 212.88/213.11  |- skos__historyNote mesh__D012944 Social Adjustment %28%1969-1982%29%
% 212.88/213.11  |- skos__hiddenLabel mesh__D012944 Psychosocial Support System
% 212.88/213.11  |- skos__hiddenLabel mesh__D012944 Support, Social
% 212.88/213.11  |- mesh__historyNote mesh__D012944
% 212.88/213.11       91%28%83%29%; was see under SOCIAL ENVIRONMENT 1983-90   
% 212.88/213.11  |- mesh__recordAuthorizer mesh__D012944 PLS
% 212.88/213.11  |- mesh__dateCreated mesh__D012944 1982-04-27
% 212.88/213.11  |- mesh__dateEstablished mesh__D012944 1991-01-01
% 212.88/213.11  |- mesh__recordOriginator mesh__D012944 EC
% 212.88/213.11  |- mesh__publicMeSHNote mesh__D012944
% 212.88/213.11       91; was see under SOCIAL ENVIRONMENT 1983-90   
% 212.88/213.11  |- mesh__recordMaintainer mesh__D012944 PLS
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012944 2005
% 212.88/213.11  |- skos__hiddenLabel mesh__D012944 Networks, Social
% 212.88/213.11  |- skos__related mesh__D012944smesh__D012657
% 212.88/213.11  |- mesh__dateRevised mesh__D012944 1994-03-17
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012944 2003
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012944 1998
% 212.88/213.11  |- skos__annotation mesh__D012944 human only; no qualif   
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012944 1995
% 212.88/213.11  |- skos__scopeNote mesh__D012944
% 212.88/213.11       Support systems that provide assistance and encouragement to individuals with physical or emotional disabilities in order that they may better cope. Informal social support is usually provided by friends, relatives, or peers, while formal assistance is provided by churches, groups, etc.%A%    
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012944 2006
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012944 2000
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012944 1996
% 212.88/213.11  |- skos__hiddenLabel mesh__D012146 Rests
% 212.88/213.11  |- skos__scopeNote mesh__D012146 Freedom from activity.     
% 212.88/213.11  |- mesh__recordMaintainer mesh__D012146 ssb
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012146 2004
% 212.88/213.11  |- skos__related mesh__D012146smesh__D001510
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012146 2003
% 212.88/213.11  |- mesh__recordOriginator mesh__D012146 NLM
% 212.88/213.11  |- mesh__dateCreated mesh__D012146 1999-01-01
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012146 2006
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012146 2002
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D012146 2005
% 212.88/213.11  |- mesh__recordAuthorizer mesh__D012146 sjn
% 212.88/213.11  |- rdf__type mesh__D012146sskos__Concept
% 212.88/213.11  |- skos__annotation mesh__D012146
% 212.88/213.11       do not confuse with IMMOBILIZATION; /physiol /psychol permitted%A%  
% 212.88/213.11  |- mesh__dateRevised mesh__D012146 2001-07-25
% 212.88/213.11  |- skos__broader mesh__D012146smesh__D012063
% 212.88/213.11  |- skos__prefLabel mesh__D012146 Rest
% 212.88/213.11  |- mesh__historyNote mesh__D006907
% 212.88/213.11       2004 %28%1964%29%; for 17-HYDROXYPREGNENOLONE use HYDROXYPREGNENOLONE %28%NM%29% 1981-2003%A%  
% 212.88/213.11  |- skos__scopeNote mesh__D006907
% 212.88/213.11       A 21-carbon steroid that is converted from PREGNENOLONE by STEROID 17-ALPHA-HYDROXYLASE. It is an intermediate in the delta-5 pathway of biosynthesis of GONADAL STEROID HORMONES and the adrenal CORTICOSTEROIDS.%A%    
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006907 2005
% 212.88/213.11  |- skos__hiddenLabel mesh__D006907 17 Hydroxypregnenolone
% 212.88/213.11  |- mesh__publicMeSHNote mesh__D006907
% 212.88/213.11       2004; see HYDROXYPREGNENOLONE 1972-2003; 17-HYDROXYPREGNENOLONE was indexed under HYDROXYPREGNENOLONE %28%NM%29% 1981-2003%A%  
% 212.88/213.11  |- mesh__recordOriginator mesh__D006907 NLM
% 212.88/213.11  |- skos__altLabel mesh__D006907 17alpha-Hydroxypregnenolone
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006907 2004
% 212.88/213.11  |- mesh__recordAuthorizer mesh__D006907 sjn
% 212.88/213.11  |- rdf__type mesh__D006907sskos__Concept
% 212.88/213.11  |- skos__altLabel mesh__D006907 Hydroxypregnenolone
% 212.88/213.11  |- skos__hiddenLabel mesh__D006907 17alpha Hydroxypregnenolone
% 212.88/213.11  |- mesh__recordMaintainer mesh__D006907 lkt
% 212.88/213.11  |- skos__altLabel mesh__D006907
% 212.88/213.11       17-Hydroxypregnenolone, %28%3beta,17alpha%29%-Isomer
% 212.88/213.11  |- mesh__dateEstablished mesh__D006907 1972-01-01
% 212.88/213.11  |- skos__prefLabel mesh__D006907 17-alpha-Hydroxypregnenolone
% 212.88/213.11  |- mesh__dateRevised mesh__D006907 2003-07-09
% 212.88/213.11  |- skos__hiddenLabel mesh__D006907 17 alpha Hydroxypregnenolone
% 212.88/213.11  |- skos__altLabel mesh__D006907
% 212.88/213.11       17-Hydroxypregnenolone, %28%3beta,13alpha%29%-Isomer
% 212.88/213.11  |- mesh__dateCreated mesh__D006907 1999-01-01
% 212.88/213.11  |- skos__broader mesh__D006907smesh__D011284
% 212.88/213.11  |- skos__altLabel mesh__D006907 17-Hydroxypregnenolone
% 212.88/213.11  |- skos__altLabel mesh__D006907 17 alpha-Hydroxypregnenolone
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D006907 2006
% 212.88/213.11  |- mesh__recordAuthorizer mesh__D031300 ags
% 212.88/213.11  |- mesh__recordOriginator mesh__D031300 ags
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D031300 2005
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D031300 2003
% 212.88/213.11  |- skos__scopeNote mesh__D031300
% 212.88/213.11       Inflammation of the retinal vasculature with various causes including infectious disease; LUPUS ERYTHEMATOSUS, SYSTEMIC; MULTIPLE SCLEROSIS; BEHCET SYNDROME; and CHORIORETINITIS.%A%    
% 212.88/213.11  |- skos__related mesh__D031300smesh__D012171
% 212.88/213.11  |- skos__historyNote mesh__D031300 Retinal Diseases %28%1967-2002%29%
% 212.88/213.11  |- mesh__recordMaintainer mesh__D031300 ags
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D031300 2006
% 212.88/213.11  |- skos__related mesh__D031300smesh__D012170
% 212.88/213.11  |- skos__broader mesh__D031300smesh__D012164
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D031300 2006A
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D031300 2004
% 212.88/213.11  |- skos__broader mesh__D031300smesh__D014657
% 212.88/213.11  |- mesh__publicMeSHNote mesh__D031300 2003   
% 212.88/213.11  |- rdf__type mesh__D031300sskos__Concept
% 212.88/213.11  |- skos__related mesh__D031300smesh__D012173
% 212.88/213.11  |- mesh__activeMeSHYear mesh__D031300 2005A
% 212.88/213.11  |- mesh__dateCreated mesh__D031300 2002-07-03
% 212.88/213.11  |- mesh__dateRevised mesh__D031300 2005-07-19
% 212.88/213.11  |- mesh__historyNote mesh__D031300 2003   
% 212.88/213.11  |- skos__prefLabel mesh__D031300 Retinal Vasculitis
% 212.88/213.11  |- skos__historyNote mesh__D031300 Vasculitis %28%1966-2002%29%
% 212.88/213.11  |- mesh__dateEstablished mesh__D031300 2003-01-01
% 212.88/213.11  |- skos__altLabel mesh__D031300 Vasculitis, Retinal
% 212.88/213.11  |- mesh__dateRevised mesh__D006109 2005-07-01
% 212.88/213.11  |- mesh__recordMaintainer mesh__D006109 sjn
% 212.88/213.11  |- mesh__dateCreated mesh__D006109 1999-01-01
% 212.88/213.12  |- skos__broader mesh__D006109smesh__D019684
% 212.88/213.12  |- skos__scopeNote mesh__D006109
% 212.88/213.12       A large family of narrow-leaved herbaceous grasses of the order Cyperales, subclass Commelinidae, class Liliopsida %28%monocotyledons%29%.  Food grains %28%CEREALS%29% come from members of this family. RHINITIS, ALLERGIC, SEASONAL can be induced by POLLEN of many of the grasses.%A%    
% 212.88/213.12  |- mesh__recordOriginator mesh__D006109 NLM
% 212.88/213.12  |- skos__annotation mesh__D006109
% 212.88/213.12       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.88/213.12  |- skos__related mesh__D006109smesh__D011058
% 212.88/213.12  |- mesh__historyNote mesh__D006109 2002%28%1963%29%   
% 212.88/213.12  |- skos__altLabel mesh__D006109 Gramineae
% 212.88/213.12  |- skos__prefLabel mesh__D006109 Poaceae
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D006109 2006
% 212.88/213.12  |- skos__altLabel mesh__D006109 Grass
% 212.88/213.12  |- skos__altLabel mesh__D006109 Grasses
% 212.88/213.12  |- mesh__recordAuthorizer mesh__D006109 sjn
% 212.88/213.12  |- mesh__publicMeSHNote mesh__D006109
% 212.88/213.12       2002; see GRASSES 1963-2001; for GRAMINEAE see GRAMINEA 1986-1997%A%  
% 212.88/213.12  |- rdf__type mesh__D006109sskos__Concept
% 212.88/213.12  |- mesh__recordAuthorizer mesh__D049711 sjn
% 212.88/213.12  |- rdf__type mesh__D049711sskos__Concept
% 212.88/213.12  |- skos__scopeNote mesh__D049711
% 212.88/213.12       The period of history from 1601 of the common era to the present.%A%    
% 212.88/213.12  |- skos__altLabel mesh__D049711 History, Modern
% 212.88/213.12  |- skos__prefLabel mesh__D049711 History, Modern 1601-
% 212.88/213.12  |- mesh__recordMaintainer mesh__D049711 jls
% 212.88/213.12  |- skos__hiddenLabel mesh__D049711 History, Modern %28%Medicine%29%
% 212.88/213.12  |- mesh__recordOriginator mesh__D049711 jls
% 212.88/213.12  |- skos__hiddenLabel mesh__D049711 Modern 1601- History
% 212.88/213.12  |- skos__hiddenLabel mesh__D049711 History, Modern 1601 
% 212.88/213.12  |- skos__altLabel mesh__D049711 Modern History
% 212.88/213.12  |- mesh__dateEstablished mesh__D049711 2005-01-01
% 212.88/213.12  |- skos__hiddenLabel mesh__D049711 1601- History, Modern
% 212.88/213.12  |- skos__altLabel mesh__D049711 Modern Medicine
% 212.88/213.12  |- mesh__dateCreated mesh__D049711 2004-07-07
% 212.88/213.12  |- mesh__publicMeSHNote mesh__D049711
% 212.88/213.12       2005; see HISTORY OF MEDICINE, MODERN 1966-2004; for MEDICINE, MODERN %26% MODERN HISTORY see HISTORY OF MEDICINE, MODERN 1995-2004%A%  
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D049711 2005
% 212.88/213.12  |- skos__broader mesh__D049711smesh__D006664
% 212.88/213.12  |- skos__altLabel mesh__D049711 Modern History %28%Medicine%29%
% 212.88/213.12  |- mesh__historyNote mesh__D049711 2005   
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D049711 2006
% 212.88/213.12  |- skos__annotation mesh__D049711 not used for indexing   
% 212.88/213.12  |- mesh__dateCreated mesh__D016537 1991-06-21
% 212.88/213.12  |- mesh__dateEstablished mesh__D016537 1992-01-01
% 212.88/213.12  |- skos__altLabel mesh__D016537 GM1 Gangliosidosis
% 212.88/213.12  |- skos__hiddenLabel mesh__D016537 Infantile Gangliosidosis GM1
% 212.88/213.12  |- skos__altLabel mesh__D016537 Gangliosidosis GM1, Type 2
% 212.88/213.12  |- skos__prefLabel mesh__D016537 Gangliosidosis GM1
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D016537 2005
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D016537 2004
% 212.88/213.12  |- skos__hiddenLabel mesh__D016537 Gangliosidosis, Generalized
% 212.88/213.12  |- skos__scopeNote mesh__D016537
% 212.88/213.12       A form of gangliosidosis characterized by accumulation of G%28%M1%29% GANGLIOSIDE and oligosaccharides in lysosomes caused by an absence or severe deficiency of the enzyme BETA-GALACTOSIDASE %28%type A1%29%. The three phenotypes of this disorder are infantile %28%generalized%29%, juvenile, and adult. The infantile form is characterized by skeletal abnormalities, hypotonia, poor psychomotor development, hirsutism, hepatosplenomegaly, and facial abnormalities. The juvenile form features hyperacusis, seizures, and psychomotor retardation. The adult form features progressive intellectual deterioration, involuntary movements, ataxia, and spasticity. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp96-7%29%%A%    
% 212.88/213.12  |- skos__broader mesh__D016537smesh__D005733
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D016537 2002
% 212.88/213.12  |- skos__altLabel mesh__D016537 Gangliosidosis GM1, Type 3
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D016537 2006
% 212.88/213.12  |- skos__altLabel mesh__D016537 Gangliosidosis G%28%M1%29%
% 212.88/213.12  |- skos__altLabel mesh__D016537 Generalized Gangliosidosis
% 212.88/213.12  |- rdf__type mesh__D016537sskos__Concept
% 212.88/213.12  |- skos__altLabel mesh__D016537 G%28%M1%29% Gangliosidosis
% 212.88/213.12  |- mesh__historyNote mesh__D016537 2000%28%1992%29%   
% 212.88/213.12  |- skos__historyNote mesh__D016537 Gangliosidoses %28%1976-1991%29%
% 212.88/213.12  |- skos__hiddenLabel mesh__D016537 Gangliosidosis, GM1
% 212.88/213.12  |- skos__historyNote mesh__D016537 Lipoidosis %28%1966-1975%29%
% 212.88/213.12  |- skos__hiddenLabel mesh__D016537 Adult Gangliosidosis GM1
% 212.88/213.12  |- mesh__recordOriginator mesh__D016537 AGS
% 212.88/213.12  |- mesh__dateRevised mesh__D016537 2001-07-25
% 212.88/213.12  |- skos__historyNote mesh__D016537
% 212.88/213.12       Metabolism, Inborn Errors %28%1966-1975%29%
% 212.88/213.12  |- skos__altLabel mesh__D016537 Gangliosidosis GM1, Type 1
% 212.88/213.12  |- mesh__publicMeSHNote mesh__D016537
% 212.88/213.12       2000; see GANGLIOSIDOSIS G%28%M1%29% 1992-1999; for GANGLIOSIDOSIS GM1 see GANGLIOSIDOSIS G%28%M1%29% 1992-1999%A%  
% 212.88/213.12  |- mesh__recordMaintainer mesh__D016537 nns
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D016537 2003
% 212.88/213.12  |- mesh__recordAuthorizer mesh__D016537 sjn
% 212.88/213.12  |- skos__related mesh__D016537smesh__D001616
% 212.88/213.12  |- skos__hiddenLabel mesh__D016537 Juvenile Gangliosidosis GM1
% 212.88/213.12  |- mesh__recordOriginator mesh__D002517 NLM
% 212.88/213.12  |- skos__historyNote mesh__D002517 Cerebrosides %28%1972-1974%29%
% 212.88/213.12  |- skos__historyNote mesh__D002517 Galactosidase %28%1972-1974%29%
% 212.88/213.12  |- skos__altLabel mesh__D002517 Galactosylgalactosylglucosylceramidase
% 212.88/213.12  |- skos__hiddenLabel mesh__D002517 Trihexosidase, Ceramide
% 212.88/213.12  |- skos__altLabel mesh__D002517 Acid Ceramidase
% 212.88/213.12  |- mesh__recordAuthorizer mesh__D002517 sjn
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D002517 2005
% 212.88/213.12  |- mesh__historyNote mesh__D002517
% 212.88/213.12       91%28%75%29%; was see under GALACTOSIDASES 1975-90   
% 212.88/213.12  |- skos__broader mesh__D002517smesh__D005696
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D002517 2006
% 212.88/213.12  |- mesh__dateEstablished mesh__D002517 1991-01-01
% 212.88/213.12  |- mesh__dateCreated mesh__D002517 1974-11-19
% 212.88/213.12  |- skos__hiddenLabel mesh__D002517 Ceramidase, Acid
% 212.88/213.12  |- mesh__recordMaintainer mesh__D002517 ssb
% 212.88/213.12  |- mesh__publicMeSHNote mesh__D002517
% 212.88/213.12       91; was see under GALACTOSIDASES 1975-90   
% 212.88/213.12  |- rdf__type mesh__D002517sskos__Concept
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D002517 2004
% 212.88/213.12  |- skos__scopeNote mesh__D002517
% 212.88/213.12       An enzyme that catalyzes the hydrolysis of a ceramidetrihexoside to a ceramidedihexoside plus galactose. EC 3.2.1.47.%A%    
% 212.88/213.12  |- skos__prefLabel mesh__D002517 Ceramide Trihexosidase
% 212.88/213.12  |- mesh__dateRevised mesh__D002517 2003-07-09
% 212.88/213.12  |- rdf__type mesh__D007202sskos__Concept
% 212.88/213.12  |- skos__related mesh__D007202smesh__D004396
% 212.88/213.12  |- skos__altLabel mesh__D007202 Reagents and Indicators
% 212.88/213.12  |- mesh__dateRevised mesh__D007202 2005-07-06
% 212.88/213.12  |- skos__scopeNote mesh__D007202
% 212.88/213.12       Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed, p301, p499%29%%A%    
% 212.88/213.12  |- skos__prefLabel mesh__D007202 Indicators and Reagents
% 212.88/213.12  |- skos__broader mesh__D007202smesh__D019995
% 212.88/213.12  |- mesh__recordMaintainer mesh__D007202 NLM
% 212.88/213.12  |- mesh__dateCreated mesh__D007202 1999-01-01
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D007202 2006
% 212.88/213.12  |- mesh__recordAuthorizer mesh__D007202 NLM
% 212.88/213.12  |- skos__related mesh__D007202smesh__D011933
% 212.88/213.12  |- skos__annotation mesh__D007202
% 212.88/213.12       NIM; coord with specific substance %28%IM or NIM%29%; D25-26 qualif except /diag use; REAGENT KITS, DIAGNOSTIC %26% REAGENT STRIPS are also available; DF: INDICATORS%A%  
% 212.88/213.12  |- mesh__recordOriginator mesh__D007202 NLM
% 212.88/213.12  |- skos__related mesh__D007202smesh__D002614
% 212.88/213.12  |- mesh__dateRevised mesh__D012945 2003-07-09
% 212.88/213.12  |- skos__historyNote mesh__D012945 Psychology, Social %28%1966-1968%29%
% 212.88/213.12  |- mesh__dateEstablished mesh__D012945 1969-01-01
% 212.88/213.12  |- skos__historyNote mesh__D012945 Judgment %28%1966-1968%29%
% 212.88/213.12  |- skos__hiddenLabel mesh__D012945 Value Orientations
% 212.88/213.12  |- skos__altLabel mesh__D012945 Values, Social
% 212.88/213.12  |- mesh__recordOriginator mesh__D012945 NLM
% 212.88/213.12  |- skos__related mesh__D012945smesh__D026712
% 212.88/213.12  |- mesh__dateCreated mesh__D012945 1999-01-01
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D012945 2005
% 212.88/213.12  |- mesh__publicMeSHNote mesh__D012945 69   
% 212.88/213.12  |- skos__related mesh__D012945smesh__D028722
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D012945 2006
% 212.88/213.12  |- skos__scopeNote mesh__D012945
% 212.88/213.12       Abstract standards or empirical variables in social life which are believed to be important and/or desirable.%A%    
% 212.88/213.12  |- skos__broader mesh__D012945smesh__D011593
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D012945 2004
% 212.88/213.12  |- skos__prefLabel mesh__D012945 Social Values
% 212.88/213.12  |- mesh__recordMaintainer mesh__D012945 lkt
% 212.88/213.12  |- mesh__historyNote mesh__D012945 69   
% 212.88/213.12  |- rdf__type mesh__D012945sskos__Concept
% 212.88/213.12  |- mesh__recordAuthorizer mesh__D012945 sjn
% 212.88/213.12  |- skos__prefLabel mesh__D012147 Restaurants
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D012147 2003
% 212.88/213.12  |- mesh__dateRevised mesh__D012147 1999-11-03
% 212.88/213.12  |- mesh__dateCreated mesh__D012147 1999-01-01
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D012147 2001
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D012147 2006
% 212.88/213.12  |- skos__broader mesh__D012147smesh__D005522
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D012147 2000
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D012147 2005
% 212.88/213.12  |- mesh__recordMaintainer mesh__D012147 kle
% 212.88/213.12  |- mesh__recordOriginator mesh__D012147 NLM
% 212.88/213.12  |- skos__hiddenLabel mesh__D012147 Restaurant
% 212.88/213.12  |- rdf__type mesh__D012147sskos__Concept
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D012147 2002
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D012147 2004
% 212.88/213.12  |- mesh__recordAuthorizer mesh__D012147 sjn
% 212.88/213.12  |- mesh__recordMaintainer mesh__D006908 lkt
% 212.88/213.12  |- mesh__onlineNote mesh__D006908
% 212.88/213.12       use HYDROXYPROGESTERONES to search HYDROXYPROGESTERONE 1966-77%A%  
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D006908 2004
% 212.88/213.12  |- rdf__type mesh__D006908sskos__Concept
% 212.88/213.12  |- skos__prefLabel mesh__D006908 Hydroxyprogesterones
% 212.88/213.12  |- mesh__dateCreated mesh__D006908 1999-01-01
% 212.88/213.12  |- mesh__publicMeSHNote mesh__D006908
% 212.88/213.12       78; was HYDROXYPROGESTERONE 1963-77   
% 212.88/213.12  |- skos__scopeNote mesh__D006908
% 212.88/213.12       Metabolites or derivatives of PROGESTERONE with hydroxyl group substitution at various sites.%A%    
% 212.88/213.12  |- mesh__recordOriginator mesh__D006908 NLM
% 212.88/213.12  |- mesh__historyNote mesh__D006908 78; was HYDROXYPROGESTERONE 1963-77   
% 212.88/213.12  |- skos__broader mesh__D006908smesh__D011374
% 212.88/213.12  |- mesh__dateRevised mesh__D006908 2003-07-09
% 212.88/213.12  |- mesh__recordAuthorizer mesh__D006908 sjn
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D006908 2005
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D006908 2006
% 212.88/213.12  |- rdf__type mesh__D017630sskos__Concept
% 212.88/213.12  |- skos__annotation mesh__D017630
% 212.88/213.12       membrane proteins forming intermembrane channels of gap junctions%A%  
% 212.88/213.12  |- mesh__dateEstablished mesh__D017630 1994-01-01
% 212.88/213.12  |- mesh__dateCreated mesh__D017630 1993-08-06
% 212.88/213.12  |- mesh__recordOriginator mesh__D017630 RAZ
% 212.88/213.12  |- mesh__recordMaintainer mesh__D017630 SYSTEM
% 212.88/213.12  |- skos__historyNote mesh__D017630 Membrane Proteins %28%1981-1993%29%
% 212.88/213.12  |- skos__hiddenLabel mesh__D017630 Junction Protein, Gap
% 212.88/213.12  |- skos__hiddenLabel mesh__D017630 Proteins, Gap Junction
% 212.88/213.12  |- skos__scopeNote mesh__D017630
% 212.88/213.12       A group of homologous proteins which form the intermembrane channels of GAP JUNCTIONS. The connexins are the products of an identified gene family which has both highly conserved and highly divergent regions. The variety contributes to the wide range of functional properties of gap junctions.%A%    
% 212.88/213.12  |- skos__prefLabel mesh__D017630 Connexins
% 212.88/213.12  |- mesh__dateRevised mesh__D017630 2005-06-30
% 212.88/213.12  |- skos__broader mesh__D017630smesh__D008565
% 212.88/213.12  |- mesh__onlineNote mesh__D017630
% 212.88/213.12       use CONNEXINS %28%NM%29% to search GAP JUNCTION PROTEIN 1982-93%A%  
% 212.88/213.12  |- skos__hiddenLabel mesh__D017630 Protein, Gap Junction
% 212.88/213.12  |- skos__altLabel mesh__D017630 Gap Junction Proteins
% 212.88/213.12  |- mesh__historyNote mesh__D017630
% 212.88/213.12       94; GAP JUNCTION PROTEIN was %28%NM%29% 1982-93   
% 212.88/213.12  |- mesh__publicMeSHNote mesh__D017630
% 212.88/213.12       94; GAP JUNCTION PROTEIN was indexed under MEMBRANE PROTEINS 1982-93%A%  
% 212.88/213.12  |- skos__altLabel mesh__D017630 Gap Junction Protein
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D017630 2006
% 212.88/213.12  |- skos__hiddenLabel mesh__D017630 Junction Proteins, Gap
% 212.88/213.12  |- mesh__recordAuthorizer mesh__D017630 sjn
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D031301 2004
% 212.88/213.12  |- mesh__dateEstablished mesh__D031301 2003-01-01
% 212.88/213.12  |- mesh__dateCreated mesh__D031301 2002-07-03
% 212.88/213.12  |- mesh__historyNote mesh__D031301 2003   
% 212.88/213.12  |- mesh__publicMeSHNote mesh__D031301 2003   
% 212.88/213.12  |- rdf__type mesh__D031301sskos__Concept
% 212.88/213.12  |- skos__scopeNote mesh__D031301
% 212.88/213.12       A plant genus of the family FABACEAE that contains linarin %28%acaciin%29% and LECTINS.%A%    
% 212.88/213.12  |- skos__altLabel mesh__D031301 Locust, Black
% 212.88/213.12  |- skos__prefLabel mesh__D031301 Robinia
% 212.88/213.12  |- skos__broader mesh__D031301smesh__D007887
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D031301 2005
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D031301 2003
% 212.88/213.12  |- skos__annotation mesh__D031301
% 212.88/213.12       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D031301 2006
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D003610 1997
% 212.88/213.12  |- mesh__historyNote mesh__D003610 75   
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D003610 1993
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D003610 1998
% 212.88/213.12  |- rdf__type mesh__D003610sskos__Concept
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D003610 2003
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D003610 1994
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D003610 1999
% 212.88/213.12  |- mesh__recordOriginator mesh__D003610 NLM
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D003610 2000
% 212.88/213.12  |- mesh__recordMaintainer mesh__D003610 PLS
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D003610 2004
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D003610 1995
% 212.88/213.12  |- skos__prefLabel mesh__D003610 Dagestan
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D003610 2001
% 212.88/213.12  |- skos__broader mesh__D003610smesh__D012426
% 212.88/213.12  |- skos__scopeNote mesh__D003610
% 212.88/213.12       One of the former Associated Soviet Socialist Republics, situated on the Caspian Sea in southwest Russia.%A%    
% 212.88/213.12  |- mesh__dateEstablished mesh__D003610 1975-01-01
% 212.88/213.12  |- mesh__dateRevised mesh__D003610 1992-05-20
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D003610 2005
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D003610 2002
% 212.88/213.12  |- mesh__dateCreated mesh__D003610 1999-01-01
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D003610 2006
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D003610 1996
% 212.88/213.12  |- mesh__recordAuthorizer mesh__D003610 PLS
% 212.88/213.12  |- mesh__recordOriginator mesh__D016538 AGS
% 212.88/213.12  |- skos__hiddenLabel mesh__D016538 Mucopolysaccharidosis VIIs
% 212.88/213.12  |- mesh__dateRevised mesh__D016538 2001-07-25
% 212.88/213.12  |- skos__scopeNote mesh__D016538
% 212.88/213.12       Mucopolysaccharidosis characterized by excessive dermatan and heparan sulfates in the urine and Hurler-like features. It is caused by a deficiency of beta-glucuronidase.%A%    
% 212.88/213.12  |- skos__hiddenLabel mesh__D016538 Disease, Sly
% 212.88/213.12  |- mesh__recordMaintainer mesh__D016538 nns
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D016538 2006
% 212.88/213.12  |- mesh__recordAuthorizer mesh__D016538 sjn
% 212.88/213.12  |- mesh__dateEstablished mesh__D016538 1992-01-01
% 212.88/213.12  |- skos__prefLabel mesh__D016538 Mucopolysaccharidosis VII
% 212.88/213.12  |- mesh__dateCreated mesh__D016538 1991-06-21
% 212.88/213.12  |- rdf__type mesh__D016538sskos__Concept
% 212.88/213.12  |- skos__hiddenLabel mesh__D016538 VIIs, Mucopolysaccharidosis
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D016538 2002
% 212.88/213.12  |- skos__altLabel mesh__D016538 Mucopolysaccharidosis 7
% 212.88/213.12  |- mesh__publicMeSHNote mesh__D016538 92   
% 212.88/213.12  |- skos__annotation mesh__D016538
% 212.88/213.12       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: MPS VII%A%  
% 212.88/213.12  |- skos__broader mesh__D016538smesh__D009083
% 212.88/213.12  |- skos__hiddenLabel mesh__D016538 Syndrome, Sly
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D016538 2003
% 212.88/213.12  |- skos__altLabel mesh__D016538 Sly Disease
% 212.88/213.12  |- skos__altLabel mesh__D016538 Sly Syndrome
% 212.88/213.12  |- skos__historyNote mesh__D016538 Mucopolysaccharidoses %28%1974-1991%29%
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D016538 2005
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D016538 2004
% 212.88/213.12  |- mesh__historyNote mesh__D016538 92   
% 212.88/213.12  |- skos__historyNote mesh__D002518 Amino Alcohols %28%1966-1971%29%
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D002518 2006
% 212.88/213.12  |- mesh__recordMaintainer mesh__D002518 ssb
% 212.88/213.12  |- mesh__dateRevised mesh__D002518 2004-07-07
% 212.88/213.12  |- mesh__dateCreated mesh__D002518 1999-01-01
% 212.88/213.12  |- mesh__dateEstablished mesh__D002518 1972-01-01
% 212.88/213.12  |- skos__broader mesh__D002518smesh__D020383
% 212.88/213.12  |- rdf__type mesh__D002518sskos__Concept
% 212.88/213.12  |- skos__historyNote mesh__D002518 Glycols %28%1966-1971%29%
% 212.88/213.12  |- mesh__recordOriginator mesh__D002518 NLM
% 212.88/213.12  |- skos__scopeNote mesh__D002518
% 212.88/213.12       Members of the class of neutral glycosphingolipids. They are the basic units of SPHINGOLIPIDS. They are sphingoids attached via their amino groups to a long chain fatty acyl group. They abnormally accumulate in FABRY DISEASE.%A%    
% 212.88/213.12  |- skos__prefLabel mesh__D002518 Ceramides
% 212.88/213.12  |- skos__historyNote mesh__D002518 Fatty Acids %28%1966-1971%29%
% 212.88/213.12  |- mesh__recordAuthorizer mesh__D002518 sjn
% 212.88/213.12  |- mesh__publicMeSHNote mesh__D002518 72   
% 212.88/213.12  |- mesh__historyNote mesh__D002518 72   
% 212.88/213.12  |- skos__related mesh__D002518smesh__D000795
% 212.88/213.12  |- skos__annotation mesh__D002518
% 212.88/213.12       carbohydrate ceramides: index under CEREBROSIDES %28%one carbohydrate group%29% or GLYCOSPHINGOLIPIDS %28%more than one carbohydrate group%29%%A%  
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D002518 2005
% 212.88/213.12  |- mesh__dateCreated mesh__D013240 1980-05-14
% 212.88/213.12  |- mesh__dateEstablished mesh__D013240 1981-01-01
% 212.88/213.12  |- mesh__publicMeSHNote mesh__D013240
% 212.88/213.12       81;STIGMATIZATION was see CHRISTIANITY 1982-1996   
% 212.88/213.12  |- skos__scopeNote mesh__D013240
% 212.88/213.12       An oversimplified perception or conception especially of persons, social groups, etc.%A%    
% 212.88/213.12  |- mesh__historyNote mesh__D013240
% 212.88/213.12       81;STIGMATIZATION was see CHRISTIANITY 1982-1996   
% 212.88/213.12  |- skos__broader mesh__D013240smesh__D012919
% 212.88/213.12  |- mesh__dateRevised mesh__D013240 2002-07-03
% 212.88/213.12  |- mesh__onlineNote mesh__D013240
% 212.88/213.12       use CHRISTIANITY to search STIGMATIZATION 1982-96   
% 212.88/213.12  |- mesh__recordAuthorizer mesh__D013240 sjn
% 212.88/213.12  |- rdf__type mesh__D013240sskos__Concept
% 212.88/213.12  |- skos__historyNote mesh__D013240 Stereotyped Behavior %28%1973-1980%29%
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D013240 2004
% 212.88/213.12  |- skos__annotation mesh__D013240
% 212.88/213.12       no qualif; includes both person using stereotype thinking %26% person or group being stereotyped; do not confuse with STEREOTYPED BEHAVIOR: read MeSH definition%A%  
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D013240 2006
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D013240 2003
% 212.88/213.12  |- skos__prefLabel mesh__D013240 Stereotyping
% 212.88/213.12  |- mesh__recordOriginator mesh__D013240 EC
% 212.88/213.12  |- mesh__recordMaintainer mesh__D013240 JLS
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D013240 2005
% 212.88/213.12  |- mesh__dateCreated mesh__D007203 1974-11-19
% 212.88/213.12  |- mesh__historyNote mesh__D007203 2002%28%1975%29%   
% 212.88/213.12  |- skos__hiddenLabel mesh__D007203 Indigo Blue, Soluble
% 212.88/213.12  |- skos__altLabel mesh__D007203 Soluble Indigo Blue
% 212.88/213.12  |- skos__hiddenLabel mesh__D007203 Blue, Indigo
% 212.88/213.12  |- skos__historyNote mesh__D007203 Indoles %28%1969-1974%29%
% 212.88/213.12  |- mesh__dateRevised mesh__D007203 2005-06-30
% 212.88/213.12  |- skos__hiddenLabel mesh__D007203 Blue, Soluble Indigo
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D007203 2006
% 212.88/213.12  |- skos__altLabel mesh__D007203 Indigo Disulfonate
% 212.88/213.12  |- skos__prefLabel mesh__D007203 Indigotindisulfonate Sodium
% 212.88/213.12  |- mesh__recordAuthorizer mesh__D007203 sjn
% 212.88/213.12  |- skos__altLabel mesh__D007203 Indigo Carmine
% 212.88/213.12  |- mesh__publicMeSHNote mesh__D007203
% 212.88/213.12       2002; see INDIGO CARMINE 1976-2001, see INDOLES 1975-1990%A%  
% 212.88/213.12  |- skos__scopeNote mesh__D007203
% 212.88/213.12       An indolesulfonic acid that is used as a dye in renal function testing and as a reagent for the detection of nitrates and chlorates and in the testing of milk.%A%    
% 212.88/213.12  |- skos__broader mesh__D007203smesh__D007211
% 212.88/213.12  |- mesh__dateEstablished mesh__D007203 1991-01-01
% 212.88/213.12  |- mesh__recordMaintainer mesh__D007203 jmp
% 212.88/213.12  |- skos__historyNote mesh__D007203 Sulfonic Acids %28%1969-1974%29%
% 212.88/213.12  |- rdf__type mesh__D007203sskos__Concept
% 212.88/213.12  |- skos__hiddenLabel mesh__D007203 Disulfonate, Indigo
% 212.88/213.12  |- mesh__recordOriginator mesh__D007203 NLM
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D012946 2002
% 212.88/213.12  |- skos__altLabel mesh__D012946 Community Services
% 212.88/213.12  |- skos__scopeNote mesh__D012946
% 212.88/213.12       Organized institutions which provide services to ameliorate conditions of need or social pathology in the community.%A%    
% 212.88/213.12  |- mesh__dateCreated mesh__D012946 1999-01-01
% 212.88/213.12  |- mesh__recordAuthorizer mesh__D012946 sjn
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D012946 2005
% 212.88/213.12  |- skos__annotation mesh__D012946 specify geog if pertinent   
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D012946 2003
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D012946 2006
% 212.88/213.12  |- mesh__dateRevised mesh__D012946 2001-07-25
% 212.88/213.12  |- mesh__recordOriginator mesh__D012946 NLM
% 212.88/213.12  |- mesh__activeMeSHYear mesh__D012946 2004
% 212.88/213.12  |- mesh__recordMaintainer mesh__D012946 jrf
% 212.88/213.12  |- rdf__type mesh__D012946sskos__Concept
% 212.88/213.12  |- skos__broader mesh__D012946smesh__D012961
% 212.88/213.12  |- skos__hiddenLabel mesh__D012946 Community Service
% 212.88/213.12  |- skos__hiddenLabel mesh__D012946 Welfare, Social
% 212.88/213.12  |- skos__hiddenLabel mesh__D012946 Service, Community
% 212.88/213.12  |- skos__prefLabel mesh__D012946 Social Welfare
% 212.88/213.12  |- skos__altLabel mesh__D045322 Plant Photosynthetic Reaction Center
% 212.88/213.12  |- mesh__historyNote mesh__D045322 2004   
% 212.88/213.12  |- skos__altLabel mesh__D045322 Plant Photosynthetic Protein Complexes
% 212.88/213.12  |- mesh__recordOriginator mesh__D045322 jmp
% 212.88/213.12  |- skos__broader mesh__D045322smesh__D011506
% 212.88/213.12  |- skos__historyNote mesh__D045322 Plant Proteins %28%1966-2003%29%
% 212.88/213.12  |- skos__altLabel mesh__D045322 Reaction Center Protein, Plant
% 212.88/213.12  |- skos__altLabel mesh__D045322
% 212.88/213.12       Photosynthetic Pigment-Protein Complexes, Bacterial
% 212.88/213.12  |- mesh__dateEstablished mesh__D045322 2004-01-01
% 212.88/213.12  |- mesh__publicMeSHNote mesh__D045322
% 212.88/213.12       2004; for PHOTOSYNTHETIC REACTION CENTER, BACTERIAL see PHOTOSYNTHETIC REACTION CENTER, BACTERIAL 1991-2003; for PHOTOSYNTHETIC REACTION CENTER, PLANT see PHOTOSYNTHETIC REACTION CENTER, PLANT 1991-2003%A%  
% 212.88/213.12  |- skos__hiddenLabel mesh__D045322 Reaction Centers, Photosynthetic
% 212.88/213.12  |- skos__hiddenLabel mesh__D045322 Complexes, Photosynthetic
% 212.88/213.12  |- skos__altLabel mesh__D045322 Photochemical Reaction Center, Plant
% 212.88/213.12  |- skos__altLabel mesh__D045322 Photoreceptors, Plant
% 212.88/213.12  |- mesh__dateCreated mesh__D045322 2003-07-09
% 212.88/213.12  |- skos__hiddenLabel mesh__D045322
% 212.88/213.12       Photosynthetic Pigment Protein Complexes, Bacterial
% 212.88/213.12  |- skos__altLabel mesh__D045322 Reaction Center Protein, Bacterial
% 212.98/213.12  |- skos__altLabel mesh__D045322 Photosynthetic Reaction Centers, Bacterial
% 212.98/213.12  |- mesh__recordAuthorizer mesh__D045322 sjn
% 212.98/213.12  |- rdf__type mesh__D045322sskos__Concept
% 212.98/213.12  |- skos__related mesh__D045322smesh__D020524
% 212.98/213.12  |- skos__altLabel mesh__D045322 Plant Photoreceptors
% 212.98/213.12  |- mesh__activeMeSHYear mesh__D045322 2006
% 212.98/213.12  |- skos__altLabel mesh__D045322 Bacterial Photosynthetic Reaction Center
% 212.98/213.12  |- mesh__recordMaintainer mesh__D045322 SYSTEM
% 212.98/213.12  |- skos__scopeNote mesh__D045322
% 212.98/213.12       Protein complexes that take part in the process of PHOTOSYNTHESIS. They are found in the THYLAKOID MEMBRANES of PLANTS and other photosynthetic organisms. There are two major complexes involved in the photosynthetic process called PHOTOSYSTEM I and PHOTOSYSTEM II.%A%    
% 212.98/213.12  |- skos__broader mesh__D045322smesh__D009097
% 212.98/213.12  |- skos__altLabel mesh__D045322 Photochemical Reaction Center, Bacterial
% 212.98/213.12  |- mesh__dateRevised mesh__D045322 2005-06-30
% 212.98/213.12  |- skos__prefLabel mesh__D045322
% 212.98/213.12       Photosynthetic Reaction Center Complex Proteins
% 212.98/213.12  |- skos__historyNote mesh__D045322 Chlorophyll %28%1966-1990%29%
% 212.98/213.12  |- skos__hiddenLabel mesh__D012148 Syndrome, Ekbom
% 212.98/213.12  |- mesh__activeMeSHYear mesh__D012148 2004
% 212.98/213.12  |- mesh__dateCreated mesh__D012148 1999-01-01
% 212.98/213.12  |- mesh__activeMeSHYear mesh__D012148 2005A
% 212.98/213.12  |- mesh__activeMeSHYear mesh__D012148 2001
% 212.98/213.12  |- mesh__activeMeSHYear mesh__D012148 2003
% 212.98/213.12  |- skos__altLabel mesh__D012148 Restless Legs
% 212.98/213.12  |- mesh__dateRevised mesh__D012148 2005-07-13
% 212.98/213.12  |- mesh__activeMeSHYear mesh__D012148 2000
% 212.98/213.12  |- mesh__publicMeSHNote mesh__D012148 2000; see Restless Legs 1973-1999   
% 212.98/213.12  |- mesh__activeMeSHYear mesh__D012148 2000A
% 212.98/213.12  |- mesh__activeMeSHYear mesh__D012148 2006
% 212.98/213.12  |- skos__altLabel mesh__D012148 Ekbom%27%s Syndrome
% 212.98/213.12  |- mesh__recordOriginator mesh__D012148 NLM
% 212.98/213.12  |- mesh__recordMaintainer mesh__D012148 ags
% 212.98/213.12  |- rdf__type mesh__D012148sskos__Concept
% 212.98/213.12  |- skos__scopeNote mesh__D012148
% 212.98/213.12       A disorder characterized by aching or burning sensations in the lower and rarely the upper extremities that occur prior to sleep or may awaken the patient from sleep. Complying with an irresistible urge to move the affected limbs brings temporary relief. Sleep may become disrupted, resulting in excessive daytime hypersomnolence. This condition may be associated with UREMIA; DIABETES MELLITUS; and rheumatoid arthritis. Restless Legs Syndrome differs from NOCTURNAL MYOCLONUS SYNDROME in that in the latter condition the individual does not report adverse sensory stimuli and it is primarily a sleep-associated movement disorder. %28%Adams et al., Principles of Neurology, 6th ed, p387; Schweiz Rundsch Med Prax 1997 Apr 30;86%28%18%29%:732-736%29%%A%    
% 212.98/213.12  |- skos__broader mesh__D012148smesh__D020919
% 212.98/213.12  |- mesh__activeMeSHYear mesh__D012148 2006A
% 212.98/213.12  |- mesh__activeMeSHYear mesh__D012148 2005
% 212.98/213.12  |- mesh__activeMeSHYear mesh__D012148 2005B
% 212.98/213.12  |- skos__prefLabel mesh__D012148 Restless Legs Syndrome
% 212.98/213.12  |- skos__broader mesh__D012148smesh__D020447
% 212.98/213.12  |- skos__hiddenLabel mesh__D012148 Syndrome, Ekbom%27%s
% 212.98/213.12  |- skos__historyNote mesh__D012148 Paresthesia %28%1966-1972%29%
% 212.98/213.12  |- skos__altLabel mesh__D012148 Ekbom Syndrome
% 212.98/213.12  |- mesh__historyNote mesh__D012148 2000%28%1973%29%   
% 212.98/213.12  |- mesh__activeMeSHYear mesh__D012148 2002
% 212.98/213.12  |- mesh__recordAuthorizer mesh__D012148 ags
% 212.98/213.12  |- skos__hiddenLabel mesh__D012148 Ekboms Syndrome
% 212.98/213.12  |- mesh__dateEstablished mesh__D012148 1973-01-01
% 212.98/213.12  |- skos__altLabel mesh__D006909 Oxyproline
% 212.98/213.12  |- skos__hiddenLabel mesh__D006909 cis 4 Hydroxyproline
% 212.98/213.12  |- skos__broader mesh__D006909smesh__D011392
% 212.98/213.12  |- skos__scopeNote mesh__D006909
% 212.98/213.12       A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.%A%    
% 212.98/213.12  |- skos__hiddenLabel mesh__D006909 4 Hydroxyproline
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D006909 2004
% 212.98/213.13  |- rdf__type mesh__D006909sskos__Concept
% 212.98/213.13  |- mesh__dateRevised mesh__D006909 2000-06-22
% 212.98/213.13  |- mesh__dateCreated mesh__D006909 1999-01-01
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D006909 2002
% 212.98/213.13  |- mesh__recordMaintainer mesh__D006909 adp
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D006909 2005
% 212.98/213.13  |- skos__prefLabel mesh__D006909 Hydroxyproline
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D006909 2006
% 212.98/213.13  |- mesh__recordOriginator mesh__D006909 NLM
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D006909 2003
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D006909 2001
% 212.98/213.13  |- mesh__recordAuthorizer mesh__D006909 sjn
% 212.98/213.13  |- mesh__publicMeSHNote mesh__D031302 2003   
% 212.98/213.13  |- rdf__type mesh__D031302sskos__Concept
% 212.98/213.13  |- skos__scopeNote mesh__D031302
% 212.98/213.13       A plant genus of the family FABACEAE that is a source of SPARTEINE. Do not confuse with Broom or Scotch Broom %28%CYTISUS%29% or Butcher%27%s Broom %28%RUSCUS%29% or Desert Broom %28%BACCHARIS%29% or Brome %28%BROMUS%29%.%A%    
% 212.98/213.13  |- skos__altLabel mesh__D031302 Broom, Spanish
% 212.98/213.13  |- mesh__dateEstablished mesh__D031302 2003-01-01
% 212.98/213.13  |- mesh__historyNote mesh__D031302 2003   
% 212.98/213.13  |- skos__broader mesh__D031302smesh__D007887
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D031302 2005
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D031302 2003
% 212.98/213.13  |- skos__annotation mesh__D031302
% 212.98/213.13       X ref BROOM, SPANISH: several other Broom terms are also available; check text and MeSH; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D031302 2006
% 212.98/213.13  |- mesh__dateCreated mesh__D031302 2002-07-02
% 212.98/213.13  |- skos__prefLabel mesh__D031302 Spartium
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D031302 2004
% 212.98/213.13  |- rdf__type mesh__D003611sskos__Concept
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D003611 2003
% 212.98/213.13  |- skos__prefLabel mesh__D003611 Dairy Products
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D003611 1999
% 212.98/213.13  |- skos__scopeNote mesh__D003611
% 212.98/213.13       Raw and processed or manufactured milk and milk-derived products. These are usually from cows %28%bovine%29% but are also from goats, sheep, reindeer, and water buffalo.%A%    
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D003611 2004
% 212.98/213.13  |- skos__broader mesh__D003611smesh__D005502
% 212.98/213.13  |- skos__hiddenLabel mesh__D003611 Product, Dairy
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D003611 2005
% 212.98/213.13  |- mesh__recordOriginator mesh__D003611 NLM
% 212.98/213.13  |- mesh__dateCreated mesh__D003611 1999-01-01
% 212.98/213.13  |- skos__annotation mesh__D003611 GEN or unspecified; prefer specifics   
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D003611 2006
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D003611 2000
% 212.98/213.13  |- mesh__recordMaintainer mesh__D003611 JLS
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D003611 2001
% 212.98/213.13  |- mesh__recordAuthorizer mesh__D003611 SJN
% 212.98/213.13  |- skos__hiddenLabel mesh__D003611 Dairy Product
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D003611 2002
% 212.98/213.13  |- skos__hiddenLabel mesh__D003611 Products, Dairy
% 212.98/213.13  |- mesh__dateRevised mesh__D003611 1997-06-20
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D003611 1998
% 212.98/213.13  |- skos__broader mesh__D019905Q000031smesh__D019905
% 212.98/213.13  |- mesh__preferredCombination mesh__D019905Q000031smesh__D001592
% 212.98/213.13  |- rdf__type mesh__D019905Q000031smesh__CompoundConcept
% 212.98/213.13  |- skos__hiddenLabel mesh__D016539 Sternberg Reed Cells
% 212.98/213.13  |- mesh__recordMaintainer mesh__D016539 TPW
% 212.98/213.13  |- mesh__recordOriginator mesh__D016539 JHM
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D016539 2003
% 212.98/213.13  |- mesh__recordAuthorizer mesh__D016539 SJN
% 212.98/213.13  |- skos__prefLabel mesh__D016539 Reed-Sternberg Cells
% 212.98/213.13  |- mesh__dateEstablished mesh__D016539 1992-01-01
% 212.98/213.13  |- mesh__historyNote mesh__D016539 92   
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D016539 2002
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D016539 1999
% 212.98/213.13  |- mesh__dateRevised mesh__D016539 1997-06-20
% 212.98/213.13  |- skos__broader mesh__D016539smesh__D002477
% 212.98/213.13  |- skos__hiddenLabel mesh__D016539 Cells, Reed-Sternberg
% 212.98/213.13  |- mesh__dateCreated mesh__D016539 1991-02-11
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D016539 2006
% 212.98/213.13  |- skos__hiddenLabel mesh__D016539 Cells, Sternberg-Reed
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D016539 1998
% 212.98/213.13  |- rdf__type mesh__D016539sskos__Concept
% 212.98/213.13  |- skos__annotation mesh__D016539 in Hodgkin%27%s dis; A 11 qualif   
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D016539 2005
% 212.98/213.13  |- skos__scopeNote mesh__D016539
% 212.98/213.13       Large cells of unknown origin, usually multinucleate, whose presence is the common histologic characteristic of HODGKIN DISEASE.%A%    
% 212.98/213.13  |- skos__historyNote mesh__D016539
% 212.98/213.13       Hodgkin%27%s Disease/pathology %28%1966-1991%29%
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D016539 2001
% 212.98/213.13  |- skos__hiddenLabel mesh__D016539 Reed Sternberg Cells
% 212.98/213.13  |- skos__altLabel mesh__D016539 Sternberg-Reed Cells
% 212.98/213.13  |- skos__related mesh__D016539smesh__D006689
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D016539 2000
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D016539 2004
% 212.98/213.13  |- mesh__publicMeSHNote mesh__D016539 92   
% 212.98/213.13  |- skos__hiddenLabel mesh__D027261 4F2 Antigen, Human
% 212.98/213.13  |- mesh__recordAuthorizer mesh__D027261 ags
% 212.98/213.13  |- skos__hiddenLabel mesh__D027261 Regulatory Protein-1, Fusion
% 212.98/213.13  |- mesh__publicMeSHNote mesh__D027261
% 212.98/213.13       2002; ANTIGEN 4F2 %28%now ANTIGENS, CD98%29% was indexed under CARRIER PROTEINS 1996-2001, under ANTIGENS CD 1996-2001, %26% under ANTIGENS, SURFACE 1989-1995%A%  
% 212.98/213.13  |- skos__broader mesh__D027261smesh__D027241
% 212.98/213.13  |- skos__hiddenLabel mesh__D027261 Fusion Regulatory Protein 1
% 212.98/213.13  |- skos__altLabel mesh__D027261 FRP-1 protein
% 212.98/213.13  |- mesh__dateRevised mesh__D027261 2005-07-12
% 212.98/213.13  |- skos__hiddenLabel mesh__D027261 Antigen, CD98
% 212.98/213.13  |- skos__hiddenLabel mesh__D027261 Human 4F2 Cell Surface Antigen
% 212.98/213.13  |- skos__altLabel mesh__D027261 Antigen 4F2
% 212.98/213.13  |- mesh__recordOriginator mesh__D027261 jmp
% 212.98/213.13  |- skos__prefLabel mesh__D027261 Antigens, CD98
% 212.98/213.13  |- skos__broader mesh__D027261smesh__D015703
% 212.98/213.13  |- skos__altLabel mesh__D027261 Fusion Regulatory Protein-1
% 212.98/213.13  |- skos__altLabel mesh__D027261 CD98 Antigens
% 212.98/213.13  |- skos__historyNote mesh__D027261 Carrier Proteins %28%1996-2001%29%
% 212.98/213.13  |- skos__altLabel mesh__D027261 Human Lymphocyte Activation Antigen 4F2
% 212.98/213.13  |- rdf__type mesh__D027261sskos__Concept
% 212.98/213.13  |- skos__historyNote mesh__D027261 Antigens, Surface %28%1989-1995%29%
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D027261 2006
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D027261 2006A
% 212.98/213.13  |- skos__altLabel mesh__D027261 Human 4F2 Cell-Surface Antigen
% 212.98/213.13  |- skos__broader mesh__D027261smesh__D027062
% 212.98/213.13  |- skos__altLabel mesh__D027261 4F2 Antigen
% 212.98/213.13  |- mesh__recordMaintainer mesh__D027261 ags
% 212.98/213.13  |- skos__altLabel mesh__D027261 CD98 Antigen
% 212.98/213.13  |- skos__scopeNote mesh__D027261
% 212.98/213.13       A heterodimeric protein that is a cell surface antigen associated with lymphocyte activation. The initial characterization of this protein revealed one identifiable heavy chain %28%ANTIGENS, CD98 HEAVY CHAIN%29% and an indeterminate smaller light chain. It is now known that a variety of light chain subunits %28%ANTIGENS, CD98 LIGHT CHAINS%29% can dimerize with the heavy chain.  Depending upon its light chain composition a diverse array of functions can be found for this protein. Functions include: type L amino acid transport, type y+L amino acid transport and regulation of cellular fusion.%A%    
% 212.98/213.13  |- skos__historyNote mesh__D027261 Antigens, CD %28%1996-2001%29%
% 212.98/213.13  |- mesh__dateEstablished mesh__D027261 2002-01-01
% 212.98/213.13  |- skos__altLabel mesh__D027261 H4F2 Antigen
% 212.98/213.13  |- skos__altLabel mesh__D027261 CD98 Transport Proteins
% 212.98/213.13  |- skos__hiddenLabel mesh__D027261 FRP 1 protein
% 212.98/213.13  |- mesh__dateCreated mesh__D027261 2001-07-25
% 212.98/213.13  |- skos__altLabel mesh__D027261 4F2-antigen
% 212.98/213.13  |- mesh__historyNote mesh__D027261
% 212.98/213.13       2002; use ANTIGENS, CD98 %28%NM%29% 1988-2001   
% 212.98/213.13  |- mesh__onlineNote mesh__D002519
% 212.98/213.13       use CERATOPOGONIDAE to search CULICOIDES 1966-80; search MIDGES under DIPTERA 1975-80%A%  
% 212.98/213.13  |- rdf__type mesh__D002519sskos__Concept
% 212.98/213.13  |- skos__scopeNote mesh__D002519
% 212.98/213.13       A family of biting midges, in the order DIPTERA. It includes the genus Culicoides which transmits filarial parasites pathogenic to man and other primates.%A%    
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D002519 2004
% 212.98/213.13  |- skos__broader mesh__D002519smesh__D004175
% 212.98/213.13  |- skos__annotation mesh__D002519
% 212.98/213.13       do not confuse X ref CULICOIDES with CULEX, mosquito; do not use /drug eff for insecticides: TN 111; gall midges: index under DIPTERA%A%  
% 212.98/213.13  |- mesh__dateRevised mesh__D002519 2003-07-09
% 212.98/213.13  |- mesh__historyNote mesh__D002519
% 212.98/213.13       81; was see CULICOIDES 1975-80; CULICOIDES was heading 1963-80; MIDGES was see under DIPTERA 1975-80%A%  
% 212.98/213.13  |- mesh__recordOriginator mesh__D002519 NLM
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D002519 2005
% 212.98/213.13  |- mesh__publicMeSHNote mesh__D002519
% 212.98/213.13       81; was see CULICOIDES 1975-80; CULICOIDES was heading 1963-80; MIDGES was see under DIPTERA 1975-80%A%  
% 212.98/213.13  |- skos__prefLabel mesh__D002519 Ceratopogonidae
% 212.98/213.13  |- mesh__recordAuthorizer mesh__D002519 sjn
% 212.98/213.13  |- skos__altLabel mesh__D002519 Midges, Biting
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D002519 2006
% 212.98/213.13  |- mesh__recordMaintainer mesh__D002519 ags
% 212.98/213.13  |- mesh__dateCreated mesh__D002519 1999-01-01
% 212.98/213.13  |- mesh__dateEstablished mesh__D013241 1991-01-01
% 212.98/213.13  |- mesh__historyNote mesh__D013241
% 212.98/213.13       91%28%75%29%; was see under XANTHENES 1975-90   
% 212.98/213.13  |- skos__historyNote mesh__D013241 Furans %28%1973-1974%29%
% 212.98/213.13  |- mesh__dateCreated mesh__D013241 1974-11-11
% 212.98/213.13  |- skos__scopeNote mesh__D013241
% 212.98/213.13       A carcinogenic mycotoxin produced in high yields by strains of the common molds, Aspergillus versicolor, A. nidulans, and an unidentified species of Bipolaris. It causes necrosis of the liver and kidney and has an inhibitory effect on orotic acid incorporation into nuclear RNA.%A%    
% 212.98/213.13  |- rdf__type mesh__D013241sskos__Concept
% 212.98/213.13  |- mesh__dateRevised mesh__D013241 2005-06-30
% 212.98/213.13  |- mesh__recordOriginator mesh__D013241 NLM
% 212.98/213.13  |- skos__historyNote mesh__D013241 Xanthenes %28%1969-1974%29%
% 212.98/213.13  |- skos__broader mesh__D013241smesh__D009183
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D013241 2006
% 212.98/213.13  |- skos__annotation mesh__D013241
% 212.98/213.13       /antag permitted but consider also ANTITOXINS;   
% 212.98/213.13  |- mesh__publicMeSHNote mesh__D013241
% 212.98/213.13       91; was see under XANTHENES 1975-90   
% 212.98/213.13  |- mesh__recordMaintainer mesh__D013241 ssb
% 212.98/213.13  |- skos__prefLabel mesh__D013241 Sterigmatocystin
% 212.98/213.13  |- skos__broader mesh__D013241smesh__D044004
% 212.98/213.13  |- mesh__recordAuthorizer mesh__D013241 sjn
% 212.98/213.13  |- rdf__type mesh__D007204sskos__Concept
% 212.98/213.13  |- skos__prefLabel mesh__D007204 Indium
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007204 2002
% 212.98/213.13  |- skos__related mesh__D007204smesh__D007205
% 212.98/213.13  |- skos__broader mesh__D007204smesh__D019216
% 212.98/213.13  |- mesh__recordAuthorizer mesh__D007204 SJN
% 212.98/213.13  |- mesh__recordOriginator mesh__D007204 NLM
% 212.98/213.13  |- mesh__recordMaintainer mesh__D007204 ADP
% 212.98/213.13  |- mesh__dateRevised mesh__D007204 1997-06-20
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007204 2006
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007204 2001
% 212.98/213.13  |- mesh__dateCreated mesh__D007204 1999-01-01
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007204 2005
% 212.98/213.13  |- skos__annotation mesh__D007204
% 212.98/213.13       In-115; In-113 = INDIUM %28%IM%29% + ISOTOPES %28%NIM%29% but In-113m = INDIUM RADIOISOTOPES %28%IM%29%; In-106-112, 114, 116-124 = INDIUM RADIOISOTOPES %28%IM%29%%A%  
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007204 2004
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007204 1999
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007204 2000
% 212.98/213.13  |- skos__scopeNote mesh__D007204
% 212.98/213.13       A metallic element, atomic number 49, atomic weight 114.82, symbol In. It is named from its blue line in the spectrum. %28%From Dorland, 28th ed%29%%A%    
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007204 2003
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007204 1998
% 212.98/213.13  |- skos__hiddenLabel mesh__D051360 Cyclin Dependent Kinase 5
% 212.98/213.13  |- mesh__recordMaintainer mesh__D051360 DRC
% 212.98/213.13  |- skos__altLabel mesh__D051360 Cdk5 Protein
% 212.98/213.13  |- skos__hiddenLabel mesh__D051360 Cdc2 Related Kinase PSSALRE
% 212.98/213.13  |- skos__altLabel mesh__D051360 Neuronal Cdc2-Like Protein Kinase
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D051360 2006
% 212.98/213.13  |- mesh__dateEstablished mesh__D051360 2006-01-01
% 212.98/213.13  |- skos__altLabel mesh__D051360 Cdk5 Protein Kinase
% 212.98/213.13  |- mesh__dateCreated mesh__D051360 2005-06-30
% 212.98/213.13  |- mesh__recordOriginator mesh__D051360 DRC
% 212.98/213.13  |- mesh__historyNote mesh__D051360 2006%28%1994%29%   
% 212.98/213.13  |- skos__altLabel mesh__D051360 Cdc2-Related Kinase PSSALRE
% 212.98/213.13  |- skos__prefLabel mesh__D051360 Cyclin-Dependent Kinase 5
% 212.98/213.13  |- skos__scopeNote mesh__D051360
% 212.98/213.13       A serine-threonine kinase that plays important roles in CELL DIFFERENTIATION; CELL MIGRATION; and CELL DEATH of NERVE CELLS. It is closely related to other CYCLIN-DEPENDENT KINASES but does not seem to participate in CELL CYCLE regulation.%A%    
% 212.98/213.13  |- skos__hiddenLabel mesh__D051360 PSSALRE, Cdc2-Related Kinase
% 212.98/213.13  |- skos__hiddenLabel mesh__D051360 Protein Kinase, Cdk5
% 212.98/213.13  |- skos__altLabel mesh__D051360 PSSALRE Protein
% 212.98/213.13  |- mesh__recordAuthorizer mesh__D051360 sjn
% 212.98/213.13  |- skos__broader mesh__D051360smesh__D042846
% 212.98/213.13  |- rdf__type mesh__D051360sskos__Concept
% 212.98/213.13  |- skos__hiddenLabel mesh__D051360 Neuronal Cdc2 Like Protein Kinase
% 212.98/213.13  |- mesh__publicMeSHNote mesh__D051360
% 212.98/213.13       2006; CYCLIN-DEPENDENT KINASE 5 was indexed under CYCLIN-DEPENDENT KINASES 2000-2005, %26% under PROTEIN-SERINE-THREONINE KINASES 1995-1999, %26% under PROTEIN KINASES 1993-1994%A%  
% 212.98/213.13  |- mesh__dateCreated mesh__D012947 1999-01-01
% 212.98/213.13  |- mesh__recordMaintainer mesh__D012947 kle
% 212.98/213.13  |- skos__broader mesh__D012947smesh__D006296
% 212.98/213.13  |- skos__related mesh__D012947smesh__D003153
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D012947 2000
% 212.98/213.13  |- skos__hiddenLabel mesh__D012947 Worker, Social
% 212.98/213.13  |- skos__hiddenLabel mesh__D012947 Social Services
% 212.98/213.13  |- skos__hiddenLabel mesh__D012947 Social Worker
% 212.98/213.13  |- mesh__historyNote mesh__D012947 78; was SOCIAL SERVICE 1963-77   
% 212.98/213.13  |- skos__annotation mesh__D012947 SPEC: SPEC qualif   
% 212.98/213.13  |- mesh__dateRevised mesh__D012947 1999-11-03
% 212.98/213.13  |- skos__hiddenLabel mesh__D012947 Work, Social
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D012947 2004
% 212.98/213.13  |- skos__related mesh__D012947smesh__D012066
% 212.98/213.13  |- mesh__onlineNote mesh__D012947
% 212.98/213.13       use SOCIAL WORK to search SOCIAL SERVICE 1966-77   
% 212.98/213.13  |- skos__prefLabel mesh__D012947 Social Work
% 212.98/213.13  |- mesh__publicMeSHNote mesh__D012947 78; was SOCIAL SERVICE 1963-77   
% 212.98/213.13  |- mesh__recordAuthorizer mesh__D012947 sjn
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D012947 2006
% 212.98/213.13  |- skos__altLabel mesh__D012947 Social Service
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D012947 2003
% 212.98/213.13  |- skos__altLabel mesh__D012947 Service, Social
% 212.98/213.13  |- skos__hiddenLabel mesh__D012947 Services, Social
% 212.98/213.13  |- skos__broader mesh__D012947smesh__D012961
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D012947 2002
% 212.98/213.13  |- skos__hiddenLabel mesh__D012947 Workers, Social
% 212.98/213.13  |- rdf__type mesh__D012947sskos__Concept
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D012947 2005
% 212.98/213.13  |- mesh__recordOriginator mesh__D012947 NLM
% 212.98/213.13  |- skos__scopeNote mesh__D012947
% 212.98/213.13       The use of community resources, individual case work, or group work to promote the adaptive capacities of individuals in relation to their social and economic environments. It includes social service agencies.%A%    
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D012947 2001
% 212.98/213.13  |- skos__historyNote mesh__D012149 Immobilization %28%1966-1976%29%
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D012149 2006
% 212.98/213.13  |- rdf__type mesh__D012149sskos__Concept
% 212.98/213.13  |- mesh__recordMaintainer mesh__D012149 nns
% 212.98/213.13  |- skos__broader mesh__D012149smesh__D032763
% 212.98/213.13  |- mesh__recordAuthorizer mesh__D012149 sjn
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D012149 2005
% 212.98/213.13  |- skos__historyNote mesh__D012149 Stress %28%1966-1976%29%
% 212.98/213.13  |- skos__hiddenLabel mesh__D012149 Physical Restraints
% 212.98/213.13  |- mesh__dateRevised mesh__D012149 2004-07-07
% 212.98/213.13  |- skos__scopeNote mesh__D012149
% 212.98/213.13       Use of a device for the purpose of controlling movement of all or part of the body. Splinting and casting are FRACTURE FIXATION.%A%    
% 212.98/213.13  |- skos__related mesh__D012149smesh__D011482
% 212.98/213.13  |- skos__historyNote mesh__D012149 Protective Devices %28%1970-1976%29%
% 212.98/213.13  |- mesh__recordOriginator mesh__D012149 SMH
% 212.98/213.13  |- skos__annotation mesh__D012149
% 212.98/213.13       human and animal: NIM with no qualif for restraint of animals in experimental stress states; do not confuse with IMMOBILIZATION: if in doubt use word of text%A%  
% 212.98/213.13  |- skos__prefLabel mesh__D012149 Restraint, Physical
% 212.98/213.13  |- mesh__dateCreated mesh__D012149 1976-05-19
% 212.98/213.13  |- skos__altLabel mesh__D012149 Immobilization, Physical
% 212.98/213.13  |- skos__broader mesh__D012149smesh__D007103
% 212.98/213.13  |- mesh__publicMeSHNote mesh__D012149 1977   
% 212.98/213.13  |- mesh__historyNote mesh__D012149 1977   
% 212.98/213.13  |- skos__altLabel mesh__D012149 Physical Restraint
% 212.98/213.13  |- mesh__dateEstablished mesh__D012149 1977-01-01
% 212.98/213.13  |- skos__hiddenLabel mesh__D012149 Restraints, Physical
% 212.98/213.13  |- skos__related mesh__D012149smesh__D007103
% 212.98/213.13  |- skos__hiddenLabel mesh__D012149 Physical Immobilization
% 212.98/213.13  |- skos__historyNote mesh__D017632 Asbestos %28%1969-1993%29%
% 212.98/213.13  |- mesh__dateEstablished mesh__D017632 1994-01-01
% 212.98/213.13  |- skos__altLabel mesh__D017632 Serpentine %28%Mineral%29%
% 212.98/213.13  |- skos__annotation mesh__D017632
% 212.98/213.13       serpentine refers to the mottled or spotted surface resembling a serpent%27%s skin%A%  
% 212.98/213.13  |- skos__broader mesh__D017632smesh__D001194
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D017632 2002
% 212.98/213.13  |- skos__altLabel mesh__D017632 Serpentine Asbestos
% 212.98/213.13  |- mesh__onlineNote mesh__D017632
% 212.98/213.13       use ASBESTOS, SERPENTINE %28%NM%29% to search CHRYSOTILE 1980-93%A%  
% 212.98/213.13  |- mesh__dateCreated mesh__D017632 1993-06-16
% 212.98/213.13  |- mesh__dateRevised mesh__D017632 2001-07-25
% 212.98/213.13  |- skos__broader mesh__D017632smesh__D017633
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D017632 2004
% 212.98/213.13  |- rdf__type mesh__D017632sskos__Concept
% 212.98/213.13  |- mesh__recordAuthorizer mesh__D017632 sjn
% 212.98/213.13  |- mesh__recordOriginator mesh__D017632 TPW
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D017632 2006
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D017632 2003
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D017632 2005
% 212.98/213.13  |- mesh__recordMaintainer mesh__D017632 jmp
% 212.98/213.13  |- skos__prefLabel mesh__D017632 Asbestos, Serpentine
% 212.98/213.13  |- mesh__publicMeSHNote mesh__D017632
% 212.98/213.13       94; CHRYSOTILE was indexed under ASBESTOS 1974-93   
% 212.98/213.13  |- mesh__historyNote mesh__D017632 94; CHRYSOTILE was %28%NM%29% 1974-93   
% 212.98/213.13  |- skos__scopeNote mesh__D017632
% 212.98/213.13       A type of asbestos that occurs in nature as the dihydrate of magnesium silicate. It exists in two forms: antigorite, a plated variety, and chrysotile, a fibrous variety. The latter makes up 95%25% of all asbestos products. %28%From Merck Index, 11th ed, p.893%29%%A%    
% 212.98/213.13  |- skos__prefLabel mesh__D031303 Sphenostylis
% 212.98/213.13  |- skos__annotation mesh__D031303
% 212.98/213.13       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D031303 2005
% 212.98/213.13  |- mesh__historyNote mesh__D031303 2003   
% 212.98/213.13  |- mesh__publicMeSHNote mesh__D031303 2003   
% 212.98/213.13  |- rdf__type mesh__D031303sskos__Concept
% 212.98/213.13  |- skos__scopeNote mesh__D031303
% 212.98/213.13       A plant genus of the family FABACEAE that contains LECTINS and raffinose oligosaccharides.%A%    
% 212.98/213.13  |- skos__altLabel mesh__D031303 Yam Bean, African
% 212.98/213.13  |- skos__altLabel mesh__D031303 Bean, African Yam
% 212.98/213.13  |- skos__broader mesh__D031303smesh__D007887
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D031303 2004
% 212.98/213.13  |- mesh__dateCreated mesh__D031303 2002-07-02
% 212.98/213.13  |- mesh__dateEstablished mesh__D031303 2003-01-01
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D031303 2006
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D031303 2003
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D003612 2003
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D003612 1999
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D003612 2004
% 212.98/213.13  |- mesh__recordOriginator mesh__D003612 NLM
% 212.98/213.13  |- skos__broader mesh__D003612smesh__D000383
% 212.98/213.13  |- mesh__dateCreated mesh__D003612 1999-01-01
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D003612 2000
% 212.98/213.13  |- skos__annotation mesh__D003612 SPEC: SPEC qualif   
% 212.98/213.13  |- mesh__recordMaintainer mesh__D003612 JLS
% 212.98/213.13  |- skos__prefLabel mesh__D003612 Dairying
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D003612 2005
% 212.98/213.13  |- mesh__recordAuthorizer mesh__D003612 SJN
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D003612 2001
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D003612 2006
% 212.98/213.13  |- mesh__dateRevised mesh__D003612 1997-06-20
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D003612 2002
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D003612 1998
% 212.98/213.13  |- rdf__type mesh__D003612sskos__Concept
% 212.98/213.13  |- skos__hiddenLabel mesh__D003612 Dairyings
% 212.98/213.13  |- mesh__recordAuthorizer mesh__D013242 PLS
% 212.98/213.13  |- mesh__recordMaintainer mesh__D013242 TGC
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D013242 2004
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D013242 2002
% 212.98/213.13  |- skos__prefLabel mesh__D013242 Sterilization
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D013242 2006
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D013242 1997
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D013242 2003
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D013242 2001
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D013242 1999
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D013242 2005
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D013242 1996
% 212.98/213.13  |- mesh__dateRevised mesh__D013242 1994-05-05
% 212.98/213.13  |- mesh__recordOriginator mesh__D013242 NLM
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D013242 1995
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D013242 1998
% 212.98/213.13  |- skos__annotation mesh__D013242
% 212.98/213.13       of the environment, not sexual; differentiate from DISINFECTION: DISINFECTION renders matter free of pathogens, STERILIZATION destroys all microbes; if in doubt, use the word of the text%A%  
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D013242 2000
% 212.98/213.13  |- skos__scopeNote mesh__D013242
% 212.98/213.13       The destroying of all forms of life, especially microorganisms, by heat, chemical, or other means.%A%    
% 212.98/213.13  |- skos__broader mesh__D013242smesh__D017053
% 212.98/213.13  |- mesh__dateCreated mesh__D013242 1999-01-01
% 212.98/213.13  |- rdf__type mesh__D013242sskos__Concept
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007205 2000
% 212.98/213.13  |- mesh__dateEstablished mesh__D007205 1988-01-01
% 212.98/213.13  |- skos__broader mesh__D007205smesh__D011868
% 212.98/213.13  |- mesh__recordOriginator mesh__D007205 RLS
% 212.98/213.13  |- mesh__publicMeSHNote mesh__D007205 88   
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007205 1995
% 212.98/213.13  |- skos__historyNote mesh__D007205 Radioisotopes %28%1966-1987%29%
% 212.98/213.13  |- mesh__dateCreated mesh__D007205 1987-04-06
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007205 2006
% 212.98/213.13  |- skos__prefLabel mesh__D007205 Indium Radioisotopes
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007205 2002
% 212.98/213.13  |- mesh__historyNote mesh__D007205 88   
% 212.98/213.13  |- skos__annotation mesh__D007205
% 212.98/213.13       In-106-112, 113m, 114, 116-124; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 212.98/213.13  |- mesh__dateRevised mesh__D007205 1993-06-02
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007205 1994
% 212.98/213.13  |- skos__hiddenLabel mesh__D007205 Radioisotopes, Indium
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007205 2004
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007205 2005
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007205 1999
% 212.98/213.13  |- skos__scopeNote mesh__D007205
% 212.98/213.13       Unstable isotopes of indium that decay or disintegrate emitting radiation. In atoms with atomic weights 106-112, 113m, 114, and 116-124 are radioactive indium isotopes.%A%    
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007205 2003
% 212.98/213.13  |- mesh__recordAuthorizer mesh__D007205 PLS
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007205 1997
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007205 1998
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007205 2001
% 212.98/213.13  |- rdf__type mesh__D007205sskos__Concept
% 212.98/213.13  |- mesh__recordMaintainer mesh__D007205 TPW
% 212.98/213.13  |- skos__historyNote mesh__D007205 Indium %28%1966-1987%29%
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D007205 1996
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D051361 2006
% 212.98/213.13  |- skos__hiddenLabel mesh__D051361 Cyclin Dependent Kinase 6
% 212.98/213.13  |- mesh__publicMeSHNote mesh__D051361
% 212.98/213.13       2006; CYCLIN-DEPENDENT KINASE 6 was indexed under CYCLIN-DEPENDENT KINASES 2003-2005,  %26% under PROTEIN-SERINE-THREONINE KINASES 1995-2002, %26% under PROTEIN KINASES 1994%A%  
% 212.98/213.13  |- skos__altLabel mesh__D051361 PLSTIRE Protein
% 212.98/213.13  |- skos__altLabel mesh__D051361 CDK6 Protein
% 212.98/213.13  |- skos__scopeNote mesh__D051361
% 212.98/213.13       Cyclin-dependent kinase 6 associates with CYCLIN D and phosphorylates RETINOBLASTOMA PROTEIN during G1 PHASE of the CELL CYCLE. It helps regulate the transition to S PHASE and its kinase activity is inhibited by CYCLIN-DEPENDENT KINASE INHIBITOR P18.%A%    
% 212.98/213.13  |- mesh__recordMaintainer mesh__D051361 DRC
% 212.98/213.13  |- skos__broader mesh__D051361smesh__D018844
% 212.98/213.13  |- mesh__recordOriginator mesh__D051361 DRC
% 212.98/213.13  |- mesh__dateEstablished mesh__D051361 2006-01-01
% 212.98/213.13  |- skos__prefLabel mesh__D051361 Cyclin-Dependent Kinase 6
% 212.98/213.13  |- mesh__dateCreated mesh__D051361 2005-06-30
% 212.98/213.13  |- skos__hiddenLabel mesh__D051361 Protein Kinase, Cdk6
% 212.98/213.13  |- mesh__historyNote mesh__D051361 2006%28%1994%29%   
% 212.98/213.13  |- rdf__type mesh__D051361sskos__Concept
% 212.98/213.13  |- mesh__recordAuthorizer mesh__D051361 sjn
% 212.98/213.13  |- skos__altLabel mesh__D051361 Cdk6 Protein Kinase
% 212.98/213.13  |- mesh__activeMeSHYear mesh__D012948 2001
% 212.98/213.13  |- skos__broader mesh__D012948smesh__D006748
% 212.98/213.13  |- skos__scopeNote mesh__D012948
% 212.98/213.13       Hospital department responsible for administering and providing social services to patients and their families.%A%    
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D012948 2004
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D012948 2000
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D012948 2006
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D012948 1997
% 212.98/213.14  |- skos__historyNote mesh__D012948 Social Work %28%1978-1983%29%
% 212.98/213.14  |- skos__historyNote mesh__D012948 Hospital Departments %28%1968-1983%29%
% 212.98/213.14  |- mesh__recordAuthorizer mesh__D012948 PLS
% 212.98/213.14  |- skos__altLabel mesh__D012948 Hospital Social Work Department
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D012948 2003
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D012948 1999
% 212.98/213.14  |- mesh__dateEstablished mesh__D012948 1991-01-01
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D012948 2005
% 212.98/213.14  |- skos__annotation mesh__D012948 DF: SOCIAL WORK DEP HOSP   
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D012948 1996
% 212.98/213.14  |- mesh__dateRevised mesh__D012948 1992-05-18
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D012948 1998
% 212.98/213.14  |- mesh__recordOriginator mesh__D012948 EC
% 212.98/213.14  |- mesh__publicMeSHNote mesh__D012948
% 212.98/213.14       91; was see under HOSPITAL DEPARTMENTS 1984-90   
% 212.98/213.14  |- rdf__type mesh__D012948sskos__Concept
% 212.98/213.14  |- skos__prefLabel mesh__D012948 Social Work Department, Hospital
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D012948 1993
% 212.98/213.14  |- mesh__dateCreated mesh__D012948 1983-06-10
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D012948 1995
% 212.98/213.14  |- mesh__historyNote mesh__D012948
% 212.98/213.14       91%28%84%29%; was see under HOSPITAL DEPARTMENTS 1984-90   
% 212.98/213.14  |- mesh__recordMaintainer mesh__D012948 TGC
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D012948 2002
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D012948 1994
% 212.98/213.14  |- skos__scopeNote mesh__D017633
% 212.98/213.14       A generic term for a variety of compounds that contain silicon, oxygen, and magnesium, and may contain hydrogen. Examples include TALC and some kinds of ASBESTOS.%A%    
% 212.98/213.14  |- skos__historyNote mesh__D017633 Magnesium %28%1966-1993%29%
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017633 1997
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017633 2004
% 212.98/213.14  |- rdf__type mesh__D017633sskos__Concept
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017633 2000
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017633 1999
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017633 2006
% 212.98/213.14  |- skos__historyNote mesh__D017633 Silicic Acid %28%1966-1993%29%
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017633 2003
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017633 1996
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017633 1995
% 212.98/213.14  |- skos__broader mesh__D017633smesh__D017616
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017633 1998
% 212.98/213.14  |- mesh__dateEstablished mesh__D017633 1994-01-01
% 212.98/213.14  |- skos__prefLabel mesh__D017633 Magnesium Silicates
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017633 2005
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017633 1994
% 212.98/213.14  |- mesh__historyNote mesh__D017633 94   
% 212.98/213.14  |- mesh__publicMeSHNote mesh__D017633 94   
% 212.98/213.14  |- skos__annotation mesh__D017633
% 212.98/213.14       inorganic cpds; TALC %26% ASBESTOS are examples of magnesium silicates%A%  
% 212.98/213.14  |- mesh__dateCreated mesh__D017633 1993-06-18
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017633 2002
% 212.98/213.14  |- skos__broader mesh__D017633smesh__D017640
% 212.98/213.14  |- skos__hiddenLabel mesh__D017633 Silicates, Magnesium
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017633 2001
% 212.98/213.14  |- mesh__dateEstablished mesh__D031304 2003-01-01
% 212.98/213.14  |- mesh__publicMeSHNote mesh__D031304 2003   
% 212.98/213.14  |- rdf__type mesh__D031304sskos__Concept
% 212.98/213.14  |- mesh__dateCreated mesh__D031304 2002-07-03
% 212.98/213.14  |- mesh__historyNote mesh__D031304 2003   
% 212.98/213.14  |- skos__broader mesh__D031304smesh__D007887
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D031304 2004
% 212.98/213.14  |- skos__scopeNote mesh__D031304
% 212.98/213.14       A plant genus of the family FABACEAE that contains tephrorin, tephrosone, and C-prenylflavonoids.%A%    
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D031304 2006
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D031304 2003
% 212.98/213.14  |- skos__annotation mesh__D031304
% 212.98/213.14       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.98/213.14  |- skos__prefLabel mesh__D031304 Tephrosia
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D031304 2005
% 212.98/213.14  |- skos__historyNote mesh__D003613 Oxazoles %28%1973-1974%29%
% 212.98/213.14  |- skos__scopeNote mesh__D003613
% 212.98/213.14       A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders.%A%    
% 212.98/213.14  |- rdf__type mesh__D003613sskos__Concept
% 212.98/213.14  |- skos__altLabel mesh__D003613 ratiopharm Brand of Danazol
% 212.98/213.14  |- skos__broader mesh__D003613smesh__D011245
% 212.98/213.14  |- mesh__dateCreated mesh__D003613 1974-11-11
% 212.98/213.14  |- skos__historyNote mesh__D003613 Pregnadienes %28%1973-1974%29%
% 212.98/213.14  |- mesh__dateRevised mesh__D003613 2005-06-30
% 212.98/213.14  |- mesh__recordMaintainer mesh__D003613 exl
% 212.98/213.14  |- skos__altLabel mesh__D003613 Alphapharm Brand of Danazol
% 212.98/213.14  |- skos__altLabel mesh__D003613 Ladogal
% 212.98/213.14  |- skos__altLabel mesh__D003613 Sanofi Synthelabo Brand of Danazol
% 212.98/213.14  |- skos__altLabel mesh__D003613 Kendrick Brand of Danazol
% 212.98/213.14  |- skos__altLabel mesh__D003613 Danatrol
% 212.98/213.14  |- skos__altLabel mesh__D003613 Cyclomen
% 212.98/213.14  |- mesh__publicMeSHNote mesh__D003613
% 212.98/213.14       91; was see under PREGNADIENES 1975-90   
% 212.98/213.14  |- skos__historyNote mesh__D003613 Hydroxysteroids %28%1973-1974%29%
% 212.98/213.14  |- skos__historyNote mesh__D003613 Alkynes %28%1973-1974%29%
% 212.98/213.14  |- mesh__historyNote mesh__D003613
% 212.98/213.14       91%28%75%29%; was see under PREGNADIENES 1975-90   
% 212.98/213.14  |- skos__altLabel mesh__D003613 Sanofi Winthrop Brand of Danazol
% 212.98/213.14  |- mesh__recordOriginator mesh__D003613 NLM
% 212.98/213.14  |- mesh__recordAuthorizer mesh__D003613 sjn
% 212.98/213.14  |- skos__altLabel mesh__D003613 Sanofi Brand of Danazol
% 212.98/213.14  |- skos__altLabel mesh__D003613 Antigen Brand of Danazol
% 212.98/213.14  |- skos__prefLabel mesh__D003613 Danazol
% 212.98/213.14  |- skos__altLabel mesh__D003613 Danol
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D003613 2006
% 212.98/213.14  |- mesh__dateEstablished mesh__D003613 1991-01-01
% 212.98/213.14  |- mesh__recordMaintainer mesh__D013243 lkt
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D013243 2005
% 212.98/213.14  |- skos__hiddenLabel mesh__D013243 Sterilization Reversals
% 212.98/213.14  |- mesh__historyNote mesh__D013243 1975   
% 212.98/213.14  |- skos__historyNote mesh__D013243 Sterilization, Tubal %28%1973-1974%29%
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D013243 2004
% 212.98/213.14  |- skos__altLabel mesh__D013243 Vas Reanastomosis
% 212.98/213.14  |- skos__hiddenLabel mesh__D013243 Reanastomoses, Tubal
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D013243 2006
% 212.98/213.14  |- mesh__publicMeSHNote mesh__D013243 1975   
% 212.98/213.14  |- mesh__dateEstablished mesh__D013243 1975-09-01
% 212.98/213.14  |- skos__hiddenLabel mesh__D013243 Reanastomosis, Fallopian Tube
% 212.98/213.14  |- skos__broader mesh__D013243smesh__D013245
% 212.98/213.14  |- skos__historyNote mesh__D013243 Vasectomy %28%1973-1974%29%
% 212.98/213.14  |- skos__prefLabel mesh__D013243 Sterilization Reversal
% 212.98/213.14  |- skos__hiddenLabel mesh__D013243 Reanastomosis, Tubal
% 212.98/213.14  |- mesh__recordAuthorizer mesh__D013243 sjn
% 212.98/213.14  |- skos__hiddenLabel mesh__D013243 Tubal Reanastomoses
% 212.98/213.14  |- mesh__dateRevised mesh__D013243 2003-07-09
% 212.98/213.14  |- skos__hiddenLabel mesh__D013243 Vas Deferens Reanastomoses
% 212.98/213.14  |- skos__hiddenLabel mesh__D013243 Fallopian Tube Reanastomoses
% 212.98/213.14  |- skos__hiddenLabel mesh__D013243 Reanastomosis, Vas Deferens
% 212.98/213.14  |- skos__altLabel mesh__D013243 Tubal Reanastomosis
% 212.98/213.14  |- skos__hiddenLabel mesh__D013243 Reanastomoses, Fallopian Tube
% 212.98/213.14  |- mesh__dateCreated mesh__D013243 1974-11-19
% 212.98/213.14  |- mesh__recordOriginator mesh__D013243 NLM
% 212.98/213.14  |- rdf__type mesh__D013243sskos__Concept
% 212.98/213.14  |- skos__scopeNote mesh__D013243
% 212.98/213.14       Procedures to reverse the effect of REPRODUCTIVE STERILIZATION and to regain fertility. Reversal procedures include those used to restore the flow in the FALLOPIAN TUBE or the VAS DEFERENS.%A%    
% 212.98/213.14  |- skos__hiddenLabel mesh__D013243 Reanastomoses, Vas Deferens
% 212.98/213.14  |- mesh__dateCreated mesh__D007206 1999-01-01
% 212.98/213.14  |- mesh__dateRevised mesh__D007206 2001-07-25
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D007206 2004
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D007206 2005
% 212.98/213.14  |- skos__altLabel mesh__D007206 Individual Differences
% 212.98/213.14  |- skos__prefLabel mesh__D007206 Individuality
% 212.98/213.14  |- mesh__historyNote mesh__D007206 75; was see under PERSONALITY 1963-74   
% 212.98/213.14  |- mesh__publicMeSHNote mesh__D007206
% 212.98/213.14       75; was see under PERSONALITY 1963-74   
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D007206 2003
% 212.98/213.14  |- skos__historyNote mesh__D007206 Personality %28%1966-1974%29%
% 212.98/213.14  |- mesh__recordMaintainer mesh__D007206 jrf
% 212.98/213.14  |- rdf__type mesh__D007206sskos__Concept
% 212.98/213.14  |- mesh__recordAuthorizer mesh__D007206 sjn
% 212.98/213.14  |- skos__hiddenLabel mesh__D007206 Differences, Individual
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D007206 2002
% 212.98/213.14  |- mesh__onlineNote mesh__D007206 search PERSONALITY 1966-74   
% 212.98/213.14  |- mesh__dateEstablished mesh__D007206 1975-01-01
% 212.98/213.14  |- skos__hiddenLabel mesh__D007206 Individual Difference
% 212.98/213.14  |- skos__annotation mesh__D007206 do not confuse with PERSONHOOD   
% 212.98/213.14  |- skos__broader mesh__D007206smesh__D010551
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D007206 2006
% 212.98/213.14  |- skos__scopeNote mesh__D007206
% 212.98/213.14       Those psychological characteristics which differentiate individuals from one another.%A%    
% 212.98/213.14  |- skos__hiddenLabel mesh__D007206 Difference, Individual
% 212.98/213.14  |- mesh__recordOriginator mesh__D007206 NLM
% 212.98/213.14  |- mesh__historyNote mesh__D012949
% 212.98/213.14       78; was SOCIAL SERVICE, PSYCHIATRIC 1963-77   
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D012949 2003
% 212.98/213.14  |- skos__hiddenLabel mesh__D012949 Services, Psychiatric Social
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D012949 2005
% 212.98/213.14  |- mesh__recordAuthorizer mesh__D012949 sjn
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D012949 2002
% 212.98/213.14  |- rdf__type mesh__D012949sskos__Concept
% 212.98/213.14  |- skos__scopeNote mesh__D012949
% 212.98/213.14       Use of all social work processes in the treatment of patients in a psychiatric or mental health setting.%A%    
% 212.98/213.14  |- skos__hiddenLabel mesh__D012949 Work, Psychiatric Social
% 212.98/213.14  |- skos__hiddenLabel mesh__D012949 Social Works, Psychiatric
% 212.98/213.14  |- skos__hiddenLabel mesh__D012949 Social Services, Psychiatric
% 212.98/213.14  |- skos__hiddenLabel mesh__D012949 Service, Psychiatric Social
% 212.98/213.14  |- skos__altLabel mesh__D012949 Psychiatric Social Service
% 212.98/213.14  |- skos__hiddenLabel mesh__D012949 Psychiatric Social Services
% 212.98/213.14  |- mesh__recordOriginator mesh__D012949 NLM
% 212.98/213.14  |- mesh__dateCreated mesh__D012949 1999-01-01
% 212.98/213.14  |- mesh__publicMeSHNote mesh__D012949
% 212.98/213.14       78; was SOCIAL SERVICE, PSYCHIATRIC 1963-77   
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D012949 2001
% 212.98/213.14  |- skos__prefLabel mesh__D012949 Social Work, Psychiatric
% 212.98/213.14  |- skos__altLabel mesh__D012949 Social Service, Psychiatric
% 212.98/213.14  |- mesh__dateRevised mesh__D012949 1999-11-03
% 212.98/213.14  |- mesh__recordMaintainer mesh__D012949 kle
% 212.98/213.14  |- mesh__onlineNote mesh__D012949
% 212.98/213.14       use SOCIAL WORK, PSYCHIATRIC to search SOCIAL SERVICE, PSYCHIATRIC 1966-77%A%  
% 212.98/213.14  |- skos__hiddenLabel mesh__D012949 Psychiatric Social Works
% 212.98/213.14  |- skos__hiddenLabel mesh__D012949 Works, Psychiatric Social
% 212.98/213.14  |- skos__annotation mesh__D012949 SPEC: SPEC qualif   
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D012949 2000
% 212.98/213.14  |- skos__broader mesh__D012949smesh__D008605
% 212.98/213.14  |- skos__altLabel mesh__D012949 Psychiatric Social Work
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D012949 2004
% 212.98/213.14  |- skos__broader mesh__D012949smesh__D012947
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D012949 2006
% 212.98/213.14  |- skos__hiddenLabel mesh__D045325 Cell, HCT-116
% 212.98/213.14  |- rdf__type mesh__D045325sskos__Concept
% 212.98/213.14  |- skos__altLabel mesh__D045325 HCT-116 Cells
% 212.98/213.14  |- mesh__publicMeSHNote mesh__D045325 2004   
% 212.98/213.14  |- skos__hiddenLabel mesh__D045325 Cells, HCT116
% 212.98/213.14  |- skos__broader mesh__D045325smesh__D045744
% 212.98/213.14  |- skos__hiddenLabel mesh__D045325 Cell, HCT116
% 212.98/213.14  |- skos__altLabel mesh__D045325 HCT 116 Cells
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D045325 2006
% 212.98/213.14  |- skos__hiddenLabel mesh__D045325 Cell, HCT 116
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D045325 2005
% 212.98/213.14  |- skos__hiddenLabel mesh__D045325 HCT-116 Cell
% 212.98/213.14  |- skos__historyNote mesh__D045325 Tumor Cells, Cultured %28%1990-2003%29%
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D045325 2004
% 212.98/213.14  |- skos__hiddenLabel mesh__D045325 Cells, HCT-116
% 212.98/213.14  |- skos__annotation mesh__D045325
% 212.98/213.14       almost always NIM with no subheadings; check HUMAN; do not routinely add COLONIC NEOPLASMS%A%  
% 212.98/213.14  |- mesh__historyNote mesh__D045325 2004   
% 212.98/213.14  |- skos__prefLabel mesh__D045325 HCT116 Cells
% 212.98/213.14  |- mesh__dateEstablished mesh__D045325 2004-01-01
% 212.98/213.14  |- skos__hiddenLabel mesh__D045325 HCT116 Cell
% 212.98/213.14  |- skos__hiddenLabel mesh__D045325 Cells, HCT 116
% 212.98/213.14  |- mesh__dateCreated mesh__D045325 2003-07-09
% 212.98/213.14  |- skos__scopeNote mesh__D045325 Human COLORECTAL CARCINOMA cell line.     
% 212.98/213.14  |- skos__hiddenLabel mesh__D045325 HCT 116 Cell
% 212.98/213.14  |- skos__hiddenLabel mesh__D017634 Self Tolerances
% 212.98/213.14  |- mesh__dateCreated mesh__D017634 1993-02-16
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017634 2003
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017634 1996
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017634 1995
% 212.98/213.14  |- skos__annotation mesh__D017634 a form of immune tolerance   
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017634 2001
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017634 1998
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017634 2005
% 212.98/213.14  |- skos__broader mesh__D017634smesh__D007108
% 212.98/213.14  |- skos__related mesh__D017634smesh__D017637
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017634 1994
% 212.98/213.14  |- mesh__historyNote mesh__D017634 94   
% 212.98/213.14  |- skos__related mesh__D017634smesh__D017635
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017634 2000
% 212.98/213.14  |- skos__related mesh__D017634smesh__D001327
% 212.98/213.14  |- mesh__dateEstablished mesh__D017634 1994-01-01
% 212.98/213.14  |- skos__hiddenLabel mesh__D017634 Tolerances, Self
% 212.98/213.14  |- skos__scopeNote mesh__D017634
% 212.98/213.14       The normal lack of the ability to produce an immunological response to autologous %28%self%29% antigens. A breakdown of self tolerance leads to autoimmune diseases. The ability to recognize the difference between self and non-self is the prime function of the immune system.%A%    
% 212.98/213.14  |- mesh__publicMeSHNote mesh__D017634 94   
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017634 1997
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017634 2004
% 212.98/213.14  |- rdf__type mesh__D017634sskos__Concept
% 212.98/213.14  |- skos__hiddenLabel mesh__D017634 Tolerance, Self
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017634 2002
% 212.98/213.14  |- skos__prefLabel mesh__D017634 Self Tolerance
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017634 2006
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017634 1999
% 212.98/213.14  |- skos__historyNote mesh__D017634 Immune Tolerance %28%1973-1993%29%
% 212.98/213.14  |- skos__scopeNote mesh__D031305
% 212.98/213.14       A plant genus of the family FABACEAE. Members contain molluscicidal triterpene glycosides %28%TRITERPENES%29%.%A%    
% 212.98/213.14  |- skos__broader mesh__D031305smesh__D007887
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D031305 2004
% 212.98/213.14  |- mesh__dateEstablished mesh__D031305 2003-01-01
% 212.98/213.14  |- skos__prefLabel mesh__D031305 Tetrapleura
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D031305 2006
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D031305 2003
% 212.98/213.14  |- skos__annotation mesh__D031305
% 212.98/213.14       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D031305 2005
% 212.98/213.14  |- mesh__publicMeSHNote mesh__D031305 2003   
% 212.98/213.14  |- rdf__type mesh__D031305sskos__Concept
% 212.98/213.14  |- mesh__dateCreated mesh__D031305 2002-07-03
% 212.98/213.14  |- mesh__historyNote mesh__D031305 2003   
% 212.98/213.14  |- skos__broader mesh__D003614smesh__D026421
% 212.98/213.14  |- mesh__recordAuthorizer mesh__D003614 sjn
% 212.98/213.14  |- skos__broader mesh__D003614smesh__D012046
% 212.98/213.14  |- mesh__recordOriginator mesh__D003614 EC
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D003614 2004
% 212.98/213.14  |- skos__prefLabel mesh__D003614 Dance Therapy
% 212.98/213.14  |- mesh__dateCreated mesh__D003614 1979-05-29
% 212.98/213.14  |- mesh__recordMaintainer mesh__D003614 ssb
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D003614 2003
% 212.98/213.14  |- skos__altLabel mesh__D003614 Therapy, Dance
% 212.98/213.14  |- skos__hiddenLabel mesh__D003614 Therapies, Dance
% 212.98/213.14  |- skos__annotation mesh__D003614 a psychother technique; DF: DANCE THER   
% 212.98/213.14  |- mesh__historyNote mesh__D003614 80   
% 212.98/213.14  |- skos__broader mesh__D003614smesh__D011613
% 212.98/213.14  |- mesh__dateRevised mesh__D003614 2001-07-25
% 212.98/213.14  |- mesh__dateEstablished mesh__D003614 1980-01-01
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D003614 2006
% 212.98/213.14  |- skos__historyNote mesh__D003614 Dancing %28%1966-1979%29%
% 212.98/213.14  |- skos__scopeNote mesh__D003614
% 212.98/213.14       The use of dancing for therapeutic purposes.     
% 212.98/213.14  |- skos__broader mesh__D003614smesh__D026241
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D003614 2002
% 212.98/213.14  |- rdf__type mesh__D003614sskos__Concept
% 212.98/213.14  |- skos__hiddenLabel mesh__D003614 Dance Therapies
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D003614 2005
% 212.98/213.14  |- mesh__publicMeSHNote mesh__D003614 80   
% 212.98/213.14  |- mesh__dateEstablished mesh__D013244 1991-01-01
% 212.98/213.14  |- skos__hiddenLabel mesh__D013244 Sterilization, Forced
% 212.98/213.14  |- skos__altLabel mesh__D013244 Compulsory Sterilization
% 212.98/213.14  |- mesh__publicMeSHNote mesh__D013244
% 212.98/213.14       91; was see under STERILIZATION, SEXUAL 1978-90   
% 212.98/213.14  |- skos__scopeNote mesh__D013244
% 212.98/213.14       Reproductive sterilization without the consent of the patient.%A%    
% 212.98/213.14  |- skos__historyNote mesh__D013244 Sterilization, Sexual %28%1966-1977%29%
% 212.98/213.14  |- skos__broader mesh__D013244smesh__D013245
% 212.98/213.14  |- skos__altLabel mesh__D013244 Involuntary Sterilization
% 212.98/213.14  |- mesh__recordMaintainer mesh__D013244 lkt
% 212.98/213.14  |- skos__hiddenLabel mesh__D013244 Compulsory Sterilizations
% 212.98/213.14  |- skos__hiddenLabel mesh__D013244 Forced Sterilizations
% 212.98/213.14  |- mesh__historyNote mesh__D013244
% 212.98/213.14       91%28%78%29%; was see under STERILIZATION, SEXUAL 1978-90   
% 212.98/213.14  |- skos__hiddenLabel mesh__D013244 Sterilizations, Involuntary
% 212.98/213.14  |- mesh__dateCreated mesh__D013244 1977-04-22
% 212.98/213.14  |- mesh__dateRevised mesh__D013244 2003-07-09
% 212.98/213.14  |- skos__hiddenLabel mesh__D013244 Sterilizations, Compulsory
% 212.98/213.14  |- skos__altLabel mesh__D013244 Forced Sterilization
% 212.98/213.14  |- mesh__recordOriginator mesh__D013244 EC
% 212.98/213.14  |- skos__hiddenLabel mesh__D013244 Sterilizations, Forced
% 212.98/213.14  |- rdf__type mesh__D013244sskos__Concept
% 212.98/213.14  |- mesh__recordAuthorizer mesh__D013244 sjn
% 212.98/213.14  |- skos__hiddenLabel mesh__D013244 Involuntary Sterilizations
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D013244 2005
% 212.98/213.14  |- skos__hiddenLabel mesh__D013244 Sterilization, Compulsory
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D013244 2004
% 212.98/213.14  |- skos__prefLabel mesh__D013244 Sterilization, Involuntary
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D013244 2006
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D007207 1992
% 212.98/213.14  |- mesh__onlineNote mesh__D007207 search PERSONALITY DISORDERS 1970-74   
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D007207 2003
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D007207 1997
% 212.98/213.14  |- mesh__recordOriginator mesh__D007207 NLM
% 212.98/213.14  |- mesh__publicMeSHNote mesh__D007207
% 212.98/213.14       91; was see under PERSONALITY DEVELOPMENT 1975-90   
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D007207 1998
% 212.98/213.14  |- rdf__type mesh__D007207sskos__Concept
% 212.98/213.14  |- mesh__recordAuthorizer mesh__D007207 PLS
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D007207 2001
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D007207 1996
% 212.98/213.14  |- mesh__dateRevised mesh__D007207 1990-04-13
% 212.98/213.14  |- skos__hiddenLabel mesh__D007207 Individuations
% 212.98/213.14  |- mesh__historyNote mesh__D007207
% 212.98/213.14       91%28%75%29%; was see under PERSONALITY DEVELOPMENT 1975-90   
% 212.98/213.14  |- mesh__dateEstablished mesh__D007207 1991-01-01
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D007207 2000
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D007207 1995
% 212.98/213.14  |- mesh__recordMaintainer mesh__D007207 NLM
% 212.98/213.14  |- skos__scopeNote mesh__D007207
% 212.98/213.14       A process of differentiation having for its goal the development of the individual personality.%A%    
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D007207 2006
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D007207 1993
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D007207 1991
% 212.98/213.14  |- mesh__dateCreated mesh__D007207 1999-01-01
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D007207 1994
% 212.98/213.14  |- skos__prefLabel mesh__D007207 Individuation
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D007207 2004
% 212.98/213.14  |- skos__annotation mesh__D007207 no qualif   
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D007207 2005
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D007207 2002
% 212.98/213.14  |- skos__broader mesh__D007207smesh__D010553
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D007207 1999
% 212.98/213.14  |- mesh__dateCreated mesh__D017635 1993-02-16
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017635 1995
% 212.98/213.14  |- mesh__publicMeSHNote mesh__D017635 94   
% 212.98/213.14  |- skos__historyNote mesh__D017635
% 212.98/213.14       specific cells/immunology %28%1980-1993%29%
% 212.98/213.14  |- mesh__historyNote mesh__D017635 94   
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017635 2000
% 212.98/213.14  |- skos__scopeNote mesh__D017635
% 212.98/213.14       Functional inactivation of T- or B-lymphocytes rendering them incapable of eliciting an immune response to antigen. This occurs through different mechanisms in the two kinds of lymphocytes and can contribute to SELF TOLERANCE.%A%    
% 212.98/213.14  |- skos__prefLabel mesh__D017635 Clonal Anergy
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017635 2001
% 212.98/213.14  |- skos__hiddenLabel mesh__D017635 Anergy, Clonal
% 212.98/213.14  |- skos__hiddenLabel mesh__D017635 Anergies, Clonal
% 212.98/213.14  |- skos__annotation mesh__D017635 a form of immune tolerance   
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017635 1996
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017635 2003
% 212.98/213.14  |- skos__historyNote mesh__D017635 Immune Tolerance %28%1980-1993%29%
% 212.98/213.14  |- skos__broader mesh__D017635smesh__D007108
% 212.98/213.14  |- mesh__dateEstablished mesh__D017635 1994-01-01
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017635 1998
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017635 2005
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017635 1997
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017635 2004
% 212.98/213.14  |- skos__hiddenLabel mesh__D017635 Clonal Anergies
% 212.98/213.14  |- rdf__type mesh__D017635sskos__Concept
% 212.98/213.14  |- skos__historyNote mesh__D017635 Clone Cells %28%1980-1993%29%
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017635 1994
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017635 2002
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017635 1999
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D017635 2006
% 212.98/213.14  |- mesh__dateCreated mesh__D031306 2002-07-03
% 212.98/213.14  |- mesh__historyNote mesh__D031306 2003   
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D031306 2006
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D031306 2003
% 212.98/213.14  |- skos__scopeNote mesh__D031306
% 212.98/213.14       A plant genus of the family FABACEAE that is widely used as ground cover and forage and known for the edible beans, VICIA FABA.%A%    
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D031306 2005
% 212.98/213.14  |- mesh__dateEstablished mesh__D031306 2003-01-01
% 212.98/213.14  |- skos__prefLabel mesh__D031306 Vicia
% 212.98/213.14  |- mesh__publicMeSHNote mesh__D031306 2003   
% 212.98/213.14  |- rdf__type mesh__D031306sskos__Concept
% 212.98/213.14  |- skos__altLabel mesh__D031306 Vetch
% 212.98/213.14  |- skos__annotation mesh__D031306
% 212.98/213.14       do not confuse X ref VETCH with MILKVETCH see ASTRAGALUS PLANT; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.98/213.14  |- skos__broader mesh__D031306smesh__D007887
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D031306 2004
% 212.98/213.14  |- skos__prefLabel mesh__D003615 Dancing
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D003615 1997
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D003615 2002
% 212.98/213.14  |- skos__scopeNote mesh__D003615
% 212.98/213.14       Rhythmic and patterned body movements which are usually performed to music.%A%    
% 212.98/213.14  |- mesh__recordMaintainer mesh__D003615 TGC
% 212.98/213.14  |- skos__annotation mesh__D003615
% 212.98/213.14       /inj: coord IM with specific inj %28%IM%29%; /physiol permitted; Manual 30.31+; dancing as therapy = DANCE THERAPY%A%  
% 212.98/213.14  |- mesh__recordOriginator mesh__D003615 NLM
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D003615 2006
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D003615 2001
% 212.98/213.14  |- skos__hiddenLabel mesh__D003615 Dancings
% 212.98/213.14  |- rdf__type mesh__D003615sskos__Concept
% 212.98/213.14  |- mesh__recordAuthorizer mesh__D003615 PLS
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D003615 2005
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D003615 2000
% 212.98/213.14  |- mesh__dateCreated mesh__D003615 1999-01-01
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D003615 2004
% 212.98/213.14  |- mesh__dateRevised mesh__D003615 1996-06-10
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D003615 1999
% 212.98/213.14  |- skos__broader mesh__D003615smesh__D011998
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D003615 2003
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D003615 1998
% 212.98/213.14  |- skos__scopeNote mesh__D008300
% 212.98/213.14       1,2-Dihydro-3,6-pyridazinedione. A herbicide and plant growth regulator; also used to control suckering of tobacco. Its residue in food and tobacco is highly toxic, causing CNS disturbances and liver damage.%A%    
% 212.98/213.14  |- skos__hiddenLabel mesh__D008300 Hydrazide, Maleic
% 212.98/213.14  |- mesh__publicMeSHNote mesh__D008300
% 212.98/213.14       91; was see under PYRIDAZINES 1977-90   
% 212.98/213.14  |- mesh__recordAuthorizer mesh__D008300 sjn
% 212.98/213.14  |- mesh__activeMeSHYear mesh__D008300 2006
% 212.98/213.14  |- skos__hiddenLabel mesh__D008300 Acid Hydrazide, Maleic
% 212.98/213.14  |- skos__broader mesh__D008300smesh__D011724
% 212.98/213.14  |- skos__historyNote mesh__D008300 Pyridazines %28%1966-1976%29%
% 212.98/213.14  |- skos__altLabel mesh__D008300 Maleic Acid Hydrazide
% 212.98/213.14  |- rdf__type mesh__D008300sskos__Concept
% 212.98/213.14  |- mesh__dateRevised mesh__D008300 2005-06-30
% 212.98/213.15  |- mesh__recordMaintainer mesh__D008300 ssb
% 212.98/213.15  |- skos__historyNote mesh__D008300 Maleates %28%1966-1976%29%
% 212.98/213.15  |- mesh__historyNote mesh__D008300
% 212.98/213.15       91%28%77%29%; was see under PYRIDAZINES 1977-90   
% 212.98/213.15  |- mesh__recordOriginator mesh__D008300 RLS
% 212.98/213.15  |- skos__hiddenLabel mesh__D008300 Hydrazide, Maleic Acid
% 212.98/213.15  |- mesh__dateCreated mesh__D008300 1976-05-19
% 212.98/213.15  |- mesh__dateEstablished mesh__D008300 1991-01-01
% 212.98/213.15  |- skos__prefLabel mesh__D008300 Maleic Hydrazide
% 212.98/213.15  |- skos__historyNote mesh__D008300 Hydrazines %28%1966-1976%29%
% 212.98/213.15  |- skos__hiddenLabel mesh__D013245 Female Sterilizations, Voluntary
% 212.98/213.15  |- skos__related mesh__D013245smesh__D010572
% 212.98/213.15  |- skos__hiddenLabel mesh__D013245 Male Sterilizations
% 212.98/213.15  |- skos__prefLabel mesh__D013245 Sterilization, Reproductive
% 212.98/213.15  |- mesh__recordAuthorizer mesh__D013245 sjn
% 212.98/213.15  |- skos__annotation mesh__D013245
% 212.98/213.15       restrict to humans and vertebrates; for invertebrates, consider PEST CONTROL, BIOLOGICAL%A%  
% 212.98/213.15  |- skos__hiddenLabel mesh__D013245 Voluntary Female Sterilization
% 212.98/213.15  |- skos__hiddenLabel mesh__D013245 Sterilization, Voluntary
% 212.98/213.15  |- rdf__type mesh__D013245sskos__Concept
% 212.98/213.15  |- mesh__recordMaintainer mesh__D013245 lkt
% 212.98/213.15  |- mesh__dateRevised mesh__D013245 2005-06-30
% 212.98/213.15  |- skos__related mesh__D013245smesh__D011155
% 212.98/213.15  |- skos__hiddenLabel mesh__D013245 Female Sterilizations
% 212.98/213.15  |- mesh__recordOriginator mesh__D013245 NLM
% 212.98/213.15  |- skos__broader mesh__D013245smesh__D003267
% 212.98/213.15  |- skos__hiddenLabel mesh__D013245 Sterilizations, Female
% 212.98/213.15  |- skos__hiddenLabel mesh__D013245 Voluntary Sterilizations
% 212.98/213.15  |- skos__hiddenLabel mesh__D013245 Voluntary Male Sterilizations
% 212.98/213.15  |- skos__hiddenLabel mesh__D013245 Sterilizations, Male
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D013245 2006
% 212.98/213.15  |- skos__altLabel mesh__D013245 Reproductive Sterilization
% 212.98/213.15  |- mesh__publicMeSHNote mesh__D013245
% 212.98/213.15       2004; see STERILIZATION, SEXUAL 1963-2003   
% 212.98/213.15  |- skos__hiddenLabel mesh__D013245 Voluntary Male Sterilization
% 212.98/213.15  |- skos__hiddenLabel mesh__D013245 Sterilizations, Voluntary
% 212.98/213.15  |- skos__hiddenLabel mesh__D013245 Sterilizations, Reproductive
% 212.98/213.15  |- skos__scopeNote mesh__D013245
% 212.98/213.15       Procedures to block or remove all or part of the genital tract for the purpose of rendering individuals sterile, incapable of reproduction. Surgical sterilization procedures are the most commonly used. There are also sterilization procedures involving chemical or physical means.%A%    
% 212.98/213.15  |- skos__hiddenLabel mesh__D013245 Voluntary Female Sterilizations
% 212.98/213.15  |- skos__hiddenLabel mesh__D013245 Sterilization, Female
% 212.98/213.15  |- skos__hiddenLabel mesh__D013245 Male Sterilizations, Voluntary
% 212.98/213.15  |- mesh__dateCreated mesh__D013245 1999-01-01
% 212.98/213.15  |- skos__hiddenLabel mesh__D013245 Sterilization, Male
% 212.98/213.15  |- skos__hiddenLabel mesh__D013245 Reproductive Sterilizations
% 212.98/213.15  |- mesh__historyNote mesh__D013245 2004 %28%1963%29%   
% 212.98/213.15  |- skos__broader mesh__D013245smesh__D013519
% 212.98/213.15  |- mesh__historyNote mesh__D007208 68%28%63%29%   
% 212.98/213.15  |- skos__scopeNote mesh__D007208
% 212.98/213.15       A tricarbocyanine dye that is used diagnostically in liver function tests and to determine blood volume and cardiac output.%A%    
% 212.98/213.15  |- rdf__type mesh__D007208sskos__Concept
% 212.98/213.15  |- skos__altLabel mesh__D007208 Wofaverdin
% 212.98/213.15  |- skos__altLabel mesh__D007208 Ujoveridin
% 212.98/213.15  |- mesh__dateRevised mesh__D007208 2005-07-06
% 212.98/213.15  |- mesh__dateCreated mesh__D007208 1999-01-01
% 212.98/213.15  |- mesh__recordMaintainer mesh__D007208 NLM
% 212.98/213.15  |- mesh__publicMeSHNote mesh__D007208 68   
% 212.98/213.15  |- skos__altLabel mesh__D007208 Cardiogreen
% 212.98/213.15  |- mesh__recordOriginator mesh__D007208 NLM
% 212.98/213.15  |- mesh__dateEstablished mesh__D007208 1968-01-01
% 212.98/213.15  |- skos__prefLabel mesh__D007208 Indocyanine Green
% 212.98/213.15  |- skos__hiddenLabel mesh__D007208 Cardio Green
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D007208 2006
% 212.98/213.15  |- mesh__recordAuthorizer mesh__D007208 NLM
% 212.98/213.15  |- skos__altLabel mesh__D007208 Vofaverdin
% 212.98/213.15  |- skos__broader mesh__D007208smesh__D007211
% 212.98/213.15  |- skos__altLabel mesh__D007208 Vophaverdin
% 212.98/213.15  |- skos__annotation mesh__D007208 D25-26 qualif   
% 212.98/213.15  |- skos__hiddenLabel mesh__D007208 Green, Indocyanine
% 212.98/213.15  |- mesh__recordMaintainer mesh__D017636 jmp
% 212.98/213.15  |- skos__broader mesh__D017636smesh__D001194
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D017636 2002
% 212.98/213.15  |- skos__altLabel mesh__D017636 Amphibole Asbestos
% 212.98/213.15  |- skos__prefLabel mesh__D017636 Asbestos, Amphibole
% 212.98/213.15  |- skos__historyNote mesh__D017636 Silicon Dioxide %28%1979-1993%29%
% 212.98/213.15  |- mesh__dateRevised mesh__D017636 2001-07-25
% 212.98/213.15  |- skos__historyNote mesh__D017636 Asbestos %28%1979-1993%29%
% 212.98/213.15  |- mesh__dateCreated mesh__D017636 1993-06-21
% 212.98/213.15  |- mesh__onlineNote mesh__D017636
% 212.98/213.15       use ASBESTOS, AMPHIBOLE %28%NM%29% to search AMPHIBOLES 1980-93%A%  
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D017636 2003
% 212.98/213.15  |- skos__scopeNote mesh__D017636
% 212.98/213.15       A class of asbestos that includes silicates of magnesium, iron, calcium, and sodium. The fibers are generally brittle and cannot be spun, but are more resistant to chemicals and heat than ASBESTOS, SERPENTINE. %28%From Hawley%27%s Condensed Chemical Dictionary, 11th ed%29%%A%    
% 212.98/213.15  |- mesh__historyNote mesh__D017636 94; was AMPHIBOLES %28%NM%29% 1979-93   
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D017636 2005
% 212.98/213.15  |- skos__annotation mesh__D017636 D25-26 qualif   
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D017636 2004
% 212.98/213.15  |- skos__altLabel mesh__D017636 Asbestos, Amphibole-group Minerals
% 212.98/213.15  |- rdf__type mesh__D017636sskos__Concept
% 212.98/213.15  |- mesh__publicMeSHNote mesh__D017636
% 212.98/213.15       94; AMPHIBOLES was indexed under SILICA 1979-93   
% 212.98/213.15  |- mesh__recordAuthorizer mesh__D017636 sjn
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D017636 2006
% 212.98/213.15  |- skos__hiddenLabel mesh__D017636 Asbestos, Amphibole group Minerals
% 212.98/213.15  |- mesh__recordOriginator mesh__D017636 TPW
% 212.98/213.15  |- mesh__dateEstablished mesh__D017636 1994-01-01
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D031307 2004
% 212.98/213.15  |- skos__altLabel mesh__D031307 Faba Bean
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D031307 2006
% 212.98/213.15  |- skos__annotation mesh__D031307
% 212.98/213.15       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.98/213.15  |- mesh__historyNote mesh__D031307 2003   
% 212.98/213.15  |- mesh__publicMeSHNote mesh__D031307 2003   
% 212.98/213.15  |- skos__altLabel mesh__D031307 Fava Bean
% 212.98/213.15  |- mesh__dateEstablished mesh__D031307 2003-01-01
% 212.98/213.15  |- skos__altLabel mesh__D031307 Bean, Horse
% 212.98/213.15  |- rdf__type mesh__D031307sskos__Concept
% 212.98/213.15  |- mesh__dateCreated mesh__D031307 2002-07-02
% 212.98/213.15  |- skos__altLabel mesh__D031307 Horsebean
% 212.98/213.15  |- skos__scopeNote mesh__D031307
% 212.98/213.15       A plant species of the genus VICIA, family FABACEAE. The edible beans are well known but they cause FAVISM in some individuals with GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY. This plant contains vicine, convicine, Vicia lectins, unknown seed protein, AAP2 transport protein, and Vicia faba DNA-binding protein 1.%A%    
% 212.98/213.15  |- skos__prefLabel mesh__D031307 Vicia faba
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D031307 2003
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D031307 2005
% 212.98/213.15  |- skos__broader mesh__D031307smesh__D031306
% 212.98/213.15  |- skos__altLabel mesh__D031307 Bean, Faba
% 212.98/213.15  |- skos__hiddenLabel mesh__D003616 Syndrome, Dandy-Walker
% 212.98/213.15  |- skos__scopeNote mesh__D003616
% 212.98/213.15       A congenital abnormality of the central nervous system marked by failure of the midline structures of the cerebellum to develop, dilation of the fourth ventricle, and upward displacement of the transverse sinuses, tentorium, and torcula. Clinical features include occipital bossing, progressive head enlargement, bulging of anterior fontanelle, papilledema, ataxia, gait disturbances, nystagmus, and intellectual compromise. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp294-5%29%%A%    
% 212.98/213.15  |- skos__hiddenLabel mesh__D003616 Malformation, Dandy-Walker
% 212.98/213.15  |- skos__hiddenLabel mesh__D003616 Dandy Walker Syndrome, Familial
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D003616 2000A
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D003616 2006
% 212.98/213.15  |- skos__broader mesh__D003616smesh__D009421
% 212.98/213.15  |- rdf__type mesh__D003616sskos__Concept
% 212.98/213.15  |- skos__broader mesh__D003616smesh__D006849
% 212.98/213.15  |- skos__broader mesh__D003616smesh__D002526
% 212.98/213.15  |- skos__altLabel mesh__D003616 Dandy-Walker Malformation
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D003616 2005
% 212.98/213.15  |- mesh__dateEstablished mesh__D003616 1991-01-01
% 212.98/213.15  |- mesh__historyNote mesh__D003616 1991%28%1970%29%   
% 212.98/213.15  |- skos__hiddenLabel mesh__D003616 Dandy Walker Malformation
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D003616 2002
% 212.98/213.15  |- mesh__recordMaintainer mesh__D003616 ags
% 212.98/213.15  |- mesh__dateRevised mesh__D003616 1999-12-02
% 212.98/213.15  |- mesh__dateCreated mesh__D003616 1999-01-01
% 212.98/213.15  |- skos__altLabel mesh__D003616 Dandy-Walker Syndrome, Familial
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D003616 2004
% 212.98/213.15  |- mesh__publicMeSHNote mesh__D003616 1991; see HYDROCEPHALUS 1970-1990   
% 212.98/213.15  |- skos__hiddenLabel mesh__D003616 Familial Dandy-Walker Syndrome
% 212.98/213.15  |- mesh__recordOriginator mesh__D003616 NLM
% 212.98/213.15  |- skos__hiddenLabel mesh__D003616 Dandy Walker Syndrome
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D003616 2001
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D003616 2003
% 212.98/213.15  |- skos__historyNote mesh__D003616 Hydrocephalus %28%1966-1969%29%
% 212.98/213.15  |- skos__prefLabel mesh__D003616 Dandy-Walker Syndrome
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D003616 2000
% 212.98/213.15  |- mesh__recordAuthorizer mesh__D003616 ags
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D003616 2000B
% 212.98/213.15  |- skos__hiddenLabel mesh__D003616 Syndrome, Familial Dandy-Walker
% 212.98/213.15  |- skos__historyNote mesh__D003616
% 212.98/213.15       Cerebral Ventricles/abnormalities %28%1966-1969%29%
% 212.98/213.15  |- mesh__dateRevised mesh__D008301 2005-06-30
% 212.98/213.15  |- mesh__dateEstablished mesh__D008301 1974-01-01
% 212.98/213.15  |- skos__historyNote mesh__D008301 Imides %28%1966-1971%29%
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D008301 2006
% 212.98/213.15  |- mesh__historyNote mesh__D008301 74%28%72%29%   
% 212.98/213.15  |- skos__broader mesh__D008301smesh__D011758
% 212.98/213.15  |- skos__broader mesh__D008301smesh__D008298
% 212.98/213.15  |- mesh__publicMeSHNote mesh__D008301 74   
% 212.98/213.15  |- mesh__recordOriginator mesh__D008301 NLM
% 212.98/213.15  |- skos__prefLabel mesh__D008301 Maleimides
% 212.98/213.15  |- rdf__type mesh__D008301sskos__Concept
% 212.98/213.15  |- skos__broader mesh__D008301smesh__D007094
% 212.98/213.15  |- skos__historyNote mesh__D008301 Maleates %28%1966-1971%29%
% 212.98/213.15  |- mesh__recordMaintainer mesh__D008301 ssb
% 212.98/213.15  |- mesh__recordAuthorizer mesh__D008301 sjn
% 212.98/213.15  |- mesh__dateCreated mesh__D008301 1999-01-01
% 212.98/213.15  |- skos__hiddenLabel mesh__D013246 Tubal Sterilizations
% 212.98/213.15  |- skos__hiddenLabel mesh__D013246 Sterilizations, Tubal
% 212.98/213.15  |- skos__prefLabel mesh__D013246 Sterilization, Tubal
% 212.98/213.15  |- skos__hiddenLabel mesh__D013246 Tubal Occlusions, Nonchemical
% 212.98/213.15  |- mesh__recordAuthorizer mesh__D013246 sjn
% 212.98/213.15  |- skos__altLabel mesh__D013246 Kroener Method
% 212.98/213.15  |- skos__hiddenLabel mesh__D013246 Nonchemical Tubal Occlusions
% 212.98/213.15  |- mesh__historyNote mesh__D013246 1973   
% 212.98/213.15  |- skos__hiddenLabel mesh__D013246 Tubal Ring
% 212.98/213.15  |- skos__hiddenLabel mesh__D013246 Rings, Tubal
% 212.98/213.15  |- skos__hiddenLabel mesh__D013246 Ring, Tubal
% 212.98/213.15  |- skos__hiddenLabel mesh__D013246 Tubal Occlusions
% 212.98/213.15  |- mesh__dateEstablished mesh__D013246 1973-01-01
% 212.98/213.15  |- skos__historyNote mesh__D013246 Fallopian Tubes %28%1966-1972%29%
% 212.98/213.15  |- skos__hiddenLabel mesh__D013246 Tubal Excisions
% 212.98/213.15  |- skos__broader mesh__D013246smesh__D013245
% 212.98/213.15  |- skos__hiddenLabel mesh__D013246 Coagulations, Cornual
% 212.98/213.15  |- mesh__dateRevised mesh__D013246 2003-07-09
% 212.98/213.15  |- skos__related mesh__D013246smesh__D013243
% 212.98/213.15  |- skos__hiddenLabel mesh__D013246 Cornual Coagulations
% 212.98/213.15  |- skos__historyNote mesh__D013246 Sterilization, Sexual %28%1966-1972%29%
% 212.98/213.15  |- skos__broader mesh__D013246smesh__D013509
% 212.98/213.15  |- mesh__recordMaintainer mesh__D013246 lkt
% 212.98/213.15  |- mesh__recordOriginator mesh__D013246 NLM
% 212.98/213.15  |- mesh__publicMeSHNote mesh__D013246 1973   
% 212.98/213.15  |- skos__altLabel mesh__D013246 Chemical Tubal Occlusion
% 212.98/213.15  |- skos__altLabel mesh__D013246 Pomeroy Sterilization
% 212.98/213.15  |- rdf__type mesh__D013246sskos__Concept
% 212.98/213.15  |- skos__scopeNote mesh__D013246
% 212.98/213.15       Procedures that render the female sterile by interrupting the flow in the FALLOPIAN TUBE. These procedures generally are surgical, and may also use chemicals or physical means.%A%    
% 212.98/213.15  |- mesh__dateCreated mesh__D013246 1999-01-01
% 212.98/213.15  |- skos__hiddenLabel mesh__D013246 Tubal Ligations
% 212.98/213.15  |- skos__altLabel mesh__D013246 Occlusion, Nonchemical Tubal
% 212.98/213.15  |- skos__hiddenLabel mesh__D013246 Tubal Occlusions, Chemical
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D013246 2006
% 212.98/213.15  |- skos__altLabel mesh__D013246 Nonchemical Tubal Occlusion
% 212.98/213.15  |- skos__altLabel mesh__D013246 Occlusion, Chemical Tubal
% 212.98/213.15  |- skos__hiddenLabel mesh__D013246 Tubal Sterilization
% 212.98/213.15  |- skos__hiddenLabel mesh__D013246 Fimbriectomies
% 212.98/213.15  |- skos__hiddenLabel mesh__D013246 Fimbriectomy, Kroener
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D013246 2005
% 212.98/213.15  |- skos__altLabel mesh__D013246 Tubal Ligation
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D013246 2004
% 212.98/213.15  |- skos__hiddenLabel mesh__D013246 Chemical Tubal Occlusions
% 212.98/213.15  |- skos__hiddenLabel mesh__D013246 Sterilization, Pomeroy
% 212.98/213.15  |- skos__hiddenLabel mesh__D013246 Ligations, Tubal
% 212.98/213.15  |- mesh__recordAuthorizer mesh__D007209 sjn
% 212.98/213.15  |- skos__historyNote mesh__D007209 Glycerophosphates %28%1970-1974%29%
% 212.98/213.15  |- rdf__type mesh__D007209sskos__Concept
% 212.98/213.15  |- mesh__recordMaintainer mesh__D007209 ssb
% 212.98/213.15  |- mesh__recordOriginator mesh__D007209 NLM
% 212.98/213.15  |- skos__scopeNote mesh__D007209
% 212.98/213.15       An enzyme in the tryptophan biosynthetic pathway. EC 4.1.1.48.%A%    
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D007209 2005
% 212.98/213.15  |- skos__historyNote mesh__D007209 Indoles %28%1970-1974%29%
% 212.98/213.15  |- mesh__publicMeSHNote mesh__D007209
% 212.98/213.15       91; was see under CARBOXY-LYASES 1975-90   
% 212.98/213.15  |- mesh__dateCreated mesh__D007209 1974-11-19
% 212.98/213.15  |- mesh__historyNote mesh__D007209
% 212.98/213.15       91%28%75%29%; was see under CARBOXY-LYASES 1975-90   
% 212.98/213.15  |- mesh__dateEstablished mesh__D007209 1991-01-01
% 212.98/213.15  |- skos__historyNote mesh__D007209 Carboxy-Lyases %28%1970-1974%29%
% 212.98/213.15  |- mesh__dateRevised mesh__D007209 2003-07-09
% 212.98/213.15  |- skos__hiddenLabel mesh__D007209 Synthase, Indole-3-Glycerol-Phosphate
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D007209 2006
% 212.98/213.15  |- skos__broader mesh__D007209smesh__D002262
% 212.98/213.15  |- skos__prefLabel mesh__D007209 Indole-3-Glycerol-Phosphate Synthase
% 212.98/213.15  |- skos__historyNote mesh__D007209 Pentosephosphates %28%1970-1974%29%
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D007209 2004
% 212.98/213.15  |- skos__hiddenLabel mesh__D007209 Indole 3 Glycerol Phosphate Synthase
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D017637 1995
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D017637 2002
% 212.98/213.15  |- mesh__historyNote mesh__D017637 94   
% 212.98/213.15  |- skos__historyNote mesh__D017637
% 212.98/213.15       specific cell/immunology %28%1978-1993%29%
% 212.98/213.15  |- skos__hiddenLabel mesh__D017637 Clonal Abortions
% 212.98/213.15  |- skos__hiddenLabel mesh__D017637 Deletion, Clonal
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D017637 1996
% 212.98/213.15  |- skos__hiddenLabel mesh__D017637 Abortion, Clonal
% 212.98/213.15  |- skos__prefLabel mesh__D017637 Clonal Deletion
% 212.98/213.15  |- mesh__publicMeSHNote mesh__D017637 94   
% 212.98/213.15  |- skos__hiddenLabel mesh__D017637 Deletions, Clonal
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D017637 2000
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D017637 1998
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D017637 2003
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D017637 1997
% 212.98/213.15  |- skos__annotation mesh__D017637 a form of immune tolerance   
% 212.98/213.15  |- rdf__type mesh__D017637sskos__Concept
% 212.98/213.15  |- skos__historyNote mesh__D017637 Immune Tolerance %28%1978-1993%29%
% 212.98/213.15  |- skos__hiddenLabel mesh__D017637 Clonal Deletions
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D017637 2001
% 212.98/213.15  |- skos__broader mesh__D017637smesh__D007108
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D017637 2005
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D017637 1999
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D017637 2004
% 212.98/213.15  |- mesh__dateCreated mesh__D017637 1993-02-16
% 212.98/213.15  |- skos__scopeNote mesh__D017637
% 212.98/213.15       Removal, via CELL DEATH, of immature lymphocytes that interact with antigens during maturation. For T-lymphocytes this occurs in the thymus and ensures that mature T-lymphocytes are self tolerant. B-lymphocytes may also undergo clonal deletion.%A%    
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D017637 1994
% 212.98/213.15  |- skos__hiddenLabel mesh__D017637 Abortions, Clonal
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D017637 2006
% 212.98/213.15  |- skos__related mesh__D017637smesh__D017209
% 212.98/213.15  |- skos__historyNote mesh__D017637 Clone Cells %28%1978-1993%29%
% 212.98/213.15  |- mesh__dateEstablished mesh__D017637 1994-01-01
% 212.98/213.15  |- skos__annotation mesh__D031308
% 212.98/213.15       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.98/213.15  |- mesh__publicMeSHNote mesh__D031308 2003   
% 212.98/213.15  |- rdf__type mesh__D031308sskos__Concept
% 212.98/213.15  |- skos__broader mesh__D031308smesh__D019684
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D031308 2003
% 212.98/213.15  |- mesh__historyNote mesh__D031308 2003   
% 212.98/213.15  |- skos__prefLabel mesh__D031308 Flacourtiaceae
% 212.98/213.15  |- mesh__dateCreated mesh__D031308 2002-07-03
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D031308 2005
% 212.98/213.15  |- mesh__dateEstablished mesh__D031308 2003-01-01
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D031308 2004
% 212.98/213.15  |- skos__scopeNote mesh__D031308
% 212.98/213.15       The Indian plum plant family of the order Violales, subclass Dilleniidae class Magnoliopsida, that are tropical and subtropical trees and shrubs.%A%    
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D031308 2006
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D003617 2001
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D003617 2006
% 212.98/213.15  |- skos__annotation mesh__D003617 no qualif   
% 212.98/213.15  |- mesh__recordMaintainer mesh__D003617 JLS
% 212.98/213.15  |- mesh__historyNote mesh__D003617
% 212.98/213.15       91%28%78%29%; was see under VIOLENCE 1978-90   
% 212.98/213.15  |- rdf__type mesh__D003617sskos__Concept
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D003617 2003
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D003617 1998
% 212.98/213.15  |- skos__prefLabel mesh__D003617 Dangerous Behavior
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D003617 2002
% 212.98/213.15  |- mesh__recordAuthorizer mesh__D003617 SJN
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D003617 2004
% 212.98/213.15  |- skos__historyNote mesh__D003617 Violence %28%1968-1977%29%
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D003617 1999
% 212.98/213.15  |- skos__broader mesh__D003617smesh__D012940
% 212.98/213.15  |- skos__altLabel mesh__D003617 Behavior, Dangerous
% 212.98/213.15  |- mesh__dateRevised mesh__D003617 1997-06-20
% 212.98/213.15  |- mesh__recordOriginator mesh__D003617 EC
% 212.98/213.15  |- mesh__dateCreated mesh__D003617 1977-04-22
% 212.98/213.15  |- skos__hiddenLabel mesh__D003617 Dangerous Behaviors
% 212.98/213.15  |- skos__scopeNote mesh__D003617
% 212.98/213.15       Actions which have a high risk of being harmful or injurious to oneself or others.%A%    
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D003617 2000
% 212.98/213.15  |- mesh__publicMeSHNote mesh__D003617 91; was see under VIOLENCE 1978-90   
% 212.98/213.15  |- mesh__dateEstablished mesh__D003617 1991-01-01
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D003617 2005
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D008302 2006
% 212.98/213.15  |- mesh__recordMaintainer mesh__D008302 TGC
% 212.98/213.15  |- skos__scopeNote mesh__D008302
% 212.98/213.15       A country in western Africa, east of MAURITANIA and north of SUDAN. Its capital is Bamako. Its earlier names give a clue to its African and overseas connections: 1904-1920 it was known as Upper Senegal-Niger; prior to 1958, as French Sudan; 1958-1960 as the Sudanese Republic and 1959-1960 it joined Senegal in the Mali Federation. It became an independent republic in 1960 but the government is at present in transition. Mali was the name of a former empire, extinct from the 17th century. It may be derived from Malinke, an indigenous people of this region or from a Mandingo word meaning hippopotamus. %28%From Webster%27%s New Geographical Dictionary, p717 %26% Room, Brewer%27%s Dictionary of Names, 1992, p329%29%%A%    
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D008302 1999
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D008302 2003
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D008302 2000
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D008302 1996
% 212.98/213.15  |- rdf__type mesh__D008302sskos__Concept
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D008302 2004
% 212.98/213.15  |- skos__prefLabel mesh__D008302 Mali
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D008302 2001
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D008302 1997
% 212.98/213.15  |- skos__broader mesh__D008302smesh__D000354
% 212.98/213.15  |- mesh__dateCreated mesh__D008302 1999-01-01
% 212.98/213.15  |- mesh__recordOriginator mesh__D008302 NLM
% 212.98/213.15  |- skos__annotation mesh__D008302 a country in western Africa   
% 212.98/213.15  |- mesh__recordAuthorizer mesh__D008302 PLS
% 212.98/213.15  |- mesh__dateRevised mesh__D008302 1995-02-21
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D008302 2005
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D008302 2002
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D008302 1998
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D013247 1991
% 212.98/213.15  |- mesh__recordMaintainer mesh__D013247 TGC
% 212.98/213.15  |- mesh__dateCreated mesh__D013247 1999-01-01
% 212.98/213.15  |- mesh__recordOriginator mesh__D013247 NLM
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D013247 1994
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D013247 2001
% 212.98/213.15  |- skos__broader mesh__D013247smesh__D007596
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D013247 2004
% 212.98/213.15  |- rdf__type mesh__D013247sskos__Concept
% 212.98/213.15  |- skos__hiddenLabel mesh__D013247 Joint, Sternoclavicular
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D013247 2000
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D013247 1997
% 212.98/213.15  |- skos__hiddenLabel mesh__D013247 Sternoclavicular Joints
% 212.98/213.15  |- mesh__dateRevised mesh__D013247 1989-04-06
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D013247 1990
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D013247 2003
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D013247 1993
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D013247 2006
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D013247 1996
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D013247 2002
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D013247 1999
% 212.98/213.15  |- mesh__recordAuthorizer mesh__D013247 PLS
% 212.98/213.15  |- skos__prefLabel mesh__D013247 Sternoclavicular Joint
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D013247 1992
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D013247 2005
% 212.98/213.15  |- skos__hiddenLabel mesh__D013247 Joints, Sternoclavicular
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D013247 1995
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D013247 1998
% 212.98/213.15  |- mesh__dateEstablished mesh__D018730 1995-01-01
% 212.98/213.15  |- skos__prefLabel mesh__D018730 Infant Behavior
% 212.98/213.15  |- rdf__type mesh__D018730sskos__Concept
% 212.98/213.15  |- mesh__historyNote mesh__D018730 95   
% 212.98/213.15  |- skos__historyNote mesh__D018730
% 212.98/213.15       specific infant heading %28%1967-1994%29%
% 212.98/213.15  |- skos__altLabel mesh__D018730 Behavior, Infant
% 212.98/213.15  |- skos__scopeNote mesh__D018730
% 212.98/213.15       Any observable response or action of a neonate or infant up through the age of 23 months.%A%    
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D018730 2005
% 212.98/213.15  |- skos__annotation mesh__D018730
% 212.98/213.15       check also tag INFANT or INFANT, NEWBORN but see note there%A%  
% 212.98/213.15  |- mesh__publicMeSHNote mesh__D018730 95   
% 212.98/213.15  |- skos__historyNote mesh__D018730 Child Behavior %28%1967-1994%29%
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D018730 2003
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D018730 2006
% 212.98/213.15  |- mesh__dateRevised mesh__D018730 2002-07-02
% 212.98/213.15  |- mesh__dateCreated mesh__D018730 1994-05-23
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D018730 2004
% 212.98/213.15  |- skos__broader mesh__D018730smesh__D002652
% 212.98/213.15  |- mesh__dateCreated mesh__D032401 2002-07-03
% 212.98/213.15  |- mesh__dateEstablished mesh__D032401 2003-01-01
% 212.98/213.15  |- skos__prefLabel mesh__D032401 Typhaceae
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D032401 2005
% 212.98/213.15  |- skos__scopeNote mesh__D032401
% 212.98/213.15       A plant family of the order Typhales, subclass Commelinidae, class Liliopsida %28%monocotyledons%29% that contains a single genus, Typha, that grows worldwide.%A%    
% 212.98/213.15  |- skos__broader mesh__D032401smesh__D019684
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D032401 2003
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D032401 2006
% 212.98/213.15  |- skos__annotation mesh__D032401
% 212.98/213.15       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.98/213.15  |- mesh__publicMeSHNote mesh__D032401 2003   
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D032401 2004
% 212.98/213.15  |- rdf__type mesh__D032401sskos__Concept
% 212.98/213.15  |- mesh__historyNote mesh__D032401 2003   
% 212.98/213.15  |- skos__altLabel mesh__D032401 Cattail
% 212.98/213.15  |- mesh__onlineNote mesh__D004710 search LABYRINTHINE FLUIDS 1966-74   
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D004710 2006
% 212.98/213.15  |- mesh__historyNote mesh__D004710
% 212.98/213.15       91%28%75%29%; was see under LABYRINTHINE FLUIDS 1975-90   
% 212.98/213.15  |- mesh__recordOriginator mesh__D004710 NLM
% 212.98/213.15  |- skos__scopeNote mesh__D004710
% 212.98/213.15       The lymph fluid found in the membranous labyrinth of the ear. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 212.98/213.15  |- mesh__dateEstablished mesh__D004710 1991-01-01
% 212.98/213.15  |- mesh__dateRevised mesh__D004710 2003-07-09
% 212.98/213.15  |- skos__prefLabel mesh__D004710 Endolymph
% 212.98/213.15  |- skos__broader mesh__D004710smesh__D007761
% 212.98/213.15  |- skos__hiddenLabel mesh__D004710 Endolymphs
% 212.98/213.15  |- mesh__publicMeSHNote mesh__D004710
% 212.98/213.15       91; was see under LABYRINTHINE FLUIDS 1975-90   
% 212.98/213.15  |- mesh__recordMaintainer mesh__D004710 nns
% 212.98/213.15  |- rdf__type mesh__D004710sskos__Concept
% 212.98/213.15  |- mesh__recordAuthorizer mesh__D004710 sjn
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D004710 2004
% 212.98/213.15  |- mesh__dateCreated mesh__D004710 1999-01-01
% 212.98/213.15  |- skos__annotation mesh__D004710
% 212.98/213.15       a labyrinthine fluid; do not use for %22%endolymphatic injections%22% %28% = INJECTIONS, ENDOLYMPHATIC see INJECTIONS, INTRALYMPHATIC%29%%A%  
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D004710 2005
% 212.98/213.15  |- mesh__recordMaintainer mesh__D017638 ssb
% 212.98/213.15  |- skos__broader mesh__D017638smesh__D017636
% 212.98/213.15  |- mesh__recordOriginator mesh__D017638 TPW
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D017638 2003
% 212.98/213.15  |- rdf__type mesh__D017638sskos__Concept
% 212.98/213.15  |- mesh__dateEstablished mesh__D017638 1994-01-01
% 212.98/213.15  |- skos__prefLabel mesh__D017638 Asbestos, Crocidolite
% 212.98/213.15  |- mesh__activeMeSHYear mesh__D017638 2005
% 212.98/213.16  |- skos__altLabel mesh__D017638 Crocidolite
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D017638 2004
% 212.98/213.16  |- skos__hiddenLabel mesh__D017638 Asbestos, Blue
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D017638 2002
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D017638 2006
% 212.98/213.16  |- mesh__publicMeSHNote mesh__D017638
% 212.98/213.16       94; CROCIDOLITE was indexed under ASBESTOS 1975-93   
% 212.98/213.16  |- skos__historyNote mesh__D017638 Asbestos %28%1975-1993%29%
% 212.98/213.16  |- skos__scopeNote mesh__D017638 A lavender, acid-resistant asbestos.     
% 212.98/213.16  |- mesh__historyNote mesh__D017638
% 212.98/213.16       94; was CROCIDOLITE %28%NM%29% 1975-93   
% 212.98/213.16  |- skos__altLabel mesh__D017638 Crocidolite Asbestos
% 212.98/213.16  |- mesh__dateRevised mesh__D017638 2001-07-25
% 212.98/213.16  |- mesh__dateCreated mesh__D017638 1993-06-21
% 212.98/213.16  |- mesh__onlineNote mesh__D017638
% 212.98/213.16       use ASBESTOS, CROCIDOLITE %28%NM%29% to search CROCIDOLITE 1980-93%A%  
% 212.98/213.16  |- skos__altLabel mesh__D017638 Blue Asbestos
% 212.98/213.16  |- mesh__recordAuthorizer mesh__D017638 sjn
% 212.98/213.16  |- skos__annotation mesh__D017638 D25-26 qualif   
% 212.98/213.16  |- rdf__type mesh__D031309sskos__Concept
% 212.98/213.16  |- mesh__historyNote mesh__D031309 2003   
% 212.98/213.16  |- mesh__dateCreated mesh__D031309 2002-07-03
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D031309 2003
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D031309 2005
% 212.98/213.16  |- skos__scopeNote mesh__D031309
% 212.98/213.16       A plant genus of the family FLACOURTIACEAE that is the source of RYANODINE.%A%    
% 212.98/213.16  |- skos__prefLabel mesh__D031309 Ryania
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D031309 2004
% 212.98/213.16  |- skos__broader mesh__D031309smesh__D031308
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D031309 2006
% 212.98/213.16  |- skos__annotation mesh__D031309
% 212.98/213.16       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.98/213.16  |- mesh__publicMeSHNote mesh__D031309 2003   
% 212.98/213.16  |- mesh__dateEstablished mesh__D031309 2003-01-01
% 212.98/213.16  |- skos__broader mesh__D010604Q000191smesh__D010604
% 212.98/213.16  |- mesh__preferredCombination mesh__D010604Q000191smesh__D017850
% 212.98/213.16  |- rdf__type mesh__D010604Q000191smesh__CompoundConcept
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D014340 2004
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D014340 2006
% 212.98/213.16  |- mesh__dateCreated mesh__D014340 1999-01-01
% 212.98/213.16  |- mesh__dateRevised mesh__D014340 2002-07-03
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D014340 2003
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D014340 2005
% 212.98/213.16  |- skos__broader mesh__D014340smesh__D013523
% 212.98/213.16  |- mesh__recordMaintainer mesh__D014340 mdb
% 212.98/213.16  |- skos__prefLabel mesh__D014340 Trusses
% 212.98/213.16  |- rdf__type mesh__D014340sskos__Concept
% 212.98/213.16  |- mesh__recordAuthorizer mesh__D014340 sjn
% 212.98/213.16  |- skos__scopeNote mesh__D014340
% 212.98/213.16       A surgical device designed for retaining a hernia in a reduced state within the abdominal cavity.%A%    
% 212.98/213.16  |- mesh__recordOriginator mesh__D014340 NLM
% 212.98/213.16  |- rdf__type mesh__D008303sskos__Concept
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D008303 2004
% 212.98/213.16  |- mesh__recordOriginator mesh__D008303 NLM
% 212.98/213.16  |- skos__scopeNote mesh__D008303
% 212.98/213.16       A symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. %28%Dorland, 27th ed; Stedman, 25th ed%29%%A%    
% 212.98/213.16  |- mesh__recordAuthorizer mesh__D008303 PLS
% 212.98/213.16  |- mesh__recordMaintainer mesh__D008303 TPW
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D008303 1997
% 212.98/213.16  |- skos__annotation mesh__D008303
% 212.98/213.16       do not use /blood supply /chem /second /secret /ultrastruct; for cardiac manifest use CARCINOID HEART DISEASE%A%  
% 212.98/213.16  |- skos__hiddenLabel mesh__D008303 Carcinoid Syndromes, Malignant
% 212.98/213.16  |- mesh__dateCreated mesh__D008303 1999-01-01
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D008303 2002
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D008303 2005
% 212.98/213.16  |- mesh__dateRevised mesh__D008303 1996-06-10
% 212.98/213.16  |- skos__hiddenLabel mesh__D008303 Carcinoid Syndrome, Malignant
% 212.98/213.16  |- skos__broader mesh__D008303smesh__D002276
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D008303 1998
% 212.98/213.16  |- skos__prefLabel mesh__D008303 Malignant Carcinoid Syndrome
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D008303 2006
% 212.98/213.16  |- skos__hiddenLabel mesh__D008303 Syndromes, Malignant Carcinoid
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D008303 2000
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D008303 1999
% 212.98/213.16  |- skos__hiddenLabel mesh__D008303 Malignant Carcinoid Syndromes
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D008303 2003
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D008303 2001
% 212.98/213.16  |- skos__hiddenLabel mesh__D008303 Syndrome, Malignant Carcinoid
% 212.98/213.16  |- skos__hiddenLabel mesh__D000320 Fiber, Sympathetic
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D000320 2006
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D000320 2000
% 212.98/213.16  |- mesh__recordMaintainer mesh__D000320 RAZ
% 212.98/213.16  |- skos__hiddenLabel mesh__D000320 Fibers, Sympathetic
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D000320 2001
% 212.98/213.16  |- mesh__dateCreated mesh__D000320 1976-04-27
% 212.98/213.16  |- skos__altLabel mesh__D000320 Sympathetic Fibers
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D000320 1996
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D000320 2002
% 212.98/213.16  |- mesh__historyNote mesh__D000320 77   
% 212.98/213.16  |- mesh__dateRevised mesh__D000320 1993-06-18
% 212.98/213.16  |- mesh__publicMeSHNote mesh__D000320 77   
% 212.98/213.16  |- rdf__type mesh__D000320sskos__Concept
% 212.98/213.16  |- mesh__recordOriginator mesh__D000320 MM
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D000320 1997
% 212.98/213.16  |- skos__hiddenLabel mesh__D000320 Sympathetic Fiber
% 212.98/213.16  |- skos__hiddenLabel mesh__D000320 Fibers, Adrenergic
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D000320 2003
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D000320 1998
% 212.98/213.16  |- skos__prefLabel mesh__D000320 Adrenergic Fibers
% 212.98/213.16  |- skos__broader mesh__D000320smesh__D009412
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D000320 2004
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D000320 1994
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D000320 1999
% 212.98/213.16  |- skos__historyNote mesh__D000320
% 212.98/213.16       Sympathetic Nervous System %28%1966-1976%29%
% 212.98/213.16  |- mesh__dateEstablished mesh__D000320 1977-01-01
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D000320 2005
% 212.98/213.16  |- mesh__recordAuthorizer mesh__D000320 PLS
% 212.98/213.16  |- skos__scopeNote mesh__D000320
% 212.98/213.16       Nerve fibers liberating catecholamines at a synapse after an impulse.%A%    
% 212.98/213.16  |- skos__hiddenLabel mesh__D000320 Fiber, Adrenergic
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D000320 1995
% 212.98/213.16  |- skos__hiddenLabel mesh__D000320 Adrenergic Fiber
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013248 1995
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013248 2001
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013248 1994
% 212.98/213.16  |- rdf__type mesh__D013248sskos__Concept
% 212.98/213.16  |- mesh__historyNote mesh__D013248
% 212.98/213.16       91%28%75%29%; was see under JOINTS 1979-90; was see under RIBS 1963-78%A%  
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013248 2000
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013248 1997
% 212.98/213.16  |- skos__hiddenLabel mesh__D013248 Sternocostal Joint
% 212.98/213.16  |- skos__hiddenLabel mesh__D013248 Joints, Sternocostal
% 212.98/213.16  |- skos__broader mesh__D013248smesh__D007596
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013248 2004
% 212.98/213.16  |- skos__hiddenLabel mesh__D013248 Joint, Sternocostal
% 212.98/213.16  |- mesh__dateRevised mesh__D013248 1992-05-18
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013248 1996
% 212.98/213.16  |- skos__prefLabel mesh__D013248 Sternocostal Joints
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013248 2003
% 212.98/213.16  |- mesh__recordAuthorizer mesh__D013248 PLS
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013248 1993
% 212.98/213.16  |- mesh__onlineNote mesh__D013248 search RIBS 1966-74   
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013248 2002
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013248 1999
% 212.98/213.16  |- mesh__recordMaintainer mesh__D013248 TAP
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013248 2006
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013248 1998
% 212.98/213.16  |- mesh__dateEstablished mesh__D013248 1991-01-01
% 212.98/213.16  |- mesh__dateCreated mesh__D013248 1999-01-01
% 212.98/213.16  |- mesh__recordOriginator mesh__D013248 NLM
% 212.98/213.16  |- mesh__publicMeSHNote mesh__D013248
% 212.98/213.16       91; was see under JOINTS 1979-90; was see under RIBS 1963-78%A%  
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013248 2005
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D032402 2005
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D032402 2003
% 212.98/213.16  |- skos__prefLabel mesh__D032402 Boehmeria
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D032402 2006
% 212.98/213.16  |- skos__annotation mesh__D032402
% 212.98/213.16       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.98/213.16  |- mesh__publicMeSHNote mesh__D032402 2003   
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D032402 2004
% 212.98/213.16  |- mesh__historyNote mesh__D032402 2003   
% 212.98/213.16  |- rdf__type mesh__D032402sskos__Concept
% 212.98/213.16  |- skos__altLabel mesh__D032402 Ramie
% 212.98/213.16  |- mesh__dateEstablished mesh__D032402 2003-01-01
% 212.98/213.16  |- skos__scopeNote mesh__D032402
% 212.98/213.16       A plant genus of the family URTICACEAE. Members contain cryptopleurine, beta-sitosterol, daucosterol and 19 alpha-hydroxyursolic acid.%A%    
% 212.98/213.16  |- skos__broader mesh__D032402smesh__D027003
% 212.98/213.16  |- mesh__dateCreated mesh__D032402 2002-07-02
% 212.98/213.16  |- skos__broader mesh__D004711smesh__D014723
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004711 1998
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004711 1993
% 212.98/213.16  |- mesh__historyNote mesh__D004711
% 212.98/213.16       91%28%79%29%; was see under VESTIBULE 1990; was see under LABYRINTH 1979-89%A%  
% 212.98/213.16  |- mesh__dateEstablished mesh__D004711 1991-01-01
% 212.98/213.16  |- skos__historyNote mesh__D004711 Labyrinth %28%1966-1978%29%
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004711 1994
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004711 2003
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004711 1999
% 212.98/213.16  |- rdf__type mesh__D004711sskos__Concept
% 212.98/213.16  |- mesh__dateCreated mesh__D004711 1978-05-19
% 212.98/213.16  |- skos__historyNote mesh__D004711 Endolymph %28%1975-1978%29%
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004711 2000
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004711 1991
% 212.98/213.16  |- mesh__recordAuthorizer mesh__D004711 PLS
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004711 1995
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004711 2004
% 212.98/213.16  |- skos__hiddenLabel mesh__D004711 Ducts, Endolymphatic
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004711 2001
% 212.98/213.16  |- mesh__recordOriginator mesh__D004711 RC
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004711 2005
% 212.98/213.16  |- skos__hiddenLabel mesh__D004711 Endolymphatic Ducts
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004711 2002
% 212.98/213.16  |- skos__scopeNote mesh__D004711
% 212.98/213.16       Duct connecting the endolymphatic sac with the membranous labyrinth.%A%    
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004711 2006
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004711 1996
% 212.98/213.16  |- mesh__dateRevised mesh__D004711 1990-05-16
% 212.98/213.16  |- mesh__publicMeSHNote mesh__D004711
% 212.98/213.16       91; was see under VESTIBULE 1990; was see under LABYRINTH 1979-89%A%  
% 212.98/213.16  |- skos__historyNote mesh__D004711 Labyrinthine Fluids %28%1966-1974%29%
% 212.98/213.16  |- skos__hiddenLabel mesh__D004711 Duct, Endolymphatic
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004711 1997
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004711 1992
% 212.98/213.16  |- skos__prefLabel mesh__D004711 Endolymphatic Duct
% 212.98/213.16  |- mesh__recordMaintainer mesh__D004711 NLM
% 212.98/213.16  |- mesh__dateCreated mesh__D017639 1993-06-21
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D017639 2000
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D017639 2005
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D017639 2004
% 212.98/213.16  |- skos__broader mesh__D017639smesh__D017633
% 212.98/213.16  |- mesh__recordAuthorizer mesh__D017639 sjn
% 212.98/213.16  |- skos__altLabel mesh__D017639 Amosite
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D017639 2001
% 212.98/213.16  |- mesh__recordOriginator mesh__D017639 TPW
% 212.98/213.16  |- mesh__recordMaintainer mesh__D017639 adp
% 212.98/213.16  |- skos__prefLabel mesh__D017639 Asbestos, Amosite
% 212.98/213.16  |- mesh__onlineNote mesh__D017639
% 212.98/213.16       use ASBESTOS, AMOSITE %28%NM%29% to search AMOSITE 1980-93   
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D017639 2006
% 212.98/213.16  |- skos__hiddenLabel mesh__D017639 Cummingtonite Grunerite
% 212.98/213.16  |- mesh__dateRevised mesh__D017639 1999-11-03
% 212.98/213.16  |- mesh__dateEstablished mesh__D017639 1994-01-01
% 212.98/213.16  |- mesh__historyNote mesh__D017639 94; was AMOSITE %28%NM%29% 1974-93   
% 212.98/213.16  |- skos__altLabel mesh__D017639 Amosite Asbestos
% 212.98/213.16  |- skos__annotation mesh__D017639 an amphibole asbestos; D25-26 qualif   
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D017639 2002
% 212.98/213.16  |- skos__scopeNote mesh__D017639
% 212.98/213.16       Asbestos, grunerite. A monoclinic amphibole form of asbestos having long fibers and a high iron content. It is used in insulation. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 212.98/213.16  |- skos__broader mesh__D017639smesh__D017636
% 212.98/213.16  |- skos__historyNote mesh__D017639 Asbestos %28%1974-1993%29%
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D017639 2003
% 212.98/213.16  |- rdf__type mesh__D017639sskos__Concept
% 212.98/213.16  |- mesh__publicMeSHNote mesh__D017639
% 212.98/213.16       94; AMOSITE was indexed under ASBESTOS 1974-93   
% 212.98/213.16  |- skos__scopeNote mesh__D028361
% 212.98/213.16       Diseases caused by abnormal function of the MITOCHONDRIA. They may be caused by mutations, acquired or inherited, in mitochondrial DNA or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes.%A%    
% 212.98/213.16  |- mesh__recordAuthorizer mesh__D028361 sjn
% 212.98/213.16  |- skos__hiddenLabel mesh__D028361 Disease, Mitochondrial
% 212.98/213.16  |- skos__hiddenLabel mesh__D028361 Disorder, Mitochondrial
% 212.98/213.16  |- skos__historyNote mesh__D028361 Mitochondria %28%1987-2001%29%
% 212.98/213.16  |- skos__hiddenLabel mesh__D028361 Phosphorylation Deficiency, Oxidative
% 212.98/213.16  |- skos__hiddenLabel mesh__D028361 Oxidative Phosphorylation Deficiency
% 212.98/213.16  |- skos__hiddenLabel mesh__D028361 Respiratory Chain Deficiency
% 212.98/213.16  |- skos__hiddenLabel mesh__D028361 Disorders, Mitochondrial
% 212.98/213.16  |- mesh__recordOriginator mesh__D028361 nns
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D028361 2006
% 212.98/213.16  |- skos__broader mesh__D028361smesh__D008659
% 212.98/213.16  |- mesh__historyNote mesh__D028361
% 212.98/213.16       2002; use MITOCHONDRIAL MYOPATHIES 2000-2001   
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D028361 2002
% 212.98/213.16  |- rdf__type mesh__D028361sskos__Concept
% 212.98/213.16  |- skos__hiddenLabel mesh__D028361 Mitochondrial Disorder
% 212.98/213.16  |- mesh__dateEstablished mesh__D028361 2002-01-01
% 212.98/213.16  |- skos__hiddenLabel mesh__D028361 Phosphorylation Deficiencies, Oxidative
% 212.98/213.16  |- mesh__dateCreated mesh__D028361 2001-08-03
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D028361 2005
% 212.98/213.16  |- skos__prefLabel mesh__D028361 Mitochondrial Diseases
% 212.98/213.16  |- skos__hiddenLabel mesh__D028361 Mitochondrial Disease
% 212.98/213.16  |- skos__annotation mesh__D028361 GEN or unspecified; prefer specifics   
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D028361 2004
% 212.98/213.16  |- skos__altLabel mesh__D028361
% 212.98/213.16       Mitochondrial Electron Transport Chain Deficiencies
% 212.98/213.16  |- skos__hiddenLabel mesh__D028361 Deficiencies, Oxidative Phosphorylation
% 212.98/213.16  |- skos__historyNote mesh__D028361
% 212.98/213.16       Mitochondrial Myopathies %28%1992-2001%29%
% 212.98/213.16  |- skos__hiddenLabel mesh__D028361 Deficiency, Oxidative Phosphorylation
% 212.98/213.16  |- mesh__recordMaintainer mesh__D028361 jls
% 212.98/213.16  |- skos__altLabel mesh__D028361 Mitochondrial Disorders
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D028361 2003
% 212.98/213.16  |- skos__hiddenLabel mesh__D028361 Deficiencies, Respiratory Chain
% 212.98/213.16  |- skos__altLabel mesh__D028361
% 212.98/213.16       Mitochondrial Respiratory Chain Deficiencies
% 212.98/213.16  |- skos__hiddenLabel mesh__D028361 Deficiency, Respiratory Chain
% 212.98/213.16  |- mesh__publicMeSHNote mesh__D028361
% 212.98/213.16       2002; see MITOCHONDRIAL MYOPATHIES 2000-2001   
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D003619 2002
% 212.98/213.16  |- skos__broader mesh__D003619smesh__D009281
% 212.98/213.16  |- skos__hiddenLabel mesh__D003619
% 212.98/213.16       Compounds, Dimethylaminonaphthalenesulfonyl
% 212.98/213.16  |- skos__hiddenLabel mesh__D003619 Compounds, Dansyl
% 212.98/213.16  |- mesh__dateEstablished mesh__D003619 1972-01-01
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D003619 2005
% 212.98/213.16  |- mesh__dateRevised mesh__D003619 2000-06-22
% 212.98/213.16  |- mesh__dateCreated mesh__D003619 1999-01-01
% 212.98/213.16  |- skos__annotation mesh__D003619 D25-26 qualif; DF: DANSYL CPDS   
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D003619 2006
% 212.98/213.16  |- mesh__recordOriginator mesh__D003619 NLM
% 212.98/213.16  |- mesh__publicMeSHNote mesh__D003619 72   
% 212.98/213.16  |- mesh__recordAuthorizer mesh__D003619 sjn
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D003619 2001
% 212.98/213.16  |- rdf__type mesh__D003619sskos__Concept
% 212.98/213.16  |- skos__altLabel mesh__D003619 Dimethylaminonaphthalenesulfonyl Compounds
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D003619 2003
% 212.98/213.16  |- mesh__historyNote mesh__D003619 72   
% 212.98/213.16  |- skos__prefLabel mesh__D003619 Dansyl Compounds
% 212.98/213.16  |- skos__historyNote mesh__D003619 Sulfonic Acids %28%1966-1971%29%
% 212.98/213.16  |- skos__historyNote mesh__D003619 Naphthalenes %28%1966-1971%29%
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D003619 2004
% 212.98/213.16  |- skos__scopeNote mesh__D003619
% 212.98/213.16       Compounds that contain a 1-dimethylaminonaphthalene-5-sulfonyl group.%A%    
% 212.98/213.16  |- mesh__recordMaintainer mesh__D003619 CCR
% 212.98/213.16  |- skos__broader mesh__D003619smesh__D013450
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D014341 2006
% 212.98/213.16  |- skos__hiddenLabel mesh__D014341 Trustee
% 212.98/213.16  |- mesh__onlineNote mesh__D014341 search GOVERNING BOARD 1968-79   
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D014341 1994
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D014341 2003
% 212.98/213.16  |- mesh__historyNote mesh__D014341
% 212.98/213.16       91%28%80%29%; was see under GOVERNING BOARD 1980-90; was see GOVERNING BOARD 1968-79%A%  
% 212.98/213.16  |- mesh__publicMeSHNote mesh__D014341
% 212.98/213.16       91; was see under GOVERNING BOARD 1980-90; was see GOVERNING BOARD 1968-79%A%  
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D014341 2005
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D014341 2000
% 212.98/213.16  |- skos__historyNote mesh__D014341 Governing Board %28%1968-1979%29%
% 212.98/213.16  |- mesh__dateCreated mesh__D014341 1979-05-29
% 212.98/213.16  |- mesh__recordAuthorizer mesh__D014341 PLS
% 212.98/213.16  |- mesh__dateEstablished mesh__D014341 1991-01-01
% 212.98/213.16  |- skos__broader mesh__D014341smesh__D000288
% 212.98/213.16  |- mesh__dateRevised mesh__D014341 1992-05-18
% 212.98/213.16  |- rdf__type mesh__D014341sskos__Concept
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D014341 1997
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D014341 2002
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D014341 1999
% 212.98/213.16  |- mesh__recordMaintainer mesh__D014341 TAP
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D014341 1993
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D014341 1996
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D014341 2004
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D014341 2001
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D014341 1995
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D014341 1998
% 212.98/213.16  |- skos__prefLabel mesh__D014341 Trustees
% 212.98/213.16  |- skos__broader mesh__D014341smesh__D006075
% 212.98/213.16  |- skos__scopeNote mesh__D014341
% 212.98/213.16       Board members of an institution or organization who are entrusted with the administering of funds and the directing of policy.%A%    
% 212.98/213.16  |- mesh__recordOriginator mesh__D014341 EC
% 212.98/213.16  |- skos__annotation mesh__D008304
% 212.98/213.16       caused by a herpesvirus; usually animal; check tag ANIMALS; don%27%t forget also CATTLE %28%NIM%29% but do not index under CATTLE DISEASES%A%  
% 212.98/213.16  |- skos__hiddenLabel mesh__D008304 Catarrh, Malignant
% 212.98/213.16  |- mesh__dateCreated mesh__D008304 1999-01-01
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D008304 2005
% 212.98/213.16  |- mesh__recordMaintainer mesh__D008304 ags
% 212.98/213.16  |- skos__historyNote mesh__D008304 Cattle Diseases %28%1966-1970%29%
% 212.98/213.16  |- mesh__recordOriginator mesh__D008304 NLM
% 212.98/213.16  |- skos__prefLabel mesh__D008304 Malignant Catarrh
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D008304 2006
% 212.98/213.16  |- mesh__recordAuthorizer mesh__D008304 sjn
% 212.98/213.16  |- skos__broader mesh__D008304smesh__D002418
% 212.98/213.16  |- skos__historyNote mesh__D008304
% 212.98/213.16       Herpesvirus Infections/VE %28%1966-1970%29%
% 212.98/213.16  |- mesh__historyNote mesh__D008304 71   
% 212.98/213.16  |- skos__broader mesh__D008304smesh__D006566
% 212.98/213.16  |- mesh__dateEstablished mesh__D008304 1971-01-01
% 212.98/213.16  |- skos__hiddenLabel mesh__D008304 Catarrhs, Malignant
% 212.98/213.16  |- rdf__type mesh__D008304sskos__Concept
% 212.98/213.16  |- skos__hiddenLabel mesh__D008304 Malignant Catarrhs
% 212.98/213.16  |- mesh__publicMeSHNote mesh__D008304 71   
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D008304 2004
% 212.98/213.16  |- mesh__dateRevised mesh__D008304 2003-07-30
% 212.98/213.16  |- skos__scopeNote mesh__D008304
% 212.98/213.16       A herpesvirus infection of cattle characterized by catarrhal inflammation of the upper respiratory and alimentary epithelia, keratoconjunctivitis, encephalitis and lymph node enlargement. Syn: bovine epitheliosis, snotsiekte.%A%    
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013249 1994
% 212.98/213.16  |- skos__hiddenLabel mesh__D013249 Sternums
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013249 1989
% 212.98/213.16  |- rdf__type mesh__D013249sskos__Concept
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013249 1997
% 212.98/213.16  |- skos__prefLabel mesh__D013249 Sternum
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013249 2004
% 212.98/213.16  |- skos__broader mesh__D013249smesh__D013909
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013249 1991
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013249 1996
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013249 2001
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013249 2003
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013249 1993
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013249 2000
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013249 1999
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013249 2006
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013249 1990
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013249 1992
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013249 1998
% 212.98/213.16  |- mesh__dateCreated mesh__D013249 1999-01-01
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013249 2005
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013249 1995
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D013249 2002
% 212.98/213.16  |- skos__broader mesh__D018732smesh__D044707
% 212.98/213.16  |- mesh__publicMeSHNote mesh__D018732 95   
% 212.98/213.16  |- mesh__recordAuthorizer mesh__D018732 sjn
% 212.98/213.16  |- skos__hiddenLabel mesh__D018732 Identification, Human
% 212.98/213.16  |- mesh__recordOriginator mesh__D018732 JLS
% 212.98/213.16  |- rdf__type mesh__D018732sskos__Concept
% 212.98/213.16  |- skos__broader mesh__D018732smesh__D000885
% 212.98/213.16  |- skos__prefLabel mesh__D018732 Forensic Anthropology
% 212.98/213.16  |- skos__historyNote mesh__D018732 Forensic Medicine %28%1966-1994%29%
% 212.98/213.16  |- mesh__dateEstablished mesh__D018732 1995-01-01
% 212.98/213.16  |- skos__annotation mesh__D018732
% 212.98/213.16       restrict to identif of skeletal remains; SPEC; NIM as coord; human identif by teeth: coord FORENSIC DENTISTRY %28%IM%29% + specific dent heading %28%IM%29%; DF: FORENSIC ANTHROPOL%A%  
% 212.98/213.16  |- mesh__dateRevised mesh__D018732 2004-07-13
% 212.98/213.16  |- skos__hiddenLabel mesh__D018732 Identifications, Human
% 212.98/213.16  |- skos__altLabel mesh__D018732 Anthropology, Forensic
% 212.98/213.16  |- skos__scopeNote mesh__D018732
% 212.98/213.16       Scientific study of human skeletal remains with the express purpose of identification. This includes establishing individual identity, trauma analysis, facial reconstruction, photographic superimposition, determination of time interval since death, and crime-scene recovery. Forensic anthropologists do not certify cause of death but provide data to assist in determination of probable cause. This is a branch of the field of physical anthropology and qualified individuals are certified by the American Board of Forensic Anthropology. %28%From Am J Forensic Med Pathol 1992 Jun;13%28%2%29%:146%29%%A%    
% 212.98/213.16  |- mesh__historyNote mesh__D018732 95   
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D018732 2006
% 212.98/213.16  |- skos__hiddenLabel mesh__D018732 Human Identifications
% 212.98/213.16  |- mesh__dateCreated mesh__D018732 1994-05-23
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D018732 2005
% 212.98/213.16  |- mesh__recordMaintainer mesh__D018732 sjn
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D032403 2006
% 212.98/213.16  |- skos__annotation mesh__D032403
% 212.98/213.16       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D032403 2004
% 212.98/213.16  |- mesh__publicMeSHNote mesh__D032403 2003   
% 212.98/213.16  |- rdf__type mesh__D032403sskos__Concept
% 212.98/213.16  |- skos__altLabel mesh__D032403 Pellitory
% 212.98/213.16  |- skos__scopeNote mesh__D032403
% 212.98/213.16       A plant genus of the family URTICACEAE which is the most common cause of pollinosis in Mediterranean countries. It is the source of %27%allergen Par o I%27% and of Pollinex used for DESENSITIZATION, IMMUNOLOGIC.%A%    
% 212.98/213.16  |- mesh__historyNote mesh__D032403 2003   
% 212.98/213.16  |- skos__broader mesh__D032403smesh__D027003
% 212.98/213.16  |- mesh__dateCreated mesh__D032403 2002-07-03
% 212.98/213.16  |- mesh__dateEstablished mesh__D032403 2003-01-01
% 212.98/213.16  |- skos__prefLabel mesh__D032403 Parietaria
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D032403 2005
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D032403 2003
% 212.98/213.16  |- mesh__historyNote mesh__D004712
% 212.98/213.16       91%28%79%29%; was see under VESTIBULE 1990; was see under LABYRINTH 1979-89%A%  
% 212.98/213.16  |- mesh__dateEstablished mesh__D004712 1991-01-01
% 212.98/213.16  |- mesh__recordMaintainer mesh__D004712 NLM
% 212.98/213.16  |- skos__prefLabel mesh__D004712 Endolymphatic Sac
% 212.98/213.16  |- rdf__type mesh__D004712sskos__Concept
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004712 1993
% 212.98/213.16  |- skos__scopeNote mesh__D004712
% 212.98/213.16       The blind pouch at the end of the endolymphatic duct.     
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004712 2000
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004712 1999
% 212.98/213.16  |- mesh__recordAuthorizer mesh__D004712 PLS
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004712 2003
% 212.98/213.16  |- skos__historyNote mesh__D004712 Labyrinth %28%1966-1978%29%
% 212.98/213.16  |- skos__historyNote mesh__D004712 Endolymph %28%1975-1978%29%
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004712 1991
% 212.98/213.16  |- skos__broader mesh__D004712smesh__D004711
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004712 1994
% 212.98/213.16  |- mesh__dateCreated mesh__D004712 1978-05-19
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004712 2001
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004712 2004
% 212.98/213.16  |- skos__hiddenLabel mesh__D004712 Sac, Endolymphatic
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004712 1995
% 212.98/213.16  |- mesh__activeMeSHYear mesh__D004712 1996
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D004712 2002
% 212.98/213.17  |- mesh__recordOriginator mesh__D004712 RC
% 212.98/213.17  |- skos__hiddenLabel mesh__D004712 Endolymphatic Sacs
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D004712 2005
% 212.98/213.17  |- mesh__dateRevised mesh__D004712 1990-05-16
% 212.98/213.17  |- mesh__publicMeSHNote mesh__D004712
% 212.98/213.17       91; was see under VESTIBULE 1990; was see under LABYRINTH 1979-89%A%  
% 212.98/213.17  |- skos__historyNote mesh__D004712 Labyrinthine Fluids %28%1966-1974%29%
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D004712 1997
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D004712 2006
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D004712 1992
% 212.98/213.17  |- skos__hiddenLabel mesh__D004712 Sacs, Endolymphatic
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D004712 1998
% 212.98/213.17  |- skos__broader mesh__D010604Q000193smesh__D010604
% 212.98/213.17  |- mesh__preferredCombination mesh__D010604Q000193smesh__D004512
% 212.98/213.17  |- rdf__type mesh__D010604Q000193smesh__CompoundConcept
% 212.98/213.17  |- mesh__recordAuthorizer mesh__D014342 jls
% 212.98/213.17  |- mesh__dateRevised mesh__D014342 2004-08-02
% 212.98/213.17  |- mesh__dateEstablished mesh__D014342 1978-01-01
% 212.98/213.17  |- mesh__recordOriginator mesh__D014342 EC
% 212.98/213.17  |- rdf__type mesh__D014342sskos__Concept
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D014342 2003A
% 212.98/213.17  |- skos__altLabel mesh__D014342 Disclosure, Truth
% 212.98/213.17  |- mesh__recordMaintainer mesh__D014342 jls
% 212.98/213.17  |- skos__related mesh__D014342smesh__D028701
% 212.98/213.17  |- skos__hiddenLabel mesh__D014342 Truth Disclosures
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D014342 2005A
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D014342 2004
% 212.98/213.17  |- mesh__dateCreated mesh__D014342 1977-04-22
% 212.98/213.17  |- skos__broader mesh__D014342smesh__D030881
% 212.98/213.17  |- skos__prefLabel mesh__D014342 Truth Disclosure
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D014342 2006
% 212.98/213.17  |- mesh__publicMeSHNote mesh__D014342 78   
% 212.98/213.17  |- skos__annotation mesh__D014342 DISCLOSURE is also available   
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D014342 2003
% 212.98/213.17  |- skos__hiddenLabel mesh__D014342 Disclosures, Truth
% 212.98/213.17  |- skos__scopeNote mesh__D014342
% 212.98/213.17       Truthful revealing of information, specifically when the information disclosed is likely to be psychologically painful %28%%22%bad news%22%%29% to the recipient %28%e.g., revelation to a patient or a patient%27%s family of the patient%27%s diagnosis or prognosis%29% or embarrassing to the teller %28%e.g., revelation of medical errors%29%.%A%    
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D014342 2005
% 212.98/213.17  |- skos__historyNote mesh__D014342 Truth Disclosure %28%1974-2001%29%
% 212.98/213.17  |- mesh__historyNote mesh__D014342 78   
% 212.98/213.17  |- skos__related mesh__D014342smesh__D022126
% 212.98/213.17  |- mesh__dateEstablished mesh__D008305 1973-01-01
% 212.98/213.17  |- rdf__type mesh__D008305sskos__Concept
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D008305 2003
% 212.98/213.17  |- mesh__historyNote mesh__D008305 73   
% 212.98/213.17  |- skos__hiddenLabel mesh__D008305 Malignant Hyperthermias
% 212.98/213.17  |- skos__scopeNote mesh__D008305
% 212.98/213.17       Rapid and excessive rise of temperature accompanied by muscular rigidity following general anesthesia.%A%    
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D008305 2002
% 212.98/213.17  |- mesh__recordMaintainer mesh__D008305 KEV
% 212.98/213.17  |- skos__altLabel mesh__D008305 Hyperpyrexia, Malignant
% 212.98/213.17  |- mesh__publicMeSHNote mesh__D008305 73   
% 212.98/213.17  |- skos__altLabel mesh__D008305 Hyperthermia, Malignant
% 212.98/213.17  |- mesh__dateCreated mesh__D008305 1999-01-01
% 212.98/213.17  |- skos__hiddenLabel mesh__D008305 Malignant Hyperpyrexias
% 212.98/213.17  |- skos__related mesh__D008305smesh__D005334
% 212.98/213.17  |- skos__prefLabel mesh__D008305 Malignant Hyperthermia
% 212.98/213.17  |- skos__hiddenLabel mesh__D008305 Hyperpyrexias, Malignant
% 212.98/213.17  |- skos__broader mesh__D008305smesh__D011183
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D008305 2006
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D008305 2001
% 212.98/213.17  |- mesh__recordOriginator mesh__D008305 NLM
% 212.98/213.17  |- skos__historyNote mesh__D008305 Anesthesia, General %28%1966-1972%29%
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D008305 2004
% 212.98/213.17  |- mesh__recordAuthorizer mesh__D008305 sjn
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D008305 2005
% 212.98/213.17  |- skos__altLabel mesh__D008305 Malignant Hyperpyrexia
% 212.98/213.17  |- mesh__dateRevised mesh__D008305 1999-11-08
% 212.98/213.17  |- skos__historyNote mesh__D008305 Fever %28%1966-1972%29%
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D008305 2000
% 212.98/213.17  |- skos__hiddenLabel mesh__D000322 Receptor Agonist, Adrenergic
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D000322 2006
% 212.98/213.17  |- mesh__publicMeSHNote mesh__D000322
% 212.98/213.17       95; was ADRENERGIC RECEPTOR AGONISTS 1975-94   
% 212.98/213.17  |- mesh__dateCreated mesh__D000322 1999-01-01
% 212.98/213.17  |- mesh__onlineNote mesh__D000322
% 212.98/213.17       use ADRENERGIC AGONISTS to search ADRENERGIC RECEPTOR AGONISTS 1975-94%A%  
% 212.98/213.17  |- mesh__dateEstablished mesh__D000322 1975-01-01
% 212.98/213.17  |- skos__prefLabel mesh__D000322 Adrenergic Agonists
% 212.98/213.17  |- rdf__type mesh__D000322sskos__Concept
% 212.98/213.17  |- mesh__recordOriginator mesh__D000322 NLM
% 212.98/213.17  |- mesh__recordMaintainer mesh__D000322 ssb
% 212.98/213.17  |- skos__scopeNote mesh__D000322
% 212.98/213.17       Drugs that bind to and activate adrenergic receptors.     
% 212.98/213.17  |- mesh__recordAuthorizer mesh__D000322 sjn
% 212.98/213.17  |- skos__altLabel mesh__D000322 Adrenergic Agonist
% 212.98/213.17  |- skos__historyNote mesh__D000322 Sympathomimetics %28%1966-1974%29%
% 212.98/213.17  |- skos__altLabel mesh__D000322 Adrenergic Receptor Agonists
% 212.98/213.17  |- skos__altLabel mesh__D000322 Adrenomimetics
% 212.98/213.17  |- skos__altLabel mesh__D000322 Receptor Agonists, Adrenergic
% 212.98/213.17  |- skos__altLabel mesh__D000322 Adrenergic Receptor Agonist
% 212.98/213.17  |- skos__hiddenLabel mesh__D000322 Agonists, Adrenergic Receptor
% 212.98/213.17  |- skos__broader mesh__D000322smesh__D018663
% 212.98/213.17  |- skos__annotation mesh__D000322
% 212.98/213.17       do not confuse with ADRENERGIC ANTAGONISTS; DF: ADREN AGON or ADREN AG%A%  
% 212.98/213.17  |- skos__hiddenLabel mesh__D000322 Agonist, Adrenergic Receptor
% 212.98/213.17  |- skos__hiddenLabel mesh__D000322 Agonist, Adrenergic
% 212.98/213.17  |- mesh__dateRevised mesh__D000322 2005-06-30
% 212.98/213.17  |- mesh__historyNote mesh__D000322
% 212.98/213.17       95; was ADRENERGIC RECEPTOR AGONISTS 1975-94   
% 212.98/213.17  |- skos__hiddenLabel mesh__D000322 Agonists, Adrenergic
% 212.98/213.17  |- skos__broader mesh__D018733smesh__D018680
% 212.98/213.17  |- mesh__publicMeSHNote mesh__D018733 95   
% 212.98/213.17  |- mesh__recordAuthorizer mesh__D018733 sjn
% 212.98/213.17  |- mesh__recordOriginator mesh__D018733 RAZ
% 212.98/213.17  |- mesh__historyNote mesh__D018733 95   
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D018733 2006
% 212.98/213.17  |- skos__historyNote mesh__D018733
% 212.98/213.17       Neuromuscular Blocking Agents %28%1975-1994%29%
% 212.98/213.17  |- mesh__recordMaintainer mesh__D018733 ssb
% 212.98/213.17  |- mesh__dateEstablished mesh__D018733 1995-01-01
% 212.98/213.17  |- skos__historyNote mesh__D018733 Ganglionic Blockers %28%1970-1994%29%
% 212.98/213.17  |- skos__hiddenLabel mesh__D018733 Antagonists, Nicotinic
% 212.98/213.17  |- skos__annotation mesh__D018733
% 212.98/213.17       GEN or unspecified; prefer specifics; DF: NICOTINIC ANTAG%A%  
% 212.98/213.17  |- mesh__dateCreated mesh__D018733 1994-06-01
% 212.98/213.17  |- mesh__dateRevised mesh__D018733 2005-06-30
% 212.98/213.17  |- skos__prefLabel mesh__D018733 Nicotinic Antagonists
% 212.98/213.17  |- skos__scopeNote mesh__D018733
% 212.98/213.17       Drugs that bind to nicotinic cholinergic receptors %28%RECEPTORS, NICOTINIC%29% and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses.%A%    
% 212.98/213.17  |- rdf__type mesh__D018733sskos__Concept
% 212.98/213.17  |- mesh__recordOriginator mesh__D010750 NLM
% 212.98/213.17  |- mesh__dateCreated mesh__D010750 1999-01-01
% 212.98/213.17  |- mesh__dateEstablished mesh__D010750 1973-01-01
% 212.98/213.17  |- skos__broader mesh__D010750smesh__D011506
% 212.98/213.17  |- skos__prefLabel mesh__D010750 Phosphoproteins
% 212.98/213.17  |- rdf__type mesh__D010750sskos__Concept
% 212.98/213.17  |- mesh__onlineNote mesh__D010750 search PROTEINS 1966-70   
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D010750 2006
% 212.98/213.17  |- skos__historyNote mesh__D010750 Phosphoric Acids %28%1968-1970%29%
% 212.98/213.17  |- mesh__publicMeSHNote mesh__D010750 73; was see under PROTEINS 1963-72   
% 212.98/213.17  |- mesh__recordAuthorizer mesh__D010750 sjn
% 212.98/213.17  |- mesh__recordMaintainer mesh__D010750 DRC
% 212.98/213.17  |- mesh__dateRevised mesh__D010750 2005-06-30
% 212.98/213.17  |- skos__historyNote mesh__D010750 Proteins %28%1966-1970%29%
% 212.98/213.17  |- mesh__historyNote mesh__D010750
% 212.98/213.17       73%28%71%29%; was see under PROTEINS 1963-72   
% 212.98/213.17  |- skos__annotation mesh__D010750 /physiol permitted   
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D032404 2004
% 212.98/213.17  |- mesh__dateEstablished mesh__D032404 2003-01-01
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D032404 2006
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D032404 2003
% 212.98/213.17  |- skos__prefLabel mesh__D032404 Nardostachys
% 212.98/213.17  |- mesh__publicMeSHNote mesh__D032404 2003   
% 212.98/213.17  |- rdf__type mesh__D032404sskos__Concept
% 212.98/213.17  |- skos__scopeNote mesh__D032404
% 212.98/213.17       A plant genus of the family VALERIANACEAE. Nardostachysin, nardostachin, nardosinone, valeranone, and patchoulene have been found in this genus. Nardostachys jatamansi is classified by some as Valeriana jatamansi.%A%    
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D032404 2005
% 212.98/213.17  |- skos__annotation mesh__D032404
% 212.98/213.17       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.98/213.17  |- mesh__historyNote mesh__D032404 2003   
% 212.98/213.17  |- mesh__dateCreated mesh__D032404 2002-07-03
% 212.98/213.17  |- skos__broader mesh__D032404smesh__D028161
% 212.98/213.17  |- skos__hiddenLabel mesh__D004713 Endolymphatic Shunts
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D004713 2003
% 212.98/213.17  |- skos__broader mesh__D004713smesh__D013506
% 212.98/213.17  |- mesh__recordAuthorizer mesh__D004713 sjn
% 212.98/213.17  |- skos__historyNote mesh__D004713
% 212.98/213.17       Endolymphatic Sac/surgery %28%1979-1987%29%
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D004713 2004
% 212.98/213.17  |- skos__broader mesh__D004713smesh__D000714
% 212.98/213.17  |- mesh__publicMeSHNote mesh__D004713 88   
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D004713 2000
% 212.98/213.17  |- mesh__dateCreated mesh__D004713 1987-03-18
% 212.98/213.17  |- mesh__historyNote mesh__D004713 88   
% 212.98/213.17  |- mesh__dateEstablished mesh__D004713 1988-01-01
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D004713 2005
% 212.98/213.17  |- skos__historyNote mesh__D004713
% 212.98/213.17       Meniere%27%s Disease/surgery %28%1966-1987%29%
% 212.98/213.17  |- mesh__recordMaintainer mesh__D004713 adp
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D004713 2001
% 212.98/213.17  |- skos__scopeNote mesh__D004713
% 212.98/213.17       Surgical fistulization of the membranous labyrinth of the inner ear with mastoid, subarachnoid or cochlear shunt. This procedure is  used in the treatment of Meniere%27%s disease.%A%    
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D004713 2006
% 212.98/213.17  |- skos__hiddenLabel mesh__D004713 Shunt, Endolymphatic
% 212.98/213.17  |- skos__prefLabel mesh__D004713 Endolymphatic Shunt
% 212.98/213.17  |- mesh__dateRevised mesh__D004713 1999-11-08
% 212.98/213.17  |- mesh__recordOriginator mesh__D004713 SCD
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D004713 2002
% 212.98/213.17  |- skos__hiddenLabel mesh__D004713 Shunts, Endolymphatic
% 212.98/213.17  |- skos__historyNote mesh__D004713 Labyrinth/surgery %28%1966-1987%29%
% 212.98/213.17  |- rdf__type mesh__D004713sskos__Concept
% 212.98/213.17  |- skos__annotation mesh__D004713
% 212.98/213.17       do not use /util except by MeSH definition   
% 212.98/213.17  |- skos__hiddenLabel mesh__D020380 Needs Assessments, Healthcare
% 212.98/213.17  |- skos__hiddenLabel mesh__D020380 Needs Assessments, Educational
% 212.98/213.17  |- mesh__historyNote mesh__D020380
% 212.98/213.17       99; ASSESSMENT OF HEALTH CARE NEEDS %26% DETERMINATION OF HEALTH CARE NEEDS use HEALTH SERVICES NEEDS AND DEMAND 1980-98%A%  
% 212.98/213.17  |- mesh__dateCreated mesh__D020380 1998-06-10
% 212.98/213.17  |- skos__scopeNote mesh__D020380
% 212.98/213.17       Systematic identification of a population%27%s needs or the assessment of individuals to determine the proper level of services needed.%A%    
% 212.98/213.17  |- skos__altLabel mesh__D020380 Assessment of Healthcare Needs
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D020380 2003
% 212.98/213.17  |- skos__hiddenLabel mesh__D020380 Needs Assessment, Educational
% 212.98/213.17  |- mesh__publicMeSHNote mesh__D020380
% 212.98/213.17       99; ASSESSMENT OF HEALTH CARE NEEDS %26% DETERMINATION OF HEALTH CARE NEEDS see HEALTH SERVICES NEEDS AND DEMAND 1980-98%A%  
% 212.98/213.17  |- skos__hiddenLabel mesh__D020380 Assessment, Educational Needs
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D020380 2004
% 212.98/213.17  |- skos__broader mesh__D020380smesh__D006302
% 212.98/213.17  |- skos__prefLabel mesh__D020380 Needs Assessment
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D020380 2005
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D020380 2000
% 212.98/213.17  |- skos__hiddenLabel mesh__D020380 Needs Assessment, Healthcare
% 212.98/213.17  |- mesh__dateEstablished mesh__D020380 1999-01-01
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D020380 2001
% 212.98/213.17  |- skos__broader mesh__D020380smesh__D004493
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D020380 2006
% 212.98/213.17  |- skos__altLabel mesh__D020380 Assessment of Health Care Needs
% 212.98/213.17  |- rdf__type mesh__D020380sskos__Concept
% 212.98/213.17  |- skos__altLabel mesh__D020380 Determination of Healthcare Needs
% 212.98/213.17  |- skos__hiddenLabel mesh__D020380 Needs Assessments
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D020380 2002
% 212.98/213.17  |- skos__broader mesh__D020380smesh__D003695
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D020380 1999
% 212.98/213.17  |- skos__broader mesh__D014343smesh__D009282
% 212.98/213.17  |- skos__prefLabel mesh__D014343 Trypan Blue
% 212.98/213.17  |- mesh__recordAuthorizer mesh__D014343 NLM
% 212.98/213.17  |- mesh__recordMaintainer mesh__D014343 NLM
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D014343 2006
% 212.98/213.17  |- mesh__dateCreated mesh__D014343 1999-01-01
% 212.98/213.17  |- skos__annotation mesh__D014343 D25-26 qualif   
% 212.98/213.17  |- skos__hiddenLabel mesh__D014343 Blue, Trypan
% 212.98/213.17  |- mesh__dateRevised mesh__D014343 2005-07-06
% 212.98/213.17  |- mesh__recordOriginator mesh__D014343 NLM
% 212.98/213.17  |- skos__scopeNote mesh__D014343
% 212.98/213.17       An azo that that is used in protozoal infections.     
% 212.98/213.17  |- skos__broader mesh__D014343smesh__D001391
% 212.98/213.17  |- rdf__type mesh__D014343sskos__Concept
% 212.98/213.17  |- mesh__recordAuthorizer mesh__D008306 sjn
% 212.98/213.17  |- skos__scopeNote mesh__D008306
% 212.98/213.17       Simulation of symptoms of illness or injury with intent to deceive in order to obtain a goal, e.g., a claim of physical illness to avoid jury duty.%A%    
% 212.98/213.17  |- skos__broader mesh__D008306smesh__D001526
% 212.98/213.17  |- mesh__dateCreated mesh__D008306 1999-01-01
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D008306 2006
% 212.98/213.17  |- mesh__recordMaintainer mesh__D008306 JLS
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D008306 2004
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D008306 2005
% 212.98/213.17  |- skos__prefLabel mesh__D008306 Malingering
% 212.98/213.17  |- rdf__type mesh__D008306sskos__Concept
% 212.98/213.17  |- mesh__dateRevised mesh__D008306 2002-07-03
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D008306 2003
% 212.98/213.17  |- mesh__recordOriginator mesh__D008306 NLM
% 212.98/213.17  |- mesh__dateCreated mesh__D000323 1999-01-01
% 212.98/213.17  |- skos__annotation mesh__D000323 /physiol permitted   
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D000323 2006
% 212.98/213.17  |- mesh__recordOriginator mesh__D000323 NLM
% 212.98/213.17  |- skos__scopeNote mesh__D000323
% 212.98/213.17       Pigment obtained by the oxidation of epinephrine.     
% 212.98/213.17  |- rdf__type mesh__D000323sskos__Concept
% 212.98/213.17  |- mesh__recordMaintainer mesh__D000323 ssb
% 212.98/213.17  |- mesh__recordAuthorizer mesh__D000323 sjn
% 212.98/213.17  |- skos__broader mesh__D000323smesh__D010860
% 212.98/213.17  |- skos__prefLabel mesh__D000323 Adrenochrome
% 212.98/213.17  |- skos__broader mesh__D000323smesh__D007211
% 212.98/213.17  |- mesh__dateRevised mesh__D000323 2005-06-30
% 212.98/213.17  |- skos__hiddenLabel mesh__D018734 c erbB 2 Genes
% 212.98/213.17  |- skos__hiddenLabel mesh__D018734 c-erbB-2 Proto-Oncogene
% 212.98/213.17  |- skos__altLabel mesh__D018734 c-erbB-2 Genes
% 212.98/213.17  |- skos__hiddenLabel mesh__D018734 erbB 2 Genes
% 212.98/213.17  |- mesh__historyNote mesh__D018734 95   
% 212.98/213.17  |- skos__prefLabel mesh__D018734 Genes, erbB-2
% 212.98/213.17  |- skos__hiddenLabel mesh__D018734 c-erbB-2 Gene
% 212.98/213.17  |- skos__altLabel mesh__D018734 Genes, HER-2
% 212.98/213.17  |- skos__hiddenLabel mesh__D018734 HER2 Genes
% 212.98/213.17  |- skos__broader mesh__D018734smesh__D018815
% 212.98/213.17  |- skos__altLabel mesh__D018734 Genes, neu
% 212.98/213.17  |- skos__historyNote mesh__D018734 Oncogenes %28%1986-1994%29%
% 212.98/213.17  |- skos__altLabel mesh__D018734 Genes, erbb2
% 212.98/213.17  |- skos__altLabel mesh__D018734 erbB-2 Genes
% 212.98/213.17  |- mesh__publicMeSHNote mesh__D018734 95   
% 212.98/213.17  |- skos__historyNote mesh__D018734 Proto-Oncogenes %28%1986-1994%29%
% 212.98/213.17  |- skos__related mesh__D018734smesh__D011958
% 212.98/213.17  |- skos__scopeNote mesh__D018734
% 212.98/213.17       The erbB-2 gene is a proto-oncogene that codes for the erbB-2 receptor %28%RECEPTOR, ERBB-2%29%, a protein with structural features similar to the epidermal growth factor receptor. Its name originates from the viral oncogene homolog %28%v-erbB%29% which is a truncated form of the chicken erbB gene found in the avian erythroblastosis virus. Overexpression and amplification of the gene is associated with a significant number of adenocarcinomas. The human c-erbB-2 gene is located at 17q21.2.%A%    
% 212.98/213.17  |- skos__hiddenLabel mesh__D018734 HER2 Gene
% 212.98/213.17  |- mesh__dateEstablished mesh__D018734 1995-01-01
% 212.98/213.17  |- mesh__recordOriginator mesh__D018734 AGS
% 212.98/213.17  |- skos__hiddenLabel mesh__D018734 erbb2 Gene
% 212.98/213.17  |- skos__hiddenLabel mesh__D018734 neu Genes
% 212.98/213.17  |- skos__altLabel mesh__D018734 c-erbB-2 Proto-Oncogenes
% 212.98/213.17  |- skos__hiddenLabel mesh__D018734 Gene, erbb2
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D018734 2006
% 212.98/213.17  |- skos__hiddenLabel mesh__D018734 c erbB 2 Proto Oncogenes
% 212.98/213.17  |- skos__hiddenLabel mesh__D018734 HER-2 Gene
% 212.98/213.17  |- rdf__type mesh__D018734sskos__Concept
% 212.98/213.17  |- skos__annotation mesh__D018734
% 212.98/213.17       in titles %26% translations spell as erbB-2; ERBB-1 is also available%A%  
% 212.98/213.17  |- skos__related mesh__D018734smesh__D018719
% 212.98/213.17  |- skos__hiddenLabel mesh__D018734 Gene, HER2
% 212.98/213.17  |- mesh__dateCreated mesh__D018734 1994-05-23
% 212.98/213.17  |- skos__altLabel mesh__D018734 Genes, HER2
% 212.98/213.17  |- mesh__dateRevised mesh__D018734 2005-06-30
% 212.98/213.17  |- skos__hiddenLabel mesh__D018734 neu Gene
% 212.98/213.17  |- mesh__recordAuthorizer mesh__D018734 sjn
% 212.98/213.17  |- skos__related mesh__D018734smesh__D018739
% 212.98/213.17  |- skos__hiddenLabel mesh__D018734 HER-2 Genes
% 212.98/213.17  |- mesh__recordMaintainer mesh__D018734 nns
% 212.98/213.17  |- skos__hiddenLabel mesh__D018734 erbb2 Genes
% 212.98/213.17  |- skos__hiddenLabel mesh__D018734 erbB-2 Gene
% 212.98/213.17  |- skos__hiddenLabel mesh__D010751 Hydrolase, 2-Phospho-D-Glycerate
% 212.98/213.17  |- mesh__dateEstablished mesh__D010751 1973-01-01
% 212.98/213.17  |- mesh__dateRevised mesh__D010751 2003-07-09
% 212.98/213.17  |- mesh__historyNote mesh__D010751 73%28%64%29%   
% 212.98/213.17  |- rdf__type mesh__D010751sskos__Concept
% 212.98/213.17  |- skos__hiddenLabel mesh__D010751 Enolase, Cobalt
% 212.98/213.17  |- skos__scopeNote mesh__D010751
% 212.98/213.17       An enzyme of the lyase class that catalyzes the dehydration of 2-phosphoglycerate to form phosphoenolpyruvate. %28%Dorland, 28th ed%29% EC 4.2.1.11.%A%    
% 212.98/213.17  |- skos__hiddenLabel mesh__D010751 Neuron Specific Enolase
% 212.98/213.17  |- skos__hiddenLabel mesh__D010751 Enolase, Nervous System-Specific
% 212.98/213.17  |- skos__hiddenLabel mesh__D010751 Hydratase, Phosphopyruvate
% 212.98/213.17  |- skos__altLabel mesh__D010751 Enolase
% 212.98/213.17  |- mesh__publicMeSHNote mesh__D010751 73   
% 212.98/213.17  |- mesh__recordAuthorizer mesh__D010751 sjn
% 212.98/213.17  |- mesh__recordMaintainer mesh__D010751 ssb
% 212.98/213.17  |- skos__hiddenLabel mesh__D010751 gamma, gamma Enolase
% 212.98/213.17  |- skos__hiddenLabel mesh__D010751 alpha, alpha Enolase
% 212.98/213.17  |- skos__hiddenLabel mesh__D010751 Non Neuronal Enolase
% 212.98/213.17  |- skos__hiddenLabel mesh__D010751 Enolase, Neuron-Specific
% 212.98/213.17  |- skos__prefLabel mesh__D010751 Phosphopyruvate Hydratase
% 212.98/213.17  |- skos__hiddenLabel mesh__D010751 Enolase, Non-Neuronal
% 212.98/213.17  |- skos__hiddenLabel mesh__D010751 2 Phospho D Glycerate Hydrolase
% 212.98/213.17  |- skos__broader mesh__D010751smesh__D006836
% 212.98/213.17  |- skos__hiddenLabel mesh__D010751 beta Enolase
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D010751 2006
% 212.98/213.17  |- skos__hiddenLabel mesh__D010751 Nervous System Specific Enolase
% 212.98/213.17  |- skos__altLabel mesh__D010751 2-Phospho-D-Glycerate Hydrolase
% 212.98/213.17  |- mesh__recordOriginator mesh__D010751 NLM
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D010751 2004
% 212.98/213.17  |- mesh__dateCreated mesh__D010751 1999-01-01
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D010751 2005
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D032405 2006
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D032405 2003
% 212.98/213.17  |- mesh__publicMeSHNote mesh__D032405 2003   
% 212.98/213.17  |- skos__broader mesh__D032405smesh__D028161
% 212.98/213.17  |- rdf__type mesh__D032405sskos__Concept
% 212.98/213.17  |- skos__annotation mesh__D032405
% 212.98/213.17       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D032405 2005
% 212.98/213.17  |- mesh__dateEstablished mesh__D032405 2003-01-01
% 212.98/213.17  |- skos__scopeNote mesh__D032405
% 212.98/213.17       A plant genus of the family VALERIANACEAE. Members contain ursolic acid and oleanolic acid glycosides, sulfapatrinosides %28%triterpenoid glycosides%29%, and patriscabrol %28%iridolactone%29%.%A%    
% 212.98/213.17  |- mesh__historyNote mesh__D032405 2003   
% 212.98/213.17  |- mesh__dateCreated mesh__D032405 2002-07-03
% 212.98/213.17  |- skos__prefLabel mesh__D032405 Patrinia
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D032405 2004
% 212.98/213.17  |- skos__hiddenLabel mesh__D004714 Hyperplasia, Complex Endometrial
% 212.98/213.17  |- skos__hiddenLabel mesh__D004714 Hyperplasias, Endometrial
% 212.98/213.17  |- skos__hiddenLabel mesh__D004714 Complex Endometrial Hyperplasias
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D004714 2005
% 212.98/213.17  |- rdf__type mesh__D004714sskos__Concept
% 212.98/213.17  |- skos__hiddenLabel mesh__D004714 Hyperplasias, Simple Endometrial
% 212.98/213.17  |- skos__hiddenLabel mesh__D004714 Hyperplasias, Complex Endometrial
% 212.98/213.17  |- skos__scopeNote mesh__D004714
% 212.98/213.17       Benign proliferation of the ENDOMETRIUM in the UTERUS. Endometrial hyperplasia is classified by its cytology and glandular tissue. There are simple, complex %28%adenomatous without atypia%29%, and atypical hyperplasia representing also the ascending risk of becoming malignant.%A%    
% 212.98/213.17  |- skos__hiddenLabel mesh__D004714 Endometrial Hyperplasias, Simple
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D004714 2004
% 212.98/213.17  |- skos__hiddenLabel mesh__D004714 Endometrial Hyperplasia, Simple
% 212.98/213.17  |- skos__prefLabel mesh__D004714 Endometrial Hyperplasia
% 212.98/213.17  |- mesh__recordMaintainer mesh__D004714 lkt
% 212.98/213.17  |- skos__hiddenLabel mesh__D004714 Endometrial Hyperplasia, Atypical
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D004714 2003
% 212.98/213.17  |- skos__hiddenLabel mesh__D004714 Endometrial Hyperplasias
% 212.98/213.17  |- mesh__recordAuthorizer mesh__D004714 sjn
% 212.98/213.17  |- mesh__dateRevised mesh__D004714 2002-07-02
% 212.98/213.17  |- skos__hiddenLabel mesh__D004714 Endometrial Hyperplasias, Atypical
% 212.98/213.17  |- skos__hiddenLabel mesh__D004714 Hyperplasia, Simple Endometrial
% 212.98/213.17  |- skos__hiddenLabel mesh__D004714 Simple Endometrial Hyperplasias
% 212.98/213.17  |- skos__hiddenLabel mesh__D004714 Atypical Endometrial Hyperplasias
% 212.98/213.17  |- skos__hiddenLabel mesh__D004714 Hyperplasia, Atypical Endometrial
% 212.98/213.17  |- skos__hiddenLabel mesh__D004714 Hyperplasias, Atypical Endometrial
% 212.98/213.17  |- skos__hiddenLabel mesh__D004714 Endometrial Hyperplasia, Complex
% 212.98/213.17  |- skos__broader mesh__D004714smesh__D014591
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D004714 2006
% 212.98/213.17  |- skos__hiddenLabel mesh__D004714 Hyperplasia, Endometrial
% 212.98/213.17  |- skos__hiddenLabel mesh__D004714 Endometrial Hyperplasias, Complex
% 212.98/213.17  |- mesh__recordOriginator mesh__D004714 NLM
% 212.98/213.17  |- mesh__dateCreated mesh__D004714 1999-01-01
% 212.98/213.17  |- skos__altLabel mesh__D020381 CTLA-8
% 212.98/213.17  |- skos__broader mesh__D020381smesh__D007378
% 212.98/213.17  |- skos__scopeNote mesh__D020381
% 212.98/213.17       Proinflammatory cytokine produced primarily by T-lymphocytes or their precursors. IL-17 is homologous to an open reading frame found in Herpesvirus saimiri.%A%    
% 212.98/213.17  |- skos__hiddenLabel mesh__D020381 17, Interleukin
% 212.98/213.17  |- skos__altLabel mesh__D020381 IL17
% 212.98/213.17  |- mesh__recordOriginator mesh__D020381 AGS
% 212.98/213.17  |- skos__altLabel mesh__D020381 IL-17
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D020381 2006
% 212.98/213.17  |- rdf__type mesh__D020381sskos__Concept
% 212.98/213.17  |- mesh__historyNote mesh__D020381
% 212.98/213.17       99; use INTERLEUKIN-17 %28%NM%29% 1996-98   
% 212.98/213.17  |- mesh__dateRevised mesh__D020381 2005-06-30
% 212.98/213.17  |- mesh__recordAuthorizer mesh__D020381 sjn
% 212.98/213.17  |- skos__prefLabel mesh__D020381 Interleukin-17
% 212.98/213.17  |- skos__annotation mesh__D020381 DF: IL 17 or IL17   
% 212.98/213.17  |- skos__altLabel mesh__D020381 Interleukin 17
% 212.98/213.17  |- mesh__dateCreated mesh__D020381 1998-06-10
% 212.98/213.17  |- mesh__publicMeSHNote mesh__D020381
% 212.98/213.17       99; INTERLEUKIN 17 was indexed under INTERLEUKINS 1996-98%A%  
% 212.98/213.17  |- skos__historyNote mesh__D020381 Interleukins %28%1995-1998%29%
% 212.98/213.17  |- mesh__recordMaintainer mesh__D020381 ssb
% 212.98/213.17  |- mesh__dateEstablished mesh__D020381 1999-01-01
% 212.98/213.17  |- mesh__historyNote mesh__D014344 74%28%72%29%   
% 212.98/213.17  |- mesh__dateCreated mesh__D014344 1999-01-01
% 212.98/213.17  |- mesh__recordAuthorizer mesh__D014344 sjn
% 212.98/213.17  |- mesh__dateRevised mesh__D014344 2003-07-09
% 212.98/213.17  |- skos__broader mesh__D014344smesh__D000981
% 212.98/213.17  |- skos__altLabel mesh__D014344 Trypanosomicidal Agents
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D014344 2005
% 212.98/213.17  |- mesh__recordOriginator mesh__D014344 NLM
% 212.98/213.17  |- mesh__recordMaintainer mesh__D014344 ssb
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D014344 2004
% 212.98/213.17  |- skos__historyNote mesh__D014344 Trypanosoma %28%1966-1971%29%
% 212.98/213.17  |- skos__altLabel mesh__D014344 Trypanosomicides
% 212.98/213.17  |- skos__annotation mesh__D014344
% 212.98/213.17       consider also TRYPANOSOMA /drug eff %26% TRYPANOSOMIASIS /drug ther or pertinent specifics%A%  
% 212.98/213.17  |- skos__historyNote mesh__D014344 specific disease %28%1966-1971%29%
% 212.98/213.17  |- mesh__activeMeSHYear mesh__D014344 2006
% 212.98/213.17  |- skos__altLabel mesh__D014344 Trypanocides
% 212.98/213.17  |- skos__historyNote mesh__D014344 Antiprotozoal Agents %28%1966-1971%29%
% 212.98/213.17  |- skos__hiddenLabel mesh__D014344 Agents, Trypanosomicidal
% 212.98/213.17  |- skos__prefLabel mesh__D014344 Trypanocidal Agents
% 212.98/213.17  |- skos__scopeNote mesh__D014344
% 212.98/213.17       Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA.%A%    
% 212.98/213.17  |- mesh__dateEstablished mesh__D014344 1974-01-01
% 212.98/213.17  |- rdf__type mesh__D014344sskos__Concept
% 212.98/213.17  |- skos__hiddenLabel mesh__D014344 Drugs, Trypanocidal
% 212.98/213.17  |- skos__hiddenLabel mesh__D014344 Agents, Trypanocidal
% 212.98/213.17  |- mesh__publicMeSHNote mesh__D014344 74   
% 212.98/213.17  |- skos__altLabel mesh__D014344 Trypanocidal Drugs
% 212.98/213.17  |- mesh__recordAuthorizer mesh__D008307 PLS
% 212.98/213.18  |- mesh__onlineNote mesh__D008307 search EAR OSSICLES 1966-74   
% 212.98/213.18  |- skos__broader mesh__D008307smesh__D004429
% 212.98/213.18  |- skos__scopeNote mesh__D008307
% 212.98/213.18       The largest of the auditory ossicles, and the one attached to the membrana tympani %28%TYMPANIC MEMBRANE%29%. Its club-shaped head articulates with the INCUS.%A%    
% 212.98/213.18  |- mesh__recordMaintainer mesh__D008307 TGC
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D008307 2006
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D008307 1999
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D008307 2004
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D008307 2005
% 212.98/213.18  |- mesh__recordOriginator mesh__D008307 NLM
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D008307 2001
% 212.98/213.18  |- skos__annotation mesh__D008307 one of the 3 ear ossicles   
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D008307 1997
% 212.98/213.18  |- rdf__type mesh__D008307sskos__Concept
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D008307 1998
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D008307 2003
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D008307 2000
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D008307 1996
% 212.98/213.18  |- mesh__dateRevised mesh__D008307 1995-03-13
% 212.98/213.18  |- mesh__publicMeSHNote mesh__D008307
% 212.98/213.18       91; was see under EAR OSSICLES 1975-90   
% 212.98/213.18  |- mesh__historyNote mesh__D008307
% 212.98/213.18       91%28%75%29%; was see under EAR OSSICLES 1975-90   
% 212.98/213.18  |- skos__prefLabel mesh__D008307 Malleus
% 212.98/213.18  |- mesh__dateEstablished mesh__D008307 1991-01-01
% 212.98/213.18  |- mesh__dateCreated mesh__D008307 1999-01-01
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D008307 2002
% 212.98/213.18  |- skos__hiddenLabel mesh__D000324 Hormone, Adrenocorticotrophic
% 212.98/213.18  |- skos__altLabel mesh__D000324 Corticotrophin %28%1-39%29%
% 212.98/213.18  |- skos__altLabel mesh__D000324 Corticotrophin
% 212.98/213.18  |- skos__altLabel mesh__D000324 1-39 ACTH
% 212.98/213.18  |- skos__altLabel mesh__D000324 Adrenocorticotrophic Hormone
% 212.98/213.18  |- skos__related mesh__D000324smesh__D018043
% 212.98/213.18  |- skos__related mesh__D000324smesh__D017591
% 212.98/213.18  |- mesh__dateRevised mesh__D000324 2005-06-30
% 212.98/213.18  |- mesh__historyNote mesh__D000324
% 212.98/213.18       94,63-86; was ADRENOCORTICOTROPIC HORMONE 1987-93; /adv eff-pois-tox was CORTICOTROPIN TOXICOLOGY 1963-65; /ther use was CORTICOTROPIN, THERAPEUTIC 1965%A%  
% 212.98/213.18  |- skos__altLabel mesh__D000324 Adrenocorticotropin
% 212.98/213.18  |- skos__broader mesh__D000324smesh__D009479
% 212.98/213.18  |- skos__altLabel mesh__D000324 ACTH
% 212.98/213.18  |- skos__broader mesh__D000324smesh__D011333
% 212.98/213.18  |- skos__scopeNote mesh__D000324
% 212.98/213.18       An anterior pituitary hormone that stimulates the secretion of CORTICOSTEROIDS and induces growth of the ADRENAL CORTEX. It is a single-chain polypeptide of about 39 amino acids, the first 24 of which are identical in all species. This 24-amino acid segment is said to be responsible for the biological activity of the peptide while the remaining 15-amino acid segment is said to be necessary for any immunological specificity. %28%From Merck Index, 11th ed%29%%A%    
% 212.98/213.18  |- mesh__recordOriginator mesh__D000324 NLM
% 212.98/213.18  |- mesh__dateCreated mesh__D000324 1999-01-01
% 212.98/213.18  |- mesh__onlineNote mesh__D000324
% 212.98/213.18       use CORTICOTROPIN to search ADRENOCORTICOTROPIC HORMONE 1987-93%A%  
% 212.98/213.18  |- skos__altLabel mesh__D000324 Corticotropin %28%1-39%29%
% 212.98/213.18  |- mesh__recordMaintainer mesh__D000324 ssb
% 212.98/213.18  |- mesh__recordAuthorizer mesh__D000324 sjn
% 212.98/213.18  |- mesh__publicMeSHNote mesh__D000324
% 212.98/213.18       94,63-86; was ADRENOCORTICOTROPIC HORMONE 1987-93; /adverse effects /poisoning /toxicity were CORTICOTROPIN TOXICOLOGY 1963-65; /therapeutic use was CORTICOTROPIN, THERAPEUTIC 1965%A%  
% 212.98/213.18  |- skos__hiddenLabel mesh__D000324 Hormone, Adrenocorticotropic
% 212.98/213.18  |- skos__prefLabel mesh__D000324 Corticotropin
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D000324 2006
% 212.98/213.18  |- rdf__type mesh__D000324sskos__Concept
% 212.98/213.18  |- skos__altLabel mesh__D000324 Adrenocorticotropic Hormone
% 212.98/213.18  |- skos__altLabel mesh__D000324 ACTH %28%1-39%29%
% 212.98/213.18  |- skos__scopeNote mesh__D010752
% 212.98/213.18       A group of nitrogen mustard compounds which are substituted with a phosphoramide group or its derivatives. They are usually cytotoxic and used as antineoplastic agents.%A%    
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010752 2001
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010752 1996
% 212.98/213.18  |- skos__prefLabel mesh__D010752 Phosphoramide Mustards
% 212.98/213.18  |- mesh__recordMaintainer mesh__D010752 JRT
% 212.98/213.18  |- skos__broader mesh__D010752smesh__D009943
% 212.98/213.18  |- rdf__type mesh__D010752sskos__Concept
% 212.98/213.18  |- skos__annotation mesh__D010752
% 212.98/213.18       nitrogen mustard cpds; alkylating antineoplastics   
% 212.98/213.18  |- mesh__historyNote mesh__D010752 79   
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010752 2000
% 212.98/213.18  |- skos__broader mesh__D010752smesh__D009588
% 212.98/213.18  |- mesh__dateCreated mesh__D010752 1978-02-08
% 212.98/213.18  |- mesh__dateEstablished mesh__D010752 1979-01-01
% 212.98/213.18  |- mesh__recordOriginator mesh__D010752 SH
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010752 2006
% 212.98/213.18  |- skos__historyNote mesh__D010752
% 212.98/213.18       Nitrogen Mustard Compounds %28%1966-1974%29%
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010752 2002
% 212.98/213.18  |- skos__historyNote mesh__D010752
% 212.98/213.18       Organophosphorus Compounds %28%1972-1974%29%
% 212.98/213.18  |- mesh__publicMeSHNote mesh__D010752 79   
% 212.98/213.18  |- mesh__dateRevised mesh__D010752 1995-06-16
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010752 2004
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010752 2005
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010752 1999
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010752 2003
% 212.98/213.18  |- mesh__recordAuthorizer mesh__D010752 PLS
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010752 1997
% 212.98/213.18  |- skos__hiddenLabel mesh__D010752 Mustards, Phosphoramide
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010752 1998
% 212.98/213.18  |- skos__historyNote mesh__D010752 Cyclophosphamide %28%1975-1978%29%
% 212.98/213.18  |- skos__altLabel mesh__D032406 Cornsalad
% 212.98/213.18  |- mesh__historyNote mesh__D032406 2003   
% 212.98/213.18  |- mesh__dateCreated mesh__D032406 2002-07-03
% 212.98/213.18  |- skos__broader mesh__D032406smesh__D028161
% 212.98/213.18  |- skos__prefLabel mesh__D032406 Valerianella
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D032406 2004
% 212.98/213.18  |- mesh__dateEstablished mesh__D032406 2003-01-01
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D032406 2006
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D032406 2003
% 212.98/213.18  |- mesh__publicMeSHNote mesh__D032406 2003   
% 212.98/213.18  |- rdf__type mesh__D032406sskos__Concept
% 212.98/213.18  |- skos__annotation mesh__D032406
% 212.98/213.18       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D032406 2005
% 212.98/213.18  |- skos__scopeNote mesh__D032406
% 212.98/213.18       A plant genus of the family VALERIANACEAE. It is sometimes called goosefoot cornsalad but should not be confused with true goosefoot %28%CHENOPODIUM%29%.%A%    
% 212.98/213.18  |- skos__annotation mesh__D004715
% 212.98/213.18       non-neoplastic %26% nothing to do with %22%endometrial carcinoma%22% %28% = ENDOMETRIAL NEOPLASMS%29%; coord IM with specific precoord organ/dis term %28%IM%29%%A%  
% 212.98/213.18  |- skos__scopeNote mesh__D004715
% 212.98/213.18       A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum.%A%    
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D004715 2004
% 212.98/213.18  |- mesh__recordOriginator mesh__D004715 NLM
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D004715 2003
% 212.98/213.18  |- skos__hiddenLabel mesh__D004715 Endometrioses
% 212.98/213.18  |- mesh__recordMaintainer mesh__D004715 lkt
% 212.98/213.18  |- skos__hiddenLabel mesh__D004715 Endometriomas
% 212.98/213.18  |- skos__broader mesh__D004715smesh__D005831
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D004715 2006
% 212.98/213.18  |- mesh__recordAuthorizer mesh__D004715 sjn
% 212.98/213.18  |- mesh__dateRevised mesh__D004715 2002-07-02
% 212.98/213.18  |- mesh__dateCreated mesh__D004715 1999-01-01
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D004715 2005
% 212.98/213.18  |- skos__prefLabel mesh__D004715 Endometriosis
% 212.98/213.18  |- rdf__type mesh__D004715sskos__Concept
% 212.98/213.18  |- mesh__recordAuthorizer mesh__D009400 sjn
% 212.98/213.18  |- mesh__dateRevised mesh__D009400 2004-07-07
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D009400 2006
% 212.98/213.18  |- mesh__dateCreated mesh__D009400 1999-01-01
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D009400 2005
% 212.98/213.18  |- skos__broader mesh__D009400smesh__D007674
% 212.98/213.18  |- mesh__recordMaintainer mesh__D009400 lkt
% 212.98/213.18  |- skos__scopeNote mesh__D009400
% 212.98/213.18       Hardening of the KIDNEY due to infiltration by fibrous connective tissue %28%FIBROSIS%29%, usually caused by renovascular diseases or chronic HYPERTENSION. Nephrosclerosis leads to renal ISCHEMIA.%A%    
% 212.98/213.18  |- skos__hiddenLabel mesh__D009400 Nephroscleroses
% 212.98/213.18  |- rdf__type mesh__D009400sskos__Concept
% 212.98/213.18  |- skos__prefLabel mesh__D009400 Nephrosclerosis
% 212.98/213.18  |- mesh__recordOriginator mesh__D009400 NLM
% 212.98/213.18  |- mesh__dateEstablished mesh__D020382 1999-01-01
% 212.98/213.18  |- skos__historyNote mesh__D020382 Cytokines %28%1995-1998%29%
% 212.98/213.18  |- skos__altLabel mesh__D020382 IL18
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D020382 2006
% 212.98/213.18  |- rdf__type mesh__D020382sskos__Concept
% 212.98/213.18  |- skos__hiddenLabel mesh__D020382 Inducing Factor, Interferon-gamma
% 212.98/213.18  |- skos__hiddenLabel mesh__D020382 Inducing Factor, IFN-gamma
% 212.98/213.18  |- skos__hiddenLabel mesh__D020382 IFN gamma Inducing Factor
% 212.98/213.18  |- skos__altLabel mesh__D020382 IFN-gamma Inducing Factor
% 212.98/213.18  |- mesh__publicMeSHNote mesh__D020382
% 212.98/213.18       99; INTERFERON-GAMMA INDUCING FACTOR %28%now INTERLEUKIN-18%29% was indexed under CYTOKINES 1995-98%A%  
% 212.98/213.18  |- mesh__recordOriginator mesh__D020382 AGS
% 212.98/213.18  |- skos__prefLabel mesh__D020382 Interleukin-18
% 212.98/213.18  |- skos__altLabel mesh__D020382 Interferon-gamma Inducing Factor
% 212.98/213.18  |- mesh__historyNote mesh__D020382
% 212.98/213.18       99; use INTERLEUKIN-18 %28%NM%29% 1995-98   
% 212.98/213.18  |- skos__scopeNote mesh__D020382
% 212.98/213.18       Cytokine which resembles IL-1 structurally and IL-12 functionally. It enhances the cytotoxic activity of NK cells and CTLs, and appears to play a role both as neuroimmunomodulator and in the induction of mucosal immunity.%A%    
% 212.98/213.18  |- skos__altLabel mesh__D020382 Interferon-gamma-Inducing Factor
% 212.98/213.18  |- mesh__dateRevised mesh__D020382 2005-06-30
% 212.98/213.18  |- skos__hiddenLabel mesh__D020382 Interleukin 18
% 212.98/213.18  |- mesh__recordAuthorizer mesh__D020382 sjn
% 212.98/213.18  |- skos__broader mesh__D020382smesh__D007378
% 212.98/213.18  |- mesh__dateCreated mesh__D020382 1998-06-10
% 212.98/213.18  |- skos__altLabel mesh__D020382 IL-18
% 212.98/213.18  |- skos__hiddenLabel mesh__D020382 Interferon gamma Inducing Factor
% 212.98/213.18  |- skos__altLabel mesh__D020382 IFN-gamma-Inducing Factor
% 212.98/213.18  |- skos__annotation mesh__D020382 DF: IL18   
% 212.98/213.18  |- mesh__recordMaintainer mesh__D020382 ssb
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D014345 2005
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D014345 2004
% 212.98/213.18  |- skos__prefLabel mesh__D014345 Trypanosoma
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D014345 2006
% 212.98/213.18  |- skos__broader mesh__D014345smesh__D014351
% 212.98/213.18  |- skos__scopeNote mesh__D014345
% 212.98/213.18       A genus of flagellate protozoans found in the blood and lymph of vertebrates and invertebrates, both hosts being required to complete the life cycle.%A%    
% 212.98/213.18  |- skos__annotation mesh__D014345
% 212.98/213.18       GEN; prefer specific; /drug eff: consider also TRYPANOCIDAL AGENTS; infection = TRYPANOSOMIASIS but prefer specific types of trypanosomiasis; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 212.98/213.18  |- mesh__recordAuthorizer mesh__D014345 sjn
% 212.98/213.18  |- mesh__recordOriginator mesh__D014345 NLM
% 212.98/213.18  |- mesh__recordMaintainer mesh__D014345 ags
% 212.98/213.18  |- rdf__type mesh__D014345sskos__Concept
% 212.98/213.18  |- mesh__dateCreated mesh__D014345 1999-01-01
% 212.98/213.18  |- mesh__dateRevised mesh__D014345 2003-07-09
% 212.98/213.18  |- skos__related mesh__D014345smesh__D014344
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D008308 2004
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D008308 2005
% 212.98/213.18  |- rdf__type mesh__D008308sskos__Concept
% 212.98/213.18  |- skos__altLabel mesh__D008308 Bovicola
% 212.98/213.18  |- mesh__publicMeSHNote mesh__D008308 72   
% 212.98/213.18  |- skos__prefLabel mesh__D008308 Mallophaga
% 212.98/213.18  |- skos__historyNote mesh__D008308 Lice %28%1966-1971%29%
% 212.98/213.18  |- skos__altLabel mesh__D008308 Chewing Lice
% 212.98/213.18  |- mesh__recordOriginator mesh__D008308 NLM
% 212.98/213.18  |- skos__annotation mesh__D008308
% 212.98/213.18       do not use /drug eff for insecticides: TN 111   
% 212.98/213.18  |- mesh__dateRevised mesh__D008308 2003-07-09
% 212.98/213.18  |- mesh__historyNote mesh__D008308 72   
% 212.98/213.18  |- skos__scopeNote mesh__D008308
% 212.98/213.18       An order of insects comprising the chewing lice or biting lice, many of which are parasitic on wild birds and domestic fowl and on wild and domestic mammals. Suborders include Amblycera and Ischnocera.%A%    
% 212.98/213.18  |- mesh__recordAuthorizer mesh__D008308 sjn
% 212.98/213.18  |- mesh__dateCreated mesh__D008308 1999-01-01
% 212.98/213.18  |- mesh__dateEstablished mesh__D008308 1972-01-01
% 212.98/213.18  |- skos__broader mesh__D008308smesh__D008003
% 212.98/213.18  |- mesh__recordMaintainer mesh__D008308 ags
% 212.98/213.18  |- skos__altLabel mesh__D008308 Biting Lice
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D008308 2006
% 212.98/213.18  |- mesh__historyNote mesh__D000325 75   
% 212.98/213.18  |- mesh__recordAuthorizer mesh__D000325 sjn
% 212.98/213.18  |- skos__historyNote mesh__D000325 Ferredoxins %28%1966-1974%29%
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D000325 2003
% 212.98/213.18  |- mesh__dateEstablished mesh__D000325 1975-09-01
% 212.98/213.18  |- skos__historyNote mesh__D000325 Metalloproteins %28%1974%29%
% 212.98/213.18  |- mesh__recordMaintainer mesh__D000325 TPW
% 212.98/213.18  |- mesh__dateRevised mesh__D000325 2002-07-02
% 212.98/213.18  |- skos__broader mesh__D000325smesh__D007506
% 212.98/213.18  |- skos__scopeNote mesh__D000325
% 212.98/213.18       An iron-sulfur protein which serves as an electron carrier in enzymatic steroid hydroxylation reactions in adrenal cortex mitochondria. The electron transport system which catalyzes this reaction consists of adrenodoxin reductase, NADP, adrenodoxin, and cytochrome P-450.%A%    
% 212.98/213.18  |- skos__prefLabel mesh__D000325 Adrenodoxin
% 212.98/213.18  |- skos__historyNote mesh__D000325 Carrier Proteins %28%1974%29%
% 212.98/213.18  |- mesh__dateCreated mesh__D000325 1974-11-19
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D000325 2006
% 212.98/213.18  |- rdf__type mesh__D000325sskos__Concept
% 212.98/213.18  |- mesh__publicMeSHNote mesh__D000325 75   
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D000325 2005
% 212.98/213.18  |- skos__annotation mesh__D000325 an iron-sulfur protein   
% 212.98/213.18  |- mesh__recordOriginator mesh__D000325 NLM
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D000325 2004
% 212.98/213.18  |- mesh__recordOriginator mesh__D019030 AGS
% 212.98/213.18  |- skos__historyNote mesh__D019030 Integrins %28%1990-1995%29%
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D019030 2005
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D019030 2004
% 212.98/213.18  |- skos__historyNote mesh__D019030 Receptors, Cytoadhesin %28%1990-1995%29%
% 212.98/213.18  |- mesh__onlineNote mesh__D019030
% 212.98/213.18       use RECEPTORS, VITRONECTIN %28%NM%29% to search VITRONECTIN RECEPTOR 1985-95%A%  
% 212.98/213.18  |- mesh__recordAuthorizer mesh__D019030 ags
% 212.98/213.18  |- mesh__dateRevised mesh__D019030 2005-07-13
% 212.98/213.18  |- skos__broader mesh__D019030smesh__D016024
% 212.98/213.18  |- mesh__dateEstablished mesh__D019030 1996-01-01
% 212.98/213.18  |- skos__hiddenLabel mesh__D019030 Vitronectin Receptors
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D019030 2006
% 212.98/213.18  |- rdf__type mesh__D019030sskos__Concept
% 212.98/213.18  |- skos__scopeNote mesh__D019030
% 212.98/213.18       Receptors such as INTEGRIN ALPHAVBETA3 that bind VITRONECTIN with high affinity and play a role in cell migration. They also bind FIBRINOGEN; VON WILLEBRAND FACTOR; osteopontin; and THROMBOSPONDINS.%A%    
% 212.98/213.18  |- mesh__recordMaintainer mesh__D019030 ags
% 212.98/213.18  |- skos__historyNote mesh__D019030
% 212.98/213.18       Receptors, Cell Surface %28%1985-1986%29%
% 212.98/213.18  |- skos__broader mesh__D019030smesh__D016023
% 212.98/213.18  |- skos__historyNote mesh__D019030 Receptors, Immunologic %28%1987-1992%29%
% 212.98/213.18  |- skos__prefLabel mesh__D019030 Receptors, Vitronectin
% 212.98/213.18  |- mesh__historyNote mesh__D019030
% 212.98/213.18       96; was VITRONECTIN RECEPTOR %28%NM%29% 1985-95   
% 212.98/213.18  |- skos__annotation mesh__D019030
% 212.98/213.18       do not confuse with VITRONECTIN RECEPTOR see INTEGRIN ALPHAVBETA3, DF: RECEPT VITRONECTIN%A%  
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D019030 2006A
% 212.98/213.18  |- mesh__dateCreated mesh__D019030 1995-06-08
% 212.98/213.18  |- mesh__publicMeSHNote mesh__D019030
% 212.98/213.18       96; VITRONECTIN RECEPTOR was indexed under INTEGRINS %26% RECEPTORS, CYTOADHESIN 1990-95; RECEPTORS, IMMUNOLOGIC 1987-92; %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1985-86%A%  
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D005010 2004
% 212.98/213.18  |- mesh__dateEstablished mesh__D005010 1969-01-01
% 212.98/213.18  |- skos__scopeNote mesh__D005010
% 212.98/213.18       The discipline pertaining to the study of animal behavior.%A%    
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D005010 1999
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D005010 2002
% 212.98/213.18  |- rdf__type mesh__D005010sskos__Concept
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D005010 1996
% 212.98/213.18  |- mesh__recordMaintainer mesh__D005010 JLS
% 212.98/213.18  |- mesh__dateRevised mesh__D005010 1993-06-04
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D005010 1997
% 212.98/213.18  |- mesh__recordAuthorizer mesh__D005010 PLS
% 212.98/213.18  |- mesh__historyNote mesh__D005010 69   
% 212.98/213.18  |- skos__annotation mesh__D005010
% 212.98/213.18       %22%the study of animal behavior%22%; do not confuse with ETHNOLOGY; SPEC: SPEC qualif; DF: ETHOL%A%  
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D005010 2000
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D005010 2005
% 212.98/213.18  |- skos__related mesh__D005010smesh__D001522
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D005010 1994
% 212.98/213.18  |- skos__prefLabel mesh__D005010 Ethology
% 212.98/213.18  |- mesh__publicMeSHNote mesh__D005010 69   
% 212.98/213.18  |- skos__broader mesh__D005010smesh__D001525
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D005010 2006
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D005010 1995
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D005010 2001
% 212.98/213.18  |- mesh__recordOriginator mesh__D005010 NLM
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D005010 2003
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D005010 1998
% 212.98/213.18  |- mesh__dateCreated mesh__D005010 1999-01-01
% 212.98/213.18  |- skos__historyNote mesh__D005010 Behavior, Animal %28%1966-1968%29%
% 212.98/213.18  |- mesh__dateRevised mesh__D018736 1995-06-08
% 212.98/213.18  |- skos__annotation mesh__D018736
% 212.98/213.18       in mutagenesis: activate DNA repair; /drug eff /ultrastruct permitted%A%  
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D018736 2000
% 212.98/213.18  |- mesh__publicMeSHNote mesh__D018736 95   
% 212.98/213.18  |- rdf__type mesh__D018736sskos__Concept
% 212.98/213.18  |- skos__prefLabel mesh__D018736 DNA Adducts
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D018736 2001
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D018736 1996
% 212.98/213.18  |- mesh__recordOriginator mesh__D018736 PXP
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D018736 1998
% 212.98/213.18  |- mesh__dateEstablished mesh__D018736 1995-01-01
% 212.98/213.18  |- skos__scopeNote mesh__D018736
% 212.98/213.18       Covalent adducts between chemical mutagens and DNA. Such couplings activate DNA repair processes and, unless repaired prior to DNA replication, may lead to nucleotide substitutions, deletions, and chromosome rearrangements. %28%Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A%    
% 212.98/213.18  |- skos__broader mesh__D018736smesh__D004247
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D018736 2003
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D018736 1997
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D018736 2005
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D018736 1999
% 212.98/213.18  |- mesh__recordAuthorizer mesh__D018736 PLS
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D018736 2004
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D018736 2002
% 212.98/213.18  |- mesh__historyNote mesh__D018736 95   
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D018736 2006
% 212.98/213.18  |- mesh__dateCreated mesh__D018736 1994-04-19
% 212.98/213.18  |- skos__historyNote mesh__D018736 DNA %28%1976-1994%29%
% 212.98/213.18  |- skos__hiddenLabel mesh__D018736 Adducts, DNA
% 212.98/213.18  |- mesh__recordMaintainer mesh__D018736 TAP
% 212.98/213.18  |- skos__broader mesh__D010753smesh__D009943
% 212.98/213.18  |- rdf__type mesh__D010753sskos__Concept
% 212.98/213.18  |- mesh__dateRevised mesh__D010753 1993-06-04
% 212.98/213.18  |- mesh__historyNote mesh__D010753 68   
% 212.98/213.18  |- mesh__dateEstablished mesh__D010753 1968-01-01
% 212.98/213.18  |- skos__broader mesh__D010753smesh__D017553
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010753 2000
% 212.98/213.18  |- skos__scopeNote mesh__D010753
% 212.98/213.18       Inorganic or organic compounds that contain pentavalent phosphorus and the general formula R5P.%A%    
% 212.98/213.18  |- mesh__recordMaintainer mesh__D010753 TPW
% 212.98/213.18  |- mesh__dateCreated mesh__D010753 1999-01-01
% 212.98/213.18  |- mesh__publicMeSHNote mesh__D010753 68   
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010753 2005
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010753 1994
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010753 2001
% 212.98/213.18  |- mesh__recordOriginator mesh__D010753 NLM
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010753 2003
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010753 1998
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010753 2006
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010753 1995
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010753 1996
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010753 2002
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010753 2004
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010753 1999
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D010753 1997
% 212.98/213.18  |- mesh__recordAuthorizer mesh__D010753 PLS
% 212.98/213.18  |- skos__prefLabel mesh__D010753 Phosphoranes
% 212.98/213.18  |- mesh__dateRevised mesh__D032407 2003-07-09
% 212.98/213.18  |- mesh__historyNote mesh__D032407 2003   
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D032407 2004
% 212.98/213.18  |- skos__scopeNote mesh__D032407
% 212.98/213.18       A plant genus of the family VERBENACEAE. Members contain NAPHTHOQUINONES.%A%    
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D032407 2006
% 212.98/213.18  |- mesh__publicMeSHNote mesh__D032407 2003   
% 212.98/213.18  |- skos__altLabel mesh__D032407 Mangrove, Grey
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D032407 2005
% 212.98/213.18  |- mesh__recordOriginator mesh__D032407 ssb
% 212.98/213.18  |- skos__broader mesh__D032407smesh__D029648
% 212.98/213.18  |- skos__annotation mesh__D032407
% 212.98/213.18       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.98/213.18  |- mesh__dateEstablished mesh__D032407 2003-01-01
% 212.98/213.18  |- skos__prefLabel mesh__D032407 Avicennia
% 212.98/213.18  |- mesh__recordMaintainer mesh__D032407 ssb
% 212.98/213.18  |- rdf__type mesh__D032407sskos__Concept
% 212.98/213.18  |- mesh__recordAuthorizer mesh__D032407 sjn
% 212.98/213.18  |- mesh__dateCreated mesh__D032407 2002-07-02
% 212.98/213.18  |- mesh__recordAuthorizer mesh__D004716 sjn
% 212.98/213.18  |- skos__scopeNote mesh__D004716
% 212.98/213.18       Inflammation of the ENDOMETRIUM, usually caused by intrauterine infections. Endometritis is the most common cause of postpartum fever.%A%    
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D004716 2006
% 212.98/213.18  |- skos__broader mesh__D004716smesh__D014591
% 212.98/213.18  |- mesh__dateCreated mesh__D004716 1999-01-01
% 212.98/213.18  |- rdf__type mesh__D004716sskos__Concept
% 212.98/213.18  |- mesh__recordOriginator mesh__D004716 NLM
% 212.98/213.18  |- mesh__dateRevised mesh__D004716 2005-06-30
% 212.98/213.18  |- skos__prefLabel mesh__D004716 Endometritis
% 212.98/213.18  |- mesh__recordMaintainer mesh__D004716 lkt
% 212.98/213.18  |- skos__broader mesh__D004716smesh__D000292
% 212.98/213.18  |- mesh__recordAuthorizer mesh__D009401 PLS
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D009401 1998
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D009401 2005
% 212.98/213.18  |- mesh__dateCreated mesh__D009401 1999-01-01
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D009401 1992
% 212.98/213.18  |- mesh__recordOriginator mesh__D009401 NLM
% 212.98/213.18  |- skos__broader mesh__D009401smesh__D007674
% 212.98/213.18  |- skos__prefLabel mesh__D009401 Nephrosis
% 212.98/213.18  |- mesh__dateRevised mesh__D009401 1991-06-20
% 212.98/213.18  |- mesh__recordMaintainer mesh__D009401 TGC
% 212.98/213.18  |- skos__hiddenLabel mesh__D009401 Nephroses
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D009401 1997
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D009401 2004
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D009401 2002
% 212.98/213.18  |- skos__annotation mesh__D009401
% 212.98/213.18       in this kidney dis, emphasis is on degen of tubules; do not diagnose: use term of text; LOWER NEPHRON NEPHROSIS see KIDNEY TUBULAR NECROSIS, ACUTE is also available%A%  
% 212.98/213.18  |- skos__scopeNote mesh__D009401
% 212.98/213.18       Descriptive histopathologic term for renal disease without an inflammatory component.%A%    
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D009401 1996
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D009401 2003
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D009401 2001
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D009401 1995
% 212.98/213.18  |- rdf__type mesh__D009401sskos__Concept
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D009401 1994
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D009401 2000
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D009401 1999
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D009401 2006
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D009401 1993
% 212.98/213.18  |- mesh__publicMeSHNote mesh__D020383 99   
% 212.98/213.18  |- skos__prefLabel mesh__D020383 Neutral Glycosphingolipids
% 212.98/213.18  |- mesh__recordAuthorizer mesh__D020383 sjn
% 212.98/213.18  |- mesh__dateRevised mesh__D020383 2004-07-07
% 212.98/213.18  |- mesh__dateCreated mesh__D020383 1998-06-10
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D020383 2006
% 212.98/213.18  |- skos__historyNote mesh__D020383 Glycolipids %28%1967-1998%29%
% 212.98/213.18  |- rdf__type mesh__D020383sskos__Concept
% 212.98/213.18  |- skos__broader mesh__D020383smesh__D006028
% 212.98/213.18  |- mesh__activeMeSHYear mesh__D020383 2005
% 212.98/213.18  |- mesh__dateEstablished mesh__D020383 1999-01-01
% 212.98/213.18  |- mesh__historyNote mesh__D020383 99   
% 212.98/213.18  |- skos__scopeNote mesh__D020383
% 212.98/213.18       A subclass of GLYCOSPHINGOLIPIDS containing one or more sugars within their head group connected directly to a ceramide moiety. They consist of monoglycosyl-, and oligoglycosylsphingoids and monoglycosyl- and oligoglycosylceramides.%A%    
% 212.98/213.18  |- mesh__recordOriginator mesh__D020383 ADP
% 212.98/213.18  |- skos__historyNote mesh__D020383 Glycosphingolipids %28%1975-1998%29%
% 212.98/213.18  |- mesh__recordMaintainer mesh__D020383 ssb
% 212.98/213.18  |- skos__hiddenLabel mesh__D020383 Glycosphingolipids, Neutral
% 212.98/213.18  |- mesh__publicMeSHNote mesh__D014346 84; was TRYPANOSOMA BRUCEI 1972-83   
% 212.98/213.18  |- skos__annotation mesh__D014346
% 212.98/213.18       causes nagana %26% also TRYPANOSOMIASIS, BOVINE in African cattle or TRYPANOSOMIASIS, AFRICAN /vet in African game animals; infection: coord IM with TRYPANOSOMIASIS, AFRICAN %28%IM%29% but see note there for X ref NAGANA see TRYPANOSOMIASIS, AFRICAN; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 212.98/213.18  |- mesh__dateEstablished mesh__D014346 1972-01-01
% 212.98/213.18  |- rdf__type mesh__D014346sskos__Concept
% 212.98/213.18  |- mesh__onlineNote mesh__D014346
% 212.98/213.18       use TRYPANOSOMA BRUCEI BRUCEI to search TRYPANOSOMA BRUCEI 1972-83%A%  
% 212.98/213.18  |- mesh__recordMaintainer mesh__D014346 ags
% 212.98/213.18  |- skos__scopeNote mesh__D014346
% 212.98/213.18       A hemoflagellate subspecies of parasitic protozoa that causes nagana in domestic and game animals in Africa. It apparently does not infect humans. It is transmitted by bites of tsetse flies %28%Glossina%29%.%A%    
% 212.98/213.18  |- mesh__dateCreated mesh__D014346 1999-01-01
% 212.98/213.19  |- mesh__dateRevised mesh__D014346 2003-07-09
% 212.98/213.19  |- skos__prefLabel mesh__D014346 Trypanosoma brucei brucei
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D014346 2005
% 212.98/213.19  |- mesh__recordAuthorizer mesh__D014346 sjn
% 212.98/213.19  |- mesh__historyNote mesh__D014346 84; was TRYPANOSOMA BRUCEI 1972-83   
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D014346 2004
% 212.98/213.19  |- skos__historyNote mesh__D014346 Trypanosoma %28%1966-1971%29%
% 212.98/213.19  |- skos__broader mesh__D014346smesh__D014345
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D014346 2006
% 212.98/213.19  |- mesh__recordOriginator mesh__D014346 NLM
% 212.98/213.19  |- skos__altLabel mesh__D014346 Trypanosoma brucei
% 212.98/213.19  |- mesh__recordMaintainer mesh__D008309 lkt
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D008309 2006
% 212.98/213.19  |- rdf__type mesh__D008309sskos__Concept
% 212.98/213.19  |- mesh__dateEstablished mesh__D008309 1966-01-01
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D008309 2005
% 212.98/213.19  |- mesh__recordOriginator mesh__D008309 NLM
% 212.98/213.19  |- mesh__publicMeSHNote mesh__D008309 66   
% 212.98/213.19  |- mesh__historyNote mesh__D008309 66%28%64%29%   
% 212.98/213.19  |- mesh__recordAuthorizer mesh__D008309 sjn
% 212.98/213.19  |- mesh__dateCreated mesh__D008309 1999-01-01
% 212.98/213.19  |- mesh__dateRevised mesh__D008309 2004-07-07
% 212.98/213.19  |- skos__scopeNote mesh__D008309
% 212.98/213.19       A condition characterized by mucosal tears at the ESOPHAGOGASTRIC JUNCTION, sometimes with HEMATEMESIS. Typically it is caused by forceful bouts of retching or VOMITING.%A%    
% 212.98/213.19  |- skos__hiddenLabel mesh__D008309 Syndrome, Mallory-Weiss
% 212.98/213.19  |- skos__prefLabel mesh__D008309 Mallory-Weiss Syndrome
% 212.98/213.19  |- skos__broader mesh__D008309smesh__D004939
% 212.98/213.19  |- skos__hiddenLabel mesh__D008309 Mallory Weiss Syndrome
% 212.98/213.19  |- mesh__historyNote mesh__D000326 1991%28%1983%29%   
% 212.98/213.19  |- skos__altLabel mesh__D000326 X-Linked Adrenoleukodystrophy
% 212.98/213.19  |- skos__scopeNote mesh__D000326
% 212.98/213.19       An X-linked recessive disorder characterized by the accumulation of saturated very long chain fatty acids in the LYSOSOMES of ADRENAL CORTEX and the white matter of CENTRAL NERVOUS SYSTEM. This disease occurs almost exclusively in the males. Clinical features include the childhood onset of ATAXIA; NEUROBEHAVIORAL MANIFESTATIONS; HYPERPIGMENTATION; ADRENAL INSUFFICIENCY; SEIZURES; MUSCLE SPASTICITY; and DEMENTIA. The slowly progressive adult form is called adrenomyeloneuropathy. The defective gene ABCD1 is located at Xq28, and encodes the adrenoleukodystrophy protein %28%ATP-BINDING CASSETTE TRANSPORTERS%29%.%A%    
% 212.98/213.19  |- skos__prefLabel mesh__D000326 Adrenoleukodystrophy
% 212.98/213.19  |- skos__broader mesh__D000326smesh__D000309
% 212.98/213.19  |- skos__hiddenLabel mesh__D000326 Adrenoleukodystrophies
% 212.98/213.19  |- skos__hiddenLabel mesh__D000326 Schilder Addison Complex
% 212.98/213.19  |- skos__hiddenLabel mesh__D000326 Adrenomyeloneuropathies
% 212.98/213.19  |- mesh__recordAuthorizer mesh__D000326 sjn
% 212.98/213.19  |- skos__altLabel mesh__D000326 ALD %28%Adrenoleukodystrophy%29%
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D000326 2005
% 212.98/213.19  |- skos__hiddenLabel mesh__D000326 Adrenoleukodystrophies, X-Linked
% 212.98/213.19  |- skos__hiddenLabel mesh__D000326 X Linked Adrenoleukodystrophy
% 212.98/213.19  |- skos__broader mesh__D000326smesh__D038901
% 212.98/213.19  |- skos__historyNote mesh__D000326
% 212.98/213.19       Adrenal Gland Hypofunction %28%1968-1982%29%
% 212.98/213.19  |- skos__annotation mesh__D000326
% 212.98/213.19       do not confuse with ADRENOLEUKODYSTROPHY, NEONATAL see PEROXISOMAL DISORDERS%A%  
% 212.98/213.19  |- mesh__recordOriginator mesh__D000326 RC
% 212.98/213.19  |- mesh__dateEstablished mesh__D000326 1991-01-01
% 212.98/213.19  |- skos__hiddenLabel mesh__D000326 X-Linked Adrenoleukodystrophies
% 212.98/213.19  |- mesh__dateRevised mesh__D000326 2004-07-07
% 212.98/213.19  |- skos__altLabel mesh__D000326 Schilder-Addison Complex
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D000326 2006
% 212.98/213.19  |- rdf__type mesh__D000326sskos__Concept
% 212.98/213.19  |- skos__broader mesh__D000326smesh__D018901
% 212.98/213.19  |- skos__hiddenLabel mesh__D000326 Adrenoleukodystrophy, X-Linked
% 212.98/213.19  |- skos__hiddenLabel mesh__D000326 ALDs %28%Adrenoleukodystrophy%29%
% 212.98/213.19  |- mesh__dateCreated mesh__D000326 1982-04-27
% 212.98/213.19  |- skos__historyNote mesh__D000326 Demyelinating Diseases %28%1966-1982%29%
% 212.98/213.19  |- skos__historyNote mesh__D000326
% 212.98/213.19       Cerebral Sclerosis, Diffuse %28%1966-1982%29%
% 212.98/213.19  |- mesh__recordMaintainer mesh__D000326 lkt
% 212.98/213.19  |- mesh__publicMeSHNote mesh__D000326
% 212.98/213.19       1991; see CEREBRAL SCLEROSIS, DIFFUSE 1983-1990   
% 212.98/213.19  |- skos__broader mesh__D000326smesh__D020279
% 212.98/213.19  |- rdf__type mesh__D005011sskos__Concept
% 212.98/213.19  |- skos__historyNote mesh__D005011 Benzoates %28%1966-1975%29%
% 212.98/213.19  |- mesh__dateRevised mesh__D005011 1998-06-10
% 212.98/213.19  |- mesh__recordAuthorizer mesh__D005011 SJN
% 212.98/213.19  |- mesh__recordMaintainer mesh__D005011 ADP
% 212.98/213.19  |- skos__historyNote mesh__D005011 Acetamides %28%1973-1975%29%
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D005011 2005
% 212.98/213.19  |- skos__historyNote mesh__D005011 Aminobenzoic Acids %28%1966-1976%29%
% 212.98/213.19  |- mesh__recordOriginator mesh__D005011 SH
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D005011 2002
% 212.98/213.19  |- mesh__historyNote mesh__D005011
% 212.98/213.19       91%28%77%29%; was see under AMINOBENZOIC ACIDS 1977-90   
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D005011 2006
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D005011 2003
% 212.98/213.19  |- skos__prefLabel mesh__D005011 Ethopabate
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D005011 2000
% 212.98/213.19  |- mesh__publicMeSHNote mesh__D005011
% 212.98/213.19       91; was see under AMINOBENZOIC ACIDS 1977-90   
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D005011 2004
% 212.98/213.19  |- skos__scopeNote mesh__D005011
% 212.98/213.19       An inhibitor of folate metabolism. It is used as a coccidiostat in poultry.%A%    
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D005011 1999
% 212.98/213.19  |- mesh__dateEstablished mesh__D005011 1991-01-01
% 212.98/213.19  |- skos__broader mesh__D005011smesh__D000610
% 212.98/213.19  |- mesh__dateCreated mesh__D005011 1976-05-03
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D005011 2001
% 212.98/213.19  |- mesh__dateCreated mesh__D046428 2004-07-07
% 212.98/213.19  |- mesh__recordMaintainer mesh__D046428 ags
% 212.98/213.19  |- skos__historyNote mesh__D046428 Birds %28%1966-1998%29%
% 212.98/213.19  |- mesh__recordAuthorizer mesh__D046428 sjn
% 212.98/213.19  |- skos__scopeNote mesh__D046428
% 212.98/213.19       Common name for many members of the FALCONIFORMES order, family Accipitridae, generally smaller than EAGLES, and containing short, rounded wings and a long tail.%A%    
% 212.98/213.19  |- mesh__publicMeSHNote mesh__D046428 2005; see RAPTORS 1999-2004   
% 212.98/213.19  |- skos__broader mesh__D046428smesh__D046093
% 212.98/213.19  |- skos__hiddenLabel mesh__D046428 Hawk
% 212.98/213.19  |- rdf__type mesh__D046428sskos__Concept
% 212.98/213.19  |- mesh__dateEstablished mesh__D046428 2005-01-01
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D046428 2005
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D046428 2006
% 212.98/213.19  |- skos__historyNote mesh__D046428 Raptors %28%1999-2004%29%
% 212.98/213.19  |- mesh__recordOriginator mesh__D046428 ags
% 212.98/213.19  |- mesh__historyNote mesh__D046428 2005; use RAPTORS 1999-2004   
% 212.98/213.19  |- skos__prefLabel mesh__D046428 Hawks
% 212.98/213.19  |- skos__hiddenLabel mesh__D018737 Grasps
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D018737 2006
% 212.98/213.19  |- mesh__recordAuthorizer mesh__D018737 sjn
% 212.98/213.19  |- mesh__dateRevised mesh__D018737 2003-07-09
% 212.98/213.19  |- skos__hiddenLabel mesh__D018737 Strengths, Hand
% 212.98/213.19  |- rdf__type mesh__D018737sskos__Concept
% 212.98/213.19  |- skos__broader mesh__D018737smesh__D043703
% 212.98/213.19  |- mesh__publicMeSHNote mesh__D018737 95   
% 212.98/213.19  |- skos__historyNote mesh__D018737 Hand/physiology %28%1966-1994%29%
% 212.98/213.19  |- mesh__recordMaintainer mesh__D018737 nns
% 212.98/213.19  |- mesh__dateCreated mesh__D018737 1994-05-23
% 212.98/213.19  |- skos__hiddenLabel mesh__D018737 Strength, Hand
% 212.98/213.19  |- skos__prefLabel mesh__D018737 Hand Strength
% 212.98/213.19  |- mesh__recordOriginator mesh__D018737 JLS
% 212.98/213.19  |- mesh__dateEstablished mesh__D018737 1995-01-01
% 212.98/213.19  |- skos__scopeNote mesh__D018737
% 212.98/213.19       Force exerted when gripping or grasping.     
% 212.98/213.19  |- skos__hiddenLabel mesh__D018737 Hand Strengths
% 212.98/213.19  |- skos__broader mesh__D018737smesh__D010808
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D018737 2005
% 212.98/213.19  |- mesh__historyNote mesh__D018737 95   
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D018737 2004
% 212.98/213.19  |- skos__altLabel mesh__D018737 Grasp
% 212.98/213.19  |- skos__hiddenLabel mesh__D018737 Grips
% 212.98/213.19  |- mesh__recordMaintainer mesh__D010754 ssb
% 212.98/213.19  |- skos__annotation mesh__D010754 DF: PRPP   
% 212.98/213.19  |- mesh__dateEstablished mesh__D010754 1991-01-01
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D010754 2005
% 212.98/213.19  |- skos__broader mesh__D010754smesh__D010428
% 212.98/213.19  |- mesh__recordAuthorizer mesh__D010754 sjn
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D010754 2006
% 212.98/213.19  |- skos__historyNote mesh__D010754 Pyrophosphoric Acids %28%1972-1974%29%
% 212.98/213.19  |- mesh__recordOriginator mesh__D010754 NLM
% 212.98/213.19  |- skos__scopeNote mesh__D010754
% 212.98/213.19       The key substance in the biosynthesis of histidine, tryptophan, and purine and pyrimidine nucleotides.%A%    
% 212.98/213.19  |- mesh__dateCreated mesh__D010754 1974-11-11
% 212.98/213.19  |- skos__prefLabel mesh__D010754 Phosphoribosyl Pyrophosphate
% 212.98/213.19  |- rdf__type mesh__D010754sskos__Concept
% 212.98/213.19  |- skos__historyNote mesh__D010754
% 212.98/213.19       Organophosphorus Compounds %28%1972-1974%29%
% 212.98/213.19  |- skos__historyNote mesh__D010754 Pentosephosphates %28%1972-1974%29%
% 212.98/213.19  |- mesh__dateRevised mesh__D010754 2004-07-07
% 212.98/213.19  |- mesh__publicMeSHNote mesh__D010754
% 212.98/213.19       91; was see under PENTOSEPHOSPHATES 1975-90   
% 212.98/213.19  |- skos__hiddenLabel mesh__D010754 Pyrophosphate, Phosphoribosyl
% 212.98/213.19  |- mesh__historyNote mesh__D010754
% 212.98/213.19       91%28%75%29%; was see under PENTOSEPHOSPHATES 1975-90   
% 212.98/213.19  |- skos__prefLabel mesh__D032408 Callicarpa
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D032408 2003
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D032408 2005
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D032408 2004
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D032408 2006
% 212.98/213.19  |- mesh__publicMeSHNote mesh__D032408 2003   
% 212.98/213.19  |- mesh__historyNote mesh__D032408 2003   
% 212.98/213.19  |- skos__broader mesh__D032408smesh__D029648
% 212.98/213.19  |- skos__annotation mesh__D032408
% 212.98/213.19       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 212.98/213.19  |- rdf__type mesh__D032408sskos__Concept
% 212.98/213.19  |- skos__scopeNote mesh__D032408
% 212.98/213.19       A plant genus of the family VERBENACEAE. Members contain clerodane DITERPENES and callicarpone.%A%    
% 212.98/213.19  |- mesh__dateCreated mesh__D032408 2002-07-03
% 212.98/213.19  |- mesh__dateEstablished mesh__D032408 2003-01-01
% 212.98/213.19  |- mesh__recordMaintainer mesh__D004717 lkt
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D004717 2006
% 212.98/213.19  |- skos__prefLabel mesh__D004717 Endometrium
% 212.98/213.19  |- mesh__dateCreated mesh__D004717 1999-01-01
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D004717 2005
% 212.98/213.19  |- mesh__recordAuthorizer mesh__D004717 sjn
% 212.98/213.19  |- rdf__type mesh__D004717sskos__Concept
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D004717 2004
% 212.98/213.19  |- skos__altLabel mesh__D004717 Endometria
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D004717 2003
% 212.98/213.19  |- skos__scopeNote mesh__D004717
% 212.98/213.19       The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing EMBRYO.%A%    
% 212.98/213.19  |- mesh__dateRevised mesh__D004717 2002-07-03
% 212.98/213.19  |- skos__annotation mesh__D004717 inflammation = ENDOMETRITIS   
% 212.98/213.19  |- mesh__recordOriginator mesh__D004717 NLM
% 212.98/213.19  |- skos__broader mesh__D004717smesh__D014599
% 212.98/213.19  |- skos__hiddenLabel mesh__D009402 Nephropathies, Minimal Change
% 212.98/213.19  |- skos__altLabel mesh__D009402 Nephrotic Syndrome, Minimal Change
% 212.98/213.19  |- skos__hiddenLabel mesh__D009402 Minimal Change Glomerulonephritis
% 212.98/213.19  |- mesh__recordAuthorizer mesh__D009402 PLS
% 212.98/213.19  |- skos__hiddenLabel mesh__D009402 Minimal Change Nephropathies
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D009402 1996
% 212.98/213.19  |- mesh__recordMaintainer mesh__D009402 TGC
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D009402 2003
% 212.98/213.19  |- skos__altLabel mesh__D009402 Glomerulonephritis, Minimal Change
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D009402 2004
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D009402 1997
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D009402 1994
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D009402 2002
% 212.98/213.19  |- skos__prefLabel mesh__D009402 Nephrosis, Lipoid
% 212.98/213.19  |- skos__broader mesh__D009402smesh__D009401
% 212.98/213.19  |- skos__hiddenLabel mesh__D009402 Minimal Change Glomerulonephritides
% 212.98/213.19  |- skos__hiddenLabel mesh__D009402 Glomerulonephritides, Minimal Change
% 212.98/213.19  |- mesh__recordOriginator mesh__D009402 NLM
% 212.98/213.19  |- skos__hiddenLabel mesh__D009402 Lipoid Nephroses
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D009402 1995
% 212.98/213.19  |- mesh__dateRevised mesh__D009402 1991-06-18
% 212.98/213.19  |- skos__hiddenLabel mesh__D009402 Lipoid Nephrosis
% 212.98/213.19  |- rdf__type mesh__D009402sskos__Concept
% 212.98/213.19  |- skos__hiddenLabel mesh__D009402 Nephroses, Lipoid
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D009402 1998
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D009402 2005
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D009402 1992
% 212.98/213.19  |- mesh__dateCreated mesh__D009402 1999-01-01
% 212.98/213.19  |- skos__altLabel mesh__D009402 Nephropathy, Minimal Change
% 212.98/213.19  |- skos__scopeNote mesh__D009402
% 212.98/213.19       Glomerular disease causing heavy proteinuria characterized by absence of obvious histologic glomerular changes on light microscopy. It is also called minimal change glomerular disease and minimal lesion glomerulonephritis.%A%    
% 212.98/213.19  |- skos__hiddenLabel mesh__D009402 Minimal Change Nephropathy
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D009402 2000
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D009402 1999
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D009402 2006
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D009402 2001
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D009402 1993
% 212.98/213.19  |- mesh__recordOriginator mesh__D020384 ADP
% 212.98/213.19  |- skos__historyNote mesh__D020384 Glycosphingolipids %28%1983-1998%29%
% 212.98/213.19  |- mesh__recordMaintainer mesh__D020384 ssb
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D020384 2006
% 212.98/213.19  |- rdf__type mesh__D020384sskos__Concept
% 212.98/213.19  |- mesh__recordAuthorizer mesh__D020384 sjn
% 212.98/213.19  |- skos__broader mesh__D020384smesh__D006028
% 212.98/213.19  |- skos__prefLabel mesh__D020384 Acidic Glycosphingolipids
% 212.98/213.19  |- skos__hiddenLabel mesh__D020384 Glycosphingolipids, Acidic
% 212.98/213.19  |- mesh__dateCreated mesh__D020384 1998-06-10
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D020384 2005
% 212.98/213.19  |- skos__scopeNote mesh__D020384
% 212.98/213.19       A subclass of GLYCOSPHINGOLIPIDS containing large polar heads made up of several sugar units. One or more of their terminal sugar units are bound to a negatively charged molecule at pH 7. Members of this class include: GANGLIOSIDES, uronoglycosphingolipids, SULFOGLYCOSPHINGOLIPIDS, phosphoglycosphingolipids, and phosphonoglycosphingolipids.%A%    
% 212.98/213.19  |- mesh__publicMeSHNote mesh__D020384 99   
% 212.98/213.19  |- mesh__dateEstablished mesh__D020384 1999-01-01
% 212.98/213.19  |- mesh__historyNote mesh__D020384 99   
% 212.98/213.19  |- mesh__dateRevised mesh__D020384 2004-07-07
% 212.98/213.19  |- skos__altLabel mesh__D014347 Trypanosoma gambiense
% 212.98/213.19  |- rdf__type mesh__D014347sskos__Concept
% 212.98/213.19  |- mesh__recordMaintainer mesh__D014347 ags
% 212.98/213.19  |- skos__prefLabel mesh__D014347 Trypanosoma brucei gambiense
% 212.98/213.19  |- mesh__dateCreated mesh__D014347 1999-01-01
% 212.98/213.19  |- mesh__dateRevised mesh__D014347 2003-07-09
% 212.98/213.19  |- skos__annotation mesh__D014347
% 212.98/213.19       causes Gambian or West African sleeping sickness in several parts of Africa; infection: coord IM with TRYPANOSOMIASIS, AFRICAN %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D014347 2005
% 212.98/213.19  |- skos__scopeNote mesh__D014347
% 212.98/213.19       A hemoflagellate subspecies of parasitic protozoa that causes Gambian or West African sleeping sickness in humans. The vector host is usually the tsetse fly %28%Glossina%29%.%A%    
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D014347 2004
% 212.98/213.19  |- mesh__dateEstablished mesh__D014347 1972-01-01
% 212.98/213.19  |- mesh__historyNote mesh__D014347 84; was TRYPANOSOMA GAMBIENSE 1972-83   
% 212.98/213.19  |- skos__broader mesh__D014347smesh__D014345
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D014347 2006
% 212.98/213.19  |- mesh__publicMeSHNote mesh__D014347
% 212.98/213.19       84; was TRYPANOSOMA GAMBIENSE 1972-83   
% 212.98/213.19  |- mesh__onlineNote mesh__D014347
% 212.98/213.19       use TRYPANOSOMA BRUCEI GAMBIENSE to search TRYPANOSOMA GAMBIENSE 1972-83%A%  
% 212.98/213.19  |- mesh__recordAuthorizer mesh__D014347 sjn
% 212.98/213.19  |- skos__historyNote mesh__D014347 Trypanosoma %28%1966-1971%29%
% 212.98/213.19  |- mesh__recordOriginator mesh__D014347 NLM
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D019830 2006
% 212.98/213.19  |- skos__scopeNote mesh__D019830
% 212.98/213.19       A stable adenosine A1 and A2 receptor agonist. Experimentally, it inhibits cAMP and cGMP phosphodiesterase activity.%A%    
% 212.98/213.19  |- skos__hiddenLabel mesh__D019830 5%27% N Ethylcarboxamidoadenosine
% 212.98/213.19  |- skos__hiddenLabel mesh__D019830 N6 Ethyl carboxamido Adenosine
% 212.98/213.19  |- skos__prefLabel mesh__D019830 Adenosine-5%27%-%28%N-ethylcarboxamide%29%
% 212.98/213.19  |- skos__historyNote mesh__D019830
% 212.98/213.19       Adenosine/analogs %26% derivatives %28%1980-1997%29%
% 212.98/213.19  |- skos__hiddenLabel mesh__D019830 Adenosine, N6-Ethyl-carboxamido
% 212.98/213.19  |- mesh__dateRevised mesh__D019830 2005-06-30
% 212.98/213.19  |- rdf__type mesh__D019830sskos__Concept
% 212.98/213.19  |- mesh__recordAuthorizer mesh__D019830 sjn
% 212.98/213.19  |- skos__altLabel mesh__D019830 NECA
% 212.98/213.19  |- skos__hiddenLabel mesh__D019830 N Ethylcarboxamidoadenosine
% 212.98/213.19  |- mesh__dateEstablished mesh__D019830 1998-01-01
% 212.98/213.19  |- mesh__historyNote mesh__D019830
% 212.98/213.19       98; use ADENOSINE-5%27%-%28%N-ETHYLCARBOXAMIDE%29% %28%NM%29% 1980-97   
% 212.98/213.19  |- skos__altLabel mesh__D019830 5%27%-N-Ethylcarboxamidoadenosine
% 212.98/213.19  |- mesh__recordMaintainer mesh__D019830 ssb
% 212.98/213.19  |- skos__altLabel mesh__D019830 N6-Ethyl-carboxamido Adenosine
% 212.98/213.19  |- mesh__publicMeSHNote mesh__D019830
% 212.98/213.19       98; ADENOSINE-5%27%-%28%N-ETHYLCARBOXAMIDE%29% was indexed under ADENOSINE/analogs %26% derivatives 1980-97%A%  
% 212.98/213.19  |- skos__altLabel mesh__D019830 Adenosine-5%27%-N-ethyluronamide
% 212.98/213.19  |- skos__hiddenLabel mesh__D019830 Adenosine 5%27% N ethyluronamide
% 212.98/213.19  |- mesh__dateCreated mesh__D019830 1997-06-20
% 212.98/213.19  |- skos__broader mesh__D019830smesh__D000241
% 212.98/213.19  |- mesh__recordOriginator mesh__D019830 ADP
% 212.98/213.19  |- skos__altLabel mesh__D019830 N-Ethylcarboxamidoadenosine
% 212.98/213.19  |- rdf__type mesh__D033501sskos__Concept
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D033501 2006
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D033501 2004
% 212.98/213.19  |- mesh__dateRevised mesh__D033501 2003-07-09
% 212.98/213.19  |- skos__broader mesh__D033501smesh__D033364
% 212.98/213.19  |- skos__historyNote mesh__D033501 Crustacea %28%1969-2002%29%
% 212.98/213.19  |- mesh__historyNote mesh__D033501 2003   
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D033501 2005
% 212.98/213.19  |- skos__scopeNote mesh__D033501
% 212.98/213.19       A family of shrimp in the class CRUSTACEA, order DECAPODA, containing a single genus, Crangon, with multiple species.%A%    
% 212.98/213.19  |- mesh__dateCreated mesh__D033501 2002-07-03
% 212.98/213.19  |- skos__prefLabel mesh__D033501 Crangonidae
% 212.98/213.19  |- mesh__dateEstablished mesh__D033501 2003-01-01
% 212.98/213.19  |- mesh__publicMeSHNote mesh__D033501 2003   
% 212.98/213.19  |- skos__annotation mesh__D000327
% 212.98/213.19       almost never IM; coord NIM with substance /pharmacokin %28%IM%29%%A%  
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D000327 2002
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D000327 1993
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D000327 1996
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D000327 2005
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D000327 1997
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D000327 2006
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D000327 2000
% 212.98/213.19  |- rdf__type mesh__D000327sskos__Concept
% 212.98/213.19  |- mesh__recordOriginator mesh__D000327 NLM
% 212.98/213.19  |- mesh__recordMaintainer mesh__D000327 TAP
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D000327 2003
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D000327 1994
% 212.98/213.19  |- skos__broader mesh__D000327smesh__D002627
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D000327 2001
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D000327 2004
% 212.98/213.19  |- mesh__recordAuthorizer mesh__D000327 PLS
% 212.98/213.19  |- skos__hiddenLabel mesh__D000327 Adsorptions
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D000327 1998
% 212.98/213.19  |- mesh__dateCreated mesh__D000327 1999-01-01
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D000327 1995
% 212.98/213.19  |- mesh__dateRevised mesh__D000327 1992-03-25
% 212.98/213.19  |- skos__scopeNote mesh__D000327
% 212.98/213.19       The condensation of gases, liquids, or dissolved substances on the surfaces of solids. It includes adsorptive phenomena of bacteria and viruses as well as of tissues treated with exogenous drugs and chemicals.%A%    
% 212.98/213.19  |- skos__prefLabel mesh__D000327 Adsorption
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D000327 1999
% 212.98/213.19  |- skos__altLabel mesh__D019032
% 212.98/213.19       Spectroscopy, Mass, Matrix-Assisted Laser Desorption-Ionization
% 212.98/213.19  |- skos__broader mesh__D019032smesh__D013058
% 212.98/213.19  |- skos__altLabel mesh__D019032
% 212.98/213.19       Mass Spectrometry, Matrix-Assisted Laser Desorption-Ionization
% 212.98/213.19  |- mesh__dateRevised mesh__D019032 2005-06-30
% 212.98/213.19  |- mesh__historyNote mesh__D019032 96   
% 212.98/213.19  |- skos__altLabel mesh__D019032
% 212.98/213.19       Laser Desorption-Ionization Mass Spectrometry, Matrix-Assisted
% 212.98/213.19  |- skos__hiddenLabel mesh__D019032
% 212.98/213.19       Mass Spectroscopy, Matrix Assisted Laser Desorption Ionization
% 212.98/213.19  |- mesh__recordMaintainer mesh__D019032 ssb
% 212.98/213.19  |- skos__altLabel mesh__D019032 MALDI-MS
% 212.98/213.19  |- mesh__publicMeSHNote mesh__D019032 96   
% 212.98/213.19  |- skos__hiddenLabel mesh__D019032
% 212.98/213.19       Mass Spectrometry, Matrix Assisted Laser Desorption Ionization
% 212.98/213.19  |- skos__hiddenLabel mesh__D019032
% 212.98/213.19       Laser Desorption Ionization Mass Spectrometry, Matrix Assisted
% 212.98/213.19  |- mesh__recordOriginator mesh__D019032 PXP
% 212.98/213.19  |- skos__altLabel mesh__D019032
% 212.98/213.19       Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
% 212.98/213.19  |- skos__scopeNote mesh__D019032
% 212.98/213.19       A mass spectrometric technique that is used for the analysis of large biomolecules. Analyte molecules are embedded in an excess matrix of small organic molecules that show a high resonant absorption at the laser wavelength used. The matrix absorbs the laser energy, thus inducing a soft disintegration of the sample-matrix mixture into free %28%gas phase%29% matrix and analyte molecules and molecular ions. In general, only molecular ions of the analyte molecules are produced, and almost no fragmentation occurs. This makes the method well suited for molecular weight determinations and mixture analysis.%A%    
% 212.98/213.19  |- skos__altLabel mesh__D019032 MALDI
% 212.98/213.19  |- skos__altLabel mesh__D019032
% 212.98/213.19       Mass Spectroscopy, Matrix-Assisted Laser Desorption-Ionization
% 212.98/213.19  |- skos__historyNote mesh__D019032
% 212.98/213.19       Spectrum Analysis, Mass %28%1989-1995%29%
% 212.98/213.19  |- skos__hiddenLabel mesh__D019032
% 212.98/213.19       Matrix Assisted Laser Desorption Ionization Mass Spectrometry
% 212.98/213.19  |- skos__altLabel mesh__D019032 MALD-MS
% 212.98/213.19  |- mesh__dateCreated mesh__D019032 1995-05-26
% 212.98/213.19  |- skos__altLabel mesh__D019032 MS-MALD
% 212.98/213.19  |- mesh__dateEstablished mesh__D019032 1996-01-01
% 212.98/213.19  |- skos__altLabel mesh__D019032 SELDI-TOF-MS
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D019032 2006
% 212.98/213.19  |- rdf__type mesh__D019032sskos__Concept
% 212.98/213.19  |- skos__prefLabel mesh__D019032
% 212.98/213.19       Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
% 212.98/213.19  |- skos__hiddenLabel mesh__D019032 MALDI MS
% 212.98/213.19  |- mesh__recordAuthorizer mesh__D019032 sjn
% 212.98/213.19  |- skos__hiddenLabel mesh__D005810 Reiterated Genes
% 212.98/213.19  |- skos__hiddenLabel mesh__D005810 Gene, Reiterated
% 212.98/213.19  |- skos__prefLabel mesh__D005810 Multigene Family
% 212.98/213.19  |- skos__related mesh__D005810smesh__D012091
% 212.98/213.19  |- skos__historyNote mesh__D005810 Genes, Bacterial %28%1982-1986%29%
% 212.98/213.19  |- mesh__historyNote mesh__D005810
% 212.98/213.19       97; was GENES, REITERATED 1987-96; MULTIGENE FAMILY was see GENES, REITERATED 1987-96%A%  
% 212.98/213.19  |- skos__historyNote mesh__D005810 Genes, Viral %28%1978-1986%29%
% 212.98/213.19  |- mesh__recordAuthorizer mesh__D005810 sjn
% 212.98/213.19  |- skos__hiddenLabel mesh__D005810 Clusters, Gene
% 212.98/213.19  |- skos__related mesh__D005810smesh__D020440
% 212.98/213.19  |- mesh__recordOriginator mesh__D005810 SCD
% 212.98/213.19  |- mesh__recordMaintainer mesh__D005810 nns
% 212.98/213.19  |- skos__hiddenLabel mesh__D005810 Cluster, Gene
% 212.98/213.19  |- skos__historyNote mesh__D005810 Genes, Structural %28%1971-1986%29%
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D005810 2006
% 212.98/213.19  |- mesh__dateRevised mesh__D005810 2005-06-30
% 212.98/213.19  |- skos__historyNote mesh__D005810 Genes %28%1966-1970%29%
% 212.98/213.19  |- mesh__publicMeSHNote mesh__D005810
% 212.98/213.19       97; was GENES, REITERATED 1987-96; MULTIGENE FAMILY was see GENES, REITERATED 1987-96%A%  
% 212.98/213.19  |- skos__hiddenLabel mesh__D005810 Gene Cluster
% 212.98/213.19  |- skos__related mesh__D005810smesh__D020131
% 212.98/213.19  |- mesh__dateEstablished mesh__D005810 1987-01-01
% 212.98/213.19  |- skos__broader mesh__D005810smesh__D005796
% 212.98/213.19  |- rdf__type mesh__D005810sskos__Concept
% 212.98/213.19  |- skos__hiddenLabel mesh__D005810 Reiterated Gene
% 212.98/213.19  |- skos__hiddenLabel mesh__D005810 Multigene Families
% 212.98/213.19  |- skos__scopeNote mesh__D005810
% 212.98/213.19       A set of genes descended by duplication and variation from some ancestral gene. Such genes may be clustered together on the same chromosome or dispersed on different chromosomes. Examples of multigene families include those that encode the hemoglobins, immunoglobulins, histocompatibility antigens, actins, tubulins, keratins, collagens, heat shock proteins, salivary glue proteins, chorion proteins, cuticle proteins, yolk proteins, and phaseolins, as well as histones, ribosomal RNA, and transfer RNA genes. The latter three are examples of reiterated genes, where hundreds of identical genes are present in a tandem array. %28%King %26% Stanfield, A Dictionary of Genetics, 4th ed%29%%A%    
% 212.98/213.19  |- mesh__dateCreated mesh__D005810 1986-06-19
% 212.98/213.19  |- skos__hiddenLabel mesh__D005810 Family, Multigene
% 212.98/213.19  |- skos__hiddenLabel mesh__D005810 Families, Multigene
% 212.98/213.19  |- skos__altLabel mesh__D046429 Penguins
% 212.98/213.19  |- rdf__type mesh__D046429sskos__Concept
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D046429 2005
% 212.98/213.19  |- mesh__recordOriginator mesh__D046429 ags
% 212.98/213.19  |- skos__hiddenLabel mesh__D046429 Penguin
% 212.98/213.19  |- mesh__activeMeSHYear mesh__D046429 2006
% 212.98/213.19  |- skos__prefLabel mesh__D046429 Spheniscidae
% 212.98/213.19  |- skos__broader mesh__D046429smesh__D001717
% 212.98/213.19  |- mesh__recordAuthorizer mesh__D046429 sjn
% 212.98/213.19  |- mesh__dateCreated mesh__D046429 2004-07-07
% 212.98/213.19  |- skos__scopeNote mesh__D046429
% 212.98/213.19       The sole family in the order Sphenisciformes, comprised of 17 species of penguins in six genera. They are flightless seabirds of the Southern Hemisphere, highly adapted for marine life.%A%    
% 212.98/213.19  |- skos__historyNote mesh__D046429 Birds %28%1963-2004%29%
% 212.98/213.19  |- mesh__publicMeSHNote mesh__D046429 2005   
% 212.98/213.19  |- mesh__dateEstablished mesh__D046429 2005-01-01
% 212.98/213.19  |- mesh__recordMaintainer mesh__D046429 ags
% 212.98/213.19  |- mesh__historyNote mesh__D046429 2005   
% 212.98/213.19  |- rdf__type mesh__D018738sskos__Concept
% 212.98/213.19  |- mesh__dateRevised mesh__D018738 2005-06-30
% 212.98/213.19  |- skos__altLabel mesh__D018738 Hexonium
% 212.98/213.19  |- skos__hiddenLabel mesh__D018738 Bitartrate, Hexamethonium
% 212.98/213.19  |- mesh__recordMaintainer mesh__D018738 ssb
% 212.98/213.19  |- skos__hiddenLabel mesh__D018738 Iodide, Hexamethonium
% 212.98/213.19  |- skos__hiddenLabel mesh__D018738 Dimethylsulfate, Hexamethonium
% 212.98/213.19  |- skos__hiddenLabel mesh__D018738 Monotartrate, Hexamethonium
% 212.98/213.19  |- skos__hiddenLabel mesh__D018738 Chloride, Hexamethonium
% 212.98/213.19  |- mesh__recordAuthorizer mesh__D018738 sjn
% 212.98/213.19  |- skos__hiddenLabel mesh__D018738 Dihydroxide, Hexamethonium
% 212.98/213.19  |- mesh__dateCreated mesh__D018738 1994-06-01
% 212.98/213.19  |- skos__hiddenLabel mesh__D018738 Dihydrate, Hexamethonium Dibromide
% 212.98/213.19  |- skos__hiddenLabel mesh__D018738 Diperchlorate, Hexamethonium
% 212.98/213.19  |- mesh__recordOriginator mesh__D018738 RAZ
% 212.98/213.19  |- skos__hiddenLabel mesh__D018738 Dihydrate, Hexamethonium Dichloride
% 212.98/213.19  |- mesh__historyNote mesh__D018738
% 212.98/213.19       95; was HEXAMETHONIUM %28%NM%29% 1980-94   
% 212.98/213.19  |- mesh__publicMeSHNote mesh__D018738
% 212.98/213.19       95; HEXAMETHONIUM was indexed under HEXAMETHONIUM COMPOUNDS 1980-94%A%  
% 212.98/213.19  |- skos__hiddenLabel mesh__D018738 Dichloride Dihydrate, Hexamethonium
% 212.98/213.19  |- skos__prefLabel mesh__D018738 Hexamethonium
% 212.98/213.19  |- skos__hiddenLabel mesh__D018738 Dibromide Dihydrate, Hexamethonium
% 212.98/213.19  |- skos__historyNote mesh__D018738
% 212.98/213.19       Hexamethonium Compounds %28%1980-1994%29%
% 212.98/213.20  |- skos__scopeNote mesh__D018738
% 212.98/213.20       A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.%A%    
% 212.98/213.20  |- skos__hiddenLabel mesh__D018738 Diiodide, Hexamethonium
% 212.98/213.20  |- mesh__dateEstablished mesh__D018738 1995-01-01
% 212.98/213.20  |- mesh__activeMeSHYear mesh__D018738 2006
% 212.98/213.20  |- mesh__onlineNote mesh__D018738
% 212.98/213.20       use HEXAMETHONIUM %28%NM%29% to search HEXAMETHONIUM 1980-94   
% 212.98/213.20  |- skos__broader mesh__D018738smesh__D006584
% 212.98/213.20  |- skos__hiddenLabel mesh__D018738 Dibromide, Hexamethonium
% 212.98/213.20  |- skos__hiddenLabel mesh__D018738 Bromide, Hexamethonium
% 212.98/213.20  |- mesh__recordOriginator mesh__D010755 NLM
% 212.98/213.20  |- skos__altLabel mesh__D010755 Phosphates, Organic
% 212.98/213.20  |- mesh__onlineNote mesh__D010755
% 212.98/213.20       use ORGANOPHOSPHORUS COMPOUNDS to search PHOSPHATES, ORGANIC 1976-93 %26% PHOSPHORIC ACID ESTERS 1972-74; use PHOSPHORIC ACIDS to search PHOSPHORIC ACID ESTERS 1968-71%A%  
% 212.98/213.20  |- mesh__recordMaintainer mesh__D010755 ssb
% 212.98/213.20  |- skos__scopeNote mesh__D010755 Organic esters of phosphoric acid.     
% 212.98/213.20  |- skos__broader mesh__D010755smesh__D009943
% 212.98/213.20  |- rdf__type mesh__D010755sskos__Concept
% 212.98/213.20  |- mesh__publicMeSHNote mesh__D010755
% 212.98/213.20       91; was see under ORGANOPHOSPHORUS COMPOUNDS 1972-90; was see under PHOSPHORIC ACIDS 1968-71; PHOSPHATES, ORGANIC was see ORGANOPHOSPHORUS COMPOUNDS 1976-93%A%  
% 212.98/213.20  |- skos__hiddenLabel mesh__D010755 Esters, Phosphoric Acid
% 212.98/213.20  |- mesh__dateRevised mesh__D010755 2004-07-07
% 212.98/213.20  |- mesh__historyNote mesh__D010755
% 212.98/213.20       91%28%75%29%; was see under ORGANOPHOSPHORUS COMPOUNDS 1972-90; was see under PHOSPHORIC ACIDS 1968-71; PHOSPHATES, ORGANIC was see ORGANOPHOSPHORUS COMPOUNDS 1976-93%A%  
% 212.98/213.20  |- skos__hiddenLabel mesh__D010755 Organic Phosphates
% 212.98/213.20  |- mesh__dateCreated mesh__D010755 1999-01-01
% 212.98/213.20  |- mesh__recordAuthorizer mesh__D010755 sjn
% 212.98/213.20  |- skos__hiddenLabel mesh__D010755 Acid Esters, Phosphoric
% 212.98/213.20  |- mesh__activeMeSHYear mesh__D010755 2005
% 212.98/213.20  |- mesh__dateEstablished mesh__D010755 1991-01-01
% 212.98/213.20  |- skos__prefLabel mesh__D010755 Phosphoric Acid Esters
% 212.98/213.20  |- mesh__activeMeSHYear mesh__D010755 2006
% 212.98/213.20  |- mesh__dateEstablished mesh__D032409 2003-01-01
% 212.98/213.20  |- mesh__activeMeSHYear mesh__D032409 2004
% 212.98/213.20  |- mesh__activeMeSHYear mesh__D032409 2006
% 212.98/213.20  |- mesh__publicMeSHNote mesh__D032409 2003   
% 212.98/213.20  |- skos__scopeNote mesh__D032409
% 212.98/213.20       A plant genus of the family VERBENACEAE. Inerminosides %28%iridoid glycosides%29%, colebroside A, STEROIDS, STEROLS, terpenoid glucosides, and abietane DITERPENES have been found in this genus.%A%    
% 213.05/213.20  |- skos__broader mesh__D032409smesh__D029648
% 213.05/213.20  |- skos__annotation mesh__D032409
% 213.05/213.20       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.05/213.20  |- rdf__type mesh__D032409sskos__Concept
% 213.05/213.20  |- mesh__recordAuthorizer mesh__D032409 sjn
% 213.05/213.20  |- skos__prefLabel mesh__D032409 Clerodendrum
% 213.05/213.20  |- mesh__recordOriginator mesh__D032409 ssb
% 213.05/213.20  |- mesh__historyNote mesh__D032409 2003   
% 213.05/213.20  |- mesh__dateRevised mesh__D032409 2003-07-09
% 213.05/213.20  |- mesh__recordMaintainer mesh__D032409 ssb
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D032409 2005
% 213.05/213.20  |- mesh__dateCreated mesh__D032409 2002-07-03
% 213.05/213.20  |- skos__altLabel mesh__D032409 Clerodendron
% 213.05/213.20  |- skos__altLabel mesh__D004718 Budding Yeast
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D004718 2006
% 213.05/213.20  |- mesh__recordOriginator mesh__D004718 NLM
% 213.05/213.20  |- skos__altLabel mesh__D004718 Endomycetales
% 213.05/213.20  |- mesh__dateRevised mesh__D004718 2005-06-30
% 213.05/213.20  |- skos__prefLabel mesh__D004718 Saccharomycetales
% 213.05/213.20  |- rdf__type mesh__D004718sskos__Concept
% 213.05/213.20  |- mesh__dateEstablished mesh__D004718 1986-01-01
% 213.05/213.20  |- mesh__historyNote mesh__D004718
% 213.05/213.20       99%28%63%29%; for EREMOTHECIUM use ASCOMYCOTA 1963-74   
% 213.05/213.20  |- mesh__recordMaintainer mesh__D004718 SYSTEM
% 213.05/213.20  |- skos__broader mesh__D004718smesh__D001203
% 213.05/213.20  |- skos__scopeNote mesh__D004718
% 213.05/213.20       An order of fungi in the phylum Ascomycota that multiply by budding. They include the telomorphic ascomycetous yeasts which are found in a very wide range of habitats.%A%    
% 213.05/213.20  |- skos__altLabel mesh__D004718 Yeast, Budding
% 213.05/213.20  |- mesh__recordAuthorizer mesh__D004718 sjn
% 213.05/213.20  |- mesh__dateCreated mesh__D004718 1999-01-01
% 213.05/213.20  |- mesh__publicMeSHNote mesh__D004718
% 213.05/213.20       99; see ENDOMYCETALES 1986-98, see ASCOMYCETES 1963-85; for ENDOMYCOPSIS see ASCOMYCETES 1975-85; for EREMOTHECIUM see ASCOMYCETES 1963-85%A%  
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D015440 2003
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D015440 1998
% 213.05/213.20  |- mesh__recordOriginator mesh__D015440 EC
% 213.05/213.20  |- skos__hiddenLabel mesh__D015440 Cutaneous Leprosy
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D015440 2006
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D015440 1993
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D015440 2001
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D015440 1994
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D015440 2005
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D015440 1992
% 213.05/213.20  |- skos__annotation mesh__D015440
% 213.05/213.20       erythema nodosum leprosum %28%ENL%29%: index under LEPROSY, LEPROMATOUS %28%IM%29% + ERYTHEMA NODOSUM %28%IM%29%%A%  
% 213.05/213.20  |- skos__altLabel mesh__D015440 Leprosy, Nodular
% 213.05/213.20  |- skos__hiddenLabel mesh__D015440 Lepromatous Leprosy
% 213.05/213.20  |- mesh__recordAuthorizer mesh__D015440 PLS
% 213.05/213.20  |- skos__hiddenLabel mesh__D015440 Leprosies, Nodular
% 213.05/213.20  |- skos__hiddenLabel mesh__D015440 Leprosies, Lepromatous
% 213.05/213.20  |- mesh__dateEstablished mesh__D015440 1989-01-01
% 213.05/213.20  |- skos__broader mesh__D015440smesh__D007918
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D015440 2000
% 213.05/213.20  |- skos__hiddenLabel mesh__D015440 Leprosies, Cutaneous
% 213.05/213.20  |- skos__hiddenLabel mesh__D015440 Nodular Leprosy
% 213.05/213.20  |- mesh__recordMaintainer mesh__D015440 PXP
% 213.05/213.20  |- skos__hiddenLabel mesh__D015440 Lepromatous Leprosies
% 213.05/213.20  |- skos__historyNote mesh__D015440 Leprosy %28%1966-1988%29%
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D015440 1997
% 213.05/213.20  |- skos__hiddenLabel mesh__D015440 Cutaneous Leprosies
% 213.05/213.20  |- rdf__type mesh__D015440sskos__Concept
% 213.05/213.20  |- mesh__historyNote mesh__D015440
% 213.05/213.20       89; CUTANEOUS LEPROSY %26% NODULAR LEPROSY were see LEPROSY, LEPROMATOUS 1989-91%A%  
% 213.05/213.20  |- skos__scopeNote mesh__D015440
% 213.05/213.20       A chronic communicable infection which is a principal or polar form of LEPROSY. This disorder is caused by MYCOBACTERIUM LEPRAE and produces diffuse granulomatous skin lesions in the form of nodules, macules, or papules. The peripheral nerves are involved symmetrically and neural sequelae occur in the advanced stage.%A%    
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D015440 2004
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D015440 1996
% 213.05/213.20  |- mesh__dateRevised mesh__D015440 1991-06-12
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D015440 1999
% 213.05/213.20  |- mesh__onlineNote mesh__D015440
% 213.05/213.20       use LEPROSY, LEPROMATOUS to search CUTANEOUS LEPROSY %26% NODULAR LEPROSY 1989-91%A%  
% 213.05/213.20  |- mesh__dateCreated mesh__D015440 1988-06-08
% 213.05/213.20  |- skos__prefLabel mesh__D015440 Leprosy, Lepromatous
% 213.05/213.20  |- skos__hiddenLabel mesh__D015440 Nodular Leprosies
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D015440 2002
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D015440 1995
% 213.05/213.20  |- mesh__publicMeSHNote mesh__D015440
% 213.05/213.20       89; CUTANEOUS LEPROSY %26% NODULAR LEPROSY were see LEPROSY, LEPROMATOUS 1989-91%A%  
% 213.05/213.20  |- skos__broader mesh__D009403smesh__D014547
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D009403 2000
% 213.05/213.20  |- mesh__dateCreated mesh__D009403 1985-02-28
% 213.05/213.20  |- skos__broader mesh__D009403smesh__D003950
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D009403 2004
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D009403 2001
% 213.05/213.20  |- skos__altLabel mesh__D009403 Percutaneous Nephrolithotomy
% 213.05/213.20  |- skos__historyNote mesh__D009403 Urinary Diversion %28%1966-1985%29%
% 213.05/213.20  |- mesh__historyNote mesh__D009403 86   
% 213.05/213.20  |- skos__scopeNote mesh__D009403
% 213.05/213.20       The insertion of a catheter through the skin and body wall into the kidney pelvis, mainly to provide urine drainage where the ureter is not functional. It is used also to remove or dissolve renal calculi and to diagnose ureteral obstruction.%A%    
% 213.05/213.20  |- mesh__recordMaintainer mesh__D009403 PXP
% 213.05/213.20  |- skos__historyNote mesh__D009403
% 213.05/213.20       Urinary Catheterization %28%1966-1985%29%
% 213.05/213.20  |- rdf__type mesh__D009403sskos__Concept
% 213.05/213.20  |- skos__hiddenLabel mesh__D009403 Percutaneous Nephrostomies
% 213.05/213.20  |- skos__broader mesh__D009403smesh__D010030
% 213.05/213.20  |- mesh__recordOriginator mesh__D009403 SN
% 213.05/213.20  |- skos__altLabel mesh__D009403 Percutaneous Nephrostomy
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D009403 1998
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D009403 2005
% 213.05/213.20  |- skos__annotation mesh__D009403
% 213.05/213.20       do not use /util except by MeSH definition; X ref NEPHROLITHOTOMY, PERCUTANEOUS is not a substitute for LITHOTRIPSY: coord NEPHROSTOMY, PERCUTANEOUS + LITHOTRIPSY for lithotripsy of urinary calculi by percutaneous nephrolithotomy%A%  
% 213.05/213.20  |- mesh__recordAuthorizer mesh__D009403 SJN
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D009403 2002
% 213.05/213.20  |- skos__hiddenLabel mesh__D009403 Percutaneous Nephrolithotomies
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D009403 2006
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D009403 1999
% 213.05/213.20  |- skos__prefLabel mesh__D009403 Nephrostomy, Percutaneous
% 213.05/213.20  |- skos__hiddenLabel mesh__D009403 Nephrolithotomies, Percutaneous
% 213.05/213.20  |- mesh__dateEstablished mesh__D009403 1986-01-01
% 213.05/213.20  |- skos__hiddenLabel mesh__D009403 Nephrostomies, Percutaneous
% 213.05/213.20  |- mesh__publicMeSHNote mesh__D009403 86   
% 213.05/213.20  |- mesh__dateRevised mesh__D009403 1997-06-20
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D009403 2003
% 213.05/213.20  |- skos__broader mesh__D001420smesh__D001419
% 213.05/213.20  |- mesh__dateEstablished mesh__D001420 1984-01-01
% 213.05/213.20  |- mesh__recordOriginator mesh__D001420 RC
% 213.05/213.20  |- mesh__dateCreated mesh__D001420 1983-06-03
% 213.05/213.20  |- skos__historyNote mesh__D001420 Aerobiosis %28%1971-1983%29%
% 213.05/213.20  |- mesh__recordAuthorizer mesh__D001420 sjn
% 213.05/213.20  |- skos__prefLabel mesh__D001420 Bacteria, Aerobic
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D001420 2006
% 213.05/213.20  |- skos__annotation mesh__D001420
% 213.05/213.20       GEN: avoid; prefer specifics; do not use as a routine coord for an aerobic bact; infection: coord IM with BACTERIAL INFECTIONS %28%IM%29%; DF: BACT AEROBIC%A%  
% 213.05/213.20  |- skos__altLabel mesh__D001420 Aerobic Bacteria
% 213.05/213.20  |- mesh__recordMaintainer mesh__D001420 SYSTEM
% 213.05/213.20  |- rdf__type mesh__D001420sskos__Concept
% 213.05/213.20  |- mesh__dateRevised mesh__D001420 2005-06-30
% 213.05/213.20  |- skos__historyNote mesh__D001420 Bacteria %28%1966-1983%29%
% 213.05/213.20  |- mesh__historyNote mesh__D001420 84   
% 213.05/213.20  |- mesh__publicMeSHNote mesh__D001420 84   
% 213.05/213.20  |- skos__hiddenLabel mesh__D020385 Generalized Myokymias
% 213.05/213.20  |- skos__altLabel mesh__D020385 Morvan%27%s Chorea
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D020385 2005
% 213.05/213.20  |- skos__hiddenLabel mesh__D020385 Morvans Chorea
% 213.05/213.20  |- skos__altLabel mesh__D020385 Morvan Chorea
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D020385 2001
% 213.05/213.20  |- mesh__historyNote mesh__D020385 2000; use FASCICULATION 1985-1999   
% 213.05/213.20  |- mesh__dateCreated mesh__D020385 1999-11-03
% 213.05/213.20  |- skos__hiddenLabel mesh__D020385 Generalized Myokymia
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D020385 2004
% 213.05/213.20  |- skos__hiddenLabel mesh__D020385 Choreas, Morvan
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D020385 2000
% 213.05/213.20  |- skos__hiddenLabel mesh__D020385 Chorea, Morvan
% 213.05/213.20  |- skos__hiddenLabel mesh__D020385 Choreas, Fibrillary
% 213.05/213.20  |- skos__annotation mesh__D020385
% 213.05/213.20       consider also FASCICULATION; for continuous myokymia use ISAACS SYNDROME%A%  
% 213.05/213.20  |- skos__altLabel mesh__D020385 Fibrillary Chorea
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D020385 2003
% 213.05/213.20  |- mesh__dateEstablished mesh__D020385 2000-01-01
% 213.05/213.20  |- skos__broader mesh__D020385smesh__D020879
% 213.05/213.20  |- skos__hiddenLabel mesh__D020385 Chorea, Fibrillary
% 213.05/213.20  |- skos__altLabel mesh__D020385 Kymatism
% 213.05/213.20  |- skos__hiddenLabel mesh__D020385 Fibrillary Choreas
% 213.05/213.20  |- skos__hiddenLabel mesh__D020385 Chorea, Morvan%27%s
% 213.05/213.20  |- skos__historyNote mesh__D020385 Fasciculation %28%1985-1999%29%
% 213.05/213.20  |- skos__hiddenLabel mesh__D020385 Myokymias, Generalized
% 213.05/213.20  |- skos__hiddenLabel mesh__D020385 Morvan Choreas
% 213.05/213.20  |- skos__scopeNote mesh__D020385
% 213.05/213.20       Successive and rapid contractions of motor units associated with chronic nerve injury. The discharges arise from the peripheral aspects of regenerating nerves, and clinically impart a nearly continuous undulation of the body surface overlying the muscle. %28%Adams et al., Principles of Neurology, 6th ed, p1491%29%%A%    
% 213.05/213.20  |- mesh__publicMeSHNote mesh__D020385 2000; see FASCICULATION 1985-1999   
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D020385 2006
% 213.05/213.20  |- skos__prefLabel mesh__D020385 Myokymia
% 213.05/213.20  |- rdf__type mesh__D020385sskos__Concept
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D020385 2002
% 213.05/213.20  |- skos__hiddenLabel mesh__D020385 Kymatisms
% 213.05/213.20  |- skos__hiddenLabel mesh__D020385 Myokymias
% 213.05/213.20  |- rdf__type mesh__D014348sskos__Concept
% 213.05/213.20  |- skos__annotation mesh__D014348
% 213.05/213.20       infection: coord IM with TRYPANOSOMIASIS, AFRICAN %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 213.05/213.20  |- mesh__recordOriginator mesh__D014348 EC
% 213.05/213.20  |- skos__scopeNote mesh__D014348
% 213.05/213.20       A species of Trypanosome hemoflagellates that is carried by tsetse flies and causes severe anemia in cattle. These parasites are also found in horses, sheep, goats, and camels.%A%    
% 213.05/213.20  |- mesh__recordMaintainer mesh__D014348 ags
% 213.05/213.20  |- mesh__dateRevised mesh__D014348 2005-07-07
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D014348 2006A
% 213.05/213.20  |- mesh__historyNote mesh__D014348 84   
% 213.05/213.20  |- skos__historyNote mesh__D014348 Trypanosoma %28%1966-1983%29%
% 213.05/213.20  |- mesh__recordAuthorizer mesh__D014348 ags
% 213.05/213.20  |- skos__prefLabel mesh__D014348 Trypanosoma congolense
% 213.05/213.20  |- skos__altLabel mesh__D014348 Trypanosoma %28%Nannomonas%29% congolense
% 213.05/213.20  |- mesh__dateCreated mesh__D014348 1983-06-06
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D014348 2005
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D014348 2004
% 213.05/213.20  |- mesh__dateEstablished mesh__D014348 1984-01-01
% 213.05/213.20  |- skos__broader mesh__D014348smesh__D014345
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D014348 2006
% 213.05/213.20  |- mesh__publicMeSHNote mesh__D014348 84   
% 213.05/213.20  |- skos__hiddenLabel mesh__D019831 Calcium Sodium Antiporter
% 213.05/213.20  |- skos__hiddenLabel mesh__D019831 Exchanger, Sodium-Calcium
% 213.05/213.20  |- skos__altLabel mesh__D019831 Calcium-Sodium Antiporter
% 213.05/213.20  |- skos__altLabel mesh__D019831 Sodium-Calcium Antiporter
% 213.05/213.20  |- mesh__dateCreated mesh__D019831 1997-06-20
% 213.05/213.20  |- skos__historyNote mesh__D019831 Antiporters %28%1993-1997%29%
% 213.05/213.20  |- skos__hiddenLabel mesh__D019831 Carrier, Sodium-Calcium
% 213.05/213.20  |- mesh__historyNote mesh__D019831
% 213.05/213.20       98; use SODIUM-CALCIUM EXCHANGER %28%NM%29% 1980-97   
% 213.05/213.20  |- skos__broader mesh__D019831smesh__D017920
% 213.05/213.20  |- mesh__recordOriginator mesh__D019831 ADP
% 213.05/213.20  |- skos__hiddenLabel mesh__D019831 Antiporter, Calcium-Sodium
% 213.05/213.20  |- skos__hiddenLabel mesh__D019831 Sodium Calcium Carrier
% 213.05/213.20  |- skos__altLabel mesh__D019831 Ca%28%2+%29%-Na%28%+%29% Exchanger
% 213.05/213.20  |- skos__altLabel mesh__D019831 Calcium-Sodium Exchanger
% 213.05/213.20  |- skos__hiddenLabel mesh__D019831 Antiporter, Sodium-Calcium
% 213.05/213.20  |- skos__prefLabel mesh__D019831 Sodium-Calcium Exchanger
% 213.05/213.20  |- skos__altLabel mesh__D019831 Na%28%+%29%-Ca%28%2+%29% Exchanger
% 213.05/213.20  |- skos__scopeNote mesh__D019831
% 213.05/213.20       An electrogenic ion exchange protein that maintains a steady level of calcium by removing an amount of calcium equal to that which enters the cells. It is widely distributed in most excitable membranes, including the brain and heart.%A%    
% 213.05/213.20  |- mesh__publicMeSHNote mesh__D019831
% 213.05/213.20       98; SODIUM-CALCIUM CARRIER %28%now SODIUM-CALCIUM EXCHANGER%29% was indexed under CARRIER PROTEINS 1980-97; CALCIUM-SODIUM ANTIPORTER was indexed under ANTIPORTERS 1993-97, CARRIER PROTEINS %26% MEMBRANE PROTEINS 1980-93%A%  
% 213.05/213.20  |- skos__hiddenLabel mesh__D019831 Exchanger, Calcium-Sodium
% 213.05/213.20  |- mesh__recordMaintainer mesh__D019831 SYSTEM
% 213.05/213.20  |- skos__hiddenLabel mesh__D019831 Sodium Calcium Exchanger
% 213.05/213.20  |- skos__hiddenLabel mesh__D019831 Calcium Sodium Exchanger
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D019831 2006
% 213.05/213.20  |- skos__altLabel mesh__D019831 Ca%28%2+%29%-Na%28%+%29% Antiporter
% 213.05/213.20  |- mesh__dateEstablished mesh__D019831 1998-01-01
% 213.05/213.20  |- mesh__dateRevised mesh__D019831 2005-06-30
% 213.05/213.20  |- skos__altLabel mesh__D019831 Sodium-Calcium Carrier
% 213.05/213.20  |- skos__historyNote mesh__D019831 Carrier Proteins %28%1980-1997%29%
% 213.05/213.20  |- skos__altLabel mesh__D019831 Na%28%+%29%-Ca%28%2+%29% Antiporter
% 213.05/213.20  |- mesh__recordAuthorizer mesh__D019831 sjn
% 213.05/213.20  |- skos__historyNote mesh__D019831 Membrane Proteins %28%1980-1993%29%
% 213.05/213.20  |- skos__annotation mesh__D019831 DF: NA CA EXCHANGER   
% 213.05/213.20  |- skos__hiddenLabel mesh__D019831 Sodium Calcium Antiporter
% 213.05/213.20  |- rdf__type mesh__D019831sskos__Concept
% 213.05/213.20  |- skos__altLabel mesh__D019831 Calcium-Sodium Carrier
% 213.05/213.20  |- skos__hiddenLabel mesh__D019831 Calcium Sodium Carrier
% 213.05/213.20  |- skos__hiddenLabel mesh__D019831 Carrier, Calcium-Sodium
% 213.05/213.20  |- mesh__recordOriginator mesh__D019033 TGC
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D019033 2006
% 213.05/213.20  |- rdf__type mesh__D019033sskos__Concept
% 213.05/213.20  |- skos__hiddenLabel mesh__D019033 Systems, Integrated Delivery
% 213.05/213.20  |- skos__prefLabel mesh__D019033 Delivery of Health Care, Integrated
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D019033 2002
% 213.05/213.20  |- mesh__dateRevised mesh__D019033 1999-11-03
% 213.05/213.20  |- skos__scopeNote mesh__D019033
% 213.05/213.20       A health care system which combines physicians, hospitals, and other medical services with a health plan to provide the complete spectrum of medical care for its customers. In a fully integrated system, the three key elements - physicians, hospital, and health plan membership - are in balance in terms of matching medical resources with the needs of purchasers and patients. %28%Coddington et al., Integrated Health Care: Reorganizing the Physician, Hospital and Health Plan Relationship, 1994, p7%29%%A%    
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D019033 2005
% 213.05/213.20  |- mesh__recordAuthorizer mesh__D019033 sjn
% 213.05/213.20  |- skos__hiddenLabel mesh__D019033 Delivery System, Integrated
% 213.05/213.20  |- skos__hiddenLabel mesh__D019033 Delivery Systems, Integrated
% 213.05/213.20  |- mesh__historyNote mesh__D019033 96   
% 213.05/213.20  |- skos__annotation mesh__D019033 specify geog if pertinent   
% 213.05/213.20  |- skos__broader mesh__D019033smesh__D003695
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D019033 2004
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D019033 2001
% 213.05/213.20  |- skos__historyNote mesh__D019033
% 213.05/213.20       Delivery of Health Care %28%1985-1995%29%
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D019033 2000
% 213.05/213.20  |- mesh__recordMaintainer mesh__D019033 kle
% 213.05/213.20  |- mesh__publicMeSHNote mesh__D019033 96   
% 213.05/213.20  |- mesh__dateEstablished mesh__D019033 1996-01-01
% 213.05/213.20  |- skos__hiddenLabel mesh__D019033 System, Integrated Delivery
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D019033 2003
% 213.05/213.20  |- skos__hiddenLabel mesh__D019033 Integrated Delivery System
% 213.05/213.20  |- mesh__dateCreated mesh__D019033 1995-05-26
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D000328 2006
% 213.05/213.20  |- mesh__dateRevised mesh__D000328 1997-06-20
% 213.05/213.20  |- mesh__recordAuthorizer mesh__D000328 SJN
% 213.05/213.20  |- rdf__type mesh__D000328sskos__Concept
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D000328 2001
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D000328 2003
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D000328 2004
% 213.05/213.20  |- mesh__publicMeSHNote mesh__D000328 66   
% 213.05/213.20  |- skos__altLabel mesh__D000328 Adults
% 213.05/213.20  |- skos__scopeNote mesh__D000328
% 213.05/213.20       A person having attained full growth or maturity. Adults are of 19 through 44 years of age.%A%    
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D000328 1998
% 213.05/213.20  |- mesh__dateCreated mesh__D000328 1999-01-01
% 213.05/213.20  |- skos__broader mesh__D000328smesh__D009273
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D000328 2002
% 213.05/213.20  |- mesh__dateEstablished mesh__D000328 1966-01-01
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D000328 1999
% 213.05/213.20  |- mesh__historyNote mesh__D000328 66   
% 213.05/213.20  |- skos__annotation mesh__D000328
% 213.05/213.20       age 19-44 yr; almost never IM; IM only as social, sociol, polit, etc. entity; NIM as check tag; no qualif when NIM, /psychol permitted when IM but ADULT as IM is unlikely; Manual 18.5+, 34.10%A%  
% 213.05/213.20  |- skos__prefLabel mesh__D000328 Adult
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D000328 2000
% 213.05/213.20  |- mesh__recordMaintainer mesh__D000328 TGC
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D000328 2005
% 213.05/213.20  |- mesh__recordOriginator mesh__D000328 NLM
% 213.05/213.20  |- mesh__onlineNote mesh__D000328 pre-explosion = ADULT %28%PX%29%   
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D011050 2006
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D011050 2003
% 213.05/213.20  |- skos__altLabel mesh__D011050 Analysis, Policy
% 213.05/213.20  |- mesh__historyNote mesh__D011050 80   
% 213.05/213.20  |- skos__prefLabel mesh__D011050 Policy Making
% 213.05/213.20  |- skos__hiddenLabel mesh__D011050 Policy Analyses
% 213.05/213.20  |- mesh__recordOriginator mesh__D011050 EC
% 213.05/213.20  |- skos__hiddenLabel mesh__D011050 Analyses, Policy
% 213.05/213.20  |- rdf__type mesh__D011050sskos__Concept
% 213.05/213.20  |- mesh__publicMeSHNote mesh__D011050 80   
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D011050 2005
% 213.05/213.20  |- mesh__dateCreated mesh__D011050 1979-06-01
% 213.05/213.20  |- skos__hiddenLabel mesh__D011050 Development, Policy
% 213.05/213.20  |- skos__hiddenLabel mesh__D011050 Making, Policy
% 213.05/213.20  |- skos__broader mesh__D011050smesh__D012926
% 213.05/213.20  |- skos__hiddenLabel mesh__D011050 Developments, Policy
% 213.05/213.20  |- skos__annotation mesh__D011050 no qualif   
% 213.05/213.20  |- skos__scopeNote mesh__D011050
% 213.05/213.20       The decision process by which individuals, groups or institutions establish policies pertaining to plans, programs or procedures.%A%    
% 213.05/213.20  |- mesh__recordAuthorizer mesh__D011050 sjn
% 213.05/213.20  |- mesh__dateRevised mesh__D011050 2002-07-02
% 213.05/213.20  |- mesh__dateEstablished mesh__D011050 1980-01-01
% 213.05/213.20  |- skos__hiddenLabel mesh__D011050 Policy Developments
% 213.05/213.20  |- skos__related mesh__D011050smesh__D034462
% 213.05/213.20  |- skos__related mesh__D011050smesh__D011640
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D011050 2004
% 213.05/213.20  |- skos__related mesh__D011050smesh__D006291
% 213.05/213.20  |- mesh__recordMaintainer mesh__D011050 hjn
% 213.05/213.20  |- mesh__recordMaintainer mesh__D005013 CCR
% 213.05/213.20  |- skos__altLabel mesh__D005013 Pfizer Brand of Ethosuximide
% 213.05/213.20  |- skos__altLabel mesh__D005013 Suxilep
% 213.05/213.20  |- skos__broader mesh__D005013smesh__D013388
% 213.05/213.20  |- skos__altLabel mesh__D005013 LAB Brand of Ethosuximide
% 213.05/213.20  |- mesh__dateRevised mesh__D005013 2005-06-30
% 213.05/213.20  |- mesh__publicMeSHNote mesh__D005013 65   
% 213.05/213.20  |- skos__hiddenLabel mesh__D005013 Warner Lambert Brand of Ethosuximide
% 213.05/213.20  |- mesh__dateCreated mesh__D005013 1999-01-01
% 213.05/213.20  |- skos__altLabel mesh__D005013 Warner-Lambert Brand of Ethosuximide
% 213.05/213.20  |- mesh__dateEstablished mesh__D005013 1965-01-01
% 213.05/213.20  |- skos__altLabel mesh__D005013 Katwijk Brand of Ethosuximide
% 213.05/213.20  |- skos__altLabel mesh__D005013 Jenapharm Brand of Ethosuximide
% 213.05/213.20  |- skos__prefLabel mesh__D005013 Ethosuximide
% 213.05/213.20  |- rdf__type mesh__D005013sskos__Concept
% 213.05/213.20  |- skos__altLabel mesh__D005013 Wernigerode Brand of Ethosuximide
% 213.05/213.20  |- mesh__historyNote mesh__D005013 65%28%63%29%   
% 213.05/213.20  |- skos__altLabel mesh__D005013 Ethylmethylsuccimide
% 213.05/213.20  |- skos__scopeNote mesh__D005013
% 213.05/213.20       An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.%A%    
% 213.05/213.20  |- skos__altLabel mesh__D005013 Parke Davis Brand of Ethosuximide
% 213.05/213.20  |- skos__altLabel mesh__D005013 Desitin Brand of Ethosuximide
% 213.05/213.20  |- skos__related mesh__D005013smesh__D019822
% 213.05/213.20  |- mesh__recordOriginator mesh__D005013 NLM
% 213.05/213.20  |- skos__altLabel mesh__D005013 Ethosuccimid
% 213.05/213.20  |- skos__hiddenLabel mesh__D005013 Faes, Etosuximida
% 213.05/213.20  |- skos__altLabel mesh__D005013 Fortbenton Brand of Ethosuximide
% 213.05/213.20  |- skos__altLabel mesh__D005013 United Drug Brand of Ethosuximide
% 213.05/213.20  |- mesh__recordAuthorizer mesh__D005013 sjn
% 213.05/213.20  |- skos__altLabel mesh__D005013 Faes Brand of Ethosuximide
% 213.05/213.20  |- skos__altLabel mesh__D005013 Pyknolepsinum
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D005013 2006
% 213.05/213.20  |- skos__broader mesh__D006782Q000662smesh__D006782
% 213.05/213.20  |- mesh__preferredCombination mesh__D006782Q000662smesh__D006762
% 213.05/213.20  |- rdf__type mesh__D006782Q000662smesh__CompoundConcept
% 213.05/213.20  |- skos__annotation mesh__D018739
% 213.05/213.20       IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 213.05/213.20  |- mesh__dateEstablished mesh__D018739 1995-01-01
% 213.05/213.20  |- mesh__dateCreated mesh__D018739 1994-05-23
% 213.05/213.20  |- mesh__recordMaintainer mesh__D018739 SYSTEM
% 213.05/213.20  |- skos__hiddenLabel mesh__D018739 Oncogene Products v erbB
% 213.05/213.20  |- skos__altLabel mesh__D018739 Oncogene Proteins erbB
% 213.05/213.20  |- mesh__publicMeSHNote mesh__D018739
% 213.05/213.20       95; ONCOGENE PROTEINS ERBB was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-94 %26% VIRAL PROTEINS 1987-89%A%  
% 213.05/213.20  |- skos__hiddenLabel mesh__D018739 v erbB Proteins
% 213.05/213.20  |- skos__prefLabel mesh__D018739 Oncogene Proteins v-erbB
% 213.05/213.20  |- skos__scopeNote mesh__D018739
% 213.05/213.20       Transforming proteins encoded by erbB oncogenes from the avian erythroblastosis virus. The protein is a truncated form of the EGF receptor %28%RECEPTOR, EPIDERMAL GROWTH FACTOR%29% whose kinase domain is constitutively activated by deletion of the ligand-binding domain.%A%    
% 213.05/213.20  |- skos__altLabel mesh__D018739 Oncogene Products v-erbB
% 213.05/213.20  |- mesh__dateRevised mesh__D018739 2005-06-30
% 213.05/213.20  |- skos__historyNote mesh__D018739
% 213.05/213.20       Oncogene Proteins, Viral %28%1988-1994%29%
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D018739 2006
% 213.05/213.20  |- skos__altLabel mesh__D018739 erbB Oncogene Proteins
% 213.05/213.20  |- mesh__recordOriginator mesh__D018739 AGS
% 213.05/213.20  |- mesh__historyNote mesh__D018739
% 213.05/213.20       95; was ONCOGENE PROTEINS ERBB %28%NM%29% 1987-94   
% 213.05/213.20  |- rdf__type mesh__D018739sskos__Concept
% 213.05/213.20  |- skos__hiddenLabel mesh__D018739 Oncogene Proteins v erbB
% 213.05/213.20  |- mesh__onlineNote mesh__D018739
% 213.05/213.20       use ONCOGENE PROTEINS V-ERBB %28%NM%29% to search ONCOGENE PROTEINS ERBB 1987-94%A%  
% 213.05/213.20  |- skos__altLabel mesh__D018739 v-erbB Proteins
% 213.05/213.20  |- mesh__recordAuthorizer mesh__D018739 sjn
% 213.05/213.20  |- skos__broader mesh__D018739smesh__D015682
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D010756 2000
% 213.05/213.20  |- mesh__activeMeSHYear mesh__D010756 1997
% 213.05/213.20  |- mesh__publicMeSHNote mesh__D010756
% 213.05/213.20       68; PYROPHOSPHORIC ACIDS was heading 1968-93   
% 213.05/213.21  |- skos__hiddenLabel mesh__D010756 Acids, Pyrophosphoric
% 213.05/213.21  |- mesh__historyNote mesh__D010756
% 213.05/213.21       68; PYROPHOSPHORIC ACIDS was heading 1968-93   
% 213.05/213.21  |- rdf__type mesh__D010756sskos__Concept
% 213.05/213.21  |- skos__hiddenLabel mesh__D010756 Acids, Phosphoric
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010756 2001
% 213.05/213.21  |- skos__prefLabel mesh__D010756 Phosphoric Acids
% 213.05/213.21  |- skos__annotation mesh__D010756
% 213.05/213.21       do not confuse with PHOSPHORUS ACIDS or PHOSPHOROUS ACIDS%A%  
% 213.05/213.21  |- mesh__recordOriginator mesh__D010756 NLM
% 213.05/213.21  |- mesh__dateEstablished mesh__D010756 1968-01-01
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010756 2002
% 213.05/213.21  |- skos__scopeNote mesh__D010756
% 213.05/213.21       Inorganic derivatives of phosphoric acid %28%H3PO4%29%. Inorganic salts are known as PHOSPHATES and organic esters are PHOSPHORIC ACID ESTERS.%A%    
% 213.05/213.21  |- mesh__onlineNote mesh__D010756
% 213.05/213.21       use PHOSPHORIC ACIDS to search PYROPHOSPHORIC ACIDS 1968-93%A%  
% 213.05/213.21  |- mesh__dateCreated mesh__D010756 1999-01-01
% 213.05/213.21  |- mesh__recordMaintainer mesh__D010756 TPW
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010756 2005
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010756 1994
% 213.05/213.21  |- mesh__recordAuthorizer mesh__D010756 PLS
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010756 2003
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010756 2006
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010756 1998
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010756 1995
% 213.05/213.21  |- mesh__dateRevised mesh__D010756 1993-06-04
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010756 2004
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010756 1996
% 213.05/213.21  |- skos__broader mesh__D010756smesh__D017976
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010756 1999
% 213.05/213.21  |- mesh__recordMaintainer mesh__D029461 sjn
% 213.05/213.21  |- mesh__dateRevised mesh__D029461 2003-07-25
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D029461 2005
% 213.05/213.21  |- skos__scopeNote mesh__D029461
% 213.05/213.21       Autosomal recessive neurodegenerative disorders caused by lysosomal membrane transport defects that result in accumulation of free sialic acid %28%N-ACETYLNEURAMINIC ACID%29% within the lysosomes. The two main clinical phenotypes, which are allelic variants of the SLC17A5 gene, are ISSD, a severe infantile form, or Salla disease, a slowly progressive adult form, named for the geographic area in Finland where the kindred first studied resided.%A%    
% 213.05/213.21  |- skos__historyNote mesh__D029461
% 213.05/213.21       Lysosomal Storage Diseases %28%1991-2001%29%
% 213.05/213.21  |- mesh__publicMeSHNote mesh__D029461 2002   
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D029461 2004
% 213.05/213.21  |- skos__altLabel mesh__D029461 Sialuria
% 213.05/213.21  |- mesh__dateEstablished mesh__D029461 2002-01-01
% 213.05/213.21  |- skos__altLabel mesh__D029461 Sialuria, Infantile Form
% 213.05/213.21  |- skos__broader mesh__D029461smesh__D020140
% 213.05/213.21  |- mesh__historyNote mesh__D029461 2002   
% 213.05/213.21  |- skos__hiddenLabel mesh__D029461 Sialurias, Finnish Type
% 213.05/213.21  |- skos__altLabel mesh__D029461 Sialuria, Finnish Type
% 213.05/213.21  |- skos__prefLabel mesh__D029461 Sialic Acid Storage Disease
% 213.05/213.21  |- skos__hiddenLabel mesh__D029461 Sialurias
% 213.05/213.21  |- mesh__dateCreated mesh__D029461 2001-07-25
% 213.05/213.21  |- skos__hiddenLabel mesh__D029461 Infantile Form Sialuria
% 213.05/213.21  |- mesh__recordAuthorizer mesh__D029461 sjn
% 213.05/213.21  |- skos__altLabel mesh__D029461 Sialic Acid Storage Disease, Infantile Form
% 213.05/213.21  |- mesh__recordOriginator mesh__D029461 nns
% 213.05/213.21  |- rdf__type mesh__D029461sskos__Concept
% 213.05/213.21  |- skos__historyNote mesh__D029461
% 213.05/213.21       Carbohydrate Metabolism, Inborn Errors %28%1986-2001%29%
% 213.05/213.21  |- skos__hiddenLabel mesh__D029461 Sialurias, Infantile Form
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D029461 2006
% 213.05/213.21  |- skos__altLabel mesh__D029461 Sialic Acid Storage Disease, Finnish Type
% 213.05/213.21  |- skos__hiddenLabel mesh__D029461 Finnish Type Sialurias
% 213.05/213.21  |- skos__hiddenLabel mesh__D029461 Finnish Type Sialuria
% 213.05/213.21  |- skos__hiddenLabel mesh__D029461 Infantile Form Sialurias
% 213.05/213.21  |- skos__broader mesh__D004719smesh__D009202
% 213.05/213.21  |- skos__prefLabel mesh__D004719 Endomyocardial Fibrosis
% 213.05/213.21  |- skos__hiddenLabel mesh__D004719 Fibroses, Endomyocardial
% 213.05/213.21  |- rdf__type mesh__D004719sskos__Concept
% 213.05/213.21  |- skos__hiddenLabel mesh__D004719 Fibrosis, Endomyocardial
% 213.05/213.21  |- mesh__historyNote mesh__D004719 65%28%63%29%   
% 213.05/213.21  |- skos__hiddenLabel mesh__D004719 Endomyocardial Fibroses
% 213.05/213.21  |- mesh__recordOriginator mesh__D004719 NLM
% 213.05/213.21  |- mesh__dateEstablished mesh__D004719 1965-01-01
% 213.05/213.21  |- mesh__publicMeSHNote mesh__D004719 65   
% 213.05/213.21  |- skos__scopeNote mesh__D004719
% 213.05/213.21       A condition characterized by the thickening of the ventricular ENDOCARDIUM and subendocardium %28%MYOCARDIUM%29%, seen mostly in children and young adults in the TROPICAL CLIMATE. The fibrous tissue extends from the apex toward and often involves the HEART VALVES causing restrictive blood flow into the respective ventricles %28%CARDIOMYOPATHY, RESTRICTIVE%29%.%A%    
% 213.05/213.21  |- mesh__dateCreated mesh__D004719 1999-01-01
% 213.05/213.21  |- mesh__dateRevised mesh__D004719 2004-07-07
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D004719 2005
% 213.05/213.21  |- mesh__recordMaintainer mesh__D004719 lkt
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D004719 2006
% 213.05/213.21  |- mesh__recordAuthorizer mesh__D004719 sjn
% 213.05/213.21  |- skos__hiddenLabel mesh__D015441 Leprosies, Tuberculoid
% 213.05/213.21  |- skos__historyNote mesh__D015441 Leprosy %28%1966-1988%29%
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D015441 2005
% 213.05/213.21  |- mesh__recordMaintainer mesh__D015441 RAZ
% 213.05/213.21  |- skos__hiddenLabel mesh__D015441 Tuberculoid Leprosies
% 213.05/213.21  |- skos__scopeNote mesh__D015441
% 213.05/213.21       A principal or polar form of LEPROSY in which the skin lesions are few and are sharply demarcated. Peripheral nerve involvement is pronounced and may be severe. Unlike lepromatous leprosy %28%LEPROSY, LEPROMATOUS%29%, the lepromin test is positive. Tuberculoid leprosy is rarely a source of infection to others.%A%    
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D015441 1997
% 213.05/213.21  |- skos__hiddenLabel mesh__D015441 Leprosies, Macular
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D015441 2002
% 213.05/213.21  |- mesh__recordOriginator mesh__D015441 EC
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D015441 1999
% 213.05/213.21  |- skos__broader mesh__D015441smesh__D007918
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D015441 1996
% 213.05/213.21  |- skos__hiddenLabel mesh__D015441 Neural Leprosy
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D015441 2001
% 213.05/213.21  |- mesh__recordAuthorizer mesh__D015441 PLS
% 213.05/213.21  |- rdf__type mesh__D015441sskos__Concept
% 213.05/213.21  |- skos__hiddenLabel mesh__D015441 Macular Leprosies
% 213.05/213.21  |- skos__hiddenLabel mesh__D015441 Leprosies, Neural
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D015441 1998
% 213.05/213.21  |- skos__hiddenLabel mesh__D015441 Neural Leprosies
% 213.05/213.21  |- skos__hiddenLabel mesh__D015441 Macular Leprosy
% 213.05/213.21  |- mesh__dateCreated mesh__D015441 1988-06-08
% 213.05/213.21  |- mesh__dateEstablished mesh__D015441 1989-01-01
% 213.05/213.21  |- mesh__dateRevised mesh__D015441 1995-06-08
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D015441 2000
% 213.05/213.21  |- mesh__publicMeSHNote mesh__D015441 89   
% 213.05/213.21  |- skos__altLabel mesh__D015441 Tuberculoid Leprosy
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D015441 2004
% 213.05/213.21  |- skos__prefLabel mesh__D015441 Leprosy, Tuberculoid
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D015441 2006
% 213.05/213.21  |- mesh__historyNote mesh__D015441 89   
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D015441 2003
% 213.05/213.21  |- mesh__recordAuthorizer mesh__D009404 ags
% 213.05/213.21  |- skos__prefLabel mesh__D009404 Nephrotic Syndrome
% 213.05/213.21  |- rdf__type mesh__D009404sskos__Concept
% 213.05/213.21  |- mesh__recordOriginator mesh__D009404 NLM
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D009404 2005
% 213.05/213.21  |- mesh__dateCreated mesh__D009404 1999-01-01
% 213.05/213.21  |- mesh__dateRevised mesh__D009404 2005-07-27
% 213.05/213.21  |- skos__scopeNote mesh__D009404
% 213.05/213.21       Clinical association of heavy PROTEINURIA; HYPOALBUMINEMIA; and generalized EDEMA.%A%    
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D009404 2006
% 213.05/213.21  |- mesh__recordMaintainer mesh__D009404 ags
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D009404 2003
% 213.05/213.21  |- skos__hiddenLabel mesh__D009404 Syndrome, Nephrotic
% 213.05/213.21  |- skos__hiddenLabel mesh__D009404 Nephrotic Syndromes
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D009404 2004
% 213.05/213.21  |- skos__hiddenLabel mesh__D009404 Syndromes, Nephrotic
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D009404 2006A
% 213.05/213.21  |- skos__broader mesh__D009404smesh__D009401
% 213.05/213.21  |- skos__prefLabel mesh__D001421 Bacteria, Anaerobic
% 213.05/213.21  |- mesh__dateRevised mesh__D001421 2005-06-30
% 213.05/213.21  |- skos__broader mesh__D001421smesh__D001419
% 213.05/213.21  |- mesh__publicMeSHNote mesh__D001421 84   
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D001421 2006
% 213.05/213.21  |- mesh__dateEstablished mesh__D001421 1984-01-01
% 213.05/213.21  |- mesh__dateCreated mesh__D001421 1983-06-03
% 213.05/213.21  |- skos__annotation mesh__D001421
% 213.05/213.21       GEN: avoid; prefer specifics; do not use as a routine coord for an anaerobic bact; facultatively anaerobic bact: index only here %26% not also under BACTERIA, AEROBIC; infection: coord IM with BACTERIAL INFECTIONS %28%IM%29%; DF: BACT ANAEROBIC%A%  
% 213.05/213.21  |- mesh__recordAuthorizer mesh__D001421 sjn
% 213.05/213.21  |- mesh__recordMaintainer mesh__D001421 SYSTEM
% 213.05/213.21  |- skos__altLabel mesh__D001421 Anaerobic Bacteria
% 213.05/213.21  |- rdf__type mesh__D001421sskos__Concept
% 213.05/213.21  |- skos__historyNote mesh__D001421 Bacteria %28%1966-1983%29%
% 213.05/213.21  |- mesh__historyNote mesh__D001421 84   
% 213.05/213.21  |- skos__historyNote mesh__D001421 Anaerobiosis %28%1971-1983%29%
% 213.05/213.21  |- mesh__recordOriginator mesh__D001421 RC
% 213.05/213.21  |- skos__historyNote mesh__D020386 Fasciculation %28%1995-1999%29%
% 213.05/213.21  |- mesh__publicMeSHNote mesh__D020386
% 213.05/213.21       2000; for ISAACS%27% SYNDROME see FASCICULATION 1995-1999   
% 213.05/213.21  |- skos__hiddenLabel mesh__D020386 Syndromes, Gamstorp-Wohlfart
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D020386 2004
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D020386 2002
% 213.05/213.21  |- skos__broader mesh__D020386smesh__D010523
% 213.05/213.21  |- skos__altLabel mesh__D020386 Isaacs-Mertens Syndrome
% 213.05/213.21  |- skos__broader mesh__D020386smesh__D009135
% 213.05/213.21  |- skos__altLabel mesh__D020386 Pseudomyotonia Syndrome of Isaacs
% 213.05/213.21  |- skos__hiddenLabel mesh__D020386 Isaacs Pseudomyotonia Syndrome
% 213.05/213.21  |- skos__hiddenLabel mesh__D020386 Myokymias, Continuous
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D020386 2003
% 213.05/213.21  |- mesh__dateEstablished mesh__D020386 2000-01-01
% 213.05/213.21  |- skos__altLabel mesh__D020386 Gamstorp-Wohlfart Syndrome
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D020386 2001
% 213.05/213.21  |- skos__hiddenLabel mesh__D020386 Gamstorp-Wohlfart Syndromes
% 213.05/213.21  |- skos__altLabel mesh__D020386 Continuous Muscle Activity Syndrome
% 213.05/213.21  |- skos__broader mesh__D020386smesh__D009468
% 213.05/213.21  |- skos__altLabel mesh__D020386 Neuromyotonia
% 213.05/213.21  |- skos__hiddenLabel mesh__D020386 Continuous Myokymia
% 213.05/213.21  |- mesh__dateCreated mesh__D020386 1999-11-03
% 213.05/213.21  |- skos__hiddenLabel mesh__D020386 Isaacs Mertens Syndrome
% 213.05/213.21  |- skos__altLabel mesh__D020386 Syndrome of Continuous Muscle Activity
% 213.05/213.21  |- skos__hiddenLabel mesh__D020386 Gamstorp Wohlfart Syndrome
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D020386 2000
% 213.05/213.21  |- rdf__type mesh__D020386sskos__Concept
% 213.05/213.21  |- skos__altLabel mesh__D020386 Isaacs%27% Syndrome
% 213.05/213.21  |- skos__scopeNote mesh__D020386
% 213.05/213.21       A rare neuromuscular disorder with onset usually in late childhood or early adulthood, characterized by intermittent or continuous widespread involuntary muscle contractions; FASCICULATION; hyporeflexia; MUSCLE CRAMP; MUSCLE WEAKNESS; HYPERHIDROSIS; TACHYCARDIA; and MYOKYMIA. Involvement of pharyngeal or laryngeal muscles may interfere with speech and breathing. The continuous motor activity persists during sleep and general anesthesia %28%distinguishing this condition from STIFF-PERSON SYNDROME%29%. Familial and acquired %28%primarily autoimmune%29% forms have been reported. %28%From Ann NY Acad Sci 1998 May 13;841:482-496; Adams et al., Principles of Neurology, 6th ed, p1491%29%%A%    
% 213.05/213.21  |- skos__hiddenLabel mesh__D020386 Continuous Myokymias
% 213.05/213.21  |- skos__altLabel mesh__D020386 Myokymia, Continuous
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D020386 2006
% 213.05/213.21  |- mesh__historyNote mesh__D020386
% 213.05/213.21       2000; for ISAACS%27% SYNDROME use FASCICULATION 1995-1999   
% 213.05/213.21  |- skos__hiddenLabel mesh__D020386 Isaac Syndrome
% 213.05/213.21  |- skos__prefLabel mesh__D020386 Isaacs Syndrome
% 213.05/213.21  |- skos__altLabel mesh__D020386 Pseudomyotonia
% 213.05/213.21  |- skos__hiddenLabel mesh__D020386 Neuromyotonia, Acquired
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D020386 2005
% 213.05/213.21  |- skos__altLabel mesh__D020386 Quantal Squander
% 213.05/213.21  |- skos__hiddenLabel mesh__D020386 Syndromes, Isaacs-Mertens
% 213.05/213.21  |- skos__prefLabel mesh__D014349 Trypanosoma cruzi
% 213.05/213.21  |- skos__broader mesh__D014349smesh__D014345
% 213.05/213.21  |- mesh__recordAuthorizer mesh__D014349 sjn
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D014349 2005
% 213.05/213.21  |- skos__annotation mesh__D014349
% 213.05/213.21       infection = TRYPANOSOMIASIS, SOUTH AMERICAN see CHAGAS DISEASE; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 213.05/213.21  |- mesh__publicMeSHNote mesh__D014349 72   
% 213.05/213.21  |- mesh__recordOriginator mesh__D014349 NLM
% 213.05/213.21  |- mesh__recordMaintainer mesh__D014349 ags
% 213.05/213.21  |- rdf__type mesh__D014349sskos__Concept
% 213.05/213.21  |- mesh__dateRevised mesh__D014349 2003-07-09
% 213.05/213.21  |- mesh__dateCreated mesh__D014349 1999-01-01
% 213.05/213.21  |- mesh__dateEstablished mesh__D014349 1972-01-01
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D014349 2004
% 213.05/213.21  |- mesh__historyNote mesh__D014349 72   
% 213.05/213.21  |- skos__scopeNote mesh__D014349
% 213.05/213.21       The agent of South American trypanosomiasis or CHAGAS DISEASE. Its vertebrate hosts are man and various domestic and wild animals. Insects of several species are vectors.%A%    
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D014349 2006
% 213.05/213.21  |- skos__historyNote mesh__D014349 Trypanosoma %28%1966-1971%29%
% 213.05/213.21  |- skos__hiddenLabel mesh__D019832 N Methylscopolamine Iodide
% 213.05/213.21  |- mesh__historyNote mesh__D019832
% 213.05/213.21       98; use N-METHYLSCOPOLAMINE %28%NM%29% 1980-97   
% 213.05/213.21  |- mesh__publicMeSHNote mesh__D019832
% 213.05/213.21       98; N-METHYLSCOPOLAMINE was indexed under SCOPOLAMINE DERIVATIVES 1972-97%A%  
% 213.05/213.21  |- skos__hiddenLabel mesh__D019832 Nitrate, N-Methylscopolamine
% 213.05/213.21  |- skos__altLabel mesh__D019832 Methylscopolamine Nitrate
% 213.05/213.21  |- mesh__dateCreated mesh__D019832 1997-06-20
% 213.05/213.21  |- skos__altLabel mesh__D019832 Hyoscine Methobromide
% 213.05/213.21  |- skos__hiddenLabel mesh__D019832 Methylsulfate, N-Methylscopolamine
% 213.05/213.21  |- skos__hiddenLabel mesh__D019832 Bromide, N-Methylscopolamine
% 213.05/213.21  |- skos__hiddenLabel mesh__D019832 Methylchloride, N-Methylscopolamine
% 213.05/213.21  |- skos__hiddenLabel mesh__D019832 N Methylscopolamine Methylsulfate
% 213.05/213.21  |- skos__hiddenLabel mesh__D019832 N Methylscopolamine
% 213.05/213.21  |- mesh__recordAuthorizer mesh__D019832 sjn
% 213.05/213.21  |- mesh__dateEstablished mesh__D019832 1998-01-01
% 213.05/213.21  |- skos__hiddenLabel mesh__D019832 N Methylscopolamine Nitrate
% 213.05/213.21  |- skos__altLabel mesh__D019832 Methylscopolammonium Methylsulfate
% 213.05/213.21  |- skos__hiddenLabel mesh__D019832 N Methylscine Methylsulfate
% 213.05/213.21  |- mesh__recordOriginator mesh__D019832 ADP
% 213.05/213.21  |- skos__hiddenLabel mesh__D019832 Iodide, N-Methylscopolamine
% 213.05/213.21  |- rdf__type mesh__D019832sskos__Concept
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D019832 2004
% 213.05/213.21  |- skos__scopeNote mesh__D019832
% 213.05/213.21       A muscarinic antagonist used to study binding characteristics of muscarinic cholinergic receptors.%A%    
% 213.05/213.21  |- skos__hiddenLabel mesh__D019832 DD234
% 213.05/213.21  |- skos__hiddenLabel mesh__D019832 Methobromide, Hyoscine
% 213.05/213.21  |- skos__hiddenLabel mesh__D019832 Methylbromide, Scopolamine
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D019832 2002
% 213.05/213.21  |- skos__hiddenLabel mesh__D019832 N Methylscopolamine Methylchloride
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D019832 2003
% 213.05/213.21  |- mesh__dateRevised mesh__D019832 2000-06-22
% 213.05/213.21  |- mesh__recordMaintainer mesh__D019832 TWD
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D019832 2006
% 213.05/213.21  |- skos__altLabel mesh__D019832 Hyoscine Methiodide
% 213.05/213.21  |- skos__hiddenLabel mesh__D019832 N Methylscopolamine Bromide
% 213.05/213.21  |- skos__historyNote mesh__D019832
% 213.05/213.21       Scopolamine Derivatives %28%1972-1997%29%
% 213.05/213.21  |- skos__broader mesh__D019832smesh__D012602
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D019832 2001
% 213.05/213.21  |- skos__prefLabel mesh__D019832 N-Methylscopolamine
% 213.05/213.21  |- skos__hiddenLabel mesh__D019832 Methylsulfate, N-Methylscine
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D019832 2005
% 213.05/213.21  |- skos__altLabel mesh__D019832 Scopolamine Methylbromide
% 213.05/213.21  |- skos__hiddenLabel mesh__D019832 DD 234
% 213.05/213.21  |- skos__altLabel mesh__D019034 Compact Disk Interactive
% 213.05/213.21  |- skos__hiddenLabel mesh__D019034 Compact Disk, Interactive
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D019034 2005
% 213.05/213.21  |- skos__hiddenLabel mesh__D019034 Compact Disks, Interactive
% 213.05/213.21  |- mesh__recordOriginator mesh__D019034 TGC
% 213.05/213.21  |- mesh__historyNote mesh__D019034 96   
% 213.05/213.21  |- mesh__dateRevised mesh__D019034 2004-07-07
% 213.05/213.21  |- skos__hiddenLabel mesh__D019034 Interactive Compact Disks
% 213.05/213.21  |- mesh__recordAuthorizer mesh__D019034 sjn
% 213.05/213.21  |- mesh__recordMaintainer mesh__D019034 jls
% 213.05/213.21  |- mesh__dateCreated mesh__D019034 1995-05-26
% 213.05/213.21  |- skos__historyNote mesh__D019034 Compact Disks %28%1993-1995%29%
% 213.05/213.21  |- skos__hiddenLabel mesh__D019034 Disks, Interactive Compact
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D019034 2006
% 213.05/213.21  |- rdf__type mesh__D019034sskos__Concept
% 213.05/213.21  |- skos__scopeNote mesh__D019034
% 213.05/213.21       An optical disk storage system used on specialized players that combine the functions of computer and CD player in a self-contained box, designed to be connected to a television set and a home stereo for video and sound output. The player is controlled with a hand-held remote unit resembling a television remote control. %28%J Allied Health 1993 Winter;22%28%1%29%:131-8%29%%A%    
% 213.05/213.21  |- skos__hiddenLabel mesh__D019034 Disk, Interactive Compact
% 213.05/213.21  |- skos__broader mesh__D019034smesh__D016250
% 213.05/213.21  |- mesh__publicMeSHNote mesh__D019034 96   
% 213.05/213.21  |- skos__annotation mesh__D019034
% 213.05/213.21       a type of compact disk; X ref explains acronym; do not use /util except by MeSH definition%A%  
% 213.05/213.21  |- skos__altLabel mesh__D019034 Interactive Compact Disk
% 213.05/213.21  |- mesh__dateEstablished mesh__D019034 1996-01-01
% 213.05/213.21  |- skos__prefLabel mesh__D019034 CD-I
% 213.05/213.21  |- skos__annotation mesh__D000329
% 213.05/213.21       IM; med advert: do not coord with MEDICINE; coord with subject of advert %26% medium if relevant %28%IM%29%; do not confuse with Publication Type ADVERTISEMENTS for newspaper, magazine, billboard, etc. advertising%A%  
% 213.05/213.21  |- mesh__recordOriginator mesh__D000329 NLM
% 213.05/213.21  |- skos__prefLabel mesh__D000329 Advertising
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D000329 2004
% 213.05/213.21  |- mesh__recordAuthorizer mesh__D000329 sjn
% 213.05/213.21  |- mesh__dateCreated mesh__D000329 1999-01-01
% 213.05/213.21  |- skos__broader mesh__D000329smesh__D040541
% 213.05/213.21  |- mesh__dateRevised mesh__D000329 2002-07-24
% 213.05/213.21  |- skos__scopeNote mesh__D000329
% 213.05/213.21       The act or practice of calling public attention to a product, service, need, etc., especially by paid announcements in newspapers, magazines, on radio, or on television. %28%Random House Unabridged Dictionary, 2d ed%29%%A%    
% 213.05/213.21  |- mesh__recordMaintainer mesh__D000329 sjn
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D000329 2005
% 213.05/213.21  |- skos__broader mesh__D000329smesh__D003142
% 213.05/213.21  |- skos__hiddenLabel mesh__D000329 Advertisements
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D000329 2006
% 213.05/213.21  |- rdf__type mesh__D000329sskos__Concept
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D000329 2003
% 213.05/213.21  |- skos__broader mesh__D011051smesh__D013118
% 213.05/213.21  |- skos__hiddenLabel mesh__D011051 Poliomyelitides, Preparalytic
% 213.05/213.21  |- skos__broader mesh__D011051smesh__D004769
% 213.05/213.21  |- skos__altLabel mesh__D011051 Epidemic Acute Poliomyelitis
% 213.05/213.21  |- mesh__dateRevised mesh__D011051 2004-07-13
% 213.05/213.21  |- skos__altLabel mesh__D011051 Polio
% 213.05/213.21  |- skos__prefLabel mesh__D011051 Poliomyelitis
% 213.05/213.21  |- skos__hiddenLabel mesh__D011051 Nonpoliovirus Poliomyelitis
% 213.05/213.21  |- mesh__dateCreated mesh__D011051 1999-01-01
% 213.05/213.21  |- skos__scopeNote mesh__D011051
% 213.05/213.21       An acute infectious disease of humans, particularly children, caused by any of three serotypes of human poliovirus %28%POLIOVIRUS%29%. Usually the infection is limited to the gastrointestinal tract and nasopharynx, and is often asymptomatic. The central nervous system, primarily the spinal cord, may be affected, leading to rapidly progressive paralysis, coarse FASCICULATION and hyporeflexia. Motor neurons are primarily affected. Encephalitis may also occur. The virus replicates in the nervous system, and may cause significant neuronal loss, most notably in the spinal cord. A rare related condition, nonpoliovirus poliomyelitis, may result from infections with nonpoliovirus enteroviruses. %28%From Adams et al., Principles of Neurology, 6th ed, pp764-5%29%%A%    
% 213.05/213.21  |- skos__hiddenLabel mesh__D011051 Paralysis, Infantile
% 213.05/213.21  |- skos__broader mesh__D011051smesh__D016472
% 213.05/213.21  |- skos__altLabel mesh__D011051 Polio Encephalitis
% 213.05/213.21  |- skos__hiddenLabel mesh__D011051 Acute Poliomyelitis, Epidemic
% 213.05/213.21  |- skos__hiddenLabel mesh__D011051 Acute Poliomyelitis
% 213.05/213.21  |- skos__hiddenLabel mesh__D011051 Polios
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D011051 2006
% 213.05/213.21  |- mesh__recordMaintainer mesh__D011051 sjn
% 213.05/213.21  |- skos__hiddenLabel mesh__D011051 Preparalytic Poliomyelitis
% 213.05/213.21  |- skos__related mesh__D011051smesh__D016262
% 213.05/213.21  |- skos__hiddenLabel mesh__D011051 Poliomyelitis, Epidemic Acute
% 213.05/213.21  |- skos__altLabel mesh__D011051 Poliomyelitis, Acute
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D011051 2005
% 213.05/213.21  |- skos__broader mesh__D011051smesh__D009187
% 213.05/213.21  |- rdf__type mesh__D011051sskos__Concept
% 213.05/213.21  |- skos__broader mesh__D011051smesh__D020805
% 213.05/213.21  |- mesh__recordOriginator mesh__D011051 NLM
% 213.05/213.21  |- mesh__recordAuthorizer mesh__D011051 sjn
% 213.05/213.21  |- skos__hiddenLabel mesh__D005812 Complexes, Switching
% 213.05/213.21  |- skos__hiddenLabel mesh__D005812 Gene, Switch
% 213.05/213.21  |- skos__scopeNote mesh__D005812
% 213.05/213.21       Genes that cause the epigenotype %28%i.e., the interrelated developmental pathways through which the adult organism is realized%29% to switch to an alternate cell lineage-related pathway. Switch complexes control the expression of normal functional development as well as oncogenic transformation.%A%    
% 213.05/213.21  |- skos__hiddenLabel mesh__D005812 Complexes, Switch
% 213.05/213.21  |- skos__historyNote mesh__D005812 Genes, Structural %28%1977-1987%29%
% 213.05/213.21  |- skos__altLabel mesh__D005812 Switching Complexes
% 213.05/213.21  |- mesh__dateEstablished mesh__D005812 1991-01-01
% 213.05/213.21  |- mesh__recordOriginator mesh__D005812 SCD
% 213.05/213.21  |- skos__hiddenLabel mesh__D005812 Switch Gene
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D005812 2006
% 213.05/213.21  |- mesh__recordAuthorizer mesh__D005812 sjn
% 213.05/213.21  |- rdf__type mesh__D005812sskos__Concept
% 213.05/213.21  |- mesh__recordMaintainer mesh__D005812 nns
% 213.05/213.21  |- skos__hiddenLabel mesh__D005812 Complex, Switching
% 213.05/213.21  |- skos__prefLabel mesh__D005812 Genes, Switch
% 213.05/213.21  |- mesh__historyNote mesh__D005812
% 213.05/213.21       91%28%88%29%; was see under GENES, REGULATOR 1988-90   
% 213.05/213.21  |- skos__altLabel mesh__D005812 Switch Genes
% 213.05/213.21  |- mesh__publicMeSHNote mesh__D005812
% 213.05/213.21       91; was see under GENES, REGULATOR 1988-90   
% 213.05/213.21  |- mesh__dateCreated mesh__D005812 1987-05-11
% 213.05/213.21  |- skos__broader mesh__D005812smesh__D005809
% 213.05/213.21  |- mesh__dateRevised mesh__D005812 2005-06-30
% 213.05/213.21  |- skos__altLabel mesh__D005812 Switching Complex
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010757 2006
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010757 2003
% 213.05/213.21  |- skos__prefLabel mesh__D010757 Phosphorous Acids
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010757 1997
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010757 2002
% 213.05/213.21  |- skos__broader mesh__D010757smesh__D009943
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010757 2005
% 213.05/213.21  |- mesh__publicMeSHNote mesh__D010757 68   
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010757 1999
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010757 1996
% 213.05/213.21  |- skos__scopeNote mesh__D010757
% 213.05/213.21       Inorganic or organic derivatives of phosphorous acid %28%P%28%OH%29%3%29%. Inorganic salts are known as PHOSPHITES. The tautomeric form of this compound %28%HPO%28%OH%29%2%29% = PHOSPHONIC ACIDS.%A%    
% 213.05/213.21  |- mesh__historyNote mesh__D010757 68   
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010757 2001
% 213.05/213.21  |- mesh__dateCreated mesh__D010757 1999-01-01
% 213.05/213.21  |- mesh__dateRevised mesh__D010757 1993-06-25
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010757 1998
% 213.05/213.21  |- rdf__type mesh__D010757sskos__Concept
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010757 2000
% 213.05/213.21  |- skos__hiddenLabel mesh__D010757 Acids, Phosphorous
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010757 1995
% 213.05/213.21  |- mesh__recordOriginator mesh__D010757 NLM
% 213.05/213.21  |- skos__broader mesh__D010757smesh__D017976
% 213.05/213.21  |- mesh__recordAuthorizer mesh__D010757 PLS
% 213.05/213.21  |- skos__annotation mesh__D010757 do not confuse with PHOSPHORUS ACIDS   
% 213.05/213.21  |- mesh__recordMaintainer mesh__D010757 TPW
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010757 1994
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D010757 2004
% 213.05/213.21  |- mesh__dateEstablished mesh__D010757 1968-01-01
% 213.05/213.21  |- skos__broader mesh__D019814Q000031smesh__D019814
% 213.05/213.21  |- mesh__preferredCombination mesh__D019814Q000031smesh__D009226
% 213.05/213.21  |- rdf__type mesh__D019814Q000031smesh__CompoundConcept
% 213.05/213.21  |- mesh__dateEstablished mesh__D015442 1991-01-01
% 213.05/213.21  |- skos__hiddenLabel mesh__D015442 Physician Assignment Acceptances
% 213.05/213.21  |- skos__historyNote mesh__D015442
% 213.05/213.21       Health Insurance for Aged and Disabled, Title 18 %28%1972-1988%29%
% 213.05/213.21  |- skos__hiddenLabel mesh__D015442 Assignments, Medicare
% 213.05/213.21  |- skos__hiddenLabel mesh__D015442 Medicare Assignments
% 213.05/213.21  |- skos__hiddenLabel mesh__D015442 Acceptance, Physician Assignment
% 213.05/213.21  |- mesh__dateRevised mesh__D015442 1999-11-03
% 213.05/213.21  |- rdf__type mesh__D015442sskos__Concept
% 213.05/213.21  |- skos__broader mesh__D015442smesh__D006278
% 213.05/213.21  |- skos__prefLabel mesh__D015442 Medicare Assignment
% 213.05/213.21  |- skos__annotation mesh__D015442 specify geog if possible   
% 213.05/213.21  |- mesh__recordMaintainer mesh__D015442 kle
% 213.05/213.21  |- skos__broader mesh__D015442smesh__D007357
% 213.05/213.21  |- mesh__recordOriginator mesh__D015442 EC
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D015442 2002
% 213.05/213.21  |- mesh__recordAuthorizer mesh__D015442 sjn
% 213.05/213.21  |- skos__historyNote mesh__D015442
% 213.05/213.21       Insurance, Physician Services %28%1981-1988%29%
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D015442 2004
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D015442 2001
% 213.05/213.21  |- skos__hiddenLabel mesh__D015442 Acceptances, Physician Assignment
% 213.05/213.21  |- skos__scopeNote mesh__D015442
% 213.05/213.21       Concept referring to the standardized fees for services rendered by health care providers, e.g., laboratories and physicians, and reimbursement for those services under Medicare Part B. It includes acceptance by the physician.%A%    
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D015442 2006
% 213.05/213.21  |- mesh__dateCreated mesh__D015442 1988-06-08
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D015442 2003
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D015442 2005
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D015442 2000
% 213.05/213.21  |- mesh__historyNote mesh__D015442
% 213.05/213.21       91%28%89%29%; was see under HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1989-90%A%  
% 213.05/213.21  |- skos__hiddenLabel mesh__D015442 Assignment, Medicare
% 213.05/213.21  |- mesh__publicMeSHNote mesh__D015442
% 213.05/213.21       91; was see under HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1989-90%A%  
% 213.05/213.21  |- skos__annotation mesh__D009405 naturally radioactive; IM   
% 213.05/213.21  |- mesh__dateRevised mesh__D009405 2005-06-30
% 213.05/213.21  |- skos__broader mesh__D009405smesh__D008671
% 213.05/213.21  |- mesh__activeMeSHYear mesh__D009405 2006
% 213.05/213.21  |- mesh__recordOriginator mesh__D009405 NLM
% 213.05/213.21  |- skos__broader mesh__D009405smesh__D019216
% 213.05/213.21  |- mesh__recordMaintainer mesh__D009405 jmp
% 213.05/213.21  |- mesh__recordAuthorizer mesh__D009405 sjn
% 213.05/213.21  |- skos__prefLabel mesh__D009405 Neptunium
% 213.05/213.21  |- rdf__type mesh__D009405sskos__Concept
% 213.05/213.21  |- mesh__dateCreated mesh__D009405 1999-01-01
% 213.05/213.21  |- skos__scopeNote mesh__D009405
% 213.05/213.21       Neptunium. A radioactive element of the actinide metals family. It has the atomic symbol Np, atomic number 93, and atomic weight 237.%A%    
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D001422 2003
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D001422 1998
% 213.05/213.22  |- mesh__dateCreated mesh__D001422 1986-06-19
% 213.05/213.22  |- mesh__recordMaintainer mesh__D001422 PXP
% 213.05/213.22  |- mesh__recordAuthorizer mesh__D001422 PLS
% 213.05/213.22  |- skos__altLabel mesh__D001422 Adhesions, Bacterial
% 213.05/213.22  |- skos__historyNote mesh__D001422 Adhesiveness %28%1969-1986%29%
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D001422 2002
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D001422 1997
% 213.05/213.22  |- skos__scopeNote mesh__D001422
% 213.05/213.22       Physicochemical property of fimbriated %28%FIMBRIAE, BACTERIAL%29% and non-fimbriated bacteria of attaching to cells, tissue, and nonbiological surfaces. It is a factor in bacterial colonization and pathogenicity.%A%    
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D001422 2006
% 213.05/213.22  |- skos__historyNote mesh__D001422 Pili, Bacterial %28%1980-1986%29%
% 213.05/213.22  |- mesh__historyNote mesh__D001422 87   
% 213.05/213.22  |- skos__prefLabel mesh__D001422 Bacterial Adhesion
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D001422 2001
% 213.05/213.22  |- mesh__recordOriginator mesh__D001422 SCD
% 213.05/213.22  |- skos__altLabel mesh__D001422 Bacterial Adhesions
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D001422 1996
% 213.05/213.22  |- mesh__publicMeSHNote mesh__D001422 87   
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D001422 1995
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D001422 2005
% 213.05/213.22  |- mesh__dateRevised mesh__D001422 1994-05-31
% 213.05/213.22  |- skos__broader mesh__D001422smesh__D018407
% 213.05/213.22  |- skos__related mesh__D001422smesh__D018829
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D001422 2000
% 213.05/213.22  |- mesh__dateEstablished mesh__D001422 1987-01-01
% 213.05/213.22  |- skos__historyNote mesh__D001422 Bacteria %28%1966-1986%29%
% 213.05/213.22  |- skos__annotation mesh__D001422
% 213.05/213.22       do not confuse with X ref BACTERIAL ADHESINS see ADHESINS, BACTERIAL, bact antigens; DF: BACT ADHESION%A%  
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D001422 2004
% 213.05/213.22  |- rdf__type mesh__D001422sskos__Concept
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D001422 1999
% 213.05/213.22  |- skos__altLabel mesh__D001422 Adhesion, Bacterial
% 213.05/213.22  |- skos__hiddenLabel mesh__D020387 Chains, Saprophytic
% 213.05/213.22  |- skos__hiddenLabel mesh__D020387 Chains, Food
% 213.05/213.22  |- skos__hiddenLabel mesh__D020387 Parasite Chains
% 213.05/213.22  |- mesh__dateEstablished mesh__D020387 1999-01-01
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D020387 2004
% 213.05/213.22  |- skos__hiddenLabel mesh__D020387 Chain, Food
% 213.05/213.22  |- skos__prefLabel mesh__D020387 Food Chain
% 213.05/213.22  |- skos__hiddenLabel mesh__D020387 Saprophytic Chains
% 213.05/213.22  |- mesh__recordMaintainer mesh__D020387 nns
% 213.05/213.22  |- skos__hiddenLabel mesh__D020387 Chain, Saprophytic
% 213.05/213.22  |- mesh__publicMeSHNote mesh__D020387 99   
% 213.05/213.22  |- skos__hiddenLabel mesh__D020387 Chain, Predator
% 213.05/213.22  |- skos__hiddenLabel mesh__D020387 Food Chains
% 213.05/213.22  |- skos__hiddenLabel mesh__D020387 Chain, Parasite
% 213.05/213.22  |- skos__hiddenLabel mesh__D020387 Predator Chains
% 213.05/213.22  |- skos__broader mesh__D020387smesh__D017753
% 213.05/213.22  |- rdf__type mesh__D020387sskos__Concept
% 213.05/213.22  |- skos__hiddenLabel mesh__D020387 Food Webs
% 213.05/213.22  |- mesh__recordOriginator mesh__D020387 JLS
% 213.05/213.22  |- skos__scopeNote mesh__D020387
% 213.05/213.22       The sequence of transfers of matter and energy from organism to organism in the form of FOOD. Food chains intertwine locally into a food web because most organisms consume more than one type of animal or plant. PLANTS, which convert SOLAR ENERGY to food by PHOTOSYNTHESIS, are the primary food source. In a predator chain, a plant-eating animal is eaten by a larger animal. In a parasite chain, a smaller organism consumes part of a larger host and may itself be parasitized by smaller organisms. In a saprophytic chain, microorganisms live on dead organic matter.%A%    
% 213.05/213.22  |- mesh__historyNote mesh__D020387 99   
% 213.05/213.22  |- mesh__recordAuthorizer mesh__D020387 sjn
% 213.05/213.22  |- mesh__dateRevised mesh__D020387 2003-07-09
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D020387 2006
% 213.05/213.22  |- skos__hiddenLabel mesh__D020387 Web, Food
% 213.05/213.22  |- skos__hiddenLabel mesh__D020387 Webs, Food
% 213.05/213.22  |- mesh__dateCreated mesh__D020387 1998-06-10
% 213.05/213.22  |- skos__hiddenLabel mesh__D020387 Chains, Parasite
% 213.05/213.22  |- skos__hiddenLabel mesh__D020387 Chains, Predator
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D020387 2005
% 213.05/213.22  |- mesh__dateEstablished mesh__D019833 1998-01-01
% 213.05/213.22  |- mesh__recordMaintainer mesh__D019833 ssb
% 213.05/213.22  |- mesh__dateRevised mesh__D019833 2005-06-30
% 213.05/213.22  |- mesh__recordAuthorizer mesh__D019833 sjn
% 213.05/213.22  |- mesh__historyNote mesh__D019833 98; use GENISTEIN %28%NM%29% 1980-97   
% 213.05/213.22  |- skos__prefLabel mesh__D019833 Genistein
% 213.05/213.22  |- skos__historyNote mesh__D019833 Isoflavones %28%1976-1997%29%
% 213.05/213.22  |- mesh__recordOriginator mesh__D019833 ADP
% 213.05/213.22  |- mesh__publicMeSHNote mesh__D019833
% 213.05/213.22       98; GENISTEIN was indexed under ISOFLAVONES 1976-97   
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D019833 2006
% 213.05/213.22  |- skos__altLabel mesh__D019833 Genestein
% 213.05/213.22  |- skos__broader mesh__D019833smesh__D007529
% 213.05/213.22  |- mesh__dateCreated mesh__D019833 1997-06-20
% 213.05/213.22  |- rdf__type mesh__D019833sskos__Concept
% 213.05/213.22  |- skos__scopeNote mesh__D019833
% 213.05/213.22       An isoflavonoid derived from soy products. It inhibits PROTEIN-TYROSINE KINASE and topoisomerase-II %28%DNA TOPOISOMERASES, TYPE II%29%; activity and is used as an antineoplastic and antitumor agent. Experimentally, it has been shown to induce G2 phase arrest in human and murine cell lines.%A%    
% 213.05/213.22  |- mesh__historyNote mesh__D011850
% 213.05/213.22       NUCLEAR WASTE was see HAZARDOUS WASTE 1988-89   
% 213.05/213.22  |- mesh__dateCreated mesh__D011850 1999-01-01
% 213.05/213.22  |- skos__hiddenLabel mesh__D011850 Wastes, Nuclear
% 213.05/213.22  |- skos__prefLabel mesh__D011850 Radioactive Waste
% 213.05/213.22  |- skos__broader mesh__D011850smesh__D006256
% 213.05/213.22  |- skos__hiddenLabel mesh__D011850 Radioactive Wastes
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D011850 2006
% 213.05/213.22  |- skos__hiddenLabel mesh__D011850 Hazardous Wastes, Radioactive
% 213.05/213.22  |- skos__annotation mesh__D011850 specify geog if pertinent   
% 213.05/213.22  |- mesh__dateRevised mesh__D011850 2005-06-30
% 213.05/213.22  |- skos__hiddenLabel mesh__D011850 Radioactive Hazardous Wastes
% 213.05/213.22  |- mesh__onlineNote mesh__D011850
% 213.05/213.22       use HAZARDOUS WASTE to search NUCLEAR WASTE 1988-89   
% 213.05/213.22  |- skos__hiddenLabel mesh__D011850 Wastes, Radioactive Hazardous
% 213.05/213.22  |- mesh__recordMaintainer mesh__D011850 ssb
% 213.05/213.22  |- skos__altLabel mesh__D011850 Nuclear Waste
% 213.05/213.22  |- skos__hiddenLabel mesh__D011850 Radioactive Hazardous Waste
% 213.05/213.22  |- skos__broader mesh__D011850smesh__D011870
% 213.05/213.22  |- rdf__type mesh__D011850sskos__Concept
% 213.05/213.22  |- skos__hiddenLabel mesh__D011850 Waste, Nuclear
% 213.05/213.22  |- skos__hiddenLabel mesh__D011850 Nuclear Wastes
% 213.05/213.22  |- skos__altLabel mesh__D011850 Hazardous Waste, Radioactive
% 213.05/213.22  |- skos__scopeNote mesh__D011850
% 213.05/213.22       Liquid, solid, or gaseous waste resulting from mining of radioactive ore, production of reactor fuel materials, reactor operation, processing of irradiated reactor fuels, and related operations, and from use of radioactive materials in research, industry, and medicine. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 213.05/213.22  |- mesh__recordAuthorizer mesh__D011850 sjn
% 213.05/213.22  |- skos__hiddenLabel mesh__D011850 Waste, Radioactive
% 213.05/213.22  |- mesh__publicMeSHNote mesh__D011850
% 213.05/213.22       NUCLEAR WASTE was see HAZARDOUS WASTE 1988-89   
% 213.05/213.22  |- skos__hiddenLabel mesh__D011850 Wastes, Radioactive
% 213.05/213.22  |- skos__hiddenLabel mesh__D011850 Waste, Radioactive Hazardous
% 213.05/213.22  |- mesh__recordOriginator mesh__D011850 NLM
% 213.05/213.22  |- skos__broader mesh__D011850smesh__D011848
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D019035 2004
% 213.05/213.22  |- skos__related mesh__D019035smesh__D019036
% 213.05/213.22  |- skos__hiddenLabel mesh__D019035 Health Centers, Rural
% 213.05/213.22  |- skos__historyNote mesh__D019035 Rural Health %28%1966-1995%29%
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D019035 2001
% 213.05/213.22  |- mesh__dateEstablished mesh__D019035 1996-01-01
% 213.05/213.22  |- skos__prefLabel mesh__D019035 Rural Health Services
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D019035 2003
% 213.05/213.22  |- skos__scopeNote mesh__D019035
% 213.05/213.22       Health services, public or private, in rural areas. The services include the promotion of health and the delivery of health care.%A%    
% 213.05/213.22  |- mesh__recordMaintainer mesh__D019035 kle
% 213.05/213.22  |- mesh__dateCreated mesh__D019035 1995-05-26
% 213.05/213.22  |- skos__hiddenLabel mesh__D019035 Rural Health Centers
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D019035 2000
% 213.05/213.22  |- mesh__publicMeSHNote mesh__D019035 96   
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D019035 2006
% 213.05/213.22  |- rdf__type mesh__D019035sskos__Concept
% 213.05/213.22  |- skos__hiddenLabel mesh__D019035 Rural Health Service
% 213.05/213.22  |- skos__hiddenLabel mesh__D019035 Center, Rural Health
% 213.05/213.22  |- mesh__recordOriginator mesh__D019035 TGC
% 213.05/213.22  |- skos__annotation mesh__D019035
% 213.05/213.22       IM; coord with specific health serv %28%IM%29%; DF: RURAL HEALTH SERV%A%  
% 213.05/213.22  |- mesh__dateRevised mesh__D019035 1999-11-03
% 213.05/213.22  |- skos__historyNote mesh__D019035 Rural Population %28%1968-1995%29%
% 213.05/213.22  |- skos__hiddenLabel mesh__D019035 Health Center, Rural
% 213.05/213.22  |- skos__broader mesh__D019035smesh__D006296
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D019035 2005
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D019035 2002
% 213.05/213.22  |- skos__altLabel mesh__D019035 Services, Rural Health
% 213.05/213.22  |- skos__hiddenLabel mesh__D019035 Service, Rural Health
% 213.05/213.22  |- skos__hiddenLabel mesh__D019035 Health Service, Rural
% 213.05/213.22  |- mesh__historyNote mesh__D019035 96   
% 213.05/213.22  |- skos__altLabel mesh__D019035 Health Services, Rural
% 213.05/213.22  |- mesh__recordAuthorizer mesh__D019035 sjn
% 213.05/213.22  |- skos__hiddenLabel mesh__D019035 Centers, Rural Health
% 213.05/213.22  |- mesh__dateCreated mesh__D011052 1999-01-01
% 213.05/213.22  |- mesh__recordOriginator mesh__D011052 NLM
% 213.05/213.22  |- mesh__recordAuthorizer mesh__D011052 sjn
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D011052 2004
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D011052 2002
% 213.05/213.22  |- skos__altLabel mesh__D011052 Bulbar Polio
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D011052 2006
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D011052 2003
% 213.05/213.22  |- mesh__recordMaintainer mesh__D011052 KEV
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D011052 2001
% 213.05/213.22  |- mesh__dateRevised mesh__D011052 1999-11-04
% 213.05/213.22  |- skos__altLabel mesh__D011052 Bulbar Poliomyelitis
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D011052 2005
% 213.05/213.22  |- rdf__type mesh__D011052sskos__Concept
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D011052 2000
% 213.05/213.22  |- skos__annotation mesh__D011052 DF: POLIO BULBAR   
% 213.05/213.22  |- skos__altLabel mesh__D011052 Poliomyelitis, Medullary Involvement
% 213.05/213.22  |- skos__scopeNote mesh__D011052
% 213.05/213.22       A form of paralytic poliomyelitis affecting neurons of the MEDULLA OBLONGATA of the brain stem. Clinical features include impaired respiration, HYPERTENSION, alterations of vasomotor control, and dysphagia. Weakness and atrophy of the limbs and trunk due to spinal cord involvement is usually associated. %28%From Adams et al., Principles of Neurology, 6th ed, p765%29%%A%    
% 213.05/213.22  |- skos__broader mesh__D011052smesh__D011051
% 213.05/213.22  |- skos__hiddenLabel mesh__D011052 Polio, Bulbar
% 213.05/213.22  |- skos__prefLabel mesh__D011052 Poliomyelitis, Bulbar
% 213.05/213.22  |- skos__hiddenLabel mesh__D011052 Medullary Involvement Poliomyelitis
% 213.05/213.22  |- skos__scopeNote mesh__D005813
% 213.05/213.22       Biologically functional sequences of DNA chemically synthesized in vitro.%A%    
% 213.05/213.22  |- mesh__dateCreated mesh__D005813 1979-05-23
% 213.05/213.22  |- mesh__publicMeSHNote mesh__D005813 80   
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D005813 2006
% 213.05/213.22  |- skos__hiddenLabel mesh__D005813 Genes, Artificial
% 213.05/213.22  |- skos__broader mesh__D005813smesh__D005796
% 213.05/213.22  |- rdf__type mesh__D005813sskos__Concept
% 213.05/213.22  |- skos__altLabel mesh__D005813 Artificial Genes
% 213.05/213.22  |- mesh__dateRevised mesh__D005813 2005-06-30
% 213.05/213.22  |- mesh__historyNote mesh__D005813 80   
% 213.05/213.22  |- skos__hiddenLabel mesh__D005813 Synthetic Gene
% 213.05/213.22  |- skos__historyNote mesh__D005813 DNA, Recombinant %28%1977-1979%29%
% 213.05/213.22  |- skos__annotation mesh__D005813 DF: GENES SYN   
% 213.05/213.22  |- skos__historyNote mesh__D005813
% 213.05/213.22       Oligodeoxyribonucleotides/chemical synthesis %28%1976-1979%29%
% 213.05/213.22  |- skos__historyNote mesh__D005813 Genes, Structural %28%1970-1979%29%
% 213.05/213.22  |- skos__historyNote mesh__D005813 Deoxyribonucleotides %28%1973-1979%29%
% 213.05/213.22  |- skos__hiddenLabel mesh__D005813 Artificial Gene
% 213.05/213.22  |- skos__historyNote mesh__D005813 DNA %28%1970-1979%29%
% 213.05/213.22  |- skos__hiddenLabel mesh__D005813 Gene, Artificial
% 213.05/213.22  |- mesh__recordMaintainer mesh__D005813 nns
% 213.05/213.22  |- mesh__recordOriginator mesh__D005813 AEP
% 213.05/213.22  |- skos__altLabel mesh__D005813 Synthetic Genes
% 213.05/213.22  |- mesh__recordAuthorizer mesh__D005813 sjn
% 213.05/213.22  |- skos__hiddenLabel mesh__D005813 Gene, Synthetic
% 213.05/213.22  |- mesh__dateEstablished mesh__D005813 1980-01-01
% 213.05/213.22  |- skos__prefLabel mesh__D005813 Genes, Synthetic
% 213.05/213.22  |- skos__historyNote mesh__D005015 Quinolines %28%1970-1974%29%
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D005015 2005
% 213.05/213.22  |- skos__prefLabel mesh__D005015 Ethoxyquin
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D005015 2004
% 213.05/213.22  |- mesh__publicMeSHNote mesh__D005015
% 213.05/213.22       91; was see under QUINOLINES 1975-90   
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D005015 2003
% 213.05/213.22  |- mesh__recordOriginator mesh__D005015 NLM
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D005015 2001
% 213.05/213.22  |- mesh__recordAuthorizer mesh__D005015 sjn
% 213.05/213.22  |- rdf__type mesh__D005015sskos__Concept
% 213.05/213.22  |- skos__broader mesh__D005015smesh__D011804
% 213.05/213.22  |- mesh__dateRevised mesh__D005015 2000-06-22
% 213.05/213.22  |- skos__historyNote mesh__D005015 Ethyl Ethers %28%1973-1974%29%
% 213.05/213.22  |- mesh__dateEstablished mesh__D005015 1991-01-01
% 213.05/213.22  |- skos__altLabel mesh__D005015
% 213.05/213.22       1,2-Dihydro-6-Ethoxy-2,2,4-Trimethylquinoline
% 213.05/213.22  |- skos__scopeNote mesh__D005015
% 213.05/213.22       Antioxidant; also a post-harvest dip to prevent scald on apples and pears.%A%    
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D005015 2006
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D005015 2002
% 213.05/213.22  |- mesh__dateCreated mesh__D005015 1974-11-19
% 213.05/213.22  |- mesh__recordMaintainer mesh__D005015 TWD
% 213.05/213.22  |- mesh__historyNote mesh__D005015
% 213.05/213.22       91%28%75%29%; was see under QUINOLINES 1975-90   
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D010758 2005
% 213.05/213.22  |- skos__hiddenLabel mesh__D010758 Level, Serum Phosphorus
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D010758 1999
% 213.05/213.22  |- skos__related mesh__D010758smesh__D010759
% 213.05/213.22  |- mesh__dateCreated mesh__D010758 1999-01-01
% 213.05/213.22  |- mesh__recordMaintainer mesh__D010758 ADP
% 213.05/213.22  |- skos__related mesh__D010758smesh__D009946
% 213.05/213.22  |- skos__annotation mesh__D010758
% 213.05/213.22       P-31; /physiol permitted; /metab: disord = PHOSPHORUS METABOLISM DISORDERS%A%  
% 213.05/213.22  |- skos__hiddenLabel mesh__D010758 Phosphorus Level, Serum
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D010758 1998
% 213.05/213.22  |- rdf__type mesh__D010758sskos__Concept
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D010758 2002
% 213.05/213.22  |- mesh__dateRevised mesh__D010758 1997-06-20
% 213.05/213.22  |- skos__broader mesh__D010758smesh__D004602
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D010758 2001
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D010758 2004
% 213.05/213.22  |- mesh__recordAuthorizer mesh__D010758 SJN
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D010758 2000
% 213.05/213.22  |- skos__related mesh__D010758smesh__D009943
% 213.05/213.22  |- skos__hiddenLabel mesh__D010758 Phosphorus, Red
% 213.05/213.22  |- skos__scopeNote mesh__D010758
% 213.05/213.22       An element that has the atomic symbol P, atomic number 15, and atomic weight 31. It is an essential element in the diet, a major component of the mineral phase of bone, and is abundant in all tissues, being involved in some form in almost all metabolic processes. %28%From Dorland, 27th ed%29%%A%    
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D010758 2006
% 213.05/213.22  |- mesh__recordOriginator mesh__D010758 NLM
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D010758 2003
% 213.05/213.22  |- mesh__publicMeSHNote mesh__D010758
% 213.05/213.22       /metabolism was PHOSPHORUS METABOLISM 1965   
% 213.05/213.22  |- mesh__historyNote mesh__D010758
% 213.05/213.22       /metabolism was PHOSPHORUS METABOLISM 1965   
% 213.05/213.22  |- skos__prefLabel mesh__D010758 Phosphorus
% 213.05/213.22  |- skos__related mesh__D010758smesh__D010761
% 213.05/213.22  |- skos__hiddenLabel mesh__D015443 Processings, Word
% 213.05/213.22  |- skos__scopeNote mesh__D015443
% 213.05/213.22       Text editing and storage functions using computer software.%A%    
% 213.05/213.22  |- skos__hiddenLabel mesh__D015443 Word Processings
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D015443 2006
% 213.05/213.22  |- skos__historyNote mesh__D015443 Software %28%1983-1988%29%
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D015443 2005
% 213.05/213.22  |- mesh__publicMeSHNote mesh__D015443 1989   
% 213.05/213.22  |- skos__broader mesh__D015443smesh__D012984
% 213.05/213.22  |- skos__broader mesh__D015443smesh__D009816
% 213.05/213.22  |- skos__hiddenLabel mesh__D015443 Processing, Word
% 213.05/213.22  |- mesh__recordOriginator mesh__D015443 EC
% 213.05/213.22  |- mesh__recordMaintainer mesh__D015443 jls
% 213.05/213.22  |- skos__prefLabel mesh__D015443 Word Processing
% 213.05/213.22  |- skos__historyNote mesh__D015443 Computers %28%1981-1988%29%
% 213.05/213.22  |- rdf__type mesh__D015443sskos__Concept
% 213.05/213.22  |- mesh__historyNote mesh__D015443 1989   
% 213.05/213.22  |- mesh__recordAuthorizer mesh__D015443 sjn
% 213.05/213.22  |- mesh__dateRevised mesh__D015443 2004-07-07
% 213.05/213.22  |- mesh__dateCreated mesh__D015443 1988-06-08
% 213.05/213.22  |- mesh__dateEstablished mesh__D015443 1989-01-01
% 213.05/213.22  |- skos__prefLabel mesh__D001423 Bacterial Infections and Mycoses
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D001423 2003
% 213.05/213.22  |- mesh__historyNote mesh__D001423 98; use explode 1975-98   
% 213.05/213.22  |- mesh__recordOriginator mesh__D001423 NLM
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D001423 2002
% 213.05/213.22  |- mesh__dateRevised mesh__D001423 1998-06-10
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D001423 2001
% 213.05/213.22  |- mesh__runningHead mesh__D001423 C1 - DISEASES-BACTERIAL AND FUNGAL   
% 213.05/213.22  |- mesh__recordAuthorizer mesh__D001423 SJN
% 213.05/213.22  |- skos__annotation mesh__D001423
% 213.05/213.22       not used for indexing; DF: BACT INFECT MYCOSES      CATALOG: do not use%A%  
% 213.05/213.22  |- skos__scopeNote mesh__D001423
% 213.05/213.22       Infections caused by bacteria and fungi, general, specified, or unspecified.%A%    
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D001423 2006
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D001423 2000
% 213.05/213.22  |- mesh__dateEstablished mesh__D001423 1998-01-01
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D001423 2005
% 213.05/213.22  |- mesh__publicMeSHNote mesh__D001423 98   
% 213.05/213.22  |- rdf__type mesh__D001423sskos__Concept
% 213.05/213.22  |- mesh__recordMaintainer mesh__D001423 MSR
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D001423 1999
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D001423 2004
% 213.05/213.22  |- mesh__dateCreated mesh__D001423 1999-01-01
% 213.05/213.22  |- skos__related mesh__D020388smesh__D016189
% 213.05/213.22  |- skos__hiddenLabel mesh__D020388 Muscular Dystrophies, Pseudohypertrophic
% 213.05/213.22  |- skos__hiddenLabel mesh__D020388 Dystrophy, Duchenne Muscular
% 213.05/213.22  |- mesh__publicMeSHNote mesh__D020388
% 213.05/213.22       2000; see MUSCULAR DYSTROPHIES 1980-1999; for MUSCULAR DYSTROPHY, BECKER %26% BECKER MUSCULAR DYSTROPHY see MUSCULAR  DYSTROPHIES 1991-1999%A%  
% 213.05/213.22  |- mesh__dateRevised mesh__D020388 2004-07-07
% 213.05/213.22  |- skos__hiddenLabel mesh__D020388 Dystrophies, Pseudohypertrophic Muscular
% 213.05/213.22  |- mesh__recordAuthorizer mesh__D020388 sjn
% 213.05/213.22  |- skos__hiddenLabel mesh__D020388 Dystrophy, Becker Muscular
% 213.05/213.22  |- skos__altLabel mesh__D020388 Duchenne Muscular Dystrophy
% 213.05/213.22  |- skos__altLabel mesh__D020388
% 213.05/213.22       Muscular Dystrophy, Pseudohypertrophic, Childhood
% 213.05/213.22  |- mesh__recordMaintainer mesh__D020388 lkt
% 213.05/213.22  |- skos__altLabel mesh__D020388
% 213.05/213.22       Childhood Muscular Dystrophy, Pseudohypertrophic
% 213.05/213.22  |- skos__hiddenLabel mesh__D020388 Pseudohypertrophic Muscular Dystrophy
% 213.05/213.22  |- skos__altLabel mesh__D020388
% 213.05/213.22       Muscular Dystrophy, Childhood, Pseudohypertrophic
% 213.05/213.22  |- rdf__type mesh__D020388sskos__Concept
% 213.05/213.22  |- mesh__dateCreated mesh__D020388 1999-11-08
% 213.05/213.22  |- skos__prefLabel mesh__D020388 Muscular Dystrophy, Duchenne
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D020388 2005
% 213.05/213.22  |- skos__altLabel mesh__D020388 Muscular Dystrophy, Becker
% 213.05/213.22  |- skos__broader mesh__D020388smesh__D040181
% 213.05/213.22  |- skos__hiddenLabel mesh__D020388 Pseudohypertrophic Muscular Dystrophies
% 213.05/213.22  |- skos__broader mesh__D020388smesh__D009136
% 213.05/213.22  |- skos__altLabel mesh__D020388
% 213.05/213.22       Duchenne-Type Progressive Muscular Dystrophy
% 213.05/213.22  |- mesh__dateEstablished mesh__D020388 2000-01-01
% 213.05/213.22  |- skos__altLabel mesh__D020388
% 213.05/213.22       Pseudohypertrophic Muscular Dystrophy, Childhood
% 213.05/213.22  |- skos__hiddenLabel mesh__D020388
% 213.05/213.22       Duchenne Type Progressive Muscular Dystrophy
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D020388 2006
% 213.05/213.22  |- skos__hiddenLabel mesh__D020388 Dystrophy, Pseudohypertrophic Muscular
% 213.05/213.22  |- skos__altLabel mesh__D020388 Muscular Dystrophy, Pseudohypertrophic
% 213.05/213.22  |- skos__altLabel mesh__D020388
% 213.05/213.22       Pseudohypertrophic Childhood Muscular Dystrophy
% 213.05/213.22  |- skos__altLabel mesh__D020388
% 213.05/213.22       Progressive Muscular Dystrophy, Duchenne Type
% 213.05/213.22  |- skos__historyNote mesh__D020388 Muscular Dystrophies %28%1966-1999%29%
% 213.05/213.22  |- mesh__historyNote mesh__D020388
% 213.05/213.22       2000; use MUSCULAR DYSTROPHIES 1980-1999; for MUSCULAR  DYSTROPHY, BECKER %26% BECKER MUSCULAR DYSTROPHY use MUSCULAR  DYSTROPHIES 1991-1999%A%  
% 213.05/213.22  |- skos__scopeNote mesh__D020388
% 213.05/213.22       An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy %28%see MYOCARDIAL DISEASES%29%, and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease %28%usually adolescence%29% and a slowly progressive course. %28%Adams et al., Principles of Neurology, 6th ed, p1415%29%%A%    
% 213.05/213.22  |- skos__altLabel mesh__D020388
% 213.05/213.22       Childhood Pseudohypertrophic Muscular Dystrophy
% 213.05/213.22  |- mesh__recordOriginator mesh__D020388 KEV
% 213.05/213.22  |- skos__broader mesh__D011851smesh__D009686
% 213.05/213.22  |- skos__hiddenLabel mesh__D011851 Radioactivities
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D011851 1999
% 213.05/213.22  |- mesh__recordMaintainer mesh__D011851 TGC
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D011851 2002
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D011851 1998
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D011851 2006
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D011851 2004
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D011851 2005
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D011851 2001
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D011851 2003
% 213.05/213.22  |- skos__prefLabel mesh__D011851 Radioactivity
% 213.05/213.22  |- rdf__type mesh__D011851sskos__Concept
% 213.05/213.22  |- skos__hiddenLabel mesh__D011851 Decay, Nuclear
% 213.05/213.22  |- skos__annotation mesh__D011851
% 213.05/213.22       IM GEN only for principle of emission of radiations; NIM as coord for degree of radioactivity of specific radioelements or radioisotopes %28%IM%29%; do not use as routine coord for amt of radiation or degree of radioactiv of radioisotope tracers; X ref NUCLEAR DECAY: coord NIM with specific radioactive substance %28%IM%29% %26% do not add RADIOMETRY; no qualif%A%  
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D011851 2000
% 213.05/213.22  |- mesh__recordOriginator mesh__D011851 NLM
% 213.05/213.22  |- mesh__dateRevised mesh__D011851 1997-06-20
% 213.05/213.22  |- mesh__dateCreated mesh__D011851 1999-01-01
% 213.05/213.22  |- mesh__recordAuthorizer mesh__D011851 SJN
% 213.05/213.22  |- skos__related mesh__D019036smesh__D019035
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D019036 2003
% 213.05/213.22  |- mesh__dateCreated mesh__D019036 1995-05-26
% 213.05/213.22  |- mesh__recordAuthorizer mesh__D019036 sjn
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D019036 2006
% 213.05/213.22  |- rdf__type mesh__D019036sskos__Concept
% 213.05/213.22  |- skos__hiddenLabel mesh__D019036 Suburban Health Service
% 213.05/213.22  |- skos__hiddenLabel mesh__D019036 Service, Suburban Health
% 213.05/213.22  |- mesh__dateEstablished mesh__D019036 1996-01-01
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D019036 2001
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D019036 2005
% 213.05/213.22  |- skos__hiddenLabel mesh__D019036 Health Service, Suburban
% 213.05/213.22  |- mesh__recordMaintainer mesh__D019036 kle
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D019036 2000
% 213.05/213.22  |- mesh__publicMeSHNote mesh__D019036 96   
% 213.05/213.22  |- skos__historyNote mesh__D019036 Suburban Population %28%1979-1995%29%
% 213.05/213.22  |- mesh__historyNote mesh__D019036 96   
% 213.05/213.22  |- skos__altLabel mesh__D019036 Services, Suburban Health
% 213.05/213.22  |- skos__prefLabel mesh__D019036 Suburban Health Services
% 213.05/213.22  |- mesh__recordOriginator mesh__D019036 TGC
% 213.05/213.22  |- mesh__dateRevised mesh__D019036 1999-11-03
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D019036 2004
% 213.05/213.22  |- skos__broader mesh__D019036smesh__D006296
% 213.05/213.22  |- skos__annotation mesh__D019036
% 213.05/213.22       IM; coord with specific health serv %28%IM%29%; DF: SUBURBAN HEALTH SERV%A%  
% 213.05/213.22  |- skos__altLabel mesh__D019036 Health Services, Suburban
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D019036 2002
% 213.05/213.22  |- skos__scopeNote mesh__D019036
% 213.05/213.22       Health services, public or private, in suburban areas. The services include the promotion of health and the delivery of health care.%A%    
% 213.05/213.22  |- mesh__recordMaintainer mesh__D011053 sjn
% 213.05/213.22  |- skos__broader mesh__D011053smesh__D004770
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D011053 2005
% 213.05/213.22  |- skos__scopeNote mesh__D011053
% 213.05/213.22       Species of ENTEROVIRUS causing acute infection in humans and leading to nervous system damage in a minority of cases. Humans are the only natural host, but infection can also occur in non-human primates and experimentally in rodents.%A%    
% 213.05/213.22  |- mesh__activeMeSHYear mesh__D011053 2006
% 213.05/213.22  |- mesh__onlineNote mesh__D011053
% 213.05/213.22       use POLIOVIRUSES to search POLIOVIRUS 1966-93   
% 213.05/213.22  |- skos__annotation mesh__D011053
% 213.05/213.22       GEN; prefer specifics for human poliovirus; infection = POLIOMYELITIS%A%  
% 213.05/213.22  |- mesh__recordOriginator mesh__D011053 NLM
% 213.05/213.22  |- mesh__recordAuthorizer mesh__D011053 sjn
% 213.05/213.22  |- mesh__historyNote mesh__D011053 94; was POLIOVIRUS 1963-93   
% 213.05/213.22  |- mesh__dateCreated mesh__D011053 1999-01-01
% 213.05/213.22  |- rdf__type mesh__D011053sskos__Concept
% 213.05/213.22  |- skos__prefLabel mesh__D011053 Polioviruses
% 213.05/213.22  |- mesh__dateRevised mesh__D011053 2004-07-13
% 213.05/213.22  |- mesh__publicMeSHNote mesh__D011053 94; was POLIOVIRUS 1963-93   
% 213.05/213.22  |- mesh__recordOriginator mesh__D005814 AEP
% 213.05/213.22  |- skos__related mesh__D005814smesh__D014764
% 213.05/213.22  |- skos__altLabel mesh__D005814 Viral Genes
% 213.05/213.22  |- mesh__recordAuthorizer mesh__D005814 sjn
% 213.05/213.22  |- skos__scopeNote mesh__D005814
% 213.05/213.22       The functional hereditary units of VIRUSES.     
% 213.05/213.22  |- skos__annotation mesh__D005814
% 213.05/213.22       coordinate IM with specific virus /genet %28%IM%29%   
% 213.05/213.22  |- skos__historyNote mesh__D005814 RNA, Viral %28%1966-1977%29%
% 213.05/213.22  |- skos__related mesh__D005814smesh__D012367
% 213.05/213.22  |- skos__broader mesh__D005814smesh__D016679
% 213.05/213.22  |- mesh__dateRevised mesh__D005814 2005-06-30
% 213.05/213.22  |- mesh__dateCreated mesh__D005814 1977-05-04
% 213.05/213.22  |- mesh__dateEstablished mesh__D005814 1978-01-01
% 213.05/213.22  |- mesh__publicMeSHNote mesh__D005814 78   
% 213.05/213.22  |- mesh__historyNote mesh__D005814 78   
% 213.05/213.22  |- skos__related mesh__D005814smesh__D004279
% 213.05/213.22  |- skos__related mesh__D005814smesh__D016679
% 213.05/213.22  |- skos__hiddenLabel mesh__D005814 Viral Gene
% 213.05/213.22  |- skos__historyNote mesh__D005814 DNA, Viral %28%1966-1977%29%
% 213.05/213.22  |- skos__hiddenLabel mesh__D005814 Gene, Viral
% 213.05/213.22  |- skos__broader mesh__D005814smesh__D005796
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D005814 2006
% 213.05/213.23  |- skos__prefLabel mesh__D005814 Genes, Viral
% 213.05/213.23  |- rdf__type mesh__D005814sskos__Concept
% 213.05/213.23  |- mesh__recordMaintainer mesh__D005814 nns
% 213.05/213.23  |- skos__broader mesh__D005016smesh__D013449
% 213.05/213.23  |- skos__altLabel mesh__D005016 Ethoxyzolamide
% 213.05/213.23  |- mesh__historyNote mesh__D005016
% 213.05/213.23       91%28%75%29%; was see under THIAZOLES 1975-90; was see under CARBONIC ANHYDRASE INHIBITORS 1965-74%A%  
% 213.05/213.23  |- rdf__type mesh__D005016sskos__Concept
% 213.05/213.23  |- mesh__dateRevised mesh__D005016 2005-06-30
% 213.05/213.23  |- skos__prefLabel mesh__D005016 Ethoxzolamide
% 213.05/213.23  |- mesh__onlineNote mesh__D005016
% 213.05/213.23       search CARBONIC ANHYDRASE INHIBITORS 1966-74   
% 213.05/213.23  |- mesh__recordMaintainer mesh__D005016 ssb
% 213.05/213.23  |- skos__broader mesh__D005016smesh__D052160
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D005016 2006
% 213.05/213.23  |- mesh__dateEstablished mesh__D005016 1991-01-01
% 213.05/213.23  |- mesh__recordOriginator mesh__D005016 NLM
% 213.05/213.23  |- mesh__publicMeSHNote mesh__D005016
% 213.05/213.23       91; was see under THIAZOLES 1975-90; was see under CARBONIC ANHYDRASE INHIBITORS 1965-74%A%  
% 213.05/213.23  |- skos__altLabel mesh__D005016 Ethoxazolamide
% 213.05/213.23  |- mesh__recordAuthorizer mesh__D005016 sjn
% 213.05/213.23  |- skos__historyNote mesh__D005016 Thiazoles %28%1966-1974%29%
% 213.05/213.23  |- skos__scopeNote mesh__D005016
% 213.05/213.23       A carbonic anhydrase inhibitor used as diuretic and  in glaucoma. It may cause hypokalemia.%A%    
% 213.05/213.23  |- skos__broader mesh__D005016smesh__D013844
% 213.05/213.23  |- mesh__dateCreated mesh__D005016 1999-01-01
% 213.05/213.23  |- skos__historyNote mesh__D005016
% 213.05/213.23       Carbonic Anhydrase Inhibitors %28%1966-1974%29%
% 213.05/213.23  |- rdf__type mesh__D010759sskos__Concept
% 213.05/213.23  |- skos__scopeNote mesh__D010759
% 213.05/213.23       Stable phosphorus atoms that have the same atomic number as the element phosphorus, but differ in atomic weight. P-31 is a stable phosphorus isotope.%A%    
% 213.05/213.23  |- mesh__recordOriginator mesh__D010759 NLM
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D010759 2004
% 213.05/213.23  |- skos__hiddenLabel mesh__D010759 Isotopes, Phosphorus
% 213.05/213.23  |- skos__annotation mesh__D010759 P-31; NIM   
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D010759 2006
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D010759 2003
% 213.05/213.23  |- skos__prefLabel mesh__D010759 Phosphorus Isotopes
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D010759 2005
% 213.05/213.23  |- skos__broader mesh__D010759smesh__D007554
% 213.05/213.23  |- mesh__recordMaintainer mesh__D010759 nns
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D010759 2002
% 213.05/213.23  |- mesh__dateCreated mesh__D010759 1999-01-01
% 213.05/213.23  |- mesh__dateRevised mesh__D010759 2000-06-22
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D010759 2001
% 213.05/213.23  |- mesh__recordAuthorizer mesh__D010759 sjn
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D015444 2006
% 213.05/213.23  |- mesh__recordAuthorizer mesh__D015444 sjn
% 213.05/213.23  |- skos__scopeNote mesh__D015444
% 213.05/213.23       Physical activity which is usually regular and done with the intention of improving or maintaining PHYSICAL FITNESS or HEALTH. Contrast with EXERTION which is concerned largely with the physiologic and metabolic response to energy expenditure.%A%    
% 213.05/213.23  |- mesh__dateCreated mesh__D015444 1988-06-08
% 213.05/213.23  |- skos__broader mesh__D015444smesh__D005082
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D015444 2005
% 213.05/213.23  |- skos__related mesh__D015444smesh__D010809
% 213.05/213.23  |- skos__broader mesh__D015444smesh__D006802
% 213.05/213.23  |- skos__historyNote mesh__D015444 Exertion %28%1966-1988%29%
% 213.05/213.23  |- skos__hiddenLabel mesh__D015444 Aerobic Exercises
% 213.05/213.23  |- skos__hiddenLabel mesh__D015444 Physical Exercise
% 213.05/213.23  |- skos__altLabel mesh__D015444 Isometric Exercise
% 213.05/213.23  |- mesh__onlineNote mesh__D015444
% 213.05/213.23       search EXERTION %26% SPORTS 1966-74; use EXERTION to search EXERCISE, PHYSICAL 1976-88; use ISOMETRIC CONTRACTION to search EXERCISE, ISOMETRIC 1984-88%A%  
% 213.05/213.23  |- skos__hiddenLabel mesh__D015444 Exercises, Physical
% 213.05/213.23  |- mesh__historyNote mesh__D015444
% 213.05/213.23       89; was see under EXERTION %26% SPORTS 1963-74; EXERCISE, ISOMETRIC was see under EXERTION 1977-83, was see ISOMETRIC CONTRACTION 1984-88; EXERCISE, PHYSICAL was see EXERTION 1976-88%A%  
% 213.05/213.23  |- skos__historyNote mesh__D015444 Physical Fitness %28%1966-1988%29%
% 213.05/213.23  |- skos__altLabel mesh__D015444 Aerobic Exercise
% 213.05/213.23  |- skos__hiddenLabel mesh__D015444 Isometric Exercises
% 213.05/213.23  |- skos__prefLabel mesh__D015444 Exercise
% 213.05/213.23  |- skos__hiddenLabel mesh__D015444 Exercises, Aerobic
% 213.05/213.23  |- mesh__recordOriginator mesh__D015444 WDJ
% 213.05/213.23  |- rdf__type mesh__D015444sskos__Concept
% 213.05/213.23  |- skos__altLabel mesh__D015444 Exercise, Physical
% 213.05/213.23  |- mesh__dateRevised mesh__D015444 2003-07-09
% 213.05/213.23  |- mesh__dateEstablished mesh__D015444 1989-01-01
% 213.05/213.23  |- skos__hiddenLabel mesh__D015444 Physical Exercises
% 213.05/213.23  |- mesh__recordMaintainer mesh__D015444 nns
% 213.05/213.23  |- skos__broader mesh__D015444smesh__D026241
% 213.05/213.23  |- skos__related mesh__D015444smesh__D005082
% 213.05/213.23  |- skos__annotation mesh__D015444
% 213.05/213.23       restrict to humans: for animals use PHYSICAL CONDITIONING, ANIMAL; EXERCISE THERAPY %26% EXERCISE TEST are also available; /inj: coord IM with specific inj %28%IM%29%; /physiol /psychol permitted; do not confuse with EXERTION: see MeSH definition; includes body building unless article specifies WEIGHT LIFTING%A%  
% 213.05/213.23  |- skos__hiddenLabel mesh__D015444 Exercises, Isometric
% 213.05/213.23  |- skos__hiddenLabel mesh__D015444 Exercises
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D015444 2004
% 213.05/213.23  |- mesh__publicMeSHNote mesh__D015444
% 213.05/213.23       89; was see under EXERTION %26% SPORTS 1963-74; EXERCISE, ISOMETRIC was see under EXERTION 1977-83, was see ISOMETRIC CONTRACTION 1984-88; EXERCISE, PHYSICAL was see EXERTION 1976-88%A%  
% 213.05/213.23  |- mesh__dateEstablished mesh__D009407 1974-01-01
% 213.05/213.23  |- skos__broader mesh__D009407smesh__D000765
% 213.05/213.23  |- mesh__dateCreated mesh__D009407 1999-01-01
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D009407 1999
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D009407 2006
% 213.05/213.23  |- mesh__recordMaintainer mesh__D009407 PXP
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D009407 2002
% 213.05/213.23  |- skos__broader mesh__D009407smesh__D003714
% 213.05/213.23  |- skos__prefLabel mesh__D009407 Nerve Block
% 213.05/213.23  |- skos__annotation mesh__D009407
% 213.05/213.23       a form of denervation %26% conduction anesthesia; differentiate from NEUROMUSCULAR BLOCKADE: see note there; do not use /util except by MeSH definition; do not use /pharmacol or /ther use with substance to induce block; don%27%t forget AUTONOMIC NERVE BLOCK exists; coord with substance %28%with no qualif%29% used to induce the block if particularly discussed%A%  
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D009407 2004
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D009407 1998
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D009407 2005
% 213.05/213.23  |- mesh__historyNote mesh__D009407 74   
% 213.05/213.23  |- mesh__recordAuthorizer mesh__D009407 SJN
% 213.05/213.23  |- mesh__publicMeSHNote mesh__D009407 74   
% 213.05/213.23  |- skos__hiddenLabel mesh__D009407 Blocks, Nerve
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D009407 2003
% 213.05/213.23  |- skos__scopeNote mesh__D009407
% 213.05/213.23       Interruption of the conduction of impulses in peripheral nerves or nerve trunks by the injection of a local anesthetic solution. %28%Stedman, 26th ed%29%%A%    
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D009407 2001
% 213.05/213.23  |- skos__hiddenLabel mesh__D009407 Nerve Blocks
% 213.05/213.23  |- mesh__dateRevised mesh__D009407 1997-06-20
% 213.05/213.23  |- rdf__type mesh__D009407sskos__Concept
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D009407 2000
% 213.05/213.23  |- skos__hiddenLabel mesh__D009407 Block, Nerve
% 213.05/213.23  |- mesh__recordOriginator mesh__D009407 NLM
% 213.05/213.23  |- mesh__dateEstablished mesh__D001424 1972-01-01
% 213.05/213.23  |- skos__altLabel mesh__D001424 Infections, Bacterial
% 213.05/213.23  |- mesh__publicMeSHNote mesh__D001424 72   
% 213.05/213.23  |- skos__altLabel mesh__D001424 Bacterial Infection
% 213.05/213.23  |- mesh__historyNote mesh__D001424 72   
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D001424 2006
% 213.05/213.23  |- skos__prefLabel mesh__D001424 Bacterial Infections
% 213.05/213.23  |- mesh__recordOriginator mesh__D001424 NLM
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D001424 2002
% 213.05/213.23  |- skos__scopeNote mesh__D001424
% 213.05/213.23       Infections by bacteria, general or unspecified.     
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D001424 2005
% 213.05/213.23  |- rdf__type mesh__D001424sskos__Concept
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D001424 2001
% 213.05/213.23  |- mesh__recordAuthorizer mesh__D001424 SJN
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D001424 1999
% 213.05/213.23  |- skos__broader mesh__D001424smesh__D001423
% 213.05/213.23  |- skos__altLabel mesh__D001424 Infection, Bacterial
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D001424 2004
% 213.05/213.23  |- mesh__dateCreated mesh__D001424 1999-01-01
% 213.05/213.23  |- mesh__recordMaintainer mesh__D001424 TGC
% 213.05/213.23  |- mesh__dateRevised mesh__D001424 1997-06-20
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D001424 2000
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D001424 1998
% 213.05/213.23  |- skos__annotation mesh__D001424
% 213.05/213.23       GEN: prefer specifics; many texts saying %22%sepsis%22% mean BACTERIAL INFECTIONS: check text; TN 209: differentiation from presence of bacteria in organs; DF: BACT INFECT%A%  
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D001424 2003
% 213.05/213.23  |- skos__historyNote mesh__D001424 Infection %28%1966-1971%29%
% 213.05/213.23  |- mesh__onlineNote mesh__D001424
% 213.05/213.23       pre-explosion = BACTERIAL INFECTIONS %28%PX%29%   
% 213.05/213.23  |- mesh__dateRevised mesh__D020389 2004-07-07
% 213.05/213.23  |- skos__hiddenLabel mesh__D020389 X-Linked Scapuloperoneal Syndrome
% 213.05/213.23  |- skos__hiddenLabel mesh__D020389 Scapuloperoneal Muscular Dystrophy
% 213.05/213.23  |- skos__hiddenLabel mesh__D020389 Muscular Dystrophy, Emery Dreifuss
% 213.05/213.23  |- skos__hiddenLabel mesh__D020389
% 213.05/213.23       Emery Dreifuss Muscular Dystrophy, Autosomal Recessive
% 213.05/213.23  |- skos__altLabel mesh__D020389 Scapuloperoneal Syndrome, X-Linked
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D020389 2006
% 213.05/213.23  |- skos__altLabel mesh__D020389
% 213.05/213.23       Scapuloilioperoneal Atrophy with Cardiopathy
% 213.05/213.23  |- skos__altLabel mesh__D020389 Emery-Dreifuss Type Muscular Dystrophy
% 213.05/213.23  |- skos__prefLabel mesh__D020389 Muscular Dystrophy, Emery-Dreifuss
% 213.05/213.23  |- skos__altLabel mesh__D020389
% 213.05/213.23       Emery-Dreifuss Muscular Dystrophy, Autosomal Recessive
% 213.05/213.23  |- skos__broader mesh__D020389smesh__D009136
% 213.05/213.23  |- skos__altLabel mesh__D020389 Muscular Dystrophy, Scapuloperoneal
% 213.05/213.23  |- skos__altLabel mesh__D020389
% 213.05/213.23       Muscular Dystrophy, Emery-Dreifuss, Autosomal Dominant
% 213.05/213.23  |- skos__hiddenLabel mesh__D020389 Hauptmann Thannhauser Muscular Dystrophy
% 213.05/213.23  |- skos__altLabel mesh__D020389 Hauptmann-Thannhauser Muscular Dystrophy
% 213.05/213.23  |- skos__hiddenLabel mesh__D020389
% 213.05/213.23       X Linked Emery Dreifuss Muscular Dystrophy
% 213.05/213.23  |- skos__historyNote mesh__D020389 Muscular Dystrophies %28%1966-1999%29%
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D020389 2005
% 213.05/213.23  |- skos__altLabel mesh__D020389 Emery-Dreifuss Syndrome
% 213.05/213.23  |- skos__hiddenLabel mesh__D020389
% 213.05/213.23       Autosomal Dominant Emery Dreifuss Muscular Dystrophy
% 213.05/213.23  |- mesh__dateEstablished mesh__D020389 2000-01-01
% 213.05/213.23  |- mesh__recordAuthorizer mesh__D020389 sjn
% 213.05/213.23  |- rdf__type mesh__D020389sskos__Concept
% 213.05/213.23  |- skos__hiddenLabel mesh__D020389 Scapuloperoneal Syndrome, X Linked
% 213.05/213.23  |- skos__hiddenLabel mesh__D020389
% 213.05/213.23       Autosomal Recessive Emery Dreifuss Muscular Dystrophy
% 213.05/213.23  |- mesh__recordOriginator mesh__D020389 KEV
% 213.05/213.23  |- skos__hiddenLabel mesh__D020389 Emery Dreifuss Muscular Dystrophy 2
% 213.05/213.23  |- mesh__publicMeSHNote mesh__D020389
% 213.05/213.23       2000; for MUSCULAR DYSTROPHY, SCAPULOPERONEAL see MUSCULAR DYSTROPHIES 2000-2004%A%  
% 213.05/213.23  |- mesh__historyNote mesh__D020389
% 213.05/213.23       2000; for MUSCULAR DYSTROPHY, SCAPULOPERONEAL use MUSCULAR DYSTROPHIES 2000-2004%A%  
% 213.05/213.23  |- skos__broader mesh__D020389smesh__D040181
% 213.05/213.23  |- skos__scopeNote mesh__D020389
% 213.05/213.23       A heterogenous group of inherited muscular dystrophy without the involvement of nervous system. The disease is characterized by MUSCULAR ATROPHY; MUSCLE WEAKNESS; CONTRACTURE of the elbows; ACHILLES TENDON; and posterior cervical muscles; with or without cardiac features. There are several INHERITANCE PATTERNS including X-linked %28%X CHROMOSOME%29%, autosomal dominant, and autosomal recessive gene mutations.%A%    
% 213.05/213.23  |- skos__altLabel mesh__D020389 Emery-Dreifuss Muscular Dystrophy 2
% 213.05/213.23  |- mesh__recordMaintainer mesh__D020389 lkt
% 213.05/213.23  |- skos__altLabel mesh__D020389
% 213.05/213.23       Muscular Dystrophy, Emery-Dreifuss, Autosomal Recessive
% 213.05/213.23  |- skos__hiddenLabel mesh__D020389 Emery Dreifuss Syndrome
% 213.05/213.23  |- skos__altLabel mesh__D020389
% 213.05/213.23       Muscular Dystrophy, Emery-Dreifuss, X-Linked
% 213.05/213.23  |- mesh__dateCreated mesh__D020389 1999-11-08
% 213.05/213.23  |- skos__altLabel mesh__D020389 Muscular Dystrophy, Emery-Dreifuss Type
% 213.05/213.23  |- skos__hiddenLabel mesh__D020389 Emery-Dreifuss Muscular Dystrophy
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D019835 2006
% 213.05/213.23  |- skos__hiddenLabel mesh__D019835 FMRF NH2
% 213.05/213.23  |- skos__historyNote mesh__D019835 Nerve Tissue Proteins %28%1986-1987%29%
% 213.05/213.23  |- skos__altLabel mesh__D019835 FMRF-amide
% 213.05/213.23  |- skos__historyNote mesh__D019835 Oligopeptides %28%1978-1986%29%
% 213.05/213.23  |- skos__altLabel mesh__D019835 Phe-Met-Arg-Phe-NH2
% 213.05/213.23  |- skos__prefLabel mesh__D019835 FMRFamide
% 213.05/213.23  |- skos__altLabel mesh__D019835 FMRF
% 213.05/213.23  |- mesh__publicMeSHNote mesh__D019835
% 213.05/213.23       98; FMRFAMIDE was indexed under NEUROPEPTIDES 1987-97, NERVE TISSUE PROTEINS 1986-87, %26% OLIGOPEPTIDES 1978-86%A%  
% 213.05/213.23  |- skos__altLabel mesh__D019835 Phe-Met-Arg-Phe-amide
% 213.05/213.23  |- skos__broader mesh__D019835smesh__D009479
% 213.05/213.23  |- rdf__type mesh__D019835sskos__Concept
% 213.05/213.23  |- mesh__recordOriginator mesh__D019835 KEV
% 213.05/213.23  |- mesh__dateCreated mesh__D019835 1997-06-20
% 213.05/213.23  |- skos__hiddenLabel mesh__D019835 Phe Met Arg Phe amide
% 213.05/213.23  |- mesh__dateEstablished mesh__D019835 1998-01-01
% 213.05/213.23  |- skos__altLabel mesh__D019835 FMRF-NH2
% 213.05/213.23  |- skos__scopeNote mesh__D019835
% 213.05/213.23       A molluscan neuroactive peptide which induces a fast excitatory depolarizing response due to direct activation of amiloride-sensitive SODIUM CHANNELS. %28%From Nature 1995; 378%28%6558%29%: 730-3%29%%A%    
% 213.05/213.23  |- mesh__recordMaintainer mesh__D019835 ssb
% 213.05/213.23  |- skos__altLabel mesh__D019835 FMRFamide, %28%D-phenylalanine%29%-Isomer
% 213.05/213.23  |- mesh__historyNote mesh__D019835 98; use FMRFAMIDE %28%NM%29% 1978-97   
% 213.05/213.23  |- mesh__dateRevised mesh__D019835 2005-06-30
% 213.05/213.23  |- mesh__recordAuthorizer mesh__D019835 sjn
% 213.05/213.23  |- skos__hiddenLabel mesh__D019835 FMRF amide
% 213.05/213.23  |- skos__historyNote mesh__D019835 Neuropeptides %28%1987-1997%29%
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D011852 2006
% 213.05/213.23  |- mesh__recordAuthorizer mesh__D011852 sjn
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D011852 2004
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D011852 2005
% 213.05/213.23  |- skos__historyNote mesh__D011852 IgE %28%1971-1976%29%
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D011852 2003
% 213.05/213.23  |- rdf__type mesh__D011852sskos__Concept
% 213.05/213.23  |- skos__hiddenLabel mesh__D011852 Test, Radioallergosorbent
% 213.05/213.23  |- mesh__dateRevised mesh__D011852 2001-08-03
% 213.05/213.23  |- skos__prefLabel mesh__D011852 Radioallergosorbent Test
% 213.05/213.23  |- skos__historyNote mesh__D011852 Radioimmunoassay %28%1968-1976%29%
% 213.05/213.23  |- skos__scopeNote mesh__D011852
% 213.05/213.23       An in vitro allergen radioimmunoassay in which allergens are coupled to an immunosorbent. The coupled allergens bind the IgE in the sera of patients which in turn binds radioisotope-labeled anti-IMMUNOGLOBULIN E antibodies.%A%    
% 213.05/213.23  |- skos__hiddenLabel mesh__D011852 Radioallergosorbent Tests
% 213.05/213.23  |- skos__hiddenLabel mesh__D011852 Allergens Radioimmunosorbent Assays
% 213.05/213.23  |- mesh__recordOriginator mesh__D011852 SMH
% 213.05/213.23  |- skos__annotation mesh__D011852
% 213.05/213.23       NIM; IMMUNOSORBENTS is also available; DF: RAST   
% 213.05/213.23  |- skos__hiddenLabel mesh__D011852 Tests, Radioallergosorbent
% 213.05/213.23  |- skos__hiddenLabel mesh__D011852 Allergens Radioimmunosorbent Assay
% 213.05/213.23  |- skos__broader mesh__D011852smesh__D011863
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D011852 2002
% 213.05/213.23  |- mesh__historyNote mesh__D011852
% 213.05/213.23       89%28%77%29%; was see under RADIOIMMUNOASSAY 1977-88   
% 213.05/213.23  |- skos__historyNote mesh__D011852 Allergens %28%1966-1976%29%
% 213.05/213.23  |- skos__broader mesh__D011852smesh__D012698
% 213.05/213.23  |- skos__broader mesh__D011852smesh__D007163
% 213.05/213.23  |- mesh__publicMeSHNote mesh__D011852
% 213.05/213.23       89; was see under RADIOIMMUNOASAY 1977-88   
% 213.05/213.23  |- mesh__dateEstablished mesh__D011852 1989-01-01
% 213.05/213.23  |- mesh__recordMaintainer mesh__D011852 sjn
% 213.05/213.23  |- skos__altLabel mesh__D011852 Radioimmunosorbent Assay of Allergens
% 213.05/213.23  |- mesh__dateCreated mesh__D011852 1976-04-16
% 213.05/213.23  |- mesh__dateCreated mesh__D019037 1995-05-26
% 213.05/213.23  |- skos__scopeNote mesh__D019037
% 213.05/213.23       Health services, public or private, in urban areas. The services include the promotion of health and the delivery of health care.%A%    
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D019037 2006
% 213.05/213.23  |- mesh__recordOriginator mesh__D019037 TGC
% 213.05/213.23  |- mesh__dateRevised mesh__D019037 1999-11-03
% 213.05/213.23  |- rdf__type mesh__D019037sskos__Concept
% 213.05/213.23  |- skos__altLabel mesh__D019037 Services, Urban Health
% 213.05/213.23  |- skos__broader mesh__D019037smesh__D006296
% 213.05/213.23  |- skos__prefLabel mesh__D019037 Urban Health Services
% 213.05/213.23  |- mesh__dateEstablished mesh__D019037 1996-01-01
% 213.05/213.23  |- mesh__historyNote mesh__D019037 96   
% 213.05/213.23  |- mesh__recordAuthorizer mesh__D019037 sjn
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D019037 2000
% 213.05/213.23  |- skos__hiddenLabel mesh__D019037 Health Service, Urban
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D019037 2003
% 213.05/213.23  |- skos__annotation mesh__D019037
% 213.05/213.23       IM; coord with specific health serv %28%IM%29%; SUBURBAN HEALTH SERVICES is also available; DF: URBAN HEALTH SERV%A%  
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D019037 2001
% 213.05/213.23  |- skos__altLabel mesh__D019037 Health Services, Urban
% 213.05/213.23  |- skos__historyNote mesh__D019037 Urban Health %28%1978-1995%29%
% 213.05/213.23  |- mesh__publicMeSHNote mesh__D019037 96   
% 213.05/213.23  |- skos__hiddenLabel mesh__D019037 Service, Urban Health
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D019037 2004
% 213.05/213.23  |- mesh__recordMaintainer mesh__D019037 kle
% 213.05/213.23  |- skos__hiddenLabel mesh__D019037 Urban Health Service
% 213.05/213.23  |- skos__historyNote mesh__D019037 Urban Population %28%1968-1995%29%
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D019037 2002
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D019037 2005
% 213.05/213.23  |- skos__hiddenLabel mesh__D011054 Vaccine, Salk
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D011054 2006
% 213.05/213.23  |- skos__hiddenLabel mesh__D011054 Vaccine, Inactivated Poliovirus
% 213.05/213.23  |- mesh__dateRevised mesh__D011054 2005-06-30
% 213.05/213.23  |- skos__scopeNote mesh__D011054
% 213.05/213.23       A suspension of formalin-inactivated poliovirus grown in monkey kidney cell tissue culture and used to prevent POLIOMYELITIS.%A%    
% 213.05/213.23  |- skos__broader mesh__D011054smesh__D015164
% 213.05/213.23  |- mesh__dateCreated mesh__D011054 1999-01-01
% 213.05/213.23  |- rdf__type mesh__D011054sskos__Concept
% 213.05/213.23  |- skos__broader mesh__D011054smesh__D023321
% 213.05/213.23  |- mesh__recordMaintainer mesh__D011054 ssb
% 213.05/213.23  |- mesh__recordOriginator mesh__D011054 NLM
% 213.05/213.23  |- mesh__recordAuthorizer mesh__D011054 sjn
% 213.05/213.23  |- skos__prefLabel mesh__D011054 Poliovirus Vaccine, Inactivated
% 213.05/213.23  |- skos__hiddenLabel mesh__D011054 Inactivated Poliovirus Vaccine
% 213.05/213.23  |- skos__prefLabel mesh__D005815 Genetic Code
% 213.05/213.23  |- mesh__historyNote mesh__D005815 66%28%64%29%   
% 213.05/213.23  |- skos__altLabel mesh__D005815 Code, Genetic
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D005815 2006
% 213.05/213.23  |- skos__scopeNote mesh__D005815
% 213.05/213.23       The meaning ascribed to the BASE SEQUENCE with respect to how it is translated into AMINO ACID SEQUENCE. The start, stop, and order of amino acids of a protein is specified by consecutive triplets of nucleotides called codons %28%CODON%29%.%A%    
% 213.05/213.23  |- rdf__type mesh__D005815sskos__Concept
% 213.05/213.23  |- skos__related mesh__D005815smesh__D014176
% 213.05/213.23  |- mesh__recordOriginator mesh__D005815 NLM
% 213.05/213.23  |- mesh__dateEstablished mesh__D005815 1966-01-01
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D005815 2005
% 213.05/213.23  |- mesh__dateRevised mesh__D005815 2004-07-20
% 213.05/213.23  |- mesh__recordMaintainer mesh__D005815 NLM
% 213.05/213.23  |- mesh__publicMeSHNote mesh__D005815 66   
% 213.05/213.23  |- mesh__recordAuthorizer mesh__D005815 NLM
% 213.05/213.23  |- skos__related mesh__D005815smesh__D042421
% 213.05/213.23  |- skos__hiddenLabel mesh__D005815 Genetic Codes
% 213.05/213.23  |- skos__hiddenLabel mesh__D005815 Codes, Genetic
% 213.05/213.23  |- mesh__dateCreated mesh__D005815 1999-01-01
% 213.05/213.23  |- skos__broader mesh__D005815smesh__D040342
% 213.05/213.23  |- skos__broader mesh__D013336Q000193smesh__D013336
% 213.05/213.23  |- mesh__preferredCombination mesh__D013336Q000193smesh__D006281Q000193
% 213.05/213.23  |- rdf__type mesh__D013336Q000193smesh__CompoundConcept
% 213.05/213.23  |- skos__broader mesh__D005017smesh__D015110
% 213.05/213.23  |- skos__hiddenLabel mesh__D005017 Biscoumacetate, Ethyl
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D005017 2006
% 213.05/213.23  |- mesh__dateRevised mesh__D005017 2005-06-30
% 213.05/213.23  |- skos__altLabel mesh__D005017 Carbethoxydicoumarol
% 213.05/213.23  |- skos__altLabel mesh__D005017 Ethyldicoumarol
% 213.05/213.23  |- skos__prefLabel mesh__D005017 Ethyl Biscoumacetate
% 213.05/213.23  |- mesh__recordMaintainer mesh__D005017 ssb
% 213.05/213.23  |- mesh__dateCreated mesh__D005017 1999-01-01
% 213.05/213.23  |- mesh__recordOriginator mesh__D005017 NLM
% 213.05/213.23  |- rdf__type mesh__D005017sskos__Concept
% 213.05/213.23  |- skos__scopeNote mesh__D005017
% 213.05/213.23       A coumarin that is used as an anticoagulant. It has actions similar to those of WARFARIN. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p226%29%%A%    
% 213.05/213.23  |- mesh__recordAuthorizer mesh__D005017 sjn
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D009408 2001
% 213.05/213.23  |- skos__hiddenLabel mesh__D009408 Neuropathies, Entrapment
% 213.05/213.23  |- skos__altLabel mesh__D009408 Nerve Compression Syndromes, Internal
% 213.05/213.23  |- mesh__dateEstablished mesh__D009408 1973-01-01
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D009408 2003
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D009408 2000A
% 213.05/213.23  |- skos__hiddenLabel mesh__D009408 Nerve Compression Syndrome
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D009408 2000
% 213.05/213.23  |- mesh__dateRevised mesh__D009408 1999-12-06
% 213.05/213.23  |- skos__hiddenLabel mesh__D009408 Neuropathy, Entrapment
% 213.05/213.23  |- mesh__recordOriginator mesh__D009408 NLM
% 213.05/213.23  |- skos__hiddenLabel mesh__D009408 Entrapment Neuropathy
% 213.05/213.23  |- skos__annotation mesh__D009408
% 213.05/213.23       coord IM with specific nerve disease %28%IM%29% or specific nerve %28%IM%29%; cauda equina syndrome: coord IM with CAUDA EQUINA %28%IM%29%%A%  
% 213.05/213.23  |- skos__hiddenLabel mesh__D009408 Entrapment, Nerve
% 213.05/213.23  |- rdf__type mesh__D009408sskos__Concept
% 213.05/213.23  |- skos__hiddenLabel mesh__D009408 Entrapments, Nerve
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D009408 2002
% 213.05/213.23  |- mesh__publicMeSHNote mesh__D009408 1973   
% 213.05/213.23  |- mesh__historyNote mesh__D009408 1973%28%1972%29%   
% 213.05/213.23  |- skos__hiddenLabel mesh__D009408 Nerve Entrapment
% 213.05/213.23  |- skos__hiddenLabel mesh__D009408 Syndromes, Nerve Compression
% 213.05/213.23  |- mesh__dateCreated mesh__D009408 1999-01-01
% 213.05/213.23  |- skos__scopeNote mesh__D009408
% 213.05/213.23       Mechanical compression of nerves or nerve roots from internal or external causes. These may result in a conduction block to nerve impulses %28%due to MYELIN SHEATH dysfunction%29% or axonal loss. The nerve and nerve sheath injuries may be caused by ISCHEMIA; INFLAMMATION; or a direct mechanical effect.%A%    
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D009408 2006
% 213.05/213.23  |- mesh__recordAuthorizer mesh__D009408 ags
% 213.05/213.23  |- skos__broader mesh__D009408smesh__D010523
% 213.05/213.23  |- skos__altLabel mesh__D009408 Nerve Compression Syndromes, External
% 213.05/213.23  |- mesh__recordMaintainer mesh__D009408 ags
% 213.05/213.23  |- skos__hiddenLabel mesh__D009408 Compression Syndrome, Nerve
% 213.05/213.23  |- skos__prefLabel mesh__D009408 Nerve Compression Syndromes
% 213.05/213.23  |- skos__hiddenLabel mesh__D009408 Compression Syndromes, Nerve
% 213.05/213.23  |- skos__historyNote mesh__D009408
% 213.05/213.23       Peripheral Nerve Diseases %28%1966-1969%29%
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D009408 2004
% 213.05/213.23  |- skos__hiddenLabel mesh__D009408 Syndrome, Nerve Compression
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D009408 2005
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D001425 2006
% 213.05/213.23  |- mesh__dateEstablished mesh__D001425 1985-01-01
% 213.05/213.23  |- skos__historyNote mesh__D001425 Bacterial Proteins %28%1966-1984%29%
% 213.05/213.23  |- mesh__historyNote mesh__D001425 85   
% 213.05/213.23  |- mesh__dateRevised mesh__D001425 2005-06-30
% 213.05/213.23  |- rdf__type mesh__D001425sskos__Concept
% 213.05/213.23  |- skos__prefLabel mesh__D001425 Bacterial Outer Membrane Proteins
% 213.05/213.23  |- mesh__publicMeSHNote mesh__D001425 85   
% 213.05/213.23  |- mesh__recordMaintainer mesh__D001425 SYSTEM
% 213.05/213.23  |- mesh__recordAuthorizer mesh__D001425 sjn
% 213.05/213.23  |- skos__altLabel mesh__D001425 OMP Proteins
% 213.05/213.23  |- mesh__dateCreated mesh__D001425 1984-05-30
% 213.05/213.23  |- skos__altLabel mesh__D001425 Outer Membrane Proteins, Bacterial
% 213.05/213.23  |- skos__broader mesh__D001425smesh__D001426
% 213.05/213.23  |- skos__historyNote mesh__D001425 Membrane Proteins %28%1977-1984%29%
% 213.05/213.23  |- skos__annotation mesh__D001425
% 213.05/213.23       coord IM with specific protein %28%IM%29% + specific gram-negative bacterium %28%IM%29%%A%  
% 213.05/213.23  |- skos__broader mesh__D001425smesh__D008565
% 213.05/213.23  |- mesh__recordOriginator mesh__D001425 RLS
% 213.05/213.23  |- skos__scopeNote mesh__D001425
% 213.05/213.23       Proteins isolated from the outer membrane of Gram-negative bacteria.%A%    
% 213.05/213.23  |- skos__annotation mesh__D006110
% 213.05/213.23       do not use /drug eff for insecticides: TN 111   
% 213.05/213.23  |- mesh__onlineNote mesh__D006110
% 213.05/213.23       use GRASSHOPPERS to search LOCUSTS 1972-77   
% 213.05/213.23  |- skos__historyNote mesh__D006110 Insects %28%1966-1971%29%
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D006110 2006
% 213.05/213.23  |- skos__broader mesh__D006110smesh__D009987
% 213.05/213.23  |- mesh__dateRevised mesh__D006110 2003-07-09
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D006110 2005
% 213.05/213.23  |- mesh__recordOriginator mesh__D006110 NLM
% 213.05/213.23  |- rdf__type mesh__D006110sskos__Concept
% 213.05/213.23  |- mesh__recordAuthorizer mesh__D006110 sjn
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D006110 2004
% 213.05/213.23  |- mesh__historyNote mesh__D006110
% 213.05/213.23       72; LOCUSTS was see under GRASSHOPPERS 1972-77   
% 213.05/213.23  |- mesh__dateCreated mesh__D006110 1999-01-01
% 213.05/213.23  |- skos__scopeNote mesh__D006110
% 213.05/213.23       Plant-eating orthopterans having hindlegs adapted for jumping. There are two main families: Acrididae and Romaleidae. Some of the more common genera are: Melanoplus, the most common grasshopper; Conocephalus, the eastern meadow grasshopper; and Pterophylla, the true katydid.%A%    
% 213.05/213.23  |- skos__prefLabel mesh__D006110 Grasshoppers
% 213.05/213.23  |- mesh__recordMaintainer mesh__D006110 ags
% 213.05/213.23  |- mesh__dateEstablished mesh__D006110 1972-01-01
% 213.05/213.23  |- skos__scopeNote mesh__D019836
% 213.05/213.23       Determination of the nature of a pathological condition or disease in the ovum, zygote, or blastocyst prior to implantation. CYTOGENETIC ANALYSIS is performed to determine the presence or absence of genetic disease.%A%    
% 213.05/213.23  |- mesh__activeMeSHYear mesh__D019836 2005
% 213.05/213.23  |- mesh__recordAuthorizer mesh__D019836 sjn
% 213.05/213.23  |- rdf__type mesh__D019836sskos__Concept
% 213.05/213.23  |- skos__annotation mesh__D019836
% 213.05/213.23        preimplant refers to ovum implant; check tags  HUMANS or ANIMALS %26% FEMALE %26% PREGNANCY%A%  
% 213.05/213.23  |- mesh__historyNote mesh__D019836 98   
% 213.05/213.23  |- skos__historyNote mesh__D019836 Prenatal Diagnosis %28%1987-1997%29%
% 213.05/213.23  |- skos__hiddenLabel mesh__D019836 Genetic Diagnoses, Preimplantation
% 213.05/213.23  |- skos__hiddenLabel mesh__D019836 Genetic Diagnosis, Preimplantation
% 213.05/213.23  |- skos__altLabel mesh__D019836 Diagnosis, Preimplantation
% 213.05/213.23  |- skos__altLabel mesh__D019836 Diagnosis, Preimplantation Genetic
% 213.05/213.23  |- skos__related mesh__D019836smesh__D011296
% 213.05/213.23  |- mesh__publicMeSHNote mesh__D019836 98   
% 213.05/213.23  |- skos__hiddenLabel mesh__D019836 Preimplantation Diagnoses
% 213.05/213.23  |- mesh__dateRevised mesh__D019836 2004-07-13
% 213.05/213.23  |- skos__hiddenLabel mesh__D019836 Diagnoses, Preimplantation Genetic
% 213.05/213.23  |- skos__prefLabel mesh__D019836 Preimplantation Diagnosis
% 213.05/213.23  |- skos__hiddenLabel mesh__D019836 Diagnoses, Preimplantation
% 213.05/213.23  |- skos__hiddenLabel mesh__D019836 Preimplantation Genetic Diagnoses
% 213.05/213.23  |- mesh__dateCreated mesh__D019836 1997-06-20
% 213.05/213.23  |- mesh__recordMaintainer mesh__D019836 sjn
% 213.05/213.24  |- mesh__dateEstablished mesh__D019836 1998-01-01
% 213.05/213.24  |- skos__altLabel mesh__D019836 Preimplantation Genetic Diagnosis
% 213.05/213.24  |- skos__broader mesh__D019836smesh__D003944
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D019836 2006
% 213.05/213.24  |- mesh__recordOriginator mesh__D019836 AGS
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011853 2003
% 213.05/213.24  |- rdf__type mesh__D011853sskos__Concept
% 213.05/213.24  |- skos__altLabel mesh__D011853 Radiation Biology
% 213.05/213.24  |- skos__related mesh__D011853smesh__D009683
% 213.05/213.24  |- mesh__dateRevised mesh__D011853 2001-07-25
% 213.05/213.24  |- mesh__publicMeSHNote mesh__D011853 66   
% 213.05/213.24  |- mesh__dateEstablished mesh__D011853 1966-01-01
% 213.05/213.24  |- skos__scopeNote mesh__D011853
% 213.05/213.24       Study of the scientific principles, mechanisms, and effects of the interaction of ionizing radiation with living matter. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 213.05/213.24  |- mesh__recordAuthorizer mesh__D011853 sjn
% 213.05/213.24  |- mesh__dateCreated mesh__D011853 1999-01-01
% 213.05/213.24  |- skos__altLabel mesh__D011853 Biology, Radiation
% 213.05/213.24  |- mesh__historyNote mesh__D011853 66   
% 213.05/213.24  |- skos__prefLabel mesh__D011853 Radiobiology
% 213.05/213.24  |- mesh__recordOriginator mesh__D011853 NLM
% 213.05/213.24  |- mesh__recordMaintainer mesh__D011853 jls
% 213.05/213.24  |- skos__broader mesh__D011853smesh__D001695
% 213.05/213.24  |- skos__annotation mesh__D011853 SPEC: SPEC qualif; DF: RADIOBIOL   
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011853 2006
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011853 2002
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011853 2004
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011853 2005
% 213.05/213.24  |- mesh__dateRevised mesh__D019038 2003-07-09
% 213.05/213.24  |- skos__annotation mesh__D019038
% 213.05/213.24       important in platelet aggreg; note X refs as CD42 antigens; DF: GPIB IX%A%  
% 213.05/213.24  |- skos__hiddenLabel mesh__D019038 Antigen, CD42d
% 213.05/213.24  |- skos__altLabel mesh__D019038 Antigens, CD42a
% 213.05/213.24  |- rdf__type mesh__D019038sskos__Concept
% 213.05/213.24  |- mesh__publicMeSHNote mesh__D019038
% 213.05/213.24       96; PLATELET MEMBRANE GLYCOPROTEIN IB was see PLATELET MEMBRANE GLYCOPROTEINS 1987-95%A%  
% 213.05/213.24  |- mesh__onlineNote mesh__D019038
% 213.05/213.24       use PLATELET MEMBRANE GLYCOPROTEINS to search PLATELET MEMBRANE GLYCOPROTEIN IB 1987-95%A%  
% 213.05/213.24  |- skos__altLabel mesh__D019038 Glycoprotein Ib
% 213.05/213.24  |- skos__altLabel mesh__D019038 CD42d Antigens
% 213.05/213.24  |- skos__hiddenLabel mesh__D019038 Antigen, CD42c
% 213.05/213.24  |- skos__hiddenLabel mesh__D019038 Platelet Glycoprotein GPIb IX Complex
% 213.05/213.24  |- mesh__recordOriginator mesh__D019038 AGS
% 213.05/213.24  |- skos__broader mesh__D019038smesh__D010980
% 213.05/213.24  |- skos__altLabel mesh__D019038 CD42a Antigens
% 213.05/213.24  |- mesh__historyNote mesh__D019038
% 213.05/213.24       96; PLATELET MEMBRANE GLYCOPROTEIN IB was see PLATELET MEMBRANE GLYCOPROTEINS 1987-95%A%  
% 213.05/213.24  |- skos__hiddenLabel mesh__D019038 Glycoprotein Ib IX Complex
% 213.05/213.24  |- skos__altLabel mesh__D019038 CD42b Antigen
% 213.05/213.24  |- skos__hiddenLabel mesh__D019038 Antigen, CD42b
% 213.05/213.24  |- skos__altLabel mesh__D019038 Antigens, CD42b
% 213.05/213.24  |- mesh__recordMaintainer mesh__D019038 jmp
% 213.05/213.24  |- skos__altLabel mesh__D019038 Antigens, CD42d
% 213.05/213.24  |- skos__altLabel mesh__D019038 Platelet Glycoprotein IX
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D019038 2004
% 213.05/213.24  |- skos__altLabel mesh__D019038 CD42a Antigen
% 213.05/213.24  |- skos__altLabel mesh__D019038 Antigens, CD42c
% 213.05/213.24  |- skos__hiddenLabel mesh__D019038 Antigen, CD42a
% 213.05/213.24  |- mesh__dateEstablished mesh__D019038 1996-01-01
% 213.05/213.24  |- skos__altLabel mesh__D019038 Glycoprotein Ib alpha
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D019038 2005
% 213.05/213.24  |- mesh__recordAuthorizer mesh__D019038 sjn
% 213.05/213.24  |- skos__altLabel mesh__D019038 Glycoprotein Ib beta
% 213.05/213.24  |- skos__altLabel mesh__D019038 Glycoprotein Ib-IX Complex
% 213.05/213.24  |- skos__altLabel mesh__D019038 CD42c Antigen
% 213.05/213.24  |- mesh__dateCreated mesh__D019038 1995-05-26
% 213.05/213.24  |- skos__broader mesh__D019038smesh__D018179
% 213.05/213.24  |- skos__historyNote mesh__D019038
% 213.05/213.24       Platelet Membrane Glycoproteins %28%1987-1995%29%
% 213.05/213.24  |- skos__scopeNote mesh__D019038
% 213.05/213.24       Platelet membrane glycoprotein complex essential for normal platelet adhesion and clot formation at sites of vascular injury. It is composed of three polypeptides, GPIb alpha, GPIb beta, and GPIX. Glycoprotein Ib functions as a receptor for von Willebrand factor and for thrombin. Congenital deficiency of the GPIb-IX complex results in Bernard-Soulier syndrome. The platelet glycoprotein GPV associates with GPIb-IX and is also absent in Bernard-Soulier syndrome.%A%    
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D019038 2006
% 213.05/213.24  |- skos__prefLabel mesh__D019038 Platelet Glycoprotein GPIb-IX Complex
% 213.05/213.24  |- mesh__recordMaintainer mesh__D011055 ssb
% 213.05/213.24  |- mesh__dateCreated mesh__D011055 1999-01-01
% 213.05/213.24  |- rdf__type mesh__D011055sskos__Concept
% 213.05/213.24  |- skos__altLabel mesh__D011055 Sabin Vaccine
% 213.05/213.24  |- mesh__recordAuthorizer mesh__D011055 sjn
% 213.05/213.24  |- skos__hiddenLabel mesh__D011055 Vaccine, Sabin
% 213.05/213.24  |- mesh__recordOriginator mesh__D011055 NLM
% 213.05/213.24  |- skos__scopeNote mesh__D011055
% 213.05/213.24       A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. %28%Dorland, 28th ed%29%%A%    
% 213.05/213.24  |- skos__broader mesh__D011055smesh__D023321
% 213.05/213.24  |- skos__prefLabel mesh__D011055 Poliovirus Vaccine, Oral
% 213.05/213.24  |- skos__hiddenLabel mesh__D011055 Vaccine, Oral Poliovirus
% 213.05/213.24  |- skos__annotation mesh__D011055
% 213.05/213.24       SABIN VACCINE is attenuated %28%live%29%   
% 213.05/213.24  |- mesh__dateRevised mesh__D011055 2005-06-30
% 213.05/213.24  |- skos__hiddenLabel mesh__D011055 Oral Poliovirus Vaccine
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011055 2006
% 213.05/213.24  |- skos__prefLabel mesh__D005816 Genetic Complementation Test
% 213.05/213.24  |- skos__hiddenLabel mesh__D005816 Cis Trans Test
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D005816 2001
% 213.05/213.24  |- skos__hiddenLabel mesh__D005816 Genetic Complementation Tests
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D005816 1995
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D005816 2003
% 213.05/213.24  |- mesh__dateRevised mesh__D005816 1992-05-15
% 213.05/213.24  |- skos__altLabel mesh__D005816 Complementation Test
% 213.05/213.24  |- skos__hiddenLabel mesh__D005816 Allelism Tests
% 213.05/213.24  |- mesh__dateCreated mesh__D005816 1999-01-01
% 213.05/213.24  |- mesh__recordMaintainer mesh__D005816 TAP
% 213.05/213.24  |- skos__altLabel mesh__D005816 Allelism Test
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D005816 2002
% 213.05/213.24  |- skos__scopeNote mesh__D005816
% 213.05/213.24       A test used to determine whether or not complementation %28%compensation in the form of dominance%29% will occur in a cell with a given mutant phenotype when another mutant genome, encoding the same mutant phenotype, is introduced into that cell.%A%    
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D005816 1996
% 213.05/213.24  |- mesh__onlineNote mesh__D005816
% 213.05/213.24       use GENETIC COMPLEMENTATION TEST to search ALLELISM TEST 1968-90%A%  
% 213.05/213.24  |- skos__altLabel mesh__D005816 Trans Test
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D005816 2004
% 213.05/213.24  |- rdf__type mesh__D005816sskos__Concept
% 213.05/213.24  |- mesh__recordAuthorizer mesh__D005816 PLS
% 213.05/213.24  |- skos__hiddenLabel mesh__D005816 Cis Tests
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D005816 1997
% 213.05/213.24  |- skos__hiddenLabel mesh__D005816 Trans Tests
% 213.05/213.24  |- mesh__dateEstablished mesh__D005816 1968-01-01
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D005816 2005
% 213.05/213.24  |- skos__hiddenLabel mesh__D005816 Complementation Test, Genetic
% 213.05/213.24  |- skos__hiddenLabel mesh__D005816 Complementation Tests
% 213.05/213.24  |- mesh__publicMeSHNote mesh__D005816
% 213.05/213.24       68; ALLELISM TEST was heading 1968-90   
% 213.05/213.24  |- mesh__historyNote mesh__D005816 68; ALLELISM TEST was heading 1968-90   
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D005816 1998
% 213.05/213.24  |- skos__historyNote mesh__D005816 Genetics %28%1966-1967%29%
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D005816 2006
% 213.05/213.24  |- skos__hiddenLabel mesh__D005816 Cis-Trans Tests
% 213.05/213.24  |- skos__annotation mesh__D005816 DF: GENET COMPLEMENTATION TEST   
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D005816 2000
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D005816 1994
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D005816 1999
% 213.05/213.24  |- mesh__recordOriginator mesh__D005816 NLM
% 213.05/213.24  |- skos__broader mesh__D005816smesh__D003433
% 213.05/213.24  |- skos__hiddenLabel mesh__D005816 Complementation Tests, Genetic
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D005816 1993
% 213.05/213.24  |- skos__hiddenLabel mesh__D005018 Chloride, Ethyl
% 213.05/213.24  |- mesh__recordOriginator mesh__D005018 NLM
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D005018 2006
% 213.05/213.24  |- skos__altLabel mesh__D005018 Chloroethane
% 213.05/213.24  |- skos__altLabel mesh__D005018 Ritter Brand of Ethyl Chloride
% 213.05/213.24  |- mesh__dateCreated mesh__D005018 1999-01-01
% 213.05/213.24  |- mesh__recordAuthorizer mesh__D005018 sjn
% 213.05/213.24  |- skos__hiddenLabel mesh__D005018 Gebauers Ethyl Chloride
% 213.05/213.24  |- skos__altLabel mesh__D005018 Gebauer Brand of Ethyl Chloride
% 213.05/213.24  |- skos__hiddenLabel mesh__D005018 Chemirosa, Cloretilo
% 213.05/213.24  |- skos__scopeNote mesh__D005018
% 213.05/213.24       A gas that condenses under slight pressure. Because of its low boiling point ethyl chloride sprayed on skin produces an intense cold by evaporation. Cold blocks nerve conduction. Ethyl chloride has been used in surgery but is primarily used to relieve local pain in sports medicine.%A%    
% 213.05/213.24  |- skos__altLabel mesh__D005018 Henning Walldorf Brand of Ethyl Chloride
% 213.05/213.24  |- skos__prefLabel mesh__D005018 Ethyl Chloride
% 213.05/213.24  |- skos__broader mesh__D005018smesh__D006843
% 213.05/213.24  |- skos__hiddenLabel mesh__D005018 Gebauer Ethyl Chloride
% 213.05/213.24  |- mesh__recordMaintainer mesh__D005018 CCR
% 213.05/213.24  |- mesh__dateRevised mesh__D005018 2005-06-30
% 213.05/213.24  |- skos__altLabel mesh__D005018 Ern Brand of Ethyl Chloride
% 213.05/213.24  |- rdf__type mesh__D005018sskos__Concept
% 213.05/213.24  |- skos__altLabel mesh__D015446 HTLV-II-HCL
% 213.05/213.24  |- skos__annotation mesh__D015446
% 213.05/213.24       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 213.05/213.24  |- skos__broader mesh__D015446smesh__D007943
% 213.05/213.24  |- skos__broader mesh__D015446smesh__D015491
% 213.05/213.24  |- skos__hiddenLabel mesh__D015446 HTLV II Associated T Cell Leukemia
% 213.05/213.24  |- skos__hiddenLabel mesh__D015446 Leukemias, HTLV-II-Associated T-Cell
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D015446 2002
% 213.05/213.24  |- skos__historyNote mesh__D015446 T Lymphocytes %28%1984-1988%29%
% 213.05/213.24  |- skos__altLabel mesh__D015446 T Cell Leukemia, HTLV II Associated
% 213.05/213.24  |- skos__hiddenLabel mesh__D015446 Leukemia, HTLV-II-Associated T-Cell
% 213.05/213.24  |- mesh__dateRevised mesh__D015446 2001-07-25
% 213.05/213.24  |- skos__hiddenLabel mesh__D015446 HTLV-II-Associated T-Cell Leukemias
% 213.05/213.24  |- mesh__historyNote mesh__D015446 89   
% 213.05/213.24  |- skos__altLabel mesh__D015446 Hairy Cell Leukemia, Atypical
% 213.05/213.24  |- rdf__type mesh__D015446sskos__Concept
% 213.05/213.24  |- skos__historyNote mesh__D015446 HTLV Infections %28%1987-1988%29%
% 213.05/213.24  |- mesh__dateCreated mesh__D015446 1988-06-09
% 213.05/213.24  |- skos__altLabel mesh__D015446 Leukemia, Hairy Cell, HTLV-II-Variant
% 213.05/213.24  |- mesh__dateEstablished mesh__D015446 1989-01-01
% 213.05/213.24  |- mesh__recordOriginator mesh__D015446 PLS
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D015446 2003
% 213.05/213.24  |- skos__prefLabel mesh__D015446 Leukemia, T-Cell, HTLV-II-Associated
% 213.05/213.24  |- skos__hiddenLabel mesh__D015446 T-Cell Leukemias, HTLV-II-Associated
% 213.05/213.24  |- skos__altLabel mesh__D015446 T-Cell Leukemia, HTLV-II-Associated
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D015446 2005
% 213.05/213.24  |- mesh__publicMeSHNote mesh__D015446 89   
% 213.05/213.24  |- mesh__recordAuthorizer mesh__D015446 sjn
% 213.05/213.24  |- skos__broader mesh__D015446smesh__D015458
% 213.05/213.24  |- skos__historyNote mesh__D015446 Leukemia, Hairy Cell %28%1984-1988%29%
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D015446 2004
% 213.05/213.24  |- skos__altLabel mesh__D015446 Leukemia, T Cell, HTLV II Associated
% 213.05/213.24  |- skos__altLabel mesh__D015446 HTLV-II-Associated T-Cell Leukemia
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D015446 2006
% 213.05/213.24  |- skos__historyNote mesh__D015446 Leukemia %28%1984-1988%29%
% 213.05/213.24  |- mesh__recordMaintainer mesh__D015446 ags
% 213.05/213.24  |- skos__altLabel mesh__D015446 Leukemia, Hairy Cell, HTLV II Variant
% 213.05/213.24  |- skos__annotation mesh__D009409
% 213.05/213.24       do not use /util except by MeSH definition   
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D009409 2004
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D009409 2005
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D009409 2000
% 213.05/213.24  |- mesh__dateEstablished mesh__D009409 1974-01-01
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D009409 2003
% 213.05/213.24  |- mesh__recordOriginator mesh__D009409 NLM
% 213.05/213.24  |- skos__prefLabel mesh__D009409 Nerve Crush
% 213.05/213.24  |- mesh__recordAuthorizer mesh__D009409 sjn
% 213.05/213.24  |- rdf__type mesh__D009409sskos__Concept
% 213.05/213.24  |- skos__broader mesh__D009409smesh__D003714
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D009409 2002
% 213.05/213.24  |- mesh__dateCreated mesh__D009409 1999-01-01
% 213.05/213.24  |- mesh__historyNote mesh__D009409 74%28%63%29%   
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D009409 2003A
% 213.05/213.24  |- skos__hiddenLabel mesh__D009409 Crush, Nerve
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D009409 1999
% 213.05/213.24  |- mesh__recordMaintainer mesh__D009409 sjn
% 213.05/213.24  |- mesh__publicMeSHNote mesh__D009409 74   
% 213.05/213.24  |- mesh__dateRevised mesh__D009409 2002-10-23
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D009409 1998
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D009409 2006
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D009409 2001
% 213.05/213.24  |- rdf__type mesh__D001426sskos__Concept
% 213.05/213.24  |- skos__altLabel mesh__D001426 Gene Protein, Bacterial
% 213.05/213.24  |- mesh__recordOriginator mesh__D001426 NLM
% 213.05/213.24  |- skos__prefLabel mesh__D001426 Bacterial Proteins
% 213.05/213.24  |- skos__altLabel mesh__D001426 Bacterial Protein
% 213.05/213.24  |- mesh__recordMaintainer mesh__D001426 DRC
% 213.05/213.24  |- skos__scopeNote mesh__D001426
% 213.05/213.24       Proteins found in any species of bacterium.     
% 213.05/213.24  |- mesh__historyNote mesh__D001426
% 213.05/213.24       GENE PROTEINS, BACTERIAL was %28%NM%29% 1981-93   
% 213.05/213.24  |- mesh__dateCreated mesh__D001426 1999-01-01
% 213.05/213.24  |- skos__altLabel mesh__D001426 Gene Products, Bacterial
% 213.05/213.24  |- skos__altLabel mesh__D001426 Proteins, Bacterial
% 213.05/213.24  |- skos__altLabel mesh__D001426 Protein, Bacterial
% 213.05/213.24  |- skos__altLabel mesh__D001426 Bacterial Gene Products
% 213.05/213.24  |- mesh__dateRevised mesh__D001426 2005-06-30
% 213.05/213.24  |- skos__annotation mesh__D001426
% 213.05/213.24       /drug eff /ultrastruct permitted; /physiol permitted for function within the bacterium; coord IM with specific protein %28%IM%29% + specific bacterium %28%IM%29%; BACTERIAL OUTER MEMBRANE PROTEINS is also available; DF: BACT PROTEINS%A%  
% 213.05/213.24  |- skos__altLabel mesh__D001426 Bacterial Gene Proteins
% 213.05/213.24  |- mesh__recordAuthorizer mesh__D001426 sjn
% 213.05/213.24  |- skos__altLabel mesh__D001426 Bacterial Gene Protein
% 213.05/213.24  |- skos__altLabel mesh__D001426 Bacterial Gene Product
% 213.05/213.24  |- skos__altLabel mesh__D001426 Gene Product, Bacterial
% 213.05/213.24  |- mesh__onlineNote mesh__D001426
% 213.05/213.24       use BACTERIAL PROTEINS %28%NM%29% to search GENE PROTEINS, BACTERIAL 1981-93%A%  
% 213.05/213.24  |- skos__broader mesh__D001426smesh__D011506
% 213.05/213.24  |- mesh__publicMeSHNote mesh__D001426
% 213.05/213.24       GENE PROTEINS, BACTERIAL was indexed under BACTERIAL PROTEINS 1981-93%A%  
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D001426 2006
% 213.05/213.24  |- skos__altLabel mesh__D001426 Gene Proteins, Bacterial
% 213.05/213.24  |- skos__broader mesh__D011970Q000037smesh__D011970
% 213.05/213.24  |- mesh__preferredCombination mesh__D011970Q000037smesh__D006635
% 213.05/213.24  |- rdf__type mesh__D011970Q000037smesh__CompoundConcept
% 213.05/213.24  |- skos__hiddenLabel mesh__D006111 Disease, Graves%27%
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D006111 2006
% 213.05/213.24  |- skos__broader mesh__D006111smesh__D006042
% 213.05/213.24  |- skos__hiddenLabel mesh__D006111 Disease, Basedow%27%s
% 213.05/213.24  |- skos__altLabel mesh__D006111 Basedow Disease
% 213.05/213.24  |- mesh__dateCreated mesh__D006111 1999-01-01
% 213.05/213.24  |- mesh__publicMeSHNote mesh__D006111
% 213.05/213.24       2006; see GRAVES%27% DISEASE 1987-2005, see GOITER, EXOPHTHALMIC 1963-1986%A%  
% 213.05/213.24  |- skos__altLabel mesh__D006111 Graves%27% Disease
% 213.05/213.24  |- mesh__dateRevised mesh__D006111 2005-06-30
% 213.05/213.24  |- rdf__type mesh__D006111sskos__Concept
% 213.05/213.24  |- skos__scopeNote mesh__D006111
% 213.05/213.24       A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes %28%GRAVES OPHTHALMOPATHY%29% and the skin %28%Graves dermopathy%29%.%A%    
% 213.05/213.24  |- skos__hiddenLabel mesh__D006111 Basedows Disease
% 213.05/213.24  |- skos__altLabel mesh__D006111 Goiter, Exophthalmic
% 213.05/213.24  |- mesh__recordMaintainer mesh__D006111 lkt
% 213.05/213.24  |- skos__prefLabel mesh__D006111 Graves Disease
% 213.05/213.24  |- skos__hiddenLabel mesh__D006111 Exophthalmic Goiters
% 213.05/213.24  |- skos__broader mesh__D006111smesh__D001327
% 213.05/213.24  |- skos__hiddenLabel mesh__D006111 Disease, Graves
% 213.05/213.24  |- skos__hiddenLabel mesh__D006111 Goiters, Exophthalmic
% 213.05/213.24  |- skos__broader mesh__D006111smesh__D006980
% 213.05/213.24  |- skos__altLabel mesh__D006111 Exophthalmic Goiter
% 213.05/213.24  |- skos__altLabel mesh__D006111 Basedow%27%s Disease
% 213.05/213.24  |- skos__broader mesh__D006111smesh__D005094
% 213.05/213.24  |- skos__hiddenLabel mesh__D006111 Disease, Basedow
% 213.05/213.24  |- skos__annotation mesh__D006111
% 213.05/213.24       GRAVES OPHTHALMOPATHY is also available   
% 213.05/213.24  |- mesh__recordOriginator mesh__D006111 NLM
% 213.05/213.24  |- mesh__recordAuthorizer mesh__D006111 sjn
% 213.05/213.24  |- mesh__historyNote mesh__D006111
% 213.05/213.24       2006 %28%1987%29%; use GOITER, EXOPHTHALMIC 1963-1986   
% 213.05/213.24  |- skos__prefLabel mesh__D047528 Stichopus
% 213.05/213.24  |- mesh__dateEstablished mesh__D047528 2005-01-01
% 213.05/213.24  |- mesh__publicMeSHNote mesh__D047528 2005   
% 213.05/213.24  |- skos__historyNote mesh__D047528 Echinodermata %28%1971-1990%29%
% 213.05/213.24  |- mesh__recordAuthorizer mesh__D047528 sjn
% 213.05/213.24  |- skos__broader mesh__D047528smesh__D012616
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D047528 2005
% 213.05/213.24  |- mesh__recordOriginator mesh__D047528 ags
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D047528 2006
% 213.05/213.24  |- mesh__historyNote mesh__D047528 2005   
% 213.05/213.24  |- skos__scopeNote mesh__D047528
% 213.05/213.24       A genus of very large, epibenthic SEA CUCUMBERS in the family Stichopodidae, commercially harvested in Southeast Asia for food.%A%    
% 213.05/213.24  |- rdf__type mesh__D047528sskos__Concept
% 213.05/213.24  |- mesh__dateCreated mesh__D047528 2004-07-07
% 213.05/213.24  |- skos__altLabel mesh__D047528 Apostichopus japonicus
% 213.05/213.24  |- mesh__recordMaintainer mesh__D047528 ags
% 213.05/213.24  |- skos__historyNote mesh__D047528 Sea Cucumbers %28%1980-2004%29%
% 213.05/213.24  |- rdf__type mesh__D019837sskos__Concept
% 213.05/213.24  |- skos__altLabel mesh__D019837 Ryanodine Receptor
% 213.05/213.24  |- skos__hiddenLabel mesh__D019837 Ca Release Channel Ryanodine Receptor
% 213.05/213.24  |- mesh__dateRevised mesh__D019837 2005-06-30
% 213.05/213.24  |- skos__altLabel mesh__D019837 Ca Release Channel-Ryanodine Receptor
% 213.05/213.24  |- mesh__publicMeSHNote mesh__D019837
% 213.05/213.24       98; CALCIUM-RYANODINE RECEPTOR COMPLEX %28%now RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL%29% was indexed under CALCIUM CHANNELS 1988-97, MUSCLE PROTEINS 1993-97, %26% RECEPTORS, CHOLINERGIC 1985-92%A%  
% 213.05/213.24  |- skos__hiddenLabel mesh__D019837 Receptor Complex, Calcium-Ryanodine
% 213.05/213.24  |- skos__prefLabel mesh__D019837 Ryanodine Receptor Calcium Release Channel
% 213.05/213.24  |- skos__historyNote mesh__D019837 Calcium Channels %28%1988-1997%29%
% 213.05/213.24  |- skos__altLabel mesh__D019837 Calcium-Ryanodine Receptor Complex
% 213.05/213.24  |- skos__broader mesh__D019837smesh__D009124
% 213.05/213.24  |- mesh__dateEstablished mesh__D019837 1998-01-01
% 213.05/213.24  |- skos__historyNote mesh__D019837 Receptors, Cholinergic %28%1985-1992%29%
% 213.05/213.24  |- skos__broader mesh__D019837smesh__D015220
% 213.05/213.24  |- mesh__historyNote mesh__D019837
% 213.05/213.24       98; use RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL %28%NM%29% 1985-97%A%  
% 213.05/213.24  |- mesh__dateCreated mesh__D019837 1997-06-20
% 213.05/213.24  |- skos__altLabel mesh__D019837 Receptor, Ryanodine
% 213.05/213.24  |- mesh__recordOriginator mesh__D019837 KEV
% 213.05/213.24  |- skos__hiddenLabel mesh__D019837 Complex, Calcium-Ryanodine Receptor
% 213.05/213.24  |- skos__scopeNote mesh__D019837
% 213.05/213.24       Protein complexes that mediate the release of calcium from the sarcoplasmic reticulum in both skeletal and cardiac muscle cells by forming tetrametric complexes. These complexes each then act as a calcium channel. There are three isoforms of the RyR: RyR1, RyR2, and RyR3. RyR1 is specifically expressed in skeletal muscles and RyR2 in cardiac muscles. RyR3 is yet another isoform found in non-muscle cells such as neuronal cells. %28%From Yonsei Med J 1996;37%28%1%29%:72-80%29%%A%    
% 213.05/213.24  |- mesh__recordMaintainer mesh__D019837 SYSTEM
% 213.05/213.24  |- skos__hiddenLabel mesh__D019837 Calcium Ryanodine Receptor Complex
% 213.05/213.24  |- mesh__recordAuthorizer mesh__D019837 sjn
% 213.05/213.24  |- skos__historyNote mesh__D019837 Muscle Proteins %28%1993-1997%29%
% 213.05/213.24  |- skos__hiddenLabel mesh__D019837 Receptors, Ryanodine
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D019837 2006
% 213.05/213.24  |- rdf__type mesh__D011854sskos__Concept
% 213.05/213.24  |- mesh__publicMeSHNote mesh__D011854 66   
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011854 1994
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011854 1998
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011854 2000
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011854 1996
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011854 1995
% 213.05/213.24  |- mesh__dateEstablished mesh__D011854 1966-01-01
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011854 1993
% 213.05/213.24  |- skos__broader mesh__D011854smesh__D002627
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011854 2005
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011854 1999
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011854 2001
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011854 2003
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011854 1997
% 213.05/213.24  |- mesh__dateRevised mesh__D011854 1992-06-25
% 213.05/213.24  |- mesh__historyNote mesh__D011854 66   
% 213.05/213.24  |- skos__annotation mesh__D011854
% 213.05/213.24       as IM, use SPEC qualif; as NIM no qualif   
% 213.05/213.24  |- mesh__recordOriginator mesh__D011854 NLM
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011854 2006
% 213.05/213.24  |- skos__hiddenLabel mesh__D011854 Radiochemistries
% 213.05/213.24  |- mesh__recordMaintainer mesh__D011854 PLS
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011854 2002
% 213.05/213.24  |- skos__prefLabel mesh__D011854 Radiochemistry
% 213.05/213.24  |- mesh__recordAuthorizer mesh__D011854 PLS
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011854 2004
% 213.05/213.24  |- mesh__dateCreated mesh__D011854 1999-01-01
% 213.05/213.24  |- skos__related mesh__D019039smesh__D013915
% 213.05/213.24  |- skos__hiddenLabel mesh__D019039 Glycoproteins IIb IIIa
% 213.05/213.24  |- skos__altLabel mesh__D019039 GPIIb-IIIa Receptors
% 213.05/213.24  |- mesh__publicMeSHNote mesh__D019039
% 213.05/213.24       1996; see PLATELET MEMBRANE GLYCOPROTEINS 1987-95;  INTEGRIN ALPHAIIBBETA3 was indexed under INTEGRINS 1992-95%A%  
% 213.05/213.24  |- skos__historyNote mesh__D019039
% 213.05/213.24       Platelet Membrane Glycoproteins %28%1987-1995%29%
% 213.05/213.24  |- mesh__recordAuthorizer mesh__D019039 sjn
% 213.05/213.24  |- skos__hiddenLabel mesh__D019039 Integrin alpha IIb beta 3
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D019039 2004
% 213.05/213.24  |- mesh__historyNote mesh__D019039
% 213.05/213.24       1996%28%1987%29%; use INTEGRIN ALPHAIIBBETA3 %28%NM%29% 1992-1995   
% 213.05/213.24  |- mesh__recordMaintainer mesh__D019039 jmp
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D019039 2005
% 213.05/213.24  |- skos__altLabel mesh__D019039 Integrin alphaIIbbeta3
% 213.05/213.24  |- mesh__dateCreated mesh__D019039 1995-05-26
% 213.05/213.24  |- skos__broader mesh__D019039smesh__D016024
% 213.05/213.24  |- skos__scopeNote mesh__D019039
% 213.05/213.24       Platelet membrane glycoprotein complex important for platelet adhesion and aggregation. It is an integrin complex containing INTEGRIN ALPHAIIB and INTEGRIN BETA3 which recognizes the arginine-glycine-aspartic acid %28%RGD%29% sequence present on several adhesive proteins. As such, it is a receptor for FIBRINOGEN; VON WILLEBRAND FACTOR; FIBRONECTIN; VITRONECTIN; and THROMBOSPONDINS. A deficiency of GPIIb-IIIa results in GLANZMANN THROMBASTHENIA.%A%    
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D019039 2006
% 213.05/213.24  |- mesh__dateRevised mesh__D019039 2003-07-09
% 213.05/213.24  |- skos__prefLabel mesh__D019039 Platelet Glycoprotein GPIIb-IIIa Complex
% 213.05/213.24  |- rdf__type mesh__D019039sskos__Concept
% 213.05/213.24  |- mesh__recordOriginator mesh__D019039 AGS
% 213.05/213.24  |- skos__altLabel mesh__D019039 Glycoproteins IIb-IIIa
% 213.05/213.24  |- skos__hiddenLabel mesh__D019039 beta-3, Integrin alpha-IIb
% 213.05/213.24  |- skos__hiddenLabel mesh__D019039 Platelet Glycoprotein GPIIb IIIa Complex
% 213.05/213.24  |- skos__historyNote mesh__D019039 Integrins %28%1992-1995%29%
% 213.05/213.24  |- skos__hiddenLabel mesh__D019039 GPIIb IIIa Receptors
% 213.05/213.24  |- skos__altLabel mesh__D019039 Integrin alpha-IIb beta-3
% 213.05/213.24  |- mesh__dateEstablished mesh__D019039 1996-01-01
% 213.05/213.24  |- skos__hiddenLabel mesh__D019039 alphaIIbbeta3, Integrin
% 213.05/213.24  |- skos__broader mesh__D019039smesh__D010980
% 213.05/213.24  |- skos__hiddenLabel mesh__D019039 Receptors, GPIIb-IIIa
% 213.05/213.24  |- skos__scopeNote mesh__D011056
% 213.05/213.24       The units based on political theory and chosen by countries under which their governmental power is organized and administered to their citizens.%A%    
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011056 2002
% 213.05/213.24  |- skos__annotation mesh__D011056 specify geog   
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011056 2003
% 213.05/213.24  |- skos__hiddenLabel mesh__D011056 Political System
% 213.05/213.24  |- mesh__recordAuthorizer mesh__D011056 sjn
% 213.05/213.24  |- mesh__recordMaintainer mesh__D011056 jrf
% 213.05/213.24  |- mesh__recordOriginator mesh__D011056 NLM
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011056 2005
% 213.05/213.24  |- mesh__dateEstablished mesh__D011056 1980-01-01
% 213.05/213.24  |- skos__hiddenLabel mesh__D011056 Systems, Political
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011056 2004
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D011056 2006
% 213.05/213.24  |- mesh__publicMeSHNote mesh__D011056 80   
% 213.05/213.24  |- skos__broader mesh__D011056smesh__D012942
% 213.05/213.24  |- skos__hiddenLabel mesh__D011056 System, Political
% 213.05/213.24  |- skos__prefLabel mesh__D011056 Political Systems
% 213.05/213.24  |- mesh__historyNote mesh__D011056 80; was NON MESH before 1980   
% 213.05/213.24  |- mesh__dateCreated mesh__D011056 1999-01-01
% 213.05/213.24  |- rdf__type mesh__D011056sskos__Concept
% 213.05/213.24  |- mesh__dateRevised mesh__D011056 2001-07-25
% 213.05/213.24  |- skos__historyNote mesh__D011056 Politics %28%1966-1979%29%
% 213.05/213.24  |- mesh__recordMaintainer mesh__D005817 lkt
% 213.05/213.24  |- mesh__recordAuthorizer mesh__D005817 sjn
% 213.05/213.24  |- skos__related mesh__D005817smesh__D016742
% 213.05/213.24  |- skos__broader mesh__D005817smesh__D033142
% 213.05/213.24  |- skos__historyNote mesh__D005817 Eugenics %28%1966-1972%29%
% 213.05/213.24  |- mesh__dateCreated mesh__D005817 1999-01-01
% 213.05/213.24  |- skos__related mesh__D005817smesh__D037001
% 213.05/213.24  |- skos__historyNote mesh__D005817 Counseling %28%1966-1972%29%
% 213.05/213.24  |- skos__altLabel mesh__D005817 Counseling, Genetic
% 213.05/213.24  |- mesh__dateEstablished mesh__D005817 1973-01-01
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D005817 2006
% 213.05/213.24  |- skos__prefLabel mesh__D005817 Genetic Counseling
% 213.05/213.24  |- skos__scopeNote mesh__D005817
% 213.05/213.24       An educational process that provides information and advice to individuals or families about a genetic condition that may affect them. The purpose is to help individuals make informed decisions about marriage, reproduction, and other health management issues based on information about the genetic disease, the available diagnostic tests, and management programs. Psychosocial support is usually offered.%A%    
% 213.05/213.24  |- rdf__type mesh__D005817sskos__Concept
% 213.05/213.24  |- skos__altLabel mesh__D005817 Prenatal Genetic Counseling
% 213.05/213.24  |- mesh__publicMeSHNote mesh__D005817 73   
% 213.05/213.24  |- skos__related mesh__D005817smesh__D005821
% 213.05/213.24  |- mesh__activeMeSHYear mesh__D005817 2005
% 213.05/213.24  |- mesh__dateRevised mesh__D005817 2003-07-09
% 213.05/213.24  |- mesh__historyNote mesh__D005817 73   
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D005817 2004
% 213.05/213.25  |- mesh__recordOriginator mesh__D005817 NLM
% 213.05/213.25  |- skos__hiddenLabel mesh__D005019 Ethers, Ethyl
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D005019 2006
% 213.05/213.25  |- mesh__dateRevised mesh__D005019 1997-06-20
% 213.05/213.25  |- mesh__recordMaintainer mesh__D005019 TGC
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D005019 2003
% 213.05/213.25  |- skos__prefLabel mesh__D005019 Ethyl Ethers
% 213.05/213.25  |- mesh__dateCreated mesh__D005019 1999-01-01
% 213.05/213.25  |- mesh__publicMeSHNote mesh__D005019 74; was ETHYL ETHER 1965-73   
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D005019 2004
% 213.05/213.25  |- mesh__dateEstablished mesh__D005019 1965-01-01
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D005019 1998
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D005019 2000
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D005019 1999
% 213.05/213.25  |- skos__hiddenLabel mesh__D005019 Compounds, Ethoxy
% 213.05/213.25  |- mesh__recordOriginator mesh__D005019 NLM
% 213.05/213.25  |- mesh__onlineNote mesh__D005019
% 213.05/213.25       use ETHYL ETHERS to search ETHYL ETHER 1966-73   
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D005019 2001
% 213.05/213.25  |- mesh__historyNote mesh__D005019 74; was ETHYL ETHER 1965-73   
% 213.05/213.25  |- skos__broader mesh__D005019smesh__D004987
% 213.05/213.25  |- skos__annotation mesh__D005019
% 213.05/213.25       do not confuse with ETHER see ETHER, ETHYL   
% 213.05/213.25  |- rdf__type mesh__D005019sskos__Concept
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D005019 2002
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D005019 2005
% 213.05/213.25  |- mesh__recordAuthorizer mesh__D005019 SJN
% 213.05/213.25  |- skos__scopeNote mesh__D015447
% 213.05/213.25       Lymphocytic leukemia where cells show little differentiation. There are three major subgroups %28%FAB L1, L2, %26% L3%29% based on distinguishing characteristics of the blast cells. Adult and childhood forms of the disease show biological differences as well.%A%    
% 213.05/213.25  |- mesh__publicMeSHNote mesh__D015447
% 213.05/213.25       1989; see LEUKEMIA, LYMPHOBLASTIC 1974-88; for ALL, ADULT see LEUKEMIA, LYMPHOCYTIC, ACUTE 1989-1999%A%  
% 213.05/213.25  |- skos__historyNote mesh__D015447
% 213.05/213.25       Leukemia, Lymphoblastic %28%1967-1988%29%
% 213.05/213.25  |- skos__altLabel mesh__D015447 Lymphoblastic Leukemia, Acute
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D015447 2000
% 213.05/213.25  |- skos__hiddenLabel mesh__D015447 Lymphoblastic Leukemias, Acute
% 213.05/213.25  |- mesh__recordAuthorizer mesh__D015447 sjn
% 213.05/213.25  |- skos__altLabel mesh__D015447 Adult Acute Lymphocytic Leukemia
% 213.05/213.25  |- skos__broader mesh__D015447smesh__D007945
% 213.05/213.25  |- mesh__dateEstablished mesh__D015447 1989-01-01
% 213.05/213.25  |- mesh__recordOriginator mesh__D015447 PLS
% 213.05/213.25  |- skos__altLabel mesh__D015447 Lymphocytic Leukemia, Acute
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D015447 2003
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D015447 2001
% 213.05/213.25  |- skos__hiddenLabel mesh__D015447 Leukemias, Acute Lymphoblastic
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D015447 2005
% 213.05/213.25  |- skos__hiddenLabel mesh__D015447 Lymphocytic Leukemias, Acute
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D015447 2004
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D015447 2006
% 213.05/213.25  |- skos__historyNote mesh__D015447 Leukemia, Lymphocytic %28%1966-1988%29%
% 213.05/213.25  |- skos__altLabel mesh__D015447 Leukemia, Lymphoblastic, Acute
% 213.05/213.25  |- skos__hiddenLabel mesh__D015447 Acute Lymphoblastic Leukemias
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D015447 2002
% 213.05/213.25  |- mesh__dateRevised mesh__D015447 1999-11-03
% 213.05/213.25  |- mesh__dateCreated mesh__D015447 1988-06-09
% 213.05/213.25  |- skos__hiddenLabel mesh__D015447 Leukemias, Acute Lymphocytic
% 213.05/213.25  |- skos__hiddenLabel mesh__D015447 Acute Lymphocytic Leukemia
% 213.05/213.25  |- skos__hiddenLabel mesh__D015447 Acute Lymphoblastic Leukemia
% 213.05/213.25  |- mesh__recordMaintainer mesh__D015447 ags
% 213.05/213.25  |- mesh__historyNote mesh__D015447
% 213.05/213.25       1989; use LEUKEMIA, LYMPHOBLASTIC 1974-88; for ALL, ADULT use LEUKEMIA, LYMPHOCYTIC, ACUTE 1989-1999%A%  
% 213.05/213.25  |- skos__annotation mesh__D015447 GEN or unspecified: prefer specifics   
% 213.05/213.25  |- skos__hiddenLabel mesh__D015447 Leukemia, Acute Lymphocytic
% 213.05/213.25  |- skos__hiddenLabel mesh__D015447 Leukemia, Acute Lymphoblastic
% 213.05/213.25  |- skos__prefLabel mesh__D015447 Leukemia, Lymphocytic, Acute
% 213.05/213.25  |- skos__hiddenLabel mesh__D015447 Acute Lymphocytic Leukemias
% 213.05/213.25  |- rdf__type mesh__D015447sskos__Concept
% 213.05/213.25  |- skos__altLabel mesh__D001427 Toxins, Bacterial
% 213.05/213.25  |- skos__annotation mesh__D001427
% 213.05/213.25       GEN or unspecified: prefer specifics; coord IM with specific bacterium %28%IM%29%; /antag permitted but consider also ANTITOXINS; DF: BACT TOXINS%A%  
% 213.05/213.25  |- skos__historyNote mesh__D001427 Toxins %28%1966-1976%29%
% 213.05/213.25  |- mesh__publicMeSHNote mesh__D001427 77   
% 213.05/213.25  |- mesh__historyNote mesh__D001427 77; was NON MESH before 1977   
% 213.05/213.25  |- mesh__recordMaintainer mesh__D001427 ssb
% 213.05/213.25  |- mesh__dateEstablished mesh__D001427 1977-01-01
% 213.05/213.25  |- skos__scopeNote mesh__D001427
% 213.05/213.25       Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases.%A%    
% 213.05/213.25  |- mesh__recordOriginator mesh__D001427 NLM
% 213.05/213.25  |- skos__historyNote mesh__D001427 Bacteria %28%1966-1976%29%
% 213.05/213.25  |- skos__broader mesh__D001427smesh__D014118
% 213.05/213.25  |- mesh__dateRevised mesh__D001427 2005-06-30
% 213.05/213.25  |- mesh__dateCreated mesh__D001427 1999-01-01
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D001427 2006
% 213.05/213.25  |- skos__prefLabel mesh__D001427 Bacterial Toxins
% 213.05/213.25  |- mesh__recordAuthorizer mesh__D001427 sjn
% 213.05/213.25  |- rdf__type mesh__D001427sskos__Concept
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006910 2000
% 213.05/213.25  |- mesh__recordMaintainer mesh__D006910 TGC
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006910 1995
% 213.05/213.25  |- mesh__recordAuthorizer mesh__D006910 PLS
% 213.05/213.25  |- skos__prefLabel mesh__D006910 Hydroxypropiophenone
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006910 1998
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006910 2004
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006910 1994
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006910 2002
% 213.05/213.25  |- rdf__type mesh__D006910sskos__Concept
% 213.05/213.25  |- mesh__recordOriginator mesh__D006910 NLM
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006910 2003
% 213.05/213.25  |- mesh__dateCreated mesh__D006910 1999-01-01
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006910 1997
% 213.05/213.25  |- mesh__dateRevised mesh__D006910 1992-05-19
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006910 2006
% 213.05/213.25  |- skos__broader mesh__D006910smesh__D011427
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006910 2001
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006910 1993
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006910 1996
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006910 2005
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006910 1999
% 213.05/213.25  |- skos__prefLabel mesh__D006112 Gravitation
% 213.05/213.25  |- skos__hiddenLabel mesh__D006112 Gravities
% 213.05/213.25  |- mesh__dateRevised mesh__D006112 1994-06-07
% 213.05/213.25  |- skos__broader mesh__D006112smesh__D010825
% 213.05/213.25  |- mesh__recordOriginator mesh__D006112 NLM
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006112 2003
% 213.05/213.25  |- mesh__dateCreated mesh__D006112 1999-01-01
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006112 1999
% 213.05/213.25  |- skos__hiddenLabel mesh__D006112 G Forces
% 213.05/213.25  |- skos__scopeNote mesh__D006112
% 213.05/213.25       Acceleration produced by the mutual attraction of two masses, and of magnitude inversely proportional to the square of the distance between the two centers of mass. It is also the force imparted by the earth, moon, or a planet to an object near its surface. %28%From NASA Thesaurus, 1988%29%%A%    
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006112 2000
% 213.05/213.25  |- rdf__type mesh__D006112sskos__Concept
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006112 2004
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006112 2001
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006112 1996
% 213.05/213.25  |- skos__annotation mesh__D006112 no qualif   
% 213.05/213.25  |- skos__related mesh__D006112smesh__D018522
% 213.05/213.25  |- skos__hiddenLabel mesh__D006112 Force, G
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006112 1997
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006112 2005
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006112 1995
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006112 2002
% 213.05/213.25  |- mesh__recordAuthorizer mesh__D006112 PLS
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006112 2006
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006112 1998
% 213.05/213.25  |- mesh__recordMaintainer mesh__D006112 JLS
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D019838 2000
% 213.05/213.25  |- skos__scopeNote mesh__D019838
% 213.05/213.25       General or unspecified injuries to the neck. It includes injuries to the skin, muscles, and other soft tissues of the neck.%A%    
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D019838 2001
% 213.05/213.25  |- skos__annotation mesh__D019838
% 213.05/213.25       GEN or unspecified; restrict to inj of soft tissue; inj of cervical vertebrae = CERVICAL VERTEBRAE /inj; coord IM with specific inj %28%IM%29%; DF: NECK INJ%A%  
% 213.05/213.25  |- skos__prefLabel mesh__D019838 Neck Injuries
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D019838 2003
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D019838 1998
% 213.05/213.25  |- skos__hiddenLabel mesh__D019838 Neck Injury
% 213.05/213.25  |- mesh__dateCreated mesh__D019838 1997-06-20
% 213.05/213.25  |- mesh__publicMeSHNote mesh__D019838 98   
% 213.05/213.25  |- skos__hiddenLabel mesh__D019838 Injury, Neck
% 213.05/213.25  |- mesh__dateEstablished mesh__D019838 1998-01-01
% 213.05/213.25  |- skos__altLabel mesh__D019838 Injuries, Neck
% 213.05/213.25  |- skos__historyNote mesh__D019838 Neck/injuries %28%1966-1997%29%
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D019838 2002
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D019838 2005
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D019838 2004
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D019838 1999
% 213.05/213.25  |- mesh__historyNote mesh__D019838 98   
% 213.05/213.25  |- skos__broader mesh__D019838smesh__D014947
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D019838 2006
% 213.05/213.25  |- rdf__type mesh__D019838sskos__Concept
% 213.05/213.25  |- skos__prefLabel mesh__D011855 Radiodermatitis
% 213.05/213.25  |- mesh__recordOriginator mesh__D011855 NLM
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D011855 1994
% 213.05/213.25  |- mesh__recordAuthorizer mesh__D011855 PLS
% 213.05/213.25  |- mesh__recordMaintainer mesh__D011855 PLS
% 213.05/213.25  |- skos__scopeNote mesh__D011855
% 213.05/213.25       A cutaneous inflammatory reaction occurring as a result of exposure to ionizing radiation.%A%    
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D011855 1998
% 213.05/213.25  |- mesh__historyNote mesh__D011855 66%28%64%29%   
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D011855 1995
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D011855 1993
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D011855 1996
% 213.05/213.25  |- mesh__dateRevised mesh__D011855 1992-05-18
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D011855 1999
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D011855 2005
% 213.05/213.25  |- skos__hiddenLabel mesh__D011855 Dermatitis, Radiation Induced
% 213.05/213.25  |- skos__altLabel mesh__D011855 Dermatitis, Radiation-Induced
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D011855 1997
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D011855 2003
% 213.05/213.25  |- skos__broader mesh__D011855smesh__D011832
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D011855 2006
% 213.05/213.25  |- skos__hiddenLabel mesh__D011855 Radiation Induced Dermatitis
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D011855 2000
% 213.05/213.25  |- skos__broader mesh__D011855smesh__D003872
% 213.05/213.25  |- mesh__dateEstablished mesh__D011855 1966-01-01
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D011855 2004
% 213.05/213.25  |- skos__hiddenLabel mesh__D011855 Dermatitides, Radiation-Induced
% 213.05/213.25  |- mesh__dateCreated mesh__D011855 1999-01-01
% 213.05/213.25  |- skos__altLabel mesh__D011855 Radiation-Induced Dermatitis
% 213.05/213.25  |- skos__annotation mesh__D011855 from ionizing radiation   
% 213.05/213.25  |- rdf__type mesh__D011855sskos__Concept
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D011855 2001
% 213.05/213.25  |- skos__hiddenLabel mesh__D011855 Radiation-Induced Dermatitides
% 213.05/213.25  |- skos__hiddenLabel mesh__D011855 Radiodermatitides
% 213.05/213.25  |- mesh__publicMeSHNote mesh__D011855 66   
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D011855 2002
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D011057 2005
% 213.05/213.25  |- rdf__type mesh__D011057sskos__Concept
% 213.05/213.25  |- skos__hiddenLabel mesh__D011057 Factor, Political
% 213.05/213.25  |- skos__hiddenLabel mesh__D011057 Factors, Political
% 213.05/213.25  |- skos__scopeNote mesh__D011057
% 213.05/213.25       Activities concerned with governmental policies, functions, etc.%A%    
% 213.05/213.25  |- mesh__dateCreated mesh__D011057 1999-01-01
% 213.05/213.25  |- skos__annotation mesh__D011057 specify geog if pertinent   
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D011057 2004
% 213.05/213.25  |- skos__related mesh__D011057smesh__D034462
% 213.05/213.25  |- skos__hiddenLabel mesh__D011057 Political Activities
% 213.05/213.25  |- skos__hiddenLabel mesh__D011057 Activity, Political
% 213.05/213.25  |- skos__hiddenLabel mesh__D011057 Activities, Political
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D011057 2003
% 213.05/213.25  |- skos__broader mesh__D011057smesh__D012942
% 213.05/213.25  |- mesh__recordAuthorizer mesh__D011057 sjn
% 213.05/213.25  |- skos__prefLabel mesh__D011057 Politics
% 213.05/213.25  |- mesh__recordOriginator mesh__D011057 NLM
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D011057 2006
% 213.05/213.25  |- skos__hiddenLabel mesh__D011057 Political Factor
% 213.05/213.25  |- mesh__dateRevised mesh__D011057 2002-07-02
% 213.05/213.25  |- mesh__recordMaintainer mesh__D011057 jrf
% 213.05/213.25  |- mesh__onlineNote mesh__D005818
% 213.05/213.25       use GENETIC ENGINEERING to search GENETIC INTERVENTION 1973-88%A%  
% 213.05/213.25  |- mesh__dateCreated mesh__D005818 1999-01-01
% 213.05/213.25  |- skos__related mesh__D005818smesh__D030781
% 213.05/213.25  |- mesh__recordOriginator mesh__D005818 NLM
% 213.05/213.25  |- skos__altLabel mesh__D005818 Engineering, Genetic
% 213.05/213.25  |- mesh__recordMaintainer mesh__D005818 jls
% 213.05/213.25  |- skos__hiddenLabel mesh__D005818 Genetic Interventions
% 213.05/213.25  |- mesh__recordAuthorizer mesh__D005818 sjn
% 213.05/213.25  |- mesh__publicMeSHNote mesh__D005818
% 213.05/213.25       89; was GENETIC INTERVENTION 1973-88; was in Cat E %26% G 1973-79%A%  
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D005818 2006
% 213.05/213.25  |- skos__altLabel mesh__D005818 Genetic Intervention
% 213.05/213.25  |- rdf__type mesh__D005818sskos__Concept
% 213.05/213.25  |- mesh__historyNote mesh__D005818
% 213.05/213.25       89; was GENETIC INTERVENTION 1973-88; was in Cat E %26% G 1973-79%A%  
% 213.05/213.25  |- skos__historyNote mesh__D005818 Eugenics %28%1966-1972%29%
% 213.05/213.25  |- skos__related mesh__D005818smesh__D030821
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D005818 2005
% 213.05/213.25  |- skos__related mesh__D005818smesh__D030801
% 213.05/213.25  |- mesh__dateEstablished mesh__D005818 1973-01-01
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D005818 2002
% 213.05/213.25  |- skos__annotation mesh__D005818 DF: GENET ENGINEERING   
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D005818 2004
% 213.05/213.25  |- skos__scopeNote mesh__D005818
% 213.05/213.25       Directed modification of the gene complement of a living organism by such techniques as altering the DNA, substituting genetic material by means of a virus, transplanting whole nuclei, transplanting cell hybrids, etc.%A%    
% 213.05/213.25  |- skos__historyNote mesh__D005818 Genetics, Medical %28%1966-1972%29%
% 213.05/213.25  |- skos__related mesh__D005818smesh__D015202
% 213.05/213.25  |- skos__related mesh__D005818smesh__D005307
% 213.05/213.25  |- skos__altLabel mesh__D005818 Intervention, Genetic
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D005818 2003
% 213.05/213.25  |- skos__related mesh__D005818smesh__D004274
% 213.05/213.25  |- skos__broader mesh__D005818smesh__D005821
% 213.05/213.25  |- skos__related mesh__D005818smesh__D008822
% 213.05/213.25  |- skos__prefLabel mesh__D005818 Genetic Engineering
% 213.05/213.25  |- skos__hiddenLabel mesh__D005818 Interventions, Genetic
% 213.05/213.25  |- skos__related mesh__D005818smesh__D018345
% 213.05/213.25  |- mesh__dateRevised mesh__D005818 2001-07-25
% 213.05/213.25  |- mesh__dateEstablished mesh__D016540 1992-01-01
% 213.05/213.25  |- skos__historyNote mesh__D016540
% 213.05/213.25       Smoking/prevention %26% control %28%1968-1991%29%
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D016540 2006
% 213.05/213.25  |- skos__hiddenLabel mesh__D016540 Cessations, Smoking
% 213.05/213.25  |- skos__broader mesh__D016540smesh__D020340
% 213.05/213.25  |- skos__historyNote mesh__D016540 Smoking/therapy %28%1972-1991%29%
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D016540 2004
% 213.05/213.25  |- mesh__recordAuthorizer mesh__D016540 sjn
% 213.05/213.25  |- mesh__dateCreated mesh__D016540 1991-06-21
% 213.05/213.25  |- skos__prefLabel mesh__D016540 Smoking Cessation
% 213.05/213.25  |- mesh__recordMaintainer mesh__D016540 sjn
% 213.05/213.25  |- rdf__type mesh__D016540sskos__Concept
% 213.05/213.25  |- skos__hiddenLabel mesh__D016540 Smoking Cessations
% 213.05/213.25  |- skos__annotation mesh__D016540
% 213.05/213.25       TOBACCO USE CESSATION is also available   
% 213.05/213.25  |- skos__scopeNote mesh__D016540
% 213.05/213.25       Discontinuation of the habit of smoking, the inhaling and exhaling of tobacco smoke.%A%    
% 213.05/213.25  |- skos__hiddenLabel mesh__D016540 Cessation, Smoking
% 213.05/213.25  |- mesh__publicMeSHNote mesh__D016540 92   
% 213.05/213.25  |- mesh__dateRevised mesh__D016540 2002-08-01
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D016540 2005
% 213.05/213.25  |- mesh__historyNote mesh__D016540 92   
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D016540 2003
% 213.05/213.25  |- mesh__recordOriginator mesh__D016540 AGS
% 213.05/213.25  |- skos__hiddenLabel mesh__D002520 World Monkey, Old
% 213.05/213.25  |- skos__hiddenLabel mesh__D002520 Catarrhinas
% 213.05/213.25  |- skos__hiddenLabel mesh__D002520 Presbyti
% 213.05/213.25  |- skos__hiddenLabel mesh__D002520 Talapoin Monkeys
% 213.05/213.25  |- skos__altLabel mesh__D002520 Monkeys, Old World
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D002520 2006
% 213.05/213.25  |- skos__scopeNote mesh__D002520
% 213.05/213.25       The family of Old World monkeys and baboons consisting of two subfamilies: CERCOPITHECINAE and COLOBINAE. They are found in Africa and part of Asia.%A%    
% 213.05/213.25  |- mesh__recordOriginator mesh__D002520 EC
% 213.05/213.25  |- skos__hiddenLabel mesh__D002520 Pygathrices
% 213.05/213.25  |- mesh__historyNote mesh__D002520 81   
% 213.05/213.25  |- skos__hiddenLabel mesh__D002520 Monkey, Old World
% 213.05/213.25  |- skos__hiddenLabel mesh__D002520 Miopithecus talapoins
% 213.05/213.25  |- mesh__recordAuthorizer mesh__D002520 sjn
% 213.05/213.25  |- mesh__publicMeSHNote mesh__D002520 81   
% 213.05/213.25  |- skos__hiddenLabel mesh__D002520 Monkeys, Talapoin
% 213.05/213.25  |- skos__altLabel mesh__D002520 Langurs
% 213.05/213.25  |- mesh__recordMaintainer mesh__D002520 ags
% 213.05/213.25  |- mesh__dateRevised mesh__D002520 2005-06-30
% 213.05/213.25  |- skos__hiddenLabel mesh__D002520 Old World Monkeys
% 213.05/213.25  |- skos__hiddenLabel mesh__D002520 Langur
% 213.05/213.25  |- skos__altLabel mesh__D002520 Miopithecus talapoin
% 213.05/213.25  |- skos__broader mesh__D002520smesh__D051079
% 213.05/213.25  |- mesh__dateCreated mesh__D002520 1980-05-07
% 213.05/213.25  |- skos__hiddenLabel mesh__D002520 talapoin, Miopithecus
% 213.05/213.25  |- rdf__type mesh__D002520sskos__Concept
% 213.05/213.25  |- skos__hiddenLabel mesh__D002520 talapoins, Miopithecus
% 213.05/213.25  |- skos__hiddenLabel mesh__D002520 World Monkeys, Old
% 213.05/213.25  |- skos__annotation mesh__D002520
% 213.05/213.25       a family of Old World monkeys: do not confuse with CERCOPITHECINAE, a subfamily; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 213.05/213.25  |- skos__prefLabel mesh__D002520 Cercopithecidae
% 213.05/213.25  |- skos__hiddenLabel mesh__D002520 Talapoin Monkey
% 213.05/213.25  |- skos__hiddenLabel mesh__D002520 Old World Monkey
% 213.05/213.25  |- mesh__dateEstablished mesh__D002520 1981-01-01
% 213.05/213.25  |- skos__broader mesh__D006225Q000002smesh__D006225
% 213.05/213.25  |- mesh__preferredCombination mesh__D006225Q000002smesh__D006228
% 213.05/213.25  |- rdf__type mesh__D006225Q000002smesh__CompoundConcept
% 213.05/213.25  |- mesh__recordOriginator mesh__D015448 PLS
% 213.05/213.25  |- skos__hiddenLabel mesh__D015448 Leukemia, B-Cell Lymphocytic
% 213.05/213.25  |- mesh__recordAuthorizer mesh__D015448 SJN
% 213.05/213.25  |- mesh__dateRevised mesh__D015448 1997-06-20
% 213.05/213.25  |- skos__hiddenLabel mesh__D015448 B-Cell Leukemias
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D015448 2001
% 213.05/213.25  |- skos__altLabel mesh__D015448 B-Lymphocytic Leukemia
% 213.05/213.25  |- mesh__publicMeSHNote mesh__D015448 89   
% 213.05/213.25  |- skos__prefLabel mesh__D015448 Leukemia, B-Cell
% 213.05/213.25  |- skos__hiddenLabel mesh__D015448 Leukemias, B-Cell Lymphocytic
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D015448 1999
% 213.05/213.25  |- mesh__dateEstablished mesh__D015448 1989-01-01
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D015448 2000
% 213.05/213.25  |- skos__hiddenLabel mesh__D015448 B Lymphocytic Leukemia
% 213.05/213.25  |- skos__historyNote mesh__D015448 B Lymphocytes %28%1973-1988%29%
% 213.05/213.25  |- mesh__historyNote mesh__D015448 89   
% 213.05/213.25  |- skos__hiddenLabel mesh__D015448 Leukemia, B-Lymphocytic
% 213.05/213.25  |- skos__hiddenLabel mesh__D015448 B-Lymphocytic Leukemias
% 213.05/213.25  |- skos__hiddenLabel mesh__D015448 Lymphocytic Leukemias, B-Cell
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D015448 1998
% 213.05/213.25  |- skos__altLabel mesh__D015448 Leukemia, Lymphocytic, B Cell
% 213.05/213.25  |- mesh__recordMaintainer mesh__D015448 PXP
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D015448 2006
% 213.05/213.25  |- skos__hiddenLabel mesh__D015448 B-Cell Lymphocytic Leukemia
% 213.05/213.25  |- skos__historyNote mesh__D015448 Leukemia, Lymphocytic %28%1966-1988%29%
% 213.05/213.25  |- skos__hiddenLabel mesh__D015448 Leukemias, B-Lymphocytic
% 213.05/213.25  |- mesh__dateCreated mesh__D015448 1988-06-09
% 213.05/213.25  |- skos__hiddenLabel mesh__D015448 Leukemias, B-Cell
% 213.05/213.25  |- skos__hiddenLabel mesh__D015448 Leukemia, B Cell
% 213.05/213.25  |- skos__hiddenLabel mesh__D015448 Lymphocytic Leukemia, B Cell
% 213.05/213.25  |- skos__hiddenLabel mesh__D015448 B-Cell Lymphocytic Leukemias
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D015448 2005
% 213.05/213.25  |- skos__annotation mesh__D015448
% 213.05/213.25       GEN or unspecified: prefer specifics; do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D015448 2004
% 213.05/213.25  |- rdf__type mesh__D015448sskos__Concept
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D015448 2002
% 213.05/213.25  |- skos__altLabel mesh__D015448 Lymphocytic Leukemia, B-Cell
% 213.05/213.25  |- skos__altLabel mesh__D015448 B-Cell Leukemia
% 213.05/213.25  |- skos__altLabel mesh__D015448 Leukemia, Lymphocytic, B-Cell
% 213.05/213.25  |- skos__broader mesh__D015448smesh__D007945
% 213.05/213.25  |- skos__hiddenLabel mesh__D015448 B Cell Leukemia
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D015448 2003
% 213.05/213.25  |- skos__altLabel mesh__D001428 Bacterin
% 213.05/213.25  |- mesh__recordAuthorizer mesh__D001428 sjn
% 213.05/213.25  |- skos__altLabel mesh__D001428 Bacterial Vaccine
% 213.05/213.25  |- skos__annotation mesh__D001428
% 213.05/213.25       for specifics not indented here coord IM with specific bacterium /immunol %28%IM%29%; DF: BACT VACCINES%A%  
% 213.05/213.25  |- skos__broader mesh__D001428smesh__D014612
% 213.05/213.25  |- skos__altLabel mesh__D001428 Vaccine, Bacterial
% 213.05/213.25  |- skos__scopeNote mesh__D001428
% 213.05/213.25       Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease.%A%    
% 213.05/213.25  |- skos__altLabel mesh__D001428 Vaccines, Bacterial
% 213.05/213.25  |- mesh__dateEstablished mesh__D001428 1965-01-01
% 213.05/213.25  |- mesh__historyNote mesh__D001428 65   
% 213.05/213.25  |- mesh__dateCreated mesh__D001428 1999-01-01
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D001428 2006
% 213.05/213.25  |- mesh__publicMeSHNote mesh__D001428 65   
% 213.05/213.25  |- mesh__recordMaintainer mesh__D001428 ssb
% 213.05/213.25  |- mesh__recordOriginator mesh__D001428 NLM
% 213.05/213.25  |- rdf__type mesh__D001428sskos__Concept
% 213.05/213.25  |- skos__prefLabel mesh__D001428 Bacterial Vaccines
% 213.05/213.25  |- mesh__dateRevised mesh__D001428 2005-06-30
% 213.05/213.25  |- skos__prefLabel mesh__D012150 Polymorphism, Restriction Fragment Length
% 213.05/213.25  |- skos__historyNote mesh__D012150 Chromosome Mapping %28%1971-1986%29%
% 213.05/213.25  |- mesh__publicMeSHNote mesh__D012150
% 213.05/213.25       95; was RESTRICTION FRAGMENT LENGTH POLYMORPHISMS 1987-94 %28%see under POLYMORPHISM %28%GENETICS%29% 1987-89%29%%A%  
% 213.05/213.25  |- mesh__dateCreated mesh__D012150 1986-06-18
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D012150 2004
% 213.05/213.25  |- skos__historyNote mesh__D012150 Genes, Structural %28%1977-1986%29%
% 213.05/213.25  |- skos__related mesh__D012150smesh__D016172
% 213.05/213.25  |- skos__historyNote mesh__D012150 DNA %28%1966-1971%29%
% 213.05/213.25  |- skos__altLabel mesh__D012150 RFLP
% 213.05/213.25  |- skos__historyNote mesh__D012150
% 213.05/213.25       DNA Restriction Enzymes %28%1979-1986%29%
% 213.05/213.25  |- skos__scopeNote mesh__D012150
% 213.05/213.25       Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment.%A%    
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D012150 2006
% 213.05/213.25  |- mesh__dateEstablished mesh__D012150 1990-01-01
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D012150 2003
% 213.05/213.25  |- mesh__recordMaintainer mesh__D012150 ags
% 213.05/213.25  |- mesh__dateRevised mesh__D012150 2002-07-03
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D012150 2005
% 213.05/213.25  |- mesh__recordOriginator mesh__D012150 SCD
% 213.05/213.25  |- rdf__type mesh__D012150sskos__Concept
% 213.05/213.25  |- mesh__onlineNote mesh__D012150
% 213.05/213.25       use POLYMORPHISM, RESTRICTION FRAGMENT LENGTH to search for RESTRICTION FRAGMENT LENGTH POLYMORPHISMS 1987-94%A%  
% 213.05/213.25  |- skos__historyNote mesh__D012150
% 213.05/213.25       Polymorphism %28%Genetics%29% %28%1980-1986%29%
% 213.05/213.25  |- mesh__historyNote mesh__D012150
% 213.05/213.25       95; was RESTRICTION FRAGMENT LENGTH POLYMORPHISMS 1987-94 %28%see under POLYMORPHISM %28%GENETICS%29% 1987-89%29%%A%  
% 213.05/213.25  |- skos__related mesh__D012150smesh__D009154
% 213.05/213.25  |- skos__historyNote mesh__D012150 Endonucleases %28%1975-1977%29%
% 213.05/213.25  |- mesh__recordAuthorizer mesh__D012150 sjn
% 213.05/213.25  |- skos__altLabel mesh__D012150 Restriction Fragment Length Polymorphism
% 213.05/213.25  |- skos__broader mesh__D012150smesh__D011110
% 213.05/213.25  |- mesh__dateCreated mesh__D006911 1974-11-19
% 213.05/213.25  |- skos__prefLabel mesh__D006911 Hydroxyprostaglandin Dehydrogenases
% 213.05/213.25  |- mesh__dateRevised mesh__D006911 2003-07-09
% 213.05/213.25  |- skos__annotation mesh__D006911 DF: HYDROXYPG DEHYDROGENASES   
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006911 2004
% 213.05/213.25  |- skos__hiddenLabel mesh__D006911 Dehydrogenases, Hydroxyprostaglandin
% 213.05/213.25  |- skos__scopeNote mesh__D006911
% 213.05/213.25       Catalyzes reversibly the oxidation of hydroxyl groups of prostaglandins.%A%    
% 213.05/213.25  |- rdf__type mesh__D006911sskos__Concept
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006911 2005
% 213.05/213.25  |- skos__historyNote mesh__D006911
% 213.05/213.25       Alcohol Oxidoreductases %28%1966-1977%29%
% 213.05/213.25  |- skos__altLabel mesh__D006911 Prostacyclin Dehydrogenase
% 213.05/213.25  |- skos__historyNote mesh__D006911 Prostaglandins %28%1966-1974%29%
% 213.05/213.25  |- mesh__activeMeSHYear mesh__D006911 2006
% 213.05/213.25  |- mesh__recordMaintainer mesh__D006911 ssb
% 213.05/213.25  |- skos__altLabel mesh__D006911 Hydroxyprostaglandin Dehydrogenase
% 213.05/213.26  |- skos__broader mesh__D006911smesh__D000429
% 213.05/213.26  |- mesh__publicMeSHNote mesh__D006911
% 213.05/213.26       78; was see under ALCOHOL OXIDOREDUCTASES 1975-77   
% 213.05/213.26  |- mesh__recordOriginator mesh__D006911 NLM
% 213.05/213.26  |- mesh__dateEstablished mesh__D006911 1978-01-01
% 213.05/213.26  |- skos__hiddenLabel mesh__D006911 Dehydrogenase, Hydroxyprostaglandin
% 213.05/213.26  |- skos__hiddenLabel mesh__D006911 Dehydrogenase, Prostacyclin
% 213.05/213.26  |- mesh__historyNote mesh__D006911
% 213.05/213.26       78%28%75%29%; was see under ALCOHOL OXIDOREDUCTASES 1975-77   
% 213.05/213.26  |- mesh__recordAuthorizer mesh__D006911 sjn
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006113 2004
% 213.05/213.26  |- rdf__type mesh__D006113sskos__Concept
% 213.05/213.26  |- skos__broader mesh__D006113smesh__D005060
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006113 2002
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006113 2005
% 213.05/213.26  |- mesh__recordOriginator mesh__D006113 NLM
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006113 2006
% 213.05/213.26  |- mesh__recordAuthorizer mesh__D006113 sjn
% 213.05/213.26  |- mesh__recordMaintainer mesh__D006113 mdb
% 213.05/213.26  |- mesh__dateCreated mesh__D006113 1999-01-01
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006113 2003
% 213.05/213.26  |- skos__annotation mesh__D006113
% 213.05/213.26       = ENGLAND; SCOTLAND %26% WALES strictly speaking; UNITED KINGDOM = GREAT BRITAIN + NORTHERN IRELAND, strictly speaking; available also are CHANNEL ISLANDS %28%see there for available X refs%29% %26% HEBRIDES%A%  
% 213.05/213.26  |- mesh__dateRevised mesh__D006113 2001-07-25
% 213.05/213.26  |- skos__prefLabel mesh__D006113 Great Britain
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011856 2005
% 213.05/213.26  |- skos__hiddenLabel mesh__D011856 Image Enhancements, Radiographic
% 213.05/213.26  |- mesh__recordMaintainer mesh__D011856 jls
% 213.05/213.26  |- skos__broader mesh__D011856smesh__D011859
% 213.05/213.26  |- skos__hiddenLabel mesh__D011856 Radiographic Image Enhancements
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011856 2006
% 213.05/213.26  |- mesh__recordAuthorizer mesh__D011856 sjn
% 213.05/213.26  |- skos__hiddenLabel mesh__D011856 Enhancements, Radiographic Image
% 213.05/213.26  |- mesh__dateCreated mesh__D011856 1999-01-01
% 213.05/213.26  |- mesh__dateRevised mesh__D011856 2004-07-07
% 213.05/213.26  |- mesh__recordOriginator mesh__D011856 NLM
% 213.05/213.26  |- rdf__type mesh__D011856sskos__Concept
% 213.05/213.26  |- skos__hiddenLabel mesh__D011856 Enhancement, Radiographic Image
% 213.05/213.26  |- skos__broader mesh__D011856smesh__D007089
% 213.05/213.26  |- mesh__publicMeSHNote mesh__D011856 74   
% 213.05/213.26  |- mesh__historyNote mesh__D011856 74   
% 213.05/213.26  |- skos__scopeNote mesh__D011856
% 213.05/213.26       Improvement in the quality of an x-ray image by use of an intensifying screen, tube, or filter and by optimum exposure techniques. Digital processing methods are often employed.%A%    
% 213.05/213.26  |- skos__prefLabel mesh__D011856 Radiographic Image Enhancement
% 213.05/213.26  |- skos__altLabel mesh__D011856 Image Enhancement, Radiographic
% 213.05/213.26  |- skos__altLabel mesh__D011856 Radiography, Digital
% 213.05/213.26  |- mesh__dateEstablished mesh__D011856 1974-01-01
% 213.05/213.26  |- skos__related mesh__D011856smesh__D014963
% 213.05/213.26  |- mesh__dateCreated mesh__D011058 1999-01-01
% 213.05/213.26  |- skos__scopeNote mesh__D011058
% 213.05/213.26       The male fertilizing element of flowering PLANTS analogous to sperm in animals. It is released from the anthers as a dust, to be carried by insect or other vectors, including wind, to the ovary %28%stigma%29% of other FLOWERS to produce the embryo enclosed by the seed. The pollens of many plants are allergenic.%A%    
% 213.05/213.26  |- skos__annotation mesh__D011058
% 213.05/213.26       coord with specific PLANTS term; pollen as an allergen: coord IM with ALLERGENS %28%IM%29%; hypersensitivity: consider RESPIRATORY HYPERSENSITIVITY and its specifics particularly RHINITIS, ALLERGIC, SEASONAL%A%  
% 213.05/213.26  |- skos__related mesh__D011058smesh__D006255
% 213.05/213.26  |- skos__related mesh__D011058smesh__D000485
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011058 2006
% 213.05/213.26  |- skos__broader mesh__D011058smesh__D035264
% 213.05/213.26  |- skos__prefLabel mesh__D011058 Pollen
% 213.05/213.26  |- mesh__recordMaintainer mesh__D011058 sjn
% 213.05/213.26  |- mesh__dateRevised mesh__D011058 2005-07-01
% 213.05/213.26  |- rdf__type mesh__D011058sskos__Concept
% 213.05/213.26  |- mesh__recordOriginator mesh__D011058 NLM
% 213.05/213.26  |- mesh__recordAuthorizer mesh__D011058 sjn
% 213.05/213.26  |- mesh__dateCreated mesh__D005819 1979-05-24
% 213.05/213.26  |- mesh__publicMeSHNote mesh__D005819 89; was GENETIC MARKER 1980-88   
% 213.05/213.26  |- skos__hiddenLabel mesh__D005819 Chromosome Marker
% 213.05/213.26  |- mesh__historyNote mesh__D005819 89; was GENETIC MARKER 1980-88   
% 213.05/213.26  |- skos__historyNote mesh__D005819
% 213.05/213.26       Linkage %28%Genetics%29% %28%1970-1979%29%
% 213.05/213.26  |- skos__scopeNote mesh__D005819
% 213.05/213.26       A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event.%A%    
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D005819 2006
% 213.05/213.26  |- skos__broader mesh__D005819smesh__D015415
% 213.05/213.26  |- skos__historyNote mesh__D005819 Phenotype %28%1968-1979%29%
% 213.05/213.26  |- mesh__recordOriginator mesh__D005819 AEP
% 213.05/213.26  |- rdf__type mesh__D005819sskos__Concept
% 213.05/213.26  |- skos__prefLabel mesh__D005819 Genetic Markers
% 213.05/213.26  |- skos__annotation mesh__D005819
% 213.05/213.26       usually NIM; IM GEN only; coord with specific genetic feature %28%IM%29% if pertinent%A%  
% 213.05/213.26  |- skos__related mesh__D005819smesh__D002874
% 213.05/213.26  |- skos__altLabel mesh__D005819 Markers, Genetic
% 213.05/213.26  |- skos__broader mesh__D005819smesh__D010641
% 213.05/213.26  |- skos__hiddenLabel mesh__D005819 Markers, Chromosome
% 213.05/213.26  |- mesh__recordAuthorizer mesh__D005819 sjn
% 213.05/213.26  |- skos__historyNote mesh__D005819 Recombination, Genetic %28%1968-1979%29%
% 213.05/213.26  |- skos__historyNote mesh__D005819 Chromosome Mapping %28%1966-1979%29%
% 213.05/213.26  |- skos__altLabel mesh__D005819 Marker, Genetic
% 213.05/213.26  |- skos__hiddenLabel mesh__D005819 DNA Marker
% 213.05/213.26  |- skos__altLabel mesh__D005819 DNA Markers
% 213.05/213.26  |- skos__hiddenLabel mesh__D005819 Marker, DNA
% 213.05/213.26  |- mesh__onlineNote mesh__D005819
% 213.05/213.26       use GENETIC MARKERS to search GENETIC MARKER 1980-88   
% 213.05/213.26  |- skos__altLabel mesh__D005819 Genetic Marker
% 213.05/213.26  |- mesh__dateRevised mesh__D005819 2005-06-30
% 213.05/213.26  |- skos__hiddenLabel mesh__D005819 Marker, Chromosome
% 213.05/213.26  |- mesh__dateEstablished mesh__D005819 1980-01-01
% 213.05/213.26  |- mesh__recordMaintainer mesh__D005819 ssb
% 213.05/213.26  |- mesh__dateRevised mesh__D002521 2005-06-30
% 213.05/213.26  |- skos__prefLabel mesh__D002521 Cercopithecus
% 213.05/213.26  |- mesh__publicMeSHNote mesh__D002521 75   
% 213.05/213.26  |- skos__historyNote mesh__D002521 Monkeys %28%1966-1974%29%
% 213.05/213.26  |- skos__broader mesh__D002521smesh__D016663
% 213.05/213.26  |- mesh__dateCreated mesh__D002521 1974-11-11
% 213.05/213.26  |- mesh__historyNote mesh__D002521 75   
% 213.05/213.26  |- skos__annotation mesh__D002521
% 213.05/213.26       Old World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 213.05/213.26  |- rdf__type mesh__D002521sskos__Concept
% 213.05/213.26  |- mesh__recordMaintainer mesh__D002521 ags
% 213.05/213.26  |- mesh__dateEstablished mesh__D002521 1975-09-01
% 213.05/213.26  |- skos__scopeNote mesh__D002521
% 213.05/213.26       A genus of Old World monkeys found in Africa although some species have been introduced into the West Indies. This genus is composed of at least twenty species:  C. AETHIOPS, C. ascanius, C. campbelli, C. cephus, C. denti, C. diana, C. dryas, C. erythrogaster, C. erythrotis, C. hamlyni, C. lhoesti, C. mitis, C. mona, C. neglectus, C. nictitans, C. petaurista, C. pogonias, C. preussi, C. salongo, and C. wolfi.%A%    
% 213.05/213.26  |- mesh__recordOriginator mesh__D002521 NLM
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D002521 2006
% 213.05/213.26  |- mesh__recordAuthorizer mesh__D002521 sjn
% 213.05/213.26  |- skos__scopeNote mesh__D001429
% 213.05/213.26       Pyrrole containing pigments found in photosynthetic bacteria.%A%    
% 213.05/213.26  |- mesh__recordOriginator mesh__D001429 NLM
% 213.05/213.26  |- mesh__publicMeSHNote mesh__D001429
% 213.05/213.26       91; was see under CHLOROPHYLL 1975-90   
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D001429 2006
% 213.05/213.26  |- mesh__dateRevised mesh__D001429 2005-06-30
% 213.05/213.26  |- rdf__type mesh__D001429sskos__Concept
% 213.05/213.26  |- skos__historyNote mesh__D001429 Chlorophyll %28%1974%29%
% 213.05/213.26  |- mesh__historyNote mesh__D001429
% 213.05/213.26       91%28%75%29%; was see under CHLOROPHYLL 1975-90   
% 213.05/213.26  |- mesh__recordAuthorizer mesh__D001429 sjn
% 213.05/213.26  |- mesh__dateEstablished mesh__D001429 1991-01-01
% 213.05/213.26  |- skos__prefLabel mesh__D001429 Bacteriochlorophylls
% 213.05/213.26  |- skos__broader mesh__D001429smesh__D002734
% 213.05/213.26  |- skos__broader mesh__D001429smesh__D020283
% 213.05/213.26  |- mesh__dateCreated mesh__D001429 1974-11-19
% 213.05/213.26  |- mesh__recordMaintainer mesh__D001429 ssb
% 213.05/213.26  |- skos__altLabel mesh__D001429 Bacteriochlorophyll
% 213.05/213.26  |- mesh__dateRevised mesh__D012151 2001-08-13
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D012151 2004
% 213.05/213.26  |- mesh__recordAuthorizer mesh__D012151 sjn
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D012151 2006
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D012151 2003
% 213.05/213.26  |- skos__scopeNote mesh__D012151
% 213.05/213.26       The restoration to life or consciousness of one apparently dead. %28%Dorland, 27th ed%29%%A%    
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D012151 2005
% 213.05/213.26  |- mesh__dateCreated mesh__D012151 1999-01-01
% 213.05/213.26  |- mesh__recordMaintainer mesh__D012151 jls
% 213.05/213.26  |- skos__annotation mesh__D012151
% 213.05/213.26       do not use /util except by MeSH definition; RESUSCITATION is correct translation for French %22%r%C3%%A9%animation%22%%A%  
% 213.05/213.26  |- rdf__type mesh__D012151sskos__Concept
% 213.05/213.26  |- mesh__recordOriginator mesh__D012151 NLM
% 213.05/213.26  |- skos__hiddenLabel mesh__D012151 Resuscitations
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D012151 2002
% 213.05/213.26  |- skos__broader mesh__D012151smesh__D004638
% 213.05/213.26  |- skos__prefLabel mesh__D012151 Resuscitation
% 213.05/213.26  |- skos__historyNote mesh__D006912 Quinolines %28%1966-1974%29%
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006912 2001
% 213.05/213.26  |- mesh__onlineNote mesh__D006912
% 213.05/213.26       use HYDROXYQUINOLINES to search CHINIOFON 1966-82   
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006912 2003
% 213.05/213.26  |- mesh__recordMaintainer mesh__D006912 TWD
% 213.05/213.26  |- skos__scopeNote mesh__D006912
% 213.05/213.26       The 8-hydroxy derivatives inhibit various enzymes and their halogenated derivatives, though neurotoxic, are used as topical anti-infective agents, among other uses.%A%    
% 213.05/213.26  |- rdf__type mesh__D006912sskos__Concept
% 213.05/213.26  |- skos__prefLabel mesh__D006912 Hydroxyquinolines
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006912 2002
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006912 2004
% 213.05/213.26  |- skos__altLabel mesh__D006912 Quinolinols
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006912 2005
% 213.05/213.26  |- mesh__dateRevised mesh__D006912 2000-06-22
% 213.05/213.26  |- skos__broader mesh__D006912smesh__D011804
% 213.05/213.26  |- mesh__publicMeSHNote mesh__D006912
% 213.05/213.26       CHINIOFON, DIIODOHYDROXYQUIN, IODOCHLORHYDROXYQUIN %26% CHLORQUINALDOL were headings 1963-82%A%  
% 213.05/213.26  |- mesh__historyNote mesh__D006912 CHINIOFON was heading 1963-82   
% 213.05/213.26  |- mesh__dateCreated mesh__D006912 1974-11-11
% 213.05/213.26  |- mesh__recordOriginator mesh__D006912 NLM
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006912 2006
% 213.05/213.26  |- mesh__recordAuthorizer mesh__D006912 sjn
% 213.05/213.26  |- mesh__dateEstablished mesh__D006912 1975-09-01
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006114 2001
% 213.05/213.26  |- skos__scopeNote mesh__D006114
% 213.05/213.26       The geographic area of the Great Lakes in general and when the specific state or states are not indicated. It usually includes Illinois, Indiana, Michigan, Minnesota, New York, Ohio, Pennsylvania, and Wisconsin.%A%    
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006114 2005
% 213.05/213.26  |- mesh__recordMaintainer mesh__D006114 PXP
% 213.05/213.26  |- skos__annotation mesh__D006114
% 213.05/213.26       includes Minn, Mich, Wisc, Ohio, Ill, Penna, Ind %26% NY; specify as needed but use GREAT LAKES REGION when text uses the term %26% when the region is the intent of the author      CATALOG: use for 4 or more states%A%  
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006114 2006
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006114 1998
% 213.05/213.26  |- mesh__dateRevised mesh__D006114 1997-06-20
% 213.05/213.26  |- skos__broader mesh__D006114smesh__D014481
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006114 2002
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006114 2003
% 213.05/213.26  |- mesh__dateCreated mesh__D006114 1999-01-01
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006114 1999
% 213.05/213.26  |- mesh__recordOriginator mesh__D006114 NLM
% 213.05/213.26  |- rdf__type mesh__D006114sskos__Concept
% 213.05/213.26  |- skos__prefLabel mesh__D006114 Great Lakes Region
% 213.05/213.26  |- mesh__recordAuthorizer mesh__D006114 SJN
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006114 2004
% 213.05/213.26  |- mesh__dateEstablished mesh__D006114 1975-01-01
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006114 2000
% 213.05/213.26  |- mesh__historyNote mesh__D006114 75   
% 213.05/213.26  |- skos__altLabel mesh__D011857
% 213.05/213.26       Radiographic Image Interpretation, Computer Assisted
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011857 2004
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011857 2000
% 213.05/213.26  |- skos__scopeNote mesh__D011857
% 213.05/213.26       Computer systems or networks designed to provide radiographic interpretive information.%A%    
% 213.05/213.26  |- skos__altLabel mesh__D011857
% 213.05/213.26       Computer-Assisted Radiographic Image Interpretation
% 213.05/213.26  |- rdf__type mesh__D011857sskos__Concept
% 213.05/213.26  |- mesh__dateRevised mesh__D011857 1997-06-20
% 213.05/213.26  |- skos__broader mesh__D011857smesh__D007090
% 213.05/213.26  |- mesh__recordOriginator mesh__D011857 EC
% 213.05/213.26  |- mesh__recordMaintainer mesh__D011857 PXP
% 213.05/213.26  |- mesh__recordAuthorizer mesh__D011857 SJN
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011857 2001
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011857 1998
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011857 2002
% 213.05/213.26  |- skos__altLabel mesh__D011857
% 213.05/213.26       Computer Assisted Radiographic Image Interpretation
% 213.05/213.26  |- mesh__publicMeSHNote mesh__D011857
% 213.05/213.26       91; was see under IMAGE INTERPRETATION, COMPUTER-ASSISTED 1987-90%A%  
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011857 1999
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011857 2005
% 213.05/213.26  |- mesh__dateCreated mesh__D011857 1986-06-17
% 213.05/213.26  |- skos__broader mesh__D011857smesh__D011859
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011857 2003
% 213.05/213.26  |- skos__prefLabel mesh__D011857
% 213.05/213.26       Radiographic Image Interpretation, Computer-Assisted
% 213.05/213.26  |- mesh__dateEstablished mesh__D011857 1991-01-01
% 213.05/213.26  |- skos__annotation mesh__D011857 DF: RADIOGR IMAGE INTERP   
% 213.05/213.26  |- mesh__historyNote mesh__D011857
% 213.05/213.26       91%28%87%29%; was see under IMAGE INTERPRETATION, COMPUTER-ASSISTED 1987-90%A%  
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011857 2006
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011059 2002
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011059 1995
% 213.05/213.26  |- skos__scopeNote mesh__D011059
% 213.05/213.26       Polonium. A radioactive element that is a member of the chalcogen family. It has the atomic symbol Po, atomic number 84, and the atomic weight of the isotope with the longest half-life %28%209Po%29% is 208.98. It decays by alpha-emission.%A%    
% 213.05/213.26  |- skos__broader mesh__D011059smesh__D018011
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011059 1994
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011059 2004
% 213.05/213.26  |- skos__prefLabel mesh__D011059 Polonium
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011059 1997
% 213.05/213.26  |- skos__broader mesh__D011059smesh__D004603
% 213.05/213.26  |- mesh__dateRevised mesh__D011059 1993-06-04
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011059 2001
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011059 2003
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011059 1996
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011059 2000
% 213.05/213.26  |- mesh__recordAuthorizer mesh__D011059 PLS
% 213.05/213.26  |- rdf__type mesh__D011059sskos__Concept
% 213.05/213.26  |- mesh__recordMaintainer mesh__D011059 TPW
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011059 2006
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011059 1999
% 213.05/213.26  |- mesh__recordOriginator mesh__D011059 NLM
% 213.05/213.26  |- skos__annotation mesh__D011059 naturally radioactive; IM   
% 213.05/213.26  |- mesh__dateCreated mesh__D011059 1999-01-01
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011059 2005
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011059 1998
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D016542 2006
% 213.05/213.26  |- mesh__dateEstablished mesh__D016542 1992-01-01
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D016542 2003
% 213.05/213.26  |- skos__historyNote mesh__D016542
% 213.05/213.26       Health Facility Administrators %28%1975-1991%29%
% 213.05/213.26  |- skos__altLabel mesh__D016542 Hospital Chief Executive Officers
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D016542 1997
% 213.05/213.26  |- skos__altLabel mesh__D016542 Hospital CEO
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D016542 2005
% 213.05/213.26  |- skos__broader mesh__D016542smesh__D006740
% 213.05/213.26  |- skos__altLabel mesh__D016542 Chief Executive Officer, Hospital
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D016542 1999
% 213.05/213.26  |- skos__prefLabel mesh__D016542 Chief Executive Officers, Hospital
% 213.05/213.26  |- mesh__recordOriginator mesh__D016542 JHM
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D016542 1993
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D016542 1996
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D016542 1995
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D016542 2002
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D016542 1998
% 213.05/213.26  |- rdf__type mesh__D016542sskos__Concept
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D016542 1994
% 213.05/213.26  |- skos__annotation mesh__D016542 DF: CEO HOSP   
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D016542 2001
% 213.05/213.26  |- skos__historyNote mesh__D016542
% 213.05/213.26       Hospital Administrators %28%1975-1991%29%
% 213.05/213.26  |- mesh__dateRevised mesh__D016542 1992-05-07
% 213.05/213.26  |- skos__scopeNote mesh__D016542
% 213.05/213.26       Individuals who have the formal authority to manage a hospital, including its programs and services, in accordance with the goals and objectives established by a governing body %28%GOVERNING BOARD%29%.%A%    
% 213.05/213.26  |- mesh__dateCreated mesh__D016542 1991-06-13
% 213.05/213.26  |- skos__altLabel mesh__D016542 Hospital Chief Executive Officer
% 213.05/213.26  |- mesh__recordAuthorizer mesh__D016542 PLS
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D016542 2000
% 213.05/213.26  |- mesh__historyNote mesh__D016542 92   
% 213.05/213.26  |- mesh__publicMeSHNote mesh__D016542 92   
% 213.05/213.26  |- skos__altLabel mesh__D016542 CEO, Hospital
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D016542 2004
% 213.05/213.26  |- mesh__recordMaintainer mesh__D016542 TAP
% 213.05/213.26  |- skos__hiddenLabel mesh__D002522 Monkeys, Grivet
% 213.05/213.26  |- mesh__recordAuthorizer mesh__D002522 sjn
% 213.05/213.26  |- skos__altLabel mesh__D002522 Cercopithecus pygerythrus
% 213.05/213.26  |- skos__altLabel mesh__D002522 Green Monkey
% 213.05/213.26  |- rdf__type mesh__D002522sskos__Concept
% 213.05/213.26  |- skos__annotation mesh__D002522
% 213.05/213.26       Old World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 213.05/213.26  |- skos__hiddenLabel mesh__D002522 Vervet Monkeys
% 213.05/213.26  |- skos__altLabel mesh__D002522 Monkey, African Green
% 213.05/213.26  |- skos__altLabel mesh__D002522 Vervet Monkey
% 213.05/213.26  |- mesh__dateCreated mesh__D002522 1980-05-07
% 213.05/213.26  |- mesh__publicMeSHNote mesh__D002522
% 213.05/213.26       91; was see under CERCOPITHECUS 1981-90; CERCOPITHECUS PYGERYTHRUS %26% CERCOPITHECUS SABEUS were see under CERCOPITHECUS 1975-80%A%  
% 213.05/213.26  |- skos__hiddenLabel mesh__D002522 aethiops, Cercopithecus
% 213.05/213.26  |- skos__hiddenLabel mesh__D002522 Monkeys, Vervet
% 213.05/213.26  |- mesh__dateEstablished mesh__D002522 1991-01-01
% 213.05/213.26  |- skos__scopeNote mesh__D002522
% 213.05/213.26       A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannas of Africa. The African green monkey %28%C. pygerythrus%29% is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research.%A%    
% 213.05/213.26  |- mesh__historyNote mesh__D002522
% 213.05/213.26       91%28%81%29%; was see under CERCOPITHECUS 1981-90; CERCOPITHECUS PYGERYTHRUS %26% CERCOPITHECUS SABEUS were see under CERCOPITHECUS 1975-80%A%  
% 213.05/213.26  |- skos__hiddenLabel mesh__D002522 Green Monkeys
% 213.05/213.26  |- mesh__onlineNote mesh__D002522
% 213.05/213.26       use CERCOPITHECUS AETHIOPS to search CERCOPITHECUS PYGERYTHRUS %26% CERCOPITHECUS SABEUS 1975-80%A%  
% 213.05/213.26  |- skos__hiddenLabel mesh__D002522 tantalus, Cercopithecus
% 213.05/213.26  |- skos__altLabel mesh__D002522 Cercopithecus sabeus
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D002522 2006
% 213.05/213.26  |- mesh__recordOriginator mesh__D002522 EC
% 213.05/213.26  |- mesh__recordMaintainer mesh__D002522 sjn
% 213.05/213.26  |- skos__altLabel mesh__D002522 Cercopithecus tantalus
% 213.05/213.26  |- skos__prefLabel mesh__D002522 Cercopithecus aethiops
% 213.05/213.26  |- skos__hiddenLabel mesh__D002522 sabeus, Cercopithecus
% 213.05/213.26  |- skos__hiddenLabel mesh__D002522 Green Monkey, African
% 213.05/213.26  |- skos__broader mesh__D002522smesh__D002521
% 213.05/213.26  |- skos__altLabel mesh__D002522 African Green Monkey
% 213.05/213.26  |- skos__hiddenLabel mesh__D002522 pygerythrus, Cercopithecus
% 213.05/213.26  |- mesh__dateRevised mesh__D002522 2005-07-01
% 213.05/213.26  |- skos__altLabel mesh__D002522 Grivet Monkey
% 213.05/213.26  |- skos__hiddenLabel mesh__D002522 Monkeys, Green
% 213.05/213.26  |- skos__hiddenLabel mesh__D002522 Grivet Monkeys
% 213.05/213.26  |- mesh__recordMaintainer mesh__D040641 ags
% 213.05/213.26  |- skos__hiddenLabel mesh__D040641 Quantitative Trait Locus
% 213.05/213.26  |- rdf__type mesh__D040641sskos__Concept
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D040641 2006
% 213.05/213.26  |- mesh__recordAuthorizer mesh__D040641 ags
% 213.05/213.26  |- skos__related mesh__D040641smesh__D019655
% 213.05/213.26  |- mesh__dateEstablished mesh__D040641 2003-01-01
% 213.05/213.26  |- skos__prefLabel mesh__D040641 Quantitative Trait Loci
% 213.05/213.26  |- skos__hiddenLabel mesh__D040641 Locus, Quantitative Trait
% 213.05/213.26  |- mesh__historyNote mesh__D040641 2003   
% 213.05/213.26  |- skos__altLabel mesh__D040641 Genes, QTL
% 213.05/213.26  |- skos__scopeNote mesh__D040641
% 213.05/213.26       Locations, on the GENOME, of GENES or other genetic elements that encode or control the expression of a quantitative trait %28%QUANTITATIVE TRAIT, HERITABLE%29%.%A%    
% 213.05/213.26  |- skos__hiddenLabel mesh__D040641 Gene, QTL
% 213.05/213.26  |- mesh__publicMeSHNote mesh__D040641 2003   
% 213.05/213.26  |- mesh__dateRevised mesh__D040641 2005-07-28
% 213.05/213.26  |- skos__hiddenLabel mesh__D040641 Trait Locus, Quantitative
% 213.05/213.26  |- skos__broader mesh__D040641smesh__D005796
% 213.05/213.26  |- skos__hiddenLabel mesh__D040641 Loci, Quantitative Trait
% 213.05/213.26  |- mesh__dateCreated mesh__D040641 2002-07-03
% 213.05/213.26  |- skos__hiddenLabel mesh__D040641 Trait Loci, Quantitative
% 213.05/213.26  |- skos__hiddenLabel mesh__D040641 QTLs %28%Quantitative Trait Loci%29%
% 213.05/213.26  |- mesh__recordOriginator mesh__D040641 nns
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D040641 2006A
% 213.05/213.26  |- skos__altLabel mesh__D040641 QTL %28%Quantitative Trait Loci%29%
% 213.05/213.26  |- skos__hiddenLabel mesh__D040641 QTL Gene
% 213.05/213.26  |- skos__broader mesh__D012950smesh__D011056
% 213.05/213.26  |- mesh__recordOriginator mesh__D012950 NLM
% 213.05/213.26  |- mesh__dateRevised mesh__D012950 1999-11-03
% 213.05/213.26  |- skos__annotation mesh__D012950
% 213.05/213.26       specify country; do not confuse with NAZISM see POLITICAL SYSTEMS%A%  
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D012950 2006
% 213.05/213.26  |- skos__hiddenLabel mesh__D012950 Socialisms
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D012950 2001
% 213.05/213.26  |- skos__prefLabel mesh__D012950 Socialism
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D012950 2004
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D012950 2005
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D012950 2000
% 213.05/213.26  |- mesh__recordMaintainer mesh__D012950 kle
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D012950 2003
% 213.05/213.26  |- mesh__dateCreated mesh__D012950 1999-01-01
% 213.05/213.26  |- mesh__recordAuthorizer mesh__D012950 sjn
% 213.05/213.26  |- rdf__type mesh__D012950sskos__Concept
% 213.05/213.26  |- skos__scopeNote mesh__D012950
% 213.05/213.26       A system of government in which means of production and distribution of goods are controlled by the state.%A%    
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D012950 2002
% 213.05/213.26  |- skos__broader mesh__D012152smesh__D013737
% 213.05/213.26  |- mesh__publicMeSHNote mesh__D012152 91; was see under TESTIS 1975-90   
% 213.05/213.26  |- mesh__historyNote mesh__D012152
% 213.05/213.26       91%28%75%29%; was see under TESTIS 1975-90   
% 213.05/213.26  |- mesh__dateRevised mesh__D012152 2002-07-03
% 213.05/213.26  |- mesh__recordOriginator mesh__D012152 NLM
% 213.05/213.26  |- rdf__type mesh__D012152sskos__Concept
% 213.05/213.26  |- skos__hiddenLabel mesh__D012152 Testis, Rete
% 213.05/213.26  |- mesh__recordAuthorizer mesh__D012152 sjn
% 213.05/213.26  |- mesh__dateEstablished mesh__D012152 1991-01-01
% 213.05/213.26  |- skos__scopeNote mesh__D012152
% 213.05/213.26       The network of channels formed at the termination of the straight SEMINIFEROUS TUBULES in the mediastinum testis. Rete testis channels drain into the efferent ductules that pass into the caput EPIDIDYMIS.%A%    
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D012152 2004
% 213.05/213.26  |- mesh__recordMaintainer mesh__D012152 lkt
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D012152 2006
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D012152 2003
% 213.05/213.26  |- skos__prefLabel mesh__D012152 Rete Testis
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D012152 2005
% 213.05/213.26  |- mesh__dateCreated mesh__D012152 1974-11-11
% 213.05/213.26  |- mesh__recordAuthorizer mesh__D006913 sjn
% 213.05/213.26  |- rdf__type mesh__D006913sskos__Concept
% 213.05/213.26  |- mesh__historyNote mesh__D006913
% 213.05/213.26       74; was HYDROXYSTEROID DEHYDROGENASE 1965-73   
% 213.05/213.26  |- mesh__dateRevised mesh__D006913 2003-07-09
% 213.05/213.26  |- skos__hiddenLabel mesh__D006913 Dehydrogenases, Hydroxysteroid
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006913 2004
% 213.05/213.26  |- mesh__publicMeSHNote mesh__D006913
% 213.05/213.26       74; was HYDROXYSTEROID DEHYDROGENASE 1965-73   
% 213.05/213.26  |- mesh__dateEstablished mesh__D006913 1965-01-01
% 213.05/213.26  |- skos__prefLabel mesh__D006913 Hydroxysteroid Dehydrogenases
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006913 2005
% 213.05/213.26  |- skos__scopeNote mesh__D006913
% 213.05/213.26       Enzymes of the oxidoreductase class that catalyze the dehydrogenation of hydroxysteroids. %28%From Enzyme Nomenclature, 1992%29% EC 1.1.-.%A%    
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006913 2006
% 213.05/213.26  |- mesh__recordMaintainer mesh__D006913 ssb
% 213.05/213.26  |- mesh__onlineNote mesh__D006913
% 213.05/213.26       use HYDROXYSTEROID DEHYDROGENASES to search HYDROXYSTEROID DEHYDROGENASE 1966-73%A%  
% 213.05/213.26  |- mesh__dateCreated mesh__D006913 1999-01-01
% 213.05/213.26  |- mesh__recordOriginator mesh__D006913 NLM
% 213.05/213.26  |- skos__broader mesh__D006913smesh__D000429
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006115 1998
% 213.05/213.26  |- skos__broader mesh__D006115smesh__D018436
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006115 1997
% 213.05/213.26  |- rdf__type mesh__D006115sskos__Concept
% 213.05/213.26  |- mesh__recordOriginator mesh__D006115 NLM
% 213.05/213.26  |- mesh__recordMaintainer mesh__D006115 ags
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006115 1996
% 213.05/213.26  |- skos__broader mesh__D006115smesh__D005060
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006115 2002
% 213.05/213.26  |- mesh__dateRevised mesh__D006115 2005-07-19
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006115 1995
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006115 2006
% 213.05/213.26  |- skos__annotation mesh__D006115
% 213.05/213.26       ancient or modern Greece; do not confuse with GREEK WORLD, the culture and civilization; do not confuse X ref MACEDONIA %28%GREECE%29% with MACEDONIA %28%REPUBLIC%29%%A%  
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006115 2001
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006115 2005
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006115 2004
% 213.05/213.26  |- skos__prefLabel mesh__D006115 Greece
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006115 1999
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006115 2006A
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006115 2000
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D006115 2003
% 213.05/213.26  |- mesh__recordAuthorizer mesh__D006115 ags
% 213.05/213.26  |- mesh__dateCreated mesh__D006115 1999-01-01
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011858 1999
% 213.05/213.26  |- mesh__activeMeSHYear mesh__D011858 2004
% 213.05/213.26  |- mesh__publicMeSHNote mesh__D011858 73   
% 213.05/213.27  |- mesh__historyNote mesh__D011858 73%28%72%29%   
% 213.05/213.27  |- skos__historyNote mesh__D011858
% 213.05/213.27       specific radiography heading %28%1966-1971%29%
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D011858 2006
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D011858 1998
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D011858 2003
% 213.05/213.27  |- skos__hiddenLabel mesh__D011858 Radiographic Magnifications
% 213.05/213.27  |- skos__scopeNote mesh__D011858
% 213.05/213.27       Use of optic and geometric techniques to enhance radiographic image quality and interpretation. It includes use of microfocal X-ray tubes and intensifying fluoroscopic screens.%A%    
% 213.05/213.27  |- mesh__dateRevised mesh__D011858 1997-06-20
% 213.05/213.27  |- skos__historyNote mesh__D011858 Technology, Radiologic %28%1966-1971%29%
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D011858 2002
% 213.05/213.27  |- mesh__dateEstablished mesh__D011858 1973-01-01
% 213.05/213.27  |- skos__historyNote mesh__D011858
% 213.05/213.27       specific heading/radiography %28%1966-1971%29%
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D011858 2005
% 213.05/213.27  |- mesh__recordAuthorizer mesh__D011858 SJN
% 213.05/213.27  |- skos__prefLabel mesh__D011858 Radiographic Magnification
% 213.05/213.27  |- rdf__type mesh__D011858sskos__Concept
% 213.05/213.27  |- skos__broader mesh__D011858smesh__D011859
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D011858 2001
% 213.05/213.27  |- skos__historyNote mesh__D011858 Radiography %28%1966-1971%29%
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D011858 2000
% 213.05/213.27  |- skos__annotation mesh__D011858
% 213.05/213.27       do not use /util except by MeSH definition   
% 213.05/213.27  |- skos__altLabel mesh__D011858 Magnification, Radiographic
% 213.05/213.27  |- mesh__recordMaintainer mesh__D011858 PXP
% 213.05/213.27  |- skos__hiddenLabel mesh__D011858 Magnifications, Radiographic
% 213.05/213.27  |- mesh__dateCreated mesh__D011858 1999-01-01
% 213.05/213.27  |- mesh__recordOriginator mesh__D011858 NLM
% 213.05/213.27  |- mesh__recordAuthorizer mesh__D016543 sjn
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D016543 2005
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D016543 2000
% 213.05/213.27  |- skos__altLabel mesh__D016543 Tumors, Central Nervous System
% 213.05/213.27  |- mesh__publicMeSHNote mesh__D016543 92   
% 213.05/213.27  |- mesh__recordMaintainer mesh__D016543 KEV
% 213.05/213.27  |- mesh__recordOriginator mesh__D016543 AGS
% 213.05/213.27  |- skos__altLabel mesh__D016543 Central Nervous System Tumors
% 213.05/213.27  |- mesh__dateEstablished mesh__D016543 1992-01-01
% 213.05/213.27  |- skos__historyNote mesh__D016543 Brain Neoplasms %28%1966-1991%29%
% 213.05/213.27  |- rdf__type mesh__D016543sskos__Concept
% 213.05/213.27  |- skos__altLabel mesh__D016543 Primary Central Nervous System Neoplasms
% 213.05/213.27  |- mesh__dateRevised mesh__D016543 1999-11-03
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D016543 2002
% 213.05/213.27  |- mesh__dateCreated mesh__D016543 1991-01-02
% 213.05/213.27  |- mesh__historyNote mesh__D016543 92   
% 213.05/213.27  |- skos__scopeNote mesh__D016543
% 213.05/213.27       Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.%A%    
% 213.05/213.27  |- skos__historyNote mesh__D016543
% 213.05/213.27       Nervous System Neoplasms %28%1980-1991%29%
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D016543 2004
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D016543 2001
% 213.05/213.27  |- skos__historyNote mesh__D016543 Spinal Cord Neoplasms %28%1966-1991%29%
% 213.05/213.27  |- skos__broader mesh__D016543smesh__D009423
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D016543 2006
% 213.05/213.27  |- skos__altLabel mesh__D016543 Neoplasms, Central Nervous System
% 213.05/213.27  |- skos__prefLabel mesh__D016543 Central Nervous System Neoplasms
% 213.05/213.27  |- skos__annotation mesh__D016543
% 213.05/213.27       GEN or unspecified, prefer specifics; coord IM with histol type of neopl %28%IM%29%; DF: CNS NEOPL%A%  
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D016543 2003
% 213.05/213.27  |- mesh__dateRevised mesh__D002523 2004-07-07
% 213.05/213.27  |- rdf__type mesh__D002523sskos__Concept
% 213.05/213.27  |- mesh__recordMaintainer mesh__D002523 ssb
% 213.05/213.27  |- mesh__publicMeSHNote mesh__D002523
% 213.05/213.27       GRAIN %26% MALT were headings 1963-84   
% 213.05/213.27  |- skos__broader mesh__D002523smesh__D010945
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D002523 2005
% 213.05/213.27  |- skos__scopeNote mesh__D002523
% 213.05/213.27       Seeds from grasses %28%POACEAE%29% which are important in the diet.%A%    
% 213.05/213.27  |- mesh__dateCreated mesh__D002523 1999-01-01
% 213.05/213.27  |- skos__prefLabel mesh__D002523 Cereals
% 213.05/213.27  |- mesh__recordOriginator mesh__D002523 NLM
% 213.05/213.27  |- mesh__historyNote mesh__D002523 GRAIN %26% MALT were headings 1963-84   
% 213.05/213.27  |- skos__hiddenLabel mesh__D002523 Malts
% 213.05/213.27  |- skos__hiddenLabel mesh__D002523 Cereal
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D002523 2006
% 213.05/213.27  |- skos__broader mesh__D002523smesh__D005502
% 213.05/213.27  |- skos__altLabel mesh__D002523 Grain
% 213.05/213.27  |- skos__annotation mesh__D002523
% 213.05/213.27       do not restrict to processed grain or cereals such as breakfast food%A%  
% 213.05/213.27  |- skos__hiddenLabel mesh__D002523 Grains
% 213.05/213.27  |- mesh__onlineNote mesh__D002523
% 213.05/213.27       use CEREALS to search GRAIN %26% MALT 1966-84   
% 213.05/213.27  |- mesh__recordAuthorizer mesh__D002523 sjn
% 213.05/213.27  |- mesh__recordAuthorizer mesh__D012951 PLS
% 213.05/213.27  |- mesh__historyNote mesh__D012951 68   
% 213.05/213.27  |- skos__broader mesh__D012951smesh__D012961
% 213.05/213.27  |- skos__historyNote mesh__D012951 Parent-Child Relations %28%1966-1967%29%
% 213.05/213.27  |- skos__historyNote mesh__D012951 Family %28%1966-1967%29%
% 213.05/213.27  |- mesh__publicMeSHNote mesh__D012951 68   
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D012951 2001
% 213.05/213.27  |- mesh__recordMaintainer mesh__D012951 TGC
% 213.05/213.27  |- skos__hiddenLabel mesh__D012951 Socializations
% 213.05/213.27  |- skos__scopeNote mesh__D012951
% 213.05/213.27       The training or molding of an individual through various relationships, educational agencies, and social controls, which enables him to become a member of a particular society.%A%    
% 213.05/213.27  |- skos__historyNote mesh__D012951 Child Rearing %28%1966-1967%29%
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D012951 1995
% 213.05/213.27  |- skos__prefLabel mesh__D012951 Socialization
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D012951 2006
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D012951 2000
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D012951 1993
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D012951 2004
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D012951 1999
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D012951 1994
% 213.05/213.27  |- mesh__dateCreated mesh__D012951 1999-01-01
% 213.05/213.27  |- skos__annotation mesh__D012951 no qualif   
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D012951 2005
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D012951 1997
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D012951 1992
% 213.05/213.27  |- rdf__type mesh__D012951sskos__Concept
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D012951 2003
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D012951 1998
% 213.05/213.27  |- mesh__dateRevised mesh__D012951 1990-03-22
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D012951 1996
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D012951 1991
% 213.05/213.27  |- mesh__activeMeSHYear mesh__D012951 2002
% 213.05/213.27  |- mesh__dateEstablished mesh__D012951 1968-01-01
% 213.05/213.27  |- mesh__recordOriginator mesh__D012951 NLM
% 213.05/213.27  |- rdf__type mesh__D012153sskos__Concept
% 213.05/213.27  |- skos__hiddenLabel mesh__D012153 Retentions %28%Psychology%29%
% 213.05/213.27  |- mesh__recordAuthorizer mesh__D012153 PLS
% 213.12/213.27  |- skos__historyNote mesh__D012153 Memory %28%1966-1974%29%
% 213.12/213.27  |- skos__broader mesh__D012153smesh__D008568
% 213.12/213.27  |- skos__annotation mesh__D012153 DF: RETENTION   
% 213.12/213.27  |- mesh__historyNote mesh__D012153
% 213.12/213.27       91%28%79%29%; was see under MEMORY 1979-90; was RETENTION see under MEMORY 1963-78%A%  
% 213.12/213.27  |- skos__altLabel mesh__D012153 Retention
% 213.12/213.27  |- mesh__dateEstablished mesh__D012153 1991-01-01
% 213.12/213.27  |- mesh__recordOriginator mesh__D012153 NLM
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012153 1997
% 213.12/213.27  |- mesh__publicMeSHNote mesh__D012153
% 213.12/213.27       91; was see under MEMORY 1979-90; was RETENTION see under MEMORY 1963-78%A%  
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012153 2004
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012153 2002
% 213.12/213.27  |- skos__prefLabel mesh__D012153 Retention %28%Psychology%29%
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012153 1999
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012153 2006
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012153 1996
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012153 2003
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012153 1995
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012153 2001
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012153 1998
% 213.12/213.27  |- skos__scopeNote mesh__D012153
% 213.12/213.27       The persistence to perform a learned behavior %28%facts or experiences%29% after an interval has elapsed in which there has been no performance or practice of the behavior.%A%    
% 213.12/213.27  |- mesh__recordMaintainer mesh__D012153 JLS
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012153 2005
% 213.12/213.27  |- mesh__dateCreated mesh__D012153 1999-01-01
% 213.12/213.27  |- mesh__dateRevised mesh__D012153 1993-06-04
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012153 1994
% 213.12/213.27  |- mesh__onlineNote mesh__D012153
% 213.12/213.27       use RETENTION %28%PSYCHOLOGY%29% to search RETENTION 1975-78; use MEMORY 1966-74%A%  
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012153 2000
% 213.12/213.27  |- mesh__historyNote mesh__D006914 74%28%72%29%   
% 213.12/213.27  |- skos__broader mesh__D006914smesh__D013256
% 213.12/213.27  |- skos__related mesh__D006914smesh__D006889
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006914 1998
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006914 2006
% 213.12/213.27  |- skos__prefLabel mesh__D006914 Hydroxysteroids
% 213.12/213.27  |- mesh__recordOriginator mesh__D006914 NLM
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006914 1999
% 213.12/213.27  |- mesh__publicMeSHNote mesh__D006914 74   
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006914 1994
% 213.12/213.27  |- skos__scopeNote mesh__D006914
% 213.12/213.27       Steroids in which one or more hydroxy groups have been substituted for hydrogen atoms either within the ring skeleton or on any of the side chains.%A%    
% 213.12/213.27  |- mesh__dateCreated mesh__D006914 1999-01-01
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006914 2000
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006914 2003
% 213.12/213.27  |- mesh__dateEstablished mesh__D006914 1974-01-01
% 213.12/213.27  |- mesh__recordAuthorizer mesh__D006914 PLS
% 213.12/213.27  |- rdf__type mesh__D006914sskos__Concept
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006914 1995
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006914 1996
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006914 2001
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006914 2004
% 213.12/213.27  |- mesh__dateRevised mesh__D006914 1993-06-15
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006914 1997
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006914 2002
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006914 2005
% 213.12/213.27  |- mesh__recordMaintainer mesh__D006914 PLS
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006116 2000
% 213.12/213.27  |- skos__altLabel mesh__D006116 Kalaallit Nunaat
% 213.12/213.27  |- skos__prefLabel mesh__D006116 Greenland
% 213.12/213.27  |- mesh__recordOriginator mesh__D006116 NLM
% 213.12/213.27  |- mesh__recordAuthorizer mesh__D006116 sjn
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006116 2006
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006116 2002
% 213.12/213.27  |- mesh__recordMaintainer mesh__D006116 jls
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006116 2004
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006116 2005
% 213.12/213.27  |- mesh__dateRevised mesh__D006116 1999-11-03
% 213.12/213.27  |- mesh__dateCreated mesh__D006116 1999-01-01
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006116 2003
% 213.12/213.27  |- skos__broader mesh__D006116smesh__D009656
% 213.12/213.27  |- rdf__type mesh__D006116sskos__Concept
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006116 2001
% 213.12/213.27  |- skos__related mesh__D011859smesh__D003287
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D011859 2003
% 213.12/213.27  |- mesh__recordAuthorizer mesh__D011859 sjn
% 213.12/213.27  |- mesh__recordMaintainer mesh__D011859 kle
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D011859 2005
% 213.12/213.27  |- skos__altLabel mesh__D011859 Roentgenography
% 213.12/213.27  |- skos__related mesh__D011859smesh__D005119
% 213.12/213.27  |- mesh__recordOriginator mesh__D011859 NLM
% 213.12/213.27  |- skos__related mesh__D011859smesh__D013679
% 213.12/213.27  |- skos__altLabel mesh__D011859 X-Ray, Diagnostic
% 213.12/213.27  |- skos__scopeNote mesh__D011859
% 213.12/213.27       Examination of any part of the body for diagnostic purposes by means of roentgen rays, recording the image on a sensitized surface %28%such as photographic film%29%.%A%    
% 213.12/213.27  |- skos__hiddenLabel mesh__D011859 Diagnostic X Ray
% 213.12/213.27  |- skos__hiddenLabel mesh__D011859 X-Rays, Diagnostic
% 213.12/213.27  |- skos__altLabel mesh__D011859 Radiology, Diagnostic X-Ray
% 213.12/213.27  |- rdf__type mesh__D011859sskos__Concept
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D011859 2002
% 213.12/213.27  |- skos__altLabel mesh__D011859 Diagnostic X-Ray
% 213.12/213.27  |- skos__altLabel mesh__D011859 X-Ray Radiology, Diagnostic
% 213.12/213.27  |- skos__altLabel mesh__D011859 Diagnostic X-Ray Radiology
% 213.12/213.27  |- skos__broader mesh__D011859smesh__D003952
% 213.12/213.27  |- skos__hiddenLabel mesh__D011859 Radiology, Diagnostic X Ray
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D011859 2001
% 213.12/213.27  |- mesh__dateRevised mesh__D011859 1999-11-03
% 213.12/213.27  |- skos__hiddenLabel mesh__D011859 Diagnostic X-Rays
% 213.12/213.27  |- skos__hiddenLabel mesh__D011859 X Ray Radiology, Diagnostic
% 213.12/213.27  |- mesh__dateCreated mesh__D011859 1999-01-01
% 213.12/213.27  |- skos__hiddenLabel mesh__D011859 X Ray, Diagnostic
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D011859 2004
% 213.12/213.27  |- skos__annotation mesh__D011859
% 213.12/213.27       GEN only: prefer /radiogr with organs %26% diseases: Manual 19.7+, 19.8.61; prefer also specific indentions in Cat E1; when GEN %26% IM, qualif permitted; Manual 26.4+; /educ = RADIOGRAPHY %28%IM%29% + RADIOLOGY /educ ; /man = RADIOGRAPHY %28%IM%29% + RADIOLOGY /man or TECHNOLOGY, RADIOLOGIC /man %28%NIM%29%; /methods: consider also TECHNOLOGY, RADIOLOGIC; DF: RADIOGR%A%  
% 213.12/213.27  |- skos__prefLabel mesh__D011859 Radiography
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D011859 2000
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D011859 2006
% 213.12/213.27  |- skos__hiddenLabel mesh__D011859 Diagnostic X Ray Radiology
% 213.12/213.27  |- mesh__dateEstablished mesh__D022581 2001-01-01
% 213.12/213.27  |- mesh__dateCreated mesh__D022581 2000-06-22
% 213.12/213.27  |- skos__annotation mesh__D022581
% 213.12/213.27       IM general only; coord NIM with specific vaccine %28%IM%29%   
% 213.12/213.27  |- mesh__dateRevised mesh__D022581 2005-06-30
% 213.12/213.27  |- mesh__recordMaintainer mesh__D022581 ssb
% 213.12/213.27  |- mesh__historyNote mesh__D022581 2001   
% 213.12/213.27  |- skos__scopeNote mesh__D022581
% 213.12/213.27       Vaccines used in conjunction with diagnostic tests to differentiate vaccinated animals from carrier animals. Marker vaccines can be either a subunit or a gene-deleted vaccine.%A%    
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D022581 2006
% 213.12/213.27  |- mesh__publicMeSHNote mesh__D022581 2001   
% 213.12/213.27  |- skos__altLabel mesh__D022581 Marker Vaccines
% 213.12/213.27  |- skos__broader mesh__D022581smesh__D014612
% 213.12/213.27  |- mesh__recordOriginator mesh__D022581 ags
% 213.12/213.27  |- rdf__type mesh__D022581sskos__Concept
% 213.12/213.27  |- mesh__recordAuthorizer mesh__D022581 sjn
% 213.12/213.27  |- skos__prefLabel mesh__D022581 Vaccines, Marker
% 213.12/213.27  |- mesh__dateCreated mesh__D016544 1991-02-11
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D016544 2001
% 213.12/213.27  |- skos__prefLabel mesh__D016544 Patient Simulation
% 213.12/213.27  |- skos__hiddenLabel mesh__D016544 Patient Simulations
% 213.12/213.27  |- mesh__historyNote mesh__D016544 92   
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D016544 2004
% 213.12/213.27  |- skos__annotation mesh__D016544
% 213.12/213.27       actual persons %28%sometimes actors%29% %22%coached to feign symptoms or conditions of real diseases%22% as a technique in med educ; no qualif%A%  
% 213.12/213.27  |- skos__broader mesh__D016544smesh__D013663
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D016544 2000
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D016544 2006
% 213.12/213.27  |- mesh__dateEstablished mesh__D016544 1992-01-01
% 213.12/213.27  |- mesh__publicMeSHNote mesh__D016544 92   
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D016544 1997
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D016544 2003
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D016544 1999
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D016544 2005
% 213.12/213.27  |- skos__hiddenLabel mesh__D016544 Simulation, Patient
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D016544 1993
% 213.12/213.27  |- skos__hiddenLabel mesh__D016544 Simulations, Patient
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D016544 1996
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D016544 1995
% 213.12/213.27  |- skos__scopeNote mesh__D016544
% 213.12/213.27       The use of persons coached to feign symptoms or conditions of real diseases in a life-like manner in order to teach or evaluate medical personnel.%A%    
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D016544 1998
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D016544 1992
% 213.12/213.27  |- rdf__type mesh__D016544sskos__Concept
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D016544 2002
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D016544 1994
% 213.12/213.27  |- skos__prefLabel mesh__D002524 Cerebellar Ataxia
% 213.12/213.27  |- mesh__recordOriginator mesh__D002524 NLM
% 213.12/213.27  |- mesh__historyNote mesh__D002524 1968   
% 213.12/213.27  |- skos__altLabel mesh__D002524 Cerebellar Incoordination
% 213.12/213.27  |- skos__hiddenLabel mesh__D002524 Incoordination, Cerebellar
% 213.12/213.27  |- skos__hiddenLabel mesh__D002524 Ataxias, Cerebellar
% 213.12/213.27  |- skos__broader mesh__D002524smesh__D001259
% 213.12/213.27  |- skos__hiddenLabel mesh__D002524 Adiadochokineses
% 213.12/213.27  |- rdf__type mesh__D002524sskos__Concept
% 213.12/213.27  |- skos__annotation mesh__D002524
% 213.12/213.27       DENTATE CEREBELLAR ATAXIA see MYOCLONIC CEREBELLAR DYSSYNERGIA is also available; ATAXIAS, HEREDITARY see SPINOCEREBELLAR DEGENERATION is also available%A%  
% 213.12/213.27  |- skos__hiddenLabel mesh__D002524 Cerebellar Hemiataxias
% 213.12/213.27  |- skos__historyNote mesh__D002524 Cerebellar Diseases %28%1966-1967%29%
% 213.12/213.27  |- skos__hiddenLabel mesh__D002524 Dysmetria, Cerebellar
% 213.12/213.27  |- mesh__recordAuthorizer mesh__D002524 sjn
% 213.12/213.27  |- skos__hiddenLabel mesh__D002524 Hemiataxias, Cerebellar
% 213.12/213.27  |- mesh__publicMeSHNote mesh__D002524 1968   
% 213.12/213.27  |- skos__hiddenLabel mesh__D002524 Cerebellar Dysmetrias
% 213.12/213.27  |- skos__broader mesh__D002524smesh__D002526
% 213.12/213.27  |- mesh__dateCreated mesh__D002524 1999-01-01
% 213.12/213.27  |- skos__hiddenLabel mesh__D002524 Hemiataxia, Cerebellar
% 213.12/213.27  |- skos__hiddenLabel mesh__D002524 Cerebellar Incoordinations
% 213.12/213.27  |- skos__altLabel mesh__D002524 Dysmetria
% 213.12/213.27  |- mesh__dateRevised mesh__D002524 2005-06-30
% 213.12/213.27  |- mesh__dateEstablished mesh__D002524 1968-01-01
% 213.12/213.27  |- skos__hiddenLabel mesh__D002524 Incoordinations, Cerebellar
% 213.12/213.27  |- mesh__recordMaintainer mesh__D002524 nns
% 213.12/213.27  |- skos__hiddenLabel mesh__D002524 Cerebellar Ataxias
% 213.12/213.27  |- skos__hiddenLabel mesh__D002524 Dysmetrias
% 213.12/213.27  |- skos__altLabel mesh__D002524 Ataxia, Cerebellar
% 213.12/213.27  |- skos__scopeNote mesh__D002524
% 213.12/213.27       Incoordination of voluntary movements that occur as a manifestation of CEREBELLAR DISEASES. Characteristic features include a tendency for limb movements to overshoot or undershoot a target %28%dysmetria%29%, a tremor that occurs during attempted movements %28%intention TREMOR%29%, impaired force and rhythm of diadochokinesis %28%rapidly alternating movements%29%, and GAIT ATAXIA. %28%From Adams et al., Principles of Neurology, 6th ed, p90%29%%A%    
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D002524 2006
% 213.12/213.27  |- skos__historyNote mesh__D002524 Ataxia %28%1966-1967%29%
% 213.12/213.27  |- skos__hiddenLabel mesh__D002524 Dysmetrias, Cerebellar
% 213.12/213.27  |- skos__hiddenLabel mesh__D002524 Hypermetrias
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012952 2002
% 213.12/213.27  |- mesh__recordOriginator mesh__D012952 NLM
% 213.12/213.27  |- skos__annotation mesh__D012952
% 213.12/213.27       GEN or unspecified; prefer specific types of societies; do not confuse with ORGANIZATIONS: see note there; Manual 35.9+; specify geog; TN 174: scope%A%  
% 213.12/213.27  |- skos__altLabel mesh__D012952 Organizations, Professional
% 213.12/213.27  |- skos__scopeNote mesh__D012952
% 213.12/213.27       Organizations composed of members with common interests and whose professions may be similar.%A%    
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012952 2006
% 213.12/213.27  |- skos__related mesh__D012952smesh__D007996
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012952 2004
% 213.12/213.27  |- mesh__dateCreated mesh__D012952 1999-01-01
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012952 2005
% 213.12/213.27  |- skos__hiddenLabel mesh__D012952 Professional Organization
% 213.12/213.27  |- skos__broader mesh__D012952smesh__D009938
% 213.12/213.27  |- mesh__dateRevised mesh__D012952 1999-11-03
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012952 2001
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012952 2003
% 213.12/213.27  |- rdf__type mesh__D012952sskos__Concept
% 213.12/213.27  |- skos__hiddenLabel mesh__D012952 Organization, Professional
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012952 2000
% 213.12/213.27  |- skos__prefLabel mesh__D012952 Societies
% 213.12/213.27  |- mesh__recordAuthorizer mesh__D012952 sjn
% 213.12/213.27  |- mesh__recordMaintainer mesh__D012952 kle
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012154 2001
% 213.12/213.27  |- mesh__dateRevised mesh__D012154 1992-05-18
% 213.12/213.27  |- mesh__recordAuthorizer mesh__D012154 PLS
% 213.12/213.27  |- skos__prefLabel mesh__D012154 Reticular Formation
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012154 1996
% 213.12/213.27  |- skos__hiddenLabel mesh__D012154 Reticular Formations
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012154 2003
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012154 1998
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012154 2005
% 213.12/213.27  |- mesh__dateCreated mesh__D012154 1999-01-01
% 213.12/213.27  |- skos__hiddenLabel mesh__D012154 Formations, Reticular
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012154 1997
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012154 1994
% 213.12/213.27  |- skos__broader mesh__D012154smesh__D001933
% 213.12/213.27  |- skos__scopeNote mesh__D012154
% 213.12/213.27       A region extending from the PONS %26% MEDULLA OBLONGATA through the MESENCEPHALON, characterized by a diversity of neurons of various sizes and shapes, arranged in different aggregations and enmeshed in a complicated fiber network.%A%    
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012154 2004
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012154 1999
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012154 2002
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012154 2006
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012154 1993
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012154 1995
% 213.12/213.27  |- mesh__recordOriginator mesh__D012154 NLM
% 213.12/213.27  |- skos__hiddenLabel mesh__D012154 Formation, Reticular
% 213.12/213.27  |- mesh__recordMaintainer mesh__D012154 TAP
% 213.12/213.27  |- rdf__type mesh__D012154sskos__Concept
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D012154 2000
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006915 2006
% 213.12/213.27  |- mesh__dateRevised mesh__D006915 1993-06-03
% 213.12/213.27  |- mesh__dateEstablished mesh__D006915 1991-01-01
% 213.12/213.27  |- mesh__dateCreated mesh__D006915 1976-04-27
% 213.12/213.27  |- mesh__recordOriginator mesh__D006915 RLS
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006915 1999
% 213.12/213.27  |- skos__prefLabel mesh__D006915 Hydroxytestosterones
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006915 2002
% 213.12/213.27  |- skos__scopeNote mesh__D006915
% 213.12/213.27       17 beta-Hydroxy-4-androsten-3-ones. Testosterone derivatives formed by the substitution of one or more hydroxyl groups in any position.%A%    
% 213.12/213.27  |- mesh__recordMaintainer mesh__D006915 PLS
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006915 1994
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006915 2003
% 213.12/213.27  |- rdf__type mesh__D006915sskos__Concept
% 213.12/213.27  |- skos__historyNote mesh__D006915 Testosterone %28%1972-1976%29%
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006915 1995
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006915 1996
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006915 2004
% 213.12/213.27  |- skos__broader mesh__D006915smesh__D013739
% 213.12/213.27  |- skos__historyNote mesh__D006915 Hydroxysteroids %28%1972-1975%29%
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006915 1997
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006915 2000
% 213.12/213.27  |- mesh__publicMeSHNote mesh__D006915
% 213.12/213.27       91; was see under TESTOSTERONE 1977-90   
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006915 2005
% 213.12/213.27  |- mesh__recordAuthorizer mesh__D006915 PLS
% 213.12/213.27  |- mesh__historyNote mesh__D006915
% 213.12/213.27       91%28%77%29%; was see under TESTOSTERONE 1977-90   
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006915 1998
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006915 2001
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006117 1993
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006117 1994
% 213.12/213.27  |- mesh__recordAuthorizer mesh__D006117 PLS
% 213.12/213.27  |- skos__hiddenLabel mesh__D006117 Griefs
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006117 2004
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006117 2005
% 213.12/213.27  |- mesh__dateEstablished mesh__D006117 1968-01-01
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006117 1999
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006117 1992
% 213.12/213.27  |- mesh__activeMeSHYear mesh__D006117 2001
% 213.12/213.27  |- skos__hiddenLabel mesh__D006117 Mournings
% 213.12/213.27  |- mesh__dateCreated mesh__D006117 1999-01-01
% 213.12/213.27  |- skos__broader mesh__D006117smesh__D001601
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006117 2003
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006117 1997
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006117 1998
% 213.12/213.28  |- rdf__type mesh__D006117sskos__Concept
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006117 2000
% 213.12/213.28  |- skos__scopeNote mesh__D006117
% 213.12/213.28       Normal, appropriate sorrowful response to an immediate cause. It is self-limiting and gradually subsides within a reasonable time.%A%    
% 213.12/213.28  |- skos__prefLabel mesh__D006117 Grief
% 213.12/213.28  |- skos__annotation mesh__D006117 human %26% animal; no qualif   
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006117 1996
% 213.12/213.28  |- mesh__publicMeSHNote mesh__D006117 68   
% 213.12/213.28  |- mesh__historyNote mesh__D006117 68   
% 213.12/213.28  |- mesh__recordOriginator mesh__D006117 NLM
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006117 2002
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006117 1995
% 213.12/213.28  |- mesh__dateRevised mesh__D006117 1991-06-11
% 213.12/213.28  |- mesh__recordMaintainer mesh__D006117 TGC
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006117 2006
% 213.12/213.28  |- skos__scopeNote mesh__D016545
% 213.12/213.28       Benign or malignant tumors which arise from the choroid plexus of the ventricles of the brain. Papillomas %28%see PAPILLOMA, CHOROID PLEXUS%29% and carcinomas are the most common histologic subtypes, and tend to seed throughout the ventricular and subarachnoid spaces. Clinical features include headaches, ataxia and alterations of consciousness, primarily resulting from associated HYDROCEPHALUS. %28%From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2072; J Neurosurg 1998 Mar;88%28%3%29%:521-8%29%%A%    
% 213.12/213.28  |- skos__prefLabel mesh__D016545 Choroid Plexus Neoplasms
% 213.12/213.28  |- skos__hiddenLabel mesh__D016545 Choroid Plexus Tumor
% 213.12/213.28  |- mesh__dateCreated mesh__D016545 1991-01-02
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D016545 2004
% 213.12/213.28  |- skos__altLabel mesh__D016545 Choroid Plexus Tumors
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D016545 2002
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D016545 2006
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D016545 2003
% 213.12/213.28  |- skos__hiddenLabel mesh__D016545 Neoplasm, Choroid Plexus
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D016545 2001
% 213.12/213.28  |- skos__historyNote mesh__D016545
% 213.12/213.28       Cerebral Ventricle Neoplasms %28%1966-1991%29%
% 213.12/213.28  |- mesh__historyNote mesh__D016545 1992   
% 213.12/213.28  |- skos__broader mesh__D016545smesh__D002551
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D016545 2005
% 213.12/213.28  |- skos__altLabel mesh__D016545 Primary Choroid Plexus Neoplasms
% 213.12/213.28  |- mesh__recordMaintainer mesh__D016545 ags
% 213.12/213.28  |- skos__historyNote mesh__D016545 Choroid Plexus %28%1966-1991%29%
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D016545 2000A
% 213.12/213.28  |- mesh__dateRevised mesh__D016545 1999-12-08
% 213.12/213.28  |- skos__hiddenLabel mesh__D016545 Choroid Plexus Neoplasm
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D016545 2000
% 213.12/213.28  |- skos__altLabel mesh__D016545 Neoplasms, Choroid Plexus
% 213.12/213.28  |- mesh__dateEstablished mesh__D016545 1992-01-01
% 213.12/213.28  |- rdf__type mesh__D016545sskos__Concept
% 213.12/213.28  |- skos__annotation mesh__D016545
% 213.12/213.28       in the brain: do not confuse with CHOROID NEOPLASMS %28%in the eye%29%; coord IM with histol type of neopl %28%IM%29%%A%  
% 213.12/213.28  |- mesh__publicMeSHNote mesh__D016545 1992   
% 213.12/213.28  |- mesh__recordAuthorizer mesh__D016545 ags
% 213.12/213.28  |- mesh__recordOriginator mesh__D016545 AGS
% 213.12/213.28  |- mesh__dateRevised mesh__D002525 1999-11-03
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D002525 2004
% 213.12/213.28  |- rdf__type mesh__D002525sskos__Concept
% 213.12/213.28  |- skos__broader mesh__D002525smesh__D002531
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D002525 2000
% 213.12/213.28  |- skos__annotation mesh__D002525
% 213.12/213.28       diseases: coord IM with CEREBELLAR DISEASES %28%IM%29%   
% 213.12/213.28  |- mesh__recordOriginator mesh__D002525 NLM
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D002525 2003
% 213.12/213.28  |- mesh__dateCreated mesh__D002525 1999-01-01
% 213.12/213.28  |- skos__scopeNote mesh__D002525
% 213.12/213.28       The superficial gray matter of the cerebellum. It consists of two main layers, the stratum moleculare and the stratum granulosum. %28%Dorland, 28th ed%29%%A%    
% 213.12/213.28  |- skos__hiddenLabel mesh__D002525 Cortex, Cerebellar
% 213.12/213.28  |- mesh__recordAuthorizer mesh__D002525 sjn
% 213.12/213.28  |- mesh__recordMaintainer mesh__D002525 ags
% 213.12/213.28  |- skos__prefLabel mesh__D002525 Cerebellar Cortex
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D002525 2006
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D002525 2002
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D002525 2005
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D002525 2001
% 213.12/213.28  |- mesh__recordMaintainer mesh__D007210 ssb
% 213.12/213.28  |- skos__altLabel mesh__D007210 Indolylacetic Acids
% 213.12/213.28  |- mesh__recordOriginator mesh__D007210 NLM
% 213.12/213.28  |- mesh__dateCreated mesh__D007210 1999-01-01
% 213.12/213.28  |- mesh__onlineNote mesh__D007210
% 213.12/213.28       use INDOLEACETIC ACIDS to search INDOLEACETIC ACID 1966-74%A%  
% 213.12/213.28  |- skos__broader mesh__D007210smesh__D007211
% 213.12/213.28  |- mesh__dateRevised mesh__D007210 2005-06-30
% 213.12/213.28  |- skos__scopeNote mesh__D007210
% 213.12/213.28       Acetic acid derivatives of the heterocyclic compound indole. %28%Merck Index, 11th ed%29%%A%    
% 213.12/213.28  |- rdf__type mesh__D007210sskos__Concept
% 213.12/213.28  |- skos__hiddenLabel mesh__D007210 Acids, Indolylacetic
% 213.12/213.28  |- mesh__historyNote mesh__D007210 75; was INDOLEACETIC ACID 1963-74   
% 213.12/213.28  |- mesh__publicMeSHNote mesh__D007210 75; was INDOLEACETIC ACID 1963-74   
% 213.12/213.28  |- mesh__recordAuthorizer mesh__D007210 sjn
% 213.12/213.28  |- skos__prefLabel mesh__D007210 Indoleacetic Acids
% 213.12/213.28  |- skos__broader mesh__D007210smesh__D000147
% 213.12/213.28  |- skos__hiddenLabel mesh__D007210 Acids, Indoleacetic
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D007210 2006
% 213.12/213.28  |- skos__altLabel mesh__D007210 Auxin
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D012953 2004
% 213.12/213.28  |- mesh__dateCreated mesh__D012953 1999-01-01
% 213.12/213.28  |- skos__broader mesh__D012953smesh__D012952
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D012953 2005
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D012953 2000
% 213.12/213.28  |- rdf__type mesh__D012953sskos__Concept
% 213.12/213.28  |- mesh__dateEstablished mesh__D012953 1965-01-01
% 213.12/213.28  |- skos__scopeNote mesh__D012953
% 213.12/213.28       Societies whose membership is limited to dentists.     
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D012953 2003
% 213.12/213.28  |- mesh__recordMaintainer mesh__D012953 kle
% 213.12/213.28  |- mesh__recordAuthorizer mesh__D012953 sjn
% 213.12/213.28  |- mesh__historyNote mesh__D012953 65   
% 213.12/213.28  |- skos__altLabel mesh__D012953 Dental Society
% 213.12/213.28  |- skos__altLabel mesh__D012953 Dental Societies
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D012953 2002
% 213.12/213.28  |- mesh__recordOriginator mesh__D012953 NLM
% 213.12/213.28  |- mesh__publicMeSHNote mesh__D012953 65   
% 213.12/213.28  |- mesh__dateRevised mesh__D012953 1999-11-03
% 213.12/213.28  |- skos__prefLabel mesh__D012953 Societies, Dental
% 213.12/213.28  |- skos__altLabel mesh__D012953 Society, Dental
% 213.12/213.28  |- skos__annotation mesh__D012953 specify geog; DF: SOCIETIES DENT   
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D012953 2006
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D012953 2001
% 213.12/213.28  |- mesh__recordOriginator mesh__D012155 NLM
% 213.12/213.28  |- skos__altLabel mesh__D012155 Reticulin Fibril
% 213.12/213.28  |- skos__altLabel mesh__D012155 Reticular Fibrils
% 213.12/213.28  |- skos__altLabel mesh__D012155 Reticulin Fiber
% 213.12/213.28  |- skos__hiddenLabel mesh__D012155 Fibrils, Reticular
% 213.12/213.28  |- mesh__dateCreated mesh__D012155 1999-01-01
% 213.12/213.28  |- skos__altLabel mesh__D012155 Reticular Fiber
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D012155 2005
% 213.12/213.28  |- skos__altLabel mesh__D012155 Reticular Fibril
% 213.12/213.28  |- skos__hiddenLabel mesh__D012155 Fibers, Reticulin
% 213.12/213.28  |- skos__hiddenLabel mesh__D012155 Fibers, Reticular
% 213.12/213.28  |- mesh__recordAuthorizer mesh__D012155 sjn
% 213.12/213.28  |- skos__hiddenLabel mesh__D012155 Fiber, Reticular
% 213.12/213.28  |- mesh__recordMaintainer mesh__D012155 jmp
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D012155 2006
% 213.12/213.28  |- skos__related mesh__D012155smesh__D004535
% 213.12/213.28  |- skos__hiddenLabel mesh__D012155 Fibril, Reticulin
% 213.12/213.28  |- skos__broader mesh__D012155smesh__D012596
% 213.12/213.28  |- skos__hiddenLabel mesh__D012155 Fiber, Reticulin
% 213.12/213.28  |- skos__broader mesh__D012155smesh__D001704
% 213.12/213.28  |- skos__hiddenLabel mesh__D012155 Fibril, Reticular
% 213.12/213.28  |- mesh__dateRevised mesh__D012155 2004-07-07
% 213.12/213.28  |- skos__altLabel mesh__D012155 Reticulin Fibers
% 213.12/213.28  |- skos__scopeNote mesh__D012155
% 213.12/213.28       A scleroprotein fibril consisting mostly of type III collagen. Reticulin fibrils are extremely thin, with a diameter of between 0.5 and 2 um. They are involved in maintaining the structural integrity in a variety of organs.%A%    
% 213.12/213.28  |- rdf__type mesh__D012155sskos__Concept
% 213.12/213.28  |- skos__altLabel mesh__D012155 Reticulin Fibrils
% 213.12/213.28  |- skos__altLabel mesh__D012155 Reticular Fibers
% 213.12/213.28  |- skos__hiddenLabel mesh__D012155 Fibrils, Reticulin
% 213.12/213.28  |- skos__prefLabel mesh__D012155 Reticulin
% 213.12/213.28  |- mesh__dateRevised mesh__D006916 2001-07-25
% 213.12/213.28  |- mesh__dateCreated mesh__D006916 1999-01-01
% 213.12/213.28  |- skos__prefLabel mesh__D006916 5-Hydroxytryptophan
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006916 2006
% 213.12/213.28  |- skos__altLabel mesh__D006916 Oxitriptan
% 213.12/213.28  |- skos__annotation mesh__D006916 a serotonin precursor   
% 213.12/213.28  |- skos__hiddenLabel mesh__D006916 5 Hydroxytryptophan
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006916 2005
% 213.12/213.28  |- skos__scopeNote mesh__D006916
% 213.12/213.28       Precursor of serotonin used as antiepileptic and antidepressant.%A%    
% 213.12/213.28  |- mesh__historyNote mesh__D006916
% 213.12/213.28       90; was HYDROXYTRYPTOPHAN 1963-89 %28%Prov 1963-65%29%   
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006916 2004
% 213.12/213.28  |- mesh__publicMeSHNote mesh__D006916 90; was HYDROXYTRYPTOPHAN 1965-89   
% 213.12/213.28  |- mesh__recordMaintainer mesh__D006916 nns
% 213.12/213.28  |- skos__altLabel mesh__D006916 5-HTP
% 213.12/213.28  |- rdf__type mesh__D006916sskos__Concept
% 213.12/213.28  |- mesh__dateEstablished mesh__D006916 1965-01-01
% 213.12/213.28  |- mesh__onlineNote mesh__D006916
% 213.12/213.28       use 5-HYDROXYTRYPTOPHAN to search HYDROXYTRYPTOPHAN 1966-89%A%  
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006916 2003
% 213.12/213.28  |- skos__altLabel mesh__D006916 Oxytryptophan
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006916 2002
% 213.12/213.28  |- mesh__recordOriginator mesh__D006916 NLM
% 213.12/213.28  |- skos__broader mesh__D006916smesh__D014364
% 213.12/213.28  |- mesh__recordAuthorizer mesh__D006916 sjn
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006118 2002
% 213.12/213.28  |- mesh__dateRevised mesh__D006118 2001-07-25
% 213.12/213.28  |- mesh__dateCreated mesh__D006118 1999-01-01
% 213.12/213.28  |- skos__broader mesh__D006118smesh__D001572
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006118 2003
% 213.12/213.28  |- rdf__type mesh__D006118sskos__Concept
% 213.12/213.28  |- skos__scopeNote mesh__D006118
% 213.12/213.28       An antifungal antibiotic. Griseofulvin may be given by mouth in the treatment of tinea infections.%A%    
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006118 2006
% 213.12/213.28  |- skos__prefLabel mesh__D006118 Griseofulvin
% 213.12/213.28  |- mesh__recordMaintainer mesh__D006118 ssb
% 213.12/213.28  |- mesh__recordOriginator mesh__D006118 NLM
% 213.12/213.28  |- mesh__recordAuthorizer mesh__D006118 sjn
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006118 2004
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006118 2005
% 213.12/213.28  |- skos__hiddenLabel mesh__D002526 Dysfunction, Cerebellar
% 213.12/213.28  |- skos__hiddenLabel mesh__D002526 Disease, Cerebellar
% 213.12/213.28  |- mesh__recordMaintainer mesh__D002526 KEV
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D002526 2002
% 213.12/213.28  |- skos__altLabel mesh__D002526 Cerebellar Disorders
% 213.12/213.28  |- mesh__dateRevised mesh__D002526 1999-11-03
% 213.12/213.28  |- skos__hiddenLabel mesh__D002526 Syndrome, Cerebellar
% 213.12/213.28  |- skos__hiddenLabel mesh__D002526 Disorder, Cerebellar
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D002526 2006
% 213.12/213.28  |- skos__annotation mesh__D002526 GEN: prefer specifics   
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D002526 2001
% 213.12/213.28  |- skos__altLabel mesh__D002526 Cerebellar Dysfunction
% 213.12/213.28  |- skos__hiddenLabel mesh__D002526 Cerebellar Dysfunctions
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D002526 2005
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D002526 2000
% 213.12/213.28  |- skos__hiddenLabel mesh__D002526 Cerebellar Disorder
% 213.12/213.28  |- mesh__recordOriginator mesh__D002526 NLM
% 213.12/213.28  |- skos__altLabel mesh__D002526 Cerebellar Syndromes
% 213.12/213.28  |- skos__prefLabel mesh__D002526 Cerebellar Diseases
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D002526 2004
% 213.12/213.28  |- rdf__type mesh__D002526sskos__Concept
% 213.12/213.28  |- skos__scopeNote mesh__D002526
% 213.12/213.28       Diseases that affect the structure or function of the cerebellum. Cardinal manifestations of cerebellar dysfunction include dysmetria, GAIT ATAXIA, and MUSCLE HYPOTONIA.%A%    
% 213.12/213.28  |- skos__broader mesh__D002526smesh__D001927
% 213.12/213.28  |- skos__altLabel mesh__D002526 Cerebellum Diseases
% 213.12/213.28  |- skos__hiddenLabel mesh__D002526 Cerebellar Syndrome
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D002526 2003
% 213.12/213.28  |- mesh__dateCreated mesh__D002526 1999-01-01
% 213.12/213.28  |- mesh__recordAuthorizer mesh__D002526 sjn
% 213.12/213.28  |- skos__hiddenLabel mesh__D002526 Cerebellar Disease
% 213.12/213.28  |- skos__hiddenLabel mesh__D002526 Disease, Cerebellum
% 213.12/213.28  |- skos__hiddenLabel mesh__D002526 Cerebellum Disease
% 213.12/213.28  |- skos__annotation mesh__D007211 includes isoindoles   
% 213.12/213.28  |- skos__broader mesh__D007211smesh__D006574
% 213.12/213.28  |- rdf__type mesh__D007211sskos__Concept
% 213.12/213.28  |- mesh__recordMaintainer mesh__D007211 TAP
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D007211 2002
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D007211 1998
% 213.12/213.28  |- mesh__recordAuthorizer mesh__D007211 PLS
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D007211 2003
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D007211 1997
% 213.12/213.28  |- mesh__recordOriginator mesh__D007211 NLM
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D007211 2001
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D007211 2000
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D007211 1996
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D007211 1995
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D007211 2006
% 213.12/213.28  |- mesh__dateRevised mesh__D007211 1992-05-19
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D007211 1994
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D007211 2005
% 213.12/213.28  |- mesh__dateCreated mesh__D007211 1999-01-01
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D007211 1993
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D007211 1999
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D007211 2004
% 213.12/213.28  |- skos__prefLabel mesh__D007211 Indoles
% 213.12/213.28  |- skos__prefLabel mesh__D048628 Ketolides
% 213.12/213.28  |- mesh__historyNote mesh__D048628 2005   
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D048628 2005
% 213.12/213.28  |- skos__scopeNote mesh__D048628
% 213.12/213.28       Compounds based on ERYTHROMYCIN with the 3-cladinose replaced by a ketone. They bind the 23S part of 70S bacterial RIBOSOMES.%A%    
% 213.12/213.28  |- mesh__dateEstablished mesh__D048628 2005-01-01
% 213.12/213.28  |- skos__altLabel mesh__D048628 3-Keto-Erythromycins
% 213.12/213.28  |- mesh__recordMaintainer mesh__D048628 ssb
% 213.12/213.28  |- mesh__dateCreated mesh__D048628 2004-07-07
% 213.12/213.28  |- skos__hiddenLabel mesh__D048628 3 Keto Erythromycins
% 213.12/213.28  |- mesh__recordOriginator mesh__D048628 ssb
% 213.12/213.28  |- skos__hiddenLabel mesh__D048628 Erythromycins, 3 Keto
% 213.12/213.28  |- skos__hiddenLabel mesh__D048628 3-Keto Erythromycins
% 213.12/213.28  |- mesh__recordAuthorizer mesh__D048628 sjn
% 213.12/213.28  |- skos__broader mesh__D048628smesh__D004917
% 213.12/213.28  |- mesh__publicMeSHNote mesh__D048628 2005   
% 213.12/213.28  |- skos__historyNote mesh__D048628 Macrolides %28%1997-2004%29%
% 213.12/213.28  |- skos__altLabel mesh__D048628 Erythromycins, 3-Keto
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D048628 2006
% 213.12/213.28  |- rdf__type mesh__D048628sskos__Concept
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D012954 2001
% 213.12/213.28  |- skos__broader mesh__D012954smesh__D012952
% 213.12/213.28  |- skos__historyNote mesh__D012954 Societies %28%1966-Jul 1977%29%
% 213.12/213.28  |- skos__historyNote mesh__D012954 Hospitals %28%1966-Jul 1977%29%
% 213.12/213.28  |- mesh__publicMeSHNote mesh__D012954
% 213.12/213.28       91; was see under SOCIETIES Aug 1977-90   
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D012954 2000
% 213.12/213.28  |- mesh__historyNote mesh__D012954
% 213.12/213.28       91%28%Aug 77%29%; was see under SOCIETIES 1977-90   
% 213.12/213.28  |- skos__prefLabel mesh__D012954 Societies, Hospital
% 213.12/213.28  |- skos__altLabel mesh__D012954 Society, Hospital
% 213.12/213.28  |- skos__altLabel mesh__D012954 Hospital Society
% 213.12/213.28  |- skos__altLabel mesh__D012954 Hospital Societies
% 213.12/213.28  |- mesh__recordMaintainer mesh__D012954 kle
% 213.12/213.28  |- mesh__recordAuthorizer mesh__D012954 sjn
% 213.12/213.28  |- skos__scopeNote mesh__D012954
% 213.12/213.28       Societies having institutional membership limited to hospitals and other health care institutions.%A%    
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D012954 2006
% 213.12/213.28  |- skos__annotation mesh__D012954 specify geog; DF: SOCIETIES HOSP   
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D012954 2002
% 213.12/213.28  |- mesh__dateCreated mesh__D012954 1977-05-12
% 213.12/213.28  |- mesh__recordOriginator mesh__D012954 EC
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D012954 2004
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D012954 2005
% 213.12/213.28  |- mesh__dateEstablished mesh__D012954 1991-01-01
% 213.12/213.28  |- rdf__type mesh__D012954sskos__Concept
% 213.12/213.28  |- mesh__dateRevised mesh__D012954 1999-11-03
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D012954 2003
% 213.12/213.28  |- skos__broader mesh__D012156smesh__D004912
% 213.12/213.28  |- rdf__type mesh__D012156sskos__Concept
% 213.12/213.28  |- mesh__recordOriginator mesh__D012156 NLM
% 213.12/213.28  |- mesh__dateRevised mesh__D012156 2003-07-09
% 213.12/213.28  |- skos__hiddenLabel mesh__D012156 Reticulocyte
% 213.12/213.28  |- mesh__recordAuthorizer mesh__D012156 sjn
% 213.12/213.28  |- skos__scopeNote mesh__D012156
% 213.12/213.28       Immature ERYTHROCYTES. In humans, these are ERYTHROID CELLS that have just undergone extrusion of their CELL NUCLEUS. They still contain some organelles that gradually decrease in number as the cells mature. RIBOSOMES are last to disappear. Certain staining techniques cause components of the ribosomes to precipitate into characteristic %22%reticulum%22% %28%not the same as the ENDOPLASMIC RETICULUM%29%, hence the name reticulocytes.%A%    
% 213.12/213.28  |- skos__prefLabel mesh__D012156 Reticulocytes
% 213.12/213.28  |- mesh__dateCreated mesh__D012156 1999-01-01
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D012156 2005
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D012156 2004
% 213.12/213.28  |- mesh__recordMaintainer mesh__D012156 nns
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D012156 2006
% 213.12/213.28  |- skos__broader mesh__D012156smesh__D015672
% 213.12/213.28  |- skos__historyNote mesh__D006917 Indoles %28%1970-1974%29%
% 213.12/213.28  |- skos__historyNote mesh__D006917 Alcohol, Ethyl %28%1972-1974%29%
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006917 2002
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006917 1999
% 213.12/213.28  |- mesh__recordOriginator mesh__D006917 NLM
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006917 1994
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006917 2005
% 213.12/213.28  |- mesh__publicMeSHNote mesh__D006917 91; was see under INDOLES 1975-90   
% 213.12/213.28  |- mesh__dateEstablished mesh__D006917 1991-01-01
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006917 2001
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006917 1993
% 213.12/213.28  |- mesh__recordMaintainer mesh__D006917 TAP
% 213.12/213.28  |- mesh__dateCreated mesh__D006917 1974-11-19
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006917 2004
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006917 1998
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006917 2000
% 213.12/213.28  |- mesh__activeMeSHYear mesh__D006917 1997
% 213.22/213.37  |- rdf__type mesh__D006917sskos__Concept
% 213.22/213.37  |- skos__prefLabel mesh__D006917 Hydroxytryptophol
% 213.22/213.37  |- mesh__dateRevised mesh__D006917 1992-05-19
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006917 2003
% 213.22/213.37  |- mesh__historyNote mesh__D006917
% 213.22/213.37       91%28%75%29%; was see under INDOLES 1975-90   
% 213.22/213.37  |- skos__broader mesh__D006917smesh__D007211
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006917 1996
% 213.22/213.37  |- skos__scopeNote mesh__D006917 5-Hydroxy-indole-3-ethanol.     
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006917 1995
% 213.22/213.37  |- mesh__recordAuthorizer mesh__D006917 PLS
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006917 2006
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D031310 2006
% 213.22/213.37  |- mesh__dateEstablished mesh__D031310 2003-01-01
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D031310 2004
% 213.22/213.37  |- skos__prefLabel mesh__D031310 Fumariaceae
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D031310 2005
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D031310 2003
% 213.22/213.37  |- mesh__publicMeSHNote mesh__D031310 2003   
% 213.22/213.37  |- rdf__type mesh__D031310sskos__Concept
% 213.22/213.37  |- skos__annotation mesh__D031310
% 213.22/213.37       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.22/213.37  |- mesh__dateCreated mesh__D031310 2002-07-03
% 213.22/213.37  |- mesh__historyNote mesh__D031310 2003   
% 213.22/213.37  |- skos__scopeNote mesh__D031310
% 213.22/213.37       The fumitory, or bleeding-heart plant family of the order Papaverales, subclass Magnoliidae, class Magnoliopsida. Flowers are bisexual, with two small sepals and four petals, one pistil and six stamens.%A%    
% 213.22/213.37  |- skos__broader mesh__D031310smesh__D019684
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006119 1999
% 213.22/213.37  |- mesh__dateRevised mesh__D006119 1987-01-13
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006119 1996
% 213.22/213.37  |- skos__annotation mesh__D006119
% 213.22/213.37       external only: do not confuse with INGUINAL CANAL, internal only; NIM when merely locational%A%  
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006119 1997
% 213.22/213.37  |- skos__prefLabel mesh__D006119 Groin
% 213.22/213.37  |- rdf__type mesh__D006119sskos__Concept
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006119 1989
% 213.22/213.37  |- mesh__historyNote mesh__D006119 81   
% 213.22/213.37  |- skos__historyNote mesh__D006119 Inguinal Canal %28%1966-1980%29%
% 213.22/213.37  |- mesh__publicMeSHNote mesh__D006119 81   
% 213.22/213.37  |- mesh__dateEstablished mesh__D006119 1981-01-01
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006119 1994
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006119 2005
% 213.22/213.37  |- skos__hiddenLabel mesh__D006119 Groins
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006119 1992
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006119 1995
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006119 2000
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006119 1990
% 213.22/213.37  |- mesh__recordOriginator mesh__D006119 AEP
% 213.22/213.37  |- mesh__dateCreated mesh__D006119 1980-04-02
% 213.22/213.37  |- skos__scopeNote mesh__D006119
% 213.22/213.37       The external junctural region between the lower part of the abdomen and the thigh.%A%    
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006119 2006
% 213.22/213.37  |- mesh__recordMaintainer mesh__D006119 BDS
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006119 2003
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006119 1993
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006119 1998
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006119 2001
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006119 1991
% 213.22/213.37  |- mesh__recordAuthorizer mesh__D006119 CAB
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006119 2004
% 213.22/213.37  |- skos__broader mesh__D006119smesh__D000005
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D006119 2002
% 213.22/213.37  |- skos__historyNote mesh__D016547 Nerve Tissue Proteins %28%1966-1991%29%
% 213.22/213.37  |- mesh__onlineNote mesh__D016547
% 213.22/213.37       use KINESIN %28%NM%29% to search KINESIN 1985-91   
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D016547 2006
% 213.22/213.37  |- skos__historyNote mesh__D016547 Microtubule Proteins %28%1985-1991%29%
% 213.22/213.37  |- mesh__dateEstablished mesh__D016547 1992-01-01
% 213.22/213.37  |- mesh__recordMaintainer mesh__D016547 jmp
% 213.22/213.37  |- mesh__recordAuthorizer mesh__D016547 sjn
% 213.22/213.37  |- mesh__historyNote mesh__D016547 92; was KINESIN %28%NM%29% 1985-91   
% 213.22/213.37  |- skos__broader mesh__D016547smesh__D000251
% 213.22/213.37  |- skos__historyNote mesh__D016547
% 213.22/213.37       Adenosine Triphosphatase %28%1966-1991%29%
% 213.22/213.37  |- skos__scopeNote mesh__D016547
% 213.22/213.37       A microtubule-associated mechanical adenosine triphosphatase, that uses the energy of ATP hydrolysis to move organelles along microtubules toward the plus end of the microtubule. The protein is found in squid axoplasm, optic lobes, and in bovine brain. Bovine kinesin is a heterotetramer composed of two heavy %28%120 kDa%29% and two light %28%62 kDa%29% chains. EC 3.6.1.-.%A%    
% 213.22/213.37  |- rdf__type mesh__D016547sskos__Concept
% 213.22/213.37  |- mesh__dateRevised mesh__D016547 2004-07-07
% 213.22/213.37  |- mesh__recordOriginator mesh__D016547 RLS
% 213.22/213.37  |- skos__annotation mesh__D016547 a microtubule-associated protein   
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D016547 2005
% 213.22/213.37  |- skos__prefLabel mesh__D016547 Kinesin
% 213.22/213.37  |- skos__broader mesh__D016547smesh__D008869
% 213.22/213.37  |- mesh__dateCreated mesh__D016547 1991-07-12
% 213.22/213.37  |- mesh__publicMeSHNote mesh__D016547
% 213.22/213.37       92; KINESIN was indexed under ADENOSINE TRIPHOSPHATASE 1985-91 %26% under NERVE TISSUE PROTEINS 1985-89%A%  
% 213.22/213.37  |- mesh__dateCreated mesh__D035701 2002-07-03
% 213.22/213.37  |- rdf__type mesh__D035701sskos__Concept
% 213.22/213.37  |- mesh__publicMeSHNote mesh__D035701 2003   
% 213.22/213.37  |- mesh__dateRevised mesh__D035701 2003-07-09
% 213.22/213.37  |- mesh__recordOriginator mesh__D035701 ssb
% 213.22/213.37  |- skos__prefLabel mesh__D035701 Eurycoma
% 213.22/213.37  |- mesh__dateEstablished mesh__D035701 2003-01-01
% 213.22/213.37  |- skos__broader mesh__D035701smesh__D029641
% 213.22/213.37  |- mesh__historyNote mesh__D035701 2003   
% 213.22/213.37  |- skos__scopeNote mesh__D035701
% 213.22/213.37       A plant genus of the family SIMAROUBACEAE. Members contain quassinoids. There is Malaysian folk use of these plants for male virility.%A%    
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D035701 2006
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D035701 2004
% 213.22/213.37  |- skos__annotation mesh__D035701
% 213.22/213.37       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.22/213.37  |- mesh__recordMaintainer mesh__D035701 ssb
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D035701 2005
% 213.22/213.37  |- mesh__recordAuthorizer mesh__D035701 sjn
% 213.22/213.37  |- skos__altLabel mesh__D035701 Long Jack
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D002527 2005
% 213.22/213.37  |- skos__prefLabel mesh__D002527 Myoclonic Cerebellar Dyssynergia
% 213.22/213.37  |- skos__hiddenLabel mesh__D002527 Atrophies, Dentate Cerebellar
% 213.22/213.37  |- mesh__recordAuthorizer mesh__D002527 sjn
% 213.22/213.37  |- mesh__historyNote mesh__D002527
% 213.22/213.37       2000%28%1970%29%; use CEREBELLAR ATAXIA 1970-1990   
% 213.22/213.37  |- skos__altLabel mesh__D002527 Dyssynergia Cerebellaris Progressiva
% 213.22/213.37  |- skos__altLabel mesh__D002527 Dentate Cerebellar Atrophy
% 213.22/213.37  |- mesh__publicMeSHNote mesh__D002527
% 213.22/213.37       2000; see CEREBELLAR DYSSYNERGIA 1991-1999; see CEREBELLAR ATAXIA 1970-1990%A%  
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D002527 2006
% 213.22/213.37  |- skos__hiddenLabel mesh__D002527 Dyssynergias, Myoclonic Cerebellar
% 213.22/213.37  |- skos__hiddenLabel mesh__D002527 Atrophy, Dentate Cerebellar
% 213.22/213.37  |- skos__annotation mesh__D002527
% 213.22/213.37       do not confuse X ref RAMSAY HUNT CEREBELLAR SYNDROME with RAMSAY HUNT AURICULAR SYNDROME see HERPES ZOSTER OTICUS or RAMSAY HUNT PARALYSIS SYNDROME see PARKINSONIAN DISORDERS%A%  
% 213.22/213.37  |- skos__hiddenLabel mesh__D002527 Ataxia, Dentate Cerebellar
% 213.22/213.37  |- skos__hiddenLabel mesh__D002527 Cerebellar Ataxias, Dentate
% 213.22/213.37  |- skos__hiddenLabel mesh__D002527 Cerebellar Dyssynergia, Myoclonic
% 213.22/213.37  |- skos__hiddenLabel mesh__D002527 Dyssynergia, Cerebellar
% 213.22/213.37  |- skos__hiddenLabel mesh__D002527 Myoclonic Cerebellar Dyssynergias
% 213.22/213.37  |- skos__historyNote mesh__D002527 Cerebellar Diseases %28%1966-1969%29%
% 213.22/213.37  |- skos__altLabel mesh__D002527 Dentate Cerebellar Ataxia
% 213.22/213.37  |- skos__hiddenLabel mesh__D002527 Cerebellar Dyssynergias, Myoclonic
% 213.22/213.37  |- mesh__dateRevised mesh__D002527 2001-07-25
% 213.22/213.37  |- mesh__dateCreated mesh__D002527 1999-01-01
% 213.22/213.37  |- skos__hiddenLabel mesh__D002527 Dyssynergia, Myoclonic Cerebellar
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D002527 2002
% 213.22/213.37  |- skos__hiddenLabel mesh__D002527 Cerebellar Dyssynergias
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D002527 2003
% 213.22/213.37  |- skos__hiddenLabel mesh__D002527 Dyssynergias, Cerebellar
% 213.22/213.37  |- skos__broader mesh__D002527smesh__D013132
% 213.22/213.37  |- skos__scopeNote mesh__D002527
% 213.22/213.37       A condition marked by progressive CEREBELLAR ATAXIA combined with MYOCLONUS usually presenting in the third decade of life or later. Additional clinical features may include generalized and focal SEIZURES, spasticity, and DYSKINESIAS. Autosomal recessive and autosomal dominant patterns of inheritance have been reported. Pathologically, the dentate nucleus and brachium conjunctivum of the CEREBELLUM are atrophic, with variable involvement of the spinal cord, cerebellar cortex, and basal ganglia. %28%From Joynt, Clinical Neurology, 1991, Ch37, pp60-1%29%%A%    
% 213.22/213.37  |- skos__altLabel mesh__D002527 Cerebellar Dyssynergia
% 213.22/213.37  |- rdf__type mesh__D002527sskos__Concept
% 213.22/213.37  |- skos__hiddenLabel mesh__D002527 Dentate Cerebellar Atrophies
% 213.22/213.37  |- skos__hiddenLabel mesh__D002527 Dentate Cerebellar Ataxias
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D002527 2004
% 213.22/213.37  |- mesh__recordMaintainer mesh__D002527 lkt
% 213.22/213.37  |- skos__hiddenLabel mesh__D002527 Cerebellar Atrophy, Dentate
% 213.22/213.37  |- skos__hiddenLabel mesh__D002527 Ataxias, Dentate Cerebellar
% 213.22/213.37  |- skos__altLabel mesh__D002527 Ramsay Hunt Cerebellar Syndrome
% 213.22/213.37  |- mesh__dateEstablished mesh__D002527 1991-01-01
% 213.22/213.37  |- skos__altLabel mesh__D002527 Ramsay Hunt Dentate Syndrome
% 213.22/213.37  |- skos__altLabel mesh__D002527 Dyssynergia Cerebellaris Myoclonica
% 213.22/213.37  |- skos__altLabel mesh__D002527 Dentate Nucleus Syndrome, Ramsay Hunt
% 213.22/213.37  |- mesh__recordOriginator mesh__D002527 NLM
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D007212 2004
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D007212 1996
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D007212 2002
% 213.22/213.37  |- skos__prefLabel mesh__D007212 Indolizines
% 213.22/213.37  |- rdf__type mesh__D007212sskos__Concept
% 213.22/213.37  |- mesh__publicMeSHNote mesh__D007212 66   
% 213.22/213.37  |- mesh__recordAuthorizer mesh__D007212 PLS
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D007212 1997
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D007212 1994
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D007212 2005
% 213.22/213.37  |- mesh__recordMaintainer mesh__D007212 TAP
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D007212 2000
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D007212 1995
% 213.22/213.37  |- mesh__dateCreated mesh__D007212 1999-01-01
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D007212 2006
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D007212 2001
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D007212 1998
% 213.22/213.37  |- skos__broader mesh__D007212smesh__D006574
% 213.22/213.37  |- mesh__dateRevised mesh__D007212 1992-05-19
% 213.22/213.37  |- mesh__recordOriginator mesh__D007212 NLM
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D007212 2003
% 213.22/213.37  |- mesh__historyNote mesh__D007212 66   
% 213.22/213.37  |- mesh__dateEstablished mesh__D007212 1966-01-01
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D007212 1999
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D007212 1993
% 213.22/213.37  |- skos__hiddenLabel mesh__D048629 Micronuclei, Genotoxicant Induced
% 213.22/213.37  |- skos__altLabel mesh__D048629 Genotoxicant-Induced Micronuclei
% 213.22/213.37  |- skos__hiddenLabel mesh__D048629 Micronuclei, Chromosome Defective
% 213.22/213.37  |- mesh__recordOriginator mesh__D048629 nns
% 213.22/213.37  |- mesh__recordMaintainer mesh__D048629 nns
% 213.22/213.37  |- skos__hiddenLabel mesh__D048629 Chromosome-Defective Micronucleus
% 213.22/213.37  |- skos__related mesh__D048629smesh__D048631
% 213.22/213.37  |- skos__altLabel mesh__D048629 Micronucleus, Chromosome-Defective
% 213.22/213.37  |- mesh__dateEstablished mesh__D048629 2005-01-01
% 213.22/213.37  |- mesh__historyNote mesh__D048629 2005   
% 213.22/213.37  |- skos__scopeNote mesh__D048629
% 213.22/213.37       Defective nuclei produced during the TELOPHASE of MITOSIS or MEIOSIS by lagging CHROMOSOMES or chromosome fragments derived from spontaneous or experimentally induced chromosomal structural changes.%A%    
% 213.22/213.37  |- mesh__publicMeSHNote mesh__D048629 2005   
% 213.22/213.37  |- skos__hiddenLabel mesh__D048629 Micronucleus, Genotoxicant-Induced
% 213.22/213.37  |- skos__broader mesh__D048629smesh__D002869
% 213.22/213.37  |- skos__hiddenLabel mesh__D048629 Genotoxicant Induced Micronuclei
% 213.22/213.37  |- skos__prefLabel mesh__D048629 Micronuclei, Chromosome-Defective
% 213.22/213.37  |- skos__hiddenLabel mesh__D048629 Chromosome Defective Micronuclei
% 213.22/213.37  |- skos__altLabel mesh__D048629 Chromosome-Defective Micronuclei
% 213.22/213.37  |- mesh__activeMeSHYear mesh__D048629 2005
% 213.22/213.37  |- skos__broader mesh__D048629smesh__D002467
% 213.22/213.37  |- skos__hiddenLabel mesh__D048629 Genotoxicant-Induced Micronucleus
% 213.22/213.37  |- skos__related mesh__D048629smesh__D015162
% 213.22/213.37  |- mesh__dateCreated mesh__D048629 2004-07-07
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D048629 2006
% 213.22/213.38  |- skos__hiddenLabel mesh__D048629 Micronucleus, Chromosome Defective
% 213.22/213.38  |- mesh__recordAuthorizer mesh__D048629 sjn
% 213.22/213.38  |- rdf__type mesh__D048629sskos__Concept
% 213.22/213.38  |- skos__altLabel mesh__D012955 Medical Society
% 213.22/213.38  |- skos__altLabel mesh__D012955 Medical Societies
% 213.22/213.38  |- skos__scopeNote mesh__D012955
% 213.22/213.38       Societies whose membership is limited to physicians.     
% 213.22/213.38  |- mesh__recordOriginator mesh__D012955 NLM
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012955 2000
% 213.22/213.38  |- skos__broader mesh__D012955smesh__D012952
% 213.22/213.38  |- mesh__dateCreated mesh__D012955 1999-01-01
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012955 2005
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012955 2001
% 213.22/213.38  |- skos__prefLabel mesh__D012955 Societies, Medical
% 213.22/213.38  |- mesh__dateRevised mesh__D012955 1999-11-03
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012955 2003
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012955 2006
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012955 2002
% 213.22/213.38  |- skos__altLabel mesh__D012955 Society, Medical
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012955 2004
% 213.22/213.38  |- skos__annotation mesh__D012955
% 213.22/213.38       for conventional medical societies %26% soc of med specialties indented under spec in Cat G2; Manual 35.9.1; TN 174: scope; specify geog; %22%College of Physicians%22% goes here; DF: SOCIETIES MED%A%  
% 213.22/213.38  |- mesh__recordAuthorizer mesh__D012955 sjn
% 213.22/213.38  |- mesh__recordMaintainer mesh__D012955 kle
% 213.22/213.38  |- rdf__type mesh__D012955sskos__Concept
% 213.22/213.38  |- mesh__dateRevised mesh__D045331 2004-07-07
% 213.22/213.38  |- skos__broader mesh__D045331smesh__D017494
% 213.22/213.38  |- skos__scopeNote mesh__D045331
% 213.22/213.38       A large multisubunit protein complex that is found in the THYLAKOID MEMBRANE. It uses light energy derived from LIGHT-HARVESTING PROTEIN COMPLEXES to drive electron transfer reactions that result in either the reduction of NADP to NADPH or the transport of PROTONS across the membrane.%A%    
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D045331 2005
% 213.22/213.38  |- skos__historyNote mesh__D045331 Chlorophyll %28%1966-1990%29%
% 213.22/213.38  |- skos__hiddenLabel mesh__D045331 I, Photosystem
% 213.22/213.38  |- mesh__dateCreated mesh__D045331 2003-07-09
% 213.22/213.38  |- mesh__recordAuthorizer mesh__D045331 sjn
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D045331 2006
% 213.22/213.38  |- mesh__recordOriginator mesh__D045331 jmp
% 213.22/213.38  |- skos__broader mesh__D045331smesh__D045322
% 213.22/213.38  |- rdf__type mesh__D045331sskos__Concept
% 213.22/213.38  |- skos__historyNote mesh__D045331 Plant Proteins %28%1966-1990%29%
% 213.22/213.38  |- skos__historyNote mesh__D045331
% 213.22/213.38       Photosynthetic Reaction Center Complex Proteins %28%1991-2003%29%
% 213.22/213.38  |- mesh__dateEstablished mesh__D045331 2004-01-01
% 213.22/213.38  |- mesh__recordMaintainer mesh__D045331 jmp
% 213.22/213.38  |- mesh__historyNote mesh__D045331
% 213.22/213.38       2004; for PHOTOSYSTEM I REACTION CENTER use PHOTOSYNTHETIC REACTION CENTER COMPLEX PROTEINS 1991-2003%A%  
% 213.22/213.38  |- skos__altLabel mesh__D045331 Photosystem I Reaction Center
% 213.22/213.38  |- skos__broader mesh__D045331smesh__D009097
% 213.22/213.38  |- mesh__publicMeSHNote mesh__D045331
% 213.22/213.38       2004; for PHOTOSYSTEM I REACTION CENTER see PHOTOSYNTHETIC REACTION CENTER, PLANT 1991-2003%A%  
% 213.22/213.38  |- skos__prefLabel mesh__D045331 Photosystem I Protein Complex
% 213.22/213.38  |- skos__broader mesh__D012157smesh__D007107
% 213.22/213.38  |- rdf__type mesh__D012157sskos__Concept
% 213.22/213.38  |- skos__related mesh__D012157smesh__D007728
% 213.22/213.38  |- skos__related mesh__D012157smesh__D010586
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012157 2002
% 213.22/213.38  |- skos__related mesh__D012157smesh__D006644
% 213.22/213.38  |- skos__hiddenLabel mesh__D012157 Systems, Reticuloendothelial
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012157 1996
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012157 1991
% 213.22/213.38  |- skos__hiddenLabel mesh__D012157 System, Reticuloendothelial
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012157 2003
% 213.22/213.38  |- skos__hiddenLabel mesh__D012157 Reticuloendothelial Systems
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012157 1998
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012157 2005
% 213.22/213.38  |- mesh__dateCreated mesh__D012157 1999-01-01
% 213.22/213.38  |- mesh__recordOriginator mesh__D012157 NLM
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012157 1997
% 213.22/213.38  |- mesh__dateRevised mesh__D012157 1990-03-22
% 213.22/213.38  |- skos__prefLabel mesh__D012157 Reticuloendothelial System
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012157 1992
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012157 2004
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012157 1994
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012157 1999
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012157 2006
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012157 2000
% 213.22/213.38  |- skos__related mesh__D012157smesh__D008264
% 213.22/213.38  |- skos__annotation mesh__D012157
% 213.22/213.38       RES; reticuloendothelial cells of liver = KUPFFER CELLS   
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012157 1993
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012157 1995
% 213.22/213.38  |- mesh__recordAuthorizer mesh__D012157 PLS
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012157 2001
% 213.22/213.38  |- mesh__recordMaintainer mesh__D012157 TGC
% 213.22/213.38  |- skos__historyNote mesh__D006918 Urea %28%1966%29%
% 213.22/213.38  |- rdf__type mesh__D006918sskos__Concept
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D006918 2003
% 213.22/213.38  |- skos__altLabel mesh__D006918 Hydroxycarbamid
% 213.22/213.38  |- mesh__dateEstablished mesh__D006918 1968-01-01
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D006918 2002
% 213.22/213.38  |- mesh__recordOriginator mesh__D006918 NLM
% 213.22/213.38  |- mesh__dateCreated mesh__D006918 1999-01-01
% 213.22/213.38  |- skos__scopeNote mesh__D006918
% 213.22/213.38       An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.%A%    
% 213.22/213.38  |- mesh__recordAuthorizer mesh__D006918 sjn
% 213.22/213.38  |- skos__prefLabel mesh__D006918 Hydroxyurea
% 213.22/213.38  |- mesh__publicMeSHNote mesh__D006918 68   
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D006918 2006
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D006918 2001
% 213.22/213.38  |- skos__broader mesh__D006918smesh__D014508
% 213.22/213.38  |- mesh__dateRevised mesh__D006918 2000-06-22
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D006918 2005
% 213.22/213.38  |- mesh__historyNote mesh__D006918 68%28%67%29%   
% 213.22/213.38  |- mesh__recordMaintainer mesh__D006918 CCR
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D006918 2004
% 213.22/213.38  |- skos__historyNote mesh__D006918 Antineoplastic Agents %28%1966%29%
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D017640 1994
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D017640 2001
% 213.22/213.38  |- skos__annotation mesh__D017640 GEN or unspecified; prefer specifics   
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D017640 2002
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D017640 1995
% 213.22/213.38  |- skos__altLabel mesh__D017640 Silicate
% 213.22/213.38  |- skos__prefLabel mesh__D017640 Silicates
% 213.22/213.38  |- mesh__dateEstablished mesh__D017640 1994-01-01
% 213.22/213.38  |- skos__historyNote mesh__D017640 Silicic Acid %28%1981-1993%29%
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D017640 1998
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D017640 2005
% 213.22/213.38  |- rdf__type mesh__D017640sskos__Concept
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D017640 2006
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D017640 1996
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D017640 2003
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D017640 1999
% 213.22/213.38  |- skos__hiddenLabel mesh__D017640 Hydrate, Silicate
% 213.22/213.38  |- skos__scopeNote mesh__D017640
% 213.22/213.38       The generic term for salts derived from silica or the silicic acids. They contain silicon, oxygen, and one or more metals, and may contain hydrogen. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th Ed%29%%A%    
% 213.22/213.38  |- skos__broader mesh__D017640smesh__D012824
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D017640 1997
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D017640 2004
% 213.22/213.38  |- skos__broader mesh__D017640smesh__D008903
% 213.22/213.38  |- mesh__historyNote mesh__D017640 94   
% 213.22/213.38  |- mesh__publicMeSHNote mesh__D017640 94   
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D017640 2000
% 213.22/213.38  |- mesh__dateCreated mesh__D017640 1993-06-04
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D031311 2006
% 213.22/213.38  |- mesh__dateCreated mesh__D031311 2002-07-03
% 213.22/213.38  |- mesh__historyNote mesh__D031311 2003   
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D031311 2004
% 213.22/213.38  |- skos__broader mesh__D031311smesh__D031310
% 213.22/213.38  |- mesh__dateEstablished mesh__D031311 2003-01-01
% 213.22/213.38  |- skos__scopeNote mesh__D031311
% 213.22/213.38       A plant genus of the family FUMARIACEAE %28%classified by some in PAPAVERACEAE%29% that contains isoquinoline alkaloids.%A%    
% 213.22/213.38  |- mesh__publicMeSHNote mesh__D031311 2003   
% 213.22/213.38  |- rdf__type mesh__D031311sskos__Concept
% 213.22/213.38  |- skos__altLabel mesh__D031311 Fumewort
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D031311 2005
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D031311 2003
% 213.22/213.38  |- skos__prefLabel mesh__D031311 Corydalis
% 213.22/213.38  |- skos__annotation mesh__D031311
% 213.22/213.38       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.22/213.38  |- skos__hiddenLabel mesh__D003620 Sodium, Dantrolene
% 213.22/213.38  |- skos__broader mesh__D003620smesh__D006827
% 213.22/213.38  |- mesh__recordAuthorizer mesh__D003620 sjn
% 213.22/213.38  |- mesh__recordOriginator mesh__D003620 NLM
% 213.22/213.38  |- mesh__historyNote mesh__D003620
% 213.22/213.38       80%28%75%29%; was see under HYDANTOINS 1975-79   
% 213.22/213.38  |- rdf__type mesh__D003620sskos__Concept
% 213.22/213.38  |- skos__prefLabel mesh__D003620 Dantrolene
% 213.22/213.38  |- mesh__publicMeSHNote mesh__D003620
% 213.22/213.38       80; was see under HYDANTOINS 1975-79   
% 213.22/213.38  |- mesh__dateRevised mesh__D003620 2005-06-30
% 213.22/213.38  |- skos__historyNote mesh__D003620 Hydantoins %28%1966-1974%29%
% 213.22/213.38  |- skos__scopeNote mesh__D003620
% 213.22/213.38       Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.%A%    
% 213.22/213.38  |- mesh__dateCreated mesh__D003620 1999-01-01
% 213.22/213.38  |- mesh__recordMaintainer mesh__D003620 ssb
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D003620 2006
% 213.22/213.38  |- mesh__dateEstablished mesh__D003620 1980-01-01
% 213.22/213.38  |- mesh__recordAuthorizer mesh__D050276 sjn
% 213.22/213.38  |- skos__prefLabel mesh__D050276 Hand Bones
% 213.22/213.38  |- mesh__dateEstablished mesh__D050276 2006-01-01
% 213.22/213.38  |- skos__altLabel mesh__D050276 Bones of Hands
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D050276 2006
% 213.22/213.38  |- skos__scopeNote mesh__D050276
% 213.22/213.38       The CARPAL BONES; METACARPAL BONES; and FINGER PHALANGES. In each hand there are eight carpal bones, five metacarpal bones, and 14 phalanges.%A%    
% 213.22/213.38  |- skos__annotation mesh__D050276 primates only; Manual 21.58   
% 213.22/213.38  |- skos__hiddenLabel mesh__D050276 Hands Bones
% 213.22/213.38  |- mesh__publicMeSHNote mesh__D050276 2006   
% 213.22/213.38  |- skos__historyNote mesh__D050276
% 213.22/213.38       Bones of Upper Extremity %28%1998-2005%29%
% 213.22/213.38  |- skos__hiddenLabel mesh__D050276 Bones, Hand
% 213.22/213.38  |- mesh__recordOriginator mesh__D050276 ags
% 213.22/213.38  |- skos__broader mesh__D050276smesh__D001133
% 213.22/213.38  |- mesh__recordMaintainer mesh__D050276 ags
% 213.22/213.38  |- skos__altLabel mesh__D050276 Bones of Hand
% 213.22/213.38  |- rdf__type mesh__D050276sskos__Concept
% 213.22/213.38  |- mesh__historyNote mesh__D050276 2006   
% 213.22/213.38  |- mesh__dateCreated mesh__D050276 2005-06-30
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D016548 1997
% 213.22/213.38  |- mesh__historyNote mesh__D016548 92   
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D016548 2006
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D016548 1999
% 213.22/213.38  |- skos__scopeNote mesh__D016548
% 213.22/213.38       The part of the brain developed from the most rostral of the three primary vesicles of the embryonic neural tube and consisting of the DIENCEPHALON and TELENCEPHALON.%A%    
% 213.22/213.38  |- skos__broader mesh__D016548smesh__D001921
% 213.22/213.38  |- mesh__dateEstablished mesh__D016548 1992-01-01
% 213.22/213.38  |- mesh__dateRevised mesh__D016548 1992-05-18
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D016548 1994
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D016548 1993
% 213.22/213.38  |- mesh__recordMaintainer mesh__D016548 TAP
% 213.22/213.38  |- skos__historyNote mesh__D016548 Telencephalon %28%1966-1991%29%
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D016548 2002
% 213.22/213.38  |- mesh__dateCreated mesh__D016548 1991-01-25
% 213.22/213.38  |- skos__annotation mesh__D016548
% 213.22/213.38       comprises the DIENCEPHALON %26% TELENCEPHALON   
% 213.22/213.38  |- rdf__type mesh__D016548sskos__Concept
% 213.22/213.38  |- mesh__publicMeSHNote mesh__D016548 92   
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D016548 1995
% 213.22/213.38  |- skos__prefLabel mesh__D016548 Prosencephalon
% 213.22/213.38  |- mesh__recordAuthorizer mesh__D016548 PLS
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D016548 2000
% 213.22/213.38  |- skos__historyNote mesh__D016548 Brain %28%1966-1991%29%
% 213.22/213.38  |- skos__altLabel mesh__D016548 Forebrain
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D016548 2003
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D016548 1996
% 213.22/213.38  |- skos__historyNote mesh__D016548 Diencephalon %28%1966-1991%29%
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D016548 2001
% 213.22/213.38  |- skos__hiddenLabel mesh__D016548 Forebrains
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D016548 2005
% 213.22/213.38  |- mesh__recordOriginator mesh__D016548 AGS
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D016548 1998
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D016548 2004
% 213.22/213.38  |- mesh__dateCreated mesh__D035702 2002-07-03
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D035702 2006
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D035702 2004
% 213.22/213.38  |- skos__broader mesh__D035702smesh__D031246
% 213.22/213.38  |- skos__annotation mesh__D035702
% 213.22/213.38       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D035702 2005
% 213.22/213.38  |- mesh__dateEstablished mesh__D035702 2003-01-01
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D035702 2003
% 213.22/213.38  |- mesh__historyNote mesh__D035702 2003   
% 213.22/213.38  |- rdf__type mesh__D035702sskos__Concept
% 213.22/213.38  |- mesh__publicMeSHNote mesh__D035702 2003   
% 213.22/213.38  |- skos__scopeNote mesh__D035702
% 213.22/213.38       A plant genus of the family CECROPIACEAE. Hypotensive and hypoglycemic effects have been observed in animals after ingesting members of this genus. There is no relation to cecropia moth %28%Hyalophora cecropia%29% see MOTHS.%A%    
% 213.22/213.38  |- skos__prefLabel mesh__D035702 Cecropia Plant
% 213.22/213.38  |- skos__hiddenLabel mesh__D002528 Neoplasm, Benign Cerebellar
% 213.22/213.38  |- skos__broader mesh__D002528smesh__D015192
% 213.22/213.38  |- skos__hiddenLabel mesh__D002528 Cancer, Cerebellar
% 213.22/213.38  |- skos__altLabel mesh__D002528 Neoplasms, Cerebellar, Primary
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D002528 2001
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D002528 2005
% 213.22/213.38  |- skos__hiddenLabel mesh__D002528 Primary Neoplasm, Cerebellum
% 213.22/213.38  |- skos__hiddenLabel mesh__D002528 Primary Cerebellar Neoplasm
% 213.22/213.38  |- skos__hiddenLabel mesh__D002528 Cerebellar Neoplasm, Benign
% 213.22/213.38  |- skos__broader mesh__D002528smesh__D002526
% 213.22/213.38  |- skos__altLabel mesh__D002528 Primary Neoplasms, Cerebellum
% 213.22/213.38  |- skos__hiddenLabel mesh__D002528 Benign Cerebellar Neoplasm
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D002528 2000
% 213.22/213.38  |- skos__hiddenLabel mesh__D002528 Neoplasm, Malignant Cerebellar
% 213.22/213.38  |- skos__hiddenLabel mesh__D002528 Cerebellar Cancers
% 213.22/213.38  |- skos__hiddenLabel mesh__D002528 Cerebellar Neoplasm
% 213.22/213.38  |- skos__hiddenLabel mesh__D002528 Tumor, Cerebellar
% 213.22/213.38  |- skos__altLabel mesh__D002528 Neoplasms, Cerebellar, Malignant
% 213.22/213.38  |- rdf__type mesh__D002528sskos__Concept
% 213.22/213.38  |- skos__hiddenLabel mesh__D002528 Cerebellum Primary Neoplasms
% 213.22/213.38  |- skos__hiddenLabel mesh__D002528 Neoplasm, Cerebellar
% 213.22/213.38  |- skos__hiddenLabel mesh__D002528 Cerebellum Primary Neoplasm
% 213.22/213.38  |- skos__altLabel mesh__D002528 Cerebellar Neoplasms, Benign
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D002528 2004
% 213.22/213.38  |- skos__scopeNote mesh__D002528
% 213.22/213.38       Primary or metastatic neoplasms of the CEREBELLUM. Tumors in this location frequently present with ATAXIA or signs of INTRACRANIAL HYPERTENSION due to obstruction of the fourth ventricle. Common primary cerebellar tumors include fibrillary ASTROCYTOMA and cerebellar HEMANGIOBLASTOMA. The cerebellum is a relatively common site for tumor metastases from the lung, breast, and other distant organs. %28%From Okazaki %26% Scheithauer, Atlas of Neuropathology, 1988, p86 and p141%29%%A%    
% 213.22/213.38  |- skos__hiddenLabel mesh__D002528 Primary Cerebellar Neoplasms
% 213.22/213.38  |- skos__hiddenLabel mesh__D002528 Cerebellar Neoplasm, Primary
% 213.22/213.38  |- skos__hiddenLabel mesh__D002528 Cerebellar Tumor
% 213.22/213.38  |- mesh__dateCreated mesh__D002528 1999-01-01
% 213.22/213.38  |- skos__altLabel mesh__D002528 Cerebellar Tumors
% 213.22/213.38  |- skos__altLabel mesh__D002528 Neoplasms, Cerebellar, Benign
% 213.22/213.38  |- skos__hiddenLabel mesh__D002528 Malignant Cerebellar Neoplasm
% 213.22/213.38  |- skos__hiddenLabel mesh__D002528 Neoplasm, Cerebellum Primary
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D002528 2003
% 213.22/213.38  |- skos__altLabel mesh__D002528 Neoplasms, Cerebellar
% 213.22/213.38  |- mesh__dateRevised mesh__D002528 1999-11-03
% 213.22/213.38  |- mesh__recordMaintainer mesh__D002528 KEV
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D002528 2002
% 213.22/213.38  |- skos__altLabel mesh__D002528 Malignant Cerebellar Neoplasms
% 213.22/213.38  |- mesh__recordOriginator mesh__D002528 NLM
% 213.22/213.38  |- skos__prefLabel mesh__D002528 Cerebellar Neoplasms
% 213.22/213.38  |- skos__altLabel mesh__D002528 Cerebellar Neoplasms, Malignant
% 213.22/213.38  |- skos__hiddenLabel mesh__D002528 Cerebellar Neoplasm, Malignant
% 213.22/213.38  |- skos__annotation mesh__D002528
% 213.22/213.38       coord IM with histol type of neopl %28%IM%29%   
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D002528 2006
% 213.22/213.38  |- mesh__recordAuthorizer mesh__D002528 sjn
% 213.22/213.38  |- mesh__historyNote mesh__D013250 73   
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D013250 2005
% 213.22/213.38  |- skos__altLabel mesh__D013250 Steroid Monooxygenases
% 213.22/213.38  |- skos__hiddenLabel mesh__D013250 Monooxygenases, Steroid
% 213.22/213.38  |- mesh__publicMeSHNote mesh__D013250 73   
% 213.22/213.38  |- skos__broader mesh__D013250smesh__D006899
% 213.22/213.38  |- skos__prefLabel mesh__D013250 Steroid Hydroxylases
% 213.22/213.38  |- skos__scopeNote mesh__D013250
% 213.22/213.38       Cytochrome P-450 monooxygenases %28%MIXED FUNCTION OXYGENASES%29% that are important in steroid biosynthesis and metabolism.%A%    
% 213.22/213.38  |- mesh__dateCreated mesh__D013250 1999-01-01
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D013250 2006
% 213.22/213.38  |- mesh__recordAuthorizer mesh__D013250 sjn
% 213.22/213.38  |- skos__historyNote mesh__D013250 Hydroxylases %28%1966-1972%29%
% 213.22/213.38  |- mesh__dateEstablished mesh__D013250 1973-01-01
% 213.22/213.38  |- mesh__dateRevised mesh__D013250 2004-07-07
% 213.22/213.38  |- mesh__recordMaintainer mesh__D013250 ssb
% 213.22/213.38  |- skos__annotation mesh__D013250 GEN; prefer specifics   
% 213.22/213.38  |- mesh__recordOriginator mesh__D013250 NLM
% 213.22/213.38  |- skos__broader mesh__D013250smesh__D003577
% 213.22/213.38  |- skos__hiddenLabel mesh__D013250 Hydroxylases, Steroid
% 213.22/213.38  |- rdf__type mesh__D013250sskos__Concept
% 213.22/213.38  |- mesh__dateEstablished mesh__D007213 1966-01-01
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D007213 2005
% 213.22/213.38  |- skos__scopeNote mesh__D007213
% 213.22/213.38       A non-steroidal anti-inflammatory agent %28%NSAID%29% that inhibits the enzyme cyclooxygenase necessary for the formation of prostaglandins and other autacoids. It also inhibits the motility of polymorphonuclear leukocytes.%A%    
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D007213 2002
% 213.22/213.38  |- mesh__dateCreated mesh__D007213 1999-01-01
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D007213 2006
% 213.22/213.38  |- mesh__historyNote mesh__D007213 66%28%64%29%   
% 213.22/213.38  |- mesh__recordAuthorizer mesh__D007213 sjn
% 213.22/213.38  |- mesh__recordMaintainer mesh__D007213 TWD
% 213.22/213.38  |- mesh__dateRevised mesh__D007213 2000-06-21
% 213.22/213.38  |- skos__altLabel mesh__D007213 Indometacin
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D007213 2003
% 213.22/213.38  |- skos__prefLabel mesh__D007213 Indomethacin
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D007213 2004
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D007213 2001
% 213.22/213.38  |- skos__broader mesh__D007213smesh__D007211
% 213.22/213.38  |- mesh__recordOriginator mesh__D007213 NLM
% 213.22/213.38  |- rdf__type mesh__D007213sskos__Concept
% 213.22/213.38  |- skos__hiddenLabel mesh__D007213 Hydrochloride, Indomethacin
% 213.22/213.38  |- mesh__publicMeSHNote mesh__D007213 66   
% 213.22/213.38  |- skos__annotation mesh__D012956 specify geog; DF: SOCIETIES NURS   
% 213.22/213.38  |- mesh__recordAuthorizer mesh__D012956 sjn
% 213.22/213.38  |- mesh__recordMaintainer mesh__D012956 kle
% 213.22/213.38  |- skos__altLabel mesh__D012956 Society, Nursing
% 213.22/213.38  |- mesh__dateCreated mesh__D012956 1999-01-01
% 213.22/213.38  |- skos__prefLabel mesh__D012956 Societies, Nursing
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012956 2005
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012956 2003
% 213.22/213.38  |- mesh__recordOriginator mesh__D012956 NLM
% 213.22/213.38  |- mesh__historyNote mesh__D012956 66   
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012956 2006
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012956 2000
% 213.22/213.38  |- skos__broader mesh__D012956smesh__D012952
% 213.22/213.38  |- skos__altLabel mesh__D012956 Nursing Society
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012956 2004
% 213.22/213.38  |- mesh__dateEstablished mesh__D012956 1966-01-01
% 213.22/213.38  |- rdf__type mesh__D012956sskos__Concept
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012956 2001
% 213.22/213.38  |- mesh__dateRevised mesh__D012956 1999-11-03
% 213.22/213.38  |- skos__altLabel mesh__D012956 Nursing Societies
% 213.22/213.38  |- skos__scopeNote mesh__D012956
% 213.22/213.38       Societies whose membership is limited to nurses.     
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012956 2002
% 213.22/213.38  |- mesh__publicMeSHNote mesh__D012956 66   
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D045332 2005
% 213.22/213.38  |- skos__scopeNote mesh__D045332
% 213.22/213.38       A large multisubunit protein complex found in the THYLAKOID MEMBRANE. It uses light energy derived from LIGHT-HARVESTING PROTEIN COMPLEXES to catalyze the splitting of WATER into DIOXYGEN and of reducing equivalents of HYDROGEN.%A%    
% 213.22/213.38  |- skos__historyNote mesh__D045332 Chlorophyll %28%1966-1990%29%
% 213.22/213.38  |- mesh__dateCreated mesh__D045332 2003-07-09
% 213.22/213.38  |- skos__historyNote mesh__D045332 Oxidoreductases %28%1983-1979%29%
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D045332 2006
% 213.22/213.38  |- skos__prefLabel mesh__D045332 Photosystem II Protein Complex
% 213.22/213.38  |- skos__broader mesh__D045332smesh__D045322
% 213.22/213.38  |- rdf__type mesh__D045332sskos__Concept
% 213.22/213.38  |- skos__hiddenLabel mesh__D045332 Water Splitting Enzyme of Photosynthesis
% 213.22/213.38  |- mesh__recordMaintainer mesh__D045332 jmp
% 213.22/213.38  |- skos__hiddenLabel mesh__D045332 Oxidase, Water
% 213.22/213.38  |- skos__hiddenLabel mesh__D045332 Photosynthesis Water-Splitting Enzyme
% 213.22/213.38  |- skos__altLabel mesh__D045332 Photosystem II Reaction Center
% 213.22/213.38  |- mesh__publicMeSHNote mesh__D045332
% 213.22/213.38       2004; for PHOTOSYSTEM II REACTION CENTER see PHOTOSYNTHETIC REACTION CENTER, PLANT 1991-2003; WATER-SPLITTING ENZYMES OF PHOTOSYTHESIS was indexed under OXIDOREDUCTASES 1983-2003 %26% under CHLOROPHYLL %26% WATER 1972-1982; PHOTOSYSTEM II REACTION CENTER COMPLEX D2 PROTEIN was indexed under PHOTOSYNTHETIC REACTION CENTER, PLANT 1992-2003; D1 PHOTOSYSTEM II PROTEIN, PLANT was indexed under PHOTOSYNTHETIC REACTION CENTER, PLANT 1995-2003, under PHOTOSYNTHETIC REACTION CENTER, BACTERIAL 1994-2001, under PLANT PROTEINS %26% BACTERIAL PROTEINS 1989-1994 %26% under FUNGAL PROTEINS 1990-1991%A%  
% 213.22/213.38  |- mesh__recordAuthorizer mesh__D045332 sjn
% 213.22/213.38  |- skos__altLabel mesh__D045332 Oxygen Evolving Enzyme
% 213.22/213.38  |- mesh__recordOriginator mesh__D045332 jmp
% 213.22/213.38  |- mesh__historyNote mesh__D045332
% 213.22/213.38       2004; for PHOTOSYSTEM II REACTION CENTER use PHOTOSYNTHETIC REACTION CENTER COMPLEX PROTEINS 1991-2003; for WATER-SPLITTING ENZYME OF PHOTOSYNTHESIS use PHOTOSYSTEM II PROTEIN COMPLEX %28%NM%29% 1980-2003; for PHOTOSYSTEM II REACTION CENTER COMPLEX D2 PROTEIN use PHOTOSYSTEM II PROTEIN COMPLEX %28%NM%29% 1992-2003; for D1 PHOTOSYSTEM II PROTEIN, PLANT use PHOTOSYSTEM II PROTEIN COMPLEX %28%NM%29% 1989-2003;%A%  
% 213.22/213.38  |- skos__historyNote mesh__D045332 Plant Proteins %28%1966-1990%29%
% 213.22/213.38  |- skos__historyNote mesh__D045332
% 213.22/213.38       Photosynthetic Reaction Center Complex Proteins %28%1991-2003%29%
% 213.22/213.38  |- skos__altLabel mesh__D045332 Chloroplast Reaction Center Protein D1
% 213.22/213.38  |- mesh__dateEstablished mesh__D045332 2004-01-01
% 213.22/213.38  |- skos__altLabel mesh__D045332 RCII-D1 Protein
% 213.22/213.38  |- skos__hiddenLabel mesh__D045332 Light Induced D1 Protein, Photosystem II
% 213.22/213.38  |- skos__altLabel mesh__D045332 PRCP II D2 Protein
% 213.22/213.38  |- mesh__dateRevised mesh__D045332 2004-07-07
% 213.22/213.38  |- skos__altLabel mesh__D045332 Light-Induced D1 Protein, Photosystem II
% 213.22/213.38  |- skos__broader mesh__D045332smesh__D009097
% 213.22/213.38  |- skos__hiddenLabel mesh__D045332 Evolving Enzyme, Oxygen
% 213.22/213.38  |- skos__altLabel mesh__D045332 Water Oxidase
% 213.22/213.38  |- skos__hiddenLabel mesh__D045332 Enzyme, Oxygen Evolving
% 213.22/213.38  |- skos__hiddenLabel mesh__D012158 Reticuloses
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012158 2002
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012158 1998
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012158 2005
% 213.22/213.38  |- skos__annotation mesh__D012158
% 213.22/213.38       neoplastic; do not use /blood supply /chem /second /secret /ultrastruct; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 213.22/213.38  |- rdf__type mesh__D012158sskos__Concept
% 213.22/213.38  |- mesh__dateRevised mesh__D012158 1995-06-08
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012158 2001
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012158 1997
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012158 2004
% 213.22/213.38  |- skos__broader mesh__D012158smesh__D008223
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012158 2000
% 213.22/213.38  |- mesh__recordMaintainer mesh__D012158 KEV
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012158 1996
% 213.22/213.38  |- skos__broader mesh__D012158smesh__D008206
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012158 2003
% 213.22/213.38  |- skos__hiddenLabel mesh__D012158 Reticuloendothelioses
% 213.22/213.38  |- skos__prefLabel mesh__D012158 Reticuloendotheliosis
% 213.22/213.38  |- mesh__recordAuthorizer mesh__D012158 PLS
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012158 1999
% 213.22/213.38  |- mesh__dateCreated mesh__D012158 1999-01-01
% 213.22/213.38  |- skos__scopeNote mesh__D012158
% 213.22/213.38       Hyperplasia of reticuloendothelial tissue, in any organ or tissue. A related concept is reticulosis which is an increase in reticuloendothelial elements.%A%    
% 213.22/213.38  |- mesh__recordOriginator mesh__D012158 NLM
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D012158 2006
% 213.22/213.38  |- mesh__recordMaintainer mesh__D006919 ssb
% 213.22/213.38  |- skos__altLabel mesh__D006919
% 213.22/213.38       2-%28%2-%28%4-%28%%28%4-Chlorophenyl%29%phenylmethyl%29%-1-piperazinyl%29%ethoxy%29%ethanol
% 213.22/213.38  |- mesh__dateCreated mesh__D006919 1999-01-01
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D006919 2006
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D006919 2005
% 213.22/213.38  |- skos__broader mesh__D006919smesh__D010879
% 213.22/213.38  |- mesh__activeMeSHYear mesh__D006919 2002
% 213.22/213.38  |- mesh__recordOriginator mesh__D006919 NLM
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D006919 2004
% 213.22/213.39  |- mesh__recordAuthorizer mesh__D006919 sjn
% 213.22/213.39  |- mesh__dateRevised mesh__D006919 2001-07-25
% 213.22/213.39  |- skos__scopeNote mesh__D006919
% 213.22/213.39       A histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative.%A%    
% 213.22/213.39  |- rdf__type mesh__D006919sskos__Concept
% 213.22/213.39  |- skos__prefLabel mesh__D006919 Hydroxyzine
% 213.22/213.39  |- skos__hiddenLabel mesh__D006919 Pamoate, Hydroxyzine
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D006919 2003
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D017641 1998
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D017641 2005
% 213.22/213.39  |- mesh__historyNote mesh__D017641 94; was ZEOLITE %28%NM%29% 1972-93   
% 213.22/213.39  |- rdf__type mesh__D017641sskos__Concept
% 213.22/213.39  |- skos__historyNote mesh__D017641 Aluminum Silicates %28%1980-1993%29%
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D017641 1996
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D017641 2003
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D017641 1999
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D017641 2006
% 213.22/213.39  |- skos__broader mesh__D017641smesh__D000538
% 213.22/213.39  |- mesh__onlineNote mesh__D017641
% 213.22/213.39       use ZEOLITES %28%NM%29% to search ZEOLITE 1980-93   
% 213.22/213.39  |- skos__annotation mesh__D017641
% 213.22/213.39       aluminum silicates; cation exchangers, molecular sieves, water softeners %26% adsorbents%A%  
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D017641 2000
% 213.22/213.39  |- mesh__dateCreated mesh__D017641 1993-06-04
% 213.22/213.39  |- mesh__publicMeSHNote mesh__D017641
% 213.22/213.39       94; ZEOLITES was indexed under ALUMINUM SILICATES 1981-93 %26% SODIUM HYDROXIDE 1972-80%A%  
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D017641 1997
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D017641 2004
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D017641 2001
% 213.22/213.39  |- mesh__dateEstablished mesh__D017641 1994-01-01
% 213.22/213.39  |- skos__scopeNote mesh__D017641
% 213.22/213.39       Zeolites. A group of crystalline, hydrated alkali-aluminum silicates. They occur naturally in sedimentary and volcanic rocks, altered basalts, ores, and clay deposits. Some 40 known zeolite minerals and a great number of synthetic zeolites are available commercially. %28%From Merck Index, 11th ed%29%%A%    
% 213.22/213.39  |- skos__prefLabel mesh__D017641 Zeolites
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D017641 1994
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D017641 2002
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D017641 1995
% 213.22/213.39  |- skos__historyNote mesh__D017641 Sodium Hydroxide %28%1972-1980%29%
% 213.22/213.39  |- skos__altLabel mesh__D017641 Zeolite
% 213.22/213.39  |- mesh__publicMeSHNote mesh__D031312 2003   
% 213.22/213.39  |- rdf__type mesh__D031312sskos__Concept
% 213.22/213.39  |- mesh__dateCreated mesh__D031312 2002-07-03
% 213.22/213.39  |- mesh__historyNote mesh__D031312 2003   
% 213.22/213.39  |- skos__prefLabel mesh__D031312 Fumaria
% 213.22/213.39  |- skos__broader mesh__D031312smesh__D031310
% 213.22/213.39  |- mesh__dateEstablished mesh__D031312 2003-01-01
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D031312 2005
% 213.22/213.39  |- skos__scopeNote mesh__D031312
% 213.22/213.39       A plant genus of the family FUMARIACEAE that contains fumariline and other isoquinoline alkaloids.%A%    
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D031312 2003
% 213.22/213.39  |- skos__annotation mesh__D031312
% 213.22/213.39       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D031312 2006
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D031312 2004
% 213.22/213.39  |- rdf__type mesh__D003621sskos__Concept
% 213.22/213.39  |- mesh__dateEstablished mesh__D003621 1972-01-01
% 213.22/213.39  |- skos__broader mesh__D003621smesh__D033361
% 213.22/213.39  |- skos__prefLabel mesh__D003621 Daphnia
% 213.22/213.39  |- mesh__recordMaintainer mesh__D003621 jls
% 213.22/213.39  |- mesh__recordAuthorizer mesh__D003621 sjn
% 213.22/213.39  |- mesh__recordOriginator mesh__D003621 NLM
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D003621 2005
% 213.22/213.39  |- skos__scopeNote mesh__D003621
% 213.22/213.39       A diverse genus of minute freshwater CRUSTACEA, of the suborder CLADOCERA. They are a major food source for both young and adult freshwater fish.%A%    
% 213.22/213.39  |- mesh__dateCreated mesh__D003621 1999-01-01
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D003621 2006
% 213.22/213.39  |- mesh__historyNote mesh__D003621 72   
% 213.22/213.39  |- skos__historyNote mesh__D003621 Crustacea %28%1966-1971%29%
% 213.22/213.39  |- mesh__publicMeSHNote mesh__D003621 72   
% 213.22/213.39  |- mesh__dateRevised mesh__D003621 2004-07-19
% 213.22/213.39  |- mesh__dateCreated mesh__D050277 2005-06-30
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D050277 2006
% 213.22/213.39  |- mesh__publicMeSHNote mesh__D050277 2006   
% 213.22/213.39  |- mesh__recordAuthorizer mesh__D050277 sjn
% 213.22/213.39  |- skos__altLabel mesh__D050277 Toe Bones
% 213.22/213.39  |- mesh__dateEstablished mesh__D050277 2006-01-01
% 213.22/213.39  |- skos__broader mesh__D050277smesh__D005529
% 213.22/213.39  |- skos__altLabel mesh__D050277 Phalanges of Toes
% 213.22/213.39  |- mesh__recordMaintainer mesh__D050277 ags
% 213.22/213.39  |- skos__scopeNote mesh__D050277
% 213.22/213.39       Bones that make up the SKELETON of the TOES, consisting of two for the great toe, and three for each of the other toes.%A%    
% 213.22/213.39  |- skos__historyNote mesh__D050277 Toes %28%1970-2005%29%
% 213.22/213.39  |- rdf__type mesh__D050277sskos__Concept
% 213.22/213.39  |- skos__hiddenLabel mesh__D050277 Bones, Toe
% 213.22/213.39  |- skos__hiddenLabel mesh__D050277 Toes Bones
% 213.22/213.39  |- mesh__recordOriginator mesh__D050277 ags
% 213.22/213.39  |- skos__annotation mesh__D050277
% 213.22/213.39       permitted with all vertebrates; Manual 21.58   
% 213.22/213.39  |- skos__hiddenLabel mesh__D050277 Phalanges, Toe
% 213.22/213.39  |- skos__prefLabel mesh__D050277 Toe Phalanges
% 213.22/213.39  |- skos__altLabel mesh__D050277 Bones of Toes
% 213.22/213.39  |- mesh__historyNote mesh__D050277 2006   
% 213.22/213.39  |- rdf__type mesh__D016549sskos__Concept
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D016549 2000
% 213.22/213.39  |- skos__broader mesh__D016549smesh__D014492
% 213.22/213.39  |- skos__altLabel mesh__D016549 Service, United States Indian Health
% 213.22/213.39  |- mesh__dateCreated mesh__D016549 1991-02-11
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D016549 2001
% 213.22/213.39  |- skos__altLabel mesh__D016549 Indian Health Service %28%U.S.%29%
% 213.22/213.39  |- mesh__recordMaintainer mesh__D016549 PXP
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D016549 2003
% 213.22/213.39  |- skos__annotation mesh__D016549
% 213.22/213.39       add UNITED STATES %28%NIM%29%; research support by this agency is checked as NIH/PHS SUP; specify geog if pertinent; DF: IHS       CATALOG: use NAF entry%A%  
% 213.22/213.39  |- skos__historyNote mesh__D016549
% 213.22/213.39       United States Public Health Service %28%1975-1991%29%
% 213.22/213.39  |- mesh__recordAuthorizer mesh__D016549 SJN
% 213.22/213.39  |- mesh__dateEstablished mesh__D016549 1992-01-01
% 213.22/213.39  |- skos__historyNote mesh__D016549
% 213.22/213.39       Indians, North American %28%1975-1991%29%
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D016549 2005
% 213.22/213.39  |- mesh__dateRevised mesh__D016549 1997-06-20
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D016549 1998
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D016549 2004
% 213.22/213.39  |- skos__prefLabel mesh__D016549 United States Indian Health Service
% 213.22/213.39  |- mesh__historyNote mesh__D016549 92   
% 213.22/213.39  |- skos__altLabel mesh__D016549 Service, Indian Health
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D016549 2002
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D016549 2006
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D016549 1999
% 213.22/213.39  |- mesh__publicMeSHNote mesh__D016549 92   
% 213.22/213.39  |- skos__scopeNote mesh__D016549
% 213.22/213.39       A division of the UNITED STATES PUBLIC HEALTH SERVICE that is responsible for the public health and the provision of medical services to native American Indian populations in the United States, primarily those residing on reservation lands.%A%    
% 213.22/213.39  |- mesh__recordOriginator mesh__D016549 JHM
% 213.22/213.39  |- mesh__recordOriginator mesh__D035703 hjn
% 213.22/213.39  |- skos__prefLabel mesh__D035703 Therapies, Investigational
% 213.22/213.39  |- skos__related mesh__D035703smesh__D002986
% 213.22/213.39  |- skos__hiddenLabel mesh__D035703 Therapies, Experimental
% 213.22/213.39  |- mesh__historyNote mesh__D035703 2003   
% 213.22/213.39  |- mesh__dateRevised mesh__D035703 2003-07-25
% 213.22/213.39  |- skos__altLabel mesh__D035703 Investigational Treatments
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D035703 2005
% 213.22/213.39  |- skos__hiddenLabel mesh__D035703 Therapy, Innovative
% 213.22/213.39  |- skos__altLabel mesh__D035703 Experimental Therapies
% 213.22/213.39  |- skos__hiddenLabel mesh__D035703 Investigational Therapy
% 213.22/213.39  |- mesh__recordAuthorizer mesh__D035703 sjn
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D035703 2006
% 213.22/213.39  |- skos__hiddenLabel mesh__D035703 Therapy, Experimental
% 213.22/213.39  |- skos__hiddenLabel mesh__D035703 Experimental Therapy
% 213.22/213.39  |- skos__hiddenLabel mesh__D035703 Treatment, Investigational
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D035703 2004
% 213.22/213.39  |- skos__hiddenLabel mesh__D035703 Therapy, Investigational
% 213.22/213.39  |- mesh__dateCreated mesh__D035703 2002-07-03
% 213.22/213.39  |- skos__scopeNote mesh__D035703
% 213.22/213.39       Treatments which are undergoing clinical trials or for which there is insufficient evidence to determine their effects on health outcomes; coverage for such treatments is often denied by health insurers.%A%    
% 213.22/213.39  |- mesh__recordMaintainer mesh__D035703 sjn
% 213.22/213.39  |- mesh__dateEstablished mesh__D035703 2003-01-01
% 213.22/213.39  |- rdf__type mesh__D035703sskos__Concept
% 213.22/213.39  |- skos__hiddenLabel mesh__D035703 Treatments, Investigational
% 213.22/213.39  |- skos__hiddenLabel mesh__D035703 Investigational Treatment
% 213.22/213.39  |- mesh__publicMeSHNote mesh__D035703 2003   
% 213.22/213.39  |- skos__hiddenLabel mesh__D035703 Innovative Therapy
% 213.22/213.39  |- skos__altLabel mesh__D035703 Investigational Therapies
% 213.22/213.39  |- skos__broader mesh__D035703smesh__D013812
% 213.22/213.39  |- skos__hiddenLabel mesh__D035703 Therapies, Innovative
% 213.22/213.39  |- mesh__dateCreated mesh__D002529 1999-01-01
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D002529 2003
% 213.22/213.39  |- mesh__publicMeSHNote mesh__D002529 71   
% 213.22/213.39  |- skos__hiddenLabel mesh__D002529 Nucleus, Dentate
% 213.22/213.39  |- skos__hiddenLabel mesh__D002529 Nuclei, Cerebellar
% 213.22/213.39  |- mesh__historyNote mesh__D002529 71   
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D002529 2001
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D002529 2004
% 213.22/213.39  |- rdf__type mesh__D002529sskos__Concept
% 213.22/213.39  |- mesh__dateRevised mesh__D002529 1999-11-03
% 213.22/213.39  |- skos__hiddenLabel mesh__D002529 Nucleus, Cerebellar
% 213.22/213.39  |- skos__broader mesh__D002529smesh__D002531
% 213.22/213.39  |- mesh__recordOriginator mesh__D002529 NLM
% 213.22/213.39  |- skos__hiddenLabel mesh__D002529 Fastigii, Nucleus
% 213.22/213.39  |- skos__scopeNote mesh__D002529
% 213.22/213.39       Four accumulations of gray substance embedded in the white substance of the cerebellum, comprising the nucleus dentatus, nucleus emboliformis, nucleus globosus, and nucleus fastigii. %28%Dorland, 28th ed%29%%A%    
% 213.22/213.39  |- skos__altLabel mesh__D002529 Dentate Nucleus
% 213.22/213.39  |- skos__hiddenLabel mesh__D002529 Emboliformis, Nucleus
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D002529 2002
% 213.22/213.39  |- skos__historyNote mesh__D002529 Cerebellum %28%1966-1970%29%
% 213.22/213.39  |- skos__prefLabel mesh__D002529 Cerebellar Nuclei
% 213.22/213.39  |- mesh__recordAuthorizer mesh__D002529 sjn
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D002529 2005
% 213.22/213.39  |- skos__hiddenLabel mesh__D002529 Nucleus Fastigius
% 213.22/213.39  |- mesh__recordMaintainer mesh__D002529 ags
% 213.22/213.39  |- skos__hiddenLabel mesh__D002529 Globosus, Nucleus
% 213.22/213.39  |- skos__hiddenLabel mesh__D002529 Cerebellar Nucleus
% 213.22/213.39  |- mesh__dateEstablished mesh__D002529 1971-01-01
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D002529 2006
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D002529 2000
% 213.22/213.39  |- skos__annotation mesh__D002529
% 213.22/213.39       diseases: coord IM with CEREBELLAR DISEASES %28%IM%29%   
% 213.22/213.39  |- mesh__dateRevised mesh__D013251 2003-07-09
% 213.22/213.39  |- mesh__recordOriginator mesh__D013251 NLM
% 213.22/213.39  |- mesh__publicMeSHNote mesh__D013251
% 213.22/213.39       91; was see under ISOMERASES 1975-90   
% 213.22/213.39  |- skos__historyNote mesh__D013251 Ketosteroids %28%1972-1974%29%
% 213.22/213.39  |- mesh__historyNote mesh__D013251
% 213.22/213.39       91%28%75%29%; was see under ISOMERASES 1975-90   
% 213.22/213.39  |- mesh__dateCreated mesh__D013251 1974-11-11
% 213.22/213.39  |- skos__hiddenLabel mesh__D013251 Isomerases, Steroid
% 213.22/213.39  |- rdf__type mesh__D013251sskos__Concept
% 213.22/213.39  |- skos__broader mesh__D013251smesh__D019748
% 213.22/213.39  |- skos__altLabel mesh__D013251 3-Oxosteroid Isomerases
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D013251 2004
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D013251 2006
% 213.22/213.39  |- skos__hiddenLabel mesh__D013251 3 Ketosteroid Isomerases
% 213.22/213.39  |- skos__hiddenLabel mesh__D013251 3 Oxosteroid Isomerases
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D013251 2005
% 213.22/213.39  |- mesh__recordMaintainer mesh__D013251 ssb
% 213.22/213.39  |- skos__hiddenLabel mesh__D013251 Isomerases, 3-Ketosteroid
% 213.22/213.39  |- skos__scopeNote mesh__D013251
% 213.22/213.39       Enzymes that catalyze the transposition of double bond%28%s%29% in a steroid molecule. EC 5.3.3.%A%    
% 213.22/213.39  |- skos__hiddenLabel mesh__D013251 Isomerases, 3-Oxosteroid
% 213.22/213.39  |- skos__prefLabel mesh__D013251 Steroid Isomerases
% 213.22/213.39  |- mesh__recordAuthorizer mesh__D013251 sjn
% 213.22/213.39  |- skos__altLabel mesh__D013251 3-Ketosteroid Isomerases
% 213.22/213.39  |- skos__historyNote mesh__D013251 Isomerases %28%1972-1974%29%
% 213.22/213.39  |- mesh__dateEstablished mesh__D013251 1991-01-01
% 213.22/213.39  |- skos__annotation mesh__D007214
% 213.22/213.39       Indonesians are of MONGOLOID RACE unless otherwise specified%A%  
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D007214 1998
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D007214 2000
% 213.22/213.39  |- skos__altLabel mesh__D007214 New Guinea, West
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D007214 2003
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D007214 2001
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D007214 1999
% 213.22/213.39  |- mesh__recordOriginator mesh__D007214 NLM
% 213.22/213.39  |- skos__altLabel mesh__D007214 Malay Archipelago
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D007214 2004
% 213.22/213.39  |- skos__altLabel mesh__D007214 Madura
% 213.22/213.39  |- rdf__type mesh__D007214sskos__Concept
% 213.22/213.39  |- skos__altLabel mesh__D007214 East Indies
% 213.22/213.39  |- mesh__historyNote mesh__D007214 TIMOR was heading 1963-94   
% 213.22/213.39  |- skos__scopeNote mesh__D007214
% 213.22/213.39       A republic stretching from the Indian Ocean east to New Guinea, comprising six main islands: Java, Sumatra, Bali, Kalimantan %28%the Indonesian portion of the island of Borneo%29%, Sulawesi %28%formerly known as the Celebes%29% and Irian Jaya %28%the western part of New Guinea%29%. Its capital is Djakarta. The ethnic groups living there are largely Chinese, Arab, Eurasian, Indian, and Pakistani; 85%25% of the peoples are of the Islamic faith.%A%    
% 213.22/213.39  |- skos__altLabel mesh__D007214 Sulawesi
% 213.22/213.39  |- mesh__recordMaintainer mesh__D007214 TGC
% 213.22/213.39  |- mesh__recordAuthorizer mesh__D007214 SJN
% 213.22/213.39  |- skos__altLabel mesh__D007214 New Guinea, Indonesian
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D007214 2002
% 213.22/213.39  |- mesh__onlineNote mesh__D007214 use INDONESIA to search TIMOR 1966-94   
% 213.22/213.39  |- mesh__dateRevised mesh__D007214 1997-06-20
% 213.22/213.39  |- skos__altLabel mesh__D007214 Indonesian New Guinea
% 213.22/213.39  |- skos__broader mesh__D007214smesh__D001210
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D007214 2005
% 213.22/213.39  |- skos__altLabel mesh__D007214 Irian Jaya
% 213.22/213.39  |- skos__prefLabel mesh__D007214 Indonesia
% 213.22/213.39  |- mesh__dateCreated mesh__D007214 1999-01-01
% 213.22/213.39  |- skos__altLabel mesh__D007214 Netherlands East Indies
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D007214 2006
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D012957 2003
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D012957 2006
% 213.22/213.39  |- mesh__dateEstablished mesh__D012957 1968-01-01
% 213.22/213.39  |- skos__altLabel mesh__D012957 Society, Pharmaceutic
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D012957 2001
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D012957 2004
% 213.22/213.39  |- skos__altLabel mesh__D012957 Pharmacy Society
% 213.22/213.39  |- skos__altLabel mesh__D012957 Pharmaceutic Society
% 213.22/213.39  |- rdf__type mesh__D012957sskos__Concept
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D012957 2002
% 213.22/213.39  |- mesh__recordMaintainer mesh__D012957 kle
% 213.22/213.39  |- mesh__recordAuthorizer mesh__D012957 sjn
% 213.22/213.39  |- skos__altLabel mesh__D012957 Pharmaceutical Society
% 213.22/213.39  |- skos__prefLabel mesh__D012957 Societies, Pharmaceutical
% 213.22/213.39  |- skos__annotation mesh__D012957 specify geog; DF: SOCIETIES PHARM   
% 213.22/213.39  |- skos__altLabel mesh__D012957 Society, Pharmacy
% 213.22/213.39  |- skos__altLabel mesh__D012957 Pharmaceutical Societies
% 213.22/213.39  |- skos__scopeNote mesh__D012957
% 213.22/213.39       Societies whose membership is limited to pharmacists.     
% 213.22/213.39  |- skos__altLabel mesh__D012957 Pharmacy Societies
% 213.22/213.39  |- mesh__recordOriginator mesh__D012957 NLM
% 213.22/213.39  |- skos__historyNote mesh__D012957 Pharmacy %28%1966-1967%29%
% 213.22/213.39  |- skos__altLabel mesh__D012957 Pharmaceutic Societies
% 213.22/213.39  |- skos__altLabel mesh__D012957 Society, Pharmaceutical
% 213.22/213.39  |- mesh__dateCreated mesh__D012957 1999-01-01
% 213.22/213.39  |- mesh__publicMeSHNote mesh__D012957 68   
% 213.22/213.39  |- mesh__historyNote mesh__D012957 68   
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D012957 2000
% 213.22/213.39  |- skos__broader mesh__D012957smesh__D012952
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D012957 2005
% 213.22/213.39  |- mesh__dateRevised mesh__D012957 1999-11-03
% 213.22/213.39  |- skos__altLabel mesh__D012957 Societies, Pharmacy
% 213.22/213.39  |- skos__altLabel mesh__D012957 Societies, Pharmaceutic
% 213.22/213.39  |- mesh__dateCreated mesh__D045333 2003-07-09
% 213.22/213.39  |- mesh__dateRevised mesh__D045333 2004-07-07
% 213.22/213.39  |- skos__hiddenLabel mesh__D045333 Peptide Nanotube
% 213.22/213.39  |- skos__broader mesh__D045333smesh__D043942
% 213.22/213.39  |- mesh__publicMeSHNote mesh__D045333 2004   
% 213.22/213.39  |- mesh__historyNote mesh__D045333 2004   
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D045333 2006
% 213.22/213.39  |- skos__prefLabel mesh__D045333 Nanotubes, Peptide
% 213.22/213.39  |- mesh__recordOriginator mesh__D045333 ssb
% 213.22/213.39  |- rdf__type mesh__D045333sskos__Concept
% 213.22/213.39  |- skos__hiddenLabel mesh__D045333 Peptide Nanotubes
% 213.22/213.39  |- mesh__dateEstablished mesh__D045333 2004-01-01
% 213.22/213.39  |- skos__broader mesh__D045333smesh__D010456
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D045333 2005
% 213.22/213.39  |- mesh__recordMaintainer mesh__D045333 ssb
% 213.22/213.39  |- skos__scopeNote mesh__D045333
% 213.22/213.39       NANOTUBES formed from cyclic peptides %28%PEPTIDES, CYCLIC%29%. Alternating D and L linkages create planar rings that self assemble by stacking into nanotubes. They can form pores through CELL MEMBRANE causing damage to cells.%A%    
% 213.22/213.39  |- skos__hiddenLabel mesh__D045333 Nanotube, Peptide
% 213.22/213.39  |- mesh__recordAuthorizer mesh__D045333 sjn
% 213.22/213.39  |- skos__scopeNote mesh__D012159
% 213.22/213.39       The second stomach of ruminants. It lies almost in the midline in the front of the abdomen, in contact with the liver and diaphragm and communicates freely with the RUMEN via the ruminoreticular orifice. The lining of the reticulum is raised into folds forming a honeycomb pattern over the surface. %28%From Concise Veterinary Dictionary, 1988%29%%A%    
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D012159 2002
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D012159 1998
% 213.22/213.39  |- skos__hiddenLabel mesh__D012159 Reticulums
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D012159 2006
% 213.22/213.39  |- skos__prefLabel mesh__D012159 Reticulum
% 213.22/213.39  |- rdf__type mesh__D012159sskos__Concept
% 213.22/213.39  |- skos__historyNote mesh__D012159 Stomach %28%1966-1967%29%
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D012159 2005
% 213.22/213.39  |- skos__broader mesh__D012159smesh__D013279
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D012159 2001
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D012159 1997
% 213.22/213.39  |- mesh__dateEstablished mesh__D012159 1968-01-01
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D012159 2000
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D012159 1996
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D012159 2004
% 213.22/213.39  |- skos__annotation mesh__D012159
% 213.22/213.39       a ruminant%27%s 2d stomach; note category: animal term; dis: coord IM with STOMACH DISEASES /vet %28%IM%29%; neopl: coord IM with STOMACH NEOPLASMS /vet %28%IM%29% + histol type /vet %28%IM%29%; ulcer: coord IM with STOMACH ULCER /vet %28%IM%29%%A%  
% 213.22/213.39  |- mesh__historyNote mesh__D012159 68   
% 213.22/213.39  |- mesh__recordAuthorizer mesh__D012159 PLS
% 213.22/213.39  |- mesh__dateCreated mesh__D012159 1999-01-01
% 213.22/213.39  |- mesh__recordOriginator mesh__D012159 NLM
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D012159 2003
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D012159 1999
% 213.22/213.39  |- mesh__publicMeSHNote mesh__D012159 68   
% 213.22/213.39  |- mesh__recordMaintainer mesh__D012159 TGC
% 213.22/213.39  |- mesh__dateRevised mesh__D012159 1995-05-18
% 213.22/213.39  |- skos__broader mesh__D017378Q000031smesh__D017378
% 213.22/213.39  |- mesh__preferredCombination mesh__D017378Q000031smesh__D011805
% 213.22/213.39  |- rdf__type mesh__D017378Q000031smesh__CompoundConcept
% 213.22/213.39  |- skos__historyNote mesh__D031313 Plants, Medicinal %28%1999-2002%29%
% 213.22/213.39  |- skos__scopeNote mesh__D031313
% 213.22/213.39       A plant genus of the family GENTIANACEAE that contains nitiol %28%a C25 sesterterpenoid%29% %26% nitidasin.%A%    
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D031313 2005
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D031313 2003
% 213.22/213.39  |- skos__altLabel mesh__D031313 Hercumpuri
% 213.22/213.39  |- skos__annotation mesh__D031313
% 213.22/213.39       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D031313 2006
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D031313 2004
% 213.22/213.39  |- mesh__dateEstablished mesh__D031313 2003-01-01
% 213.22/213.39  |- mesh__dateCreated mesh__D031313 2002-07-03
% 213.22/213.39  |- skos__broader mesh__D031313smesh__D029965
% 213.22/213.39  |- skos__prefLabel mesh__D031313 Gentianella
% 213.22/213.39  |- mesh__historyNote mesh__D031313 2003   
% 213.22/213.39  |- mesh__publicMeSHNote mesh__D031313 2003   
% 213.22/213.39  |- rdf__type mesh__D031313sskos__Concept
% 213.22/213.39  |- mesh__dateRevised mesh__D003622 2005-06-30
% 213.22/213.39  |- skos__broader mesh__D003622smesh__D013450
% 213.22/213.39  |- skos__altLabel mesh__D003622 4,4%27%-Diaminophenyl Sulfone
% 213.22/213.39  |- skos__altLabel mesh__D003622 Fatol Brand of Dapsone
% 213.22/213.39  |- mesh__dateCreated mesh__D003622 1999-01-01
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D003622 2006
% 213.22/213.39  |- mesh__recordMaintainer mesh__D003622 lkw
% 213.22/213.39  |- skos__altLabel mesh__D003622 DADPS
% 213.22/213.39  |- skos__altLabel mesh__D003622 Diaminodiphenylsulfone
% 213.22/213.39  |- skos__altLabel mesh__D003622 Mex-America Brand of Dapsone
% 213.22/213.39  |- skos__scopeNote mesh__D003622
% 213.22/213.39       A sulfone active against a wide range of bacteria but mainly employed for its actions against MYCOBACTERIUM LEPRAE. Its mechanism of action is probably similar to that of the SULFONAMIDES which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with PYRIMETHAMINE in the treatment of malaria. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8%29%%A%    
% 213.22/213.39  |- skos__hiddenLabel mesh__D003622 4,4%27% Diaminophenyl Sulfone
% 213.22/213.39  |- rdf__type mesh__D003622sskos__Concept
% 213.22/213.39  |- skos__prefLabel mesh__D003622 Dapsone
% 213.22/213.39  |- skos__hiddenLabel mesh__D003622 Sulfone, 4,4%27%-Diaminophenyl
% 213.22/213.39  |- mesh__recordAuthorizer mesh__D003622 sjn
% 213.22/213.39  |- mesh__recordOriginator mesh__D003622 NLM
% 213.22/213.39  |- skos__altLabel mesh__D003622 Sulfonyldianiline
% 213.22/213.39  |- skos__altLabel mesh__D003622 Orsade Brand of Dapsone
% 213.22/213.39  |- skos__altLabel mesh__D003622 Diaphenylsulfone
% 213.22/213.39  |- mesh__recordOriginator mesh__D050278 ags
% 213.22/213.39  |- skos__historyNote mesh__D050278 Fingers %28%1966-2005%29%
% 213.22/213.39  |- rdf__type mesh__D050278sskos__Concept
% 213.22/213.39  |- mesh__recordMaintainer mesh__D050278 ags
% 213.22/213.39  |- mesh__historyNote mesh__D050278 2006   
% 213.22/213.39  |- skos__altLabel mesh__D050278 Finger Bones
% 213.22/213.39  |- mesh__dateCreated mesh__D050278 2005-06-30
% 213.22/213.39  |- mesh__dateEstablished mesh__D050278 2006-01-01
% 213.22/213.39  |- skos__prefLabel mesh__D050278 Finger Phalanges
% 213.22/213.39  |- mesh__recordAuthorizer mesh__D050278 sjn
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D050278 2006
% 213.22/213.39  |- skos__altLabel mesh__D050278 Bones of Fingers
% 213.22/213.39  |- skos__scopeNote mesh__D050278
% 213.22/213.39       Bones that make up the SKELETON of the FINGERS, consisting of two for the THUMB, and three for each of the other fingers.%A%    
% 213.22/213.39  |- skos__hiddenLabel mesh__D050278 Fingers Bones
% 213.22/213.39  |- skos__hiddenLabel mesh__D050278 Phalanges, Finger
% 213.22/213.39  |- mesh__publicMeSHNote mesh__D050278 2006   
% 213.22/213.39  |- skos__broader mesh__D050278smesh__D050276
% 213.22/213.39  |- skos__hiddenLabel mesh__D050278 Bones, Finger
% 213.22/213.39  |- skos__annotation mesh__D050278 primates only; Manual 21.58   
% 213.22/213.39  |- skos__altLabel mesh__D050278 Phalanges of Fingers
% 213.22/213.39  |- skos__annotation mesh__D041741 GEN; prefer specifics   
% 213.22/213.39  |- skos__hiddenLabel mesh__D041741 Gastrointestinal Tract, Lower
% 213.22/213.39  |- skos__prefLabel mesh__D041741 Lower Gastrointestinal Tract
% 213.22/213.39  |- rdf__type mesh__D041741sskos__Concept
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D041741 2005
% 213.22/213.39  |- mesh__dateCreated mesh__D041741 2003-07-09
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D041741 2004
% 213.22/213.39  |- skos__broader mesh__D041741smesh__D041981
% 213.22/213.39  |- skos__scopeNote mesh__D041741
% 213.22/213.39       The segment of GASTROINTESTINAL TRACT that includes the small intestine below the DUODENUM, and the LARGE INTESTINE.%A%    
% 213.22/213.39  |- mesh__historyNote mesh__D041741 2004   
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D041741 2006
% 213.22/213.39  |- skos__altLabel mesh__D041741 Lower GI Tract
% 213.22/213.39  |- mesh__dateEstablished mesh__D041741 2004-01-01
% 213.22/213.39  |- mesh__publicMeSHNote mesh__D041741 2004   
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D035704 2003
% 213.22/213.39  |- skos__scopeNote mesh__D035704
% 213.22/213.39       A plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. Some members contain triterpenoid saponins.%A%    
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D035704 2006
% 213.22/213.39  |- skos__broader mesh__D035704smesh__D019684
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D035704 2004
% 213.22/213.39  |- skos__annotation mesh__D035704
% 213.22/213.39       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.22/213.39  |- skos__prefLabel mesh__D035704 Molluginaceae
% 213.22/213.39  |- mesh__historyNote mesh__D035704 2003   
% 213.22/213.39  |- rdf__type mesh__D035704sskos__Concept
% 213.22/213.39  |- mesh__publicMeSHNote mesh__D035704 2003   
% 213.22/213.39  |- mesh__dateCreated mesh__D035704 2002-07-03
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D035704 2005
% 213.22/213.39  |- mesh__dateEstablished mesh__D035704 2003-01-01
% 213.22/213.39  |- skos__hiddenLabel mesh__D013252 Steroid 11 beta Monooxygenase
% 213.22/213.39  |- skos__altLabel mesh__D013252 Cytochrome P450 11B1
% 213.22/213.39  |- mesh__recordAuthorizer mesh__D013252 sjn
% 213.22/213.39  |- rdf__type mesh__D013252sskos__Concept
% 213.22/213.39  |- skos__prefLabel mesh__D013252 Steroid 11-beta-Hydroxylase
% 213.22/213.39  |- skos__altLabel mesh__D013252 Steroid 11-Hydroxylase
% 213.22/213.39  |- skos__altLabel mesh__D013252 Steroid 11-beta-Monooxygenase
% 213.22/213.39  |- mesh__recordOriginator mesh__D013252 RLS
% 213.22/213.39  |- mesh__activeMeSHYear mesh__D013252 2006
% 213.22/213.39  |- skos__hiddenLabel mesh__D013252 Steroid 11 beta Hydroxylase
% 213.22/213.39  |- mesh__dateCreated mesh__D013252 1977-04-15
% 213.22/213.39  |- skos__altLabel mesh__D013252 Cytochrome P-450%28%11 beta%29%
% 213.22/213.39  |- skos__scopeNote mesh__D013252
% 213.22/213.39       A mitochondrial cytochrome P450 enzyme that catalyzes the 11-beta-hydroxylation of steroids in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP11B1 gene, is important in the synthesis of CORTICOSTERONE and HYDROCORTISONE. Defects in CYP11B1 cause congenital adrenal hyperplasia %28%ADRENAL HYPERPLASIA, CONGENITAL%29%.%A%    
% 213.22/213.39  |- skos__related mesh__D013252smesh__D000312
% 213.22/213.39  |- skos__hiddenLabel mesh__D013252 11 beta Hydroxylase
% 213.22/213.39  |- skos__historyNote mesh__D013252 Steroid Hydroxylases %28%1973-1977%29%
% 213.22/213.39  |- skos__hiddenLabel mesh__D013252 Cytochrome P 450 CYP11B1
% 213.22/213.40  |- mesh__historyNote mesh__D013252 2003 %28%1978%29%   
% 213.22/213.40  |- mesh__activeMeSHYear mesh__D013252 2005
% 213.22/213.40  |- skos__broader mesh__D013252smesh__D013250
% 213.22/213.40  |- skos__altLabel mesh__D013252 CYP11B1
% 213.22/213.40  |- skos__altLabel mesh__D013252 Steroid-11-Hydroxylase
% 213.22/213.40  |- skos__altLabel mesh__D013252 11 beta-Hydroxylase
% 213.22/213.40  |- skos__altLabel mesh__D013252 CYP 11B1
% 213.22/213.40  |- skos__altLabel mesh__D013252 Steroid 11 Hydroxylase
% 213.22/213.40  |- skos__altLabel mesh__D013252 Cytochrome P-450 CYP11B1
% 213.22/213.40  |- mesh__dateEstablished mesh__D013252 1991-01-01
% 213.22/213.40  |- mesh__dateRevised mesh__D013252 2004-07-07
% 213.22/213.40  |- mesh__publicMeSHNote mesh__D013252
% 213.22/213.40       2003; see STEROID 11 BETA-MONOOXYGENASE 1997-2002, see STEROID 11-HYDROXYLASE 1991-1996, see STEROID HYDROXYLASES 1990, see STEROID-11-HYDROXYLASE 1978-1989%A%  
% 213.22/213.40  |- mesh__recordMaintainer mesh__D013252 ssb
% 213.22/213.40  |- skos__prefLabel mesh__D007215 Indophenol
% 213.22/213.40  |- mesh__recordAuthorizer mesh__D007215 PLS
% 213.22/213.40  |- mesh__activeMeSHYear mesh__D007215 1999
% 213.22/213.40  |- mesh__activeMeSHYear mesh__D007215 1993
% 213.22/213.40  |- skos__broader mesh__D007215smesh__D010636
% 213.25/213.40  |- mesh__recordMaintainer mesh__D007215 TAP
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007215 2004
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007215 1996
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007215 2000
% 213.25/213.40  |- rdf__type mesh__D007215sskos__Concept
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007215 2001
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007215 1997
% 213.25/213.40  |- mesh__recordOriginator mesh__D007215 NLM
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007215 1994
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007215 2005
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007215 1995
% 213.25/213.40  |- mesh__dateCreated mesh__D007215 1999-01-01
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007215 2006
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007215 1998
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007215 2002
% 213.25/213.40  |- mesh__dateRevised mesh__D007215 1992-05-19
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007215 2003
% 213.25/213.40  |- mesh__dateRevised mesh__D012958 2002-07-02
% 213.25/213.40  |- skos__broader mesh__D012958smesh__D012952
% 213.25/213.40  |- rdf__type mesh__D012958sskos__Concept
% 213.25/213.40  |- skos__hiddenLabel mesh__D012958 Scientific Society
% 213.25/213.40  |- skos__prefLabel mesh__D012958 Societies, Scientific
% 213.25/213.40  |- mesh__recordMaintainer mesh__D012958 jls
% 213.25/213.40  |- skos__altLabel mesh__D012958 Scientific Societies
% 213.25/213.40  |- skos__annotation mesh__D012958
% 213.25/213.40       for societies of scientists %26% professionals in disciplines not covered under SOCIETIES, MEDICAL; Manual 35.9.1; specify geog%A%  
% 213.25/213.40  |- mesh__dateCreated mesh__D012958 1999-01-01
% 213.25/213.40  |- mesh__recordAuthorizer mesh__D012958 sjn
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D012958 2005
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D012958 2003
% 213.25/213.40  |- skos__hiddenLabel mesh__D012958 Society, Scientific
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D012958 2006
% 213.25/213.40  |- skos__scopeNote mesh__D012958
% 213.25/213.40       Societies whose membership is limited to scientists.     
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D012958 2004
% 213.25/213.40  |- mesh__recordOriginator mesh__D012958 NLM
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D031314 2005
% 213.25/213.40  |- skos__prefLabel mesh__D031314 Geraniaceae
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D031314 2003
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D031314 2006
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D031314 2004
% 213.25/213.40  |- skos__scopeNote mesh__D031314
% 213.25/213.40       A plant family of the order Geraniales, subclass Rosidae, class Magnoliopsida.%A%    
% 213.25/213.40  |- skos__broader mesh__D031314smesh__D019684
% 213.25/213.40  |- mesh__publicMeSHNote mesh__D031314 2003   
% 213.25/213.40  |- rdf__type mesh__D031314sskos__Concept
% 213.25/213.40  |- skos__annotation mesh__D031314
% 213.25/213.40       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.25/213.40  |- mesh__dateCreated mesh__D031314 2002-07-03
% 213.25/213.40  |- mesh__dateEstablished mesh__D031314 2003-01-01
% 213.25/213.40  |- mesh__historyNote mesh__D031314 2003   
% 213.25/213.40  |- mesh__dateRevised mesh__D003623 2003-07-09
% 213.25/213.40  |- mesh__dateCreated mesh__D003623 1999-01-01
% 213.25/213.40  |- skos__historyNote mesh__D003623 Adaptation, Ocular %28%1966-1967%29%
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D003623 2005
% 213.25/213.40  |- mesh__historyNote mesh__D003623 72%28%68%29%   
% 213.25/213.40  |- mesh__dateEstablished mesh__D003623 1972-01-01
% 213.25/213.40  |- mesh__publicMeSHNote mesh__D003623 72   
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D003623 2006
% 213.25/213.40  |- skos__prefLabel mesh__D003623 Dark Adaptation
% 213.25/213.40  |- skos__hiddenLabel mesh__D003623 Adaptation, Scotopic
% 213.25/213.40  |- skos__scopeNote mesh__D003623
% 213.25/213.40       Adjustment of the eyes under conditions of low light. The sensitivity of the eye to light is increased during dark adaptation.%A%    
% 213.25/213.40  |- rdf__type mesh__D003623sskos__Concept
% 213.25/213.40  |- mesh__recordOriginator mesh__D003623 NLM
% 213.25/213.40  |- mesh__recordAuthorizer mesh__D003623 sjn
% 213.25/213.40  |- skos__broader mesh__D003623smesh__D000221
% 213.25/213.40  |- skos__altLabel mesh__D003623 Scotopic Adaptation
% 213.25/213.40  |- mesh__recordMaintainer mesh__D003623 nns
% 213.25/213.40  |- skos__hiddenLabel mesh__D003623 Adaptation, Dark
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D003623 2004
% 213.25/213.40  |- skos__related mesh__D050279smesh__D008663
% 213.25/213.40  |- skos__prefLabel mesh__D050279 Metacarpal Bones
% 213.25/213.40  |- mesh__recordOriginator mesh__D050279 ags
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D050279 2006
% 213.25/213.40  |- skos__annotation mesh__D050279
% 213.25/213.40       do not confuse with METACARPUS, the anatomical region   
% 213.25/213.40  |- skos__scopeNote mesh__D050279
% 213.25/213.40       The five cylindrical bones of the METACARPUS, articulating with the CARPAL BONES proximally and the PHALANGES OF FINGERS distally.%A%    
% 213.25/213.40  |- mesh__historyNote mesh__D050279 2006   
% 213.25/213.40  |- mesh__publicMeSHNote mesh__D050279 2006   
% 213.25/213.40  |- mesh__dateCreated mesh__D050279 2005-06-30
% 213.25/213.40  |- mesh__dateEstablished mesh__D050279 2006-01-01
% 213.25/213.40  |- mesh__recordAuthorizer mesh__D050279 sjn
% 213.25/213.40  |- skos__altLabel mesh__D050279 Metacarpals
% 213.25/213.40  |- skos__hiddenLabel mesh__D050279 Bones, Metacarpal
% 213.25/213.40  |- skos__historyNote mesh__D050279 Metacarpus %28%1965-2005%29%
% 213.25/213.40  |- rdf__type mesh__D050279sskos__Concept
% 213.25/213.40  |- skos__broader mesh__D050279smesh__D050276
% 213.25/213.40  |- mesh__recordMaintainer mesh__D050279 ags
% 213.25/213.40  |- mesh__historyNote mesh__D041742 2004   
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D041742 2005
% 213.25/213.40  |- mesh__publicMeSHNote mesh__D041742 2004   
% 213.25/213.40  |- skos__scopeNote mesh__D041742
% 213.25/213.40       The segment of GASTROINTESTINAL TRACT that includes the ESOPHAGUS; the STOMACH; and the DUODENUM.%A%    
% 213.25/213.40  |- skos__prefLabel mesh__D041742 Upper Gastrointestinal Tract
% 213.25/213.40  |- skos__altLabel mesh__D041742 Upper GI Tract
% 213.25/213.40  |- skos__broader mesh__D041742smesh__D041981
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D041742 2004
% 213.25/213.40  |- mesh__dateCreated mesh__D041742 2003-07-09
% 213.25/213.40  |- mesh__dateEstablished mesh__D041742 2004-01-01
% 213.25/213.40  |- rdf__type mesh__D041742sskos__Concept
% 213.25/213.40  |- skos__annotation mesh__D041742 GEN; prefer specifics   
% 213.25/213.40  |- skos__hiddenLabel mesh__D041742 Gastrointestinal Tract, Upper
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D041742 2006
% 213.25/213.40  |- skos__hiddenLabel mesh__D041742 GI Tract, Upper
% 213.25/213.40  |- skos__hiddenLabel mesh__D013253 Steroid 12 Hydroxylase
% 213.25/213.40  |- skos__altLabel mesh__D013253 Sterol 12 alpha-Hydroxylase
% 213.25/213.40  |- skos__altLabel mesh__D013253 CYP8B1
% 213.25/213.40  |- skos__altLabel mesh__D013253 Cytochrome P450 8B1
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D013253 2005
% 213.25/213.40  |- skos__altLabel mesh__D013253 Steroid-12-Monooxygenase
% 213.25/213.40  |- skos__altLabel mesh__D013253 12alpha-Hydroxylase
% 213.25/213.40  |- skos__historyNote mesh__D013253 Steroid Hydroxylases %28%1973-1977%29%
% 213.25/213.40  |- mesh__recordMaintainer mesh__D013253 ssb
% 213.25/213.40  |- skos__altLabel mesh__D013253 Cytochrome P450 CYP8B1
% 213.25/213.40  |- skos__scopeNote mesh__D013253
% 213.25/213.40       A liver microsomal cytochrome P450 enzyme that catalyzes the 12-alpha-hydroxylation of a broad spectrum of sterols in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP8B1gene, converts 7-alpha-hydroxy-4-cholesten-3-one to 7-alpha-12-alpha-dihydroxy-4-cholesten-3-one and is required in the synthesis of BILE ACIDS from cholesterol.%A%    
% 213.25/213.40  |- skos__hiddenLabel mesh__D013253 12 alpha Hydroxylase
% 213.25/213.40  |- skos__altLabel mesh__D013253 Steroid 12-Hydroxylase
% 213.25/213.40  |- mesh__dateRevised mesh__D013253 2004-07-07
% 213.25/213.40  |- mesh__recordAuthorizer mesh__D013253 sjn
% 213.25/213.40  |- mesh__recordOriginator mesh__D013253 RLS
% 213.25/213.40  |- skos__prefLabel mesh__D013253 Steroid 12-alpha-Hydroxylase
% 213.25/213.40  |- skos__hiddenLabel mesh__D013253 12 alpha-Hydroxylase, Sterol
% 213.25/213.40  |- mesh__dateEstablished mesh__D013253 1991-01-01
% 213.25/213.40  |- skos__hiddenLabel mesh__D013253 alpha-Hydroxylase, Sterol 12
% 213.25/213.40  |- skos__hiddenLabel mesh__D013253 Sterol 12 alpha Hydroxylase
% 213.25/213.40  |- mesh__historyNote mesh__D013253 2003 %28%1978%29%   
% 213.25/213.40  |- skos__hiddenLabel mesh__D013253 12alpha Hydroxylase
% 213.25/213.40  |- skos__altLabel mesh__D013253 Sterol 12-alpha-Hydroxylase
% 213.25/213.40  |- skos__broader mesh__D013253smesh__D013250
% 213.25/213.40  |- rdf__type mesh__D013253sskos__Concept
% 213.25/213.40  |- skos__altLabel mesh__D013253 Steroid 12-Monooxygenase
% 213.25/213.40  |- skos__altLabel mesh__D013253 12-alpha-Hydroxylase
% 213.25/213.40  |- mesh__publicMeSHNote mesh__D013253
% 213.25/213.40       2003; see STEROID 12-MONOOXYGENASE 1997-2002, see STEROID 12-HYDROXYLASE 1991-1996, see STEROID HYDROXYLASES 1978-1990; for STEROID 12-MONOOXYGENASE see STEROID 12-HYDROXYLASE 1978-1996%A%  
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D013253 2006
% 213.25/213.40  |- skos__hiddenLabel mesh__D013253 Steroid 12 alpha Hydroxylase
% 213.25/213.40  |- mesh__dateCreated mesh__D013253 1977-04-15
% 213.25/213.40  |- skos__hiddenLabel mesh__D013253 Steroid 12 Monooxygenase
% 213.25/213.40  |- skos__altLabel mesh__D013253 Steroid-12-Hydroxylase
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007216 2001
% 213.25/213.40  |- mesh__dateRevised mesh__D007216 2000-06-22
% 213.25/213.40  |- mesh__dateCreated mesh__D007216 1978-03-20
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007216 2004
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007216 2005
% 213.25/213.40  |- skos__scopeNote mesh__D007216
% 213.25/213.40       A drug that has analgesic and anti-inflammatory properties. Following reports of adverse reactions including reports of carcinogenicity in animal studies it was withdrawn from the market worldwide. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p21%29%%A%    
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007216 2003
% 213.25/213.40  |- mesh__recordAuthorizer mesh__D007216 sjn
% 213.25/213.40  |- mesh__recordMaintainer mesh__D007216 CCR
% 213.25/213.40  |- skos__broader mesh__D007216smesh__D010666
% 213.25/213.40  |- rdf__type mesh__D007216sskos__Concept
% 213.25/213.40  |- mesh__recordOriginator mesh__D007216 SH
% 213.25/213.40  |- skos__prefLabel mesh__D007216 Indoprofen
% 213.25/213.40  |- mesh__dateEstablished mesh__D007216 1991-01-01
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007216 2002
% 213.25/213.40  |- skos__historyNote mesh__D007216 Phenylpropionates %28%1974-1978%29%
% 213.25/213.40  |- mesh__historyNote mesh__D007216
% 213.25/213.40       91%28%79%29%; was see under PHENYLPROPIONATES 1979-90   
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007216 2006
% 213.25/213.40  |- mesh__publicMeSHNote mesh__D007216
% 213.25/213.40       91; was see under PHENYLPROPIONATES 1979-90   
% 213.25/213.40  |- skos__historyNote mesh__D007216 Propionates %28%1966-1973%29%
% 213.25/213.40  |- mesh__dateRevised mesh__D012959 2002-07-03
% 213.25/213.40  |- skos__hiddenLabel mesh__D012959 Populations, High-Income
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D012959 2006
% 213.25/213.40  |- mesh__recordAuthorizer mesh__D012959 sjn
% 213.25/213.40  |- skos__annotation mesh__D012959
% 213.25/213.40       NIM; no qualif; Manual 35.7; includes both social %26% economic aspects: purely economic aspect = ECONOMICS%A%  
% 213.25/213.40  |- skos__hiddenLabel mesh__D012959 Inequality
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D012959 2003
% 213.25/213.40  |- skos__hiddenLabel mesh__D012959 Socioeconomic Factor
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D012959 2005
% 213.25/213.40  |- skos__broader mesh__D012959smesh__D012961
% 213.25/213.40  |- skos__hiddenLabel mesh__D012959 Population, High-Income
% 213.25/213.40  |- rdf__type mesh__D012959sskos__Concept
% 213.25/213.40  |- skos__historyNote mesh__D012959 Social Conditions %28%1966-1967%29%
% 213.25/213.40  |- skos__hiddenLabel mesh__D012959 Living Standard
% 213.25/213.40  |- mesh__historyNote mesh__D012959 68   
% 213.25/213.40  |- skos__hiddenLabel mesh__D012959 Factor, Socioeconomic
% 213.25/213.40  |- mesh__recordOriginator mesh__D012959 NLM
% 213.25/213.40  |- skos__hiddenLabel mesh__D012959 Tenure, Land
% 213.25/213.40  |- skos__prefLabel mesh__D012959 Socioeconomic Factors
% 213.25/213.40  |- mesh__publicMeSHNote mesh__D012959 68   
% 213.25/213.40  |- mesh__dateEstablished mesh__D012959 1968-01-01
% 213.25/213.40  |- mesh__recordMaintainer mesh__D012959 tjk
% 213.25/213.40  |- mesh__dateCreated mesh__D012959 1999-01-01
% 213.25/213.40  |- skos__hiddenLabel mesh__D012959 Living Standards
% 213.25/213.40  |- skos__hiddenLabel mesh__D012959 High-Income Populations
% 213.25/213.40  |- skos__broader mesh__D012959smesh__D011154
% 213.25/213.40  |- skos__altLabel mesh__D012959 Factors, Socioeconomic
% 213.25/213.40  |- skos__hiddenLabel mesh__D012959 High Income Population
% 213.25/213.40  |- skos__scopeNote mesh__D012959
% 213.25/213.40       Social and economic factors that characterize the individual or group within the social structure.%A%    
% 213.25/213.40  |- skos__historyNote mesh__D012959 Sociology %28%1966-1967%29%
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D012959 2004
% 213.25/213.40  |- skos__altLabel mesh__D023681 Tilapia nilotica
% 213.25/213.40  |- skos__hiddenLabel mesh__D023681 Cichlid
% 213.25/213.40  |- skos__altLabel mesh__D023681 Cichlidae
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D023681 2005
% 213.25/213.40  |- mesh__dateEstablished mesh__D023681 2002-01-01
% 213.25/213.40  |- mesh__dateCreated mesh__D023681 2001-07-25
% 213.25/213.40  |- rdf__type mesh__D023681sskos__Concept
% 213.25/213.40  |- skos__altLabel mesh__D023681 Cichlid Fish
% 213.25/213.40  |- mesh__publicMeSHNote mesh__D023681
% 213.25/213.40       2002; see PERCHES 1987-2001; for TILAPIA NILOTICA use TILAPIA 1992-2001%A%  
% 213.25/213.40  |- skos__annotation mesh__D023681
% 213.25/213.40       note X refs TILAPIA NILOTICA and NILE TILAPIA; TILAPIA is also available%A%  
% 213.25/213.40  |- skos__altLabel mesh__D023681 Oreochromis nilotica
% 213.25/213.40  |- skos__altLabel mesh__D023681 Nile Tilapia
% 213.25/213.40  |- skos__prefLabel mesh__D023681 Cichlids
% 213.25/213.40  |- mesh__recordOriginator mesh__D023681 ags
% 213.25/213.40  |- skos__historyNote mesh__D023681 Perches %28%1986-2001%29%
% 213.25/213.40  |- mesh__recordAuthorizer mesh__D023681 sjn
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D023681 2004
% 213.25/213.40  |- mesh__recordMaintainer mesh__D023681 ags
% 213.25/213.40  |- mesh__historyNote mesh__D023681
% 213.25/213.40       2002; use PERCHES 1987-2001; for TILAPIA NILOTICA use TILAPIA 1992-2001%A%  
% 213.25/213.40  |- skos__hiddenLabel mesh__D023681 Fish, Cichlid
% 213.25/213.40  |- mesh__dateRevised mesh__D023681 2003-07-09
% 213.25/213.40  |- skos__scopeNote mesh__D023681
% 213.25/213.40       Common name for perch-like fish of the family Cichlidae, belonging to the suborder Labroidei, order PERCIFORMES.%A%    
% 213.25/213.40  |- skos__broader mesh__D023681smesh__D010473
% 213.25/213.40  |- skos__historyNote mesh__D023681 Fishes %28%1965-1986%29%
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D023681 2006
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D031315 2006
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D031315 2003
% 213.25/213.40  |- skos__scopeNote mesh__D031315
% 213.25/213.40       A plant genus of the family GERANIACEAE. Geranium is also used as a common name for PELARGONIUM.%A%    
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D031315 2005
% 213.25/213.40  |- rdf__type mesh__D031315sskos__Concept
% 213.25/213.40  |- mesh__dateEstablished mesh__D031315 2003-01-01
% 213.25/213.40  |- skos__broader mesh__D031315smesh__D031314
% 213.25/213.40  |- mesh__historyNote mesh__D031315 2003   
% 213.25/213.40  |- mesh__publicMeSHNote mesh__D031315 2003   
% 213.25/213.40  |- skos__prefLabel mesh__D031315 Geranium
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D031315 2004
% 213.25/213.40  |- mesh__dateCreated mesh__D031315 2002-07-03
% 213.25/213.40  |- skos__annotation mesh__D031315
% 213.25/213.40       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D003624 2005
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D003624 2006
% 213.25/213.40  |- rdf__type mesh__D003624sskos__Concept
% 213.25/213.40  |- skos__hiddenLabel mesh__D003624 Darknesses
% 213.25/213.40  |- skos__broader mesh__D003624smesh__D008027
% 213.25/213.40  |- mesh__recordMaintainer mesh__D003624 ssb
% 213.25/213.40  |- mesh__dateRevised mesh__D003624 2004-07-07
% 213.25/213.40  |- skos__prefLabel mesh__D003624 Darkness
% 213.25/213.40  |- mesh__recordOriginator mesh__D003624 NLM
% 213.25/213.40  |- mesh__dateCreated mesh__D003624 1999-01-01
% 213.25/213.40  |- mesh__recordAuthorizer mesh__D003624 sjn
% 213.25/213.40  |- skos__hiddenLabel mesh__D041743 Drug-Herb Interaction
% 213.25/213.40  |- skos__annotation mesh__D041743
% 213.25/213.40       coord IM with specific plant %28%IM%29% + specific drug %28%IM%29% with pertinent qualif%A%  
% 213.25/213.40  |- skos__hiddenLabel mesh__D041743 Interaction, Drug-Herb
% 213.25/213.40  |- skos__hiddenLabel mesh__D041743 Interaction, Drug-Plant
% 213.25/213.40  |- skos__historyNote mesh__D041743 Drug Interactions %28%1970-2003%29%
% 213.25/213.40  |- skos__hiddenLabel mesh__D041743 Herb-Drug Interaction
% 213.25/213.40  |- skos__scopeNote mesh__D041743
% 213.25/213.40       The effect of herbs, other PLANTS, or PLANT EXTRACTS on the activity, metabolism, or toxicity of drugs.%A%    
% 213.25/213.40  |- skos__hiddenLabel mesh__D041743 Drug Herb Interactions
% 213.25/213.40  |- mesh__historyNote mesh__D041743 2004   
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D041743 2004
% 213.25/213.40  |- skos__hiddenLabel mesh__D041743 Drug Interaction, Herbal
% 213.25/213.40  |- mesh__dateCreated mesh__D041743 2003-07-09
% 213.25/213.40  |- skos__hiddenLabel mesh__D041743 Drug-Plant Interaction
% 213.25/213.40  |- skos__hiddenLabel mesh__D041743 Interactions, Drug-Herb
% 213.25/213.40  |- skos__hiddenLabel mesh__D041743 Plant Drug Interactions
% 213.25/213.40  |- skos__hiddenLabel mesh__D041743 Drug Plant Interactions
% 213.25/213.40  |- rdf__type mesh__D041743sskos__Concept
% 213.25/213.40  |- skos__hiddenLabel mesh__D041743 Interactions, Drug-Plant
% 213.25/213.40  |- skos__hiddenLabel mesh__D041743 Interactions, Plant-Drug
% 213.25/213.40  |- skos__hiddenLabel mesh__D041743 Interactions, Herb-Drug
% 213.25/213.40  |- skos__hiddenLabel mesh__D041743 Interaction, Herb-Drug
% 213.25/213.40  |- skos__altLabel mesh__D041743 Herbal Drug Interactions
% 213.25/213.40  |- skos__altLabel mesh__D041743 Drug-Plant Interactions
% 213.25/213.40  |- skos__altLabel mesh__D041743 Drug-Herb Interactions
% 213.25/213.40  |- skos__hiddenLabel mesh__D041743 Interactions, Herbal Drug
% 213.25/213.40  |- skos__hiddenLabel mesh__D041743 Interaction, Herbal Drug
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D041743 2006
% 213.25/213.40  |- skos__hiddenLabel mesh__D041743 Herb Drug Interactions
% 213.25/213.40  |- skos__hiddenLabel mesh__D041743 Plant-Drug Interaction
% 213.25/213.40  |- skos__hiddenLabel mesh__D041743 Herbal Drug Interaction
% 213.25/213.40  |- skos__hiddenLabel mesh__D041743 Drug Interactions, Herbal
% 213.25/213.40  |- skos__hiddenLabel mesh__D041743 Interaction, Plant-Drug
% 213.25/213.40  |- skos__prefLabel mesh__D041743 Herb-Drug Interactions
% 213.25/213.40  |- mesh__dateEstablished mesh__D041743 2004-01-01
% 213.25/213.40  |- skos__altLabel mesh__D041743 Plant-Drug Interactions
% 213.25/213.40  |- skos__broader mesh__D041743smesh__D004347
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D041743 2005
% 213.25/213.40  |- mesh__publicMeSHNote mesh__D041743 2004   
% 213.25/213.40  |- skos__hiddenLabel mesh__D013254 17-alpha-Hydroxylase, Steroid
% 213.25/213.40  |- mesh__recordAuthorizer mesh__D013254 sjn
% 213.25/213.40  |- skos__hiddenLabel mesh__D013254 Aldolase, Hydroxyprogesterone
% 213.25/213.40  |- skos__hiddenLabel mesh__D013254 17 alpha-Monooxygenase, Steroid
% 213.25/213.40  |- skos__hiddenLabel mesh__D013254 Steroid 17 Hydroxylase
% 213.25/213.40  |- skos__hiddenLabel mesh__D013254 Steroid 17 alpha Monooxygenase
% 213.25/213.40  |- skos__altLabel mesh__D013254 Steroid 17 alpha-Hydroxylase
% 213.25/213.40  |- rdf__type mesh__D013254sskos__Concept
% 213.25/213.40  |- skos__hiddenLabel mesh__D013254 17 alpha Hydroxylase
% 213.25/213.40  |- skos__altLabel mesh__D013254 Cytochrome P-450%28%17 alpha%29%
% 213.25/213.40  |- skos__scopeNote mesh__D013254
% 213.25/213.40       A microsomal cytochrome P450 enzyme that catalyzes the 17-alpha-hydroxylation of progesterone or pregnenolone and subsequent cleavage of the residual two carbons at C17 in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP17 gene, generates precursors for glucocorticoid, androgen, and estrogen synthesis. Defects in CYP17 gene cause congenital adrenal hyperplasia %28%ADRENAL HYPERPLASIA, CONGENITAL%29% and abnormal sexual differentiation.%A%    
% 213.25/213.40  |- skos__altLabel mesh__D013254 17,20-Lyase
% 213.25/213.40  |- mesh__recordOriginator mesh__D013254 RLS
% 213.25/213.40  |- skos__altLabel mesh__D013254 Cytochrome P-450%28%17-alpha%29%
% 213.25/213.40  |- skos__hiddenLabel mesh__D013254 17-Monooxygenase, Steroid
% 213.25/213.40  |- skos__broader mesh__D013254smesh__D013250
% 213.25/213.40  |- skos__hiddenLabel mesh__D013254 17,20 Lyase
% 213.25/213.40  |- skos__related mesh__D013254smesh__D000312
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D013254 2005
% 213.25/213.40  |- skos__hiddenLabel mesh__D013254 Steroid 17 Monooxygenase
% 213.25/213.40  |- skos__altLabel mesh__D013254 Steroid 17-Hydroxylase
% 213.25/213.40  |- mesh__dateEstablished mesh__D013254 1991-01-01
% 213.25/213.40  |- skos__hiddenLabel mesh__D013254 17 alpha-Hydroxylase, Steroid
% 213.25/213.40  |- skos__altLabel mesh__D013254 Steroid 17 alpha-Monooxygenase
% 213.25/213.40  |- skos__altLabel mesh__D013254 17 alpha-Hydroxylase Cytochrome P-450
% 213.25/213.40  |- mesh__dateCreated mesh__D013254 1977-04-15
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D013254 2006
% 213.25/213.40  |- skos__hiddenLabel mesh__D013254 Steroid 17 alpha Hydroxylase
% 213.25/213.40  |- skos__altLabel mesh__D013254 CYP17
% 213.25/213.40  |- mesh__historyNote mesh__D013254 2003 %28%1978%29%   
% 213.25/213.40  |- skos__prefLabel mesh__D013254 Steroid 17-alpha-Hydroxylase
% 213.25/213.40  |- skos__hiddenLabel mesh__D013254 17 alpha Hydroxylase Cytochrome P 450
% 213.25/213.40  |- skos__altLabel mesh__D013254 17,20-Desmolase
% 213.25/213.40  |- skos__altLabel mesh__D013254 Steroid 17-Monooxygenase
% 213.25/213.40  |- skos__hiddenLabel mesh__D013254 17-Hydroxylase, Steroid
% 213.25/213.40  |- skos__hiddenLabel mesh__D013254 alpha-Monooxygenase, Steroid 17
% 213.25/213.40  |- skos__altLabel mesh__D013254 Steroid-17-Hydroxylase
% 213.25/213.40  |- skos__historyNote mesh__D013254 Steroid Hydroxylases %28%1973-1977%29%
% 213.25/213.40  |- mesh__recordMaintainer mesh__D013254 ssb
% 213.25/213.40  |- skos__hiddenLabel mesh__D013254 17,20 Desmolase
% 213.25/213.40  |- skos__altLabel mesh__D013254 17 alpha-Hydroxylase
% 213.25/213.40  |- mesh__dateRevised mesh__D013254 2004-07-07
% 213.25/213.40  |- skos__hiddenLabel mesh__D013254 alpha-Hydroxylase, 17
% 213.25/213.40  |- skos__altLabel mesh__D013254 Hydroxyprogesterone Aldolase
% 213.25/213.40  |- skos__altLabel mesh__D013254 Cytochrome P450%28%17 alpha%29%
% 213.25/213.40  |- skos__hiddenLabel mesh__D013254 alpha-Hydroxyprogesterone Aldolase, 17
% 213.25/213.40  |- skos__hiddenLabel mesh__D013254 17 alpha Hydroxyprogesterone Aldolase
% 213.25/213.40  |- skos__hiddenLabel mesh__D013254 Aldolase, 17 alpha-Hydroxyprogesterone
% 213.25/213.40  |- mesh__publicMeSHNote mesh__D013254
% 213.25/213.40       2003; see STEROID 17 ALPHA-MONOOXYGENASE 1997-2002, see STEROID 17-HYDROXYLASE 1991-1996, see STEROID HYDROXYLASES 1990; for STEROID-17-HYDROXYLASE see STEROID HYDROXYLASES 1978-1989; for 17,20-LYASE see 17 ALPHA-HYDROXYPROGESTERONE ALDOLASE 1996-1997%A%  
% 213.25/213.40  |- skos__altLabel mesh__D013254 P450%28%c17%29%
% 213.25/213.40  |- skos__hiddenLabel mesh__D007217 Wy21901
% 213.25/213.40  |- skos__scopeNote mesh__D007217
% 213.25/213.40       A hypotensive agent with some anti-arrhythmic effects.     
% 213.25/213.40  |- skos__historyNote mesh__D007217 Indoles %28%1971-1974%29%
% 213.25/213.40  |- mesh__recordOriginator mesh__D007217 NLM
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007217 2003
% 213.25/213.40  |- mesh__publicMeSHNote mesh__D007217 91; was see under INDOLES 1975-90   
% 213.25/213.40  |- skos__prefLabel mesh__D007217 Indoramin
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007217 2001
% 213.25/213.40  |- rdf__type mesh__D007217sskos__Concept
% 213.25/213.40  |- mesh__dateEstablished mesh__D007217 1991-01-01
% 213.25/213.40  |- skos__broader mesh__D007217smesh__D001549
% 213.25/213.40  |- skos__historyNote mesh__D007217 Piperidines %28%1971-1974%29%
% 213.25/213.40  |- mesh__recordAuthorizer mesh__D007217 sjn
% 213.25/213.40  |- skos__broader mesh__D007217smesh__D010880
% 213.25/213.40  |- mesh__recordMaintainer mesh__D007217 CCR
% 213.25/213.40  |- skos__broader mesh__D007217smesh__D007211
% 213.25/213.40  |- skos__hiddenLabel mesh__D007217 Wy 21901
% 213.25/213.40  |- mesh__dateCreated mesh__D007217 1974-11-19
% 213.25/213.40  |- mesh__historyNote mesh__D007217
% 213.25/213.40       91%28%75%29%; was see under INDOLES 1975-90   
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007217 2006
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007217 2002
% 213.25/213.40  |- skos__historyNote mesh__D007217 Benzamides %28%1973-1974%29%
% 213.25/213.40  |- mesh__dateRevised mesh__D007217 2000-06-22
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007217 2004
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D007217 2005
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D031316 2005
% 213.25/213.40  |- mesh__dateCreated mesh__D031316 2002-07-03
% 213.25/213.40  |- rdf__type mesh__D031316sskos__Concept
% 213.25/213.40  |- mesh__publicMeSHNote mesh__D031316 2003   
% 213.25/213.40  |- skos__scopeNote mesh__D031316
% 213.25/213.40       A plant genus of the family GERANIACEAE. The common name of geranium is also used for the GERANIUM genus.%A%    
% 213.25/213.40  |- skos__prefLabel mesh__D031316 Pelargonium
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D031316 2004
% 213.25/213.40  |- skos__annotation mesh__D031316
% 213.25/213.40       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.25/213.40  |- mesh__dateEstablished mesh__D031316 2003-01-01
% 213.25/213.40  |- skos__broader mesh__D031316smesh__D031314
% 213.25/213.40  |- mesh__historyNote mesh__D031316 2003   
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D031316 2006
% 213.25/213.40  |- mesh__activeMeSHYear mesh__D031316 2003
% 213.25/213.40  |- skos__hiddenLabel mesh__D003625 Linkage, Data
% 213.25/213.40  |- skos__hiddenLabel mesh__D003625 Method, Survey
% 213.25/213.40  |- skos__hiddenLabel mesh__D003625 Randomized Response Technics
% 213.25/213.40  |- skos__hiddenLabel mesh__D003625 Surveys, Community
% 213.25/213.40  |- skos__hiddenLabel mesh__D003625 Survey Method
% 213.25/213.40  |- skos__broader mesh__D003625smesh__D007254
% 213.25/213.40  |- skos__hiddenLabel mesh__D003625 Technique, Randomized Response
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Aggregation, Data
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Response Technique, Randomized
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Surveys, Contraceptive Prevalence
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Surveys, Baseline
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Data Linkages
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Response Techniques, Randomized
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Response Technic, Randomized
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D003625 2003
% 213.25/213.41  |- mesh__recordAuthorizer mesh__D003625 sjn
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Randomized Response Techniques
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Methods, Survey
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Nonrespondent
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Data Source
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Technics, Randomized Response
% 213.25/213.41  |- skos__prefLabel mesh__D003625 Data Collection
% 213.25/213.41  |- mesh__historyNote mesh__D003625 80   
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D003625 2004
% 213.25/213.41  |- mesh__dateRevised mesh__D003625 2002-07-02
% 213.25/213.41  |- skos__scopeNote mesh__D003625
% 213.25/213.41       Systematic gathering of data for a particular purpose from various sources, including questionnaires, interviews, observation, existing records, and electronic devices. The process is usually preliminary to statistical analysis of the data.%A%    
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Community Survey
% 213.25/213.41  |- mesh__publicMeSHNote mesh__D003625 80   
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Survey, Baseline
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Techniques, Randomized Response
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Technic, Randomized Response
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Baseline Surveys
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Sources, Data
% 213.25/213.41  |- skos__altLabel mesh__D003625 Randomized Response Technic
% 213.25/213.41  |- skos__broader mesh__D003625smesh__D004812
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D003625 2005
% 213.25/213.41  |- mesh__dateEstablished mesh__D003625 1980-01-01
% 213.25/213.41  |- skos__annotation mesh__D003625
% 213.25/213.41       X ref SURVEYS is GEN or unspecified; prefer specific survey, as DIET SURVEYS; HEALTH SURVEYS; NUTRITION SURVEYS; etc.%A%  
% 213.25/213.41  |- mesh__dateCreated mesh__D003625 1979-06-01
% 213.25/213.41  |- mesh__recordOriginator mesh__D003625 SMH
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Collection, Dual Data
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Collection, Data
% 213.25/213.41  |- skos__altLabel mesh__D003625 Methodology, Survey
% 213.25/213.41  |- rdf__type mesh__D003625sskos__Concept
% 213.25/213.41  |- skos__related mesh__D003625smesh__D036262
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Response Technics, Randomized
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Source, Data
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Contraceptive Prevalence Survey
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D003625 2006
% 213.25/213.41  |- skos__broader mesh__D003625smesh__D017531
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Survey, Contraceptive Prevalence
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Survey, Community
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Respondent
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Linkages, Data
% 213.25/213.41  |- mesh__recordMaintainer mesh__D003625 hjn
% 213.25/213.41  |- skos__altLabel mesh__D003625 Survey Methodology
% 213.25/213.41  |- skos__hiddenLabel mesh__D003625 Survey
% 213.25/213.41  |- skos__altLabel mesh__D008310 Cross Bite
% 213.25/213.41  |- skos__hiddenLabel mesh__D008310 Crowding, Tooth
% 213.25/213.41  |- skos__broader mesh__D008310smesh__D014076
% 213.25/213.41  |- skos__hiddenLabel mesh__D008310 Angle Classification
% 213.25/213.41  |- skos__prefLabel mesh__D008310 Malocclusion
% 213.25/213.41  |- mesh__recordAuthorizer mesh__D008310 sjn
% 213.25/213.41  |- skos__scopeNote mesh__D008310
% 213.25/213.41       Such malposition and contact of the maxillary and mandibular teeth as to interfere with the highest efficiency during the excursive movements of the jaw that are essential for mastication. %28%Jablonski, Illustrated Dictionary of Dentistry, 1982%29%%A%    
% 213.25/213.41  |- skos__hiddenLabel mesh__D008310 Classification, Angle%27%s
% 213.25/213.41  |- skos__hiddenLabel mesh__D008310 Crossbites
% 213.25/213.41  |- mesh__dateCreated mesh__D008310 1999-01-01
% 213.25/213.41  |- skos__related mesh__D008310smesh__D012182
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D008310 2006
% 213.25/213.41  |- skos__hiddenLabel mesh__D008310 Malocclusions
% 213.25/213.41  |- skos__hiddenLabel mesh__D008310 Crowdings, Tooth
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D008310 2005
% 213.25/213.41  |- mesh__dateRevised mesh__D008310 2001-07-25
% 213.25/213.41  |- mesh__recordMaintainer mesh__D008310 lkt
% 213.25/213.41  |- rdf__type mesh__D008310sskos__Concept
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D008310 2002
% 213.25/213.41  |- skos__hiddenLabel mesh__D008310 Angles Classification
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D008310 2004
% 213.25/213.41  |- skos__hiddenLabel mesh__D008310 Bites, Cross
% 213.25/213.41  |- skos__related mesh__D008310smesh__D011378
% 213.25/213.41  |- skos__related mesh__D008310smesh__D009971
% 213.25/213.41  |- skos__hiddenLabel mesh__D008310 Bite, Cross
% 213.25/213.41  |- skos__annotation mesh__D008310
% 213.25/213.41       X ref ANGLE%27%S CLASSIFICATION: Angle%27%s classes MALOCCLUSION, ANGLE CLASS I %26% MALOCCLUSION, ANGLE CLASS II %26% MALOCCLUSION, ANGLE CLASS III are also available but index Angle%27%s classification in general or unspecified as MALOCCLUSION /class%A%  
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D008310 2003
% 213.25/213.41  |- skos__hiddenLabel mesh__D008310 Cross Bites
% 213.25/213.41  |- mesh__recordOriginator mesh__D008310 NLM
% 213.25/213.41  |- skos__related mesh__D008310smesh__D019186
% 213.25/213.41  |- skos__altLabel mesh__D013255 Cytochrome P-450 21-Hydroxylase
% 213.25/213.41  |- mesh__recordAuthorizer mesh__D013255 sjn
% 213.25/213.41  |- skos__altLabel mesh__D013255 Steroid 21-Monooxygenase
% 213.25/213.41  |- skos__broader mesh__D013255smesh__D013250
% 213.25/213.41  |- skos__hiddenLabel mesh__D013255 Steroid 21 Hydroxylase
% 213.25/213.41  |- skos__altLabel mesh__D013255 21-Hydroxylase
% 213.25/213.41  |- skos__hiddenLabel mesh__D013255 Cytochrome P 450 CYP21
% 213.25/213.41  |- mesh__recordOriginator mesh__D013255 RLS
% 213.25/213.41  |- mesh__dateCreated mesh__D013255 1977-04-15
% 213.25/213.41  |- skos__hiddenLabel mesh__D013255 Cytochrome P 450 21 Hydroxylase
% 213.25/213.41  |- skos__altLabel mesh__D013255 Cytochrome P-450 c21
% 213.25/213.41  |- skos__altLabel mesh__D013255 Cytochrome P-450 CYP21
% 213.25/213.41  |- mesh__historyNote mesh__D013255 2003 %28%1978%29%   
% 213.25/213.41  |- rdf__type mesh__D013255sskos__Concept
% 213.25/213.41  |- skos__scopeNote mesh__D013255
% 213.25/213.41       An adrenal microsomal cytochrome P450 enzyme that catalyzes the 21-hydroxylation of steroids in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP21 gene, converts progesterones to precursors of adrenal steroid hormones %28%CORTICOSTERONE; HYDROCORTISONE%29%. Defects in CYP21 cause congenital adrenal hyperplasia %28%ADRENAL HYPERPLASIA, CONGENITAL%29%.%A%    
% 213.25/213.41  |- skos__hiddenLabel mesh__D013255 Steroid 21 Monooxygenase
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D013255 2005
% 213.25/213.41  |- skos__hiddenLabel mesh__D013255 21 Hydroxylase
% 213.25/213.41  |- skos__hiddenLabel mesh__D013255 Progesterone 21 Hydroxylase
% 213.25/213.41  |- skos__hiddenLabel mesh__D013255 Cytochrome P 450 c21
% 213.25/213.41  |- skos__altLabel mesh__D013255 Progesterone 21-Hydroxylase
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D013255 2006
% 213.25/213.41  |- skos__prefLabel mesh__D013255 Steroid 21-Hydroxylase
% 213.25/213.41  |- mesh__dateEstablished mesh__D013255 1991-01-01
% 213.25/213.41  |- skos__historyNote mesh__D013255 Steroid Hydroxylases %28%1973-1977%29%
% 213.25/213.41  |- mesh__publicMeSHNote mesh__D013255
% 213.25/213.41       2003; see STE see STEROID 21-MONOOXYGENASE 1997-2002, see STEROID 21-HYDROXYLASE 1991-1996, see STEROID HYDROXYLASES 1978-1990; for STEROID 21-MONOOXYGENASE see STEROID 21-HYDROXYLASE 1978-1996; CYTOCHROME P-450 C21 was indexed under STEROID 21-HYDROXYLASE 2004 %26% under CYTOCHROME P-450 ENZYME SYSTEM 1996-2003%A%  
% 213.25/213.41  |- skos__hiddenLabel mesh__D013255 P-450 c21, Cytochrome
% 213.25/213.41  |- skos__altLabel mesh__D013255 Cytochrome P450c21
% 213.25/213.41  |- mesh__dateRevised mesh__D013255 2004-07-07
% 213.25/213.41  |- skos__altLabel mesh__D013255 Cytochrome P-450%28%c-21%29%
% 213.25/213.41  |- mesh__recordMaintainer mesh__D013255 jmp
% 213.25/213.41  |- skos__altLabel mesh__D013255 Steroid-21-Hydroxylase
% 213.25/213.41  |- skos__broader mesh__D007218smesh__D008829
% 213.25/213.41  |- skos__annotation mesh__D007218
% 213.25/213.41       SPEC: SPEC qualif; coord IM with specific bact, virus or fungus %28%IM%29% if pertinent; DF: INDUST MICROBIOL%A%  
% 213.25/213.41  |- mesh__recordAuthorizer mesh__D007218 sjn
% 213.25/213.41  |- mesh__publicMeSHNote mesh__D007218 87   
% 213.25/213.41  |- skos__altLabel mesh__D007218 Microbiology, Industrial
% 213.25/213.41  |- mesh__historyNote mesh__D007218 87   
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D007218 2002
% 213.25/213.41  |- mesh__recordMaintainer mesh__D007218 jls
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D007218 2006
% 213.25/213.41  |- mesh__dateCreated mesh__D007218 1986-03-27
% 213.25/213.41  |- skos__prefLabel mesh__D007218 Industrial Microbiology
% 213.25/213.41  |- skos__broader mesh__D007218smesh__D001709
% 213.25/213.41  |- mesh__dateRevised mesh__D007218 2001-07-25
% 213.25/213.41  |- skos__scopeNote mesh__D007218
% 213.25/213.41       The study, utilization, and manipulation of those microorganisms capable of economically producing desirable substances or changes in substances, and the control of undesirable microorganisms.%A%    
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D007218 2004
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D007218 2005
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D007218 2003
% 213.25/213.41  |- rdf__type mesh__D007218sskos__Concept
% 213.25/213.41  |- mesh__recordOriginator mesh__D007218 VDK
% 213.25/213.41  |- mesh__dateEstablished mesh__D007218 1987-01-01
% 213.25/213.41  |- skos__related mesh__D007218smesh__D005818
% 213.25/213.41  |- mesh__dateEstablished mesh__D017646 1994-01-01
% 213.25/213.41  |- skos__historyNote mesh__D017646 Silicon %28%1966-1993%29%
% 213.25/213.41  |- skos__scopeNote mesh__D017646
% 213.25/213.41       Organic compounds that contain silicon as an integral part of the molecule.%A%    
% 213.25/213.41  |- mesh__publicMeSHNote mesh__D017646 94   
% 213.25/213.41  |- skos__annotation mesh__D017646 DF: ORGANOSILICON CPDS   
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D017646 1997
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D017646 2004
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D017646 2002
% 213.25/213.41  |- rdf__type mesh__D017646sskos__Concept
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D017646 1999
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D017646 2006
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D017646 2003
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D017646 1996
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D017646 1995
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D017646 2001
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D017646 1998
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D017646 2005
% 213.25/213.41  |- mesh__dateCreated mesh__D017646 1992-12-28
% 213.25/213.41  |- skos__broader mesh__D017646smesh__D009930
% 213.25/213.41  |- skos__prefLabel mesh__D017646 Organosilicon Compounds
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D017646 1994
% 213.25/213.41  |- mesh__historyNote mesh__D017646 94   
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D017646 2000
% 213.25/213.41  |- skos__broader mesh__D031317smesh__D029201
% 213.25/213.41  |- mesh__publicMeSHNote mesh__D031317 2003   
% 213.25/213.41  |- skos__scopeNote mesh__D031317
% 213.25/213.41       A plant genus of the family HAMAMELIDACEAE. The sap is a source of storax, which should not be confused with the similar named STYRAX genus.%A%    
% 213.25/213.41  |- mesh__historyNote mesh__D031317 2003   
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D031317 2004
% 213.25/213.41  |- skos__annotation mesh__D031317
% 213.25/213.41       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D031317 2006
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D031317 2003
% 213.25/213.41  |- mesh__dateCreated mesh__D031317 2002-07-03
% 213.25/213.41  |- skos__altLabel mesh__D031317 Sweetgum
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D031317 2005
% 213.25/213.41  |- rdf__type mesh__D031317sskos__Concept
% 213.25/213.41  |- skos__prefLabel mesh__D031317 Liquidambar
% 213.25/213.41  |- mesh__dateEstablished mesh__D031317 2003-01-01
% 213.25/213.41  |- skos__hiddenLabel mesh__D003626 Data Displays
% 213.25/213.41  |- skos__broader mesh__D003626smesh__D006804
% 213.25/213.41  |- skos__prefLabel mesh__D003626 Data Display
% 213.25/213.41  |- mesh__publicMeSHNote mesh__D003626 66   
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D003626 2006
% 213.25/213.41  |- skos__broader mesh__D003626smesh__D007254
% 213.25/213.41  |- skos__hiddenLabel mesh__D003626 Displays, Information
% 213.25/213.41  |- skos__scopeNote mesh__D003626
% 213.25/213.41       The visual display of data in a man-machine system. An example is a cathode ray tube display in which certain data can be called for from the computer and presented on the screen.%A%    
% 213.25/213.41  |- rdf__type mesh__D003626sskos__Concept
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D003626 2005
% 213.25/213.41  |- skos__altLabel mesh__D003626 Information Display
% 213.25/213.41  |- mesh__recordMaintainer mesh__D003626 jls
% 213.25/213.41  |- mesh__historyNote mesh__D003626 66%28%64%29%   
% 213.25/213.41  |- mesh__recordOriginator mesh__D003626 NLM
% 213.25/213.41  |- mesh__recordAuthorizer mesh__D003626 sjn
% 213.25/213.41  |- skos__hiddenLabel mesh__D003626 Displays, Data
% 213.25/213.41  |- mesh__dateCreated mesh__D003626 1999-01-01
% 213.25/213.41  |- skos__hiddenLabel mesh__D003626 Display, Data
% 213.25/213.41  |- mesh__dateEstablished mesh__D003626 1966-01-01
% 213.25/213.41  |- mesh__dateRevised mesh__D003626 2004-07-07
% 213.25/213.41  |- skos__hiddenLabel mesh__D003626 Information Displays
% 213.25/213.41  |- skos__hiddenLabel mesh__D003626 Display, Information
% 213.25/213.41  |- skos__altLabel mesh__D036002 NAD-Arginine ADP-Ribosyltransferase
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 Transferases, Mono ADP-ribose
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 ADPribose Transferase, Mono
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D036002 2006
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 Transferase, ADP Ribose
% 213.25/213.41  |- rdf__type mesh__D036002sskos__Concept
% 213.25/213.41  |- mesh__dateEstablished mesh__D036002 2003-01-01
% 213.25/213.41  |- skos__altLabel mesh__D036002 ART Transferase
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 ADP-ribose Transferases, Mono
% 213.25/213.41  |- mesh__recordMaintainer mesh__D036002 ssb
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 Transferases, ART
% 213.25/213.41  |- mesh__recordAuthorizer mesh__D036002 sjn
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 NAD ADP Ribosyltransferase
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 NADP Arginine ADP Ribosyltransferase
% 213.25/213.41  |- skos__scopeNote mesh__D036002
% 213.25/213.41       Enzymes that transfer the ADP-RIBOSE group of NAD or NADP to proteins or other small molecules. Transfer of ADP-ribose to water %28%i.e., hydrolysis%29% is catalyzed by the NADASES. The mono%28%ADP-ribose%29%transferases transfer a single ADP-ribose.  POLY%28%ADP-RIBOSE%29% POLYMERASES transfer multiple units of ADP-ribose to protein targets, building POLY ADENOSINE DIPHOSPHATE RIBOSE in linear or branched chains.%A%    
% 213.25/213.41  |- mesh__dateCreated mesh__D036002 2002-07-02
% 213.25/213.41  |- skos__broader mesh__D036002smesh__D010430
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D036002 2004
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 NAD+ ADP Ribosyltransferase
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 Ribose Transferases, ADP
% 213.25/213.41  |- skos__altLabel mesh__D036002
% 213.25/213.41       NAD%28%+%29%-L-arginine ADP-D-ribosyltransferase
% 213.25/213.41  |- skos__altLabel mesh__D036002 Mono ADP-ribose Transferases
% 213.25/213.41  |- mesh__dateRevised mesh__D036002 2003-07-09
% 213.25/213.41  |- skos__altLabel mesh__D036002 ART Transferases
% 213.25/213.41  |- skos__altLabel mesh__D036002 Mono ADPribose Transferase
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 ADPribose Transferases, Mono
% 213.25/213.41  |- skos__altLabel mesh__D036002 ADP Ribose Transferase
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 ADP-Ribosyltransferase, NAD+
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 Transferase, Mono ADPribose
% 213.25/213.41  |- skos__altLabel mesh__D036002 MonoADPribosyltransferase
% 213.25/213.41  |- skos__altLabel mesh__D036002 ADP-Ribosyltransferase
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 Mono ADP ribose Transferases
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 ADP-Ribosyltransferase, NAD-Agmatine
% 213.25/213.41  |- mesh__historyNote mesh__D036002
% 213.25/213.41       2003; for NAD+ ADP-RIBOSYLTRANSFERASE use  POLY%28%ADP-RIBOSE%29% POLYMERASES 1988-2002%A%  
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 NAD Arginine ADP Ribosyltransferase
% 213.25/213.41  |- skos__altLabel mesh__D036002 NADP-Arginine ADP-Ribosyltransferase
% 213.25/213.41  |- skos__altLabel mesh__D036002 NAD ADP-Ribosyltransferase
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 Ribose Transferase, ADP
% 213.25/213.41  |- skos__altLabel mesh__D036002 Mono%28%ADP-Ribosyl%29%transferase
% 213.25/213.41  |- mesh__publicMeSHNote mesh__D036002
% 213.25/213.41       2003; see NAD%28%P%29%%28%+%29%-ARGININE ADP-RIBOSYLTRANSFERASE 1992-2002, see NAD-ARGININE ADP-RIBOSYLTRANSFERASE 1989-1991; for NAD+ ADP-RIBOSYLTRANSFERASE see NAD+ ADP-RIBOSYLTRANSFERASE 1992-2002, see POLY ADP RIBOSE POLYMERASE 1988-1991; for MONO-ADP-RIBOSYLTRANSFERASE and NAD-ARGININE ADP-RIBOSYLTRANSFERASE and NADP-ARGININE ADP-RIBOSYLTRANSFERASE see NAD%28%P%29%%28%+%29%-ARGININE ADP-RIBOSYLTRANSFERASE 1992-2002, see NAD-ARGININE ADP-RIBOSYLTRANSFERASE 1989-1991%A%  
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 ADP-Ribosyltransferase, NAD-Arginine
% 213.25/213.41  |- skos__altLabel mesh__D036002 NADP-ADPRTase
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 NAD Agmatine ADP Ribosyltransferase
% 213.25/213.41  |- skos__altLabel mesh__D036002 Mono ADPribose Transferases
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 Transferases, Mono ADPribose
% 213.25/213.41  |- skos__prefLabel mesh__D036002 ADP Ribose Transferases
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 Transferase, ART
% 213.25/213.41  |- mesh__recordOriginator mesh__D036002 nns
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 ADP Ribosyltransferase
% 213.25/213.41  |- skos__altLabel mesh__D036002 Mono%28%ADPribosyl%29%transferase
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D036002 2005
% 213.25/213.41  |- skos__altLabel mesh__D036002 Mono%28%ADP-Ribose%29% Transferase
% 213.25/213.41  |- skos__altLabel mesh__D036002 NAD-Agmatine ADP-Ribosyltransferase
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 Mono ADP Ribosyltransferase
% 213.25/213.41  |- skos__altLabel mesh__D036002 ADPRTs
% 213.25/213.41  |- skos__altLabel mesh__D036002 ARTase
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 ADP-Ribosyltransferase, NADP-Arginine
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 ADP-Ribosyltransferase, NAD
% 213.25/213.41  |- skos__altLabel mesh__D036002 ADPRT
% 213.25/213.41  |- skos__altLabel mesh__D036002 ARTases
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 Transferases, ADP Ribose
% 213.25/213.41  |- skos__altLabel mesh__D036002 Mono-ADP-Ribosyltransferase
% 213.25/213.41  |- skos__hiddenLabel mesh__D036002 NADP ADPRTase
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D008311 2006
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D008311 2002
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D008311 1994
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D008311 1993
% 213.25/213.41  |- skos__broader mesh__D008311smesh__D008310
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D008311 2005
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D008311 1999
% 213.25/213.41  |- skos__annotation mesh__D008311
% 213.25/213.41       Angle refers to Edward Hartley Angle, Amer orthodontist   
% 213.25/213.41  |- rdf__type mesh__D008311sskos__Concept
% 213.25/213.41  |- mesh__dateCreated mesh__D008311 1978-01-26
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D008311 2001
% 213.25/213.41  |- mesh__recordMaintainer mesh__D008311 TGC
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D008311 2004
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D008311 1992
% 213.25/213.41  |- skos__historyNote mesh__D008311 Malocclusion %28%1966-1978%29%
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D008311 2000
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D008311 1998
% 213.25/213.41  |- skos__altLabel mesh__D008311 Angle Class I
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D008311 1997
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D008311 2003
% 213.25/213.41  |- mesh__recordOriginator mesh__D008311 SMH
% 213.25/213.41  |- skos__prefLabel mesh__D008311 Malocclusion, Angle Class I
% 213.25/213.41  |- mesh__historyNote mesh__D008311
% 213.25/213.41       91%28%79%29%; was see under MALOCCLUSION 1979-90   
% 213.25/213.41  |- mesh__dateEstablished mesh__D008311 1991-01-01
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D008311 1996
% 213.25/213.41  |- mesh__dateRevised mesh__D008311 1991-06-18
% 213.25/213.41  |- skos__hiddenLabel mesh__D008311 Class I, Angle
% 213.25/213.41  |- mesh__recordAuthorizer mesh__D008311 PLS
% 213.25/213.41  |- mesh__publicMeSHNote mesh__D008311
% 213.25/213.41       91; was see under MALOCCLUSION 1979-90   
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D008311 1995
% 213.25/213.41  |- skos__scopeNote mesh__D008311
% 213.25/213.41       Malocclusion in which the mandible and maxilla are anteroposteriorly normal as reflected by the relationship of the first permanent molar %28%i.e., in neutroclusion%29%, but in which individual teeth are abnormally related to each other.%A%    
% 213.25/213.41  |- skos__annotation mesh__D013256
% 213.25/213.41       GEN; avoid: too general; prefer more specific steroid groups or specific steroids%A%  
% 213.25/213.41  |- mesh__onlineNote mesh__D013256 pre-explosion = STEROIDS %28%PX%29%   
% 213.25/213.41  |- skos__prefLabel mesh__D013256 Steroids
% 213.25/213.41  |- skos__scopeNote mesh__D013256
% 213.25/213.41       A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols %28%STEROLS%29%, and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. %28%From Hawley%27%s Condensed Chemical Dictionary, 11th ed%29%%A%    
% 213.25/213.41  |- mesh__recordAuthorizer mesh__D013256 sjn
% 213.25/213.41  |- rdf__type mesh__D013256sskos__Concept
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D013256 2005
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D013256 2006
% 213.25/213.41  |- skos__related mesh__D013256smesh__D011987
% 213.25/213.41  |- mesh__recordOriginator mesh__D013256 NLM
% 213.25/213.41  |- mesh__dateRevised mesh__D013256 2004-07-07
% 213.25/213.41  |- skos__hiddenLabel mesh__D013256 Steroids, Catatoxic
% 213.25/213.41  |- mesh__recordMaintainer mesh__D013256 ags
% 213.25/213.41  |- mesh__dateCreated mesh__D013256 1999-01-01
% 213.25/213.41  |- mesh__historyNote mesh__D013256
% 213.25/213.41       63; CATATOXIC STEROIDS was heading 1974-95   
% 213.25/213.41  |- skos__broader mesh__D013256smesh__D011083
% 213.25/213.41  |- mesh__publicMeSHNote mesh__D013256
% 213.25/213.41       63; CATATOXIC STEROIDS was heading 1974-95   
% 213.25/213.41  |- mesh__dateEstablished mesh__D032410 2003-01-01
% 213.25/213.41  |- skos__scopeNote mesh__D032410
% 213.25/213.41       A plant genus of the family VERBENACEAE. Members contain lantadene and other TRITERPENES.%A%    
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D032410 2006
% 213.25/213.41  |- skos__annotation mesh__D032410
% 213.25/213.41       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.25/213.41  |- mesh__publicMeSHNote mesh__D032410 2003   
% 213.25/213.41  |- skos__prefLabel mesh__D032410 Lantana
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D032410 2004
% 213.25/213.41  |- skos__broader mesh__D032410smesh__D029648
% 213.25/213.41  |- mesh__historyNote mesh__D032410 2003   
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D032410 2005
% 213.25/213.41  |- mesh__dateCreated mesh__D032410 2002-07-03
% 213.25/213.41  |- rdf__type mesh__D032410sskos__Concept
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D032410 2003
% 213.25/213.41  |- mesh__recordOriginator mesh__D007219 RLS
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D007219 2000
% 213.25/213.41  |- skos__historyNote mesh__D007219 Oils %28%1966-1986%29%
% 213.25/213.41  |- mesh__dateEstablished mesh__D007219 1987-01-01
% 213.25/213.41  |- skos__hiddenLabel mesh__D007219 Oil, Commercial
% 213.25/213.41  |- skos__hiddenLabel mesh__D007219 Oils, Commercial
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D007219 2006
% 213.25/213.41  |- skos__hiddenLabel mesh__D007219 Commercial Oil
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D007219 2004
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D007219 2005
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D007219 2002
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D007219 1999
% 213.25/213.41  |- mesh__dateCreated mesh__D007219 1986-06-16
% 213.25/213.41  |- mesh__recordMaintainer mesh__D007219 JLS
% 213.25/213.41  |- skos__scopeNote mesh__D007219
% 213.25/213.41       Oils which are used in industrial or commercial applications.%A%    
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D007219 2003
% 213.25/213.41  |- skos__altLabel mesh__D007219 Oils, Industrial
% 213.25/213.41  |- skos__annotation mesh__D007219
% 213.25/213.41       coord IM with specific oil %28%IM or NIM%29% if pertinent; DF: INDUST OILS%A%  
% 213.25/213.41  |- mesh__recordAuthorizer mesh__D007219 SJN
% 213.25/213.41  |- skos__broader mesh__D007219smesh__D008420
% 213.25/213.41  |- rdf__type mesh__D007219sskos__Concept
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D007219 1998
% 213.25/213.41  |- mesh__dateRevised mesh__D007219 1997-06-20
% 213.25/213.41  |- skos__hiddenLabel mesh__D007219 Oil, Industrial
% 213.25/213.41  |- mesh__publicMeSHNote mesh__D007219
% 213.25/213.41       87; POLISHES was see OILS 1978-86; was see under OILS 1975-77%A%  
% 213.25/213.41  |- mesh__onlineNote mesh__D007219
% 213.25/213.41       use INDUSTRIAL OILS to search POLISHES 1987; use OILS to search POLISHES 1966-86 %28%as Prov 1966-74%29%%A%  
% 213.25/213.41  |- mesh__historyNote mesh__D007219
% 213.25/213.41       87; POLISHES was see OILS 1978-86; was see under OILS 1966-77 %28%Prov 1966-74%29%%A%  
% 213.25/213.41  |- skos__hiddenLabel mesh__D007219 Industrial Oil
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D007219 2001
% 213.25/213.41  |- skos__prefLabel mesh__D007219 Industrial Oils
% 213.25/213.41  |- mesh__dateEstablished mesh__D031318 2003-01-01
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D031318 2004
% 213.25/213.41  |- skos__scopeNote mesh__D031318
% 213.25/213.41       A plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida.%A%    
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D031318 2006
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D031318 2003
% 213.25/213.41  |- mesh__historyNote mesh__D031318 2003   
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D031318 2005
% 213.25/213.41  |- skos__broader mesh__D031318smesh__D019684
% 213.25/213.41  |- skos__prefLabel mesh__D031318 Hippocastanaceae
% 213.25/213.41  |- rdf__type mesh__D031318sskos__Concept
% 213.25/213.41  |- skos__annotation mesh__D031318
% 213.25/213.41       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.25/213.41  |- mesh__publicMeSHNote mesh__D031318 2003   
% 213.25/213.41  |- mesh__dateCreated mesh__D031318 2002-07-03
% 213.25/213.41  |- skos__broader mesh__D036801smesh__D011247
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D036801 2005
% 213.25/213.41  |- mesh__recordAuthorizer mesh__D036801 sjn
% 213.25/213.41  |- rdf__type mesh__D036801sskos__Concept
% 213.25/213.41  |- skos__historyNote mesh__D036801 Labor %28%1966-2002%29%
% 213.25/213.41  |- mesh__historyNote mesh__D036801 2003   
% 213.25/213.41  |- mesh__publicMeSHNote mesh__D036801 2003   
% 213.25/213.41  |- skos__hiddenLabel mesh__D036801 Childbirths
% 213.25/213.41  |- skos__hiddenLabel mesh__D036801 Parturitions
% 213.25/213.41  |- mesh__dateRevised mesh__D036801 2004-07-07
% 213.25/213.41  |- skos__hiddenLabel mesh__D036801 Births
% 213.25/213.41  |- mesh__dateEstablished mesh__D036801 2003-01-01
% 213.25/213.41  |- mesh__recordMaintainer mesh__D036801 lkt
% 213.25/213.41  |- mesh__recordOriginator mesh__D036801 lkt
% 213.25/213.41  |- skos__prefLabel mesh__D036801 Parturition
% 213.25/213.41  |- mesh__dateCreated mesh__D036801 2002-07-02
% 213.25/213.41  |- skos__scopeNote mesh__D036801
% 213.25/213.41       The process of giving birth to one or more offspring.     
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D036801 2006
% 213.25/213.41  |- skos__altLabel mesh__D036801 Birth
% 213.25/213.41  |- skos__historyNote mesh__D036801 Pregnancy %28%1965-2002%29%
% 213.25/213.41  |- rdf__type mesh__D003627sskos__Concept
% 213.25/213.41  |- mesh__activeMeSHYear mesh__D003627 2005
% 213.25/213.41  |- skos__altLabel mesh__D003627 Data Interpretations, Statistical
% 213.25/213.41  |- skos__hiddenLabel mesh__D003627 Data Analyses, Statistical
% 213.25/213.41  |- skos__hiddenLabel mesh__D003627 Statistical Data Analyses
% 213.25/213.41  |- skos__broader mesh__D003627smesh__D013223
% 213.25/213.41  |- mesh__dateRevised mesh__D003627 2004-07-07
% 213.25/213.41  |- skos__altLabel mesh__D003627 Data Analysis, Statistical
% 213.25/213.41  |- mesh__publicMeSHNote mesh__D003627 88   
% 213.25/213.41  |- skos__hiddenLabel mesh__D003627 Analysis, Statistical Data
% 213.25/213.41  |- skos__altLabel mesh__D003627 Statistical Data Analysis
% 213.25/213.41  |- skos__altLabel mesh__D003627 Statistical Data Interpretation
% 213.25/213.41  |- skos__annotation mesh__D003627
% 213.25/213.41       IM GEN only; do not use as routine NIM for an author%27%s interpretation of statistical findings: must be discussed substantively; coord NIM with specific disease or other concept %28%IM%29%; no qualif; DF: DATA INTERP%A%  
% 213.25/213.41  |- mesh__historyNote mesh__D003627 88   
% 213.25/213.41  |- mesh__dateEstablished mesh__D003627 1988-01-01
% 213.25/213.41  |- skos__prefLabel mesh__D003627 Data Interpretation, Statistical
% 213.25/213.41  |- skos__hiddenLabel mesh__D003627 Analyses, Statistical Data
% 213.25/213.42  |- skos__hiddenLabel mesh__D003627 Interpretations, Statistical Data
% 213.25/213.42  |- mesh__recordMaintainer mesh__D003627 jls
% 213.25/213.42  |- skos__scopeNote mesh__D003627
% 213.25/213.42       Application of statistical procedures to analyze specific observed or assumed facts from a particular study.%A%    
% 213.25/213.42  |- skos__broader mesh__D003627smesh__D003661
% 213.25/213.42  |- mesh__recordOriginator mesh__D003627 EC
% 213.25/213.42  |- skos__altLabel mesh__D003627 Interpretation, Statistical Data
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D003627 2006
% 213.25/213.42  |- mesh__recordAuthorizer mesh__D003627 sjn
% 213.25/213.42  |- mesh__dateCreated mesh__D003627 1987-04-06
% 213.25/213.42  |- skos__hiddenLabel mesh__D003627 Statistical Data Interpretations
% 213.25/213.42  |- mesh__publicMeSHNote mesh__D008312
% 213.25/213.42       91; was see under MALOCCLUSION 1979-90   
% 213.25/213.42  |- mesh__dateRevised mesh__D008312 1996-06-10
% 213.25/213.42  |- mesh__recordMaintainer mesh__D008312 TGC
% 213.25/213.42  |- mesh__recordAuthorizer mesh__D008312 PLS
% 213.25/213.42  |- skos__annotation mesh__D008312
% 213.25/213.42       Angle refers to Edward Hartley Angle, Amer orthodontist   
% 213.25/213.42  |- skos__scopeNote mesh__D008312
% 213.25/213.42       Malocclusion in which the mandible is posterior to the maxilla as reflected by the relationship of the first permanent molar %28%distoclusion%29%.%A%    
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D008312 1998
% 213.25/213.42  |- rdf__type mesh__D008312sskos__Concept
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D008312 2004
% 213.25/213.42  |- skos__altLabel mesh__D008312 Angle Class II
% 213.25/213.42  |- skos__prefLabel mesh__D008312 Malocclusion, Angle Class II
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D008312 2002
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D008312 2003
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D008312 2001
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D008312 1997
% 213.25/213.42  |- skos__broader mesh__D008312smesh__D008310
% 213.25/213.42  |- mesh__dateEstablished mesh__D008312 1991-01-01
% 213.25/213.42  |- mesh__dateCreated mesh__D008312 1978-01-26
% 213.25/213.42  |- skos__historyNote mesh__D008312 Malocclusion %28%1966-1978%29%
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D008312 2000
% 213.25/213.42  |- skos__related mesh__D008312smesh__D012182
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D008312 2006
% 213.25/213.42  |- mesh__recordOriginator mesh__D008312 SMH
% 213.25/213.42  |- mesh__historyNote mesh__D008312
% 213.25/213.42       91%28%79%29%; was see under MALOCCLUSION 1979-90   
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D008312 2005
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D008312 1999
% 213.25/213.42  |- skos__hiddenLabel mesh__D008312 Class II, Angle
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013257 2004
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013257 1996
% 213.25/213.42  |- mesh__recordAuthorizer mesh__D013257 PLS
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013257 2006
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013257 1998
% 213.25/213.42  |- skos__historyNote mesh__D013257 Bromine %28%1966-1974%29%
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013257 1997
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013257 2002
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013257 1994
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013257 1999
% 213.25/213.42  |- mesh__dateRevised mesh__D013257 1993-06-03
% 213.25/213.42  |- mesh__publicMeSHNote mesh__D013257 77; was see under STEROIDS 1975-76   
% 213.25/213.42  |- mesh__recordMaintainer mesh__D013257 PLS
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013257 1995
% 213.25/213.42  |- mesh__dateEstablished mesh__D013257 1977-01-01
% 213.25/213.42  |- skos__altLabel mesh__D013257 Brominated Steroids
% 213.25/213.42  |- skos__historyNote mesh__D013257 Steroids %28%1966-1974%29%
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013257 2000
% 213.25/213.42  |- skos__prefLabel mesh__D013257 Steroids, Brominated
% 213.25/213.42  |- mesh__dateCreated mesh__D013257 1974-11-19
% 213.25/213.42  |- mesh__historyNote mesh__D013257
% 213.25/213.42       77%28%75%29%; was see under STEROIDS 1975-76   
% 213.25/213.42  |- skos__scopeNote mesh__D013257
% 213.25/213.42       Steroids which are substituted with one or more bromine atoms in any position.%A%    
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013257 2003
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013257 2001
% 213.25/213.42  |- skos__broader mesh__D013257smesh__D013256
% 213.25/213.42  |- rdf__type mesh__D013257sskos__Concept
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013257 2005
% 213.25/213.42  |- mesh__recordOriginator mesh__D013257 NLM
% 213.25/213.42  |- skos__hiddenLabel mesh__D018740 Genetic Heterogeneities
% 213.25/213.42  |- mesh__dateEstablished mesh__D018740 1995-01-01
% 213.25/213.42  |- rdf__type mesh__D018740sskos__Concept
% 213.25/213.42  |- mesh__historyNote mesh__D018740 95   
% 213.25/213.42  |- mesh__dateRevised mesh__D018740 2004-07-13
% 213.25/213.42  |- skos__scopeNote mesh__D018740
% 213.25/213.42       The presence of apparently similar characters for which the genetic evidence indicates that different genes or different genetic mechanisms are involved in different pedigrees. In clinical settings genetic heterogeneity refers to the presence of a variety of genetic defects which cause the same disease, often due to mutations at different loci on the same gene, a finding common to many human diseases including ALZHEIMER DISEASE; CYSTIC FIBROSIS; LIPOPROTEIN LIPASE DEFICIENCY, FAMILIAL; and POLYCYSTIC KIDNEY DISEASES. %28%Rieger, et al., Glossary of Genetics: Classical and Molecular, 5th ed; Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 213.25/213.42  |- skos__altLabel mesh__D018740 Heterogeneity, Genetic
% 213.25/213.42  |- mesh__publicMeSHNote mesh__D018740 95   
% 213.25/213.42  |- mesh__recordAuthorizer mesh__D018740 sjn
% 213.25/213.42  |- mesh__dateCreated mesh__D018740 1994-04-19
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D018740 2005
% 213.25/213.42  |- skos__hiddenLabel mesh__D018740 Heterogeneities, Genetic
% 213.25/213.42  |- mesh__recordOriginator mesh__D018740 PXP
% 213.25/213.42  |- skos__annotation mesh__D018740 DF: GENET HETEROGENEITY   
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D018740 2006
% 213.25/213.42  |- mesh__recordMaintainer mesh__D018740 sjn
% 213.25/213.42  |- skos__broader mesh__D018740smesh__D014644
% 213.25/213.42  |- skos__prefLabel mesh__D018740 Genetic Heterogeneity
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D032411 2006A
% 213.25/213.42  |- mesh__recordOriginator mesh__D032411 ssb
% 213.25/213.42  |- mesh__recordAuthorizer mesh__D032411 ags
% 213.25/213.42  |- skos__scopeNote mesh__D032411
% 213.25/213.42       A plant genus of the family VERBENACEAE. Lippsidoquinone; TRITERPENES; SESQUITERPENES; and THYMOL have been found in this genus.  Plant extracts have cytotoxic activity.  It is sometimes called Mexican oregano but that confuses it with real oregano %28%ORIGANUM%29%.%A%    
% 213.25/213.42  |- skos__annotation mesh__D032411
% 213.25/213.42       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D032411 2006
% 213.25/213.42  |- mesh__publicMeSHNote mesh__D032411 2003   
% 213.25/213.42  |- skos__prefLabel mesh__D032411 Lippia
% 213.25/213.42  |- mesh__dateEstablished mesh__D032411 2003-01-01
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D032411 2004
% 213.25/213.42  |- skos__broader mesh__D032411smesh__D029648
% 213.25/213.42  |- mesh__dateRevised mesh__D032411 2005-08-02
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D032411 2005
% 213.25/213.42  |- rdf__type mesh__D032411sskos__Concept
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D032411 2003
% 213.25/213.42  |- mesh__recordMaintainer mesh__D032411 ags
% 213.25/213.42  |- mesh__historyNote mesh__D032411 2003   
% 213.25/213.42  |- mesh__dateCreated mesh__D032411 2002-07-03
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D004720 2005
% 213.25/213.42  |- skos__prefLabel mesh__D004720 Endonucleases
% 213.25/213.42  |- mesh__dateEstablished mesh__D004720 1973-01-01
% 213.25/213.42  |- mesh__dateCreated mesh__D004720 1999-01-01
% 213.25/213.42  |- mesh__publicMeSHNote mesh__D004720 73   
% 213.25/213.42  |- mesh__dateRevised mesh__D004720 2003-07-09
% 213.25/213.42  |- skos__scopeNote mesh__D004720
% 213.25/213.42       Enzymes that catalyze the hydrolysis of the internal bonds and thereby the formation of polynucleotides or oligonucleotides from ribo- or deoxyribonucleotide chains.  EC 3.1.-.%A%    
% 213.25/213.42  |- mesh__recordOriginator mesh__D004720 NLM
% 213.25/213.42  |- mesh__recordMaintainer mesh__D004720 ssb
% 213.25/213.42  |- rdf__type mesh__D004720sskos__Concept
% 213.25/213.42  |- skos__broader mesh__D004720smesh__D004950
% 213.25/213.42  |- skos__historyNote mesh__D004720
% 213.25/213.42       Nucleotidyltransferases %28%1966-1972%29%
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D004720 2004
% 213.25/213.42  |- skos__historyNote mesh__D004720 Phosphatases %28%1966-1972%29%
% 213.25/213.42  |- mesh__recordAuthorizer mesh__D004720 sjn
% 213.25/213.42  |- mesh__historyNote mesh__D004720 73   
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D004720 2006
% 213.25/213.42  |- skos__altLabel mesh__D051376 Arp2-3 Complex
% 213.25/213.42  |- skos__broader mesh__D051376smesh__D008840
% 213.25/213.42  |- mesh__recordOriginator mesh__D051376 DRC
% 213.25/213.42  |- mesh__recordMaintainer mesh__D051376 DRC
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D051376 2006
% 213.25/213.42  |- mesh__publicMeSHNote mesh__D051376 2006   
% 213.25/213.42  |- skos__prefLabel mesh__D051376 Actin-Related Protein 2-3 Complex
% 213.25/213.42  |- mesh__historyNote mesh__D051376 2006   
% 213.25/213.42  |- skos__altLabel mesh__D051376 Arp2-3 Protein Complex
% 213.25/213.42  |- skos__hiddenLabel mesh__D051376 Actin Related Protein 2 3 Complex
% 213.25/213.42  |- mesh__dateEstablished mesh__D051376 2006-01-01
% 213.25/213.42  |- skos__hiddenLabel mesh__D051376 Arp2 3 Protein Complex
% 213.25/213.42  |- rdf__type mesh__D051376sskos__Concept
% 213.25/213.42  |- skos__scopeNote mesh__D051376
% 213.25/213.42       A complex of seven proteins including ARP2 PROTEIN and ARP3 PROTEIN that plays an essential role in maintenance and assembly of the CYTOSKELETON. Arp2-3 complex binds WASP PROTEIN and existing ACTIN FILAMENTS, and it nucleates the formation of new branch point filaments.%A%    
% 213.25/213.42  |- mesh__recordAuthorizer mesh__D051376 sjn
% 213.25/213.42  |- skos__hiddenLabel mesh__D051376 Arp2 3 Complex
% 213.25/213.42  |- mesh__dateCreated mesh__D051376 2005-06-30
% 213.25/213.42  |- skos__annotation mesh__D031319
% 213.25/213.42       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D031319 2004
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D031319 2006
% 213.25/213.42  |- mesh__dateEstablished mesh__D031319 2003-01-01
% 213.25/213.42  |- skos__altLabel mesh__D031319 Horse Chestnut
% 213.25/213.42  |- mesh__dateCreated mesh__D031319 2002-07-02
% 213.25/213.42  |- skos__altLabel mesh__D031319 Buckeye
% 213.25/213.42  |- skos__prefLabel mesh__D031319 Aesculus
% 213.25/213.42  |- rdf__type mesh__D031319sskos__Concept
% 213.25/213.42  |- mesh__historyNote mesh__D031319 2003   
% 213.25/213.42  |- mesh__publicMeSHNote mesh__D031319 2003   
% 213.25/213.42  |- skos__broader mesh__D031319smesh__D031318
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D031319 2003
% 213.25/213.42  |- skos__scopeNote mesh__D031319
% 213.25/213.42       A plant genus of the family HIPPOCASTANACEAE %28%or SAPINDACEAE by some%29% that contains antimicrobial protein 1 and escin. A. hippocastanum is used in folk medicine for treating chronic venous insufficiency.%A%    
% 213.25/213.42  |- skos__altLabel mesh__D031319 Chestnut, Horse
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D031319 2005
% 213.25/213.42  |- mesh__historyNote mesh__D042041 2004   
% 213.25/213.42  |- skos__scopeNote mesh__D042041
% 213.25/213.42       A genus of the family BRUCELLACEAE comprising obligately aerobic gram-negative rods with parallel sides and rounded ends.%A%    
% 213.25/213.42  |- skos__annotation mesh__D042041
% 213.25/213.42       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 213.25/213.42  |- mesh__recordMaintainer mesh__D042041 SYSTEM
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D042041 2006
% 213.25/213.42  |- mesh__recordAuthorizer mesh__D042041 sjn
% 213.25/213.42  |- mesh__dateCreated mesh__D042041 2003-07-09
% 213.25/213.42  |- mesh__recordOriginator mesh__D042041 ags
% 213.25/213.42  |- skos__historyNote mesh__D042041 Alphaproteobacteria %28%2000-2003%29%
% 213.25/213.42  |- skos__broader mesh__D042041smesh__D042021
% 213.25/213.42  |- mesh__dateEstablished mesh__D042041 2004-01-01
% 213.25/213.42  |- skos__broader mesh__D042041smesh__D016946
% 213.25/213.42  |- skos__prefLabel mesh__D042041 Ochrobactrum
% 213.25/213.42  |- mesh__dateRevised mesh__D042041 2005-06-30
% 213.25/213.42  |- mesh__publicMeSHNote mesh__D042041 2004   
% 213.25/213.42  |- rdf__type mesh__D042041sskos__Concept
% 213.25/213.42  |- skos__hiddenLabel mesh__D003628 Systems, Database Management
% 213.25/213.42  |- mesh__recordAuthorizer mesh__D003628 sjn
% 213.25/213.42  |- mesh__dateCreated mesh__D003628 1986-06-17
% 213.25/213.42  |- mesh__dateRevised mesh__D003628 2004-07-07
% 213.25/213.42  |- skos__altLabel mesh__D003628 Management Systems, Data Base
% 213.25/213.42  |- skos__hiddenLabel mesh__D003628 Database Management System
% 213.25/213.42  |- skos__altLabel mesh__D003628 Systems, Data Base Management
% 213.25/213.42  |- skos__altLabel mesh__D003628 Management System, Data Base
% 213.25/213.42  |- skos__altLabel mesh__D003628 System, Data Base Management
% 213.25/213.42  |- skos__hiddenLabel mesh__D003628 System, Database Management
% 213.25/213.42  |- mesh__publicMeSHNote mesh__D003628 91; was see under SOFTWARE 1987-90   
% 213.25/213.42  |- skos__prefLabel mesh__D003628 Database Management Systems
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D003628 2006
% 213.25/213.42  |- skos__broader mesh__D003628smesh__D008331
% 213.25/213.42  |- mesh__historyNote mesh__D003628
% 213.25/213.42       91%28%87%29%; was see under SOFTWARE 1987-90   
% 213.25/213.42  |- rdf__type mesh__D003628sskos__Concept
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D003628 2005
% 213.25/213.42  |- mesh__dateEstablished mesh__D003628 1991-01-01
% 213.25/213.42  |- skos__altLabel mesh__D003628 Data Base Management Systems
% 213.25/213.42  |- mesh__recordMaintainer mesh__D003628 jls
% 213.25/213.42  |- skos__broader mesh__D003628smesh__D012984
% 213.25/213.42  |- skos__annotation mesh__D003628 IM: DF: DBMS   
% 213.25/213.42  |- skos__scopeNote mesh__D003628
% 213.25/213.42       Software designed to store, manipulate, manage, and control data for specific uses.%A%    
% 213.25/213.42  |- mesh__recordOriginator mesh__D003628 EC
% 213.25/213.42  |- mesh__dateCreated mesh__D014350 1999-01-01
% 213.25/213.42  |- skos__historyNote mesh__D014350 Trypanosoma %28%1966-1971%29%
% 213.25/213.42  |- mesh__publicMeSHNote mesh__D014350 72   
% 213.25/213.42  |- rdf__type mesh__D014350sskos__Concept
% 213.25/213.42  |- mesh__dateRevised mesh__D014350 2003-07-09
% 213.25/213.42  |- skos__scopeNote mesh__D014350
% 213.25/213.42       A trypanosome found in the blood of adult rats and transmitted by the rat flea. It is generally non-pathogenic in adult rats but can cause lethal infection in suckling rats.%A%    
% 213.25/213.42  |- mesh__dateEstablished mesh__D014350 1972-01-01
% 213.25/213.42  |- mesh__historyNote mesh__D014350 72   
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D014350 2005
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D014350 2006
% 213.25/213.42  |- mesh__recordMaintainer mesh__D014350 ags
% 213.25/213.42  |- skos__annotation mesh__D014350
% 213.25/213.42       in rats; infection: coord IM with TRYPANOSOMIASIS %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 213.25/213.42  |- mesh__recordAuthorizer mesh__D014350 sjn
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D014350 2004
% 213.25/213.42  |- mesh__recordOriginator mesh__D014350 NLM
% 213.25/213.42  |- skos__broader mesh__D014350smesh__D014345
% 213.25/213.42  |- skos__prefLabel mesh__D014350 Trypanosoma lewisi
% 213.25/213.42  |- mesh__publicMeSHNote mesh__D008313
% 213.25/213.42       91; was see under MALOCCLUSION 1979-90   
% 213.25/213.42  |- mesh__recordAuthorizer mesh__D008313 PLS
% 213.25/213.42  |- skos__annotation mesh__D008313
% 213.25/213.42       Angle refers to Edward Hartley Angle, Amer orthodontist   
% 213.25/213.42  |- skos__prefLabel mesh__D008313 Malocclusion, Angle Class III
% 213.25/213.42  |- skos__hiddenLabel mesh__D008313 Class III, Angle
% 213.25/213.42  |- rdf__type mesh__D008313sskos__Concept
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D008313 2004
% 213.25/213.42  |- mesh__recordOriginator mesh__D008313 SMH
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D008313 2002
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D008313 1997
% 213.25/213.42  |- mesh__dateRevised mesh__D008313 1996-06-10
% 213.25/213.42  |- mesh__historyNote mesh__D008313
% 213.25/213.42       91%28%79%29%; was see under MALOCCLUSION 1979-90   
% 213.25/213.42  |- skos__related mesh__D008313smesh__D011378
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D008313 2005
% 213.25/213.42  |- skos__historyNote mesh__D008313 Malocclusion %28%1966-1978%29%
% 213.25/213.42  |- skos__broader mesh__D008313smesh__D008310
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D008313 2000
% 213.25/213.42  |- skos__scopeNote mesh__D008313
% 213.25/213.42       Malocclusion in which the mandible is anterior to the maxilla as reflected by the first relationship of the first permanent molar %28%mesioclusion%29%.%A%    
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D008313 1998
% 213.25/213.42  |- mesh__dateCreated mesh__D008313 1978-01-26
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D008313 2006
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D008313 2001
% 213.25/213.42  |- mesh__recordMaintainer mesh__D008313 TGC
% 213.25/213.42  |- mesh__dateEstablished mesh__D008313 1991-01-01
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D008313 2003
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D008313 1999
% 213.25/213.42  |- skos__altLabel mesh__D008313 Angle Class III
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D000330 2006
% 213.25/213.42  |- mesh__recordMaintainer mesh__D000330 ags
% 213.25/213.42  |- mesh__dateRevised mesh__D000330 2003-07-09
% 213.25/213.42  |- rdf__type mesh__D000330sskos__Concept
% 213.25/213.42  |- skos__annotation mesh__D000330
% 213.25/213.42       mosquito; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111%A%  
% 213.25/213.42  |- mesh__dateCreated mesh__D000330 1999-01-01
% 213.25/213.42  |- skos__broader mesh__D000330smesh__D009033
% 213.25/213.42  |- mesh__recordOriginator mesh__D000330 NLM
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D000330 2004
% 213.25/213.42  |- mesh__recordAuthorizer mesh__D000330 sjn
% 213.25/213.42  |- skos__prefLabel mesh__D000330 Aedes
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D000330 2005
% 213.25/213.42  |- skos__scopeNote mesh__D000330
% 213.25/213.42       A genus of mosquitoes %28%CULICIDAE%29% frequently found in tropical and subtropical regions. YELLOW FEVER and DENGUE are two of the diseases that can be transmitted by species of this genus.%A%    
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013258 1997
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013258 2001
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013258 1994
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013258 1999
% 213.25/213.42  |- skos__altLabel mesh__D013258 Chlorinated Steroids
% 213.25/213.42  |- mesh__recordOriginator mesh__D013258 NLM
% 213.25/213.42  |- mesh__dateCreated mesh__D013258 1999-01-01
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013258 1995
% 213.25/213.42  |- mesh__recordAuthorizer mesh__D013258 PLS
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013258 2002
% 213.25/213.42  |- skos__scopeNote mesh__D013258
% 213.25/213.42       Steroids which are substituted with one or more chlorine atoms in any position.%A%    
% 213.25/213.42  |- mesh__dateRevised mesh__D013258 1993-06-03
% 213.25/213.42  |- mesh__recordMaintainer mesh__D013258 PLS
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013258 2003
% 213.25/213.42  |- skos__broader mesh__D013258smesh__D013256
% 213.25/213.42  |- rdf__type mesh__D013258sskos__Concept
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013258 2005
% 213.25/213.42  |- mesh__publicMeSHNote mesh__D013258 74   
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013258 2004
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013258 1996
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013258 2006
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013258 2000
% 213.25/213.42  |- mesh__historyNote mesh__D013258 74   
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D013258 1998
% 213.25/213.42  |- skos__prefLabel mesh__D013258 Steroids, Chlorinated
% 213.25/213.42  |- mesh__dateEstablished mesh__D013258 1974-01-01
% 213.25/213.42  |- rdf__type mesh__D018741sskos__Concept
% 213.25/213.42  |- mesh__historyNote mesh__D018741 95   
% 213.25/213.42  |- mesh__dateRevised mesh__D018741 2005-06-30
% 213.25/213.42  |- skos__hiddenLabel mesh__D018741 Origins, Replication
% 213.25/213.42  |- mesh__dateCreated mesh__D018741 1994-04-19
% 213.25/213.42  |- skos__altLabel mesh__D018741 ori Region
% 213.25/213.42  |- skos__broader mesh__D018741smesh__D021901
% 213.25/213.42  |- mesh__dateEstablished mesh__D018741 1995-01-01
% 213.25/213.42  |- skos__hiddenLabel mesh__D018741 ori Regions
% 213.25/213.42  |- mesh__recordOriginator mesh__D018741 PXP
% 213.25/213.42  |- skos__scopeNote mesh__D018741
% 213.25/213.42       A unique DNA sequence of a replicon at which DNA REPLICATION is initiated and proceeds bidirectionally or unidirectionally. It contains the sites where the first separation of the complementary strands occurs, a primer RNA is synthesized, and the switch from primer RNA to DNA synthesis takes place. %28%Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A%    
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D018741 2006
% 213.25/213.42  |- mesh__publicMeSHNote mesh__D018741 95   
% 213.25/213.42  |- mesh__recordAuthorizer mesh__D018741 sjn
% 213.25/213.42  |- skos__hiddenLabel mesh__D018741 Origin, Replication
% 213.25/213.42  |- skos__altLabel mesh__D018741 Origin of Replication
% 213.25/213.42  |- skos__hiddenLabel mesh__D018741 Replication Origins
% 213.25/213.42  |- skos__hiddenLabel mesh__D018741 Regions, ori
% 213.25/213.42  |- skos__historyNote mesh__D018741 DNA Replication %28%1969-1994%29%
% 213.25/213.42  |- skos__broader mesh__D018741smesh__D012093
% 213.25/213.42  |- skos__hiddenLabel mesh__D018741 Region, ori
% 213.25/213.42  |- mesh__recordMaintainer mesh__D018741 nns
% 213.25/213.42  |- skos__prefLabel mesh__D018741 Replication Origin
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D032412 2005
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D032412 2003
% 213.25/213.42  |- skos__prefLabel mesh__D032412 Verbena
% 213.25/213.42  |- mesh__historyNote mesh__D032412 2003   
% 213.25/213.42  |- skos__annotation mesh__D032412
% 213.25/213.42       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D032412 2006
% 213.25/213.42  |- mesh__publicMeSHNote mesh__D032412 2003   
% 213.25/213.42  |- mesh__dateCreated mesh__D032412 2002-07-03
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D032412 2004
% 213.25/213.42  |- skos__broader mesh__D032412smesh__D029648
% 213.25/213.42  |- skos__scopeNote mesh__D032412
% 213.25/213.42       A plant genus of the family VERBENACEAE. Members contain verbenachalcone %28%dimeric dihydrochalcone%29%, iridoids, and phenylethanoids.%A%    
% 213.25/213.42  |- rdf__type mesh__D032412sskos__Concept
% 213.25/213.42  |- skos__altLabel mesh__D032412 Vervain
% 213.25/213.42  |- mesh__dateEstablished mesh__D032412 2003-01-01
% 213.25/213.42  |- skos__annotation mesh__D004721
% 213.25/213.42       GEN or unspecified; prefer specifics; A 11 qualif except /cytol; /genet permitted%A%  
% 213.25/213.42  |- mesh__dateRevised mesh__D004721 2003-07-09
% 213.25/213.42  |- mesh__dateEstablished mesh__D004721 1965-01-01
% 213.25/213.42  |- rdf__type mesh__D004721sskos__Concept
% 213.25/213.42  |- skos__prefLabel mesh__D004721 Endoplasmic Reticulum
% 213.25/213.42  |- mesh__publicMeSHNote mesh__D004721 65   
% 213.25/213.42  |- mesh__historyNote mesh__D004721 65   
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D004721 2004
% 213.25/213.42  |- skos__scopeNote mesh__D004721
% 213.25/213.42       A system of cisternae in the CYTOPLASM of many cells. In places the endoplasmic reticulum is continuous with the plasma membrane %28%CELL MEMBRANE%29% or outer membrane of the nuclear envelope. If the outer surfaces of the endoplasmic reticulum membranes are coated with ribosomes, the endoplasmic reticulum is said to be rough-surfaced %28%ENDOPLASMIC RETICULUM, ROUGH%29%; otherwise it is said to be smooth-surfaced %28%ENDOPLASMIC RETICULUM, SMOOTH%29%. %28%King %26% Stansfield, A Dictionary of Genetics, 4th ed%29%%A%    
% 213.25/213.42  |- skos__broader mesh__D004721smesh__D015388
% 213.25/213.42  |- skos__hiddenLabel mesh__D004721 Reticulum, Endoplasmic
% 213.25/213.42  |- mesh__recordOriginator mesh__D004721 NLM
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D004721 2005
% 213.25/213.42  |- mesh__dateCreated mesh__D004721 1999-01-01
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D004721 2006
% 213.25/213.42  |- mesh__recordMaintainer mesh__D004721 nns
% 213.25/213.42  |- mesh__recordAuthorizer mesh__D004721 sjn
% 213.25/213.42  |- skos__altLabel mesh__D004721 Ergastoplasm
% 213.25/213.42  |- skos__hiddenLabel mesh__D051377 Actin Related Protein 2
% 213.25/213.42  |- mesh__dateEstablished mesh__D051377 2006-01-01
% 213.25/213.42  |- skos__scopeNote mesh__D051377
% 213.25/213.42       A PROFILIN binding domain protein that is part of the Arp2-3 complex. It is related in sequence and structure to ACTIN and binds ATP.%A%    
% 213.25/213.42  |- skos__broader mesh__D051377smesh__D051376
% 213.25/213.42  |- skos__altLabel mesh__D051377 ACTR2 Protein
% 213.25/213.42  |- mesh__recordAuthorizer mesh__D051377 sjn
% 213.25/213.42  |- mesh__activeMeSHYear mesh__D051377 2006
% 213.25/213.42  |- mesh__recordMaintainer mesh__D051377 DRC
% 213.25/213.42  |- mesh__historyNote mesh__D051377 2006%28%1998%29%   
% 213.25/213.42  |- rdf__type mesh__D051377sskos__Concept
% 213.25/213.42  |- skos__prefLabel mesh__D051377 Actin-Related Protein 2
% 213.25/213.42  |- mesh__dateCreated mesh__D051377 2005-06-30
% 213.28/213.42  |- mesh__publicMeSHNote mesh__D051377
% 213.28/213.42       2006; ACTIN-RELATED PROTEIN 2 was indexed under CYTOSKELETAL PROTEINS 2005, %26% under ACTINS 1998-2004%A%  
% 213.28/213.42  |- skos__altLabel mesh__D051377 Arp2 Protein
% 213.28/213.42  |- mesh__recordOriginator mesh__D051377 DRC
% 213.28/213.42  |- mesh__recordMaintainer mesh__D003629 jls
% 213.28/213.42  |- skos__prefLabel mesh__D003629 Modems
% 213.28/213.42  |- skos__altLabel mesh__D003629 Dataphone
% 213.28/213.42  |- skos__broader mesh__D003629smesh__D013689
% 213.28/213.42  |- mesh__dateEstablished mesh__D003629 1991-01-01
% 213.28/213.42  |- skos__hiddenLabel mesh__D003629 Modem
% 213.28/213.42  |- mesh__publicMeSHNote mesh__D003629
% 213.28/213.42       2000; see DATAPHONE 1991-1999; see TELECOMMUNICATIONS 1998-1999; see TELEPHONE 1975-1990; see COMPUTERS 1967-1974%A%  
% 213.28/213.42  |- mesh__activeMeSHYear mesh__D003629 2005
% 213.28/213.42  |- skos__historyNote mesh__D003629 Computers %28%1966%29%
% 213.28/213.42  |- mesh__recordAuthorizer mesh__D003629 sjn
% 213.28/213.42  |- mesh__recordOriginator mesh__D003629 NLM
% 213.28/213.42  |- mesh__dateCreated mesh__D003629 1999-01-01
% 213.28/213.42  |- skos__broader mesh__D003629smesh__D016287
% 213.28/213.42  |- mesh__activeMeSHYear mesh__D003629 2006
% 213.28/213.42  |- mesh__dateRevised mesh__D003629 2004-07-07
% 213.28/213.42  |- mesh__historyNote mesh__D003629
% 213.28/213.42       2000%28%1967%29%; use TELECOMMUNICATIONS 1998-1999   
% 213.28/213.42  |- rdf__type mesh__D003629sskos__Concept
% 213.28/213.42  |- skos__altLabel mesh__D003629 Dataphones
% 213.28/213.42  |- skos__scopeNote mesh__D003629
% 213.28/213.42       Equipment that sends digital information over telephone lines. The term Modem is a short form of the phrase modulator-demodulator.%A%    
% 213.28/213.42  |- mesh__recordAuthorizer mesh__D014351 sjn
% 213.28/213.42  |- skos__altLabel mesh__D014351 Trypanosomatidae
% 213.28/213.42  |- rdf__type mesh__D014351sskos__Concept
% 213.28/213.42  |- mesh__onlineNote mesh__D014351
% 213.28/213.42       use TRYPANOSOMATINA to search TRYPANOSOMATIDAE 1986-91   
% 213.28/213.42  |- skos__scopeNote mesh__D014351
% 213.28/213.42       A suborder of monoflagellate parasitic protozoa that lives in the blood and tissues of man and animals. Representative genera include: Blastocrithidia, Leptomonas, CRITHIDIA, Herpetomonas, LEISHMANIA, Phytomonas, and TRYPANOSOMA. Species of this suborder may exist in two or more morphologic stages formerly named after genera exemplifying these forms - amastigote %28%LEISHMANIA%29%, choanomastigote %28%CRITHIDIA%29%, promastigote %28%Leptomonas%29%, opisthomastigote %28%Herpetomonas%29%, epimastigote %28%Blastocrithidia%29%, and trypomastigote %28%TRYPANOSOMA%29%.%A%    
% 213.28/213.42  |- mesh__dateCreated mesh__D014351 1985-03-11
% 213.28/213.42  |- mesh__activeMeSHYear mesh__D014351 2005
% 213.28/213.42  |- skos__annotation mesh__D014351
% 213.28/213.42       infection: coord IM with MASTIGOPHORA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 213.28/213.42  |- skos__prefLabel mesh__D014351 Trypanosomatina
% 213.28/213.42  |- mesh__activeMeSHYear mesh__D014351 2006
% 213.28/213.42  |- skos__historyNote mesh__D014351 Trypanosoma %28%1966-1985%29%
% 213.28/213.42  |- mesh__recordMaintainer mesh__D014351 ags
% 213.28/213.42  |- mesh__historyNote mesh__D014351 92; was TRYPANOSOMATIDAE 1986-91   
% 213.28/213.42  |- mesh__activeMeSHYear mesh__D014351 2004
% 213.28/213.42  |- mesh__recordOriginator mesh__D014351 EC
% 213.28/213.42  |- mesh__dateRevised mesh__D014351 2003-07-09
% 213.28/213.42  |- mesh__publicMeSHNote mesh__D014351 92; was TRYPANOSOMATIDAE 1986-91   
% 213.28/213.42  |- mesh__dateEstablished mesh__D014351 1986-01-01
% 213.28/213.42  |- skos__broader mesh__D014351smesh__D016830
% 213.28/213.42  |- mesh__activeMeSHYear mesh__D008314 2001
% 213.28/213.42  |- mesh__recordOriginator mesh__D008314 NLM
% 213.28/213.42  |- mesh__activeMeSHYear mesh__D008314 1997
% 213.28/213.42  |- mesh__activeMeSHYear mesh__D008314 1994
% 213.28/213.42  |- mesh__dateCreated mesh__D008314 1999-01-01
% 213.28/213.42  |- mesh__recordAuthorizer mesh__D008314 PLS
% 213.28/213.42  |- mesh__activeMeSHYear mesh__D008314 2005
% 213.28/213.42  |- skos__broader mesh__D008314smesh__D003998
% 213.28/213.42  |- mesh__activeMeSHYear mesh__D008314 1995
% 213.28/213.42  |- mesh__activeMeSHYear mesh__D008314 2002
% 213.28/213.42  |- mesh__dateRevised mesh__D008314 1992-05-18
% 213.28/213.42  |- mesh__activeMeSHYear mesh__D008314 1998
% 213.28/213.42  |- mesh__activeMeSHYear mesh__D008314 2006
% 213.28/213.42  |- skos__prefLabel mesh__D008314 Malonates
% 213.28/213.42  |- mesh__recordMaintainer mesh__D008314 TAP
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D008314 1999
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D008314 2003
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D008314 1993
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D008314 2000
% 213.28/213.43  |- rdf__type mesh__D008314sskos__Concept
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D008314 1996
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D008314 2004
% 213.28/213.43  |- skos__historyNote mesh__D000331 Proteins %28%1972-1974%29%
% 213.28/213.43  |- mesh__dateRevised mesh__D000331 2004-07-07
% 213.28/213.43  |- skos__altLabel mesh__D000331 Aequorine
% 213.28/213.43  |- rdf__type mesh__D000331sskos__Concept
% 213.28/213.43  |- mesh__dateEstablished mesh__D000331 1991-01-01
% 213.28/213.43  |- mesh__recordOriginator mesh__D000331 NLM
% 213.28/213.43  |- mesh__recordAuthorizer mesh__D000331 sjn
% 213.28/213.43  |- mesh__publicMeSHNote mesh__D000331
% 213.28/213.43       91; was see under LUMINESCENT PROTEINS 1979-90; was see under PROTEINS 1975-78%A%  
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D000331 2005
% 213.28/213.43  |- skos__historyNote mesh__D000331 Coelenterata %28%1972-1974%29%
% 213.28/213.43  |- mesh__recordMaintainer mesh__D000331 ssb
% 213.28/213.43  |- mesh__historyNote mesh__D000331
% 213.28/213.43       91%28%75%29%; was see under LUMINESCENT PROTEINS 1979-90; was see under PROTEINS 1975-78%A%  
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D000331 2006
% 213.28/213.43  |- skos__prefLabel mesh__D000331 Aequorin
% 213.28/213.43  |- skos__broader mesh__D000331smesh__D008164
% 213.28/213.43  |- skos__scopeNote mesh__D000331
% 213.28/213.43       A photoprotein isolated from the bioluminescent jellyfish Aequorea. It emits visible light by an intramolecular reaction when a trace amount of calcium ion is added. The light-emitting moiety in the bioluminescence reaction is believed to be 2-amino-3-benzyl-5-%28%p-hydroxyphenyl%29%pyrazine %28%AF-350%29%.%A%    
% 213.28/213.43  |- mesh__dateCreated mesh__D000331 1974-11-19
% 213.28/213.43  |- mesh__dateCreated mesh__D013259 1999-01-01
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D013259 2006
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D013259 1999
% 213.28/213.43  |- mesh__recordAuthorizer mesh__D013259 PLS
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D013259 1994
% 213.28/213.43  |- skos__altLabel mesh__D013259 Fluorinated Steroids
% 213.28/213.43  |- skos__prefLabel mesh__D013259 Steroids, Fluorinated
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D013259 1995
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D013259 2002
% 213.28/213.43  |- mesh__dateRevised mesh__D013259 1993-06-03
% 213.28/213.43  |- rdf__type mesh__D013259sskos__Concept
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D013259 2003
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D013259 1996
% 213.28/213.43  |- skos__scopeNote mesh__D013259
% 213.28/213.43       Steroids which are substituted with one or more fluorine atoms in any position.%A%    
% 213.28/213.43  |- mesh__publicMeSHNote mesh__D013259 74   
% 213.28/213.43  |- mesh__recordMaintainer mesh__D013259 PLS
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D013259 2000
% 213.28/213.43  |- mesh__historyNote mesh__D013259 74   
% 213.28/213.43  |- skos__broader mesh__D013259smesh__D013256
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D013259 2005
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D013259 1998
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D013259 2004
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D013259 1997
% 213.28/213.43  |- mesh__dateEstablished mesh__D013259 1974-01-01
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D013259 2001
% 213.28/213.43  |- mesh__recordOriginator mesh__D013259 NLM
% 213.28/213.43  |- skos__broader mesh__D018742smesh__D018744
% 213.28/213.43  |- mesh__publicMeSHNote mesh__D018742 95   
% 213.28/213.43  |- mesh__recordAuthorizer mesh__D018742 sjn
% 213.28/213.43  |- skos__annotation mesh__D018742
% 213.28/213.43       IM; coord with PLANTS; ALGAE; or specific plant or alga IM; /drug eff /ultrastruct permitted%A%  
% 213.28/213.43  |- skos__historyNote mesh__D018742 DNA %28%1966-1994%29%
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D018742 2003
% 213.28/213.43  |- mesh__recordMaintainer mesh__D018742 nns
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D018742 2006
% 213.28/213.43  |- mesh__recordOriginator mesh__D018742 PXP
% 213.28/213.43  |- skos__broader mesh__D018742smesh__D004270
% 213.28/213.43  |- skos__altLabel mesh__D018742 Chloroplast DNA
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D018742 2004
% 213.28/213.43  |- skos__related mesh__D018742smesh__D005111
% 213.28/213.43  |- skos__prefLabel mesh__D018742 DNA, Chloroplast
% 213.28/213.43  |- mesh__dateEstablished mesh__D018742 1995-01-01
% 213.28/213.43  |- rdf__type mesh__D018742sskos__Concept
% 213.28/213.43  |- mesh__historyNote mesh__D018742 95   
% 213.28/213.43  |- mesh__dateRevised mesh__D018742 2002-07-03
% 213.28/213.43  |- skos__scopeNote mesh__D018742
% 213.28/213.43       Deoxyribonucleic acid that makes up the genetic material of CHLOROPLASTS.%A%    
% 213.28/213.43  |- mesh__dateCreated mesh__D018742 1994-04-19
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D018742 2005
% 213.28/213.43  |- skos__historyNote mesh__D018742 Chloroplasts %28%1966-1994%29%
% 213.28/213.43  |- skos__annotation mesh__D032413
% 213.28/213.43       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D032413 2006
% 213.28/213.43  |- mesh__publicMeSHNote mesh__D032413 2003   
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D032413 2004
% 213.28/213.43  |- skos__altLabel mesh__D032413 Violet
% 213.28/213.43  |- rdf__type mesh__D032413sskos__Concept
% 213.28/213.43  |- skos__scopeNote mesh__D032413
% 213.28/213.43       A plant genus of the family VIOLACEAE. Some species in this genus are called bouncing bet which is a common name more often used with SAPONARIA OFFICINALIS. Members contain macrocyclic peptides.%A%    
% 213.28/213.43  |- mesh__historyNote mesh__D032413 2003   
% 213.28/213.43  |- skos__prefLabel mesh__D032413 Viola
% 213.28/213.43  |- mesh__dateCreated mesh__D032413 2002-07-03
% 213.28/213.43  |- skos__altLabel mesh__D032413 Pansy
% 213.28/213.43  |- mesh__dateEstablished mesh__D032413 2003-01-01
% 213.28/213.43  |- skos__broader mesh__D032413smesh__D029649
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D032413 2005
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D032413 2003
% 213.28/213.43  |- rdf__type mesh__D004722sskos__Concept
% 213.28/213.43  |- skos__historyNote mesh__D004722 Ribonucleases %28%1966-1982%29%
% 213.28/213.43  |- skos__historyNote mesh__D004722 Endonucleases %28%1973-1982%29%
% 213.28/213.43  |- mesh__recordAuthorizer mesh__D004722 sjn
% 213.28/213.43  |- skos__broader mesh__D004722smesh__D004720
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D004722 2004
% 213.28/213.43  |- skos__prefLabel mesh__D004722 Endoribonucleases
% 213.28/213.43  |- mesh__historyNote mesh__D004722 83   
% 213.28/213.43  |- mesh__recordMaintainer mesh__D004722 ssb
% 213.28/213.43  |- skos__scopeNote mesh__D004722
% 213.28/213.43       A family of enzymes that catalyze the endonucleolytic cleavage of RNA. It includes EC 3.1.26.-, EC 3.1.27.-, EC 3.1.30.-, and EC 3.1.31.-.%A%    
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D004722 2005
% 213.28/213.43  |- mesh__dateEstablished mesh__D004722 1983-01-01
% 213.28/213.43  |- mesh__publicMeSHNote mesh__D004722 83   
% 213.28/213.43  |- mesh__recordOriginator mesh__D004722 RLS
% 213.28/213.43  |- mesh__dateCreated mesh__D004722 1982-04-29
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D004722 2006
% 213.28/213.43  |- skos__broader mesh__D004722smesh__D012260
% 213.28/213.43  |- skos__historyNote mesh__D004722 Phosphatases %28%1966-1972%29%
% 213.28/213.43  |- mesh__dateRevised mesh__D004722 2003-07-09
% 213.28/213.43  |- mesh__dateCreated mesh__D051378 2005-06-30
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D051378 2006
% 213.28/213.43  |- skos__scopeNote mesh__D051378
% 213.28/213.43       A component of the Arp2-3 complex that is related in sequence and structure to ACTIN and that binds ATP. It is expressed at higher levels than ARP2 PROTEIN and does not contain a PROFILIN binding domain.%A%    
% 213.28/213.43  |- mesh__dateEstablished mesh__D051378 2006-01-01
% 213.28/213.43  |- skos__broader mesh__D051378smesh__D051376
% 213.28/213.43  |- mesh__recordAuthorizer mesh__D051378 sjn
% 213.28/213.43  |- skos__hiddenLabel mesh__D051378 Actin Related Protein 3
% 213.28/213.43  |- mesh__historyNote mesh__D051378 2006%28%1998%29%   
% 213.28/213.43  |- rdf__type mesh__D051378sskos__Concept
% 213.28/213.43  |- mesh__recordMaintainer mesh__D051378 DRC
% 213.28/213.43  |- mesh__recordOriginator mesh__D051378 DRC
% 213.28/213.43  |- skos__prefLabel mesh__D051378 Actin-Related Protein 3
% 213.28/213.43  |- mesh__publicMeSHNote mesh__D051378
% 213.28/213.43       2006; ACTIN-RELATED PROTEIN 3 was indexed under CYTOSKELETAL PROTEINS 2003-2005, %26% under ACTINS 1998-2002%A%  
% 213.28/213.43  |- skos__altLabel mesh__D051378 ACTR3 Protein
% 213.28/213.43  |- skos__altLabel mesh__D051378 Arp3 Protein
% 213.28/213.43  |- skos__broader mesh__D001921Q000293smesh__D001921
% 213.28/213.43  |- mesh__preferredCombination mesh__D001921Q000293smesh__D001930
% 213.28/213.43  |- rdf__type mesh__D001921Q000293smesh__CompoundConcept
% 213.28/213.43  |- mesh__recordMaintainer mesh__D014352 TGC
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D014352 2002
% 213.28/213.43  |- skos__annotation mesh__D014352
% 213.28/213.43       protozoan infect; GEN: prefer specific; /drug ther: consider also TRYPANOCIDAL AGENTS; exper trypanosomiasis: TN 187%A%  
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D014352 2001
% 213.28/213.43  |- rdf__type mesh__D014352sskos__Concept
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D014352 1997
% 213.28/213.43  |- skos__broader mesh__D014352smesh__D016772
% 213.28/213.43  |- skos__hiddenLabel mesh__D014352 Trypanosomiases
% 213.28/213.43  |- skos__related mesh__D014352smesh__D014344
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D014352 1999
% 213.28/213.43  |- skos__prefLabel mesh__D014352 Trypanosomiasis
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D014352 2000
% 213.28/213.43  |- mesh__recordOriginator mesh__D014352 NLM
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D014352 1996
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D014352 1995
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D014352 2004
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D014352 1998
% 213.28/213.43  |- mesh__recordAuthorizer mesh__D014352 PLS
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D014352 2006
% 213.28/213.43  |- mesh__dateRevised mesh__D014352 1993-06-03
% 213.28/213.43  |- mesh__dateCreated mesh__D014352 1999-01-01
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D014352 1994
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D014352 2003
% 213.28/213.43  |- skos__scopeNote mesh__D014352
% 213.28/213.43       Infection with protozoa of the genus TRYPANOSOMA.     
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D014352 2005
% 213.28/213.43  |- skos__hiddenLabel mesh__D008315 Malondialdehyde, Sodium
% 213.28/213.43  |- skos__historyNote mesh__D008315 Malonates %28%1971-1974%29%
% 213.28/213.43  |- mesh__recordMaintainer mesh__D008315 KEV
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D008315 1998
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D008315 2006
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D008315 2000
% 213.28/213.43  |- mesh__recordAuthorizer mesh__D008315 SJN
% 213.28/213.43  |- skos__broader mesh__D008315smesh__D000447
% 213.28/213.43  |- skos__altLabel mesh__D008315 Malonylaldehyde
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D008315 1999
% 213.28/213.43  |- skos__prefLabel mesh__D008315 Malondialdehyde
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D008315 2003
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D008315 2001
% 213.28/213.43  |- mesh__dateCreated mesh__D008315 1974-11-19
% 213.28/213.43  |- mesh__historyNote mesh__D008315
% 213.28/213.43       91%28%75%29%; was see under MALONATES 1975-90   
% 213.28/213.43  |- rdf__type mesh__D008315sskos__Concept
% 213.28/213.43  |- mesh__dateEstablished mesh__D008315 1991-01-01
% 213.28/213.43  |- skos__altLabel mesh__D008315 Propanedial
% 213.28/213.43  |- mesh__recordOriginator mesh__D008315 NLM
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D008315 2004
% 213.28/213.43  |- skos__altLabel mesh__D008315 Malonyldialdehyde
% 213.28/213.43  |- mesh__dateRevised mesh__D008315 1997-06-20
% 213.28/213.43  |- skos__altLabel mesh__D008315 Malonaldehyde
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D008315 2002
% 213.28/213.43  |- skos__scopeNote mesh__D008315 The dialdehyde of malonic acid.     
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D008315 2005
% 213.28/213.43  |- skos__historyNote mesh__D008315 Aldehydes %28%1971-1974%29%
% 213.28/213.43  |- mesh__publicMeSHNote mesh__D008315
% 213.28/213.43       91; was see under MALONATES 1975-90   
% 213.28/213.43  |- mesh__recordMaintainer mesh__D000332 adp
% 213.28/213.43  |- mesh__dateCreated mesh__D000332 1999-01-01
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D000332 2003
% 213.28/213.43  |- skos__annotation mesh__D000332 almost never IM   
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D000332 2004
% 213.28/213.43  |- mesh__dateRevised mesh__D000332 2000-06-21
% 213.28/213.43  |- mesh__recordOriginator mesh__D000332 NLM
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D000332 2005
% 213.28/213.43  |- mesh__recordAuthorizer mesh__D000332 sjn
% 213.28/213.43  |- skos__scopeNote mesh__D000332
% 213.28/213.43       Life or metabolic reactions occurring in an environment containing oxygen.%A%    
% 213.28/213.43  |- mesh__publicMeSHNote mesh__D000332
% 213.28/213.43       91; was see under METABOLISM 1971-90   
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D000332 2006
% 213.28/213.43  |- skos__hiddenLabel mesh__D000332 Aerobioses
% 213.28/213.43  |- mesh__historyNote mesh__D000332
% 213.28/213.43       91%28%71%29%; was see under METABOLISM 1971-90   
% 213.28/213.43  |- skos__broader mesh__D000332smesh__D001669
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D000332 2001
% 213.28/213.43  |- skos__prefLabel mesh__D000332 Aerobiosis
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D000332 2002
% 213.28/213.43  |- rdf__type mesh__D000332sskos__Concept
% 213.28/213.43  |- mesh__dateEstablished mesh__D000332 1991-01-01
% 213.28/213.43  |- skos__broader mesh__D018743smesh__D007224
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D018743 2004
% 213.28/213.43  |- skos__scopeNote mesh__D018743
% 213.28/213.43       The care of a fetus or newborn given before, during, and after delivery from the 28th week of gestation through the 7th day after delivery.%A%    
% 213.28/213.43  |- skos__annotation mesh__D018743
% 213.28/213.43       from 28th wk of pregn through 7 days after birth; care of fetus %26% neonate: differentiate from PRENATAL CARE %26% POSTNATAL CARE which are care of the mother; check the tags FEMALE %26% PREGNANCY %26% INFANT, NEWBORN if relevant%A%  
% 213.28/213.43  |- mesh__publicMeSHNote mesh__D018743 95   
% 213.28/213.43  |- mesh__recordAuthorizer mesh__D018743 sjn
% 213.28/213.43  |- rdf__type mesh__D018743sskos__Concept
% 213.28/213.43  |- skos__prefLabel mesh__D018743 Perinatal Care
% 213.28/213.43  |- mesh__recordMaintainer mesh__D018743 KEV
% 213.28/213.43  |- mesh__historyNote mesh__D018743 95   
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D018743 2000
% 213.28/213.43  |- skos__hiddenLabel mesh__D018743 Care, Perinatal
% 213.28/213.43  |- mesh__dateRevised mesh__D018743 1999-11-03
% 213.28/213.43  |- mesh__dateCreated mesh__D018743 1994-05-23
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D018743 2001
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D018743 2005
% 213.28/213.43  |- skos__broader mesh__D018743smesh__D005791
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D018743 2002
% 213.28/213.43  |- mesh__dateEstablished mesh__D018743 1995-01-01
% 213.28/213.43  |- mesh__recordOriginator mesh__D018743 TGC
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D018743 2003
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D018743 2006
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D010760 2000
% 213.28/213.43  |- skos__annotation mesh__D010760
% 213.28/213.43       HYPOPHOSPHATEMIA is also available; DF: PHOSPHORUS METAB DIS%A%  
% 213.28/213.43  |- skos__scopeNote mesh__D010760
% 213.28/213.43       Disorders in the processing of phosphorus in the body: its absorption, transport, storage, and utilization.%A%    
% 213.28/213.43  |- mesh__dateRevised mesh__D010760 1996-06-10
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D010760 2003
% 213.28/213.43  |- skos__prefLabel mesh__D010760 Phosphorus Metabolism Disorders
% 213.28/213.43  |- mesh__dateCreated mesh__D010760 1999-01-01
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D010760 1999
% 213.28/213.43  |- skos__hiddenLabel mesh__D010760 Phosphorus Metabolism Disorder
% 213.28/213.43  |- skos__broader mesh__D010760smesh__D008659
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D010760 2002
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D010760 1997
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D010760 1998
% 213.28/213.43  |- skos__hiddenLabel mesh__D010760 Metabolism Disorders, Phosphorus
% 213.28/213.43  |- rdf__type mesh__D010760sskos__Concept
% 213.28/213.43  |- mesh__recordAuthorizer mesh__D010760 PLS
% 213.28/213.43  |- skos__hiddenLabel mesh__D010760 Disorder, Phosphorus Metabolism
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D010760 2006
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D010760 2001
% 213.28/213.43  |- skos__hiddenLabel mesh__D010760 Metabolism Disorder, Phosphorus
% 213.28/213.43  |- mesh__recordOriginator mesh__D010760 NLM
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D010760 2004
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D010760 2005
% 213.28/213.43  |- mesh__recordMaintainer mesh__D010760 TGC
% 213.28/213.43  |- skos__hiddenLabel mesh__D010760 Disorders, Phosphorus Metabolism
% 213.28/213.43  |- mesh__recordAuthorizer mesh__D004723 sjn
% 213.28/213.43  |- skos__scopeNote mesh__D004723
% 213.28/213.43       One of the three major groups of endogenous opioid peptides. They are large peptides derived from the PRO-OPIOMELANOCORTIN precursor. The known members of this group are alpha-, beta-, and gamma-endorphin. The term endorphin is also sometimes used to refer to all opioid peptides, but the narrower sense is used here; OPIOID PEPTIDES is used for the broader group.%A%    
% 213.28/213.43  |- mesh__recordMaintainer mesh__D004723 ssb
% 213.28/213.43  |- mesh__dateCreated mesh__D004723 1977-05-16
% 213.28/213.43  |- mesh__dateEstablished mesh__D004723 1978-01-01
% 213.28/213.43  |- mesh__dateRevised mesh__D004723 2005-06-30
% 213.28/213.43  |- skos__altLabel mesh__D004723 Endorphin
% 213.28/213.43  |- mesh__recordOriginator mesh__D004723 RLS
% 213.28/213.43  |- skos__historyNote mesh__D004723
% 213.28/213.43       Nerve Tissue Proteins %28%1966-Jul 1977%29%
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D004723 2006
% 213.28/213.43  |- skos__historyNote mesh__D004723 Peptides %28%1966-Jul 1977%29%
% 213.28/213.43  |- skos__broader mesh__D004723smesh__D018847
% 213.28/213.43  |- rdf__type mesh__D004723sskos__Concept
% 213.28/213.43  |- mesh__historyNote mesh__D004723
% 213.28/213.43       78%28%Aug 77%29%; was see under PEPTIDES Aug-Dec 1977   
% 213.28/213.43  |- skos__related mesh__D004723smesh__D011957
% 213.28/213.43  |- skos__prefLabel mesh__D004723 Endorphins
% 213.28/213.43  |- mesh__publicMeSHNote mesh__D004723
% 213.28/213.43       78; was indexed under PEPTIDES Aug-Dec 1977   
% 213.28/213.43  |- skos__altLabel mesh__D051379 Mus musculus domesticus
% 213.28/213.43  |- mesh__historyNote mesh__D051379 2006   
% 213.28/213.43  |- rdf__type mesh__D051379sskos__Concept
% 213.28/213.43  |- skos__altLabel mesh__D051379 Mus
% 213.28/213.43  |- skos__prefLabel mesh__D051379 Mice
% 213.28/213.43  |- mesh__publicMeSHNote mesh__D051379 2006   
% 213.28/213.43  |- skos__annotation mesh__D051379
% 213.28/213.43       check tag: NIM no qualifiers for MICE, the genus MUS unspecified, or any MUS species%A%  
% 213.28/213.43  |- mesh__recordOriginator mesh__D051379 ags
% 213.28/213.43  |- skos__hiddenLabel mesh__D051379 House Mice
% 213.28/213.43  |- skos__altLabel mesh__D051379 Mouse
% 213.28/213.43  |- skos__altLabel mesh__D051379 Mice, House
% 213.28/213.43  |- mesh__dateEstablished mesh__D051379 2006-01-01
% 213.28/213.43  |- mesh__dateCreated mesh__D051379 2005-06-30
% 213.28/213.43  |- skos__broader mesh__D051379smesh__D051189
% 213.28/213.43  |- skos__hiddenLabel mesh__D051379 musculus domesticus, Mus
% 213.28/213.43  |- skos__hiddenLabel mesh__D051379 domesticus, Mus
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D051379 2006
% 213.28/213.43  |- skos__hiddenLabel mesh__D051379 domesticus, Mus musculus
% 213.28/213.43  |- skos__scopeNote mesh__D051379 The common name for the genus Mus.     
% 213.28/213.43  |- mesh__recordAuthorizer mesh__D051379 sjn
% 213.28/213.43  |- skos__hiddenLabel mesh__D051379 Mice, Swiss
% 213.28/213.43  |- skos__altLabel mesh__D051379 Swiss Mice
% 213.28/213.43  |- skos__hiddenLabel mesh__D051379 Swiss Mouse
% 213.28/213.43  |- skos__hiddenLabel mesh__D051379 House Mouse
% 213.28/213.43  |- skos__hiddenLabel mesh__D051379 Laboratory Mouse
% 213.28/213.43  |- skos__altLabel mesh__D051379 Mouse, Laboratory
% 213.28/213.43  |- skos__altLabel mesh__D051379 Mouse, House
% 213.28/213.43  |- mesh__recordMaintainer mesh__D051379 ags
% 213.28/213.43  |- skos__hiddenLabel mesh__D051379 Laboratory Mice
% 213.28/213.43  |- skos__broader mesh__D042842smesh__D006913
% 213.28/213.43  |- skos__altLabel mesh__D042842 11B-Hydroxysteroid Dehydrogenase
% 213.28/213.43  |- skos__scopeNote mesh__D042842
% 213.28/213.43       Hydroxysteroid dehydrogenases that catalyzes the reversible conversion of CORTISOL to the inactive metabolite CORTISONE. Enzymes in this class can utilize either NAD or NADP as cofactors.%A%    
% 213.28/213.43  |- mesh__publicMeSHNote mesh__D042842
% 213.28/213.43       2004; 11BETA-HYDROXYSTEROID DEHYDROGENASE was indexed under HYDROXYSTEROID DEHYDROGENASES 1978-2003%A%  
% 213.28/213.43  |- rdf__type mesh__D042842sskos__Concept
% 213.28/213.43  |- skos__hiddenLabel mesh__D042842 11-Oxidoreductase, Corticosteroid
% 213.28/213.43  |- skos__hiddenLabel mesh__D042842 Dehydrogenase, 11 beta-Hydroxysteroid
% 213.28/213.43  |- skos__hiddenLabel mesh__D042842 11 beta Hydroxysteroid Dehydrogenase
% 213.28/213.43  |- skos__altLabel mesh__D042842 11beta-Hydroxysteroid Dehydrogenase
% 213.28/213.43  |- mesh__recordMaintainer mesh__D042842 AKE
% 213.28/213.43  |- skos__hiddenLabel mesh__D042842 Dehydrogenase, 11-Hydroxysteroid
% 213.28/213.43  |- skos__hiddenLabel mesh__D042842 11B Hydroxysteroid Dehydrogenase
% 213.28/213.43  |- skos__altLabel mesh__D042842 11-Hydroxysteroid Dehydrogenase
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D042842 2004
% 213.28/213.43  |- mesh__dateEstablished mesh__D042842 2004-01-01
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D042842 2005
% 213.28/213.43  |- mesh__dateCreated mesh__D042842 2003-07-09
% 213.28/213.43  |- skos__prefLabel mesh__D042842 11-beta-Hydroxysteroid Dehydrogenases
% 213.28/213.43  |- skos__hiddenLabel mesh__D042842 11-Oxoreductase, Cortisone
% 213.28/213.43  |- mesh__recordOriginator mesh__D042842 AKE
% 213.28/213.43  |- skos__hiddenLabel mesh__D042842 Corticosteroid 11 Oxidoreductase
% 213.28/213.43  |- skos__hiddenLabel mesh__D042842 11 beta Hydroxysteroid Dehydrogenases
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D042842 2006
% 213.28/213.43  |- skos__hiddenLabel mesh__D042842 Dehydrogenase, 11beta-Hydroxysteroid
% 213.28/213.43  |- skos__hiddenLabel mesh__D042842 11-Reductase, Corticosteroid
% 213.28/213.43  |- skos__altLabel mesh__D042842 Corticosteroid 11-Reductase
% 213.28/213.43  |- skos__altLabel mesh__D042842 Corticosteroid 11-Oxidoreductase
% 213.28/213.43  |- skos__hiddenLabel mesh__D042842 Dehydrogenase, 11B-Hydroxysteroid
% 213.28/213.43  |- skos__hiddenLabel mesh__D042842 Corticosteroid 11 Reductase
% 213.28/213.43  |- mesh__historyNote mesh__D042842
% 213.28/213.43       2004; use 11-BETA-HYDROXYSTEROID DEHYDROGENASES %28%NM%29% 1978-2003%A%  
% 213.28/213.43  |- skos__hiddenLabel mesh__D042842 Dehydrogenases, 11-beta-Hydroxysteroid
% 213.28/213.43  |- skos__hiddenLabel mesh__D042842 Cortisone 11 Oxoreductase
% 213.28/213.43  |- skos__altLabel mesh__D042842 11 beta-Hydroxysteroid Dehydrogenase
% 213.28/213.43  |- skos__hiddenLabel mesh__D042842 beta-Hydroxysteroid Dehydrogenase, 11
% 213.28/213.43  |- skos__hiddenLabel mesh__D042842 11beta Hydroxysteroid Dehydrogenase
% 213.28/213.43  |- skos__altLabel mesh__D042842 Cortisone 11-Oxoreductase
% 213.28/213.43  |- skos__hiddenLabel mesh__D042842 11 Hydroxysteroid Dehydrogenase
% 213.28/213.43  |- mesh__recordAuthorizer mesh__D042842 sjn
% 213.28/213.43  |- skos__historyNote mesh__D042842
% 213.28/213.43       Hydroxysteroid Dehydrogenases %28%1978-2003%29%
% 213.28/213.43  |- mesh__publicMeSHNote mesh__D020390 99   
% 213.28/213.43  |- skos__hiddenLabel mesh__D020390 Socket, Tooth
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D020390 2004
% 213.28/213.43  |- skos__altLabel mesh__D020390 Dental Alveolus
% 213.28/213.43  |- mesh__historyNote mesh__D020390 99   
% 213.28/213.43  |- mesh__dateRevised mesh__D020390 2004-08-02
% 213.28/213.43  |- skos__hiddenLabel mesh__D020390 Alveolus, Dental
% 213.28/213.43  |- skos__hiddenLabel mesh__D020390 Dentalis, Alveolus
% 213.28/213.43  |- mesh__dateEstablished mesh__D020390 1999-01-01
% 213.28/213.43  |- skos__hiddenLabel mesh__D020390 Sockets, Tooth
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D020390 2006
% 213.28/213.43  |- skos__broader mesh__D020390smesh__D000539
% 213.28/213.43  |- skos__scopeNote mesh__D020390
% 213.28/213.43       A hollow part of the alveolar process of the MAXILLA or MANDIBLE where each tooth fits and is attached via the periodontal ligament.%A%    
% 213.28/213.43  |- skos__hiddenLabel mesh__D020390 Tooth Sockets
% 213.28/213.43  |- rdf__type mesh__D020390sskos__Concept
% 213.28/213.43  |- skos__hiddenLabel mesh__D020390 Alveolus Dentali
% 213.28/213.43  |- skos__historyNote mesh__D020390 Alveolar Process %28%1966-1998%29%
% 213.28/213.43  |- mesh__dateCreated mesh__D020390 1998-06-18
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D020390 2005
% 213.28/213.43  |- mesh__recordAuthorizer mesh__D020390 jls
% 213.28/213.43  |- mesh__recordMaintainer mesh__D020390 jls
% 213.28/213.43  |- skos__hiddenLabel mesh__D020390 Dentali, Alveolus
% 213.28/213.43  |- mesh__recordOriginator mesh__D020390 JLS
% 213.28/213.43  |- skos__prefLabel mesh__D020390 Tooth Socket
% 213.28/213.43  |- skos__altLabel mesh__D020390 Alveolus Dentalis
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D020390 2005A
% 213.28/213.43  |- skos__hiddenLabel mesh__D014353 African Trypanosomiases
% 213.28/213.43  |- rdf__type mesh__D014353sskos__Concept
% 213.28/213.43  |- mesh__onlineNote mesh__D014353
% 213.28/213.43       use TRYPANOSOMIASIS, AFRICAN to search NAGANA 1975-94; use TRYPANOSOMIASIS, AFRICAN/VE 1972-74; use TRYPANOSOMIASIS, BOVINE 1968-72%A%  
% 213.28/213.43  |- mesh__recordMaintainer mesh__D014353 sjn
% 213.28/213.43  |- skos__altLabel mesh__D014353 African Trypanosomiasis
% 213.28/213.43  |- mesh__publicMeSHNote mesh__D014353
% 213.28/213.43       NAGANA was heading 1991-94; was see under TRYPANOSOMIASIS, AFRICAN 1973-90; was see under TRYPANOSOMIASIS, BOVINE 1968-mid 72%A%  
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D014353 2004
% 213.28/213.43  |- skos__broader mesh__D014353smesh__D014352
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D014353 2006
% 213.28/213.43  |- skos__altLabel mesh__D014353 African Sleeping Sickness
% 213.28/213.43  |- skos__prefLabel mesh__D014353 Trypanosomiasis, African
% 213.28/213.43  |- mesh__dateCreated mesh__D014353 1999-01-01
% 213.28/213.43  |- mesh__recordAuthorizer mesh__D014353 sjn
% 213.28/213.43  |- skos__annotation mesh__D014353
% 213.28/213.43       for trypanosomiasis in tropical Africa caused by any species of Trypanosoma: TN 188; coord IM with TRYPANOSOMA BRUCEI GAMBIENSE %28%IM%29% for Gambian trypanosomiasis; X ref NAGANA: see MeSH definition %26% index under TRYPANOSOMIASIS, AFRICAN /vet %28%IM%29% + specific Trypanosoma genus %28%IM%29% + animal/dis precoord %28%IM%29% + animal %28%IM or NIM%29% + check tag ANIMALS; specify geog if pertinent%A%  
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D014353 2005
% 213.28/213.43  |- mesh__dateRevised mesh__D014353 2003-07-30
% 213.28/213.43  |- mesh__recordOriginator mesh__D014353 NLM
% 213.28/213.43  |- skos__scopeNote mesh__D014353
% 213.28/213.43       A disease endemic among people and animals in Central Africa. It is caused by various species of trypanosomes, particularly T. gambiense and T. rhodesiense. Its second host is the tsetse fly. Involvement of the central nervous system produces %22%African sleeping sickness.%22% Nagana is a rapidly fatal trypanosomiasis of horses and other animals.%A%    
% 213.28/213.43  |- mesh__historyNote mesh__D014353
% 213.28/213.43       NAGANA was heading 1991-94; was see under TRYPANOSOMIASIS, AFRICAN 1973-90; was see under TRYPANOSOMIASIS, BOVINE 1968-mid 72%A%  
% 213.28/213.43  |- skos__hiddenLabel mesh__D014353 Trypanosomiases, African
% 213.28/213.43  |- skos__hiddenLabel mesh__D014353 Sleeping Sickness, African
% 213.28/213.43  |- skos__hiddenLabel mesh__D008316 CoA, Malonyl
% 213.28/213.43  |- skos__hiddenLabel mesh__D008316 A, Malonyl Coenzyme
% 213.28/213.43  |- skos__scopeNote mesh__D008316
% 213.28/213.43       A coenzyme A derivative which plays a key role in the fatty acid synthesis in the cytoplasmic and microsomal systems.%A%    
% 213.28/213.43  |- mesh__publicMeSHNote mesh__D008316
% 213.28/213.43       91; was see under ACYL COENZYME A 1978-90   
% 213.28/213.43  |- mesh__dateEstablished mesh__D008316 1991-01-01
% 213.28/213.43  |- rdf__type mesh__D008316sskos__Concept
% 213.28/213.43  |- mesh__activeMeSHYear mesh__D008316 2004
% 213.28/213.43  |- mesh__recordOriginator mesh__D008316 RLS
% 213.28/213.43  |- skos__historyNote mesh__D008316 Malonates %28%1966-1977%29%
% 213.28/213.43  |- skos__broader mesh__D008316smesh__D000214
% 213.28/213.44  |- skos__prefLabel mesh__D008316 Malonyl Coenzyme A
% 213.28/213.44  |- mesh__dateCreated mesh__D008316 1977-05-20
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D008316 2005
% 213.28/213.44  |- mesh__historyNote mesh__D008316
% 213.28/213.44       91%28%78%29%; was see under ACYL COENZYME A 1978-90   
% 213.28/213.44  |- mesh__recordMaintainer mesh__D008316 ssb
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D008316 2006
% 213.28/213.44  |- skos__historyNote mesh__D008316 Coenzyme A %28%1966-1977%29%
% 213.28/213.44  |- mesh__recordAuthorizer mesh__D008316 sjn
% 213.28/213.44  |- skos__hiddenLabel mesh__D008316 Coenzyme A, Malonyl
% 213.28/213.44  |- mesh__dateRevised mesh__D008316 2003-07-09
% 213.28/213.44  |- skos__altLabel mesh__D008316 Malonyl CoA
% 213.28/213.44  |- rdf__type mesh__D000333sskos__Concept
% 213.28/213.44  |- mesh__dateRevised mesh__D000333 2005-06-30
% 213.28/213.44  |- mesh__recordMaintainer mesh__D000333 SYSTEM
% 213.28/213.44  |- skos__broader mesh__D000333smesh__D044044
% 213.28/213.44  |- skos__annotation mesh__D000333
% 213.28/213.44       in fish; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 213.28/213.44  |- skos__scopeNote mesh__D000333
% 213.28/213.44       A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs singly, in pairs, or in short chains. Its organisms are found in fresh water and sewage and are pathogenic to humans, frogs, and fish.%A%    
% 213.28/213.44  |- mesh__recordOriginator mesh__D000333 NLM
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D000333 2006
% 213.28/213.44  |- mesh__recordAuthorizer mesh__D000333 sjn
% 213.28/213.44  |- mesh__dateCreated mesh__D000333 1999-01-01
% 213.28/213.44  |- skos__prefLabel mesh__D000333 Aeromonas
% 213.28/213.44  |- skos__historyNote mesh__D018744 specific plant %28%1966-1994%29%
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D018744 2004
% 213.28/213.44  |- skos__prefLabel mesh__D018744 DNA, Plant
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D018744 1999
% 213.28/213.44  |- skos__scopeNote mesh__D018744
% 213.28/213.44       Deoxyribonucleic acid that makes up the genetic material of plants.%A%    
% 213.28/213.44  |- mesh__dateCreated mesh__D018744 1994-04-19
% 213.28/213.44  |- skos__historyNote mesh__D018744 Plants %28%1966-1994%29%
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D018744 2006
% 213.28/213.44  |- mesh__historyNote mesh__D018744 95   
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D018744 1996
% 213.28/213.44  |- mesh__recordOriginator mesh__D018744 PXP
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D018744 2003
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D018744 1998
% 213.28/213.44  |- skos__broader mesh__D018744smesh__D004247
% 213.28/213.44  |- mesh__dateRevised mesh__D018744 1995-06-08
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D018744 2005
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D018744 2002
% 213.28/213.44  |- skos__altLabel mesh__D018744 Plant DNA
% 213.28/213.44  |- rdf__type mesh__D018744sskos__Concept
% 213.28/213.44  |- mesh__publicMeSHNote mesh__D018744 95   
% 213.28/213.44  |- mesh__recordAuthorizer mesh__D018744 PLS
% 213.28/213.44  |- skos__historyNote mesh__D018744 DNA %28%1966-1994%29%
% 213.28/213.44  |- skos__annotation mesh__D018744
% 213.28/213.44       IM; coord with specific plant %28%IM or NIM%29%; /drug eff /ultrastruct permitted%A%  
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D018744 2001
% 213.28/213.44  |- mesh__dateEstablished mesh__D018744 1995-01-01
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D018744 2000
% 213.28/213.44  |- mesh__recordMaintainer mesh__D018744 KEV
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D018744 1997
% 213.28/213.44  |- mesh__onlineNote mesh__D010761 search PHOSPHORUS ISOTOPES 1966-73   
% 213.28/213.44  |- mesh__publicMeSHNote mesh__D010761 74   
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D010761 2001
% 213.28/213.44  |- skos__prefLabel mesh__D010761 Phosphorus Radioisotopes
% 213.28/213.44  |- skos__annotation mesh__D010761
% 213.28/213.44       P-28 through 34 except P-31; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 213.28/213.44  |- mesh__recordOriginator mesh__D010761 NLM
% 213.28/213.44  |- skos__broader mesh__D010761smesh__D010759
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D010761 1997
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D010761 1998
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D010761 2000
% 213.28/213.44  |- rdf__type mesh__D010761sskos__Concept
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D010761 1996
% 213.28/213.44  |- mesh__recordMaintainer mesh__D010761 TPW
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D010761 2006
% 213.28/213.44  |- mesh__dateEstablished mesh__D010761 1974-01-01
% 213.28/213.44  |- skos__broader mesh__D010761smesh__D011868
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D010761 2002
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D010761 1995
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D010761 2004
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D010761 2005
% 213.28/213.44  |- mesh__historyNote mesh__D010761 74   
% 213.28/213.44  |- skos__scopeNote mesh__D010761
% 213.28/213.44       Unstable isotopes of phosphorus that decay or disintegrate emitting radiation. P atoms with atomic weights 28-34 except 31 are radioactive phosphorus isotopes.%A%    
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D010761 1994
% 213.28/213.44  |- mesh__recordAuthorizer mesh__D010761 PLS
% 213.28/213.44  |- mesh__dateRevised mesh__D010761 1993-06-04
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D010761 2003
% 213.28/213.44  |- mesh__dateCreated mesh__D010761 1999-01-01
% 213.28/213.44  |- skos__hiddenLabel mesh__D010761 Radioisotopes, Phosphorus
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D010761 1999
% 213.28/213.44  |- skos__scopeNote mesh__D004724
% 213.28/213.44       Procedures of applying ENDOSCOPES for disease diagnosis and treatment. Endoscopy involves passing an optical instrument along either natural body pathways such as the digestive tract, or through keyhole incisions to examine the interior parts of the body. With advances in imaging, endoscope, and miniaturization of endosurgical equipment, surgery can be performed during endoscopy.%A%    
% 213.28/213.44  |- mesh__dateRevised mesh__D004724 2004-07-26
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D004724 2005
% 213.28/213.44  |- skos__prefLabel mesh__D004724 Endoscopy
% 213.28/213.44  |- mesh__recordMaintainer mesh__D004724 jls
% 213.28/213.44  |- skos__annotation mesh__D004724 GEN: prefer specifics   
% 213.28/213.44  |- skos__altLabel mesh__D004724 Endoscopic Surgical Procedures
% 213.28/213.44  |- skos__hiddenLabel mesh__D004724 Procedures, Endoscopic Surgical
% 213.28/213.44  |- skos__altLabel mesh__D004724 Surgical Procedure, Endoscopic
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D004724 2005A
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D004724 2006
% 213.28/213.44  |- mesh__recordAuthorizer mesh__D004724 jls
% 213.28/213.44  |- mesh__historyNote mesh__D004724 1963   
% 213.28/213.44  |- skos__broader mesh__D004724smesh__D003949
% 213.28/213.44  |- rdf__type mesh__D004724sskos__Concept
% 213.28/213.44  |- skos__hiddenLabel mesh__D004724 Endoscopies
% 213.28/213.44  |- skos__altLabel mesh__D004724 Endoscopy, Surgical
% 213.28/213.44  |- skos__hiddenLabel mesh__D004724 Surgical Endoscopies
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D004724 2003
% 213.28/213.44  |- skos__altLabel mesh__D004724 Endoscopic Surgical Procedure
% 213.28/213.44  |- mesh__publicMeSHNote mesh__D004724
% 213.28/213.44       1963; for SURGICAL PROCEDURES, ENDOSCOPIC and ENDOSCOPIC SURGICAL PROCEDURES see SURGICAL PROCEDURES, ENDOSCOPIC 1998-1999, see SURGERY, ENDOSCOPIC 1996-1997%A%  
% 213.28/213.44  |- skos__altLabel mesh__D004724 Surgical Endoscopy
% 213.28/213.44  |- skos__hiddenLabel mesh__D004724 Procedure, Endoscopic Surgical
% 213.28/213.44  |- skos__broader mesh__D004724smesh__D019060
% 213.28/213.44  |- skos__hiddenLabel mesh__D004724 Endoscopies, Surgical
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D004724 2004
% 213.28/213.44  |- mesh__dateCreated mesh__D004724 1999-01-01
% 213.28/213.44  |- mesh__recordOriginator mesh__D004724 NLM
% 213.28/213.44  |- mesh__recordOriginator mesh__D042843 AKE
% 213.28/213.44  |- skos__historyNote mesh__D042843 Glucose Dehydrogenases %28%1974-2003%29%
% 213.28/213.44  |- mesh__dateEstablished mesh__D042843 2004-01-01
% 213.28/213.44  |- skos__broader mesh__D042843smesh__D005948
% 213.28/213.44  |- skos__altLabel mesh__D042843 Glucose Dehydrogenase
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D042843 2004
% 213.28/213.44  |- mesh__dateCreated mesh__D042843 2003-07-09
% 213.28/213.44  |- rdf__type mesh__D042843sskos__Concept
% 213.28/213.44  |- mesh__recordAuthorizer mesh__D042843 sjn
% 213.28/213.44  |- skos__hiddenLabel mesh__D042843 Glucose 1 Dehydrogenase
% 213.28/213.44  |- mesh__publicMeSHNote mesh__D042843
% 213.28/213.44       2004; GLUCOSE 1-DEHYDROGENASE was indexed under GLUCOSE DEHYDROGENASES 1983-2003%A%  
% 213.28/213.44  |- skos__scopeNote mesh__D042843
% 213.28/213.44       A glucose dehydrogenase that catalyzes the oxidation of beta-D-glucose to form D-glucono-1,5-lactone, using NAD as well as NADP as a coenzyme.%A%    
% 213.28/213.44  |- skos__prefLabel mesh__D042843 Glucose 1-Dehydrogenase
% 213.28/213.44  |- mesh__recordMaintainer mesh__D042843 jmp
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D042843 2006
% 213.28/213.44  |- mesh__historyNote mesh__D042843
% 213.28/213.44       2004; use GLUCOSE 1-DEHYDROGENASE %28%NM%29% 1983-2003   
% 213.28/213.44  |- skos__hiddenLabel mesh__D042843 Dehydrogenase, Glucose
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D042843 2005
% 213.28/213.44  |- mesh__recordMaintainer mesh__D020391 jls
% 213.28/213.44  |- skos__hiddenLabel mesh__D020391
% 213.28/213.44       Dystrophies, Facioscapulohumeral Muscular
% 213.28/213.44  |- skos__hiddenLabel mesh__D020391 Dystrophy, Landouzy-Dejerine
% 213.28/213.44  |- mesh__recordAuthorizer mesh__D020391 jls
% 213.28/213.44  |- skos__broader mesh__D020391smesh__D009136
% 213.28/213.44  |- skos__hiddenLabel mesh__D020391
% 213.28/213.44       Muscular Dystrophies, Facioscapulohumeral
% 213.28/213.44  |- mesh__historyNote mesh__D020391 2000   
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D020391 2005
% 213.28/213.44  |- skos__scopeNote mesh__D020391
% 213.28/213.44       An autosomal dominant degenerative muscle disease characterized by slowly progressive weakness of the muscles of the face, upper-arm, and shoulder girdle. The onset of symptoms usually occurs in the first or second decade of life. Affected individuals usually present with impairment of upper extremity elevation. This tends to be followed by facial weakness, primarily involving the orbicularis oris and orbicularis oculi muscles. %28%Neuromuscul Disord 1997;7%28%1%29%:55-62; Adams et al., Principles of Neurology, 6th ed, p1420%29%%A%    
% 213.28/213.44  |- skos__hiddenLabel mesh__D020391 Landouzy-Dejerine Dystrophies
% 213.28/213.44  |- skos__altLabel mesh__D020391
% 213.28/213.44       Facioscapulohumeral Type Progressive Muscular Dystrophy
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D020391 2005A
% 213.28/213.44  |- skos__historyNote mesh__D020391 Muscular Dystrophies %28%1966-1999%29%
% 213.28/213.44  |- skos__hiddenLabel mesh__D020391 Landouzy Dejerine Dystrophy
% 213.28/213.44  |- mesh__publicMeSHNote mesh__D020391 2000   
% 213.28/213.44  |- skos__altLabel mesh__D020391 Facioscapulohumeral Muscular Dystrophy
% 213.28/213.44  |- skos__altLabel mesh__D020391
% 213.28/213.44       Progressive Muscular Dystrophy, Facioscapulohumeral Type
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D020391 2006
% 213.28/213.44  |- skos__hiddenLabel mesh__D020391 Atrophies, Facioscapulohumeral
% 213.28/213.44  |- rdf__type mesh__D020391sskos__Concept
% 213.28/213.44  |- skos__hiddenLabel mesh__D020391 Dystrophies, Landouzy-Dejerine
% 213.28/213.44  |- mesh__dateCreated mesh__D020391 1999-11-03
% 213.28/213.44  |- mesh__dateRevised mesh__D020391 2004-07-29
% 213.28/213.44  |- skos__altLabel mesh__D020391 Facioscapulohumeral Atrophy
% 213.28/213.44  |- skos__hiddenLabel mesh__D020391 Facioscapulohumeral Muscular Dystrophies
% 213.28/213.44  |- skos__hiddenLabel mesh__D020391 Dystrophy, Facioscapulohumeral Muscular
% 213.28/213.44  |- mesh__recordOriginator mesh__D020391 KEV
% 213.28/213.44  |- skos__altLabel mesh__D020391 Landouzy-Dejerine Dystrophy
% 213.28/213.44  |- mesh__dateEstablished mesh__D020391 2000-01-01
% 213.28/213.44  |- skos__hiddenLabel mesh__D020391 Facioscapulohumeral Atrophies
% 213.28/213.44  |- skos__prefLabel mesh__D020391 Muscular Dystrophy, Facioscapulohumeral
% 213.28/213.44  |- skos__hiddenLabel mesh__D020391 Atrophy, Facioscapulohumeral
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D014354 2004
% 213.28/213.44  |- skos__scopeNote mesh__D014354
% 213.28/213.44       Infection in cattle caused by various species of trypanosomes.%A%    
% 213.28/213.44  |- mesh__historyNote mesh__D014354 68   
% 213.28/213.44  |- skos__broader mesh__D014354smesh__D014352
% 213.28/213.44  |- mesh__recordOriginator mesh__D014354 NLM
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D014354 2006
% 213.28/213.44  |- mesh__dateCreated mesh__D014354 1999-01-01
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D014354 2005
% 213.28/213.44  |- mesh__publicMeSHNote mesh__D014354 68   
% 213.28/213.44  |- skos__historyNote mesh__D014354 Trypanosomiasis %28%1966-1967%29%
% 213.28/213.44  |- mesh__dateRevised mesh__D014354 2003-07-30
% 213.28/213.44  |- skos__annotation mesh__D014354
% 213.28/213.44       don%27%t forget also CATTLE %28%NIM%29% %26% check tag ANIMALS; coord IM with specific type of trypanosomiasis /vet %28%NIM%29%%A%  
% 213.28/213.44  |- skos__historyNote mesh__D014354
% 213.28/213.44       Trypanosomiasis, African %28%1966-1967%29%
% 213.28/213.44  |- mesh__recordMaintainer mesh__D014354 ags
% 213.28/213.44  |- rdf__type mesh__D014354sskos__Concept
% 213.28/213.44  |- skos__hiddenLabel mesh__D014354 Bovine Trypanosomiases
% 213.28/213.44  |- skos__prefLabel mesh__D014354 Trypanosomiasis, Bovine
% 213.28/213.44  |- skos__broader mesh__D014354smesh__D002418
% 213.28/213.44  |- mesh__dateEstablished mesh__D014354 1968-01-01
% 213.28/213.44  |- skos__hiddenLabel mesh__D014354 Trypanosomiases, Bovine
% 213.28/213.44  |- skos__broader mesh__D014354smesh__D011529
% 213.28/213.44  |- mesh__recordAuthorizer mesh__D014354 sjn
% 213.28/213.44  |- skos__hiddenLabel mesh__D014354 Bovine Trypanosomiasis
% 213.28/213.44  |- mesh__dateRevised mesh__D008317 2005-07-07
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D008317 2006
% 213.28/213.44  |- mesh__recordOriginator mesh__D008317 NLM
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D008317 2006A
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D008317 2001
% 213.28/213.44  |- mesh__publicMeSHNote mesh__D008317 91; was see under CLOACA 1964-90   
% 213.28/213.44  |- skos__scopeNote mesh__D008317
% 213.28/213.44       Slender tubular or hairlike excretory structures found in insects. They emerge from the alimentary canal between the mesenteron %28%midgut%29% and the proctodeum %28%hindgut%29%.%A%    
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D008317 2005
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D008317 2004
% 213.28/213.44  |- mesh__recordAuthorizer mesh__D008317 ags
% 213.28/213.44  |- mesh__historyNote mesh__D008317
% 213.28/213.44       91%28%64%29%; was see under CLOACA 1964-90   
% 213.28/213.44  |- skos__hiddenLabel mesh__D008317 Tubules, Malpighian
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D008317 2000
% 213.28/213.44  |- skos__annotation mesh__D008317
% 213.28/213.44       in intestines of arthropods; %22%malpighian%22% is not capitalized in titles or translations%A%  
% 213.28/213.44  |- rdf__type mesh__D008317sskos__Concept
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D008317 2003
% 213.28/213.44  |- mesh__dateEstablished mesh__D008317 1991-01-01
% 213.28/213.44  |- skos__prefLabel mesh__D008317 Malpighian Tubules
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D008317 2002
% 213.28/213.44  |- mesh__recordMaintainer mesh__D008317 ags
% 213.28/213.44  |- skos__broader mesh__D008317smesh__D000825
% 213.28/213.44  |- mesh__dateCreated mesh__D008317 1999-01-01
% 213.28/213.44  |- mesh__dateRevised mesh__D000334 1999-11-03
% 213.28/213.44  |- rdf__type mesh__D000334sskos__Concept
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D000334 2005
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D000334 2004
% 213.28/213.44  |- skos__altLabel mesh__D000334 Air Swallowing
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D000334 2003
% 213.28/213.44  |- skos__prefLabel mesh__D000334 Aerophagy
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D000334 2002
% 213.28/213.44  |- mesh__recordOriginator mesh__D000334 NLM
% 213.28/213.44  |- mesh__recordMaintainer mesh__D000334 KEV
% 213.28/213.44  |- skos__scopeNote mesh__D000334 Spasmodic swallowing of air.     
% 213.28/213.44  |- mesh__recordAuthorizer mesh__D000334 sjn
% 213.28/213.44  |- skos__broader mesh__D000334smesh__D012817
% 213.28/213.44  |- mesh__dateCreated mesh__D000334 1999-01-01
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D000334 2001
% 213.28/213.44  |- skos__hiddenLabel mesh__D000334 Swallowing, Air
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D000334 2006
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D000334 2000
% 213.28/213.44  |- mesh__recordOriginator mesh__D018745 PXP
% 213.28/213.44  |- mesh__dateRevised mesh__D018745 2005-06-30
% 213.28/213.44  |- skos__historyNote mesh__D018745 specific plant %28%1973-1994%29%
% 213.28/213.44  |- skos__historyNote mesh__D018745 Base Sequence %28%1973-1991%29%
% 213.28/213.44  |- mesh__recordMaintainer mesh__D018745 nns
% 213.28/213.44  |- skos__historyNote mesh__D018745 Genome %28%1992-1994%29%
% 213.28/213.44  |- rdf__type mesh__D018745sskos__Concept
% 213.28/213.44  |- skos__hiddenLabel mesh__D018745 Plant Genomes
% 213.28/213.44  |- skos__prefLabel mesh__D018745 Genome, Plant
% 213.28/213.44  |- skos__related mesh__D018745smesh__D017343
% 213.28/213.44  |- skos__historyNote mesh__D018745 DNA %28%1973-1984%29%
% 213.28/213.44  |- skos__annotation mesh__D018745
% 213.28/213.44       coordinate IM with specific plant /genet %28%IM%29%   
% 213.28/213.44  |- skos__broader mesh__D018745smesh__D016678
% 213.28/213.44  |- mesh__publicMeSHNote mesh__D018745 95   
% 213.28/213.44  |- mesh__recordAuthorizer mesh__D018745 sjn
% 213.28/213.44  |- skos__hiddenLabel mesh__D018745 Genomes, Plant
% 213.28/213.44  |- skos__scopeNote mesh__D018745
% 213.28/213.44       The genetic complement of a plant %28%PLANTS%29% as represented in its DNA.%A%    
% 213.28/213.44  |- skos__historyNote mesh__D018745 Plants %28%1973-1994%29%
% 213.28/213.44  |- mesh__dateCreated mesh__D018745 1994-04-19
% 213.28/213.44  |- mesh__dateEstablished mesh__D018745 1995-01-01
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D018745 2006
% 213.28/213.44  |- skos__altLabel mesh__D018745 Plant Genome
% 213.28/213.44  |- mesh__historyNote mesh__D018745 95   
% 213.28/213.44  |- skos__scopeNote mesh__D010762
% 213.28/213.44       The active form of GLYCOGEN PHOSPHORYLASE that is derived from the phosphorylation of PHOSPHORYLASE B. Phosphorylase a is deactivated via hydrolysis of phosphoserine by PHOSPHORYLASE PHOSPHATASE to form PHOSPHORYLASE B.%A%    
% 213.28/213.44  |- rdf__type mesh__D010762sskos__Concept
% 213.28/213.44  |- mesh__dateRevised mesh__D010762 2003-07-09
% 213.28/213.44  |- mesh__onlineNote mesh__D010762 search GLYCOGEN PHOSPHORYLASE 1975-78   
% 213.28/213.44  |- skos__historyNote mesh__D010762 Glucosyltransferases %28%1966-1970%29%
% 213.28/213.44  |- skos__broader mesh__D010762smesh__D006005
% 213.28/213.44  |- mesh__dateCreated mesh__D010762 1978-05-19
% 213.28/213.44  |- skos__historyNote mesh__D010762 Glycogen Phosphorylase %28%1971-1978%29%
% 213.28/213.44  |- mesh__recordMaintainer mesh__D010762 ssb
% 213.28/213.44  |- skos__prefLabel mesh__D010762 Phosphorylase a
% 213.28/213.44  |- mesh__recordAuthorizer mesh__D010762 sjn
% 213.28/213.44  |- mesh__publicMeSHNote mesh__D010762
% 213.28/213.44       91; was see under GLYCOGEN PHOSPHORYLASE 1979-90; was see GLYCOGEN PHOSPHORYLASE 1975-78%A%  
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D010762 2006
% 213.28/213.44  |- mesh__historyNote mesh__D010762
% 213.28/213.44       91%28%79%29%; was see under GLYCOGEN PHOSPHORYLASE 1979-90; was see GLYCOGEN PHOSPHORYLASE 1975-78%A%  
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D010762 2004
% 213.28/213.44  |- mesh__dateEstablished mesh__D010762 1991-01-01
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D010762 2005
% 213.28/213.44  |- mesh__recordOriginator mesh__D010762 RLS
% 213.28/213.44  |- skos__scopeNote mesh__D004725
% 213.28/213.44       A group of rods or cocci whose taxonomic affinities are uncertain. They form endospores, thick-walled bodies formed within the vegetative cells of certain bacteria, able to withstand adverse environmental conditions for prolonged periods.%A%    
% 213.28/213.44  |- mesh__dateRevised mesh__D004725 2005-06-30
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D004725 2006
% 213.28/213.44  |- skos__historyNote mesh__D004725 Spores, Bacterial %28%1976-1997%29%
% 213.28/213.44  |- rdf__type mesh__D004725sskos__Concept
% 213.28/213.44  |- skos__annotation mesh__D004725
% 213.28/213.44       avoid: too general; prefer specific families %26% genera; DF: ENDOSPORE FORMING BACT%A%  
% 213.28/213.44  |- mesh__dateCreated mesh__D004725 1975-07-25
% 213.28/213.44  |- mesh__recordMaintainer mesh__D004725 SYSTEM
% 213.28/213.44  |- skos__broader mesh__D004725smesh__D001419
% 213.28/213.44  |- skos__altLabel mesh__D004725 Endospore Forming Bacteria
% 213.28/213.44  |- skos__prefLabel mesh__D004725 Endospore-Forming Bacteria
% 213.28/213.44  |- mesh__historyNote mesh__D004725 98; use explode 1976-97   
% 213.28/213.44  |- mesh__publicMeSHNote mesh__D004725 98   
% 213.28/213.44  |- mesh__recordAuthorizer mesh__D004725 sjn
% 213.28/213.44  |- skos__historyNote mesh__D004725 Bacteria %28%1976-1997%29%
% 213.28/213.44  |- mesh__recordOriginator mesh__D004725 JW
% 213.28/213.44  |- mesh__dateEstablished mesh__D004725 1998-01-01
% 213.28/213.44  |- mesh__publicMeSHNote mesh__D037101
% 213.28/213.44       2003; LUTEINIZING HORMONE, BETA SUBUNIT was indexed under LH 1983-2002%A%  
% 213.28/213.44  |- skos__historyNote mesh__D037101 Luteinizing Hormone %28%1974-2002%29%
% 213.28/213.44  |- skos__prefLabel mesh__D037101 Luteinizing Hormone, beta Subunit
% 213.28/213.44  |- mesh__recordMaintainer mesh__D037101 ags
% 213.28/213.44  |- mesh__recordOriginator mesh__D037101 lkt
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D037101 2006B
% 213.28/213.44  |- mesh__dateCreated mesh__D037101 2002-07-03
% 213.28/213.44  |- mesh__historyNote mesh__D037101
% 213.28/213.44       2003; use LUTEINIZING HORMONE, BETA SUBUNIT %28%NM%29% 1983-2002%A%  
% 213.28/213.44  |- skos__altLabel mesh__D037101 Lutropin-beta
% 213.28/213.44  |- skos__broader mesh__D037101smesh__D007986
% 213.28/213.44  |- skos__altLabel mesh__D037101 Luteinizing Hormone, beta Chain
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D037101 2006A
% 213.28/213.44  |- mesh__dateEstablished mesh__D037101 2003-01-01
% 213.28/213.44  |- skos__altLabel mesh__D037101 ICSH, beta Subunit
% 213.28/213.44  |- mesh__dateRevised mesh__D037101 2005-07-12
% 213.28/213.44  |- skos__scopeNote mesh__D037101
% 213.28/213.44       The beta subunit of luteinizing hormone. It is a 15-kDa glycopolypeptide with structure similar to the beta subunit of the placental chorionic gonadatropin %28%CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN%29% except for the additional 31 amino acids at the C-terminal of CG-beta. Full biological activity of LH requires the non-covalently bound heterodimers of an alpha and a beta subunit. Mutation of the LHB gene causes HYPOGONADISM and infertility.%A%    
% 213.28/213.44  |- skos__altLabel mesh__D037101 LH-beta
% 213.28/213.44  |- skos__hiddenLabel mesh__D037101 Lutropin beta
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D037101 2006
% 213.28/213.44  |- skos__altLabel mesh__D037101 Luteinizing Hormone, beta Polypeptide Chain
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D037101 2005
% 213.28/213.44  |- skos__altLabel mesh__D037101 Lutropin, beta Subunit
% 213.28/213.44  |- mesh__recordAuthorizer mesh__D037101 ags
% 213.28/213.44  |- skos__hiddenLabel mesh__D037101 LH beta
% 213.28/213.44  |- rdf__type mesh__D037101sskos__Concept
% 213.28/213.44  |- skos__altLabel mesh__D037101 LH, beta Subunit
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D009410 2002
% 213.28/213.44  |- skos__hiddenLabel mesh__D009410 Degenerations, Nerve
% 213.28/213.44  |- skos__scopeNote mesh__D009410
% 213.28/213.44       Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.%A%    
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D009410 2006
% 213.28/213.44  |- skos__annotation mesh__D009410
% 213.28/213.44       IM as a pathol process; coord with specific neurol dis /pathol %28%IM%29% or specific nerve /pathol %28%IM or NIM%29% if pertinent%A%  
% 213.28/213.44  |- skos__hiddenLabel mesh__D009410 Degenerations, Neuron
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D009410 2001
% 213.28/213.44  |- mesh__dateCreated mesh__D009410 1999-01-01
% 213.28/213.44  |- skos__hiddenLabel mesh__D009410 Neuron Degenerations
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D009410 2005
% 213.28/213.44  |- mesh__dateEstablished mesh__D009410 1967-01-01
% 213.28/213.44  |- mesh__recordMaintainer mesh__D009410 TGC
% 213.28/213.44  |- mesh__publicMeSHNote mesh__D009410 67   
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D009410 2000
% 213.28/213.44  |- skos__prefLabel mesh__D009410 Nerve Degeneration
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D009410 2004
% 213.28/213.44  |- skos__altLabel mesh__D009410 Neuron Degeneration
% 213.28/213.44  |- mesh__dateRevised mesh__D009410 1999-11-03
% 213.28/213.44  |- skos__hiddenLabel mesh__D009410 Degeneration, Neuron
% 213.28/213.44  |- skos__broader mesh__D009410smesh__D010335
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D009410 2003
% 213.28/213.44  |- mesh__recordOriginator mesh__D009410 NLM
% 213.28/213.44  |- mesh__historyNote mesh__D009410 67%28%64%29%   
% 213.28/213.44  |- rdf__type mesh__D009410sskos__Concept
% 213.28/213.44  |- mesh__recordAuthorizer mesh__D009410 sjn
% 213.28/213.44  |- skos__hiddenLabel mesh__D009410 Nerve Degenerations
% 213.28/213.44  |- skos__hiddenLabel mesh__D009410 Degeneration, Nerve
% 213.28/213.44  |- skos__hiddenLabel mesh__D042844 Reductase, Lactate Flavocytochrome
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D042844 2004
% 213.28/213.44  |- mesh__dateCreated mesh__D042844 2003-07-09
% 213.28/213.44  |- rdf__type mesh__D042844sskos__Concept
% 213.28/213.44  |- skos__altLabel mesh__D042844 Cytochrome B2
% 213.28/213.44  |- skos__altLabel mesh__D042844 Lactate Dehydrogenase %28%Cytochrome%29%
% 213.28/213.44  |- mesh__recordOriginator mesh__D042844 AKE
% 213.28/213.44  |- mesh__recordMaintainer mesh__D042844 AKE
% 213.28/213.44  |- mesh__publicMeSHNote mesh__D042844
% 213.28/213.44       2004; L-LACTATE DEHYDROGENASE %28%CYTOCHROME%29% was indexed under LACTATE DEHYDROGENASE 1981-2003 %26% under CYTOCHROMES 1974-1980%A%  
% 213.28/213.44  |- skos__prefLabel mesh__D042844 L-Lactate Dehydrogenase %28%Cytochrome%29%
% 213.28/213.44  |- skos__scopeNote mesh__D042844
% 213.28/213.44       A cytochrome form of lactate dehydrogenase found in the MITOCHONDRIA. It catalyzes the oxidation of L-lactate to PYRUVATE with transfer of electrons to CYTOCHROME C. The enzyme utilizes FMN and PROTOHEME IX as cofactors.%A%    
% 213.28/213.44  |- mesh__dateEstablished mesh__D042844 2004-01-01
% 213.28/213.44  |- skos__historyNote mesh__D042844
% 213.28/213.44       L-Lactate Dehydrogenase %28%1974-2003%29%
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D042844 2006
% 213.28/213.44  |- skos__hiddenLabel mesh__D042844 Cytochrome Reductase, Lactic
% 213.28/213.44  |- skos__altLabel mesh__D042844 Lactate-Ferricytochrome C Oxidoreductase
% 213.28/213.44  |- mesh__recordAuthorizer mesh__D042844 sjn
% 213.28/213.44  |- mesh__historyNote mesh__D042844
% 213.28/213.44       2004; use L-LACTATE DEHYDROGENASE %28%CYTOCHROME%29% %28%NM%29% 1980-2003%A%  
% 213.28/213.44  |- skos__broader mesh__D042844smesh__D045022
% 213.28/213.44  |- skos__altLabel mesh__D042844 Lactic Cytochrome Reductase
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D042844 2005
% 213.28/213.44  |- skos__hiddenLabel mesh__D042844 Lactate Ferricytochrome C Oxidoreductase
% 213.28/213.44  |- skos__altLabel mesh__D042844 Flavocytochrome B2
% 213.28/213.44  |- skos__altLabel mesh__D042844 L-Lactate Cytochrome C Oxidoreductase
% 213.28/213.44  |- skos__hiddenLabel mesh__D042844 Flavocytochrome Reductase, Lactate
% 213.28/213.44  |- skos__annotation mesh__D042844
% 213.28/213.44       do not confuce with L-LACTATE DEHYDROGENASE   
% 213.28/213.44  |- skos__altLabel mesh__D042844 Lactate Flavocytochrome Reductase
% 213.28/213.44  |- skos__hiddenLabel mesh__D042844 L Lactate Cytochrome C Oxidoreductase
% 213.28/213.44  |- mesh__recordOriginator mesh__D020392 nns
% 213.28/213.44  |- mesh__historyNote mesh__D020392 2000   
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D020392 2005
% 213.28/213.44  |- skos__hiddenLabel mesh__D020392 Nucleus, Entopeduncular
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D020392 2006
% 213.28/213.44  |- skos__broader mesh__D020392smesh__D020530
% 213.28/213.44  |- rdf__type mesh__D020392sskos__Concept
% 213.28/213.44  |- skos__annotation mesh__D020392
% 213.28/213.44       for non-primates medial globus pallidus is ENTOPEDUNCULAR NUCLEUS%A%  
% 213.28/213.44  |- skos__altLabel mesh__D020392 Nucleus Endopeduncularis
% 213.28/213.44  |- skos__altLabel mesh__D020392 Endopeduncular Nucleus
% 213.28/213.44  |- skos__hiddenLabel mesh__D020392 Entopeduncularis, Nucleus
% 213.28/213.44  |- skos__hiddenLabel mesh__D020392 Endopeduncularis, Nucleus
% 213.28/213.44  |- mesh__publicMeSHNote mesh__D020392 2000   
% 213.28/213.44  |- mesh__recordAuthorizer mesh__D020392 sjn
% 213.28/213.44  |- skos__prefLabel mesh__D020392 Entopeduncular Nucleus
% 213.28/213.44  |- mesh__dateEstablished mesh__D020392 2000-01-01
% 213.28/213.44  |- skos__hiddenLabel mesh__D020392 Nucleus, Endopeduncular
% 213.28/213.44  |- mesh__dateRevised mesh__D020392 2003-07-22
% 213.28/213.44  |- mesh__recordMaintainer mesh__D020392 sjn
% 213.28/213.44  |- mesh__dateCreated mesh__D020392 1999-11-03
% 213.28/213.44  |- skos__historyNote mesh__D020392 Globus Pallidus %28%1967-1999%29%
% 213.28/213.44  |- skos__scopeNote mesh__D020392
% 213.28/213.44       A portion of the nucleus of ansa lenticularis located medial to the posterior limb of the internal capsule, along the course of the ansa lenticularis and the inferior thalamic peduncle or as a separate nucleus within the internal capsule adjacent to the medial GLOBUS PALLIDUS %28%NeuroNames, http://rprcsgi.rprc. washington.edu/neuronames/ %28%September 28, 1998%29%%29%. In non-primates, the entopeduncular nucleus is analogous to both the medial globus pallidus and the entopeduncular nucleus of human.%A%    
% 213.28/213.44  |- skos__altLabel mesh__D020392 Nucleus Entopeduncularis
% 213.28/213.44  |- skos__related mesh__D020392smesh__D005917
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D020392 2004
% 213.28/213.44  |- mesh__activeMeSHYear mesh__D014355 2005
% 213.28/213.44  |- mesh__dateRevised mesh__D014355 2004-07-07
% 213.28/213.44  |- skos__scopeNote mesh__D014355
% 213.28/213.44       Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite %28%positive serologic result only%29% is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.%A%    
% 213.28/213.44  |- mesh__recordAuthorizer mesh__D014355 sjn
% 213.28/213.44  |- mesh__onlineNote mesh__D014355
% 213.28/213.44       use CHAGAS DISEASE to search TRYPANOSOMIASIS, SOUTH AMERICAN 1966-91%A%  
% 213.28/213.44  |- skos__annotation mesh__D014355
% 213.28/213.44       CHAGAS CARDIOMYOPATHY is also available   
% 213.28/213.44  |- mesh__publicMeSHNote mesh__D014355
% 213.28/213.44       92; was TRYPANOSOMIASIS, SOUTH AMERICAN 1966-91; CHAGAS DISEASE was see TRYPANOSOMIASIS, SOUTH AMERICAN 1981-91%A%  
% 213.28/213.44  |- mesh__recordOriginator mesh__D014355 NLM
% 213.28/213.44  |- skos__altLabel mesh__D014355 Trypanosomiasis, South American
% 213.28/213.44  |- skos__prefLabel mesh__D014355 Chagas Disease
% 213.28/213.44  |- skos__hiddenLabel mesh__D014355 Trypanosomiasis, American
% 213.28/213.44  |- rdf__type mesh__D014355sskos__Concept
% 213.28/213.44  |- skos__altLabel mesh__D014355 Chagas%27% Disease
% 213.28/213.44  |- skos__hiddenLabel mesh__D014355 Disease, Chagas%27%
% 213.28/213.45  |- mesh__historyNote mesh__D014355
% 213.28/213.45       92; was TRYPANOSOMIASIS, SOUTH AMERICAN 1966-91; CHAGAS DISEASE was see TRYPANOSOMIASIS, SOUTH AMERICAN 1981-91%A%  
% 213.28/213.45  |- skos__hiddenLabel mesh__D014355 South American Trypanosomiasis
% 213.28/213.45  |- skos__broader mesh__D014355smesh__D014352
% 213.28/213.45  |- mesh__recordMaintainer mesh__D014355 lkt
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D014355 2006
% 213.28/213.45  |- skos__hiddenLabel mesh__D014355 Disease, Chagas
% 213.28/213.45  |- mesh__dateCreated mesh__D014355 1999-01-01
% 213.28/213.45  |- skos__altLabel mesh__D014355 American Trypanosomiasis
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D008318 2002
% 213.28/213.45  |- skos__related mesh__D008318smesh__D007351
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D008318 2004
% 213.28/213.45  |- skos__scopeNote mesh__D008318
% 213.28/213.45       Failure of a professional person, a physician or lawyer, to render proper services through reprehensible ignorance or negligence or through criminal intent, especially when injury or loss follows. %28%Random House Unabridged Dictionary, 2d ed%29%%A%    
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D008318 2005
% 213.28/213.45  |- mesh__dateRevised mesh__D008318 2001-07-25
% 213.28/213.45  |- skos__broader mesh__D008318smesh__D007603
% 213.28/213.45  |- rdf__type mesh__D008318sskos__Concept
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D008318 2003
% 213.28/213.45  |- mesh__recordOriginator mesh__D008318 NLM
% 213.28/213.45  |- mesh__recordMaintainer mesh__D008318 jrf
% 213.28/213.45  |- skos__prefLabel mesh__D008318 Malpractice
% 213.28/213.45  |- mesh__recordAuthorizer mesh__D008318 sjn
% 213.28/213.45  |- mesh__dateCreated mesh__D008318 1999-01-01
% 213.28/213.45  |- skos__annotation mesh__D008318
% 213.28/213.45       not restricted to med malpractice; coord IM with specialty %28%IM%29%%A%  
% 213.28/213.45  |- skos__related mesh__D008318smesh__D028743
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D008318 2006
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D000335 2004
% 213.28/213.45  |- mesh__dateEstablished mesh__D000335 1991-01-01
% 213.28/213.45  |- skos__historyNote mesh__D000335 Aerosols %28%1966-1972%29%
% 213.28/213.45  |- mesh__dateRevised mesh__D000335 2003-07-09
% 213.28/213.45  |- skos__prefLabel mesh__D000335 Aerosol Propellants
% 213.28/213.45  |- skos__historyNote mesh__D000335 specific chemical %28%1966-1972%29%
% 213.28/213.45  |- skos__broader mesh__D000335smesh__D000336
% 213.28/213.45  |- mesh__dateCreated mesh__D000335 1999-01-01
% 213.28/213.45  |- skos__hiddenLabel mesh__D000335 Propellants, Aerosol
% 213.28/213.45  |- mesh__historyNote mesh__D000335
% 213.28/213.45       91%28%73%29%; was see under AEROSOLS 1973-90; was in Cat D %26% J 1973-82%A%  
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D000335 2006
% 213.28/213.45  |- mesh__publicMeSHNote mesh__D000335
% 213.28/213.45       91; was see under AEROSOLS 1973-90; was in Cat D %26% J 1973-82%A%  
% 213.28/213.45  |- mesh__recordOriginator mesh__D000335 NLM
% 213.28/213.45  |- skos__scopeNote mesh__D000335
% 213.28/213.45       Compressed gases or vapors in a container which, upon release of pressure and expansion through a valve, carry another substance from the container. They are used for cosmetics, household cleaners, and so on. Examples are BUTANES; CARBON DIOXIDE; FLUOROCARBONS; NITROGEN; and PROPANE. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 213.28/213.45  |- rdf__type mesh__D000335sskos__Concept
% 213.28/213.45  |- skos__annotation mesh__D000335
% 213.28/213.45       IM; coord with propellant if relevant %28%IM%29%; D25-26 qualif with discretion%A%  
% 213.28/213.45  |- mesh__recordAuthorizer mesh__D000335 sjn
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D000335 2005
% 213.28/213.45  |- mesh__recordMaintainer mesh__D000335 ssb
% 213.28/213.45  |- skos__scopeNote mesh__D019040
% 213.28/213.45       Cell adhesion molecule and CD antigen that mediates neutrophil, monocyte, and memory T-cell adhesion to cytokine-activated endothelial cells. E-selectin recognizes sialylated carbohydrate groups related to the Lewis X or Lewis A family.%A%    
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D019040 2006
% 213.28/213.45  |- rdf__type mesh__D019040sskos__Concept
% 213.28/213.45  |- skos__broader mesh__D019040smesh__D015703
% 213.28/213.45  |- skos__altLabel mesh__D019040 ELAM-1
% 213.28/213.45  |- mesh__recordAuthorizer mesh__D019040 sjn
% 213.28/213.45  |- mesh__recordOriginator mesh__D019040 AGS
% 213.28/213.45  |- skos__broader mesh__D019040smesh__D019087
% 213.28/213.45  |- skos__prefLabel mesh__D019040 E-Selectin
% 213.28/213.45  |- mesh__dateRevised mesh__D019040 2005-06-30
% 213.28/213.45  |- mesh__dateEstablished mesh__D019040 1996-01-01
% 213.28/213.45  |- skos__historyNote mesh__D019040
% 213.28/213.45       Cell Adhesion Molecules %28%1989-1995%29%
% 213.28/213.45  |- mesh__historyNote mesh__D019040
% 213.28/213.45       96; was ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1 %28%NM%29% 1989-95%A%  
% 213.28/213.45  |- skos__hiddenLabel mesh__D019040 Selectin, E
% 213.28/213.45  |- skos__altLabel mesh__D019040 Antigens, CD62E
% 213.28/213.45  |- skos__hiddenLabel mesh__D019040 Antigen, CD62E
% 213.28/213.45  |- mesh__onlineNote mesh__D019040
% 213.28/213.45       use E-SELECTIN %28%NM%29% to search ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1 1989-95%A%  
% 213.28/213.45  |- skos__annotation mesh__D019040
% 213.28/213.45       a cell adhesion molecule %26% CD antigen   
% 213.28/213.45  |- skos__altLabel mesh__D019040 CD62E Antigens
% 213.28/213.45  |- skos__altLabel mesh__D019040 CD62E Antigen
% 213.28/213.45  |- skos__altLabel mesh__D019040 Endothelial Leukocyte Adhesion Molecule 1
% 213.28/213.45  |- skos__altLabel mesh__D019040 LECAM-2
% 213.28/213.45  |- skos__altLabel mesh__D019040 E Selectin
% 213.28/213.45  |- mesh__recordMaintainer mesh__D019040 ssb
% 213.28/213.45  |- mesh__dateCreated mesh__D019040 1995-05-26
% 213.28/213.45  |- mesh__publicMeSHNote mesh__D019040
% 213.28/213.45       96; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1 was indexed under CELL ADHESION MOLECULES 1989-95%A%  
% 213.28/213.45  |- skos__altLabel mesh__D019040 Endothelial Leukocyte Adhesion Molecule-1
% 213.28/213.45  |- skos__historyNote mesh__D005020 Alkanes %28%1966-1973%29%
% 213.28/213.45  |- skos__broader mesh__D005020smesh__D008698
% 213.28/213.45  |- mesh__historyNote mesh__D005020
% 213.28/213.45       80%28%75%29%; was see under METHANESULFONATES 1975-79; ETHYLMESYLATE %26% MESILATE, ETHYL were see ETHYL METHANESULFONATE 1981-93; ETHYL MESILATE was see ETHYL METHANESULFONATE 1980-93%A%  
% 213.28/213.45  |- skos__historyNote mesh__D005020 Methane %28%1966-1973%29%
% 213.28/213.45  |- mesh__onlineNote mesh__D005020
% 213.28/213.45       use ETHYL METHANESULFONATE to search ETHYLMESYLATE %26% MESILATE, ETHYL 1981-93 and ETHYL MESILATE 1980-93%A%  
% 213.28/213.45  |- skos__scopeNote mesh__D005020
% 213.28/213.45       An antineoplastic agent with alkylating properties. It also acts as a mutagen by damaging DNA and is used experimentally for that effect.%A%    
% 213.28/213.45  |- skos__hiddenLabel mesh__D005020 Mesylate, Ethyl
% 213.28/213.45  |- skos__altLabel mesh__D005020 Ethyl Mesylate
% 213.28/213.45  |- skos__historyNote mesh__D005020 Methanesulfonates %28%1974%29%
% 213.28/213.45  |- skos__hiddenLabel mesh__D005020 Mesilate, Ethyl
% 213.28/213.45  |- mesh__dateCreated mesh__D005020 1974-11-19
% 213.28/213.45  |- skos__hiddenLabel mesh__D005020 Methanesulfonate, Ethyl
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D005020 2006
% 213.28/213.45  |- skos__altLabel mesh__D005020 Ethylmesilate
% 213.28/213.45  |- skos__altLabel mesh__D005020 Ethylmethane Sulfonate
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D005020 2002
% 213.28/213.45  |- mesh__publicMeSHNote mesh__D005020
% 213.28/213.45       80; was see under METHANESULFONATES 1975-79; ETHYLMESYLATE %26% MESILATE, ETHYL were see ETHYL METHANESULFONATE 1981-93; ETHYL MESILATE was see ETHYL METHANESULFONATE 1980-93%A%  
% 213.28/213.45  |- skos__altLabel mesh__D005020 Ethyl Mesilate
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D005020 2005
% 213.28/213.45  |- mesh__dateRevised mesh__D005020 2000-06-22
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D005020 2001
% 213.28/213.45  |- skos__altLabel mesh__D005020 Ethylmesylate
% 213.28/213.45  |- mesh__recordOriginator mesh__D005020 NLM
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D005020 2004
% 213.28/213.45  |- skos__prefLabel mesh__D005020 Ethyl Methanesulfonate
% 213.28/213.45  |- mesh__recordAuthorizer mesh__D005020 sjn
% 213.28/213.45  |- mesh__dateEstablished mesh__D005020 1980-01-01
% 213.28/213.45  |- rdf__type mesh__D005020sskos__Concept
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D005020 2003
% 213.28/213.45  |- skos__hiddenLabel mesh__D005020 Sulfonate, Ethylmethane
% 213.28/213.45  |- skos__historyNote mesh__D005020 Sulfonic Acids %28%1966-1973%29%
% 213.28/213.45  |- mesh__recordMaintainer mesh__D005020 CCR
% 213.28/213.45  |- skos__annotation mesh__D018746
% 213.28/213.45       often leads to RESPIRATORY DISTRESS SYNDROME, ADULT   
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D018746 2002
% 213.28/213.45  |- skos__altLabel mesh__D018746 Systemic Inflammatory Response Syndrome
% 213.28/213.45  |- mesh__publicMeSHNote mesh__D018746 95   
% 213.28/213.45  |- mesh__dateEstablished mesh__D018746 1995-01-01
% 213.28/213.45  |- mesh__recordAuthorizer mesh__D018746 sjn
% 213.28/213.45  |- skos__altLabel mesh__D018746 Inflammatory Response Syndrome, Systemic
% 213.28/213.45  |- skos__broader mesh__D018746smesh__D012687
% 213.28/213.45  |- skos__hiddenLabel mesh__D018746 Syndrome, Sepsis
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D018746 2001
% 213.28/213.45  |- mesh__recordMaintainer mesh__D018746 KEV
% 213.28/213.45  |- skos__broader mesh__D018746smesh__D012769
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D018746 2004
% 213.28/213.45  |- mesh__dateRevised mesh__D018746 1999-11-08
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D018746 2000
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D018746 2006
% 213.28/213.45  |- skos__prefLabel mesh__D018746 Sepsis Syndrome
% 213.28/213.45  |- mesh__historyNote mesh__D018746 95   
% 213.28/213.45  |- mesh__recordOriginator mesh__D018746 TGC
% 213.28/213.45  |- skos__scopeNote mesh__D018746
% 213.28/213.45       A systemic response to infection, defined as hypothermia or hyperthermia, tachycardia, tachypnea, a clinically evident focus of infection or positive blood cultures, one or more end organs with either dysfunction or inadequate perfusion, cerebral dysfunction, hypoxemia, increased plasma lactate or unexplained metabolic acidosis, and oliguria. It is one of the most common causes of adult respiratory distress syndrome %28%RESPIRATORY DISTRESS SYNDROME, ADULT%29%. %28%Segen, Dictionary of Modern Medicine, 1992%29% While usually related to infection, it can also be associated with noninfectious insults such as trauma, burns, pancreatitis. %28%JAMA 1995;273%28%2%29%:155-6%29%%A%    
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D018746 2003
% 213.28/213.45  |- skos__hiddenLabel mesh__D018746 Syndromes, Sepsis
% 213.28/213.45  |- skos__hiddenLabel mesh__D018746 Sepsis Syndromes
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D018746 2005
% 213.28/213.45  |- skos__related mesh__D018746smesh__D012128
% 213.28/213.45  |- mesh__dateCreated mesh__D018746 1994-05-23
% 213.28/213.45  |- rdf__type mesh__D018746sskos__Concept
% 213.28/213.45  |- skos__historyNote mesh__D010763 Glycogen Phosphorylase %28%1971-1978%29%
% 213.28/213.45  |- mesh__recordMaintainer mesh__D010763 ssb
% 213.28/213.45  |- mesh__recordAuthorizer mesh__D010763 sjn
% 213.28/213.45  |- mesh__recordOriginator mesh__D010763 RLS
% 213.28/213.45  |- mesh__publicMeSHNote mesh__D010763
% 213.28/213.45       91; was see under GLYCOGEN PHOSPHORYLASE 1979-90; was see GLYCOGEN PHOSPHORYLASE 1975-78%A%  
% 213.28/213.45  |- skos__broader mesh__D010763smesh__D006005
% 213.28/213.45  |- skos__historyNote mesh__D010763 Glucosyltransferases %28%1966-1970%29%
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D010763 2006
% 213.28/213.45  |- mesh__historyNote mesh__D010763
% 213.28/213.45       91%28%79%29%; was see under GLYCOGEN PHOSPHORYLASE 1979-90; was see GLYCOGEN PHOSPHORYLASE 1975-78%A%  
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D010763 2004
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D010763 2005
% 213.28/213.45  |- mesh__dateCreated mesh__D010763 1978-05-18
% 213.28/213.45  |- skos__prefLabel mesh__D010763 Phosphorylase b
% 213.28/213.45  |- mesh__dateEstablished mesh__D010763 1991-01-01
% 213.28/213.45  |- skos__scopeNote mesh__D010763
% 213.28/213.45       The inactive form of GLYCOGEN PHOSPHORYLASE that is converted to the active form PHOSPHORYLASE A via phosphorylation by PHOSPHORYLASE KINASE and ATP.%A%    
% 213.28/213.45  |- rdf__type mesh__D010763sskos__Concept
% 213.28/213.45  |- mesh__onlineNote mesh__D010763 search GLYCOGEN PHOSPHORYLASE 1975-78   
% 213.28/213.45  |- mesh__dateRevised mesh__D010763 2003-07-09
% 213.28/213.45  |- mesh__recordAuthorizer mesh__D004726 sjn
% 213.28/213.45  |- mesh__publicMeSHNote mesh__D004726 74   
% 213.28/213.45  |- skos__hiddenLabel mesh__D004726 beta Endosulfan
% 213.28/213.45  |- skos__hiddenLabel mesh__D004726 alpha Endosulfan
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D004726 2006
% 213.28/213.45  |- mesh__dateRevised mesh__D004726 2005-06-30
% 213.28/213.45  |- mesh__dateEstablished mesh__D004726 1974-01-01
% 213.28/213.45  |- skos__annotation mesh__D004726 TN 111 for eff on insects   
% 213.28/213.45  |- skos__prefLabel mesh__D004726 Endosulfan
% 213.28/213.45  |- rdf__type mesh__D004726sskos__Concept
% 213.28/213.45  |- mesh__recordOriginator mesh__D004726 NLM
% 213.28/213.45  |- mesh__dateCreated mesh__D004726 1999-01-01
% 213.28/213.45  |- skos__altLabel mesh__D004726 Thiodan
% 213.28/213.45  |- skos__altLabel mesh__D004726 Thiodon
% 213.28/213.45  |- skos__broader mesh__D004726smesh__D001582
% 213.28/213.45  |- mesh__recordMaintainer mesh__D004726 ssb
% 213.28/213.45  |- skos__historyNote mesh__D004726 Insecticides %28%1966-1972%29%
% 213.28/213.45  |- mesh__historyNote mesh__D004726 74%28%72%29%   
% 213.28/213.45  |- skos__scopeNote mesh__D004726
% 213.28/213.45       A polychlorinated compound used for controlling a variety of insects. It is practically water-insoluble, but readily adheres to clay particles and persists in soil and water for several years. Its mode of action involves repetitive nerve-discharges positively correlated to increase in temperature. This compound is extremely toxic to most fish. %28%From Comp Biochem Physiol %28%C%29% 1993 Jul;105%28%3%29%:347-61%29%%A%    
% 213.28/213.45  |- skos__altLabel mesh__D037102 Isolectin
% 213.28/213.45  |- skos__hiddenLabel mesh__D037102 Lectins, Animal
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D037102 2006
% 213.28/213.45  |- mesh__publicMeSHNote mesh__D037102
% 213.28/213.45       2003; ISOLECTIN was indexed under LECTINS 1979-2002   
% 213.28/213.45  |- mesh__recordOriginator mesh__D037102 jmp
% 213.28/213.45  |- mesh__dateRevised mesh__D037102 2005-06-30
% 213.28/213.45  |- skos__historyNote mesh__D037102 Lectins %28%1966-2002%29%
% 213.28/213.45  |- skos__broader mesh__D037102smesh__D011506
% 213.28/213.45  |- rdf__type mesh__D037102sskos__Concept
% 213.28/213.45  |- mesh__historyNote mesh__D037102
% 213.28/213.45       2003; for ISOLECTIN use LECTINS %28%NM%29% 1979-2002   
% 213.28/213.45  |- skos__scopeNote mesh__D037102
% 213.28/213.45       Proteins that share the common characteristic of binding to carbohydrates. Some ANTIBODIES and carbohydrate-metabolizing proteins %28%ENZYMES%29% also bind to carbohydrates, however they are not considered lectins. PLANT LECTINS are carbohydrate-binding proteins that have been primarily identified by their hemagglutinating activity %28%HEMAGGLUTININS%29%. However, a variety of lectins occur in animal species where they serve diverse array of functions through specific carbohydrate recognition.%A%    
% 213.28/213.45  |- mesh__dateEstablished mesh__D037102 2003-01-01
% 213.28/213.45  |- mesh__dateCreated mesh__D037102 2002-07-03
% 213.28/213.45  |- skos__prefLabel mesh__D037102 Lectins
% 213.28/213.45  |- mesh__recordMaintainer mesh__D037102 SYSTEM
% 213.28/213.45  |- mesh__recordAuthorizer mesh__D037102 sjn
% 213.28/213.45  |- mesh__recordOriginator mesh__D009411 NLM
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D009411 1999
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D009411 2006
% 213.28/213.45  |- mesh__dateCreated mesh__D009411 1999-01-01
% 213.28/213.45  |- skos__hiddenLabel mesh__D009411 Endings, Nerve
% 213.28/213.45  |- skos__hiddenLabel mesh__D009411 Ending, Nerve
% 213.28/213.45  |- skos__hiddenLabel mesh__D009411 Nerve Ending
% 213.28/213.45  |- mesh__recordAuthorizer mesh__D009411 SJN
% 213.28/213.45  |- mesh__recordMaintainer mesh__D009411 TGC
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D009411 1998
% 213.28/213.45  |- skos__prefLabel mesh__D009411 Nerve Endings
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D009411 2005
% 213.28/213.45  |- skos__scopeNote mesh__D009411
% 213.28/213.45       Specialized terminations of peripheral neurons. Nerve endings include NEUROEFFECTOR JUNCTION%28%s%29% by which neurons activate target organs and sensory receptors %28%see RECEPTORS, SENSORY%29% which transduce information from the various sensory modalities and send it centrally in the nervous system. Presynaptic nerve endings are PRESYNAPTIC TERMINALS.%A%    
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D009411 2002
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D009411 2004
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D009411 2001
% 213.28/213.45  |- skos__annotation mesh__D009411 do not confuse with MOTOR ENDPLATE   
% 213.28/213.45  |- mesh__dateRevised mesh__D009411 1997-06-20
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D009411 2003
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D009411 2000
% 213.28/213.45  |- skos__broader mesh__D009411smesh__D017933
% 213.28/213.45  |- rdf__type mesh__D009411sskos__Concept
% 213.28/213.45  |- skos__related mesh__D009411smesh__D017729
% 213.28/213.45  |- skos__hiddenLabel mesh__D042845 Oxidase, Urishiol
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D042845 2006
% 213.28/213.45  |- skos__scopeNote mesh__D042845
% 213.28/213.45       A copper-containing oxidoreductase enzyme that catalyzes the oxidation of 4-benzenediol to 4-benzosemiquinone. It also has activity towards a variety of O-quinols and P-quinols. It primarily found in FUNGI and is involved in LIGNIN degradation, pigment biosynthesis and detoxification of lignin-derived products.%A%    
% 213.28/213.45  |- skos__prefLabel mesh__D042845 Laccase
% 213.28/213.45  |- skos__altLabel mesh__D042845 p-Diphenol Oxidase
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D042845 2005
% 213.28/213.45  |- skos__broader mesh__D042845smesh__D010088
% 213.28/213.45  |- mesh__recordOriginator mesh__D042845 AKE
% 213.28/213.45  |- mesh__publicMeSHNote mesh__D042845
% 213.28/213.45       2004; LACCASE was indexed under OXIDOREDUCTASES 1980-2003%A%  
% 213.28/213.45  |- skos__altLabel mesh__D042845 Urishiol Oxidase
% 213.28/213.45  |- skos__hiddenLabel mesh__D042845 p Diphenol Oxidase
% 213.28/213.45  |- mesh__dateEstablished mesh__D042845 2004-01-01
% 213.28/213.45  |- mesh__historyNote mesh__D042845
% 213.28/213.45       2004; use LACCASE %28%NM%29% 1980-2003   
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D042845 2004
% 213.28/213.45  |- skos__historyNote mesh__D042845 Oxidoreductases %28%1980-2003%29%
% 213.28/213.45  |- mesh__dateCreated mesh__D042845 2003-07-09
% 213.28/213.45  |- rdf__type mesh__D042845sskos__Concept
% 213.28/213.45  |- mesh__recordMaintainer mesh__D042845 AKE
% 213.28/213.45  |- skos__hiddenLabel mesh__D042845 Oxidase, p-Diphenol
% 213.28/213.45  |- mesh__recordAuthorizer mesh__D042845 sjn
% 213.28/213.45  |- mesh__recordAuthorizer mesh__D020393 sjn
% 213.28/213.45  |- mesh__dateRevised mesh__D020393 2005-06-30
% 213.28/213.45  |- skos__annotation mesh__D020393
% 213.28/213.45       prefer MANIPULATION, OSTEOPATHIC; MANIPULATION, ORTHOPEDIC; MANIPULATION, CHIROPRACTIC%A%  
% 213.28/213.45  |- mesh__dateCreated mesh__D020393 1998-06-10
% 213.28/213.45  |- skos__historyNote mesh__D020393
% 213.28/213.45       Manipulation, Orthopedic %28%1966-1998%29%
% 213.28/213.45  |- skos__altLabel mesh__D020393 Spinal Manipulation
% 213.28/213.45  |- mesh__recordOriginator mesh__D020393 JLS
% 213.28/213.45  |- skos__hiddenLabel mesh__D020393 Manipulation, Cervical
% 213.28/213.45  |- skos__broader mesh__D020393smesh__D026201
% 213.28/213.45  |- mesh__dateEstablished mesh__D020393 1999-01-01
% 213.28/213.45  |- mesh__historyNote mesh__D020393 1999   
% 213.28/213.45  |- mesh__recordMaintainer mesh__D020393 lkt
% 213.28/213.45  |- skos__prefLabel mesh__D020393 Manipulation, Spinal
% 213.28/213.45  |- mesh__publicMeSHNote mesh__D020393 1999   
% 213.28/213.45  |- skos__hiddenLabel mesh__D020393 Manipulation, Lumbar
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D020393 2006
% 213.28/213.45  |- skos__scopeNote mesh__D020393
% 213.28/213.45       Adjustment and manipulation of the vertebral column.     
% 213.28/213.45  |- rdf__type mesh__D020393sskos__Concept
% 213.28/213.45  |- skos__annotation mesh__D008319 a state of 3 islands south of Sicily   
% 213.28/213.45  |- skos__scopeNote mesh__D008319
% 213.28/213.45       An independent state consisting of three islands in the Mediterranean Sea, south of Sicily. Its capital is Valetta. The major island is Malta, the two smaller islands are Comino and Gozo. It was a Phoenician and Carthaginian colony, captured by the Romans in 218 B.C. It was overrun by Saracens in 870, taken by the Normans in 1090, and subsequently held by the French and later the British who allotted them a dominion government in 1921. It became a crown colony in 1933, achieving independence in 1964. The name possibly comes from a pre-Indoeuropean root mel, high, referring to its rocks, but a more picturesque origin derives the name from the Greek melitta or melissa, honey, with reference to its early fame for its honey production. %28%From Webster%27%s New Geographical Dictionary, 1988, p719 %26% Room, Brewer%27%s Dictionary of Names, 1992, p330%29%%A%    
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D008319 2000
% 213.28/213.45  |- skos__prefLabel mesh__D008319 Malta
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D008319 1996
% 213.28/213.45  |- mesh__historyNote mesh__D008319 75   
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D008319 2002
% 213.28/213.45  |- skos__broader mesh__D008319smesh__D008521
% 213.28/213.45  |- mesh__recordAuthorizer mesh__D008319 PLS
% 213.28/213.45  |- mesh__dateEstablished mesh__D008319 1975-01-01
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D008319 2006
% 213.28/213.45  |- mesh__recordMaintainer mesh__D008319 TGC
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D008319 2005
% 213.28/213.45  |- mesh__dateRevised mesh__D008319 1995-05-31
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D008319 2004
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D008319 1999
% 213.28/213.45  |- mesh__recordOriginator mesh__D008319 NLM
% 213.28/213.45  |- mesh__dateCreated mesh__D008319 1974-11-11
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D008319 2001
% 213.28/213.45  |- rdf__type mesh__D008319sskos__Concept
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D008319 1997
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D008319 2003
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D008319 1998
% 213.28/213.45  |- skos__broader mesh__D000336smesh__D003102
% 213.28/213.45  |- mesh__dateCreated mesh__D000336 1999-01-01
% 213.28/213.45  |- mesh__recordOriginator mesh__D000336 NLM
% 213.28/213.45  |- skos__prefLabel mesh__D000336 Aerosols
% 213.28/213.45  |- mesh__recordAuthorizer mesh__D000336 sjn
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D000336 2006
% 213.28/213.45  |- rdf__type mesh__D000336sskos__Concept
% 213.28/213.45  |- mesh__recordMaintainer mesh__D000336 jls
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D000336 2005
% 213.28/213.45  |- skos__scopeNote mesh__D000336
% 213.28/213.45       Colloids with a gaseous dispersing phase and either liquid %28%fog%29% or solid %28%smoke%29% dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents.%A%    
% 213.28/213.45  |- mesh__dateRevised mesh__D000336 2004-07-19
% 213.28/213.45  |- mesh__historyNote mesh__D000336
% 213.28/213.45       was in Cat D %26% J 1973-82, was in Cat D only 1963-72   
% 213.28/213.45  |- skos__annotation mesh__D000336
% 213.28/213.45       IM for general only, qualif permitted; NIM %28%no qualif%29% with specific drug IM %28%with qualif%29%; /adv eff permitted but be careful: it may be the adv eff of the drug in aerosol form, not the aerosol%A%  
% 213.28/213.45  |- skos__broader mesh__D019041smesh__D019087
% 213.28/213.45  |- skos__hiddenLabel mesh__D019041 Leu 8 Antigen
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D019041 2006
% 213.28/213.45  |- mesh__publicMeSHNote mesh__D019041
% 213.28/213.45       96; LEUKOCYTE ADHESION MOLECULE, LAM-1 was indexed under CELL ADHESION MOLECULES 1989-95%A%  
% 213.28/213.45  |- rdf__type mesh__D019041sskos__Concept
% 213.28/213.45  |- skos__historyNote mesh__D019041
% 213.28/213.45       Cell Adhesion Molecules %28%1989-1995%29%
% 213.28/213.45  |- skos__hiddenLabel mesh__D019041 Selectin, L
% 213.28/213.45  |- skos__hiddenLabel mesh__D019041 Mel 14 Antigen
% 213.28/213.45  |- skos__altLabel mesh__D019041 L Selectin
% 213.28/213.45  |- skos__altLabel mesh__D019041 Leukocyte Adhesion Molecule, LAM-1
% 213.28/213.45  |- skos__altLabel mesh__D019041 Mel-14 Antigen
% 213.28/213.45  |- skos__hiddenLabel mesh__D019041 Antigen, TQ1
% 213.28/213.45  |- skos__annotation mesh__D019041
% 213.28/213.45       a cell adhesion molecule %26% CD antigen   
% 213.28/213.45  |- skos__prefLabel mesh__D019041 L-Selectin
% 213.28/213.45  |- skos__altLabel mesh__D019041 TQ1 Antigen
% 213.28/213.45  |- skos__hiddenLabel mesh__D019041 Leukocyte Adhesion Molecule, LAM 1
% 213.28/213.45  |- mesh__recordOriginator mesh__D019041 AGS
% 213.28/213.45  |- skos__hiddenLabel mesh__D019041 Antigen, Mel-14
% 213.28/213.45  |- mesh__historyNote mesh__D019041
% 213.28/213.45       96; was LEUKOCYTE ADHESION MOLECULE, LAM-1 %28%NM%29% 1989-95   
% 213.28/213.45  |- skos__scopeNote mesh__D019041
% 213.28/213.45       Cell adhesion molecule and CD antigen that serves as a homing receptor for lymphocytes to lymph node high endothelial venules.%A%    
% 213.28/213.45  |- mesh__recordAuthorizer mesh__D019041 sjn
% 213.28/213.45  |- skos__altLabel mesh__D019041 LECAM-1
% 213.28/213.45  |- mesh__dateEstablished mesh__D019041 1996-01-01
% 213.28/213.45  |- skos__broader mesh__D019041smesh__D016201
% 213.28/213.45  |- skos__altLabel mesh__D019041 LAM-1
% 213.28/213.45  |- skos__altLabel mesh__D019041 Antigens, CD62L
% 213.28/213.45  |- skos__altLabel mesh__D019041 CD62L Antigens
% 213.28/213.45  |- skos__hiddenLabel mesh__D019041 Antigen, CD62L
% 213.28/213.45  |- skos__altLabel mesh__D019041 Leu-8 Antigen
% 213.28/213.45  |- skos__hiddenLabel mesh__D019041 Antigen, Leu-8
% 213.28/213.45  |- mesh__onlineNote mesh__D019041
% 213.28/213.45       use L-SELECTIN %28%NM%29% to search LEUKOCYTE ADHESION MOLECULE, LAM-1 1989-95%A%  
% 213.28/213.45  |- mesh__dateRevised mesh__D019041 2005-06-30
% 213.28/213.45  |- skos__altLabel mesh__D019041 CD62L Antigen
% 213.28/213.45  |- mesh__dateCreated mesh__D019041 1995-05-26
% 213.28/213.45  |- mesh__recordMaintainer mesh__D019041 ssb
% 213.28/213.45  |- mesh__recordMaintainer mesh__D005021 TAP
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D005021 1996
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D005021 2006
% 213.28/213.45  |- skos__broader mesh__D005021smesh__D000588
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D005021 1995
% 213.28/213.45  |- mesh__dateRevised mesh__D005021 1992-05-19
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D005021 2005
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D005021 1994
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D005021 2004
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D005021 1993
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D005021 1999
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D005021 2002
% 213.28/213.45  |- rdf__type mesh__D005021sskos__Concept
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D005021 2003
% 213.28/213.45  |- mesh__dateCreated mesh__D005021 1999-01-01
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D005021 1998
% 213.28/213.45  |- mesh__recordAuthorizer mesh__D005021 PLS
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D005021 2001
% 213.28/213.45  |- mesh__recordOriginator mesh__D005021 NLM
% 213.28/213.45  |- skos__prefLabel mesh__D005021 Ethylamines
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D005021 1997
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D005021 2000
% 213.28/213.45  |- skos__scopeNote mesh__D018747
% 213.28/213.45       Ribonucleic acid in chloroplasts having regulatory and catalytic roles as well as involvement in protein synthesis.%A%    
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D018747 2004
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D018747 2002
% 213.28/213.45  |- mesh__recordMaintainer mesh__D018747 mdb
% 213.28/213.45  |- skos__prefLabel mesh__D018747 RNA, Chloroplast
% 213.28/213.45  |- mesh__dateCreated mesh__D018747 1994-04-19
% 213.28/213.45  |- mesh__publicMeSHNote mesh__D018747 95   
% 213.28/213.45  |- mesh__dateEstablished mesh__D018747 1995-01-01
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D018747 2006
% 213.28/213.45  |- mesh__historyNote mesh__D018747 95   
% 213.28/213.45  |- mesh__recordAuthorizer mesh__D018747 sjn
% 213.28/213.45  |- skos__annotation mesh__D018747
% 213.28/213.45       IM; coord with PLANTS; ALGAE; or specific plant or alga %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 213.28/213.45  |- skos__broader mesh__D018747smesh__D012313
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D018747 2003
% 213.28/213.45  |- skos__broader mesh__D018747smesh__D018749
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D018747 2005
% 213.28/213.45  |- mesh__recordOriginator mesh__D018747 PXP
% 213.28/213.45  |- skos__historyNote mesh__D018747 RNA %28%1966-1994%29%
% 213.28/213.45  |- rdf__type mesh__D018747sskos__Concept
% 213.28/213.45  |- mesh__dateRevised mesh__D018747 2001-07-25
% 213.28/213.45  |- skos__altLabel mesh__D018747 Chloroplast RNA
% 213.28/213.45  |- skos__historyNote mesh__D018747 Chloroplasts %28%1966-1994%29%
% 213.28/213.45  |- skos__hiddenLabel mesh__D010764 Kinase, Glycogen Phosphorylase
% 213.28/213.45  |- skos__scopeNote mesh__D010764
% 213.28/213.45       An enzyme that catalyzes the conversion of ATP and phosphorylase b to ADP and phosphorylase a. EC 2.7.1.38.%A%    
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D010764 2006
% 213.28/213.45  |- skos__hiddenLabel mesh__D010764 Kinase, Phosphorylase b
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D010764 2004
% 213.28/213.45  |- mesh__dateCreated mesh__D010764 1999-01-01
% 213.28/213.45  |- mesh__recordMaintainer mesh__D010764 ssb
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D010764 2005
% 213.28/213.45  |- mesh__recordAuthorizer mesh__D010764 sjn
% 213.28/213.45  |- skos__altLabel mesh__D010764 Phosphorylase b Kinase
% 213.28/213.45  |- skos__hiddenLabel mesh__D010764 Phosphorylase Kinase, Glycogen
% 213.28/213.45  |- skos__prefLabel mesh__D010764 Phosphorylase Kinase
% 213.28/213.45  |- mesh__recordOriginator mesh__D010764 NLM
% 213.28/213.45  |- skos__hiddenLabel mesh__D010764 Kinase, Phosphorylase
% 213.28/213.45  |- rdf__type mesh__D010764sskos__Concept
% 213.28/213.45  |- mesh__dateRevised mesh__D010764 2003-07-09
% 213.28/213.45  |- skos__broader mesh__D010764smesh__D011494
% 213.28/213.45  |- skos__hiddenLabel mesh__D010764 b Kinase, Phosphorylase
% 213.28/213.45  |- skos__scopeNote mesh__D037901
% 213.28/213.45       The killing of animals for reasons of mercy, to control disease transmission or maintain the health of animal populations, or for experimental purposes %28%ANIMAL EXPERIMENTATION%29%.%A%    
% 213.28/213.45  |- mesh__recordAuthorizer mesh__D037901 sjn
% 213.28/213.45  |- mesh__dateEstablished mesh__D037901 2003-01-01
% 213.28/213.45  |- skos__altLabel mesh__D037901 Animal Euthanasia
% 213.28/213.45  |- skos__hiddenLabel mesh__D037901 Animal Mercy Killing
% 213.28/213.45  |- mesh__dateCreated mesh__D037901 2002-07-02
% 213.28/213.45  |- skos__annotation mesh__D037901
% 213.28/213.45       methods of %22%sacrificing%22% animals go here if the topic of discussion; for euthanasia of laboratory animals, coordinate with ANIMALS, LABORATORY%A%  
% 213.28/213.45  |- skos__related mesh__D037901smesh__D000827
% 213.28/213.45  |- mesh__recordMaintainer mesh__D037901 sjn
% 213.28/213.45  |- mesh__recordOriginator mesh__D037901 hjn
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D037901 2006
% 213.28/213.45  |- skos__prefLabel mesh__D037901 Euthanasia, Animal
% 213.28/213.45  |- mesh__dateRevised mesh__D037901 2003-07-25
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D037901 2004
% 213.28/213.45  |- rdf__type mesh__D037901sskos__Concept
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D037901 2005
% 213.28/213.45  |- mesh__publicMeSHNote mesh__D037901 2003   
% 213.28/213.45  |- skos__altLabel mesh__D037901 Mercy Killing, Animal
% 213.28/213.45  |- mesh__historyNote mesh__D037901 2003   
% 213.28/213.45  |- skos__broader mesh__D037901smesh__D008919
% 213.28/213.45  |- skos__broader mesh__D037901smesh__D028601
% 213.28/213.45  |- skos__historyNote mesh__D004727 Epithelium %28%1966-1972%29%
% 213.28/213.45  |- skos__hiddenLabel mesh__D004727 Endotheliums
% 213.28/213.45  |- mesh__activeMeSHYear mesh__D004727 2006
% 213.28/213.46  |- mesh__recordAuthorizer mesh__D004727 sjn
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D004727 2002
% 213.28/213.46  |- mesh__publicMeSHNote mesh__D004727 74   
% 213.28/213.46  |- rdf__type mesh__D004727sskos__Concept
% 213.28/213.46  |- mesh__recordMaintainer mesh__D004727 KEV
% 213.28/213.46  |- mesh__dateCreated mesh__D004727 1999-01-01
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D004727 2005
% 213.28/213.46  |- skos__prefLabel mesh__D004727 Endothelium
% 213.28/213.46  |- mesh__historyNote mesh__D004727 74%28%73%29%   
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D004727 2001
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D004727 2004
% 213.28/213.46  |- mesh__dateRevised mesh__D004727 1999-11-03
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D004727 2000
% 213.28/213.46  |- skos__annotation mesh__D004727
% 213.28/213.46       GEN or unspecified; prefer specifics; usually NIM with specific organ IM%A%  
% 213.28/213.46  |- skos__scopeNote mesh__D004727
% 213.28/213.46       A layer of epithelium that lines the heart, blood vessels %28%ENDOTHELIUM, VASCULAR%29%, lymph vessels %28%ENDOTHELIUM, LYMPHATIC%29%, and the serous cavities of the body.%A%    
% 213.28/213.46  |- mesh__dateEstablished mesh__D004727 1974-01-01
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D004727 2003
% 213.28/213.46  |- mesh__recordOriginator mesh__D004727 NLM
% 213.28/213.46  |- skos__broader mesh__D004727smesh__D004848
% 213.28/213.46  |- mesh__recordMaintainer mesh__D009412 lkt
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D009412 2004
% 213.28/213.46  |- skos__annotation mesh__D009412
% 213.28/213.46       do not confuse X ref MOSSY FIBERS, CEREBELLAR with MOSSY FIBERS, HIPPOCAMPAL%A%  
% 213.28/213.46  |- mesh__publicMeSHNote mesh__D009412 77   
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D009412 2003
% 213.28/213.46  |- mesh__recordOriginator mesh__D009412 MM
% 213.28/213.46  |- skos__historyNote mesh__D009412
% 213.28/213.46       Nerve Fibers, Myelinated %28%1969-1976%29%
% 213.28/213.46  |- mesh__onlineNote mesh__D009412
% 213.28/213.46       search NERVE FIBERS, MYELINATED 1969-71 %28%as Prov%29%   
% 213.28/213.46  |- skos__historyNote mesh__D009412 Neurons %28%1966-1976%29%
% 213.28/213.46  |- mesh__dateEstablished mesh__D009412 1977-01-01
% 213.28/213.46  |- rdf__type mesh__D009412sskos__Concept
% 213.28/213.46  |- skos__hiddenLabel mesh__D009412 Nerve Fiber
% 213.28/213.46  |- skos__scopeNote mesh__D009412
% 213.28/213.46       Slender processes of NEURONS, including the AXONS and their glial envelopes %28%MYELIN SHEATH%29%. Nerve fibers conduct nerve impulses to and from the central nervous system.%A%    
% 213.28/213.46  |- mesh__dateCreated mesh__D009412 1976-05-03
% 213.28/213.46  |- mesh__dateRevised mesh__D009412 2002-07-03
% 213.28/213.46  |- mesh__historyNote mesh__D009412 77%28%69-71%29%   
% 213.28/213.46  |- skos__hiddenLabel mesh__D009412 Cerebellar Mossy Fiber
% 213.28/213.46  |- mesh__recordAuthorizer mesh__D009412 sjn
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D009412 2006
% 213.28/213.46  |- skos__hiddenLabel mesh__D009412 Mossy Fiber, Cerebellar
% 213.28/213.46  |- skos__broader mesh__D009412smesh__D009474
% 213.28/213.46  |- skos__prefLabel mesh__D009412 Nerve Fibers
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D009412 2005
% 213.28/213.46  |- skos__altLabel mesh__D009412 Mossy Fibers, Cerebellar
% 213.28/213.46  |- skos__hiddenLabel mesh__D042846 CDC28 Related Kinases
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D042846 2005
% 213.28/213.46  |- skos__hiddenLabel mesh__D042846 CDC2 CDC28 Kinases
% 213.28/213.46  |- mesh__recordAuthorizer mesh__D042846 ags
% 213.28/213.46  |- mesh__recordMaintainer mesh__D042846 ags
% 213.28/213.46  |- mesh__historyNote mesh__D042846
% 213.28/213.46       2004; for CDC2-RELATED KINASE use CDC2-CDC28 KINASES %28%NM%29% 2000-2004; for CDC2+-CDC28-RELATED PROTEIN KINASE use CDC2-CDC28 KINASES %28%NM%29% 1991-2003%A%  
% 213.28/213.46  |- mesh__dateRevised mesh__D042846 2005-07-12
% 213.28/213.46  |- skos__altLabel mesh__D042846 CDC2-Related Kinase
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D042846 2006A
% 213.28/213.46  |- skos__altLabel mesh__D042846 CDC2+-CDC28-related Protein Kinase
% 213.28/213.46  |- skos__scopeNote mesh__D042846
% 213.28/213.46       A family of cell cycle-dependent kinases that are related in structure to CDC28 PROTEIN KINASE; S CEREVISIAE; and the CDC2 PROTEIN KINASE found in mammalian species.%A%    
% 213.28/213.46  |- mesh__publicMeSHNote mesh__D042846
% 213.28/213.46       2004; CDC2-RELATED KINASE was indexed under CYCLIN-DEPENDENT KINASES 2000-2004; CDC2+-CDC28-RELATED PROTEIN KINASE was indexed under CDC28 PROTEIN KINASE 2003; PROTEIN-SERINE-THREONINE KINASES 1992-2002 %26% PROTEIN KINASES 1991-2003%A%  
% 213.28/213.46  |- skos__broader mesh__D042846smesh__D018844
% 213.28/213.46  |- mesh__dateCreated mesh__D042846 2003-07-09
% 213.28/213.46  |- skos__prefLabel mesh__D042846 CDC2-CDC28 Kinases
% 213.28/213.46  |- skos__historyNote mesh__D042846
% 213.28/213.46       Cyclin-Dependent Kinases %28%2000-2003%29%
% 213.28/213.46  |- rdf__type mesh__D042846sskos__Concept
% 213.28/213.46  |- mesh__recordOriginator mesh__D042846 jmp
% 213.28/213.46  |- skos__hiddenLabel mesh__D042846 CDC2+ CDC28 related Protein Kinase
% 213.28/213.46  |- skos__hiddenLabel mesh__D042846 CDC2 Related Kinase
% 213.28/213.46  |- mesh__dateEstablished mesh__D042846 2004-01-01
% 213.28/213.46  |- skos__annotation mesh__D042846 GEN; prefer specifics   
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D042846 2006
% 213.28/213.46  |- skos__hiddenLabel mesh__D042846 CDC2 Related Kinases
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D042846 2006B
% 213.28/213.46  |- skos__hiddenLabel mesh__D020394 Particle, Vault Ribonucleoprotein
% 213.28/213.46  |- skos__altLabel mesh__D020394 Ribonucleoprotein Particles, Vault
% 213.28/213.46  |- skos__broader mesh__D020394smesh__D012261
% 213.28/213.46  |- skos__hiddenLabel mesh__D020394 RNP Particles, Vault
% 213.28/213.46  |- skos__broader mesh__D020394smesh__D015388
% 213.28/213.46  |- skos__hiddenLabel mesh__D020394 Particles, Vault RNP
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D020394 2004
% 213.28/213.46  |- mesh__dateCreated mesh__D020394 1998-06-11
% 213.28/213.46  |- skos__hiddenLabel mesh__D020394 Particle, Vault RNP
% 213.28/213.46  |- mesh__dateRevised mesh__D020394 2003-07-09
% 213.28/213.46  |- skos__hiddenLabel mesh__D020394 Particles, Vault Ribonucleoprotein
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D020394 2005
% 213.28/213.46  |- mesh__dateEstablished mesh__D020394 1999-01-01
% 213.28/213.46  |- skos__prefLabel mesh__D020394 Vault Ribonucleoprotein Particles
% 213.28/213.46  |- skos__altLabel mesh__D020394 Vault RNP Particles
% 213.28/213.46  |- skos__hiddenLabel mesh__D020394 Vault RNP Particle
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D020394 2006
% 213.28/213.46  |- skos__historyNote mesh__D020394 Ribonucleoproteins %28%1986-1998%29%
% 213.28/213.46  |- skos__hiddenLabel mesh__D020394 RNP Particle, Vault
% 213.28/213.46  |- rdf__type mesh__D020394sskos__Concept
% 213.28/213.46  |- skos__hiddenLabel mesh__D020394 Vault Ribonucleoprotein Particle
% 213.28/213.46  |- skos__scopeNote mesh__D020394
% 213.28/213.46       Large cytoplasmic ribonucleoprotein particles that have an eight-fold symmetry with a central pore and petal-like structure giving the appearance of an octagonal dome. %28%The Dictionary of Cell Biology, Lackie and Dow, 2nd ed.%29%%A%    
% 213.28/213.46  |- skos__hiddenLabel mesh__D020394 Ribonucleoprotein Particle, Vault
% 213.28/213.46  |- mesh__publicMeSHNote mesh__D020394 99   
% 213.28/213.46  |- mesh__historyNote mesh__D020394 99   
% 213.28/213.46  |- skos__scopeNote mesh__D014357
% 213.28/213.46       A serine endopeptidase that is formed from TRYPSINOGEN in the pancreas. It is converted into its active form by ENTEROPEPTIDASE in the small intestine. It catalyzes hydrolysis of the carboxyl group of either arginine or lysine. EC 3.4.21.4.%A%    
% 213.28/213.46  |- skos__hiddenLabel mesh__D014357 beta Trypsin
% 213.28/213.46  |- rdf__type mesh__D014357sskos__Concept
% 213.28/213.46  |- skos__altLabel mesh__D014357 Tripcellim
% 213.28/213.46  |- skos__prefLabel mesh__D014357 Trypsin
% 213.28/213.46  |- mesh__dateCreated mesh__D014357 1999-01-01
% 213.28/213.46  |- skos__broader mesh__D014357smesh__D012697
% 213.28/213.46  |- mesh__dateRevised mesh__D014357 2003-07-09
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D014357 2005
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D014357 2004
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D014357 2006
% 213.28/213.46  |- mesh__recordAuthorizer mesh__D014357 sjn
% 213.28/213.46  |- mesh__recordOriginator mesh__D014357 NLM
% 213.28/213.46  |- mesh__recordMaintainer mesh__D014357 ssb
% 213.28/213.46  |- rdf__type mesh__D019840sskos__Concept
% 213.28/213.46  |- skos__prefLabel mesh__D019840 2-Propanol
% 213.28/213.46  |- mesh__dateCreated mesh__D019840 1997-06-20
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D019840 2003
% 213.28/213.46  |- skos__broader mesh__D019840smesh__D020005
% 213.28/213.46  |- mesh__recordMaintainer mesh__D019840 jmp
% 213.28/213.46  |- skos__scopeNote mesh__D019840
% 213.28/213.46       An isomer of 1-PROPANOL. It is a colorless liquid having disinfectant properties. It is used in the manufacture of acetone and its derivatives and as a solvent. Topically, it is used as an antiseptic.%A%    
% 213.28/213.46  |- mesh__recordAuthorizer mesh__D019840 sjn
% 213.28/213.46  |- skos__historyNote mesh__D019840 1-Propanol %28%1975-1997%29%
% 213.28/213.46  |- skos__hiddenLabel mesh__D019840 Alcohol, Isopropyl
% 213.28/213.46  |- mesh__dateRevised mesh__D019840 1999-11-03
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D019840 2001
% 213.28/213.46  |- mesh__dateEstablished mesh__D019840 1998-01-01
% 213.28/213.46  |- skos__altLabel mesh__D019840 Isopropanol
% 213.28/213.46  |- skos__altLabel mesh__D019840 Isopropyl Alcohol
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D019840 2000
% 213.28/213.46  |- skos__hiddenLabel mesh__D019840 Alcohol, Rubbing
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D019840 2006
% 213.28/213.46  |- skos__hiddenLabel mesh__D019840 2 Propanol
% 213.28/213.46  |- mesh__recordOriginator mesh__D019840 ADP
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D019840 2005
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D019840 2004
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D019840 2002
% 213.28/213.46  |- skos__altLabel mesh__D019840 Rubbing Alcohol
% 213.28/213.46  |- mesh__historyNote mesh__D019840 98   
% 213.28/213.46  |- mesh__publicMeSHNote mesh__D019840 98   
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D000337 2006
% 213.28/213.46  |- mesh__dateCreated mesh__D000337 1979-05-29
% 213.28/213.46  |- rdf__type mesh__D000337sskos__Concept
% 213.28/213.46  |- skos__related mesh__D000337smesh__D003665
% 213.28/213.46  |- skos__related mesh__D000337smesh__D000531
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D000337 2005
% 213.28/213.46  |- skos__related mesh__D000337smesh__D000060
% 213.28/213.46  |- mesh__onlineNote mesh__D000337
% 213.28/213.46       search SPACE FLIGHT 1975-79; use AEROSPACE MEDICINE to search AVIATION MEDICINE 1966-74; use AEROSPACE MEDICINE + DENTISTRY to search AVIATION DENTISTRY 1966-79%A%  
% 213.28/213.46  |- mesh__publicMeSHNote mesh__D000337
% 213.28/213.46       80; was see SPACE FLIGHT 1975-79; AVIATION MEDICINE was heading 1963-79; AVIATION DENTISTRY was heading 1965-79%A%  
% 213.28/213.46  |- mesh__recordOriginator mesh__D000337 EC
% 213.28/213.46  |- skos__scopeNote mesh__D000337
% 213.28/213.46       A specialty which is concerned with the health and medical problems of man in AVIATION %28%aviation medicine%29% and SPACE FLIGHT.%A%    
% 213.28/213.46  |- mesh__historyNote mesh__D000337
% 213.28/213.46       80; was see SPACE FLIGHT 1975-79; AVIATION MEDICINE was heading 1963-79; AVIATION DENTISTRY was heading 1965-79%A%  
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D000337 2004
% 213.28/213.46  |- mesh__recordAuthorizer mesh__D000337 sjn
% 213.28/213.46  |- skos__broader mesh__D000337smesh__D013040
% 213.28/213.46  |- skos__related mesh__D000337smesh__D013026
% 213.28/213.46  |- skos__annotation mesh__D000337
% 213.28/213.46       specialty; med, physiol or psychol aspects of AVIATION go here but med, physiol or psychol aspects of space flight go under SPACE FLIGHT or other space related terms: Manual 28.8; DF: AEROSPACE MED%A%  
% 213.28/213.46  |- skos__prefLabel mesh__D000337 Aerospace Medicine
% 213.28/213.46  |- skos__altLabel mesh__D000337 Medicine, Aviation
% 213.28/213.46  |- mesh__dateRevised mesh__D000337 2003-07-09
% 213.28/213.46  |- skos__altLabel mesh__D000337 Space Medicine
% 213.28/213.46  |- mesh__recordMaintainer mesh__D000337 nns
% 213.28/213.46  |- skos__altLabel mesh__D000337 Medicine, Aerospace
% 213.28/213.46  |- skos__historyNote mesh__D000337 Space Flight %28%1975-1979%29%
% 213.28/213.46  |- mesh__dateEstablished mesh__D000337 1980-01-01
% 213.28/213.46  |- skos__altLabel mesh__D019042 Muscle Cancer
% 213.28/213.46  |- mesh__recordMaintainer mesh__D019042 nns
% 213.28/213.46  |- mesh__publicMeSHNote mesh__D019042 96   
% 213.28/213.46  |- skos__hiddenLabel mesh__D019042 Muscle Neoplasm
% 213.28/213.46  |- skos__historyNote mesh__D019042 Soft Tissue Neoplasms %28%1969-1995%29%
% 213.28/213.46  |- skos__hiddenLabel mesh__D019042 Neoplasm, Muscle
% 213.28/213.46  |- skos__scopeNote mesh__D019042
% 213.28/213.46       Tumors or cancer located in muscle tissue or specific muscles. They are differentiated from NEOPLASMS, MUSCLE TISSUE which are neoplasms composed of skeletal, cardiac, or smooth muscle tissue, such as MYOSARCOMA or LEIOMYOMA.%A%    
% 213.28/213.46  |- skos__broader mesh__D019042smesh__D012983
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D019042 2002
% 213.28/213.46  |- mesh__recordOriginator mesh__D019042 TGC
% 213.28/213.46  |- mesh__historyNote mesh__D019042 96   
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D019042 2003
% 213.28/213.46  |- skos__prefLabel mesh__D019042 Muscle Neoplasms
% 213.28/213.46  |- skos__hiddenLabel mesh__D019042 Cancer, Muscle
% 213.28/213.46  |- skos__hiddenLabel mesh__D019042 Muscle Cancers
% 213.28/213.46  |- mesh__dateRevised mesh__D019042 1999-11-03
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D019042 2000
% 213.28/213.46  |- skos__broader mesh__D019042smesh__D009135
% 213.28/213.46  |- skos__annotation mesh__D019042
% 213.28/213.46       neopl located in muscles: do not confuse with NEOPLASMS, MUSCLE TISSUE, neopl composed of muscle tissue; coord IM with specific muscle %28%IM%29% + histol type of neopl %28%IM%29%; DF: MUSCLE NEOPL%A%  
% 213.28/213.46  |- skos__historyNote mesh__D019042
% 213.28/213.46       Neoplasms, Muscle Tissue %28%1966-1995%29%
% 213.28/213.46  |- skos__altLabel mesh__D019042 Neoplasms, Muscle
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D019042 2005
% 213.28/213.46  |- skos__altLabel mesh__D019042 Cancer of the Muscle
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D019042 2004
% 213.28/213.46  |- skos__hiddenLabel mesh__D019042 Cancers, Muscle
% 213.28/213.46  |- mesh__dateCreated mesh__D019042 1995-05-26
% 213.28/213.46  |- skos__historyNote mesh__D019042 Muscular Diseases %28%1975-1995%29%
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D019042 2001
% 213.28/213.46  |- mesh__recordAuthorizer mesh__D019042 sjn
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D019042 2006
% 213.28/213.46  |- mesh__dateEstablished mesh__D019042 1996-01-01
% 213.28/213.46  |- rdf__type mesh__D019042sskos__Concept
% 213.28/213.46  |- skos__scopeNote mesh__D005820
% 213.28/213.46       Searching a population or individuals for persons possessing certain genotypes or karyotypes that: %28%1%29% are already associated with disease or predispose to disease; %28%2%29% may lead to disease in their descendants; or %28%3%29% produce other variations not known to be associated with disease. Genetic screening may be directed toward identifying phenotypic expression of genetic traits. It includes prenatal genetic screening.%A%    
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D005820 2003
% 213.28/213.46  |- skos__broader mesh__D005820smesh__D033142
% 213.28/213.46  |- skos__related mesh__D005820smesh__D025202
% 213.28/213.46  |- skos__annotation mesh__D005820
% 213.28/213.46       human %26% animal; for phenotype or genotype; Manual 19.7+, 19.8.34, 22.25, 28.36.8; DF: GENET SCREENING%A%  
% 213.28/213.46  |- skos__historyNote mesh__D005820 Mass Screening %28%1968-1977%29%
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D005820 2006
% 213.28/213.46  |- mesh__dateEstablished mesh__D005820 1978-01-01
% 213.28/213.46  |- skos__hiddenLabel mesh__D005820 Screenings, Genetic
% 213.28/213.46  |- mesh__publicMeSHNote mesh__D005820 78   
% 213.28/213.46  |- mesh__recordAuthorizer mesh__D005820 sjn
% 213.28/213.46  |- skos__prefLabel mesh__D005820 Genetic Screening
% 213.28/213.46  |- skos__historyNote mesh__D005820 Genetic Counseling %28%1973-1977%29%
% 213.28/213.46  |- skos__historyNote mesh__D005820 Hereditary Diseases %28%1968-1977%29%
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D005820 2005
% 213.28/213.46  |- mesh__recordMaintainer mesh__D005820 jrf
% 213.28/213.46  |- skos__related mesh__D005820smesh__D006580
% 213.28/213.46  |- skos__related mesh__D005820smesh__D030661
% 213.28/213.46  |- skos__related mesh__D005820smesh__D020732
% 213.28/213.46  |- skos__related mesh__D005820smesh__D020022
% 213.28/213.46  |- skos__hiddenLabel mesh__D005820 Genetic Screenings
% 213.28/213.46  |- skos__broader mesh__D005820smesh__D008403
% 213.28/213.46  |- rdf__type mesh__D005820sskos__Concept
% 213.28/213.46  |- skos__altLabel mesh__D005820 Genetic Predisposition Testing
% 213.28/213.46  |- mesh__dateRevised mesh__D005820 2002-07-03
% 213.28/213.46  |- skos__altLabel mesh__D005820 Screening, Genetic
% 213.28/213.46  |- skos__related mesh__D005820smesh__D030541
% 213.28/213.46  |- mesh__recordOriginator mesh__D005820 SMH
% 213.28/213.46  |- skos__related mesh__D005820smesh__D011296
% 213.28/213.46  |- skos__historyNote mesh__D005820 Genetics, Population %28%1966-1977%29%
% 213.28/213.46  |- mesh__dateCreated mesh__D005820 1977-04-22
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D005820 2004
% 213.28/213.46  |- skos__related mesh__D005820smesh__D030561
% 213.28/213.46  |- mesh__historyNote mesh__D005820 78   
% 213.28/213.46  |- skos__hiddenLabel mesh__D005820 Predisposition Testing, Genetic
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D005022 2005
% 213.28/213.46  |- skos__historyNote mesh__D005022 Carbodiimides %28%1973-1974%29%
% 213.28/213.46  |- skos__historyNote mesh__D005022 Dimethylamines %28%1973-1974%29%
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D005022 2006
% 213.28/213.46  |- skos__altLabel mesh__D005022
% 213.28/213.46       1-Ethyl-3-%28%3-Dimethylaminopropyl%29%Carbodiimide
% 213.28/213.46  |- skos__altLabel mesh__D005022
% 213.28/213.46       3-%28%3-Dimethylaminopropyl%29%-1-Ethylcarbodiimide
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D005022 2001
% 213.28/213.46  |- mesh__recordOriginator mesh__D005022 NLM
% 213.28/213.46  |- mesh__historyNote mesh__D005022
% 213.28/213.46       91%28%75%29%; was see under CARBODIIMIDES 1975-90   
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D005022 2003
% 213.28/213.46  |- skos__scopeNote mesh__D005022 Carbodiimide cross-linking reagent.     
% 213.28/213.46  |- skos__altLabel mesh__D005022 EDAP-Carbodiimide
% 213.28/213.46  |- mesh__publicMeSHNote mesh__D005022
% 213.28/213.46       91; was see under CARBODIIMIDES 1975-90   
% 213.28/213.46  |- mesh__recordAuthorizer mesh__D005022 sjn
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D005022 2004
% 213.28/213.46  |- mesh__dateEstablished mesh__D005022 1991-01-01
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D005022 2002
% 213.28/213.46  |- skos__broader mesh__D005022smesh__D002234
% 213.28/213.46  |- rdf__type mesh__D005022sskos__Concept
% 213.28/213.46  |- skos__prefLabel mesh__D005022 Ethyldimethylaminopropyl Carbodiimide
% 213.28/213.46  |- mesh__recordMaintainer mesh__D005022 CCR
% 213.28/213.46  |- mesh__dateCreated mesh__D005022 1974-11-19
% 213.28/213.46  |- skos__hiddenLabel mesh__D005022 EDAP Carbodiimide
% 213.28/213.46  |- mesh__dateRevised mesh__D005022 2000-06-22
% 213.28/213.46  |- skos__hiddenLabel mesh__D005022 Carbodiimide, Ethyldimethylaminopropyl
% 213.28/213.46  |- skos__hiddenLabel mesh__D010765 Phosphorylase Phosphatase, Glycogen
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D010765 2006
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D010765 2004
% 213.28/213.46  |- skos__scopeNote mesh__D010765
% 213.28/213.46       An enzyme that deactivates glycogen phosphorylase a by releasing inorganic phosphate and phosphorylase b, the inactive form. EC 3.1.3.17.%A%    
% 213.28/213.46  |- mesh__recordMaintainer mesh__D010765 ssb
% 213.28/213.46  |- skos__prefLabel mesh__D010765 Phosphorylase Phosphatase
% 213.28/213.46  |- mesh__onlineNote mesh__D010765
% 213.28/213.46       use PHOSPHORYLASE PHOSPHATASE to search PR-ENZYME 1975-93%A%  
% 213.28/213.46  |- skos__historyNote mesh__D010765 Phosphatases %28%1973-1974%29%
% 213.28/213.46  |- skos__historyNote mesh__D010765 Glycogen Phosphorylase %28%1973-1974%29%
% 213.28/213.46  |- mesh__historyNote mesh__D010765
% 213.28/213.46       91%28%75%29%; was see under PHOSPHOPROTEIN PHOSPHATASES 1979-90; was see under PHOSPHOMONOESTERASES 1975-78; PR-ENZYME was see PHOSPHORYLASE PHOSPHATASE 1975-93%A%  
% 213.28/213.46  |- skos__hiddenLabel mesh__D010765 Phosphatase, Phosphorylase
% 213.28/213.46  |- skos__broader mesh__D010765smesh__D010749
% 213.28/213.46  |- skos__hiddenLabel mesh__D010765 Phosphatase, Glycogen Phosphorylase
% 213.28/213.46  |- rdf__type mesh__D010765sskos__Concept
% 213.28/213.46  |- mesh__dateRevised mesh__D010765 2003-07-09
% 213.28/213.46  |- mesh__recordAuthorizer mesh__D010765 sjn
% 213.28/213.46  |- mesh__publicMeSHNote mesh__D010765
% 213.28/213.46       91; was see under PHOSPHOPROTEIN PHOSPHATASES 1979-90; was see under PHOSPHOMONOESTERASES 1975-78; PR-ENZYME was see PHOSPHORYLASE PHOSPHATASE 1975-93%A%  
% 213.28/213.46  |- mesh__dateCreated mesh__D010765 1974-11-19
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D010765 2005
% 213.28/213.46  |- mesh__dateEstablished mesh__D010765 1991-01-01
% 213.28/213.46  |- mesh__recordOriginator mesh__D010765 NLM
% 213.28/213.46  |- mesh__dateCreated mesh__D004728 1987-05-08
% 213.28/213.46  |- skos__altLabel mesh__D004728 Corneal Endothelium
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D004728 2004
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D004728 1999
% 213.28/213.46  |- mesh__publicMeSHNote mesh__D004728 88   
% 213.28/213.46  |- skos__annotation mesh__D004728
% 213.28/213.46       do not confuse with EPITHELIUM, CORNEAL; do not confuse X ref ANTERIOR CHAMBER EPITHELIUM with ANTERIOR CORNEAL EPITHELIUM see EPITHELIUM, CORNEAL%A%  
% 213.28/213.46  |- skos__scopeNote mesh__D004728
% 213.28/213.46       Single layer of large flattened cells covering the surface of the cornea.%A%    
% 213.28/213.46  |- skos__broader mesh__D004728smesh__D004727
% 213.28/213.46  |- skos__broader mesh__D004728smesh__D000867
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D004728 2003
% 213.28/213.46  |- skos__broader mesh__D004728smesh__D003315
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D004728 1998
% 213.28/213.46  |- mesh__dateEstablished mesh__D004728 1988-01-01
% 213.28/213.46  |- skos__historyNote mesh__D004728 Epithelium %28%1966-1987%29%
% 213.28/213.46  |- skos__altLabel mesh__D004728 Epithelium, Anterior Chamber
% 213.28/213.46  |- mesh__recordMaintainer mesh__D004728 TGC
% 213.28/213.46  |- mesh__historyNote mesh__D004728 88   
% 213.28/213.46  |- mesh__recordAuthorizer mesh__D004728 SJN
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D004728 2002
% 213.28/213.46  |- mesh__recordOriginator mesh__D004728 SCD
% 213.28/213.46  |- skos__historyNote mesh__D004728 Cornea %28%1966-1987%29%
% 213.28/213.46  |- skos__historyNote mesh__D004728 Endothelium %28%1973-1987%29%
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D004728 2006
% 213.28/213.46  |- mesh__dateRevised mesh__D004728 1997-06-20
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D004728 2001
% 213.28/213.46  |- rdf__type mesh__D004728sskos__Concept
% 213.28/213.46  |- skos__hiddenLabel mesh__D004728 Anterior Chamber Endothelium
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D004728 2000
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D004728 2005
% 213.28/213.46  |- skos__prefLabel mesh__D004728 Endothelium, Corneal
% 213.28/213.46  |- skos__hiddenLabel mesh__D015450 Burkitts Leukemia
% 213.28/213.46  |- skos__hiddenLabel mesh__D015450 Acute B-Lymphocytic Leukemia
% 213.28/213.46  |- skos__hiddenLabel mesh__D015450 B Lymphocytic Leukemia, Acute
% 213.28/213.46  |- skos__hiddenLabel mesh__D015450 Leukemia, Acute B-Lymphocytic
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D015450 2000
% 213.28/213.46  |- skos__altLabel mesh__D015450 B-Cell Leukemia, Acute
% 213.28/213.46  |- mesh__recordMaintainer mesh__D015450 PXP
% 213.28/213.46  |- skos__hiddenLabel mesh__D015450 L3 Lymphocytic Leukemia
% 213.28/213.46  |- skos__altLabel mesh__D015450 Lymphocytic Leukemia, B-Cell, Acute
% 213.28/213.46  |- mesh__recordOriginator mesh__D015450 PLS
% 213.28/213.46  |- mesh__publicMeSHNote mesh__D015450
% 213.28/213.46       89; BURKITT LEUKEMIA was BURKITT%27%S LEUKEMIA 1989-97   
% 213.28/213.46  |- skos__altLabel mesh__D015450 Leukemia, Lymphocytic, L3
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D015450 2004
% 213.28/213.46  |- skos__broader mesh__D015450smesh__D015447
% 213.28/213.46  |- skos__altLabel mesh__D015450 Leukemia, Lymphocytic, Acute, B Cell
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D015450 1999
% 213.28/213.46  |- skos__altLabel mesh__D015450 B-ALL
% 213.28/213.46  |- skos__historyNote mesh__D015450 Leukemia, Lymphocytic %28%1977-1988%29%
% 213.28/213.46  |- skos__altLabel mesh__D015450 Burkitt%27%s Leukemia
% 213.28/213.46  |- skos__prefLabel mesh__D015450 Leukemia, B-Cell, Acute
% 213.28/213.46  |- skos__hiddenLabel mesh__D015450 B-Cell Leukemias, Acute
% 213.28/213.46  |- skos__altLabel mesh__D015450 Leukemia, Lymphoblastic, Burkitt-Type
% 213.28/213.46  |- skos__broader mesh__D015450smesh__D015448
% 213.28/213.46  |- skos__historyNote mesh__D015450 B Lymphocytes %28%1977-1988%29%
% 213.28/213.46  |- mesh__recordAuthorizer mesh__D015450 SJN
% 213.28/213.46  |- mesh__dateRevised mesh__D015450 1997-06-20
% 213.28/213.46  |- skos__hiddenLabel mesh__D015450 Leukemia, L3 Lymphocytic
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D015450 2003
% 213.28/213.46  |- skos__hiddenLabel mesh__D015450 Leukemia, Burkitt
% 213.28/213.46  |- skos__altLabel mesh__D015450 Burkitt Leukemia
% 213.28/213.46  |- skos__hiddenLabel mesh__D015450 Leukemia, Burkitt%27%s
% 213.28/213.46  |- skos__hiddenLabel mesh__D015450 L3 Lymphocytic Leukemias
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D015450 2006
% 213.28/213.46  |- skos__historyNote mesh__D015450
% 213.28/213.46       Leukemia, Lymphoblastic %28%1977-1988%29%
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D015450 1998
% 213.28/213.46  |- skos__altLabel mesh__D015450 Leukemia, Lymphocytic, Acute, B-Cell
% 213.28/213.46  |- skos__altLabel mesh__D015450 Lymphocytic Leukemia, B Cell, Acute
% 213.28/213.46  |- skos__hiddenLabel mesh__D015450 Acute B-Lymphocytic Leukemias
% 213.28/213.46  |- skos__hiddenLabel mesh__D015450 Acute B-Cell Leukemia
% 213.28/213.46  |- skos__hiddenLabel mesh__D015450 B-Lymphocytic Leukemias, Acute
% 213.28/213.46  |- mesh__historyNote mesh__D015450
% 213.28/213.46       89; BURKITT LEUKEMIA was BURKITT%27%S LEUKEMIA 1989-97   
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D015450 2002
% 213.28/213.46  |- skos__hiddenLabel mesh__D015450 B Cell Leukemia, Acute
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D015450 2005
% 213.28/213.46  |- mesh__dateCreated mesh__D015450 1988-06-09
% 213.28/213.46  |- skos__hiddenLabel mesh__D015450 Leukemias, L3 Lymphocytic
% 213.28/213.46  |- skos__hiddenLabel mesh__D015450 Leukemias, Acute B-Cell
% 213.28/213.46  |- rdf__type mesh__D015450sskos__Concept
% 213.28/213.46  |- skos__annotation mesh__D015450
% 213.28/213.46       do not use /blood supply /chem /second /secret /ultrastruct; DF: note short X ref B-ALL%A%  
% 213.28/213.46  |- skos__altLabel mesh__D015450 Lymphocytic Leukemia, L3
% 213.28/213.46  |- skos__hiddenLabel mesh__D015450 Leukemia, Acute B-Cell
% 213.28/213.46  |- skos__altLabel mesh__D015450 B-Lymphocytic Leukemia, Acute
% 213.28/213.46  |- skos__hiddenLabel mesh__D015450 Lymphocytic Leukemias, L3
% 213.28/213.46  |- skos__hiddenLabel mesh__D015450 Acute B-Cell Leukemias
% 213.28/213.46  |- mesh__dateEstablished mesh__D015450 1989-01-01
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D015450 2001
% 213.28/213.46  |- skos__hiddenLabel mesh__D015450 Leukemias, Acute B-Lymphocytic
% 213.28/213.46  |- mesh__publicMeSHNote mesh__D009413
% 213.28/213.46       1974; for B FIBERS see AUTONOMIC FIBERS, PREGANGLIONIC 1976-2002%A%  
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D009413 2003
% 213.28/213.46  |- mesh__historyNote mesh__D009413
% 213.28/213.46       1974 %28%1972%29%; for B FIBERS use AUTONOMIC FIBERS, PREGANGLIONIC 1976-2002%A%  
% 213.28/213.46  |- skos__hiddenLabel mesh__D009413 Fibers, B
% 213.28/213.46  |- skos__hiddenLabel mesh__D009413 B Fiber
% 213.28/213.46  |- skos__hiddenLabel mesh__D009413 Fiber, Myelinated Nerve
% 213.28/213.46  |- skos__broader mesh__D009413smesh__D009412
% 213.28/213.46  |- rdf__type mesh__D009413sskos__Concept
% 213.28/213.46  |- mesh__recordMaintainer mesh__D009413 lkt
% 213.28/213.46  |- skos__hiddenLabel mesh__D009413 Fibers, Myelinated Nerve
% 213.28/213.46  |- mesh__dateRevised mesh__D009413 2002-07-02
% 213.28/213.46  |- skos__hiddenLabel mesh__D009413 A Fiber
% 213.28/213.46  |- mesh__dateEstablished mesh__D009413 1974-01-01
% 213.28/213.46  |- skos__hiddenLabel mesh__D009413 Nerve Fiber, Myelinated
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D009413 2006
% 213.28/213.46  |- skos__hiddenLabel mesh__D009413 Myelinated Nerve Fibers
% 213.28/213.46  |- skos__prefLabel mesh__D009413 Nerve Fibers, Myelinated
% 213.28/213.46  |- skos__hiddenLabel mesh__D009413 Fiber, A
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D009413 2005
% 213.28/213.46  |- mesh__dateCreated mesh__D009413 1999-01-01
% 213.28/213.46  |- mesh__recordOriginator mesh__D009413 NLM
% 213.28/213.46  |- skos__scopeNote mesh__D009413
% 213.28/213.46       A class of nerve fibers as defined by their structure, specifically the nerve sheath arrangement. The AXONS of the myelinated nerve fibers are completely encased in a MYELIN SHEATH. They are fibers of relatively large and varied diameters. Their NEURAL CONDUCTION rates are faster than those of the unmyelinated nerve fibers %28%NERVE FIBERS, UNMYELINATED%29%. Myelinated nerve fibers are present in somatic and autonomic nerves.%A%    
% 213.28/213.46  |- skos__hiddenLabel mesh__D009413 Fiber, B
% 213.28/213.46  |- mesh__recordAuthorizer mesh__D009413 sjn
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D009413 2004
% 213.28/213.46  |- skos__broader mesh__D009413smesh__D009474
% 213.28/213.46  |- skos__historyNote mesh__D009413 Neurons %28%1966-1971%29%
% 213.28/213.46  |- skos__hiddenLabel mesh__D009413 Fibers, A
% 213.28/213.46  |- skos__hiddenLabel mesh__D009413 Myelinated Nerve Fiber
% 213.28/213.46  |- mesh__recordAuthorizer mesh__D001430 sjn
% 213.28/213.46  |- mesh__recordMaintainer mesh__D001430 ssb
% 213.28/213.46  |- mesh__activeMeSHYear mesh__D001430 2006
% 213.28/213.46  |- skos__prefLabel mesh__D001430 Bacteriocins
% 213.28/213.46  |- mesh__dateRevised mesh__D001430 2005-06-30
% 213.28/213.46  |- mesh__dateCreated mesh__D001430 1999-01-01
% 213.28/213.46  |- mesh__recordOriginator mesh__D001430 NLM
% 213.28/213.46  |- skos__scopeNote mesh__D001430
% 213.28/213.46       Substances elaborated by specific strains of bacteria that are lethal against other strains of the same or related species. They are protein or lipopolysaccharide-protein complexes used in taxonomy studies of bacteria.%A%    
% 213.28/213.46  |- mesh__historyNote mesh__D001430 68%28%65%29%   
% 213.28/213.46  |- rdf__type mesh__D001430sskos__Concept
% 213.28/213.46  |- mesh__dateEstablished mesh__D001430 1968-01-01
% 213.28/213.46  |- skos__broader mesh__D001430smesh__D001426
% 213.28/213.46  |- skos__hiddenLabel mesh__D020395 Receptor, IL-7
% 213.28/213.46  |- skos__prefLabel mesh__D020395 Receptors, Interleukin-7
% 213.28/213.47  |- skos__hiddenLabel mesh__D020395 Interleukin 7 Receptors
% 213.28/213.47  |- skos__historyNote mesh__D020395 Receptors, Interleukin %28%1994-1998%29%
% 213.28/213.47  |- skos__broader mesh__D020395smesh__D015703
% 213.28/213.47  |- mesh__publicMeSHNote mesh__D020395
% 213.28/213.47       99; INTERLEUKIN 7 RECEPTOR %28%now RECEPTORS, INTERLEUKIN-7%29% was indexed under RECEPTORS, INTERLEUKIN 1994-98, ANTIGENS, CD 1991-98, %26% RECEPTORS, IMMUNOLOGIC 1990-93%A%  
% 213.28/213.47  |- skos__hiddenLabel mesh__D020395 Receptors, IL 7
% 213.28/213.47  |- skos__altLabel mesh__D020395 IL7 Receptors
% 213.28/213.47  |- mesh__dateEstablished mesh__D020395 1999-01-01
% 213.28/213.47  |- skos__historyNote mesh__D020395 Antigens, CD %28%1991-1998%29%
% 213.28/213.47  |- skos__broader mesh__D020395smesh__D018123
% 213.28/213.47  |- skos__altLabel mesh__D020395 CD127 Antigens
% 213.28/213.47  |- skos__hiddenLabel mesh__D020395 Receptor, Interleukin 7
% 213.28/213.47  |- mesh__dateCreated mesh__D020395 1998-06-11
% 213.28/213.47  |- skos__altLabel mesh__D020395 Interleukin 7 Receptor
% 213.28/213.47  |- skos__altLabel mesh__D020395 Antigens, CD127
% 213.28/213.47  |- mesh__historyNote mesh__D020395
% 213.28/213.47       99; use RECEPTORS, INTERLEUKIN-7 %28%NM%29% 1990-98   
% 213.28/213.47  |- skos__altLabel mesh__D020395 Receptors, IL-7
% 213.28/213.47  |- mesh__recordMaintainer mesh__D020395 ssb
% 213.28/213.47  |- skos__hiddenLabel mesh__D020395 IL 7 Receptors
% 213.28/213.47  |- mesh__dateRevised mesh__D020395 2005-06-30
% 213.28/213.47  |- mesh__recordAuthorizer mesh__D020395 sjn
% 213.28/213.47  |- skos__hiddenLabel mesh__D020395 Receptors, Interleukin 7
% 213.28/213.47  |- skos__altLabel mesh__D020395 IL7 Receptor
% 213.28/213.47  |- skos__altLabel mesh__D020395 IL-7 Receptors
% 213.28/213.47  |- skos__historyNote mesh__D020395 Receptors, Immunologic %28%1990-1993%29%
% 213.28/213.47  |- skos__hiddenLabel mesh__D020395 Receptors, IL7
% 213.28/213.47  |- mesh__recordOriginator mesh__D020395 AGS
% 213.28/213.47  |- skos__scopeNote mesh__D020395
% 213.28/213.47       Receptors present on T cells and B cell precursors but not mature B cells. The receptor is a strongly glycosylated protein of 76 kD.%A%    
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D020395 2006
% 213.28/213.47  |- rdf__type mesh__D020395sskos__Concept
% 213.28/213.47  |- skos__hiddenLabel mesh__D020395 IL 7 Receptor
% 213.28/213.47  |- skos__altLabel mesh__D020395 Interleukin-7 Receptors
% 213.28/213.47  |- skos__altLabel mesh__D020395 IL-7 Receptor
% 213.28/213.47  |- skos__altLabel mesh__D014358 Trypsin Inhibitor, Bowman Birk Soybean
% 213.28/213.47  |- skos__prefLabel mesh__D014358 Trypsin Inhibitor, Bowman-Birk Soybean
% 213.28/213.47  |- mesh__recordMaintainer mesh__D014358 SYSTEM
% 213.28/213.47  |- skos__hiddenLabel mesh__D014358 Bowman Birk Soybean Trypsin Inhibitor
% 213.28/213.47  |- mesh__recordAuthorizer mesh__D014358 sjn
% 213.28/213.47  |- skos__historyNote mesh__D014358 Soy Beans %28%1972-1974%29%
% 213.28/213.47  |- mesh__dateCreated mesh__D014358 1974-11-19
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D014358 2006
% 213.28/213.47  |- mesh__recordOriginator mesh__D014358 NLM
% 213.28/213.47  |- mesh__historyNote mesh__D014358
% 213.28/213.47       91%28%75%29%; was see under TRYPSIN INHIBITORS 1975-90   
% 213.28/213.47  |- mesh__dateEstablished mesh__D014358 1991-01-01
% 213.28/213.47  |- skos__broader mesh__D014358smesh__D030262
% 213.28/213.47  |- skos__scopeNote mesh__D014358
% 213.28/213.47       A low-molecular-weight protein %28%minimum molecular weight 8000%29% which has the ability to inhibit trypsin as well as chymotrypsin at independent binding sites. It is characterized by a high cystine content and the absence of glycine.%A%    
% 213.28/213.47  |- skos__altLabel mesh__D014358 Bowman-Birk Soybean Trypsin Inhibitor
% 213.28/213.47  |- mesh__publicMeSHNote mesh__D014358
% 213.28/213.47       91; was see under TRYPSIN INHIBITORS 1975-90   
% 213.28/213.47  |- skos__annotation mesh__D014358
% 213.28/213.47       /drug eff /ultrastruct permitted; DF: TRYPSIN INHIB BOWMAN%A%  
% 213.28/213.47  |- skos__historyNote mesh__D014358 Plant Proteins %28%1972-1974%29%
% 213.28/213.47  |- rdf__type mesh__D014358sskos__Concept
% 213.28/213.47  |- mesh__dateRevised mesh__D014358 2005-06-30
% 213.28/213.47  |- rdf__type mesh__D019841sskos__Concept
% 213.28/213.47  |- mesh__dateCreated mesh__D019841 1997-06-20
% 213.28/213.47  |- mesh__recordOriginator mesh__D019841 TGC
% 213.28/213.47  |- skos__hiddenLabel mesh__D019841 Defecographies
% 213.28/213.47  |- mesh__publicMeSHNote mesh__D019841 98   
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D019841 2005
% 213.28/213.47  |- skos__historyNote mesh__D019841 Fecal Incontinence %28%1978-1997%29%
% 213.28/213.47  |- skos__scopeNote mesh__D019841
% 213.28/213.47       Radiographic examination of the process of defecation after the instillation of a CONTRAST MEDIA into the rectum.%A%    
% 213.28/213.47  |- mesh__recordMaintainer mesh__D019841 KEV
% 213.28/213.47  |- mesh__recordAuthorizer mesh__D019841 sjn
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D019841 2000
% 213.28/213.47  |- skos__prefLabel mesh__D019841 Defecography
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D019841 2003
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D019841 2006
% 213.28/213.47  |- skos__historyNote mesh__D019841
% 213.28/213.47       Barium Sulfate/diagnostic use %28%1981-1997%29%
% 213.28/213.47  |- mesh__dateEstablished mesh__D019841 1998-01-01
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D019841 2001
% 213.28/213.47  |- skos__historyNote mesh__D019841 Defecation %28%1978-1997%29%
% 213.28/213.47  |- mesh__dateRevised mesh__D019841 1999-11-03
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D019841 2004
% 213.28/213.47  |- skos__broader mesh__D019841smesh__D011860
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D019841 2002
% 213.28/213.47  |- mesh__historyNote mesh__D019841 98   
% 213.28/213.47  |- skos__annotation mesh__D019841 DF: DEFECOGR   
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D019043 1996
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D019043 2000
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D019043 2003
% 213.28/213.47  |- mesh__dateEstablished mesh__D019043 1996-01-01
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D019043 1998
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D019043 1997
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D019043 2001
% 213.28/213.47  |- skos__hiddenLabel mesh__D019043 Vascular Neoplasm
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D019043 2005
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D019043 2004
% 213.28/213.47  |- mesh__dateCreated mesh__D019043 1995-05-26
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D019043 1999
% 213.28/213.47  |- skos__prefLabel mesh__D019043 Vascular Neoplasms
% 213.28/213.47  |- skos__historyNote mesh__D019043 Soft Tissue Neoplasms %28%1976-1995%29%
% 213.28/213.47  |- skos__hiddenLabel mesh__D019043 Neoplasm, Vascular
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D019043 2006
% 213.28/213.47  |- mesh__publicMeSHNote mesh__D019043 96   
% 213.28/213.47  |- rdf__type mesh__D019043sskos__Concept
% 213.28/213.47  |- skos__historyNote mesh__D019043 Vascular Diseases %28%1968-1995%29%
% 213.28/213.47  |- skos__altLabel mesh__D019043 Neoplasms, Vascular
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D019043 2002
% 213.28/213.47  |- skos__broader mesh__D019043smesh__D014652
% 213.28/213.47  |- skos__annotation mesh__D019043
% 213.28/213.47       neopl located in veins %26% arteries: do not confuse with NEOPLASMS, VASCULAR TISSUE, neopl composed of vascular tissue; /blood supply /chem /secret /second /ultrastruct permitted; coord IM with specific vessel %28%IM%29% + histol type of neopl %28%IM%29%; DF: VASCULAR NEOPL%A%  
% 213.28/213.47  |- skos__broader mesh__D019043smesh__D012983
% 213.28/213.47  |- skos__scopeNote mesh__D019043
% 213.28/213.47       Neoplasms located in vascular tissue or specific veins. They are differentiated from NEOPLASMS, VASCULAR TISSUE which are neoplasms composed of vascular tissue, such as ANGIOFIBROMA or HEMANGIOMA.%A%    
% 213.28/213.47  |- mesh__historyNote mesh__D019043 96   
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338
% 213.28/213.47       beta Aminoethylisothiuronium Dihydrochloride
% 213.28/213.47  |- skos__altLabel mesh__D000338 2-Aminoethylisothiuronium Diperchlorate
% 213.28/213.47  |- mesh__recordAuthorizer mesh__D000338 sjn
% 213.28/213.47  |- skos__prefLabel mesh__D000338 beta-Aminoethyl Isothiourea
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D000338 2003
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D000338 2002
% 213.28/213.47  |- mesh__recordMaintainer mesh__D000338 CCR
% 213.28/213.47  |- mesh__dateCreated mesh__D000338 1999-01-01
% 213.28/213.47  |- mesh__publicMeSHNote mesh__D000338
% 213.28/213.47       2001; see AET 1967-2000; for S-%28%2-AMINOETHYL%29%ISOTHIOTHIOUREA see ISOTHIUREA, %28%BETA-AMINOETHYL%29% 1997-2000%A%  
% 213.28/213.47  |- skos__altLabel mesh__D000338
% 213.28/213.47       Aminoethylisothiuronium Bromide Hydrobromide
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338
% 213.28/213.47       Dihydrochloride, 2-Aminoethylisothiuronium
% 213.28/213.47  |- mesh__historyNote mesh__D000338
% 213.28/213.47       2001%28%1967%29%; for S-%28%2-AMINOETHYL%29%ISOTHIOTHIOUREA use ISOTHIUREA, %28%BETA-AMINOETHYL%29% %28%NM%29% 1997-2000%A%  
% 213.28/213.47  |- skos__altLabel mesh__D000338
% 213.28/213.47       2-Aminoethylisothiuronium Sulfate %28%1:1%29%
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338
% 213.28/213.47       Dihydrochloride, beta-Aminoethylisothiuronium
% 213.28/213.47  |- skos__altLabel mesh__D000338
% 213.28/213.47       Carbamimidothioic acid, 2-aminoethyl ester, dihydrobromide
% 213.28/213.47  |- skos__altLabel mesh__D000338 2-Aminoethylisothiuronium Monohydrobromide
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338 2 Aminoethylisothiuronium Dihydroiodide
% 213.28/213.47  |- skos__altLabel mesh__D000338 2-Aminoethylisothiuronium Dihydroiodide
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D000338 2006
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338 beta Aminoethyl Isothiourea
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338
% 213.28/213.47       Monohydrobromide, 2-Aminoethylisothiuronium
% 213.28/213.47  |- skos__altLabel mesh__D000338 2-Aminoethylisothiuronium Diacetate
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338 Diacetate, 2-Aminoethylisothiuronium
% 213.28/213.47  |- skos__altLabel mesh__D000338 Isothiourea, %28%2-Aminoethyl%29%
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338 Isothiourea, beta-Aminoethyl
% 213.28/213.47  |- mesh__dateRevised mesh__D000338 2000-06-21
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338
% 213.28/213.47       beta Aminoethylisothiuronium Dihydrobromide
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338
% 213.28/213.47       Hydrobromide, Aminoethylisothiuronium Bromide
% 213.28/213.47  |- skos__altLabel mesh__D000338 AET
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338 Diacetate, beta-Aminoethylisothiuronium
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D000338 2001
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338
% 213.28/213.47       Dihydrobromide, beta-Aminoethylisothiuronium
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D000338 2005
% 213.28/213.47  |- mesh__recordOriginator mesh__D000338 NLM
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338 Dihydroiodide, 2-Aminoethylisothiuronium
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338
% 213.28/213.47       2 Aminoethylisothiuronium Monohydrobromide
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338 beta Aminoethylisothiuronium Diacetate
% 213.28/213.47  |- skos__altLabel mesh__D000338 2-Aminoethylisothiuronium Bromide
% 213.28/213.47  |- skos__altLabel mesh__D000338 S-%28%2-Aminoethyl%29%isothiourea
% 213.28/213.47  |- skos__altLabel mesh__D000338 2-Aminoethylisothiuronium Dihydrochloride
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338
% 213.28/213.47       Monohydrobromide, beta-Aminoethylisothiuronium
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338 2 Aminoethylisothiuronium Bromide
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338 Bromide, beta-Aminoethylisothiuronium
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338 2 Aminoethylisothiuronium Diacetate
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338
% 213.28/213.47       beta Aminoethylisothiuronium Monohydrobromide
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338 2 Aminoethylisothiuronium Diperchlorate
% 213.28/213.47  |- skos__scopeNote mesh__D000338
% 213.28/213.47       A radiation-protective agent that can inhibit DNA damage by binding to the DNA. It also increases the susceptibility of blood cells to complement-mediated lysis.%A%    
% 213.28/213.47  |- skos__broader mesh__D000338smesh__D013890
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338 beta Aminoethylisothiuronium Bromide
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338 Bromide, 2-Aminoethylisothiuronium
% 213.28/213.47  |- skos__altLabel mesh__D000338 beta-Aminoethylisothiuronium Bromide
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D000338 2004
% 213.28/213.47  |- skos__altLabel mesh__D000338
% 213.28/213.47       2-Aminoethylisothiuronium Phosphate %28%1:1%29%
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338
% 213.28/213.47       beta Aminoethylisothiuronium Dihydroiodide
% 213.28/213.47  |- rdf__type mesh__D000338sskos__Concept
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338
% 213.28/213.47       Dihydroiodide, beta-Aminoethylisothiuronium
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338 Diperchlorate, 2-Aminoethylisothiuronium
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338
% 213.28/213.47       2 Aminoethylisothiuronium Dihydrochloride
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338
% 213.28/213.47       Diperchlorate, beta-Aminoethylisothiuronium
% 213.28/213.47  |- skos__hiddenLabel mesh__D000338
% 213.28/213.47       beta Aminoethylisothiuronium Diperchlorate
% 213.28/213.47  |- skos__hiddenLabel mesh__D011060 SK%26%F18667
% 213.28/213.47  |- mesh__historyNote mesh__D011060
% 213.28/213.47       91%28%75%29%; was see under POLYETHYLENE GLYCOLS 1975-90   
% 213.28/213.47  |- mesh__dateCreated mesh__D011060 1974-11-19
% 213.28/213.47  |- skos__altLabel mesh__D011060 Oxyethylene Oxypropylene Polymer
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D011060 2005
% 213.28/213.47  |- mesh__publicMeSHNote mesh__D011060
% 213.28/213.47       91; was see under POLYETHYLENE GLYCOLS 1975-90   
% 213.28/213.47  |- skos__altLabel mesh__D011060
% 213.28/213.47       Polyoxyethylene Polyoxypropylene Polyoxyethylene Polymer
% 213.28/213.47  |- mesh__dateRevised mesh__D011060 2004-07-07
% 213.28/213.47  |- mesh__recordAuthorizer mesh__D011060 sjn
% 213.28/213.47  |- mesh__dateEstablished mesh__D011060 1991-01-01
% 213.28/213.47  |- mesh__recordOriginator mesh__D011060 NLM
% 213.28/213.47  |- skos__scopeNote mesh__D011060
% 213.28/213.47       A copolymer of polyethylene and polypropylene ether glycol. It is a non-ionic polyol surface-active agent used medically as a fecal softener and in cattle for prevention of bloat.%A%    
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D011060 2006
% 213.28/213.47  |- skos__broader mesh__D011060smesh__D011092
% 213.28/213.47  |- skos__historyNote mesh__D011060 Polyethylene Glycols %28%1974%29%
% 213.28/213.47  |- skos__hiddenLabel mesh__D011060 SK%26%F 18667
% 213.28/213.47  |- skos__hiddenLabel mesh__D011060 Oxypropylene Polymer, Oxyethylene
% 213.28/213.47  |- skos__prefLabel mesh__D011060 Poloxalene
% 213.28/213.47  |- rdf__type mesh__D011060sskos__Concept
% 213.28/213.47  |- skos__hiddenLabel mesh__D011060 Polymer, Oxyethylene Oxypropylene
% 213.28/213.47  |- mesh__recordMaintainer mesh__D011060 jmp
% 213.28/213.47  |- mesh__recordMaintainer mesh__D005821 NLM
% 213.28/213.47  |- skos__related mesh__D005821smesh__D018244
% 213.28/213.47  |- mesh__recordAuthorizer mesh__D005821 NLM
% 213.28/213.47  |- mesh__publicMeSHNote mesh__D005821 91; was GENETIC TECHNICS 1973-90   
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D005821 2005
% 213.28/213.47  |- skos__annotation mesh__D005821
% 213.28/213.47       do not use /util except by MeSH definition   
% 213.28/213.47  |- skos__altLabel mesh__D005821 Techniques, Genetic
% 213.28/213.47  |- mesh__recordOriginator mesh__D005821 NLM
% 213.28/213.47  |- rdf__type mesh__D005821sskos__Concept
% 213.28/213.47  |- mesh__historyNote mesh__D005821 91; was GENETIC TECHNICS 1973-90   
% 213.28/213.47  |- skos__altLabel mesh__D005821 Genetic Technic
% 213.28/213.47  |- skos__prefLabel mesh__D005821 Genetic Techniques
% 213.28/213.47  |- skos__altLabel mesh__D005821 Technique, Genetic
% 213.28/213.47  |- skos__scopeNote mesh__D005821
% 213.28/213.47       Chromosomal, biochemical, intracellular, and other methods used in the study of genetics.%A%    
% 213.28/213.47  |- skos__altLabel mesh__D005821 Technic, Genetic
% 213.28/213.47  |- mesh__onlineNote mesh__D005821
% 213.28/213.47       use GENETIC TECHNIQUES to search GENETIC TECHNICS 1973-90%A%  
% 213.28/213.47  |- skos__altLabel mesh__D005821 Genetic Technique
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D005821 2004
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D005821 2002
% 213.28/213.47  |- mesh__dateCreated mesh__D005821 1999-01-01
% 213.28/213.47  |- mesh__dateRevised mesh__D005821 2001-08-14
% 213.28/213.47  |- mesh__dateEstablished mesh__D005821 1973-01-01
% 213.28/213.47  |- skos__broader mesh__D005821smesh__D008919
% 213.28/213.47  |- skos__altLabel mesh__D005821 Genetic Technics
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D005821 2003
% 213.28/213.47  |- skos__altLabel mesh__D005821 Technics, Genetic
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D005821 2006
% 213.28/213.47  |- mesh__recordMaintainer mesh__D005023 CCR
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D005023 2003
% 213.28/213.47  |- skos__broader mesh__D005023smesh__D000431
% 213.28/213.47  |- skos__prefLabel mesh__D005023 Ethylene Chlorohydrin
% 213.28/213.47  |- skos__broader mesh__D005023smesh__D002728
% 213.28/213.47  |- mesh__publicMeSHNote mesh__D005023
% 213.28/213.47       91; was see under CHLOROHYDRINS 1975-90   
% 213.28/213.47  |- skos__historyNote mesh__D005023 Alcohol, Ethyl %28%1969-1974%29%
% 213.28/213.47  |- skos__altLabel mesh__D005023 2-Chloroethyl Alcohol
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D005023 2004
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D005023 2001
% 213.28/213.47  |- skos__hiddenLabel mesh__D005023 2 Chloroethyl Alcohol
% 213.28/213.47  |- mesh__dateEstablished mesh__D005023 1991-01-01
% 213.28/213.47  |- mesh__recordOriginator mesh__D005023 NLM
% 213.28/213.47  |- rdf__type mesh__D005023sskos__Concept
% 213.28/213.47  |- skos__altLabel mesh__D005023 2-Chlorethanol
% 213.28/213.47  |- mesh__recordAuthorizer mesh__D005023 sjn
% 213.28/213.47  |- skos__scopeNote mesh__D005023
% 213.28/213.47       Used as a solvent, in the manufacture of insecticides, and for treating sweet potatoes before planting. May cause nausea, vomiting, pains in head and chest, stupefaction. Irritates mucous membranes and causes kidney and liver degeneration.%A%    
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D005023 2005
% 213.28/213.47  |- skos__altLabel mesh__D005023 Ethylenechlorhydrin
% 213.28/213.47  |- mesh__dateRevised mesh__D005023 2000-06-21
% 213.28/213.47  |- mesh__historyNote mesh__D005023
% 213.28/213.47       91%28%75%29%; was see under CHLOROHYDRINS 1975-90   
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D005023 2002
% 213.28/213.47  |- skos__hiddenLabel mesh__D005023 2 Chlorethanol
% 213.28/213.47  |- mesh__dateCreated mesh__D005023 1974-11-19
% 213.28/213.47  |- skos__hiddenLabel mesh__D005023 Chlorohydrin, Ethylene
% 213.28/213.47  |- skos__hiddenLabel mesh__D005023 Alcohol, 2-Chloroethyl
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D005023 2006
% 213.28/213.47  |- skos__historyNote mesh__D005023 Chlorine %28%1971-1974%29%
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D018749 1998
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D018749 1997
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D018749 2003
% 213.28/213.47  |- mesh__dateCreated mesh__D018749 1994-04-19
% 213.28/213.47  |- mesh__recordMaintainer mesh__D018749 KEV
% 213.28/213.47  |- skos__historyNote mesh__D018749 RNA %28%1966-1994%29%
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D018749 1999
% 213.28/213.47  |- mesh__recordAuthorizer mesh__D018749 PLS
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D018749 2002
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D018749 2005
% 213.28/213.47  |- skos__scopeNote mesh__D018749
% 213.28/213.47       Ribonucleic acid in plants having regulatory and catalytic roles as well as involvement in protein synthesis.%A%    
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D018749 2004
% 213.28/213.47  |- mesh__historyNote mesh__D018749 95   
% 213.28/213.47  |- mesh__dateRevised mesh__D018749 1995-06-08
% 213.28/213.47  |- skos__historyNote mesh__D018749 Plants %28%1966-1994%29%
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D018749 2006
% 213.28/213.47  |- skos__annotation mesh__D018749
% 213.28/213.47       IM; coord with specific plant %28%IM or NIM%29%; /drug eff /ultrastruct permitted%A%  
% 213.28/213.47  |- rdf__type mesh__D018749sskos__Concept
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D018749 2000
% 213.28/213.47  |- mesh__publicMeSHNote mesh__D018749 95   
% 213.28/213.47  |- skos__prefLabel mesh__D018749 RNA, Plant
% 213.28/213.47  |- skos__historyNote mesh__D018749 specific plant %28%1966-1994%29%
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D018749 2001
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D018749 1996
% 213.28/213.47  |- skos__broader mesh__D018749smesh__D012313
% 213.28/213.47  |- skos__altLabel mesh__D018749 Plant RNA
% 213.28/213.47  |- mesh__recordOriginator mesh__D018749 PXP
% 213.28/213.47  |- mesh__dateEstablished mesh__D018749 1995-01-01
% 213.28/213.47  |- mesh__dateRevised mesh__D010766 1997-06-20
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D010766 1999
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D010766 2001
% 213.28/213.47  |- mesh__recordMaintainer mesh__D010766 PXP
% 213.28/213.47  |- mesh__historyNote mesh__D010766
% 213.28/213.47       91%28%79%29%; was see under CHEMISTRY, ORGANIC 1979-90   
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D010766 2002
% 213.28/213.47  |- mesh__recordAuthorizer mesh__D010766 SJN
% 213.28/213.47  |- rdf__type mesh__D010766sskos__Concept
% 213.28/213.47  |- skos__broader mesh__D010766smesh__D008660
% 213.28/213.47  |- skos__hiddenLabel mesh__D010766 Phosphorylations
% 213.28/213.47  |- mesh__recordOriginator mesh__D010766 VDK
% 213.28/213.47  |- skos__annotation mesh__D010766
% 213.28/213.47       almost never IM; enzymatic phosphorylation: coord NIM with PHOSPHOTRANSFERASES %28%IM%29% + substrate %28%NIM%29% or specific phosphotransferase %28%particularly KINASES or PROTEIN KINASES%29% %28%IM%29%; OXIDATIVE PHOSPHORYLATION %26% PHOTOPHOSPHORYLATION are also available%A%  
% 213.28/213.47  |- mesh__publicMeSHNote mesh__D010766
% 213.28/213.47       91; was see under CHEMISTRY, ORGANIC 1979-90   
% 213.28/213.47  |- mesh__dateEstablished mesh__D010766 1991-01-01
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D010766 2005
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D010766 2003
% 213.28/213.47  |- mesh__dateCreated mesh__D010766 1978-05-19
% 213.28/213.47  |- skos__prefLabel mesh__D010766 Phosphorylation
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D010766 2006
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D010766 2000
% 213.28/213.47  |- skos__broader mesh__D010766smesh__D002625
% 213.28/213.47  |- skos__scopeNote mesh__D010766
% 213.28/213.47       The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety.%A%    
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D010766 1998
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D010766 2004
% 213.28/213.47  |- skos__broader mesh__D004729smesh__D042601
% 213.28/213.47  |- skos__hiddenLabel mesh__D004729 Lymphatic Endotheliums
% 213.28/213.47  |- mesh__dateRevised mesh__D004729 2003-07-09
% 213.28/213.47  |- mesh__dateEstablished mesh__D004729 1991-01-01
% 213.28/213.47  |- mesh__dateCreated mesh__D004729 1987-05-08
% 213.28/213.47  |- skos__historyNote mesh__D004729 Epithelium %28%1966-1987%29%
% 213.28/213.47  |- skos__historyNote mesh__D004729
% 213.28/213.47       Lymphatic System or specific %28%1966-1987%29%
% 213.28/213.47  |- mesh__recordMaintainer mesh__D004729 jmp
% 213.28/213.47  |- mesh__recordOriginator mesh__D004729 SCD
% 213.28/213.47  |- skos__broader mesh__D004729smesh__D004727
% 213.28/213.47  |- skos__hiddenLabel mesh__D004729 Endotheliums, Lymphatic
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D004729 2006
% 213.28/213.47  |- skos__altLabel mesh__D004729 Lymphatic Endothelium
% 213.28/213.47  |- skos__scopeNote mesh__D004729
% 213.28/213.47       Unbroken cellular lining %28%intima%29% of the lymph vessels %28%e.g., the high endothelial lymphatic venules%29%. It is more permeable than vascular endothelium, lacking selective absorption and functioning mainly to remove plasma proteins that have filtered through the capillaries into the tissue spaces.%A%    
% 213.28/213.47  |- rdf__type mesh__D004729sskos__Concept
% 213.28/213.47  |- skos__prefLabel mesh__D004729 Endothelium, Lymphatic
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D004729 2005
% 213.28/213.47  |- mesh__recordAuthorizer mesh__D004729 sjn
% 213.28/213.47  |- mesh__historyNote mesh__D004729
% 213.28/213.47       91%28%88%29%; was see under ENDOTHELIUM 1988-90   
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D004729 2004
% 213.28/213.47  |- skos__historyNote mesh__D004729 Endothelium %28%1973-1987%29%
% 213.28/213.47  |- mesh__publicMeSHNote mesh__D004729
% 213.28/213.47       91; was see under ENDOTHELIUM 1988-90   
% 213.28/213.47  |- skos__hiddenLabel mesh__D015451 B-Cell Leukemias, Chronic
% 213.28/213.47  |- skos__broader mesh__D015451smesh__D015462
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D015451 2000
% 213.28/213.47  |- skos__hiddenLabel mesh__D015451 Chronic B-Cell Leukemia
% 213.28/213.47  |- skos__hiddenLabel mesh__D015451 B Lymphocytic Leukemia, Chronic
% 213.28/213.47  |- skos__altLabel mesh__D015451 Leukemia, B Cell, Chronic
% 213.28/213.47  |- mesh__recordMaintainer mesh__D015451 PXP
% 213.28/213.47  |- rdf__type mesh__D015451sskos__Concept
% 213.28/213.47  |- mesh__dateEstablished mesh__D015451 1989-01-01
% 213.28/213.47  |- skos__hiddenLabel mesh__D015451 B Cell Leukemia, Chronic
% 213.28/213.47  |- skos__altLabel mesh__D015451 B-Cell Leukemia, Chronic
% 213.28/213.47  |- skos__hiddenLabel mesh__D015451 Leukemia, Chronic B-Cell
% 213.28/213.47  |- skos__hiddenLabel mesh__D015451 Chronic B-Cell Leukemias
% 213.28/213.47  |- skos__altLabel mesh__D015451 Leukemia, Lymphocytic, Chronic, B Cell
% 213.28/213.47  |- skos__hiddenLabel mesh__D015451 Leukemias, Chronic B-Lymphocytic
% 213.28/213.47  |- skos__hiddenLabel mesh__D015451 B-Lymphocytic Leukemias, Chronic
% 213.28/213.47  |- skos__altLabel mesh__D015451 Lymphocytic Leukemia, Chronic, B-Cell
% 213.28/213.47  |- skos__broader mesh__D015451smesh__D015448
% 213.28/213.47  |- skos__hiddenLabel mesh__D015451 Leukemias, Chronic B-Cell
% 213.28/213.47  |- mesh__recordAuthorizer mesh__D015451 SJN
% 213.28/213.47  |- mesh__dateRevised mesh__D015451 1997-06-20
% 213.28/213.47  |- skos__annotation mesh__D015451
% 213.28/213.47       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 213.28/213.47  |- skos__historyNote mesh__D015451 Leukemia, Lymphocytic %28%1977-1988%29%
% 213.28/213.47  |- skos__altLabel mesh__D015451 Leukemia, Lymphocytic, Chronic, B-Cell
% 213.28/213.47  |- mesh__recordOriginator mesh__D015451 PLS
% 213.28/213.47  |- skos__hiddenLabel mesh__D015451 Leukemia, Chronic B-Lymphocytic
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D015451 2004
% 213.28/213.47  |- skos__historyNote mesh__D015451 B Lymphocytes %28%1977-1988%29%
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D015451 1999
% 213.28/213.47  |- skos__historyNote mesh__D015451
% 213.28/213.47       Leukemia, Lymphoblastic %28%1977-1988%29%
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D015451 2002
% 213.28/213.47  |- mesh__publicMeSHNote mesh__D015451 89   
% 213.28/213.47  |- mesh__historyNote mesh__D015451 89   
% 213.28/213.47  |- skos__hiddenLabel mesh__D015451 Chronic B-Lymphocytic Leukemia
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D015451 2003
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D015451 1998
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D015451 2006
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D015451 2001
% 213.28/213.47  |- skos__hiddenLabel mesh__D015451 Chronic B-Lymphocytic Leukemias
% 213.28/213.47  |- skos__prefLabel mesh__D015451 Leukemia, B-Cell, Chronic
% 213.28/213.47  |- mesh__dateCreated mesh__D015451 1988-06-09
% 213.28/213.47  |- skos__altLabel mesh__D015451 Lymphocytic Leukemia, Chronic, B Cell
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D015451 2005
% 213.28/213.47  |- skos__altLabel mesh__D015451 B-Lymphocytic Leukemia, Chronic
% 213.28/213.47  |- skos__broader mesh__D009414smesh__D009419
% 213.28/213.47  |- skos__altLabel mesh__D009414 Proteins, Neuronal Growth-Associated
% 213.28/213.47  |- skos__altLabel mesh__D009414 Neurotrophic Factors
% 213.28/213.47  |- mesh__recordOriginator mesh__D009414 NLM
% 213.28/213.47  |- rdf__type mesh__D009414sskos__Concept
% 213.28/213.47  |- mesh__recordAuthorizer mesh__D009414 sjn
% 213.28/213.47  |- skos__hiddenLabel mesh__D009414 Factors, Neurotrophic
% 213.28/213.47  |- skos__hiddenLabel mesh__D009414 Factors, Neurite Outgrowth
% 213.28/213.47  |- mesh__dateCreated mesh__D009414 1999-01-01
% 213.28/213.47  |- skos__altLabel mesh__D009414 Neurotrophic Proteins
% 213.28/213.47  |- skos__scopeNote mesh__D009414
% 213.28/213.47       Factors which enhance the growth potentialities of sensory and sympathetic nerve cells.%A%    
% 213.28/213.47  |- skos__related mesh__D009414smesh__D017475
% 213.28/213.47  |- skos__altLabel mesh__D009414 Neuronal Growth-Associated Proteins
% 213.28/213.47  |- mesh__publicMeSHNote mesh__D009414
% 213.28/213.47       1980; see NERVE GROWTH FACTOR 1972-1979; NEUROTROPHIC PROTEIN was indexed under NERVE TISSUE PROTEINS 1978-1999%A%  
% 213.28/213.47  |- skos__annotation mesh__D009414 NERVE GROWTH FACTOR is also available   
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D009414 2006
% 213.28/213.47  |- skos__broader mesh__D009414smesh__D036341
% 213.28/213.47  |- skos__hiddenLabel mesh__D009414 Neuronal Growth Associated Proteins
% 213.28/213.47  |- skos__hiddenLabel mesh__D009414 Factors, Nerve Growth
% 213.28/213.47  |- skos__prefLabel mesh__D009414 Nerve Growth Factors
% 213.28/213.47  |- mesh__dateEstablished mesh__D009414 1972-01-01
% 213.28/213.47  |- skos__hiddenLabel mesh__D009414 Outgrowth Factors, Neurite
% 213.28/213.47  |- mesh__recordMaintainer mesh__D009414 ssb
% 213.28/213.47  |- skos__altLabel mesh__D009414 Neurotrophins
% 213.28/213.47  |- mesh__historyNote mesh__D009414
% 213.28/213.47       1980; use NERVE GROWTH FACTOR 1966-1979; for NEUROTROPHIC PROTEIN use NERVE GROWTH FACTORS %28%NM%29% 1978-1999%A%  
% 213.28/213.47  |- mesh__dateRevised mesh__D009414 2005-06-30
% 213.28/213.47  |- skos__hiddenLabel mesh__D009414 Growth Associated Proteins, Neuronal
% 213.28/213.47  |- skos__hiddenLabel mesh__D009414 Factors, Neuronotrophic
% 213.28/213.47  |- skos__altLabel mesh__D009414 Neurotrophic Protein
% 213.28/213.47  |- skos__broader mesh__D009414smesh__D006133
% 213.28/213.47  |- skos__altLabel mesh__D009414 Neuronotrophic Factors
% 213.28/213.47  |- skos__related mesh__D001431smesh__D003470
% 213.28/213.47  |- skos__altLabel mesh__D001431 Technique, Bacteriological
% 213.28/213.47  |- skos__altLabel mesh__D001431 Bacteriologic Technic
% 213.28/213.47  |- skos__hiddenLabel mesh__D001431 Technic, Bacteriologic
% 213.28/213.47  |- mesh__recordOriginator mesh__D001431 NLM
% 213.28/213.47  |- skos__altLabel mesh__D001431 Technics, Bacteriological
% 213.28/213.47  |- skos__altLabel mesh__D001431 Bacteriologic Technics
% 213.28/213.47  |- mesh__activeMeSHYear mesh__D001431 2005
% 213.28/213.47  |- skos__altLabel mesh__D001431 Bacteriologic Techniques
% 213.28/213.47  |- skos__annotation mesh__D001431 NIM; DF: BACTERIOL TECHNIQUES   
% 213.28/213.47  |- skos__altLabel mesh__D001431 Techniques, Bacteriological
% 213.28/213.47  |- skos__hiddenLabel mesh__D001431 Technics, Bacteriologic
% 213.28/213.47  |- skos__prefLabel mesh__D001431 Bacteriological Techniques
% 213.28/213.47  |- skos__hiddenLabel mesh__D001431 Techniques, Bacteriologic
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D001431 2001
% 213.28/213.48  |- skos__altLabel mesh__D001431 Technic, Bacteriological
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D001431 2006
% 213.28/213.48  |- mesh__recordMaintainer mesh__D001431 kle
% 213.28/213.48  |- mesh__recordAuthorizer mesh__D001431 sjn
% 213.28/213.48  |- mesh__onlineNote mesh__D001431
% 213.28/213.48       use BACTERIOLOGICAL TECHNIQUES to search BACTERIOLOGICAL TECHNICS 1966-90%A%  
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D001431 2002
% 213.28/213.48  |- mesh__dateCreated mesh__D001431 1999-01-01
% 213.28/213.48  |- skos__altLabel mesh__D001431 Bacteriological Technique
% 213.28/213.48  |- skos__hiddenLabel mesh__D001431 Bacteriologic Technique
% 213.28/213.48  |- skos__hiddenLabel mesh__D001431 Bacteriological Technics
% 213.28/213.48  |- rdf__type mesh__D001431sskos__Concept
% 213.28/213.48  |- mesh__historyNote mesh__D001431
% 213.28/213.48       91; was BACTERIOLOGICAL TECHNICS 1963-90   
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D001431 2003
% 213.28/213.48  |- skos__hiddenLabel mesh__D001431 Technique, Bacteriologic
% 213.28/213.48  |- skos__hiddenLabel mesh__D001431 Bacteriological Technic
% 213.28/213.48  |- mesh__publicMeSHNote mesh__D001431
% 213.28/213.48       91; was BACTERIOLOGICAL TECHNICS 1963-90   
% 213.28/213.48  |- skos__broader mesh__D001431smesh__D008828
% 213.28/213.48  |- mesh__dateRevised mesh__D001431 2000-06-21
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D001431 2004
% 213.28/213.48  |- mesh__dateRevised mesh__D014359 2005-06-30
% 213.28/213.48  |- skos__hiddenLabel mesh__D014359 Tumor Associated Trypsin Inhibitor
% 213.28/213.48  |- skos__broader mesh__D014359smesh__D000209
% 213.28/213.48  |- mesh__dateCreated mesh__D014359 1974-11-19
% 213.28/213.48  |- mesh__recordOriginator mesh__D014359 NLM
% 213.28/213.48  |- mesh__recordMaintainer mesh__D014359 SYSTEM
% 213.28/213.48  |- skos__historyNote mesh__D014359 Trypsin Inhibitors %28%1972-1974%29%
% 213.28/213.48  |- skos__altLabel mesh__D014359 Trypsin Inhibitor Kazal Pancreatic
% 213.28/213.48  |- mesh__dateEstablished mesh__D014359 1991-01-01
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D014359 2006
% 213.28/213.48  |- skos__hiddenLabel mesh__D014359 Trypsin Inhibitor, Tumor Associated
% 213.28/213.48  |- skos__annotation mesh__D014359
% 213.28/213.48       /drug eff /ultrastruct permitted; DF: TRYPSIN INHIB KAZAL%A%  
% 213.28/213.48  |- mesh__publicMeSHNote mesh__D014359
% 213.28/213.48       91; was see under TRYPSIN INHIBITORS 1975-90   
% 213.28/213.48  |- skos__altLabel mesh__D014359 Trypsin Inhibitor, Tumor-Associated
% 213.28/213.48  |- skos__altLabel mesh__D014359
% 213.28/213.48       Pancreatic Trypsin Secretory Inhibitor, Kazal
% 213.28/213.48  |- skos__altLabel mesh__D014359
% 213.28/213.48       Pancreatic Secretory Trypsin Inhibitor, Kazal
% 213.28/213.48  |- mesh__historyNote mesh__D014359
% 213.28/213.48       91%28%75%29%; was see under TRYPSIN INHIBITORS 1975-90   
% 213.28/213.48  |- skos__altLabel mesh__D014359 Kazal Pancreatic Trypsin Inhibitor
% 213.28/213.48  |- skos__prefLabel mesh__D014359 Trypsin Inhibitor, Kazal Pancreatic
% 213.28/213.48  |- skos__historyNote mesh__D014359 Pancreatic Juice %28%1972-1974%29%
% 213.28/213.48  |- rdf__type mesh__D014359sskos__Concept
% 213.28/213.48  |- skos__hiddenLabel mesh__D014359 Inhibitor, Tumor Associated Trypsin
% 213.28/213.48  |- skos__scopeNote mesh__D014359
% 213.28/213.48       A pancreatic trypsin inhibitor common to all mammals. It is secreted with the zymogens into the pancreatic juice. It is a protein composed of 56 amino acid residues and is different in amino acid composition and physiological activity from the Kunitz bovine pancreatic trypsin inhibitor %28%APROTININ%29%.%A%    
% 213.28/213.48  |- skos__altLabel mesh__D014359 Inhibitor, Tumor-Associated Trypsin
% 213.28/213.48  |- mesh__recordAuthorizer mesh__D014359 sjn
% 213.28/213.48  |- mesh__dateRevised mesh__D019842 1999-11-03
% 213.28/213.48  |- skos__broader mesh__D019842smesh__D001158
% 213.28/213.48  |- skos__hiddenLabel mesh__D019842 Artery, Ciliary
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D019842 2002
% 213.28/213.48  |- skos__hiddenLabel mesh__D019842 Arteries, Ciliary
% 213.28/213.48  |- mesh__dateCreated mesh__D019842 1997-06-20
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D019842 2005
% 213.28/213.48  |- mesh__recordMaintainer mesh__D019842 KEV
% 213.28/213.48  |- skos__hiddenLabel mesh__D019842 Ciliary Artery
% 213.28/213.48  |- mesh__recordOriginator mesh__D019842 TGC
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D019842 2003
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D019842 2006
% 213.28/213.48  |- skos__prefLabel mesh__D019842 Ciliary Arteries
% 213.28/213.48  |- mesh__publicMeSHNote mesh__D019842 98   
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D019842 2004
% 213.28/213.48  |- mesh__historyNote mesh__D019842 98   
% 213.28/213.48  |- rdf__type mesh__D019842sskos__Concept
% 213.28/213.48  |- skos__scopeNote mesh__D019842
% 213.28/213.48       Three groups of arteries found in the eye which supply the iris, pupil, sclera, conjunctiva, and the muscles of the iris.%A%    
% 213.28/213.48  |- mesh__recordAuthorizer mesh__D019842 sjn
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D019842 2000
% 213.28/213.48  |- mesh__dateEstablished mesh__D019842 1998-01-01
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D019842 2001
% 213.28/213.48  |- skos__hiddenLabel mesh__D019044 Cytometries, Image
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D019044 2005
% 213.28/213.48  |- skos__altLabel mesh__D019044 Cytometry, Image
% 213.28/213.48  |- mesh__dateCreated mesh__D019044 1995-05-26
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D019044 2006
% 213.28/213.48  |- skos__historyNote mesh__D019044
% 213.28/213.48       Image Processing, Computer-Assisted %28%1987-1995%29%
% 213.28/213.48  |- skos__broader mesh__D019044smesh__D003592
% 213.28/213.48  |- rdf__type mesh__D019044sskos__Concept
% 213.28/213.48  |- mesh__dateEstablished mesh__D019044 1996-01-01
% 213.28/213.48  |- mesh__recordAuthorizer mesh__D019044 sjn
% 213.28/213.48  |- skos__prefLabel mesh__D019044 Image Cytometry
% 213.28/213.48  |- skos__historyNote mesh__D019044 Cytological Techniques %28%1983-1989%29%
% 213.28/213.48  |- mesh__dateRevised mesh__D019044 2004-07-07
% 213.28/213.48  |- skos__hiddenLabel mesh__D019044 Image Cytometries
% 213.28/213.48  |- mesh__recordMaintainer mesh__D019044 ssb
% 213.28/213.48  |- mesh__historyNote mesh__D019044 96   
% 213.28/213.48  |- mesh__publicMeSHNote mesh__D019044 96   
% 213.28/213.48  |- skos__scopeNote mesh__D019044
% 213.28/213.48       A technique encompassing morphometry, densitometry, neural networks, and expert systems that has numerous clinical and research applications and is particularly useful in anatomic pathology for the study of malignant lesions. The most common current application of image cytometry is for DNA analysis, followed by quantitation of immunohistochemical staining.%A%    
% 213.28/213.48  |- skos__annotation mesh__D019044 a cytophotometry technique   
% 213.28/213.48  |- mesh__recordOriginator mesh__D019044 PXP
% 213.28/213.48  |- mesh__recordOriginator mesh__D000339 NLM
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D000339 2003
% 213.28/213.48  |- mesh__recordMaintainer mesh__D000339 TAP
% 213.28/213.48  |- mesh__publicMeSHNote mesh__D000339 65; was see under EMOTIONS 1963-64   
% 213.28/213.48  |- mesh__historyNote mesh__D000339
% 213.28/213.48       65%28%64%29%; was see under EMOTIONS 1963-64   
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D000339 1994
% 213.28/213.48  |- skos__prefLabel mesh__D000339 Affect
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D000339 2001
% 213.28/213.48  |- skos__scopeNote mesh__D000339
% 213.28/213.48       The feeling-tone accompaniment of an idea or mental representation. It is the most direct psychic derivative of instinct and the psychic representative of the various bodily changes by means of which instincts manifest themselves.%A%    
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D000339 2004
% 213.28/213.48  |- mesh__recordAuthorizer mesh__D000339 PLS
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D000339 1998
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D000339 1995
% 213.28/213.48  |- mesh__dateCreated mesh__D000339 1999-01-01
% 213.28/213.48  |- mesh__dateRevised mesh__D000339 1992-03-25
% 213.28/213.48  |- skos__broader mesh__D000339smesh__D004644
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D000339 1999
% 213.28/213.48  |- skos__hiddenLabel mesh__D000339 Affects
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D000339 2002
% 213.28/213.48  |- skos__hiddenLabel mesh__D000339 Moods
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D000339 1996
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D000339 1993
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D000339 2005
% 213.28/213.48  |- mesh__dateEstablished mesh__D000339 1965-01-01
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D000339 1997
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D000339 2006
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D000339 2000
% 213.28/213.48  |- rdf__type mesh__D000339sskos__Concept
% 213.28/213.48  |- mesh__historyNote mesh__D011061 76   
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D011061 2002
% 213.28/213.48  |- mesh__dateCreated mesh__D011061 1975-07-25
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D011061 1998
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D011061 2001
% 213.28/213.48  |- skos__prefLabel mesh__D011061 Poly A
% 213.28/213.48  |- skos__annotation mesh__D011061 do not confuse with POLY A-U   
% 213.28/213.48  |- mesh__recordOriginator mesh__D011061 RLS
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D011061 2000
% 213.28/213.48  |- mesh__dateEstablished mesh__D011061 1976-01-01
% 213.28/213.48  |- mesh__publicMeSHNote mesh__D011061 76   
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D011061 2004
% 213.28/213.48  |- mesh__recordMaintainer mesh__D011061 ADP
% 213.28/213.48  |- skos__historyNote mesh__D011061 Polynucleotides %28%1966-1975%29%
% 213.28/213.48  |- mesh__dateRevised mesh__D011061 1997-06-20
% 213.28/213.48  |- skos__broader mesh__D011061smesh__D011131
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D011061 2006
% 213.28/213.48  |- skos__hiddenLabel mesh__D011061 Polynucleotides, Adenine
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D011061 2003
% 213.28/213.48  |- mesh__recordAuthorizer mesh__D011061 SJN
% 213.28/213.48  |- skos__altLabel mesh__D011061 Poly%28%rA%29%
% 213.28/213.48  |- rdf__type mesh__D011061sskos__Concept
% 213.28/213.48  |- skos__altLabel mesh__D011061 Polyadenylic Acids
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D011061 2005
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D011061 1999
% 213.28/213.48  |- skos__scopeNote mesh__D011061
% 213.28/213.48       A group of adenine ribonucleotides in which the phosphate residues of each adenine ribonucleotide act as bridges in forming diester linkages between the ribose moieties.%A%    
% 213.28/213.48  |- skos__hiddenLabel mesh__D005822 Vector, Shuttle
% 213.28/213.48  |- skos__hiddenLabel mesh__D005822 Shuttle Vector
% 213.28/213.48  |- mesh__dateRevised mesh__D005822 2003-07-09
% 213.28/213.48  |- skos__hiddenLabel mesh__D005822 Cloning Vector
% 213.28/213.48  |- skos__historyNote mesh__D005822 Bacteriophages %28%1966-1979%29%
% 213.28/213.48  |- skos__hiddenLabel mesh__D005822 Vectors, Cloning
% 213.28/213.48  |- skos__prefLabel mesh__D005822 Genetic Vectors
% 213.28/213.48  |- skos__related mesh__D005822smesh__D014780
% 213.28/213.48  |- mesh__historyNote mesh__D005822 80   
% 213.28/213.48  |- mesh__dateCreated mesh__D005822 1978-12-21
% 213.28/213.48  |- skos__altLabel mesh__D005822 Vectors, Genetic
% 213.28/213.48  |- rdf__type mesh__D005822sskos__Concept
% 213.28/213.48  |- skos__historyNote mesh__D005822 DNA, Recombinant %28%1977-1979%29%
% 213.28/213.48  |- skos__annotation mesh__D005822
% 213.28/213.48       coord with specific bacterium, virus, phage or plasmid   
% 213.28/213.48  |- skos__historyNote mesh__D005822 Plasmids %28%1975-1979%29%
% 213.28/213.48  |- skos__hiddenLabel mesh__D005822 Vector, Cloning
% 213.28/213.48  |- mesh__recordOriginator mesh__D005822 AEP
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D005822 2004
% 213.28/213.48  |- skos__historyNote mesh__D005822 Coliphages %28%1966-1979%29%
% 213.28/213.48  |- skos__related mesh__D005822smesh__D004274
% 213.28/213.48  |- skos__hiddenLabel mesh__D005822 Genetic Vector
% 213.28/213.48  |- mesh__publicMeSHNote mesh__D005822 80   
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D005822 2005
% 213.28/213.48  |- skos__broader mesh__D005822smesh__D040342
% 213.28/213.48  |- skos__hiddenLabel mesh__D005822 Vector, Genetic
% 213.28/213.48  |- skos__scopeNote mesh__D005822
% 213.28/213.48       DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition.%A%    
% 213.28/213.48  |- mesh__recordAuthorizer mesh__D005822 sjn
% 213.28/213.48  |- skos__related mesh__D005822smesh__D001435
% 213.28/213.48  |- mesh__recordMaintainer mesh__D005822 nns
% 213.28/213.48  |- skos__hiddenLabel mesh__D005822 Vectors, Shuttle
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D005822 2006
% 213.28/213.48  |- mesh__dateEstablished mesh__D005822 1980-01-01
% 213.28/213.48  |- skos__hiddenLabel mesh__D010767 Phosphate Chloride, Choline
% 213.28/213.48  |- skos__hiddenLabel mesh__D010767 Chloride, Phosphorylcholine
% 213.28/213.48  |- skos__scopeNote mesh__D010767
% 213.28/213.48       Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.%A%    
% 213.28/213.48  |- skos__altLabel mesh__D010767 Phosphocholine
% 213.28/213.48  |- skos__historyNote mesh__D010767 Choline %28%1969-1974%29%
% 213.28/213.48  |- skos__hiddenLabel mesh__D010767 Chloride, Choline Phosphate
% 213.28/213.48  |- mesh__recordAuthorizer mesh__D010767 sjn
% 213.28/213.48  |- mesh__dateCreated mesh__D010767 1974-11-19
% 213.28/213.48  |- skos__altLabel mesh__D010767 Phosphorylcholine Chloride
% 213.28/213.48  |- skos__altLabel mesh__D010767 Choline Phosphate
% 213.28/213.48  |- mesh__dateEstablished mesh__D010767 1991-01-01
% 213.28/213.48  |- skos__altLabel mesh__D010767 Choline Phosphate Chloride
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D010767 2006
% 213.28/213.48  |- skos__historyNote mesh__D010767
% 213.28/213.48       Organophosphorus Compounds %28%1973-1974%29%
% 213.28/213.48  |- mesh__dateRevised mesh__D010767 2005-06-30
% 213.28/213.48  |- mesh__recordOriginator mesh__D010767 NLM
% 213.28/213.48  |- skos__broader mesh__D010767smesh__D002794
% 213.28/213.48  |- mesh__recordMaintainer mesh__D010767 ssb
% 213.28/213.48  |- skos__prefLabel mesh__D010767 Phosphorylcholine
% 213.28/213.48  |- skos__hiddenLabel mesh__D010767 Phosphate, Choline
% 213.28/213.48  |- mesh__publicMeSHNote mesh__D010767 91; was see under CHOLINE 1975-90   
% 213.28/213.48  |- mesh__historyNote mesh__D010767
% 213.28/213.48       91%28%75%29%; was see under CHOLINE 1975-90   
% 213.28/213.48  |- skos__altLabel mesh__D010767 Choline Chloride Dihydrogen Phosphate
% 213.28/213.48  |- rdf__type mesh__D010767sskos__Concept
% 213.28/213.48  |- skos__historyNote mesh__D043143 Liver %28%1964-1997%29%
% 213.28/213.48  |- skos__prefLabel mesh__D043143 Hepatopancreas
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D043143 2004
% 213.28/213.48  |- skos__historyNote mesh__D043143 Pancreas %28%1964-1997%29%
% 213.28/213.48  |- mesh__dateEstablished mesh__D043143 2004-01-01
% 213.28/213.48  |- mesh__dateCreated mesh__D043143 2003-07-09
% 213.28/213.48  |- skos__historyNote mesh__D043143 Digestive System %28%1997-2003%29%
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D043143 2006
% 213.28/213.48  |- skos__scopeNote mesh__D043143
% 213.28/213.48       A primitive form of digestive gland found in marine ARTHROPODS, that contains cells similar to those found in the mammalian liver %28%HEPATOCYTES%29%, and the PANCREAS.%A%    
% 213.28/213.48  |- mesh__publicMeSHNote mesh__D043143
% 213.28/213.48       2004; see DIGESTIVE SYSTEM 1998-2003   
% 213.28/213.48  |- skos__broader mesh__D043143smesh__D000825
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D043143 2005
% 213.28/213.48  |- mesh__historyNote mesh__D043143 2004; use DIGESTIVE SYSTEM 1998-2003   
% 213.28/213.48  |- rdf__type mesh__D043143sskos__Concept
% 213.28/213.48  |- skos__prefLabel mesh__D015452 Leukemia, Pre-B-Cell
% 213.28/213.48  |- mesh__dateEstablished mesh__D015452 1989-01-01
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D015452 2003
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D015452 2006
% 213.28/213.48  |- skos__historyNote mesh__D015452 Leukemia, Lymphocytic %28%1977-1988%29%
% 213.28/213.48  |- skos__historyNote mesh__D015452
% 213.28/213.48       Leukemia, Lymphoblastic %28%1977-1988%29%
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D015452 2004
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D015452 1998
% 213.28/213.48  |- skos__altLabel mesh__D015452 Pre-B-Cell Leukemia
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D015452 1999
% 213.28/213.48  |- mesh__recordOriginator mesh__D015452 PLS
% 213.28/213.48  |- mesh__recordMaintainer mesh__D015452 PXP
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D015452 2000
% 213.28/213.48  |- mesh__dateCreated mesh__D015452 1988-06-09
% 213.28/213.48  |- mesh__publicMeSHNote mesh__D015452 89   
% 213.28/213.48  |- rdf__type mesh__D015452sskos__Concept
% 213.28/213.48  |- skos__annotation mesh__D015452
% 213.28/213.48       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D015452 2001
% 213.28/213.48  |- mesh__historyNote mesh__D015452 89   
% 213.28/213.48  |- skos__hiddenLabel mesh__D015452 Pre-B-Cell Leukemias
% 213.28/213.48  |- skos__hiddenLabel mesh__D015452 Pre B Cell Leukemia
% 213.28/213.48  |- mesh__dateRevised mesh__D015452 1997-06-20
% 213.28/213.48  |- skos__historyNote mesh__D015452 B Lymphocytes %28%1977-1988%29%
% 213.28/213.48  |- skos__hiddenLabel mesh__D015452 Leukemias, Pre-B-Cell
% 213.28/213.48  |- skos__hiddenLabel mesh__D015452 Leukemia, Pre B Cell
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D015452 2005
% 213.28/213.48  |- skos__broader mesh__D015452smesh__D015448
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D015452 2002
% 213.28/213.48  |- mesh__recordAuthorizer mesh__D015452 SJN
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D009415 1998
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D009415 2005
% 213.28/213.48  |- mesh__dateCreated mesh__D009415 1999-01-01
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D009415 2002
% 213.28/213.48  |- skos__broader mesh__D009415smesh__D009420
% 213.28/213.48  |- skos__hiddenLabel mesh__D009415 Neural Network %28%Anatomic%29%
% 213.28/213.48  |- mesh__publicMeSHNote mesh__D009415
% 213.28/213.48       91; was see under NERVOUS SYSTEM 1964-90   
% 213.28/213.48  |- skos__hiddenLabel mesh__D009415 Network, Neural %28%Anatomic%29%
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D009415 2006
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D009415 1999
% 213.28/213.48  |- skos__prefLabel mesh__D009415 Nerve Net
% 213.28/213.48  |- mesh__recordOriginator mesh__D009415 NLM
% 213.28/213.48  |- mesh__historyNote mesh__D009415
% 213.28/213.48       91%28%64%29%; was see under NERVOUS SYSTEM 1964-90   
% 213.28/213.48  |- skos__scopeNote mesh__D009415
% 213.28/213.48       A meshlike structure composed of interconnecting nerve cells that are separated at the synaptic junction or joined to one another by cytoplasmic processes. In invertebrates, for example, the nerve net allows nerve impulses to spread over a wide area of the net because synapses can pass information in any direction.%A%    
% 213.28/213.48  |- mesh__dateEstablished mesh__D009415 1991-01-01
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D009415 1996
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D009415 2003
% 213.28/213.48  |- skos__hiddenLabel mesh__D009415 Networks, Neural %28%Anatomic%29%
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D009415 2000
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D009415 1997
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D009415 2004
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D009415 2001
% 213.28/213.48  |- skos__hiddenLabel mesh__D009415 Nerve Nets
% 213.28/213.48  |- skos__annotation mesh__D009415
% 213.28/213.48       do not confuse X ref on anat neural networks with NEURAL NETWORKS %28%COMPUTER%29%%A%  
% 213.28/213.48  |- mesh__recordAuthorizer mesh__D009415 PLS
% 213.28/213.48  |- mesh__recordMaintainer mesh__D009415 PXP
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D009415 1995
% 213.28/213.48  |- mesh__dateRevised mesh__D009415 1994-05-12
% 213.28/213.48  |- skos__hiddenLabel mesh__D009415 Nets, Nerve
% 213.28/213.48  |- rdf__type mesh__D009415sskos__Concept
% 213.28/213.48  |- skos__hiddenLabel mesh__D009415 Net, Nerve
% 213.28/213.48  |- skos__prefLabel mesh__D001432 Bacteriology
% 213.28/213.48  |- mesh__dateCreated mesh__D001432 1999-01-01
% 213.28/213.48  |- skos__broader mesh__D001432smesh__D008829
% 213.28/213.48  |- rdf__type mesh__D001432sskos__Concept
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D001432 2003
% 213.28/213.48  |- mesh__recordOriginator mesh__D001432 NLM
% 213.28/213.48  |- skos__annotation mesh__D001432 SPEC: SPEC qualif; DF: BACTERIOL   
% 213.28/213.48  |- mesh__dateRevised mesh__D001432 2001-07-25
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D001432 2004
% 213.28/213.48  |- mesh__recordAuthorizer mesh__D001432 sjn
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D001432 2005
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D001432 2002
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D001432 2006
% 213.28/213.48  |- mesh__recordMaintainer mesh__D001432 jls
% 213.28/213.48  |- skos__broader mesh__D020397smesh__D007820
% 213.28/213.48  |- mesh__recordOriginator mesh__D020397 NNS
% 213.28/213.48  |- mesh__dateRevised mesh__D020397 2005-06-30
% 213.28/213.48  |- mesh__recordAuthorizer mesh__D020397 sjn
% 213.28/213.48  |- skos__broader mesh__D020397smesh__D020545
% 213.28/213.48  |- mesh__dateCreated mesh__D020397 1998-06-10
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D020397 2006
% 213.28/213.48  |- skos__hiddenLabel mesh__D020397 Cell, Goblet
% 213.28/213.48  |- rdf__type mesh__D020397sskos__Concept
% 213.28/213.48  |- mesh__dateEstablished mesh__D020397 1999-01-01
% 213.28/213.48  |- skos__hiddenLabel mesh__D020397 Cells, Goblet
% 213.28/213.48  |- skos__broader mesh__D020397smesh__D009297
% 213.28/213.48  |- skos__broader mesh__D020397smesh__D004847
% 213.28/213.48  |- skos__prefLabel mesh__D020397 Goblet Cells
% 213.28/213.48  |- skos__broader mesh__D020397smesh__D007413
% 213.28/213.48  |- skos__scopeNote mesh__D020397
% 213.28/213.48       A glandular epithelial cell or a unicellular gland. Goblet cells secrete MUCUS. They are scattered in the epithelial linings of many organs, especially the SMALL INTESTINE and the RESPIRATORY TRACT.%A%    
% 213.28/213.48  |- mesh__historyNote mesh__D020397 99   
% 213.28/213.48  |- mesh__recordMaintainer mesh__D020397 lkt
% 213.28/213.48  |- mesh__publicMeSHNote mesh__D020397 99   
% 213.28/213.48  |- skos__hiddenLabel mesh__D020397 Goblet Cell
% 213.28/213.48  |- mesh__recordMaintainer mesh__D019843 SYSTEM
% 213.28/213.48  |- skos__altLabel mesh__D019843 Gene Products, Archaeal
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D019843 2006
% 213.28/213.48  |- mesh__dateEstablished mesh__D019843 1998-01-01
% 213.28/213.48  |- skos__scopeNote mesh__D019843
% 213.28/213.48       Proteins found in any species of archaeon.     
% 213.28/213.48  |- mesh__dateRevised mesh__D019843 2005-06-30
% 213.28/213.48  |- mesh__recordAuthorizer mesh__D019843 sjn
% 213.28/213.48  |- skos__altLabel mesh__D019843 Archaeal Gene Proteins
% 213.28/213.48  |- mesh__historyNote mesh__D019843 98   
% 213.28/213.48  |- rdf__type mesh__D019843sskos__Concept
% 213.28/213.48  |- skos__annotation mesh__D019843
% 213.28/213.48       /drug eff /ultrastruct permitted; /physiol permitted for function within the archaeon; coord IM with specific protein %28%IM%29% + specific archaeon %28%IM%29%%A%  
% 213.28/213.48  |- skos__broader mesh__D019843smesh__D011506
% 213.28/213.48  |- skos__altLabel mesh__D019843 Archaeal Gene Products
% 213.28/213.48  |- skos__historyNote mesh__D019843 Bacterial Proteins %28%1994-1997%29%
% 213.28/213.48  |- mesh__recordOriginator mesh__D019843 AGS
% 213.28/213.48  |- mesh__dateCreated mesh__D019843 1997-06-20
% 213.28/213.48  |- skos__hiddenLabel mesh__D019843 Gene Proteins, Archaeal
% 213.28/213.48  |- skos__altLabel mesh__D019843 Archaeal Peptides
% 213.28/213.48  |- skos__prefLabel mesh__D019843 Archaeal Proteins
% 213.28/213.48  |- mesh__publicMeSHNote mesh__D019843 98   
% 213.28/213.48  |- skos__broader mesh__D011860smesh__D011859
% 213.28/213.48  |- mesh__historyNote mesh__D011860 98; use explode 1975-97   
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D011860 2004
% 213.28/213.48  |- skos__annotation mesh__D011860
% 213.28/213.48       GEN or unspecified; prefer specifics or specific organ /radiogr; DF: RADIOGR ABDOMINAL%A%  
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D011860 2000
% 213.28/213.48  |- skos__hiddenLabel mesh__D011860 Radiographies, Abdominal
% 213.28/213.48  |- rdf__type mesh__D011860sskos__Concept
% 213.28/213.48  |- mesh__dateRevised mesh__D011860 1997-06-20
% 213.28/213.48  |- mesh__dateCreated mesh__D011860 1999-01-01
% 213.28/213.48  |- skos__scopeNote mesh__D011860
% 213.28/213.48       Radiographic visualization of the body between the thorax and the pelvis, i.e., within the peritoneal cavity.%A%    
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D011860 2001
% 213.28/213.48  |- skos__prefLabel mesh__D011860 Radiography, Abdominal
% 213.28/213.48  |- mesh__recordAuthorizer mesh__D011860 SJN
% 213.28/213.48  |- skos__hiddenLabel mesh__D011860 Abdominal Radiographies
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D011860 2005
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D011860 1998
% 213.28/213.48  |- skos__altLabel mesh__D011860 Abdominal Radiography
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D011860 2006
% 213.28/213.48  |- mesh__dateEstablished mesh__D011860 1998-01-01
% 213.28/213.48  |- skos__historyNote mesh__D011860 Abdomen/radiography %28%1967-1997%29%
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D011860 1999
% 213.28/213.48  |- mesh__publicMeSHNote mesh__D011860 98   
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D011860 2002
% 213.28/213.48  |- mesh__recordOriginator mesh__D011860 NLM
% 213.28/213.48  |- mesh__recordMaintainer mesh__D011860 TGC
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D011860 2003
% 213.28/213.48  |- skos__hiddenLabel mesh__D011062 Adenylyltransferase, Polynucleotide
% 213.28/213.48  |- skos__scopeNote mesh__D011062
% 213.28/213.48       An enzyme that catalyzes the synthesis of polyadenylic acid from ATP. May be due to the action of RNA polymerase %28%EC 2.7.7.6%29% or polynucleotide adenylyltransferase %28%EC 2.7.7.19%29%. EC 2.7.7.19.%A%    
% 213.28/213.48  |- skos__hiddenLabel mesh__D011062 A Polymerase, Poly
% 213.28/213.48  |- mesh__recordAuthorizer mesh__D011062 sjn
% 213.28/213.48  |- mesh__recordOriginator mesh__D011062 NLM
% 213.28/213.48  |- skos__altLabel mesh__D011062 Polyadenylate Polymerase
% 213.28/213.48  |- mesh__recordMaintainer mesh__D011062 ssb
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D011062 2004
% 213.28/213.48  |- skos__hiddenLabel mesh__D011062 Adenylyltransferase, ATP-RNA
% 213.28/213.48  |- skos__hiddenLabel mesh__D011062 Polymerase, Polyadenylate
% 213.28/213.48  |- skos__historyNote mesh__D011062 Adenosine Triphosphate %28%1972-1974%29%
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D011062 2006
% 213.28/213.48  |- skos__hiddenLabel mesh__D011062 Synthetase, Polyadenylate
% 213.28/213.48  |- mesh__historyNote mesh__D011062 98%28%75%29%   
% 213.28/213.48  |- mesh__dateRevised mesh__D011062 2003-07-09
% 213.28/213.48  |- skos__altLabel mesh__D011062 Poly A Polymerase
% 213.28/213.48  |- skos__hiddenLabel mesh__D011062 ATP RNA Adenylyltransferase
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D011062 2005
% 213.28/213.48  |- skos__historyNote mesh__D011062
% 213.28/213.48       Nucleotidyltransferases %28%1972-1974%29%
% 213.28/213.48  |- skos__altLabel mesh__D011062 Polyadenylate Synthetase
% 213.28/213.48  |- skos__hiddenLabel mesh__D011062 Polymerase, Poly A
% 213.28/213.48  |- mesh__dateEstablished mesh__D011062 1991-01-01
% 213.28/213.48  |- skos__broader mesh__D011062smesh__D009713
% 213.28/213.48  |- skos__altLabel mesh__D011062 ATP-RNA Adenylyltransferase
% 213.28/213.48  |- rdf__type mesh__D011062sskos__Concept
% 213.28/213.48  |- skos__prefLabel mesh__D011062 Polynucleotide Adenylyltransferase
% 213.28/213.48  |- mesh__dateCreated mesh__D011062 1974-11-19
% 213.28/213.48  |- mesh__publicMeSHNote mesh__D011062
% 213.28/213.48       98; see POLY A POLYMERASE 1991-97; see NUCLEOTIDYLTRANSFERASES 1975-90%A%  
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D005823 2006
% 213.28/213.48  |- skos__related mesh__D005823smesh__D040341
% 213.28/213.48  |- mesh__dateCreated mesh__D005823 1999-01-01
% 213.28/213.48  |- rdf__type mesh__D005823sskos__Concept
% 213.28/213.48  |- skos__broader mesh__D005823smesh__D001695
% 213.28/213.48  |- mesh__dateRevised mesh__D005823 2002-07-03
% 213.28/213.48  |- skos__scopeNote mesh__D005823
% 213.28/213.48       The branch of science concerned with the means and consequences of transmission and generation of the components of biological inheritance. %28%Stedman, 26th ed%29%%A%    
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D005823 2003
% 213.28/213.48  |- mesh__recordOriginator mesh__D005823 NLM
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D005823 2004
% 213.28/213.48  |- skos__annotation mesh__D005823
% 213.28/213.48       GEN or SPEC only: prefer /genet with specific terms: Manual 19.7+, 19.8.34, 28.22+, 28.24+; DF: GENET%A%  
% 213.28/213.48  |- mesh__recordAuthorizer mesh__D005823 sjn
% 213.28/213.48  |- skos__related mesh__D005823smesh__D006650
% 213.28/213.48  |- mesh__recordMaintainer mesh__D005823 nns
% 213.28/213.48  |- skos__prefLabel mesh__D005823 Genetics
% 213.28/213.48  |- mesh__activeMeSHYear mesh__D005823 2005
% 213.28/213.48  |- skos__related mesh__D005823smesh__D040342
% 213.28/213.48  |- skos__related mesh__D005823smesh__D039361
% 213.28/213.48  |- rdf__type mesh__D005025sskos__Concept
% 213.28/213.49  |- mesh__dateEstablished mesh__D005025 1991-01-01
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D005025 2005
% 213.28/213.49  |- mesh__publicMeSHNote mesh__D005025
% 213.28/213.49       91; was see under HYDROCARBONS, CHLORINATED 1976-90   
% 213.28/213.49  |- mesh__dateRevised mesh__D005025 2000-06-22
% 213.28/213.49  |- skos__prefLabel mesh__D005025 Ethylene Dichlorides
% 213.28/213.49  |- skos__broader mesh__D005025smesh__D004980
% 213.28/213.49  |- mesh__recordAuthorizer mesh__D005025 sjn
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D005025 2006
% 213.28/213.49  |- mesh__dateCreated mesh__D005025 1975-07-25
% 213.28/213.49  |- mesh__recordMaintainer mesh__D005025 CCR
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D005025 2002
% 213.28/213.49  |- skos__hiddenLabel mesh__D005025 Dichlorides, Ethylene
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D005025 2003
% 213.28/213.49  |- skos__annotation mesh__D005025 do not confuse with DICHLOROETHYLENES   
% 213.28/213.49  |- skos__historyNote mesh__D005025 Ethane %28%1974%29% /AA %28%1975%29%
% 213.28/213.49  |- mesh__recordOriginator mesh__D005025 RLS
% 213.28/213.49  |- mesh__historyNote mesh__D005025
% 213.28/213.49       91%28%76%29%; was see under HYDROCARBONS, CHLORINATED 1976-90   
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D005025 2004
% 213.28/213.49  |- skos__historyNote mesh__D005025 Chlorine %28%1974-1975%29%
% 213.28/213.49  |- skos__scopeNote mesh__D005025
% 213.28/213.49       Toxic, chlorinated, saturated hydrocarbons. Include both the 1,1- and 1,2-dichloro isomers. The latter is considerably more toxic. It has a sweet taste, ethereal odor and has been used as a fumigant and intoxicant among sniffers. Has many household and industrial uses.%A%    
% 213.28/213.49  |- skos__altLabel mesh__D005025 Dichloroethanes
% 213.28/213.49  |- skos__broader mesh__D005025smesh__D006843
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D005025 2001
% 213.28/213.49  |- skos__hiddenLabel mesh__D043942 Nanosphere
% 213.28/213.49  |- mesh__dateRevised mesh__D043942 2004-07-07
% 213.28/213.49  |- mesh__dateEstablished mesh__D043942 2004-01-01
% 213.28/213.49  |- skos__hiddenLabel mesh__D043942 Nanotube
% 213.28/213.49  |- rdf__type mesh__D043942sskos__Concept
% 213.28/213.49  |- mesh__recordMaintainer mesh__D043942 ssb
% 213.28/213.49  |- skos__prefLabel mesh__D043942 Nanotubes
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D043942 2005
% 213.28/213.49  |- mesh__recordOriginator mesh__D043942 ssb
% 213.28/213.49  |- mesh__recordAuthorizer mesh__D043942 sjn
% 213.28/213.49  |- skos__related mesh__D043942smesh__D036103
% 213.28/213.49  |- mesh__dateCreated mesh__D043942 2003-07-09
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D043942 2006
% 213.28/213.49  |- mesh__publicMeSHNote mesh__D043942 2004   
% 213.28/213.49  |- mesh__historyNote mesh__D043942 2004   
% 213.28/213.49  |- skos__broader mesh__D043942smesh__D049329
% 213.28/213.49  |- skos__scopeNote mesh__D043942
% 213.28/213.49       Nanometer-sized tubes composed of various substances including carbon %28%CARBON NANOTUBES%29%, boron nitride, or nickel vanadate.%A%    
% 213.28/213.49  |- mesh__publicMeSHNote mesh__D010768 91; was see under SERINE 1980-90   
% 213.28/213.49  |- skos__historyNote mesh__D010768
% 213.28/213.49       Organophosphorus Compounds %28%1971-1978%29%
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D010768 2005
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D010768 2003
% 213.28/213.49  |- skos__historyNote mesh__D010768 Phosphoric Acids %28%1968-1970%29%
% 213.28/213.49  |- mesh__dateEstablished mesh__D010768 1991-01-01
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D010768 2006
% 213.28/213.49  |- skos__historyNote mesh__D010768
% 213.28/213.49       Serine %28%1966-1974%29% /analogs %26% derivatives %28%1975-1979%29%
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D010768 2004
% 213.28/213.49  |- mesh__historyNote mesh__D010768
% 213.28/213.49       91%28%80%29%; was see under SERINE 1980-90   
% 213.28/213.49  |- mesh__recordOriginator mesh__D010768 RLS
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D010768 2000
% 213.28/213.49  |- skos__altLabel mesh__D010768 Seryl Phosphate
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D010768 1999
% 213.28/213.49  |- mesh__dateRevised mesh__D010768 1998-06-10
% 213.28/213.49  |- skos__altLabel mesh__D010768 Phosphorylserine
% 213.28/213.49  |- skos__broader mesh__D010768smesh__D019606
% 213.28/213.49  |- mesh__dateCreated mesh__D010768 1979-05-23
% 213.28/213.49  |- skos__altLabel mesh__D010768 Serine Phosphate
% 213.28/213.49  |- rdf__type mesh__D010768sskos__Concept
% 213.28/213.49  |- skos__hiddenLabel mesh__D010768 Phosphate, Seryl
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D010768 2001
% 213.28/213.49  |- skos__hiddenLabel mesh__D010768 Phosphate, Serine
% 213.28/213.49  |- skos__historyNote mesh__D010768 Phosphoric Acid Esters %28%1979%29%
% 213.28/213.49  |- mesh__recordMaintainer mesh__D010768 ADP
% 213.28/213.49  |- skos__broader mesh__D010768smesh__D012694
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D010768 2002
% 213.28/213.49  |- mesh__recordAuthorizer mesh__D010768 SJN
% 213.28/213.49  |- skos__prefLabel mesh__D010768 Phosphoserine
% 213.28/213.49  |- skos__scopeNote mesh__D010768 The phosphoric acid ester of serine.     
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D015453 2000
% 213.28/213.49  |- skos__annotation mesh__D015453
% 213.28/213.49       do not use /blood supply /chem /second /secret /ultrastruct; CALLA stands for %22%common acute lymphoblastic leukemia antigen%22% or %22%common ALL antigen%22% %28% = CALLA see NEPRILYSIN%29%%A%  
% 213.28/213.49  |- skos__historyNote mesh__D015453
% 213.28/213.49       Leukemia, Lymphoblastic/immunology %28%1977-1988%29%
% 213.28/213.49  |- mesh__dateRevised mesh__D015453 1996-06-10
% 213.28/213.49  |- skos__historyNote mesh__D015453 Antigens, Neoplasm %28%1977-1988%29%
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D015453 2005
% 213.28/213.49  |- skos__hiddenLabel mesh__D015453 CALLA-Positive Leukemia
% 213.28/213.49  |- skos__hiddenLabel mesh__D015453 CALLA-Positive Lymphoblastic Leukemias
% 213.28/213.49  |- skos__altLabel mesh__D015453 CALLA-Positive Lymphoblastic Leukemia
% 213.28/213.49  |- skos__hiddenLabel mesh__D015453 Lymphoblastic Leukemias, CALLA-Positive
% 213.28/213.49  |- skos__scopeNote mesh__D015453
% 213.28/213.49       Acute leukemia in which lymphocytes are positive for the common acute lymphoblastic leukemia antigen %28%CALLA%29%.%A%    
% 213.28/213.49  |- skos__hiddenLabel mesh__D015453 Leukemias, CALLA-Positive Lymphoblastic
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D015453 2001
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D015453 1998
% 213.28/213.49  |- skos__hiddenLabel mesh__D015453 CALLA-Positive Leukemias
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D015453 2006
% 213.28/213.49  |- skos__hiddenLabel mesh__D015453 CALLA Positive Lymphoblastic Leukemia
% 213.28/213.49  |- skos__altLabel mesh__D015453
% 213.28/213.49       Lymphoblastic Leukemia, Acute, CALLA Positive
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D015453 2003
% 213.28/213.49  |- skos__hiddenLabel mesh__D015453 Leukemias, CALLA-Positive Lymphocytic
% 213.28/213.49  |- skos__prefLabel mesh__D015453 Leukemia, CALLA-Positive
% 213.28/213.49  |- skos__broader mesh__D015453smesh__D015447
% 213.28/213.49  |- skos__hiddenLabel mesh__D015453 Leukemia, CALLA Positive
% 213.28/213.49  |- skos__hiddenLabel mesh__D015453 Lymphoblastic Leukemia, CALLA-Positive
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D015453 2002
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D015453 1999
% 213.28/213.49  |- skos__hiddenLabel mesh__D015453 Lymphocytic Leukemia, CALLA Positive
% 213.28/213.49  |- mesh__dateCreated mesh__D015453 1988-06-09
% 213.28/213.49  |- skos__hiddenLabel mesh__D015453 Leukemias, CALLA-Positive
% 213.28/213.49  |- mesh__dateEstablished mesh__D015453 1989-01-01
% 213.28/213.49  |- skos__hiddenLabel mesh__D015453 CALLA-Positive Lymphocytic Leukemias
% 213.28/213.49  |- skos__altLabel mesh__D015453 Lymphocytic Leukemia, CALLA-Positive
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D015453 2004
% 213.28/213.49  |- rdf__type mesh__D015453sskos__Concept
% 213.28/213.49  |- mesh__publicMeSHNote mesh__D015453 89   
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D015453 1997
% 213.28/213.49  |- skos__hiddenLabel mesh__D015453 Leukemia, CALLA-Positive Lymphoblastic
% 213.28/213.49  |- mesh__historyNote mesh__D015453 89   
% 213.28/213.49  |- skos__altLabel mesh__D015453
% 213.28/213.49       Leukemia, Lymphocytic, Acute, CALLA Positive
% 213.28/213.49  |- skos__altLabel mesh__D015453
% 213.28/213.49       Leukemia, Lymphoblastic, Acute, Common ALL Antigen-Positive
% 213.28/213.49  |- skos__historyNote mesh__D015453
% 213.28/213.49       Leukemia, Lymphocytic/immunology %28%1977-1988%29%
% 213.28/213.49  |- mesh__recordMaintainer mesh__D015453 TGC
% 213.28/213.49  |- skos__altLabel mesh__D015453
% 213.28/213.49       Leukemia, Lymphocytic, Acute, CALLA-Positive
% 213.28/213.49  |- skos__altLabel mesh__D015453
% 213.28/213.49       Lymphoblastic Leukemia, Acute, CALLA-Positive
% 213.28/213.49  |- skos__altLabel mesh__D015453
% 213.28/213.49       Leukemia, Lymphoblastic, Acute, Common ALL Antigen Positive
% 213.28/213.49  |- mesh__recordOriginator mesh__D015453 PLS
% 213.28/213.49  |- skos__hiddenLabel mesh__D015453 Lymphocytic Leukemias, CALLA-Positive
% 213.28/213.49  |- mesh__recordAuthorizer mesh__D015453 PLS
% 213.28/213.49  |- skos__hiddenLabel mesh__D015453 CALLA-Positive Lymphocytic Leukemia
% 213.28/213.49  |- skos__hiddenLabel mesh__D015453 Leukemia, CALLA-Positive Lymphocytic
% 213.28/213.49  |- mesh__dateRevised mesh__D009416 1992-05-15
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D009416 2003
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D009416 1996
% 213.28/213.49  |- skos__prefLabel mesh__D009416 Nerve Regeneration
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D009416 2001
% 213.28/213.49  |- mesh__recordAuthorizer mesh__D009416 PLS
% 213.28/213.49  |- mesh__dateEstablished mesh__D009416 1966-01-01
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D009416 1997
% 213.28/213.49  |- mesh__publicMeSHNote mesh__D009416 66   
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D009416 2004
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D009416 1994
% 213.28/213.49  |- mesh__recordMaintainer mesh__D009416 TAP
% 213.28/213.49  |- skos__scopeNote mesh__D009416
% 213.28/213.49       Renewal or physiological repair of damaged nerve tissue.%A%    
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D009416 1995
% 213.28/213.49  |- mesh__historyNote mesh__D009416 66   
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D009416 2002
% 213.28/213.49  |- skos__broader mesh__D009416smesh__D009424
% 213.28/213.49  |- skos__hiddenLabel mesh__D009416 Nerve Regenerations
% 213.28/213.49  |- rdf__type mesh__D009416sskos__Concept
% 213.28/213.49  |- skos__hiddenLabel mesh__D009416 Regeneration, Nerve
% 213.28/213.49  |- skos__hiddenLabel mesh__D009416 Regenerations, Nerve
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D009416 1998
% 213.28/213.49  |- mesh__dateCreated mesh__D009416 1999-01-01
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D009416 2005
% 213.28/213.49  |- mesh__recordOriginator mesh__D009416 NLM
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D009416 1999
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D009416 2006
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D009416 1993
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D009416 2000
% 213.28/213.49  |- skos__broader mesh__D009416smesh__D012038
% 213.28/213.49  |- skos__annotation mesh__D009416
% 213.28/213.49       coord IM with specific nerve /physiol %28%IM or NIM%29%   
% 213.28/213.49  |- skos__broader mesh__D001433smesh__D018407
% 213.28/213.49  |- skos__annotation mesh__D001433 coord with specific bacterium   
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D001433 2002
% 213.28/213.49  |- rdf__type mesh__D001433sskos__Concept
% 213.28/213.49  |- skos__scopeNote mesh__D001433
% 213.28/213.49       Rupture of bacterial cells due to mechanical force, chemical action, or the lytic growth of BACTERIOPHAGES.%A%    
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D001433 2003
% 213.28/213.49  |- mesh__recordMaintainer mesh__D001433 KEV
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D001433 2004
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D001433 2005
% 213.28/213.49  |- mesh__recordOriginator mesh__D001433 NLM
% 213.28/213.49  |- mesh__dateRevised mesh__D001433 1999-11-03
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D001433 2006
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D001433 2000
% 213.28/213.49  |- skos__prefLabel mesh__D001433 Bacteriolysis
% 213.28/213.49  |- skos__related mesh__D001433smesh__D008248
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D001433 2001
% 213.28/213.49  |- mesh__dateCreated mesh__D001433 1999-01-01
% 213.28/213.49  |- skos__hiddenLabel mesh__D001433 Bacteriolyses
% 213.28/213.49  |- mesh__recordAuthorizer mesh__D001433 sjn
% 213.28/213.49  |- mesh__historyNote mesh__D020398 99   
% 213.28/213.49  |- skos__hiddenLabel mesh__D020398 C, Medicare Part
% 213.28/213.49  |- mesh__recordAuthorizer mesh__D020398 sjn
% 213.28/213.49  |- mesh__publicMeSHNote mesh__D020398 99   
% 213.28/213.49  |- mesh__recordMaintainer mesh__D020398 kle
% 213.28/213.49  |- mesh__dateCreated mesh__D020398 1998-06-10
% 213.28/213.49  |- rdf__type mesh__D020398sskos__Concept
% 213.28/213.49  |- skos__scopeNote mesh__D020398
% 213.28/213.49       The Balanced Budget Act %28%BBA%29% of 1997 establishes a Medicare+Choice program under part C of Title XVIII, Section 4001, of the Social Security Act. Under this program, an eligible individual may elect to receive Medicare benefits through enrollment in a Medicare+Choice plan. Beneficiaries may choose to use private pay options, establish medical savings accounts, use managed care plans, or join provider-sponsored plans.%A%    
% 213.28/213.49  |- skos__hiddenLabel mesh__D020398 Plus Choice, Medicare
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D020398 2002
% 213.28/213.49  |- mesh__recordOriginator mesh__D020398 JLS
% 213.28/213.49  |- skos__annotation mesh__D020398 specify state if given; DF: MEDICARE C   
% 213.28/213.49  |- mesh__dateEstablished mesh__D020398 1999-01-01
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D020398 2006
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D020398 2001
% 213.28/213.49  |- skos__altLabel mesh__D020398 Medicare Choice
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D020398 2005
% 213.28/213.49  |- skos__hiddenLabel mesh__D020398 Choice, Medicare Plus
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D020398 2000
% 213.28/213.49  |- mesh__dateRevised mesh__D020398 1999-11-03
% 213.28/213.49  |- skos__broader mesh__D020398smesh__D006278
% 213.28/213.49  |- skos__altLabel mesh__D020398 Medicare Plus Choice
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D020398 2004
% 213.28/213.49  |- skos__prefLabel mesh__D020398 Medicare Part C
% 213.28/213.49  |- skos__hiddenLabel mesh__D020398 Part C, Medicare
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D020398 2003
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D025881 2002
% 213.28/213.49  |- skos__scopeNote mesh__D025881
% 213.28/213.49       A species of VARICELLOVIRUS that causes a fatal MENINGOENCEPHALITIS in calves.%A%    
% 213.28/213.49  |- skos__altLabel mesh__D025881 Bovine encephalitis virus
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D025881 2004
% 213.28/213.49  |- skos__broader mesh__D025881smesh__D018140
% 213.28/213.49  |- mesh__publicMeSHNote mesh__D025881 2002   
% 213.28/213.49  |- skos__hiddenLabel mesh__D025881 Bovine encephalitis viruses
% 213.28/213.49  |- skos__historyNote mesh__D025881 Alphaherpesvirinae %28%1994-2001%29%
% 213.28/213.49  |- skos__hiddenLabel mesh__D025881 encephalitis viruses, Bovine
% 213.28/213.49  |- skos__prefLabel mesh__D025881 Herpesvirus 5, Bovine
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D025881 2003
% 213.28/213.49  |- skos__altLabel mesh__D025881 Bovine herpesvirus 5
% 213.28/213.49  |- mesh__dateCreated mesh__D025881 2001-07-25
% 213.28/213.49  |- mesh__historyNote mesh__D025881 2002   
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D025881 2006
% 213.28/213.49  |- mesh__dateEstablished mesh__D025881 2002-01-01
% 213.28/213.49  |- rdf__type mesh__D025881sskos__Concept
% 213.28/213.49  |- skos__historyNote mesh__D025881 Herpesviridae %28%1982-2001%29%
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D025881 2005
% 213.28/213.49  |- skos__annotation mesh__D025881
% 213.28/213.49       infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29% + MENINGOENCEPHALITIS %28%IM%29% + ENCEPHALITIS, VIRAL %28%IM%29%%A%  
% 213.28/213.49  |- skos__hiddenLabel mesh__D025881 encephalitis virus, Bovine
% 213.28/213.49  |- skos__annotation mesh__D019844
% 213.28/213.49       coordinate IM with specific archaeon /immunol %28%IM%29%; do not coordinate with ANTIBODY FORMATION for /biosyn%A%  
% 213.28/213.49  |- skos__altLabel mesh__D019844 Archaeal Antibodies
% 213.28/213.49  |- skos__broader mesh__D019844smesh__D000906
% 213.28/213.49  |- rdf__type mesh__D019844sskos__Concept
% 213.28/213.49  |- mesh__historyNote mesh__D019844 98   
% 213.28/213.49  |- mesh__publicMeSHNote mesh__D019844 98   
% 213.28/213.49  |- mesh__dateEstablished mesh__D019844 1998-01-01
% 213.28/213.49  |- mesh__dateRevised mesh__D019844 2005-06-30
% 213.28/213.49  |- mesh__recordAuthorizer mesh__D019844 sjn
% 213.28/213.49  |- skos__historyNote mesh__D019844 Antibodies, Bacterial %28%1984-1997%29%
% 213.28/213.49  |- mesh__recordMaintainer mesh__D019844 ssb
% 213.28/213.49  |- skos__prefLabel mesh__D019844 Antibodies, Archaeal
% 213.28/213.49  |- mesh__dateCreated mesh__D019844 1997-06-20
% 213.28/213.49  |- skos__scopeNote mesh__D019844
% 213.28/213.49       Immunoglobulins induced by substances elaborated by ARCHAEA that have an antigenic activity.%A%    
% 213.28/213.49  |- mesh__recordOriginator mesh__D019844 AGS
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D019844 2006
% 213.28/213.49  |- skos__scopeNote mesh__D011861
% 213.28/213.49       Radiographic techniques used in dentistry.     
% 213.28/213.49  |- mesh__recordMaintainer mesh__D011861 PXP
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D011861 2004
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D011861 2005
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D011861 1998
% 213.28/213.49  |- skos__annotation mesh__D011861
% 213.28/213.49       GEN; prefer /radiogr with dental organ terms; do not use /util except by MeSH definition; DF: RADIOGR DENT%A%  
% 213.28/213.49  |- skos__altLabel mesh__D011861 Dental Radiography
% 213.28/213.49  |- skos__broader mesh__D011861smesh__D011859
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D011861 2000
% 213.28/213.49  |- mesh__recordOriginator mesh__D011861 NLM
% 213.28/213.49  |- mesh__dateRevised mesh__D011861 1997-06-20
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D011861 2003
% 213.28/213.49  |- mesh__recordAuthorizer mesh__D011861 SJN
% 213.28/213.49  |- skos__broader mesh__D011861smesh__D003945
% 213.28/213.49  |- rdf__type mesh__D011861sskos__Concept
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D011861 2002
% 213.28/213.49  |- skos__prefLabel mesh__D011861 Radiography, Dental
% 213.28/213.49  |- mesh__dateCreated mesh__D011861 1999-01-01
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D011861 2006
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D011861 1999
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D011861 2001
% 213.28/213.49  |- skos__historyNote mesh__D019046 Bone Marrow/pathology %28%1968-1995%29%
% 213.28/213.49  |- skos__annotation mesh__D019046
% 213.28/213.49       neopl located in bone marrow: do not confuse with neopl composed of bone marrow cells %28%like myeloma%29%; /blood supply /chem /secret /second /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%: DF: BONE MARROW NEOPL%A%  
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D019046 2003
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D019046 1999
% 213.28/213.49  |- skos__hiddenLabel mesh__D019046 Bone Marrow Neoplasm
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D019046 2001
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D019046 2006
% 213.28/213.49  |- rdf__type mesh__D019046sskos__Concept
% 213.28/213.49  |- mesh__publicMeSHNote mesh__D019046 96   
% 213.28/213.49  |- skos__prefLabel mesh__D019046 Bone Marrow Neoplasms
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D019046 2000
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D019046 1998
% 213.28/213.49  |- skos__altLabel mesh__D019046 Neoplasms, Bone Marrow
% 213.28/213.49  |- mesh__recordMaintainer mesh__D019046 ags
% 213.28/213.49  |- skos__broader mesh__D019046smesh__D019337
% 213.28/213.49  |- skos__broader mesh__D019046smesh__D001855
% 213.28/213.49  |- mesh__dateCreated mesh__D019046 1995-06-08
% 213.28/213.49  |- skos__hiddenLabel mesh__D019046 Neoplasm, Bone Marrow
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D019046 2005
% 213.28/213.49  |- mesh__dateEstablished mesh__D019046 1996-01-01
% 213.28/213.49  |- skos__historyNote mesh__D019046 Bone Marrow Diseases %28%1966-1995%29%
% 213.28/213.49  |- mesh__recordAuthorizer mesh__D019046 ags
% 213.28/213.49  |- mesh__dateRevised mesh__D019046 2005-07-20
% 213.28/213.49  |- mesh__recordOriginator mesh__D019046 TGC
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D019046 2006A
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D019046 1997
% 213.28/213.49  |- mesh__historyNote mesh__D019046 96   
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D019046 2002
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D019046 2004
% 213.28/213.49  |- skos__scopeNote mesh__D019046
% 213.28/213.49       Neoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as MULTIPLE MYELOMA. Most bone marrow neoplasms are metastatic.%A%    
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D011063 2004
% 213.28/213.49  |- skos__scopeNote mesh__D011063
% 213.28/213.49       A double-stranded polyribonucleotide comprising polyadenylic and polyuridylic acids.%A%    
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D011063 2000
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D011063 2006
% 213.28/213.49  |- skos__altLabel mesh__D011063 Poly r%28%A-U%29%
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D011063 2003
% 213.28/213.49  |- mesh__recordMaintainer mesh__D011063 KEV
% 213.28/213.49  |- skos__broader mesh__D011063smesh__D011072
% 213.28/213.49  |- skos__annotation mesh__D011063 Do not confuse with POLY A   
% 213.28/213.49  |- skos__historyNote mesh__D011063 Polynucleotides %28%1966-1971%29%
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D011063 2005
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D011063 1999
% 213.28/213.49  |- skos__prefLabel mesh__D011063 Poly A-U
% 213.28/213.49  |- mesh__recordAuthorizer mesh__D011063 SJN
% 213.28/213.49  |- rdf__type mesh__D011063sskos__Concept
% 213.28/213.49  |- skos__altLabel mesh__D011063 Polyadenylic-Polyuridylic Acid
% 213.28/213.49  |- mesh__dateEstablished mesh__D011063 1974-01-01
% 213.28/213.49  |- mesh__recordOriginator mesh__D011063 NLM
% 213.28/213.49  |- mesh__publicMeSHNote mesh__D011063 74   
% 213.28/213.49  |- skos__hiddenLabel mesh__D011063 Acid, Polyadenylic-Polyuridylic
% 213.28/213.49  |- skos__altLabel mesh__D011063 Poly%28%rA%29%-Poly%28%rU%29%
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D011063 2002
% 213.28/213.49  |- mesh__dateCreated mesh__D011063 1999-01-01
% 213.28/213.49  |- skos__hiddenLabel mesh__D011063 Polyadenylic Polyuridylic Acid
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D011063 2001
% 213.28/213.49  |- mesh__historyNote mesh__D011063 74%28%72%29%   
% 213.28/213.49  |- skos__broader mesh__D011063smesh__D011061
% 213.28/213.49  |- mesh__dateRevised mesh__D011063 1998-06-10
% 213.28/213.49  |- skos__historyNote mesh__D011063 Interferon Inducers %28%1966-1971%29%
% 213.28/213.49  |- skos__hiddenLabel mesh__D011063 Poly A U
% 213.28/213.49  |- mesh__publicMeSHNote mesh__D005824 68   
% 213.28/213.49  |- mesh__dateRevised mesh__D005824 2002-07-02
% 213.28/213.49  |- mesh__dateCreated mesh__D005824 1999-01-01
% 213.28/213.49  |- rdf__type mesh__D005824sskos__Concept
% 213.28/213.49  |- skos__historyNote mesh__D005824 Genetics %28%1966-1967%29%
% 213.28/213.49  |- mesh__historyNote mesh__D005824 68   
% 213.28/213.49  |- skos__scopeNote mesh__D005824
% 213.28/213.49       The experimental study of the relationship between the genotype of an organism and its behavior. The scope includes the effects of genes on simple sensory processes to complex organization of the nervous system.%A%    
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D005824 2003
% 213.28/213.49  |- skos__related mesh__D005824smesh__D035503
% 213.28/213.49  |- skos__broader mesh__D005824smesh__D001525
% 213.28/213.49  |- skos__altLabel mesh__D005824 Behavioral Genetics
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D005824 2004
% 213.28/213.49  |- skos__broader mesh__D005824smesh__D005823
% 213.28/213.49  |- skos__annotation mesh__D005824 SPEC or GEN; prefer specifics   
% 213.28/213.49  |- mesh__recordMaintainer mesh__D005824 jrf
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D005824 2005
% 213.28/213.49  |- mesh__recordOriginator mesh__D005824 NLM
% 213.28/213.49  |- skos__historyNote mesh__D005824 Behavior, Animal %28%1966-1967%29%
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D005824 2006
% 213.28/213.49  |- skos__prefLabel mesh__D005824 Genetics, Behavioral
% 213.28/213.49  |- mesh__recordAuthorizer mesh__D005824 sjn
% 213.28/213.49  |- mesh__dateEstablished mesh__D005824 1968-01-01
% 213.28/213.49  |- skos__historyNote mesh__D005824 Behavior %28%1966-1967%29%
% 213.28/213.49  |- skos__broader mesh__D005026smesh__D006018
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D005026 1999
% 213.28/213.49  |- skos__altLabel mesh__D005026 Dihydroxyethanes
% 213.28/213.49  |- mesh__dateCreated mesh__D005026 1999-01-01
% 213.28/213.49  |- skos__historyNote mesh__D005026 Glycols %28%1966-1974%29%
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D005026 1998
% 213.28/213.49  |- rdf__type mesh__D005026sskos__Concept
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D005026 2002
% 213.28/213.49  |- mesh__dateEstablished mesh__D005026 1975-01-01
% 213.28/213.49  |- mesh__recordAuthorizer mesh__D005026 SJN
% 213.28/213.49  |- skos__altLabel mesh__D005026 Ethanediols
% 213.28/213.49  |- mesh__recordMaintainer mesh__D005026 ADP
% 213.28/213.49  |- mesh__recordOriginator mesh__D005026 NLM
% 213.28/213.49  |- mesh__onlineNote mesh__D005026 search GLYCOLS 1966-74   
% 213.28/213.49  |- mesh__publicMeSHNote mesh__D005026
% 213.28/213.49       75; was ETHYLENE GLYCOL see under GLYCOLS 1963-74   
% 213.28/213.49  |- skos__prefLabel mesh__D005026 Ethylene Glycols
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D005026 2006
% 213.28/213.49  |- mesh__dateRevised mesh__D005026 1997-06-20
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D005026 2001
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D005026 2005
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D005026 2004
% 213.28/213.49  |- skos__annotation mesh__D005026 ETHYLENE GLYCOL is also available   
% 213.28/213.49  |- skos__scopeNote mesh__D005026
% 213.28/213.49       An ethylene compound with two hydroxy groups %28%-OH%29% located on adjacent carbons. They are viscous and colorless liquids. Some are used as anesthetics or hypnotics. However, the class is best known for their use as a coolant or antifreeze.%A%    
% 213.28/213.49  |- mesh__historyNote mesh__D005026
% 213.28/213.49       75; was ETHYLENE GLYCOL see under GLYCOLS 1963-74   
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D005026 2000
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D005026 2003
% 213.28/213.49  |- skos__hiddenLabel mesh__D005026 Glycols, Ethylene
% 213.28/213.49  |- rdf__type mesh__D010769sskos__Concept
% 213.28/213.49  |- mesh__historyNote mesh__D010769
% 213.28/213.49       91%28%80%29%; was see under THREONINE 1980-90   
% 213.28/213.49  |- skos__scopeNote mesh__D010769
% 213.28/213.49       The phosphoric acid ester of threonine. Used as an identifier in the analysis of peptides, proteins, and enzymes.%A%    
% 213.28/213.49  |- skos__prefLabel mesh__D010769 Phosphothreonine
% 213.28/213.49  |- mesh__dateCreated mesh__D010769 1979-05-23
% 213.28/213.49  |- mesh__recordMaintainer mesh__D010769 TPW
% 213.28/213.49  |- skos__broader mesh__D010769smesh__D019606
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D010769 2004
% 213.28/213.49  |- skos__historyNote mesh__D010769
% 213.28/213.49       Threonine %28%1966-1974%29% /AA %28%1975-1979%29%
% 213.28/213.49  |- skos__broader mesh__D010769smesh__D013912
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D010769 2006
% 213.28/213.49  |- skos__historyNote mesh__D010769 Phosphoric Acids %28%1968-1970%29%
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D010769 2003
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D010769 2002
% 213.28/213.49  |- mesh__dateEstablished mesh__D010769 1991-01-01
% 213.28/213.49  |- skos__hiddenLabel mesh__D010769 Phosphate, Threonine
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D010769 2005
% 213.28/213.49  |- mesh__dateRevised mesh__D010769 1997-06-20
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D010769 1999
% 213.28/213.49  |- mesh__recordOriginator mesh__D010769 RLS
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D010769 2001
% 213.28/213.49  |- skos__historyNote mesh__D010769 Phosphoric Acid Esters %28%1979%29%
% 213.28/213.49  |- skos__historyNote mesh__D010769
% 213.28/213.49       Organophosphorus Compounds %28%1971-1978%29%
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D010769 1998
% 213.28/213.49  |- mesh__publicMeSHNote mesh__D010769
% 213.28/213.49       91; was see under THREONINE 1980-90   
% 213.28/213.49  |- skos__altLabel mesh__D010769 Threonine Phosphate
% 213.28/213.49  |- mesh__recordAuthorizer mesh__D010769 SJN
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D010769 2000
% 213.28/213.49  |- skos__hiddenLabel mesh__D015454 L1 Lymphocytic Leukemia
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D015454 2004
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D015454 2001
% 213.28/213.49  |- skos__altLabel mesh__D015454 ALL, Childhood
% 213.28/213.49  |- skos__hiddenLabel mesh__D015454 Lymphocytic Leukemias, L1
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D015454 2006
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D015454 2003
% 213.28/213.49  |- mesh__recordAuthorizer mesh__D015454 PLS
% 213.28/213.49  |- skos__historyNote mesh__D015454
% 213.28/213.49       Leukemia, Lymphoblastic %28%1975-1988%29%
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D015454 2005
% 213.28/213.49  |- mesh__activeMeSHYear mesh__D015454 2000
% 213.28/213.49  |- skos__altLabel mesh__D015454 Lymphoblastic Leukemia, Acute, Childhood
% 213.28/213.50  |- skos__hiddenLabel mesh__D015454 Leukemias, L1 Lymphocytic
% 213.28/213.50  |- skos__altLabel mesh__D015454 Lymphocytic Leukemia, L1
% 213.28/213.50  |- skos__hiddenLabel mesh__D015454 L1 Lymphocytic Leukemias
% 213.28/213.50  |- mesh__recordMaintainer mesh__D015454 KEV
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D015454 1997
% 213.28/213.50  |- mesh__historyNote mesh__D015454 89   
% 213.28/213.50  |- rdf__type mesh__D015454sskos__Concept
% 213.28/213.50  |- mesh__dateCreated mesh__D015454 1988-06-09
% 213.28/213.50  |- skos__broader mesh__D015454smesh__D015447
% 213.28/213.50  |- skos__hiddenLabel mesh__D015454 Leukemia, L1 Lymphocytic
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D015454 1999
% 213.28/213.50  |- skos__historyNote mesh__D015454 Leukemia, Lymphocytic %28%1975-1988%29%
% 213.28/213.50  |- mesh__recordOriginator mesh__D015454 PLS
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D015454 1996
% 213.28/213.50  |- skos__hiddenLabel mesh__D015454 Childhood ALL
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D015454 1998
% 213.28/213.50  |- skos__annotation mesh__D015454
% 213.28/213.50       do not use /blood supply /chem /second /secret /ultrastruct; don%27%t forget CHILD check tags; DF: note short X ref ALL, CHILDHOOD%A%  
% 213.28/213.50  |- skos__altLabel mesh__D015454 Leukemia, Lymphoblastic, Acute, L1
% 213.28/213.50  |- mesh__dateRevised mesh__D015454 1995-06-08
% 213.28/213.50  |- skos__altLabel mesh__D015454 Lymphoblastic Leukemia, Acute, L1
% 213.28/213.50  |- mesh__dateEstablished mesh__D015454 1989-01-01
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D015454 2002
% 213.28/213.50  |- skos__prefLabel mesh__D015454 Leukemia, Lymphocytic, Acute, L1
% 213.28/213.50  |- mesh__publicMeSHNote mesh__D015454 89   
% 213.28/213.50  |- mesh__dateRevised mesh__D009417 1997-06-20
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D009417 2004
% 213.28/213.50  |- skos__hiddenLabel mesh__D009417 Tissue, Nerve
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D009417 2000
% 213.28/213.50  |- skos__hiddenLabel mesh__D009417 Nerve Tissues
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D009417 2001
% 213.28/213.50  |- rdf__type mesh__D009417sskos__Concept
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D009417 1998
% 213.28/213.50  |- mesh__dateCreated mesh__D009417 1999-01-01
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D009417 2005
% 213.28/213.50  |- skos__broader mesh__D009417smesh__D014024
% 213.28/213.50  |- skos__annotation mesh__D009417
% 213.28/213.50       nerve as tissue: not for specific nerves %28%see Cat 8%29% or unspecified nerves %28% = NERVOUS SYSTEM%29%; inflammation = NEURITIS%A%  
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D009417 1999
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D009417 2006
% 213.28/213.50  |- skos__broader mesh__D009417smesh__D009420
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D009417 2002
% 213.28/213.50  |- mesh__recordAuthorizer mesh__D009417 SJN
% 213.28/213.50  |- skos__prefLabel mesh__D009417 Nerve Tissue
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D009417 2003
% 213.28/213.50  |- skos__hiddenLabel mesh__D009417 Tissues, Nerve
% 213.28/213.50  |- mesh__recordOriginator mesh__D009417 NLM
% 213.28/213.50  |- mesh__recordMaintainer mesh__D009417 TGC
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D001434 2002
% 213.28/213.50  |- skos__scopeNote mesh__D001434
% 213.28/213.50       A technique of bacterial typing which differentiates between bacteria or strains of bacteria by their susceptibility to one or more bacteriophages.%A%    
% 213.28/213.50  |- skos__annotation mesh__D001434 policy: Manual 22.24.4   
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D001434 2003
% 213.28/213.50  |- skos__altLabel mesh__D001434 Phage Typing
% 213.28/213.50  |- skos__broader mesh__D001434smesh__D015373
% 213.28/213.50  |- skos__prefLabel mesh__D001434 Bacteriophage Typing
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D001434 2004
% 213.28/213.50  |- mesh__dateRevised mesh__D001434 2000-06-21
% 213.28/213.50  |- mesh__recordOriginator mesh__D001434 NLM
% 213.28/213.50  |- mesh__recordMaintainer mesh__D001434 TAP
% 213.28/213.50  |- skos__hiddenLabel mesh__D001434 Typing, Phage
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D001434 2005
% 213.28/213.50  |- mesh__dateCreated mesh__D001434 1999-01-01
% 213.28/213.50  |- mesh__recordAuthorizer mesh__D001434 sjn
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D001434 2001
% 213.28/213.50  |- skos__altLabel mesh__D001434 Typing, Bacteriophage
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D001434 2006
% 213.28/213.50  |- rdf__type mesh__D001434sskos__Concept
% 213.28/213.50  |- rdf__type mesh__D020399sskos__Concept
% 213.28/213.50  |- skos__altLabel mesh__D020399 Practice Management Services, Medical
% 213.28/213.50  |- skos__altLabel mesh__D020399 Practice Management Services, Dental
% 213.28/213.50  |- mesh__recordOriginator mesh__D020399 JLS
% 213.28/213.50  |- skos__broader mesh__D020399smesh__D011364
% 213.28/213.50  |- mesh__historyNote mesh__D020399 99   
% 213.28/213.50  |- skos__hiddenLabel mesh__D020399 Managements, Practice
% 213.28/213.50  |- mesh__recordAuthorizer mesh__D020399 sjn
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D020399 2006
% 213.28/213.50  |- mesh__recordMaintainer mesh__D020399 kle
% 213.28/213.50  |- skos__scopeNote mesh__D020399
% 213.28/213.50       Business management of medical and dental practices that may include capital financing, utilization management, and arrangement of capitation agreements with other parties.%A%    
% 213.28/213.50  |- mesh__dateCreated mesh__D020399 1998-06-10
% 213.28/213.50  |- skos__hiddenLabel mesh__D020399 Management Service, Practice
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D020399 2005
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D020399 2002
% 213.28/213.50  |- skos__prefLabel mesh__D020399 Practice Management
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D020399 2004
% 213.28/213.50  |- mesh__dateEstablished mesh__D020399 1999-01-01
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D020399 2001
% 213.28/213.50  |- skos__hiddenLabel mesh__D020399 Practice Managements
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D020399 2003
% 213.28/213.50  |- mesh__publicMeSHNote mesh__D020399 99   
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D020399 2000
% 213.28/213.50  |- mesh__dateRevised mesh__D020399 1999-11-03
% 213.28/213.50  |- skos__hiddenLabel mesh__D020399 Management, Practice
% 213.28/213.50  |- skos__hiddenLabel mesh__D020399 Practice Management Service
% 213.28/213.50  |- skos__hiddenLabel mesh__D020399 Service, Practice Management
% 213.28/213.50  |- skos__broader mesh__D019845smesh__D000941
% 213.28/213.50  |- mesh__publicMeSHNote mesh__D019845 98   
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D019845 2006
% 213.28/213.50  |- skos__historyNote mesh__D019845 Antigens, Bacterial %28%1981-1997%29%
% 213.28/213.50  |- mesh__dateCreated mesh__D019845 1997-06-20
% 213.28/213.50  |- mesh__historyNote mesh__D019845 98   
% 213.28/213.50  |- rdf__type mesh__D019845sskos__Concept
% 213.28/213.50  |- skos__prefLabel mesh__D019845 Antigens, Archaeal
% 213.28/213.50  |- skos__scopeNote mesh__D019845
% 213.28/213.50       Substances of archaeal origin that have antigenic activity.%A%    
% 213.28/213.50  |- mesh__dateEstablished mesh__D019845 1998-01-01
% 213.28/213.50  |- mesh__recordOriginator mesh__D019845 AGS
% 213.28/213.50  |- mesh__recordMaintainer mesh__D019845 ssb
% 213.28/213.50  |- skos__altLabel mesh__D019845 Archaeal Antigens
% 213.28/213.50  |- mesh__recordAuthorizer mesh__D019845 sjn
% 213.28/213.50  |- mesh__dateRevised mesh__D019845 2005-06-30
% 213.28/213.50  |- skos__annotation mesh__D019845
% 213.28/213.50       coord IM with specific archaeon /immunol %28%IM%29%   
% 213.28/213.50  |- skos__hiddenLabel mesh__D011862 Radiographies, Panoramic
% 213.28/213.50  |- mesh__recordMaintainer mesh__D011862 AGS
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D011862 2006
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D011862 2000
% 213.28/213.50  |- mesh__recordOriginator mesh__D011862 NLM
% 213.28/213.50  |- skos__broader mesh__D011862smesh__D011861
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D011862 2004
% 213.28/213.50  |- skos__hiddenLabel mesh__D011862 Pantomographies
% 213.28/213.50  |- mesh__dateEstablished mesh__D011862 1974-01-01
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D011862 2005
% 213.28/213.50  |- mesh__publicMeSHNote mesh__D011862 74   
% 213.28/213.50  |- mesh__recordAuthorizer mesh__D011862 SJN
% 213.28/213.50  |- mesh__dateRevised mesh__D011862 1998-06-11
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D011862 2003
% 213.28/213.50  |- skos__altLabel mesh__D011862 Pantomography
% 213.28/213.50  |- rdf__type mesh__D011862sskos__Concept
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D011862 2002
% 213.28/213.50  |- mesh__historyNote mesh__D011862 74   
% 213.28/213.50  |- skos__prefLabel mesh__D011862 Radiography, Panoramic
% 213.28/213.50  |- mesh__dateCreated mesh__D011862 1999-01-01
% 213.28/213.50  |- skos__hiddenLabel mesh__D011862 Panoramic Radiographies
% 213.28/213.50  |- skos__scopeNote mesh__D011862
% 213.28/213.50       Extraoral body-section radiography depicting an entire maxilla, or both maxilla and mandible, on a single film.%A%    
% 213.28/213.50  |- skos__altLabel mesh__D011862 Panoramic Radiography
% 213.28/213.50  |- skos__altLabel mesh__D011862 Orthopantomography
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D011862 1999
% 213.28/213.50  |- skos__annotation mesh__D011862
% 213.28/213.50       do not use /util except by MeSH definition; DF: RADIOGR PANORAMIC%A%  
% 213.28/213.50  |- skos__hiddenLabel mesh__D011862 Orthopantomographies
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D011862 2001
% 213.28/213.50  |- skos__hiddenLabel mesh__D019047 Phantom, Imaging
% 213.28/213.50  |- skos__broader mesh__D019047smesh__D004864
% 213.28/213.50  |- skos__scopeNote mesh__D019047
% 213.28/213.50       Devices or objects in various imaging techniques used to visualize or enhance visualization by simulating conditions encountered in the procedure. Phantoms are used very often in procedures employing or measuring x-irradiation or radioactive material to evaluate performance. Phantoms often have properties similar to human tissue. Water demonstrates absorbing properties similar to normal tissue, hence water-filled phantoms are used to map radiation levels. Phantoms are used also as teaching aids to simulate real conditions with x-ray or ultrasonic machines. %28%From Iturralde, Dictionary and Handbook of Nuclear Medicine and Clinical Imaging, 1990%29%%A%    
% 213.28/213.50  |- mesh__dateRevised mesh__D019047 2004-07-13
% 213.28/213.50  |- skos__prefLabel mesh__D019047 Phantoms, Imaging
% 213.28/213.50  |- mesh__recordOriginator mesh__D019047 TGC
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D019047 2005
% 213.28/213.50  |- skos__altLabel mesh__D019047 Phantoms, Radiologic
% 213.28/213.50  |- skos__altLabel mesh__D019047 Phantom, Radiologic
% 213.28/213.50  |- mesh__historyNote mesh__D019047 96   
% 213.28/213.50  |- mesh__recordAuthorizer mesh__D019047 sjn
% 213.28/213.50  |- skos__hiddenLabel mesh__D019047 Imaging Phantoms
% 213.28/213.50  |- skos__altLabel mesh__D019047 Radiographic Phantom
% 213.28/213.50  |- skos__altLabel mesh__D019047 Radiologic Phantom
% 213.28/213.50  |- skos__hiddenLabel mesh__D019047 Imaging Phantom
% 213.28/213.50  |- mesh__dateEstablished mesh__D019047 1996-01-01
% 213.28/213.50  |- mesh__recordMaintainer mesh__D019047 sjn
% 213.28/213.50  |- mesh__publicMeSHNote mesh__D019047 96   
% 213.28/213.50  |- skos__altLabel mesh__D019047 Phantoms, Radiographic
% 213.28/213.50  |- skos__altLabel mesh__D019047 Phantom, Radiographic
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D019047 2006
% 213.28/213.50  |- mesh__dateCreated mesh__D019047 1995-06-05
% 213.28/213.50  |- skos__annotation mesh__D019047
% 213.28/213.50       IM or NIM; coord with specific technique /instrum %28%IM%29%   
% 213.28/213.50  |- rdf__type mesh__D019047sskos__Concept
% 213.28/213.50  |- skos__hiddenLabel mesh__D011064 Poly ADPR
% 213.28/213.50  |- skos__broader mesh__D011064smesh__D000246
% 213.28/213.50  |- mesh__dateRevised mesh__D011064 2004-07-07
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D011064 2005
% 213.28/213.50  |- skos__altLabel mesh__D011064 Poly ADP Ribose
% 213.28/213.50  |- skos__related mesh__D011064smesh__D011065
% 213.28/213.50  |- rdf__type mesh__D011064sskos__Concept
% 213.28/213.50  |- skos__hiddenLabel mesh__D011064 ADP Ribose, Poly
% 213.28/213.50  |- mesh__dateCreated mesh__D011064 1974-11-19
% 213.28/213.50  |- mesh__dateEstablished mesh__D011064 1991-01-01
% 213.28/213.50  |- skos__historyNote mesh__D011064 Adenosine Diphosphate %28%1973-1974%29%
% 213.28/213.50  |- skos__historyNote mesh__D011064
% 213.28/213.50       Nucleoside Diphosphate Sugars %28%1973-1974%29%
% 213.28/213.50  |- mesh__publicMeSHNote mesh__D011064
% 213.28/213.50       91; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90   
% 213.28/213.50  |- skos__altLabel mesh__D011064 Poly%28%ADP-Ribose%29%
% 213.28/213.50  |- skos__altLabel mesh__D011064 Poly-Adenosine Diphosphate-Ribose
% 213.28/213.50  |- skos__hiddenLabel mesh__D011064 Diphosphate-Ribose, Poly-Adenosine
% 213.28/213.50  |- skos__related mesh__D011064smesh__D000246
% 213.28/213.50  |- skos__hiddenLabel mesh__D011064 Ribose, Poly ADP
% 213.28/213.50  |- mesh__recordOriginator mesh__D011064 NLM
% 213.28/213.50  |- mesh__recordAuthorizer mesh__D011064 sjn
% 213.28/213.50  |- skos__scopeNote mesh__D011064
% 213.28/213.50       A polynucleotide formed from the ADP-RIBOSE moiety of nicotinamide-adenine dinucleotide %28%NAD%29% by POLY%28%ADP-RIBOSE%29% POLYMERASES.%A%    
% 213.28/213.50  |- skos__prefLabel mesh__D011064 Poly Adenosine Diphosphate Ribose
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D011064 2006
% 213.28/213.50  |- skos__altLabel mesh__D011064 Poly-ADPR
% 213.28/213.50  |- mesh__recordMaintainer mesh__D011064 ssb
% 213.28/213.50  |- skos__broader mesh__D011064smesh__D011131
% 213.28/213.50  |- skos__historyNote mesh__D011064 Polynucleotides %28%1973-1974%29%
% 213.28/213.50  |- mesh__historyNote mesh__D011064
% 213.28/213.50       91%28%75%29%; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90%A%  
% 213.28/213.50  |- skos__hiddenLabel mesh__D038201 alpha Crystallin
% 213.28/213.50  |- mesh__recordMaintainer mesh__D038201 SYSTEM
% 213.28/213.50  |- skos__broader mesh__D038201smesh__D003459
% 213.28/213.50  |- skos__historyNote mesh__D038201 Crystallins %28%1965-2002%29%
% 213.28/213.50  |- skos__broader mesh__D038201smesh__D018832
% 213.28/213.50  |- skos__hiddenLabel mesh__D038201 alpha Crystallins
% 213.28/213.50  |- skos__prefLabel mesh__D038201 alpha-Crystallins
% 213.28/213.50  |- mesh__dateEstablished mesh__D038201 2003-01-01
% 213.28/213.50  |- skos__altLabel mesh__D038201 Crystallins, alpha
% 213.28/213.50  |- skos__scopeNote mesh__D038201
% 213.28/213.50       A subclass of crystallins that provides the majority of refractive power and translucency to the lens %28%LENS, CRYSTALLINE%29% in VERTEBRATES. Alpha-crystallins also act as molecular chaperones that bind to denatured proteins, keep them in solution and thereby maintain the translucency of the lens. The proteins exist as large oligomers that are formed from ALPHA-CRYSTALLIN A CHAIN and ALPHA-CRYSTALLIN B CHAIN subunits.%A%    
% 213.28/213.50  |- skos__altLabel mesh__D038201 alpha-Crystallin
% 213.28/213.50  |- mesh__recordAuthorizer mesh__D038201 sjn
% 213.28/213.50  |- rdf__type mesh__D038201sskos__Concept
% 213.28/213.50  |- mesh__historyNote mesh__D038201
% 213.28/213.50       2003; for ALPHA-CRYSTALLIN use CRYSTALLINS 1982-2002   
% 213.28/213.50  |- mesh__recordOriginator mesh__D038201 jmp
% 213.28/213.50  |- mesh__publicMeSHNote mesh__D038201
% 213.28/213.50       2003; for ALPHA-CRYSTALLIN see CRYSTALLINS 1982-2002   
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D038201 2006
% 213.28/213.50  |- mesh__dateRevised mesh__D038201 2005-06-30
% 213.28/213.50  |- mesh__dateCreated mesh__D038201 2002-07-02
% 213.28/213.50  |- rdf__type mesh__D005027sskos__Concept
% 213.28/213.50  |- skos__broader mesh__D005027smesh__D004852
% 213.28/213.50  |- skos__hiddenLabel mesh__D005027 Oxide, Ethylene
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D005027 2006
% 213.28/213.50  |- mesh__recordMaintainer mesh__D005027 ssb
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D005027 2005
% 213.28/213.50  |- skos__prefLabel mesh__D005027 Ethylene Oxide
% 213.28/213.50  |- mesh__recordOriginator mesh__D005027 NLM
% 213.28/213.50  |- mesh__dateCreated mesh__D005027 1999-01-01
% 213.28/213.50  |- mesh__recordAuthorizer mesh__D005027 sjn
% 213.28/213.50  |- skos__scopeNote mesh__D005027
% 213.28/213.50       A colorless and flammable gas at room temperature and pressure. Ethylene oxide is a bactericidal, fungicidal, and sporicidal disinfectant. It is effective against most micro-organisms, including viruses. It is used as a fumigant for foodstuffs and textiles and as an agent for the gaseous sterilization of heat-labile pharmaceutical and surgical materials. %28%From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p794%29%%A%    
% 213.28/213.50  |- mesh__dateRevised mesh__D005027 2004-07-07
% 213.28/213.50  |- skos__altLabel mesh__D005027 Oxirane
% 213.28/213.50  |- skos__historyNote mesh__D015455
% 213.28/213.50       Leukemia, Lymphoblastic %28%1975-1988%29%
% 213.28/213.50  |- skos__hiddenLabel mesh__D015455 Lymphocytic Leukemias, L2
% 213.28/213.50  |- rdf__type mesh__D015455sskos__Concept
% 213.28/213.50  |- skos__hiddenLabel mesh__D015455 Leukemias, L2 Lymphocytic
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D015455 2002
% 213.28/213.50  |- skos__broader mesh__D015455smesh__D015447
% 213.28/213.50  |- skos__hiddenLabel mesh__D015455 Leukemia, L2 Lymphocytic
% 213.28/213.50  |- mesh__recordAuthorizer mesh__D015455 sjn
% 213.28/213.50  |- mesh__recordOriginator mesh__D015455 PLS
% 213.28/213.50  |- skos__hiddenLabel mesh__D015455 L2 Lymphocytic Leukemias
% 213.28/213.50  |- skos__altLabel mesh__D015455 Lymphocytic Leukemia, L2
% 213.28/213.50  |- skos__annotation mesh__D015455
% 213.28/213.50       note X ref on Philadelphia-positive: LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE is also available; do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 213.28/213.50  |- skos__historyNote mesh__D015455 Leukemia, Lymphocytic %28%1975-1988%29%
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D015455 2001
% 213.28/213.50  |- skos__altLabel mesh__D015455 Lymphoblastic Leukemia, Acute, Adult
% 213.28/213.50  |- mesh__dateEstablished mesh__D015455 1989-01-01
% 213.28/213.50  |- mesh__publicMeSHNote mesh__D015455 89   
% 213.28/213.50  |- skos__altLabel mesh__D015455 Leukemia, Lymphoblastic, Acute, L2
% 213.28/213.50  |- skos__hiddenLabel mesh__D015455 L2 Lymphocytic Leukemia
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D015455 2004
% 213.28/213.50  |- skos__altLabel mesh__D015455 Lymphoblastic Leukemia, Acute, L2
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D015455 2000
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D015455 2006
% 213.28/213.50  |- skos__prefLabel mesh__D015455 Leukemia, Lymphocytic, Acute, L2
% 213.28/213.50  |- skos__altLabel mesh__D015455
% 213.28/213.50       Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
% 213.28/213.50  |- mesh__dateCreated mesh__D015455 1988-06-09
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D015455 2003
% 213.28/213.50  |- mesh__dateRevised mesh__D015455 1999-11-03
% 213.28/213.50  |- mesh__recordMaintainer mesh__D015455 ags
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D015455 2005
% 213.28/213.50  |- mesh__historyNote mesh__D015455 89   
% 213.28/213.50  |- skos__altLabel mesh__D009418 Antigen S 100
% 213.28/213.50  |- mesh__dateEstablished mesh__D009418 1984-01-01
% 213.28/213.50  |- mesh__recordOriginator mesh__D009418 NLM
% 213.28/213.50  |- skos__altLabel mesh__D009418 Nerve Tissue Protein S 100
% 213.28/213.50  |- skos__broader mesh__D009418smesh__D002135
% 213.28/213.50  |- mesh__recordAuthorizer mesh__D009418 sjn
% 213.28/213.50  |- skos__altLabel mesh__D009418 S100 Protein Family
% 213.28/213.50  |- mesh__recordMaintainer mesh__D009418 SYSTEM
% 213.28/213.50  |- skos__hiddenLabel mesh__D009418 S 100 Protein
% 213.28/213.50  |- skos__prefLabel mesh__D009418 S100 Proteins
% 213.28/213.50  |- skos__altLabel mesh__D009418 S-100 Protein
% 213.28/213.50  |- rdf__type mesh__D009418sskos__Concept
% 213.28/213.50  |- skos__broader mesh__D009418smesh__D009419
% 213.28/213.50  |- skos__scopeNote mesh__D009418
% 213.28/213.50       A family of highly acidic calcium-binding proteins found in large concentration in the brain and believed to be glial in origin. They are also found in other organs in the body. They have in common the EF-hand motif %28%EF-HAND MOTIFS%29% found on a number of calcium binding proteins. The name of this family derives from the property of being soluble in a 100%25% saturated ammonium sulfate solution.%A%    
% 213.28/213.50  |- mesh__dateCreated mesh__D009418 1999-01-01
% 213.28/213.50  |- mesh__historyNote mesh__D009418 2003%28%1973%29%   
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D009418 2006
% 213.28/213.50  |- mesh__publicMeSHNote mesh__D009418
% 213.28/213.50       2003; see NERVE TISSUE PROTEIN S 100 1984-2002, see NERVE TISSUE PROTEINS 1975-1983%A%  
% 213.28/213.50  |- mesh__dateRevised mesh__D009418 2005-06-30
% 213.28/213.50  |- skos__historyNote mesh__D009418 Nerve Tissue Proteins %28%1966-1972%29%
% 213.28/213.50  |- skos__related mesh__D001435smesh__D008242
% 213.28/213.50  |- skos__related mesh__D001435smesh__D005822
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D001435 2006
% 213.28/213.50  |- rdf__type mesh__D001435sskos__Concept
% 213.28/213.50  |- mesh__historyNote mesh__D001435 75; was BACTERIOPHAGE 1963-74   
% 213.28/213.50  |- mesh__recordAuthorizer mesh__D001435 sjn
% 213.28/213.50  |- mesh__recordMaintainer mesh__D001435 nns
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D001435 2005
% 213.28/213.50  |- skos__annotation mesh__D001435
% 213.28/213.50       = %22%bacterial virus%22%; GEN or unspecified: prefer specific available phages; for other phages, coord IM with specific bacterium /virol %28%NIM; IM only when identity of bacterium is particularly significant%29%; policy: Manual 22.24.3%A%  
% 213.28/213.50  |- skos__hiddenLabel mesh__D001435 Phage
% 213.28/213.50  |- skos__scopeNote mesh__D001435
% 213.28/213.50       Viruses whose hosts are bacterial cells.     
% 213.28/213.50  |- mesh__onlineNote mesh__D001435
% 213.28/213.50       use BACTERIOPHAGES to search BACTERIOPHAGE 1966-74   
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D001435 2004
% 213.28/213.50  |- skos__broader mesh__D001435smesh__D014780
% 213.28/213.50  |- skos__hiddenLabel mesh__D001435 Bacteriophage
% 213.28/213.50  |- mesh__dateCreated mesh__D001435 1999-01-01
% 213.28/213.50  |- mesh__publicMeSHNote mesh__D001435 75; was BACTERIOPHAGE 1963-74   
% 213.28/213.50  |- skos__prefLabel mesh__D001435 Bacteriophages
% 213.28/213.50  |- skos__altLabel mesh__D001435 Phages
% 213.28/213.50  |- mesh__recordOriginator mesh__D001435 NLM
% 213.28/213.50  |- mesh__dateRevised mesh__D001435 2003-07-09
% 213.28/213.50  |- mesh__publicMeSHNote mesh__D006120
% 213.28/213.50       68; PREENING was see under GROOMING 1975-90   
% 213.28/213.50  |- skos__historyNote mesh__D006120 Behavior, Animal %28%1966-1967%29%
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D006120 2006
% 213.28/213.50  |- skos__scopeNote mesh__D006120
% 213.28/213.50       An animal%27%s cleaning and caring for the body surface. This includes preening, the cleaning and oiling of feathers with the bill or of hair with the tongue.%A%    
% 213.28/213.50  |- mesh__recordAuthorizer mesh__D006120 sjn
% 213.28/213.50  |- mesh__recordOriginator mesh__D006120 NLM
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D006120 2005
% 213.28/213.50  |- mesh__dateEstablished mesh__D006120 1968-01-01
% 213.28/213.50  |- mesh__onlineNote mesh__D006120
% 213.28/213.50       use GROOMING to search PREENING 1975-90   
% 213.28/213.50  |- mesh__dateRevised mesh__D006120 2002-07-03
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D006120 2004
% 213.28/213.50  |- skos__annotation mesh__D006120
% 213.28/213.50       animal only; for personal grooming of humans use HYGIENE   
% 213.28/213.50  |- rdf__type mesh__D006120sskos__Concept
% 213.28/213.50  |- skos__prefLabel mesh__D006120 Grooming
% 213.28/213.50  |- mesh__historyNote mesh__D006120
% 213.28/213.50       68; PREENING was see under GROOMING 1975-90   
% 213.28/213.50  |- mesh__recordMaintainer mesh__D006120 TAP
% 213.28/213.50  |- skos__broader mesh__D006120smesh__D001070
% 213.28/213.50  |- mesh__dateCreated mesh__D006120 1999-01-01
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D006120 2003
% 213.28/213.50  |- skos__hiddenLabel mesh__D006120 Preenings
% 213.28/213.50  |- skos__hiddenLabel mesh__D006120 Groomings
% 213.28/213.50  |- skos__broader mesh__D019846smesh__D015835
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D019846 2003
% 213.28/213.50  |- skos__historyNote mesh__D019846 Reflex, Abnormal %28%1966-1997%29%
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D019846 2000
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D019846 2005
% 213.28/213.50  |- skos__hiddenLabel mesh__D019846 Syndrome, Fisher
% 213.28/213.50  |- rdf__type mesh__D019846sskos__Concept
% 213.28/213.50  |- skos__broader mesh__D019846smesh__D020275
% 213.28/213.50  |- mesh__publicMeSHNote mesh__D019846 1998   
% 213.28/213.50  |- skos__historyNote mesh__D019846 Cerebellar Ataxia %28%1970-1997%29%
% 213.28/213.50  |- skos__historyNote mesh__D019846 Polyradiculitis %28%1966-1984%29%
% 213.28/213.50  |- mesh__dateRevised mesh__D019846 1999-11-08
% 213.28/213.50  |- skos__altLabel mesh__D019846 Miller-Fisher Syndrome
% 213.28/213.50  |- mesh__recordOriginator mesh__D019846 TGC
% 213.28/213.50  |- skos__prefLabel mesh__D019846 Miller Fisher Syndrome
% 213.28/213.50  |- skos__scopeNote mesh__D019846
% 213.28/213.50       A variant of the GUILLAIN-BARRE SYNDROME characterized by the acute onset of oculomotor dysfunction, ataxia, and loss of deep tendon reflexes with relative sparing of strength in the extremities and trunk. The ataxia is produced by peripheral sensory nerve dysfunction and not by cerebellar injury. Facial weakness and sensory loss may also occur. The process is mediated by autoantibodies directed against a component of myelin found in peripheral nerves. %28%Adams et al., Principles of Neurology, 6th ed, p1313; Neurology 1987 Sep;37%28%9%29%:1493-8%29%%A%    
% 213.28/213.50  |- mesh__dateCreated mesh__D019846 1997-06-20
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D019846 2002
% 213.28/213.50  |- skos__altLabel mesh__D019846
% 213.28/213.50       Guillain Barre Syndrome, Miller Fisher Variant
% 213.28/213.50  |- skos__historyNote mesh__D019846 Ophthalmoplegia %28%1966-1997%29%
% 213.28/213.50  |- mesh__dateEstablished mesh__D019846 1998-01-01
% 213.28/213.50  |- skos__annotation mesh__D019846
% 213.28/213.50       X ref FISHER SYNDROME: do not confuse with the Fisher one-and-a-half syndrome, an eye movement disorder caused by a brain stem lesion%A%  
% 213.28/213.50  |- skos__hiddenLabel mesh__D019846 Syndrome, Miller-Fisher
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D019846 2004
% 213.28/213.50  |- skos__hiddenLabel mesh__D019846 Syndrome, Miller Fisher
% 213.28/213.50  |- skos__historyNote mesh__D019846 Polyradiculoneuritis %28%1981-1997%29%
% 213.28/213.50  |- skos__altLabel mesh__D019846
% 213.28/213.50       Ophthalmoplegia, Ataxia and Areflexia Syndrome
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D019846 2001
% 213.28/213.50  |- mesh__historyNote mesh__D019846 1998   
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D019846 2006
% 213.28/213.50  |- skos__altLabel mesh__D019846 Fisher Syndrome
% 213.28/213.50  |- skos__altLabel mesh__D019846
% 213.28/213.50       Miller Fisher Variant of Guillain Barre Syndrome
% 213.28/213.50  |- mesh__recordAuthorizer mesh__D019846 sjn
% 213.28/213.50  |- skos__broader mesh__D019846smesh__D002526
% 213.28/213.50  |- mesh__recordMaintainer mesh__D019846 KEV
% 213.28/213.50  |- skos__altLabel mesh__D019846
% 213.28/213.50       Guillain-Barre Syndrome, Miller Fisher Variant
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D011863 2005
% 213.28/213.50  |- skos__prefLabel mesh__D011863 Radioimmunoassay
% 213.28/213.50  |- skos__annotation mesh__D011863
% 213.28/213.50       NIM; coord with substance /anal or body fluid qualif but not /immunol; do not confuse with IMMUNORADIOMETRIC ASSAY%A%  
% 213.28/213.50  |- mesh__recordMaintainer mesh__D011863 sjn
% 213.28/213.50  |- mesh__recordAuthorizer mesh__D011863 sjn
% 213.28/213.50  |- rdf__type mesh__D011863sskos__Concept
% 213.28/213.50  |- skos__broader mesh__D011863smesh__D007118
% 213.28/213.50  |- skos__broader mesh__D011863smesh__D003947
% 213.28/213.50  |- skos__historyNote mesh__D011863 Immunoassay %28%1966-1967%29%
% 213.28/213.50  |- mesh__recordOriginator mesh__D011863 NLM
% 213.28/213.50  |- mesh__dateCreated mesh__D011863 1999-01-01
% 213.28/213.50  |- mesh__dateRevised mesh__D011863 2004-07-13
% 213.28/213.50  |- mesh__historyNote mesh__D011863 68   
% 213.28/213.50  |- mesh__publicMeSHNote mesh__D011863 68   
% 213.28/213.50  |- mesh__dateEstablished mesh__D011863 1968-01-01
% 213.28/213.50  |- skos__scopeNote mesh__D011863
% 213.28/213.50       Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance %28%radioligand%29% either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances %28%e.g., haptens%29% can be measured if coupled to larger carrier proteins %28%e.g., bovine gamma-globulin or human serum albumin%29% capable of inducing antibody formation.%A%    
% 213.28/213.50  |- skos__hiddenLabel mesh__D011863 Radioimmunoassays
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D011863 2006
% 213.28/213.50  |- skos__hiddenLabel mesh__D019048 Neoplasm, Prostatic Intraepithelial
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D019048 2000
% 213.28/213.50  |- mesh__historyNote mesh__D019048 96   
% 213.28/213.50  |- skos__hiddenLabel mesh__D019048 Neoplasms, Prostatic Intraepithelial
% 213.28/213.50  |- mesh__dateRevised mesh__D019048 1999-11-03
% 213.28/213.50  |- skos__hiddenLabel mesh__D019048 Intraepithelial Neoplasms, Prostatic
% 213.28/213.50  |- skos__scopeNote mesh__D019048
% 213.28/213.50       A premalignant change arising in the prostatic epithelium, regarded as the most important and most likely precursor of prostatic adenocarcinoma. The neoplasia takes the form of an intra-acinar or ductal proliferation of secretory cells with unequivocal nuclear anaplasia, which corresponds to nuclear grade 2 and 3 invasive prostate cancer.%A%    
% 213.28/213.50  |- skos__historyNote mesh__D019048 Prostatic Neoplasms %28%1989-1995%29%
% 213.28/213.50  |- skos__altLabel mesh__D019048 Prostatic Intraepithelial Neoplasms
% 213.28/213.50  |- skos__prefLabel mesh__D019048 Prostatic Intraepithelial Neoplasia
% 213.28/213.50  |- mesh__recordMaintainer mesh__D019048 nns
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D019048 2004
% 213.28/213.50  |- mesh__recordOriginator mesh__D019048 TGC
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D019048 2002
% 213.28/213.50  |- skos__hiddenLabel mesh__D019048 Prostatic Neoplasia, Intraepithelial
% 213.28/213.50  |- skos__broader mesh__D019048smesh__D002278
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D019048 2003
% 213.28/213.50  |- skos__hiddenLabel mesh__D019048 Intraepithelial Neoplasm, Prostatic
% 213.28/213.50  |- skos__hiddenLabel mesh__D019048 Intraepithelial Neoplasia, Prostatic
% 213.28/213.50  |- skos__annotation mesh__D019048
% 213.28/213.50       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with PROSTATIC NEOPLASMS %28%IM%29%; DF: PROSTATIC INTRAEPITHELIAL NEOPL%A%  
% 213.28/213.50  |- mesh__recordAuthorizer mesh__D019048 sjn
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D019048 2006
% 213.28/213.50  |- skos__altLabel mesh__D019048 Intraepithelial Prostatic Neoplasia
% 213.28/213.50  |- skos__hiddenLabel mesh__D019048 Neoplasia, Intraepithelial Prostatic
% 213.28/213.50  |- skos__hiddenLabel mesh__D019048 Prostatic Intraepithelial Neoplasias
% 213.28/213.50  |- skos__altLabel mesh__D019048 Neoplasia, Prostatic Intraepithelial
% 213.28/213.50  |- mesh__activeMeSHYear mesh__D019048 2001
% 213.28/213.50  |- rdf__type mesh__D019048sskos__Concept
% 213.28/213.50  |- skos__hiddenLabel mesh__D019048 Intraepithelial Prostatic Neoplasias
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D019048 2005
% 213.28/213.51  |- mesh__dateCreated mesh__D019048 1995-06-08
% 213.28/213.51  |- mesh__dateEstablished mesh__D019048 1996-01-01
% 213.28/213.51  |- mesh__publicMeSHNote mesh__D019048 96   
% 213.28/213.51  |- skos__hiddenLabel mesh__D019048 Prostatic Intraepithelial Neoplasm
% 213.28/213.51  |- rdf__type mesh__D011065sskos__Concept
% 213.28/213.51  |- mesh__historyNote mesh__D011065
% 213.28/213.51       2003 %28%1977%29%; use NAD NUCLEOSIDASE 1975-1976   
% 213.28/213.51  |- skos__altLabel mesh__D011065 Poly ADP-Ribose Synthase
% 213.28/213.51  |- mesh__dateEstablished mesh__D011065 1986-01-01
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011065 2005
% 213.28/213.51  |- skos__altLabel mesh__D011065 Nuclear ADP-Ribosyltransferase
% 213.28/213.51  |- skos__altLabel mesh__D011065 Poly ADP Ribose Transferase
% 213.28/213.51  |- skos__altLabel mesh__D011065 ADP-Ribosyltransferase, Nuclear
% 213.28/213.51  |- mesh__dateRevised mesh__D011065 2003-07-09
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011065 2004
% 213.28/213.51  |- skos__altLabel mesh__D011065 Poly ADP Ribose Polymerase
% 213.28/213.51  |- skos__hiddenLabel mesh__D011065 ADPRT, Nuclear
% 213.28/213.51  |- skos__hiddenLabel mesh__D011065 ADP Ribosyltransferase, Nuclear
% 213.28/213.51  |- skos__historyNote mesh__D011065 Nucleosidases %28%1966-1974%29%
% 213.28/213.51  |- skos__hiddenLabel mesh__D011065
% 213.28/213.51       Adenosine Diphosphoribosyltransferase, Nuclear
% 213.28/213.51  |- skos__hiddenLabel mesh__D011065 Nuclear ADP Ribosyltransferase
% 213.28/213.51  |- skos__hiddenLabel mesh__D011065 Poly ADP Ribose Synthase
% 213.28/213.51  |- skos__historyNote mesh__D011065 NAD Nucleosidase %28%1975-1976%29%
% 213.28/213.51  |- skos__hiddenLabel mesh__D011065 NAD+ ADP-Ribosyltransferase, Nuclear
% 213.28/213.51  |- skos__altLabel mesh__D011065 Poly%28%ADPR%29% Polymerase
% 213.28/213.51  |- skos__altLabel mesh__D011065 Poly%28%ADPribose%29% Polymerase
% 213.28/213.51  |- skos__altLabel mesh__D011065 Poly%28%ADP-ribose%29% Polymerase
% 213.28/213.51  |- skos__hiddenLabel mesh__D011065 Synthase, Poly ADP-Ribose
% 213.28/213.51  |- mesh__recordAuthorizer mesh__D011065 sjn
% 213.28/213.51  |- skos__prefLabel mesh__D011065 Poly%28%ADP-ribose%29% Polymerases
% 213.28/213.51  |- skos__altLabel mesh__D011065
% 213.28/213.51       Nuclear Adenosine Diphosphoribosyltransferase
% 213.28/213.51  |- skos__altLabel mesh__D011065 Nuclear ADPRT
% 213.28/213.51  |- skos__altLabel mesh__D011065 Poly%28%ADP-Ribose%29% Transferase
% 213.28/213.51  |- mesh__dateCreated mesh__D011065 1976-04-19
% 213.28/213.51  |- skos__hiddenLabel mesh__D011065 ADP-Ribosyltransferase, Nuclear NAD+
% 213.28/213.51  |- mesh__publicMeSHNote mesh__D011065
% 213.28/213.51       2003 %28%1977%29%; see NAD+ ADP-RIBOSYLTRANSFERASE 1992-2002, see POLY ADP RIBOSE POLYMERASE 1977-1991, see NAD NUCLEOSIDASE 1975-1976%A%  
% 213.28/213.51  |- skos__broader mesh__D011065smesh__D036002
% 213.28/213.51  |- skos__altLabel mesh__D011065 Poly%28%ADP-Ribose%29% Synthase
% 213.28/213.51  |- skos__altLabel mesh__D011065 ADP-Ribosyltransferase %28%Polymerizing%29%
% 213.28/213.51  |- skos__altLabel mesh__D011065 PARP Polymerase
% 213.28/213.51  |- mesh__recordOriginator mesh__D011065 RLS
% 213.28/213.51  |- skos__hiddenLabel mesh__D011065 Nuclear NAD+ ADP Ribosyltransferase
% 213.28/213.51  |- skos__altLabel mesh__D011065 Nuclear NAD+ ADP-Ribosyltransferase
% 213.28/213.51  |- skos__hiddenLabel mesh__D011065 Polymerase, PARP
% 213.28/213.51  |- mesh__recordMaintainer mesh__D011065 ssb
% 213.28/213.51  |- skos__scopeNote mesh__D011065
% 213.28/213.51       Enzymes that catalyze the transfer of multiple ADP-RIBOSE groups from nicotinamide-adenine dinucleotide %28%NAD%29% onto protein targets, thus building up a linear or branched homopolymer of repeating ADP-ribose units i.e., POLY ADENOSINE DIPHOSPHATE RIBOSE.%A%    
% 213.28/213.51  |- skos__hiddenLabel mesh__D011065
% 213.28/213.51       Diphosphoribosyltransferase, Nuclear Adenosine
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011065 2006
% 213.28/213.51  |- mesh__historyNote mesh__D005826 80; was GENETICS, HUMAN 1963-79   
% 213.28/213.51  |- skos__prefLabel mesh__D005826 Genetics, Medical
% 213.28/213.51  |- skos__broader mesh__D005826smesh__D005823
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D005826 2005
% 213.28/213.51  |- mesh__recordMaintainer mesh__D005826 sjn
% 213.28/213.51  |- skos__altLabel mesh__D005826 Genetics, Human
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D005826 2006
% 213.28/213.51  |- mesh__recordOriginator mesh__D005826 NLM
% 213.28/213.51  |- rdf__type mesh__D005826sskos__Concept
% 213.28/213.51  |- mesh__publicMeSHNote mesh__D005826 80; was GENETICS, HUMAN 1963-79   
% 213.28/213.51  |- mesh__dateRevised mesh__D005826 2004-07-13
% 213.28/213.51  |- mesh__dateCreated mesh__D005826 1999-01-01
% 213.28/213.51  |- skos__related mesh__D005826smesh__D030342
% 213.28/213.51  |- mesh__recordAuthorizer mesh__D005826 sjn
% 213.28/213.51  |- skos__related mesh__D005826smesh__D002869
% 213.28/213.51  |- skos__related mesh__D005826smesh__D004200
% 213.28/213.51  |- skos__related mesh__D005826smesh__D005053
% 213.28/213.51  |- skos__broader mesh__D005826smesh__D008511
% 213.28/213.51  |- mesh__onlineNote mesh__D005826
% 213.28/213.51       use GENETICS, MEDICAL to search GENETICS, HUMAN 1966-79   
% 213.28/213.51  |- skos__scopeNote mesh__D005826
% 213.28/213.51       A subdiscipline of human genetics which entails the reliable prediction of certain human disorders as a function of the lineage and/or genetic makeup of an individual or of any two parents or potential parents.%A%    
% 213.28/213.51  |- skos__altLabel mesh__D005826 Medical Genetics
% 213.28/213.51  |- skos__annotation mesh__D005826
% 213.28/213.51       SPEC; restrict to the field of human genetics dealing with genet or hered disord; see note on GENETICS; DF: GENET MED%A%  
% 213.28/213.51  |- skos__historyNote mesh__D038202 Crystallins %28%1984-2002%29%
% 213.28/213.51  |- mesh__dateCreated mesh__D038202 2002-07-02
% 213.28/213.51  |- skos__prefLabel mesh__D038202 alpha-Crystallin A Chain
% 213.28/213.51  |- skos__scopeNote mesh__D038202
% 213.28/213.51       One of the subunits of alpha-crystallins. Unlike ALPHA-CRYSTALLIN B CHAIN the expression of ALPHA-CRYSTALLIN A CHAIN is limited primarily to the lens %28%LENS, CRYSTALLINE%29%.%A%    
% 213.28/213.51  |- skos__altLabel mesh__D038202 alpha-Crystallin, A Subunit
% 213.28/213.51  |- skos__altLabel mesh__D038202 Crystallins, alpha A Chain
% 213.28/213.51  |- rdf__type mesh__D038202sskos__Concept
% 213.28/213.51  |- skos__altLabel mesh__D038202 alpha A-Crystallin
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D038202 2004
% 213.28/213.51  |- mesh__publicMeSHNote mesh__D038202
% 213.28/213.51       2003; for ALPHA A-CRYSTALLIN see CRYSTALLINS 1986-2002   
% 213.28/213.51  |- mesh__dateEstablished mesh__D038202 2003-01-01
% 213.28/213.51  |- skos__broader mesh__D038202smesh__D038201
% 213.28/213.51  |- skos__hiddenLabel mesh__D038202 alpha A Crystallin
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D038202 2006
% 213.28/213.51  |- mesh__historyNote mesh__D038202
% 213.28/213.51       2003; for ALPHA A-CRYSTALLIN use CRYSTALLINS 1986-2002   
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D038202 2003
% 213.28/213.51  |- skos__hiddenLabel mesh__D038202 alpha Crystallin, A Subunit
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D038202 2005
% 213.28/213.51  |- skos__hiddenLabel mesh__D038202 alpha Crystallin A Chain
% 213.28/213.51  |- skos__annotation mesh__D005028 an antifungal   
% 213.28/213.51  |- mesh__recordOriginator mesh__D005028 RLS
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D005028 1995
% 213.28/213.51  |- mesh__dateRevised mesh__D005028 1993-06-04
% 213.28/213.51  |- mesh__dateEstablished mesh__D005028 1991-01-01
% 213.28/213.51  |- skos__prefLabel mesh__D005028 Ethylenebis%28%dithiocarbamates%29%
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D005028 2004
% 213.28/213.51  |- skos__scopeNote mesh__D005028
% 213.28/213.51       A class of thiocarbamate derivatives whose salts possess fungicidal activity.%A%    
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D005028 2005
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D005028 2001
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D005028 1994
% 213.28/213.51  |- mesh__recordAuthorizer mesh__D005028 PLS
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D005028 2003
% 213.28/213.51  |- mesh__publicMeSHNote mesh__D005028
% 213.28/213.51       91; was see under THIOCARBAMATES 1977-90   
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D005028 1999
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D005028 2000
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D005028 1997
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D005028 1998
% 213.28/213.51  |- rdf__type mesh__D005028sskos__Concept
% 213.28/213.51  |- mesh__dateCreated mesh__D005028 1976-04-16
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D005028 2002
% 213.28/213.51  |- mesh__recordMaintainer mesh__D005028 TPW
% 213.28/213.51  |- mesh__historyNote mesh__D005028
% 213.28/213.51       91%28%77%29%; was see under THIOCARBAMATES 1977-90   
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D005028 1996
% 213.28/213.51  |- skos__historyNote mesh__D005028 Thiocarbamates %28%1966-1976%29%
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D005028 2006
% 213.28/213.51  |- skos__broader mesh__D005028smesh__D013859
% 213.28/213.51  |- mesh__recordMaintainer mesh__D048630 ssb
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D048630 2005
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 Polyketide Synthase, Rifamycin
% 213.28/213.51  |- rdf__type mesh__D048630sskos__Concept
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 Polyketide Synthase, Griseusin
% 213.28/213.51  |- skos__historyNote mesh__D048630 Multienzyme Complexes %28%1989-2004%29%
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630
% 213.28/213.51       Type II Polyketide Beta Ketoacyl Synthase
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 Protein, WdPKS1
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 Polyketide Synthase, Niddamycin
% 213.28/213.51  |- mesh__publicMeSHNote mesh__D048630
% 213.28/213.51       2005; POLYKETIDE SYNTHASE was indexed under MULTIENZYME COMPLEXES 1989-2004%A%  
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 Polyketide Synthase, Erythromycin
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 Synthase, Erythromycin Polyketide
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 Synthase, Urdamycin Polyketide
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 Synthase, Niddamycin Polyketide
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 Polyketide Synthase, Epothilone
% 213.28/213.51  |- mesh__dateCreated mesh__D048630 2004-07-08
% 213.28/213.51  |- skos__scopeNote mesh__D048630
% 213.28/213.51       Large enzyme complexes composed of a number of component enzymes that are found in STREPTOMYCES which biosynthesize MACROLIDES and other polyketides.%A%    
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 Synthase, Epothilone Polyketide
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 Synthase, Griseusin Polyketide
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 Synthases, Polyketide
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 Polyketide Synthase, Urdamycin
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 Synthase, Rifamycin Polyketide
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 Synthase, WhiE Polyketide
% 213.28/213.51  |- mesh__recordAuthorizer mesh__D048630 sjn
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 Synthase, 6-Deoxyerythronolide-B
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 Synthase, Sterigmatocystin Polyketide
% 213.28/213.51  |- skos__broader mesh__D048630smesh__D019735
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 Polyketide Synthase, WhiE
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 6 Deoxyerythronolide B Synthase
% 213.28/213.51  |- skos__broader mesh__D048630smesh__D009097
% 213.28/213.51  |- skos__prefLabel mesh__D048630 Polyketide Synthases
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 Polyketide Synthase, Sterigmatocystin
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 Synthase WA, Polyketide
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D048630 2006
% 213.28/213.51  |- mesh__dateEstablished mesh__D048630 2005-01-01
% 213.28/213.51  |- mesh__historyNote mesh__D048630 2005%28%1989%29%   
% 213.28/213.51  |- mesh__recordOriginator mesh__D048630 ssb
% 213.28/213.51  |- skos__hiddenLabel mesh__D048630 Synthase L1, Polyketide
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D015456 1999
% 213.28/213.51  |- mesh__dateCreated mesh__D015456 1988-06-09
% 213.28/213.51  |- skos__broader mesh__D015456smesh__D015447
% 213.28/213.51  |- skos__altLabel mesh__D015456 B and T Cell Leukemia, Acute
% 213.28/213.51  |- skos__altLabel mesh__D015456 B and T Cell Acute Lymphoblastic Leukemia
% 213.28/213.51  |- mesh__recordOriginator mesh__D015456 PLS
% 213.28/213.51  |- mesh__historyNote mesh__D015456 89   
% 213.28/213.51  |- mesh__recordMaintainer mesh__D015456 TGC
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D015456 1998
% 213.28/213.51  |- skos__altLabel mesh__D015456 Leukemia, Mixed, B- and T-Cell
% 213.28/213.51  |- mesh__dateEstablished mesh__D015456 1989-01-01
% 213.28/213.51  |- skos__hiddenLabel mesh__D015456 Leukemia, Mixed Cell
% 213.28/213.51  |- skos__hiddenLabel mesh__D015456 Mixed-Cell Leukemia
% 213.28/213.51  |- mesh__publicMeSHNote mesh__D015456 89   
% 213.28/213.51  |- skos__historyNote mesh__D015456
% 213.28/213.51       Leukemia, Lymphoblastic %28%1977-1988%29%
% 213.28/213.51  |- skos__altLabel mesh__D015456 Leukemia, Mixed, B and T Cell
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D015456 2004
% 213.28/213.51  |- skos__historyNote mesh__D015456 T Lymphocytes %28%1977-1988%29%
% 213.28/213.51  |- skos__altLabel mesh__D015456 Lymphocytic Leukemia, Acute, B- and T-Cell
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D015456 2002
% 213.28/213.51  |- skos__prefLabel mesh__D015456 Leukemia, Mixed-Cell
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D015456 2006
% 213.28/213.51  |- skos__altLabel mesh__D015456 Lymphocytic Leukemia, Acute, B and T Cell
% 213.28/213.51  |- skos__hiddenLabel mesh__D015456 Leukemias, Mixed-Cell
% 213.28/213.51  |- skos__altLabel mesh__D015456 Leukemia, Lymphocytic, Acute, Mixed-Cell
% 213.28/213.51  |- skos__altLabel mesh__D015456 B- and T-Cell Acute Lymphoblastic Leukemia
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D015456 2003
% 213.28/213.51  |- mesh__recordAuthorizer mesh__D015456 SJN
% 213.28/213.51  |- mesh__dateRevised mesh__D015456 1997-06-20
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D015456 2001
% 213.28/213.51  |- skos__altLabel mesh__D015456 Leukemia, Lymphocytic, Acute, Mixed Cell
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D015456 2005
% 213.28/213.51  |- skos__hiddenLabel mesh__D015456 Mixed-Cell Leukemias
% 213.28/213.51  |- skos__historyNote mesh__D015456 Leukemia, Lymphocytic %28%1977-1988%29%
% 213.28/213.51  |- skos__historyNote mesh__D015456 B Lymphocytes %28%1977-1988%29%
% 213.28/213.51  |- skos__annotation mesh__D015456
% 213.28/213.51       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D015456 2000
% 213.28/213.51  |- skos__altLabel mesh__D015456 B- and T-Cell Leukemia, Acute
% 213.28/213.51  |- rdf__type mesh__D015456sskos__Concept
% 213.28/213.51  |- skos__hiddenLabel mesh__D009419 Proteins, Nerve Tissue
% 213.28/213.51  |- mesh__dateRevised mesh__D009419 2005-06-30
% 213.28/213.51  |- skos__annotation mesh__D009419
% 213.28/213.51       IM %26% coord with specific protein %28%IM%29% + specific nerve or nerve tissue %28%IM%29%; /biosyn /drug eff /physiol /ultrastruct permitted%A%  
% 213.28/213.51  |- mesh__recordMaintainer mesh__D009419 SYSTEM
% 213.28/213.51  |- rdf__type mesh__D009419sskos__Concept
% 213.28/213.51  |- mesh__recordOriginator mesh__D009419 NLM
% 213.28/213.51  |- mesh__recordAuthorizer mesh__D009419 sjn
% 213.28/213.51  |- skos__broader mesh__D009419smesh__D011506
% 213.28/213.51  |- mesh__dateCreated mesh__D009419 1999-01-01
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D009419 2006
% 213.28/213.51  |- skos__hiddenLabel mesh__D009419 Tissue Proteins, Nerve
% 213.28/213.51  |- skos__prefLabel mesh__D009419 Nerve Tissue Proteins
% 213.28/213.51  |- mesh__publicMeSHNote mesh__D001436
% 213.28/213.51       2002; see BACTERIORHODOPSIN 1977-2001, see CAROTENOIDS 1976-1986%A%  
% 213.28/213.51  |- skos__altLabel mesh__D001436 Bacteriorhodopsin
% 213.28/213.51  |- mesh__recordOriginator mesh__D001436 RLS
% 213.28/213.51  |- mesh__recordMaintainer mesh__D001436 SYSTEM
% 213.28/213.51  |- mesh__dateRevised mesh__D001436 2005-06-30
% 213.28/213.51  |- skos__related mesh__D001436smesh__D018717
% 213.28/213.51  |- skos__historyNote mesh__D001436 Bacterial Proteins %28%1974-1975%29%
% 213.28/213.51  |- mesh__dateCreated mesh__D001436 1975-07-18
% 213.28/213.51  |- mesh__recordAuthorizer mesh__D001436 sjn
% 213.28/213.51  |- skos__broader mesh__D001436smesh__D019843
% 213.28/213.51  |- mesh__dateEstablished mesh__D001436 1987-01-01
% 213.28/213.51  |- skos__scopeNote mesh__D001436
% 213.28/213.51       Rhodopsins found in the PURPLE MEMBRANE of halophilic archaea such as HALOBACTERIUM HALOBIUM. Bacteriorhodopsins function as an energy transducers, converting light energy into electrochemical energy via PROTON PUMPS.%A%    
% 213.28/213.51  |- mesh__historyNote mesh__D001436 2002%28%1976%29%   
% 213.28/213.51  |- skos__prefLabel mesh__D001436 Bacteriorhodopsins
% 213.28/213.51  |- skos__annotation mesh__D001436
% 213.28/213.51       do not confuse with BACTERIAL RHODOPSINS see RHODOPSINS, MICROBIAL%A%  
% 213.28/213.51  |- skos__broader mesh__D001436smesh__D025604
% 213.28/213.51  |- skos__historyNote mesh__D001436 Retinal Pigments %28%1974-1975%29%
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D001436 2006
% 213.28/213.51  |- skos__broader mesh__D001436smesh__D017494
% 213.28/213.51  |- rdf__type mesh__D001436sskos__Concept
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D006121 2005
% 213.28/213.51  |- skos__prefLabel mesh__D006121 Gross Virus
% 213.28/213.51  |- skos__broader mesh__D006121smesh__D009052
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D006121 2004
% 213.28/213.51  |- rdf__type mesh__D006121sskos__Concept
% 213.28/213.51  |- mesh__dateEstablished mesh__D006121 1966-01-01
% 213.28/213.51  |- mesh__dateCreated mesh__D006121 1999-01-01
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D006121 2003
% 213.28/213.51  |- mesh__recordMaintainer mesh__D006121 ags
% 213.28/213.51  |- skos__scopeNote mesh__D006121
% 213.28/213.51       A strain of Murine leukemia virus %28%LEUKEMIA VIRUS, MURINE%29% obtained from inbred mice with a high incidence of spontaneous lymphoid leukemia. Infection is passed by vertical transmission from one generation to another through the ovum.%A%    
% 213.28/213.51  |- skos__hiddenLabel mesh__D006121 Virus, Gross
% 213.28/213.51  |- mesh__publicMeSHNote mesh__D006121 66   
% 213.28/213.51  |- mesh__recordAuthorizer mesh__D006121 sjn
% 213.28/213.51  |- mesh__recordOriginator mesh__D006121 NLM
% 213.28/213.51  |- mesh__historyNote mesh__D006121 66   
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D006121 2006
% 213.28/213.51  |- mesh__dateRevised mesh__D006121 2002-07-03
% 213.28/213.51  |- skos__annotation mesh__D006121
% 213.28/213.51       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% + LEUKEMIA, EXPERIMENTAL %28%IM%29%or LEUKEMIA %28%IM%29% %28%for spontaneous leukemia%29%%A%  
% 213.28/213.51  |- skos__annotation mesh__D019847
% 213.28/213.51       A 11 qualif except /cytol; /genet /permitted; coord IM with specific archaeon /genet %28%IM%29%%A%  
% 213.28/213.51  |- skos__broader mesh__D019847smesh__D002875
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D019847 2004
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D019847 2006
% 213.28/213.51  |- skos__historyNote mesh__D019847 Chromosomes, Bacterial %28%1989-1997%29%
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D019847 2003
% 213.28/213.51  |- mesh__publicMeSHNote mesh__D019847 98   
% 213.28/213.51  |- mesh__dateRevised mesh__D019847 2002-07-02
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D019847 2005
% 213.28/213.51  |- skos__hiddenLabel mesh__D019847 Archaeal Chromosome
% 213.28/213.51  |- skos__scopeNote mesh__D019847
% 213.28/213.51       Structures within the nucleus of archaeal cells consisting of or containing DNA, which carry genetic information essential to the cell.%A%    
% 213.28/213.51  |- rdf__type mesh__D019847sskos__Concept
% 213.28/213.51  |- skos__hiddenLabel mesh__D019847 Archaeal Chromosomes
% 213.28/213.51  |- mesh__historyNote mesh__D019847 98   
% 213.28/213.51  |- skos__hiddenLabel mesh__D019847 Chromosome, Archaeal
% 213.28/213.51  |- skos__prefLabel mesh__D019847 Chromosomes, Archaeal
% 213.28/213.51  |- mesh__dateCreated mesh__D019847 1997-06-20
% 213.28/213.51  |- mesh__dateEstablished mesh__D019847 1998-01-01
% 213.28/213.51  |- skos__broader mesh__D011864smesh__D011863
% 213.28/213.51  |- skos__hiddenLabel mesh__D011864 Tests, Radioimmunosorbent
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011864 2002
% 213.28/213.51  |- skos__hiddenLabel mesh__D011864 Radioimmunosorbent Tests
% 213.28/213.51  |- skos__broader mesh__D011864smesh__D007163
% 213.28/213.51  |- skos__hiddenLabel mesh__D011864 Test, Radioimmunosorbent
% 213.28/213.51  |- skos__historyNote mesh__D011864 Iodine Radioisotopes %28%1974-1976%29%
% 213.28/213.51  |- skos__related mesh__D011864smesh__D011852
% 213.28/213.51  |- mesh__dateCreated mesh__D011864 1976-04-16
% 213.28/213.51  |- mesh__recordMaintainer mesh__D011864 nns
% 213.28/213.51  |- skos__annotation mesh__D011864
% 213.28/213.51       NIM; coord with substance /anal or body fluid qualif but not /immunol; IMMUNOSORBENTS is also available; DF: RIST%A%  
% 213.28/213.51  |- mesh__dateRevised mesh__D011864 2001-07-25
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011864 2006
% 213.28/213.51  |- mesh__publicMeSHNote mesh__D011864
% 213.28/213.51       91; was see under RADIOIMMUNOASSAY 1977-90   
% 213.28/213.51  |- mesh__recordAuthorizer mesh__D011864 sjn
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011864 2004
% 213.28/213.51  |- skos__prefLabel mesh__D011864 Radioimmunosorbent Test
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011864 2005
% 213.28/213.51  |- skos__scopeNote mesh__D011864
% 213.28/213.51       Radioimmunoassay of proteins using antibody coupled to an immunosorbent.%A%    
% 213.28/213.51  |- skos__historyNote mesh__D011864 IgE %28%1971-1976%29%
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011864 2003
% 213.28/213.51  |- rdf__type mesh__D011864sskos__Concept
% 213.28/213.51  |- mesh__dateEstablished mesh__D011864 1991-01-01
% 213.28/213.51  |- skos__historyNote mesh__D011864 Radioimmunoassay %28%1968-1976%29%
% 213.28/213.51  |- mesh__recordOriginator mesh__D011864 SMH
% 213.28/213.51  |- mesh__historyNote mesh__D011864
% 213.28/213.51       91%28%77%29%; was see under RADIOIMMUNOASSAY 1977-90   
% 213.28/213.51  |- skos__altLabel mesh__D019049 Industrialized Countries
% 213.28/213.51  |- mesh__recordAuthorizer mesh__D019049 sjn
% 213.28/213.51  |- mesh__dateEstablished mesh__D019049 1996-01-01
% 213.28/213.51  |- skos__hiddenLabel mesh__D019049 Countries, Industrialized
% 213.28/213.51  |- mesh__historyNote mesh__D019049 96   
% 213.28/213.51  |- mesh__recordMaintainer mesh__D019049 sjn
% 213.28/213.51  |- skos__hiddenLabel mesh__D019049 Country, Industrialized
% 213.28/213.51  |- skos__hiddenLabel mesh__D019049 Nation, Developed
% 213.28/213.51  |- mesh__publicMeSHNote mesh__D019049 96   
% 213.28/213.51  |- skos__annotation mesh__D019049
% 213.28/213.51       use with caution: follow text of author; do not confuse with DEVELOPING COUNTRIES; IM; specify country or countries if relevant%A%  
% 213.28/213.51  |- skos__hiddenLabel mesh__D019049 Industrialized Country
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D019049 2005
% 213.28/213.51  |- skos__historyNote mesh__D019049 specific country %28%1966-1995%29%
% 213.28/213.51  |- skos__broader mesh__D019049smesh__D007391
% 213.28/213.51  |- skos__prefLabel mesh__D019049 Developed Countries
% 213.28/213.51  |- mesh__dateCreated mesh__D019049 1995-05-26
% 213.28/213.51  |- skos__altLabel mesh__D019049 Industrialized Nations
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D019049 2006
% 213.28/213.51  |- skos__hiddenLabel mesh__D019049 Nations, Industrialized
% 213.28/213.51  |- mesh__dateRevised mesh__D019049 2004-07-13
% 213.28/213.51  |- mesh__recordOriginator mesh__D019049 TGC
% 213.28/213.51  |- rdf__type mesh__D019049sskos__Concept
% 213.28/213.51  |- skos__hiddenLabel mesh__D019049 Industrialized Nation
% 213.28/213.51  |- skos__hiddenLabel mesh__D019049 Country, Developed
% 213.28/213.51  |- skos__hiddenLabel mesh__D019049 Nations, Developed
% 213.28/213.51  |- skos__hiddenLabel mesh__D019049 Developed Country
% 213.28/213.51  |- skos__altLabel mesh__D019049 Developed Nations
% 213.28/213.51  |- skos__scopeNote mesh__D019049
% 213.28/213.51       Countries that have reached a level of economic achievement through an increase of production, per capita income and consumption, and utilization of natural and human resources.%A%    
% 213.28/213.51  |- skos__hiddenLabel mesh__D019049 Nation, Industrialized
% 213.28/213.51  |- skos__hiddenLabel mesh__D019049 Developed Nation
% 213.28/213.51  |- skos__hiddenLabel mesh__D019049 Countries, Developed
% 213.28/213.51  |- rdf__type mesh__D011066sskos__Concept
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011066 1995
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011066 2002
% 213.28/213.51  |- skos__hiddenLabel mesh__D011066 Acids, Polycytidylic
% 213.28/213.51  |- mesh__historyNote mesh__D011066
% 213.28/213.51       91%28%76%29%; was see under POLYRIBONUCLEOTIDES 1976-90   
% 213.28/213.51  |- skos__altLabel mesh__D011066 Cytosine Polynucleotides
% 213.28/213.51  |- mesh__publicMeSHNote mesh__D011066
% 213.28/213.51       91; was see under POLYRIBONUCLEOTIDES 1976-90   
% 213.28/213.51  |- skos__broader mesh__D011066smesh__D011131
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011066 2003
% 213.28/213.51  |- skos__altLabel mesh__D011066 Polycytidylic Acids
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011066 2000
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011066 2005
% 213.28/213.51  |- mesh__recordAuthorizer mesh__D011066 PLS
% 213.28/213.51  |- mesh__dateEstablished mesh__D011066 1991-01-01
% 213.28/213.51  |- skos__historyNote mesh__D011066 Polynucleotides %28%1966-1975%29%
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011066 2004
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011066 2001
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011066 1996
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011066 2006
% 213.28/213.51  |- skos__prefLabel mesh__D011066 Poly C
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011066 1998
% 213.28/213.51  |- skos__hiddenLabel mesh__D011066 Polynucleotides, Cytosine
% 213.28/213.51  |- mesh__recordOriginator mesh__D011066 RLS
% 213.28/213.51  |- skos__hiddenLabel mesh__D011066 C, Poly
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011066 1997
% 213.28/213.51  |- mesh__dateCreated mesh__D011066 1975-08-01
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011066 1994
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011066 1999
% 213.28/213.51  |- skos__scopeNote mesh__D011066
% 213.28/213.51       A group of cytosine ribonucleotides in which the phosphate residues of each cytosine ribonucleotide act as bridges in forming diester linkages between the ribose moieties.%A%    
% 213.28/213.51  |- mesh__dateRevised mesh__D011066 1992-05-20
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D011066 1993
% 213.28/213.51  |- mesh__recordMaintainer mesh__D011066 TGC
% 213.28/213.51  |- skos__hiddenLabel mesh__D005827 Genetic, Microbial
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D005827 2003
% 213.28/213.51  |- mesh__publicMeSHNote mesh__D005827 68   
% 213.28/213.51  |- skos__related mesh__D005827smesh__D002876
% 213.28/213.51  |- mesh__historyNote mesh__D005827 68   
% 213.28/213.51  |- skos__related mesh__D005827smesh__D015825
% 213.28/213.51  |- mesh__dateCreated mesh__D005827 1999-01-01
% 213.28/213.51  |- skos__altLabel mesh__D005827 Microbial Genetics
% 213.28/213.51  |- skos__prefLabel mesh__D005827 Genetics, Microbial
% 213.28/213.51  |- skos__broader mesh__D005827smesh__D005823
% 213.28/213.51  |- skos__scopeNote mesh__D005827
% 213.28/213.51       A subdiscipline of genetics which deals with the genetic mechanisms and processes of microorganisms.%A%    
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D005827 2006
% 213.28/213.51  |- skos__annotation mesh__D005827
% 213.28/213.51       GEN %26% unspecified only: prefer /genet with specific microbes: Manual 19.8.34; Manual 22.25; Manual 28.36.8.1; TN 196: avoid as an added coord with better specifics; SPEC qualif permitted when viewed as specialty; DF: GENET MICROBIAL%A%  
% 213.28/213.51  |- mesh__dateRevised mesh__D005827 2002-07-03
% 213.28/213.51  |- rdf__type mesh__D005827sskos__Concept
% 213.28/213.51  |- skos__historyNote mesh__D005827 Genetics %28%1966-1967%29%
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D005827 2005
% 213.28/213.51  |- skos__hiddenLabel mesh__D005827 Microbial Genetic
% 213.28/213.51  |- mesh__recordOriginator mesh__D005827 NLM
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D005827 2004
% 213.28/213.51  |- skos__broader mesh__D005827smesh__D008829
% 213.28/213.51  |- mesh__recordMaintainer mesh__D005827 TGC
% 213.28/213.51  |- mesh__recordAuthorizer mesh__D005827 sjn
% 213.28/213.51  |- mesh__dateEstablished mesh__D005827 1968-01-01
% 213.28/213.51  |- skos__altLabel mesh__D038203 Crystallins, alpha B Chain
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D038203 2004
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D038203 2006
% 213.28/213.51  |- skos__broader mesh__D038203smesh__D038201
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D038203 2003
% 213.28/213.51  |- skos__hiddenLabel mesh__D038203 alpha B Crystallin
% 213.28/213.51  |- skos__hiddenLabel mesh__D038203 B Subunit alpha-Crystallin
% 213.28/213.51  |- skos__altLabel mesh__D038203 alpha B-Crystallin
% 213.28/213.51  |- skos__altLabel mesh__D038203 Rosenthal Fiber Component
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D038203 2005
% 213.28/213.51  |- mesh__recordOriginator mesh__D038203 jmp
% 213.28/213.51  |- skos__hiddenLabel mesh__D038203 alpha Crystallin, B Subunit
% 213.28/213.51  |- mesh__historyNote mesh__D038203
% 213.28/213.51       2003; for ALPHA B-CRYSTALLIN use CRYSTALLINS 1998-2002   
% 213.28/213.51  |- skos__altLabel mesh__D038203 alpha-Crystallin, B Subunit
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D038203 2006A
% 213.28/213.51  |- mesh__dateCreated mesh__D038203 2002-07-02
% 213.28/213.51  |- mesh__dateEstablished mesh__D038203 2003-01-01
% 213.28/213.51  |- mesh__recordAuthorizer mesh__D038203 ags
% 213.28/213.51  |- skos__scopeNote mesh__D038203
% 213.28/213.51       One of the alpha crystallin subunits. In addition to being expressed in the lens %28%LENS, CRYSTALLINE%29%, alpha-crystallin B chain has been found in a variety of tissues such as HEART; BRAIN; MUSCLE; and KIDNEY. Accumulation of the protein in the brain is associated with NEURODEGENERATIVE DISEASES such as CREUTZFELDT-JAKOB SYNDROME and ALEXANDER DISEASE.%A%    
% 213.28/213.51  |- mesh__publicMeSHNote mesh__D038203
% 213.28/213.51       2003; for ALPHA B-CRYSTALLIN see CRYSTALLINS 1998-2002   
% 213.28/213.51  |- skos__hiddenLabel mesh__D038203 alpha Crystallin B Chain
% 213.28/213.51  |- mesh__dateRevised mesh__D038203 2005-07-15
% 213.28/213.51  |- skos__historyNote mesh__D038203 Crystallins %28%1985-2002%29%
% 213.28/213.51  |- skos__hiddenLabel mesh__D038203 B Chain, alpha-Crystallin
% 213.28/213.51  |- rdf__type mesh__D038203sskos__Concept
% 213.28/213.51  |- mesh__recordMaintainer mesh__D038203 ags
% 213.28/213.51  |- skos__prefLabel mesh__D038203 alpha-Crystallin B Chain
% 213.28/213.51  |- mesh__activeMeSHYear mesh__D005029 1993
% 213.28/213.51  |- mesh__recordMaintainer mesh__D005029 TGC
% 213.28/213.52  |- skos__broader mesh__D005029smesh__D003959
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D005029 1994
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D005029 2003
% 213.28/213.52  |- skos__prefLabel mesh__D005029 Ethylenediamines
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D005029 1999
% 213.28/213.52  |- mesh__dateCreated mesh__D005029 1999-01-01
% 213.28/213.52  |- mesh__recordOriginator mesh__D005029 NLM
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D005029 1997
% 213.28/213.52  |- rdf__type mesh__D005029sskos__Concept
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D005029 1998
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D005029 2001
% 213.28/213.52  |- mesh__recordAuthorizer mesh__D005029 PLS
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D005029 1996
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D005029 2000
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D005029 2006
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D005029 1995
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D005029 2004
% 213.28/213.52  |- mesh__dateRevised mesh__D005029 1992-05-19
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D005029 2005
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D005029 2002
% 213.28/213.52  |- mesh__dateEstablished mesh__D048631 2005-01-01
% 213.28/213.52  |- skos__scopeNote mesh__D048631
% 213.28/213.52       The smaller, reproductive, transcriptionally inert nucleus in the cells of ciliate PROTOZOANS, as distinguished from the larger, vegetative, transcriptionally active MACRONUCLEUS.  Micronuclei participate in MEIOSIS and autogamy during GENETIC CONJUGATION.%A%    
% 213.28/213.52  |- skos__related mesh__D048631smesh__D048629
% 213.28/213.52  |- mesh__publicMeSHNote mesh__D048631 2005   
% 213.28/213.52  |- mesh__dateCreated mesh__D048631 2004-07-07
% 213.28/213.52  |- skos__hiddenLabel mesh__D048631 Micronucleus, Germinal
% 213.28/213.52  |- skos__altLabel mesh__D048631 Germline Micronucleus
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D048631 2006
% 213.28/213.52  |- skos__prefLabel mesh__D048631 Micronucleus, Germline
% 213.28/213.52  |- skos__broader mesh__D048631smesh__D002467
% 213.28/213.52  |- mesh__recordMaintainer mesh__D048631 nns
% 213.28/213.52  |- skos__altLabel mesh__D048631 Germinal Micronucleus
% 213.28/213.52  |- mesh__recordAuthorizer mesh__D048631 sjn
% 213.28/213.52  |- mesh__recordOriginator mesh__D048631 nns
% 213.28/213.52  |- mesh__historyNote mesh__D048631 2005   
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D048631 2005
% 213.28/213.52  |- rdf__type mesh__D048631sskos__Concept
% 213.28/213.52  |- skos__altLabel mesh__D048631 Micronuclei, Germline
% 213.28/213.52  |- skos__hiddenLabel mesh__D048631 Germline Micronuclei
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D015457 2006
% 213.28/213.52  |- skos__hiddenLabel mesh__D015457 Null-Cell Leukemia
% 213.28/213.52  |- skos__altLabel mesh__D015457 Leukemia, Lymphocytic, Acute, Non B, Non T
% 213.28/213.52  |- skos__hiddenLabel mesh__D015457 Null-Cell Lymphocytic Leukemias
% 213.28/213.52  |- skos__altLabel mesh__D015457 Leukemia, Lymphocytic, Acute, Null-Cell
% 213.28/213.52  |- skos__broader mesh__D015457smesh__D015447
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D015457 1999
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D015457 2000
% 213.28/213.52  |- skos__altLabel mesh__D015457 Leukemia, Lymphoblastic, Acute, Null-Cell
% 213.28/213.52  |- mesh__dateCreated mesh__D015457 1988-06-09
% 213.28/213.52  |- skos__altLabel mesh__D015457 Non B, Non T Acute Lymphoblastic Leukemia
% 213.28/213.52  |- skos__altLabel mesh__D015457 Leukemia, Lymphocytic, Acute, Null Cell
% 213.28/213.52  |- mesh__dateEstablished mesh__D015457 1989-01-01
% 213.28/213.52  |- skos__historyNote mesh__D015457
% 213.28/213.52       Leukemia, Lymphoblastic %28%1977-1988%29%
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D015457 2005
% 213.28/213.52  |- skos__hiddenLabel mesh__D015457 Null-Cell Leukemias
% 213.28/213.52  |- skos__hiddenLabel mesh__D015457 Lymphocytic Leukemia, Null Cell
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D015457 2004
% 213.28/213.52  |- rdf__type mesh__D015457sskos__Concept
% 213.28/213.52  |- skos__hiddenLabel mesh__D015457 Leukemias, Null-Cell Lymphocytic
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D015457 1998
% 213.28/213.52  |- skos__altLabel mesh__D015457 Non-B, Non-T, Acute Lymphoblastic Leukemia
% 213.28/213.52  |- mesh__publicMeSHNote mesh__D015457 89   
% 213.28/213.52  |- skos__altLabel mesh__D015457 Lymphoblastic Leukemia, Acute, Non B, Non T
% 213.28/213.52  |- skos__prefLabel mesh__D015457 Leukemia, Null-Cell
% 213.28/213.52  |- skos__annotation mesh__D015457
% 213.28/213.52       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 213.28/213.52  |- skos__hiddenLabel mesh__D015457 Leukemia, Null Cell
% 213.28/213.52  |- mesh__historyNote mesh__D015457 89   
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D015457 2003
% 213.28/213.52  |- mesh__recordMaintainer mesh__D015457 TGC
% 213.28/213.52  |- mesh__dateRevised mesh__D015457 1997-06-20
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D015457 2002
% 213.28/213.52  |- skos__historyNote mesh__D015457 Leukemia, Lymphocytic %28%1977-1988%29%
% 213.28/213.52  |- mesh__recordOriginator mesh__D015457 PLS
% 213.28/213.52  |- skos__altLabel mesh__D015457 Leukemia, Lymphocytic, Acute, Non-B, Non-T
% 213.28/213.52  |- skos__altLabel mesh__D015457 Lymphocytic Leukemia, Null-Cell
% 213.28/213.52  |- skos__hiddenLabel mesh__D015457 Leukemia, Null-Cell Lymphocytic
% 213.28/213.52  |- skos__hiddenLabel mesh__D015457 Leukemias, Null-Cell
% 213.28/213.52  |- skos__hiddenLabel mesh__D015457 Lymphocytic Leukemias, Null-Cell
% 213.28/213.52  |- mesh__recordAuthorizer mesh__D015457 SJN
% 213.28/213.52  |- skos__altLabel mesh__D015457 Lymphoblastic Leukemia, Acute, Non-B, Non-T
% 213.28/213.52  |- skos__hiddenLabel mesh__D015457 Null-Cell Lymphocytic Leukemia
% 213.28/213.52  |- skos__altLabel mesh__D015457 Leukemia, Lymphoblastic, Acute, Null Cell
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D015457 2001
% 213.28/213.52  |- skos__broader mesh__D007854Q000506smesh__D007854
% 213.28/213.52  |- mesh__preferredCombination mesh__D007854Q000506smesh__D007855
% 213.28/213.52  |- rdf__type mesh__D007854Q000506smesh__CompoundConcept
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D001437 2003
% 213.28/213.52  |- mesh__dateCreated mesh__D001437 1999-01-01
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D001437 1998
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D001437 1993
% 213.28/213.52  |- mesh__dateRevised mesh__D001437 1978-10-20
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D001437 1992
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D001437 1997
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D001437 1989
% 213.28/213.52  |- skos__broader mesh__D001437smesh__D014552
% 213.28/213.52  |- skos__scopeNote mesh__D001437
% 213.28/213.52       The presence of bacteria in the urine with or without consequent urinary tract infection. Since BACTERIURIA is a clinical entity, the term does not preclude the use of URINE/microbiology for technical discussions on the isolation and segregation of bacteria in the urine.%A%    
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D001437 2002
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D001437 1996
% 213.28/213.52  |- mesh__recordMaintainer mesh__D001437 HMM
% 213.28/213.52  |- mesh__recordOriginator mesh__D001437 NLM
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D001437 2006
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D001437 2001
% 213.28/213.52  |- rdf__type mesh__D001437sskos__Concept
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D001437 1991
% 213.28/213.52  |- mesh__dateEstablished mesh__D001437 1966-01-01
% 213.28/213.52  |- mesh__publicMeSHNote mesh__D001437 66   
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D001437 2005
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D001437 2000
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D001437 1995
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D001437 1990
% 213.28/213.52  |- mesh__historyNote mesh__D001437 66%28%64%29%   
% 213.28/213.52  |- skos__annotation mesh__D001437
% 213.28/213.52       TN 190: differentiate from URINE /microbiol; coord IM with specific bacterium with probably /isol %28%IM%29%%A%  
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D001437 2004
% 213.28/213.52  |- mesh__recordAuthorizer mesh__D001437 NLM
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D001437 1999
% 213.28/213.52  |- skos__prefLabel mesh__D001437 Bacteriuria
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D001437 1994
% 213.28/213.52  |- skos__hiddenLabel mesh__D001437 Bacteriurias
% 213.28/213.52  |- skos__broader mesh__D006920smesh__D011634
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D006920 1999
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D006920 2002
% 213.28/213.52  |- skos__broader mesh__D006920smesh__D013812
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D006920 1998
% 213.28/213.52  |- mesh__recordOriginator mesh__D006920 NLM
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D006920 2004
% 213.28/213.52  |- skos__scopeNote mesh__D006920
% 213.28/213.52       The science dealing with the establishment and maintenance of health in the individual and the group. It includes the conditions and practices conducive to health. %28%Webster, 3d ed%29%%A%    
% 213.28/213.52  |- skos__annotation mesh__D006920
% 213.28/213.52       hygiene as a principle %26% personal hygiene go here; dental hygiene = DENTAL HYGIENE see ORAL HYGIENE; industrial hygiene = INDUSTRIAL HYGIENE see OCCUPATIONAL HEALTH; mental hygiene = MENTAL HYGIENE see MENTAL HEALTH; MILITARY HYGIENE is also available%A%  
% 213.28/213.52  |- rdf__type mesh__D006920sskos__Concept
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D006920 2003
% 213.28/213.52  |- mesh__dateCreated mesh__D006920 1999-01-01
% 213.28/213.52  |- mesh__dateRevised mesh__D006920 1997-06-20
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D006920 2001
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D006920 2006
% 213.28/213.52  |- mesh__recordAuthorizer mesh__D006920 SJN
% 213.28/213.52  |- skos__prefLabel mesh__D006920 Hygiene
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D006920 2000
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D006920 2005
% 213.28/213.52  |- mesh__recordMaintainer mesh__D006920 TGC
% 213.28/213.52  |- skos__historyNote mesh__D019848
% 213.28/213.52       Gene Expression Regulation, Bacterial %28%1990-1997%29%
% 213.28/213.52  |- skos__scopeNote mesh__D019848
% 213.28/213.52       Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in archaea.%A%    
% 213.28/213.52  |- skos__altLabel mesh__D019848 Regulation, Gene Expression, Archaeal
% 213.28/213.52  |- skos__prefLabel mesh__D019848 Gene Expression Regulation, Archaeal
% 213.28/213.52  |- skos__historyNote mesh__D019848
% 213.28/213.52       Gene Expression Regulation %28%1982-1989%29%
% 213.28/213.52  |- skos__annotation mesh__D019848
% 213.28/213.52       coord IM with specific archaeon /genet %28%IM%29%; DF: GENE EXPRESSION REG ARCHAEAL%A%  
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D019848 2004
% 213.28/213.52  |- mesh__publicMeSHNote mesh__D019848 98   
% 213.28/213.52  |- skos__broader mesh__D019848smesh__D005786
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D019848 2003
% 213.28/213.52  |- mesh__historyNote mesh__D019848 98   
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D019848 2006
% 213.28/213.52  |- rdf__type mesh__D019848sskos__Concept
% 213.28/213.52  |- mesh__dateEstablished mesh__D019848 1998-01-01
% 213.28/213.52  |- mesh__dateRevised mesh__D019848 2002-07-02
% 213.28/213.52  |- skos__altLabel mesh__D019848 Archaeal Gene Expression Regulation
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D019848 2005
% 213.28/213.52  |- mesh__dateCreated mesh__D019848 1997-06-20
% 213.28/213.52  |- skos__altLabel mesh__D019848 Regulation of Gene Expression, Archaeal
% 213.28/213.52  |- mesh__publicMeSHNote mesh__D011865
% 213.28/213.52       91; was RADIOISOTOPE DILUTION TECHNIC 1967-90   
% 213.28/213.52  |- skos__broader mesh__D011865smesh__D007201
% 213.28/213.52  |- skos__hiddenLabel mesh__D011865 Dilution Technic, Radioisotope
% 213.28/213.52  |- skos__prefLabel mesh__D011865 Radioisotope Dilution Technique
% 213.28/213.52  |- skos__hiddenLabel mesh__D011865 Technics, Radioisotope Dilution
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D011865 2006
% 213.28/213.52  |- mesh__dateRevised mesh__D011865 1999-11-03
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D011865 2002
% 213.28/213.52  |- mesh__recordMaintainer mesh__D011865 kle
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D011865 2004
% 213.28/213.52  |- skos__hiddenLabel mesh__D011865 Dilution Technique, Radioisotope
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D011865 2005
% 213.28/213.52  |- skos__hiddenLabel mesh__D011865 Radioisotope Dilution Techniques
% 213.28/213.52  |- skos__scopeNote mesh__D011865
% 213.28/213.52       Method for assessing flow through a system by injection of a known quantity of radionuclide into the system and monitoring its concentration over time at a specific point in the system. %28%From Dorland, 28th ed%29%%A%    
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D011865 2003
% 213.28/213.52  |- skos__hiddenLabel mesh__D011865 Technique, Radioisotope Dilution
% 213.28/213.52  |- rdf__type mesh__D011865sskos__Concept
% 213.28/213.52  |- skos__annotation mesh__D011865
% 213.28/213.52       NIM; do not use /util except by MeSH definition; coord with specific radioisotope /diag use%A%  
% 213.28/213.52  |- skos__hiddenLabel mesh__D011865 Technic, Radioisotope Dilution
% 213.28/213.52  |- skos__hiddenLabel mesh__D011865 Dilution Techniques, Radioisotope
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D011865 2001
% 213.28/213.52  |- mesh__historyNote mesh__D011865
% 213.28/213.52       91%28%64%29%; was RADIOISOTOPE DILUTION TECHNIC 1964-90 %28%Prov 1964-66%29%%A%  
% 213.28/213.52  |- skos__hiddenLabel mesh__D011865 Techniques, Radioisotope Dilution
% 213.28/213.52  |- mesh__dateEstablished mesh__D011865 1967-01-01
% 213.28/213.52  |- mesh__recordAuthorizer mesh__D011865 sjn
% 213.28/213.52  |- mesh__dateCreated mesh__D011865 1999-01-01
% 213.28/213.52  |- mesh__onlineNote mesh__D011865
% 213.28/213.52       use RADIOISOTOPE DILUTION TECHNIQUE to search RADIOISOTOPE DILUTION TECHNIC 1966-90%A%  
% 213.28/213.52  |- skos__broader mesh__D011865smesh__D003947
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D011865 2000
% 213.28/213.52  |- mesh__recordOriginator mesh__D011865 NLM
% 213.28/213.52  |- skos__hiddenLabel mesh__D011865 Radioisotope Dilution Technics
% 213.28/213.52  |- skos__hiddenLabel mesh__D011865 Dilution Technics, Radioisotope
% 213.28/213.52  |- skos__altLabel mesh__D011865 Radioisotope Dilution Technic
% 213.28/213.52  |- skos__altLabel mesh__D038204 Crystallins, beta
% 213.28/213.52  |- mesh__recordAuthorizer mesh__D038204 sjn
% 213.28/213.52  |- skos__prefLabel mesh__D038204 beta-Crystallins
% 213.28/213.52  |- skos__hiddenLabel mesh__D038204 beta Crystallin
% 213.28/213.52  |- mesh__publicMeSHNote mesh__D038204
% 213.28/213.52       2003; for BETA-CRYSTALLIN see CRYSTALLINS 1982-2002   
% 213.28/213.52  |- skos__hiddenLabel mesh__D038204 beta Crystallins
% 213.28/213.52  |- mesh__recordMaintainer mesh__D038204 SYSTEM
% 213.28/213.52  |- mesh__dateRevised mesh__D038204 2005-06-30
% 213.28/213.52  |- mesh__recordOriginator mesh__D038204 jmp
% 213.28/213.52  |- skos__altLabel mesh__D038204 beta-Crystallin
% 213.28/213.52  |- rdf__type mesh__D038204sskos__Concept
% 213.28/213.52  |- mesh__dateCreated mesh__D038204 2002-07-02
% 213.28/213.52  |- skos__historyNote mesh__D038204 Crystallins %28%1966-2002%29%
% 213.28/213.52  |- mesh__dateEstablished mesh__D038204 2003-01-01
% 213.28/213.52  |- mesh__historyNote mesh__D038204
% 213.28/213.52       2003; for BETA-CRYSTALLIN use CRYSTALLINS 1982-2002   
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D038204 2006
% 213.28/213.52  |- skos__scopeNote mesh__D038204
% 213.28/213.52       A class of crystallins that provides refractive power and translucency to the lens %28%LENS, CRYSTALLINE%29% in VERTEBRATES. Beta-crystallins are similar in structure to GAMMA-CRYSTALLINS in that they both contain Greek key motifs. Beta-crystallins exist as oligomers formed from acidic %28%BETA-CRYSTALLIN A CHAIN%29% and basic %28%BETA-CRYSTALLIN B CHAIN%29% subunits.%A%    
% 213.28/213.52  |- skos__broader mesh__D038204smesh__D003459
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D011067 2003
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D011067 2001
% 213.28/213.52  |- skos__hiddenLabel mesh__D011067
% 213.28/213.52       Nucleotides-Polythymine Nucleotides, Polydeoxyadenine
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D011067 2005
% 213.28/213.52  |- skos__historyNote mesh__D011067 Thymine Nucleotides %28%1972-1976%29%
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D011067 2004
% 213.28/213.52  |- skos__historyNote mesh__D011067 Polynucleotides %28%1966-1976%29%
% 213.28/213.52  |- skos__hiddenLabel mesh__D011067 dA dT, Poly
% 213.28/213.52  |- mesh__dateRevised mesh__D011067 1995-05-31
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D011067 1996
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D011067 2006
% 213.28/213.52  |- mesh__dateEstablished mesh__D011067 1991-01-01
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D011067 1998
% 213.28/213.52  |- skos__prefLabel mesh__D011067 Poly dA-dT
% 213.28/213.52  |- skos__hiddenLabel mesh__D011067 dA-dT, Poly
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D011067 1997
% 213.28/213.52  |- mesh__dateCreated mesh__D011067 1976-04-16
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D011067 2002
% 213.28/213.52  |- skos__historyNote mesh__D011067 Adenine Nucleotides %28%1966-1976%29%
% 213.28/213.52  |- skos__altLabel mesh__D011067 Poly dA dT
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D011067 1999
% 213.28/213.52  |- skos__altLabel mesh__D011067
% 213.28/213.52       Polydeoxyadenine Nucleotides-Polythymine Nucleotides
% 213.28/213.52  |- skos__hiddenLabel mesh__D011067 dT, Poly dA
% 213.28/213.52  |- skos__altLabel mesh__D011067 Poly%28%Deoxyadenylate-Thymidylate%29%
% 213.28/213.52  |- skos__broader mesh__D011067smesh__D011089
% 213.28/213.52  |- rdf__type mesh__D011067sskos__Concept
% 213.28/213.52  |- skos__annotation mesh__D011067 used in DNA studies   
% 213.28/213.52  |- skos__altLabel mesh__D011067 Poly%28%dA-dT%29%
% 213.28/213.52  |- mesh__historyNote mesh__D011067
% 213.28/213.52       91%28%77%29%; was see under POLYDEOXYRIBONUCLEOTIDES 1977-90   
% 213.28/213.52  |- skos__hiddenLabel mesh__D011067
% 213.28/213.52       Nucleotides, Polydeoxyadenine Nucleotides-Polythymine
% 213.28/213.52  |- mesh__publicMeSHNote mesh__D011067
% 213.28/213.52       91; was see under POLYDEOXYRIBONUCLEOTIDES 1977-90   
% 213.28/213.52  |- mesh__recordMaintainer mesh__D011067 TAP
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D011067 2000
% 213.28/213.52  |- mesh__recordAuthorizer mesh__D011067 PLS
% 213.28/213.52  |- skos__scopeNote mesh__D011067
% 213.28/213.52       Polydeoxyribonucleotides made up of deoxyadenine nucleotides and thymine nucleotides. Present in DNA preparations isolated from crab species. Synthetic preparations have been used extensively in the study of DNA.%A%    
% 213.28/213.52  |- skos__hiddenLabel mesh__D011067
% 213.28/213.52       Polydeoxyadenine Nucleotides Polythymine Nucleotides
% 213.28/213.52  |- mesh__recordOriginator mesh__D011067 RLS
% 213.28/213.52  |- mesh__recordOriginator mesh__D005828 NLM
% 213.28/213.52  |- skos__annotation mesh__D005828
% 213.28/213.52       GEN or SPEC; prefer specifics treed under GENETIC PHENOMENA: Manual 28.22, 28.22.5; human %26% animal specify geog%A%  
% 213.28/213.52  |- mesh__dateCreated mesh__D005828 1999-01-01
% 213.28/213.52  |- skos__related mesh__D005828smesh__D011157
% 213.28/213.52  |- mesh__recordAuthorizer mesh__D005828 sjn
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D005828 2006
% 213.28/213.52  |- mesh__recordMaintainer mesh__D005828 sjn
% 213.28/213.52  |- skos__scopeNote mesh__D005828
% 213.28/213.52       The discipline studying genetic composition of populations and effects of factors such as SELECTION %28%GENETICS%29%, population size, MUTATION, migration, and GENETIC DRIFT on the frequencies of various GENOTYPES and PHENOTYPES using a variety of GENETIC TECHNIQUES.%A%    
% 213.28/213.52  |- skos__altLabel mesh__D005828 Population Genetics
% 213.28/213.52  |- rdf__type mesh__D005828sskos__Concept
% 213.28/213.52  |- mesh__dateRevised mesh__D005828 2004-07-13
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D005828 2005
% 213.28/213.52  |- skos__broader mesh__D005828smesh__D005823
% 213.28/213.52  |- mesh__publicMeSHNote mesh__D005828 66   
% 213.28/213.52  |- skos__prefLabel mesh__D005828 Genetics, Population
% 213.28/213.52  |- mesh__dateEstablished mesh__D005828 1966-01-01
% 213.28/213.52  |- mesh__historyNote mesh__D005828 66   
% 213.28/213.52  |- mesh__dateCreated mesh__D016550 1991-02-08
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D016550 1993
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D016550 1998
% 213.28/213.52  |- mesh__publicMeSHNote mesh__D016550 92   
% 213.28/213.52  |- mesh__dateEstablished mesh__D016550 1992-01-01
% 213.28/213.52  |- mesh__historyNote mesh__D016550 92   
% 213.28/213.52  |- skos__scopeNote mesh__D016550
% 213.28/213.52       Free-standing facilities that provide prenatal, childbirth, and postnatal care and usually incorporate family-centered maternity care concepts and practices.%A%    
% 213.28/213.52  |- skos__hiddenLabel mesh__D016550 Center, Birthing
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D016550 1994
% 213.28/213.52  |- rdf__type mesh__D016550sskos__Concept
% 213.28/213.52  |- mesh__recordOriginator mesh__D016550 JHM
% 213.28/213.52  |- mesh__dateRevised mesh__D016550 1992-03-25
% 213.28/213.52  |- skos__hiddenLabel mesh__D016550 Centers, Birthing
% 213.28/213.52  |- skos__altLabel mesh__D016550 Birth Centers
% 213.28/213.52  |- skos__hiddenLabel mesh__D016550 Birthing Center, Free-Standing
% 213.28/213.52  |- skos__hiddenLabel mesh__D016550 Free-Standing Birth Center
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D016550 2004
% 213.28/213.52  |- mesh__recordAuthorizer mesh__D016550 PLS
% 213.28/213.52  |- skos__hiddenLabel mesh__D016550 Birth Centers, Free-Standing
% 213.28/213.52  |- skos__broader mesh__D016550smesh__D006268
% 213.28/213.52  |- skos__hiddenLabel mesh__D016550 Centers, Birth
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D016550 2003
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D016550 1997
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D016550 2006
% 213.28/213.52  |- skos__hiddenLabel mesh__D016550 Free-Standing Birthing Center
% 213.28/213.52  |- skos__altLabel mesh__D016550 Free-Standing Birth Centers
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D016550 2002
% 213.28/213.52  |- skos__prefLabel mesh__D016550 Birthing Centers
% 213.28/213.52  |- skos__hiddenLabel mesh__D016550 Free Standing Birth Centers
% 213.28/213.52  |- skos__hiddenLabel mesh__D016550 Center, Birth
% 213.28/213.52  |- skos__hiddenLabel mesh__D016550 Birthing Center
% 213.28/213.52  |- skos__hiddenLabel mesh__D016550 Free-Standing Birthing Centers
% 213.28/213.52  |- mesh__recordMaintainer mesh__D016550 TGC
% 213.28/213.52  |- skos__hiddenLabel mesh__D016550 Birth Center
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D016550 1996
% 213.28/213.52  |- skos__altLabel mesh__D016550 Birthing Centers, Free-Standing
% 213.28/213.52  |- skos__hiddenLabel mesh__D016550 Birthing Centers, Free Standing
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D016550 2005
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D016550 1999
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D016550 2001
% 213.28/213.52  |- skos__annotation mesh__D016550
% 213.28/213.52       note X ref BIRTHING CENTERS, FREE-STANDING: do not confuse with BIRTHING CENTERS, HOSPITAL see DELIVERY ROOMS; check also tags PREGNANCY %26% INFANT, NEWBORN%A%  
% 213.28/213.52  |- skos__hiddenLabel mesh__D016550 Birth Center, Free-Standing
% 213.28/213.52  |- skos__altLabel mesh__D016550 Birth Center, Free Standing
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D016550 1995
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D016550 2000
% 213.28/213.52  |- mesh__publicMeSHNote mesh__D030221 2002   
% 213.28/213.52  |- skos__annotation mesh__D030221
% 213.28/213.52       don%27%t confuse with the cola beverage; for Gotu Kola use CENTELLA, for Bitter Kola check if GARCINIA KOLA or COLA;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.28/213.52  |- skos__scopeNote mesh__D030221
% 213.28/213.52       A plant genus of the family STERCULIACEAE.  This is the source of the kola nut which contains CAFFEINE and is used in popular beverages.%A%    
% 213.28/213.52  |- mesh__dateCreated mesh__D030221 2001-07-25
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D030221 2006
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D030221 2002
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D030221 2004
% 213.28/213.52  |- skos__prefLabel mesh__D030221 Cola
% 213.28/213.52  |- mesh__dateEstablished mesh__D030221 2002-01-01
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D030221 2005
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D030221 2003
% 213.28/213.52  |- mesh__historyNote mesh__D030221 2002   
% 213.28/213.52  |- rdf__type mesh__D030221sskos__Concept
% 213.28/213.52  |- skos__broader mesh__D030221smesh__D029643
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D002530 2005
% 213.28/213.52  |- skos__hiddenLabel mesh__D002530 Angles, Cerebellopontile
% 213.28/213.52  |- mesh__historyNote mesh__D002530
% 213.28/213.52       90; was CEREBELLOPONTILE ANGLE 1966-89   
% 213.28/213.52  |- skos__prefLabel mesh__D002530 Cerebellopontine Angle
% 213.28/213.52  |- mesh__recordOriginator mesh__D002530 NLM
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D002530 2000
% 213.28/213.52  |- skos__annotation mesh__D002530
% 213.28/213.52       diseases: coord IM with CEREBELLAR DISEASES %28%IM%29%; neopl: coord %28%IM%29% with CEREBELLAR NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 213.28/213.52  |- mesh__recordAuthorizer mesh__D002530 sjn
% 213.28/213.52  |- skos__hiddenLabel mesh__D002530 Angle, Cerebellopontine
% 213.28/213.52  |- skos__hiddenLabel mesh__D002530 Cerebellopontine Angles
% 213.28/213.52  |- mesh__dateCreated mesh__D002530 1999-01-01
% 213.28/213.52  |- mesh__onlineNote mesh__D002530
% 213.28/213.52       use CEREBELLOPONTINE ANGLE to search CEREBELLOPONTILE ANGLE 1966-89%A%  
% 213.28/213.52  |- mesh__dateRevised mesh__D002530 1999-11-03
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D002530 2004
% 213.28/213.52  |- skos__broader mesh__D002530smesh__D002531
% 213.28/213.52  |- rdf__type mesh__D002530sskos__Concept
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D002530 2002
% 213.28/213.52  |- mesh__recordMaintainer mesh__D002530 ags
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D002530 2003
% 213.28/213.52  |- skos__hiddenLabel mesh__D002530 Angles, Cerebellopontine
% 213.28/213.52  |- skos__altLabel mesh__D002530 Cerebellopontile Angle
% 213.28/213.52  |- skos__hiddenLabel mesh__D002530 Cerebellopontile Angles
% 213.28/213.52  |- mesh__activeMeSHYear mesh__D002530 2006
% 213.28/213.52  |- skos__scopeNote mesh__D002530
% 213.28/213.52       Junction between the cerebellum and the pons.     
% 213.28/213.52  |- mesh__publicMeSHNote mesh__D002530
% 213.28/213.52       90; was CEREBELLOPONTILE ANGLE 1966-89   
% 213.38/213.52  |- skos__hiddenLabel mesh__D002530 Angle, Cerebellopontile
% 213.38/213.52  |- mesh__activeMeSHYear mesh__D002530 2001
% 213.38/213.52  |- skos__historyNote mesh__D015458 HTLV Infections %28%1987-1988%29%
% 213.38/213.52  |- mesh__activeMeSHYear mesh__D015458 2006
% 213.38/213.52  |- mesh__activeMeSHYear mesh__D015458 2001
% 213.38/213.52  |- skos__altLabel mesh__D015458 Leukemia, Lymphocytic, T-Cell
% 213.38/213.52  |- skos__scopeNote mesh__D015458
% 213.38/213.52       A subtype of lymphocytic leukemia classified as acute or chronic depending on the degree of cell differentiation, not the duration of the disease.%A%    
% 213.38/213.52  |- mesh__publicMeSHNote mesh__D015458
% 213.38/213.52       1989; see HTLV INFECTIONS 1987-88; for LEUKEMIA, ADULT T-CELL %26% T-CELL LEUKEMIA, ADULT see HTLV INFECTIONS 1987-88%A%  
% 213.38/213.52  |- skos__hiddenLabel mesh__D015458 T-Cell Leukemias
% 213.38/213.52  |- skos__hiddenLabel mesh__D015458 Leukemias, T Lymphocytic
% 213.38/213.52  |- skos__hiddenLabel mesh__D015458 Leukemia, T Lymphocytic
% 213.38/213.52  |- mesh__dateRevised mesh__D015458 2000-06-22
% 213.38/213.52  |- mesh__recordAuthorizer mesh__D015458 sjn
% 213.38/213.52  |- mesh__recordMaintainer mesh__D015458 ags
% 213.38/213.52  |- mesh__dateEstablished mesh__D015458 1989-01-01
% 213.38/213.52  |- skos__hiddenLabel mesh__D015458 Lymphocytic Leukemia, T Cell
% 213.38/213.52  |- mesh__activeMeSHYear mesh__D015458 2005
% 213.38/213.52  |- skos__hiddenLabel mesh__D015458 Leukemias, T-Cell
% 213.38/213.52  |- mesh__activeMeSHYear mesh__D015458 2004
% 213.38/213.52  |- mesh__dateCreated mesh__D015458 1988-06-09
% 213.38/213.52  |- rdf__type mesh__D015458sskos__Concept
% 213.38/213.52  |- skos__altLabel mesh__D015458 T-Lymphocytic Leukemia
% 213.38/213.52  |- skos__hiddenLabel mesh__D015458 Leukemias, T-Lymphocytic
% 213.38/213.52  |- skos__hiddenLabel mesh__D015458 T-Cell Lymphocytic Leukemia
% 213.38/213.52  |- skos__altLabel mesh__D015458 Leukemia, Lymphocytic, T Cell
% 213.38/213.52  |- skos__broader mesh__D015458smesh__D007945
% 213.38/213.52  |- skos__prefLabel mesh__D015458 Leukemia, T-Cell
% 213.38/213.52  |- skos__altLabel mesh__D015458 T Lymphocytic Leukemia
% 213.38/213.52  |- mesh__activeMeSHYear mesh__D015458 2003
% 213.38/213.52  |- skos__altLabel mesh__D015458 T-Cell Leukemia
% 213.38/213.52  |- skos__altLabel mesh__D015458 Lymphocytic Leukemia, T-Cell
% 213.38/213.52  |- skos__hiddenLabel mesh__D015458 Leukemia, T-Lymphocytic
% 213.38/213.52  |- mesh__recordOriginator mesh__D015458 PLS
% 213.38/213.52  |- skos__historyNote mesh__D015458 T Lymphocytes %28%1975-1988%29%
% 213.38/213.52  |- mesh__activeMeSHYear mesh__D015458 2002
% 213.38/213.52  |- skos__hiddenLabel mesh__D015458 Leukemia, T Cell
% 213.38/213.52  |- skos__hiddenLabel mesh__D015458 Leukemias, T-Cell Lymphocytic
% 213.38/213.52  |- skos__hiddenLabel mesh__D015458 Leukemia, T-Cell Lymphocytic
% 213.38/213.52  |- skos__hiddenLabel mesh__D015458 Lymphocytic Leukemias, T
% 213.38/213.52  |- skos__annotation mesh__D015458 GEN or unspecified: prefer specifics   
% 213.38/213.52  |- skos__historyNote mesh__D015458 Leukemia, Lymphocytic %28%1975-1988%29%
% 213.38/213.52  |- skos__hiddenLabel mesh__D015458 T Cell Leukemia
% 213.38/213.52  |- skos__hiddenLabel mesh__D015458 T-Lymphocytic Leukemias
% 213.38/213.52  |- mesh__historyNote mesh__D015458 1989; use HTLV INFECTIONS 1987-1988   
% 213.38/213.53  |- skos__hiddenLabel mesh__D015458 Lymphocytic Leukemias, T-Cell
% 213.38/213.53  |- skos__hiddenLabel mesh__D015458 T Lymphocytic Leukemias
% 213.38/213.53  |- skos__hiddenLabel mesh__D015458 Lymphocytic Leukemia, T
% 213.38/213.53  |- skos__hiddenLabel mesh__D015458 T-Cell Lymphocytic Leukemias
% 213.38/213.53  |- skos__broader mesh__D001438smesh__D041963
% 213.38/213.53  |- mesh__dateEstablished mesh__D001438 1975-01-01
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D001438 2006
% 213.38/213.53  |- skos__broader mesh__D001438smesh__D016965
% 213.38/213.53  |- rdf__type mesh__D001438sskos__Concept
% 213.38/213.53  |- skos__prefLabel mesh__D001438 Bacteroidaceae
% 213.38/213.53  |- skos__historyNote mesh__D001438 Bacteria %28%1966-1974%29%
% 213.38/213.53  |- skos__scopeNote mesh__D001438
% 213.38/213.53       A family of gram-negative bacteria found primarily in the intestinal tracts and mucous membranes of warm-blooded animals. Its organisms are sometimes pathogenic.%A%    
% 213.38/213.53  |- mesh__recordOriginator mesh__D001438 NLM
% 213.38/213.53  |- mesh__dateRevised mesh__D001438 2005-06-30
% 213.38/213.53  |- mesh__publicMeSHNote mesh__D001438 75   
% 213.38/213.53  |- mesh__recordMaintainer mesh__D001438 SYSTEM
% 213.38/213.53  |- mesh__dateCreated mesh__D001438 1999-01-01
% 213.38/213.53  |- mesh__historyNote mesh__D001438 75   
% 213.38/213.53  |- mesh__recordAuthorizer mesh__D001438 sjn
% 213.38/213.53  |- skos__related mesh__D012160smesh__D004596
% 213.38/213.53  |- rdf__type mesh__D012160sskos__Concept
% 213.38/213.53  |- skos__prefLabel mesh__D012160 Retina
% 213.38/213.53  |- skos__hiddenLabel mesh__D012160 Retinas
% 213.38/213.53  |- skos__related mesh__D012160smesh__D000793
% 213.38/213.53  |- mesh__dateRevised mesh__D012160 2004-07-07
% 213.38/213.53  |- mesh__dateCreated mesh__D012160 1999-01-01
% 213.38/213.53  |- mesh__recordOriginator mesh__D012160 NLM
% 213.38/213.53  |- skos__annotation mesh__D012160
% 213.38/213.53       /blood supply = RETINAL VESSELS or RETINAL ARTERY or RETINAL VEIN; inflammation = RETINITIS or CHORIORETINITIS; neopl: majority will be RETINOBLASTOMA %28%see note there%29%, otherwise retinal neopl goes under RETINAL NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%; retinal dystrophy: index under RETINAL DEGENERATION or MACULAR DEGENERATION relying on text %26% refs; pigment epithelium of retina: coord RETINA with PIGMENT EPITHELIUM OF EYE%A%  
% 213.38/213.53  |- mesh__recordMaintainer mesh__D012160 ags
% 213.38/213.53  |- skos__broader mesh__D012160smesh__D005123
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D012160 2005
% 213.38/213.53  |- mesh__recordAuthorizer mesh__D012160 sjn
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D012160 2006
% 213.38/213.53  |- skos__scopeNote mesh__D012160
% 213.38/213.53       The ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent.%A%    
% 213.38/213.53  |- skos__historyNote mesh__D006921 Antibiotics %28%1970-1974%29%
% 213.38/213.53  |- rdf__type mesh__D006921sskos__Concept
% 213.38/213.53  |- mesh__dateEstablished mesh__D006921 1991-01-01
% 213.38/213.53  |- mesh__dateCreated mesh__D006921 1974-11-19
% 213.38/213.53  |- skos__broader mesh__D006921smesh__D000617
% 213.38/213.53  |- mesh__publicMeSHNote mesh__D006921
% 213.38/213.53       91; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1975-90   
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006921 2006
% 213.38/213.53  |- skos__prefLabel mesh__D006921 Hygromycin B
% 213.38/213.53  |- mesh__dateRevised mesh__D006921 2004-07-07
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006921 2005
% 213.38/213.53  |- mesh__recordOriginator mesh__D006921 NLM
% 213.38/213.53  |- mesh__historyNote mesh__D006921
% 213.38/213.53       91%28%75%29%; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1975-90%A%  
% 213.38/213.53  |- skos__historyNote mesh__D006921 Aminoglycosides %28%1974%29%
% 213.38/213.53  |- skos__scopeNote mesh__D006921
% 213.38/213.53       Aminoglycoside produced by Streptomyces hygroscopicus. It is used as an anthelmintic against swine infections by large roundworms, nodular worms, and whipworms.%A%    
% 213.38/213.53  |- mesh__recordAuthorizer mesh__D006921 sjn
% 213.38/213.53  |- mesh__recordMaintainer mesh__D006921 ssb
% 213.38/213.53  |- skos__hiddenLabel mesh__D006921 B, Hygromycin
% 213.38/213.53  |- skos__annotation mesh__D006123
% 213.38/213.53       coord IM with med or other specialty %28%IM%29%; do not confuse with PARTNERSHIP PRACTICE but do not interpret: use word of text%A%  
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006123 2004
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006123 1996
% 213.38/213.53  |- skos__hiddenLabel mesh__D006123 Practice, Group
% 213.38/213.53  |- rdf__type mesh__D006123sskos__Concept
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006123 2002
% 213.38/213.53  |- mesh__recordAuthorizer mesh__D006123 PLS
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006123 1997
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006123 2005
% 213.38/213.53  |- skos__scopeNote mesh__D006123
% 213.38/213.53       Any group of three or more full-time physicians organized in a legally recognized entity for the provision of health care services, sharing space, equipment, personnel and records for both patient care and business management, and who have a predetermined arrangement for the distribution of income.%A%    
% 213.38/213.53  |- mesh__recordOriginator mesh__D006123 NLM
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006123 1995
% 213.38/213.53  |- mesh__dateRevised mesh__D006123 1994-05-05
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006123 2000
% 213.38/213.53  |- mesh__recordMaintainer mesh__D006123 TGC
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006123 2006
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006123 1998
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006123 2001
% 213.38/213.53  |- skos__broader mesh__D006123smesh__D011364
% 213.38/213.53  |- skos__hiddenLabel mesh__D006123 Group Practices
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006123 2003
% 213.38/213.53  |- mesh__dateCreated mesh__D006123 1999-01-01
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006123 1999
% 213.38/213.53  |- skos__prefLabel mesh__D006123 Group Practice
% 213.38/213.53  |- skos__hiddenLabel mesh__D006123 Practices, Group
% 213.38/213.53  |- skos__broader mesh__D019849smesh__D039361
% 213.38/213.53  |- mesh__dateCreated mesh__D019849 1997-06-20
% 213.38/213.53  |- skos__historyNote mesh__D019849
% 213.38/213.53       Sex Determination %28%Analysis%29% %28%1966-1997%29%
% 213.38/213.53  |- skos__scopeNote mesh__D019849
% 213.38/213.53       The mechanism in a given species, by which the SEX of an individual is fixed. In many species, sex is established at FERTILIZATION by the SPERM that fertilizes the EGG. In human, the Y CHROMOSOME bearing sperm determine production of the male ZYGOTE.%A%    
% 213.38/213.53  |- skos__related mesh__D019849smesh__D012743
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D019849 2004
% 213.38/213.53  |- mesh__historyNote mesh__D019849 1998   
% 213.38/213.53  |- mesh__recordOriginator mesh__D019849 AGS
% 213.38/213.53  |- skos__related mesh__D019849smesh__D024282
% 213.38/213.53  |- mesh__recordAuthorizer mesh__D019849 sjn
% 213.38/213.53  |- skos__annotation mesh__D019849
% 213.38/213.53       do not confuse with SEX DETERMINATION %28%ANALYSIS%29% which is validation of sex by exam of gonads or genet tests; DF: SEX DETERMINATION GENET%A%  
% 213.38/213.53  |- skos__prefLabel mesh__D019849 Sex Determination %28%Genetics%29%
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D019849 2006
% 213.38/213.53  |- mesh__publicMeSHNote mesh__D019849 1998   
% 213.38/213.53  |- rdf__type mesh__D019849sskos__Concept
% 213.38/213.53  |- skos__hiddenLabel mesh__D019849 Determination, Sex %28%Genetics%29%
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D019849 2005
% 213.38/213.53  |- mesh__dateRevised mesh__D019849 2003-07-09
% 213.38/213.53  |- skos__related mesh__D019849smesh__D012733
% 213.38/213.53  |- mesh__recordMaintainer mesh__D019849 nns
% 213.38/213.53  |- skos__hiddenLabel mesh__D019849 Sex Determinations %28%Genetics%29%
% 213.38/213.53  |- skos__hiddenLabel mesh__D019849 Determinations, Sex %28%Genetics%29%
% 213.38/213.53  |- mesh__dateEstablished mesh__D019849 1998-01-01
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011866 1999
% 213.38/213.53  |- mesh__recordMaintainer mesh__D011866 PXP
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011866 2005
% 213.38/213.53  |- mesh__recordAuthorizer mesh__D011866 SJN
% 213.38/213.53  |- skos__hiddenLabel mesh__D011866 Radioisotope Renographies
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011866 2001
% 213.38/213.53  |- skos__broader mesh__D011866smesh__D011875
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011866 2003
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011866 2006
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011866 2002
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011866 2004
% 213.38/213.53  |- mesh__recordOriginator mesh__D011866 NLM
% 213.38/213.53  |- mesh__dateCreated mesh__D011866 1999-01-01
% 213.38/213.53  |- mesh__historyNote mesh__D011866 66%28%64%29%   
% 213.38/213.53  |- rdf__type mesh__D011866sskos__Concept
% 213.38/213.53  |- skos__annotation mesh__D011866
% 213.38/213.53       a specific kidney function test: read MeSH definition; do not confuse with KIDNEY /radionuclide; coord dis with /radionuclide, not /diag %26% not /radiogr; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: RADIOISOTOPE RENOGR%A%  
% 213.38/213.53  |- skos__hiddenLabel mesh__D011866 Renographies, Radioisotope
% 213.38/213.53  |- mesh__publicMeSHNote mesh__D011866 66   
% 213.38/213.53  |- skos__hiddenLabel mesh__D011866 Renographies
% 213.38/213.53  |- skos__scopeNote mesh__D011866
% 213.38/213.53       Graphic tracing over a time period of radioactivity measured externally over the kidneys following intravenous injection of a radionuclide which is taken up and excreted by the kidneys.%A%    
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011866 2000
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011866 1998
% 213.38/213.53  |- skos__hiddenLabel mesh__D011866 Renography, Radioisotope
% 213.38/213.53  |- skos__prefLabel mesh__D011866 Radioisotope Renography
% 213.38/213.53  |- mesh__dateRevised mesh__D011866 1997-06-20
% 213.38/213.53  |- mesh__dateEstablished mesh__D011866 1966-01-01
% 213.38/213.53  |- skos__broader mesh__D011866smesh__D007677
% 213.38/213.53  |- skos__related mesh__D044242smesh__D044243
% 213.38/213.53  |- mesh__dateEstablished mesh__D044242 2004-01-01
% 213.38/213.53  |- skos__hiddenLabel mesh__D044242 Acids, Trans-Fatty
% 213.38/213.53  |- mesh__historyNote mesh__D044242 2004   
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D044242 2004
% 213.38/213.53  |- skos__annotation mesh__D044242
% 213.38/213.53       coord with specific fatty acid if pertinent   
% 213.38/213.53  |- mesh__publicMeSHNote mesh__D044242 2004   
% 213.38/213.53  |- skos__broader mesh__D044242smesh__D005231
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D044242 2005
% 213.38/213.53  |- skos__hiddenLabel mesh__D044242 Acids, Trans Fatty
% 213.38/213.53  |- skos__scopeNote mesh__D044242
% 213.38/213.53       UNSATURATED FATTY ACIDS that contain at least one double bond in the trans configuration, which results in a greater bond angle than the cis configuration. This results in a more extended fatty acid chain similar to SATURATED FATTY ACIDS, with closer packing and reduced fluidity. HYDROGENATION of unsaturated fatty acids increases the trans content.%A%    
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D044242 2006
% 213.38/213.53  |- rdf__type mesh__D044242sskos__Concept
% 213.38/213.53  |- skos__hiddenLabel mesh__D044242 Fatty Acids, Trans
% 213.38/213.53  |- mesh__dateCreated mesh__D044242 2003-07-09
% 213.38/213.53  |- skos__historyNote mesh__D044242 Fatty Acids %28%1968-2003%29%
% 213.38/213.53  |- skos__prefLabel mesh__D044242 Trans Fatty Acids
% 213.38/213.53  |- skos__altLabel mesh__D044242 Trans-Fatty Acids
% 213.38/213.53  |- skos__hiddenLabel mesh__D011068 G, Poly
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011068 1996
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011068 2006
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011068 2000
% 213.38/213.53  |- mesh__recordAuthorizer mesh__D011068 PLS
% 213.38/213.53  |- mesh__dateEstablished mesh__D011068 1991-01-01
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011068 1998
% 213.38/213.53  |- mesh__recordOriginator mesh__D011068 RLS
% 213.38/213.53  |- skos__historyNote mesh__D011068 Polynucleotides %28%1966-1975%29%
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011068 1997
% 213.38/213.53  |- skos__hiddenLabel mesh__D011068 Polynucleotides, Guanine
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011068 2001
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011068 1994
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011068 1999
% 213.38/213.53  |- skos__hiddenLabel mesh__D011068 Acids, Polyguanylic
% 213.38/213.53  |- rdf__type mesh__D011068sskos__Concept
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011068 1993
% 213.38/213.53  |- mesh__dateCreated mesh__D011068 1975-08-01
% 213.38/213.53  |- skos__altLabel mesh__D011068 Polyguanylic Acids
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011068 1995
% 213.38/213.53  |- mesh__dateRevised mesh__D011068 1992-05-20
% 213.38/213.53  |- skos__altLabel mesh__D011068 Guanine Polynucleotides
% 213.38/213.53  |- mesh__recordMaintainer mesh__D011068 TGC
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011068 2002
% 213.38/213.53  |- skos__scopeNote mesh__D011068
% 213.38/213.53       A group of guanine ribonucleotides in which the phosphate residues of each guanine ribonucleotide act as bridges in forming diester linkages between the ribose moieties.%A%    
% 213.38/213.53  |- skos__prefLabel mesh__D011068 Poly G
% 213.38/213.53  |- mesh__publicMeSHNote mesh__D011068
% 213.38/213.53       91; was see under POLYRIBONUCLEOTIDES 1976-90   
% 213.38/213.53  |- skos__broader mesh__D011068smesh__D011131
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011068 2003
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011068 2005
% 213.38/213.53  |- mesh__historyNote mesh__D011068
% 213.38/213.53       91%28%76%29%; was see under POLYRIBONUCLEOTIDES 1976-90   
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D011068 2004
% 213.38/213.53  |- skos__hiddenLabel mesh__D005829 Medial Geniculate Bodies
% 213.38/213.53  |- skos__hiddenLabel mesh__D005829 Geniculate Body, Lateral
% 213.38/213.53  |- skos__hiddenLabel mesh__D005829 Bodies, Geniculate
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D005829 2001
% 213.38/213.53  |- rdf__type mesh__D005829sskos__Concept
% 213.38/213.53  |- skos__hiddenLabel mesh__D005829 Body, Lateral Geniculate
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D005829 2000
% 213.38/213.53  |- skos__altLabel mesh__D005829 Metathalamus
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D005829 2005
% 213.38/213.53  |- skos__prefLabel mesh__D005829 Geniculate Bodies
% 213.38/213.53  |- skos__hiddenLabel mesh__D005829 Geniculate Body, Medial
% 213.38/213.53  |- skos__hiddenLabel mesh__D005829 Body, Medial Geniculate
% 213.38/213.53  |- skos__hiddenLabel mesh__D005829 Geniculate Bodies, Lateral
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D005829 2004
% 213.38/213.53  |- skos__hiddenLabel mesh__D005829 Bodies, Medial Geniculate
% 213.38/213.53  |- mesh__recordMaintainer mesh__D005829 ags
% 213.38/213.53  |- mesh__recordOriginator mesh__D005829 NLM
% 213.38/213.53  |- skos__hiddenLabel mesh__D005829 Lateral Geniculate Bodies
% 213.38/213.53  |- skos__scopeNote mesh__D005829
% 213.38/213.53       Part of the diencephalon inferior to the caudal end of the dorsal thalamus. Includes the lateral geniculate body which relays visual impulses from the optic tract to the calcarine cortex, and the medial geniculate body which relays auditory impulses from the lateral lemniscus to the auditory cortex.%A%    
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D005829 2003
% 213.38/213.53  |- mesh__recordAuthorizer mesh__D005829 sjn
% 213.38/213.53  |- skos__hiddenLabel mesh__D005829 Geniculate Bodies, Medial
% 213.38/213.53  |- mesh__dateCreated mesh__D005829 1999-01-01
% 213.38/213.53  |- skos__hiddenLabel mesh__D005829 Bodies, Lateral Geniculate
% 213.38/213.53  |- mesh__dateRevised mesh__D005829 1999-11-03
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D005829 2002
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D005829 2006
% 213.38/213.53  |- skos__broader mesh__D005829smesh__D013787
% 213.38/213.53  |- mesh__dateEstablished mesh__D038205 2003-01-01
% 213.38/213.53  |- skos__altLabel mesh__D038205 beta A-Crystallin
% 213.38/213.53  |- skos__hiddenLabel mesh__D038205 beta Crystallin A Chain
% 213.38/213.53  |- skos__hiddenLabel mesh__D038205 beta A Crystallin
% 213.38/213.53  |- skos__altLabel mesh__D038205 Crystallins, beta A Chain
% 213.38/213.53  |- skos__hiddenLabel mesh__D038205 A Chain, beta-Crystallin
% 213.38/213.53  |- skos__historyNote mesh__D038205 Crystallins %28%1984-2002%29%
% 213.38/213.53  |- mesh__publicMeSHNote mesh__D038205 2003   
% 213.38/213.53  |- mesh__historyNote mesh__D038205 2003   
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D038205 2003
% 213.38/213.53  |- skos__hiddenLabel mesh__D038205 A Subunit beta-Crystallin
% 213.38/213.53  |- rdf__type mesh__D038205sskos__Concept
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D038205 2005
% 213.38/213.53  |- skos__altLabel mesh__D038205 beta-Crystallin, A Subunit
% 213.38/213.53  |- mesh__dateCreated mesh__D038205 2002-07-02
% 213.38/213.53  |- skos__scopeNote mesh__D038205
% 213.38/213.53       The acidic subunit of beta-crystallins.     
% 213.38/213.53  |- skos__prefLabel mesh__D038205 beta-Crystallin A Chain
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D038205 2004
% 213.38/213.53  |- skos__hiddenLabel mesh__D038205 beta Crystallin, A Subunit
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D038205 2006
% 213.38/213.53  |- skos__broader mesh__D038205smesh__D038204
% 213.38/213.53  |- mesh__dateCreated mesh__D002531 1999-01-01
% 213.38/213.53  |- skos__annotation mesh__D002531
% 213.38/213.53       cerebellar artery = CEREBELLUM /blood supply %28%IM%29% + ARTERIES %28%NIM%29%%A%  
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D002531 2000
% 213.38/213.53  |- skos__prefLabel mesh__D002531 Cerebellum
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D002531 2003
% 213.38/213.53  |- skos__broader mesh__D002531smesh__D020540
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D002531 2001
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D002531 2004
% 213.38/213.53  |- rdf__type mesh__D002531sskos__Concept
% 213.38/213.53  |- mesh__recordOriginator mesh__D002531 NLM
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D002531 2002
% 213.38/213.53  |- skos__scopeNote mesh__D002531
% 213.38/213.53       Part of the metencephalon that lies in the posterior cranial fossa behind the brain stem. It is concerned with the coordination of movement.%A%    
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D002531 2005
% 213.38/213.53  |- mesh__dateRevised mesh__D002531 1999-11-08
% 213.38/213.53  |- mesh__recordMaintainer mesh__D002531 adp
% 213.38/213.53  |- mesh__recordAuthorizer mesh__D002531 sjn
% 213.38/213.53  |- skos__broader mesh__D002531smesh__D001921
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D002531 2006
% 213.38/213.53  |- skos__hiddenLabel mesh__D002531 Cerebellums
% 213.38/213.53  |- skos__hiddenLabel mesh__D015459 Acute T-Cell Leukemias
% 213.38/213.53  |- skos__altLabel mesh__D015459 Leukemia, Lymphocytic, Acute T Cell
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D015459 2001
% 213.38/213.53  |- mesh__recordMaintainer mesh__D015459 PXP
% 213.38/213.53  |- skos__altLabel mesh__D015459 T-Lymphocytic Leukemia, Acute
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D015459 2006
% 213.38/213.53  |- skos__altLabel mesh__D015459 T-Cell Leukemia, Acute
% 213.38/213.53  |- skos__hiddenLabel mesh__D015459 Leukemia, Acute T-Lymphocytic
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D015459 1999
% 213.38/213.53  |- skos__broader mesh__D015459smesh__D015447
% 213.38/213.53  |- skos__altLabel mesh__D015459 Leukemia, Lymphocytic, Acute, T-Cell
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D015459 2000
% 213.38/213.53  |- skos__annotation mesh__D015459
% 213.38/213.53       do not use /blood supply /chem /second /secret /ultrastruct; DF: note short X ref T-ALL%A%  
% 213.38/213.53  |- mesh__dateEstablished mesh__D015459 1989-01-01
% 213.38/213.53  |- skos__hiddenLabel mesh__D015459 Acute T-Cell Leukemia
% 213.38/213.53  |- skos__hiddenLabel mesh__D015459 Leukemias, Acute T-Lymphocytic
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D015459 2005
% 213.38/213.53  |- skos__prefLabel mesh__D015459 Leukemia, T-Cell, Acute
% 213.38/213.53  |- mesh__dateCreated mesh__D015459 1988-06-09
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D015459 2004
% 213.38/213.53  |- rdf__type mesh__D015459sskos__Concept
% 213.38/213.53  |- skos__altLabel mesh__D015459 Leukemia, Lymphoblastic, Acute, T-Cell
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D015459 1998
% 213.38/213.53  |- mesh__publicMeSHNote mesh__D015459 89   
% 213.38/213.53  |- skos__hiddenLabel mesh__D015459 T Lymphocytic Leukemia, Acute
% 213.38/213.53  |- skos__altLabel mesh__D015459 T-ALL
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D015459 2003
% 213.38/213.53  |- mesh__recordOriginator mesh__D015459 PLS
% 213.38/213.53  |- skos__hiddenLabel mesh__D015459 T Cell Leukemia, Acute
% 213.38/213.53  |- mesh__historyNote mesh__D015459 89   
% 213.38/213.53  |- mesh__dateRevised mesh__D015459 1997-06-20
% 213.38/213.53  |- skos__altLabel mesh__D015459 Leukemia, Lymphoblastic, Acute, T Cell
% 213.38/213.53  |- skos__hiddenLabel mesh__D015459 Acute T-Lymphocytic Leukemias
% 213.38/213.53  |- skos__hiddenLabel mesh__D015459 Acute T-Lymphocytic Leukemia
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D015459 2002
% 213.38/213.53  |- skos__historyNote mesh__D015459 T Lymphocytes %28%1975-1988%29%
% 213.38/213.53  |- skos__altLabel mesh__D015459 Lymphoblastic Leukemia, Acute, T Cell
% 213.38/213.53  |- skos__historyNote mesh__D015459
% 213.38/213.53       Leukemia, Lymphoblastic %28%1975-1988%29%
% 213.38/213.53  |- skos__broader mesh__D015459smesh__D015458
% 213.38/213.53  |- skos__historyNote mesh__D015459 Leukemia, Lymphocytic %28%1975-1988%29%
% 213.38/213.53  |- skos__hiddenLabel mesh__D015459 T-Cell Leukemias, Acute
% 213.38/213.53  |- skos__altLabel mesh__D015459 Lymphoblastic Leukemia, Acute, T-Cell
% 213.38/213.53  |- skos__hiddenLabel mesh__D015459 T-Lymphocytic Leukemias, Acute
% 213.38/213.53  |- skos__altLabel mesh__D015459 Lymphocytic Leukemia, T-Cell, Acute
% 213.38/213.53  |- skos__hiddenLabel mesh__D015459 Leukemia, Acute T-Cell
% 213.38/213.53  |- skos__altLabel mesh__D015459 Lymphocytic Leukemia, T Cell, Acute
% 213.38/213.53  |- skos__hiddenLabel mesh__D015459 Leukemias, Acute T-Cell
% 213.38/213.53  |- mesh__recordAuthorizer mesh__D015459 SJN
% 213.38/213.53  |- skos__historyNote mesh__D015459 HTLV Infections %28%1987-1988%29%
% 213.38/213.53  |- mesh__recordOriginator mesh__D001439 NLM
% 213.38/213.53  |- mesh__dateRevised mesh__D001439 2005-06-30
% 213.38/213.53  |- skos__annotation mesh__D001439
% 213.38/213.53       infection = BACTEROIDES INFECTIONS; BACTEROIDES CORRODENS see EIKENELLA CORRODENS and BACTEROIDES NODOSUS see DICHELOBACTER NODOSUS are also available%A%  
% 213.38/213.53  |- mesh__recordMaintainer mesh__D001439 SYSTEM
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D001439 2006
% 213.38/213.53  |- mesh__recordAuthorizer mesh__D001439 sjn
% 213.38/213.53  |- rdf__type mesh__D001439sskos__Concept
% 213.38/213.53  |- mesh__dateCreated mesh__D001439 1999-01-01
% 213.38/213.53  |- skos__prefLabel mesh__D001439 Bacteroides
% 213.38/213.53  |- skos__scopeNote mesh__D001439
% 213.38/213.53       A genus of gram-negative, anaerobic, rod-shaped bacteria. Its organisms are normal inhabitants of the oral, respiratory, intestinal, and urogenital cavities of humans, animals, and insects. Some species may be pathogenic.%A%    
% 213.38/213.53  |- skos__broader mesh__D001439smesh__D001438
% 213.38/213.53  |- skos__hiddenLabel mesh__D012161 Artery, Central Retinal
% 213.38/213.53  |- skos__hiddenLabel mesh__D012161 Central Retinal Arteries
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D012161 2000
% 213.38/213.53  |- mesh__dateCreated mesh__D012161 1999-01-01
% 213.38/213.53  |- mesh__recordMaintainer mesh__D012161 MSR
% 213.38/213.53  |- skos__historyNote mesh__D012161 Retinal Vessels %28%1966-1972%29%
% 213.38/213.53  |- skos__hiddenLabel mesh__D012161 Artery, Retinal
% 213.38/213.53  |- skos__broader mesh__D012161smesh__D001158
% 213.38/213.53  |- skos__hiddenLabel mesh__D012161 Retinal Artery, Central
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D012161 2001
% 213.38/213.53  |- skos__hiddenLabel mesh__D012161 Arteries, Retinal
% 213.38/213.53  |- skos__hiddenLabel mesh__D012161 Retinal Arteries
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D012161 2005
% 213.38/213.53  |- mesh__historyNote mesh__D012161 73   
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D012161 2002
% 213.38/213.53  |- mesh__recordAuthorizer mesh__D012161 SJN
% 213.38/213.53  |- skos__hiddenLabel mesh__D012161 Retinal Arteries, Central
% 213.38/213.53  |- skos__prefLabel mesh__D012161 Retinal Artery
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D012161 2003
% 213.38/213.53  |- mesh__publicMeSHNote mesh__D012161 73   
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D012161 1999
% 213.38/213.53  |- skos__scopeNote mesh__D012161
% 213.38/213.53       Central retinal artery and its branches. It arises from the ophthalmic artery, pierces the optic nerve and runs through its center, enters the eye through the porus opticus and branches to supply the retina.%A%    
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D012161 2006
% 213.38/213.53  |- mesh__dateRevised mesh__D012161 1998-06-11
% 213.38/213.53  |- mesh__recordOriginator mesh__D012161 NLM
% 213.38/213.53  |- mesh__dateEstablished mesh__D012161 1973-01-01
% 213.38/213.53  |- skos__hiddenLabel mesh__D012161 Arteries, Central Retinal
% 213.38/213.53  |- skos__annotation mesh__D012161
% 213.38/213.53       retinal artery dis: coord IM with RETINAL DISEASES %28%IM%29%, not VASCULAR DISEASES%A%  
% 213.38/213.53  |- skos__altLabel mesh__D012161 Central Retinal Artery
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D012161 2004
% 213.38/213.53  |- skos__broader mesh__D012161smesh__D012171
% 213.38/213.53  |- rdf__type mesh__D012161sskos__Concept
% 213.38/213.53  |- mesh__recordAuthorizer mesh__D006922 sjn
% 213.38/213.53  |- skos__annotation mesh__D006922
% 213.38/213.53       gibbon, not monkey %26% not ape; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with specific dis /vet %28%IM%29%%A%  
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006922 2006
% 213.38/213.53  |- skos__broader mesh__D006922smesh__D016674
% 213.38/213.53  |- skos__prefLabel mesh__D006922 Hylobates
% 213.38/213.53  |- skos__hiddenLabel mesh__D006922 Gibbon
% 213.38/213.53  |- skos__scopeNote mesh__D006922
% 213.38/213.53       A genus of the family HYLOBATIDAE consisting of six species. The members of this genus inhabit rain forests in southeast Asia. They are arboreal and differ from other anthropoids in the great length of their arms and very slender bodies and limbs. Their major means of locomotion is by swinging from branch to branch by their arms. Hylobates means dweller in the trees. Some authors refer to Symphalangus and Nomascus as Hylobates. The six genera include: H. concolor %28%crested or black gibbon%29%, H. hoolock %28%Hoolock gibbon%29%, H. klossii %28%Kloss%27%s gibbon; dwarf siamang%29%, H. lar %28%common gibbon%29%, H. pileatus %28%pileated gibbon%29%, and H. syndactylus %28%siamang%29%. H. lar is also known as H. agilis %28%lar gibbon%29%, H. moloch %28%agile gibbon%29%, and H. muelleri %28%silvery gibbon%29%.%A%    
% 213.38/213.53  |- mesh__recordMaintainer mesh__D006922 ags
% 213.38/213.53  |- mesh__dateRevised mesh__D006922 2005-06-30
% 213.38/213.53  |- mesh__historyNote mesh__D006922
% 213.38/213.53       91%28%81%29%; was see under PONGIDAE 1981-90; was GIBBONS see under APES 1975-80%A%  
% 213.38/213.53  |- skos__altLabel mesh__D006922 Symphalangus
% 213.38/213.53  |- skos__altLabel mesh__D006922 Gibbons
% 213.38/213.53  |- mesh__dateCreated mesh__D006922 1974-11-11
% 213.38/213.53  |- skos__hiddenLabel mesh__D006922 Siamangs
% 213.38/213.53  |- rdf__type mesh__D006922sskos__Concept
% 213.38/213.53  |- skos__hiddenLabel mesh__D006922 Hylobate
% 213.38/213.53  |- mesh__onlineNote mesh__D006922
% 213.38/213.53       use HYLOBATES to search GIBBONS 1975-80   
% 213.38/213.53  |- mesh__recordOriginator mesh__D006922 NLM
% 213.38/213.53  |- mesh__dateEstablished mesh__D006922 1991-01-01
% 213.38/213.53  |- skos__altLabel mesh__D006922 Nomascus
% 213.38/213.53  |- mesh__publicMeSHNote mesh__D006922
% 213.38/213.53       91; was see under PONGIDAE 1981-90; was GIBBONS see under APES 1975-80%A%  
% 213.38/213.53  |- skos__historyNote mesh__D006124 Dentistry %28%1966%29%
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006124 1997
% 213.38/213.53  |- skos__prefLabel mesh__D006124 Group Practice, Dental
% 213.38/213.53  |- skos__altLabel mesh__D006124 Dental Group Practices
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006124 2005
% 213.38/213.53  |- mesh__dateEstablished mesh__D006124 1967-01-01
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006124 1995
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006124 2002
% 213.38/213.53  |- mesh__dateRevised mesh__D006124 1994-05-05
% 213.38/213.53  |- skos__altLabel mesh__D006124 Dental Group Practice
% 213.38/213.53  |- skos__altLabel mesh__D006124 Group Practices, Dental
% 213.38/213.53  |- mesh__recordAuthorizer mesh__D006124 PLS
% 213.38/213.53  |- mesh__recordMaintainer mesh__D006124 TGC
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006124 2006
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006124 1998
% 213.38/213.53  |- skos__annotation mesh__D006124
% 213.38/213.53       coord IM with specific dent specialty %28%IM%29%; do not confuse with PARTNERSHIP PRACTICE, DENTAL but do not interpret: use word of text; DF: GROUP PRACTICE DENT%A%  
% 213.38/213.53  |- skos__historyNote mesh__D006124 Group Practice %28%1966%29%
% 213.38/213.53  |- mesh__historyNote mesh__D006124 67   
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006124 2003
% 213.38/213.53  |- mesh__dateCreated mesh__D006124 1999-01-01
% 213.38/213.53  |- mesh__recordOriginator mesh__D006124 NLM
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006124 1999
% 213.38/213.53  |- skos__altLabel mesh__D006124 Practice, Dental Group
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006124 2000
% 213.38/213.53  |- skos__broader mesh__D006124smesh__D006123
% 213.38/213.53  |- mesh__activeMeSHYear mesh__D006124 2004
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D006124 2001
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D006124 1996
% 213.38/213.54  |- skos__altLabel mesh__D006124 Practices, Dental Group
% 213.38/213.54  |- mesh__publicMeSHNote mesh__D006124 67   
% 213.38/213.54  |- rdf__type mesh__D006124sskos__Concept
% 213.38/213.54  |- skos__scopeNote mesh__D006124
% 213.38/213.54       Any group of three or more full-time dentists, organized in a legally recognized entity for the provision of dental care, sharing space, equipment, personnel and records for both patient care and business management, and who have a predetermined arrangement for the distribution of income.%A%    
% 213.38/213.54  |- skos__annotation mesh__D050280
% 213.38/213.54       general or unspecified; prefer specifics; primates only; Manual 21.58%A%  
% 213.38/213.54  |- skos__historyNote mesh__D050280
% 213.38/213.54       Bones of Upper Extremity %28%1998-2005%29%
% 213.38/213.54  |- skos__prefLabel mesh__D050280 Arm Bones
% 213.38/213.54  |- mesh__dateEstablished mesh__D050280 2006-01-01
% 213.38/213.54  |- skos__altLabel mesh__D050280 Bones of Arm
% 213.38/213.54  |- mesh__publicMeSHNote mesh__D050280
% 213.38/213.54       2006; see BONES OF UPPER EXTREMITY 1998-2005   
% 213.38/213.54  |- mesh__dateCreated mesh__D050280 2005-06-30
% 213.38/213.54  |- skos__broader mesh__D050280smesh__D001133
% 213.38/213.54  |- mesh__recordAuthorizer mesh__D050280 sjn
% 213.38/213.54  |- rdf__type mesh__D050280sskos__Concept
% 213.38/213.54  |- skos__hiddenLabel mesh__D050280 Bone, Arm
% 213.38/213.54  |- mesh__recordMaintainer mesh__D050280 ags
% 213.38/213.54  |- skos__hiddenLabel mesh__D050280 Arm Bone
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D050280 2006
% 213.38/213.54  |- mesh__historyNote mesh__D050280
% 213.38/213.54       2006; use BONES OF UPPER EXTREMITY 1998-2005   
% 213.38/213.54  |- mesh__recordOriginator mesh__D050280 ags
% 213.38/213.54  |- skos__scopeNote mesh__D050280
% 213.38/213.54       The bones of the free part of the upper extremity including the HUMERUS; RADIUS; and ULNA.%A%    
% 213.38/213.54  |- skos__hiddenLabel mesh__D050280 Bones, Arm
% 213.38/213.54  |- skos__altLabel mesh__D011867 Teletherapy, Radioisotope
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011867 2006
% 213.38/213.54  |- skos__broader mesh__D011867smesh__D011882
% 213.38/213.54  |- mesh__dateRevised mesh__D011867 2005-06-30
% 213.38/213.54  |- mesh__dateCreated mesh__D011867 1999-01-01
% 213.38/213.54  |- skos__prefLabel mesh__D011867 Radioisotope Teletherapy
% 213.38/213.54  |- mesh__recordAuthorizer mesh__D011867 sjn
% 213.38/213.54  |- rdf__type mesh__D011867sskos__Concept
% 213.38/213.54  |- skos__annotation mesh__D011867
% 213.38/213.54       ionizing; do not use /util except by MeSH definition; coord IM with specific radioisotope /ther use %28%IM%29%%A%  
% 213.38/213.54  |- skos__altLabel mesh__D011867 Teleradioisotope Therapy
% 213.38/213.54  |- skos__altLabel mesh__D011867 Therapy, Teleradioisotope
% 213.38/213.54  |- mesh__recordOriginator mesh__D011867 NLM
% 213.38/213.54  |- skos__scopeNote mesh__D011867
% 213.38/213.54       A type of high-energy radiotherapy using a beam of gamma-radiation produced by a radioisotope source encapsulated within a teletherapy unit.%A%    
% 213.38/213.54  |- mesh__recordMaintainer mesh__D011867 lkt
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D044243 2004
% 213.38/213.54  |- skos__related mesh__D044243smesh__D044242
% 213.38/213.54  |- skos__historyNote mesh__D044243 Linoleic Acid %28%1992-2003%29%
% 213.38/213.54  |- mesh__publicMeSHNote mesh__D044243 2004   
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D044243 2005
% 213.38/213.54  |- skos__hiddenLabel mesh__D044243 Acids, Conjugated Linoleic
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D044243 2006
% 213.38/213.54  |- skos__hiddenLabel mesh__D044243 Conjugated Linoleic Acids
% 213.38/213.54  |- mesh__dateEstablished mesh__D044243 2004-01-01
% 213.38/213.54  |- mesh__historyNote mesh__D044243 2004   
% 213.38/213.54  |- skos__scopeNote mesh__D044243
% 213.38/213.54       A collective term for a group of around nine geometric and positional isomers of LINOLEIC ACID in which the trans/cis double bonds are conjugated, where double bonds alternate with single bonds.%A%    
% 213.38/213.54  |- skos__annotation mesh__D044243 LINOLEIC ACID is also available   
% 213.38/213.54  |- rdf__type mesh__D044243sskos__Concept
% 213.38/213.54  |- mesh__dateCreated mesh__D044243 2003-07-09
% 213.38/213.54  |- skos__broader mesh__D044243smesh__D008041
% 213.38/213.54  |- skos__prefLabel mesh__D044243 Linoleic Acids, Conjugated
% 213.38/213.54  |- mesh__dateCreated mesh__D011069 1975-08-01
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011069 2000
% 213.38/213.54  |- skos__annotation mesh__D011069 do not confuse with POLY I-C   
% 213.38/213.54  |- mesh__recordAuthorizer mesh__D011069 PLS
% 213.38/213.54  |- mesh__publicMeSHNote mesh__D011069
% 213.38/213.54       91; was see under POLYRIBONUCLEOTIDES 1976-90   
% 213.38/213.54  |- skos__broader mesh__D011069smesh__D011131
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011069 2003
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011069 1997
% 213.38/213.54  |- skos__historyNote mesh__D011069 Polynucleotides %28%1966-1975%29%
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011069 2006
% 213.38/213.54  |- skos__hiddenLabel mesh__D011069 Acids, Polyinosinic
% 213.38/213.54  |- skos__prefLabel mesh__D011069 Poly I
% 213.38/213.54  |- mesh__recordMaintainer mesh__D011069 TGC
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011069 1993
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011069 2002
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011069 1996
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011069 2005
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011069 1999
% 213.38/213.54  |- mesh__dateEstablished mesh__D011069 1991-01-01
% 213.38/213.54  |- skos__altLabel mesh__D011069 Polyinosinic Acids
% 213.38/213.54  |- skos__hiddenLabel mesh__D011069 Polynucleotides, Inosine
% 213.38/213.54  |- rdf__type mesh__D011069sskos__Concept
% 213.38/213.54  |- skos__scopeNote mesh__D011069
% 213.38/213.54       A group of inosine ribonucleotides in which the phosphate residues of each inosine ribonucleotide act as bridges in forming diester linkages between the ribose moieties.%A%    
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011069 1995
% 213.38/213.54  |- mesh__historyNote mesh__D011069
% 213.38/213.54       91%28%76%29%; was see under POLYRIBONUCLEOTIDES 1976-90   
% 213.38/213.54  |- skos__altLabel mesh__D011069 Inosine Polynucleotides
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011069 1998
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011069 2001
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011069 1994
% 213.38/213.54  |- mesh__dateRevised mesh__D011069 1992-05-20
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011069 2004
% 213.38/213.54  |- mesh__recordOriginator mesh__D011069 RLS
% 213.38/213.54  |- rdf__type mesh__D016552sskos__Concept
% 213.38/213.54  |- mesh__recordOriginator mesh__D016552 PXP
% 213.38/213.54  |- mesh__recordAuthorizer mesh__D016552 PLS
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D016552 1994
% 213.38/213.54  |- skos__related mesh__D016552smesh__D005082
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D016552 2005
% 213.38/213.54  |- skos__scopeNote mesh__D016552
% 213.38/213.54       Any method of measuring the amount of work done by an organism, usually during EXERTION. Ergometry also includes measures of power. Some instruments used in these determinations include the hand crank and the bicycle ergometer.%A%    
% 213.38/213.54  |- mesh__publicMeSHNote mesh__D016552 92   
% 213.38/213.54  |- mesh__historyNote mesh__D016552 92   
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D016552 1995
% 213.38/213.54  |- skos__historyNote mesh__D016552 Exercise Test %28%1966-1991%29%
% 213.38/213.54  |- mesh__dateEstablished mesh__D016552 1992-01-01
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D016552 2003
% 213.38/213.54  |- skos__hiddenLabel mesh__D016552 Ergometries
% 213.38/213.54  |- mesh__dateRevised mesh__D016552 1992-05-15
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D016552 1998
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D016552 2006
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D016552 1993
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D016552 2000
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D016552 1996
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D016552 2004
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D016552 1999
% 213.38/213.54  |- skos__broader mesh__D016552smesh__D008919
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D016552 2001
% 213.38/213.54  |- skos__historyNote mesh__D016552 Exertion %28%1966-1991%29%
% 213.38/213.54  |- mesh__dateCreated mesh__D016552 1991-01-02
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D016552 1997
% 213.38/213.54  |- skos__prefLabel mesh__D016552 Ergometry
% 213.38/213.54  |- mesh__recordMaintainer mesh__D016552 TAP
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D016552 2002
% 213.38/213.54  |- mesh__dateCreated mesh__D038206 2002-07-02
% 213.38/213.54  |- skos__hiddenLabel mesh__D038206 B-Crystallin, beta
% 213.38/213.54  |- mesh__recordMaintainer mesh__D038206 jmp
% 213.38/213.54  |- skos__hiddenLabel mesh__D038206 beta Crystallin B Chain
% 213.38/213.54  |- mesh__recordOriginator mesh__D038206 jmp
% 213.38/213.54  |- skos__altLabel mesh__D038206 beta B-Crystallin
% 213.38/213.54  |- mesh__historyNote mesh__D038206
% 213.38/213.54       2003; for BETA-CRYSTALLIN BASIC PRINCIPAL POLYPEPTIDE use CRYSTALLINS 1990-2002%A%  
% 213.38/213.54  |- mesh__dateEstablished mesh__D038206 2003-01-01
% 213.38/213.54  |- skos__prefLabel mesh__D038206 beta-Crystallin B Chain
% 213.38/213.54  |- skos__hiddenLabel mesh__D038206 beta B Crystallin
% 213.38/213.54  |- skos__hiddenLabel mesh__D038206 B Chain, beta-Crystallin
% 213.38/213.54  |- skos__historyNote mesh__D038206 Crystallins %28%1978-2002%29%
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D038206 2003
% 213.38/213.54  |- mesh__publicMeSHNote mesh__D038206
% 213.38/213.54       2003; for BETA-CRYSTALLIN BASIC PRINCIPAL POLYPEPTIDE see CRYSTALLINS 1990-2002%A%  
% 213.38/213.54  |- rdf__type mesh__D038206sskos__Concept
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D038206 2005
% 213.38/213.54  |- skos__altLabel mesh__D038206 Crystallins, beta B Chain
% 213.38/213.54  |- skos__altLabel mesh__D038206 beta-Crystallin Basic Principal Polypeptide
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D038206 2004
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D038206 2006
% 213.38/213.54  |- skos__scopeNote mesh__D038206
% 213.38/213.54       The basic subunit of beta-crystallins.     
% 213.38/213.54  |- skos__broader mesh__D038206smesh__D038204
% 213.38/213.54  |- mesh__recordAuthorizer mesh__D038206 sjn
% 213.38/213.54  |- skos__broader mesh__D002532smesh__D000783
% 213.38/213.54  |- skos__scopeNote mesh__D002532
% 213.38/213.54       Congenital or acquired abnormal outpouching of an intracranial blood vessel wall. Saccular %28%berry%29% aneurysms are the most common variant, and tend to form at arterial branch points near the base of the brain. Rupture results in SUBARACHNOID HEMORRHAGE or INTRACRANIAL HEMORRHAGES. Giant aneurysms %28%%3E%2.5 cm in diameter%29% may compress adjacent structures, including the OCULOMOTOR NERVE %28%see also OCULOMOTOR NERVE DISEASES%29%. %28%From Adams et al., Principles of Neurology, 6th ed, p841%29%%A%    
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Aneurysm, Brain
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Intracranial Mycotic Aneurysm
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Aneurysm, Berry
% 213.38/213.54  |- mesh__dateCreated mesh__D002532 1999-01-01
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Aneurysms, Basilar Artery
% 213.38/213.54  |- skos__prefLabel mesh__D002532 Intracranial Aneurysm
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Artery Aneurysms, Basilar
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D002532 2006
% 213.38/213.54  |- mesh__recordAuthorizer mesh__D002532 sjn
% 213.38/213.54  |- skos__altLabel mesh__D002532 Saccular Aneurysm
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Basilar Artery Aneurysm
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Aneurysms, Intracranial
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Aneurysms, Intracranial Mycotic
% 213.38/213.54  |- skos__altLabel mesh__D002532 Posterior Cerebral Artery Aneurysm
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Intracranial Aneurysm, Giant
% 213.38/213.54  |- skos__altLabel mesh__D002532 Anterior Cerebral Artery Aneurysm
% 213.38/213.54  |- mesh__historyNote mesh__D002532 2000%28%1969%29%   
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Mycotic Aneurysms, Intracranial
% 213.38/213.54  |- skos__altLabel mesh__D002532 Anterior Communicating Artery Aneurysm
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Aneurysms, Cerebral
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Aneurysm, Intracranial Mycotic
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Aneurysms, Berry
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Aneurysm, Intracranial
% 213.38/213.54  |- rdf__type mesh__D002532sskos__Concept
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Basilar Artery Aneurysms
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Aneurysms, Giant Intracranial
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Berry Aneurysms
% 213.38/213.54  |- mesh__recordMaintainer mesh__D002532 ags
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Intracranial Mycotic Aneurysms
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Aneurysms, Saccular
% 213.38/213.54  |- skos__altLabel mesh__D002532 Posterior Communicating Artery Aneurysm
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Aneurysm, Saccular
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Aneurysms, Brain
% 213.38/213.54  |- mesh__recordOriginator mesh__D002532 NLM
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Saccular Aneurysms
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Giant Intracranial Aneurysms
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Aneurysm, Giant Intracranial
% 213.38/213.54  |- skos__broader mesh__D002532smesh__D002539
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Brain Aneurysms
% 213.38/213.54  |- skos__altLabel mesh__D002532 Middle Cerebral Artery Aneurysm
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Intracranial Aneurysms
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Intracranial Aneurysms, Giant
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Artery Aneurysm, Basilar
% 213.38/213.54  |- skos__hiddenLabel mesh__D002532 Cerebral Aneurysms
% 213.38/213.54  |- mesh__publicMeSHNote mesh__D002532
% 213.38/213.54       2000; see CEREBRAL ANEURYSM 1969-1999; for CEREBRAL ANEURYSM see CEREBRAL ANEURYSM 1966-1999%A%  
% 213.38/213.54  |- skos__altLabel mesh__D002532 Aneurysm, Cerebral
% 213.38/213.54  |- mesh__dateRevised mesh__D002532 2005-06-30
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012960 1998
% 213.38/213.54  |- mesh__recordMaintainer mesh__D012960 KEV
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012960 2003
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012960 2001
% 213.38/213.54  |- mesh__recordOriginator mesh__D012960 NLM
% 213.38/213.54  |- skos__altLabel mesh__D012960 Therapy, Socioenvironmental
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012960 1999
% 213.38/213.54  |- rdf__type mesh__D012960sskos__Concept
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012960 2004
% 213.38/213.54  |- mesh__dateCreated mesh__D012960 1999-01-01
% 213.38/213.54  |- mesh__publicMeSHNote mesh__D012960 73   
% 213.38/213.54  |- skos__historyNote mesh__D012960 Psychotherapy %28%1966-1972%29%
% 213.38/213.54  |- skos__prefLabel mesh__D012960 Socioenvironmental Therapy
% 213.38/213.54  |- skos__annotation mesh__D012960
% 213.38/213.54       a psychother technique; DF: SOCIOENVIR THER   
% 213.38/213.54  |- skos__scopeNote mesh__D012960
% 213.38/213.54       Therapy whose primary emphasis is on the physical and social structuring of the environment to promote interpersonal relationships which will be influential in reducing behavioral disturbances of patients.%A%    
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012960 1996
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012960 2002
% 213.38/213.54  |- skos__hiddenLabel mesh__D012960 Socioenvironmental Therapies
% 213.38/213.54  |- mesh__historyNote mesh__D012960 73   
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012960 1997
% 213.38/213.54  |- mesh__recordAuthorizer mesh__D012960 PLS
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012960 2005
% 213.38/213.54  |- mesh__dateEstablished mesh__D012960 1973-01-01
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012960 2006
% 213.38/213.54  |- skos__broader mesh__D012960smesh__D011613
% 213.38/213.54  |- mesh__dateRevised mesh__D012960 1995-05-19
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012960 2000
% 213.38/213.54  |- skos__hiddenLabel mesh__D012960 Therapies, Socioenvironmental
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012162 2005
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012162 1998
% 213.38/213.54  |- skos__annotation mesh__D012162
% 213.38/213.54       retinal dystrophy or macular dystrophy: index under RETINAL DEGENERATION or MACULAR DEGENERATION relying on text %26% refs%A%  
% 213.38/213.54  |- rdf__type mesh__D012162sskos__Concept
% 213.38/213.54  |- mesh__recordOriginator mesh__D012162 NLM
% 213.38/213.54  |- mesh__dateCreated mesh__D012162 1999-01-01
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012162 2002
% 213.38/213.54  |- skos__hiddenLabel mesh__D012162 Retinal Degenerations
% 213.38/213.54  |- skos__hiddenLabel mesh__D012162 Degenerations, Retinal
% 213.38/213.54  |- mesh__recordMaintainer mesh__D012162 TAP
% 213.38/213.54  |- mesh__publicMeSHNote mesh__D012162 70   
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012162 2001
% 213.38/213.54  |- skos__prefLabel mesh__D012162 Retinal Degeneration
% 213.38/213.54  |- skos__historyNote mesh__D012162 Retina %28%1966-1967%29%
% 213.38/213.54  |- mesh__historyNote mesh__D012162 70%28%68%29%   
% 213.38/213.54  |- skos__broader mesh__D012162smesh__D012164
% 213.38/213.54  |- mesh__dateRevised mesh__D012162 1995-06-08
% 213.38/213.54  |- skos__hiddenLabel mesh__D012162 Degeneration, Retinal
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012162 2000
% 213.38/213.54  |- skos__scopeNote mesh__D012162
% 213.38/213.54       A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. %28%Newell, Ophthalmology: Principles and Concepts, 7th ed, p304%29%%A%    
% 213.38/213.54  |- skos__historyNote mesh__D012162 Eye Diseases %28%1966-1967%29%
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012162 2004
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012162 1997
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012162 2006
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012162 1999
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012162 2003
% 213.38/213.54  |- mesh__dateEstablished mesh__D012162 1970-01-01
% 213.38/213.54  |- mesh__recordAuthorizer mesh__D012162 PLS
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D012162 1996
% 213.38/213.54  |- skos__scopeNote mesh__D006923
% 213.38/213.54       A coumarin derivative possessing properties as a spasmolytic, choleretic and light-protective agent. It is also used in analytical chemistry for the determination of nitric acid.%A%    
% 213.38/213.54  |- skos__altLabel mesh__D006923 Imecromone
% 213.38/213.54  |- skos__altLabel mesh__D006923 Resocyanine
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D006923 2006
% 213.38/213.54  |- skos__prefLabel mesh__D006923 Hymecromone
% 213.38/213.54  |- mesh__dateCreated mesh__D006923 1974-11-19
% 213.38/213.54  |- skos__broader mesh__D006923smesh__D014468
% 213.38/213.54  |- mesh__dateRevised mesh__D006923 2005-06-30
% 213.38/213.54  |- mesh__historyNote mesh__D006923
% 213.38/213.54       91%28%75%29%; was see under UMBELLIFERONES 1977-90; was see under COUMARINS 1975-76%A%  
% 213.38/213.54  |- skos__altLabel mesh__D006923 Methylumbelliferone
% 213.38/213.54  |- rdf__type mesh__D006923sskos__Concept
% 213.38/213.54  |- mesh__recordOriginator mesh__D006923 NLM
% 213.38/213.54  |- mesh__publicMeSHNote mesh__D006923
% 213.38/213.54       91; was see under UMBELLIFERONES 1977-90; was see under COUMARINS 1975-76%A%  
% 213.38/213.54  |- mesh__dateEstablished mesh__D006923 1991-01-01
% 213.38/213.54  |- mesh__recordAuthorizer mesh__D006923 sjn
% 213.38/213.54  |- skos__historyNote mesh__D006923 Coumarins %28%1969-1974%29%
% 213.38/213.54  |- mesh__recordMaintainer mesh__D006923 ssb
% 213.38/213.54  |- skos__broader mesh__D012867Q000502smesh__D012867
% 213.38/213.54  |- mesh__preferredCombination mesh__D012867Q000502smesh__D012879
% 213.38/213.54  |- rdf__type mesh__D012867Q000502smesh__CompoundConcept
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D006125 2006
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D006125 1998
% 213.38/213.54  |- skos__prefLabel mesh__D006125 Group Practice, Prepaid
% 213.38/213.54  |- skos__annotation mesh__D006125
% 213.38/213.54       coord IM with med or other specialty %28%IM%29%   
% 213.38/213.54  |- skos__scopeNote mesh__D006125
% 213.38/213.54       An organized group of three or more full-time physicians rendering services for a fixed prepayment.%A%    
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D006125 2000
% 213.38/213.54  |- mesh__dateEstablished mesh__D006125 1991-01-01
% 213.38/213.54  |- mesh__recordMaintainer mesh__D006125 TGC
% 213.38/213.54  |- skos__hiddenLabel mesh__D006125 Prepaid Group Practices
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D006125 2003
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D006125 2001
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D006125 1999
% 213.38/213.54  |- skos__hiddenLabel mesh__D006125 Practice, Prepaid Group
% 213.38/213.54  |- skos__broader mesh__D006125smesh__D006123
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D006125 2004
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D006125 1996
% 213.38/213.54  |- mesh__recordOriginator mesh__D006125 EC
% 213.38/213.54  |- mesh__dateCreated mesh__D006125 1979-06-01
% 213.38/213.54  |- rdf__type mesh__D006125sskos__Concept
% 213.38/213.54  |- mesh__publicMeSHNote mesh__D006125
% 213.38/213.54       91; was see under GROUP PRACTICE 1980-90   
% 213.38/213.54  |- skos__historyNote mesh__D006125 Group Practice %28%1966-1979%29%
% 213.38/213.54  |- mesh__historyNote mesh__D006125
% 213.38/213.54       91%28%80%29%; was see under GROUP PRACTICE 1980-90   
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D006125 1997
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D006125 2002
% 213.38/213.54  |- skos__historyNote mesh__D006125 Insurance, Health %28%1966-1979%29%
% 213.38/213.54  |- mesh__recordAuthorizer mesh__D006125 PLS
% 213.38/213.54  |- skos__hiddenLabel mesh__D006125 Practices, Prepaid Group
% 213.38/213.54  |- skos__hiddenLabel mesh__D006125 Group Practices, Prepaid
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D006125 2005
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D006125 1995
% 213.38/213.54  |- skos__altLabel mesh__D006125 Prepaid Group Practice
% 213.38/213.54  |- mesh__dateRevised mesh__D006125 1994-05-05
% 213.38/213.54  |- skos__historyNote mesh__D050281 specific bones of leg %28%1966-2005%29%
% 213.38/213.54  |- skos__prefLabel mesh__D050281 Bones of Lower Extremity
% 213.38/213.54  |- rdf__type mesh__D050281sskos__Concept
% 213.38/213.54  |- mesh__publicMeSHNote mesh__D050281 2006   
% 213.38/213.54  |- mesh__recordOriginator mesh__D050281 ags
% 213.38/213.54  |- skos__hiddenLabel mesh__D050281 Lower Extremity Bones
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D050281 2006
% 213.38/213.54  |- skos__hiddenLabel mesh__D050281 Extremity Bones, Lower
% 213.38/213.54  |- skos__scopeNote mesh__D050281
% 213.38/213.54       The bones of the upper and lower LEG. They include the PELVIC BONES.%A%    
% 213.38/213.54  |- mesh__historyNote mesh__D050281 2006   
% 213.38/213.54  |- mesh__dateEstablished mesh__D050281 2006-01-01
% 213.38/213.54  |- mesh__recordMaintainer mesh__D050281 ags
% 213.38/213.54  |- skos__broader mesh__D050281smesh__D001842
% 213.38/213.54  |- skos__annotation mesh__D050281
% 213.38/213.54       avoid: too general; prefer specifics; permitted with all vertebrates; Manual 21.58%A%  
% 213.38/213.54  |- skos__historyNote mesh__D050281 Leg Bones %28%1997-2005%29%
% 213.38/213.54  |- mesh__dateCreated mesh__D050281 2005-06-30
% 213.38/213.54  |- mesh__recordAuthorizer mesh__D050281 sjn
% 213.38/213.54  |- skos__related mesh__D011868smesh__D004603
% 213.38/213.54  |- skos__prefLabel mesh__D011868 Radioisotopes
% 213.38/213.54  |- skos__annotation mesh__D011868
% 213.38/213.54       IM for general or unspecified or as coord for a specific radioisotope not in MeSH; when IM, qualif permitted; indexing policy: Manual 25.20-25.20.8; /blood-csf-urine /metab permitted but use with caution %26% not for tracer studies %28% = /diag use%29%; diag use = DIAGNOSTIC TECHNIQUES, RADIOISOTOPE but /diag use permitted with specific radioisotopes: Manual 25.15.1; relation to /rad eff: Manual 28.11.3; m for metastable = RADIOISOTOPES or specific pre-coord radioisotope; decay: coord RADIOISOTOPES or specific radioisotope %28%IM%29% with RADIOACTIVITY %28%NIM%29% %26% do not add RADIOMETRY; radioisotope implants = RADIOISOTOPES or specific /admin or BRACHYTHERAPY %28%see X refs there%29%%A%  
% 213.38/213.54  |- skos__related mesh__D011868smesh__D007554
% 213.38/213.54  |- mesh__recordMaintainer mesh__D011868 ADP
% 213.38/213.54  |- skos__related mesh__D011868smesh__D007553
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011868 1998
% 213.38/213.54  |- skos__altLabel mesh__D011868 Radionuclides
% 213.38/213.54  |- skos__scopeNote mesh__D011868
% 213.38/213.54       Isotopes that exhibit radioactivity and undergo radioactive decay. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed %26% McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011868 1999
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011868 2000
% 213.38/213.54  |- skos__altLabel mesh__D011868 Radioactive Isotopes
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011868 2005
% 213.38/213.54  |- mesh__dateRevised mesh__D011868 1997-06-20
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011868 2003
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011868 2006
% 213.38/213.54  |- skos__broader mesh__D011868smesh__D007554
% 213.38/213.54  |- mesh__recordAuthorizer mesh__D011868 SJN
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011868 2001
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011868 2004
% 213.38/213.54  |- mesh__dateCreated mesh__D011868 1999-01-01
% 213.38/213.54  |- skos__hiddenLabel mesh__D011868 Isotopes, Radioactive
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D011868 2002
% 213.38/213.54  |- mesh__recordOriginator mesh__D011868 NLM
% 213.38/213.54  |- rdf__type mesh__D011868sskos__Concept
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D044244 2004
% 213.38/213.54  |- skos__scopeNote mesh__D044244
% 213.38/213.54       A subclass of eicosanoid receptors that have specificity for THROMBOXANE A2 and PROSTAGLANDIN H2.%A%    
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D044244 2005A
% 213.38/213.54  |- skos__historyNote mesh__D044244
% 213.38/213.54       Receptors, Prostaglandin %28%1985-2003%29%
% 213.38/213.54  |- skos__hiddenLabel mesh__D044244 TXA2 PGH2 Receptors
% 213.38/213.54  |- mesh__dateEstablished mesh__D044244 2004-01-01
% 213.38/213.54  |- skos__hiddenLabel mesh__D044244 Receptors, PGH2
% 213.38/213.54  |- skos__altLabel mesh__D044244 Thromboxane A2 Receptor
% 213.38/213.54  |- skos__altLabel mesh__D044244 Thromboxane A2, Prostaglandin H2 Receptors
% 213.38/213.54  |- mesh__recordAuthorizer mesh__D044244 jls
% 213.38/213.54  |- skos__altLabel mesh__D044244 Prostaglandin H2 Receptor
% 213.38/213.54  |- skos__historyNote mesh__D044244 Receptors, Thromboxane %28%1992-2003%29%
% 213.38/213.54  |- skos__hiddenLabel mesh__D044244 Receptor, Prostaglandin H2
% 213.38/213.54  |- skos__hiddenLabel mesh__D044244 Receptors, TXA2 PGH2
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D044244 2006
% 213.38/213.54  |- skos__broader mesh__D044244smesh__D011982
% 213.38/213.54  |- mesh__dateCreated mesh__D044244 2003-07-09
% 213.38/213.54  |- mesh__recordOriginator mesh__D044244 jmp
% 213.38/213.54  |- mesh__historyNote mesh__D044244
% 213.38/213.54       2004; for THROMBOXANE A2 RECEPTOR use RECEPTORS, THROMBOXANE 1994-2003; for PROSTAGLANDIN H2 RECEPTOR use RECEPTORS, TROMBOXANE A2, PROSTAGLANDIN H2 %28%NM%29% 1985-2003%A%  
% 213.38/213.54  |- rdf__type mesh__D044244sskos__Concept
% 213.38/213.54  |- skos__prefLabel mesh__D044244
% 213.38/213.54       Receptors, Thromboxane A2, Prostaglandin H2
% 213.38/213.54  |- mesh__dateRevised mesh__D044244 2004-08-02
% 213.38/213.54  |- mesh__recordMaintainer mesh__D044244 jls
% 213.38/213.54  |- skos__altLabel mesh__D044244 TXA2-PGH2 Receptors
% 213.38/213.54  |- skos__hiddenLabel mesh__D044244 H2 Receptors, Prostaglandin
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D044244 2005
% 213.38/213.54  |- skos__altLabel mesh__D044244 PGH2 Receptors
% 213.38/213.54  |- skos__broader mesh__D044244smesh__D017482
% 213.38/213.54  |- mesh__publicMeSHNote mesh__D044244
% 213.38/213.54       2004; for THROMBOXANE A2 RECEPTOR see RECEPTORS, THROMBOXANE 1994-2003; PROSTAGLANDIN H2 RECEPTOR was indexed under RECEPTORS, PROSTAGLANDIN 1985-2003%A%  
% 213.38/213.54  |- skos__hiddenLabel mesh__D044244 Prostaglandin H2 Receptors
% 213.38/213.54  |- skos__altLabel mesh__D044244 Receptors, TXA2-PGH2
% 213.38/213.54  |- skos__hiddenLabel mesh__D016553 Werlhofs Disease
% 213.38/213.54  |- skos__hiddenLabel mesh__D016553 Purpuras, Idiopathic Thrombocytopenic
% 213.38/213.54  |- skos__broader mesh__D016553smesh__D011696
% 213.38/213.54  |- skos__hiddenLabel mesh__D016553 Purpura, Idiopathic Thrombocytopenic
% 213.38/213.54  |- skos__altLabel mesh__D016553 Purpura, Thrombocytopenic, Autoimmune
% 213.38/213.54  |- skos__altLabel mesh__D016553 Werlhof Disease
% 213.38/213.54  |- skos__hiddenLabel mesh__D016553 Autoimmune Thrombocytopenias
% 213.38/213.54  |- skos__hiddenLabel mesh__D016553 Autoimmune Thrombocytopenic Purpuras
% 213.38/213.54  |- mesh__dateEstablished mesh__D016553 1992-01-01
% 213.38/213.54  |- mesh__dateCreated mesh__D016553 1991-04-29
% 213.38/213.54  |- mesh__historyNote mesh__D016553
% 213.38/213.54       92; WERLHOF%27%S DISEASE was see PURPURA, THROMBOCYTOPENIC 1975-91%A%  
% 213.38/213.54  |- rdf__type mesh__D016553sskos__Concept
% 213.38/213.54  |- skos__hiddenLabel mesh__D016553 Disease, Werlhof%27%s
% 213.38/213.54  |- skos__altLabel mesh__D016553 Idiopathic Thrombocytopenic Purpura
% 213.38/213.54  |- skos__broader mesh__D016553smesh__D001327
% 213.38/213.54  |- skos__hiddenLabel mesh__D016553 Idiopathic Thrombocytopenic Purpuras
% 213.38/213.54  |- mesh__publicMeSHNote mesh__D016553
% 213.38/213.54       92; WERLHOF%27%S DISEASE was see PURPURA, THROMBOCYTOPENIC 1975-91%A%  
% 213.38/213.54  |- skos__hiddenLabel mesh__D016553 Thrombocytopenic Purpura, Idiopathic
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D016553 2004
% 213.38/213.54  |- skos__altLabel mesh__D016553 Werlhof%27%s Disease
% 213.38/213.54  |- skos__prefLabel mesh__D016553 Purpura, Thrombocytopenic, Idiopathic
% 213.38/213.54  |- mesh__dateRevised mesh__D016553 2001-08-07
% 213.38/213.54  |- skos__scopeNote mesh__D016553
% 213.38/213.54       Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute %28%affecting children%29% and chronic %28%adult%29% forms.%A%    
% 213.38/213.54  |- skos__altLabel mesh__D016553 Autoimmune Thrombocytopenic Purpura
% 213.38/213.54  |- mesh__recordMaintainer mesh__D016553 sjn
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D016553 2002
% 213.38/213.54  |- skos__hiddenLabel mesh__D016553 Thrombocytopenias, Autoimmune
% 213.38/213.54  |- skos__hiddenLabel mesh__D016553 Thrombocytopenic Purpura, Autoimmune
% 213.38/213.54  |- skos__historyNote mesh__D016553
% 213.38/213.54       Purpura, Thrombocytopenic %28%1966-1991%29%
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D016553 2003
% 213.38/213.54  |- mesh__activeMeSHYear mesh__D016553 2006
% 213.38/213.55  |- skos__hiddenLabel mesh__D016553 Thrombocytopenic Purpuras, Idiopathic
% 213.38/213.55  |- skos__broader mesh__D016553smesh__D006474
% 213.38/213.55  |- skos__hiddenLabel mesh__D016553 Purpuras, Autoimmune Thrombocytopenic
% 213.38/213.55  |- skos__hiddenLabel mesh__D016553 Thrombocytopenic Purpuras, Autoimmune
% 213.38/213.55  |- mesh__recordOriginator mesh__D016553 AGS
% 213.38/213.55  |- skos__hiddenLabel mesh__D016553 Purpura, Autoimmune Thrombocytopenic
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D016553 2005
% 213.38/213.55  |- skos__hiddenLabel mesh__D016553 Disease, Werlhof
% 213.38/213.55  |- skos__hiddenLabel mesh__D016553 Thrombocytopenia, Autoimmune
% 213.38/213.55  |- mesh__onlineNote mesh__D016553
% 213.38/213.55       use PURPURA, THROMBOCYTOPENIC to search WERLHOF%27%S DISEASE 1975-91%A%  
% 213.38/213.55  |- mesh__recordAuthorizer mesh__D016553 sjn
% 213.38/213.55  |- skos__hiddenLabel mesh__D038207 delta Crystallins
% 213.38/213.55  |- mesh__recordOriginator mesh__D038207 jmp
% 213.38/213.55  |- mesh__dateRevised mesh__D038207 2005-06-30
% 213.38/213.55  |- skos__altLabel mesh__D038207 delta-Crystallin
% 213.38/213.55  |- skos__hiddenLabel mesh__D038207 delta Crystallin
% 213.38/213.55  |- rdf__type mesh__D038207sskos__Concept
% 213.38/213.55  |- mesh__dateEstablished mesh__D038207 2003-01-01
% 213.38/213.55  |- skos__altLabel mesh__D038207 Crystallins, delta
% 213.38/213.55  |- skos__historyNote mesh__D038207 Crystallins %28%1973-2002%29%
% 213.38/213.55  |- skos__broader mesh__D038207smesh__D003459
% 213.38/213.55  |- skos__prefLabel mesh__D038207 delta-Crystallins
% 213.38/213.55  |- mesh__recordAuthorizer mesh__D038207 sjn
% 213.38/213.55  |- mesh__historyNote mesh__D038207
% 213.38/213.55       2003; for DELTA-CRYSTALLIN use CRYSTALLINS 1981-2002   
% 213.38/213.55  |- mesh__publicMeSHNote mesh__D038207
% 213.38/213.55       2003; for DELTA-CRYSTALLIN see CRYSTALLINS 1981-2002   
% 213.38/213.55  |- mesh__recordMaintainer mesh__D038207 SYSTEM
% 213.38/213.55  |- skos__broader mesh__D038207smesh__D001123
% 213.38/213.55  |- mesh__dateCreated mesh__D038207 2002-07-03
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D038207 2006
% 213.38/213.55  |- skos__scopeNote mesh__D038207
% 213.38/213.55       A subclass of crystallins found in the lens %28%LENS, CRYSTALLINE%29% in BIRDS and REPTILES. They are inactive forms of the enzyme argininosuccinate lyase.%A%    
% 213.38/213.55  |- skos__altLabel mesh__D002533 Angiography, Cerebral
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D002533 2005
% 213.38/213.55  |- mesh__recordOriginator mesh__D002533 NLM
% 213.38/213.55  |- skos__hiddenLabel mesh__D002533 Cerebral Angiographies
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D002533 2002
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D002533 2006
% 213.38/213.55  |- skos__scopeNote mesh__D002533
% 213.38/213.55       Radiography of the vascular system of the brain after injection of a contrast medium.%A%    
% 213.38/213.55  |- skos__annotation mesh__D002533
% 213.38/213.55       GEN or unspecified only: not a substitute for CEREBRAL ARTERIES /radiogr or CEREBRAL VEINS /radiogr; NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: CEREBRAL ANGIOGR%A%  
% 213.38/213.55  |- mesh__dateRevised mesh__D002533 1997-06-20
% 213.38/213.55  |- mesh__recordMaintainer mesh__D002533 PXP
% 213.38/213.55  |- mesh__dateCreated mesh__D002533 1999-01-01
% 213.38/213.55  |- skos__broader mesh__D002533smesh__D009485
% 213.38/213.55  |- skos__broader mesh__D002533smesh__D000792
% 213.38/213.55  |- skos__hiddenLabel mesh__D002533 Angiographies, Cerebral
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D002533 1998
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D002533 2003
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D002533 2000
% 213.38/213.55  |- mesh__recordAuthorizer mesh__D002533 SJN
% 213.38/213.55  |- rdf__type mesh__D002533sskos__Concept
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D002533 1999
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D002533 2004
% 213.38/213.55  |- skos__prefLabel mesh__D002533 Cerebral Angiography
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D002533 2001
% 213.38/213.55  |- mesh__historyNote mesh__D012961
% 213.38/213.55       RELIGION AND SOCIOLOGY was heading 1963-65   
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012961 2004
% 213.38/213.55  |- mesh__dateCreated mesh__D012961 1999-01-01
% 213.38/213.55  |- skos__scopeNote mesh__D012961
% 213.38/213.55       A social science dealing with group relationships, patterns of collective behavior, and social organization.%A%    
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012961 2000
% 213.38/213.55  |- skos__prefLabel mesh__D012961 Sociology
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012961 1996
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012961 2001
% 213.38/213.55  |- mesh__recordOriginator mesh__D012961 NLM
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012961 1997
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012961 2005
% 213.38/213.55  |- skos__related mesh__D012961smesh__D006126
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012961 2006
% 213.38/213.55  |- skos__hiddenLabel mesh__D012961 Characteristics, Social
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012961 2002
% 213.38/213.55  |- skos__broader mesh__D012961smesh__D012942
% 213.38/213.55  |- mesh__publicMeSHNote mesh__D012961
% 213.38/213.55       RELIGION AND SOCIOLOGY was heading 1963-65   
% 213.38/213.55  |- skos__annotation mesh__D012961
% 213.38/213.55       IM: SPEC with SPEC qualif; for %22%sociological aspects of%22%, NIM with no qualif; Manual 30.5; /methods: probably SOCIOMETRIC TECHNIQUES; DF: SOCIOL%A%  
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012961 1998
% 213.38/213.55  |- mesh__recordAuthorizer mesh__D012961 PLS
% 213.38/213.55  |- mesh__recordMaintainer mesh__D012961 KEV
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012961 2003
% 213.38/213.55  |- mesh__dateRevised mesh__D012961 1995-05-23
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012961 1999
% 213.38/213.55  |- rdf__type mesh__D012961sskos__Concept
% 213.38/213.55  |- mesh__dateCreated mesh__D012163 1999-01-01
% 213.38/213.55  |- skos__annotation mesh__D012163
% 213.38/213.55       /surg: consider also SCLERAL BUCKLING; X ref RETINAL PIGMENT EPITHELIAL DETACHMENT: do not coord with PIGMENT EPITHELIUM OF EYE unless particularly discussed%A%  
% 213.38/213.55  |- mesh__recordOriginator mesh__D012163 NLM
% 213.38/213.55  |- skos__broader mesh__D012163smesh__D012164
% 213.38/213.55  |- skos__hiddenLabel mesh__D012163 Detachments, Retinal
% 213.38/213.55  |- skos__hiddenLabel mesh__D012163 Retinal Detachments
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012163 2004
% 213.38/213.55  |- mesh__recordAuthorizer mesh__D012163 sjn
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012163 2006
% 213.38/213.55  |- mesh__recordMaintainer mesh__D012163 ags
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012163 2003
% 213.38/213.55  |- skos__prefLabel mesh__D012163 Retinal Detachment
% 213.38/213.55  |- skos__related mesh__D012163smesh__D041441
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012163 2005
% 213.38/213.55  |- skos__related mesh__D012163smesh__D012591
% 213.38/213.55  |- mesh__dateRevised mesh__D012163 2002-07-18
% 213.38/213.55  |- skos__hiddenLabel mesh__D012163 Detachment, Retinal
% 213.38/213.55  |- rdf__type mesh__D012163sskos__Concept
% 213.38/213.55  |- skos__scopeNote mesh__D012163
% 213.38/213.55       Separation of the inner layers of the retina %28%neural retina%29% from the pigment epithelium. Retinal detachment occurs more commonly in men than in women, in eyes with degenerative myopia, in aging and in aphakia. It may occur after an uncomplicated cataract extraction, but it is seen more often if vitreous humor has been lost during surgery. %28%Dorland, 27th ed; Newell, Ophthalmology: Principles and Concepts, 7th ed, p310-12%29%.%A%    
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006924 1997
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006924 2005
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006924 1990
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006924 1992
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006924 1998
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006924 2006
% 213.38/213.55  |- skos__broader mesh__D006924smesh__D014621
% 213.38/213.55  |- skos__hiddenLabel mesh__D006924 Hymens
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006924 1991
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006924 2000
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006924 1993
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006924 1999
% 213.38/213.55  |- mesh__dateCreated mesh__D006924 1999-01-01
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006924 2001
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006924 1994
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006924 2003
% 213.38/213.55  |- skos__prefLabel mesh__D006924 Hymen
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006924 1989
% 213.38/213.55  |- rdf__type mesh__D006924sskos__Concept
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006924 2002
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006924 1995
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006924 1996
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006924 2004
% 213.38/213.55  |- mesh__dateCreated mesh__D006126 1999-01-01
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006126 2003
% 213.38/213.55  |- skos__altLabel mesh__D006126 Group Process
% 213.38/213.55  |- skos__scopeNote mesh__D006126
% 213.38/213.55       The procedures through which a group approaches, attacks, and solves a common problem.%A%    
% 213.38/213.55  |- skos__hiddenLabel mesh__D006126 Meeting, Group
% 213.38/213.55  |- mesh__recordOriginator mesh__D006126 NLM
% 213.38/213.55  |- skos__hiddenLabel mesh__D006126 Meetings, Group
% 213.38/213.55  |- skos__hiddenLabel mesh__D006126 Processes, Group
% 213.38/213.55  |- mesh__recordAuthorizer mesh__D006126 sjn
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006126 2004
% 213.38/213.55  |- rdf__type mesh__D006126sskos__Concept
% 213.38/213.55  |- skos__annotation mesh__D006126
% 213.38/213.55       differentiate from MASS BEHAVIOR: mass will probably be on a civil, pathol or mob level%A%  
% 213.38/213.55  |- mesh__dateRevised mesh__D006126 2002-07-03
% 213.38/213.55  |- skos__prefLabel mesh__D006126 Group Processes
% 213.38/213.55  |- skos__related mesh__D006126smesh__D012922
% 213.38/213.55  |- mesh__recordMaintainer mesh__D006126 ags
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006126 2005
% 213.38/213.55  |- skos__hiddenLabel mesh__D006126 Group Meeting
% 213.38/213.55  |- skos__hiddenLabel mesh__D006126 Process, Group
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006126 2006
% 213.38/213.55  |- skos__broader mesh__D006126smesh__D011593
% 213.38/213.55  |- skos__broader mesh__D011869smesh__D003942
% 213.38/213.55  |- skos__hiddenLabel mesh__D011869 Radioreceptor Assays
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D011869 1998
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D011869 2002
% 213.38/213.55  |- mesh__recordOriginator mesh__D011869 NLM
% 213.38/213.55  |- skos__scopeNote mesh__D011869
% 213.38/213.55       Quantitative determination of receptor %28%binding%29% proteins in body fluids or tissue using radioactively labeled binding reagents %28%e.g., antibodies, intracellular receptors, plasma binders%29%.%A%    
% 213.38/213.55  |- skos__historyNote mesh__D011869 Binding Sites %28%1968-1972%29%
% 213.38/213.55  |- skos__hiddenLabel mesh__D011869 Radioassay, Protein-Binding
% 213.38/213.55  |- skos__altLabel mesh__D011869 Protein-Binding Radioassay
% 213.38/213.55  |- skos__hiddenLabel mesh__D011869 Protein-Binding Radioassays
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D011869 1999
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D011869 2005
% 213.38/213.55  |- skos__hiddenLabel mesh__D011869 Assay, Radioligand
% 213.38/213.55  |- skos__hiddenLabel mesh__D011869 Assays, Radioreceptor
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D011869 2003
% 213.38/213.55  |- skos__hiddenLabel mesh__D011869 Radioassays, Protein-Binding
% 213.38/213.55  |- skos__hiddenLabel mesh__D011869 Assays, Radioligand
% 213.38/213.55  |- skos__broader mesh__D011869smesh__D003940
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D011869 2006
% 213.38/213.55  |- mesh__publicMeSHNote mesh__D011869 73   
% 213.38/213.55  |- skos__prefLabel mesh__D011869 Radioligand Assay
% 213.38/213.55  |- skos__historyNote mesh__D011869 Protein Binding %28%1966-1972%29%
% 213.38/213.55  |- mesh__dateEstablished mesh__D011869 1973-01-01
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D011869 2004
% 213.38/213.55  |- mesh__dateCreated mesh__D011869 1999-01-01
% 213.38/213.55  |- skos__annotation mesh__D011869
% 213.38/213.55       do not use /util except by MeSH definition; coord with substance /anal or body fluid qualif but not /immunol%A%  
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D011869 2000
% 213.38/213.55  |- skos__hiddenLabel mesh__D011869 Protein Binding Radioassay
% 213.38/213.55  |- skos__broader mesh__D011869smesh__D003947
% 213.38/213.55  |- mesh__historyNote mesh__D011869 73   
% 213.38/213.55  |- skos__hiddenLabel mesh__D011869 Assay, Radioreceptor
% 213.38/213.55  |- rdf__type mesh__D011869sskos__Concept
% 213.38/213.55  |- mesh__dateRevised mesh__D011869 1997-06-20
% 213.38/213.55  |- skos__altLabel mesh__D011869 Radioreceptor Assay
% 213.38/213.55  |- mesh__recordMaintainer mesh__D011869 PXP
% 213.38/213.55  |- mesh__recordAuthorizer mesh__D011869 SJN
% 213.38/213.55  |- skos__hiddenLabel mesh__D011869 Radioligand Assays
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D011869 2001
% 213.38/213.55  |- skos__broader mesh__D016554smesh__D019747
% 213.38/213.55  |- skos__historyNote mesh__D016554 Neoplasm Proteins %28%1966-1991%29%
% 213.38/213.55  |- rdf__type mesh__D016554sskos__Concept
% 213.38/213.55  |- skos__hiddenLabel mesh__D016554 Motility Factor, Autocrine
% 213.38/213.55  |- skos__scopeNote mesh__D016554
% 213.38/213.55       A protein cytokine secreted by tumor cells. It elicits increases in cell motility and phosphoinositide metabolism in the secreting cell via a pertussis toxin-sensitive G-protein signal transduction pathway. It is closely related to PHOSPHOHEXOSE ISOMERASE; NEUROLEUKIN; and maturation factor.%A%    
% 213.38/213.55  |- mesh__onlineNote mesh__D016554
% 213.38/213.55       use AUTOCRINE MOTILITY FACTOR %28%NM%29% to search TUMOR AUTOCRINE MOTILITY FACTOR %28%NM%29% 1986-91%A%  
% 213.38/213.55  |- mesh__publicMeSHNote mesh__D016554
% 213.38/213.55       92; TUMOR AUTOCRINE MOTILITY FACTOR was indexed under NEOPLASM PROTEINS 1987-91%A%  
% 213.38/213.55  |- mesh__recordAuthorizer mesh__D016554 sjn
% 213.38/213.55  |- skos__broader mesh__D016554smesh__D014408
% 213.38/213.55  |- skos__altLabel mesh__D016554 Tumor Autocrine Motility Factor
% 213.38/213.55  |- mesh__dateRevised mesh__D016554 2005-06-30
% 213.38/213.55  |- mesh__historyNote mesh__D016554
% 213.38/213.55       92; was TUMOR AUTOCRINE MOTILITY FACTOR %28%NM%29% 1987-91   
% 213.38/213.55  |- skos__historyNote mesh__D016554
% 213.38/213.55       Tumor Markers, Biological %28%1988-1991%29%
% 213.38/213.55  |- mesh__dateCreated mesh__D016554 1991-07-12
% 213.38/213.55  |- skos__broader mesh__D016554smesh__D016207
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D016554 2006
% 213.38/213.55  |- mesh__dateEstablished mesh__D016554 1992-01-01
% 213.38/213.55  |- skos__prefLabel mesh__D016554 Autocrine Motility Factor
% 213.38/213.55  |- skos__hiddenLabel mesh__D016554 Tumor Cell Autocrine Motility Factor
% 213.38/213.55  |- skos__altLabel mesh__D016554 Tumor-Cell Autocrine Motility Factor
% 213.38/213.55  |- mesh__recordOriginator mesh__D016554 RLS
% 213.38/213.55  |- mesh__recordMaintainer mesh__D016554 ssb
% 213.38/213.55  |- skos__broader mesh__D016554smesh__D009363
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Injuries, Brain Anoxic
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Injuries, Hypoxic Brain
% 213.38/213.55  |- skos__altLabel mesh__D002534 Hypoxic Encephalopathy
% 213.38/213.55  |- skos__altLabel mesh__D002534 Anoxic Injury, Brain
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Injuries, Brain Hypoxic
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Brain Anoxic Injuries
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Brain Anoxic Injury
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Damage, Anoxic Brain
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Brain Hypoxic Injuries
% 213.38/213.55  |- skos__scopeNote mesh__D002534
% 213.38/213.55       A reduction in brain oxygen supply. Severe hypoxia is referred to as anoxia, and is a relatively common cause of injury to the central nervous system. Prolonged brain anoxia may lead to BRAIN DEATH or a PERSISTENT VEGETATIVE STATE. Histologically, this condition is characterized by neuronal loss which is most prominent in the HIPPOCAMPUS; GLOBUS PALLIDUS; CEREBELLUM; and inferior olives. %28%From Adams et al., Principles of Neurology, 6th ed, pp1109-11%29%%A%    
% 213.38/213.55  |- skos__annotation mesh__D002534
% 213.38/213.55       do not confuse with BRAIN ISCHEMIA, a reduced blood supply%A%  
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D002534 2000
% 213.38/213.55  |- skos__altLabel mesh__D002534 Hypoxic Injury, Brain
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Encephalopathies, Anoxic
% 213.38/213.55  |- mesh__dateCreated mesh__D002534 1999-01-01
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Hypoxic Injuries, Brain
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Brain Damage, Hypoxic
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Injury, Anoxic Brain
% 213.38/213.55  |- skos__altLabel mesh__D002534 Anoxic Encephalopathy
% 213.38/213.55  |- skos__altLabel mesh__D002534 Brain Anoxia
% 213.38/213.55  |- mesh__recordMaintainer mesh__D002534 KEV
% 213.38/213.55  |- mesh__historyNote mesh__D002534 2000%28%1963%29%   
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D002534 2006
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Injury, Brain Hypoxic
% 213.38/213.55  |- skos__broader mesh__D002534smesh__D020925
% 213.38/213.55  |- mesh__publicMeSHNote mesh__D002534
% 213.38/213.55       2000; see CEREBRAL ANOXIA 1963-1999   
% 213.38/213.55  |- skos__altLabel mesh__D002534 Hypoxic Brain Injury
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Anoxic Brain Injuries
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Damage, Hypoxic Brain
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Brain Damage, Anoxic
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Injury, Brain Anoxic
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Brain Hypoxic Injury
% 213.38/213.55  |- mesh__recordOriginator mesh__D002534 NLM
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Anoxic Encephalopathies
% 213.38/213.55  |- rdf__type mesh__D002534sskos__Concept
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D002534 2005
% 213.38/213.55  |- skos__altLabel mesh__D002534 Hypoxic Brain Damage
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Brain Injuries, Anoxic
% 213.38/213.55  |- skos__altLabel mesh__D002534 Anoxic Brain Injury
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Injury, Hypoxic Brain
% 213.38/213.55  |- skos__prefLabel mesh__D002534 Hypoxia, Brain
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Anoxic Injuries, Brain
% 213.38/213.55  |- skos__altLabel mesh__D002534 Hypoxia, Cerebral
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D002534 2004
% 213.38/213.55  |- skos__altLabel mesh__D002534 Anoxia, Cerebral
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Brain Injuries, Hypoxic
% 213.38/213.55  |- skos__altLabel mesh__D002534 Brain Hypoxia
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D002534 2002
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Encephalopathy, Anoxic
% 213.38/213.55  |- skos__altLabel mesh__D002534 Encephalopathy, Hypoxic
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Encephalopathies, Hypoxic
% 213.38/213.55  |- mesh__dateRevised mesh__D002534 1999-11-04
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Hypoxic Encephalopathies
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D002534 2003
% 213.38/213.55  |- mesh__recordAuthorizer mesh__D002534 sjn
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Hypoxic Brain Injuries
% 213.38/213.55  |- skos__altLabel mesh__D002534 Brain Injury, Anoxic
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D002534 2001
% 213.38/213.55  |- skos__hiddenLabel mesh__D002534 Injuries, Anoxic Brain
% 213.38/213.55  |- mesh__publicMeSHNote mesh__D026982 2002; see HAMAMELIDAE 1999-2001   
% 213.38/213.55  |- mesh__recordAuthorizer mesh__D026982 ags
% 213.38/213.55  |- mesh__recordOriginator mesh__D026982 ssb
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D026982 2004
% 213.38/213.55  |- skos__altLabel mesh__D026982 Nettle, Stinging
% 213.38/213.55  |- mesh__dateRevised mesh__D026982 2005-08-03
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D026982 2003
% 213.38/213.55  |- mesh__dateCreated mesh__D026982 2001-07-25
% 213.38/213.55  |- rdf__type mesh__D026982sskos__Concept
% 213.38/213.55  |- skos__scopeNote mesh__D026982
% 213.38/213.55       A plant species of the genus Urtica, family URTICACEAE.  Roots have been used to treat PROSTATIC HYPERPLASIA.  Leaves are edible after the stinging quality is  eliminated by brief heating.%A%    
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D026982 2006
% 213.38/213.55  |- skos__annotation mesh__D026982
% 213.38/213.55       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.38/213.55  |- skos__prefLabel mesh__D026982 Urtica dioica
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D026982 2006A
% 213.38/213.55  |- mesh__dateEstablished mesh__D026982 2002-01-01
% 213.38/213.55  |- mesh__recordMaintainer mesh__D026982 ags
% 213.38/213.55  |- skos__altLabel mesh__D026982 Stinging Nettle
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D026982 2005
% 213.38/213.55  |- mesh__historyNote mesh__D026982 2002; use HAMAMELIDAE 1999-2001   
% 213.38/213.55  |- skos__broader mesh__D026982smesh__D027003
% 213.38/213.55  |- mesh__historyNote mesh__D012962
% 213.38/213.55       80%28%78%29%; was see under SOCIOLOGY 1978-79   
% 213.38/213.55  |- skos__broader mesh__D012962smesh__D006281
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012962 2004
% 213.38/213.55  |- skos__scopeNote mesh__D012962
% 213.38/213.55       The study of the social determinants and social effects of health and disease, and of the social structure of medical institutions or professions.%A%    
% 213.38/213.55  |- skos__altLabel mesh__D012962 Sociology of Medicine
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012962 2001
% 213.38/213.55  |- mesh__dateRevised mesh__D012962 1999-11-03
% 213.38/213.55  |- mesh__publicMeSHNote mesh__D012962
% 213.38/213.55       80; was see under SOCIOLOGY 1978-79   
% 213.38/213.55  |- mesh__dateEstablished mesh__D012962 1980-01-01
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012962 2005
% 213.38/213.55  |- mesh__dateCreated mesh__D012962 1977-04-22
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012962 2002
% 213.38/213.55  |- skos__historyNote mesh__D012962 Sociology %28%1966-1977%29%
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012962 2006
% 213.38/213.55  |- skos__prefLabel mesh__D012962 Sociology, Medical
% 213.38/213.55  |- mesh__recordAuthorizer mesh__D012962 sjn
% 213.38/213.55  |- mesh__recordOriginator mesh__D012962 EC
% 213.38/213.55  |- skos__altLabel mesh__D012962 Medical Sociology
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012962 2003
% 213.38/213.55  |- skos__annotation mesh__D012962 IM; SPEC: SPEC qualif; DF: SOCIOL MED   
% 213.38/213.55  |- mesh__recordMaintainer mesh__D012962 kle
% 213.38/213.55  |- rdf__type mesh__D012962sskos__Concept
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012962 2000
% 213.38/213.55  |- skos__broader mesh__D012962smesh__D012961
% 213.38/213.55  |- skos__historyNote mesh__D012164 Retina %28%1966-1971%29%
% 213.38/213.55  |- skos__prefLabel mesh__D012164 Retinal Diseases
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012164 2004
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012164 1997
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012164 2000
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012164 2006
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012164 1999
% 213.38/213.55  |- skos__annotation mesh__D012164
% 213.38/213.55       inflamm dis = RETINITIS or CHORIORETINITIS; retinal dystrophy: index under RETINAL DEGENERATION or MACULAR DEGENERATION relying on text %26% refs%A%  
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012164 2003
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012164 1993
% 213.38/213.55  |- skos__hiddenLabel mesh__D012164 Retinal Disease
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012164 1996
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012164 2005
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012164 1995
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012164 1998
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012164 1992
% 213.38/213.55  |- rdf__type mesh__D012164sskos__Concept
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012164 1994
% 213.38/213.55  |- mesh__publicMeSHNote mesh__D012164 72   
% 213.38/213.55  |- mesh__dateCreated mesh__D012164 1999-01-01
% 213.38/213.55  |- skos__hiddenLabel mesh__D012164 Diseases, Retinal
% 213.38/213.55  |- mesh__recordOriginator mesh__D012164 NLM
% 213.38/213.55  |- mesh__dateRevised mesh__D012164 1990-05-29
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012164 2002
% 213.38/213.55  |- skos__broader mesh__D012164smesh__D005128
% 213.38/213.55  |- skos__hiddenLabel mesh__D012164 Disease, Retinal
% 213.38/213.55  |- mesh__recordMaintainer mesh__D012164 PLS
% 213.38/213.55  |- mesh__historyNote mesh__D012164 72   
% 213.38/213.55  |- mesh__dateEstablished mesh__D012164 1972-01-01
% 213.38/213.55  |- mesh__recordAuthorizer mesh__D012164 NLM
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012164 2001
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D012164 1991
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006925 2002
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006925 1998
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006925 2006
% 213.38/213.55  |- skos__broader mesh__D006925smesh__D002590
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006925 1999
% 213.38/213.55  |- mesh__dateEstablished mesh__D006925 1968-01-01
% 213.38/213.55  |- mesh__recordOriginator mesh__D006925 NLM
% 213.38/213.55  |- mesh__dateRevised mesh__D006925 1993-06-02
% 213.38/213.55  |- mesh__recordMaintainer mesh__D006925 TGC
% 213.38/213.55  |- mesh__dateCreated mesh__D006925 1999-01-01
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006925 1994
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006925 2003
% 213.38/213.55  |- rdf__type mesh__D006925sskos__Concept
% 213.38/213.55  |- mesh__publicMeSHNote mesh__D006925 68   
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006925 2000
% 213.38/213.55  |- mesh__historyNote mesh__D006925 68   
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006925 1996
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006925 1995
% 213.38/213.55  |- skos__prefLabel mesh__D006925 Hymenolepiasis
% 213.38/213.55  |- skos__scopeNote mesh__D006925
% 213.38/213.55       Infection with tapeworms of the genus Hymenolepis.     
% 213.38/213.55  |- skos__annotation mesh__D006925 tapeworm infect   
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006925 2004
% 213.38/213.55  |- mesh__recordAuthorizer mesh__D006925 PLS
% 213.38/213.55  |- skos__hiddenLabel mesh__D006925 Hymenolepiases
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006925 2001
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006925 1997
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006925 2005
% 213.38/213.55  |- skos__historyNote mesh__D006925 Cestode Infections %28%1966-1967%29%
% 213.38/213.55  |- mesh__recordMaintainer mesh__D039301 jls
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D039301 2006
% 213.38/213.55  |- skos__annotation mesh__D039301
% 213.38/213.55       do not confuse DNA Computers with DNA MICROCHIPS see OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS%A%  
% 213.38/213.55  |- skos__hiddenLabel mesh__D039301 DNA Computations
% 213.38/213.55  |- mesh__dateRevised mesh__D039301 2004-07-07
% 213.38/213.55  |- skos__hiddenLabel mesh__D039301 Computations, Molecular
% 213.38/213.55  |- mesh__dateEstablished mesh__D039301 2003-01-01
% 213.38/213.55  |- mesh__recordAuthorizer mesh__D039301 sjn
% 213.38/213.55  |- skos__hiddenLabel mesh__D039301 Computers, DNA
% 213.38/213.55  |- skos__hiddenLabel mesh__D039301 Computer, DNA
% 213.38/213.55  |- skos__hiddenLabel mesh__D039301 Computations, RNA
% 213.38/213.55  |- mesh__historyNote mesh__D039301 2003   
% 213.38/213.55  |- skos__hiddenLabel mesh__D039301 Computations, DNA
% 213.38/213.55  |- skos__hiddenLabel mesh__D039301 Computation, Molecular
% 213.38/213.55  |- skos__hiddenLabel mesh__D039301 Molecular Computer
% 213.38/213.55  |- mesh__publicMeSHNote mesh__D039301 2003   
% 213.38/213.55  |- skos__broader mesh__D039301smesh__D003205
% 213.38/213.55  |- skos__prefLabel mesh__D039301 Computers, Molecular
% 213.38/213.55  |- rdf__type mesh__D039301sskos__Concept
% 213.38/213.55  |- skos__scopeNote mesh__D039301
% 213.38/213.55       Computers whose input, output and state transitions are carried out by biochemical interactions and reactions.%A%    
% 213.38/213.55  |- skos__hiddenLabel mesh__D039301 Molecular Computers
% 213.38/213.55  |- skos__broader mesh__D039301smesh__D003201
% 213.38/213.55  |- skos__hiddenLabel mesh__D039301 Computers, RNA
% 213.38/213.55  |- skos__hiddenLabel mesh__D039301 Computer, Molecular
% 213.38/213.55  |- skos__hiddenLabel mesh__D039301 Computation, DNA
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D039301 2005
% 213.38/213.55  |- mesh__dateCreated mesh__D039301 2002-07-03
% 213.38/213.55  |- skos__hiddenLabel mesh__D039301 Molecular Computations
% 213.38/213.55  |- skos__hiddenLabel mesh__D039301 RNA Computer
% 213.38/213.55  |- skos__hiddenLabel mesh__D039301 Computer, RNA
% 213.38/213.55  |- skos__hiddenLabel mesh__D039301 DNA Computer
% 213.38/213.55  |- skos__hiddenLabel mesh__D039301 Computation, RNA
% 213.38/213.55  |- mesh__recordOriginator mesh__D039301 nns
% 213.38/213.55  |- skos__hiddenLabel mesh__D039301 RNA Computations
% 213.38/213.55  |- mesh__activeMeSHYear mesh__D006127 1990
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006127 2006
% 213.38/213.56  |- skos__broader mesh__D006127smesh__D006126
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006127 2001
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006127 1993
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006127 1994
% 213.38/213.56  |- mesh__publicMeSHNote mesh__D006127 69   
% 213.38/213.56  |- skos__hiddenLabel mesh__D006127 Structures, Group
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006127 2004
% 213.38/213.56  |- mesh__dateEstablished mesh__D006127 1969-01-01
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006127 2005
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006127 1999
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006127 1992
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006127 2000
% 213.38/213.56  |- mesh__dateCreated mesh__D006127 1999-01-01
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006127 2003
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006127 1997
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006127 1998
% 213.38/213.56  |- mesh__dateRevised mesh__D006127 1989-04-28
% 213.38/213.56  |- rdf__type mesh__D006127sskos__Concept
% 213.38/213.56  |- skos__annotation mesh__D006127 no qualif   
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006127 1991
% 213.38/213.56  |- mesh__historyNote mesh__D006127 69%28%68%29%   
% 213.38/213.56  |- skos__hiddenLabel mesh__D006127 Structure, Group
% 213.38/213.56  |- skos__hiddenLabel mesh__D006127 Group Structures
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006127 2002
% 213.38/213.56  |- mesh__recordOriginator mesh__D006127 NLM
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006127 1996
% 213.38/213.56  |- skos__scopeNote mesh__D006127
% 213.38/213.56       The informal or formal organization of a group of people based on a network of personal relationships which is influenced by the size and composition, etc., of the group.%A%    
% 213.38/213.56  |- mesh__recordMaintainer mesh__D006127 TGC
% 213.38/213.56  |- skos__historyNote mesh__D006127 Group Processes %28%1966-1967%29%
% 213.38/213.56  |- skos__prefLabel mesh__D006127 Group Structure
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006127 1995
% 213.38/213.56  |- mesh__recordAuthorizer mesh__D006127 PLS
% 213.38/213.56  |- mesh__recordOriginator mesh__D016555 JHM
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D016555 2002
% 213.38/213.56  |- skos__annotation mesh__D016555
% 213.38/213.56       IM GEN only; coord NIM with specific disease or other concept %28%IM%29% + matched parameter %28%e.g. age, sex, physiol state%29% %28%IM or NIM%29%; no qualif%A%  
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D016555 2004
% 213.38/213.56  |- mesh__historyNote mesh__D016555 92   
% 213.38/213.56  |- skos__hiddenLabel mesh__D016555 Comparison, Paired
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D016555 2006
% 213.38/213.56  |- skos__hiddenLabel mesh__D016555 Analyses, Matched-Pair
% 213.38/213.56  |- skos__broader mesh__D016555smesh__D013223
% 213.38/213.56  |- mesh__recordMaintainer mesh__D016555 ags
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D016555 2003
% 213.38/213.56  |- skos__scopeNote mesh__D016555
% 213.38/213.56       A type of analysis in which subjects in a study group and a comparison group are made comparable with respect to extraneous factors by individually pairing study subjects with the comparison group subjects %28%e.g., age-matched controls%29%.%A%    
% 213.38/213.56  |- mesh__recordAuthorizer mesh__D016555 sjn
% 213.38/213.56  |- mesh__dateRevised mesh__D016555 2001-07-25
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D016555 2005
% 213.38/213.56  |- skos__hiddenLabel mesh__D016555 Matched-Pair Analyses
% 213.38/213.56  |- skos__hiddenLabel mesh__D016555 Matched Pair Analysis
% 213.38/213.56  |- skos__hiddenLabel mesh__D016555 Analysis, Matched Pair
% 213.38/213.56  |- mesh__publicMeSHNote mesh__D016555 92   
% 213.38/213.56  |- skos__altLabel mesh__D016555 Analysis, Matched-Pair
% 213.38/213.56  |- skos__prefLabel mesh__D016555 Matched-Pair Analysis
% 213.38/213.56  |- mesh__dateCreated mesh__D016555 1991-06-20
% 213.38/213.56  |- mesh__dateEstablished mesh__D016555 1992-01-01
% 213.38/213.56  |- skos__broader mesh__D016555smesh__D015340
% 213.38/213.56  |- rdf__type mesh__D016555sskos__Concept
% 213.38/213.56  |- skos__hiddenLabel mesh__D016555 Paired Comparison
% 213.38/213.56  |- skos__hiddenLabel mesh__D016555 Comparisons, Paired
% 213.38/213.56  |- skos__prefLabel mesh__D002535 Cerebral Aqueduct
% 213.38/213.56  |- mesh__publicMeSHNote mesh__D002535 71   
% 213.38/213.56  |- skos__historyNote mesh__D002535 Cerebral Ventricles %28%1966-1970%29%
% 213.38/213.56  |- mesh__dateCreated mesh__D002535 1999-01-01
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D002535 2001
% 213.38/213.56  |- mesh__recordOriginator mesh__D002535 NLM
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D002535 2006
% 213.38/213.56  |- skos__broader mesh__D002535smesh__D013681
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D002535 2002
% 213.38/213.56  |- skos__hiddenLabel mesh__D002535 Cerebral Aqueducts
% 213.38/213.56  |- mesh__dateEstablished mesh__D002535 1971-01-01
% 213.38/213.56  |- mesh__recordAuthorizer mesh__D002535 sjn
% 213.38/213.56  |- skos__scopeNote mesh__D002535
% 213.38/213.56       Narrow channel in the mesencephalon that connects the third and fourth ventricles.%A%    
% 213.38/213.56  |- skos__hiddenLabel mesh__D002535 Aqueduct, Cerebral
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D002535 2003
% 213.38/213.56  |- rdf__type mesh__D002535sskos__Concept
% 213.38/213.56  |- mesh__historyNote mesh__D002535 71   
% 213.38/213.56  |- skos__altLabel mesh__D002535 Aqueduct of Sylvius
% 213.38/213.56  |- skos__annotation mesh__D002535
% 213.38/213.56       /radiogr: coord with CEREBRAL VENTRICULOGRAPHY   
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D002535 2004
% 213.38/213.56  |- mesh__recordMaintainer mesh__D002535 ags
% 213.38/213.56  |- mesh__dateRevised mesh__D002535 1999-11-03
% 213.38/213.56  |- skos__hiddenLabel mesh__D002535 Aqueducts, Cerebral
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D002535 2000
% 213.38/213.56  |- skos__broader mesh__D002535smesh__D002552
% 213.38/213.56  |- skos__hiddenLabel mesh__D002535 Sylvius Aqueduct
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D002535 2005
% 213.38/213.56  |- skos__broader mesh__D007220smesh__D004785
% 213.38/213.56  |- mesh__recordOriginator mesh__D007220 NLM
% 213.38/213.56  |- mesh__historyNote mesh__D007220 66   
% 213.38/213.56  |- skos__broader mesh__D007220smesh__D014866
% 213.38/213.56  |- skos__scopeNote mesh__D007220
% 213.38/213.56       Worthless, damaged, defective, superfluous or effluent material from industrial operations. It represents an ecological problem and health hazard.%A%    
% 213.38/213.56  |- rdf__type mesh__D007220sskos__Concept
% 213.38/213.56  |- mesh__dateEstablished mesh__D007220 1966-01-01
% 213.38/213.56  |- mesh__dateCreated mesh__D007220 1999-01-01
% 213.38/213.56  |- skos__prefLabel mesh__D007220 Industrial Waste
% 213.38/213.56  |- mesh__recordAuthorizer mesh__D007220 sjn
% 213.38/213.56  |- skos__altLabel mesh__D007220 Waste, Industrial
% 213.38/213.56  |- mesh__publicMeSHNote mesh__D007220 66   
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D007220 2006
% 213.38/213.56  |- mesh__recordMaintainer mesh__D007220 ssb
% 213.38/213.56  |- skos__hiddenLabel mesh__D007220 Wastes, Industrial
% 213.38/213.56  |- skos__hiddenLabel mesh__D007220 Industrial Wastes
% 213.38/213.56  |- mesh__dateRevised mesh__D007220 2005-06-30
% 213.38/213.56  |- skos__annotation mesh__D007220
% 213.38/213.56       specify geog if pertinent; DF: INDUST WASTE   
% 213.38/213.56  |- skos__hiddenLabel mesh__D012963 Technic, Sociometric
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012963 2004
% 213.38/213.56  |- rdf__type mesh__D012963sskos__Concept
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012963 2005
% 213.38/213.56  |- mesh__publicMeSHNote mesh__D012963
% 213.38/213.56       91; was SOCIOMETRIC TECHNICS 1968-90   
% 213.38/213.56  |- skos__historyNote mesh__D012963 Sociology %28%1966-1967%29%
% 213.38/213.56  |- mesh__recordAuthorizer mesh__D012963 sjn
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012963 2003
% 213.38/213.56  |- mesh__recordMaintainer mesh__D012963 kle
% 213.38/213.56  |- mesh__dateCreated mesh__D012963 1999-01-01
% 213.38/213.56  |- skos__annotation mesh__D012963 no qualif   
% 213.38/213.56  |- mesh__onlineNote mesh__D012963
% 213.38/213.56       use SOCIOMETRIC TECHNIQUES to search SOCIOMETRIC TECHNICS 1968-90%A%  
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012963 2002
% 213.38/213.56  |- skos__hiddenLabel mesh__D012963 Sociometric Technique
% 213.38/213.56  |- skos__hiddenLabel mesh__D012963 Technics, Sociometric
% 213.38/213.56  |- mesh__dateEstablished mesh__D012963 1968-01-01
% 213.38/213.56  |- skos__altLabel mesh__D012963 Sociometric Technics
% 213.38/213.56  |- mesh__recordOriginator mesh__D012963 NLM
% 213.38/213.56  |- skos__broader mesh__D012963smesh__D012961
% 213.38/213.56  |- skos__hiddenLabel mesh__D012963 Sociometric Technic
% 213.38/213.56  |- skos__hiddenLabel mesh__D012963 Technique, Sociometric
% 213.38/213.56  |- skos__historyNote mesh__D012963 Psychology, Social %28%1966-1967%29%
% 213.38/213.56  |- mesh__dateRevised mesh__D012963 1999-11-03
% 213.38/213.56  |- mesh__historyNote mesh__D012963 91; was SOCIOMETRIC TECHNICS 1968-90   
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012963 2001
% 213.38/213.56  |- skos__prefLabel mesh__D012963 Sociometric Techniques
% 213.38/213.56  |- skos__scopeNote mesh__D012963
% 213.38/213.56       Methods for quantitatively assessing and measuring interpersonal and group relationships.%A%    
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012963 2006
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012963 2000
% 213.38/213.56  |- skos__hiddenLabel mesh__D012963 Techniques, Sociometric
% 213.38/213.56  |- skos__prefLabel mesh__D012165 Retinal Ganglion Cells
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012165 2006
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012165 2003
% 213.38/213.56  |- mesh__dateCreated mesh__D012165 1982-04-28
% 213.38/213.56  |- mesh__recordAuthorizer mesh__D012165 sjn
% 213.38/213.56  |- skos__broader mesh__D012165smesh__D012160
% 213.38/213.56  |- skos__broader mesh__D012165smesh__D010786
% 213.38/213.56  |- mesh__historyNote mesh__D012165
% 213.38/213.56       91%28%83%29%; was see under RETINA 1983-90   
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012165 2005
% 213.38/213.56  |- skos__hiddenLabel mesh__D012165 Cell, Retinal Ganglion
% 213.38/213.56  |- skos__scopeNote mesh__D012165
% 213.38/213.56       Cells of the innermost nuclear layer of the retina, the ganglion cell layer, which project axons through the optic nerve to the brain. They are quite variable in size and in the shapes of their dendritic arbors, which are generally confined to the inner plexiform layer. A small subset of these cells act as photoreceptors and project to the SUPRACHIASMATIC NUCLEUS, the location of the circadian clock, setting the CIRCADIAN RHYTHM.%A%    
% 213.38/213.56  |- mesh__recordMaintainer mesh__D012165 ags
% 213.38/213.56  |- rdf__type mesh__D012165sskos__Concept
% 213.38/213.56  |- skos__hiddenLabel mesh__D012165 Cells, Retinal Ganglion
% 213.38/213.56  |- skos__historyNote mesh__D012165 Retina %28%1966-1982%29%
% 213.38/213.56  |- mesh__recordOriginator mesh__D012165 RC
% 213.38/213.56  |- skos__broader mesh__D012165smesh__D009475
% 213.38/213.56  |- skos__hiddenLabel mesh__D012165 Retinal Ganglion Cell
% 213.38/213.56  |- skos__hiddenLabel mesh__D012165 Ganglion Cells, Retinal
% 213.38/213.56  |- skos__hiddenLabel mesh__D012165 Ganglion Cell, Retinal
% 213.38/213.56  |- skos__broader mesh__D012165smesh__D020419
% 213.38/213.56  |- mesh__dateEstablished mesh__D012165 1991-01-01
% 213.38/213.56  |- mesh__publicMeSHNote mesh__D012165 91; was see under RETINA 1983-90   
% 213.38/213.56  |- mesh__dateRevised mesh__D012165 2002-07-03
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012165 2004
% 213.38/213.56  |- mesh__historyNote mesh__D006926
% 213.38/213.56       79%28%75%29%; was see under CESTODA 1965-78, was see under TAPEWORMS 1963-64%A%  
% 213.38/213.56  |- skos__annotation mesh__D006926
% 213.38/213.56       infection = HYMENOLEPIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 213.38/213.56  |- skos__broader mesh__D006926smesh__D002589
% 213.38/213.56  |- mesh__onlineNote mesh__D006926 search CESTODA 1966-74   
% 213.38/213.56  |- skos__historyNote mesh__D006926 Cestoda %28%1966-1974%29%
% 213.38/213.56  |- skos__scopeNote mesh__D006926
% 213.38/213.56       A genus of small tapeworms of birds and mammals.     
% 213.38/213.56  |- rdf__type mesh__D006926sskos__Concept
% 213.38/213.56  |- mesh__dateRevised mesh__D006926 2003-07-09
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006926 2004
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006926 2005
% 213.38/213.56  |- mesh__dateEstablished mesh__D006926 1979-01-01
% 213.38/213.56  |- skos__prefLabel mesh__D006926 Hymenolepis
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006926 2006
% 213.38/213.56  |- mesh__recordOriginator mesh__D006926 NLM
% 213.38/213.56  |- mesh__recordMaintainer mesh__D006926 ags
% 213.38/213.56  |- mesh__publicMeSHNote mesh__D006926
% 213.38/213.56       79; was see under CESTODA 1965-78, was see under TAPEWORMS 1963-64%A%  
% 213.38/213.56  |- mesh__recordAuthorizer mesh__D006926 sjn
% 213.38/213.56  |- mesh__dateCreated mesh__D006926 1999-01-01
% 213.38/213.56  |- mesh__historyNote mesh__D039302
% 213.38/213.56       2003; use RECEPTORS, VITRONECTIN 1996-2002   
% 213.38/213.56  |- mesh__recordOriginator mesh__D039302 MDJ
% 213.38/213.56  |- skos__broader mesh__D039302smesh__D019030
% 213.38/213.56  |- skos__hiddenLabel mesh__D039302 Receptors, alpha v beta 3 Integrin
% 213.38/213.56  |- mesh__dateRevised mesh__D039302 2003-07-09
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D039302 2004
% 213.38/213.56  |- skos__hiddenLabel mesh__D039302 Receptor, Vitronectin
% 213.38/213.56  |- skos__hiddenLabel mesh__D039302 alpha v beta 3 Integrin Receptors
% 213.38/213.56  |- mesh__dateCreated mesh__D039302 2002-07-02
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D039302 2006
% 213.38/213.56  |- skos__altLabel mesh__D039302 Receptors, alpha-v beta-3 Integrin
% 213.38/213.56  |- skos__altLabel mesh__D039302 Vitronectin Receptor
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D039302 2005
% 213.38/213.56  |- skos__annotation mesh__D039302
% 213.38/213.56       do not confuse X ref VITRONECTIN RECEPTOR with VITRONECTIN RECEPTORS%A%  
% 213.38/213.56  |- skos__hiddenLabel mesh__D039302 alpha-v beta-3, Integrin
% 213.38/213.56  |- mesh__publicMeSHNote mesh__D039302
% 213.38/213.56       2003; see RECEPTORS, VITRONECTIN 1996-2002   
% 213.38/213.56  |- skos__altLabel mesh__D039302 alpha-v beta-3 Integrin Receptors
% 213.38/213.56  |- mesh__recordAuthorizer mesh__D039302 sjn
% 213.38/213.56  |- skos__broader mesh__D039302smesh__D010980
% 213.38/213.56  |- mesh__dateEstablished mesh__D039302 2003-01-01
% 213.38/213.56  |- skos__altLabel mesh__D039302 Integrin alpha-v beta-3
% 213.38/213.56  |- skos__hiddenLabel mesh__D039302 beta-3, Integrin alpha-v
% 213.38/213.56  |- skos__hiddenLabel mesh__D039302 alphaVbeta3, Integrin
% 213.38/213.56  |- skos__hiddenLabel mesh__D039302 Integrin alpha v beta 3
% 213.38/213.56  |- mesh__recordMaintainer mesh__D039302 jmp
% 213.38/213.56  |- skos__scopeNote mesh__D039302
% 213.38/213.56       An integrin that binds to a variety of plasma and extracellular matrix proteins containing the conserved RGD amino acid sequence and modulates cell adhesion. Integrin alphavbeta3 is highly expressed in OSTEOCLASTS where it may play role in BONE RESORPTION.  It is also abundant in vascular smooth muscle and endothelial cells, and in some tumor cells, where it is involved in angiogenesis and cell migration. Although often referred to as the vitronectin receptor there is more than one receptor for vitronectin %28%RECEPTORS, VITRONECTIN%29%.%A%    
% 213.38/213.56  |- skos__prefLabel mesh__D039302 Integrin alphaVbeta3
% 213.38/213.56  |- rdf__type mesh__D039302sskos__Concept
% 213.38/213.56  |- skos__broader mesh__D011494Q000037smesh__D011494
% 213.38/213.56  |- mesh__preferredCombination mesh__D011494Q000037smesh__D047428
% 213.38/213.56  |- rdf__type mesh__D011494Q000037smesh__CompoundConcept
% 213.38/213.56  |- skos__broader mesh__D006128smesh__D048788
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006128 2005
% 213.38/213.56  |- skos__scopeNote mesh__D006128
% 213.38/213.56       Gradual increase in the number, the size, and the complexity of cells of an individual. Growth generally results in increase in ORGAN WEIGHT; BODY WEIGHT; and BODY HEIGHT.%A%    
% 213.38/213.56  |- skos__prefLabel mesh__D006128 Growth
% 213.38/213.56  |- mesh__dateCreated mesh__D006128 1999-01-01
% 213.38/213.56  |- rdf__type mesh__D006128sskos__Concept
% 213.38/213.56  |- mesh__dateRevised mesh__D006128 2004-07-07
% 213.38/213.56  |- mesh__recordMaintainer mesh__D006128 lkt
% 213.38/213.56  |- skos__related mesh__D006128smesh__D002657
% 213.38/213.56  |- skos__related mesh__D006128smesh__D010553
% 213.38/213.56  |- mesh__recordAuthorizer mesh__D006128 sjn
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006128 2006
% 213.38/213.56  |- skos__annotation mesh__D006128
% 213.38/213.56       General only; prefer /growth with specific organ or organism: Manual 19.7+, 19.8.35%A%  
% 213.38/213.56  |- mesh__recordOriginator mesh__D006128 NLM
% 213.38/213.56  |- mesh__dateEstablished mesh__D016556 1992-01-01
% 213.38/213.56  |- mesh__publicMeSHNote mesh__D016556 92   
% 213.38/213.56  |- mesh__recordMaintainer mesh__D016556 ssb
% 213.38/213.56  |- rdf__type mesh__D016556sskos__Concept
% 213.38/213.56  |- mesh__recordOriginator mesh__D016556 MXR
% 213.38/213.56  |- skos__scopeNote mesh__D016556
% 213.38/213.56       Technique combining controlled eruptive tooth movement and incision of the supracrestal gingival attachment to allow for proper restoration of a destroyed or damaged crown of a tooth. Controlled eruption of the tooth is obtained using ORTHODONTIC APPLIANCES. During this eruptive phase, repeated incisions are made at the junctional epithelium of the sulcus and the supracrestal connective tissue to prevent coronal displacement of the gingiva and of the attachment apparatus.%A%    
% 213.38/213.56  |- mesh__historyNote mesh__D016556 92   
% 213.38/213.56  |- mesh__dateCreated mesh__D016556 1991-01-02
% 213.38/213.56  |- skos__hiddenLabel mesh__D016556 Lengthening, Crown
% 213.38/213.56  |- mesh__recordAuthorizer mesh__D016556 sjn
% 213.38/213.56  |- skos__broader mesh__D016556smesh__D003814
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D016556 2006
% 213.38/213.56  |- skos__prefLabel mesh__D016556 Crown Lengthening
% 213.38/213.56  |- skos__related mesh__D016556smesh__D050793
% 213.38/213.56  |- mesh__dateRevised mesh__D016556 2005-06-30
% 213.38/213.56  |- skos__broader mesh__D016556smesh__D009971
% 213.38/213.56  |- skos__hiddenLabel mesh__D002536 Cerebral Artery
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D002536 2002
% 213.38/213.56  |- mesh__onlineNote mesh__D002536
% 213.38/213.56       use CEREBRAL ANGIOGRAPHY to search CEREBRAL ARTERIES/radiography 1975-94%A%  
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D002536 2001
% 213.38/213.56  |- mesh__historyNote mesh__D002536
% 213.38/213.56       /radiography was CEREBRAL ANGIOGRAPHY 1975-94   
% 213.38/213.56  |- skos__broader mesh__D002536smesh__D001158
% 213.38/213.56  |- mesh__dateRevised mesh__D002536 1999-11-03
% 213.38/213.56  |- skos__hiddenLabel mesh__D002536 Arteries, Cerebral
% 213.38/213.56  |- mesh__recordMaintainer mesh__D002536 jmp
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D002536 2006
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D002536 2000
% 213.38/213.56  |- skos__hiddenLabel mesh__D002536 Artery, Cerebral
% 213.38/213.56  |- mesh__recordOriginator mesh__D002536 NLM
% 213.38/213.56  |- skos__annotation mesh__D002536
% 213.38/213.56       for cerebral arteries in general or unspecified or for specific cerebral arteries not in MeSH or as coord %28%IM%29% for arteries of specific parts of brain indented under CEREBRAL CORTEX in tree %28%IM%29%; not as coord for non-cerebrum parts of the brain, as cerebellar artery %28% = CEREBELLUM /blood supply %28%IM%29% + ARTERIES %28%NIM%29%, not CEREBRAL ARTERIES%29%; /abnorm: consider also INTRACRANIAL ARTERIOVENOUS MALFORMATIONS%A%  
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D002536 2005
% 213.38/213.56  |- mesh__publicMeSHNote mesh__D002536
% 213.38/213.56       /radiography was CEREBRAL ANGIOGRAPHY 1975-94   
% 213.38/213.56  |- skos__scopeNote mesh__D002536
% 213.38/213.56       The arteries supplying the cerebral cortex.     
% 213.38/213.56  |- skos__prefLabel mesh__D002536 Cerebral Arteries
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D002536 2004
% 213.38/213.56  |- mesh__recordAuthorizer mesh__D002536 sjn
% 213.38/213.56  |- rdf__type mesh__D002536sskos__Concept
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D002536 2003
% 213.38/213.56  |- mesh__dateCreated mesh__D002536 1999-01-01
% 213.38/213.56  |- skos__related mesh__D002536smesh__D002533
% 213.38/213.56  |- skos__broader mesh__D009206Q000187smesh__D009206
% 213.38/213.56  |- mesh__preferredCombination mesh__D009206Q000187smesh__D006321Q000187
% 213.38/213.56  |- rdf__type mesh__D009206Q000187smesh__CompoundConcept
% 213.38/213.56  |- skos__scopeNote mesh__D007221
% 213.38/213.56       The aggregate of manufacturing or technically productive enterprises in a particular field, often named after its principle product, as %22%the automobile industry%22%, %22%the steel industry%22%. It includes the ownership and management of companies, factories, industrial plants, etc. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 213.38/213.56  |- skos__hiddenLabel mesh__D007221 Sectors, Tertiary
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D007221 2004
% 213.38/213.56  |- mesh__dateCreated mesh__D007221 1999-01-01
% 213.38/213.56  |- skos__related mesh__D007221smesh__D040861
% 213.38/213.56  |- skos__prefLabel mesh__D007221 Industry
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D007221 2003
% 213.38/213.56  |- mesh__recordOriginator mesh__D007221 NLM
% 213.38/213.56  |- skos__broader mesh__D007221smesh__D013676
% 213.38/213.56  |- skos__related mesh__D007221smesh__D009784
% 213.38/213.56  |- skos__annotation mesh__D007221
% 213.38/213.56       SPEC: SPEC qualif; relation to INDUSTRIAL MEDICINE see OCCUPATIONAL MEDICINE %26% OCCUPATIONAL DISEASES: Manual 31.2, 31.14; DF: INDUST%A%  
% 213.38/213.56  |- skos__hiddenLabel mesh__D007221 Sector, Tertiary
% 213.38/213.56  |- mesh__dateRevised mesh__D007221 2002-07-03
% 213.38/213.56  |- skos__related mesh__D007221smesh__D003132
% 213.38/213.56  |- mesh__historyNote mesh__D007221 73   
% 213.38/213.56  |- skos__hiddenLabel mesh__D007221 Industries
% 213.38/213.56  |- skos__related mesh__D007221smesh__D009787
% 213.38/213.56  |- mesh__recordAuthorizer mesh__D007221 sjn
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D007221 2006
% 213.38/213.56  |- skos__related mesh__D007221smesh__D017132
% 213.38/213.56  |- mesh__dateEstablished mesh__D007221 1973-01-01
% 213.38/213.56  |- skos__hiddenLabel mesh__D007221 Tertiary Sectors
% 213.38/213.56  |- mesh__publicMeSHNote mesh__D007221 73   
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D007221 2005
% 213.38/213.56  |- mesh__recordMaintainer mesh__D007221 hjn
% 213.38/213.56  |- rdf__type mesh__D007221sskos__Concept
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012964 2001
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012964 2003
% 213.38/213.56  |- mesh__dateCreated mesh__D012964 1999-01-01
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012964 1998
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012964 2000
% 213.38/213.56  |- skos__related mesh__D012964smesh__D012975
% 213.38/213.56  |- skos__related mesh__D012964smesh__D009318
% 213.38/213.56  |- mesh__recordAuthorizer mesh__D012964 SJN
% 213.38/213.56  |- skos__annotation mesh__D012964
% 213.38/213.56       an alkali metal; Na-23; /physiol permitted; /blood: note also HYPERNATREMIA %26% HYPONATREMIA; /defic: consider also HYPONATREMIA; /metab: consider also SODIUM CHANNELS %26% SODIUM-POTASSIUM PUMP; /urine: consider also NATRIURESIS; SODIUM, DIETARY is also available%A%  
% 213.38/213.56  |- skos__hiddenLabel mesh__D012964 Level, Sodium Ion
% 213.38/213.56  |- mesh__dateRevised mesh__D012964 1997-06-20
% 213.38/213.56  |- skos__broader mesh__D012964smesh__D008672
% 213.38/213.56  |- skos__scopeNote mesh__D012964
% 213.38/213.56       An element that is a member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. With a valence of 1, it has a strong affinity for oxygen and other nonmetallic elements. Sodium provides the chief cation of the extracellular body fluids. Its salts are the most widely used in medicine. %28%From Dorland, 27th ed%29% Physiologically the sodium ion plays a major role in blood pressure regulation, maintenance of fluid volume, and electrolyte balance.%A%    
% 213.38/213.56  |- skos__related mesh__D012964smesh__D006955
% 213.38/213.56  |- skos__hiddenLabel mesh__D012964 Ion Level, Sodium
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012964 2002
% 213.38/213.56  |- skos__prefLabel mesh__D012964 Sodium
% 213.38/213.56  |- mesh__recordMaintainer mesh__D012964 ADP
% 213.38/213.56  |- mesh__recordOriginator mesh__D012964 NLM
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012964 2006
% 213.38/213.56  |- skos__related mesh__D012964smesh__D012979
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012964 2004
% 213.38/213.56  |- skos__related mesh__D012964smesh__D007010
% 213.38/213.56  |- rdf__type mesh__D012964sskos__Concept
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012964 2005
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012964 1999
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012166 2002
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012166 2006
% 213.38/213.56  |- skos__scopeNote mesh__D012166
% 213.38/213.56       Bleeding from the vessels of the retina.     
% 213.38/213.56  |- skos__broader mesh__D012166smesh__D005130
% 213.38/213.56  |- mesh__recordMaintainer mesh__D012166 KEV
% 213.38/213.56  |- skos__hiddenLabel mesh__D012166 Retinal Hemorrhages
% 213.38/213.56  |- rdf__type mesh__D012166sskos__Concept
% 213.38/213.56  |- mesh__recordOriginator mesh__D012166 NLM
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012166 2000
% 213.38/213.56  |- mesh__recordAuthorizer mesh__D012166 sjn
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012166 2001
% 213.38/213.56  |- skos__prefLabel mesh__D012166 Retinal Hemorrhage
% 213.38/213.56  |- skos__broader mesh__D012166smesh__D012164
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012166 2003
% 213.38/213.56  |- mesh__dateRevised mesh__D012166 1999-11-03
% 213.38/213.56  |- skos__altLabel mesh__D012166 Hemorrhage, Retinal
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012166 2005
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D012166 2004
% 213.38/213.56  |- mesh__dateCreated mesh__D012166 1999-01-01
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006927 2004
% 213.38/213.56  |- skos__broader mesh__D006927smesh__D007313
% 213.38/213.56  |- skos__prefLabel mesh__D006927 Hymenoptera
% 213.38/213.56  |- skos__historyNote mesh__D006927 specific insect
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006927 2005
% 213.38/213.56  |- skos__historyNote mesh__D006927 Insects %28%1966-1974%29%
% 213.38/213.56  |- mesh__dateRevised mesh__D006927 2005-07-08
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006927 2006A
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D006927 2006
% 213.38/213.56  |- mesh__publicMeSHNote mesh__D006927 75   
% 213.38/213.56  |- skos__annotation mesh__D006927
% 213.38/213.56       includes ANTS; BEES; WASPS; /microbiol /parasitol /virol permitted%A%  
% 213.38/213.56  |- mesh__recordMaintainer mesh__D006927 ags
% 213.38/213.56  |- skos__scopeNote mesh__D006927
% 213.38/213.56       An extensive order of highly specialized insects including bees, wasps, and ants.%A%    
% 213.38/213.56  |- mesh__dateCreated mesh__D006927 1999-01-01
% 213.38/213.56  |- mesh__dateEstablished mesh__D006927 1975-01-01
% 213.38/213.56  |- mesh__historyNote mesh__D006927 75   
% 213.38/213.56  |- mesh__recordAuthorizer mesh__D006927 ags
% 213.38/213.56  |- rdf__type mesh__D006927sskos__Concept
% 213.38/213.56  |- mesh__recordOriginator mesh__D006927 NLM
% 213.38/213.56  |- mesh__dateCreated mesh__D031320 2002-07-03
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D031320 2006
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D031320 2004
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D031320 2005
% 213.38/213.56  |- mesh__dateEstablished mesh__D031320 2003-01-01
% 213.38/213.56  |- skos__scopeNote mesh__D031320
% 213.38/213.56       A plant family of the order Celastrales, subclass Rosidae, class Magnoliopsida. The Hippocratea genus contains friedelanes, triterpenoid quinone, and hippocrateine I.%A%    
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D031320 2003
% 213.38/213.56  |- mesh__historyNote mesh__D031320 2003   
% 213.38/213.56  |- mesh__publicMeSHNote mesh__D031320 2003   
% 213.38/213.56  |- rdf__type mesh__D031320sskos__Concept
% 213.38/213.56  |- skos__prefLabel mesh__D031320 Hippocrateaceae
% 213.38/213.56  |- skos__broader mesh__D031320smesh__D019684
% 213.38/213.56  |- skos__annotation mesh__D031320
% 213.38/213.56       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.38/213.56  |- skos__historyNote mesh__D016557 Periodontitis %28%1986-1991%29%
% 213.38/213.56  |- mesh__recordAuthorizer mesh__D016557 sjn
% 213.38/213.56  |- skos__broader mesh__D016557smesh__D010517
% 213.38/213.56  |- mesh__dateEstablished mesh__D016557 1992-01-01
% 213.38/213.56  |- rdf__type mesh__D016557sskos__Concept
% 213.38/213.56  |- skos__altLabel mesh__D016557 Regeneration, Periodontal Guided Tissue
% 213.38/213.56  |- mesh__recordMaintainer mesh__D016557 nns
% 213.38/213.56  |- mesh__historyNote mesh__D016557 2005%28%1992%29%   
% 213.38/213.56  |- mesh__recordOriginator mesh__D016557 MXR
% 213.38/213.56  |- skos__scopeNote mesh__D016557
% 213.38/213.56       Techniques for enhancing and directing cell growth to repopulate specific parts of the PERIODONTIUM that have been damaged by PERIODONTAL DISEASES; TOOTH DISEASES; or TRAUMA, or to correct TOOTH ABNORMALITIES. Repopulation and repair is achieved by guiding the progenitor cells to reproduce in the desired location by blocking contact with surrounding tissue by use of membranes composed of synthetic or natural material that may include growth inducing factors as well.%A%    
% 213.38/213.56  |- skos__historyNote mesh__D016557 Periodontal Ligament %28%1986-1991%29%
% 213.38/213.56  |- skos__altLabel mesh__D016557 Guided Periodontal Tissue Regeneration
% 213.38/213.56  |- skos__annotation mesh__D016557 note category: a periodontal technique   
% 213.38/213.56  |- mesh__dateCreated mesh__D016557 1991-01-02
% 213.38/213.56  |- skos__historyNote mesh__D016557 Periodontal Diseases %28%1986-1991%29%
% 213.38/213.56  |- skos__historyNote mesh__D016557 Periodontium %28%1987-1991%29%
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D016557 2006
% 213.38/213.56  |- skos__broader mesh__D016557smesh__D048091
% 213.38/213.56  |- skos__prefLabel mesh__D016557 Guided Tissue Regeneration, Periodontal
% 213.38/213.56  |- mesh__dateRevised mesh__D016557 2004-07-07
% 213.38/213.56  |- mesh__publicMeSHNote mesh__D016557
% 213.38/213.56       2005; see GUIDED TISSUE REGENERATION 1992-2004   
% 213.38/213.56  |- skos__historyNote mesh__D016557 Regeneration %28%1986-1991%29%
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D016557 2005
% 213.38/213.56  |- skos__altLabel mesh__D016557 Periodontal Guided Tissue Regeneration
% 213.38/213.56  |- mesh__recordAuthorizer mesh__D002537 sjn
% 213.38/213.56  |- skos__hiddenLabel mesh__D002537 Intracranial Arterioscleroses
% 213.38/213.56  |- skos__hiddenLabel mesh__D002537 Arterioscleroses, Cerebral
% 213.38/213.56  |- mesh__recordMaintainer mesh__D002537 KEV
% 213.38/213.56  |- skos__hiddenLabel mesh__D002537 Atheroscleroses, Intracranial
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D002537 2006
% 213.38/213.56  |- mesh__activeMeSHYear mesh__D002537 2002
% 213.38/213.56  |- skos__hiddenLabel mesh__D002537 Cerebral Arterioscleroses
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D002537 2005
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D002537 2001
% 213.38/213.57  |- skos__hiddenLabel mesh__D002537 Intracranial Atheroscleroses
% 213.38/213.57  |- skos__broader mesh__D002537smesh__D002539
% 213.38/213.57  |- skos__hiddenLabel mesh__D002537 Cerebral Atheroscleroses
% 213.38/213.57  |- skos__hiddenLabel mesh__D002537 Arteriosclerosis, Intracranial
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D002537 2004
% 213.38/213.57  |- skos__broader mesh__D002537smesh__D001161
% 213.38/213.57  |- rdf__type mesh__D002537sskos__Concept
% 213.38/213.57  |- skos__hiddenLabel mesh__D002537 Arterioscleroses, Intracranial
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D002537 2000
% 213.38/213.57  |- skos__hiddenLabel mesh__D002537 Atheroscleroses, Cerebral
% 213.38/213.57  |- skos__prefLabel mesh__D002537 Intracranial Arteriosclerosis
% 213.38/213.57  |- skos__hiddenLabel mesh__D002537 Arteriosclerosis, Cerebral
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D002537 2003
% 213.38/213.57  |- mesh__recordOriginator mesh__D002537 NLM
% 213.38/213.57  |- mesh__dateCreated mesh__D002537 1999-01-01
% 213.38/213.57  |- skos__scopeNote mesh__D002537
% 213.38/213.57       Vascular diseases characterized by thickening, hardening, and remodeling of the walls of intracranial arteries. There are three subtypes: %28%1%29% atherosclerosis, marked by fatty depositions in the innermost layer of the arterial walls, %28%2%29% Monckeberg%27%s sclerosis, which features calcium deposition in the media and %28%3%29% arteriolosclerosis, which refers to sclerosis of small caliber arteries. Clinically, this process may be associated with ISCHEMIC ATTACK, TRANSIENT; BRAIN INFARCTION; INTRACRANIAL EMBOLISM AND THROMBOSIS; or INTRACRANIAL ANEURYSM.%A%    
% 213.38/213.57  |- mesh__publicMeSHNote mesh__D002537
% 213.38/213.57       2000; see CEREBRAL ARTERIOSCLEROSIS 1963-1999   
% 213.38/213.57  |- mesh__dateRevised mesh__D002537 1999-11-08
% 213.38/213.57  |- mesh__historyNote mesh__D002537 2000%28%1963%29%   
% 213.38/213.57  |- skos__hiddenLabel mesh__D002537 Atherosclerosis, Intracranial
% 213.38/213.57  |- skos__hiddenLabel mesh__D002537 Atherosclerosis, Cerebral
% 213.38/213.57  |- skos__hiddenLabel mesh__D007222 Intoxication, Depth
% 213.38/213.57  |- mesh__recordAuthorizer mesh__D007222 sjn
% 213.38/213.57  |- mesh__publicMeSHNote mesh__D007222 70   
% 213.38/213.57  |- skos__annotation mesh__D007222 IM; specify gas %28%IM%29%   
% 213.38/213.57  |- skos__hiddenLabel mesh__D007222 Nitrogen Narcoses
% 213.38/213.57  |- skos__scopeNote mesh__D007222
% 213.38/213.57       Progressive mental disturbances and unconsciousness due to breathing mixtures of oxygen and inert gases %28%argon, helium, xenon, krypton, and atmospheric nitrogen%29% at high pressure.%A%    
% 213.38/213.57  |- skos__hiddenLabel mesh__D007222 Narcoses, Inert Gas
% 213.38/213.57  |- mesh__dateEstablished mesh__D007222 1970-01-01
% 213.38/213.57  |- skos__hiddenLabel mesh__D007222 Inert Gas Narcoses
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D007222 2006
% 213.38/213.57  |- skos__hiddenLabel mesh__D007222 Narcosis, Nitrogen
% 213.38/213.57  |- skos__hiddenLabel mesh__D007222 Intoxications, Depth
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D007222 2002
% 213.38/213.57  |- mesh__historyNote mesh__D007222 70%28%68%29%   
% 213.38/213.57  |- mesh__dateRevised mesh__D007222 1999-11-03
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D007222 2005
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D007222 2001
% 213.38/213.57  |- rdf__type mesh__D007222sskos__Concept
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D007222 2004
% 213.38/213.57  |- skos__historyNote mesh__D007222 specific gas %28%1966-1967%29%
% 213.38/213.57  |- mesh__recordOriginator mesh__D007222 NLM
% 213.38/213.57  |- skos__broader mesh__D007222smesh__D005739
% 213.38/213.57  |- skos__hiddenLabel mesh__D007222 Depth Intoxications
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D007222 2000
% 213.38/213.57  |- mesh__dateCreated mesh__D007222 1999-01-01
% 213.38/213.57  |- skos__hiddenLabel mesh__D007222 Narcoses, Nitrogen
% 213.38/213.57  |- mesh__recordMaintainer mesh__D007222 adp
% 213.38/213.57  |- skos__hiddenLabel mesh__D007222 Narcosis, Inert Gas
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D007222 2003
% 213.38/213.57  |- skos__broader mesh__D007222smesh__D009784
% 213.38/213.57  |- skos__prefLabel mesh__D007222 Inert Gas Narcosis
% 213.38/213.57  |- skos__broader mesh__D012965smesh__D002712
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D012965 2002
% 213.38/213.57  |- skos__altLabel mesh__D012965 Saline Solution
% 213.38/213.57  |- skos__related mesh__D012965smesh__D004039
% 213.38/213.57  |- mesh__recordOriginator mesh__D012965 NLM
% 213.38/213.57  |- mesh__dateRevised mesh__D012965 2001-07-25
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D012965 2006
% 213.38/213.57  |- skos__scopeNote mesh__D012965
% 213.38/213.57       A ubiquitous sodium salt that is commonly used to season food. It plays an important biological role in maintaining the osmotic tension of blood and tissues.%A%    
% 213.38/213.57  |- skos__annotation mesh__D012965
% 213.38/213.57       for intake of table salt use SODIUM CHLORIDE, DIETARY   
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D012965 2004
% 213.38/213.57  |- rdf__type mesh__D012965sskos__Concept
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D012965 2005
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D012965 2003
% 213.38/213.57  |- mesh__dateCreated mesh__D012965 1999-01-01
% 213.38/213.57  |- mesh__recordAuthorizer mesh__D012965 sjn
% 213.38/213.57  |- skos__broader mesh__D012965smesh__D017670
% 213.38/213.57  |- mesh__recordMaintainer mesh__D012965 jmp
% 213.38/213.57  |- skos__prefLabel mesh__D012965 Sodium Chloride
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D012167 2005
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D012167 2000
% 213.38/213.57  |- skos__hiddenLabel mesh__D012167 Perforations, Retinal
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D012167 2004
% 213.38/213.57  |- skos__hiddenLabel mesh__D012167 Holes, Macular
% 213.38/213.57  |- mesh__dateEstablished mesh__D012167 1984-01-01
% 213.38/213.57  |- skos__hiddenLabel mesh__D012167 Retinal Hole
% 213.38/213.57  |- skos__hiddenLabel mesh__D012167 Hole, Retinal
% 213.38/213.57  |- mesh__recordMaintainer mesh__D012167 TGC
% 213.38/213.57  |- mesh__publicMeSHNote mesh__D012167
% 213.38/213.57       84; RETINAL TEARS was see RETINAL DETACHMENT 1977-83   
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D012167 1999
% 213.38/213.57  |- skos__hiddenLabel mesh__D012167 Holes, Retinal
% 213.38/213.57  |- rdf__type mesh__D012167sskos__Concept
% 213.38/213.57  |- mesh__recordOriginator mesh__D012167 RC
% 213.38/213.57  |- skos__broader mesh__D012167smesh__D012164
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D012167 2003
% 213.38/213.57  |- mesh__historyNote mesh__D012167
% 213.38/213.57       84; RETINAL TEARS was see RETINAL DETACHMENT 1977-83   
% 213.38/213.57  |- skos__scopeNote mesh__D012167
% 213.38/213.57       Perforations through the whole thickness of the retina including the macula as the result of inflammation, trauma, degeneration, etc. The concept includes retinal breaks, tears, dialyses, and holes.%A%    
% 213.38/213.57  |- skos__altLabel mesh__D012167 Retinal Dialyses
% 213.38/213.57  |- skos__hiddenLabel mesh__D012167 Retinal Break
% 213.38/213.57  |- skos__hiddenLabel mesh__D012167 Retinal Tear
% 213.38/213.57  |- mesh__dateRevised mesh__D012167 1997-06-20
% 213.38/213.57  |- mesh__dateCreated mesh__D012167 1983-03-11
% 213.38/213.57  |- skos__hiddenLabel mesh__D012167 Tear, Retinal
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D012167 1998
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D012167 2002
% 213.38/213.57  |- skos__altLabel mesh__D012167 Retinal Breaks
% 213.38/213.57  |- skos__altLabel mesh__D012167 Retinal Tears
% 213.38/213.57  |- skos__hiddenLabel mesh__D012167 Perforation, Retinal
% 213.38/213.57  |- skos__hiddenLabel mesh__D012167 Hole, Macular
% 213.38/213.57  |- skos__altLabel mesh__D012167 Retinal Holes
% 213.38/213.57  |- skos__hiddenLabel mesh__D012167 Retinal Perforation
% 213.38/213.57  |- skos__historyNote mesh__D012167 Retinal Detachment %28%1966-1983%29%
% 213.38/213.57  |- skos__hiddenLabel mesh__D012167 Macular Hole
% 213.38/213.57  |- mesh__recordAuthorizer mesh__D012167 SJN
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D012167 2006
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D012167 2001
% 213.38/213.57  |- skos__hiddenLabel mesh__D012167 Breaks, Retinal
% 213.38/213.57  |- skos__hiddenLabel mesh__D012167 Break, Retinal
% 213.38/213.57  |- skos__hiddenLabel mesh__D012167 Dialyses, Retinal
% 213.38/213.57  |- skos__prefLabel mesh__D012167 Retinal Perforations
% 213.38/213.57  |- skos__hiddenLabel mesh__D012167 Tears, Retinal
% 213.38/213.57  |- mesh__onlineNote mesh__D012167
% 213.38/213.57       use RETINAL DETACHMENT to search RETINAL TEARS 1977-83   
% 213.38/213.57  |- skos__hiddenLabel mesh__D012167 Retinal Dialyse
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D006928 2004
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D006928 1993
% 213.38/213.57  |- skos__hiddenLabel mesh__D006928 Lingual Bones
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D006928 1998
% 213.38/213.57  |- skos__hiddenLabel mesh__D006928 Bone, Lingual
% 213.38/213.57  |- skos__broader mesh__D006928smesh__D001842
% 213.38/213.57  |- skos__hiddenLabel mesh__D006928 Bone, Hyoid
% 213.38/213.57  |- rdf__type mesh__D006928sskos__Concept
% 213.38/213.57  |- skos__hiddenLabel mesh__D006928 Bones, Hyoid
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D006928 1997
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D006928 2003
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D006928 1992
% 213.38/213.57  |- skos__prefLabel mesh__D006928 Hyoid Bone
% 213.38/213.57  |- mesh__recordAuthorizer mesh__D006928 PLS
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D006928 2002
% 213.38/213.57  |- mesh__recordOriginator mesh__D006928 NLM
% 213.38/213.57  |- skos__hiddenLabel mesh__D006928 Hyoid Bones
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D006928 1996
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D006928 2001
% 213.38/213.57  |- mesh__dateCreated mesh__D006928 1999-01-01
% 213.38/213.57  |- skos__hiddenLabel mesh__D006928 Bones, Lingual
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D006928 2006
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D006928 2000
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D006928 1995
% 213.38/213.57  |- mesh__recordMaintainer mesh__D006928 TGC
% 213.38/213.57  |- skos__annotation mesh__D006928
% 213.38/213.57       mylohyoid ridge or groove is indexed under MANDIBLE   
% 213.38/213.57  |- skos__altLabel mesh__D006928 Lingual Bone
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D006928 1999
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D006928 2005
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D006928 1994
% 213.38/213.57  |- mesh__dateRevised mesh__D006928 1991-01-07
% 213.38/213.57  |- skos__scopeNote mesh__D031321
% 213.38/213.57       A plant family of the order Hydrocharitales, subclass ALISMATIDAE, class Liliopsida %28%monocotyledons%29%.%A%    
% 213.38/213.57  |- mesh__dateCreated mesh__D031321 2002-07-03
% 213.38/213.57  |- mesh__recordAuthorizer mesh__D031321 sjn
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D031321 2006
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D031321 2004
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D031321 2005
% 213.38/213.57  |- mesh__dateEstablished mesh__D031321 2003-01-01
% 213.38/213.57  |- mesh__dateRevised mesh__D031321 2003-07-25
% 213.38/213.57  |- skos__broader mesh__D031321smesh__D035961
% 213.38/213.57  |- rdf__type mesh__D031321sskos__Concept
% 213.38/213.57  |- mesh__historyNote mesh__D031321 2003   
% 213.38/213.57  |- skos__prefLabel mesh__D031321 Hydrocharitaceae
% 213.38/213.57  |- mesh__publicMeSHNote mesh__D031321 2003   
% 213.38/213.57  |- mesh__recordOriginator mesh__D031321 ssb
% 213.38/213.57  |- skos__annotation mesh__D031321
% 213.38/213.57       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.38/213.57  |- mesh__recordMaintainer mesh__D031321 sjn
% 213.38/213.57  |- rdf__type mesh__D003630sskos__Concept
% 213.38/213.57  |- skos__altLabel mesh__D003630 Daunoblastine
% 213.38/213.57  |- mesh__recordOriginator mesh__D003630 NLM
% 213.38/213.57  |- mesh__recordAuthorizer mesh__D003630 sjn
% 213.38/213.57  |- skos__broader mesh__D003630smesh__D018943
% 213.38/213.57  |- skos__altLabel mesh__D003630 Rubidomycin
% 213.38/213.57  |- skos__altLabel mesh__D003630 Rubomycin
% 213.38/213.57  |- skos__hiddenLabel mesh__D003630 NSC82151
% 213.38/213.57  |- mesh__recordMaintainer mesh__D003630 exl
% 213.38/213.57  |- skos__scopeNote mesh__D003630
% 213.38/213.57       A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS.%A%    
% 213.38/213.57  |- skos__hiddenLabel mesh__D003630 Hydrochloride, Daunorubicin
% 213.38/213.57  |- skos__prefLabel mesh__D003630 Daunorubicin
% 213.38/213.57  |- mesh__publicMeSHNote mesh__D003630 80; was DAUNOMYCIN 1966-79   
% 213.38/213.57  |- mesh__historyNote mesh__D003630
% 213.38/213.57       80; was DAUNOMYCIN 1964-79 %28%Prov 1964-65%29%   
% 213.38/213.57  |- mesh__dateRevised mesh__D003630 2005-06-30
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D003630 2006
% 213.38/213.57  |- skos__hiddenLabel mesh__D003630 NSC 82151
% 213.38/213.57  |- mesh__dateEstablished mesh__D003630 1966-01-01
% 213.38/213.57  |- skos__altLabel mesh__D003630 Daunomycin
% 213.38/213.57  |- skos__hiddenLabel mesh__D003630 Dauno Rubidomycine
% 213.38/213.57  |- skos__altLabel mesh__D003630 Dauno-Rubidomycine
% 213.38/213.57  |- mesh__dateCreated mesh__D003630 1999-01-01
% 213.38/213.57  |- mesh__onlineNote mesh__D003630
% 213.38/213.57       use DAUNORUBICIN to search DAUNOMYCIN 1966-79   
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D016558 1993
% 213.38/213.57  |- skos__annotation mesh__D016558
% 213.38/213.57       do not use /util except by MeSH definition; coord IM with dis /ther %28%IM%29%, not /surg%A%  
% 213.38/213.57  |- skos__historyNote mesh__D016558 Hemostasis, Surgical %28%1985-1991%29%
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D016558 1995
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D016558 2000
% 213.38/213.57  |- skos__hiddenLabel mesh__D016558 Hemostases, Endoscopic
% 213.38/213.57  |- skos__hiddenLabel mesh__D016558 Endoscopic Hemostases
% 213.38/213.57  |- rdf__type mesh__D016558sskos__Concept
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D016558 2001
% 213.38/213.57  |- skos__broader mesh__D016558smesh__D006489
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D016558 2003
% 213.38/213.57  |- mesh__dateEstablished mesh__D016558 1992-01-01
% 213.38/213.57  |- skos__scopeNote mesh__D016558
% 213.38/213.57       Control of bleeding performed through the channel of the endoscope. Techniques include use of lasers, heater probes, bipolar electrocoagulation, and local injection. Endoscopic hemostasis is commonly used to treat bleeding esophageal and gastrointestinal varices and ulcers.%A%    
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D016558 2005
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D016558 2004
% 213.38/213.57  |- skos__prefLabel mesh__D016558 Hemostasis, Endoscopic
% 213.38/213.57  |- mesh__historyNote mesh__D016558 92   
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D016558 1996
% 213.38/213.57  |- mesh__publicMeSHNote mesh__D016558 92   
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D016558 2002
% 213.38/213.57  |- skos__historyNote mesh__D016558 Hemostatic Techniques %28%1976-1991%29%
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D016558 2006
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D016558 1998
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D016558 1997
% 213.38/213.57  |- skos__altLabel mesh__D016558 Endoscopic Hemostasis
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D016558 1992
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D016558 1994
% 213.38/213.57  |- skos__historyNote mesh__D016558
% 213.38/213.57       Gastrointestinal Hemorrhage/surgery %28%1976-1991%29%
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D016558 1999
% 213.38/213.57  |- mesh__dateCreated mesh__D016558 1991-01-25
% 213.38/213.57  |- skos__historyNote mesh__D002538
% 213.38/213.57       Arteriovenous Fistula/congenital %28%1966-1972%29%
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D002538 2005
% 213.38/213.57  |- skos__hiddenLabel mesh__D002538 Intracranial Arteriovenous Malformation
% 213.38/213.57  |- skos__hiddenLabel mesh__D002538 Arteriovenous Malformation, Cerebral
% 213.38/213.57  |- skos__altLabel mesh__D002538
% 213.38/213.57       Ruptured Intracranial Arteriovenous Malformation
% 213.38/213.57  |- skos__hiddenLabel mesh__D002538
% 213.38/213.57       Arteriovenous Malformations, Intracranial
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D002538 2004
% 213.38/213.57  |- skos__hiddenLabel mesh__D002538
% 213.38/213.57       Malformations, Intracranial Arteriovenous
% 213.38/213.57  |- mesh__recordOriginator mesh__D002538 NLM
% 213.38/213.57  |- skos__hiddenLabel mesh__D002538 Malformation, Cerebral Arteriovenous
% 213.38/213.57  |- mesh__dateEstablished mesh__D002538 1973-01-01
% 213.38/213.57  |- rdf__type mesh__D002538sskos__Concept
% 213.38/213.57  |- skos__altLabel mesh__D002538
% 213.38/213.57       AVM %28%Arteriovenous Malformation%29% Intracranial
% 213.38/213.57  |- mesh__historyNote mesh__D002538 2000%28%1973%29%   
% 213.38/213.57  |- skos__broader mesh__D002538smesh__D002561
% 213.38/213.57  |- mesh__publicMeSHNote mesh__D002538
% 213.38/213.57       2000; see CEREBRAL ARTERIOVENOUS MALFORMATIONS 1973-1999; for INTRACRANIAL ARTERIOVENOUS MALFORMATIONS see CEREBRAL ARTERIOVENOUS MALFORMATIONS 1974-1999%A%  
% 213.38/213.57  |- mesh__dateCreated mesh__D002538 1999-01-01
% 213.38/213.57  |- skos__altLabel mesh__D002538
% 213.38/213.57       Congenital Intracranial Arteriovenous Malformations
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D002538 2003
% 213.38/213.57  |- mesh__recordAuthorizer mesh__D002538 sjn
% 213.38/213.57  |- skos__hiddenLabel mesh__D002538 Arteriovenous Malformation, Intracranial
% 213.38/213.57  |- skos__broader mesh__D002538smesh__D009421
% 213.38/213.57  |- skos__altLabel mesh__D002538
% 213.38/213.57       Intracranial Arteriovenous Malformations, Congenital
% 213.38/213.57  |- skos__hiddenLabel mesh__D002538 Cerebral Arteriovenous Malformation
% 213.38/213.57  |- skos__broader mesh__D002538smesh__D020765
% 213.38/213.57  |- skos__annotation mesh__D002538
% 213.38/213.57       congen cerebral arteriovenous fistula: coord IM with ARTERIOVENOUS FISTULA/congen%28%IM%29%; DF: INTRACRANIAL AVM%A%  
% 213.38/213.57  |- skos__altLabel mesh__D002538 Cerebral Arteriovenous Malformations
% 213.38/213.57  |- skos__hiddenLabel mesh__D002538 Malformation, Intracranial Arteriovenous
% 213.38/213.57  |- skos__historyNote mesh__D002538
% 213.38/213.57       Cerebrovascular Disorders %28%1966-1972%29%
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D002538 2002
% 213.38/213.57  |- mesh__recordMaintainer mesh__D002538 KEV
% 213.38/213.57  |- skos__hiddenLabel mesh__D002538 Malformations, Cerebral Arteriovenous
% 213.38/213.57  |- skos__scopeNote mesh__D002538
% 213.38/213.57       Congenital vascular anomalies of the brain characterized by tangles of thin walled arteries which communicate directly with veins without intervening capillaries. The malformations vary greatly in size and location, and produce symptoms through rupture %28%see also INTRACRANIAL HEMORRHAGES%29%, mass effect, and vascular steal effect. Clinical presentation is often delayed until the fourth or fifth decade when affected individuals may develop headaches, seizures, and focal neurologic deficits. Large hemorrhages may result in coma or death. %28%From Adams et al., Principles of Neurology, 6th ed, p848%29%%A%    
% 213.38/213.57  |- mesh__dateRevised mesh__D002538 1999-11-03
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D002538 2006
% 213.38/213.57  |- skos__prefLabel mesh__D002538 Intracranial Arteriovenous Malformations
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D002538 2001
% 213.38/213.57  |- skos__broader mesh__D002538smesh__D001165
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D002538 2000
% 213.38/213.57  |- mesh__dateEstablished mesh__D013260 1975-09-01
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D013260 2002
% 213.38/213.57  |- rdf__type mesh__D013260sskos__Concept
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D013260 1994
% 213.38/213.57  |- mesh__recordMaintainer mesh__D013260 PLS
% 213.38/213.57  |- skos__historyNote mesh__D013260
% 213.38/213.57       specific steroid class compound %28%1968-1974%29%
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D013260 2005
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D013260 1995
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D013260 2003
% 213.38/213.57  |- mesh__dateRevised mesh__D013260 1993-06-03
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D013260 2006
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D013260 1998
% 213.38/213.57  |- skos__broader mesh__D013260smesh__D013256
% 213.38/213.57  |- skos__historyNote mesh__D013260 Steroids %28%1968-1974%29%
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D013260 2004
% 213.38/213.57  |- mesh__recordAuthorizer mesh__D013260 PLS
% 213.38/213.57  |- mesh__historyNote mesh__D013260 75   
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D013260 1996
% 213.38/213.57  |- skos__prefLabel mesh__D013260 Steroids, Heterocyclic
% 213.38/213.57  |- mesh__publicMeSHNote mesh__D013260 75   
% 213.38/213.57  |- skos__hiddenLabel mesh__D013260 Heterocyclic Steroids
% 213.38/213.57  |- mesh__dateCreated mesh__D013260 1974-11-11
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D013260 1999
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D013260 2000
% 213.38/213.57  |- mesh__recordOriginator mesh__D013260 NLM
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D013260 1997
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D013260 2001
% 213.38/213.57  |- skos__scopeNote mesh__D013260
% 213.38/213.57       Steroidal compounds in which one or more carbon atoms in the steroid ring system have been substituted with non-carbon atoms.%A%    
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D007223 2006
% 213.38/213.57  |- skos__prefLabel mesh__D007223 Infant
% 213.38/213.57  |- mesh__dateRevised mesh__D007223 2002-07-03
% 213.38/213.57  |- mesh__onlineNote mesh__D007223 pre-explosion = INFANT %28%PX%29%   
% 213.38/213.57  |- skos__annotation mesh__D007223
% 213.38/213.57       age 1-23 mo; IM as psychol %26% sociol or social entity: Manual 18.5.11, 34.9.2; NIM as check tag: 18.5.7, 18.5.8; no qualif IM; psychol of the infant = INFANT PSYCHOLOGY see CHILD PSYCHOLOGY %26% check the tag INFANT%A%  
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D007223 2005
% 213.38/213.57  |- skos__scopeNote mesh__D007223
% 213.38/213.57       A child between 1 and 23 months of age.     
% 213.38/213.57  |- mesh__recordAuthorizer mesh__D007223 sjn
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D007223 2004
% 213.38/213.57  |- skos__broader mesh__D007223smesh__D009273
% 213.38/213.57  |- rdf__type mesh__D007223sskos__Concept
% 213.38/213.57  |- mesh__dateCreated mesh__D007223 1999-01-01
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D007223 2003
% 213.38/213.57  |- mesh__recordMaintainer mesh__D007223 TGC
% 213.38/213.57  |- skos__altLabel mesh__D007223 Infants
% 213.38/213.57  |- mesh__recordOriginator mesh__D007223 NLM
% 213.38/213.57  |- skos__scopeNote mesh__D012966
% 213.38/213.57       A highly poisonous compound that is an inhibitor of many metabolic processes and is used as a test reagent for the function of chemoreceptors. It is also used in many industrial processes.%A%    
% 213.38/213.57  |- mesh__recordMaintainer mesh__D012966 ssb
% 213.38/213.57  |- mesh__dateCreated mesh__D012966 1978-03-15
% 213.38/213.57  |- mesh__historyNote mesh__D012966
% 213.38/213.57       91%28%79%29%; was see under CYANIDES 1979-90   
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D012966 2006
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D012966 2002
% 213.38/213.57  |- mesh__recordOriginator mesh__D012966 RLS
% 213.38/213.57  |- mesh__publicMeSHNote mesh__D012966 91; was see under CYANIDES 1979-90   
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D012966 2004
% 213.38/213.57  |- rdf__type mesh__D012966sskos__Concept
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D012966 2005
% 213.38/213.57  |- mesh__dateEstablished mesh__D012966 1991-01-01
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D012966 2003
% 213.38/213.57  |- skos__hiddenLabel mesh__D012966 Cyanide, Sodium
% 213.38/213.57  |- mesh__dateRevised mesh__D012966 2001-07-25
% 213.38/213.57  |- skos__historyNote mesh__D012966 Sodium %28%1966-1978%29%
% 213.38/213.57  |- skos__prefLabel mesh__D012966 Sodium Cyanide
% 213.38/213.57  |- mesh__recordAuthorizer mesh__D012966 sjn
% 213.38/213.57  |- skos__historyNote mesh__D012966 Cyanides %28%1966-1978%29%
% 213.38/213.57  |- skos__broader mesh__D012966smesh__D017670
% 213.38/213.57  |- skos__broader mesh__D012966smesh__D003486
% 213.38/213.57  |- mesh__recordMaintainer mesh__D045342 SYSTEM
% 213.38/213.57  |- skos__hiddenLabel mesh__D045342 Chlorophyll ac Proteins
% 213.38/213.57  |- skos__related mesh__D045342smesh__D045524
% 213.38/213.57  |- skos__hiddenLabel mesh__D045342
% 213.38/213.57       Light Harvesting Bacteriochlorophyll Protein Complexes
% 213.38/213.57  |- skos__hiddenLabel mesh__D045342 Bacterial Antenna Polypeptide
% 213.38/213.57  |- skos__broader mesh__D045342smesh__D046912
% 213.38/213.57  |- mesh__dateEstablished mesh__D045342 2004-01-01
% 213.38/213.57  |- mesh__dateRevised mesh__D045342 2005-06-30
% 213.38/213.57  |- skos__scopeNote mesh__D045342
% 213.38/213.57       Complexes containing CHLOROPHYLL and other photosensitive molecules. They serve to capture energy in the form of PHOTONS are generally found as components of the PHOTOSYSTEM I PROTEIN COMPLEX or  the PHOTOSYSTEM II PROTEIN COMPLEX.%A%    
% 213.38/213.57  |- skos__hiddenLabel mesh__D045342 Protein Complexes, Light-Harvesting
% 213.38/213.57  |- mesh__publicMeSHNote mesh__D045342
% 213.38/213.57       2004; ANTENNA POLYPEPTIDE, BACTERIAL was indexed under BACTERIAL PROTEINS %26% PHOTOSYNTHETIC REACTION CENTER, BACTERIAL 1992-2003; for CHLOROPHYLL AB-PROTEINS; CHLOROPHYL A-PROTEINS; CHLOROPHYLL AC-PROTEINS %26% LIGHT-HARVESTING CHLOROPHYLL PROTEIN see PHOTOSYNTHETIC REACTION CENTER, PLANT 1991-2003; PHYCOBILIPROTEINS was indexed under PROTEINS 1978-2003%A%  
% 213.38/213.57  |- skos__hiddenLabel mesh__D045342 Chlorophyll Protein, Light-Harvesting
% 213.38/213.57  |- mesh__recordAuthorizer mesh__D045342 sjn
% 213.38/213.57  |- mesh__recordOriginator mesh__D045342 jmp
% 213.38/213.57  |- mesh__historyNote mesh__D045342
% 213.38/213.57       2004; for ANTENNA POLYPEPTIDE, BACTERIAL use LIGHT-HARVESTING PROTEIN COMPLEXES %28%NM%29% 1992-2003; for CHLOROPHYLL AB-PROTEINS; CHLOROPHYL A-PROTEINS; CHLOROPHYLL AC-PROTEINS %26% LIGHT-HARVESTING CHLOROPHYLL PROTEIN use PHOTOSYNTHETIC REACTION CENTER COMPLEX PROTEINS 1991-2003; for PHYCOBILIPROTEINS use LIGHT-HARVESTING PROTEIN COMPLEXES %28%NM%29% 1980-2003 %26% PROTEINS 1978-1979%A%  
% 213.38/213.57  |- skos__historyNote mesh__D045342 Chlorophyll %28%1976-2003%29%
% 213.38/213.57  |- skos__hiddenLabel mesh__D045342 Chlorophyll ab Proteins
% 213.38/213.57  |- skos__hiddenLabel mesh__D045342 Complexes, Light-Harvesting Protein
% 213.38/213.57  |- skos__broader mesh__D045342smesh__D002352
% 213.38/213.57  |- skos__hiddenLabel mesh__D045342 Light Harvesting Protein Complexes
% 213.38/213.57  |- mesh__dateCreated mesh__D045342 2003-07-09
% 213.38/213.57  |- skos__prefLabel mesh__D045342 Light-Harvesting Protein Complexes
% 213.38/213.57  |- skos__altLabel mesh__D045342 Chlorophyll Protein Complexes
% 213.38/213.57  |- rdf__type mesh__D045342sskos__Concept
% 213.38/213.57  |- skos__hiddenLabel mesh__D045342 Chlorophyll a Proteins
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D045342 2006
% 213.38/213.57  |- skos__broader mesh__D045342smesh__D045322
% 213.38/213.57  |- skos__historyNote mesh__D045342
% 213.38/213.57       Photosynthetic Reaction Center Complex Proteins %28%1983-2003%29%
% 213.38/213.57  |- skos__hiddenLabel mesh__D045342 Light Harvesting Chlorophyll Protein
% 213.38/213.57  |- skos__altLabel mesh__D012168 Visual Pigments
% 213.38/213.57  |- skos__prefLabel mesh__D012168 Retinal Pigments
% 213.38/213.57  |- mesh__recordAuthorizer mesh__D012168 sjn
% 213.38/213.57  |- skos__hiddenLabel mesh__D012168 Pigments, Visual
% 213.38/213.57  |- mesh__dateCreated mesh__D012168 1999-01-01
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D012168 2006
% 213.38/213.57  |- skos__hiddenLabel mesh__D012168 Pigments, Retinal
% 213.38/213.57  |- rdf__type mesh__D012168sskos__Concept
% 213.38/213.57  |- skos__scopeNote mesh__D012168
% 213.38/213.57       Chemicals functioning in the visual cycle in retinal rod cells. Through excitation by visible light, a series of complex molecular changes occur that serve to trigger in the optical nerve endings an impulse transmitted to the brain, resulting in the perception of vision.%A%    
% 213.38/213.57  |- mesh__recordMaintainer mesh__D012168 ssb
% 213.38/213.57  |- skos__broader mesh__D012168smesh__D010860
% 213.38/213.57  |- mesh__dateRevised mesh__D012168 2005-06-30
% 213.38/213.57  |- mesh__recordOriginator mesh__D012168 NLM
% 213.38/213.57  |- skos__annotation mesh__D012168
% 213.38/213.57       not for deposition of pigments in the retina %28%= RETINITIS PIGMENTOSA%29%%A%  
% 213.38/213.57  |- skos__scopeNote mesh__D006929
% 213.38/213.57       A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.%A%    
% 213.38/213.57  |- skos__altLabel mesh__D006929 Primary Hyperaldosteronism
% 213.38/213.57  |- skos__annotation mesh__D006929
% 213.38/213.57       do not confuse with HYPOALDOSTERONISM; do not confuse X ref CONN SYNDROME with CONN DISEASE see ADRENOCORTICAL ADENOMA%A%  
% 213.38/213.57  |- mesh__dateRevised mesh__D006929 2004-07-07
% 213.38/213.57  |- skos__hiddenLabel mesh__D006929 Hyperaldosteronism, Primary
% 213.38/213.57  |- mesh__dateCreated mesh__D006929 1999-01-01
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D006929 2006
% 213.38/213.57  |- mesh__recordOriginator mesh__D006929 NLM
% 213.38/213.57  |- skos__altLabel mesh__D006929 Aldosteronism
% 213.38/213.57  |- skos__hiddenLabel mesh__D006929 Syndrome, Conn
% 213.38/213.57  |- mesh__recordAuthorizer mesh__D006929 sjn
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D006929 2005
% 213.38/213.57  |- skos__prefLabel mesh__D006929 Hyperaldosteronism
% 213.38/213.57  |- skos__broader mesh__D006929smesh__D000308
% 213.38/213.57  |- rdf__type mesh__D006929sskos__Concept
% 213.38/213.57  |- mesh__recordMaintainer mesh__D006929 lkt
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D031322 2006
% 213.38/213.57  |- skos__prefLabel mesh__D031322 Eriodictyon
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D031322 2004
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D031322 2005
% 213.38/213.57  |- mesh__dateCreated mesh__D031322 2002-07-03
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D031322 2003
% 213.38/213.57  |- skos__altLabel mesh__D031322 Yerba Santa
% 213.38/213.57  |- rdf__type mesh__D031322sskos__Concept
% 213.38/213.57  |- mesh__publicMeSHNote mesh__D031322 2003   
% 213.38/213.57  |- mesh__dateEstablished mesh__D031322 2003-01-01
% 213.38/213.57  |- skos__annotation mesh__D031322
% 213.38/213.57       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.38/213.57  |- skos__broader mesh__D031322smesh__D029522
% 213.38/213.57  |- skos__scopeNote mesh__D031322
% 213.38/213.57       A plant genus of the family HYDROPHYLLACEAE that has a characteristic strong smell.%A%    
% 213.38/213.57  |- mesh__historyNote mesh__D031322 2003   
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D003631 2004
% 213.38/213.57  |- mesh__activeMeSHYear mesh__D003631 2002
% 213.38/213.57  |- skos__historyNote mesh__D003631 Halfway Houses %28%1966-1967%29%
% 213.38/213.57  |- mesh__dateRevised mesh__D003631 1997-06-20
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D003631 1998
% 213.38/213.58  |- skos__scopeNote mesh__D003631
% 213.38/213.58       Institutional health care of patients during the day. The patients return home at night.%A%    
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D003631 2003
% 213.38/213.58  |- mesh__recordOriginator mesh__D003631 NLM
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D003631 2006
% 213.38/213.58  |- skos__hiddenLabel mesh__D003631 Care, Day
% 213.38/213.58  |- mesh__historyNote mesh__D003631 68   
% 213.38/213.58  |- skos__prefLabel mesh__D003631 Day Care
% 213.38/213.58  |- skos__broader mesh__D003631smesh__D005791
% 213.38/213.58  |- skos__annotation mesh__D003631
% 213.38/213.58       care to patients hospitalized only during day-time hours; for children in day-care schools use CHILD DAY CARE CENTERS or SCHOOLS, NURSERY%A%  
% 213.38/213.58  |- mesh__recordMaintainer mesh__D003631 PXP
% 213.38/213.58  |- skos__hiddenLabel mesh__D003631 Partial Hospitalization
% 213.38/213.58  |- skos__hiddenLabel mesh__D003631 Hospitalizations, Partial
% 213.38/213.58  |- mesh__publicMeSHNote mesh__D003631 68   
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D003631 2001
% 213.38/213.58  |- skos__hiddenLabel mesh__D003631 Partial Hospitalizations
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D003631 2005
% 213.38/213.58  |- mesh__dateEstablished mesh__D003631 1968-01-01
% 213.38/213.58  |- skos__altLabel mesh__D003631 Hospitalization, Partial
% 213.38/213.58  |- mesh__dateCreated mesh__D003631 1999-01-01
% 213.38/213.58  |- skos__historyNote mesh__D003631
% 213.38/213.58       Outpatient Clinics, Hospital %28%1966-1967%29%
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D003631 2000
% 213.38/213.58  |- rdf__type mesh__D003631sskos__Concept
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D003631 1999
% 213.38/213.58  |- mesh__recordAuthorizer mesh__D003631 SJN
% 213.38/213.58  |- skos__broader mesh__D017895Q000506smesh__D017895
% 213.38/213.58  |- mesh__preferredCombination mesh__D017895Q000506smesh__D020149
% 213.38/213.58  |- rdf__type mesh__D017895Q000506smesh__CompoundConcept
% 213.38/213.58  |- skos__altLabel mesh__D016559 FK506
% 213.38/213.58  |- skos__altLabel mesh__D016559 Prograft
% 213.38/213.58  |- mesh__onlineNote mesh__D016559
% 213.38/213.58       use TACROLIMUS %28%NM%29% to search FK-506 1987-91   
% 213.38/213.58  |- skos__hiddenLabel mesh__D016559 Tacrolimus, Anhydrous
% 213.38/213.58  |- rdf__type mesh__D016559sskos__Concept
% 213.38/213.58  |- mesh__historyNote mesh__D016559
% 213.38/213.58       96; was FK-506 1992-95, was FK 506 %28%NM%29% 1987-91   
% 213.38/213.58  |- skos__hiddenLabel mesh__D016559 FR900506
% 213.38/213.58  |- skos__broader mesh__D016559smesh__D018942
% 213.38/213.58  |- skos__altLabel mesh__D016559 Fujisawa Brand of Tacrolimus
% 213.38/213.58  |- mesh__dateCreated mesh__D016559 1991-04-24
% 213.38/213.58  |- mesh__recordAuthorizer mesh__D016559 sjn
% 213.38/213.58  |- skos__altLabel mesh__D016559 Janssen Brand of Tacrolimus
% 213.38/213.58  |- mesh__recordMaintainer mesh__D016559 CCR
% 213.38/213.58  |- mesh__dateEstablished mesh__D016559 1992-01-01
% 213.38/213.58  |- skos__historyNote mesh__D016559 Antibiotics, Macrolide %28%1987-1991%29%
% 213.38/213.58  |- skos__historyNote mesh__D016559
% 213.38/213.58       Immunosuppressive Agents %28%1987-1991%29%
% 213.38/213.58  |- mesh__dateRevised mesh__D016559 2005-06-30
% 213.38/213.58  |- skos__altLabel mesh__D016559 Cilag Brand of Tacrolimus
% 213.38/213.58  |- mesh__recordOriginator mesh__D016559 PXP
% 213.38/213.58  |- skos__hiddenLabel mesh__D016559 FR 900506
% 213.38/213.58  |- mesh__publicMeSHNote mesh__D016559
% 213.38/213.58       96; was FK-506 1992-95; FK-506 was indexed under ANTIBIOTICS, MACROLIDE 1989-91 %26% PYRIDINES 1987-89%A%  
% 213.38/213.58  |- skos__prefLabel mesh__D016559 Tacrolimus
% 213.38/213.58  |- skos__hiddenLabel mesh__D016559 FK 506
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D016559 2006
% 213.38/213.58  |- skos__scopeNote mesh__D016559
% 213.38/213.58       A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro.%A%    
% 213.38/213.58  |- rdf__type mesh__D002539sskos__Concept
% 213.38/213.58  |- skos__broader mesh__D002539smesh__D002561
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D002539 2001
% 213.38/213.58  |- mesh__dateCreated mesh__D002539 1999-01-01
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D002539 2003
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D002539 2000
% 213.38/213.58  |- mesh__historyNote mesh__D002539 2000%28%1963%29%   
% 213.38/213.58  |- mesh__recordOriginator mesh__D002539 NLM
% 213.38/213.58  |- skos__hiddenLabel mesh__D002539 Artery Diseases, Cerebral
% 213.38/213.58  |- skos__hiddenLabel mesh__D002539 Disease, Cerebral Artery
% 213.38/213.58  |- mesh__publicMeSHNote mesh__D002539
% 213.38/213.58       2000; see CEREBRAL ARTERY DISEASES 1963-1999   
% 213.38/213.58  |- skos__hiddenLabel mesh__D002539 Disease, Cerebral Arterial
% 213.38/213.58  |- mesh__recordMaintainer mesh__D002539 KEV
% 213.38/213.58  |- skos__hiddenLabel mesh__D002539 Cerebral Arterial Disease
% 213.38/213.58  |- mesh__recordAuthorizer mesh__D002539 sjn
% 213.38/213.58  |- skos__hiddenLabel mesh__D002539 Arterial Disease, Cerebral
% 213.38/213.58  |- skos__altLabel mesh__D002539 Cerebral Artery Diseases
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D002539 2006
% 213.38/213.58  |- skos__scopeNote mesh__D002539
% 213.38/213.58       Diseases of intracranial arteries which supply the cerebrum of the brain, including the ANTERIOR CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY; and POSTERIOR CEREBRAL ARTERY. Included in this category are atherosclerotic, congenital, traumatic, infectious, inflammatory, and other conditions.%A%    
% 213.38/213.58  |- skos__hiddenLabel mesh__D002539 Artery Disease, Cerebral
% 213.38/213.58  |- skos__hiddenLabel mesh__D002539 Diseases, Cerebral Artery
% 213.38/213.58  |- skos__annotation mesh__D002539
% 213.38/213.58       coord IM with specific artery %28%IM%29%; see note under CEREBRAL ARTERIES for scope of %22%cerebral arteries%22%%A%  
% 213.38/213.58  |- skos__broader mesh__D002539smesh__D020765
% 213.38/213.58  |- skos__prefLabel mesh__D002539 Cerebral Arterial Diseases
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D002539 2005
% 213.38/213.58  |- skos__altLabel mesh__D002539 Arterial Diseases, Cerebral
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D002539 2002
% 213.38/213.58  |- skos__hiddenLabel mesh__D002539 Diseases, Cerebral Arterial
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D002539 2004
% 213.38/213.58  |- skos__hiddenLabel mesh__D002539 Cerebral Artery Disease
% 213.38/213.58  |- mesh__dateRevised mesh__D002539 1999-11-03
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D013261 2006
% 213.38/213.58  |- mesh__recordOriginator mesh__D013261 NLM
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D013261 2004
% 213.38/213.58  |- skos__broader mesh__D013261smesh__D008055
% 213.38/213.58  |- mesh__dateRevised mesh__D013261 2003-07-09
% 213.38/213.58  |- skos__scopeNote mesh__D013261
% 213.38/213.58       Steroids with a hydroxyl group at C-3 and most of the skeleton of cholestane. Additional carbon atoms may be present in the side chain. %28%IUPAC Steroid Nomenclature, 1987%29%%A%    
% 213.38/213.58  |- skos__prefLabel mesh__D013261 Sterols
% 213.38/213.58  |- rdf__type mesh__D013261sskos__Concept
% 213.38/213.58  |- mesh__recordAuthorizer mesh__D013261 sjn
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D013261 2005
% 213.38/213.58  |- mesh__recordMaintainer mesh__D013261 ssb
% 213.38/213.58  |- mesh__dateCreated mesh__D013261 1999-01-01
% 213.38/213.58  |- skos__broader mesh__D013261smesh__D002776
% 213.38/213.58  |- skos__broader mesh__D013261smesh__D008563
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D007224 2006
% 213.38/213.58  |- skos__related mesh__D007224smesh__D015931
% 213.38/213.58  |- mesh__recordAuthorizer mesh__D007224 ags
% 213.38/213.58  |- skos__altLabel mesh__D007224 Kangaroo Mother Care
% 213.38/213.58  |- mesh__dateCreated mesh__D007224 1999-01-01
% 213.38/213.58  |- mesh__historyNote mesh__D007224 DIAPERS was see INFANT CARE 1989-91   
% 213.38/213.58  |- mesh__dateRevised mesh__D007224 2005-10-11
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D007224 2006A
% 213.38/213.58  |- skos__scopeNote mesh__D007224
% 213.38/213.58       Care of infants in the home or institution.     
% 213.38/213.58  |- mesh__recordOriginator mesh__D007224 NLM
% 213.38/213.58  |- skos__annotation mesh__D007224
% 213.38/213.58       humans only; check the tags HUMAN and INFANT or INFANT, NEWBORN%A%  
% 213.38/213.58  |- mesh__onlineNote mesh__D007224
% 213.38/213.58       use INFANT CARE to search DIAPERS 1989-91   
% 213.38/213.58  |- skos__broader mesh__D007224smesh__D002654
% 213.38/213.58  |- skos__related mesh__D007224smesh__D007186
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D007224 2004
% 213.38/213.58  |- rdf__type mesh__D007224sskos__Concept
% 213.38/213.58  |- skos__prefLabel mesh__D007224 Infant Care
% 213.38/213.58  |- skos__altLabel mesh__D007224 Kangaroo-Mother Care
% 213.38/213.58  |- mesh__recordMaintainer mesh__D007224 ags
% 213.38/213.58  |- skos__related mesh__D007224smesh__D001522
% 213.38/213.58  |- skos__hiddenLabel mesh__D007224 Kangaroo Mother Care Method
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D007224 2005
% 213.38/213.58  |- mesh__publicMeSHNote mesh__D007224
% 213.38/213.58       DIAPERS was see INFANT CARE 1989-91   
% 213.38/213.58  |- skos__related mesh__D007224smesh__D002654
% 213.38/213.58  |- skos__altLabel mesh__D051380 Grb3-3 Adaptor Protein
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D051380 2006
% 213.38/213.58  |- mesh__recordAuthorizer mesh__D051380 ags
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D051380 2006A
% 213.38/213.58  |- mesh__dateEstablished mesh__D051380 2006-01-01
% 213.38/213.58  |- skos__prefLabel mesh__D051380 GRB2 Adaptor Protein
% 213.38/213.58  |- mesh__publicMeSHNote mesh__D051380
% 213.38/213.58       2006; GROWTH FACTOR RECEPTOR-BOUND PROTEIN-2 was indexed under ADAPTOR PROTEINS, SIGNAL TRANSDUCING 2005, %26% under PROTEINS 1992-2004%A%  
% 213.38/213.58  |- mesh__dateCreated mesh__D051380 2005-06-30
% 213.38/213.58  |- skos__altLabel mesh__D051380 Growth Factor Receptor-Bound Protein-2
% 213.38/213.58  |- skos__scopeNote mesh__D051380
% 213.38/213.58       A signal transducing adaptor protein that links extracellular signals to the MAP KINASE SIGNALING SYSTEM. Grb2 associates with activated EPIDERMAL GROWTH FACTOR RECEPTOR and PLATELET-DERIVED GROWTH FACTOR RECEPTORS via its SH2 DOMAIN. It also binds to and translocates the SON OF SEVENLESS PROTEINS through its SH3 DOMAINS to activate PROTO-ONCOGENE PROTEIN P21%28%RAS%29%.%A%    
% 213.38/213.58  |- mesh__recordMaintainer mesh__D051380 ags
% 213.38/213.58  |- mesh__recordOriginator mesh__D051380 DRC
% 213.38/213.58  |- mesh__dateRevised mesh__D051380 2005-07-13
% 213.38/213.58  |- rdf__type mesh__D051380sskos__Concept
% 213.38/213.58  |- skos__broader mesh__D051380smesh__D048868
% 213.38/213.58  |- skos__hiddenLabel mesh__D051380 Growth Factor Receptor Bound Protein 2
% 213.38/213.58  |- mesh__historyNote mesh__D051380 2006%28%1992%29%   
% 213.38/213.58  |- skos__hiddenLabel mesh__D051380 GRB2 Adaptor Protein, Grb3 3 Isoform
% 213.38/213.58  |- skos__altLabel mesh__D051380 Abundant Src Homology Protein
% 213.38/213.58  |- skos__hiddenLabel mesh__D012967 Sulfate, Sodium Lauryl
% 213.38/213.58  |- mesh__recordMaintainer mesh__D012967 ssb
% 213.38/213.58  |- mesh__dateCreated mesh__D012967 1999-01-01
% 213.38/213.58  |- skos__annotation mesh__D012967 D25-26 qualif   
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D012967 2006
% 213.38/213.58  |- rdf__type mesh__D012967sskos__Concept
% 213.38/213.58  |- skos__broader mesh__D012967smesh__D000476
% 213.38/213.58  |- mesh__recordAuthorizer mesh__D012967 sjn
% 213.38/213.58  |- skos__broader mesh__D012967smesh__D007851
% 213.38/213.58  |- skos__hiddenLabel mesh__D012967 Dodecyl Sulfate, Sodium
% 213.38/213.58  |- mesh__dateRevised mesh__D012967 2005-06-30
% 213.38/213.58  |- mesh__publicMeSHNote mesh__D012967 74   
% 213.38/213.58  |- skos__hiddenLabel mesh__D012967 Sulfate, Sodium Dodecyl
% 213.38/213.58  |- skos__hiddenLabel mesh__D012967 Lauryl Sulfate, Sodium
% 213.38/213.58  |- mesh__dateEstablished mesh__D012967 1974-01-01
% 213.38/213.58  |- mesh__historyNote mesh__D012967 74%28%72%29%   
% 213.38/213.58  |- skos__historyNote mesh__D012967 Surface-Active Agents %28%1966-1971%29%
% 213.38/213.58  |- skos__altLabel mesh__D012967 Sodium Lauryl Sulfate
% 213.38/213.58  |- mesh__recordOriginator mesh__D012967 NLM
% 213.38/213.58  |- skos__prefLabel mesh__D012967 Sodium Dodecyl Sulfate
% 213.38/213.58  |- skos__scopeNote mesh__D012967
% 213.38/213.58       An anionic surfactant, usually a mixture of sodium alkyl sulfates, mainly the lauryl; lowers surface tension of aqueous solutions; used as fat emulsifier, wetting agent, detergent in cosmetics, pharmaceuticals and toothpastes; also as research tool in protein biochemistry.%A%    
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D012169 2005
% 213.38/213.58  |- mesh__recordAuthorizer mesh__D012169 SJN
% 213.38/213.58  |- skos__annotation mesh__D012169
% 213.38/213.58       retinal vein dis: coord IM with RETINAL DISEASES %28%IM%29%, not VASCULAR DISEASES%A%  
% 213.38/213.58  |- skos__prefLabel mesh__D012169 Retinal Vein
% 213.38/213.58  |- skos__hiddenLabel mesh__D012169 Vein, Central Retinal
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D012169 2004
% 213.38/213.58  |- skos__altLabel mesh__D012169 Central Retinal Vein
% 213.38/213.58  |- mesh__recordOriginator mesh__D012169 NLM
% 213.38/213.58  |- mesh__dateCreated mesh__D012169 1999-01-01
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D012169 2006
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D012169 2000
% 213.38/213.58  |- skos__broader mesh__D012169smesh__D012171
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D012169 1999
% 213.38/213.58  |- skos__hiddenLabel mesh__D012169 Retinal Veins
% 213.38/213.58  |- skos__broader mesh__D012169smesh__D014680
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D012169 2001
% 213.38/213.58  |- skos__hiddenLabel mesh__D012169 Veins, Retinal
% 213.38/213.58  |- skos__hiddenLabel mesh__D012169 Veins, Central Retinal
% 213.38/213.58  |- rdf__type mesh__D012169sskos__Concept
% 213.38/213.58  |- mesh__publicMeSHNote mesh__D012169 73   
% 213.38/213.58  |- skos__scopeNote mesh__D012169
% 213.38/213.58       Central retinal vein and its tributaries. It runs a short course within the optic nerve and then leaves and empties into the superior ophthalmic vein or cavernous sinus.%A%    
% 213.38/213.58  |- mesh__recordMaintainer mesh__D012169 MSR
% 213.38/213.58  |- skos__hiddenLabel mesh__D012169 Retinal Veins, Central
% 213.38/213.58  |- mesh__dateRevised mesh__D012169 1998-06-11
% 213.38/213.58  |- mesh__dateEstablished mesh__D012169 1973-01-01
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D012169 2002
% 213.38/213.58  |- mesh__historyNote mesh__D012169 73   
% 213.38/213.58  |- skos__hiddenLabel mesh__D012169 Vein, Retinal
% 213.38/213.58  |- skos__hiddenLabel mesh__D012169 Central Retinal Veins
% 213.38/213.58  |- skos__hiddenLabel mesh__D012169 Retinal Vein, Central
% 213.38/213.58  |- skos__historyNote mesh__D012169 Retinal Vessels %28%1966-1972%29%
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D012169 2003
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D031323 2003
% 213.38/213.58  |- skos__prefLabel mesh__D031323 Iris Plant
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D031323 2006
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D031323 2004
% 213.38/213.58  |- skos__scopeNote mesh__D031323
% 213.38/213.58       A plant genus of the family IRIDACEAE that contains IRIP, a type-1 ribosome-inactivating protein, and iridals %28%TRITERPENES%29%.%A%    
% 213.38/213.58  |- skos__broader mesh__D031323smesh__D027621
% 213.38/213.58  |- mesh__historyNote mesh__D031323 2003   
% 213.38/213.58  |- rdf__type mesh__D031323sskos__Concept
% 213.38/213.58  |- mesh__publicMeSHNote mesh__D031323 2003   
% 213.38/213.58  |- skos__annotation mesh__D031323
% 213.38/213.58       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.38/213.58  |- mesh__dateCreated mesh__D031323 2002-07-03
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D031323 2005
% 213.38/213.58  |- mesh__dateEstablished mesh__D031323 2003-01-01
% 213.38/213.58  |- mesh__publicMeSHNote mesh__D003632 2005; see DDD 1965-2004   
% 213.38/213.58  |- skos__altLabel mesh__D003632 TDE
% 213.38/213.58  |- mesh__historyNote mesh__D003632 2005%28%1965%29%   
% 213.38/213.58  |- skos__scopeNote mesh__D003632
% 213.38/213.58       An organochlorine insecticide that is slightly irritating to the skin. %28%From Merck Index, 11th ed, p482%29%%A%    
% 213.38/213.58  |- mesh__dateEstablished mesh__D003632 1968-01-01
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D003632 2005
% 213.38/213.58  |- mesh__recordMaintainer mesh__D003632 ssb
% 213.38/213.58  |- mesh__dateCreated mesh__D003632 1999-01-01
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D003632 2006
% 213.38/213.58  |- skos__prefLabel mesh__D003632 Dichlorodiphenyldichloroethane
% 213.38/213.58  |- mesh__recordOriginator mesh__D003632 NLM
% 213.38/213.58  |- mesh__recordAuthorizer mesh__D003632 sjn
% 213.38/213.58  |- skos__annotation mesh__D003632
% 213.38/213.58       do not confuse with o,p-DDD; for use as an insecticide, see note at INSECTICIDES%A%  
% 213.38/213.58  |- mesh__dateRevised mesh__D003632 2004-07-07
% 213.38/213.58  |- skos__broader mesh__D003632smesh__D006843
% 213.38/213.58  |- rdf__type mesh__D003632sskos__Concept
% 213.38/213.58  |- skos__altLabel mesh__D003632 DDD
% 213.38/213.58  |- mesh__dateRevised mesh__D027282 2005-07-08
% 213.38/213.58  |- skos__historyNote mesh__D027282 Carrier Proteins %28%1996-2001%29%
% 213.38/213.58  |- mesh__dateCreated mesh__D027282 2001-07-25
% 213.38/213.58  |- skos__scopeNote mesh__D027282
% 213.38/213.58       A transmembrane glycoprotein subunit that can dimerize with a variety of light chain subunits %28%ANTIGENS, CD98 LIGHT CHAINS%29%. This protein subunit serves a diverse array of functions including amino acid transport and cell fusion. Its function is altered depending which of the light chain subunits it interacts with.%A%    
% 213.38/213.58  |- skos__hiddenLabel mesh__D027282 FRP 1 Heavy Chain
% 213.38/213.58  |- mesh__publicMeSHNote mesh__D027282
% 213.38/213.58       2002; 4F2 ANTIGEN, HEAVY CHAIN was indexed under CARRIER PROTEINS %26% ANTIGENS, CD 1996-2001%A%  
% 213.38/213.58  |- skos__historyNote mesh__D027282 Antigens, CD %28%1996-2001%29%
% 213.38/213.58  |- skos__altLabel mesh__D027282 4F2 Heavy Chain
% 213.38/213.58  |- skos__altLabel mesh__D027282 4F2 Antigen, Heavy Chain
% 213.38/213.58  |- mesh__recordMaintainer mesh__D027282 ags
% 213.38/213.58  |- skos__prefLabel mesh__D027282 Antigens, CD98 Heavy Chain
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D027282 2006
% 213.38/213.58  |- mesh__dateEstablished mesh__D027282 2002-01-01
% 213.38/213.58  |- skos__altLabel mesh__D027282 Fusion Regulatory Protein 1, Heavy Chain
% 213.38/213.58  |- rdf__type mesh__D027282sskos__Concept
% 213.38/213.58  |- mesh__historyNote mesh__D027282
% 213.38/213.58       2002; for 4F2 ANTIGEN, HEAVY CHAIN use ANTIGENS, CD98 %28%NM%29% 1996-2001%A%  
% 213.38/213.58  |- mesh__recordOriginator mesh__D027282 jmp
% 213.38/213.58  |- skos__altLabel mesh__D027282 CD98 Antigen Heavy Chain
% 213.38/213.58  |- skos__altLabel mesh__D027282 FRP-1 Heavy Chain
% 213.38/213.58  |- skos__altLabel mesh__D027282 CD98 Antigens Heavy Chain
% 213.38/213.58  |- skos__altLabel mesh__D027282 4F2HC Subunit
% 213.38/213.58  |- mesh__recordAuthorizer mesh__D027282 ags
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D027282 2006A
% 213.38/213.58  |- skos__broader mesh__D027282smesh__D027261
% 213.38/213.58  |- skos__altLabel mesh__D027282 Antigen 4F2, Heavy Chain
% 213.38/213.58  |- skos__annotation mesh__D013262
% 213.38/213.58       a sometimes fatal form of erythema multiforme   
% 213.38/213.58  |- mesh__recordMaintainer mesh__D013262 lkt
% 213.38/213.58  |- mesh__recordOriginator mesh__D013262 NLM
% 213.38/213.58  |- skos__broader mesh__D013262smesh__D013280
% 213.38/213.58  |- mesh__dateRevised mesh__D013262 2005-06-30
% 213.38/213.58  |- skos__prefLabel mesh__D013262 Stevens-Johnson Syndrome
% 213.38/213.58  |- skos__scopeNote mesh__D013262
% 213.38/213.58       A variant of bullous erythema multiforme. It ranges from mild skin and mucous membrane lesions to a severe, sometimes fatal systemic disorder. Ocular symptoms include ulcerative conjunctivitis, keratitis, iritis, uveitis, and sometimes blindness. The cause of the disease is unknown.%A%    
% 213.38/213.58  |- rdf__type mesh__D013262sskos__Concept
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D013262 2006
% 213.38/213.58  |- mesh__dateCreated mesh__D013262 1999-01-01
% 213.38/213.58  |- skos__hiddenLabel mesh__D013262 Stevens Johnson Syndrome
% 213.38/213.58  |- skos__broader mesh__D013262smesh__D004892
% 213.38/213.58  |- mesh__recordAuthorizer mesh__D013262 sjn
% 213.38/213.58  |- skos__historyNote mesh__D007225 Food %28%1966-1969%29%
% 213.38/213.58  |- mesh__publicMeSHNote mesh__D007225 73   
% 213.38/213.58  |- mesh__dateEstablished mesh__D007225 1973-01-01
% 213.38/213.58  |- mesh__dateRevised mesh__D007225 2003-07-09
% 213.38/213.58  |- rdf__type mesh__D007225sskos__Concept
% 213.38/213.58  |- skos__hiddenLabel mesh__D007225 Infant Foods
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D007225 2004
% 213.38/213.58  |- mesh__recordOriginator mesh__D007225 NLM
% 213.38/213.58  |- skos__altLabel mesh__D007225 Food, Infant
% 213.38/213.58  |- mesh__historyNote mesh__D007225
% 213.38/213.58       73; was INFANT FOODS 1970-72 %28%Prov%29%   
% 213.38/213.58  |- skos__scopeNote mesh__D007225
% 213.38/213.58       Food processed and manufactured for the nutritional health of children in their first year of life.%A%    
% 213.38/213.58  |- skos__historyNote mesh__D007225 Infant Nutrition %28%1966-1969%29%
% 213.38/213.58  |- skos__prefLabel mesh__D007225 Infant Food
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D007225 2005
% 213.38/213.58  |- skos__related mesh__D007225smesh__D041943
% 213.38/213.58  |- skos__hiddenLabel mesh__D007225 Foods, Infant
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D007225 2006
% 213.38/213.58  |- skos__broader mesh__D007225smesh__D019648
% 213.38/213.58  |- mesh__onlineNote mesh__D007225
% 213.38/213.58       use INFANT FOOD to search INFANT FOODS 1970-72 %28%as Prov%29%   
% 213.38/213.58  |- mesh__recordAuthorizer mesh__D007225 sjn
% 213.38/213.58  |- mesh__recordMaintainer mesh__D007225 ssb
% 213.38/213.58  |- mesh__dateCreated mesh__D007225 1999-01-01
% 213.38/213.58  |- mesh__publicMeSHNote mesh__D051381 2006   
% 213.38/213.58  |- mesh__recordOriginator mesh__D051381 ags
% 213.38/213.58  |- skos__altLabel mesh__D051381 Rattus
% 213.38/213.58  |- skos__broader mesh__D051381smesh__D051189
% 213.38/213.58  |- skos__prefLabel mesh__D051381 Rats
% 213.38/213.58  |- skos__hiddenLabel mesh__D051381 Laboratory Rat
% 213.38/213.58  |- mesh__dateEstablished mesh__D051381 2006-01-01
% 213.38/213.58  |- skos__annotation mesh__D051381
% 213.38/213.58       check tag: NIM no qualifiers for RATS, the genus RATTUS unspecified, or any RATTUS species%A%  
% 213.38/213.58  |- mesh__recordMaintainer mesh__D051381 ags
% 213.38/213.58  |- mesh__dateCreated mesh__D051381 2005-06-30
% 213.38/213.58  |- skos__scopeNote mesh__D051381 The common name for the genus Rattus.     
% 213.38/213.58  |- rdf__type mesh__D051381sskos__Concept
% 213.38/213.58  |- mesh__recordAuthorizer mesh__D051381 sjn
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D051381 2006
% 213.38/213.58  |- skos__hiddenLabel mesh__D051381 Laboratory Rats
% 213.38/213.58  |- skos__hiddenLabel mesh__D051381 Rat, Laboratory
% 213.38/213.58  |- mesh__historyNote mesh__D051381 2006   
% 213.38/213.58  |- skos__hiddenLabel mesh__D051381 Rat
% 213.38/213.58  |- skos__altLabel mesh__D051381 Rats, Norway
% 213.38/213.58  |- mesh__recordMaintainer mesh__D012968 ssb
% 213.38/213.58  |- rdf__type mesh__D012968sskos__Concept
% 213.38/213.58  |- skos__prefLabel mesh__D012968 Etidronic Acid
% 213.38/213.58  |- mesh__dateRevised mesh__D012968 2005-06-30
% 213.38/213.58  |- skos__hiddenLabel mesh__D012968 Etidronate, Sodium
% 213.38/213.58  |- skos__hiddenLabel mesh__D012968 Etidronate, Dicalcium
% 213.38/213.58  |- skos__altLabel mesh__D012968 Xidiphon
% 213.38/213.58  |- skos__altLabel mesh__D012968 EHDP
% 213.38/213.58  |- skos__altLabel mesh__D012968 Disodium 1-Hydroxyethylene Diphosphonate
% 213.38/213.58  |- skos__altLabel mesh__D012968 HEDP
% 213.38/213.58  |- skos__hiddenLabel mesh__D012968 Tetrapotassium Salt Etidronate
% 213.38/213.58  |- mesh__recordOriginator mesh__D012968 NLM
% 213.38/213.58  |- mesh__dateEstablished mesh__D012968 1977-01-01
% 213.38/213.58  |- skos__altLabel mesh__D012968 Ethanehydroxydiphosphonate
% 213.38/213.58  |- skos__hiddenLabel mesh__D012968 1 Hydroxyethane 1,1 Diphosphonate
% 213.38/213.58  |- skos__altLabel mesh__D012968 Disodium Etidronate
% 213.38/213.58  |- mesh__recordAuthorizer mesh__D012968 sjn
% 213.38/213.58  |- skos__altLabel mesh__D012968
% 213.38/213.58       %28%1-hydroxyethylene%29%diphosphonic acid, Tetrapotassium Salt
% 213.38/213.58  |- skos__altLabel mesh__D012968 Hydroxyethanediphosphonate
% 213.38/213.58  |- skos__hiddenLabel mesh__D012968
% 213.38/213.58       Diphosphonate, Disodium 1-Hydroxyethylene
% 213.38/213.58  |- mesh__publicMeSHNote mesh__D012968
% 213.38/213.58       2001; see ETIDRONATE DISODIUM 1993-2000, see SODIUM ETIDRONATE 1977-1991, see DIPHOSPHONATES 1973-1976; %28%1-HYDROXYETHYLENE%29%DIPHOSPHONIC ACID was indexed under DIPHOSPHONATES 1987-2000%A%  
% 213.38/213.58  |- skos__hiddenLabel mesh__D012968 Diphosphonic Acid, Hydroxyethylidene
% 213.38/213.58  |- skos__altLabel mesh__D012968 Hydroxyethylidene Diphosphonic Acid
% 213.38/213.58  |- skos__hiddenLabel mesh__D012968
% 213.38/213.58       1-Hydroxyethylene Diphosphonate, Disodium
% 213.38/213.58  |- skos__historyNote mesh__D012968 Organophosphorus Compounds %28%1972%29%
% 213.38/213.58  |- skos__scopeNote mesh__D012968
% 213.38/213.58       A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.%A%    
% 213.38/213.58  |- skos__hiddenLabel mesh__D012968 1,1 hydroxyethylenediphosphonate
% 213.38/213.58  |- skos__altLabel mesh__D012968 %28%1-hydroxyethylene%29%diphosphonic acid
% 213.38/213.58  |- skos__hiddenLabel mesh__D012968 1 Hydroxyethylidene 1,1 Bisphosphonate
% 213.38/213.58  |- skos__altLabel mesh__D012968 HEDSPA
% 213.38/213.58  |- skos__hiddenLabel mesh__D012968 Etidronate, Disodium
% 213.38/213.58  |- skos__altLabel mesh__D012968 1-Hydroxyethylidene-1,1-Bisphosphonate
% 213.38/213.58  |- mesh__historyNote mesh__D012968
% 213.38/213.58       2001%28%1973%29%; for %28%1-HYDROXYETHLENE%29%DIPHOSPHONIC ACID use ETIDRONAT DISODIUM %28%NM%29% 1987-2000%A%  
% 213.38/213.58  |- skos__altLabel mesh__D012968 Dicalcium EHDP
% 213.38/213.58  |- skos__altLabel mesh__D012968
% 213.38/213.58       Phosphonic acid, %28%1-hydroxyethylidene%29%bis-, disodium salt
% 213.38/213.58  |- skos__altLabel mesh__D012968 Ethanehydroxyphosphate
% 213.38/213.58  |- skos__altLabel mesh__D012968 Xydiphone
% 213.38/213.58  |- skos__hiddenLabel mesh__D012968 Disodium 1 Hydroxyethylene Diphosphonate
% 213.38/213.58  |- skos__broader mesh__D012968smesh__D004164
% 213.38/213.58  |- skos__hiddenLabel mesh__D012968 Salt Etidronate, Tetrapotassium
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D012968 2006
% 213.38/213.58  |- mesh__dateCreated mesh__D012968 1999-01-01
% 213.38/213.58  |- skos__altLabel mesh__D012968 Sodium Etidronate
% 213.38/213.58  |- skos__altLabel mesh__D012968 1,1-hydroxyethylenediphosphonate
% 213.38/213.58  |- skos__altLabel mesh__D012968 1-Hydroxyethane-1,1-Diphosphonate
% 213.38/213.58  |- skos__hiddenLabel mesh__D012968 EHDP, Dicalcium
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D031324 2004
% 213.38/213.58  |- mesh__dateEstablished mesh__D031324 2003-01-01
% 213.38/213.58  |- skos__scopeNote mesh__D031324
% 213.38/213.58       A plant genus of the family JUGLANDACEAE that provides the familiar walnut.%A%    
% 213.38/213.58  |- rdf__type mesh__D031324sskos__Concept
% 213.38/213.58  |- skos__prefLabel mesh__D031324 Juglans
% 213.38/213.58  |- mesh__publicMeSHNote mesh__D031324 2003   
% 213.38/213.58  |- skos__annotation mesh__D031324
% 213.38/213.58       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.38/213.58  |- skos__altLabel mesh__D031324 Walnut
% 213.38/213.58  |- mesh__historyNote mesh__D031324 2003   
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D031324 2005
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D031324 2003
% 213.38/213.58  |- skos__broader mesh__D031324smesh__D029525
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D031324 2006
% 213.38/213.58  |- mesh__dateCreated mesh__D031324 2002-07-03
% 213.38/213.58  |- mesh__historyNote mesh__D003633 2005%28%1973%29%   
% 213.38/213.58  |- skos__hiddenLabel mesh__D003633 Dichloroethylene, Dichlorodiphenyl
% 213.38/213.58  |- skos__annotation mesh__D003633 TN 111 for eff on insects   
% 213.38/213.58  |- mesh__dateCreated mesh__D003633 1999-01-01
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D003633 2006
% 213.38/213.58  |- skos__historyNote mesh__D003633 Insecticides %28%1966-1972%29%
% 213.38/213.58  |- skos__prefLabel mesh__D003633 Dichlorodiphenyl Dichloroethylene
% 213.38/213.58  |- skos__altLabel mesh__D003633 DDX
% 213.38/213.58  |- mesh__dateEstablished mesh__D003633 1974-01-01
% 213.38/213.58  |- mesh__publicMeSHNote mesh__D003633 2005; see DDE 1973-2004   
% 213.38/213.58  |- skos__scopeNote mesh__D003633
% 213.38/213.58       An organochlorine pesticide, it is the ethylene metabolite of DDT.%A%    
% 213.38/213.58  |- skos__altLabel mesh__D003633 DDE
% 213.38/213.58  |- mesh__recordMaintainer mesh__D003633 ssb
% 213.38/213.58  |- skos__altLabel mesh__D003633 p,p%27%-DDE
% 213.38/213.58  |- mesh__dateRevised mesh__D003633 2004-07-07
% 213.38/213.58  |- skos__broader mesh__D003633smesh__D006843
% 213.38/213.58  |- rdf__type mesh__D003633sskos__Concept
% 213.38/213.58  |- skos__altLabel mesh__D003633 p,p-Dichlorodiphenyldichloroethylene
% 213.38/213.58  |- mesh__recordOriginator mesh__D003633 NLM
% 213.38/213.58  |- mesh__recordAuthorizer mesh__D003633 sjn
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D003633 2005
% 213.38/213.58  |- skos__historyNote mesh__D027283 Membrane Proteins %28%1995-2001%29%
% 213.38/213.58  |- skos__broader mesh__D027283smesh__D027301
% 213.38/213.58  |- skos__altLabel mesh__D027283
% 213.38/213.58       Solute Carrier Family-7 %28%Cationic Amino Acid Transporter, y+ System%29%, Member 5
% 213.38/213.58  |- mesh__publicMeSHNote mesh__D027283
% 213.38/213.58       2002; MEMBRANE PROTEIN E16 was indexed under MEMBRANE PROTEINS 1995-2001; LAT1 PROTEIN was indexed under CARRIER PROTEINS 1999-2001; SCL7A5 was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1999-2001%A%  
% 213.38/213.58  |- skos__historyNote mesh__D027283 Carrier Proteins %28%1999-2001%29%
% 213.38/213.58  |- mesh__historyNote mesh__D027283
% 213.38/213.58       2002; for MEMBRANE PROTEIN E16 use LARGE NEUTRAL AMINO ACID-TRANSPORTER 1 %28%NM%29% 1995-2001; for LAT1 PROTEIN use AMINO ACID TRANSPORT SYSTEMS %28%NM%29% 1999-2001; for SLC7A5 use BASIC AMINO ACID TRANSPORT SYSTEMS %28%NM%29% 1999-2001%A%  
% 213.38/213.58  |- mesh__dateEstablished mesh__D027283 2002-01-01
% 213.38/213.58  |- mesh__activeMeSHYear mesh__D027283 2006
% 213.38/213.58  |- mesh__dateCreated mesh__D027283 2001-07-25
% 213.38/213.58  |- skos__altLabel mesh__D027283 E16 Membrane Protein
% 213.38/213.58  |- skos__altLabel mesh__D027283 SLC7A5 Protein
% 213.38/213.58  |- rdf__type mesh__D027283sskos__Concept
% 213.38/213.58  |- mesh__dateRevised mesh__D027283 2005-06-30
% 213.38/213.58  |- mesh__recordAuthorizer mesh__D027283 sjn
% 213.38/213.58  |- skos__hiddenLabel mesh__D027283 Large Neutral Amino Acid Transporter 1
% 213.38/213.58  |- skos__prefLabel mesh__D027283 Large Neutral Amino Acid-Transporter 1
% 213.38/213.59  |- skos__altLabel mesh__D027283 Membrane Protein E16
% 213.38/213.59  |- skos__scopeNote mesh__D027283
% 213.38/213.59       A CD98 antigen light chain that when heterodimerized with CD98 antigen heavy chain %28%ANTIGENS, CD98 HEAVY CHAIN%29% forms a protein that mediates sodium-independent L-type amino acid transport.%A%    
% 213.38/213.59  |- skos__altLabel mesh__D027283 SLC7A5
% 213.38/213.59  |- skos__altLabel mesh__D027283 LAT1 Protein
% 213.38/213.59  |- mesh__recordOriginator mesh__D027283 jmp
% 213.38/213.59  |- skos__hiddenLabel mesh__D027283 Membrane Protein, E16
% 213.38/213.59  |- mesh__recordMaintainer mesh__D027283 ssb
% 213.38/213.59  |- skos__hiddenLabel mesh__D007226 Mortalities, Neonatal
% 213.38/213.59  |- mesh__dateRevised mesh__D007226 2004-07-07
% 213.38/213.59  |- skos__annotation mesh__D007226
% 213.38/213.59       a statistical concept %26% not a substitute for /mortal with INFANT, NEWBORN, DISEASES or with specific diseases in infants; specify geography; check the tag INFANT or INFANT, NEWBORN%A%  
% 213.38/213.59  |- skos__hiddenLabel mesh__D007226 Mortality, Perinatal
% 213.38/213.59  |- skos__hiddenLabel mesh__D007226 Perinatal Mortalities
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D007226 2005
% 213.38/213.59  |- skos__broader mesh__D007226smesh__D009026
% 213.38/213.59  |- skos__hiddenLabel mesh__D007226 Mortality, Neonatal
% 213.38/213.59  |- skos__hiddenLabel mesh__D007226 Infant Mortalities
% 213.38/213.59  |- skos__hiddenLabel mesh__D007226 Neonatal Mortalities
% 213.38/213.59  |- mesh__recordAuthorizer mesh__D007226 sjn
% 213.38/213.59  |- skos__altLabel mesh__D007226 Postneonatal Mortality
% 213.38/213.59  |- skos__hiddenLabel mesh__D007226 Mortalities, Postneonatal
% 213.38/213.59  |- skos__hiddenLabel mesh__D007226 Postneonatal Mortalities
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D007226 2006
% 213.38/213.59  |- mesh__recordMaintainer mesh__D007226 lkt
% 213.38/213.59  |- skos__prefLabel mesh__D007226 Infant Mortality
% 213.38/213.59  |- mesh__dateCreated mesh__D007226 1999-01-01
% 213.38/213.59  |- skos__scopeNote mesh__D007226
% 213.38/213.59       Postneonatal deaths between 28 days and 365 days after BIRTH in a given population %28%as defined by National Center for Health Statistics%29%. Perinatal mortality represents deaths from 28th week of GESTATION to 7th day after birth. Neonatal mortality represents deaths from birth to 27 days after birth.%A%    
% 213.38/213.59  |- skos__hiddenLabel mesh__D007226 Mortalities, Perinatal
% 213.38/213.59  |- skos__altLabel mesh__D007226 Mortality, Infant
% 213.38/213.59  |- mesh__recordOriginator mesh__D007226 NLM
% 213.38/213.59  |- rdf__type mesh__D007226sskos__Concept
% 213.38/213.59  |- skos__hiddenLabel mesh__D007226 Mortality, Postneonatal
% 213.38/213.59  |- skos__hiddenLabel mesh__D007226 Mortalities, Infant
% 213.38/213.59  |- skos__related mesh__D007226smesh__D005313
% 213.38/213.59  |- skos__scopeNote mesh__D051382
% 213.38/213.59       A SH2 DOMAIN-containing protein that mediates SIGNAL TRANSDUCTION pathways from multiple CELL SURFACE RECEPTORS, including the EPHB1 RECEPTOR. It interacts with FOCAL ADHESION KINASE and is involved in CELL MIGRATION.%A%    
% 213.38/213.59  |- mesh__recordAuthorizer mesh__D051382 sjn
% 213.38/213.59  |- mesh__recordOriginator mesh__D051382 DRC
% 213.38/213.59  |- skos__prefLabel mesh__D051382 GRB7 Adaptor Protein
% 213.38/213.59  |- rdf__type mesh__D051382sskos__Concept
% 213.38/213.59  |- skos__altLabel mesh__D051382 Growth Factor Receptor-Bound Protein-7
% 213.38/213.59  |- skos__hiddenLabel mesh__D051382 Growth Factor Receptor Bound Protein 7
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D051382 2006
% 213.38/213.59  |- skos__broader mesh__D051382smesh__D048868
% 213.38/213.59  |- mesh__historyNote mesh__D051382 2006%28%1992%29%   
% 213.38/213.59  |- mesh__dateEstablished mesh__D051382 2006-01-01
% 213.38/213.59  |- mesh__recordMaintainer mesh__D051382 DRC
% 213.38/213.59  |- skos__altLabel mesh__D051382 GRB7 Protein
% 213.38/213.59  |- mesh__publicMeSHNote mesh__D051382
% 213.38/213.59       2006; GROWTH FACTOR RECEPTOR-BOUND PROTEIN-7 was indexed under PROTEINS 1995-2005%A%  
% 213.38/213.59  |- mesh__dateCreated mesh__D051382 2005-06-30
% 213.38/213.59  |- mesh__historyNote mesh__D012969
% 213.38/213.59       84%28%77%29%; was see under FLUORIDES 1977-83   
% 213.38/213.59  |- mesh__recordOriginator mesh__D012969 RLS
% 213.38/213.59  |- skos__historyNote mesh__D012969 Fluorides %28%1966-1976%29%
% 213.38/213.59  |- mesh__dateRevised mesh__D012969 2001-07-25
% 213.38/213.59  |- skos__broader mesh__D012969smesh__D005459
% 213.38/213.59  |- skos__historyNote mesh__D012969 Fluorides, Topical %28%1966-1976%29%
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D012969 2005
% 213.38/213.59  |- skos__hiddenLabel mesh__D012969 Fluoride, Sodium
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D012969 2003
% 213.38/213.59  |- skos__broader mesh__D012969smesh__D002327
% 213.38/213.59  |- mesh__dateCreated mesh__D012969 1976-04-16
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D012969 2006
% 213.38/213.59  |- skos__prefLabel mesh__D012969 Sodium Fluoride
% 213.38/213.59  |- mesh__dateEstablished mesh__D012969 1984-01-01
% 213.38/213.59  |- mesh__publicMeSHNote mesh__D012969
% 213.38/213.59       84; was see under FLUORIDES 1977-83; ACIDULATED PHOSPHATE FLUORIDE was see under FLUORIDES 1977-83%A%  
% 213.38/213.59  |- mesh__recordMaintainer mesh__D012969 ssb
% 213.38/213.59  |- skos__broader mesh__D012969smesh__D017670
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D012969 2004
% 213.38/213.59  |- rdf__type mesh__D012969sskos__Concept
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D012969 2002
% 213.38/213.59  |- skos__scopeNote mesh__D012969
% 213.38/213.59       A source of inorganic fluoride which is used topically to prevent dental caries.%A%    
% 213.38/213.59  |- mesh__recordAuthorizer mesh__D012969 sjn
% 213.38/213.59  |- mesh__publicMeSHNote mesh__D031325 2003   
% 213.38/213.59  |- skos__annotation mesh__D031325
% 213.38/213.59       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.38/213.59  |- mesh__dateCreated mesh__D031325 2002-07-03
% 213.38/213.59  |- skos__prefLabel mesh__D031325 Carya
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D031325 2005
% 213.38/213.59  |- mesh__dateEstablished mesh__D031325 2003-01-01
% 213.38/213.59  |- skos__altLabel mesh__D031325 Hickory Tree
% 213.38/213.59  |- mesh__recordAuthorizer mesh__D031325 sjn
% 213.38/213.59  |- skos__altLabel mesh__D031325 Pecan Tree
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D031325 2006
% 213.38/213.59  |- skos__broader mesh__D031325smesh__D029525
% 213.38/213.59  |- mesh__recordOriginator mesh__D031325 ssb
% 213.38/213.59  |- rdf__type mesh__D031325sskos__Concept
% 213.38/213.59  |- mesh__dateRevised mesh__D031325 2004-07-13
% 213.38/213.59  |- mesh__recordMaintainer mesh__D031325 sjn
% 213.38/213.59  |- skos__scopeNote mesh__D031325
% 213.38/213.59       A plant genus of the family JUGLANDACEAE that bears edible nuts.%A%    
% 213.38/213.59  |- mesh__historyNote mesh__D031325 2003   
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D003634 2001
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D003634 2005
% 213.38/213.59  |- skos__altLabel mesh__D003634 Benzochloryl
% 213.38/213.59  |- skos__altLabel mesh__D003634 p%27%,p%27%-DDT
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D003634 2002
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D003634 2006
% 213.38/213.59  |- mesh__dateRevised mesh__D003634 1999-11-03
% 213.38/213.59  |- rdf__type mesh__D003634sskos__Concept
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D003634 2003
% 213.38/213.59  |- mesh__recordMaintainer mesh__D003634 adp
% 213.38/213.59  |- skos__prefLabel mesh__D003634 DDT
% 213.38/213.59  |- mesh__recordOriginator mesh__D003634 NLM
% 213.38/213.59  |- skos__broader mesh__D003634smesh__D006843
% 213.38/213.59  |- mesh__recordAuthorizer mesh__D003634 sjn
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D003634 2000
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D003634 2004
% 213.38/213.59  |- skos__scopeNote mesh__D003634
% 213.38/213.59       A polychlorinated pesticide that is resistant to destruction by light and oxidation. Its unusual stability has resulted in difficulties in residue removal from water, soil, and foodstuffs. This substance may reasonably be anticipated to be a carcinogen: Fourth Annual Report on Carcinogens %28%NTP-85-002, 1985%29%. %28%From Merck Index, 11th ed%29%%A%    
% 213.38/213.59  |- skos__annotation mesh__D003634 TN 111 for eff on insects   
% 213.38/213.59  |- mesh__dateCreated mesh__D003634 1999-01-01
% 213.38/213.59  |- mesh__recordMaintainer mesh__D013264 sjn
% 213.38/213.59  |- mesh__historyNote mesh__D013264
% 213.38/213.59       91%28%75%29%; was see under HINDLIMB 1975-90   
% 213.38/213.59  |- mesh__publicMeSHNote mesh__D013264 91; was see under HINDLIMB 1975-90   
% 213.38/213.59  |- mesh__dateRevised mesh__D013264 2004-07-13
% 213.38/213.59  |- skos__scopeNote mesh__D013264
% 213.38/213.59       In horses, cattle, and other quadrupeds, the joint between the femur and the tibia, corresponding to the human knee.%A%    
% 213.38/213.59  |- mesh__dateEstablished mesh__D013264 1991-01-01
% 213.38/213.59  |- skos__hiddenLabel mesh__D013264 Stifles
% 213.38/213.59  |- mesh__dateCreated mesh__D013264 1999-01-01
% 213.38/213.59  |- mesh__onlineNote mesh__D013264 search HINDLIMB 1968-74   
% 213.38/213.59  |- skos__broader mesh__D013264smesh__D006614
% 213.38/213.59  |- skos__annotation mesh__D013264
% 213.38/213.59       in quadrupeds, corresponds to the human knee   
% 213.38/213.59  |- skos__prefLabel mesh__D013264 Stifle
% 213.38/213.59  |- mesh__recordAuthorizer mesh__D013264 sjn
% 213.38/213.59  |- rdf__type mesh__D013264sskos__Concept
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D013264 2006
% 213.38/213.59  |- mesh__recordOriginator mesh__D013264 NLM
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D013264 2005
% 213.38/213.59  |- skos__hiddenLabel mesh__D007227 Feedings, Supplementary
% 213.38/213.59  |- skos__related mesh__D007227smesh__D008892
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D007227 2005
% 213.38/213.59  |- skos__hiddenLabel mesh__D007227 Feeding, Supplementary
% 213.38/213.59  |- mesh__recordOriginator mesh__D007227 NLM
% 213.38/213.59  |- skos__hiddenLabel mesh__D007227 Feeding, Complementary
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D007227 2006
% 213.38/213.59  |- skos__broader mesh__D007227smesh__D002664
% 213.38/213.59  |- skos__hiddenLabel mesh__D007227 Nutrition, Infant
% 213.38/213.59  |- skos__altLabel mesh__D007227 Complementary Feeding
% 213.38/213.59  |- mesh__dateCreated mesh__D007227 1999-01-01
% 213.38/213.59  |- skos__hiddenLabel mesh__D007227 Complementary Feedings
% 213.38/213.59  |- skos__scopeNote mesh__D007227
% 213.38/213.59       Nutrition of children from birth to 2 years of age.     
% 213.38/213.59  |- mesh__recordAuthorizer mesh__D007227 sjn
% 213.38/213.59  |- skos__prefLabel mesh__D007227 Infant Nutrition
% 213.38/213.59  |- skos__hiddenLabel mesh__D007227 Supplementary Feedings
% 213.38/213.59  |- skos__annotation mesh__D007227 check the tag INFANT   
% 213.38/213.59  |- rdf__type mesh__D007227sskos__Concept
% 213.38/213.59  |- skos__hiddenLabel mesh__D007227 Feedings, Complementary
% 213.38/213.59  |- skos__related mesh__D007227smesh__D002664
% 213.38/213.59  |- mesh__recordMaintainer mesh__D007227 lkt
% 213.38/213.59  |- mesh__dateRevised mesh__D007227 2004-07-07
% 213.38/213.59  |- skos__related mesh__D007227smesh__D008895
% 213.38/213.59  |- mesh__dateCreated mesh__D051383 2005-06-30
% 213.38/213.59  |- mesh__historyNote mesh__D051383 2006%28%1995%29%   
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D051383 2006
% 213.38/213.59  |- skos__altLabel mesh__D051383 Maternally Expressed Gene 1 Protein
% 213.38/213.59  |- mesh__recordAuthorizer mesh__D051383 sjn
% 213.38/213.59  |- skos__altLabel mesh__D051383 GRB10 Protein
% 213.38/213.59  |- mesh__publicMeSHNote mesh__D051383
% 213.38/213.59       2006; GROWTH FACTOR RECEPTOR-BOUND PROTEIN 10 was indexed under PROTEINS 1995-2005%A%  
% 213.38/213.59  |- skos__hiddenLabel mesh__D051383 Growth Factor Receptor Bound Protein 10
% 213.38/213.59  |- skos__scopeNote mesh__D051383
% 213.38/213.59       A binding partner for several RECEPTOR PROTEIN-TYROSINE KINASES, including INSULIN RECEPTOR and INSULIN-LIKE GROWTH FACTOR RECEPTOR. It contains a C-terminal SH2 DOMAIN and mediates various SIGNAL TRANSDUCTION pathways.%A%    
% 213.38/213.59  |- skos__broader mesh__D051383smesh__D048868
% 213.38/213.59  |- skos__prefLabel mesh__D051383 GRB10 Adaptor Protein
% 213.38/213.59  |- mesh__dateEstablished mesh__D051383 2006-01-01
% 213.38/213.59  |- skos__altLabel mesh__D051383 Growth Factor Receptor-Bound Protein 10
% 213.38/213.59  |- mesh__recordMaintainer mesh__D051383 DRC
% 213.38/213.59  |- mesh__recordOriginator mesh__D051383 DRC
% 213.38/213.59  |- rdf__type mesh__D051383sskos__Concept
% 213.38/213.59  |- skos__scopeNote mesh__D045346
% 213.38/213.59       A protein complex that includes CYTOCHROME B6 and CYTOCHROME F. It is found in the THYLAKOID MEMBRANE and plays an important role in process of PHOTOSYNTHESIS by transferring electrons from PLASTOQUINONE to PLASTOCYANIN or CYTOCHROME C6. The transfer of electrons is coupled to the transport of PROTONS across the membrane.%A%    
% 213.38/213.59  |- skos__historyNote mesh__D045346 Cytochrome b Group %28%1984-2003%29%
% 213.38/213.59  |- skos__altLabel mesh__D045346 Cytochrome b%28%6%29%-f Complex
% 213.38/213.59  |- skos__broader mesh__D045346smesh__D045322
% 213.38/213.59  |- mesh__dateCreated mesh__D045346 2003-07-09
% 213.38/213.59  |- skos__broader mesh__D045346smesh__D017494
% 213.38/213.59  |- mesh__historyNote mesh__D045346
% 213.38/213.59       2004; use CYTOCHROME B6F COMPLEX %28%NM%29% 1984-2003   
% 213.38/213.59  |- mesh__recordAuthorizer mesh__D045346 sjn
% 213.38/213.59  |- mesh__dateRevised mesh__D045346 2004-07-19
% 213.38/213.59  |- rdf__type mesh__D045346sskos__Concept
% 213.38/213.59  |- skos__hiddenLabel mesh__D045346 Cytochrome b6 f
% 213.38/213.59  |- skos__altLabel mesh__D045346 Cytochrome b6f
% 213.38/213.59  |- skos__altLabel mesh__D045346 Cytochrome b6-f
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D045346 2006
% 213.38/213.59  |- mesh__recordMaintainer mesh__D045346 jmp
% 213.38/213.59  |- mesh__dateEstablished mesh__D045346 2004-01-01
% 213.38/213.59  |- skos__prefLabel mesh__D045346 Cytochrome b6f Complex
% 213.38/213.59  |- mesh__publicMeSHNote mesh__D045346
% 213.38/213.59       2004; CYTOCHROME B6F was indexed under CYTOCHROME B 1984-2003%A%  
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D045346 2005
% 213.38/213.59  |- skos__broader mesh__D045346smesh__D009097
% 213.38/213.59  |- mesh__recordOriginator mesh__D045346 jmp
% 213.38/213.59  |- skos__altLabel mesh__D045346 Cytochrome bf Complex
% 213.38/213.59  |- skos__broader mesh__D007596Q000530smesh__D007596
% 213.38/213.59  |- mesh__preferredCombination mesh__D007596Q000530smesh__D001175
% 213.38/213.59  |- rdf__type mesh__D007596Q000530smesh__CompoundConcept
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D017655 1998
% 213.38/213.59  |- mesh__dateCreated mesh__D017655 1993-06-04
% 213.38/213.59  |- skos__broader mesh__D017655smesh__D007287
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D017655 2002
% 213.38/213.59  |- skos__prefLabel mesh__D017655 Silicon Compounds
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D017655 1994
% 213.38/213.59  |- mesh__historyNote mesh__D017655 94   
% 213.38/213.59  |- skos__hiddenLabel mesh__D017655 Compounds, Silicon
% 213.38/213.59  |- skos__scopeNote mesh__D017655
% 213.38/213.59       Inorganic compounds that contain silicon as an integral part of the molecule.%A%    
% 213.38/213.59  |- skos__historyNote mesh__D017655 Silicon %28%1966-1993%29%
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D017655 2001
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D017655 2000
% 213.38/213.59  |- skos__annotation mesh__D017655
% 213.38/213.59       inorganic; GEN or unspecified; prefer specifics; DF: SILICON CPDS%A%  
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D017655 2004
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D017655 1997
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D017655 2006
% 213.38/213.59  |- rdf__type mesh__D017655sskos__Concept
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D017655 1999
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D017655 2003
% 213.38/213.59  |- mesh__publicMeSHNote mesh__D017655 94   
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D017655 1996
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D017655 1995
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D017655 2005
% 213.38/213.59  |- mesh__dateEstablished mesh__D017655 1994-01-01
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D031326 2005
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D031326 2003
% 213.38/213.59  |- skos__prefLabel mesh__D031326 Krameriaceae
% 213.38/213.59  |- mesh__historyNote mesh__D031326
% 213.38/213.59       2003; for RHATANY use KRAMERIACEAE 1992-2002   
% 213.38/213.59  |- skos__altLabel mesh__D031326 Ratany
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D031326 2006
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D031326 2004
% 213.38/213.59  |- skos__scopeNote mesh__D031326
% 213.38/213.59       A plant family of the order Polygalales, subclass Rosidae, class Magnoliopsida.%A%    
% 213.38/213.59  |- skos__altLabel mesh__D031326 Rhatany
% 213.38/213.59  |- mesh__recordOriginator mesh__D031326 ssb
% 213.38/213.59  |- mesh__dateCreated mesh__D031326 2002-07-03
% 213.38/213.59  |- mesh__dateEstablished mesh__D031326 2003-01-01
% 213.38/213.59  |- rdf__type mesh__D031326sskos__Concept
% 213.38/213.59  |- mesh__publicMeSHNote mesh__D031326
% 213.38/213.59       2003; RHATANY was indexed under TANNINS 1992-2002   
% 213.38/213.59  |- mesh__recordAuthorizer mesh__D031326 sjn
% 213.38/213.59  |- mesh__recordMaintainer mesh__D031326 ssb
% 213.38/213.59  |- skos__broader mesh__D031326smesh__D019684
% 213.38/213.59  |- skos__annotation mesh__D031326
% 213.38/213.59       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.38/213.59  |- rdf__type mesh__D003635sskos__Concept
% 213.38/213.59  |- mesh__recordOriginator mesh__D003635 NLM
% 213.38/213.59  |- skos__altLabel mesh__D003635 De Lange%27%s Syndrome
% 213.38/213.59  |- skos__altLabel mesh__D003635 Brachmann-De Lange Syndrome
% 213.38/213.59  |- mesh__recordAuthorizer mesh__D003635 sjn
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D003635 2003
% 213.38/213.59  |- skos__hiddenLabel mesh__D003635 Amstelodamensis, Typus Degenerativus
% 213.38/213.59  |- skos__scopeNote mesh__D003635
% 213.38/213.59       A syndrome characterized by growth retardation, severe MENTAL RETARDATION, short stature, a low-pitched growling cry, brachycephaly, low-set ears, webbed neck, carp mouth, depressed nasal bridge, bushy eyebrows meeting at the midline, hirsutism, and malformations of the hands. The condition may occur sporadically or be associated with an autosomal dominant pattern of inheritance or duplication of the long arm of chromosome 3. %28%Menkes, Textbook of Child Neurology, 5th ed, p231%29%%A%    
% 213.38/213.59  |- skos__related mesh__D003635smesh__D008607
% 213.38/213.59  |- skos__hiddenLabel mesh__D003635 Brachmann De Lange Syndrome
% 213.38/213.59  |- mesh__dateEstablished mesh__D003635 1966-01-01
% 213.38/213.59  |- mesh__historyNote mesh__D003635 2000%28%1964%29%   
% 213.38/213.59  |- skos__broader mesh__D003635smesh__D008607
% 213.38/213.59  |- skos__prefLabel mesh__D003635 De Lange Syndrome
% 213.38/213.59  |- mesh__recordMaintainer mesh__D003635 nns
% 213.38/213.59  |- mesh__publicMeSHNote mesh__D003635
% 213.38/213.59       2000; see DE LANGE%27%S SYNDROME 1966-1999   
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D003635 2004
% 213.38/213.59  |- mesh__dateRevised mesh__D003635 2001-07-25
% 213.38/213.59  |- skos__hiddenLabel mesh__D003635 Syndrome, Brachmann-De Lange
% 213.38/213.59  |- mesh__dateCreated mesh__D003635 1999-01-01
% 213.38/213.59  |- skos__altLabel mesh__D003635 Cornelia De Lange Syndrome
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D003635 2002
% 213.38/213.59  |- skos__hiddenLabel mesh__D003635 Syndrome, De Lange%27%s
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D003635 2005
% 213.38/213.59  |- skos__hiddenLabel mesh__D003635 Syndrome, De Lange
% 213.38/213.59  |- skos__broader mesh__D003635smesh__D000015
% 213.38/213.59  |- skos__altLabel mesh__D003635 Typus Degenerativus Amstelodamensis
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D003635 2006
% 213.38/213.59  |- skos__broader mesh__D003635smesh__D025063
% 213.38/213.59  |- mesh__recordAuthorizer mesh__D008320 sjn
% 213.38/213.59  |- skos__broader mesh__D008320smesh__D005936
% 213.38/213.59  |- mesh__recordMaintainer mesh__D008320 jmp
% 213.38/213.59  |- skos__prefLabel mesh__D008320 Maltose
% 213.38/213.59  |- skos__annotation mesh__D008320 ISOMALTOSE is available   
% 213.38/213.59  |- mesh__dateCreated mesh__D008320 1999-01-01
% 213.38/213.59  |- rdf__type mesh__D008320sskos__Concept
% 213.38/213.59  |- mesh__dateRevised mesh__D008320 2004-07-07
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D008320 2005
% 213.38/213.59  |- skos__scopeNote mesh__D008320
% 213.38/213.59       A dextrodisaccharide from malt and starch. It is used as a sweetening agent and fermentable intermediate in brewing. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D008320 2006
% 213.38/213.59  |- mesh__recordOriginator mesh__D008320 NLM
% 213.38/213.59  |- skos__broader mesh__D008320smesh__D004187
% 213.38/213.59  |- mesh__dateCreated mesh__D013265 1999-01-01
% 213.38/213.59  |- mesh__dateEstablished mesh__D013265 1991-01-01
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D013265 2001
% 213.38/213.59  |- mesh__dateRevised mesh__D013265 1992-05-20
% 213.38/213.59  |- rdf__type mesh__D013265sskos__Concept
% 213.38/213.59  |- mesh__recordOriginator mesh__D013265 NLM
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D013265 2004
% 213.38/213.59  |- mesh__recordMaintainer mesh__D013265 TGC
% 213.38/213.59  |- skos__annotation mesh__D013265 called %22%anti-stiffness factor%22%   
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D013265 2000
% 213.38/213.59  |- skos__broader mesh__D013265smesh__D002775
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D013265 2006
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D013265 2003
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D013265 1997
% 213.38/213.59  |- skos__altLabel mesh__D013265 Poriferasterol
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D013265 2005
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D013265 1999
% 213.38/213.59  |- mesh__publicMeSHNote mesh__D013265
% 213.38/213.59       91; was see under PHYTOSTEROLS 1972-90   
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D013265 1996
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D013265 1993
% 213.38/213.59  |- mesh__historyNote mesh__D013265
% 213.38/213.59       91%28%72%29%; was see under PHYTOSTEROLS 1972-90   
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D013265 1995
% 213.38/213.59  |- mesh__recordAuthorizer mesh__D013265 PLS
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D013265 1998
% 213.38/213.59  |- skos__broader mesh__D013265smesh__D010840
% 213.38/213.59  |- skos__prefLabel mesh__D013265 Stigmasterol
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D013265 1994
% 213.38/213.59  |- skos__historyNote mesh__D013265 Sterols %28%1966-1971%29%
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D013265 2002
% 213.38/213.59  |- skos__broader mesh__D007228smesh__D009748
% 213.38/213.59  |- mesh__recordOriginator mesh__D007228 VDK
% 213.38/213.59  |- skos__hiddenLabel mesh__D007228 Malnutrition, Infantile
% 213.38/213.59  |- skos__altLabel mesh__D007228 Infantile Malnutrition
% 213.38/213.59  |- mesh__recordMaintainer mesh__D007228 lkt
% 213.38/213.59  |- skos__hiddenLabel mesh__D007228 Malnutrition in Infants
% 213.38/213.59  |- skos__hiddenLabel mesh__D007228 Overnutrition, Infant
% 213.38/213.59  |- skos__altLabel mesh__D007228 Malnutrition, Infant
% 213.38/213.59  |- skos__related mesh__D007228smesh__D015362
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D007228 2006
% 213.38/213.59  |- skos__scopeNote mesh__D007228
% 213.38/213.59       Disorders caused by nutritional imbalance, either overnutrition or undernutrition, occurring in infants ages 1 month to 24 months.%A%    
% 213.38/213.59  |- mesh__dateRevised mesh__D007228 2003-07-09
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D007228 2004
% 213.38/213.59  |- skos__hiddenLabel mesh__D007228 Infant Nutrition Disorder
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D007228 2005
% 213.38/213.59  |- skos__annotation mesh__D007228
% 213.38/213.59       GEN only; prefer specific dis with infant check tag   
% 213.38/213.59  |- skos__prefLabel mesh__D007228 Infant Nutrition Disorders
% 213.38/213.59  |- mesh__dateCreated mesh__D007228 1999-01-01
% 213.38/213.59  |- skos__altLabel mesh__D007228 Malnutrition in Infant
% 213.38/213.59  |- mesh__recordAuthorizer mesh__D007228 sjn
% 213.38/213.59  |- rdf__type mesh__D007228sskos__Concept
% 213.38/213.59  |- skos__altLabel mesh__D007228 Nutrition Disorders, Infant
% 213.38/213.59  |- skos__hiddenLabel mesh__D007228 Nutrition Disorder, Infant
% 213.38/213.59  |- skos__scopeNote mesh__D045347
% 213.38/213.59       Cytochromes of the b group that are found as components of the CYTOCHROME B6F COMPLEX. They contain two non-covalently bound HEME B groups.%A%    
% 213.38/213.59  |- mesh__recordOriginator mesh__D045347 jmp
% 213.38/213.59  |- rdf__type mesh__D045347sskos__Concept
% 213.38/213.59  |- mesh__historyNote mesh__D045347
% 213.38/213.59       2004; for CYTOCHROME B6 use CYTOCHROME B6F COMPLEX %28%NM%29% 1984-2003; for APOPCYTOCHROME B6 use CYTOCHROMES B6 %28%NM%29% 1991-2003%A%  
% 213.38/213.59  |- mesh__dateRevised mesh__D045347 2004-07-07
% 213.38/213.59  |- skos__historyNote mesh__D045347 Cytochromes %28%1973-1983%29%
% 213.38/213.59  |- skos__prefLabel mesh__D045347 Cytochromes b6
% 213.38/213.59  |- skos__broader mesh__D045347smesh__D045346
% 213.38/213.59  |- mesh__publicMeSHNote mesh__D045347
% 213.38/213.59       2004; CYTOCHROME B6 was indexed under CYTOCHROME B 1984-2003; APOCYTOCHROME B6 was indexed under APOPROTEINS %26% CYTOCHROME B 1991-2003%A%  
% 213.38/213.59  |- skos__broader mesh__D045347smesh__D003573
% 213.38/213.59  |- mesh__recordMaintainer mesh__D045347 jmp
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D045347 2006
% 213.38/213.59  |- mesh__recordAuthorizer mesh__D045347 sjn
% 213.38/213.59  |- skos__altLabel mesh__D045347 Cytochrome b6
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D045347 2005
% 213.38/213.59  |- skos__historyNote mesh__D045347 Cytochromes b %28%1984-2003%29%
% 213.38/213.59  |- mesh__dateEstablished mesh__D045347 2004-01-01
% 213.38/213.59  |- mesh__dateCreated mesh__D045347 2003-07-09
% 213.38/213.59  |- mesh__dateCreated mesh__D031327 2002-07-02
% 213.38/213.59  |- mesh__dateEstablished mesh__D031327 2003-01-01
% 213.38/213.59  |- mesh__historyNote mesh__D031327 2003   
% 213.38/213.59  |- mesh__publicMeSHNote mesh__D031327 2003   
% 213.38/213.59  |- skos__prefLabel mesh__D031327 Agastache
% 213.38/213.59  |- skos__altLabel mesh__D031327 Hyssop, Giant
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D031327 2004
% 213.38/213.59  |- skos__annotation mesh__D031327
% 213.38/213.59       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D031327 2006
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D031327 2003
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D031327 2005
% 213.38/213.59  |- rdf__type mesh__D031327sskos__Concept
% 213.38/213.59  |- skos__broader mesh__D031327smesh__D019686
% 213.38/213.59  |- skos__scopeNote mesh__D031327
% 213.38/213.59       A plant genus of the family LAMIACEAE that contains tilianin, agastanol, and agastaquinone %28%a cytotoxic diterpenoid quinone%29%.%A%    
% 213.38/213.59  |- mesh__publicMeSHNote mesh__D003636
% 213.38/213.59       91; was see under CELLULOSE/analogs %26% derivatives 1975-90; was see under CELLULOSE 1970-74%A%  
% 213.38/213.59  |- mesh__dateRevised mesh__D003636 2004-07-07
% 213.38/213.59  |- mesh__recordMaintainer mesh__D003636 jmp
% 213.38/213.59  |- mesh__recordOriginator mesh__D003636 NLM
% 213.38/213.59  |- skos__broader mesh__D003636smesh__D002482
% 213.38/213.59  |- mesh__onlineNote mesh__D003636
% 213.38/213.59       use CELLULOSE to search DEAE-CELLULOSE 1968-74 %28%as Prov 1968-69%29%%A%  
% 213.38/213.59  |- mesh__dateCreated mesh__D003636 1999-01-01
% 213.38/213.59  |- mesh__recordAuthorizer mesh__D003636 sjn
% 213.38/213.59  |- skos__hiddenLabel mesh__D003636 DEAE Cellulose
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D003636 2005
% 213.38/213.59  |- mesh__dateEstablished mesh__D003636 1991-01-01
% 213.38/213.59  |- skos__prefLabel mesh__D003636 DEAE-Cellulose
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D003636 2006
% 213.38/213.59  |- skos__scopeNote mesh__D003636
% 213.38/213.59       Cellulose derivative used in chromatography, as ion-exchange material, and for various industrial applications.%A%    
% 213.38/213.59  |- mesh__historyNote mesh__D003636
% 213.38/213.59       91%28%75%29%%28%68-69%29%; was see under CELLULOSE/analogs %26% derivatives 1975-90; was see under CELLULOSE 1968-74 %28%Prov 1968-69%29%%A%  
% 213.38/213.59  |- rdf__type mesh__D003636sskos__Concept
% 213.38/213.59  |- mesh__dateCreated mesh__D008321 1999-01-01
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D008321 2006
% 213.38/213.59  |- skos__annotation mesh__D008321
% 213.38/213.59       animal only; inflammation = MASTITIS or MASTITIS, BOVINE; for neoplasms use MAMMARY NEOPLASMS: see note there; MAMMARY NEOPLASMS, EXPERIMENTAL is also available; Manual 24.5+, 24.6+%A%  
% 213.38/213.59  |- mesh__dateRevised mesh__D008321 2003-07-09
% 213.38/213.59  |- mesh__recordOriginator mesh__D008321 NLM
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D008321 2005
% 213.38/213.59  |- skos__broader mesh__D008321smesh__D005088
% 213.38/213.59  |- skos__hiddenLabel mesh__D008321 Animal Mammary Gland
% 213.38/213.59  |- rdf__type mesh__D008321sskos__Concept
% 213.38/213.59  |- mesh__recordAuthorizer mesh__D008321 sjn
% 213.38/213.59  |- mesh__activeMeSHYear mesh__D008321 2004
% 213.38/213.59  |- skos__altLabel mesh__D008321 Mammae
% 213.38/213.59  |- mesh__historyNote mesh__D008321 2004 %28%1966%29%   
% 213.38/213.59  |- skos__hiddenLabel mesh__D008321 Mammary Gland, Animal
% 213.38/213.59  |- mesh__publicMeSHNote mesh__D008321
% 213.38/213.59       2004 %28%1966%29%; for UDDER see UDDER 1968-1978   
% 213.38/213.59  |- skos__broader mesh__D008321smesh__D000825
% 213.38/213.59  |- skos__scopeNote mesh__D008321
% 213.38/213.59       MAMMARY GLANDS in the non-human MAMMALS.     
% 213.38/213.59  |- skos__prefLabel mesh__D008321 Mammary Glands, Animal
% 213.38/213.59  |- mesh__recordMaintainer mesh__D008321 lkt
% 213.38/213.59  |- skos__hiddenLabel mesh__D008321 Udders
% 213.38/213.59  |- skos__altLabel mesh__D008321 Animal Mammary Glands
% 213.38/213.59  |- rdf__type mesh__D013266sskos__Concept
% 213.38/213.60  |- mesh__recordAuthorizer mesh__D013266 sjn
% 213.38/213.60  |- mesh__activeMeSHYear mesh__D013266 2006
% 213.38/213.60  |- skos__scopeNote mesh__D013266 STILBENES with AMIDINES attached.     
% 213.38/213.60  |- skos__broader mesh__D013266smesh__D013267
% 213.38/213.60  |- skos__prefLabel mesh__D013266 Stilbamidines
% 213.38/213.60  |- mesh__activeMeSHYear mesh__D013266 2005
% 213.38/213.60  |- skos__broader mesh__D013266smesh__D000578
% 213.38/213.60  |- mesh__recordOriginator mesh__D013266 NLM
% 213.38/213.60  |- mesh__dateRevised mesh__D013266 2004-07-07
% 213.38/213.60  |- mesh__dateCreated mesh__D013266 1999-01-01
% 213.38/213.60  |- mesh__recordMaintainer mesh__D013266 ssb
% 213.38/213.60  |- mesh__recordAuthorizer mesh__D007229 sjn
% 213.38/213.60  |- skos__scopeNote mesh__D007229
% 213.38/213.60       Organized efforts by communities or organizations to improve the health and well-being of the infant.%A%    
% 213.38/213.60  |- mesh__recordMaintainer mesh__D007229 kle
% 213.38/213.60  |- mesh__activeMeSHYear mesh__D007229 2006
% 213.38/213.60  |- mesh__activeMeSHYear mesh__D007229 2002
% 213.38/213.60  |- mesh__publicMeSHNote mesh__D007229
% 213.38/213.60       91; was see under CHILD WELFARE 1975-90   
% 213.38/213.60  |- mesh__activeMeSHYear mesh__D007229 2004
% 213.38/213.60  |- mesh__activeMeSHYear mesh__D007229 2005
% 213.38/213.60  |- mesh__dateCreated mesh__D007229 1999-01-01
% 213.38/213.60  |- skos__hiddenLabel mesh__D007229 Health, Infant
% 213.38/213.60  |- skos__annotation mesh__D007229
% 213.38/213.60       specify geog if pertinent; check the tag INFANT   
% 213.38/213.60  |- skos__prefLabel mesh__D007229 Infant Welfare
% 213.38/213.60  |- mesh__dateRevised mesh__D007229 1999-11-03
% 213.38/213.60  |- mesh__activeMeSHYear mesh__D007229 2003
% 213.38/213.60  |- rdf__type mesh__D007229sskos__Concept
% 213.38/213.60  |- mesh__recordOriginator mesh__D007229 NLM
% 213.38/213.60  |- mesh__activeMeSHYear mesh__D007229 2001
% 213.38/213.60  |- mesh__historyNote mesh__D007229
% 213.38/213.60       91%28%75%29%; was see under CHILD WELFARE 1975-90   
% 213.38/213.60  |- skos__broader mesh__D007229smesh__D012946
% 213.38/213.60  |- skos__hiddenLabel mesh__D007229 Welfare, Infant
% 213.38/213.60  |- mesh__onlineNote mesh__D007229 search CHILD WELFARE 1966-74   
% 213.45/213.60  |- mesh__dateEstablished mesh__D007229 1991-01-01
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D007229 2000
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D045348 2006
% 213.45/213.60  |- mesh__dateEstablished mesh__D045348 2004-01-01
% 213.45/213.60  |- skos__scopeNote mesh__D045348
% 213.45/213.60       Cytochromes f are found as components of the CYTOCHROME B6F COMPLEX. They play important role in the transfer of electrons from PHOTOSYSTEM I to PHOTOSYSTEM II.%A%    
% 213.45/213.60  |- mesh__recordMaintainer mesh__D045348 jmp
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D045348 2005
% 213.45/213.60  |- mesh__recordOriginator mesh__D045348 jmp
% 213.45/213.60  |- mesh__publicMeSHNote mesh__D045348
% 213.45/213.60       2004; CYTOCHROME F was indexed under CYTOCHROMES 1979-2003; APOCYTOCHROME F was indexed under APOPROTEINS %26% CYTOCHROMES 1987-2003%A%  
% 213.45/213.60  |- mesh__dateCreated mesh__D045348 2003-07-09
% 213.45/213.60  |- skos__broader mesh__D045348smesh__D045346
% 213.45/213.60  |- rdf__type mesh__D045348sskos__Concept
% 213.45/213.60  |- skos__historyNote mesh__D045348 Cytochromes %28%1980-2003%29%
% 213.45/213.60  |- mesh__dateRevised mesh__D045348 2004-07-07
% 213.45/213.60  |- skos__altLabel mesh__D045348 Cytochrome f
% 213.45/213.60  |- skos__historyNote mesh__D045348 Apoproteins %28%1987-2003%29%
% 213.45/213.60  |- mesh__recordAuthorizer mesh__D045348 sjn
% 213.45/213.60  |- mesh__historyNote mesh__D045348
% 213.45/213.60       2004; use CYTOCHROMES F %28%NM%29% 1980-2003; for APOCYTOCHROME F use CYTOCHROMES F %28%NM%29% 1987-2003%A%  
% 213.45/213.60  |- skos__broader mesh__D045348smesh__D003580
% 213.45/213.60  |- skos__prefLabel mesh__D045348 Cytochromes f
% 213.45/213.60  |- skos__scopeNote mesh__D031328
% 213.45/213.60       A plant genus of the family LAMIACEAE that contains cyasterone, ajugasterone, 20-hydroxyecdysone, 8-acetylharpagide %28%an iridoid glycoside%29%.%A%    
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D031328 2004
% 213.45/213.60  |- skos__annotation mesh__D031328
% 213.45/213.60       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.45/213.60  |- mesh__dateCreated mesh__D031328 2002-07-02
% 213.45/213.60  |- mesh__dateEstablished mesh__D031328 2003-01-01
% 213.45/213.60  |- mesh__historyNote mesh__D031328 2003   
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D031328 2006
% 213.45/213.60  |- skos__altLabel mesh__D031328 Bugle
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D031328 2003
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D031328 2005
% 213.45/213.60  |- rdf__type mesh__D031328sskos__Concept
% 213.45/213.60  |- skos__broader mesh__D031328smesh__D019686
% 213.45/213.60  |- skos__prefLabel mesh__D031328 Ajuga
% 213.45/213.60  |- mesh__publicMeSHNote mesh__D031328 2003   
% 213.45/213.60  |- mesh__dateEstablished mesh__D003637 1991-01-01
% 213.45/213.60  |- skos__hiddenLabel mesh__D003637 DEAE Dextran
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D003637 2005
% 213.45/213.60  |- rdf__type mesh__D003637sskos__Concept
% 213.45/213.60  |- skos__scopeNote mesh__D003637
% 213.45/213.60       Used as a support for ion-exchange chromatography.     
% 213.45/213.60  |- skos__historyNote mesh__D003637 Dextrans %28%1972-1974%29%
% 213.45/213.60  |- skos__broader mesh__D003637smesh__D003911
% 213.45/213.60  |- mesh__recordMaintainer mesh__D003637 jmp
% 213.45/213.60  |- mesh__publicMeSHNote mesh__D003637
% 213.45/213.60       91; was see under DEXTRANS 1979-90; was see under DEXTRAN 1975-78%A%  
% 213.45/213.60  |- mesh__dateRevised mesh__D003637 2004-07-07
% 213.45/213.60  |- mesh__dateCreated mesh__D003637 1974-11-19
% 213.45/213.60  |- mesh__recordOriginator mesh__D003637 NLM
% 213.45/213.60  |- mesh__historyNote mesh__D003637
% 213.45/213.60       91%28%75%29%; was see under DEXTRANS 1979-90; was see under DEXTRAN 1975-78%A%  
% 213.45/213.60  |- mesh__recordAuthorizer mesh__D003637 sjn
% 213.45/213.60  |- skos__hiddenLabel mesh__D003637 Sephadex, DEAE
% 213.45/213.60  |- skos__altLabel mesh__D003637 Diethylaminoethyldextran
% 213.45/213.60  |- skos__historyNote mesh__D003637 Diethylamines %28%1974%29%
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D003637 2006
% 213.45/213.60  |- skos__prefLabel mesh__D003637 DEAE-Dextran
% 213.45/213.60  |- mesh__onlineNote mesh__D008322 pre-explosion = MAMMALS %28%PX%29%   
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D008322 2005A
% 213.45/213.60  |- mesh__dateRevised mesh__D008322 2004-07-28
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D008322 2005
% 213.45/213.60  |- mesh__recordAuthorizer mesh__D008322 jls
% 213.45/213.60  |- rdf__type mesh__D008322sskos__Concept
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D008322 2004
% 213.45/213.60  |- skos__broader mesh__D008322smesh__D014714
% 213.45/213.60  |- skos__prefLabel mesh__D008322 Mammals
% 213.45/213.60  |- mesh__recordOriginator mesh__D008322 NLM
% 213.45/213.60  |- skos__annotation mesh__D008322 avoid: too general: prefer specifics   
% 213.45/213.60  |- skos__scopeNote mesh__D008322
% 213.45/213.60       Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young. It includes three major groups: placentals and marsupials, which are viviparous, and monotremes, which are oviparous. %28%Dorland, 28th ed.%29%%A%    
% 213.45/213.60  |- mesh__recordMaintainer mesh__D008322 jls
% 213.45/213.60  |- mesh__dateCreated mesh__D008322 1999-01-01
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D008322 2006
% 213.45/213.60  |- skos__hiddenLabel mesh__D008322 Mammal
% 213.45/213.60  |- rdf__type mesh__D013267sskos__Concept
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013267 2004
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013267 1996
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013267 2002
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013267 2006
% 213.45/213.60  |- skos__prefLabel mesh__D013267 Stilbenes
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013267 1998
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013267 1997
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013267 1994
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013267 1999
% 213.45/213.60  |- mesh__dateCreated mesh__D013267 1999-01-01
% 213.45/213.60  |- skos__broader mesh__D013267smesh__D001597
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013267 1995
% 213.45/213.60  |- skos__scopeNote mesh__D013267
% 213.45/213.60       Organic compounds that contain 1,2-diphenylethylene as a functional group.%A%    
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013267 2000
% 213.45/213.60  |- mesh__dateRevised mesh__D013267 1993-02-16
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013267 2001
% 213.45/213.60  |- mesh__recordOriginator mesh__D013267 NLM
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013267 2003
% 213.45/213.60  |- mesh__recordMaintainer mesh__D013267 TPW
% 213.45/213.60  |- mesh__recordAuthorizer mesh__D013267 PLS
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013267 2005
% 213.45/213.60  |- mesh__publicMeSHNote mesh__D018750
% 213.45/213.60       95; FG 9065 was indexed under QUINOXALINES 1988-94   
% 213.45/213.60  |- mesh__dateRevised mesh__D018750 2004-07-19
% 213.45/213.60  |- mesh__recordAuthorizer mesh__D018750 sjn
% 213.45/213.60  |- mesh__dateCreated mesh__D018750 1994-06-03
% 213.45/213.60  |- skos__altLabel mesh__D018750
% 213.45/213.60       1,4-dihydro-2,3-dihydroxy-7-nitro-6-quinoxalinecarbonitrile
% 213.45/213.60  |- skos__hiddenLabel mesh__D018750 FG9065
% 213.45/213.60  |- skos__hiddenLabel mesh__D018750 6 Cyano 7 nitroquinoxaline 2,3 dione
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D018750 2006
% 213.45/213.60  |- skos__scopeNote mesh__D018750
% 213.45/213.60       A potent excitatory amino acid antagonist with a preference for non-NMDA iontropic receptors. It is used primarily as a research tool.%A%    
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D018750 2005
% 213.45/213.60  |- mesh__dateEstablished mesh__D018750 1995-01-01
% 213.45/213.60  |- rdf__type mesh__D018750sskos__Concept
% 213.45/213.60  |- skos__broader mesh__D018750smesh__D011810
% 213.45/213.60  |- skos__prefLabel mesh__D018750 6-Cyano-7-nitroquinoxaline-2,3-dione
% 213.45/213.60  |- mesh__recordMaintainer mesh__D018750 jls
% 213.45/213.60  |- mesh__recordOriginator mesh__D018750 RAZ
% 213.45/213.60  |- mesh__onlineNote mesh__D018750
% 213.45/213.60       use 6-CYANO-7-NITROQUINOXALINE-2,3-DIONE %28%NM%29% to search FG 9065 1988-94%A%  
% 213.45/213.60  |- skos__annotation mesh__D018750 DF: note short X ref   
% 213.45/213.60  |- skos__altLabel mesh__D018750 CNQX
% 213.45/213.60  |- mesh__historyNote mesh__D018750 95; was FG 9065 %28%NM%29% 1988-94   
% 213.45/213.60  |- skos__hiddenLabel mesh__D018750 FG 9065
% 213.45/213.60  |- skos__hiddenLabel mesh__D018750 6 Cyano 2,3 dihydroxy 7 nitroquinoxaline
% 213.45/213.60  |- skos__prefLabel mesh__D032421 Ampelopsis
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D032421 2006
% 213.45/213.60  |- skos__scopeNote mesh__D032421
% 213.45/213.60       A plant genus of the family VITACEAE. Members contain momordin and SITOSTEROLS.%A%    
% 213.45/213.60  |- skos__annotation mesh__D032421
% 213.45/213.60       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.45/213.60  |- mesh__publicMeSHNote mesh__D032421 2003   
% 213.45/213.60  |- mesh__dateEstablished mesh__D032421 2003-01-01
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D032421 2004
% 213.45/213.60  |- skos__broader mesh__D032421smesh__D027844
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D032421 2005
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D032421 2003
% 213.45/213.60  |- mesh__dateCreated mesh__D032421 2002-07-02
% 213.45/213.60  |- rdf__type mesh__D032421sskos__Concept
% 213.45/213.60  |- mesh__historyNote mesh__D032421 2003   
% 213.45/213.60  |- mesh__dateCreated mesh__D004730 1987-05-08
% 213.45/213.60  |- skos__scopeNote mesh__D004730
% 213.45/213.60       Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components from interstitium to lumen; this function has been most intensively studied in the blood capillaries.%A%    
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D004730 2000
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D004730 2005
% 213.45/213.60  |- mesh__recordOriginator mesh__D004730 SCD
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D004730 1997
% 213.45/213.60  |- skos__hiddenLabel mesh__D004730 Endothelium, Capillary
% 213.45/213.60  |- mesh__dateEstablished mesh__D004730 1988-01-01
% 213.45/213.60  |- mesh__recordAuthorizer mesh__D004730 PLS
% 213.45/213.60  |- skos__prefLabel mesh__D004730 Endothelium, Vascular
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D004730 1993
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D004730 1996
% 213.45/213.60  |- rdf__type mesh__D004730sskos__Concept
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D004730 2002
% 213.45/213.60  |- skos__broader mesh__D004730smesh__D004727
% 213.45/213.60  |- skos__historyNote mesh__D004730 Endothelium %28%1973-1987%29%
% 213.45/213.60  |- mesh__historyNote mesh__D004730 88   
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D004730 1999
% 213.45/213.60  |- skos__broader mesh__D004730smesh__D001808
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D004730 1992
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D004730 2004
% 213.45/213.60  |- skos__hiddenLabel mesh__D004730 Endotheliums, Vascular
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D004730 1995
% 213.45/213.60  |- mesh__publicMeSHNote mesh__D004730 88   
% 213.45/213.60  |- skos__historyNote mesh__D004730 Capillaries %28%1966-1987%29%
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D004730 1998
% 213.45/213.60  |- mesh__dateRevised mesh__D004730 1991-01-07
% 213.45/213.60  |- mesh__recordMaintainer mesh__D004730 TGC
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D004730 2003
% 213.45/213.60  |- skos__hiddenLabel mesh__D004730 Vascular Endotheliums
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D004730 1994
% 213.45/213.60  |- skos__historyNote mesh__D004730
% 213.45/213.60       Blood Vessels or specific %28%1966-1987%29%
% 213.45/213.60  |- skos__hiddenLabel mesh__D004730 Endotheliums, Capillary
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D004730 2001
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D004730 2006
% 213.45/213.60  |- skos__altLabel mesh__D004730 Vascular Endothelium
% 213.45/213.60  |- skos__hiddenLabel mesh__D004730 Capillary Endotheliums
% 213.45/213.60  |- skos__historyNote mesh__D031329 Plants, Medicinal %28%1998-2002%29%
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D031329 2005
% 213.45/213.60  |- skos__altLabel mesh__D031329 Horehound, Black
% 213.45/213.60  |- skos__scopeNote mesh__D031329
% 213.45/213.60       A plant genus of the family LAMIACEAE that contains phenylpropanoids.%A%    
% 213.45/213.60  |- skos__broader mesh__D031329smesh__D019686
% 213.45/213.60  |- rdf__type mesh__D031329sskos__Concept
% 213.45/213.60  |- mesh__dateEstablished mesh__D031329 2003-01-01
% 213.45/213.60  |- mesh__publicMeSHNote mesh__D031329 2003   
% 213.45/213.60  |- mesh__dateCreated mesh__D031329 2002-07-02
% 213.45/213.60  |- mesh__historyNote mesh__D031329 2003   
% 213.45/213.60  |- skos__prefLabel mesh__D031329 Ballota
% 213.45/213.60  |- skos__annotation mesh__D031329
% 213.45/213.60       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D031329 2004
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D031329 2006
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D031329 2003
% 213.45/213.60  |- skos__annotation mesh__D003638
% 213.45/213.60       differentiate from HEARING LOSS, BILATERAL; see various specific terms under HEARING LOSS%A%  
% 213.45/213.60  |- skos__hiddenLabel mesh__D003638 Deafness, Bilateral
% 213.45/213.60  |- mesh__dateRevised mesh__D003638 2004-07-07
% 213.45/213.60  |- skos__hiddenLabel mesh__D003638 Extreme Hearing Loss
% 213.45/213.60  |- skos__hiddenLabel mesh__D003638 Complete Hearing Loss
% 213.45/213.60  |- mesh__recordMaintainer mesh__D003638 lkt
% 213.45/213.60  |- mesh__publicMeSHNote mesh__D003638 DEAF-MUTISM was heading 1963-79   
% 213.45/213.60  |- skos__scopeNote mesh__D003638
% 213.45/213.60       A general term for the complete loss of the ability to hear from both ears.%A%    
% 213.45/213.60  |- skos__broader mesh__D003638smesh__D034381
% 213.45/213.60  |- skos__prefLabel mesh__D003638 Deafness
% 213.45/213.60  |- mesh__onlineNote mesh__D003638
% 213.45/213.60       use DEAFNESS to search DEAF-MUTISM 1966-79   
% 213.45/213.60  |- skos__related mesh__D003638smesh__D006310
% 213.45/213.60  |- skos__hiddenLabel mesh__D003638 Acquired Deafness
% 213.45/213.60  |- skos__altLabel mesh__D003638 Deaf Mutism
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D003638 2006
% 213.45/213.60  |- skos__related mesh__D003638smesh__D008085
% 213.45/213.60  |- mesh__historyNote mesh__D003638 DEAF-MUTISM was heading 1963-79   
% 213.45/213.60  |- skos__altLabel mesh__D003638 Hearing Loss, Complete
% 213.45/213.60  |- skos__altLabel mesh__D003638 Bilateral Deafness
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D003638 2005
% 213.45/213.60  |- rdf__type mesh__D003638sskos__Concept
% 213.45/213.60  |- mesh__recordOriginator mesh__D003638 NLM
% 213.45/213.60  |- mesh__recordAuthorizer mesh__D003638 sjn
% 213.45/213.60  |- mesh__dateCreated mesh__D003638 1999-01-01
% 213.45/213.60  |- skos__hiddenLabel mesh__D014360 Trypsin Inhibitor DE 3
% 213.45/213.60  |- skos__scopeNote mesh__D014360
% 213.45/213.60       A high-molecular-weight protein %28%approximately 22,500%29% containing 198 amino acid residues. It is a strong inhibitor of trypsin and human plasmin.%A%    
% 213.45/213.60  |- skos__annotation mesh__D014360
% 213.45/213.60       /drug eff /ultrastruct permitted; DF: TRYPSIN INHIB KUNITZ%A%  
% 213.45/213.60  |- mesh__publicMeSHNote mesh__D014360
% 213.45/213.60       91; was see under TRYPSIN INHIBITORS 1975-90   
% 213.45/213.60  |- skos__altLabel mesh__D014360 Trypsin Inhibitor Kunitz Soybean
% 213.45/213.60  |- mesh__historyNote mesh__D014360
% 213.45/213.60       91%28%75%29%; was see under TRYPSIN INHIBITORS 1975-90   
% 213.45/213.60  |- rdf__type mesh__D014360sskos__Concept
% 213.45/213.60  |- skos__altLabel mesh__D014360 Trypsin Inhibitor DE-3
% 213.45/213.60  |- skos__prefLabel mesh__D014360 Trypsin Inhibitor, Kunitz Soybean
% 213.45/213.60  |- skos__broader mesh__D014360smesh__D030262
% 213.45/213.60  |- skos__altLabel mesh__D014360 Kunitz Soybean Trypsin Inhibitor
% 213.45/213.60  |- mesh__dateRevised mesh__D014360 2005-06-30
% 213.45/213.60  |- mesh__dateCreated mesh__D014360 1974-11-19
% 213.45/213.60  |- mesh__recordAuthorizer mesh__D014360 sjn
% 213.45/213.60  |- skos__historyNote mesh__D014360 Soybeans %28%1972-1974%29%
% 213.45/213.60  |- mesh__dateEstablished mesh__D014360 1991-01-01
% 213.45/213.60  |- skos__historyNote mesh__D014360 Plant Proteins %28%1972-1974%29%
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D014360 2006
% 213.45/213.60  |- mesh__recordOriginator mesh__D014360 NLM
% 213.45/213.60  |- mesh__recordMaintainer mesh__D014360 SYSTEM
% 213.45/213.60  |- skos__hiddenLabel mesh__D008323 Arteries, Internal Thoracic
% 213.45/213.60  |- mesh__recordAuthorizer mesh__D008323 SJN
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D008323 2003
% 213.45/213.60  |- skos__hiddenLabel mesh__D008323 Artery, Mammary
% 213.45/213.60  |- mesh__recordMaintainer mesh__D008323 NDW
% 213.45/213.60  |- mesh__publicMeSHNote mesh__D008323
% 213.45/213.60       91; was see under THORACIC ARTERIES 1975-90   
% 213.45/213.60  |- mesh__dateEstablished mesh__D008323 1991-01-01
% 213.45/213.60  |- skos__hiddenLabel mesh__D008323 Thoracic Arteries, Internal
% 213.45/213.60  |- skos__hiddenLabel mesh__D008323 Internal Mammary Arteries
% 213.45/213.60  |- skos__hiddenLabel mesh__D008323 Mammary Arteries, Internal
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D008323 2006
% 213.45/213.60  |- skos__broader mesh__D008323smesh__D013895
% 213.45/213.60  |- mesh__dateCreated mesh__D008323 1999-01-01
% 213.45/213.60  |- skos__hiddenLabel mesh__D008323 Mammary Artery
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D008323 2002
% 213.45/213.60  |- skos__hiddenLabel mesh__D008323 Artery, Internal Thoracic
% 213.45/213.60  |- skos__hiddenLabel mesh__D008323 Arteries, Mammary
% 213.45/213.60  |- mesh__onlineNote mesh__D008323 search THORACIC ARTERIES 1966-74   
% 213.45/213.60  |- skos__altLabel mesh__D008323 Internal Thoracic Artery
% 213.45/213.60  |- mesh__dateRevised mesh__D008323 1998-06-10
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D008323 2005
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D008323 1999
% 213.45/213.60  |- skos__prefLabel mesh__D008323 Mammary Arteries
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D008323 2001
% 213.45/213.60  |- skos__hiddenLabel mesh__D008323 Artery, Internal Mammary
% 213.45/213.60  |- skos__hiddenLabel mesh__D008323 Internal Thoracic Arteries
% 213.45/213.60  |- skos__hiddenLabel mesh__D008323 Arteries, Internal Mammary
% 213.45/213.60  |- rdf__type mesh__D008323sskos__Concept
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D008323 2004
% 213.45/213.60  |- skos__hiddenLabel mesh__D008323 Mammary Artery, Internal
% 213.45/213.60  |- mesh__recordOriginator mesh__D008323 NLM
% 213.45/213.60  |- mesh__historyNote mesh__D008323
% 213.45/213.60       91%28%75%29%; was see under THORACIC ARTERIES 1975-90   
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D008323 2000
% 213.45/213.60  |- skos__scopeNote mesh__D008323
% 213.45/213.60       Arteries originating from the subclavian or axillary arteries and distributing to the anterior thoracic wall, mediastinal structures, diaphragm, pectoral muscles and mammary gland.%A%    
% 213.45/213.60  |- skos__hiddenLabel mesh__D008323 Thoracic Artery, Internal
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013268 1998
% 213.45/213.60  |- skos__annotation mesh__D013268
% 213.45/213.60       NIM; no qualif; TN 49: definition %26% use as NIM   
% 213.45/213.60  |- mesh__recordOriginator mesh__D013268 NLM
% 213.45/213.60  |- skos__altLabel mesh__D013268 Chemical Stimulation
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013268 1997
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013268 1992
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013268 1994
% 213.45/213.60  |- mesh__recordAuthorizer mesh__D013268 PLS
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013268 1999
% 213.45/213.60  |- mesh__dateCreated mesh__D013268 1999-01-01
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013268 1993
% 213.45/213.60  |- mesh__publicMeSHNote mesh__D013268 68   
% 213.45/213.60  |- mesh__dateRevised mesh__D013268 1991-05-28
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013268 1995
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013268 2002
% 213.45/213.60  |- mesh__historyNote mesh__D013268 68   
% 213.45/213.60  |- mesh__dateEstablished mesh__D013268 1968-01-01
% 213.45/213.60  |- mesh__recordMaintainer mesh__D013268 TGC
% 213.45/213.60  |- skos__hiddenLabel mesh__D013268 Chemical Stimulations
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013268 2003
% 213.45/213.60  |- skos__prefLabel mesh__D013268 Stimulation, Chemical
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013268 2000
% 213.45/213.60  |- rdf__type mesh__D013268sskos__Concept
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013268 2005
% 213.45/213.60  |- skos__broader mesh__D013268smesh__D002620
% 213.45/213.60  |- skos__related mesh__D013268smesh__D004790
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013268 2004
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013268 1996
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013268 2001
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D013268 2006
% 213.45/213.60  |- skos__hiddenLabel mesh__D013268 Stimulations, Chemical
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D032422 2006
% 213.45/213.60  |- skos__annotation mesh__D032422
% 213.45/213.60       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.45/213.60  |- mesh__publicMeSHNote mesh__D032422 2003   
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D032422 2004
% 213.45/213.60  |- skos__broader mesh__D032422smesh__D027844
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D032422 2005
% 213.45/213.60  |- mesh__historyNote mesh__D032422 2003   
% 213.45/213.60  |- skos__prefLabel mesh__D032422 Cissus
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D032422 2003
% 213.45/213.60  |- mesh__dateCreated mesh__D032422 2002-07-03
% 213.45/213.60  |- rdf__type mesh__D032422sskos__Concept
% 213.45/213.60  |- skos__scopeNote mesh__D032422
% 213.45/213.60       A plant genus of the family VITACEAE. Cissus rufescence gum is considered comparable to TRAGACANTH.%A%    
% 213.45/213.60  |- mesh__dateEstablished mesh__D032422 2003-01-01
% 213.45/213.60  |- mesh__dateRevised mesh__D004731 2005-06-30
% 213.45/213.60  |- skos__broader mesh__D004731smesh__D014118
% 213.45/213.60  |- mesh__recordOriginator mesh__D004731 NLM
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D004731 2006
% 213.45/213.60  |- mesh__recordMaintainer mesh__D004731 ssb
% 213.45/213.60  |- skos__annotation mesh__D004731
% 213.45/213.60       /antag permitted but consider also ANTITOXINS; coord IM with specific bacterium %28%IM with no qualif%29% but do not coord with BACTERIAL TOXINS%A%  
% 213.45/213.60  |- skos__related mesh__D004731smesh__D008033
% 213.45/213.60  |- mesh__dateCreated mesh__D004731 1999-01-01
% 213.45/213.60  |- skos__scopeNote mesh__D004731
% 213.45/213.60       Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells.%A%    
% 213.45/213.60  |- mesh__recordAuthorizer mesh__D004731 sjn
% 213.45/213.60  |- skos__prefLabel mesh__D004731 Endotoxins
% 213.45/213.60  |- rdf__type mesh__D004731sskos__Concept
% 213.45/213.60  |- skos__prefLabel mesh__D028381 Nidovirales
% 213.45/213.60  |- mesh__dateRevised mesh__D028381 2004-07-07
% 213.45/213.60  |- skos__broader mesh__D028381smesh__D012328
% 213.45/213.60  |- mesh__dateCreated mesh__D028381 2001-07-25
% 213.45/213.60  |- mesh__recordOriginator mesh__D028381 ags
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D028381 2005
% 213.45/213.60  |- skos__annotation mesh__D028381
% 213.45/213.60       infection: coord IM with RNA VIRUS INFECTIONS %28%IM%29%   
% 213.45/213.60  |- mesh__recordMaintainer mesh__D028381 ags
% 213.45/213.60  |- skos__scopeNote mesh__D028381
% 213.45/213.60       An order comprising two families of eukaryotic viruses possessing linear, nonsegmented, positive sense RNA genomes. The families are CORONAVIRIDAE; ARTERIVIRIDAE; and RONIVIRIDAE.%A%    
% 213.45/213.60  |- mesh__publicMeSHNote mesh__D028381 2002   
% 213.45/213.60  |- mesh__historyNote mesh__D028381 2002   
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D028381 2006
% 213.45/213.60  |- mesh__dateEstablished mesh__D028381 2002-01-01
% 213.45/213.60  |- mesh__recordAuthorizer mesh__D028381 sjn
% 213.45/213.60  |- rdf__type mesh__D028381sskos__Concept
% 213.45/213.60  |- skos__prefLabel mesh__D003639 Hearing Loss, Sudden
% 213.45/213.60  |- mesh__publicMeSHNote mesh__D003639
% 213.45/213.60       2003; see DEAFNESS, SUDDEN 1979-2002   
% 213.45/213.60  |- mesh__dateCreated mesh__D003639 1978-05-22
% 213.45/213.60  |- skos__historyNote mesh__D003639 Deafness %28%1966-1978%29%
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D003639 2006
% 213.45/213.60  |- mesh__dateEstablished mesh__D003639 1979-01-01
% 213.45/213.60  |- mesh__recordAuthorizer mesh__D003639 sjn
% 213.45/213.60  |- mesh__recordOriginator mesh__D003639 RC
% 213.45/213.60  |- mesh__recordMaintainer mesh__D003639 lkt
% 213.45/213.60  |- mesh__historyNote mesh__D003639 2003 %28%1979%29%   
% 213.45/213.60  |- skos__scopeNote mesh__D003639
% 213.45/213.60       Sensorineural hearing loss which develops suddenly over a period of hours or a few days. It varies in severity from mild to total deafness. Sudden deafness can be due to head trauma, vascular diseases, infections, or can appear without obvious cause or warning.%A%    
% 213.45/213.60  |- mesh__activeMeSHYear mesh__D003639 2005
% 213.45/213.60  |- rdf__type mesh__D003639sskos__Concept
% 213.45/213.60  |- skos__historyNote mesh__D003639 Deafness, Sudden %28%1979-2002%29%
% 213.45/213.60  |- skos__broader mesh__D003639smesh__D034381
% 213.45/213.60  |- mesh__dateRevised mesh__D003639 2004-07-07
% 213.45/213.60  |- skos__hiddenLabel mesh__D003639 Sudden Hearing Loss
% 213.45/213.61  |- skos__altLabel mesh__D003639 Sudden Deafness
% 213.45/213.61  |- mesh__recordOriginator mesh__D014361 NLM
% 213.45/213.61  |- rdf__type mesh__D014361sskos__Concept
% 213.45/213.61  |- skos__broader mesh__D014361smesh__D015842
% 213.45/213.61  |- skos__scopeNote mesh__D014361
% 213.45/213.61       Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds.%A%    
% 213.45/213.61  |- skos__hiddenLabel mesh__D014361 Inhibitors, Trypsin
% 213.45/213.61  |- mesh__dateEstablished mesh__D014361 1965-01-01
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D014361 2006
% 213.45/213.61  |- mesh__dateRevised mesh__D014361 2005-06-30
% 213.45/213.61  |- mesh__recordMaintainer mesh__D014361 SYSTEM
% 213.45/213.61  |- mesh__publicMeSHNote mesh__D014361 65   
% 213.45/213.61  |- mesh__historyNote mesh__D014361 65   
% 213.45/213.61  |- skos__annotation mesh__D014361
% 213.45/213.61       GEN or unspecified; prefer specifics; /drug eff /ultrastruct permitted; ALPHA 1-ANTITRYPSIN is available; DF: TRYPSIN INHIB%A%  
% 213.45/213.61  |- mesh__recordAuthorizer mesh__D014361 sjn
% 213.45/213.61  |- skos__prefLabel mesh__D014361 Trypsin Inhibitors
% 213.45/213.61  |- mesh__dateCreated mesh__D014361 1999-01-01
% 213.45/213.61  |- skos__altLabel mesh__D008324 Mammary Tumor Viruses, Mouse
% 213.45/213.61  |- skos__annotation mesh__D008324
% 213.45/213.61       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% + %28%if pertinent%29% MAMMARY NEOPLASMS, EXPERIMENTAL %28%IM%29%%A%  
% 213.45/213.61  |- mesh__historyNote mesh__D008324 2002 %28%1966%29%   
% 213.45/213.61  |- mesh__recordOriginator mesh__D008324 NLM
% 213.45/213.61  |- mesh__recordMaintainer mesh__D008324 ags
% 213.45/213.61  |- skos__prefLabel mesh__D008324 Mammary Tumor Virus, Mouse
% 213.45/213.61  |- skos__altLabel mesh__D008324 Mouse mammary tumor virus
% 213.45/213.61  |- skos__related mesh__D008324smesh__D016744
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D008324 2006
% 213.45/213.61  |- mesh__recordAuthorizer mesh__D008324 sjn
% 213.45/213.61  |- mesh__dateCreated mesh__D008324 1999-01-01
% 213.45/213.61  |- skos__related mesh__D008324smesh__D016747
% 213.45/213.61  |- skos__altLabel mesh__D008324 Mammary Cancer Virus
% 213.45/213.61  |- mesh__publicMeSHNote mesh__D008324
% 213.45/213.61       2002; see MAMMARY TUMOR VIRUSES, MOUSE 1994-2001, see MAMMARY CANCER VIRUS 1966-1993%A%  
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D008324 2005
% 213.45/213.61  |- mesh__dateRevised mesh__D008324 2001-07-25
% 213.45/213.61  |- rdf__type mesh__D008324sskos__Concept
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D008324 2004
% 213.45/213.61  |- skos__broader mesh__D008324smesh__D030121
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D008324 2002
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D008324 2003
% 213.45/213.61  |- mesh__dateEstablished mesh__D008324 1966-01-01
% 213.45/213.61  |- skos__altLabel mesh__D008324 Bittner Virus
% 213.45/213.61  |- skos__scopeNote mesh__D008324
% 213.45/213.61       The type species of BETARETROVIRUS commonly latent in mice. It causes mammary adenocarcinoma in a genetically susceptible strain of mice when the appropriate hormonal influences operate.%A%    
% 213.45/213.61  |- mesh__dateRevised mesh__D000341 1997-06-20
% 213.45/213.61  |- mesh__recordAuthorizer mesh__D000341 SJN
% 213.45/213.61  |- mesh__recordMaintainer mesh__D000341 JLS
% 213.45/213.61  |- skos__hiddenLabel mesh__D000341 Psychotic Affective Disorder
% 213.45/213.61  |- skos__hiddenLabel mesh__D000341 Disorder, Psychotic Affective
% 213.45/213.61  |- mesh__dateEstablished mesh__D000341 1981-01-01
% 213.45/213.61  |- skos__hiddenLabel mesh__D000341 Affective Psychoses
% 213.45/213.61  |- mesh__historyNote mesh__D000341
% 213.45/213.61       81; DEPRESSION, REACTIVE, PSYCHOTIC was see under PSYCHOSES 1977-80; AFFECTIVE DISTURBANCES was heading 1969-80%A%  
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D000341 2000
% 213.45/213.61  |- mesh__recordOriginator mesh__D000341 EC
% 213.45/213.61  |- skos__hiddenLabel mesh__D000341 Psychotic Mood Disorder
% 213.45/213.61  |- rdf__type mesh__D000341sskos__Concept
% 213.45/213.61  |- mesh__onlineNote mesh__D000341
% 213.45/213.61       use AFFECTIVE DISORDERS, PSYCHOTIC to search DEPRESSION, REACTIVE, PSYCHOTIC 1977-80; search AFFECTIVE DISTURBANCES under AFFECTIVE SYMPTOMS 1969-80%A%  
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D000341 2003
% 213.45/213.61  |- skos__broader mesh__D000341smesh__D019964
% 213.45/213.61  |- skos__hiddenLabel mesh__D000341 Affective Disorder, Psychotic
% 213.45/213.61  |- skos__altLabel mesh__D000341 Mood Disorders, Psychotic
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D000341 2001
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D000341 2004
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D000341 1998
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D000341 2002
% 213.45/213.61  |- skos__scopeNote mesh__D000341
% 213.45/213.61       Disorders in which the essential feature is a severe disturbance in mood %28%depression, anxiety, elation, and excitement%29% accompanied by psychotic symptoms such as delusions, hallucinations, gross impairment in reality testing, etc.%A%    
% 213.45/213.61  |- mesh__publicMeSHNote mesh__D000341
% 213.45/213.61       81; DEPRESSION, REACTIVE, PSYCHOTIC was see under PSYCHOSES 1977-80; AFFECTIVE DISTURBANCES was heading 1969-80%A%  
% 213.45/213.61  |- skos__altLabel mesh__D000341 Psychoses, Affective
% 213.45/213.61  |- skos__altLabel mesh__D000341 Psychotic Affective Disorders
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D000341 2005
% 213.45/213.61  |- mesh__dateCreated mesh__D000341 1980-05-21
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D000341 1999
% 213.45/213.61  |- skos__hiddenLabel mesh__D000341 Mood Disorder, Psychotic
% 213.45/213.61  |- skos__hiddenLabel mesh__D000341 Disorders, Psychotic Affective
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D000341 2006
% 213.45/213.61  |- skos__prefLabel mesh__D000341 Affective Disorders, Psychotic
% 213.45/213.61  |- skos__altLabel mesh__D013269 Process, Stochastic
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D013269 2000
% 213.45/213.61  |- skos__broader mesh__D013269smesh__D013223
% 213.45/213.61  |- skos__hiddenLabel mesh__D013269 Processes, Stochastic
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D013269 2003
% 213.45/213.61  |- skos__prefLabel mesh__D013269 Stochastic Processes
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D013269 2001
% 213.45/213.61  |- rdf__type mesh__D013269sskos__Concept
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D013269 2005
% 213.45/213.61  |- mesh__dateRevised mesh__D013269 1994-04-11
% 213.45/213.61  |- mesh__recordOriginator mesh__D013269 NLM
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D013269 2004
% 213.45/213.61  |- mesh__recordMaintainer mesh__D013269 TGC
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D013269 1996
% 213.45/213.61  |- mesh__recordAuthorizer mesh__D013269 PLS
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D013269 2006
% 213.45/213.61  |- skos__altLabel mesh__D013269 Stochastic Process
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D013269 1998
% 213.45/213.61  |- mesh__publicMeSHNote mesh__D013269
% 213.45/213.61       91; was see under STATISTICS 1990-90; was see under PROBABILITY 1968-89%A%  
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D013269 1997
% 213.45/213.61  |- mesh__historyNote mesh__D013269
% 213.45/213.61       91%28%75%29%; was see under STATISTICS 1990-90; was see under PROBABILITY 1968-89%A%  
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D013269 2002
% 213.45/213.61  |- skos__scopeNote mesh__D013269
% 213.45/213.61       Processes that incorporate some element of randomness, used particularly to refer to a time series of random variables.%A%    
% 213.45/213.61  |- skos__annotation mesh__D013269
% 213.45/213.61       IM GEN only; coord NIM with specific disease or other concept %28%IM%29%; no qualif; specify geog if pertinent%A%  
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D013269 1999
% 213.45/213.61  |- mesh__onlineNote mesh__D013269 search PROBABILITY 1968-74   
% 213.45/213.61  |- mesh__dateEstablished mesh__D013269 1991-01-01
% 213.45/213.61  |- mesh__dateCreated mesh__D013269 1999-01-01
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D013269 1995
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D018752 2005
% 213.45/213.61  |- skos__scopeNote mesh__D018752
% 213.45/213.61       A diet that contains limited amounts of fat with less than 30%25% of calories from all fats and less than 10%25% from saturated fat. Such a diet is used in control of HYPERLIPIDEMIA. %28%From Bondy et al, Metabolic Control and Disease, 8th ed, pp468-70; Dorland, 27th ed%29%%A%    
% 213.45/213.61  |- mesh__dateCreated mesh__D018752 1994-05-23
% 213.45/213.61  |- mesh__dateRevised mesh__D018752 2003-07-09
% 213.45/213.61  |- skos__hiddenLabel mesh__D018752 Diet, Fat Restricted
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D018752 2006
% 213.45/213.61  |- skos__hiddenLabel mesh__D018752 Diet, Fat Free
% 213.45/213.61  |- skos__hiddenLabel mesh__D018752 Fat Restricted Diet
% 213.45/213.61  |- mesh__recordOriginator mesh__D018752 JLS
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D018752 2004
% 213.45/213.61  |- skos__altLabel mesh__D018752 Fat-Restricted Diet
% 213.45/213.61  |- skos__annotation mesh__D018752
% 213.45/213.61       IM; coord with dis /diet ther %28%IM%29%   
% 213.45/213.61  |- skos__hiddenLabel mesh__D018752 Low-Fat Diets
% 213.45/213.61  |- skos__hiddenLabel mesh__D018752 Diets, Low-Fat
% 213.45/213.61  |- mesh__dateEstablished mesh__D018752 1995-01-01
% 213.45/213.61  |- skos__historyNote mesh__D018752 Dietary Fats %28%1966-1994%29%
% 213.45/213.61  |- skos__hiddenLabel mesh__D018752 Diets, Fat-Restricted
% 213.45/213.61  |- rdf__type mesh__D018752sskos__Concept
% 213.45/213.61  |- skos__hiddenLabel mesh__D018752 Diets, Fat-Free
% 213.45/213.61  |- skos__hiddenLabel mesh__D018752 Low-Fat Diet
% 213.45/213.61  |- skos__hiddenLabel mesh__D018752 Fat-Free Diets
% 213.45/213.61  |- skos__altLabel mesh__D018752 Diet, Low-Fat
% 213.45/213.61  |- skos__prefLabel mesh__D018752 Diet, Fat-Restricted
% 213.45/213.61  |- mesh__historyNote mesh__D018752 95   
% 213.45/213.61  |- skos__broader mesh__D018752smesh__D004035
% 213.45/213.61  |- mesh__recordMaintainer mesh__D018752 lkt
% 213.45/213.61  |- skos__hiddenLabel mesh__D018752 Fat-Restricted Diets
% 213.45/213.61  |- skos__hiddenLabel mesh__D018752 Diet, Low Fat
% 213.45/213.61  |- mesh__publicMeSHNote mesh__D018752 95   
% 213.45/213.61  |- mesh__recordAuthorizer mesh__D018752 sjn
% 213.45/213.61  |- skos__hiddenLabel mesh__D018752 Fat-Free Diet
% 213.45/213.61  |- skos__broader mesh__D032423smesh__D019684
% 213.45/213.61  |- rdf__type mesh__D032423sskos__Concept
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D032423 2003
% 213.45/213.61  |- skos__annotation mesh__D032423
% 213.45/213.61       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.45/213.61  |- mesh__historyNote mesh__D032423 2003   
% 213.45/213.61  |- mesh__dateCreated mesh__D032423 2002-07-03
% 213.45/213.61  |- skos__scopeNote mesh__D032423
% 213.45/213.61       A plant family of the order Magnoliales, subclass Magnoliidae, class Magnoliopsida. The wood lacks water-conducting cells but has acrid sap. The leaves are gland-dotted, leathery, and smooth-margined.  The flowers are small, in clusters, with two to six sepals, petals in two or more series, several stamens, and one to several carpels.%A%    
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D032423 2006
% 213.45/213.61  |- skos__prefLabel mesh__D032423 Winteraceae
% 213.45/213.61  |- mesh__publicMeSHNote mesh__D032423 2003   
% 213.45/213.61  |- mesh__dateEstablished mesh__D032423 2003-01-01
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D032423 2004
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D032423 2005
% 213.45/213.61  |- mesh__recordAuthorizer mesh__D004732 sjn
% 213.45/213.61  |- skos__scopeNote mesh__D004732
% 213.45/213.61       An organochlorine compound that was formerly used as an insecticide. Its manufacture and use has been discontinued in the United States. %28%From Merck Index, 11th ed%29%%A%    
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D004732 2006
% 213.45/213.61  |- skos__prefLabel mesh__D004732 Endrin
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D004732 2005
% 213.45/213.61  |- mesh__dateEstablished mesh__D004732 1974-01-01
% 213.45/213.61  |- mesh__dateCreated mesh__D004732 1999-01-01
% 213.45/213.61  |- mesh__historyNote mesh__D004732 74%28%71%29%   
% 213.45/213.61  |- skos__annotation mesh__D004732 TN 111 for eff on insects   
% 213.45/213.61  |- skos__broader mesh__D004732smesh__D006843
% 213.45/213.61  |- mesh__recordOriginator mesh__D004732 NLM
% 213.45/213.61  |- mesh__recordMaintainer mesh__D004732 ssb
% 213.45/213.61  |- rdf__type mesh__D004732sskos__Concept
% 213.45/213.61  |- mesh__dateRevised mesh__D004732 2004-07-07
% 213.45/213.61  |- skos__historyNote mesh__D004732 Insecticides %28%1966-1972%29%
% 213.45/213.61  |- mesh__publicMeSHNote mesh__D004732 74   
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D028382 2002
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D028382 2003
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D028382 2004
% 213.45/213.61  |- skos__prefLabel mesh__D028382 Arteriviridae
% 213.45/213.61  |- skos__scopeNote mesh__D028382
% 213.45/213.61       A family of viruses, of the order NIDOVIRALES, containing spherical virions. In contrast to CORONAVIRIDAE, no protruding spikes are obvious on the surface.%A%    
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D028382 2005
% 213.45/213.61  |- skos__annotation mesh__D028382
% 213.45/213.61       infection: coord IM with RNA VIRUS INFECTIONS %28%IM%29%   
% 213.45/213.61  |- mesh__publicMeSHNote mesh__D028382 2002   
% 213.45/213.61  |- mesh__dateCreated mesh__D028382 2001-07-25
% 213.45/213.61  |- mesh__dateEstablished mesh__D028382 2002-01-01
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D028382 2006
% 213.45/213.61  |- rdf__type mesh__D028382sskos__Concept
% 213.45/213.61  |- skos__broader mesh__D028382smesh__D028381
% 213.45/213.61  |- mesh__historyNote mesh__D028382 2002   
% 213.45/213.61  |- skos__scopeNote mesh__D014362
% 213.45/213.61       The inactive proenzyme of trypsin secreted by the pancreas, activated in the duodenum via cleavage by enteropeptidase. %28%Stedman, 25th ed%29%%A%    
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D014362 2006
% 213.45/213.61  |- skos__broader mesh__D014362smesh__D004792
% 213.45/213.61  |- mesh__recordMaintainer mesh__D014362 ssb
% 213.45/213.61  |- mesh__recordAuthorizer mesh__D014362 sjn
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D014362 2004
% 213.45/213.61  |- mesh__recordOriginator mesh__D014362 NLM
% 213.45/213.61  |- skos__annotation mesh__D014362
% 213.45/213.61       an enzyme precursor; /defic: consider also MALABSORPTION SYNDROMES %28%IM%29% + AMINO ACID METABOLISM, INBORN ERRORS %28%IM%29%%A%  
% 213.45/213.61  |- mesh__dateCreated mesh__D014362 1999-01-01
% 213.45/213.61  |- mesh__dateRevised mesh__D014362 2003-07-09
% 213.45/213.61  |- skos__hiddenLabel mesh__D014362 1, Trypsinogen
% 213.45/213.61  |- rdf__type mesh__D014362sskos__Concept
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D014362 2005
% 213.45/213.61  |- skos__prefLabel mesh__D014362 Trypsinogen
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D008325 2005
% 213.45/213.61  |- mesh__dateRevised mesh__D008325 2004-07-13
% 213.45/213.61  |- skos__broader mesh__D008325smesh__D015674
% 213.45/213.61  |- skos__scopeNote mesh__D008325
% 213.45/213.61       Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS.%A%    
% 213.45/213.61  |- skos__annotation mesh__D008325
% 213.45/213.61       animal only; coordinate IM with histological type of neoplasm %28%IM%29% + specific animal %28%NIM%29% + check tag ANIMALS; DF: MAMMARY NEOPL EXPER%A%  
% 213.45/213.61  |- mesh__recordMaintainer mesh__D008325 sjn
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D008325 2006
% 213.45/213.61  |- skos__hiddenLabel mesh__D008325 Experimental Mammary Neoplasm
% 213.45/213.61  |- skos__altLabel mesh__D008325 Neoplasms, Experimental Mammary
% 213.45/213.61  |- skos__hiddenLabel mesh__D008325 Neoplasm, Experimental Mammary
% 213.45/213.61  |- mesh__recordOriginator mesh__D008325 NLM
% 213.45/213.61  |- skos__broader mesh__D008325smesh__D009374
% 213.45/213.61  |- skos__hiddenLabel mesh__D008325 Mammary Neoplasm, Experimental
% 213.45/213.61  |- rdf__type mesh__D008325sskos__Concept
% 213.45/213.61  |- mesh__recordAuthorizer mesh__D008325 sjn
% 213.45/213.61  |- mesh__dateCreated mesh__D008325 1999-01-01
% 213.45/213.61  |- skos__altLabel mesh__D008325 Experimental Mammary Neoplasms
% 213.45/213.61  |- skos__prefLabel mesh__D008325 Mammary Neoplasms, Experimental
% 213.45/213.61  |- skos__hiddenLabel mesh__D000342 Emotional Disturbance
% 213.45/213.61  |- rdf__type mesh__D000342sskos__Concept
% 213.45/213.61  |- mesh__dateCreated mesh__D000342 1999-01-01
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D000342 2003
% 213.45/213.61  |- skos__hiddenLabel mesh__D000342 Symptom, Affective
% 213.45/213.61  |- mesh__dateEstablished mesh__D000342 1969-01-01
% 213.45/213.61  |- skos__prefLabel mesh__D000342 Affective Symptoms
% 213.45/213.61  |- mesh__recordOriginator mesh__D000342 NLM
% 213.45/213.61  |- mesh__recordMaintainer mesh__D000342 JLS
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D000342 2004
% 213.45/213.61  |- mesh__recordAuthorizer mesh__D000342 sjn
% 213.45/213.61  |- mesh__dateRevised mesh__D000342 2002-07-02
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D000342 2005
% 213.45/213.61  |- skos__historyNote mesh__D000342 Emotions %28%1966-1968%29%
% 213.45/213.61  |- mesh__onlineNote mesh__D000342
% 213.45/213.61       use AFFECTIVE SYMPTOMS to search AFFECTIVE DISTURBANCES 1969-80%A%  
% 213.45/213.61  |- skos__hiddenLabel mesh__D000342 Symptoms, Affective
% 213.45/213.61  |- skos__hiddenLabel mesh__D000342 Alexithymias
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D000342 2006
% 213.45/213.61  |- mesh__historyNote mesh__D000342
% 213.45/213.61       81; was AFFECTIVE DISTURBANCES 1969-80   
% 213.45/213.61  |- skos__hiddenLabel mesh__D000342 Disturbances, Emotional
% 213.45/213.61  |- skos__broader mesh__D000342smesh__D001526
% 213.45/213.61  |- skos__historyNote mesh__D000342 Affect %28%1966-1968%29%
% 213.45/213.61  |- skos__scopeNote mesh__D000342
% 213.45/213.61       Mood or emotional responses dissonant with or inappropriate to the behavior and/or stimulus.%A%    
% 213.45/213.61  |- skos__historyNote mesh__D000342 Anxiety %28%1966-1968%29%
% 213.45/213.61  |- skos__hiddenLabel mesh__D000342 Affective Symptom
% 213.45/213.61  |- skos__annotation mesh__D000342
% 213.45/213.61       human only; do not confuse with AFFECTIVE DISORDERS: read MeSH definitions %26% follow text%A%  
% 213.45/213.61  |- mesh__publicMeSHNote mesh__D000342
% 213.45/213.61       81; was AFFECTIVE DISTURBANCES 1969-80   
% 213.45/213.61  |- skos__hiddenLabel mesh__D000342 Disturbance, Emotional
% 213.45/213.61  |- mesh__dateRevised mesh__D018753 2003-07-09
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D018753 2006
% 213.45/213.61  |- skos__hiddenLabel mesh__D018753 Protein-Restricted Diets
% 213.45/213.61  |- mesh__publicMeSHNote mesh__D018753 95   
% 213.45/213.61  |- skos__hiddenLabel mesh__D018753 Low-Protein Diets
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D018753 2004
% 213.45/213.61  |- skos__hiddenLabel mesh__D018753 Diets, Protein-Restricted
% 213.45/213.61  |- skos__hiddenLabel mesh__D018753 Diet, Protein Free
% 213.45/213.61  |- skos__altLabel mesh__D018753 Protein-Restricted Diet
% 213.45/213.61  |- skos__altLabel mesh__D018753 Low-Protein Diet
% 213.45/213.61  |- rdf__type mesh__D018753sskos__Concept
% 213.45/213.61  |- mesh__dateCreated mesh__D018753 1994-05-23
% 213.45/213.61  |- skos__hiddenLabel mesh__D018753 Protein Restricted Diet
% 213.45/213.61  |- skos__hiddenLabel mesh__D018753 Diet, Protein Restricted
% 213.45/213.61  |- skos__hiddenLabel mesh__D018753 Low Protein Diet
% 213.45/213.61  |- skos__broader mesh__D018753smesh__D004035
% 213.45/213.61  |- skos__hiddenLabel mesh__D018753 Protein-Free Diets
% 213.45/213.61  |- mesh__historyNote mesh__D018753 95   
% 213.45/213.61  |- skos__hiddenLabel mesh__D018753 Diet, Low Protein
% 213.45/213.61  |- skos__altLabel mesh__D018753 Diet, Low-Protein
% 213.45/213.61  |- skos__annotation mesh__D018753
% 213.45/213.61       IM; coord with dis /diet ther %28%IM%29%   
% 213.45/213.61  |- skos__historyNote mesh__D018753 Dietary Proteins %28%1966-1994%29%
% 213.45/213.61  |- skos__hiddenLabel mesh__D018753 Diets, Protein-Free
% 213.45/213.61  |- skos__scopeNote mesh__D018753
% 213.45/213.61       A diet that contains limited amounts of protein. It is prescribed in some cases to slow the progression of renal failure. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 213.45/213.61  |- mesh__dateEstablished mesh__D018753 1995-01-01
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D018753 2005
% 213.45/213.61  |- skos__hiddenLabel mesh__D018753 Diets, Low-Protein
% 213.45/213.61  |- skos__hiddenLabel mesh__D018753 Protein-Free Diet
% 213.45/213.61  |- skos__prefLabel mesh__D018753 Diet, Protein-Restricted
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D010770 2005
% 213.45/213.61  |- rdf__type mesh__D010770sskos__Concept
% 213.45/213.61  |- skos__broader mesh__D010770smesh__D014166
% 213.45/213.61  |- skos__annotation mesh__D010770
% 213.45/213.61       GEN or unspecified; prefer specific groups or specific phosphotransferases%A%  
% 213.45/213.61  |- mesh__onlineNote mesh__D010770
% 213.45/213.61       use PHOSPHOTRANSFERASES to search PHOSPHOTRANSFERASES, ATP 1974-93 %26% KINASES 1966-93%A%  
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D010770 2006
% 213.45/213.61  |- mesh__publicMeSHNote mesh__D010770
% 213.45/213.61       PHOSPHOTRANSFERASES, ATP was heading 1974-93; KINASES was see PHOSPHOTRANSFERASES, ATP 1977-93, was see PHOSPHOTRANSFERASES 1963-76%A%  
% 213.45/213.61  |- skos__hiddenLabel mesh__D010770 ATP Phosphotransferases
% 213.45/213.61  |- mesh__historyNote mesh__D010770
% 213.45/213.61       PHOSPHOTRANSFERASES, ATP was heading 1974-93; KINASES was see PHOSPHOTRANSFERASES, ATP 1977-93, was see PHOSPHOTRANSFERASES 1963-76%A%  
% 213.45/213.61  |- mesh__dateCreated mesh__D010770 1999-01-01
% 213.45/213.61  |- mesh__recordAuthorizer mesh__D010770 sjn
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D010770 2004
% 213.45/213.61  |- skos__altLabel mesh__D010770 Transphosphorylases
% 213.45/213.61  |- skos__altLabel mesh__D010770 Kinases
% 213.45/213.61  |- skos__scopeNote mesh__D010770
% 213.45/213.61       A rather large group of enzymes comprising not only those transferring phosphate but also diphosphate, nucleotidyl residues, and others. These have also been subdivided according to the acceptor group. %28%From Enzyme Nomenclature, 1992%29% EC 2.7.%A%    
% 213.45/213.61  |- mesh__recordOriginator mesh__D010770 NLM
% 213.45/213.61  |- skos__altLabel mesh__D010770 Kinase
% 213.45/213.61  |- mesh__recordMaintainer mesh__D010770 ssb
% 213.45/213.61  |- skos__prefLabel mesh__D010770 Phosphotransferases
% 213.45/213.61  |- mesh__dateRevised mesh__D010770 2003-07-09
% 213.45/213.61  |- rdf__type mesh__D032424sskos__Concept
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D032424 2003A
% 213.45/213.61  |- mesh__dateEstablished mesh__D032424 2003-01-01
% 213.45/213.61  |- mesh__recordOriginator mesh__D032424 ssb
% 213.45/213.61  |- skos__prefLabel mesh__D032424 Drimys
% 213.45/213.61  |- skos__scopeNote mesh__D032424
% 213.45/213.61       A plant genus of the family WINTERACEAE. They have leathery, elliptic-shaped leaves; red-tinged shoots; and jasmine-scented, cream-colored, 8- to 12-petaled, 2.5-centimeter %28%1-inch%29% flowers in clusters.%A%    
% 213.45/213.61  |- skos__broader mesh__D032424smesh__D032423
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D032424 2005
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D032424 2003
% 213.45/213.61  |- mesh__historyNote mesh__D032424 2003   
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D032424 2006
% 213.45/213.61  |- skos__annotation mesh__D032424
% 213.45/213.61       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.45/213.61  |- mesh__dateCreated mesh__D032424 2002-07-03
% 213.45/213.61  |- mesh__publicMeSHNote mesh__D032424 2003   
% 213.45/213.61  |- mesh__dateRevised mesh__D032424 2002-09-19
% 213.45/213.61  |- mesh__recordMaintainer mesh__D032424 jls
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D032424 2004
% 213.45/213.61  |- mesh__recordAuthorizer mesh__D032424 jls
% 213.45/213.61  |- mesh__recordOriginator mesh__D004733 NLM
% 213.45/213.61  |- mesh__dateCreated mesh__D004733 1999-01-01
% 213.45/213.61  |- skos__broader mesh__D004733smesh__D004358
% 213.45/213.61  |- mesh__recordMaintainer mesh__D004733 lkt
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D004733 2006
% 213.45/213.61  |- skos__annotation mesh__D004733
% 213.45/213.61       barium enema: coordinate with BARIUM SULFATE /diag use, not BARIUM%A%  
% 213.45/213.61  |- skos__altLabel mesh__D004733 Enemata
% 213.45/213.61  |- mesh__recordAuthorizer mesh__D004733 sjn
% 213.45/213.61  |- skos__hiddenLabel mesh__D004733 Enematas
% 213.45/213.61  |- skos__scopeNote mesh__D004733
% 213.45/213.61       A solution or compound that is introduced into the RECTUM with the purpose of cleansing the COLON or for diagnostic procedures.%A%    
% 213.45/213.61  |- mesh__dateRevised mesh__D004733 2005-06-30
% 213.45/213.61  |- rdf__type mesh__D004733sskos__Concept
% 213.45/213.61  |- skos__hiddenLabel mesh__D004733 Enemas
% 213.45/213.61  |- skos__prefLabel mesh__D004733 Enema
% 213.45/213.61  |- mesh__historyNote mesh__D014363 66%28%64%29%   
% 213.45/213.61  |- skos__prefLabel mesh__D014363 Tryptamines
% 213.45/213.61  |- mesh__dateEstablished mesh__D014363 1966-01-01
% 213.45/213.61  |- mesh__dateCreated mesh__D014363 1999-01-01
% 213.45/213.61  |- mesh__recordAuthorizer mesh__D014363 sjn
% 213.45/213.61  |- rdf__type mesh__D014363sskos__Concept
% 213.45/213.61  |- mesh__recordMaintainer mesh__D014363 sjn
% 213.45/213.61  |- mesh__recordOriginator mesh__D014363 NLM
% 213.45/213.61  |- skos__broader mesh__D014363smesh__D007211
% 213.45/213.61  |- skos__broader mesh__D014363smesh__D015306
% 213.45/213.61  |- skos__scopeNote mesh__D014363
% 213.45/213.61       Decarboxylated monoamine derivatives of TRYPTOPHAN.     
% 213.45/213.61  |- mesh__dateRevised mesh__D014363 2005-07-01
% 213.45/213.61  |- mesh__publicMeSHNote mesh__D014363
% 213.45/213.61       66; METHOXYDIMETHYLTRYPTAMINES was see under SEROTONIN 1980-88%A%  
% 213.45/213.61  |- skos__altLabel mesh__D014363 Indolylethylamines
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D014363 2006
% 213.45/213.61  |- skos__related mesh__D014363smesh__D011985
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D008326 1998
% 213.45/213.61  |- skos__altLabel mesh__D008326 Mammillary Bodies
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D008326 2006
% 213.45/213.61  |- skos__hiddenLabel mesh__D008326 Bodies, Mamillary
% 213.45/213.61  |- skos__scopeNote mesh__D008326
% 213.45/213.61       A pair of nuclei and associated gray matter in the interpeduncular space rostral to the posterior perforated substance in the posterior hypothalamus.%A%    
% 213.45/213.61  |- mesh__historyNote mesh__D008326
% 213.45/213.61       92; was MAMMILLARY BODIES 1971-91; was MAMMILLARY BODIES see under HYPOTHALAMUS 1963-70%A%  
% 213.45/213.61  |- mesh__dateRevised mesh__D008326 1992-05-14
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D008326 2003
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D008326 1999
% 213.45/213.61  |- mesh__recordMaintainer mesh__D008326 TAP
% 213.45/213.61  |- skos__historyNote mesh__D008326 Hypothalamus %28%1966-1970%29%
% 213.45/213.61  |- mesh__publicMeSHNote mesh__D008326
% 213.45/213.61       92; was MAMMILLARY BODIES 1971-91; was MAMMILLARY BODIES see under HYPOTHALAMUS 1963-70%A%  
% 213.45/213.61  |- skos__hiddenLabel mesh__D008326 Bodies, Mammillary
% 213.45/213.61  |- mesh__dateEstablished mesh__D008326 1971-01-01
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D008326 1993
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D008326 2000
% 213.45/213.61  |- skos__broader mesh__D008326smesh__D007034
% 213.45/213.61  |- rdf__type mesh__D008326sskos__Concept
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D008326 1996
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D008326 2004
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D008326 2001
% 213.45/213.61  |- skos__hiddenLabel mesh__D008326 Mammillary Body
% 213.45/213.61  |- skos__prefLabel mesh__D008326 Mamillary Bodies
% 213.45/213.61  |- skos__hiddenLabel mesh__D008326 Body, Mamillary
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D008326 1997
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D008326 1994
% 213.45/213.61  |- mesh__recordOriginator mesh__D008326 NLM
% 213.45/213.61  |- mesh__dateCreated mesh__D008326 1999-01-01
% 213.45/213.61  |- skos__hiddenLabel mesh__D008326 Mamillary Body
% 213.45/213.61  |- mesh__recordAuthorizer mesh__D008326 PLS
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D008326 2005
% 213.45/213.61  |- mesh__onlineNote mesh__D008326
% 213.45/213.61       use MAMILLARY BODIES to search MAMMILLARY BODIES 1971-91   
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D008326 1995
% 213.45/213.61  |- skos__hiddenLabel mesh__D008326 Body, Mammillary
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D008326 2002
% 213.45/213.61  |- skos__broader mesh__D000343smesh__D011183
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D000343 2005
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D000343 2006
% 213.45/213.61  |- mesh__historyNote mesh__D000343
% 213.45/213.61       70%28%69%29%; was see under DUMPING SYNDROME 1963-69   
% 213.45/213.61  |- skos__hiddenLabel mesh__D000343 Syndromes, Afferent Loop
% 213.45/213.61  |- skos__hiddenLabel mesh__D000343 Loop Syndrome, Afferent
% 213.45/213.61  |- skos__broader mesh__D000343smesh__D007415
% 213.45/213.61  |- mesh__dateRevised mesh__D000343 2003-07-09
% 213.45/213.61  |- mesh__recordOriginator mesh__D000343 NLM
% 213.45/213.61  |- rdf__type mesh__D000343sskos__Concept
% 213.45/213.61  |- mesh__dateCreated mesh__D000343 1999-01-01
% 213.45/213.61  |- mesh__recordAuthorizer mesh__D000343 sjn
% 213.45/213.61  |- skos__hiddenLabel mesh__D000343 Loop Syndromes, Afferent
% 213.45/213.61  |- skos__historyNote mesh__D000343 Dumping Syndrome %28%1966-1968%29%
% 213.45/213.61  |- skos__hiddenLabel mesh__D000343 Afferent Loop Syndromes
% 213.45/213.61  |- skos__scopeNote mesh__D000343
% 213.45/213.61       A complication of gastrojejunostomy %28%BILLROTH II PROCEDURE%29%, a reconstructive GASTROENTEROSTOMY. It is caused by acute %28%complete%29% or chronic %28%intermittent%29% obstruction of the afferent jejunal loop due to HERNIA, intussusception, kinking, VOLVULUS, etc. It is characterized by PAIN and VOMITING of BILE-stained fluid.%A%    
% 213.45/213.61  |- skos__hiddenLabel mesh__D000343 Syndrome, Afferent Loop
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D000343 2004
% 213.45/213.61  |- mesh__publicMeSHNote mesh__D000343
% 213.45/213.61       70; was see under DUMPING SYNDROME 1963-69   
% 213.45/213.61  |- mesh__recordMaintainer mesh__D000343 lkt
% 213.45/213.61  |- skos__prefLabel mesh__D000343 Afferent Loop Syndrome
% 213.45/213.61  |- mesh__dateEstablished mesh__D000343 1970-01-01
% 213.45/213.61  |- mesh__onlineNote mesh__D000343 search DUMPING SYNDROME 1966-68   
% 213.45/213.61  |- skos__annotation mesh__D018754
% 213.45/213.61       ventric refers to the heart, not the cerebral ventricles; GEN or unspecified: prefer VENTRICULAR DYSFUNCTION, LEFT or VENTRICULAR DYSFUNCTION, RIGHT%A%  
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D018754 2002
% 213.45/213.61  |- mesh__historyNote mesh__D018754 95   
% 213.45/213.61  |- skos__hiddenLabel mesh__D018754 Ventricular Dysfunctions
% 213.45/213.61  |- mesh__recordMaintainer mesh__D018754 TGC
% 213.45/213.61  |- mesh__activeMeSHYear mesh__D018754 1998
% 213.45/213.61  |- skos__hiddenLabel mesh__D018754 Dysfunctions, Ventricular
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D018754 2005
% 213.45/213.62  |- mesh__dateRevised mesh__D018754 1996-06-10
% 213.45/213.62  |- mesh__publicMeSHNote mesh__D018754 95   
% 213.45/213.62  |- skos__scopeNote mesh__D018754
% 213.45/213.62       A condition in which the ventricles of the heart exhibit a decreased functionality.%A%    
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D018754 1999
% 213.45/213.62  |- skos__prefLabel mesh__D018754 Ventricular Dysfunction
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D018754 2003
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D018754 2006
% 213.45/213.62  |- mesh__dateCreated mesh__D018754 1994-02-28
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D018754 2000
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D018754 1997
% 213.45/213.62  |- skos__broader mesh__D018754smesh__D006331
% 213.45/213.62  |- mesh__recordOriginator mesh__D018754 PXP
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D018754 2004
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D018754 2001
% 213.45/213.62  |- mesh__recordAuthorizer mesh__D018754 PLS
% 213.45/213.62  |- skos__hiddenLabel mesh__D018754 Dysfunction, Ventricular
% 213.45/213.62  |- mesh__dateEstablished mesh__D018754 1995-01-01
% 213.45/213.62  |- rdf__type mesh__D018754sskos__Concept
% 213.45/213.62  |- mesh__historyNote mesh__D032425 2003   
% 213.45/213.62  |- mesh__dateCreated mesh__D032425 2002-07-03
% 213.45/213.62  |- mesh__dateEstablished mesh__D032425 2003-01-01
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D032425 2005
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D032425 2003
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D032425 2006
% 213.45/213.62  |- skos__annotation mesh__D032425
% 213.45/213.62       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D032425 2004
% 213.45/213.62  |- mesh__publicMeSHNote mesh__D032425 2003   
% 213.45/213.62  |- skos__scopeNote mesh__D032425
% 213.45/213.62       A plant genus of the family WINTERACEAE. Members contain polygodial.%A%    
% 213.45/213.62  |- skos__prefLabel mesh__D032425 Pseudowintera
% 213.45/213.62  |- skos__broader mesh__D032425smesh__D032423
% 213.45/213.62  |- rdf__type mesh__D032425sskos__Concept
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004734 2004
% 213.45/213.62  |- mesh__dateCreated mesh__D004734 1999-01-01
% 213.45/213.62  |- skos__hiddenLabel mesh__D004734 Bioenergetic
% 213.45/213.62  |- skos__broader mesh__D004734smesh__D008660
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004734 1995
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004734 1996
% 213.45/213.62  |- mesh__historyNote mesh__D004734 74,63-65   
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004734 2005
% 213.45/213.62  |- skos__hiddenLabel mesh__D004734 Energy Metabolisms
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004734 1997
% 213.45/213.62  |- skos__hiddenLabel mesh__D004734 Metabolisms, Energy
% 213.45/213.62  |- skos__hiddenLabel mesh__D004734 Energy Expenditures
% 213.45/213.62  |- mesh__publicMeSHNote mesh__D004734 74,63-65   
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004734 2006
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004734 2000
% 213.45/213.62  |- skos__prefLabel mesh__D004734 Energy Metabolism
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004734 1998
% 213.45/213.62  |- mesh__recordMaintainer mesh__D004734 TAP
% 213.45/213.62  |- rdf__type mesh__D004734sskos__Concept
% 213.45/213.62  |- mesh__dateEstablished mesh__D004734 1974-01-01
% 213.45/213.62  |- skos__hiddenLabel mesh__D004734 Expenditures, Energy
% 213.45/213.62  |- mesh__recordAuthorizer mesh__D004734 PLS
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004734 2001
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004734 1993
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004734 2003
% 213.45/213.62  |- skos__altLabel mesh__D004734 Energy Expenditure
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004734 1999
% 213.45/213.62  |- skos__hiddenLabel mesh__D004734 Metabolism, Energy
% 213.45/213.62  |- skos__hiddenLabel mesh__D004734 Expenditure, Energy
% 213.45/213.62  |- mesh__recordOriginator mesh__D004734 NLM
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004734 1994
% 213.45/213.62  |- mesh__dateRevised mesh__D004734 1992-05-15
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004734 2002
% 213.45/213.62  |- skos__altLabel mesh__D014364 ratio-Tryptophan
% 213.45/213.62  |- skos__altLabel mesh__D014364 Levotryptophan
% 213.45/213.62  |- skos__altLabel mesh__D014364 Ardeypharm Brand of Tryptophan
% 213.45/213.62  |- skos__hiddenLabel mesh__D014364 ratio Tryptophan
% 213.45/213.62  |- skos__altLabel mesh__D014364 L-Tryptophan
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D014364 2006
% 213.45/213.62  |- mesh__dateCreated mesh__D014364 1999-01-01
% 213.45/213.62  |- skos__altLabel mesh__D014364 Niddapharm Brand of Tryptophan
% 213.45/213.62  |- skos__hiddenLabel mesh__D014364 PMS Tryptophan
% 213.45/213.62  |- skos__related mesh__D014364smesh__D016603
% 213.45/213.62  |- skos__hiddenLabel mesh__D014364 L Tryptophan ratiopharm
% 213.45/213.62  |- skos__altLabel mesh__D014364 esparma Brand of Tryptophan
% 213.45/213.62  |- skos__broader mesh__D014364smesh__D024322
% 213.45/213.62  |- skos__altLabel mesh__D014364 Ratiopharm Brand of Tryptophan
% 213.45/213.62  |- skos__hiddenLabel mesh__D014364 L Tryptophan
% 213.45/213.62  |- mesh__recordMaintainer mesh__D014364 CCR
% 213.45/213.62  |- skos__altLabel mesh__D014364 Ardeytropin
% 213.45/213.62  |- skos__altLabel mesh__D014364 Pharmascience Brand of Tryptophan
% 213.45/213.62  |- skos__altLabel mesh__D014364 Naturruhe
% 213.45/213.62  |- skos__altLabel mesh__D014364 Merck Brand of Tryptophan
% 213.45/213.62  |- mesh__dateRevised mesh__D014364 2005-06-30
% 213.45/213.62  |- skos__prefLabel mesh__D014364 Tryptophan
% 213.45/213.62  |- skos__broader mesh__D014364smesh__D000601
% 213.45/213.62  |- rdf__type mesh__D014364sskos__Concept
% 213.45/213.62  |- skos__scopeNote mesh__D014364
% 213.45/213.62       An essential amino acid that is necessary for normal growth in infants and for NITROGEN balance in adults. It is a precursor of INDOLE ALKALOIDS in plants. It is a precursor of SEROTONIN %28%hence its use as an antidepressant and sleep aid%29%. It can be a precursor to NIACIN, albeit inefficiently, in mammals.%A%    
% 213.45/213.62  |- mesh__recordAuthorizer mesh__D014364 sjn
% 213.45/213.62  |- skos__altLabel mesh__D014364 ICN Brand of Tryptophan
% 213.45/213.62  |- mesh__recordOriginator mesh__D014364 NLM
% 213.45/213.62  |- skos__altLabel mesh__D014364 Upsher-Smith Brand of Tryptophan
% 213.45/213.62  |- skos__annotation mesh__D008327 DF: MAMMOGR   
% 213.45/213.62  |- mesh__publicMeSHNote mesh__D008327 66   
% 213.45/213.62  |- rdf__type mesh__D008327sskos__Concept
% 213.45/213.62  |- skos__hiddenLabel mesh__D008327 Mammographies
% 213.45/213.62  |- mesh__recordOriginator mesh__D008327 NLM
% 213.45/213.62  |- mesh__historyNote mesh__D008327 66%28%64%29%   
% 213.45/213.62  |- mesh__recordAuthorizer mesh__D008327 sjn
% 213.45/213.62  |- mesh__dateCreated mesh__D008327 1999-01-01
% 213.45/213.62  |- skos__broader mesh__D008327smesh__D011859
% 213.45/213.62  |- skos__scopeNote mesh__D008327
% 213.45/213.62       Radiographic examination of the breast.     
% 213.45/213.62  |- mesh__dateEstablished mesh__D008327 1966-01-01
% 213.45/213.62  |- mesh__recordMaintainer mesh__D008327 ags
% 213.45/213.62  |- mesh__dateRevised mesh__D008327 2005-06-30
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D008327 2006
% 213.45/213.62  |- skos__prefLabel mesh__D008327 Mammography
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D000344 1995
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D000344 2000
% 213.45/213.62  |- skos__hiddenLabel mesh__D000344 Afferent Pathway
% 213.45/213.62  |- skos__historyNote mesh__D000344 specific central nervous system heading
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D000344 2001
% 213.45/213.62  |- skos__scopeNote mesh__D000344
% 213.45/213.62       Nerve structures through which impulses are conducted from a peripheral part toward a nerve center.%A%    
% 213.45/213.62  |- skos__hiddenLabel mesh__D000344 Pathway, Afferent
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D000344 2002
% 213.45/213.62  |- skos__historyNote mesh__D000344 Receptors, Sensory %28%1966-1975%29%
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D000344 1996
% 213.45/213.62  |- rdf__type mesh__D000344sskos__Concept
% 213.45/213.62  |- mesh__historyNote mesh__D000344 76; was NON MESH before 1976   
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D000344 2003
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D000344 1997
% 213.45/213.62  |- skos__historyNote mesh__D000344 specific sensory receptor
% 213.45/213.62  |- mesh__publicMeSHNote mesh__D000344 76   
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D000344 1993
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D000344 2004
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D000344 1998
% 213.45/213.62  |- skos__broader mesh__D000344smesh__D009434
% 213.45/213.62  |- skos__historyNote mesh__D000344 Neurons, Afferent %28%1969-1975%29%
% 213.45/213.62  |- skos__hiddenLabel mesh__D000344 Pathways, Afferent
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D000344 2005
% 213.45/213.62  |- skos__annotation mesh__D000344
% 213.45/213.62       coord NIM with origin %28%IM%29% + termination %28%IM%29%   
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D000344 1994
% 213.45/213.62  |- skos__prefLabel mesh__D000344 Afferent Pathways
% 213.45/213.62  |- mesh__dateRevised mesh__D000344 1992-03-25
% 213.45/213.62  |- mesh__recordMaintainer mesh__D000344 TAP
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D000344 1999
% 213.45/213.62  |- mesh__recordAuthorizer mesh__D000344 PLS
% 213.45/213.62  |- mesh__dateEstablished mesh__D000344 1976-01-01
% 213.45/213.62  |- mesh__recordOriginator mesh__D000344 SMH
% 213.45/213.62  |- mesh__dateCreated mesh__D000344 1975-07-25
% 213.45/213.62  |- skos__historyNote mesh__D000344 Neural Transmission %28%1968-1975%29%
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D000344 2006
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D032426 2005
% 213.45/213.62  |- skos__broader mesh__D032426smesh__D019862
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D032426 2003
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D032426 2006
% 213.45/213.62  |- skos__prefLabel mesh__D032426 Marantaceae
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D032426 2004
% 213.45/213.62  |- mesh__publicMeSHNote mesh__D032426 2003   
% 213.45/213.62  |- mesh__historyNote mesh__D032426 2003   
% 213.45/213.62  |- skos__altLabel mesh__D032426 Arrowroot
% 213.45/213.62  |- rdf__type mesh__D032426sskos__Concept
% 213.45/213.62  |- skos__scopeNote mesh__D032426
% 213.45/213.62       A plant family of the order ZINGIBERALES, subclass Zingiberidae, class Liliopsida.%A%    
% 213.45/213.62  |- mesh__dateEstablished mesh__D032426 2003-01-01
% 213.45/213.62  |- skos__annotation mesh__D032426
% 213.45/213.62       X ref ARROWROOT: BRAZILIAN ARROWROOT see MANIHOT is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.45/213.62  |- mesh__dateCreated mesh__D032426 2002-07-02
% 213.45/213.62  |- mesh__dateRevised mesh__D018755 2005-06-30
% 213.45/213.62  |- skos__hiddenLabel mesh__D018755 Agonist, GABA Receptor
% 213.45/213.62  |- skos__altLabel mesh__D018755 gamma-Aminobutyric Acid Agonist
% 213.45/213.62  |- skos__annotation mesh__D018755
% 213.45/213.62       GEN or unspecified; prefer specifics; do not confuse with GABA ANTAGONISTS; DF: GABA AGON or GABA AG%A%  
% 213.45/213.62  |- mesh__dateEstablished mesh__D018755 1995-01-01
% 213.45/213.62  |- skos__hiddenLabel mesh__D018755 Acid Agonist, gamma-Aminobutyric
% 213.45/213.62  |- skos__altLabel mesh__D018755 GABA Agonist
% 213.45/213.62  |- mesh__recordMaintainer mesh__D018755 ssb
% 213.45/213.62  |- skos__hiddenLabel mesh__D018755 Agonist, GABA
% 213.45/213.62  |- skos__altLabel mesh__D018755 gamma-Aminobutyric Acid Agonists
% 213.45/213.62  |- mesh__recordOriginator mesh__D018755 RAZ
% 213.45/213.62  |- mesh__dateCreated mesh__D018755 1994-06-03
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D018755 2006
% 213.45/213.62  |- skos__hiddenLabel mesh__D018755 gamma Aminobutyric Acid Agonists
% 213.45/213.62  |- skos__hiddenLabel mesh__D018755 Agonists, GABA Receptor
% 213.45/213.62  |- skos__hiddenLabel mesh__D018755 gamma Aminobutyric Acid Agonist
% 213.45/213.62  |- skos__hiddenLabel mesh__D018755 Agonists, gamma-Aminobutyric Acid
% 213.45/213.62  |- skos__scopeNote mesh__D018755
% 213.45/213.62       Drugs that bind to and activate GAMMA-AMINOBUTYRIC ACID receptors %28%RECEPTORS, GABA%29%.%A%    
% 213.45/213.62  |- skos__altLabel mesh__D018755 GABA Receptor Agonist
% 213.45/213.62  |- skos__hiddenLabel mesh__D018755 Receptor Agonist, GABA
% 213.45/213.62  |- mesh__publicMeSHNote mesh__D018755 95   
% 213.45/213.62  |- mesh__recordAuthorizer mesh__D018755 sjn
% 213.45/213.62  |- rdf__type mesh__D018755sskos__Concept
% 213.45/213.62  |- skos__hiddenLabel mesh__D018755 Receptor Agonists, GABA
% 213.45/213.62  |- skos__hiddenLabel mesh__D018755 Agonist, gamma-Aminobutyric Acid
% 213.45/213.62  |- skos__hiddenLabel mesh__D018755 Acid Agonists, gamma-Aminobutyric
% 213.45/213.62  |- skos__broader mesh__D018755smesh__D018682
% 213.45/213.62  |- mesh__historyNote mesh__D018755 95   
% 213.45/213.62  |- skos__altLabel mesh__D018755 GABA Receptor Agonists
% 213.45/213.62  |- skos__hiddenLabel mesh__D018755 Agonists, GABA
% 213.45/213.62  |- skos__prefLabel mesh__D018755 GABA Agonists
% 213.45/213.62  |- skos__broader mesh__D010772smesh__D017973
% 213.45/213.62  |- rdf__type mesh__D010772sskos__Concept
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D010772 1996
% 213.45/213.62  |- mesh__publicMeSHNote mesh__D010772 68   
% 213.45/213.62  |- mesh__historyNote mesh__D010772 68%28%64%29%   
% 213.45/213.62  |- skos__scopeNote mesh__D010772
% 213.45/213.62       Tungsten hydroxide oxide phosphate. A white or slightly yellowish-green, slightly efflorescent crystal or crystalline powder. It is used as a reagent for alkaloids and many other nitrogen bases, for phenols, albumin, peptone, amino acids, uric acid, urea, blood, and carbohydrates. %28%From Merck Index, 11th ed%29%%A%    
% 213.45/213.62  |- mesh__recordAuthorizer mesh__D010772 PLS
% 213.45/213.62  |- mesh__dateEstablished mesh__D010772 1968-01-01
% 213.45/213.62  |- mesh__recordMaintainer mesh__D010772 TPW
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D010772 2006
% 213.45/213.62  |- mesh__dateRevised mesh__D010772 1993-06-04
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D010772 2001
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D010772 1995
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D010772 2005
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D010772 2004
% 213.45/213.62  |- skos__prefLabel mesh__D010772 Phosphotungstic Acid
% 213.45/213.62  |- mesh__recordOriginator mesh__D010772 NLM
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D010772 2000
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D010772 1994
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D010772 2003
% 213.45/213.62  |- mesh__dateCreated mesh__D010772 1999-01-01
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D010772 1999
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D010772 2002
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D010772 1997
% 213.45/213.62  |- skos__hiddenLabel mesh__D010772 Acid, Phosphotungstic
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D010772 1998
% 213.45/213.62  |- skos__broader mesh__D010772smesh__D010756
% 213.45/213.62  |- skos__broader mesh__D002648Q000523smesh__D002648
% 213.45/213.62  |- mesh__preferredCombination mesh__D002648Q000523smesh__D002666
% 213.45/213.62  |- rdf__type mesh__D002648Q000523smesh__CompoundConcept
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004735 2005
% 213.45/213.62  |- mesh__recordOriginator mesh__D004735 NLM
% 213.45/213.62  |- mesh__historyNote mesh__D004735 68%28%65%29%   
% 213.45/213.62  |- skos__scopeNote mesh__D004735
% 213.45/213.62       The transfer of energy of a given form among different scales of motion. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%. In biochemistry, this concept generally refers to the transfer of groups from compounds that contain energy-rich bonding arrangements to compounds that have relatively energy-poor bonding characteristics via thermodynamically permissible enzymatic reactions. This principle is a major premise of the interaction between energy-producing and energy-utilizing metabolic pathways in living cells. %28%From Devlin, Textbook of biochemistry with clinical correlations, 3d ed, p246%29%%A%    
% 213.45/213.62  |- skos__broader mesh__D004735smesh__D001669
% 213.45/213.62  |- skos__broader mesh__D004735smesh__D001703
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004735 2002
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004735 1997
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004735 2006
% 213.45/213.62  |- mesh__dateEstablished mesh__D004735 1968-01-01
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004735 1998
% 213.45/213.62  |- rdf__type mesh__D004735sskos__Concept
% 213.45/213.62  |- mesh__publicMeSHNote mesh__D004735 68   
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004735 2003
% 213.45/213.62  |- mesh__dateRevised mesh__D004735 1995-06-08
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004735 1999
% 213.45/213.62  |- skos__hiddenLabel mesh__D004735 Transfer, Energy
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004735 2000
% 213.45/213.62  |- skos__broader mesh__D004735smesh__D002627
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004735 2004
% 213.45/213.62  |- mesh__recordMaintainer mesh__D004735 TAP
% 213.45/213.62  |- mesh__dateCreated mesh__D004735 1999-01-01
% 213.45/213.62  |- mesh__recordAuthorizer mesh__D004735 PLS
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004735 2001
% 213.45/213.62  |- skos__prefLabel mesh__D004735 Energy Transfer
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D004735 1996
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D009420 2003
% 213.45/213.62  |- mesh__dateCreated mesh__D009420 1999-01-01
% 213.45/213.62  |- mesh__considerAlso mesh__D009420
% 213.45/213.62       consider also terms at NERVE and NEUR-   
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D009420 2004
% 213.45/213.62  |- mesh__recordMaintainer mesh__D009420 lkt
% 213.45/213.62  |- skos__hiddenLabel mesh__D009420 Nervous Systems
% 213.45/213.62  |- rdf__type mesh__D009420sskos__Concept
% 213.45/213.62  |- skos__hiddenLabel mesh__D009420 System, Nervous
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D009420 2005
% 213.45/213.62  |- skos__scopeNote mesh__D009420
% 213.45/213.62       The entire nerve apparatus, composed of a central part, the brain and spinal cord, and a peripheral part, the cranial and spinal nerves, autonomic ganglia, and plexuses. %28%Stedman, 26th ed%29%%A%    
% 213.45/213.62  |- skos__hiddenLabel mesh__D009420 Systems, Nervous
% 213.45/213.62  |- skos__annotation mesh__D009420
% 213.45/213.62       GEN only; /innerv is available for organs: Manual 19.8.39, 21.7+; for %22%nerves%22% but not for a specific nerve nor NERVE TISSUE; NERVOUS SYSTEM /anat as a SPEC = NEUROANATOMY, NERVOUS SYSTEM /chem as a SPEC = NEUROCHEMISTRY, NERVOUS SYSTEM /physiol as a SPEC = NEUROPHYSIOLOGY, NERVOUS SYSTEM /radiogr as a SPEC = NEURORADIOGRAPHY, NERVOUS SYSTEM /surg as a SPEC = NEUROSURGERY;%A%  
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D009420 2006
% 213.45/213.62  |- mesh__recordOriginator mesh__D009420 NLM
% 213.45/213.62  |- mesh__dateRevised mesh__D009420 2002-07-03
% 213.45/213.62  |- mesh__recordAuthorizer mesh__D009420 sjn
% 213.45/213.62  |- skos__prefLabel mesh__D009420 Nervous System
% 213.45/213.62  |- skos__related mesh__D009420smesh__D009461
% 213.45/213.62  |- mesh__runningHead mesh__D009420 A8 - ANATOMY-NERVOUS SYSTEM   
% 213.45/213.62  |- mesh__dateCreated mesh__D014365 1999-01-01
% 213.45/213.62  |- mesh__recordAuthorizer mesh__D014365 sjn
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D014365 2005
% 213.45/213.62  |- mesh__recordOriginator mesh__D014365 NLM
% 213.45/213.62  |- mesh__dateRevised mesh__D014365 2004-07-07
% 213.45/213.62  |- mesh__publicMeSHNote mesh__D014365
% 213.45/213.62       78; was see under HYDROXYLASES 1975-77   
% 213.45/213.62  |- skos__hiddenLabel mesh__D014365 Hydroxylase, Tryptophan
% 213.45/213.62  |- skos__broader mesh__D014365smesh__D006899
% 213.45/213.62  |- skos__historyNote mesh__D014365 Hydroxylases %28%1966-1972%29%
% 213.45/213.62  |- mesh__dateEstablished mesh__D014365 1978-01-01
% 213.45/213.62  |- mesh__recordMaintainer mesh__D014365 ssb
% 213.45/213.62  |- mesh__historyNote mesh__D014365
% 213.45/213.62       78%28%73%29%; was see under HYDROXYLASES 1975-77   
% 213.45/213.62  |- rdf__type mesh__D014365sskos__Concept
% 213.45/213.62  |- skos__altLabel mesh__D014365 Tryptophan Monooxygenase
% 213.45/213.62  |- skos__related mesh__D014365smesh__D014366
% 213.45/213.62  |- skos__hiddenLabel mesh__D014365 Monooxygenase, Tryptophan
% 213.45/213.62  |- skos__scopeNote mesh__D014365
% 213.45/213.62       An enzyme that catalyzes the hydroxylation of TRYPTOPHAN to 5-HYDROXYTRYPTOPHAN in the presence of NADPH and molecular oxygen. It is important in the biosynthesis of SEROTONIN.%A%    
% 213.45/213.62  |- skos__prefLabel mesh__D014365 Tryptophan Hydroxylase
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D014365 2006
% 213.45/213.62  |- skos__broader mesh__D008328smesh__D006804
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D008328 1997
% 213.45/213.62  |- mesh__historyNote mesh__D008328 70%28%66%29%   
% 213.45/213.62  |- skos__prefLabel mesh__D008328 Man-Machine Systems
% 213.45/213.62  |- mesh__dateCreated mesh__D008328 1999-01-01
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D008328 2001
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D008328 1994
% 213.45/213.62  |- skos__scopeNote mesh__D008328
% 213.45/213.62       A system in which the functions of the man and the machine are interrelated and necessary for the operation of the system.%A%    
% 213.45/213.62  |- mesh__dateEstablished mesh__D008328 1970-01-01
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D008328 2005
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D008328 1995
% 213.45/213.62  |- skos__hiddenLabel mesh__D008328 System, Man-Machine
% 213.45/213.62  |- mesh__recordAuthorizer mesh__D008328 PLS
% 213.45/213.62  |- mesh__recordOriginator mesh__D008328 NLM
% 213.45/213.62  |- mesh__publicMeSHNote mesh__D008328 70   
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D008328 2006
% 213.45/213.62  |- skos__annotation mesh__D008328
% 213.45/213.62       no qualif; with computers, USER-COMPUTER INTERFACE is also available%A%  
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D008328 1998
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D008328 2002
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D008328 1992
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D008328 1999
% 213.45/213.62  |- mesh__dateRevised mesh__D008328 1991-01-08
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D008328 2003
% 213.45/213.62  |- skos__hiddenLabel mesh__D008328 Systems, Man-Machine
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D008328 1993
% 213.45/213.62  |- mesh__recordMaintainer mesh__D008328 TGC
% 213.45/213.62  |- skos__broader mesh__D008328smesh__D013672
% 213.45/213.62  |- rdf__type mesh__D008328sskos__Concept
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D008328 2004
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D008328 1996
% 213.45/213.62  |- skos__hiddenLabel mesh__D008328 Man Machine Systems
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D008328 2000
% 213.45/213.62  |- skos__hiddenLabel mesh__D008328 Man-Machine System
% 213.45/213.62  |- skos__scopeNote mesh__D000345
% 213.45/213.62       Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids.%A%    
% 213.45/213.62  |- skos__hiddenLabel mesh__D000345 Labeling Reagents, Affinity
% 213.45/213.62  |- skos__historyNote mesh__D000345 Binding Sites %28%1968-1974%29%
% 213.45/213.62  |- mesh__recordMaintainer mesh__D000345 ssb
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D000345 2006
% 213.45/213.62  |- skos__hiddenLabel mesh__D000345 Reagents, Affinity Labeling
% 213.45/213.62  |- rdf__type mesh__D000345sskos__Concept
% 213.45/213.62  |- skos__broader mesh__D000345smesh__D007202
% 213.45/213.62  |- mesh__dateRevised mesh__D000345 2003-07-09
% 213.45/213.62  |- skos__historyNote mesh__D000345
% 213.45/213.62       Indicators and Reagents %28%1968-1974%29%
% 213.45/213.62  |- skos__hiddenLabel mesh__D000345 Labels, Affinity
% 213.45/213.62  |- mesh__dateCreated mesh__D000345 1974-11-19
% 213.45/213.62  |- mesh__recordOriginator mesh__D000345 NLM
% 213.45/213.62  |- skos__prefLabel mesh__D000345 Affinity Labels
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D000345 2004
% 213.45/213.62  |- skos__altLabel mesh__D000345 Affinity Labeling Reagents
% 213.45/213.62  |- mesh__historyNote mesh__D000345 75   
% 213.45/213.62  |- mesh__recordAuthorizer mesh__D000345 sjn
% 213.45/213.62  |- skos__annotation mesh__D000345
% 213.45/213.62       D25-26 qualif; use with caution: few apply   
% 213.45/213.62  |- mesh__publicMeSHNote mesh__D000345 75   
% 213.45/213.62  |- mesh__dateEstablished mesh__D000345 1975-09-01
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D000345 2005
% 213.45/213.62  |- mesh__recordAuthorizer mesh__D019050 sjn
% 213.45/213.62  |- skos__broader mesh__D019050smesh__D008405
% 213.45/213.62  |- skos__altLabel mesh__D019050 Zhi Ya
% 213.45/213.62  |- rdf__type mesh__D019050sskos__Concept
% 213.45/213.62  |- skos__historyNote mesh__D019050 Acupuncture Points %28%1990-1995%29%
% 213.45/213.62  |- skos__altLabel mesh__D019050 Chih Ya
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D019050 2006
% 213.45/213.62  |- skos__prefLabel mesh__D019050 Acupressure
% 213.45/213.62  |- mesh__dateCreated mesh__D019050 1995-05-26
% 213.45/213.62  |- mesh__recordMaintainer mesh__D019050 lkt
% 213.45/213.62  |- mesh__publicMeSHNote mesh__D019050 96   
% 213.45/213.62  |- mesh__dateEstablished mesh__D019050 1996-01-01
% 213.45/213.62  |- mesh__historyNote mesh__D019050 96   
% 213.45/213.62  |- mesh__recordOriginator mesh__D019050 TGC
% 213.45/213.62  |- mesh__dateRevised mesh__D019050 2005-06-30
% 213.45/213.62  |- skos__scopeNote mesh__D019050
% 213.45/213.62       A type of massage in which finger pressure on specific body sites is used to promote healing, relieve fatigue, etc. Although the anatomical locations are the same as the ACUPUNCTURE POINTS used in ACUPUNCTURE THERAPY %28%hence acu-%29%, no needle or other acupuncture technique is employed in acupressure. %28%From Random House Unabridged Dictionary, 2d ed%29%. Shiatsu is a modern outgrowth that focuses more on prevention than healing.%A%    
% 213.45/213.62  |- skos__historyNote mesh__D019050 Pressure %28%1983-1995%29%
% 213.45/213.62  |- skos__altLabel mesh__D019050 Shiatzu
% 213.45/213.62  |- skos__broader mesh__D019050smesh__D015670
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D005030 2003
% 213.45/213.62  |- rdf__type mesh__D005030sskos__Concept
% 213.45/213.62  |- mesh__dateCreated mesh__D005030 1999-01-01
% 213.45/213.62  |- mesh__historyNote mesh__D005030 75; was ETHYLENE 1963-74   
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D005030 1998
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D005030 1997
% 213.45/213.62  |- mesh__publicMeSHNote mesh__D005030 75; was ETHYLENE 1963-74   
% 213.45/213.62  |- skos__scopeNote mesh__D005030
% 213.45/213.62       Derivatives of ethylene, a simple organic gas of biological origin with many industrial and biological use.%A%    
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D005030 2002
% 213.45/213.62  |- skos__broader mesh__D005030smesh__D000475
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D005030 1996
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D005030 2006
% 213.45/213.62  |- mesh__onlineNote mesh__D005030
% 213.45/213.62       use ETHYLENES to search ETHYLENE 1966-74   
% 213.45/213.62  |- mesh__recordAuthorizer mesh__D005030 PLS
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D005030 2001
% 213.45/213.62  |- skos__prefLabel mesh__D005030 Ethylenes
% 213.45/213.62  |- mesh__recordOriginator mesh__D005030 NLM
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D005030 2000
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D005030 2005
% 213.45/213.62  |- skos__related mesh__D005030smesh__D011095
% 213.45/213.62  |- mesh__dateRevised mesh__D005030 1995-05-18
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D005030 2004
% 213.45/213.62  |- mesh__recordMaintainer mesh__D005030 TAP
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D005030 1999
% 213.45/213.62  |- mesh__recordOriginator mesh__D018756 RAZ
% 213.45/213.62  |- skos__hiddenLabel mesh__D018756 Antagonists, gamma-Aminobutyric Acid
% 213.45/213.62  |- rdf__type mesh__D018756sskos__Concept
% 213.45/213.62  |- mesh__publicMeSHNote mesh__D018756 95   
% 213.45/213.62  |- mesh__recordAuthorizer mesh__D018756 sjn
% 213.45/213.62  |- skos__hiddenLabel mesh__D018756 Receptor Antagonists, GABA
% 213.45/213.62  |- skos__hiddenLabel mesh__D018756 Antagonists, GABA Receptor
% 213.45/213.62  |- skos__hiddenLabel mesh__D018756 gamma Aminobutyric Acid Antagonists
% 213.45/213.62  |- mesh__dateCreated mesh__D018756 1994-06-03
% 213.45/213.62  |- skos__broader mesh__D018756smesh__D018682
% 213.45/213.62  |- skos__altLabel mesh__D018756 GABA Antagonist
% 213.45/213.62  |- mesh__dateEstablished mesh__D018756 1995-01-01
% 213.45/213.62  |- mesh__recordMaintainer mesh__D018756 ssb
% 213.45/213.62  |- skos__hiddenLabel mesh__D018756 Antagonists, GABA
% 213.45/213.62  |- mesh__dateRevised mesh__D018756 2005-06-30
% 213.45/213.62  |- skos__historyNote mesh__D018756
% 213.45/213.62       GABA/antagonists %26% inhibitors %28%1974-1994%29%
% 213.45/213.62  |- skos__altLabel mesh__D018756 GABA Receptor Antagonists
% 213.45/213.62  |- skos__hiddenLabel mesh__D018756 Antagonist, GABA
% 213.45/213.62  |- skos__scopeNote mesh__D018756
% 213.45/213.62       Drugs that bind to but do not activate GAMMA-AMINOBUTYRIC ACID receptors, thereby blocking the actions of endogenous GAMMA-AMINOBUTYRIC ACID or GAMMA-AMINOBUTYRIC ACID agonists.%A%    
% 213.45/213.62  |- mesh__activeMeSHYear mesh__D018756 2006
% 213.45/213.62  |- mesh__historyNote mesh__D018756 95   
% 213.45/213.62  |- skos__altLabel mesh__D018756 gamma-Aminobutyric Acid Antagonists
% 213.45/213.62  |- skos__prefLabel mesh__D018756 GABA Antagonists
% 213.45/213.62  |- skos__annotation mesh__D018756
% 213.45/213.62       GEN or unspecified; prefer specifics; do not confuse with GABA AGONISTS; DF: GABA ANTAG%A%  
% 213.45/213.63  |- skos__hiddenLabel mesh__D018756 Acid Antagonists, gamma-Aminobutyric
% 213.45/213.63  |- skos__historyNote mesh__D010773
% 213.45/213.63       Insecticides, Organothiophosphate %28%1973-1974%29%
% 213.45/213.63  |- skos__historyNote mesh__D010773 Benzene Derivatives %28%1974%29%
% 213.45/213.63  |- skos__prefLabel mesh__D010773 Leptophos
% 213.45/213.63  |- mesh__recordOriginator mesh__D010773 NLM
% 213.45/213.63  |- mesh__publicMeSHNote mesh__D010773
% 213.45/213.63       96; was PHOSVEL 1975-95 %28%see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1975-90%29%; LEPTOPHOS was see PHOSVEL 1975-95%A%  
% 213.45/213.63  |- mesh__dateRevised mesh__D010773 2005-06-30
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D010773 2006
% 213.45/213.63  |- skos__scopeNote mesh__D010773 An organothiophosphate insecticide.     
% 213.45/213.63  |- mesh__historyNote mesh__D010773
% 213.45/213.63       96; was PHOSVEL 1975-95 %28%see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1975-90%29%; LEPTOPHOS was see PHOSVEL 1975-95%A%  
% 213.45/213.63  |- mesh__dateEstablished mesh__D010773 1991-01-01
% 213.45/213.63  |- mesh__dateCreated mesh__D010773 1974-11-19
% 213.45/213.63  |- skos__annotation mesh__D010773 TN 111 for eff on insects   
% 213.45/213.63  |- skos__broader mesh__D010773smesh__D009946
% 213.45/213.63  |- rdf__type mesh__D010773sskos__Concept
% 213.45/213.63  |- mesh__recordAuthorizer mesh__D010773 sjn
% 213.45/213.63  |- mesh__recordMaintainer mesh__D010773 ssb
% 213.45/213.63  |- skos__prefLabel mesh__D032427 Heliconiaceae
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D032427 2004
% 213.45/213.63  |- mesh__publicMeSHNote mesh__D032427 2003   
% 213.45/213.63  |- rdf__type mesh__D032427sskos__Concept
% 213.45/213.63  |- skos__scopeNote mesh__D032427
% 213.45/213.63       A plant family of the order ZINGIBERALES, subclass Zingiberidae, class Liliopsida.%A%    
% 213.45/213.63  |- mesh__historyNote mesh__D032427 2003   
% 213.45/213.63  |- mesh__dateCreated mesh__D032427 2002-07-03
% 213.45/213.63  |- mesh__dateEstablished mesh__D032427 2003-01-01
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D032427 2005
% 213.45/213.63  |- skos__broader mesh__D032427smesh__D019862
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D032427 2003
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D032427 2006
% 213.45/213.63  |- skos__annotation mesh__D032427
% 213.45/213.63       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.45/213.63  |- rdf__type mesh__D004736sskos__Concept
% 213.45/213.63  |- skos__hiddenLabel mesh__D004736 Resources, Energy-Generating
% 213.45/213.63  |- mesh__dateEstablished mesh__D004736 1982-01-01
% 213.45/213.63  |- skos__hiddenLabel mesh__D004736 Energy-Generating Resource
% 213.45/213.63  |- skos__prefLabel mesh__D004736 Energy-Generating Resources
% 213.45/213.63  |- mesh__historyNote mesh__D004736 82   
% 213.45/213.63  |- mesh__dateRevised mesh__D004736 2005-06-30
% 213.45/213.63  |- skos__related mesh__D004736smesh__D011211
% 213.45/213.63  |- mesh__publicMeSHNote mesh__D004736 82   
% 213.45/213.63  |- skos__hiddenLabel mesh__D004736 Energy Generating Resources
% 213.45/213.63  |- skos__related mesh__D004736smesh__D011210
% 213.45/213.63  |- mesh__recordOriginator mesh__D004736 EC
% 213.45/213.63  |- mesh__recordMaintainer mesh__D004736 nns
% 213.45/213.63  |- mesh__dateCreated mesh__D004736 1981-05-19
% 213.45/213.63  |- skos__scopeNote mesh__D004736
% 213.45/213.63       Natural sources from which power is obtained.     
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D004736 2006
% 213.45/213.63  |- skos__hiddenLabel mesh__D004736 Resource, Energy-Generating
% 213.45/213.63  |- mesh__recordAuthorizer mesh__D004736 sjn
% 213.45/213.63  |- skos__broader mesh__D004736smesh__D004777
% 213.45/213.63  |- mesh__dateEstablished mesh__D009421 1998-01-01
% 213.45/213.63  |- mesh__recordAuthorizer mesh__D009421 sjn
% 213.45/213.63  |- skos__historyNote mesh__D009421
% 213.45/213.63       Nervous System/abnormalities %28%1966-1997%29%
% 213.45/213.63  |- skos__altLabel mesh__D009421 Anomalies, Nervous System
% 213.45/213.63  |- skos__altLabel mesh__D009421 Malformations, Nervous System, Congenital
% 213.45/213.63  |- mesh__recordMaintainer mesh__D009421 ags
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D009421 2004
% 213.45/213.63  |- skos__altLabel mesh__D009421 Congenital Anomalies, Nervous System
% 213.45/213.63  |- skos__hiddenLabel mesh__D009421 Malformations, Nervous System
% 213.45/213.63  |- skos__annotation mesh__D009421
% 213.45/213.63       for congen struct abnorm only; GEN or unspecified; prefer specifics or specific organ/abnorm; DF: NERVOUS SYSTEM ABNORM%A%  
% 213.45/213.63  |- skos__scopeNote mesh__D009421
% 213.45/213.63       Structural abnormalities of the central or peripheral nervous system resulting primarily from defects of embryogenesis.%A%    
% 213.45/213.63  |- rdf__type mesh__D009421sskos__Concept
% 213.45/213.63  |- skos__hiddenLabel mesh__D009421 Nervous System Malformation
% 213.45/213.63  |- skos__altLabel mesh__D009421 Nervous System Congenital Abnormalities
% 213.45/213.63  |- skos__altLabel mesh__D009421 Abnormalities, Congenital, Nervous System
% 213.45/213.63  |- skos__altLabel mesh__D009421 Abnormalities, Nervous System
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D009421 2005
% 213.45/213.63  |- mesh__dateRevised mesh__D009421 2003-07-09
% 213.45/213.63  |- skos__hiddenLabel mesh__D009421 Cranioschises
% 213.45/213.63  |- skos__hiddenLabel mesh__D009421 Abnormality, Nervous System
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D009421 2006
% 213.45/213.63  |- skos__prefLabel mesh__D009421 Nervous System Malformations
% 213.45/213.63  |- skos__broader mesh__D009421smesh__D009422
% 213.45/213.63  |- skos__broader mesh__D009421smesh__D000013
% 213.45/213.63  |- mesh__historyNote mesh__D009421
% 213.45/213.63       2000%28%1966%29%; use explode 1971-1997   
% 213.45/213.63  |- skos__altLabel mesh__D009421 Congenital Abnormalities, Nervous System
% 213.45/213.63  |- mesh__publicMeSHNote mesh__D009421
% 213.45/213.63       2000; see NERVOUS SYSTEM ABNORMALITIES 1966-1999   
% 213.45/213.63  |- skos__hiddenLabel mesh__D009421 Anomaly, Nervous System
% 213.45/213.63  |- skos__altLabel mesh__D009421 Nervous System Abnormalities
% 213.45/213.63  |- skos__hiddenLabel mesh__D009421 Nervous System Anomaly
% 213.45/213.63  |- skos__altLabel mesh__D009421 Congenital Malformations, Nervous System
% 213.45/213.63  |- skos__altLabel mesh__D009421 Nervous System Anomalies
% 213.45/213.63  |- skos__altLabel mesh__D009421 Nervous System Malformations, Congenital
% 213.45/213.63  |- mesh__recordOriginator mesh__D009421 NLM
% 213.45/213.63  |- skos__hiddenLabel mesh__D009421 Nervous System Abnormality
% 213.45/213.63  |- skos__altLabel mesh__D009421 Nervous System Congenital Malformations
% 213.45/213.63  |- skos__hiddenLabel mesh__D009421 Malformation, Nervous System
% 213.45/213.63  |- mesh__dateCreated mesh__D009421 1999-01-01
% 213.45/213.63  |- skos__altLabel mesh__D014366 Tryptophan 2,3-Dioxygenase
% 213.45/213.63  |- skos__related mesh__D014366smesh__D014365
% 213.45/213.63  |- skos__altLabel mesh__D014366 TDO Dioxygenase
% 213.45/213.63  |- rdf__type mesh__D014366sskos__Concept
% 213.45/213.63  |- skos__hiddenLabel mesh__D014366 Tryptophan 2,3 Dioxygenase
% 213.45/213.63  |- mesh__dateEstablished mesh__D014366 1968-01-01
% 213.45/213.63  |- mesh__historyNote mesh__D014366 68%28%65%29%   
% 213.45/213.63  |- mesh__dateRevised mesh__D014366 2005-06-30
% 213.45/213.63  |- skos__prefLabel mesh__D014366 Tryptophan Oxygenase
% 213.45/213.63  |- skos__scopeNote mesh__D014366
% 213.45/213.63       A dioxygenase with specificity for the oxidation of the indoleamine ring of TRYPTOPHAN. It is a LIVER-specific enzyme that is the first and rate limiting enzyme in the kynurenine pathway of TRYPTOPHAN catabolism.%A%    
% 213.45/213.63  |- skos__altLabel mesh__D014366 Tryptophan Pyrrolase
% 213.45/213.63  |- mesh__recordAuthorizer mesh__D014366 sjn
% 213.45/213.63  |- mesh__recordMaintainer mesh__D014366 jmp
% 213.45/213.63  |- skos__hiddenLabel mesh__D014366 2,3-Dioxygenase, Tryptophan
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D014366 2006
% 213.45/213.63  |- mesh__recordOriginator mesh__D014366 NLM
% 213.45/213.63  |- mesh__dateCreated mesh__D014366 1999-01-01
% 213.45/213.63  |- skos__hiddenLabel mesh__D014366 Pyrrolase, Tryptophan
% 213.45/213.63  |- skos__hiddenLabel mesh__D014366 Oxygenase, Tryptophan
% 213.45/213.63  |- mesh__publicMeSHNote mesh__D014366 68   
% 213.45/213.63  |- skos__broader mesh__D014366smesh__D049308
% 213.45/213.63  |- skos__hiddenLabel mesh__D014366 Dioxygenase, TDO
% 213.45/213.63  |- rdf__type mesh__D008329sskos__Concept
% 213.45/213.63  |- mesh__dateCreated mesh__D008329 1987-05-02
% 213.45/213.63  |- skos__altLabel mesh__D008329 Case Management, Insurance
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D008329 2003
% 213.45/213.63  |- skos__hiddenLabel mesh__D008329 Managed Care Program
% 213.45/213.63  |- skos__hiddenLabel mesh__D008329 Care, Managed
% 213.45/213.63  |- skos__scopeNote mesh__D008329
% 213.45/213.63       Health insurance plans intended to reduce unnecessary health care costs through a variety of mechanisms, including: economic incentives for physicians and patients to select less costly forms of care; programs for reviewing the medical necessity of specific services; increased beneficiary cost sharing; controls on inpatient admissions and lengths of stay; the establishment of cost-sharing incentives for outpatient surgery; selective contracting with health care providers; and the intensive management of high-cost health care cases. The programs may be provided in a variety of settings, such as HEALTH MAINTENANCE ORGANIZATIONS and PREFERRED PROVIDER ORGANIZATIONS.%A%    
% 213.45/213.63  |- skos__annotation mesh__D008329 specify geog   
% 213.45/213.63  |- skos__hiddenLabel mesh__D008329 Program, Managed Care
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D008329 2002
% 213.45/213.63  |- skos__broader mesh__D008329smesh__D003695
% 213.45/213.63  |- mesh__historyNote mesh__D008329
% 213.45/213.63       90%28%88%29%; was see under DELIVERY OF HEALTH CARE 1988-89   
% 213.45/213.63  |- mesh__dateRevised mesh__D008329 1999-11-03
% 213.45/213.63  |- skos__hiddenLabel mesh__D008329 Programs, Managed Care
% 213.45/213.63  |- skos__hiddenLabel mesh__D008329 Management, Insurance Case
% 213.45/213.63  |- mesh__dateEstablished mesh__D008329 1990-01-01
% 213.45/213.63  |- mesh__recordOriginator mesh__D008329 EC
% 213.45/213.63  |- skos__altLabel mesh__D008329 Managed Health Care Insurance Plans
% 213.45/213.63  |- skos__broader mesh__D008329smesh__D007348
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D008329 2006
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D008329 2001
% 213.45/213.63  |- mesh__recordMaintainer mesh__D008329 kle
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D008329 2004
% 213.45/213.63  |- mesh__recordAuthorizer mesh__D008329 sjn
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D008329 2005
% 213.45/213.63  |- skos__prefLabel mesh__D008329 Managed Care Programs
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D008329 2000
% 213.45/213.63  |- mesh__publicMeSHNote mesh__D008329
% 213.45/213.63       90; was see under DELIVERY OF HEALTH CARE 1988-89   
% 213.45/213.63  |- mesh__recordOriginator mesh__D000346 NLM
% 213.45/213.63  |- skos__broader mesh__D000346smesh__D008877
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D000346 1999
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D000346 2002
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D000346 1994
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D000346 1998
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D000346 1993
% 213.45/213.63  |- mesh__dateCreated mesh__D000346 1999-01-01
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D000346 2001
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D000346 2006
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D000346 1997
% 213.45/213.63  |- mesh__recordMaintainer mesh__D000346 PLS
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D000346 2000
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D000346 1996
% 213.45/213.63  |- rdf__type mesh__D000346sskos__Concept
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D000346 2005
% 213.45/213.63  |- mesh__dateRevised mesh__D000346 1992-05-07
% 213.45/213.63  |- skos__prefLabel mesh__D000346 Afghanistan
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D000346 2004
% 213.45/213.63  |- mesh__recordAuthorizer mesh__D000346 PLS
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D000346 2003
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D000346 1995
% 213.45/213.63  |- skos__historyNote mesh__D019051
% 213.45/213.63       Spinal Nerve Roots/surgery %28%1970-1995%29%
% 213.45/213.63  |- mesh__recordOriginator mesh__D019051 TGC
% 213.45/213.63  |- mesh__recordAuthorizer mesh__D019051 SJN
% 213.45/213.63  |- skos__prefLabel mesh__D019051 Rhizotomy
% 213.45/213.63  |- mesh__historyNote mesh__D019051 96   
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D019051 2002
% 213.45/213.63  |- skos__broader mesh__D019051smesh__D003714
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D019051 2001
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D019051 2004
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D019051 2000
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D019051 1999
% 213.45/213.63  |- mesh__dateCreated mesh__D019051 1995-05-26
% 213.45/213.63  |- mesh__dateRevised mesh__D019051 1997-06-20
% 213.45/213.63  |- mesh__recordMaintainer mesh__D019051 PXP
% 213.45/213.63  |- skos__hiddenLabel mesh__D019051 Rhizotomies
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D019051 2003
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D019051 2006
% 213.45/213.63  |- mesh__dateEstablished mesh__D019051 1996-01-01
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D019051 1998
% 213.45/213.63  |- skos__scopeNote mesh__D019051
% 213.45/213.63       Surgical interruption of a spinal or cranial nerve root. %28%From Dorland, 28th ed%29%%A%    
% 213.45/213.63  |- mesh__publicMeSHNote mesh__D019051 96   
% 213.45/213.63  |- skos__annotation mesh__D019051
% 213.45/213.63       surg interruption of spinal and cranial nerve roots; do not use /util except by MeSH definition%A%  
% 213.45/213.63  |- rdf__type mesh__D019051sskos__Concept
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D019051 2005
% 213.45/213.63  |- mesh__dateEstablished mesh__D005031 1991-01-01
% 213.45/213.63  |- skos__hiddenLabel mesh__D005031 2 Mercaptoimidazoline
% 213.45/213.63  |- skos__scopeNote mesh__D005031
% 213.45/213.63       A degradation product of ethylenebis%28%dithiocarbamate%29% fungicides. It has been found to be carcinogenic and to cause THYROID hyperplasia.%A%    
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D005031 2006
% 213.45/213.63  |- skos__broader mesh__D005031smesh__D048289
% 213.45/213.63  |- mesh__recordMaintainer mesh__D005031 ssb
% 213.45/213.63  |- skos__historyNote mesh__D005031 Thiones %28%1974-1975%29%
% 213.45/213.63  |- skos__broader mesh__D005031smesh__D013890
% 213.45/213.63  |- mesh__dateRevised mesh__D005031 2005-06-30
% 213.45/213.63  |- skos__altLabel mesh__D005031 Imidazolidinethione
% 213.45/213.63  |- skos__prefLabel mesh__D005031 Ethylenethiourea
% 213.45/213.63  |- mesh__historyNote mesh__D005031
% 213.45/213.63       91%28%77%29%; was see under IMIDAZOLES 1977-90   
% 213.45/213.63  |- skos__altLabel mesh__D005031 2-Mercaptoimidazoline
% 213.45/213.63  |- skos__historyNote mesh__D005031 Thiourea %28%1966-1976%29%
% 213.45/213.63  |- skos__historyNote mesh__D005031 Imidazoles %28%1974-1976%29%
% 213.45/213.63  |- mesh__recordOriginator mesh__D005031 RLS
% 213.45/213.63  |- mesh__publicMeSHNote mesh__D005031
% 213.45/213.63       91; was see under IMIDAZOLES 1977-90   
% 213.45/213.63  |- rdf__type mesh__D005031sskos__Concept
% 213.45/213.63  |- mesh__dateCreated mesh__D005031 1976-04-16
% 213.45/213.63  |- mesh__recordAuthorizer mesh__D005031 sjn
% 213.45/213.63  |- mesh__recordAuthorizer mesh__D046448 sjn
% 213.45/213.63  |- skos__hiddenLabel mesh__D046448 Sheet, Ice
% 213.45/213.63  |- skos__hiddenLabel mesh__D046448 Ice Covers
% 213.45/213.63  |- skos__hiddenLabel mesh__D046448 Covers, Ice
% 213.45/213.63  |- skos__hiddenLabel mesh__D046448 Iceberg
% 213.45/213.63  |- skos__hiddenLabel mesh__D046448 Ice, Sea
% 213.45/213.63  |- skos__hiddenLabel mesh__D046448 Ice Sheets
% 213.45/213.63  |- skos__hiddenLabel mesh__D046448 Ice Cover, Sea
% 213.45/213.63  |- skos__prefLabel mesh__D046448 Ice Cover
% 213.45/213.63  |- skos__hiddenLabel mesh__D046448 Glaciers, Marine
% 213.45/213.63  |- mesh__dateCreated mesh__D046448 2004-07-07
% 213.45/213.63  |- skos__historyNote mesh__D046448 Ice %28%1969-2004%29%
% 213.45/213.63  |- skos__hiddenLabel mesh__D046448 Marine Glacier
% 213.45/213.63  |- skos__altLabel mesh__D046448 Sea Ice
% 213.45/213.63  |- mesh__historyNote mesh__D046448 2005   
% 213.45/213.63  |- rdf__type mesh__D046448sskos__Concept
% 213.45/213.63  |- skos__hiddenLabel mesh__D046448 Cover, Sea Ice
% 213.45/213.63  |- skos__historyNote mesh__D046448 Arctic Regions %28%2000-2004%29%
% 213.45/213.63  |- skos__hiddenLabel mesh__D046448 Sheets, Ice
% 213.45/213.63  |- mesh__recordMaintainer mesh__D046448 nns
% 213.45/213.63  |- skos__hiddenLabel mesh__D046448 Glacier, Marine
% 213.45/213.63  |- mesh__recordOriginator mesh__D046448 nns
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D046448 2006
% 213.45/213.63  |- skos__hiddenLabel mesh__D046448 Covers, Sea Ice
% 213.45/213.63  |- skos__altLabel mesh__D046448 Ice Sheet
% 213.45/213.63  |- skos__hiddenLabel mesh__D046448 Cover, Ice
% 213.45/213.63  |- mesh__dateEstablished mesh__D046448 2005-01-01
% 213.45/213.63  |- skos__hiddenLabel mesh__D046448 Sea Ice Covers
% 213.45/213.63  |- skos__broader mesh__D046448smesh__D007053
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D046448 2005
% 213.45/213.63  |- skos__hiddenLabel mesh__D046448 Ice Covers, Sea
% 213.45/213.63  |- skos__scopeNote mesh__D046448
% 213.45/213.63       A thick mass of ICE formed over large regions of land, RIVERS, lakes, ponds, or SEAWATER.%A%    
% 213.45/213.63  |- skos__hiddenLabel mesh__D046448 Glacier
% 213.45/213.63  |- skos__historyNote mesh__D046448 Antarctic Regions %28%1991-2004%29%
% 213.45/213.63  |- mesh__publicMeSHNote mesh__D046448 2005   
% 213.45/213.63  |- skos__hiddenLabel mesh__D018757 gamma Aminobutyric Acid Modulators
% 213.45/213.63  |- skos__hiddenLabel mesh__D018757 Acid Modulators, gamma-Aminobutyric
% 213.45/213.63  |- mesh__recordOriginator mesh__D018757 RAZ
% 213.45/213.63  |- skos__related mesh__D018757smesh__D018681
% 213.45/213.63  |- skos__altLabel mesh__D018757 GABAergic Modulators
% 213.45/213.63  |- mesh__publicMeSHNote mesh__D018757 95   
% 213.45/213.63  |- mesh__recordAuthorizer mesh__D018757 sjn
% 213.45/213.63  |- skos__broader mesh__D018757smesh__D018682
% 213.45/213.63  |- mesh__dateCreated mesh__D018757 1994-06-03
% 213.45/213.63  |- skos__scopeNote mesh__D018757
% 213.45/213.63       Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors %28%RECEPTORS, GABA-A%29% appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here.%A%    
% 213.45/213.63  |- skos__altLabel mesh__D018757 gamma-Aminobutyric Acid Modulators
% 213.45/213.63  |- skos__prefLabel mesh__D018757 GABA Modulators
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D018757 2006
% 213.45/213.63  |- mesh__recordMaintainer mesh__D018757 ssb
% 213.45/213.63  |- mesh__dateEstablished mesh__D018757 1995-01-01
% 213.45/213.63  |- mesh__historyNote mesh__D018757 95   
% 213.45/213.63  |- skos__related mesh__D018757smesh__D006993
% 213.45/213.63  |- skos__hiddenLabel mesh__D018757 Modulators, GABAergic
% 213.45/213.63  |- skos__hiddenLabel mesh__D018757 Modulators, gamma-Aminobutyric Acid
% 213.45/213.63  |- mesh__dateRevised mesh__D018757 2005-06-30
% 213.45/213.63  |- skos__related mesh__D018757smesh__D014151
% 213.45/213.63  |- skos__annotation mesh__D018757 GEN or unspecified; prefer specifics   
% 213.45/213.63  |- rdf__type mesh__D018757sskos__Concept
% 213.45/213.63  |- skos__hiddenLabel mesh__D018757 Modulators, GABA
% 213.45/213.63  |- skos__altLabel mesh__D010774 Phosphovitellin
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D010774 2002
% 213.45/213.63  |- mesh__dateCreated mesh__D010774 1974-11-11
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D010774 2006
% 213.45/213.63  |- mesh__recordAuthorizer mesh__D010774 PLS
% 213.45/213.63  |- skos__broader mesh__D010774smesh__D015387
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D010774 2004
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D010774 1995
% 213.45/213.63  |- skos__broader mesh__D010774smesh__D004527
% 213.45/213.63  |- mesh__dateRevised mesh__D010774 1992-05-19
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D010774 2005
% 213.45/213.63  |- mesh__recordMaintainer mesh__D010774 TAP
% 213.45/213.63  |- mesh__dateEstablished mesh__D010774 1991-01-01
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D010774 1993
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D010774 2001
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D010774 1999
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D010774 2003
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D010774 1994
% 213.45/213.63  |- mesh__recordOriginator mesh__D010774 NLM
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D010774 1997
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D010774 2000
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D010774 1998
% 213.45/213.63  |- skos__prefLabel mesh__D010774 Phosvitin
% 213.45/213.63  |- skos__broader mesh__D010774smesh__D010750
% 213.45/213.63  |- skos__scopeNote mesh__D010774
% 213.45/213.63       An egg yolk phosphoglycoprotein which contains about 90%25% of the yolk protein phosphorus. It is synthesized in the liver of the hen and transferred to the developing oocyte, where it is bound to lipoproteins within the yolk granules.%A%    
% 213.45/213.63  |- skos__historyNote mesh__D010774 Phosphoproteins %28%1973-1974%29%
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D010774 1996
% 213.45/213.63  |- rdf__type mesh__D010774sskos__Concept
% 213.45/213.63  |- mesh__publicMeSHNote mesh__D010774
% 213.45/213.63       91; was see under EGG PROTEINS 1975-90   
% 213.45/213.63  |- skos__annotation mesh__D010774 an egg yolk protein   
% 213.45/213.63  |- mesh__historyNote mesh__D010774
% 213.45/213.63       91%28%75%29%; was see under EGG PROTEINS 1975-90   
% 213.45/213.63  |- skos__historyNote mesh__D010774 Egg Proteins %28%1973-1974%29%
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D032428 2004
% 213.45/213.63  |- mesh__dateEstablished mesh__D032428 2003-01-01
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D032428 2006
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D032428 2003
% 213.45/213.63  |- skos__prefLabel mesh__D032428 Strelitziaceae
% 213.45/213.63  |- rdf__type mesh__D032428sskos__Concept
% 213.45/213.63  |- mesh__historyNote mesh__D032428 2003   
% 213.45/213.63  |- skos__annotation mesh__D032428
% 213.45/213.63       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D032428 2005
% 213.45/213.63  |- mesh__publicMeSHNote mesh__D032428 2003   
% 213.45/213.63  |- mesh__dateCreated mesh__D032428 2002-07-03
% 213.45/213.63  |- skos__broader mesh__D032428smesh__D019862
% 213.45/213.63  |- skos__scopeNote mesh__D032428
% 213.45/213.63       A plant family of the order ZINGIBERALES, subclass Zingiberidae, class Liliopsida. Some species in this genus are called bird-of-paradise which is also a common name for CAESALPINIA and Heliconia %28%HELICONIACEAE%29%.%A%    
% 213.45/213.63  |- skos__historyNote mesh__D004737
% 213.45/213.63       Hydrocarbons, Halogenated %28%1969-1974%29%
% 213.45/213.63  |- mesh__publicMeSHNote mesh__D004737
% 213.45/213.63       80; was see under METHYL ETHERS 1975-79   
% 213.45/213.63  |- skos__prefLabel mesh__D004737 Enflurane
% 213.45/213.63  |- mesh__recordAuthorizer mesh__D004737 sjn
% 213.45/213.63  |- skos__altLabel mesh__D004737 Pisa Brand of Enflurane
% 213.45/213.63  |- mesh__historyNote mesh__D004737
% 213.45/213.63       80%28%75%29%; was see under METHYL ETHERS 1975-79   
% 213.45/213.63  |- skos__historyNote mesh__D004737 Anesthesia, Inhalation %28%1969-1974%29%
% 213.45/213.63  |- skos__altLabel mesh__D004737 Zeneca Brand of Enflurane
% 213.45/213.63  |- skos__altLabel mesh__D004737 AstraZeneca Brand of Enflurane
% 213.45/213.63  |- skos__historyNote mesh__D004737 Anesthetics %28%1969-1974%29%
% 213.45/213.63  |- skos__altLabel mesh__D004737 Baxter Anaesthesia Brand of Enflurane
% 213.45/213.63  |- skos__altLabel mesh__D004737 Abbott Brand of Enflurane
% 213.45/213.63  |- mesh__dateRevised mesh__D004737 2005-06-30
% 213.45/213.63  |- skos__broader mesh__D004737smesh__D008738
% 213.45/213.63  |- skos__historyNote mesh__D004737 Ethers %28%1969-1973%29%
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D004737 2006
% 213.45/213.63  |- mesh__recordOriginator mesh__D004737 NLM
% 213.45/213.63  |- mesh__dateEstablished mesh__D004737 1980-01-01
% 213.45/213.63  |- skos__historyNote mesh__D004737 Methyl Ethers %28%1973-1974%29%
% 213.45/213.63  |- rdf__type mesh__D004737sskos__Concept
% 213.45/213.63  |- mesh__dateCreated mesh__D004737 1974-11-11
% 213.45/213.63  |- skos__scopeNote mesh__D004737
% 213.45/213.63       An extremely stable inhalation anesthetic that allows rapid adjustments of anesthesia depth with little change in pulse or respiratory rate.%A%    
% 213.45/213.63  |- mesh__recordMaintainer mesh__D004737 exl
% 213.45/213.63  |- skos__hiddenLabel mesh__D009422 Disorder, Nervous System
% 213.45/213.63  |- skos__altLabel mesh__D009422 Neurologic Disorders
% 213.45/213.63  |- skos__altLabel mesh__D009422 Nervous System Disorders
% 213.45/213.63  |- skos__prefLabel mesh__D009422 Nervous System Diseases
% 213.45/213.63  |- mesh__runningHead mesh__D009422 C10 - DISEASES-NEUROLOGIC   
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D009422 2004
% 213.45/213.63  |- mesh__publicMeSHNote mesh__D009422 1965   
% 213.45/213.63  |- skos__hiddenLabel mesh__D009422 Disorders, Neurological
% 213.45/213.63  |- mesh__dateRevised mesh__D009422 1999-12-06
% 213.45/213.63  |- skos__hiddenLabel mesh__D009422 Nervous System Disorder
% 213.45/213.63  |- skos__hiddenLabel mesh__D009422 Disorder, Neurologic
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D009422 2000A
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D009422 2003
% 213.45/213.63  |- mesh__recordOriginator mesh__D009422 NLM
% 213.45/213.63  |- skos__scopeNote mesh__D009422
% 213.45/213.63       Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.%A%    
% 213.45/213.63  |- skos__hiddenLabel mesh__D009422 Diseases, Nervous System
% 213.45/213.63  |- mesh__historyNote mesh__D009422 1965   
% 213.45/213.63  |- rdf__type mesh__D009422sskos__Concept
% 213.45/213.63  |- skos__hiddenLabel mesh__D009422 Neurologic Disorder
% 213.45/213.63  |- skos__hiddenLabel mesh__D009422 Nervous System Disease
% 213.45/213.63  |- skos__hiddenLabel mesh__D009422 Disease, Nervous System
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D009422 2002
% 213.45/213.63  |- mesh__recordMaintainer mesh__D009422 ags
% 213.45/213.63  |- mesh__dateEstablished mesh__D009422 1965-01-01
% 213.45/213.63  |- skos__hiddenLabel mesh__D009422 Neurological Disorder
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D009422 2006
% 213.45/213.63  |- skos__annotation mesh__D009422
% 213.45/213.63       GEN or unspecified; prefer specifics; /diag: consider also DIAGNOSTIC TECHNIQUES, NEUROLOGICAL; inflamm dis = NEURITIS; %22%diabetic neuropathy%22% %26% %22%diabetic peripheral neuropathy%22%: index only under DIABETIC NEUROPATHIES;/chem ind: consider  NEUROTOXICITY SYNDROMES%A%  
% 213.45/213.63  |- mesh__recordAuthorizer mesh__D009422 ags
% 213.45/213.63  |- skos__hiddenLabel mesh__D009422 Disorders, Neurologic
% 213.45/213.63  |- mesh__onlineNote mesh__D009422
% 213.45/213.63       pre-explosion = NERVOUS SYSTEM DISEASES %28%PX%29%   
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D009422 2001
% 213.45/213.63  |- mesh__dateCreated mesh__D009422 1999-01-01
% 213.45/213.63  |- skos__hiddenLabel mesh__D009422 Disorders, Nervous System
% 213.45/213.63  |- skos__altLabel mesh__D009422 Neurological Disorders
% 213.45/213.63  |- skos__hiddenLabel mesh__D009422 Disorder, Neurological
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D009422 2000
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D009422 2005
% 213.45/213.63  |- rdf__type mesh__D014367sskos__Concept
% 213.45/213.63  |- mesh__historyNote mesh__D014367
% 213.45/213.63       80; was TRYPTOPHAN SYNTHETASE 1972-79 %28%Prov 1972-73%29%   
% 213.45/213.63  |- mesh__publicMeSHNote mesh__D014367
% 213.45/213.63       80; was TRYPTOPHAN SYNTHETASE 1974-79   
% 213.45/213.63  |- skos__scopeNote mesh__D014367
% 213.45/213.63       An enzyme that catalyzes the conversion of L-serine and 1-%28%indol-3-yl%29%glycerol 3-phosphate to L-tryptophan and glyceraldehyde 3-phosphate. It is a pyridoxal phosphate protein that also catalyzes the conversion of serine and indole into tryptophan and water and of indoleglycerol phosphate into indole and glyceraldehyde phosphate. %28%From Enzyme Nomenclature, 1992%29% EC 4.2.1.20.%A%    
% 213.45/213.63  |- skos__altLabel mesh__D014367 Tryptophan Synthetase
% 213.45/213.63  |- mesh__dateRevised mesh__D014367 2003-07-09
% 213.45/213.63  |- mesh__recordMaintainer mesh__D014367 ssb
% 213.45/213.63  |- mesh__onlineNote mesh__D014367
% 213.45/213.63       use TRYPTOPHAN SYNTHASE to search TRYPTOPHAN SYNTHETASE 1972-79 %28%as Prov 1972-73%29%%A%  
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D014367 2004
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D014367 2006
% 213.45/213.63  |- mesh__dateCreated mesh__D014367 1999-01-01
% 213.45/213.63  |- skos__broader mesh__D014367smesh__D009097
% 213.45/213.63  |- skos__hiddenLabel mesh__D014367 Synthase, Tryptophan
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D014367 2005
% 213.45/213.63  |- mesh__dateEstablished mesh__D014367 1974-01-01
% 213.45/213.63  |- mesh__recordAuthorizer mesh__D014367 sjn
% 213.45/213.63  |- skos__prefLabel mesh__D014367 Tryptophan Synthase
% 213.45/213.63  |- mesh__recordOriginator mesh__D014367 NLM
% 213.45/213.63  |- skos__broader mesh__D014367smesh__D006836
% 213.45/213.63  |- skos__hiddenLabel mesh__D014367 Synthetase, Tryptophan
% 213.45/213.63  |- skos__historyNote mesh__D014367 Hydro-Lyases %28%1966-1971%29%
% 213.45/213.63  |- skos__hiddenLabel mesh__D019850 Heptyl Alcohol
% 213.45/213.63  |- skos__historyNote mesh__D019850 Alcohols %28%1980-1997%29%
% 213.45/213.63  |- mesh__activeMeSHYear mesh__D019850 2005
% 213.45/213.63  |- rdf__type mesh__D019850sskos__Concept
% 213.45/213.63  |- skos__prefLabel mesh__D019850 Heptanol
% 213.45/213.63  |- skos__altLabel mesh__D019850 1-Heptanol
% 213.45/213.63  |- skos__altLabel mesh__D019850 n-Heptanol
% 213.45/213.63  |- mesh__historyNote mesh__D019850 98; use HEPTANOL %28%NM%29% 1980-97   
% 213.45/213.63  |- mesh__publicMeSHNote mesh__D019850
% 213.45/213.63       98; N-HEPTANOL was indexed under ALCOHOLS 1980-97   
% 213.45/213.63  |- skos__broader mesh__D019850smesh__D005233
% 213.45/213.63  |- skos__hiddenLabel mesh__D019850 1 Heptanol
% 213.45/213.64  |- mesh__dateEstablished mesh__D019850 1998-01-01
% 213.45/213.64  |- mesh__dateRevised mesh__D019850 2003-07-09
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D019850 2006
% 213.45/213.64  |- skos__hiddenLabel mesh__D019850 n Heptanol
% 213.45/213.64  |- skos__altLabel mesh__D019850 Alcohol, Heptyl
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D019850 2004
% 213.45/213.64  |- skos__scopeNote mesh__D019850
% 213.45/213.64       A colorless liquid with a fragrant odor. It is used as an intermediate, solvent and in cosmetics.%A%    
% 213.45/213.64  |- mesh__dateCreated mesh__D019850 1997-06-20
% 213.45/213.64  |- skos__prefLabel mesh__D033521 Palinuridae
% 213.45/213.64  |- mesh__dateEstablished mesh__D033521 2003-01-01
% 213.45/213.64  |- skos__altLabel mesh__D033521 Spiny Lobsters
% 213.45/213.64  |- skos__broader mesh__D033521smesh__D033364
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D033521 2005A
% 213.45/213.64  |- skos__historyNote mesh__D033521 Nephropidae %28%1971-2002%29%
% 213.45/213.64  |- mesh__recordAuthorizer mesh__D033521 jls
% 213.45/213.64  |- mesh__historyNote mesh__D033521 2003   
% 213.45/213.64  |- mesh__dateCreated mesh__D033521 2002-07-03
% 213.45/213.64  |- mesh__publicMeSHNote mesh__D033521 2003   
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D033521 2006
% 213.45/213.64  |- rdf__type mesh__D033521sskos__Concept
% 213.45/213.64  |- skos__altLabel mesh__D033521 Lobsters, Spiny
% 213.45/213.64  |- mesh__dateRevised mesh__D033521 2004-07-30
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D033521 2004
% 213.45/213.64  |- mesh__recordOriginator mesh__D033521 ags
% 213.45/213.64  |- mesh__recordMaintainer mesh__D033521 jls
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D033521 2005
% 213.45/213.64  |- skos__scopeNote mesh__D033521
% 213.45/213.64       A family of marine CRUSTACEA, in the order DECAPODA, comprising the clawless lobsters. They are found in tropical and subtropical waters and characterized by short spines along the length of the tail and body.%A%    
% 213.45/213.64  |- mesh__dateCreated mesh__D000347 1999-01-01
% 213.45/213.64  |- skos__annotation mesh__D000347 a blood coag disord   
% 213.45/213.64  |- skos__scopeNote mesh__D000347
% 213.45/213.64       A deficiency or absence of fibrinogen %28%coagulation factor I%29% in the blood. %28%Dorland, 27th ed%29%%A%    
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D000347 2006
% 213.45/213.64  |- mesh__recordOriginator mesh__D000347 NLM
% 213.45/213.64  |- skos__altLabel mesh__D000347 Deficiency, Fibrinogen
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D000347 2002
% 213.45/213.64  |- skos__hiddenLabel mesh__D000347 Afibrinogenemias
% 213.45/213.64  |- rdf__type mesh__D000347sskos__Concept
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D000347 2005
% 213.45/213.64  |- mesh__recordAuthorizer mesh__D000347 sjn
% 213.45/213.64  |- skos__broader mesh__D000347smesh__D025861
% 213.45/213.64  |- skos__hiddenLabel mesh__D000347 Deficiencies, Fibrinogen
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D000347 2004
% 213.45/213.64  |- skos__prefLabel mesh__D000347 Afibrinogenemia
% 213.45/213.64  |- mesh__dateRevised mesh__D000347 2001-07-25
% 213.45/213.64  |- skos__broader mesh__D000347smesh__D006474
% 213.45/213.64  |- skos__broader mesh__D000347smesh__D020147
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D000347 2003
% 213.45/213.64  |- skos__altLabel mesh__D000347 Fibrinogen Deficiency
% 213.45/213.64  |- skos__hiddenLabel mesh__D000347 Fibrinogen Deficiencies
% 213.45/213.64  |- mesh__recordMaintainer mesh__D000347 nns
% 213.45/213.64  |- mesh__dateEstablished mesh__D019052 1996-01-01
% 213.45/213.64  |- skos__hiddenLabel mesh__D019052 Depression, Post-Natal
% 213.45/213.64  |- mesh__dateRevised mesh__D019052 2005-06-30
% 213.45/213.64  |- mesh__historyNote mesh__D019052 96   
% 213.45/213.64  |- mesh__publicMeSHNote mesh__D019052 96   
% 213.45/213.64  |- mesh__recordOriginator mesh__D019052 TGC
% 213.45/213.64  |- skos__altLabel mesh__D019052 Postnatal Depression
% 213.45/213.64  |- skos__altLabel mesh__D019052 Post-Partum Depression
% 213.45/213.64  |- skos__altLabel mesh__D019052 Post-Natal Depression
% 213.45/213.64  |- skos__hiddenLabel mesh__D019052 Depression, Post-Partum
% 213.45/213.64  |- skos__hiddenLabel mesh__D019052 Depression, Postnatal
% 213.45/213.64  |- skos__altLabel mesh__D019052 Postpartum Depression
% 213.45/213.64  |- skos__historyNote mesh__D019052 Depression %28%1966-1995%29%
% 213.45/213.64  |- mesh__dateCreated mesh__D019052 1995-05-26
% 213.45/213.64  |- skos__hiddenLabel mesh__D019052 Post Partum Depression
% 213.45/213.64  |- mesh__recordMaintainer mesh__D019052 lkt
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D019052 2006
% 213.45/213.64  |- skos__broader mesh__D019052smesh__D003866
% 213.45/213.64  |- skos__prefLabel mesh__D019052 Depression, Postpartum
% 213.45/213.64  |- rdf__type mesh__D019052sskos__Concept
% 213.45/213.64  |- skos__hiddenLabel mesh__D019052 Post Natal Depression
% 213.45/213.64  |- mesh__recordAuthorizer mesh__D019052 sjn
% 213.45/213.64  |- skos__scopeNote mesh__D019052
% 213.45/213.64       Depression in POSTPARTUM WOMEN, usually within four weeks after giving birth %28%PARTURITION%29%. The degree of depression ranges from mild transient depression to neurotic or psychotic depressive disorders. %28%From DSM-IV, p386%29%%A%    
% 213.45/213.64  |- skos__historyNote mesh__D019052 Puerperal Disorders %28%1966-1995%29%
% 213.45/213.64  |- skos__annotation mesh__D019052
% 213.45/213.64       coordinate IM with specific psychiatric disease %28%IM%29% if relevant; check the tag FEMALE%A%  
% 213.45/213.64  |- skos__broader mesh__D019052smesh__D011644
% 213.45/213.64  |- skos__historyNote mesh__D019052 Depressive Disorder %28%1981-1995%29%
% 213.45/213.64  |- skos__broader mesh__D005830smesh__D017950
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D005830 2000
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D005830 2003
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D005830 1997
% 213.45/213.64  |- mesh__recordOriginator mesh__D005830 NLM
% 213.45/213.64  |- skos__prefLabel mesh__D005830 Geniculate Ganglion
% 213.45/213.64  |- skos__altLabel mesh__D005830 Geniculate Ganglia
% 213.45/213.64  |- skos__hiddenLabel mesh__D005830 Ganglia, Geniculate
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D005830 2006
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D005830 1996
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D005830 2002
% 213.45/213.64  |- mesh__publicMeSHNote mesh__D005830
% 213.45/213.64       91; was see under FACIAL NERVE 1975-90   
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D005830 2005
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D005830 1999
% 213.45/213.64  |- skos__scopeNote mesh__D005830
% 213.45/213.64       The sensory ganglion of the facial %28%7th cranial%29% nerve. The geniculate ganglion cells send central processes to the brain stem and peripheral processes to the taste buds in the anterior tongue, the soft palate, and the skin of the external auditory meatus and the mastoid process.%A%    
% 213.45/213.64  |- rdf__type mesh__D005830sskos__Concept
% 213.45/213.64  |- skos__hiddenLabel mesh__D005830 Ganglion, Geniculate
% 213.45/213.64  |- mesh__dateEstablished mesh__D005830 1991-01-01
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D005830 1995
% 213.45/213.64  |- mesh__recordAuthorizer mesh__D005830 PLS
% 213.45/213.64  |- mesh__onlineNote mesh__D005830 search FACIAL NERVE 1966-74   
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D005830 1998
% 213.45/213.64  |- mesh__recordMaintainer mesh__D005830 TGC
% 213.45/213.64  |- skos__broader mesh__D005830smesh__D005154
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D005830 2001
% 213.45/213.64  |- mesh__historyNote mesh__D005830
% 213.45/213.64       91%28%75%29%; was see under FACIAL NERVE 1975-90   
% 213.45/213.64  |- mesh__dateCreated mesh__D005830 1999-01-01
% 213.45/213.64  |- skos__annotation mesh__D005830
% 213.45/213.64       sensory ganglion of facial %28%7th cranial%29% nerve; neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D005830 2004
% 213.45/213.64  |- mesh__dateRevised mesh__D005830 1994-04-11
% 213.45/213.64  |- mesh__historyNote mesh__D005032 65   
% 213.45/213.64  |- mesh__publicMeSHNote mesh__D005032 65   
% 213.45/213.64  |- mesh__recordMaintainer mesh__D005032 exl
% 213.45/213.64  |- mesh__recordOriginator mesh__D005032 NLM
% 213.45/213.64  |- skos__scopeNote mesh__D005032
% 213.45/213.64       An anabolic steroid with some progestational activity and little androgenic effect.%A%    
% 213.45/213.64  |- mesh__recordAuthorizer mesh__D005032 sjn
% 213.45/213.64  |- rdf__type mesh__D005032sskos__Concept
% 213.45/213.64  |- mesh__dateCreated mesh__D005032 1999-01-01
% 213.45/213.64  |- skos__broader mesh__D005032smesh__D009652
% 213.45/213.64  |- mesh__dateRevised mesh__D005032 2005-06-30
% 213.45/213.64  |- mesh__dateEstablished mesh__D005032 1965-01-01
% 213.45/213.64  |- skos__altLabel mesh__D005032 Ethyloestrenol
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D005032 2006
% 213.45/213.64  |- skos__prefLabel mesh__D005032 Ethylestrenol
% 213.45/213.64  |- rdf__type mesh__D046449sskos__Concept
% 213.45/213.64  |- skos__hiddenLabel mesh__D046449 Abdominal Hernia
% 213.45/213.64  |- skos__historyNote mesh__D046449 Hernia %28%1966-2004%29%
% 213.45/213.64  |- skos__hiddenLabel mesh__D046449 Abdominal Hernias
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D046449 2006
% 213.45/213.64  |- skos__scopeNote mesh__D046449
% 213.45/213.64       A protrusion of abdominal structures through the retaining ABDOMINAL WALL. It involves two parts: an opening in the abdominal wall, and a hernia sac consisting of PERITONEUM and abdominal contents. Abdominal hernias include groin hernia %28%HERNIA, FEMORAL; HERNIA, INGUINAL%29% and VENTRAL HERNIA.%A%    
% 213.45/213.64  |- mesh__recordAuthorizer mesh__D046449 sjn
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D046449 2005
% 213.45/213.64  |- mesh__recordOriginator mesh__D046449 lkt
% 213.45/213.64  |- skos__broader mesh__D046449smesh__D006547
% 213.45/213.64  |- mesh__publicMeSHNote mesh__D046449
% 213.45/213.64       2005; see HERNIA, VENTRAL 1989-2004   
% 213.45/213.64  |- skos__hiddenLabel mesh__D046449 Hernias, Abdominal
% 213.45/213.64  |- mesh__recordMaintainer mesh__D046449 lkt
% 213.45/213.64  |- skos__historyNote mesh__D046449 Hernia, Ventral %28%1965-2004%29%
% 213.45/213.64  |- mesh__dateEstablished mesh__D046449 2005-01-01
% 213.45/213.64  |- mesh__dateCreated mesh__D046449 2004-07-07
% 213.45/213.64  |- skos__prefLabel mesh__D046449 Hernia, Abdominal
% 213.45/213.64  |- mesh__historyNote mesh__D046449 2005; use HERNIA, VENTRAL 1989-2004   
% 213.45/213.64  |- mesh__dateCreated mesh__D018758 1994-04-19
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D018758 2006
% 213.45/213.64  |- mesh__historyNote mesh__D018758 95   
% 213.45/213.64  |- skos__annotation mesh__D018758
% 213.45/213.64       hist articles %26% hist contexts only: do not confuse with CNS, ganglionic or cardiac stimulants; D25-26 qualif%A%  
% 213.45/213.64  |- skos__scopeNote mesh__D018758
% 213.45/213.64       Agents or remedies that historically have produced stimulation or excited functional activity. %28%From Dorland, 27th ed%29%%A%    
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D018758 2005
% 213.45/213.64  |- mesh__dateRevised mesh__D018758 2003-07-09
% 213.45/213.64  |- rdf__type mesh__D018758sskos__Concept
% 213.45/213.64  |- skos__prefLabel mesh__D018758 Stimulants %28%Historical%29%
% 213.45/213.64  |- mesh__publicMeSHNote mesh__D018758 95   
% 213.45/213.64  |- mesh__dateEstablished mesh__D018758 1995-01-01
% 213.45/213.64  |- skos__broader mesh__D018758smesh__D045506
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D018758 2004
% 213.45/213.64  |- mesh__historyNote mesh__D010775 73%28%72%29%   
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D010775 1999
% 213.45/213.64  |- skos__historyNote mesh__D010775 Light %28%1966-1971%29%
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D010775 2003
% 213.45/213.64  |- skos__hiddenLabel mesh__D010775 Stimulations, Photic
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D010775 1998
% 213.45/213.64  |- mesh__recordMaintainer mesh__D010775 TGC
% 213.45/213.64  |- mesh__dateRevised mesh__D010775 1997-06-20
% 213.45/213.64  |- mesh__dateEstablished mesh__D010775 1973-01-01
% 213.45/213.64  |- rdf__type mesh__D010775sskos__Concept
% 213.45/213.64  |- skos__altLabel mesh__D010775 Stimulation, Photic
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D010775 2002
% 213.45/213.64  |- mesh__recordAuthorizer mesh__D010775 SJN
% 213.45/213.64  |- mesh__publicMeSHNote mesh__D010775 73   
% 213.45/213.64  |- skos__hiddenLabel mesh__D010775 Visual Stimulations
% 213.45/213.64  |- skos__hiddenLabel mesh__D010775 Photic Stimulations
% 213.45/213.64  |- skos__broader mesh__D010775smesh__D010812
% 213.45/213.64  |- skos__altLabel mesh__D010775 Visual Stimulation
% 213.45/213.64  |- skos__hiddenLabel mesh__D010775 Stimulations, Visual
% 213.45/213.64  |- skos__hiddenLabel mesh__D010775 Stimulation, Visual
% 213.45/213.64  |- skos__prefLabel mesh__D010775 Photic Stimulation
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D010775 2006
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D010775 2001
% 213.45/213.64  |- mesh__recordOriginator mesh__D010775 NLM
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D010775 2004
% 213.45/213.64  |- mesh__dateCreated mesh__D010775 1999-01-01
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D010775 2005
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D010775 2000
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D032429 2003
% 213.45/213.64  |- mesh__publicMeSHNote mesh__D032429 2003   
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D032429 2005
% 213.45/213.64  |- mesh__dateEstablished mesh__D032429 2003-01-01
% 213.45/213.64  |- skos__annotation mesh__D032429
% 213.45/213.64       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.45/213.64  |- rdf__type mesh__D032429sskos__Concept
% 213.45/213.64  |- skos__broader mesh__D032429smesh__D030521
% 213.45/213.64  |- mesh__dateCreated mesh__D032429 2002-07-02
% 213.45/213.64  |- skos__altLabel mesh__D032429 Galanga
% 213.45/213.64  |- mesh__historyNote mesh__D032429 2003   
% 213.45/213.64  |- skos__scopeNote mesh__D032429
% 213.45/213.64       A plant genus of the family ZINGIBERACEAE. Members contain galangin, yakuchinone-A, and diarylheptanoids.%A%    
% 213.45/213.64  |- skos__prefLabel mesh__D032429 Alpinia
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D032429 2004
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D032429 2006
% 213.45/213.64  |- mesh__recordMaintainer mesh__D004738 KEV
% 213.45/213.64  |- rdf__type mesh__D004738sskos__Concept
% 213.45/213.64  |- mesh__dateCreated mesh__D004738 1999-01-01
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D004738 2005
% 213.45/213.64  |- mesh__recordOriginator mesh__D004738 NLM
% 213.45/213.64  |- skos__scopeNote mesh__D004738
% 213.45/213.64       The practical application of physical, mechanical, and mathematical principles. %28%Stedman, 25th ed%29%%A%    
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D004738 2004
% 213.45/213.64  |- skos__annotation mesh__D004738 SPEC: SPEC qualif   
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D004738 1999
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D004738 2003
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D004738 1998
% 213.45/213.64  |- skos__prefLabel mesh__D004738 Engineering
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D004738 2002
% 213.45/213.64  |- mesh__recordAuthorizer mesh__D004738 PLS
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D004738 1997
% 213.45/213.64  |- mesh__dateRevised mesh__D004738 1995-05-23
% 213.45/213.64  |- skos__broader mesh__D004738smesh__D013676
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D004738 2001
% 213.45/213.64  |- skos__hiddenLabel mesh__D004738 Engineerings
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D004738 1996
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D004738 2006
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D004738 2000
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460 Adult T-Cell Leukemias
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460 Human T-Cell Leukemia-Lymphomas
% 213.45/213.64  |- skos__altLabel mesh__D015460 HTLV-I-Associated T-Cell Leukemia-Lymphoma
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460 Leukemia-Lymphomas, Human T-Cell
% 213.45/213.64  |- skos__altLabel mesh__D015460 ATLL
% 213.45/213.64  |- skos__historyNote mesh__D015460
% 213.45/213.64       Leukemia, Lymphoblastic %28%1983-1988%29%
% 213.45/213.64  |- skos__altLabel mesh__D015460 HTLV-Associated Leukemia-Lymphoma
% 213.45/213.64  |- skos__altLabel mesh__D015460 T-Cell Leukemia-Lymphoma, HTLV-I-Associated
% 213.45/213.64  |- skos__altLabel mesh__D015460 T Cell Leukemia Lymphoma, HTLV I Associated
% 213.45/213.64  |- mesh__recordMaintainer mesh__D015460 sjn
% 213.45/213.64  |- mesh__dateEstablished mesh__D015460 1989-01-01
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460 HTLV-Associated Leukemia-Lymphomas
% 213.45/213.64  |- skos__scopeNote mesh__D015460
% 213.45/213.64       Aggressive T-Cell malignancy with adult onset, caused by HUMAN T-LYMPHOTROPIC VIRUS 1. It is endemic in Japan, the Caribbean basin, Southeastern United States, Hawaii, and parts of Central and South America and sub-Saharan Africa.%A%    
% 213.45/213.64  |- skos__altLabel mesh__D015460 Leukemia, Adult T-Cell
% 213.45/213.64  |- mesh__recordOriginator mesh__D015460 PLS
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460 Human T Cell Leukemia Lymphoma
% 213.45/213.64  |- skos__historyNote mesh__D015460 HTLV Infections %28%1987-1988%29%
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460 ATLLs
% 213.45/213.64  |- skos__altLabel mesh__D015460
% 213.45/213.64       Human T Lymphotropic Virus Associated Leukemia Lymphoma
% 213.45/213.64  |- skos__broader mesh__D015460smesh__D015459
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D015460 2005
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460 T Cell Leukemia Lymphoma, Adult
% 213.45/213.64  |- skos__prefLabel mesh__D015460
% 213.45/213.64       Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated
% 213.45/213.64  |- mesh__publicMeSHNote mesh__D015460
% 213.45/213.64       1989; see LEUKEMIA, LYMPHOBLASTIC 1974-88; for ALL, ADULT see LEUKEMIA, LYMPHOCYTIC, ACUTE 1989-1999%A%  
% 213.45/213.64  |- skos__altLabel mesh__D015460 Human T-Cell Leukemia-Lymphoma
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460 T-Cell Leukemia-Lymphoma, Human
% 213.45/213.64  |- skos__altLabel mesh__D015460 T-Cell Leukemia, Adult
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460
% 213.45/213.64       T-Cell Leukemia-Lymphomas, HTLV-I-Associated
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460
% 213.45/213.64       Leukemia-Lymphomas, HTLV-I-Associated T-Cell
% 213.45/213.64  |- skos__altLabel mesh__D015460 Leukemia-Lymphoma, Adult T-Cell
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460 Leukemia-Lymphoma, Human T-Cell
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D015460 2006
% 213.45/213.64  |- mesh__dateRevised mesh__D015460 2004-07-13
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460 Leukemia-Lymphomas, HTLV-Associated
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460 Leukemia-Lymphoma, HTLV-Associated
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460 Leukemias, Adult T-Cell
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460
% 213.45/213.64       HTLV-I-Associated T-Cell Leukemia-Lymphomas
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460
% 213.45/213.64       Leukemia-Lymphoma, HTLV-I-Associated T-Cell
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460 T-Cell Leukemia-Lymphomas, Adult
% 213.45/213.64  |- skos__historyNote mesh__D015460 T Lymphocytes %28%1983-1988%29%
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460 Leukemia-Lymphomas, Adult T-Cell
% 213.45/213.64  |- skos__altLabel mesh__D015460
% 213.45/213.64       Leukemia Lymphoma, T Cell, Acute, HTLV I Associated
% 213.45/213.64  |- skos__altLabel mesh__D015460 T-Cell Leukemia-Lymphoma, Adult
% 213.45/213.64  |- skos__altLabel mesh__D015460 Leukemia Lymphoma, Adult T Cell
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460 Adult T-Cell Leukemia-Lymphomas
% 213.45/213.64  |- skos__broader mesh__D015460smesh__D015490
% 213.45/213.64  |- skos__historyNote mesh__D015460 Leukemia, Lymphocytic %28%1983-1988%29%
% 213.45/213.64  |- skos__altLabel mesh__D015460 T Cell Leukemia, Adult
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460 HTLV Associated Leukemia Lymphoma
% 213.45/213.64  |- mesh__dateCreated mesh__D015460 1988-06-09
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460 T-Cell Leukemias, Adult
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460 Leukemia, Adult T Cell
% 213.45/213.64  |- rdf__type mesh__D015460sskos__Concept
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460 Adult T-Cell Leukemia
% 213.45/213.64  |- mesh__historyNote mesh__D015460
% 213.45/213.64       1989; use LEUKEMIA, LYMPHOBLASTIC 1974-88; for ALL, ADULT use LEUKEMIA, LYMPHOCYTIC, ACUTE 1989-1999%A%  
% 213.45/213.64  |- skos__altLabel mesh__D015460
% 213.45/213.64       Human T Lymphotropic Virus-Associated Leukemia-Lymphoma
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460 T-Cell Leukemia-Lymphomas, Human
% 213.45/213.64  |- skos__hiddenLabel mesh__D015460 Adult T-Cell Leukemia-Lymphoma
% 213.45/213.64  |- mesh__recordAuthorizer mesh__D015460 sjn
% 213.45/213.64  |- skos__altLabel mesh__D015460 HTLV I Associated T Cell Leukemia Lymphoma
% 213.45/213.64  |- skos__historyNote mesh__D009423 Brain Neoplasms %28%1966-1979%29%
% 213.45/213.64  |- skos__hiddenLabel mesh__D009423 Tumor, Nervous System
% 213.45/213.64  |- skos__hiddenLabel mesh__D009423 Tumors, Nervous System
% 213.45/213.64  |- skos__historyNote mesh__D009423
% 213.45/213.64       Nervous System Diseases %28%1966-1979%29%
% 213.45/213.64  |- skos__hiddenLabel mesh__D009423 Nervous System Tumor
% 213.45/213.64  |- skos__altLabel mesh__D009423 Neoplasms, Nervous System
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D009423 2003
% 213.45/213.64  |- skos__broader mesh__D009423smesh__D009371
% 213.45/213.64  |- mesh__dateEstablished mesh__D009423 1980-01-01
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D009423 2000
% 213.45/213.64  |- mesh__dateRevised mesh__D009423 1999-11-03
% 213.45/213.64  |- mesh__historyNote mesh__D009423 80; was NON MESH before 1980   
% 213.45/213.64  |- rdf__type mesh__D009423sskos__Concept
% 213.45/213.64  |- skos__hiddenLabel mesh__D009423 Neoplasm, Nervous System
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D009423 2006
% 213.45/213.64  |- mesh__recordOriginator mesh__D009423 NLM
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D009423 2005
% 213.45/213.64  |- mesh__recordAuthorizer mesh__D009423 sjn
% 213.45/213.64  |- skos__annotation mesh__D009423
% 213.45/213.64       GEN: prefer specific precoord; do not confuse with NEOPLASMS, NERVOUS TISSUE %28%neopl composed of nerve tissue; TN 135%29%; coord IM with histol type of neopl %28%IM%29%%A%  
% 213.45/213.64  |- mesh__dateCreated mesh__D009423 1999-01-01
% 213.45/213.64  |- skos__historyNote mesh__D009423 Neoplasms %28%1966-1979%29%
% 213.45/213.64  |- skos__hiddenLabel mesh__D009423 Nervous System Neoplasm
% 213.45/213.64  |- skos__prefLabel mesh__D009423 Nervous System Neoplasms
% 213.45/213.64  |- skos__altLabel mesh__D009423 Nervous System Tumors
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D009423 2002
% 213.45/213.64  |- mesh__publicMeSHNote mesh__D009423 80   
% 213.45/213.64  |- mesh__recordMaintainer mesh__D009423 KEV
% 213.45/213.64  |- skos__broader mesh__D009423smesh__D009422
% 213.45/213.64  |- skos__scopeNote mesh__D009423
% 213.45/213.64       Benign and malignant neoplastic processes arising from or involving components of the central, peripheral, and autonomic nervous systems, cranial nerves, and meninges. Included in this category are primary and metastatic nervous system neoplasms.%A%    
% 213.45/213.64  |- skos__historyNote mesh__D009423
% 213.45/213.64       Neoplasms, Experimental %28%1966-1979%29%
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D009423 2004
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D009423 2001
% 213.45/213.64  |- skos__altLabel mesh__D009423 Tumors of the Nervous System
% 213.45/213.64  |- mesh__dateCreated mesh__D014368 1999-01-01
% 213.45/213.64  |- mesh__recordAuthorizer mesh__D014368 sjn
% 213.45/213.64  |- skos__altLabel mesh__D014368 Tryptophan Indole-Lyase
% 213.45/213.64  |- skos__scopeNote mesh__D014368
% 213.45/213.64       An enzyme that catalyzes the conversion of L-tryptophan and water to indole, pyruvate, and ammonia. It is a pyridoxal-phosphate protein, requiring K+. It also catalyzes 2,3-elimination and beta-replacement reactions of some indole-substituted tryptophan analogs of L-cysteine, L-serine, and other 3-substituted amino acids. %28%From Enzyme Nomenclature, 1992%29% EC 4.1.99.1.%A%    
% 213.45/213.64  |- skos__hiddenLabel mesh__D014368 Tryptophan Indole Lyase
% 213.45/213.64  |- mesh__dateRevised mesh__D014368 2003-07-09
% 213.45/213.64  |- mesh__recordOriginator mesh__D014368 NLM
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D014368 2005
% 213.45/213.64  |- mesh__recordMaintainer mesh__D014368 ssb
% 213.45/213.64  |- mesh__publicMeSHNote mesh__D014368 91; was see under LYASES 1972-90   
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D014368 2004
% 213.45/213.64  |- skos__hiddenLabel mesh__D014368 Indole-Lyase, Tryptophan
% 213.45/213.64  |- mesh__historyNote mesh__D014368
% 213.45/213.64       91%28%72%29%; was see under LYASES 1972-90   
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D014368 2006
% 213.45/213.64  |- mesh__dateEstablished mesh__D014368 1991-01-01
% 213.45/213.64  |- skos__broader mesh__D014368smesh__D019755
% 213.45/213.64  |- skos__prefLabel mesh__D014368 Tryptophanase
% 213.45/213.64  |- skos__historyNote mesh__D014368 Hydro-Lyases %28%1966-1971%29%
% 213.45/213.64  |- rdf__type mesh__D014368sskos__Concept
% 213.45/213.64  |- skos__hiddenLabel mesh__D019851 Thrombophilias
% 213.45/213.64  |- skos__altLabel mesh__D019851 Hypercoagulability
% 213.45/213.64  |- mesh__dateRevised mesh__D019851 2000-06-22
% 213.45/213.64  |- skos__historyNote mesh__D019851 Thrombosis %28%1966-1997%29%
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D019851 2002
% 213.45/213.64  |- mesh__recordOriginator mesh__D019851 NDW
% 213.45/213.64  |- mesh__publicMeSHNote mesh__D019851 98   
% 213.45/213.64  |- mesh__dateCreated mesh__D019851 1997-06-20
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D019851 2006
% 213.45/213.64  |- mesh__recordAuthorizer mesh__D019851 sjn
% 213.45/213.64  |- skos__hiddenLabel mesh__D019851 Hypercoagulabilities
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D019851 2005
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D019851 2004
% 213.45/213.64  |- skos__broader mesh__D019851smesh__D006402
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D019851 2001
% 213.45/213.64  |- mesh__historyNote mesh__D019851 98   
% 213.45/213.64  |- skos__prefLabel mesh__D019851 Thrombophilia
% 213.45/213.64  |- rdf__type mesh__D019851sskos__Concept
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D019851 2003
% 213.45/213.64  |- skos__scopeNote mesh__D019851
% 213.45/213.64       A disorder of HEMOSTASIS in which there is a tendency for the occurrence of THROMBOSIS.%A%    
% 213.45/213.64  |- mesh__dateEstablished mesh__D019851 1998-01-01
% 213.45/213.64  |- mesh__recordMaintainer mesh__D019851 jmp
% 213.45/213.64  |- skos__altLabel mesh__D019053 Idiopathic AIDS Enteropathy
% 213.45/213.64  |- mesh__dateRevised mesh__D019053 2004-07-28
% 213.45/213.64  |- skos__scopeNote mesh__D019053
% 213.45/213.64       A syndrome characterized by chronic, well-established DIARRHEA %28%greater than one month in duration%29% without an identified infectious cause after thorough evaluation, in an HIV-positive individual. It is thought to be due to direct or indirect effects of HIV on the enteric mucosa. HIV enteropathy is a diagnosis of exclusion and can be made only after other forms of diarrheal illness have been ruled out. %28%Harrison%27%s Principles of Internal Medicine, 13th ed, pp1607-8; Haubrich et al., Bockus Gastroenterology, 5th ed, p1155%29%%A%    
% 213.45/213.64  |- skos__hiddenLabel mesh__D019053 Idiopathic AIDS Enteropathies
% 213.45/213.64  |- skos__hiddenLabel mesh__D019053 AIDS Enteropathies
% 213.45/213.64  |- skos__altLabel mesh__D019053 Enteropathy, HIV-Associated
% 213.45/213.64  |- skos__hiddenLabel mesh__D019053 AIDS-Associated Enteropathies
% 213.45/213.64  |- skos__hiddenLabel mesh__D019053 Enteropathies, HIV-Associated
% 213.45/213.64  |- skos__hiddenLabel mesh__D019053 AIDS Enteropathy, Idiopathic
% 213.45/213.64  |- skos__prefLabel mesh__D019053 HIV Enteropathy
% 213.45/213.64  |- mesh__recordAuthorizer mesh__D019053 jls
% 213.45/213.64  |- skos__hiddenLabel mesh__D019053 HIV Enteropathies
% 213.45/213.64  |- skos__hiddenLabel mesh__D019053 Enteropathy, AIDS
% 213.45/213.64  |- mesh__dateEstablished mesh__D019053 1996-01-01
% 213.45/213.64  |- skos__hiddenLabel mesh__D019053 Enteropathy, HIV Associated
% 213.45/213.64  |- skos__hiddenLabel mesh__D019053 AIDS Enteropathies, Idiopathic
% 213.45/213.64  |- skos__broader mesh__D019053smesh__D007410
% 213.45/213.64  |- skos__hiddenLabel mesh__D019053 Enteropathies, HIV
% 213.45/213.64  |- skos__hiddenLabel mesh__D019053 Enteropathies, AIDS
% 213.45/213.64  |- mesh__historyNote mesh__D019053 96   
% 213.45/213.64  |- skos__altLabel mesh__D019053 HIV-Associated Enteropathy
% 213.45/213.64  |- mesh__publicMeSHNote mesh__D019053 96   
% 213.45/213.64  |- mesh__recordMaintainer mesh__D019053 jls
% 213.45/213.64  |- mesh__recordOriginator mesh__D019053 AGS
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D019053 2006
% 213.45/213.64  |- skos__hiddenLabel mesh__D019053 Enteropathies, Idiopathic AIDS
% 213.45/213.64  |- skos__hiddenLabel mesh__D019053 HIV Associated Enteropathy
% 213.45/213.64  |- mesh__activeMeSHYear mesh__D019053 2005A
% 213.45/213.64  |- skos__hiddenLabel mesh__D019053 HIV-Associated Enteropathies
% 213.45/213.64  |- skos__hiddenLabel mesh__D019053 Enteropathy, Idiopathic AIDS
% 213.45/213.64  |- skos__altLabel mesh__D019053 AIDS-Associated Enteropathy
% 213.45/213.64  |- mesh__dateCreated mesh__D019053 1995-06-08
% 213.45/213.64  |- rdf__type mesh__D019053sskos__Concept
% 213.45/213.64  |- skos__hiddenLabel mesh__D019053 Enteropathies, AIDS-Associated
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D019053 2005
% 213.45/213.65  |- skos__altLabel mesh__D019053 AIDS Enteropathy
% 213.45/213.65  |- skos__hiddenLabel mesh__D019053 AIDS Associated Enteropathy
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D019053 2004
% 213.45/213.65  |- skos__altLabel mesh__D019053 Enteropathy, AIDS-Associated
% 213.45/213.65  |- skos__altLabel mesh__D019053 Enteropathy, HIV
% 213.45/213.65  |- skos__broader mesh__D019053smesh__D015658
% 213.45/213.65  |- skos__hiddenLabel mesh__D019053 Enteropathy, AIDS Associated
% 213.45/213.65  |- skos__scopeNote mesh__D000348
% 213.45/213.65       Furano-furano-benzopyrans that are produced by ASPERGILLUS from STERIGMATOCYSTIN. They are structurally related to COUMARINS and easily oxidized to an epoxide form to become ALKYLATING AGENTS. Members of the group include AFLATOXIN B1; aflatoxin B2, aflatoxin G1, aflatoxin G2; AFLATOXIN M1; and aflatoxin M2.%A%    
% 213.45/213.65  |- mesh__historyNote mesh__D000348
% 213.45/213.65       75; was AFLATOXIN 1965-74 %28%Prov 1965-66%29%   
% 213.45/213.65  |- skos__prefLabel mesh__D000348 Aflatoxins
% 213.45/213.65  |- mesh__publicMeSHNote mesh__D000348 75; was AFLATOXIN 1967-74   
% 213.45/213.65  |- skos__broader mesh__D000348smesh__D009183
% 213.45/213.65  |- skos__annotation mesh__D000348
% 213.45/213.65       /antag permitted but consider also ANTITOXINS   
% 213.45/213.65  |- mesh__dateRevised mesh__D000348 2005-06-30
% 213.45/213.65  |- mesh__onlineNote mesh__D000348
% 213.45/213.65       use AFLATOXINS to search AFLATOXIN 1966-74   
% 213.45/213.65  |- skos__altLabel mesh__D000348 Aflatoxin
% 213.45/213.65  |- mesh__recordOriginator mesh__D000348 NLM
% 213.45/213.65  |- mesh__dateCreated mesh__D000348 1999-01-01
% 213.45/213.65  |- mesh__recordMaintainer mesh__D000348 ssb
% 213.45/213.65  |- mesh__dateEstablished mesh__D000348 1967-01-01
% 213.45/213.65  |- mesh__recordAuthorizer mesh__D000348 sjn
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D000348 2006
% 213.45/213.65  |- skos__broader mesh__D000348smesh__D001578
% 213.45/213.65  |- rdf__type mesh__D000348sskos__Concept
% 213.45/213.65  |- skos__prefLabel mesh__D011070 Poly I-C
% 213.45/213.65  |- skos__annotation mesh__D011070
% 213.45/213.65       an interferon inducer; do not confuse with POLY I   
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011070 2001
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011070 2002
% 213.45/213.65  |- mesh__recordAuthorizer mesh__D011070 PLS
% 213.45/213.65  |- skos__altLabel mesh__D011070 Polyribose Inosin-Cytidil
% 213.45/213.65  |- skos__scopeNote mesh__D011070
% 213.45/213.65       Interferon inducer consisting of a synthetic, mismatched double-stranded RNA. The polymer is made of one strand each of polyinosinic acid and polycytidylic acid.%A%    
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011070 2005
% 213.45/213.65  |- mesh__recordOriginator mesh__D011070 NLM
% 213.45/213.65  |- mesh__dateEstablished mesh__D011070 1973-01-01
% 213.45/213.65  |- mesh__publicMeSHNote mesh__D011070 73   
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011070 2003
% 213.45/213.65  |- mesh__dateRevised mesh__D011070 1995-06-08
% 213.45/213.65  |- mesh__dateCreated mesh__D011070 1999-01-01
% 213.45/213.65  |- skos__hiddenLabel mesh__D011070 Polyinosinic Polycytidylic Acid
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011070 2006
% 213.45/213.65  |- skos__altLabel mesh__D011070 Polyinosinic-Polycytidylic Acid
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011070 1998
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011070 2004
% 213.45/213.65  |- mesh__historyNote mesh__D011070 73%28%71%29%   
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011070 1996
% 213.45/213.65  |- skos__broader mesh__D011070smesh__D011069
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011070 2000
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011070 1999
% 213.45/213.65  |- rdf__type mesh__D011070sskos__Concept
% 213.45/213.65  |- skos__broader mesh__D011070smesh__D011066
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011070 1997
% 213.45/213.65  |- skos__historyNote mesh__D011070 Polynucleotides %28%1966-1970%29%
% 213.45/213.65  |- mesh__recordMaintainer mesh__D011070 JRT
% 213.45/213.65  |- skos__altLabel mesh__D011070 Poly%28%rI%29%.Poly%28%rC%29%
% 213.45/213.65  |- skos__hiddenLabel mesh__D011070 Poly I C
% 213.45/213.65  |- skos__hiddenLabel mesh__D011070 Inosin-Cytidil, Polyribose
% 213.45/213.65  |- skos__historyNote mesh__D011070
% 213.45/213.65       Interferons/biosynthesis %28%1966-1970%29%
% 213.45/213.65  |- skos__hiddenLabel mesh__D011070 Polyribose Inosin Cytidil
% 213.45/213.65  |- skos__broader mesh__D005831smesh__D005261
% 213.45/213.65  |- skos__hiddenLabel mesh__D005831 Genital Disease, Female
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D005831 2006
% 213.45/213.65  |- mesh__recordMaintainer mesh__D005831 lkt
% 213.45/213.65  |- skos__hiddenLabel mesh__D005831 Female Genital Disease
% 213.45/213.65  |- rdf__type mesh__D005831sskos__Concept
% 213.45/213.65  |- mesh__recordAuthorizer mesh__D005831 sjn
% 213.45/213.65  |- mesh__recordOriginator mesh__D005831 NLM
% 213.45/213.65  |- skos__hiddenLabel mesh__D005831 Gynecologic Disease
% 213.45/213.65  |- skos__scopeNote mesh__D005831
% 213.45/213.65       Pathological processes involving the female reproductive tract %28%GENITALIA, FEMALE%29%.%A%    
% 213.45/213.65  |- skos__annotation mesh__D005831
% 213.45/213.65       human %26% animal; general: prefer specifics   
% 213.45/213.65  |- mesh__historyNote mesh__D005831 79; was GYNECOLOGIC DISEASES 1965-78   
% 213.45/213.65  |- skos__hiddenLabel mesh__D005831 Diseases, Female Genital
% 213.45/213.65  |- mesh__onlineNote mesh__D005831
% 213.45/213.65       use GENITAL DISEASES, FEMALE to search GYNECOLOGIC DISEASES 1966-78%A%  
% 213.45/213.65  |- skos__hiddenLabel mesh__D005831 Diseases, Gynecologic
% 213.45/213.65  |- mesh__publicMeSHNote mesh__D005831
% 213.45/213.65       79; was GYNECOLOGIC DISEASES 1965-78   
% 213.45/213.65  |- skos__altLabel mesh__D005831 Female Genital Diseases
% 213.45/213.65  |- mesh__dateRevised mesh__D005831 2005-06-30
% 213.45/213.65  |- mesh__dateCreated mesh__D005831 1999-01-01
% 213.45/213.65  |- mesh__dateEstablished mesh__D005831 1965-01-01
% 213.45/213.65  |- skos__altLabel mesh__D005831 Gynecologic Diseases
% 213.45/213.65  |- skos__prefLabel mesh__D005831 Genital Diseases, Female
% 213.45/213.65  |- skos__broader mesh__D005033smesh__D008301
% 213.45/213.65  |- skos__prefLabel mesh__D005033 Ethylmaleimide
% 213.45/213.65  |- skos__hiddenLabel mesh__D005033 N Ethylmaleimide
% 213.45/213.65  |- rdf__type mesh__D005033sskos__Concept
% 213.45/213.65  |- mesh__dateCreated mesh__D005033 1999-01-01
% 213.45/213.65  |- mesh__publicMeSHNote mesh__D005033 66   
% 213.45/213.65  |- mesh__recordOriginator mesh__D005033 NLM
% 213.45/213.65  |- mesh__dateEstablished mesh__D005033 1966-01-01
% 213.45/213.65  |- mesh__recordAuthorizer mesh__D005033 sjn
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D005033 2006
% 213.45/213.65  |- skos__altLabel mesh__D005033 N-Ethylmaleimide
% 213.45/213.65  |- skos__scopeNote mesh__D005033
% 213.45/213.65       A sulfhydryl reagent that is widely used in experimental biochemical studies.%A%    
% 213.45/213.65  |- mesh__recordMaintainer mesh__D005033 ssb
% 213.45/213.65  |- mesh__dateRevised mesh__D005033 2005-06-30
% 213.45/213.65  |- mesh__historyNote mesh__D005033 66%28%64%29%   
% 213.45/213.65  |- skos__related mesh__D018759smesh__D000929
% 213.45/213.65  |- skos__altLabel mesh__D018759 Adrenergic Reuptake Inhibitors
% 213.45/213.65  |- mesh__dateCreated mesh__D018759 1994-06-01
% 213.45/213.65  |- mesh__historyNote mesh__D018759 95   
% 213.45/213.65  |- skos__broader mesh__D018759smesh__D014179
% 213.45/213.65  |- skos__prefLabel mesh__D018759 Adrenergic Uptake Inhibitors
% 213.45/213.65  |- mesh__dateRevised mesh__D018759 2005-06-30
% 213.45/213.65  |- skos__altLabel mesh__D018759 Inhibitors, Adrenergic Reuptake
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D018759 2006
% 213.45/213.65  |- skos__related mesh__D018759smesh__D018765
% 213.45/213.65  |- skos__altLabel mesh__D018759 Inhibitors, Adrenergic Uptake
% 213.45/213.65  |- rdf__type mesh__D018759sskos__Concept
% 213.45/213.65  |- skos__scopeNote mesh__D018759
% 213.45/213.65       Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants %28%ANTIDEPRESSIVE AGENTS, TRICYCLIC%29% and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin.%A%    
% 213.45/213.65  |- mesh__recordAuthorizer mesh__D018759 sjn
% 213.45/213.65  |- skos__altLabel mesh__D018759 Uptake Inhibitors, Adrenergic
% 213.45/213.65  |- skos__broader mesh__D018759smesh__D018663
% 213.45/213.65  |- mesh__publicMeSHNote mesh__D018759 95   
% 213.45/213.65  |- mesh__recordOriginator mesh__D018759 RAZ
% 213.45/213.65  |- skos__altLabel mesh__D018759 Reuptake Inhibitors, Adrenergic
% 213.45/213.65  |- mesh__dateEstablished mesh__D018759 1995-01-01
% 213.45/213.65  |- mesh__recordMaintainer mesh__D018759 ssb
% 213.45/213.65  |- skos__related mesh__D018759smesh__D000662
% 213.45/213.65  |- skos__annotation mesh__D018759
% 213.45/213.65       GEN or unspecified; prefer specifics; DF: ADREN UPTAKE INHIB%A%  
% 213.45/213.65  |- mesh__recordOriginator mesh__D010776 NLM
% 213.45/213.65  |- mesh__dateRevised mesh__D010776 2005-06-30
% 213.45/213.65  |- rdf__type mesh__D010776sskos__Concept
% 213.45/213.65  |- mesh__recordMaintainer mesh__D010776 SYSTEM
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D010776 2006
% 213.45/213.65  |- skos__scopeNote mesh__D010776
% 213.45/213.65       A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that are common in the marine environment and on the surfaces and in the intestinal contents of marine animals. Some species are bioluminescent and are found as symbionts in specialized luminous organs of fish.%A%    
% 213.45/213.65  |- skos__broader mesh__D010776smesh__D014737
% 213.45/213.65  |- mesh__dateCreated mesh__D010776 1999-01-01
% 213.45/213.65  |- mesh__recordAuthorizer mesh__D010776 sjn
% 213.45/213.65  |- skos__prefLabel mesh__D010776 Photobacterium
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D029481 2004
% 213.45/213.65  |- mesh__dateEstablished mesh__D029481 2002-01-01
% 213.45/213.65  |- skos__altLabel mesh__D029481 Chronic Bronchitis
% 213.45/213.65  |- mesh__historyNote mesh__D029481 2002   
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D029481 2005
% 213.45/213.65  |- rdf__type mesh__D029481sskos__Concept
% 213.45/213.65  |- skos__broader mesh__D029481smesh__D029424
% 213.45/213.65  |- mesh__publicMeSHNote mesh__D029481 2002   
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D029481 2006
% 213.45/213.65  |- skos__historyNote mesh__D029481 Bronchitis %28%1965-2001%29%
% 213.45/213.65  |- skos__scopeNote mesh__D029481
% 213.45/213.65       A subcategory of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. The disease is characterized by hypersecretion of mucus accompanied by a chronic %28%more than 3 months in 2 consecutive years%29% productive cough. Infectious agents are a major cause of chronic bronchitis.%A%    
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D029481 2002
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D029481 2003
% 213.45/213.65  |- mesh__dateCreated mesh__D029481 2001-07-25
% 213.45/213.65  |- skos__annotation mesh__D029481 BRONCHITIS is also available   
% 213.45/213.65  |- skos__broader mesh__D029481smesh__D001991
% 213.45/213.65  |- skos__prefLabel mesh__D029481 Bronchitis, Chronic
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D004739 1999
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D004739 2000
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D004739 1994
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D004739 1990
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D004739 2003
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D004739 1993
% 213.45/213.65  |- skos__annotation mesh__D004739 LONDON is also available   
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D004739 1998
% 213.45/213.65  |- mesh__recordMaintainer mesh__D004739 PLS
% 213.45/213.65  |- mesh__recordOriginator mesh__D004739 NLM
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D004739 1997
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D004739 1992
% 213.45/213.65  |- mesh__dateRevised mesh__D004739 1991-11-07
% 213.45/213.65  |- skos__prefLabel mesh__D004739 England
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D004739 1996
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D004739 2006
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D004739 2002
% 213.45/213.65  |- mesh__recordAuthorizer mesh__D004739 PLS
% 213.45/213.65  |- rdf__type mesh__D004739sskos__Concept
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D004739 1989
% 213.45/213.65  |- mesh__dateCreated mesh__D004739 1999-01-01
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D004739 2005
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D004739 1995
% 213.45/213.65  |- skos__broader mesh__D004739smesh__D006113
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D004739 2001
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D004739 1991
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D004739 2004
% 213.45/213.65  |- mesh__dateEstablished mesh__D015461 1989-01-01
% 213.45/213.65  |- skos__altLabel mesh__D015461 Leukemia, Lymphocytic, Chronic, T Cell
% 213.45/213.65  |- mesh__recordOriginator mesh__D015461 PLS
% 213.45/213.65  |- skos__hiddenLabel mesh__D015461 Chronic T-Lymphocytic Leukemia
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D015461 2004
% 213.45/213.65  |- skos__hiddenLabel mesh__D015461 T Cell Leukemia, Chronic
% 213.45/213.65  |- skos__hiddenLabel mesh__D015461 T-Lymphocytic Leukemias, Chronic
% 213.45/213.65  |- skos__hiddenLabel mesh__D015461 Leukemia, Chronic T-Cell
% 213.45/213.65  |- skos__altLabel mesh__D015461 Lymphocytic Leukemia, T Cell, Chronic
% 213.45/213.65  |- skos__altLabel mesh__D015461 Lymphocytic Leukemia, T-Cell, Chronic
% 213.45/213.65  |- mesh__recordAuthorizer mesh__D015461 SJN
% 213.45/213.65  |- skos__prefLabel mesh__D015461 Leukemia, T-Cell, Chronic
% 213.45/213.65  |- skos__annotation mesh__D015461
% 213.45/213.65       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 213.45/213.65  |- skos__hiddenLabel mesh__D015461 Leukemias, Chronic T-Lymphocytic
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D015461 2003
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D015461 2006
% 213.45/213.65  |- skos__altLabel mesh__D015461 T-Cell Leukemia, Chronic
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D015461 2002
% 213.45/213.65  |- skos__historyNote mesh__D015461 Leukemia, Lymphocytic %28%1977-1988%29%
% 213.45/213.65  |- skos__hiddenLabel mesh__D015461 Chronic T-Cell Leukemias
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D015461 1999
% 213.45/213.65  |- mesh__dateCreated mesh__D015461 1988-06-09
% 213.45/213.65  |- mesh__recordMaintainer mesh__D015461 PXP
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D015461 2005
% 213.45/213.65  |- skos__broader mesh__D015461smesh__D015458
% 213.45/213.65  |- skos__broader mesh__D015461smesh__D015462
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D015461 2001
% 213.45/213.65  |- skos__altLabel mesh__D015461 T-Lymphocytic Leukemia, Chronic
% 213.45/213.65  |- rdf__type mesh__D015461sskos__Concept
% 213.45/213.65  |- skos__historyNote mesh__D015461 T Lymphocytes %28%1977-1988%29%
% 213.45/213.65  |- skos__hiddenLabel mesh__D015461 T-Cell Leukemias, Chronic
% 213.45/213.65  |- skos__hiddenLabel mesh__D015461 Leukemias, Chronic T-Cell
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D015461 1998
% 213.45/213.65  |- skos__hiddenLabel mesh__D015461 T Lymphocytic Leukemia, Chronic
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D015461 2000
% 213.45/213.65  |- mesh__historyNote mesh__D015461 89   
% 213.45/213.65  |- mesh__dateRevised mesh__D015461 1997-06-20
% 213.45/213.65  |- mesh__publicMeSHNote mesh__D015461 89   
% 213.45/213.65  |- skos__hiddenLabel mesh__D015461 Chronic T-Lymphocytic Leukemias
% 213.45/213.65  |- skos__altLabel mesh__D015461 Leukemia, Lymphocytic, Chronic, T-Cell
% 213.45/213.65  |- skos__altLabel mesh__D015461 Leukemia, T Cell, Chronic
% 213.45/213.65  |- skos__hiddenLabel mesh__D015461 Chronic T-Cell Leukemia
% 213.45/213.65  |- skos__hiddenLabel mesh__D015461 Leukemia, Chronic T-Lymphocytic
% 213.45/213.65  |- skos__hiddenLabel mesh__D009424 Physiologies, Nervous System
% 213.45/213.65  |- skos__scopeNote mesh__D009424
% 213.45/213.65       Functions and activities of the nervous system as a whole or with reference to the peripheral or the central nervous system.%A%    
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D009424 2006
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D009424 2002
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D009424 1999
% 213.45/213.65  |- mesh__recordAuthorizer mesh__D009424 SJN
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D009424 2005
% 213.45/213.65  |- skos__historyNote mesh__D009424
% 213.45/213.65       Nervous System/physiology %28%1966-1997%29%
% 213.45/213.65  |- mesh__dateCreated mesh__D009424 1999-01-01
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D009424 2001
% 213.45/213.65  |- skos__hiddenLabel mesh__D009424 System Physiologies, Nervous
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D009424 2004
% 213.45/213.65  |- skos__hiddenLabel mesh__D009424 System Physiology, Nervous
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D009424 2000
% 213.45/213.65  |- mesh__dateEstablished mesh__D009424 1998-01-01
% 213.45/213.65  |- skos__altLabel mesh__D009424 Physiology, Nervous System
% 213.45/213.65  |- skos__annotation mesh__D009424
% 213.45/213.65       GEN or unspecified; prefer specifics; DF: NERVOUS SYSTEM PHYSIOL%A%  
% 213.45/213.65  |- skos__broader mesh__D009424smesh__D009143
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D009424 2003
% 213.45/213.65  |- mesh__historyNote mesh__D009424 98; use explode 1970-97   
% 213.45/213.65  |- mesh__recordMaintainer mesh__D009424 NNS
% 213.45/213.65  |- mesh__dateRevised mesh__D009424 1998-06-10
% 213.45/213.65  |- skos__hiddenLabel mesh__D009424 Nervous System Physiologies
% 213.45/213.65  |- skos__prefLabel mesh__D009424 Nervous System Physiology
% 213.45/213.65  |- mesh__publicMeSHNote mesh__D009424 98   
% 213.45/213.65  |- rdf__type mesh__D009424sskos__Concept
% 213.45/213.65  |- mesh__recordOriginator mesh__D009424 NLM
% 213.45/213.65  |- skos__annotation mesh__D001441
% 213.45/213.65       infection: coord IM with BACTEROIDES INFECTIONS %28%IM%29%   
% 213.45/213.65  |- skos__broader mesh__D001441smesh__D001439
% 213.45/213.65  |- skos__historyNote mesh__D001441 Bacteroides %28%1966-1975%29%
% 213.45/213.65  |- skos__prefLabel mesh__D001441 Bacteroides fragilis
% 213.45/213.65  |- mesh__recordAuthorizer mesh__D001441 sjn
% 213.45/213.65  |- mesh__recordOriginator mesh__D001441 JW
% 213.45/213.65  |- mesh__historyNote mesh__D001441 76   
% 213.45/213.65  |- rdf__type mesh__D001441sskos__Concept
% 213.45/213.65  |- mesh__dateEstablished mesh__D001441 1976-01-01
% 213.45/213.65  |- skos__scopeNote mesh__D001441
% 213.45/213.65       Gram-negative bacteria occurring in the lower intestinal tracts of man and other animals. It is the most common species of anaerobic bacteria isolated from human soft tissue infections.%A%    
% 213.45/213.65  |- mesh__dateRevised mesh__D001441 2005-06-30
% 213.45/213.65  |- mesh__dateCreated mesh__D001441 1975-07-25
% 213.45/213.65  |- mesh__recordMaintainer mesh__D001441 SYSTEM
% 213.45/213.65  |- mesh__publicMeSHNote mesh__D001441 76   
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D001441 2006
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D014369 2004
% 213.45/213.65  |- skos__hiddenLabel mesh__D014369 Trp tRNA Ligase
% 213.45/213.65  |- skos__hiddenLabel mesh__D014369 Ligase, Trp-tRNA
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D014369 2006
% 213.45/213.65  |- mesh__historyNote mesh__D014369 98%28%75%29%   
% 213.45/213.65  |- mesh__recordAuthorizer mesh__D014369 sjn
% 213.45/213.65  |- skos__broader mesh__D014369smesh__D000604
% 213.45/213.65  |- mesh__dateEstablished mesh__D014369 1991-01-01
% 213.45/213.65  |- mesh__recordOriginator mesh__D014369 NLM
% 213.45/213.65  |- mesh__recordMaintainer mesh__D014369 ssb
% 213.45/213.65  |- skos__hiddenLabel mesh__D014369 Tryptophanyl tRNA Synthetase
% 213.45/213.65  |- skos__altLabel mesh__D014369 Tryptophanyl-tRNA Synthetase
% 213.45/213.65  |- skos__altLabel mesh__D014369 Trp-tRNA Ligase
% 213.45/213.65  |- mesh__dateCreated mesh__D014369 1974-11-19
% 213.45/213.65  |- skos__altLabel mesh__D014369 Tryptophanyl T RNA Synthetase
% 213.45/213.65  |- skos__historyNote mesh__D014369 Tryptophan %28%1974%29%
% 213.45/213.65  |- mesh__publicMeSHNote mesh__D014369
% 213.45/213.65       98; see TRYPTOPHANYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A%  
% 213.45/213.65  |- skos__hiddenLabel mesh__D014369 Synthetase, Tryptophanyl-tRNA
% 213.45/213.65  |- rdf__type mesh__D014369sskos__Concept
% 213.45/213.65  |- skos__scopeNote mesh__D014369
% 213.45/213.65       An enzyme that activates tryptophan with its specific transfer RNA. EC 6.1.1.2.%A%    
% 213.45/213.65  |- skos__historyNote mesh__D014369
% 213.45/213.65       Amino Acyl T RNA Synthetases %28%1974%29%
% 213.45/213.65  |- skos__hiddenLabel mesh__D014369 Ligase, Tryptophan-tRNA
% 213.45/213.65  |- mesh__dateRevised mesh__D014369 2003-07-09
% 213.45/213.65  |- skos__prefLabel mesh__D014369 Tryptophan-tRNA Ligase
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D014369 2005
% 213.45/213.65  |- skos__hiddenLabel mesh__D014369 Tryptophan tRNA Ligase
% 213.45/213.65  |- mesh__recordOriginator mesh__D019852 KEV
% 213.45/213.65  |- skos__hiddenLabel mesh__D019852 Kinase, Arachidonoyl-Diacylglycerol
% 213.45/213.65  |- mesh__dateRevised mesh__D019852 2003-07-09
% 213.45/213.65  |- skos__scopeNote mesh__D019852
% 213.45/213.65       An enzyme of the transferase class that uses ATP to catalyze the phosphorylation of diacylglycerol to a phosphatidate.  EC 2.7.1.107.%A%    
% 213.45/213.65  |- skos__hiddenLabel mesh__D019852 alpha, DGK
% 213.45/213.65  |- skos__historyNote mesh__D019852
% 213.45/213.65       Phosphotransferases %28%Alcohol Group Acceptor%29% %28%1994-1997%29%
% 213.45/213.65  |- skos__historyNote mesh__D019852 Diglycerides %28%1975-1980%29%
% 213.45/213.65  |- skos__altLabel mesh__D019852 Diglyceride Kinase
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D019852 2006
% 213.45/213.65  |- skos__historyNote mesh__D019852 Phosphotransferases %28%1973-1993%29%
% 213.45/213.65  |- skos__historyNote mesh__D019852 Glycerides %28%1973-1974%29%
% 213.45/213.65  |- mesh__dateCreated mesh__D019852 1997-07-02
% 213.45/213.65  |- skos__hiddenLabel mesh__D019852 Kinase, Ceramide-Diglyceride
% 213.45/213.65  |- mesh__recordMaintainer mesh__D019852 ssb
% 213.45/213.65  |- skos__hiddenLabel mesh__D019852 Kinase, Diglyceride
% 213.45/213.65  |- skos__hiddenLabel mesh__D019852 Kinase, Diacylglycerol
% 213.45/213.65  |- mesh__historyNote mesh__D019852
% 213.45/213.65       98; use DIACYLGLYCEROL KINASE %28%NM%29% 1980-97   
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D019852 2005
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D019852 2004
% 213.45/213.65  |- skos__altLabel mesh__D019852 DGKdelta
% 213.45/213.65  |- rdf__type mesh__D019852sskos__Concept
% 213.45/213.65  |- skos__hiddenLabel mesh__D019852 Arachidonoyl Diacylglycerol Kinase
% 213.45/213.65  |- skos__hiddenLabel mesh__D019852 beta, DGK
% 213.45/213.65  |- skos__hiddenLabel mesh__D019852 Kinase, DAG
% 213.45/213.65  |- skos__altLabel mesh__D019852 1,2-Diacylglycerol Kinase
% 213.45/213.65  |- mesh__recordAuthorizer mesh__D019852 sjn
% 213.45/213.65  |- mesh__publicMeSHNote mesh__D019852
% 213.45/213.65       98; DIACYLGLYCEROL KINASE was indexed under PHOSPHOTRANSFERASES %28%ALCOHOL GROUP ACCEPTOR%29% 1994-97, PHOSPHOTRANSFERASES, ATP  1975-93, DIGLYCERIDES 1975-80, and GLYCERIDES %26% PHOSPHOTRANSFERASES 1973-74%A%  
% 213.45/213.65  |- skos__hiddenLabel mesh__D019852 delta, DGK
% 213.45/213.65  |- skos__prefLabel mesh__D019852 Diacylglycerol Kinase
% 213.45/213.65  |- skos__hiddenLabel mesh__D019852 Ceramide Diglyceride Kinase
% 213.45/213.65  |- skos__hiddenLabel mesh__D019852 Kinase, 1,2-Diacylglycerol
% 213.45/213.65  |- skos__broader mesh__D019852smesh__D017853
% 213.45/213.65  |- skos__hiddenLabel mesh__D019852 gamma, DGK
% 213.45/213.65  |- skos__hiddenLabel mesh__D019852 1,2 Diacylglycerol Kinase
% 213.45/213.65  |- skos__altLabel mesh__D019852 DAG Kinase
% 213.45/213.65  |- mesh__dateEstablished mesh__D019852 1998-01-01
% 213.45/213.65  |- skos__broader mesh__D019054smesh__D005071
% 213.45/213.65  |- skos__scopeNote mesh__D019054
% 213.45/213.65       The electrical response evoked in a muscle or motor nerve by electrical or magnetic stimulation. Common methods of stimulation are by transcranial electrical and TRANSCRANIAL MAGNETIC STIMULATION. It is often used for monitoring during neurosurgery.%A%    
% 213.45/213.65  |- mesh__dateCreated mesh__D019054 1995-05-26
% 213.45/213.65  |- skos__hiddenLabel mesh__D019054 Motor Evoked Potential
% 213.45/213.65  |- mesh__recordAuthorizer mesh__D019054 sjn
% 213.45/213.65  |- skos__hiddenLabel mesh__D019054 Potential, Motor Evoked
% 213.45/213.65  |- skos__altLabel mesh__D019054 Motor Evoked Potentials
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D019054 2006
% 213.45/213.65  |- skos__hiddenLabel mesh__D019054 Potentials, Motor Evoked
% 213.45/213.65  |- mesh__dateEstablished mesh__D019054 1996-01-01
% 213.45/213.65  |- skos__hiddenLabel mesh__D019054 Evoked Potential, Motor
% 213.45/213.65  |- rdf__type mesh__D019054sskos__Concept
% 213.45/213.65  |- skos__historyNote mesh__D019054 Evoked Potentials %28%1966-1995%29%
% 213.45/213.65  |- mesh__dateRevised mesh__D019054 2005-06-30
% 213.45/213.65  |- mesh__recordMaintainer mesh__D019054 ssb
% 213.45/213.65  |- skos__prefLabel mesh__D019054 Evoked Potentials, Motor
% 213.45/213.65  |- mesh__publicMeSHNote mesh__D019054 96   
% 213.45/213.65  |- mesh__recordOriginator mesh__D019054 TGC
% 213.45/213.65  |- mesh__historyNote mesh__D019054 96   
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D000349 2001
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D000349 1995
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D000349 2003
% 213.45/213.65  |- skos__annotation mesh__D000349
% 213.45/213.65       for the continent or unspecified only: prefer smaller geog subdivisions, as AFRICA, NORTHERN; AFRICA, CENTRAL; etc.%A%  
% 213.45/213.65  |- skos__broader mesh__D000349smesh__D005842
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D000349 2000
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D000349 1999
% 213.45/213.65  |- mesh__dateRevised mesh__D000349 1993-05-24
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D000349 1994
% 213.45/213.65  |- mesh__dateCreated mesh__D000349 1999-01-01
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D000349 1998
% 213.45/213.65  |- mesh__recordMaintainer mesh__D000349 TGC
% 213.45/213.65  |- mesh__recordAuthorizer mesh__D000349 PLS
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D000349 1997
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D000349 2006
% 213.45/213.65  |- skos__prefLabel mesh__D000349 Africa
% 213.45/213.65  |- rdf__type mesh__D000349sskos__Concept
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D000349 1996
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D000349 2005
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D000349 2002
% 213.45/213.65  |- mesh__recordOriginator mesh__D000349 NLM
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D000349 2004
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011071 2005
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011071 1995
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011071 2003
% 213.45/213.65  |- mesh__dateEstablished mesh__D011071 1991-01-01
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011071 1993
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011071 2006
% 213.45/213.65  |- mesh__publicMeSHNote mesh__D011071
% 213.45/213.65       91; was see under POLYDEOXYRIBONUCLEOTIDES 1976-90   
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011071 2000
% 213.45/213.65  |- skos__scopeNote mesh__D011071
% 213.45/213.65       A group of thymine nucleotides in which the phosphate residues of each thymine nucleotide act as bridges in forming diester linkages between the deoxyribose moieties.%A%    
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011071 1998
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011071 2004
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011071 1996
% 213.45/213.65  |- mesh__recordOriginator mesh__D011071 RLS
% 213.45/213.65  |- rdf__type mesh__D011071sskos__Concept
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011071 1999
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011071 2001
% 213.45/213.65  |- skos__hiddenLabel mesh__D011071 Polynucleotides, Thymine
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011071 1997
% 213.45/213.65  |- skos__prefLabel mesh__D011071 Poly T
% 213.45/213.65  |- mesh__dateCreated mesh__D011071 1975-08-01
% 213.45/213.65  |- skos__altLabel mesh__D011071 Poly dT
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011071 2002
% 213.45/213.65  |- skos__altLabel mesh__D011071 Polythymidylic Acids
% 213.45/213.65  |- mesh__recordAuthorizer mesh__D011071 PLS
% 213.45/213.65  |- skos__hiddenLabel mesh__D011071 Acids, Polythymidylic
% 213.45/213.65  |- skos__hiddenLabel mesh__D011071 dT, Poly
% 213.45/213.65  |- skos__altLabel mesh__D011071 Thymine Polynucleotides
% 213.45/213.65  |- skos__historyNote mesh__D011071 Polynucleotides %28%1966-1975%29%
% 213.45/213.65  |- skos__broader mesh__D011071smesh__D011089
% 213.45/213.65  |- skos__altLabel mesh__D011071 Polydeoxythymidylate
% 213.45/213.65  |- mesh__dateRevised mesh__D011071 1992-05-20
% 213.45/213.65  |- mesh__activeMeSHYear mesh__D011071 1994
% 213.45/213.66  |- mesh__recordMaintainer mesh__D011071 TGC
% 213.45/213.66  |- mesh__historyNote mesh__D011071
% 213.45/213.66       91%28%76%29%; was see under POLYDEOXYRIBONUCLEOTIDES 1976-90   
% 213.45/213.66  |- skos__hiddenLabel mesh__D005832 Disease, Male Genital
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005832 1995
% 213.45/213.66  |- skos__hiddenLabel mesh__D005832 Diseases, Male Genital
% 213.45/213.66  |- skos__hiddenLabel mesh__D005832 Male Genital Diseases
% 213.45/213.66  |- mesh__recordAuthorizer mesh__D005832 NLM
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005832 1998
% 213.45/213.66  |- mesh__dateRevised mesh__D005832 1990-05-29
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005832 1994
% 213.45/213.66  |- mesh__historyNote mesh__D005832 66   
% 213.45/213.66  |- skos__hiddenLabel mesh__D005832 Genital Disease, Male
% 213.45/213.66  |- mesh__dateCreated mesh__D005832 1999-01-01
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005832 1991
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005832 2004
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005832 2001
% 213.45/213.66  |- mesh__recordMaintainer mesh__D005832 PLS
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005832 2003
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005832 1997
% 213.45/213.66  |- skos__hiddenLabel mesh__D005832 Male Genital Disease
% 213.45/213.66  |- mesh__publicMeSHNote mesh__D005832 66   
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005832 2000
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005832 2006
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005832 1993
% 213.45/213.66  |- skos__broader mesh__D005832smesh__D014569
% 213.45/213.66  |- skos__annotation mesh__D005832
% 213.45/213.66       human %26% animal; GEN: prefer specifics   
% 213.45/213.66  |- mesh__recordOriginator mesh__D005832 NLM
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005832 1996
% 213.45/213.66  |- mesh__dateEstablished mesh__D005832 1966-01-01
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005832 2005
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005832 1999
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005832 1992
% 213.45/213.66  |- skos__prefLabel mesh__D005832 Genital Diseases, Male
% 213.45/213.66  |- rdf__type mesh__D005832sskos__Concept
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005832 2002
% 213.45/213.66  |- skos__hiddenLabel mesh__D005034 Chloride, Ethyl Mercury
% 213.45/213.66  |- skos__historyNote mesh__D005034 Mercury Poisoning %28%1966-1971%29%
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005034 2004
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005034 2002
% 213.45/213.66  |- skos__historyNote mesh__D005034
% 213.45/213.66       Organometallic Compounds %28%1968-1971%29%
% 213.45/213.66  |- skos__broader mesh__D005034smesh__D005035
% 213.45/213.66  |- skos__altLabel mesh__D005034 Ethyl Mercury Chloride
% 213.45/213.66  |- mesh__dateEstablished mesh__D005034 1991-01-01
% 213.45/213.66  |- skos__hiddenLabel mesh__D005034 Chloride, Ethylmercury
% 213.45/213.66  |- mesh__onlineNote mesh__D005034
% 213.45/213.66       use ETHYLMERCURIC CHLORIDE to search ETHYLMERCURY CHLORIDE 1980-90 %26% ETHYL MERCURY CHLORIDE 1972-79 %28%as Prov 1972-74%29%%A%  
% 213.45/213.66  |- skos__altLabel mesh__D005034 Ethylmercury Chloride
% 213.45/213.66  |- skos__altLabel mesh__D005034 Chloroethylmercury
% 213.45/213.66  |- mesh__dateRevised mesh__D005034 2000-06-22
% 213.45/213.66  |- rdf__type mesh__D005034sskos__Concept
% 213.45/213.66  |- mesh__recordMaintainer mesh__D005034 CCR
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005034 2005
% 213.45/213.66  |- skos__historyNote mesh__D005034 Mercury %28%1966-1971%29%
% 213.45/213.66  |- mesh__publicMeSHNote mesh__D005034
% 213.45/213.66       91; was ETHYLMERCURY CHLORIDE see under ETHYLMERCURY COMPOUNDS 1980-90; was ETHYL MERCURY CHLORIDE see under ETHYL MERCURY COMPOUNDS 1975-79%A%  
% 213.45/213.66  |- skos__scopeNote mesh__D005034
% 213.45/213.66       A highly toxic compound used as a fungicide for treating seeds.%A%    
% 213.45/213.66  |- skos__hiddenLabel mesh__D005034 Chloride, Ethylmercuric
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005034 2006
% 213.45/213.66  |- mesh__historyNote mesh__D005034
% 213.45/213.66       91%28%80%29%; was ETHYLMERCURY CHLORIDE see under ETHYLMERCURY COMPOUNDS 1980-90; was ETHYL MERCURY CHLORIDE see under ETHYL MERCURY COMPOUNDS 1972-79 %28%Prov 1972-74%29%%A%  
% 213.45/213.66  |- skos__prefLabel mesh__D005034 Ethylmercuric Chloride
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005034 2001
% 213.45/213.66  |- skos__historyNote mesh__D005034 Antifungal Agents %28%1966-1971%29%
% 213.45/213.66  |- mesh__recordOriginator mesh__D005034 NLM
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005034 2003
% 213.45/213.66  |- mesh__dateCreated mesh__D005034 1999-01-01
% 213.45/213.66  |- mesh__recordAuthorizer mesh__D005034 sjn
% 213.45/213.66  |- skos__broader mesh__D010777smesh__D002627
% 213.45/213.66  |- mesh__publicMeSHNote mesh__D010777 71   
% 213.45/213.66  |- skos__historyNote mesh__D010777 Light %28%1966-1970%29%
% 213.45/213.66  |- rdf__type mesh__D010777sskos__Concept
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D010777 2000
% 213.45/213.66  |- mesh__dateCreated mesh__D010777 1999-01-01
% 213.45/213.66  |- skos__prefLabel mesh__D010777 Photochemistry
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D010777 2005
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D010777 2001
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D010777 2003
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D010777 1994
% 213.45/213.66  |- mesh__recordOriginator mesh__D010777 NLM
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D010777 1990
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D010777 2006
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D010777 1992
% 213.45/213.66  |- mesh__historyNote mesh__D010777 71   
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D010777 2002
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D010777 1998
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D010777 2004
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D010777 1995
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D010777 1991
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D010777 1996
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D010777 1993
% 213.45/213.66  |- mesh__dateEstablished mesh__D010777 1971-01-01
% 213.45/213.66  |- mesh__dateRevised mesh__D010777 1989-05-16
% 213.45/213.66  |- skos__annotation mesh__D010777
% 213.45/213.66       IM when SPEC: SPEC qualif; no qualif when NIM coord   
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D010777 1999
% 213.45/213.66  |- mesh__recordMaintainer mesh__D010777 TGC
% 213.45/213.66  |- mesh__recordAuthorizer mesh__D010777 PLS
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D010777 1997
% 213.45/213.66  |- skos__hiddenLabel mesh__D010777 Photochemistries
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D029482 2002
% 213.45/213.66  |- skos__broader mesh__D029482smesh__D019213
% 213.45/213.66  |- skos__scopeNote mesh__D029482
% 213.45/213.66       A species of RUBULAVIRUS causing endemic upper respiratory infections in children. It produces only a mild clinical disease and often goes undetected.%A%    
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D029482 2006
% 213.45/213.66  |- skos__annotation mesh__D029482
% 213.45/213.66       infection: coord IM with RUBULAVIRUS INFECTIONS %28%IM%29%   
% 213.45/213.66  |- mesh__dateCreated mesh__D029482 2001-07-25
% 213.45/213.66  |- mesh__historyNote mesh__D029482
% 213.45/213.66       2002; use RUBULAVIRUS 1997-2001, use PARAINFLUENZA VIRUSES 1994-1996%A%  
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D029482 2003
% 213.45/213.66  |- skos__historyNote mesh__D029482 Rubulavirus %28%1997-2001%29%
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D029482 2004
% 213.45/213.66  |- skos__prefLabel mesh__D029482 Parainfluenza Virus 4, Human
% 213.45/213.66  |- mesh__dateEstablished mesh__D029482 2002-01-01
% 213.45/213.66  |- skos__altLabel mesh__D029482 Human parainfluenza virus 4
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D029482 2005
% 213.45/213.66  |- rdf__type mesh__D029482sskos__Concept
% 213.45/213.66  |- skos__historyNote mesh__D029482 Paramyxovirus %28%1966-1996%29%
% 213.45/213.66  |- mesh__publicMeSHNote mesh__D029482
% 213.45/213.66       2002; see RUBULAVIRUS 1997-2001, see PARAINFLUENZA VIRUSES 1994-1996%A%  
% 213.45/213.66  |- skos__hiddenLabel mesh__D015462 Chronic Lymphoblastic Leukemia
% 213.45/213.66  |- mesh__onlineNote mesh__D015462
% 213.45/213.66       use LEUKEMIA, LYMPHOCYTIC to search LEUKEMIA, LYMPHOCYTIC, CHRONIC 1974-88%A%  
% 213.45/213.66  |- mesh__historyNote mesh__D015462
% 213.45/213.66       89; was see LEUKEMIA, LYMPHOCYTIC 1974-88   
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D015462 2003
% 213.45/213.66  |- mesh__dateRevised mesh__D015462 1995-06-08
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D015462 2006
% 213.45/213.66  |- mesh__dateEstablished mesh__D015462 1989-01-01
% 213.45/213.66  |- skos__broader mesh__D015462smesh__D007945
% 213.45/213.66  |- mesh__recordMaintainer mesh__D015462 KEV
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D015462 2004
% 213.45/213.66  |- skos__hiddenLabel mesh__D015462 Lymphoblastic Leukemias, Chronic
% 213.45/213.66  |- skos__hiddenLabel mesh__D015462 Leukemia, Chronic Lymphoblastic
% 213.45/213.66  |- skos__hiddenLabel mesh__D015462 Chronic Lymphocytic Leukemias
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D015462 1998
% 213.45/213.66  |- skos__hiddenLabel mesh__D015462 Leukemias, Chronic Lymphocytic
% 213.45/213.66  |- skos__hiddenLabel mesh__D015462 Chronic Lymphoblastic Leukemias
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D015462 2000
% 213.45/213.66  |- mesh__recordOriginator mesh__D015462 PLS
% 213.45/213.66  |- skos__altLabel mesh__D015462 Lymphoblastic Leukemia, Chronic
% 213.45/213.66  |- rdf__type mesh__D015462sskos__Concept
% 213.45/213.66  |- skos__hiddenLabel mesh__D015462 Chronic Lymphocytic Leukemia
% 213.45/213.66  |- skos__annotation mesh__D015462
% 213.45/213.66       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 213.45/213.66  |- mesh__dateCreated mesh__D015462 1988-06-09
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D015462 2001
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D015462 1996
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D015462 1999
% 213.45/213.66  |- skos__prefLabel mesh__D015462 Leukemia, Lymphocytic, Chronic
% 213.45/213.66  |- mesh__publicMeSHNote mesh__D015462
% 213.45/213.66       89; was see LEUKEMIA, LYMPHOCYTIC 1974-88   
% 213.45/213.66  |- skos__altLabel mesh__D015462 Leukemia, Lymphoblastic, Chronic
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D015462 2002
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D015462 1997
% 213.45/213.66  |- mesh__recordAuthorizer mesh__D015462 PLS
% 213.45/213.66  |- skos__hiddenLabel mesh__D015462 Leukemias, Chronic Lymphoblastic
% 213.45/213.66  |- skos__hiddenLabel mesh__D015462 Leukemia, Chronic Lymphocytic
% 213.45/213.66  |- skos__altLabel mesh__D015462 Lymphocytic Leukemia, Chronic
% 213.45/213.66  |- skos__historyNote mesh__D015462 Leukemia, Lymphocytic %28%1966-1988%29%
% 213.45/213.66  |- skos__hiddenLabel mesh__D015462 Lymphocytic Leukemias, Chronic
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D015462 2005
% 213.45/213.66  |- mesh__historyNote mesh__D009425 69%28%67%29%   
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D009425 2005
% 213.45/213.66  |- mesh__recordOriginator mesh__D009425 NLM
% 213.45/213.66  |- mesh__dateCreated mesh__D009425 1999-01-01
% 213.45/213.66  |- skos__prefLabel mesh__D009425 Nesting Behavior
% 213.45/213.66  |- mesh__recordAuthorizer mesh__D009425 sjn
% 213.45/213.66  |- skos__hiddenLabel mesh__D009425 Behaviors, Nesting
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D009425 2004
% 213.45/213.66  |- skos__broader mesh__D009425smesh__D003259
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D009425 2003
% 213.45/213.66  |- skos__scopeNote mesh__D009425
% 213.45/213.66       Animal behavior associated with the nest; includes construction, effects of size and material; behavior of the adult during the nesting period and the effect of the nest on the behavior of the young.%A%    
% 213.45/213.66  |- skos__hiddenLabel mesh__D009425 Nesting Behaviors
% 213.45/213.66  |- rdf__type mesh__D009425sskos__Concept
% 213.45/213.66  |- mesh__dateRevised mesh__D009425 2002-07-02
% 213.45/213.66  |- mesh__dateEstablished mesh__D009425 1969-01-01
% 213.45/213.66  |- mesh__publicMeSHNote mesh__D009425 69   
% 213.45/213.66  |- mesh__recordMaintainer mesh__D009425 TAP
% 213.45/213.66  |- skos__annotation mesh__D009425 animal only   
% 213.45/213.66  |- skos__hiddenLabel mesh__D009425 Behavior, Nesting
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D009425 2006
% 213.45/213.66  |- skos__historyNote mesh__D009425 Behavior, Animal %28%1966%29%
% 213.45/213.66  |- skos__annotation mesh__D001442 gram-neg bact infect   
% 213.45/213.66  |- skos__prefLabel mesh__D001442 Bacteroides Infections
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D001442 1996
% 213.45/213.66  |- skos__scopeNote mesh__D001442
% 213.45/213.66       Infections with bacteria of the genus BACTEROIDES.     
% 213.45/213.66  |- mesh__dateCreated mesh__D001442 1999-01-01
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D001442 1997
% 213.45/213.66  |- mesh__recordMaintainer mesh__D001442 PLS
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D001442 2000
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D001442 1998
% 213.45/213.66  |- mesh__recordOriginator mesh__D001442 NLM
% 213.45/213.66  |- rdf__type mesh__D001442sskos__Concept
% 213.45/213.66  |- skos__hiddenLabel mesh__D001442 Bacteroides Infection
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D001442 2003
% 213.45/213.66  |- mesh__dateEstablished mesh__D001442 1968-01-01
% 213.45/213.66  |- skos__historyNote mesh__D001442 Bacteroides %28%1966-1967%29%
% 213.45/213.66  |- mesh__recordAuthorizer mesh__D001442 PLS
% 213.45/213.66  |- skos__broader mesh__D001442smesh__D016866
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D001442 1994
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D001442 2001
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D001442 1999
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D001442 2004
% 213.45/213.66  |- mesh__historyNote mesh__D001442 68   
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D001442 1995
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D001442 2002
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D001442 2005
% 213.45/213.66  |- skos__hiddenLabel mesh__D001442 Infection, Bacteroides
% 213.45/213.66  |- skos__altLabel mesh__D001442 Infections, Bacteroides
% 213.45/213.66  |- mesh__publicMeSHNote mesh__D001442 68   
% 213.45/213.66  |- mesh__dateRevised mesh__D001442 1993-06-02
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D001442 2006
% 213.45/213.66  |- skos__prefLabel mesh__D019853
% 213.45/213.66       O%28%6%29%-Methylguanine-DNA Methyltransferase
% 213.45/213.66  |- skos__altLabel mesh__D019853
% 213.45/213.66       O%28%6%29%-Alkylguanine-DNA Alkyltransferase
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D019853 2005A
% 213.45/213.66  |- skos__altLabel mesh__D019853
% 213.45/213.66       Methylated-DNA-Protein-Cysteine S-Methyltransferase
% 213.45/213.66  |- mesh__publicMeSHNote mesh__D019853
% 213.45/213.66       98; O%28%6%29%-METHYLGUANINE-DNA METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1978-97 %26% DNA %28%CYTOSINE-5-%29%-METHYLTRANSFERASE 1978-82%A%  
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D019853 2006
% 213.45/213.66  |- skos__altLabel mesh__D019853 O%28%6%29%-Methylguanine DNA Transmethylase
% 213.45/213.66  |- mesh__dateEstablished mesh__D019853 1998-01-01
% 213.45/213.66  |- mesh__historyNote mesh__D019853
% 213.45/213.66       98; use O%28%6%29%-METHYLGUANINE-DNA METHYLTRANSFERASE %28%NM%29% 1980-97%A%  
% 213.45/213.66  |- mesh__recordAuthorizer mesh__D019853 jls
% 213.45/213.66  |- skos__hiddenLabel mesh__D019853
% 213.45/213.66       S-Methyltransferase, Methylated-DNA-Protein-Cysteine
% 213.45/213.66  |- mesh__recordMaintainer mesh__D019853 jls
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D019853 2004
% 213.45/213.66  |- skos__broader mesh__D019853smesh__D011496
% 213.45/213.66  |- skos__hiddenLabel mesh__D019853
% 213.45/213.66       Methylated DNA Protein Cysteine S Methyltransferase
% 213.45/213.66  |- mesh__dateRevised mesh__D019853 2004-07-29
% 213.45/213.66  |- skos__altLabel mesh__D019853 O%28%6%29%-MeG-DNA Methyltransferase
% 213.45/213.66  |- rdf__type mesh__D019853sskos__Concept
% 213.45/213.66  |- skos__altLabel mesh__D019853 Guanine-O%28%6%29%-Alkyltransferase
% 213.45/213.66  |- skos__scopeNote mesh__D019853
% 213.45/213.66       An enzyme that transfers methyl groups from O%28%6%29%-methylguanine, and other methylated moieties of DNA, to a cysteine residue in itself, thus repairing alkylated DNA in a single-step reaction. EC 2.1.1.63.%A%    
% 213.45/213.66  |- mesh__recordOriginator mesh__D019853 KEV
% 213.45/213.66  |- mesh__dateCreated mesh__D019853 1997-06-20
% 213.45/213.66  |- skos__altLabel mesh__D019853 O%28%6%29%-Methylguanine Methyltransferase
% 213.45/213.66  |- skos__historyNote mesh__D019853
% 213.45/213.66       DNA %28%Cytosine-5-%29%-Methyltransferase %28%1978-1982%29%
% 213.45/213.66  |- skos__altLabel mesh__D019853 O%28%6%29%-AGT
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D019853 2005
% 213.45/213.66  |- skos__historyNote mesh__D019853 Methyltransferases %28%1978-1997%29%
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D011870 2003
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D011870 2000
% 213.45/213.66  |- mesh__historyNote mesh__D011870 98; use explode 1970-97   
% 213.45/213.66  |- skos__prefLabel mesh__D011870 Radiologic Health
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D011870 2004
% 213.45/213.66  |- skos__broader mesh__D011870smesh__D011634
% 213.45/213.66  |- mesh__dateRevised mesh__D011870 1997-06-20
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D011870 2001
% 213.45/213.66  |- mesh__recordAuthorizer mesh__D011870 SJN
% 213.45/213.66  |- rdf__type mesh__D011870sskos__Concept
% 213.45/213.66  |- skos__scopeNote mesh__D011870
% 213.45/213.66       Health concerns associated with the effects of radiation on the environment and on public and personal health.%A%    
% 213.45/213.66  |- mesh__dateCreated mesh__D011870 1999-01-01
% 213.45/213.66  |- skos__altLabel mesh__D011870 Radiological Health
% 213.45/213.66  |- skos__altLabel mesh__D011870 Health, Radiologic
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D011870 2005
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D011870 2002
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D011870 1998
% 213.45/213.66  |- mesh__publicMeSHNote mesh__D011870 98   
% 213.45/213.66  |- skos__hiddenLabel mesh__D011870 Health, Radiological
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D011870 2006
% 213.45/213.66  |- mesh__dateEstablished mesh__D011870 1998-01-01
% 213.45/213.66  |- mesh__recordOriginator mesh__D011870 NLM
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D011870 1999
% 213.45/213.66  |- skos__annotation mesh__D011870 SPEC: SPEC qualif   
% 213.45/213.66  |- mesh__recordMaintainer mesh__D011870 TGC
% 213.45/213.66  |- mesh__dateRevised mesh__D019055 1996-06-10
% 213.45/213.66  |- skos__hiddenLabel mesh__D019055 Levels, No-Observed-Adverse-Effect
% 213.45/213.66  |- rdf__type mesh__D019055sskos__Concept
% 213.45/213.66  |- mesh__publicMeSHNote mesh__D019055 96   
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D019055 2002
% 213.45/213.66  |- skos__broader mesh__D019055smesh__D018675
% 213.45/213.66  |- mesh__recordOriginator mesh__D019055 TGC
% 213.45/213.66  |- skos__scopeNote mesh__D019055
% 213.45/213.66       The highest dosage administered that does not produce toxic effects. The NOAEL will depend on how closely dosages are spaced %28%lowest-observed-adverse-effect level and no-observed-effect level%29% and the number of animals examined. The ultimate objective is usually to determine not the %22%safe%22% dosage in laboratory animals but the %22%safe%22% dosage for humans. Therefore, the extrapolation most often required of toxicologists is from high-dosage studies in laboratory animals to low doses in humans. %28%Casarett and Doull%27%s Toxicology: The Basic Science of Poisons, 4th ed%29%%A%    
% 213.45/213.66  |- skos__historyNote mesh__D019055
% 213.45/213.66       specific drug /toxicity %28%1983-1995%29%
% 213.45/213.66  |- skos__hiddenLabel mesh__D019055 No-Observed-Adverse-Effect Levels
% 213.45/213.66  |- skos__hiddenLabel mesh__D019055 No Observed Effect Level
% 213.45/213.66  |- skos__hiddenLabel mesh__D019055 Level, No-Observed-Adverse-Effect
% 213.45/213.66  |- skos__prefLabel mesh__D019055 No-Observed-Adverse-Effect Level
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D019055 2000
% 213.45/213.66  |- mesh__historyNote mesh__D019055 96   
% 213.45/213.66  |- skos__hiddenLabel mesh__D019055 No-Observed-Effect Levels
% 213.45/213.66  |- mesh__recordMaintainer mesh__D019055 TPW
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D019055 2003
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D019055 1997
% 213.45/213.66  |- mesh__dateEstablished mesh__D019055 1996-01-01
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D019055 1998
% 213.45/213.66  |- skos__altLabel mesh__D019055 NOAEL
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D019055 2001
% 213.45/213.66  |- skos__hiddenLabel mesh__D019055 No Observed Adverse Effect Level
% 213.45/213.66  |- skos__hiddenLabel mesh__D019055 Level, No-Observed-Effect
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D019055 2004
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D019055 2005
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D019055 1999
% 213.45/213.66  |- skos__hiddenLabel mesh__D019055 Levels, No-Observed-Effect
% 213.45/213.66  |- mesh__recordAuthorizer mesh__D019055 PLS
% 213.45/213.66  |- mesh__dateCreated mesh__D019055 1995-05-26
% 213.45/213.66  |- skos__altLabel mesh__D019055 NOEL
% 213.45/213.66  |- skos__broader mesh__D019055smesh__D002620
% 213.45/213.66  |- skos__annotation mesh__D019055
% 213.45/213.66       NIM; coord with specific drug /tox %28%IM%29%; DF: note short X refs%A%  
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D019055 2006
% 213.45/213.66  |- mesh__recordMaintainer mesh__D011072 ADP
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D011072 1998
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D011072 2004
% 213.45/213.66  |- skos__prefLabel mesh__D011072 Poly U
% 213.45/213.66  |- mesh__dateRevised mesh__D011072 1997-06-20
% 213.45/213.66  |- rdf__type mesh__D011072sskos__Concept
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D011072 1999
% 213.45/213.66  |- mesh__recordAuthorizer mesh__D011072 SJN
% 213.45/213.66  |- skos__hiddenLabel mesh__D011072 Polynucleotides, Uracil
% 213.45/213.66  |- skos__broader mesh__D011072smesh__D011131
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D011072 2000
% 213.45/213.66  |- skos__altLabel mesh__D011072 Polyuridylic Acids
% 213.45/213.66  |- skos__scopeNote mesh__D011072
% 213.45/213.66       A group of uridine ribonucleotides in which the phosphate residues of each uridine ribonucleotide act as bridges in forming diester linkages between the ribose moieties.%A%    
% 213.45/213.66  |- skos__hiddenLabel mesh__D011072 Acids, Polyuridylic
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D011072 2001
% 213.45/213.66  |- mesh__historyNote mesh__D011072 74%28%72%29%   
% 213.45/213.66  |- skos__altLabel mesh__D011072 Uracil Polynucleotides
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D011072 2005
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D011072 2002
% 213.45/213.66  |- mesh__publicMeSHNote mesh__D011072 74   
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D011072 2003
% 213.45/213.66  |- mesh__dateCreated mesh__D011072 1999-01-01
% 213.45/213.66  |- mesh__dateEstablished mesh__D011072 1974-01-01
% 213.45/213.66  |- skos__hiddenLabel mesh__D011072 U, Poly
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D011072 2006
% 213.45/213.66  |- mesh__recordOriginator mesh__D011072 NLM
% 213.45/213.66  |- skos__altLabel mesh__D011072 Poly%28%rU%29%
% 213.45/213.66  |- skos__altLabel mesh__D005833 Neoplasms, Gynecologic
% 213.45/213.66  |- skos__altLabel mesh__D005833 Neoplasms, Female Genital
% 213.45/213.66  |- mesh__dateCreated mesh__D005833 1999-01-01
% 213.45/213.66  |- mesh__dateRevised mesh__D005833 2005-06-30
% 213.45/213.66  |- skos__scopeNote mesh__D005833
% 213.45/213.66       Tumor or cancer of the female reproductive tract %28%GENITALIA, FEMALE%29%.%A%    
% 213.45/213.66  |- skos__altLabel mesh__D005833 Gynecologic Neoplasms
% 213.45/213.66  |- mesh__historyNote mesh__D005833 79; was GYNECOLOGIC NEOPLASMS 1963-78   
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005833 2006
% 213.45/213.66  |- mesh__recordMaintainer mesh__D005833 lkt
% 213.45/213.66  |- skos__hiddenLabel mesh__D005833 Female Genital Neoplasm
% 213.45/213.66  |- skos__altLabel mesh__D005833 Female Genital Neoplasms
% 213.45/213.66  |- skos__hiddenLabel mesh__D005833 Genital Neoplasm, Female
% 213.45/213.66  |- skos__prefLabel mesh__D005833 Genital Neoplasms, Female
% 213.45/213.66  |- rdf__type mesh__D005833sskos__Concept
% 213.45/213.66  |- skos__hiddenLabel mesh__D005833 Neoplasm, Female Genital
% 213.45/213.66  |- skos__hiddenLabel mesh__D005833 Gynecologic Neoplasm
% 213.45/213.66  |- skos__hiddenLabel mesh__D005833 Neoplasm, Gynecologic
% 213.45/213.66  |- mesh__onlineNote mesh__D005833
% 213.45/213.66       use GENITAL NEOPLASMS, FEMALE to search GYNECOLOGIC NEOPLASMS 1966-78%A%  
% 213.45/213.66  |- skos__annotation mesh__D005833
% 213.45/213.66       human %26% animal; general or unspecified only: prefer specifics; coordinate IM with histological type of neoplasm %28%IM%29%; /vet: consider also VENEREAL TUMORS, VETERINARY%A%  
% 213.45/213.66  |- skos__broader mesh__D005833smesh__D014565
% 213.45/213.66  |- mesh__publicMeSHNote mesh__D005833
% 213.45/213.66       79; was GYNECOLOGIC NEOPLASMS 1963-78   
% 213.45/213.66  |- mesh__recordOriginator mesh__D005833 NLM
% 213.45/213.66  |- mesh__recordAuthorizer mesh__D005833 sjn
% 213.45/213.66  |- skos__historyNote mesh__D005035 Antifungal Agents %28%1966-1971%29%
% 213.45/213.66  |- mesh__recordOriginator mesh__D005035 NLM
% 213.45/213.66  |- skos__hiddenLabel mesh__D005035 Mercury Compounds, Ethyl
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005035 1996
% 213.45/213.66  |- rdf__type mesh__D005035sskos__Concept
% 213.45/213.66  |- skos__prefLabel mesh__D005035 Ethylmercury Compounds
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005035 2005
% 213.45/213.66  |- mesh__dateEstablished mesh__D005035 1974-01-01
% 213.45/213.66  |- skos__historyNote mesh__D005035 Mercury %28%1966-1971%29%
% 213.45/213.66  |- skos__scopeNote mesh__D005035
% 213.45/213.66       Organic mercury compounds in which the mercury is attached to an ethyl group.%A%    
% 213.45/213.66  |- skos__annotation mesh__D005035
% 213.45/213.66       indust fungicides; DF: ETHYLMERCURY CPDS   
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005035 1997
% 213.45/213.66  |- mesh__publicMeSHNote mesh__D005035
% 213.45/213.66       80; was ETHYL MERCURY COMPOUNDS 1974-79   
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005035 2002
% 213.45/213.66  |- skos__historyNote mesh__D005035
% 213.45/213.66       Organometallic Compounds %28%1968-1971%29%
% 213.45/213.66  |- skos__altLabel mesh__D005035 Ethylmercurials
% 213.45/213.66  |- skos__hiddenLabel mesh__D005035 Compounds, Ethylmercury
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005035 2006
% 213.45/213.66  |- skos__altLabel mesh__D005035 Ethyl Mercury Compounds
% 213.45/213.66  |- mesh__onlineNote mesh__D005035
% 213.45/213.66       use ETHYLMERCURY COMPOUNDS to search ETHYL MERCURY COMPOUNDS 1972-79 %28%as Prov 1972-73%29%%A%  
% 213.45/213.66  |- mesh__recordAuthorizer mesh__D005035 PLS
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005035 2003
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005035 1998
% 213.45/213.66  |- skos__broader mesh__D005035smesh__D000479
% 213.45/213.66  |- mesh__recordMaintainer mesh__D005035 JRT
% 213.45/213.66  |- skos__hiddenLabel mesh__D005035 Compounds, Ethyl Mercury
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005035 2000
% 213.45/213.66  |- mesh__dateCreated mesh__D005035 1999-01-01
% 213.45/213.66  |- mesh__dateRevised mesh__D005035 1995-06-08
% 213.45/213.66  |- mesh__historyNote mesh__D005035
% 213.45/213.66       80; was ETHYL MERCURY COMPOUNDS 1972-79 %28%Prov 1972-73%29%   
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005035 2004
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005035 2001
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D005035 1999
% 213.45/213.66  |- skos__historyNote mesh__D010778 Light %28%1966-1977%29%
% 213.45/213.66  |- skos__altLabel mesh__D010778 Photodynamic Therapy
% 213.45/213.66  |- skos__broader mesh__D010778smesh__D010789
% 213.45/213.66  |- skos__broader mesh__D010778smesh__D003131
% 213.45/213.66  |- skos__annotation mesh__D010778
% 213.45/213.66       %22%therapy using oral or topical photosensitizing agents with subsequent exposure to light%22%; IM; coord with disease /drug ther %28%IM%29%%A%  
% 213.45/213.66  |- skos__hiddenLabel mesh__D010778 Therapies, Photodynamic
% 213.45/213.66  |- skos__altLabel mesh__D010778 Therapy, Photodynamic
% 213.45/213.66  |- mesh__recordAuthorizer mesh__D010778 sjn
% 213.45/213.66  |- mesh__recordOriginator mesh__D010778 SMH
% 213.45/213.66  |- mesh__activeMeSHYear mesh__D010778 2006
% 213.45/213.66  |- mesh__dateEstablished mesh__D010778 1978-01-01
% 213.45/213.66  |- mesh__publicMeSHNote mesh__D010778 78   
% 213.45/213.66  |- mesh__recordMaintainer mesh__D010778 lkt
% 213.45/213.66  |- skos__broader mesh__D010778smesh__D004358
% 213.45/213.66  |- skos__scopeNote mesh__D010778
% 213.45/213.66       Therapy using oral or topical photosensitizing agents with subsequent exposure to light.%A%    
% 213.45/213.66  |- skos__hiddenLabel mesh__D010778 Photochemotherapies
% 213.45/213.66  |- mesh__dateCreated mesh__D010778 1977-03-01
% 213.45/213.66  |- mesh__dateRevised mesh__D010778 2005-06-30
% 213.45/213.66  |- mesh__historyNote mesh__D010778 78   
% 213.45/213.66  |- skos__historyNote mesh__D010778 Ultraviolet Therapy %28%1966-1977%29%
% 213.45/213.66  |- skos__prefLabel mesh__D010778 Photochemotherapy
% 213.45/213.66  |- skos__hiddenLabel mesh__D010778 Photodynamic Therapies
% 213.45/213.66  |- rdf__type mesh__D010778sskos__Concept
% 213.45/213.66  |- mesh__historyNote mesh__D015463 89   
% 213.45/213.67  |- skos__annotation mesh__D015463
% 213.45/213.67       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D015463 2001
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D015463 1998
% 213.45/213.67  |- mesh__recordOriginator mesh__D015463 PLS
% 213.45/213.67  |- skos__historyNote mesh__D015463 Leukemia, Lymphocytic %28%1966-1988%29%
% 213.45/213.67  |- rdf__type mesh__D015463sskos__Concept
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D015463 2002
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D015463 1996
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D015463 1999
% 213.45/213.67  |- mesh__recordAuthorizer mesh__D015463 PLS
% 213.45/213.67  |- skos__hiddenLabel mesh__D015463 Prolymphocytic Leukemias
% 213.45/213.67  |- skos__hiddenLabel mesh__D015463 Leukemias, Prolymphocytic
% 213.45/213.67  |- mesh__publicMeSHNote mesh__D015463 89   
% 213.45/213.67  |- skos__broader mesh__D015463smesh__D015462
% 213.45/213.67  |- skos__altLabel mesh__D015463 Prolymphocytic Leukemia
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D015463 1997
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D015463 2005
% 213.45/213.67  |- skos__historyNote mesh__D015463
% 213.45/213.67       Leukemia, Lymphoblastic %28%1967-1988%29%
% 213.45/213.67  |- skos__prefLabel mesh__D015463 Leukemia, Prolymphocytic
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D015463 2003
% 213.45/213.67  |- mesh__dateRevised mesh__D015463 1995-06-08
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D015463 2006
% 213.45/213.67  |- mesh__dateEstablished mesh__D015463 1989-01-01
% 213.45/213.67  |- mesh__dateCreated mesh__D015463 1988-06-09
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D015463 2000
% 213.45/213.67  |- mesh__recordMaintainer mesh__D015463 KEV
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D015463 2004
% 213.45/213.67  |- mesh__recordAuthorizer mesh__D009426 PLS
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009426 2003
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009426 1996
% 213.45/213.67  |- skos__broader mesh__D009426smesh__D005060
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009426 2004
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009426 2002
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009426 1997
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009426 1994
% 213.45/213.67  |- mesh__recordMaintainer mesh__D009426 PLS
% 213.45/213.67  |- mesh__recordOriginator mesh__D009426 NLM
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009426 1995
% 213.45/213.67  |- rdf__type mesh__D009426sskos__Concept
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009426 2005
% 213.45/213.67  |- mesh__dateRevised mesh__D009426 1993-06-03
% 213.45/213.67  |- skos__prefLabel mesh__D009426 Netherlands
% 213.45/213.67  |- mesh__dateCreated mesh__D009426 1999-01-01
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009426 1998
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009426 2000
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009426 2006
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009426 2001
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009426 1999
% 213.45/213.67  |- skos__broader mesh__D001443smesh__D018720
% 213.45/213.67  |- skos__scopeNote mesh__D001443
% 213.45/213.67       A species of gram-negative, anaerobic, rod-shaped bacteria originally classified within the BACTEROIDES genus. This bacterium has been isolated from the mouth, urine, feces, and infections of the mouth, soft tissue, respiratory tract, urogenital tract, and intestinal tract. It is pathogenic, but usually in association with other kinds of organisms.%A%    
% 213.45/213.67  |- mesh__recordMaintainer mesh__D001443 SYSTEM
% 213.45/213.67  |- rdf__type mesh__D001443sskos__Concept
% 213.45/213.67  |- skos__annotation mesh__D001443
% 213.45/213.67       infection: coord IM with BACTEROIDACEAE INFECTIONS %28%IM%29%   
% 213.45/213.67  |- mesh__dateCreated mesh__D001443 1975-07-25
% 213.45/213.67  |- mesh__publicMeSHNote mesh__D001443
% 213.45/213.67       95; was BACTEROIDES MELANINOGENICUS 1976-94 %28%see under BACTEROIDES 1976-90%29%%A%  
% 213.45/213.67  |- mesh__dateEstablished mesh__D001443 1991-01-01
% 213.45/213.67  |- mesh__dateRevised mesh__D001443 2005-06-30
% 213.45/213.67  |- skos__altLabel mesh__D001443 Bacteroides melaninogenicus
% 213.45/213.67  |- mesh__onlineNote mesh__D001443
% 213.45/213.67       use PREVOTELLA MELANINOGENICA to search BACTEROIDES MELANINOGENICUS 1976-94%A%  
% 213.45/213.67  |- skos__prefLabel mesh__D001443 Prevotella melaninogenica
% 213.45/213.67  |- mesh__historyNote mesh__D001443
% 213.45/213.67       95; was BACTEROIDES MELANINOGENICUS 1976-94 %28%see under BACTEROIDES 1976-90%29%%A%  
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D001443 2006
% 213.45/213.67  |- mesh__recordOriginator mesh__D001443 JW
% 213.45/213.67  |- mesh__recordAuthorizer mesh__D001443 sjn
% 213.45/213.67  |- skos__historyNote mesh__D001443 Bacteroides %28%1966-1975%29%
% 213.45/213.67  |- rdf__type mesh__D011871sskos__Concept
% 213.45/213.67  |- mesh__dateCreated mesh__D011871 1999-01-01
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011871 2002
% 213.45/213.67  |- mesh__recordOriginator mesh__D011871 NLM
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011871 2005
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011871 1998
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011871 2006
% 213.45/213.67  |- skos__scopeNote mesh__D011871
% 213.45/213.67       A specialty concerned with the use of x-ray and other forms of radiant energy in the diagnosis and treatment of disease.%A%    
% 213.45/213.67  |- mesh__recordMaintainer mesh__D011871 PXP
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011871 1999
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011871 2000
% 213.45/213.67  |- mesh__dateRevised mesh__D011871 1997-06-20
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011871 2003
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011871 2001
% 213.45/213.67  |- skos__annotation mesh__D011871
% 213.45/213.67       SPEC: SPEC qualif; /methods: probably better is TECHNOLOGY, RADIOLOGIC; DF: RADIOL%A%  
% 213.45/213.67  |- mesh__recordAuthorizer mesh__D011871 SJN
% 213.45/213.67  |- skos__broader mesh__D011871smesh__D013040
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011871 2004
% 213.45/213.67  |- skos__prefLabel mesh__D011871 Radiology
% 213.45/213.67  |- skos__prefLabel mesh__D019056 Receptors, Polymeric Immunoglobulin
% 213.45/213.67  |- skos__annotation mesh__D019056
% 213.45/213.67       specialized Fc receptors; DF: RECEPT POLY IG   
% 213.45/213.67  |- mesh__dateRevised mesh__D019056 2003-07-09
% 213.45/213.67  |- skos__scopeNote mesh__D019056
% 213.45/213.67       Specialized Fc receptors %28%RECEPTORS, FC%29% for polymeric immunoglobulins, which mediate transcytosis of polymeric IMMUNOGLOBULIN A and IMMUNOGLOBULIN M into external secretions. They are found on the surfaces of epithelial cells and hepatocytes. After binding to IMMUNOGLOBULIN A, the receptor-ligand complex undergoes endocytosis, transport by vesicle, and secretion into the lumen by exocytosis. Before release, the part of the receptor %28%SECRETORY COMPONENT%29% that is bound to IMMUNOGLOBULIN A is proteolytically cleaved from its transmembrane tail. %28%From Rosen et al., The Dictionary of Immunology, 1989%29%%A%    
% 213.45/213.67  |- skos__broader mesh__D019056smesh__D011961
% 213.45/213.67  |- skos__altLabel mesh__D019056 Receptor, Polyimmunoglobulin
% 213.45/213.67  |- skos__hiddenLabel mesh__D019056 Poly Ig Receptor
% 213.45/213.67  |- mesh__historyNote mesh__D019056 96   
% 213.45/213.67  |- mesh__publicMeSHNote mesh__D019056 96   
% 213.45/213.67  |- skos__historyNote mesh__D019056 Receptors, Immunologic %28%1989-1995%29%
% 213.45/213.67  |- skos__altLabel mesh__D019056 Polymeric Ig Receptor
% 213.45/213.67  |- skos__hiddenLabel mesh__D019056 Ig Receptor, Polymeric
% 213.45/213.67  |- skos__altLabel mesh__D019056 Polymeric Immunoglobulin Receptors
% 213.45/213.67  |- skos__altLabel mesh__D019056 Receptor, Polymeric Ig
% 213.45/213.67  |- skos__altLabel mesh__D019056 Polymeric Immunoglobulin Receptor
% 213.45/213.67  |- skos__hiddenLabel mesh__D019056 Immunoglobulin Receptors, Polymeric
% 213.45/213.67  |- skos__altLabel mesh__D019056 Poly-Ig Receptor
% 213.45/213.67  |- mesh__recordMaintainer mesh__D019056 jmp
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D019056 2004
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D019056 2005
% 213.45/213.67  |- skos__hiddenLabel mesh__D019056 Immunoglobulin Receptor, Polymeric
% 213.45/213.67  |- skos__altLabel mesh__D019056 Polyimmunoglobulin Receptor
% 213.45/213.67  |- mesh__dateCreated mesh__D019056 1995-05-26
% 213.45/213.67  |- mesh__recordOriginator mesh__D019056 AGS
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D019056 2006
% 213.45/213.67  |- skos__historyNote mesh__D019056 Secretory Component %28%1992-1995%29%
% 213.45/213.67  |- skos__hiddenLabel mesh__D019056 Receptor, Poly-Ig
% 213.45/213.67  |- skos__hiddenLabel mesh__D019056 Receptor, Polymeric Immunoglobulin
% 213.45/213.67  |- mesh__dateEstablished mesh__D019056 1996-01-01
% 213.45/213.67  |- rdf__type mesh__D019056sskos__Concept
% 213.45/213.67  |- mesh__recordAuthorizer mesh__D019056 sjn
% 213.45/213.67  |- mesh__dateRevised mesh__D011073 1992-05-20
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011073 2004
% 213.45/213.67  |- mesh__dateEstablished mesh__D011073 1972-01-01
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011073 2006
% 213.45/213.67  |- mesh__historyNote mesh__D011073 72%28%71%29%   
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011073 2003
% 213.45/213.67  |- skos__broader mesh__D011073smesh__D000588
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011073 2005
% 213.45/213.67  |- skos__historyNote mesh__D011073 Amines %28%1966-1970%29%
% 213.45/213.67  |- mesh__recordOriginator mesh__D011073 NLM
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011073 1997
% 213.45/213.67  |- skos__prefLabel mesh__D011073 Polyamines
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011073 1999
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011073 2002
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011073 1993
% 213.45/213.67  |- mesh__recordMaintainer mesh__D011073 TAP
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011073 1996
% 213.45/213.67  |- rdf__type mesh__D011073sskos__Concept
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011073 1995
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011073 1998
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011073 2001
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011073 1994
% 213.45/213.67  |- mesh__publicMeSHNote mesh__D011073 72   
% 213.45/213.67  |- mesh__dateCreated mesh__D011073 1999-01-01
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011073 2000
% 213.45/213.67  |- mesh__recordAuthorizer mesh__D011073 PLS
% 213.45/213.67  |- mesh__historyNote mesh__D005834 78   
% 213.45/213.67  |- skos__historyNote mesh__D005834 Urogenital Neoplasms %28%1966-1977%29%
% 213.45/213.67  |- mesh__dateRevised mesh__D005834 2001-07-25
% 213.45/213.67  |- skos__broader mesh__D005834smesh__D014565
% 213.45/213.67  |- skos__hiddenLabel mesh__D005834 Genital Neoplasm, Male
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D005834 2002
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D005834 2004
% 213.45/213.67  |- mesh__recordOriginator mesh__D005834 SMH
% 213.45/213.67  |- mesh__dateCreated mesh__D005834 1977-03-29
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D005834 2003
% 213.45/213.67  |- mesh__publicMeSHNote mesh__D005834 78   
% 213.45/213.67  |- skos__hiddenLabel mesh__D005834 Male Genital Neoplasm
% 213.45/213.67  |- skos__annotation mesh__D005834
% 213.45/213.67       human %26% animal; GEN or unspecified only: prefer specifics PENILE NEOPLASMS; PROSTATIC NEOPLASMS; TESTICULAR NEOPLASMS; coord IM with histol type of neopl %28%IM%29%; /blood supply /chem /second /secret /ultrastruct permitted; /vet: consider also VENEREAL TUMORS, VETERINARY%A%  
% 213.45/213.67  |- skos__altLabel mesh__D005834 Male Genital Neoplasms
% 213.45/213.67  |- skos__prefLabel mesh__D005834 Genital Neoplasms, Male
% 213.45/213.67  |- mesh__recordMaintainer mesh__D005834 mdb
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D005834 2006
% 213.45/213.67  |- rdf__type mesh__D005834sskos__Concept
% 213.45/213.67  |- skos__hiddenLabel mesh__D005834 Neoplasm, Male Genital
% 213.45/213.67  |- skos__broader mesh__D005834smesh__D005832
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D005834 2005
% 213.45/213.67  |- skos__scopeNote mesh__D005834 Neoplasms of the male genitalia.     
% 213.45/213.67  |- mesh__dateEstablished mesh__D005834 1978-01-01
% 213.45/213.67  |- mesh__recordAuthorizer mesh__D005834 sjn
% 213.45/213.67  |- skos__altLabel mesh__D005834 Neoplasms, Male Genital
% 213.45/213.67  |- mesh__dateRevised mesh__D005036 2005-06-30
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D005036 2006
% 213.45/213.67  |- skos__historyNote mesh__D005036 Morphine %28%1966-1968%29%
% 213.45/213.67  |- skos__scopeNote mesh__D005036
% 213.45/213.67       A narcotic analgesic and antitussive. It is metabolized in the liver by ETHYLMORPHINE-N-DEMETHYLASE and used as an indicator of liver function.%A%    
% 213.45/213.67  |- skos__altLabel mesh__D005036 Ethomorphine
% 213.45/213.67  |- mesh__publicMeSHNote mesh__D005036
% 213.45/213.67       91; was see under MORPHINE DERIVATIVES 1978-90; CODETHYLINE was see ETHYLMORPHINE 1978-94%A%  
% 213.45/213.67  |- skos__historyNote mesh__D005036 Morphine Derivatives %28%1975-1977%29%
% 213.45/213.67  |- skos__broader mesh__D005036smesh__D009022
% 213.45/213.67  |- skos__altLabel mesh__D005036
% 213.45/213.67       Novartis Brand of Ethylmorphine Hydrochloride, %28%5alpha,6alpha%29%-Isomer
% 213.45/213.67  |- skos__historyNote mesh__D005036 Morphinans %28%1969-1974%29%
% 213.45/213.67  |- mesh__recordAuthorizer mesh__D005036 sjn
% 213.45/213.67  |- mesh__onlineNote mesh__D005036
% 213.45/213.67       use ETHYLMORPHINE to search CODETHYLINE 1978-94   
% 213.45/213.67  |- rdf__type mesh__D005036sskos__Concept
% 213.45/213.67  |- mesh__recordMaintainer mesh__D005036 CCR
% 213.45/213.67  |- mesh__dateEstablished mesh__D005036 1991-01-01
% 213.45/213.67  |- skos__prefLabel mesh__D005036 Ethylmorphine
% 213.45/213.67  |- mesh__historyNote mesh__D005036
% 213.45/213.67       91%28%78%29%; was see under MORPHINE DERIVATIVES 1978-90; CODETHYLINE was see ETHYLMORPHINE 1978-94%A%  
% 213.45/213.67  |- mesh__dateCreated mesh__D005036 1977-05-09
% 213.45/213.67  |- mesh__recordOriginator mesh__D005036 SH
% 213.45/213.67  |- mesh__dateEstablished mesh__D010779 1988-01-01
% 213.45/213.67  |- mesh__recordMaintainer mesh__D010779 PXP
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D010779 2001
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D010779 1998
% 213.45/213.67  |- skos__prefLabel mesh__D010779 Photofluorography
% 213.45/213.67  |- mesh__recordOriginator mesh__D010779 NLM
% 213.45/213.67  |- skos__scopeNote mesh__D010779
% 213.45/213.67       The photography of images produced on a fluorescent screen by X-rays.%A%    
% 213.45/213.67  |- skos__hiddenLabel mesh__D010779 Photofluorographies
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D010779 2002
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D010779 1999
% 213.45/213.67  |- mesh__recordAuthorizer mesh__D010779 SJN
% 213.45/213.67  |- mesh__publicMeSHNote mesh__D010779
% 213.45/213.67       88; was see under FLUOROSCOPY 1975-87   
% 213.45/213.67  |- mesh__dateCreated mesh__D010779 1974-12-12
% 213.45/213.67  |- rdf__type mesh__D010779sskos__Concept
% 213.45/213.67  |- skos__broader mesh__D010779smesh__D010781
% 213.45/213.67  |- mesh__historyNote mesh__D010779
% 213.45/213.67       88%28%75%29%; was see under FLUOROSCOPY 1975-87   
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D010779 2000
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D010779 2005
% 213.45/213.67  |- skos__annotation mesh__D010779 NIM; DF: PHOTOFLUOROGR   
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D010779 2003
% 213.45/213.67  |- skos__broader mesh__D010779smesh__D005471
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D010779 2006
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D010779 2004
% 213.45/213.67  |- mesh__dateRevised mesh__D010779 1997-06-20
% 213.45/213.67  |- skos__altLabel mesh__D015464 Leukemia, Myelogenous, Chronic
% 213.45/213.67  |- skos__altLabel mesh__D015464 Myelogenous Leukemia, Chronic
% 213.45/213.67  |- skos__hiddenLabel mesh__D015464 Myeloid Leukemias, Chronic
% 213.45/213.67  |- skos__altLabel mesh__D015464 Leukemia, Granulocytic, Chronic
% 213.45/213.67  |- skos__altLabel mesh__D015464 Granulocytic Leukemia, Chronic
% 213.45/213.67  |- mesh__dateEstablished mesh__D015464 1989-01-01
% 213.45/213.67  |- skos__hiddenLabel mesh__D015464 Chronic Myeloid Leukemia
% 213.45/213.67  |- skos__hiddenLabel mesh__D015464 Leukemia, Chronic Myeloid
% 213.45/213.67  |- mesh__recordOriginator mesh__D015464 PLS
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D015464 2004
% 213.45/213.67  |- mesh__recordAuthorizer mesh__D015464 SJN
% 213.45/213.67  |- skos__hiddenLabel mesh__D015464 Leukemias, Chronic Myelogenous
% 213.45/213.67  |- skos__annotation mesh__D015464
% 213.45/213.67       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 213.45/213.67  |- skos__hiddenLabel mesh__D015464 Chronic Myelocytic Leukemia
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D015464 2002
% 213.45/213.67  |- skos__altLabel mesh__D015464 Myeloid Leukemia, Chronic
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D015464 2003
% 213.45/213.67  |- skos__hiddenLabel mesh__D015464 Chronic Granulocytic Leukemias
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D015464 2006
% 213.45/213.67  |- skos__altLabel mesh__D015464 Leukemia, Myelocytic, Chronic
% 213.45/213.67  |- skos__hiddenLabel mesh__D015464 Chronic Myelogenous Leukemia
% 213.45/213.67  |- mesh__onlineNote mesh__D015464
% 213.45/213.67       use LEUKEMIA, MYELOID to search LEUKEMIA, MYELOCYTIC, CHRONIC %26% LEUKEMIA, MYELOGENOUS, CHRONIC 1974-88%A%  
% 213.45/213.67  |- skos__hiddenLabel mesh__D015464 Chronic Myelocytic Leukemias
% 213.45/213.67  |- skos__hiddenLabel mesh__D015464 Myelogenous Leukemias, Chronic
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D015464 1999
% 213.45/213.67  |- skos__hiddenLabel mesh__D015464 Leukemia, Chronic Myelogenous
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D015464 2001
% 213.45/213.67  |- skos__hiddenLabel mesh__D015464 Chronic Myeloid Leukemias
% 213.45/213.67  |- skos__hiddenLabel mesh__D015464 Chronic Myelogenous Leukemias
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D015464 2005
% 213.45/213.67  |- skos__hiddenLabel mesh__D015464 Chronic Granulocytic Leukemia
% 213.45/213.67  |- skos__prefLabel mesh__D015464 Leukemia, Myeloid, Chronic
% 213.45/213.67  |- mesh__dateCreated mesh__D015464 1988-06-09
% 213.45/213.67  |- rdf__type mesh__D015464sskos__Concept
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D015464 1998
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D015464 2000
% 213.45/213.67  |- skos__hiddenLabel mesh__D015464 Leukemias, Chronic Myelocytic
% 213.45/213.67  |- skos__hiddenLabel mesh__D015464 Myelocytic Leukemias, Chronic
% 213.45/213.67  |- mesh__dateRevised mesh__D015464 1997-06-20
% 213.45/213.67  |- mesh__recordMaintainer mesh__D015464 TPW
% 213.45/213.67  |- mesh__historyNote mesh__D015464
% 213.45/213.67       89; LEUKEMIA, MYELOCYTIC, CHRONIC %26% LEUKEMIA, MYELOGENOUS, CHRONIC were see LEUKEMIA, MYELOCYTIC 1974-88%A%  
% 213.45/213.67  |- skos__historyNote mesh__D015464 Leukemia, Myelocytic %28%1966-1988%29%
% 213.45/213.67  |- skos__broader mesh__D015464smesh__D007951
% 213.45/213.67  |- skos__hiddenLabel mesh__D015464 Leukemias, Chronic Granulocytic
% 213.45/213.67  |- mesh__publicMeSHNote mesh__D015464
% 213.45/213.67       89; LEUKEMIA, MYELOCYTIC, CHRONIC %26% LEUKEMIA, MYELOGENOUS, CHRONIC were see LEUKEMIA, MYELOCYTIC 1974-88%A%  
% 213.45/213.67  |- skos__hiddenLabel mesh__D015464 Leukemia, Chronic Granulocytic
% 213.45/213.67  |- skos__hiddenLabel mesh__D015464 Leukemias, Chronic Myeloid
% 213.45/213.67  |- skos__altLabel mesh__D015464 Myelocytic Leukemia, Chronic
% 213.45/213.67  |- skos__historyNote mesh__D015464 Leukemia, Myeloid %28%1966-1988%29%
% 213.45/213.67  |- skos__hiddenLabel mesh__D015464 Granulocytic Leukemias, Chronic
% 213.45/213.67  |- skos__hiddenLabel mesh__D015464 Leukemia, Chronic Myelocytic
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009427 1996
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009427 2004
% 213.45/213.67  |- mesh__dateRevised mesh__D009427 1995-02-21
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009427 2001
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009427 1997
% 213.45/213.67  |- skos__scopeNote mesh__D009427
% 213.45/213.67       A Netherlands overseas territory in the Lesser Antilles in the West Indies. It includes the islands of Aruba, Bonaire, Curacao, Saba, St. Eustatius, and the southern part of St. Martin. Its capital is Willemstad. Its former names are Curacao, Netherlands West Indies, and Dutch West Indies. Its colonial status was abolished by the Netherlands government in 1954 but it is considered an integral part of the Dutch realm. There is no positive evidence for the name Antilles. %28%From Random House Unabridged Dictionary, 2d ed, 1993 %26% Webster%27%s New Geographical Dictionary, 1988, p823%29%%A%    
% 213.45/213.67  |- skos__prefLabel mesh__D009427 Netherlands Antilles
% 213.45/213.67  |- skos__broader mesh__D009427smesh__D014900
% 213.45/213.67  |- mesh__recordAuthorizer mesh__D009427 PLS
% 213.45/213.67  |- rdf__type mesh__D009427sskos__Concept
% 213.45/213.67  |- mesh__dateCreated mesh__D009427 1999-01-01
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009427 2005
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009427 2002
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009427 1998
% 213.45/213.67  |- skos__annotation mesh__D009427
% 213.45/213.67       a Netherlands overseas territory in the Lesser Antilles in the West Indies%A%  
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009427 2006
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009427 1999
% 213.45/213.67  |- mesh__recordOriginator mesh__D009427 NLM
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009427 2003
% 213.45/213.67  |- mesh__recordMaintainer mesh__D009427 TGC
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D009427 2000
% 213.45/213.67  |- skos__annotation mesh__D001444 a chain of islands in the West Indies   
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D001444 2004
% 213.45/213.67  |- mesh__recordMaintainer mesh__D001444 TGC
% 213.45/213.67  |- mesh__recordAuthorizer mesh__D001444 PLS
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D001444 2001
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D001444 2005
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D001444 2002
% 213.45/213.67  |- skos__broader mesh__D001444smesh__D014900
% 213.45/213.67  |- skos__scopeNote mesh__D001444
% 213.45/213.67       A chain of islands, cays, and reefs in the West Indies, lying southeast of Florida and north of Cuba. It is an independent state, called also the Commonwealth of the Bahamas or the Bahama Islands. The name likely represents the local name Guanahani, itself of uncertain origin. %28%From Webster%27%s New Geographical Dictionary, 1988, p106 %26% Room, Brewer%27%s Dictionary of Names, 1992, p45%29%%A%    
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D001444 2006
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D001444 1996
% 213.45/213.67  |- mesh__dateCreated mesh__D001444 1999-01-01
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D001444 1997
% 213.45/213.67  |- mesh__dateRevised mesh__D001444 1995-02-17
% 213.45/213.67  |- rdf__type mesh__D001444sskos__Concept
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D001444 1998
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D001444 2003
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D001444 1999
% 213.45/213.67  |- skos__prefLabel mesh__D001444 Bahamas
% 213.45/213.67  |- mesh__recordOriginator mesh__D001444 NLM
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D001444 2000
% 213.45/213.67  |- mesh__historyNote mesh__D019855
% 213.45/213.67       98; use ETHYLENE GLYCOL %28%NM%29% 1982-97   
% 213.45/213.67  |- skos__altLabel mesh__D019855 Monoethylene Glycol
% 213.45/213.67  |- skos__hiddenLabel mesh__D019855 1,2 Ethanediol
% 213.45/213.67  |- mesh__dateCreated mesh__D019855 1997-06-20
% 213.45/213.67  |- skos__hiddenLabel mesh__D019855 Glycol, Monoethylene
% 213.45/213.67  |- skos__altLabel mesh__D019855 1,2-Ethanediol
% 213.45/213.67  |- skos__scopeNote mesh__D019855
% 213.45/213.67       A colorless, odorless, viscous dihydroxy alcohol. It has a sweet taste, but is poisonous if ingested. Ethylene glycol is the most important glycol commercially available and is manufactured on a large scale in the United States. It is used as an antifreeze and coolant, in hydraulic fluids, and in the manufacture of low-freezing dynamites and resins.%A%    
% 213.45/213.67  |- skos__historyNote mesh__D019855 Ethylene Glycols %28%1982-1997%29%
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D019855 2005
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D019855 1998
% 213.45/213.67  |- skos__annotation mesh__D019855 ETHYLENE GLYCOLS also available   
% 213.45/213.67  |- skos__broader mesh__D019855smesh__D005026
% 213.45/213.67  |- skos__altLabel mesh__D019855 2-Hydroxyethanol
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D019855 2006
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D019855 1999
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D019855 2003
% 213.45/213.67  |- mesh__dateEstablished mesh__D019855 1998-01-01
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D019855 2000
% 213.45/213.67  |- skos__hiddenLabel mesh__D019855 2 Hydroxyethanol
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D019855 2004
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D019855 2001
% 213.45/213.67  |- rdf__type mesh__D019855sskos__Concept
% 213.45/213.67  |- mesh__publicMeSHNote mesh__D019855
% 213.45/213.67       98; ETHYLENE GLYCOL was indexed under ETHYLENE GLYCOLS 1982-97%A%  
% 213.45/213.67  |- skos__prefLabel mesh__D019855 Ethylene Glycol
% 213.45/213.67  |- skos__hiddenLabel mesh__D019855 Glycol, Ethylene
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D019855 2002
% 213.45/213.67  |- skos__altLabel mesh__D011872 Departments, X-Ray
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011872 1997
% 213.45/213.67  |- mesh__dateEstablished mesh__D011872 1991-01-01
% 213.45/213.67  |- skos__hiddenLabel mesh__D011872 Hospital Radiology Departments
% 213.45/213.67  |- mesh__historyNote mesh__D011872
% 213.45/213.67       91%28%Aug 77%29%; was see under HOSPITAL DEPARTMENTS 1977-90   
% 213.45/213.67  |- mesh__recordAuthorizer mesh__D011872 PLS
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011872 2006
% 213.45/213.67  |- skos__altLabel mesh__D011872 Hospital Radiology Department
% 213.45/213.67  |- skos__altLabel mesh__D011872 Departments, Hospital Radiology
% 213.45/213.67  |- mesh__dateCreated mesh__D011872 1977-05-19
% 213.45/213.67  |- skos__scopeNote mesh__D011872
% 213.45/213.67       Hospital department which is responsible for the administration and provision of x-ray diagnostic and therapeutic services.%A%    
% 213.45/213.67  |- skos__altLabel mesh__D011872 Radiology Departments, Hospital
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011872 1996
% 213.45/213.67  |- skos__altLabel mesh__D011872 X-Ray Departments
% 213.45/213.67  |- mesh__dateRevised mesh__D011872 1993-06-04
% 213.45/213.67  |- skos__historyNote mesh__D011872 Radiology %28%1966-Jul 1977%29%
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011872 2001
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011872 2005
% 213.45/213.67  |- skos__historyNote mesh__D011872
% 213.45/213.67       Hospital Departments %28%1968-Jul 1977%29%
% 213.45/213.67  |- skos__prefLabel mesh__D011872 Radiology Department, Hospital
% 213.45/213.67  |- skos__altLabel mesh__D011872 Department, Hospital Radiology
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011872 1999
% 213.45/213.67  |- skos__hiddenLabel mesh__D011872 X Ray Departments
% 213.45/213.67  |- skos__altLabel mesh__D011872 X-Ray Department
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011872 2000
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011872 1995
% 213.45/213.67  |- mesh__recordOriginator mesh__D011872 EC
% 213.45/213.67  |- skos__hiddenLabel mesh__D011872 Department, X Ray
% 213.45/213.67  |- skos__annotation mesh__D011872
% 213.45/213.67       restricted to x-ray %26% radiocobalt diag %26% ther serv: does not include other radioisotopes %28% = NUCLEAR MEDICINE DEPARTMENT, HOSPITAL%29%; DF: RADIOL DEP%A%  
% 213.45/213.67  |- skos__broader mesh__D011872smesh__D006748
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011872 1998
% 213.45/213.67  |- skos__hiddenLabel mesh__D011872 Departments, X Ray
% 213.45/213.67  |- rdf__type mesh__D011872sskos__Concept
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011872 2004
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011872 1994
% 213.45/213.67  |- mesh__publicMeSHNote mesh__D011872
% 213.45/213.67       91; was see under HOSPITAL DEPARTMENTS Aug 1977-90   
% 213.45/213.67  |- skos__hiddenLabel mesh__D011872 X Ray Department
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011872 2002
% 213.45/213.67  |- mesh__recordMaintainer mesh__D011872 JLS
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D011872 2003
% 213.45/213.67  |- mesh__activeMeSHYear mesh__D019057 2006
% 213.45/213.67  |- skos__altLabel mesh__D019057 QALY
% 213.45/213.67  |- skos__hiddenLabel mesh__D019057 Life Years, Adjusted
% 213.45/213.67  |- rdf__type mesh__D019057sskos__Concept
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019057 2002
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019057 2005
% 213.45/213.68  |- skos__hiddenLabel mesh__D019057 Year, Adjusted Life
% 213.45/213.68  |- mesh__dateRevised mesh__D019057 2001-07-25
% 213.45/213.68  |- mesh__recordAuthorizer mesh__D019057 sjn
% 213.45/213.68  |- skos__hiddenLabel mesh__D019057 Year, Quality-Adjusted Life
% 213.45/213.68  |- skos__prefLabel mesh__D019057 Quality-Adjusted Life Years
% 213.45/213.68  |- mesh__recordOriginator mesh__D019057 JLS
% 213.45/213.68  |- skos__hiddenLabel mesh__D019057 Years, Adjusted Life
% 213.45/213.68  |- skos__hiddenLabel mesh__D019057 Quality-Adjusted Life Year
% 213.45/213.68  |- skos__hiddenLabel mesh__D019057 Life Years, Quality-Adjusted
% 213.45/213.68  |- mesh__recordMaintainer mesh__D019057 tjk
% 213.45/213.68  |- mesh__historyNote mesh__D019057 96   
% 213.45/213.68  |- skos__hiddenLabel mesh__D019057 Life Year, Quality-Adjusted
% 213.45/213.68  |- skos__hiddenLabel mesh__D019057 Life Year, Adjusted
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019057 2004
% 213.45/213.68  |- skos__hiddenLabel mesh__D019057 Years, Quality-Adjusted Life
% 213.45/213.68  |- mesh__publicMeSHNote mesh__D019057 96   
% 213.45/213.68  |- skos__annotation mesh__D019057 DF: note short X ref   
% 213.45/213.68  |- skos__scopeNote mesh__D019057
% 213.45/213.68       A measurement index derived from a modification of standard life-table procedures and designed to take account of the quality as well as the duration of survival. This index can be used in assessing the outcome of health care procedures or services. %28%BIOETHICS Thesaurus, 1994%29%%A%    
% 213.45/213.68  |- skos__hiddenLabel mesh__D019057 Adjusted Life Year
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019057 2003
% 213.45/213.68  |- skos__altLabel mesh__D019057 Quality Adjusted Life Years
% 213.45/213.68  |- skos__historyNote mesh__D019057 Quality of Life %28%1991-1995%29%
% 213.45/213.68  |- mesh__dateEstablished mesh__D019057 1996-01-01
% 213.45/213.68  |- skos__broader mesh__D019057smesh__D015993
% 213.45/213.68  |- mesh__dateCreated mesh__D019057 1995-06-20
% 213.45/213.68  |- skos__historyNote mesh__D011074 Polymers %28%1966-1976%29%
% 213.45/213.68  |- skos__scopeNote mesh__D011074
% 213.45/213.68       A compound originally developed as an anticoagulant, but possessing anticomplement action and lowering the bactericidal action of blood. It is used in vitro to inhibit blood coagulation and as a diagnostic reagent to encourage the growth of pathogens in the blood. It is also used to stabilize colloidal solutions such as milk and gelatin. %28%From Merck Index, 11th ed%29%%A%    
% 213.45/213.68  |- mesh__onlineNote mesh__D011074
% 213.45/213.68       use POLYANETHOLESULFONATE to search POLYANETHOL SULFONATE 1977-93%A%  
% 213.45/213.68  |- skos__altLabel mesh__D011074 Polyanethol Sulfonate
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D011074 2005
% 213.45/213.68  |- mesh__dateRevised mesh__D011074 2004-07-07
% 213.45/213.68  |- skos__broader mesh__D011074smesh__D011108
% 213.45/213.68  |- mesh__dateCreated mesh__D011074 1976-05-19
% 213.45/213.68  |- mesh__dateEstablished mesh__D011074 1991-01-01
% 213.45/213.68  |- mesh__recordMaintainer mesh__D011074 jmp
% 213.45/213.68  |- skos__prefLabel mesh__D011074 Polyanetholesulfonate
% 213.45/213.68  |- skos__broader mesh__D011074smesh__D001557
% 213.45/213.68  |- rdf__type mesh__D011074sskos__Concept
% 213.45/213.68  |- mesh__publicMeSHNote mesh__D011074
% 213.45/213.68       94; was POLYANETHOL SULFONATE 1977-93 %28%see under BENZENESULFONATES 1977-90%29%%A%  
% 213.45/213.68  |- skos__historyNote mesh__D011074 Sulfonic Acids %28%1966-1973%29%
% 213.45/213.68  |- skos__hiddenLabel mesh__D011074 Sulfonate, Polyanethol
% 213.45/213.68  |- mesh__recordAuthorizer mesh__D011074 sjn
% 213.45/213.68  |- mesh__recordOriginator mesh__D011074 SH
% 213.45/213.68  |- skos__hiddenLabel mesh__D011074 Homopolymer, Polyanetholesulfonate
% 213.45/213.68  |- skos__historyNote mesh__D011074 Benzenesulfonates %28%1974-1976%29%
% 213.45/213.68  |- skos__hiddenLabel mesh__D011074 Polyanetholesulfonate, Sodium
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D011074 2006
% 213.45/213.68  |- mesh__historyNote mesh__D011074
% 213.45/213.68       94; was POLYANETHOL SULFONATE 1977-93 %28%see under BENZENESULFONATES 1977-90%29%%A%  
% 213.45/213.68  |- skos__prefLabel mesh__D005835 Genitalia
% 213.45/213.68  |- skos__hiddenLabel mesh__D005835 Organs, Genital
% 213.45/213.68  |- mesh__recordOriginator mesh__D005835 NLM
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D005835 2004
% 213.45/213.68  |- mesh__recordAuthorizer mesh__D005835 sjn
% 213.45/213.68  |- skos__hiddenLabel mesh__D005835 Organs, Accessory Sex
% 213.45/213.68  |- skos__hiddenLabel mesh__D005835 Organ, Accessory Sex
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D005835 2005
% 213.45/213.68  |- mesh__dateRevised mesh__D005835 2002-07-02
% 213.45/213.68  |- skos__altLabel mesh__D005835 Sex Organs, Accessory
% 213.45/213.68  |- mesh__recordMaintainer mesh__D005835 ags
% 213.45/213.68  |- skos__hiddenLabel mesh__D005835 Accessory Sex Organ
% 213.45/213.68  |- skos__broader mesh__D005835smesh__D014566
% 213.45/213.68  |- mesh__dateCreated mesh__D005835 1999-01-01
% 213.45/213.68  |- rdf__type mesh__D005835sskos__Concept
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D005835 2006
% 213.45/213.68  |- skos__annotation mesh__D005835
% 213.45/213.68       GEN; GENITALIA, FEMALE and GENITALIA, MALE and their specifics are also available%A%  
% 213.45/213.68  |- skos__altLabel mesh__D005835 Genital Organs
% 213.45/213.68  |- skos__hiddenLabel mesh__D005835 Sex Organ, Accessory
% 213.45/213.68  |- skos__scopeNote mesh__D005835
% 213.45/213.68       The external and internal organs related to reproduction.%A%    
% 213.45/213.68  |- skos__hiddenLabel mesh__D005835 Organ, Genital
% 213.45/213.68  |- skos__hiddenLabel mesh__D005835 Genital Organ
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D005835 2003
% 213.45/213.68  |- mesh__dateCreated mesh__D005037 1974-11-11
% 213.45/213.68  |- skos__hiddenLabel mesh__D005037 Demethylase, Ethylmorphine N
% 213.45/213.68  |- mesh__historyNote mesh__D005037
% 213.45/213.68       91%28%75%29%; was see under OXIDOREDUCTASES, N-DEMETHYLATING 1975-90%A%  
% 213.45/213.68  |- mesh__dateRevised mesh__D005037 2005-06-30
% 213.45/213.68  |- skos__scopeNote mesh__D005037
% 213.45/213.68       A drug-metabolizing enzyme of the hepatic microsomal oxidase system which catalyzes the oxidation of the N-methyl group of ethylmorphine with the formation of formaldehyde.%A%    
% 213.45/213.68  |- skos__prefLabel mesh__D005037 Ethylmorphine-N-Demethylase
% 213.45/213.68  |- skos__historyNote mesh__D005037 Morphinans %28%1973-1974%29%
% 213.45/213.68  |- skos__hiddenLabel mesh__D005037 N Demethylase, Ethylmorphine
% 213.45/213.68  |- rdf__type mesh__D005037sskos__Concept
% 213.45/213.68  |- mesh__dateEstablished mesh__D005037 1991-01-01
% 213.45/213.68  |- skos__broader mesh__D005037smesh__D010089
% 213.45/213.68  |- mesh__recordOriginator mesh__D005037 NLM
% 213.45/213.68  |- skos__altLabel mesh__D005037 Ethylmorphine N Demethylase
% 213.45/213.68  |- skos__historyNote mesh__D005037
% 213.45/213.68       Oxidoreductases, N-Demethylating %28%1973-1974%29%
% 213.45/213.68  |- mesh__recordMaintainer mesh__D005037 jmp
% 213.45/213.68  |- mesh__recordAuthorizer mesh__D005037 sjn
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D005037 2006
% 213.45/213.68  |- mesh__publicMeSHNote mesh__D005037
% 213.45/213.68       91; was see under OXIDOREDUCTASES, N-DEMETHYLATING 1975-90%A%  
% 213.45/213.68  |- skos__prefLabel mesh__D015465 Leukemia, Myeloid, Aggressive-Phase
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D015465 2005
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D015465 2002
% 213.45/213.68  |- mesh__recordMaintainer mesh__D015465 KEV
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D015465 1997
% 213.45/213.68  |- rdf__type mesh__D015465sskos__Concept
% 213.45/213.68  |- skos__altLabel mesh__D015465
% 213.45/213.68       Myeloid Leukemia, Chronic, Accelerated Phase
% 213.45/213.68  |- skos__historyNote mesh__D015465 Leukemia, Myelocytic %28%1972-1988%29%
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D015465 1999
% 213.45/213.68  |- skos__altLabel mesh__D015465 Myeloid Leukemia, Chronic, Aggressive-Phase
% 213.45/213.68  |- skos__altLabel mesh__D015465
% 213.45/213.68       Myelogenous Leukemia, Chronic, Aggressive-Phase
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D015465 2001
% 213.45/213.68  |- skos__altLabel mesh__D015465
% 213.45/213.68       Myelogenous Leukemia, Chronic, Aggressive Phase
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D015465 1996
% 213.45/213.68  |- skos__altLabel mesh__D015465 Myeloid Leukemia, Chronic, Aggressive Phase
% 213.45/213.68  |- mesh__recordOriginator mesh__D015465 PLS
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D015465 1998
% 213.45/213.68  |- mesh__recordAuthorizer mesh__D015465 PLS
% 213.45/213.68  |- skos__altLabel mesh__D015465 Leukemia, Myelogenous, Aggressive-Phase
% 213.45/213.68  |- skos__altLabel mesh__D015465
% 213.45/213.68       Myeloid Leukemia, Chronic, Accelerated-Phase
% 213.45/213.68  |- skos__altLabel mesh__D015465 Leukemia, Myeloid, Accelerated Phase
% 213.45/213.68  |- mesh__dateEstablished mesh__D015465 1989-01-01
% 213.45/213.68  |- mesh__dateRevised mesh__D015465 1995-06-08
% 213.45/213.68  |- skos__altLabel mesh__D015465 Leukemia, Myeloid, Accelerated-Phase
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D015465 2000
% 213.45/213.68  |- skos__annotation mesh__D015465
% 213.45/213.68       do not use /blood supply /chem /second /secret /ultrastruct; DF: CML AGGRESSIVE%A%  
% 213.45/213.68  |- mesh__publicMeSHNote mesh__D015465 89   
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D015465 2004
% 213.45/213.68  |- skos__historyNote mesh__D015465 Leukemia, Myeloid %28%1972-1988%29%
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D015465 2006
% 213.45/213.68  |- mesh__historyNote mesh__D015465 89   
% 213.45/213.68  |- skos__altLabel mesh__D015465 Leukemia, Myelogenous, Aggressive Phase
% 213.45/213.68  |- mesh__dateCreated mesh__D015465 1988-06-09
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D015465 2003
% 213.45/213.68  |- skos__broader mesh__D015465smesh__D015464
% 213.45/213.68  |- skos__altLabel mesh__D009428 Schering Brand of Netilmicin Sulfate
% 213.45/213.68  |- skos__altLabel mesh__D009428 Netromycine
% 213.45/213.68  |- skos__altLabel mesh__D009428 Pharmacia Brand of Netilmicin Sulfate
% 213.45/213.68  |- rdf__type mesh__D009428sskos__Concept
% 213.45/213.68  |- skos__hiddenLabel mesh__D009428 Sulfate, Netilmicin
% 213.45/213.68  |- mesh__recordAuthorizer mesh__D009428 sjn
% 213.45/213.68  |- skos__hiddenLabel mesh__D009428 Sch20569
% 213.45/213.68  |- skos__altLabel mesh__D009428 Schering-Plough Brand of Netilmicin Sulfate
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D009428 2006
% 213.45/213.68  |- skos__historyNote mesh__D009428 Gentamicins %28%1966-1974%29%
% 213.45/213.68  |- mesh__historyNote mesh__D009428
% 213.45/213.68       86%28%79%29%; was see under GENTAMICINS 1979-85   
% 213.45/213.68  |- skos__broader mesh__D009428smesh__D012853
% 213.45/213.68  |- skos__altLabel mesh__D009428 Netrocin
% 213.45/213.68  |- skos__altLabel mesh__D009428 Netromicina
% 213.45/213.68  |- skos__altLabel mesh__D009428 Essex Brand of Netilmicin Sulfate
% 213.45/213.68  |- skos__scopeNote mesh__D009428
% 213.45/213.68       Semisynthetic 1-N-ethyl derivative of SISOMYCIN, an aminoglycoside antibiotic with action similar to gentamicin, but less ear and kidney toxicity.%A%    
% 213.45/213.68  |- skos__altLabel mesh__D009428 Netillin
% 213.45/213.68  |- skos__historyNote mesh__D009428 Sisomicin %28%1975-1978%29%
% 213.45/213.68  |- mesh__publicMeSHNote mesh__D009428
% 213.45/213.68       86; was see under GENTAMICINS 1979-85   
% 213.45/213.68  |- skos__prefLabel mesh__D009428 Netilmicin
% 213.45/213.68  |- skos__altLabel mesh__D009428 N%C3%%A9%tromicine
% 213.45/213.68  |- mesh__recordMaintainer mesh__D009428 lkw
% 213.45/213.68  |- mesh__dateRevised mesh__D009428 2005-06-30
% 213.45/213.68  |- mesh__dateCreated mesh__D009428 1978-05-03
% 213.45/213.68  |- mesh__recordOriginator mesh__D009428 SH
% 213.45/213.68  |- skos__hiddenLabel mesh__D009428 Sch 20569
% 213.45/213.68  |- mesh__dateEstablished mesh__D009428 1986-01-01
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D001445 2001
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D001445 2004
% 213.45/213.68  |- skos__annotation mesh__D001445 a state in the Persian Gulf   
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D001445 2002
% 213.45/213.68  |- mesh__recordMaintainer mesh__D001445 TGC
% 213.45/213.68  |- skos__prefLabel mesh__D001445 Bahrain
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D001445 1996
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D001445 2005
% 213.45/213.68  |- mesh__historyNote mesh__D001445 75   
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D001445 1997
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D001445 2006
% 213.45/213.68  |- mesh__dateRevised mesh__D001445 1995-02-17
% 213.45/213.68  |- skos__broader mesh__D001445smesh__D008877
% 213.45/213.68  |- rdf__type mesh__D001445sskos__Concept
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D001445 1998
% 213.45/213.68  |- mesh__recordOriginator mesh__D001445 NLM
% 213.45/213.68  |- mesh__dateCreated mesh__D001445 1974-11-11
% 213.45/213.68  |- skos__scopeNote mesh__D001445
% 213.45/213.68       An independent state, an archipelago in the western Persian Gulf, northwest of Qatar. It comprises low-lying islands of Bahrain %28%the largest%29%, Muharraq, Sitra, and several islets. It has extensive oil fields. The name comes from the Arabic al-bahrayn, %22%the two seas%22%, with reference to its lying in the middle of a bay with its %22%two seas%22% east and west of it. %28%From Webster%27%s New Geographical Dictionary, 1988, p107 %26% Room, Brewer%27%s Dictionary of Names, 1992, p45%29%%A%    
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D001445 2000
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D001445 2003
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D001445 1999
% 213.45/213.68  |- mesh__recordAuthorizer mesh__D001445 PLS
% 213.45/213.68  |- mesh__dateEstablished mesh__D001445 1975-01-01
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D006130 2002
% 213.45/213.68  |- skos__hiddenLabel mesh__D006130 Disorder, Growth
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D006130 2003
% 213.45/213.68  |- rdf__type mesh__D006130sskos__Concept
% 213.45/213.68  |- skos__hiddenLabel mesh__D006130 Growth Disorder
% 213.45/213.68  |- mesh__historyNote mesh__D006130 72%28%69%29%   
% 213.45/213.68  |- skos__annotation mesh__D006130
% 213.45/213.68       do not confuse with NUTRITION DISORDERS %28%disord of assimilating %26% utilizing nutrients%29%%A%  
% 213.45/213.68  |- skos__related mesh__D006130smesh__D004392
% 213.45/213.68  |- mesh__recordOriginator mesh__D006130 NLM
% 213.45/213.68  |- mesh__recordAuthorizer mesh__D006130 sjn
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D006130 2004
% 213.45/213.68  |- mesh__dateEstablished mesh__D006130 1972-01-01
% 213.45/213.68  |- mesh__dateRevised mesh__D006130 1999-11-03
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D006130 2005
% 213.45/213.68  |- mesh__publicMeSHNote mesh__D006130 72   
% 213.45/213.68  |- mesh__dateCreated mesh__D006130 1999-01-01
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D006130 2000
% 213.45/213.68  |- skos__broader mesh__D006130smesh__D010335
% 213.45/213.68  |- mesh__recordMaintainer mesh__D006130 KEV
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D006130 2006
% 213.45/213.68  |- skos__scopeNote mesh__D006130
% 213.45/213.68       Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.%A%    
% 213.45/213.68  |- skos__related mesh__D006130smesh__D005877
% 213.45/213.68  |- skos__related mesh__D006130smesh__D001848
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D006130 2001
% 213.45/213.68  |- skos__prefLabel mesh__D006130 Growth Disorders
% 213.45/213.68  |- skos__historyNote mesh__D006130 Growth %28%1966-1968%29%
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019856 2001
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019856 2005
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019856 2002
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019856 1998
% 213.45/213.68  |- mesh__historyNote mesh__D019856
% 213.45/213.68       98; use ETHANOLAMINE %28%NM%29% 1980-97   
% 213.45/213.68  |- skos__scopeNote mesh__D019856
% 213.45/213.68       A viscous, hygroscopic amino alcohol with an ammoniacal odor. It is widely distributed in biological tissue and is a component of lecithin. It is used as a surfactant, fluorimetric reagent, and to remove CO2 and H2S from natural gas and other gases.%A%    
% 213.45/213.68  |- mesh__dateCreated mesh__D019856 1997-06-20
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019856 2006
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019856 1999
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019856 2003
% 213.45/213.68  |- skos__altLabel mesh__D019856 2-Aminoethanol
% 213.45/213.68  |- skos__altLabel mesh__D019856 Colamine
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019856 2004
% 213.45/213.68  |- skos__prefLabel mesh__D019856 Ethanolamine
% 213.45/213.68  |- skos__broader mesh__D019856smesh__D004983
% 213.45/213.68  |- rdf__type mesh__D019856sskos__Concept
% 213.45/213.68  |- skos__annotation mesh__D019856 ETHANOLAMINES also available   
% 213.45/213.68  |- skos__altLabel mesh__D019856 Monoethanolamine
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019856 2000
% 213.45/213.68  |- mesh__dateEstablished mesh__D019856 1998-01-01
% 213.45/213.68  |- skos__hiddenLabel mesh__D019856 2 Aminoethanol
% 213.45/213.68  |- skos__historyNote mesh__D019856 Ethanolamines %28%1973-1997%29%
% 213.45/213.68  |- mesh__publicMeSHNote mesh__D019856
% 213.45/213.68       98; ETHANOLAMINE was indexed under ETHANOLAMINES 1973-97   
% 213.45/213.68  |- skos__hiddenLabel mesh__D011873 X-Ray Information System
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D011873 1997
% 213.45/213.68  |- mesh__dateEstablished mesh__D011873 1991-01-01
% 213.45/213.68  |- skos__altLabel mesh__D011873 Radiologic Information Systems
% 213.45/213.68  |- skos__hiddenLabel mesh__D011873 Xray Information System
% 213.45/213.68  |- skos__altLabel mesh__D011873 Systems, Radiology Information
% 213.45/213.68  |- mesh__historyNote mesh__D011873
% 213.45/213.68       91%28%87%29%; was see under HOSPITAL INFORMATION SYSTEMS 1987-90%A%  
% 213.45/213.68  |- skos__altLabel mesh__D011873 Systems, Radiologic Information
% 213.45/213.68  |- mesh__recordAuthorizer mesh__D011873 PLS
% 213.45/213.68  |- skos__altLabel mesh__D011873 Information System, Radiology
% 213.45/213.68  |- skos__prefLabel mesh__D011873 Radiology Information Systems
% 213.45/213.68  |- skos__hiddenLabel mesh__D011873 PACSs %28%Radiology%29%
% 213.45/213.68  |- mesh__dateRevised mesh__D011873 1994-06-28
% 213.45/213.68  |- skos__hiddenLabel mesh__D011873 Information System, Xray
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D011873 2006
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D011873 1996
% 213.45/213.68  |- skos__broader mesh__D011873smesh__D007256
% 213.45/213.68  |- mesh__dateCreated mesh__D011873 1986-06-17
% 213.45/213.68  |- skos__altLabel mesh__D011873 Xray Information Systems
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D011873 2001
% 213.45/213.68  |- mesh__recordMaintainer mesh__D011873 PLS
% 213.45/213.68  |- skos__altLabel mesh__D011873 PACS %28%Radiology%29%
% 213.45/213.68  |- skos__annotation mesh__D011873 DF: RADIOL INFORMATION SYSTEMS   
% 213.45/213.68  |- skos__hiddenLabel mesh__D011873 X Ray Information Systems
% 213.45/213.68  |- skos__broader mesh__D011873smesh__D006751
% 213.45/213.68  |- skos__altLabel mesh__D011873 Radiologic Picture Archiving
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D011873 2005
% 213.45/213.68  |- mesh__publicMeSHNote mesh__D011873
% 213.45/213.68       91; was see under HOSPITAL INFORMATION SYSTEMS 1987-90   
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D011873 1999
% 213.45/213.68  |- skos__hiddenLabel mesh__D011873 System, X-Ray Information
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D011873 2000
% 213.45/213.68  |- skos__hiddenLabel mesh__D011873 Information Systems, Xray
% 213.45/213.68  |- skos__hiddenLabel mesh__D011873 Information System, X-Ray
% 213.45/213.68  |- skos__altLabel mesh__D011873 System, Radiology Information
% 213.45/213.68  |- skos__hiddenLabel mesh__D011873 Systems, Xray Information
% 213.45/213.68  |- mesh__recordOriginator mesh__D011873 EC
% 213.45/213.68  |- skos__altLabel mesh__D011873 Archiving, Radiologic Picture
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D011873 1995
% 213.45/213.68  |- skos__hiddenLabel mesh__D011873 System, Xray Information
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D011873 1998
% 213.45/213.68  |- skos__altLabel mesh__D011873 Radiology Information System
% 213.45/213.68  |- skos__altLabel mesh__D011873 Radiologic Information System
% 213.45/213.68  |- skos__broader mesh__D011873smesh__D008331
% 213.45/213.68  |- rdf__type mesh__D011873sskos__Concept
% 213.45/213.68  |- skos__altLabel mesh__D011873 Information Systems, Radiology
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D011873 2004
% 213.45/213.68  |- skos__hiddenLabel mesh__D011873 Systems, X-Ray Information
% 213.45/213.68  |- skos__scopeNote mesh__D011873
% 213.45/213.68       Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative activities associated with the provision and utilization of radiology services and facilities.%A%    
% 213.45/213.68  |- skos__altLabel mesh__D011873 Information System, Radiologic
% 213.45/213.68  |- skos__altLabel mesh__D011873 System, Radiologic Information
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D011873 2002
% 213.45/213.68  |- skos__altLabel mesh__D011873 Information Systems, Radiologic
% 213.45/213.68  |- skos__hiddenLabel mesh__D011873 Information Systems, X-Ray
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D011873 2003
% 213.45/213.68  |- skos__broader mesh__D019058smesh__D003153
% 213.45/213.68  |- skos__hiddenLabel mesh__D019058 Health Networks, Community
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019058 2005
% 213.45/213.68  |- mesh__dateEstablished mesh__D019058 1996-01-01
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019058 1997
% 213.45/213.68  |- skos__hiddenLabel mesh__D019058 Health Network, Community
% 213.45/213.68  |- mesh__historyNote mesh__D019058 96   
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019058 2002
% 213.45/213.68  |- skos__hiddenLabel mesh__D019058 Network, Community Health
% 213.45/213.68  |- skos__hiddenLabel mesh__D019058 Network, Community Care
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019058 2004
% 213.45/213.68  |- skos__prefLabel mesh__D019058 Community Networks
% 213.45/213.68  |- skos__hiddenLabel mesh__D019058 Networks, Community Care
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019058 1996
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019058 2003
% 213.45/213.68  |- skos__broader mesh__D019058smesh__D007256
% 213.45/213.68  |- skos__hiddenLabel mesh__D019058 Network, Community
% 213.45/213.68  |- skos__hiddenLabel mesh__D019058 Care Networks, Community
% 213.45/213.68  |- skos__hiddenLabel mesh__D019058 Care Network, Community
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019058 1999
% 213.45/213.68  |- skos__scopeNote mesh__D019058
% 213.45/213.68       Organizations and individuals cooperating together toward a common goal at the local or grassroots level.%A%    
% 213.45/213.68  |- skos__hiddenLabel mesh__D019058 Networks, Community Health
% 213.45/213.68  |- skos__hiddenLabel mesh__D019058 Community Network
% 213.45/213.68  |- skos__hiddenLabel mesh__D019058 Community Health Network
% 213.45/213.68  |- skos__historyNote mesh__D019058
% 213.45/213.68       Community Health Services %28%1980-1995%29%
% 213.45/213.68  |- skos__hiddenLabel mesh__D019058 Community Care Network
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019058 2001
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019058 2006
% 213.45/213.68  |- mesh__dateCreated mesh__D019058 1995-06-05
% 213.45/213.68  |- skos__broader mesh__D019058smesh__D012931
% 213.45/213.68  |- rdf__type mesh__D019058sskos__Concept
% 213.45/213.68  |- skos__hiddenLabel mesh__D019058 Networks, Community
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019058 2000
% 213.45/213.68  |- skos__annotation mesh__D019058 IM   
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D019058 1998
% 213.45/213.68  |- mesh__publicMeSHNote mesh__D019058 96   
% 213.45/213.68  |- mesh__dateEstablished mesh__D011075 1984-01-01
% 213.45/213.68  |- mesh__recordMaintainer mesh__D011075 CCR
% 213.45/213.68  |- skos__broader mesh__D011075smesh__D001713
% 213.45/213.68  |- mesh__dateCreated mesh__D011075 1976-04-27
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D011075 2002
% 213.45/213.68  |- mesh__publicMeSHNote mesh__D011075
% 213.45/213.68       94; was POLYBROMOBIPHENYL COMPOUNDS 1977-93 %28%see under BIPHENYL COMPOUNDS 1977-83%29%%A%  
% 213.45/213.68  |- skos__historyNote mesh__D011075
% 213.45/213.68       Hydrocarbons, Brominated %28%1974-1975%29%
% 213.45/213.68  |- skos__hiddenLabel mesh__D011075 Biphenyls, Polybrominated
% 213.45/213.68  |- skos__broader mesh__D011075smesh__D006842
% 213.45/213.68  |- skos__hiddenLabel mesh__D011075 Compounds, Polybromobiphenyl
% 213.45/213.68  |- mesh__recordOriginator mesh__D011075 RLS
% 213.45/213.68  |- mesh__onlineNote mesh__D011075
% 213.45/213.68       use POLYBROMINATED BIPHENYLS to search POLYBROMOBIPHENYL COMPOUNDS 1977-93%A%  
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D011075 2001
% 213.45/213.68  |- skos__altLabel mesh__D011075 Polybromobiphenyl Compounds
% 213.45/213.68  |- mesh__dateRevised mesh__D011075 2000-06-22
% 213.45/213.68  |- skos__annotation mesh__D011075 DF: PBBS   
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D011075 2004
% 213.45/213.68  |- mesh__historyNote mesh__D011075
% 213.45/213.68       94; was POLYBROMOBIPHENYL COMPOUNDS 1977-93 %28%see under BIPHENYL COMPOUNDS 1977-83%29%%A%  
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D011075 2006
% 213.45/213.68  |- skos__scopeNote mesh__D011075
% 213.45/213.68       Biphenyl compounds which are extensively brominated. Many of these compounds are toxic environmental pollutants.%A%    
% 213.45/213.68  |- skos__historyNote mesh__D011075 Biphenyl Compounds %28%1966-1976%29%
% 213.45/213.68  |- skos__prefLabel mesh__D011075 Polybrominated Biphenyls
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D011075 2003
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D011075 2005
% 213.45/213.68  |- rdf__type mesh__D011075sskos__Concept
% 213.45/213.68  |- mesh__recordAuthorizer mesh__D011075 sjn
% 213.45/213.68  |- skos__hiddenLabel mesh__D005836 Female Genitalia
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D005836 2006A
% 213.45/213.68  |- skos__hiddenLabel mesh__D005836 Organs, Female Genital
% 213.45/213.68  |- skos__hiddenLabel mesh__D005836 Female Genital Organs
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D005836 2005
% 213.45/213.68  |- mesh__recordMaintainer mesh__D005836 ags
% 213.45/213.68  |- skos__altLabel mesh__D005836 Sex Organs, Accessory, Female
% 213.45/213.68  |- mesh__recordAuthorizer mesh__D005836 ags
% 213.45/213.68  |- mesh__recordOriginator mesh__D005836 NLM
% 213.45/213.68  |- mesh__dateCreated mesh__D005836 1999-01-01
% 213.45/213.68  |- rdf__type mesh__D005836sskos__Concept
% 213.45/213.68  |- skos__related mesh__D005836smesh__D007047
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D005836 2006
% 213.45/213.68  |- skos__altLabel mesh__D005836 Genital Organs, Female
% 213.45/213.68  |- skos__annotation mesh__D005836
% 213.45/213.68       GEN: prefer specifics; /surg: consider also GYNECOLOGIC SURGICAL PROCEDURES; dis = GENITAL DISEASES, FEMALE%A%  
% 213.45/213.68  |- skos__broader mesh__D005836smesh__D005835
% 213.45/213.68  |- skos__scopeNote mesh__D005836
% 213.45/213.68       The female reproductive organs. The external organs include the VULVA; BARTHOLIN%27%S GLANDS; and CLITORIS. The internal organs include the VAGINA; UTERUS; OVARY; and FALLOPIAN TUBES.%A%    
% 213.45/213.68  |- skos__prefLabel mesh__D005836 Genitalia, Female
% 213.45/213.68  |- mesh__dateRevised mesh__D005836 2005-08-03
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D005038 2006
% 213.45/213.68  |- skos__annotation mesh__D005038 D25-D26 qualif   
% 213.45/213.68  |- mesh__recordOriginator mesh__D005038 NLM
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D005038 2001
% 213.45/213.68  |- skos__historyNote mesh__D005038 Nitrosourea Compounds %28%1973-1974%29%
% 213.45/213.68  |- mesh__recordAuthorizer mesh__D005038 sjn
% 213.45/213.68  |- mesh__publicMeSHNote mesh__D005038
% 213.45/213.68       86; was see under NITROSOUREA COMPOUNDS 1975-85   
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D005038 2004
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D005038 2005
% 213.45/213.68  |- skos__scopeNote mesh__D005038
% 213.45/213.68       A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties.%A%    
% 213.45/213.68  |- mesh__historyNote mesh__D005038
% 213.45/213.68       86%28%75%29%; was see under NITROSOUREA COMPOUNDS 1975-85   
% 213.45/213.68  |- mesh__activeMeSHYear mesh__D005038 2003
% 213.45/213.68  |- mesh__dateCreated mesh__D005038 1974-11-11
% 213.45/213.69  |- mesh__recordMaintainer mesh__D005038 CCR
% 213.45/213.69  |- skos__broader mesh__D005038smesh__D009607
% 213.45/213.69  |- mesh__activeMeSHYear mesh__D005038 2002
% 213.45/213.69  |- mesh__dateEstablished mesh__D005038 1986-01-01
% 213.45/213.69  |- rdf__type mesh__D005038sskos__Concept
% 213.45/213.69  |- skos__altLabel mesh__D005038 N-Ethyl-N-nitrosourea
% 213.45/213.69  |- skos__altLabel mesh__D005038 Nitrosoethylurea
% 213.45/213.69  |- skos__hiddenLabel mesh__D005038 N Ethyl N nitrosourea
% 213.45/213.69  |- mesh__dateRevised mesh__D005038 2000-06-22
% 213.45/213.69  |- skos__prefLabel mesh__D005038 Ethylnitrosourea
% 213.45/213.69  |- mesh__activeMeSHYear mesh__D015466 1997
% 213.45/213.69  |- skos__altLabel mesh__D015466 Myeloid Leukemia, Chronic, Chronic Phase
% 213.45/213.69  |- rdf__type mesh__D015466sskos__Concept
% 213.45/213.69  |- mesh__activeMeSHYear mesh__D015466 1999
% 213.45/213.69  |- mesh__historyNote mesh__D015466 89   
% 213.45/213.69  |- mesh__dateCreated mesh__D015466 1988-06-09
% 213.45/213.69  |- skos__historyNote mesh__D015466 Leukemia, Myelocytic %28%1972-1988%29%
% 213.45/213.69  |- mesh__activeMeSHYear mesh__D015466 1996
% 213.45/213.69  |- skos__altLabel mesh__D015466 Leukemia, Granulocytic, Chronic Phase
% 213.45/213.69  |- skos__prefLabel mesh__D015466 Leukemia, Myeloid, Chronic-Phase
% 213.45/213.69  |- mesh__recordOriginator mesh__D015466 PLS
% 213.45/213.69  |- mesh__activeMeSHYear mesh__D015466 1998
% 213.45/213.69  |- skos__annotation mesh__D015466
% 213.45/213.69       do not use /blood supply /chem /second /secret /ultrastruct; DF: CML CHRONIC%A%  
% 213.45/213.69  |- mesh__dateRevised mesh__D015466 1995-06-08
% 213.45/213.69  |- mesh__activeMeSHYear mesh__D015466 2002
% 213.45/213.69  |- mesh__dateEstablished mesh__D015466 1989-01-01
% 213.45/213.69  |- skos__altLabel mesh__D015466 Myeloid Leukemia, Chronic, Chronic-Phase
% 213.45/213.69  |- skos__altLabel mesh__D015466 Leukemia, Myeloid, Chronic Phase
% 213.45/213.69  |- mesh__activeMeSHYear mesh__D015466 2004
% 213.45/213.69  |- mesh__publicMeSHNote mesh__D015466 89   
% 213.45/213.69  |- skos__altLabel mesh__D015466
% 213.45/213.69       Granulocytic Leukemia, Chronic, Stable-Phase
% 213.45/213.69  |- skos__altLabel mesh__D015466
% 213.45/213.69       Granulocytic Leukemia, Chronic, Stable Phase
% 213.45/213.69  |- skos__altLabel mesh__D015466 Leukemia, Myeloid, Stable Phase
% 213.45/213.69  |- skos__altLabel mesh__D015466 Leukemia, Myelogenous, Chronic-Phase
% 213.45/213.69  |- mesh__activeMeSHYear mesh__D015466 2001
% 213.45/213.69  |- mesh__activeMeSHYear mesh__D015466 2006
% 213.45/213.69  |- skos__altLabel mesh__D015466 Leukemia, Myeloid, Stable-Phase
% 213.45/213.69  |- mesh__recordAuthorizer mesh__D015466 PLS
% 213.45/213.69  |- skos__altLabel mesh__D015466 Myeloid Leukemia, Chronic, Stable-Phase
% 213.45/213.69  |- skos__altLabel mesh__D015466 Leukemia, Granulocytic, Chronic-Phase
% 213.45/213.69  |- mesh__activeMeSHYear mesh__D015466 2003
% 213.54/213.69  |- skos__broader mesh__D015466smesh__D015464
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D015466 2000
% 213.54/213.69  |- skos__altLabel mesh__D015466
% 213.54/213.69       Myelogenous Leukemia, Chronic, Chronic-Phase
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D015466 2005
% 213.54/213.69  |- skos__altLabel mesh__D015466
% 213.54/213.69       Myelogenous Leukemia, Chronic, Chronic Phase
% 213.54/213.69  |- skos__altLabel mesh__D015466 Leukemia, Myelogenous, Chronic Phase
% 213.54/213.69  |- skos__historyNote mesh__D015466 Leukemia, Myeloid %28%1972-1988%29%
% 213.54/213.69  |- mesh__recordMaintainer mesh__D015466 KEV
% 213.54/213.69  |- skos__altLabel mesh__D009429 Sinanomycin
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D009429 2006
% 213.54/213.69  |- mesh__dateCreated mesh__D009429 1976-05-03
% 213.54/213.69  |- skos__hiddenLabel mesh__D009429 Hydrochloride, Netropsin
% 213.54/213.69  |- mesh__historyNote mesh__D009429
% 213.54/213.69       91%28%77%29%; was see under GUANIDINES 1977-90; CONGOCIDINE was %28%NM%29% 1973-93%A%  
% 213.54/213.69  |- skos__broader mesh__D009429smesh__D009842
% 213.54/213.69  |- mesh__dateRevised mesh__D009429 2003-07-09
% 213.54/213.69  |- skos__altLabel mesh__D009429 Congocidine
% 213.54/213.69  |- skos__historyNote mesh__D009429 Pyrroles %28%1966-1976%29%
% 213.54/213.69  |- mesh__recordAuthorizer mesh__D009429 sjn
% 213.54/213.69  |- mesh__dateEstablished mesh__D009429 1991-01-01
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D009429 2004
% 213.54/213.69  |- mesh__onlineNote mesh__D009429
% 213.54/213.69       use NETROPSIN %28%NM%29% to search CONGOCIDINE 1980-93   
% 213.54/213.69  |- skos__scopeNote mesh__D009429
% 213.54/213.69       A basic polypeptide isolated from Streptomyces netropsis. It is cytotoxic and its strong, specific binding to A-T areas of DNA is useful to genetics research.%A%    
% 213.54/213.69  |- skos__prefLabel mesh__D009429 Netropsin
% 213.54/213.69  |- mesh__recordOriginator mesh__D009429 SH
% 213.54/213.69  |- skos__historyNote mesh__D009429 Guanidines %28%1966-1976%29%
% 213.54/213.69  |- mesh__publicMeSHNote mesh__D009429
% 213.54/213.69       91; was see under GUANIDINES 1977-90; CONGOCIDINE was indexed under PYRROLES 1983-93, GUANIDINES 1973-83 %26% AMIDINES 1973-76%A%  
% 213.54/213.69  |- rdf__type mesh__D009429sskos__Concept
% 213.54/213.69  |- mesh__recordMaintainer mesh__D009429 ssb
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D009429 2005
% 213.54/213.69  |- mesh__recordOriginator mesh__D001446 NLM
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D001446 2000
% 213.54/213.69  |- skos__broader mesh__D001446smesh__D010409
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D001446 2005
% 213.54/213.69  |- mesh__dateCreated mesh__D001446 1999-01-01
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D001446 2001
% 213.54/213.69  |- mesh__recordAuthorizer mesh__D001446 sjn
% 213.54/213.69  |- mesh__publicMeSHNote mesh__D001446
% 213.54/213.69       KRAUROSIS PENIS was see under BALANITIS 1963-85   
% 213.54/213.69  |- mesh__dateRevised mesh__D001446 1999-11-03
% 213.54/213.69  |- mesh__onlineNote mesh__D001446
% 213.54/213.69       use BALANITIS to search KRAUROSIS PENIS 1966-85   
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D001446 2006
% 213.54/213.69  |- skos__hiddenLabel mesh__D001446 Penis, Kraurosis
% 213.54/213.69  |- rdf__type mesh__D001446sskos__Concept
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D001446 2002
% 213.54/213.69  |- skos__hiddenLabel mesh__D001446 Balanitides
% 213.54/213.69  |- mesh__historyNote mesh__D001446
% 213.54/213.69       KRAUROSIS PENIS was see under BALANITIS 1963-85   
% 213.54/213.69  |- skos__prefLabel mesh__D001446 Balanitis
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D001446 2003
% 213.54/213.69  |- skos__scopeNote mesh__D001446 Inflammation of the glans penis.     
% 213.54/213.69  |- mesh__recordMaintainer mesh__D001446 KEV
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D001446 2004
% 213.54/213.69  |- mesh__recordAuthorizer mesh__D020600 sjn
% 213.54/213.69  |- skos__broader mesh__D020600smesh__D020576
% 213.54/213.69  |- mesh__historyNote mesh__D020600 2000   
% 213.54/213.69  |- skos__scopeNote mesh__D020600
% 213.54/213.69       A rod-shaped to ellipsoidal, gram-negative bacterium which oxidizes ethanol to acetic acid and prefers sugar-enriched environments. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 213.54/213.69  |- mesh__dateRevised mesh__D020600 2005-06-30
% 213.54/213.69  |- skos__historyNote mesh__D020600 Acetobacteraceae %28%1993-1999%29%
% 213.54/213.69  |- skos__historyNote mesh__D020600 Pseudomonadaceae %28%1976-1992%29%
% 213.54/213.69  |- mesh__recordOriginator mesh__D020600 ndw
% 213.54/213.69  |- skos__prefLabel mesh__D020600 Gluconobacter oxydans
% 213.54/213.69  |- skos__annotation mesh__D020600
% 213.54/213.69       do not confuse with GLUCONOBACTER SUBOXYDANS see GLUCONOBACTER%A%  
% 213.54/213.69  |- mesh__recordMaintainer mesh__D020600 ags
% 213.54/213.69  |- mesh__dateEstablished mesh__D020600 2000-01-01
% 213.54/213.69  |- mesh__dateCreated mesh__D020600 1999-11-03
% 213.54/213.69  |- rdf__type mesh__D020600sskos__Concept
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D020600 2006
% 213.54/213.69  |- mesh__publicMeSHNote mesh__D020600 2000   
% 213.54/213.69  |- skos__altLabel mesh__D006131 Cell Growth Inhibitors
% 213.54/213.69  |- skos__hiddenLabel mesh__D006131 Inhibitors, Growth
% 213.54/213.69  |- mesh__onlineNote mesh__D006131
% 213.54/213.69       use GROWTH INHIBITORS to search CHALONES 1969-92 %28%as Prov 1969-71%29%%A%  
% 213.54/213.69  |- mesh__dateRevised mesh__D006131 2005-06-30
% 213.54/213.69  |- skos__annotation mesh__D006131 DF: GROWTH INHIB   
% 213.54/213.69  |- rdf__type mesh__D006131sskos__Concept
% 213.54/213.69  |- mesh__recordMaintainer mesh__D006131 ssb
% 213.54/213.69  |- mesh__recordOriginator mesh__D006131 RLS
% 213.54/213.69  |- skos__prefLabel mesh__D006131 Growth Inhibitors
% 213.54/213.69  |- mesh__historyNote mesh__D006131 1979   
% 213.54/213.69  |- mesh__recordAuthorizer mesh__D006131 sjn
% 213.54/213.69  |- skos__scopeNote mesh__D006131
% 213.54/213.69       Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth %28%= PLANT GROWTH REGULATORS%29%.%A%    
% 213.54/213.69  |- mesh__dateCreated mesh__D006131 1978-02-13
% 213.54/213.69  |- skos__hiddenLabel mesh__D006131 Inhibitors, Cell Growth
% 213.54/213.69  |- skos__broader mesh__D006131smesh__D006133
% 213.54/213.69  |- skos__hiddenLabel mesh__D006131 Growth Inhibitors, Cell
% 213.54/213.69  |- mesh__publicMeSHNote mesh__D006131 1979   
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D006131 2006
% 213.54/213.69  |- mesh__dateEstablished mesh__D006131 1979-01-01
% 213.54/213.69  |- mesh__publicMeSHNote mesh__D047548 2005   
% 213.54/213.69  |- mesh__recordOriginator mesh__D047548 nns
% 213.54/213.69  |- skos__historyNote mesh__D047548 Electric Countershock %28%1967-2004%29%
% 213.54/213.69  |- mesh__dateCreated mesh__D047548 2004-07-07
% 213.54/213.69  |- skos__hiddenLabel mesh__D047548 External Defibrillators, Automated
% 213.54/213.69  |- mesh__recordAuthorizer mesh__D047548 sjn
% 213.54/213.69  |- mesh__recordMaintainer mesh__D047548 nns
% 213.54/213.69  |- mesh__dateEstablished mesh__D047548 2005-01-01
% 213.54/213.69  |- skos__hiddenLabel mesh__D047548 Defibrillator
% 213.54/213.69  |- skos__hiddenLabel mesh__D047548 Automated External Defibrillator
% 213.54/213.69  |- skos__broader mesh__D047548smesh__D004566
% 213.54/213.69  |- mesh__historyNote mesh__D047548 2005   
% 213.54/213.69  |- skos__hiddenLabel mesh__D047548 Defibrillator, Automated External
% 213.54/213.69  |- skos__altLabel mesh__D047548 Electric Shock Cardiac Stimulators
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D047548 2006
% 213.54/213.69  |- skos__related mesh__D047548smesh__D004554
% 213.54/213.69  |- skos__prefLabel mesh__D047548 Defibrillators
% 213.54/213.69  |- skos__hiddenLabel mesh__D047548 External Defibrillators
% 213.54/213.69  |- rdf__type mesh__D047548sskos__Concept
% 213.54/213.69  |- skos__scopeNote mesh__D047548
% 213.54/213.69       Cardiac electrical stimulators that apply brief high-voltage electroshocks to the HEART. These stimulators are used to restore normal rhythm and contractile function in hearts of patients who are experiencing VENTRICULAR FIBRILLATION or ventricular tachycardia %28%TACHYCARDIA, VENTRICULAR%29% that is not accompanied by a palpable PULSE. Some defibrillators may also be used to correct certain noncritical dysrhythmias %28%called synchronized defibrillation or CARDIOVERSION%29%, using relatively low-level discharges synchronized to the patient%27%s ECG waveform. %28%UMDNS, 2003%29%%A%    
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D047548 2005
% 213.54/213.69  |- skos__hiddenLabel mesh__D047548 External Defibrillator, Automated
% 213.54/213.69  |- skos__hiddenLabel mesh__D047548 Defibrillators, Automated External
% 213.54/213.69  |- skos__hiddenLabel mesh__D047548 External Defibrillator
% 213.54/213.69  |- skos__hiddenLabel mesh__D047548 Defibrillator, External
% 213.54/213.69  |- skos__altLabel mesh__D047548 Stimulators, Electrical, Cardiac, Shock
% 213.54/213.69  |- skos__altLabel mesh__D019857 Distraction Osteogenesis
% 213.54/213.69  |- skos__scopeNote mesh__D019857
% 213.54/213.69       Bone lengthening by gradual mechanical distraction. An external fixation device produces the distraction across the bone plate. The technique was originally applied to long bones but in recent years the method has been adapted for use with mandibular implants in maxillofacial surgery.%A%    
% 213.54/213.69  |- skos__prefLabel mesh__D019857 Osteogenesis, Distraction
% 213.54/213.69  |- skos__hiddenLabel mesh__D019857 Distraction Osteogeneses
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D019857 2001
% 213.54/213.69  |- skos__hiddenLabel mesh__D019857 Osteogeneses, Distraction
% 213.54/213.69  |- mesh__historyNote mesh__D019857 98   
% 213.54/213.69  |- skos__historyNote mesh__D019857 Osteogenesis %28%1985-1997%29%
% 213.54/213.69  |- mesh__dateEstablished mesh__D019857 1998-01-01
% 213.54/213.69  |- mesh__publicMeSHNote mesh__D019857 98   
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D019857 1999
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D019857 2000
% 213.54/213.69  |- skos__annotation mesh__D019857
% 213.54/213.69       bone lengthening by gradual distraction; not restricted to long bones%A%  
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D019857 2004
% 213.54/213.69  |- skos__hiddenLabel mesh__D019857 Callotases
% 213.54/213.69  |- skos__related mesh__D019857smesh__D016267
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D019857 2006
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D019857 1998
% 213.54/213.69  |- skos__historyNote mesh__D019857 Bone Lengthening %28%1987-1997%29%
% 213.54/213.69  |- skos__related mesh__D019857smesh__D018889
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D019857 2003
% 213.54/213.69  |- rdf__type mesh__D019857sskos__Concept
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D019857 2005
% 213.54/213.69  |- mesh__dateCreated mesh__D019857 1997-06-25
% 213.54/213.69  |- skos__broader mesh__D019857smesh__D001852
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D019857 2002
% 213.54/213.69  |- skos__altLabel mesh__D011874 Radiation Dosimetry
% 213.54/213.69  |- mesh__publicMeSHNote mesh__D011874
% 213.54/213.69       GEIGER-MUELLER COUNTER was see under RADIOMETRY 1963-77   
% 213.54/213.69  |- mesh__dateCreated mesh__D011874 1999-01-01
% 213.54/213.69  |- skos__scopeNote mesh__D011874
% 213.54/213.69       The measurement of radiation by photography, as in x-ray film and film badge, by Geiger-Mueller tube, and by SCINTILLATION COUNTING.%A%    
% 213.54/213.69  |- mesh__onlineNote mesh__D011874
% 213.54/213.69       use RADIOMETRY to search GEIGER-MUELLER COUNTER 1966-77   
% 213.54/213.69  |- skos__hiddenLabel mesh__D011874 Geiger Mueller Counters
% 213.54/213.69  |- skos__hiddenLabel mesh__D011874 Detection, Nuclear Track
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D011874 2001
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D011874 1999
% 213.54/213.69  |- skos__broader mesh__D011874smesh__D011827
% 213.54/213.69  |- mesh__recordMaintainer mesh__D011874 TGC
% 213.54/213.69  |- skos__hiddenLabel mesh__D011874 Counters, Geiger-Mueller
% 213.54/213.69  |- skos__annotation mesh__D011874
% 213.54/213.69       IM general only for measurement of radiation %26% techniques %26% equipment related to it; NIM as coord with specific radiation %28%IM%29% for measurement of its radiations; do not use with radioisotope tracers for measurement of amt of radiat emitted by the tracer: this is inherent in the concept of tracing: Manual 29.14; for nuclear decay index under RADIOACTIVITY for general articles or specific radioactive substance %28%IM%29% + RADIOACTIVITY %28%NIM%29% but do not add RADIOMETRY; ionization chambers: index under RADIOMETRY /instrum%A%  
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D011874 2006
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D011874 2000
% 213.54/213.69  |- mesh__recordOriginator mesh__D011874 NLM
% 213.54/213.69  |- skos__altLabel mesh__D011874 Dosimetry, Radiation
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D011874 1998
% 213.54/213.69  |- skos__hiddenLabel mesh__D011874 Radiation Dosimetries
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D011874 2004
% 213.54/213.69  |- mesh__historyNote mesh__D011874
% 213.54/213.69       GEIGER-MUELLER COUNTER was see under RADIOMETRY 1963-77   
% 213.54/213.69  |- skos__prefLabel mesh__D011874 Radiometry
% 213.54/213.69  |- mesh__dateRevised mesh__D011874 1997-06-20
% 213.54/213.69  |- skos__broader mesh__D011874smesh__D008919
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D011874 2005
% 213.54/213.69  |- skos__hiddenLabel mesh__D011874 Dosimetries, Radiation
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D011874 2003
% 213.54/213.69  |- mesh__recordAuthorizer mesh__D011874 SJN
% 213.54/213.69  |- rdf__type mesh__D011874sskos__Concept
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D011874 2002
% 213.54/213.69  |- mesh__dateCreated mesh__D011076 1999-01-01
% 213.54/213.69  |- mesh__dateRevised mesh__D011076 1997-06-20
% 213.54/213.69  |- mesh__historyNote mesh__D011076
% 213.54/213.69       91%28%72%29%; was see under DENTAL CEMENTS 1982-90; was see under ACRYLIC RESINS 1977-81; was see under ACRYLATES 1975-76%A%  
% 213.54/213.69  |- skos__hiddenLabel mesh__D011076 Cement, Zinc Polycarboxylate
% 213.54/213.69  |- mesh__recordOriginator mesh__D011076 NLM
% 213.54/213.69  |- skos__hiddenLabel mesh__D011076 Cement, Polycarboxylate
% 213.54/213.69  |- mesh__recordAuthorizer mesh__D011076 SJN
% 213.54/213.69  |- mesh__publicMeSHNote mesh__D011076
% 213.54/213.69       91; was see under DENTAL CEMENTS 1982-90; was see under ACRYLIC RESINS 1977-81; was see under ACRYLATES 1975-76%A%  
% 213.54/213.69  |- skos__historyNote mesh__D011076 Zinc %28%1966-1971%29%
% 213.54/213.69  |- skos__hiddenLabel mesh__D011076 Polycarboxylate Cement, Zinc
% 213.54/213.69  |- skos__broader mesh__D011076smesh__D003738
% 213.54/213.69  |- skos__historyNote mesh__D011076 Acrylates %28%1966-1971%29%
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D011076 2004
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D011076 2002
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D011076 2006
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D011076 2003
% 213.54/213.69  |- skos__prefLabel mesh__D011076 Polycarboxylate Cement
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D011076 2001
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D011076 2005
% 213.54/213.69  |- mesh__recordMaintainer mesh__D011076 ADP
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D011076 1999
% 213.54/213.69  |- rdf__type mesh__D011076sskos__Concept
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D011076 2000
% 213.54/213.69  |- skos__annotation mesh__D011076 a dent cement; D25-26 qualif   
% 213.54/213.69  |- skos__historyNote mesh__D011076 Dental Cements %28%1971%29%
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D011076 1998
% 213.54/213.69  |- mesh__dateEstablished mesh__D011076 1991-01-01
% 213.54/213.69  |- skos__scopeNote mesh__D011076
% 213.54/213.69       Water-soluble low-molecular-weight polymers of acrylic or methacrylic acid that form solid, insoluble products when mixed with specially prepared ZnO powder. The resulting cement adheres to dental enamel and is also used as a luting agent.%A%    
% 213.54/213.69  |- mesh__recordAuthorizer mesh__D005837 ags
% 213.54/213.69  |- rdf__type mesh__D005837sskos__Concept
% 213.54/213.69  |- mesh__recordMaintainer mesh__D005837 ags
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D005837 2006
% 213.54/213.69  |- skos__broader mesh__D005837smesh__D005835
% 213.54/213.69  |- skos__annotation mesh__D005837
% 213.54/213.69       GEN: prefer specifics; dis = GENITAL DISEASES, MALE   
% 213.54/213.69  |- skos__hiddenLabel mesh__D005837 Organs, Male Genital
% 213.54/213.69  |- skos__hiddenLabel mesh__D005837 Male Genital Organs
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D005837 2006A
% 213.54/213.69  |- skos__scopeNote mesh__D005837
% 213.54/213.69       The male reproductive organs. They are divided into the external organs %28%PENIS; SCROTUM;and URETHRA%29% and the internal organs %28%TESTIS; EPIDIDYMIS; VAS DEFERENS; SEMINAL VESICLES; EJACULATORY DUCTS; PROSTATE; and BULBOURETHRAL GLANDS%29%.%A%    
% 213.54/213.69  |- skos__prefLabel mesh__D005837 Genitalia, Male
% 213.54/213.69  |- skos__altLabel mesh__D005837 Sex Organs, Accessory, Male
% 213.54/213.69  |- mesh__recordOriginator mesh__D005837 NLM
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D005837 2005
% 213.54/213.69  |- skos__altLabel mesh__D005837 Genital Organs, Male
% 213.54/213.69  |- skos__hiddenLabel mesh__D005837 Male Genitalia
% 213.54/213.69  |- mesh__dateRevised mesh__D005837 2005-07-22
% 213.54/213.69  |- mesh__dateCreated mesh__D005837 1999-01-01
% 213.54/213.69  |- skos__broader mesh__D005039smesh__D010656
% 213.54/213.69  |- skos__hiddenLabel mesh__D005039 Eti Puren
% 213.54/213.69  |- skos__altLabel mesh__D005039
% 213.54/213.69       ratiopharm Brand of Etilefrine Hydrochloride
% 213.54/213.69  |- mesh__dateRevised mesh__D005039 2005-06-30
% 213.54/213.69  |- skos__hiddenLabel mesh__D005039 Adrianol, Ethyl
% 213.54/213.69  |- mesh__recordAuthorizer mesh__D005039 sjn
% 213.54/213.69  |- mesh__recordMaintainer mesh__D005039 CCR
% 213.54/213.69  |- skos__historyNote mesh__D005039
% 213.54/213.69       Phenylephrine/analogs %26% derivatives %28%1975%29%
% 213.54/213.69  |- skos__altLabel mesh__D005039 Fetanol
% 213.54/213.69  |- skos__hiddenLabel mesh__D005039 Hydrochloride, Etilefrine Pivalate
% 213.54/213.69  |- skos__hiddenLabel mesh__D005039 Pivalate Hydrochloride, Etilefrine
% 213.54/213.69  |- skos__altLabel mesh__D005039
% 213.54/213.69       Boehringer Ingelheim Brand of Etilefrine Hydrochloride
% 213.54/213.69  |- skos__altLabel mesh__D005039
% 213.54/213.69       S%C3%%BC%dmedica Brand of Etilefrine Hydrochloride
% 213.54/213.69  |- skos__altLabel mesh__D005039 NAM Brand of Etilefrine Hydrochloride
% 213.54/213.69  |- mesh__historyNote mesh__D005039
% 213.54/213.69       95; was ETHYLPHENYLEPHRINE 1976-94 %28%see under PHENYLEPHRINE 1976-90%29%; ETHYLNORMETAOXEDRIN %26% ETILEFRIN were see ETHYLPHENYLEPHRINE 1976-94%A%  
% 213.54/213.69  |- skos__altLabel mesh__D005039 Apogepha Brand of Etilefrine Hydrochloride
% 213.54/213.69  |- skos__altLabel mesh__D005039 Ethyladrianol
% 213.54/213.69  |- skos__hiddenLabel mesh__D005039 Etilefrin ratiopharm
% 213.54/213.69  |- skos__altLabel mesh__D005039 Temmler Brand of Etilefrine Hydrochloride
% 213.54/213.69  |- skos__altLabel mesh__D005039 Alpharma Brand of Etilefrine Hydrochloride
% 213.54/213.69  |- skos__altLabel mesh__D005039 Aliud Brand of Etilefrine Hydrochloride
% 213.54/213.69  |- skos__hiddenLabel mesh__D005039 Hydrochloride, Etilefrine
% 213.54/213.69  |- mesh__dateEstablished mesh__D005039 1991-01-01
% 213.54/213.69  |- mesh__onlineNote mesh__D005039
% 213.54/213.69       use ETILEFRINE to search ETHYLPHENYLEPHRINE, ETHYLNORMETAOXEDRIN, %26% ETILEFRIN 1976-94%A%  
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D005039 2006
% 213.54/213.69  |- skos__hiddenLabel mesh__D005039
% 213.54/213.69       ct Arzneimittel Brand of Etilefrine Hydrochloride
% 213.54/213.69  |- mesh__recordOriginator mesh__D005039 SH
% 213.54/213.69  |- skos__altLabel mesh__D005039 Ethylphenylephrine
% 213.54/213.69  |- skos__altLabel mesh__D005039
% 213.54/213.69       ct-Arzneimittel Brand of Etilefrine Hydrochloride
% 213.54/213.69  |- skos__altLabel mesh__D005039 Fher Brand of Etilefrine Hydrochloride
% 213.54/213.69  |- skos__prefLabel mesh__D005039 Etilefrine
% 213.54/213.69  |- mesh__publicMeSHNote mesh__D005039
% 213.54/213.69       95; was ETHYLPHENYLEPHRINE 1976-94 %28%see under PHENYLEPHRINE 1976-90%29%; ETHYLNORMETAOXEDRIN %26% ETILEFRIN were see ETHYLPHENYLEPHRINE 1976-94%A%  
% 213.54/213.69  |- rdf__type mesh__D005039sskos__Concept
% 213.54/213.69  |- skos__altLabel mesh__D005039 Ethylnorphenylephrine
% 213.54/213.69  |- skos__historyNote mesh__D005039 Phenethylamines %28%1970-1974%29%
% 213.54/213.69  |- skos__altLabel mesh__D005039 Etilefrin
% 213.54/213.69  |- skos__historyNote mesh__D005039 Ethanolamines %28%1970-1974%29%
% 213.54/213.69  |- skos__historyNote mesh__D005039 Phenols %28%1974%29%
% 213.54/213.69  |- mesh__dateCreated mesh__D005039 1975-07-18
% 213.54/213.69  |- skos__scopeNote mesh__D005039
% 213.54/213.69       An adrenergic agonist that appears to interact with beta-2 and some alpha adrenergic receptors. It has been used as a vasoconstrictor agent.%A%    
% 213.54/213.69  |- mesh__dateEstablished mesh__D015467 1989-01-01
% 213.54/213.69  |- mesh__recordAuthorizer mesh__D015467 PLS
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D015467 2004
% 213.54/213.69  |- mesh__publicMeSHNote mesh__D015467 89   
% 213.54/213.69  |- skos__altLabel mesh__D015467 Neutrophilic Leukemia, Chronic
% 213.54/213.69  |- skos__annotation mesh__D015467
% 213.54/213.69       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D015467 2000
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D015467 2006
% 213.54/213.69  |- skos__hiddenLabel mesh__D015467 Chronic Neutrophilic Leukemia
% 213.54/213.69  |- skos__hiddenLabel mesh__D015467 Chronic Neutrophilic Leukemias
% 213.54/213.69  |- mesh__dateCreated mesh__D015467 1988-06-09
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D015467 2003
% 213.54/213.69  |- skos__broader mesh__D015467smesh__D015464
% 213.54/213.69  |- skos__hiddenLabel mesh__D015467 Neutrophilic Leukemias, Chronic
% 213.54/213.69  |- skos__hiddenLabel mesh__D015467 Leukemia, Chronic Neutrophilic
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D015467 2005
% 213.54/213.69  |- mesh__historyNote mesh__D015467 89   
% 213.54/213.69  |- skos__prefLabel mesh__D015467 Leukemia, Neutrophilic, Chronic
% 213.54/213.69  |- mesh__recordMaintainer mesh__D015467 KEV
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D015467 1997
% 213.54/213.69  |- skos__historyNote mesh__D015467 Neutrophils %28%1966-1988%29%
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D015467 1999
% 213.54/213.69  |- rdf__type mesh__D015467sskos__Concept
% 213.54/213.69  |- skos__hiddenLabel mesh__D015467 Leukemias, Chronic Neutrophilic
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D015467 2002
% 213.54/213.69  |- skos__historyNote mesh__D015467 Leukemia, Myeloid %28%1966-1988%29%
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D015467 1996
% 213.54/213.69  |- mesh__recordOriginator mesh__D015467 PLS
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D015467 1998
% 213.54/213.69  |- skos__historyNote mesh__D015467 Leukemia, Myelocytic %28%1966-1988%29%
% 213.54/213.69  |- mesh__dateRevised mesh__D015467 1995-06-08
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D015467 2001
% 213.54/213.69  |- rdf__type mesh__D034621sskos__Concept
% 213.54/213.69  |- skos__annotation mesh__D034621
% 213.54/213.69       do not confuse with BELGIAN HARE see RABBITS   
% 213.54/213.69  |- skos__altLabel mesh__D034621 Lepus
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D034621 2004
% 213.54/213.69  |- mesh__historyNote mesh__D034621 2003   
% 213.54/213.69  |- mesh__dateRevised mesh__D034621 2003-07-09
% 213.54/213.69  |- mesh__publicMeSHNote mesh__D034621 2003   
% 213.54/213.69  |- skos__scopeNote mesh__D034621
% 213.54/213.69       The genus Lepus, in the family Leporidae, order LAGOMORPHA. Hares are born above ground, fully furred, and with their eyes and ears open. In contrast with RABBITS, hares have 24 chromosome pairs.%A%    
% 213.54/213.69  |- skos__hiddenLabel mesh__D034621 Hare
% 213.54/213.69  |- skos__historyNote mesh__D034621 Rabbits %28%1964-1974%29%
% 213.54/213.69  |- skos__hiddenLabel mesh__D034621 Jackrabbit
% 213.54/213.69  |- mesh__dateCreated mesh__D034621 2002-07-03
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D034621 2005
% 213.54/213.69  |- skos__broader mesh__D034621smesh__D007793
% 213.54/213.69  |- skos__prefLabel mesh__D034621 Hares
% 213.54/213.69  |- skos__historyNote mesh__D034621 Lagomorpha %28%1974-2002%29%
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D034621 2006
% 213.54/213.69  |- mesh__dateEstablished mesh__D034621 2003-01-01
% 213.54/213.69  |- mesh__dateCreated mesh__D001447 1999-01-01
% 213.54/213.69  |- skos__broader mesh__D001447smesh__D016770
% 213.54/213.69  |- skos__prefLabel mesh__D001447 Balantidiasis
% 213.54/213.69  |- skos__scopeNote mesh__D001447
% 213.54/213.69       Infection by parasitic PROTOZOA of the genus BALANTIDIUM. The presence of Balantidium in the LARGE INTESTINE leads to DIARRHEA; DYSENTERY; and occasionally ULCER.%A%    
% 213.54/213.69  |- mesh__recordOriginator mesh__D001447 NLM
% 213.54/213.69  |- mesh__dateRevised mesh__D001447 2003-07-09
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D001447 2006
% 213.54/213.69  |- mesh__recordAuthorizer mesh__D001447 sjn
% 213.54/213.69  |- rdf__type mesh__D001447sskos__Concept
% 213.54/213.69  |- skos__hiddenLabel mesh__D001447 Balantidiases
% 213.54/213.69  |- skos__broader mesh__D001447smesh__D007411
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D001447 2005
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D001447 2004
% 213.54/213.69  |- mesh__recordMaintainer mesh__D001447 lkt
% 213.54/213.69  |- rdf__type mesh__D006930sskos__Concept
% 213.54/213.69  |- skos__hiddenLabel mesh__D006930 Primary Hyperalgesias
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D006930 2004
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D006930 2000A
% 213.54/213.69  |- skos__annotation mesh__D006930 coord with TOUCH or HEAT if pertinent   
% 213.54/213.69  |- skos__prefLabel mesh__D006930 Hyperalgesia
% 213.54/213.69  |- skos__hiddenLabel mesh__D006930 Sensations, Hyperalgesic
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D006930 2006
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D006930 2000
% 213.54/213.69  |- skos__broader mesh__D006930smesh__D020886
% 213.54/213.69  |- skos__hiddenLabel mesh__D006930 Secondary Hyperalgesia
% 213.54/213.69  |- mesh__recordOriginator mesh__D006930 NLM
% 213.54/213.69  |- skos__hiddenLabel mesh__D006930 Hyperalgesias, Thermal
% 213.54/213.69  |- skos__hiddenLabel mesh__D006930 Hyperalgesic Sensation
% 213.54/213.69  |- mesh__activeMeSHYear mesh__D006930 2001
% 213.54/213.69  |- skos__hiddenLabel mesh__D006930 Thermal Hyperalgesia
% 213.54/213.69  |- skos__hiddenLabel mesh__D006930 Tactile Hyperalgesias
% 213.54/213.69  |- skos__hiddenLabel mesh__D006930 Hyperalgesias, Tactile
% 213.54/213.69  |- mesh__recordMaintainer mesh__D006930 ags
% 213.54/213.69  |- mesh__publicMeSHNote mesh__D006930 1991; see HYPERESTHESIA 1975-90   
% 213.54/213.70  |- skos__hiddenLabel mesh__D006930 Sensation, Hyperalgesic
% 213.54/213.70  |- mesh__dateEstablished mesh__D006930 1991-01-01
% 213.54/213.70  |- skos__hiddenLabel mesh__D006930 Hyperalgesias, Secondary
% 213.54/213.70  |- skos__hiddenLabel mesh__D006930 Hyperalgesias, Primary
% 213.54/213.70  |- skos__altLabel mesh__D006930 Hyperalgesic Sensations
% 213.54/213.70  |- skos__hiddenLabel mesh__D006930 Thermal Hyperalgesias
% 213.54/213.70  |- skos__hiddenLabel mesh__D006930 Primary Hyperalgesia
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D006930 2002
% 213.54/213.70  |- skos__hiddenLabel mesh__D006930 Tactile Hyperalgesia
% 213.54/213.70  |- mesh__historyNote mesh__D006930 1991%28%1975%29%   
% 213.54/213.70  |- skos__scopeNote mesh__D006930
% 213.54/213.70       An increased sensation to painful stimuli that may follow damage to soft tissue containing NOCICEPTORS or injury to a peripheral nerve. Hyperalgesia can occur both at the site of tissue damage %28%primary hyperalgesia%29% and in the surrounding undamaged areas %28%secondary hyperalgesia%29%. %28%Kandel et al., Principles of Neural Science, 3d ed, p386%29%%A%    
% 213.54/213.70  |- skos__hiddenLabel mesh__D006930 Secondary Hyperalgesias
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D006930 2003
% 213.54/213.70  |- mesh__recordAuthorizer mesh__D006930 ags
% 213.54/213.70  |- mesh__dateRevised mesh__D006930 1999-12-03
% 213.54/213.70  |- skos__hiddenLabel mesh__D006930 Hyperalgesias
% 213.54/213.70  |- mesh__dateCreated mesh__D006930 1999-01-01
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D006930 2005
% 213.54/213.70  |- skos__prefLabel mesh__D020601 Methylobacterium extorquens
% 213.54/213.70  |- mesh__recordMaintainer mesh__D020601 SYSTEM
% 213.54/213.70  |- mesh__recordOriginator mesh__D020601 ndw
% 213.54/213.70  |- rdf__type mesh__D020601sskos__Concept
% 213.54/213.70  |- skos__historyNote mesh__D020601
% 213.54/213.70       Gram-Negative Aerobic Bacteria %28%1989-1999%29%
% 213.54/213.70  |- mesh__publicMeSHNote mesh__D020601 2000   
% 213.54/213.70  |- mesh__dateEstablished mesh__D020601 2000-01-01
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D020601 2006
% 213.54/213.70  |- mesh__recordAuthorizer mesh__D020601 sjn
% 213.54/213.70  |- skos__scopeNote mesh__D020601
% 213.54/213.70       A species of METHYLOBACTERIUM which can utilize acetate, ethanol, or methylamine as a sole carbon source. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 213.54/213.70  |- skos__annotation mesh__D020601 DF: METHYLOBACT EXTORQUENS   
% 213.54/213.70  |- mesh__dateRevised mesh__D020601 2005-06-30
% 213.54/213.70  |- mesh__historyNote mesh__D020601 2000   
% 213.54/213.70  |- mesh__dateCreated mesh__D020601 1999-11-03
% 213.54/213.70  |- skos__broader mesh__D020601smesh__D020580
% 213.54/213.70  |- mesh__dateEstablished mesh__D006132 1984-01-01
% 213.54/213.70  |- skos__hiddenLabel mesh__D006132 Plate, Growth
% 213.54/213.70  |- mesh__publicMeSHNote mesh__D006132 84   
% 213.54/213.70  |- skos__historyNote mesh__D006132 Cartilage %28%1966-1983%29%
% 213.54/213.70  |- skos__hiddenLabel mesh__D006132 Plates, Growth
% 213.54/213.70  |- rdf__type mesh__D006132sskos__Concept
% 213.54/213.70  |- skos__broader mesh__D006132smesh__D004838
% 213.54/213.70  |- skos__prefLabel mesh__D006132 Growth Plate
% 213.54/213.70  |- mesh__historyNote mesh__D006132 84   
% 213.54/213.70  |- skos__scopeNote mesh__D006132
% 213.54/213.70       The area between the EPIPHYSIS and the DIAPHYSIS within which bone growth occurs.%A%    
% 213.54/213.70  |- skos__hiddenLabel mesh__D006132 Epiphyseal Cartilages
% 213.54/213.70  |- mesh__recordMaintainer mesh__D006132 ags
% 213.54/213.70  |- skos__hiddenLabel mesh__D006132 Cartilages, Epiphyseal
% 213.54/213.70  |- skos__related mesh__D006132smesh__D001846
% 213.54/213.70  |- skos__hiddenLabel mesh__D006132 Plate, Epiphyseal
% 213.54/213.70  |- skos__altLabel mesh__D006132 Epiphyseal Plate
% 213.54/213.70  |- mesh__dateRevised mesh__D006132 2004-07-07
% 213.54/213.70  |- mesh__recordOriginator mesh__D006132 RC
% 213.54/213.70  |- skos__historyNote mesh__D006132 Epiphyses %28%1966-1983%29%
% 213.54/213.70  |- skos__hiddenLabel mesh__D006132 Growth Plates
% 213.54/213.70  |- skos__altLabel mesh__D006132 Cartilage, Epiphyseal
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D006132 2006
% 213.54/213.70  |- skos__altLabel mesh__D006132 Epiphyseal Cartilage
% 213.54/213.70  |- skos__hiddenLabel mesh__D006132 Plates, Epiphyseal
% 213.54/213.70  |- skos__hiddenLabel mesh__D006132 Epiphyseal Plates
% 213.54/213.70  |- mesh__recordAuthorizer mesh__D006132 sjn
% 213.54/213.70  |- mesh__dateCreated mesh__D006132 1983-02-09
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D006132 2005
% 213.54/213.70  |- skos__altLabel mesh__D047549 Beating Heart Coronary Artery Bypass
% 213.54/213.70  |- skos__scopeNote mesh__D047549
% 213.54/213.70       Coronary artery bypass surgery on a beating HEART without a CARDIOPULMONARY BYPASS %28%diverting the flow of blood from the heart and lungs through an oxygenator%29%.%A%    
% 213.54/213.70  |- skos__hiddenLabel mesh__D047549 Coronary Artery Bypass, Off Pump
% 213.54/213.70  |- skos__historyNote mesh__D047549
% 213.54/213.70       Coronary Artery Bypass/methods %28%1996-2004%29%
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D047549 2006
% 213.54/213.70  |- mesh__recordAuthorizer mesh__D047549 sjn
% 213.54/213.70  |- rdf__type mesh__D047549sskos__Concept
% 213.54/213.70  |- skos__altLabel mesh__D047549 Off-Pump Coronary Artery Bypass
% 213.54/213.70  |- skos__hiddenLabel mesh__D047549 Off Pump Coronary Artery Bypass
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D047549 2005
% 213.54/213.70  |- skos__prefLabel mesh__D047549 Coronary Artery Bypass, Off-Pump
% 213.54/213.70  |- mesh__recordMaintainer mesh__D047549 nns
% 213.54/213.70  |- mesh__dateEstablished mesh__D047549 2005-01-01
% 213.54/213.70  |- skos__broader mesh__D047549smesh__D001026
% 213.54/213.70  |- skos__altLabel mesh__D047549 Coronary Artery Bypass, Beating Heart
% 213.54/213.70  |- mesh__historyNote mesh__D047549 2005   
% 213.54/213.70  |- mesh__recordOriginator mesh__D047549 nns
% 213.54/213.70  |- mesh__publicMeSHNote mesh__D047549 2005   
% 213.54/213.70  |- mesh__dateCreated mesh__D047549 2004-07-07
% 213.54/213.70  |- skos__hiddenLabel mesh__D019858 Secretin Cell, Intestinal
% 213.54/213.70  |- mesh__recordOriginator mesh__D019858 AGS
% 213.54/213.70  |- skos__hiddenLabel mesh__D019858 L Cell %28%Intestine%29%
% 213.54/213.70  |- skos__related mesh__D019858smesh__D001078
% 213.54/213.70  |- skos__hiddenLabel mesh__D019858 L Cell, Intestinal
% 213.54/213.70  |- skos__hiddenLabel mesh__D019858 Gut Secretin Cell
% 213.54/213.70  |- skos__altLabel mesh__D019858 Endocrine Cells of Gut
% 213.54/213.70  |- skos__scopeNote mesh__D019858
% 213.54/213.70       Cells found throughout the lining of the GASTROINTESTINAL TRACT that contain and secrete regulatory PEPTIDE HORMONES and/or BIOGENIC AMINES.%A%    
% 213.54/213.70  |- skos__hiddenLabel mesh__D019858 S Cell %28%Intestine%29%
% 213.54/213.70  |- mesh__publicMeSHNote mesh__D019858
% 213.54/213.70       2006; see ENDOCRINE CELLS OF GUT 1998-2005   
% 213.54/213.70  |- skos__broader mesh__D019858smesh__D004703
% 213.54/213.70  |- skos__altLabel mesh__D019858 S Cells %28%Intestine%29%
% 213.54/213.70  |- skos__hiddenLabel mesh__D019858 Gut Endocrine Cells
% 213.54/213.70  |- skos__hiddenLabel mesh__D019858 Gut Endocrine Cell
% 213.54/213.70  |- mesh__recordMaintainer mesh__D019858 lkt
% 213.54/213.70  |- skos__hiddenLabel mesh__D019858 Intestinal L Cell
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D019858 2006
% 213.54/213.70  |- skos__hiddenLabel mesh__D019858 Gut Secretin Cells
% 213.54/213.70  |- mesh__recordAuthorizer mesh__D019858 sjn
% 213.54/213.70  |- skos__hiddenLabel mesh__D019858 Gastrointestinal Endocrine Cell
% 213.54/213.70  |- skos__historyNote mesh__D019858 APUD Cells %28%1977-1997%29%
% 213.54/213.70  |- skos__hiddenLabel mesh__D019858 Enteroendocrine Cell
% 213.54/213.70  |- mesh__dateEstablished mesh__D019858 1998-01-01
% 213.54/213.70  |- skos__altLabel mesh__D019858 L Cells %28%Intestine%29%
% 213.54/213.70  |- skos__hiddenLabel mesh__D019858 L Cells, Intestinal
% 213.54/213.70  |- skos__historyNote mesh__D019858 Endocrine Glands %28%1973-1997%29%
% 213.54/213.70  |- rdf__type mesh__D019858sskos__Concept
% 213.54/213.70  |- skos__broader mesh__D019858smesh__D004847
% 213.54/213.70  |- mesh__dateRevised mesh__D019858 2005-06-30
% 213.54/213.70  |- skos__hiddenLabel mesh__D019858 Intestinal Secretin Cell
% 213.54/213.70  |- skos__prefLabel mesh__D019858 Enteroendocrine Cells
% 213.54/213.70  |- skos__hiddenLabel mesh__D019858 Secretin Cells, Intestinal
% 213.54/213.70  |- skos__altLabel mesh__D019858 Endocrine Cells, Gastrointestinal
% 213.54/213.70  |- skos__altLabel mesh__D019858 Secretin Cells of Gut
% 213.54/213.70  |- skos__annotation mesh__D019858
% 213.54/213.70       %22%endocrine cells%22% of Russian literature probably goes here%A%  
% 213.54/213.70  |- mesh__dateCreated mesh__D019858 1997-06-20
% 213.54/213.70  |- skos__hiddenLabel mesh__D019858 Endocrine Cell, Gastrointestinal
% 213.54/213.70  |- skos__hiddenLabel mesh__D019858 Gastrointestinal Endocrine Cells
% 213.54/213.70  |- mesh__historyNote mesh__D019858 2006 %28%1998%29%   
% 213.54/213.70  |- skos__hiddenLabel mesh__D011875 Angiographies, Radionuclide
% 213.54/213.70  |- mesh__recordMaintainer mesh__D011875 PXP
% 213.54/213.70  |- mesh__recordAuthorizer mesh__D011875 SJN
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D011875 2002
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D011875 1999
% 213.54/213.70  |- skos__historyNote mesh__D011875
% 213.54/213.70       specific disease/radionuclide imaging %28%1978-1986%29%
% 213.54/213.70  |- skos__altLabel mesh__D011875 Radioisotope Angiography
% 213.54/213.70  |- mesh__publicMeSHNote mesh__D011875 87   
% 213.54/213.70  |- skos__prefLabel mesh__D011875 Radionuclide Angiography
% 213.54/213.70  |- skos__altLabel mesh__D011875 Angiography, Radionuclide
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D011875 2006
% 213.54/213.70  |- mesh__dateEstablished mesh__D011875 1987-01-01
% 213.54/213.70  |- mesh__dateCreated mesh__D011875 1986-06-20
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D011875 1998
% 213.54/213.70  |- skos__historyNote mesh__D011875 Angiocardiography %28%1966-1986%29%
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D011875 2004
% 213.54/213.70  |- mesh__recordOriginator mesh__D011875 SH
% 213.54/213.70  |- skos__altLabel mesh__D011875 Angiography, Radioisotope
% 213.54/213.70  |- skos__hiddenLabel mesh__D011875 Radionuclide Angiographies
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D011875 2005
% 213.54/213.70  |- skos__hiddenLabel mesh__D011875 Angiographies, Radioisotope
% 213.54/213.70  |- mesh__historyNote mesh__D011875 87   
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D011875 2001
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D011875 2003
% 213.54/213.70  |- skos__historyNote mesh__D011875
% 213.54/213.70       specific organ/radionuclide imaging %28%1978-1986%29%
% 213.54/213.70  |- rdf__type mesh__D011875sskos__Concept
% 213.54/213.70  |- skos__hiddenLabel mesh__D011875 Radioisotope Angiographies
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D011875 2000
% 213.54/213.70  |- skos__scopeNote mesh__D011875
% 213.54/213.70       The measurement of visualization by radiation of any organ after a radionuclide has been injected into its blood supply. It is used to diagnose heart, liver, lung, and other diseases and to measure the function of those organs, except renography, for which RADIOISOTOPE RENOGRAPHY is available.%A%    
% 213.54/213.70  |- skos__annotation mesh__D011875
% 213.54/213.70       a specific diag technique: read MeSH definition; NIM; coord with disease /radionuclide, not /diag %26% not /radiogr; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: RADIONUCLIDE ANGIOGR%A%  
% 213.54/213.70  |- skos__broader mesh__D011875smesh__D011877
% 213.54/213.70  |- mesh__dateRevised mesh__D011875 1997-06-20
% 213.54/213.70  |- skos__broader mesh__D011875smesh__D000792
% 213.54/213.70  |- skos__broader mesh__D011077smesh__D000845
% 213.54/213.70  |- mesh__dateCreated mesh__D011077 1974-11-19
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D011077 2005
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D011077 2004
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D011077 2006
% 213.54/213.70  |- skos__scopeNote mesh__D011077
% 213.54/213.70       A class of marine annelids including sandworms, tube worms, clamworms, and fire worms. It includes also the genus Myxicola infundibulum.%A%    
% 213.54/213.70  |- mesh__recordMaintainer mesh__D011077 ags
% 213.54/213.70  |- skos__historyNote mesh__D011077 Annelida %28%1966-1974%29%
% 213.54/213.70  |- mesh__recordAuthorizer mesh__D011077 sjn
% 213.54/213.70  |- mesh__historyNote mesh__D011077 75   
% 213.54/213.70  |- mesh__recordOriginator mesh__D011077 NLM
% 213.54/213.70  |- mesh__dateRevised mesh__D011077 2003-07-09
% 213.54/213.70  |- rdf__type mesh__D011077sskos__Concept
% 213.54/213.70  |- mesh__dateEstablished mesh__D011077 1975-09-01
% 213.54/213.70  |- skos__prefLabel mesh__D011077 Polychaeta
% 213.54/213.70  |- mesh__publicMeSHNote mesh__D011077 75   
% 213.54/213.70  |- skos__annotation mesh__D011077
% 213.54/213.70       marine worms; /microbiol /parasitol /virol permitted   
% 213.54/213.70  |- mesh__recordOriginator mesh__D005838 NLM
% 213.54/213.70  |- mesh__publicMeSHNote mesh__D005838 68   
% 213.54/213.70  |- skos__prefLabel mesh__D005838 Genotype
% 213.54/213.70  |- skos__broader mesh__D005838smesh__D040341
% 213.54/213.70  |- skos__scopeNote mesh__D005838
% 213.54/213.70       The genetic constitution of the individual; the characterization of the genes.%A%    
% 213.54/213.70  |- mesh__historyNote mesh__D005838 68   
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D005838 2003
% 213.54/213.70  |- skos__hiddenLabel mesh__D005838 Genotypes
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D005838 2004
% 213.54/213.70  |- mesh__recordMaintainer mesh__D005838 TGC
% 213.54/213.70  |- skos__historyNote mesh__D005838 Genetics %28%1966-1967%29%
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D005838 2005
% 213.54/213.70  |- mesh__dateEstablished mesh__D005838 1968-01-01
% 213.54/213.70  |- skos__historyNote mesh__D005838 Genes %28%1966-1967%29%
% 213.54/213.70  |- mesh__dateCreated mesh__D005838 1999-01-01
% 213.54/213.70  |- mesh__dateRevised mesh__D005838 2002-07-03
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D005838 2006
% 213.54/213.70  |- rdf__type mesh__D005838sskos__Concept
% 213.54/213.70  |- skos__annotation mesh__D005838 NIM; no qualif   
% 213.54/213.70  |- mesh__recordAuthorizer mesh__D005838 sjn
% 213.54/213.70  |- mesh__dateRevised mesh__D002540 1996-06-10
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D002540 2002
% 213.54/213.70  |- rdf__type mesh__D002540sskos__Concept
% 213.54/213.70  |- mesh__recordAuthorizer mesh__D002540 PLS
% 213.54/213.70  |- mesh__historyNote mesh__D002540
% 213.54/213.70       INSULA OF REIL was see under CEREBRAL CORTEX 1968-78   
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D002540 2004
% 213.54/213.70  |- mesh__dateCreated mesh__D002540 1999-01-01
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D002540 2003
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D002540 1997
% 213.54/213.70  |- skos__hiddenLabel mesh__D002540 Cortex, Cerebral
% 213.54/213.70  |- skos__related mesh__D002540smesh__D013181
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D002540 2001
% 213.54/213.70  |- skos__hiddenLabel mesh__D002540 Cortices, Cerebral
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D002540 2006
% 213.54/213.70  |- mesh__onlineNote mesh__D002540
% 213.54/213.70       use CEREBRAL CORTEX to search INSULA OF REIL 1968-78   
% 213.54/213.70  |- mesh__recordMaintainer mesh__D002540 TGC
% 213.54/213.70  |- skos__scopeNote mesh__D002540
% 213.54/213.70       The thin layer of gray matter on the surface of the cerebral hemisphere that develops from the telencephalon and folds into gyri. It reaches its highest development in man and is responsible for intellectual faculties and higher mental functions.%A%    
% 213.54/213.70  |- skos__prefLabel mesh__D002540 Cerebral Cortex
% 213.54/213.70  |- skos__related mesh__D002540smesh__D002541
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D002540 2005
% 213.54/213.70  |- mesh__recordOriginator mesh__D002540 NLM
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D002540 2000
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D002540 1999
% 213.54/213.70  |- skos__broader mesh__D002540smesh__D013687
% 213.54/213.70  |- skos__related mesh__D002540smesh__D004569
% 213.54/213.70  |- mesh__publicMeSHNote mesh__D002540
% 213.54/213.70       INSULA OF REIL was see under CEREBRAL CORTEX 1968-78   
% 213.54/213.70  |- skos__hiddenLabel mesh__D002540 Reil Insula
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D002540 1998
% 213.54/213.70  |- skos__annotation mesh__D002540 /surg: probably CEREBRAL DECORTICATION   
% 213.54/213.70  |- skos__hiddenLabel mesh__D002540 Cerebral Cortices
% 213.54/213.70  |- mesh__historyNote mesh__D015468 89   
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D015468 2002
% 213.54/213.70  |- mesh__publicMeSHNote mesh__D015468 89   
% 213.54/213.70  |- skos__altLabel mesh__D015468 Leukemia, Myeloid, Ph1 Negative
% 213.54/213.70  |- skos__broader mesh__D015468smesh__D007951
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D015468 2003
% 213.54/213.70  |- skos__hiddenLabel mesh__D015468 Leukemia, Philadelphia-Negative Myeloid
% 213.54/213.70  |- skos__altLabel mesh__D015468 Leukemia, Myelogenous, Ph1 Negative
% 213.54/213.70  |- skos__related mesh__D015468smesh__D010677
% 213.54/213.70  |- skos__historyNote mesh__D015468
% 213.54/213.70       Philadelphia Chromosome %28%1986-1988%29%
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D015468 1999
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D015468 1996
% 213.54/213.70  |- skos__annotation mesh__D015468
% 213.54/213.70       %22%Philadelphia%22% refers to the Philadelphia chromosome; do not use /blood supply /chem /second /secret /ultrastruct; DF: LEUKEMIA PHILA NEG%A%  
% 213.54/213.70  |- skos__altLabel mesh__D015468 Myelogenous Leukemia, Ph1-Negative
% 213.54/213.70  |- skos__hiddenLabel mesh__D015468 Myeloid Leukemias, Ph1-Negative
% 213.54/213.70  |- mesh__recordOriginator mesh__D015468 PLS
% 213.54/213.70  |- mesh__dateRevised mesh__D015468 1995-06-08
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D015468 2004
% 213.54/213.70  |- skos__hiddenLabel mesh__D015468 Leukemias, Ph1-Negative Myeloid
% 213.54/213.70  |- skos__altLabel mesh__D015468 Leukemia, Myeloid, Ph1-Negative
% 213.54/213.70  |- skos__hiddenLabel mesh__D015468 Philadelphia-Negative Myeloid Leukemia
% 213.54/213.70  |- skos__hiddenLabel mesh__D015468 Ph1-Negative Myeloid Leukemia
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D015468 1997
% 213.54/213.70  |- skos__altLabel mesh__D015468 Myeloid Leukemia, Ph1-Negative
% 213.54/213.70  |- skos__hiddenLabel mesh__D015468 Leukemias, Ph1-Negative Myelogenous
% 213.54/213.70  |- skos__historyNote mesh__D015468 Leukemia, Myeloid %28%1966-1988%29%
% 213.54/213.70  |- skos__altLabel mesh__D015468 Leukemia, Myeloid, Philadelphia Negative
% 213.54/213.70  |- skos__altLabel mesh__D015468 Leukemia, Myelogenous, Ph1-Negative
% 213.54/213.70  |- skos__hiddenLabel mesh__D015468 Leukemias, Philadelphia-Negative Myeloid
% 213.54/213.70  |- mesh__recordAuthorizer mesh__D015468 PLS
% 213.54/213.70  |- skos__hiddenLabel mesh__D015468 Leukemia, Ph1-Negative Myeloid
% 213.54/213.70  |- skos__historyNote mesh__D015468 Leukemia, Myelocytic %28%1966-1988%29%
% 213.54/213.70  |- skos__hiddenLabel mesh__D015468 Philadelphia-Negative Myeloid Leukemias
% 213.54/213.70  |- mesh__recordMaintainer mesh__D015468 KEV
% 213.54/213.70  |- skos__hiddenLabel mesh__D015468 Ph1-Negative Myelogenous Leukemia
% 213.54/213.70  |- skos__hiddenLabel mesh__D015468 Ph1-Negative Myeloid Leukemias
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D015468 2000
% 213.54/213.70  |- skos__hiddenLabel mesh__D015468 Myeloid Leukemia, Ph1 Negative
% 213.54/213.70  |- skos__altLabel mesh__D015468 Myeloid Leukemia, Philadelphia-Negative
% 213.54/213.70  |- skos__hiddenLabel mesh__D015468 Leukemia, Ph1-Negative Myelogenous
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D015468 2005
% 213.54/213.70  |- skos__hiddenLabel mesh__D015468 Myelogenous Leukemias, Ph1-Negative
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D015468 2001
% 213.54/213.70  |- skos__hiddenLabel mesh__D015468 Ph1-Negative Myelogenous Leukemias
% 213.54/213.70  |- mesh__dateEstablished mesh__D015468 1988-01-01
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D015468 1998
% 213.54/213.70  |- mesh__dateCreated mesh__D015468 1988-06-09
% 213.54/213.70  |- skos__hiddenLabel mesh__D015468 Myeloid Leukemias, Philadelphia-Negative
% 213.54/213.70  |- skos__prefLabel mesh__D015468 Leukemia, Myeloid, Philadelphia-Negative
% 213.54/213.70  |- skos__hiddenLabel mesh__D015468 Myelogenous Leukemia, Ph1 Negative
% 213.54/213.70  |- rdf__type mesh__D015468sskos__Concept
% 213.54/213.70  |- skos__hiddenLabel mesh__D015468 Myeloid Leukemia, Philadelphia Negative
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D015468 2006
% 213.54/213.70  |- skos__prefLabel mesh__D034622 RNA Interference
% 213.54/213.70  |- skos__hiddenLabel mesh__D034622 Silencing, Post-Transcriptional Gene
% 213.54/213.70  |- skos__hiddenLabel mesh__D034622 Interference, RNA
% 213.54/213.70  |- mesh__dateCreated mesh__D034622 2002-07-03
% 213.54/213.70  |- skos__hiddenLabel mesh__D034622 Gene Silencing, Post Transcriptional
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D034622 2006
% 213.54/213.70  |- rdf__type mesh__D034622sskos__Concept
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D034622 2004
% 213.54/213.70  |- skos__altLabel mesh__D034622 Post-Transcriptional Gene Silencing
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D034622 2005
% 213.54/213.70  |- skos__hiddenLabel mesh__D034622 Posttranscriptional Gene Silencings
% 213.54/213.70  |- skos__hiddenLabel mesh__D034622 Post Transcriptional Gene Silencing
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D034622 2003
% 213.54/213.70  |- skos__hiddenLabel mesh__D034622 RNA Interferences
% 213.54/213.70  |- skos__scopeNote mesh__D034622
% 213.54/213.70       A gene silencing phenomenon whereby specific dsRNAs %28%RNA, DOUBLE-STRANDED%29% trigger the degradation of homologous mRNA %28%RNA, MESSENGER%29%. The specific dsRNAs are processed into SMALL INTERFERING RNA %28%siRNA%29% which serves as a guide for cleavage of the homologous mRNA in the RNA-INDUCED SILENCING COMPLEX %28%RISC%29%. DNA METHYLATION may also be triggered during this process.%A%    
% 213.54/213.70  |- skos__altLabel mesh__D034622 Gene Silencing, Post-Transcriptional
% 213.54/213.70  |- mesh__publicMeSHNote mesh__D034622 2003   
% 213.54/213.70  |- skos__broader mesh__D034622smesh__D020868
% 213.54/213.70  |- mesh__historyNote mesh__D034622 2003   
% 213.54/213.70  |- skos__hiddenLabel mesh__D034622 Post-Transcriptional Gene Silencings
% 213.54/213.70  |- skos__hiddenLabel mesh__D034622 Gene Silencings, Post-Transcriptional
% 213.54/213.70  |- skos__related mesh__D034622smesh__D034741
% 213.54/213.70  |- skos__hiddenLabel mesh__D034622 RNA Silencings
% 213.54/213.70  |- skos__related mesh__D034622smesh__D034743
% 213.54/213.70  |- skos__altLabel mesh__D034622 RNA Silencing
% 213.54/213.70  |- mesh__dateEstablished mesh__D034622 2003-01-01
% 213.54/213.70  |- skos__hiddenLabel mesh__D034622 Gene Silencings, Posttranscriptional
% 213.54/213.70  |- skos__hiddenLabel mesh__D034622 Gene Silencing, Posttranscriptional
% 213.54/213.70  |- skos__altLabel mesh__D034622 Posttranscriptional Gene Silencing
% 213.54/213.70  |- skos__hiddenLabel mesh__D034622 Interferences, RNA
% 213.54/213.70  |- mesh__dateRevised mesh__D001448 2003-07-09
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D001448 2006
% 213.54/213.70  |- rdf__type mesh__D001448sskos__Concept
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D001448 2005
% 213.54/213.70  |- mesh__recordOriginator mesh__D001448 NLM
% 213.54/213.70  |- skos__annotation mesh__D001448
% 213.54/213.70       infection = BALANTIDIASIS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 213.54/213.70  |- skos__prefLabel mesh__D001448 Balantidium
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D001448 2004
% 213.54/213.70  |- skos__scopeNote mesh__D001448
% 213.54/213.70       A genus of protozoa parasitic in the digestive tract of vertebrate or invertebrate hosts. Asexual multiplication is accomplished by transverse binary fission. Its organisms are ovoidal in shape and have a ciliated covering over the entire body.%A%    
% 213.54/213.70  |- mesh__recordMaintainer mesh__D001448 ags
% 213.54/213.70  |- mesh__recordAuthorizer mesh__D001448 sjn
% 213.54/213.70  |- mesh__dateCreated mesh__D001448 1999-01-01
% 213.54/213.70  |- skos__broader mesh__D001448smesh__D016801
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D012170 2004
% 213.54/213.70  |- skos__hiddenLabel mesh__D012170 Occlusion, Retinal Vein
% 213.54/213.70  |- mesh__dateEstablished mesh__D012170 1987-01-01
% 213.54/213.70  |- rdf__type mesh__D012170sskos__Concept
% 213.54/213.70  |- skos__historyNote mesh__D012170 Retinal Vein %28%1973-1986%29%
% 213.54/213.70  |- skos__scopeNote mesh__D012170
% 213.54/213.70       Occlusion of the retinal vein. Those at high risk for this condition include patients with hypertension, diabetes mellitus, arteriosclerosis, and other cardiovascular diseases.%A%    
% 213.54/213.70  |- skos__historyNote mesh__D012170 Retinal Diseases %28%1972-1986%29%
% 213.54/213.70  |- skos__hiddenLabel mesh__D012170 Vein Thrombosis, Retinal
% 213.54/213.70  |- skos__hiddenLabel mesh__D012170 Retinal Vein Thromboses
% 213.54/213.70  |- mesh__publicMeSHNote mesh__D012170 87   
% 213.54/213.70  |- skos__prefLabel mesh__D012170 Retinal Vein Occlusion
% 213.54/213.70  |- skos__hiddenLabel mesh__D012170 Vein Occlusions, Retinal
% 213.54/213.70  |- mesh__recordMaintainer mesh__D012170 ags
% 213.54/213.70  |- skos__hiddenLabel mesh__D012170 Occlusions, Retinal Vein
% 213.54/213.70  |- mesh__dateRevised mesh__D012170 2002-07-03
% 213.54/213.70  |- skos__broader mesh__D012170smesh__D012164
% 213.54/213.70  |- skos__related mesh__D012170smesh__D031300
% 213.54/213.70  |- mesh__historyNote mesh__D012170 87   
% 213.54/213.70  |- mesh__recordAuthorizer mesh__D012170 sjn
% 213.54/213.70  |- skos__broader mesh__D012170smesh__D020246
% 213.54/213.70  |- skos__hiddenLabel mesh__D012170 Vein Thromboses, Retinal
% 213.54/213.70  |- skos__hiddenLabel mesh__D012170 Vein Occlusion, Retinal
% 213.54/213.70  |- mesh__recordOriginator mesh__D012170 VDK
% 213.54/213.70  |- skos__hiddenLabel mesh__D012170 Retinal Vein Occlusions
% 213.54/213.70  |- skos__altLabel mesh__D012170 Thrombosis, Retinal Vein
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D012170 2005
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D012170 2003
% 213.54/213.70  |- skos__broader mesh__D012170smesh__D014652
% 213.54/213.70  |- skos__hiddenLabel mesh__D012170 Thromboses, Retinal Vein
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D012170 2006
% 213.54/213.70  |- mesh__dateCreated mesh__D012170 1986-04-18
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D006931 2004
% 213.54/213.70  |- skos__altLabel mesh__D006931 Oxygenation, Hyperbaric
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D006931 2000
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D006931 2005A
% 213.54/213.70  |- rdf__type mesh__D006931sskos__Concept
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D006931 2003
% 213.54/213.70  |- mesh__publicMeSHNote mesh__D006931 65   
% 213.54/213.70  |- mesh__dateCreated mesh__D006931 1999-01-01
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D006931 2006
% 213.54/213.70  |- skos__annotation mesh__D006931
% 213.54/213.70       do not use /util except by MeSH definition; coord IM with disease /ther %28%IM%29%, not /drug ther%A%  
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D006931 1997
% 213.54/213.70  |- mesh__recordAuthorizer mesh__D006931 jls
% 213.54/213.70  |- mesh__historyNote mesh__D006931 65%28%64%29%   
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D006931 2002
% 213.54/213.70  |- skos__scopeNote mesh__D006931
% 213.54/213.70       The therapeutic intermittent administration of oxygen in a chamber at greater than sea-level atmospheric pressures %28%three atmospheres%29%. It is considered effective treatment for air and gas embolisms, smoke inhalation, acute carbon monoxide poisoning, caisson disease, clostridial gangrene, etc. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D006931 2005
% 213.54/213.70  |- skos__broader mesh__D006931smesh__D010102
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D006931 1996
% 213.54/213.70  |- mesh__recordOriginator mesh__D006931 NLM
% 213.54/213.70  |- skos__prefLabel mesh__D006931 Hyperbaric Oxygenation
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D006931 1999
% 213.54/213.70  |- skos__hiddenLabel mesh__D006931 Oxygenations, Hyperbaric
% 213.54/213.70  |- skos__hiddenLabel mesh__D006931 Hyperbaric Oxygenations
% 213.54/213.70  |- mesh__dateRevised mesh__D006931 2004-07-28
% 213.54/213.70  |- mesh__recordMaintainer mesh__D006931 jls
% 213.54/213.70  |- mesh__dateEstablished mesh__D006931 1965-01-01
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D006931 2001
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D006931 1998
% 213.54/213.70  |- mesh__recordOriginator mesh__D020602 ndw
% 213.54/213.70  |- skos__prefLabel mesh__D020602 Methylosinus trichosporium
% 213.54/213.70  |- mesh__dateCreated mesh__D020602 1999-11-03
% 213.54/213.70  |- rdf__type mesh__D020602sskos__Concept
% 213.54/213.70  |- mesh__dateEstablished mesh__D020602 2000-01-01
% 213.54/213.70  |- mesh__activeMeSHYear mesh__D020602 2006
% 213.54/213.70  |- skos__scopeNote mesh__D020602
% 213.54/213.70       A species of METHYLOSINUS which is capable of degrading trichloroethylene and other organic pollutants.%A%    
% 213.54/213.70  |- mesh__historyNote mesh__D020602 2000   
% 213.54/213.70  |- mesh__publicMeSHNote mesh__D020602 2000   
% 213.54/213.70  |- mesh__recordAuthorizer mesh__D020602 sjn
% 213.54/213.70  |- mesh__dateRevised mesh__D020602 2005-06-30
% 213.54/213.70  |- skos__broader mesh__D020602smesh__D020581
% 213.54/213.70  |- mesh__recordMaintainer mesh__D020602 SYSTEM
% 213.54/213.70  |- mesh__recordMaintainer mesh__D006133 ssb
% 213.54/213.70  |- skos__hiddenLabel mesh__D006133 Factor, Growth
% 213.54/213.70  |- skos__prefLabel mesh__D006133 Growth Substances
% 213.54/213.70  |- skos__annotation mesh__D006133 GEN or unspecified: prefer specifics   
% 213.54/213.70  |- skos__broader mesh__D006133smesh__D045505
% 213.54/213.70  |- skos__hiddenLabel mesh__D006133 Substances, Growth
% 213.54/213.70  |- mesh__recordOriginator mesh__D006133 NLM
% 213.54/213.70  |- mesh__recordAuthorizer mesh__D006133 sjn
% 213.54/213.70  |- skos__altLabel mesh__D006133 Growth Factors
% 213.54/213.71  |- skos__broader mesh__D006133smesh__D016207
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D006133 2006
% 213.54/213.71  |- skos__altLabel mesh__D006133 Growth Factor
% 213.54/213.71  |- skos__scopeNote mesh__D006133
% 213.54/213.71       Signal molecules that are involved in the control of cell growth and differentiation.%A%    
% 213.54/213.71  |- skos__related mesh__D006133smesh__D017978
% 213.54/213.71  |- skos__hiddenLabel mesh__D006133 Factors, Growth
% 213.54/213.71  |- skos__broader mesh__D006133smesh__D001685
% 213.54/213.71  |- rdf__type mesh__D006133sskos__Concept
% 213.54/213.71  |- mesh__dateCreated mesh__D006133 1999-01-01
% 213.54/213.71  |- mesh__dateRevised mesh__D006133 2005-06-30
% 213.54/213.71  |- skos__hiddenLabel mesh__D006133 Endogenous Mitogens
% 213.54/213.71  |- skos__broader mesh__D019859smesh__D011518
% 213.54/213.71  |- skos__altLabel mesh__D019859 met Proto-Oncogene Proteins
% 213.54/213.71  |- mesh__recordOriginator mesh__D019859 KEV
% 213.54/213.71  |- skos__broader mesh__D019859smesh__D020794
% 213.54/213.71  |- skos__hiddenLabel mesh__D019859 Proto-Oncogene Proteins, met
% 213.54/213.71  |- skos__prefLabel mesh__D019859 Proto-Oncogene Proteins c-met
% 213.54/213.71  |- skos__altLabel mesh__D019859 Receptor, HGF
% 213.54/213.71  |- mesh__recordAuthorizer mesh__D019859 sjn
% 213.54/213.71  |- mesh__recordMaintainer mesh__D019859 sjn
% 213.54/213.71  |- skos__hiddenLabel mesh__D019859 c met Proteins
% 213.54/213.71  |- mesh__dateEstablished mesh__D019859 1998-01-01
% 213.54/213.71  |- skos__altLabel mesh__D019859 Receptor, Hepatocyte Growth Factor
% 213.54/213.71  |- rdf__type mesh__D019859sskos__Concept
% 213.54/213.71  |- mesh__historyNote mesh__D019859 2006%28%1998%29%   
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D019859 2006
% 213.54/213.71  |- skos__annotation mesh__D019859 DF: C MET PROTEINS   
% 213.54/213.71  |- skos__broader mesh__D019859smesh__D017978
% 213.54/213.71  |- mesh__dateRevised mesh__D019859 2005-07-01
% 213.54/213.71  |- skos__altLabel mesh__D019859 Receptor, Scatter Factor
% 213.54/213.71  |- mesh__publicMeSHNote mesh__D019859
% 213.54/213.71       2006; PROTO-ONCOGENE PROTEIN C-MET was indexed under RECEPTOR PROTEIN-TYROSINE KINASE 1994-1997 %26% PROTO-ONCOGENE PROTEINS 1989-1993%A%  
% 213.54/213.71  |- skos__scopeNote mesh__D019859
% 213.54/213.71       Cell surface protein-tyrosine kinase receptors for HEPATOCYTE GROWTH FACTOR. They consists of an extracellular alpha chain which is disulfide-linked to the transmembrane beta chain. The cytoplasmic portion contains the catalytic domain and sites critical for the regulation of kinase activity. Mutations of the gene for PROTO-ONCOGENE PROTEINS C-MET are associated with papillary renal carcinoma and other neoplasia.%A%    
% 213.54/213.71  |- skos__altLabel mesh__D019859 Scatter Factor Receptor
% 213.54/213.71  |- skos__altLabel mesh__D019859 HGF Receptor
% 213.54/213.71  |- skos__altLabel mesh__D019859 Hepatocyte Growth Factor Receptor
% 213.54/213.71  |- skos__hiddenLabel mesh__D019859 Proto Oncogene Proteins c met
% 213.54/213.71  |- mesh__dateCreated mesh__D019859 1997-06-20
% 213.54/213.71  |- skos__altLabel mesh__D019859 c-met Proteins
% 213.54/213.71  |- skos__hiddenLabel mesh__D019859 met Proto Oncogene Proteins
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011876 2001
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011876 1998
% 213.54/213.71  |- mesh__publicMeSHNote mesh__D011876 79   
% 213.54/213.71  |- mesh__dateRevised mesh__D011876 1992-05-18
% 213.54/213.71  |- mesh__dateEstablished mesh__D011876 1979-01-01
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011876 2004
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011876 1996
% 213.54/213.71  |- skos__hiddenLabel mesh__D011876 Generator, Radioisotope
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011876 2005
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011876 2000
% 213.54/213.71  |- skos__hiddenLabel mesh__D011876 Radioisotope Generator
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011876 2003
% 213.54/213.71  |- rdf__type mesh__D011876sskos__Concept
% 213.54/213.71  |- skos__broader mesh__D011876smesh__D009686
% 213.54/213.71  |- skos__annotation mesh__D011876 IM   
% 213.54/213.71  |- skos__scopeNote mesh__D011876
% 213.54/213.71       Separation systems containing a relatively long-lived parent radionuclide which produces a short-lived daughter in its decay scheme. The daughter can be periodically extracted %28%milked%29% by means of an appropriate eluting agent.%A%    
% 213.54/213.71  |- skos__hiddenLabel mesh__D011876 Radionuclide Generator
% 213.54/213.71  |- skos__historyNote mesh__D011876 Radioisotopes %28%1966-1978%29%
% 213.54/213.71  |- skos__prefLabel mesh__D011876 Radionuclide Generators
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011876 2002
% 213.54/213.71  |- skos__hiddenLabel mesh__D011876 Generator, Radionuclide
% 213.54/213.71  |- mesh__recordAuthorizer mesh__D011876 PLS
% 213.54/213.71  |- mesh__dateCreated mesh__D011876 1978-05-19
% 213.54/213.71  |- skos__hiddenLabel mesh__D011876 Generators, Radionuclide
% 213.54/213.71  |- mesh__historyNote mesh__D011876 79   
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011876 1995
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011876 1993
% 213.54/213.71  |- skos__hiddenLabel mesh__D011876 Generators, Radioisotope
% 213.54/213.71  |- skos__altLabel mesh__D011876 Radioisotope Generators
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011876 1999
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011876 1994
% 213.54/213.71  |- mesh__recordMaintainer mesh__D011876 TAP
% 213.54/213.71  |- mesh__recordOriginator mesh__D011876 VDK
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011876 1997
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011876 2006
% 213.54/213.71  |- skos__annotation mesh__D011078
% 213.54/213.71       %22%yusho poisoning%22%: see note on RICE   
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011078 2004
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011078 2001
% 213.54/213.71  |- mesh__dateRevised mesh__D011078 1998-06-10
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011078 2006
% 213.54/213.71  |- mesh__publicMeSHNote mesh__D011078
% 213.54/213.71       92; was POLYCHLOROBIPHENYL COMPOUNDS 1973-91   
% 213.54/213.71  |- skos__hiddenLabel mesh__D011078 Biphenyls, Polychlorinated
% 213.54/213.71  |- mesh__recordAuthorizer mesh__D011078 SJN
% 213.54/213.71  |- mesh__dateCreated mesh__D011078 1999-01-01
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011078 1999
% 213.54/213.71  |- skos__broader mesh__D011078smesh__D001713
% 213.54/213.71  |- skos__historyNote mesh__D011078 Biphenyl Compounds %28%1966-1970%29%
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011078 2002
% 213.54/213.71  |- rdf__type mesh__D011078sskos__Concept
% 213.54/213.71  |- skos__broader mesh__D011078smesh__D006843
% 213.54/213.71  |- mesh__dateEstablished mesh__D011078 1973-01-01
% 213.54/213.71  |- skos__altLabel mesh__D011078 PCBs
% 213.54/213.71  |- mesh__recordOriginator mesh__D011078 NLM
% 213.54/213.71  |- mesh__historyNote mesh__D011078
% 213.54/213.71       92; was POLYCHLOROBIPHENYL COMPOUNDS 1971-91 %28%Prov 1971-72%29%%A%  
% 213.54/213.71  |- skos__scopeNote mesh__D011078
% 213.54/213.71       Industrial products consisting of a mixture of chlorinated biphenyl congeners and isomers. These compounds are highly lipophilic and tend to accumulate in fat stores of animals. Many of these compounds are considered toxic and potential environmental pollutants.%A%    
% 213.54/213.71  |- skos__prefLabel mesh__D011078 Polychlorinated Biphenyls
% 213.54/213.71  |- skos__hiddenLabel mesh__D011078 Compounds, Polychlorobiphenyl
% 213.54/213.71  |- mesh__onlineNote mesh__D011078
% 213.54/213.71       use POLYCHLORINATED BIPHENYLS to search POLYCHLOROBIPHENYL COMPOUNDS 1971-91 %28%as Prov 1971-72%29%%A%  
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011078 2003
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011078 2000
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011078 2005
% 213.54/213.71  |- mesh__recordMaintainer mesh__D011078 JAG
% 213.54/213.71  |- skos__altLabel mesh__D011078 Polychlorobiphenyl Compounds
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D005839 2006
% 213.54/213.71  |- rdf__type mesh__D005839sskos__Concept
% 213.54/213.71  |- skos__altLabel mesh__D005839 Gentamycins
% 213.54/213.71  |- mesh__dateRevised mesh__D005839 2005-08-02
% 213.54/213.71  |- mesh__dateEstablished mesh__D005839 1966-01-01
% 213.54/213.71  |- skos__altLabel mesh__D005839 Gentamycin
% 213.54/213.71  |- skos__hiddenLabel mesh__D005839 GMyticin
% 213.54/213.71  |- skos__hiddenLabel mesh__D005839 Sulfate, Gentamicin
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D005839 2005
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D005839 2006A
% 213.54/213.71  |- skos__hiddenLabel mesh__D005839 G Myticin
% 213.54/213.71  |- mesh__recordOriginator mesh__D005839 NLM
% 213.54/213.71  |- mesh__recordMaintainer mesh__D005839 ags
% 213.54/213.71  |- skos__prefLabel mesh__D005839 Gentamicins
% 213.54/213.71  |- mesh__historyNote mesh__D005839
% 213.54/213.71       78; was GENTAMICIN 1963-77 %28%Prov 1963-65%29%   
% 213.54/213.71  |- mesh__dateCreated mesh__D005839 1999-01-01
% 213.54/213.71  |- skos__broader mesh__D005839smesh__D000617
% 213.54/213.71  |- skos__altLabel mesh__D005839 Gentamicin
% 213.54/213.71  |- skos__scopeNote mesh__D005839
% 213.54/213.71       A complex of three different closely related aminoglycoside sulfates, Gentamicins C1, C2, and C1%28%subA%29%, obtained from Micromonospora purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit protein synthesis %28%GENETIC TRANSLATION%29%.%A%    
% 213.54/213.71  |- mesh__onlineNote mesh__D005839
% 213.54/213.71       use GENTAMICINS to search GENTAMICIN 1966-77   
% 213.54/213.71  |- mesh__recordAuthorizer mesh__D005839 ags
% 213.54/213.71  |- mesh__publicMeSHNote mesh__D005839 78; was GENTAMICIN 1966-77   
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D002541 2003
% 213.54/213.71  |- skos__hiddenLabel mesh__D002541 Decortication, Cerebral
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D002541 2000
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D002541 2006
% 213.54/213.71  |- mesh__recordOriginator mesh__D002541 NLM
% 213.54/213.71  |- mesh__historyNote mesh__D002541
% 213.54/213.71       82; was CEREBRAL CORTEX DECORTICATION 1965-81   
% 213.54/213.71  |- mesh__recordMaintainer mesh__D002541 PXP
% 213.54/213.71  |- skos__prefLabel mesh__D002541 Cerebral Decortication
% 213.54/213.71  |- mesh__dateEstablished mesh__D002541 1965-01-01
% 213.54/213.71  |- skos__hiddenLabel mesh__D002541 Cortex Decortication, Cerebral
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D002541 2005
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D002541 1999
% 213.54/213.71  |- skos__hiddenLabel mesh__D002541 Decortications, Cerebral Cortex
% 213.54/213.71  |- skos__annotation mesh__D002541
% 213.54/213.71       %22%partial or total removal, ablation or destruction of the cerebral cortex; may be chemical%22%; usually exper; coord IM or NIM with specific part of brain with probably /physiol %28%IM%29%%A%  
% 213.54/213.71  |- mesh__publicMeSHNote mesh__D002541
% 213.54/213.71       82; was CEREBRAL CORTEX DECORTICATION 1965-81   
% 213.54/213.71  |- mesh__onlineNote mesh__D002541
% 213.54/213.71       use CEREBRAL DECORTICATION to search CEREBRAL CORTEX DECORTICATION 1966-81%A%  
% 213.54/213.71  |- mesh__dateRevised mesh__D002541 1997-06-20
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D002541 2002
% 213.54/213.71  |- mesh__recordAuthorizer mesh__D002541 SJN
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D002541 1998
% 213.54/213.71  |- skos__altLabel mesh__D002541 Decortication, Cerebral Cortex
% 213.54/213.71  |- skos__hiddenLabel mesh__D002541 Decortications, Cerebral
% 213.54/213.71  |- skos__hiddenLabel mesh__D002541 Cortex Decortications, Cerebral
% 213.54/213.71  |- skos__hiddenLabel mesh__D002541 Cerebral Cortex Decortications
% 213.54/213.71  |- skos__scopeNote mesh__D002541
% 213.54/213.71       Partial or total removal, ablation, or destruction of the cerebral cortex; may be chemical. It is not used with animals that do not possess a cortex, i.e., it is used only with mammals.%A%    
% 213.54/213.71  |- rdf__type mesh__D002541sskos__Concept
% 213.54/213.71  |- skos__broader mesh__D002541smesh__D019635
% 213.54/213.71  |- skos__hiddenLabel mesh__D002541 Cerebral Decortications
% 213.54/213.71  |- skos__altLabel mesh__D002541 Cerebral Cortex Decortication
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D002541 2004
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D002541 2001
% 213.54/213.71  |- mesh__dateCreated mesh__D002541 1999-01-01
% 213.54/213.71  |- skos__broader mesh__D000450Q000037smesh__D000450
% 213.54/213.71  |- mesh__preferredCombination mesh__D000450Q000037smesh__D000451
% 213.54/213.71  |- rdf__type mesh__D000450Q000037smesh__CompoundConcept
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D015469 2004
% 213.54/213.71  |- skos__altLabel mesh__D015469 Leukemia, Myeloid, Ph1-Positive
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D015469 1998
% 213.54/213.71  |- skos__altLabel mesh__D015469 Myeloid Leukemia, Philadelphia-Positive
% 213.54/213.71  |- skos__hiddenLabel mesh__D015469 Leukemias, Ph1-Positive Myelogenous
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D015469 1997
% 213.54/213.71  |- skos__altLabel mesh__D015469 Myelogenous Leukemia, Ph1-Positive
% 213.54/213.71  |- skos__altLabel mesh__D015469 Leukemia, Myeloid, Ph1 Positive
% 213.54/213.71  |- skos__hiddenLabel mesh__D015469 Philadelphia-Positive Myeloid Leukemia
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D015469 2003
% 213.54/213.71  |- skos__hiddenLabel mesh__D015469 Ph1-Positive Myelogenous Leukemia
% 213.54/213.71  |- skos__annotation mesh__D015469
% 213.54/213.71       %22%Philadelphia%22% refers to the Philadelphia chromosome; do not use /blood supply /chem /second /secret /ultrastruct; DF: LEUKEMIA PHILA POS%A%  
% 213.54/213.71  |- skos__hiddenLabel mesh__D015469 Leukemia, Ph1-Positive Myelogenous
% 213.54/213.71  |- skos__hiddenLabel mesh__D015469 Myelogenous Leukemia, Ph1 Positive
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D015469 2002
% 213.54/213.71  |- skos__historyNote mesh__D015469 Leukemia, Myeloid %28%1966-1988%29%
% 213.54/213.71  |- skos__hiddenLabel mesh__D015469 Myeloid Leukemias, Ph1-Positive
% 213.54/213.71  |- mesh__recordMaintainer mesh__D015469 KEV
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D015469 1996
% 213.54/213.71  |- skos__related mesh__D015469smesh__D010677
% 213.54/213.71  |- skos__hiddenLabel mesh__D015469 Myeloid Leukemia, Ph1 Positive
% 213.54/213.71  |- skos__hiddenLabel mesh__D015469 Leukemia, Ph1-Positive Myeloid
% 213.54/213.71  |- skos__altLabel mesh__D015469 Leukemia, Myelogenous, Ph1 Positive
% 213.54/213.71  |- skos__hiddenLabel mesh__D015469 Ph1-Positive Myeloid Leukemia
% 213.54/213.71  |- skos__altLabel mesh__D015469 Myeloid Leukemia, Ph1-Positive
% 213.54/213.71  |- skos__hiddenLabel mesh__D015469 Philadelphia-Positive Myeloid Leukemias
% 213.54/213.71  |- mesh__dateCreated mesh__D015469 1988-06-09
% 213.54/213.71  |- skos__historyNote mesh__D015469 Leukemia, Myelocytic %28%1966-1988%29%
% 213.54/213.71  |- skos__hiddenLabel mesh__D015469 Leukemias, Philadelphia-Positive Myeloid
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D015469 2001
% 213.54/213.71  |- skos__hiddenLabel mesh__D015469 Ph1-Positive Myeloid Leukemias
% 213.54/213.71  |- rdf__type mesh__D015469sskos__Concept
% 213.54/213.71  |- skos__hiddenLabel mesh__D015469 Myelogenous Leukemias, Ph1-Positive
% 213.54/213.71  |- skos__hiddenLabel mesh__D015469 Myeloid Leukemias, Philadelphia-Positive
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D015469 2006
% 213.54/213.71  |- mesh__publicMeSHNote mesh__D015469 89   
% 213.54/213.71  |- skos__historyNote mesh__D015469
% 213.54/213.71       Philadelphia Chromosome %28%1986-1988%29%
% 213.54/213.71  |- skos__broader mesh__D015469smesh__D007951
% 213.54/213.71  |- mesh__recordAuthorizer mesh__D015469 PLS
% 213.54/213.71  |- mesh__historyNote mesh__D015469 89   
% 213.54/213.71  |- skos__hiddenLabel mesh__D015469 Ph1-Positive Myelogenous Leukemias
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D015469 1999
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D015469 2000
% 213.54/213.71  |- skos__hiddenLabel mesh__D015469 Myeloid Leukemia, Philadelphia Positive
% 213.54/213.71  |- skos__hiddenLabel mesh__D015469 Leukemia, Philadelphia-Positive Myeloid
% 213.54/213.71  |- mesh__dateEstablished mesh__D015469 1988-01-01
% 213.54/213.71  |- skos__altLabel mesh__D015469 Leukemia, Myelogenous, Ph1-Positive
% 213.54/213.71  |- skos__hiddenLabel mesh__D015469 Leukemias, Ph1-Positive Myeloid
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D015469 2005
% 213.54/213.71  |- mesh__recordOriginator mesh__D015469 PLS
% 213.54/213.71  |- skos__prefLabel mesh__D015469 Leukemia, Myeloid, Philadelphia-Positive
% 213.54/213.71  |- mesh__dateRevised mesh__D015469 1995-06-08
% 213.54/213.71  |- skos__altLabel mesh__D015469 Leukemia, Myeloid, Philadelphia Positive
% 213.54/213.71  |- skos__annotation mesh__D001449
% 213.54/213.71       an interstitial nephritis; do not specify geog unless particularly discussed%A%  
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D001449 2001
% 213.54/213.71  |- rdf__type mesh__D001449sskos__Concept
% 213.54/213.71  |- mesh__recordMaintainer mesh__D001449 TAP
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D001449 2000
% 213.54/213.71  |- skos__altLabel mesh__D001449 Endemic Nephropathy, Balkan
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D001449 2005
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D001449 1995
% 213.54/213.71  |- skos__historyNote mesh__D001449 Kidney Diseases %28%1966-1981%29%
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D001449 2004
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D001449 1999
% 213.54/213.71  |- skos__historyNote mesh__D001449 Nephritis %28%1966-1975%29%
% 213.54/213.71  |- mesh__historyNote mesh__D001449
% 213.54/213.71       91%28%82%29%; was see under NEPHRITIS, INTERSTITIAL 1982-90   
% 213.54/213.71  |- mesh__dateRevised mesh__D001449 1993-06-02
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D001449 1994
% 213.54/213.71  |- skos__historyNote mesh__D001449
% 213.54/213.71       Nephritis, Interstitial %28%1969-1981%29%
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D001449 2003
% 213.54/213.71  |- skos__historyNote mesh__D001449 Pyelonephritis %28%1966-1969%29%
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D001449 1998
% 213.54/213.71  |- skos__hiddenLabel mesh__D001449 Nephropathy, Balkan Endemic
% 213.54/213.71  |- skos__altLabel mesh__D001449 Nephropathy, Balkan
% 213.54/213.71  |- skos__scopeNote mesh__D001449
% 213.54/213.71       A tubulointerstitial disease of unknown etiology occurring in a limited geographic area including adjacent regions of Romania, Bulgaria, and Yugoslavia.%A%    
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D001449 1997
% 213.54/213.71  |- mesh__recordOriginator mesh__D001449 SMH
% 213.54/213.71  |- mesh__recordAuthorizer mesh__D001449 PLS
% 213.54/213.71  |- skos__broader mesh__D001449smesh__D009395
% 213.54/213.71  |- skos__hiddenLabel mesh__D001449 Balkan Endemic Nephropathy
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D001449 2002
% 213.54/213.71  |- mesh__dateEstablished mesh__D001449 1991-01-01
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D001449 1996
% 213.54/213.71  |- mesh__publicMeSHNote mesh__D001449
% 213.54/213.71       91; was see under NEPHRITIS, INTERSTITIAL 1982-90   
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D001449 2006
% 213.54/213.71  |- skos__prefLabel mesh__D001449 Balkan Nephropathy
% 213.54/213.71  |- mesh__dateCreated mesh__D001449 1981-02-23
% 213.54/213.71  |- skos__scopeNote mesh__D012171
% 213.54/213.71       The blood vessels which supply and drain the RETINA.     
% 213.54/213.71  |- mesh__dateRevised mesh__D012171 2003-07-09
% 213.54/213.71  |- skos__prefLabel mesh__D012171 Retinal Vessels
% 213.54/213.71  |- skos__annotation mesh__D012171
% 213.54/213.71       GEN %26% unspecified: prefer RETINAL ARTERY or RETINAL VEIN; dis of retinal vessels: coord IM with RETINAL DISEASES %28%IM%29%, not VASCULAR DISEASES%A%  
% 213.54/213.71  |- skos__hiddenLabel mesh__D012171 Retinal Vessel
% 213.54/213.71  |- skos__hiddenLabel mesh__D012171 Blood Vessels, Retinal
% 213.54/213.71  |- skos__related mesh__D012171smesh__D015356
% 213.54/213.71  |- skos__broader mesh__D012171smesh__D001808
% 213.54/213.71  |- skos__related mesh__D012171smesh__D005451
% 213.54/213.71  |- mesh__dateCreated mesh__D012171 1999-01-01
% 213.54/213.71  |- skos__hiddenLabel mesh__D012171 Vessel, Retinal Blood
% 213.54/213.71  |- mesh__historyNote mesh__D012171
% 213.54/213.71       PECTEN OCULI was see under RETINAL VESSELS 1969-83   
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D012171 2005
% 213.54/213.71  |- skos__altLabel mesh__D012171 Retinal Blood Vessels
% 213.54/213.71  |- mesh__onlineNote mesh__D012171
% 213.54/213.71       use RETINAL VESSELS to search PECTEN OCULI 1969-83   
% 213.54/213.71  |- mesh__recordMaintainer mesh__D012171 nns
% 213.54/213.71  |- mesh__recordOriginator mesh__D012171 NLM
% 213.54/213.71  |- skos__related mesh__D012171smesh__D012170
% 213.54/213.71  |- skos__hiddenLabel mesh__D012171 Vessel, Retinal
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D012171 2006
% 213.54/213.71  |- skos__related mesh__D012171smesh__D031300
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D012171 2004
% 213.54/213.71  |- mesh__recordAuthorizer mesh__D012171 sjn
% 213.54/213.71  |- skos__hiddenLabel mesh__D012171 Vessels, Retinal
% 213.54/213.71  |- rdf__type mesh__D012171sskos__Concept
% 213.54/213.71  |- skos__hiddenLabel mesh__D012171 Vessels, Retinal Blood
% 213.54/213.71  |- skos__hiddenLabel mesh__D012171 Retinal Blood Vessel
% 213.54/213.71  |- skos__hiddenLabel mesh__D012171 Blood Vessel, Retinal
% 213.54/213.71  |- rdf__type mesh__D006932sskos__Concept
% 213.54/213.71  |- mesh__recordMaintainer mesh__D006932 lkt
% 213.54/213.71  |- skos__broader mesh__D006932smesh__D008659
% 213.54/213.71  |- mesh__dateCreated mesh__D006932 1999-01-01
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D006932 2006
% 213.54/213.71  |- mesh__dateRevised mesh__D006932 2005-06-30
% 213.54/213.71  |- skos__altLabel mesh__D006932 Bilirubinemia
% 213.54/213.71  |- skos__hiddenLabel mesh__D006932 Bilirubinemias
% 213.54/213.71  |- skos__hiddenLabel mesh__D006932 Hyperbilirubinemias
% 213.54/213.71  |- skos__scopeNote mesh__D006932
% 213.54/213.71       Pathologic process consisting of an abnormal increase in the amount of BILIRUBIN in the circulating BLOOD, which may result in JAUNDICE.%A%    
% 213.54/213.71  |- skos__prefLabel mesh__D006932 Hyperbilirubinemia
% 213.54/213.71  |- skos__broader mesh__D006932smesh__D010335
% 213.54/213.71  |- mesh__recordOriginator mesh__D006932 NLM
% 213.54/213.71  |- mesh__recordAuthorizer mesh__D006932 sjn
% 213.54/213.71  |- skos__broader mesh__D002256Q000037smesh__D002256
% 213.54/213.71  |- mesh__preferredCombination mesh__D002256Q000037smesh__D002257
% 213.54/213.71  |- rdf__type mesh__D002256Q000037smesh__CompoundConcept
% 213.54/213.71  |- skos__broader mesh__D011877smesh__D003952
% 213.54/213.71  |- skos__hiddenLabel mesh__D011877 Imaging, Gamma Camera
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011877 2003
% 213.54/213.71  |- skos__prefLabel mesh__D011877 Radionuclide Imaging
% 213.54/213.71  |- skos__altLabel mesh__D011877 Scanning, Radioisotope
% 213.54/213.71  |- rdf__type mesh__D011877sskos__Concept
% 213.54/213.71  |- skos__altLabel mesh__D011877 Radioisotope Scanning
% 213.54/213.71  |- mesh__dateEstablished mesh__D011877 1964-01-01
% 213.54/213.71  |- skos__related mesh__D011877smesh__D012588
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011877 2001
% 213.54/213.71  |- mesh__dateCreated mesh__D011877 1999-01-01
% 213.54/213.71  |- mesh__historyNote mesh__D011877
% 213.54/213.71       77; was RADIOISOTOPE SCANNING 1964-76; was RADIOISOTOPE SCANNING see under RADIOMETRY 1963%A%  
% 213.54/213.71  |- skos__related mesh__D011877smesh__D015902
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011877 2000
% 213.54/213.71  |- skos__broader mesh__D011877smesh__D003947
% 213.54/213.71  |- mesh__onlineNote mesh__D011877
% 213.54/213.71       use RADIONUCLIDE IMAGING to search RADIOISOTOPE SCANNING 1966-76%A%  
% 213.54/213.71  |- mesh__recordOriginator mesh__D011877 NLM
% 213.54/213.71  |- mesh__dateRevised mesh__D011877 1997-06-20
% 213.54/213.71  |- mesh__recordAuthorizer mesh__D011877 SJN
% 213.54/213.71  |- mesh__recordMaintainer mesh__D011877 PXP
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011877 1999
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011877 2006
% 213.54/213.71  |- skos__annotation mesh__D011877
% 213.54/213.71       IM general or unspecified only: prefer /radionuclide: Manual 19.7+, 19.8.62; do not use /util except by MeSH definition; myocardial imaging, myocardial perfusion imaging, myocardial perfusion scintigraphy = HEART /radionuclide only %26% not also here; DF: do NOT shorten: short form can be confused with RADIONUCLIDES%A%  
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011877 2002
% 213.54/213.71  |- mesh__publicMeSHNote mesh__D011877
% 213.54/213.71       77; was RADIOISOTOPE SCANNING 1964-76; was RADIOISOTOPE SCANNING see under RADIOMETRY 1963%A%  
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011877 2004
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011877 1998
% 213.54/213.71  |- skos__altLabel mesh__D011877 Gamma Camera Imaging
% 213.54/213.71  |- skos__altLabel mesh__D011877 Scintigraphy
% 213.54/213.71  |- skos__scopeNote mesh__D011877
% 213.54/213.71       Process whereby a radionuclide is injected or measured %28%through tissue%29% from an external source, and a display is obtained from any one of several rectilinear scanner or gamma camera systems. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph.%A%    
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D011877 2005
% 213.54/213.71  |- skos__hiddenLabel mesh__D011877 Imaging, Radionuclide
% 213.54/213.71  |- skos__historyNote mesh__D016562 Home Care Services %28%1974-1991%29%
% 213.54/213.71  |- skos__prefLabel mesh__D016562 Parenteral Nutrition, Home Total
% 213.54/213.71  |- skos__broader mesh__D016562smesh__D016331
% 213.54/213.71  |- skos__historyNote mesh__D016562 Home Nursing %28%1977-1991%29%
% 213.54/213.71  |- rdf__type mesh__D016562sskos__Concept
% 213.54/213.71  |- skos__altLabel mesh__D016562 Total Parenteral Nutrition, Home
% 213.54/213.71  |- mesh__publicMeSHNote mesh__D016562 92   
% 213.54/213.71  |- mesh__dateRevised mesh__D016562 2003-07-09
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D016562 2005
% 213.54/213.71  |- skos__altLabel mesh__D016562 Home Parenteral Nutrition, Total
% 213.54/213.71  |- mesh__historyNote mesh__D016562 92   
% 213.54/213.71  |- skos__altLabel mesh__D016562 Home Total Parenteral Nutrition
% 213.54/213.71  |- mesh__recordMaintainer mesh__D016562 lkt
% 213.54/213.71  |- mesh__recordOriginator mesh__D016562 MXR
% 213.54/213.71  |- skos__historyNote mesh__D016562
% 213.54/213.71       Parenteral Nutrition, Total %28%1975-1991%29%
% 213.54/213.71  |- skos__historyNote mesh__D016562 Parenteral Nutrition %28%1974-1991%29%
% 213.54/213.71  |- mesh__dateEstablished mesh__D016562 1992-01-01
% 213.54/213.71  |- mesh__dateCreated mesh__D016562 1991-01-25
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D016562 2006
% 213.54/213.71  |- mesh__recordAuthorizer mesh__D016562 sjn
% 213.54/213.71  |- skos__broader mesh__D016562smesh__D010289
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D016562 2004
% 213.54/213.71  |- skos__scopeNote mesh__D016562
% 213.54/213.71       The at-home administering of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously or by some other non-alimentary route.%A%    
% 213.54/213.71  |- skos__annotation mesh__D016562
% 213.54/213.71       do not use /util except by MeSH definition; coord IM with dis /ther %28%IM%29%, not dis /diet ther; DF: HOME TPN or HTPN%A%  
% 213.54/213.71  |- skos__altLabel mesh__D016562 Nutrition, Home Total Parenteral
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D002542 2005
% 213.54/213.71  |- mesh__historyNote mesh__D002542 2000%28%1963%29%   
% 213.54/213.71  |- skos__prefLabel mesh__D002542 Intracranial Embolism and Thrombosis
% 213.54/213.71  |- mesh__recordOriginator mesh__D002542 NLM
% 213.54/213.71  |- mesh__publicMeSHNote mesh__D002542
% 213.54/213.71       2000; see CEREBRAL EMBOLISM AND THROMBOSIS 1963-1999   
% 213.54/213.71  |- rdf__type mesh__D002542sskos__Concept
% 213.54/213.71  |- mesh__dateRevised mesh__D002542 2001-07-25
% 213.54/213.71  |- skos__altLabel mesh__D002542 Embolism and Thrombosis, Brain
% 213.54/213.71  |- mesh__recordMaintainer mesh__D002542 nns
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D002542 2004
% 213.54/213.71  |- mesh__recordAuthorizer mesh__D002542 sjn
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D002542 2002
% 213.54/213.71  |- skos__broader mesh__D002542smesh__D002561
% 213.54/213.71  |- mesh__dateCreated mesh__D002542 1999-01-01
% 213.54/213.71  |- skos__scopeNote mesh__D002542
% 213.54/213.71       Embolism or thrombosis involving blood vessels which supply intracranial structures. Emboli may originate from extracranial or intracranial sources. Thrombosis may occur in arterial or venous structures.%A%    
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D002542 2003
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D002542 2006
% 213.54/213.71  |- skos__broader mesh__D002542smesh__D013923
% 213.54/213.71  |- skos__annotation mesh__D002542 Not used for indexing or cataloging.   
% 213.54/213.71  |- mesh__publicMeSHNote mesh__D012970
% 213.54/213.71       91; was see under GLUTAMATES 1975-90   
% 213.54/213.71  |- mesh__recordOriginator mesh__D012970 NLM
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D012970 2003
% 213.54/213.71  |- skos__prefLabel mesh__D012970 Sodium Glutamate
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D012970 2004
% 213.54/213.71  |- mesh__dateRevised mesh__D012970 2001-07-25
% 213.54/213.71  |- rdf__type mesh__D012970sskos__Concept
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D012970 2002
% 213.54/213.71  |- skos__historyNote mesh__D012970 Glutamates %28%1966-1974%29%
% 213.54/213.71  |- skos__scopeNote mesh__D012970
% 213.54/213.71       One of the FLAVORING AGENTS used to impart a meat-like flavor. Medically it has been used to reduce blood ammonia levels in ammoniacal azotemia, therapy of hepatic coma, in psychosis, and mental retardation.%A%    
% 213.54/213.71  |- mesh__recordAuthorizer mesh__D012970 sjn
% 213.54/213.71  |- skos__altLabel mesh__D012970 Monosodium Glutamate
% 213.54/213.71  |- mesh__recordMaintainer mesh__D012970 nns
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D012970 2005
% 213.54/213.71  |- skos__broader mesh__D012970smesh__D005971
% 213.54/213.71  |- mesh__dateCreated mesh__D012970 1974-11-19
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D012970 2006
% 213.54/213.71  |- mesh__dateEstablished mesh__D012970 1991-01-01
% 213.54/213.71  |- mesh__historyNote mesh__D012970
% 213.54/213.71       91%28%75%29%; was see under GLUTAMATES 1975-90   
% 213.54/213.71  |- skos__hiddenLabel mesh__D012970 Glutamate, Sodium
% 213.54/213.71  |- skos__altLabel mesh__D012970 MSG
% 213.54/213.71  |- skos__broader mesh__D018079Q000819smesh__D018079
% 213.54/213.71  |- mesh__preferredCombination mesh__D018079Q000819smesh__D018755
% 213.54/213.71  |- rdf__type mesh__D018079Q000819smesh__CompoundConcept
% 213.54/213.71  |- mesh__dateRevised mesh__D012172 2005-06-30
% 213.54/213.71  |- skos__broader mesh__D012172smesh__D012176
% 213.54/213.71  |- mesh__onlineNote mesh__D012172 search VITAMIN A 1968-74   
% 213.54/213.71  |- mesh__recordOriginator mesh__D012172 NLM
% 213.54/213.71  |- mesh__historyNote mesh__D012172
% 213.54/213.71       91%28%75%29%; was see under RETINOIDS 1984-90; was see under VITAMIN A 1968-83%A%  
% 213.54/213.71  |- skos__hiddenLabel mesh__D012172 11 cis Retinal
% 213.54/213.71  |- mesh__recordAuthorizer mesh__D012172 sjn
% 213.54/213.71  |- mesh__activeMeSHYear mesh__D012172 2006
% 213.54/213.71  |- skos__annotation mesh__D012172 /biosyn /physiol permitted   
% 213.54/213.71  |- skos__altLabel mesh__D012172 Axerophthal
% 213.54/213.71  |- skos__prefLabel mesh__D012172 Retinaldehyde
% 213.54/213.71  |- rdf__type mesh__D012172sskos__Concept
% 213.54/213.71  |- skos__broader mesh__D012172smesh__D000447
% 213.54/213.71  |- skos__scopeNote mesh__D012172
% 213.54/213.71       A carotenoid constituent of visual pigments. It is the oxidized form of retinol which functions as the active component of the visual cycle. It is bound to the protein opsin forming the complex rhodopsin. When stimulated by visible light, the retinal component of the rhodopsin complex undergoes isomerization at the 11-position of the double bond to the cis-form; this is reversed in %22%dark%22% reactions to return to the native trans-configuration.%A%    
% 213.54/213.72  |- mesh__dateEstablished mesh__D012172 1991-01-01
% 213.54/213.72  |- mesh__recordMaintainer mesh__D012172 ssb
% 213.54/213.72  |- skos__altLabel mesh__D012172 Retinene
% 213.54/213.72  |- mesh__publicMeSHNote mesh__D012172
% 213.54/213.72       91; was see under RETINOIDS 1984-90; was see under VITAMIN A 1968-83%A%  
% 213.54/213.72  |- skos__altLabel mesh__D012172 Retinal
% 213.54/213.72  |- skos__altLabel mesh__D012172 Vitamin A Aldehyde
% 213.54/213.72  |- skos__hiddenLabel mesh__D012172 Aldehyde, Vitamin A
% 213.54/213.72  |- mesh__dateCreated mesh__D012172 1999-01-01
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006933 2005
% 213.54/213.72  |- skos__prefLabel mesh__D006933 Hyperbilirubinemia, Hereditary
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006933 2002
% 213.54/213.72  |- skos__annotation mesh__D006933
% 213.54/213.72       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 213.54/213.72  |- mesh__recordOriginator mesh__D006933 NLM
% 213.54/213.72  |- skos__broader mesh__D006933smesh__D008661
% 213.54/213.72  |- skos__scopeNote mesh__D006933
% 213.54/213.72       Inborn errors of bilirubin metabolism resulting in excessive amounts of bilirubin in the circulating blood, either because of increased bilirubin production or because of delayed clearance of bilirubin from the blood.%A%    
% 213.54/213.72  |- skos__hiddenLabel mesh__D006933 Hereditary Hyperbilirubinemias
% 213.54/213.72  |- mesh__dateRevised mesh__D006933 2001-07-25
% 213.54/213.72  |- mesh__recordAuthorizer mesh__D006933 sjn
% 213.54/213.72  |- mesh__dateEstablished mesh__D006933 1965-01-01
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006933 2004
% 213.54/213.72  |- rdf__type mesh__D006933sskos__Concept
% 213.54/213.72  |- skos__hiddenLabel mesh__D006933 Syndrome, Rotor
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006933 2003
% 213.54/213.72  |- skos__hiddenLabel mesh__D006933 Hereditary Hyperbilirubinemia
% 213.54/213.72  |- mesh__dateCreated mesh__D006933 1999-01-01
% 213.54/213.72  |- skos__hiddenLabel mesh__D006933 Hyperbilirubinemias, Hereditary
% 213.54/213.72  |- mesh__historyNote mesh__D006933 65   
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006933 2006
% 213.54/213.72  |- mesh__recordMaintainer mesh__D006933 nns
% 213.54/213.72  |- mesh__publicMeSHNote mesh__D006933 65   
% 213.54/213.72  |- skos__broader mesh__D020604smesh__D020585
% 213.54/213.72  |- mesh__recordMaintainer mesh__D020604 SYSTEM
% 213.54/213.72  |- skos__altLabel mesh__D020604 Pseudomonas testosteroni
% 213.54/213.72  |- mesh__dateEstablished mesh__D020604 2000-01-01
% 213.54/213.72  |- rdf__type mesh__D020604sskos__Concept
% 213.54/213.72  |- skos__scopeNote mesh__D020604
% 213.54/213.72       A species of gram-negative, aerobic rods formerly called Pseudomonas testosteroni. It is differentiated from other Comamonas species by its ability to assimilate testosterone and to utilize phenylacetate or maleate as carbon sources.%A%    
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D020604 2006
% 213.54/213.72  |- mesh__recordAuthorizer mesh__D020604 sjn
% 213.54/213.72  |- mesh__dateRevised mesh__D020604 2005-06-30
% 213.54/213.72  |- mesh__recordOriginator mesh__D020604 ndw
% 213.54/213.72  |- skos__prefLabel mesh__D020604 Comamonas testosteroni
% 213.54/213.72  |- mesh__historyNote mesh__D020604 2000   
% 213.54/213.72  |- mesh__publicMeSHNote mesh__D020604 2000   
% 213.54/213.72  |- mesh__dateCreated mesh__D020604 1999-11-03
% 213.54/213.72  |- skos__annotation mesh__D020604
% 213.54/213.72       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006135 2006
% 213.54/213.72  |- skos__prefLabel mesh__D006135 Gryllidae
% 213.54/213.72  |- mesh__dateEstablished mesh__D006135 1991-01-01
% 213.54/213.72  |- skos__scopeNote mesh__D006135
% 213.54/213.72       The family Gryllidae consists of the common house cricket, Acheta domesticus, which is used in neurological and physiological studies. Other genera include Gryllotalpa %28%mole cricket%29%; Gryllus %28%field cricket%29%; and Oecanthus %28%tree cricket%29%.%A%    
% 213.54/213.72  |- skos__broader mesh__D006135smesh__D009987
% 213.54/213.72  |- mesh__dateRevised mesh__D006135 2003-07-09
% 213.54/213.72  |- mesh__dateCreated mesh__D006135 1985-03-15
% 213.54/213.72  |- mesh__historyNote mesh__D006135
% 213.54/213.72       91%28%86%29%; was see under ORTHOPTERA 1986-90   
% 213.54/213.72  |- mesh__recordOriginator mesh__D006135 EC
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006135 2004
% 213.54/213.72  |- rdf__type mesh__D006135sskos__Concept
% 213.54/213.72  |- mesh__recordMaintainer mesh__D006135 ags
% 213.54/213.72  |- skos__historyNote mesh__D006135 Orthoptera %28%1975-1985%29%
% 213.54/213.72  |- mesh__publicMeSHNote mesh__D006135
% 213.54/213.72       91; was see under ORTHOPTERA 1986-90   
% 213.54/213.72  |- skos__altLabel mesh__D006135 Crickets
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006135 2005
% 213.54/213.72  |- mesh__recordAuthorizer mesh__D006135 sjn
% 213.54/213.72  |- skos__annotation mesh__D006135
% 213.54/213.72       /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111%A%  
% 213.54/213.72  |- skos__annotation mesh__D011878
% 213.54/213.72       general only: prefer / radiother with diseases: Manual 19.7+, 19.8.63; / adv eff: consider also RADIATION INJURIES or its specifics; many specific types of radiotherapy are available%A%  
% 213.54/213.72  |- rdf__type mesh__D011878sskos__Concept
% 213.54/213.72  |- skos__altLabel mesh__D011878 Targeted Radiotherapy
% 213.54/213.72  |- skos__hiddenLabel mesh__D011878 Radiotherapies
% 213.54/213.72  |- mesh__recordMaintainer mesh__D011878 lkt
% 213.54/213.72  |- skos__hiddenLabel mesh__D011878 Radiotherapies, Targeted
% 213.54/213.72  |- skos__scopeNote mesh__D011878
% 213.54/213.72       The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions.%A%    
% 213.54/213.72  |- skos__prefLabel mesh__D011878 Radiotherapy
% 213.54/213.72  |- mesh__dateRevised mesh__D011878 2005-06-30
% 213.54/213.72  |- skos__hiddenLabel mesh__D011878 Targeted Radiotherapies
% 213.54/213.72  |- mesh__recordAuthorizer mesh__D011878 sjn
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D011878 2006
% 213.54/213.72  |- mesh__recordOriginator mesh__D011878 NLM
% 213.54/213.72  |- mesh__dateCreated mesh__D011878 1999-01-01
% 213.54/213.72  |- skos__broader mesh__D011878smesh__D013812
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D016563 2002
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D016563 2005
% 213.54/213.72  |- mesh__historyNote mesh__D016563 92   
% 213.54/213.72  |- skos__historyNote mesh__D016563 Rhabdoviridae %28%1987-1991%29%
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D016563 2003
% 213.54/213.72  |- skos__prefLabel mesh__D016563 Filoviridae
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D016563 2006
% 213.54/213.72  |- mesh__publicMeSHNote mesh__D016563 92   
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D016563 2004
% 213.54/213.72  |- mesh__recordOriginator mesh__D016563 AGS
% 213.54/213.72  |- mesh__dateRevised mesh__D016563 2001-07-25
% 213.54/213.72  |- skos__scopeNote mesh__D016563
% 213.54/213.72       A family of viruses, of the order MONONEGAVIRALES, containing filamentous virions. Although they resemble RHABDOVIRIDAE in possessing helical nucleocapsids, Filoviridae differ in the length and degree of branching in their virions. There are two genera: EBOLA-LIKE VIRUSES and MARBURG-LIKE VIRUSES.%A%    
% 213.54/213.72  |- mesh__dateCreated mesh__D016563 1991-01-02
% 213.54/213.72  |- mesh__dateEstablished mesh__D016563 1992-01-01
% 213.54/213.72  |- skos__broader mesh__D016563smesh__D018096
% 213.54/213.72  |- mesh__recordAuthorizer mesh__D016563 sjn
% 213.54/213.72  |- skos__annotation mesh__D016563 infection = FILOVIRIDAE INFECTIONS   
% 213.54/213.72  |- mesh__recordMaintainer mesh__D016563 ags
% 213.54/213.72  |- rdf__type mesh__D016563sskos__Concept
% 213.54/213.72  |- skos__hiddenLabel mesh__D002543 Cerebral Brain Hemorrhage
% 213.54/213.72  |- skos__hiddenLabel mesh__D002543 Parenchymal Hemorrhage, Cerebral
% 213.54/213.72  |- skos__altLabel mesh__D002543 Cerebral Parenchymal Hemorrhage
% 213.54/213.72  |- skos__hiddenLabel mesh__D002543 Cerebral Parenchymal Hemorrhages
% 213.54/213.72  |- skos__hiddenLabel mesh__D002543 Hemorrhages, Cerebral Brain
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D002543 2003
% 213.54/213.72  |- mesh__dateCreated mesh__D002543 1999-01-01
% 213.54/213.72  |- skos__hiddenLabel mesh__D002543 Brain Hemorrhages, Cerebral
% 213.54/213.72  |- skos__hiddenLabel mesh__D002543 Hemorrhage, Intracerebral
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D002543 2002
% 213.54/213.72  |- skos__hiddenLabel mesh__D002543 Hemorrhages, Intracerebral
% 213.54/213.72  |- skos__hiddenLabel mesh__D002543 Cerebral Hemorrhages
% 213.54/213.72  |- skos__broader mesh__D002543smesh__D002561
% 213.54/213.72  |- skos__scopeNote mesh__D002543
% 213.54/213.72       Bleeding into a cerebral hemisphere of the brain, including lobar, subcortical white matter, and basal ganglia hemorrhages. Commonly associated conditions include HYPERTENSION; INTRACRANIAL ARTERIOSCLEROSIS; INTRACRANIAL ANEURYSM; CRANIOCEREBRAL TRAUMA; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; CEREBRAL AMYLOID ANGIOPATHY; and CEREBRAL INFARCTION.%A%    
% 213.54/213.72  |- mesh__dateRevised mesh__D002543 1999-11-03
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D002543 2001
% 213.54/213.72  |- skos__hiddenLabel mesh__D002543 Parenchymal Hemorrhages, Cerebral
% 213.54/213.72  |- skos__altLabel mesh__D002543 Hemorrhage, Cerebrum
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D002543 2006
% 213.54/213.72  |- mesh__recordAuthorizer mesh__D002543 sjn
% 213.54/213.72  |- mesh__recordMaintainer mesh__D002543 KEV
% 213.54/213.72  |- skos__hiddenLabel mesh__D002543 Hemorrhage, Cerebral Parenchymal
% 213.54/213.72  |- skos__hiddenLabel mesh__D002543 Hemorrhages, Cerebral Parenchymal
% 213.54/213.72  |- skos__altLabel mesh__D002543 Intracerebral Hemorrhage
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D002543 2000
% 213.54/213.72  |- skos__prefLabel mesh__D002543 Cerebral Hemorrhage
% 213.54/213.72  |- skos__hiddenLabel mesh__D002543 Cerebrum Hemorrhage
% 213.54/213.72  |- skos__hiddenLabel mesh__D002543 Hemorrhages, Cerebrum
% 213.54/213.72  |- skos__altLabel mesh__D002543 Brain Hemorrhage, Cerebral
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D002543 2005
% 213.54/213.72  |- skos__altLabel mesh__D002543 Hemorrhage, Cerebral
% 213.54/213.72  |- skos__hiddenLabel mesh__D002543 Cerebrum Hemorrhages
% 213.54/213.72  |- rdf__type mesh__D002543sskos__Concept
% 213.54/213.72  |- skos__hiddenLabel mesh__D002543 Hemorrhage, Cerebral Brain
% 213.54/213.72  |- skos__broader mesh__D002543smesh__D020300
% 213.54/213.72  |- skos__hiddenLabel mesh__D002543 Hemorrhages, Cerebral
% 213.54/213.72  |- skos__hiddenLabel mesh__D002543 Cerebral Brain Hemorrhages
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D002543 2004
% 213.54/213.72  |- mesh__recordOriginator mesh__D002543 NLM
% 213.54/213.72  |- skos__hiddenLabel mesh__D002543 Intracerebral Hemorrhages
% 213.54/213.72  |- skos__altLabel mesh__D012971 Sanocrisin
% 213.54/213.72  |- rdf__type mesh__D012971sskos__Concept
% 213.54/213.72  |- mesh__dateCreated mesh__D012971 1999-01-01
% 213.54/213.72  |- mesh__historyNote mesh__D012971
% 213.54/213.72       92; was SODIUM GOLD THIOSULFATE 1975-91 %28%see under GOLD 1975-90%29%%A%  
% 213.54/213.72  |- skos__altLabel mesh__D012971 Sanochrysin
% 213.54/213.72  |- skos__broader mesh__D012971smesh__D017670
% 213.54/213.72  |- mesh__recordMaintainer mesh__D012971 ssb
% 213.54/213.72  |- mesh__recordOriginator mesh__D012971 NLM
% 213.54/213.72  |- mesh__onlineNote mesh__D012971
% 213.54/213.72       use GOLD SODIUM THIOSULFATE to search SODIUM GOLD THIOSULFATE 1975-91; search GOLD 1966-74%A%  
% 213.54/213.72  |- skos__hiddenLabel mesh__D012971 Thiosulfate, Gold Sodium
% 213.54/213.72  |- skos__hiddenLabel mesh__D012971 Gold Thiosulfate, Sodium
% 213.54/213.72  |- skos__hiddenLabel mesh__D012971 Aurothiosulfate, Sodium
% 213.54/213.72  |- skos__hiddenLabel mesh__D012971 Sodium Thiosulfate, Gold
% 213.54/213.72  |- mesh__publicMeSHNote mesh__D012971
% 213.54/213.72       92; was SODIUM GOLD THIOSULFATE 1975-91 %28%see under GOLD 1975-90%29%%A%  
% 213.54/213.72  |- skos__altLabel mesh__D012971 Sodium Aurothiosulfate
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D012971 2006
% 213.54/213.72  |- mesh__dateEstablished mesh__D012971 1991-01-01
% 213.54/213.72  |- skos__broader mesh__D012971smesh__D013885
% 213.54/213.72  |- skos__prefLabel mesh__D012971 Gold Sodium Thiosulfate
% 213.54/213.72  |- mesh__dateRevised mesh__D012971 2005-06-30
% 213.54/213.72  |- skos__altLabel mesh__D012971 Thiosulfatoaurate
% 213.54/213.72  |- skos__altLabel mesh__D012971
% 213.54/213.72       Bis%28%monothiosulfato%28%2-%29%-O,S%29%aurate%28%3-%29% Trisodium
% 213.54/213.72  |- skos__broader mesh__D012971smesh__D017612
% 213.54/213.72  |- skos__hiddenLabel mesh__D012971 Thiosulfate, Sodium Gold
% 213.54/213.72  |- mesh__recordAuthorizer mesh__D012971 sjn
% 213.54/213.72  |- skos__scopeNote mesh__D012971
% 213.54/213.72       A sodium salt of gold thiosulfate. It has uses like the ORGANOGOLD COMPOUNDS.%A%    
% 213.54/213.72  |- skos__altLabel mesh__D012971 Sodium Gold Thiosulfate
% 213.54/213.72  |- skos__scopeNote mesh__D012173
% 213.54/213.72       Inflammation of the RETINA. It is rarely limited to the retina, but is commonly associated with diseases of the choroid %28%CHORIORETINITIS%29% and of the OPTIC DISK %28%neuroretinitis%29%.%A%    
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D012173 2003
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D012173 2006
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D012173 2004
% 213.54/213.72  |- mesh__dateRevised mesh__D012173 2002-07-03
% 213.54/213.72  |- mesh__recordOriginator mesh__D012173 NLM
% 213.54/213.72  |- skos__related mesh__D012173smesh__D031300
% 213.54/213.72  |- rdf__type mesh__D012173sskos__Concept
% 213.54/213.72  |- mesh__recordAuthorizer mesh__D012173 sjn
% 213.54/213.72  |- skos__prefLabel mesh__D012173 Retinitis
% 213.54/213.72  |- mesh__dateCreated mesh__D012173 1999-01-01
% 213.54/213.72  |- skos__broader mesh__D012173smesh__D012164
% 213.54/213.72  |- mesh__recordMaintainer mesh__D012173 ags
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D012173 2005
% 213.54/213.72  |- mesh__dateRevised mesh__D006934 1994-09-23
% 213.54/213.72  |- skos__prefLabel mesh__D006934 Hypercalcemia
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006934 2002
% 213.54/213.72  |- mesh__recordOriginator mesh__D006934 NLM
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006934 2005
% 213.54/213.72  |- skos__broader mesh__D006934smesh__D002128
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006934 1999
% 213.54/213.72  |- skos__annotation mesh__D006934
% 213.54/213.72       high blood calcium levels; do not confuse with HYPOCALCEMIA; X ref is also called Burnett%27%s syndrome or milk-drinker%27%s syndrome%A%  
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006934 1998
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006934 2001
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006934 1995
% 213.54/213.72  |- rdf__type mesh__D006934sskos__Concept
% 213.54/213.72  |- skos__hiddenLabel mesh__D006934 Syndrome, Milk-Alkali
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006934 2004
% 213.54/213.72  |- mesh__dateCreated mesh__D006934 1999-01-01
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006934 2000
% 213.54/213.72  |- skos__broader mesh__D006934smesh__D014883
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006934 1994
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006934 2003
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006934 1997
% 213.54/213.72  |- mesh__publicMeSHNote mesh__D006934
% 213.54/213.72       MILK-ALKALI SYNDROME was see under CALCINOSIS 1975-77   
% 213.54/213.72  |- skos__scopeNote mesh__D006934
% 213.54/213.72       Abnormally high level of calcium in the blood.     
% 213.54/213.72  |- mesh__recordAuthorizer mesh__D006934 PLS
% 213.54/213.72  |- mesh__recordMaintainer mesh__D006934 PLS
% 213.54/213.72  |- mesh__historyNote mesh__D006934
% 213.54/213.72       MILK-ALKALI SYNDROME was see under HYPERCALCEMIA 1978-83, was see under CALCINOSIS 1975-77%A%  
% 213.54/213.72  |- mesh__onlineNote mesh__D006934
% 213.54/213.72       use HYPERCALCEMIA to search MILK-ALKALI SYNDROME 1966-77   
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006934 1996
% 213.54/213.72  |- skos__hiddenLabel mesh__D006934 Milk Alkali Syndrome
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006934 2006
% 213.54/213.72  |- skos__hiddenLabel mesh__D006934 Hypercalcemias
% 213.54/213.72  |- mesh__dateCreated mesh__D020605 1999-11-03
% 213.54/213.72  |- skos__prefLabel mesh__D020605 Delftia acidovorans
% 213.54/213.72  |- skos__annotation mesh__D020605
% 213.54/213.72       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 213.54/213.72  |- mesh__historyNote mesh__D020605 2004 %28%2000%29%   
% 213.54/213.72  |- mesh__recordOriginator mesh__D020605 ndw
% 213.54/213.72  |- skos__altLabel mesh__D020605 Comamonas acidovorans
% 213.54/213.72  |- mesh__publicMeSHNote mesh__D020605
% 213.54/213.72       2004; see COMAMONAS ACIDOVORANS 2000-2003   
% 213.54/213.72  |- skos__altLabel mesh__D020605 Pseudomonas acidovorans
% 213.54/213.72  |- skos__scopeNote mesh__D020605
% 213.54/213.72       A species of gram-negative rod-shaped bacteria found ubiquitously and formerly called Comamonas acidovorans and Pseudomonas acidovorans. It is the type species of the genus DELFTIA.%A%    
% 213.54/213.72  |- mesh__recordAuthorizer mesh__D020605 sjn
% 213.54/213.72  |- rdf__type mesh__D020605sskos__Concept
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D020605 2006
% 213.54/213.72  |- skos__broader mesh__D020605smesh__D042742
% 213.54/213.72  |- mesh__dateRevised mesh__D020605 2005-06-30
% 213.54/213.72  |- mesh__recordMaintainer mesh__D020605 SYSTEM
% 213.54/213.72  |- mesh__dateEstablished mesh__D020605 2000-01-01
% 213.54/213.72  |- skos__hiddenLabel mesh__D006136
% 213.54/213.72       Synthetase, 7,8-Dihydroneopterintriphosphate
% 213.54/213.72  |- skos__historyNote mesh__D006136 Guanosine Triphosphate %28%1974%29%
% 213.54/213.72  |- mesh__recordOriginator mesh__D006136 NLM
% 213.54/213.72  |- mesh__recordAuthorizer mesh__D006136 sjn
% 213.54/213.72  |- mesh__dateRevised mesh__D006136 2003-07-09
% 213.54/213.72  |- skos__hiddenLabel mesh__D006136 Cyclohydrolase I, GTP
% 213.54/213.72  |- mesh__historyNote mesh__D006136
% 213.54/213.72       91%28%75%29%; was see under AMINOHYDROLASES 1975-90   
% 213.54/213.72  |- mesh__dateCreated mesh__D006136 1974-11-19
% 213.54/213.72  |- skos__prefLabel mesh__D006136 GTP Cyclohydrolase
% 213.54/213.72  |- skos__altLabel mesh__D006136 GTP 8-Formylhydrolase
% 213.54/213.72  |- skos__broader mesh__D006136smesh__D000619
% 213.54/213.72  |- skos__scopeNote mesh__D006136
% 213.54/213.72       %28%GTP cyclohydrolase I%29% or GTP 7,8-8,9-dihydrolase %28%pyrophosphate-forming%29% %28%GTP cyclohydrolase II%29%. An enzyme group that hydrolyzes the imidazole ring of GTP, releasing carbon-8 as formate. Two C-N bonds are hydrolyzed and the pentase unit is isomerized. This is the first step in the synthesis of folic acid from GTP. EC 3.5.4.16 %28%GTP cyclohydrolase I%29% and EC 3.5.4.25 %28%GTP cyclohydrolase II%29%.%A%    
% 213.54/213.72  |- skos__hiddenLabel mesh__D006136 Dihydrolase, GTP
% 213.54/213.72  |- skos__hiddenLabel mesh__D006136 GTP 8 Formylhydrolase
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006136 2004
% 213.54/213.72  |- rdf__type mesh__D006136sskos__Concept
% 213.54/213.72  |- mesh__recordMaintainer mesh__D006136 ssb
% 213.54/213.72  |- skos__altLabel mesh__D006136 GTP Dihydrolase
% 213.54/213.72  |- skos__hiddenLabel mesh__D006136 8-Formylhydrolase, GTP
% 213.54/213.72  |- skos__historyNote mesh__D006136 Aminohydrolases %28%1974%29%
% 213.54/213.72  |- mesh__publicMeSHNote mesh__D006136
% 213.54/213.72       91; was see under AMINOHYDROLASES 1975-90   
% 213.54/213.72  |- skos__hiddenLabel mesh__D006136 GTP Ring Opening Enzyme
% 213.54/213.72  |- skos__hiddenLabel mesh__D006136 Cyclohydrolase II, GTP
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006136 2005
% 213.54/213.72  |- skos__altLabel mesh__D006136 7,8-Dihydroneopterintriphosphate Synthetase
% 213.54/213.72  |- skos__hiddenLabel mesh__D006136 Cyclohydrolase, GTP
% 213.54/213.72  |- skos__hiddenLabel mesh__D006136
% 213.54/213.72       7,8 Dihydroneopterintriphosphate Synthetase
% 213.54/213.72  |- skos__hiddenLabel mesh__D006136 Ring-Opening Enzyme, GTP
% 213.54/213.72  |- skos__altLabel mesh__D006136 GTP Ring-Opening Enzyme
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006136 2006
% 213.54/213.72  |- mesh__dateEstablished mesh__D006136 1991-01-01
% 213.54/213.72  |- skos__altLabel mesh__D011879 Dosage, Radiotherapy
% 213.54/213.72  |- skos__hiddenLabel mesh__D011879 Dosages, Radiotherapy
% 213.54/213.72  |- mesh__publicMeSHNote mesh__D011879 64   
% 213.54/213.72  |- mesh__recordMaintainer mesh__D011879 lkt
% 213.54/213.72  |- skos__related mesh__D011879smesh__D020266
% 213.54/213.72  |- skos__related mesh__D011879smesh__D004307
% 213.54/213.72  |- mesh__dateEstablished mesh__D011879 1964-01-01
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D011879 2006
% 213.54/213.72  |- skos__annotation mesh__D011879 NIM   
% 213.54/213.72  |- skos__prefLabel mesh__D011879 Radiotherapy Dosage
% 213.54/213.72  |- mesh__dateRevised mesh__D011879 2005-06-30
% 213.54/213.72  |- mesh__dateCreated mesh__D011879 1999-01-01
% 213.54/213.72  |- mesh__historyNote mesh__D011879 64   
% 213.54/213.72  |- mesh__recordAuthorizer mesh__D011879 sjn
% 213.54/213.72  |- rdf__type mesh__D011879sskos__Concept
% 213.54/213.72  |- skos__scopeNote mesh__D011879
% 213.54/213.72       The total amount of radiation absorbed by tissues as a result of radiotherapy.%A%    
% 213.54/213.72  |- skos__hiddenLabel mesh__D011879 Radiotherapy Dosages
% 213.54/213.72  |- skos__broader mesh__D011879smesh__D011878
% 213.54/213.72  |- mesh__recordOriginator mesh__D011879 NLM
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D016564 2006
% 213.54/213.72  |- skos__historyNote mesh__D016564 Amyloid %28%1988-1991%29%
% 213.54/213.72  |- skos__broader mesh__D016564smesh__D016229
% 213.54/213.72  |- mesh__publicMeSHNote mesh__D016564
% 213.54/213.72       92; AMYLOID BETA-PROTEIN PRECURSOR was indexed under AMYLOID BETA-PROTEIN 1990-91 and AMYLOID %26% PROTEIN PRECURSORS 1988-91; AMYLOID A4 PROTEIN PRECURSOR was indexed under AMYLOID BETA-PROTEIN PRECURSOR 1993-94, AMYLOID BETA-PROTEIN 1991-92, PROTEIN PRECURSORS 1987-92, %26% AMYLOID 1987-90%A%  
% 213.54/213.72  |- mesh__recordOriginator mesh__D016564 MXR
% 213.54/213.72  |- skos__hiddenLabel mesh__D016564 Amyloid beta Protein Precursor
% 213.54/213.72  |- mesh__recordAuthorizer mesh__D016564 sjn
% 213.54/213.72  |- mesh__recordMaintainer mesh__D016564 nns
% 213.54/213.72  |- mesh__historyNote mesh__D016564
% 213.54/213.72       92; was AMYLOID BETA PROTEIN PRECURSOR %28%NM%29% 1988-91; AMYLOID A4 PROTEIN PRECURSOR was NM 1987-94%A%  
% 213.54/213.72  |- skos__annotation mesh__D016564
% 213.54/213.72       /drug eff /ultrastruct permitted; DF: ABPP   
% 213.54/213.72  |- skos__altLabel mesh__D016564 Amyloid A4 Protein Precursor
% 213.54/213.72  |- mesh__onlineNote mesh__D016564
% 213.54/213.72       use AMYLOID BETA-PROTEIN PRECURSOR %28%NM%29% to search AMYLOID BETA-PROTEIN PRECURSOR 1988-91 %26% AMYLOID A4 PROTEIN PRECURSOR 1987-94%A%  
% 213.54/213.72  |- mesh__dateCreated mesh__D016564 1991-07-12
% 213.54/213.72  |- skos__historyNote mesh__D016564 Protein Precursors %28%1988-1991%29%
% 213.54/213.72  |- rdf__type mesh__D016564sskos__Concept
% 213.54/213.72  |- skos__scopeNote mesh__D016564
% 213.54/213.72       A precursor to the AMYLOID-BETA PROTEIN %28%beta/A4%29%. Alterations in the expression of the amyloid beta-protein precursor %28%ABPP%29% gene, located on chromosome 21, plays a role in the development of the neuropathology common to both ALZHEIMER DISEASE and DOWN SYNDROME. ABPP is associated with the extensive extracellular matrix secreted by neuronal cells. Upon cleavage, this precursor produces three proteins of varying amino acid lengths: 695, 751, and 770. The beta/A4 %28%695 amino acids%29% or beta-amyloid protein is the principal component of the extracellular amyloid in senile plaques found in ALZHEIMER DISEASE; DOWN SYNDROME and, to a limited extent, in normal aging.%A%    
% 213.54/213.72  |- skos__hiddenLabel mesh__D016564 beta Amyloid Protein Precursor
% 213.54/213.72  |- skos__altLabel mesh__D016564 beta-Amyloid Protein Precursor
% 213.54/213.72  |- skos__altLabel mesh__D016564 Amyloid Protein Precursor
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D016564 2005
% 213.54/213.72  |- skos__hiddenLabel mesh__D016564 beta-Protein Precursor, Amyloid
% 213.54/213.72  |- skos__broader mesh__D016564smesh__D011498
% 213.54/213.72  |- skos__prefLabel mesh__D016564 Amyloid beta-Protein Precursor
% 213.54/213.72  |- skos__altLabel mesh__D016564 Amyloid beta Precursor Protein
% 213.54/213.72  |- mesh__dateEstablished mesh__D016564 1992-01-01
% 213.54/213.72  |- mesh__dateRevised mesh__D016564 2004-07-07
% 213.54/213.72  |- skos__broader mesh__D010820Q000193smesh__D010820
% 213.54/213.72  |- mesh__preferredCombination mesh__D010820Q000193smesh__D004501
% 213.54/213.72  |- rdf__type mesh__D010820Q000193smesh__CompoundConcept
% 213.54/213.72  |- mesh__dateEstablished mesh__D002544 1979-01-01
% 213.54/213.72  |- skos__hiddenLabel mesh__D002544 Cerebral Infarctions
% 213.54/213.72  |- skos__altLabel mesh__D002544 Right Hemisphere, Infarction, Cerebral
% 213.54/213.72  |- skos__historyNote mesh__D002544 Brain %28%1966-1978%29%
% 213.54/213.72  |- skos__altLabel mesh__D002544 Left Hemisphere, Infarction, Cerebral
% 213.54/213.72  |- mesh__recordAuthorizer mesh__D002544 sjn
% 213.54/213.72  |- skos__altLabel mesh__D002544 Infarction, Cerebral
% 213.54/213.72  |- mesh__dateRevised mesh__D002544 2005-06-30
% 213.54/213.72  |- skos__annotation mesh__D002544 DF: CEREBRAL INFARCT   
% 213.54/213.72  |- rdf__type mesh__D002544sskos__Concept
% 213.54/213.72  |- skos__hiddenLabel mesh__D002544 Infarctions, Cerebral
% 213.54/213.72  |- skos__broader mesh__D002544smesh__D020520
% 213.54/213.72  |- skos__altLabel mesh__D002544 Left Hemisphere, Cerebral Infarction
% 213.54/213.72  |- skos__prefLabel mesh__D002544 Cerebral Infarction
% 213.54/213.72  |- mesh__recordMaintainer mesh__D002544 ssb
% 213.54/213.72  |- mesh__publicMeSHNote mesh__D002544 1979   
% 213.54/213.72  |- skos__altLabel mesh__D002544 Cerebral, Right Hemisphere, Infarction
% 213.54/213.72  |- skos__altLabel mesh__D002544 Infarction, Right Hemisphere, Cerebral
% 213.54/213.72  |- skos__historyNote mesh__D002544 Infarction %28%1966-1978%29%
% 213.54/213.72  |- skos__altLabel mesh__D002544 Infarction, Left Hemisphere, Cerebral
% 213.54/213.72  |- mesh__dateCreated mesh__D002544 1978-05-22
% 213.54/213.72  |- skos__hiddenLabel mesh__D002544 Infarction, Subcortical
% 213.54/213.72  |- mesh__historyNote mesh__D002544 1979   
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D002544 2006
% 213.54/213.72  |- skos__altLabel mesh__D002544 Right Hemisphere, Cerebral Infarction
% 213.54/213.72  |- skos__hiddenLabel mesh__D002544 Infarctions, Subcortical
% 213.54/213.72  |- skos__scopeNote mesh__D002544
% 213.54/213.72       The formation of an area of necrosis in the cerebrum caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere %28%i.e., left vs. right%29%, lobe %28%e.g., frontal lobe infarction%29%, arterial distribution %28%e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY%29%, and etiology %28%e.g., embolic infarction%29%.%A%    
% 213.54/213.72  |- mesh__recordOriginator mesh__D002544 RC
% 213.54/213.72  |- skos__altLabel mesh__D002544 Infarction, Cerebral, Left Hemisphere
% 213.54/213.72  |- skos__historyNote mesh__D002544
% 213.54/213.72       Cerebral Embolism and Thrombosis %28%1966-1978%29%
% 213.54/213.72  |- skos__hiddenLabel mesh__D002544 Subcortical Infarctions
% 213.54/213.72  |- skos__altLabel mesh__D002544 Cerebral, Left Hemisphere, Infarction
% 213.54/213.72  |- skos__altLabel mesh__D002544 Infarction, Cerebral, Right Hemisphere
% 213.54/213.72  |- mesh__publicMeSHNote mesh__D012972 65   
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D012972 2005
% 213.54/213.72  |- skos__broader mesh__D012972smesh__D006878
% 213.54/213.72  |- skos__prefLabel mesh__D012972 Sodium Hydroxide
% 213.54/213.72  |- mesh__recordAuthorizer mesh__D012972 sjn
% 213.54/213.72  |- mesh__dateEstablished mesh__D012972 1965-01-01
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D012972 2006
% 213.54/213.72  |- mesh__historyNote mesh__D012972 65%28%64%29%   
% 213.54/213.72  |- skos__altLabel mesh__D012972 Caustic Soda
% 213.54/213.72  |- skos__broader mesh__D012972smesh__D017670
% 213.54/213.72  |- skos__hiddenLabel mesh__D012972 Soda, Caustic
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D012972 2000
% 213.54/213.72  |- mesh__dateRevised mesh__D012972 1999-11-03
% 213.54/213.72  |- skos__scopeNote mesh__D012972
% 213.54/213.72       A highly caustic substance that is used to neutralize acids and make sodium salts. %28%From Merck Index, 11th ed%29%%A%    
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D012972 2003
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D012972 2001
% 213.54/213.72  |- skos__hiddenLabel mesh__D012972 Hydroxide, Sodium
% 213.54/213.72  |- skos__annotation mesh__D012972 a caustic   
% 213.54/213.72  |- mesh__recordOriginator mesh__D012972 NLM
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D012972 2004
% 213.54/213.72  |- mesh__dateCreated mesh__D012972 1999-01-01
% 213.54/213.72  |- rdf__type mesh__D012972sskos__Concept
% 213.54/213.72  |- mesh__recordMaintainer mesh__D012972 jmp
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D012972 2002
% 213.54/213.72  |- skos__altLabel mesh__D012174 Pigmentary Retinopathy
% 213.54/213.72  |- skos__hiddenLabel mesh__D012174 Rod-Cone Dystrophies
% 213.54/213.72  |- skos__hiddenLabel mesh__D012174 Degenerations, Tapetoretinal
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D012174 2004
% 213.54/213.72  |- skos__hiddenLabel mesh__D012174 Rod Cone Dystrophy
% 213.54/213.72  |- skos__altLabel mesh__D012174 Rod-Cone Dystrophy
% 213.54/213.72  |- skos__hiddenLabel mesh__D012174 Dystrophies, Rod-Cone
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D012174 2006
% 213.54/213.72  |- skos__related mesh__D012174smesh__D013631
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D012174 2003
% 213.54/213.72  |- skos__hiddenLabel mesh__D012174 Retinopathy, Pigmentary
% 213.54/213.72  |- skos__hiddenLabel mesh__D012174 Pigmentary Retinopathies
% 213.54/213.72  |- skos__prefLabel mesh__D012174 Retinitis Pigmentosa
% 213.54/213.72  |- skos__hiddenLabel mesh__D012174 Retinopathies, Pigmentary
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D012174 2005
% 213.54/213.72  |- skos__broader mesh__D012174smesh__D015785
% 213.54/213.72  |- skos__broader mesh__D012174smesh__D012162
% 213.54/213.72  |- skos__hiddenLabel mesh__D012174 Dystrophies, Rod Cone
% 213.54/213.72  |- rdf__type mesh__D012174sskos__Concept
% 213.54/213.72  |- skos__hiddenLabel mesh__D012174 Dystrophy, Rod-Cone
% 213.54/213.72  |- skos__altLabel mesh__D012174 Rod Cone Dystrophies
% 213.54/213.72  |- mesh__recordMaintainer mesh__D012174 nns
% 213.54/213.72  |- mesh__dateCreated mesh__D012174 1999-01-01
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D012174 2002
% 213.54/213.72  |- mesh__recordOriginator mesh__D012174 NLM
% 213.54/213.72  |- skos__hiddenLabel mesh__D012174 Tapetoretinal Degenerations
% 213.54/213.72  |- skos__hiddenLabel mesh__D012174 Degeneration, Tapetoretinal
% 213.54/213.72  |- mesh__dateRevised mesh__D012174 2001-07-25
% 213.54/213.72  |- skos__hiddenLabel mesh__D012174 Dystrophy, Rod Cone
% 213.54/213.72  |- mesh__recordAuthorizer mesh__D012174 sjn
% 213.54/213.72  |- skos__altLabel mesh__D012174 Tapetoretinal Degeneration
% 213.54/213.72  |- skos__scopeNote mesh__D012174
% 213.54/213.72       Hereditary, progressive degeneration of the neuroepithelium of the retina characterized by night blindness and progressive contraction of the visual field.%A%    
% 213.54/213.72  |- mesh__historyNote mesh__D006935 68%28%66%29%   
% 213.54/213.72  |- skos__annotation mesh__D006935 CARBON DIOXIDE/blood is also available   
% 213.54/213.72  |- mesh__dateRevised mesh__D006935 1999-11-03
% 213.54/213.72  |- mesh__publicMeSHNote mesh__D006935 68   
% 213.54/213.72  |- mesh__activeMeSHYear mesh__D006935 2002
% 213.54/213.72  |- mesh__recordOriginator mesh__D006935 NLM
% 213.54/213.73  |- rdf__type mesh__D006935sskos__Concept
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D006935 2004
% 213.54/213.73  |- skos__scopeNote mesh__D006935
% 213.54/213.73       A clinical manifestation of abnormal increase in the amount of carbon dioxide in arterial blood.%A%    
% 213.54/213.73  |- mesh__recordAuthorizer mesh__D006935 sjn
% 213.54/213.73  |- mesh__recordMaintainer mesh__D006935 KEV
% 213.54/213.73  |- mesh__dateEstablished mesh__D006935 1968-01-01
% 213.54/213.73  |- mesh__dateCreated mesh__D006935 1999-01-01
% 213.54/213.73  |- skos__broader mesh__D006935smesh__D012818
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D006935 2003
% 213.54/213.73  |- skos__prefLabel mesh__D006935 Hypercapnia
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D006935 2001
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D006935 2006
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D006935 2000
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D006935 2005
% 213.54/213.73  |- mesh__dateRevised mesh__D020606 2005-06-30
% 213.54/213.73  |- skos__historyNote mesh__D020606 Bacteria %28%1969-1977%29%
% 213.54/213.73  |- mesh__historyNote mesh__D020606 2000   
% 213.54/213.73  |- mesh__recordOriginator mesh__D020606 ndw
% 213.54/213.73  |- skos__prefLabel mesh__D020606 Stigmatella aurantiaca
% 213.54/213.73  |- mesh__dateCreated mesh__D020606 1999-11-03
% 213.54/213.73  |- skos__scopeNote mesh__D020606
% 213.54/213.73       A species of STIGMATELLA usually isolated from rotting wood. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 213.54/213.73  |- mesh__publicMeSHNote mesh__D020606 2000   
% 213.54/213.73  |- skos__broader mesh__D020606smesh__D020597
% 213.54/213.73  |- skos__historyNote mesh__D020606 Myxococcales %28%1978-1999%29%
% 213.54/213.73  |- rdf__type mesh__D020606sskos__Concept
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D020606 2006
% 213.54/213.73  |- mesh__recordMaintainer mesh__D020606 SYSTEM
% 213.54/213.73  |- mesh__dateEstablished mesh__D020606 2000-01-01
% 213.54/213.73  |- mesh__recordAuthorizer mesh__D020606 sjn
% 213.54/213.73  |- skos__hiddenLabel mesh__D016565 Lemurs, Dwarf
% 213.54/213.73  |- mesh__dateCreated mesh__D016565 1991-01-02
% 213.54/213.73  |- mesh__dateEstablished mesh__D016565 1992-01-01
% 213.54/213.73  |- skos__historyNote mesh__D016565 Lemuridae %28%1982-1991%29%
% 213.54/213.73  |- skos__annotation mesh__D016565
% 213.54/213.73       prosimians; do not confuse X refs with genus LEMUR; IM; qualif permitted%A%  
% 213.54/213.73  |- rdf__type mesh__D016565sskos__Concept
% 213.54/213.73  |- skos__prefLabel mesh__D016565 Cheirogaleidae
% 213.54/213.73  |- skos__hiddenLabel mesh__D016565 Dwarf Lemur
% 213.54/213.73  |- mesh__recordAuthorizer mesh__D016565 sjn
% 213.54/213.73  |- mesh__onlineNote mesh__D016565
% 213.54/213.73       use LEMURIDAE to search CHEIROGALEUS; LEMUR, DWARF; LEMUR, MOUSE and MICROCEBUS 1981-91%A%  
% 213.54/213.73  |- mesh__historyNote mesh__D016565
% 213.54/213.73       92; CHEIROGALEUS; LEMUR, DWARF; LEMUR, MOUSE and MICROCEBUS were see LEMURIDAE 1981-91%A%  
% 213.54/213.73  |- skos__hiddenLabel mesh__D016565 Dwarf Lemurs
% 213.54/213.73  |- skos__altLabel mesh__D016565 Lemur, Mouse
% 213.54/213.73  |- mesh__recordMaintainer mesh__D016565 ags
% 213.54/213.73  |- skos__broader mesh__D016565smesh__D011443
% 213.54/213.73  |- mesh__dateRevised mesh__D016565 2003-07-09
% 213.54/213.73  |- skos__scopeNote mesh__D016565
% 213.54/213.73       A family of the order PRIMATES, suborder Strepsirhini %28%PROSIMII%29%, containing five genera. All inhabitants of Madagascar, the genera are: Allocebus, Cheirogaleus %28%dwarf lemurs%29%, Microcebus %28%mouse lemurs%29%, Mirza, and Phaner.%A%    
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D016565 2005
% 213.54/213.73  |- skos__historyNote mesh__D016565 Lemur %28%1976-1991%29%
% 213.54/213.73  |- skos__historyNote mesh__D016565 Strepsirhini %28%1976-1991%29%
% 213.54/213.73  |- mesh__publicMeSHNote mesh__D016565
% 213.54/213.73       92; CHEIROGALEUS; LEMUR, DWARF; LEMUR, MOUSE and MICROCEBUS were see LEMURIDAE 1981-91%A%  
% 213.54/213.73  |- skos__altLabel mesh__D016565 Cheirogaleus
% 213.54/213.73  |- skos__hiddenLabel mesh__D016565 Lemurs, Mouse
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D016565 2006
% 213.54/213.73  |- skos__hiddenLabel mesh__D016565 Mouse Lemurs
% 213.54/213.73  |- mesh__recordOriginator mesh__D016565 MXR
% 213.54/213.73  |- skos__hiddenLabel mesh__D016565 Mouse Lemur
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D016565 2004
% 213.54/213.73  |- mesh__publicMeSHNote mesh__D002545
% 213.54/213.73       2000; see CEREBRAL ISCHEMIA 1979-1999   
% 213.54/213.73  |- skos__hiddenLabel mesh__D002545 Ischemic Encephalopathies
% 213.54/213.73  |- mesh__recordAuthorizer mesh__D002545 sjn
% 213.54/213.73  |- skos__historyNote mesh__D002545 Brain/blood supply %28%1966-1978%29%
% 213.54/213.73  |- skos__hiddenLabel mesh__D002545 Injury, Ischemic Brain
% 213.54/213.73  |- skos__broader mesh__D002545smesh__D020925
% 213.54/213.73  |- skos__scopeNote mesh__D002545
% 213.54/213.73       Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia %28%HYPOXIA, BRAIN%29%. Prolonged ischemia is associated with BRAIN INFARCTION.%A%    
% 213.54/213.73  |- rdf__type mesh__D002545sskos__Concept
% 213.54/213.73  |- skos__altLabel mesh__D002545 Ischemic Encephalopathy
% 213.54/213.73  |- mesh__dateEstablished mesh__D002545 1979-01-01
% 213.54/213.73  |- skos__annotation mesh__D002545
% 213.54/213.73       ISCHEMIC ATTACK, TRANSIENT is abailable; do not confuse with HYPOXIA, BRAIN, reduced oxygen supply%A%  
% 213.54/213.73  |- skos__hiddenLabel mesh__D002545 Ischemic Brain Injuries
% 213.54/213.73  |- skos__broader mesh__D002545smesh__D002561
% 213.54/213.73  |- skos__altLabel mesh__D002545 Ischemia, Cerebral
% 213.54/213.73  |- skos__hiddenLabel mesh__D002545 Ischemia, Brain
% 213.54/213.73  |- skos__prefLabel mesh__D002545 Brain Ischemia
% 213.54/213.73  |- skos__historyNote mesh__D002545
% 213.54/213.73       Cerebrovascular Disorders %28%1966-1978%29%
% 213.54/213.73  |- mesh__dateCreated mesh__D002545 1977-12-08
% 213.54/213.73  |- skos__altLabel mesh__D002545 Encephalopathy, Ischemic
% 213.54/213.73  |- skos__hiddenLabel mesh__D002545 Cerebral Ischemias
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D002545 2005
% 213.54/213.73  |- skos__broader mesh__D002545smesh__D007511
% 213.54/213.73  |- skos__hiddenLabel mesh__D002545 Brain Ischemias
% 213.54/213.73  |- skos__historyNote mesh__D002545 Ischemia %28%1966-1978%29%
% 213.54/213.73  |- mesh__historyNote mesh__D002545 2000%28%1979%29%   
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D002545 2006
% 213.54/213.73  |- skos__hiddenLabel mesh__D002545 Brain Injuries, Ischemic
% 213.54/213.73  |- mesh__recordMaintainer mesh__D002545 jls
% 213.54/213.73  |- skos__altLabel mesh__D002545 Ischemic Brain Injury
% 213.54/213.73  |- mesh__recordOriginator mesh__D002545 RC
% 213.54/213.73  |- skos__hiddenLabel mesh__D002545 Ischemias, Cerebral
% 213.54/213.73  |- mesh__dateRevised mesh__D002545 2004-07-19
% 213.54/213.73  |- skos__broader mesh__D009206Q000196smesh__D009206
% 213.54/213.73  |- mesh__preferredCombination mesh__D009206Q000196smesh__D006321Q000196
% 213.54/213.73  |- rdf__type mesh__D009206Q000196smesh__CompoundConcept
% 213.54/213.73  |- skos__altLabel mesh__D007230 Low-Birth-Weight Infant
% 213.54/213.73  |- mesh__historyNote mesh__D007230 77   
% 213.54/213.73  |- mesh__recordMaintainer mesh__D007230 PXP
% 213.54/213.73  |- skos__annotation mesh__D007230
% 213.54/213.73       born weighing 2500 gms %28%5.5 lbs%29% or less; qualif permitted as for INFANT, NEWBORN; check tag INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT is also available; DF: INFANT LBW%A%  
% 213.54/213.73  |- skos__hiddenLabel mesh__D007230 Low Birth Weights
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D007230 2005
% 213.54/213.73  |- skos__historyNote mesh__D007230 Birth Weight %28%1966-1976%29%
% 213.54/213.73  |- skos__hiddenLabel mesh__D007230 Infant, Low-Birth-Weight
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D007230 2006
% 213.54/213.73  |- mesh__recordOriginator mesh__D007230 SMH
% 213.54/213.73  |- mesh__recordAuthorizer mesh__D007230 sjn
% 213.54/213.73  |- skos__historyNote mesh__D007230 Infant, Premature %28%1966-1976%29%
% 213.54/213.73  |- mesh__publicMeSHNote mesh__D007230 77   
% 213.54/213.73  |- mesh__dateCreated mesh__D007230 1976-04-27
% 213.54/213.73  |- skos__historyNote mesh__D007230 Infant, Newborn %28%1966-1976%29%
% 213.54/213.73  |- mesh__dateEstablished mesh__D007230 1977-01-01
% 213.54/213.73  |- skos__hiddenLabel mesh__D007230 Low-Birth-Weight Infants
% 213.54/213.73  |- skos__scopeNote mesh__D007230
% 213.54/213.73       An infant having a birth weight of 2500 gm. %28%5.5 lb.%29% or less but INFANT, VERY LOW BIRTH WEIGHT is available for infants having a birth weight of 1500 grams %28%3.3 lb.%29% or less.%A%    
% 213.54/213.73  |- skos__hiddenLabel mesh__D007230 Birth Weight, Low
% 213.54/213.73  |- mesh__dateRevised mesh__D007230 2002-07-02
% 213.54/213.73  |- rdf__type mesh__D007230sskos__Concept
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D007230 2003
% 213.54/213.73  |- skos__hiddenLabel mesh__D007230 Infants, Low-Birth-Weight
% 213.54/213.73  |- skos__broader mesh__D007230smesh__D007231
% 213.54/213.73  |- skos__prefLabel mesh__D007230 Infant, Low Birth Weight
% 213.54/213.73  |- skos__hiddenLabel mesh__D007230 Birth Weights, Low
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D007230 2004
% 213.54/213.73  |- skos__hiddenLabel mesh__D007230 Low Birth Weight Infant
% 213.54/213.73  |- mesh__recordAuthorizer mesh__D012973 sjn
% 213.54/213.73  |- mesh__dateRevised mesh__D012973 2001-07-25
% 213.54/213.73  |- mesh__dateEstablished mesh__D012973 1965-01-01
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D012973 2005
% 213.54/213.73  |- skos__hiddenLabel mesh__D012973 Hypochlorite, Sodium
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D012973 2006
% 213.54/213.73  |- mesh__recordOriginator mesh__D012973 NLM
% 213.54/213.73  |- skos__broader mesh__D012973smesh__D017670
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D012973 2003
% 213.54/213.73  |- mesh__recordMaintainer mesh__D012973 ssb
% 213.54/213.73  |- mesh__dateCreated mesh__D012973 1999-01-01
% 213.54/213.73  |- rdf__type mesh__D012973sskos__Concept
% 213.54/213.73  |- skos__scopeNote mesh__D012973
% 213.54/213.73       It is used as an oxidizing and bleaching agent and as a disinfectant. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 213.54/213.73  |- mesh__historyNote mesh__D012973 65   
% 213.54/213.73  |- skos__broader mesh__D012973smesh__D006997
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D012973 2004
% 213.54/213.73  |- skos__prefLabel mesh__D012973 Sodium Hypochlorite
% 213.54/213.73  |- skos__annotation mesh__D012973
% 213.54/213.73       needle bleaching %28%as by intravenous drug users%29% is indexed under SODIUM HYPOCHLORITE + DISINFECTION + NEEDLES%A%  
% 213.54/213.73  |- mesh__publicMeSHNote mesh__D012973 65   
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D012973 2002
% 213.54/213.73  |- skos__altLabel mesh__D012973 Sodium Hypochlorite %28%Solution%29%
% 213.54/213.73  |- skos__broader mesh__D004064Q000601smesh__D004064
% 213.54/213.73  |- mesh__preferredCombination mesh__D004064Q000601smesh__D013505
% 213.54/213.73  |- rdf__type mesh__D004064Q000601smesh__CompoundConcept
% 213.54/213.73  |- skos__hiddenLabel mesh__D012175 Neuroblastomas, Retinal
% 213.54/213.73  |- skos__hiddenLabel mesh__D012175 Hereditary Retinoblastomas
% 213.54/213.73  |- skos__related mesh__D012175smesh__D016161
% 213.54/213.73  |- skos__hiddenLabel mesh__D012175 Retinoblastomas, Hereditary
% 213.54/213.73  |- skos__hiddenLabel mesh__D012175 Retinal Gliomas
% 213.54/213.73  |- skos__altLabel mesh__D012175 Glioblastoma, Retinal
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D012175 2006
% 213.54/213.73  |- skos__prefLabel mesh__D012175 Retinoblastoma
% 213.54/213.73  |- skos__hiddenLabel mesh__D012175 Retinoblastoma, Hereditary
% 213.54/213.73  |- skos__hiddenLabel mesh__D012175 Familial Retinoblastomas
% 213.54/213.73  |- mesh__recordMaintainer mesh__D012175 ags
% 213.54/213.73  |- skos__hiddenLabel mesh__D012175 Retinal Neuroblastoma
% 213.54/213.73  |- skos__hiddenLabel mesh__D012175 Retinal Neuroblastomas
% 213.54/213.73  |- skos__hiddenLabel mesh__D012175 Retinoblastomas, Familial
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D012175 2005
% 213.54/213.73  |- skos__hiddenLabel mesh__D012175 Retinoblastomas, Sporadic
% 213.54/213.73  |- skos__altLabel mesh__D012175 Hereditary Retinoblastoma
% 213.54/213.73  |- mesh__dateRevised mesh__D012175 2005-07-21
% 213.54/213.73  |- skos__hiddenLabel mesh__D012175 Sporadic Retinoblastomas
% 213.54/213.73  |- skos__hiddenLabel mesh__D012175 Retinal Glioma
% 213.54/213.73  |- skos__altLabel mesh__D012175 Glioma, Retinal
% 213.54/213.73  |- rdf__type mesh__D012175sskos__Concept
% 213.54/213.73  |- mesh__dateCreated mesh__D012175 1999-01-01
% 213.54/213.73  |- skos__hiddenLabel mesh__D012175 Retinoblastoma, Familial
% 213.54/213.73  |- skos__hiddenLabel mesh__D012175 Retinoblastoma, Sporadic
% 213.54/213.73  |- skos__hiddenLabel mesh__D012175 Glioblastomas, Retinal
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D012175 2006A
% 213.54/213.73  |- skos__annotation mesh__D012175
% 213.54/213.73       coordinate IM with RETINAL NEOPLASMS %28%IM%29%; /genetics: consider also GENES, RETINOBLASTOMA%A%  
% 213.54/213.73  |- skos__hiddenLabel mesh__D012175 Retinal Glioblastomas
% 213.54/213.73  |- skos__broader mesh__D012175smesh__D019572
% 213.54/213.73  |- skos__broader mesh__D012175smesh__D018302
% 213.54/213.73  |- skos__hiddenLabel mesh__D012175 Gliomas, Retinal
% 213.54/213.73  |- mesh__recordAuthorizer mesh__D012175 ags
% 213.54/213.73  |- skos__scopeNote mesh__D012175
% 213.54/213.73       A malignant tumor arising from the nuclear layer of the retina that is the most common primary tumor of the eye in children. The tumor tends to occur in early childhood or infancy and may be present at birth. The majority are sporadic, but the condition may be transmitted as an autosomal dominant trait. Histologic features include dense cellularity, small round polygonal cells, and areas of calcification and necrosis. An abnormal pupil reflex %28%leukokoria%29%; NYSTAGMUS, PATHOLOGIC; STRABISMUS; and visual loss represent common clinical characteristics of this condition. %28%From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2104%29%%A%    
% 213.54/213.73  |- mesh__recordOriginator mesh__D012175 NLM
% 213.54/213.73  |- skos__hiddenLabel mesh__D012175 Retinoblastomas
% 213.54/213.73  |- skos__hiddenLabel mesh__D012175 Retinal Glioblastoma
% 213.54/213.73  |- skos__altLabel mesh__D012175 Neuroblastoma, Retinal
% 213.54/213.73  |- mesh__recordMaintainer mesh__D006936 TGC
% 213.54/213.73  |- mesh__dateCreated mesh__D006936 1999-01-01
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D006936 2001
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D006936 1994
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D006936 2003
% 213.54/213.73  |- rdf__type mesh__D006936sskos__Concept
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D006936 2002
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D006936 1995
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D006936 1996
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D006936 2004
% 213.54/213.73  |- skos__broader mesh__D006936smesh__D014076
% 213.54/213.73  |- skos__scopeNote mesh__D006936
% 213.54/213.73       A regressive change of teeth characterized by excessive development of secondary cementum on the tooth surface. It may occur on any part of the root, but the apical two-thirds are most commonly affected. %28%Dorland, 27th ed%29%%A%    
% 213.54/213.73  |- mesh__publicMeSHNote mesh__D006936
% 213.54/213.73       91; was see under TOOTH DISEASES 1975-90   
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D006936 1997
% 213.54/213.73  |- mesh__onlineNote mesh__D006936 search TOOTH DISEASES 1969-74   
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D006936 2005
% 213.54/213.73  |- mesh__dateRevised mesh__D006936 1993-06-02
% 213.54/213.73  |- skos__prefLabel mesh__D006936 Hypercementosis
% 213.54/213.73  |- mesh__recordOriginator mesh__D006936 NLM
% 213.54/213.73  |- mesh__historyNote mesh__D006936
% 213.54/213.73       91%28%75%29%; was see under TOOTH DISEASES 1975-90   
% 213.54/213.73  |- mesh__dateEstablished mesh__D006936 1991-01-01
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D006936 1998
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D006936 2006
% 213.54/213.73  |- skos__hiddenLabel mesh__D006936 Hypercementoses
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D006936 2000
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D006936 1999
% 213.54/213.73  |- mesh__recordAuthorizer mesh__D006936 PLS
% 213.54/213.73  |- skos__annotation mesh__D006936
% 213.54/213.73       excessive develop of secondary cementum on tooth surface   
% 213.54/213.73  |- mesh__publicMeSHNote mesh__D020607
% 213.54/213.73       2004; see ECTOTHIORHODOSPIRA HALOPHILA 2000-2003   
% 213.54/213.73  |- skos__broader mesh__D020607smesh__D042001
% 213.54/213.73  |- mesh__recordMaintainer mesh__D020607 SYSTEM
% 213.54/213.73  |- skos__prefLabel mesh__D020607 Halorhodospira halophila
% 213.54/213.73  |- mesh__dateEstablished mesh__D020607 2000-01-01
% 213.54/213.73  |- mesh__recordAuthorizer mesh__D020607 sjn
% 213.54/213.73  |- skos__altLabel mesh__D020607 Ectothiorhodospira halophila
% 213.54/213.73  |- mesh__historyNote mesh__D020607 2004 %28%2000%29%   
% 213.54/213.73  |- mesh__dateRevised mesh__D020607 2005-06-30
% 213.54/213.73  |- skos__scopeNote mesh__D020607
% 213.54/213.73       A species of Halorhodospira distinguished by its ability to grow optimally in an environment of 15-20%25% salinity. It was formerly called Ectothiorhodospira halophila.%A%    
% 213.54/213.73  |- rdf__type mesh__D020607sskos__Concept
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D020607 2006
% 213.54/213.73  |- mesh__dateCreated mesh__D020607 1999-11-03
% 213.54/213.73  |- mesh__recordOriginator mesh__D020607 ndw
% 213.54/213.73  |- mesh__recordMaintainer mesh__D006138 ssb
% 213.54/213.73  |- skos__scopeNote mesh__D006138
% 213.54/213.73       Resin from wood of certain species of GUAIACUM. It is used as clinical reagent for occult blood.%A%    
% 213.54/213.73  |- skos__broader mesh__D006138smesh__D010936
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D006138 2006
% 213.54/213.73  |- skos__annotation mesh__D006138 D25-26 qualif   
% 213.54/213.73  |- mesh__dateRevised mesh__D006138 2005-06-30
% 213.54/213.73  |- skos__prefLabel mesh__D006138 Guaiac
% 213.54/213.73  |- mesh__dateCreated mesh__D006138 1999-01-01
% 213.54/213.73  |- mesh__recordOriginator mesh__D006138 NLM
% 213.54/213.73  |- mesh__recordAuthorizer mesh__D006138 sjn
% 213.54/213.73  |- rdf__type mesh__D006138sskos__Concept
% 213.54/213.73  |- rdf__type mesh__D016566sskos__Concept
% 213.54/213.73  |- skos__scopeNote mesh__D016566
% 213.54/213.73       Organic compounds which contain selenium as an integral part of the molecule.%A%    
% 213.54/213.73  |- mesh__recordMaintainer mesh__D016566 TAP
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D016566 2001
% 213.54/213.73  |- mesh__dateCreated mesh__D016566 1991-01-03
% 213.54/213.73  |- skos__annotation mesh__D016566 DF: ORGANOSELENIUM CPDS   
% 213.54/213.73  |- skos__hiddenLabel mesh__D016566 Compounds, Organoselenium
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D016566 2000
% 213.54/213.73  |- mesh__dateRevised mesh__D016566 1992-05-19
% 213.54/213.73  |- skos__prefLabel mesh__D016566 Organoselenium Compounds
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D016566 1997
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D016566 2004
% 213.54/213.73  |- skos__historyNote mesh__D016566 Selenium %28%1966-1991%29%
% 213.54/213.73  |- mesh__publicMeSHNote mesh__D016566 92   
% 213.54/213.73  |- mesh__dateEstablished mesh__D016566 1992-01-01
% 213.54/213.73  |- skos__broader mesh__D016566smesh__D009930
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D016566 1999
% 213.54/213.73  |- mesh__recordOriginator mesh__D016566 RLS
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D016566 2006
% 213.54/213.73  |- mesh__recordAuthorizer mesh__D016566 PLS
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D016566 1993
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D016566 1996
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D016566 1995
% 213.54/213.73  |- mesh__historyNote mesh__D016566 92   
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D016566 2003
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D016566 1998
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D016566 2005
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D016566 1994
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D016566 2002
% 213.54/213.73  |- skos__altLabel mesh__D002546
% 213.54/213.73       Anterior Circulation Transient Ischemic Attack
% 213.54/213.73  |- skos__hiddenLabel mesh__D002546 TIAs %28%Transient Ischemic Attack%29%
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D002546 2004
% 213.54/213.73  |- skos__altLabel mesh__D002546 Brain Stem Transient Ischemic Attack
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D002546 2002
% 213.54/213.73  |- skos__hiddenLabel mesh__D002546 TIA, Brain
% 213.54/213.73  |- skos__prefLabel mesh__D002546 Ischemic Attack, Transient
% 213.54/213.73  |- skos__altLabel mesh__D002546 TIA %28%Transient Ischemic Attack%29%
% 213.54/213.73  |- skos__hiddenLabel mesh__D002546 Ischemia, Transient Cerebral
% 213.54/213.73  |- skos__scopeNote mesh__D002546
% 213.54/213.73       Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology %28%e.g., embolic vs. thrombotic%29%. %28%From Adams et al., Principles of Neurology, 6th ed, pp814-6%29%%A%    
% 213.54/213.73  |- skos__hiddenLabel mesh__D002546 Ischemias, Transient Brainstem
% 213.54/213.73  |- mesh__dateCreated mesh__D002546 1999-01-01
% 213.54/213.73  |- skos__hiddenLabel mesh__D002546 Transient Cerebral Ischemias
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D002546 2003
% 213.54/213.73  |- skos__altLabel mesh__D002546 Brainstem Ischemia, Transient
% 213.54/213.73  |- skos__altLabel mesh__D002546 Transient Ischemic Attacks, Crescendo
% 213.54/213.73  |- skos__hiddenLabel mesh__D002546 Transient Cerebral Ischemia
% 213.54/213.73  |- skos__hiddenLabel mesh__D002546 Transient Brainstem Ischemia
% 213.54/213.73  |- skos__altLabel mesh__D002546
% 213.54/213.73       Transient Ischemic Attack, Posterior Circulation
% 213.54/213.73  |- mesh__recordAuthorizer mesh__D002546 sjn
% 213.54/213.73  |- skos__altLabel mesh__D002546 Brainstem Transient Ischemic Attack
% 213.54/213.73  |- skos__hiddenLabel mesh__D002546 Ischemia, Transient Brainstem
% 213.54/213.73  |- mesh__recordMaintainer mesh__D002546 ags
% 213.54/213.73  |- skos__hiddenLabel mesh__D002546 Cerebral Ischemias, Transient
% 213.54/213.73  |- skos__hiddenLabel mesh__D002546 Attack, Transient Ischemic
% 213.54/213.73  |- skos__hiddenLabel mesh__D002546 Ischemic Attacks, Transient
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D002546 2006
% 213.54/213.73  |- skos__altLabel mesh__D002546 Transient Ischemic Attack, Brain Stem
% 213.54/213.73  |- mesh__dateRevised mesh__D002546 2001-07-25
% 213.54/213.73  |- skos__broader mesh__D002546smesh__D002545
% 213.54/213.73  |- skos__hiddenLabel mesh__D002546 Ischemias, Transient Cerebral
% 213.54/213.73  |- mesh__publicMeSHNote mesh__D002546
% 213.54/213.73       2000; see CEREBRAL ISCHEMIA, TRANSIENT 1966-1999   
% 213.54/213.73  |- skos__altLabel mesh__D002546 Transient Ischemic Attack, Brainstem
% 213.54/213.73  |- mesh__recordOriginator mesh__D002546 NLM
% 213.54/213.73  |- rdf__type mesh__D002546sskos__Concept
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D002546 2005
% 213.54/213.73  |- skos__annotation mesh__D002546 DF: BRAIN TIA   
% 213.54/213.73  |- skos__hiddenLabel mesh__D002546 Attacks, Transient Ischemic
% 213.54/213.73  |- skos__altLabel mesh__D002546 Transient Ischemic Attack
% 213.54/213.73  |- mesh__historyNote mesh__D002546 2000%28%1966%29%   
% 213.54/213.73  |- skos__altLabel mesh__D002546
% 213.54/213.73       Vertebrobasilar Circulation Transient Ischemic Attack
% 213.54/213.73  |- skos__altLabel mesh__D002546
% 213.54/213.73       Transient Ischemic Attack, Carotid Circulation
% 213.54/213.73  |- skos__altLabel mesh__D002546 Brain TIA
% 213.54/213.73  |- skos__hiddenLabel mesh__D002546 Brainstem Ischemias, Transient
% 213.54/213.73  |- skos__hiddenLabel mesh__D002546 Transient Ischemic Attacks
% 213.54/213.73  |- skos__altLabel mesh__D007231 Newborns
% 213.54/213.73  |- skos__broader mesh__D007231smesh__D007223
% 213.54/213.73  |- skos__altLabel mesh__D007231 Neonate
% 213.54/213.73  |- skos__hiddenLabel mesh__D007231 Infants, Newborn
% 213.54/213.73  |- skos__hiddenLabel mesh__D007231 Newborn Infant
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D007231 2006
% 213.54/213.73  |- mesh__recordOriginator mesh__D007231 NLM
% 213.54/213.73  |- mesh__recordMaintainer mesh__D007231 kle
% 213.54/213.73  |- mesh__dateRevised mesh__D007231 2002-07-03
% 213.54/213.73  |- rdf__type mesh__D007231sskos__Concept
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D007231 2003
% 213.54/213.73  |- mesh__recordAuthorizer mesh__D007231 sjn
% 213.54/213.73  |- skos__related mesh__D007231smesh__D000831
% 213.54/213.73  |- skos__annotation mesh__D007231
% 213.54/213.73       from birth to 1 mo; IM; qualif permitted: /blood-csf-urine /growth /immunol /metab /physiol /psychol; also a check tag; as IM: Manual 18.5.9, 34.8, 34.9.1; specialty for only newborn inf = NEONATOLOGY, specialty for fetus %26% newborn inf = PERINATOLOGY%A%  
% 213.54/213.73  |- skos__prefLabel mesh__D007231 Infant, Newborn
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D007231 2004
% 213.54/213.73  |- skos__hiddenLabel mesh__D007231 Newborn Infants
% 213.54/213.73  |- skos__hiddenLabel mesh__D007231 Newborn
% 213.54/213.73  |- skos__hiddenLabel mesh__D007231 Neonates
% 213.54/213.73  |- mesh__dateCreated mesh__D007231 1999-01-01
% 213.54/213.73  |- skos__scopeNote mesh__D007231
% 213.54/213.73       An infant during the first month after birth.     
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D007231 2005
% 213.54/213.73  |- mesh__publicMeSHNote mesh__D048648 2005   
% 213.54/213.73  |- skos__broader mesh__D048648smesh__D002467
% 213.54/213.73  |- mesh__recordOriginator mesh__D048648 nns
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D048648 2005
% 213.54/213.73  |- mesh__recordAuthorizer mesh__D048648 sjn
% 213.54/213.73  |- rdf__type mesh__D048648sskos__Concept
% 213.54/213.73  |- mesh__dateEstablished mesh__D048648 2005-01-01
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D048648 2006
% 213.54/213.73  |- mesh__historyNote mesh__D048648 2005   
% 213.54/213.73  |- skos__scopeNote mesh__D048648
% 213.54/213.73       The larger of two types of nuclei in ciliate PROTOZOANS. It is the transcriptionally active nucleus of the vegetative cells as distinguished from the smaller transcriptionally inert GERMLINE MICRONUCLEUS.%A%    
% 213.54/213.73  |- skos__altLabel mesh__D048648 Macronuclei
% 213.54/213.73  |- skos__prefLabel mesh__D048648 Macronucleus
% 213.54/213.73  |- mesh__recordMaintainer mesh__D048648 nns
% 213.54/213.73  |- mesh__dateCreated mesh__D048648 2004-07-07
% 213.54/213.73  |- skos__historyNote mesh__D048648 Cell Nucleus %28%1965-2004%29%
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D012974 2005
% 213.54/213.73  |- skos__historyNote mesh__D012974 Iodides %28%1966-1978%29%
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D012974 2002
% 213.54/213.73  |- mesh__dateEstablished mesh__D012974 1991-01-01
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D012974 2006
% 213.54/213.73  |- mesh__dateRevised mesh__D012974 2001-07-25
% 213.54/213.73  |- mesh__recordOriginator mesh__D012974 RLS
% 213.54/213.73  |- mesh__recordAuthorizer mesh__D012974 sjn
% 213.54/213.73  |- skos__historyNote mesh__D012974 Sodium %28%1966-1978%29%
% 213.54/213.73  |- skos__prefLabel mesh__D012974 Sodium Iodide
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D012974 2003
% 213.54/213.73  |- mesh__dateCreated mesh__D012974 1978-03-15
% 213.54/213.73  |- skos__scopeNote mesh__D012974
% 213.54/213.73       A compound forming white, odorless deliquescent crystals and used as iodine supplement, expectorant or in its radioactive %28%I-131%29% form as an diagnostic aid, particularly for thyroid function tests.%A%    
% 213.54/213.73  |- rdf__type mesh__D012974sskos__Concept
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D012974 2004
% 213.54/213.73  |- skos__broader mesh__D012974smesh__D017670
% 213.54/213.73  |- mesh__recordMaintainer mesh__D012974 ssb
% 213.54/213.73  |- skos__broader mesh__D012974smesh__D007454
% 213.54/213.73  |- mesh__publicMeSHNote mesh__D012974 91; was see under IODIDES 1979-90   
% 213.54/213.73  |- mesh__historyNote mesh__D012974
% 213.54/213.73       91%28%79%29%; was see under IODIDES 1979-90   
% 213.54/213.73  |- mesh__recordOriginator mesh__D012176 RLS
% 213.54/213.73  |- mesh__historyNote mesh__D012176 84   
% 213.54/213.73  |- skos__prefLabel mesh__D012176 Retinoids
% 213.54/213.73  |- rdf__type mesh__D012176sskos__Concept
% 213.54/213.73  |- mesh__dateRevised mesh__D012176 2005-06-30
% 213.54/213.73  |- skos__historyNote mesh__D012176
% 213.54/213.73       Vitamin A/analogs %26% derivatives %28%1975-1983%29%
% 213.54/213.73  |- mesh__recordAuthorizer mesh__D012176 sjn
% 213.54/213.73  |- skos__broader mesh__D012176smesh__D002338
% 213.54/213.73  |- mesh__recordMaintainer mesh__D012176 ssb
% 213.54/213.73  |- mesh__dateEstablished mesh__D012176 1984-01-01
% 213.54/213.73  |- skos__scopeNote mesh__D012176
% 213.54/213.73       A group of tetraterpenes, with four terpene units joined head-to-tail. Biologically active members of this class are used clinically in the treatment of severe cystic ACNE; PSORIASIS; and other disorders of keratinization.%A%    
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D012176 2006
% 213.54/213.73  |- skos__historyNote mesh__D012176 Vitamin A %28%1969-1974%29%
% 213.54/213.73  |- mesh__dateCreated mesh__D012176 1983-06-16
% 213.54/213.73  |- mesh__publicMeSHNote mesh__D012176
% 213.54/213.73       84; RETINALDEHYDE was see under VITAMIN A 1968-83   
% 213.54/213.73  |- rdf__type mesh__D006937sskos__Concept
% 213.54/213.73  |- mesh__publicMeSHNote mesh__D006937
% 213.54/213.73       80; was HYPERCHOLESTEREMIA 1963-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 %28%see note under HYPERLIPIDEMIA for former cross refs to it%29%%A%  
% 213.54/213.73  |- skos__annotation mesh__D006937 high blood cholesterol levels   
% 213.54/213.73  |- mesh__recordMaintainer mesh__D006937 lkt
% 213.54/213.73  |- skos__hiddenLabel mesh__D006937 Hypercholesterolemias
% 213.54/213.73  |- skos__prefLabel mesh__D006937 Hypercholesterolemia
% 213.54/213.73  |- skos__broader mesh__D006937smesh__D006949
% 213.54/213.73  |- skos__scopeNote mesh__D006937
% 213.54/213.73       Abnormally high levels of cholesterol in the blood.     
% 213.54/213.73  |- mesh__onlineNote mesh__D006937
% 213.54/213.73       use HYPERCHOLESTEROLEMIA to search HYPERCHOLESTEREMIA 1966-79; search HYPERLIPEMIA, ESSENTIAL FAMILIAL under HYPERLIPIDEMIA/genetics 1966-79%A%  
% 213.54/213.73  |- mesh__dateRevised mesh__D006937 2005-06-30
% 213.54/213.73  |- mesh__activeMeSHYear mesh__D006937 2006
% 213.54/213.73  |- skos__hiddenLabel mesh__D006937 Hypercholesteremias
% 213.54/213.73  |- skos__altLabel mesh__D006937 Hypercholesteremia
% 213.54/213.73  |- mesh__historyNote mesh__D006937
% 213.54/213.73       80; was HYPERCHOLESTEREMIA 1963-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 %28%see note under HYPERLIPIDEMIA for former cross refs to it%29%%A%  
% 213.54/213.73  |- mesh__dateCreated mesh__D006937 1999-01-01
% 213.54/213.73  |- mesh__recordOriginator mesh__D006937 NLM
% 213.54/213.73  |- mesh__recordAuthorizer mesh__D006937 sjn
% 213.54/213.73  |- skos__prefLabel mesh__D020608 Ectothiorhodospira shaposhnikovii
% 213.54/213.73  |- mesh__dateCreated mesh__D020608 1999-11-03
% 213.54/213.74  |- mesh__recordMaintainer mesh__D020608 ags
% 213.54/213.74  |- rdf__type mesh__D020608sskos__Concept
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D020608 2006
% 213.54/213.74  |- skos__broader mesh__D020608smesh__D020587
% 213.54/213.74  |- mesh__recordAuthorizer mesh__D020608 sjn
% 213.54/213.74  |- mesh__historyNote mesh__D020608
% 213.54/213.74       2000; for ECTOTHIORHODOSPIRA VACUOLATA use ECTOTHIORHODOSPIRA 2000-2005%A%  
% 213.54/213.74  |- mesh__publicMeSHNote mesh__D020608
% 213.54/213.74       2000; for ECTOTHIORHODOSPIRA VACUOLATA see ECTOTHIORHODOSPIRA 2000-2005%A%  
% 213.54/213.74  |- mesh__dateRevised mesh__D020608 2005-06-30
% 213.54/213.74  |- skos__scopeNote mesh__D020608
% 213.54/213.74       A species of ECTOTHIORHODOSPIRA distinguished by its ability to utilize nitrate. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 213.54/213.74  |- skos__altLabel mesh__D020608 Ectothiorhodospira vacuolata
% 213.54/213.74  |- mesh__recordOriginator mesh__D020608 ndw
% 213.54/213.74  |- mesh__dateEstablished mesh__D020608 2000-01-01
% 213.54/213.74  |- skos__annotation mesh__D031330
% 213.54/213.74       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D031330 2006
% 213.54/213.74  |- skos__prefLabel mesh__D031330 Coleus
% 213.54/213.74  |- skos__altLabel mesh__D031330 Coleus forskohli
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D031330 2004
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D031330 2005
% 213.54/213.74  |- mesh__dateEstablished mesh__D031330 2003-01-01
% 213.54/213.74  |- mesh__historyNote mesh__D031330 2003   
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D031330 2003
% 213.54/213.74  |- skos__scopeNote mesh__D031330
% 213.54/213.74       A plant genus of the family LAMIACEAE which is the natural source of FORSKOLIN.%A%    
% 213.54/213.74  |- skos__broader mesh__D031330smesh__D019686
% 213.54/213.74  |- mesh__publicMeSHNote mesh__D031330 2003   
% 213.54/213.74  |- rdf__type mesh__D031330sskos__Concept
% 213.54/213.74  |- mesh__dateCreated mesh__D031330 2002-07-03
% 213.54/213.74  |- skos__broader mesh__D006139smesh__D010647
% 213.54/213.74  |- skos__altLabel mesh__D006139 2-Methoxy-Phenol
% 213.54/213.74  |- skos__broader mesh__D006139smesh__D002396
% 213.54/213.74  |- rdf__type mesh__D006139sskos__Concept
% 213.54/213.74  |- mesh__recordMaintainer mesh__D006139 ssb
% 213.54/213.74  |- mesh__recordOriginator mesh__D006139 NLM
% 213.54/213.74  |- mesh__recordAuthorizer mesh__D006139 sjn
% 213.54/213.74  |- mesh__dateRevised mesh__D006139 2004-07-07
% 213.54/213.74  |- skos__scopeNote mesh__D006139
% 213.54/213.74       An agent thought to have disinfectant properties and used as an expectorant. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p747%29%%A%    
% 213.54/213.74  |- skos__altLabel mesh__D006139 2-Methoxyphenol
% 213.54/213.74  |- skos__hiddenLabel mesh__D006139 Catechol, Methyl
% 213.54/213.74  |- skos__altLabel mesh__D006139 Methyl Catechol
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D006139 2006
% 213.54/213.74  |- skos__broader mesh__D006139smesh__D000840
% 213.54/213.74  |- skos__altLabel mesh__D006139 2-Hydroxy-Anisole
% 213.54/213.74  |- skos__altLabel mesh__D006139 Guaicol
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D006139 2005
% 213.54/213.74  |- skos__prefLabel mesh__D006139 Guaiacol
% 213.54/213.74  |- skos__broader mesh__D006139smesh__D008738
% 213.54/213.74  |- skos__altLabel mesh__D006139 2-Hydroxyanisole
% 213.54/213.74  |- mesh__dateCreated mesh__D006139 1999-01-01
% 213.54/213.74  |- mesh__recordMaintainer mesh__D016567 ssb
% 213.54/213.74  |- skos__hiddenLabel mesh__D016567 LY 139037
% 213.54/213.74  |- skos__historyNote mesh__D016567 Thiazoles %28%1966-1991%29%
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D016567 2006
% 213.54/213.74  |- skos__scopeNote mesh__D016567
% 213.54/213.74       A histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion. The drug is used for the treatment of duodenal ulcers.%A%    
% 213.54/213.74  |- skos__altLabel mesh__D016567
% 213.54/213.74       N-%28%2-%28%%28%%28%2-%28%%28%Dimethylamino%29%methyl%29%-4-thiazolyl%29%methyl%29%thio%29%ethyl%29%-N%27%-methyl-2-nitro-1,1-ethenediamine
% 213.54/213.74  |- mesh__dateRevised mesh__D016567 2005-06-30
% 213.54/213.74  |- skos__broader mesh__D016567smesh__D013844
% 213.54/213.74  |- skos__hiddenLabel mesh__D016567 LY139037
% 213.54/213.74  |- mesh__dateEstablished mesh__D016567 1992-01-01
% 213.54/213.74  |- skos__prefLabel mesh__D016567 Nizatidine
% 213.54/213.74  |- mesh__recordOriginator mesh__D016567 RLS
% 213.54/213.74  |- rdf__type mesh__D016567sskos__Concept
% 213.54/213.74  |- mesh__historyNote mesh__D016567 92; was NIZATIDINE %28%NM%29% 1985-91   
% 213.54/213.74  |- mesh__onlineNote mesh__D016567
% 213.54/213.74       use NIZATIDINE %28%NM%29% to search NIZATIDINE 1985-91   
% 213.54/213.74  |- mesh__recordAuthorizer mesh__D016567 sjn
% 213.54/213.74  |- mesh__dateCreated mesh__D016567 1991-01-03
% 213.54/213.74  |- mesh__publicMeSHNote mesh__D016567
% 213.54/213.74       92; NIZATIDINE was indexed under THIAZOLES 1985-91   
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D035721 2006
% 213.54/213.74  |- mesh__historyNote mesh__D035721 2003   
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D035721 2003
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D035721 2004
% 213.54/213.74  |- skos__annotation mesh__D035721
% 213.54/213.74       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.54/213.74  |- rdf__type mesh__D035721sskos__Concept
% 213.54/213.74  |- mesh__dateEstablished mesh__D035721 2003-01-01
% 213.54/213.74  |- mesh__publicMeSHNote mesh__D035721 2003   
% 213.54/213.74  |- mesh__dateCreated mesh__D035721 2002-07-03
% 213.54/213.74  |- skos__prefLabel mesh__D035721 Pterocarpus
% 213.54/213.74  |- skos__scopeNote mesh__D035721
% 213.54/213.74       A plant genus of the family FABACEAE. Members contain TRITERPENES.%A%    
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D035721 2005
% 213.54/213.74  |- skos__broader mesh__D035721smesh__D007887
% 213.54/213.74  |- skos__hiddenLabel mesh__D002547 Monoplegic Cerebral Palsies
% 213.54/213.74  |- skos__hiddenLabel mesh__D002547 Hypotonic Cerebral Palsies
% 213.54/213.74  |- skos__altLabel mesh__D002547 Diplegic Infantile Cerebral Palsy
% 213.54/213.74  |- skos__hiddenLabel mesh__D002547 Cerebral Palsy, Dystonic Rigid
% 213.54/213.74  |- skos__hiddenLabel mesh__D002547 Atonic Cerebral Palsy
% 213.54/213.74  |- mesh__dateCreated mesh__D002547 1999-01-01
% 213.54/213.74  |- skos__altLabel mesh__D002547 Congenital Cerebral Palsy
% 213.54/213.74  |- skos__altLabel mesh__D002547 Cerebral Palsy, Hypotonic
% 213.54/213.74  |- skos__hiddenLabel mesh__D002547 Dystonic-Rigid Cerebral Palsy
% 213.54/213.74  |- skos__hiddenLabel mesh__D002547 Cerebral Palsies, Dyskinetic
% 213.54/213.74  |- skos__hiddenLabel mesh__D002547 Dyskinetic Cerebral Palsy
% 213.54/213.74  |- mesh__recordAuthorizer mesh__D002547 sjn
% 213.54/213.74  |- skos__hiddenLabel mesh__D002547 Spastic Cerebral Palsies
% 213.54/213.74  |- skos__hiddenLabel mesh__D002547 Athetoid Cerebral Palsy
% 213.54/213.74  |- skos__hiddenLabel mesh__D002547 Cerebral Palsy, Monoplegic
% 213.54/213.74  |- skos__altLabel mesh__D002547 CP %28%Cerebral Palsy%29%
% 213.54/213.74  |- skos__hiddenLabel mesh__D002547 Diplegias, Spastic
% 213.54/213.74  |- skos__altLabel mesh__D002547 Quadriplegic Infantile Cerebral Palsy
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D002547 2006
% 213.54/213.74  |- skos__altLabel mesh__D002547 Infantile Cerebral Palsy, Quadriplegic
% 213.54/213.74  |- skos__altLabel mesh__D002547 Little%27%s Disease
% 213.54/213.74  |- skos__broader mesh__D002547smesh__D001925
% 213.54/213.74  |- mesh__recordMaintainer mesh__D002547 sjn
% 213.54/213.74  |- skos__hiddenLabel mesh__D002547 Spastic Cerebral Palsy
% 213.54/213.74  |- skos__altLabel mesh__D002547 Monoplegic Infantile Cerebral Palsy
% 213.54/213.74  |- rdf__type mesh__D002547sskos__Concept
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D002547 2005
% 213.54/213.74  |- skos__hiddenLabel mesh__D002547 Mixed Cerebral Palsy
% 213.54/213.74  |- skos__scopeNote mesh__D002547
% 213.54/213.74       A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity %28%see MUSCLE SPASTICITY%29% in all limbs. Spastic diplegia %28%Little disease%29% is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. %28%From Dev Med Child Neurol 1998 Aug;40%28%8%29%:520-7%29%%A%    
% 213.54/213.74  |- skos__hiddenLabel mesh__D002547 Cerebral Palsies, Monoplegic
% 213.54/213.74  |- skos__altLabel mesh__D002547 Cerebral Palsy, Dyskinetic
% 213.54/213.74  |- skos__annotation mesh__D002547
% 213.54/213.74       do not index under MUSCLE SPASTICITY unless especially discussed %26% then only NIM%A%  
% 213.54/213.74  |- mesh__recordOriginator mesh__D002547 NLM
% 213.54/213.74  |- skos__hiddenLabel mesh__D002547 Dystonic-Rigid Cerebral Palsies
% 213.54/213.74  |- skos__hiddenLabel mesh__D002547 Cerebral Palsies, Dystonic-Rigid
% 213.54/213.74  |- skos__altLabel mesh__D002547 Spastic Diplegia
% 213.54/213.74  |- skos__altLabel mesh__D002547 Infantile Cerebral Palsy, Monoplegic
% 213.54/213.74  |- skos__altLabel mesh__D002547 Diplegia, Spastic
% 213.54/213.74  |- skos__hiddenLabel mesh__D002547 Mixed Cerebral Palsies
% 213.54/213.74  |- skos__prefLabel mesh__D002547 Cerebral Palsy
% 213.54/213.74  |- skos__hiddenLabel mesh__D002547 Spastic Diplegias
% 213.54/213.74  |- skos__hiddenLabel mesh__D002547 Cerebral Palsies, Athetoid
% 213.54/213.74  |- mesh__dateRevised mesh__D002547 2003-07-25
% 213.54/213.74  |- skos__altLabel mesh__D002547 Infantile Cerebral Palsy, Diplegic
% 213.54/213.74  |- skos__altLabel mesh__D002547 Rolandic Type Cerebral Palsy
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D002547 2004
% 213.54/213.74  |- skos__hiddenLabel mesh__D002547 Hypotonic Cerebral Palsy
% 213.54/213.74  |- skos__scopeNote mesh__D021701
% 213.54/213.74       A diagnostic procedure used to determine whether LYMPHATIC METASTASIS has occurred. The sentinel lymph node is the first lymph node to receive drainage from a neoplasm.%A%    
% 213.54/213.74  |- skos__related mesh__D021701smesh__D008207
% 213.54/213.74  |- mesh__recordOriginator mesh__D021701 jmp
% 213.54/213.74  |- mesh__recordAuthorizer mesh__D021701 ags
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D021701 2003
% 213.54/213.74  |- rdf__type mesh__D021701sskos__Concept
% 213.54/213.74  |- mesh__publicMeSHNote mesh__D021701 2001   
% 213.54/213.74  |- mesh__dateCreated mesh__D021701 2000-07-05
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D021701 2001
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D021701 2004
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D021701 2005
% 213.54/213.74  |- skos__prefLabel mesh__D021701 Sentinel Lymph Node Biopsy
% 213.54/213.74  |- skos__historyNote mesh__D021701 Biopsy %28%1966-2000%29%
% 213.54/213.74  |- skos__altLabel mesh__D021701 Lymph Node Biopsy, Sentinel
% 213.54/213.74  |- mesh__recordMaintainer mesh__D021701 jmp
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D021701 2006
% 213.54/213.74  |- mesh__historyNote mesh__D021701 2001   
% 213.54/213.74  |- mesh__dateEstablished mesh__D021701 2001-01-01
% 213.54/213.74  |- skos__altLabel mesh__D021701 Biopsy, Sentinel Lymph Node
% 213.54/213.74  |- skos__broader mesh__D021701smesh__D001706
% 213.54/213.74  |- skos__broader mesh__D021701smesh__D008197
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D021701 2002
% 213.54/213.74  |- skos__annotation mesh__D007232
% 213.54/213.74       IM GEN only; for specific dis in newborn inf use specific dis %28%IM%29% + check tag INFANT, NEWBORN; do not use /compl /congen; check the tag INFANT, NEWBORN: Manual 18.5.10; relation to /congen: Manual 19.8.18, 23.21+; TN 109: relation to other Cat C16 terms%A%  
% 213.54/213.74  |- mesh__recordMaintainer mesh__D007232 kle
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D007232 2002
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D007232 2006
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D007232 2001
% 213.54/213.74  |- skos__broader mesh__D007232smesh__D009358
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D007232 2005
% 213.54/213.74  |- mesh__recordOriginator mesh__D007232 NLM
% 213.54/213.74  |- mesh__dateRevised mesh__D007232 1999-11-03
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D007232 2000
% 213.54/213.74  |- skos__prefLabel mesh__D007232 Infant, Newborn, Diseases
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D007232 2004
% 213.54/213.74  |- skos__scopeNote mesh__D007232
% 213.54/213.74       Diseases of newborn infants present at birth %28%congenital%29% or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.%A%    
% 213.54/213.74  |- rdf__type mesh__D007232sskos__Concept
% 213.54/213.74  |- mesh__dateCreated mesh__D007232 1999-01-01
% 213.54/213.74  |- skos__related mesh__D007232smesh__D000013
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D007232 2003
% 213.54/213.74  |- mesh__recordAuthorizer mesh__D007232 sjn
% 213.54/213.74  |- mesh__recordOriginator mesh__D012975 NLM
% 213.54/213.74  |- skos__scopeNote mesh__D012975
% 213.54/213.74       Stable sodium atoms that have the same atomic number as the element sodium, but differ in atomic weight. Na-23 is a stable sodium isotope.%A%    
% 213.54/213.74  |- mesh__dateRevised mesh__D012975 2000-06-22
% 213.54/213.74  |- skos__broader mesh__D012975smesh__D007554
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D012975 2001
% 213.54/213.74  |- skos__annotation mesh__D012975 Na-23; NIM   
% 213.54/213.74  |- mesh__recordMaintainer mesh__D012975 nns
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D012975 2006
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D012975 2004
% 213.54/213.74  |- rdf__type mesh__D012975sskos__Concept
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D012975 2005
% 213.54/213.74  |- mesh__recordAuthorizer mesh__D012975 sjn
% 213.54/213.74  |- skos__hiddenLabel mesh__D012975 Isotopes, Sodium
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D012975 2003
% 213.54/213.74  |- skos__prefLabel mesh__D012975 Sodium Isotopes
% 213.54/213.74  |- mesh__dateCreated mesh__D012975 1999-01-01
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D012975 2002
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D020609 2006
% 213.54/213.74  |- mesh__publicMeSHNote mesh__D020609 2000   
% 213.54/213.74  |- mesh__dateRevised mesh__D020609 2005-06-30
% 213.54/213.74  |- mesh__historyNote mesh__D020609 2000   
% 213.54/213.74  |- skos__prefLabel mesh__D020609 Edwardsiella tarda
% 213.54/213.74  |- skos__broader mesh__D020609smesh__D020594
% 213.54/213.74  |- mesh__dateCreated mesh__D020609 1999-11-03
% 213.54/213.74  |- skos__annotation mesh__D020609
% 213.54/213.74       infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 213.54/213.74  |- mesh__recordOriginator mesh__D020609 ndw
% 213.54/213.74  |- skos__scopeNote mesh__D020609
% 213.54/213.74       A species of EDWARDSIELLA distinguished by its hydrogen sulfide production. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 213.54/213.74  |- skos__historyNote mesh__D020609 Enterobacteriaceae %28%1966-1999%29%
% 213.54/213.74  |- mesh__dateEstablished mesh__D020609 2000-01-01
% 213.54/213.74  |- mesh__recordMaintainer mesh__D020609 SYSTEM
% 213.54/213.74  |- mesh__recordAuthorizer mesh__D020609 sjn
% 213.54/213.74  |- rdf__type mesh__D020609sskos__Concept
% 213.54/213.74  |- skos__broader mesh__D012177smesh__D002352
% 213.54/213.74  |- skos__broader mesh__D012177smesh__D000510
% 213.54/213.74  |- skos__hiddenLabel mesh__D012177 Binding Proteins, Retinoid
% 213.54/213.74  |- mesh__dateRevised mesh__D012177 2004-07-07
% 213.54/213.74  |- mesh__historyNote mesh__D012177 76   
% 213.54/213.74  |- skos__hiddenLabel mesh__D012177 Binding Proteins, Retinol
% 213.54/213.74  |- skos__prefLabel mesh__D012177 Retinol-Binding Proteins
% 213.54/213.74  |- skos__altLabel mesh__D012177 Retinoid Binding Proteins
% 213.54/213.74  |- skos__scopeNote mesh__D012177
% 213.54/213.74       Proteins which bind with RETINOL. The retinol-binding protein found in plasma has an alpha-1 mobility on electrophoresis and a molecular weight of about 21 kDa. The protein has one binding site for retinol and is responsible for the transport of Vitamin A. The retinol-protein complex %28%MW=80-90 kDa%29% circulates in plasma in the form of a protein-protein complex with prealbumin. The retinol-binding protein found in tissue has a molecular weight of 14 kDa and carries retinol as a non-covalently-bound ligand.%A%    
% 213.54/213.74  |- skos__altLabel mesh__D012177 Retinol-Binding Protein 1
% 213.54/213.74  |- mesh__recordOriginator mesh__D012177 RLS
% 213.54/213.74  |- skos__historyNote mesh__D012177 Retinol %28%1975%29%
% 213.54/213.74  |- skos__related mesh__D012177smesh__D018168
% 213.54/213.74  |- skos__hiddenLabel mesh__D012177 Protein 1, Retinol-Binding
% 213.54/213.74  |- skos__hiddenLabel mesh__D012177 Proteins, Retinoid Binding
% 213.54/213.74  |- mesh__publicMeSHNote mesh__D012177 76   
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D012177 2006
% 213.54/213.74  |- mesh__dateCreated mesh__D012177 1975-07-25
% 213.54/213.74  |- skos__hiddenLabel mesh__D012177 Proteins, Retinol Binding
% 213.54/213.74  |- skos__historyNote mesh__D012177 Vitamin A %28%1972-1974%29%
% 213.54/213.74  |- mesh__recordAuthorizer mesh__D012177 sjn
% 213.54/213.74  |- skos__historyNote mesh__D012177 Proteins %28%1972-1975%29%
% 213.54/213.74  |- skos__historyNote mesh__D012177 Blood Proteins %28%1972-1975%29%
% 213.54/213.74  |- skos__hiddenLabel mesh__D012177 Retinol Binding Protein 1
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D012177 2005
% 213.54/213.74  |- skos__hiddenLabel mesh__D012177 Retinoid Binding Protein, F Type
% 213.54/213.74  |- mesh__recordMaintainer mesh__D012177 ssb
% 213.54/213.74  |- skos__hiddenLabel mesh__D012177 Proteins, Retinol-Binding
% 213.54/213.74  |- skos__altLabel mesh__D012177 Retinol Binding Proteins
% 213.54/213.74  |- rdf__type mesh__D012177sskos__Concept
% 213.54/213.74  |- skos__historyNote mesh__D012177 Protein Binding %28%1972-1975%29%
% 213.54/213.74  |- mesh__dateEstablished mesh__D012177 1976-01-01
% 213.54/213.74  |- skos__annotation mesh__D006938
% 213.54/213.74       do not coord with INFANT, NEWBORN, DISEASES   
% 213.54/213.74  |- mesh__recordOriginator mesh__D006938 VDK
% 213.54/213.74  |- skos__broader mesh__D006938smesh__D006950
% 213.54/213.74  |- skos__hiddenLabel mesh__D006938 Type II, Hyperlipoproteinemia
% 213.54/213.74  |- skos__hiddenLabel mesh__D006938 Hyperlipoproteinemia Type IIs
% 213.54/213.74  |- skos__hiddenLabel mesh__D006938 Essential Hypercholesterolemia
% 213.54/213.74  |- skos__broader mesh__D006938smesh__D008052
% 213.54/213.74  |- skos__hiddenLabel mesh__D006938 Hypercholesterolemias, Familial
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D006938 2006
% 213.54/213.74  |- mesh__dateCreated mesh__D006938 1979-04-23
% 213.54/213.74  |- mesh__historyNote mesh__D006938 80   
% 213.54/213.74  |- mesh__dateEstablished mesh__D006938 1980-01-01
% 213.54/213.74  |- skos__altLabel mesh__D006938 Hyperlipoproteinemia Type II
% 213.54/213.74  |- mesh__recordAuthorizer mesh__D006938 sjn
% 213.54/213.74  |- skos__hiddenLabel mesh__D006938 Hypercholesterolemias, Essential
% 213.54/213.74  |- skos__hiddenLabel mesh__D006938 Familial Hypercholesterolemias
% 213.54/213.74  |- skos__scopeNote mesh__D006938
% 213.54/213.74       A familial disorder characterized by increased plasma concentration of cholesterol carried in low density lipoproteins %28%LDL%29% and by a deficiency in a cell surface receptor which regulates LDL degradation and cholesterol synthesis.%A%    
% 213.54/213.74  |- mesh__publicMeSHNote mesh__D006938 80   
% 213.54/213.74  |- skos__prefLabel mesh__D006938 Hypercholesterolemia, Familial
% 213.54/213.74  |- mesh__recordMaintainer mesh__D006938 lkt
% 213.54/213.74  |- skos__historyNote mesh__D006938
% 213.54/213.74       Hyperlipidemia/familial %26% genetic %28%1966-1979%29%
% 213.54/213.74  |- skos__hiddenLabel mesh__D006938 IIs, Hyperlipoproteinemia Type
% 213.54/213.74  |- skos__hiddenLabel mesh__D006938 Familial Hypercholesterolemia
% 213.54/213.74  |- skos__hiddenLabel mesh__D006938 Type IIs, Hyperlipoproteinemia
% 213.54/213.74  |- skos__hiddenLabel mesh__D006938 Hyperbetalipoproteinemias
% 213.54/213.74  |- rdf__type mesh__D006938sskos__Concept
% 213.54/213.74  |- skos__altLabel mesh__D006938 Hyperbetalipoproteinemia
% 213.54/213.74  |- skos__broader mesh__D006938smesh__D006937
% 213.54/213.74  |- skos__hiddenLabel mesh__D006938 Essential Hypercholesterolemias
% 213.54/213.74  |- mesh__dateRevised mesh__D006938 2005-06-30
% 213.54/213.74  |- skos__broader mesh__D006938smesh__D006951
% 213.54/213.74  |- skos__altLabel mesh__D006938 Hypercholesterolemia, Essential
% 213.54/213.74  |- skos__historyNote mesh__D006938 Hypercholesterolemia %28%1966-1979%29%
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D017660 2000
% 213.54/213.74  |- skos__broader mesh__D017660smesh__D017661
% 213.54/213.74  |- rdf__type mesh__D017660sskos__Concept
% 213.54/213.74  |- mesh__recordAuthorizer mesh__D017660 SJN
% 213.54/213.74  |- mesh__dateCreated mesh__D017660 1993-06-30
% 213.54/213.74  |- skos__prefLabel mesh__D017660 Autoreceptors
% 213.54/213.74  |- mesh__recordOriginator mesh__D017660 RAZ
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D017660 2006
% 213.54/213.74  |- skos__annotation mesh__D017660 presynaptic receptors; DF: AUTORECEPT   
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D017660 2002
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D017660 1999
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D017660 2004
% 213.54/213.74  |- mesh__dateEstablished mesh__D017660 1994-01-01
% 213.54/213.74  |- skos__scopeNote mesh__D017660
% 213.54/213.74       Transmitter receptors on or near presynaptic terminals %28%or varicosities%29% which are sensitive to the transmitter%28%s%29% released by the terminal itself. Receptors for the hormones released by hormone-releasing cells are also included.%A%    
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D017660 2005
% 213.54/213.74  |- skos__altLabel mesh__D017660 Autoreceptor
% 213.54/213.74  |- mesh__publicMeSHNote mesh__D017660 94   
% 213.54/213.74  |- skos__broader mesh__D017660smesh__D011956
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D017660 1998
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D017660 2003
% 213.54/213.74  |- mesh__historyNote mesh__D017660 94   
% 213.54/213.74  |- mesh__dateRevised mesh__D017660 1997-06-20
% 213.54/213.74  |- mesh__recordMaintainer mesh__D017660 NDW
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D017660 2001
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D031331 2006
% 213.54/213.74  |- skos__scopeNote mesh__D031331
% 213.54/213.74       A plant genus of the family LAMIACEAE that contains 5-methoxydehydropodophyllotoxin %28%a PODOPHYLLOTOXIN%29% and other LIGNANS.%A%    
% 213.54/213.74  |- mesh__dateCreated mesh__D031331 2002-07-03
% 213.54/213.74  |- skos__prefLabel mesh__D031331 Hyptis
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D031331 2004
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D031331 2005
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D031331 2003
% 213.54/213.74  |- skos__broader mesh__D031331smesh__D019686
% 213.54/213.74  |- mesh__publicMeSHNote mesh__D031331 2003   
% 213.54/213.74  |- rdf__type mesh__D031331sskos__Concept
% 213.54/213.74  |- mesh__dateEstablished mesh__D031331 2003-01-01
% 213.54/213.74  |- mesh__historyNote mesh__D031331 2003   
% 213.54/213.74  |- skos__annotation mesh__D031331
% 213.54/213.74       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.54/213.74  |- mesh__recordOriginator mesh__D003640 NLM
% 213.54/213.74  |- skos__broader mesh__D003640smesh__D008660
% 213.54/213.74  |- skos__broader mesh__D003640smesh__D002625
% 213.54/213.74  |- mesh__recordMaintainer mesh__D003640 PXP
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D003640 2001
% 213.54/213.74  |- rdf__type mesh__D003640sskos__Concept
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D003640 1999
% 213.54/213.74  |- mesh__publicMeSHNote mesh__D003640 74   
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D003640 2004
% 213.54/213.74  |- skos__prefLabel mesh__D003640 Dealkylation
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D003640 2000
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D003640 1998
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D003640 2003
% 213.54/213.74  |- mesh__historyNote mesh__D003640 74%28%71%29%   
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D003640 2006
% 213.54/213.74  |- skos__hiddenLabel mesh__D003640 Dealkylations
% 213.54/213.74  |- mesh__recordAuthorizer mesh__D003640 SJN
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D003640 2002
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D003640 2005
% 213.54/213.74  |- skos__historyNote mesh__D003640 Alkylation %28%1966-1970%29%
% 213.54/213.74  |- skos__annotation mesh__D003640
% 213.54/213.74       almost never IM; enzymatic dealkylation: coord NIM with specific enzyme %28%IM%29% + substrate %28%NIM%29%%A%  
% 213.54/213.74  |- skos__scopeNote mesh__D003640
% 213.54/213.74       The removing of alkyl groups from a compound. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%    
% 213.54/213.74  |- mesh__dateEstablished mesh__D003640 1974-01-01
% 213.54/213.74  |- mesh__dateRevised mesh__D003640 1997-06-20
% 213.54/213.74  |- mesh__dateCreated mesh__D003640 1999-01-01
% 213.54/213.74  |- skos__hiddenLabel mesh__D050296 Viability, Virus
% 213.54/213.74  |- skos__broader mesh__D050296smesh__D008827
% 213.54/213.74  |- skos__hiddenLabel mesh__D050296 Viability, Bacterial
% 213.54/213.74  |- skos__hiddenLabel mesh__D050296 Viability, Microbial
% 213.54/213.74  |- skos__historyNote mesh__D050296
% 213.54/213.74       organism/growth %26% development %28%1966-2005%29%
% 213.54/213.74  |- skos__scopeNote mesh__D050296
% 213.54/213.74       Ability of a microbe to survive under given conditions. This can also be related to a colony%27%s ability to replicate.%A%    
% 213.54/213.74  |- mesh__recordOriginator mesh__D050296 ags
% 213.54/213.74  |- skos__related mesh__D050296smesh__D015169
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D050296 2006
% 213.54/213.74  |- skos__hiddenLabel mesh__D050296 Viability, Bacteria
% 213.54/213.74  |- mesh__historyNote mesh__D050296 2006   
% 213.54/213.74  |- skos__prefLabel mesh__D050296 Microbial Viability
% 213.54/213.74  |- mesh__dateEstablished mesh__D050296 2006-01-01
% 213.54/213.74  |- skos__altLabel mesh__D050296 Bacteria Viability
% 213.54/213.74  |- rdf__type mesh__D050296sskos__Concept
% 213.54/213.74  |- mesh__recordAuthorizer mesh__D050296 sjn
% 213.54/213.74  |- mesh__recordMaintainer mesh__D050296 ags
% 213.54/213.74  |- mesh__dateCreated mesh__D050296 2005-06-30
% 213.54/213.74  |- skos__hiddenLabel mesh__D050296 Inactivation, Microbial
% 213.54/213.74  |- mesh__publicMeSHNote mesh__D050296 2006   
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D016568 2006
% 213.54/213.74  |- mesh__historyNote mesh__D016568 92   
% 213.54/213.74  |- mesh__publicMeSHNote mesh__D016568 92   
% 213.54/213.74  |- skos__prefLabel mesh__D016568 Drugs, Generic
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D016568 2005
% 213.54/213.74  |- skos__hiddenLabel mesh__D016568 Nonproprietary Drugs
% 213.54/213.74  |- mesh__recordAuthorizer mesh__D016568 sjn
% 213.54/213.74  |- skos__altLabel mesh__D016568 Drugs, Nonproprietary
% 213.54/213.74  |- mesh__dateCreated mesh__D016568 1991-01-02
% 213.54/213.74  |- rdf__type mesh__D016568sskos__Concept
% 213.54/213.74  |- mesh__recordMaintainer mesh__D016568 ssb
% 213.54/213.74  |- mesh__dateRevised mesh__D016568 2003-07-09
% 213.54/213.74  |- skos__historyNote mesh__D016568 Drugs %28%1966-1991%29%
% 213.54/213.74  |- skos__annotation mesh__D016568
% 213.54/213.74       GEN only or unspecified; D25-26 qualif; for specific drug as a generic, coord IM with drug %28%IM%29%%A%  
% 213.54/213.74  |- skos__altLabel mesh__D016568 Generic Drugs
% 213.54/213.74  |- skos__broader mesh__D016568smesh__D004364
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D016568 2004
% 213.54/213.74  |- mesh__dateEstablished mesh__D016568 1992-01-01
% 213.54/213.74  |- skos__scopeNote mesh__D016568
% 213.54/213.74       Drugs whose drug name is not protected by a trademark. They may be manufactured by several companies.%A%    
% 213.54/213.74  |- mesh__recordOriginator mesh__D016568 RLS
% 213.54/213.74  |- skos__broader mesh__D035722smesh__D019684
% 213.54/213.74  |- mesh__dateCreated mesh__D035722 2002-07-02
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D035722 2004
% 213.54/213.74  |- skos__scopeNote mesh__D035722
% 213.54/213.74       A plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida.%A%    
% 213.54/213.74  |- rdf__type mesh__D035722sskos__Concept
% 213.54/213.74  |- mesh__historyNote mesh__D035722 2003   
% 213.54/213.74  |- mesh__publicMeSHNote mesh__D035722 2003   
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D035722 2005
% 213.54/213.74  |- skos__annotation mesh__D035722
% 213.54/213.74       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.54/213.74  |- mesh__dateEstablished mesh__D035722 2003-01-01
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D035722 2006
% 213.54/213.74  |- skos__prefLabel mesh__D035722 Aizoaceae
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D035722 2003
% 213.54/213.74  |- skos__hiddenLabel mesh__D002548 Arterial Bypass, EC-IC
% 213.54/213.74  |- mesh__dateCreated mesh__D002548 1979-03-08
% 213.54/213.74  |- mesh__recordMaintainer mesh__D002548 PXP
% 213.54/213.74  |- skos__altLabel mesh__D002548 Brain Revascularization
% 213.54/213.74  |- skos__hiddenLabel mesh__D002548
% 213.54/213.74       Arterial Bypass, Extracranial-Intracranial
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D002548 2000
% 213.54/213.74  |- skos__historyNote mesh__D002548
% 213.54/213.74       Cerebrovascular Circulation %28%1966-1979%29%
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D002548 2006
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D002548 1999
% 213.54/213.74  |- skos__broader mesh__D002548smesh__D014656
% 213.54/213.74  |- skos__hiddenLabel mesh__D002548 STA-MCA Bypasses
% 213.54/213.74  |- skos__hiddenLabel mesh__D002548 Bypasses, EC-IC Arterial
% 213.54/213.74  |- skos__hiddenLabel mesh__D002548 Revascularization, Cerebral
% 213.54/213.74  |- skos__hiddenLabel mesh__D002548 STA MCA Bypass
% 213.54/213.74  |- skos__historyNote mesh__D002548
% 213.54/213.74       Temporal Arteries/surgery %28%1966-1979%29%
% 213.54/213.74  |- mesh__historyNote mesh__D002548 80   
% 213.54/213.74  |- mesh__recordOriginator mesh__D002548 SMH
% 213.54/213.74  |- skos__historyNote mesh__D002548 Brain/blood supply%28%1966-1979%29%
% 213.54/213.74  |- rdf__type mesh__D002548sskos__Concept
% 213.54/213.74  |- mesh__activeMeSHYear mesh__D002548 2001
% 213.54/213.74  |- skos__historyNote mesh__D002548
% 213.54/213.74       Cerebral Arteries/surgery %28%1966-1979%29%
% 213.54/213.74  |- skos__broader mesh__D002548smesh__D008866
% 213.54/213.74  |- skos__historyNote mesh__D002548
% 213.54/213.74       Arterial Occlusive Diseases/surgery %28%1973-1979%29%
% 213.54/213.75  |- skos__hiddenLabel mesh__D002548 EC-IC Arterial Bypasses
% 213.54/213.75  |- skos__prefLabel mesh__D002548 Cerebral Revascularization
% 213.54/213.75  |- skos__historyNote mesh__D002548
% 213.54/213.75       specific cerebrovascular disorder/surgery %28%1966-1979%29%
% 213.54/213.75  |- skos__hiddenLabel mesh__D002548
% 213.54/213.75       Extracranial-Intracranial Arterial Bypasses
% 213.54/213.75  |- skos__altLabel mesh__D002548 EC-IC Arterial Bypass
% 213.54/213.75  |- skos__hiddenLabel mesh__D002548 Revascularization, Brain
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D002548 2003
% 213.54/213.75  |- skos__annotation mesh__D002548
% 213.54/213.75       do not use /util except by MeSH definition   
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D002548 2002
% 213.54/213.75  |- skos__hiddenLabel mesh__D002548 Arterial Bypasses, EC-IC
% 213.54/213.75  |- skos__hiddenLabel mesh__D002548
% 213.54/213.75       Bypass, Extracranial-Intracranial Arterial
% 213.54/213.75  |- mesh__dateRevised mesh__D002548 1997-06-20
% 213.54/213.75  |- skos__hiddenLabel mesh__D002548
% 213.54/213.75       Revascularization, Cerebral Microsurgical
% 213.54/213.75  |- skos__historyNote mesh__D002548
% 213.54/213.75       Cerebrovascular Disorders/surgery %28%1966-1979%29%
% 213.54/213.75  |- skos__hiddenLabel mesh__D002548 Bypass, EC-IC Arterial
% 213.54/213.75  |- skos__hiddenLabel mesh__D002548
% 213.54/213.75       Bypasses, Extracranial-Intracranial Arterial
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D002548 2004
% 213.54/213.75  |- skos__hiddenLabel mesh__D002548 Bypass, STA-MCA
% 213.54/213.75  |- skos__hiddenLabel mesh__D002548 EC IC Arterial Bypass
% 213.54/213.75  |- skos__hiddenLabel mesh__D002548
% 213.54/213.75       Extracranial Intracranial Arterial Bypass
% 213.54/213.75  |- mesh__dateEstablished mesh__D002548 1980-01-01
% 213.54/213.75  |- skos__altLabel mesh__D002548 Microsurgical Revascularization, Cerebral
% 213.54/213.75  |- mesh__publicMeSHNote mesh__D002548 80   
% 213.54/213.75  |- skos__hiddenLabel mesh__D002548
% 213.54/213.75       Cerebral Microsurgical Revascularizations
% 213.54/213.75  |- skos__altLabel mesh__D002548 Cerebral Microsurgical Revascularization
% 213.54/213.75  |- skos__hiddenLabel mesh__D002548 Bypasses, STA-MCA
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D002548 2005
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D002548 1998
% 213.54/213.75  |- skos__scopeNote mesh__D002548
% 213.54/213.75       Microsurgical revascularization to improve intracranial circulation. It usually involves joining the extracranial circulation to the intracranial circulation but may include extracranial revascularization %28%e.g., subclavian-vertebral artery bypass, subclavian-external carotid artery bypass%29%. It is performed by joining two arteries %28%direct anastomosis or use of graft%29% or by free autologous transplantation of highly vascularized tissue to the surface of the brain.%A%    
% 213.54/213.75  |- mesh__recordAuthorizer mesh__D002548 SJN
% 213.54/213.75  |- skos__hiddenLabel mesh__D002548
% 213.54/213.75       Arterial Bypasses, Extracranial-Intracranial
% 213.54/213.75  |- skos__related mesh__D013270smesh__D018662
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D013270 2006
% 213.54/213.75  |- skos__annotation mesh__D013270
% 213.54/213.75       /blood supply: gastric varix or varices = ESOPHAGEAL AND GASTRIC VARICES %26% see note there; perforation = STOMACH /inj, not STOMACH RUPTURE; gastric secretion = GASTRIC JUICE /secret or GASTRIC MUCOSA /secret, not STOMACH /secret; stomach secretes GASTRIN; HYDROCHLORIC ACID, GASTRIC %28%see GASTRIC ACID%29%; INTRINSIC FACTOR %26% PEPSINOGENS; /surg: consider also GASTRECTOMY; GASTROENTEROSTOMY %26% GASTROSTOMY; inflammation = GASTRITIS; Heidenhain pouch: index STOMACH /physiol; gastric hyperacidity: index under GASTRIC ACID /secret; mucosal prolapse = GASTRIC MUCOSA %28%IM%29% + STOMACH DISEASES %28%NIM%29% + PROLAPSE; many parts of STOMACH are available%A%  
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D013270 2004
% 213.54/213.75  |- mesh__recordAuthorizer mesh__D013270 sjn
% 213.54/213.75  |- skos__related mesh__D013270smesh__D005763
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D013270 2005
% 213.54/213.75  |- skos__broader mesh__D013270smesh__D041742
% 213.54/213.75  |- mesh__dateCreated mesh__D013270 1999-01-01
% 213.54/213.75  |- mesh__dateRevised mesh__D013270 2003-07-09
% 213.54/213.75  |- skos__related mesh__D013270smesh__D005773
% 213.54/213.75  |- mesh__recordMaintainer mesh__D013270 lkt
% 213.54/213.75  |- mesh__considerAlso mesh__D013270 consider also terms at GASTR-   
% 213.54/213.75  |- skos__scopeNote mesh__D013270
% 213.54/213.75       An organ of digestion situated in the left upper quadrant of the abdomen between the termination of the ESOPHAGUS and the beginning of the DUODENUM.%A%    
% 213.54/213.75  |- mesh__recordOriginator mesh__D013270 NLM
% 213.54/213.75  |- skos__prefLabel mesh__D013270 Stomach
% 213.54/213.75  |- skos__related mesh__D013270smesh__D005774
% 213.54/213.75  |- skos__hiddenLabel mesh__D013270 Stomachs
% 213.54/213.75  |- rdf__type mesh__D013270sskos__Concept
% 213.54/213.75  |- skos__related mesh__D013270smesh__D005743
% 213.54/213.75  |- skos__related mesh__D013270smesh__D015391
% 213.54/213.75  |- mesh__dateRevised mesh__D007233 2002-07-03
% 213.54/213.75  |- mesh__recordAuthorizer mesh__D007233 sjn
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D007233 2006
% 213.54/213.75  |- skos__hiddenLabel mesh__D007233 Postmature Infants
% 213.54/213.75  |- mesh__historyNote mesh__D007233
% 213.54/213.75       91%28%75%29%; was see under INFANT, NEWBORN 1975-90   
% 213.54/213.75  |- skos__scopeNote mesh__D007233
% 213.54/213.75       An infant born at or after 42 weeks of gestation.     
% 213.54/213.75  |- skos__annotation mesh__D007233
% 213.54/213.75       IM; born after 42 wks gestation: do not confuse with FETAL MACROSOMIA %28%fetus %22%weighing more than 4000 grams%22%%29%; qualif permitted as for INFANT, NEWBORN; check the tag INFANT, NEWBORN%A%  
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D007233 2005
% 213.54/213.75  |- mesh__publicMeSHNote mesh__D007233
% 213.54/213.75       91; was see under INFANT, NEWBORN 1975-90   
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D007233 2004
% 213.54/213.75  |- rdf__type mesh__D007233sskos__Concept
% 213.54/213.75  |- skos__hiddenLabel mesh__D007233 Infants, Postmature
% 213.54/213.75  |- mesh__dateCreated mesh__D007233 1974-11-11
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D007233 2003
% 213.54/213.75  |- mesh__dateEstablished mesh__D007233 1991-01-01
% 213.54/213.75  |- mesh__recordOriginator mesh__D007233 NLM
% 213.54/213.75  |- skos__broader mesh__D007233smesh__D007231
% 213.54/213.75  |- mesh__recordMaintainer mesh__D007233 PXP
% 213.54/213.75  |- skos__hiddenLabel mesh__D007233 Postmature Infant
% 213.54/213.75  |- skos__prefLabel mesh__D007233 Infant, Postmature
% 213.54/213.75  |- skos__annotation mesh__D012976 D25-26 qualif   
% 213.54/213.75  |- skos__hiddenLabel mesh__D012976 Morrhuate, Sodium
% 213.54/213.75  |- mesh__recordMaintainer mesh__D012976 CCR
% 213.54/213.75  |- mesh__onlineNote mesh__D012976 search SCLEROSING SOLUTIONS 1966-74   
% 213.54/213.75  |- mesh__historyNote mesh__D012976
% 213.54/213.75       91%28%75%29%; was see under FATTY ACIDS 1975-90; was see under SCLEROSING SOLUTIONS 1963-74%A%  
% 213.54/213.75  |- skos__hiddenLabel mesh__D012976 Sodium, Morrhuate
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012976 2006
% 213.54/213.75  |- mesh__recordOriginator mesh__D012976 NLM
% 213.54/213.75  |- skos__altLabel mesh__D012976 Morrhuate Sodium
% 213.54/213.75  |- mesh__dateEstablished mesh__D012976 1991-01-01
% 213.54/213.75  |- skos__prefLabel mesh__D012976 Sodium Morrhuate
% 213.54/213.75  |- rdf__type mesh__D012976sskos__Concept
% 213.54/213.75  |- mesh__publicMeSHNote mesh__D012976
% 213.54/213.75       91; was see under FATTY ACIDS 1975-90; was see under SCLEROSING SOLUTIONS 1963-74%A%  
% 213.54/213.75  |- skos__altLabel mesh__D012976 Glenwood Brand of Sodium Morrhuate
% 213.54/213.75  |- mesh__dateCreated mesh__D012976 1999-01-01
% 213.54/213.75  |- skos__broader mesh__D012976smesh__D005227
% 213.54/213.75  |- mesh__recordAuthorizer mesh__D012976 sjn
% 213.54/213.75  |- skos__scopeNote mesh__D012976
% 213.54/213.75       The sodium salts of the fatty acids in cod liver oil; an irritant and sclerosing agent used to treat varicose veins and arthritic joints.%A%    
% 213.54/213.75  |- mesh__dateRevised mesh__D012976 2005-06-30
% 213.54/213.75  |- mesh__onlineNote mesh__D012178
% 213.54/213.75       use RETINOPATHY OF PREMATURITY to search RETROLENTAL FIBROPLASIA 1966-86%A%  
% 213.54/213.75  |- mesh__recordAuthorizer mesh__D012178 sjn
% 213.54/213.75  |- skos__hiddenLabel mesh__D012178 Prematurity Retinopathy
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012178 2001
% 213.54/213.75  |- skos__prefLabel mesh__D012178 Retinopathy of Prematurity
% 213.54/213.75  |- skos__hiddenLabel mesh__D012178 Fibroplasias, Retrolental
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012178 2003
% 213.54/213.75  |- skos__broader mesh__D012178smesh__D012164
% 213.54/213.75  |- mesh__dateRevised mesh__D012178 1999-11-03
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012178 2005
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012178 2004
% 213.54/213.75  |- mesh__publicMeSHNote mesh__D012178
% 213.54/213.75       87; was RETROLENTAL FIBROPLASIA 1963-86   
% 213.54/213.75  |- mesh__dateCreated mesh__D012178 1999-01-01
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012178 2002
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012178 2006
% 213.54/213.75  |- skos__hiddenLabel mesh__D012178 Prematurity Retinopathies
% 213.54/213.75  |- skos__altLabel mesh__D012178 Retrolental Fibroplasia
% 213.54/213.75  |- skos__annotation mesh__D012178
% 213.54/213.75       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; caused by oxygen ther of premature inf but for this etiol, do not use /chem ind: use /etiol if this etiol is discussed at all %28%%26% then probably NIM%29%: TN 167%A%  
% 213.54/213.75  |- mesh__recordMaintainer mesh__D012178 kle
% 213.54/213.75  |- mesh__historyNote mesh__D012178
% 213.54/213.75       87; was RETROLENTAL FIBROPLASIA 1963-86   
% 213.54/213.75  |- skos__broader mesh__D012178smesh__D007235
% 213.54/213.75  |- skos__hiddenLabel mesh__D012178 Retrolental Fibroplasias
% 213.54/213.75  |- rdf__type mesh__D012178sskos__Concept
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012178 2000
% 213.54/213.75  |- mesh__recordOriginator mesh__D012178 NLM
% 213.54/213.75  |- skos__hiddenLabel mesh__D012178 Fibroplasia, Retrolental
% 213.54/213.75  |- skos__scopeNote mesh__D012178
% 213.54/213.75       A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. %28%Dorland, 27th ed%29%%A%    
% 213.54/213.75  |- mesh__dateRevised mesh__D006939 2005-06-30
% 213.54/213.75  |- mesh__dateCreated mesh__D006939 1999-01-01
% 213.54/213.75  |- skos__annotation mesh__D006939 check tags FEMALE %26% PREGNANCY   
% 213.54/213.75  |- skos__broader mesh__D006939smesh__D048968
% 213.54/213.75  |- skos__altLabel mesh__D006939 Pernicious Vomiting of Pregnancy
% 213.54/213.75  |- skos__prefLabel mesh__D006939 Hyperemesis Gravidarum
% 213.54/213.75  |- rdf__type mesh__D006939sskos__Concept
% 213.54/213.75  |- mesh__recordOriginator mesh__D006939 NLM
% 213.54/213.75  |- mesh__recordAuthorizer mesh__D006939 sjn
% 213.54/213.75  |- skos__scopeNote mesh__D006939
% 213.54/213.75       Intractable VOMITING that develops in early PREGNANCY and persists. This can lead to DEHYDRATION and WEIGHT LOSS.%A%    
% 213.54/213.75  |- mesh__recordMaintainer mesh__D006939 lkt
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D006939 2006
% 213.54/213.75  |- skos__hiddenLabel mesh__D006939 Pregnancy Pernicious Vomiting
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D017661 2006
% 213.54/213.75  |- mesh__publicMeSHNote mesh__D017661 94   
% 213.54/213.75  |- skos__annotation mesh__D017661
% 213.54/213.75       cell surface receptors: do not confuse with NEURORECEPTORS see RECEPTORS, SENSORY %28%Cat A8%29% or with RECEPTORS, NEUROTRANSMITTER; DF: RECEPT PRESYNAPTIC%A%  
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D017661 1999
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D017661 2004
% 213.54/213.75  |- mesh__dateCreated mesh__D017661 1993-06-21
% 213.54/213.75  |- mesh__dateRevised mesh__D017661 1997-06-20
% 213.54/213.75  |- mesh__recordMaintainer mesh__D017661 NDW
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D017661 2005
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D017661 2001
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D017661 1998
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D017661 2003
% 213.54/213.75  |- mesh__historyNote mesh__D017661 94   
% 213.54/213.75  |- skos__hiddenLabel mesh__D017661 Receptor, Presynaptic
% 213.54/213.75  |- skos__altLabel mesh__D017661 Presynaptic Receptor
% 213.54/213.75  |- skos__altLabel mesh__D017661 Presynaptic Receptors
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D017661 2000
% 213.54/213.75  |- skos__broader mesh__D017661smesh__D017981
% 213.54/213.75  |- skos__scopeNote mesh__D017661
% 213.54/213.75       Neurotransmitter receptors located on or near presynaptic terminals or varicosities. Presynaptic receptors which bind transmitter molecules released by the terminal itself are termed AUTORECEPTORS.%A%    
% 213.54/213.75  |- mesh__recordAuthorizer mesh__D017661 SJN
% 213.54/213.75  |- mesh__dateEstablished mesh__D017661 1994-01-01
% 213.54/213.75  |- mesh__recordOriginator mesh__D017661 RAZ
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D017661 2002
% 213.54/213.75  |- skos__prefLabel mesh__D017661 Receptors, Presynaptic
% 213.54/213.75  |- rdf__type mesh__D017661sskos__Concept
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D031332 2006
% 213.54/213.75  |- mesh__dateCreated mesh__D031332 2002-07-03
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D031332 2004
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D031332 2005
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D031332 2003
% 213.54/213.75  |- skos__prefLabel mesh__D031332 Leonurus
% 213.54/213.75  |- rdf__type mesh__D031332sskos__Concept
% 213.54/213.75  |- skos__broader mesh__D031332smesh__D019686
% 213.54/213.75  |- skos__scopeNote mesh__D031332
% 213.54/213.75       A plant genus of the family LAMIACEAE that contains leonurine.%A%    
% 213.54/213.75  |- mesh__publicMeSHNote mesh__D031332 2003   
% 213.54/213.75  |- mesh__dateEstablished mesh__D031332 2003-01-01
% 213.54/213.75  |- skos__annotation mesh__D031332
% 213.54/213.75       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.54/213.75  |- mesh__historyNote mesh__D031332 2003   
% 213.54/213.75  |- skos__altLabel mesh__D031332 Motherwort
% 213.54/213.75  |- skos__scopeNote mesh__D003641
% 213.54/213.75       The removal of an amino group %28%NH2%29% from a chemical compound.%A%    
% 213.54/213.75  |- mesh__dateRevised mesh__D003641 2000-06-22
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D003641 2004
% 213.54/213.75  |- skos__annotation mesh__D003641
% 213.54/213.75       almost never IM; enzymatic deamination: coord NIM with specific enzyme %28%IM%29% + substrate %28%NIM%29%%A%  
% 213.54/213.75  |- mesh__dateEstablished mesh__D003641 1974-01-01
% 213.54/213.75  |- mesh__recordAuthorizer mesh__D003641 sjn
% 213.54/213.75  |- mesh__recordOriginator mesh__D003641 NLM
% 213.54/213.75  |- skos__broader mesh__D003641smesh__D008660
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D003641 2003
% 213.54/213.75  |- skos__broader mesh__D003641smesh__D002625
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D003641 2001
% 213.54/213.75  |- mesh__recordMaintainer mesh__D003641 adp
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D003641 2006
% 213.54/213.75  |- mesh__publicMeSHNote mesh__D003641 74   
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D003641 2005
% 213.54/213.75  |- skos__prefLabel mesh__D003641 Deamination
% 213.54/213.75  |- mesh__historyNote mesh__D003641 74%28%71%29%   
% 213.54/213.75  |- mesh__dateCreated mesh__D003641 1999-01-01
% 213.54/213.75  |- skos__historyNote mesh__D003641 Chemistry, Organic %28%1966-1970%29%
% 213.54/213.75  |- skos__hiddenLabel mesh__D003641 Deaminations
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D003641 2002
% 213.54/213.75  |- rdf__type mesh__D003641sskos__Concept
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D016569 2005
% 213.54/213.75  |- skos__broader mesh__D016569smesh__D005141
% 213.54/213.75  |- mesh__recordMaintainer mesh__D016569 kle
% 213.54/213.75  |- mesh__dateEstablished mesh__D016569 1992-01-01
% 213.54/213.75  |- skos__broader mesh__D016569smesh__D005124
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D016569 2000
% 213.54/213.75  |- rdf__type mesh__D016569sskos__Concept
% 213.54/213.75  |- mesh__dateCreated mesh__D016569 1991-01-02
% 213.54/213.75  |- skos__historyNote mesh__D016569 Eye %28%1975-1991%29%
% 213.54/213.75  |- skos__historyNote mesh__D016569 Eyelids/abnormalities %28%1966-1991%29%
% 213.54/213.75  |- mesh__publicMeSHNote mesh__D016569 92   
% 213.54/213.75  |- skos__annotation mesh__D016569
% 213.54/213.75       eyelid abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 213.54/213.75  |- skos__scopeNote mesh__D016569
% 213.54/213.75       The abnormal narrowness of the palpebral fissure in the horizontal direction caused by the lateral displacement of the medial canthi of the eyelids. %28%Dorland, 27th ed%29%%A%    
% 213.54/213.75  |- mesh__recordAuthorizer mesh__D016569 sjn
% 213.54/213.75  |- mesh__dateRevised mesh__D016569 1999-11-03
% 213.54/213.75  |- skos__historyNote mesh__D016569 Eyelid Diseases %28%1976-1991%29%
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D016569 2004
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D016569 2002
% 213.54/213.75  |- mesh__recordOriginator mesh__D016569 MXR
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D016569 2006
% 213.54/213.75  |- skos__hiddenLabel mesh__D016569 Blepharophimoses
% 213.54/213.75  |- skos__prefLabel mesh__D016569 Blepharophimosis
% 213.54/213.75  |- mesh__historyNote mesh__D016569 92   
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D016569 2003
% 213.54/213.75  |- skos__historyNote mesh__D016569 Eye Diseases %28%1976-1991%29%
% 213.54/213.75  |- skos__historyNote mesh__D016569 Blepharoptosis %28%1972-1991%29%
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D016569 2001
% 213.54/213.75  |- skos__broader mesh__D035723smesh__D035722
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D035723 2006
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D035723 2004
% 213.54/213.75  |- skos__annotation mesh__D035723
% 213.54/213.75       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D035723 2005
% 213.54/213.75  |- skos__altLabel mesh__D035723 Iceplant
% 213.54/213.75  |- skos__prefLabel mesh__D035723 Mesembryanthemum
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D035723 2003
% 213.54/213.75  |- mesh__dateCreated mesh__D035723 2002-07-03
% 213.54/213.75  |- rdf__type mesh__D035723sskos__Concept
% 213.54/213.75  |- mesh__publicMeSHNote mesh__D035723 2003   
% 213.54/213.75  |- mesh__historyNote mesh__D035723 2003   
% 213.54/213.75  |- skos__altLabel mesh__D035723 Ice Plant
% 213.54/213.75  |- mesh__dateEstablished mesh__D035723 2003-01-01
% 213.54/213.75  |- skos__scopeNote mesh__D035723
% 213.54/213.75       A plant genus of the family AIZOACEAE. It is a native of Africa and widely planted for erosion control to stabilize soil along roadsides and beaches.%A%    
% 213.54/213.75  |- skos__hiddenLabel mesh__D002549 Disease, Schilder
% 213.54/213.75  |- mesh__dateRevised mesh__D002549 1999-11-04
% 213.54/213.75  |- skos__hiddenLabel mesh__D002549 Diffuse Sclerosis, Myelinoclastic
% 213.54/213.75  |- mesh__dateCreated mesh__D002549 1999-01-01
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D002549 2006
% 213.54/213.75  |- skos__hiddenLabel mesh__D002549 Schilders Disease
% 213.54/213.75  |- skos__altLabel mesh__D002549 Balo%27%s Concentric Sclerosis
% 213.54/213.75  |- skos__prefLabel mesh__D002549 Diffuse Cerebral Sclerosis of Schilder
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D002549 2000
% 213.54/213.75  |- skos__altLabel mesh__D002549 Encephalitis Periaxialis Concentrica
% 213.54/213.75  |- skos__altLabel mesh__D002549 Schilder%27%s Disease
% 213.54/213.75  |- skos__hiddenLabel mesh__D002549 Alper%27%s Disease
% 213.54/213.75  |- skos__altLabel mesh__D002549 Cerebral Sclerosis, Diffuse
% 213.54/213.75  |- skos__altLabel mesh__D002549 Encephalitis Periaxialis
% 213.54/213.75  |- skos__hiddenLabel mesh__D002549 Disease, Schilder%27%s
% 213.54/213.75  |- skos__broader mesh__D002549smesh__D001927
% 213.54/213.75  |- rdf__type mesh__D002549sskos__Concept
% 213.54/213.75  |- mesh__recordAuthorizer mesh__D002549 sjn
% 213.54/213.75  |- skos__hiddenLabel mesh__D002549 Sclerosis, Diffuse Cerebral
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D002549 2001
% 213.54/213.75  |- skos__hiddenLabel mesh__D002549 Syndrome, Alpers
% 213.54/213.75  |- mesh__historyNote mesh__D002549 2000%28%1963%29%   
% 213.54/213.75  |- skos__altLabel mesh__D002549 Schilder Disease
% 213.54/213.75  |- skos__hiddenLabel mesh__D002549 Alper Syndrome
% 213.54/213.75  |- skos__hiddenLabel mesh__D002549 Diffuse Cerebral Scleroses
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D002549 2003
% 213.54/213.75  |- skos__hiddenLabel mesh__D002549 Diffuse Scleroses, Myelinoclastic
% 213.54/213.75  |- skos__hiddenLabel mesh__D002549 Diffuse Cerebral Sclerosis
% 213.54/213.75  |- skos__hiddenLabel mesh__D002549 Alper Disease
% 213.54/213.75  |- skos__hiddenLabel mesh__D002549 Sclerosis, Myelinoclastic Diffuse
% 213.54/213.75  |- skos__hiddenLabel mesh__D002549 Alper%27%s Syndrome
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D002549 2002
% 213.54/213.75  |- skos__hiddenLabel mesh__D002549 Scleroses, Myelinoclastic Diffuse
% 213.54/213.75  |- skos__hiddenLabel mesh__D002549 Concentric Sclerosis, Balo%27%s
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D002549 2004
% 213.54/213.75  |- skos__altLabel mesh__D002549 Alpers%27% Disease
% 213.54/213.75  |- skos__hiddenLabel mesh__D002549 Myelinoclastic Diffuse Scleroses
% 213.54/213.75  |- skos__broader mesh__D002549smesh__D020278
% 213.54/213.75  |- skos__altLabel mesh__D002549 Myelinoclastic Diffuse Sclerosis
% 213.54/213.75  |- mesh__recordOriginator mesh__D002549 NLM
% 213.54/213.75  |- skos__hiddenLabel mesh__D002549 Disease, Alpers%27%
% 213.54/213.75  |- skos__scopeNote mesh__D002549
% 213.54/213.75       A rare central nervous system demyelinating condition affecting children and young adults. Pathologic findings include a large, sharply defined, asymmetric focus of myelin destruction that may involve an entire lobe or cerebral hemisphere. The clinical course tends to be progressive and includes dementia, cortical blindness, cortical deafness, spastic hemiplegia, and pseudobulbar palsy. Concentric sclerosis of Balo is differentiated from diffuse cerebral sclerosis of Schilder by the pathologic finding of alternating bands of destruction and preservation of myelin in concentric rings. Alpers%27% Syndrome refers to a heterogeneous group of diseases that feature progressive cerebral deterioration and liver disease. %28%From Adams et al., Principles of Neurology, 6th ed, p914; Dev Neurosci 1991;13%28%4-5%29%:267-73%29%%A%    
% 213.54/213.75  |- skos__altLabel mesh__D002549 Alpers%27% Syndrome
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D002549 2005
% 213.54/213.75  |- skos__altLabel mesh__D002549 Encephalitis Periaxialis Diffusa
% 213.54/213.75  |- skos__hiddenLabel mesh__D002549 Concentric Sclerosis, Balo
% 213.54/213.75  |- skos__altLabel mesh__D002549 Poliodystrophia Cerebri
% 213.54/213.75  |- mesh__recordMaintainer mesh__D002549 KEV
% 213.54/213.75  |- mesh__publicMeSHNote mesh__D002549
% 213.54/213.75       2000; see CEREBRAL SCLEROSIS, DIFFUSE 1963-1999; for ENCEPHALITIS PERIAXIALIS see ENCEPHALITIS PERIAXIALIS 1963-1999; for BALO%27%S DISEASE, ENCEPHALITIS PERIAXIALIS DIFFUSA, MYELINOCLASTIC DIFFUSE SCLEROSIS, %26% SCHILDER%27%S DISEASE see ENCEPHALITIS PERIAXIALIS 1990-1999%A%  
% 213.54/213.75  |- skos__hiddenLabel mesh__D002549 Scleroses, Balo%27%s Concentric
% 213.54/213.75  |- mesh__dateCreated mesh__D013271 1999-01-01
% 213.54/213.75  |- skos__altLabel mesh__D013271 Gastric Dilation
% 213.54/213.75  |- mesh__historyNote mesh__D013271 2005 %28%1966%29%   
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D013271 2006
% 213.54/213.75  |- mesh__recordMaintainer mesh__D013271 lkt
% 213.54/213.75  |- skos__scopeNote mesh__D013271
% 213.54/213.75       Abnormal distention of the STOMACH due to accumulation of gastric contents that may reach 10 to 15 liters. Gastric dilatation may be the result of GASTRIC OUTLET OBSTRUCTION; ILEUS; GASTROPARESIS; or denervation.%A%    
% 213.54/213.75  |- skos__altLabel mesh__D013271 Stomach Dilation
% 213.54/213.75  |- skos__hiddenLabel mesh__D013271 Dilatation, Stomach
% 213.54/213.75  |- skos__broader mesh__D013271smesh__D013272
% 213.54/213.75  |- mesh__dateRevised mesh__D013271 2004-07-07
% 213.54/213.75  |- skos__hiddenLabel mesh__D013271 Dilation, Gastric
% 213.54/213.75  |- mesh__publicMeSHNote mesh__D013271
% 213.54/213.75       2005; see STOMACH DILATATION 1966-2004   
% 213.54/213.75  |- skos__hiddenLabel mesh__D013271 Dilation, Stomach
% 213.54/213.75  |- mesh__recordAuthorizer mesh__D013271 sjn
% 213.54/213.75  |- skos__prefLabel mesh__D013271 Gastric Dilatation
% 213.54/213.75  |- skos__hiddenLabel mesh__D013271 Dilatation, Gastric
% 213.54/213.75  |- rdf__type mesh__D013271sskos__Concept
% 213.54/213.75  |- skos__altLabel mesh__D013271 Stomach Dilatation
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D013271 2005
% 213.54/213.75  |- mesh__recordOriginator mesh__D013271 NLM
% 213.54/213.75  |- mesh__recordMaintainer mesh__D007234 sjn
% 213.54/213.75  |- skos__broader mesh__D007234smesh__D007231
% 213.54/213.75  |- skos__annotation mesh__D007234 check the tag INFANT, NEWBORN   
% 213.54/213.75  |- mesh__recordOriginator mesh__D007234 NLM
% 213.54/213.75  |- rdf__type mesh__D007234sskos__Concept
% 213.54/213.75  |- mesh__dateCreated mesh__D007234 1999-01-01
% 213.54/213.75  |- skos__related mesh__D007234smesh__D047928
% 213.54/213.75  |- skos__hiddenLabel mesh__D007234 Premature Infant
% 213.54/213.75  |- skos__hiddenLabel mesh__D007234 Infants, Premature
% 213.54/213.75  |- skos__prefLabel mesh__D007234 Infant, Premature
% 213.54/213.75  |- mesh__recordAuthorizer mesh__D007234 sjn
% 213.54/213.75  |- skos__scopeNote mesh__D007234
% 213.54/213.75       A human infant born before 37 weeks of GESTATION.     
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D007234 2006
% 213.54/213.75  |- mesh__dateRevised mesh__D007234 2004-07-13
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D007234 2005
% 213.54/213.75  |- skos__hiddenLabel mesh__D007234 Premature Infants
% 213.54/213.75  |- rdf__type mesh__D012977sskos__Concept
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012977 2000
% 213.54/213.75  |- skos__hiddenLabel mesh__D012977 Nitrite, Sodium
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012977 2005
% 213.54/213.75  |- mesh__publicMeSHNote mesh__D012977 91; was see under NITRITES 1979-90   
% 213.54/213.75  |- mesh__dateEstablished mesh__D012977 1991-01-01
% 213.54/213.75  |- skos__prefLabel mesh__D012977 Sodium Nitrite
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012977 2003
% 213.54/213.75  |- mesh__recordAuthorizer mesh__D012977 sjn
% 213.54/213.75  |- mesh__dateCreated mesh__D012977 1978-03-15
% 213.54/213.75  |- skos__broader mesh__D012977smesh__D017670
% 213.54/213.75  |- skos__historyNote mesh__D012977 Sodium %28%1966-1978%29%
% 213.54/213.75  |- mesh__recordMaintainer mesh__D012977 jmp
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012977 2002
% 213.54/213.75  |- mesh__recordOriginator mesh__D012977 RLS
% 213.54/213.75  |- skos__scopeNote mesh__D012977
% 213.54/213.75       Nitrous acid sodium salt. Used in many industrial processes, in meat curing, coloring, and preserving, and as a reagent in analytical chemistry. It is used therapeutically as an antidote in cyanide poisoning. The compound is toxic and mutagenic and will react in vivo with secondary or tertiary amines thereby producing highly carcinogenic nitrosamines.%A%    
% 213.54/213.75  |- skos__annotation mesh__D012977
% 213.54/213.75       a food preservative %26% chem reagent; D25-26 qualif   
% 213.54/213.75  |- skos__broader mesh__D012977smesh__D009573
% 213.54/213.75  |- mesh__dateRevised mesh__D012977 1999-11-03
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012977 2006
% 213.54/213.75  |- skos__historyNote mesh__D012977 Nitrites %28%1966-1978%29%
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012977 2001
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012977 2004
% 213.54/213.75  |- mesh__historyNote mesh__D012977
% 213.54/213.75       91%28%79%29%; was see under NITRITES 1979-90   
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012179 2003
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012179 1996
% 213.54/213.75  |- mesh__dateRevised mesh__D012179 1995-05-23
% 213.54/213.75  |- mesh__recordOriginator mesh__D012179 NLM
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012179 2000
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012179 2005
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012179 1998
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012179 2004
% 213.54/213.75  |- skos__hiddenLabel mesh__D012179 Retirements
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012179 1997
% 213.54/213.75  |- mesh__dateCreated mesh__D012179 1999-01-01
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012179 2001
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012179 2006
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012179 1999
% 213.54/213.75  |- mesh__recordMaintainer mesh__D012179 KEV
% 213.54/213.75  |- mesh__recordAuthorizer mesh__D012179 PLS
% 213.54/213.75  |- skos__prefLabel mesh__D012179 Retirement
% 213.54/213.75  |- skos__broader mesh__D012179smesh__D006802
% 213.54/213.75  |- rdf__type mesh__D012179sskos__Concept
% 213.54/213.75  |- skos__scopeNote mesh__D012179
% 213.54/213.75       The state of being retired from one%27%s position or occupation.%A%    
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D012179 2002
% 213.54/213.75  |- skos__altLabel mesh__D031333 Horehound, Water
% 213.54/213.75  |- mesh__dateEstablished mesh__D031333 2003-01-01
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D031333 2003
% 213.54/213.75  |- rdf__type mesh__D031333sskos__Concept
% 213.54/213.75  |- skos__broader mesh__D031333smesh__D019686
% 213.54/213.75  |- mesh__historyNote mesh__D031333 2003   
% 213.54/213.75  |- mesh__publicMeSHNote mesh__D031333 2003   
% 213.54/213.75  |- mesh__dateCreated mesh__D031333 2002-07-02
% 213.54/213.75  |- skos__annotation mesh__D031333
% 213.54/213.75       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.54/213.75  |- skos__altLabel mesh__D031333 Bugleweed
% 213.54/213.75  |- skos__scopeNote mesh__D031333
% 213.54/213.75       A plant genus of the family LAMIACEAE that contains rosmarinic acid and isopimarane diterpenoids and has been used in folk medicine for HYPERTHYROIDISM.%A%    
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D031333 2006
% 213.54/213.75  |- skos__prefLabel mesh__D031333 Lycopus
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D031333 2004
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D031333 2005
% 213.54/213.75  |- skos__broader mesh__D009732Q000266smesh__D009732
% 213.54/213.75  |- mesh__preferredCombination mesh__D009732Q000266smesh__D006676
% 213.54/213.75  |- rdf__type mesh__D009732Q000266smesh__CompoundConcept
% 213.54/213.75  |- mesh__activeMeSHYear mesh__D003642 2006
% 213.54/213.75  |- mesh__historyNote mesh__D003642
% 213.54/213.75       91%28%63%29%; was see under ETHANOLAMINES 1963-90   
% 213.54/213.75  |- skos__hiddenLabel mesh__D003642 N,N Dimethyl 2 hydroxyethylamine
% 213.54/213.75  |- skos__altLabel mesh__D003642 Dimethylaminoethanol
% 213.54/213.75  |- mesh__dateCreated mesh__D003642 1999-01-01
% 213.54/213.75  |- skos__broader mesh__D003642smesh__D004983
% 213.54/213.75  |- skos__altLabel mesh__D003642 Demanol
% 213.54/213.75  |- skos__altLabel mesh__D003642 N,N-Dimethylethanolamine
% 213.54/213.75  |- rdf__type mesh__D003642sskos__Concept
% 213.54/213.75  |- mesh__recordAuthorizer mesh__D003642 sjn
% 213.54/213.75  |- mesh__dateEstablished mesh__D003642 1991-01-01
% 213.54/213.75  |- skos__prefLabel mesh__D003642 Deanol
% 213.54/213.75  |- mesh__recordOriginator mesh__D003642 NLM
% 213.54/213.75  |- skos__scopeNote mesh__D003642
% 213.54/213.75       An antidepressive agent that has also been used in the treatment of movement disorders. The mechanism of action is not well understood.%A%    
% 213.54/213.75  |- skos__altLabel mesh__D003642 Demanyl
% 213.54/213.75  |- mesh__recordMaintainer mesh__D003642 exl
% 213.54/213.75  |- mesh__publicMeSHNote mesh__D003642
% 213.54/213.75       91; was see under ETHANOLAMINES 1963-90   
% 213.54/213.75  |- skos__hiddenLabel mesh__D003642 Bisorcate, Deanol
% 213.54/213.76  |- skos__altLabel mesh__D003642 Dimethylethanolamine
% 213.54/213.76  |- skos__altLabel mesh__D003642 Laphal Brand of Deanol Bisorcate
% 213.54/213.76  |- mesh__dateRevised mesh__D003642 2005-06-30
% 213.54/213.76  |- skos__altLabel mesh__D003642 N,N-Dimethyl-2-hydroxyethylamine
% 213.54/213.76  |- mesh__runningHead mesh__D050298 B8 - ORGANISMS-MESOMYCETOZOEA   
% 213.54/213.76  |- rdf__type mesh__D050298sskos__Concept
% 213.54/213.76  |- mesh__recordAuthorizer mesh__D050298 ags
% 213.54/213.76  |- skos__annotation mesh__D050298
% 213.54/213.76       infection = MESOMYCETOZOEA INFECTIONS; use /parasitol not /microbiol on other terms to indicate the presence of Mesomycetozoea%A%  
% 213.54/213.76  |- skos__hiddenLabel mesh__D050298 Clade, DRIP
% 213.54/213.76  |- skos__altLabel mesh__D050298 DRIP Clade
% 213.54/213.76  |- mesh__recordMaintainer mesh__D050298 ags
% 213.54/213.76  |- mesh__publicMeSHNote mesh__D050298 2006   
% 213.54/213.76  |- skos__prefLabel mesh__D050298 Mesomycetozoea
% 213.54/213.76  |- skos__scopeNote mesh__D050298
% 213.54/213.76       A class of parasitic and saprophytic microorganisms whose origins can be traced near the animal-fungal divergence. Members of the class are typically pathogens of FISHES, but there are exceptions. There are two recognized orders: Icthyophonida and Dermocystida.%A%    
% 213.54/213.76  |- skos__altLabel mesh__D050298 Ichthyosporea
% 213.54/213.76  |- mesh__dateCreated mesh__D050298 2005-07-05
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D050298 2006
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D050298 2006A
% 213.54/213.76  |- mesh__dateEstablished mesh__D050298 2006-01-01
% 213.54/213.76  |- mesh__recordOriginator mesh__D050298 ags
% 213.54/213.76  |- mesh__dateRevised mesh__D050298 2005-07-14
% 213.54/213.76  |- mesh__historyNote mesh__D050298 2006   
% 213.54/213.76  |- skos__broader mesh__D041761smesh__D005705
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D041761 2004
% 213.54/213.76  |- mesh__dateCreated mesh__D041761 2003-07-09
% 213.54/213.76  |- rdf__type mesh__D041761sskos__Concept
% 213.54/213.76  |- skos__prefLabel mesh__D041761 Cholecystolithiasis
% 213.54/213.76  |- mesh__historyNote mesh__D041761 2004   
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D041761 2006
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D041761 2005
% 213.54/213.76  |- mesh__dateEstablished mesh__D041761 2004-01-01
% 213.54/213.76  |- skos__scopeNote mesh__D041761
% 213.54/213.76       Presence or formation of GALLSTONES in the GALLBLADDER.%A%    
% 213.54/213.76  |- skos__historyNote mesh__D041761 Cholelithiasis %28%1965-2003%29%
% 213.54/213.76  |- skos__broader mesh__D041761smesh__D002769
% 213.54/213.76  |- mesh__publicMeSHNote mesh__D041761 2004   
% 213.54/213.76  |- skos__hiddenLabel mesh__D013272 Diseases, Gastric
% 213.54/213.76  |- skos__annotation mesh__D013272
% 213.54/213.76       GEN; inflamm dis = GASTRITIS; gastric varix or varices = ESOPHAGEAL AND GASTRIC VARICES %26% see note there%A%  
% 213.54/213.76  |- skos__altLabel mesh__D013272 Gastric Diseases
% 213.54/213.76  |- skos__hiddenLabel mesh__D013272 Stomach Disease
% 213.54/213.76  |- mesh__recordOriginator mesh__D013272 NLM
% 213.54/213.76  |- skos__broader mesh__D013272smesh__D005767
% 213.54/213.76  |- mesh__dateRevised mesh__D013272 2004-07-07
% 213.54/213.76  |- skos__hiddenLabel mesh__D013272 Diseases, Stomach
% 213.54/213.76  |- skos__hiddenLabel mesh__D013272 Disease, Gastric
% 213.54/213.76  |- mesh__historyNote mesh__D013272 66   
% 213.54/213.76  |- mesh__recordMaintainer mesh__D013272 lkt
% 213.54/213.76  |- rdf__type mesh__D013272sskos__Concept
% 213.54/213.76  |- mesh__publicMeSHNote mesh__D013272 66   
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D013272 2005
% 213.54/213.76  |- skos__prefLabel mesh__D013272 Stomach Diseases
% 213.54/213.76  |- mesh__dateCreated mesh__D013272 1999-01-01
% 213.54/213.76  |- mesh__recordAuthorizer mesh__D013272 sjn
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D013272 2006
% 213.54/213.76  |- skos__scopeNote mesh__D013272
% 213.54/213.76       Pathological processes involving the STOMACH.     
% 213.54/213.76  |- skos__hiddenLabel mesh__D013272 Gastric Disease
% 213.54/213.76  |- skos__hiddenLabel mesh__D013272 Disease, Stomach
% 213.54/213.76  |- mesh__dateEstablished mesh__D013272 1966-01-01
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007235 2002
% 213.54/213.76  |- skos__prefLabel mesh__D007235 Infant, Premature, Diseases
% 213.54/213.76  |- rdf__type mesh__D007235sskos__Concept
% 213.54/213.76  |- mesh__dateCreated mesh__D007235 1999-01-01
% 213.54/213.76  |- mesh__dateRevised mesh__D007235 1999-11-03
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007235 2003
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007235 2001
% 213.54/213.76  |- skos__annotation mesh__D007235
% 213.54/213.76       IM; do not use /compl /congen %26% do not coord with INFANT, NEWBORN, DISEASES; check the tag INFANT, NEWBORN: Manual 23.21.4%A%  
% 213.54/213.76  |- mesh__recordOriginator mesh__D007235 NLM
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007235 2000
% 213.54/213.76  |- skos__broader mesh__D007235smesh__D007232
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007235 2006
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007235 2005
% 213.54/213.76  |- mesh__recordAuthorizer mesh__D007235 sjn
% 213.54/213.76  |- mesh__recordMaintainer mesh__D007235 kle
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007235 2004
% 213.54/213.76  |- skos__altLabel mesh__D012978 Oxybate Sodium
% 213.54/213.76  |- skos__prefLabel mesh__D012978 Sodium Oxybate
% 213.54/213.76  |- skos__altLabel mesh__D012978 4-Hydroxybutyrate Sodium
% 213.54/213.76  |- mesh__historyNote mesh__D012978
% 213.54/213.76       91%28%75%29%; was see under HYDROXYBUTYRATES 1975-90   
% 213.54/213.76  |- skos__altLabel mesh__D012978 Sodium gamma-Hydroxybutyrate
% 213.54/213.76  |- skos__altLabel mesh__D012978 K%C3%%B6%hler Brand of Sodium Oxybate
% 213.54/213.76  |- skos__broader mesh__D012978smesh__D006885
% 213.54/213.76  |- mesh__recordAuthorizer mesh__D012978 sjn
% 213.54/213.76  |- skos__hiddenLabel mesh__D012978 gamma Hydroxybutyrate
% 213.54/213.76  |- skos__hiddenLabel mesh__D012978 Sodium gamma Hydroxybutyrate
% 213.54/213.76  |- mesh__recordMaintainer mesh__D012978 CCR
% 213.54/213.76  |- mesh__dateRevised mesh__D012978 2005-06-30
% 213.54/213.76  |- skos__scopeNote mesh__D012978
% 213.54/213.76       The sodium salt of 4-hydroxybutyric acid. Anesthetic used for both induction and maintenance. It may cause bradycardia and dyskinesias.%A%    
% 213.54/213.76  |- skos__hiddenLabel mesh__D012978 4 Hydroxybutyrate Sodium
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D012978 2006
% 213.54/213.76  |- skos__altLabel mesh__D012978 Sodium Oxybutyrate
% 213.54/213.76  |- skos__hiddenLabel mesh__D012978 Gamma OH
% 213.54/213.76  |- skos__historyNote mesh__D012978 Hydroxybutyrates %28%1969-1974%29%
% 213.54/213.76  |- skos__hiddenLabel mesh__D012978 Oxybutyrate, Sodium
% 213.54/213.76  |- rdf__type mesh__D012978sskos__Concept
% 213.54/213.76  |- skos__hiddenLabel mesh__D012978 Oxybate, Sodium
% 213.54/213.76  |- skos__altLabel mesh__D012978 Orphan Brand of Sodium Oxybate
% 213.54/213.76  |- mesh__dateEstablished mesh__D012978 1991-01-01
% 213.54/213.76  |- mesh__recordOriginator mesh__D012978 NLM
% 213.54/213.76  |- mesh__publicMeSHNote mesh__D012978
% 213.54/213.76       91; was see under HYDROXYBUTYRATES 1975-90   
% 213.54/213.76  |- mesh__dateCreated mesh__D012978 1974-11-19
% 213.54/213.76  |- skos__altLabel mesh__D012978 SERB Brand of Sodium Oxybate
% 213.54/213.76  |- skos__hiddenLabel mesh__D017663 Sulfate, Peplomycin
% 213.54/213.76  |- mesh__dateEstablished mesh__D017663 1994-01-01
% 213.54/213.76  |- mesh__recordOriginator mesh__D017663 TPW
% 213.54/213.76  |- skos__hiddenLabel mesh__D017663 NK 631
% 213.54/213.76  |- mesh__onlineNote mesh__D017663
% 213.54/213.76       use PEPLOMYCIN %28%NM%29% to search PEPLEOMYCIN 1980-93   
% 213.54/213.76  |- mesh__recordMaintainer mesh__D017663 ssb
% 213.54/213.76  |- mesh__dateRevised mesh__D017663 2004-07-07
% 213.54/213.76  |- skos__historyNote mesh__D017663 Bleomycins %28%1979-1993%29%
% 213.54/213.76  |- skos__hiddenLabel mesh__D017663 NK631
% 213.54/213.76  |- skos__altLabel mesh__D017663 Pepleomycin
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D017663 2005
% 213.54/213.76  |- mesh__publicMeSHNote mesh__D017663
% 213.54/213.76       94; PEPLEOMYCIN was indexed under BLEOMYCINS 1979-93   
% 213.54/213.76  |- mesh__recordAuthorizer mesh__D017663 sjn
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D017663 2006
% 213.54/213.76  |- rdf__type mesh__D017663sskos__Concept
% 213.54/213.76  |- skos__broader mesh__D017663smesh__D001761
% 213.54/213.76  |- skos__scopeNote mesh__D017663
% 213.54/213.76       An antineoplastic agent derived from BLEOMYCIN.     
% 213.54/213.76  |- mesh__dateCreated mesh__D017663 1993-02-16
% 213.54/213.76  |- mesh__historyNote mesh__D017663
% 213.54/213.76       94; was PEPLEOMYCIN %28%NM%29% 1979-93   
% 213.54/213.76  |- skos__prefLabel mesh__D017663 Peplomycin
% 213.54/213.76  |- mesh__publicMeSHNote mesh__D031334 2003   
% 213.54/213.76  |- mesh__dateEstablished mesh__D031334 2003-01-01
% 213.54/213.76  |- skos__annotation mesh__D031334
% 213.54/213.76       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.54/213.76  |- skos__scopeNote mesh__D031334
% 213.54/213.76       A plant genus of the family LAMIACEAE. The common names of beebalm or lemonbalm are also used for MONARDA.%A%    
% 213.54/213.76  |- mesh__historyNote mesh__D031334 2003   
% 213.54/213.76  |- skos__prefLabel mesh__D031334 Melissa
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D031334 2006
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D031334 2004
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D031334 2005
% 213.54/213.76  |- mesh__dateCreated mesh__D031334 2002-07-03
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D031334 2003
% 213.54/213.76  |- rdf__type mesh__D031334sskos__Concept
% 213.54/213.76  |- skos__broader mesh__D031334smesh__D019686
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D003643 2005
% 213.54/213.76  |- skos__prefLabel mesh__D003643 Death
% 213.54/213.76  |- mesh__dateRevised mesh__D003643 1999-11-08
% 213.54/213.76  |- skos__annotation mesh__D003643
% 213.54/213.76       IM; /mortal is available with Cat C, F, E; do not confuse with MORTALITY, a statist concept: DEATH is the biol or physiol, psychol concept; for theory, doctrine %26% philosophy of death THANATOLOGY is available; for death as a result of a dis or ther or diag procedure, FATAL OUTCOME is available: see note there%A%  
% 213.54/213.76  |- skos__related mesh__D003643smesh__D013795
% 213.54/213.76  |- mesh__dateCreated mesh__D003643 1999-01-01
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D003643 2000
% 213.54/213.76  |- mesh__considerAlso mesh__D003643 consider also terms at THANATO-   
% 213.54/213.76  |- rdf__type mesh__D003643sskos__Concept
% 213.54/213.76  |- skos__related mesh__D003643smesh__D009027
% 213.54/213.76  |- skos__related mesh__D003643smesh__D017809
% 213.54/213.76  |- skos__related mesh__D003643smesh__D006708
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D003643 2004
% 213.54/213.76  |- mesh__recordMaintainer mesh__D003643 KEV
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D003643 2002
% 213.54/213.76  |- skos__scopeNote mesh__D003643
% 213.54/213.76       Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.%A%    
% 213.54/213.76  |- skos__related mesh__D003643smesh__D007237
% 213.54/213.76  |- skos__related mesh__D003643smesh__D001601
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D003643 2003
% 213.54/213.76  |- skos__related mesh__D003643smesh__D013727
% 213.54/213.76  |- skos__related mesh__D003643smesh__D001926
% 213.54/213.76  |- skos__related mesh__D003643smesh__D013405
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D003643 2006
% 213.54/213.76  |- mesh__recordAuthorizer mesh__D003643 sjn
% 213.54/213.76  |- mesh__recordOriginator mesh__D003643 NLM
% 213.54/213.76  |- skos__broader mesh__D003643smesh__D010335
% 213.54/213.76  |- skos__related mesh__D003643smesh__D002423
% 213.54/213.76  |- skos__related mesh__D003643smesh__D001293
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D003643 2001
% 213.54/213.76  |- skos__hiddenLabel mesh__D003643 Death, Cardiac
% 213.54/213.76  |- mesh__dateEstablished mesh__D050299 2006-01-01
% 213.54/213.76  |- skos__broader mesh__D050299smesh__D045504
% 213.54/213.76  |- skos__scopeNote mesh__D050299
% 213.54/213.76       Agents that affect the function of FIBRIN in BLOOD COAGULATION. They used as COAGULANTS for HEMORRHAGE or ANTICOAGULANTS for THROMBOSIS.%A%    
% 213.54/213.76  |- mesh__historyNote mesh__D050299 2006   
% 213.54/213.76  |- mesh__publicMeSHNote mesh__D050299 2006   
% 213.54/213.76  |- mesh__recordMaintainer mesh__D050299 ssb
% 213.54/213.76  |- mesh__recordOriginator mesh__D050299 ssb
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D050299 2006
% 213.54/213.76  |- skos__prefLabel mesh__D050299 Fibrin Modulating Agents
% 213.54/213.76  |- mesh__recordAuthorizer mesh__D050299 sjn
% 213.54/213.76  |- mesh__dateCreated mesh__D050299 2005-06-30
% 213.54/213.76  |- skos__altLabel mesh__D050299 Fibrin Modulators
% 213.54/213.76  |- rdf__type mesh__D050299sskos__Concept
% 213.54/213.76  |- skos__altLabel mesh__D013273 Gastric Diverticula
% 213.54/213.76  |- skos__broader mesh__D013273smesh__D004240
% 213.54/213.76  |- skos__prefLabel mesh__D013273 Diverticulum, Stomach
% 213.54/213.76  |- skos__altLabel mesh__D013273 Diverticula, Stomach
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D013273 2005
% 213.54/213.76  |- rdf__type mesh__D013273sskos__Concept
% 213.54/213.76  |- mesh__recordAuthorizer mesh__D013273 sjn
% 213.54/213.76  |- skos__related mesh__D013273smesh__D045724
% 213.54/213.76  |- mesh__historyNote mesh__D013273 92; was STOMACH DIVERTICULA 1963-91   
% 213.54/213.76  |- skos__annotation mesh__D013273
% 213.54/213.76       inflamm divertic or diverticulitis: coord IM with DIVERTICULITIS %28%IM%29%%A%  
% 213.54/213.76  |- skos__hiddenLabel mesh__D013273 Diverticula, Gastric
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D013273 2006
% 213.54/213.76  |- mesh__dateCreated mesh__D013273 1999-01-01
% 213.54/213.76  |- skos__hiddenLabel mesh__D013273 Stomach Diverticula
% 213.54/213.76  |- skos__altLabel mesh__D013273 Diverticulum, Gastric
% 213.54/213.76  |- mesh__recordMaintainer mesh__D013273 lkt
% 213.54/213.76  |- skos__hiddenLabel mesh__D013273 Gastric Diverticulum
% 213.54/213.76  |- skos__scopeNote mesh__D013273
% 213.54/213.76       Saccular, outward protrusion of all or a portion of the wall of the STOMACH.%A%    
% 213.54/213.76  |- mesh__recordOriginator mesh__D013273 NLM
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D013273 2004
% 213.54/213.76  |- mesh__dateRevised mesh__D013273 2003-07-09
% 213.54/213.76  |- mesh__publicMeSHNote mesh__D013273
% 213.54/213.76       92; was STOMACH DIVERTICULA 1963-91   
% 213.54/213.76  |- skos__altLabel mesh__D013273 Stomach Diverticulum
% 213.54/213.76  |- mesh__onlineNote mesh__D013273
% 213.54/213.76       use STOMACH DIVERTICULUM to search STOMACH DIVERTICULA 1966-91%A%  
% 213.54/213.76  |- mesh__dateRevised mesh__D007236 2002-07-03
% 213.54/213.76  |- rdf__type mesh__D007236sskos__Concept
% 213.54/213.76  |- mesh__recordOriginator mesh__D007236 SMH
% 213.54/213.76  |- skos__historyNote mesh__D007236 Infant, Newborn %28%1966-1976%29%
% 213.54/213.76  |- skos__historyNote mesh__D007236 Infant, Premature %28%1966-1976%29%
% 213.54/213.76  |- mesh__dateEstablished mesh__D007236 1978-01-01
% 213.54/213.76  |- mesh__historyNote mesh__D007236
% 213.54/213.76       78%28%77%29%; was see under INFANT, LOW BIRTH WEIGHT 1977   
% 213.54/213.76  |- mesh__recordAuthorizer mesh__D007236 sjn
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007236 2005
% 213.54/213.76  |- skos__scopeNote mesh__D007236
% 213.54/213.76       An infant having a birth weight lower than expected for its gestational age.%A%    
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007236 2006
% 213.54/213.76  |- mesh__recordMaintainer mesh__D007236 PXP
% 213.54/213.76  |- skos__broader mesh__D007236smesh__D007230
% 213.54/213.76  |- skos__historyNote mesh__D007236 Birth Weight %28%1966-1976%29%
% 213.54/213.76  |- mesh__dateCreated mesh__D007236 1976-05-05
% 213.54/213.76  |- skos__annotation mesh__D007236
% 213.54/213.76       born weighing less than expected for age; qualif permitted as for INFANT, NEWBORN; check the tag INFANT, NEWBORN; DF: INFANT SGA%A%  
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007236 2003
% 213.54/213.76  |- skos__prefLabel mesh__D007236 Infant, Small for Gestational Age
% 213.54/213.76  |- skos__historyNote mesh__D007236 Infant, Low Birth Weight %28%1977%29%
% 213.54/213.76  |- mesh__publicMeSHNote mesh__D007236
% 213.54/213.76       78; was see under INFANT, LOW BIRTH WEIGHT 1977   
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007236 2004
% 213.54/213.76  |- skos__annotation mesh__D012979
% 213.54/213.76       Na-20-22, 24-26; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 213.54/213.76  |- mesh__dateRevised mesh__D012979 1993-06-04
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D012979 2000
% 213.54/213.76  |- skos__historyNote mesh__D012979 Radioisotopes %28%1966-1974%29%
% 213.54/213.76  |- mesh__recordOriginator mesh__D012979 NLM
% 213.54/213.76  |- skos__broader mesh__D012979smesh__D011868
% 213.54/213.76  |- skos__broader mesh__D012979smesh__D012975
% 213.54/213.76  |- mesh__dateEstablished mesh__D012979 1975-09-01
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D012979 2005
% 213.54/213.76  |- skos__prefLabel mesh__D012979 Sodium Radioisotopes
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D012979 1994
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D012979 2001
% 213.54/213.76  |- skos__historyNote mesh__D012979 Sodium Isotopes %28%1966-1974%29%
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D012979 2003
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D012979 2006
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D012979 1998
% 213.54/213.76  |- skos__scopeNote mesh__D012979
% 213.54/213.76       Unstable isotopes of sodium that decay or disintegrate emitting radiation. Na atoms with atomic weights 20-22 and 24-26 are radioactive sodium isotopes.%A%    
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D012979 1995
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D012979 2002
% 213.54/213.76  |- skos__hiddenLabel mesh__D012979 Radioisotopes, Sodium
% 213.54/213.76  |- mesh__historyNote mesh__D012979 75   
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D012979 2004
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D012979 1996
% 213.54/213.76  |- rdf__type mesh__D012979sskos__Concept
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D012979 1999
% 213.54/213.76  |- mesh__publicMeSHNote mesh__D012979 75   
% 213.54/213.76  |- mesh__dateCreated mesh__D012979 1974-11-11
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D012979 1997
% 213.54/213.76  |- mesh__onlineNote mesh__D012979 search SODIUM ISOTOPES 1966-74   
% 213.54/213.76  |- mesh__recordAuthorizer mesh__D012979 PLS
% 213.54/213.76  |- mesh__recordMaintainer mesh__D012979 TPW
% 213.54/213.76  |- skos__related mesh__D017664smesh__D008489
% 213.54/213.76  |- skos__scopeNote mesh__D017664
% 213.54/213.76       Medical services for which no payment is received. Uncompensated care includes charity care and bad debts.%A%    
% 213.54/213.76  |- mesh__dateCreated mesh__D017664 1992-12-28
% 213.54/213.76  |- mesh__publicMeSHNote mesh__D017664
% 213.54/213.76       1994; for INDIGENT CARE see MEDICAL INDIGENCY 1968-1999, see INDIGENT CARE 1963-1967%A%  
% 213.54/213.76  |- skos__broader mesh__D017664smesh__D003695
% 213.54/213.76  |- mesh__historyNote mesh__D017664
% 213.54/213.76       1994; for INDIGENT CARE use MEDICAL INDIGENCY 1968-1999, use INDIGENT CARE 1963-1967%A%  
% 213.54/213.76  |- skos__hiddenLabel mesh__D017664 Care, Uncompensated
% 213.54/213.76  |- mesh__dateEstablished mesh__D017664 1994-01-01
% 213.54/213.76  |- skos__prefLabel mesh__D017664 Uncompensated Care
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D017664 2005
% 213.54/213.76  |- mesh__dateRevised mesh__D017664 2002-07-18
% 213.54/213.76  |- mesh__recordMaintainer mesh__D017664 sjn
% 213.54/213.76  |- skos__hiddenLabel mesh__D017664 Care, Indigent
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D017664 2003
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D017664 2006
% 213.54/213.76  |- rdf__type mesh__D017664sskos__Concept
% 213.54/213.76  |- skos__related mesh__D017664smesh__D017057
% 213.54/213.76  |- mesh__recordOriginator mesh__D017664 RAZ
% 213.54/213.76  |- skos__annotation mesh__D017664
% 213.54/213.76       absence of payment to physician, dentist, other health professional, hosp; includes lack of compensation in pro bono work %26% charity care %26% as a result of bad debts%A%  
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D017664 2004
% 213.54/213.76  |- mesh__recordAuthorizer mesh__D017664 sjn
% 213.54/213.76  |- skos__altLabel mesh__D031335 Pennyroyal, European
% 213.54/213.76  |- mesh__publicMeSHNote mesh__D031335 2003   
% 213.54/213.76  |- skos__altLabel mesh__D031335 European Pennyroyal
% 213.54/213.76  |- mesh__dateCreated mesh__D031335 2002-07-03
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D031335 2005
% 213.54/213.76  |- mesh__dateEstablished mesh__D031335 2003-01-01
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D031335 2003
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D031335 2006
% 213.54/213.76  |- skos__prefLabel mesh__D031335 Mentha pulegium
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D031335 2004
% 213.54/213.76  |- skos__scopeNote mesh__D031335
% 213.54/213.76       A plant genus of the family LAMIACEAE that contains pulegone. Do not confuse with %27%American false pennyroyal%27% %28%HEDEOMA%29%.%A%    
% 213.54/213.76  |- skos__broader mesh__D031335smesh__D027541
% 213.54/213.76  |- skos__annotation mesh__D031335
% 213.54/213.76       American False Pennyroyal = HEDEOMA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.54/213.76  |- mesh__historyNote mesh__D031335 2003   
% 213.54/213.76  |- rdf__type mesh__D031335sskos__Concept
% 213.54/213.76  |- skos__altLabel mesh__D031335 Pulegium vulgare
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D003644 1997
% 213.54/213.76  |- skos__hiddenLabel mesh__D003644 Certificates, Death
% 213.54/213.76  |- skos__broader mesh__D003644smesh__D011996
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D003644 2000
% 213.54/213.76  |- mesh__recordOriginator mesh__D003644 NLM
% 213.54/213.76  |- skos__hiddenLabel mesh__D003644 Death Certificate
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D003644 1998
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D003644 1993
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D003644 2003
% 213.54/213.76  |- rdf__type mesh__D003644sskos__Concept
% 213.54/213.76  |- skos__hiddenLabel mesh__D003644 Death Record
% 213.54/213.76  |- skos__scopeNote mesh__D003644
% 213.54/213.76       Official records of individual deaths including the cause of death certified by a physician, and any other required identifying information.%A%    
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D003644 2001
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D003644 1994
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D003644 1999
% 213.54/213.76  |- skos__hiddenLabel mesh__D003644 Records, Death
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D003644 2004
% 213.54/213.76  |- mesh__recordMaintainer mesh__D003644 PLS
% 213.54/213.76  |- skos__hiddenLabel mesh__D003644 Record, Death
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D003644 2002
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D003644 1995
% 213.54/213.76  |- skos__annotation mesh__D003644 IM   
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D003644 2005
% 213.54/213.76  |- mesh__recordAuthorizer mesh__D003644 PLS
% 213.54/213.76  |- mesh__dateRevised mesh__D003644 1992-05-14
% 213.54/213.76  |- mesh__dateCreated mesh__D003644 1999-01-01
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D003644 2006
% 213.54/213.76  |- skos__prefLabel mesh__D003644 Death Certificates
% 213.54/213.76  |- skos__hiddenLabel mesh__D003644 Certificate, Death
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D003644 1996
% 213.54/213.76  |- skos__hiddenLabel mesh__D013274 Cancer, Gastric
% 213.54/213.76  |- skos__altLabel mesh__D013274 Neoplasms, Stomach
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D013274 2005
% 213.54/213.76  |- skos__broader mesh__D013274smesh__D013272
% 213.54/213.76  |- rdf__type mesh__D013274sskos__Concept
% 213.54/213.76  |- skos__hiddenLabel mesh__D013274 Stomach Cancers
% 213.54/213.76  |- skos__hiddenLabel mesh__D013274 Gastric Neoplasm
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D013274 2006
% 213.54/213.76  |- skos__altLabel mesh__D013274 Gastric Cancer
% 213.54/213.76  |- skos__scopeNote mesh__D013274 Tumors or cancer of the STOMACH.     
% 213.54/213.76  |- mesh__dateCreated mesh__D013274 1999-01-01
% 213.54/213.76  |- skos__hiddenLabel mesh__D013274 Cancers, Gastric
% 213.54/213.76  |- skos__hiddenLabel mesh__D013274 Stomach Neoplasm
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D013274 2004
% 213.54/213.76  |- skos__altLabel mesh__D013274 Stomach Cancer
% 213.54/213.76  |- mesh__recordAuthorizer mesh__D013274 sjn
% 213.54/213.76  |- skos__broader mesh__D013274smesh__D005770
% 213.54/213.76  |- skos__hiddenLabel mesh__D013274 Neoplasm, Stomach
% 213.54/213.76  |- mesh__dateRevised mesh__D013274 2003-07-09
% 213.54/213.76  |- skos__hiddenLabel mesh__D013274 Gastric Cancers
% 213.54/213.76  |- skos__hiddenLabel mesh__D013274 Neoplasm, Gastric
% 213.54/213.76  |- skos__altLabel mesh__D013274 Neoplasms, Gastric
% 213.54/213.76  |- mesh__recordMaintainer mesh__D013274 lkt
% 213.54/213.76  |- mesh__recordOriginator mesh__D013274 NLM
% 213.54/213.76  |- skos__altLabel mesh__D013274 Gastric Neoplasms
% 213.54/213.76  |- skos__annotation mesh__D013274
% 213.54/213.76       coord IM with histol type of neopl %28%IM%29%; neopl of ruminant stomach or its parts: coord STOMACH, RUMINANT or indention %28%IM%29% with STOMACH NEOPLASMS /vet %28%IM%29% + histol type of neopl /vet %28%IM%29%%A%  
% 213.54/213.76  |- skos__altLabel mesh__D013274 Cancer of the Stomach
% 213.54/213.76  |- skos__prefLabel mesh__D013274 Stomach Neoplasms
% 213.54/213.76  |- skos__hiddenLabel mesh__D013274 Cancers, Stomach
% 213.54/213.76  |- skos__hiddenLabel mesh__D013274 Cancer, Stomach
% 213.54/213.76  |- mesh__recordOriginator mesh__D007237 NLM
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007237 1997
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007237 2005
% 213.54/213.76  |- skos__scopeNote mesh__D007237
% 213.54/213.76       The killing of infants at birth or soon after.     
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007237 2002
% 213.54/213.76  |- skos__prefLabel mesh__D007237 Infanticide
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007237 2006
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007237 1995
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007237 1998
% 213.54/213.76  |- skos__hiddenLabel mesh__D007237 Infanticides
% 213.54/213.76  |- mesh__dateCreated mesh__D007237 1999-01-01
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007237 2003
% 213.54/213.76  |- mesh__recordAuthorizer mesh__D007237 PLS
% 213.54/213.76  |- skos__broader mesh__D007237smesh__D006708
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007237 2000
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007237 1999
% 213.54/213.76  |- mesh__recordMaintainer mesh__D007237 TGC
% 213.54/213.76  |- skos__annotation mesh__D007237
% 213.54/213.76       restrict to humans: do not use for the killing of young of other primates or other animals in scientific exper; do not use for killing of newborn or young animals by their parents %28% = BEHAVIOR, ANIMAL%29%%A%  
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007237 2004
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007237 2001
% 213.54/213.76  |- rdf__type mesh__D007237sskos__Concept
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D007237 1996
% 213.54/213.76  |- mesh__dateRevised mesh__D007237 1994-01-25
% 213.54/213.76  |- mesh__onlineNote mesh__D017665
% 213.54/213.76       use HYDROXYL RADICAL %28%NM%29% to search HYDROXYL RADICAL 1980-93%A%  
% 213.54/213.76  |- mesh__historyNote mesh__D017665
% 213.54/213.76       94; was HYDROXYL RADICAL %28%NM%29% 1978-93   
% 213.54/213.76  |- skos__broader mesh__D017665smesh__D006878
% 213.54/213.76  |- mesh__publicMeSHNote mesh__D017665
% 213.54/213.76       94; HYDROXYL RADICAL was indexed under HYDROXIDES 1978-93%A%  
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D017665 2006
% 213.54/213.76  |- rdf__type mesh__D017665sskos__Concept
% 213.54/213.76  |- mesh__recordAuthorizer mesh__D017665 sjn
% 213.54/213.76  |- skos__broader mesh__D017665smesh__D017382
% 213.54/213.76  |- skos__scopeNote mesh__D017665
% 213.54/213.76       The univalent radical OH. Hydroxyl radical is a potent oxidizing agent.%A%    
% 213.54/213.76  |- mesh__dateRevised mesh__D017665 2005-06-30
% 213.54/213.76  |- skos__historyNote mesh__D017665 Hydroxides %28%1978-1993%29%
% 213.54/213.76  |- mesh__dateCreated mesh__D017665 1993-06-03
% 213.54/213.76  |- mesh__recordOriginator mesh__D017665 TPW
% 213.54/213.76  |- mesh__dateEstablished mesh__D017665 1994-01-01
% 213.54/213.76  |- skos__prefLabel mesh__D017665 Hydroxyl Radical
% 213.54/213.76  |- mesh__recordMaintainer mesh__D017665 ssb
% 213.54/213.76  |- mesh__recordMaintainer mesh__D031336 ags
% 213.54/213.76  |- skos__prefLabel mesh__D031336 Hedeoma
% 213.54/213.76  |- mesh__historyNote mesh__D031336 2003   
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D031336 2005
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D031336 2003
% 213.54/213.76  |- skos__altLabel mesh__D031336 American Pennyroyal, False
% 213.54/213.76  |- skos__broader mesh__D031336smesh__D019686
% 213.54/213.76  |- mesh__recordOriginator mesh__D031336 ssb
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D031336 2006
% 213.54/213.76  |- mesh__recordAuthorizer mesh__D031336 ags
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D031336 2004
% 213.54/213.76  |- skos__altLabel mesh__D031336 Melissa pulegioides
% 213.54/213.76  |- mesh__dateRevised mesh__D031336 2005-07-22
% 213.54/213.76  |- skos__altLabel mesh__D031336 Pennyroyal, American False
% 213.54/213.76  |- mesh__activeMeSHYear mesh__D031336 2006A
% 213.54/213.76  |- skos__altLabel mesh__D031336 American False Pennyroyal
% 213.54/213.77  |- mesh__dateEstablished mesh__D031336 2003-01-01
% 213.54/213.77  |- rdf__type mesh__D031336sskos__Concept
% 213.54/213.77  |- skos__scopeNote mesh__D031336
% 213.54/213.77       A plant genus of the family LAMIACEAE that is closely related to the European pennyroyal %28%MENTHA PULEGIUM%29%.%A%    
% 213.54/213.77  |- skos__annotation mesh__D031336
% 213.54/213.77       X ref PENNYROYAL, AMERICAN FALSE: PENNYROYAL, EUROPEAN see MENTHA PULEGIUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.54/213.77  |- mesh__dateCreated mesh__D031336 2002-07-02
% 213.54/213.77  |- mesh__publicMeSHNote mesh__D031336 2003   
% 213.54/213.77  |- mesh__recordOriginator mesh__D003645 NLM
% 213.54/213.77  |- mesh__recordAuthorizer mesh__D003645 sjn
% 213.54/213.77  |- skos__broader mesh__D003645smesh__D003643
% 213.54/213.77  |- rdf__type mesh__D003645sskos__Concept
% 213.54/213.77  |- skos__scopeNote mesh__D003645
% 213.54/213.77       The abrupt cessation of all vital bodily functions, manifested by the permanent loss of total cerebral, respiratory, and cardiovascular functions.%A%    
% 213.54/213.77  |- skos__hiddenLabel mesh__D003645 Sudden Death
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D003645 2003
% 213.54/213.77  |- skos__annotation mesh__D003645
% 213.54/213.77       DEATH, SUDDEN, CARDIAC is also available   
% 213.54/213.77  |- skos__prefLabel mesh__D003645 Death, Sudden
% 213.54/213.77  |- mesh__dateRevised mesh__D003645 2001-07-25
% 213.54/213.77  |- mesh__recordMaintainer mesh__D003645 nns
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D003645 2002
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D003645 2004
% 213.54/213.77  |- skos__related mesh__D003645smesh__D012151
% 213.54/213.77  |- mesh__dateCreated mesh__D003645 1999-01-01
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D003645 2005
% 213.54/213.77  |- skos__related mesh__D003645smesh__D013398
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D003645 2006
% 213.54/213.77  |- skos__broader mesh__D004194Q000451smesh__D004194
% 213.54/213.77  |- mesh__preferredCombination mesh__D004194Q000451smesh__D009732
% 213.54/213.77  |- rdf__type mesh__D004194Q000451smesh__CompoundConcept
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008330 1995
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008330 2002
% 213.54/213.77  |- rdf__type mesh__D008330sskos__Concept
% 213.54/213.77  |- mesh__publicMeSHNote mesh__D008330
% 213.54/213.77       91; was see under ORGANIZATION AND ADMINISTRATION 1982-90%A%  
% 213.54/213.77  |- skos__prefLabel mesh__D008330 Management Audit
% 213.54/213.77  |- mesh__historyNote mesh__D008330
% 213.54/213.77       91%28%82%29%; was see under ORGANIZATION AND ADMINISTRATION 1982-90%A%  
% 213.54/213.77  |- mesh__dateCreated mesh__D008330 1981-02-26
% 213.54/213.77  |- mesh__recordMaintainer mesh__D008330 TGC
% 213.54/213.77  |- skos__hiddenLabel mesh__D008330 Audits, Operational
% 213.54/213.77  |- mesh__dateRevised mesh__D008330 1994-05-05
% 213.54/213.77  |- skos__broader mesh__D008330smesh__D009934
% 213.54/213.77  |- skos__scopeNote mesh__D008330
% 213.54/213.77       Management review designed to evaluate efficiency and to identify areas in need of management improvement within the institution in order to ensure effectiveness in meeting organizational goals.%A%    
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008330 1996
% 213.54/213.77  |- skos__hiddenLabel mesh__D008330 Audits, Management
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008330 2003
% 213.54/213.77  |- skos__hiddenLabel mesh__D008330 Audit, Operational
% 213.54/213.77  |- mesh__recordAuthorizer mesh__D008330 PLS
% 213.54/213.77  |- skos__hiddenLabel mesh__D008330 Audit, Management
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008330 1997
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008330 2004
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008330 2000
% 213.54/213.77  |- skos__hiddenLabel mesh__D008330 Management Audits
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008330 1998
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008330 2005
% 213.54/213.77  |- mesh__dateEstablished mesh__D008330 1991-01-01
% 213.54/213.77  |- skos__hiddenLabel mesh__D008330 Operational Audits
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008330 2001
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008330 1999
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008330 2006
% 213.54/213.77  |- skos__annotation mesh__D008330
% 213.54/213.77       do not use /util except by MeSH definition   
% 213.54/213.77  |- skos__altLabel mesh__D008330 Operational Audit
% 213.54/213.77  |- mesh__recordOriginator mesh__D008330 EC
% 213.54/213.77  |- skos__hiddenLabel mesh__D022001 Cell-Matrix Adherens Junction
% 213.54/213.77  |- skos__related mesh__D022001smesh__D002448
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D022001 2003
% 213.54/213.77  |- skos__hiddenLabel mesh__D022001 Contact, Focal
% 213.54/213.77  |- skos__hiddenLabel mesh__D022001 Adhesion Plaque
% 213.54/213.77  |- skos__prefLabel mesh__D022001 Focal Adhesions
% 213.54/213.77  |- mesh__publicMeSHNote mesh__D022001 2001   
% 213.54/213.77  |- skos__hiddenLabel mesh__D022001 Plaque, Adhesion
% 213.54/213.77  |- skos__altLabel mesh__D022001 Cell-Matrix Adherens Junctions
% 213.54/213.77  |- skos__hiddenLabel mesh__D022001 Adherens Junction, Cell-Matrix
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D022001 2004
% 213.54/213.77  |- skos__scopeNote mesh__D022001
% 213.54/213.77       An anchoring junction of the cell to a non-cellular substrate. It is composed of a specialized area of the plasma membrane where bundles of MICROFILAMENTS terminate and attach to the transmembrane linkers, INTEGRINS, which in turn attach through their extracellular domains to EXTRACELLULAR MATRIX PROTEINS.%A%    
% 213.54/213.77  |- mesh__dateEstablished mesh__D022001 2001-01-01
% 213.54/213.77  |- skos__hiddenLabel mesh__D022001 Adherens Junctions, Cell-Matrix
% 213.54/213.77  |- skos__altLabel mesh__D022001 Adhesion Plaques
% 213.54/213.77  |- skos__broader mesh__D022001smesh__D021982
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D022001 2005
% 213.54/213.77  |- skos__hiddenLabel mesh__D022001 Adhesions, Focal
% 213.54/213.77  |- skos__altLabel mesh__D022001 Focal Contacts
% 213.54/213.77  |- skos__hiddenLabel mesh__D022001 Focal Contact
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D022001 2001
% 213.54/213.77  |- skos__hiddenLabel mesh__D022001 Junction, Cell-Matrix Adherens
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D022001 2006
% 213.54/213.77  |- skos__hiddenLabel mesh__D022001 Focal Adhesion
% 213.54/213.77  |- mesh__dateCreated mesh__D022001 2000-06-21
% 213.54/213.77  |- skos__hiddenLabel mesh__D022001 Cell Matrix Adherens Junctions
% 213.54/213.77  |- skos__historyNote mesh__D022001 Extracellular Matrix %28%1986-2000%29%
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D022001 2002
% 213.54/213.77  |- mesh__historyNote mesh__D022001 2001   
% 213.54/213.77  |- skos__hiddenLabel mesh__D022001 Junctions, Cell-Matrix Adherens
% 213.54/213.77  |- skos__hiddenLabel mesh__D022001 Plaques, Adhesion
% 213.54/213.77  |- skos__hiddenLabel mesh__D022001 Adhesion, Focal
% 213.54/213.77  |- skos__historyNote mesh__D022001 Cell Adhesion %28%1986-2000%29%
% 213.54/213.77  |- rdf__type mesh__D022001sskos__Concept
% 213.54/213.77  |- skos__hiddenLabel mesh__D022001 Contacts, Focal
% 213.54/213.77  |- skos__altLabel mesh__D013275 Gastric Rupture
% 213.54/213.77  |- skos__hiddenLabel mesh__D013275 Stomach Ruptures
% 213.54/213.77  |- mesh__recordMaintainer mesh__D013275 lkt
% 213.54/213.77  |- skos__scopeNote mesh__D013275 Bursting of the STOMACH.     
% 213.54/213.77  |- rdf__type mesh__D013275sskos__Concept
% 213.54/213.77  |- skos__hiddenLabel mesh__D013275 Ruptures, Gastric
% 213.54/213.77  |- mesh__dateRevised mesh__D013275 2004-07-07
% 213.54/213.77  |- mesh__recordOriginator mesh__D013275 NLM
% 213.54/213.77  |- skos__hiddenLabel mesh__D013275 Rupture, Stomach
% 213.54/213.77  |- skos__prefLabel mesh__D013275 Stomach Rupture
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D013275 2006
% 213.54/213.77  |- skos__hiddenLabel mesh__D013275 Gastric Ruptures
% 213.54/213.77  |- skos__broader mesh__D013275smesh__D012421
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D013275 2005
% 213.54/213.77  |- skos__broader mesh__D013275smesh__D000007
% 213.54/213.77  |- skos__annotation mesh__D013275
% 213.54/213.77       traumatic or spontaneous; if spontaneous coord IM with RUPTURE, SPONTANEOUS %28%NIM%29%; differentiate from traumatic stomach perforation %28% = STOMACH /inj%29%%A%  
% 213.54/213.77  |- skos__broader mesh__D013275smesh__D013272
% 213.54/213.77  |- mesh__recordAuthorizer mesh__D013275 sjn
% 213.54/213.77  |- skos__hiddenLabel mesh__D013275 Ruptures, Stomach
% 213.54/213.77  |- skos__hiddenLabel mesh__D013275 Rupture, Gastric
% 213.54/213.77  |- mesh__dateCreated mesh__D013275 1999-01-01
% 213.54/213.77  |- mesh__dateCreated mesh__D007238 1999-01-01
% 213.54/213.77  |- skos__related mesh__D007238smesh__D002544
% 213.54/213.77  |- skos__hiddenLabel mesh__D007238 Infarctions
% 213.54/213.77  |- skos__related mesh__D007238smesh__D020243
% 213.54/213.77  |- skos__related mesh__D007238smesh__D013159
% 213.54/213.77  |- skos__scopeNote mesh__D007238
% 213.54/213.77       Formation of an infarct, which is NECROSIS in tissue due to local ISCHEMIA resulting from obstruction of BLOOD CIRCULATION, most commonly by a THROMBUS or EMBOLUS.%A%    
% 213.54/213.77  |- mesh__dateRevised mesh__D007238 2005-06-30
% 213.54/213.77  |- skos__broader mesh__D007238smesh__D009336
% 213.54/213.77  |- skos__broader mesh__D007238smesh__D007511
% 213.54/213.77  |- rdf__type mesh__D007238sskos__Concept
% 213.54/213.77  |- skos__related mesh__D007238smesh__D020762
% 213.54/213.77  |- skos__prefLabel mesh__D007238 Infarction
% 213.54/213.77  |- mesh__recordOriginator mesh__D007238 NLM
% 213.54/213.77  |- skos__related mesh__D007238smesh__D020244
% 213.54/213.77  |- skos__related mesh__D007238smesh__D020520
% 213.54/213.77  |- skos__related mesh__D007238smesh__D020526
% 213.54/213.77  |- skos__annotation mesh__D007238
% 213.54/213.77       general or unspecified; prefer specific; coord IM with organ /blood supply %28%IM%29%: Manual 23.14.2; DF: INFARCT%A%  
% 213.54/213.77  |- mesh__recordAuthorizer mesh__D007238 sjn
% 213.54/213.77  |- skos__related mesh__D007238smesh__D009203
% 213.54/213.77  |- mesh__recordMaintainer mesh__D007238 ssb
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D007238 2006
% 213.54/213.77  |- skos__related mesh__D007238smesh__D011655
% 213.54/213.77  |- skos__broader mesh__D002339Q000293smesh__D002339
% 213.54/213.77  |- mesh__preferredCombination mesh__D002339Q000293smesh__D020212
% 213.54/213.77  |- rdf__type mesh__D002339Q000293smesh__CompoundConcept
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D017666 2003
% 213.54/213.77  |- mesh__historyNote mesh__D017666
% 213.54/213.77       94; was DEUTERIUM OXIDE %28%NM%29% 1980-93   
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D017666 1999
% 213.54/213.77  |- skos__broader mesh__D017666smesh__D003903
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D017666 2004
% 213.54/213.77  |- mesh__dateCreated mesh__D017666 1993-06-18
% 213.54/213.77  |- mesh__publicMeSHNote mesh__D017666
% 213.54/213.77       94; DEUTERIUM OXIDE was indexed under DEUTERIUM %26% WATER 1980-93%A%  
% 213.54/213.77  |- skos__broader mesh__D017666smesh__D014867
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D017666 2000
% 213.54/213.77  |- skos__hiddenLabel mesh__D017666 Water, Heavy
% 213.54/213.77  |- mesh__recordMaintainer mesh__D017666 JAG
% 213.54/213.77  |- mesh__onlineNote mesh__D017666
% 213.54/213.77       use DEUTERIUM OXIDE %28%NM%29% to search DEUTERIUM OXIDE 1980-93%A%  
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D017666 2001
% 213.54/213.77  |- skos__prefLabel mesh__D017666 Deuterium Oxide
% 213.54/213.77  |- skos__scopeNote mesh__D017666
% 213.54/213.77       The isotopic compound of hydrogen of mass 2 %28%deuterium%29% with oxygen. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29% It is used to study mechanisms and rates of chemical or nuclear reactions, as well as biological processes.%A%    
% 213.54/213.77  |- skos__historyNote mesh__D017666 Water %28%1980-1993%29%
% 213.54/213.77  |- skos__hiddenLabel mesh__D017666 Oxide, Deuterium
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D017666 2005
% 213.54/213.77  |- mesh__recordAuthorizer mesh__D017666 SJN
% 213.54/213.77  |- mesh__dateEstablished mesh__D017666 1994-01-01
% 213.54/213.77  |- mesh__recordOriginator mesh__D017666 TPW
% 213.54/213.77  |- skos__altLabel mesh__D017666 Heavy Water
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D017666 2002
% 213.54/213.77  |- rdf__type mesh__D017666sskos__Concept
% 213.54/213.77  |- skos__historyNote mesh__D017666 Deuterium %28%1980-1993%29%
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D017666 2006
% 213.54/213.77  |- mesh__dateRevised mesh__D017666 1998-06-10
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D031337 2004
% 213.54/213.77  |- skos__prefLabel mesh__D031337 Mentha spicata
% 213.54/213.77  |- rdf__type mesh__D031337sskos__Concept
% 213.54/213.77  |- skos__broader mesh__D031337smesh__D027541
% 213.54/213.77  |- skos__scopeNote mesh__D031337
% 213.54/213.77       A plant genus of the family LAMIACEAE having characteristic flavor.%A%    
% 213.54/213.77  |- mesh__historyNote mesh__D031337 2003   
% 213.54/213.77  |- mesh__publicMeSHNote mesh__D031337 2003   
% 213.54/213.77  |- skos__altLabel mesh__D031337 Spearmint
% 213.54/213.77  |- skos__annotation mesh__D031337
% 213.54/213.77       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.54/213.77  |- mesh__dateCreated mesh__D031337 2002-07-03
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D031337 2005
% 213.54/213.77  |- mesh__dateEstablished mesh__D031337 2003-01-01
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D031337 2003
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D031337 2006
% 213.54/213.77  |- rdf__type mesh__D003646sskos__Concept
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D003646 2003
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D003646 1999
% 213.54/213.77  |- mesh__recordOriginator mesh__D003646 NLM
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D003646 2000
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D003646 2004
% 213.54/213.77  |- mesh__dateCreated mesh__D003646 1999-01-01
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D003646 2001
% 213.54/213.77  |- skos__broader mesh__D003646smesh__D013514
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D003646 2005
% 213.54/213.77  |- skos__prefLabel mesh__D003646 Debridement
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D003646 1996
% 213.54/213.77  |- skos__scopeNote mesh__D003646
% 213.54/213.77       The removal of foreign material and devitalized or contaminated tissue from or adjacent to a traumatic or infected lesion until surrounding healthy tissue is exposed. %28%Dorland, 27th ed%29%%A%    
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D003646 2002
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D003646 2006
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D003646 1997
% 213.54/213.77  |- mesh__recordAuthorizer mesh__D003646 PLS
% 213.54/213.77  |- mesh__dateRevised mesh__D003646 1995-03-13
% 213.54/213.77  |- mesh__recordMaintainer mesh__D003646 TGC
% 213.54/213.77  |- skos__hiddenLabel mesh__D003646 Debridements
% 213.54/213.77  |- skos__annotation mesh__D003646
% 213.54/213.77       do not use /util except by MeSH definition   
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D003646 1998
% 213.54/213.77  |- skos__altLabel mesh__D036022 Capsid Protein
% 213.54/213.77  |- skos__annotation mesh__D036022
% 213.54/213.77       CAPSID is also available; see SCR for many organism-specific VP numbered proteins%A%  
% 213.54/213.77  |- mesh__dateEstablished mesh__D036022 2003-01-01
% 213.54/213.77  |- mesh__recordOriginator mesh__D036022 jmp
% 213.54/213.77  |- skos__altLabel mesh__D036022 Coat Proteins
% 213.54/213.77  |- mesh__recordAuthorizer mesh__D036022 sjn
% 213.54/213.77  |- skos__related mesh__D036022smesh__D002213
% 213.54/213.77  |- skos__broader mesh__D036022smesh__D019590
% 213.54/213.77  |- mesh__dateRevised mesh__D036022 2005-06-30
% 213.54/213.77  |- skos__altLabel mesh__D036022 Viral Outer Coat Protein
% 213.54/213.77  |- skos__prefLabel mesh__D036022 Capsid Proteins
% 213.54/213.77  |- skos__hiddenLabel mesh__D036022 Coat Proteins, Viral
% 213.54/213.77  |- mesh__recordMaintainer mesh__D036022 SYSTEM
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D036022 2006
% 213.54/213.77  |- skos__scopeNote mesh__D036022
% 213.54/213.77       Proteins that form the CAPSID of VIRUSES.     
% 213.54/213.77  |- mesh__dateCreated mesh__D036022 2002-07-03
% 213.54/213.77  |- mesh__historyNote mesh__D036022 2003; use CAPSID 1988-2002   
% 213.54/213.77  |- mesh__publicMeSHNote mesh__D036022 2003; see CAPSID 1988-2002   
% 213.54/213.77  |- skos__historyNote mesh__D036022 Capsid %28%1987-2002%29%
% 213.54/213.77  |- skos__altLabel mesh__D036022 Viral Coat Proteins
% 213.54/213.77  |- rdf__type mesh__D036022sskos__Concept
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008331 2000
% 213.54/213.77  |- skos__hiddenLabel mesh__D008331 Systems, Management Information
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008331 1997
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008331 2004
% 213.54/213.77  |- skos__hiddenLabel mesh__D008331 Management Information System
% 213.54/213.77  |- mesh__dateCreated mesh__D008331 1982-04-28
% 213.54/213.77  |- mesh__publicMeSHNote mesh__D008331
% 213.54/213.77       87; was see under INFORMATION SYSTEMS 1983-86   
% 213.54/213.77  |- mesh__recordOriginator mesh__D008331 EC
% 213.54/213.77  |- skos__annotation mesh__D008331
% 213.54/213.77       for automated systems do not coord with AUTOMATIC DATA PROCESSING%A%  
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008331 1993
% 213.54/213.77  |- skos__hiddenLabel mesh__D008331 Information System, Management
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008331 2001
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008331 1998
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008331 2005
% 213.54/213.77  |- skos__scopeNote mesh__D008331
% 213.54/213.77       Systems designed to provide information primarily concerned with the administrative functions associated with the provision and utilization of services; also includes program planning, etc.%A%    
% 213.54/213.77  |- skos__prefLabel mesh__D008331 Management Information Systems
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008331 2002
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008331 1994
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008331 1999
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008331 2006
% 213.54/213.77  |- mesh__dateRevised mesh__D008331 1992-05-14
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008331 1995
% 213.54/213.77  |- skos__historyNote mesh__D008331
% 213.54/213.77       Organization and Administration %28%1968-1982%29%
% 213.54/213.77  |- rdf__type mesh__D008331sskos__Concept
% 213.54/213.77  |- mesh__recordAuthorizer mesh__D008331 PLS
% 213.54/213.77  |- skos__broader mesh__D008331smesh__D009934
% 213.54/213.77  |- skos__hiddenLabel mesh__D008331 System, Management Information
% 213.54/213.77  |- mesh__dateEstablished mesh__D008331 1987-01-01
% 213.54/213.77  |- mesh__recordMaintainer mesh__D008331 TAP
% 213.54/213.77  |- mesh__historyNote mesh__D008331
% 213.54/213.77       87%28%83%29%; was see under INFORMATION SYSTEMS 1983-86   
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008331 1996
% 213.54/213.77  |- skos__historyNote mesh__D008331 Information Systems %28%1966-1982%29%
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D008331 2003
% 213.54/213.77  |- skos__broader mesh__D008331smesh__D007256
% 213.54/213.77  |- skos__hiddenLabel mesh__D008331 Information Systems, Management
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D022002 2005
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D022002 2002
% 213.54/213.77  |- mesh__dateEstablished mesh__D022002 2001-01-01
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D022002 2006
% 213.54/213.77  |- mesh__dateCreated mesh__D022002 2000-06-22
% 213.54/213.77  |- mesh__historyNote mesh__D022002 2001   
% 213.54/213.77  |- skos__hiddenLabel mesh__D022002 Hemidesmosome
% 213.54/213.77  |- rdf__type mesh__D022002sskos__Concept
% 213.54/213.77  |- skos__historyNote mesh__D022002 Desmosomes %28%1972-2000%29%
% 213.54/213.77  |- mesh__publicMeSHNote mesh__D022002 2001   
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D022002 2003
% 213.54/213.77  |- skos__broader mesh__D022002smesh__D021982
% 213.54/213.77  |- skos__prefLabel mesh__D022002 Hemidesmosomes
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D022002 2004
% 213.54/213.77  |- skos__scopeNote mesh__D022002
% 213.54/213.77       An anchoring junction of the cell to a non-cellular substrate, similar in morphology to halves of DESMOSOMES. They are composed of specialized areas of the plasma membrane where INTERMEDIATE FILAMENTS bind on the cytoplasmic face to the transmembrane linkers, INTEGRINS, via intracellular attachment proteins, while the extracellular domain of the integrins binds to EXTRACELLULAR MATRIX PROTEINS.%A%    
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D022002 2001
% 213.54/213.77  |- mesh__dateRevised mesh__D013276 2004-07-07
% 213.54/213.77  |- mesh__recordAuthorizer mesh__D013276 sjn
% 213.54/213.77  |- skos__hiddenLabel mesh__D013276 Ulcer, Stomach
% 213.54/213.77  |- skos__annotation mesh__D013276
% 213.54/213.77       perforated = STOMACH ULCER /compl %28%IM%29% + PEPTIC ULCER PERFORATION %28%IM%29%; hemorrhage = STOMACH ULCER /compl %28%IM%29% + PEPTIC ULCER HEMORRHAGE %28%IM%29%; %22%gastroduodenal ulcer%22% = GASTRODUODENAL ULCER see PEPTIC ULCER%A%  
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D013276 2006
% 213.54/213.77  |- mesh__recordMaintainer mesh__D013276 lkt
% 213.54/213.77  |- skos__hiddenLabel mesh__D013276 Stomach Ulcers
% 213.54/213.77  |- skos__broader mesh__D013276smesh__D010437
% 213.54/213.77  |- skos__scopeNote mesh__D013276
% 213.54/213.77       Ulceration of the GASTRIC MUCOSA due to contact with GASTRIC JUICE. It is often associated with HELICOBACTER PYLORI infection or consumption of nonsteroidal anti-inflammatory drugs %28%NSAIDS%29%.%A%    
% 213.54/213.77  |- skos__altLabel mesh__D013276 Gastric Ulcer
% 213.54/213.77  |- mesh__recordOriginator mesh__D013276 NLM
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D013276 2005
% 213.54/213.77  |- skos__hiddenLabel mesh__D013276 Ulcer, Gastric
% 213.54/213.77  |- skos__hiddenLabel mesh__D013276 Gastric Ulcers
% 213.54/213.77  |- skos__hiddenLabel mesh__D013276 Ulcers, Gastric
% 213.54/213.77  |- mesh__dateCreated mesh__D013276 1999-01-01
% 213.54/213.77  |- skos__prefLabel mesh__D013276 Stomach Ulcer
% 213.54/213.77  |- skos__hiddenLabel mesh__D013276 Ulcers, Stomach
% 213.54/213.77  |- rdf__type mesh__D013276sskos__Concept
% 213.54/213.77  |- rdf__type mesh__D032430sskos__Concept
% 213.54/213.77  |- skos__annotation mesh__D032430
% 213.54/213.77       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D032430 2004
% 213.54/213.77  |- skos__prefLabel mesh__D032430 Balanites
% 213.54/213.77  |- mesh__historyNote mesh__D032430 2003   
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D032430 2005
% 213.54/213.77  |- mesh__dateEstablished mesh__D032430 2003-01-01
% 213.54/213.77  |- skos__scopeNote mesh__D032430
% 213.54/213.77       A plant genus of the family ZYGOPHYLLACEAE. Feruloyltyramine, balanitoside %28%a furostanol glycoside%29%, and cytostatic steroidal saponins have been found in this genus. B. aegyptiaca fruit water extract is traditionally used as an anthelmintic in the Sudan.%A%    
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D032430 2006
% 213.54/213.77  |- skos__broader mesh__D032430smesh__D028461
% 213.54/213.77  |- mesh__dateCreated mesh__D032430 2002-07-02
% 213.54/213.77  |- mesh__publicMeSHNote mesh__D032430 2003   
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D032430 2003
% 213.54/213.77  |- mesh__dateRevised mesh__D007239 1996-06-10
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D007239 1999
% 213.54/213.77  |- mesh__recordAuthorizer mesh__D007239 PLS
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D007239 2004
% 213.54/213.77  |- rdf__type mesh__D007239sskos__Concept
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D007239 2000
% 213.54/213.77  |- skos__annotation mesh__D007239
% 213.54/213.77       GEN only as concept of dis caused by organisms; many texts saying %22%infection%22% %26% many saying %22%sepsis%22% mean BACTERIAL INFECTIONS: check text but note that SEPSIS is available; %22%infectious disease%22% can be INFECTION but is more likely COMMUNICABLE DISEASES; policy: Manual 22.12-.19, 23.12+; relation to organisms: Manual 22.11-.19 %26% TN 209; /drug ther: consider also ANTI-INFECTIVE AGENTS %26% its specific groups; /prev = INFECTION CONTROL but see note there%A%  
% 213.54/213.77  |- mesh__historyNote mesh__D007239
% 213.54/213.77       /prevention %26% control was INFECTION/prevention %26% control 1966-91%A%  
% 213.54/213.77  |- mesh__recordMaintainer mesh__D007239 TGC
% 213.54/213.77  |- skos__prefLabel mesh__D007239 Infection
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D007239 2001
% 213.54/213.77  |- skos__hiddenLabel mesh__D007239 Reproductive Tract Infection
% 213.54/213.77  |- mesh__publicMeSHNote mesh__D007239
% 213.54/213.77       /prevention %26% control was INFECTION/prevention %26% control 1966-91%A%  
% 213.54/213.77  |- skos__hiddenLabel mesh__D007239 Infections
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D007239 1997
% 213.54/213.77  |- skos__altLabel mesh__D007239 Reproductive Tract Infections
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D007239 2005
% 213.54/213.77  |- mesh__recordOriginator mesh__D007239 NLM
% 213.54/213.77  |- skos__broader mesh__D007239smesh__D001423
% 213.54/213.77  |- mesh__onlineNote mesh__D007239
% 213.54/213.77       use INFECTION CONTROL to search INFECTION/prevention %26% control 1966-91%A%  
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D007239 2006
% 213.54/213.77  |- skos__scopeNote mesh__D007239
% 213.54/213.77       Invasion and multiplication of microorganisms in body tissues, which may be clinically inapparent or result in local cellular injury. A local infection may persist and spread by extension to become an acute, subacute, or chronic clinical infection or disease state. It may also become systemic when the microorganisms gain access to the lymphatic or vascular system. %28%From Dorland, 27th ed%29%%A%    
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D007239 2002
% 213.54/213.77  |- skos__hiddenLabel mesh__D007239 Infection, Reproductive Tract
% 213.54/213.77  |- mesh__dateCreated mesh__D007239 1999-01-01
% 213.54/213.77  |- skos__related mesh__D007239smesh__D000890
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D007239 1998
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D007239 2003
% 213.54/213.77  |- mesh__recordOriginator mesh__D017667 TGC
% 213.54/213.77  |- skos__altLabel mesh__D017667 Fat Cells
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D017667 2004
% 213.54/213.77  |- skos__hiddenLabel mesh__D017667 Fat Cell
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D017667 2006
% 213.54/213.77  |- skos__hiddenLabel mesh__D017667 Lipocyte
% 213.54/213.77  |- skos__hiddenLabel mesh__D017667 Cells, Fat
% 213.54/213.77  |- rdf__type mesh__D017667sskos__Concept
% 213.54/213.77  |- skos__prefLabel mesh__D017667 Adipocytes
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D017667 2003
% 213.54/213.77  |- mesh__publicMeSHNote mesh__D017667 94   
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D017667 2005
% 213.54/213.77  |- skos__scopeNote mesh__D017667
% 213.54/213.77       Fat-storing cells found mostly in the abdominal cavity and subcutaneous tissue. Fat is usually stored in the form of TRYGLYCERIDES.%A%    
% 213.54/213.77  |- mesh__dateEstablished mesh__D017667 1994-01-01
% 213.54/213.77  |- mesh__recordMaintainer mesh__D017667 jls
% 213.54/213.77  |- mesh__dateCreated mesh__D017667 1992-12-28
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D017667 2002
% 213.54/213.77  |- skos__historyNote mesh__D017667 Adipose Tissue %28%1967-1993%29%
% 213.54/213.77  |- mesh__historyNote mesh__D017667 94   
% 213.54/213.77  |- skos__broader mesh__D017667smesh__D003239
% 213.54/213.77  |- mesh__recordAuthorizer mesh__D017667 sjn
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D017667 2001
% 213.54/213.77  |- skos__altLabel mesh__D017667 Lipocytes
% 213.54/213.77  |- skos__hiddenLabel mesh__D017667 Adipocyte
% 213.54/213.77  |- skos__hiddenLabel mesh__D017667 Cell, Fat
% 213.54/213.77  |- mesh__dateRevised mesh__D017667 1999-11-03
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D017667 2000
% 213.54/213.77  |- mesh__dateCreated mesh__D031338 2002-07-03
% 213.54/213.77  |- rdf__type mesh__D031338sskos__Concept
% 213.54/213.77  |- mesh__dateEstablished mesh__D031338 2003-01-01
% 213.54/213.77  |- skos__prefLabel mesh__D031338 Monarda
% 213.54/213.77  |- mesh__recordAuthorizer mesh__D031338 sjn
% 213.54/213.77  |- skos__scopeNote mesh__D031338
% 213.54/213.77       A plant genus of the family LAMIACEAE. The common names of beebalm or lemonbalm are also used for MELISSA. The common name of bergamot is also used for Citrus bergamia %28%CITRUS%29%.%A%    
% 213.54/213.77  |- mesh__recordMaintainer mesh__D031338 ssb
% 213.54/213.77  |- mesh__publicMeSHNote mesh__D031338 2003   
% 213.54/213.77  |- skos__annotation mesh__D031338
% 213.54/213.77       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D031338 2005
% 213.54/213.77  |- mesh__historyNote mesh__D031338 2003   
% 213.54/213.77  |- skos__broader mesh__D031338smesh__D019686
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D031338 2006
% 213.54/213.77  |- mesh__dateRevised mesh__D031338 2003-07-09
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D031338 2004
% 213.54/213.77  |- mesh__recordOriginator mesh__D031338 ssb
% 213.54/213.77  |- skos__hiddenLabel mesh__D036821 Myosis, Endolymphatic Stromal
% 213.54/213.77  |- skos__altLabel mesh__D036821 Endolymphatic Stromal Myosis
% 213.54/213.77  |- mesh__dateEstablished mesh__D036821 2003-01-01
% 213.54/213.77  |- skos__historyNote mesh__D036821 Endometrial Neoplasms %28%1992-2002%29%
% 213.54/213.77  |- mesh__historyNote mesh__D036821 2003   
% 213.54/213.77  |- skos__broader mesh__D036821smesh__D016889
% 213.54/213.77  |- skos__hiddenLabel mesh__D036821 Stromal Tumors, Endometrial
% 213.54/213.77  |- skos__hiddenLabel mesh__D036821 Stromal Myoses, Endolymphatic
% 213.54/213.77  |- mesh__recordOriginator mesh__D036821 lkt
% 213.54/213.77  |- skos__hiddenLabel mesh__D036821 Stromal Tumor, Endometrial
% 213.54/213.77  |- mesh__recordMaintainer mesh__D036821 lkt
% 213.54/213.77  |- skos__hiddenLabel mesh__D036821 Tumor, Endometrial Stromal
% 213.54/213.77  |- mesh__activeMeSHYear mesh__D036821 2006
% 213.54/213.77  |- skos__annotation mesh__D036821
% 213.54/213.77       coord IM with histol type of neopl %28%IM%29%   
% 213.54/213.77  |- skos__hiddenLabel mesh__D036821 Stromal Myosis, Endolymphatic
% 213.54/213.77  |- rdf__type mesh__D036821sskos__Concept
% 213.54/213.77  |- skos__hiddenLabel mesh__D036821 Endolymphatic Stromal Myoses
% 213.54/213.77  |- mesh__dateCreated mesh__D036821 2002-07-03
% 213.54/213.77  |- mesh__recordAuthorizer mesh__D036821 sjn
% 213.54/213.77  |- skos__hiddenLabel mesh__D036821 Endometrial Stromal Tumor
% 213.54/213.77  |- skos__hiddenLabel mesh__D036821 Myoses, Endolymphatic Stromal
% 213.54/213.78  |- mesh__publicMeSHNote mesh__D036821 2003   
% 213.54/213.78  |- skos__historyNote mesh__D036821 Uterine Neoplasms %28%1966-1991%29%
% 213.54/213.78  |- skos__scopeNote mesh__D036821
% 213.54/213.78       Neoplasms of the endometrial stroma that sometimes involve the MYOMETRIUM. These tumors contain cells that may closely or remotely resemble the normal stromal cells. Endometrial stromal neoplasms are divided into three categories: %28%1%29% benign stromal nodules; %28%2%29% low-grade stromal sarcoma, or endolymphatic stromal myosis; and %28%3%29% malignant endometrial stromal sarcoma %28%SARCOMA, ENDOMETRIAL STROMAL%29%.%A%    
% 213.54/213.78  |- skos__hiddenLabel mesh__D036821 Tumors, Endometrial Stromal
% 213.54/213.78  |- skos__prefLabel mesh__D036821 Endometrial Stromal Tumors
% 213.54/213.78  |- mesh__dateRevised mesh__D036821 2005-06-30
% 213.54/213.78  |- mesh__dateCreated mesh__D003647 1999-01-01
% 213.54/213.78  |- mesh__historyNote mesh__D003647
% 213.54/213.78       91%28%73%29%; was see under ISOQUINOLINES 1973-90   
% 213.54/213.78  |- mesh__activeMeSHYear mesh__D003647 2002
% 213.54/213.78  |- mesh__activeMeSHYear mesh__D003647 2005
% 213.54/213.78  |- mesh__publicMeSHNote mesh__D003647
% 213.54/213.78       91; was see under ISOQUINOLINES 1973-90   
% 213.54/213.78  |- skos__historyNote mesh__D003647
% 213.54/213.78       Antihypertensive Agents %28%1966-1972%29%
% 213.68/213.86  |- mesh__dateEstablished mesh__D003647 1991-01-01
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D003647 2006
% 213.68/213.86  |- skos__altLabel mesh__D003647 Debrisoquine
% 213.68/213.86  |- skos__prefLabel mesh__D003647 Debrisoquin
% 213.68/213.86  |- skos__broader mesh__D003647smesh__D007546
% 213.68/213.86  |- rdf__type mesh__D003647sskos__Concept
% 213.68/213.86  |- skos__historyNote mesh__D003647 Isoquinolines %28%1969-1972%29%
% 213.68/213.86  |- mesh__recordOriginator mesh__D003647 NLM
% 213.68/213.86  |- mesh__dateRevised mesh__D003647 2000-06-22
% 213.68/213.86  |- mesh__recordAuthorizer mesh__D003647 sjn
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D003647 2003
% 213.68/213.86  |- mesh__recordMaintainer mesh__D003647 TWD
% 213.68/213.86  |- skos__scopeNote mesh__D003647
% 213.68/213.86       An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.%A%    
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D003647 2001
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D003647 2004
% 213.68/213.86  |- skos__broader mesh__D022801smesh__D001666
% 213.68/213.86  |- skos__historyNote mesh__D022801
% 213.68/213.86       Immunoglobulin Variable Region %28%1982-2000%29%
% 213.68/213.86  |- mesh__dateRevised mesh__D022801 2005-06-30
% 213.68/213.86  |- skos__broader mesh__D022801smesh__D011948
% 213.68/213.86  |- skos__altLabel mesh__D022801 Complementarity Determining Region I
% 213.68/213.86  |- mesh__dateCreated mesh__D022801 2000-06-22
% 213.68/213.86  |- skos__altLabel mesh__D022801 Complementarity Determining Region III
% 213.68/213.86  |- mesh__dateEstablished mesh__D022801 2001-01-01
% 213.68/213.86  |- skos__altLabel mesh__D022801 Hypervariable Region
% 213.68/213.86  |- mesh__recordAuthorizer mesh__D022801 sjn
% 213.68/213.86  |- skos__hiddenLabel mesh__D022801 Regions, Hypervariable
% 213.68/213.86  |- skos__hiddenLabel mesh__D022801
% 213.68/213.86       Third Complementarity-Determining Regions
% 213.68/213.86  |- skos__hiddenLabel mesh__D022801 Region, Complementarity Determining
% 213.68/213.86  |- skos__broader mesh__D022801smesh__D007135
% 213.68/213.86  |- rdf__type mesh__D022801sskos__Concept
% 213.68/213.86  |- skos__altLabel mesh__D022801 Complementarity Determining Region
% 213.68/213.86  |- mesh__publicMeSHNote mesh__D022801
% 213.68/213.86       2001; for COMPLEMENTARITY DETERMINING REGION and HYPERVARIABLE REGION see IMMUNOGLOBULIN VARIABLE REGION 1988-2000; COMPLEMENTARITY-DETERMINING REGION 3 was indexed under COMPLEMENTARITY DETERMINING REGIONS 1998-2005%A%  
% 213.68/213.86  |- skos__hiddenLabel mesh__D022801 Regions, Complementarity-Determining
% 213.68/213.86  |- skos__hiddenLabel mesh__D022801 Regions, Complementarity Determining
% 213.68/213.86  |- skos__hiddenLabel mesh__D022801 Complementarity-Determining Regions
% 213.68/213.86  |- skos__altLabel mesh__D022801 Hypervariable Regions
% 213.68/213.86  |- skos__altLabel mesh__D022801 Complementarity-Determining Region 3
% 213.68/213.86  |- skos__altLabel mesh__D022801 Complementarity Determining Region II
% 213.68/213.86  |- skos__altLabel mesh__D022801 Complementarity-Determining Region
% 213.68/213.86  |- skos__prefLabel mesh__D022801 Complementarity Determining Regions
% 213.68/213.86  |- skos__hiddenLabel mesh__D022801 Third Complementarity Determining Region
% 213.68/213.86  |- skos__altLabel mesh__D022801 Third Complementarity-Determining Region
% 213.68/213.86  |- skos__scopeNote mesh__D022801
% 213.68/213.86       Three regions %28%CDR1; CDR2 and CDR3%29% of amino acid sequence in the IMMUNOGLOBULIN VARIABLE REGION that are highly divergent. Together the CDRs from the light and heavy immunoglobulin chains form a surface that is complementary to the antigen. These regions are also present in other members of the immunoglobulin superfamily, for example, T-cell receptors %28%RECEPTORS, ANTIGEN, T-CELL%29%.%A%    
% 213.68/213.86  |- skos__hiddenLabel mesh__D022801
% 213.68/213.86       Complementarity-Determining Region, Third
% 213.68/213.86  |- skos__hiddenLabel mesh__D022801 Complementarity-Determining Region 3s
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D022801 2006
% 213.68/213.86  |- mesh__recordOriginator mesh__D022801 nns
% 213.68/213.86  |- mesh__historyNote mesh__D022801
% 213.68/213.86       2001; for COMPLEMENTARITY DETERMINING REGION and HYPERVARIABLE REGION use IMMUNOGLOBULIN VARIABLE REGION 1988-2000%A%  
% 213.68/213.86  |- mesh__recordMaintainer mesh__D022801 nns
% 213.68/213.86  |- skos__related mesh__D022801smesh__D011948
% 213.68/213.86  |- skos__hiddenLabel mesh__D022801
% 213.68/213.86       Complementarity-Determining Regions, Third
% 213.68/213.86  |- skos__broader mesh__D004194Q000453smesh__D004194
% 213.68/213.86  |- mesh__preferredCombination mesh__D004194Q000453smesh__D004813
% 213.68/213.86  |- rdf__type mesh__D004194Q000453smesh__CompoundConcept
% 213.68/213.86  |- skos__hiddenLabel mesh__D008332 Quality Circles, Management
% 213.68/213.86  |- mesh__recordAuthorizer mesh__D008332 PLS
% 213.68/213.86  |- mesh__dateCreated mesh__D008332 1984-04-11
% 213.68/213.86  |- skos__historyNote mesh__D008332 Personnel Management %28%1966-1984%29%
% 213.68/213.86  |- mesh__publicMeSHNote mesh__D008332
% 213.68/213.86       91; was see under PERSONNEL MANAGEMENT 1985-90   
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D008332 1998
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D008332 2005
% 213.68/213.86  |- skos__hiddenLabel mesh__D008332 Quality Circle, Management
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D008332 2000
% 213.68/213.86  |- skos__hiddenLabel mesh__D008332 Management Quality Circle
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D008332 1999
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D008332 2006
% 213.68/213.86  |- skos__scopeNote mesh__D008332
% 213.68/213.86       Participation of employees with management as a labor-management team, in decisions pertaining to the operational activities of the organization or industry.%A%    
% 213.68/213.86  |- mesh__dateEstablished mesh__D008332 1991-01-01
% 213.68/213.86  |- mesh__recordOriginator mesh__D008332 EC
% 213.68/213.86  |- skos__hiddenLabel mesh__D008332 Circles, Quality
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D008332 1995
% 213.68/213.86  |- skos__broader mesh__D008332smesh__D010559
% 213.68/213.86  |- skos__historyNote mesh__D008332
% 213.68/213.86       Quality Assurance, Health Care %28%1980-1984%29%
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D008332 2001
% 213.68/213.86  |- rdf__type mesh__D008332sskos__Concept
% 213.68/213.86  |- skos__hiddenLabel mesh__D008332 Quality Circle
% 213.68/213.86  |- skos__hiddenLabel mesh__D008332 Circle, Management Quality
% 213.68/213.86  |- skos__hiddenLabel mesh__D008332 Circle, Quality
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D008332 2002
% 213.68/213.86  |- mesh__dateRevised mesh__D008332 1994-05-05
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D008332 1996
% 213.68/213.86  |- skos__prefLabel mesh__D008332 Management Quality Circles
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D008332 2003
% 213.68/213.86  |- mesh__recordMaintainer mesh__D008332 TGC
% 213.68/213.86  |- skos__annotation mesh__D008332
% 213.68/213.86       personnel %26% management as a labor-management team   
% 213.68/213.86  |- skos__hiddenLabel mesh__D008332 Circles, Management Quality
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D008332 1997
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D008332 2004
% 213.68/213.86  |- mesh__historyNote mesh__D008332
% 213.68/213.86       91%28%85%29%; was see under PERSONNEL MANAGEMENT 1985-90   
% 213.68/213.86  |- mesh__historyNote mesh__D022003 2001   
% 213.68/213.86  |- rdf__type mesh__D022003sskos__Concept
% 213.68/213.86  |- mesh__dateRevised mesh__D022003 2003-07-09
% 213.68/213.86  |- mesh__recordOriginator mesh__D022003 nns
% 213.68/213.86  |- skos__hiddenLabel mesh__D022003 Structure, Cell Nucleus
% 213.68/213.86  |- skos__hiddenLabel mesh__D022003 Cell Nucleus Structure
% 213.68/213.86  |- skos__hiddenLabel mesh__D022003 Structures, Cell Nucleus
% 213.68/213.86  |- skos__annotation mesh__D022003 GEN: avoid; prefer specifics   
% 213.68/213.86  |- skos__historyNote mesh__D022003 Cell Nucleus/UL %28%1966-2000%29%
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D022003 2004
% 213.68/213.86  |- mesh__recordMaintainer mesh__D022003 nns
% 213.68/213.86  |- skos__broader mesh__D022003smesh__D002467
% 213.68/213.86  |- skos__prefLabel mesh__D022003 Cell Nucleus Structures
% 213.68/213.86  |- mesh__dateCreated mesh__D022003 2000-07-05
% 213.68/213.86  |- mesh__publicMeSHNote mesh__D022003 2001   
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D022003 2005
% 213.68/213.86  |- mesh__recordAuthorizer mesh__D022003 sjn
% 213.68/213.86  |- skos__scopeNote mesh__D022003
% 213.68/213.86       Structures that are part of or contained in the CELL NUCLEUS.%A%    
% 213.68/213.86  |- mesh__dateEstablished mesh__D022003 2001-01-01
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D022003 2006
% 213.68/213.86  |- skos__altLabel mesh__D013277 Gastric Volvulus
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D013277 2005
% 213.68/213.86  |- skos__hiddenLabel mesh__D013277 Volvulus, Gastric
% 213.68/213.86  |- skos__broader mesh__D013277smesh__D013272
% 213.68/213.86  |- mesh__dateCreated mesh__D013277 1999-01-01
% 213.68/213.86  |- mesh__recordAuthorizer mesh__D013277 sjn
% 213.68/213.86  |- mesh__recordMaintainer mesh__D013277 lkt
% 213.68/213.86  |- rdf__type mesh__D013277sskos__Concept
% 213.68/213.86  |- skos__scopeNote mesh__D013277
% 213.68/213.86       Twisting of the STOMACH that may result in gastric ISCHEMIA and GASTRIC OUTLET OBSTRUCTION. It is often associated with DIAPHRAGMATIC HERNIA.%A%    
% 213.68/213.86  |- mesh__dateRevised mesh__D013277 2004-07-07
% 213.68/213.86  |- skos__altLabel mesh__D013277 Volvulus, Stomach
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D013277 2006
% 213.68/213.86  |- mesh__recordOriginator mesh__D013277 NLM
% 213.68/213.86  |- skos__prefLabel mesh__D013277 Stomach Volvulus
% 213.68/213.86  |- skos__broader mesh__D004740smesh__D052181
% 213.68/213.86  |- skos__prefLabel mesh__D004740 English Abstract
% 213.68/213.86  |- skos__annotation mesh__D004740
% 213.68/213.86       check tag only for English Abstracts of foreign articles only; do not confuse  with author abstracts; policy: Manual 16.7+; CATALOG: do not use%A%  
% 213.68/213.86  |- mesh__recordAuthorizer mesh__D004740 sjn
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D004740 2006
% 213.68/213.86  |- mesh__dateCreated mesh__D004740 1999-01-01
% 213.68/213.86  |- mesh__historyNote mesh__D004740 1969   
% 213.68/213.86  |- mesh__dateRevised mesh__D004740 2005-06-30
% 213.68/213.86  |- rdf__type mesh__D004740sskos__Concept
% 213.68/213.86  |- mesh__recordMaintainer mesh__D004740 jls
% 213.68/213.86  |- mesh__recordOriginator mesh__D004740 NLM
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D017668 2006
% 213.68/213.86  |- skos__broader mesh__D017668smesh__D000367
% 213.68/213.86  |- rdf__type mesh__D017668sskos__Concept
% 213.68/213.86  |- skos__annotation mesh__D017668
% 213.68/213.86       IM: GEN only; not for routine age of onset of dis in individual case reports; coord NIM with disease /epidemiol %28%IM%29%, as %22%age of onset in peptic ulcer%22% = AGE OF ONSET %28%NIM%29% + PEPTIC ULCER /epidemiol %28%IM%29%; no qualif%A%  
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D017668 1999
% 213.68/213.86  |- skos__hiddenLabel mesh__D017668 Onset Age
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D017668 2003
% 213.68/213.86  |- mesh__recordAuthorizer mesh__D017668 PLS
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D017668 2000
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D017668 1996
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D017668 1995
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D017668 2005
% 213.68/213.86  |- mesh__recordOriginator mesh__D017668 TGC
% 213.68/213.86  |- skos__hiddenLabel mesh__D017668 Disorders, Late-Onset
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D017668 1998
% 213.68/213.86  |- mesh__dateCreated mesh__D017668 1992-12-28
% 213.68/213.86  |- skos__scopeNote mesh__D017668
% 213.68/213.86       The age or period of life at which a disease or the initial symptoms or manifestations of a disease appear in an individual.%A%    
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D017668 1994
% 213.68/213.86  |- skos__prefLabel mesh__D017668 Age of Onset
% 213.68/213.86  |- mesh__historyNote mesh__D017668 94   
% 213.68/213.86  |- skos__hiddenLabel mesh__D017668 Disorder, Late-Onset
% 213.68/213.86  |- mesh__publicMeSHNote mesh__D017668 94   
% 213.68/213.86  |- mesh__dateEstablished mesh__D017668 1994-01-01
% 213.68/213.86  |- skos__historyNote mesh__D017668 Age Factors %28%1966-1993%29%
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D017668 2002
% 213.68/213.86  |- mesh__dateRevised mesh__D017668 1996-03-15
% 213.68/213.86  |- mesh__recordMaintainer mesh__D017668 PLS
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D017668 2004
% 213.68/213.86  |- skos__hiddenLabel mesh__D017668 Late Onset Disorders
% 213.68/213.86  |- skos__hiddenLabel mesh__D017668 Late-Onset Disorder
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D017668 2001
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D017668 1997
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D031339 2006
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D031339 2003
% 213.68/213.86  |- mesh__historyNote mesh__D031339 2003; use OCIMUM BASILICUM 1998-2002   
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D031339 2005
% 213.68/213.86  |- skos__broader mesh__D031339smesh__D019686
% 213.68/213.86  |- rdf__type mesh__D031339sskos__Concept
% 213.68/213.86  |- mesh__dateEstablished mesh__D031339 2003-01-01
% 213.68/213.86  |- skos__historyNote mesh__D031339 Ocimum basilicum %28%1998-2002%29%
% 213.68/213.86  |- mesh__publicMeSHNote mesh__D031339
% 213.68/213.86       2003; see OCIMUM BASILICUM 1998-2002   
% 213.68/213.86  |- skos__prefLabel mesh__D031339 Ocimum
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D031339 2004
% 213.68/213.86  |- skos__annotation mesh__D031339
% 213.68/213.86       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.68/213.86  |- mesh__dateCreated mesh__D031339 2002-07-03
% 213.68/213.86  |- mesh__dateCreated mesh__D042061 2003-07-09
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D042061 2006
% 213.68/213.86  |- mesh__recordAuthorizer mesh__D042061 sjn
% 213.68/213.86  |- skos__annotation mesh__D042061
% 213.68/213.86       infection: coord IM with BRUCELLOSIS %28%IM%29%   
% 213.68/213.86  |- mesh__recordOriginator mesh__D042061 ags
% 213.68/213.86  |- mesh__dateEstablished mesh__D042061 2004-01-01
% 213.68/213.86  |- skos__altLabel mesh__D042061 Brucella melitensis biovar ovis
% 213.68/213.86  |- skos__prefLabel mesh__D042061 Brucella ovis
% 213.68/213.86  |- mesh__recordMaintainer mesh__D042061 SYSTEM
% 213.68/213.86  |- mesh__historyNote mesh__D042061 2004   
% 213.68/213.86  |- rdf__type mesh__D042061sskos__Concept
% 213.68/213.86  |- mesh__dateRevised mesh__D042061 2005-06-30
% 213.68/213.86  |- mesh__publicMeSHNote mesh__D042061 2004   
% 213.68/213.86  |- skos__historyNote mesh__D042061 Brucella %28%1964-2003%29%
% 213.68/213.86  |- skos__broader mesh__D042061smesh__D002002
% 213.68/213.86  |- skos__scopeNote mesh__D042061
% 213.68/213.86       A species of the genus BRUCELLA which are pathogenic to SHEEP.%A%    
% 213.68/213.86  |- skos__altLabel mesh__D003648 Decalcification Technic
% 213.68/213.86  |- skos__hiddenLabel mesh__D003648 Technics, Decalcification
% 213.68/213.86  |- skos__annotation mesh__D003648 NIM   
% 213.68/213.86  |- mesh__publicMeSHNote mesh__D003648
% 213.68/213.86       91; was DECALCIFICATION TECHNIC 1965-90   
% 213.68/213.86  |- skos__hiddenLabel mesh__D003648 Decalcification Technics
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D003648 2001
% 213.68/213.86  |- skos__hiddenLabel mesh__D003648 Technique, Decalcification
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D003648 2006
% 213.68/213.86  |- mesh__dateEstablished mesh__D003648 1965-01-01
% 213.68/213.86  |- skos__broader mesh__D003648smesh__D006652
% 213.68/213.86  |- skos__hiddenLabel mesh__D003648 Technic, Decalcification
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D003648 2002
% 213.68/213.86  |- skos__hiddenLabel mesh__D003648 Techniques, Decalcification
% 213.68/213.86  |- skos__prefLabel mesh__D003648 Decalcification Technique
% 213.68/213.86  |- skos__hiddenLabel mesh__D003648 Decalcification Techniques
% 213.68/213.86  |- rdf__type mesh__D003648sskos__Concept
% 213.68/213.86  |- mesh__historyNote mesh__D003648
% 213.68/213.86       91; was DECALCIFICATION TECHNIC 1965-90   
% 213.68/213.86  |- mesh__dateRevised mesh__D003648 2000-06-22
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D003648 2003
% 213.68/213.86  |- mesh__recordMaintainer mesh__D003648 kle
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D003648 2004
% 213.68/213.86  |- mesh__recordOriginator mesh__D003648 NLM
% 213.68/213.86  |- mesh__dateCreated mesh__D003648 1999-01-01
% 213.68/213.86  |- mesh__recordAuthorizer mesh__D003648 sjn
% 213.68/213.86  |- mesh__onlineNote mesh__D003648
% 213.68/213.86       use DECALCIFICATION TECHNIQUE to search DECALCIFICATION TECHNIC 1966-90%A%  
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D003648 2005
% 213.68/213.86  |- skos__broader mesh__D014370smesh__D018429
% 213.68/213.86  |- mesh__dateRevised mesh__D014370 2003-07-09
% 213.68/213.86  |- rdf__type mesh__D014370sskos__Concept
% 213.68/213.86  |- mesh__dateCreated mesh__D014370 1999-01-01
% 213.68/213.86  |- skos__annotation mesh__D014370
% 213.68/213.86       vectors of various species of Trypanosoma; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111%A%  
% 213.68/213.86  |- skos__altLabel mesh__D014370 Glossina
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D014370 2006
% 213.68/213.86  |- mesh__recordAuthorizer mesh__D014370 sjn
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D014370 2004
% 213.68/213.86  |- mesh__recordMaintainer mesh__D014370 ags
% 213.68/213.86  |- mesh__recordOriginator mesh__D014370 NLM
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D014370 2005
% 213.68/213.86  |- skos__prefLabel mesh__D014370 Tsetse Flies
% 213.68/213.86  |- skos__scopeNote mesh__D014370
% 213.68/213.86       Bloodsucking flies of the genus Glossina, found primarily in equatorial Africa. Several species are intermediate hosts of trypanosomes.%A%    
% 213.68/213.86  |- mesh__recordAuthorizer mesh__D008333 PLS
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D008333 1996
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D008333 2003
% 213.68/213.86  |- skos__prefLabel mesh__D008333 Mandelic Acids
% 213.68/213.86  |- mesh__dateCreated mesh__D008333 1999-01-01
% 213.68/213.86  |- skos__scopeNote mesh__D008333
% 213.68/213.86       Analogs or derivatives of mandelic acid %28%alpha-hydroxybenzeneacetic acid%29%.%A%    
% 213.68/213.86  |- mesh__publicMeSHNote mesh__D008333 75; was MANDELIC ACID 1963-74   
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D008333 2002
% 213.68/213.86  |- mesh__historyNote mesh__D008333 75; was MANDELIC ACID 1963-74   
% 213.68/213.86  |- skos__broader mesh__D008333smesh__D006880
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D008333 1999
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D008333 2006
% 213.68/213.86  |- mesh__recordMaintainer mesh__D008333 JRT
% 213.68/213.86  |- mesh__dateRevised mesh__D008333 1995-05-18
% 213.68/213.86  |- mesh__activeMeSHYear mesh__D008333 2001
% 213.68/213.87  |- skos__annotation mesh__D008333 a urinary anti-infective   
% 213.68/213.87  |- skos__hiddenLabel mesh__D008333 Acids, Mandelic
% 213.68/213.87  |- rdf__type mesh__D008333sskos__Concept
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D008333 1998
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D008333 2000
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D008333 2005
% 213.68/213.87  |- mesh__onlineNote mesh__D008333
% 213.68/213.87       use MANDELIC ACIDS to search MANDELIC ACID 1966-74   
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D008333 1997
% 213.68/213.87  |- mesh__recordOriginator mesh__D008333 NLM
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D008333 2004
% 213.68/213.87  |- skos__broader mesh__D008333smesh__D000146
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D000350 2005
% 213.68/213.87  |- skos__annotation mesh__D000350 a geog area; prefer specific countries   
% 213.68/213.87  |- mesh__recordMaintainer mesh__D000350 mdb
% 213.68/213.87  |- rdf__type mesh__D000350sskos__Concept
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D000350 2002
% 213.68/213.87  |- mesh__recordOriginator mesh__D000350 NLM
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D000350 2004
% 213.68/213.87  |- mesh__recordAuthorizer mesh__D000350 sjn
% 213.68/213.87  |- skos__scopeNote mesh__D000350
% 213.68/213.87       The geographical area of Africa comprising CAMEROON; CENTRAL AFRICAN REPUBLIC; CHAD; CONGO; EQUATORIAL GUINEA; GABON; and DEMOCRATIC REPUBLIC OF THE CONGO.%A%    
% 213.68/213.87  |- mesh__dateRevised mesh__D000350 2001-07-25
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D000350 2003
% 213.68/213.87  |- skos__broader mesh__D000350smesh__D017954
% 213.68/213.87  |- mesh__dateCreated mesh__D000350 1999-01-01
% 213.68/213.87  |- skos__prefLabel mesh__D000350 Africa, Central
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D000350 2006
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D022004 2006
% 213.68/213.87  |- rdf__type mesh__D022004sskos__Concept
% 213.68/213.87  |- skos__broader mesh__D022004smesh__D040342
% 213.68/213.87  |- mesh__recordOriginator mesh__D022004 nns
% 213.68/213.87  |- skos__broader mesh__D022004smesh__D002875
% 213.68/213.87  |- mesh__dateRevised mesh__D022004 2003-07-09
% 213.68/213.87  |- skos__scopeNote mesh__D022004
% 213.68/213.87       Structures which are contained in or part of CHROMOSOMES.%A%    
% 213.68/213.87  |- skos__historyNote mesh__D022004 Chromosomes/UL %28%1975-2000%29%
% 213.68/213.87  |- skos__hiddenLabel mesh__D022004 Structures, Chromosome
% 213.68/213.87  |- mesh__recordMaintainer mesh__D022004 nns
% 213.68/213.87  |- mesh__publicMeSHNote mesh__D022004 2001   
% 213.68/213.87  |- skos__annotation mesh__D022004 GEN: avoid; prefer specifics   
% 213.68/213.87  |- mesh__recordAuthorizer mesh__D022004 sjn
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D022004 2004
% 213.68/213.87  |- skos__hiddenLabel mesh__D022004 Chromosome Structure
% 213.68/213.87  |- skos__hiddenLabel mesh__D022004 Structure, Chromosome
% 213.68/213.87  |- mesh__dateEstablished mesh__D022004 2001-01-01
% 213.68/213.87  |- mesh__dateCreated mesh__D022004 2000-07-05
% 213.68/213.87  |- skos__prefLabel mesh__D022004 Chromosome Structures
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D022004 2005
% 213.68/213.87  |- mesh__historyNote mesh__D022004 2001   
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013278 2000
% 213.68/213.87  |- mesh__recordOriginator mesh__D013278 NLM
% 213.68/213.87  |- mesh__publicMeSHNote mesh__D013278 68   
% 213.68/213.87  |- skos__hiddenLabel mesh__D013278 Stomachs, Avian
% 213.68/213.87  |- mesh__dateCreated mesh__D013278 1999-01-01
% 213.68/213.87  |- skos__historyNote mesh__D013278 Stomach %28%1966-1967%29%
% 213.68/213.87  |- mesh__recordAuthorizer mesh__D013278 PLS
% 213.68/213.87  |- mesh__dateRevised mesh__D013278 1993-06-29
% 213.68/213.87  |- mesh__historyNote mesh__D013278 68   
% 213.68/213.87  |- skos__historyNote mesh__D013278 Birds %28%1966-1967%29%
% 213.68/213.87  |- rdf__type mesh__D013278sskos__Concept
% 213.68/213.87  |- skos__broader mesh__D013278smesh__D000825
% 213.68/213.87  |- mesh__dateEstablished mesh__D013278 1968-01-01
% 213.68/213.87  |- mesh__recordMaintainer mesh__D013278 TGC
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013278 1997
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013278 2004
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013278 2002
% 213.68/213.87  |- skos__hiddenLabel mesh__D013278 Avian Stomach
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013278 1999
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013278 2006
% 213.68/213.87  |- skos__hiddenLabel mesh__D013278 Avian Stomachs
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013278 1996
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013278 1995
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013278 2003
% 213.68/213.87  |- skos__historyNote mesh__D013278 Poultry %28%1966-1967%29%
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013278 2001
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013278 1998
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013278 2005
% 213.68/213.87  |- skos__annotation mesh__D013278
% 213.68/213.87       dis: coord IM with STOMACH DISEASES /vet %28%IM%29%; neopl: coord IM with STOMACH NEOPLASMS /vet %28%IM%29% + histol type %28%IM%29%; Manual 24.6.4.1%A%  
% 213.68/213.87  |- skos__prefLabel mesh__D013278 Stomach, Avian
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013278 1994
% 213.68/213.87  |- mesh__dateEstablished mesh__D018761 1995-01-01
% 213.68/213.87  |- skos__altLabel mesh__D018761 MEA 1
% 213.68/213.87  |- mesh__dateCreated mesh__D018761 1994-05-23
% 213.68/213.87  |- skos__altLabel mesh__D018761 MEN1
% 213.68/213.87  |- mesh__onlineNote mesh__D018761
% 213.68/213.87       use MULTIPLE ENDOCRINE NEOPLASIA to search MEA I, MEN I, %26% WERMER SYNDROME 1983-94%A%  
% 213.68/213.87  |- mesh__recordMaintainer mesh__D018761 lkt
% 213.68/213.87  |- skos__broader mesh__D018761smesh__D009377
% 213.68/213.87  |- skos__historyNote mesh__D018761
% 213.68/213.87       Multiple Endocrine Neoplasia %28%1972-1994%29%
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D018761 2006
% 213.68/213.87  |- mesh__recordAuthorizer mesh__D018761 sjn
% 213.68/213.87  |- skos__annotation mesh__D018761
% 213.68/213.87       coordinate IM with specific endocrine/neoplasm pre-coordinates %28%IM%29% + specific histological type %28%IM%29% if pertinent%A%  
% 213.68/213.87  |- skos__prefLabel mesh__D018761 Multiple Endocrine Neoplasia Type 1
% 213.68/213.87  |- skos__altLabel mesh__D018761 Wermer Syndrome
% 213.68/213.87  |- skos__altLabel mesh__D018761 Multiple Endocrine Neoplasms Type 1
% 213.68/213.87  |- skos__altLabel mesh__D018761 Neoplasia, Multiple Endocrine Type 1
% 213.68/213.87  |- rdf__type mesh__D018761sskos__Concept
% 213.68/213.87  |- skos__altLabel mesh__D018761 Multiple Endocrine Neoplasia Type I
% 213.68/213.87  |- mesh__recordOriginator mesh__D018761 AGS
% 213.68/213.87  |- mesh__historyNote mesh__D018761
% 213.68/213.87       95; MEA I, MEN I, %26% WERMER SYNDROME were see NEOPLASMS, MULTIPLE ENDOCRINE 1983-94%A%  
% 213.68/213.87  |- mesh__publicMeSHNote mesh__D018761
% 213.68/213.87       95; MEA I, MEN I, %26% WERMER SYNDROME were see NEOPLASMS, MULTIPLE ENDOCRINE 1983-94%A%  
% 213.68/213.87  |- skos__altLabel mesh__D018761 MEA I
% 213.68/213.87  |- mesh__dateRevised mesh__D018761 2005-06-30
% 213.68/213.87  |- skos__altLabel mesh__D018761 MEN I
% 213.68/213.87  |- skos__altLabel mesh__D018761 Neoplasms, Multiple Endocrine Type I
% 213.68/213.87  |- skos__altLabel mesh__D018761 Neoplasms, Multiple Endocrine Type 1
% 213.68/213.87  |- skos__altLabel mesh__D018761 MEN 1
% 213.68/213.87  |- skos__scopeNote mesh__D018761
% 213.68/213.87       A form of multiple endocrine neoplasia that is characterized by the combined occurrence of tumors in the PARATHYROID GLANDS, the PITUITARY GLAND, and the PANCREATIC ISLETS. The resulting clinical signs include HYPERPARATHYROIDISM; HYPERCALCEMIA; HYPERPROLACTINEMIA; CUSHING DISEASE; GASTRINOMA; and ZOLLINGER-ELLISON SYNDROME. This disease is due to loss-of-function of the MEN1 gene, a tumor suppressor gene %28%GENES, TUMOR SUPPRESSOR%29% on CHROMOSOME 11 %28%Locus: 11q13%29%.%A%    
% 213.68/213.87  |- skos__annotation mesh__D004741 DF: ENGRAVING   
% 213.68/213.87  |- rdf__type mesh__D004741sskos__Concept
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D004741 2004
% 213.68/213.87  |- skos__hiddenLabel mesh__D004741 Engravings and Engraving
% 213.68/213.87  |- mesh__recordOriginator mesh__D004741 NLM
% 213.68/213.87  |- mesh__recordMaintainer mesh__D004741 ssb
% 213.68/213.87  |- skos__broader mesh__D004741smesh__D001154
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D004741 2006
% 213.68/213.87  |- skos__prefLabel mesh__D004741 Engraving and Engravings
% 213.68/213.87  |- skos__hiddenLabel mesh__D004741 Engravings
% 213.68/213.87  |- mesh__recordAuthorizer mesh__D004741 sjn
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D004741 2005
% 213.68/213.87  |- mesh__dateCreated mesh__D004741 1999-01-01
% 213.68/213.87  |- mesh__dateRevised mesh__D004741 2003-07-09
% 213.68/213.87  |- mesh__dateCreated mesh__D051397 2005-06-30
% 213.68/213.87  |- skos__hiddenLabel mesh__D051397 Aquaporins, Non-Specific
% 213.68/213.87  |- skos__scopeNote mesh__D051397
% 213.68/213.87       A subgroup of aquaporins that transport WATER; GLYCEROL; and other small solutes across CELL MEMBRANES.%A%    
% 213.68/213.87  |- mesh__historyNote mesh__D051397 2006   
% 213.68/213.87  |- rdf__type mesh__D051397sskos__Concept
% 213.68/213.87  |- skos__hiddenLabel mesh__D051397 Aquaporins, Multi-Functional
% 213.68/213.87  |- skos__hiddenLabel mesh__D051397 Non Specific Aquaporins
% 213.68/213.87  |- mesh__recordMaintainer mesh__D051397 DRC
% 213.68/213.87  |- skos__hiddenLabel mesh__D051397 Multi Functional Aquaporins
% 213.68/213.87  |- skos__altLabel mesh__D051397 Non-Specific Aquaporins
% 213.68/213.87  |- skos__broader mesh__D051397smesh__D020346
% 213.68/213.87  |- skos__altLabel mesh__D051397 Multi-Functional Aquaporins
% 213.68/213.87  |- mesh__dateEstablished mesh__D051397 2006-01-01
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D051397 2006
% 213.68/213.87  |- skos__prefLabel mesh__D051397 Aquaglyceroporins
% 213.68/213.87  |- mesh__publicMeSHNote mesh__D051397 2006   
% 213.68/213.87  |- mesh__recordOriginator mesh__D051397 DRC
% 213.68/213.87  |- mesh__recordAuthorizer mesh__D051397 sjn
% 213.68/213.87  |- mesh__publicMeSHNote mesh__D017669 94   
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D017669 1994
% 213.68/213.87  |- mesh__historyNote mesh__D017669 94   
% 213.68/213.87  |- mesh__dateCreated mesh__D017669 1993-06-04
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D017669 2002
% 213.68/213.87  |- skos__annotation mesh__D017669
% 213.68/213.87       inorganic; GEN or unspecified; prefer specifics; DF: MERCURY CPDS%A%  
% 213.68/213.87  |- skos__hiddenLabel mesh__D017669 Compounds, Mercury
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D017669 2001
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D017669 2004
% 213.68/213.87  |- skos__scopeNote mesh__D017669
% 213.68/213.87       Inorganic compounds that contain mercury as an integral part of the molecule.%A%    
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D017669 2000
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D017669 1997
% 213.68/213.87  |- skos__historyNote mesh__D017669 Mercury %28%1966-1993%29%
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D017669 2006
% 213.68/213.87  |- rdf__type mesh__D017669sskos__Concept
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D017669 1999
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D017669 2003
% 213.68/213.87  |- skos__prefLabel mesh__D017669 Mercury Compounds
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D017669 1996
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D017669 1995
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D017669 2005
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D017669 1998
% 213.68/213.87  |- skos__broader mesh__D017669smesh__D007287
% 213.68/213.87  |- mesh__dateEstablished mesh__D017669 1994-01-01
% 213.68/213.87  |- skos__broader mesh__D042062smesh__D020561
% 213.68/213.87  |- mesh__dateEstablished mesh__D042062 2004-01-01
% 213.68/213.87  |- mesh__recordMaintainer mesh__D042062 SYSTEM
% 213.68/213.87  |- mesh__historyNote mesh__D042062 2004   
% 213.68/213.87  |- mesh__dateRevised mesh__D042062 2005-06-30
% 213.68/213.87  |- mesh__dateCreated mesh__D042062 2003-07-09
% 213.68/213.87  |- skos__scopeNote mesh__D042062
% 213.68/213.87       A family of aerobic gram-negative rods that are nitrogen fixers. They are highly viscous, and appear as a semitransparent slime in giant colonies.%A%    
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D042062 2006
% 213.68/213.87  |- skos__prefLabel mesh__D042062 Beijerinckiaceae
% 213.68/213.87  |- rdf__type mesh__D042062sskos__Concept
% 213.68/213.87  |- mesh__recordAuthorizer mesh__D042062 sjn
% 213.68/213.87  |- mesh__publicMeSHNote mesh__D042062 2004   
% 213.68/213.87  |- mesh__recordOriginator mesh__D042062 ags
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D003649 1998
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D003649 2002
% 213.68/213.87  |- skos__related mesh__D003649smesh__D017001
% 213.68/213.87  |- skos__prefLabel mesh__D003649 Decalcification, Pathologic
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D003649 1997
% 213.68/213.87  |- skos__altLabel mesh__D003649 Decalcification, Pathological
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D003649 2001
% 213.68/213.87  |- mesh__recordOriginator mesh__D003649 NLM
% 213.68/213.87  |- mesh__onlineNote mesh__D003649
% 213.68/213.87       use CALCIUM METABOLISM DISORDERS to search DECALCIFICATION, PATHOLOGIC 1966-74%A%  
% 213.68/213.87  |- mesh__recordAuthorizer mesh__D003649 PLS
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D003649 1996
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D003649 2006
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D003649 2000
% 213.68/213.87  |- skos__broader mesh__D003649smesh__D002128
% 213.68/213.87  |- skos__annotation mesh__D003649
% 213.68/213.87       loss of calcium from bone %26% tooth but consider also TOOTH DEMINERALIZATION; DF: DECALCIFICATION PATHOL%A%  
% 213.68/213.87  |- mesh__dateEstablished mesh__D003649 1991-01-01
% 213.68/213.87  |- skos__scopeNote mesh__D003649
% 213.68/213.87       The loss of calcium salts from bones and teeth. Bacteria may be responsible for this occurrence in teeth. Old age may be a factor contributing to calcium loss, as is the presence of diseases such as rheumatoid arthritis.%A%    
% 213.68/213.87  |- mesh__recordMaintainer mesh__D003649 JLS
% 213.68/213.87  |- mesh__dateRevised mesh__D003649 1994-02-28
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D003649 2005
% 213.68/213.87  |- rdf__type mesh__D003649sskos__Concept
% 213.68/213.87  |- skos__altLabel mesh__D003649 Pathologic Decalcification
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D003649 1995
% 213.68/213.87  |- mesh__dateCreated mesh__D003649 1999-01-01
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D003649 2004
% 213.68/213.87  |- skos__broader mesh__D003649smesh__D018488
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D003649 1999
% 213.68/213.87  |- skos__hiddenLabel mesh__D003649 Pathological Decalcification
% 213.68/213.87  |- mesh__publicMeSHNote mesh__D003649
% 213.68/213.87       91; was see under CALCIUM METABOLISM DISORDERS 1965-90   
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D003649 2003
% 213.68/213.87  |- mesh__historyNote mesh__D003649
% 213.68/213.87       91%28%65%29%; was see under CALCIUM METABOLISM DISORDERS 1965-90%A%  
% 213.68/213.87  |- mesh__onlineNote mesh__D014371 search HYPOTHALAMUS 1969-74   
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D014371 2000
% 213.68/213.87  |- skos__hiddenLabel mesh__D014371 Tuber Cinereums
% 213.68/213.87  |- skos__hiddenLabel mesh__D014371 Cinereums, Tuber
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D014371 2006
% 213.68/213.87  |- mesh__historyNote mesh__D014371
% 213.68/213.87       91%28%75%29%; was see under HYPOTHALAMUS 1975-90   
% 213.68/213.87  |- mesh__recordMaintainer mesh__D014371 ags
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D014371 2004
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D014371 2005
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D014371 2002
% 213.68/213.87  |- mesh__dateRevised mesh__D014371 1999-11-03
% 213.68/213.87  |- skos__scopeNote mesh__D014371
% 213.68/213.87       Layer of gray matter in the hypothalamus that also forms part of the floor of the third ventricle and merges anteriorly into the infundibulum %28%see PITUITARY GLAND, POSTERIOR%29%.%A%    
% 213.68/213.87  |- mesh__publicMeSHNote mesh__D014371
% 213.68/213.87       91; was see under HYPOTHALAMUS 1975-90   
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D014371 2003
% 213.68/213.87  |- skos__broader mesh__D014371smesh__D007033
% 213.68/213.87  |- skos__hiddenLabel mesh__D014371 Cinereum, Tuber
% 213.68/213.87  |- mesh__recordAuthorizer mesh__D014371 sjn
% 213.68/213.87  |- skos__prefLabel mesh__D014371 Tuber Cinereum
% 213.68/213.87  |- rdf__type mesh__D014371sskos__Concept
% 213.68/213.87  |- mesh__recordOriginator mesh__D014371 NLM
% 213.68/213.87  |- mesh__dateEstablished mesh__D014371 1991-01-01
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D014371 2001
% 213.68/213.87  |- mesh__dateCreated mesh__D014371 1999-01-01
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D008334 2000
% 213.68/213.87  |- mesh__recordMaintainer mesh__D008334 KEV
% 213.68/213.87  |- mesh__recordOriginator mesh__D008334 NLM
% 213.68/213.87  |- skos__prefLabel mesh__D008334 Mandible
% 213.68/213.87  |- mesh__recordAuthorizer mesh__D008334 sjn
% 213.68/213.87  |- skos__annotation mesh__D008334
% 213.68/213.87       /growth: consider also MAXILLOFACIAL DEVELOPMENT; /innerv: consider also MANDIBULAR NERVE%A%  
% 213.68/213.87  |- mesh__dateCreated mesh__D008334 1999-01-01
% 213.68/213.87  |- skos__scopeNote mesh__D008334
% 213.68/213.87       The largest and strongest bone of the FACE constituting the lower jaw. It supports the lower teeth.%A%    
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D008334 2006
% 213.68/213.87  |- skos__broader mesh__D008334smesh__D007568
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D008334 2005
% 213.68/213.87  |- skos__related mesh__D008334smesh__D013704
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D008334 2002
% 213.68/213.87  |- mesh__dateRevised mesh__D008334 1999-11-03
% 213.68/213.87  |- rdf__type mesh__D008334sskos__Concept
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D008334 2004
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D008334 2001
% 213.68/213.87  |- skos__related mesh__D008334smesh__D002680
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D008334 2003
% 213.68/213.87  |- skos__hiddenLabel mesh__D008334 Mandibles
% 213.68/213.87  |- rdf__type mesh__D000351sskos__Concept
% 213.68/213.87  |- mesh__recordAuthorizer mesh__D000351 sjn
% 213.68/213.87  |- mesh__recordMaintainer mesh__D000351 mdb
% 213.68/213.87  |- mesh__dateRevised mesh__D000351 2001-07-25
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D000351 2004
% 213.68/213.87  |- skos__altLabel mesh__D000351 Eastern Africa
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D000351 2003
% 213.68/213.87  |- skos__broader mesh__D000351smesh__D017954
% 213.68/213.87  |- mesh__dateCreated mesh__D000351 1999-01-01
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D000351 2006
% 213.68/213.87  |- skos__scopeNote mesh__D000351
% 213.68/213.87       The geographical area of Africa comprising BURUNDI; DJIBOUTI; ETHIOPIA; KENYA; RWANDA; SOMALIA; SUDAN; TANZANIA; and UGANDA.%A%    
% 213.68/213.87  |- skos__prefLabel mesh__D000351 Africa, Eastern
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D000351 2005
% 213.68/213.87  |- skos__annotation mesh__D000351 a geog area; prefer specific countries   
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D000351 2002
% 213.68/213.87  |- mesh__recordOriginator mesh__D000351 NLM
% 213.68/213.87  |- mesh__recordMaintainer mesh__D022005 mdb
% 213.68/213.87  |- skos__hiddenLabel mesh__D022005 Junction, Adherens
% 213.68/213.87  |- mesh__recordAuthorizer mesh__D022005 sjn
% 213.68/213.87  |- skos__prefLabel mesh__D022005 Adherens Junctions
% 213.68/213.87  |- skos__hiddenLabel mesh__D022005 Junctions, Adherens
% 213.68/213.87  |- mesh__dateCreated mesh__D022005 2000-06-21
% 213.68/213.87  |- mesh__dateEstablished mesh__D022005 2001-01-01
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D022005 2006
% 213.68/213.87  |- rdf__type mesh__D022005sskos__Concept
% 213.68/213.87  |- skos__scopeNote mesh__D022005
% 213.68/213.87       Anchoring points where the CYTOSKELETON of neighboring cells are connected to each other. They are composed of specialized areas of the plasma membrane where bundles of MICROFILAMENTS attach to the membrane through the transmembrane linkers, CADHERINS, which in turn attach through their extracellular domains to cadherins in the neighboring cell membranes. In sheets of cells, they form into adhesion belts %28%zonula adherens%29% that go all the way around a cell.%A%    
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D022005 2005
% 213.68/213.87  |- skos__broader mesh__D022005smesh__D007365
% 213.68/213.87  |- mesh__publicMeSHNote mesh__D022005 2001   
% 213.68/213.87  |- mesh__dateRevised mesh__D022005 2002-07-02
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D022005 2004
% 213.68/213.87  |- mesh__recordOriginator mesh__D022005 nns
% 213.68/213.87  |- mesh__historyNote mesh__D022005 2001   
% 213.68/213.87  |- skos__hiddenLabel mesh__D022005 Adherens Junction
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D022005 2003
% 213.68/213.87  |- skos__historyNote mesh__D022005
% 213.68/213.87       Intercellular Junctions %28%1984-2000%29%
% 213.68/213.87  |- skos__hiddenLabel mesh__D022005 Adherens, Zonula
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013279 2000
% 213.68/213.87  |- mesh__dateEstablished mesh__D013279 1968-01-01
% 213.68/213.87  |- mesh__publicMeSHNote mesh__D013279 68   
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013279 2001
% 213.68/213.87  |- skos__historyNote mesh__D013279 Stomach %28%1966-1967%29%
% 213.68/213.87  |- mesh__recordAuthorizer mesh__D013279 PLS
% 213.68/213.87  |- mesh__recordMaintainer mesh__D013279 TGC
% 213.68/213.87  |- rdf__type mesh__D013279sskos__Concept
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013279 1996
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013279 2003
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013279 1998
% 213.68/213.87  |- mesh__recordOriginator mesh__D013279 NLM
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013279 2005
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013279 1997
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013279 2004
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013279 1994
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013279 2002
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013279 1999
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013279 2006
% 213.68/213.87  |- skos__prefLabel mesh__D013279 Stomach, Ruminant
% 213.68/213.87  |- mesh__historyNote mesh__D013279 68   
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D013279 1995
% 213.68/213.87  |- mesh__dateCreated mesh__D013279 1999-01-01
% 213.68/213.87  |- skos__annotation mesh__D013279
% 213.68/213.87       dis: coord IM with STOMACH DISEASES /vet %28%IM%29%; neopl: coord IM with STOMACH NEOPLASMS /vet %28%IM%29% + histol type %28%IM%29%; ulcer: coord IM with STOMACH ULCER /vet %28%IM%29%; Manual 24.6.4.1%A%  
% 213.68/213.87  |- skos__broader mesh__D013279smesh__D000825
% 213.68/213.87  |- skos__hiddenLabel mesh__D013279 Ruminant Stomach
% 213.68/213.87  |- mesh__dateRevised mesh__D013279 1993-06-29
% 213.68/213.87  |- skos__hiddenLabel mesh__D013279 Ruminant Stomachs
% 213.68/213.87  |- skos__hiddenLabel mesh__D013279 Stomachs, Ruminant
% 213.68/213.87  |- skos__hiddenLabel mesh__D004742 Enhancer Element %28%Genetics%29%
% 213.68/213.87  |- mesh__historyNote mesh__D004742
% 213.68/213.87       88%28%85%29%; was see under GENES, REGULATOR 1985-87   
% 213.68/213.87  |- skos__hiddenLabel mesh__D004742 Enhancers
% 213.68/213.87  |- skos__altLabel mesh__D004742 Enhancer Elements
% 213.68/213.87  |- skos__historyNote mesh__D004742 Genes, Regulator %28%1968-1984%29%
% 213.68/213.87  |- mesh__dateRevised mesh__D004742 2005-06-30
% 213.68/213.87  |- mesh__recordMaintainer mesh__D004742 nns
% 213.68/213.87  |- skos__historyNote mesh__D004742 Genes %28%1966-1967%29%
% 213.68/213.87  |- skos__broader mesh__D004742smesh__D012045
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D004742 2006
% 213.68/213.87  |- skos__hiddenLabel mesh__D004742 Element, Enhancer
% 213.68/213.87  |- mesh__recordOriginator mesh__D004742 AEP
% 213.68/213.87  |- skos__hiddenLabel mesh__D004742 Element, Enhancer %28%Genetics%29%
% 213.68/213.87  |- skos__broader mesh__D004742smesh__D050436
% 213.68/213.87  |- skos__prefLabel mesh__D004742 Enhancer Elements %28%Genetics%29%
% 213.68/213.87  |- skos__scopeNote mesh__D004742
% 213.68/213.87       Cis-acting DNA sequences which can increase transcription of genes. Enhancers can usually function in either orientation and at various distances from a promoter.%A%    
% 213.68/213.87  |- skos__hiddenLabel mesh__D004742 Elements, Enhancer %28%Genetics%29%
% 213.68/213.87  |- skos__historyNote mesh__D004742
% 213.68/213.87       Gene Expression Regulation %28%1981-1984%29%
% 213.68/213.87  |- mesh__dateEstablished mesh__D004742 1988-01-01
% 213.68/213.87  |- skos__historyNote mesh__D004742 Transcription, Genetic %28%1973-1984%29%
% 213.68/213.87  |- skos__annotation mesh__D004742 DF: ENHANCER ELEMENTS   
% 213.68/213.87  |- skos__hiddenLabel mesh__D004742 Elements, Enhancer
% 213.68/213.87  |- mesh__publicMeSHNote mesh__D004742
% 213.68/213.87       88; was see under GENES, REGULATOR 1985-87   
% 213.68/213.87  |- rdf__type mesh__D004742sskos__Concept
% 213.68/213.87  |- mesh__recordAuthorizer mesh__D004742 sjn
% 213.68/213.87  |- skos__hiddenLabel mesh__D004742 Enhancer Element
% 213.68/213.87  |- mesh__dateCreated mesh__D004742 1984-04-05
% 213.68/213.87  |- skos__altLabel mesh__D051398 AQP-CHIP Protein
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D051398 2006B
% 213.68/213.87  |- skos__broader mesh__D051398smesh__D020346
% 213.68/213.87  |- mesh__dateEstablished mesh__D051398 2006-01-01
% 213.68/213.87  |- mesh__recordAuthorizer mesh__D051398 ags
% 213.68/213.87  |- skos__altLabel mesh__D051398 Aquaporin 1 Protein
% 213.68/213.87  |- rdf__type mesh__D051398sskos__Concept
% 213.68/213.87  |- mesh__recordMaintainer mesh__D051398 ags
% 213.68/213.87  |- mesh__publicMeSHNote mesh__D051398
% 213.68/213.87       2006; AQUAPORIN 1 was indexed under AQUAPORINS 1999-2005, %26% under ION CHANNELS 1994-1998, %26% under MEMBRANE PROTEINS 1992-1993%A%  
% 213.68/213.87  |- mesh__historyNote mesh__D051398 2006%28%1992%29%   
% 213.68/213.87  |- skos__prefLabel mesh__D051398 Aquaporin 1
% 213.68/213.87  |- skos__altLabel mesh__D051398 Aquaporin-CHIP
% 213.68/213.87  |- mesh__dateCreated mesh__D051398 2005-06-30
% 213.68/213.87  |- skos__hiddenLabel mesh__D051398 AQP CHIP Protein
% 213.68/213.87  |- skos__hiddenLabel mesh__D051398 Aquaporin CHIP
% 213.68/213.87  |- skos__altLabel mesh__D051398 AQP1 Protein
% 213.68/213.87  |- skos__scopeNote mesh__D051398
% 213.68/213.87       Aquaporin 1 forms a water-specific channel that is constitutively expressed at the PLASMA MEMBRANE of ERYTHROCYTES and KIDNEY TUBULES, PROXIMAL. It provides these cells with a high permeability to WATER. In humans polymorphisms of this protein result in the Colton blood group antigen.%A%    
% 213.68/213.87  |- skos__altLabel mesh__D051398
% 213.68/213.87       Channel-Forming Integral Membrane Protein Of 28 kDa
% 213.68/213.87  |- skos__altLabel mesh__D051398 CHIP28 Protein
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D051398 2006
% 213.68/213.87  |- mesh__recordOriginator mesh__D051398 DRC
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D051398 2006A
% 213.68/213.87  |- mesh__dateRevised mesh__D051398 2005-07-18
% 213.68/213.87  |- skos__hiddenLabel mesh__D051398
% 213.68/213.87       Channel Forming Integral Membrane Protein Of 28 kDa
% 213.68/213.87  |- mesh__dateCreated mesh__D042063 2003-07-09
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D042063 2006
% 213.68/213.87  |- mesh__dateEstablished mesh__D042063 2004-01-01
% 213.68/213.87  |- skos__scopeNote mesh__D042063
% 213.68/213.87       A family of stalked bacteria that reproduces by budding. There are four genera: CAULOBACTER, Asticcacaulis, Brevundimonas, and Phenylobacterium.%A%    
% 213.68/213.87  |- mesh__historyNote mesh__D042063 2004   
% 213.68/213.87  |- mesh__dateRevised mesh__D042063 2005-06-30
% 213.68/213.87  |- skos__prefLabel mesh__D042063 Caulobacteraceae
% 213.68/213.87  |- rdf__type mesh__D042063sskos__Concept
% 213.68/213.87  |- mesh__publicMeSHNote mesh__D042063 2004   
% 213.68/213.87  |- skos__broader mesh__D042063smesh__D020561
% 213.68/213.87  |- mesh__recordMaintainer mesh__D042063 SYSTEM
% 213.68/213.87  |- mesh__recordAuthorizer mesh__D042063 sjn
% 213.68/213.87  |- skos__broader mesh__D042063smesh__D016946
% 213.68/213.87  |- mesh__recordOriginator mesh__D042063 ags
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D014372 2005
% 213.68/213.87  |- skos__hiddenLabel mesh__D014372 7 Deazaadenosine
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D014372 2000
% 213.68/213.87  |- mesh__dateRevised mesh__D014372 1999-11-03
% 213.68/213.87  |- mesh__recordAuthorizer mesh__D014372 sjn
% 213.68/213.87  |- mesh__historyNote mesh__D014372
% 213.68/213.87       91%28%75%29%; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1975-90%A%  
% 213.68/213.87  |- skos__altLabel mesh__D014372 7-Deazaadenosine
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D014372 2003
% 213.68/213.87  |- skos__historyNote mesh__D014372 Ribonucleosides %28%1973-1974%29%
% 213.68/213.87  |- mesh__recordOriginator mesh__D014372 NLM
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D014372 2006
% 213.68/213.87  |- skos__historyNote mesh__D014372 Pyrimidines %28%1973-1974%29%
% 213.68/213.87  |- mesh__dateEstablished mesh__D014372 1991-01-01
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D014372 2004
% 213.68/213.87  |- skos__annotation mesh__D014372 an antineoplastic antimetabolite   
% 213.68/213.87  |- mesh__activeMeSHYear mesh__D014372 2001
% 213.68/213.87  |- skos__altLabel mesh__D014372
% 213.68/213.87       4-Amino-7 beta-D-ribofuranosyl-7H-pyrrolo%28%2,3-d%29%pyrimidine
% 213.68/213.88  |- skos__historyNote mesh__D014372 Pyrroles %28%1973-1974%29%
% 213.68/213.88  |- skos__broader mesh__D014372smesh__D011684
% 213.68/213.88  |- skos__scopeNote mesh__D014372
% 213.68/213.88       An antibiotic purine ribonucleoside that readily substitutes for adenosine in the biological system, but its incorporation into DNA and RNA has an inhibitory effect on the metabolism of these nucleic acids.%A%    
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D014372 2002
% 213.68/213.88  |- mesh__dateCreated mesh__D014372 1974-11-11
% 213.68/213.88  |- skos__broader mesh__D014372smesh__D012263
% 213.68/213.88  |- skos__prefLabel mesh__D014372 Tubercidin
% 213.68/213.88  |- rdf__type mesh__D014372sskos__Concept
% 213.68/213.88  |- skos__altLabel mesh__D014372 Deazaadenosine
% 213.68/213.88  |- mesh__publicMeSHNote mesh__D014372
% 213.68/213.88       91; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1975-90   
% 213.68/213.88  |- mesh__recordMaintainer mesh__D014372 jmp
% 213.68/213.88  |- skos__hiddenLabel mesh__D008335 Mandibular Condyles
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008335 1998
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008335 2005
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008335 2001
% 213.68/213.88  |- rdf__type mesh__D008335sskos__Concept
% 213.68/213.88  |- skos__scopeNote mesh__D008335
% 213.68/213.88       The posterior process on the ramus of the mandible composed of two parts: a superior part, the articular portion, and an inferior part, the condylar neck.%A%    
% 213.68/213.88  |- mesh__dateEstablished mesh__D008335 1965-01-01
% 213.68/213.88  |- skos__broader mesh__D008335smesh__D008334
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008335 1997
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008335 2004
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008335 2000
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008335 2003
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008335 1996
% 213.68/213.88  |- mesh__recordOriginator mesh__D008335 NLM
% 213.68/213.88  |- mesh__recordMaintainer mesh__D008335 PXP
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008335 1995
% 213.68/213.88  |- skos__hiddenLabel mesh__D008335 Condyles, Mandibular
% 213.68/213.88  |- mesh__historyNote mesh__D008335 65   
% 213.68/213.88  |- mesh__publicMeSHNote mesh__D008335 65   
% 213.68/213.88  |- skos__hiddenLabel mesh__D008335 Condyle, Mandibular
% 213.68/213.88  |- mesh__recordAuthorizer mesh__D008335 PLS
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008335 1994
% 213.68/213.88  |- skos__prefLabel mesh__D008335 Mandibular Condyle
% 213.68/213.88  |- mesh__dateCreated mesh__D008335 1999-01-01
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008335 1999
% 213.68/213.88  |- skos__related mesh__D008335smesh__D013704
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008335 2006
% 213.68/213.88  |- mesh__dateRevised mesh__D008335 1993-06-03
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008335 2002
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D000352 2002
% 213.68/213.88  |- skos__altLabel mesh__D000352 Africa, French-Speaking
% 213.68/213.88  |- mesh__recordOriginator mesh__D000352 NLM
% 213.68/213.88  |- mesh__dateCreated mesh__D000352 1999-01-01
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D000352 2003
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D000352 2006A
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D000352 2006
% 213.68/213.88  |- skos__altLabel mesh__D000352 French Speaking Africa
% 213.68/213.88  |- mesh__recordAuthorizer mesh__D000352 jls
% 213.68/213.88  |- skos__altLabel mesh__D000352 French-Speaking Africa
% 213.68/213.88  |- mesh__dateRevised mesh__D000352 2005-07-29
% 213.68/213.88  |- skos__broader mesh__D000352smesh__D000349
% 213.68/213.88  |- skos__scopeNote mesh__D000352
% 213.68/213.88       The geographical area of Africa comprising ALGERIA; EGYPT; LIBYA; MOROCCO; and TUNISIA. It includes also the vast deserts and oases of the Sahara. It is often referred to as North Africa, French-speaking Africa, or the Maghreb. %28%From Webster%27%s New Geographical Dictionary, 1988, p856%29%%A%    
% 213.68/213.88  |- skos__altLabel mesh__D000352 Northern Africa
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D000352 2005
% 213.68/213.88  |- skos__altLabel mesh__D000352 Maghrib
% 213.68/213.88  |- skos__prefLabel mesh__D000352 Africa, Northern
% 213.68/213.88  |- skos__annotation mesh__D000352
% 213.68/213.88       = Algeria, Egypt, Libya, Morocco, Tunisia collectively: prefer specifics; titles often refer to the Maghreb or Maghrib, the Arabic name for Algeria, Morocco, Tunisia %26% sometimes Libya collectively: check text for possible specificity, otherwise index under AFRICA, NORTHERN%A%  
% 213.68/213.88  |- mesh__recordMaintainer mesh__D000352 jls
% 213.68/213.88  |- skos__altLabel mesh__D000352 North Africa
% 213.68/213.88  |- rdf__type mesh__D000352sskos__Concept
% 213.68/213.88  |- skos__altLabel mesh__D000352 Maghreb
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D000352 2004
% 213.68/213.88  |- mesh__publicMeSHNote mesh__D018763 95   
% 213.68/213.88  |- mesh__recordAuthorizer mesh__D018763 sjn
% 213.68/213.88  |- skos__annotation mesh__D018763 note category   
% 213.68/213.88  |- rdf__type mesh__D018763sskos__Concept
% 213.68/213.88  |- skos__historyNote mesh__D018763 specific muscle %28%1966-1994%29%
% 213.68/213.88  |- skos__historyNote mesh__D018763 Fatigue %28%1966-1994%29%
% 213.68/213.88  |- mesh__historyNote mesh__D018763 95   
% 213.68/213.88  |- mesh__recordOriginator mesh__D018763 PXP
% 213.68/213.88  |- skos__prefLabel mesh__D018763 Muscle Fatigue
% 213.68/213.88  |- mesh__dateEstablished mesh__D018763 1995-01-01
% 213.68/213.88  |- mesh__recordMaintainer mesh__D018763 nns
% 213.68/213.88  |- skos__hiddenLabel mesh__D018763 Fatigue, Muscular
% 213.68/213.88  |- mesh__dateRevised mesh__D018763 2003-07-09
% 213.68/213.88  |- mesh__dateCreated mesh__D018763 1994-05-23
% 213.68/213.88  |- skos__scopeNote mesh__D018763
% 213.68/213.88       A state arrived at through prolonged and strong contraction of a muscle. Studies in athletes during prolonged submaximal exercise have shown that muscle fatigue increases in almost direct proportion to the rate of muscle glycogen depletion. Muscle fatigue in short-term maximal exercise is associated with oxygen lack and an increased level of blood and muscle lactic acid, and an accompanying increase in hydrogen-ion concentration in the exercised muscle.%A%    
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D018763 2006
% 213.68/213.88  |- skos__altLabel mesh__D018763 Muscular Fatigue
% 213.68/213.88  |- skos__broader mesh__D018763smesh__D043703
% 213.68/213.88  |- skos__historyNote mesh__D018763 Muscles %28%1966-1994%29%
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D018763 2005
% 213.68/213.88  |- skos__altLabel mesh__D018763 Fatigue, Muscle
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D018763 2004
% 213.68/213.88  |- skos__hiddenLabel mesh__D010780 Photogrammetries
% 213.68/213.88  |- mesh__recordMaintainer mesh__D010780 PXP
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010780 2005
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010780 2000
% 213.68/213.88  |- skos__scopeNote mesh__D010780
% 213.68/213.88       Making measurements by the use of stereoscopic photographs.%A%    
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010780 2006
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010780 1998
% 213.68/213.88  |- mesh__publicMeSHNote mesh__D010780
% 213.68/213.88       88; was see under PHOTOGRAPHY 1975-87   
% 213.68/213.88  |- skos__hiddenLabel mesh__D010780 Stereophotogrammetries
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010780 2001
% 213.68/213.88  |- mesh__historyNote mesh__D010780
% 213.68/213.88       88%28%75%29%; was see under PHOTOGRAPHY 1975-87   
% 213.68/213.88  |- skos__broader mesh__D010780smesh__D010781
% 213.68/213.88  |- mesh__dateRevised mesh__D010780 1997-06-20
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010780 1999
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010780 2003
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010780 2004
% 213.68/213.88  |- skos__annotation mesh__D010780
% 213.68/213.88       measurement by stereoscopic photographs   
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010780 2002
% 213.68/213.88  |- mesh__dateEstablished mesh__D010780 1988-01-01
% 213.68/213.88  |- mesh__recordAuthorizer mesh__D010780 SJN
% 213.68/213.88  |- mesh__dateCreated mesh__D010780 1974-12-12
% 213.68/213.88  |- skos__prefLabel mesh__D010780 Photogrammetry
% 213.68/213.88  |- mesh__recordOriginator mesh__D010780 NLM
% 213.68/213.88  |- rdf__type mesh__D010780sskos__Concept
% 213.68/213.88  |- skos__historyNote mesh__D004743 Peptides %28%1966-Jul 1977%29%
% 213.68/213.88  |- skos__altLabel mesh__D004743 Leu-Enkephalin
% 213.68/213.88  |- mesh__publicMeSHNote mesh__D004743 83   
% 213.68/213.88  |- skos__prefLabel mesh__D004743 Enkephalin, Leucine
% 213.68/213.88  |- mesh__dateCreated mesh__D004743 1982-05-04
% 213.68/213.88  |- skos__annotation mesh__D004743 DF: LEU ENKEPHALIN   
% 213.68/213.88  |- mesh__historyNote mesh__D004743 83   
% 213.68/213.88  |- skos__altLabel mesh__D004743 Leu%28%5%29%-Enkephalin
% 213.68/213.88  |- skos__historyNote mesh__D004743 Enkephalins %28%Aug 1977-1982%29%
% 213.68/213.88  |- mesh__recordAuthorizer mesh__D004743 sjn
% 213.68/213.88  |- skos__scopeNote mesh__D004743
% 213.68/213.88       Tyrosylglycylglycylphenylalanylleucine. Endogenous pentapeptide with morphine-like activity. The amino acid in position 5 is leucine.%A%    
% 213.68/213.88  |- rdf__type mesh__D004743sskos__Concept
% 213.68/213.88  |- mesh__dateEstablished mesh__D004743 1983-01-01
% 213.68/213.88  |- skos__historyNote mesh__D004743
% 213.68/213.88       Nerve Tissue Proteins %28%1966-Jul 1977%29%
% 213.68/213.88  |- mesh__recordOriginator mesh__D004743 RLS
% 213.68/213.88  |- mesh__dateRevised mesh__D004743 2005-06-30
% 213.68/213.88  |- skos__broader mesh__D004743smesh__D004745
% 213.68/213.88  |- skos__altLabel mesh__D004743 Leucine Enkephalin
% 213.68/213.88  |- skos__altLabel mesh__D004743 5-Leucine Enkephalin
% 213.68/213.88  |- skos__hiddenLabel mesh__D004743 5 Leucine Enkephalin
% 213.68/213.88  |- skos__hiddenLabel mesh__D004743 Enkephalin, 5-Leucine
% 213.68/213.88  |- skos__hiddenLabel mesh__D004743 Leu Enkephalin
% 213.68/213.88  |- mesh__recordMaintainer mesh__D004743 ssb
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D004743 2006
% 213.68/213.88  |- mesh__publicMeSHNote mesh__D051399
% 213.68/213.88       2006; AQUAPORIN 2 was indexed under AQUAPORINS 1999-2005, %26% under ION CHANNELS 1995-1998, %26% under MEMBRANE PROTEINS 1993-1994%A%  
% 213.68/213.88  |- mesh__historyNote mesh__D051399 2006%28%1993%29%   
% 213.68/213.88  |- skos__altLabel mesh__D051399 Aquaporin-2
% 213.68/213.88  |- skos__hiddenLabel mesh__D051399 Aquaporin CD
% 213.68/213.88  |- mesh__dateEstablished mesh__D051399 2006-01-01
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D051399 2006
% 213.68/213.88  |- mesh__recordOriginator mesh__D051399 DRC
% 213.68/213.88  |- skos__broader mesh__D051399smesh__D020346
% 213.68/213.88  |- mesh__recordAuthorizer mesh__D051399 sjn
% 213.68/213.88  |- skos__altLabel mesh__D051399 Water Channel Of Collecting Duct
% 213.68/213.88  |- skos__scopeNote mesh__D051399
% 213.68/213.88       Aquaporin 2 is a water-specific channel protein that is expressed in KIDNEY COLLECTING DUCTS. The translocation of aquaporin 2 to the apical PLASMA MEMBRANE is regulated by VASOPRESSIN, and MUTATIONS in AQP2 have been implicated in a variety of kidney disorders including DIABETES INSIPIDUS.%A%    
% 213.68/213.88  |- rdf__type mesh__D051399sskos__Concept
% 213.68/213.88  |- mesh__dateCreated mesh__D051399 2005-06-30
% 213.68/213.88  |- skos__altLabel mesh__D051399 AQP2 Protein
% 213.68/213.88  |- skos__prefLabel mesh__D051399 Aquaporin 2
% 213.68/213.88  |- skos__altLabel mesh__D051399 Aquaporin-CD
% 213.68/213.88  |- mesh__recordMaintainer mesh__D051399 DRC
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D014373 2006
% 213.68/213.88  |- skos__hiddenLabel mesh__D014373 PPD B
% 213.68/213.88  |- skos__prefLabel mesh__D014373 Tuberculin
% 213.68/213.88  |- skos__altLabel mesh__D014373 PPD-S
% 213.68/213.88  |- mesh__dateRevised mesh__D014373 2005-06-30
% 213.68/213.88  |- mesh__recordMaintainer mesh__D014373 ssb
% 213.68/213.88  |- mesh__recordAuthorizer mesh__D014373 sjn
% 213.68/213.88  |- skos__altLabel mesh__D014373 PPD
% 213.68/213.88  |- mesh__dateCreated mesh__D014373 1999-01-01
% 213.68/213.88  |- mesh__recordOriginator mesh__D014373 NLM
% 213.68/213.88  |- skos__hiddenLabel mesh__D014373 PPD L
% 213.68/213.88  |- skos__hiddenLabel mesh__D014373 PPD F
% 213.68/213.88  |- skos__annotation mesh__D014373 /diag use = probably TUBERCULIN TEST   
% 213.68/213.88  |- rdf__type mesh__D014373sskos__Concept
% 213.68/213.88  |- skos__broader mesh__D014373smesh__D000942
% 213.68/213.88  |- skos__hiddenLabel mesh__D014373 PPD CG
% 213.68/213.88  |- skos__scopeNote mesh__D014373
% 213.68/213.88       A protein extracted from boiled culture of tubercle bacilli %28%MYCOBACTERIUM TUBERCULOSIS%29%.  It is used in the tuberculin skin test %28%TUBERCULIN TEST%29% for the diagnosis of  tuberculosis infection in asymptomatic persons.%A%    
% 213.68/213.88  |- rdf__type mesh__D008336sskos__Concept
% 213.68/213.88  |- skos__hiddenLabel mesh__D008336 Mandibular Disease
% 213.68/213.88  |- skos__prefLabel mesh__D008336 Mandibular Diseases
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008336 1997
% 213.68/213.88  |- mesh__recordMaintainer mesh__D008336 PLS
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008336 2004
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008336 2002
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008336 1996
% 213.68/213.88  |- mesh__historyNote mesh__D008336 67   
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008336 2003
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008336 2001
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008336 1995
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008336 1994
% 213.68/213.88  |- mesh__publicMeSHNote mesh__D008336 67   
% 213.68/213.88  |- mesh__dateCreated mesh__D008336 1999-01-01
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008336 2000
% 213.68/213.88  |- skos__broader mesh__D008336smesh__D007571
% 213.68/213.88  |- skos__hiddenLabel mesh__D008336 Disease, Mandibular
% 213.68/213.88  |- mesh__recordOriginator mesh__D008336 NLM
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008336 1999
% 213.68/213.88  |- mesh__dateRevised mesh__D008336 1990-05-29
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008336 2006
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008336 1993
% 213.68/213.88  |- skos__hiddenLabel mesh__D008336 Diseases, Mandibular
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008336 1991
% 213.68/213.88  |- skos__historyNote mesh__D008336 Bone Diseases %28%1966%29%
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008336 1998
% 213.68/213.88  |- mesh__recordAuthorizer mesh__D008336 NLM
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008336 2005
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008336 1992
% 213.68/213.88  |- mesh__dateEstablished mesh__D008336 1967-01-01
% 213.68/213.88  |- skos__historyNote mesh__D008336 Mandible %28%1966%29%
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D000353 2002
% 213.68/213.88  |- skos__annotation mesh__D000353
% 213.68/213.88       a geog area: prefer specific countries; do not confuse with SOUTH AFRICA %28% = Union of South Africa 1910-60%29%%A%  
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D000353 2005
% 213.68/213.88  |- skos__broader mesh__D000353smesh__D017954
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D000353 2006
% 213.68/213.88  |- mesh__recordMaintainer mesh__D000353 mdb
% 213.68/213.88  |- mesh__dateRevised mesh__D000353 2001-07-25
% 213.68/213.88  |- skos__prefLabel mesh__D000353 Africa, Southern
% 213.68/213.88  |- mesh__recordOriginator mesh__D000353 NLM
% 213.68/213.88  |- mesh__recordAuthorizer mesh__D000353 sjn
% 213.68/213.88  |- skos__scopeNote mesh__D000353
% 213.68/213.88       The geographical area of Africa comprising ANGOLA; BOTSWANA; LESOTHO; MALAWI; MOZAMBIQUE; NAMIBIA; SOUTH AFRICA; SWAZILAND; ZAMBIA; and ZIMBABWE. It includes what was formerly called South-West Africa or German Southwest Africa but it was terminated in 1966 by a United Nations resolution. %28%From Webster%27%s New Geographical Dictionary, 1988, p1144%29%%A%    
% 213.68/213.88  |- rdf__type mesh__D000353sskos__Concept
% 213.68/213.88  |- mesh__dateCreated mesh__D000353 1999-01-01
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D000353 2003
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D000353 2004
% 213.68/213.88  |- skos__altLabel mesh__D000353 Southern Africa
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010781 2006
% 213.68/213.88  |- mesh__recordAuthorizer mesh__D010781 SJN
% 213.68/213.88  |- mesh__recordOriginator mesh__D010781 NLM
% 213.68/213.88  |- skos__prefLabel mesh__D010781 Photography
% 213.68/213.88  |- skos__related mesh__D010781smesh__D008843
% 213.68/213.88  |- mesh__dateCreated mesh__D010781 1999-01-01
% 213.68/213.88  |- mesh__recordMaintainer mesh__D010781 JLS
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010781 1999
% 213.68/213.88  |- skos__scopeNote mesh__D010781
% 213.68/213.88       Method of making images on a sensitized surface by exposure to light or other radiant energy.%A%    
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010781 2003
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010781 2000
% 213.68/213.88  |- mesh__dateRevised mesh__D010781 1998-06-10
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010781 2004
% 213.68/213.88  |- skos__hiddenLabel mesh__D010781 Photographies
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010781 2001
% 213.68/213.88  |- skos__related mesh__D010781smesh__D009040
% 213.68/213.88  |- skos__broader mesh__D010781smesh__D003952
% 213.68/213.88  |- skos__broader mesh__D010781smesh__D008919
% 213.68/213.88  |- rdf__type mesh__D010781sskos__Concept
% 213.68/213.88  |- skos__broader mesh__D010781smesh__D009906
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010781 2005
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010781 2002
% 213.68/213.88  |- mesh__historyNote mesh__D004744 83   
% 213.68/213.88  |- skos__historyNote mesh__D004744 Enkephalins %28%Aug 1977-1982%29%
% 213.68/213.88  |- skos__altLabel mesh__D004744 Methionine Enkephalin
% 213.68/213.88  |- mesh__recordMaintainer mesh__D004744 ssb
% 213.68/213.88  |- skos__hiddenLabel mesh__D004744 Met Enkephalin
% 213.68/213.88  |- skos__historyNote mesh__D004744 Peptides %28%1966-Jul 1977%29%
% 213.68/213.88  |- mesh__publicMeSHNote mesh__D004744 83   
% 213.68/213.88  |- rdf__type mesh__D004744sskos__Concept
% 213.68/213.88  |- skos__historyNote mesh__D004744
% 213.68/213.88       Nerve Tissue Proteins %28%1966-Jul 1977%29%
% 213.68/213.88  |- skos__scopeNote mesh__D004744
% 213.68/213.88       Endogenous pentapeptide with morphine-like activity. The amino acid in position 5 is methionine.%A%    
% 213.68/213.88  |- skos__hiddenLabel mesh__D004744 5 Methionine Enkephalin
% 213.68/213.88  |- skos__annotation mesh__D004744 DF: ENKEPHALIN MET or MET ENKEPHALIN   
% 213.68/213.88  |- mesh__recordAuthorizer mesh__D004744 sjn
% 213.68/213.88  |- skos__prefLabel mesh__D004744 Enkephalin, Methionine
% 213.68/213.88  |- skos__hiddenLabel mesh__D004744 Enkephalin, 5-Methionine
% 213.68/213.88  |- skos__altLabel mesh__D004744 Met%28%5%29%-Enkephalin
% 213.68/213.88  |- mesh__dateEstablished mesh__D004744 1983-01-01
% 213.68/213.88  |- skos__altLabel mesh__D004744 Met-Enkephalin
% 213.68/213.88  |- mesh__recordOriginator mesh__D004744 RLS
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D004744 2006
% 213.68/213.88  |- skos__altLabel mesh__D004744 5-Methionine Enkephalin
% 213.68/213.88  |- mesh__dateRevised mesh__D004744 2005-06-30
% 213.68/213.88  |- skos__broader mesh__D004744smesh__D004745
% 213.68/213.88  |- mesh__dateCreated mesh__D004744 1982-05-04
% 213.68/213.88  |- mesh__publicMeSHNote mesh__D042863
% 213.68/213.88       2006; see CDK9 PROTEIN KINASE 2004-2005, CDK9 KINASE %28%now CYCLIN-DEPENDENT KINASE 9%29% was indexed under CYCLIN-DEPENDENT KINASES 2000-2003, under PROTEIN KINASES 1994-1999%A%  
% 213.68/213.88  |- skos__altLabel mesh__D042863 CDK9 Kinase
% 213.68/213.88  |- mesh__dateCreated mesh__D042863 2003-07-09
% 213.68/213.88  |- mesh__recordAuthorizer mesh__D042863 sjn
% 213.68/213.88  |- skos__scopeNote mesh__D042863
% 213.68/213.88       A multifunctional CDC2 kinase-related kinase that plays roles in transcriptional elongation, CELL DIFFERENTIATION and APOPTOSIS. It is a component of POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B.%A%    
% 213.68/213.88  |- skos__altLabel mesh__D042863 Cdk9 Protein Kinase
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D042863 2006
% 213.68/213.88  |- skos__annotation mesh__D042863 see SCR for organism-specific terms   
% 213.68/213.88  |- mesh__historyNote mesh__D042863 2006%28%1994%29%   
% 213.68/213.88  |- mesh__dateRevised mesh__D042863 2005-06-30
% 213.68/213.88  |- skos__hiddenLabel mesh__D042863 PITALRE, Cdc2-related Kinase
% 213.68/213.88  |- skos__broader mesh__D042863smesh__D042925
% 213.68/213.88  |- mesh__recordMaintainer mesh__D042863 DRC
% 213.68/213.88  |- skos__prefLabel mesh__D042863 Cyclin-Dependent Kinase 9
% 213.68/213.88  |- mesh__recordOriginator mesh__D042863 jmp
% 213.68/213.88  |- skos__broader mesh__D042863smesh__D042846
% 213.68/213.88  |- skos__altLabel mesh__D042863 PITALRE Kinase
% 213.68/213.88  |- mesh__dateEstablished mesh__D042863 2004-01-01
% 213.68/213.88  |- skos__altLabel mesh__D042863 Cdc2-related Kinase PITALRE
% 213.68/213.88  |- skos__hiddenLabel mesh__D042863 Cdc2 related Kinase PITALRE
% 213.68/213.88  |- skos__hiddenLabel mesh__D042863 Kinase PITALRE, Cdc2-related
% 213.68/213.88  |- rdf__type mesh__D042863sskos__Concept
% 213.68/213.88  |- skos__hiddenLabel mesh__D042863 Cyclin Dependent Kinase 9
% 213.68/213.88  |- mesh__publicMeSHNote mesh__D014374
% 213.68/213.88       66; was TUBERCULIN REACTION 1963-65   
% 213.68/213.88  |- mesh__dateCreated mesh__D014374 1999-01-01
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D014374 2002
% 213.68/213.88  |- mesh__historyNote mesh__D014374 66; was TUBERCULIN REACTION 1963-65   
% 213.68/213.88  |- skos__hiddenLabel mesh__D014374 Test, Tuberculin
% 213.68/213.88  |- mesh__recordMaintainer mesh__D014374 KEV
% 213.68/213.88  |- skos__hiddenLabel mesh__D014374 Tuberculin Tests
% 213.68/213.88  |- skos__hiddenLabel mesh__D014374 Tests, Tuberculin
% 213.68/213.88  |- rdf__type mesh__D014374sskos__Concept
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D014374 2005
% 213.68/213.88  |- mesh__dateRevised mesh__D014374 1999-11-03
% 213.68/213.88  |- mesh__dateEstablished mesh__D014374 1966-01-01
% 213.68/213.88  |- skos__scopeNote mesh__D014374
% 213.68/213.88       One of several skin tests to determine past or present tuberculosis infection. A purified protein derivative of the tubercle bacilli, called tuberculin, is introduced into the skin by scratch, puncture, or interdermal injection.%A%    
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D014374 2003
% 213.68/213.88  |- skos__prefLabel mesh__D014374 Tuberculin Test
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D014374 2006
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D014374 2000
% 213.68/213.88  |- mesh__recordAuthorizer mesh__D014374 sjn
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D014374 2004
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D014374 2001
% 213.68/213.88  |- mesh__recordOriginator mesh__D014374 NLM
% 213.68/213.88  |- skos__broader mesh__D014374smesh__D012882
% 213.68/213.88  |- rdf__type mesh__D008337sskos__Concept
% 213.68/213.88  |- skos__scopeNote mesh__D008337 Fractures of the lower jaw.     
% 213.68/213.88  |- mesh__recordMaintainer mesh__D008337 ssb
% 213.68/213.88  |- skos__broader mesh__D008337smesh__D007572
% 213.68/213.88  |- mesh__recordOriginator mesh__D008337 NLM
% 213.68/213.88  |- mesh__recordAuthorizer mesh__D008337 sjn
% 213.68/213.88  |- mesh__publicMeSHNote mesh__D008337 66   
% 213.68/213.88  |- mesh__dateCreated mesh__D008337 1999-01-01
% 213.68/213.88  |- skos__hiddenLabel mesh__D008337 Fractures, Mandibular
% 213.68/213.88  |- skos__hiddenLabel mesh__D008337 Mandibular Fracture
% 213.68/213.88  |- mesh__dateEstablished mesh__D008337 1966-01-01
% 213.68/213.88  |- mesh__historyNote mesh__D008337 66   
% 213.68/213.88  |- mesh__dateRevised mesh__D008337 2005-06-30
% 213.68/213.88  |- skos__prefLabel mesh__D008337 Mandibular Fractures
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D008337 2006
% 213.68/213.88  |- skos__hiddenLabel mesh__D008337 Fracture, Mandibular
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D000354 2006
% 213.68/213.88  |- skos__prefLabel mesh__D000354 Africa, Western
% 213.68/213.88  |- mesh__recordMaintainer mesh__D000354 mdb
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D000354 2002
% 213.68/213.88  |- skos__annotation mesh__D000354 a geog area: prefer specific countries   
% 213.68/213.88  |- skos__scopeNote mesh__D000354
% 213.68/213.88       The geographical area of Africa comprising BENIN; BURKINA FASO; COTE D%27%IVOIRE; GAMBIA; GHANA; GUINEA; GUINEA-BISSAU; LIBERIA; MALI; MAURITANIA; NIGER; NIGERIA; SENEGAL; SIERRA LEONE; and TOGO.%A%    
% 213.68/213.88  |- skos__altLabel mesh__D000354 Western Africa
% 213.68/213.88  |- rdf__type mesh__D000354sskos__Concept
% 213.68/213.88  |- mesh__dateRevised mesh__D000354 2001-07-25
% 213.68/213.88  |- mesh__dateCreated mesh__D000354 1999-01-01
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D000354 2003
% 213.68/213.88  |- mesh__recordOriginator mesh__D000354 NLM
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D000354 2004
% 213.68/213.88  |- mesh__recordAuthorizer mesh__D000354 sjn
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D000354 2005
% 213.68/213.88  |- skos__broader mesh__D000354smesh__D017954
% 213.68/213.88  |- mesh__dateRevised mesh__D018765 2005-06-30
% 213.68/213.88  |- skos__altLabel mesh__D018765 Dopamine Reuptake Inhibitors
% 213.68/213.88  |- skos__altLabel mesh__D018765 Inhibitors, Dopamine Reuptake
% 213.68/213.88  |- skos__broader mesh__D018765smesh__D015259
% 213.68/213.88  |- mesh__historyNote mesh__D018765 95   
% 213.68/213.88  |- mesh__recordMaintainer mesh__D018765 ssb
% 213.68/213.88  |- skos__scopeNote mesh__D018765
% 213.68/213.88       Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake.%A%    
% 213.68/213.88  |- skos__broader mesh__D018765smesh__D014179
% 213.68/213.88  |- mesh__dateEstablished mesh__D018765 1995-01-01
% 213.68/213.88  |- mesh__recordOriginator mesh__D018765 TPW
% 213.68/213.88  |- skos__altLabel mesh__D018765 Reuptake Inhibitors, Dopamine
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D018765 2006
% 213.68/213.88  |- skos__altLabel mesh__D018765 Inhibitors, Dopamine Uptake
% 213.68/213.88  |- skos__historyNote mesh__D018765
% 213.68/213.88       Neurotransmitter Uptake Inhibitors %28%1985-1994%29%
% 213.68/213.88  |- skos__annotation mesh__D018765
% 213.68/213.88       GEN or unspecified; prefer specifics; DF: DOPAMINE UPTAKE INHIB%A%  
% 213.68/213.88  |- mesh__publicMeSHNote mesh__D018765 95   
% 213.68/213.88  |- mesh__recordAuthorizer mesh__D018765 sjn
% 213.68/213.88  |- skos__historyNote mesh__D018765 Dopamine Agents %28%1989-1994%29%
% 213.68/213.88  |- skos__altLabel mesh__D018765 Uptake Inhibitors, Dopamine
% 213.68/213.88  |- skos__prefLabel mesh__D018765 Dopamine Uptake Inhibitors
% 213.68/213.88  |- mesh__dateCreated mesh__D018765 1994-06-01
% 213.68/213.88  |- rdf__type mesh__D018765sskos__Concept
% 213.68/213.88  |- mesh__historyNote mesh__D010782 74%28%71%29%   
% 213.68/213.88  |- skos__historyNote mesh__D010782 Ultraviolet Rays %28%1966-1970%29%
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010782 2004
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010782 1996
% 213.68/213.88  |- mesh__dateEstablished mesh__D010782 1974-01-01
% 213.68/213.88  |- mesh__publicMeSHNote mesh__D010782 74   
% 213.68/213.88  |- mesh__recordMaintainer mesh__D010782 TGC
% 213.68/213.88  |- mesh__recordAuthorizer mesh__D010782 PLS
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010782 1997
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010782 2002
% 213.68/213.88  |- skos__prefLabel mesh__D010782 Photolysis
% 213.68/213.88  |- rdf__type mesh__D010782sskos__Concept
% 213.68/213.88  |- mesh__recordOriginator mesh__D010782 NLM
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010782 2005
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010782 2006
% 213.68/213.88  |- skos__historyNote mesh__D010782 Light %28%1966-1970%29%
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010782 1998
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010782 2000
% 213.68/213.88  |- mesh__dateCreated mesh__D010782 1999-01-01
% 213.68/213.88  |- skos__scopeNote mesh__D010782
% 213.68/213.88       Chemical decomposition by the action of light and the lysis or solution of cells under the influence of light. %28%Dorland, 28th ed%29%%A%    
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010782 1999
% 213.68/213.88  |- mesh__dateRevised mesh__D010782 1995-03-13
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010782 2003
% 213.68/213.88  |- mesh__activeMeSHYear mesh__D010782 2001
% 213.68/213.88  |- skos__hiddenLabel mesh__D010782 Photolyses
% 213.68/213.88  |- skos__broader mesh__D010782smesh__D010777
% 213.68/213.88  |- mesh__recordMaintainer mesh__D004745 ssb
% 213.68/213.88  |- skos__altLabel mesh__D004745 Enkephalin
% 213.68/213.88  |- skos__prefLabel mesh__D004745 Enkephalins
% 213.68/213.88  |- rdf__type mesh__D004745sskos__Concept
% 213.68/213.88  |- skos__historyNote mesh__D004745 Oligopeptides %28%1973-Jul 1977%29%
% 213.68/213.88  |- skos__related mesh__D004745smesh__D011957
% 213.68/213.88  |- mesh__recordAuthorizer mesh__D004745 sjn
% 213.68/213.88  |- skos__historyNote mesh__D004745
% 213.68/213.88       Nerve Tissue Proteins %28%1966-Jul 1977%29%
% 213.68/213.89  |- mesh__historyNote mesh__D004745
% 213.68/213.89       83%28%Aug 77%29%; was see under ENDORPHINS Aug 1977-82   
% 213.68/213.89  |- mesh__dateCreated mesh__D004745 1977-05-16
% 213.68/213.89  |- skos__annotation mesh__D004745
% 213.68/213.89       general or unspecified; prefer specifics   
% 213.68/213.89  |- skos__broader mesh__D004745smesh__D018847
% 213.68/213.89  |- mesh__dateEstablished mesh__D004745 1983-01-01
% 213.68/213.89  |- skos__scopeNote mesh__D004745
% 213.68/213.89       One of the three major families of endogenous opioid peptides. The enkephalins are pentapeptides that are widespread in the central and peripheral nervous systems and in the adrenal medulla.%A%    
% 213.68/213.89  |- mesh__publicMeSHNote mesh__D004745
% 213.68/213.89       83; was see under ENDORPHINS Aug 1977-82   
% 213.68/213.89  |- mesh__recordOriginator mesh__D004745 RLS
% 213.68/213.89  |- mesh__dateRevised mesh__D004745 2005-06-30
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D004745 2006
% 213.68/213.89  |- skos__historyNote mesh__D037121 Lectins %28%1963-2002%29%
% 213.68/213.89  |- skos__altLabel mesh__D037121 Plant Agglutinins
% 213.68/213.89  |- skos__broader mesh__D037121smesh__D037102
% 213.68/213.89  |- skos__prefLabel mesh__D037121 Plant Lectins
% 213.68/213.89  |- skos__altLabel mesh__D037121 Lectins, Plant
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D037121 2003
% 213.68/213.89  |- mesh__recordOriginator mesh__D037121 jmp
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D037121 2006
% 213.68/213.89  |- mesh__recordAuthorizer mesh__D037121 sjn
% 213.68/213.89  |- mesh__historyNote mesh__D037121 2003; use LECTINS 1979-2002   
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D037121 2004
% 213.68/213.89  |- mesh__dateEstablished mesh__D037121 2003-01-01
% 213.68/213.89  |- skos__scopeNote mesh__D037121
% 213.68/213.89       Protein or glycoprotein substances of plant origin that bind to sugar moieties in cell walls or membranes. Some carbohydrate-metabolizing proteins %28%ENZYMES%29% from PLANTS also bind to carbohydrates, however they are not considered lectins. Many plant lectins change the physiology of the membrane of BLOOD CELLS to cause agglutination, mitosis, or other biochemical changes. They may play a role in plant defense mechanisms.%A%    
% 213.68/213.89  |- skos__altLabel mesh__D037121 Phytagglutinins
% 213.68/213.89  |- rdf__type mesh__D037121sskos__Concept
% 213.68/213.89  |- mesh__publicMeSHNote mesh__D037121
% 213.68/213.89       2003; see LECTINS 1979-2002, PLANT AGGLUTININS 1963-1978 %26% PHYTOMITOGENS 1972-1978%A%  
% 213.68/213.89  |- mesh__recordMaintainer mesh__D037121 ssb
% 213.68/213.89  |- skos__altLabel mesh__D037121 Hemagglutinins, Plant
% 213.68/213.89  |- skos__hiddenLabel mesh__D037121 Plant Hemagglutinins
% 213.68/213.89  |- skos__broader mesh__D037121smesh__D010940
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D037121 2005
% 213.68/213.89  |- mesh__dateCreated mesh__D037121 2002-07-02
% 213.68/213.89  |- skos__hiddenLabel mesh__D009430 Analyzer, Neural
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009430 2000
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009430 2003
% 213.68/213.89  |- skos__hiddenLabel mesh__D009430 Neural Analyzer
% 213.68/213.89  |- mesh__historyNote mesh__D009430 65%28%64%29%   
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009430 1996
% 213.68/213.89  |- mesh__dateCreated mesh__D009430 1999-01-01
% 213.68/213.89  |- skos__prefLabel mesh__D009430 Neural Analyzers
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009430 2004
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009430 2001
% 213.68/213.89  |- skos__annotation mesh__D009430 DF: NEURAL ANAL   
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009430 1997
% 213.68/213.89  |- mesh__recordMaintainer mesh__D009430 TAP
% 213.68/213.89  |- mesh__dateEstablished mesh__D009430 1965-01-01
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009430 2002
% 213.68/213.89  |- rdf__type mesh__D009430sskos__Concept
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009430 1993
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009430 2005
% 213.68/213.89  |- mesh__recordOriginator mesh__D009430 NLM
% 213.68/213.89  |- mesh__publicMeSHNote mesh__D009430 65   
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009430 1998
% 213.68/213.89  |- skos__broader mesh__D009430smesh__D002490
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009430 2006
% 213.68/213.89  |- mesh__dateRevised mesh__D009430 1992-05-15
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009430 1994
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009430 1999
% 213.68/213.89  |- mesh__recordAuthorizer mesh__D009430 PLS
% 213.68/213.89  |- skos__altLabel mesh__D009430 Analyzers, Neural
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009430 1995
% 213.68/213.89  |- skos__annotation mesh__D014375
% 213.68/213.89       not a neoplasm; coord IM with precoord tuberculosis term %28%IM%29% or organ/dis precoord %28%IM%29% if tuberc term is not available%A%  
% 213.68/213.89  |- mesh__recordOriginator mesh__D014375 NLM
% 213.68/213.89  |- rdf__type mesh__D014375sskos__Concept
% 213.68/213.89  |- skos__broader mesh__D014375smesh__D014376
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D014375 2005
% 213.68/213.89  |- skos__scopeNote mesh__D014375
% 213.68/213.89       A tumor-like mass resulting from the enlargement of a tuberculous lesion.%A%    
% 213.68/213.89  |- skos__hiddenLabel mesh__D014375 Tuberculomas
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D014375 2006
% 213.68/213.89  |- skos__prefLabel mesh__D014375 Tuberculoma
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D014375 2004
% 213.68/213.89  |- mesh__recordMaintainer mesh__D014375 lkt
% 213.68/213.89  |- mesh__dateCreated mesh__D014375 1999-01-01
% 213.68/213.89  |- mesh__dateRevised mesh__D014375 2003-07-09
% 213.68/213.89  |- mesh__recordAuthorizer mesh__D014375 sjn
% 213.68/213.89  |- skos__broader mesh__D008338smesh__D008446
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D008338 2005
% 213.68/213.89  |- mesh__recordAuthorizer mesh__D008338 sjn
% 213.68/213.89  |- mesh__recordOriginator mesh__D008338 NLM
% 213.68/213.89  |- skos__prefLabel mesh__D008338 Mandibular Injuries
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D008338 2002
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D008338 2006
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D008338 2003
% 213.68/213.89  |- rdf__type mesh__D008338sskos__Concept
% 213.68/213.89  |- skos__hiddenLabel mesh__D008338 Mandibular Injury
% 213.68/213.89  |- skos__hiddenLabel mesh__D008338 Injury, Mandibular
% 213.68/213.89  |- skos__altLabel mesh__D008338 Injuries, Mandibular
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D008338 2000
% 213.68/213.89  |- mesh__dateRevised mesh__D008338 1999-11-03
% 213.68/213.89  |- skos__scopeNote mesh__D008338 Injuries to the lower jaw bone.     
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D008338 2004
% 213.68/213.89  |- mesh__recordMaintainer mesh__D008338 PXP
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D008338 2001
% 213.68/213.89  |- mesh__dateCreated mesh__D008338 1999-01-01
% 213.68/213.89  |- mesh__recordMaintainer mesh__D000355 ags
% 213.68/213.89  |- mesh__recordOriginator mesh__D000355 NLM
% 213.68/213.89  |- rdf__type mesh__D000355sskos__Concept
% 213.68/213.89  |- mesh__dateCreated mesh__D000355 1999-01-01
% 213.68/213.89  |- mesh__recordAuthorizer mesh__D000355 sjn
% 213.68/213.89  |- mesh__publicMeSHNote mesh__D000355
% 213.68/213.89       98; see AFRICAN HORSESICKNESS 1970-97   
% 213.68/213.89  |- skos__hiddenLabel mesh__D000355 Sickness, African Horse
% 213.68/213.89  |- skos__altLabel mesh__D000355 Equine Plague
% 213.68/213.89  |- skos__hiddenLabel mesh__D000355 Plagues, Equine
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D000355 2004
% 213.68/213.89  |- skos__historyNote mesh__D000355 Horse Diseases %28%1966-1969%29%
% 213.68/213.89  |- skos__altLabel mesh__D000355 African Horsesickness
% 213.68/213.89  |- mesh__dateEstablished mesh__D000355 1970-01-01
% 213.68/213.89  |- skos__hiddenLabel mesh__D000355 Horse Sickness, African
% 213.68/213.89  |- skos__hiddenLabel mesh__D000355 Horsesickness, African
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D000355 2005
% 213.68/213.89  |- skos__historyNote mesh__D000355 Reovirus Infections %28%1968-1979%29%
% 213.68/213.89  |- skos__scopeNote mesh__D000355
% 213.68/213.89       An insect-borne reovirus infection of horses, mules and donkeys in Africa and the Middle East; characterized by pulmonary edema, cardiac involvement, and edema of the head and neck.%A%    
% 213.68/213.89  |- skos__annotation mesh__D000355
% 213.68/213.89       caused by an Orbivirus; in horses, mules %26% donkeys; if in horses don%27%t forget also HORSES %28%NIM%29% %26% check tag ANIMALS; if in mules or donkeys, coord IM with EQUIDAE %28%IM%29% %26% check tag ANIMALS%A%  
% 213.68/213.89  |- skos__hiddenLabel mesh__D000355 Equine Plagues
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D000355 2006
% 213.68/213.89  |- skos__broader mesh__D000355smesh__D006734
% 213.68/213.89  |- skos__broader mesh__D000355smesh__D001102
% 213.68/213.89  |- skos__hiddenLabel mesh__D000355 African Horse Sicknesses
% 213.68/213.89  |- mesh__historyNote mesh__D000355 98   
% 213.68/213.89  |- skos__hiddenLabel mesh__D000355 Plague, Equine
% 213.68/213.89  |- skos__hiddenLabel mesh__D000355 Horsesicknesses, African
% 213.68/213.89  |- skos__hiddenLabel mesh__D000355 Sicknesses, African Horse
% 213.68/213.89  |- skos__prefLabel mesh__D000355 African Horse Sickness
% 213.68/213.89  |- mesh__dateRevised mesh__D000355 2003-07-30
% 213.68/213.89  |- skos__hiddenLabel mesh__D000355 African Horsesicknesses
% 213.68/213.89  |- skos__broader mesh__D000355smesh__D012088
% 213.68/213.89  |- skos__hiddenLabel mesh__D000355 Horse Sicknesses, African
% 213.68/213.89  |- mesh__recordAuthorizer mesh__D019060 sjn
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D019060 2000
% 213.68/213.89  |- skos__scopeNote mesh__D019060
% 213.68/213.89       Procedures that avoid use of open invasive surgery in favor of closed or local surgery. These generally involve use of laparoscopic devices and remote-control manipulation of instruments with indirect observation of the surgical field through an endoscope or similar device. With the reduced trauma associated with minimally invasive surgery, long hospital stays may be reduced with increased rates of short stay or day surgery.%A%    
% 213.68/213.89  |- skos__altLabel mesh__D019060 Surgical Procedure, Minimal
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D019060 2001
% 213.68/213.89  |- mesh__publicMeSHNote mesh__D019060
% 213.68/213.89       98; see SURGERY, MINIMALLY INVASIVE 1996-97   
% 213.68/213.89  |- skos__altLabel mesh__D019060 Minimal Surgical Procedure
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D019060 2002
% 213.68/213.89  |- mesh__dateEstablished mesh__D019060 1996-01-01
% 213.68/213.89  |- skos__altLabel mesh__D019060 Minimal Access Surgical Procedures
% 213.68/213.89  |- skos__broader mesh__D019060smesh__D013514
% 213.68/213.89  |- skos__altLabel mesh__D019060 Procedures, Minimal Surgical
% 213.68/213.89  |- skos__prefLabel mesh__D019060 Surgical Procedures, Minimally Invasive
% 213.68/213.89  |- skos__altLabel mesh__D019060 Procedures, Minimal Access Surgical
% 213.68/213.89  |- skos__altLabel mesh__D019060 Procedures, Minimally Invasive Surgical
% 213.68/213.89  |- mesh__recordMaintainer mesh__D019060 jls
% 213.68/213.89  |- skos__altLabel mesh__D019060 Procedure, Minimal Surgical
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D019060 2005
% 213.68/213.89  |- skos__altLabel mesh__D019060 Surgical Procedures, Minimal Access
% 213.68/213.89  |- mesh__recordOriginator mesh__D019060 JLS
% 213.68/213.89  |- rdf__type mesh__D019060sskos__Concept
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D019060 2006
% 213.68/213.89  |- mesh__historyNote mesh__D019060 98%28%96%29%   
% 213.68/213.89  |- mesh__dateRevised mesh__D019060 1999-11-08
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D019060 2003
% 213.68/213.89  |- skos__annotation mesh__D019060
% 213.68/213.89       IM for general only; do not use /util except by MeSH definition; DF: MINIMAL SURG PROCEDURES%A%  
% 213.68/213.89  |- skos__altLabel mesh__D019060 Minimally Invasive Surgical Procedures
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D019060 2004
% 213.68/213.89  |- skos__altLabel mesh__D019060 Surgical Procedures, Minimal
% 213.68/213.89  |- mesh__dateCreated mesh__D019060 1995-06-05
% 213.68/213.89  |- skos__altLabel mesh__D019060 Minimal Surgical Procedures
% 213.68/213.89  |- skos__historyNote mesh__D019060 Surgery, Laparoscopic %28%1990-1995%29%
% 213.68/213.89  |- rdf__type mesh__D005040sskos__Concept
% 213.68/213.89  |- skos__scopeNote mesh__D005040
% 213.68/213.89       A synthetic progestational hormone used alone or in combination with estrogens as an oral contraceptive.%A%    
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D005040 2004
% 213.68/213.89  |- mesh__recordOriginator mesh__D005040 NLM
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D005040 2005
% 213.68/213.89  |- mesh__recordMaintainer mesh__D005040 lkt
% 213.68/213.89  |- mesh__recordAuthorizer mesh__D005040 sjn
% 213.68/213.89  |- skos__hiddenLabel mesh__D005040 Diacetate, Ethynodiol
% 213.68/213.89  |- mesh__publicMeSHNote mesh__D005040 68   
% 213.68/213.89  |- skos__altLabel mesh__D005040 Ethyndiol Diacetate
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D005040 2006
% 213.68/213.89  |- mesh__dateEstablished mesh__D005040 1968-01-01
% 213.68/213.89  |- skos__hiddenLabel mesh__D005040 Diacetate, Ethyndiol
% 213.68/213.89  |- skos__altLabel mesh__D005040
% 213.68/213.89       %28%3 beta, 17 alpha%29%-19-Norpregn-4-en-20-yne-3,17 diol Diacetate
% 213.68/213.89  |- mesh__dateCreated mesh__D005040 1999-01-01
% 213.68/213.89  |- mesh__dateRevised mesh__D005040 2003-07-09
% 213.68/213.89  |- skos__prefLabel mesh__D005040 Ethynodiol Diacetate
% 213.68/213.89  |- mesh__historyNote mesh__D005040 68%28%64%29%   
% 213.68/213.89  |- skos__broader mesh__D005040smesh__D009652
% 213.68/213.89  |- rdf__type mesh__D010783sskos__Concept
% 213.68/213.89  |- mesh__recordAuthorizer mesh__D010783 sjn
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D010783 2005
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D010783 2006
% 213.68/213.89  |- skos__prefLabel mesh__D010783 Photometry
% 213.68/213.89  |- mesh__dateCreated mesh__D010783 1999-01-01
% 213.68/213.89  |- mesh__recordOriginator mesh__D010783 NLM
% 213.68/213.89  |- skos__broader mesh__D010783smesh__D002623
% 213.68/213.89  |- mesh__dateRevised mesh__D010783 2002-07-03
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D010783 2003
% 213.68/213.89  |- mesh__recordMaintainer mesh__D010783 lkt
% 213.68/213.89  |- skos__hiddenLabel mesh__D010783 Photometries
% 213.68/213.89  |- skos__annotation mesh__D010783 NIM   
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D010783 2004
% 213.68/213.89  |- mesh__recordOriginator mesh__D004746 RLS
% 213.68/213.89  |- skos__prefLabel mesh__D004746 Enoyl-CoA Hydratase
% 213.68/213.89  |- mesh__publicMeSHNote mesh__D004746
% 213.68/213.89       97; was ENOYL COA HYDRATASES 1978-96 %28%see under HYDRO-LYASES 1978-90%29%%A%  
% 213.68/213.89  |- mesh__historyNote mesh__D004746
% 213.68/213.89       97; was ENOYL COA HYDRATASES 1978-96 %28%see under HYDRO-LYASES 1978-90%29%%A%  
% 213.68/213.89  |- skos__altLabel mesh__D004746 trans-2-Enoyl-Coenzyme A Hydratase
% 213.68/213.89  |- skos__altLabel mesh__D004746 beta-Hydroxyacyl-CoA Dehydrases
% 213.68/213.89  |- skos__hiddenLabel mesh__D004746 Hydratase, Enoyl-CoA
% 213.68/213.89  |- skos__altLabel mesh__D004746 beta-Hydroxyacyl Dehydratases
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D004746 2006
% 213.68/213.89  |- skos__hiddenLabel mesh__D004746 Dehydrases, beta-Hydroxyacyl-CoA
% 213.68/213.89  |- skos__hiddenLabel mesh__D004746 Hydratase, trans-2-Enoyl-Coenzyme A
% 213.68/213.89  |- mesh__dateRevised mesh__D004746 2003-07-09
% 213.68/213.89  |- skos__hiddenLabel mesh__D004746 Hydratases, Enoyl CoA
% 213.68/213.89  |- skos__broader mesh__D004746smesh__D006836
% 213.68/213.89  |- skos__hiddenLabel mesh__D004746 Enoyl CoA Hydratase
% 213.68/213.89  |- skos__historyNote mesh__D004746 Hydro-Lyases %28%1966-1977%29%
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D004746 2005
% 213.68/213.89  |- mesh__dateEstablished mesh__D004746 1991-01-01
% 213.68/213.89  |- skos__hiddenLabel mesh__D004746 3 Hydroxyacyl CoA Hydrolyases
% 213.68/213.89  |- skos__hiddenLabel mesh__D004746 trans 2 Enoyl Coenzyme A Hydratase
% 213.68/213.89  |- skos__hiddenLabel mesh__D004746 Hydrase, Enoyl
% 213.68/213.89  |- skos__hiddenLabel mesh__D004746 Dehydratases, beta-Hydroxyacyl
% 213.68/213.89  |- mesh__dateCreated mesh__D004746 1977-05-20
% 213.68/213.89  |- skos__hiddenLabel mesh__D004746 A Hydratase, trans-2-Enoyl-Coenzyme
% 213.68/213.89  |- skos__historyNote mesh__D004746 Coenzyme A %28%1966-1977%29%
% 213.68/213.89  |- skos__hiddenLabel mesh__D004746 beta Hydroxyacyl Dehydratases
% 213.68/213.89  |- skos__scopeNote mesh__D004746
% 213.68/213.89       An enzyme that catalyzes reversibly the hydration of unsaturated fatty acyl-CoA to yield beta-hydroxyacyl-CoA. It plays a role in the oxidation of fatty acids and in mitochondrial fatty acid synthesis, has broad specificity, and is most active with crotonyl-CoA. EC 4.2.1.17.%A%    
% 213.68/213.89  |- skos__hiddenLabel mesh__D004746 3 Hydroxyacyl Dehydratases
% 213.68/213.89  |- mesh__recordMaintainer mesh__D004746 ssb
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D004746 2004
% 213.68/213.89  |- mesh__recordAuthorizer mesh__D004746 sjn
% 213.68/213.89  |- skos__hiddenLabel mesh__D004746 CoA Hydrolyases, 3-Hydroxyacyl
% 213.68/213.89  |- skos__altLabel mesh__D004746 Crotonase
% 213.68/213.89  |- skos__altLabel mesh__D004746 3-Hydroxyacyl Dehydratases
% 213.68/213.89  |- rdf__type mesh__D004746sskos__Concept
% 213.68/213.89  |- skos__hiddenLabel mesh__D004746 Dehydratases, 3-Hydroxyacyl
% 213.68/213.89  |- skos__hiddenLabel mesh__D004746 Hydrolyases, 3-Hydroxyacyl CoA
% 213.68/213.89  |- skos__hiddenLabel mesh__D004746 CoA Hydratases, Enoyl
% 213.68/213.89  |- skos__altLabel mesh__D004746 Enoyl Hydrase
% 213.68/213.89  |- skos__hiddenLabel mesh__D004746 beta Hydroxyacyl CoA Dehydrases
% 213.68/213.89  |- skos__altLabel mesh__D004746 Enoyl CoA Hydratases
% 213.68/213.89  |- skos__altLabel mesh__D004746 3-Hydroxyacyl CoA Hydrolyases
% 213.68/213.89  |- mesh__onlineNote mesh__D009431
% 213.68/213.89       use NEURAL CONDUCTION to search WEDENSKY INHIBITION 1977-96, VVEDENSKII%27%S INHIBITION 1966-96, %26% NERVE CONDUCTION 1966-67%A%  
% 213.68/213.89  |- mesh__recordAuthorizer mesh__D009431 PLS
% 213.68/213.89  |- mesh__dateCreated mesh__D009431 1999-01-01
% 213.68/213.89  |- skos__hiddenLabel mesh__D009431 Nerve Conductions
% 213.68/213.89  |- skos__hiddenLabel mesh__D009431 Conduction, Neural
% 213.68/213.89  |- skos__hiddenLabel mesh__D009431 Conductions, Nerve
% 213.68/213.89  |- mesh__dateRevised mesh__D009431 1996-06-10
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009431 2004
% 213.68/213.89  |- skos__hiddenLabel mesh__D009431 Conduction, Nerve
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009431 1997
% 213.68/213.89  |- skos__broader mesh__D009431smesh__D009424
% 213.68/213.89  |- skos__related mesh__D009431smesh__D009433
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009431 2000
% 213.68/213.89  |- skos__altLabel mesh__D009431 Inhibition, Vvedenskii
% 213.68/213.89  |- skos__altLabel mesh__D009431 Nerve Conduction
% 213.68/213.89  |- rdf__type mesh__D009431sskos__Concept
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009431 2005
% 213.68/213.89  |- mesh__publicMeSHNote mesh__D009431
% 213.68/213.89       68; was NERVE CONDUCTION 1965-67; WEDENSKY INHIBITION was heading 1977-96 %28%see under NEURAL CONDUCTION 1977-90%29%, was VVEDENSKII%27%S INHIBITION see under NEURAL CONDUCTION 1975-76; VVEDENSKII%27%S INHIBITION was see WEDENSKY INHIBITION 1990-96%A%  
% 213.68/213.89  |- skos__hiddenLabel mesh__D009431 Neural Conductions
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009431 1998
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009431 2001
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009431 2006
% 213.68/213.89  |- skos__prefLabel mesh__D009431 Neural Conduction
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009431 1999
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009431 2002
% 213.68/213.89  |- mesh__recordMaintainer mesh__D009431 PXP
% 213.68/213.89  |- mesh__recordOriginator mesh__D009431 NLM
% 213.68/213.89  |- mesh__dateEstablished mesh__D009431 1968-01-01
% 213.68/213.89  |- skos__altLabel mesh__D009431 Vvedenskii Inhibition
% 213.68/213.89  |- mesh__historyNote mesh__D009431
% 213.68/213.89       68; was NERVE CONDUCTION 1965-67; WEDENSKY INHIBITION was heading 1977-96 %28%see under NEURAL CONDUCTION 1977-90%29%, was VVEDENSKII%27%S INHIBITION see under NEURAL CONDUCTION 1965-76 %28%Prov 1965-74%29%; VVEDENSKII%27%S INHIBITION was see WEDENSKY INHIBITION 1990-96%A%  
% 213.68/213.89  |- skos__annotation mesh__D009431
% 213.68/213.89       along a single nerve; differentiate from NEURAL TRANSMISSION %28%between nerves%29%%A%  
% 213.68/213.89  |- skos__altLabel mesh__D009431 Wedensky Inhibition
% 213.68/213.89  |- skos__hiddenLabel mesh__D009431 Conductions, Neural
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D009431 2003
% 213.68/213.89  |- mesh__dateEstablished mesh__D023102 2001-01-01
% 213.68/213.89  |- skos__broader mesh__D023102smesh__D017209
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D023102 2004
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D023102 2005
% 213.68/213.89  |- mesh__dateCreated mesh__D023102 2000-06-21
% 213.68/213.89  |- skos__prefLabel mesh__D023102 Anoikis
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D023102 2001
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D023102 2006
% 213.68/213.89  |- rdf__type mesh__D023102sskos__Concept
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D023102 2002
% 213.68/213.89  |- skos__scopeNote mesh__D023102
% 213.68/213.89       APOPTOSIS triggered by loss of contact with the EXTRACELLULAR MATRIX.%A%    
% 213.68/213.89  |- mesh__publicMeSHNote mesh__D023102 2001   
% 213.68/213.89  |- skos__historyNote mesh__D023102 Apoptosis %28%1994-2000%29%
% 213.68/213.89  |- mesh__historyNote mesh__D023102 2001   
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D023102 2003
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D014376 2002
% 213.68/213.89  |- skos__related mesh__D014376smesh__D014374
% 213.68/213.89  |- skos__hiddenLabel mesh__D014376 Tuberculoses
% 213.68/213.89  |- mesh__recordMaintainer mesh__D014376 TAP
% 213.68/213.89  |- skos__annotation mesh__D014376
% 213.68/213.89       caused by various species of Mycobacterium; GEN: prefer specifics; if unspecified as just %22%tuberculosis%22%, TUBERCULOSIS, PULMONARY is probably the correct heading but check text carefully; tuberculid: index under TUBERCULOSIS, CUTANEOUS; /drug ther: consider also ANTITUBERCULAR AGENTS; indexing policy: Manual 23.13.2%A%  
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D014376 2001
% 213.68/213.89  |- skos__prefLabel mesh__D014376 Tuberculosis
% 213.68/213.89  |- skos__broader mesh__D014376smesh__D009164
% 213.68/213.89  |- mesh__publicMeSHNote mesh__D014376
% 213.68/213.89       TUBERCULOSIS IMMUNITY was heading 1963-66   
% 213.68/213.89  |- rdf__type mesh__D014376sskos__Concept
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D014376 1997
% 213.68/213.89  |- skos__related mesh__D014376smesh__D000995
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D014376 2000
% 213.68/213.89  |- mesh__recordOriginator mesh__D014376 NLM
% 213.68/213.89  |- mesh__historyNote mesh__D014376
% 213.68/213.89       TUBERCULOSIS IMMUNITY was heading 1963-66   
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D014376 1999
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D014376 2004
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D014376 1996
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D014376 1995
% 213.68/213.89  |- mesh__recordAuthorizer mesh__D014376 PLS
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D014376 2006
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D014376 1998
% 213.68/213.89  |- mesh__dateRevised mesh__D014376 1993-06-03
% 213.68/213.89  |- mesh__dateCreated mesh__D014376 1999-01-01
% 213.68/213.89  |- skos__scopeNote mesh__D014376
% 213.68/213.89       Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM.%A%    
% 213.68/213.89  |- mesh__onlineNote mesh__D014376
% 213.68/213.89       use TUBERCULOSIS to search TUBERCULOSIS IMMUNITY 1966   
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D014376 2003
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D014376 1994
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D014376 2005
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D008339 2006
% 213.68/213.89  |- skos__broader mesh__D008339smesh__D007573
% 213.68/213.89  |- mesh__dateRevised mesh__D008339 2000-06-22
% 213.68/213.89  |- mesh__recordMaintainer mesh__D008339 nns
% 213.68/213.89  |- skos__prefLabel mesh__D008339 Mandibular Neoplasms
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D008339 2003
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D008339 2001
% 213.68/213.89  |- rdf__type mesh__D008339sskos__Concept
% 213.68/213.89  |- skos__hiddenLabel mesh__D008339 Neoplasm, Mandibular
% 213.68/213.89  |- skos__hiddenLabel mesh__D008339 Mandibular Neoplasm
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D008339 2004
% 213.68/213.89  |- skos__broader mesh__D008339smesh__D008336
% 213.68/213.89  |- skos__scopeNote mesh__D008339 Tumors or cancer of the MANDIBLE.     
% 213.68/213.89  |- skos__annotation mesh__D008339
% 213.68/213.89       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%  
% 213.68/213.89  |- mesh__dateCreated mesh__D008339 1999-01-01
% 213.68/213.89  |- mesh__recordAuthorizer mesh__D008339 sjn
% 213.68/213.89  |- mesh__recordOriginator mesh__D008339 NLM
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D008339 2002
% 213.68/213.89  |- skos__hiddenLabel mesh__D008339 Neoplasms, Mandibular
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D008339 2005
% 213.68/213.89  |- rdf__type mesh__D000356sskos__Concept
% 213.68/213.89  |- skos__prefLabel mesh__D000356 African horse sickness virus
% 213.68/213.89  |- mesh__recordAuthorizer mesh__D000356 sjn
% 213.68/213.89  |- mesh__dateEstablished mesh__D000356 1991-01-01
% 213.68/213.89  |- skos__hiddenLabel mesh__D000356 Horsesickness Viruses, African
% 213.68/213.89  |- mesh__recordMaintainer mesh__D000356 jls
% 213.68/213.89  |- mesh__dateRevised mesh__D000356 2004-07-19
% 213.68/213.89  |- skos__hiddenLabel mesh__D000356 Horsesickness Virus, African
% 213.68/213.89  |- skos__hiddenLabel mesh__D000356 African Horsesickness Viruses
% 213.68/213.89  |- skos__scopeNote mesh__D000356
% 213.68/213.89       A species of ORBIVIRUS that causes disease in horses, mules, and donkeys. Via its principal vector CULICOIDES, it can also infect dogs, elephants, camels, cattle, sheep, goats, and, in special circumstances, humans.%A%    
% 213.68/213.89  |- skos__altLabel mesh__D000356 African Horsesickness Virus
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D000356 2005
% 213.68/213.89  |- mesh__publicMeSHNote mesh__D000356
% 213.68/213.89       98; see AFRICAN HORSESICKNESS  VIRUS 1991-97, see  REOVIRIDAE 1981-90, see  REOVIRUSES 1975-80%A%  
% 213.68/213.89  |- skos__annotation mesh__D000356 infection = AFRICAN HORSE SICKNESS   
% 213.68/213.89  |- mesh__historyNote mesh__D000356 98%28%75%29%   
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D000356 2006
% 213.68/213.89  |- mesh__dateCreated mesh__D000356 1974-11-19
% 213.68/213.89  |- skos__broader mesh__D000356smesh__D018163
% 213.68/213.89  |- mesh__recordOriginator mesh__D000356 NLM
% 213.68/213.89  |- skos__prefLabel mesh__D019061 src-Family Kinases
% 213.68/213.89  |- skos__historyNote mesh__D019061
% 213.68/213.89       Protein-Tyrosine Kinase %28%1986-1995%29%
% 213.68/213.89  |- skos__hiddenLabel mesh__D019061 src Family Tyrosine Kinases
% 213.68/213.89  |- skos__hiddenLabel mesh__D019061 src Protein-Tyrosine Kinases
% 213.68/213.89  |- skos__hiddenLabel mesh__D019061 Tyrosine Kinases, src-Family
% 213.68/213.89  |- skos__scopeNote mesh__D019061
% 213.68/213.89       A PROTEIN-TYROSINE KINASE family that was originally identified by homology to the Rous sarcoma virus ONCOGENE PROTEIN PP60%28%V-SRC%29%. They interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. Oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src %28%v-src%29% genes.%A%    
% 213.68/213.89  |- mesh__publicMeSHNote mesh__D019061 96   
% 213.68/213.89  |- skos__hiddenLabel mesh__D019061 Kinases, src Tyrosine
% 213.68/213.89  |- mesh__recordAuthorizer mesh__D019061 sjn
% 213.68/213.89  |- mesh__dateRevised mesh__D019061 2003-07-09
% 213.68/213.89  |- rdf__type mesh__D019061sskos__Concept
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D019061 2004
% 213.68/213.89  |- mesh__dateCreated mesh__D019061 1995-05-26
% 213.68/213.89  |- skos__altLabel mesh__D019061 src Tyrosine Kinases
% 213.68/213.89  |- skos__hiddenLabel mesh__D019061 src Family Kinases
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D019061 2006
% 213.68/213.89  |- mesh__dateEstablished mesh__D019061 1996-01-01
% 213.68/213.89  |- skos__altLabel mesh__D019061 src Kinases
% 213.68/213.89  |- mesh__recordMaintainer mesh__D019061 ssb
% 213.68/213.89  |- skos__hiddenLabel mesh__D019061 Tyrosine Kinases, src
% 213.68/213.89  |- skos__related mesh__D019061smesh__D018909
% 213.68/213.89  |- skos__altLabel mesh__D019061 src-Family Tyrosine Kinases
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D019061 2005
% 213.68/213.89  |- skos__hiddenLabel mesh__D019061 Kinases, src
% 213.68/213.89  |- mesh__recordOriginator mesh__D019061 AGS
% 213.68/213.89  |- skos__hiddenLabel mesh__D019061 Kinases, src Protein-Tyrosine
% 213.68/213.89  |- skos__altLabel mesh__D019061 Protein-Tyrosine Kinases, src
% 213.68/213.89  |- skos__broader mesh__D019061smesh__D011505
% 213.68/213.89  |- mesh__historyNote mesh__D019061 96   
% 213.68/213.89  |- skos__hiddenLabel mesh__D005041 W 19053
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D005041 2005
% 213.68/213.89  |- skos__prefLabel mesh__D005041 Etidocaine
% 213.68/213.89  |- mesh__dateRevised mesh__D005041 2000-06-22
% 213.68/213.89  |- mesh__historyNote mesh__D005041
% 213.68/213.89       91%28%76%29%; was see under ACETANILIDES 1976-90   
% 213.68/213.89  |- skos__altLabel mesh__D005041
% 213.68/213.89       2-%28%Ethylpropylamino%29%-2%27%,6%27%-butyroxylidide
% 213.68/213.89  |- skos__broader mesh__D005041smesh__D000083
% 213.68/213.89  |- skos__scopeNote mesh__D005041
% 213.68/213.89       A local anesthetic with rapid onset and long action, similar to BUPIVACAINE.%A%    
% 213.68/213.89  |- mesh__activeMeSHYear mesh__D005041 2006
% 213.68/213.90  |- skos__historyNote mesh__D005041 Ethylamines %28%1974-1975%29%
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D005041 2001
% 213.68/213.90  |- mesh__publicMeSHNote mesh__D005041
% 213.68/213.90       91; was see under ACETANILIDES 1976-90   
% 213.68/213.90  |- mesh__recordAuthorizer mesh__D005041 sjn
% 213.68/213.90  |- mesh__dateEstablished mesh__D005041 1991-01-01
% 213.68/213.90  |- skos__historyNote mesh__D005041 Propylamines %28%1973-1975%29%
% 213.68/213.90  |- skos__historyNote mesh__D005041
% 213.68/213.90       Acetanilides %28%1973-1974%29%/analogs %26% derivatives %28%1975%29%
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D005041 2002
% 213.68/213.90  |- mesh__recordOriginator mesh__D005041 SH
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D005041 2003
% 213.68/213.90  |- skos__hiddenLabel mesh__D005041 W19053
% 213.68/213.90  |- rdf__type mesh__D005041sskos__Concept
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D005041 2004
% 213.68/213.90  |- mesh__dateCreated mesh__D005041 1975-07-23
% 213.68/213.90  |- mesh__recordMaintainer mesh__D005041 CCR
% 213.68/213.90  |- mesh__recordAuthorizer mesh__D010784 sjn
% 213.68/213.90  |- rdf__type mesh__D010784sskos__Concept
% 213.68/213.90  |- skos__prefLabel mesh__D010784 Photomicrography
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D010784 2005
% 213.68/213.90  |- skos__scopeNote mesh__D010784
% 213.68/213.90       Photography of objects viewed under a microscope using ordinary photographic methods.%A%    
% 213.68/213.90  |- skos__annotation mesh__D010784
% 213.68/213.90       avoid: read Manual 26.12.3; when IM, qualif permitted; do not confuse with %22%microphotography%22% %28%MICROFILMING or PHOTOMICROGRAPHY: be careful%29%; DF: PHOTOMICROGR%A%  
% 213.68/213.90  |- mesh__dateCreated mesh__D010784 1999-01-01
% 213.68/213.90  |- mesh__recordOriginator mesh__D010784 NLM
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D010784 2006
% 213.68/213.90  |- mesh__dateRevised mesh__D010784 2004-07-07
% 213.68/213.90  |- skos__broader mesh__D010784smesh__D008853
% 213.68/213.90  |- mesh__recordMaintainer mesh__D010784 nns
% 213.68/213.90  |- skos__broader mesh__D010784smesh__D010781
% 213.68/213.90  |- skos__hiddenLabel mesh__D010784 Photomicrographies
% 213.68/213.90  |- skos__related mesh__D037921smesh__D005378
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D037921 2006
% 213.68/213.90  |- skos__scopeNote mesh__D037921
% 213.68/213.90       The bestowing of tangible or intangible benefits, voluntarily and usually without expectation of anything in return. However, gift giving may be motivated by feelings of ALTRUISM or gratitude, by a sense of obligation, or by the hope of receiving something in return.%A%    
% 213.68/213.90  |- skos__related mesh__D037921smesh__D000533
% 213.68/213.90  |- skos__hiddenLabel mesh__D037921 Financial Gift
% 213.68/213.90  |- mesh__recordOriginator mesh__D037921 hjn
% 213.68/213.90  |- skos__hiddenLabel mesh__D037921 Financial Gifts
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D037921 2003
% 213.68/213.90  |- skos__hiddenLabel mesh__D037921 Contribution, Financial
% 213.68/213.90  |- mesh__dateCreated mesh__D037921 2002-07-03
% 213.68/213.90  |- mesh__recordMaintainer mesh__D037921 jls
% 213.68/213.90  |- rdf__type mesh__D037921sskos__Concept
% 213.68/213.90  |- mesh__dateRevised mesh__D037921 2002-10-31
% 213.68/213.90  |- mesh__publicMeSHNote mesh__D037921
% 213.68/213.90       2003; for GIFTS, FINANCIAL see FUND RAISING 1978-2002   
% 213.68/213.90  |- mesh__historyNote mesh__D037921
% 213.68/213.90       2003; for GIFTS, FINANCIAL use FUND RAISING 1978-2002   
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D037921 2004
% 213.68/213.90  |- skos__related mesh__D037921smesh__D005653
% 213.68/213.90  |- skos__related mesh__D037921smesh__D002608
% 213.68/213.90  |- skos__broader mesh__D037921smesh__D012919
% 213.68/213.90  |- skos__hiddenLabel mesh__D037921 Gift, Financial
% 213.68/213.90  |- mesh__dateEstablished mesh__D037921 2003-01-01
% 213.68/213.90  |- skos__altLabel mesh__D037921 Giftgiving
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D037921 2003A
% 213.68/213.90  |- skos__prefLabel mesh__D037921 Gift Giving
% 213.68/213.90  |- skos__hiddenLabel mesh__D037921 Financial Contribution
% 213.68/213.90  |- skos__hiddenLabel mesh__D037921 Contributions, Financial
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D037921 2005
% 213.68/213.90  |- mesh__recordAuthorizer mesh__D037921 jls
% 213.68/213.90  |- mesh__recordAuthorizer mesh__D004747 sjn
% 213.68/213.90  |- skos__annotation mesh__D004747
% 213.68/213.90       infection = ENTAMOEBIASIS but see note there; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 213.68/213.90  |- mesh__dateRevised mesh__D004747 2003-07-09
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D004747 2004
% 213.68/213.90  |- mesh__recordMaintainer mesh__D004747 ags
% 213.68/213.90  |- mesh__dateCreated mesh__D004747 1999-01-01
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D004747 2005
% 213.68/213.90  |- mesh__recordOriginator mesh__D004747 NLM
% 213.68/213.90  |- skos__prefLabel mesh__D004747 Entamoeba
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D004747 2006
% 213.68/213.90  |- skos__scopeNote mesh__D004747
% 213.68/213.90       A genus of ameboid protozoa characterized by the presence of beaded chromatin on the inner surface of the nuclear membrane. Its organisms are parasitic in invertebrates and vertebrates, including humans.%A%    
% 213.68/213.90  |- skos__broader mesh__D004747smesh__D016846
% 213.68/213.90  |- rdf__type mesh__D004747sskos__Concept
% 213.68/213.90  |- mesh__dateEstablished mesh__D009432 1979-01-01
% 213.68/213.90  |- mesh__recordMaintainer mesh__D009432 TAP
% 213.68/213.90  |- skos__historyNote mesh__D009432 Nervous System/EM %28%1966-1978%29%
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009432 2005
% 213.68/213.90  |- mesh__recordOriginator mesh__D009432 AEP
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009432 1998
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009432 2002
% 213.68/213.90  |- skos__hiddenLabel mesh__D009432 Neural Crests
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009432 2006
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009432 1994
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009432 1999
% 213.68/213.90  |- skos__prefLabel mesh__D009432 Neural Crest
% 213.68/213.90  |- mesh__historyNote mesh__D009432 79   
% 213.68/213.90  |- skos__broader mesh__D009432smesh__D004622
% 213.68/213.90  |- skos__hiddenLabel mesh__D009432 Crests, Neural
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009432 1995
% 213.68/213.90  |- mesh__dateRevised mesh__D009432 1992-05-15
% 213.68/213.90  |- mesh__publicMeSHNote mesh__D009432 79   
% 213.68/213.90  |- skos__hiddenLabel mesh__D009432 Crest, Neural
% 213.68/213.90  |- mesh__recordAuthorizer mesh__D009432 PLS
% 213.68/213.90  |- mesh__dateCreated mesh__D009432 1977-12-05
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009432 2003
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009432 1996
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009432 2000
% 213.68/213.90  |- skos__scopeNote mesh__D009432
% 213.68/213.90       A strip of specialized ectoderm flanking each side of the embryonal neural plate, which after the closure of the neural tube, forms a column of isolated cells along the dorsal aspect of the neural tube. Most of the cranial and all of the spinal sensory ganglion cells arise by differentiation of neural crest cells.%A%    
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009432 2004
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009432 1997
% 213.68/213.90  |- rdf__type mesh__D009432sskos__Concept
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009432 2001
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009432 1993
% 213.68/213.90  |- skos__scopeNote mesh__D019860
% 213.68/213.90       This enzyme is a lymphoid-specific src family tyrosine kinase that is critical for T-cell development and activation. Lck is associated with the cytoplasmic domains of CD4, CD8 and the beta-chain of the IL-2 receptor, and is thought to be involved in the earliest steps of TCR-mediated T-cell activation.%A%    
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D019860 2005
% 213.68/213.90  |- skos__hiddenLabel mesh__D019860 Protein lck, Proto-Oncogene
% 213.68/213.90  |- skos__historyNote mesh__D019860 src-Family Kinases %28%1996-1997%29%
% 213.68/213.90  |- skos__hiddenLabel mesh__D019860 lck, Proto-Oncogene Protein
% 213.68/213.90  |- skos__broader mesh__D019860smesh__D011518
% 213.68/213.90  |- skos__hiddenLabel mesh__D019860 c-lck, Proto-Oncogene Protein
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D019860 2006
% 213.68/213.90  |- mesh__historyNote mesh__D019860
% 213.68/213.90       98; use LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56%28%LCK%29% %28%NM%29% 1988-97%A%  
% 213.68/213.90  |- skos__prefLabel mesh__D019860
% 213.68/213.90       Lymphocyte Specific Protein Tyrosine Kinase p56%28%lck%29%
% 213.68/213.90  |- rdf__type mesh__D019860sskos__Concept
% 213.68/213.90  |- skos__hiddenLabel mesh__D019860 Proto Oncogene Protein lck
% 213.68/213.90  |- skos__altLabel mesh__D019860 p56 lck
% 213.68/213.90  |- mesh__dateCreated mesh__D019860 1997-07-02
% 213.68/213.90  |- skos__altLabel mesh__D019860 Proto-Oncogene Protein lck
% 213.68/213.90  |- skos__broader mesh__D019860smesh__D019061
% 213.68/213.90  |- mesh__dateRevised mesh__D019860 2003-07-09
% 213.68/213.90  |- skos__altLabel mesh__D019860 Proto-Oncogene Protein c-lck
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D019860 2004
% 213.68/213.90  |- skos__hiddenLabel mesh__D019860 Proto Oncogene Protein c lck
% 213.68/213.90  |- skos__altLabel mesh__D019860 lck Kinase
% 213.68/213.90  |- skos__historyNote mesh__D019860
% 213.68/213.90       Protein-Tyrosine Kinase %28%1988-1995%29%
% 213.68/213.90  |- skos__altLabel mesh__D019860 Protein Tyrosine Kinase p56%28%lck%29%
% 213.68/213.90  |- mesh__recordMaintainer mesh__D019860 ssb
% 213.68/213.90  |- mesh__recordOriginator mesh__D019860 KEV
% 213.68/213.90  |- skos__hiddenLabel mesh__D019860 Protein c-lck, Proto-Oncogene
% 213.68/213.90  |- skos__hiddenLabel mesh__D019860 Kinase, lck
% 213.68/213.90  |- mesh__publicMeSHNote mesh__D019860
% 213.68/213.90       98; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56%28%LCK%29% was indexed under SRC-FAMILY KINASES 1996-97 %26% PROTEIN-TYROSINE KINASE 1988-95%A%  
% 213.68/213.90  |- mesh__recordAuthorizer mesh__D019860 sjn
% 213.68/213.90  |- mesh__dateEstablished mesh__D019860 1998-01-01
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D000357 2003
% 213.68/213.90  |- skos__prefLabel mesh__D000357 African Swine Fever
% 213.68/213.90  |- skos__broader mesh__D000357smesh__D017282
% 213.68/213.90  |- skos__historyNote mesh__D000357 Swine Diseases %28%1966-1969%29%
% 213.68/213.90  |- mesh__publicMeSHNote mesh__D000357 70   
% 213.68/213.90  |- mesh__recordOriginator mesh__D000357 NLM
% 213.68/213.90  |- skos__scopeNote mesh__D000357
% 213.68/213.90       A sometimes fatal ASFIVIRUS infection of pigs, characterized by fever, cough, diarrhea, hemorrhagic lymph nodes, and edema of the gallbladder. It is transmitted between domestic swine by direct contact, ingestion of infected meat, or fomites, or mechanically by biting flies or soft ticks %28%genus Ornithodoros%29%.%A%    
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D000357 2004
% 213.68/213.90  |- skos__altLabel mesh__D000357 Wart-Hog Disease
% 213.68/213.90  |- mesh__recordAuthorizer mesh__D000357 sjn
% 213.68/213.90  |- mesh__dateRevised mesh__D000357 2001-07-25
% 213.68/213.90  |- skos__altLabel mesh__D000357 Swine Fever, African
% 213.68/213.90  |- skos__broader mesh__D000357smesh__D004266
% 213.68/213.90  |- skos__broader mesh__D000357smesh__D013553
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D000357 2005
% 213.68/213.90  |- skos__annotation mesh__D000357
% 213.68/213.90       do not confuse with SWINE FEVER see CLASSICAL SWINE FEVER%A%  
% 213.68/213.90  |- mesh__historyNote mesh__D000357 70   
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D000357 2006
% 213.68/213.90  |- skos__hiddenLabel mesh__D000357 Wart Hog Disease
% 213.68/213.90  |- mesh__dateEstablished mesh__D000357 1970-01-01
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D000357 2002
% 213.68/213.90  |- rdf__type mesh__D000357sskos__Concept
% 213.68/213.90  |- mesh__dateCreated mesh__D000357 1999-01-01
% 213.68/213.90  |- mesh__recordMaintainer mesh__D000357 ags
% 213.68/213.90  |- skos__historyNote mesh__D000357 Virus Diseases %28%1966-1969%29%
% 213.68/213.90  |- skos__hiddenLabel mesh__D000357 Wart-Hog Diseases
% 213.68/213.90  |- skos__altLabel mesh__D019062 G4 Antigen
% 213.68/213.90  |- mesh__dateCreated mesh__D019062 1995-05-26
% 213.68/213.90  |- mesh__recordOriginator mesh__D019062 AGS
% 213.68/213.90  |- skos__altLabel mesh__D019062 Neuron-Glia Adhesion Molecules
% 213.68/213.90  |- mesh__publicMeSHNote mesh__D019062
% 213.68/213.90       96; was NEURON-GLIA ADHESION MOLECULES see CELL ADHESION MOLECULES, NEURONAL 1990-95%A%  
% 213.68/213.90  |- rdf__type mesh__D019062sskos__Concept
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D019062 2006
% 213.68/213.90  |- skos__altLabel mesh__D019062 Neuron-Glia Cell Adhesion Molecules
% 213.68/213.90  |- skos__scopeNote mesh__D019062
% 213.68/213.90       Cell adhesion molecules that mediate neuron-neuron adhesion and neuron-astrocyte adhesion. They are expressed on neurons and Schwann cells, but not astrocytes and are involved in neuronal migration, neurite fasciculation, and outgrowth. Ng-CAM is immunologically and structurally distinct from NCAM %28%NEURAL CELL ADHESION MOLECULES%29%.%A%    
% 213.68/213.90  |- skos__prefLabel mesh__D019062 Cell Adhesion Molecules, Neuron-Glia
% 213.68/213.90  |- skos__hiddenLabel mesh__D019062 Neuron Glia Adhesion Molecules
% 213.68/213.90  |- skos__hiddenLabel mesh__D019062 Cell Adhesion Molecules, Neuron Glia
% 213.68/213.90  |- skos__hiddenLabel mesh__D019062 Adhesion Molecules, Neuron-Glia
% 213.68/213.90  |- mesh__dateRevised mesh__D019062 2005-06-30
% 213.68/213.90  |- skos__altLabel mesh__D019062 Ng-CAM
% 213.68/213.90  |- mesh__recordAuthorizer mesh__D019062 sjn
% 213.68/213.90  |- skos__hiddenLabel mesh__D019062 Neuron Glia Cell Adhesion Molecules
% 213.68/213.90  |- mesh__historyNote mesh__D019062
% 213.68/213.90       96; was NEURON-GLIA ADHESION MOLECULES see CELL ADHESION MOLECULES, NEURONAL 1990-95%A%  
% 213.68/213.90  |- skos__historyNote mesh__D019062
% 213.68/213.90       Cell Adhesion Molecules, Neuronal %28%1990-1995%29%
% 213.68/213.90  |- skos__annotation mesh__D019062
% 213.68/213.90       do not confuse with CELL ADHESION MOLECULES, NEURONAL   
% 213.68/213.90  |- mesh__dateEstablished mesh__D019062 1996-01-01
% 213.68/213.90  |- mesh__recordMaintainer mesh__D019062 ssb
% 213.68/213.90  |- skos__broader mesh__D019062smesh__D015816
% 213.68/213.90  |- mesh__onlineNote mesh__D019062
% 213.68/213.90       use CELL ADHESION MOLECULES, NEURONAL to search NEURON-GLIA ADHESION MOLECULES 1990-95%A%  
% 213.68/213.90  |- mesh__recordMaintainer mesh__D005840 CCR
% 213.68/213.90  |- mesh__recordOriginator mesh__D005840 NLM
% 213.68/213.90  |- rdf__type mesh__D005840sskos__Concept
% 213.68/213.90  |- mesh__recordAuthorizer mesh__D005840 sjn
% 213.68/213.90  |- skos__broader mesh__D005840smesh__D000814
% 213.68/213.90  |- mesh__dateCreated mesh__D005840 1999-01-01
% 213.68/213.90  |- skos__altLabel mesh__D005840 Estedi Brand of Gentian Violet
% 213.68/213.90  |- skos__altLabel mesh__D005840 Crystal Violet
% 213.68/213.90  |- skos__altLabel mesh__D005840 Dr. K. Hollborn Brand of Gentian Violet
% 213.68/213.90  |- skos__altLabel mesh__D005840 Methylrosaniline Chloride
% 213.68/213.90  |- skos__hiddenLabel mesh__D005840 Violet, Methyl
% 213.68/213.90  |- mesh__dateRevised mesh__D005840 2005-06-30
% 213.68/213.90  |- skos__annotation mesh__D005840 D25-26 qualif   
% 213.68/213.90  |- skos__hiddenLabel mesh__D005840 Chloride, Hexamethylpararosaniline
% 213.68/213.90  |- skos__hiddenLabel mesh__D005840 Violet, Crystal
% 213.68/213.90  |- skos__hiddenLabel mesh__D005840 Chloride, Methylrosaniline
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D005840 2006
% 213.68/213.90  |- skos__prefLabel mesh__D005840 Gentian Violet
% 213.68/213.90  |- skos__hiddenLabel mesh__D005840 FNA, Gentiaanviolet
% 213.68/213.90  |- skos__scopeNote mesh__D005840
% 213.68/213.90       A dye that is a mixture of violet rosanilinis with antibacterial, antifungal, and anthelmintic properties.%A%    
% 213.68/213.90  |- skos__altLabel mesh__D005840 Hexamethylpararosaniline Chloride
% 213.68/213.90  |- skos__hiddenLabel mesh__D005840 Kristallviolett L%C3%%B6%sung
% 213.68/213.90  |- skos__altLabel mesh__D005840 FNA Brand of Gentian Violet
% 213.68/213.90  |- skos__altLabel mesh__D005840 Methyl Violet
% 213.68/213.90  |- skos__hiddenLabel mesh__D005840 Violet, Gentian
% 213.68/213.90  |- skos__broader mesh__D005042smesh__D007093
% 213.68/213.90  |- rdf__type mesh__D005042sskos__Concept
% 213.68/213.90  |- skos__historyNote mesh__D005042 Dicarboxylic Acids %28%1972-1974%29%
% 213.68/213.90  |- mesh__dateRevised mesh__D005042 2005-06-30
% 213.68/213.90  |- skos__altLabel mesh__D005042 Ethymisole
% 213.68/213.90  |- skos__prefLabel mesh__D005042 Etimizol
% 213.68/213.90  |- skos__altLabel mesh__D005042 Ethimizole
% 213.68/213.90  |- skos__altLabel mesh__D005042 Ethymizol
% 213.68/213.90  |- mesh__recordMaintainer mesh__D005042 ssb
% 213.68/213.90  |- skos__altLabel mesh__D005042 Aethimizole
% 213.68/213.90  |- skos__altLabel mesh__D005042 Ethimizol
% 213.68/213.90  |- mesh__dateCreated mesh__D005042 1974-11-19
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D005042 2006
% 213.68/213.90  |- mesh__publicMeSHNote mesh__D005042
% 213.68/213.90       91; was see under IMIDAZOLES 1975-90   
% 213.68/213.90  |- mesh__historyNote mesh__D005042
% 213.68/213.90       91%28%75%29%; was see under IMIDAZOLES 1975-90   
% 213.68/213.90  |- skos__scopeNote mesh__D005042
% 213.68/213.90       A xanthine-related, putative nootropic drug.     
% 213.68/213.90  |- skos__historyNote mesh__D005042 Imidazoles %28%1972-1974%29%
% 213.68/213.90  |- skos__altLabel mesh__D005042 Ethylnorantifeine
% 213.68/213.90  |- mesh__recordOriginator mesh__D005042 NLM
% 213.68/213.90  |- skos__historyNote mesh__D005042 Amides %28%1972-1974%29%
% 213.68/213.90  |- mesh__recordAuthorizer mesh__D005042 sjn
% 213.68/213.90  |- mesh__dateEstablished mesh__D005042 1991-01-01
% 213.68/213.90  |- skos__broader mesh__D010785smesh__D010766
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D010785 2005
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D010785 1998
% 213.68/213.90  |- mesh__recordMaintainer mesh__D010785 PXP
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D010785 2003
% 213.68/213.90  |- mesh__dateRevised mesh__D010785 1997-06-20
% 213.68/213.90  |- skos__scopeNote mesh__D010785
% 213.68/213.90       The formation of ATP occurring in chloroplasts during photosynthesis. It is analogous to oxidative phosphorylation. %28%Dorland, 28th ed%29%%A%    
% 213.68/213.90  |- rdf__type mesh__D010785sskos__Concept
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D010785 2002
% 213.68/213.90  |- skos__prefLabel mesh__D010785 Photophosphorylation
% 213.68/213.90  |- skos__hiddenLabel mesh__D010785 Photophosphorylations
% 213.68/213.90  |- mesh__dateEstablished mesh__D010785 1974-01-01
% 213.68/213.90  |- mesh__recordAuthorizer mesh__D010785 SJN
% 213.68/213.90  |- skos__historyNote mesh__D010785 Photosynthesis %28%1966-1971%29%
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D010785 2001
% 213.68/213.90  |- skos__broader mesh__D010785smesh__D010788
% 213.68/213.90  |- skos__broader mesh__D010785smesh__D010777
% 213.68/213.90  |- skos__annotation mesh__D010785
% 213.68/213.90       in plants: ATP formation in chloroplasts during photosynthesis%A%  
% 213.68/213.90  |- mesh__dateCreated mesh__D010785 1999-01-01
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D010785 2006
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D010785 2000
% 213.68/213.90  |- mesh__recordOriginator mesh__D010785 NLM
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D010785 1999
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D010785 2004
% 213.68/213.90  |- mesh__historyNote mesh__D010785 74%28%72%29%   
% 213.68/213.90  |- mesh__publicMeSHNote mesh__D010785 74   
% 213.68/213.90  |- skos__broader mesh__D004748smesh__D004747
% 213.68/213.90  |- mesh__recordMaintainer mesh__D004748 ags
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D004748 2005
% 213.68/213.90  |- skos__altLabel mesh__D004748 Endamoeba histolytica
% 213.68/213.90  |- skos__annotation mesh__D004748
% 213.68/213.90       infection = ENTAMOEBIASIS but see note there; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D004748 2006
% 213.68/213.90  |- mesh__recordAuthorizer mesh__D004748 sjn
% 213.68/213.90  |- rdf__type mesh__D004748sskos__Concept
% 213.68/213.90  |- skos__scopeNote mesh__D004748
% 213.68/213.90       A species of parasitic protozoa causing ENTAMOEBIASIS and amebic dysentery %28%DYSENTERY, AMEBIC%29%. Characteristics include a single nucleus containing a small central karyosome and peripheral chromatin that is finely and regularly beaded.%A%    
% 213.68/213.90  |- mesh__dateRevised mesh__D004748 2003-07-09
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D004748 2004
% 213.68/213.90  |- mesh__recordOriginator mesh__D004748 NLM
% 213.68/213.90  |- mesh__dateCreated mesh__D004748 1999-01-01
% 213.68/213.90  |- skos__prefLabel mesh__D004748 Entamoeba histolytica
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D015470 1997
% 213.68/213.90  |- mesh__dateCreated mesh__D015470 1988-06-09
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D015470 1998
% 213.68/213.90  |- skos__hiddenLabel mesh__D015470 Acute Nonlymphocytic Leukemia
% 213.68/213.90  |- skos__prefLabel mesh__D015470 Leukemia, Nonlymphocytic, Acute
% 213.68/213.90  |- rdf__type mesh__D015470sskos__Concept
% 213.68/213.90  |- skos__hiddenLabel mesh__D015470 Nonlymphocytic Leukemias, Acute
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D015470 2006
% 213.68/213.90  |- skos__hiddenLabel mesh__D015470 Leukemias, Acute Nonlymphocytic
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D015470 2000
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D015470 1999
% 213.68/213.90  |- skos__broader mesh__D015470smesh__D007951
% 213.68/213.90  |- mesh__publicMeSHNote mesh__D015470 89   
% 213.68/213.90  |- skos__altLabel mesh__D015470 ANLL
% 213.68/213.90  |- mesh__historyNote mesh__D015470 89   
% 213.68/213.90  |- skos__hiddenLabel mesh__D015470 Leukemias, Acute Nonlymphoblastic
% 213.68/213.90  |- skos__hiddenLabel mesh__D015470 Leukemia, Acute Nonlymphoblastic
% 213.68/213.90  |- skos__hiddenLabel mesh__D015470 Acute Nonlymphocytic Leukemias
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D015470 2001
% 213.68/213.90  |- skos__hiddenLabel mesh__D015470 Leukemia, Acute Nonlymphocytic
% 213.68/213.90  |- mesh__recordOriginator mesh__D015470 PLS
% 213.68/213.90  |- skos__altLabel mesh__D015470 Nonlymphoblastic Leukemia, Acute
% 213.68/213.90  |- skos__altLabel mesh__D015470 Leukemia, Nonlymphoblastic, Acute
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D015470 2003
% 213.68/213.90  |- skos__hiddenLabel mesh__D015470 Acute Nonlymphoblastic Leukemia
% 213.68/213.90  |- skos__historyNote mesh__D015470 Leukemia, Myeloblastic %28%1966-1988%29%
% 213.68/213.90  |- skos__annotation mesh__D015470
% 213.68/213.90       GEN or unspecified: prefer specifics; do not use /blood supply /chem /second /secret /ultrastruct; DF: note short X ref ANLL%A%  
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D015470 1996
% 213.68/213.90  |- skos__altLabel mesh__D015470 Nonlymphocytic Leukemia, Acute
% 213.68/213.90  |- mesh__dateEstablished mesh__D015470 1989-01-01
% 213.68/213.90  |- skos__scopeNote mesh__D015470
% 213.68/213.90       Acute leukemia distinguished from acute lymphocytic leukemia %28%ALL%29% by the morphology of the marrow and blood leukemic cells. Cytoplasmic granules are usually present and the nucleus is usually large and irregular. ANLL is more common in adults than ALL and occurs at any age.%A%    
% 213.68/213.90  |- mesh__dateRevised mesh__D015470 1995-06-08
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D015470 2002
% 213.68/213.90  |- mesh__recordAuthorizer mesh__D015470 PLS
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D015470 2004
% 213.68/213.90  |- skos__historyNote mesh__D015470 Leukemia %28%1966-1988%29%
% 213.68/213.90  |- skos__hiddenLabel mesh__D015470 Nonlymphoblastic Leukemias, Acute
% 213.68/213.90  |- mesh__recordMaintainer mesh__D015470 KEV
% 213.68/213.90  |- skos__hiddenLabel mesh__D015470 Acute Nonlymphoblastic Leukemias
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D015470 2005
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D023902 2006
% 213.68/213.90  |- skos__altLabel mesh__D023902 Synapsis
% 213.68/213.90  |- skos__related mesh__D023902smesh__D003434
% 213.68/213.90  |- rdf__type mesh__D023902sskos__Concept
% 213.68/213.90  |- skos__altLabel mesh__D023902 Synapsis, Chromosomal
% 213.68/213.90  |- mesh__recordAuthorizer mesh__D023902 sjn
% 213.68/213.90  |- mesh__dateCreated mesh__D023902 2001-07-25
% 213.68/213.90  |- skos__hiddenLabel mesh__D023902 Chromosomal Synapsis
% 213.68/213.90  |- skos__hiddenLabel mesh__D023902 Chromosome Pairings
% 213.68/213.90  |- mesh__recordMaintainer mesh__D023902 nns
% 213.68/213.90  |- skos__scopeNote mesh__D023902
% 213.68/213.90       The alignment of CHROMOSOMES at homologous sequences.     
% 213.68/213.90  |- skos__annotation mesh__D023902
% 213.68/213.90       do not confuse SYNAPSIS with SYNAPSES %28%neuron cell junctions%29%%A%  
% 213.68/213.90  |- mesh__dateRevised mesh__D023902 2005-06-30
% 213.68/213.90  |- skos__prefLabel mesh__D023902 Chromosome Pairing
% 213.68/213.90  |- mesh__historyNote mesh__D023902 2002   
% 213.68/213.90  |- mesh__dateEstablished mesh__D023902 2002-01-01
% 213.68/213.90  |- skos__broader mesh__D023902smesh__D049469
% 213.68/213.90  |- mesh__publicMeSHNote mesh__D023902 2002   
% 213.68/213.90  |- mesh__recordOriginator mesh__D023902 nns
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009433 2006
% 213.68/213.90  |- mesh__dateEstablished mesh__D009433 1974-01-01
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009433 1994
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009433 1999
% 213.68/213.90  |- skos__historyNote mesh__D009433
% 213.68/213.90       specific neuroanatomic site %28%1966-1971%29%
% 213.68/213.90  |- mesh__historyNote mesh__D009433
% 213.68/213.90       74; was INHIBITION, NEURAL 1972-73 %28%Prov%29%   
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009433 2001
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009433 1995
% 213.68/213.90  |- mesh__recordMaintainer mesh__D009433 TAP
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009433 2002
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009433 2003
% 213.68/213.90  |- mesh__recordOriginator mesh__D009433 NLM
% 213.68/213.90  |- mesh__onlineNote mesh__D009433
% 213.68/213.90       use NEURAL INHIBITION to search INHIBITION, NEURAL 1972-73 %28%as Prov%29%%A%  
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009433 1996
% 213.68/213.90  |- mesh__dateCreated mesh__D009433 1999-01-01
% 213.68/213.90  |- mesh__publicMeSHNote mesh__D009433 74   
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009433 2004
% 213.68/213.90  |- skos__altLabel mesh__D009433 Inhibition, Neural
% 213.68/213.90  |- skos__historyNote mesh__D009433 Neural Transmission %28%1966-1971%29%
% 213.68/213.90  |- mesh__dateRevised mesh__D009433 1992-05-15
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009433 1997
% 213.68/213.90  |- mesh__recordAuthorizer mesh__D009433 PLS
% 213.68/213.90  |- skos__broader mesh__D009433smesh__D009424
% 213.68/213.90  |- rdf__type mesh__D009433sskos__Concept
% 213.68/213.90  |- skos__prefLabel mesh__D009433 Neural Inhibition
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009433 1993
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009433 2005
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009433 2000
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D009433 1998
% 213.68/213.90  |- skos__annotation mesh__D001450
% 213.68/213.90       /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: BALLISTOCARDIOGR%A%  
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D001450 2000
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D001450 1998
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D001450 2003
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D001450 2006
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D001450 2002
% 213.68/213.90  |- mesh__recordAuthorizer mesh__D001450 SJN
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D001450 2005
% 213.68/213.90  |- mesh__recordMaintainer mesh__D001450 PXP
% 213.68/213.90  |- skos__broader mesh__D001450smesh__D006334
% 213.68/213.90  |- mesh__recordOriginator mesh__D001450 NLM
% 213.68/213.90  |- skos__scopeNote mesh__D001450
% 213.68/213.90       Technique of graphic representation of the movements of the body imparted by the ballistic forces %28%recoil and impact%29% associated with cardiac contraction and ejection of blood and with the deceleration of blood flow through the large blood vessels. These movements, quantitatively very minute, are translated by a pickup device %28%transducer%29% into an electrical potential which is suitably amplified and recorded on a conventional electrocardiograph or other recording machine.%A%    
% 213.68/213.90  |- mesh__dateRevised mesh__D001450 1997-06-20
% 213.68/213.90  |- rdf__type mesh__D001450sskos__Concept
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D001450 2001
% 213.68/213.90  |- mesh__dateCreated mesh__D001450 1999-01-01
% 213.68/213.90  |- skos__hiddenLabel mesh__D001450 Ballistocardiographies
% 213.68/213.90  |- skos__prefLabel mesh__D001450 Ballistocardiography
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D001450 1999
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D001450 2004
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D014378 1995
% 213.68/213.90  |- mesh__dateRevised mesh__D014378 1993-09-16
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D014378 2006
% 213.68/213.90  |- skos__prefLabel mesh__D014378 Tuberculosis Societies
% 213.68/213.90  |- skos__scopeNote mesh__D014378
% 213.68/213.90       Voluntary agencies concerned with prevention and treatment of tuberculosis.%A%    
% 213.68/213.90  |- mesh__dateCreated mesh__D014378 1999-01-01
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D014378 1998
% 213.68/213.90  |- mesh__recordOriginator mesh__D014378 NLM
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D014378 2003
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D014378 2005
% 213.68/213.90  |- mesh__recordMaintainer mesh__D014378 PLS
% 213.68/213.90  |- mesh__publicMeSHNote mesh__D014378
% 213.68/213.90       91; was see under VOLUNTARY HEALTH AGENCIES 1967-90; was heading 1963-66%A%  
% 213.68/213.90  |- mesh__activeMeSHYear mesh__D014378 2002
% 213.68/213.90  |- skos__hiddenLabel mesh__D014378 Tuberculosis Society
% 213.68/213.90  |- mesh__onlineNote mesh__D014378
% 213.68/213.90       use VOLUNTARY HEALTH AGENCIES to search TUBERCULOSIS SOCIETIES 1966-74%A%  
% 213.68/213.90  |- skos__hiddenLabel mesh__D014378 Society, Tuberculosis
% 213.68/213.90  |- mesh__historyNote mesh__D014378
% 213.68/213.90       91%28%75%29%63-66; was see under VOLUNTARY HEALTH AGENCIES 1967-90; was heading 1963-66%A%  
% 213.68/213.90  |- rdf__type mesh__D014378sskos__Concept
% 213.68/213.91  |- mesh__dateEstablished mesh__D014378 1991-01-01
% 213.68/213.91  |- skos__broader mesh__D014378smesh__D014837
% 213.68/213.91  |- mesh__activeMeSHYear mesh__D014378 1997
% 213.68/213.91  |- mesh__activeMeSHYear mesh__D014378 2001
% 213.68/213.91  |- skos__hiddenLabel mesh__D014378 Societies, Tuberculosis
% 213.68/213.91  |- mesh__activeMeSHYear mesh__D014378 1999
% 213.68/213.91  |- mesh__recordAuthorizer mesh__D014378 NLM
% 213.68/213.91  |- mesh__activeMeSHYear mesh__D014378 2004
% 213.68/213.91  |- mesh__activeMeSHYear mesh__D014378 2000
% 213.68/213.91  |- mesh__activeMeSHYear mesh__D014378 1996
% 213.68/213.91  |- mesh__recordOriginator mesh__D019861 AGS
% 213.68/213.91  |- mesh__historyNote mesh__D019861 98   
% 213.68/213.91  |- mesh__dateEstablished mesh__D019861 1998-01-01
% 213.68/213.91  |- mesh__dateCreated mesh__D019861 1997-06-20
% 213.68/213.91  |- mesh__recordMaintainer mesh__D019861 lkt
% 213.68/213.91  |- skos__hiddenLabel mesh__D019861 Enterochromaffin-like Cell
% 213.68/213.91  |- skos__historyNote mesh__D019861 Enterochromaffin Cells %28%1975-1997%29%
% 213.68/213.91  |- skos__hiddenLabel mesh__D019861 Enterochromaffin like Cells
% 213.68/213.91  |- mesh__recordAuthorizer mesh__D019861 sjn
% 213.76/213.91  |- skos__prefLabel mesh__D019861 Enterochromaffin-like Cells
% 213.76/213.91  |- skos__scopeNote mesh__D019861
% 213.76/213.91       Neuroendocrine cells in the glands of the GASTRIC MUCOSA. They produce HISTAMINE and peptides such as CHROMOGRANINS. ECL cells respond to GASTRIN by releasing histamine which acts as a paracrine stimulator of the release of HYDROCHLORIC ACID from the GASTRIC PARIETAL CELLS.%A%    
% 213.76/213.91  |- skos__broader mesh__D019861smesh__D019858
% 213.76/213.91  |- skos__altLabel mesh__D019861 ECL Cells
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D019861 2006
% 213.76/213.91  |- mesh__dateRevised mesh__D019861 2005-06-30
% 213.76/213.91  |- skos__historyNote mesh__D019861 Chromaffin System %28%1969-1971%29%
% 213.76/213.91  |- rdf__type mesh__D019861sskos__Concept
% 213.76/213.91  |- skos__historyNote mesh__D019861 Gastric Mucosa %28%1967-1971%29%
% 213.76/213.91  |- skos__hiddenLabel mesh__D019861 ECL Cell
% 213.76/213.91  |- mesh__publicMeSHNote mesh__D019861 98   
% 213.76/213.91  |- skos__related mesh__D019861smesh__D004759
% 213.76/213.91  |- skos__broader mesh__D019861smesh__D002838
% 213.76/213.91  |- skos__scopeNote mesh__D019063
% 213.76/213.91       Hexameric extracellular matrix glycoprotein transiently expressed in many developing organs and often re-expressed in tumors. It is present in the central and peripheral nervous systems as well as in smooth muscle and tendons. %28%From Kreis %26% Vale, Guidebook to the Extracellular Matrix and Adhesion Proteins, 1993, p93%29%%A%    
% 213.76/213.91  |- mesh__recordAuthorizer mesh__D019063 sjn
% 213.76/213.91  |- skos__altLabel mesh__D019063 Cytotactin
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D019063 2005
% 213.76/213.91  |- mesh__dateEstablished mesh__D019063 1996-01-01
% 213.76/213.91  |- skos__historyNote mesh__D019063
% 213.76/213.91       Cell Adhesion Molecules, Neuronal %28%1990-1995%29%
% 213.76/213.91  |- skos__altLabel mesh__D019063 Tenascin-C
% 213.76/213.91  |- mesh__recordMaintainer mesh__D019063 ssb
% 213.76/213.91  |- skos__historyNote mesh__D019063 Glycoproteins %28%1986-1989%29%
% 213.76/213.91  |- mesh__dateRevised mesh__D019063 2001-07-25
% 213.76/213.91  |- skos__hiddenLabel mesh__D019063 Tenascin C
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D019063 2002
% 213.76/213.91  |- skos__historyNote mesh__D019063 Proteins %28%1986-1989%29%
% 213.76/213.91  |- mesh__recordOriginator mesh__D019063 AGS
% 213.76/213.91  |- skos__altLabel mesh__D019063 Hexabrachion
% 213.76/213.91  |- mesh__dateCreated mesh__D019063 1995-05-26
% 213.76/213.91  |- skos__historyNote mesh__D019063
% 213.76/213.91       Extracellular Matrix Proteins %28%1990-1995%29%
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D019063 2004
% 213.76/213.91  |- skos__broader mesh__D019063smesh__D016326
% 213.76/213.91  |- rdf__type mesh__D019063sskos__Concept
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D019063 2003
% 213.76/213.91  |- mesh__publicMeSHNote mesh__D019063
% 213.76/213.91       96; TENASCIN was indexed under CELL ADHESION MOLECULES, NEURONAL %26% EXTRACELLULAR MATRIX PROTEINS 1990-95; PROTEINS %26% GLYCOPROTEINS 1986-89%A%  
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D019063 2006
% 213.76/213.91  |- mesh__onlineNote mesh__D019063
% 213.76/213.91       use TENASCIN %28%NM%29% to search TENASCIN 1986-95   
% 213.76/213.91  |- mesh__historyNote mesh__D019063 96; was TENASCIN %28%NM%29% 1986-95   
% 213.76/213.91  |- skos__prefLabel mesh__D019063 Tenascin
% 213.76/213.91  |- rdf__type mesh__D000358sskos__Concept
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D000358 2005
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D000358 2004
% 213.76/213.91  |- mesh__dateEstablished mesh__D000358 1991-01-01
% 213.76/213.91  |- skos__historyNote mesh__D000358 DNA Viruses %28%1966-1974%29%
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D000358 2003
% 213.76/213.91  |- mesh__recordMaintainer mesh__D000358 ags
% 213.76/213.91  |- skos__annotation mesh__D000358
% 213.76/213.91       infection = AFRICAN SWINE FEVER: see note there   
% 213.76/213.91  |- skos__broader mesh__D000358smesh__D025701
% 213.76/213.91  |- mesh__recordOriginator mesh__D000358 NLM
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D000358 2002
% 213.76/213.91  |- skos__prefLabel mesh__D000358 African Swine Fever Virus
% 213.76/213.91  |- mesh__historyNote mesh__D000358
% 213.76/213.91       91%28%75%29%; was see under IRIDOVIRIDAE 1981-90; was see under IRIDOVIRUSES 1978-80; was see under DNA VIRUSES 1975-77%A%  
% 213.76/213.91  |- mesh__recordAuthorizer mesh__D000358 sjn
% 213.76/213.91  |- skos__altLabel mesh__D000358 Wart-Hog Disease Virus
% 213.76/213.91  |- skos__hiddenLabel mesh__D000358 Virus, Wart-Hog Disease
% 213.76/213.91  |- mesh__publicMeSHNote mesh__D000358
% 213.76/213.91       91; was see under IRIDOVIRIDAE 1981-90; was see under IRIDOVIRUSES 1978-80; was see under DNA VIRUSES 1975-77%A%  
% 213.76/213.91  |- mesh__dateCreated mesh__D000358 1974-12-12
% 213.76/213.91  |- mesh__dateRevised mesh__D000358 2001-07-25
% 213.76/213.91  |- skos__scopeNote mesh__D000358
% 213.76/213.91       The lone species of the genus Asfivirus. It infects domestic and wild pigs, warthogs, and bushpigs.  Disease is endemic in domestic swine in many African countries and Sardinia. Soft ticks of the genus Ornithodoros are also infected and act as vectors.%A%    
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D000358 2006
% 213.76/213.91  |- skos__hiddenLabel mesh__D000358 Wart Hog Disease Virus
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D011080 2000
% 213.76/213.91  |- skos__altLabel mesh__D011080 Polychlorotriphenyl Compounds
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D011080 1995
% 213.76/213.91  |- mesh__recordOriginator mesh__D011080 NLM
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D011080 2006
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D011080 1993
% 213.76/213.91  |- mesh__dateCreated mesh__D011080 1974-11-14
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D011080 2004
% 213.76/213.91  |- skos__broader mesh__D011080smesh__D006843
% 213.76/213.91  |- mesh__dateRevised mesh__D011080 1992-05-20
% 213.76/213.91  |- skos__broader mesh__D011080smesh__D013730
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D011080 1994
% 213.76/213.91  |- mesh__historyNote mesh__D011080
% 213.76/213.91       91%28%75%29%; was see under TERPHENYL COMPOUNDS 1975-90   
% 213.76/213.91  |- rdf__type mesh__D011080sskos__Concept
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D011080 2005
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D011080 2002
% 213.76/213.91  |- skos__scopeNote mesh__D011080
% 213.76/213.91       Compounds consisting of three benzene rings linked to each other in either ortho, meta or para positions and substituted with chlorine atoms.%A%    
% 213.76/213.91  |- skos__prefLabel mesh__D011080 Polychloroterphenyl Compounds
% 213.76/213.91  |- skos__hiddenLabel mesh__D011080 Compounds, Polychloroterphenyl
% 213.76/213.91  |- mesh__recordMaintainer mesh__D011080 TAP
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D011080 2003
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D011080 1999
% 213.76/213.91  |- mesh__recordAuthorizer mesh__D011080 PLS
% 213.76/213.91  |- mesh__publicMeSHNote mesh__D011080
% 213.76/213.91       91; was see under TERPHENYL COMPOUNDS 1975-90   
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D011080 1997
% 213.76/213.91  |- mesh__dateEstablished mesh__D011080 1991-01-01
% 213.76/213.91  |- skos__historyNote mesh__D011080 Polycyclic Compounds %28%1974%29%
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D011080 1998
% 213.76/213.91  |- skos__annotation mesh__D011080 DF: POLYCHLOROTERPHENYL CPDS   
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D011080 1996
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D011080 2001
% 213.76/213.91  |- skos__historyNote mesh__D011080 Hydrocarbons, Chlorinated %28%1974%29%
% 213.76/213.91  |- skos__historyNote mesh__D011080 Chlorobenzenes %28%1974%29%
% 213.76/213.91  |- skos__hiddenLabel mesh__D011080 Compounds, Polychlorotriphenyl
% 213.76/213.91  |- mesh__dateCreated mesh__D005841 1999-01-01
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D005841 2002
% 213.76/213.91  |- skos__prefLabel mesh__D005841 Gentisates
% 213.76/213.91  |- skos__hiddenLabel mesh__D005841 Acids, 2,5-Dihydroxybenzoic
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D005841 2003
% 213.76/213.91  |- mesh__recordOriginator mesh__D005841 NLM
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D005841 2005
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D005841 2004
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D005841 2006
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D005841 2000
% 213.76/213.91  |- mesh__recordAuthorizer mesh__D005841 SJN
% 213.76/213.91  |- mesh__dateRevised mesh__D005841 1998-06-10
% 213.76/213.91  |- skos__altLabel mesh__D005841 2,5-Dihydroxybenzoic Acids
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D005841 2001
% 213.76/213.91  |- skos__scopeNote mesh__D005841 Salts and esters of gentisic acid.     
% 213.76/213.91  |- skos__hiddenLabel mesh__D005841 2,5 Dihydroxybenzoic Acids
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D005841 1999
% 213.76/213.91  |- mesh__recordMaintainer mesh__D005841 ADP
% 213.76/213.91  |- skos__broader mesh__D005841smesh__D012459
% 213.76/213.91  |- rdf__type mesh__D005841sskos__Concept
% 213.76/213.91  |- skos__broader mesh__D005043smesh__D015068
% 213.76/213.91  |- mesh__recordOriginator mesh__D005043 NLM
% 213.76/213.91  |- skos__altLabel mesh__D005043 3-alpha-Hydroxy-5-beta-Androstan-17-One
% 213.76/213.91  |- skos__altLabel mesh__D005043 5-beta-Androsterone
% 213.76/213.91  |- mesh__recordAuthorizer mesh__D005043 sjn
% 213.76/213.91  |- mesh__dateCreated mesh__D005043 1999-01-01
% 213.76/213.91  |- mesh__dateEstablished mesh__D005043 1965-01-01
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D005043 2006
% 213.76/213.91  |- skos__scopeNote mesh__D005043
% 213.76/213.91       The 5-beta-reduced isomer of ANDROSTERONE. Etiocholanolone is a major metabolite of TESTOSTERONE and ANDROSTENEDIONE in many mammalian species including humans. It is excreted in the URINE.%A%    
% 213.76/213.91  |- mesh__recordMaintainer mesh__D005043 lkt
% 213.76/213.91  |- skos__hiddenLabel mesh__D005043 5 beta Androsterone
% 213.76/213.91  |- skos__broader mesh__D005043smesh__D045165
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D005043 2005
% 213.76/213.91  |- skos__prefLabel mesh__D005043 Etiocholanolone
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D005043 2004
% 213.76/213.91  |- skos__hiddenLabel mesh__D005043 3 alpha Hydroxy 5 beta Androstan 17 One
% 213.76/213.91  |- rdf__type mesh__D005043sskos__Concept
% 213.76/213.91  |- mesh__publicMeSHNote mesh__D005043 65   
% 213.76/213.91  |- skos__broader mesh__D005043smesh__D000732
% 213.76/213.91  |- mesh__historyNote mesh__D005043 65%28%63%29%   
% 213.76/213.91  |- mesh__dateRevised mesh__D005043 2003-07-09
% 213.76/213.91  |- skos__broader mesh__D009729Q000941smesh__D009729
% 213.76/213.91  |- mesh__preferredCombination mesh__D009729Q000941smesh__D004993
% 213.76/213.91  |- rdf__type mesh__D009729Q000941smesh__CompoundConcept
% 213.76/213.91  |- mesh__recordOriginator mesh__D010786 NLM
% 213.76/213.91  |- rdf__type mesh__D010786sskos__Concept
% 213.76/213.91  |- skos__related mesh__D010786smesh__D012168
% 213.76/213.91  |- skos__related mesh__D010786smesh__D019174
% 213.76/213.91  |- mesh__recordMaintainer mesh__D010786 mdb
% 213.76/213.91  |- skos__annotation mesh__D010786
% 213.76/213.91       GEN or unspecified but note PHOTORECEPTORS, VERTEBRATE; PHOTORECEPTORS, INVERTEBRATE; PHOTORECEPTORS, MICROBIAL %26% PHOTORECEPTORS, PLANT see PHOTOSYNTHETIC REACTION CENTER, PLANT are also available; DF: PHOTORECEPT%A%  
% 213.76/213.91  |- mesh__dateEstablished mesh__D010786 1971-01-01
% 213.76/213.91  |- skos__scopeNote mesh__D010786
% 213.76/213.91       Cells specialized to detect and transduce light.     
% 213.76/213.91  |- skos__hiddenLabel mesh__D010786 Retinal Photoreceptor
% 213.76/213.91  |- mesh__dateRevised mesh__D010786 2001-07-25
% 213.76/213.91  |- skos__broader mesh__D010786smesh__D009475
% 213.76/213.91  |- skos__broader mesh__D010786smesh__D012160
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D010786 2002
% 213.76/213.91  |- skos__historyNote mesh__D010786 Receptors, Sensory %28%1966-1970%29%
% 213.76/213.91  |- skos__prefLabel mesh__D010786 Photoreceptors
% 213.76/213.91  |- mesh__dateCreated mesh__D010786 1999-01-01
% 213.76/213.91  |- mesh__recordAuthorizer mesh__D010786 sjn
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D010786 2006
% 213.76/213.91  |- skos__altLabel mesh__D010786 Photoreceptors, Retinal
% 213.76/213.91  |- skos__hiddenLabel mesh__D010786 Photoreceptor
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D010786 2004
% 213.76/213.91  |- mesh__historyNote mesh__D010786 71   
% 213.76/213.91  |- mesh__publicMeSHNote mesh__D010786
% 213.76/213.91       71; for PHOTORECEPTORS, RETINAL %26% RETINAL PHOTORECEPTORS see RODS AND CONES 1994-96%A%  
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D010786 2005
% 213.76/213.91  |- skos__hiddenLabel mesh__D010786 Photoreceptor, Retinal
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D010786 2003
% 213.76/213.91  |- skos__broader mesh__D010786smesh__D011984
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D004749 2001
% 213.76/213.91  |- mesh__recordAuthorizer mesh__D004749 SJN
% 213.76/213.91  |- mesh__onlineNote mesh__D004749 search AMEBIASIS 1966-74   
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D004749 2006
% 213.76/213.91  |- mesh__recordOriginator mesh__D004749 NLM
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D004749 2002
% 213.76/213.91  |- mesh__recordMaintainer mesh__D004749 TGC
% 213.76/213.91  |- mesh__dateRevised mesh__D004749 1997-06-20
% 213.76/213.91  |- mesh__publicMeSHNote mesh__D004749
% 213.76/213.91       91; was see under AMEBIASIS 1975-90   
% 213.76/213.91  |- skos__scopeNote mesh__D004749
% 213.76/213.91       Infection with amoebae of the genus ENTAMOEBA. Infection with E. histolytica causes DYSENTERY, AMEBIC and LIVER ABSCESS, AMEBIC.%A%    
% 213.76/213.91  |- rdf__type mesh__D004749sskos__Concept
% 213.76/213.91  |- mesh__dateEstablished mesh__D004749 1991-01-01
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D004749 1998
% 213.76/213.91  |- skos__hiddenLabel mesh__D004749 Entamoebiases
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D004749 2003
% 213.76/213.91  |- skos__prefLabel mesh__D004749 Entamoebiasis
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D004749 1999
% 213.76/213.91  |- mesh__historyNote mesh__D004749
% 213.76/213.91       91%28%75%29%; was see under AMEBIASIS 1975-90   
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D004749 2004
% 213.76/213.91  |- mesh__dateCreated mesh__D004749 1999-01-01
% 213.76/213.91  |- skos__broader mesh__D004749smesh__D000562
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D004749 2000
% 213.76/213.91  |- skos__annotation mesh__D004749 amebic infect   
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D004749 2005
% 213.76/213.91  |- mesh__dateRevised mesh__D015471 1995-06-08
% 213.76/213.91  |- skos__broader mesh__D015471smesh__D015470
% 213.76/213.91  |- skos__historyNote mesh__D015471 Leukemia, Myeloblastic %28%1966-1988%29%
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D015471 2006
% 213.76/213.91  |- mesh__dateCreated mesh__D015471 1988-06-09
% 213.76/213.91  |- skos__hiddenLabel mesh__D015471 Leukemias, Acute Basophilic
% 213.76/213.91  |- mesh__dateEstablished mesh__D015471 1989-01-01
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D015471 2004
% 213.76/213.91  |- skos__annotation mesh__D015471
% 213.76/213.91       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 213.76/213.91  |- mesh__recordMaintainer mesh__D015471 KEV
% 213.76/213.91  |- skos__hiddenLabel mesh__D015471 Acute Basophilic Leukemia
% 213.76/213.91  |- skos__prefLabel mesh__D015471 Leukemia, Basophilic, Acute
% 213.76/213.91  |- skos__historyNote mesh__D015471 Leukemia %28%1966-1988%29%
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D015471 2005
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D015471 2001
% 213.76/213.91  |- mesh__historyNote mesh__D015471 89   
% 213.76/213.91  |- mesh__recordOriginator mesh__D015471 PLS
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D015471 2003
% 213.76/213.91  |- rdf__type mesh__D015471sskos__Concept
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D015471 2000
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D015471 1999
% 213.76/213.91  |- skos__altLabel mesh__D015471 Basophilic Leukemia, Acute
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D015471 1997
% 213.76/213.91  |- skos__historyNote mesh__D015471 Basophils %28%1966-1988%29%
% 213.76/213.91  |- skos__hiddenLabel mesh__D015471 Acute Basophilic Leukemias
% 213.76/213.91  |- mesh__publicMeSHNote mesh__D015471 89   
% 213.76/213.91  |- skos__hiddenLabel mesh__D015471 Leukemia, Acute Basophilic
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D015471 1998
% 213.76/213.91  |- mesh__recordAuthorizer mesh__D015471 PLS
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D015471 1996
% 213.76/213.91  |- skos__hiddenLabel mesh__D015471 Basophilic Leukemias, Acute
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D015471 2002
% 213.76/213.91  |- skos__hiddenLabel mesh__D023903 Restenosis, Coronary
% 213.76/213.91  |- mesh__dateCreated mesh__D023903 2001-07-25
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D023903 2003
% 213.76/213.91  |- skos__broader mesh__D023903smesh__D023921
% 213.76/213.91  |- skos__hiddenLabel mesh__D023903 Restenoses, Coronary
% 213.76/213.91  |- skos__hiddenLabel mesh__D023903 Coronary Restenoses
% 213.76/213.91  |- mesh__dateEstablished mesh__D023903 2002-01-01
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D023903 2004
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D023903 2005
% 213.76/213.91  |- mesh__publicMeSHNote mesh__D023903 2002   
% 213.76/213.91  |- skos__scopeNote mesh__D023903
% 213.76/213.91       Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.%A%    
% 213.76/213.91  |- skos__historyNote mesh__D023903 Recurrence %28%1983-2001%29%
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D023903 2006
% 213.76/213.91  |- skos__historyNote mesh__D023903 Coronary Disease %28%1983-2001%29%
% 213.76/213.91  |- mesh__historyNote mesh__D023903 2002   
% 213.76/213.91  |- skos__prefLabel mesh__D023903 Coronary Restenosis
% 213.76/213.91  |- rdf__type mesh__D023903sskos__Concept
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D023903 2002
% 213.76/213.91  |- rdf__type mesh__D009434sskos__Concept
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D009434 2002
% 213.76/213.91  |- skos__scopeNote mesh__D009434
% 213.76/213.91       Neural tracts connecting one part of the nervous system with another.%A%    
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D009434 2006
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D009434 2001
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D009434 1999
% 213.76/213.91  |- skos__annotation mesh__D009434
% 213.76/213.91       = %22%neural tracts%22%; coord NIM with origin %28%IM%29% + termination %28%IM%29%%A%  
% 213.76/213.91  |- mesh__onlineNote mesh__D009434
% 213.76/213.91       use NEURAL PATHWAYS to search NEURAL INTERCONNECTIONS 1969-76 %28%as Prov 1969-74%29%%A%  
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D009434 2005
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D009434 1998
% 213.76/213.91  |- skos__hiddenLabel mesh__D009434 Interconnections, Neural
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D009434 2000
% 213.76/213.91  |- mesh__historyNote mesh__D009434
% 213.76/213.91       77; was NEURAL INTERCONNECTIONS see under NERVOUS SYSTEM 1975-76, was NEURAL INTERCONNECTIONS 1969-74 %28%Prov%29%%A%  
% 213.76/213.91  |- skos__hiddenLabel mesh__D009434 Pathway, Neural
% 213.76/213.91  |- mesh__recordMaintainer mesh__D009434 TAP
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D009434 2004
% 213.76/213.91  |- skos__prefLabel mesh__D009434 Neural Pathways
% 213.76/213.91  |- skos__hiddenLabel mesh__D009434 Pathways, Neural
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D009434 1997
% 213.76/213.91  |- skos__hiddenLabel mesh__D009434 Interconnection, Neural
% 213.76/213.91  |- mesh__recordAuthorizer mesh__D009434 PLS
% 213.76/213.91  |- skos__hiddenLabel mesh__D009434 Neural Interconnection
% 213.76/213.91  |- skos__hiddenLabel mesh__D009434 Neural Pathway
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D009434 2003
% 213.76/213.91  |- mesh__recordOriginator mesh__D009434 MM
% 213.76/213.91  |- skos__broader mesh__D009434smesh__D009420
% 213.76/213.91  |- mesh__publicMeSHNote mesh__D009434
% 213.76/213.91       77; was NEURAL INTERCONNECTIONS see under NERVOUS SYSTEM 1975-76%A%  
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D009434 1996
% 213.76/213.91  |- mesh__dateCreated mesh__D009434 1976-04-16
% 213.76/213.91  |- mesh__dateEstablished mesh__D009434 1977-01-01
% 213.76/213.91  |- mesh__dateRevised mesh__D009434 1995-05-18
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D001451 2005
% 213.76/213.91  |- skos__hiddenLabel mesh__D001451 Balloon Dilatations
% 213.76/213.91  |- skos__historyNote mesh__D001451
% 213.76/213.91       Catheterization or specific %28%1966-1987%29%
% 213.76/213.91  |- skos__hiddenLabel mesh__D001451 Valvuloplasty, Balloon
% 213.76/213.91  |- skos__hiddenLabel mesh__D001451 Balloon Tamponades
% 213.76/213.91  |- skos__hiddenLabel mesh__D001451 Valvotomies, Balloon
% 213.76/213.91  |- skos__historyNote mesh__D001451 Dilatation %28%1976-1987%29%
% 213.76/213.91  |- skos__altLabel mesh__D001451 Dilatation, Balloon
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D001451 2006
% 213.76/213.91  |- skos__altLabel mesh__D001451 Catheterization, Balloon
% 213.76/213.91  |- skos__altLabel mesh__D001451 Balloon Dilation
% 213.76/213.91  |- mesh__publicMeSHNote mesh__D001451 88   
% 213.76/213.91  |- skos__scopeNote mesh__D001451
% 213.76/213.91       Nonoperative repair of occluded vessels, ducts, or valves by insertion of a balloon catheter. It is used, among other things, to treat varices, torn retinas, renal and biliary calculi, gastric, bronchial and rectal stenoses, and heart valves, and includes catheterization with Fogarty and Foley catheters.%A%    
% 213.76/213.91  |- skos__hiddenLabel mesh__D001451 Valvotomy, Balloon
% 213.76/213.91  |- skos__altLabel mesh__D001451 Balloon Valvotomy
% 213.76/213.91  |- mesh__recordMaintainer mesh__D001451 jls
% 213.76/213.91  |- skos__related mesh__D001451smesh__D015905
% 213.76/213.91  |- skos__altLabel mesh__D001451 Balloon Catheterization
% 213.76/213.91  |- skos__broader mesh__D001451smesh__D002404
% 213.76/213.91  |- skos__hiddenLabel mesh__D001451 Tamponades, Balloon
% 213.76/213.91  |- skos__hiddenLabel mesh__D001451 Balloon Catheterization, Foley
% 213.76/213.91  |- rdf__type mesh__D001451sskos__Concept
% 213.76/213.91  |- skos__altLabel mesh__D001451 Dilation, Balloon
% 213.76/213.91  |- skos__hiddenLabel mesh__D001451 Dilatations, Balloon
% 213.76/213.91  |- skos__hiddenLabel mesh__D001451 Valvuloplasties, Balloon
% 213.76/213.91  |- skos__hiddenLabel mesh__D001451 Dilations, Balloon
% 213.76/213.91  |- skos__hiddenLabel mesh__D001451 Balloon Dilations
% 213.76/213.91  |- skos__hiddenLabel mesh__D001451 Catheterization, Fogarty Balloon
% 213.76/213.91  |- skos__prefLabel mesh__D001451 Balloon Dilatation
% 213.76/213.91  |- skos__hiddenLabel mesh__D001451 Balloon Valvuloplasties
% 213.76/213.91  |- mesh__recordOriginator mesh__D001451 SCD
% 213.76/213.91  |- mesh__dateRevised mesh__D001451 2004-07-19
% 213.76/213.91  |- mesh__dateCreated mesh__D001451 1987-03-16
% 213.76/213.91  |- skos__historyNote mesh__D001451 Assisted Circulation %28%1967-1975%29%
% 213.76/213.91  |- mesh__historyNote mesh__D001451 88   
% 213.76/213.91  |- skos__hiddenLabel mesh__D001451 Catheterizations, Balloon
% 213.76/213.91  |- skos__hiddenLabel mesh__D001451 Catheterization, Foley Balloon
% 213.76/213.91  |- skos__hiddenLabel mesh__D001451 Balloon Catheterization, Fogarty
% 213.76/213.91  |- skos__altLabel mesh__D001451 Balloon Tamponade
% 213.76/213.91  |- skos__hiddenLabel mesh__D001451 Balloon Catheterizations
% 213.76/213.91  |- skos__annotation mesh__D001451
% 213.76/213.91       coord IM with dis/ther %28%IM%29%, not /surg; DF: BALLOON CATH   
% 213.76/213.91  |- mesh__recordAuthorizer mesh__D001451 sjn
% 213.76/213.91  |- skos__hiddenLabel mesh__D001451 Balloon Valvotomies
% 213.76/213.91  |- skos__hiddenLabel mesh__D001451 Tamponade, Balloon
% 213.76/213.91  |- skos__historyNote mesh__D001451
% 213.76/213.91       Angioplasty, Transluminal %28%1982-1987%29%
% 213.76/213.91  |- mesh__dateEstablished mesh__D001451 1988-01-01
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D014379 2001
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D014379 2005
% 213.76/213.91  |- skos__annotation mesh__D014379
% 213.76/213.91       coord IM with BIRDS %28%NIM%29% or specific bird %28%IM%29%   
% 213.76/213.91  |- skos__hiddenLabel mesh__D014379 Avian Tuberculosis
% 213.76/213.91  |- skos__broader mesh__D014379smesh__D001715
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D014379 2000
% 213.76/213.91  |- mesh__recordOriginator mesh__D014379 NLM
% 213.76/213.91  |- mesh__recordMaintainer mesh__D014379 NDW
% 213.76/213.91  |- rdf__type mesh__D014379sskos__Concept
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D014379 1999
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D014379 2004
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D014379 2002
% 213.76/213.91  |- mesh__dateRevised mesh__D014379 1998-06-11
% 213.76/213.91  |- skos__broader mesh__D014379smesh__D014376
% 213.76/213.91  |- mesh__recordAuthorizer mesh__D014379 SJN
% 213.76/213.91  |- skos__scopeNote mesh__D014379
% 213.76/213.91       A variety of TUBERCULOSIS affecting various birds, including chickens and ducks. It is caused by MYCOBACTERIUM AVIUM and characterized by tubercles consisting principally of epithelioid cells.%A%    
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D014379 2006
% 213.76/213.91  |- mesh__dateCreated mesh__D014379 1999-01-01
% 213.76/213.91  |- skos__prefLabel mesh__D014379 Tuberculosis, Avian
% 213.76/213.91  |- skos__hiddenLabel mesh__D014379 Tuberculoses, Avian
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D014379 2003
% 213.76/213.91  |- skos__hiddenLabel mesh__D014379 Avian Tuberculoses
% 213.76/213.91  |- mesh__recordMaintainer mesh__D019862 ssb
% 213.76/213.91  |- mesh__publicMeSHNote mesh__D019862 1998   
% 213.76/213.91  |- skos__scopeNote mesh__D019862
% 213.76/213.91       This plant order includes 8 families, 66 genera, and about 1,800 species. These herbaceous perennials are mainly found in the wet tropics. Members include the banana family %28%MUSACEAE%29% and GINGER family %28%ZINGIBERACEAE%29%.%A%    
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D019862 2006
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D019862 2002
% 213.76/213.91  |- mesh__dateCreated mesh__D019862 1997-06-20
% 213.76/213.91  |- mesh__dateEstablished mesh__D019862 1998-01-01
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D019862 2005
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D019862 2004
% 213.76/213.91  |- skos__prefLabel mesh__D019862 Zingiberales
% 213.76/213.91  |- mesh__historyNote mesh__D019862 1998   
% 213.76/213.91  |- rdf__type mesh__D019862sskos__Concept
% 213.76/213.91  |- mesh__recordAuthorizer mesh__D019862 sjn
% 213.76/213.91  |- mesh__activeMeSHYear mesh__D019862 2003
% 213.76/213.91  |- mesh__dateRevised mesh__D019862 2001-07-25
% 213.76/213.91  |- skos__broader mesh__D019862smesh__D019684
% 213.76/213.91  |- mesh__recordOriginator mesh__D019862 JLS
% 213.76/213.91  |- skos__annotation mesh__D019862
% 213.76/213.91       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.76/213.91  |- skos__hiddenLabel mesh__D019064 Product Container
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D019064 2005A
% 213.76/213.92  |- mesh__dateRevised mesh__D019064 2004-07-30
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D019064 1997
% 213.76/213.92  |- skos__altLabel mesh__D019064 Packaging, Product
% 213.76/213.92  |- skos__scopeNote mesh__D019064
% 213.76/213.92       Form in which product is processed or wrapped and labeled. PRODUCT LABELING is also available.%A%    
% 213.76/213.92  |- mesh__dateCreated mesh__D019064 1995-06-05
% 213.76/213.92  |- mesh__publicMeSHNote mesh__D019064 96   
% 213.76/213.92  |- mesh__dateEstablished mesh__D019064 1996-01-01
% 213.76/213.92  |- mesh__historyNote mesh__D019064 96   
% 213.76/213.92  |- skos__annotation mesh__D019064
% 213.76/213.92       includes containers, packaging methods, packaging materials; IM; coord with specific product %28%IM%29%; FOOD PACKAGING %26% DRUG PACKAGING are also available%A%  
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D019064 1996
% 213.76/213.92  |- skos__hiddenLabel mesh__D019064 Container, Product
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D019064 1999
% 213.76/213.92  |- mesh__recordAuthorizer mesh__D019064 jls
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D019064 2004
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D019064 1998
% 213.76/213.92  |- skos__hiddenLabel mesh__D019064 Packagings, Product
% 213.76/213.92  |- mesh__recordOriginator mesh__D019064 JLS
% 213.76/213.92  |- rdf__type mesh__D019064sskos__Concept
% 213.76/213.92  |- skos__hiddenLabel mesh__D019064 Product Packagings
% 213.76/213.92  |- skos__hiddenLabel mesh__D019064 Packagings
% 213.76/213.92  |- skos__prefLabel mesh__D019064 Product Packaging
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D019064 2002
% 213.76/213.92  |- skos__hiddenLabel mesh__D019064 Containers, Product
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D019064 2003
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D019064 2006
% 213.76/213.92  |- skos__broader mesh__D019064smesh__D007221
% 213.76/213.92  |- mesh__recordMaintainer mesh__D019064 jls
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D019064 2001
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D019064 2005
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D019064 2000
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D000359 2004
% 213.76/213.92  |- skos__prefLabel mesh__D000359 Aftercare
% 213.76/213.92  |- skos__hiddenLabel mesh__D000359 After Treatment
% 213.76/213.92  |- skos__hiddenLabel mesh__D000359 Postabortal Program
% 213.76/213.92  |- skos__hiddenLabel mesh__D000359 After-Treatments
% 213.76/213.92  |- skos__hiddenLabel mesh__D000359 Program, Postabortal
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D000359 2003
% 213.76/213.92  |- skos__historyNote mesh__D000359
% 213.76/213.92       Progressive Patient Care %28%1966-1967%29%
% 213.76/213.92  |- mesh__onlineNote mesh__D000359
% 213.76/213.92       use AFTERCARE to search AFTER CARE 1968-93   
% 213.76/213.92  |- mesh__dateRevised mesh__D000359 2002-07-02
% 213.76/213.92  |- mesh__recordMaintainer mesh__D000359 mdb
% 213.76/213.92  |- skos__hiddenLabel mesh__D000359 Programs, Postabortal
% 213.76/213.92  |- skos__scopeNote mesh__D000359
% 213.76/213.92       The care and treatment of a convalescent patient, especially that of a patient after surgery.%A%    
% 213.76/213.92  |- mesh__dateCreated mesh__D000359 1999-01-01
% 213.76/213.92  |- mesh__dateEstablished mesh__D000359 1968-01-01
% 213.76/213.92  |- mesh__historyNote mesh__D000359 94; was AFTER CARE 1968-93   
% 213.76/213.92  |- skos__related mesh__D000359smesh__D006208
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D000359 2006
% 213.76/213.92  |- mesh__recordOriginator mesh__D000359 NLM
% 213.76/213.92  |- skos__broader mesh__D000359smesh__D005791
% 213.76/213.92  |- skos__annotation mesh__D000359
% 213.76/213.92       med, nurs, psychiat care after discharge from a hosp or other health facil; differentiate from REHABILITATION which is for getting a person back to pre-illness work or other activity%A%  
% 213.76/213.92  |- skos__altLabel mesh__D000359 After-Treatment
% 213.76/213.92  |- rdf__type mesh__D000359sskos__Concept
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D000359 2005
% 213.76/213.92  |- mesh__recordAuthorizer mesh__D000359 sjn
% 213.76/213.92  |- skos__altLabel mesh__D000359 After Care
% 213.76/213.92  |- mesh__publicMeSHNote mesh__D000359 94; was AFTER CARE 1968-93   
% 213.76/213.92  |- mesh__dateEstablished mesh__D011081 1972-01-01
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011081 1994
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011081 2000
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011081 2005
% 213.76/213.92  |- skos__scopeNote mesh__D011081
% 213.76/213.92       An acquired disease of unknown etiology, chronic course, and tendency to recur. It is characterized by inflammation and degeneration of cartilage and can result in deformities such as floppy ear and saddle nose. Loss of cartilage in the respiratory tract can lead to respiratory obstruction.%A%    
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011081 2003
% 213.76/213.92  |- mesh__dateCreated mesh__D011081 1999-01-01
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011081 1995
% 213.76/213.92  |- skos__broader mesh__D011081smesh__D002357
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011081 2006
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011081 1993
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011081 2004
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011081 2001
% 213.76/213.92  |- skos__hiddenLabel mesh__D011081 Chronic Atrophic Polychondritis
% 213.76/213.92  |- skos__prefLabel mesh__D011081 Polychondritis, Relapsing
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011081 1998
% 213.76/213.92  |- skos__hiddenLabel mesh__D011081 Chronic Atrophic Polychondritides
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011081 1996
% 213.76/213.92  |- skos__hiddenLabel mesh__D011081 Polychondritides, Chronic Atrophic
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011081 2002
% 213.76/213.92  |- rdf__type mesh__D011081sskos__Concept
% 213.76/213.92  |- skos__hiddenLabel mesh__D011081 Atrophic Polychondritis, Chronic
% 213.76/213.92  |- skos__hiddenLabel mesh__D011081 Atrophic Polychondritides, Chronic
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011081 1999
% 213.76/213.92  |- mesh__recordAuthorizer mesh__D011081 PLS
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011081 1997
% 213.76/213.92  |- mesh__recordOriginator mesh__D011081 NLM
% 213.76/213.92  |- mesh__recordMaintainer mesh__D011081 PLS
% 213.76/213.92  |- skos__altLabel mesh__D011081 Polychondritis, Chronic Atrophic
% 213.76/213.92  |- mesh__dateRevised mesh__D011081 1992-05-22
% 213.76/213.92  |- skos__hiddenLabel mesh__D011081 Relapsing Polychondritis
% 213.76/213.92  |- skos__hiddenLabel mesh__D011081 Relapsing Polychondritides
% 213.76/213.92  |- skos__hiddenLabel mesh__D011081 Polychondritides, Relapsing
% 213.76/213.92  |- mesh__publicMeSHNote mesh__D011081 72   
% 213.76/213.92  |- mesh__historyNote mesh__D011081 72%28%67%29%   
% 213.76/213.92  |- skos__scopeNote mesh__D005842
% 213.76/213.92       All of the continents and every country situated within, the UNITED STATES and each of the constituent states arranged by region, CANADA and each of its provinces, AUSTRALIA and each of its states, the major bodies of water and major islands on both hemispheres, and selected major cities. Although the geographic locations are not printed in INDEX MEDICUS as main headings, in indexing they are significant in epidemiologic studies and historical articles and for locating administrative units in education and the delivery of health care.%A%    
% 213.76/213.92  |- skos__historyNote mesh__D005842
% 213.76/213.92       specific geographic location %28%1966-1997%29%
% 213.76/213.92  |- mesh__historyNote mesh__D005842 98; use explode 1967-97   
% 213.76/213.92  |- rdf__type mesh__D005842sskos__Concept
% 213.76/213.92  |- mesh__runningHead mesh__D005842 Z1 - GEOGRAPHIC LOCATIONS   
% 213.76/213.92  |- skos__prefLabel mesh__D005842 Geographic Locations
% 213.76/213.92  |- skos__annotation mesh__D005842
% 213.76/213.92       not used for indexing or cataloging; Cat Z: do not confuse with GEOGRAPHY %28%Cat H%29%; rules on Cat Z terms as coords: Manual section 36; DF: GEOGR LOCATIONS%A%  
% 213.76/213.92  |- mesh__dateCreated mesh__D005842 1999-01-01
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D005842 2004
% 213.76/213.92  |- mesh__recordAuthorizer mesh__D005842 sjn
% 213.76/213.92  |- mesh__recordOriginator mesh__D005842 NLM
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D005842 2006
% 213.76/213.92  |- mesh__recordMaintainer mesh__D005842 ags
% 213.76/213.92  |- mesh__dateEstablished mesh__D005842 1998-01-01
% 213.76/213.92  |- mesh__dateRevised mesh__D005842 2003-07-09
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D005842 2005
% 213.76/213.92  |- mesh__publicMeSHNote mesh__D005044
% 213.76/213.92       91; was see under PORPHYRINS 1975-90   
% 213.76/213.92  |- mesh__historyNote mesh__D005044
% 213.76/213.92       91%28%75%29%; was see under PORPHYRINS 1975-90   
% 213.76/213.92  |- skos__historyNote mesh__D005044 Porphyrins %28%1966-1974%29%
% 213.76/213.92  |- skos__prefLabel mesh__D005044 Etioporphyrins
% 213.76/213.92  |- mesh__recordOriginator mesh__D005044 NLM
% 213.76/213.92  |- rdf__type mesh__D005044sskos__Concept
% 213.76/213.92  |- mesh__recordAuthorizer mesh__D005044 sjn
% 213.76/213.92  |- mesh__dateEstablished mesh__D005044 1991-01-01
% 213.76/213.92  |- skos__scopeNote mesh__D005044
% 213.76/213.92       Porphyrins with four methyl and four ethyl side chains attached to the pyrrole rings.%A%    
% 213.76/213.92  |- skos__annotation mesh__D005044 pigments   
% 213.76/213.92  |- skos__broader mesh__D005044smesh__D011166
% 213.76/213.92  |- mesh__dateRevised mesh__D005044 2005-06-30
% 213.76/213.92  |- mesh__dateCreated mesh__D005044 1974-11-19
% 213.76/213.92  |- mesh__recordMaintainer mesh__D005044 ssb
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D005044 2006
% 213.76/213.92  |- skos__scopeNote mesh__D010787
% 213.76/213.92       Abnormal responses to sunlight or artificial light due to extreme reactivity of light-absorbing molecules in tissues. It refers almost exclusively to skin photosensitivity, including sunburn, reactions due to repeated prolonged exposure in the absence of photosensitizing factors, and reactions requiring photosensitizing factors such as photosensitizing agents and certain diseases. With restricted reference to skin tissue, it does not include photosensitivity of the eye to light, as in photophobia or photosensitive epilepsy.%A%    
% 213.76/213.92  |- skos__hiddenLabel mesh__D010787 Reticuloid Syndrome, Actinic
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010787 2002
% 213.76/213.92  |- skos__prefLabel mesh__D010787 Photosensitivity Disorders
% 213.76/213.92  |- skos__hiddenLabel mesh__D010787 Reticuloid Syndromes, Actinic
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010787 2003
% 213.76/213.92  |- skos__hiddenLabel mesh__D010787 Dermatitides, Chronic Actinic
% 213.76/213.92  |- mesh__recordAuthorizer mesh__D010787 PLS
% 213.76/213.92  |- skos__hiddenLabel mesh__D010787 Actinic Dermatitis, Chronic
% 213.76/213.92  |- mesh__onlineNote mesh__D010787
% 213.76/213.92       use PHOTOSENSITIVITY DISORDERS to search PHOTOSENSITIZATION 1966-79%A%  
% 213.76/213.92  |- skos__hiddenLabel mesh__D010787 Disorder, Photosensitivity
% 213.76/213.92  |- skos__hiddenLabel mesh__D010787 Photosensitivity Disorder
% 213.76/213.92  |- skos__hiddenLabel mesh__D010787 Syndromes, Actinic Reticuloid
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010787 1996
% 213.76/213.92  |- skos__hiddenLabel mesh__D010787 Photodermatitides
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010787 2004
% 213.76/213.92  |- skos__broader mesh__D010787smesh__D012871
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010787 2000
% 213.76/213.92  |- skos__hiddenLabel mesh__D010787 Chronic Actinic Dermatitides
% 213.76/213.92  |- skos__hiddenLabel mesh__D010787 Actinic Reticuloid Syndromes
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010787 2005
% 213.76/213.92  |- skos__hiddenLabel mesh__D010787 Syndrome, Actinic Reticuloid
% 213.76/213.92  |- skos__annotation mesh__D010787
% 213.76/213.92       a skin disease entity: does not mean sensitivity to light of eye, plants, bacteria, etc. %28% = LIGHT%29%%A%  
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010787 1997
% 213.76/213.92  |- mesh__dateCreated mesh__D010787 1999-01-01
% 213.76/213.92  |- skos__hiddenLabel mesh__D010787 Dermatitis, Chronic Actinic
% 213.76/213.92  |- mesh__dateRevised mesh__D010787 1995-02-22
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010787 1998
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010787 2001
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010787 2006
% 213.76/213.92  |- skos__hiddenLabel mesh__D010787 Actinic Dermatitides
% 213.76/213.92  |- rdf__type mesh__D010787sskos__Concept
% 213.76/213.92  |- mesh__recordOriginator mesh__D010787 NLM
% 213.76/213.92  |- skos__hiddenLabel mesh__D010787 Disorders, Photosensitivity
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010787 1999
% 213.76/213.92  |- skos__hiddenLabel mesh__D010787 Actinic Dermatitides, Chronic
% 213.76/213.92  |- mesh__historyNote mesh__D010787 80; was PHOTOSENSITIZATION 1963-79   
% 213.76/213.92  |- mesh__publicMeSHNote mesh__D010787 80; was PHOTOSENSITIZATION 1963-79   
% 213.76/213.92  |- skos__altLabel mesh__D010787 Photodermatitis
% 213.76/213.92  |- skos__hiddenLabel mesh__D010787 Actinic Dermatitis
% 213.76/213.92  |- skos__hiddenLabel mesh__D010787 Dermatitides, Actinic
% 213.76/213.92  |- mesh__recordMaintainer mesh__D010787 TGC
% 213.76/213.92  |- mesh__dateEstablished mesh__D015472 1989-01-01
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D015472 2004
% 213.76/213.92  |- mesh__recordMaintainer mesh__D015472 KEV
% 213.76/213.92  |- mesh__recordAuthorizer mesh__D015472 PLS
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D015472 2005
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D015472 2002
% 213.76/213.92  |- mesh__recordOriginator mesh__D015472 PLS
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D015472 2003
% 213.76/213.92  |- rdf__type mesh__D015472sskos__Concept
% 213.76/213.92  |- skos__prefLabel mesh__D015472 Leukemia, Eosinophilic, Acute
% 213.76/213.92  |- skos__broader mesh__D015472smesh__D015470
% 213.76/213.92  |- mesh__dateCreated mesh__D015472 1988-06-09
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D015472 1999
% 213.76/213.92  |- skos__annotation mesh__D015472
% 213.76/213.92       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 213.76/213.92  |- skos__altLabel mesh__D015472 Eosinophilic Leukemia, Acute
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D015472 1997
% 213.76/213.92  |- skos__hiddenLabel mesh__D015472 Eosinophilic Leukemias, Acute
% 213.76/213.92  |- skos__historyNote mesh__D015472 Leukemia %28%1966-1988%29%
% 213.76/213.92  |- skos__hiddenLabel mesh__D015472 Leukemia, Acute Eosinophilic
% 213.76/213.92  |- skos__hiddenLabel mesh__D015472 Acute Eosinophilic Leukemia
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D015472 2001
% 213.76/213.92  |- mesh__publicMeSHNote mesh__D015472 89   
% 213.76/213.92  |- mesh__historyNote mesh__D015472 89   
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D015472 1998
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D015472 1996
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D015472 2000
% 213.76/213.92  |- skos__hiddenLabel mesh__D015472 Leukemias, Acute Eosinophilic
% 213.76/213.92  |- skos__hiddenLabel mesh__D015472 Acute Eosinophilic Leukemias
% 213.76/213.92  |- mesh__dateRevised mesh__D015472 1995-06-08
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D015472 2006
% 213.76/213.92  |- skos__historyNote mesh__D015472 Leukemia, Myeloblastic %28%1966-1988%29%
% 213.76/213.92  |- skos__historyNote mesh__D015472 Eosinophils %28%1966-1988%29%
% 213.76/213.92  |- mesh__recordMaintainer mesh__D009435 ssb
% 213.76/213.92  |- mesh__recordOriginator mesh__D009435 NLM
% 213.76/213.92  |- skos__broader mesh__D009435smesh__D015398
% 213.76/213.92  |- skos__related mesh__D009435smesh__D013569
% 213.76/213.92  |- mesh__recordAuthorizer mesh__D009435 sjn
% 213.76/213.92  |- mesh__onlineNote mesh__D009435
% 213.76/213.92       use SYNAPTIC TRANSMISSION to search NEURAL TRANSMISSION 1969-93, NEUROHUMORAL TRANSMISSION 1968, %26% NERVE TRANSMISSION 1968-93%A%  
% 213.76/213.92  |- skos__altLabel mesh__D009435 Transmission, Synaptic
% 213.76/213.92  |- mesh__dateCreated mesh__D009435 1999-01-01
% 213.76/213.92  |- skos__altLabel mesh__D009435 Transmission, Neural
% 213.76/213.92  |- skos__historyNote mesh__D009435 Neural Conduction %28%1966-1967%29%
% 213.76/213.92  |- skos__prefLabel mesh__D009435 Synaptic Transmission
% 213.76/213.92  |- skos__related mesh__D009435smesh__D017629
% 213.76/213.92  |- skos__annotation mesh__D009435
% 213.76/213.92       between nerves; differentiate X ref NEURAL TRANSMISSION from NEURAL CONDUCTION %28%along a single nerve%29%; consider also NEURAL INHIBITION; neuromusc transm = NEUROMUSCULAR JUNCTION /physiol + SYNAPTIC TRANSMISSION%A%  
% 213.76/213.92  |- mesh__dateEstablished mesh__D009435 1968-01-01
% 213.76/213.92  |- skos__broader mesh__D009435smesh__D009424
% 213.76/213.92  |- skos__hiddenLabel mesh__D009435 Potentials, Synaptic
% 213.76/213.92  |- mesh__dateRevised mesh__D009435 2005-06-30
% 213.76/213.92  |- rdf__type mesh__D009435sskos__Concept
% 213.76/213.92  |- skos__altLabel mesh__D009435 Neural Transmission
% 213.76/213.92  |- mesh__publicMeSHNote mesh__D009435
% 213.76/213.92       94; was NEURAL TRANSMISSION 1969-93, was NEUROHUMORAL TRANSMISSION 1968; NERVE TRANSMISSION was see NEURAL TRANSMISSION%A%  
% 213.76/213.92  |- mesh__historyNote mesh__D009435
% 213.76/213.92       94; was NEURAL TRANSMISSION 1969-93, was NEUROHUMORAL TRANSMISSION 1968; NERVE TRANSMISSION was see NEURAL TRANSMISSION 1969-93%A%  
% 213.76/213.92  |- skos__scopeNote mesh__D009435
% 213.76/213.92       The communication from a neuron to a target %28%neuron, muscle, or secretory cell%29% across a synapse. In chemical synaptic transmission, the presynaptic neuron releases a neurotransmitter that diffuses across the synaptic cleft and binds to specific synaptic receptors. These activated receptors modulate ion channels and/or second-messenger systems to influence the postsynaptic cell. Electrical transmission is less common in the nervous system, and, as in other tissues, is mediated by gap junctions.%A%    
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D009435 2006
% 213.76/213.92  |- skos__related mesh__D001452smesh__D008900
% 213.76/213.92  |- mesh__dateRevised mesh__D001452 2005-06-30
% 213.76/213.92  |- rdf__type mesh__D001452sskos__Concept
% 213.76/213.92  |- mesh__recordOriginator mesh__D001452 NLM
% 213.76/213.92  |- mesh__dateCreated mesh__D001452 1999-01-01
% 213.76/213.92  |- skos__broader mesh__D001452smesh__D013812
% 213.76/213.92  |- mesh__recordMaintainer mesh__D001452 lkt
% 213.76/213.92  |- mesh__recordAuthorizer mesh__D001452 sjn
% 213.76/213.92  |- skos__prefLabel mesh__D001452 Balneology
% 213.76/213.92  |- skos__related mesh__D001452smesh__D006294
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D001452 2006
% 213.76/213.92  |- skos__scopeNote mesh__D001452
% 213.76/213.92       Therapy by various hot or warm baths in natural mineral waters, spas, or %22%cures%22%. It includes not only bathing in, but also drinking the waters, but it does not include whirlpool baths %28%HYDROTHERAPY%29%.%A%    
% 213.76/213.92  |- skos__broader mesh__D001452smesh__D026741
% 213.76/213.92  |- skos__annotation mesh__D001452
% 213.76/213.92       SPEC: SPEC qualif; -ology on BATHS %26% mineral springs, spas %26% %22%cures%22%; includes bathing or drinking MINERAL WATERS; balneotherapy goes here unless specifically an indention under BALNEOLOGY; differentiate from HYDROTHERAPY where emphasis is on plain water %28%not natural mineral water; see note there%29%; DF: BALNEOL%A%  
% 213.76/213.92  |- skos__broader mesh__D013254Q000172smesh__D013254
% 213.76/213.92  |- mesh__preferredCombination mesh__D013254Q000172smesh__D000312
% 213.76/213.92  |- rdf__type mesh__D013254Q000172smesh__CompoundConcept
% 213.76/213.92  |- skos__hiddenLabel mesh__D019863 Cell, Gastrin-Secreting
% 213.76/213.92  |- mesh__historyNote mesh__D019863 2006 %28%1998%29%   
% 213.76/213.92  |- skos__broader mesh__D019863smesh__D005753
% 213.76/213.92  |- rdf__type mesh__D019863sskos__Concept
% 213.76/213.92  |- mesh__dateRevised mesh__D019863 2005-06-30
% 213.76/213.92  |- skos__hiddenLabel mesh__D019863 Cells, Gastrin-Secreting
% 213.76/213.92  |- skos__historyNote mesh__D019863 Pyloric Antrum %28%1972-1997%29%
% 213.76/213.92  |- skos__altLabel mesh__D019863 Gastrin Cells
% 213.76/213.92  |- skos__hiddenLabel mesh__D019863 Gastrin-Secreting Cell
% 213.76/213.92  |- skos__hiddenLabel mesh__D019863 G Cell
% 213.76/213.92  |- mesh__recordOriginator mesh__D019863 AGS
% 213.76/213.92  |- mesh__dateEstablished mesh__D019863 1998-01-01
% 213.76/213.92  |- skos__altLabel mesh__D019863 G Cells
% 213.76/213.92  |- mesh__recordMaintainer mesh__D019863 lkt
% 213.76/213.92  |- skos__hiddenLabel mesh__D019863 Gastrin Cell
% 213.76/213.92  |- mesh__dateCreated mesh__D019863 1997-06-20
% 213.76/213.92  |- mesh__publicMeSHNote mesh__D019863 2006; see G CELLS 1998-2005   
% 213.76/213.92  |- skos__scopeNote mesh__D019863
% 213.76/213.92       Endocrine cells which secrete GASTRIN, a peptide that induces GASTRIC ACID secretion. They are found predominantly in the GASTRIC GLANDS of PYLORIC ANTRUM in the STOMACH, but can also be found in the DUODENUM, nervous and other tissues.%A%    
% 213.76/213.92  |- skos__broader mesh__D019863smesh__D019858
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D019863 2006
% 213.76/213.92  |- skos__historyNote mesh__D019863 Gastric Mucosa %28%1970-1997%29%
% 213.76/213.92  |- skos__hiddenLabel mesh__D019863 Gastrin Secreting Cells
% 213.76/213.92  |- skos__prefLabel mesh__D019863 Gastrin-Secreting Cells
% 213.76/213.92  |- mesh__recordAuthorizer mesh__D019863 sjn
% 213.76/213.92  |- mesh__publicMeSHNote mesh__D011880
% 213.76/213.92       91; was see under RADIOTHERAPY, COMPUTER-ASSISTED 1987-90%A%  
% 213.76/213.92  |- skos__historyNote mesh__D011880 Computer Programs %28%1983-1986%29%
% 213.76/213.92  |- mesh__dateRevised mesh__D011880 1998-06-11
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011880 2003
% 213.76/213.92  |- mesh__historyNote mesh__D011880
% 213.76/213.92       91%28%87%29%; was see under RADIOTHERAPY, COMPUTER-ASSISTED 1987-90%A%  
% 213.76/213.92  |- skos__hiddenLabel mesh__D011880 Calculation, Computer-Assisted Dosimetry
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011880 2001
% 213.76/213.92  |- skos__altLabel mesh__D011880 Computer-Assisted Radiotherapy Planning
% 213.76/213.92  |- rdf__type mesh__D011880sskos__Concept
% 213.76/213.92  |- mesh__dateEstablished mesh__D011880 1991-01-01
% 213.76/213.92  |- skos__prefLabel mesh__D011880 Radiotherapy Planning, Computer-Assisted
% 213.76/213.92  |- skos__hiddenLabel mesh__D011880 Planning, Computer Assisted Radiotherapy
% 213.76/213.92  |- skos__hiddenLabel mesh__D011880
% 213.76/213.92       Calculations, Computer-Assisted Dosimetry
% 213.76/213.92  |- skos__scopeNote mesh__D011880
% 213.76/213.92       Computer-assisted mathematical calculations of beam angles, intensities of radiation, and duration of irradiation in radiotherapy.%A%    
% 213.76/213.92  |- skos__historyNote mesh__D011880 Radiotherapy Dosage %28%1966-1986%29%
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011880 2000
% 213.76/213.92  |- skos__hiddenLabel mesh__D011880 Computer-Assisted Dosimetry Calculations
% 213.76/213.92  |- skos__hiddenLabel mesh__D011880 Computer-Assisted Dosimetry Calculation
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011880 2006
% 213.76/213.92  |- skos__broader mesh__D011880smesh__D013813
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011880 1999
% 213.76/213.92  |- skos__annotation mesh__D011880
% 213.76/213.92       differentiate from RADIOTHERAPY, COMPUTER-ASSISTED in that in planning the emphasis is on theoretical principles of radiother rather than on the patient%A%  
% 213.76/213.92  |- mesh__recordAuthorizer mesh__D011880 SJN
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011880 2005
% 213.76/213.92  |- mesh__recordOriginator mesh__D011880 EC
% 213.76/213.92  |- mesh__dateCreated mesh__D011880 1986-06-17
% 213.76/213.92  |- skos__altLabel mesh__D011880 Planning, Computer-Assisted Radiotherapy
% 213.76/213.92  |- skos__historyNote mesh__D011880 Computers %28%1966-1986%29%
% 213.76/213.92  |- mesh__recordMaintainer mesh__D011880 AGS
% 213.76/213.92  |- skos__hiddenLabel mesh__D011880 Dosimetry Calculation, Computer-Assisted
% 213.76/213.92  |- skos__altLabel mesh__D011880 Dosimetry Calculations, Computer-Assisted
% 213.76/213.92  |- skos__hiddenLabel mesh__D011880
% 213.76/213.92       Dosimetry Calculations, Computer Assisted
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011880 2004
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D011880 2002
% 213.76/213.92  |- skos__hiddenLabel mesh__D011880 Radiotherapy Planning, Computer Assisted
% 213.76/213.92  |- skos__hiddenLabel mesh__D011880 Computer Assisted Radiotherapy Planning
% 213.76/213.92  |- skos__broader mesh__D011880smesh__D011881
% 213.76/213.92  |- skos__related mesh__D011880smesh__D020266
% 213.76/213.92  |- skos__hiddenLabel mesh__D019065 Packagings, Viral
% 213.76/213.92  |- skos__hiddenLabel mesh__D019065 Viral Packagings
% 213.76/213.92  |- skos__hiddenLabel mesh__D019065 Assemblies, Virus
% 213.76/213.92  |- mesh__recordMaintainer mesh__D019065 nns
% 213.76/213.92  |- skos__prefLabel mesh__D019065 Virus Assembly
% 213.76/213.92  |- skos__hiddenLabel mesh__D019065 Virus Assemblies
% 213.76/213.92  |- skos__broader mesh__D019065smesh__D014779
% 213.76/213.92  |- skos__altLabel mesh__D019065 Packaging, Viral
% 213.76/213.92  |- skos__historyNote mesh__D019065 Virus Replication %28%1986-1995%29%
% 213.76/213.92  |- mesh__historyNote mesh__D019065 96   
% 213.76/213.92  |- skos__hiddenLabel mesh__D019065 Assembly, Virus
% 213.76/213.92  |- skos__hiddenLabel mesh__D019065 Virus Packagings
% 213.76/213.92  |- skos__hiddenLabel mesh__D019065 Virus Packaging
% 213.76/213.92  |- mesh__dateEstablished mesh__D019065 1996-01-01
% 213.76/213.92  |- skos__hiddenLabel mesh__D019065 Packagings, Virus
% 213.76/213.92  |- mesh__dateRevised mesh__D019065 2005-06-30
% 213.76/213.92  |- mesh__recordOriginator mesh__D019065 JLS
% 213.76/213.92  |- skos__altLabel mesh__D019065 Viral Packaging
% 213.76/213.92  |- mesh__recordAuthorizer mesh__D019065 sjn
% 213.76/213.92  |- mesh__publicMeSHNote mesh__D019065 96   
% 213.76/213.92  |- rdf__type mesh__D019065sskos__Concept
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D019065 2006
% 213.76/213.92  |- skos__annotation mesh__D019065
% 213.76/213.92       coordinate with specific virus /physiol   
% 213.76/213.92  |- skos__scopeNote mesh__D019065
% 213.76/213.92       The assembly of VIRAL STRUCTURAL PROTEINS and nucleic acid %28%VIRAL DNA or VIRAL RNA%29% to form a VIRUS PARTICLE.%A%    
% 213.76/213.92  |- mesh__dateCreated mesh__D019065 1995-06-05
% 213.76/213.92  |- skos__hiddenLabel mesh__D005843 County
% 213.76/213.92  |- skos__altLabel mesh__D005843 Factors, Geographic
% 213.76/213.92  |- mesh__dateCreated mesh__D005843 1999-01-01
% 213.76/213.92  |- skos__prefLabel mesh__D005843 Geography
% 213.76/213.92  |- skos__hiddenLabel mesh__D005843 Medical Geographies
% 213.76/213.92  |- skos__broader mesh__D005843smesh__D010811
% 213.76/213.92  |- skos__related mesh__D005843smesh__D019371
% 213.76/213.92  |- skos__scopeNote mesh__D005843
% 213.76/213.92       The science dealing with the earth and its life, especially the description of land, sea, and air and the distribution of plant and animal life, including humanity and human industries with reference to the mutual relations of these elements. %28%From Webster, 3d ed%29%%A%    
% 213.76/213.92  |- skos__related mesh__D005843smesh__D008377
% 213.76/213.92  |- skos__hiddenLabel mesh__D005843 Administrative District
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D005843 2006
% 213.76/213.92  |- skos__altLabel mesh__D005843 Geography, Human
% 213.76/213.92  |- skos__altLabel mesh__D005843 Geographic Factor
% 213.76/213.92  |- skos__hiddenLabel mesh__D005843 District, Administrative
% 213.76/213.92  |- skos__hiddenLabel mesh__D005843 Island
% 213.76/213.92  |- skos__annotation mesh__D005843
% 213.76/213.92       for Earth, Moon, etc.; must discuss geog features %28%lakes, streams, shores, mountains, plains, seas, etc.%29%; not for epidemiol aspects of disease nor for occur of diseases in cities named in a country or a country %28% = /epidemiol%29%; no qualif unless as SPEC; for X ref GEOGRAPHY, MEDICAL, do not coord with MEDICINE; TOPOGRAPHY, MEDICAL is also available; DF: GEOGR%A%  
% 213.76/213.92  |- mesh__recordMaintainer mesh__D005843 sjn
% 213.76/213.92  |- skos__altLabel mesh__D005843 Medical Geography
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D005843 2005
% 213.76/213.92  |- skos__hiddenLabel mesh__D005843 Districts, Administrative
% 213.76/213.92  |- rdf__type mesh__D005843sskos__Concept
% 213.76/213.92  |- mesh__recordAuthorizer mesh__D005843 sjn
% 213.76/213.92  |- mesh__dateRevised mesh__D005843 2004-07-13
% 213.76/213.92  |- mesh__recordOriginator mesh__D005843 NLM
% 213.76/213.92  |- skos__hiddenLabel mesh__D005843 Geographies, Medical
% 213.76/213.92  |- skos__altLabel mesh__D005843 Factor, Geographic
% 213.76/213.92  |- mesh__recordOriginator mesh__D005045 SH
% 213.76/213.92  |- mesh__dateRevised mesh__D005045 2005-06-30
% 213.76/213.92  |- skos__prefLabel mesh__D005045 Etomidate
% 213.76/213.92  |- mesh__dateCreated mesh__D005045 1976-04-13
% 213.76/213.92  |- mesh__recordMaintainer mesh__D005045 ssb
% 213.76/213.92  |- rdf__type mesh__D005045sskos__Concept
% 213.76/213.92  |- skos__hiddenLabel mesh__D005045 R26490
% 213.76/213.92  |- skos__broader mesh__D005045smesh__D007093
% 213.76/213.92  |- skos__historyNote mesh__D005045 Imidazoles %28%1969-1976%29%
% 213.76/213.92  |- skos__historyNote mesh__D005045 Benzyl Compounds %28%1969-1975%29%
% 213.76/213.92  |- skos__altLabel mesh__D005045 Ethomidate
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D005045 2006
% 213.76/213.92  |- skos__hiddenLabel mesh__D005045 R 26490
% 213.76/213.92  |- mesh__historyNote mesh__D005045
% 213.76/213.92       86%28%77%29%; was see under IMIDAZOLES 1977-85   
% 213.76/213.92  |- mesh__recordAuthorizer mesh__D005045 sjn
% 213.76/213.92  |- mesh__publicMeSHNote mesh__D005045
% 213.76/213.92       86; was see under IMIDAZOLES 1977-85   
% 213.76/213.92  |- mesh__dateEstablished mesh__D005045 1986-01-01
% 213.76/213.92  |- skos__scopeNote mesh__D005045
% 213.76/213.92       Imidazole derivative anesthetic and hypnotic with little effect on blood gases, ventilation, or the cardiovascular system. It has been proposed as an induction anesthetic.%A%    
% 213.76/213.92  |- mesh__dateCreated mesh__D010788 1999-01-01
% 213.76/213.92  |- skos__prefLabel mesh__D010788 Photosynthesis
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010788 2006
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010788 1999
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010788 2002
% 213.76/213.92  |- skos__broader mesh__D010788smesh__D004734
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010788 2004
% 213.76/213.92  |- mesh__recordAuthorizer mesh__D010788 PLS
% 213.76/213.92  |- mesh__dateRevised mesh__D010788 1994-06-07
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010788 1997
% 213.76/213.92  |- skos__scopeNote mesh__D010788
% 213.76/213.92       The formation of carbohydrates, with release of molecular oxygen, from carbon dioxide and water in the chlorophyll tissue of plants and blue-green algae under the influence of light. In bacteria, photosynthesis uses hydrogen sulfide, molecular hydrogen, and other reduced compounds in place of water, so that molecular oxygen is not released. %28%Dorland, 27th ed.%29%%A%    
% 213.76/213.92  |- skos__broader mesh__D010788smesh__D018521
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010788 2005
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010788 1998
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010788 2003
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010788 1996
% 213.76/213.92  |- rdf__type mesh__D010788sskos__Concept
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010788 2001
% 213.76/213.92  |- skos__broader mesh__D010788smesh__D010777
% 213.76/213.92  |- mesh__activeMeSHYear mesh__D010788 2000
% 213.76/213.92  |- skos__hiddenLabel mesh__D010788 Photosyntheses
% 213.76/213.92  |- mesh__recordOriginator mesh__D010788 NLM
% 213.76/213.93  |- mesh__recordMaintainer mesh__D010788 JLS
% 213.76/213.93  |- skos__annotation mesh__D010788
% 213.76/213.93       in plants, blue-green algae %26% bacteria; DF: PHOTOSYN   
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D010788 1995
% 213.76/213.93  |- skos__altLabel mesh__D015473 Leukemia, Progranulocytic
% 213.76/213.93  |- skos__altLabel mesh__D015473 Myeloid Leukemia, Acute, M3
% 213.76/213.93  |- mesh__recordMaintainer mesh__D015473 KEV
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D015473 2004
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D015473 2002
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D015473 1998
% 213.76/213.93  |- skos__hiddenLabel mesh__D015473 Acute Promyelocytic Leukemia
% 213.76/213.93  |- mesh__recordAuthorizer mesh__D015473 PLS
% 213.76/213.93  |- skos__prefLabel mesh__D015473 Leukemia, Promyelocytic, Acute
% 213.76/213.93  |- mesh__recordOriginator mesh__D015473 PLS
% 213.76/213.93  |- skos__altLabel mesh__D015473 Leukemia, Myeloid, Acute, M3
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D015473 1996
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D015473 1999
% 213.76/213.93  |- rdf__type mesh__D015473sskos__Concept
% 213.76/213.93  |- skos__hiddenLabel mesh__D015473 Leukemias, Progranulocytic
% 213.76/213.93  |- skos__broader mesh__D015473smesh__D015470
% 213.76/213.93  |- skos__historyNote mesh__D015473 Leukemia, Myelocytic %28%1966-1988%29%
% 213.76/213.93  |- mesh__publicMeSHNote mesh__D015473 89   
% 213.76/213.93  |- skos__altLabel mesh__D015473 Progranulocytic Leukemia
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D015473 1997
% 213.76/213.93  |- skos__hiddenLabel mesh__D015473 Promyelocytic Leukemias, Acute
% 213.76/213.93  |- skos__hiddenLabel mesh__D015473 Leukemias, Acute Promyelocytic
% 213.76/213.93  |- skos__hiddenLabel mesh__D015473 Leukemia, Acute Promyelocytic
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D015473 2005
% 213.76/213.93  |- skos__hiddenLabel mesh__D015473 Acute Promyelocytic Leukemias
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D015473 2000
% 213.76/213.93  |- skos__annotation mesh__D015473
% 213.76/213.93       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 213.76/213.93  |- skos__hiddenLabel mesh__D015473 Progranulocytic Leukemias
% 213.76/213.93  |- skos__altLabel mesh__D015473 Promyelocytic Leukemia, Acute
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D015473 2003
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D015473 2006
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D015473 2001
% 213.76/213.93  |- mesh__dateEstablished mesh__D015473 1989-01-01
% 213.76/213.93  |- mesh__dateRevised mesh__D015473 1995-06-08
% 213.76/213.93  |- mesh__historyNote mesh__D015473 89   
% 213.76/213.93  |- mesh__dateCreated mesh__D015473 1988-06-09
% 213.76/213.93  |- skos__historyNote mesh__D015473 Leukemia, Myeloid %28%1966-1988%29%
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D009436 2003
% 213.76/213.93  |- skos__scopeNote mesh__D009436
% 213.76/213.93       Congenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy generally occurring between days 18-29 of gestation. Ectodermal and mesodermal malformations %28%mainly involving the skull and vertebrae%29% may occur as a result of defects of neural tube closure. %28%From Joynt, Clinical Neurology, 1992, Ch55, pp31-41%29%%A%    
% 213.76/213.93  |- skos__hiddenLabel mesh__D009436 Neural Tube Defect
% 213.76/213.93  |- skos__annotation mesh__D009436
% 213.76/213.93       do not confuse X ref MYELODYSPLASIA with MYELODYSPLASTIC SYNDROMES, a defect of bone marrow formation%A%  
% 213.76/213.93  |- skos__hiddenLabel mesh__D009436 Tethered Cord Syndromes
% 213.76/213.93  |- skos__broader mesh__D009436smesh__D009421
% 213.76/213.93  |- skos__hiddenLabel mesh__D009436 Iniencephalies
% 213.76/213.93  |- skos__hiddenLabel mesh__D009436 Craniorachischises
% 213.76/213.93  |- mesh__historyNote mesh__D009436
% 213.76/213.93       1979; for DIASTEMATOMYELIA and TETHERED CORD SYNDROME use SPINA BIFIDA OCCULTA 1991-1999; for NEURENTERIC CYST use SPINA BIFIDA OCCULTA 1991-1999, use NEURAL TUBE DEFECTS 1979-1990%A%  
% 213.76/213.93  |- skos__historyNote mesh__D009436 Central Nervous System %28%1966-1978%29%
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D009436 2004
% 213.76/213.93  |- skos__hiddenLabel mesh__D009436 Cyst, Neuroenteric
% 213.76/213.93  |- skos__altLabel mesh__D009436 Developmental Neural Tube Defects
% 213.76/213.93  |- skos__hiddenLabel mesh__D009436 Neuroenteric Cysts
% 213.76/213.93  |- skos__hiddenLabel mesh__D009436 Exencephalies
% 213.76/213.93  |- skos__historyNote mesh__D009436 Anencephaly %28%1966-1978%29%
% 213.76/213.93  |- skos__hiddenLabel mesh__D009436 Myelodysplasias
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D009436 2005
% 213.76/213.93  |- mesh__recordAuthorizer mesh__D009436 sjn
% 213.76/213.93  |- mesh__recordOriginator mesh__D009436 AEP
% 213.76/213.93  |- mesh__dateEstablished mesh__D009436 1979-01-01
% 213.76/213.93  |- skos__hiddenLabel mesh__D009436 Myelodysplasia, Spinal Cord
% 213.76/213.93  |- mesh__recordMaintainer mesh__D009436 jls
% 213.76/213.93  |- skos__prefLabel mesh__D009436 Neural Tube Defects
% 213.76/213.93  |- skos__hiddenLabel mesh__D009436 Cysts, Neuroenteric
% 213.76/213.93  |- mesh__dateCreated mesh__D009436 1978-05-15
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D009436 2006
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D009436 2001
% 213.76/213.93  |- skos__historyNote mesh__D009436 Spina Bifida %28%1966-1978%29%
% 213.76/213.93  |- skos__altLabel mesh__D009436 Developmental Defects, Neural Tube
% 213.76/213.93  |- skos__hiddenLabel mesh__D009436 Neurenteric Cysts
% 213.76/213.93  |- mesh__publicMeSHNote mesh__D009436
% 213.76/213.93       1979; for DIASTEMATOMYELIA and TETHERED CORD SYNDROME see SPINA BIFIDA OCCULTA 1991-1999; for NEURENTERIC CYST see SPINA BIFIDA OCCULTA 1991-1999, see NEURAL TUBE DEFECTS 1979-1990%A%  
% 213.76/213.93  |- skos__hiddenLabel mesh__D009436 Cyst, Neurenteric
% 213.76/213.93  |- skos__hiddenLabel mesh__D009436 Spinal Cord Myelodysplasias
% 213.76/213.93  |- rdf__type mesh__D009436sskos__Concept
% 213.76/213.93  |- skos__hiddenLabel mesh__D009436 Cysts, Neurenteric
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D009436 2002
% 213.76/213.93  |- mesh__dateRevised mesh__D009436 2000-06-22
% 213.76/213.93  |- skos__hiddenLabel mesh__D009436 Diastematomyelias
% 213.76/213.93  |- skos__hiddenLabel mesh__D009436 Myelodysplasias, Spinal Cord
% 213.76/213.93  |- skos__altLabel mesh__D009436 Neural Tube Developmental Defects
% 213.76/213.93  |- skos__hiddenLabel mesh__D009436 Defect, Neural Tube
% 213.76/213.93  |- skos__hiddenLabel mesh__D009436 Defects, Neural Tube
% 213.76/213.93  |- skos__hiddenLabel mesh__D009436 Acranias
% 213.76/213.93  |- skos__altLabel mesh__D009436 Neuroenteric Cyst
% 213.76/213.93  |- mesh__dateCreated mesh__D001453 1999-01-01
% 213.76/213.93  |- mesh__recordMaintainer mesh__D001453 ssb
% 213.76/213.93  |- mesh__dateRevised mesh__D001453 2005-06-30
% 213.76/213.93  |- mesh__recordOriginator mesh__D001453 NLM
% 213.76/213.93  |- skos__prefLabel mesh__D001453 Balsams
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D001453 2006
% 213.76/213.93  |- mesh__recordAuthorizer mesh__D001453 sjn
% 213.76/213.93  |- skos__broader mesh__D001453smesh__D012116
% 213.76/213.93  |- skos__scopeNote mesh__D001453
% 213.76/213.93       Resinous substances which most commonly originate from trees. In addition to resins, they contain oils, cinnamic acid and BENZOIC ACID.%A%    
% 213.76/213.93  |- rdf__type mesh__D001453sskos__Concept
% 213.76/213.93  |- skos__annotation mesh__D001453 D25-26 qualif   
% 213.76/213.93  |- skos__hiddenLabel mesh__D019864 D Cell
% 213.76/213.93  |- skos__altLabel mesh__D019864 Somatostatin Cells
% 213.76/213.93  |- skos__hiddenLabel mesh__D019864 Somatostatin Cell
% 213.76/213.93  |- rdf__type mesh__D019864sskos__Concept
% 213.76/213.93  |- skos__altLabel mesh__D019864 Gastric D Cells
% 213.76/213.93  |- mesh__recordMaintainer mesh__D019864 ags
% 213.76/213.93  |- skos__broader mesh__D019864smesh__D005753
% 213.76/213.93  |- skos__historyNote mesh__D019864 Pancreas/cytology %28%1968-1989%29%
% 213.76/213.93  |- mesh__publicMeSHNote mesh__D019864
% 213.76/213.93       2006, see D CELLS 1998-2005; for PANCREATIC DELTA CELLS see ISLETS OF LANGERHANS 1991-1997%A%  
% 213.76/213.93  |- skos__broader mesh__D019864smesh__D019858
% 213.76/213.93  |- mesh__dateCreated mesh__D019864 1997-06-20
% 213.76/213.93  |- skos__altLabel mesh__D019864 Pancreatic D Cells
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D019864 2006A
% 213.76/213.93  |- skos__altLabel mesh__D019864 delta Cells
% 213.76/213.93  |- skos__hiddenLabel mesh__D019864 D Cell, Gastric
% 213.76/213.93  |- skos__scopeNote mesh__D019864
% 213.76/213.93       Endocrine cells found throughout the GASTROINTESTINAL TRACT and in islets of the PANCREAS. D cells secrete SOMATOSTATIN that acts in both an endocrine and paracrine manner. Somatostatin acts on a variety of tissues including the PITUITARY GLAND; gastrointestinal tract; pancreas; and KIDNEY by inhibiting the release of hormones, such as GROWTH HORMONE; GASTRIN; INSULIN; and RENIN.%A%    
% 213.76/213.93  |- skos__hiddenLabel mesh__D019864 delta Cells, Gastric
% 213.76/213.93  |- skos__hiddenLabel mesh__D019864 Pancreatic delta Cell
% 213.76/213.93  |- mesh__dateEstablished mesh__D019864 1998-01-01
% 213.76/213.93  |- skos__hiddenLabel mesh__D019864 Gastric D Cell
% 213.76/213.93  |- skos__historyNote mesh__D019864 Gastric Mucosa %28%1976-1997%29%
% 213.76/213.93  |- skos__hiddenLabel mesh__D019864 Gastric delta Cell
% 213.76/213.93  |- skos__hiddenLabel mesh__D019864 D Cells, Gastric
% 213.76/213.93  |- skos__prefLabel mesh__D019864 Somatostatin-Secreting Cells
% 213.76/213.93  |- skos__hiddenLabel mesh__D019864 D Cells, Pancreatic
% 213.76/213.93  |- mesh__recordOriginator mesh__D019864 AGS
% 213.76/213.93  |- skos__hiddenLabel mesh__D019864 delta Cell
% 213.76/213.93  |- mesh__recordAuthorizer mesh__D019864 ags
% 213.76/213.93  |- skos__hiddenLabel mesh__D019864 Pancreatic D Cell
% 213.76/213.93  |- skos__annotation mesh__D019864
% 213.76/213.93       /transpl: if from pancreas, coordinate with ISLETS OF LANGERHANS TRANSPLANTATION%A%  
% 213.76/213.93  |- skos__hiddenLabel mesh__D019864 Somatostatin Secreting Cells
% 213.76/213.93  |- skos__hiddenLabel mesh__D019864 delta Cell, Pancreatic
% 213.76/213.93  |- skos__hiddenLabel mesh__D019864 delta Cell, Gastric
% 213.76/213.93  |- mesh__historyNote mesh__D019864
% 213.76/213.93       2006 %28%1998%29%; for PANCREATIC DELTA CELLS use ISLETS OF LANGERHANS 1991-1997%A%  
% 213.76/213.93  |- skos__broader mesh__D019864smesh__D007515
% 213.76/213.93  |- skos__altLabel mesh__D019864 D Cells
% 213.76/213.93  |- skos__hiddenLabel mesh__D019864 delta Cells, Pancreatic
% 213.76/213.93  |- skos__hiddenLabel mesh__D019864 Somatostatin-Secreting Cell
% 213.76/213.93  |- mesh__dateRevised mesh__D019864 2005-07-27
% 213.76/213.93  |- skos__historyNote mesh__D019864 Islets of Langerhans %28%1966-1997%29%
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D019864 2006
% 213.76/213.93  |- skos__related mesh__D011881smesh__D020266
% 213.76/213.93  |- skos__hiddenLabel mesh__D011881 Therapies, Computer-Assisted Radiation
% 213.76/213.93  |- skos__hiddenLabel mesh__D011881 Radiotherapy, Computer Assisted
% 213.76/213.93  |- skos__hiddenLabel mesh__D011881 Computer Assisted Radiation Therapy
% 213.76/213.93  |- skos__hiddenLabel mesh__D011881 Radiation Therapies, Computer-Assisted
% 213.76/213.93  |- rdf__type mesh__D011881sskos__Concept
% 213.76/213.93  |- mesh__publicMeSHNote mesh__D011881 87   
% 213.76/213.93  |- skos__hiddenLabel mesh__D011881 Computer-Assisted Radiotherapies
% 213.76/213.93  |- mesh__recordMaintainer mesh__D011881 lkt
% 213.76/213.93  |- skos__hiddenLabel mesh__D011881 Radiotherapies, Computer-Assisted
% 213.76/213.93  |- mesh__dateEstablished mesh__D011881 1987-01-01
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D011881 2006
% 213.76/213.93  |- skos__altLabel mesh__D011881 Radiation Therapy, Computer-Assisted
% 213.76/213.93  |- skos__altLabel mesh__D011881 Computer-Assisted Radiation Therapy
% 213.76/213.93  |- skos__broader mesh__D011881smesh__D013813
% 213.76/213.93  |- skos__hiddenLabel mesh__D011881 Therapy, Computer-Assisted Radiation
% 213.76/213.93  |- mesh__dateRevised mesh__D011881 2005-06-30
% 213.76/213.93  |- skos__hiddenLabel mesh__D011881 Radiation Therapy, Computer Assisted
% 213.76/213.93  |- skos__hiddenLabel mesh__D011881 Computer Assisted Radiotherapy
% 213.76/213.93  |- skos__altLabel mesh__D011881 Computer-Assisted Radiotherapy
% 213.76/213.93  |- skos__hiddenLabel mesh__D011881 Computer-Assisted Radiation Therapies
% 213.76/213.93  |- mesh__historyNote mesh__D011881 87   
% 213.76/213.93  |- skos__prefLabel mesh__D011881 Radiotherapy, Computer-Assisted
% 213.76/213.93  |- skos__broader mesh__D011881smesh__D011878
% 213.76/213.93  |- mesh__dateCreated mesh__D011881 1986-06-17
% 213.76/213.93  |- mesh__recordAuthorizer mesh__D011881 sjn
% 213.76/213.93  |- mesh__recordOriginator mesh__D011881 EC
% 213.76/213.93  |- skos__scopeNote mesh__D011881
% 213.76/213.93       Computer systems or programs used in accurate computations for providing radiation dosage treatment to patients.%A%    
% 213.76/213.93  |- skos__annotation mesh__D011881
% 213.76/213.93       RADIOTHERAPY PLANNING, COMPUTER-ASSISTED is also available: see note there%A%  
% 213.76/213.93  |- skos__annotation mesh__D019066
% 213.76/213.93       do not confuse with FACIAL EXPRESSION, a psychol response; coord IM with assoc dis %28%IM%29%%A%  
% 213.76/213.93  |- mesh__publicMeSHNote mesh__D019066
% 213.76/213.93       96; was see under FACIAL EXPRESSION 1963-73   
% 213.76/213.93  |- skos__prefLabel mesh__D019066 Facies
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D019066 2005
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D019066 2004
% 213.76/213.93  |- mesh__dateCreated mesh__D019066 1995-05-26
% 213.76/213.93  |- mesh__onlineNote mesh__D019066
% 213.76/213.93       use FACIAL EXPRESSION to search FACIES 1966-73   
% 213.76/213.93  |- mesh__dateRevised mesh__D019066 2003-07-09
% 213.76/213.93  |- mesh__recordMaintainer mesh__D019066 nns
% 213.76/213.93  |- rdf__type mesh__D019066sskos__Concept
% 213.76/213.93  |- skos__scopeNote mesh__D019066
% 213.76/213.93       The appearance of the face that is often characteristic of a disease or pathological condition, as the elfin facies of WILLIAMS SYNDROME or the mongoloid facies of DOWN SYNDROME. %28%Random House Unabridged Dictionary, 2d ed%29%%A%    
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D019066 2006
% 213.76/213.93  |- mesh__recordOriginator mesh__D019066 TGC
% 213.76/213.93  |- mesh__dateEstablished mesh__D019066 1996-01-01
% 213.76/213.93  |- mesh__recordAuthorizer mesh__D019066 sjn
% 213.76/213.93  |- skos__broader mesh__D019066smesh__D010808
% 213.76/213.93  |- mesh__historyNote mesh__D019066
% 213.76/213.93       96; was see under FACIAL EXPRESSION 1963-73   
% 213.76/213.93  |- skos__broader mesh__D019066smesh__D020969
% 213.76/213.93  |- mesh__dateEstablished mesh__D011083 1974-01-01
% 213.76/213.93  |- mesh__recordAuthorizer mesh__D011083 sjn
% 213.76/213.93  |- mesh__recordOriginator mesh__D011083 NLM
% 213.76/213.93  |- skos__hiddenLabel mesh__D011083 Compounds, Polycyclic
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D011083 2005
% 213.76/213.93  |- mesh__dateCreated mesh__D011083 1999-01-01
% 213.76/213.93  |- mesh__dateRevised mesh__D011083 2004-07-07
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D011083 2006
% 213.76/213.93  |- skos__altLabel mesh__D011083 Hydrocarbons, Polycyclic
% 213.76/213.93  |- mesh__recordMaintainer mesh__D011083 ssb
% 213.76/213.93  |- mesh__historyNote mesh__D011083
% 213.76/213.93       2005%28%1974%29%; POLYCYCLIC COMPOUNDS was heading 1966-1995; POLYCYCLIC HYDROCARBONS was heading 1966-1995%A%  
% 213.76/213.93  |- rdf__type mesh__D011083sskos__Concept
% 213.76/213.93  |- mesh__publicMeSHNote mesh__D011083
% 213.76/213.93       2005%28%1974%29%; POLYCYCLIC COMPOUNDS was heading 1966-1995; POLYCYCLIC HYDROCARBONS was heading 1966-1995%A%  
% 213.76/213.93  |- skos__prefLabel mesh__D011083 Polycyclic Compounds
% 213.76/213.93  |- skos__scopeNote mesh__D011083
% 213.76/213.93       Compounds consisting of two or more fused ring structures.%A%    
% 213.76/213.93  |- mesh__runningHead mesh__D011083 D4 - POLYCYCLIC COMPOUNDS   
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D005844 2003
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D005844 1997
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D005844 2000
% 213.76/213.93  |- mesh__dateRevised mesh__D005844 1993-06-04
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D005844 2006
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D005844 1996
% 213.76/213.93  |- mesh__recordOriginator mesh__D005844 NLM
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D005844 2005
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D005844 1999
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D005844 2002
% 213.76/213.93  |- rdf__type mesh__D005844sskos__Concept
% 213.76/213.93  |- skos__annotation mesh__D005844 for Earth, Moon, etc.; DF: GEOL   
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D005844 1995
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D005844 1998
% 213.76/213.93  |- skos__broader mesh__D005844smesh__D010811
% 213.76/213.93  |- mesh__recordAuthorizer mesh__D005844 PLS
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D005844 1994
% 213.76/213.93  |- mesh__dateCreated mesh__D005844 1999-01-01
% 213.76/213.93  |- mesh__recordMaintainer mesh__D005844 JLS
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D005844 2004
% 213.76/213.93  |- skos__prefLabel mesh__D005844 Geology
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D005844 2001
% 213.76/213.93  |- skos__broader mesh__D043963smesh__D003108
% 213.76/213.93  |- mesh__dateCreated mesh__D043963 2003-07-09
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D043963 2004
% 213.76/213.93  |- skos__annotation mesh__D043963
% 213.76/213.93       do not confuse with DIVERTICULITIS, COLONIC   
% 213.76/213.93  |- mesh__historyNote mesh__D043963
% 213.76/213.93       2004, 1963-2000; use DIVERTICULUM, COLON 2001-2003   
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D043963 2006
% 213.76/213.93  |- mesh__dateEstablished mesh__D043963 2004-01-01
% 213.76/213.93  |- skos__historyNote mesh__D043963 Diverticulum, Colon %28%1965-2003%29%
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D043963 2005
% 213.76/213.93  |- skos__prefLabel mesh__D043963 Diverticulosis, Colonic
% 213.76/213.93  |- skos__altLabel mesh__D043963 Colonic Diverticulosis
% 213.76/213.93  |- mesh__publicMeSHNote mesh__D043963
% 213.76/213.93       2004, 1963-2000; see DIVERTICULUM, COLON 2001-2003   
% 213.76/213.93  |- skos__scopeNote mesh__D043963
% 213.76/213.93       A pathological condition characterized by the presence of a number of COLONIC DIVERTICULA in the COLON. Its pathogenesis is multifactorial, including colon aging, motor dysfunction, increases in intraluminal pressure, and lack of dietary fibers.%A%    
% 213.76/213.93  |- rdf__type mesh__D043963sskos__Concept
% 213.76/213.93  |- skos__hiddenLabel mesh__D010789 Therapies, Photoradiation
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D010789 2006
% 213.76/213.93  |- skos__hiddenLabel mesh__D010789 Photoradiation Therapies
% 213.76/213.93  |- mesh__dateCreated mesh__D010789 1980-04-09
% 213.76/213.93  |- mesh__onlineNote mesh__D010789
% 213.76/213.93       to search LIGHT/TU use PHOTOTHERAPY 1966-80 %28%with no qualif%29%%A%  
% 213.76/213.93  |- mesh__dateEstablished mesh__D010789 1981-01-01
% 213.76/213.93  |- skos__historyNote mesh__D010789 Light/therapeutic use %28%1967-1980%29%
% 213.76/213.93  |- skos__altLabel mesh__D010789 Therapy, Photoradiation
% 213.76/213.93  |- mesh__dateRevised mesh__D010789 2005-07-25
% 213.76/213.93  |- skos__hiddenLabel mesh__D010789 Phototherapies
% 213.76/213.93  |- skos__historyNote mesh__D010789
% 213.76/213.93       Jaundice, Neonatal/therapy %28%1966-1980%29%
% 213.76/213.93  |- mesh__recordMaintainer mesh__D010789 ags
% 213.76/213.93  |- rdf__type mesh__D010789sskos__Concept
% 213.76/213.93  |- mesh__historyNote mesh__D010789 81; was LIGHT/therapeutic use 1966-80   
% 213.76/213.93  |- skos__annotation mesh__D010789
% 213.76/213.93       coord disease with /ther, not /radiother; PHOTOCHEMOTHERAPY; COLOR THERAPY; %26% ULTRAVIOLET THERAPY are also available%A%  
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D010789 2006A
% 213.76/213.93  |- skos__scopeNote mesh__D010789
% 213.76/213.93       Treatment of disease by exposure to light, especially by variously concentrated light rays or specific wavelengths.%A%    
% 213.76/213.93  |- skos__hiddenLabel mesh__D010789 Therapies, Light
% 213.76/213.93  |- mesh__recordOriginator mesh__D010789 RC
% 213.76/213.93  |- skos__broader mesh__D010789smesh__D013812
% 213.76/213.93  |- skos__altLabel mesh__D010789 Light Therapy
% 213.76/213.93  |- skos__hiddenLabel mesh__D010789 Light Therapies
% 213.76/213.93  |- mesh__publicMeSHNote mesh__D010789
% 213.76/213.93       81; was LIGHT/therapeutic use 1966-80; HELIOTHERAPY was see under PHYSICAL THERAPY 1975-85 %26% SUNLIGHT 1963-74%A%  
% 213.76/213.93  |- mesh__recordAuthorizer mesh__D010789 ags
% 213.76/213.93  |- skos__hiddenLabel mesh__D010789 Therapy, Light
% 213.76/213.93  |- skos__altLabel mesh__D010789 Photoradiation Therapy
% 213.76/213.93  |- skos__prefLabel mesh__D010789 Phototherapy
% 213.76/213.93  |- skos__broader mesh__D043165smesh__D042501
% 213.76/213.93  |- mesh__publicMeSHNote mesh__D043165 2004   
% 213.76/213.93  |- mesh__dateRevised mesh__D043165 2005-06-30
% 213.76/213.93  |- mesh__recordAuthorizer mesh__D043165 sjn
% 213.76/213.93  |- mesh__dateEstablished mesh__D043165 2004-01-01
% 213.76/213.93  |- skos__prefLabel mesh__D043165 Angiostatic Proteins
% 213.76/213.93  |- mesh__dateCreated mesh__D043165 2003-07-09
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D043165 2006
% 213.76/213.93  |- skos__scopeNote mesh__D043165
% 213.76/213.93       Proteins that specifically inhibit the growth of new blood vessels %28%ANGIOGENESIS, PHYSIOLOGIC%29%.%A%    
% 213.76/213.93  |- mesh__recordMaintainer mesh__D043165 ssb
% 213.76/213.93  |- mesh__historyNote mesh__D043165 2004   
% 213.76/213.93  |- rdf__type mesh__D043165sskos__Concept
% 213.76/213.93  |- mesh__recordOriginator mesh__D043165 jmp
% 213.76/213.93  |- mesh__historyNote mesh__D015474 89   
% 213.76/213.93  |- mesh__dateCreated mesh__D015474 1988-06-09
% 213.76/213.93  |- rdf__type mesh__D015474sskos__Concept
% 213.76/213.93  |- skos__historyNote mesh__D015474 Dermatologic Agents %28%1975-1988%29%
% 213.76/213.93  |- mesh__recordOriginator mesh__D015474 RLS
% 213.76/213.93  |- mesh__publicMeSHNote mesh__D015474 89   
% 213.76/213.93  |- skos__hiddenLabel mesh__D015474 13 cis Retinoic Acid
% 213.76/213.93  |- skos__scopeNote mesh__D015474
% 213.76/213.93       A topical dermatologic agent that is used in the treatment of acne vulgaris and several other skin diseases. The drug has teratogenic and other adverse effects.%A%    
% 213.76/213.93  |- skos__broader mesh__D015474smesh__D012176
% 213.76/213.93  |- skos__hiddenLabel mesh__D015474 Ro 43780
% 213.76/213.93  |- skos__hiddenLabel mesh__D015474 Isotretinoin Zinc Salt, 13 cis Isomer
% 213.76/213.93  |- mesh__dateRevised mesh__D015474 2005-06-30
% 213.76/213.93  |- skos__historyNote mesh__D015474 Keratolytic Agents %28%1975-1988%29%
% 213.76/213.93  |- skos__hiddenLabel mesh__D015474 Ro 4 3780
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D015474 2006
% 213.76/213.93  |- mesh__dateEstablished mesh__D015474 1989-01-01
% 213.76/213.93  |- mesh__recordAuthorizer mesh__D015474 sjn
% 213.76/213.93  |- skos__altLabel mesh__D015474 13-cis-Retinoic Acid
% 213.76/213.93  |- mesh__recordMaintainer mesh__D015474 ssb
% 213.76/213.93  |- skos__historyNote mesh__D015474 Tretinoin %28%1975-1988%29%
% 213.76/213.93  |- skos__prefLabel mesh__D015474 Isotretinoin
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Paroxysmal Nerve Pains
% 213.76/213.93  |- skos__broader mesh__D009437smesh__D010146
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Neurodynias
% 213.76/213.93  |- skos__annotation mesh__D009437
% 213.76/213.93       coord IM with specific nerve %28%IM%29% if pertinent   
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Nerve Pains
% 213.76/213.93  |- skos__altLabel mesh__D009437 Neurodynia
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Stump Neuralgia
% 213.76/213.93  |- mesh__dateRevised mesh__D009437 1999-11-08
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D009437 2004
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Neuralgias, Iliohypogastric Nerve
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Neuralgias, Stump
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D009437 2005
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Perineal Neuralgias
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Atypical Neuralgias
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Ilioinguinal Neuralgia
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Neuralgias, Vidian
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Nerve Pains, Paroxysmal
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Pains, Paroxysmal Nerve
% 213.76/213.93  |- mesh__recordAuthorizer mesh__D009437 sjn
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Iliohypogastric Nerve Neuralgia
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D009437 2000
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Nerve Pain, Paroxysmal
% 213.76/213.93  |- skos__scopeNote mesh__D009437
% 213.76/213.93       Intense or aching pain that occurs along the course or distribution of a peripheral or cranial nerve.%A%    
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D009437 2006
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Vidian Neuralgia
% 213.76/213.93  |- mesh__dateCreated mesh__D009437 1999-01-01
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Pain, Nerve
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Neuralgias, Perineal
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Pains, Nerve
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Supraorbital Neuralgias
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Atypical Neuralgia
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Neuralgias, Supraorbital
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D009437 2001
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Nerve Neuralgias, Iliohypogastric
% 213.76/213.93  |- rdf__type mesh__D009437sskos__Concept
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Stump Neuralgias
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Vidian Neuralgias
% 213.76/213.93  |- mesh__recordMaintainer mesh__D009437 KEV
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Neuralgias
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Perineal Neuralgia
% 213.76/213.93  |- skos__broader mesh__D009437smesh__D010523
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Pain, Paroxysmal Nerve
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D009437 2002
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Supraorbital Neuralgia
% 213.76/213.93  |- mesh__recordOriginator mesh__D009437 NLM
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Ilioinguinal Neuralgias
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Neuralgias, Ilioinguinal
% 213.76/213.93  |- skos__prefLabel mesh__D009437 Neuralgia
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Iliohypogastric Nerve Neuralgias
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Nerve Neuralgia, Iliohypogastric
% 213.76/213.93  |- skos__hiddenLabel mesh__D009437 Neuralgias, Atypical
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D009437 2003
% 213.76/213.93  |- mesh__dateEstablished mesh__D001454 1975-01-01
% 213.76/213.93  |- skos__annotation mesh__D001454
% 213.76/213.93       = ESTONIA; LATVIA %26% LITHUANIA collectively   
% 213.76/213.93  |- mesh__recordAuthorizer mesh__D001454 sjn
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D001454 2004
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D001454 2002
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D001454 2005
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D001454 2006
% 213.76/213.93  |- skos__prefLabel mesh__D001454 Baltic States
% 213.76/213.93  |- skos__broader mesh__D001454smesh__D005061
% 213.76/213.93  |- skos__broader mesh__D001454smesh__D014586
% 213.76/213.93  |- mesh__dateCreated mesh__D001454 1999-01-01
% 213.76/213.93  |- mesh__historyNote mesh__D001454 75   
% 213.76/213.93  |- skos__scopeNote mesh__D001454
% 213.76/213.93       The collective name for the republics of ESTONIA; LATVIA; and LITHUANIA on the eastern shore of the Baltic Sea. %28%Webster%27%s New Geographical Dictionary, 1988, p111%29%%A%    
% 213.76/213.93  |- mesh__recordMaintainer mesh__D001454 mdb
% 213.76/213.93  |- mesh__recordOriginator mesh__D001454 NLM
% 213.76/213.93  |- mesh__dateRevised mesh__D001454 2001-07-25
% 213.76/213.93  |- rdf__type mesh__D001454sskos__Concept
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D001454 2003
% 213.76/213.93  |- mesh__historyNote mesh__D011882 64   
% 213.76/213.93  |- mesh__recordAuthorizer mesh__D011882 sjn
% 213.76/213.93  |- skos__annotation mesh__D011882 ionizing only   
% 213.76/213.93  |- mesh__publicMeSHNote mesh__D011882 64   
% 213.76/213.93  |- skos__scopeNote mesh__D011882
% 213.76/213.93       Radiotherapy using high-energy %28%megavolt or higher%29% ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles %28%helium ions%29% and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons %28%pions%29%, produced as secondary particles following bombardment of a target with a primary particle.%A%    
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D011882 2006
% 213.76/213.93  |- mesh__recordOriginator mesh__D011882 NLM
% 213.76/213.93  |- skos__altLabel mesh__D011882 Megavolt Radiotherapy
% 213.76/213.93  |- skos__hiddenLabel mesh__D011882 High Energy Radiotherapy
% 213.76/213.93  |- skos__altLabel mesh__D011882 High-Energy Radiotherapy
% 213.76/213.93  |- mesh__recordMaintainer mesh__D011882 lkt
% 213.76/213.93  |- mesh__dateEstablished mesh__D011882 1964-01-01
% 213.76/213.93  |- skos__prefLabel mesh__D011882 Radiotherapy, High-Energy
% 213.76/213.93  |- mesh__dateRevised mesh__D011882 2005-06-30
% 213.76/213.93  |- skos__hiddenLabel mesh__D011882 Radiotherapy, High Energy
% 213.76/213.93  |- skos__broader mesh__D011882smesh__D011878
% 213.76/213.93  |- mesh__dateCreated mesh__D011882 1999-01-01
% 213.76/213.93  |- rdf__type mesh__D011882sskos__Concept
% 213.76/213.93  |- skos__broader mesh__D009222Q000151smesh__D009222
% 213.76/213.93  |- mesh__preferredCombination mesh__D009222Q000151smesh__D009224
% 213.76/213.93  |- rdf__type mesh__D009222Q000151smesh__CompoundConcept
% 213.76/213.93  |- rdf__type mesh__D019067sskos__Concept
% 213.76/213.93  |- mesh__activeMeSHYear mesh__D019067 2006
% 213.76/213.93  |- skos__scopeNote mesh__D019067
% 213.76/213.93       Enhancement of viral infectivity caused by non-neutralizing antibodies. There are at least two mechanisms known to account for this: mediation by Fc receptors %28%RECEPTORS, FC%29% or by complement receptors %28%RECEPTORS, COMPLEMENT%29%. Either the virus is complexed with antiviral IMMUNOGLOBULIN G and binds to Fc receptors, or virus is coated with antiviral IMMUNOGLOBULIN M and binds to complement receptors.%A%    
% 213.76/213.93  |- mesh__recordAuthorizer mesh__D019067 sjn
% 213.76/213.94  |- mesh__dateRevised mesh__D019067 2001-08-07
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D019067 2002
% 213.76/213.94  |- mesh__publicMeSHNote mesh__D019067 96   
% 213.76/213.94  |- skos__prefLabel mesh__D019067 Antibody-Dependent Enhancement
% 213.76/213.94  |- skos__hiddenLabel mesh__D019067 Antibody-Dependent Enhancements
% 213.76/213.94  |- mesh__recordOriginator mesh__D019067 AGS
% 213.76/213.94  |- skos__broader mesh__D019067smesh__D007109
% 213.76/213.94  |- skos__broader mesh__D019067smesh__D018406
% 213.76/213.94  |- mesh__historyNote mesh__D019067 96   
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D019067 2003
% 213.76/213.94  |- mesh__recordMaintainer mesh__D019067 sjn
% 213.76/213.94  |- skos__hiddenLabel mesh__D019067 Enhancement, Antibody-Dependent
% 213.76/213.94  |- skos__annotation mesh__D019067
% 213.76/213.94       enhancement of viral infectivity: read MeSH definition   
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D019067 2004
% 213.76/213.94  |- mesh__dateCreated mesh__D019067 1995-05-26
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D019067 2005
% 213.76/213.94  |- mesh__dateEstablished mesh__D019067 1996-01-01
% 213.76/213.94  |- skos__hiddenLabel mesh__D019067 Antibody Dependent Enhancement
% 213.76/213.94  |- mesh__onlineNote mesh__D011084
% 213.76/213.94       use POLYCYCLIC HYDROCARBONS to search POLYNUCLEAR AROMATIC HYDROCARBONS 1975-95%A%  
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D011084 2001
% 213.76/213.94  |- mesh__recordMaintainer mesh__D011084 adp
% 213.76/213.94  |- mesh__dateEstablished mesh__D011084 1996-01-01
% 213.76/213.94  |- mesh__dateRevised mesh__D011084 2000-06-21
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D011084 2005
% 213.76/213.94  |- skos__prefLabel mesh__D011084 Polycyclic Hydrocarbons, Aromatic
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D011084 2002
% 213.76/213.94  |- skos__hiddenLabel mesh__D011084 Hydrocarbons, Polycyclic Aromatic
% 213.76/213.94  |- mesh__historyNote mesh__D011084
% 213.76/213.94       96; was NON MESH 1974-95; POLYNUCLEAR AROMATIC HYDROCARBONS was see POLYCYCLIC HYDROCARBONS 1975-95%A%  
% 213.76/213.94  |- skos__hiddenLabel mesh__D011084 Aromatic Hydrocarbons, Polycyclic
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D011084 2003
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D011084 2006
% 213.76/213.94  |- skos__broader mesh__D011084smesh__D011083
% 213.76/213.94  |- mesh__recordOriginator mesh__D011084 NLM
% 213.76/213.94  |- mesh__dateCreated mesh__D011084 1999-01-01
% 213.76/213.94  |- skos__scopeNote mesh__D011084
% 213.76/213.94       A major group of unsaturated cyclic hydrocarbons containing two or more rings. The vast number of compounds of this important group, derived chiefly from petroleum and coal tar, are rather highly reactive and chemically versatile. The name is due to the strong and not unpleasant odor characteristic of most substances of this nature. %28%From Hawley%27%s Condensed Chemical Dictionary, 12th ed, p96%29%%A%    
% 213.76/213.94  |- mesh__recordAuthorizer mesh__D011084 sjn
% 213.76/213.94  |- skos__hiddenLabel mesh__D011084 Aromatic Hydrocarbons, Polynuclear
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D011084 2004
% 213.76/213.94  |- mesh__publicMeSHNote mesh__D011084
% 213.76/213.94       96; POLYNUCLEAR AROMATIC HYDROCARBONS was see POLYCYCLIC HYDROCARBONS 1975-95%A%  
% 213.76/213.94  |- skos__hiddenLabel mesh__D011084 Aromatic Polycyclic Hydrocarbons
% 213.76/213.94  |- rdf__type mesh__D011084sskos__Concept
% 213.76/213.94  |- skos__hiddenLabel mesh__D011084 Hydrocarbons, Polynuclear Aromatic
% 213.76/213.94  |- skos__altLabel mesh__D011084 Polycyclic Aromatic Hydrocarbons
% 213.76/213.94  |- skos__altLabel mesh__D011084 Polynuclear Aromatic Hydrocarbons
% 213.76/213.94  |- skos__hiddenLabel mesh__D011084 Hydrocarbons, Aromatic Polycyclic
% 213.76/213.94  |- mesh__recordAuthorizer mesh__D005845 SJN
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005845 2003
% 213.76/213.94  |- mesh__recordOriginator mesh__D005845 NLM
% 213.76/213.94  |- mesh__recordMaintainer mesh__D005845 PXP
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005845 2006
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005845 1999
% 213.76/213.94  |- mesh__dateRevised mesh__D005845 1997-06-20
% 213.76/213.94  |- rdf__type mesh__D005845sskos__Concept
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005845 2002
% 213.76/213.94  |- skos__prefLabel mesh__D005845 Georgia
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005845 2005
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005845 1998
% 213.76/213.94  |- skos__annotation mesh__D005845
% 213.76/213.94       U.S. only; do not confuse with GEORGIA %28%REPUBLIC%29% in the former Soviet Union%A%  
% 213.76/213.94  |- mesh__dateCreated mesh__D005845 1999-01-01
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005845 2001
% 213.76/213.94  |- skos__broader mesh__D005845smesh__D015144
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005845 2004
% 213.76/213.94  |- skos__broader mesh__D005845smesh__D001061
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005845 2000
% 213.76/213.94  |- rdf__type mesh__D038221sskos__Concept
% 213.76/213.94  |- mesh__recordOriginator mesh__D038221 jmp
% 213.76/213.94  |- mesh__dateEstablished mesh__D038221 2003-01-01
% 213.76/213.94  |- skos__altLabel mesh__D038221 Crystallins, epsilon
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D038221 2006
% 213.76/213.94  |- mesh__recordMaintainer mesh__D038221 ags
% 213.76/213.94  |- skos__broader mesh__D038221smesh__D003459
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D038221 2006A
% 213.76/213.94  |- skos__historyNote mesh__D038221 Crystallins %28%1982-2002%29%
% 213.76/213.94  |- skos__hiddenLabel mesh__D038221 epsilon Crystallin
% 213.76/213.94  |- skos__hiddenLabel mesh__D038221 epsilon Crystallins
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D038221 2006B
% 213.76/213.94  |- mesh__dateRevised mesh__D038221 2005-07-18
% 213.76/213.94  |- mesh__dateCreated mesh__D038221 2002-07-03
% 213.76/213.94  |- skos__broader mesh__D038221smesh__D045022
% 213.76/213.94  |- mesh__publicMeSHNote mesh__D038221
% 213.76/213.94       2003; for EPSILON-CRYSTALLIN see CRYSTALLIN 1988-2002   
% 213.76/213.94  |- mesh__historyNote mesh__D038221
% 213.76/213.94       2003; for EPSILON-CRYSTALLIN use CRYSTALLIN 1988-2002   
% 213.76/213.94  |- skos__scopeNote mesh__D038221
% 213.76/213.94       A group of crystallins that have been found in the lens %28%LENS, CRYSTALLINE%29% of DUCKS and CROCODILES. They are inactivated forms of the B chain subunit of lactate dehydrogenase.%A%    
% 213.76/213.94  |- skos__prefLabel mesh__D038221 epsilon-Crystallins
% 213.76/213.94  |- skos__altLabel mesh__D038221 epsilon-Crystallin
% 213.76/213.94  |- mesh__recordAuthorizer mesh__D038221 ags
% 213.76/213.94  |- skos__hiddenLabel mesh__D005047 V%C3%%A9%p%C3%%A9%side Sandoz
% 213.76/213.94  |- skos__prefLabel mesh__D005047 Etoposide
% 213.76/213.94  |- skos__hiddenLabel mesh__D005047 NSC 141540
% 213.76/213.94  |- mesh__historyNote mesh__D005047
% 213.76/213.94       87%28%81%29%; was see under PODOPHYLLOTOXIN 1981-86; was VP 16-213 see under PODOPHYLLOTOXIN 1976-80%A%  
% 213.76/213.94  |- skos__altLabel mesh__D005047 Pierre Fabre Brand of Etoposide
% 213.76/213.94  |- skos__hiddenLabel mesh__D005047 alpha-D-Glucopyranosyl Isomer Etoposide
% 213.76/213.94  |- skos__hiddenLabel mesh__D005047 VP 16 213
% 213.76/213.94  |- skos__altLabel mesh__D005047 Pharmacia Brand of Etoposide
% 213.76/213.94  |- skos__hiddenLabel mesh__D005047 VP16
% 213.76/213.94  |- skos__altLabel mesh__D005047 Tedec Meiji Brand of Etoposide
% 213.76/213.94  |- skos__altLabel mesh__D005047
% 213.76/213.94       Demethyl Epipodophyllotoxin Ethylidine Glucoside
% 213.76/213.94  |- skos__hiddenLabel mesh__D005047 Bristol Myers Squibb Brand of Etoposide
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005047 2006
% 213.76/213.94  |- mesh__dateCreated mesh__D005047 1975-07-25
% 213.76/213.94  |- skos__altLabel mesh__D005047 Eposide
% 213.76/213.94  |- skos__altLabel mesh__D005047 Bristol-Myers Squibb Brand of Etoposide
% 213.76/213.94  |- skos__hiddenLabel mesh__D005047 Etoposide, alpha D Glucopyranosyl Isomer
% 213.76/213.94  |- skos__altLabel mesh__D005047 Teva Brand of Etoposide
% 213.76/213.94  |- skos__hiddenLabel mesh__D005047 VP 16
% 213.76/213.94  |- mesh__onlineNote mesh__D005047
% 213.76/213.94       use ETOPOSIDE to search VP 16-213 1976-80   
% 213.76/213.94  |- skos__altLabel mesh__D005047 ribosepharm Brand of Etoposide
% 213.76/213.94  |- skos__altLabel mesh__D005047 Pharmachemie Brand of Etoposide
% 213.76/213.94  |- rdf__type mesh__D005047sskos__Concept
% 213.76/213.94  |- skos__hiddenLabel mesh__D005047 Bristol Myers Brand of Etoposide
% 213.76/213.94  |- skos__hiddenLabel mesh__D005047 Eto GRY
% 213.76/213.94  |- skos__altLabel mesh__D005047 Baxter Brand of Etoposide
% 213.76/213.94  |- skos__hiddenLabel mesh__D005047 VP 16213
% 213.76/213.94  |- skos__broader mesh__D005047smesh__D005960
% 213.76/213.94  |- mesh__recordOriginator mesh__D005047 SH
% 213.76/213.94  |- mesh__dateRevised mesh__D005047 2005-06-30
% 213.76/213.94  |- skos__altLabel mesh__D005047 Medac Brand of Etoposide
% 213.76/213.94  |- skos__altLabel mesh__D005047 Onkoworks Brand of Etoposide
% 213.76/213.94  |- mesh__recordAuthorizer mesh__D005047 sjn
% 213.76/213.94  |- skos__altLabel mesh__D005047 Bristol-Myers Brand of Etoposide
% 213.76/213.94  |- mesh__recordMaintainer mesh__D005047 CCR
% 213.76/213.94  |- skos__historyNote mesh__D005047
% 213.76/213.94       Podophyllotoxin %28%1973-1974%29%/analogs %26% derivatives %28%1975%29%
% 213.76/213.94  |- mesh__publicMeSHNote mesh__D005047
% 213.76/213.94       87; was see under PODOPHYLLOTOXIN 1981-86; was VP 16-213 see under PODOPHYLLOTOXIN 1976-80%A%  
% 213.76/213.94  |- skos__historyNote mesh__D005047 Glucosides %28%1975%29%
% 213.76/213.94  |- skos__altLabel mesh__D005047 Etomedac
% 213.76/213.94  |- skos__altLabel mesh__D005047 Novartis Brand of Etoposide
% 213.76/213.94  |- skos__historyNote mesh__D005047 Glycosides %28%1973-1974%29%
% 213.76/213.94  |- skos__altLabel mesh__D005047 Lemery Brand of Etoposide
% 213.76/213.94  |- mesh__dateEstablished mesh__D005047 1987-01-01
% 213.76/213.94  |- skos__altLabel mesh__D005047 Sanfer Brand of Etoposide
% 213.76/213.94  |- skos__altLabel mesh__D005047 Eto CS
% 213.76/213.94  |- skos__hiddenLabel mesh__D005047 NSC141540
% 213.76/213.94  |- skos__altLabel mesh__D005047 Ferrer Brand of Etoposide
% 213.76/213.94  |- skos__scopeNote mesh__D005047
% 213.76/213.94       A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle.%A%    
% 213.76/213.94  |- skos__broader mesh__D005047smesh__D011034
% 213.76/213.94  |- skos__altLabel mesh__D005047 Baxter Oncology Brand of Etoposide
% 213.76/213.94  |- skos__altLabel mesh__D005047 Gry Brand of Etoposide
% 213.76/213.94  |- skos__altLabel mesh__D005047 Prasfarma Brand of Etoposide
% 213.76/213.94  |- mesh__recordAuthorizer mesh__D024201 sjn
% 213.76/213.94  |- skos__hiddenLabel mesh__D024201 Bystander Effects
% 213.76/213.94  |- skos__scopeNote mesh__D024201
% 213.76/213.94       The result of a positive or negative response %28%to drugs, for example%29% in one cell being passed onto other cells via the GAP JUNCTIONS or the intracellular milieu.%A%    
% 213.76/213.94  |- mesh__dateCreated mesh__D024201 2001-07-25
% 213.76/213.94  |- rdf__type mesh__D024201sskos__Concept
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D024201 2006
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D024201 2005
% 213.76/213.94  |- mesh__historyNote mesh__D024201 2002   
% 213.76/213.94  |- skos__hiddenLabel mesh__D024201 Effect, Bystander
% 213.76/213.94  |- skos__hiddenLabel mesh__D024201 Suppression, Bystander
% 213.76/213.94  |- skos__hiddenLabel mesh__D024201 Effects, Bystander
% 213.76/213.94  |- skos__hiddenLabel mesh__D024201 Help, Bystander
% 213.76/213.94  |- mesh__publicMeSHNote mesh__D024201 2002   
% 213.76/213.94  |- mesh__dateRevised mesh__D024201 2003-07-25
% 213.76/213.94  |- skos__broader mesh__D024201smesh__D002450
% 213.76/213.94  |- mesh__dateEstablished mesh__D024201 2002-01-01
% 213.76/213.94  |- mesh__recordOriginator mesh__D024201 nns
% 213.76/213.94  |- skos__annotation mesh__D024201
% 213.76/213.94       note category: cell physiol context only   
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D024201 2004
% 213.76/213.94  |- mesh__recordMaintainer mesh__D024201 sjn
% 213.76/213.94  |- skos__prefLabel mesh__D024201 Bystander Effect
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D043964 2004
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D043964 2005
% 213.76/213.94  |- mesh__dateCreated mesh__D043964 2003-07-09
% 213.76/213.94  |- mesh__publicMeSHNote mesh__D043964 2004   
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D043964 2006
% 213.76/213.94  |- mesh__historyNote mesh__D043964 2004   
% 213.76/213.94  |- skos__altLabel mesh__D043964 Pepperwort
% 213.76/213.94  |- skos__scopeNote mesh__D043964
% 213.76/213.94       A plant family of the order Hydropteridales, class Filicopsida, division PTERIDOPHYTA. They are aquatic ferns with quatrifoliate leaves resembling four leaf clover, creeping rhizome, and bean shaped sporocarps.%A%    
% 213.76/213.94  |- skos__annotation mesh__D043964
% 213.76/213.94       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.76/213.94  |- skos__altLabel mesh__D043964 Clover, Water
% 213.76/213.94  |- skos__prefLabel mesh__D043964 Marsileaceae
% 213.76/213.94  |- skos__altLabel mesh__D043964 Waterclover
% 213.76/213.94  |- skos__broader mesh__D043964smesh__D029624
% 213.76/213.94  |- rdf__type mesh__D043964sskos__Concept
% 213.76/213.94  |- mesh__dateEstablished mesh__D043964 2004-01-01
% 213.76/213.94  |- skos__hiddenLabel mesh__D009438 Acids, Neuraminic
% 213.76/213.94  |- mesh__recordOriginator mesh__D009438 NLM
% 213.76/213.94  |- mesh__recordAuthorizer mesh__D009438 sjn
% 213.76/213.94  |- mesh__dateRevised mesh__D009438 2004-07-07
% 213.76/213.94  |- mesh__dateCreated mesh__D009438 1999-01-01
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D009438 2005
% 213.76/213.94  |- rdf__type mesh__D009438sskos__Concept
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D009438 2006
% 213.76/213.94  |- skos__broader mesh__D009438smesh__D000606
% 213.76/213.94  |- skos__prefLabel mesh__D009438 Neuraminic Acids
% 213.76/213.94  |- mesh__recordMaintainer mesh__D009438 ssb
% 213.76/213.94  |- skos__broader mesh__D009438smesh__D013400
% 213.76/213.94  |- skos__historyNote mesh__D001455 Antibiotics %28%1966-1978%29%
% 213.76/213.94  |- skos__altLabel mesh__D001455 Moenomycins
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D001455 2005
% 213.76/213.94  |- mesh__dateRevised mesh__D001455 2004-07-07
% 213.76/213.94  |- mesh__publicMeSHNote mesh__D001455
% 213.76/213.94       91; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1979-90   
% 213.76/213.94  |- skos__broader mesh__D001455smesh__D011135
% 213.76/213.94  |- mesh__dateCreated mesh__D001455 1978-03-16
% 213.76/213.94  |- skos__altLabel mesh__D001455 Flavophospholipol
% 213.76/213.94  |- skos__altLabel mesh__D001455 Bambermycin
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D001455 2006
% 213.76/213.94  |- mesh__recordAuthorizer mesh__D001455 sjn
% 213.76/213.94  |- mesh__recordOriginator mesh__D001455 SH
% 213.76/213.94  |- skos__historyNote mesh__D001455 Glycolipids %28%1966-1978%29%
% 213.76/213.94  |- skos__prefLabel mesh__D001455 Bambermycins
% 213.76/213.94  |- skos__altLabel mesh__D001455 Menomycin
% 213.76/213.94  |- skos__altLabel mesh__D001455 Flavomycins
% 213.76/213.94  |- mesh__recordMaintainer mesh__D001455 ssb
% 213.76/213.94  |- skos__scopeNote mesh__D001455
% 213.76/213.94       Antibiotic complex obtained from Streptomyces bambergiensis containing mainly Moenomycins A and C. They are used as feed additives and growth promoters for poultry, swine, and cattle.%A%    
% 213.76/213.94  |- mesh__historyNote mesh__D001455
% 213.76/213.94       91%28%79%29%; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1979-90%A%  
% 213.76/213.94  |- skos__altLabel mesh__D001455 Flavophospholipols
% 213.76/213.94  |- rdf__type mesh__D001455sskos__Concept
% 213.76/213.94  |- mesh__dateEstablished mesh__D001455 1991-01-01
% 213.76/213.94  |- skos__hiddenLabel mesh__D006140 Scott Tussin
% 213.76/213.94  |- skos__altLabel mesh__D006140 Guaiacol Glyceryl Ether
% 213.76/213.94  |- skos__altLabel mesh__D006140 Guaiphenezine
% 213.76/213.94  |- mesh__historyNote mesh__D006140 2004%28%1966%29%   
% 213.76/213.94  |- skos__hiddenLabel mesh__D006140 My 301
% 213.76/213.94  |- mesh__recordOriginator mesh__D006140 NLM
% 213.76/213.94  |- mesh__recordAuthorizer mesh__D006140 sjn
% 213.76/213.94  |- rdf__type mesh__D006140sskos__Concept
% 213.76/213.94  |- skos__altLabel mesh__D006140 Glycerol Guaiacolate
% 213.76/213.94  |- mesh__recordMaintainer mesh__D006140 ssb
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D006140 2004
% 213.76/213.94  |- skos__altLabel mesh__D006140 Guaiphenesin
% 213.76/213.94  |- skos__prefLabel mesh__D006140 Guaifenesin
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D006140 2005
% 213.76/213.94  |- skos__hiddenLabel mesh__D006140 Guaiacolate, Glycerol
% 213.76/213.94  |- mesh__publicMeSHNote mesh__D006140
% 213.76/213.94       2004; see GUAIACOL GLYCERYL ETHER 1966-2003   
% 213.76/213.94  |- mesh__dateCreated mesh__D006140 1999-01-01
% 213.76/213.94  |- skos__scopeNote mesh__D006140
% 213.76/213.94       An expectorant that also has some muscle relaxing action. It is used in many cough preparations.%A%    
% 213.76/213.94  |- skos__hiddenLabel mesh__D006140 My301
% 213.76/213.94  |- skos__broader mesh__D006140smesh__D006139
% 213.76/213.94  |- skos__hiddenLabel mesh__D006140 Ether, Guaiacol Glyceryl
% 213.76/213.94  |- mesh__dateRevised mesh__D006140 2003-07-09
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D006140 2006
% 213.76/213.94  |- skos__hiddenLabel mesh__D006140 Glyceryl Ether, Guaiacol
% 213.76/213.94  |- skos__hiddenLabel mesh__D006140 ScottTussin
% 213.76/213.94  |- skos__broader mesh__D011883smesh__D019216
% 213.76/213.94  |- mesh__dateRevised mesh__D011883 1996-06-10
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D011883 2003
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D011883 2001
% 213.76/213.94  |- skos__annotation mesh__D011883
% 213.76/213.94       naturally radioactive; IM; /ther use: for curietherapy consider also BRACHYTHERAPY%A%  
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D011883 2004
% 213.76/213.94  |- skos__prefLabel mesh__D011883 Radium
% 213.76/213.94  |- mesh__recordMaintainer mesh__D011883 JLS
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D011883 1997
% 213.76/213.94  |- skos__broader mesh__D011883smesh__D004603
% 213.76/213.94  |- mesh__recordAuthorizer mesh__D011883 PLS
% 213.76/213.94  |- mesh__dateCreated mesh__D011883 1999-01-01
% 213.76/213.94  |- rdf__type mesh__D011883sskos__Concept
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D011883 2002
% 213.76/213.94  |- mesh__recordOriginator mesh__D011883 NLM
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D011883 2005
% 213.76/213.94  |- skos__scopeNote mesh__D011883
% 213.76/213.94       Radium. A radioactive element of the alkaline earth series of metals. It has the atomic symbol Ra, atomic number 88, and atomic weight 226. Radium is the product of the disintegration of uranium and is present in pitchblende and all ores containing uranium. It is used clinically as a source of beta and gamma-rays in radiotherapy, particularly BRACHYTHERAPY.%A%    
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D011883 1998
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D011883 2006
% 213.76/213.94  |- skos__broader mesh__D011883smesh__D008673
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D011883 1999
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D011883 2000
% 213.76/213.94  |- mesh__dateCreated mesh__D019068 1995-06-05
% 213.76/213.94  |- skos__annotation mesh__D019068
% 213.76/213.94       X ref MOSSES, TRUE: check MeSH for other moss terms; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.76/213.94  |- mesh__dateEstablished mesh__D019068 1996-01-01
% 213.76/213.94  |- skos__historyNote mesh__D019068 Plants %28%1966-1995%29%
% 213.76/213.94  |- mesh__recordMaintainer mesh__D019068 ssb
% 213.76/213.94  |- mesh__recordAuthorizer mesh__D019068 sjn
% 213.76/213.94  |- skos__prefLabel mesh__D019068 Bryopsida
% 213.76/213.94  |- skos__altLabel mesh__D019068 Mosses, True
% 213.76/213.94  |- skos__broader mesh__D019068smesh__D044002
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D019068 2004
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D019068 2005
% 213.76/213.94  |- mesh__dateRevised mesh__D019068 2003-07-09
% 213.76/213.94  |- skos__scopeNote mesh__D019068
% 213.76/213.94       A class of plants within the Bryophyta comprising the mosses, which are found in both damp %28%including freshwater%29% and drier situations. Mosses possess erect or prostrate leafless stems, which give rise to leafless stalks bearing capsules. Spores formed in the capsules are released and grow to produce new plants. %28%Concise Dictionary of Biology, 1990%29%.  Many small plants bearing the name moss are in fact not mosses. The %22%moss%22% found on the north side of trees is actually a green alga %28%ALGAE, GREEN%29%. Irish moss is really a red alga %28%ALGAE, RED%29%. Beard lichen %28%beard moss%29%, Iceland moss, oak moss, and reindeer moss are actually LICHENS. Spanish moss is a common name for both LICHENS and an air plant of the pineapple family %28%BROMELIACEAE%29%. Club moss is an evergreen herb of the family LYCOPODIACEAE.%A%    
% 213.76/213.94  |- mesh__historyNote mesh__D019068 2004%28%1996%29%   
% 213.76/213.94  |- mesh__recordOriginator mesh__D019068 JLS
% 213.76/213.94  |- rdf__type mesh__D019068sskos__Concept
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D019068 2006
% 213.76/213.94  |- mesh__publicMeSHNote mesh__D019068 2004; see MOSSES 1996-2003   
% 213.76/213.94  |- skos__hiddenLabel mesh__D011085 Sclerocystic Ovary
% 213.76/213.94  |- skos__hiddenLabel mesh__D011085 Syndrome, Stein-Leventhal
% 213.76/213.94  |- rdf__type mesh__D011085sskos__Concept
% 213.76/213.94  |- skos__altLabel mesh__D011085 Sclerocystic Ovary Syndrome
% 213.76/213.94  |- skos__broader mesh__D011085smesh__D010048
% 213.76/213.94  |- skos__prefLabel mesh__D011085 Polycystic Ovary Syndrome
% 213.76/213.94  |- skos__hiddenLabel mesh__D011085 Ovarian Degeneration, Sclerocystic
% 213.76/213.94  |- mesh__dateRevised mesh__D011085 2002-07-03
% 213.76/213.94  |- skos__altLabel mesh__D011085 Stein-Leventhal Syndrome
% 213.76/213.94  |- skos__annotation mesh__D011085 non-neoplastic   
% 213.76/213.94  |- mesh__onlineNote mesh__D011085
% 213.76/213.94       use POLYCYSTIC OVARY SYNDROME to search STEIN-LEVENTHAL SYNDROME 1966-84%A%  
% 213.76/213.94  |- skos__altLabel mesh__D011085 Sclerocystic Ovarian Degeneration
% 213.76/213.94  |- mesh__dateCreated mesh__D011085 1999-01-01
% 213.76/213.94  |- skos__related mesh__D011085smesh__D017588
% 213.76/213.94  |- skos__hiddenLabel mesh__D011085 Ovary, Sclerocystic
% 213.76/213.94  |- skos__hiddenLabel mesh__D011085 Syndrome, Polycystic Ovary
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D011085 2004
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D011085 2006
% 213.76/213.94  |- mesh__recordMaintainer mesh__D011085 lkt
% 213.76/213.94  |- mesh__publicMeSHNote mesh__D011085
% 213.76/213.94       85; was STEIN-LEVENTHAL SYNDROME 1963-84   
% 213.76/213.94  |- skos__hiddenLabel mesh__D011085 Ovary Syndrome, Polycystic
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D011085 2003
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D011085 2005
% 213.76/213.94  |- skos__scopeNote mesh__D011085
% 213.76/213.94       A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.%A%    
% 213.76/213.94  |- mesh__recordAuthorizer mesh__D011085 sjn
% 213.76/213.94  |- mesh__recordOriginator mesh__D011085 NLM
% 213.76/213.94  |- skos__hiddenLabel mesh__D011085 Ovaries, Sclerocystic
% 213.76/213.94  |- skos__hiddenLabel mesh__D011085 Stein Leventhal Syndrome
% 213.76/213.94  |- mesh__historyNote mesh__D011085
% 213.76/213.94       85; was STEIN-LEVENTHAL SYNDROME 1963-84   
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005846 2001
% 213.76/213.94  |- mesh__historyNote mesh__D005846
% 213.76/213.94       93; was GEORGIAN S.S.R. 1982-92; was GEORGIAN SSR 1967-81; was GEORGIA SSR 1963-66%A%  
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005846 2006
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005846 1999
% 213.76/213.94  |- skos__altLabel mesh__D005846 Georgia SSR
% 213.76/213.94  |- rdf__type mesh__D005846sskos__Concept
% 213.76/213.94  |- skos__altLabel mesh__D005846 Georgia %28%Western Asia%29%
% 213.76/213.94  |- skos__broader mesh__D005846smesh__D014154
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005846 2000
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005846 2005
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005846 1998
% 213.76/213.94  |- mesh__recordOriginator mesh__D005846 NLM
% 213.76/213.94  |- mesh__recordMaintainer mesh__D005846 PLS
% 213.76/213.94  |- skos__altLabel mesh__D005846 Georgian S.S.R.
% 213.76/213.94  |- mesh__dateCreated mesh__D005846 1999-01-01
% 213.76/213.94  |- mesh__dateRevised mesh__D005846 1995-06-08
% 213.76/213.94  |- skos__broader mesh__D005846smesh__D017517
% 213.76/213.94  |- mesh__onlineNote mesh__D005846
% 213.76/213.94       use GEORGIA %28%REPUBLIC%29% to search GEORGIAN S.S.R. 1982-92, GEORGIAN SSR 1967-81 %26% GEORGIA SSR 1966%A%  
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005846 2002
% 213.76/213.94  |- skos__broader mesh__D005846smesh__D014586
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005846 2004
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005846 1997
% 213.76/213.94  |- mesh__recordAuthorizer mesh__D005846 PLS
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005846 2003
% 213.76/213.94  |- skos__prefLabel mesh__D005846 Georgia %28%Republic%29%
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005846 1996
% 213.76/213.94  |- skos__altLabel mesh__D005846 Georgian SSR
% 213.76/213.94  |- mesh__historyNote mesh__D038222
% 213.76/213.94       2003; for GAMMA-CRYSTALLIN use CRYSTALLINS 1983-2002   
% 213.76/213.94  |- skos__altLabel mesh__D038222 gamma-Crystallin
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D038222 2006
% 213.76/213.94  |- mesh__recordOriginator mesh__D038222 jmp
% 213.76/213.94  |- skos__hiddenLabel mesh__D038222 gamma Crystallins
% 213.76/213.94  |- mesh__dateEstablished mesh__D038222 2003-01-01
% 213.76/213.94  |- skos__altLabel mesh__D038222 Crystallins, gamma
% 213.76/213.94  |- skos__historyNote mesh__D038222 Crystallins %28%1968-2002%29%
% 213.76/213.94  |- mesh__recordAuthorizer mesh__D038222 sjn
% 213.76/213.94  |- skos__broader mesh__D038222smesh__D003459
% 213.76/213.94  |- mesh__publicMeSHNote mesh__D038222
% 213.76/213.94       2003; for GAMMA-CRYSTALLIN see CRYSTALLINS 1983-2002   
% 213.76/213.94  |- mesh__dateRevised mesh__D038222 2005-06-30
% 213.76/213.94  |- mesh__recordMaintainer mesh__D038222 SYSTEM
% 213.76/213.94  |- skos__hiddenLabel mesh__D038222 gamma Crystallin
% 213.76/213.94  |- rdf__type mesh__D038222sskos__Concept
% 213.76/213.94  |- skos__scopeNote mesh__D038222
% 213.76/213.94       A subclass of crystallins that found in the lens %28%LENS, CRYSTALLINE%29% of VERTEBRATES. Gamma-crystallins are similar in structure to BETA-CRYSTALLINS in that they both form into a Greek key-like structure. They are composed of monomeric subunits.%A%    
% 213.76/213.94  |- skos__prefLabel mesh__D038222 gamma-Crystallins
% 213.76/213.94  |- mesh__dateCreated mesh__D038222 2002-07-03
% 213.76/213.94  |- skos__broader mesh__D005048smesh__D009019
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005048 2006
% 213.76/213.94  |- skos__historyNote mesh__D005048 Alcohols, Amyl %28%1973-1974%29%
% 213.76/213.94  |- mesh__historyNote mesh__D005048
% 213.76/213.94       91%28%75%29%; was see under MORPHINANS 1975-90   
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005048 2003
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005048 2001
% 213.76/213.94  |- mesh__dateEstablished mesh__D005048 1991-01-01
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005048 2004
% 213.76/213.94  |- mesh__recordMaintainer mesh__D005048 TWD
% 213.76/213.94  |- mesh__dateCreated mesh__D005048 1974-11-19
% 213.76/213.94  |- skos__prefLabel mesh__D005048 Etorphine
% 213.76/213.94  |- mesh__recordOriginator mesh__D005048 NLM
% 213.76/213.94  |- skos__scopeNote mesh__D005048
% 213.76/213.94       A narcotic analgesic morphinan used as a sedative in veterinary practice.%A%    
% 213.76/213.94  |- skos__altLabel mesh__D005048 Ethorphine
% 213.76/213.94  |- mesh__publicMeSHNote mesh__D005048
% 213.76/213.94       91; was see under MORPHINANS 1975-90   
% 213.76/213.94  |- rdf__type mesh__D005048sskos__Concept
% 213.76/213.94  |- mesh__dateRevised mesh__D005048 2000-06-22
% 213.76/213.94  |- skos__historyNote mesh__D005048 Morphinans %28%1969-1974%29%
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005048 2002
% 213.76/213.94  |- mesh__recordAuthorizer mesh__D005048 sjn
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D005048 2005
% 213.76/213.94  |- skos__hiddenLabel mesh__D024202 Assay, Mobility Shift
% 213.76/213.94  |- rdf__type mesh__D024202sskos__Concept
% 213.76/213.94  |- mesh__dateCreated mesh__D024202 2001-08-03
% 213.76/213.94  |- skos__hiddenLabel mesh__D024202 Gel Shift Analyses
% 213.76/213.94  |- skos__altLabel mesh__D024202 Band Shift Mobility Assay
% 213.76/213.94  |- skos__altLabel mesh__D024202 Mobility Shift Assay
% 213.76/213.94  |- mesh__publicMeSHNote mesh__D024202 2002   
% 213.76/213.94  |- mesh__recordOriginator mesh__D024202 nns
% 213.76/213.94  |- skos__historyNote mesh__D024202
% 213.76/213.94       Electrophoresis or specifics %28%1976-2001%29%
% 213.76/213.94  |- skos__hiddenLabel mesh__D024202 Bandshift Mobility Assays
% 213.76/213.94  |- mesh__activeMeSHYear mesh__D024202 2006
% 213.76/213.94  |- skos__hiddenLabel mesh__D024202 Analysis, Gel Shift
% 213.76/213.94  |- skos__annotation mesh__D024202
% 213.76/213.94       coord with the specific type of electrophoresis used   
% 213.76/213.94  |- mesh__recordAuthorizer mesh__D024202 sjn
% 213.76/213.94  |- skos__hiddenLabel mesh__D024202 Analyses, Gel Shift
% 213.76/213.94  |- skos__hiddenLabel mesh__D024202 Mobility Assay, Bandshift
% 213.76/213.94  |- skos__hiddenLabel mesh__D024202 Mobility Assays, Supershift
% 213.76/213.94  |- skos__hiddenLabel mesh__D024202 Supershift Mobility Assays
% 213.76/213.94  |- mesh__historyNote mesh__D024202 2002   
% 213.76/213.94  |- skos__hiddenLabel mesh__D024202 Assay, Supershift Mobility
% 213.76/213.94  |- skos__altLabel mesh__D024202 Gelshift Analysis
% 213.76/213.94  |- mesh__dateEstablished mesh__D024202 2002-01-01
% 213.76/213.94  |- skos__broader mesh__D024202smesh__D004586
% 213.76/213.94  |- skos__hiddenLabel mesh__D024202 Assay, Bandshift Mobility
% 213.76/213.94  |- skos__hiddenLabel mesh__D024202 Assays, Bandshift Mobility
% 213.76/213.94  |- skos__altLabel mesh__D024202 Bandshift Mobility Assay
% 213.76/213.94  |- skos__hiddenLabel mesh__D024202 Assays, Mobility Shift
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D024202 2005
% 213.76/213.95  |- skos__hiddenLabel mesh__D024202 Mobility Shift Assays
% 213.76/213.95  |- skos__hiddenLabel mesh__D024202 Assay, Gel Retardation
% 213.76/213.95  |- skos__hiddenLabel mesh__D024202 Mobility Assays, Bandshift
% 213.76/213.95  |- skos__hiddenLabel mesh__D024202 Assays, Supershift Mobility
% 213.76/213.95  |- skos__hiddenLabel mesh__D024202 Assays, Gel Retardation
% 213.76/213.95  |- mesh__recordMaintainer mesh__D024202 jls
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D024202 2004
% 213.76/213.95  |- skos__prefLabel mesh__D024202 Electrophoretic Mobility Shift Assay
% 213.76/213.95  |- skos__hiddenLabel mesh__D024202 Gel Retardation Assays
% 213.76/213.95  |- skos__scopeNote mesh__D024202
% 213.76/213.95       An electrophoretic technique employed to assay for binding of one compound to another. Typically one compound is labeled to follow its mobility during electrophoresis. The movement of the labeled compound through the electrophoretic medium will be retarded if it is bound by the other.%A%    
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D024202 2003
% 213.76/213.95  |- skos__altLabel mesh__D024202 Gel Retardation Assay
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D024202 2002
% 213.76/213.95  |- skos__hiddenLabel mesh__D024202 Mobility Assay, Supershift
% 213.76/213.95  |- mesh__recordAuthorizer mesh__D043167 sjn
% 213.76/213.95  |- skos__scopeNote mesh__D043167
% 213.76/213.95       A family of gram-negative bacteria in the order Nitrosomonadales. It formerly included the genera CAMPYLOBACTER and SPIRILLUM, then was abandoned, and is now reinstated as a family with a single genus SPIRILLUM.%A%    
% 213.76/213.95  |- mesh__historyNote mesh__D043167
% 213.76/213.95       2004, 1975-1991; use BACTERIA 1992-2003   
% 213.76/213.95  |- skos__prefLabel mesh__D043167 Spirillaceae
% 213.76/213.95  |- mesh__recordMaintainer mesh__D043167 SYSTEM
% 213.76/213.95  |- skos__broader mesh__D043167smesh__D006090
% 213.76/213.95  |- mesh__publicMeSHNote mesh__D043167
% 213.76/213.95       2004; see BACTERIA 1992-2003, see SPIRILLACEAE 1975-1991   
% 213.76/213.95  |- mesh__dateCreated mesh__D043167 2003-07-09
% 213.76/213.95  |- mesh__dateEstablished mesh__D043167 2004-01-01
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D043167 2006
% 213.76/213.95  |- skos__broader mesh__D043167smesh__D020562
% 213.76/213.95  |- rdf__type mesh__D043167sskos__Concept
% 213.76/213.95  |- mesh__recordOriginator mesh__D043167 ags
% 213.76/213.95  |- mesh__dateRevised mesh__D043167 2005-06-30
% 213.76/213.95  |- mesh__publicMeSHNote mesh__D015476
% 213.76/213.95       89; was see LEUKEMIA, MONOCYTIC 1974-88; LEUKEMIA, MONOCYTIC was heading 1963-88%A%  
% 213.76/213.95  |- skos__hiddenLabel mesh__D015476 Chronic Monocytic Leukemias
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D015476 2003
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D015476 2006
% 213.76/213.95  |- mesh__dateEstablished mesh__D015476 1989-01-01
% 213.76/213.95  |- mesh__historyNote mesh__D015476
% 213.76/213.95       89; was see LEUKEMIA, MONOCYTIC 1974-88; LEUKEMIA, MONOCYTIC was heading 1963-88%A%  
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D015476 2004
% 213.76/213.95  |- skos__hiddenLabel mesh__D015476 Chronic Monocytic Leukemia
% 213.76/213.95  |- skos__broader mesh__D015476smesh__D015464
% 213.76/213.95  |- mesh__recordAuthorizer mesh__D015476 sjn
% 213.76/213.95  |- mesh__onlineNote mesh__D015476
% 213.76/213.95       use LEUKEMIA, MONOCYTIC, CHRONIC to search LEUKEMIA, MONOCYTIC 1966-88%A%  
% 213.76/213.95  |- mesh__recordOriginator mesh__D015476 PLS
% 213.76/213.95  |- skos__hiddenLabel mesh__D015476 Monocytic Leukemias, Chronic
% 213.76/213.95  |- rdf__type mesh__D015476sskos__Concept
% 213.76/213.95  |- mesh__dateCreated mesh__D015476 1988-06-09
% 213.76/213.95  |- mesh__recordMaintainer mesh__D015476 ndw
% 213.76/213.95  |- skos__altLabel mesh__D015476 Monocytic Leukemia, Chronic
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D015476 2000
% 213.76/213.95  |- skos__annotation mesh__D015476
% 213.76/213.95       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 213.76/213.95  |- skos__historyNote mesh__D015476
% 213.76/213.95       Leukemia, Monocytic, Chronic %28%1974-1988%29%
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D015476 2001
% 213.76/213.95  |- skos__hiddenLabel mesh__D015476 Leukemia, Chronic Monocytic
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D015476 2005
% 213.76/213.95  |- mesh__dateRevised mesh__D015476 1999-11-03
% 213.76/213.95  |- skos__prefLabel mesh__D015476 Leukemia, Monocytic, Chronic
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D015476 2002
% 213.76/213.95  |- skos__hiddenLabel mesh__D015476 Leukemias, Chronic Monocytic
% 213.76/213.95  |- rdf__type mesh__D009439sskos__Concept
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D009439 2006
% 213.76/213.95  |- mesh__dateRevised mesh__D009439 2003-07-09
% 213.76/213.95  |- mesh__recordOriginator mesh__D009439 NLM
% 213.76/213.95  |- mesh__recordAuthorizer mesh__D009439 sjn
% 213.76/213.95  |- skos__altLabel mesh__D009439 Oligosaccharide Sialidase
% 213.76/213.95  |- skos__hiddenLabel mesh__D009439 N Acylneuraminate Glycohydrolases
% 213.76/213.95  |- skos__altLabel mesh__D009439 Sialidase
% 213.76/213.95  |- skos__hiddenLabel mesh__D009439 Glycohydrolases, N-Acylneuraminate
% 213.76/213.95  |- skos__scopeNote mesh__D009439
% 213.76/213.95       An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages %28%at a decreasing rate, respectively%29% of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. %28%From Enzyme Nomenclature, 1992%29% EC 3.2.1.18.%A%    
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D009439 2004
% 213.76/213.95  |- skos__prefLabel mesh__D009439 Neuraminidase
% 213.76/213.95  |- skos__broader mesh__D009439smesh__D006026
% 213.76/213.95  |- skos__altLabel mesh__D009439 N-Acylneuraminate Glycohydrolases
% 213.76/213.95  |- mesh__recordMaintainer mesh__D009439 ssb
% 213.76/213.95  |- skos__hiddenLabel mesh__D009439 Sialidase, Oligosaccharide
% 213.76/213.95  |- mesh__dateCreated mesh__D009439 1999-01-01
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D009439 2005
% 213.76/213.95  |- mesh__dateRevised mesh__D020610 2005-06-30
% 213.76/213.95  |- mesh__historyNote mesh__D020610 2000   
% 213.76/213.95  |- mesh__publicMeSHNote mesh__D020610 2000   
% 213.76/213.95  |- skos__scopeNote mesh__D020610
% 213.76/213.95       A species of EDWARDSIELLA distinguished by its nonmotility. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 213.76/213.95  |- mesh__recordOriginator mesh__D020610 ndw
% 213.76/213.95  |- skos__broader mesh__D020610smesh__D020594
% 213.76/213.95  |- mesh__dateCreated mesh__D020610 1999-11-03
% 213.76/213.95  |- rdf__type mesh__D020610sskos__Concept
% 213.76/213.95  |- skos__annotation mesh__D020610
% 213.76/213.95       infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 213.76/213.95  |- skos__historyNote mesh__D020610 Enterobacteriaceae %28%1984-1999%29%
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D020610 2006
% 213.76/213.95  |- skos__prefLabel mesh__D020610 Edwardsiella ictaluri
% 213.76/213.95  |- mesh__recordMaintainer mesh__D020610 SYSTEM
% 213.76/213.95  |- mesh__dateEstablished mesh__D020610 2000-01-01
% 213.76/213.95  |- mesh__recordAuthorizer mesh__D020610 sjn
% 213.76/213.95  |- mesh__recordAuthorizer mesh__D006141 PLS
% 213.76/213.95  |- mesh__historyNote mesh__D006141 75   
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006141 1996
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006141 2001
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006141 2005
% 213.76/213.95  |- mesh__dateEstablished mesh__D006141 1975-01-01
% 213.76/213.95  |- skos__annotation mesh__D006141 an island in Micronesia   
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006141 1997
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006141 2002
% 213.76/213.95  |- skos__prefLabel mesh__D006141 Guam
% 213.76/213.95  |- skos__scopeNote mesh__D006141
% 213.76/213.95       An island in Micronesia, east of the Philippines, the largest and southernmost of the Marianas. Its capital is Agana. It was discovered by Magellan in 1521 and occupied by Spain in 1565. They ceded it to the United States in 1898. It is an unincorporated territory of the United States, administered by the Department of the Interior since 1950. The derivation of the name Guam is in dispute. %28%From Webster%27%s New Geographical Dictionary, 1988, p471%29%%A%    
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006141 2006
% 213.76/213.95  |- skos__broader mesh__D006141smesh__D008849
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006141 1998
% 213.76/213.95  |- mesh__recordOriginator mesh__D006141 NLM
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006141 1999
% 213.76/213.95  |- mesh__dateRevised mesh__D006141 1995-06-08
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006141 2003
% 213.76/213.95  |- mesh__dateCreated mesh__D006141 1974-11-11
% 213.76/213.95  |- rdf__type mesh__D006141sskos__Concept
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006141 2000
% 213.76/213.95  |- mesh__recordMaintainer mesh__D006141 TGC
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006141 2004
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D019867 2006
% 213.76/213.95  |- mesh__recordAuthorizer mesh__D019867 sjn
% 213.76/213.95  |- skos__hiddenLabel mesh__D019867 Diseases, Anti-GBM
% 213.76/213.95  |- skos__related mesh__D019867smesh__D050533
% 213.76/213.95  |- rdf__type mesh__D019867sskos__Concept
% 213.76/213.95  |- skos__hiddenLabel mesh__D019867 Disease, Anti-GBM
% 213.76/213.95  |- skos__hiddenLabel mesh__D019867 Anti-GBM Diseases
% 213.76/213.95  |- skos__hiddenLabel mesh__D019867
% 213.76/213.95       Anti Glomerular Basement Membrane Disease
% 213.76/213.95  |- mesh__dateRevised mesh__D019867 2005-06-30
% 213.76/213.95  |- skos__hiddenLabel mesh__D019867 Anti GBM Disease
% 213.76/213.95  |- mesh__dateEstablished mesh__D019867 1998-01-01
% 213.76/213.95  |- skos__broader mesh__D019867smesh__D001327
% 213.76/213.95  |- skos__prefLabel mesh__D019867 Anti-Glomerular Basement Membrane Disease
% 213.76/213.95  |- skos__scopeNote mesh__D019867
% 213.76/213.95       Glomerulonephritis, usually of a generalized proliferative crescent-forming histologic type with a rapidly progressive course, marked by circulating anti-GBM antibodies and linear deposits of immunoglobulin and complement along the glomerular basement membrane. When associated with pulmonary hemorrhage the condition is called GOODPASTURE SYNDROME. %28%Dorland, 28th ed%29%%A%    
% 213.76/213.95  |- mesh__dateCreated mesh__D019867 1997-06-20
% 213.76/213.95  |- mesh__recordOriginator mesh__D019867 TGC
% 213.76/213.95  |- skos__altLabel mesh__D019867 Anti-GBM Disease
% 213.76/213.95  |- mesh__historyNote mesh__D019867 98   
% 213.76/213.95  |- mesh__publicMeSHNote mesh__D019867 98   
% 213.76/213.95  |- mesh__recordMaintainer mesh__D019867 lkt
% 213.76/213.95  |- skos__broader mesh__D019867smesh__D005921
% 213.76/213.95  |- skos__broader mesh__D011884smesh__D050280
% 213.76/213.95  |- rdf__type mesh__D011884sskos__Concept
% 213.76/213.95  |- skos__prefLabel mesh__D011884 Radius
% 213.76/213.95  |- mesh__recordOriginator mesh__D011884 NLM
% 213.76/213.95  |- mesh__recordMaintainer mesh__D011884 ags
% 213.76/213.95  |- mesh__recordAuthorizer mesh__D011884 sjn
% 213.76/213.95  |- mesh__dateRevised mesh__D011884 2005-06-30
% 213.76/213.95  |- mesh__dateCreated mesh__D011884 1999-01-01
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D011884 2006
% 213.76/213.95  |- mesh__recordOriginator mesh__D019069 JLS
% 213.76/213.95  |- rdf__type mesh__D019069sskos__Concept
% 213.76/213.95  |- mesh__dateEstablished mesh__D019069 1996-01-01
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D019069 2006
% 213.76/213.95  |- skos__historyNote mesh__D019069 Oxygen Consumption %28%1966-1995%29%
% 213.76/213.95  |- skos__altLabel mesh__D019069 Respiration, Cell
% 213.76/213.95  |- skos__hiddenLabel mesh__D019069 Cellular Respirations
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D019069 2002
% 213.76/213.95  |- skos__scopeNote mesh__D019069
% 213.76/213.95       The metabolic process of all living cells %28%animal and plant%29% in which oxygen is used to provide a source of energy for the cell.%A%    
% 213.76/213.95  |- skos__annotation mesh__D019069
% 213.76/213.95       NIM; not for micro-organisms; for plant resp, coord NIM with PLANTS /metab %28%IM%29% or specific plant /metab %28%IM%29%; CELL HYPOXIA is also available%A%  
% 213.76/213.95  |- skos__hiddenLabel mesh__D019069 Cell Respirations
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D019069 2005
% 213.76/213.95  |- mesh__dateCreated mesh__D019069 1995-06-05
% 213.76/213.95  |- skos__hiddenLabel mesh__D019069 Respiration, Cellular
% 213.76/213.95  |- skos__prefLabel mesh__D019069 Cell Respiration
% 213.76/213.95  |- skos__broader mesh__D019069smesh__D002468
% 213.76/213.95  |- skos__related mesh__D019069smesh__D010101
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D019069 2004
% 213.76/213.95  |- mesh__recordMaintainer mesh__D019069 adp
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D019069 2001
% 213.76/213.95  |- mesh__dateRevised mesh__D019069 2000-06-22
% 213.76/213.95  |- mesh__historyNote mesh__D019069 96   
% 213.76/213.95  |- skos__altLabel mesh__D019069 Cellular Respiration
% 213.76/213.95  |- mesh__recordAuthorizer mesh__D019069 sjn
% 213.76/213.95  |- mesh__publicMeSHNote mesh__D019069 96   
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D019069 2003
% 213.76/213.95  |- skos__scopeNote mesh__D011086
% 213.76/213.95       An increase in the total red cell mass of the blood. %28%Dorland, 27th ed%29%%A%    
% 213.76/213.95  |- mesh__recordOriginator mesh__D011086 NLM
% 213.76/213.95  |- mesh__dateCreated mesh__D011086 1999-01-01
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D011086 2002
% 213.76/213.95  |- skos__prefLabel mesh__D011086 Polycythemia
% 213.76/213.95  |- mesh__dateRevised mesh__D011086 1995-06-08
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D011086 2004
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D011086 2001
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D011086 2006
% 213.76/213.95  |- mesh__recordMaintainer mesh__D011086 RAZ
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D011086 2003
% 213.76/213.95  |- skos__broader mesh__D011086smesh__D006402
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D011086 2005
% 213.76/213.95  |- skos__hiddenLabel mesh__D011086 Polycythemias
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D011086 2000
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D011086 1997
% 213.76/213.95  |- mesh__recordAuthorizer mesh__D011086 PLS
% 213.76/213.95  |- skos__hiddenLabel mesh__D011086 Erythrocytoses
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D011086 1999
% 213.76/213.95  |- skos__annotation mesh__D011086 increase in total red cell mass   
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D011086 1996
% 213.76/213.95  |- rdf__type mesh__D011086sskos__Concept
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D011086 1998
% 213.76/213.95  |- skos__hiddenLabel mesh__D005847 Geotrichoses
% 213.76/213.95  |- mesh__dateCreated mesh__D005847 1999-01-01
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D005847 2006
% 213.76/213.95  |- mesh__historyNote mesh__D005847
% 213.76/213.95       91%28%66%29%; was see under MYCOSES 1966-90   
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D005847 1999
% 213.76/213.95  |- rdf__type mesh__D005847sskos__Concept
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D005847 2000
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D005847 1994
% 213.76/213.95  |- mesh__recordMaintainer mesh__D005847 TAP
% 213.76/213.95  |- skos__broader mesh__D005847smesh__D009181
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D005847 2001
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D005847 2003
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D005847 1995
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D005847 1996
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D005847 2002
% 213.76/213.95  |- skos__scopeNote mesh__D005847
% 213.76/213.95       Infection due to the fungus Geotrichum.     
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D005847 2004
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D005847 1997
% 213.76/213.95  |- mesh__recordOriginator mesh__D005847 NLM
% 213.76/213.95  |- mesh__publicMeSHNote mesh__D005847 91; was see under MYCOSES 1966-90   
% 213.76/213.95  |- skos__prefLabel mesh__D005847 Geotrichosis
% 213.76/213.95  |- mesh__dateEstablished mesh__D005847 1991-01-01
% 213.76/213.95  |- mesh__recordAuthorizer mesh__D005847 PLS
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D005847 2005
% 213.76/213.95  |- mesh__dateRevised mesh__D005847 1993-06-02
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D005847 1998
% 213.76/213.95  |- skos__annotation mesh__D005847 fungus dis   
% 213.76/213.95  |- skos__hiddenLabel mesh__D038223 Post-Concussion Symptom
% 213.76/213.95  |- skos__hiddenLabel mesh__D038223 Syndromes, Chronic Post-Concussive
% 213.76/213.95  |- mesh__publicMeSHNote mesh__D038223
% 213.76/213.95       2003; see BRAIN INJURY, CHRONIC 2001-2002   
% 213.76/213.95  |- skos__scopeNote mesh__D038223
% 213.76/213.95       The organic and psychogenic disturbances observed after closed head injuries %28%HEAD INJURIES, CLOSED%29%. Post-concussion syndrome includes subjective physical complaints %28%i.e. headache, dizziness%29%, cognitive, emotional, and behavioral changes. These disturbances can be chronic, permanent, or late emerging.%A%    
% 213.76/213.95  |- skos__historyNote mesh__D038223 Brain Injury, Chronic %28%2000-2002%29%
% 213.76/213.95  |- mesh__dateCreated mesh__D038223 2002-07-03
% 213.76/213.95  |- skos__hiddenLabel mesh__D038223 Post Concussive Syndrome
% 213.76/213.95  |- skos__hiddenLabel mesh__D038223 Post-Concussive Symptom
% 213.76/213.95  |- skos__historyNote mesh__D038223 Brain Concussion %28%1964-2002%29%
% 213.76/213.95  |- skos__altLabel mesh__D038223 Post-Concussive Symptoms
% 213.76/213.95  |- skos__hiddenLabel mesh__D038223 Syndrome, Chronic Post-Concussive
% 213.76/213.95  |- mesh__recordOriginator mesh__D038223 lkt
% 213.76/213.95  |- rdf__type mesh__D038223sskos__Concept
% 213.76/213.95  |- skos__hiddenLabel mesh__D038223 Post-Concussive Syndromes, Chronic
% 213.76/213.95  |- skos__hiddenLabel mesh__D038223 Post Concussive Symptoms
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D038223 2005
% 213.76/213.95  |- mesh__dateEstablished mesh__D038223 2003-01-01
% 213.76/213.95  |- skos__hiddenLabel mesh__D038223 Post Concussion Syndrome
% 213.76/213.95  |- skos__hiddenLabel mesh__D038223 Post-Concussive Syndromes
% 213.76/213.95  |- skos__hiddenLabel mesh__D038223 Post Concussive Syndrome, Chronic
% 213.76/213.95  |- skos__hiddenLabel mesh__D038223 Post Concussion Symptoms
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D038223 2003
% 213.76/213.95  |- skos__altLabel mesh__D038223 Post-Concussion Symptoms
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D038223 2006
% 213.76/213.95  |- skos__hiddenLabel mesh__D038223 Chronic Post-Concussive Syndromes
% 213.76/213.95  |- mesh__historyNote mesh__D038223
% 213.76/213.95       2003; use BRAIN INJURY, CHRONIC 2001-2002   
% 213.76/213.95  |- skos__hiddenLabel mesh__D038223 Chronic Post-Concussive Syndrome
% 213.76/213.95  |- skos__broader mesh__D038223smesh__D001924
% 213.76/213.95  |- skos__hiddenLabel mesh__D038223 Syndromes, Post-Concussive
% 213.76/213.95  |- skos__hiddenLabel mesh__D038223 Symptom, Post-Concussive
% 213.76/213.95  |- mesh__recordAuthorizer mesh__D038223 sjn
% 213.76/213.95  |- skos__altLabel mesh__D038223 Post-Concussive Syndrome
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D038223 2004
% 213.76/213.95  |- skos__prefLabel mesh__D038223 Post-Concussion Syndrome
% 213.76/213.95  |- skos__hiddenLabel mesh__D038223 Syndrome, Post-Concussive
% 213.76/213.95  |- mesh__recordMaintainer mesh__D038223 lkt
% 213.76/213.95  |- mesh__dateRevised mesh__D043168 2005-06-30
% 213.76/213.95  |- mesh__historyNote mesh__D043168
% 213.76/213.95       2004; use ANGIOSTATINS %28%NM%29% 1994-2003   
% 213.76/213.95  |- skos__historyNote mesh__D043168 Peptide Fragments %28%1994-2003%29%
% 213.76/213.95  |- skos__prefLabel mesh__D043168 Angiostatins
% 213.76/213.95  |- skos__broader mesh__D043168smesh__D010958
% 213.76/213.95  |- mesh__dateCreated mesh__D043168 2003-07-09
% 213.76/213.95  |- skos__historyNote mesh__D043168 Angiostatin %28%1994-2003%29%
% 213.76/213.95  |- skos__broader mesh__D043168smesh__D043165
% 213.76/213.95  |- mesh__dateEstablished mesh__D043168 2004-01-01
% 213.76/213.95  |- skos__altLabel mesh__D043168 Angiostatin
% 213.76/213.95  |- mesh__publicMeSHNote mesh__D043168
% 213.76/213.95       2004; ANGIOSTATINS was indexed under PEPTIDE FRAGMENTS %26% PLASMINOGEN 1994-2003%A%  
% 213.76/213.95  |- rdf__type mesh__D043168sskos__Concept
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D043168 2006
% 213.76/213.95  |- mesh__recordMaintainer mesh__D043168 ssb
% 213.76/213.95  |- mesh__recordAuthorizer mesh__D043168 sjn
% 213.76/213.95  |- mesh__recordOriginator mesh__D043168 jmp
% 213.76/213.95  |- skos__scopeNote mesh__D043168
% 213.76/213.95       Circulating 38-kDa proteins that are internal peptide fragments of PLASMINOGEN. The name derives from the fact that they are potent ANGIOGENESIS INHIBITORS. Angiostatins contain four KRINGLE DOMAINS which are associated with their potent angiostatic activity.%A%    
% 213.76/213.95  |- skos__annotation mesh__D015477
% 213.76/213.95       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D015477 2000
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D015477 1998
% 213.76/213.95  |- mesh__publicMeSHNote mesh__D015477
% 213.76/213.95       89; was see LEUKEMIA, MYELOCYTIC 1981-88   
% 213.76/213.95  |- mesh__dateRevised mesh__D015477 1995-06-08
% 213.76/213.95  |- skos__hiddenLabel mesh__D015477 Leukemia, Chronic Myelomonocytic
% 213.76/213.95  |- mesh__dateEstablished mesh__D015477 1989-01-01
% 213.76/213.95  |- skos__prefLabel mesh__D015477 Leukemia, Myelomonocytic, Chronic
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D015477 2004
% 213.76/213.95  |- skos__hiddenLabel mesh__D015477 Chronic Myelomonocytic Leukemia
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D015477 2006
% 213.76/213.95  |- skos__altLabel mesh__D015477 Myelomonocytic Leukemia, Chronic
% 213.76/213.95  |- skos__hiddenLabel mesh__D015477 Chronic Myelomonocytic Leukemias
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D015477 2003
% 213.76/213.95  |- skos__broader mesh__D015477smesh__D015464
% 213.76/213.95  |- mesh__dateCreated mesh__D015477 1988-06-09
% 213.76/213.95  |- mesh__onlineNote mesh__D015477
% 213.76/213.95       use LEUKEMIA, MYELOID to search LEUKEMIA, MYELOMONOCYTIC 1981-88%A%  
% 213.76/213.95  |- skos__historyNote mesh__D015477 Leukemia, Myelocytic %28%1980-1988%29%
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D015477 2005
% 213.76/213.95  |- skos__hiddenLabel mesh__D015477 Myelomonocytic Leukemias, Chronic
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D015477 2002
% 213.76/213.95  |- mesh__historyNote mesh__D015477
% 213.76/213.95       89; was see LEUKEMIA, MYELOCYTIC 1981-88   
% 213.76/213.95  |- mesh__recordMaintainer mesh__D015477 KEV
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D015477 1997
% 213.76/213.95  |- rdf__type mesh__D015477sskos__Concept
% 213.76/213.95  |- skos__historyNote mesh__D015477 Leukemia, Myeloid %28%1980-1988%29%
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D015477 1999
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D015477 2001
% 213.76/213.95  |- skos__hiddenLabel mesh__D015477 Leukemias, Chronic Myelomonocytic
% 213.76/213.95  |- mesh__recordAuthorizer mesh__D015477 PLS
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D015477 1996
% 213.76/213.95  |- mesh__recordOriginator mesh__D015477 PLS
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D001457 2006
% 213.76/213.95  |- skos__hiddenLabel mesh__D001457 Anion Exchanger, Erythrocyte
% 213.76/213.95  |- mesh__historyNote mesh__D001457
% 213.76/213.95       2002%28%1984%29%; for AE1 ANION EXCHANGER, AE1 CHLORIDE-BICARBONATE EXCHANGER, AE1 Cl- HCO3- EXCHANGER %26% AE1 GENE PRODUCT use CHLORIDE-BICARBONATE ANTIPORTERS %28%NM%29% 1998-2001%A%  
% 213.76/213.95  |- skos__prefLabel mesh__D001457 Anion Exchange Protein 1, Erythrocyte
% 213.76/213.95  |- skos__altLabel mesh__D001457 Protein Band 3
% 213.76/213.95  |- rdf__type mesh__D001457sskos__Concept
% 213.76/213.95  |- skos__altLabel mesh__D001457 AE1 Cl- HCO3- Exchanger
% 213.76/213.95  |- mesh__dateCreated mesh__D001457 1983-05-31
% 213.76/213.95  |- skos__scopeNote mesh__D001457
% 213.76/213.95       A ubiquitous membrane transport protein found in the plasma membrane of diverse cell types and tissues, and in nuclear, mitochondrial, and Golgi membranes. It is the major integral transmembrane protein of the erythrocyte plasma membrane, comprising 25%25% of the total membrane protein. It exists as a dimer and performs the important function of allowing the efficient transport of bicarbonate across erythrocyte cell membranes in exchange for chloride ion.%A%    
% 213.76/213.95  |- skos__altLabel mesh__D001457 Erythrocyte Membrane Band 3 Protein
% 213.76/213.95  |- skos__altLabel mesh__D001457 Erythrocyte Anion Exchanger
% 213.76/213.95  |- skos__broader mesh__D001457smesh__D017920
% 213.76/213.95  |- mesh__recordOriginator mesh__D001457 RLS
% 213.76/213.95  |- mesh__dateRevised mesh__D001457 2005-06-30
% 213.76/213.95  |- skos__broader mesh__D001457smesh__D001798
% 213.76/213.95  |- mesh__publicMeSHNote mesh__D001457
% 213.76/213.95       2002; see BAND 3 PROTEIN 1984-2000; AE1 ANION EXCHANGER, AE1 CHLORIDE-BICARBONATE EXCHANGER, AE1 Cl- HCO3- EXCHANGER %26% AE1 GENE PRODUCT were indexed under ANTIPORTERS 1998-2001%A%  
% 213.76/213.95  |- skos__altLabel mesh__D001457 AE1 Chloride-Bicarbonate Exchanger
% 213.76/213.95  |- skos__hiddenLabel mesh__D001457 AE1 Chloride Bicarbonate Exchanger
% 213.76/213.95  |- skos__hiddenLabel mesh__D001457 AE1 Cl  HCO3  Exchanger
% 213.76/213.95  |- mesh__recordAuthorizer mesh__D001457 sjn
% 213.76/213.95  |- skos__hiddenLabel mesh__D001457 Chloride-Bicarbonate Exchanger, AE1
% 213.76/213.95  |- skos__broader mesh__D001457smesh__D027963
% 213.76/213.95  |- skos__altLabel mesh__D001457
% 213.76/213.95       Erythrocyte Membrane Anion Transport Protein
% 213.76/213.95  |- skos__altLabel mesh__D001457 AE1 Gene Product
% 213.76/213.95  |- skos__altLabel mesh__D001457 Erythrocyte Anion Transport Protein
% 213.76/213.95  |- skos__altLabel mesh__D001457 Capnophorin
% 213.76/213.95  |- skos__historyNote mesh__D001457 Blood Proteins %28%1966-1983%29%
% 213.76/213.95  |- skos__historyNote mesh__D001457 Membrane Proteins %28%1977-1983%29%
% 213.76/213.95  |- skos__hiddenLabel mesh__D001457 Protein, Band III
% 213.76/213.95  |- mesh__dateEstablished mesh__D001457 1984-01-01
% 213.76/213.95  |- mesh__recordMaintainer mesh__D001457 jmp
% 213.76/213.95  |- skos__hiddenLabel mesh__D001457 Protein, Band 3
% 213.76/213.95  |- skos__altLabel mesh__D001457 Band III Protein
% 213.76/213.95  |- skos__altLabel mesh__D001457 Band 3 Protein
% 213.76/213.95  |- skos__altLabel mesh__D001457 Anion Transport Protein, Erythrocyte
% 213.76/213.95  |- skos__altLabel mesh__D001457 AE1 Anion Exchanger
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006940 2005
% 213.76/213.95  |- mesh__dateRevised mesh__D006940 1993-06-02
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006940 2000
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006940 2004
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006940 2001
% 213.76/213.95  |- skos__broader mesh__D006940smesh__D002318
% 213.76/213.95  |- mesh__recordOriginator mesh__D006940 NLM
% 213.76/213.95  |- mesh__dateCreated mesh__D006940 1999-01-01
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006940 2006
% 213.76/213.95  |- mesh__recordMaintainer mesh__D006940 TAP
% 213.76/213.95  |- skos__hiddenLabel mesh__D006940 Hyperemias
% 213.76/213.95  |- mesh__recordAuthorizer mesh__D006940 PLS
% 213.76/213.95  |- skos__prefLabel mesh__D006940 Hyperemia
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006940 1996
% 213.76/213.95  |- skos__scopeNote mesh__D006940
% 213.76/213.95       The presence of an increased amount of blood in a part or organ. %28%Stedman, 25th ed%29%%A%    
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006940 1998
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006940 2002
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006940 1997
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006940 1994
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006940 1999
% 213.76/213.95  |- skos__annotation mesh__D006940 increased amount of blood in an organ   
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006940 1995
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D006940 2003
% 213.76/213.95  |- rdf__type mesh__D006940sskos__Concept
% 213.76/213.95  |- mesh__recordMaintainer mesh__D020611 SYSTEM
% 213.76/213.95  |- mesh__recordOriginator mesh__D020611 ndw
% 213.76/213.95  |- skos__historyNote mesh__D020611 Enterobacteriaceae %28%1969-1999%29%
% 213.76/213.95  |- mesh__publicMeSHNote mesh__D020611 2000   
% 213.76/213.95  |- skos__prefLabel mesh__D020611 Hafnia alvei
% 213.76/213.95  |- mesh__recordAuthorizer mesh__D020611 sjn
% 213.76/213.95  |- mesh__dateEstablished mesh__D020611 2000-01-01
% 213.76/213.95  |- rdf__type mesh__D020611sskos__Concept
% 213.76/213.95  |- skos__broader mesh__D020611smesh__D020595
% 213.76/213.95  |- mesh__activeMeSHYear mesh__D020611 2006
% 213.76/213.95  |- mesh__dateRevised mesh__D020611 2005-06-30
% 213.76/213.95  |- skos__scopeNote mesh__D020611
% 213.76/213.95       The type species for the genus HAFNIA. It is distinguished from other biochemically similar bacteria by its lack of acid production on media containing sucrose. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 213.76/213.95  |- mesh__historyNote mesh__D020611 2000   
% 213.76/213.95  |- skos__annotation mesh__D020611
% 213.76/213.95       infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 213.76/213.95  |- mesh__dateCreated mesh__D020611 1999-11-03
% 213.76/213.95  |- skos__hiddenLabel mesh__D019868 3%27%-Phosphotransferase, Amikacin
% 213.76/213.95  |- rdf__type mesh__D019868sskos__Concept
% 213.76/213.95  |- skos__hiddenLabel mesh__D019868 Kanamycin Neomycin Phosphate Transferase
% 213.76/213.95  |- mesh__recordMaintainer mesh__D019868 jmp
% 213.76/213.95  |- skos__hiddenLabel mesh__D019868 APT 3%27% I and II
% 213.76/213.95  |- skos__altLabel mesh__D019868 Neomycin Phosphotransferase
% 213.76/213.95  |- skos__hiddenLabel mesh__D019868 Phosphotransferase II, Neomycin
% 213.76/213.95  |- skos__hiddenLabel mesh__D019868 Amikacin 3%27% Phosphotransferase
% 213.76/213.95  |- skos__altLabel mesh__D019868
% 213.76/213.95       Aminoglycoside 3%27%-Phosphotransferase Type VIII
% 213.76/213.95  |- skos__altLabel mesh__D019868 Amikacin 3%27%-Phosphotransferase
% 213.76/213.95  |- mesh__recordAuthorizer mesh__D019868 sjn
% 213.76/213.95  |- skos__hiddenLabel mesh__D019868 Phosphotransferase, Aminoglycoside
% 213.76/213.95  |- skos__scopeNote mesh__D019868
% 213.76/213.95       A class of enzymes that inactivate aminocyclitol-aminoglycoside antibiotics %28%AMINOGLYCOSIDES%29% by regiospecific PHOSPHORYLATION of the 3%27% and/or 5%27% hydroxyl.%A%    
% 213.76/213.95  |- skos__altLabel mesh__D019868 APT-3%27%-I and II
% 213.76/213.95  |- skos__hiddenLabel mesh__D019868 Kinase, Kanamycin
% 213.76/213.95  |- skos__hiddenLabel mesh__D019868
% 213.76/213.95       Aminoglycoside 3%27% Phosphotransferase Type VIII
% 213.76/213.95  |- skos__altLabel mesh__D019868 Aminocyclitol Phosphotransferase
% 213.76/213.95  |- mesh__recordOriginator mesh__D019868 KEV
% 213.76/213.96  |- mesh__dateRevised mesh__D019868 2004-07-07
% 213.76/213.96  |- skos__altLabel mesh__D019868 Aminoglycoside Phosphotransferase
% 213.76/213.96  |- skos__hiddenLabel mesh__D019868 Phosphotransferase, Neomycin
% 213.76/213.96  |- skos__altLabel mesh__D019868 Kanamycin-Neomycin Phosphate Transferase
% 213.76/213.96  |- mesh__dateEstablished mesh__D019868 1998-01-01
% 213.76/213.96  |- skos__hiddenLabel mesh__D019868
% 213.76/213.96       Phosphate Transferase, Kanamycin-Neomycin
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D019868 2005
% 213.76/213.96  |- skos__historyNote mesh__D019868 Phosphotransferases %28%1976-1993%29%
% 213.76/213.96  |- mesh__historyNote mesh__D019868
% 213.76/213.96       98; use KANAMYCIN KINASE %28%NM%29% 1980-97   
% 213.76/213.96  |- skos__historyNote mesh__D019868 Kanamycin %28%1976-1980%29%
% 213.76/213.96  |- skos__hiddenLabel mesh__D019868
% 213.76/213.96       Transferase, Kanamycin-Neomycin Phosphate
% 213.76/213.96  |- skos__broader mesh__D019868smesh__D017853
% 213.76/213.96  |- mesh__publicMeSHNote mesh__D019868
% 213.76/213.96       98; KANAMYCIN KINASE was indexed under PHOSPHOTRANSFERASES %28%ALCOHOL GROUP ACCEPTOR%29% 1994-97, PHOSPHOTRANSFERASES, ATP 1976-93 %26% KANAMYCIN 1976-80%A%  
% 213.76/213.96  |- mesh__dateCreated mesh__D019868 1997-07-02
% 213.76/213.96  |- skos__hiddenLabel mesh__D019868 Phosphotransferase, Aminocyclitol
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D019868 2006
% 213.76/213.96  |- skos__prefLabel mesh__D019868 Kanamycin Kinase
% 213.76/213.96  |- skos__altLabel mesh__D019868 aphVII Gene Product
% 213.76/213.96  |- skos__historyNote mesh__D019868
% 213.76/213.96       Phosphotransferases %28%Alcohol Group Acceptor%29% %28%1994-1997%29%
% 213.76/213.96  |- mesh__dateCreated mesh__D011885 1999-01-01
% 213.76/213.96  |- rdf__type mesh__D011885sskos__Concept
% 213.76/213.96  |- skos__hiddenLabel mesh__D011885 Fractures, Radius
% 213.76/213.96  |- mesh__dateRevised mesh__D011885 2005-06-30
% 213.76/213.96  |- skos__broader mesh__D011885smesh__D005543
% 213.76/213.96  |- mesh__recordAuthorizer mesh__D011885 sjn
% 213.76/213.96  |- skos__hiddenLabel mesh__D011885 Fracture, Radius
% 213.76/213.96  |- skos__hiddenLabel mesh__D011885 Radius Fracture
% 213.76/213.96  |- mesh__recordOriginator mesh__D011885 NLM
% 213.76/213.96  |- mesh__recordMaintainer mesh__D011885 ssb
% 213.76/213.96  |- skos__prefLabel mesh__D011885 Radius Fractures
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D011885 2006
% 213.76/213.96  |- skos__broader mesh__D011885smesh__D050723
% 213.76/213.96  |- mesh__recordAuthorizer mesh__D038224 sjn
% 213.76/213.96  |- skos__altLabel mesh__D038224 omega-Crystallin
% 213.76/213.96  |- mesh__recordMaintainer mesh__D038224 jmp
% 213.76/213.96  |- skos__broader mesh__D038224smesh__D003459
% 213.76/213.96  |- skos__altLabel mesh__D038224 Crystallins, omega
% 213.76/213.96  |- rdf__type mesh__D038224sskos__Concept
% 213.76/213.96  |- mesh__dateRevised mesh__D038224 2005-06-30
% 213.76/213.96  |- skos__hiddenLabel mesh__D038224 omega Crystallin
% 213.76/213.96  |- skos__broader mesh__D038224smesh__D000444
% 213.76/213.96  |- mesh__dateCreated mesh__D038224 2002-07-03
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D038224 2006
% 213.76/213.96  |- mesh__historyNote mesh__D038224
% 213.76/213.96       2003; for OMEGA-CRYSTALLIN use CRYSTALLINS 1998-2002   
% 213.76/213.96  |- mesh__publicMeSHNote mesh__D038224
% 213.76/213.96       2003; for OMEGA-CRYSTALLIN see CRYSTALLINS 1998-2002   
% 213.76/213.96  |- skos__hiddenLabel mesh__D038224 omega Crystallins
% 213.76/213.96  |- mesh__dateEstablished mesh__D038224 2003-01-01
% 213.76/213.96  |- skos__scopeNote mesh__D038224
% 213.76/213.96       A type of crystallin that has been found in the lens %28%LENS, CRYSTALLINE%29% of certain species of MOLLUSCA such as SQUID and OCTOPUS. It is an inactivated form of aldehyde dehydrogenase.%A%    
% 213.76/213.96  |- mesh__recordOriginator mesh__D038224 jmp
% 213.76/213.96  |- skos__historyNote mesh__D038224 Crystallins %28%1988-2002%29%
% 213.76/213.96  |- skos__prefLabel mesh__D038224 omega-Crystallins
% 213.76/213.96  |- skos__annotation mesh__D011087 a myeloproliferative disord   
% 213.76/213.96  |- skos__prefLabel mesh__D011087 Polycythemia Vera
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D011087 2000
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D011087 2006
% 213.76/213.96  |- mesh__recordAuthorizer mesh__D011087 PLS
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D011087 2003
% 213.76/213.96  |- skos__broader mesh__D011087smesh__D009196
% 213.76/213.96  |- skos__scopeNote mesh__D011087
% 213.76/213.96       A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites %28%liver and spleen%29%. In time myelofibrosis occurs.%A%    
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D011087 2005
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D011087 1997
% 213.76/213.96  |- skos__hiddenLabel mesh__D011087 Disease, Osler-Vaquez
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D011087 1999
% 213.76/213.96  |- mesh__recordMaintainer mesh__D011087 PXP
% 213.76/213.96  |- mesh__recordOriginator mesh__D011087 NLM
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D011087 1996
% 213.76/213.96  |- rdf__type mesh__D011087sskos__Concept
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D011087 1995
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D011087 1998
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D011087 2002
% 213.76/213.96  |- skos__altLabel mesh__D011087 Osler-Vaquez Disease
% 213.76/213.96  |- skos__altLabel mesh__D011087 Erythremia
% 213.76/213.96  |- mesh__dateCreated mesh__D011087 1999-01-01
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D011087 2001
% 213.76/213.96  |- skos__hiddenLabel mesh__D011087 Osler Vaquez Disease
% 213.76/213.96  |- skos__hiddenLabel mesh__D011087 Erythremias
% 213.76/213.96  |- mesh__dateRevised mesh__D011087 1994-04-16
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D011087 2004
% 213.76/213.96  |- skos__scopeNote mesh__D005848
% 213.76/213.96       A mitosporic Saccharomycetales fungal genus, various species of which have been isolated from pulmonary lesions. Teleomorphs include Dipodascus and Galactomyces.%A%    
% 213.76/213.96  |- skos__annotation mesh__D005848 infection = GEOTRICHOSIS   
% 213.76/213.96  |- mesh__dateRevised mesh__D005848 2005-06-30
% 213.76/213.96  |- mesh__dateCreated mesh__D005848 1974-11-19
% 213.76/213.96  |- mesh__dateEstablished mesh__D005848 1991-01-01
% 213.76/213.96  |- skos__prefLabel mesh__D005848 Geotrichum
% 213.76/213.96  |- skos__broader mesh__D005848smesh__D003904
% 213.76/213.96  |- mesh__recordMaintainer mesh__D005848 SYSTEM
% 213.76/213.96  |- mesh__publicMeSHNote mesh__D005848
% 213.76/213.96       91; see HYPHOMYCETES 1986-90, see MONILIALES 1975-85   
% 213.76/213.96  |- mesh__recordOriginator mesh__D005848 NLM
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D005848 2006
% 213.76/213.96  |- mesh__recordAuthorizer mesh__D005848 sjn
% 213.76/213.96  |- rdf__type mesh__D005848sskos__Concept
% 213.76/213.96  |- mesh__historyNote mesh__D005848 91%28%75%29%   
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D016570 2006A
% 213.76/213.96  |- skos__hiddenLabel mesh__D016570 Membrane, Bruch%27%s
% 213.76/213.96  |- skos__historyNote mesh__D016570 Choroid %28%1966-1991%29%
% 213.76/213.96  |- mesh__dateRevised mesh__D016570 2005-07-28
% 213.76/213.96  |- mesh__publicMeSHNote mesh__D016570 92   
% 213.76/213.96  |- skos__historyNote mesh__D016570 Membranes %28%1972-1991%29%
% 213.76/213.96  |- skos__broader mesh__D016570smesh__D001485
% 213.76/213.96  |- skos__historyNote mesh__D016570 Basement Membrane %28%1967-1991%29%
% 213.76/213.96  |- skos__altLabel mesh__D016570 Bruch%27%s Membrane
% 213.76/213.96  |- skos__scopeNote mesh__D016570
% 213.76/213.96       The inner layer of CHOROID, also called the lamina basalis choroideae, located adjacent to the RETINAL PIGMENT EPITHELIUM; %28%RPE%29% of the EYE. It is a membrane composed of the basement membranes of the choriocapillaris ENDOTHELIUM and that of the RPE. The membrane stops at the OPTIC NERVE, as does the RPE.%A%    
% 213.76/213.96  |- skos__altLabel mesh__D016570 Lamina Basalis Choroideae
% 213.76/213.96  |- mesh__dateCreated mesh__D016570 1991-01-02
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D016570 2006
% 213.76/213.96  |- skos__prefLabel mesh__D016570 Bruch Membrane
% 213.76/213.96  |- mesh__recordMaintainer mesh__D016570 ags
% 213.76/213.96  |- mesh__historyNote mesh__D016570 92   
% 213.76/213.96  |- skos__hiddenLabel mesh__D016570 Bruchs Membrane
% 213.76/213.96  |- mesh__recordOriginator mesh__D016570 MXR
% 213.76/213.96  |- mesh__recordAuthorizer mesh__D016570 ags
% 213.76/213.96  |- mesh__dateEstablished mesh__D016570 1992-01-01
% 213.76/213.96  |- skos__broader mesh__D016570smesh__D002829
% 213.76/213.96  |- skos__hiddenLabel mesh__D016570 Membrane, Bruch
% 213.76/213.96  |- rdf__type mesh__D016570sskos__Concept
% 213.76/213.96  |- mesh__recordMaintainer mesh__D030241 ags
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D030241 2004
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D030241 2005
% 213.76/213.96  |- skos__annotation mesh__D030241
% 213.76/213.96       infection: coord IM with BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE %28%IM%29% or PESTIVIRUS INFECTIONS %28%IM%29% if not in cattle%A%  
% 213.76/213.96  |- mesh__dateEstablished mesh__D030241 2002-01-01
% 213.76/213.96  |- mesh__recordOriginator mesh__D030241 ags
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D030241 2006A
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D030241 2003
% 213.76/213.96  |- skos__broader mesh__D030241smesh__D001908
% 213.76/213.96  |- mesh__recordAuthorizer mesh__D030241 ags
% 213.76/213.96  |- skos__altLabel mesh__D030241 Bovine Viral Diarrhea Virus Type 1
% 213.76/213.96  |- mesh__dateCreated mesh__D030241 2001-07-25
% 213.76/213.96  |- skos__prefLabel mesh__D030241 Diarrhea Virus 1, Bovine Viral
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D030241 2002
% 213.76/213.96  |- skos__altLabel mesh__D030241 Bovine viral diarrhea virus 1
% 213.76/213.96  |- rdf__type mesh__D030241sskos__Concept
% 213.76/213.96  |- skos__altLabel mesh__D030241 BVDV Type 1
% 213.76/213.96  |- mesh__publicMeSHNote mesh__D030241 2002   
% 213.76/213.96  |- mesh__historyNote mesh__D030241 2002   
% 213.76/213.96  |- skos__scopeNote mesh__D030241
% 213.76/213.96       A species of PESTIVIRUS causing systemic infections %28%BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE%29% in cattle and some other cloven-hoofed animals. There are several strains and two biotypes: cytopathic %28%rare%29% and non-cytopathic. Infections range from clinically inapparent to severe, but do not correlate with biotypes.%A%    
% 213.76/213.96  |- mesh__dateRevised mesh__D030241 2005-07-08
% 213.76/213.96  |- skos__altLabel mesh__D030241 BVDV-1
% 213.76/213.96  |- skos__altLabel mesh__D030241 BVDV1
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D030241 2006
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D002550 1998
% 213.76/213.96  |- skos__hiddenLabel mesh__D002550 Vein, Sylvian
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D002550 2001
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D002550 1997
% 213.76/213.96  |- mesh__recordOriginator mesh__D002550 VDK
% 213.76/213.96  |- skos__hiddenLabel mesh__D002550 Thalamostriate Veins
% 213.76/213.96  |- skos__hiddenLabel mesh__D002550 Vein, Pial
% 213.76/213.96  |- mesh__dateEstablished mesh__D002550 1987-01-01
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D002550 1999
% 213.76/213.96  |- mesh__dateCreated mesh__D002550 1986-04-18
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D002550 1995
% 213.76/213.96  |- skos__related mesh__D002550smesh__D002533
% 213.76/213.96  |- mesh__dateRevised mesh__D002550 1994-06-03
% 213.76/213.96  |- mesh__recordAuthorizer mesh__D002550 PLS
% 213.76/213.96  |- mesh__historyNote mesh__D002550 87   
% 213.76/213.96  |- skos__hiddenLabel mesh__D002550 Galen Vein
% 213.76/213.96  |- skos__prefLabel mesh__D002550 Cerebral Veins
% 213.76/213.96  |- skos__hiddenLabel mesh__D002550 Veins, Basal
% 213.76/213.96  |- mesh__recordMaintainer mesh__D002550 TGC
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D002550 2002
% 213.76/213.96  |- rdf__type mesh__D002550sskos__Concept
% 213.76/213.96  |- skos__hiddenLabel mesh__D002550 Veins, Pial
% 213.76/213.96  |- skos__scopeNote mesh__D002550 Veins draining the cerebrum.     
% 213.76/213.96  |- skos__hiddenLabel mesh__D002550 Cerebral Vein
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D002550 2003
% 213.76/213.96  |- skos__hiddenLabel mesh__D002550 Vein, Basal
% 213.76/213.96  |- skos__hiddenLabel mesh__D002550 Vein, Cerebral
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D002550 2005
% 213.76/213.96  |- mesh__publicMeSHNote mesh__D002550 87   
% 213.76/213.96  |- skos__hiddenLabel mesh__D002550 Basal Veins
% 213.76/213.96  |- skos__hiddenLabel mesh__D002550 Veins, Thalamostriate
% 213.76/213.96  |- skos__hiddenLabel mesh__D002550 Pial Veins
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D002550 2004
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D002550 1996
% 213.76/213.96  |- skos__hiddenLabel mesh__D002550 Vein, Thalamostriate
% 213.76/213.96  |- skos__hiddenLabel mesh__D002550 Veins, Cerebral
% 213.76/213.96  |- skos__broader mesh__D002550smesh__D014680
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D002550 2006
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D002550 2000
% 213.76/213.96  |- mesh__recordMaintainer mesh__D043169 ssb
% 213.76/213.96  |- mesh__recordAuthorizer mesh__D043169 sjn
% 213.76/213.96  |- skos__historyNote mesh__D043169 Collagen %28%1997-2003%29%
% 213.76/213.96  |- mesh__recordOriginator mesh__D043169 jmp
% 213.76/213.96  |- mesh__dateCreated mesh__D043169 2003-07-09
% 213.76/213.96  |- mesh__dateRevised mesh__D043169 2005-06-30
% 213.76/213.96  |- skos__broader mesh__D043169smesh__D043170
% 213.76/213.96  |- skos__broader mesh__D043169smesh__D043165
% 213.76/213.96  |- rdf__type mesh__D043169sskos__Concept
% 213.76/213.96  |- skos__prefLabel mesh__D043169 Endostatins
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D043169 2006
% 213.76/213.96  |- skos__altLabel mesh__D043169 Endostatin
% 213.76/213.96  |- skos__historyNote mesh__D043169 Peptide Fragments %28%1997-2003%29%
% 213.76/213.96  |- skos__scopeNote mesh__D043169
% 213.76/213.96       Angiostatic proteins that are formed from proteolytic cleavage of COLLAGEN TYPE XVIII.%A%    
% 213.76/213.96  |- mesh__dateEstablished mesh__D043169 2004-01-01
% 213.76/213.96  |- mesh__historyNote mesh__D043169
% 213.76/213.96       2004; use ENDOSTATINS %28%NM%29% 1997-2003   
% 213.76/213.96  |- mesh__publicMeSHNote mesh__D043169
% 213.76/213.96       2004; ENDOSTATINS was indexed under COLLAGEN and PEPTIDE FRAGMENTS 1997-2003%A%  
% 213.76/213.96  |- skos__altLabel mesh__D015478 Antigens, Heterophil
% 213.76/213.96  |- mesh__dateCreated mesh__D015478 1999-01-01
% 213.76/213.96  |- mesh__onlineNote mesh__D015478
% 213.76/213.96       use ANTIGENS, HETEROPHILE to search ANTIGENS, HETEROGENETIC 1966-89 %28%Prov 1966-71%29%%A%  
% 213.76/213.96  |- skos__hiddenLabel mesh__D015478 Paul Bunnell Antigens
% 213.76/213.96  |- skos__hiddenLabel mesh__D015478 Antigens, H-D
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D015478 2006
% 213.76/213.96  |- skos__altLabel mesh__D015478 Xenoantigens
% 213.76/213.96  |- skos__altLabel mesh__D015478 Heteroantigens
% 213.76/213.96  |- skos__altLabel mesh__D015478 Paul-Bunnell Antigens
% 213.76/213.96  |- skos__hiddenLabel mesh__D015478 Xenogeneic Antigens
% 213.76/213.96  |- skos__hiddenLabel mesh__D015478 Hanganutziu Deicher Antigens
% 213.76/213.96  |- skos__hiddenLabel mesh__D015478 H D Antigens
% 213.76/213.96  |- skos__altLabel mesh__D015478 Antigens, Xenogeneic
% 213.76/213.96  |- skos__altLabel mesh__D015478 Heterologous Antigens
% 213.76/213.96  |- skos__altLabel mesh__D015478 Antigens, Heterogenetic
% 213.76/213.96  |- mesh__historyNote mesh__D015478
% 213.76/213.96       90; was ANTIGENS, HETEROGENETIC 1972-89 %28%Prov 1966-71%29%   
% 213.76/213.96  |- skos__altLabel mesh__D015478 Antigens, Xenogenic
% 213.76/213.96  |- skos__altLabel mesh__D015478 Antigens, Heterologous
% 213.76/213.96  |- mesh__publicMeSHNote mesh__D015478
% 213.76/213.96       90; was ANTIGENS, HETEROGENETIC 1972-89   
% 213.76/213.96  |- skos__hiddenLabel mesh__D015478 Antigens, Hanganutziu-Deicher
% 213.76/213.96  |- skos__broader mesh__D015478smesh__D000941
% 213.76/213.96  |- skos__annotation mesh__D015478
% 213.76/213.96       coord IM with specific antigen/organism heading %28%IM%29%   
% 213.76/213.96  |- rdf__type mesh__D015478sskos__Concept
% 213.76/213.96  |- mesh__recordMaintainer mesh__D015478 ssb
% 213.76/213.96  |- skos__scopeNote mesh__D015478
% 213.76/213.96       Antigens stimulating the formation of, or combining with heterophile antibodies. They are cross-reacting antigens found in phylogenetically unrelated species.%A%    
% 213.76/213.96  |- skos__hiddenLabel mesh__D015478 Antigens, Paul-Bunnell
% 213.76/213.96  |- skos__hiddenLabel mesh__D015478 Heterophil Antigens
% 213.76/213.96  |- mesh__recordOriginator mesh__D015478 CAB
% 213.76/213.96  |- skos__altLabel mesh__D015478 Heterogenetic Antigens
% 213.76/213.96  |- skos__prefLabel mesh__D015478 Antigens, Heterophile
% 213.76/213.96  |- mesh__dateEstablished mesh__D015478 1972-01-01
% 213.76/213.96  |- mesh__dateRevised mesh__D015478 2005-06-30
% 213.76/213.96  |- skos__altLabel mesh__D015478 Hanganutziu-Deicher Antigens
% 213.76/213.96  |- skos__hiddenLabel mesh__D015478 Xenogenic Antigens
% 213.76/213.96  |- skos__altLabel mesh__D015478 H-D Antigens
% 213.76/213.96  |- mesh__recordAuthorizer mesh__D015478 sjn
% 213.76/213.96  |- skos__altLabel mesh__D015478 Heterophile Antigens
% 213.76/213.96  |- skos__altLabel mesh__D001458 Elastic Stockings
% 213.76/213.96  |- skos__hiddenLabel mesh__D001458 Stocking, Elastic
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D001458 1998
% 213.76/213.96  |- mesh__dateRevised mesh__D001458 1992-03-25
% 213.76/213.96  |- skos__hiddenLabel mesh__D001458 Compression Stocking
% 213.76/213.96  |- skos__hiddenLabel mesh__D001458 Bandage
% 213.76/213.96  |- skos__prefLabel mesh__D001458 Bandages
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D001458 2003
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D001458 1993
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D001458 1999
% 213.76/213.96  |- skos__annotation mesh__D001458
% 213.76/213.96       spray-on bandages = OCCLUSIVE DRESSINGS   
% 213.76/213.96  |- mesh__publicMeSHNote mesh__D001458
% 213.76/213.96       ELASTIC STOCKINGS %26% STOCKINGS, COMPRESSION were see CLOTHING 1982-89%A%  
% 213.76/213.96  |- skos__hiddenLabel mesh__D001458 Elastic Stocking
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D001458 2004
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D001458 1994
% 213.76/213.96  |- mesh__recordOriginator mesh__D001458 NLM
% 213.76/213.96  |- skos__hiddenLabel mesh__D001458 Compression Stockings
% 213.76/213.96  |- mesh__historyNote mesh__D001458
% 213.76/213.96       ELASTIC STOCKINGS %26% STOCKINGS, COMPRESSION were see CLOTHING 1982-89%A%  
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D001458 2000
% 213.76/213.96  |- skos__hiddenLabel mesh__D001458 Stocking, Compression
% 213.76/213.96  |- mesh__recordMaintainer mesh__D001458 TAP
% 213.76/213.96  |- mesh__onlineNote mesh__D001458
% 213.76/213.96       Use CLOTHING to search ELASTIC STOCKINGS %26% STOCKINGS, COMPRESSION 1982-89%A%  
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D001458 2005
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D001458 1996
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D001458 1995
% 213.76/213.96  |- mesh__recordAuthorizer mesh__D001458 PLS
% 213.76/213.96  |- mesh__dateCreated mesh__D001458 1999-01-01
% 213.76/213.96  |- skos__broader mesh__D001458smesh__D004864
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D001458 2001
% 213.76/213.96  |- skos__hiddenLabel mesh__D001458 Dressing
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D001458 2006
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D001458 1997
% 213.76/213.96  |- skos__scopeNote mesh__D001458
% 213.76/213.96       Material used for wrapping or binding any part of the body.%A%    
% 213.76/213.96  |- rdf__type mesh__D001458sskos__Concept
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D001458 2002
% 213.76/213.96  |- mesh__dateEstablished mesh__D012180 1984-01-01
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D012180 2000
% 213.76/213.96  |- mesh__dateCreated mesh__D012180 1984-06-13
% 213.76/213.96  |- mesh__onlineNote mesh__D012180
% 213.76/213.96       search PUBLISHING for citations about retractions of publication 1984-90%A%  
% 213.76/213.96  |- mesh__historyNote mesh__D012180
% 213.76/213.96       for citations that were retractions of publication 1984-90%A%  
% 213.76/213.96  |- mesh__publicMeSHNote mesh__D012180 84   
% 213.76/213.96  |- skos__annotation mesh__D012180
% 213.76/213.96       IM for publication retraction as a subject %28%e.g., an article on %22%Retraction of Fraudulent Data%22%%29%; do not confuse with Publication Type RETRACTION OF PUBLICATION; do not confuse with Publication Type RETRACTED PUBLICATION which identifies an article or book cited in an NLM database as having been retracted; do not use for authors%27% or editors%27% errata; no qualif; Manual 33.16+%A%  
% 213.76/213.96  |- mesh__recordOriginator mesh__D012180 CAB
% 213.76/213.96  |- skos__prefLabel mesh__D012180 Retraction of Publication
% 213.76/213.96  |- skos__hiddenLabel mesh__D012180 Publication Retractions
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D012180 2002
% 213.76/213.96  |- skos__hiddenLabel mesh__D012180 Publication Retraction
% 213.76/213.96  |- mesh__recordMaintainer mesh__D012180 TAP
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D012180 2006
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D012180 1999
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D012180 2004
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D012180 1997
% 213.76/213.96  |- skos__broader mesh__D012180smesh__D011643
% 213.76/213.96  |- mesh__recordAuthorizer mesh__D012180 PLS
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D012180 2005
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D012180 1998
% 213.76/213.96  |- rdf__type mesh__D012180sskos__Concept
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D012180 2001
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D012180 2003
% 213.76/213.96  |- mesh__dateRevised mesh__D012180 1996-06-10
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D006941 2002
% 213.76/213.96  |- skos__hiddenLabel mesh__D006941 Thermal Hyperesthesias
% 213.76/213.96  |- mesh__dateRevised mesh__D006941 1999-11-03
% 213.76/213.96  |- skos__hiddenLabel mesh__D006941 Hyperesthesias
% 213.76/213.96  |- skos__scopeNote mesh__D006941
% 213.76/213.96       Increased sensitivity to cutaneous stimulation due to a diminished threshold or an increased response to stimuli.%A%    
% 213.76/213.96  |- skos__hiddenLabel mesh__D006941 Hyperesthesias, Tactile
% 213.76/213.96  |- skos__hiddenLabel mesh__D006941 Sensations, Hyperesthetic
% 213.76/213.96  |- skos__hiddenLabel mesh__D006941 Tactile Hyperesthesia
% 213.76/213.96  |- skos__hiddenLabel mesh__D006941 Tactile Hyperesthesias
% 213.76/213.96  |- skos__hiddenLabel mesh__D006941 Sensation, Hyperesthetic
% 213.76/213.96  |- skos__hiddenLabel mesh__D006941 Hyperesthesias, Thermal
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D006941 2000
% 213.76/213.96  |- skos__broader mesh__D006941smesh__D020886
% 213.76/213.96  |- skos__hiddenLabel mesh__D006941 Oxyesthesias
% 213.76/213.96  |- skos__hiddenLabel mesh__D006941 Thermal Hyperesthesia
% 213.76/213.96  |- skos__annotation mesh__D006941
% 213.76/213.96       do not confuse with HYPESTHESIA, diminished sensitivity; coord with TOUCH or HEAT if pertinent%A%  
% 213.76/213.96  |- rdf__type mesh__D006941sskos__Concept
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D006941 2003
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D006941 2001
% 213.76/213.96  |- mesh__recordAuthorizer mesh__D006941 sjn
% 213.76/213.96  |- mesh__recordOriginator mesh__D006941 NLM
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D006941 2005
% 213.76/213.96  |- skos__hiddenLabel mesh__D006941 Hyperesthetic Sensation
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D006941 2004
% 213.76/213.96  |- skos__altLabel mesh__D006941 Hyperesthetic Sensations
% 213.76/213.96  |- mesh__dateCreated mesh__D006941 1999-01-01
% 213.76/213.96  |- skos__altLabel mesh__D006941 Oxyesthesia
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D006941 2006
% 213.76/213.96  |- skos__prefLabel mesh__D006941 Hyperesthesia
% 213.76/213.96  |- mesh__recordMaintainer mesh__D006941 KEV
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D006143 2003
% 213.76/213.96  |- mesh__recordMaintainer mesh__D006143 CCR
% 213.76/213.96  |- mesh__historyNote mesh__D006143
% 213.76/213.96       91%28%75%29%; was see under GUANIDINES 1975-90   
% 213.76/213.96  |- skos__historyNote mesh__D006143 Imines %28%1973-1974%29%
% 213.76/213.96  |- skos__prefLabel mesh__D006143 Guanabenz
% 213.76/213.96  |- mesh__recordAuthorizer mesh__D006143 sjn
% 213.76/213.96  |- mesh__recordOriginator mesh__D006143 NLM
% 213.76/213.96  |- skos__hiddenLabel mesh__D006143 WY8678
% 213.76/213.96  |- skos__scopeNote mesh__D006143
% 213.76/213.96       An alpha-2 selective adrenergic agonist used as an antihypertensive agent.%A%    
% 213.76/213.96  |- skos__hiddenLabel mesh__D006143 BR750
% 213.76/213.96  |- skos__hiddenLabel mesh__D006143 WY 8678
% 213.76/213.96  |- skos__altLabel mesh__D006143 Guanabenz Monoacetate
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D006143 2002
% 213.76/213.96  |- skos__altLabel mesh__D006143 2,6-Dichlorobenzylideneaminoguanidine
% 213.76/213.96  |- skos__historyNote mesh__D006143 Guanidines %28%1973-1974%29%
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D006143 2006
% 213.76/213.96  |- mesh__publicMeSHNote mesh__D006143
% 213.76/213.96       91; was see under GUANIDINES 1975-90   
% 213.76/213.96  |- mesh__dateRevised mesh__D006143 2000-06-22
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D006143 2001
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D006143 2005
% 213.76/213.96  |- mesh__dateEstablished mesh__D006143 1991-01-01
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D006143 2004
% 213.76/213.96  |- mesh__dateCreated mesh__D006143 1974-11-19
% 213.76/213.96  |- skos__broader mesh__D006143smesh__D006146
% 213.76/213.96  |- skos__hiddenLabel mesh__D006143 BR 750
% 213.76/213.96  |- rdf__type mesh__D006143sskos__Concept
% 213.76/213.96  |- skos__hiddenLabel mesh__D006143 Monoacetate, Guanabenz
% 213.76/213.96  |- skos__hiddenLabel mesh__D006143 2,6 Dichlorobenzylideneaminoguanidine
% 213.76/213.96  |- skos__hiddenLabel mesh__D019869 Kinase, Phosphatidylinositol-3-OH
% 213.76/213.96  |- skos__historyNote mesh__D019869
% 213.76/213.96       Phosphotransferases %28%Alcohol Group Acceptor%29% %28%1994-1997%29%
% 213.76/213.96  |- mesh__publicMeSHNote mesh__D019869
% 213.76/213.96       98; 1-PHOSPHATIDYLINOSITOL 3-KINASE was indexed under PHOSPHOTRANSFERASES %28%ALCOHOL GROUP ACCEPTOR%29% 1994-97 %26% PHOSPHOTRANSFERASES, ATP 1988-93%A%  
% 213.76/213.96  |- skos__altLabel mesh__D019869 PI-3 Kinase
% 213.76/213.96  |- mesh__dateRevised mesh__D019869 2003-07-09
% 213.76/213.96  |- skos__hiddenLabel mesh__D019869 Phosphatidylinositol 3 OH Kinase
% 213.76/213.96  |- skos__altLabel mesh__D019869 PI3-Kinase
% 213.76/213.96  |- rdf__type mesh__D019869sskos__Concept
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D019869 2005
% 213.76/213.96  |- skos__altLabel mesh__D019869 Phosphatidylinositol 3-Kinase
% 213.76/213.96  |- skos__hiddenLabel mesh__D019869 3-Kinase, Vps34 Phosphatidylinositol
% 213.76/213.96  |- skos__broader mesh__D019869smesh__D017853
% 213.76/213.96  |- skos__hiddenLabel mesh__D019869 PI 3 Kinase
% 213.76/213.96  |- skos__scopeNote mesh__D019869
% 213.76/213.96       An enzyme that catalyzes the conversion of phosphatidylinositol to phosphatidylinositol 3-phosphate. This is the first committed step in the biosynthesis of phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate. This pathway is thought to play a critical role in DNA repair, V%28%D%29%J recombination and cell cycle checkpoints. EC 2.7.1.137.%A%    
% 213.76/213.96  |- skos__hiddenLabel mesh__D019869 1 Phosphatidylinositol 3 Kinase
% 213.76/213.96  |- skos__altLabel mesh__D019869 PI 3-Kinase
% 213.76/213.96  |- mesh__historyNote mesh__D019869
% 213.76/213.96       98; use 1-PHOSPHATIDYLINOSITOL 3-KINASE %28%NM%29% 1988-97   
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D019869 2006
% 213.76/213.96  |- skos__hiddenLabel mesh__D019869 PI3 Kinase
% 213.76/213.96  |- skos__hiddenLabel mesh__D019869 gamma, p110
% 213.76/213.96  |- skos__hiddenLabel mesh__D019869 PI 3K Isotype p110 gamma
% 213.76/213.96  |- skos__prefLabel mesh__D019869 1-Phosphatidylinositol 3-Kinase
% 213.76/213.96  |- skos__hiddenLabel mesh__D019869 Subunit, PI-3K alpha-P85
% 213.76/213.96  |- skos__hiddenLabel mesh__D019869 3-Hydroxykinase, Phosphoinositide
% 213.76/213.96  |- mesh__recordAuthorizer mesh__D019869 sjn
% 213.76/213.96  |- skos__hiddenLabel mesh__D019869 Kinase, PI-3
% 213.76/213.96  |- skos__altLabel mesh__D019869 PI-3K
% 213.76/213.96  |- skos__hiddenLabel mesh__D019869 Vps34 Phosphatidylinositol 3 Kinase
% 213.76/213.96  |- skos__hiddenLabel mesh__D019869 3-Kinase, 1-Phosphatidylinositol
% 213.76/213.96  |- mesh__activeMeSHYear mesh__D019869 2004
% 213.76/213.96  |- skos__altLabel mesh__D019869 Phosphatidylinositol-3-OH Kinase
% 213.76/213.96  |- skos__hiddenLabel mesh__D019869 Phosphoinositide 3 Hydroxykinase
% 213.76/213.96  |- skos__altLabel mesh__D019869 Phosphoinositide 3-Hydroxykinase
% 213.76/213.96  |- mesh__recordMaintainer mesh__D019869 ssb
% 213.76/213.96  |- skos__hiddenLabel mesh__D019869 3-Kinase, Phosphatidylinositol
% 213.76/213.96  |- skos__hiddenLabel mesh__D019869 Phosphatidylinositol 3-Kinase, Vps34
% 213.76/213.96  |- skos__hiddenLabel mesh__D019869 PI-3K alpha-P85 Subunit
% 213.76/213.96  |- mesh__dateEstablished mesh__D019869 1998-01-01
% 213.76/213.96  |- skos__altLabel mesh__D019869 PtdIns 3-Kinase
% 213.76/213.96  |- skos__hiddenLabel mesh__D019869 PtdIns 3 Kinase
% 213.76/213.96  |- skos__altLabel mesh__D019869 p110 gamma
% 213.76/213.96  |- skos__hiddenLabel mesh__D019869 alpha P85 Subunit, PI 3K
% 213.76/213.96  |- skos__hiddenLabel mesh__D019869 Phosphatidylinositol 3 Kinase
% 213.76/213.97  |- skos__historyNote mesh__D019869 Phosphotransferases %28%1988-1993%29%
% 213.76/213.97  |- mesh__recordOriginator mesh__D019869 KEV
% 213.76/213.97  |- mesh__dateCreated mesh__D019869 1997-07-02
% 213.76/213.97  |- skos__hiddenLabel mesh__D019869 3-Kinase, PI
% 213.76/213.97  |- skos__hiddenLabel mesh__D019869 3-Kinase, PtdIns
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D011886 1997
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D011886 2006
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D011886 2000
% 213.76/213.97  |- mesh__recordOriginator mesh__D011886 NLM
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D011886 1998
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D011886 2004
% 213.76/213.97  |- skos__broader mesh__D011886smesh__D004603
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D011886 2005
% 213.76/213.97  |- skos__related mesh__D011886smesh__D000396
% 213.76/213.97  |- skos__broader mesh__D011886smesh__D005741
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D011886 2003
% 213.76/213.97  |- skos__prefLabel mesh__D011886 Radon
% 213.76/213.97  |- mesh__historyNote mesh__D011886
% 213.76/213.97       ACTINON was see RADON 1978-93; THORON %28%ELEMENT%29% was %28%NM%29% 1974-93%A%  
% 213.76/213.97  |- rdf__type mesh__D011886sskos__Concept
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D011886 2002
% 213.76/213.97  |- mesh__recordAuthorizer mesh__D011886 PLS
% 213.76/213.97  |- mesh__dateCreated mesh__D011886 1999-01-01
% 213.76/213.97  |- mesh__publicMeSHNote mesh__D011886
% 213.76/213.97       ACTINON was see RADON 1978-93; THORON %28%ELEMENT%29% was indexed under RADON 1983-93 %26% RADIOISOTOPES 1974-82%A%  
% 213.76/213.97  |- mesh__dateRevised mesh__D011886 1996-06-10
% 213.76/213.97  |- skos__annotation mesh__D011886
% 213.76/213.97       naturally radioactive; a rare gas; IM; /ther use: for curietherapy consider also BRACHYTHERAPY; RADON DAUGHTERS is also available%A%  
% 213.76/213.97  |- skos__scopeNote mesh__D011886
% 213.76/213.97       Radon. A naturally radioactive element with atomic symbol Rn, atomic number 86, and atomic weight 222. It is a member of the noble gas family and released during the decay of radium and found in soil. There is a link between exposure to radon and lung cancer.%A%    
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D011886 2001
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D011886 1999
% 213.76/213.97  |- mesh__recordMaintainer mesh__D011886 TGC
% 213.76/213.97  |- mesh__onlineNote mesh__D011886
% 213.76/213.97       use RADON to search ACTINON 1978-93; use RADON %28%NM%29% to search THORON %28%ELEMENT%29% 1980-93%A%  
% 213.76/213.97  |- mesh__recordAuthorizer mesh__D044262 sjn
% 213.76/213.97  |- skos__prefLabel mesh__D044262 Prostaglandin H2
% 213.76/213.97  |- mesh__dateEstablished mesh__D044262 2004-01-01
% 213.76/213.97  |- skos__historyNote mesh__D044262
% 213.76/213.97       Prostaglandin Endoperoxides, Synthetic %28%1986-1992%29%
% 213.76/213.97  |- skos__altLabel mesh__D044262 PGH2
% 213.76/213.97  |- mesh__publicMeSHNote mesh__D044262
% 213.76/213.97       2004; PROSTAGLANDIN H2 was indexed under PROSTAGLANDINS H 1993-2003 %26% PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC 1986-1992%A%  
% 213.76/213.97  |- mesh__recordOriginator mesh__D044262 jmp
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D044262 2006
% 213.76/213.97  |- skos__altLabel mesh__D044262 PGH%28%2%29%
% 213.76/213.97  |- skos__historyNote mesh__D044262 Prostaglandins H %28%1993-2003%29%
% 213.76/213.97  |- rdf__type mesh__D044262sskos__Concept
% 213.76/213.97  |- skos__scopeNote mesh__D044262
% 213.76/213.97       A cyclic endoperoxide intermediate produced by the action of CYCLOOXYGENASE on ARACHIDONIC ACID. It is further converted by a series of specific enzymes to the series 2 prostaglandins.%A%    
% 213.76/213.97  |- skos__broader mesh__D044262smesh__D011463
% 213.76/213.97  |- mesh__dateCreated mesh__D044262 2003-07-09
% 213.76/213.97  |- mesh__dateRevised mesh__D044262 2005-06-30
% 213.76/213.97  |- mesh__historyNote mesh__D044262
% 213.76/213.97       2004; use PROSTAGLANDIN H2 %28%NM%29% 1980-2003   
% 213.76/213.97  |- skos__annotation mesh__D044262
% 213.76/213.97       /analogs: coord with PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC if pertinent%A%  
% 213.76/213.97  |- mesh__recordMaintainer mesh__D044262 ssb
% 213.76/213.97  |- mesh__historyNote mesh__D038225
% 213.76/213.97       2003; for TAU-CRYSTALLIN use CRYSTALLINS 2001-2002   
% 213.76/213.97  |- skos__broader mesh__D038225smesh__D003459
% 213.76/213.97  |- mesh__dateEstablished mesh__D038225 2003-01-01
% 213.76/213.97  |- mesh__recordAuthorizer mesh__D038225 ags
% 213.76/213.97  |- mesh__recordMaintainer mesh__D038225 ags
% 213.76/213.97  |- mesh__dateCreated mesh__D038225 2002-07-03
% 213.76/213.97  |- skos__scopeNote mesh__D038225
% 213.76/213.97       A type of crystallin that has been found in the lens %28%LENS, CRYSTALLINE%29% of certain species of VERTEBRATES. They are inactivated form of PHOSPHOPYRUVATE HYDRATASE.%A%    
% 213.76/213.97  |- skos__broader mesh__D038225smesh__D010751
% 213.76/213.97  |- skos__altLabel mesh__D038225 tau-Crystallin
% 213.76/213.97  |- rdf__type mesh__D038225sskos__Concept
% 213.76/213.97  |- skos__prefLabel mesh__D038225 tau-Crystallins
% 213.76/213.97  |- skos__altLabel mesh__D038225 Crystallins, tau
% 213.76/213.97  |- skos__historyNote mesh__D038225 Crystallins %28%1985-2002%29%
% 213.76/213.97  |- skos__hiddenLabel mesh__D038225 tau Crystallins
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D038225 2006
% 213.76/213.97  |- mesh__recordOriginator mesh__D038225 jmp
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D038225 2006A
% 213.76/213.97  |- skos__hiddenLabel mesh__D038225 tau Crystallin
% 213.76/213.97  |- mesh__publicMeSHNote mesh__D038225
% 213.76/213.97       2003; for TAU-CRYSTALLIN see CRYSTALLINS 2001-2002   
% 213.76/213.97  |- mesh__dateRevised mesh__D038225 2005-07-18
% 213.76/213.97  |- mesh__recordOriginator mesh__D011088 RLS
% 213.76/213.97  |- mesh__historyNote mesh__D011088
% 213.76/213.97       98%28%77%29%; for DNA LIGASES use POLYNUCLEOTIDE SYNTHETASES 1973-76%A%  
% 213.76/213.97  |- skos__hiddenLabel mesh__D011088 Joinases, DNA
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D011088 2005
% 213.76/213.97  |- mesh__dateRevised mesh__D011088 2003-07-09
% 213.76/213.97  |- mesh__dateCreated mesh__D011088 1977-05-23
% 213.76/213.97  |- rdf__type mesh__D011088sskos__Concept
% 213.76/213.97  |- skos__hiddenLabel mesh__D011088 Ligases, Polydeoxyribonucleotide
% 213.76/213.97  |- skos__hiddenLabel mesh__D011088 DNA Ligase, T4
% 213.76/213.97  |- mesh__dateEstablished mesh__D011088 1991-01-01
% 213.76/213.97  |- skos__broader mesh__D011088smesh__D011118
% 213.76/213.97  |- skos__hiddenLabel mesh__D011088 Ligase, T4 DNA
% 213.76/213.97  |- mesh__recordMaintainer mesh__D011088 jmp
% 213.76/213.97  |- skos__altLabel mesh__D011088 Polydeoxyribonucleotide Ligases
% 213.76/213.97  |- skos__historyNote mesh__D011088
% 213.76/213.97       Polynucleotide Synthetases %28%1974-1977%29%
% 213.76/213.97  |- skos__altLabel mesh__D011088 Polydeoxyribonucleotide Synthetases
% 213.76/213.97  |- mesh__recordAuthorizer mesh__D011088 sjn
% 213.76/213.97  |- skos__scopeNote mesh__D011088
% 213.76/213.97       Poly%28%deoxyribonucleotide%29%:poly%28%deoxyribonucleotide%29%ligases. Enzymes that catalyze the joining of preformed deoxyribonucleotides in phosphodiester linkage during genetic processes during repair of a single-stranded break in duplex DNA. The class includes both EC 6.5.1.1 %28%ATP%29% and EC 6.5.1.2 %28%NAD%29%.%A%    
% 213.76/213.97  |- skos__altLabel mesh__D011088 DNA Joinases
% 213.76/213.97  |- skos__hiddenLabel mesh__D011088 Ligases, DNA
% 213.76/213.97  |- mesh__publicMeSHNote mesh__D011088
% 213.76/213.97       98; see POLYDEOXYRIBONUCLEOTIDE SYNTHETASES 1991-97, see POLYNUCLEOTIDE SYNTHETASES 1978-90; for DNA LIGASES see POLYNUCLEOTIDE SYNTHETASES 1974-77, %26% see DNA LIGASE 1973-76%A%  
% 213.76/213.97  |- skos__hiddenLabel mesh__D011088 Synthetases, Polydeoxyribonucleotide
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D011088 2004
% 213.76/213.97  |- skos__annotation mesh__D011088
% 213.76/213.97       do not confuse X ref POLYDEOXYRIBONUCLEOTIDE SYNTHETASES with X ref POLYRIBONUCLEOTIDE SYNTHETASE%A%  
% 213.76/213.97  |- skos__broader mesh__D011088smesh__D045643
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D011088 2006
% 213.76/213.97  |- skos__prefLabel mesh__D011088 DNA Ligases
% 213.76/213.97  |- mesh__publicMeSHNote mesh__D005849
% 213.76/213.97       82; was GERBILS 1968-81; PSAMMOMYS was see CRICETIDAE 1982-90%A%  
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D005849 2004
% 213.76/213.97  |- mesh__onlineNote mesh__D005849
% 213.76/213.97       use GERBILLINAE to search GERBILS 1968-81; use MICROTINAE to search PSAMMOMYS 1982-90%A%  
% 213.76/213.97  |- skos__hiddenLabel mesh__D005849 Sand Rat
% 213.76/213.97  |- skos__broader mesh__D005849smesh__D009115
% 213.76/213.97  |- skos__hiddenLabel mesh__D005849 Gerbil
% 213.76/213.97  |- mesh__recordAuthorizer mesh__D005849 sjn
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D005849 2005
% 213.76/213.97  |- mesh__recordOriginator mesh__D005849 NLM
% 213.76/213.97  |- mesh__dateEstablished mesh__D005849 1968-01-01
% 213.76/213.97  |- skos__annotation mesh__D005849
% 213.76/213.97       rodents; NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 213.76/213.97  |- skos__prefLabel mesh__D005849 Gerbillinae
% 213.76/213.97  |- skos__altLabel mesh__D005849 Jird
% 213.76/213.97  |- mesh__historyNote mesh__D005849
% 213.76/213.97       82; was GERBILS 1968-81; PSAMMOMYS was see CRICETIDAE 1982-90%A%  
% 213.76/213.97  |- skos__hiddenLabel mesh__D005849 Jirds
% 213.76/213.97  |- skos__hiddenLabel mesh__D005849 Sand Rats
% 213.76/213.97  |- mesh__dateCreated mesh__D005849 1999-01-01
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D005849 2006
% 213.76/213.97  |- skos__scopeNote mesh__D005849
% 213.76/213.97       A subfamily of the Muridae consisting of several genera including Gerbillus, Rhombomys, Tatera, Meriones, and Psammomys.%A%    
% 213.76/213.97  |- rdf__type mesh__D005849sskos__Concept
% 213.76/213.97  |- mesh__recordMaintainer mesh__D005849 ags
% 213.76/213.97  |- mesh__dateRevised mesh__D005849 2003-07-09
% 213.76/213.97  |- skos__hiddenLabel mesh__D005849 Rat, Sand
% 213.76/213.97  |- skos__hiddenLabel mesh__D005849 Merione
% 213.76/213.97  |- skos__historyNote mesh__D005849 Rodentia %28%1966-1967%29%
% 213.76/213.97  |- mesh__recordAuthorizer mesh__D016571 sjn
% 213.76/213.97  |- skos__hiddenLabel mesh__D016571 Network Model, Neural
% 213.76/213.97  |- skos__broader mesh__D016571smesh__D010363
% 213.76/213.97  |- skos__hiddenLabel mesh__D016571 Network Models, Neural
% 213.76/213.97  |- skos__altLabel mesh__D016571 Connectionist Models
% 213.76/213.97  |- skos__historyNote mesh__D016571 Computer Simulation %28%1987-1991%29%
% 213.76/213.97  |- skos__altLabel mesh__D016571 Models, Neural Network
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D016571 2006
% 213.76/213.97  |- skos__hiddenLabel mesh__D016571 Models, Connectionist
% 213.76/213.97  |- skos__hiddenLabel mesh__D016571 Model, Neural Network
% 213.76/213.97  |- mesh__publicMeSHNote mesh__D016571 92   
% 213.76/213.97  |- skos__historyNote mesh__D016571
% 213.76/213.97       Image Processing, Computer-Assisted %28%1990-1991%29%
% 213.76/213.97  |- mesh__historyNote mesh__D016571 92   
% 213.76/213.97  |- skos__hiddenLabel mesh__D016571 Model, Connectionist
% 213.76/213.97  |- mesh__recordOriginator mesh__D016571 MXR
% 213.76/213.97  |- mesh__recordMaintainer mesh__D016571 jls
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D016571 2005
% 213.76/213.97  |- mesh__dateRevised mesh__D016571 2004-07-07
% 213.76/213.97  |- skos__broader mesh__D016571smesh__D001185
% 213.76/213.97  |- skos__historyNote mesh__D016571
% 213.76/213.97       Artificial Intelligence %28%1987-1991%29%
% 213.76/213.97  |- skos__hiddenLabel mesh__D016571 Perceptron
% 213.76/213.97  |- skos__broader mesh__D016571smesh__D003661
% 213.76/213.97  |- rdf__type mesh__D016571sskos__Concept
% 213.76/213.97  |- skos__hiddenLabel mesh__D016571 Networks, Neural %28%Computer%29%
% 213.76/213.97  |- skos__hiddenLabel mesh__D016571 Connectionist Model
% 213.76/213.97  |- skos__hiddenLabel mesh__D016571 Neural Network Model
% 213.76/213.97  |- skos__hiddenLabel mesh__D016571 Neural Network %28%Computer%29%
% 213.76/213.97  |- skos__altLabel mesh__D016571 Neural Network Models
% 213.76/213.97  |- skos__scopeNote mesh__D016571
% 213.76/213.97       A computer architecture, implementable in either hardware or software, modeled after biological neural networks. Like the biological system in which the processing capability is a result of the interconnection strengths between arrays of nonlinear processing nodes, computerized neural networks, often called perceptrons or multilayer connectionist models, consist of neuron-like units. A homogeneous group of units makes up a layer. These networks are good at pattern recognition. They are adaptive, performing tasks by example, and thus are better for decision-making than are linear learning machines or cluster analysis. They do not require explicit programming.%A%    
% 213.76/213.97  |- skos__hiddenLabel mesh__D016571 Network, Neural %28%Computer%29%
% 213.76/213.97  |- skos__annotation mesh__D016571
% 213.76/213.97       no qualif; do not confuse with NEURAL NETWORKS %28%ANATOMIC%29% see NERVE NET%A%  
% 213.76/213.97  |- mesh__dateCreated mesh__D016571 1991-01-25
% 213.76/213.97  |- skos__prefLabel mesh__D016571 Neural Networks %28%Computer%29%
% 213.76/213.97  |- skos__altLabel mesh__D016571 Perceptrons
% 213.76/213.97  |- mesh__dateEstablished mesh__D016571 1992-01-01
% 213.76/213.97  |- mesh__dateEstablished mesh__D030242 2002-01-01
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D030242 2003
% 213.76/213.97  |- mesh__recordAuthorizer mesh__D030242 ags
% 213.76/213.97  |- skos__broader mesh__D030242smesh__D001908
% 213.76/213.97  |- skos__altLabel mesh__D030242 Bovine Viral Diarrhea Virus Type 2
% 213.76/213.97  |- skos__prefLabel mesh__D030242 Diarrhea Virus 2, Bovine Viral
% 213.76/213.97  |- rdf__type mesh__D030242sskos__Concept
% 213.76/213.97  |- mesh__publicMeSHNote mesh__D030242 2002   
% 213.76/213.97  |- skos__scopeNote mesh__D030242
% 213.76/213.97       A species of PESTIVIRUS causing systemic infections including BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE and BOVINE HEMORRHAGIC SYNDROME in cattle and some other cloven-hoofed animals. There are several strains and two biotypes: cytopathic %28%rare%29% and non-cytopathic. The severity of disease appears to be strain dependent. Cytopathogenic effects do not correlate with virulence as non-cytopathic BVDV-2 is associated only with Hemorrhagic Disease, Bovine.%A%    
% 213.76/213.97  |- mesh__recordOriginator mesh__D030242 ags
% 213.76/213.97  |- skos__altLabel mesh__D030242 BVDV-2
% 213.76/213.97  |- skos__altLabel mesh__D030242 BVDV2
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D030242 2006A
% 213.76/213.97  |- skos__altLabel mesh__D030242 Bovine viral diarrhea virus 2
% 213.76/213.97  |- skos__altLabel mesh__D030242 BVDV Type 2
% 213.76/213.97  |- mesh__dateCreated mesh__D030242 2001-07-25
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D030242 2006
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D030242 2002
% 213.76/213.97  |- skos__annotation mesh__D030242
% 213.76/213.97       infection = HEMORRHAGIC SYNDROME, BOVINE or coord IM with BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE %28%IM%29% or PESTIVIRUS INFECTIONS %28%IM%29% if not in cattle%A%  
% 213.76/213.97  |- mesh__recordMaintainer mesh__D030242 ags
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D030242 2005
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D030242 2004
% 213.76/213.97  |- mesh__historyNote mesh__D030242 2002   
% 213.76/213.97  |- mesh__dateRevised mesh__D030242 2005-07-15
% 213.76/213.97  |- skos__altLabel mesh__D002551 Cerebral Ventricle Tumors
% 213.76/213.97  |- skos__hiddenLabel mesh__D002551 Brain Ventricular Tumor
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D002551 2000
% 213.76/213.97  |- skos__hiddenLabel mesh__D002551 Neoplasm, Intraventricular
% 213.76/213.97  |- skos__hiddenLabel mesh__D002551 Ventricular Tumor, Brain
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D002551 2005
% 213.76/213.97  |- skos__broader mesh__D002551smesh__D001932
% 213.76/213.97  |- skos__hiddenLabel mesh__D002551 Tumors, Brain Ventricular
% 213.76/213.97  |- skos__hiddenLabel mesh__D002551 Neoplasms, Brain Ventricular
% 213.76/213.97  |- skos__hiddenLabel mesh__D002551 Intraventricular Neoplasm
% 213.76/213.97  |- skos__hiddenLabel mesh__D002551 Tumors, Cerebral Ventricle
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D002551 2001
% 213.76/213.97  |- rdf__type mesh__D002551sskos__Concept
% 213.76/213.97  |- skos__annotation mesh__D002551
% 213.76/213.97       coord IM with histol type of neopl %28%IM%29%   
% 213.76/213.97  |- skos__hiddenLabel mesh__D002551 Neoplasm, Brain Ventricular
% 213.76/213.97  |- skos__hiddenLabel mesh__D002551 Tumor, Cerebral Ventricle
% 213.76/213.97  |- skos__hiddenLabel mesh__D002551 Tumor, Brain Ventricular
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D002551 2006
% 213.76/213.97  |- skos__hiddenLabel mesh__D002551 Cerebral Ventricle Tumor
% 213.76/213.97  |- skos__hiddenLabel mesh__D002551 Ventricle Tumors, Cerebral
% 213.76/213.97  |- mesh__recordAuthorizer mesh__D002551 sjn
% 213.76/213.97  |- mesh__recordMaintainer mesh__D002551 KEV
% 213.76/213.97  |- skos__scopeNote mesh__D002551
% 213.76/213.97       Neoplasms located in the brain ventricles, including the two lateral, the third, and the fourth ventricle. Ventricular tumors may be primary %28%e.g., CHOROID PLEXUS NEOPLASMS and GLIOMA, SUBEPENDYMAL%29%, metastasize from distant organs, or occur as extensions of locally invasive tumors from adjacent brain structures.%A%    
% 213.76/213.97  |- skos__hiddenLabel mesh__D002551 Brain Ventricular Neoplasm
% 213.76/213.97  |- mesh__recordOriginator mesh__D002551 NLM
% 213.76/213.97  |- skos__altLabel mesh__D002551 Ventricular Neoplasms, Brain
% 213.76/213.97  |- skos__hiddenLabel mesh__D002551 Ventricular Neoplasm, Brain
% 213.76/213.97  |- skos__altLabel mesh__D002551 Intraventricular Neoplasms
% 213.76/213.97  |- skos__altLabel mesh__D002551 Neoplasms, Cerebral Ventricle
% 213.76/213.97  |- skos__altLabel mesh__D002551 Neoplasms, Intraventricular
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D002551 2003
% 213.76/213.97  |- mesh__dateCreated mesh__D002551 1999-01-01
% 213.76/213.97  |- skos__hiddenLabel mesh__D002551 Brain Ventricular Tumors
% 213.76/213.97  |- skos__altLabel mesh__D002551 Cerebroventricular Neoplasms
% 213.76/213.97  |- skos__hiddenLabel mesh__D002551 Neoplasm, Cerebroventricular
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D002551 2002
% 213.76/213.97  |- skos__altLabel mesh__D002551 Neoplasms, Ventricular, Brain
% 213.76/213.97  |- skos__altLabel mesh__D002551 Ventricular Tumors, Brain
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D002551 2004
% 213.76/213.97  |- skos__hiddenLabel mesh__D002551 Cerebral Ventricle Neoplasm
% 213.76/213.97  |- skos__altLabel mesh__D002551 Neoplasms, Cerebroventricular
% 213.76/213.97  |- skos__hiddenLabel mesh__D002551 Ventricle Tumor, Cerebral
% 213.76/213.97  |- skos__hiddenLabel mesh__D002551 Neoplasm, Cerebral Ventricle
% 213.76/213.97  |- skos__altLabel mesh__D002551 Brain Ventricular Neoplasms
% 213.76/213.97  |- skos__prefLabel mesh__D002551 Cerebral Ventricle Neoplasms
% 213.76/213.97  |- mesh__dateRevised mesh__D002551 1999-11-03
% 213.76/213.97  |- skos__hiddenLabel mesh__D002551 Cerebroventricular Neoplasm
% 213.76/213.97  |- skos__hiddenLabel mesh__D015479 Naegeli-Type Myeloid Leukemia
% 213.76/213.97  |- skos__hiddenLabel mesh__D015479 Acute Myelomonocytic Leukemias
% 213.76/213.97  |- skos__hiddenLabel mesh__D015479 Acute Myelomonocytic Leukemia
% 213.76/213.97  |- skos__hiddenLabel mesh__D015479 Myelomonocytic Leukemias, Acute
% 213.76/213.97  |- skos__altLabel mesh__D015479 Leukemia, Myeloid, Naegeli-Type
% 213.76/213.97  |- mesh__recordMaintainer mesh__D015479 KEV
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D015479 1997
% 213.76/213.97  |- rdf__type mesh__D015479sskos__Concept
% 213.76/213.97  |- mesh__onlineNote mesh__D015479
% 213.76/213.97       use LEUKEMIA, MYELOID to search LEUKEMIA, MYELOMONOCYTIC 1981-88 %26% LEUKEMIA, NAEGELI-TYPE 1981-88%A%  
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D015479 2002
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D015479 1999
% 213.76/213.97  |- skos__hiddenLabel mesh__D015479 Leukemia, Naegeli-Type Myeloid
% 213.76/213.97  |- mesh__historyNote mesh__D015479
% 213.76/213.97       89; LEUKEMIA, MYELOMONOCYTIC was see LEUKEMIA, MYELOCYTIC 1981-88; LEUKEMIA, NAEGELI-TYPE was see LEUKEMIA, MYELOCYTIC 1975-88%A%  
% 213.76/213.97  |- skos__altLabel mesh__D015479 Myelomonocytic Leukemia, Acute
% 213.76/213.97  |- skos__historyNote mesh__D015479 Leukemia %28%1966-1988%29%
% 213.76/213.97  |- mesh__publicMeSHNote mesh__D015479
% 213.76/213.97       89; LEUKEMIA, MYELOMONOCYTIC was see LEUKEMIA, MYELOCYTIC 1981-88; LEUKEMIA, NAEGELI-TYPE was see LEUKEMIA, MYELOCYTIC 1975-88%A%  
% 213.76/213.97  |- mesh__recordOriginator mesh__D015479 PLS
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D015479 1996
% 213.76/213.97  |- skos__hiddenLabel mesh__D015479 Myeloid Leukemia, Naegeli Type
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D015479 2001
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D015479 1998
% 213.76/213.97  |- mesh__dateRevised mesh__D015479 1995-06-08
% 213.76/213.97  |- mesh__recordAuthorizer mesh__D015479 PLS
% 213.76/213.97  |- mesh__dateEstablished mesh__D015479 1989-01-01
% 213.76/213.97  |- skos__prefLabel mesh__D015479 Leukemia, Myelomonocytic, Acute
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D015479 2004
% 213.76/213.97  |- skos__annotation mesh__D015479
% 213.76/213.97       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 213.76/213.97  |- skos__hiddenLabel mesh__D015479 Leukemias, Acute Myelomonocytic
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D015479 2000
% 213.76/213.97  |- skos__altLabel mesh__D015479 Leukemia, Myeloid, Acute, M4
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D015479 2006
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D015479 2003
% 213.76/213.97  |- skos__broader mesh__D015479smesh__D007951
% 213.76/213.97  |- mesh__dateCreated mesh__D015479 1988-06-09
% 213.76/213.97  |- skos__hiddenLabel mesh__D015479 Leukemia, Acute Myelomonocytic
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D015479 2005
% 213.76/213.97  |- skos__altLabel mesh__D015479 Myeloid Leukemia, Naegeli-Type
% 213.76/213.97  |- skos__altLabel mesh__D015479 Myeloid Leukemia, Acute, M4
% 213.76/213.97  |- skos__historyNote mesh__D015479 Leukemia, Myelocytic %28%1981-1988%29%
% 213.76/213.97  |- skos__broader mesh__D005502Q000032smesh__D005502
% 213.76/213.97  |- mesh__preferredCombination mesh__D005502Q000032smesh__D005504
% 213.76/213.97  |- rdf__type mesh__D005502Q000032smesh__CompoundConcept
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D001459 1996
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D001459 1991
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D001459 2006
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D001459 2000
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D001459 1990
% 213.76/213.97  |- rdf__type mesh__D001459sskos__Concept
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D001459 2005
% 213.76/213.97  |- mesh__historyNote mesh__D001459 73   
% 213.76/213.97  |- mesh__dateRevised mesh__D001459 1991-11-02
% 213.76/213.97  |- skos__prefLabel mesh__D001459 Bangladesh
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D001459 1995
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D001459 2004
% 213.76/213.97  |- mesh__recordMaintainer mesh__D001459 PLS
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D001459 1999
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D001459 1994
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D001459 2003
% 213.76/213.97  |- mesh__dateCreated mesh__D001459 1999-01-01
% 213.76/213.97  |- mesh__recordAuthorizer mesh__D001459 PLS
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D001459 1993
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D001459 1998
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D001459 2002
% 213.76/213.97  |- mesh__recordOriginator mesh__D001459 NLM
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D001459 1992
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D001459 1997
% 213.76/213.97  |- skos__broader mesh__D001459smesh__D001211
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D001459 1989
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D001459 2001
% 213.76/213.97  |- mesh__publicMeSHNote mesh__D012181 98   
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D012181 2001
% 213.76/213.97  |- mesh__recordMaintainer mesh__D012181 ags
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D012181 2000
% 213.76/213.97  |- skos__prefLabel mesh__D012181 Retrocochlear Diseases
% 213.76/213.97  |- skos__broader mesh__D012181smesh__D004427
% 213.76/213.97  |- skos__annotation mesh__D012181
% 213.76/213.97       %22%retrocochlear%22% refers to the vestibulocochlear nerve, not the cochlea; GEN or unspecified; prefer specifics; DF: RETROCOCHLEAR DIS%A%  
% 213.76/213.97  |- mesh__dateCreated mesh__D012181 1978-12-22
% 213.76/213.97  |- skos__scopeNote mesh__D012181
% 213.76/213.97       Diseases of the VESTIBULOCOCHLEAR NERVE. Retrocochlear refers to the eighth cranial nerve and cerebellopontine angle as opposed to the cochlea. %28%Dorland, 28th ed%29%%A%    
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D012181 2006
% 213.76/213.97  |- mesh__recordOriginator mesh__D012181 RC
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D012181 2004
% 213.76/213.97  |- skos__historyNote mesh__D012181 Acoustic Nerve %28%1966-1997%29%
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D012181 2005
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D012181 2002
% 213.76/213.97  |- rdf__type mesh__D012181sskos__Concept
% 213.76/213.97  |- mesh__recordAuthorizer mesh__D012181 sjn
% 213.76/213.97  |- skos__hiddenLabel mesh__D012181 Diseases, Retrocochlear
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D012181 2003
% 213.76/213.97  |- skos__hiddenLabel mesh__D012181 Retrocochlear Disease
% 213.76/213.97  |- mesh__historyNote mesh__D012181 98; use explode 1980-97   
% 213.76/213.97  |- mesh__dateEstablished mesh__D012181 1998-01-01
% 213.76/213.97  |- mesh__dateRevised mesh__D012181 1999-11-03
% 213.76/213.97  |- skos__hiddenLabel mesh__D012181 Disease, Retrocochlear
% 213.76/213.97  |- mesh__publicMeSHNote mesh__D006942 72   
% 213.76/213.97  |- skos__annotation mesh__D006942
% 213.76/213.97       coord IM with specific immunoglobulin %28%IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E;  IMMUNOGLOBULIN G or  IMMUNOGLOBULIN M%29% %28%IM%29%; for light-chain gammopathy see TN 226; for heavy-chain gammopathy index under HEAVY CHAIN DISEASE %28%IM%29% + specific heavy chain %28%IMMUNOGLOBULINS, ALPHA-CHAIN; IMMUNOGLOBULINS, DELTA-CHAIN; etc.%29% %28%NIM%29% %28%TN 226%29%%A%  
% 213.76/213.97  |- mesh__dateRevised mesh__D006942 2005-07-18
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D006942 2002
% 213.76/213.97  |- skos__scopeNote mesh__D006942
% 213.76/213.97       An excess of GAMMA-GLOBULINS in the blood. It is seen frequently in chronic infectious diseases. %28%Dorland, 27th ed%29%%A%    
% 213.76/213.97  |- mesh__recordAuthorizer mesh__D006942 ags
% 213.76/213.97  |- rdf__type mesh__D006942sskos__Concept
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D006942 2003
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D006942 2005
% 213.76/213.97  |- skos__broader mesh__D006942smesh__D001796
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D006942 2004
% 213.76/213.97  |- skos__broader mesh__D006942smesh__D007160
% 213.76/213.97  |- mesh__dateCreated mesh__D006942 1999-01-01
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D006942 2006
% 213.76/213.97  |- mesh__dateEstablished mesh__D006942 1972-01-01
% 213.76/213.97  |- skos__hiddenLabel mesh__D006942 Hypergammaglobulinemias
% 213.76/213.97  |- mesh__recordMaintainer mesh__D006942 ags
% 213.76/213.97  |- skos__historyNote mesh__D006942
% 213.76/213.97       Blood Protein Disorders %28%1966-1968%29%
% 213.76/213.97  |- mesh__recordOriginator mesh__D006942 NLM
% 213.76/213.97  |- mesh__historyNote mesh__D006942 72%28%69%29%   
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D006942 2006A
% 213.76/213.97  |- skos__prefLabel mesh__D006942 Hypergammaglobulinemia
% 213.76/213.97  |- skos__scopeNote mesh__D020613
% 213.76/213.97       A species of MORGANELLA formerly classified as a Proteus species. It is found in the feces of humans, dogs, other mammals, and reptiles. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 213.76/213.97  |- mesh__dateRevised mesh__D020613 2005-06-30
% 213.76/213.97  |- mesh__historyNote mesh__D020613 2000   
% 213.76/213.97  |- skos__broader mesh__D020613smesh__D020596
% 213.76/213.97  |- skos__prefLabel mesh__D020613 Morganella morganii
% 213.76/213.97  |- mesh__dateCreated mesh__D020613 1999-11-03
% 213.76/213.97  |- skos__annotation mesh__D020613
% 213.76/213.97       infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 213.76/213.97  |- skos__historyNote mesh__D020613 Enterobacteriaceae %28%1988-1999%29%
% 213.76/213.97  |- skos__historyNote mesh__D020613 Proteus %28%1975-1987%29%
% 213.76/213.97  |- mesh__recordMaintainer mesh__D020613 SYSTEM
% 213.76/213.97  |- mesh__recordOriginator mesh__D020613 ndw
% 213.76/213.97  |- rdf__type mesh__D020613sskos__Concept
% 213.76/213.97  |- mesh__publicMeSHNote mesh__D020613 2000   
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D020613 2006
% 213.76/213.97  |- mesh__recordAuthorizer mesh__D020613 sjn
% 213.76/213.97  |- mesh__dateEstablished mesh__D020613 2000-01-01
% 213.76/213.97  |- mesh__dateCreated mesh__D006144 1974-11-19
% 213.76/213.97  |- mesh__historyNote mesh__D006144
% 213.76/213.97       91%28%75%29%; was see under TRIAZOLES 1975-90   
% 213.76/213.97  |- mesh__publicMeSHNote mesh__D006144
% 213.76/213.97       91; was see under TRIAZOLES 1975-90   
% 213.76/213.97  |- mesh__dateRevised mesh__D006144 2005-06-30
% 213.76/213.97  |- mesh__recordMaintainer mesh__D006144 ssb
% 213.76/213.97  |- skos__annotation mesh__D006144
% 213.76/213.97       do not confuse with GUANAZOLO %28% = AZAGUANINE%29%   
% 213.76/213.97  |- skos__historyNote mesh__D006144 Diamines %28%1972-1974%29%
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D006144 2006
% 213.76/213.97  |- mesh__recordAuthorizer mesh__D006144 sjn
% 213.76/213.97  |- mesh__recordOriginator mesh__D006144 NLM
% 213.76/213.97  |- skos__prefLabel mesh__D006144 Guanazole
% 213.76/213.97  |- skos__broader mesh__D006144smesh__D014230
% 213.76/213.97  |- mesh__dateEstablished mesh__D006144 1991-01-01
% 213.76/213.97  |- skos__historyNote mesh__D006144 Triazoles %28%1972-1974%29%
% 213.76/213.97  |- rdf__type mesh__D006144sskos__Concept
% 213.76/213.97  |- skos__scopeNote mesh__D006144
% 213.76/213.97       A cytostatic triazole derivative which is not to be confused with guanazolo, the generic name for 8-azaguanine.%A%    
% 213.76/213.97  |- skos__prefLabel mesh__D011887 Raffinose
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D011887 2005
% 213.76/213.97  |- skos__altLabel mesh__D011887 Melitose
% 213.76/213.97  |- mesh__dateEstablished mesh__D011887 1991-01-01
% 213.76/213.97  |- mesh__recordAuthorizer mesh__D011887 sjn
% 213.76/213.97  |- rdf__type mesh__D011887sskos__Concept
% 213.76/213.97  |- mesh__publicMeSHNote mesh__D011887
% 213.76/213.97       91; was see under OLIGOSACCHARIDES 1975-90   
% 213.76/213.97  |- mesh__historyNote mesh__D011887
% 213.76/213.97       91%28%75%29%; was see under OLIGOSACCHARIDES 1975-90   
% 213.76/213.97  |- mesh__recordOriginator mesh__D011887 NLM
% 213.76/213.97  |- mesh__dateRevised mesh__D011887 2004-07-07
% 213.76/213.97  |- skos__scopeNote mesh__D011887
% 213.76/213.97       A trisaccharide occurring in Australian manna %28%from Eucalyptus spp, Myrtaceae%29% and in cottonseed meal.%A%    
% 213.76/213.97  |- skos__historyNote mesh__D011887 Oligosaccharides %28%1970-1974%29%
% 213.76/213.97  |- mesh__dateCreated mesh__D011887 1974-11-19
% 213.76/213.97  |- skos__altLabel mesh__D011887 Gossypose
% 213.76/213.97  |- skos__broader mesh__D011887smesh__D014312
% 213.76/213.97  |- mesh__activeMeSHYear mesh__D011887 2006
% 213.76/213.97  |- mesh__recordMaintainer mesh__D011887 ssb
% 213.76/213.97  |- skos__altLabel mesh__D011887 Melitriose
% 213.76/213.97  |- skos__hiddenLabel mesh__D044263 5 HT1 Receptor
% 213.76/213.97  |- mesh__recordMaintainer mesh__D044263 jmp
% 213.76/213.98  |- skos__prefLabel mesh__D044263 Receptors, Serotonin, 5-HT1
% 213.76/213.98  |- skos__hiddenLabel mesh__D044263 Receptors, 5-HT1 Serotonin
% 213.76/213.98  |- mesh__activeMeSHYear mesh__D044263 2006
% 213.76/213.98  |- skos__hiddenLabel mesh__D044263 Receptor, 5-HT1
% 213.76/213.98  |- skos__hiddenLabel mesh__D044263 5 HT1 Receptors
% 213.76/213.98  |- skos__historyNote mesh__D044263 Receptors, Serotonin %28%1993-2003%29%
% 213.76/213.98  |- skos__altLabel mesh__D044263 Serotonin, 5-HT1 Receptors
% 213.76/213.98  |- mesh__recordAuthorizer mesh__D044263 sjn
% 213.76/213.98  |- mesh__dateEstablished mesh__D044263 2004-01-01
% 213.76/213.98  |- skos__hiddenLabel mesh__D044263 5-HT1 Serotonin Receptors
% 213.76/213.98  |- skos__altLabel mesh__D044263 Serotonin 5-HT1 Receptor
% 213.76/213.98  |- rdf__type mesh__D044263sskos__Concept
% 213.76/213.98  |- skos__altLabel mesh__D044263 5-HT1 Receptors
% 213.76/213.98  |- skos__broader mesh__D044263smesh__D011985
% 213.76/213.98  |- mesh__dateCreated mesh__D044263 2003-07-09
% 213.76/213.98  |- skos__altLabel mesh__D044263 Serotonin Receptors, 5-HT1
% 213.76/213.98  |- skos__hiddenLabel mesh__D044263 Serotonin Receptors, 5 HT1
% 213.76/213.98  |- mesh__recordOriginator mesh__D044263 jmp
% 213.76/213.98  |- skos__altLabel mesh__D044263 5-HT1 Receptor
% 213.76/213.98  |- skos__hiddenLabel mesh__D044263 Receptors, 5-HT1
% 213.76/213.98  |- mesh__publicMeSHNote mesh__D044263
% 213.76/213.98       2004; SEROTONIN 5-HT1 RECEPTOR %28%now RECEPTORS, SEROTONIN, 5-HT1%29% was indexed under RECEPTORS, SEROTONIN 1993-2003%A%  
% 213.76/213.98  |- skos__hiddenLabel mesh__D044263 5-HT1 Receptors Serotonin
% 213.76/213.98  |- skos__hiddenLabel mesh__D044263 Receptors Serotonin, 5-HT1
% 213.76/213.98  |- skos__scopeNote mesh__D044263
% 213.76/213.98       A subclass of G-protein coupled SEROTONIN receptors that couple preferentially to GI-GO G-PROTEINS resulting in decreased intracellular CYCLIC AMP levels.%A%    
% 213.76/213.98  |- mesh__historyNote mesh__D044263
% 213.76/213.98       2004; use RECEPTORS, SEROTONIN, 5-HT1 %28%NM%29% 1993-2003   
% 213.76/213.98  |- mesh__dateRevised mesh__D044263 2005-06-30
% 213.76/213.98  |- skos__hiddenLabel mesh__D044263 Serotonin, 5 HT1 Receptors
% 213.76/213.98  |- mesh__activeMeSHYear mesh__D011089 1997
% 213.76/213.98  |- mesh__activeMeSHYear mesh__D011089 1994
% 213.76/213.98  |- mesh__activeMeSHYear mesh__D011089 1999
% 213.76/213.98  |- rdf__type mesh__D011089sskos__Concept
% 213.76/213.98  |- mesh__activeMeSHYear mesh__D011089 2000
% 213.76/213.98  |- mesh__historyNote mesh__D011089 76   
% 213.76/213.98  |- mesh__activeMeSHYear mesh__D011089 1993
% 213.76/213.98  |- mesh__recordMaintainer mesh__D011089 TGC
% 213.76/213.98  |- mesh__dateEstablished mesh__D011089 1976-01-01
% 213.76/213.98  |- mesh__activeMeSHYear mesh__D011089 1995
% 213.76/213.98  |- mesh__recordAuthorizer mesh__D011089 PLS
% 213.76/213.98  |- skos__prefLabel mesh__D011089 Polydeoxyribonucleotides
% 213.76/213.98  |- skos__annotation mesh__D011089 13 or more nucleotides   
% 213.76/213.98  |- mesh__activeMeSHYear mesh__D011089 2001
% 213.76/213.98  |- skos__broader mesh__D011089smesh__D011119
% 213.76/213.98  |- mesh__activeMeSHYear mesh__D011089 2003
% 213.76/213.98  |- mesh__recordOriginator mesh__D011089 RLS
% 213.76/213.98  |- mesh__activeMeSHYear mesh__D011089 2005
% 213.76/213.98  |- mesh__activeMeSHYear mesh__D011089 2004
% 213.76/213.98  |- mesh__publicMeSHNote mesh__D011089 76   
% 213.76/213.98  |- mesh__dateRevised mesh__D011089 1992-05-20
% 213.76/213.98  |- mesh__activeMeSHYear mesh__D011089 2002
% 213.76/213.98  |- skos__historyNote mesh__D011089 Polynucleotides %28%1966-1975%29%
% 213.76/213.98  |- mesh__activeMeSHYear mesh__D011089 2006
% 213.76/213.98  |- skos__scopeNote mesh__D011089
% 213.76/213.98       A group of 13 or more deoxyribonucleotides in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties.%A%    
% 213.76/213.98  |- mesh__activeMeSHYear mesh__D011089 1996
% 213.76/213.98  |- mesh__dateCreated mesh__D011089 1975-07-25
% 213.76/213.98  |- mesh__activeMeSHYear mesh__D011089 1998
% 213.76/213.98  |- mesh__recordAuthorizer mesh__D038226 ags
% 213.76/213.98  |- mesh__recordMaintainer mesh__D038226 ags
% 213.76/213.98  |- mesh__activeMeSHYear mesh__D038226 2006A
% 213.76/213.98  |- skos__broader mesh__D038226smesh__D003459
% 213.76/213.98  |- skos__hiddenLabel mesh__D038226 zeta Crystallin
% 213.76/213.98  |- rdf__type mesh__D038226sskos__Concept
% 213.76/213.98  |- skos__hiddenLabel mesh__D038226 zeta Crystallins
% 213.76/213.98  |- skos__historyNote mesh__D038226 Crystallins %28%1987-2002%29%
% 213.76/213.98  |- mesh__dateRevised mesh__D038226 2005-07-15
% 213.76/213.98  |- skos__prefLabel mesh__D038226 zeta-Crystallins
% 213.76/213.98  |- skos__hiddenLabel mesh__D038226 zeta Crystallin NADPH Oxidoreductase
% 213.76/213.98  |- mesh__dateEstablished mesh__D038226 2003-01-01
% 213.76/213.98  |- skos__scopeNote mesh__D038226
% 213.76/213.98       A group of crystallins that have been found in the lens %28%LENS, CRYSTALLINE%29% of certain species of VERTEBRATES including GUINEA PIGS; CAMELS; and LLAMAS. They are inactivated forms of NAD%28%P%29%H DEHYDROGENASE %28%QUINONE%29%.%A%    
% 213.76/213.98  |- skos__hiddenLabel mesh__D038226 Crystallin-NADPH Oxidoreductase, zeta
% 213.76/213.98  |- mesh__activeMeSHYear mesh__D038226 2006
% 213.76/213.98  |- skos__altLabel mesh__D038226 zeta Crystallin-NADPH Oxidoreductase
% 213.76/213.98  |- mesh__dateCreated mesh__D038226 2002-07-03
% 213.76/213.98  |- mesh__historyNote mesh__D038226
% 213.76/213.98       2003; for ZETA-CRYSTALLIN use CRYSTALLINS 1989-2002; for ZETA-CRYSTALLIN-NADPH OXIDOREDUCTASE use ZETA-CRYSTALLINS %28%NM%29% 1997-2002%A%  
% 213.76/213.98  |- mesh__publicMeSHNote mesh__D038226
% 213.76/213.98       2003; for ZETA-CRYSTALLIN see CRYSTALLINS 1989-2002; ZETA-CRYSTALLIN-NADPH OXIDOREDUCTASE was indexed under CRYSTALLINS %26% NAD%28%P%29%H DEHYDROGENASE %28%QUINONE%29% 1997-2002%A%  
% 213.76/213.98  |- skos__altLabel mesh__D038226 Crystallins, zeta
% 213.76/213.98  |- skos__altLabel mesh__D038226 zeta-Crystallin
% 213.76/213.98  |- mesh__recordOriginator mesh__D038226 jmp
% 213.76/213.98  |- skos__broader mesh__D038226smesh__D016660
% 213.76/213.98  |- skos__hiddenLabel mesh__D038226 Oxidoreductase, zeta Crystallin-NADPH
% 213.76/213.98  |- skos__altLabel mesh__D016572 Cyclosporin A
% 213.76/213.98  |- skos__hiddenLabel mesh__D016572 OL 27400
% 213.76/213.98  |- mesh__dateRevised mesh__D016572 2004-07-21
% 213.76/213.98  |- mesh__dateCreated mesh__D016572 1991-01-08
% 213.76/213.98  |- skos__altLabel mesh__D016572 CyA-NOF
% 213.76/213.98  |- mesh__dateEstablished mesh__D016572 1992-01-01
% 213.76/213.98  |- mesh__activeMeSHYear mesh__D016572 2005
% 213.76/213.98  |- skos__altLabel mesh__D016572 Cyclosporine A
% 213.76/213.98  |- skos__annotation mesh__D016572
% 213.76/213.98       a specific drug: do not confuse this or X ref with CYCLOSPORINS%A%  
% 213.76/213.98  |- skos__scopeNote mesh__D016572
% 213.76/213.98       A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. %28%From Martindale, The Extra Pharmacopoeia, 30th ed%29%.%A%    
% 213.76/213.98  |- skos__hiddenLabel mesh__D016572 CsANeoral
% 213.76/213.98  |- rdf__type mesh__D016572sskos__Concept
% 213.76/213.98  |- skos__hiddenLabel mesh__D016572 Neoral, Sandimmun
% 213.76/213.98  |- mesh__recordMaintainer mesh__D016572 ssb
% 213.76/213.98  |- skos__prefLabel mesh__D016572 Cyclosporine
% 213.76/213.98  |- mesh__recordOriginator mesh__D016572 RLS
% 213.76/213.98  |- skos__hiddenLabel mesh__D016572 CyA NOF
% 213.76/213.98  |- mesh__recordAuthorizer mesh__D016572 sjn
% 213.76/213.98  |- skos__altLabel mesh__D016572 Sandimmun
% 213.76/213.98  |- skos__historyNote mesh__D016572
% 213.76/213.98       Immunosuppressive Agents %28%1966-1991%29%
% 213.76/213.98  |- skos__historyNote mesh__D016572 Peptides %28%1966-1970%29%
% 213.76/213.98  |- skos__broader mesh__D016572smesh__D003524
% 213.83/213.98  |- skos__historyNote mesh__D016572 Cyclosporins %28%1982-1991%29%
% 213.83/213.98  |- mesh__historyNote mesh__D016572
% 213.83/213.98       92; for CYCLOSPORIN A use CYCLOSPORINS 1982-91   
% 213.83/213.98  |- skos__hiddenLabel mesh__D016572 CsA Neoral
% 213.83/213.98  |- skos__historyNote mesh__D016572 Peptides, Cyclic %28%1971-1981%29%
% 213.83/213.98  |- mesh__publicMeSHNote mesh__D016572
% 213.83/213.98       92%28%82%29%; for CYCLOSPORIN A see CYCLOSPORINS 1982-91   
% 213.83/213.98  |- skos__altLabel mesh__D016572 Cyclosporin
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D016572 2006
% 213.83/213.98  |- skos__hiddenLabel mesh__D016572 OL 27 400
% 213.83/213.98  |- skos__altLabel mesh__D016572 Ciclosporin
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D030243 2005
% 213.83/213.98  |- mesh__historyNote mesh__D030243 2002   
% 213.83/213.98  |- skos__broader mesh__D030243smesh__D018182
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D030243 2003
% 213.83/213.98  |- skos__historyNote mesh__D030243
% 213.83/213.98       Bovine Virus Diarrhea-Mucosal Disease %28%1995-2001%29%
% 213.83/213.98  |- rdf__type mesh__D030243sskos__Concept
% 213.83/213.98  |- skos__prefLabel mesh__D030243 Hemorrhagic Syndrome, Bovine
% 213.83/213.98  |- skos__scopeNote mesh__D030243
% 213.83/213.98       Clinically severe acute disease of cattle caused by noncytopathic forms of Bovine viral diarrhea virus 2 %28%DIARRHEA VIRUS 2, BOVINE VIRAL%29%. Outbreaks are characterized by high morbidity and high mortality.%A%    
% 213.83/213.98  |- mesh__publicMeSHNote mesh__D030243 2002   
% 213.83/213.98  |- mesh__dateCreated mesh__D030243 2001-07-25
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D030243 2002
% 213.83/213.98  |- skos__altLabel mesh__D030243 Bovine Hemorrhagic Syndrome
% 213.83/213.98  |- skos__broader mesh__D030243smesh__D002418
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D030243 2006
% 213.83/213.98  |- mesh__dateEstablished mesh__D030243 2002-01-01
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D030243 2004
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D002552 1993
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D002552 1996
% 213.83/213.98  |- skos__related mesh__D002552smesh__D014696
% 213.83/213.98  |- skos__hiddenLabel mesh__D002552 Ventricle, Cerebral
% 213.83/213.98  |- skos__hiddenLabel mesh__D002552 Ventricles, Cerebral
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D002552 2000
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D002552 2005
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D002552 1999
% 213.83/213.98  |- mesh__dateRevised mesh__D002552 1992-05-07
% 213.83/213.98  |- skos__hiddenLabel mesh__D002552 Monro Foramen
% 213.83/213.98  |- skos__annotation mesh__D002552
% 213.83/213.98       ventriculitis: coord IM with ENCEPHALITIS %28%IM%29%   
% 213.83/213.98  |- mesh__recordOriginator mesh__D002552 NLM
% 213.83/213.98  |- mesh__recordMaintainer mesh__D002552 TAP
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D002552 1995
% 213.83/213.98  |- skos__related mesh__D002552smesh__D007276
% 213.83/213.98  |- skos__prefLabel mesh__D002552 Cerebral Ventricles
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D002552 1998
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D002552 2002
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D002552 1994
% 213.83/213.98  |- mesh__recordAuthorizer mesh__D002552 PLS
% 213.83/213.98  |- rdf__type mesh__D002552sskos__Concept
% 213.83/213.98  |- skos__broader mesh__D002552smesh__D001921
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D002552 2004
% 213.83/213.98  |- skos__related mesh__D002552smesh__D014695
% 213.83/213.98  |- skos__hiddenLabel mesh__D002552 Cerebral Ventricle
% 213.83/213.98  |- mesh__dateCreated mesh__D002552 1999-01-01
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D002552 2003
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D002552 1997
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D002552 2001
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D002552 2006
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012980 1999
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012980 2000
% 213.83/213.98  |- rdf__type mesh__D012980sskos__Concept
% 213.83/213.98  |- skos__scopeNote mesh__D012980
% 213.83/213.98       A non-steroidal anti-inflammatory agent that is less effective than equal doses of ASPIRIN in relieving pain and reducing fever. However, individuals who are hypersensitive to ASPIRIN may tolerate sodium salicylate. In general, this salicylate produces the same adverse reactions as ASPIRIN, but there is less occult gastrointestinal bleeding. %28%From AMA Drug Evaluations Annual, 1992, p120%29%%A%    
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012980 2003
% 213.83/213.98  |- mesh__dateRevised mesh__D012980 1998-06-11
% 213.83/213.98  |- mesh__recordAuthorizer mesh__D012980 SJN
% 213.83/213.98  |- skos__hiddenLabel mesh__D012980 Salicylate, Sodium
% 213.83/213.98  |- mesh__dateCreated mesh__D012980 1999-01-01
% 213.83/213.98  |- skos__prefLabel mesh__D012980 Sodium Salicylate
% 213.83/213.98  |- skos__broader mesh__D012980smesh__D012459
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012980 2006
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012980 2002
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012980 2005
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012980 2001
% 213.83/213.98  |- mesh__recordOriginator mesh__D012980 NLM
% 213.83/213.98  |- mesh__recordMaintainer mesh__D012980 ADP
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012980 2004
% 213.83/213.98  |- mesh__dateCreated mesh__D012182 1999-01-01
% 213.83/213.98  |- mesh__recordAuthorizer mesh__D012182 sjn
% 213.83/213.98  |- skos__hiddenLabel mesh__D012182 Retrognathisms
% 213.83/213.98  |- mesh__publicMeSHNote mesh__D012182 65   
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012182 2000
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012182 2005
% 213.83/213.98  |- skos__annotation mesh__D012182
% 213.83/213.98       a mandibular abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; consider also MALOCCLUSION, ANGLE CLASS II%A%  
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012182 2003
% 213.83/213.98  |- mesh__recordMaintainer mesh__D012182 kle
% 213.83/213.98  |- skos__broader mesh__D012182smesh__D007569
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012182 2006
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012182 2004
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012182 2001
% 213.83/213.98  |- mesh__historyNote mesh__D012182 65   
% 213.83/213.98  |- mesh__dateRevised mesh__D012182 1999-11-03
% 213.83/213.98  |- skos__broader mesh__D012182smesh__D008336
% 213.83/213.98  |- skos__related mesh__D012182smesh__D019186
% 213.83/213.98  |- mesh__dateEstablished mesh__D012182 1965-01-01
% 213.83/213.98  |- rdf__type mesh__D012182sskos__Concept
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012182 2002
% 213.83/213.98  |- skos__scopeNote mesh__D012182
% 213.83/213.98       Retrusion of the mandible. %28%Dorland, 27th ed%29%     
% 213.83/213.98  |- skos__prefLabel mesh__D012182 Retrognathism
% 213.83/213.98  |- mesh__recordOriginator mesh__D012182 NLM
% 213.83/213.98  |- skos__annotation mesh__D006943
% 213.83/213.98       do not confuse with HYPOGLYCEMIA; obese hyperglycemic mice go under MICE, OBESE: do not index under HYPERGLYCEMIA or OBESITY unless particularly discussed as disease; Somogyi effect or rebound hyperglycemia: index under HYPERGLYCEMIA /chem ind + DIABETES MELLITUS /drug ther + INSULIN /adv eff; %22%induced hyperglycemia%22% in disease states or physiol studies: index under BLOOD GLUCOSE, not HYPERGLYCEMIA%A%  
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D006943 2005
% 213.83/213.98  |- mesh__recordAuthorizer mesh__D006943 sjn
% 213.83/213.98  |- mesh__recordOriginator mesh__D006943 NLM
% 213.83/213.98  |- skos__scopeNote mesh__D006943
% 213.83/213.98       Abnormally high BLOOD GLUCOSE level, beyond the normal range %28%roughly 70 to 150 mg/100 ml of PLASMA%29%.%A%    
% 213.83/213.98  |- skos__prefLabel mesh__D006943 Hyperglycemia
% 213.83/213.98  |- skos__hiddenLabel mesh__D006943 Hyperglycemias
% 213.83/213.98  |- mesh__recordMaintainer mesh__D006943 lkt
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D006943 2004
% 213.83/213.98  |- mesh__dateRevised mesh__D006943 2003-07-09
% 213.83/213.98  |- rdf__type mesh__D006943sskos__Concept
% 213.83/213.98  |- skos__broader mesh__D006943smesh__D044882
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D006943 2006
% 213.83/213.98  |- mesh__dateCreated mesh__D006943 1999-01-01
% 213.83/213.98  |- mesh__historyNote mesh__D020614 2000   
% 213.83/213.98  |- skos__historyNote mesh__D020614 Gram-Negative Bacteria %28%1990-1994%29%
% 213.83/213.98  |- mesh__publicMeSHNote mesh__D020614 2000   
% 213.83/213.98  |- skos__annotation mesh__D020614
% 213.83/213.98       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 213.83/213.98  |- mesh__recordAuthorizer mesh__D020614 sjn
% 213.83/213.98  |- skos__broader mesh__D020614smesh__D020592
% 213.83/213.98  |- skos__scopeNote mesh__D020614
% 213.83/213.98       A species of SHEWANELLA noted for its ability to reduce iron and manganese anaerobically.%A%    
% 213.83/213.98  |- mesh__dateRevised mesh__D020614 2005-06-30
% 213.83/213.98  |- skos__historyNote mesh__D020614
% 213.83/213.98       Gram-Negative Anaerobic Bacteria %28%1991-1995%29%
% 213.83/213.98  |- mesh__recordMaintainer mesh__D020614 SYSTEM
% 213.83/213.98  |- mesh__recordOriginator mesh__D020614 ndw
% 213.83/213.98  |- mesh__dateCreated mesh__D020614 1999-11-03
% 213.83/213.98  |- rdf__type mesh__D020614sskos__Concept
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D020614 2006
% 213.83/213.98  |- mesh__dateEstablished mesh__D020614 2000-01-01
% 213.83/213.98  |- skos__prefLabel mesh__D020614 Shewanella putrefaciens
% 213.83/213.98  |- skos__historyNote mesh__D020614
% 213.83/213.98       Gram-Negative Facultatively Anaerobic Rods %28%1995-1999%29%
% 213.83/213.98  |- skos__broader mesh__D006145smesh__D006146
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D006145 2004
% 213.83/213.98  |- skos__prefLabel mesh__D006145 Guanethidine
% 213.83/213.98  |- skos__altLabel mesh__D006145 Guanethidine Sulfate %28%1:1%29%
% 213.83/213.98  |- rdf__type mesh__D006145sskos__Concept
% 213.83/213.98  |- mesh__dateCreated mesh__D006145 1999-01-01
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D006145 2003
% 213.83/213.98  |- mesh__recordMaintainer mesh__D006145 CCR
% 213.83/213.98  |- mesh__dateRevised mesh__D006145 2001-07-25
% 213.83/213.98  |- skos__altLabel mesh__D006145 Guanethidine Sulfate %28%2:1%29%
% 213.83/213.98  |- skos__altLabel mesh__D006145 Oktadin
% 213.83/213.98  |- skos__altLabel mesh__D006145 Octadine
% 213.83/213.98  |- skos__hiddenLabel mesh__D006145 Monosulfate, Guanethidine
% 213.83/213.98  |- skos__altLabel mesh__D006145
% 213.83/213.98       %28%%28%2-Hexahydro-1%28%2H%29%-azocinyl%29%ethyl%29%guanidine
% 213.83/213.98  |- skos__hiddenLabel mesh__D006145 Sulfate, Guanethidine
% 213.83/213.98  |- skos__scopeNote mesh__D006145
% 213.83/213.98       An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.%A%    
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D006145 2006
% 213.83/213.98  |- mesh__recordOriginator mesh__D006145 NLM
% 213.83/213.98  |- mesh__recordAuthorizer mesh__D006145 sjn
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D006145 2002
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D006145 2005
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D011888 2002
% 213.83/213.98  |- mesh__dateRevised mesh__D011888 2000-06-22
% 213.83/213.98  |- skos__altLabel mesh__D011888 Rafoxanid
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D011888 2006
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D011888 2001
% 213.83/213.98  |- mesh__recordAuthorizer mesh__D011888 sjn
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D011888 2004
% 213.83/213.98  |- skos__historyNote mesh__D011888 Iodine %28%1972-1974%29%
% 213.83/213.98  |- skos__hiddenLabel mesh__D011888 990, MK
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D011888 2005
% 213.83/213.98  |- skos__broader mesh__D011888smesh__D012458
% 213.83/213.98  |- skos__prefLabel mesh__D011888 Rafoxanide
% 213.83/213.98  |- mesh__recordMaintainer mesh__D011888 CCR
% 213.83/213.98  |- mesh__recordOriginator mesh__D011888 NLM
% 213.83/213.98  |- skos__historyNote mesh__D011888 Phenyl Ethers %28%1974%29%
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D011888 2003
% 213.83/213.98  |- skos__scopeNote mesh__D011888
% 213.83/213.98       Veterinary anthelmintic for grazing animals; used to treat fluke, hookworm and other infestations.%A%    
% 213.83/213.98  |- mesh__historyNote mesh__D011888
% 213.83/213.98       91%28%75%29%; was see under SALICYLAMIDES 1975-90   
% 213.83/213.98  |- rdf__type mesh__D011888sskos__Concept
% 213.83/213.98  |- mesh__dateEstablished mesh__D011888 1991-01-01
% 213.83/213.98  |- mesh__publicMeSHNote mesh__D011888
% 213.83/213.98       91; was see under SALICYLAMIDES 1975-90   
% 213.83/213.98  |- skos__historyNote mesh__D011888 Salicylamides %28%1971-1974%29%
% 213.83/213.98  |- mesh__dateCreated mesh__D011888 1974-11-19
% 213.83/213.98  |- rdf__type mesh__D016573sskos__Concept
% 213.83/213.98  |- skos__broader mesh__D016573smesh__D020313
% 213.83/213.98  |- mesh__dateEstablished mesh__D016573 1992-01-01
% 213.83/213.98  |- skos__altLabel mesh__D016573 Chemicals, Agricultural
% 213.83/213.98  |- skos__annotation mesh__D016573 D25-26 qualif; DF: AGROCHEM   
% 213.83/213.98  |- skos__scopeNote mesh__D016573
% 213.83/213.98       Chemicals used in agriculture. These include pesticides, fumigants, fertilizers, plant hormones, steroids, antibiotics, mycotoxins, etc.%A%    
% 213.83/213.98  |- mesh__recordOriginator mesh__D016573 RLS
% 213.83/213.98  |- mesh__dateCreated mesh__D016573 1991-01-02
% 213.83/213.98  |- mesh__recordMaintainer mesh__D016573 ssb
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D016573 2006
% 213.83/213.98  |- mesh__recordAuthorizer mesh__D016573 sjn
% 213.83/213.98  |- skos__related mesh__D016573smesh__D010575
% 213.83/213.98  |- mesh__historyNote mesh__D016573 92   
% 213.83/213.98  |- skos__altLabel mesh__D016573 Agricultural Chemicals
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D016573 2005
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D016573 2004
% 213.83/213.98  |- skos__prefLabel mesh__D016573 Agrochemicals
% 213.83/213.98  |- mesh__dateRevised mesh__D016573 2003-07-09
% 213.83/213.98  |- mesh__publicMeSHNote mesh__D016573 92   
% 213.83/213.98  |- skos__altLabel mesh__D016573 Agrichemicals
% 213.83/213.98  |- skos__historyNote mesh__D002553 Sulfatases %28%1972-1974%29%
% 213.83/213.98  |- mesh__dateCreated mesh__D002553 1975-07-25
% 213.83/213.98  |- skos__related mesh__D002553smesh__D007966
% 213.83/213.98  |- skos__altLabel mesh__D002553 Sulfatidate Sulfatase
% 213.83/213.98  |- rdf__type mesh__D002553sskos__Concept
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D002553 2004
% 213.83/213.98  |- skos__broader mesh__D002553smesh__D001192
% 213.83/213.98  |- skos__historyNote mesh__D002553 Arylsulfatases %28%1975%29%
% 213.83/213.98  |- skos__hiddenLabel mesh__D002553 Cerebroside Sulfatase
% 213.83/213.98  |- mesh__recordOriginator mesh__D002553 RLS
% 213.83/213.98  |- mesh__publicMeSHNote mesh__D002553
% 213.83/213.98       87; was see under SULFATASES 1976-86   
% 213.83/213.98  |- skos__hiddenLabel mesh__D002553 Sulfatase, Sulfatidate
% 213.83/213.98  |- mesh__dateEstablished mesh__D002553 1987-01-01
% 213.83/213.98  |- mesh__recordMaintainer mesh__D002553 ssb
% 213.83/213.98  |- mesh__historyNote mesh__D002553
% 213.83/213.98       87%28%76%29%; was see under SULFATASES 1976-86   
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D002553 2006
% 213.83/213.98  |- mesh__dateRevised mesh__D002553 2003-07-09
% 213.83/213.98  |- skos__scopeNote mesh__D002553
% 213.83/213.98       An enzyme that catalyzes the hydrolysis of cerebroside 3-sulfate %28%sulfatide%29% to yield a cerebroside and inorganic sulfate. A marked deficiency of arylsulfatase A, which is considered the heat-labile component of cerebroside sulfatase, has been demonstrated in all forms of metachromatic leukodystrophy %28%LEUKODYSTROPHY, METACHROMATIC%29%. EC 3.1.6.8.%A%    
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D002553 2005
% 213.83/213.98  |- skos__altLabel mesh__D002553 Arylsulfatase A
% 213.83/213.98  |- mesh__recordAuthorizer mesh__D002553 sjn
% 213.83/213.98  |- skos__annotation mesh__D002553
% 213.83/213.98       /defic: consider also LEUKODYSTROPHY, METACHROMATIC   
% 213.83/213.98  |- skos__prefLabel mesh__D002553 Cerebroside-Sulfatase
% 213.83/213.98  |- mesh__dateEstablished mesh__D012981 1991-01-01
% 213.83/213.98  |- mesh__recordOriginator mesh__D012981 NLM
% 213.83/213.98  |- mesh__dateCreated mesh__D012981 1999-01-01
% 213.83/213.98  |- mesh__onlineNote mesh__D012981
% 213.83/213.98       use SODIUM TETRADECYL SULFATE to search SODIUM TETRADECYL SULFATES 1975-80; use SCLEROSING SOLUTIONS 1966-74%A%  
% 213.83/213.98  |- skos__hiddenLabel mesh__D012981 Sulfate, Sodium Tetradecyl
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012981 2006
% 213.83/213.98  |- mesh__publicMeSHNote mesh__D012981
% 213.83/213.98       91; was see under FATTY ALCOHOLS 1981-90; was SODIUM TETRADECYL SULFATES see under FATTY ALCOHOLS 1975-80, see under SCLEROSING SOLUTIONS 1963-74%A%  
% 213.83/213.98  |- skos__hiddenLabel mesh__D012981 Tetradecyl Sulfate, Sodium
% 213.83/213.98  |- skos__altLabel mesh__D012981 Sotradecol
% 213.83/213.98  |- mesh__recordMaintainer mesh__D012981 ssb
% 213.83/213.98  |- mesh__dateRevised mesh__D012981 2005-06-30
% 213.83/213.98  |- mesh__historyNote mesh__D012981
% 213.83/213.98       91%28%81%29%; was see under FATTY ALCOHOLS 1981-90; was SODIUM TETRADECYL SULFATES see under FATTY ALCOHOLS 1975-80, see under SCLEROSING SOLUTIONS 1963-74%A%  
% 213.83/213.98  |- mesh__recordAuthorizer mesh__D012981 sjn
% 213.83/213.98  |- skos__historyNote mesh__D012981 Sclerosing Solutions %28%1966-1974%29%
% 213.83/213.98  |- skos__broader mesh__D012981smesh__D000476
% 213.83/213.98  |- skos__scopeNote mesh__D012981
% 213.83/213.98       An anionic surface-active agent used for its wetting properties in industry and used in medicine as an irritant and sclerosing agent for hemorrhoids and varicose veins.%A%    
% 213.83/213.98  |- skos__prefLabel mesh__D012981 Sodium Tetradecyl Sulfate
% 213.83/213.98  |- skos__annotation mesh__D012981 D25-26 qualif   
% 213.83/213.98  |- skos__broader mesh__D012981smesh__D005233
% 213.83/213.98  |- rdf__type mesh__D012981sskos__Concept
% 213.83/213.98  |- skos__altLabel mesh__D012981 Trombovar
% 213.83/213.98  |- mesh__recordAuthorizer mesh__D012183 ags
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012183 2001
% 213.83/213.98  |- skos__hiddenLabel mesh__D012183 Degeneration, Trans-Synaptic
% 213.83/213.98  |- mesh__dateEstablished mesh__D012183 1991-01-01
% 213.83/213.98  |- skos__altLabel mesh__D012183 Nissl Degeneration
% 213.83/213.98  |- skos__hiddenLabel mesh__D012183 Reaction, Axon
% 213.83/213.98  |- skos__hiddenLabel mesh__D012183 Degeneration, Nissl
% 213.83/213.98  |- skos__altLabel mesh__D012183 Trans-Synaptic Degeneration
% 213.83/213.98  |- skos__hiddenLabel mesh__D012183 Transneuronal Retrograde Degeneration
% 213.83/213.98  |- skos__hiddenLabel mesh__D012183 Reactions, Axon
% 213.83/213.98  |- skos__hiddenLabel mesh__D012183 Retrograde Degenerations
% 213.83/213.98  |- skos__hiddenLabel mesh__D012183 Axonal Reactions
% 213.83/213.98  |- skos__hiddenLabel mesh__D012183 Transneuronal Retrograde Degenerations
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012183 2000
% 213.83/213.98  |- mesh__publicMeSHNote mesh__D012183
% 213.83/213.98       91; was see under NERVE DEGENERATION 1975-90; NISSL DEGENERATION was see NERVE DEGENERATION 1997, was heading 1975-96 %28%see under NERVE DEGENERATION 1975-90%29%%A%  
% 213.83/213.98  |- skos__hiddenLabel mesh__D012183 Retrograde Degenerations, Transneuronal
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012183 2000A
% 213.83/213.98  |- skos__broader mesh__D012183smesh__D009410
% 213.83/213.98  |- skos__hiddenLabel mesh__D012183 Trans Synaptic Degeneration
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012183 2004
% 213.83/213.98  |- mesh__recordOriginator mesh__D012183 NLM
% 213.83/213.98  |- skos__scopeNote mesh__D012183
% 213.83/213.98       Pathologic changes that occur in the axon and cell body of a neuron proximal to an axonal lesion. The process is characterized by central chromatolysis which features flattening and displacement of the nucleus, loss of Nissl bodies, and cellular edema. Central chromatolysis primarily occurs in lower motor neurons.%A%    
% 213.83/213.98  |- skos__hiddenLabel mesh__D012183 Degeneration, Retrograde
% 213.83/213.98  |- skos__altLabel mesh__D012183 Axon Reaction
% 213.83/213.98  |- mesh__historyNote mesh__D012183
% 213.83/213.98       91%28%75%29%; was see under NERVE DEGENERATION 1975-90; NISSL DEGENERATION was see NERVE DEGENERATION 1997, was heading 1975-96 %28%see under NERVE DEGENERATION 1975-90%29%%A%  
% 213.83/213.98  |- skos__prefLabel mesh__D012183 Retrograde Degeneration
% 213.83/213.98  |- mesh__dateRevised mesh__D012183 1999-11-26
% 213.83/213.98  |- mesh__dateCreated mesh__D012183 1999-01-01
% 213.83/213.98  |- skos__hiddenLabel mesh__D012183 Reactions, Axonal
% 213.83/213.98  |- mesh__onlineNote mesh__D012183
% 213.83/213.98       use NERVE DEGENERATION to search NISSL DEGENERATION 1975-97 %26% RETROGRADE DEGENERATION 1967-74%A%  
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012183 2003
% 213.83/213.98  |- skos__hiddenLabel mesh__D012183 Degenerations, Retrograde
% 213.83/213.98  |- skos__hiddenLabel mesh__D012183 Degenerations, Trans-Synaptic
% 213.83/213.98  |- mesh__activeMeSHYear mesh__D012183 2006
% 213.83/213.98  |- skos__hiddenLabel mesh__D012183 Degeneration, Transneuronal Retrograde
% 213.83/213.98  |- rdf__type mesh__D012183sskos__Concept
% 213.83/213.98  |- skos__hiddenLabel mesh__D012183 Trans-Synaptic Degenerations
% 213.83/213.98  |- skos__hiddenLabel mesh__D012183 Reaction, Axonal
% 213.83/213.99  |- mesh__recordMaintainer mesh__D012183 ags
% 213.83/213.99  |- skos__altLabel mesh__D012183 Axonal Reaction
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012183 2002
% 213.83/213.99  |- skos__hiddenLabel mesh__D012183 Axon Reactions
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012183 2005
% 213.83/213.99  |- skos__hiddenLabel mesh__D012183 Degenerations, Transneuronal Retrograde
% 213.83/213.99  |- mesh__dateCreated mesh__D006944 1976-04-27
% 213.83/213.99  |- mesh__publicMeSHNote mesh__D006944
% 213.83/213.99       91; was see under DIABETIC COMA 1977-90   
% 213.83/213.99  |- skos__hiddenLabel mesh__D006944 Hyperglycemic Coma, Nonketotic
% 213.83/213.99  |- skos__historyNote mesh__D006944 Diabetic Coma %28%1966-1976%29%
% 213.83/213.99  |- skos__altLabel mesh__D006944 Coma, Hyperglycemic Hyperosmolar Nonketotic
% 213.83/213.99  |- skos__broader mesh__D006944smesh__D003926
% 213.83/213.99  |- mesh__recordOriginator mesh__D006944 VDK
% 213.83/213.99  |- skos__altLabel mesh__D006944 HHNC
% 213.83/213.99  |- mesh__dateEstablished mesh__D006944 1991-01-01
% 213.83/213.99  |- rdf__type mesh__D006944sskos__Concept
% 213.83/213.99  |- mesh__historyNote mesh__D006944
% 213.83/213.99       91%28%77%29%; was see under DIABETIC COMA 1977-90   
% 213.83/213.99  |- skos__scopeNote mesh__D006944
% 213.83/213.99       A serious complication of TYPE 2 DIABETES MELLITUS. It is characterized by extreme HYPERGLYCEMIA; DEHYDRATION; serum hyperosmolarity; and depressed consciousness leading to COMA in the absence of KETOSIS and ACIDOSIS.%A%    
% 213.83/213.99  |- skos__historyNote mesh__D006944 Osmolar Concentration %28%1970-1976%29%
% 213.83/213.99  |- mesh__dateRevised mesh__D006944 2005-07-18
% 213.83/213.99  |- mesh__recordMaintainer mesh__D006944 ags
% 213.83/213.99  |- skos__altLabel mesh__D006944 Nonketotic Hyperglycemic Coma
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006944 2006
% 213.83/213.99  |- skos__annotation mesh__D006944
% 213.83/213.99       not for nonketotic hyperglycinemia %28%= AMINO ACID METAB INBORN ERR + GLYCINE/metab%29%; DF: HHNC or HHNK%A%  
% 213.83/213.99  |- mesh__recordAuthorizer mesh__D006944 ags
% 213.83/213.99  |- skos__historyNote mesh__D006944 Hyperglycemia %28%1966-1976%29%
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006944 2006A
% 213.83/213.99  |- skos__prefLabel mesh__D006944 Hyperglycemic Hyperosmolar Nonketotic Coma
% 213.83/213.99  |- skos__hiddenLabel mesh__D006944 Coma, Nonketotic Hyperglycemic
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006944 2005
% 213.83/213.99  |- skos__altLabel mesh__D006944 Hyperosmolar Hyperglycemic Nonketotic Coma
% 213.83/213.99  |- mesh__publicMeSHNote mesh__D020615 2000   
% 213.83/213.99  |- mesh__dateCreated mesh__D020615 1999-11-03
% 213.83/213.99  |- skos__altLabel mesh__D020615 Xanthomonas maltophilia
% 213.83/213.99  |- skos__annotation mesh__D020615
% 213.83/213.99       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 213.83/213.99  |- mesh__recordOriginator mesh__D020615 ndw
% 213.83/213.99  |- skos__historyNote mesh__D020615 Xanthomonas %28%1995-1999%29%
% 213.83/213.99  |- skos__broader mesh__D020615smesh__D020588
% 213.83/213.99  |- mesh__historyNote mesh__D020615 2000   
% 213.83/213.99  |- skos__scopeNote mesh__D020615
% 213.83/213.99       A species of STENOTROPHOMONAS, formerly called Xanthomonas maltophilia, which reduces nitrate. It is a cause of hospital-acquired ocular and lung infections, especially in those patients with cystic fibrosis and those who are immunosuppressed.%A%    
% 213.83/213.99  |- mesh__recordAuthorizer mesh__D020615 sjn
% 213.83/213.99  |- skos__prefLabel mesh__D020615 Stenotrophomonas maltophilia
% 213.83/213.99  |- mesh__dateRevised mesh__D020615 2005-06-30
% 213.83/213.99  |- mesh__recordMaintainer mesh__D020615 SYSTEM
% 213.83/213.99  |- mesh__dateEstablished mesh__D020615 2000-01-01
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D020615 2006
% 213.83/213.99  |- rdf__type mesh__D020615sskos__Concept
% 213.83/213.99  |- mesh__recordOriginator mesh__D006146 NLM
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006146 2004
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006146 2002
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006146 1998
% 213.83/213.99  |- skos__broader mesh__D006146smesh__D000578
% 213.83/213.99  |- mesh__recordAuthorizer mesh__D006146 PLS
% 213.83/213.99  |- rdf__type mesh__D006146sskos__Concept
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006146 2003
% 213.83/213.99  |- mesh__dateCreated mesh__D006146 1999-01-01
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006146 2001
% 213.83/213.99  |- skos__annotation mesh__D006146 do not confuse with GUANINE   
% 213.83/213.99  |- skos__prefLabel mesh__D006146 Guanidines
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006146 1997
% 213.83/213.99  |- mesh__recordMaintainer mesh__D006146 PLS
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006146 2000
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006146 1996
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006146 1995
% 213.83/213.99  |- skos__scopeNote mesh__D006146
% 213.83/213.99       A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.%A%    
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006146 2006
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006146 1994
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006146 2005
% 213.83/213.99  |- mesh__dateRevised mesh__D006146 1993-06-03
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006146 1999
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D011889 1993
% 213.83/213.99  |- skos__annotation mesh__D011889 human %26% animal   
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D011889 1999
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D011889 1997
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D011889 1994
% 213.83/213.99  |- mesh__publicMeSHNote mesh__D011889 91; was see under ANGER 1975-90   
% 213.83/213.99  |- skos__prefLabel mesh__D011889 Rage
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D011889 2006
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D011889 2002
% 213.83/213.99  |- skos__broader mesh__D011889smesh__D000786
% 213.83/213.99  |- mesh__recordAuthorizer mesh__D011889 PLS
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D011889 2004
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D011889 1998
% 213.83/213.99  |- mesh__dateRevised mesh__D011889 1992-05-18
% 213.83/213.99  |- mesh__historyNote mesh__D011889
% 213.83/213.99       91%28%75%29%; was see under ANGER 1975-90   
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D011889 1996
% 213.83/213.99  |- mesh__onlineNote mesh__D011889 search ANGER 1972-74   
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D011889 2005
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D011889 2003
% 213.83/213.99  |- rdf__type mesh__D011889sskos__Concept
% 213.83/213.99  |- mesh__recordMaintainer mesh__D011889 TAP
% 213.83/213.99  |- mesh__dateEstablished mesh__D011889 1991-01-01
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D011889 2001
% 213.83/213.99  |- mesh__dateCreated mesh__D011889 1999-01-01
% 213.83/213.99  |- skos__scopeNote mesh__D011889 Fury; violent, intense anger.     
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D011889 2000
% 213.83/213.99  |- mesh__recordOriginator mesh__D011889 NLM
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D011889 1995
% 213.83/213.99  |- skos__hiddenLabel mesh__D011889 Rages
% 213.83/213.99  |- mesh__recordAuthorizer mesh__D016574 SJN
% 213.83/213.99  |- skos__historyNote mesh__D016574 Affective Disorders %28%1985-1991%29%
% 213.83/213.99  |- skos__scopeNote mesh__D016574
% 213.83/213.99       A syndrome characterized by depressions that recur annually at the same time each year, usually during the winter months. Other symptoms include anxiety, irritability, decreased energy, increased appetite %28%carbohydrate cravings%29%, increased duration of sleep, and weight gain. SAD %28%seasonal affective disorder%29% can be treated by daily exposure to bright artificial lights %28%PHOTOTHERAPY%29%, during the season of recurrence.%A%    
% 213.83/213.99  |- rdf__type mesh__D016574sskos__Concept
% 213.83/213.99  |- skos__annotation mesh__D016574
% 213.83/213.99       %22%seasonal%22% refers usually to winter; DF: SAD   
% 213.83/213.99  |- skos__hiddenLabel mesh__D016574 Disorders, Seasonal Affective
% 213.83/213.99  |- skos__altLabel mesh__D016574 Seasonal Affective Disorders
% 213.83/213.99  |- skos__prefLabel mesh__D016574 Seasonal Affective Disorder
% 213.83/213.99  |- skos__hiddenLabel mesh__D016574 Affective Disorder, Seasonal
% 213.83/213.99  |- mesh__publicMeSHNote mesh__D016574 92   
% 213.83/213.99  |- skos__hiddenLabel mesh__D016574 Disorder, Seasonal Affective
% 213.83/213.99  |- skos__hiddenLabel mesh__D016574 Seasonal Mood Disorders
% 213.83/213.99  |- mesh__dateCreated mesh__D016574 1991-01-03
% 213.83/213.99  |- skos__altLabel mesh__D016574 Seasonal Mood Disorder
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D016574 1998
% 213.83/213.99  |- mesh__dateRevised mesh__D016574 1997-06-20
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D016574 2005
% 213.83/213.99  |- mesh__dateEstablished mesh__D016574 1992-01-01
% 213.83/213.99  |- skos__hiddenLabel mesh__D016574 Mood Disorder, Seasonal
% 213.83/213.99  |- skos__hiddenLabel mesh__D016574 Affective Disorders, Seasonal
% 213.83/213.99  |- skos__hiddenLabel mesh__D016574 Mood Disorders, Seasonal
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D016574 2000
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D016574 2003
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D016574 1999
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D016574 2006
% 213.83/213.99  |- mesh__recordMaintainer mesh__D016574 JLS
% 213.83/213.99  |- skos__broader mesh__D016574smesh__D003866
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D016574 2001
% 213.83/213.99  |- skos__hiddenLabel mesh__D016574 Disorders, Seasonal Mood
% 213.83/213.99  |- mesh__historyNote mesh__D016574 92   
% 213.83/213.99  |- skos__historyNote mesh__D016574 Depressive Disorder %28%1984-1991%29%
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D016574 2004
% 213.83/213.99  |- skos__hiddenLabel mesh__D016574 Disorder, Seasonal Mood
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D016574 2002
% 213.83/213.99  |- mesh__recordOriginator mesh__D016574 MXR
% 213.83/213.99  |- skos__historyNote mesh__D016574 Seasons %28%1984-1991%29%
% 213.83/213.99  |- rdf__type mesh__D002554sskos__Concept
% 213.83/213.99  |- mesh__dateRevised mesh__D002554 2004-07-07
% 213.83/213.99  |- mesh__recordAuthorizer mesh__D002554 sjn
% 213.83/213.99  |- mesh__dateCreated mesh__D002554 1999-01-01
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D002554 2006
% 213.83/213.99  |- skos__broader mesh__D002554smesh__D002518
% 213.83/213.99  |- skos__scopeNote mesh__D002554
% 213.83/213.99       Neutral glycosphingolipids that contain a monosaccharide, normally glucose or galactose, in 1-ortho-beta-glycosidic linkage with the primary alcohol of an N-acyl sphingoid %28%ceramide%29%. In plants the monosaccharide is normally glucose and the sphingoid usually phytosphingosine. In animals, the monosaccharide is usually galactose, though this may vary with the tissue and the sphingoid is usually sphingosine or dihydrosphingosine. %28%From Oxford Dictionary of Biochemistry and Molecular Biology, 1st ed%29%%A%    
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D002554 2005
% 213.83/213.99  |- skos__prefLabel mesh__D002554 Cerebrosides
% 213.83/213.99  |- mesh__recordMaintainer mesh__D002554 ssb
% 213.83/213.99  |- mesh__recordOriginator mesh__D002554 NLM
% 213.83/213.99  |- mesh__recordOriginator mesh__D012982 RLS
% 213.83/213.99  |- skos__historyNote mesh__D012982 Sodium Glutamate %28%1975-1987%29%
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012982 2005
% 213.83/213.99  |- skos__historyNote mesh__D012982 Sodium %28%1966-1987%29%
% 213.83/213.99  |- mesh__dateCreated mesh__D012982 1987-03-23
% 213.83/213.99  |- mesh__publicMeSHNote mesh__D012982 88   
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012982 2000
% 213.83/213.99  |- mesh__recordMaintainer mesh__D012982 JLS
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012982 2006
% 213.83/213.99  |- skos__broader mesh__D012982smesh__D017670
% 213.83/213.99  |- mesh__dateEstablished mesh__D012982 1988-01-01
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012982 2001
% 213.83/213.99  |- mesh__recordAuthorizer mesh__D012982 SJN
% 213.83/213.99  |- mesh__dateRevised mesh__D012982 1997-06-20
% 213.83/213.99  |- skos__prefLabel mesh__D012982 Sodium, Dietary
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012982 2003
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012982 1998
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012982 2004
% 213.83/213.99  |- skos__altLabel mesh__D012982 Dietary Sodium
% 213.83/213.99  |- mesh__historyNote mesh__D012982 88   
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012982 1999
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012982 2002
% 213.83/213.99  |- rdf__type mesh__D012982sskos__Concept
% 213.83/213.99  |- skos__annotation mesh__D012982
% 213.83/213.99       /adv eff: coord with disease /etiol, not /chem ind; /defic = SODIUM /defic but consider also HYPONATREMIA; for intake of table salt index under SODIUM CHLORIDE, DIETARY%A%  
% 213.83/213.99  |- skos__scopeNote mesh__D012982
% 213.83/213.99       Sodium or sodium compounds used in foods or as a food. The most frequently used compounds are sodium chloride or sodium glutamate.%A%    
% 213.83/213.99  |- skos__historyNote mesh__D012982 Sodium Chloride %28%1966-1987%29%
% 213.83/213.99  |- skos__historyNote mesh__D012982
% 213.83/213.99       Diet, Sodium-Restricted %28%1966-1987%29%
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012184 1997
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012184 2001
% 213.83/213.99  |- mesh__dateEstablished mesh__D012184 1965-01-01
% 213.83/213.99  |- rdf__type mesh__D012184sskos__Concept
% 213.83/213.99  |- skos__hiddenLabel mesh__D012184 Obturations, Retrograde
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012184 2002
% 213.83/213.99  |- skos__hiddenLabel mesh__D012184 Obturation, Retrograde
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012184 1994
% 213.83/213.99  |- mesh__recordMaintainer mesh__D012184 SMH
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012184 1992
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012184 1995
% 213.83/213.99  |- mesh__dateRevised mesh__D012184 1978-11-02
% 213.83/213.99  |- mesh__dateCreated mesh__D012184 1999-01-01
% 213.83/213.99  |- skos__broader mesh__D012184smesh__D012389
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012184 2005
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012184 1998
% 213.83/213.99  |- mesh__recordOriginator mesh__D012184 NLM
% 213.83/213.99  |- mesh__recordAuthorizer mesh__D012184 NLM
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012184 1993
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012184 1990
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012184 2003
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012184 2006
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012184 1996
% 213.83/213.99  |- skos__hiddenLabel mesh__D012184 Retrograde Obturations
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012184 1999
% 213.83/213.99  |- mesh__publicMeSHNote mesh__D012184 65   
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012184 1989
% 213.83/213.99  |- skos__prefLabel mesh__D012184 Retrograde Obturation
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012184 2000
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012184 1991
% 213.83/213.99  |- mesh__historyNote mesh__D012184 65   
% 213.83/213.99  |- skos__annotation mesh__D012184
% 213.83/213.99       do not use /util except by MeSH definition   
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012184 2004
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006945 2005
% 213.83/213.99  |- skos__prefLabel mesh__D006945 Hyperhidrosis
% 213.83/213.99  |- skos__scopeNote mesh__D006945
% 213.83/213.99       Excessive sweating. In the localized type, the most frequent sites are the palms, soles, axillae, inguinal folds, and the perineal area. Its chief cause is thought to be emotional. Generalized hyperhidrosis may be induced by a hot, humid environment, by fever, or by vigorous exercise.%A%    
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006945 2002
% 213.83/213.99  |- mesh__historyNote mesh__D006945 76; was see under SWEATING 1963-75   
% 213.83/213.99  |- mesh__publicMeSHNote mesh__D006945 76; was see under SWEATING 1963-75   
% 213.83/213.99  |- rdf__type mesh__D006945sskos__Concept
% 213.83/213.99  |- mesh__recordOriginator mesh__D006945 NLM
% 213.83/213.99  |- mesh__recordAuthorizer mesh__D006945 sjn
% 213.83/213.99  |- skos__historyNote mesh__D006945 Sweating %28%1966-1975%29%
% 213.83/213.99  |- mesh__dateEstablished mesh__D006945 1976-01-01
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006945 2004
% 213.83/213.99  |- mesh__dateRevised mesh__D006945 2001-07-25
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006945 2003
% 213.83/213.99  |- mesh__dateCreated mesh__D006945 1999-01-01
% 213.83/213.99  |- skos__annotation mesh__D006945
% 213.83/213.99       excessive sweating; do not confuse with HYPOHIDROSIS, reduced sweating%A%  
% 213.83/213.99  |- mesh__recordMaintainer mesh__D006945 lkt
% 213.83/213.99  |- mesh__onlineNote mesh__D006945 search SWEATING 1966-75   
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006945 2006
% 213.83/213.99  |- skos__broader mesh__D006945smesh__D013543
% 213.83/213.99  |- mesh__dateRevised mesh__D020616 2005-06-30
% 213.83/213.99  |- mesh__recordOriginator mesh__D020616 ndw
% 213.83/213.99  |- skos__historyNote mesh__D020616 Chromatiaceae %28%1976-1999%29%
% 213.83/213.99  |- skos__historyNote mesh__D020616 Bacteria %28%1972-1975%29%
% 213.83/213.99  |- mesh__historyNote mesh__D020616 2000   
% 213.83/213.99  |- mesh__publicMeSHNote mesh__D020616 2000   
% 213.83/213.99  |- mesh__dateCreated mesh__D020616 1999-11-03
% 213.83/213.99  |- mesh__recordMaintainer mesh__D020616 SYSTEM
% 213.83/213.99  |- mesh__dateEstablished mesh__D020616 2000-01-01
% 213.83/213.99  |- skos__scopeNote mesh__D020616
% 213.83/213.99       A species of THIOCAPSA which is facultatively aerobic and chemotrophic and which can utilize thiosulfate. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D020616 2006
% 213.83/213.99  |- rdf__type mesh__D020616sskos__Concept
% 213.83/213.99  |- mesh__recordAuthorizer mesh__D020616 sjn
% 213.83/213.99  |- skos__broader mesh__D020616smesh__D020586
% 213.83/213.99  |- skos__prefLabel mesh__D020616 Thiocapsa roseopersicina
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D039321 2003
% 213.83/213.99  |- mesh__historyNote mesh__D039321 2003   
% 213.83/213.99  |- skos__altLabel mesh__D039321 Golden Seal
% 213.83/213.99  |- skos__scopeNote mesh__D039321
% 213.83/213.99       A plant genus of the family RANUNCULACEAE. Members contain BERBERINE.%A%    
% 213.83/213.99  |- mesh__publicMeSHNote mesh__D039321 2003   
% 213.83/213.99  |- mesh__dateEstablished mesh__D039321 2003-01-01
% 213.83/213.99  |- skos__broader mesh__D039321smesh__D029626
% 213.83/213.99  |- rdf__type mesh__D039321sskos__Concept
% 213.83/213.99  |- skos__altLabel mesh__D039321 Goldenseal
% 213.83/213.99  |- mesh__dateCreated mesh__D039321 2002-07-03
% 213.83/213.99  |- skos__annotation mesh__D039321
% 213.83/213.99       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.83/213.99  |- skos__prefLabel mesh__D039321 Hydrastis
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D039321 2006
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D039321 2005
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D039321 2004
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006147 2004
% 213.83/213.99  |- mesh__recordMaintainer mesh__D006147 TWD
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006147 2002
% 213.83/213.99  |- rdf__type mesh__D006147sskos__Concept
% 213.83/213.99  |- mesh__dateRevised mesh__D006147 2000-06-22
% 213.83/213.99  |- skos__annotation mesh__D006147
% 213.83/213.99       do not confuse with GUANIDINES; /biosyn /physiol permitted; guanine riboside, guanine ribonucleoside = GUANOSINE%A%  
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006147 2005
% 213.83/213.99  |- mesh__recordOriginator mesh__D006147 NLM
% 213.83/213.99  |- mesh__recordAuthorizer mesh__D006147 sjn
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006147 2006
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006147 2001
% 213.83/213.99  |- skos__broader mesh__D006147smesh__D007042
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D006147 2003
% 213.83/213.99  |- mesh__dateCreated mesh__D006147 1999-01-01
% 213.83/213.99  |- skos__prefLabel mesh__D006147 Guanine
% 213.83/213.99  |- skos__scopeNote mesh__D025301
% 213.83/213.99       Microscopic threadlike filaments in FUNGI that are filled with a layer of protoplasm. Collectively, the hyphae make up the MYCELIUM.%A%    
% 213.83/213.99  |- rdf__type mesh__D025301sskos__Concept
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D025301 2006
% 213.83/213.99  |- mesh__publicMeSHNote mesh__D025301 2002   
% 213.83/213.99  |- skos__altLabel mesh__D025301 Hypha
% 213.83/213.99  |- mesh__dateRevised mesh__D025301 2005-06-30
% 213.83/213.99  |- mesh__dateCreated mesh__D025301 2001-07-25
% 213.83/213.99  |- mesh__historyNote mesh__D025301 2002   
% 213.83/213.99  |- mesh__recordOriginator mesh__D025301 ags
% 213.83/213.99  |- mesh__recordAuthorizer mesh__D025301 sjn
% 213.83/213.99  |- skos__prefLabel mesh__D025301 Hyphae
% 213.83/213.99  |- mesh__recordMaintainer mesh__D025301 SYSTEM
% 213.83/213.99  |- skos__annotation mesh__D025301 coord with specific fungus   
% 213.83/213.99  |- skos__broader mesh__D025301smesh__D025282
% 213.83/213.99  |- mesh__dateEstablished mesh__D025301 2002-01-01
% 213.83/213.99  |- mesh__recordMaintainer mesh__D016575 lkt
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D016575 2002
% 213.83/213.99  |- skos__hiddenLabel mesh__D016575 Neutrophilic Eccrine Hidradenitides
% 213.83/213.99  |- skos__broader mesh__D016575smesh__D013543
% 213.83/213.99  |- skos__historyNote mesh__D016575 Sweat Glands %28%1966-1991%29%
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D016575 2005
% 213.83/213.99  |- skos__hiddenLabel mesh__D016575 Hydradenitides
% 213.83/213.99  |- mesh__recordAuthorizer mesh__D016575 sjn
% 213.83/213.99  |- skos__hiddenLabel mesh__D016575 Hidrosadenitides
% 213.83/213.99  |- mesh__dateCreated mesh__D016575 1991-01-02
% 213.83/213.99  |- skos__altLabel mesh__D016575 Hidrosadenitis
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D016575 2003
% 213.83/213.99  |- skos__hiddenLabel mesh__D016575 Hidradenitides, Neutrophilic Eccrine
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D016575 2006
% 213.83/213.99  |- mesh__publicMeSHNote mesh__D016575 92   
% 213.83/213.99  |- skos__hiddenLabel mesh__D016575 Hidradenitides
% 213.83/213.99  |- mesh__historyNote mesh__D016575 92   
% 213.83/213.99  |- skos__prefLabel mesh__D016575 Hidradenitis
% 213.83/213.99  |- skos__scopeNote mesh__D016575
% 213.83/213.99       The inflammation of a sweat gland %28%usually of the apocrine type%29%. The condition can be idiopathic or occur as a result of or in association with another underlying condition. Neutrophilic eccrine hidradenitis is a relatively rare variant that has been reported in patients undergoing chemotherapy, usually for non-Hodgkin lymphomas or leukemic conditions.%A%    
% 213.83/213.99  |- skos__historyNote mesh__D016575 Sweat Gland Diseases %28%1976-1991%29%
% 213.83/213.99  |- skos__hiddenLabel mesh__D016575 Eccrine Hidradenitis, Neutrophilic
% 213.83/213.99  |- skos__hiddenLabel mesh__D016575 Eccrine Hidradenitides, Neutrophilic
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D016575 2004
% 213.83/213.99  |- mesh__dateEstablished mesh__D016575 1992-01-01
% 213.83/213.99  |- skos__altLabel mesh__D016575 Hydradenitis
% 213.83/213.99  |- mesh__recordOriginator mesh__D016575 MXR
% 213.83/213.99  |- skos__annotation mesh__D016575 inflamm of a sweat gland   
% 213.83/213.99  |- mesh__dateRevised mesh__D016575 2001-07-25
% 213.83/213.99  |- skos__hiddenLabel mesh__D016575 Hidradenitis, Neutrophilic Eccrine
% 213.83/213.99  |- rdf__type mesh__D016575sskos__Concept
% 213.83/213.99  |- rdf__type mesh__D002555sskos__Concept
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D002555 2004
% 213.83/213.99  |- skos__hiddenLabel mesh__D002555 Fluid, Cerebrospinal
% 213.83/213.99  |- skos__prefLabel mesh__D002555 Cerebrospinal Fluid
% 213.83/213.99  |- skos__related mesh__D002555smesh__D001812
% 213.83/213.99  |- mesh__recordOriginator mesh__D002555 NLM
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D002555 2005
% 213.83/213.99  |- mesh__recordMaintainer mesh__D002555 nns
% 213.83/213.99  |- skos__broader mesh__D002555smesh__D045604
% 213.83/213.99  |- skos__hiddenLabel mesh__D002555 Cerebrospinal Fluids
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D002555 2006
% 213.83/213.99  |- mesh__dateRevised mesh__D002555 2003-07-09
% 213.83/213.99  |- mesh__recordAuthorizer mesh__D002555 sjn
% 213.83/213.99  |- skos__annotation mesh__D002555
% 213.83/213.99       IM as substance only: with diseases %26% drugs, use /csf as qualif: Manual 19.7+, 19.8.12; csf production = /physiol, not /secret; csf pressure = CEREBROSPINAL FLUID PRESSURE; DF: CSF%A%  
% 213.83/213.99  |- skos__hiddenLabel mesh__D002555 Fluids, Cerebrospinal
% 213.83/213.99  |- mesh__dateCreated mesh__D002555 1999-01-01
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D007240 2004
% 213.83/213.99  |- skos__broader mesh__D007240smesh__D018018
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D007240 2005
% 213.83/213.99  |- skos__scopeNote mesh__D007240
% 213.83/213.99       The type species of the genus ARTERIVIRUS and the etiologic agent of an important equine respiratory disease causing abortion, pneumonia, or other infections.%A%    
% 213.83/213.99  |- mesh__recordAuthorizer mesh__D007240 sjn
% 213.83/213.99  |- skos__prefLabel mesh__D007240 Arteritis Virus, Equine
% 213.83/213.99  |- skos__altLabel mesh__D007240 Infectious Arteritis Virus of Horses
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D007240 2006
% 213.83/213.99  |- mesh__recordMaintainer mesh__D007240 ags
% 213.83/213.99  |- mesh__dateRevised mesh__D007240 2003-07-30
% 213.83/213.99  |- skos__altLabel mesh__D007240 Equine Infectious Arteritis Virus
% 213.83/213.99  |- skos__hiddenLabel mesh__D007240 Equine Arteritis Viruses
% 213.83/213.99  |- mesh__historyNote mesh__D007240
% 213.83/213.99       94; was INFECTIOUS ARTERITIS VIRUS, EQUINE 1981-93 %28%see under RNA VIRUSES 1981-90%29%; was INFECTIOUS ARTERITIS VIRUS OF HORSES see under RNA VIRUSES 1975-80%A%  
% 213.83/213.99  |- mesh__publicMeSHNote mesh__D007240
% 213.83/213.99       91; was INFECTIOUS ARTERITIS VIRUS, EQUINE 1981-93 %28%see under RNA VIRUSES 1981-90%29%; was INFECTIOUS ARTERITIS VIRUS OF HORSES see under RNA VIRUSES 1975-80%A%  
% 213.83/213.99  |- skos__altLabel mesh__D007240 Infectious Arteritis Virus, Equine
% 213.83/213.99  |- skos__altLabel mesh__D007240 Equine arteritis virus
% 213.83/213.99  |- skos__annotation mesh__D007240
% 213.83/213.99       infection = ARTERIVIRUS INFECTIONS /vet %28%IM%29% + HORSE DISEASES %28%IM%29% + HORSES %28%NIM%29% + check tag ANIMALS%A%  
% 213.83/213.99  |- mesh__dateEstablished mesh__D007240 1991-01-01
% 213.83/213.99  |- mesh__dateCreated mesh__D007240 1974-12-12
% 213.83/213.99  |- mesh__recordOriginator mesh__D007240 NLM
% 213.83/213.99  |- rdf__type mesh__D007240sskos__Concept
% 213.83/213.99  |- skos__hiddenLabel mesh__D007240 Arteritis Viruses, Equine
% 213.83/213.99  |- mesh__onlineNote mesh__D007240
% 213.83/213.99       use ARTERITIS VIRUS, EQUINE to search INFECTIOUS ARTERITIS VIRUS, EQUINE 1981-93 %26% INFECTIOUS ARTERITIS VIRUS OF HORSES 1975-80%A%  
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012983 1997
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012983 2002
% 213.83/213.99  |- mesh__dateCreated mesh__D012983 1975-07-21
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012983 2006
% 213.83/213.99  |- mesh__recordAuthorizer mesh__D012983 PLS
% 213.83/213.99  |- mesh__recordOriginator mesh__D012983 CAB
% 213.83/213.99  |- skos__hiddenLabel mesh__D012983 Soft Tissue Neoplasm
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012983 2003
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012983 1998
% 213.83/213.99  |- skos__broader mesh__D012983smesh__D009371
% 213.83/213.99  |- mesh__recordMaintainer mesh__D012983 KEV
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012983 2000
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012983 2004
% 213.83/213.99  |- skos__prefLabel mesh__D012983 Soft Tissue Neoplasms
% 213.83/213.99  |- skos__hiddenLabel mesh__D012983 Neoplasm, Soft Tissue
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012983 1999
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012983 2001
% 213.83/213.99  |- rdf__type mesh__D012983sskos__Concept
% 213.83/213.99  |- mesh__publicMeSHNote mesh__D012983 76   
% 213.83/213.99  |- skos__annotation mesh__D012983
% 213.83/213.99       neoplasms located in soft %28%connective%29% tissue, NOT neoplasms composed of soft tissue; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term or site %28%IM%29%%A%  
% 213.83/213.99  |- mesh__dateRevised mesh__D012983 1995-06-08
% 213.83/213.99  |- skos__hiddenLabel mesh__D012983 Neoplasms, Soft Tissue
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012983 1996
% 213.83/213.99  |- skos__scopeNote mesh__D012983
% 213.83/213.99       Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc.%A%    
% 213.83/213.99  |- mesh__dateEstablished mesh__D012983 1976-01-01
% 213.83/213.99  |- mesh__historyNote mesh__D012983 76   
% 213.83/213.99  |- mesh__activeMeSHYear mesh__D012983 2005
% 213.83/213.99  |- mesh__dateEstablished mesh__D012185 1966-01-01
% 213.83/213.99  |- skos__hiddenLabel mesh__D012185 Chronic Periaortitides
% 213.83/214.00  |- mesh__dateRevised mesh__D012185 1999-11-03
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D012185 2000
% 213.83/214.00  |- skos__altLabel mesh__D012185 Fibrosis, Inflammatory Perianeurysmal
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D012185 2001
% 213.83/214.00  |- skos__altLabel mesh__D012185 Perianeurysmal Fibrosis, Inflammatory
% 213.83/214.00  |- skos__hiddenLabel mesh__D012185 Periaortitides, Chronic
% 213.83/214.00  |- skos__hiddenLabel mesh__D012185 Fibroses, Retroperitoneal
% 213.83/214.00  |- skos__hiddenLabel mesh__D012185 Disease, Ormond%27%s
% 213.83/214.00  |- skos__altLabel mesh__D012185 Ormond Disease
% 213.83/214.00  |- mesh__dateCreated mesh__D012185 1999-01-01
% 213.83/214.00  |- skos__altLabel mesh__D012185 Perianeurysmal Inflammatory Fibrosis
% 213.83/214.00  |- skos__prefLabel mesh__D012185 Retroperitoneal Fibrosis
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D012185 2005
% 213.83/214.00  |- skos__altLabel mesh__D012185 Ormond%27%s Disease
% 213.83/214.00  |- skos__scopeNote mesh__D012185
% 213.83/214.00       A slowly progressive condition of unknown etiology, characterized by deposition of fibrous tissue in the retroperitoneal space compressing the ureters, great vessels, bile duct, and other structures. When associated with abdominal aortic aneurysm, it may be called chronic periaortitis or inflammatory perianeurysmal fibrosis.%A%    
% 213.83/214.00  |- skos__hiddenLabel mesh__D012185 Fibrosis, Retroperitoneal
% 213.83/214.00  |- skos__altLabel mesh__D012185 Fibrosis, Perianeurysmal Inflammatory
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D012185 2002
% 213.83/214.00  |- mesh__recordMaintainer mesh__D012185 KEV
% 213.83/214.00  |- skos__altLabel mesh__D012185 Inflammatory Fibrosis, Perianeurysmal
% 213.83/214.00  |- skos__altLabel mesh__D012185 Inflammatory Perianeurysmal Fibrosis
% 213.83/214.00  |- skos__broader mesh__D012185smesh__D005355
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D012185 2003
% 213.83/214.00  |- mesh__publicMeSHNote mesh__D012185
% 213.83/214.00       66; for ORMOND DISEASE see ORMOND%27%S DISEASE 1966-97   
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D012185 2006
% 213.83/214.00  |- mesh__historyNote mesh__D012185 66%28%64%29%   
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D012185 2004
% 213.83/214.00  |- mesh__recordOriginator mesh__D012185 NLM
% 213.83/214.00  |- skos__hiddenLabel mesh__D012185 Disease, Ormond
% 213.83/214.00  |- skos__hiddenLabel mesh__D012185 Retroperitoneal Fibroses
% 213.83/214.00  |- rdf__type mesh__D012185sskos__Concept
% 213.83/214.00  |- skos__hiddenLabel mesh__D012185 Chronic Periaortitis
% 213.83/214.00  |- mesh__recordAuthorizer mesh__D012185 sjn
% 213.83/214.00  |- mesh__historyNote mesh__D006946 1963   
% 213.83/214.00  |- skos__scopeNote mesh__D006946
% 213.83/214.00       A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor %28%INSULINOMA%29%; autoantibodies against insulin %28%INSULIN ANTIBODIES%29%; defective insulin receptor %28%INSULIN RESISTANCE%29%; or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS.%A%    
% 213.83/214.00  |- skos__hiddenLabel mesh__D006946 Hyperinsulinemia, Compensatory
% 213.83/214.00  |- mesh__dateCreated mesh__D006946 1999-01-01
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D006946 2005A
% 213.83/214.00  |- skos__broader mesh__D006946smesh__D044882
% 213.83/214.00  |- skos__hiddenLabel mesh__D006946 Hyperinsulinism, Endogenous
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D006946 2006
% 213.83/214.00  |- skos__altLabel mesh__D006946 Hyperinsulinemia
% 213.83/214.00  |- mesh__publicMeSHNote mesh__D006946
% 213.83/214.00       1963; for HYPERINSULINEMIA see HYPERINSULINEMIA 1997-2003%A%  
% 213.83/214.00  |- mesh__recordMaintainer mesh__D006946 jls
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D006946 2005
% 213.83/214.00  |- mesh__recordAuthorizer mesh__D006946 jls
% 213.83/214.00  |- skos__hiddenLabel mesh__D006946 Hyperinsulinism, Exogenous
% 213.83/214.00  |- mesh__recordOriginator mesh__D006946 NLM
% 213.83/214.00  |- mesh__dateRevised mesh__D006946 2004-07-28
% 213.83/214.00  |- skos__related mesh__D006946smesh__D007328
% 213.83/214.00  |- skos__prefLabel mesh__D006946 Hyperinsulinism
% 213.83/214.00  |- rdf__type mesh__D006946sskos__Concept
% 213.83/214.00  |- skos__scopeNote mesh__D039322
% 213.83/214.00       A plant genus of the family RANUNCULACEAE. Members contain hellebrin %28%BUFANOLIDES%29%. The extract is the basis of Biocil preparation used for rheumatism.%A%    
% 213.83/214.00  |- mesh__publicMeSHNote mesh__D039322 2003   
% 213.83/214.00  |- skos__altLabel mesh__D039322 Hellebore, Stinking
% 213.83/214.00  |- mesh__recordAuthorizer mesh__D039322 ags
% 213.83/214.00  |- skos__altLabel mesh__D039322 Hellebore, Green
% 213.83/214.00  |- rdf__type mesh__D039322sskos__Concept
% 213.83/214.00  |- skos__broader mesh__D039322smesh__D029626
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D039322 2005
% 213.83/214.00  |- mesh__historyNote mesh__D039322 2003   
% 213.83/214.00  |- skos__prefLabel mesh__D039322 Helleborus
% 213.83/214.00  |- mesh__dateEstablished mesh__D039322 2003-01-01
% 213.83/214.00  |- skos__annotation mesh__D039322
% 213.83/214.00       HELLEBORE, FALSE see VERATRUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D039322 2003
% 213.83/214.00  |- skos__altLabel mesh__D039322 Heleborus
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D039322 2006
% 213.83/214.00  |- mesh__recordOriginator mesh__D039322 ssb
% 213.83/214.00  |- mesh__dateRevised mesh__D039322 2005-07-13
% 213.83/214.00  |- mesh__recordMaintainer mesh__D039322 ags
% 213.83/214.00  |- skos__altLabel mesh__D039322 Hellebore
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D039322 2006A
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D039322 2004
% 213.83/214.00  |- mesh__dateCreated mesh__D039322 2002-07-03
% 213.83/214.00  |- skos__scopeNote mesh__D006148
% 213.83/214.00       An enzyme that catalyzes the deamination of guanine to form xanthine. EC 3.5.4.3.%A%    
% 213.83/214.00  |- skos__altLabel mesh__D006148 Guanine Aminohydrolase
% 213.83/214.00  |- mesh__recordMaintainer mesh__D006148 ssb
% 213.83/214.00  |- mesh__publicMeSHNote mesh__D006148
% 213.83/214.00       91; was see under AMINOHYDROLASES 1975-90   
% 213.83/214.00  |- skos__historyNote mesh__D006148 Aminohydrolases %28%1973-1974%29%
% 213.83/214.00  |- skos__hiddenLabel mesh__D006148 Aminase, Guanine
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D006148 2005
% 213.83/214.00  |- skos__historyNote mesh__D006148 Guanine %28%1973-1974%29%
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D006148 2006
% 213.83/214.00  |- skos__altLabel mesh__D006148 Guanine Aminase
% 213.83/214.00  |- mesh__dateEstablished mesh__D006148 1991-01-01
% 213.83/214.00  |- skos__altLabel mesh__D006148 Guanase
% 213.83/214.00  |- skos__hiddenLabel mesh__D006148 Deaminase, Guanine
% 213.83/214.00  |- mesh__recordOriginator mesh__D006148 NLM
% 213.83/214.00  |- mesh__recordAuthorizer mesh__D006148 sjn
% 213.83/214.00  |- mesh__dateRevised mesh__D006148 2003-07-09
% 213.83/214.00  |- mesh__historyNote mesh__D006148
% 213.83/214.00       91%28%75%29%; was see under AMINOHYDROLASES 1975-90   
% 213.83/214.00  |- mesh__dateCreated mesh__D006148 1974-11-19
% 213.83/214.00  |- skos__hiddenLabel mesh__D006148 Aminohydrolase, Guanine
% 213.83/214.00  |- skos__prefLabel mesh__D006148 Guanine Deaminase
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D006148 2004
% 213.83/214.00  |- skos__broader mesh__D006148smesh__D000619
% 213.83/214.00  |- rdf__type mesh__D006148sskos__Concept
% 213.83/214.00  |- skos__prefLabel mesh__D049750 Genome, Insect
% 213.83/214.00  |- mesh__dateEstablished mesh__D049750 2006-01-01
% 213.83/214.00  |- mesh__publicMeSHNote mesh__D049750 2006   
% 213.83/214.00  |- mesh__recordAuthorizer mesh__D049750 sjn
% 213.83/214.00  |- skos__related mesh__D049750smesh__D017344
% 213.83/214.00  |- mesh__recordOriginator mesh__D049750 nns
% 213.83/214.00  |- mesh__recordMaintainer mesh__D049750 nns
% 213.83/214.00  |- skos__scopeNote mesh__D049750
% 213.83/214.00       The genetic complement of an insect %28%INSECTS%29% as represented in its DNA.%A%    
% 213.83/214.00  |- skos__hiddenLabel mesh__D049750 Genomes, Insect
% 213.83/214.00  |- skos__broader mesh__D049750smesh__D016678
% 213.83/214.00  |- skos__hiddenLabel mesh__D049750 Insect Genomes
% 213.83/214.00  |- mesh__dateCreated mesh__D049750 2005-06-30
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D049750 2006
% 213.83/214.00  |- rdf__type mesh__D049750sskos__Concept
% 213.83/214.00  |- skos__altLabel mesh__D049750 Insect Genome
% 213.83/214.00  |- mesh__historyNote mesh__D049750 2006   
% 213.83/214.00  |- skos__annotation mesh__D049750
% 213.83/214.00       coordinate IM with specific insect/genet%28%IM%29%   
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D016576 2006
% 213.83/214.00  |- skos__historyNote mesh__D016576 Anti-Infective Agents %28%1966-1988%29%
% 213.83/214.00  |- mesh__publicMeSHNote mesh__D016576
% 213.83/214.00       92; FLEROXACIN was indexed under QUINOLINES 1986 %26% under CIPROFLOXACIN/analogs %26% derivatives 1987-91%A%  
% 213.83/214.00  |- skos__historyNote mesh__D016576
% 213.83/214.00       Ciprofloxacin/analogs %26% derivatives %28%1987-1991%29%
% 213.83/214.00  |- skos__hiddenLabel mesh__D016576 AM 833
% 213.83/214.00  |- skos__altLabel mesh__D016576 Gr%C3%%BC%nenthal Brand of Fleroxacin
% 213.83/214.00  |- mesh__historyNote mesh__D016576 92; was FLEROXACIN %28%NM%29% 1986-91   
% 213.83/214.00  |- skos__prefLabel mesh__D016576 Fleroxacin
% 213.83/214.00  |- mesh__dateRevised mesh__D016576 2005-06-30
% 213.83/214.00  |- skos__historyNote mesh__D016576
% 213.83/214.00       Anti-Infective Agents, Quinolone %28%1989-1991%29%
% 213.83/214.00  |- skos__hiddenLabel mesh__D016576 AM833
% 213.83/214.00  |- rdf__type mesh__D016576sskos__Concept
% 213.83/214.00  |- mesh__recordOriginator mesh__D016576 RLS
% 213.83/214.00  |- skos__hiddenLabel mesh__D016576 Ro 236240
% 213.83/214.00  |- skos__broader mesh__D016576smesh__D002939
% 213.83/214.00  |- skos__hiddenLabel mesh__D016576 Ro 23 6240
% 213.83/214.00  |- mesh__recordAuthorizer mesh__D016576 sjn
% 213.83/214.00  |- mesh__recordMaintainer mesh__D016576 CCR
% 213.83/214.00  |- skos__scopeNote mesh__D016576
% 213.83/214.00       A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.%A%    
% 213.83/214.00  |- mesh__dateEstablished mesh__D016576 1992-01-01
% 213.83/214.00  |- skos__historyNote mesh__D016576 Quinolines %28%1966-1986%29%
% 213.83/214.00  |- mesh__onlineNote mesh__D016576
% 213.83/214.00       use FLEROXACIN %28%NM%29% to search FLEROXACIN 1986-91   
% 213.83/214.00  |- mesh__dateCreated mesh__D016576 1991-01-02
% 213.83/214.00  |- skos__scopeNote mesh__D002556
% 213.83/214.00       Proteins in the cerebrospinal fluid, normally albumin and globulin present in the ratio of 8 to 1. Increases in protein levels are of diagnostic value in neurological diseases. %28%Brain and Bannister%27%s Clinical Neurology, 7th ed, p221%29%%A%    
% 213.83/214.00  |- skos__annotation mesh__D002556
% 213.83/214.00       IM %26% coord with specific protein /csf %28%IM%29%   
% 213.83/214.00  |- mesh__recordOriginator mesh__D002556 NLM
% 213.83/214.00  |- mesh__recordMaintainer mesh__D002556 SYSTEM
% 213.83/214.00  |- mesh__recordAuthorizer mesh__D002556 sjn
% 213.83/214.00  |- skos__prefLabel mesh__D002556 Cerebrospinal Fluid Proteins
% 213.83/214.00  |- skos__hiddenLabel mesh__D002556 Fluid Proteins, Cerebrospinal
% 213.83/214.00  |- skos__broader mesh__D002556smesh__D011506
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D002556 2006
% 213.83/214.00  |- mesh__dateRevised mesh__D002556 2005-06-30
% 213.83/214.00  |- mesh__dateCreated mesh__D002556 1999-01-01
% 213.83/214.00  |- rdf__type mesh__D002556sskos__Concept
% 213.83/214.00  |- skos__altLabel mesh__D002556 Proteins, Cerebrospinal Fluid
% 213.83/214.00  |- skos__broader mesh__D001940Q000736smesh__D001940
% 213.83/214.00  |- mesh__preferredCombination mesh__D001940Q000736smesh__D016217
% 213.83/214.00  |- rdf__type mesh__D001940Q000736smesh__CompoundConcept
% 213.83/214.00  |- mesh__dateRevised mesh__D007241 2004-07-28
% 213.83/214.00  |- skos__historyNote mesh__D007241 Cattle Diseases %28%1966-1972%29%
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D007241 2005
% 213.83/214.00  |- mesh__historyNote mesh__D007241
% 213.83/214.00       78%28%73%29%; was see under CATTLE DISEASES 1975-77   
% 213.83/214.00  |- mesh__recordOriginator mesh__D007241 NLM
% 213.83/214.00  |- skos__hiddenLabel mesh__D007241 Bovine Rhinotracheitis, Infectious
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D007241 2006
% 213.83/214.00  |- mesh__recordAuthorizer mesh__D007241 jls
% 213.83/214.00  |- mesh__publicMeSHNote mesh__D007241
% 213.83/214.00       78; was see under CATTLE DISEASES 1975-77   
% 213.83/214.00  |- skos__broader mesh__D007241smesh__D002418
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D007241 2005A
% 213.83/214.00  |- skos__historyNote mesh__D007241
% 213.83/214.00       Infectious Bovine Rhinotracheitis Virus %28%1966-1972%29%
% 213.83/214.00  |- skos__prefLabel mesh__D007241 Infectious Bovine Rhinotracheitis
% 213.83/214.00  |- mesh__recordMaintainer mesh__D007241 jls
% 213.83/214.00  |- rdf__type mesh__D007241sskos__Concept
% 213.83/214.00  |- skos__hiddenLabel mesh__D007241 Bovine Rhinotracheitides, Infectious
% 213.83/214.00  |- skos__hiddenLabel mesh__D007241 Rhinotracheitis, Infectious Bovine
% 213.83/214.00  |- skos__hiddenLabel mesh__D007241 Infectious Bovine Rhinotracheitides
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D007241 2004
% 213.83/214.00  |- skos__scopeNote mesh__D007241
% 213.83/214.00       A herpesvirus infection of CATTLE characterized by INFLAMMATION and NECROSIS of the mucous membranes of the upper RESPIRATORY TRACT.%A%    
% 213.83/214.00  |- skos__annotation mesh__D007241
% 213.83/214.00       check the tags ANIMALS and CATTLE; DF: INFECT BOVINE RHINOTRACHEITIS%A%  
% 213.83/214.00  |- skos__broader mesh__D007241smesh__D006566
% 213.83/214.00  |- skos__hiddenLabel mesh__D007241 Rhinotracheitides, Infectious Bovine
% 213.83/214.00  |- mesh__dateEstablished mesh__D007241 1978-01-01
% 213.83/214.00  |- mesh__dateCreated mesh__D007241 1999-01-01
% 213.83/214.00  |- skos__hiddenLabel mesh__D012984 Engineering, Software
% 213.83/214.00  |- skos__altLabel mesh__D012984 Computer Programs
% 213.83/214.00  |- mesh__dateCreated mesh__D012984 1982-04-30
% 213.83/214.00  |- skos__altLabel mesh__D012984 Computer Software
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D012984 2005
% 213.83/214.00  |- skos__historyNote mesh__D012984 Computers %28%1966-1982%29%
% 213.83/214.00  |- skos__hiddenLabel mesh__D012984 Computer Program
% 213.83/214.00  |- mesh__recordAuthorizer mesh__D012984 sjn
% 213.83/214.00  |- skos__hiddenLabel mesh__D012984 Program, Computer
% 213.83/214.00  |- mesh__dateEstablished mesh__D012984 1987-01-01
% 213.83/214.00  |- skos__broader mesh__D012984smesh__D003205
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D012984 2006
% 213.83/214.00  |- mesh__recordOriginator mesh__D012984 EC
% 213.83/214.00  |- skos__annotation mesh__D012984 IM   
% 213.83/214.00  |- mesh__onlineNote mesh__D012984
% 213.83/214.00       use SOFTWARE to search COMPUTER PROGRAMS 1983-86; use COMPUTERS to search PROGRAMS, COMPUTER 1979-82 %26% PROGRAMMING, COMPUTER 1966-74%A%  
% 213.83/214.00  |- mesh__historyNote mesh__D012984
% 213.83/214.00       87%28%83%29%; was COMPUTER PROGRAMS see under COMPUTERS 1983-86, was PROGRAMS, COMPUTER see COMPUTERS 1979-82, was PROGRAMMIMG, COMPUTER see under COMPUTERS 1966-74%A%  
% 213.83/214.00  |- mesh__publicMeSHNote mesh__D012984
% 213.83/214.00       87; was COMPUTER PROGRAMS see under COMPUTERS 1983-86, was PROGRAMS, COMPUTER see COMPUTERS 1979-82, was PROGRAMMING, COMPUTER see under COMPUTERS 1966-74%A%  
% 213.83/214.00  |- rdf__type mesh__D012984sskos__Concept
% 213.83/214.00  |- skos__hiddenLabel mesh__D012984 Software, Computer
% 213.83/214.00  |- skos__hiddenLabel mesh__D012984 Programs, Computer
% 213.83/214.00  |- skos__hiddenLabel mesh__D012984 Software Tool
% 213.83/214.00  |- skos__prefLabel mesh__D012984 Software
% 213.83/214.00  |- skos__hiddenLabel mesh__D012984 Tools, Software
% 213.83/214.00  |- skos__hiddenLabel mesh__D012984 Tool, Software
% 213.83/214.00  |- mesh__recordMaintainer mesh__D012984 jls
% 213.83/214.00  |- mesh__dateRevised mesh__D012984 2004-07-07
% 213.83/214.00  |- skos__scopeNote mesh__D012984
% 213.83/214.00       Sequential operating instructions for a particular problem or function to be run on a digital computer.%A%    
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D012186 1996
% 213.83/214.00  |- mesh__recordMaintainer mesh__D012186 KEV
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D012186 1998
% 213.83/214.00  |- mesh__recordOriginator mesh__D012186 NLM
% 213.83/214.00  |- mesh__dateCreated mesh__D012186 1999-01-01
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D012186 2002
% 213.83/214.00  |- rdf__type mesh__D012186sskos__Concept
% 213.83/214.00  |- skos__broader mesh__D012186smesh__D000008
% 213.83/214.00  |- skos__annotation mesh__D012186
% 213.83/214.00       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%  
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D012186 2001
% 213.83/214.00  |- skos__hiddenLabel mesh__D012186 Neoplasms, Retroperitoneal
% 213.83/214.00  |- skos__hiddenLabel mesh__D012186 Neoplasm, Retroperitoneal
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D012186 2000
% 213.83/214.00  |- mesh__dateRevised mesh__D012186 1995-06-08
% 213.83/214.00  |- skos__hiddenLabel mesh__D012186 Retroperitoneal Neoplasm
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D012186 2004
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D012186 2006
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D012186 1997
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D012186 2003
% 213.83/214.00  |- mesh__recordAuthorizer mesh__D012186 PLS
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D012186 1999
% 213.83/214.00  |- skos__prefLabel mesh__D012186 Retroperitoneal Neoplasms
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D012186 2005
% 213.83/214.00  |- skos__related mesh__D006947smesh__D020513
% 213.83/214.00  |- mesh__dateCreated mesh__D006947 1999-01-01
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D006947 2001
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D006947 2006
% 213.83/214.00  |- skos__altLabel mesh__D006947 Hyperpotassemia
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D006947 2000
% 213.83/214.00  |- skos__hiddenLabel mesh__D006947 Hyperkalemias
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D006947 2005
% 213.83/214.00  |- mesh__dateRevised mesh__D006947 1999-11-08
% 213.83/214.00  |- rdf__type mesh__D006947sskos__Concept
% 213.83/214.00  |- skos__prefLabel mesh__D006947 Hyperkalemia
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D006947 2002
% 213.83/214.00  |- skos__annotation mesh__D006947
% 213.83/214.00       high blood potassium levels; do not confuse with HYPOKALEMIA%A%  
% 213.83/214.00  |- skos__hiddenLabel mesh__D006947 Hyperpotassemias
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D006947 2004
% 213.83/214.00  |- skos__scopeNote mesh__D006947
% 213.83/214.00       Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities %28%elevated T waves and depressed P waves, and eventually by atrial asystole%29%. In severe cases, weakness and flaccid paralysis may occur. %28%Dorland, 27th ed%29%%A%    
% 213.83/214.00  |- mesh__recordOriginator mesh__D006947 NLM
% 213.83/214.00  |- mesh__recordAuthorizer mesh__D006947 sjn
% 213.83/214.00  |- mesh__recordMaintainer mesh__D006947 KEV
% 213.83/214.00  |- skos__broader mesh__D006947smesh__D014883
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D006947 2003
% 213.83/214.00  |- skos__prefLabel mesh__D020618 Methylococcus
% 213.83/214.00  |- rdf__type mesh__D020618sskos__Concept
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D020618 2006
% 213.83/214.00  |- mesh__recordMaintainer mesh__D020618 SYSTEM
% 213.83/214.00  |- mesh__dateEstablished mesh__D020618 2000-01-01
% 213.83/214.00  |- mesh__recordAuthorizer mesh__D020618 sjn
% 213.83/214.00  |- skos__historyNote mesh__D020618 Methylococcaceae %28%1978-1999%29%
% 213.83/214.00  |- skos__broader mesh__D020618smesh__D008772
% 213.83/214.00  |- mesh__dateRevised mesh__D020618 2005-06-30
% 213.83/214.00  |- mesh__historyNote mesh__D020618 2000   
% 213.83/214.00  |- mesh__recordOriginator mesh__D020618 ndw
% 213.83/214.00  |- skos__scopeNote mesh__D020618
% 213.83/214.00       A genus of gram-negative, aerobic, spherical cells usually occurring in pairs. The resting stage is considered a cyst. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 213.83/214.00  |- mesh__dateCreated mesh__D020618 1999-11-03
% 213.83/214.00  |- mesh__publicMeSHNote mesh__D020618 2000   
% 213.83/214.00  |- mesh__publicMeSHNote mesh__D039323 2003   
% 213.83/214.00  |- mesh__dateCreated mesh__D039323 2002-07-03
% 213.83/214.00  |- skos__altLabel mesh__D039323 Goldthread
% 213.83/214.00  |- rdf__type mesh__D039323sskos__Concept
% 213.83/214.00  |- skos__broader mesh__D039323smesh__D029626
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D039323 2005
% 213.83/214.00  |- skos__annotation mesh__D039323
% 213.83/214.00       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.83/214.00  |- skos__scopeNote mesh__D039323
% 213.83/214.00       A plant genus of the family RANUNCULACEAE. Members contain BERBERINE and other isoquinoline ALKALOIDS.%A%    
% 213.83/214.00  |- skos__prefLabel mesh__D039323 Coptis
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D039323 2003
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D039323 2006
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D039323 2004
% 213.83/214.00  |- mesh__historyNote mesh__D039323 2003   
% 213.83/214.00  |- mesh__dateEstablished mesh__D039323 2003-01-01
% 213.83/214.00  |- skos__hiddenLabel mesh__D049751 Helminth Genomes
% 213.83/214.00  |- skos__prefLabel mesh__D049751 Genome, Helminth
% 213.83/214.00  |- skos__broader mesh__D049751smesh__D016678
% 213.83/214.00  |- skos__hiddenLabel mesh__D049751 Genomes, Helminth
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D049751 2006
% 213.83/214.00  |- mesh__dateEstablished mesh__D049751 2006-01-01
% 213.83/214.00  |- mesh__historyNote mesh__D049751 2006   
% 213.83/214.00  |- skos__altLabel mesh__D049751 Helminth Genome
% 213.83/214.00  |- rdf__type mesh__D049751sskos__Concept
% 213.83/214.00  |- skos__annotation mesh__D049751
% 213.83/214.00       coordinate IM with specific helminth/genet%28%IM%29%   
% 213.83/214.00  |- mesh__recordMaintainer mesh__D049751 nns
% 213.83/214.00  |- mesh__recordAuthorizer mesh__D049751 sjn
% 213.83/214.00  |- skos__scopeNote mesh__D049751
% 213.83/214.00       The genetic complement of a helminth %28%HELMINTHS%29% as represented in its DNA.%A%    
% 213.83/214.00  |- mesh__publicMeSHNote mesh__D049751 2006   
% 213.83/214.00  |- skos__related mesh__D049751smesh__D017238
% 213.83/214.00  |- mesh__recordOriginator mesh__D049751 nns
% 213.83/214.00  |- mesh__dateCreated mesh__D049751 2005-06-30
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D016577 2004
% 213.83/214.00  |- skos__hiddenLabel mesh__D016577 Duodenopancreatectomies
% 213.83/214.00  |- mesh__dateEstablished mesh__D016577 1992-01-01
% 213.83/214.00  |- mesh__dateRevised mesh__D016577 1997-06-20
% 213.83/214.00  |- skos__scopeNote mesh__D016577
% 213.83/214.00       The excision of the head of the pancreas and the encircling loop of the duodenum to which it is connected.%A%    
% 213.83/214.00  |- rdf__type mesh__D016577sskos__Concept
% 213.83/214.00  |- mesh__recordOriginator mesh__D016577 MXR
% 213.83/214.00  |- mesh__historyNote mesh__D016577 95; was PANCREATODUODENECTOMY 1992-94   
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D016577 2000
% 213.83/214.00  |- skos__broader mesh__D016577smesh__D013505
% 213.83/214.00  |- skos__hiddenLabel mesh__D016577 Pancreaticoduodenectomies
% 213.83/214.00  |- skos__altLabel mesh__D016577 Pancreatoduodenectomy
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D016577 2001
% 213.83/214.00  |- mesh__onlineNote mesh__D016577
% 213.83/214.00       use PANCREATICODUODENECTOMY to search PANCREATODUODENECTOMY 1992-94%A%  
% 213.83/214.00  |- mesh__dateCreated mesh__D016577 1991-01-03
% 213.83/214.00  |- skos__hiddenLabel mesh__D016577 Pancreatoduodenectomies
% 213.83/214.00  |- skos__historyNote mesh__D016577 Duodenum %28%1966-1991%29%
% 213.83/214.00  |- mesh__recordMaintainer mesh__D016577 PXP
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D016577 1998
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D016577 2005
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D016577 2002
% 213.83/214.00  |- skos__annotation mesh__D016577
% 213.83/214.00       do not use /util except by MeSH definition   
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D016577 1999
% 213.83/214.00  |- mesh__recordAuthorizer mesh__D016577 SJN
% 213.83/214.00  |- skos__historyNote mesh__D016577 Pancreatectomy %28%1966-1991%29%
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D016577 2006
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D016577 2003
% 213.83/214.00  |- mesh__publicMeSHNote mesh__D016577
% 213.83/214.00       95; was PANCREATODUODENECTOMY 1992-94   
% 213.83/214.00  |- skos__altLabel mesh__D016577 Duodenopancreatectomy
% 213.83/214.00  |- skos__prefLabel mesh__D016577 Pancreaticoduodenectomy
% 213.83/214.00  |- skos__broader mesh__D002557smesh__D019635
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D002557 2001
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D002557 2005
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D002557 1998
% 213.83/214.00  |- skos__historyNote mesh__D002557 Cerebral Ventricles %28%1966-1968%29%
% 213.83/214.00  |- mesh__dateRevised mesh__D002557 1997-06-20
% 213.83/214.00  |- mesh__recordOriginator mesh__D002557 NLM
% 213.83/214.00  |- mesh__recordMaintainer mesh__D002557 PXP
% 213.83/214.00  |- mesh__recordAuthorizer mesh__D002557 SJN
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D002557 2002
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D002557 2006
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D002557 1999
% 213.83/214.00  |- skos__altLabel mesh__D002557 Cerebrospinal Fluid Shunt
% 213.83/214.00  |- skos__prefLabel mesh__D002557 Cerebrospinal Fluid Shunts
% 213.83/214.00  |- skos__scopeNote mesh__D002557
% 213.83/214.00       Tubes inserted to create communication between a cerebral ventricle and the internal jugular vein. Their emplacement permits draining of cerebrospinal fluid for relief of hydrocephalus or other condition leading to fluid accumulation in the ventricles.%A%    
% 213.83/214.00  |- skos__broader mesh__D002557smesh__D000714
% 213.83/214.00  |- skos__historyNote mesh__D002557 Hydrocephalus/surgery %28%1966-1968%29%
% 213.83/214.00  |- mesh__dateCreated mesh__D002557 1999-01-01
% 213.83/214.00  |- skos__annotation mesh__D002557
% 213.83/214.00       do not use /util except by MeSH definition; NIM destination of shunt; VENTRICULOPERITONEAL SHUNT is available%A%  
% 213.83/214.00  |- mesh__historyNote mesh__D002557 72%28%69%29%   
% 213.83/214.00  |- mesh__publicMeSHNote mesh__D002557 72   
% 213.83/214.00  |- rdf__type mesh__D002557sskos__Concept
% 213.83/214.00  |- skos__altLabel mesh__D002557 Shunts, Cerebrospinal Fluid
% 213.83/214.00  |- skos__altLabel mesh__D002557 Shunt, Cerebrospinal Fluid
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D002557 2003
% 213.83/214.00  |- mesh__dateEstablished mesh__D002557 1972-01-01
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D002557 2000
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D002557 2004
% 213.83/214.00  |- mesh__dateRevised mesh__D007242 2003-07-09
% 213.83/214.00  |- skos__broader mesh__D007242smesh__D018140
% 213.83/214.00  |- skos__scopeNote mesh__D007242
% 213.83/214.00       A species of VARICELLOVIRUS that causes INFECTIOUS BOVINE RHINOTRACHEITIS and other associated syndromes in CATTLE.%A%    
% 213.83/214.00  |- mesh__historyNote mesh__D007242
% 213.83/214.00       94; was INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS 1966-93   
% 213.83/214.00  |- skos__altLabel mesh__D007242 Infectious Bovine Rhinotracheitis Virus
% 213.83/214.00  |- mesh__recordMaintainer mesh__D007242 ags
% 213.83/214.00  |- skos__hiddenLabel mesh__D007242 Viruses, IBR-IPV
% 213.83/214.00  |- skos__altLabel mesh__D007242 IBR-IPV Virus
% 213.83/214.00  |- skos__altLabel mesh__D007242 Bovine herpesvirus 1
% 213.83/214.00  |- rdf__type mesh__D007242sskos__Concept
% 213.83/214.00  |- skos__altLabel mesh__D007242 Pustular Vulvovaginitis Virus, Infectious
% 213.83/214.00  |- skos__altLabel mesh__D007242 Infectious Pustular Vulvovaginitis Virus
% 213.83/214.00  |- skos__prefLabel mesh__D007242 Herpesvirus 1, Bovine
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D007242 2004
% 213.83/214.00  |- skos__hiddenLabel mesh__D007242 IBR IPV Virus
% 213.83/214.00  |- skos__annotation mesh__D007242
% 213.83/214.00       infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29% but consider also INFECTIOUS BOVINE RHINOTRACHEITIS%A%  
% 213.83/214.00  |- mesh__recordOriginator mesh__D007242 NLM
% 213.83/214.00  |- mesh__onlineNote mesh__D007242
% 213.83/214.00       use HERPESVIRUS 1, BOVINE to search INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS 1966-93%A%  
% 213.83/214.00  |- mesh__dateCreated mesh__D007242 1999-01-01
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D007242 2005
% 213.83/214.00  |- mesh__dateEstablished mesh__D007242 1966-01-01
% 213.83/214.00  |- skos__altLabel mesh__D007242 Bovine Rhinotracheitis Virus, Infectious
% 213.83/214.00  |- skos__altLabel mesh__D007242 Herpesvirus 1 %28%alpha%29%, Bovine
% 213.83/214.00  |- mesh__activeMeSHYear mesh__D007242 2006
% 213.83/214.00  |- mesh__recordAuthorizer mesh__D007242 sjn
% 213.83/214.00  |- mesh__publicMeSHNote mesh__D007242
% 213.83/214.00       94; was INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS 1966-93   
% 213.83/214.00  |- skos__hiddenLabel mesh__D007242 IBR-IPV Viruses
% 213.83/214.00  |- skos__hiddenLabel mesh__D007242 Virus, IBR-IPV
% 213.83/214.00  |- skos__hiddenLabel mesh__D012985 Flowchart %28%Computer%29%
% 213.83/214.00  |- mesh__historyNote mesh__D012985
% 213.83/214.00       91%28%87%29%; was see under SOFTWARE 1987-90   
% 213.83/214.00  |- rdf__type mesh__D012985sskos__Concept
% 213.83/214.00  |- skos__hiddenLabel mesh__D012985 Software Designs
% 213.83/214.00  |- skos__annotation mesh__D012985 IM; no qualif   
% 213.83/214.00  |- skos__prefLabel mesh__D012985 Software Design
% 213.83/214.00  |- skos__hiddenLabel mesh__D012985 Designs, Software
% 213.83/214.00  |- skos__altLabel mesh__D012985 Flowcharts
% 213.83/214.00  |- skos__altLabel mesh__D012985 Flow Charts %28%Computer%29%
% 213.83/214.00  |- skos__hiddenLabel mesh__D012985 Flow Chart %28%Computer%29%
% 213.83/214.00  |- mesh__recordAuthorizer mesh__D012985 sjn
% 213.83/214.00  |- mesh__dateRevised mesh__D012985 2004-07-07
% 213.83/214.00  |- mesh__recordOriginator mesh__D012985 EC
% 213.83/214.01  |- skos__hiddenLabel mesh__D012985 Chart, Flow %28%Computer%29%
% 213.83/214.01  |- skos__hiddenLabel mesh__D012985 Design, Software
% 213.83/214.01  |- skos__hiddenLabel mesh__D012985 Charts, Flow %28%Computer%29%
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D012985 2005
% 213.83/214.01  |- skos__scopeNote mesh__D012985
% 213.83/214.01       Specifications and instructions applied to the software.%A%    
% 213.83/214.01  |- skos__hiddenLabel mesh__D012985 Flowchart
% 213.83/214.01  |- mesh__dateEstablished mesh__D012985 1991-01-01
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D012985 2006
% 213.83/214.01  |- mesh__publicMeSHNote mesh__D012985 91; was see under SOFTWARE 1987-90   
% 213.83/214.01  |- mesh__recordMaintainer mesh__D012985 jls
% 213.83/214.01  |- mesh__dateCreated mesh__D012985 1986-06-18
% 213.83/214.01  |- skos__broader mesh__D012985smesh__D012984
% 213.83/214.01  |- mesh__dateEstablished mesh__D039324 2003-01-01
% 213.83/214.01  |- skos__annotation mesh__D039324
% 213.83/214.01       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.83/214.01  |- skos__prefLabel mesh__D039324 Clematis
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D039324 2003
% 213.83/214.01  |- mesh__historyNote mesh__D039324 2003   
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D039324 2006
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D039324 2004
% 213.83/214.01  |- mesh__dateCreated mesh__D039324 2002-07-03
% 213.83/214.01  |- skos__scopeNote mesh__D039324
% 213.83/214.01       A plant genus of the family RANUNCULACEAE. Members contain SCOPOLETIN and SAPONINS.%A%    
% 213.83/214.01  |- mesh__publicMeSHNote mesh__D039324 2003   
% 213.83/214.01  |- rdf__type mesh__D039324sskos__Concept
% 213.83/214.01  |- skos__broader mesh__D039324smesh__D029626
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D039324 2005
% 213.83/214.01  |- skos__scopeNote mesh__D020619
% 213.83/214.01       A species of METHYLOCOCCUS which forms capsules and is capable of autotrophic carbon dioxide fixation. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 213.83/214.01  |- skos__historyNote mesh__D020619 Methylococcaceae %28%1978-1999%29%
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D020619 2006
% 213.83/214.01  |- rdf__type mesh__D020619sskos__Concept
% 213.83/214.01  |- mesh__historyNote mesh__D020619 2000   
% 213.83/214.01  |- mesh__dateCreated mesh__D020619 1999-11-03
% 213.83/214.01  |- skos__prefLabel mesh__D020619 Methylococcus capsulatus
% 213.83/214.01  |- mesh__recordOriginator mesh__D020619 ndw
% 213.83/214.01  |- mesh__recordMaintainer mesh__D020619 SYSTEM
% 213.83/214.01  |- mesh__dateEstablished mesh__D020619 2000-01-01
% 213.83/214.01  |- skos__broader mesh__D020619smesh__D020618
% 213.83/214.01  |- mesh__recordAuthorizer mesh__D020619 sjn
% 213.83/214.01  |- skos__historyNote mesh__D020619 Bacteria %28%1969-1975%29%
% 213.83/214.01  |- mesh__publicMeSHNote mesh__D020619 2000   
% 213.83/214.01  |- mesh__dateRevised mesh__D020619 2005-06-30
% 213.83/214.01  |- skos__historyNote mesh__D020619
% 213.83/214.01       Gram-Negative Aerobic Bacteria %28%1976-1977%29%
% 213.83/214.01  |- rdf__type mesh__D012187sskos__Concept
% 213.83/214.01  |- skos__hiddenLabel mesh__D012187 Space, Retroperitoneal
% 213.83/214.01  |- skos__prefLabel mesh__D012187 Retroperitoneal Space
% 213.83/214.01  |- skos__annotation mesh__D012187
% 213.83/214.01       NIM: usually locational so few qualif apply; diagnostic retropneumoperitoneum or pneumoretroperitoneum: index under RETROPERITONEAL SPACE /radiogr %28%IM%29% + PNEUMORADIOGRAPHY %28%NIM%29%: do not confuse with RETROPNEUMOPERITONEUM %28%Cat C%29%%A%  
% 213.83/214.01  |- skos__hiddenLabel mesh__D012187 Retroperitoneal Spaces
% 213.83/214.01  |- mesh__recordOriginator mesh__D012187 NLM
% 213.83/214.01  |- mesh__dateRevised mesh__D012187 2002-07-03
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D012187 2004
% 213.83/214.01  |- mesh__recordAuthorizer mesh__D012187 sjn
% 213.83/214.01  |- skos__scopeNote mesh__D012187
% 213.83/214.01       An area occupying the most posterior aspect of the ABDOMINAL CAVITY. It is bounded laterally by the borders of the quadratus lumborum muscles and extends from the DIAPHRAGM to the brim of the true PELVIS, where it continues as the pelvic extraperitoneal space.%A%    
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D012187 2006
% 213.83/214.01  |- mesh__recordMaintainer mesh__D012187 TGC
% 213.83/214.01  |- skos__broader mesh__D012187smesh__D034841
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D012187 2003
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D012187 2005
% 213.83/214.01  |- skos__hiddenLabel mesh__D012187 Spaces, Retroperitoneal
% 213.83/214.01  |- mesh__dateCreated mesh__D012187 1999-01-01
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D006948 2005
% 213.83/214.01  |- skos__hiddenLabel mesh__D006948 Motor Hyperactivity
% 213.83/214.01  |- skos__altLabel mesh__D006948 Hyperkinesia
% 213.83/214.01  |- skos__altLabel mesh__D006948 Hyperactivity, Motor
% 213.83/214.01  |- mesh__dateRevised mesh__D006948 1999-11-03
% 213.83/214.01  |- mesh__dateEstablished mesh__D006948 1969-01-01
% 213.83/214.01  |- skos__annotation mesh__D006948
% 213.83/214.01       human %26% animal; MOTOR ACTIVITY is also available: see note there; do not confuse with MYOKYMIA or ISAACS SYNDROME%A%  
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D006948 2006
% 213.83/214.01  |- mesh__recordOriginator mesh__D006948 NLM
% 213.83/214.01  |- mesh__recordAuthorizer mesh__D006948 sjn
% 213.83/214.01  |- mesh__historyNote mesh__D006948
% 213.83/214.01       69; was HYPERKINESIA see under MOVEMENT DISORDERS 1963-68%A%  
% 213.83/214.01  |- skos__prefLabel mesh__D006948 Hyperkinesis
% 213.83/214.01  |- skos__historyNote mesh__D006948 Movement Disorders %28%1966-1967%29%
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D006948 2000
% 213.83/214.01  |- skos__hiddenLabel mesh__D006948 Generalized Hyperkinesia
% 213.83/214.01  |- skos__broader mesh__D006948smesh__D020820
% 213.83/214.01  |- skos__scopeNote mesh__D006948
% 213.83/214.01       Excessive movement of muscles of the body as a whole, which may be associated with organic or psychological disorders.%A%    
% 213.83/214.01  |- skos__hiddenLabel mesh__D006948 Hyperkinetic Movement
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D006948 2001
% 213.83/214.01  |- skos__altLabel mesh__D006948 Hyperkinetic Movements
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D006948 2003
% 213.83/214.01  |- mesh__onlineNote mesh__D006948
% 213.83/214.01       use MOVEMENT DISORDERS to search HYPERKINESIA 1966-68   
% 213.83/214.01  |- rdf__type mesh__D006948sskos__Concept
% 213.83/214.01  |- mesh__dateCreated mesh__D006948 1999-01-01
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D006948 2002
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D006948 2004
% 213.83/214.01  |- skos__hiddenLabel mesh__D006948 Movements, Hyperkinetic
% 213.83/214.01  |- skos__hiddenLabel mesh__D006948 Movement, Hyperkinetic
% 213.83/214.01  |- mesh__publicMeSHNote mesh__D006948
% 213.83/214.01       69; was HYPERKINESIA see under MOVEMENT DISORDERS 1963-68%A%  
% 213.83/214.01  |- skos__hiddenLabel mesh__D006948 Hyperkinesias, Generalized
% 213.83/214.01  |- mesh__recordMaintainer mesh__D006948 KEV
% 213.83/214.01  |- skos__hiddenLabel mesh__D006948 Generalized Hyperkinesias
% 213.83/214.01  |- skos__annotation mesh__D017670
% 213.83/214.01       inorganic; GEN or unspecified; prefer specifics; DF: SODIUM CPDS%A%  
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017670 2003
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017670 1996
% 213.83/214.01  |- skos__broader mesh__D017670smesh__D007287
% 213.83/214.01  |- mesh__historyNote mesh__D017670 94   
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017670 2004
% 213.83/214.01  |- skos__prefLabel mesh__D017670 Sodium Compounds
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017670 1997
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017670 2000
% 213.83/214.01  |- mesh__dateCreated mesh__D017670 1993-06-04
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017670 1994
% 213.83/214.01  |- skos__historyNote mesh__D017670 Sodium %28%1966-1993%29%
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017670 2001
% 213.83/214.01  |- mesh__publicMeSHNote mesh__D017670 94   
% 213.83/214.01  |- skos__hiddenLabel mesh__D017670 Compounds, Sodium
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017670 1995
% 213.83/214.01  |- mesh__dateEstablished mesh__D017670 1994-01-01
% 213.83/214.01  |- skos__scopeNote mesh__D017670
% 213.83/214.01       Inorganic compounds that contain sodium as an integral part of the molecule.%A%    
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017670 2005
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017670 1998
% 213.83/214.01  |- rdf__type mesh__D017670sskos__Concept
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017670 2006
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017670 1999
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017670 2002
% 213.83/214.01  |- mesh__dateCreated mesh__D031341 2002-07-03
% 213.83/214.01  |- mesh__publicMeSHNote mesh__D031341 2003   
% 213.83/214.01  |- mesh__dateEstablished mesh__D031341 2003-01-01
% 213.83/214.01  |- rdf__type mesh__D031341sskos__Concept
% 213.83/214.01  |- skos__prefLabel mesh__D031341 Origanum
% 213.83/214.01  |- skos__altLabel mesh__D031341 Marjoram Plant
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D031341 2005
% 213.83/214.01  |- skos__scopeNote mesh__D031341
% 213.83/214.01       A plant genus of the family LAMIACEAE that is the source of a familiar food seasoning.%A%    
% 213.83/214.01  |- skos__altLabel mesh__D031341 Majorana hortensis
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D031341 2006
% 213.83/214.01  |- skos__annotation mesh__D031341
% 213.83/214.01       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.83/214.01  |- skos__broader mesh__D031341smesh__D019686
% 213.83/214.01  |- mesh__historyNote mesh__D031341 2003   
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D031341 2003
% 213.83/214.01  |- skos__altLabel mesh__D031341 Oregano Plant
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D031341 2004
% 213.83/214.01  |- mesh__recordOriginator mesh__D003650 NLM
% 213.83/214.01  |- skos__scopeNote mesh__D003650
% 213.83/214.01       Compounds that contain the decamethylenebis%28%trimethyl%29%ammonium radical. These compounds frequently act as neuromuscular depolarizing agents.%A%    
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D003650 2006
% 213.83/214.01  |- mesh__dateRevised mesh__D003650 2005-06-30
% 213.83/214.01  |- mesh__recordMaintainer mesh__D003650 ssb
% 213.83/214.01  |- skos__hiddenLabel mesh__D003650 Compounds, Decamethonium
% 213.83/214.01  |- mesh__dateCreated mesh__D003650 1999-01-01
% 213.83/214.01  |- rdf__type mesh__D003650sskos__Concept
% 213.83/214.01  |- skos__prefLabel mesh__D003650 Decamethonium Compounds
% 213.83/214.01  |- skos__broader mesh__D003650smesh__D008725
% 213.83/214.01  |- skos__related mesh__D003650smesh__D009467
% 213.83/214.01  |- skos__annotation mesh__D003650 DF: DECAMETHONIUM CPDS   
% 213.83/214.01  |- mesh__recordAuthorizer mesh__D003650 sjn
% 213.83/214.01  |- skos__prefLabel mesh__D016578 Crack Cocaine
% 213.83/214.01  |- skos__annotation mesh__D016578
% 213.83/214.01       addiction to crack cocaine = CRACK COCAINE %28%IM%29% + COCAINE-RELATED DISORDERS %28%IM%29%%A%  
% 213.83/214.01  |- mesh__publicMeSHNote mesh__D016578 92   
% 213.83/214.01  |- mesh__dateEstablished mesh__D016578 1992-01-01
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D016578 2006
% 213.83/214.01  |- skos__scopeNote mesh__D016578
% 213.83/214.01       The purified, alkaloidal, extra-potent form of cocaine. It is smoked %28%free-based%29%, injected intravenously, and orally ingested. Use of crack results in alterations in function of the cardiovascular system, the autonomic nervous system, the central nervous system, and the gastrointestinal system. The slang term %22%crack%22% was derived from the crackling sound made upon igniting of this form of cocaine for smoking.%A%    
% 213.83/214.01  |- mesh__recordAuthorizer mesh__D016578 sjn
% 213.83/214.01  |- mesh__historyNote mesh__D016578 92   
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D016578 2005
% 213.83/214.01  |- skos__broader mesh__D016578smesh__D013287
% 213.83/214.01  |- mesh__recordMaintainer mesh__D016578 ssb
% 213.83/214.01  |- mesh__dateCreated mesh__D016578 1991-01-02
% 213.83/214.01  |- skos__hiddenLabel mesh__D016578 Cocaine, Crack
% 213.83/214.01  |- rdf__type mesh__D016578sskos__Concept
% 213.83/214.01  |- mesh__dateRevised mesh__D016578 2003-07-09
% 213.83/214.01  |- mesh__recordOriginator mesh__D016578 MXR
% 213.83/214.01  |- skos__historyNote mesh__D016578 Cocaine %28%1986-1991%29%
% 213.83/214.01  |- skos__broader mesh__D016578smesh__D003042
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D016578 2004
% 213.83/214.01  |- skos__hiddenLabel mesh__D002558
% 213.83/214.01       Post Traumatic Cerebrospinal Fluid Otorrhea
% 213.83/214.01  |- skos__altLabel mesh__D002558 Cerebrospinal Otorrhea
% 213.83/214.01  |- skos__altLabel mesh__D002558
% 213.83/214.01       Otorrhea, Post-Traumatic, Cerebrospinal Fluid
% 213.83/214.01  |- mesh__recordOriginator mesh__D002558 NLM
% 213.83/214.01  |- skos__altLabel mesh__D002558 Traumatic Otorrhea, Cerebrospinal Fluid
% 213.83/214.01  |- skos__annotation mesh__D002558 DF: CSF OTORRHEA   
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D002558 2000
% 213.83/214.01  |- rdf__type mesh__D002558sskos__Concept
% 213.83/214.01  |- mesh__recordAuthorizer mesh__D002558 ags
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D002558 2006
% 213.83/214.01  |- mesh__dateRevised mesh__D002558 2005-08-02
% 213.83/214.01  |- skos__altLabel mesh__D002558
% 213.83/214.01       Cerebrospinal Fluid Otorrhea, Post-Traumatic
% 213.83/214.01  |- skos__hiddenLabel mesh__D002558
% 213.83/214.01       Cerebrospinal Fluid Otorrhea, Post Traumatic
% 213.83/214.01  |- skos__altLabel mesh__D002558 Post-Traumatic Cerebrospinal Fluid Otorrhea
% 213.83/214.01  |- skos__broader mesh__D002558smesh__D009461
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D002558 2005
% 213.83/214.01  |- skos__altLabel mesh__D002558 Spontaneous Cerebrospinal Fluid Otorrhea
% 213.83/214.01  |- skos__altLabel mesh__D002558 Spontaneous Otorrhea, Cerebrospinal Fluid
% 213.83/214.01  |- skos__altLabel mesh__D002558 Otorrhea, Cerebrospinal Fluid, Traumatic
% 213.83/214.01  |- mesh__historyNote mesh__D002558 2000%28%1966%29%   
% 213.83/214.01  |- skos__hiddenLabel mesh__D002558 Otorrhea, Cerebrospinal
% 213.83/214.01  |- skos__broader mesh__D002558smesh__D006259
% 213.83/214.01  |- skos__altLabel mesh__D002558 Traumatic Cerebrospinal Fluid Otorrhea
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D002558 2006A
% 213.83/214.01  |- skos__altLabel mesh__D002558
% 213.83/214.01       Post-Traumatic Otorrhea, Cerebrospinal Fluid
% 213.83/214.01  |- skos__altLabel mesh__D002558 Otorrhea, Spontaneous, Cerebrospinal Fluid
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D002558 2004
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D002558 2002
% 213.83/214.01  |- skos__scopeNote mesh__D002558
% 213.83/214.01       Discharge of cerebrospinal fluid through the external auditory meatus or through the eustachian tube into the nasopharynx. This is usually associated with CRANIOCEREBRAL TRAUMA %28%e.g., SKULL FRACTURE involving the TEMPORAL BONE;%29%, NEUROSURGICAL PROCEDURES; or other conditions, but may rarely occur spontaneously. %28%From Am J Otol 1995 Nov;16%28%6%29%:765-71%29%%A%    
% 213.83/214.01  |- mesh__recordMaintainer mesh__D002558 ags
% 213.83/214.01  |- mesh__dateCreated mesh__D002558 1999-01-01
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D002558 2003
% 213.83/214.01  |- skos__prefLabel mesh__D002558 Cerebrospinal Fluid Otorrhea
% 213.83/214.01  |- mesh__publicMeSHNote mesh__D002558
% 213.83/214.01       2000; see CEREBROSPINAL OTORRHEA 1988-1999; for CEREBROSPINAL FLUID OTORRHEA see CEREBROSPINAL OTORRHEA 1988-1999%A%  
% 213.83/214.01  |- skos__hiddenLabel mesh__D002558 Cerebrospinal Fluid Otorrheas
% 213.83/214.01  |- skos__altLabel mesh__D002558 Otorrhea, Traumatic Cerebrospinal Fluid
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D002558 2001
% 213.83/214.01  |- skos__hiddenLabel mesh__D002558
% 213.83/214.01       Post Traumatic Otorrhea, Cerebrospinal Fluid
% 213.83/214.01  |- skos__altLabel mesh__D002558 Otorrhea, Cerebrospinal Fluid, Spontaneous
% 213.83/214.01  |- skos__altLabel mesh__D002558
% 213.83/214.01       Otorrhea, Cerebrospinal Fluid, Post-Traumatic
% 213.83/214.01  |- skos__hiddenLabel mesh__D002558 Otorrhea, Cerebrospinal Fluid
% 213.83/214.01  |- skos__prefLabel mesh__D013280 Stomatitis
% 213.83/214.01  |- skos__scopeNote mesh__D013280
% 213.83/214.01       INFLAMMATION of the soft tissues of the MOUTH, such as MUCOSA; PALATE; GINGIVA; and LIP.%A%    
% 213.83/214.01  |- mesh__recordAuthorizer mesh__D013280 sjn
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D013280 2006
% 213.83/214.01  |- skos__altLabel mesh__D013280 Oromucositis
% 213.83/214.01  |- skos__hiddenLabel mesh__D013280 Oromucositides
% 213.83/214.01  |- mesh__dateCreated mesh__D013280 1999-01-01
% 213.83/214.01  |- skos__broader mesh__D013280smesh__D009059
% 213.83/214.01  |- mesh__recordMaintainer mesh__D013280 lkt
% 213.83/214.01  |- skos__hiddenLabel mesh__D013280 Mucositides, Oral
% 213.83/214.01  |- mesh__recordOriginator mesh__D013280 NLM
% 213.83/214.01  |- skos__annotation mesh__D013280 mycotic stomatitis = CANDIDIASIS, ORAL   
% 213.83/214.01  |- skos__altLabel mesh__D013280 Mucositis, Oral
% 213.83/214.01  |- mesh__dateRevised mesh__D013280 2005-06-30
% 213.83/214.01  |- skos__hiddenLabel mesh__D013280 Stomatitides
% 213.83/214.01  |- skos__hiddenLabel mesh__D013280 Oral Mucositides
% 213.83/214.01  |- rdf__type mesh__D013280sskos__Concept
% 213.83/214.01  |- rdf__type mesh__D007243sskos__Concept
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D007243 2003
% 213.83/214.01  |- mesh__recordAuthorizer mesh__D007243 sjn
% 213.83/214.01  |- skos__hiddenLabel mesh__D007243 Bursal Agents, Infectious
% 213.83/214.01  |- skos__hiddenLabel mesh__D007243 Nephrosis Virus, Avian
% 213.83/214.01  |- mesh__dateEstablished mesh__D007243 1991-01-01
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D007243 2004
% 213.83/214.01  |- skos__altLabel mesh__D007243 Infectious Bursal Agent
% 213.83/214.01  |- mesh__dateRevised mesh__D007243 2001-07-25
% 213.83/214.01  |- skos__altLabel mesh__D007243 Bursal Disease Virus, Infectious
% 213.83/214.01  |- mesh__onlineNote mesh__D007243
% 213.83/214.01       use INFECTIOUS BURSAL DISEASE VIRUS to search INFECTIOUS BURSAL AGENT 1975-93%A%  
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D007243 2005
% 213.83/214.01  |- skos__prefLabel mesh__D007243 Infectious bursal disease virus
% 213.83/214.01  |- mesh__historyNote mesh__D007243
% 213.83/214.01       94; was INFECTIOUS BURSAL AGENT 1975-93 %28%see under REOVIRIDAE 1981-90, see under REOVIRUSES 1975-80%29%%A%  
% 213.83/214.01  |- skos__altLabel mesh__D007243 Gumboro Disease Virus
% 213.83/214.01  |- mesh__publicMeSHNote mesh__D007243
% 213.83/214.01       94; was INFECTIOUS BURSAL AGENT 1975-93 %28%see under REOVIRIDAE 1981-90, see under REOVIRUSES 1975-80%29%%A%  
% 213.83/214.01  |- skos__altLabel mesh__D007243 Avian Nephrosis Virus
% 213.83/214.01  |- skos__hiddenLabel mesh__D007243 Avian Nephrosis Viruses
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D007243 2006
% 213.83/214.01  |- mesh__recordOriginator mesh__D007243 NLM
% 213.83/214.01  |- skos__annotation mesh__D007243
% 213.83/214.01       infection: coord IM with BIRNAVIRIDAE INFECTIONS %28%IM%29%; DF: note short cross ref%A%  
% 213.83/214.01  |- skos__scopeNote mesh__D007243
% 213.83/214.01       A species of AVIBIRNAVIRUS causing severe inflammation of the bursa of Fabricius in chickens and other fowl. Transmission is thought to be through contaminated feed or water. Vaccines have been used with varying degrees of success.%A%    
% 213.83/214.01  |- skos__hiddenLabel mesh__D007243 Infectious Bursal Agents
% 213.83/214.01  |- skos__altLabel mesh__D007243 IBDV
% 213.83/214.01  |- mesh__recordMaintainer mesh__D007243 ags
% 213.83/214.01  |- skos__broader mesh__D007243smesh__D019202
% 213.83/214.01  |- skos__altLabel mesh__D007243 Bursal Agent, Infectious
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D007243 2002
% 213.83/214.01  |- skos__hiddenLabel mesh__D007243 Nephrosis Viruses, Avian
% 213.83/214.01  |- mesh__dateCreated mesh__D007243 1974-12-12
% 213.83/214.01  |- skos__altLabel mesh__D012986 Software Verification
% 213.83/214.01  |- mesh__recordMaintainer mesh__D012986 jls
% 213.83/214.01  |- mesh__publicMeSHNote mesh__D012986 91; was see under SOFTWARE 1987-90   
% 213.83/214.01  |- skos__broader mesh__D012986smesh__D012984
% 213.83/214.01  |- skos__annotation mesh__D012986 IM; no qualif   
% 213.83/214.01  |- skos__hiddenLabel mesh__D012986 Software Validations
% 213.83/214.01  |- mesh__dateRevised mesh__D012986 2004-07-07
% 213.83/214.01  |- skos__hiddenLabel mesh__D012986 Validations, Software
% 213.83/214.01  |- skos__scopeNote mesh__D012986
% 213.83/214.01       The act of testing the software for compliance with a standard.%A%    
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D012986 2005
% 213.83/214.01  |- skos__hiddenLabel mesh__D012986 Verifications, Software
% 213.83/214.01  |- skos__hiddenLabel mesh__D012986 Verification, Software
% 213.83/214.01  |- skos__prefLabel mesh__D012986 Software Validation
% 213.83/214.01  |- mesh__dateEstablished mesh__D012986 1991-01-01
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D012986 2006
% 213.83/214.01  |- skos__hiddenLabel mesh__D012986 Validation, Software
% 213.83/214.01  |- mesh__recordAuthorizer mesh__D012986 sjn
% 213.83/214.01  |- mesh__dateCreated mesh__D012986 1986-06-18
% 213.83/214.01  |- mesh__recordOriginator mesh__D012986 EC
% 213.83/214.01  |- skos__hiddenLabel mesh__D012986 Software Verifications
% 213.83/214.01  |- mesh__historyNote mesh__D012986
% 213.83/214.01       91%28%87%29%; was see under SOFTWARE 1987-90   
% 213.83/214.01  |- rdf__type mesh__D012986sskos__Concept
% 213.83/214.01  |- skos__prefLabel mesh__D045362 Cytochromes c2
% 213.83/214.01  |- skos__broader mesh__D045362smesh__D003574
% 213.83/214.01  |- mesh__dateEstablished mesh__D045362 2004-01-01
% 213.83/214.01  |- skos__altLabel mesh__D045362 Cytochrome C-2
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D045362 2004
% 213.83/214.01  |- mesh__dateCreated mesh__D045362 2003-07-09
% 213.83/214.01  |- skos__altLabel mesh__D045362 Ferrocytochrome c2
% 213.83/214.01  |- skos__altLabel mesh__D045362 Cytochrome c2
% 213.83/214.01  |- skos__scopeNote mesh__D045362
% 213.83/214.01       Type C cytochromes that are small %28%12-14 kD%29% single-heme proteins. They function as mobile electron carriers between membrane-bound enzymes in photosynthetic BACTERIA.%A%    
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D045362 2006
% 213.83/214.01  |- rdf__type mesh__D045362sskos__Concept
% 213.83/214.01  |- skos__hiddenLabel mesh__D045362 Cytochrome C 2
% 213.83/214.01  |- skos__historyNote mesh__D045362 Cytochromes %28%1967-1972%29%
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D045362 2005
% 213.83/214.01  |- skos__historyNote mesh__D045362 Cytochrome c Group %28%1973-2003%29%
% 213.83/214.01  |- mesh__historyNote mesh__D045362
% 213.83/214.01       2004; use CYTOCHROMES C2 %28%NM%29% 1980-2003   
% 213.83/214.01  |- mesh__publicMeSHNote mesh__D045362
% 213.83/214.01       2004; CYTOCHROMES C2 was indexed under CYTOCHROME C 1979-2003%A%  
% 213.83/214.01  |- mesh__historyNote mesh__D012188 was in Cat E only 1963-85   
% 213.83/214.01  |- skos__broader mesh__D012188smesh__D010335
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D012188 2004
% 213.83/214.01  |- skos__annotation mesh__D012188
% 213.83/214.01       note category: disease only; for diagnostic retropneumoperitoneum: index under RETROPERITONEAL SPACE /radiogr %28%IM%29% + PNEUMORADIOGRAPHY %28%NIM%29%%A%  
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D012188 2000
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D012188 2006
% 213.83/214.01  |- skos__altLabel mesh__D012188 Pneumoretroperitoneum
% 213.83/214.01  |- skos__broader mesh__D012188smesh__D014947
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D012188 2003
% 213.83/214.01  |- mesh__recordMaintainer mesh__D012188 KEV
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D012188 2005
% 213.83/214.01  |- skos__prefLabel mesh__D012188 Retropneumoperitoneum
% 213.83/214.01  |- mesh__dateCreated mesh__D012188 1999-01-01
% 213.83/214.01  |- skos__scopeNote mesh__D012188
% 213.83/214.01       Pathological or accidental introduction of air into the retroperitoneal space.%A%    
% 213.83/214.01  |- rdf__type mesh__D012188sskos__Concept
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D012188 2002
% 213.83/214.01  |- mesh__recordOriginator mesh__D012188 NLM
% 213.83/214.01  |- mesh__recordAuthorizer mesh__D012188 sjn
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D012188 2001
% 213.83/214.01  |- mesh__dateRevised mesh__D012188 1999-11-03
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D006949 2006
% 213.83/214.01  |- skos__broader mesh__D006949smesh__D050171
% 213.83/214.01  |- skos__hiddenLabel mesh__D006949 Hyperlipidemias
% 213.83/214.01  |- skos__prefLabel mesh__D006949 Hyperlipidemia
% 213.83/214.01  |- mesh__historyNote mesh__D006949
% 213.83/214.01       80; was HYPERLIPEMIA 1963-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79; HYPERCHOLESTEREMIA, ESSENTIAL FAMILIAL was see under HYPERLIPEMIA, ESSENTIAL FAMILIAL 1963-74; HYPERLIPOPROTEINEMIA, FAMILIAL was see HYPERLIPEMIA, ESSENTIAL FAMILIAL 1974-79%A%  
% 213.83/214.01  |- rdf__type mesh__D006949sskos__Concept
% 213.83/214.01  |- mesh__recordAuthorizer mesh__D006949 sjn
% 213.83/214.01  |- mesh__dateCreated mesh__D006949 1999-01-01
% 213.83/214.01  |- mesh__recordOriginator mesh__D006949 NLM
% 213.83/214.01  |- mesh__publicMeSHNote mesh__D006949
% 213.83/214.01       80; was HYPERLIPEMIA 1963-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79; HYPERCHOLESTEREMIA, ESSENTIAL FAMILIAL was see under HYPERLIPEMIA, ESSENTIAL FAMILIAL 1963-74; HYPERLIPOPROTEINEMIA, FAMILIAL was see HYPERLIPEMIA, ESSENTIAL FAMILIAL 1974-79%A%  
% 213.83/214.01  |- skos__altLabel mesh__D006949 Hyperlipemia
% 213.83/214.01  |- skos__annotation mesh__D006949 general; prefer specifics   
% 213.83/214.01  |- skos__scopeNote mesh__D006949 An excess of LIPIDS in the BLOOD.     
% 213.83/214.01  |- mesh__onlineNote mesh__D006949
% 213.83/214.01       use HYPERLIPIDEMIA to search HYPERLIPEMIA 1966-79; search HYPERLIPEMIA, ESSENTIAL FAMILIAL under HYPERLIPIDEMIA/genetics 1966-79%A%  
% 213.83/214.01  |- mesh__dateRevised mesh__D006949 2005-06-30
% 213.83/214.01  |- mesh__recordMaintainer mesh__D006949 lkt
% 213.83/214.01  |- skos__hiddenLabel mesh__D006949 Hyperlipemias
% 213.83/214.01  |- skos__prefLabel mesh__D017671 Platinum Compounds
% 213.83/214.01  |- mesh__dateCreated mesh__D017671 1993-06-02
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017671 1994
% 213.83/214.01  |- rdf__type mesh__D017671sskos__Concept
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017671 2006
% 213.83/214.01  |- skos__annotation mesh__D017671
% 213.83/214.01       inorganic; GEN or unspecified; prefer specifics; DF: PLATINUM CPDS%A%  
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017671 1999
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017671 2004
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017671 2001
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017671 1997
% 213.83/214.01  |- skos__broader mesh__D017671smesh__D007287
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017671 2000
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017671 2005
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017671 1998
% 213.83/214.01  |- skos__hiddenLabel mesh__D017671 Inorganic Platinum Compounds
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017671 2003
% 213.83/214.01  |- mesh__historyNote mesh__D017671 94   
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017671 1996
% 213.83/214.01  |- skos__scopeNote mesh__D017671
% 213.83/214.01       Inorganic compounds which contain platinum as the central atom.%A%    
% 213.83/214.01  |- skos__hiddenLabel mesh__D017671 Compounds, Inorganic Platinum
% 213.83/214.01  |- skos__altLabel mesh__D017671 Platinum Compounds, Inorganic
% 213.83/214.01  |- skos__hiddenLabel mesh__D017671 Compounds, Platinum
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017671 2002
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D017671 1995
% 213.83/214.01  |- mesh__dateEstablished mesh__D017671 1994-01-01
% 213.83/214.01  |- mesh__publicMeSHNote mesh__D017671 94   
% 213.83/214.01  |- skos__historyNote mesh__D017671 Platinum %28%1966-1993%29%
% 213.83/214.01  |- mesh__dateEstablished mesh__D031342 2003-01-01
% 213.83/214.01  |- mesh__historyNote mesh__D031342 2003   
% 213.83/214.01  |- skos__prefLabel mesh__D031342 Orthosiphon
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D031342 2003
% 213.83/214.01  |- skos__broader mesh__D031342smesh__D019686
% 213.83/214.01  |- mesh__publicMeSHNote mesh__D031342 2003   
% 213.83/214.01  |- skos__scopeNote mesh__D031342
% 213.83/214.01       A plant genus of the family LAMIACEAE that contains pimarane-type diterpenes.%A%    
% 213.83/214.01  |- rdf__type mesh__D031342sskos__Concept
% 213.83/214.01  |- mesh__dateCreated mesh__D031342 2002-07-03
% 213.83/214.01  |- skos__annotation mesh__D031342
% 213.83/214.01       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D031342 2006
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D031342 2004
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D031342 2005
% 213.83/214.01  |- mesh__recordAuthorizer mesh__D003651 sjn
% 213.83/214.01  |- skos__historyNote mesh__D003651 Fatty Acids %28%1966-1974%29%
% 213.83/214.01  |- mesh__dateEstablished mesh__D003651 1991-01-01
% 213.83/214.01  |- mesh__recordOriginator mesh__D003651 NLM
% 213.83/214.01  |- rdf__type mesh__D003651sskos__Concept
% 213.83/214.01  |- mesh__historyNote mesh__D003651
% 213.83/214.01       91%28%75%29%; was see under DECANOIC ACIDS 1975-90   
% 213.83/214.01  |- mesh__recordMaintainer mesh__D003651 ssb
% 213.83/214.01  |- skos__broader mesh__D003651smesh__D003652
% 213.83/214.01  |- mesh__dateCreated mesh__D003651 1974-11-14
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D003651 2005
% 213.83/214.01  |- skos__prefLabel mesh__D003651 Decanoates
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D003651 2004
% 213.83/214.01  |- mesh__publicMeSHNote mesh__D003651
% 213.83/214.01       91; was see under DECANOIC ACIDS 1975-90   
% 213.83/214.01  |- mesh__activeMeSHYear mesh__D003651 2006
% 213.83/214.01  |- skos__scopeNote mesh__D003651
% 213.83/214.01       Salts and esters of the 10-carbon monocarboxylic acid-decanoic acid.%A%    
% 213.83/214.01  |- mesh__dateRevised mesh__D003651 2003-07-09
% 213.83/214.01  |- skos__altLabel mesh__D002559 Spontaneous Rhinorrhea, Cerebrospinal Fluid
% 213.83/214.01  |- skos__altLabel mesh__D002559 Cerebrospinal Fluid Rhinorrhea, Traumatic
% 213.83/214.01  |- skos__hiddenLabel mesh__D002559 Rhinorrheas, Cerebrospinal
% 213.83/214.01  |- mesh__recordAuthorizer mesh__D002559 sjn
% 213.83/214.01  |- rdf__type mesh__D002559sskos__Concept
% 213.83/214.01  |- skos__altLabel mesh__D002559 Cerebrospinal Rhinorrhea
% 213.83/214.01  |- mesh__recordOriginator mesh__D002559 NLM
% 213.83/214.01  |- skos__altLabel mesh__D002559
% 213.83/214.01       Post-Traumatic Cerebrospinal Fluid Rhinorrhea
% 213.83/214.01  |- skos__altLabel mesh__D002559 Rhinorrhea, Traumatic Cerebrospinal Fluid
% 213.83/214.02  |- skos__altLabel mesh__D002559 Rhinorrhea, Cerebrospinal Fluid, Traumatic
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D002559 2000
% 213.83/214.02  |- skos__altLabel mesh__D002559 Spontaneous Cerebrospinal Fluid Rhinorrhea
% 213.83/214.02  |- mesh__recordMaintainer mesh__D002559 KEV
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D002559 2006
% 213.83/214.02  |- mesh__dateRevised mesh__D002559 1999-11-08
% 213.83/214.02  |- skos__hiddenLabel mesh__D002559
% 213.83/214.02       Post Traumatic Cerebrospinal Fluid Rhinorrhea
% 213.83/214.02  |- skos__prefLabel mesh__D002559 Cerebrospinal Fluid Rhinorrhea
% 213.83/214.02  |- skos__altLabel mesh__D002559 Traumatic Rhinorrhea, Cerebrospinal Fluid
% 213.83/214.02  |- skos__hiddenLabel mesh__D002559
% 213.83/214.02       Post Traumatic Rhinorrhea, Cerebrospinal Fluid
% 213.83/214.02  |- skos__altLabel mesh__D002559 Rhinorrhea, Spontaneous Cerebrospinal Fluid
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D002559 2005
% 213.83/214.02  |- skos__broader mesh__D002559smesh__D006259
% 213.83/214.02  |- skos__hiddenLabel mesh__D002559 Rhinorrhea, Cerebrospinal Fluid
% 213.83/214.02  |- skos__hiddenLabel mesh__D002559 Cerebrospinal Rhinorrheas
% 213.83/214.02  |- skos__broader mesh__D002559smesh__D009461
% 213.83/214.02  |- skos__altLabel mesh__D002559
% 213.83/214.02       Rhinorrhea, Cerebrospinal Fluid, Spontaneous
% 213.83/214.02  |- mesh__historyNote mesh__D002559 2000%28%1966%29%   
% 213.83/214.02  |- skos__hiddenLabel mesh__D002559 Cerebrospinal Fluid Rhinorrheas
% 213.83/214.02  |- skos__hiddenLabel mesh__D002559
% 213.83/214.02       Cerebrospinal Fluid Rhinorrhea, Post Traumatic
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D002559 2004
% 213.83/214.02  |- skos__scopeNote mesh__D002559
% 213.83/214.02       Discharge of cerebrospinal fluid through the nose. Common etiologies include trauma, neoplasms, and prior surgery, although the condition may occur spontaneously. %28%Otolaryngol Head Neck Surg 1997 Apr;116%28%4%29%:442-9%29%%A%    
% 213.83/214.02  |- skos__altLabel mesh__D002559
% 213.83/214.02       Post-Traumatic Rhinorrhea, Cerebrospinal Fluid
% 213.83/214.02  |- skos__hiddenLabel mesh__D002559 Rhinorrheas, Cerebrospinal Fluid
% 213.83/214.02  |- skos__altLabel mesh__D002559
% 213.83/214.02       Rhinorrhea, Post-Traumatic, Cerebrospinal Fluid
% 213.83/214.02  |- mesh__publicMeSHNote mesh__D002559
% 213.83/214.02       2000; see CEREBROSPINAL RHINORRHEA 1966-1999; for CEREBROSPINAL FLUID RHINORRHEA see CEREBROSPINAL RHINORRHEA 1966-1999%A%  
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D002559 2002
% 213.83/214.02  |- skos__hiddenLabel mesh__D002559 Rhinorrhea, Cerebrospinal
% 213.83/214.02  |- skos__annotation mesh__D002559 DF: CSF RHINORRHEA   
% 213.83/214.02  |- mesh__dateCreated mesh__D002559 1999-01-01
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D002559 2003
% 213.83/214.02  |- skos__altLabel mesh__D002559 Traumatic Cerebrospinal Fluid Rhinorrhea
% 213.83/214.02  |- skos__altLabel mesh__D002559
% 213.83/214.02       Rhinorrhea, Cerebrospinal Fluid, Post-Traumatic
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D002559 2001
% 213.83/214.02  |- skos__annotation mesh__D013281
% 213.83/214.02       do not confuse X refs ULCER, APHTHOUS or CANKER SORE with %22%oral ulcers%22% %28% = ORAL ULCER %29%%A%  
% 213.83/214.02  |- mesh__dateRevised mesh__D013281 2005-06-30
% 213.83/214.02  |- skos__hiddenLabel mesh__D013281 Aphthous Ulcers
% 213.83/214.02  |- mesh__dateEstablished mesh__D013281 1965-01-01
% 213.83/214.02  |- mesh__historyNote mesh__D013281 65   
% 213.83/214.02  |- rdf__type mesh__D013281sskos__Concept
% 213.83/214.02  |- skos__altLabel mesh__D013281 Canker Sore
% 213.83/214.02  |- skos__hiddenLabel mesh__D013281 Aphthous Stomatitides
% 213.83/214.02  |- skos__hiddenLabel mesh__D013281 Sore, Canker
% 213.83/214.02  |- skos__hiddenLabel mesh__D013281 Aphthous Ulcer
% 213.83/214.02  |- mesh__recordAuthorizer mesh__D013281 sjn
% 213.83/214.02  |- skos__prefLabel mesh__D013281 Stomatitis, Aphthous
% 213.83/214.02  |- skos__broader mesh__D013281smesh__D013280
% 213.83/214.02  |- skos__hiddenLabel mesh__D013281 Canker Sores
% 213.83/214.02  |- mesh__recordMaintainer mesh__D013281 lkt
% 213.83/214.02  |- mesh__publicMeSHNote mesh__D013281 65   
% 213.83/214.02  |- skos__hiddenLabel mesh__D013281 Ulcers, Aphthous
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D013281 2006
% 213.83/214.02  |- skos__hiddenLabel mesh__D013281 Stomatitides, Aphthous
% 213.83/214.02  |- skos__hiddenLabel mesh__D013281 Sores, Canker
% 213.83/214.02  |- skos__hiddenLabel mesh__D013281 Aphthous Stomatitis
% 213.83/214.02  |- skos__altLabel mesh__D013281 Ulcer, Aphthous
% 213.83/214.02  |- mesh__dateCreated mesh__D013281 1999-01-01
% 213.83/214.02  |- mesh__recordOriginator mesh__D013281 NLM
% 213.83/214.02  |- skos__scopeNote mesh__D013281
% 213.83/214.02       A recurrent disease of the oral mucosa of unknown etiology. It is characterized by small white ulcerative lesions, single or multiple, round or oval. Two to eight crops of lesions occur per year, lasting for 7 to 14 days and then heal without scarring. %28%From Jablonski%27%s Dictionary of Dentistry, 1992, p742%29%%A%    
% 213.83/214.02  |- skos__altLabel mesh__D013281 Aphthae
% 213.83/214.02  |- mesh__recordOriginator mesh__D007244 NLM
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007244 2006A
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007244 2000
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007244 2005
% 213.83/214.02  |- skos__annotation mesh__D007244
% 213.83/214.02       if not caused by Epstein-Barr Virus %28%HERPESVIRUS 4, HUMAN%29% coord IM with specific infection %28%IM%29%%A%  
% 213.83/214.02  |- mesh__dateRevised mesh__D007244 2005-07-13
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007244 2004
% 213.83/214.02  |- rdf__type mesh__D007244sskos__Concept
% 213.83/214.02  |- skos__altLabel mesh__D007244 Mononucleosis, Infectious
% 213.83/214.02  |- mesh__dateCreated mesh__D007244 1999-01-01
% 213.83/214.02  |- mesh__recordAuthorizer mesh__D007244 ags
% 213.83/214.02  |- skos__broader mesh__D007244smesh__D020031
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007244 2003
% 213.83/214.02  |- mesh__recordMaintainer mesh__D007244 ags
% 213.83/214.02  |- skos__scopeNote mesh__D007244
% 213.83/214.02       A common, acute infection usually caused by the Epstein-Barr virus %28%HERPESVIRUS 4, HUMAN%29%. There is an increase in mononuclear white blood cells and other atypical lymphocytes, generalized lymphadenopathy, splenomegaly, and occasionally hepatomegaly with hepatitis.%A%    
% 213.83/214.02  |- skos__hiddenLabel mesh__D007244 Fever, Glandular
% 213.83/214.02  |- skos__broader mesh__D007244smesh__D007960
% 213.83/214.02  |- skos__altLabel mesh__D007244 Glandular Fever
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007244 2002
% 213.83/214.02  |- skos__broader mesh__D007244smesh__D008232
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007244 2006
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007244 2001
% 213.83/214.02  |- skos__prefLabel mesh__D007244 Infectious Mononucleosis
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D012987 2005
% 213.83/214.02  |- mesh__recordAuthorizer mesh__D012987 sjn
% 213.83/214.02  |- rdf__type mesh__D012987sskos__Concept
% 213.83/214.02  |- mesh__publicMeSHNote mesh__D012987 PEAT was heading 1963-81   
% 213.83/214.02  |- mesh__dateCreated mesh__D012987 1999-01-01
% 213.83/214.02  |- mesh__historyNote mesh__D012987 PEAT was heading 1963-81   
% 213.83/214.02  |- mesh__recordMaintainer mesh__D012987 sjn
% 213.83/214.02  |- mesh__dateRevised mesh__D012987 2004-07-15
% 213.83/214.02  |- skos__prefLabel mesh__D012987 Soil
% 213.83/214.02  |- mesh__onlineNote mesh__D012987 use SOIL to search PEAT 1966-81   
% 213.83/214.02  |- mesh__recordOriginator mesh__D012987 NLM
% 213.83/214.02  |- skos__broader mesh__D012987smesh__D004777
% 213.83/214.02  |- skos__altLabel mesh__D012987 Soils
% 213.83/214.02  |- skos__scopeNote mesh__D012987
% 213.83/214.02       The loose surface material of the earth in which plants grow. %28%Webster, 3d ed%29%%A%    
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D012987 2006
% 213.83/214.02  |- skos__broader mesh__D012987smesh__D045424
% 213.83/214.02  |- skos__altLabel mesh__D045363 Pneumocystis carini
% 213.83/214.02  |- skos__scopeNote mesh__D045363
% 213.83/214.02       The prototype species of PNEUMOCYSTIS infecting the laboratory rat, Rattus norvegicus %28%RATS%29%. It was formerly called Pneumocystis carinii f. sp. carinii. Other species of Pneumocystis can also infect rats.%A%    
% 213.83/214.02  |- mesh__dateCreated mesh__D045363 2003-07-09
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D045363 2006
% 213.83/214.02  |- rdf__type mesh__D045363sskos__Concept
% 213.83/214.02  |- mesh__dateEstablished mesh__D045363 2004-01-01
% 213.83/214.02  |- mesh__recordOriginator mesh__D045363 ags
% 213.83/214.02  |- mesh__publicMeSHNote mesh__D045363
% 213.83/214.02       2004; see PNEUMOCYSTIS CARINII 1974-2003   
% 213.83/214.02  |- skos__broader mesh__D045363smesh__D011010
% 213.83/214.02  |- skos__annotation mesh__D045363
% 213.83/214.02       do not confuse with the human form, Pneumocystis carinii f. sp. hominis %28%previously indexed with PNEUMOCYSTIS CARINII%29% now PNEUMOCYSTIS JIROVECI; infection: coord IM with probably PNEUMONIA, PNEUMOCYSTIS %28%IM%29% but if not of lungs, coord with PNEUMOCYSTIS INFECTIONS %28%IM%29% + precoord organ/dis term %28%IM%29%%A%  
% 213.83/214.02  |- mesh__dateRevised mesh__D045363 2005-06-30
% 213.83/214.02  |- mesh__recordAuthorizer mesh__D045363 sjn
% 213.83/214.02  |- skos__prefLabel mesh__D045363 Pneumocystis carinii
% 213.83/214.02  |- skos__historyNote mesh__D045363 Protozoa %28%1968-1994%29%
% 213.83/214.02  |- mesh__recordMaintainer mesh__D045363 SYSTEM
% 213.83/214.02  |- mesh__historyNote mesh__D045363 2004; use PNEUMOCYSTIS 1974-2003   
% 213.83/214.02  |- skos__historyNote mesh__D045363 Pneumocystis carinii %28%1974-2003%29%
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D012189 2006
% 213.83/214.02  |- mesh__dateRevised mesh__D012189 2001-07-25
% 213.83/214.02  |- skos__broader mesh__D012189smesh__D016022
% 213.83/214.02  |- skos__annotation mesh__D012189
% 213.83/214.02       IM GEN only; coord NIM with specific disease %28%IM%29%; no qualif; specify geog if pertinent%A%  
% 213.83/214.02  |- mesh__recordAuthorizer mesh__D012189 sjn
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D012189 2003
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D012189 2005
% 213.83/214.02  |- mesh__historyNote mesh__D012189 67%28%65%29%   
% 213.83/214.02  |- skos__hiddenLabel mesh__D012189 Studies, Retrospective
% 213.83/214.02  |- mesh__dateCreated mesh__D012189 1999-01-01
% 213.83/214.02  |- mesh__recordMaintainer mesh__D012189 ags
% 213.83/214.02  |- rdf__type mesh__D012189sskos__Concept
% 213.83/214.02  |- skos__scopeNote mesh__D012189
% 213.83/214.02       Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.%A%    
% 213.83/214.02  |- mesh__dateEstablished mesh__D012189 1967-01-01
% 213.83/214.02  |- skos__prefLabel mesh__D012189 Retrospective Studies
% 213.83/214.02  |- mesh__publicMeSHNote mesh__D012189 67   
% 213.83/214.02  |- skos__hiddenLabel mesh__D012189 Study, Retrospective
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D012189 2004
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D012189 2002
% 213.83/214.02  |- mesh__recordOriginator mesh__D012189 NLM
% 213.83/214.02  |- skos__altLabel mesh__D012189 Retrospective Study
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017672 2004
% 213.83/214.02  |- mesh__dateEstablished mesh__D017672 1994-01-01
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017672 1997
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017672 2005
% 213.83/214.02  |- mesh__publicMeSHNote mesh__D017672 94   
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017672 1998
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017672 2003
% 213.83/214.02  |- mesh__historyNote mesh__D017672 94   
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017672 1996
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017672 2001
% 213.83/214.02  |- skos__annotation mesh__D017672
% 213.83/214.02       inorganic; GEN or unspecified; prefer specifics; DF: NITROGEN CPDS%A%  
% 213.83/214.02  |- skos__broader mesh__D017672smesh__D007287
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017672 2000
% 213.83/214.02  |- mesh__dateCreated mesh__D017672 1993-06-04
% 213.83/214.02  |- skos__historyNote mesh__D017672 Nitrogen %28%1966-1993%29%
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017672 1995
% 213.83/214.02  |- skos__scopeNote mesh__D017672
% 213.83/214.02       Inorganic compounds that contain nitrogen as an integral part of the molecule.%A%    
% 213.83/214.02  |- skos__prefLabel mesh__D017672 Nitrogen Compounds
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017672 1994
% 213.83/214.02  |- rdf__type mesh__D017672sskos__Concept
% 213.83/214.02  |- skos__hiddenLabel mesh__D017672 Compounds, Nitrogen
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017672 2006
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017672 2002
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017672 1999
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D031343 2005
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D031343 2003
% 213.83/214.02  |- mesh__dateEstablished mesh__D031343 2003-01-01
% 213.83/214.02  |- skos__broader mesh__D031343smesh__D019686
% 213.83/214.02  |- mesh__historyNote mesh__D031343 2003   
% 213.83/214.02  |- rdf__type mesh__D031343sskos__Concept
% 213.83/214.02  |- skos__annotation mesh__D031343
% 213.83/214.02       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.83/214.02  |- skos__scopeNote mesh__D031343
% 213.83/214.02       A plant genus of the family LAMIACEAE that is a source of perilla alcohol and the oil is rich in alpha-linolenic acid %28%alpha-18:3%29%.%A%    
% 213.83/214.02  |- mesh__publicMeSHNote mesh__D031343 2003   
% 213.83/214.02  |- mesh__dateCreated mesh__D031343 2002-07-03
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D031343 2006
% 213.83/214.02  |- skos__prefLabel mesh__D031343 Perilla
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D031343 2004
% 213.83/214.02  |- mesh__dateEstablished mesh__D003652 1975-09-01
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D003652 2006
% 213.83/214.02  |- skos__hiddenLabel mesh__D003652 Acids, Capric
% 213.83/214.02  |- skos__prefLabel mesh__D003652 Decanoic Acids
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D003652 2005
% 213.83/214.02  |- mesh__historyNote mesh__D003652 75   
% 213.83/214.02  |- mesh__recordMaintainer mesh__D003652 ssb
% 213.83/214.02  |- skos__hiddenLabel mesh__D003652 Acids, Decanoic
% 213.83/214.02  |- mesh__recordAuthorizer mesh__D003652 sjn
% 213.83/214.02  |- mesh__dateCreated mesh__D003652 1974-11-11
% 213.83/214.02  |- rdf__type mesh__D003652sskos__Concept
% 213.83/214.02  |- mesh__publicMeSHNote mesh__D003652 75   
% 213.83/214.02  |- mesh__recordOriginator mesh__D003652 NLM
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D003652 2004
% 213.83/214.02  |- skos__altLabel mesh__D003652 Capric Acids
% 213.83/214.02  |- skos__broader mesh__D003652smesh__D005227
% 213.83/214.02  |- skos__historyNote mesh__D003652 Fatty Acids %28%1966-1974%29%
% 213.83/214.02  |- skos__scopeNote mesh__D003652
% 213.83/214.02       10-carbon saturated monocarboxylic acids.     
% 213.83/214.02  |- mesh__dateRevised mesh__D003652 2003-07-09
% 213.83/214.02  |- mesh__recordOriginator mesh__D013282 NLM
% 213.83/214.02  |- skos__historyNote mesh__D013282
% 213.83/214.02       specific dental prosthesis/AE %28%1966-1971%29%
% 213.83/214.02  |- rdf__type mesh__D013282sskos__Concept
% 213.83/214.02  |- skos__historyNote mesh__D013282 Dental Prosthesis/AE %28%1966-1971%29%
% 213.83/214.02  |- mesh__historyNote mesh__D013282
% 213.83/214.02       91%28%72%29%; was see under STOMATITIS 1972-90   
% 213.83/214.02  |- mesh__dateRevised mesh__D013282 2005-06-30
% 213.83/214.02  |- skos__prefLabel mesh__D013282 Stomatitis, Denture
% 213.83/214.02  |- skos__hiddenLabel mesh__D013282 Denture Stomatitis
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D013282 2006
% 213.83/214.02  |- skos__historyNote mesh__D013282 Stomatitis %28%1966-1971%29%
% 213.83/214.02  |- skos__scopeNote mesh__D013282
% 213.83/214.02       Inflammation of the mouth due to denture irritation.     
% 213.83/214.02  |- skos__annotation mesh__D013282
% 213.83/214.02       coord with specific denture /adv eff; unspecified mycotic denture-sore mouth: coord IM with CANDIDIASIS, ORAL %28%IM%29%%A%  
% 213.83/214.02  |- mesh__recordAuthorizer mesh__D013282 sjn
% 213.83/214.02  |- mesh__dateCreated mesh__D013282 1999-01-01
% 213.83/214.02  |- skos__hiddenLabel mesh__D013282 Stomatitides, Denture
% 213.83/214.02  |- skos__broader mesh__D013282smesh__D013280
% 213.83/214.02  |- mesh__recordMaintainer mesh__D013282 lkt
% 213.83/214.02  |- skos__hiddenLabel mesh__D013282 Denture Stomatitides
% 213.83/214.02  |- mesh__dateEstablished mesh__D013282 1991-01-01
% 213.83/214.02  |- skos__historyNote mesh__D013282 Mouth Diseases %28%1966-1971%29%
% 213.83/214.02  |- mesh__publicMeSHNote mesh__D013282
% 213.83/214.02       91; was see under STOMATITIS 1972-90   
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007245 1999
% 213.83/214.02  |- skos__altLabel mesh__D007245 Colliculus, Inferior
% 213.83/214.02  |- mesh__dateEstablished mesh__D007245 1971-01-01
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007245 2004
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007245 2001
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007245 1993
% 213.83/214.02  |- mesh__dateCreated mesh__D007245 1999-01-01
% 213.83/214.02  |- mesh__dateRevised mesh__D007245 1992-05-14
% 213.83/214.02  |- rdf__type mesh__D007245sskos__Concept
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007245 2003
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007245 1998
% 213.83/214.02  |- mesh__recordAuthorizer mesh__D007245 PLS
% 213.83/214.02  |- mesh__historyNote mesh__D007245 71   
% 213.83/214.02  |- mesh__recordOriginator mesh__D007245 NLM
% 213.83/214.02  |- skos__prefLabel mesh__D007245 Inferior Colliculus
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007245 2000
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007245 1997
% 213.83/214.02  |- skos__historyNote mesh__D007245 Corpora Quadrigemina %28%1966-1970%29%
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007245 2006
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007245 1996
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007245 1995
% 213.83/214.02  |- skos__broader mesh__D007245smesh__D003336
% 213.83/214.02  |- mesh__publicMeSHNote mesh__D007245 71   
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007245 2005
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007245 1994
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007245 2002
% 213.83/214.02  |- mesh__recordMaintainer mesh__D007245 TAP
% 213.83/214.02  |- mesh__dateCreated mesh__D012988 1999-01-01
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D012988 2003
% 213.83/214.02  |- skos__broader mesh__D012988smesh__D004783
% 213.83/214.02  |- skos__prefLabel mesh__D012988 Soil Microbiology
% 213.83/214.02  |- mesh__recordAuthorizer mesh__D012988 sjn
% 213.83/214.02  |- skos__altLabel mesh__D012988 Microbiology, Soil
% 213.83/214.02  |- skos__annotation mesh__D012988
% 213.83/214.02       IM; coord IM with specific bact, virus or fungus %28%IM%29%; DF: SOIL MICROBIOL%A%  
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D012988 2002
% 213.83/214.02  |- mesh__recordMaintainer mesh__D012988 jls
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D012988 2006
% 213.83/214.02  |- mesh__recordOriginator mesh__D012988 NLM
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D012988 2004
% 213.83/214.02  |- skos__scopeNote mesh__D012988
% 213.83/214.02       The presence of bacteria, viruses, and fungi in the soil. This term is not restricted to pathogenic organisms.%A%    
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D012988 2005
% 213.83/214.02  |- rdf__type mesh__D012988sskos__Concept
% 213.83/214.02  |- mesh__dateRevised mesh__D012988 2001-07-25
% 213.83/214.02  |- mesh__dateCreated mesh__D017673 1993-06-04
% 213.83/214.02  |- skos__prefLabel mesh__D017673 Sodium Chloride, Dietary
% 213.83/214.02  |- skos__annotation mesh__D017673
% 213.83/214.02       note X ref TABLE SALT; /adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with disease /diet ther%A%  
% 213.83/214.02  |- skos__altLabel mesh__D017673 Table Salt
% 213.83/214.02  |- mesh__dateEstablished mesh__D017673 1994-01-01
% 213.83/214.02  |- mesh__recordAuthorizer mesh__D017673 SJN
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017673 2002
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017673 2006
% 213.83/214.02  |- skos__broader mesh__D017673smesh__D012965
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017673 1999
% 213.83/214.02  |- rdf__type mesh__D017673sskos__Concept
% 213.83/214.02  |- mesh__publicMeSHNote mesh__D017673 94   
% 213.83/214.02  |- skos__hiddenLabel mesh__D017673 Salt, Table
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017673 2005
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017673 2004
% 213.83/214.02  |- skos__altLabel mesh__D017673 Dietary Sodium Chloride
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017673 2001
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017673 1998
% 213.83/214.02  |- skos__historyNote mesh__D017673 Sodium Chloride %28%1966-1993%29%
% 213.83/214.02  |- skos__historyNote mesh__D017673 Sodium, Dietary %28%1988-1993%29%
% 213.83/214.02  |- mesh__dateRevised mesh__D017673 1997-06-20
% 213.83/214.02  |- skos__broader mesh__D017673smesh__D012982
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017673 2003
% 213.83/214.02  |- mesh__historyNote mesh__D017673 94   
% 213.83/214.02  |- mesh__recordOriginator mesh__D017673 TPW
% 213.83/214.02  |- skos__hiddenLabel mesh__D017673 Chloride, Dietary Sodium
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D017673 2000
% 213.83/214.02  |- skos__scopeNote mesh__D017673 Sodium chloride used in foods.     
% 213.83/214.02  |- mesh__recordMaintainer mesh__D017673 JLS
% 213.83/214.02  |- rdf__type mesh__D031344sskos__Concept
% 213.83/214.02  |- mesh__publicMeSHNote mesh__D031344 2003   
% 213.83/214.02  |- skos__scopeNote mesh__D031344
% 213.83/214.02       A plant genus of the family LAMIACEAE that is an ingredient of Banxia Houpu %28%DRUGS, CHINESE HERBAL%29%.%A%    
% 213.83/214.02  |- skos__annotation mesh__D031344
% 213.83/214.02       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.83/214.02  |- skos__prefLabel mesh__D031344 Perilla frutescens
% 213.83/214.02  |- mesh__dateEstablished mesh__D031344 2003-01-01
% 213.83/214.02  |- mesh__historyNote mesh__D031344 2003   
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D031344 2006
% 213.83/214.02  |- mesh__dateCreated mesh__D031344 2002-07-03
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D031344 2004
% 213.83/214.02  |- skos__broader mesh__D031344smesh__D031343
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D031344 2005
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D031344 2003
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D003653 2005
% 213.83/214.02  |- skos__annotation mesh__D003653
% 213.83/214.02       almost never IM; enzymatic decarboxylation: coord NIM with CARBOXY-LYASES %28%IM%29% + substrate %28%NIM%29% or specific carboxy-lyase %28%IM%29%%A%  
% 213.83/214.02  |- mesh__historyNote mesh__D003653
% 213.83/214.02       91%28%71%29%; was see under CHEMISTRY, ORGANIC 1971-90   
% 213.83/214.02  |- mesh__publicMeSHNote mesh__D003653
% 213.83/214.02       91; was see under CHEMISTRY, ORGANIC 1971-90   
% 213.83/214.02  |- skos__historyNote mesh__D003653 Chemistry, Organic %28%1966-1970%29%
% 213.83/214.02  |- rdf__type mesh__D003653sskos__Concept
% 213.83/214.02  |- mesh__dateEstablished mesh__D003653 1991-01-01
% 213.83/214.02  |- mesh__dateCreated mesh__D003653 1999-01-01
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D003653 2002
% 213.83/214.02  |- skos__prefLabel mesh__D003653 Decarboxylation
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D003653 2004
% 213.83/214.02  |- skos__hiddenLabel mesh__D003653 Decarboxylations
% 213.83/214.02  |- mesh__dateRevised mesh__D003653 2000-06-22
% 213.83/214.02  |- skos__scopeNote mesh__D003653
% 213.83/214.02       The removal of a carboxyl group, usually in the form of carbon dioxide, from a chemical compound.%A%    
% 213.83/214.02  |- mesh__recordAuthorizer mesh__D003653 sjn
% 213.83/214.02  |- skos__broader mesh__D003653smesh__D008660
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D003653 2003
% 213.83/214.02  |- mesh__recordOriginator mesh__D003653 NLM
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D003653 2001
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D003653 2006
% 213.83/214.02  |- mesh__recordMaintainer mesh__D003653 adp
% 213.83/214.02  |- skos__broader mesh__D003653smesh__D002625
% 213.83/214.02  |- mesh__recordAuthorizer mesh__D013283 sjn
% 213.83/214.02  |- skos__hiddenLabel mesh__D013283 Herpetic Stomatitis
% 213.83/214.02  |- skos__hiddenLabel mesh__D013283 Gingivostomatitides, Herpetic
% 213.83/214.02  |- rdf__type mesh__D013283sskos__Concept
% 213.83/214.02  |- skos__scopeNote mesh__D013283
% 213.83/214.02       Stomatitis caused by Herpesvirus hominis. It usually occurs as acute herpetic stomatitis %28%or gingivostomatitis%29%, an oral manifestation of primary herpes simplex seen primarily in children and adolescents.%A%    
% 213.83/214.02  |- skos__hiddenLabel mesh__D013283 Stomatitides, Herpetic
% 213.83/214.02  |- mesh__dateEstablished mesh__D013283 1980-01-01
% 213.83/214.02  |- skos__annotation mesh__D013283
% 213.83/214.02       Herpes simplex virus infect of the mouth; %22%cold sore%22% %26% %22%fever blister%22% of the mouth go here but of the lips %26% nares = HERPES LABIALIS%A%  
% 213.83/214.02  |- skos__historyNote mesh__D013283 Herpesvirus Hominis %28%1966-1979%29%
% 213.83/214.02  |- skos__historyNote mesh__D013283 Stomatitis, Aphthous %28%1966-1979%29%
% 213.83/214.02  |- mesh__recordMaintainer mesh__D013283 lkt
% 213.83/214.02  |- skos__broader mesh__D013283smesh__D006561
% 213.83/214.02  |- mesh__publicMeSHNote mesh__D013283 80   
% 213.83/214.02  |- skos__hiddenLabel mesh__D013283 Herpetic Gingivostomatitis
% 213.83/214.02  |- mesh__historyNote mesh__D013283 80   
% 213.83/214.02  |- skos__hiddenLabel mesh__D013283 Herpetic Stomatitides
% 213.83/214.02  |- skos__hiddenLabel mesh__D013283 Herpetic Gingivostomatitides
% 213.83/214.02  |- mesh__recordOriginator mesh__D013283 SMH
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D013283 2006
% 213.83/214.02  |- skos__historyNote mesh__D013283 Herpes Simplex %28%1966-1979%29%
% 213.83/214.02  |- mesh__dateRevised mesh__D013283 2005-06-30
% 213.83/214.02  |- skos__hiddenLabel mesh__D013283 Simplex, Oral Herpes
% 213.83/214.02  |- skos__historyNote mesh__D013283 Stomatitis %28%1966-1979%29%
% 213.83/214.02  |- skos__hiddenLabel mesh__D013283 Oral Herpes Simplex
% 213.83/214.02  |- mesh__dateCreated mesh__D013283 1978-12-19
% 213.83/214.02  |- skos__prefLabel mesh__D013283 Stomatitis, Herpetic
% 213.83/214.02  |- skos__altLabel mesh__D013283 Herpes Simplex, Oral
% 213.83/214.02  |- skos__historyNote mesh__D013283 Mouth Diseases %28%1966-1979%29%
% 213.83/214.02  |- skos__broader mesh__D013283smesh__D013280
% 213.83/214.02  |- skos__historyNote mesh__D013283 Herpesvirus Infections %28%1966-1979%29%
% 213.83/214.02  |- skos__prefLabel mesh__D007246 Infertility
% 213.83/214.02  |- mesh__recordAuthorizer mesh__D007246 sjn
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D007246 2006
% 213.83/214.02  |- mesh__onlineNote mesh__D007246
% 213.83/214.02       use INFERTILITY to search STERILITY 1966-82   
% 213.83/214.02  |- mesh__recordMaintainer mesh__D007246 lkt
% 213.83/214.02  |- skos__annotation mesh__D007246
% 213.83/214.02       general or unspecified as male or female; prefer the specifics; PLANT INFERTILITY is available%A%  
% 213.83/214.02  |- skos__altLabel mesh__D007246 Sterility
% 213.83/214.02  |- skos__altLabel mesh__D007246 Reproductive Sterility
% 213.83/214.02  |- mesh__dateRevised mesh__D007246 2005-06-30
% 213.83/214.02  |- mesh__recordOriginator mesh__D007246 NLM
% 213.83/214.02  |- skos__broader mesh__D007246smesh__D005831
% 213.83/214.02  |- mesh__dateCreated mesh__D007246 1999-01-01
% 213.83/214.02  |- mesh__publicMeSHNote mesh__D007246 83; was STERILITY 1963-82   
% 213.83/214.02  |- rdf__type mesh__D007246sskos__Concept
% 213.83/214.02  |- mesh__historyNote mesh__D007246 83; was STERILITY 1963-82   
% 213.83/214.02  |- skos__scopeNote mesh__D007246
% 213.83/214.02       Inability to reproduce after a specified period of unprotected intercourse. Reproductive sterility is permanent infertility.%A%    
% 213.83/214.02  |- skos__broader mesh__D007246smesh__D005832
% 213.83/214.02  |- skos__broader mesh__D012989smesh__D004785
% 213.83/214.02  |- mesh__recordOriginator mesh__D012989 NLM
% 213.83/214.02  |- skos__annotation mesh__D012989
% 213.83/214.02       specify pollutant if pertinent %28%IM or NIM%29%   
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D012989 2006
% 213.83/214.02  |- mesh__historyNote mesh__D012989 75   
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D012989 2004
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D012989 2005
% 213.83/214.02  |- rdf__type mesh__D012989sskos__Concept
% 213.83/214.02  |- skos__scopeNote mesh__D012989
% 213.83/214.02       Substances which pollute the soil. Use for soil pollutants in general or for which there is no specific heading.%A%    
% 213.83/214.02  |- mesh__dateCreated mesh__D012989 1999-01-01
% 213.83/214.02  |- mesh__dateEstablished mesh__D012989 1975-09-01
% 213.83/214.02  |- skos__historyNote mesh__D012989
% 213.83/214.02       Environmental Pollution %28%1971-1974%29%
% 213.83/214.02  |- mesh__recordAuthorizer mesh__D012989 sjn
% 213.83/214.02  |- skos__hiddenLabel mesh__D012989 Pollutants, Soil
% 213.83/214.02  |- mesh__publicMeSHNote mesh__D012989 75   
% 213.83/214.02  |- mesh__recordMaintainer mesh__D012989 ssb
% 213.83/214.02  |- skos__historyNote mesh__D012989 Soil %28%1966-1974%29%
% 213.83/214.02  |- skos__prefLabel mesh__D012989 Soil Pollutants
% 213.83/214.02  |- mesh__dateRevised mesh__D012989 2003-07-09
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D045365 2006
% 213.83/214.02  |- rdf__type mesh__D045365sskos__Concept
% 213.83/214.02  |- mesh__dateEstablished mesh__D045365 2004-01-01
% 213.83/214.02  |- skos__broader mesh__D045365smesh__D003574
% 213.83/214.02  |- skos__prefLabel mesh__D045365 Cytochromes c6
% 213.83/214.02  |- skos__historyNote mesh__D045365 Cytochromes %28%1991-2003%29%
% 213.83/214.02  |- mesh__publicMeSHNote mesh__D045365
% 213.83/214.02       2004; CYTOCHROME C6 was indexed under CYTOCHROMES 1991-2003%A%  
% 213.83/214.02  |- mesh__historyNote mesh__D045365
% 213.83/214.02       2004; for CYTCHROME C6 use CYTOCHROMES F %28%NM%29% 1991-2003   
% 213.83/214.02  |- mesh__activeMeSHYear mesh__D045365 2004
% 213.83/214.02  |- skos__scopeNote mesh__D045365
% 213.83/214.02       Cytochromes of the c type that are involved in the transfer of electrons from CYTOCHROME B6F COMPLEX and PHOTOSYSTEM I.%A%    
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D045365 2005
% 213.83/214.03  |- skos__altLabel mesh__D045365 Cytochrome c6
% 213.83/214.03  |- mesh__dateCreated mesh__D045365 2003-07-09
% 213.83/214.03  |- skos__prefLabel mesh__D017674 Hypophosphatemia
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017674 1995
% 213.83/214.03  |- skos__annotation mesh__D017674
% 213.83/214.03       a clin entity %28%abnorm decreased blood phosphates%29%: not for transient decreased blood phosphate levels %28% = PHOSPHATES /blood%29%; do not use /congen %28% = HYPOPHOSPHATEMIA, FAMILIAL%29%%A%  
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017674 1994
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017674 2000
% 213.83/214.03  |- skos__broader mesh__D017674smesh__D010760
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017674 2006
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017674 1999
% 213.83/214.03  |- rdf__type mesh__D017674sskos__Concept
% 213.83/214.03  |- skos__historyNote mesh__D017674 Phosphates/blood %28%1966-1993%29%
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017674 2005
% 213.83/214.03  |- mesh__dateEstablished mesh__D017674 1994-01-01
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017674 2004
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017674 2002
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017674 1998
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017674 1997
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017674 2003
% 213.83/214.03  |- mesh__historyNote mesh__D017674 94   
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017674 1996
% 213.83/214.03  |- mesh__publicMeSHNote mesh__D017674 94   
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017674 2001
% 213.83/214.03  |- skos__hiddenLabel mesh__D017674 Hypophosphatemias
% 213.83/214.03  |- skos__scopeNote mesh__D017674
% 213.83/214.03       An abnormally decreased level of phosphates in the blood. The manifestations include hemolysis, lassitude, weakness, and convulsions. It may be found in hyperparathyroidism, rickets, osteomalacia, and several renal tubular abnormalities. %28%Dorland, 27th ed%29%%A%    
% 213.83/214.03  |- mesh__dateCreated mesh__D017674 1993-06-03
% 213.83/214.03  |- mesh__dateCreated mesh__D031345 2002-07-03
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D031345 2006
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D031345 2004
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D031345 2005
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D031345 2003
% 213.83/214.03  |- mesh__dateEstablished mesh__D031345 2003-01-01
% 213.83/214.03  |- skos__broader mesh__D031345smesh__D019686
% 213.83/214.03  |- rdf__type mesh__D031345sskos__Concept
% 213.83/214.03  |- skos__scopeNote mesh__D031345
% 213.83/214.03       A plant genus of the family LAMIACEAE that contains phlorigidosides, iridoid glucosides and megastigmane glycosides.%A%    
% 213.83/214.03  |- mesh__publicMeSHNote mesh__D031345 2003   
% 213.83/214.03  |- mesh__historyNote mesh__D031345 2003   
% 213.83/214.03  |- skos__annotation mesh__D031345
% 213.83/214.03       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.83/214.03  |- skos__prefLabel mesh__D031345 Phlomis
% 213.83/214.03  |- mesh__dateCreated mesh__D003654 1999-01-01
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003654 1993
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003654 1996
% 213.83/214.03  |- skos__hiddenLabel mesh__D003654 Decelerations
% 213.83/214.03  |- mesh__recordAuthorizer mesh__D003654 PLS
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003654 2004
% 213.83/214.03  |- mesh__dateEstablished mesh__D003654 1991-01-01
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003654 1999
% 213.83/214.03  |- mesh__recordOriginator mesh__D003654 NLM
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003654 2001
% 213.83/214.03  |- mesh__onlineNote mesh__D003654 search ACCELERATION 1966-74   
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003654 1995
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003654 2003
% 213.83/214.03  |- skos__broader mesh__D003654smesh__D000054
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003654 1998
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003654 2000
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003654 2006
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003654 1994
% 213.83/214.03  |- mesh__historyNote mesh__D003654
% 213.83/214.03       91%28%75%29%; was see under ACCELERATION 1975-90   
% 213.83/214.03  |- mesh__dateRevised mesh__D003654 1992-05-14
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003654 2005
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003654 2002
% 213.83/214.03  |- skos__prefLabel mesh__D003654 Deceleration
% 213.83/214.03  |- mesh__recordMaintainer mesh__D003654 TAP
% 213.83/214.03  |- mesh__publicMeSHNote mesh__D003654
% 213.83/214.03       91; was see under ACCELERATION 1975-90   
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003654 1997
% 213.83/214.03  |- rdf__type mesh__D003654sskos__Concept
% 213.83/214.03  |- skos__hiddenLabel mesh__D013284 Systems, Masticatory
% 213.83/214.03  |- mesh__dateEstablished mesh__D013284 1986-01-01
% 213.83/214.03  |- rdf__type mesh__D013284sskos__Concept
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D013284 1998
% 213.83/214.03  |- mesh__recordAuthorizer mesh__D013284 SJN
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D013284 2005
% 213.83/214.03  |- mesh__publicMeSHNote mesh__D013284 86   
% 213.83/214.03  |- skos__hiddenLabel mesh__D013284 Stomatognathic Systems
% 213.83/214.03  |- skos__hiddenLabel mesh__D013284 System, Masticatory
% 213.83/214.03  |- mesh__dateCreated mesh__D013284 1999-01-01
% 213.83/214.03  |- skos__scopeNote mesh__D013284
% 213.83/214.03       The mouth, teeth, jaws, pharynx, and related structures as they relate to mastication, deglutition, and speech.%A%    
% 213.83/214.03  |- mesh__recordMaintainer mesh__D013284 TGC
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D013284 2003
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D013284 1999
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D013284 2006
% 213.83/214.03  |- skos__prefLabel mesh__D013284 Stomatognathic System
% 213.83/214.03  |- skos__hiddenLabel mesh__D013284 Masticatory Systems
% 213.83/214.03  |- skos__annotation mesh__D013284
% 213.83/214.03       includes mouth, teeth, jaws %26% pharynx; GEN: prefer specifics%A%  
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D013284 2004
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D013284 2000
% 213.83/214.03  |- mesh__dateRevised mesh__D013284 1997-06-20
% 213.83/214.03  |- skos__hiddenLabel mesh__D013284 Systems, Stomatognathic
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D013284 2001
% 213.83/214.03  |- mesh__recordOriginator mesh__D013284 NLM
% 213.83/214.03  |- skos__hiddenLabel mesh__D013284 System, Stomatognathic
% 213.83/214.03  |- mesh__historyNote mesh__D013284
% 213.83/214.03       86; was MOUTH AND TEETH %28%NON MESH%29% 1975-85   
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D013284 2002
% 213.83/214.03  |- mesh__runningHead mesh__D013284 A14 - ANATOMY-STOMATOGNATHIC SYSTEM   
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D007247 2006
% 213.83/214.03  |- mesh__publicMeSHNote mesh__D007247 83; was STERILITY, FEMALE 1963-82   
% 213.83/214.03  |- skos__prefLabel mesh__D007247 Infertility, Female
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D007247 2005
% 213.83/214.03  |- skos__hiddenLabel mesh__D007247 Female Infertility
% 213.83/214.03  |- skos__broader mesh__D007247smesh__D007246
% 213.83/214.03  |- mesh__recordAuthorizer mesh__D007247 sjn
% 213.83/214.03  |- skos__hiddenLabel mesh__D007247 Female Sterility
% 213.83/214.03  |- skos__scopeNote mesh__D007247
% 213.83/214.03       Diminished or absent ability of a female to achieve conception.%A%    
% 213.83/214.03  |- mesh__historyNote mesh__D007247 83; was STERILITY, FEMALE 1963-82   
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D007247 2004
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D007247 2002
% 213.83/214.03  |- rdf__type mesh__D007247sskos__Concept
% 213.83/214.03  |- skos__hiddenLabel mesh__D007247 Postpartum Sterility
% 213.83/214.03  |- mesh__dateCreated mesh__D007247 1999-01-01
% 213.83/214.03  |- mesh__dateRevised mesh__D007247 1999-11-03
% 213.83/214.03  |- mesh__onlineNote mesh__D007247
% 213.83/214.03       use INFERTILITY, FEMALE to search STERILITY, FEMALE 1966-82%A%  
% 213.83/214.03  |- skos__annotation mesh__D007247
% 213.83/214.03       /chem ind permitted but not for testing of contraceptives%A%  
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D007247 2003
% 213.83/214.03  |- mesh__recordMaintainer mesh__D007247 adp
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D007247 2001
% 213.83/214.03  |- mesh__recordOriginator mesh__D007247 NLM
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D007247 2000
% 213.83/214.03  |- skos__broader mesh__D003331Q000002smesh__D003331
% 213.83/214.03  |- mesh__preferredCombination mesh__D003331Q000002smesh__D003330
% 213.83/214.03  |- rdf__type mesh__D003331Q000002smesh__CompoundConcept
% 213.83/214.03  |- mesh__dateRevised mesh__D017675 2004-07-07
% 213.83/214.03  |- skos__annotation mesh__D017675
% 213.83/214.03       CREST syndrome: an acronym for Calcinosis, Raynaud phenomenon, Esophageal dysfunction, Sclerodactyly, Telangiectasis%A%  
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017675 2005
% 213.83/214.03  |- skos__historyNote mesh__D017675 Scleroderma, Systemic %28%1975-1993%29%
% 213.83/214.03  |- skos__prefLabel mesh__D017675 CREST Syndrome
% 213.83/214.03  |- skos__scopeNote mesh__D017675
% 213.83/214.03       A mild form of LIMITED SCLERODERMA, a multi-system disorder. Its features include symptoms of CALCINOSIS; RAYNAUD DISEASE; ESOPHAGEAL MOTILITY DISORDERS; sclerodactyly, and TELANGIECTASIS. When the defect in esophageal function is not prominent, it is known as CRST syndrome.%A%    
% 213.83/214.03  |- mesh__recordAuthorizer mesh__D017675 sjn
% 213.83/214.03  |- skos__broader mesh__D017675smesh__D045745
% 213.83/214.03  |- skos__broader mesh__D017675smesh__D015154
% 213.83/214.03  |- mesh__publicMeSHNote mesh__D017675 94   
% 213.83/214.03  |- skos__broader mesh__D017675smesh__D013684
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017675 2006
% 213.83/214.03  |- skos__broader mesh__D017675smesh__D011928
% 213.83/214.03  |- rdf__type mesh__D017675sskos__Concept
% 213.83/214.03  |- skos__historyNote mesh__D017675 Calcinosis %28%1975-1993%29%
% 213.83/214.03  |- mesh__recordMaintainer mesh__D017675 lkt
% 213.83/214.03  |- skos__hiddenLabel mesh__D017675 Syndrome, CREST
% 213.83/214.03  |- mesh__recordOriginator mesh__D017675 TGC
% 213.83/214.03  |- mesh__historyNote mesh__D017675 94   
% 213.83/214.03  |- mesh__dateEstablished mesh__D017675 1994-01-01
% 213.83/214.03  |- skos__broader mesh__D017675smesh__D002114
% 213.83/214.03  |- skos__historyNote mesh__D017675 Raynaud%27%s Disease %28%1975-1993%29%
% 213.83/214.03  |- mesh__dateCreated mesh__D017675 1992-12-28
% 213.83/214.03  |- skos__hiddenLabel mesh__D017675 Syndrome, CRST
% 213.83/214.03  |- mesh__historyNote mesh__D031346 2003   
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D031346 2006
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D031346 2004
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D031346 2005
% 213.83/214.03  |- mesh__dateCreated mesh__D031346 2002-07-03
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D031346 2003
% 213.83/214.03  |- skos__broader mesh__D031346smesh__D019686
% 213.83/214.03  |- rdf__type mesh__D031346sskos__Concept
% 213.83/214.03  |- mesh__publicMeSHNote mesh__D031346 2003   
% 213.83/214.03  |- skos__annotation mesh__D031346
% 213.83/214.03       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.83/214.03  |- mesh__dateEstablished mesh__D031346 2003-01-01
% 213.83/214.03  |- skos__scopeNote mesh__D031346
% 213.83/214.03       A plant genus of the family LAMIACEAE that contains eudesmane sesquiterpenes and antimicrobial abietane diterpenoids.%A%    
% 213.83/214.03  |- skos__prefLabel mesh__D031346 Plectranthus
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D050500 2006
% 213.83/214.03  |- mesh__historyNote mesh__D050500 2006   
% 213.83/214.03  |- rdf__type mesh__D050500sskos__Concept
% 213.83/214.03  |- skos__broader mesh__D050500smesh__D010195
% 213.83/214.03  |- mesh__recordAuthorizer mesh__D050500 sjn
% 213.83/214.03  |- skos__historyNote mesh__D050500 Pancreatitis %28%1965-2005%29%
% 213.83/214.03  |- mesh__dateEstablished mesh__D050500 2006-01-01
% 213.83/214.03  |- skos__altLabel mesh__D050500 Chronic Pancreatitis
% 213.83/214.03  |- mesh__recordOriginator mesh__D050500 lkt
% 213.83/214.03  |- mesh__recordMaintainer mesh__D050500 lkt
% 213.83/214.03  |- skos__scopeNote mesh__D050500
% 213.83/214.03       INFLAMMATION of the PANCREAS that is characterized by recurring or persistent ABDOMINAL PAIN with or without STEATORRHEA or DIABETES MELLITUS. It is characterized by the irregular destruction of the pancreatic parenchyma which may be focal, segmental, or diffuse.%A%    
% 213.83/214.03  |- mesh__dateCreated mesh__D050500 2005-06-30
% 213.83/214.03  |- skos__prefLabel mesh__D050500 Pancreatitis, Chronic
% 213.83/214.03  |- mesh__publicMeSHNote mesh__D050500 2006   
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003655 2002
% 213.83/214.03  |- skos__hiddenLabel mesh__D003655 State, Decerebrate
% 213.83/214.03  |- mesh__dateRevised mesh__D003655 2001-08-13
% 213.83/214.03  |- skos__hiddenLabel mesh__D003655 Decerebrate States
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003655 2003
% 213.83/214.03  |- skos__hiddenLabel mesh__D003655 Decorticate States
% 213.83/214.03  |- skos__hiddenLabel mesh__D003655 States, Decerebrate
% 213.83/214.03  |- skos__broader mesh__D003655smesh__D009461
% 213.83/214.03  |- mesh__recordMaintainer mesh__D003655 jls
% 213.83/214.03  |- mesh__recordAuthorizer mesh__D003655 sjn
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003655 2006
% 213.83/214.03  |- skos__annotation mesh__D003655
% 213.83/214.03       %22%brain-isolated%22%, %22%enc%C3%%A9%phale isol%C3%%A9%%22%, %22%pithed%22%, %22%spinal%22% as in %22%spinal cat%22%, %22%cerveau isol%C3%%A9%%22% go here%A%  
% 213.83/214.03  |- skos__prefLabel mesh__D003655 Decerebrate State
% 213.83/214.03  |- mesh__recordOriginator mesh__D003655 NLM
% 213.83/214.03  |- skos__hiddenLabel mesh__D003655 Rigidities, Decorticate
% 213.83/214.03  |- skos__hiddenLabel mesh__D003655 Decerebrate Posturings
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003655 2005
% 213.83/214.03  |- skos__altLabel mesh__D003655 Rigidity, Decorticate
% 213.83/214.03  |- skos__altLabel mesh__D003655 Rigidity, Decerebrate
% 213.83/214.03  |- skos__hiddenLabel mesh__D003655 Decorticate Rigidities
% 213.83/214.03  |- rdf__type mesh__D003655sskos__Concept
% 213.83/214.03  |- skos__scopeNote mesh__D003655
% 213.83/214.03       A condition characterized by abnormal posturing of the limbs that is associated with injury to the brainstem. This may occur as a clinical manifestation or induced experimentally in animals. The extensor reflexes are exaggerated leading to rigid extension of the limbs accompanied by hyperreflexia and opisthotonus. This condition is usually caused by lesions which occur in the region of the brainstem that lies between the red nuclei and the vestibular nuclei. In contrast, decorticate rigidity is characterized by flexion of the elbows and wrists with extension of the legs and feet. The causative lesion for this condition is located above the red nuclei and usually consists of diffuse cerebral damage. %28%From Adams et al., Principles of Neurology, 6th ed, p358%29%%A%    
% 213.83/214.03  |- mesh__dateCreated mesh__D003655 1999-01-01
% 213.83/214.03  |- skos__hiddenLabel mesh__D003655 Posturings, Decerebrate
% 213.83/214.03  |- skos__hiddenLabel mesh__D003655 Posturing, Decerebrate
% 213.83/214.03  |- skos__hiddenLabel mesh__D003655 Decerebrate Rigidity
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003655 2004
% 213.83/214.03  |- skos__hiddenLabel mesh__D008340 Nerve, Inferior Alveolar
% 213.83/214.03  |- skos__broader mesh__D008340smesh__D014276
% 213.83/214.03  |- skos__hiddenLabel mesh__D008340 Nerves, Inferior Alveolar
% 213.83/214.03  |- mesh__dateCreated mesh__D008340 1999-01-01
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D008340 2004
% 213.83/214.03  |- skos__annotation mesh__D008340
% 213.83/214.03       a branch of the trigeminal %28%5th cranial%29% nerve; dis: coord IM with CRANIAL NERVE DISEASES %28%IM%29%; neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 213.83/214.03  |- skos__hiddenLabel mesh__D008340 Inferior Alveolar Nerves
% 213.83/214.03  |- skos__hiddenLabel mesh__D008340 Mandibular Nerves
% 213.83/214.03  |- skos__hiddenLabel mesh__D008340 Nerves, Mandibular
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D008340 2002
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D008340 2003
% 213.83/214.03  |- skos__prefLabel mesh__D008340 Mandibular Nerve
% 213.83/214.03  |- skos__hiddenLabel mesh__D008340 Nerve, Mandibular
% 213.83/214.03  |- skos__hiddenLabel mesh__D008340 Alveolar Nerves, Inferior
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D008340 1999
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D008340 2006
% 213.83/214.03  |- mesh__recordMaintainer mesh__D008340 MSR
% 213.83/214.03  |- skos__hiddenLabel mesh__D008340 Inferior Alveolar Nerve
% 213.83/214.03  |- mesh__recordAuthorizer mesh__D008340 SJN
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D008340 2001
% 213.83/214.03  |- skos__scopeNote mesh__D008340
% 213.83/214.03       A branch of the trigeminal %28%5th cranial%29% nerve. The mandibular nerve carries motor fibers to the muscles of mastication and sensory fibers to the teeth and gingivae, the face in the region of the mandible, and parts of the dura.%A%    
% 213.83/214.03  |- mesh__recordOriginator mesh__D008340 NLM
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D008340 2005
% 213.83/214.03  |- mesh__dateRevised mesh__D008340 1998-06-10
% 213.83/214.03  |- rdf__type mesh__D008340sskos__Concept
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D008340 2000
% 213.83/214.03  |- mesh__recordMaintainer mesh__D013285 ags
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D013285 2000
% 213.83/214.03  |- skos__hiddenLabel mesh__D013285 Noncomitant Strabismus
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D013285 2000A
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D013285 2004
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D013285 2001
% 213.83/214.03  |- mesh__recordOriginator mesh__D013285 NLM
% 213.83/214.03  |- skos__hiddenLabel mesh__D013285 Comitant Strabismus
% 213.83/214.03  |- skos__related mesh__D013285smesh__D009988
% 213.83/214.03  |- skos__altLabel mesh__D013285 Phorias
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D013285 2002
% 213.83/214.03  |- skos__hiddenLabel mesh__D013285 Phoria
% 213.83/214.03  |- skos__hiddenLabel mesh__D013285 Hypertropias
% 213.83/214.03  |- mesh__dateRevised mesh__D013285 1999-11-26
% 213.83/214.03  |- skos__prefLabel mesh__D013285 Strabismus
% 213.83/214.03  |- mesh__recordAuthorizer mesh__D013285 ags
% 213.83/214.03  |- skos__broader mesh__D013285smesh__D015835
% 213.83/214.03  |- skos__hiddenLabel mesh__D013285 Strabismus, Convergent Comitant
% 213.83/214.03  |- skos__altLabel mesh__D013285 Squint
% 213.83/214.03  |- rdf__type mesh__D013285sskos__Concept
% 213.83/214.03  |- skos__hiddenLabel mesh__D013285 Comitant Strabismus, Convergent
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D013285 2005
% 213.83/214.03  |- skos__hiddenLabel mesh__D013285 Strabismus, Mechanical
% 213.83/214.03  |- mesh__dateCreated mesh__D013285 1999-01-01
% 213.83/214.03  |- skos__scopeNote mesh__D013285
% 213.83/214.03       Misalignment of the visual axes of the eyes. In comitant strabismus the degree of ocular misalignment does not vary with the direction of gaze. In noncomitant strabismus the degree of misalignment varies depending on direction of gaze or which eye is fixating on the target. %28%Miller, Walsh %26% Hoyt%27%s Clinical Neuro-Ophthalmology, 4th ed, p641%29%%A%    
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D013285 2003
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D013285 2006
% 213.83/214.03  |- skos__annotation mesh__D007248
% 213.83/214.03       /chem ind permitted but not for testing of contraceptives%A%  
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D007248 2006
% 213.83/214.03  |- skos__hiddenLabel mesh__D007248 Male Sterility
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D007248 2001
% 213.83/214.03  |- mesh__recordMaintainer mesh__D007248 adp
% 213.83/214.03  |- skos__prefLabel mesh__D007248 Infertility, Male
% 213.83/214.03  |- mesh__dateRevised mesh__D007248 1999-11-03
% 213.83/214.03  |- mesh__dateCreated mesh__D007248 1999-01-01
% 213.83/214.03  |- skos__broader mesh__D007248smesh__D007246
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D007248 2003
% 213.83/214.03  |- mesh__recordOriginator mesh__D007248 NLM
% 213.83/214.03  |- skos__related mesh__D007248smesh__D020554
% 213.83/214.03  |- mesh__publicMeSHNote mesh__D007248 83; was STERILITY, MALE 1963-82   
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D007248 2004
% 213.83/214.03  |- mesh__historyNote mesh__D007248 83; was STERILITY, MALE 1963-82   
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D007248 2002
% 213.83/214.03  |- rdf__type mesh__D007248sskos__Concept
% 213.83/214.03  |- skos__hiddenLabel mesh__D007248 Male Infertility
% 213.83/214.03  |- mesh__recordAuthorizer mesh__D007248 sjn
% 213.83/214.03  |- skos__scopeNote mesh__D007248
% 213.83/214.03       Diminished or absent ability of the male to effect conception.%A%    
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D007248 2005
% 213.83/214.03  |- mesh__onlineNote mesh__D007248
% 213.83/214.03       use INFERTILITY, MALE to search STERILITY, MALE 1966-82   
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D007248 2000
% 213.83/214.03  |- skos__broader mesh__D017676smesh__D009059
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017676 2003
% 213.83/214.03  |- skos__scopeNote mesh__D017676
% 213.83/214.03       Oral lesions accompanying cutaneous lichen planus or often occurring alone. The buccal mucosa, lips, gingivae, floor of the mouth, and palate are usually affected %28%in a descending order of frequency%29%. Typically, oral lesions consist of radiating white or gray, velvety, threadlike lines, arranged in a reticular pattern, at the intersection of which there may be minute, white, elevated dots or streaks %28%Wickham%27%s striae%29%. %28%Jablonski, Illustrated Dictionary of Dentistry%29%%A%    
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017676 2006
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017676 1996
% 213.83/214.03  |- rdf__type mesh__D017676sskos__Concept
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017676 1999
% 213.83/214.03  |- skos__broader mesh__D017676smesh__D008010
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017676 2004
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017676 1997
% 213.83/214.03  |- mesh__publicMeSHNote mesh__D017676 94   
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017676 2000
% 213.83/214.03  |- skos__prefLabel mesh__D017676 Lichen Planus, Oral
% 213.83/214.03  |- mesh__historyNote mesh__D017676 94   
% 213.83/214.03  |- skos__historyNote mesh__D017676 Mouth Diseases %28%1966-1993%29%
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017676 2001
% 213.83/214.03  |- skos__annotation mesh__D017676 alone or with cutaneous lichen planus   
% 213.83/214.03  |- skos__hiddenLabel mesh__D017676 Oral Lichen Planus
% 213.83/214.03  |- skos__historyNote mesh__D017676 Lichen Planus %28%1966-1993%29%
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017676 1994
% 213.83/214.03  |- mesh__dateCreated mesh__D017676 1992-12-28
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017676 2002
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017676 1995
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017676 2005
% 213.83/214.03  |- mesh__dateEstablished mesh__D017676 1994-01-01
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D017676 1998
% 213.83/214.03  |- skos__broader mesh__D031347smesh__D019686
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D031347 2006
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D031347 2004
% 213.83/214.03  |- rdf__type mesh__D031347sskos__Concept
% 213.83/214.03  |- mesh__historyNote mesh__D031347 2003   
% 213.83/214.03  |- skos__scopeNote mesh__D031347
% 213.83/214.03       A plant genus of the family LAMIACEAE. Members contain TRITERPENES. Heal all is another common name.%A%    
% 213.83/214.03  |- skos__prefLabel mesh__D031347 Prunella
% 213.83/214.03  |- mesh__publicMeSHNote mesh__D031347 2003   
% 213.83/214.03  |- mesh__dateCreated mesh__D031347 2002-07-03
% 213.83/214.03  |- skos__annotation mesh__D031347
% 213.83/214.03       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.83/214.03  |- skos__altLabel mesh__D031347 Xiakucao
% 213.83/214.03  |- skos__altLabel mesh__D031347 Self Heal
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D031347 2005
% 213.83/214.03  |- mesh__dateEstablished mesh__D031347 2003-01-01
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D031347 2003
% 213.83/214.03  |- skos__historyNote mesh__D050501 Cyanobacteria %28%1985-2004%29%
% 213.83/214.03  |- skos__prefLabel mesh__D050501 Nostoc commune
% 213.83/214.03  |- mesh__recordOriginator mesh__D050501 ags
% 213.83/214.03  |- skos__historyNote mesh__D050501 Nostoc %28%2005%29%
% 213.83/214.03  |- mesh__publicMeSHNote mesh__D050501 2006   
% 213.83/214.03  |- mesh__dateEstablished mesh__D050501 2006-01-01
% 213.83/214.03  |- mesh__historyNote mesh__D050501 2006   
% 213.83/214.03  |- mesh__recordAuthorizer mesh__D050501 sjn
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D050501 2006
% 213.83/214.03  |- skos__broader mesh__D050501smesh__D046937
% 213.83/214.03  |- mesh__recordMaintainer mesh__D050501 ags
% 213.83/214.03  |- rdf__type mesh__D050501sskos__Concept
% 213.83/214.03  |- mesh__dateCreated mesh__D050501 2005-06-30
% 213.83/214.03  |- skos__scopeNote mesh__D050501
% 213.83/214.03       A form species of spore-producing CYANOBACTERIA, in the family Nostocaceae, order Nostocales. It is an important source of fixed NITROGEN in nutrient-depleted soils. When wet, it appears as a jelly-like mass.%A%    
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003656 2004
% 213.83/214.03  |- mesh__recordAuthorizer mesh__D003656 sjn
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003656 2003
% 213.83/214.03  |- mesh__recordOriginator mesh__D003656 NLM
% 213.83/214.03  |- skos__broader mesh__D003656smesh__D004717
% 213.83/214.03  |- skos__prefLabel mesh__D003656 Decidua
% 213.83/214.03  |- mesh__recordMaintainer mesh__D003656 lkt
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003656 2006
% 213.83/214.03  |- skos__scopeNote mesh__D003656
% 213.83/214.03       The hormone-responsive glandular layer of ENDOMETRIUM that sloughs off at each menstrual flow %28%decidua menstrualis%29% or at the termination of pregnancy. During pregnancy, the thickest part of the decidua forms the maternal portion of the PLACENTA, thus named decidua placentalis. The thin portion of the decidua covering the rest of the embryo is the decidua capsularis.%A%    
% 213.83/214.03  |- rdf__type mesh__D003656sskos__Concept
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D003656 2005
% 213.83/214.03  |- skos__hiddenLabel mesh__D003656 Deciduas
% 213.83/214.03  |- skos__altLabel mesh__D003656 Deciduum
% 213.83/214.03  |- mesh__dateRevised mesh__D003656 2002-07-03
% 213.83/214.03  |- skos__broader mesh__D003656smesh__D010920
% 213.83/214.03  |- mesh__dateCreated mesh__D003656 1999-01-01
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D008341 2003
% 213.83/214.03  |- mesh__dateRevised mesh__D008341 1997-06-20
% 213.83/214.03  |- skos__hiddenLabel mesh__D008341 Prostheses, Mandibular
% 213.83/214.03  |- skos__annotation mesh__D008341
% 213.83/214.03       to replace missing part of mandible: do not use for prosthetic replacement of teeth in mandible %28% = DENTAL PROSTHESIS + MANDIBLE%29%%A%  
% 213.83/214.03  |- mesh__recordMaintainer mesh__D008341 PXP
% 213.83/214.03  |- skos__hiddenLabel mesh__D008341 Mandibular Prostheses
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D008341 2004
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D008341 2001
% 213.83/214.03  |- mesh__recordOriginator mesh__D008341 NLM
% 213.83/214.03  |- skos__historyNote mesh__D008341 Prosthesis %28%1966%29%
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D008341 2002
% 213.83/214.03  |- skos__broader mesh__D008341smesh__D008447
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D008341 1998
% 213.83/214.03  |- mesh__historyNote mesh__D008341 67   
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D008341 2005
% 213.83/214.03  |- skos__scopeNote mesh__D008341
% 213.83/214.03       A prosthetic appliance for the replacement of areas of the mandible missing or defective as a result of deformity, disease, injury, or surgery.%A%    
% 213.83/214.03  |- mesh__publicMeSHNote mesh__D008341 67   
% 213.83/214.03  |- skos__hiddenLabel mesh__D008341 Prosthesis, Mandibular
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D008341 1999
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D008341 2006
% 213.83/214.03  |- skos__prefLabel mesh__D008341 Mandibular Prosthesis
% 213.83/214.03  |- mesh__recordAuthorizer mesh__D008341 SJN
% 213.83/214.03  |- mesh__dateCreated mesh__D008341 1999-01-01
% 213.83/214.03  |- skos__related mesh__D008341smesh__D019930
% 213.83/214.03  |- rdf__type mesh__D008341sskos__Concept
% 213.83/214.03  |- mesh__dateEstablished mesh__D008341 1967-01-01
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D008341 2000
% 213.83/214.03  |- mesh__publicMeSHNote mesh__D013286 2003; see STRAMONIUM 1963-2002   
% 213.83/214.03  |- skos__broader mesh__D013286smesh__D032302
% 213.83/214.03  |- mesh__recordMaintainer mesh__D013286 ssb
% 213.83/214.03  |- skos__annotation mesh__D013286
% 213.83/214.03       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.83/214.03  |- mesh__recordOriginator mesh__D013286 NLM
% 213.83/214.03  |- mesh__historyNote mesh__D013286 2003%28%1963%29%   
% 213.83/214.03  |- rdf__type mesh__D013286sskos__Concept
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D013286 2005
% 213.83/214.03  |- skos__altLabel mesh__D013286 Thornapple
% 213.83/214.03  |- mesh__dateCreated mesh__D013286 1999-01-01
% 213.83/214.03  |- skos__prefLabel mesh__D013286 Datura stramonium
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D013286 2003
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D013286 2006
% 213.83/214.03  |- skos__scopeNote mesh__D013286
% 213.83/214.03       A plant species of the genus DATURA, family SOLANACEAE, that contains TROPANES and other SOLANACEOUS ALKALOIDS.%A%    
% 213.83/214.03  |- skos__altLabel mesh__D013286 Jimsonweed
% 213.83/214.03  |- skos__altLabel mesh__D013286 Jimson Weed
% 213.83/214.03  |- skos__altLabel mesh__D013286 Stramonium
% 213.83/214.03  |- mesh__dateRevised mesh__D013286 2002-07-03
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D013286 2004
% 213.83/214.03  |- mesh__recordAuthorizer mesh__D013286 sjn
% 213.83/214.03  |- mesh__recordMaintainer mesh__D007249 KEV
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D007249 2003
% 213.83/214.03  |- mesh__activeMeSHYear mesh__D007249 2000
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D007249 2004
% 213.83/214.04  |- skos__related mesh__D007249smesh__D000893
% 213.83/214.04  |- skos__annotation mesh__D007249
% 213.83/214.04       IM general inflammatory process; look for specific inflamm dis in MeSH as -ITIS; NIM as coord for organ /dis not in MeSH as -ITIS; /drug ther: consider also ANTI-INFLAMMATORY AGENTS %26% its specifics; ACUTE PHASE REACTION %28%an early local inflammatory reaction to inj: see MeSH definition%29% is available; Manual 23.13+; DF: INFLAMM%A%  
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D007249 2001
% 213.83/214.04  |- rdf__type mesh__D007249sskos__Concept
% 213.83/214.04  |- mesh__dateRevised mesh__D007249 1999-11-03
% 213.83/214.04  |- mesh__recordOriginator mesh__D007249 NLM
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D007249 2005
% 213.83/214.04  |- skos__broader mesh__D007249smesh__D010335
% 213.83/214.04  |- skos__hiddenLabel mesh__D007249 Inflammations
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D007249 2002
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D007249 2006
% 213.83/214.04  |- skos__related mesh__D007249smesh__D000210
% 213.83/214.04  |- mesh__recordAuthorizer mesh__D007249 sjn
% 213.83/214.04  |- skos__prefLabel mesh__D007249 Inflammation
% 213.83/214.04  |- mesh__dateCreated mesh__D007249 1999-01-01
% 213.83/214.04  |- skos__scopeNote mesh__D007249
% 213.83/214.04       A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.%A%    
% 213.83/214.04  |- rdf__type mesh__D026403sskos__Concept
% 213.83/214.04  |- mesh__recordAuthorizer mesh__D026403 sjn
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D026403 2004
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D026403 2002
% 213.83/214.04  |- skos__scopeNote mesh__D026403
% 213.83/214.04       A group of organic sulfur-containing nitrites, alkyl thionitrites. S-Nitrosothiols include compounds such as S-NITROSO-N-ACETYLPENICILLAMINE and S-NITROSOGLUTATHIONE.%A%    
% 213.83/214.04  |- mesh__dateCreated mesh__D026403 2001-07-25
% 213.83/214.04  |- skos__broader mesh__D026403smesh__D026361
% 213.83/214.04  |- skos__broader mesh__D026403smesh__D013438
% 213.83/214.04  |- skos__historyNote mesh__D026403 Nitroso Compounds %28%1992-2001%29%
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D026403 2003
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D026403 2006
% 213.83/214.04  |- mesh__dateEstablished mesh__D026403 2002-01-01
% 213.83/214.04  |- skos__prefLabel mesh__D026403 S-Nitrosothiols
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D026403 2005
% 213.83/214.04  |- skos__altLabel mesh__D026403 S-Nitrosothiol
% 213.83/214.04  |- mesh__historyNote mesh__D026403 2002   
% 213.83/214.04  |- mesh__recordOriginator mesh__D026403 lkt
% 213.83/214.04  |- mesh__recordMaintainer mesh__D026403 lkt
% 213.83/214.04  |- mesh__publicMeSHNote mesh__D026403 2002   
% 213.83/214.04  |- skos__scopeNote mesh__D017677
% 213.83/214.04       The frequency of different ages or age groups in a given population. The distribution may refer to either how many or what proportion of the group. The population is usually patients with a specific disease but the concept is not restricted to humans and is not restricted to medicine.%A%    
% 213.83/214.04  |- mesh__historyNote mesh__D017677 94   
% 213.83/214.04  |- skos__hiddenLabel mesh__D017677 Distribution, Age
% 213.83/214.04  |- mesh__dateEstablished mesh__D017677 1994-01-01
% 213.83/214.04  |- skos__broader mesh__D017677smesh__D003710
% 213.83/214.04  |- skos__hiddenLabel mesh__D017677 Distributions, Age
% 213.83/214.04  |- mesh__recordOriginator mesh__D017677 TGC
% 213.83/214.04  |- mesh__recordMaintainer mesh__D017677 sjn
% 213.83/214.04  |- mesh__dateCreated mesh__D017677 1992-12-28
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D017677 2005
% 213.83/214.04  |- skos__historyNote mesh__D017677 Age Factors %28%1968-1993%29%
% 213.83/214.04  |- skos__hiddenLabel mesh__D017677 Age Distributions
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D017677 2006
% 213.83/214.04  |- mesh__recordAuthorizer mesh__D017677 sjn
% 213.83/214.04  |- mesh__dateRevised mesh__D017677 2004-07-13
% 213.83/214.04  |- rdf__type mesh__D017677sskos__Concept
% 213.83/214.04  |- skos__historyNote mesh__D017677 Aging %28%1966-1967%29%
% 213.83/214.04  |- mesh__publicMeSHNote mesh__D017677 94   
% 213.83/214.04  |- skos__prefLabel mesh__D017677 Age Distribution
% 213.83/214.04  |- skos__annotation mesh__D017677
% 213.83/214.04       NIM; no qualif; human %26% animal; a statist concept: do not confuse with AGE FACTORS, more related to cause %26% effect; age-sex distribution: coord %28%NIM%29% with SEX DISTRIBUTION %28%NIM%29%%A%  
% 213.83/214.04  |- mesh__dateCreated mesh__D050502 2005-06-30
% 213.83/214.04  |- mesh__publicMeSHNote mesh__D050502 2006   
% 213.83/214.04  |- skos__historyNote mesh__D050502 Cyanobacteria %28%1971-2004%29%
% 213.83/214.04  |- skos__prefLabel mesh__D050502 Nostoc muscorum
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D050502 2006
% 213.83/214.04  |- mesh__recordOriginator mesh__D050502 ags
% 213.83/214.04  |- skos__scopeNote mesh__D050502
% 213.83/214.04       A form-species of nitrogen-fixing CYANOBACTERIA, in the family Nostocaceae, order Nostocales.%A%    
% 213.83/214.04  |- skos__historyNote mesh__D050502 Nostoc %28%2005%29%
% 213.83/214.04  |- mesh__recordMaintainer mesh__D050502 ags
% 213.83/214.04  |- mesh__historyNote mesh__D050502 2006   
% 213.83/214.04  |- rdf__type mesh__D050502sskos__Concept
% 213.83/214.04  |- mesh__dateEstablished mesh__D050502 2006-01-01
% 213.83/214.04  |- mesh__recordAuthorizer mesh__D050502 sjn
% 213.83/214.04  |- skos__broader mesh__D050502smesh__D046937
% 213.83/214.04  |- mesh__dateRevised mesh__D003657 2002-07-03
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D003657 2004
% 213.83/214.04  |- mesh__recordMaintainer mesh__D003657 hjn
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D003657 2005
% 213.83/214.04  |- skos__related mesh__D003657smesh__D011050
% 213.83/214.04  |- mesh__dateCreated mesh__D003657 1999-01-01
% 213.83/214.04  |- skos__broader mesh__D003657smesh__D013850
% 213.83/214.04  |- skos__related mesh__D003657smesh__D005716
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D003657 2006
% 213.83/214.04  |- mesh__recordAuthorizer mesh__D003657 sjn
% 213.83/214.04  |- rdf__type mesh__D003657sskos__Concept
% 213.83/214.04  |- mesh__recordOriginator mesh__D003657 NLM
% 213.83/214.04  |- skos__scopeNote mesh__D003657
% 213.83/214.04       The process of making a selective intellectual judgment when presented with several complex alternatives consisting of several variables, and usually defining a course of action or an idea.%A%    
% 213.83/214.04  |- skos__prefLabel mesh__D003657 Decision Making
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D003657 2003
% 213.83/214.04  |- skos__related mesh__D003657smesh__D003661
% 213.83/214.04  |- skos__annotation mesh__D003657
% 213.83/214.04       not for a physician making a diagnostic decision: this is /diag or if GEN, DIAGNOSIS or DIAGNOSIS, DIFFERENTIAL%A%  
% 213.83/214.04  |- skos__prefLabel mesh__D008342 Mandibulofacial Dysostosis
% 213.83/214.04  |- mesh__dateRevised mesh__D008342 2001-07-25
% 213.83/214.04  |- skos__hiddenLabel mesh__D008342 Dysostosis, Mandibulofacial
% 213.83/214.04  |- skos__hiddenLabel mesh__D008342 Dysostoses, Mandibulofacial
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D008342 2005
% 213.83/214.04  |- mesh__recordAuthorizer mesh__D008342 sjn
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D008342 2006
% 213.83/214.04  |- skos__hiddenLabel mesh__D008342 Collins Syndrome, Treacher
% 213.83/214.04  |- mesh__recordOriginator mesh__D008342 NLM
% 213.83/214.04  |- skos__scopeNote mesh__D008342
% 213.83/214.04       A hereditary disorder occurring in two forms: the complete form %28%Franceschetti%27%s syndrome%29% is characterized by antimongoloid slant of the palpebral fissures, coloboma of the lower lid, micrognathia and hypoplasia of the zygomatic arches, and microtia. It is transmitted as an autosomal trait. The incomplete form %28%Treacher Collins syndrome%29% is characterized by the same anomalies in less pronounced degree. It occurs sporadically, but an autosomal dominant mode of transmission is suspected. %28%Dorland, 27th ed%29%%A%    
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D008342 2002
% 213.83/214.04  |- mesh__dateCreated mesh__D008342 1999-01-01
% 213.83/214.04  |- rdf__type mesh__D008342sskos__Concept
% 213.83/214.04  |- skos__hiddenLabel mesh__D008342 Syndrome, Treacher Collins
% 213.83/214.04  |- mesh__recordMaintainer mesh__D008342 ags
% 213.83/214.04  |- skos__annotation mesh__D008342
% 213.83/214.04       a form of craniofacial dysostosis; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D008342 2003
% 213.83/214.04  |- skos__broader mesh__D008342smesh__D003394
% 213.83/214.04  |- skos__hiddenLabel mesh__D008342 Mandibulofacial Dysostoses
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D008342 2004
% 213.83/214.04  |- skos__altLabel mesh__D008342 Treacher Collins Syndrome
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D013287 2005
% 213.83/214.04  |- mesh__recordMaintainer mesh__D013287 ssb
% 213.83/214.04  |- skos__hiddenLabel mesh__D013287 Drugs, Recreational
% 213.83/214.04  |- mesh__recordAuthorizer mesh__D013287 sjn
% 213.83/214.04  |- skos__hiddenLabel mesh__D013287 Abuse Drugs
% 213.83/214.04  |- skos__prefLabel mesh__D013287 Street Drugs
% 213.83/214.04  |- skos__hiddenLabel mesh__D013287 Drugs, Illicit
% 213.83/214.04  |- skos__altLabel mesh__D013287 Drugs of Abuse
% 213.83/214.04  |- skos__broader mesh__D013287smesh__D004364
% 213.83/214.04  |- skos__scopeNote mesh__D013287
% 213.83/214.04       Drugs obtained and often manufactured illegally for the subjective effects they are said to produce. They are often distributed in urban areas, but are also available in suburban and rural areas, and tend to be grossly impure and may cause unexpected toxicity.%A%    
% 213.83/214.04  |- mesh__historyNote mesh__D013287
% 213.83/214.04       87%28%77%29%; was see under DRUGS 1977-86   
% 213.83/214.04  |- mesh__dateRevised mesh__D013287 2003-07-09
% 213.83/214.04  |- mesh__recordOriginator mesh__D013287 SH
% 213.83/214.04  |- skos__hiddenLabel mesh__D013287 Drugs, Street
% 213.83/214.04  |- rdf__type mesh__D013287sskos__Concept
% 213.83/214.04  |- skos__annotation mesh__D013287
% 213.83/214.04       /econ /legis permitted; coord IM with specific drug or chemical %28%IM%29%; CRACK COCAINE is available%A%  
% 213.83/214.04  |- skos__historyNote mesh__D013287 Substance Abuse %28%1968-1976%29%
% 213.83/214.04  |- mesh__dateEstablished mesh__D013287 1987-01-01
% 213.83/214.04  |- skos__historyNote mesh__D013287
% 213.83/214.04       Drug and Narcotic Control %28%1968-1976%29%
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D013287 2004
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D013287 2006
% 213.83/214.04  |- mesh__publicMeSHNote mesh__D013287 87; was see under DRUGS 1977-86   
% 213.83/214.04  |- mesh__dateCreated mesh__D013287 1976-04-16
% 213.83/214.04  |- skos__broader mesh__D032441smesh__D028461
% 213.83/214.04  |- skos__prefLabel mesh__D032441 Guaiacum
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D032441 2005
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D032441 2006
% 213.83/214.04  |- mesh__publicMeSHNote mesh__D032441 2003   
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D032441 2003
% 213.83/214.04  |- skos__scopeNote mesh__D032441
% 213.83/214.04       A plant genus of the family ZYGOPHYLLACEAE. GUAIAC is obtained from G. officinale or G. sanctum. Some species in this genus are called lignum vitae which is also a common name for other trees.%A%    
% 213.83/214.04  |- mesh__historyNote mesh__D032441 2003   
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D032441 2004
% 213.83/214.04  |- skos__annotation mesh__D032441
% 213.83/214.04       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.83/214.04  |- rdf__type mesh__D032441sskos__Concept
% 213.83/214.04  |- mesh__dateEstablished mesh__D032441 2003-01-01
% 213.83/214.04  |- mesh__dateCreated mesh__D032441 2002-07-03
% 213.83/214.04  |- skos__historyNote mesh__D032441 Guaiac %28%1982-2002%29%
% 213.83/214.04  |- mesh__recordMaintainer mesh__D004750 lkt
% 213.83/214.04  |- mesh__dateRevised mesh__D004750 2003-07-09
% 213.83/214.04  |- skos__hiddenLabel mesh__D004750 Force Feedings
% 213.83/214.04  |- mesh__onlineNote mesh__D004750
% 213.83/214.04       use ENTERAL NUTRITION to search ENTERAL FEEDING 1980-91 %26% TUBE FEEDING 1966-79%A%  
% 213.83/214.04  |- skos__hiddenLabel mesh__D004750 Gastric Feeding Tube
% 213.83/214.04  |- mesh__publicMeSHNote mesh__D004750
% 213.83/214.04       92; was ENTERAL FEEDING 1980-91, was TUBE FEEDING 1966-79; ENTERAL NUTRITION was see ENTERAL FEEDING 1990-91%A%  
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D004750 2005
% 213.83/214.04  |- mesh__recordAuthorizer mesh__D004750 sjn
% 213.83/214.04  |- skos__broader mesh__D004750smesh__D018529
% 213.83/214.04  |- skos__hiddenLabel mesh__D004750 Feeding Tube, Gastric
% 213.83/214.04  |- skos__related mesh__D004750smesh__D007441
% 213.83/214.04  |- mesh__dateEstablished mesh__D004750 1966-01-01
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D004750 2004
% 213.83/214.04  |- skos__hiddenLabel mesh__D004750 Feeding Tubes, Gastric
% 213.83/214.04  |- skos__broader mesh__D004750smesh__D005248
% 213.83/214.04  |- skos__hiddenLabel mesh__D004750 Tubes, Gastric Feeding
% 213.83/214.04  |- mesh__historyNote mesh__D004750
% 213.83/214.04       92; was ENTERAL FEEDING 1980-91, was TUBE FEEDING 1964-79 %28%Prov 1964-65%29%; ENTERAL NUTRITION was see ENTERAL FEEDING 1990-91%A%  
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D004750 2006
% 213.83/214.04  |- skos__hiddenLabel mesh__D004750 Feeding, Force
% 213.83/214.04  |- skos__prefLabel mesh__D004750 Enteral Nutrition
% 213.83/214.04  |- mesh__dateCreated mesh__D004750 1999-01-01
% 213.83/214.04  |- skos__hiddenLabel mesh__D004750 Feedings, Force
% 213.83/214.04  |- skos__related mesh__D004750smesh__D005526
% 213.83/214.04  |- skos__related mesh__D004750smesh__D005774
% 213.83/214.04  |- skos__hiddenLabel mesh__D004750 Tube, Gastric Feeding
% 213.83/214.04  |- skos__scopeNote mesh__D004750
% 213.83/214.04       Nutritional support given via the alimentary canal or any route connected to the gastrointestinal system %28%i.e., the enteral route%29%. This includes oral feeding, sip feeding, and tube feeding using nasogastric, gastrostomy, and jejunostomy tubes.%A%    
% 213.83/214.04  |- skos__hiddenLabel mesh__D004750 Feeding, Enteral
% 213.83/214.04  |- skos__hiddenLabel mesh__D004750 Feeding, Tube
% 213.83/214.04  |- mesh__recordOriginator mesh__D004750 NLM
% 213.83/214.04  |- skos__annotation mesh__D004750
% 213.83/214.04       do not use /util except by MeSH definition; coord IM with dis /ther %28%IM%29%, not dis /diet ther; do not confuse with PARENTERAL NUTRITION or PARENTERAL NUTRITION, TOTAL; %22%includes oral feeding, sip feeding %26% tube feeding using nasogastric, gastrostomy %26% jejunostomy tubes%22%%A%  
% 213.83/214.04  |- skos__altLabel mesh__D004750 Nutrition, Enteral
% 213.83/214.04  |- rdf__type mesh__D004750sskos__Concept
% 213.83/214.04  |- mesh__publicMeSHNote mesh__D017678 94   
% 213.83/214.04  |- mesh__dateCreated mesh__D017678 1992-12-28
% 213.83/214.04  |- skos__hiddenLabel mesh__D017678 Distributions, Sex
% 213.83/214.04  |- skos__hiddenLabel mesh__D017678 Distribution, Sex
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D017678 2005
% 213.83/214.04  |- mesh__dateEstablished mesh__D017678 1994-01-01
% 213.83/214.04  |- skos__historyNote mesh__D017678 Sex Factors %28%1968-1993%29%
% 213.83/214.04  |- mesh__recordOriginator mesh__D017678 TGC
% 213.83/214.04  |- mesh__recordMaintainer mesh__D017678 sjn
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D017678 2006
% 213.83/214.04  |- skos__scopeNote mesh__D017678
% 213.83/214.04       The number of males and females in a given population. The distribution may refer to how many men or women or what proportion of either in the group. The population is usually patients with a specific disease but the concept is not restricted to humans and is not restricted to medicine.%A%    
% 213.83/214.04  |- rdf__type mesh__D017678sskos__Concept
% 213.83/214.04  |- skos__prefLabel mesh__D017678 Sex Distribution
% 213.83/214.04  |- skos__hiddenLabel mesh__D017678 Sex Distributions
% 213.83/214.04  |- skos__annotation mesh__D017678
% 213.83/214.04       NIM; no qualif; human %26% animal; a statist concept: do not confuse with SEX FACTORS, more related to cause %26% effect; age-sex distribution: coord %28%NIM%29% with AGE DISTRIBUTION %28%NIM%29%%A%  
% 213.83/214.04  |- skos__historyNote mesh__D017678 Sex %28%1966-1967%29%
% 213.83/214.04  |- mesh__historyNote mesh__D017678 94   
% 213.83/214.04  |- mesh__recordAuthorizer mesh__D017678 sjn
% 213.83/214.04  |- skos__broader mesh__D017678smesh__D003710
% 213.83/214.04  |- mesh__dateRevised mesh__D017678 2004-07-13
% 213.83/214.04  |- mesh__historyNote mesh__D050503 2006%28%1990%29%   
% 213.83/214.04  |- skos__hiddenLabel mesh__D050503 Indoleamine 2,3 Dioxygenase
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D050503 2006A
% 213.83/214.04  |- mesh__recordOriginator mesh__D050503 jmp
% 213.83/214.04  |- skos__altLabel mesh__D050503
% 213.83/214.04       Indoleamine-Oxygen 2,3-Oxidoreductase %28%Decyclizing%29%
% 213.83/214.04  |- skos__hiddenLabel mesh__D050503 Dioxygenase, IDO
% 213.83/214.04  |- mesh__dateEstablished mesh__D050503 2006-01-01
% 213.83/214.04  |- mesh__dateRevised mesh__D050503 2005-11-09
% 213.83/214.04  |- skos__hiddenLabel mesh__D050503 Indolamine 2,3 Dioxygenase
% 213.83/214.04  |- skos__altLabel mesh__D050503 Indolamine-2,3-Dioxygenase
% 213.83/214.04  |- skos__historyNote mesh__D050503 Dioxygenases %28%2005%29%
% 213.83/214.04  |- mesh__recordMaintainer mesh__D050503 ags
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D050503 2006
% 213.83/214.04  |- skos__historyNote mesh__D050503 Tryptophan Oxygenase %28%1968-2005%29%
% 213.83/214.04  |- mesh__dateCreated mesh__D050503 2005-06-30
% 213.83/214.04  |- skos__prefLabel mesh__D050503 Indoleamine-Pyrrole 2,3,-Dioxygenase
% 213.83/214.04  |- skos__altLabel mesh__D050503 Indoleamine 2,3-Dioxygenase
% 213.83/214.04  |- rdf__type mesh__D050503sskos__Concept
% 213.83/214.04  |- skos__scopeNote mesh__D050503
% 213.83/214.04       A dioxygenase with specificity for the oxidation of the indoleamine ring of TRYPTOPHAN. It is an extrahepatic enzyme that plays a role in metabolism as the first and rate limiting enzyme in the kynurenine pathway of TRYPTOPHAN catabolism.%A%    
% 213.83/214.04  |- mesh__publicMeSHNote mesh__D050503
% 213.83/214.04       2006; see TRYPTOPHAN OXYGENASE 1990-2005; INDOLAMINE-2,3-DIOXYGENASE was indexed under DIOXYGENASES 2005 and OXYGENASES 1990-2004%A%  
% 213.83/214.04  |- mesh__recordAuthorizer mesh__D050503 ags
% 213.83/214.04  |- skos__historyNote mesh__D050503 Oxygenases %28%1970-2004%29%
% 213.83/214.04  |- skos__altLabel mesh__D050503 IDO Dioxygenase
% 213.83/214.04  |- skos__broader mesh__D050503smesh__D049308
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D003658 2005
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D003658 1991
% 213.83/214.04  |- skos__altLabel mesh__D003658 Computer-Assisted Decision Making
% 213.83/214.04  |- mesh__recordOriginator mesh__D003658 EC
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D003658 1995
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D003658 1996
% 213.83/214.04  |- skos__hiddenLabel mesh__D003658 Decision Making, Computer Assisted
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D003658 2002
% 213.83/214.04  |- mesh__recordMaintainer mesh__D003658 TGC
% 213.83/214.04  |- mesh__publicMeSHNote mesh__D003658 87   
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D003658 2006
% 213.83/214.04  |- skos__broader mesh__D003658smesh__D008491
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D003658 1997
% 213.83/214.04  |- rdf__type mesh__D003658sskos__Concept
% 213.83/214.04  |- mesh__recordAuthorizer mesh__D003658 PLS
% 213.83/214.04  |- skos__annotation mesh__D003658 no qualif   
% 213.83/214.04  |- skos__scopeNote mesh__D003658
% 213.83/214.04       Use of an interactive computer system designed to assist the physician or other health professional in choosing between certain relationships or variables for the purpose of making a diagnostic or therapeutic decision.%A%    
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D003658 1992
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D003658 1998
% 213.83/214.04  |- skos__hiddenLabel mesh__D003658
% 213.83/214.04       Medical Decision Making, Computer Assisted
% 213.83/214.04  |- skos__prefLabel mesh__D003658 Decision Making, Computer-Assisted
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D003658 2003
% 213.83/214.04  |- skos__historyNote mesh__D003658 Decision Making %28%1966-1986%29%
% 213.83/214.04  |- skos__hiddenLabel mesh__D003658 Computer Assisted Decision Making
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D003658 1993
% 213.83/214.04  |- skos__historyNote mesh__D003658 Computer Programs %28%1983-1986%29%
% 213.83/214.04  |- skos__historyNote mesh__D003658 Computers %28%1966-1986%29%
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D003658 2000
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D003658 1999
% 213.83/214.04  |- mesh__historyNote mesh__D003658 87   
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D003658 2004
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D003658 1994
% 213.83/214.04  |- mesh__dateRevised mesh__D003658 1990-05-07
% 213.83/214.04  |- mesh__dateEstablished mesh__D003658 1987-01-01
% 213.83/214.04  |- mesh__dateCreated mesh__D003658 1986-06-17
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D003658 2001
% 213.83/214.04  |- skos__broader mesh__D014380smesh__D002418
% 213.83/214.04  |- rdf__type mesh__D014380sskos__Concept
% 213.83/214.04  |- skos__broader mesh__D014380smesh__D014376
% 213.83/214.04  |- mesh__dateCreated mesh__D014380 1999-01-01
% 213.83/214.04  |- skos__scopeNote mesh__D014380
% 213.83/214.04       An infection of cattle caused by MYCOBACTERIUM BOVIS. It is transmissible to man and other animals.%A%    
% 213.83/214.04  |- mesh__dateRevised mesh__D014380 2003-07-30
% 213.83/214.04  |- mesh__recordAuthorizer mesh__D014380 sjn
% 213.83/214.04  |- skos__prefLabel mesh__D014380 Tuberculosis, Bovine
% 213.83/214.04  |- mesh__recordMaintainer mesh__D014380 ags
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D014380 2006
% 213.83/214.04  |- mesh__recordOriginator mesh__D014380 NLM
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D014380 2004
% 213.83/214.04  |- skos__hiddenLabel mesh__D014380 Tuberculoses, Bovine
% 213.83/214.04  |- skos__annotation mesh__D014380
% 213.83/214.04       caused by Mycobacterium bovis; don%27%t forget also CATTLE %28%NIM%29% %26% check tag ANIMALS%A%  
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D014380 2005
% 213.83/214.04  |- skos__hiddenLabel mesh__D014380 Bovine Tuberculoses
% 213.83/214.04  |- skos__hiddenLabel mesh__D014380 Bovine Tuberculosis
% 213.83/214.04  |- skos__scopeNote mesh__D000360
% 213.83/214.04       Continuation of visual impression after cessation of stimuli causing the original image.%A%    
% 213.83/214.04  |- skos__prefLabel mesh__D000360 Afterimage
% 213.83/214.04  |- skos__hiddenLabel mesh__D000360 Afterimages
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D000360 2005
% 213.83/214.04  |- mesh__dateCreated mesh__D000360 1999-01-01
% 213.83/214.04  |- skos__broader mesh__D000360smesh__D043722
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D000360 2004
% 213.83/214.04  |- mesh__recordMaintainer mesh__D000360 nns
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D000360 2006
% 213.83/214.04  |- mesh__recordAuthorizer mesh__D000360 sjn
% 213.83/214.04  |- mesh__recordOriginator mesh__D000360 NLM
% 213.83/214.04  |- skos__annotation mesh__D000360
% 213.83/214.04       differentiate from FIGURAL AFTEREFFECT which is displacement of %28%usually%29% geometric pattern in shape %26% space; while both are in the field of perception, AFTERIMAGE is likely to be in ophthalmol jrnls, FIGURAL AFTEREFFECT, in psychol jrnls%A%  
% 213.83/214.04  |- rdf__type mesh__D000360sskos__Concept
% 213.83/214.04  |- skos__broader mesh__D000360smesh__D014796
% 213.83/214.04  |- mesh__dateRevised mesh__D000360 2003-07-09
% 213.83/214.04  |- mesh__recordOriginator mesh__D013288 NLM
% 213.83/214.04  |- skos__annotation mesh__D013288
% 213.83/214.04       infection: coord IM with FUSOBACTERIUM INFECTIONS %28%IM%29% or RAT-BITE FEVER %28%IM%29% %28%see MeSH definition%29%%A%  
% 213.83/214.04  |- skos__scopeNote mesh__D013288
% 213.83/214.04       A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that require SERUM; ASCITIC FLUID; or BLOOD for growth. Its organisms inhabit the THROAT; and NASOPHARYNX of wild and laboratory rats and cause one form of RAT-BITE FEVER in man.%A%    
% 213.83/214.04  |- mesh__recordMaintainer mesh__D013288 ags
% 213.83/214.04  |- mesh__recordAuthorizer mesh__D013288 ags
% 213.83/214.04  |- mesh__dateCreated mesh__D013288 1999-01-01
% 213.83/214.04  |- skos__prefLabel mesh__D013288 Streptobacillus
% 213.83/214.04  |- skos__broader mesh__D013288smesh__D006092
% 213.83/214.04  |- mesh__dateRevised mesh__D013288 2005-07-14
% 213.83/214.04  |- rdf__type mesh__D013288sskos__Concept
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D013288 2006A
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D013288 2006
% 213.83/214.04  |- skos__broader mesh__D013288smesh__D045182
% 213.83/214.04  |- skos__altLabel mesh__D018771 Joint Pain
% 213.83/214.04  |- rdf__type mesh__D018771sskos__Concept
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D018771 2004
% 213.83/214.04  |- skos__hiddenLabel mesh__D018771 Joint Pains
% 213.83/214.04  |- skos__scopeNote mesh__D018771 Pain in the joint.     
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D018771 2000
% 213.83/214.04  |- mesh__recordAuthorizer mesh__D018771 sjn
% 213.83/214.04  |- mesh__publicMeSHNote mesh__D018771 95   
% 213.83/214.04  |- skos__historyNote mesh__D018771 Joint Diseases %28%1967-1994%29%
% 213.83/214.04  |- skos__hiddenLabel mesh__D018771 Arthralgias
% 213.83/214.04  |- skos__prefLabel mesh__D018771 Arthralgia
% 213.83/214.04  |- skos__historyNote mesh__D018771 Arthritis %28%1975-1994%29%
% 213.83/214.04  |- mesh__historyNote mesh__D018771 95   
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D018771 2001
% 213.83/214.04  |- mesh__dateCreated mesh__D018771 1994-05-31
% 213.83/214.04  |- skos__hiddenLabel mesh__D018771 Polyarthralgias
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D018771 2005
% 213.83/214.04  |- mesh__recordMaintainer mesh__D018771 KEV
% 213.83/214.04  |- mesh__recordOriginator mesh__D018771 TGC
% 213.83/214.04  |- mesh__dateEstablished mesh__D018771 1995-01-01
% 213.83/214.04  |- mesh__dateRevised mesh__D018771 1999-11-08
% 213.83/214.04  |- skos__broader mesh__D018771smesh__D010146
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D018771 2006
% 213.83/214.04  |- skos__historyNote mesh__D018771 Pain %28%1967-1994%29%
% 213.83/214.04  |- skos__hiddenLabel mesh__D018771 Pains, Joint
% 213.83/214.04  |- skos__broader mesh__D018771smesh__D007592
% 213.83/214.04  |- skos__hiddenLabel mesh__D018771 Pain, Joint
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D018771 2002
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D018771 2003
% 213.83/214.04  |- skos__annotation mesh__D018771
% 213.83/214.04       non-inflamm joint pain: do not confuse with ARTHRITIS which is inflamm; term used more in foreign lit than in Amer; coord IM with specific joint %28%IM%29%%A%  
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D032442 2005
% 213.83/214.04  |- mesh__dateEstablished mesh__D032442 2003-01-01
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D032442 2006
% 213.83/214.04  |- mesh__dateCreated mesh__D032442 2002-07-03
% 213.83/214.04  |- skos__altLabel mesh__D032442 Gobernadora
% 213.83/214.04  |- skos__broader mesh__D032442smesh__D028461
% 213.83/214.04  |- skos__scopeNote mesh__D032442
% 213.83/214.04       A plant genus of the family ZYGOPHYLLACEAE. It is sometimes called chaparral but that is a generic word which is used with a number of other plants. Members contain NORDIHYDROGUAIARETIC ACID.%A%    
% 213.83/214.04  |- mesh__publicMeSHNote mesh__D032442 2003   
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D032442 2003
% 213.83/214.04  |- skos__altLabel mesh__D032442 Creosote Bush
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D032442 2004
% 213.83/214.04  |- skos__annotation mesh__D032442
% 213.83/214.04       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.83/214.04  |- rdf__type mesh__D032442sskos__Concept
% 213.83/214.04  |- skos__prefLabel mesh__D032442 Larrea
% 213.83/214.04  |- mesh__historyNote mesh__D032442 2003   
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D004751 2006
% 213.83/214.04  |- mesh__dateCreated mesh__D004751 1999-01-01
% 213.83/214.04  |- mesh__recordOriginator mesh__D004751 NLM
% 213.83/214.04  |- mesh__recordMaintainer mesh__D004751 lkt
% 213.83/214.04  |- skos__scopeNote mesh__D004751
% 213.83/214.04       Inflammation of any segment of the SMALL INTESTINE.     
% 213.83/214.04  |- skos__annotation mesh__D004751
% 213.83/214.04       GEN or unspecified; jejunitis: coord JEJUNAL DISEASES %28%IM%29% + ENTERITIS %28%IM%29%%A%  
% 213.83/214.04  |- skos__related mesh__D004751smesh__D007079
% 213.83/214.04  |- skos__broader mesh__D004751smesh__D007410
% 213.83/214.04  |- skos__broader mesh__D004751smesh__D005759
% 213.83/214.04  |- skos__prefLabel mesh__D004751 Enteritis
% 213.83/214.04  |- rdf__type mesh__D004751sskos__Concept
% 213.83/214.04  |- mesh__dateRevised mesh__D004751 2003-07-09
% 213.83/214.04  |- mesh__recordAuthorizer mesh__D004751 sjn
% 213.83/214.04  |- skos__related mesh__D004751smesh__D004382
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D004751 2005
% 213.83/214.04  |- skos__related mesh__D004751smesh__D004760
% 213.83/214.04  |- skos__hiddenLabel mesh__D004751 Enteritides
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D004751 2004
% 213.83/214.04  |- mesh__publicMeSHNote mesh__D017679 94; was see CRYOSURGERY 1984-93   
% 213.83/214.04  |- skos__related mesh__D017679smesh__D007036
% 213.83/214.04  |- mesh__dateEstablished mesh__D017679 1994-01-01
% 213.83/214.04  |- skos__altLabel mesh__D017679 Therapy, Cold
% 213.83/214.04  |- mesh__dateCreated mesh__D017679 1992-12-28
% 213.83/214.04  |- mesh__recordAuthorizer mesh__D017679 sjn
% 213.83/214.04  |- skos__scopeNote mesh__D017679
% 213.83/214.04       A form of therapy consisting in the local or general use of cold. The selective destruction of tissue by extreme cold or freezing is CRYOSURGERY. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 213.83/214.04  |- skos__broader mesh__D017679smesh__D013812
% 213.83/214.04  |- mesh__dateRevised mesh__D017679 2005-06-30
% 213.83/214.04  |- mesh__historyNote mesh__D017679 94; was see CRYOSURGERY 1984-93   
% 213.83/214.04  |- skos__historyNote mesh__D017679 Cryosurgery %28%1966-1993%29%
% 213.83/214.04  |- skos__hiddenLabel mesh__D017679 Cold Therapies
% 213.83/214.04  |- mesh__onlineNote mesh__D017679
% 213.83/214.04       use CRYOSURGERY to search CRYOTHERAPY 1984-93   
% 213.83/214.04  |- skos__prefLabel mesh__D017679 Cryotherapy
% 213.83/214.04  |- mesh__recordOriginator mesh__D017679 TGC
% 213.83/214.04  |- skos__altLabel mesh__D017679 Cold Therapy
% 213.83/214.04  |- rdf__type mesh__D017679sskos__Concept
% 213.83/214.04  |- skos__hiddenLabel mesh__D017679 Cryotherapies
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D017679 2006
% 213.83/214.04  |- skos__hiddenLabel mesh__D017679 Therapies, Cold
% 213.83/214.04  |- mesh__recordMaintainer mesh__D017679 lkt
% 213.83/214.04  |- mesh__recordOriginator mesh__D050504 ags
% 213.83/214.04  |- skos__hiddenLabel mesh__D050504 Viruses, Oncolytic
% 213.83/214.04  |- mesh__recordMaintainer mesh__D050504 ags
% 213.83/214.04  |- mesh__historyNote mesh__D050504
% 213.83/214.04       2006, 1966-1993; use VIRUSES 1994-2005   
% 213.83/214.04  |- skos__annotation mesh__D050504 ONCOGENIC VIRUSES is available   
% 213.83/214.04  |- mesh__activeMeSHYear mesh__D050504 2006
% 213.83/214.04  |- skos__hiddenLabel mesh__D050504 Oncolytic Virus
% 213.83/214.04  |- mesh__publicMeSHNote mesh__D050504
% 213.83/214.04       2006, 1966-1993; see VIRUSES 1994-2005   
% 213.83/214.05  |- rdf__type mesh__D050504sskos__Concept
% 213.83/214.05  |- skos__broader mesh__D050504smesh__D014780
% 213.83/214.05  |- mesh__recordAuthorizer mesh__D050504 sjn
% 213.83/214.05  |- mesh__dateEstablished mesh__D050504 2006-01-01
% 213.83/214.05  |- skos__related mesh__D050504smesh__D050130
% 213.83/214.05  |- mesh__dateCreated mesh__D050504 2005-06-30
% 213.83/214.05  |- skos__scopeNote mesh__D050504
% 213.83/214.05       Tumor-selective, replication competent VIRUSES that have antineoplastic effects. This is achieved by producing cytotoxicity-enhancing proteins and/or eliciting an antitumor immune response. They are genetically engineered so that they can replicate in CANCER cells but not in normal cells, and are used in ONCOLYTIC VIROTHERAPY.%A%    
% 213.83/214.05  |- skos__historyNote mesh__D050504 Viruses %28%1999-2005%29%
% 213.83/214.05  |- skos__hiddenLabel mesh__D050504 Virus, Oncolytic
% 213.83/214.05  |- skos__prefLabel mesh__D050504 Oncolytic Viruses
% 213.83/214.05  |- rdf__type mesh__D003659sskos__Concept
% 213.83/214.05  |- skos__historyNote mesh__D003659 Decision Making %28%1966-1985%29%
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D003659 1992
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D003659 2000
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D003659 1998
% 213.83/214.05  |- skos__annotation mesh__D003659 no qualif   
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D003659 2003
% 213.83/214.05  |- skos__related mesh__D003659smesh__D003661
% 213.83/214.05  |- mesh__historyNote mesh__D003659 86   
% 213.83/214.05  |- skos__altLabel mesh__D003659 Organizational Decision Making
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D003659 1993
% 213.83/214.05  |- mesh__recordOriginator mesh__D003659 EC
% 213.83/214.05  |- skos__prefLabel mesh__D003659 Decision Making, Organizational
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D003659 2001
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D003659 1999
% 213.83/214.05  |- skos__scopeNote mesh__D003659
% 213.83/214.05       The process by which decisions are made in an institution or other organization.%A%    
% 213.83/214.05  |- mesh__publicMeSHNote mesh__D003659 86   
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D003659 2004
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D003659 1991
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D003659 1994
% 213.83/214.05  |- mesh__dateEstablished mesh__D003659 1986-01-01
% 213.83/214.05  |- skos__broader mesh__D003659smesh__D009934
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D003659 2002
% 213.83/214.05  |- mesh__recordMaintainer mesh__D003659 PLS
% 213.83/214.05  |- mesh__dateCreated mesh__D003659 1985-05-23
% 213.83/214.05  |- skos__related mesh__D003659smesh__D011050
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D003659 2005
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D003659 1995
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D003659 1996
% 213.83/214.05  |- mesh__recordAuthorizer mesh__D003659 PLS
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D003659 2006
% 213.83/214.05  |- mesh__dateRevised mesh__D003659 1990-08-02
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D003659 1997
% 213.83/214.05  |- skos__broader mesh__D014381smesh__D014376
% 213.83/214.05  |- mesh__dateCreated mesh__D014381 1999-01-01
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014381 1994
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014381 1992
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014381 1999
% 213.83/214.05  |- mesh__recordMaintainer mesh__D014381 PXP
% 213.83/214.05  |- skos__hiddenLabel mesh__D014381 Cardiovascular Tuberculoses
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014381 1997
% 213.83/214.05  |- skos__hiddenLabel mesh__D014381 Tuberculoses, Cardiovascular
% 213.83/214.05  |- skos__hiddenLabel mesh__D014381 Cardiovascular Tuberculosis
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014381 2006
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014381 2002
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014381 1998
% 213.83/214.05  |- skos__prefLabel mesh__D014381 Tuberculosis, Cardiovascular
% 213.83/214.05  |- skos__annotation mesh__D014381
% 213.83/214.05       IM; coord IM with specific organ or organ /dis %28%IM%29%   
% 213.83/214.05  |- skos__scopeNote mesh__D014381
% 213.83/214.05       Tuberculosis of the heart, pericardium, or blood vessels.%A%    
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014381 2004
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014381 1996
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014381 2005
% 213.83/214.05  |- mesh__recordAuthorizer mesh__D014381 PLS
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014381 2003
% 213.83/214.05  |- skos__broader mesh__D014381smesh__D002318
% 213.83/214.05  |- mesh__recordOriginator mesh__D014381 NLM
% 213.83/214.05  |- mesh__dateRevised mesh__D014381 1991-06-12
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014381 2001
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014381 1995
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014381 1993
% 213.83/214.05  |- rdf__type mesh__D014381sskos__Concept
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014381 2000
% 213.83/214.05  |- mesh__historyNote mesh__D008344
% 213.83/214.05       91%28%72%29%; was see under THIOCARBAMATES 1972-90   
% 213.83/214.05  |- skos__historyNote mesh__D008344 Thiocarbamates %28%1966-1971%29%
% 213.83/214.05  |- rdf__type mesh__D008344sskos__Concept
% 213.83/214.05  |- mesh__publicMeSHNote mesh__D008344
% 213.83/214.05       91; was see under THIOCARBAMATES 1972-90   
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D008344 2002
% 213.83/214.05  |- skos__scopeNote mesh__D008344
% 213.83/214.05       Manganese derivative of ethylenebisdithiocarbamate. It is used in agriculture as a fungicide and has been shown to cause irritation to the eyes, nose, skin, and throat.%A%    
% 213.83/214.05  |- mesh__dateRevised mesh__D008344 2000-06-22
% 213.83/214.05  |- skos__historyNote mesh__D008344 Pesticides %28%1966-1971%29%
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D008344 2003
% 213.83/214.05  |- skos__prefLabel mesh__D008344 Maneb
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D008344 2004
% 213.83/214.05  |- skos__historyNote mesh__D008344 Manganese %28%1966-1971%29%
% 213.83/214.05  |- skos__historyNote mesh__D008344 Antifungal Agents %28%1966-1971%29%
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D008344 2005
% 213.83/214.05  |- mesh__recordMaintainer mesh__D008344 CCR
% 213.83/214.05  |- skos__broader mesh__D008344smesh__D005028
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D008344 2006
% 213.83/214.05  |- skos__broader mesh__D008344smesh__D009942
% 213.83/214.05  |- mesh__dateEstablished mesh__D008344 1991-01-01
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D008344 2001
% 213.83/214.05  |- mesh__dateCreated mesh__D008344 1999-01-01
% 213.83/214.05  |- mesh__recordAuthorizer mesh__D008344 sjn
% 213.83/214.05  |- mesh__recordOriginator mesh__D008344 NLM
% 213.83/214.05  |- skos__broader mesh__D000361smesh__D007153
% 213.83/214.05  |- skos__related mesh__D000361smesh__D011504
% 213.83/214.05  |- skos__broader mesh__D000361smesh__D008232
% 213.83/214.05  |- skos__prefLabel mesh__D000361 Agammaglobulinemia
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D000361 2004
% 213.83/214.05  |- skos__scopeNote mesh__D000361
% 213.83/214.05       An immunologic deficiency state characterized by an extremely low level of generally all classes of gamma-globulin in the blood.%A%    
% 213.83/214.05  |- mesh__recordMaintainer mesh__D000361 lkt
% 213.83/214.05  |- skos__annotation mesh__D000361 DYSGAMMAGLOBULINEMIA is also available   
% 213.83/214.05  |- skos__hiddenLabel mesh__D000361 Agammaglobulinemias
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D000361 2006
% 213.83/214.05  |- mesh__dateCreated mesh__D000361 1999-01-01
% 213.83/214.05  |- skos__broader mesh__D000361smesh__D001796
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D000361 2005
% 213.83/214.05  |- mesh__recordOriginator mesh__D000361 NLM
% 213.83/214.05  |- mesh__recordAuthorizer mesh__D000361 sjn
% 213.83/214.05  |- skos__hiddenLabel mesh__D000361 Hypogammaglobulinemias
% 213.83/214.05  |- rdf__type mesh__D000361sskos__Concept
% 213.83/214.05  |- mesh__dateRevised mesh__D000361 2003-07-09
% 213.83/214.05  |- skos__scopeNote mesh__D013289
% 213.83/214.05       Gram-positive non-sporing bacteria including many parasitic, pathogenic, and saprophytic forms.%A%    
% 213.83/214.05  |- rdf__type mesh__D013289sskos__Concept
% 213.83/214.05  |- mesh__historyNote mesh__D013289
% 213.83/214.05       76; GAFFKYA was see under MICROCOCCACEAE 1976-78, was heading 1963-75%A%  
% 213.83/214.05  |- skos__historyNote mesh__D013289 Lactobacillaceae %28%1975%29%
% 213.83/214.05  |- skos__prefLabel mesh__D013289 Streptococcaceae
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D013289 2006
% 213.83/214.05  |- mesh__dateEstablished mesh__D013289 1976-01-01
% 213.83/214.05  |- mesh__publicMeSHNote mesh__D013289
% 213.83/214.05       76; GAFFKYA was see under MICROCOCCACEAE 1976-78, was heading 1963-75%A%  
% 213.83/214.05  |- mesh__dateRevised mesh__D013289 2005-06-30
% 213.83/214.05  |- skos__historyNote mesh__D013289 Bacteria %28%1966-1974%29%
% 213.83/214.05  |- skos__broader mesh__D013289smesh__D006095
% 213.83/214.05  |- mesh__dateCreated mesh__D013289 1975-07-23
% 213.83/214.05  |- mesh__onlineNote mesh__D013289
% 213.83/214.05       use STREPTOCOCCACEAE %26% MICROCOCCUS to search GAFFKYA %28%all species%29% 1966-78%A%  
% 213.83/214.05  |- skos__historyNote mesh__D013289 Micrococcaceae %28%1975%29%
% 213.83/214.05  |- mesh__recordOriginator mesh__D013289 JW
% 213.83/214.05  |- skos__annotation mesh__D013289
% 213.83/214.05       DF: do not abbreviate since it would conflict with DF for STREPTOCOCCUS%A%  
% 213.83/214.05  |- mesh__recordMaintainer mesh__D013289 SYSTEM
% 213.83/214.05  |- mesh__recordAuthorizer mesh__D013289 sjn
% 213.83/214.05  |- skos__historyNote mesh__D018772
% 213.83/214.05       Dental Cavity Preparation %28%1967-1994%29%
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D018772 2006
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D018772 1999
% 213.83/214.05  |- skos__altLabel mesh__D018772 Adaptation, Marginal %28%Dentistry%29%
% 213.83/214.05  |- skos__hiddenLabel mesh__D018772 Dental Marginal Adaptation
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D018772 2004
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D018772 2001
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D018772 1997
% 213.83/214.05  |- skos__hiddenLabel mesh__D018772 Marginal Adaptations %28%Dentistry%29%
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D018772 2005
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D018772 2000
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D018772 1998
% 213.83/214.05  |- rdf__type mesh__D018772sskos__Concept
% 213.83/214.05  |- skos__altLabel mesh__D018772 Adaptation, Marginal, Dental
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D018772 2003
% 213.83/214.05  |- skos__prefLabel mesh__D018772 Marginal Adaptation %28%Dentistry%29%
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D018772 1996
% 213.83/214.05  |- mesh__dateEstablished mesh__D018772 1995-01-01
% 213.83/214.05  |- mesh__dateCreated mesh__D018772 1994-05-31
% 213.83/214.05  |- skos__hiddenLabel mesh__D018772 Marginal Adaptations, Dental
% 213.83/214.05  |- skos__hiddenLabel mesh__D018772 Adaptation, Dental Marginal
% 213.83/214.05  |- skos__annotation mesh__D018772
% 213.83/214.05       degree of interlocking of a filling to a tooth cavity wall; DF: MARGINAL ADAPTATION%A%  
% 213.83/214.05  |- skos__hiddenLabel mesh__D018772 Adaptations, Dental Marginal
% 213.83/214.05  |- skos__broader mesh__D018772smesh__D003793
% 213.83/214.05  |- mesh__historyNote mesh__D018772 95   
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D018772 2002
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D018772 1995
% 213.83/214.05  |- mesh__publicMeSHNote mesh__D018772 95   
% 213.83/214.05  |- skos__hiddenLabel mesh__D018772 Adaptations, Marginal %28%Dentistry%29%
% 213.83/214.05  |- skos__altLabel mesh__D018772 Marginal Adaptation, Dental
% 213.83/214.05  |- skos__scopeNote mesh__D018772
% 213.83/214.05       The degree of proximity and interlocking of filling material to the wall of the cavity of a tooth. The term has come to be used synonymously with adaptation at the cavosurface margin. %28%Jablonski, Illustrated Dictionary of Dentistry, 1982; J Dent 1993;21:265-73%29%%A%    
% 213.83/214.05  |- skos__hiddenLabel mesh__D018772 Dental Marginal Adaptations
% 213.83/214.05  |- skos__historyNote mesh__D018772
% 213.83/214.05       Dental Restoration, Permanent %28%1967-1994%29%
% 213.83/214.05  |- skos__prefLabel mesh__D032443 Peganum
% 213.83/214.05  |- mesh__historyNote mesh__D032443 2003   
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D032443 2005
% 213.83/214.05  |- mesh__dateEstablished mesh__D032443 2003-01-01
% 213.83/214.05  |- skos__scopeNote mesh__D032443
% 213.83/214.05       A plant genus of the family ZYGOPHYLLACEAE. Harmala and other ALKALOIDS, phenylpropanoids, and TRITERPENES have been found in plants of this genus.%A%    
% 213.83/214.05  |- mesh__dateCreated mesh__D032443 2002-07-03
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D032443 2006
% 213.83/214.05  |- skos__broader mesh__D032443smesh__D028461
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D032443 2003
% 213.83/214.05  |- rdf__type mesh__D032443sskos__Concept
% 213.83/214.05  |- mesh__publicMeSHNote mesh__D032443 2003   
% 213.83/214.05  |- skos__annotation mesh__D032443
% 213.83/214.05       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D032443 2004
% 213.83/214.05  |- mesh__onlineNote mesh__D004752
% 213.83/214.05       use CORONAVIRUS, TURKEY to search ENTERITIS VIRUS, TURKEY 1975-93%A%  
% 213.83/214.05  |- skos__hiddenLabel mesh__D004752 Coronaviruses, Turkey
% 213.83/214.05  |- skos__altLabel mesh__D004752 Transmissible Enteritis Virus of Turkeys
% 213.83/214.05  |- skos__prefLabel mesh__D004752 Coronavirus, Turkey
% 213.83/214.05  |- skos__hiddenLabel mesh__D004752 Turkey Enteritis Viruses
% 213.83/214.05  |- rdf__type mesh__D004752sskos__Concept
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D004752 2002
% 213.83/214.05  |- mesh__dateEstablished mesh__D004752 1991-01-01
% 213.83/214.05  |- mesh__recordOriginator mesh__D004752 NLM
% 213.83/214.05  |- skos__broader mesh__D004752smesh__D017934
% 213.83/214.05  |- skos__hiddenLabel mesh__D004752 Turkey Enteritis Virus
% 213.83/214.05  |- skos__altLabel mesh__D004752 Bluecomb Virus
% 213.83/214.05  |- skos__annotation mesh__D004752
% 213.83/214.05       infection = ENTERITIS, TRANSMISSIBLE, OF TURKEYS   
% 213.83/214.05  |- skos__altLabel mesh__D004752 Enteritis Virus, Turkey
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D004752 2003
% 213.83/214.05  |- mesh__publicMeSHNote mesh__D004752
% 213.83/214.05       94; was ENTERITIS VIRUS, TURKEY 1991-93 %28%see under CORONAVIRIDAE 1981-90, see under REOVIRUSES 1975-80%29%%A%  
% 213.83/214.05  |- mesh__dateCreated mesh__D004752 1974-12-12
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D004752 2005
% 213.83/214.05  |- skos__altLabel mesh__D004752 Transmissible Enteritis Virus, Turkeys
% 213.83/214.05  |- mesh__dateRevised mesh__D004752 2001-07-25
% 213.83/214.05  |- mesh__historyNote mesh__D004752
% 213.83/214.05       94; was ENTERITIS VIRUS, TURKEY 1975-93 %28%see under CORONAVIRIDAE 1981-90, see under REOVIRUSES 1975-80%29%%A%  
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D004752 2004
% 213.83/214.05  |- skos__hiddenLabel mesh__D004752 Enteritis Viruses, Turkey
% 213.83/214.05  |- skos__altLabel mesh__D004752 Turkey coronavirus
% 213.83/214.05  |- mesh__recordMaintainer mesh__D004752 ags
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D004752 2006
% 213.83/214.05  |- mesh__recordAuthorizer mesh__D004752 sjn
% 213.83/214.05  |- skos__scopeNote mesh__D004752
% 213.83/214.05       A species of CORONAVIRUS causing enteritis in turkeys and pullets.%A%    
% 213.83/214.05  |- skos__hiddenLabel mesh__D004752 Turkey Coronaviruses
% 213.83/214.05  |- skos__hiddenLabel mesh__D004752 Bluecomb Viruses
% 213.83/214.05  |- skos__hiddenLabel mesh__D050505 Protein, Mutant
% 213.83/214.05  |- mesh__dateCreated mesh__D050505 2005-06-30
% 213.83/214.05  |- skos__historyNote mesh__D050505 Mutation %28%1966-2005%29%
% 213.83/214.05  |- mesh__recordMaintainer mesh__D050505 nns
% 213.83/214.05  |- skos__scopeNote mesh__D050505
% 213.83/214.05       Proteins produced from GENES that have acquired MUTATIONS.%A%    
% 213.83/214.05  |- skos__hiddenLabel mesh__D050505 Proteins, Mutant
% 213.83/214.05  |- mesh__publicMeSHNote mesh__D050505 2006   
% 213.83/214.05  |- mesh__historyNote mesh__D050505 2006   
% 213.83/214.05  |- mesh__dateEstablished mesh__D050505 2006-01-01
% 213.83/214.05  |- skos__prefLabel mesh__D050505 Mutant Proteins
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D050505 2006
% 213.83/214.05  |- mesh__recordAuthorizer mesh__D050505 sjn
% 213.83/214.05  |- skos__broader mesh__D050505smesh__D011506
% 213.83/214.05  |- skos__annotation mesh__D050505
% 213.83/214.05       coordinate with specific mutant protein   
% 213.83/214.05  |- rdf__type mesh__D050505sskos__Concept
% 213.83/214.05  |- mesh__recordOriginator mesh__D050505 nns
% 213.83/214.05  |- skos__altLabel mesh__D050505 Mutant Protein
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014382 1998
% 213.83/214.05  |- skos__hiddenLabel mesh__D014382 Scrofulodermas
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014382 2004
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014382 2005
% 213.83/214.05  |- mesh__recordOriginator mesh__D014382 NLM
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014382 2001
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014382 2003
% 213.83/214.05  |- mesh__dateRevised mesh__D014382 1997-06-20
% 213.83/214.05  |- skos__hiddenLabel mesh__D014382 Cutaneous Tuberculoses
% 213.83/214.05  |- skos__prefLabel mesh__D014382 Tuberculosis, Cutaneous
% 213.83/214.05  |- skos__hiddenLabel mesh__D014382 Tuberculosis, Skin
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014382 2000
% 213.83/214.05  |- skos__hiddenLabel mesh__D014382 Cutaneous Tuberculosis
% 213.83/214.05  |- mesh__recordAuthorizer mesh__D014382 SJN
% 213.83/214.05  |- skos__hiddenLabel mesh__D014382 Tuberculoses, Skin
% 213.83/214.05  |- rdf__type mesh__D014382sskos__Concept
% 213.83/214.05  |- skos__hiddenLabel mesh__D014382 Tuberculids
% 213.83/214.05  |- skos__scopeNote mesh__D014382
% 213.83/214.05       Tuberculosis of the skin. It includes scrofuloderma and tuberculid, but not lupus vulgaris, which is LUPUS.%A%    
% 213.83/214.05  |- skos__broader mesh__D014382smesh__D014376
% 213.83/214.05  |- skos__altLabel mesh__D014382 Skin Tuberculosis
% 213.83/214.05  |- mesh__dateCreated mesh__D014382 1999-01-01
% 213.83/214.05  |- skos__broader mesh__D014382smesh__D017192
% 213.83/214.05  |- skos__hiddenLabel mesh__D014382 Skin Tuberculoses
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014382 2002
% 213.83/214.05  |- mesh__recordMaintainer mesh__D014382 TGC
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014382 1999
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014382 2006
% 213.83/214.05  |- skos__hiddenLabel mesh__D014382 Tuberculoses, Cutaneous
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D008345 2006
% 213.83/214.05  |- skos__scopeNote mesh__D008345
% 213.83/214.05       A trace element with atomic symbol Mn, atomic number 25, and atomic weight 54.94. It is concentrated in cell mitochondria, mostly in the pituitary gland, liver, pancreas, kidney, and bone, influences the synthesis of mucopolysaccharides, stimulates hepatic synthesis of cholesterol and fatty acids, and is a cofactor in many enzymes, including arginase and alkaline phosphatase in the liver. %28%From AMA Drug Evaluations Annual 1992, p2035%29%%A%    
% 213.83/214.05  |- mesh__dateRevised mesh__D008345 2005-06-30
% 213.83/214.05  |- skos__broader mesh__D008345smesh__D019216
% 213.83/214.05  |- rdf__type mesh__D008345sskos__Concept
% 213.83/214.05  |- skos__prefLabel mesh__D008345 Manganese
% 213.83/214.05  |- mesh__recordAuthorizer mesh__D008345 sjn
% 213.83/214.05  |- mesh__recordOriginator mesh__D008345 NLM
% 213.83/214.05  |- skos__annotation mesh__D008345
% 213.83/214.05       Mn-55; Mn-50-54, 56-58 = MANGANESE %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 213.83/214.05  |- skos__broader mesh__D008345smesh__D028561
% 213.83/214.05  |- mesh__recordMaintainer mesh__D008345 ssb
% 213.83/214.05  |- mesh__dateCreated mesh__D008345 1999-01-01
% 213.83/214.05  |- mesh__recordOriginator mesh__D000362 NLM
% 213.83/214.05  |- mesh__dateRevised mesh__D000362 2004-07-07
% 213.83/214.05  |- mesh__recordAuthorizer mesh__D000362 sjn
% 213.83/214.05  |- skos__scopeNote mesh__D000362
% 213.83/214.05       A complex sulfated polymer of galactose units, extracted from Gelidium cartilagineum, Gracilaria confervoides, and related red algae. It is used as a gel in the preparation of solid culture media for microorganisms, as a bulk laxative, in making emulsions, and as a supporting medium for immunodiffusion and immunoelectrophoresis.%A%    
% 213.83/214.05  |- skos__annotation mesh__D000362 D25-26 qualif   
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D000362 2006
% 213.83/214.05  |- mesh__dateCreated mesh__D000362 1999-01-01
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D000362 2005
% 213.83/214.05  |- skos__broader mesh__D000362smesh__D005685
% 213.83/214.05  |- skos__prefLabel mesh__D000362 Agar
% 213.83/214.05  |- rdf__type mesh__D000362sskos__Concept
% 213.83/214.05  |- mesh__recordMaintainer mesh__D000362 ssb
% 213.83/214.05  |- skos__hiddenLabel mesh__D018773 v-erbB Oncogene
% 213.83/214.05  |- skos__hiddenLabel mesh__D018773 c-erbB-1 Gene
% 213.83/214.05  |- skos__altLabel mesh__D018773 c-erbB-1 Proto-Oncogenes
% 213.83/214.05  |- skos__altLabel mesh__D018773 Genes, EGFR
% 213.83/214.05  |- skos__prefLabel mesh__D018773 Genes, erbB-1
% 213.83/214.05  |- skos__hiddenLabel mesh__D018773 erbB 1 Genes
% 213.83/214.05  |- mesh__recordOriginator mesh__D018773 AGS
% 213.83/214.05  |- rdf__type mesh__D018773sskos__Concept
% 213.83/214.05  |- skos__altLabel mesh__D018773 EGFR Genes
% 213.83/214.05  |- skos__historyNote mesh__D018773 Oncogenes %28%1986-1994%29%
% 213.83/214.05  |- skos__hiddenLabel mesh__D018773 c erbB 1 Proto Oncogenes
% 213.83/214.05  |- skos__hiddenLabel mesh__D018773 v-erbB Gene
% 213.83/214.05  |- mesh__dateRevised mesh__D018773 2005-06-30
% 213.83/214.05  |- skos__scopeNote mesh__D018773
% 213.83/214.05       The proto-oncogene c-erbB-1 codes for the epidermal growth factor receptor. Its name originates from the viral homolog v-erbB which was isolated from an avian erythroblastosis virus %28%AEV%29% where it was contained as a fragment of the chicken c-ErbB-1 gene lacking the amino-terminal ligand-binding domain. Overexpression of erbB-1 genes occurs in a wide range of tumors, commonly squamous carcinomas of various sites and less commonly adenocarcinomas. The human c-erbB-1 gene is located in the chromosomal region 7p14 and 7p12.%A%    
% 213.83/214.05  |- skos__hiddenLabel mesh__D018773 c erbB 1 Genes
% 213.83/214.05  |- skos__hiddenLabel mesh__D018773 EGFR Gene
% 213.83/214.05  |- skos__hiddenLabel mesh__D018773 erbB1 Gene
% 213.83/214.05  |- mesh__historyNote mesh__D018773 95   
% 213.83/214.05  |- skos__related mesh__D018773smesh__D011958
% 213.83/214.05  |- skos__broader mesh__D018773smesh__D018815
% 213.83/214.05  |- skos__altLabel mesh__D018773 erbB-1 Genes
% 213.83/214.05  |- skos__related mesh__D018773smesh__D018739
% 213.83/214.05  |- mesh__dateCreated mesh__D018773 1994-05-23
% 213.83/214.05  |- skos__altLabel mesh__D018773 Genes, erbB1
% 213.83/214.05  |- mesh__recordMaintainer mesh__D018773 nns
% 213.83/214.05  |- skos__historyNote mesh__D018773 Proto-Oncogenes %28%1985-1994%29%
% 213.83/214.05  |- skos__hiddenLabel mesh__D018773 v erbB Oncogenes
% 213.83/214.05  |- mesh__dateEstablished mesh__D018773 1995-01-01
% 213.83/214.05  |- skos__hiddenLabel mesh__D018773 c-erbB-1 Proto-Oncogene
% 213.83/214.05  |- skos__altLabel mesh__D018773 v-erbB Oncogenes
% 213.83/214.05  |- skos__hiddenLabel mesh__D018773 erbB-1 Gene
% 213.83/214.05  |- skos__annotation mesh__D018773
% 213.83/214.05       spell in titles %26% translations as erbB-1; GENES ERBB-2 is also available%A%  
% 213.83/214.05  |- skos__altLabel mesh__D018773 Epidermal Growth Factor Receptor Genes
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D018773 2006
% 213.83/214.05  |- mesh__publicMeSHNote mesh__D018773 95   
% 213.83/214.05  |- skos__hiddenLabel mesh__D018773 v erbB Genes
% 213.83/214.05  |- mesh__recordAuthorizer mesh__D018773 sjn
% 213.83/214.05  |- skos__hiddenLabel mesh__D018773 Gene, erbB1
% 213.83/214.05  |- skos__hiddenLabel mesh__D018773 erbB1 Genes
% 213.83/214.05  |- skos__prefLabel mesh__D032444 Tribulus
% 213.83/214.05  |- mesh__dateEstablished mesh__D032444 2003-01-01
% 213.83/214.05  |- skos__broader mesh__D032444smesh__D028461
% 213.83/214.05  |- mesh__historyNote mesh__D032444 2003   
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D032444 2006
% 213.83/214.05  |- skos__annotation mesh__D032444
% 213.83/214.05       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.83/214.05  |- skos__altLabel mesh__D032444 Puncture Vine
% 213.83/214.05  |- mesh__dateCreated mesh__D032444 2002-07-03
% 213.83/214.05  |- skos__scopeNote mesh__D032444
% 213.83/214.05       A plant genus of the family ZYGOPHYLLACEAE. Members contain steroidal saponins. Ingestion by grazing animals causes PHOTOSENSITIVITY DISORDERS called geeldikkop %28%yellow thick head%29% in South Africa.%A%    
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D032444 2004
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D032444 2005
% 213.83/214.05  |- rdf__type mesh__D032444sskos__Concept
% 213.83/214.05  |- mesh__publicMeSHNote mesh__D032444 2003   
% 213.83/214.05  |- skos__altLabel mesh__D032444 Goathead
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D032444 2003
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D004753 2006
% 213.83/214.05  |- skos__historyNote mesh__D004753 Poultry Diseases %28%1966-1975%29%
% 213.83/214.05  |- skos__prefLabel mesh__D004753 Enteritis, Transmissible, of Turkeys
% 213.83/214.05  |- mesh__dateEstablished mesh__D004753 1976-01-01
% 213.83/214.05  |- mesh__recordAuthorizer mesh__D004753 sjn
% 213.83/214.05  |- skos__altLabel mesh__D004753 Bluecomb of Turkeys
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D004753 2005
% 213.83/214.05  |- mesh__publicMeSHNote mesh__D004753 76   
% 213.83/214.05  |- skos__broader mesh__D004753smesh__D011201
% 213.83/214.05  |- mesh__dateRevised mesh__D004753 2002-07-02
% 213.83/214.05  |- mesh__historyNote mesh__D004753 76   
% 213.83/214.05  |- mesh__recordOriginator mesh__D004753 FPG
% 213.83/214.05  |- skos__related mesh__D004753smesh__D031261
% 213.83/214.05  |- skos__annotation mesh__D004753
% 213.83/214.05       don%27%t forget TURKEYS %28%NIM%29%; POULT ENTERITIS MORTALITY SYNDROME is also available%A%  
% 213.83/214.05  |- rdf__type mesh__D004753sskos__Concept
% 213.83/214.05  |- mesh__dateCreated mesh__D004753 1975-07-25
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D004753 2004
% 213.83/214.05  |- skos__scopeNote mesh__D004753
% 213.83/214.05       An acute, highly contagious virus disease of turkeys characterized by chilling, anorexia, decreased water intake, diarrhea, dehydration and weight loss. The infectious agent is a CORONAVIRUS.%A%    
% 213.83/214.05  |- skos__altLabel mesh__D004753 Transmissible Enteritis of Turkeys
% 213.83/214.05  |- mesh__recordMaintainer mesh__D004753 ags
% 213.83/214.05  |- skos__broader mesh__D004753smesh__D018352
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D004753 2003
% 213.83/214.05  |- mesh__dateCreated mesh__D050506 2005-06-30
% 213.83/214.05  |- mesh__publicMeSHNote mesh__D050506 2006   
% 213.83/214.05  |- skos__altLabel mesh__D050506 Chimeric Proteins, Mutant
% 213.83/214.05  |- skos__broader mesh__D050506smesh__D050505
% 213.83/214.05  |- mesh__recordMaintainer mesh__D050506 nns
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D050506 2006
% 213.83/214.05  |- skos__hiddenLabel mesh__D050506 Proteins, Mutant Chimeric
% 213.83/214.05  |- mesh__historyNote mesh__D050506 2006   
% 213.83/214.05  |- rdf__type mesh__D050506sskos__Concept
% 213.83/214.05  |- mesh__recordOriginator mesh__D050506 nns
% 213.83/214.05  |- mesh__dateEstablished mesh__D050506 2006-01-01
% 213.83/214.05  |- skos__prefLabel mesh__D050506 Mutant Chimeric Proteins
% 213.83/214.05  |- mesh__recordAuthorizer mesh__D050506 sjn
% 213.83/214.05  |- skos__scopeNote mesh__D050506
% 213.83/214.05       Proteins produced from GENES that have mutated by the fusing of protein coding regions of more than one gene.%A%    
% 213.83/214.05  |- skos__prefLabel mesh__D014383 Tuberculosis, Endocrine
% 213.83/214.05  |- skos__scopeNote mesh__D014383
% 213.83/214.05       Infection of the ENDOCRINE GLANDS with species of MYCOBACTERIUM, most often MYCOBACTERIUM TUBERCULOSIS.%A%    
% 213.83/214.05  |- mesh__dateRevised mesh__D014383 2005-06-30
% 213.83/214.05  |- mesh__recordAuthorizer mesh__D014383 sjn
% 213.83/214.05  |- skos__hiddenLabel mesh__D014383 Tuberculoses, Endocrine
% 213.83/214.05  |- rdf__type mesh__D014383sskos__Concept
% 213.83/214.05  |- mesh__recordOriginator mesh__D014383 NLM
% 213.83/214.05  |- skos__broader mesh__D014383smesh__D014376
% 213.83/214.05  |- mesh__dateCreated mesh__D014383 1999-01-01
% 213.83/214.05  |- skos__broader mesh__D014383smesh__D004700
% 213.83/214.05  |- skos__annotation mesh__D014383
% 213.83/214.05       coordinate IM with specific endocrine system disease %28%IM%29%%A%  
% 213.83/214.05  |- skos__hiddenLabel mesh__D014383 Endocrine Tuberculosis
% 213.83/214.05  |- mesh__activeMeSHYear mesh__D014383 2006
% 213.83/214.05  |- skos__hiddenLabel mesh__D014383 Endocrine Tuberculoses
% 213.83/214.05  |- mesh__recordMaintainer mesh__D014383 lkt
% 213.83/214.05  |- skos__historyNote mesh__D000363 Basidiomycetes %28%1966-1974%29%
% 213.83/214.05  |- mesh__historyNote mesh__D000363
% 213.83/214.05       86%28%75%29%; for MUSHROOMS use BASIDIOMYCOTA 1963-98; for AGARICACEAE use BASIDIOMYCOTA 1966-74%A%  
% 213.83/214.05  |- skos__broader mesh__D000363smesh__D001487
% 213.83/214.05  |- mesh__publicMeSHNote mesh__D000363
% 213.83/214.05       86; for MUSHROOMS see BASIDOMYCETES 1986-98, see MUSHROOMS 1963-85; for CORTINARIUS see CORTINARIUS 1991-96, see AGARICALES 1986-90; for AGARICACEAE see AGARICACEAE 1975-85, see MUSHROOMS 1963-74%A%  
% 213.83/214.05  |- mesh__recordMaintainer mesh__D000363 SYSTEM
% 213.83/214.05  |- rdf__type mesh__D000363sskos__Concept
% 213.83/214.05  |- skos__scopeNote mesh__D000363
% 213.83/214.05       An extensive order of basidiomycetous fungi whose fruiting bodies are commonly call mushrooms.%A%    
% 213.83/214.05  |- skos__prefLabel mesh__D000363 Agaricales
% 213.83/214.05  |- mesh__recordAuthorizer mesh__D000363 sjn
% 213.83/214.05  |- mesh__recordOriginator mesh__D000363 NLM
% 213.83/214.05  |- mesh__dateEstablished mesh__D000363 1975-01-01
% 213.83/214.05  |- mesh__dateCreated mesh__D000363 1974-11-19
% 213.83/214.06  |- skos__annotation mesh__D000363
% 213.83/214.06       note x ref MUSHROOMS; pois = MUSHROOM POISONING   
% 213.83/214.06  |- mesh__dateRevised mesh__D000363 2005-06-30
% 213.83/214.06  |- skos__altLabel mesh__D000363 Mushrooms
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D000363 2006
% 213.83/214.06  |- mesh__onlineNote mesh__D018774
% 213.83/214.06       use ONCOGENE PROTEINS V-ERBA %28%NM%29% to search ONCOGENE PROTEIN ERBA 1987-94%A%  
% 213.83/214.06  |- skos__prefLabel mesh__D018774 Oncogene Proteins v-erbA
% 213.83/214.06  |- mesh__recordMaintainer mesh__D018774 SYSTEM
% 213.83/214.06  |- skos__hiddenLabel mesh__D018774 Oncogene Products v erbA
% 213.83/214.06  |- mesh__publicMeSHNote mesh__D018774
% 213.83/214.06       95; ONCOGENE PROTEIN ERBA was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-94 %26% RETROVIRIDAE PROTEINS 1987-89%A%  
% 213.83/214.06  |- mesh__recordAuthorizer mesh__D018774 sjn
% 213.83/214.06  |- skos__historyNote mesh__D018774 Retroviridae Proteins %28%1987-1989%29%
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D018774 2006
% 213.83/214.06  |- skos__scopeNote mesh__D018774
% 213.83/214.06       Transforming proteins encoded by erbA oncogenes from the avian erythroblastosis virus. They are truncated versions of c-erbA, the thyroid hormone receptor %28%RECEPTORS, THYROID HORMONE%29% that have retained both the DNA-binding and hormone-binding domains. Mutations in the hormone-binding domains abolish the transcriptional activation function. v-erbA acts as a dominant repressor of c-erbA, inducing transformation by disinhibiting proliferation.%A%    
% 213.83/214.06  |- skos__altLabel mesh__D018774 Oncogene Products v-erbA
% 213.83/214.06  |- mesh__recordOriginator mesh__D018774 AGS
% 213.83/214.06  |- skos__hiddenLabel mesh__D018774 Oncogene Proteins v erbA
% 213.83/214.06  |- mesh__dateRevised mesh__D018774 2005-06-30
% 213.83/214.06  |- mesh__historyNote mesh__D018774
% 213.83/214.06       95; was ONCOGENE PROTEIN ERBA %28%NM%29% 1987-94   
% 213.83/214.06  |- skos__altLabel mesh__D018774 v-erbA Proteins
% 213.83/214.06  |- skos__altLabel mesh__D018774 erbA Oncogene Proteins
% 213.83/214.06  |- mesh__dateEstablished mesh__D018774 1995-01-01
% 213.83/214.06  |- skos__broader mesh__D018774smesh__D015682
% 213.83/214.06  |- rdf__type mesh__D018774sskos__Concept
% 213.83/214.06  |- skos__historyNote mesh__D018774
% 213.83/214.06       Retroviridae Proteins, Oncogenic %28%1990-1994%29%
% 213.83/214.06  |- skos__hiddenLabel mesh__D018774 v erbA Proteins
% 213.83/214.06  |- skos__annotation mesh__D018774
% 213.83/214.06       IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 213.83/214.06  |- mesh__dateCreated mesh__D018774 1994-05-23
% 213.83/214.06  |- skos__broader mesh__D010791smesh__D002572
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D010791 2004
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D010791 2002
% 213.83/214.06  |- skos__annotation mesh__D010791
% 213.83/214.06       dis: coord IM with PERIPHERAL NERVOUS SYSTEM DISEASES %28%IM%29%; neopl: coord IM with PERIPHERAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 213.83/214.06  |- mesh__dateCreated mesh__D010791 1999-01-01
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D010791 2003
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D010791 2001
% 213.83/214.06  |- skos__prefLabel mesh__D010791 Phrenic Nerve
% 213.83/214.06  |- mesh__recordAuthorizer mesh__D010791 sjn
% 213.83/214.06  |- rdf__type mesh__D010791sskos__Concept
% 213.83/214.06  |- skos__hiddenLabel mesh__D010791 Phrenic Nerves
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D010791 2000
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D010791 2006
% 213.83/214.06  |- mesh__recordMaintainer mesh__D010791 kle
% 213.83/214.06  |- skos__scopeNote mesh__D010791
% 213.83/214.06       The motor nerve of the diaphragm. The phrenic nerve fibers originate in the cervical spinal column %28%mostly C4%29% and travel through the cervical plexus to the diaphragm.%A%    
% 213.83/214.06  |- mesh__dateRevised mesh__D010791 1999-11-03
% 213.83/214.06  |- skos__hiddenLabel mesh__D010791 Nerves, Phrenic
% 213.83/214.06  |- skos__hiddenLabel mesh__D010791 Nerve, Phrenic
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D010791 2005
% 213.83/214.06  |- mesh__recordOriginator mesh__D010791 NLM
% 213.83/214.06  |- skos__scopeNote mesh__D032445
% 213.83/214.06       A plant genus of the family ZYGOPHYLLACEAE. Members contain SAPONINS.%A%    
% 213.83/214.06  |- mesh__dateEstablished mesh__D032445 2003-01-01
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D032445 2006
% 213.83/214.06  |- skos__annotation mesh__D032445
% 213.83/214.06       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D032445 2004
% 213.83/214.06  |- rdf__type mesh__D032445sskos__Concept
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D032445 2005
% 213.83/214.06  |- mesh__publicMeSHNote mesh__D032445 2003   
% 213.83/214.06  |- skos__broader mesh__D032445smesh__D028461
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D032445 2003
% 213.83/214.06  |- mesh__historyNote mesh__D032445 2003   
% 213.83/214.06  |- mesh__dateCreated mesh__D032445 2002-07-03
% 213.83/214.06  |- skos__prefLabel mesh__D032445 Zygophyllum
% 213.83/214.06  |- skos__broader mesh__D004754smesh__D004755
% 213.83/214.06  |- skos__scopeNote mesh__D004754
% 213.83/214.06       Gram-negative gas-producing rods found in feces of man and other animals, sewage, soil, water, and dairy products.%A%    
% 213.83/214.06  |- mesh__recordOriginator mesh__D004754 NLM
% 213.83/214.06  |- skos__prefLabel mesh__D004754 Enterobacter
% 213.83/214.06  |- mesh__dateCreated mesh__D004754 1999-01-01
% 213.83/214.06  |- mesh__recordAuthorizer mesh__D004754 ags
% 213.83/214.06  |- rdf__type mesh__D004754sskos__Concept
% 213.83/214.06  |- mesh__publicMeSHNote mesh__D004754
% 213.83/214.06       91; was see under ENTEROBACTERIACEAE 1978-90; was AEROBACTER see under ENTEROBACTERIACEAE 1976-77; was AEROBACTER 1963-75%A%  
% 213.83/214.06  |- mesh__onlineNote mesh__D004754
% 213.83/214.06       use ENTEROBACTER to search AEROBACTER 1966-77   
% 213.83/214.06  |- skos__annotation mesh__D004754
% 213.83/214.06       infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%; not X ref AEROBACTER but AEROBACTER AEROGENES see ENTEROBACTER AEROGENES is available%A%  
% 213.83/214.06  |- mesh__recordMaintainer mesh__D004754 ags
% 213.83/214.06  |- mesh__dateEstablished mesh__D004754 1991-01-01
% 213.83/214.06  |- mesh__dateRevised mesh__D004754 2005-07-13
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D004754 2006A
% 213.83/214.06  |- mesh__historyNote mesh__D004754
% 213.83/214.06       91%28%78%29%; was see under ENTEROBACTERIACEAE 1978-90; was AEROBACTER see under ENTEROBACTERIACEAE 1976-77; was AEROBACTER 1963-75%A%  
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D004754 2006
% 213.83/214.06  |- skos__altLabel mesh__D004754 Aerobacter
% 213.83/214.06  |- rdf__type mesh__D050507sskos__Concept
% 213.83/214.06  |- mesh__recordOriginator mesh__D050507 lkt
% 213.83/214.06  |- mesh__historyNote mesh__D050507 2006   
% 213.83/214.06  |- skos__altLabel mesh__D050507 Abdominal Subcutaneous Adipose Tissue
% 213.83/214.06  |- skos__broader mesh__D050507smesh__D050151
% 213.83/214.06  |- mesh__recordAuthorizer mesh__D050507 sjn
% 213.83/214.06  |- skos__hiddenLabel mesh__D050507 Abdominal Subcutaneous Fats
% 213.83/214.06  |- mesh__dateEstablished mesh__D050507 2006-01-01
% 213.83/214.06  |- mesh__publicMeSHNote mesh__D050507 2006   
% 213.83/214.06  |- mesh__recordMaintainer mesh__D050507 lkt
% 213.83/214.06  |- skos__prefLabel mesh__D050507 Subcutaneous Fat, Abdominal
% 213.83/214.06  |- skos__historyNote mesh__D050507 Abdomen %28%1967-2005%29%
% 213.83/214.06  |- skos__altLabel mesh__D050507 Adipose Tissue, Abdominal Subcutaneous
% 213.83/214.06  |- mesh__dateCreated mesh__D050507 2005-06-30
% 213.83/214.06  |- skos__hiddenLabel mesh__D050507 Subcutaneous Fats, Abdominal
% 213.83/214.06  |- skos__scopeNote mesh__D050507
% 213.83/214.06       Fatty tissue under the SKIN in the region of the ABDOMEN.%A%    
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D050507 2006
% 213.83/214.06  |- skos__altLabel mesh__D050507 Fat, Abdominal Subcutaneous
% 213.83/214.06  |- skos__broader mesh__D050507smesh__D050153
% 213.83/214.06  |- skos__altLabel mesh__D050507 Abdominal Subcutaneous Fat
% 213.83/214.06  |- skos__historyNote mesh__D050507 Adipose Tissue %28%1967-2005%29%
% 213.83/214.06  |- skos__hiddenLabel mesh__D050507 Fats, Abdominal Subcutaneous
% 213.83/214.06  |- skos__hiddenLabel mesh__D014384 Tuberculoses, Female Genital
% 213.83/214.06  |- mesh__dateCreated mesh__D014384 1999-01-01
% 213.83/214.06  |- skos__hiddenLabel mesh__D014384 Genital Tuberculoses, Female
% 213.83/214.06  |- skos__prefLabel mesh__D014384 Tuberculosis, Female Genital
% 213.83/214.06  |- skos__scopeNote mesh__D014384
% 213.83/214.06       MYCOBACTERIUM infections of the female reproductive tract %28%GENITALIA, FEMALE%29%.%A%    
% 213.83/214.06  |- rdf__type mesh__D014384sskos__Concept
% 213.83/214.06  |- skos__annotation mesh__D014384
% 213.83/214.06       coordinate IM with specific organ %28%IM%29% or organ/disease %28%IM%29%%A%  
% 213.83/214.06  |- mesh__recordMaintainer mesh__D014384 lkt
% 213.83/214.06  |- mesh__dateRevised mesh__D014384 2005-06-30
% 213.83/214.06  |- mesh__recordAuthorizer mesh__D014384 sjn
% 213.83/214.06  |- skos__broader mesh__D014384smesh__D014401
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D014384 2006
% 213.83/214.06  |- skos__hiddenLabel mesh__D014384 Female Genital Tuberculoses
% 213.83/214.06  |- mesh__recordOriginator mesh__D014384 NLM
% 213.83/214.06  |- skos__hiddenLabel mesh__D014384 Female Genital Tuberculosis
% 213.83/214.06  |- skos__hiddenLabel mesh__D014384 Genital Tuberculosis, Female
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D008347 2003
% 213.83/214.06  |- mesh__recordOriginator mesh__D008347 NLM
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D008347 1995
% 213.83/214.06  |- mesh__historyNote mesh__D008347
% 213.83/214.06       91%28%75%29%; was see under PERSONALITY INVENTORY 1975-90   
% 213.83/214.06  |- skos__prefLabel mesh__D008347 Manifest Anxiety Scale
% 213.83/214.06  |- mesh__recordAuthorizer mesh__D008347 PLS
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D008347 1994
% 213.83/214.06  |- skos__hiddenLabel mesh__D008347 Manifest Anxiety Scales
% 213.83/214.06  |- skos__scopeNote mesh__D008347
% 213.83/214.06       True-false questionnaire made up of items believed to indicate anxiety, in which the subject answers verbally the statement that describes him.%A%    
% 213.83/214.06  |- mesh__dateCreated mesh__D008347 1999-01-01
% 213.83/214.06  |- skos__hiddenLabel mesh__D008347 Anxiety Scales, Manifest
% 213.83/214.06  |- mesh__onlineNote mesh__D008347 search PERSONALITY INVENTORY 1968-74   
% 213.83/214.06  |- skos__broader mesh__D008347smesh__D010555
% 213.83/214.06  |- mesh__dateRevised mesh__D008347 1992-05-14
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D008347 1999
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D008347 2006
% 213.83/214.06  |- mesh__publicMeSHNote mesh__D008347
% 213.83/214.06       91; was see under PERSONALITY INVENTORY 1975-90   
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D008347 2002
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D008347 1993
% 213.83/214.06  |- mesh__recordMaintainer mesh__D008347 TAP
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D008347 1998
% 213.83/214.06  |- skos__hiddenLabel mesh__D008347 Anxiety Scale, Manifest
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D008347 2005
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D008347 2001
% 213.83/214.06  |- rdf__type mesh__D008347sskos__Concept
% 213.83/214.06  |- skos__hiddenLabel mesh__D008347 Scale, Manifest Anxiety
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D008347 1997
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D008347 2004
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D008347 2000
% 213.83/214.06  |- mesh__dateEstablished mesh__D008347 1991-01-01
% 213.83/214.06  |- skos__hiddenLabel mesh__D008347 Scales, Manifest Anxiety
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D008347 1996
% 213.83/214.06  |- mesh__dateRevised mesh__D000364 2005-06-30
% 213.83/214.06  |- mesh__historyNote mesh__D000364
% 213.83/214.06       91%28%86%29%; was see under AGARICALES 1986-90   
% 213.83/214.06  |- mesh__recordMaintainer mesh__D000364 SYSTEM
% 213.83/214.06  |- skos__historyNote mesh__D000364 Agaricales %28%1966-1985%29%
% 213.83/214.06  |- mesh__dateCreated mesh__D000364 1985-02-08
% 213.83/214.06  |- rdf__type mesh__D000364sskos__Concept
% 213.83/214.06  |- skos__prefLabel mesh__D000364 Agaricus
% 213.83/214.06  |- skos__historyNote mesh__D000364 Basidiomycetes %28%1966-1985%29%
% 213.83/214.06  |- skos__annotation mesh__D000364 a basidiomycete   
% 213.83/214.06  |- skos__scopeNote mesh__D000364
% 213.83/214.06       A basidiomycetous fungal genus of the family Agaricaceae, order Agaricales, which includes the field mushroom %28%A. campestris%29% and the commercial mushroom %28%A. bisporus%29%.%A%    
% 213.83/214.06  |- mesh__recordAuthorizer mesh__D000364 sjn
% 213.83/214.06  |- mesh__dateEstablished mesh__D000364 1991-01-01
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D000364 2006
% 213.83/214.06  |- mesh__recordOriginator mesh__D000364 RC
% 213.83/214.06  |- mesh__publicMeSHNote mesh__D000364
% 213.83/214.06       91; was see under AGARICALES 1986-90   
% 213.83/214.06  |- skos__broader mesh__D000364smesh__D000363
% 213.83/214.06  |- skos__hiddenLabel mesh__D027501 Transporters, Erythrocyte Lactate
% 213.83/214.06  |- skos__altLabel mesh__D027501 Lactate Transporter
% 213.83/214.06  |- skos__hiddenLabel mesh__D027501 Transporter, Erythrocyte Lactate
% 213.83/214.06  |- mesh__publicMeSHNote mesh__D027501
% 213.83/214.06       2002; MONOCARBOXYLIC ACID TRANSPORT PROTEIN was indexed under CARRIER PROTEINS 1997-2001; ERYTHROCYTE LACTATE TRANSPORTER was indexed under CARRIER PROTEINS 1995-2001; LACTATE TRANSLOCASE %26% LACTATE TRANSPORTER were indexed under CARRIER PROTEINS 1991-2001; MONOCARBOXYLATE TRANSLOCATOR %26% MITOCHONDRIAL MONOCARBOXYLATE TRANSLOCATOR were indexed under CARRIER PROTEINS 1991-2001%A%  
% 213.83/214.06  |- mesh__historyNote mesh__D027501
% 213.83/214.06       2002; for MONOCARBOXYLIC ACID TRANSPORT PROTEIN use ANION TRANSPORT PROTEINS %28%NM%29% 1997-2001; for ERYTHROCYTE LACTATE TRANSPORTER use MONOCARBOXYLIC ACID TRANSPORTERS %28%NM%29% 1995-2001; for LACTATE TRANSLOCASE %26% LACTATE TRANSPORTER use MONOCARBOXYLIC ACID TRANSPORTERS %28%NM%29% 1991-2001; for MONOCARBOXYLATE TRANSLOCATOR %26% MITOCHONDRIAL MONOCARBOXYLATE TRANSLOCATOR use MONOCARBOXYLIC ACID TRANSPORTERS %28%NM%29% 1991-2001%A%  
% 213.83/214.06  |- skos__hiddenLabel mesh__D027501
% 213.83/214.06       Monocarboxylate Translocator, Mitochondrial
% 213.83/214.06  |- skos__prefLabel mesh__D027501 Monocarboxylic Acid Transporters
% 213.83/214.06  |- skos__hiddenLabel mesh__D027501 Transporter, Lactate
% 213.83/214.06  |- skos__altLabel mesh__D027501 MCT Proteins
% 213.83/214.06  |- skos__hiddenLabel mesh__D027501 Transport Protein, Lactate
% 213.83/214.06  |- skos__historyNote mesh__D027501 Carrier Proteins %28%1991-2001%29%
% 213.83/214.06  |- skos__altLabel mesh__D027501 Monocarboxylic Acid Transport Proteins
% 213.83/214.06  |- skos__broader mesh__D027501smesh__D027361
% 213.83/214.06  |- skos__scopeNote mesh__D027501
% 213.83/214.06       A family of proteins involved in the transport of monocarboxylic acids such as LACTIC ACID and PYRUVIC ACID across cellular membranes.%A%    
% 213.83/214.06  |- skos__hiddenLabel mesh__D027501 Transport Proteins, Lactate
% 213.83/214.06  |- skos__hiddenLabel mesh__D027501 Acid Transporters, Monocarboxylic
% 213.83/214.06  |- skos__altLabel mesh__D027501 Monocarboxylic Acid Transport Protein
% 213.83/214.06  |- skos__altLabel mesh__D027501 Lactate Transport Protein
% 213.83/214.06  |- skos__hiddenLabel mesh__D027501 Lactate Transporter, Erythrocyte
% 213.83/214.06  |- mesh__dateCreated mesh__D027501 2001-07-25
% 213.83/214.06  |- skos__altLabel mesh__D027501 Erythrocyte Lactate Transporter
% 213.83/214.06  |- skos__hiddenLabel mesh__D027501
% 213.83/214.06       Translocator, Mitochondrial Monocarboxylate
% 213.83/214.06  |- mesh__recordMaintainer mesh__D027501 SYSTEM
% 213.83/214.06  |- skos__hiddenLabel mesh__D027501 Translocase, Lactate
% 213.83/214.06  |- skos__hiddenLabel mesh__D027501 Lactate Transporters, Erythrocyte
% 213.83/214.06  |- mesh__dateRevised mesh__D027501 2005-06-30
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D027501 2006
% 213.83/214.06  |- skos__altLabel mesh__D027501 Monocarboxylate Translocator
% 213.83/214.06  |- mesh__dateEstablished mesh__D027501 2002-01-01
% 213.83/214.06  |- skos__historyNote mesh__D027501 Ion Pumps %28%1994-2001%29%
% 213.83/214.06  |- skos__hiddenLabel mesh__D027501 Transporters, Monocarboxylic Acid
% 213.83/214.06  |- mesh__recordAuthorizer mesh__D027501 sjn
% 213.83/214.06  |- skos__hiddenLabel mesh__D027501 Translocator, Monocarboxylate
% 213.83/214.06  |- mesh__recordOriginator mesh__D027501 jmp
% 213.83/214.06  |- skos__altLabel mesh__D027501 Lactate Translocase
% 213.83/214.06  |- rdf__type mesh__D027501sskos__Concept
% 213.83/214.06  |- skos__prefLabel mesh__D018775 Bone Demineralization Technique
% 213.83/214.06  |- mesh__dateEstablished mesh__D018775 1995-01-01
% 213.83/214.06  |- skos__hiddenLabel mesh__D018775 Demineralization Techniques, Bone
% 213.83/214.06  |- skos__altLabel mesh__D018775 Bone Demineralization Technic
% 213.83/214.06  |- skos__hiddenLabel mesh__D018775 Bone Demineralization Techniques
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D018775 2006
% 213.83/214.06  |- mesh__dateCreated mesh__D018775 1994-05-31
% 213.83/214.06  |- mesh__recordOriginator mesh__D018775 TGC
% 213.83/214.06  |- skos__broader mesh__D018775smesh__D006652
% 213.83/214.06  |- skos__hiddenLabel mesh__D018775 Bone Demineralization Technics
% 213.83/214.06  |- skos__hiddenLabel mesh__D018775 Technic, Bone Demineralization
% 213.83/214.06  |- skos__hiddenLabel mesh__D018775 Demineralization Technique, Bone
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D018775 2005
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D018775 2004
% 213.83/214.06  |- skos__annotation mesh__D018775
% 213.83/214.06       a histol technique; do not confuse with BONE DEMINERALIZATION, PATHOLOGIC, a metab bone dis%A%  
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D018775 2002
% 213.83/214.06  |- mesh__publicMeSHNote mesh__D018775 95   
% 213.83/214.06  |- mesh__recordAuthorizer mesh__D018775 sjn
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D018775 2003
% 213.83/214.06  |- mesh__dateRevised mesh__D018775 2000-06-22
% 213.83/214.06  |- rdf__type mesh__D018775sskos__Concept
% 213.83/214.06  |- skos__hiddenLabel mesh__D018775 Technique, Bone Demineralization
% 213.83/214.06  |- skos__hiddenLabel mesh__D018775 Demineralization Technics, Bone
% 213.83/214.06  |- mesh__historyNote mesh__D018775 95   
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D018775 2001
% 213.83/214.06  |- skos__hiddenLabel mesh__D018775 Demineralization Technic, Bone
% 213.83/214.06  |- skos__scopeNote mesh__D018775
% 213.83/214.06       Removal of mineral constituents or salts from bone or bone tissue. Demineralization is used as a method of studying bone strength and bone chemistry.%A%    
% 213.83/214.06  |- skos__hiddenLabel mesh__D018775 Techniques, Bone Demineralization
% 213.83/214.06  |- skos__hiddenLabel mesh__D018775 Technics, Bone Demineralization
% 213.83/214.06  |- mesh__recordMaintainer mesh__D018775 PXP
% 213.83/214.06  |- skos__scopeNote mesh__D010792
% 213.83/214.06       The study of the conformation of the skull as indicative of mental faculties and traits of character, especially according to the hypothesis of F. J. Gall %28%1758-1828%29%. %28%Webster 3d ed%29%%A%    
% 213.83/214.06  |- skos__prefLabel mesh__D010792 Phrenology
% 213.83/214.06  |- mesh__recordMaintainer mesh__D010792 jls
% 213.83/214.06  |- mesh__recordOriginator mesh__D010792 NLM
% 213.83/214.06  |- rdf__type mesh__D010792sskos__Concept
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D010792 2005
% 213.83/214.06  |- skos__annotation mesh__D010792 DF: PHRENOL   
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D010792 2006
% 213.83/214.06  |- skos__broader mesh__D010792smesh__D006664
% 213.83/214.06  |- mesh__recordAuthorizer mesh__D010792 sjn
% 213.83/214.06  |- mesh__dateCreated mesh__D010792 1999-01-01
% 213.83/214.06  |- mesh__dateRevised mesh__D010792 2004-07-07
% 213.83/214.06  |- skos__broader mesh__D032446smesh__D002477
% 213.83/214.06  |- skos__hiddenLabel mesh__D032446 Precursor Muscle Cells
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D032446 2004
% 213.83/214.06  |- mesh__historyNote mesh__D032446 2003   
% 213.83/214.06  |- rdf__type mesh__D032446sskos__Concept
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D032446 2005
% 213.83/214.06  |- mesh__publicMeSHNote mesh__D032446 2003   
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D032446 2003
% 213.83/214.06  |- mesh__dateCreated mesh__D032446 2002-07-03
% 213.83/214.06  |- skos__related mesh__D032446smesh__D032342
% 213.83/214.06  |- skos__hiddenLabel mesh__D032446 Myoblast
% 213.83/214.06  |- skos__hiddenLabel mesh__D032446 Embryonic Muscle Cells
% 213.83/214.06  |- skos__altLabel mesh__D032446 Muscle Cells, Embryonic
% 213.83/214.06  |- skos__scopeNote mesh__D032446
% 213.83/214.06       Embryonic %28%precursor%29% cells of the myogenic lineage that develop from the MESODERM. They undergo proliferation, migrate to their various sites, and then differentiate into the appropriate form of myocytes %28%MYOCYTES, SKELETAL; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE%29%.%A%    
% 213.83/214.06  |- skos__historyNote mesh__D032446 Muscle, Skeletal %28%1972-2002%29%
% 213.83/214.06  |- skos__historyNote mesh__D032446 Muscles %28%1966-2002%29%
% 213.83/214.06  |- skos__annotation mesh__D032446 prefer specifics   
% 213.83/214.06  |- skos__hiddenLabel mesh__D032446 Precursor Muscle Cell
% 213.83/214.06  |- skos__broader mesh__D032446smesh__D013234
% 213.83/214.06  |- skos__hiddenLabel mesh__D032446 Embryonic Muscle Cell
% 213.83/214.06  |- mesh__dateEstablished mesh__D032446 2003-01-01
% 213.83/214.06  |- skos__hiddenLabel mesh__D032446 Muscle Cell, Precursor
% 213.83/214.06  |- skos__hiddenLabel mesh__D032446 Muscle Cell, Embryonic
% 213.83/214.06  |- skos__altLabel mesh__D032446 Muscle Cells, Precursor
% 213.83/214.06  |- skos__prefLabel mesh__D032446 Myoblasts
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D032446 2006
% 213.83/214.06  |- rdf__type mesh__D004755sskos__Concept
% 213.83/214.06  |- mesh__recordMaintainer mesh__D004755 SYSTEM
% 213.83/214.06  |- skos__broader mesh__D004755smesh__D006092
% 213.83/214.06  |- mesh__dateRevised mesh__D004755 2005-06-30
% 213.83/214.06  |- skos__scopeNote mesh__D004755
% 213.83/214.06       A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock.%A%    
% 213.83/214.06  |- mesh__recordOriginator mesh__D004755 NLM
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D004755 2006
% 213.83/214.06  |- skos__altLabel mesh__D004755 Enterobacteria
% 213.83/214.06  |- skos__prefLabel mesh__D004755 Enterobacteriaceae
% 213.83/214.06  |- mesh__dateCreated mesh__D004755 1999-01-01
% 213.83/214.06  |- skos__altLabel mesh__D004755 Enteric Bacteria
% 213.83/214.06  |- skos__altLabel mesh__D004755 Coliform Bacilli
% 213.83/214.06  |- mesh__recordAuthorizer mesh__D004755 sjn
% 213.83/214.06  |- skos__annotation mesh__D004755
% 213.83/214.06       infection = ENTEROBACTERIACEAE INFECTIONS   
% 213.83/214.06  |- skos__broader mesh__D004755smesh__D020563
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D009440 2004
% 213.83/214.06  |- rdf__type mesh__D009440sskos__Concept
% 213.83/214.06  |- skos__related mesh__D009440smesh__D015673
% 213.83/214.06  |- mesh__recordMaintainer mesh__D009440 JLS
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D009440 2001
% 213.83/214.06  |- skos__annotation mesh__D009440
% 213.83/214.06       remember also NEUROCIRCULATORY ASTHENIA exists   
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D009440 2003
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D009440 2000
% 213.83/214.06  |- skos__broader mesh__D009440smesh__D013001
% 213.83/214.06  |- skos__altLabel mesh__D009440 Neuroses, Neurasthenic
% 213.83/214.06  |- mesh__recordAuthorizer mesh__D009440 SJN
% 213.83/214.06  |- skos__scopeNote mesh__D009440
% 213.83/214.06       A mental disorder characterized by chronic fatigue and concomitant physiologic symptoms.%A%    
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D009440 2006
% 213.83/214.06  |- skos__prefLabel mesh__D009440 Neurasthenia
% 213.83/214.06  |- mesh__dateCreated mesh__D009440 1999-01-01
% 213.83/214.06  |- mesh__recordOriginator mesh__D009440 NLM
% 213.83/214.06  |- skos__altLabel mesh__D009440 Neurasthenic Neuroses
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D009440 1999
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D009440 2005
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D009440 2002
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D009440 1998
% 213.83/214.06  |- mesh__dateRevised mesh__D009440 1997-06-20
% 213.83/214.06  |- mesh__dateRevised mesh__D014385 2003-07-09
% 213.83/214.06  |- skos__altLabel mesh__D014385 Gastrointestinal Tuberculosis
% 213.83/214.06  |- rdf__type mesh__D014385sskos__Concept
% 213.83/214.06  |- skos__broader mesh__D014385smesh__D014376
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D014385 2005
% 213.83/214.06  |- skos__scopeNote mesh__D014385
% 213.83/214.06       TUBERCULOSIS that involves any region of the GASTROINTESTINAL TRACT, mostly in the distal ILEUM and the CECUM. In most cases, MYCOBACTERIUM TUBERCULOSIS is the pathogen. Clinical features include ABDOMINAL PAIN; FEVER; and palpable mass in the ileocecal area.%A%    
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D014385 2006
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D014385 2004
% 213.83/214.06  |- mesh__recordMaintainer mesh__D014385 lkt
% 213.83/214.06  |- skos__annotation mesh__D014385
% 213.83/214.06       coord IM with specific organ or organ /dis %28%IM%29%   
% 213.83/214.06  |- skos__prefLabel mesh__D014385 Tuberculosis, Gastrointestinal
% 213.83/214.06  |- mesh__recordAuthorizer mesh__D014385 sjn
% 213.83/214.06  |- mesh__dateCreated mesh__D014385 1999-01-01
% 213.83/214.06  |- skos__broader mesh__D014385smesh__D005767
% 213.83/214.06  |- mesh__recordOriginator mesh__D014385 NLM
% 213.83/214.06  |- skos__hiddenLabel mesh__D008348 Manikin
% 213.83/214.06  |- skos__prefLabel mesh__D008348 Manikins
% 213.83/214.06  |- mesh__dateCreated mesh__D008348 1999-01-01
% 213.83/214.06  |- skos__annotation mesh__D008348 no qualif   
% 213.83/214.06  |- mesh__onlineNote mesh__D008348 search MODELS, STRUCTURAL 1971-74   
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D008348 2006
% 213.83/214.06  |- mesh__recordOriginator mesh__D008348 NLM
% 213.83/214.06  |- mesh__recordAuthorizer mesh__D008348 sjn
% 213.83/214.06  |- mesh__recordMaintainer mesh__D008348 ags
% 213.83/214.06  |- mesh__publicMeSHNote mesh__D008348
% 213.83/214.06       91; was see under MODELS, ANATOMIC 1984-90; was see under MODELS, STRUCTURAL 1971-83%A%  
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D008348 2005
% 213.83/214.06  |- mesh__dateRevised mesh__D008348 2004-07-07
% 213.83/214.06  |- skos__hiddenLabel mesh__D008348 Mannequin
% 213.83/214.06  |- rdf__type mesh__D008348sskos__Concept
% 213.83/214.06  |- skos__altLabel mesh__D008348 Mannequins
% 213.83/214.06  |- skos__broader mesh__D008348smesh__D008953
% 213.83/214.06  |- mesh__historyNote mesh__D008348
% 213.83/214.06       91%28%75%29%; was see under MODELS, ANATOMIC 1984-90; was see under MODELS, STRUCTURAL 1971-83%A%  
% 213.83/214.06  |- mesh__dateEstablished mesh__D008348 1991-01-01
% 213.83/214.06  |- mesh__dateRevised mesh__D000365 1997-06-20
% 213.83/214.06  |- skos__hiddenLabel mesh__D000365 Bone Age Measurements
% 213.83/214.06  |- skos__hiddenLabel mesh__D000365 Measurements, Skeletal Age
% 213.83/214.06  |- mesh__recordOriginator mesh__D000365 NLM
% 213.83/214.06  |- rdf__type mesh__D000365sskos__Concept
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D000365 2000
% 213.83/214.06  |- skos__hiddenLabel mesh__D000365 Age Measurements, Bone
% 213.83/214.06  |- skos__hiddenLabel mesh__D000365 Age Measurements, Skeletal
% 213.83/214.06  |- skos__altLabel mesh__D000365 Bone Age Measurement
% 213.83/214.06  |- mesh__onlineNote mesh__D000365
% 213.83/214.06       use AGE DETERMINATION BY SKELETON to search SKELETAL AGE MEASUREMENT 1966%A%  
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D000365 2003
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D000365 2001
% 213.83/214.06  |- mesh__dateCreated mesh__D000365 1999-01-01
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D000365 2004
% 213.83/214.06  |- skos__hiddenLabel mesh__D000365 Measurements, Bone Age
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D000365 2002
% 213.83/214.06  |- mesh__recordMaintainer mesh__D000365 PXP
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D000365 1998
% 213.83/214.06  |- mesh__publicMeSHNote mesh__D000365
% 213.83/214.06       67; was SKELETAL AGE MEASUREMENT 1965-66   
% 213.83/214.06  |- mesh__historyNote mesh__D000365
% 213.83/214.06       67; was SKELETAL AGE MEASUREMENT 1965-66   
% 213.83/214.06  |- skos__hiddenLabel mesh__D000365 Age Measurement, Skeletal
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D000365 2005
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D000365 1999
% 213.83/214.06  |- skos__hiddenLabel mesh__D000365 Measurement, Skeletal Age
% 213.83/214.06  |- skos__broader mesh__D000365smesh__D011859
% 213.83/214.06  |- skos__hiddenLabel mesh__D000365 Age Measurement, Bone
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D000365 2006
% 213.83/214.06  |- skos__altLabel mesh__D000365 Skeletal Age Measurement
% 213.83/214.06  |- mesh__dateEstablished mesh__D000365 1967-01-01
% 213.83/214.06  |- skos__hiddenLabel mesh__D000365 Measurement, Bone Age
% 213.83/214.06  |- skos__prefLabel mesh__D000365 Age Determination by Skeleton
% 213.83/214.06  |- skos__hiddenLabel mesh__D000365 Skeletal Age Measurements
% 213.83/214.06  |- mesh__recordAuthorizer mesh__D000365 SJN
% 213.83/214.06  |- skos__hiddenLabel mesh__D019070 Cell Lineages
% 213.83/214.06  |- mesh__dateRevised mesh__D019070 2004-07-07
% 213.83/214.06  |- mesh__dateEstablished mesh__D019070 1996-01-01
% 213.83/214.06  |- mesh__recordOriginator mesh__D019070 PXP
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D019070 2005
% 213.83/214.06  |- rdf__type mesh__D019070sskos__Concept
% 213.83/214.06  |- skos__scopeNote mesh__D019070
% 213.83/214.06       The developmental history of specific differentiated cell types as traced back to the original STEM CELLS in the EMBRYO.%A%    
% 213.83/214.06  |- skos__broader mesh__D019070smesh__D047108
% 213.83/214.06  |- mesh__publicMeSHNote mesh__D019070 96   
% 213.83/214.06  |- mesh__activeMeSHYear mesh__D019070 2006
% 213.83/214.06  |- skos__hiddenLabel mesh__D019070 Lineages, Cell
% 213.83/214.06  |- skos__annotation mesh__D019070
% 213.83/214.06       do not confuse with CELL LINE which is derived from cultured cells%A%  
% 213.83/214.06  |- skos__hiddenLabel mesh__D019070 Lineage, Cell
% 213.83/214.06  |- skos__historyNote mesh__D019070 Cell Differentiation %28%1969-1995%29%
% 213.83/214.06  |- skos__prefLabel mesh__D019070 Cell Lineage
% 213.83/214.06  |- skos__broader mesh__D019070smesh__D002468
% 213.83/214.06  |- mesh__historyNote mesh__D019070 96   
% 213.83/214.06  |- mesh__recordAuthorizer mesh__D019070 sjn
% 213.83/214.06  |- mesh__dateCreated mesh__D019070 1995-05-24
% 213.83/214.06  |- mesh__recordMaintainer mesh__D019070 lkt
% 213.83/214.06  |- skos__related mesh__D019070smesh__D002454
% 213.83/214.06  |- skos__hiddenLabel mesh__D005050 Ro 109359
% 213.83/214.06  |- mesh__dateCreated mesh__D005050 1979-05-25
% 213.83/214.06  |- mesh__recordMaintainer mesh__D005050 ssb
% 213.83/214.07  |- rdf__type mesh__D005050sskos__Concept
% 213.83/214.07  |- skos__hiddenLabel mesh__D005050 Etrinoate, Ethyl
% 213.83/214.07  |- skos__altLabel mesh__D005050 Tigazon
% 213.83/214.07  |- skos__scopeNote mesh__D005050
% 213.83/214.07       An oral retinoid used in the treatment of keratotic genodermatosis, lichen planus, and psoriasis. Beneficial effects have also been claimed in the prophylaxis of epithelial neoplasia. The compound may be teratogenic.%A%    
% 213.83/214.07  |- skos__hiddenLabel mesh__D005050 Ro109359
% 213.83/214.07  |- skos__altLabel mesh__D005050 Ro-10-9359
% 213.83/214.07  |- mesh__recordAuthorizer mesh__D005050 sjn
% 213.83/214.07  |- mesh__publicMeSHNote mesh__D005050
% 213.83/214.07       84%28%80%29%; was RO 10-9359 see under TRETINOIN 1980-83   
% 213.83/214.07  |- skos__altLabel mesh__D005050 Ethyl Etrinoate
% 213.83/214.07  |- skos__hiddenLabel mesh__D005050 B109359
% 213.83/214.07  |- skos__historyNote mesh__D005050
% 213.83/214.07       Tretinoin/analogs %26% derivatives %28%1975-1979%29%
% 213.83/214.07  |- skos__broader mesh__D005050smesh__D012176
% 213.83/214.07  |- mesh__recordOriginator mesh__D005050 RLS
% 213.83/214.07  |- mesh__dateRevised mesh__D005050 2005-06-30
% 213.83/214.07  |- mesh__dateEstablished mesh__D005050 1984-01-01
% 213.83/214.07  |- mesh__activeMeSHYear mesh__D005050 2006
% 213.83/214.07  |- mesh__historyNote mesh__D005050
% 213.83/214.07       84%28%80%29%; was RO 10-9359 see under TRETINOIN 1980-83   
% 213.83/214.07  |- skos__hiddenLabel mesh__D005050 Ro 10 9359
% 213.83/214.07  |- skos__historyNote mesh__D005050 Vitamin A %28%1966-1974%29%
% 213.83/214.07  |- skos__prefLabel mesh__D005050 Etretinate
% 213.83/214.07  |- mesh__onlineNote mesh__D005050
% 213.83/214.07       use ETRETINATE to search RO 10-9359 1980-83   
% 213.83/214.07  |- skos__hiddenLabel mesh__D005050 B10 9359
% 213.83/214.07  |- skos__altLabel mesh__D018776 Genes, THRA
% 213.83/214.07  |- skos__broader mesh__D018776smesh__D011519
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 beta Gene, TR
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 c erbA Proto Oncogenes
% 213.83/214.07  |- mesh__recordOriginator mesh__D018776 AGS
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 v erbA Genes
% 213.83/214.07  |- skos__altLabel mesh__D018776 Genes, TR-alpha
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 erbA alpha Gene
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 erbA-alpha Gene
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 TR-beta Genes
% 213.83/214.07  |- skos__prefLabel mesh__D018776 Genes, erbA
% 213.83/214.07  |- mesh__dateCreated mesh__D018776 1994-05-23
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 alpha Genes, erbA
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 c-erbA Gene
% 213.83/214.07  |- skos__altLabel mesh__D018776 Genes, erbA beta
% 213.83/214.07  |- skos__historyNote mesh__D018776 Proto-Oncogenes %28%1987-1994%29%
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 erbA-alpha Genes
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 c-erbA Proto-Oncogene
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 erbA beta Gene
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 alpha Genes, TR
% 213.83/214.07  |- mesh__publicMeSHNote mesh__D018776 95   
% 213.83/214.07  |- skos__altLabel mesh__D018776 v-erbA Oncogenes
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 erbA Gene
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 TR-beta Gene
% 213.83/214.07  |- skos__annotation mesh__D018776
% 213.83/214.07       erbA stands for %22%ERythroBlastosis virus, Avian%22%; GENES, ERBB %26% its specifics are also available; in titles %26% translations spell as erbA%A%  
% 213.83/214.07  |- mesh__historyNote mesh__D018776 95   
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 alpha Gene, erbA
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 v-erbA Oncogene
% 213.83/214.07  |- skos__altLabel mesh__D018776 Genes, TR beta
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 TR-alpha Gene
% 213.83/214.07  |- skos__altLabel mesh__D018776 c-erbA Proto-Oncogenes
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 TR-alpha Genes
% 213.83/214.07  |- skos__scopeNote mesh__D018776
% 213.83/214.07       Genes related to the erbA DNA sequence that was first isolated from the avian erythroblastosis virus %28%ERYTHROBLASTOSIS VIRUS, AVIAN%29%, v-erbA. In cells, erbA genes encode thyroid hormone receptors %28%RECEPTORS, THYROID HORMONE%29%. Two distinct c-erbA genes have been identified: erbA-alpha located at 17q21; and erbA-beta located at 3p24. Truncations at the N- and C-terminals of erbA result in products resembling v-erbA. Truncations affect hormone responsiveness but not DNA binding capacity.%A%    
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 TR beta Genes
% 213.83/214.07  |- mesh__recordAuthorizer mesh__D018776 sjn
% 213.83/214.07  |- skos__altLabel mesh__D018776 erbA Genes
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 Gene, THRB
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 TR alpha Genes
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 v erbA Oncogenes
% 213.83/214.07  |- mesh__activeMeSHYear mesh__D018776 2006
% 213.83/214.07  |- mesh__recordMaintainer mesh__D018776 nns
% 213.83/214.07  |- skos__altLabel mesh__D018776 Genes, TR alpha
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 THRA Genes
% 213.83/214.07  |- skos__altLabel mesh__D018776 Genes, THRB
% 213.83/214.07  |- skos__historyNote mesh__D018776 Oncogenes %28%1984-1994%29%
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 THRB Genes
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 beta Genes, TR
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 alpha Gene, TR
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 erbA-beta Genes
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 beta Genes, erbA
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 TR beta Gene
% 213.83/214.07  |- skos__altLabel mesh__D018776 Genes, erbA alpha
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 erbA alpha Genes
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 TR alpha Gene
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 THRA Gene
% 213.83/214.07  |- skos__altLabel mesh__D018776 Genes, TR-beta
% 213.83/214.07  |- skos__related mesh__D018776smesh__D018774
% 213.83/214.07  |- mesh__dateEstablished mesh__D018776 1995-01-01
% 213.83/214.07  |- mesh__dateRevised mesh__D018776 2005-06-30
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 c erbA Genes
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 beta Gene, erbA
% 213.83/214.07  |- skos__related mesh__D018776smesh__D011988
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 THRB Gene
% 213.83/214.07  |- rdf__type mesh__D018776sskos__Concept
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 erbA-beta Gene
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 v-erbA Gene
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 erbA beta Genes
% 213.83/214.07  |- skos__hiddenLabel mesh__D018776 Gene, THRA
% 213.83/214.07  |- mesh__activeMeSHYear mesh__D010793 2001
% 213.83/214.07  |- mesh__activeMeSHYear mesh__D010793 1996
% 213.83/214.07  |- mesh__onlineNote mesh__D010793 search HETEROCYCLIC COMPOUNDS 1966-74   
% 213.83/214.07  |- mesh__publicMeSHNote mesh__D010793
% 213.83/214.07       91; was see under PYRIDAZINES 1975-90; was see under HETEROCYCLIC COMPOUNDS 1966-74%A%  
% 213.83/214.07  |- skos__broader mesh__D010793smesh__D011724
% 213.83/214.07  |- mesh__activeMeSHYear mesh__D010793 1997
% 213.83/214.07  |- mesh__activeMeSHYear mesh__D010793 1994
% 213.83/214.07  |- mesh__recordMaintainer mesh__D010793 TAP
% 213.83/214.07  |- rdf__type mesh__D010793sskos__Concept
% 213.83/214.07  |- mesh__recordAuthorizer mesh__D010793 PLS
% 213.83/214.07  |- mesh__activeMeSHYear mesh__D010793 2005
% 213.83/214.07  |- mesh__historyNote mesh__D010793
% 213.83/214.07       91%28%75%29%; was see under PYRIDAZINES 1975-90; was see under HETEROCYCLIC COMPOUNDS 1966-74%A%  
% 213.83/214.07  |- mesh__dateEstablished mesh__D010793 1991-01-01
% 213.83/214.07  |- mesh__activeMeSHYear mesh__D010793 1995
% 213.83/214.07  |- mesh__activeMeSHYear mesh__D010793 2002
% 213.83/214.07  |- mesh__activeMeSHYear mesh__D010793 2006
% 213.83/214.07  |- mesh__recordOriginator mesh__D010793 NLM
% 213.83/214.07  |- mesh__activeMeSHYear mesh__D010793 1998
% 213.83/214.07  |- mesh__dateCreated mesh__D010793 1999-01-01
% 213.83/214.07  |- mesh__dateRevised mesh__D010793 1992-05-19
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D010793 1999
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D010793 2003
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D010793 1993
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D010793 2000
% 213.93/214.07  |- skos__prefLabel mesh__D010793 Phthalazines
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D010793 2004
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D032447 2003
% 213.93/214.07  |- mesh__historyNote mesh__D032447 2003   
% 213.93/214.07  |- mesh__dateCreated mesh__D032447 2002-07-03
% 213.93/214.07  |- skos__prefLabel mesh__D032447 Wisteria
% 213.93/214.07  |- skos__broader mesh__D032447smesh__D007887
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D032447 2006
% 213.93/214.07  |- skos__scopeNote mesh__D032447
% 213.93/214.07       A plant genus of the family FABACEAE. Members contain wistarin.%A%    
% 213.93/214.07  |- skos__annotation mesh__D032447
% 213.93/214.07       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.93/214.07  |- mesh__dateEstablished mesh__D032447 2003-01-01
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D032447 2004
% 213.93/214.07  |- rdf__type mesh__D032447sskos__Concept
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D032447 2005
% 213.93/214.07  |- mesh__publicMeSHNote mesh__D032447 2003   
% 213.93/214.07  |- mesh__historyNote mesh__D004756 68   
% 213.93/214.07  |- skos__hiddenLabel mesh__D004756 Infection, Enterobacteriaceae
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D004756 1999
% 213.93/214.07  |- skos__hiddenLabel mesh__D004756 Enterobacterial Infection
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D004756 2001
% 213.93/214.07  |- mesh__dateEstablished mesh__D004756 1968-01-01
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D004756 2004
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D004756 1998
% 213.93/214.07  |- mesh__recordOriginator mesh__D004756 NLM
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D004756 2000
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D004756 2003
% 213.93/214.07  |- skos__altLabel mesh__D004756 Infections, Enterobacteriaceae
% 213.93/214.07  |- mesh__recordAuthorizer mesh__D004756 SJN
% 213.93/214.07  |- mesh__dateCreated mesh__D004756 1999-01-01
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D004756 2006
% 213.93/214.07  |- skos__scopeNote mesh__D004756
% 213.93/214.07       Infections with bacteria of the family ENTEROBACTERIACEAE.%A%    
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D004756 2002
% 213.93/214.07  |- skos__broader mesh__D004756smesh__D016905
% 213.93/214.07  |- skos__historyNote mesh__D004756 Enterobacteriaceae %28%1966-1967%29%
% 213.93/214.07  |- mesh__recordMaintainer mesh__D004756 TGC
% 213.93/214.07  |- skos__altLabel mesh__D004756 Enterobacterial Infections
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D004756 2005
% 213.93/214.07  |- mesh__dateRevised mesh__D004756 1997-06-20
% 213.93/214.07  |- skos__prefLabel mesh__D004756 Enterobacteriaceae Infections
% 213.93/214.07  |- skos__annotation mesh__D004756 gram-neg bact infect   
% 213.93/214.07  |- rdf__type mesh__D004756sskos__Concept
% 213.93/214.07  |- skos__hiddenLabel mesh__D004756 Enterobacteriaceae Infection
% 213.93/214.07  |- skos__hiddenLabel mesh__D004756 Infection, Enterobacterial
% 213.93/214.07  |- mesh__publicMeSHNote mesh__D004756 68   
% 213.93/214.07  |- skos__altLabel mesh__D004756 Infections, Enterobacterial
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D009441 2003
% 213.93/214.07  |- mesh__publicMeSHNote mesh__D009441 65   
% 213.93/214.07  |- skos__altLabel mesh__D009441 Neurolemma
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D009441 2006
% 213.93/214.07  |- mesh__dateCreated mesh__D009441 1999-01-01
% 213.93/214.07  |- mesh__historyNote mesh__D009441 65   
% 213.93/214.07  |- mesh__recordMaintainer mesh__D009441 lkt
% 213.93/214.07  |- skos__scopeNote mesh__D009441
% 213.93/214.07       The nerve husk. The outermost part of the MYELIN SHEATH covering a myelinated nerve fiber %28%NERVE FIBERS, MYELINATED%29% or a bundle of unmyelinated nerve fibers %28%NERVE FIBERS, UNMYELINATED%29%.%A%    
% 213.93/214.07  |- skos__prefLabel mesh__D009441 Neurilemma
% 213.93/214.07  |- skos__broader mesh__D009441smesh__D009417
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D009441 2005
% 213.93/214.07  |- mesh__dateEstablished mesh__D009441 1965-01-01
% 213.93/214.07  |- skos__broader mesh__D009441smesh__D009186
% 213.93/214.07  |- mesh__recordAuthorizer mesh__D009441 sjn
% 213.93/214.07  |- mesh__recordOriginator mesh__D009441 NLM
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D009441 2004
% 213.93/214.07  |- rdf__type mesh__D009441sskos__Concept
% 213.93/214.07  |- mesh__dateRevised mesh__D009441 2002-07-03
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D014386 2006
% 213.93/214.07  |- skos__hiddenLabel mesh__D014386 Hepatic Tuberculoses
% 213.93/214.07  |- skos__broader mesh__D014386smesh__D008107
% 213.93/214.07  |- mesh__recordAuthorizer mesh__D014386 sjn
% 213.93/214.07  |- mesh__dateRevised mesh__D014386 2004-07-07
% 213.93/214.07  |- skos__prefLabel mesh__D014386 Tuberculosis, Hepatic
% 213.93/214.07  |- mesh__recordOriginator mesh__D014386 NLM
% 213.93/214.07  |- skos__scopeNote mesh__D014386
% 213.93/214.07       Infection of the LIVER with species of MYCOBACTERIUM, most often MYCOBACTERIUM TUBERCULOSIS. It is characterized by localized small tuberculous miliary lesions or tumor-like mass %28%TUBERCULOMA%29%, and abnormalities in liver function tests.%A%    
% 213.93/214.07  |- mesh__dateCreated mesh__D014386 1999-01-01
% 213.93/214.07  |- skos__hiddenLabel mesh__D014386 Tuberculoses, Hepatic
% 213.93/214.07  |- rdf__type mesh__D014386sskos__Concept
% 213.93/214.07  |- skos__broader mesh__D014386smesh__D014376
% 213.93/214.07  |- mesh__recordMaintainer mesh__D014386 lkt
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D014386 2005
% 213.93/214.07  |- skos__hiddenLabel mesh__D014386 Hepatic Tuberculosis
% 213.93/214.07  |- skos__prefLabel mesh__D008349 Manipulation, Orthopedic
% 213.93/214.07  |- skos__scopeNote mesh__D008349
% 213.93/214.07       The planned and carefully managed manual movement of the musculoskeletal system, extremities, and spine to produce increased motion. The term is sometimes used to denote a precise sequence of movements of a joint to determine the presence of disease or to reduce a dislocation. In the case of fractures, orthopedic manipulation can produce better position and alignment of the fracture. %28%From Blauvelt %26% Nelson, A Manual of Orthopaedic Terminology, 5th ed, p264%29%%A%    
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D008349 2006
% 213.93/214.07  |- mesh__dateRevised mesh__D008349 2005-06-30
% 213.93/214.07  |- skos__related mesh__D008349smesh__D002684
% 213.93/214.07  |- rdf__type mesh__D008349sskos__Concept
% 213.93/214.07  |- skos__altLabel mesh__D008349 Orthopedic Manipulation
% 213.93/214.07  |- mesh__recordAuthorizer mesh__D008349 sjn
% 213.93/214.07  |- mesh__recordOriginator mesh__D008349 NLM
% 213.93/214.07  |- mesh__dateCreated mesh__D008349 1999-01-01
% 213.93/214.07  |- skos__broader mesh__D008349smesh__D026201
% 213.93/214.07  |- mesh__recordMaintainer mesh__D008349 lkt
% 213.93/214.07  |- mesh__publicMeSHNote mesh__D000366 67   
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D000366 2003
% 213.93/214.07  |- skos__prefLabel mesh__D000366 Age Determination by Teeth
% 213.93/214.07  |- mesh__recordAuthorizer mesh__D000366 SJN
% 213.93/214.07  |- mesh__dateCreated mesh__D000366 1999-01-01
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D000366 2004
% 213.93/214.07  |- mesh__dateRevised mesh__D000366 1997-06-20
% 213.93/214.07  |- mesh__recordOriginator mesh__D000366 NLM
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D000366 1998
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D000366 2000
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D000366 2005
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D000366 1999
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D000366 2001
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D000366 2006
% 213.93/214.07  |- mesh__dateEstablished mesh__D000366 1967-01-01
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D000366 2002
% 213.93/214.07  |- mesh__recordMaintainer mesh__D000366 PXP
% 213.93/214.07  |- skos__broader mesh__D000366smesh__D011861
% 213.93/214.07  |- rdf__type mesh__D000366sskos__Concept
% 213.93/214.07  |- mesh__historyNote mesh__D000366 67%28%64%29%   
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D019071 2003
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D019071 2001
% 213.93/214.07  |- skos__annotation mesh__D019071 the ancient empire: note X ref   
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D019071 2004
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D019071 2002
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D019071 1998
% 213.93/214.07  |- skos__prefLabel mesh__D019071 Persia
% 213.93/214.07  |- mesh__dateEstablished mesh__D019071 1996-01-01
% 213.93/214.07  |- mesh__historyNote mesh__D019071 96   
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D019071 1999
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D019071 1996
% 213.93/214.07  |- skos__scopeNote mesh__D019071
% 213.93/214.07       An ancient civilization, known as early as 2000 B.C. The Persian Empire was founded by Cyrus the Great %28%550-529 B.C.%29% and for 200 years, from 550 to 331 B.C., the Persians ruled the ancient world from India to Egypt. The territory west of India was called Persis by the Greeks who later called the entire empire Persia. In 331 B.C. the Persian wars against the Greeks ended disastrously under the counterattacks by Alexander the Great. The name Persia in modern times for the modern country was changed to Iran in 1935. %28%From Webster%27%s New Geographical Dictionary, 1988, p546 %26% Asimov, Words on the Map, 1962, p176%29%%A%    
% 213.93/214.07  |- mesh__dateCreated mesh__D019071 1995-06-05
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D019071 1997
% 213.93/214.07  |- skos__broader mesh__D019071smesh__D018436
% 213.93/214.07  |- skos__altLabel mesh__D019071 Persian Empire
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D019071 2005
% 213.93/214.07  |- rdf__type mesh__D019071sskos__Concept
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D019071 2000
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D019071 2006
% 213.93/214.07  |- mesh__publicMeSHNote mesh__D005051 76; was BUTYRIBACTERIUM 1963-75   
% 213.93/214.07  |- skos__scopeNote mesh__D005051
% 213.93/214.07       A genus of gram-positive, rod-shaped bacteria found in cavities of man and animals, animal and plant products, infections of soft tissue, and soil. Some species may be pathogenic. No endospores are produced. The genus Eubacterium should not be confused with EUBACTERIA, one of the three domains of life.%A%    
% 213.93/214.07  |- skos__broader mesh__D005051smesh__D016988
% 213.93/214.07  |- mesh__historyNote mesh__D005051 76; was BUTYRIBACTERIUM 1963-75   
% 213.93/214.07  |- mesh__recordOriginator mesh__D005051 NLM
% 213.93/214.07  |- skos__prefLabel mesh__D005051 Eubacterium
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D005051 2006
% 213.93/214.07  |- mesh__recordAuthorizer mesh__D005051 sjn
% 213.93/214.07  |- mesh__onlineNote mesh__D005051
% 213.93/214.07       use EUBACTERIUM to search BUTYRIBACTERIUM 1966-75   
% 213.93/214.07  |- mesh__dateCreated mesh__D005051 1999-01-01
% 213.93/214.07  |- mesh__recordMaintainer mesh__D005051 SYSTEM
% 213.93/214.07  |- mesh__dateRevised mesh__D005051 2005-06-30
% 213.93/214.07  |- rdf__type mesh__D005051sskos__Concept
% 213.93/214.07  |- skos__annotation mesh__D005051
% 213.93/214.07       for genus Eubacterium only: not for EUBACTERIA the domain %28%see BACTERIA%29%; infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D046468 2006
% 213.93/214.07  |- skos__hiddenLabel mesh__D046468 Development, Sexual
% 213.93/214.07  |- mesh__dateCreated mesh__D046468 2004-07-07
% 213.93/214.07  |- mesh__publicMeSHNote mesh__D046468 2005   
% 213.93/214.07  |- skos__scopeNote mesh__D046468
% 213.93/214.07       The processes of anatomical and physiological changes related to sexual or reproductive functions during the life span of a human or an animal, from FERTILIZATION to DEATH. These processes include SEX DIFFERENTIATION; SEXUAL MATURATION; and changes during AGING.%A%    
% 213.93/214.07  |- skos__annotation mesh__D046468 human and animal   
% 213.93/214.07  |- mesh__recordMaintainer mesh__D046468 lkt
% 213.93/214.07  |- skos__broader mesh__D046468smesh__D012098
% 213.93/214.07  |- skos__prefLabel mesh__D046468 Sexual Development
% 213.93/214.07  |- mesh__recordAuthorizer mesh__D046468 sjn
% 213.93/214.07  |- mesh__historyNote mesh__D046468 2005   
% 213.93/214.07  |- rdf__type mesh__D046468sskos__Concept
% 213.93/214.07  |- mesh__recordOriginator mesh__D046468 lkt
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D046468 2005
% 213.93/214.07  |- mesh__dateEstablished mesh__D046468 2005-01-01
% 213.93/214.07  |- skos__altLabel mesh__D018777 Chemical Sensitivities, Multiple
% 213.93/214.07  |- mesh__publicMeSHNote mesh__D018777 95   
% 213.93/214.07  |- skos__scopeNote mesh__D018777
% 213.93/214.07       An acquired disorder characterized by recurrent symptoms, referable to multiple organ systems, occurring in response to demonstrable exposure to many chemically unrelated compounds at doses below those established in the general population to cause harmful effects. %28%Cullen MR. The worker with multiple chemical sensitivities: an overview. Occup Med 1987;2%28%4%29%:655-61%29%%A%    
% 213.93/214.07  |- skos__annotation mesh__D018777
% 213.93/214.07       coord IM with specific chemical IM or NIM if discussed   
% 213.93/214.07  |- mesh__recordAuthorizer mesh__D018777 sjn
% 213.93/214.07  |- skos__altLabel mesh__D018777 Chemical Sensitivity, Multiple
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D018777 2004
% 213.93/214.07  |- skos__historyNote mesh__D018777 Hypersensitivity %28%1987-1994%29%
% 213.93/214.07  |- skos__altLabel mesh__D018777 Idiopathic Environmental Intolerance
% 213.93/214.07  |- skos__historyNote mesh__D018777 Environmental Exposure %28%1987-1994%29%
% 213.93/214.07  |- skos__altLabel mesh__D018777 Multiple Chemical Sensitivities
% 213.93/214.07  |- skos__related mesh__D018777smesh__D018923
% 213.93/214.07  |- skos__altLabel mesh__D018777 Sensitivities, Multiple Chemical
% 213.93/214.07  |- skos__hiddenLabel mesh__D018777 Intolerance, Idiopathic Environmental
% 213.93/214.07  |- skos__prefLabel mesh__D018777 Multiple Chemical Sensitivity
% 213.93/214.07  |- rdf__type mesh__D018777sskos__Concept
% 213.93/214.07  |- mesh__dateCreated mesh__D018777 1994-05-31
% 213.93/214.07  |- skos__altLabel mesh__D018777 Idiopathic Environmental Intolerances
% 213.93/214.07  |- mesh__historyNote mesh__D018777 95   
% 213.93/214.07  |- skos__historyNote mesh__D018777 Occupational Diseases %28%1987-1994%29%
% 213.93/214.07  |- skos__altLabel mesh__D018777 Sensitivity, Multiple Chemical
% 213.93/214.07  |- skos__altLabel mesh__D018777 Multiple Chemical Sensitivity Syndrome
% 213.93/214.07  |- mesh__dateEstablished mesh__D018777 1995-01-01
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D018777 2005
% 213.93/214.07  |- skos__hiddenLabel mesh__D018777 Environmental Intolerance, Idiopathic
% 213.93/214.07  |- mesh__recordOriginator mesh__D018777 TGC
% 213.93/214.07  |- skos__broader mesh__D018777smesh__D018876
% 213.93/214.07  |- skos__hiddenLabel mesh__D018777 Environmental Intolerances, Idiopathic
% 213.93/214.07  |- skos__hiddenLabel mesh__D018777 Intolerances, Idiopathic Environmental
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D018777 2006
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D018777 2003
% 213.93/214.07  |- mesh__dateRevised mesh__D018777 2002-07-03
% 213.93/214.07  |- mesh__recordMaintainer mesh__D018777 ags
% 213.93/214.07  |- skos__hiddenLabel mesh__D032448 Myoblast, Skeletal
% 213.93/214.07  |- skos__hiddenLabel mesh__D032448 Skeletal Myoblast
% 213.93/214.07  |- skos__historyNote mesh__D032448
% 213.93/214.07       Muscle, Skeletal/cytology %28%1994-2002%29%
% 213.93/214.07  |- skos__broader mesh__D032448smesh__D032446
% 213.93/214.07  |- skos__altLabel mesh__D032448 Skeletal Myoblasts
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D032448 2005
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D032448 2003
% 213.93/214.07  |- mesh__historyNote mesh__D032448 2003   
% 213.93/214.07  |- skos__related mesh__D032448smesh__D018485
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D032448 2006
% 213.93/214.07  |- mesh__dateCreated mesh__D032448 2002-07-03
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D032448 2004
% 213.93/214.07  |- rdf__type mesh__D032448sskos__Concept
% 213.93/214.07  |- skos__scopeNote mesh__D032448
% 213.93/214.07       Precursor cells destined to differentiate into skeletal myocytes %28%MYOCYTES, SKELETAL%29%.%A%    
% 213.93/214.07  |- skos__prefLabel mesh__D032448 Myoblasts, Skeletal
% 213.93/214.07  |- skos__historyNote mesh__D032448 Muscles %28%1969-1994%29%
% 213.93/214.07  |- mesh__publicMeSHNote mesh__D032448 2003   
% 213.93/214.07  |- mesh__dateEstablished mesh__D032448 2003-01-01
% 213.93/214.07  |- skos__broader mesh__D043170smesh__D024041
% 213.93/214.07  |- skos__historyNote mesh__D043170 Collagen %28%1994-2003%29%
% 213.93/214.07  |- skos__altLabel mesh__D043170 XVIII Collagen
% 213.93/214.07  |- skos__scopeNote mesh__D043170
% 213.93/214.07       A non-fibrillar collagen found in BASEMENT MEMBRANE. The C-terminal end of the alpha1 chain of collagen type XVIII contains the ENDOSTATIN peptide, which can be released by proteolytic cleavage.%A%    
% 213.93/214.07  |- skos__altLabel mesh__D043170 alpha1%28%XVIII%29% Collagen
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D043170 2005
% 213.93/214.07  |- mesh__recordOriginator mesh__D043170 jmp
% 213.93/214.07  |- skos__altLabel mesh__D043170 Collagen alpha1%28%XVIII%29%
% 213.93/214.07  |- skos__altLabel mesh__D043170 Type XVIII Collagen
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D043170 2006
% 213.93/214.07  |- mesh__dateCreated mesh__D043170 2003-07-09
% 213.93/214.07  |- mesh__historyNote mesh__D043170
% 213.93/214.07       2004; use COLLAGEN TYPE XVIII %28%NM%29% 1994-2002   
% 213.93/214.07  |- rdf__type mesh__D043170sskos__Concept
% 213.93/214.07  |- skos__hiddenLabel mesh__D043170 Type XVIII, Procollagen
% 213.93/214.07  |- skos__annotation mesh__D043170
% 213.93/214.07       precursors: coord IM with PROCOLLAGEN %28%IM%29%   
% 213.93/214.07  |- skos__historyNote mesh__D043170 Peptide Fragments %28%1997-2003%29%
% 213.93/214.07  |- mesh__dateEstablished mesh__D043170 2004-01-01
% 213.93/214.07  |- skos__hiddenLabel mesh__D043170 Collagen, Type XVIII
% 213.93/214.07  |- skos__altLabel mesh__D043170 Collagen XVIII
% 213.93/214.07  |- mesh__recordAuthorizer mesh__D043170 sjn
% 213.93/214.07  |- mesh__dateRevised mesh__D043170 2004-07-07
% 213.93/214.07  |- skos__hiddenLabel mesh__D043170 Collagen, XVIII
% 213.93/214.07  |- skos__prefLabel mesh__D043170 Collagen Type XVIII
% 213.93/214.07  |- mesh__publicMeSHNote mesh__D043170
% 213.93/214.07       2004; COLLAGEN TYPE XVIII %26% COLLAGEN XVIII were indexed under COLLAGEN %26% PEPTIDE FRAGMENTS 1997-2002; COLLAGEN ALPHA1%28%XVIII%29% was indexed under COLLAGEN 1994-2002%A%  
% 213.93/214.07  |- skos__hiddenLabel mesh__D043170 Type XVIII, Collagen
% 213.93/214.07  |- mesh__recordMaintainer mesh__D043170 jmp
% 213.93/214.07  |- skos__broader mesh__D004757smesh__D010124
% 213.93/214.07  |- skos__prefLabel mesh__D004757 Enterobius
% 213.93/214.07  |- skos__scopeNote mesh__D004757
% 213.93/214.07       A genus of intestinal nematode worms which includes the pinworm or threadworm Enterobius vermicularis.%A%    
% 213.93/214.07  |- mesh__publicMeSHNote mesh__D004757
% 213.93/214.07       OXYURIS VERMICULARIS was see under ENTEROBIUS 1963-78   
% 213.93/214.07  |- mesh__recordMaintainer mesh__D004757 ags
% 213.93/214.07  |- mesh__historyNote mesh__D004757
% 213.93/214.07       OXYURIS VERMICULARIS was see under ENTEROBIUS 1963-78   
% 213.93/214.07  |- skos__altLabel mesh__D004757 Oxyuris vermicularis
% 213.93/214.07  |- mesh__dateCreated mesh__D004757 1999-01-01
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D004757 2006
% 213.93/214.07  |- mesh__recordOriginator mesh__D004757 NLM
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D004757 2005
% 213.93/214.07  |- skos__altLabel mesh__D004757 Threadworms
% 213.93/214.07  |- rdf__type mesh__D004757sskos__Concept
% 213.93/214.07  |- mesh__dateRevised mesh__D004757 2003-07-09
% 213.93/214.07  |- mesh__onlineNote mesh__D004757
% 213.93/214.07       use ENTEROBIUS to search OXYURIS VERMICULARIS 1966-78   
% 213.93/214.07  |- mesh__recordAuthorizer mesh__D004757 sjn
% 213.93/214.07  |- skos__altLabel mesh__D004757 Pinworms
% 213.93/214.07  |- skos__annotation mesh__D004757
% 213.93/214.07       a genus of nematodes; infection = ENTEROBIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D004757 2004
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D009442 2002
% 213.93/214.07  |- skos__hiddenLabel mesh__D009442 Neurilemmosarcomas
% 213.93/214.07  |- skos__broader mesh__D009442smesh__D018358
% 213.93/214.07  |- skos__prefLabel mesh__D009442 Neurilemmoma
% 213.93/214.07  |- skos__hiddenLabel mesh__D009442 Plexiform Schwannomatoses
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D009442 2005
% 213.93/214.07  |- skos__altLabel mesh__D009442 Neurilemoma
% 213.93/214.07  |- mesh__recordAuthorizer mesh__D009442 sjn
% 213.93/214.07  |- mesh__recordOriginator mesh__D009442 NLM
% 213.93/214.07  |- mesh__activeMeSHYear mesh__D009442 2006
% 213.93/214.07  |- skos__broader mesh__D009442smesh__D018317
% 213.93/214.08  |- skos__hiddenLabel mesh__D009442 Neurilemomas
% 213.93/214.08  |- skos__altLabel mesh__D009442 Schwannoma
% 213.93/214.08  |- skos__altLabel mesh__D009442 Neurinoma
% 213.93/214.08  |- mesh__recordMaintainer mesh__D009442 KEV
% 213.93/214.08  |- skos__altLabel mesh__D009442 Malignant Neurilemoma
% 213.93/214.08  |- skos__hiddenLabel mesh__D009442 Neurilemomas, Malignant
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D009442 2000
% 213.93/214.08  |- skos__hiddenLabel mesh__D009442 Schwannomas
% 213.93/214.08  |- skos__hiddenLabel mesh__D009442 Malignant Neurilemomas
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D009442 2003
% 213.93/214.08  |- mesh__dateRevised mesh__D009442 1999-11-04
% 213.93/214.08  |- skos__annotation mesh__D009442
% 213.93/214.08       benign or malignant; coord IM with precoord organ/neopl term %28%IM%29%; ameloblastic neurilemmoma goes under ODONTOGENIC TUMORS%A%  
% 213.93/214.08  |- skos__hiddenLabel mesh__D009442 Neurilemoma, Malignant
% 213.93/214.08  |- skos__hiddenLabel mesh__D009442 Plexiform Schwannomatosis
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D009442 2004
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D009442 2001
% 213.93/214.08  |- rdf__type mesh__D009442sskos__Concept
% 213.93/214.08  |- mesh__dateCreated mesh__D009442 1999-01-01
% 213.93/214.08  |- skos__hiddenLabel mesh__D009442 Schwannomatoses, Plexiform
% 213.93/214.08  |- skos__broader mesh__D009442smesh__D009463
% 213.93/214.08  |- skos__scopeNote mesh__D009442
% 213.93/214.08       A neoplasm that arises from SCHWANN CELLS of the cranial, peripheral, and autonomic nerves. Clinically, these tumors may present as a cranial neuropathy, abdominal or soft tissue mass, intracranial lesion, or with spinal cord compression. Histologically, these tumors are encapsulated, highly vascular, and composed of a homogenous pattern of biphasic fusiform-shaped cells that may have a palisaded appearance. %28%From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp964-5%29%%A%    
% 213.93/214.08  |- skos__hiddenLabel mesh__D009442 Neurinomas
% 213.93/214.08  |- skos__hiddenLabel mesh__D009442 Neurilemmomas
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D014387 2004
% 213.93/214.08  |- mesh__recordAuthorizer mesh__D014387 PLS
% 213.93/214.08  |- mesh__dateRevised mesh__D014387 1991-06-12
% 213.93/214.08  |- skos__hiddenLabel mesh__D014387 Tuberculoses, Laryngeal
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D014387 1994
% 213.93/214.08  |- mesh__dateCreated mesh__D014387 1999-01-01
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D014387 1992
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D014387 1995
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D014387 2000
% 213.93/214.08  |- skos__broader mesh__D014387smesh__D012141
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D014387 1998
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D014387 2001
% 213.93/214.08  |- rdf__type mesh__D014387sskos__Concept
% 213.93/214.08  |- mesh__recordOriginator mesh__D014387 NLM
% 213.93/214.08  |- mesh__recordMaintainer mesh__D014387 PXP
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D014387 1993
% 213.93/214.08  |- skos__broader mesh__D014387smesh__D014376
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D014387 2005
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D014387 1996
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D014387 1999
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D014387 2002
% 213.93/214.08  |- skos__broader mesh__D014387smesh__D007818
% 213.93/214.08  |- skos__hiddenLabel mesh__D014387 Laryngeal Tuberculoses
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D014387 2003
% 213.93/214.08  |- skos__prefLabel mesh__D014387 Tuberculosis, Laryngeal
% 213.93/214.08  |- skos__hiddenLabel mesh__D014387 Laryngeal Tuberculosis
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D014387 2006
% 213.93/214.08  |- skos__scopeNote mesh__D014387
% 213.93/214.08       Tuberculosis involving the larynx, producing ulceration of the vocal cords and laryngeal mucosa. It is commonly attended by hoarseness, cough, pain on swallowing, and hemoptysis.%A%    
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D014387 1997
% 213.93/214.08  |- mesh__dateEstablished mesh__D019870 1998-01-01
% 213.93/214.08  |- skos__altLabel mesh__D019870 PI 4-Kinase
% 213.93/214.08  |- skos__prefLabel mesh__D019870 1-Phosphatidylinositol 4-Kinase
% 213.93/214.08  |- skos__historyNote mesh__D019870
% 213.93/214.08       Phosphotransferases, ATP %28%1974-1993%29%
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D019870 2005
% 213.93/214.08  |- skos__altLabel mesh__D019870 Phosphatidylinositol 4-Kinase
% 213.93/214.08  |- skos__hiddenLabel mesh__D019870 PtdIns 4 Kinase
% 213.93/214.08  |- mesh__publicMeSHNote mesh__D019870
% 213.93/214.08       98; 1-PHOSPHATIDYLINOSITOL 4-KINASE was indexed under PHOSPHOTRANSFERASES %28%ALCOHOL GROUP ACCEPTOR%29% 1994-97, PHOSPHATIDYLINOSITOLS 1980-82, PHOSPHOTRANSFERASES, ATP 1974-93, %26% PHOSPHOINOSITIDES 1974-75%A%  
% 213.93/214.08  |- skos__altLabel mesh__D019870 Phosphatidylinositol Kinase Type II
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D019870 2006
% 213.93/214.08  |- skos__altLabel mesh__D019870 PtdIns 4-Kinase
% 213.93/214.08  |- skos__hiddenLabel mesh__D019870 PI 4 Kinase
% 213.93/214.08  |- skos__broader mesh__D019870smesh__D017853
% 213.93/214.08  |- rdf__type mesh__D019870sskos__Concept
% 213.93/214.08  |- skos__historyNote mesh__D019870
% 213.93/214.08       Phosphotransferases %28%Alcohol Group Acceptor%29% %28%1994-1997%29%
% 213.93/214.08  |- skos__historyNote mesh__D019870 Phosphatidylinositols %28%1974-1982%29%
% 213.93/214.08  |- skos__altLabel mesh__D019870 Phosphatidylinositiol Kinase
% 213.93/214.08  |- skos__hiddenLabel mesh__D019870 Phosphatidylinositol 4 Kinase
% 213.93/214.08  |- skos__hiddenLabel mesh__D019870 Kinase, Phosphoinositide
% 213.93/214.08  |- mesh__dateCreated mesh__D019870 1997-07-02
% 213.93/214.08  |- mesh__dateRevised mesh__D019870 2003-07-09
% 213.93/214.08  |- skos__hiddenLabel mesh__D019870 Kinase, Phosphatidylinositiol
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D019870 2004
% 213.93/214.08  |- skos__hiddenLabel mesh__D019870 1 Phosphatidylinositol 4 Kinase
% 213.93/214.08  |- skos__altLabel mesh__D019870 Phosphoinositide Kinase
% 213.93/214.08  |- mesh__historyNote mesh__D019870
% 213.93/214.08       98; use 1-PHOSPHATIDYLINOSITOL 4-KINASE %28%NM%29% 1980-97   
% 213.93/214.08  |- mesh__recordMaintainer mesh__D019870 ssb
% 213.93/214.08  |- mesh__recordAuthorizer mesh__D019870 sjn
% 213.93/214.08  |- skos__scopeNote mesh__D019870
% 213.93/214.08       An enzyme that catalyzes the conversion of phosphatidylinositol %28%PHOSPHATIDYLINOSITOLS%29% to phosphatidylinositol 4-phosphate, the first committed step in the biosynthesis of phosphatidylinositol 4,5-bisphosphate.%A%    
% 213.93/214.08  |- mesh__recordOriginator mesh__D019870 KEV
% 213.93/214.08  |- skos__altLabel mesh__D033541 Shrimp, Palaemonid
% 213.93/214.08  |- skos__annotation mesh__D033541
% 213.93/214.08       note X ref PALAEMONID SHRIMP: several other shrimp terms are available; check text and MeSH; unspecified shrimp as food is probably PENAEIDAE%A%  
% 213.93/214.08  |- skos__altLabel mesh__D033541 Palaemonid Shrimp
% 213.93/214.08  |- rdf__type mesh__D033541sskos__Concept
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D033541 2004
% 213.93/214.08  |- skos__scopeNote mesh__D033541
% 213.93/214.08       A family of CRUSTACEA, order DECAPODA, comprising the palaemonid shrimp. Genera include Macrobrachium, Palaemon, and Palaemonetes. Palaemonidae osmoregulate by means of gills.%A%    
% 213.93/214.08  |- mesh__dateRevised mesh__D033541 2003-07-09
% 213.93/214.08  |- mesh__dateCreated mesh__D033541 2002-07-03
% 213.93/214.08  |- mesh__historyNote mesh__D033541 2003   
% 213.93/214.08  |- skos__broader mesh__D033541smesh__D033364
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D033541 2005
% 213.93/214.08  |- mesh__publicMeSHNote mesh__D033541 2003   
% 213.93/214.08  |- mesh__dateEstablished mesh__D033541 2003-01-01
% 213.93/214.08  |- skos__historyNote mesh__D033541 Crustacea %28%1968-2002%29%
% 213.93/214.08  |- skos__prefLabel mesh__D033541 Palaemonidae
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D033541 2006
% 213.93/214.08  |- skos__hiddenLabel mesh__D000367 Age Factor
% 213.93/214.08  |- mesh__dateCreated mesh__D000367 1999-01-01
% 213.93/214.08  |- skos__hiddenLabel mesh__D000367 Factor, Age
% 213.93/214.08  |- mesh__recordAuthorizer mesh__D000367 sjn
% 213.93/214.08  |- mesh__recordOriginator mesh__D000367 NLM
% 213.93/214.08  |- mesh__onlineNote mesh__D000367
% 213.93/214.08       use AGE DISTRIBUTION and SEX DISTRIBUTION to search AGE-SEX DISTRIBUTION 1994 forward; use AGE FACTORS to search AGE-SEX DISTRIBUTION 1990-92%A%  
% 213.93/214.08  |- mesh__dateEstablished mesh__D000367 1968-01-01
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D000367 2005
% 213.93/214.08  |- skos__historyNote mesh__D000367 Aging %28%1966-1967%29%
% 213.93/214.08  |- skos__hiddenLabel mesh__D000367 Factors, Age
% 213.93/214.08  |- mesh__recordMaintainer mesh__D000367 sjn
% 213.93/214.08  |- mesh__historyNote mesh__D000367
% 213.93/214.08       68; AGE-SEX DISTRIBUTION was see AGE FACTORS 1990-92   
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D000367 2006
% 213.93/214.08  |- skos__annotation mesh__D000367
% 213.93/214.08       NIM; no qualif; human %26% animal; related to cause %26% effect: do not confuse with AGE DISTRIBUTION which is largely statistical; differentiate from AGING, a physiol concept; policy: Manual 35.7%A%  
% 213.93/214.08  |- skos__broader mesh__D000367smesh__D015981
% 213.93/214.08  |- skos__scopeNote mesh__D000367
% 213.93/214.08       Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.%A%    
% 213.93/214.08  |- rdf__type mesh__D000367sskos__Concept
% 213.93/214.08  |- skos__prefLabel mesh__D000367 Age Factors
% 213.93/214.08  |- mesh__publicMeSHNote mesh__D000367
% 213.93/214.08       68; AGE-SEX DISTRIBUTION was see AGE FACTORS 1990-92   
% 213.93/214.08  |- mesh__dateRevised mesh__D000367 2004-07-13
% 213.93/214.08  |- skos__hiddenLabel mesh__D019072 Premedications, Antibiotic
% 213.93/214.08  |- skos__prefLabel mesh__D019072 Antibiotic Prophylaxis
% 213.93/214.08  |- skos__scopeNote mesh__D019072
% 213.93/214.08       Use of antibiotics before, during, or after a diagnostic, therapeutic, or surgical procedure to prevent infectious complications.%A%    
% 213.93/214.08  |- mesh__historyNote mesh__D019072 96   
% 213.93/214.08  |- skos__historyNote mesh__D019072
% 213.93/214.08       Postoperative Complications %28%1966-1995%29%
% 213.93/214.08  |- skos__historyNote mesh__D019072
% 213.93/214.08       Antibiotics/therapeutic use %28%1966-1995%29%
% 213.93/214.08  |- mesh__dateCreated mesh__D019072 1995-06-05
% 213.93/214.08  |- mesh__recordMaintainer mesh__D019072 lkt
% 213.93/214.08  |- skos__hiddenLabel mesh__D019072 Prophylaxis, Antibiotic
% 213.93/214.08  |- skos__broader mesh__D019072smesh__D011292
% 213.93/214.08  |- mesh__recordAuthorizer mesh__D019072 sjn
% 213.93/214.08  |- mesh__recordOriginator mesh__D019072 TGC
% 213.93/214.08  |- mesh__dateRevised mesh__D019072 2005-06-30
% 213.93/214.08  |- mesh__dateEstablished mesh__D019072 1996-01-01
% 213.93/214.08  |- skos__broader mesh__D019072smesh__D018890
% 213.93/214.08  |- skos__historyNote mesh__D019072
% 213.93/214.08       Surgical Wound Infection %28%1966-1995%29%
% 213.93/214.08  |- rdf__type mesh__D019072sskos__Concept
% 213.93/214.08  |- skos__historyNote mesh__D019072 Premedication %28%1973-1995%29%
% 213.93/214.08  |- skos__annotation mesh__D019072
% 213.93/214.08       IM; coord with specific antibiotic /ther use %28%IM%29%   
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D019072 2006
% 213.93/214.08  |- skos__altLabel mesh__D019072 Premedication, Antibiotic
% 213.93/214.08  |- skos__altLabel mesh__D019072 Antibiotic Premedication
% 213.93/214.08  |- mesh__publicMeSHNote mesh__D019072 96   
% 213.93/214.08  |- skos__hiddenLabel mesh__D019072 Antibiotic Premedications
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D005850 1997
% 213.93/214.08  |- skos__annotation mesh__D005850 SPEC: SPEC qualif; DF: GERIATRIC DENT   
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D005850 1999
% 213.93/214.08  |- rdf__type mesh__D005850sskos__Concept
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D005850 2000
% 213.93/214.08  |- mesh__dateCreated mesh__D005850 1999-01-01
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D005850 2001
% 213.93/214.08  |- skos__scopeNote mesh__D005850
% 213.93/214.08       The branch of dentistry concerned with the dental problems of older people.%A%    
% 213.93/214.08  |- mesh__historyNote mesh__D005850 66   
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D005850 2003
% 213.93/214.08  |- skos__broader mesh__D005850smesh__D003813
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D005850 2005
% 213.93/214.08  |- mesh__recordMaintainer mesh__D005850 TGC
% 213.93/214.08  |- skos__prefLabel mesh__D005850 Geriatric Dentistry
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D005850 2004
% 213.93/214.08  |- skos__related mesh__D005850smesh__D016321
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D005850 2002
% 213.93/214.08  |- mesh__recordAuthorizer mesh__D005850 PLS
% 213.93/214.08  |- mesh__dateRevised mesh__D005850 1995-06-08
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D005850 1996
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D005850 2006
% 213.93/214.08  |- mesh__publicMeSHNote mesh__D005850 66   
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D005850 1998
% 213.93/214.08  |- mesh__dateEstablished mesh__D005850 1966-01-01
% 213.93/214.08  |- mesh__recordOriginator mesh__D005850 NLM
% 213.93/214.08  |- skos__altLabel mesh__D005850 Dentistry, Geriatric
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D005052 2006
% 213.93/214.08  |- mesh__publicMeSHNote mesh__D005052
% 213.93/214.08       91,63-85; was see under TREES 1986-90; was heading 1963-85%A%  
% 213.93/214.08  |- skos__annotation mesh__D005052 chiefly Australian   
% 213.93/214.08  |- mesh__dateCreated mesh__D005052 1999-01-01
% 213.93/214.08  |- mesh__dateEstablished mesh__D005052 1991-01-01
% 213.93/214.08  |- skos__scopeNote mesh__D005052
% 213.93/214.08       A genus of Australian trees of the Myrtaceae family that yields gums, oils, and resins which are used as flavoring agents, astringents, and aromatics, and formerly to treat diarrhea, asthma, bronchitis, and respiratory tract infections.%A%    
% 213.93/214.08  |- mesh__historyNote mesh__D005052
% 213.93/214.08       91%28%86%29%63; was see under TREES 1986-90; was heading 1963-86%A%  
% 213.93/214.08  |- mesh__dateRevised mesh__D005052 2003-07-09
% 213.93/214.08  |- skos__broader mesh__D005052smesh__D027822
% 213.93/214.08  |- skos__prefLabel mesh__D005052 Eucalyptus
% 213.93/214.08  |- rdf__type mesh__D005052sskos__Concept
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D005052 2004
% 213.93/214.08  |- mesh__recordMaintainer mesh__D005052 ssb
% 213.93/214.08  |- mesh__recordOriginator mesh__D005052 NLM
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D005052 2005
% 213.93/214.08  |- mesh__recordAuthorizer mesh__D005052 sjn
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D018778 2002
% 213.93/214.08  |- rdf__type mesh__D018778sskos__Concept
% 213.93/214.08  |- skos__scopeNote mesh__D018778
% 213.93/214.08       Infections with viruses of the genus HANTAVIRUS. This is associated with at least four clinical syndromes: HEMORRHAGIC FEVER WITH RENAL SYNDROME caused by viruses of the Hantaan group; a milder form of HFRS caused by SEOUL VIRUS; nephropathia epidemica caused by PUUMALA VIRUS; and HANTAVIRUS PULMONARY SYNDROME caused by SIN NOMBRE VIRUS.%A%    
% 213.93/214.08  |- mesh__historyNote mesh__D018778 95   
% 213.93/214.08  |- skos__broader mesh__D018778smesh__D002044
% 213.93/214.08  |- mesh__recordOriginator mesh__D018778 AGS
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D018778 2005
% 213.93/214.08  |- mesh__publicMeSHNote mesh__D018778 95   
% 213.93/214.08  |- mesh__recordAuthorizer mesh__D018778 sjn
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D018778 2006
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D018778 2003
% 213.93/214.08  |- skos__hiddenLabel mesh__D018778 Hantavirus Infection
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D018778 2004
% 213.93/214.08  |- mesh__dateCreated mesh__D018778 1994-05-23
% 213.93/214.08  |- skos__historyNote mesh__D018778
% 213.93/214.08       Bunyaviridae Infections %28%1984-1994%29%
% 213.93/214.08  |- mesh__recordMaintainer mesh__D018778 ags
% 213.93/214.08  |- mesh__dateRevised mesh__D018778 2001-07-25
% 213.93/214.08  |- skos__annotation mesh__D018778 GEN or unspecified; prefer specifics   
% 213.93/214.08  |- skos__prefLabel mesh__D018778 Hantavirus Infections
% 213.93/214.08  |- skos__altLabel mesh__D018778 Infections, Hantavirus
% 213.93/214.08  |- mesh__dateEstablished mesh__D018778 1995-01-01
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D010795 2005
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D010795 1998
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D010795 2000
% 213.93/214.08  |- mesh__dateCreated mesh__D010795 1999-01-01
% 213.93/214.08  |- mesh__dateRevised mesh__D010795 1995-05-18
% 213.93/214.08  |- mesh__historyNote mesh__D010795 75; was PHTHALIC ACID 1963-74   
% 213.93/214.08  |- skos__scopeNote mesh__D010795
% 213.93/214.08       A group of compounds that has the general structure of a dicarboxylic acid-substituted benzene ring. The ortho-isomer is used in dye manufacture. %28%Dorland, 28th ed%29%%A%    
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D010795 2006
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D010795 2001
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D010795 1999
% 213.93/214.08  |- mesh__recordMaintainer mesh__D010795 KEV
% 213.93/214.08  |- skos__broader mesh__D010795smesh__D000146
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D010795 2003
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D010795 1996
% 213.93/214.08  |- mesh__recordAuthorizer mesh__D010795 PLS
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D010795 2004
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D010795 1997
% 213.93/214.08  |- rdf__type mesh__D010795sskos__Concept
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D010795 2002
% 213.93/214.08  |- mesh__recordOriginator mesh__D010795 NLM
% 213.93/214.08  |- skos__hiddenLabel mesh__D010795 Acids, Phthalic
% 213.93/214.08  |- mesh__onlineNote mesh__D010795
% 213.93/214.08       use PHTHALIC ACIDS to search PHTHALIC ACID 1966-74   
% 213.93/214.08  |- mesh__publicMeSHNote mesh__D010795 75; was PHTHALIC ACID 1963-74   
% 213.93/214.08  |- skos__prefLabel mesh__D010795 Phthalic Acids
% 213.93/214.08  |- mesh__dateCreated mesh__D032449 2002-07-03
% 213.93/214.08  |- mesh__dateEstablished mesh__D032449 2003-01-01
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D032449 2005
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D032449 2003
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D032449 2006
% 213.93/214.08  |- skos__annotation mesh__D032449
% 213.93/214.08       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D032449 2004
% 213.93/214.08  |- rdf__type mesh__D032449sskos__Concept
% 213.93/214.08  |- skos__prefLabel mesh__D032449 Canavalia
% 213.93/214.08  |- mesh__publicMeSHNote mesh__D032449 2003   
% 213.93/214.08  |- skos__scopeNote mesh__D032449
% 213.93/214.08       A plant genus of the family FABACEAE. Canavalia ensiformis is the source of CONCANAVALIN A.%A%    
% 213.93/214.08  |- skos__broader mesh__D032449smesh__D007887
% 213.93/214.08  |- mesh__historyNote mesh__D032449 2003   
% 213.93/214.08  |- skos__hiddenLabel mesh__D043171 Stability, Chromosome
% 213.93/214.08  |- skos__hiddenLabel mesh__D043171 Chromosome Stabilities
% 213.93/214.08  |- skos__hiddenLabel mesh__D043171 Chromosome Instabilities
% 213.93/214.08  |- skos__hiddenLabel mesh__D043171 Instabilities, Chromosome
% 213.93/214.08  |- mesh__publicMeSHNote mesh__D043171 2004   
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D043171 2004
% 213.93/214.08  |- skos__hiddenLabel mesh__D043171 Instability, Chromosomal
% 213.93/214.08  |- skos__prefLabel mesh__D043171 Chromosomal Instability
% 213.93/214.08  |- skos__historyNote mesh__D043171 Chromosome Aberrations %28%1967-2003%29%
% 213.93/214.08  |- skos__broader mesh__D043171smesh__D002869
% 213.93/214.08  |- skos__hiddenLabel mesh__D043171 Chromosomal Stabilities
% 213.93/214.08  |- skos__altLabel mesh__D043171 Chromosomal Stability
% 213.93/214.08  |- mesh__dateEstablished mesh__D043171 2004-01-01
% 213.93/214.08  |- mesh__dateCreated mesh__D043171 2003-07-09
% 213.93/214.08  |- skos__hiddenLabel mesh__D043171 Chromosomal Instabilities
% 213.93/214.08  |- mesh__historyNote mesh__D043171 2004   
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D043171 2006
% 213.93/214.08  |- skos__altLabel mesh__D043171 Chromosome Instability
% 213.93/214.08  |- skos__broader mesh__D043171smesh__D042822
% 213.93/214.08  |- skos__hiddenLabel mesh__D043171 Instability, Chromosome
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D043171 2005
% 213.93/214.08  |- skos__hiddenLabel mesh__D043171 Instabilities, Chromosomal
% 213.93/214.08  |- skos__hiddenLabel mesh__D043171 Stabilities, Chromosome
% 213.93/214.08  |- rdf__type mesh__D043171sskos__Concept
% 213.93/214.08  |- skos__hiddenLabel mesh__D043171 Stabilities, Chromosomal
% 213.93/214.08  |- skos__hiddenLabel mesh__D043171 Stability, Chromosomal
% 213.93/214.08  |- skos__scopeNote mesh__D043171
% 213.93/214.08       An increased tendency to acquire CHROMOSOME ABERRATIONS when various processes involved in chromosome replication, repair, or segregation are dysfunctional.%A%    
% 213.93/214.08  |- skos__altLabel mesh__D051603 Cancer-Associated Retinopathy Antigen
% 213.93/214.08  |- mesh__historyNote mesh__D051603 2006%28%1987%29%   
% 213.93/214.08  |- mesh__publicMeSHNote mesh__D051603
% 213.93/214.08       2006; RECOVERIN was indexed under CALCIUM-BINDING PROTEINS, EYE PROTEINS %26% LIPOPROTEINS 1987-2005, %26% under ANTIGENS, NEOPLASM 1987-1993%A%  
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D051603 2006
% 213.93/214.08  |- skos__prefLabel mesh__D051603 Recoverin
% 213.93/214.08  |- mesh__recordAuthorizer mesh__D051603 sjn
% 213.93/214.08  |- skos__altLabel mesh__D051603 S-Modulin
% 213.93/214.08  |- mesh__dateEstablished mesh__D051603 2006-01-01
% 213.93/214.08  |- mesh__dateCreated mesh__D051603 2005-06-30
% 213.93/214.08  |- skos__hiddenLabel mesh__D051603 Cancer Associated Retinopathy Antigen
% 213.93/214.08  |- skos__hiddenLabel mesh__D051603 S Modulin
% 213.93/214.08  |- mesh__recordOriginator mesh__D051603 DRC
% 213.93/214.08  |- skos__hiddenLabel mesh__D051603 Sensitivity Modulating Protein
% 213.93/214.08  |- skos__broader mesh__D051603smesh__D051580
% 213.93/214.08  |- rdf__type mesh__D051603sskos__Concept
% 213.93/214.08  |- skos__scopeNote mesh__D051603
% 213.93/214.08       A neuronal calcium-sensor protein that is found in ROD PHOTORECEPTORS and CONE PHOTORECEPTORS. It interacts with RHODOPSIN KINASE in a Ca2+ dependent manner and plays an important role in PHOTOTRANSDUCTION.%A%    
% 213.93/214.08  |- mesh__recordMaintainer mesh__D051603 DRC
% 213.93/214.08  |- skos__broader mesh__D051603smesh__D005136
% 213.93/214.08  |- skos__altLabel mesh__D051603 Sensitivity-Modulating Protein
% 213.93/214.08  |- mesh__onlineNote mesh__D004758
% 213.93/214.08       use ENTEROBACTIN to search ENTEROCHELIN 1975-92   
% 213.93/214.08  |- skos__prefLabel mesh__D004758 Enterobactin
% 213.93/214.08  |- mesh__dateCreated mesh__D004758 1974-11-19
% 213.93/214.08  |- skos__historyNote mesh__D004758 Catechols %28%1971-1974%29%
% 213.93/214.08  |- mesh__publicMeSHNote mesh__D004758
% 213.93/214.08       91; was ENTEROCHELIN 1975-92; ENTEROCHELIN was see under SERINE 1975-92; ENTEROBACTIN was see ENTEROCHELIN 1975-92%A%  
% 213.93/214.08  |- skos__historyNote mesh__D004758 Benzoates %28%1971-1974%29%
% 213.93/214.08  |- mesh__recordAuthorizer mesh__D004758 sjn
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D004758 2006
% 213.93/214.08  |- mesh__dateEstablished mesh__D004758 1991-01-01
% 213.93/214.08  |- mesh__recordMaintainer mesh__D004758 ssb
% 213.93/214.08  |- skos__scopeNote mesh__D004758
% 213.93/214.08       An iron-binding cyclic trimer of 2,3-dihydroxy-N-benzoyl-L-serine. It is produced by E COLI and other enteric bacteria.%A%    
% 213.93/214.08  |- rdf__type mesh__D004758sskos__Concept
% 213.93/214.08  |- skos__historyNote mesh__D004758 Serine %28%1971-1974%29%
% 213.93/214.08  |- mesh__dateRevised mesh__D004758 2005-06-30
% 213.93/214.08  |- mesh__recordOriginator mesh__D004758 NLM
% 213.93/214.08  |- mesh__historyNote mesh__D004758
% 213.93/214.08       93%28%75%29%; was ENTEROCHELIN 1975-92; ENTEROCHELIN was see under SERINE 1975-90; ENTEROBACTIN was see ENTEROCHELIN 1975-92%A%  
% 213.93/214.08  |- skos__altLabel mesh__D004758 Enterochelin
% 213.93/214.08  |- skos__broader mesh__D004758smesh__D012694
% 213.93/214.08  |- skos__scopeNote mesh__D015480
% 213.93/214.08       Antibodies reactive with various types of human T-cell leukemia/lymphoma antigens or bovine leukemia virus antigens.%A%    
% 213.93/214.08  |- mesh__dateEstablished mesh__D015480 1988-01-01
% 213.93/214.08  |- skos__hiddenLabel mesh__D015480 Antibodies, HTLV-BLV
% 213.93/214.08  |- skos__altLabel mesh__D015480 HTLV Antibodies
% 213.93/214.08  |- skos__altLabel mesh__D015480 HTLV-BLV Antibodies
% 213.93/214.08  |- skos__altLabel mesh__D015480 Leukemia Virus Antibodies, Human T Cell
% 213.93/214.08  |- skos__annotation mesh__D015480
% 213.93/214.08       general or unspecified: prefer specifics; do not coordinate with specific delta retrovirus /immunol; do not coordinate with ANTIBODY FORMATION for /biosyn%A%  
% 213.93/214.08  |- skos__hiddenLabel mesh__D015480 Antibodies, Deltaretrovirus
% 213.93/214.08  |- mesh__recordMaintainer mesh__D015480 ssb
% 213.93/214.08  |- skos__altLabel mesh__D015480 Human T-Cell Leukemia Virus Antibodies
% 213.93/214.08  |- skos__altLabel mesh__D015480
% 213.93/214.08       Leukemia-Lymphoma Virus Antibodies, Human T-Cell
% 213.93/214.08  |- mesh__dateRevised mesh__D015480 2005-06-30
% 213.93/214.08  |- skos__hiddenLabel mesh__D015480 Antibodies, HTLV
% 213.93/214.08  |- skos__altLabel mesh__D015480 Human T Cell Leukemia Virus Antibodies
% 213.93/214.08  |- rdf__type mesh__D015480sskos__Concept
% 213.93/214.08  |- mesh__recordOriginator mesh__D015480 SCD
% 213.93/214.08  |- skos__altLabel mesh__D015480
% 213.93/214.08       T-Cell Leukemia-Lymphoma Virus Antibodies, Human
% 213.93/214.08  |- mesh__recordAuthorizer mesh__D015480 sjn
% 213.93/214.08  |- skos__altLabel mesh__D015480
% 213.93/214.08       T Cell Leukemia Lymphoma Virus Antibodies, Human
% 213.93/214.08  |- mesh__publicMeSHNote mesh__D015480
% 213.93/214.08       2003; see HTLV-BLV ANTIBODIES 1995-2002, see HTLV ANTIBODIES 1989-1994%A%  
% 213.93/214.08  |- skos__historyNote mesh__D015480 Antibodies, Monoclonal %28%1982-1988%29%
% 213.93/214.08  |- skos__broader mesh__D015480smesh__D000914
% 213.93/214.08  |- skos__historyNote mesh__D015480 HIV/immunology %28%1988%29%
% 213.93/214.08  |- skos__prefLabel mesh__D015480 Deltaretrovirus Antibodies
% 213.93/214.08  |- skos__historyNote mesh__D015480 Antibodies, Viral %28%1982-1988%29%
% 213.93/214.08  |- skos__hiddenLabel mesh__D015480 HTLV BLV Antibodies
% 213.93/214.08  |- skos__hiddenLabel mesh__D015480 Antibodies, BLV
% 213.93/214.08  |- mesh__dateCreated mesh__D015480 1988-06-10
% 213.93/214.08  |- skos__historyNote mesh__D015480
% 213.93/214.08       Human T-Cell Leukemia Virus/immunology %28%1984-1988%29%
% 213.93/214.08  |- skos__historyNote mesh__D015480 HTLV-III %28%1987%29%
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D015480 2006
% 213.93/214.08  |- mesh__historyNote mesh__D015480 2003 %28%1989%29%   
% 213.93/214.08  |- skos__hiddenLabel mesh__D009443 Neuritides, Motor
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D009443 2006
% 213.93/214.08  |- skos__hiddenLabel mesh__D009443 Motor Neuritis
% 213.93/214.08  |- mesh__recordMaintainer mesh__D009443 lkt
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D009443 2002
% 213.93/214.08  |- skos__scopeNote mesh__D009443
% 213.93/214.08       A general term indicating inflammation of a peripheral or cranial nerve. Clinical manifestation may include PAIN; PARESTHESIAS; PARESIS; or HYPESTHESIA.%A%    
% 213.93/214.08  |- skos__related mesh__D009443smesh__D009902
% 213.93/214.08  |- skos__hiddenLabel mesh__D009443 Sensory Neuritis
% 213.93/214.08  |- skos__hiddenLabel mesh__D009443 Motor Neuritides
% 213.93/214.08  |- skos__hiddenLabel mesh__D009443 Sensory Neuritides
% 213.93/214.08  |- mesh__recordAuthorizer mesh__D009443 sjn
% 213.93/214.08  |- mesh__recordOriginator mesh__D009443 NLM
% 213.93/214.08  |- skos__related mesh__D009443smesh__D020338
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D009443 2003
% 213.93/214.08  |- skos__prefLabel mesh__D009443 Neuritis
% 213.93/214.08  |- mesh__dateRevised mesh__D009443 2001-07-25
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D009443 2004
% 213.93/214.08  |- skos__annotation mesh__D009443
% 213.93/214.08       coord IM with specific nerve disease or specific nerve %28%IM%29%; do not confuse with NEURITES, a hairlike projection of a neuron %26% in French %26% other foreign titles do not confuse %22%neurite%22% referring to a neurite %28%i.e., NEURITES%29% with %22%nevrite%22% meaning neuritis; neuritis of optic nerve = OPTIC NEURITIS; retrobulbar neuritis = OPTIC NEURITIS; SMON %28%subacute myelo-optico-neuropathy%29% is indexed OPTIC NEURITIS %28%IM%29% + MYELITIS %28%IM%29% + SYNDROME %28%NIM%29%%A%  
% 213.93/214.08  |- skos__hiddenLabel mesh__D009443 Peripheral Neuritis
% 213.93/214.08  |- rdf__type mesh__D009443sskos__Concept
% 213.93/214.08  |- skos__broader mesh__D009443smesh__D010523
% 213.93/214.08  |- mesh__dateCreated mesh__D009443 1999-01-01
% 213.93/214.08  |- skos__hiddenLabel mesh__D009443 Neuritides, Sensory
% 213.93/214.08  |- skos__altLabel mesh__D009443 Neuritis, Peripheral
% 213.93/214.08  |- skos__hiddenLabel mesh__D009443 Neuritides, Peripheral
% 213.93/214.08  |- skos__hiddenLabel mesh__D009443 Peripheral Neuritides
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D009443 2005
% 213.93/214.08  |- skos__hiddenLabel mesh__D009443 Polyneuritides
% 213.93/214.08  |- skos__hiddenLabel mesh__D009443 Neuritides
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D001460 1996
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D001460 1998
% 213.93/214.08  |- mesh__historyNote mesh__D001460 75   
% 213.93/214.08  |- rdf__type mesh__D001460sskos__Concept
% 213.93/214.08  |- mesh__dateRevised mesh__D001460 1995-02-17
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D001460 1997
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D001460 2000
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D001460 1999
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D001460 2003
% 213.93/214.08  |- mesh__recordAuthorizer mesh__D001460 PLS
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D001460 2001
% 213.93/214.08  |- skos__scopeNote mesh__D001460
% 213.93/214.08       An island in the Lesser Antilles in the West Indies. It is chiefly of coral formation with no good harbors and only small streams. It was probably discovered by the Portuguese in the sixteenth century. The name was given by 16th-century Spanish explorers from barbados, the plural for %22%bearded%22%, with reference to the beard-like leaves or trails of moss on the trees that grew there in abundance. %28%From Webster%27%s New Geographical Dictionary, 1988, p116 %26% Room, Brewer%27%s Dictionary of Names, 1992, p49%29%%A%    
% 213.93/214.08  |- mesh__dateCreated mesh__D001460 1974-11-11
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D001460 2005
% 213.93/214.08  |- mesh__recordOriginator mesh__D001460 NLM
% 213.93/214.08  |- skos__annotation mesh__D001460
% 213.93/214.08       an island in the Lesser Antilles in the West Indies   
% 213.93/214.08  |- mesh__dateEstablished mesh__D001460 1975-01-01
% 213.93/214.08  |- mesh__activeMeSHYear mesh__D001460 2004
% 213.93/214.09  |- mesh__activeMeSHYear mesh__D001460 2006
% 213.93/214.09  |- skos__prefLabel mesh__D001460 Barbados
% 213.93/214.09  |- mesh__recordMaintainer mesh__D001460 TGC
% 213.93/214.09  |- mesh__activeMeSHYear mesh__D001460 2002
% 213.93/214.09  |- skos__broader mesh__D001460smesh__D014900
% 213.93/214.09  |- skos__altLabel mesh__D014388 Cervical Tuberculous Lymphadenitis
% 213.93/214.09  |- mesh__activeMeSHYear mesh__D014388 2004
% 213.93/214.09  |- skos__prefLabel mesh__D014388 Tuberculosis, Lymph Node
% 213.93/214.09  |- mesh__recordMaintainer mesh__D014388 jmp
% 213.93/214.09  |- skos__hiddenLabel mesh__D014388 Scrofulas
% 213.93/214.09  |- mesh__recordOriginator mesh__D014388 NLM
% 213.93/214.09  |- mesh__activeMeSHYear mesh__D014388 2006
% 213.93/214.09  |- skos__hiddenLabel mesh__D014388 Lymphadenitis, Cervical Tuberculous
% 213.93/214.09  |- skos__hiddenLabel mesh__D014388 Tuberculous Lymphadenitis, Cervical
% 213.93/214.09  |- skos__broader mesh__D014388smesh__D014376
% 213.93/214.09  |- skos__hiddenLabel mesh__D014388 Tuberculoses, Lymph Node
% 213.93/214.09  |- mesh__activeMeSHYear mesh__D014388 2003
% 213.93/214.09  |- skos__hiddenLabel mesh__D014388 Lymphadenitis, Mycobacterial Cervical
% 213.93/214.09  |- mesh__dateRevised mesh__D014388 2000-06-22
% 213.93/214.09  |- mesh__dateCreated mesh__D014388 1999-01-01
% 213.93/214.09  |- mesh__activeMeSHYear mesh__D014388 2005
% 213.93/214.09  |- skos__related mesh__D014388smesh__D018601
% 213.93/214.09  |- mesh__activeMeSHYear mesh__D014388 2002
% 213.93/214.09  |- skos__scopeNote mesh__D014388
% 213.93/214.09       Infection of the lymph nodes by tuberculosis. Tuberculous infection of the cervical lymph nodes is scrofula.%A%    
% 213.93/214.09  |- skos__altLabel mesh__D014388 Lymphadenitis, Tuberculous
% 213.93/214.09  |- skos__annotation mesh__D014388
% 213.93/214.09       X ref SCROFULA in hist articles = KING%27%S EVIL: see MeSH definition there%A%  
% 213.93/214.09  |- skos__hiddenLabel mesh__D014388 Lymph Node Tuberculoses
% 213.93/214.09  |- skos__altLabel mesh__D014388 Mycobacterial Cervical Lymphadenitis
% 213.93/214.09  |- mesh__activeMeSHYear mesh__D014388 2001
% 213.93/214.09  |- rdf__type mesh__D014388sskos__Concept
% 213.93/214.09  |- mesh__recordAuthorizer mesh__D014388 sjn
% 213.93/214.09  |- skos__hiddenLabel mesh__D014388 Lymph Node Tuberculosis
% 213.93/214.09  |- skos__broader mesh__D014388smesh__D008199
% 213.93/214.09  |- skos__hiddenLabel mesh__D014388 Cervical Lymphadenitis, Mycobacterial
% 213.94/214.09  |- skos__broader mesh__D014388smesh__D008206
% 213.94/214.09  |- skos__hiddenLabel mesh__D014388 Tuberculous Lymphadenitis
% 213.94/214.09  |- mesh__dateEstablished mesh__D033542 2003-01-01
% 213.94/214.09  |- mesh__dateRevised mesh__D033542 2003-07-09
% 213.94/214.09  |- mesh__historyNote mesh__D033542 2003   
% 213.94/214.09  |- skos__altLabel mesh__D033542 Pandalid Shrimp
% 213.94/214.09  |- skos__broader mesh__D033542smesh__D033364
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D033542 2005
% 213.94/214.09  |- mesh__publicMeSHNote mesh__D033542 2003   
% 213.94/214.09  |- skos__scopeNote mesh__D033542
% 213.94/214.09       A family of CRUSTACEA, order DECAPODA, comprising the pandalid shrimp. They are protandic hermaphrodites and can breed in both male and female stages. Many species are commercially harvested in the Pacific Northwest.%A%    
% 213.94/214.09  |- skos__altLabel mesh__D033542 Shrimp, Pandalid
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D033542 2006
% 213.94/214.09  |- skos__annotation mesh__D033542
% 213.94/214.09       note X ref PANDALID SHRIMP: several other shrimp termsare available; check text and MeSH; unspecified shrimp as food is probably PENAEIDAE%A%  
% 213.94/214.09  |- rdf__type mesh__D033542sskos__Concept
% 213.94/214.09  |- skos__historyNote mesh__D033542 Crustacea %28%1967-2002%29%
% 213.94/214.09  |- mesh__dateCreated mesh__D033542 2002-07-03
% 213.94/214.09  |- skos__prefLabel mesh__D033542 Pandalidae
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D033542 2004
% 213.94/214.09  |- skos__hiddenLabel mesh__D019871 Dyskeratosis Congenita, X Linked
% 213.94/214.09  |- rdf__type mesh__D019871sskos__Concept
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D019871 2003
% 213.94/214.09  |- mesh__recordAuthorizer mesh__D019871 sjn
% 213.94/214.09  |- mesh__dateRevised mesh__D019871 2002-07-03
% 213.94/214.09  |- mesh__dateEstablished mesh__D019871 1998-01-01
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D019871 2004
% 213.94/214.09  |- skos__broader mesh__D019871smesh__D012873
% 213.94/214.09  |- skos__hiddenLabel mesh__D019871 Congenita, X-Linked Dyskeratosis
% 213.94/214.09  |- skos__prefLabel mesh__D019871 Dyskeratosis Congenita
% 213.94/214.09  |- mesh__dateCreated mesh__D019871 1997-06-20
% 213.94/214.09  |- mesh__historyNote mesh__D019871 98   
% 213.94/214.09  |- skos__altLabel mesh__D019871 Dyskeratosis Congenita, X-Linked
% 213.94/214.09  |- skos__broader mesh__D019871smesh__D012868
% 213.94/214.09  |- mesh__recordMaintainer mesh__D019871 nns
% 213.94/214.09  |- skos__hiddenLabel mesh__D019871 X-Linked Dyskeratosis Congenitas
% 213.94/214.09  |- skos__hiddenLabel mesh__D019871 X-Linked Dyskeratosis Congenita
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D019871 2005
% 213.94/214.09  |- mesh__publicMeSHNote mesh__D019871 98   
% 213.94/214.09  |- skos__hiddenLabel mesh__D019871 Zinsser Cole Engman Syndrome
% 213.94/214.09  |- skos__hiddenLabel mesh__D019871 Syndrome, Zinsser-Cole-Engman
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D019871 2006
% 213.94/214.09  |- mesh__recordOriginator mesh__D019871 NDW
% 213.94/214.09  |- skos__broader mesh__D019871smesh__D040181
% 213.94/214.09  |- skos__scopeNote mesh__D019871
% 213.94/214.09       A predominantly X-linked recessive syndrome characterized by a triad of reticular skin pigmentation, nail dystrophy and leukoplakia of mucous membranes. Oral and dental abnormalities may also be present. Complications are a predisposition to malignancy and bone marrow involvement with pancytopenia. %28%from  Int J Paediatr Dent 2000 Dec;10%28%4%29%:328-34%29% The X-linked form is also known as Zinsser-Cole-Engman syndrome and involves the gene which encodes a highly conserved protein called dyskerin.%A%    
% 213.94/214.09  |- skos__hiddenLabel mesh__D019073 Cells, HT29
% 213.94/214.09  |- rdf__type mesh__D019073sskos__Concept
% 213.94/214.09  |- mesh__recordOriginator mesh__D019073 PXP
% 213.94/214.09  |- skos__historyNote mesh__D019073 Tumor Cells, Cultured %28%1988-1995%29%
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D019073 2005
% 213.94/214.09  |- mesh__dateEstablished mesh__D019073 1996-01-01
% 213.94/214.09  |- skos__hiddenLabel mesh__D019073 Cell, HT-29
% 213.94/214.09  |- skos__hiddenLabel mesh__D019073 Cell, HT29
% 213.94/214.09  |- skos__hiddenLabel mesh__D019073 Cells, HT-29
% 213.94/214.09  |- skos__prefLabel mesh__D019073 HT29 Cells
% 213.94/214.09  |- skos__historyNote mesh__D019073 Cell Line %28%1979-1995%29%
% 213.94/214.09  |- skos__broader mesh__D019073smesh__D045744
% 213.94/214.09  |- skos__hiddenLabel mesh__D019073 HT29 Cell
% 213.94/214.09  |- skos__historyNote mesh__D019073 Cells, Cultured %28%1979-1987%29%
% 213.94/214.09  |- skos__annotation mesh__D019073
% 213.94/214.09       almost always NIM with no subheadings; check HUMAN; do not routinely add ADENOCARCINOMA or COLONIC NEOPLASMS%A%  
% 213.94/214.09  |- mesh__historyNote mesh__D019073 96   
% 213.94/214.09  |- skos__scopeNote mesh__D019073
% 213.94/214.09       Human colonic ADENOCARCINOMA cells that are able to express differentiation features characteristic of mature intestinal cells such as the GOBLET CELLS.%A%    
% 213.94/214.09  |- skos__hiddenLabel mesh__D019073 HT 29 Cells
% 213.94/214.09  |- mesh__dateCreated mesh__D019073 1995-06-08
% 213.94/214.09  |- skos__altLabel mesh__D019073 HT-29 Cells
% 213.94/214.09  |- mesh__dateRevised mesh__D019073 2003-07-09
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D019073 2004
% 213.94/214.09  |- mesh__recordMaintainer mesh__D019073 nns
% 213.94/214.09  |- skos__broader mesh__D019073smesh__D004847
% 213.94/214.09  |- mesh__recordAuthorizer mesh__D019073 sjn
% 213.94/214.09  |- mesh__publicMeSHNote mesh__D019073 96   
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D019073 2006
% 213.94/214.09  |- skos__hiddenLabel mesh__D019073 HT-29 Cell
% 213.94/214.09  |- mesh__dateRevised mesh__D000368 2005-06-30
% 213.94/214.09  |- skos__related mesh__D000368smesh__D006707
% 213.94/214.09  |- skos__related mesh__D000368smesh__D012179
% 213.94/214.09  |- skos__broader mesh__D000368smesh__D000328
% 213.94/214.09  |- mesh__publicMeSHNote mesh__D000368
% 213.94/214.09       66; was see under GERIATRICS 1963-65   
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D000368 2006
% 213.94/214.09  |- mesh__onlineNote mesh__D000368 pre-explosion = AGED %28%PX%29%   
% 213.94/214.09  |- rdf__type mesh__D000368sskos__Concept
% 213.94/214.09  |- mesh__recordMaintainer mesh__D000368 ags
% 213.94/214.09  |- skos__scopeNote mesh__D000368
% 213.94/214.09       A person 65 through 79 years of age. For a person older than 79 years, AGED, 80 AND OVER is available.%A%    
% 213.94/214.09  |- mesh__recordAuthorizer mesh__D000368 sjn
% 213.94/214.09  |- mesh__recordOriginator mesh__D000368 NLM
% 213.94/214.09  |- skos__related mesh__D000368smesh__D010415
% 213.94/214.09  |- mesh__dateEstablished mesh__D000368 1966-01-01
% 213.94/214.09  |- skos__altLabel mesh__D000368 Elderly
% 213.94/214.09  |- mesh__dateCreated mesh__D000368 1999-01-01
% 213.94/214.09  |- skos__prefLabel mesh__D000368 Aged
% 213.94/214.09  |- skos__related mesh__D000368smesh__D016852
% 213.94/214.09  |- skos__annotation mesh__D000368
% 213.94/214.09       age 65-79; NIM as check tag; IM only as psychological or sociological entity; differentiate from AGING, a physiological process, %26% AGE FACTORS %26% AGE DISTRIBUTION, statistical concepts%A%  
% 213.94/214.09  |- mesh__historyNote mesh__D000368 66; was see under GERIATRICS 1963-65   
% 213.94/214.09  |- skos__related mesh__D000368smesh__D006299
% 213.94/214.09  |- mesh__publicMeSHNote mesh__D011090 74   
% 213.94/214.09  |- skos__prefLabel mesh__D011090 Polyenes
% 213.94/214.09  |- mesh__recordMaintainer mesh__D011090 sjn
% 213.94/214.09  |- mesh__recordOriginator mesh__D011090 NLM
% 213.94/214.09  |- mesh__recordAuthorizer mesh__D011090 sjn
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D011090 2006
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D011090 2004
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D011090 2005
% 213.94/214.09  |- mesh__dateEstablished mesh__D011090 1974-01-01
% 213.94/214.09  |- rdf__type mesh__D011090sskos__Concept
% 213.94/214.09  |- mesh__dateCreated mesh__D011090 1999-01-01
% 213.94/214.09  |- mesh__historyNote mesh__D011090 74   
% 213.94/214.09  |- skos__annotation mesh__D011090
% 213.94/214.09       polyene antibiotics: index under ANTI-BACTERIAL AGENTS %28%IM%29% + POLYENES %28%NIM%29%, using the same qualif for both%A%  
% 213.94/214.09  |- mesh__dateRevised mesh__D011090 2003-07-25
% 213.94/214.09  |- skos__broader mesh__D011090smesh__D000475
% 213.94/214.09  |- mesh__recordAuthorizer mesh__D005851 PLS
% 213.94/214.09  |- skos__broader mesh__D005851smesh__D013041
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D005851 1995
% 213.94/214.09  |- mesh__recordOriginator mesh__D005851 NLM
% 213.94/214.09  |- mesh__dateCreated mesh__D005851 1999-01-01
% 213.94/214.09  |- skos__historyNote mesh__D005851 Nursing %28%1966%29%
% 213.94/214.09  |- skos__scopeNote mesh__D005851
% 213.94/214.09       Nursing care of the aged patient given in the home, the hospital, or special institutions such as nursing homes, psychiatric institutions, etc.%A%    
% 213.94/214.09  |- mesh__historyNote mesh__D005851 67   
% 213.94/214.09  |- skos__historyNote mesh__D005851 Nursing Care %28%1966%29%
% 213.94/214.09  |- skos__historyNote mesh__D005851 Geriatrics %28%1966%29%
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D005851 2003
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D005851 2005
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D005851 2000
% 213.94/214.09  |- mesh__recordMaintainer mesh__D005851 TGC
% 213.94/214.09  |- mesh__dateEstablished mesh__D005851 1967-01-01
% 213.94/214.09  |- skos__hiddenLabel mesh__D005851 Nursings, Geriatric
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D005851 2004
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D005851 2001
% 213.94/214.09  |- mesh__publicMeSHNote mesh__D005851 67   
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D005851 2006
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D005851 1996
% 213.94/214.09  |- mesh__dateRevised mesh__D005851 1992-05-20
% 213.94/214.09  |- skos__broader mesh__D005851smesh__D009732
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D005851 1998
% 213.94/214.09  |- skos__annotation mesh__D005851 SPEC: SPEC qualif; check also tag AGED   
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D005851 1997
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D005851 1994
% 213.94/214.09  |- skos__altLabel mesh__D005851 Nursing, Geriatric
% 213.94/214.09  |- skos__prefLabel mesh__D005851 Geriatric Nursing
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D005851 1999
% 213.94/214.09  |- rdf__type mesh__D005851sskos__Concept
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D005851 1993
% 213.94/214.09  |- skos__hiddenLabel mesh__D005851 Geriatric Nursings
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D005851 2002
% 213.94/214.09  |- mesh__dateCreated mesh__D005053 1999-01-01
% 213.94/214.09  |- mesh__recordAuthorizer mesh__D005053 sjn
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D005053 2003
% 213.94/214.09  |- skos__broader mesh__D005053smesh__D005826
% 213.94/214.09  |- mesh__recordMaintainer mesh__D005053 PLS
% 213.94/214.09  |- rdf__type mesh__D005053sskos__Concept
% 213.94/214.09  |- skos__hiddenLabel mesh__D005053 Eugenics, Positive
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D005053 2004
% 213.94/214.09  |- skos__hiddenLabel mesh__D005053 Eugenics, Negative
% 213.94/214.09  |- mesh__dateRevised mesh__D005053 2002-07-03
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D005053 2005
% 213.94/214.09  |- skos__related mesh__D005053smesh__D005817
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D005053 2006
% 213.94/214.09  |- skos__prefLabel mesh__D005053 Eugenics
% 213.94/214.09  |- mesh__recordOriginator mesh__D005053 NLM
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D010796 2002
% 213.94/214.09  |- skos__scopeNote mesh__D010796
% 213.94/214.09       Phthalic acid anhydrides. Can be substituted on any carbon atom. Used extensively in industry and as a reagent in the acylation of amino- and hydroxyl groups.%A%    
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D010796 2006
% 213.94/214.09  |- skos__broader mesh__D010796smesh__D000812
% 213.94/214.09  |- skos__historyNote mesh__D010796 Phthalic Acids %28%1966-1978%29%
% 213.94/214.09  |- skos__prefLabel mesh__D010796 Phthalic Anhydrides
% 213.94/214.09  |- mesh__publicMeSHNote mesh__D010796
% 213.94/214.09       91; was see under PHTHALIC ACIDS 1979-90   
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D010796 2003
% 213.94/214.09  |- skos__historyNote mesh__D010796 Anhydrides %28%1966-1978%29%
% 213.94/214.09  |- mesh__dateCreated mesh__D010796 1977-12-15
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D010796 2004
% 213.94/214.09  |- skos__broader mesh__D010796smesh__D010795
% 213.94/214.09  |- mesh__recordAuthorizer mesh__D010796 sjn
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D010796 2001
% 213.94/214.09  |- mesh__recordOriginator mesh__D010796 RLS
% 213.94/214.09  |- rdf__type mesh__D010796sskos__Concept
% 213.94/214.09  |- mesh__recordMaintainer mesh__D010796 CCR
% 213.94/214.09  |- mesh__dateRevised mesh__D010796 2000-06-21
% 213.94/214.09  |- mesh__historyNote mesh__D010796
% 213.94/214.09       91%28%79%29%; was see under PHTHALIC ACIDS 1979-90   
% 213.94/214.09  |- skos__hiddenLabel mesh__D010796 Anhydrides, Phthalic
% 213.94/214.09  |- mesh__dateEstablished mesh__D010796 1991-01-01
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D010796 2005
% 213.94/214.09  |- mesh__recordMaintainer mesh__D051604 DRC
% 213.94/214.09  |- skos__hiddenLabel mesh__D051604 Guanylate Cyclase Activating Protein 3
% 213.94/214.09  |- mesh__publicMeSHNote mesh__D051604
% 213.94/214.09       2006; GUANYLATE CYCLASE-ACTIVATING PROTEINS  was indexed under CALCIUM-BINDING PROTEINS 1995-2005%A%  
% 213.94/214.09  |- skos__altLabel mesh__D051604 GCAP2 Protein
% 213.94/214.09  |- skos__prefLabel mesh__D051604 Guanylate Cyclase-Activating Proteins
% 213.94/214.09  |- mesh__dateEstablished mesh__D051604 2006-01-01
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D051604 2006
% 213.94/214.09  |- skos__scopeNote mesh__D051604
% 213.94/214.09       Neuronal calcium sensor proteins that regulate the activation of membrane-bound GUANYLATE CYCLASE. They are primarily expressed in the RETINA where they play an important role in PHOTOTRANSDUCTION.%A%    
% 213.94/214.09  |- skos__altLabel mesh__D051604 Guanylyl Cyclase-Activating Protein 1
% 213.94/214.09  |- skos__hiddenLabel mesh__D051604 Guanylate Cyclase Activating Protein 2
% 213.94/214.09  |- mesh__recordOriginator mesh__D051604 DRC
% 213.94/214.09  |- mesh__historyNote mesh__D051604 2006%28%1995%29%   
% 213.94/214.09  |- skos__hiddenLabel mesh__D051604 Guanylyl Cyclase Activating Protein 3
% 213.94/214.09  |- skos__hiddenLabel mesh__D051604 Guanylyl Cyclase Activating Protein 2
% 213.94/214.09  |- skos__broader mesh__D051604smesh__D005136
% 213.94/214.09  |- skos__altLabel mesh__D051604 GCAP1 Protein
% 213.94/214.09  |- skos__altLabel mesh__D051604 Guanylyl Cyclase-Activating Protein 2
% 213.94/214.09  |- skos__hiddenLabel mesh__D051604 Guanylyl Cyclase Activating Protein 1
% 213.94/214.09  |- skos__altLabel mesh__D051604 Guanylyl Cyclase Activating Proteins
% 213.94/214.09  |- skos__broader mesh__D051604smesh__D051580
% 213.94/214.09  |- skos__hiddenLabel mesh__D051604 Guanylate Cyclase Activating Protein 1
% 213.94/214.09  |- skos__altLabel mesh__D051604 GCAP Proteins
% 213.94/214.09  |- skos__altLabel mesh__D051604 Guanylyl Cyclase-Activating Protein 3
% 213.94/214.09  |- skos__altLabel mesh__D051604 GCAP3 Protein
% 213.94/214.09  |- rdf__type mesh__D051604sskos__Concept
% 213.94/214.09  |- skos__hiddenLabel mesh__D051604 Guanylate Cyclase Activating Proteins
% 213.94/214.09  |- mesh__recordAuthorizer mesh__D051604 sjn
% 213.94/214.09  |- mesh__dateCreated mesh__D051604 2005-06-30
% 213.94/214.09  |- mesh__dateRevised mesh__D004759 2005-06-30
% 213.94/214.09  |- mesh__recordOriginator mesh__D004759 NLM
% 213.94/214.09  |- skos__broader mesh__D004759smesh__D019858
% 213.94/214.09  |- skos__hiddenLabel mesh__D004759 Cell, Enterochromaffin
% 213.94/214.09  |- skos__hiddenLabel mesh__D004759 Cells, Enterochromaffin
% 213.94/214.09  |- skos__altLabel mesh__D004759 Argentaffin Cells
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D004759 2006
% 213.94/214.09  |- skos__broader mesh__D004759smesh__D007107
% 213.94/214.09  |- skos__hiddenLabel mesh__D004759 Argentaffin Cell
% 213.94/214.09  |- skos__hiddenLabel mesh__D004759 5-HT-Containing Enterochromaffin Cell
% 213.94/214.09  |- mesh__dateEstablished mesh__D004759 1991-01-01
% 213.94/214.09  |- skos__hiddenLabel mesh__D004759 Enterochromaffin Cell
% 213.94/214.09  |- mesh__publicMeSHNote mesh__D004759
% 213.94/214.09       91; was see under CHROMAFFIN SYSTEM 1975-90   
% 213.94/214.09  |- rdf__type mesh__D004759sskos__Concept
% 213.94/214.09  |- mesh__recordMaintainer mesh__D004759 lkt
% 213.94/214.09  |- mesh__recordAuthorizer mesh__D004759 sjn
% 213.94/214.09  |- skos__hiddenLabel mesh__D004759 Enterochromaffin Cell, 5-HT-Containing
% 213.94/214.09  |- skos__altLabel mesh__D004759 5-HT-Containing Enterochromaffin Cells
% 213.94/214.09  |- skos__hiddenLabel mesh__D004759
% 213.94/214.09       Serotonin-Containing Enterochromaffin Cell
% 213.94/214.09  |- skos__hiddenLabel mesh__D004759 Enterochromaffin Cells, 5-HT-Containing
% 213.94/214.09  |- skos__scopeNote mesh__D004759
% 213.94/214.09       A subtype of enteroendocrine cells found in the gastrointestinal MUCOSA, particularly in the glands of PYLORIC ANTRUM; DUODENUM; and ILEUM. These cells secrete mainly SEROTONIN and some neuropeptides. Their secretory granules stain readily with silver %28%argentaffin stain%29%.%A%    
% 213.94/214.09  |- skos__hiddenLabel mesh__D004759 5 HT Containing Enterochromaffin Cells
% 213.94/214.09  |- mesh__historyNote mesh__D004759
% 213.94/214.09       91%28%75%29%; was see under CHROMAFFIN SYSTEM 1975-90   
% 213.94/214.09  |- mesh__dateCreated mesh__D004759 1999-01-01
% 213.94/214.09  |- skos__hiddenLabel mesh__D004759
% 213.94/214.09       Serotonin Containing Enterochromaffin Cells
% 213.94/214.09  |- mesh__onlineNote mesh__D004759 search CHROMAFFIN SYSTEM 1968-74   
% 213.94/214.09  |- skos__broader mesh__D004759smesh__D005753
% 213.94/214.09  |- skos__broader mesh__D004759smesh__D002838
% 213.94/214.09  |- skos__altLabel mesh__D004759 Serotonin-Containing Enterochromaffin Cells
% 213.94/214.09  |- skos__hiddenLabel mesh__D004759
% 213.94/214.09       Enterochromaffin Cell, Serotonin-Containing
% 213.94/214.09  |- skos__prefLabel mesh__D004759 Enterochromaffin Cells
% 213.94/214.09  |- skos__hiddenLabel mesh__D004759
% 213.94/214.09       Enterochromaffin Cells, Serotonin-Containing
% 213.94/214.09  |- skos__related mesh__D004759smesh__D019861
% 213.94/214.09  |- skos__altLabel mesh__D015481 Human T Cell Leukemia Virus I Antibodies
% 213.94/214.09  |- skos__hiddenLabel mesh__D015481 Antibodies, ATLV
% 213.94/214.09  |- skos__scopeNote mesh__D015481
% 213.94/214.09       Antibodies reactive with the HTLV-I ANTIGENS.     
% 213.94/214.09  |- mesh__dateEstablished mesh__D015481 1988-01-01
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D015481 2006
% 213.94/214.09  |- mesh__recordMaintainer mesh__D015481 ssb
% 213.94/214.09  |- mesh__historyNote mesh__D015481 89   
% 213.94/214.09  |- skos__historyNote mesh__D015481 Antibodies, Viral %28%1982-1988%29%
% 213.94/214.09  |- skos__altLabel mesh__D015481 HTLV I Antibodies
% 213.94/214.09  |- mesh__dateCreated mesh__D015481 1988-06-10
% 213.94/214.09  |- mesh__recordOriginator mesh__D015481 RLS
% 213.94/214.09  |- skos__altLabel mesh__D015481
% 213.94/214.09       Leukemia-Lymphoma Virus I Antibodies, Human T-Cell
% 213.94/214.09  |- skos__altLabel mesh__D015481
% 213.94/214.09       Leukemia Lymphoma Virus I Antibodies, Human T Cell
% 213.94/214.09  |- skos__altLabel mesh__D015481 Human T-Cell Leukemia Virus I Antibodies
% 213.94/214.09  |- skos__prefLabel mesh__D015481 HTLV-I Antibodies
% 213.94/214.09  |- skos__altLabel mesh__D015481 T-Cell Leukemia Virus I Antibodies, Human
% 213.94/214.09  |- rdf__type mesh__D015481sskos__Concept
% 213.94/214.09  |- skos__altLabel mesh__D015481 T Cell Leukemia Virus I Antibodies, Human
% 213.94/214.09  |- skos__hiddenLabel mesh__D015481 Antibodies, HTLV-I
% 213.94/214.09  |- mesh__dateRevised mesh__D015481 2005-06-30
% 213.94/214.09  |- skos__altLabel mesh__D015481 T-Cell Leukemia Virus I Antibodies, Adult
% 213.94/214.09  |- skos__broader mesh__D015481smesh__D015480
% 213.94/214.09  |- skos__annotation mesh__D015481
% 213.94/214.09       do not coordinate with ANTIBODY FORMATION for /biosyn   
% 213.94/214.09  |- mesh__recordAuthorizer mesh__D015481 sjn
% 213.94/214.09  |- skos__altLabel mesh__D015481 ATLV Antibodies
% 213.94/214.09  |- skos__historyNote mesh__D015481
% 213.94/214.09       Human T-Cell Leukemia Virus/immunology %28%1984-1988%29%
% 213.94/214.09  |- skos__hiddenLabel mesh__D015481 Antibodies, HTLV I
% 213.94/214.09  |- skos__altLabel mesh__D015481 T Cell Leukemia Virus I Antibodies, Adult
% 213.94/214.09  |- mesh__publicMeSHNote mesh__D015481 89   
% 213.94/214.09  |- skos__hiddenLabel mesh__D015481 I Antibodies, HTLV
% 213.94/214.09  |- mesh__publicMeSHNote mesh__D009444
% 213.94/214.09       2005; see NEURITIS, EXPERIMENTAL ALLERGIC 1982-2004   
% 213.94/214.09  |- mesh__historyNote mesh__D009444 2005 %28%1982%29%   
% 213.94/214.09  |- skos__hiddenLabel mesh__D009444 Autoimmune Neuropathy, Experimental
% 213.94/214.09  |- skos__altLabel mesh__D009444 Neuritis, Experimental Autoimmune
% 213.94/214.09  |- skos__historyNote mesh__D009444 Peripheral Nerves %28%1966-1981%29%
% 213.94/214.09  |- skos__scopeNote mesh__D009444
% 213.94/214.09       An experimental animal model for the demyelinating disease of GUILLAINE-BARRE SYNDROME. In the most frequently used protocol, animals are injected with a peripheral nerve tissue protein homogenate. After approximately 2 weeks the animals develop a neuropathy secondary to a T cell-mediated autoimmune response directed towards the MYELIN P2 PROTEIN in peripheral nerves. Pathologic findings include a perivascular accumulation of macrophages and T lymphocytes in the peripheral nervous system, similar to that seen in the Guillaine-Barre syndrome. %28%From Adams et al., Principles of Neurology, 6th ed, p1314; J Neuroimmunol 1998 Apr 1;84%28%1%29%:40-52%29%%A%    
% 213.94/214.09  |- skos__altLabel mesh__D009444 Neuritis, Experimental Allergic
% 213.94/214.09  |- skos__altLabel mesh__D009444 Experimental Allergic Neuritis
% 213.94/214.09  |- skos__altLabel mesh__D009444
% 213.94/214.09       EAN %28%Experimental Autoimmune Neuritis%29%
% 213.94/214.09  |- mesh__dateEstablished mesh__D009444 1982-01-01
% 213.94/214.09  |- rdf__type mesh__D009444sskos__Concept
% 213.94/214.09  |- skos__hiddenLabel mesh__D009444 Autoimmune Neuropathies, Experimental
% 213.94/214.09  |- skos__altLabel mesh__D009444 Experimental Autoimmune Neuropathy
% 213.94/214.09  |- mesh__recordMaintainer mesh__D009444 lkt
% 213.94/214.09  |- mesh__dateRevised mesh__D009444 2004-07-07
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D009444 2005
% 213.94/214.09  |- skos__hiddenLabel mesh__D009444 Neuropathy, Experimental Autoimmune
% 213.94/214.09  |- skos__altLabel mesh__D009444 Allergic Neuritis, Experimental
% 213.94/214.09  |- mesh__recordOriginator mesh__D009444 AEP
% 213.94/214.09  |- skos__broader mesh__D009444smesh__D020721
% 213.94/214.09  |- skos__altLabel mesh__D009444 Experimental Autoimmune Neuritis
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D009444 2006
% 213.94/214.09  |- skos__altLabel mesh__D009444 Autoimmune Neuritis, Experimental
% 213.94/214.09  |- skos__broader mesh__D009444smesh__D009443
% 213.94/214.09  |- skos__hiddenLabel mesh__D009444 Neuropathies, Experimental Autoimmune
% 213.94/214.09  |- skos__historyNote mesh__D009444 Neuritis %28%1966-1981%29%
% 213.94/214.09  |- mesh__recordAuthorizer mesh__D009444 sjn
% 213.94/214.09  |- skos__prefLabel mesh__D009444 Neuritis, Autoimmune, Experimental
% 213.94/214.09  |- skos__historyNote mesh__D009444 Myelin Sheath %28%1966-1981%29%
% 213.94/214.09  |- skos__altLabel mesh__D009444 EAN %28%Experimental Allergic Neuritis%29%
% 213.94/214.09  |- skos__annotation mesh__D009444
% 213.94/214.09       coordinate with GUILLAINE-BARRE SYNDROME if pertinent; DF: NEURITIS EXPER ALLERGIC%A%  
% 213.94/214.09  |- mesh__dateCreated mesh__D009444 1981-02-23
% 213.94/214.09  |- skos__hiddenLabel mesh__D009444 Experimental Autoimmune Neuropathies
% 213.94/214.09  |- rdf__type mesh__D001461sskos__Concept
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D001461 1997
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D001461 2002
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D001461 1999
% 213.94/214.09  |- mesh__dateRevised mesh__D001461 1995-05-31
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D001461 2003
% 213.94/214.09  |- skos__related mesh__D001461smesh__D019024
% 213.94/214.09  |- skos__annotation mesh__D001461 SPEC: SPEC qualif   
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D001461 2005
% 213.94/214.09  |- skos__prefLabel mesh__D001461 Barbering
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D001461 2004
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D001461 2006
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D001461 2000
% 213.94/214.09  |- mesh__recordMaintainer mesh__D001461 TGC
% 213.94/214.09  |- mesh__recordAuthorizer mesh__D001461 PLS
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D001461 2001
% 213.94/214.09  |- mesh__recordOriginator mesh__D001461 NLM
% 213.94/214.09  |- skos__broader mesh__D001461smesh__D007221
% 213.94/214.09  |- skos__hiddenLabel mesh__D001461 Barberings
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D001461 1996
% 213.94/214.09  |- skos__scopeNote mesh__D001461
% 213.94/214.09       The occupation concerned with the cutting and dressing of the hair of customers and, of men, the shaving and trimming of the beard and mustache. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 213.94/214.09  |- mesh__dateCreated mesh__D001461 1999-01-01
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D001461 1998
% 213.94/214.09  |- skos__hiddenLabel mesh__D014389 Genital Tuberculosis, Male
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D014389 2003
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D014389 1998
% 213.94/214.09  |- skos__broader mesh__D014389smesh__D005832
% 213.94/214.09  |- skos__prefLabel mesh__D014389 Tuberculosis, Male Genital
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D014389 2000
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D014389 1992
% 213.94/214.09  |- mesh__dateCreated mesh__D014389 1999-01-01
% 213.94/214.09  |- skos__scopeNote mesh__D014389 Tuberculosis of the genitalia in men.     
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D014389 2005
% 213.94/214.09  |- mesh__activeMeSHYear mesh__D014389 1994
% 213.94/214.09  |- mesh__recordMaintainer mesh__D014389 PXP
% 213.94/214.09  |- skos__hiddenLabel mesh__D014389 Male Genital Tuberculosis
% 213.94/214.09  |- mesh__recordOriginator mesh__D014389 NLM
% 213.94/214.09  |- skos__hiddenLabel mesh__D014389 Tuberculoses, Male Genital
% 213.94/214.09  |- mesh__recordAuthorizer mesh__D014389 PLS
% 213.94/214.10  |- skos__hiddenLabel mesh__D014389 Genital Tuberculoses, Male
% 213.94/214.10  |- rdf__type mesh__D014389sskos__Concept
% 213.94/214.10  |- skos__annotation mesh__D014389
% 213.94/214.10       IM; coord IM with specific organ or organ /dis %28%IM%29%   
% 213.94/214.10  |- skos__hiddenLabel mesh__D014389 Male Genital Tuberculoses
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D014389 2002
% 213.94/214.10  |- mesh__dateRevised mesh__D014389 1991-06-12
% 213.94/214.10  |- skos__broader mesh__D014389smesh__D014401
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D014389 1997
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D014389 2004
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D014389 1999
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D014389 1993
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D014389 2001
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D014389 2006
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D014389 1996
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D014389 1995
% 213.94/214.10  |- mesh__publicMeSHNote mesh__D019872 98   
% 213.94/214.10  |- skos__hiddenLabel mesh__D019872 Zymogenic Cell, Gastric
% 213.94/214.10  |- skos__hiddenLabel mesh__D019872 Gastric Chief Cell
% 213.94/214.10  |- mesh__recordMaintainer mesh__D019872 lkt
% 213.94/214.10  |- skos__broader mesh__D019872smesh__D004847
% 213.94/214.10  |- skos__hiddenLabel mesh__D019872 Gastric Zymogenic Cell
% 213.94/214.10  |- skos__broader mesh__D019872smesh__D005753
% 213.94/214.10  |- skos__hiddenLabel mesh__D019872 Cell, Gastric Zymogenic
% 213.94/214.10  |- skos__prefLabel mesh__D019872 Chief Cells, Gastric
% 213.94/214.10  |- mesh__historyNote mesh__D019872 98   
% 213.94/214.10  |- skos__altLabel mesh__D019872 Gastric Zymogenic Cells
% 213.94/214.10  |- mesh__recordAuthorizer mesh__D019872 sjn
% 213.94/214.10  |- mesh__dateEstablished mesh__D019872 1998-01-01
% 213.94/214.10  |- skos__scopeNote mesh__D019872
% 213.94/214.10       Epithelial cells that line the basal half of the GASTRIC GLANDS. Chief cells synthesize and export an inactive enzyme PEPSINOGEN which is converted into the highly proteolytic enzyme PEPSIN in the acid environment of the STOMACH.%A%    
% 213.94/214.10  |- skos__hiddenLabel mesh__D019872 Cells, Gastric Zymogenic
% 213.94/214.10  |- mesh__dateRevised mesh__D019872 2005-06-30
% 213.94/214.10  |- mesh__dateCreated mesh__D019872 1997-06-20
% 213.94/214.10  |- mesh__recordOriginator mesh__D019872 AGS
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D019872 2006
% 213.94/214.10  |- skos__hiddenLabel mesh__D019872 Chief Cell, Gastric
% 213.94/214.10  |- rdf__type mesh__D019872sskos__Concept
% 213.94/214.10  |- skos__altLabel mesh__D019872 Gastric Chief Cells
% 213.94/214.10  |- skos__historyNote mesh__D019872 Gastric Mucosa %28%1966-1997%29%
% 213.94/214.10  |- skos__hiddenLabel mesh__D019872 Zymogenic Cells, Gastric
% 213.94/214.10  |- skos__hiddenLabel mesh__D019074 Arteries, Epigastric
% 213.94/214.10  |- skos__prefLabel mesh__D019074 Epigastric Arteries
% 213.94/214.10  |- mesh__publicMeSHNote mesh__D019074 96   
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D019074 1997
% 213.94/214.10  |- mesh__dateEstablished mesh__D019074 1996-01-01
% 213.94/214.10  |- skos__hiddenLabel mesh__D019074 Artery, Epigastric
% 213.94/214.10  |- mesh__historyNote mesh__D019074 96   
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D019074 1996
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D019074 1999
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D019074 2002
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D019074 2004
% 213.94/214.10  |- skos__historyNote mesh__D019074
% 213.94/214.10       Abdominal Muscles/blood supply %28%1966-1995%29%
% 213.94/214.10  |- mesh__dateCreated mesh__D019074 1995-05-26
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D019074 1998
% 213.94/214.10  |- skos__annotation mesh__D019074
% 213.94/214.10       nothing to do with stomach or gastric: read MeSH definition%A%  
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D019074 2001
% 213.94/214.10  |- skos__broader mesh__D019074smesh__D001158
% 213.94/214.10  |- skos__hiddenLabel mesh__D019074 Epigastric Artery
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D019074 2003
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D019074 2006
% 213.94/214.10  |- skos__scopeNote mesh__D019074
% 213.94/214.10       Inferior and external epigastric arteries arise from external iliac; superficial from femoral; superior from internal thoracic. They supply the abdominal muscles, diaphragm, iliac region, and groin. The inferior epigastric artery is used in coronary artery bypass grafting and myocardial revascularization.%A%    
% 213.94/214.10  |- rdf__type mesh__D019074sskos__Concept
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D019074 2000
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D019074 2005
% 213.94/214.10  |- skos__hiddenLabel mesh__D000369 Centenarian
% 213.94/214.10  |- mesh__publicMeSHNote mesh__D000369
% 213.94/214.10       87; CENTENARIANS, NONAGENARIANS, %26% OCTOGENARIANS were CENTENARIAN, NONAGENARIAN, %26% OCTOGENARIAN 1987-95%A%  
% 213.94/214.10  |- skos__hiddenLabel mesh__D000369 Octogenarian
% 213.94/214.10  |- skos__prefLabel mesh__D000369 Aged, 80 and over
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D000369 2006
% 213.94/214.10  |- skos__broader mesh__D000369smesh__D000368
% 213.94/214.10  |- rdf__type mesh__D000369sskos__Concept
% 213.94/214.10  |- mesh__recordMaintainer mesh__D000369 ags
% 213.94/214.10  |- mesh__dateRevised mesh__D000369 2005-06-30
% 213.94/214.10  |- skos__scopeNote mesh__D000369 A person 80 years of age and older.     
% 213.94/214.10  |- mesh__dateEstablished mesh__D000369 1987-01-01
% 213.94/214.10  |- skos__hiddenLabel mesh__D000369 Nonagenarian
% 213.94/214.10  |- skos__annotation mesh__D000369
% 213.94/214.10       NIM as check tag; IM only as psychological or sociological entity;  DF: AGED 80%A%  
% 213.94/214.10  |- skos__altLabel mesh__D000369 Oldest Old
% 213.94/214.10  |- mesh__recordAuthorizer mesh__D000369 sjn
% 213.94/214.10  |- mesh__dateCreated mesh__D000369 1986-03-25
% 213.94/214.10  |- mesh__recordOriginator mesh__D000369 EC
% 213.94/214.10  |- skos__historyNote mesh__D000369 Aged %28%1966-1986%29%
% 213.94/214.10  |- mesh__historyNote mesh__D000369
% 213.94/214.10       87; CENTENERIANS, NONAGENARIANS, %26% OCTOGENARIANS were CENTENARIAN, NONAGENARIAN, %26% OCTOGENARIAN 1987-95%A%  
% 213.94/214.10  |- mesh__publicMeSHNote mesh__D011091 77   
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D011091 2005
% 213.94/214.10  |- rdf__type mesh__D011091sskos__Concept
% 213.94/214.10  |- skos__prefLabel mesh__D011091 Polyesters
% 213.94/214.10  |- skos__broader mesh__D011091smesh__D011108
% 213.94/214.10  |- mesh__historyNote mesh__D011091 77   
% 213.94/214.10  |- mesh__dateRevised mesh__D011091 2004-07-07
% 213.94/214.10  |- mesh__recordMaintainer mesh__D011091 jmp
% 213.94/214.10  |- mesh__dateCreated mesh__D011091 1976-04-13
% 213.94/214.10  |- mesh__recordAuthorizer mesh__D011091 sjn
% 213.94/214.10  |- skos__scopeNote mesh__D011091
% 213.94/214.10       Polymers of organic acids and alcohols, with ester linkages--usually polyethylene terephthalate; can be cured into hard plastic, films or tapes, or fibers which can be woven into fabrics, meshes or velours.%A%    
% 213.94/214.10  |- mesh__dateEstablished mesh__D011091 1977-01-01
% 213.94/214.10  |- skos__historyNote mesh__D011091 Polymers %28%1966-1976%29%
% 213.94/214.10  |- mesh__recordOriginator mesh__D011091 SH
% 213.94/214.10  |- skos__annotation mesh__D011091 D25-26 qualif   
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D011091 2006
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D005852 2005
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D005852 2004
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D005852 2006
% 213.94/214.10  |- mesh__historyNote mesh__D005852 75   
% 213.94/214.10  |- skos__altLabel mesh__D005852 Psychogeriatrics
% 213.94/214.10  |- mesh__recordMaintainer mesh__D005852 TGC
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D005852 1996
% 213.94/214.10  |- mesh__dateRevised mesh__D005852 1991-08-23
% 213.94/214.10  |- skos__scopeNote mesh__D005852
% 213.94/214.10       A subspecialty of psychiatry concerned with the mental health of the aged.%A%    
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D005852 1998
% 213.94/214.10  |- skos__historyNote mesh__D005852 Psychiatry %28%1966-1974%29%
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D005852 2002
% 213.94/214.10  |- mesh__publicMeSHNote mesh__D005852 75   
% 213.94/214.10  |- mesh__recordAuthorizer mesh__D005852 PLS
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D005852 1992
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D005852 1997
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D005852 1994
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D005852 1999
% 213.94/214.10  |- skos__prefLabel mesh__D005852 Geriatric Psychiatry
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D005852 1993
% 213.94/214.10  |- mesh__recordOriginator mesh__D005852 NLM
% 213.94/214.10  |- rdf__type mesh__D005852sskos__Concept
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D005852 1995
% 213.94/214.10  |- mesh__dateCreated mesh__D005852 1974-11-11
% 213.94/214.10  |- mesh__dateEstablished mesh__D005852 1975-09-01
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D005852 2000
% 213.94/214.10  |- skos__altLabel mesh__D005852 Psychiatry, Geriatric
% 213.94/214.10  |- skos__broader mesh__D005852smesh__D011570
% 213.94/214.10  |- skos__annotation mesh__D005852
% 213.94/214.10       SPEC: SPEC qualif, not for mental disorders in the aged %28% = MENTAL DISORDERS %28%IM%29% + AGED %28%NIM%29% %29%: Manual 27.9%A%  
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D005852 2003
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D005852 2001
% 213.94/214.10  |- skos__prefLabel mesh__D005054 Eugenol
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D005054 2006
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D005054 2005
% 213.94/214.10  |- mesh__recordOriginator mesh__D005054 NLM
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D005054 2004
% 213.94/214.10  |- mesh__recordAuthorizer mesh__D005054 sjn
% 213.94/214.10  |- skos__scopeNote mesh__D005054
% 213.94/214.10       A cinnamate derivative of the shikamate pathway found in CLOVE OIL and other PLANTS.%A%    
% 213.94/214.10  |- rdf__type mesh__D005054sskos__Concept
% 213.94/214.10  |- mesh__dateRevised mesh__D005054 2003-07-09
% 213.94/214.10  |- skos__related mesh__D005054smesh__D015035
% 213.94/214.10  |- mesh__recordMaintainer mesh__D005054 ssb
% 213.94/214.10  |- mesh__dateCreated mesh__D005054 1999-01-01
% 213.94/214.10  |- skos__broader mesh__D005054smesh__D002109
% 213.94/214.10  |- skos__broader mesh__D010797smesh__D010795
% 213.94/214.10  |- skos__historyNote mesh__D010797 Phthalic Acids %28%1966-1974%29%
% 213.94/214.10  |- mesh__recordMaintainer mesh__D010797 TAP
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D010797 2001
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D010797 1995
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D010797 1993
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D010797 2006
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D010797 2000
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D010797 1999
% 213.94/214.10  |- mesh__recordOriginator mesh__D010797 NLM
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D010797 1994
% 213.94/214.10  |- skos__prefLabel mesh__D010797 Phthalimides
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D010797 2004
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D010797 1997
% 213.94/214.10  |- mesh__dateRevised mesh__D010797 1992-05-19
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D010797 2005
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D010797 1998
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D010797 2003
% 213.94/214.10  |- skos__scopeNote mesh__D010797 The imide of phthalic acids.     
% 213.94/214.10  |- mesh__dateEstablished mesh__D010797 1975-09-01
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D010797 1996
% 213.94/214.10  |- mesh__publicMeSHNote mesh__D010797 75   
% 213.94/214.10  |- skos__historyNote mesh__D010797 Imides %28%1966-1974%29%
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D010797 2002
% 213.94/214.10  |- rdf__type mesh__D010797sskos__Concept
% 213.94/214.10  |- mesh__historyNote mesh__D010797 75   
% 213.94/214.10  |- mesh__recordAuthorizer mesh__D010797 PLS
% 213.94/214.10  |- skos__broader mesh__D010797smesh__D007094
% 213.94/214.10  |- mesh__dateCreated mesh__D010797 1974-11-11
% 213.94/214.10  |- skos__altLabel mesh__D051605 Potassium Channel Interacting Proteins
% 213.94/214.10  |- skos__hiddenLabel mesh__D051605
% 213.94/214.10       A Type Potassium Channel Modulatory Proteins
% 213.94/214.10  |- skos__hiddenLabel mesh__D051605
% 213.94/214.10       A Type Potassium Channel Modulatory Protein 2
% 213.94/214.10  |- mesh__recordMaintainer mesh__D051605 ags
% 213.94/214.10  |- skos__hiddenLabel mesh__D051605 Protein, KChIP4
% 213.94/214.10  |- skos__altLabel mesh__D051605 KChIP Proteins
% 213.94/214.10  |- skos__hiddenLabel mesh__D051605 Kv Channel Interacting Protein 1
% 213.94/214.10  |- skos__hiddenLabel mesh__D051605 Kv Channel Interacting Proteins
% 213.94/214.10  |- skos__altLabel mesh__D051605
% 213.94/214.10       A-Type Potassium Channel Modulatory Protein 3
% 213.94/214.10  |- skos__prefLabel mesh__D051605 Kv Channel-Interacting Proteins
% 213.94/214.10  |- skos__altLabel mesh__D051605
% 213.94/214.10       A-Type Potassium Channel Modulatory Protein 1
% 213.94/214.10  |- skos__altLabel mesh__D051605 KChIP3 Protein
% 213.94/214.10  |- skos__hiddenLabel mesh__D051605 Kv Channel Interacting Protein 4
% 213.94/214.10  |- skos__altLabel mesh__D051605 KChIP4 Protein
% 213.94/214.10  |- mesh__dateCreated mesh__D051605 2005-06-30
% 213.94/214.10  |- mesh__recordAuthorizer mesh__D051605 ags
% 213.94/214.10  |- rdf__type mesh__D051605sskos__Concept
% 213.94/214.10  |- skos__hiddenLabel mesh__D051605
% 213.94/214.10       A Type Potassium Channel Modulatory Protein 3
% 213.94/214.10  |- skos__altLabel mesh__D051605
% 213.94/214.10       A-Type Potassium Channel Modulatory Protein 2
% 213.94/214.10  |- mesh__historyNote mesh__D051605 2006%28%1998%29%   
% 213.94/214.10  |- skos__altLabel mesh__D051605
% 213.94/214.10       Downstream Regulatory Element Antagonist Modulator
% 213.94/214.10  |- skos__altLabel mesh__D051605 Calsenilin
% 213.94/214.10  |- skos__hiddenLabel mesh__D051605 Kv Channel Interacting Protein 2
% 213.94/214.10  |- skos__altLabel mesh__D051605
% 213.94/214.10       Type A Potassium Channel Interacting Proteins
% 213.94/214.10  |- mesh__recordOriginator mesh__D051605 DRC
% 213.94/214.10  |- skos__hiddenLabel mesh__D051605
% 213.94/214.10       A Type Potassium Channel Modulatory Protein 4
% 213.94/214.10  |- skos__altLabel mesh__D051605
% 213.94/214.10       A-Type Potassium Channel Modulatory Proteins
% 213.94/214.10  |- skos__altLabel mesh__D051605 Calsenilin-Like Protein
% 213.94/214.10  |- skos__scopeNote mesh__D051605
% 213.94/214.10       A family of neuronal calcium-sensor proteins that interact with and regulate potassium channels, type A.%A%    
% 213.94/214.10  |- mesh__dateRevised mesh__D051605 2005-07-27
% 213.94/214.10  |- skos__altLabel mesh__D051605 KChIP1 Protein
% 213.94/214.10  |- skos__altLabel mesh__D051605 KChIP2 Protein
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D051605 2006A
% 213.94/214.10  |- skos__hiddenLabel mesh__D051605 Kv Channel Interacting Protein 3
% 213.94/214.10  |- mesh__publicMeSHNote mesh__D051605
% 213.94/214.10       2006; KV CHANNEL-INTERACTING PROTEIN 1 %26% KV CHANNEL-INTERACTING PROTEIN 2 were indexed under CALCIUM-BINDING PROTEINS 2000-2005; KV CHANNEL-INTERACTING PROTEIN 3 was indexed under CALCIUM-BINDING PROTEINS %26% REPRESSOR PROTEINS 1998-2005; KV CHANNEL-INTERACTING PROTEIN 4 was indexed under POTASSIUM-CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 2004%A%  
% 213.94/214.10  |- skos__hiddenLabel mesh__D051605
% 213.94/214.10       A Type Potassium Channel Modulatory Protein 1
% 213.94/214.10  |- skos__hiddenLabel mesh__D051605 Calsenilin Like Protein
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D051605 2006
% 213.94/214.10  |- skos__broader mesh__D051605smesh__D051580
% 213.94/214.10  |- mesh__dateEstablished mesh__D051605 2006-01-01
% 213.94/214.10  |- skos__altLabel mesh__D051605
% 213.94/214.10       A-Type Potassium Channel Modulatory Protein 4
% 213.94/214.10  |- skos__altLabel mesh__D015482
% 213.94/214.10       Leukemia-Lymphoma Virus II Antibodies, Human T-Cell
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D015482 2006
% 213.94/214.10  |- mesh__recordAuthorizer mesh__D015482 sjn
% 213.94/214.10  |- skos__prefLabel mesh__D015482 HTLV-II Antibodies
% 213.94/214.10  |- skos__historyNote mesh__D015482
% 213.94/214.10       Human T-Cell Leukemia Virus/immunology %28%1984-1988%29%
% 213.94/214.10  |- skos__scopeNote mesh__D015482
% 213.94/214.10       Antibodies reactive with the HTLV-II ANTIGENS.     
% 213.94/214.10  |- mesh__dateEstablished mesh__D015482 1989-01-01
% 213.94/214.10  |- skos__altLabel mesh__D015482 Human T Cell Leukemia Virus II Antibodies
% 213.94/214.10  |- mesh__dateCreated mesh__D015482 1988-06-10
% 213.94/214.10  |- skos__hiddenLabel mesh__D015482 II Antibodies, HTLV
% 213.94/214.10  |- skos__altLabel mesh__D015482 Human T-Cell Leukemia Virus II Antibodies
% 213.94/214.10  |- skos__altLabel mesh__D015482 T Cell Leukemia Virus II Antibodies, Human
% 213.94/214.10  |- skos__altLabel mesh__D015482 Human T-Lymphotropic Virus II Antibodies
% 213.94/214.10  |- mesh__recordMaintainer mesh__D015482 ssb
% 213.94/214.10  |- rdf__type mesh__D015482sskos__Concept
% 213.94/214.10  |- mesh__historyNote mesh__D015482 89   
% 213.94/214.10  |- skos__altLabel mesh__D015482 Human T Lymphotropic Virus II Antibodies
% 213.94/214.10  |- skos__altLabel mesh__D015482 HTLV II Antibodies
% 213.94/214.10  |- skos__historyNote mesh__D015482 Antibodies, Viral %28%1982-1988%29%
% 213.94/214.10  |- mesh__recordOriginator mesh__D015482 RLS
% 213.94/214.10  |- skos__altLabel mesh__D015482 T-Cell Leukemia Virus II Antibodies, Human
% 213.94/214.10  |- skos__altLabel mesh__D015482
% 213.94/214.10       Leukemia Lymphoma Virus II Antibodies, Human T Cell
% 213.94/214.10  |- mesh__publicMeSHNote mesh__D015482 89   
% 213.94/214.10  |- skos__hiddenLabel mesh__D015482 Antibodies, HTLV-II
% 213.94/214.10  |- skos__hiddenLabel mesh__D015482 Antibodies, HTLV II
% 213.94/214.10  |- mesh__dateRevised mesh__D015482 2005-06-30
% 213.94/214.10  |- skos__broader mesh__D015482smesh__D015480
% 213.94/214.10  |- skos__annotation mesh__D015482
% 213.94/214.10       do not coordinate with ANTIBODY FORMATION for /biosyn   
% 213.94/214.10  |- skos__annotation mesh__D009445
% 213.94/214.10       SPEC only, SPEC qualif; not for NERVOUS SYSTEM /anat   
% 213.94/214.10  |- skos__broader mesh__D009445smesh__D009488
% 213.94/214.10  |- mesh__recordAuthorizer mesh__D009445 sjn
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D009445 2004
% 213.94/214.10  |- skos__broader mesh__D009445smesh__D000715
% 213.94/214.10  |- mesh__dateRevised mesh__D009445 2001-07-25
% 213.94/214.10  |- rdf__type mesh__D009445sskos__Concept
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D009445 2005
% 213.94/214.10  |- skos__scopeNote mesh__D009445
% 213.94/214.10       Study of the anatomy of the nervous system as a specialty or discipline.%A%    
% 213.94/214.10  |- skos__hiddenLabel mesh__D009445 Neuroanatomies
% 213.94/214.10  |- mesh__dateEstablished mesh__D009445 1976-01-01
% 213.94/214.10  |- mesh__publicMeSHNote mesh__D009445 76   
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D009445 2006
% 213.94/214.10  |- mesh__recordMaintainer mesh__D009445 jls
% 213.94/214.10  |- skos__historyNote mesh__D009445
% 213.94/214.10       specific nervous system heading/anatomy %26% histology %28%1966-1975%29%
% 213.94/214.10  |- mesh__dateCreated mesh__D009445 1975-07-25
% 213.94/214.10  |- skos__altLabel mesh__D009445 Neuranatomy
% 213.94/214.10  |- mesh__recordOriginator mesh__D009445 SMH
% 213.94/214.10  |- skos__hiddenLabel mesh__D009445 Neuranatomies
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D009445 2002
% 213.94/214.10  |- mesh__historyNote mesh__D009445 76   
% 213.94/214.10  |- skos__prefLabel mesh__D009445 Neuroanatomy
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D009445 2003
% 213.94/214.10  |- mesh__publicMeSHNote mesh__D001462
% 213.94/214.10       91; was see under BARBITURATES 1976-90   
% 213.94/214.10  |- mesh__dateRevised mesh__D001462 2004-07-07
% 213.94/214.10  |- skos__altLabel mesh__D001462 Diethylmalonylurea
% 213.94/214.10  |- rdf__type mesh__D001462sskos__Concept
% 213.94/214.10  |- skos__altLabel mesh__D001462 Ethylbarbital
% 213.94/214.10  |- mesh__recordAuthorizer mesh__D001462 sjn
% 213.94/214.10  |- mesh__recordMaintainer mesh__D001462 mdb
% 213.94/214.10  |- skos__broader mesh__D001462smesh__D001463
% 213.94/214.10  |- skos__altLabel mesh__D001462 Faes Brand of Barbital
% 213.94/214.10  |- mesh__historyNote mesh__D001462
% 213.94/214.10       91%28%76%29%; was see under BARBITURATES 1976-90   
% 213.94/214.10  |- skos__altLabel mesh__D001462 Barbitone
% 213.94/214.10  |- mesh__dateCreated mesh__D001462 1975-07-21
% 213.94/214.10  |- skos__hiddenLabel mesh__D001462 Barbital Faes Brand
% 213.94/214.10  |- skos__scopeNote mesh__D001462
% 213.94/214.10       A long-acting barbiturate that depresses most metabolic processes at high doses. It is used as a hypnotic and sedative and may induce dependence. Barbital is also used in veterinary practice for central nervous system depression.%A%    
% 213.94/214.10  |- skos__historyNote mesh__D001462 Barbiturates %28%1968-1975%29%
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D001462 2006
% 213.94/214.10  |- skos__prefLabel mesh__D001462 Barbital
% 213.94/214.10  |- mesh__recordOriginator mesh__D001462 SH
% 213.94/214.10  |- mesh__dateEstablished mesh__D001462 1991-01-01
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D001462 2005
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D019873 2005
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D019873 2004
% 213.94/214.10  |- mesh__dateRevised mesh__D019873 2001-08-07
% 213.94/214.10  |- skos__broader mesh__D019873smesh__D008998
% 213.94/214.10  |- rdf__type mesh__D019873sskos__Concept
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D019873 2003
% 213.94/214.10  |- skos__prefLabel mesh__D019873 Schnitzler Syndrome
% 213.94/214.10  |- mesh__publicMeSHNote mesh__D019873 98   
% 213.94/214.10  |- mesh__historyNote mesh__D019873 98   
% 213.94/214.10  |- mesh__recordMaintainer mesh__D019873 sjn
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D019873 2002
% 213.94/214.10  |- mesh__dateCreated mesh__D019873 1997-06-20
% 213.94/214.10  |- mesh__dateEstablished mesh__D019873 1998-01-01
% 213.94/214.10  |- skos__scopeNote mesh__D019873
% 213.94/214.10       An extremely rare condition manifested as monoclonal IMMUNOGLOBULIN M dysproteinemia without features of lymphoproliferative disease, but with chronic urticaria, fever of unknown origin, disabling bone pain, hyperostosis, and increased erythrocyte sedimentation rate.%A%    
% 213.94/214.10  |- mesh__recordAuthorizer mesh__D019873 sjn
% 213.94/214.10  |- mesh__recordOriginator mesh__D019873 NDW
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D019873 2006
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D011890 2001
% 213.94/214.10  |- skos__hiddenLabel mesh__D011890 Subway
% 213.94/214.10  |- rdf__type mesh__D011890sskos__Concept
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D011890 2003
% 213.94/214.10  |- skos__broader mesh__D011890smesh__D014186
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D011890 2000
% 213.94/214.10  |- skos__scopeNote mesh__D011890
% 213.94/214.10       Permanent roads having a line of rails fixed to ties and laid to gage, usually on a leveled or graded ballasted roadbed and providing a track for freight cars, passenger cars, and other rolling stock. Cars are designed to be drawn by locomotives or sometimes propelled by self-contained motors. %28%From Webster%27%s 3d%29% The concept includes the organizational and administrative aspects of railroads as well.%A%    
% 213.94/214.10  |- mesh__recordAuthorizer mesh__D011890 SJN
% 213.94/214.10  |- mesh__dateRevised mesh__D011890 1997-06-20
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D011890 2006
% 213.94/214.10  |- mesh__recordMaintainer mesh__D011890 TGC
% 213.94/214.10  |- mesh__recordOriginator mesh__D011890 NLM
% 213.94/214.10  |- skos__prefLabel mesh__D011890 Railroads
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D011890 1999
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D011890 2005
% 213.94/214.10  |- mesh__dateCreated mesh__D011890 1999-01-01
% 213.94/214.10  |- skos__hiddenLabel mesh__D011890 Railroad
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D011890 2002
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D011890 1998
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D011890 2004
% 213.94/214.10  |- mesh__historyNote mesh__D019075 96   
% 213.94/214.10  |- skos__hiddenLabel mesh__D019075 Capillary Electrophoresis
% 213.94/214.10  |- mesh__recordMaintainer mesh__D019075 lkt
% 213.94/214.10  |- skos__annotation mesh__D019075
% 213.94/214.10       capillary refers to the highly sensitive equipment used; NIM%A%  
% 213.94/214.10  |- mesh__dateCreated mesh__D019075 1995-05-26
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D019075 2004
% 213.94/214.10  |- skos__broader mesh__D019075smesh__D004586
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D019075 2003
% 213.94/214.10  |- rdf__type mesh__D019075sskos__Concept
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D019075 2006
% 213.94/214.10  |- mesh__dateRevised mesh__D019075 2002-07-03
% 213.94/214.10  |- mesh__recordAuthorizer mesh__D019075 sjn
% 213.94/214.10  |- skos__hiddenLabel mesh__D019075 Capillary Electrophoreses
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D019075 2005
% 213.94/214.10  |- mesh__publicMeSHNote mesh__D019075 96   
% 213.94/214.10  |- mesh__dateEstablished mesh__D019075 1996-01-01
% 213.94/214.10  |- mesh__recordOriginator mesh__D019075 PXP
% 213.94/214.10  |- skos__prefLabel mesh__D019075 Electrophoresis, Capillary
% 213.94/214.10  |- skos__historyNote mesh__D019075
% 213.94/214.10       Electrophoresis/methods %28%1980-1995%29%
% 213.94/214.10  |- skos__scopeNote mesh__D019075
% 213.94/214.10       A highly-sensitive %28%in the picomolar range, which is 10,000-fold more sensitive than conventional electrophoresis%29% and efficient technique that allows separation of proteins, nucleic acids, and carbohydrates. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 213.94/214.10  |- skos__hiddenLabel mesh__D019075 Electrophoreses, Capillary
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 1000, PEG
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 6000, PEG
% 213.94/214.10  |- skos__altLabel mesh__D011092 PEG 6000
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 Carbowax400
% 213.94/214.10  |- skos__altLabel mesh__D011092 Macrogols
% 213.94/214.10  |- skos__altLabel mesh__D011092 Polyoxyethylenes
% 213.94/214.10  |- mesh__dateRevised mesh__D011092 2005-06-30
% 213.94/214.10  |- mesh__onlineNote mesh__D011092
% 213.94/214.10       to search TRITONS use POLYETHYLENE GLYCOLS 1975-82 %26% SURFACE-ACTIVE AGENTS 1966-74%A%  
% 213.94/214.10  |- rdf__type mesh__D011092sskos__Concept
% 213.94/214.10  |- skos__altLabel mesh__D011092 Polyethylene Oxide
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 4000, Polyethylene Glycol
% 213.94/214.10  |- mesh__publicMeSHNote mesh__D011092
% 213.94/214.10       74; TRITONS was heading 1975-82, was see under AMMONIUM COMPOUNDS 1975-78, was see under SURFACE-ACTIVE AGENTS 1963-74%A%  
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 PEO 400
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 2000, Polyethylene Glycol
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 Glycol 6000, Polyethylene
% 213.94/214.10  |- skos__scopeNote mesh__D011092
% 213.94/214.10       Polymers of ETHYLENE OXIDE and water and their ethers. They vary in consistency from liquid to solid, depending on the molecular weight, indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are lauromagrogols, nonoxynols, octoxynols and poloxamers.%A%    
% 213.94/214.10  |- mesh__dateEstablished mesh__D011092 1974-01-01
% 213.94/214.10  |- skos__altLabel mesh__D011092 Peg 400
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 Glycol, Polyethylene
% 213.94/214.10  |- mesh__dateCreated mesh__D011092 1999-01-01
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 6000, Polyethylene Glycol
% 213.94/214.10  |- skos__altLabel mesh__D011092 PEO-400
% 213.94/214.10  |- skos__altLabel mesh__D011092 Polyethyleneoxide
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 Glycol 2000, Polyethylene
% 213.94/214.10  |- skos__altLabel mesh__D011092 PEG-400
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 300, Polyethylene Glycol
% 213.94/214.10  |- mesh__recordMaintainer mesh__D011092 lkw
% 213.94/214.10  |- skos__prefLabel mesh__D011092 Polyethylene Glycols
% 213.94/214.10  |- skos__altLabel mesh__D011092 Polyethylene Glycol
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 Oxide, Polyethylene
% 213.94/214.10  |- skos__broader mesh__D011092smesh__D005026
% 213.94/214.10  |- mesh__historyNote mesh__D011092
% 213.94/214.10       74; TRITONS was heading 1975-82, was see under AMMONIUM COMPOUNDS 1975-78, was see under SURFACE-ACTIVE AGENTS 1963-74%A%  
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 300, Macrogol
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 400, Polyethylene Glycol
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 Glycol 300, Polyethylene
% 213.94/214.10  |- mesh__recordOriginator mesh__D011092 NLM
% 213.94/214.10  |- mesh__recordAuthorizer mesh__D011092 sjn
% 213.94/214.10  |- skos__altLabel mesh__D011092 Macrogol 300
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 Glycol 4000, Polyethylene
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 Glycols, Polyethylene
% 213.94/214.10  |- skos__broader mesh__D011092smesh__D011108
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 Carbowax 400
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D011092 2006
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 Glycol 400, Polyethylene
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 600, Carbowax
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 8000, PEG
% 213.94/214.10  |- skos__hiddenLabel mesh__D011092 FRA, Polyox
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D005853 1998
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D005853 2001
% 213.94/214.10  |- skos__broader mesh__D005853smesh__D008511
% 213.94/214.10  |- mesh__activeMeSHYear mesh__D005853 1997
% 213.94/214.11  |- skos__prefLabel mesh__D005853 Geriatrics
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D005853 1999
% 213.94/214.11  |- mesh__recordMaintainer mesh__D005853 TAP
% 213.94/214.11  |- rdf__type mesh__D005853sskos__Concept
% 213.94/214.11  |- mesh__dateCreated mesh__D005853 1999-01-01
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D005853 2002
% 213.94/214.11  |- mesh__dateRevised mesh__D005853 1996-06-10
% 213.94/214.11  |- mesh__recordAuthorizer mesh__D005853 PLS
% 213.94/214.11  |- skos__related mesh__D005853smesh__D000368
% 213.94/214.11  |- skos__scopeNote mesh__D005853
% 213.94/214.11       The branch of medicine concerned with the physiological and pathological aspects of the aged, including the clinical problems of senescence and senility.%A%    
% 213.94/214.11  |- skos__annotation mesh__D005853
% 213.94/214.11       SPEC: SPEC qualif; when permitted for %22%geriatric dis%22%: Manual 28.10.1; relation to AGED: Manual 34.10.1%A%  
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D005853 2003
% 213.94/214.11  |- mesh__recordOriginator mesh__D005853 NLM
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D005853 2005
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D005853 2004
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D005853 2006
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D005853 2000
% 213.94/214.11  |- skos__scopeNote mesh__D005055
% 213.94/214.11       An organism considered both a protozoon %28%Dorland, 27th ed%29% and an alga %28%Bold, Introduction to the Algae, 2d ed, p292%29%. Characteristics include a pellicle usually marked by spiral or longitudinal striations. Most are found in stagnant water.%A%    
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D005055 2005
% 213.94/214.11  |- skos__prefLabel mesh__D005055 Euglena
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D005055 2004
% 213.94/214.11  |- rdf__type mesh__D005055sskos__Concept
% 213.94/214.11  |- mesh__dateRevised mesh__D005055 2003-07-09
% 213.94/214.11  |- mesh__recordOriginator mesh__D005055 NLM
% 213.94/214.11  |- skos__annotation mesh__D005055
% 213.94/214.11       %22%considered both a protozoon %26% an alga%22%; in stagnant water%A%  
% 213.94/214.11  |- mesh__recordAuthorizer mesh__D005055 sjn
% 213.94/214.11  |- mesh__dateCreated mesh__D005055 1999-01-01
% 213.94/214.11  |- skos__broader mesh__D005055smesh__D016822
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D005055 2006
% 213.94/214.11  |- mesh__recordMaintainer mesh__D005055 ags
% 213.94/214.11  |- skos__annotation mesh__D010798 plant pigment proteins   
% 213.94/214.11  |- mesh__dateEstablished mesh__D010798 1991-01-01
% 213.94/214.11  |- mesh__recordMaintainer mesh__D010798 ssb
% 213.94/214.11  |- mesh__recordAuthorizer mesh__D010798 sjn
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D010798 2006
% 213.94/214.11  |- mesh__historyNote mesh__D010798
% 213.94/214.11       91%28%75%29%; was see under PIGMENTS 1975-90   
% 213.94/214.11  |- skos__broader mesh__D010798smesh__D010940
% 213.94/214.11  |- skos__scopeNote mesh__D010798
% 213.94/214.11       The metal-free blue phycobilin pigment in a conjugated chromoprotein of blue-green algae. It functions as light-absorbing substance together with chlorophylls.%A%    
% 213.94/214.11  |- skos__historyNote mesh__D010798 Plant Proteins %28%1971-1974%29%
% 213.94/214.11  |- skos__historyNote mesh__D010798 Pigments %28%1974%29%
% 213.94/214.11  |- skos__historyNote mesh__D010798 Bile Pigments %28%1971-1974%29%
% 213.94/214.11  |- skos__broader mesh__D010798smesh__D010860
% 213.94/214.11  |- mesh__recordOriginator mesh__D010798 NLM
% 213.94/214.11  |- rdf__type mesh__D010798sskos__Concept
% 213.94/214.11  |- mesh__dateRevised mesh__D010798 2005-06-30
% 213.94/214.11  |- mesh__publicMeSHNote mesh__D010798 91; was see under PIGMENTS 1975-90   
% 213.94/214.11  |- mesh__dateCreated mesh__D010798 1974-11-11
% 213.94/214.11  |- skos__prefLabel mesh__D010798 Phycocyanin
% 213.94/214.11  |- skos__hiddenLabel mesh__D010798 C Phycocyanin
% 213.94/214.11  |- skos__altLabel mesh__D051606 Opsin Kinase
% 213.94/214.11  |- skos__prefLabel mesh__D051606 Rhodopsin Kinase
% 213.94/214.11  |- skos__hiddenLabel mesh__D051606 G Protein Coupled Receptor Kinase 1
% 213.94/214.11  |- skos__hiddenLabel mesh__D051606 Kinase, Rhodopsin
% 213.94/214.11  |- rdf__type mesh__D051606sskos__Concept
% 213.94/214.11  |- skos__broader mesh__D051606smesh__D017346
% 213.94/214.11  |- skos__scopeNote mesh__D051606
% 213.94/214.11       A PROTEIN-SERINE-THREONINE KINASE that is found in PHOTORECEPTORS. It mediates light-dependent PHOSPHORYLATION of RHODOPSIN and plays an important role in PHOTOTRANSDUCTION.%A%    
% 213.94/214.11  |- mesh__recordAuthorizer mesh__D051606 sjn
% 213.94/214.11  |- mesh__recordMaintainer mesh__D051606 DRC
% 213.94/214.11  |- mesh__dateEstablished mesh__D051606 2006-01-01
% 213.94/214.11  |- mesh__dateCreated mesh__D051606 2005-06-30
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D051606 2006
% 213.94/214.11  |- mesh__publicMeSHNote mesh__D051606
% 213.94/214.11       2006; RHODOPSIN KINASE was indexed under EYE PROTEINS %26% PROTEIN KINASES 1983-2005, %26% under RHODOPSIN 1979-1982%A%  
% 213.94/214.11  |- skos__altLabel mesh__D051606 G Protein-Coupled Receptor Kinase 1
% 213.94/214.11  |- mesh__recordOriginator mesh__D051606 DRC
% 213.94/214.11  |- skos__hiddenLabel mesh__D051606 Kinase, Opsin
% 213.94/214.11  |- skos__broader mesh__D051606smesh__D005136
% 213.94/214.11  |- mesh__historyNote mesh__D051606 2006%28%1980%29% use RHODOPSIN 1979   
% 213.94/214.11  |- skos__hiddenLabel mesh__D015483 Antibodies, HTLV-III-LAV
% 213.94/214.11  |- skos__altLabel mesh__D015483 HTLV III LAV Antibodies
% 213.94/214.11  |- skos__broader mesh__D015483smesh__D015480
% 213.94/214.11  |- mesh__historyNote mesh__D015483 89   
% 213.94/214.11  |- mesh__recordOriginator mesh__D015483 SCD
% 213.94/214.11  |- mesh__recordAuthorizer mesh__D015483 sjn
% 213.94/214.11  |- skos__altLabel mesh__D015483
% 213.94/214.11       T-Lymphotropic Virus Type III Antibodies, Human
% 213.94/214.11  |- skos__hiddenLabel mesh__D015483 Antibodies, LAV
% 213.94/214.11  |- skos__hiddenLabel mesh__D015483 Antibodies, HIV
% 213.94/214.11  |- mesh__recordMaintainer mesh__D015483 ssb
% 213.94/214.11  |- skos__hiddenLabel mesh__D015483 Antibodies, Lymphadenopathy-Associated
% 213.94/214.11  |- skos__historyNote mesh__D015483 HIV/immunology %28%1988%29%
% 213.94/214.11  |- skos__hiddenLabel mesh__D015483 Antibodies, HIV-Associated
% 213.94/214.11  |- skos__prefLabel mesh__D015483 HIV Antibodies
% 213.94/214.11  |- skos__scopeNote mesh__D015483
% 213.94/214.11       Antibodies reactive with HIV ANTIGENS.     
% 213.94/214.11  |- skos__annotation mesh__D015483
% 213.94/214.11       coordinate IM with HIV-1/ immunol %28%IM%29% or HIV 2/ immunol %28%IM%29% if pertinent; do not coordinate with ANTIBODY FORMATION for /biosyn%A%  
% 213.94/214.11  |- mesh__dateEstablished mesh__D015483 1988-01-01
% 213.94/214.11  |- skos__hiddenLabel mesh__D015483 Antibodies, HIV Associated
% 213.94/214.11  |- skos__altLabel mesh__D015483
% 213.94/214.11       T Lymphotropic Virus Type III Antibodies, Human
% 213.94/214.11  |- skos__historyNote mesh__D015483 HTLV-III/immunology %28%1987%29%
% 213.94/214.11  |- skos__altLabel mesh__D015483 HTLV-III Antibodies
% 213.94/214.11  |- skos__hiddenLabel mesh__D015483 Antibodies, AIDS
% 213.94/214.11  |- rdf__type mesh__D015483sskos__Concept
% 213.94/214.11  |- skos__related mesh__D015483smesh__D015492
% 213.94/214.11  |- skos__altLabel mesh__D015483 Lymphadenopathy Associated Antibodies
% 213.94/214.11  |- skos__historyNote mesh__D015483
% 213.94/214.11       Human T-Cell Leukemia Virus/immunology %28%1986-1987%29%
% 213.94/214.11  |- skos__hiddenLabel mesh__D015483 Antibodies, Lymphadenopathy Associated
% 213.94/214.11  |- skos__altLabel mesh__D015483 HIV Associated Antibodies
% 213.94/214.11  |- skos__hiddenLabel mesh__D015483 Antibodies, HTLV III
% 213.94/214.11  |- skos__altLabel mesh__D015483 LAV Antibodies
% 213.94/214.11  |- skos__altLabel mesh__D015483 HTLV-III-LAV Antibodies
% 213.94/214.11  |- mesh__dateRevised mesh__D015483 2005-06-30
% 213.94/214.11  |- mesh__dateCreated mesh__D015483 1988-06-10
% 213.94/214.11  |- mesh__publicMeSHNote mesh__D015483 89   
% 213.94/214.11  |- skos__historyNote mesh__D015483 Antibodies, Viral %28%1986-1988%29%
% 213.94/214.11  |- skos__hiddenLabel mesh__D015483 Antibodies, HTLV-III
% 213.94/214.11  |- skos__altLabel mesh__D015483 Lymphadenopathy-Associated Antibodies
% 213.94/214.11  |- skos__altLabel mesh__D015483 AIDS Antibodies
% 213.94/214.11  |- skos__altLabel mesh__D015483 HIV-Associated Antibodies
% 213.94/214.11  |- skos__altLabel mesh__D015483 HTLV III Antibodies
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D015483 2006
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D009446 2004
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D009446 2003
% 213.94/214.11  |- mesh__recordMaintainer mesh__D009446 jls
% 213.94/214.11  |- mesh__dateCreated mesh__D009446 1985-06-06
% 213.94/214.11  |- skos__altLabel mesh__D009446 Neurobiology, Cellular
% 213.94/214.11  |- rdf__type mesh__D009446sskos__Concept
% 213.94/214.11  |- mesh__recordAuthorizer mesh__D009446 sjn
% 213.94/214.11  |- skos__broader mesh__D009446smesh__D001695
% 213.94/214.11  |- skos__prefLabel mesh__D009446 Neurobiology
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D009446 2002
% 213.94/214.11  |- mesh__historyNote mesh__D009446 86   
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D009446 2006
% 213.94/214.11  |- mesh__dateRevised mesh__D009446 2001-07-25
% 213.94/214.11  |- skos__annotation mesh__D009446 SPEC: SPEC qualif; DF: NEUROBIOL   
% 213.94/214.11  |- skos__altLabel mesh__D009446 Neurobiology, Molecular
% 213.94/214.11  |- mesh__dateEstablished mesh__D009446 1986-01-01
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D009446 2005
% 213.94/214.11  |- skos__broader mesh__D009446smesh__D009488
% 213.94/214.11  |- mesh__recordOriginator mesh__D009446 EC
% 213.94/214.11  |- mesh__publicMeSHNote mesh__D009446 86   
% 213.94/214.11  |- rdf__type mesh__D001463sskos__Concept
% 213.94/214.11  |- skos__related mesh__D001463smesh__D000927
% 213.94/214.11  |- mesh__dateCreated mesh__D001463 1999-01-01
% 213.94/214.11  |- skos__prefLabel mesh__D001463 Barbiturates
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D001463 2004
% 213.94/214.11  |- mesh__recordMaintainer mesh__D001463 ssb
% 213.94/214.11  |- mesh__dateRevised mesh__D001463 2003-07-09
% 213.94/214.11  |- mesh__recordOriginator mesh__D001463 NLM
% 213.94/214.11  |- mesh__historyNote mesh__D001463
% 213.94/214.11       /adv eff-pois-tox was BARBITURATE TOXICOLOGY 1963-65   
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D001463 2006
% 213.94/214.11  |- mesh__recordAuthorizer mesh__D001463 sjn
% 213.94/214.11  |- skos__annotation mesh__D001463 GEN or unspecified; prefer specifics   
% 213.94/214.11  |- skos__related mesh__D001463smesh__D018686
% 213.94/214.11  |- mesh__publicMeSHNote mesh__D001463
% 213.94/214.11       /adverse effects /poisoning /toxicity were BARBITURATE TOXICOLOGY 1963-65%A%  
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D001463 2005
% 213.94/214.11  |- skos__broader mesh__D001463smesh__D011744
% 213.94/214.11  |- skos__scopeNote mesh__D001463
% 213.94/214.11       A class of chemicals derived from barbituric acid or thiobarbituric acid. Many of these are GABA MODULATORS used as HYPNOTICS AND SEDATIVES, as ANESTHETICS, or as ANTICONVULSANTS.%A%    
% 213.94/214.11  |- skos__related mesh__D001463smesh__D006993
% 213.94/214.11  |- mesh__dateRevised mesh__D011891 2004-07-07
% 213.94/214.11  |- mesh__recordOriginator mesh__D011891 NLM
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D011891 2006
% 213.94/214.11  |- mesh__onlineNote mesh__D011891 search WEATHER 1969-74   
% 213.94/214.11  |- skos__hiddenLabel mesh__D011891 Rains
% 213.94/214.11  |- mesh__recordMaintainer mesh__D011891 nns
% 213.94/214.11  |- mesh__dateCreated mesh__D011891 1999-01-01
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D011891 2005
% 213.94/214.11  |- skos__broader mesh__D011891smesh__D014867
% 213.94/214.11  |- skos__broader mesh__D011891smesh__D014887
% 213.94/214.11  |- mesh__historyNote mesh__D011891
% 213.94/214.11       91%28%75%29%; was see under WEATHER 1975-90   
% 213.94/214.11  |- skos__scopeNote mesh__D011891
% 213.94/214.11       Water particles that fall from the ATMOSPHERE.     
% 213.94/214.11  |- skos__prefLabel mesh__D011891 Rain
% 213.94/214.11  |- mesh__publicMeSHNote mesh__D011891 91; was see under WEATHER 1975-90   
% 213.94/214.11  |- rdf__type mesh__D011891sskos__Concept
% 213.94/214.11  |- mesh__recordAuthorizer mesh__D011891 sjn
% 213.94/214.11  |- mesh__dateEstablished mesh__D011891 1991-01-01
% 213.94/214.11  |- rdf__type mesh__D019076sskos__Concept
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D019076 2006
% 213.94/214.11  |- skos__related mesh__D019076smesh__D018014
% 213.94/214.11  |- skos__hiddenLabel mesh__D019076 Transgene, Recombinant
% 213.94/214.11  |- skos__hiddenLabel mesh__D019076 Transgenes, Recombinant
% 213.94/214.11  |- skos__prefLabel mesh__D019076 Transgenes
% 213.94/214.11  |- skos__scopeNote mesh__D019076
% 213.94/214.11       Genes that are introduced into an organism using GENE TRANSFER TECHNIQUES.%A%    
% 213.94/214.11  |- skos__broader mesh__D019076smesh__D005796
% 213.94/214.11  |- mesh__recordOriginator mesh__D019076 PXP
% 213.94/214.11  |- mesh__recordMaintainer mesh__D019076 nns
% 213.94/214.11  |- skos__related mesh__D019076smesh__D030801
% 213.94/214.11  |- mesh__dateRevised mesh__D019076 2005-06-30
% 213.94/214.11  |- skos__hiddenLabel mesh__D019076 Transgene
% 213.94/214.11  |- skos__hiddenLabel mesh__D019076 Recombinant Transgene
% 213.94/214.11  |- skos__related mesh__D019076smesh__D030821
% 213.94/214.11  |- mesh__recordAuthorizer mesh__D019076 sjn
% 213.94/214.11  |- mesh__publicMeSHNote mesh__D019076 96   
% 213.94/214.11  |- mesh__dateEstablished mesh__D019076 1996-01-01
% 213.94/214.11  |- mesh__historyNote mesh__D019076 96   
% 213.94/214.11  |- skos__related mesh__D019076smesh__D030781
% 213.94/214.11  |- mesh__dateCreated mesh__D019076 1995-05-26
% 213.94/214.11  |- mesh__recordMaintainer mesh__D011093 jmp
% 213.94/214.11  |- rdf__type mesh__D011093sskos__Concept
% 213.94/214.11  |- mesh__recordAuthorizer mesh__D011093 sjn
% 213.94/214.11  |- mesh__recordOriginator mesh__D011093 NLM
% 213.94/214.11  |- mesh__dateEstablished mesh__D011093 1973-01-01
% 213.94/214.11  |- mesh__historyNote mesh__D011093
% 213.94/214.11       93; was POLYETHYLENE TEREPHTHALATE 1973-92   
% 213.94/214.11  |- skos__prefLabel mesh__D011093 Polyethylene Terephthalates
% 213.94/214.11  |- skos__scopeNote mesh__D011093
% 213.94/214.11       Polyester polymers formed from terephthalic acid or its esters and ethylene glycol. They can be formed into tapes, films or pulled into fibers that are pressed into meshes or woven into fabrics.%A%    
% 213.94/214.11  |- skos__broader mesh__D011093smesh__D011091
% 213.94/214.11  |- skos__hiddenLabel mesh__D011093 Terephthalate, Polyethylene
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D011093 2005
% 213.94/214.11  |- mesh__publicMeSHNote mesh__D011093
% 213.94/214.11       93; was POLYETHYLENE TEREPHTHALATE 1973-92   
% 213.94/214.11  |- mesh__dateCreated mesh__D011093 1999-01-01
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D011093 2006
% 213.94/214.11  |- mesh__dateRevised mesh__D011093 2004-07-07
% 213.94/214.11  |- skos__altLabel mesh__D011093 Polyethylene Terephthalate
% 213.94/214.11  |- skos__hiddenLabel mesh__D011093 Terephthalates, Polyethylene
% 213.94/214.11  |- skos__historyNote mesh__D011093 Polymers %28%1966-1972%29%
% 213.94/214.11  |- mesh__onlineNote mesh__D011093
% 213.94/214.11       use POLYETHYLENE TEREPHTHALATES to search POLYETHYLENE TEREPHTHALATE 1973-92%A%  
% 213.94/214.11  |- skos__annotation mesh__D011093 D25-26 qualif   
% 213.94/214.11  |- mesh__dateRevised mesh__D005854 2001-07-25
% 213.94/214.11  |- skos__hiddenLabel mesh__D005854 Germ Line Cells
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D005854 2003
% 213.94/214.11  |- mesh__recordOriginator mesh__D005854 NLM
% 213.94/214.11  |- mesh__recordAuthorizer mesh__D005854 sjn
% 213.94/214.11  |- skos__hiddenLabel mesh__D005854 Cell, Germ-Line
% 213.94/214.11  |- skos__hiddenLabel mesh__D005854 Gamete
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D005854 2006
% 213.94/214.11  |- skos__prefLabel mesh__D005854 Germ Cells
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D005854 2002
% 213.94/214.11  |- skos__broader mesh__D005854smesh__D002477
% 213.94/214.11  |- skos__hiddenLabel mesh__D005854 Germ-Line Cell
% 213.94/214.11  |- skos__broader mesh__D005854smesh__D005835
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D005854 2005
% 213.94/214.11  |- skos__hiddenLabel mesh__D005854 Cells, Germ-Line
% 213.94/214.11  |- skos__hiddenLabel mesh__D005854 Germ Lines
% 213.94/214.11  |- skos__hiddenLabel mesh__D005854 Germ Cell
% 213.94/214.11  |- skos__altLabel mesh__D005854 Germ-Line Cells
% 213.94/214.11  |- rdf__type mesh__D005854sskos__Concept
% 213.94/214.11  |- skos__annotation mesh__D005854
% 213.94/214.11       GEN; prefer specific OVUM or SPERMATOZOA; A 11 qualif %26% /growth%A%  
% 213.94/214.11  |- skos__scopeNote mesh__D005854
% 213.94/214.11       The reproductive cells in multicellular organisms.     
% 213.94/214.11  |- skos__hiddenLabel mesh__D005854 Cell, Germ
% 213.94/214.11  |- skos__hiddenLabel mesh__D005854 Cells, Germ
% 213.94/214.11  |- mesh__recordMaintainer mesh__D005854 nns
% 213.94/214.11  |- mesh__dateCreated mesh__D005854 1999-01-01
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D005854 2004
% 213.94/214.11  |- skos__altLabel mesh__D005854 Gametes
% 213.94/214.11  |- skos__broader mesh__D005056smesh__D005055
% 213.94/214.11  |- rdf__type mesh__D005056sskos__Concept
% 213.94/214.11  |- mesh__recordAuthorizer mesh__D005056 sjn
% 213.94/214.11  |- mesh__historyNote mesh__D005056 72   
% 213.94/214.11  |- skos__annotation mesh__D005056
% 213.94/214.11       %22%considered both a protozoon %26% an alga%22%   
% 213.94/214.11  |- skos__historyNote mesh__D005056 Euglena %28%1966-1971%29%
% 213.94/214.11  |- mesh__dateCreated mesh__D005056 1999-01-01
% 213.94/214.11  |- skos__scopeNote mesh__D005056
% 213.94/214.11       An organism considered both a protozoon %28%Dorland, 27th ed%29% and an alga %28%Bold, Introduction to the Algae, 2d ed, p292%29%. It is a flagellate organism commonly found in stagnant water.%A%    
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D005056 2006
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D005056 2005
% 213.94/214.11  |- mesh__recordMaintainer mesh__D005056 ags
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D005056 2004
% 213.94/214.11  |- mesh__dateEstablished mesh__D005056 1972-01-01
% 213.94/214.11  |- mesh__dateRevised mesh__D005056 2003-07-09
% 213.94/214.11  |- mesh__publicMeSHNote mesh__D005056 72   
% 213.94/214.11  |- mesh__recordOriginator mesh__D005056 NLM
% 213.94/214.11  |- skos__prefLabel mesh__D005056 Euglena gracilis
% 213.94/214.11  |- mesh__recordOriginator mesh__D010799 NLM
% 213.94/214.11  |- mesh__dateRevised mesh__D010799 2005-06-30
% 213.94/214.11  |- skos__historyNote mesh__D010799 Bile Pigments %28%1972-1974%29%
% 213.94/214.11  |- skos__broader mesh__D010799smesh__D010860
% 213.94/214.11  |- rdf__type mesh__D010799sskos__Concept
% 213.94/214.11  |- skos__scopeNote mesh__D010799
% 213.94/214.11       The metal-free red phycobilin pigment in a conjugated chromoprotein of red algae. It functions as a light-absorbing substance together with chlorophylls.%A%    
% 213.94/214.11  |- mesh__dateCreated mesh__D010799 1974-11-11
% 213.94/214.11  |- mesh__historyNote mesh__D010799
% 213.94/214.11       91%28%75%29%; was see under PIGMENTS 1975-90   
% 213.94/214.11  |- mesh__recordAuthorizer mesh__D010799 sjn
% 213.94/214.11  |- mesh__recordMaintainer mesh__D010799 ssb
% 213.94/214.11  |- skos__broader mesh__D010799smesh__D010940
% 213.94/214.11  |- skos__annotation mesh__D010799 a plant pigment protein   
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D010799 2006
% 213.94/214.11  |- skos__historyNote mesh__D010799 Pigments %28%1974%29%
% 213.94/214.11  |- mesh__dateEstablished mesh__D010799 1991-01-01
% 213.94/214.11  |- skos__historyNote mesh__D010799 Plant Proteins %28%1972-1974%29%
% 213.94/214.11  |- mesh__publicMeSHNote mesh__D010799 91; was see under PIGMENTS 1975-90   
% 213.94/214.11  |- skos__prefLabel mesh__D010799 Phycoerythrin
% 213.94/214.11  |- skos__altLabel mesh__D051607 CDP-Diglyceride-Inositol Transferase
% 213.94/214.11  |- skos__altLabel mesh__D051607
% 213.94/214.11       CDP-1,2-Diacyl-sn-Glycerol-Myoinositol 3-Phosphatidyltransferase
% 213.94/214.11  |- skos__broader mesh__D051607smesh__D017855
% 213.94/214.11  |- skos__hiddenLabel mesh__D051607
% 213.94/214.11       Cytidine 5%27% Diphosphate 1,2 Diacyl sn Glycerol   Inositol Transferase
% 213.94/214.11  |- skos__hiddenLabel mesh__D051607 CDP Diglyceride Inositoltransferase
% 213.94/214.11  |- skos__altLabel mesh__D051607
% 213.94/214.11       Cytidine 5%27%-Diphosphate 1,2-Diacyl-sn-Glycerol - Inositol Transferase
% 213.94/214.11  |- skos__altLabel mesh__D051607
% 213.94/214.11       CDPdiglyceride-Inositol Phosphatidyltransferase
% 213.94/214.11  |- skos__altLabel mesh__D051607
% 213.94/214.11       CDPdiacylglycerol-Inositol 3-Phosphatidyltransferase
% 213.94/214.11  |- mesh__recordMaintainer mesh__D051607 AKE
% 213.94/214.11  |- skos__hiddenLabel mesh__D051607
% 213.94/214.11       CDP Diacylglycerol Inositol 3 Phosphatidyltransferase
% 213.94/214.11  |- skos__altLabel mesh__D051607 CDP-DG Inositol Transferase
% 213.94/214.11  |- skos__hiddenLabel mesh__D051607
% 213.94/214.11       Phosphatidyltransferase, CDPdiglyceride-Inositol
% 213.94/214.11  |- skos__hiddenLabel mesh__D051607 CDP Diglyceride Inositol Transferase
% 213.94/214.11  |- skos__altLabel mesh__D051607 Inositol Phosphatidyltransferase
% 213.94/214.11  |- skos__hiddenLabel mesh__D051607
% 213.94/214.11       3-Phosphatidyltransferase, CDP-Diacylglycerol-Myo-Inositol
% 213.94/214.11  |- skos__hiddenLabel mesh__D051607
% 213.94/214.11       CDPdiacylglycerol Inositol 3 Phosphatidyltransferase
% 213.94/214.11  |- skos__hiddenLabel mesh__D051607
% 213.94/214.11       CDP Diacylglycerol Myo Inositol 3 Phosphatidyltransferase
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D051607 2006
% 213.94/214.11  |- mesh__recordOriginator mesh__D051607 AKE
% 213.94/214.11  |- skos__hiddenLabel mesh__D051607
% 213.94/214.11       3-Phosphatidyltransferase, CDP-1,2-Diacyl-sn-Glycerol-Myoinositol
% 213.94/214.11  |- skos__altLabel mesh__D051607
% 213.94/214.11       CDP-Diacylglycerol-Myo-Inositol 3-Phosphatidyltransferase
% 213.94/214.11  |- mesh__publicMeSHNote mesh__D051607
% 213.94/214.11       2006; CDP-DIACYLGLYCEROL-INOSITOL 3-PHOSPHATIDYLTRANSFERASE was indexed under TRANSFERASES %28%OTHER SUBSTITUTED PHOSPHATE GROUPS%29% 1970-2005, under PHOSPHOINOSITIDES 1970-1977, %26% under TRANSFERASES 1970-1972%A%  
% 213.94/214.11  |- skos__prefLabel mesh__D051607
% 213.94/214.11       CDP-Diacylglycerol-Inositol 3-Phosphatidyltransferase
% 213.94/214.11  |- mesh__recordAuthorizer mesh__D051607 sjn
% 213.94/214.11  |- skos__hiddenLabel mesh__D051607 Phosphatidyltransferase, Inositol
% 213.94/214.11  |- skos__hiddenLabel mesh__D051607
% 213.94/214.11       CDP 1,2 Diacyl sn Glycerol Myoinositol 3 Phosphatidyltransferase
% 213.94/214.11  |- mesh__dateEstablished mesh__D051607 2006-01-01
% 213.94/214.11  |- mesh__dateCreated mesh__D051607 2005-06-30
% 213.94/214.11  |- mesh__historyNote mesh__D051607
% 213.94/214.11       2006%28%1980%29%; use PHOSPHOINOSITIDES 1970-1977, TRANSFERASES 1970-1972, %26% TRANSFERASES %28%OTHER SUBSTITUTED PHOSPHATE GROUPS%29% 1970-1979%A%  
% 213.94/214.11  |- skos__altLabel mesh__D051607 Phosphatidylinositol Synthase
% 213.94/214.11  |- skos__hiddenLabel mesh__D051607
% 213.94/214.11       CDPdiglyceride Inositol Phosphatidyltransferase
% 213.94/214.11  |- skos__altLabel mesh__D051607 CDP-Diglyceride-Inositoltransferase
% 213.94/214.11  |- skos__hiddenLabel mesh__D051607 CDP DG Inositol Transferase
% 213.94/214.11  |- skos__scopeNote mesh__D051607
% 213.94/214.11       An enzyme that catalyzes the formation of PHOSPHATIDYLINOSITOL and CMP from CDP-DIACYLGLYCEROL and MYOINOSITOL.%A%    
% 213.94/214.11  |- skos__hiddenLabel mesh__D051607
% 213.94/214.11       3-Phosphatidyltransferase, CDP-Diacylglycerol-Inositol
% 213.94/214.11  |- rdf__type mesh__D051607sskos__Concept
% 213.94/214.11  |- skos__hiddenLabel mesh__D051607
% 213.94/214.11       3-Phosphatidyltransferase, CDPdiacylglycerol-Inositol
% 213.94/214.11  |- skos__scopeNote mesh__D009447
% 213.94/214.11       A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. %28%From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10%28%1%29%:43-51%29%%A%    
% 213.94/214.11  |- mesh__recordAuthorizer mesh__D009447 jls
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D009447 2003
% 213.94/214.11  |- rdf__type mesh__D009447sskos__Concept
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D009447 2000
% 213.94/214.11  |- skos__prefLabel mesh__D009447 Neuroblastoma
% 213.94/214.11  |- mesh__recordMaintainer mesh__D009447 jls
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D009447 2006
% 213.94/214.11  |- skos__hiddenLabel mesh__D009447 Neuroblastomas
% 213.94/214.11  |- mesh__recordOriginator mesh__D009447 NLM
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D009447 2005
% 213.94/214.11  |- skos__broader mesh__D009447smesh__D018241
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D009447 2002
% 213.94/214.11  |- mesh__dateRevised mesh__D009447 2004-07-29
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D009447 2005A
% 213.94/214.11  |- skos__annotation mesh__D009447
% 213.94/214.11       coord IM with precoord organ/neopl term %28%IM%29%; for NEUROBLASTOMA, RETINAL see RETINOBLASTOMA%A%  
% 213.94/214.11  |- mesh__dateCreated mesh__D009447 1999-01-01
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D009447 2004
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D009447 2001
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D001464 1998
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D001464 2003
% 213.94/214.11  |- skos__prefLabel mesh__D001464 Barium
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D001464 2000
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D001464 2006
% 213.94/214.11  |- skos__related mesh__D001464smesh__D001465
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D001464 2005
% 213.94/214.11  |- skos__scopeNote mesh__D001464
% 213.94/214.11       An element of the alkaline earth group of metals. It has an atomic symbol Ba, atomic number 56, and atomic weight 138. All of its acid-soluble salts are poisonous.%A%    
% 213.94/214.11  |- mesh__activeMeSHYear mesh__D001464 2002
% 213.94/214.11  |- mesh__recordAuthorizer mesh__D001464 SJN
% 213.94/214.11  |- skos__annotation mesh__D001464
% 213.94/214.11       an alkaline earth metal; Ba-138; Ba-130, 132, 134-137 = BARIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Ba-126-129, 131, 133, 139-143 = BARIUM RADIOISOTOPES %28%IM%29%; barium enema = BARIUM SULFATE /diag use + ENEMA%A%  
% 213.94/214.11  |- skos__broader mesh__D001464smesh__D008673
% 213.94/214.11  |- mesh__recordMaintainer mesh__D001464 ADP
% 213.94/214.11  |- rdf__type mesh__D001464sskos__Concept
% 213.94/214.11  |- mesh__dateCreated mesh__D001464 1999-01-01
% 213.97/214.11  |- mesh__recordOriginator mesh__D001464 NLM
% 213.97/214.11  |- mesh__dateRevised mesh__D001464 1997-06-20
% 213.97/214.11  |- mesh__activeMeSHYear mesh__D001464 1999
% 213.97/214.11  |- mesh__activeMeSHYear mesh__D001464 2004
% 213.97/214.11  |- skos__broader mesh__D001464smesh__D019216
% 213.97/214.11  |- mesh__activeMeSHYear mesh__D001464 2001
% 213.97/214.11  |- mesh__activeMeSHYear mesh__D028601 2002
% 213.97/214.11  |- skos__related mesh__D028601smesh__D017236
% 213.97/214.11  |- skos__altLabel mesh__D028601 Active Euthanasia
% 213.97/214.11  |- skos__broader mesh__D028601smesh__D005065
% 213.97/214.11  |- mesh__activeMeSHYear mesh__D028601 2003
% 213.97/214.11  |- mesh__activeMeSHYear mesh__D028601 2005
% 213.97/214.11  |- mesh__activeMeSHYear mesh__D028601 2004
% 213.97/214.11  |- skos__annotation mesh__D028601 human only   
% 213.97/214.11  |- mesh__historyNote mesh__D028601 2002   
% 213.97/214.11  |- skos__related mesh__D028601smesh__D005066
% 213.97/214.11  |- skos__scopeNote mesh__D028601
% 213.97/214.11       The act or practice of killing for reasons of mercy, i.e., in order to release a person or animal from incurable disease, intolerable suffering, or undignified death. %28%from Beauchamp and Walters, Contemporary Issues in Bioethics, 5th ed%29%%A%    
% 213.97/214.11  |- mesh__activeMeSHYear mesh__D028601 2006
% 213.97/214.11  |- mesh__publicMeSHNote mesh__D028601 2002   
% 213.97/214.11  |- mesh__dateCreated mesh__D028601 2001-07-25
% 213.97/214.11  |- mesh__recordMaintainer mesh__D028601 jls
% 213.97/214.11  |- rdf__type mesh__D028601sskos__Concept
% 213.97/214.11  |- mesh__recordAuthorizer mesh__D028601 jls
% 213.97/214.11  |- mesh__dateRevised mesh__D028601 2002-10-31
% 213.97/214.11  |- skos__prefLabel mesh__D028601 Euthanasia, Active
% 213.97/214.11  |- mesh__recordOriginator mesh__D028601 jrf
% 213.97/214.11  |- skos__historyNote mesh__D028601 Euthanasia %28%1974-2001%29%
% 213.97/214.11  |- mesh__activeMeSHYear mesh__D028601 2003A
% 213.97/214.11  |- mesh__dateEstablished mesh__D028601 2002-01-01
% 213.97/214.11  |- skos__broader mesh__D006281Q000193smesh__D006281
% 213.97/214.11  |- rdf__type mesh__D006281Q000193smesh__CompoundConcept
% 213.97/214.11  |- mesh__publicMeSHNote mesh__D019875 98   
% 213.97/214.11  |- mesh__dateEstablished mesh__D019875 1998-01-01
% 213.97/214.11  |- skos__prefLabel mesh__D019875 One-Carbon Group Transferases
% 213.97/214.11  |- skos__hiddenLabel mesh__D019875 Transferases, One-Carbon Group
% 213.97/214.11  |- mesh__dateCreated mesh__D019875 1997-06-20
% 213.97/214.11  |- mesh__activeMeSHYear mesh__D019875 2006
% 213.97/214.11  |- mesh__dateRevised mesh__D019875 2003-07-09
% 213.97/214.11  |- skos__hiddenLabel mesh__D019875 Single Carbon Group Transferases
% 213.97/214.11  |- skos__scopeNote mesh__D019875
% 213.97/214.11       A subclass of transferases that transfer chemical groups containing a single carbon. These include the METHYLTRANSFERASES, the HYDROXYMETHYL AND FORMYL TRANSFERASES, the CARBOXYL AND CARBAMOYL TRANSFERASES, and the AMIDINOTRANSFERASES. EC 2.1.%A%    
% 213.97/214.11  |- mesh__activeMeSHYear mesh__D019875 2005
% 213.97/214.11  |- mesh__activeMeSHYear mesh__D019875 2004
% 213.97/214.11  |- skos__hiddenLabel mesh__D019875 Transferases, Single-Carbon Group
% 213.97/214.11  |- rdf__type mesh__D019875sskos__Concept
% 213.97/214.11  |- skos__broader mesh__D019875smesh__D014166
% 213.97/214.11  |- skos__hiddenLabel mesh__D019875 One Carbon Group Transferases
% 213.97/214.11  |- skos__altLabel mesh__D019875 Single-Carbon Group Transferases
% 213.97/214.11  |- mesh__historyNote mesh__D019875 98   
% 213.97/214.12  |- mesh__dateRevised mesh__D011892 2003-07-09
% 213.97/214.12  |- skos__broader mesh__D011892smesh__D011898
% 213.97/214.12  |- skos__scopeNote mesh__D011892
% 213.97/214.12       A species of the family Ranidae %28%true frogs%29%. The only anuran properly referred to by the common name %22%bullfrog%22%, it is the largest native anuran in North America.%A%    
% 213.97/214.12  |- mesh__dateCreated mesh__D011892 1999-01-01
% 213.97/214.12  |- mesh__dateEstablished mesh__D011892 1972-01-01
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D011892 2005
% 213.97/214.12  |- mesh__recordOriginator mesh__D011892 NLM
% 213.97/214.12  |- skos__historyNote mesh__D011892 Anura %28%1966-1971%29%
% 213.97/214.12  |- skos__altLabel mesh__D011892 Bullfrog
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D011892 2004
% 213.97/214.12  |- mesh__publicMeSHNote mesh__D011892 72   
% 213.97/214.12  |- rdf__type mesh__D011892sskos__Concept
% 213.97/214.12  |- mesh__recordMaintainer mesh__D011892 ags
% 213.97/214.12  |- skos__hiddenLabel mesh__D011892 Rana catesbeianas
% 213.97/214.12  |- skos__hiddenLabel mesh__D011892 catesbeiana, Rana
% 213.97/214.12  |- skos__annotation mesh__D011892
% 213.97/214.12       bullfrog; NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 213.97/214.12  |- skos__hiddenLabel mesh__D011892 catesbeianas, Rana
% 213.97/214.12  |- mesh__historyNote mesh__D011892 72   
% 213.97/214.12  |- skos__hiddenLabel mesh__D011892 Bullfrogs
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D011892 2006
% 213.97/214.12  |- mesh__recordAuthorizer mesh__D011892 sjn
% 213.97/214.12  |- skos__prefLabel mesh__D011892 Rana catesbeiana
% 213.97/214.12  |- mesh__recordAuthorizer mesh__D019077 sjn
% 213.97/214.12  |- mesh__onlineNote mesh__D019077
% 213.97/214.12       use HELIX-LOOP-HELIX MOTIFS to search HELIX-TURN-HELIX MOTIFS 1994-95%A%  
% 213.97/214.12  |- skos__hiddenLabel mesh__D019077 Motifs, Helix Turn Helix
% 213.97/214.12  |- skos__altLabel mesh__D019077 HTH Motifs
% 213.97/214.12  |- skos__hiddenLabel mesh__D019077 HTH Motif
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D019077 2006
% 213.97/214.12  |- rdf__type mesh__D019077sskos__Concept
% 213.97/214.12  |- skos__hiddenLabel mesh__D019077 Helix Turn Helix Motifs
% 213.97/214.12  |- skos__hiddenLabel mesh__D019077 Motifs, HTH
% 213.97/214.12  |- skos__annotation mesh__D019077
% 213.97/214.12       do not confuse with HELIX-LOOP-HELIX MOTIFS   
% 213.97/214.12  |- skos__hiddenLabel mesh__D019077 Helix-Turn-Helix Motif
% 213.97/214.12  |- skos__hiddenLabel mesh__D019077 Motif, HTH
% 213.97/214.12  |- skos__broader mesh__D019077smesh__D018257
% 213.97/214.12  |- skos__scopeNote mesh__D019077
% 213.97/214.12       The first DNA-binding protein motif to be recognized. Helix-turn-helix motifs were originally identified in bacterial proteins but have since been found in hundreds of DNA-BINDING PROTEINS from both eukaryotes and prokaryotes. They are constructed from two alpha helices connected by a short extended chain of amino acids, which constitute the %22%turn.%22% The two helices are held at a fixed angle, primarily through interactions between the two helices. %28%From Alberts et al., Molecular Biology of the Cell, 3d ed, p408-9%29%%A%    
% 213.97/214.12  |- mesh__dateRevised mesh__D019077 2004-07-07
% 213.97/214.12  |- mesh__recordMaintainer mesh__D019077 nns
% 213.97/214.12  |- mesh__historyNote mesh__D019077
% 213.97/214.12       96; was see HELIX-LOOP-HELIX MOTIFS 1994-95   
% 213.97/214.12  |- skos__altLabel mesh__D019077 Motifs, Helix-Turn-Helix
% 213.97/214.12  |- skos__hiddenLabel mesh__D019077 Motif, Helix-Turn-Helix
% 213.97/214.12  |- mesh__recordOriginator mesh__D019077 PXP
% 213.97/214.12  |- skos__historyNote mesh__D019077
% 213.97/214.12       Helix-Loop-Helix Motifs %28%1994-1995%29%
% 213.97/214.12  |- mesh__publicMeSHNote mesh__D019077
% 213.97/214.12       96; was see HELIX-LOOP-HELIX MOTIFS 1994-95   
% 213.97/214.12  |- skos__historyNote mesh__D019077 Amino Acid Sequence %28%1985-1994%29%
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D019077 2005
% 213.97/214.12  |- skos__prefLabel mesh__D019077 Helix-Turn-Helix Motifs
% 213.97/214.12  |- mesh__dateEstablished mesh__D019077 1996-01-01
% 213.97/214.12  |- mesh__dateCreated mesh__D019077 1995-05-26
% 213.97/214.12  |- skos__altLabel mesh__D011094 Polyethylenimine
% 213.97/214.12  |- skos__annotation mesh__D011094 D25-26 qualif   
% 213.97/214.12  |- skos__historyNote mesh__D011094 Imines %28%1973-1974%29%
% 213.97/214.12  |- mesh__recordAuthorizer mesh__D011094 sjn
% 213.97/214.12  |- skos__broader mesh__D011094smesh__D011095
% 213.97/214.12  |- skos__broader mesh__D011094smesh__D007097
% 213.97/214.12  |- mesh__recordOriginator mesh__D011094 NLM
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D011094 2005
% 213.97/214.12  |- mesh__dateEstablished mesh__D011094 1991-01-01
% 213.97/214.12  |- skos__prefLabel mesh__D011094 Polyethyleneimine
% 213.97/214.12  |- mesh__dateCreated mesh__D011094 1974-11-19
% 213.97/214.12  |- mesh__historyNote mesh__D011094
% 213.97/214.12       91%28%75%29%; was see under POLYETHYLENES 1975-90   
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D011094 2006
% 213.97/214.12  |- mesh__dateRevised mesh__D011094 2004-07-07
% 213.97/214.12  |- skos__altLabel mesh__D011094 Polyaziridine
% 213.97/214.12  |- mesh__recordMaintainer mesh__D011094 jmp
% 213.97/214.12  |- mesh__publicMeSHNote mesh__D011094
% 213.97/214.12       91; was see under POLYETHYLENES 1975-90   
% 213.97/214.12  |- rdf__type mesh__D011094sskos__Concept
% 213.97/214.12  |- skos__scopeNote mesh__D011094
% 213.97/214.12       Strongly cationic polymer that binds to certain proteins; used as a marker in immunology, to precipitate and purify enzymes and lipids. Synonyms: aziridine polymer; Epamine; Epomine; ethylenimine polymer; Montrek; PEI; Polymin%28%e%29%.%A%    
% 213.97/214.12  |- skos__historyNote mesh__D011094 Polyethylenes %28%1973-1974%29%
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005855 2001
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005855 2006
% 213.97/214.12  |- skos__hiddenLabel mesh__D005855 Layers, Germ
% 213.97/214.12  |- skos__scopeNote mesh__D005855
% 213.97/214.12       The three layers of cells comprising the early embryo.     
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005855 1993
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005855 1996
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005855 2000
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005855 2005
% 213.97/214.12  |- skos__broader mesh__D005855smesh__D004622
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005855 1999
% 213.97/214.12  |- mesh__recordOriginator mesh__D005855 NLM
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005855 1992
% 213.97/214.12  |- mesh__recordMaintainer mesh__D005855 PLS
% 213.97/214.12  |- rdf__type mesh__D005855sskos__Concept
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005855 1995
% 213.97/214.12  |- skos__hiddenLabel mesh__D005855 Layer, Germ
% 213.97/214.12  |- mesh__recordAuthorizer mesh__D005855 NLM
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005855 1998
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005855 2002
% 213.97/214.12  |- skos__hiddenLabel mesh__D005855 Germ Layer
% 213.97/214.12  |- skos__prefLabel mesh__D005855 Germ Layers
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005855 1994
% 213.97/214.12  |- mesh__dateCreated mesh__D005855 1999-01-01
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005855 2004
% 213.97/214.12  |- skos__annotation mesh__D005855 A 11 qualif   
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005855 2003
% 213.97/214.12  |- mesh__dateRevised mesh__D005855 1990-05-26
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005855 1991
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005855 1997
% 213.97/214.12  |- skos__hiddenLabel mesh__D005057 Eukaryotic Cell
% 213.97/214.12  |- skos__prefLabel mesh__D005057 Eukaryotic Cells
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005057 1994
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005057 2000
% 213.97/214.12  |- skos__broader mesh__D005057smesh__D002477
% 213.97/214.12  |- skos__hiddenLabel mesh__D005057 Cell, Eukaryotic
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005057 2006
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005057 1999
% 213.97/214.12  |- mesh__dateRevised mesh__D005057 1990-04-13
% 213.97/214.12  |- mesh__recordMaintainer mesh__D005057 NLM
% 213.97/214.12  |- mesh__historyNote mesh__D005057
% 213.97/214.12       91%28%78%29%; was see under CELLS 1978-90   
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005057 1993
% 213.97/214.12  |- skos__historyNote mesh__D005057
% 213.97/214.12       appropriate cell, organism, subcellular fraction, or process
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005057 1991
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005057 2005
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005057 1998
% 213.97/214.12  |- mesh__dateCreated mesh__D005057 1977-03-01
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005057 1992
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005057 2004
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005057 1997
% 213.97/214.12  |- mesh__recordAuthorizer mesh__D005057 PLS
% 213.97/214.12  |- mesh__publicMeSHNote mesh__D005057 91; was see under CELLS 1978-90   
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005057 2002
% 213.97/214.12  |- mesh__recordOriginator mesh__D005057 AEP
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005057 2003
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005057 1996
% 213.97/214.12  |- rdf__type mesh__D005057sskos__Concept
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005057 2001
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005057 1995
% 213.97/214.12  |- skos__hiddenLabel mesh__D005057 Cells, Eukaryotic
% 213.97/214.12  |- skos__annotation mesh__D005057 A 11 qualif with discretion   
% 213.97/214.12  |- mesh__dateEstablished mesh__D005057 1991-01-01
% 213.97/214.12  |- skos__scopeNote mesh__D005057
% 213.97/214.12       Cells of the higher organisms, containing a true nucleus bounded by a nuclear membrane.%A%    
% 213.97/214.12  |- mesh__recordAuthorizer mesh__D015485 sjn
% 213.97/214.12  |- mesh__dateEstablished mesh__D015485 1988-01-01
% 213.97/214.12  |- mesh__recordMaintainer mesh__D015485 ssb
% 213.97/214.12  |- skos__hiddenLabel mesh__D015485 Antigens, HTLV-BLV
% 213.97/214.12  |- skos__altLabel mesh__D015485
% 213.97/214.12       T-Cell Leukemia-Lymphoma Virus Antigens, Human
% 213.97/214.12  |- mesh__dateCreated mesh__D015485 1988-06-10
% 213.97/214.12  |- skos__altLabel mesh__D015485 Human T Cell Leukemia Virus Antigens
% 213.97/214.12  |- skos__altLabel mesh__D015485 Human T-Cell Leukemia Virus Antigens
% 213.97/214.12  |- skos__annotation mesh__D015485 GEN or unspecified: prefer specifics   
% 213.97/214.12  |- skos__altLabel mesh__D015485
% 213.97/214.12       T Cell Leukemia Lymphoma Virus Antigens, Human
% 213.97/214.12  |- skos__altLabel mesh__D015485
% 213.97/214.12       Leukemia-Lymphoma Virus Antigens, Human T-Cell
% 213.97/214.12  |- skos__historyNote mesh__D015485 HTLV-III/immunology %28%1987%29%
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D015485 2006
% 213.97/214.12  |- skos__hiddenLabel mesh__D015485 Antigens, Deltaretrovirus
% 213.97/214.12  |- skos__hiddenLabel mesh__D015485 Antigens, BLV
% 213.97/214.12  |- skos__prefLabel mesh__D015485 Deltaretrovirus Antigens
% 213.97/214.12  |- skos__historyNote mesh__D015485 Antigens, Viral %28%1983-1988%29%
% 213.97/214.12  |- skos__altLabel mesh__D015485 HTLV Antigens
% 213.97/214.12  |- skos__hiddenLabel mesh__D015485 Antigens, HTLV
% 213.97/214.12  |- skos__hiddenLabel mesh__D015485 HTLV BLV Antigens
% 213.97/214.12  |- skos__historyNote mesh__D015485 HIV/immunology %28%1988%29%
% 213.97/214.12  |- mesh__recordOriginator mesh__D015485 SCD
% 213.97/214.12  |- mesh__publicMeSHNote mesh__D015485
% 213.97/214.12       2003; see HTLV-BLV ANTIGENS 1995-2002, see HTLV ANTIGENS 1989-1994%A%  
% 213.97/214.12  |- mesh__historyNote mesh__D015485 2003 %28%1989%29%   
% 213.97/214.12  |- skos__altLabel mesh__D015485 HTLV-BLV Antigens
% 213.97/214.12  |- skos__scopeNote mesh__D015485
% 213.97/214.12       Antigens associated with the DELTARETROVIRUS; HTLV-I ANTIGENS and HTLV-II ANTIGENS belong to this group.%A%    
% 213.97/214.12  |- skos__historyNote mesh__D015485
% 213.97/214.12       Human T-Cell Leukemia Virus/immunology %28%1984-1987%29%
% 213.97/214.12  |- rdf__type mesh__D015485sskos__Concept
% 213.97/214.12  |- skos__broader mesh__D015485smesh__D000956
% 213.97/214.12  |- mesh__dateRevised mesh__D015485 2005-06-30
% 213.97/214.12  |- skos__altLabel mesh__D015485 Leukemia Virus Antigens, Human T Cell
% 213.97/214.12  |- mesh__recordOriginator mesh__D009448 NLM
% 213.97/214.12  |- mesh__recordAuthorizer mesh__D009448 sjn
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D009448 2006
% 213.97/214.12  |- skos__broader mesh__D009448smesh__D001671
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D009448 2002
% 213.97/214.12  |- skos__annotation mesh__D009448
% 213.97/214.12       SPEC: SPEC qualif; not for NERVE TISSUE /chem   
% 213.97/214.12  |- skos__broader mesh__D009448smesh__D009488
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D009448 2005
% 213.97/214.12  |- mesh__dateRevised mesh__D009448 2001-07-25
% 213.97/214.12  |- skos__prefLabel mesh__D009448 Neurochemistry
% 213.97/214.12  |- mesh__dateCreated mesh__D009448 1999-01-01
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D009448 2004
% 213.97/214.12  |- mesh__recordMaintainer mesh__D009448 jls
% 213.97/214.12  |- mesh__dateEstablished mesh__D009448 1964-01-01
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D009448 2003
% 213.97/214.12  |- mesh__historyNote mesh__D009448 64   
% 213.97/214.12  |- rdf__type mesh__D009448sskos__Concept
% 213.97/214.12  |- mesh__publicMeSHNote mesh__D009448 64   
% 213.97/214.12  |- skos__hiddenLabel mesh__D009448 Neurochemistries
% 213.97/214.12  |- skos__broader mesh__D001465smesh__D011868
% 213.97/214.12  |- mesh__dateEstablished mesh__D001465 1988-01-01
% 213.97/214.12  |- skos__prefLabel mesh__D001465 Barium Radioisotopes
% 213.97/214.12  |- skos__historyNote mesh__D001465 Barium %28%1968-1987%29%
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D001465 2001
% 213.97/214.12  |- skos__annotation mesh__D001465
% 213.97/214.12       Ba-126-129, 131, 133, 139-143; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D001465 2005
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D001465 1997
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D001465 2000
% 213.97/214.12  |- mesh__historyNote mesh__D001465 88   
% 213.97/214.12  |- rdf__type mesh__D001465sskos__Concept
% 213.97/214.12  |- mesh__recordAuthorizer mesh__D001465 PLS
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D001465 1996
% 213.97/214.12  |- mesh__recordMaintainer mesh__D001465 TPW
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D001465 1999
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D001465 2004
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D001465 2002
% 213.97/214.12  |- mesh__dateCreated mesh__D001465 1987-03-31
% 213.97/214.12  |- mesh__dateRevised mesh__D001465 1993-06-01
% 213.97/214.12  |- skos__hiddenLabel mesh__D001465 Radioisotopes, Barium
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D001465 1995
% 213.97/214.12  |- mesh__recordOriginator mesh__D001465 RLS
% 213.97/214.12  |- mesh__publicMeSHNote mesh__D001465 88   
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D001465 1998
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D001465 2003
% 213.97/214.12  |- skos__scopeNote mesh__D001465
% 213.97/214.12       Unstable isotopes of barium that decay or disintegrate emitting radiation. Ba atoms with atomic weights 126-129, 131, 133, and 139-143 are radioactive barium isotopes.%A%    
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D001465 2006
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D001465 1994
% 213.97/214.12  |- skos__historyNote mesh__D001465 Radioisotopes %28%1966-1987%29%
% 213.97/214.12  |- skos__hiddenLabel mesh__D006150 Phosphates, Guanosine
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D006150 1995
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D006150 1998
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D006150 2004
% 213.97/214.12  |- mesh__recordAuthorizer mesh__D006150 PLS
% 213.97/214.12  |- mesh__recordOriginator mesh__D006150 NLM
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D006150 1994
% 213.97/214.12  |- skos__hiddenLabel mesh__D006150 Nucleotides, Guanine
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D006150 2002
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D006150 2003
% 213.97/214.12  |- skos__broader mesh__D006150smesh__D012265
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D006150 1997
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D006150 2006
% 213.97/214.12  |- mesh__dateRevised mesh__D006150 1992-05-19
% 213.97/214.12  |- skos__altLabel mesh__D006150 Guanosine Phosphates
% 213.97/214.12  |- skos__prefLabel mesh__D006150 Guanine Nucleotides
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D006150 1993
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D006150 2001
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D006150 1996
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D006150 2005
% 213.97/214.12  |- skos__broader mesh__D006150smesh__D011685
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D006150 2000
% 213.97/214.12  |- rdf__type mesh__D006150sskos__Concept
% 213.97/214.12  |- skos__annotation mesh__D006150 /biosyn /physiol permitted   
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D006150 1999
% 213.97/214.12  |- mesh__recordMaintainer mesh__D006150 TGC
% 213.97/214.12  |- mesh__dateCreated mesh__D006150 1999-01-01
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D019876 2000
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D019876 1998
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D019876 2006
% 213.97/214.12  |- skos__prefLabel mesh__D019876 Sports Equipment
% 213.97/214.12  |- mesh__publicMeSHNote mesh__D019876 98   
% 213.97/214.12  |- mesh__dateEstablished mesh__D019876 1998-01-01
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D019876 2005
% 213.97/214.12  |- skos__related mesh__D019876smesh__D011482
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D019876 2004
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D019876 2002
% 213.97/214.12  |- rdf__type mesh__D019876sskos__Concept
% 213.97/214.12  |- skos__hiddenLabel mesh__D019876 Equipment, Athletic
% 213.97/214.12  |- mesh__dateCreated mesh__D019876 1997-06-20
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D019876 2003
% 213.97/214.12  |- skos__historyNote mesh__D019876 Sports %28%1966-1997%29%
% 213.97/214.12  |- skos__broader mesh__D019876smesh__D008420
% 213.97/214.12  |- skos__altLabel mesh__D019876 Athletic Equipment
% 213.97/214.12  |- skos__annotation mesh__D019876
% 213.97/214.12       coord IM with specific sport %28%IM%29%; for protective equipment coord with PROTECTIVE DEVICES %28%IM%29% or specific protective device %28%IM%29%%A%  
% 213.97/214.12  |- skos__historyNote mesh__D019876 specific sport %28%1966-1997%29%
% 213.97/214.12  |- skos__scopeNote mesh__D019876
% 213.97/214.12       Equipment required for engaging in a sport %28%such as balls, bats, rackets, skis, skates, ropes, weights%29% and devices for the protection of athletes during their performance %28%such as masks, gloves, mouth pieces%29%.%A%    
% 213.97/214.12  |- skos__historyNote mesh__D019876 Athletic Injuries %28%1968-1997%29%
% 213.97/214.12  |- mesh__historyNote mesh__D019876 98   
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D019876 2001
% 213.97/214.12  |- skos__hiddenLabel mesh__D019876 Equipment, Sports
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D019876 1999
% 213.97/214.12  |- mesh__dateRevised mesh__D011893 2003-07-09
% 213.97/214.12  |- skos__hiddenLabel mesh__D011893 Green Frogs
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D011893 2004
% 213.97/214.12  |- mesh__dateEstablished mesh__D011893 1972-01-01
% 213.97/214.12  |- mesh__recordAuthorizer mesh__D011893 sjn
% 213.97/214.12  |- skos__altLabel mesh__D011893 Green Frog
% 213.97/214.12  |- mesh__recordMaintainer mesh__D011893 ags
% 213.97/214.12  |- skos__broader mesh__D011893smesh__D011898
% 213.97/214.12  |- rdf__type mesh__D011893sskos__Concept
% 213.97/214.12  |- skos__historyNote mesh__D011893 Anura %28%1966-1971%29%
% 213.97/214.12  |- skos__scopeNote mesh__D011893
% 213.97/214.12       An edible species of the family Ranidae, occurring in Europe and used extensively in biomedical research. Commonly referred to as %22%edible frog%22%.%A%    
% 213.97/214.12  |- skos__annotation mesh__D011893
% 213.97/214.12       edible frog; NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 213.97/214.12  |- skos__hiddenLabel mesh__D011893 Frogs, Green
% 213.97/214.12  |- mesh__recordOriginator mesh__D011893 NLM
% 213.97/214.12  |- mesh__dateCreated mesh__D011893 1999-01-01
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D011893 2005
% 213.97/214.12  |- skos__altLabel mesh__D011893 Frog, Green
% 213.97/214.12  |- mesh__publicMeSHNote mesh__D011893 72   
% 213.97/214.12  |- mesh__historyNote mesh__D011893 72   
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D011893 2006
% 213.97/214.12  |- skos__prefLabel mesh__D011893 Rana esculenta
% 213.97/214.12  |- skos__broader mesh__D011095smesh__D010969
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D011095 2006
% 213.97/214.12  |- mesh__dateCreated mesh__D011095 1999-01-01
% 213.97/214.12  |- skos__broader mesh__D011095smesh__D011090
% 213.97/214.12  |- mesh__dateRevised mesh__D011095 2004-07-07
% 213.97/214.12  |- skos__altLabel mesh__D011095 Ethylene Polymers
% 213.97/214.12  |- rdf__type mesh__D011095sskos__Concept
% 213.97/214.12  |- mesh__recordMaintainer mesh__D011095 jmp
% 213.97/214.12  |- mesh__recordAuthorizer mesh__D011095 sjn
% 213.97/214.12  |- mesh__recordOriginator mesh__D011095 NLM
% 213.97/214.12  |- skos__hiddenLabel mesh__D011095 Polymers, Ethylene
% 213.97/214.12  |- skos__annotation mesh__D011095
% 213.97/214.12       POLYETHYLENE is available; D25-26 qualif   
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D011095 2005
% 213.97/214.12  |- skos__altLabel mesh__D011095 Ethene Homopolymers
% 213.97/214.12  |- skos__scopeNote mesh__D011095
% 213.97/214.12       Synthetic thermoplastics that are tough, flexible, inert, and resistant to chemicals and electrical current. They are often used as biocompatible materials for prostheses and implants.%A%    
% 213.97/214.12  |- skos__hiddenLabel mesh__D011095 Homopolymers, Ethene
% 213.97/214.12  |- skos__prefLabel mesh__D011095 Polyethylenes
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005856 1996
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005856 2000
% 213.97/214.12  |- skos__prefLabel mesh__D005856 Germ-Free Life
% 213.97/214.12  |- mesh__recordOriginator mesh__D005856 NLM
% 213.97/214.12  |- skos__altLabel mesh__D005856 Germfree Life
% 213.97/214.12  |- mesh__dateRevised mesh__D005856 1992-05-15
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005856 2006
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005856 1993
% 213.97/214.12  |- skos__hiddenLabel mesh__D005856 Germ Free Life
% 213.97/214.12  |- rdf__type mesh__D005856sskos__Concept
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005856 1999
% 213.97/214.12  |- skos__hiddenLabel mesh__D005856 Gnotobiotic
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005856 2005
% 213.97/214.12  |- skos__hiddenLabel mesh__D005856 Life, Germfree
% 213.97/214.12  |- mesh__activeMeSHYear mesh__D005856 1998
% 213.97/214.12  |- skos__scopeNote mesh__D005856
% 213.97/214.12       Animals not contaminated by or associated with any foreign organisms.%A%    
% 213.98/214.12  |- skos__hiddenLabel mesh__D005856 Life, Germ-Free
% 213.98/214.12  |- mesh__activeMeSHYear mesh__D005856 2002
% 213.98/214.12  |- skos__hiddenLabel mesh__D005856 Axenic Animal
% 213.98/214.12  |- mesh__dateCreated mesh__D005856 1999-01-01
% 213.98/214.12  |- skos__annotation mesh__D005856 IM   
% 213.98/214.12  |- mesh__activeMeSHYear mesh__D005856 1995
% 213.98/214.12  |- mesh__recordAuthorizer mesh__D005856 PLS
% 213.98/214.12  |- skos__hiddenLabel mesh__D005856 Animals, Axenic
% 213.98/214.12  |- mesh__activeMeSHYear mesh__D005856 2004
% 213.98/214.12  |- mesh__activeMeSHYear mesh__D005856 1994
% 213.98/214.12  |- mesh__recordMaintainer mesh__D005856 TAP
% 213.98/214.12  |- mesh__activeMeSHYear mesh__D005856 1997
% 213.98/214.12  |- skos__hiddenLabel mesh__D005856 Animal, Axenic
% 213.98/214.12  |- skos__broader mesh__D005856smesh__D008827
% 213.98/214.12  |- mesh__activeMeSHYear mesh__D005856 2001
% 213.98/214.12  |- mesh__activeMeSHYear mesh__D005856 2003
% 213.98/214.12  |- mesh__dateRevised mesh__D005058 2005-06-30
% 213.98/214.12  |- skos__broader mesh__D005058smesh__D007006
% 213.98/214.12  |- mesh__activeMeSHYear mesh__D005058 2006
% 213.98/214.12  |- skos__annotation mesh__D005058
% 213.98/214.12       do not routinely interpret hypogonadism in males as EUNUCHISM: use terminology of the author; check tags  HUMANS and MALE%A%  
% 213.98/214.12  |- mesh__recordOriginator mesh__D005058 NLM
% 213.98/214.12  |- skos__prefLabel mesh__D005058 Eunuchism
% 213.98/214.12  |- mesh__recordAuthorizer mesh__D005058 sjn
% 213.98/214.12  |- mesh__dateCreated mesh__D005058 1999-01-01
% 213.98/214.12  |- rdf__type mesh__D005058sskos__Concept
% 213.98/214.12  |- skos__scopeNote mesh__D005058
% 213.98/214.12       The state of being a eunuch, a male without TESTES or whose testes failed to develop. It is characterized by the lack of mature male GERM CELLS and TESTICULAR HORMONES.%A%    
% 213.98/214.12  |- mesh__recordMaintainer mesh__D005058 lkt
% 213.98/214.12  |- skos__altLabel mesh__D015486 T Cell Leukemia Virus I Antigens, Human
% 213.98/214.12  |- skos__altLabel mesh__D015486 T-Cell Leukemia Virus I Antigens, Adult
% 213.98/214.12  |- mesh__dateRevised mesh__D015486 2005-06-30
% 213.98/214.12  |- mesh__activeMeSHYear mesh__D015486 2006
% 213.98/214.12  |- skos__altLabel mesh__D015486 HTLV I Antigens
% 213.98/214.12  |- skos__altLabel mesh__D015486 T Cell Leukemia Virus I Antigens, Adult
% 213.98/214.12  |- skos__historyNote mesh__D015486 Antigens, Viral %28%1983-1988%29%
% 213.98/214.12  |- skos__hiddenLabel mesh__D015486 I Antigens, HTLV
% 213.98/214.12  |- mesh__recordMaintainer mesh__D015486 ssb
% 213.98/214.12  |- mesh__recordAuthorizer mesh__D015486 sjn
% 213.98/214.12  |- skos__altLabel mesh__D015486
% 213.98/214.12       Leukemia Lymphoma Virus I Antigens, Human T Cell
% 213.98/214.12  |- mesh__dateEstablished mesh__D015486 1988-01-01
% 213.98/214.12  |- skos__hiddenLabel mesh__D015486 Antigens, ATLV
% 213.98/214.12  |- skos__altLabel mesh__D015486 ATLV Antigens
% 213.98/214.12  |- mesh__historyNote mesh__D015486 89   
% 213.98/214.12  |- skos__altLabel mesh__D015486 T-Cell Leukemia Virus I Antigens, Human
% 213.98/214.12  |- rdf__type mesh__D015486sskos__Concept
% 213.98/214.12  |- skos__scopeNote mesh__D015486
% 213.98/214.12       Antigens associated with  HUMAN T-LYMPHOTROPIC VIRUS 1.%A%    
% 213.98/214.12  |- skos__hiddenLabel mesh__D015486 Antigens, HTLV-I
% 213.98/214.12  |- skos__hiddenLabel mesh__D015486 Antigens, HTLV I
% 213.98/214.12  |- mesh__recordOriginator mesh__D015486 RLS
% 213.98/214.12  |- skos__altLabel mesh__D015486 Human T Cell Leukemia Virus I Antigens
% 213.98/214.12  |- skos__broader mesh__D015486smesh__D015485
% 213.98/214.12  |- mesh__publicMeSHNote mesh__D015486 89   
% 213.98/214.12  |- skos__altLabel mesh__D015486
% 213.98/214.12       Leukemia-Lymphoma Virus I Antigens, Human T-Cell
% 213.98/214.12  |- skos__prefLabel mesh__D015486 HTLV-I Antigens
% 213.98/214.12  |- skos__altLabel mesh__D015486 Human T-Cell Leukemia Virus I Antigens
% 213.98/214.12  |- skos__historyNote mesh__D015486
% 213.98/214.12       Human T-Cell Leukemia Virus/immunology %28%1984-1988%29%
% 213.98/214.12  |- mesh__dateCreated mesh__D015486 1988-06-10
% 213.98/214.12  |- mesh__dateRevised mesh__D009449 2003-07-09
% 213.98/214.13  |- skos__hiddenLabel mesh__D009449 Neuroses, Cardiac
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D009449 2005
% 213.98/214.13  |- mesh__recordAuthorizer mesh__D009449 sjn
% 213.98/214.13  |- mesh__dateCreated mesh__D009449 1999-01-01
% 213.98/214.13  |- mesh__recordOriginator mesh__D009449 NLM
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D009449 2004
% 213.98/214.13  |- skos__scopeNote mesh__D009449
% 213.98/214.13       A clinical syndrome characterized by palpitation, SHORTNESS OF BREATH, labored breathing, subjective complaints of effort and discomfort, all following slight EXERTION. Other symptoms may be DIZZINESS, tremulousness, SWEATING, and INSOMNIA. Neurocirculatory asthenia is most typically seen as a form of anxiety disorder.%A%    
% 213.98/214.13  |- skos__hiddenLabel mesh__D009449 Syndrome, Hyperkinetic Heart
% 213.98/214.13  |- skos__hiddenLabel mesh__D009449 Neurosis, Cardiac
% 213.98/214.13  |- skos__hiddenLabel mesh__D009449 Cardiac Neuroses
% 213.98/214.13  |- skos__prefLabel mesh__D009449 Neurocirculatory Asthenia
% 213.98/214.13  |- skos__broader mesh__D009449smesh__D001008
% 213.98/214.13  |- rdf__type mesh__D009449sskos__Concept
% 213.98/214.13  |- skos__altLabel mesh__D009449 Cardiac Neurosis
% 213.98/214.13  |- skos__hiddenLabel mesh__D009449 Neurocirculatory Asthenias
% 213.98/214.13  |- skos__altLabel mesh__D009449 Effort Syndrome
% 213.98/214.13  |- skos__hiddenLabel mesh__D009449 Heart Syndrome, Hyperkinetic
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D009449 2006
% 213.98/214.13  |- mesh__recordMaintainer mesh__D009449 lkt
% 213.98/214.13  |- skos__hiddenLabel mesh__D009449 Syndrome, Effort
% 213.98/214.13  |- skos__hiddenLabel mesh__D009449 Asthenia, Neurocirculatory
% 213.98/214.13  |- skos__hiddenLabel mesh__D009449 Asthenias, Neurocirculatory
% 213.98/214.13  |- skos__annotation mesh__D009449 remember NEURASTHENIA also exists   
% 213.98/214.13  |- skos__scopeNote mesh__D001466
% 213.98/214.13       A compound used as an x-ray contrast medium that occurs in nature as the mineral barite. It is also used in various manufacturing applications and mixed into heavy concrete to serve as a radiation shield.%A%    
% 213.98/214.13  |- mesh__dateCreated mesh__D001466 1999-01-01
% 213.98/214.13  |- skos__hiddenLabel mesh__D001466 Sulfate, Barium
% 213.98/214.13  |- skos__annotation mesh__D001466
% 213.98/214.13       D25-26 qualif; for enema use BARIUM SULFATE /diag use, not BARIUM%A%  
% 213.98/214.13  |- mesh__recordOriginator mesh__D001466 NLM
% 213.98/214.13  |- mesh__dateRevised mesh__D001466 2001-07-25
% 213.98/214.13  |- rdf__type mesh__D001466sskos__Concept
% 213.98/214.13  |- skos__broader mesh__D001466smesh__D017609
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D001466 2003
% 213.98/214.13  |- mesh__recordAuthorizer mesh__D001466 sjn
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D001466 2004
% 213.98/214.13  |- skos__prefLabel mesh__D001466 Barium Sulfate
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D001466 2002
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D001466 2005
% 213.98/214.13  |- mesh__recordMaintainer mesh__D001466 ssb
% 213.98/214.13  |- skos__broader mesh__D001466smesh__D013431
% 213.98/214.13  |- skos__hiddenLabel mesh__D001466 EZCAT
% 213.98/214.13  |- skos__hiddenLabel mesh__D001466 E Z CAT
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D001466 2006
% 213.98/214.13  |- mesh__recordOriginator mesh__D020620 ndw
% 213.98/214.13  |- mesh__historyNote mesh__D020620 2000   
% 213.98/214.13  |- mesh__publicMeSHNote mesh__D020620 2000   
% 213.98/214.13  |- skos__prefLabel mesh__D020620 Methylomonas
% 213.98/214.13  |- rdf__type mesh__D020620sskos__Concept
% 213.98/214.13  |- skos__historyNote mesh__D020620 Methylococcaceae %28%1976-1999%29%
% 213.98/214.13  |- mesh__dateCreated mesh__D020620 1999-11-03
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D020620 2006
% 213.98/214.13  |- mesh__recordMaintainer mesh__D020620 SYSTEM
% 213.98/214.13  |- skos__scopeNote mesh__D020620
% 213.98/214.13       A genus of gram-negative, aerobic, straight, curved, or branched rods which are motile by a single polar flagellum. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 213.98/214.13  |- mesh__recordAuthorizer mesh__D020620 sjn
% 213.98/214.13  |- skos__broader mesh__D020620smesh__D008772
% 213.98/214.13  |- mesh__dateRevised mesh__D020620 2005-06-30
% 213.98/214.13  |- mesh__dateEstablished mesh__D020620 2000-01-01
% 213.98/214.13  |- skos__broader mesh__D018079Q000037smesh__D018079
% 213.98/214.13  |- mesh__preferredCombination mesh__D018079Q000037smesh__D018756
% 213.98/214.13  |- rdf__type mesh__D018079Q000037smesh__CompoundConcept
% 213.98/214.13  |- skos__scopeNote mesh__D006151
% 213.98/214.13       A purine nucleoside that has guanine linked by its N9 nitrogen to the C1 carbon of ribose. It is a component of ribonucleic acid and its nucleotides play important roles in metabolism. %28%From Dorland, 28th ed%29%%A%    
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D006151 2001
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D006151 2004
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D006151 2002
% 213.98/214.13  |- skos__prefLabel mesh__D006151 Guanosine
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D006151 2005
% 213.98/214.13  |- mesh__recordMaintainer mesh__D006151 adp
% 213.98/214.13  |- mesh__historyNote mesh__D006151 72; was see under NUCLEOSIDES 1963-71   
% 213.98/214.13  |- mesh__recordAuthorizer mesh__D006151 sjn
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D006151 2006
% 213.98/214.13  |- mesh__dateCreated mesh__D006151 1999-01-01
% 213.98/214.13  |- mesh__recordOriginator mesh__D006151 NLM
% 213.98/214.13  |- mesh__publicMeSHNote mesh__D006151
% 213.98/214.13       72; was see under NUCLEOSIDES 1963-71   
% 213.98/214.13  |- mesh__onlineNote mesh__D006151 search NUCLEOSIDES 1966-71   
% 213.98/214.13  |- mesh__dateEstablished mesh__D006151 1972-01-01
% 213.98/214.13  |- skos__broader mesh__D006151smesh__D012263
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D006151 2000
% 213.98/214.13  |- rdf__type mesh__D006151sskos__Concept
% 213.98/214.13  |- skos__historyNote mesh__D006151 Nucleosides %28%1966-1971%29%
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D006151 2003
% 213.98/214.13  |- mesh__dateRevised mesh__D006151 1999-11-03
% 213.98/214.13  |- skos__broader mesh__D006151smesh__D011684
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D047568 2006
% 213.98/214.13  |- skos__altLabel mesh__D047568 High-Risk Sex
% 213.98/214.13  |- rdf__type mesh__D047568sskos__Concept
% 213.98/214.13  |- skos__prefLabel mesh__D047568 Unsafe Sex
% 213.98/214.13  |- skos__broader mesh__D047568smesh__D012725
% 213.98/214.13  |- skos__hiddenLabel mesh__D047568 High Risk Sex
% 213.98/214.13  |- mesh__publicMeSHNote mesh__D047568 2005; see SAFE SEX 2001-2004   
% 213.98/214.13  |- skos__altLabel mesh__D047568 Unprotected Sex
% 213.98/214.13  |- mesh__recordMaintainer mesh__D047568 lkt
% 213.98/214.13  |- skos__historyNote mesh__D047568 Risk %28%1987-2004%29%
% 213.98/214.13  |- mesh__dateEstablished mesh__D047568 2005-01-01
% 213.98/214.13  |- mesh__historyNote mesh__D047568 2005; use SAFE SEX 2001-2004   
% 213.98/214.13  |- mesh__dateCreated mesh__D047568 2004-07-07
% 213.98/214.13  |- skos__scopeNote mesh__D047568
% 213.98/214.13       Sexual behaviors which are high-risk for contracting SEXUALLY TRANSMITTED DISEASES or for producing PREGNANCY.%A%    
% 213.98/214.13  |- skos__hiddenLabel mesh__D047568 Sex, Unsafe
% 213.98/214.13  |- skos__hiddenLabel mesh__D047568 Sex, Unprotected
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D047568 2005
% 213.98/214.13  |- mesh__recordOriginator mesh__D047568 lkt
% 213.98/214.13  |- skos__historyNote mesh__D047568 Sexual Behavior %28%1988-2004%29%
% 213.98/214.13  |- skos__hiddenLabel mesh__D047568 Sex, High-Risk
% 213.98/214.13  |- mesh__recordAuthorizer mesh__D047568 sjn
% 213.98/214.13  |- mesh__recordAuthorizer mesh__D019877 sjn
% 213.98/214.13  |- skos__altLabel mesh__D019877 Transformylases
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D019877 2006
% 213.98/214.13  |- skos__broader mesh__D019877smesh__D019875
% 213.98/214.13  |- skos__altLabel mesh__D019877 Formyl Transferases
% 213.98/214.13  |- skos__scopeNote mesh__D019877
% 213.98/214.13       Enzymes that catalyze the transfer of hydroxymethyl or formyl groups. EC 2.1.2.%A%    
% 213.98/214.13  |- mesh__dateRevised mesh__D019877 2005-06-30
% 213.98/214.13  |- skos__altLabel mesh__D019877 Hydroxymethyltransferases
% 213.98/214.13  |- mesh__recordMaintainer mesh__D019877 DRC
% 213.98/214.13  |- skos__altLabel mesh__D019877 Hydroxymethyl Transferases
% 213.98/214.13  |- rdf__type mesh__D019877sskos__Concept
% 213.98/214.13  |- mesh__dateCreated mesh__D019877 1997-06-20
% 213.98/214.13  |- mesh__recordOriginator mesh__D019877 KEV
% 213.98/214.13  |- mesh__dateEstablished mesh__D019877 1998-01-01
% 213.98/214.13  |- skos__prefLabel mesh__D019877 Hydroxymethyl and Formyl Transferases
% 213.98/214.13  |- skos__altLabel mesh__D019877 Transformylase
% 213.98/214.13  |- skos__altLabel mesh__D019877 Formyltransferases
% 213.98/214.13  |- mesh__publicMeSHNote mesh__D019877 98   
% 213.98/214.13  |- mesh__historyNote mesh__D019877 98   
% 213.98/214.13  |- skos__hiddenLabel mesh__D019877 Transferases, Hydroxymethyl
% 213.98/214.13  |- skos__hiddenLabel mesh__D019877 Transferases, Formyl
% 213.98/214.13  |- skos__hiddenLabel mesh__D011894 Frogs, Leopard
% 213.98/214.13  |- mesh__publicMeSHNote mesh__D011894 72   
% 213.98/214.13  |- skos__altLabel mesh__D011894 Leopard Frog
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D011894 2004
% 213.98/214.13  |- mesh__recordMaintainer mesh__D011894 ags
% 213.98/214.13  |- skos__hiddenLabel mesh__D011894 Leopard Frogs
% 213.98/214.13  |- rdf__type mesh__D011894sskos__Concept
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D011894 2005
% 213.98/214.13  |- mesh__dateCreated mesh__D011894 1999-01-01
% 213.98/214.13  |- mesh__dateEstablished mesh__D011894 1972-01-01
% 213.98/214.13  |- mesh__recordAuthorizer mesh__D011894 sjn
% 213.98/214.13  |- skos__annotation mesh__D011894
% 213.98/214.13       NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 213.98/214.13  |- skos__broader mesh__D011894smesh__D011898
% 213.98/214.13  |- mesh__historyNote mesh__D011894 72   
% 213.98/214.13  |- skos__historyNote mesh__D011894 Anura %28%1966-1971%29%
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D011894 2006
% 213.98/214.13  |- skos__altLabel mesh__D011894 Frog, Leopard
% 213.98/214.13  |- mesh__dateRevised mesh__D011894 2003-07-09
% 213.98/214.13  |- mesh__recordOriginator mesh__D011894 NLM
% 213.98/214.13  |- skos__prefLabel mesh__D011894 Rana pipiens
% 213.98/214.13  |- skos__scopeNote mesh__D011894
% 213.98/214.13       A highly variable species of the family Ranidae in Canada, the United States and Central America. It is the most widely used Anuran in biomedical research.%A%    
% 213.98/214.13  |- skos__altLabel mesh__D011096 Pectinase
% 213.98/214.13  |- mesh__dateEstablished mesh__D011096 1991-01-01
% 213.98/214.13  |- mesh__historyNote mesh__D011096
% 213.98/214.13       91%28%77%29%; was see under GLYCOSIDE HYDROLASES 1977-90   
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D011096 2004
% 213.98/214.13  |- skos__prefLabel mesh__D011096 Polygalacturonase
% 213.98/214.13  |- mesh__publicMeSHNote mesh__D011096
% 213.98/214.13       91; was see under GLYCOSIDE HYDROLASES 1977-90   
% 213.98/214.13  |- skos__historyNote mesh__D011096 Glycoside Hydrolases %28%1966-1976%29%
% 213.98/214.13  |- skos__broader mesh__D011096smesh__D006026
% 213.98/214.13  |- rdf__type mesh__D011096sskos__Concept
% 213.98/214.13  |- skos__hiddenLabel mesh__D011096 Depolymerase, Pectin
% 213.98/214.13  |- skos__historyNote mesh__D011096 Pectins %28%1966-1976%29%
% 213.98/214.13  |- mesh__recordOriginator mesh__D011096 RLS
% 213.98/214.13  |- mesh__recordMaintainer mesh__D011096 ssb
% 213.98/214.13  |- skos__annotation mesh__D011096 in microorganisms %26% higher plants   
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D011096 2005
% 213.98/214.13  |- mesh__dateRevised mesh__D011096 2003-07-09
% 213.98/214.13  |- skos__altLabel mesh__D011096 Pectin Depolymerase
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D011096 2006
% 213.98/214.13  |- mesh__dateCreated mesh__D011096 1976-04-27
% 213.98/214.13  |- skos__scopeNote mesh__D011096
% 213.98/214.13       A cell wall-degrading enzyme found in microorganisms and higher plants. It catalyzes the random hydrolysis of 1,4-alpha-D-galactosiduronic linkages in pectate and other galacturonans. EC 3.2.1.15.%A%    
% 213.98/214.13  |- mesh__recordAuthorizer mesh__D011096 sjn
% 213.98/214.13  |- skos__historyNote mesh__D011096 Uronic Acids %28%1966-1976%29%
% 213.98/214.13  |- skos__scopeNote mesh__D005857
% 213.98/214.13       A rare metal element with a blue-gray appearance and atomic symbol Ge, atomic number 32, and atomic weight 72.59.%A%    
% 213.98/214.13  |- skos__annotation mesh__D005857
% 213.98/214.13       Ge-74; Ge-70, 72, 73, 76 = GERMANIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Ge-65-69, 71, 75, 77, 78 = GERMANIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 213.98/214.13  |- mesh__recordMaintainer mesh__D005857 adp
% 213.98/214.13  |- mesh__dateCreated mesh__D005857 1999-01-01
% 213.98/214.13  |- skos__broader mesh__D005857smesh__D019216
% 213.98/214.13  |- skos__prefLabel mesh__D005857 Germanium
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D005857 2001
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D005857 2004
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D005857 2003
% 213.98/214.13  |- mesh__recordOriginator mesh__D005857 NLM
% 213.98/214.13  |- mesh__recordAuthorizer mesh__D005857 sjn
% 213.98/214.13  |- mesh__dateRevised mesh__D005857 2000-06-22
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D005857 2006
% 213.98/214.13  |- rdf__type mesh__D005857sskos__Concept
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D005857 2002
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D005857 2005
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D005059 1999
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D005059 1993
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D005059 2003
% 213.98/214.13  |- skos__prefLabel mesh__D005059 Euphoria
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D005059 1996
% 213.98/214.13  |- mesh__recordMaintainer mesh__D005059 TAP
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D005059 2000
% 213.98/214.13  |- skos__scopeNote mesh__D005059
% 213.98/214.13       An exaggerated feeling of physical and emotional well-being not consonant with apparent stimuli or events; usually of psychologic origin, but also seen in organic brain disease and toxic states.%A%    
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D005059 2004
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D005059 2001
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D005059 1997
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D005059 1994
% 213.98/214.13  |- skos__broader mesh__D005059smesh__D004644
% 213.98/214.13  |- mesh__dateCreated mesh__D005059 1999-01-01
% 213.98/214.13  |- rdf__type mesh__D005059sskos__Concept
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D005059 1995
% 213.98/214.13  |- mesh__recordOriginator mesh__D005059 NLM
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D005059 2005
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D005059 1998
% 213.98/214.13  |- mesh__dateRevised mesh__D005059 1992-05-15
% 213.98/214.13  |- skos__hiddenLabel mesh__D005059 Euphorias
% 213.98/214.13  |- mesh__recordAuthorizer mesh__D005059 PLS
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D005059 2002
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D005059 2006
% 213.98/214.13  |- skos__broader mesh__D011528Q000662smesh__D011528
% 213.98/214.13  |- mesh__preferredCombination mesh__D011528Q000662smesh__D011529
% 213.98/214.13  |- rdf__type mesh__D011528Q000662smesh__CompoundConcept
% 213.98/214.13  |- skos__altLabel mesh__D015487 Human T Lymphotropic Virus II Antigens
% 213.98/214.13  |- skos__altLabel mesh__D015487 HTLV II Antigens
% 213.98/214.13  |- rdf__type mesh__D015487sskos__Concept
% 213.98/214.13  |- skos__altLabel mesh__D015487
% 213.98/214.13       Leukemia Lymphoma Virus II Antigens, Human T Cell
% 213.98/214.13  |- skos__historyNote mesh__D015487
% 213.98/214.13       Human T-Cell Leukemia Virus/immunology %28%1984-1988%29%
% 213.98/214.13  |- skos__altLabel mesh__D015487 Human T-Lymphotropic Virus II Antigens
% 213.98/214.13  |- skos__altLabel mesh__D015487
% 213.98/214.13       Leukemia-Lymphoma Virus II Antigens, Human T-Cell
% 213.98/214.13  |- skos__broader mesh__D015487smesh__D015485
% 213.98/214.13  |- mesh__publicMeSHNote mesh__D015487 89   
% 213.98/214.13  |- skos__altLabel mesh__D015487 Human T-Cell Leukemia Virus II Antigens
% 213.98/214.13  |- skos__prefLabel mesh__D015487 HTLV-II Antigens
% 213.98/214.13  |- mesh__dateRevised mesh__D015487 2005-06-30
% 213.98/214.13  |- mesh__dateCreated mesh__D015487 1988-06-10
% 213.98/214.13  |- skos__hiddenLabel mesh__D015487 II Antigens, HTLV
% 213.98/214.13  |- skos__hiddenLabel mesh__D015487 Antigens, HTLV II
% 213.98/214.13  |- skos__altLabel mesh__D015487 Human T Cell Leukemia Virus II Antigens
% 213.98/214.13  |- mesh__recordMaintainer mesh__D015487 ssb
% 213.98/214.13  |- mesh__recordAuthorizer mesh__D015487 sjn
% 213.98/214.13  |- skos__altLabel mesh__D015487 T-Cell Leukemia Virus II Antigens, Human
% 213.98/214.13  |- skos__hiddenLabel mesh__D015487 Antigens, HTLV-II
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D015487 2006
% 213.98/214.13  |- skos__historyNote mesh__D015487 Antigens, Viral %28%1983-1988%29%
% 213.98/214.13  |- skos__altLabel mesh__D015487 T Cell Leukemia Virus II Antigens, Human
% 213.98/214.13  |- mesh__dateEstablished mesh__D015487 1989-01-01
% 213.98/214.13  |- mesh__recordOriginator mesh__D015487 RLS
% 213.98/214.13  |- skos__scopeNote mesh__D015487
% 213.98/214.13       Antigens associated with HUMAN T-LYMPHOTROPIC VIRUS 2.     
% 213.98/214.13  |- mesh__historyNote mesh__D015487 89   
% 213.98/214.13  |- mesh__publicMeSHNote mesh__D034641
% 213.98/214.13       2003; DC-STRETCH-BINDING PROTEIN %28%now HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K%29% was indexed under DNA-BINDING PROTEINS 1994-2002; HNRNP K was indexed under RIBONUCLEOPROTEINS 1994-2002%A%  
% 213.98/214.13  |- skos__altLabel mesh__D034641 dC-Stretch-Binding Protein
% 213.98/214.13  |- mesh__dateRevised mesh__D034641 2005-08-03
% 213.98/214.13  |- skos__hiddenLabel mesh__D034641 dC Stretch Binding Protein
% 213.98/214.13  |- skos__annotation mesh__D034641 see SCR for specific hnRNP entries   
% 213.98/214.13  |- mesh__recordMaintainer mesh__D034641 ags
% 213.98/214.13  |- mesh__dateEstablished mesh__D034641 2003-01-01
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D034641 2006A
% 213.98/214.13  |- skos__hiddenLabel mesh__D034641
% 213.98/214.13       Ribonucleoprotein K, Heterogeneous-Nuclear
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D034641 2005
% 213.98/214.13  |- mesh__recordAuthorizer mesh__D034641 ags
% 213.98/214.13  |- skos__broader mesh__D034641smesh__D034441
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D034641 2006
% 213.98/214.13  |- skos__prefLabel mesh__D034641 Heterogeneous-Nuclear Ribonucleoprotein K
% 213.98/214.13  |- skos__broader mesh__D034641smesh__D004268
% 213.98/214.13  |- mesh__recordOriginator mesh__D034641 jmp
% 213.98/214.13  |- skos__scopeNote mesh__D034641
% 213.98/214.13       A heterogeneous-nuclear ribonucleoprotein found in the CELL NUCLEUS and the CYTOPLASM. Heterogeneous-nuclear ribonucleoprotein K has been implicated in the regulation of gene expression at nearly all levels: GENETIC TRANSCRIPTION; mRNA processing %28%RNA PROCESSING, POST-TRANSCRIPTIONAL%29%, mRNA transport, mRNA stability, and translation %28%TRANSLATION, GENETIC%29%. The hnRNP protein has a strong affinity for polypyrimidine-rich RNA and for single-stranded polypyrimidine-rich DNA.  Multiple hnRNP K protein isoforms exist due to alternative splicing and display different nucleic-acid-binding properties.%A%    
% 213.98/214.13  |- skos__historyNote mesh__D034641 Ribonucleoproteins %28%1994-2002%29%
% 213.98/214.13  |- mesh__dateCreated mesh__D034641 2002-07-03
% 213.98/214.13  |- skos__historyNote mesh__D034641 DNA-Binding Proteins %28%1994-2002%29%
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D034641 2003
% 213.98/214.13  |- mesh__historyNote mesh__D034641
% 213.98/214.13       2003; use HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K %28%NM%29% 1994-2002; for HNRNP K use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 1994-2002%A%  
% 213.98/214.13  |- skos__hiddenLabel mesh__D034641
% 213.98/214.13       Heterogeneous Nuclear Ribonucleoprotein K
% 213.98/214.13  |- rdf__type mesh__D034641sskos__Concept
% 213.98/214.13  |- skos__altLabel mesh__D034641 hnRNP K
% 213.98/214.13  |- skos__altLabel mesh__D034641
% 213.98/214.13       Heterogeneous Nuclear Ribonucleoprotein Particle K Protein
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D034641 2004
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D001467 2006
% 213.98/214.13  |- mesh__recordOriginator mesh__D001467 NLM
% 213.98/214.13  |- skos__broader mesh__D001467smesh__D002523
% 213.98/214.13  |- mesh__dateRevised mesh__D001467 2002-07-02
% 213.98/214.13  |- mesh__publicMeSHNote mesh__D001467
% 213.98/214.13       2003; see BARLEY 1991-2002, see CEREALS 1985-1990, see GRAIN 1963-1984%A%  
% 213.98/214.13  |- rdf__type mesh__D001467sskos__Concept
% 213.98/214.13  |- skos__annotation mesh__D001467
% 213.98/214.13       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.98/214.13  |- mesh__historyNote mesh__D001467 2003%28%1963%29%   
% 213.98/214.13  |- mesh__recordAuthorizer mesh__D001467 sjn
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D001467 2003
% 213.98/214.13  |- mesh__dateEstablished mesh__D001467 1991-01-01
% 213.98/214.13  |- skos__prefLabel mesh__D001467 Hordeum
% 213.98/214.13  |- skos__broader mesh__D001467smesh__D006109
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D001467 2004
% 213.98/214.13  |- mesh__recordMaintainer mesh__D001467 ssb
% 213.98/214.13  |- skos__scopeNote mesh__D001467
% 213.98/214.13       A plant genus of the family POACEAE. The seed grain, barley, is widely used as food.%A%    
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D001467 2005
% 213.98/214.13  |- mesh__dateCreated mesh__D001467 1999-01-01
% 213.98/214.13  |- skos__hiddenLabel mesh__D006950
% 213.98/214.13       Hyperlipidemias, Multiple Lipoprotein-Type
% 213.98/214.13  |- skos__hiddenLabel mesh__D006950
% 213.98/214.13       Multiple Lipoprotein-Type Hyperlipidemias
% 213.98/214.13  |- skos__hiddenLabel mesh__D006950 Combined Hyperlipidemias, Familial
% 213.98/214.13  |- mesh__onlineNote mesh__D006950
% 213.98/214.13       search HYPERLIPOPROTEINEMIA under HYPERLIPIDEMIA 1975-79; search HYPERLIPEMIA, ESSENTIAL FAMILIAL under HYPERLIPIDEMIA/genetics 1966-79%A%  
% 213.98/214.13  |- skos__hiddenLabel mesh__D006950 Familial Combined Hyperlipidemia
% 213.98/214.13  |- mesh__recordAuthorizer mesh__D006950 sjn
% 213.98/214.13  |- mesh__recordMaintainer mesh__D006950 lkt
% 213.98/214.13  |- mesh__publicMeSHNote mesh__D006950
% 213.98/214.13       80; HYPERLIPOPROTEINEMIA was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 %28%see note under HYPERLIPIDEMIA for former cross refs to it%29%%A%  
% 213.98/214.13  |- mesh__dateEstablished mesh__D006950 1980-01-01
% 213.98/214.13  |- mesh__dateRevised mesh__D006950 2005-06-30
% 213.98/214.13  |- skos__hiddenLabel mesh__D006950 Combined Hyperlipidemia, Familial
% 213.98/214.13  |- skos__hiddenLabel mesh__D006950 Hyperlipidemias, Familial Combined
% 213.98/214.13  |- mesh__recordOriginator mesh__D006950 VDK
% 213.98/214.13  |- skos__hiddenLabel mesh__D006950
% 213.98/214.13       Lipoprotein-Type Hyperlipidemias, Multiple
% 213.98/214.13  |- skos__broader mesh__D006950smesh__D006949
% 213.98/214.13  |- skos__hiddenLabel mesh__D006950 Familial Combined Hyperlipidemias
% 213.98/214.13  |- skos__broader mesh__D006950smesh__D008052
% 213.98/214.13  |- skos__hiddenLabel mesh__D006950
% 213.98/214.13       Hyperlipidemia, Multiple Lipoprotein Type
% 213.98/214.13  |- skos__altLabel mesh__D006950 Hyperlipidemia, Multiple Lipoprotein-Type
% 213.98/214.13  |- rdf__type mesh__D006950sskos__Concept
% 213.98/214.13  |- skos__prefLabel mesh__D006950 Hyperlipidemia, Familial Combined
% 213.98/214.13  |- skos__scopeNote mesh__D006950
% 213.98/214.13       A disorder genetically distinct from the other inherited hyperlipidemias characterized by the type II or type IV lipoprotein pattern %28%the pattern may change from time to time and the lipid level may be normal at one time and abnormal at another time%29%.%A%    
% 213.98/214.13  |- skos__hiddenLabel mesh__D006950
% 213.98/214.13       Lipoprotein-Type Hyperlipidemia, Multiple
% 213.98/214.13  |- skos__annotation mesh__D006950 familial or acquired   
% 213.98/214.13  |- mesh__historyNote mesh__D006950
% 213.98/214.13       80; HYPERLIPOPROTEINEMIA was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 %28%see note under HYPERLIPIDEMIA for former cross refs to it%29%%A%  
% 213.98/214.13  |- mesh__dateCreated mesh__D006950 1979-04-23
% 213.98/214.13  |- skos__hiddenLabel mesh__D006950 Multiple Lipoprotein-Type Hyperlipidemia
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D006950 2006
% 213.98/214.13  |- mesh__recordOriginator mesh__D020621 ndw
% 213.98/214.13  |- rdf__type mesh__D020621sskos__Concept
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D020621 2006
% 213.98/214.13  |- mesh__recordAuthorizer mesh__D020621 sjn
% 213.98/214.13  |- mesh__dateRevised mesh__D020621 2005-06-30
% 213.98/214.13  |- mesh__recordMaintainer mesh__D020621 SYSTEM
% 213.98/214.13  |- skos__annotation mesh__D020621
% 213.98/214.13       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 213.98/214.13  |- mesh__publicMeSHNote mesh__D020621 2000   
% 213.98/214.13  |- mesh__dateEstablished mesh__D020621 2000-01-01
% 213.98/214.13  |- mesh__dateCreated mesh__D020621 1999-11-03
% 213.98/214.13  |- mesh__historyNote mesh__D020621 2000   
% 213.98/214.13  |- skos__broader mesh__D020621smesh__D042041
% 213.98/214.13  |- skos__scopeNote mesh__D020621
% 213.98/214.13       A species of gram-negative, obligately aerobic rods. Motility occurs by peritrichous flagella. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 213.98/214.13  |- skos__prefLabel mesh__D020621 Ochrobactrum anthropi
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D006152 1999
% 213.98/214.13  |- skos__broader mesh__D006152smesh__D009712
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D006152 1994
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D006152 2003
% 213.98/214.13  |- skos__altLabel mesh__D006152 Guanosine Cyclic 3,5 Monophosphate
% 213.98/214.13  |- skos__hiddenLabel mesh__D006152 Monophosphate, Guanosine Cyclic
% 213.98/214.13  |- mesh__dateRevised mesh__D006152 1993-06-03
% 213.98/214.13  |- skos__altLabel mesh__D006152 Guanosine Cyclic-3%27%,5%27%-Monophosphate
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D006152 1998
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D006152 2002
% 213.98/214.13  |- skos__hiddenLabel mesh__D006152 GMP, Cyclic
% 213.98/214.13  |- skos__hiddenLabel mesh__D006152 Cyclic Monophosphate, Guanosine
% 213.98/214.13  |- skos__altLabel mesh__D006152 Guanosine Cyclic 3%27%,5%27%-Monophosphate
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D006152 1997
% 213.98/214.13  |- mesh__publicMeSHNote mesh__D006152
% 213.98/214.13       94; was GUANOSINE CYCLIC MONOPHOSPHATE 1980-93, was GUANOSINE CYCLIC-3%27%,5%27%-MONOPHOSPHATE 1978-79, was GUANOSINE CYCLIC 3%27%,5%27% MONOPHOSPHATE 1972-77; CYCLIC GMP was see GUANOSINE CYCLIC MONOPHOSPHATE 1975-93; GUANOSINE CYCLIC 2%27%,3%27%-MONOPHOSPHATE was see GUANOSINE CYCLIC MONOPHOSPHATE 1980-93%A%  
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D006152 2006
% 213.98/214.13  |- mesh__dateEstablished mesh__D006152 1972-01-01
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D006152 2001
% 213.98/214.13  |- skos__hiddenLabel mesh__D006152
% 213.98/214.13       3%27%,5%27%-Monophosphate, Guanosine Cyclic
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D006152 1996
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D006152 2000
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D006152 2005
% 213.98/214.13  |- skos__annotation mesh__D006152
% 213.98/214.13       /biosyn /physiol permitted; DF: CYCL GMP   
% 213.98/214.13  |- skos__altLabel mesh__D006152 Guanosine Cyclic Monophosphate
% 213.98/214.13  |- mesh__recordOriginator mesh__D006152 NLM
% 213.98/214.13  |- rdf__type mesh__D006152sskos__Concept
% 213.98/214.13  |- skos__hiddenLabel mesh__D006152
% 213.98/214.13       Cyclic 3%27%,5%27%-Monophosphate, Guanosine
% 213.98/214.13  |- mesh__recordAuthorizer mesh__D006152 PLS
% 213.98/214.13  |- skos__broader mesh__D006152smesh__D006150
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D006152 1995
% 213.98/214.13  |- mesh__onlineNote mesh__D006152
% 213.98/214.13       use CYCLIC GMP to search GUANOSINE CYCLIC MONOPHOSPHATE %26% GUANOSINE CYCLIC 2%27%,3%27%-MONOPHOSPHATE 1980-93 %26% GUANOSINE CYCLIC-3%27%,5%27%-MONOPHOSPHATE 1971-79 %28%as Prov 1971%29%%A%  
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D006152 2004
% 213.98/214.13  |- mesh__recordMaintainer mesh__D006152 PLS
% 213.98/214.13  |- skos__scopeNote mesh__D006152
% 213.98/214.13       Guanosine cyclic 3%27%,5%27%-%28%hydrogen phosphate%29%. A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3%27%- and 5%27%-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. %28%From Merck Index, 11th ed%29%%A%    
% 213.98/214.13  |- skos__historyNote mesh__D006152 Guanine Nucleotides %28%1966-1971%29%
% 213.98/214.13  |- skos__hiddenLabel mesh__D006152
% 213.98/214.13       Cyclic-3%27%,5%27%-Monophosphate, Guanosine
% 213.98/214.13  |- mesh__historyNote mesh__D006152
% 213.98/214.13       94; was GUANOSINE CYCLIC MONOPHOSPHATE 1980-93, was GUANOSINE CYCLIC-3%27%,5%27%-MONOPHOSPHATE 1978-79, was GUANOSINE CYCLIC 3%27%,5%27% MONOPHOSPHATE 1971-77 %28%Prov 1971%29%; CYCLIC GMP was see GUANOSINE CYCLIC MONOPHOSPHATE 1975-93; GUANOSINE CYCLIC 2%27%,3%27%-MONOPHOSPHATE was see GUANOSINE CYCLIC MONOPHOSPHATE 1980-93%A%  
% 213.98/214.13  |- skos__hiddenLabel mesh__D006152
% 213.98/214.13       Guanosine Cyclic 3%27%,5%27% Monophosphate
% 213.98/214.13  |- mesh__dateCreated mesh__D006152 1999-01-01
% 213.98/214.13  |- skos__prefLabel mesh__D006152 Cyclic GMP
% 213.98/214.13  |- skos__broader mesh__D047569smesh__D019044
% 213.98/214.13  |- mesh__historyNote mesh__D047569 2005   
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D047569 2006A
% 213.98/214.13  |- mesh__recordAuthorizer mesh__D047569 ags
% 213.98/214.13  |- mesh__publicMeSHNote mesh__D047569 2005   
% 213.98/214.13  |- skos__scopeNote mesh__D047569
% 213.98/214.13       A scanning microscope-based, cytofluorimetry technique for making fluorescence measurements and topographic analysis on individual cells. Lasers are used to excite fluorochromes in labeled cellular specimens. Fluorescence is detected in multiple discrete wavelengths and the locational data is processed to quantitatively assess APOPTOSIS; PLOIDIES; cell proliferation; GENE EXPRESSION; PROTEIN TRANSPORT; and other cellular processes.%A%    
% 213.98/214.13  |- skos__historyNote mesh__D047569 Lasers %28%1992-2004%29%
% 213.98/214.13  |- mesh__recordOriginator mesh__D047569 nns
% 213.98/214.13  |- skos__prefLabel mesh__D047569 Laser Scanning Cytometry
% 213.98/214.13  |- mesh__dateRevised mesh__D047569 2005-07-27
% 213.98/214.13  |- mesh__dateCreated mesh__D047569 2004-07-07
% 213.98/214.13  |- skos__hiddenLabel mesh__D047569 Scanning Cytometry, Laser
% 213.98/214.13  |- mesh__activeMeSHYear mesh__D047569 2005
% 213.98/214.13  |- skos__altLabel mesh__D047569 Cytometry, Laser Scanning
% 213.98/214.13  |- skos__broader mesh__D047569smesh__D018613
% 213.98/214.13  |- mesh__recordMaintainer mesh__D047569 ags
% 213.98/214.13  |- skos__historyNote mesh__D047569 Image Cytometry %28%2001-2004%29%
% 213.98/214.13  |- mesh__dateEstablished mesh__D047569 2005-01-01
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D047569 2006
% 213.98/214.14  |- rdf__type mesh__D047569sskos__Concept
% 213.98/214.14  |- skos__scopeNote mesh__D019878
% 213.98/214.14       A group of enzymes that catalyze the transfer of carboxyl- or carbamoyl- groups. EC 2.1.3.%A%    
% 213.98/214.14  |- skos__historyNote mesh__D019878 Transferases %28%1969-1997%29%
% 213.98/214.14  |- skos__hiddenLabel mesh__D019878 Transferases, Carboxyl
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D019878 2004
% 213.98/214.14  |- skos__altLabel mesh__D019878 Carbamoyl Transferases
% 213.98/214.14  |- rdf__type mesh__D019878sskos__Concept
% 213.98/214.14  |- skos__altLabel mesh__D019878 Carboxyl Transferases
% 213.98/214.14  |- mesh__historyNote mesh__D019878 98   
% 213.98/214.14  |- mesh__dateCreated mesh__D019878 1997-06-20
% 213.98/214.14  |- skos__hiddenLabel mesh__D019878 Transferases, Carbamoyl
% 213.98/214.14  |- skos__prefLabel mesh__D019878 Carboxyl and Carbamoyl Transferases
% 213.98/214.14  |- mesh__dateEstablished mesh__D019878 1998-01-01
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D019878 2005
% 213.98/214.14  |- mesh__publicMeSHNote mesh__D019878 98   
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D019878 2006
% 213.98/214.14  |- skos__broader mesh__D019878smesh__D019875
% 213.98/214.14  |- mesh__dateRevised mesh__D019878 2003-07-09
% 213.98/214.14  |- skos__historyNote mesh__D011895 Anura %28%1966-1980%29%
% 213.98/214.14  |- rdf__type mesh__D011895sskos__Concept
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D011895 2004
% 213.98/214.14  |- mesh__recordMaintainer mesh__D011895 ags
% 213.98/214.14  |- mesh__recordAuthorizer mesh__D011895 sjn
% 213.98/214.14  |- skos__broader mesh__D011895smesh__D011898
% 213.98/214.14  |- mesh__historyNote mesh__D011895
% 213.98/214.14       91%28%81%29%; was see under RANIDAE 1981-90   
% 213.98/214.14  |- skos__scopeNote mesh__D011895
% 213.98/214.14       A species of the family Ranidae which occurs primarily in Europe and is used widely in biomedical research.%A%    
% 213.98/214.14  |- skos__annotation mesh__D011895
% 213.98/214.14       laughing frog; NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D011895 2005
% 213.98/214.14  |- mesh__recordOriginator mesh__D011895 EC
% 213.98/214.14  |- skos__prefLabel mesh__D011895 Rana ridibunda
% 213.98/214.14  |- mesh__dateEstablished mesh__D011895 1991-01-01
% 213.98/214.14  |- skos__historyNote mesh__D011895 Ranidae %28%1972-1980%29%
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D011895 2006
% 213.98/214.14  |- mesh__dateCreated mesh__D011895 1980-05-12
% 213.98/214.14  |- mesh__publicMeSHNote mesh__D011895 91; was see under RANIDAE 1981-90   
% 213.98/214.14  |- mesh__dateRevised mesh__D011895 2003-07-09
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D011097 2006
% 213.98/214.14  |- skos__altLabel mesh__D011097 Hoechst Brand of Polygeline
% 213.98/214.14  |- skos__prefLabel mesh__D011097 Polygeline
% 213.98/214.14  |- skos__historyNote mesh__D011097 Peptides %28%1972-1974%29%
% 213.98/214.14  |- mesh__dateCreated mesh__D011097 1974-11-19
% 213.98/214.14  |- mesh__historyNote mesh__D011097
% 213.98/214.14       91%28%75%29%; was see under POLYMERS 1975-90   
% 213.98/214.14  |- skos__historyNote mesh__D011097 Polymers %28%1972-1974%29%
% 213.98/214.14  |- skos__altLabel mesh__D011097 Aventis Brand of Polygeline
% 213.98/214.14  |- skos__hiddenLabel mesh__D011097 Delta Pharma Brand of Polygeline
% 213.98/214.14  |- mesh__recordAuthorizer mesh__D011097 sjn
% 213.98/214.14  |- rdf__type mesh__D011097sskos__Concept
% 213.98/214.14  |- mesh__recordOriginator mesh__D011097 NLM
% 213.98/214.14  |- skos__altLabel mesh__D011097 Braun Brand of Polygeline
% 213.98/214.14  |- mesh__publicMeSHNote mesh__D011097 91; was see under POLYMERS 1975-90   
% 213.98/214.14  |- mesh__dateEstablished mesh__D011097 1991-01-01
% 213.98/214.14  |- skos__altLabel mesh__D011097 Delta-Pharma Brand of Polygeline
% 213.98/214.14  |- skos__altLabel mesh__D011097 Beacon Brand of Polygeline
% 213.98/214.14  |- mesh__recordMaintainer mesh__D011097 lkw
% 213.98/214.14  |- skos__scopeNote mesh__D011097
% 213.98/214.14       A 3.5 per cent colloidal solution containing urea-cross-linked polymerized peptides. It has a molecular weight of approximately 35,000 and is prepared from gelatin and electrolytes. The polymeric solution is used as a plasma expander.%A%    
% 213.98/214.14  |- mesh__dateRevised mesh__D011097 2005-06-30
% 213.98/214.14  |- skos__annotation mesh__D011097 D25-26 qualif   
% 213.98/214.14  |- skos__broader mesh__D011097smesh__D011108
% 213.98/214.14  |- skos__broader mesh__D011097smesh__D010455
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005858 1995
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005858 2002
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005858 2004
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005858 1994
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005858 1997
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005858 2003
% 213.98/214.14  |- skos__broader mesh__D005858smesh__D005060
% 213.98/214.14  |- mesh__dateRevised mesh__D005858 1999-12-01
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005858 1996
% 213.98/214.14  |- skos__annotation mesh__D005858
% 213.98/214.14       for Germany before 23 May 1949 %26% after 3 Oct 1990; for historical articles before %26% after 1949: Manual 36.11; BERLIN is also available%A%  
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005858 2001
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005858 2006
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005858 1993
% 213.98/214.14  |- skos__broader mesh__D005858smesh__D017516
% 213.98/214.14  |- rdf__type mesh__D005858sskos__Concept
% 213.98/214.14  |- mesh__recordMaintainer mesh__D005858 ags
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005858 2000
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005858 1999
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005858 2000A
% 213.98/214.14  |- mesh__recordOriginator mesh__D005858 NLM
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005858 2005
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005858 1998
% 213.98/214.14  |- skos__prefLabel mesh__D005858 Germany
% 213.98/214.14  |- mesh__dateCreated mesh__D005858 1999-01-01
% 213.98/214.14  |- mesh__recordAuthorizer mesh__D005858 ags
% 213.98/214.14  |- skos__altLabel mesh__D002560 Circulation, Cerebrovascular
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D002560 2006
% 213.98/214.14  |- skos__annotation mesh__D002560
% 213.98/214.14       consider also BRAIN /blood supply; DF: CEREBROVASCULAR CIRC%A%  
% 213.98/214.14  |- skos__broader mesh__D002560smesh__D001775
% 213.98/214.14  |- mesh__recordMaintainer mesh__D002560 nns
% 213.98/214.14  |- skos__prefLabel mesh__D002560 Cerebrovascular Circulation
% 213.98/214.14  |- mesh__dateRevised mesh__D002560 2003-07-09
% 213.98/214.14  |- skos__scopeNote mesh__D002560
% 213.98/214.14       The circulation of blood through the vessels of the BRAIN.%A%    
% 213.98/214.14  |- mesh__dateEstablished mesh__D002560 1964-01-01
% 213.98/214.14  |- mesh__recordOriginator mesh__D002560 NLM
% 213.98/214.14  |- rdf__type mesh__D002560sskos__Concept
% 213.98/214.14  |- mesh__dateCreated mesh__D002560 1999-01-01
% 213.98/214.14  |- mesh__recordAuthorizer mesh__D002560 sjn
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D002560 2005
% 213.98/214.14  |- mesh__historyNote mesh__D002560 64   
% 213.98/214.14  |- mesh__publicMeSHNote mesh__D002560 64   
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D002560 2004
% 213.98/214.14  |- skos__hiddenLabel mesh__D015488 Antigens, HTLV-III-LAV
% 213.98/214.14  |- mesh__historyNote mesh__D015488 89   
% 213.98/214.14  |- skos__hiddenLabel mesh__D015488 Antigens, HIV Associated
% 213.98/214.14  |- mesh__recordAuthorizer mesh__D015488 sjn
% 213.98/214.14  |- skos__altLabel mesh__D015488 LAV Antigens
% 213.98/214.14  |- skos__altLabel mesh__D015488 Lymphadenopathy Associated Antigens
% 213.98/214.14  |- skos__hiddenLabel mesh__D015488 Antigens, HTLV III
% 213.98/214.14  |- rdf__type mesh__D015488sskos__Concept
% 213.98/214.14  |- skos__hiddenLabel mesh__D015488 Antigens, HTLV-III
% 213.98/214.14  |- skos__hiddenLabel mesh__D015488 III Antigens, HTLV
% 213.98/214.14  |- skos__altLabel mesh__D015488 HTLV III LAV Antigens
% 213.98/214.14  |- skos__historyNote mesh__D015488
% 213.98/214.14       Human T-Cell Leukemia Virus/immunology %28%1984-1987%29%
% 213.98/214.14  |- skos__historyNote mesh__D015488 HIV/immunology %28%1988%29%
% 213.98/214.14  |- skos__broader mesh__D015488smesh__D000956
% 213.98/214.14  |- skos__hiddenLabel mesh__D015488 Antigens, Lymphadenopathy-Associated
% 213.98/214.14  |- skos__altLabel mesh__D015488 HTLV-III Antigens
% 213.98/214.14  |- mesh__publicMeSHNote mesh__D015488 89   
% 213.98/214.14  |- mesh__recordMaintainer mesh__D015488 ssb
% 213.98/214.14  |- skos__altLabel mesh__D015488
% 213.98/214.14       T Lymphotropic Virus Type III Antigens, Human
% 213.98/214.14  |- skos__altLabel mesh__D015488 HTLV III Antigens
% 213.98/214.14  |- skos__altLabel mesh__D015488
% 213.98/214.14       T-Lymphotropic Virus Type III Antigens, Human
% 213.98/214.14  |- mesh__dateRevised mesh__D015488 2005-06-30
% 213.98/214.14  |- mesh__recordOriginator mesh__D015488 RLS
% 213.98/214.14  |- mesh__dateEstablished mesh__D015488 1988-01-01
% 213.98/214.14  |- skos__historyNote mesh__D015488 Antigens, Viral %28%1983-1988%29%
% 213.98/214.14  |- skos__hiddenLabel mesh__D015488 Antigens, HIV
% 213.98/214.14  |- skos__historyNote mesh__D015488 HTLV-III %28%1987%29%
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D015488 2006
% 213.98/214.14  |- skos__scopeNote mesh__D015488
% 213.98/214.14       Antigens associated with specific proteins of the human adult T-cell immunodeficiency virus %28%HIV%29%; also called HTLV-III-associated and lymphadenopathy-associated virus %28%LAV%29% antigens.%A%    
% 213.98/214.14  |- skos__altLabel mesh__D015488 HIV Associated Antigens
% 213.98/214.14  |- skos__hiddenLabel mesh__D015488 Associated Antigens, Lymphadenopathy
% 213.98/214.14  |- skos__hiddenLabel mesh__D015488 Associated Antigens, HIV
% 213.98/214.14  |- skos__prefLabel mesh__D015488 HIV Antigens
% 213.98/214.14  |- skos__altLabel mesh__D015488 Lymphadenopathy-Associated Antigens
% 213.98/214.14  |- skos__altLabel mesh__D015488 AIDS Antigens
% 213.98/214.14  |- skos__altLabel mesh__D015488 HTLV-III-LAV Antigens
% 213.98/214.14  |- skos__hiddenLabel mesh__D015488 Antigens, AIDS
% 213.98/214.14  |- skos__hiddenLabel mesh__D015488 Antigens, HIV-Associated
% 213.98/214.14  |- skos__altLabel mesh__D015488 HIV-Associated Antigens
% 213.98/214.14  |- skos__hiddenLabel mesh__D015488 Antigens, Lymphadenopathy Associated
% 213.98/214.14  |- mesh__dateCreated mesh__D015488 1988-06-10
% 213.98/214.14  |- skos__hiddenLabel mesh__D015488 Antigens, LAV
% 213.98/214.14  |- skos__broader mesh__D001468smesh__D003445
% 213.98/214.14  |- rdf__type mesh__D001468sskos__Concept
% 213.98/214.14  |- mesh__historyNote mesh__D001468 2003 %28%1972%29%   
% 213.98/214.14  |- skos__prefLabel mesh__D001468 Thoracica
% 213.98/214.14  |- skos__altLabel mesh__D001468 Barnacles
% 213.98/214.14  |- mesh__recordOriginator mesh__D001468 NLM
% 213.98/214.14  |- mesh__publicMeSHNote mesh__D001468 2003; see BARNACLES 1972-2002   
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D001468 2004
% 213.98/214.14  |- mesh__dateEstablished mesh__D001468 1972-01-01
% 213.98/214.14  |- skos__historyNote mesh__D001468 Crustacea %28%1966-1971%29%
% 213.98/214.14  |- skos__scopeNote mesh__D001468
% 213.98/214.14       A superorder of marine CRUSTACEA, free swimming in the larval state, but permanently fixed as adults. There are some 800 described species, grouped in several genera, and comprising of two major orders of barnacles: stalked %28%Pedunculata%29% and sessile %28%Sessilia%29%.%A%    
% 213.98/214.14  |- mesh__dateRevised mesh__D001468 2003-07-09
% 213.98/214.14  |- mesh__recordAuthorizer mesh__D001468 sjn
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D001468 2005
% 213.98/214.14  |- mesh__dateCreated mesh__D001468 1999-01-01
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D001468 2006
% 213.98/214.14  |- mesh__recordMaintainer mesh__D001468 ags
% 213.98/214.14  |- skos__hiddenLabel mesh__D012190 Retrovirus
% 213.98/214.14  |- skos__hiddenLabel mesh__D012190 Oncovirus
% 213.98/214.14  |- skos__hiddenLabel mesh__D012190 Type C Oncovirus
% 213.98/214.14  |- skos__broader mesh__D012190smesh__D009858
% 213.98/214.14  |- mesh__dateCreated mesh__D012190 1999-01-01
% 213.98/214.14  |- skos__altLabel mesh__D012190 RNA Tumor Viruses
% 213.98/214.14  |- skos__altLabel mesh__D012190 Retroviruses
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D012190 2003
% 213.98/214.14  |- skos__hiddenLabel mesh__D012190 Oncornavirus
% 213.98/214.14  |- skos__hiddenLabel mesh__D012190 Viruses, RNA Tumor
% 213.98/214.14  |- skos__hiddenLabel mesh__D012190 C Oncoviruses, Type
% 213.98/214.14  |- skos__annotation mesh__D012190
% 213.98/214.14       infection = RETROVIRIDAE INFECTIONS; if discussed as tumor viruses, add TUMOR VIRUS INFECTIONS %28%IM%29%; antiretroviral agents is likely to be ANTI-HIV AGENTS, otherwise index under ANTIVIRAL AGENTS%A%  
% 213.98/214.14  |- mesh__dateRevised mesh__D012190 2001-08-07
% 213.98/214.14  |- skos__hiddenLabel mesh__D012190 Tumor Viruses, RNA
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D012190 2002
% 213.98/214.14  |- mesh__onlineNote mesh__D012190
% 213.98/214.14       use RETROVIRIDAE to search RETROVIRUSES, MLV-RELATED; MURINE LEUKEMIA VIRUS-RELATED RETROVIRUSES; %26% RETROVIRUSES, MURINE LEUKEMIA VIRUS-RELATED 1994-96; ONCOVIRINAE, TYPE C ONCORNAVIRUSES, TYPE C ONCOVIRUSES, %26% ONCOVIRUSES, TYPE C 1991-93; ONCOVIRUSES 1981-93; LEUKOVIRUSES, ONCORNAVIRUSES, %26% RNA TUMOR VIRUSES 1978-93; C-TYPE VIRUSES 1972-93 %28%as Prov 1972-73%29%; use ONCOGENIC VIRUSES to search LEUKOVIRUSES %26% ONCORNAVIRUSES 1975-77%A%  
% 213.98/214.14  |- skos__hiddenLabel mesh__D012190 RNA Tumor Virus
% 213.98/214.14  |- skos__hiddenLabel mesh__D012190 Leukemogenic Virus
% 213.98/214.14  |- rdf__type mesh__D012190sskos__Concept
% 213.98/214.14  |- skos__altLabel mesh__D012190 Oncoviruses
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D012190 2004
% 213.98/214.14  |- skos__hiddenLabel mesh__D012190 C Oncovirus, Type
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D012190 2005
% 213.98/214.14  |- mesh__recordMaintainer mesh__D012190 sjn
% 213.98/214.14  |- skos__hiddenLabel mesh__D012190 Leukovirus
% 213.98/214.14  |- skos__hiddenLabel mesh__D012190 Virus, Leukemogenic
% 213.98/214.14  |- skos__scopeNote mesh__D012190
% 213.98/214.14       Family of RNA viruses that infects birds and mammals and encodes the enzyme reverse transcriptase. The family contains seven genera: DELTARETROVIRUS; LENTIVIRUS; RETROVIRUSES TYPE B, MAMMALIAN; ALPHARETROVIRUS; GAMMARETROVIRUS; RETROVIRUSES TYPE D; and SPUMAVIRUS. A key feature of retrovirus biology is the synthesis of a DNA copy of the genome which is integrated into cellular DNA. After integration it is sometimes not expressed but maintained in a latent state %28%PROVIRUSES%29%.%A%    
% 213.98/214.14  |- mesh__historyNote mesh__D012190
% 213.98/214.14       81; was LEUKOVIRUSES 1978-80; was LEUKEMOGENIC VIRUSES 1966-77; RETROVIRUSES, MLV-RELATED was heading 1994-96; ONCOVIRINAE was heading 1992-93, was see RETROVIRIDAE 1991; MURINE LEUKEMIA VIRUS-RELATED RETROVIRUSES %26% RETROVIRUSES, MURINE LEUKEMIA VIRUS-RELATED were see RETROVIRUSES, MLV-RELATED 1994-96; ONCOVIRUSES was see ONCOVIRINAE 1992-93, was see RETROVIRIDAE 1981-91; RNA TUMOR VIRUSES was see ONCOVIRINAE 1992-3, was see RETROVIRIDAE 1978-91; ONCORNAVIRUSES was see ONCOVIRINAE 1992-93, was see RETROVIRIDAE 1981-91, was see LEUKOVIRUSES 1978-80, %26% was see ONCOGENIC VIRUSES 1975-77; ONCOVIRUSES, TYPE C was heading 1991-93, was C-TYPE VIRUSES 1974-90 %28%Prov 1972-73%29%; C-TYPE VIRUSES was see ONCOVIRUSES, TYPE C 1991-93; LEUKOVIRUSES was see ONCOVIRUSES, TYPE C 1991-93, was see ONCOGENIC VIRUSES 1975-77, was heading 1978-90, was see RETROVIRIDAE 1981-90; TYPE C ONCOVIRUSES %26% TYPE C ONCORNAVIRUSES were see ONCOVIRUSES, TYPE C 1991-93%A%  
% 213.98/214.14  |- skos__hiddenLabel mesh__D012190 Oncovirus, Type C
% 213.98/214.14  |- skos__prefLabel mesh__D012190 Retroviridae
% 213.98/214.14  |- mesh__recordOriginator mesh__D012190 NLM
% 213.98/214.14  |- mesh__recordAuthorizer mesh__D012190 sjn
% 213.98/214.14  |- skos__hiddenLabel mesh__D012190 Tumor Virus, RNA
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D012190 2006
% 213.98/214.14  |- mesh__dateEstablished mesh__D012190 1966-01-01
% 213.98/214.14  |- skos__altLabel mesh__D012190 Oncoviruses, Type C
% 213.98/214.14  |- mesh__publicMeSHNote mesh__D012190
% 213.98/214.14       81; was LEUKOVIRUSES 1978-80; was LEUKEMOGENIC VIRUSES 1966-77; RETROVIRUSES, MLV-RELATED was heading 1994-96; ONCOVIRINAE was heading 1992-93, was see RETROVIRIDAE 1991; MURINE LEUKEMIA VIRUS-RELATED RETROVIRUSES %26% RETROVIRUSES, MURINE LEUKEMIA VIRUS-RELATED were see RETROVIRUSES, MLV-RELATED 1994-96; ONCOVIRUSES was see ONCOVIRINAE 1992-93, was see RETROVIRIDAE 1981-91; RNA TUMOR VIRUSES was see ONCOVIRINAE 1992-93, was see RETROVIRIDAE 1978-91; ONCORNAVIRUSES was see ONCOVIRINAE 1992-93, was see RETROVIRIDAE 1981-91, was see LEUKOVIRUSES 1978-80, %26% was see ONCOGENIC VIRUSES 1975-77; ONCOVIRUSES, TYPE C was heading 1991-93, was C-TYPE VIRUSES 1974-90; C-TYPE VIRUSES was see ONCOVIRUSES, TYPE C 1991-93; LEUKOVIRUSES was see ONCOVIRUSES, TYPE C 1991-93, was see ONCOGENIC VIRUSES 1975-77, was heading 1978-90, was see RETROVIRIDAE 1981-90; TYPE C ONCOVIRUSES %26% TYPE C ONCORNAVIRUSES were see ONCOVIRUSES, TYPE C 1991-93%A%  
% 213.98/214.14  |- skos__altLabel mesh__D012190 Leukoviruses
% 213.98/214.14  |- skos__altLabel mesh__D012190 Oncovirinae
% 213.98/214.14  |- skos__hiddenLabel mesh__D012190 Viruses, Leukemogenic
% 213.98/214.14  |- skos__broader mesh__D012190smesh__D012328
% 213.98/214.14  |- skos__hiddenLabel mesh__D012190 Virus, RNA Tumor
% 213.98/214.14  |- skos__historyNote mesh__D006951 Hyperlipidemia %28%1966-1979%29%
% 213.98/214.14  |- mesh__recordOriginator mesh__D006951 VDK
% 213.98/214.14  |- mesh__dateEstablished mesh__D006951 1980-01-01
% 213.98/214.14  |- skos__broader mesh__D006951smesh__D050171
% 213.98/214.14  |- mesh__onlineNote mesh__D006951
% 213.98/214.14       search HYPERLIPIDEMIA 1975-79; search HYPERLIPEMIA, ESSENTIAL FAMILIAL under HYPERLIPIDEMIA /FG 1966-79%A%  
% 213.98/214.14  |- mesh__dateCreated mesh__D006951 1979-04-23
% 213.98/214.14  |- skos__prefLabel mesh__D006951 Hyperlipoproteinemia
% 213.98/214.14  |- mesh__recordAuthorizer mesh__D006951 sjn
% 213.98/214.14  |- skos__annotation mesh__D006951
% 213.98/214.14       do not confuse with HYPOLIPOPROTEINEMIA; familial or acquired; GEN or unspecified: specific Types I-V are available%A%  
% 213.98/214.14  |- skos__scopeNote mesh__D006951
% 213.98/214.14       Metabolic disease characterized by excess plasma LIPOPROTEINS.%A%    
% 213.98/214.14  |- rdf__type mesh__D006951sskos__Concept
% 213.98/214.14  |- mesh__historyNote mesh__D006951
% 213.98/214.14       80; was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 %28%see note under HYPERLIPIDEMIA for former cross refs to it%29%%A%  
% 213.98/214.14  |- mesh__recordMaintainer mesh__D006951 lkt
% 213.98/214.14  |- skos__hiddenLabel mesh__D006951 Hyperlipoproteinemias
% 213.98/214.14  |- mesh__dateRevised mesh__D006951 2005-06-30
% 213.98/214.14  |- mesh__publicMeSHNote mesh__D006951
% 213.98/214.14       80; was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 %28%see note under HYPERLIPIDEMIA for former cross refs to it%29%%A%  
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D006951 2006
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D020622 2006
% 213.98/214.14  |- skos__historyNote mesh__D020622
% 213.98/214.14       Cat-Scratch Disease/microbiology %28%1992-1999%29%
% 213.98/214.14  |- skos__annotation mesh__D020622
% 213.98/214.14       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29% or CAT-SCRATCH DISEASE %28%IM%29%%A%  
% 213.98/214.14  |- skos__broader mesh__D020622smesh__D016946
% 213.98/214.14  |- mesh__recordMaintainer mesh__D020622 SYSTEM
% 213.98/214.14  |- mesh__recordAuthorizer mesh__D020622 sjn
% 213.98/214.14  |- skos__historyNote mesh__D020622 Gram-Negative Bacteria %28%1992-1999%29%
% 213.98/214.14  |- mesh__dateRevised mesh__D020622 2005-06-30
% 213.98/214.14  |- skos__prefLabel mesh__D020622 Afipia
% 213.98/214.14  |- mesh__dateEstablished mesh__D020622 2000-01-01
% 213.98/214.14  |- skos__broader mesh__D020622smesh__D041841
% 213.98/214.14  |- mesh__dateCreated mesh__D020622 1999-11-05
% 213.98/214.14  |- mesh__historyNote mesh__D020622 2000   
% 213.98/214.14  |- rdf__type mesh__D020622sskos__Concept
% 213.98/214.14  |- mesh__recordOriginator mesh__D020622 ndw
% 213.98/214.14  |- skos__scopeNote mesh__D020622
% 213.98/214.14       A genus of gram-negative, oxidase-positive, nonfermentative rods which are motile by means of a single flagellum. Afipia felis and BARTONELLA HENSELAE are causative agents of CAT-SCRATCH DISEASE. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 213.98/214.14  |- mesh__publicMeSHNote mesh__D020622 2000   
% 213.98/214.14  |- skos__hiddenLabel mesh__D006153 5%27%-Diphosphate, Guanosine
% 213.98/214.14  |- mesh__dateEstablished mesh__D006153 1991-01-01
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D006153 1998
% 213.98/214.14  |- rdf__type mesh__D006153sskos__Concept
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D006153 1994
% 213.98/214.14  |- skos__hiddenLabel mesh__D006153 Guanosine 5%27% Diphosphate
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D006153 1999
% 213.98/214.14  |- skos__annotation mesh__D006153 /biosyn /physiol permitted   
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D006153 2003
% 213.98/214.14  |- skos__altLabel mesh__D006153 Guanosine 5%27%-Diphosphate
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D006153 1991
% 213.98/214.14  |- mesh__recordMaintainer mesh__D006153 NLM
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D006153 2000
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D006153 1995
% 213.98/214.14  |- mesh__publicMeSHNote mesh__D006153
% 213.98/214.14       91; was see under GUANINE NUCLEOTIDES 1978-90   
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D006153 2004
% 213.98/214.14  |- mesh__dateCreated mesh__D006153 1977-04-22
% 213.98/214.14  |- skos__prefLabel mesh__D006153 Guanosine Diphosphate
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D006153 2001
% 213.98/214.14  |- mesh__historyNote mesh__D006153
% 213.98/214.14       91%28%78%29%; was see under GUANINE NUCLEOTIDES 1978-90   
% 213.98/214.14  |- mesh__dateRevised mesh__D006153 1990-04-13
% 213.98/214.14  |- skos__scopeNote mesh__D006153
% 213.98/214.14       Guanosine 5%27%-%28%trihydrogen diphosphate%29%. A guanine nucleotide containing two phosphate groups esterified to the sugar moiety. Synonyms: GRPP; guanosine pyrophosphate.%A%    
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D006153 1996
% 213.98/214.14  |- mesh__recordAuthorizer mesh__D006153 PLS
% 213.98/214.14  |- skos__broader mesh__D006153smesh__D006150
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D006153 2005
% 213.98/214.14  |- mesh__recordOriginator mesh__D006153 RLS
% 213.98/214.14  |- skos__historyNote mesh__D006153 Guanine Nucleotides %28%1966-1977%29%
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D006153 2002
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D006153 1992
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D006153 1997
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D006153 2006
% 213.98/214.14  |- skos__hiddenLabel mesh__D006153 Diphosphate, Guanosine
% 213.98/214.14  |- skos__altLabel mesh__D006153 GDP
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D006153 1993
% 213.98/214.14  |- mesh__dateCreated mesh__D019879 1997-06-20
% 213.98/214.14  |- skos__hiddenLabel mesh__D019879 Cells, Paneth
% 213.98/214.14  |- mesh__historyNote mesh__D019879 98   
% 213.98/214.14  |- skos__scopeNote mesh__D019879
% 213.98/214.14       Differentiated epithelial cells of the INTESTINAL MUCOSA, found in the basal part of the intestinal crypts of Lieberkuhn. Paneth cells secrete GROWTH FACTORS, digestive enzymes such as LYSOZYME and antimicrobial peptides such as cryptdins %28%ALPHA-DEFENSINS%29% into the crypt lumen.%A%    
% 213.98/214.14  |- mesh__publicMeSHNote mesh__D019879 98   
% 213.98/214.14  |- mesh__recordMaintainer mesh__D019879 lkt
% 213.98/214.14  |- skos__broader mesh__D019879smesh__D004847
% 213.98/214.14  |- skos__historyNote mesh__D019879 Intestine, Small %28%1966-1997%29%
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D019879 2006
% 213.98/214.14  |- mesh__recordAuthorizer mesh__D019879 sjn
% 213.98/214.14  |- rdf__type mesh__D019879sskos__Concept
% 213.98/214.14  |- mesh__recordOriginator mesh__D019879 AGS
% 213.98/214.14  |- mesh__dateRevised mesh__D019879 2005-06-30
% 213.98/214.14  |- mesh__dateEstablished mesh__D019879 1998-01-01
% 213.98/214.14  |- skos__historyNote mesh__D019879 Intestinal Mucosa %28%1966-1997%29%
% 213.98/214.14  |- skos__prefLabel mesh__D019879 Paneth Cells
% 213.98/214.14  |- skos__broader mesh__D019879smesh__D007413
% 213.98/214.14  |- mesh__dateCreated mesh__D011896 1999-01-01
% 213.98/214.14  |- skos__hiddenLabel mesh__D011896 Common Frog, European
% 213.98/214.14  |- mesh__recordMaintainer mesh__D011896 ags
% 213.98/214.14  |- skos__prefLabel mesh__D011896 Rana temporaria
% 213.98/214.14  |- skos__hiddenLabel mesh__D011896 Common European Frog
% 213.98/214.14  |- skos__historyNote mesh__D011896 Anura %28%1966-1971%29%
% 213.98/214.14  |- mesh__recordOriginator mesh__D011896 NLM
% 213.98/214.14  |- skos__annotation mesh__D011896
% 213.98/214.14       NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 213.98/214.14  |- skos__scopeNote mesh__D011896
% 213.98/214.14       A species of the family Ranidae occurring in a wide variety of habitats from within the Arctic Circle to South Africa, Australia, etc.%A%    
% 213.98/214.14  |- skos__altLabel mesh__D011896 European Common Frog
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D011896 2005
% 213.98/214.14  |- mesh__historyNote mesh__D011896 72   
% 213.98/214.14  |- mesh__publicMeSHNote mesh__D011896 72   
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D011896 2006
% 213.98/214.14  |- mesh__dateRevised mesh__D011896 2003-07-09
% 213.98/214.14  |- skos__hiddenLabel mesh__D011896 European Frog, Common
% 213.98/214.14  |- skos__hiddenLabel mesh__D011896 Frog, European Common
% 213.98/214.14  |- mesh__dateEstablished mesh__D011896 1972-01-01
% 213.98/214.14  |- rdf__type mesh__D011896sskos__Concept
% 213.98/214.14  |- skos__altLabel mesh__D011896 Frog, Common European
% 213.98/214.14  |- mesh__recordAuthorizer mesh__D011896 sjn
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D011896 2004
% 213.98/214.14  |- skos__broader mesh__D011896smesh__D011898
% 213.98/214.14  |- skos__hiddenLabel mesh__D011098 Glycolic Lactic Acid Polyester
% 213.98/214.14  |- skos__prefLabel mesh__D011098 Polyglactin 910
% 213.98/214.14  |- mesh__dateRevised mesh__D011098 2004-07-07
% 213.98/214.14  |- skos__altLabel mesh__D011098 Poly%28%Lactide-Co-Glycolide%29%
% 213.98/214.14  |- skos__altLabel mesh__D011098 Poly%28%Glycolide Lactide%29%Copolymer
% 213.98/214.14  |- skos__hiddenLabel mesh__D011098 910, Polyglactin
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D011098 2005
% 213.98/214.14  |- skos__annotation mesh__D011098 D25-26 qualif   
% 213.98/214.14  |- skos__hiddenLabel mesh__D011098 Acid Polyester, Glycolic-Lactic
% 213.98/214.14  |- mesh__publicMeSHNote mesh__D011098 91; was see under POLYMERS 1979-90   
% 213.98/214.14  |- skos__scopeNote mesh__D011098
% 213.98/214.14       A polyester used for absorbable sutures %26% surgical mesh, especially in ophthalmic surgery.  2-Hydroxy-propanoic acid polymer with polymerized hydroxyacetic acid, which forms 3,6-dimethyl-1,4-dioxane-dione polymer with 1,4-dioxane-2,5-dione copolymer of molecular weight about 80,000 daltons.%A%    
% 213.98/214.14  |- rdf__type mesh__D011098sskos__Concept
% 213.98/214.14  |- skos__broader mesh__D011098smesh__D011091
% 213.98/214.14  |- skos__altLabel mesh__D011098 Polyglactin
% 213.98/214.14  |- skos__altLabel mesh__D011098
% 213.98/214.14       Dioxanedione Polymer with Dimethyldioxanedione Polymer
% 213.98/214.14  |- mesh__dateEstablished mesh__D011098 1991-01-01
% 213.98/214.14  |- mesh__recordMaintainer mesh__D011098 jmp
% 213.98/214.14  |- skos__hiddenLabel mesh__D011098 Polyester, Glycolic-Lactic Acid
% 213.98/214.14  |- mesh__recordAuthorizer mesh__D011098 sjn
% 213.98/214.14  |- skos__altLabel mesh__D011098 Polygalactin 910
% 213.98/214.14  |- mesh__recordOriginator mesh__D011098 SH
% 213.98/214.14  |- mesh__dateCreated mesh__D011098 1977-12-09
% 213.98/214.14  |- skos__historyNote mesh__D011098 Polymers %28%1966-1978%29%
% 213.98/214.14  |- skos__hiddenLabel mesh__D011098 910, Polygalactin
% 213.98/214.14  |- skos__altLabel mesh__D011098
% 213.98/214.14       Dimethyldioxanedione Polymer with Dioxanedione Polymer
% 213.98/214.14  |- mesh__historyNote mesh__D011098
% 213.98/214.14       91%28%79%29%; was see under POLYMERS 1979-90   
% 213.98/214.14  |- skos__altLabel mesh__D011098 Glycolic-Lactic Acid Polyester
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D011098 2006
% 213.98/214.14  |- skos__altLabel mesh__D005859 Democratic Republic of Germany
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005859 1995
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005859 1996
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005859 2002
% 213.98/214.14  |- mesh__recordOriginator mesh__D005859 NLM
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005859 2004
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005859 1997
% 213.98/214.14  |- skos__annotation mesh__D005859
% 213.98/214.14       for East Germany 7 Oct 1949-3 Oct 1990; Manual 36.11; BERLIN is also available; in German texts as DDR %28%Deutsche Demokratische Republik%29%%A%  
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005859 2000A
% 213.98/214.14  |- mesh__dateRevised mesh__D005859 1999-12-01
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005859 2005
% 213.98/214.14  |- skos__altLabel mesh__D005859 Germany, Democratic Republic of
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005859 1998
% 213.98/214.14  |- mesh__recordMaintainer mesh__D005859 ags
% 213.98/214.14  |- skos__broader mesh__D005859smesh__D005858
% 213.98/214.14  |- mesh__dateCreated mesh__D005859 1999-01-01
% 213.98/214.14  |- mesh__recordAuthorizer mesh__D005859 ags
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005859 2006
% 213.98/214.14  |- rdf__type mesh__D005859sskos__Concept
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005859 1999
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005859 2000
% 213.98/214.14  |- skos__altLabel mesh__D005859 German Democratic Republic
% 213.98/214.14  |- skos__prefLabel mesh__D005859 Germany, East
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005859 1994
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005859 2001
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D005859 2003
% 213.98/214.14  |- skos__hiddenLabel mesh__D002561 Occlusion, Cerebrovascular
% 213.98/214.14  |- skos__altLabel mesh__D002561 Intracranial Vascular Disorders
% 213.98/214.14  |- skos__scopeNote mesh__D002561
% 213.98/214.14       A broad category of disorders characterized by impairment of blood flow in the arteries and veins which supply the brain. These include CEREBRAL INFARCTION; BRAIN ISCHEMIA; HYPOXIA, BRAIN; INTRACRANIAL EMBOLISM AND THROMBOSIS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; and VASCULITIS, CENTRAL NERVOUS SYSTEM. In common usage, the term cerebrovascular disorders is not limited to conditions that affect the cerebrum, but refers to vascular disorders of the entire brain including the DIENCEPHALON; BRAIN STEM; and CEREBELLUM.%A%    
% 213.98/214.14  |- mesh__dateRevised mesh__D002561 1999-11-04
% 213.98/214.14  |- skos__hiddenLabel mesh__D002561 Intracranial Vascular Disease
% 213.98/214.14  |- mesh__recordMaintainer mesh__D002561 sjn
% 213.98/214.14  |- mesh__recordAuthorizer mesh__D002561 sjn
% 213.98/214.14  |- skos__hiddenLabel mesh__D002561 Brain Vascular Disorder
% 213.98/214.14  |- rdf__type mesh__D002561sskos__Concept
% 213.98/214.14  |- skos__altLabel mesh__D002561 Vascular Diseases, Intracranial
% 213.98/214.14  |- skos__hiddenLabel mesh__D002561 Insufficiencies, Cerebrovascular
% 213.98/214.14  |- mesh__dateCreated mesh__D002561 1999-01-01
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D002561 2003
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D002561 2001
% 213.98/214.14  |- skos__hiddenLabel mesh__D002561 Vascular Disease, Intracranial
% 213.98/214.14  |- skos__prefLabel mesh__D002561 Cerebrovascular Disorders
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D002561 2005
% 213.98/214.14  |- skos__hiddenLabel mesh__D002561 Intracranial Vascular Disorder
% 213.98/214.14  |- skos__hiddenLabel mesh__D002561 Vascular Disorders, Intracranial
% 213.98/214.14  |- skos__hiddenLabel mesh__D002561 Intracranial Vascular Diseases
% 213.98/214.14  |- skos__hiddenLabel mesh__D002561 Vascular Disorders, Brain
% 213.98/214.14  |- mesh__activeMeSHYear mesh__D002561 2004
% 213.98/214.14  |- skos__hiddenLabel mesh__D002561 Vascular Disorder, Brain
% 213.98/214.15  |- skos__altLabel mesh__D002561 Brain Vascular Disorders
% 213.98/214.15  |- skos__broader mesh__D002561smesh__D001927
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D002561 2006
% 213.98/214.15  |- skos__hiddenLabel mesh__D002561 Insufficiency, Cerebrovascular
% 213.98/214.15  |- skos__annotation mesh__D002561 GEN   
% 213.98/214.15  |- skos__hiddenLabel mesh__D002561 Vascular Disorder, Intracranial
% 213.98/214.15  |- skos__hiddenLabel mesh__D002561 Cerebrovascular Occlusions
% 213.98/214.15  |- skos__hiddenLabel mesh__D002561 Cerebrovascular Disorder
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D002561 2002
% 213.98/214.15  |- mesh__recordOriginator mesh__D002561 NLM
% 213.98/214.15  |- skos__hiddenLabel mesh__D002561 Cerebrovascular Insufficiencies
% 213.98/214.15  |- skos__broader mesh__D002561smesh__D014652
% 213.98/214.15  |- skos__hiddenLabel mesh__D002561 Occlusions, Cerebrovascular
% 213.98/214.15  |- skos__historyNote mesh__D001469 Decompression Sickness %28%1966-1978%29%
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D001469 2001
% 213.98/214.15  |- mesh__recordAuthorizer mesh__D001469 sjn
% 213.98/214.15  |- skos__prefLabel mesh__D001469 Barotrauma
% 213.98/214.15  |- mesh__recordMaintainer mesh__D001469 KEV
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D001469 2004
% 213.98/214.15  |- skos__scopeNote mesh__D001469
% 213.98/214.15       Injury following pressure changes; includes injury to the eustachian tube, ear drum, lung and stomach.%A%    
% 213.98/214.15  |- skos__related mesh__D001469smesh__D006610
% 213.98/214.15  |- mesh__recordOriginator mesh__D001469 RC
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D001469 2002
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D001469 2005
% 213.98/214.15  |- skos__annotation mesh__D001469
% 213.98/214.15       inj caused by pressure changes: not restricted to ear; IM; coord with organ injured by pressure with /inj; also available is BLAST INJURIES%A%  
% 213.98/214.15  |- skos__hiddenLabel mesh__D001469 Barotraumas
% 213.98/214.15  |- mesh__dateCreated mesh__D001469 1978-05-22
% 213.98/214.15  |- skos__related mesh__D001469smesh__D003665
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D001469 2006
% 213.98/214.15  |- mesh__dateRevised mesh__D001469 1999-11-08
% 213.98/214.15  |- rdf__type mesh__D001469sskos__Concept
% 213.98/214.15  |- skos__historyNote mesh__D001469 Pressure %28%1966-1978%29%
% 213.98/214.15  |- skos__broader mesh__D001469smesh__D014947
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D001469 2000
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D001469 2003
% 213.98/214.15  |- mesh__dateEstablished mesh__D001469 1979-01-01
% 213.98/214.15  |- mesh__historyNote mesh__D001469 79   
% 213.98/214.15  |- mesh__publicMeSHNote mesh__D001469 79   
% 213.98/214.15  |- skos__historyNote mesh__D012191 Antigens, Viral, Tumor %28%1984-1985%29%
% 213.98/214.15  |- skos__broader mesh__D012191smesh__D014764
% 213.98/214.15  |- skos__hiddenLabel mesh__D012191 Proteins, Retroviridae
% 213.98/214.15  |- mesh__publicMeSHNote mesh__D012191 86   
% 213.98/214.15  |- skos__scopeNote mesh__D012191
% 213.98/214.15       Proteins from the family Retroviridae. The most frequently encountered member of this family is the Rous sarcoma virus protein.%A%    
% 213.98/214.15  |- skos__prefLabel mesh__D012191 Retroviridae Proteins
% 213.98/214.15  |- mesh__dateRevised mesh__D012191 2005-06-30
% 213.98/214.15  |- mesh__dateCreated mesh__D012191 1985-04-25
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D012191 2006
% 213.98/214.15  |- skos__hiddenLabel mesh__D012191 Proteins, Retrovirus
% 213.98/214.15  |- skos__historyNote mesh__D012191 Viral Proteins %28%1966-1985%29%
% 213.98/214.15  |- mesh__historyNote mesh__D012191 86   
% 213.98/214.15  |- skos__hiddenLabel mesh__D012191 Proteins, Leukovirus
% 213.98/214.15  |- mesh__recordAuthorizer mesh__D012191 sjn
% 213.98/214.15  |- skos__annotation mesh__D012191
% 213.98/214.15       IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 213.98/214.15  |- mesh__dateEstablished mesh__D012191 1986-01-01
% 213.98/214.15  |- mesh__recordMaintainer mesh__D012191 SYSTEM
% 213.98/214.15  |- rdf__type mesh__D012191sskos__Concept
% 213.98/214.15  |- mesh__recordOriginator mesh__D012191 RLS
% 213.98/214.15  |- skos__hiddenLabel mesh__D006952 Disease, Broad Beta
% 213.98/214.15  |- skos__hiddenLabel mesh__D006952 Beta Diseases, Broad
% 213.98/214.15  |- skos__broader mesh__D006952smesh__D006951
% 213.98/214.15  |- skos__hiddenLabel mesh__D006952 III, Hyperlipoproteinemia Type
% 213.98/214.15  |- skos__hiddenLabel mesh__D006952 IIIs, Hyperlipoproteinemia Type
% 213.98/214.15  |- skos__hiddenLabel mesh__D006952 Type IIIs, Hyperlipoproteinemia
% 213.98/214.15  |- skos__hiddenLabel mesh__D006952 Diseases, Broad Beta
% 213.98/214.15  |- mesh__dateCreated mesh__D006952 1979-04-23
% 213.98/214.15  |- skos__hiddenLabel mesh__D006952 Type III, Hyperlipoproteinemia
% 213.98/214.15  |- mesh__recordOriginator mesh__D006952 VDK
% 213.98/214.15  |- skos__broader mesh__D006952smesh__D008052
% 213.98/214.15  |- mesh__publicMeSHNote mesh__D006952 80   
% 213.98/214.15  |- rdf__type mesh__D006952sskos__Concept
% 213.98/214.15  |- skos__scopeNote mesh__D006952
% 213.98/214.15       A rather uncommon form of familial hyperlipemia characterized by the presence of lipoproteins of abnormal composition. The main abnormal lipoproteins are called beta-VLDL and have a different apoprotein content and a higher proportion of cholesterol relative to triglyceride than normal VLDL.%A%    
% 213.98/214.15  |- skos__historyNote mesh__D006952
% 213.98/214.15       Hyperlipidemia/familial %26% genetic %28%1966-1979%29%
% 213.98/214.15  |- skos__hiddenLabel mesh__D006952 Dysbetalipoproteinemias
% 213.98/214.15  |- skos__hiddenLabel mesh__D006952 Hyperlipoproteinemia Type IIIs
% 213.98/214.15  |- skos__hiddenLabel mesh__D006952 Beta Disease, Broad
% 213.98/214.15  |- skos__altLabel mesh__D006952 Broad Beta Disease
% 213.98/214.15  |- skos__altLabel mesh__D006952 Dysbetalipoproteinemia
% 213.98/214.15  |- mesh__recordAuthorizer mesh__D006952 sjn
% 213.98/214.15  |- skos__hiddenLabel mesh__D006952 Broad Beta Diseases
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D006952 2006
% 213.98/214.15  |- skos__prefLabel mesh__D006952 Hyperlipoproteinemia Type III
% 213.98/214.15  |- skos__annotation mesh__D006952
% 213.98/214.15       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 213.98/214.15  |- mesh__dateEstablished mesh__D006952 1980-01-01
% 213.98/214.15  |- mesh__dateRevised mesh__D006952 2005-06-30
% 213.98/214.15  |- mesh__recordMaintainer mesh__D006952 lkt
% 213.98/214.15  |- mesh__historyNote mesh__D006952 80   
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D020623 2006
% 213.98/214.15  |- skos__scopeNote mesh__D020623
% 213.98/214.15       A genus, in the family HYPHOMICROBIACEAE, comprised of ovoid-shaped bacteria with polar growth and a characteristic vegetative growth cycle. Cells grow preferably photoheterotrophically under anaerobic conditions in the light, but will also grow under microaerobic or aerobic conditions in the dark. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 213.98/214.15  |- mesh__historyNote mesh__D020623 2004 %28%2000%29%   
% 213.98/214.15  |- skos__broader mesh__D020623smesh__D041921
% 213.98/214.15  |- skos__broader mesh__D020623smesh__D006090
% 213.98/214.15  |- skos__prefLabel mesh__D020623 Rhodomicrobium
% 213.98/214.15  |- skos__historyNote mesh__D020623 Rhodospirillaceae %28%1978-1999%29%
% 213.98/214.15  |- mesh__dateCreated mesh__D020623 1999-11-03
% 213.98/214.15  |- mesh__recordOriginator mesh__D020623 ndw
% 213.98/214.15  |- skos__historyNote mesh__D020623 Bacteria %28%1967-1977%29%
% 213.98/214.15  |- mesh__recordMaintainer mesh__D020623 SYSTEM
% 213.98/214.15  |- rdf__type mesh__D020623sskos__Concept
% 213.98/214.15  |- mesh__recordAuthorizer mesh__D020623 sjn
% 213.98/214.15  |- mesh__dateRevised mesh__D020623 2005-06-30
% 213.98/214.15  |- mesh__publicMeSHNote mesh__D020623
% 213.98/214.15       2004; see RHODOMICROBIUM VANNIELII 2000-2003   
% 213.98/214.15  |- mesh__dateEstablished mesh__D020623 2000-01-01
% 213.98/214.15  |- rdf__type mesh__D006154sskos__Concept
% 213.98/214.15  |- skos__historyNote mesh__D006154 Fucose %28%1973-1974%29%
% 213.98/214.15  |- skos__annotation mesh__D006154 /biosyn /physiol permitted   
% 213.98/214.15  |- skos__scopeNote mesh__D006154
% 213.98/214.15       A nucleoside diphosphate sugar formed from GDPmannose, which provides fucose for lipopolysaccharides of bacterial cell walls, and for blood group substances and other glycoproteins.%A%    
% 213.98/214.15  |- mesh__dateRevised mesh__D006154 2004-07-07
% 213.98/214.15  |- mesh__historyNote mesh__D006154
% 213.98/214.15       91%28%75%29%; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90%A%  
% 213.98/214.15  |- mesh__recordAuthorizer mesh__D006154 sjn
% 213.98/214.15  |- skos__historyNote mesh__D006154 Guanine Nucleotides %28%1973-1974%29%
% 213.98/214.15  |- skos__hiddenLabel mesh__D006154 Fucose, GDP
% 213.98/214.15  |- skos__altLabel mesh__D006154 GDP Fucose
% 213.98/214.15  |- skos__prefLabel mesh__D006154 Guanosine Diphosphate Fucose
% 213.98/214.15  |- mesh__recordMaintainer mesh__D006154 ssb
% 213.98/214.15  |- mesh__recordOriginator mesh__D006154 NLM
% 213.98/214.15  |- skos__historyNote mesh__D006154
% 213.98/214.15       Nucleoside Diphosphate Sugars %28%1973-1974%29%
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D006154 2005
% 213.98/214.15  |- skos__broader mesh__D006154smesh__D006156
% 213.98/214.15  |- skos__hiddenLabel mesh__D006154 Diphosphofucose, Guanosine
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D006154 2006
% 213.98/214.15  |- skos__hiddenLabel mesh__D006154 Fucose, Guanosine Diphosphate
% 213.98/214.15  |- mesh__dateCreated mesh__D006154 1974-11-19
% 213.98/214.15  |- mesh__dateEstablished mesh__D006154 1991-01-01
% 213.98/214.15  |- skos__hiddenLabel mesh__D006154 Diphosphate Fucose, Guanosine
% 213.98/214.15  |- mesh__publicMeSHNote mesh__D006154
% 213.98/214.15       91; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90   
% 213.98/214.15  |- skos__altLabel mesh__D006154 Guanosine Diphosphofucose
% 213.98/214.15  |- mesh__recordAuthorizer mesh__D011897 sjn
% 213.98/214.15  |- mesh__recordOriginator mesh__D011897 EC
% 213.98/214.15  |- skos__broader mesh__D011897smesh__D015340
% 213.98/214.15  |- skos__hiddenLabel mesh__D011897 Allocation, Random
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D011897 2005
% 213.98/214.15  |- skos__broader mesh__D011897smesh__D012107
% 213.98/214.15  |- skos__prefLabel mesh__D011897 Random Allocation
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D011897 2006
% 213.98/214.15  |- mesh__recordMaintainer mesh__D011897 sjn
% 213.98/214.15  |- mesh__dateEstablished mesh__D011897 1991-01-01
% 213.98/214.15  |- mesh__dateRevised mesh__D011897 2004-07-13
% 213.98/214.15  |- skos__historyNote mesh__D011897 Research Design %28%1973-1977%29%
% 213.98/214.15  |- mesh__publicMeSHNote mesh__D011897
% 213.98/214.15       91; was see under RESEARCH DESIGN 1978-90   
% 213.98/214.15  |- rdf__type mesh__D011897sskos__Concept
% 213.98/214.15  |- skos__altLabel mesh__D011897 Randomization
% 213.98/214.15  |- skos__altLabel mesh__D011897 Random Selection
% 213.98/214.15  |- mesh__dateCreated mesh__D011897 1977-04-22
% 213.98/214.15  |- skos__hiddenLabel mesh__D011897 Selection, Random
% 213.98/214.15  |- skos__scopeNote mesh__D011897
% 213.98/214.15       A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects.%A%    
% 213.98/214.15  |- skos__annotation mesh__D011897
% 213.98/214.15       IM GEN only; coord NIM with specific subject %28%IM%29%; no qualif%A%  
% 213.98/214.15  |- mesh__historyNote mesh__D011897
% 213.98/214.15       91%28%78%29%; was see under RESEARCH DESIGN 1978-90   
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D011099 2002
% 213.98/214.15  |- skos__prefLabel mesh__D011099 Polyglutamic Acid
% 213.98/214.15  |- mesh__dateEstablished mesh__D011099 1991-01-01
% 213.98/214.15  |- mesh__recordOriginator mesh__D011099 RLS
% 213.98/214.15  |- skos__historyNote mesh__D011099 Glutamates %28%1966-1978%29%
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D011099 2004
% 213.98/214.15  |- skos__broader mesh__D011099smesh__D005971
% 213.98/214.15  |- mesh__publicMeSHNote mesh__D011099 91; was see under PEPTIDES 1979-90   
% 213.98/214.15  |- skos__scopeNote mesh__D011099
% 213.98/214.15       A peptide that is a homopolymer of glutamic acid.     
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D011099 2006
% 213.98/214.15  |- skos__broader mesh__D011099smesh__D010455
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D011099 2003
% 213.98/214.15  |- skos__historyNote mesh__D011099 Peptides %28%1966-1978%29%
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D011099 2005
% 213.98/214.15  |- rdf__type mesh__D011099sskos__Concept
% 213.98/214.15  |- mesh__dateCreated mesh__D011099 1978-05-19
% 213.98/214.15  |- mesh__dateRevised mesh__D011099 2001-07-25
% 213.98/214.15  |- mesh__historyNote mesh__D011099
% 213.98/214.15       91%28%79%29%; was see under PEPTIDES 1979-90   
% 213.98/214.15  |- mesh__recordAuthorizer mesh__D011099 sjn
% 213.98/214.15  |- mesh__recordMaintainer mesh__D011099 nns
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D016582 2006
% 213.98/214.15  |- mesh__recordOriginator mesh__D016582 AGS
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D016582 2004
% 213.98/214.15  |- mesh__recordMaintainer mesh__D016582 ags
% 213.98/214.15  |- skos__prefLabel mesh__D016582 Leukemia, Feline
% 213.98/214.15  |- mesh__historyNote mesh__D016582 92   
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D016582 2005
% 213.98/214.15  |- mesh__dateEstablished mesh__D016582 1992-01-01
% 213.98/214.15  |- mesh__recordAuthorizer mesh__D016582 sjn
% 213.98/214.15  |- skos__hiddenLabel mesh__D016582 Feline Leukemias
% 213.98/214.15  |- rdf__type mesh__D016582sskos__Concept
% 213.98/214.15  |- skos__broader mesh__D016582smesh__D002371
% 213.98/214.15  |- skos__annotation mesh__D016582
% 213.98/214.15       caused by a retrovirus; don%27%t forget also CATS %28%NIM%29% %26% check tag ANIMALS%A%  
% 213.98/214.15  |- skos__broader mesh__D016582smesh__D007938
% 213.98/214.15  |- skos__historyNote mesh__D016582 Leukemia/veterinary %28%1966-1991%29%
% 213.98/214.15  |- mesh__dateCreated mesh__D016582 1991-06-21
% 213.98/214.15  |- mesh__publicMeSHNote mesh__D016582 92   
% 213.98/214.15  |- skos__historyNote mesh__D016582 Cat Diseases %28%1966-1991%29%
% 213.98/214.15  |- skos__broader mesh__D016582smesh__D012192
% 213.98/214.15  |- mesh__dateRevised mesh__D016582 2003-07-30
% 213.98/214.15  |- skos__scopeNote mesh__D016582
% 213.98/214.15       A neoplastic disease of cats frequently associated with feline leukemia virus infection.%A%    
% 213.98/214.15  |- skos__hiddenLabel mesh__D016582 Leukemias, Feline
% 213.98/214.15  |- skos__altLabel mesh__D016582 Feline Leukemia
% 213.98/214.15  |- skos__broader mesh__D002562smesh__D012919
% 213.98/214.15  |- mesh__recordOriginator mesh__D002562 NLM
% 213.98/214.15  |- skos__historyNote mesh__D002562 Culture %28%1966-1967%29%
% 213.98/214.15  |- rdf__type mesh__D002562sskos__Concept
% 213.98/214.15  |- mesh__dateCreated mesh__D002562 1999-01-01
% 213.98/214.15  |- skos__historyNote mesh__D002562 Sex Behavior %28%1966-1967%29%
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D002562 2005
% 213.98/214.15  |- mesh__dateRevised mesh__D002562 2003-07-25
% 213.98/214.15  |- mesh__recordMaintainer mesh__D002562 sjn
% 213.98/214.15  |- skos__historyNote mesh__D002562 Anthropology %28%1966-1967%29%
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D002562 2004
% 213.98/214.15  |- mesh__recordAuthorizer mesh__D002562 sjn
% 213.98/214.15  |- skos__hiddenLabel mesh__D002562 Behaviors, Ceremonial
% 213.98/214.15  |- skos__annotation mesh__D002562 human %26% animal; no qualif   
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D002562 2006
% 213.98/214.15  |- skos__hiddenLabel mesh__D002562 Ceremonial Behaviors
% 213.98/214.15  |- skos__historyNote mesh__D002562 Behavior, Animal %28%1966-1967%29%
% 213.98/214.15  |- skos__scopeNote mesh__D002562
% 213.98/214.15       A series of actions, sometimes symbolic actions which may be associated with a behavior pattern, and are often indispensable to its performance.%A%    
% 213.98/214.15  |- mesh__dateEstablished mesh__D002562 1968-01-01
% 213.98/214.15  |- skos__related mesh__D002562smesh__D001070
% 213.98/214.15  |- skos__prefLabel mesh__D002562 Ceremonial Behavior
% 213.98/214.15  |- skos__broader mesh__D002562smesh__D003469
% 213.98/214.15  |- skos__hiddenLabel mesh__D002562 Behavior, Ceremonial
% 213.98/214.15  |- mesh__publicMeSHNote mesh__D002562 98; see CEREMONIAL 1968-97   
% 213.98/214.15  |- mesh__historyNote mesh__D002562 98%28%68%29%   
% 213.98/214.15  |- skos__altLabel mesh__D040681 Protein Structural Homologs
% 213.98/214.15  |- mesh__publicMeSHNote mesh__D040681 2003   
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Homologies, Protein 3-Dimensional
% 213.98/214.15  |- rdf__type mesh__D040681sskos__Concept
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Protein 3-Dimensional Homologs
% 213.98/214.15  |- skos__altLabel mesh__D040681 3-D Homologs, Protein
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Protein 3-D Homologs
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Homolog, Protein 3-Dimensional
% 213.98/214.15  |- skos__broader mesh__D040681smesh__D017386
% 213.98/214.15  |- skos__broader mesh__D040681smesh__D011487
% 213.98/214.15  |- skos__altLabel mesh__D040681 3-Dimensional Homology, Protein
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Homologs, Protein 3-Dimensional
% 213.98/214.15  |- skos__altLabel mesh__D040681 Homologs, Sturctural, Protein
% 213.98/214.15  |- skos__altLabel mesh__D040681 Homologs, 3-Dimensional, Protein
% 213.98/214.15  |- skos__altLabel mesh__D040681 3-D Homology, Protein
% 213.98/214.15  |- mesh__dateRevised mesh__D040681 2004-07-07
% 213.98/214.15  |- mesh__recordMaintainer mesh__D040681 nns
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Structural Homolog, Protein
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Protein 3-D Homology
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 3-Dimensional Homolog, Protein
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Homology, Protein 3-D
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Homologs, Protein 3-D
% 213.98/214.15  |- skos__related mesh__D040681smesh__D018716
% 213.98/214.15  |- skos__scopeNote mesh__D040681
% 213.98/214.15       The degree of 3-dimensional shape similarity between proteins. It can be an indication of distant AMINO ACID SEQUENCE HOMOLOGY and used for rational DRUG DESIGN.%A%    
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Structural Homologies, Protein
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Homologies, Protein Structural
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D040681 2005
% 213.98/214.15  |- skos__prefLabel mesh__D040681 Structural Homology, Protein
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Homologs, Protein Structural
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Homolog, Protein 3-D
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Protein 3-Dimensional Homologies
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 3-D Homolog, Protein
% 213.98/214.15  |- mesh__historyNote mesh__D040681 2003   
% 213.98/214.15  |- skos__altLabel mesh__D040681 Protein Structural Homology
% 213.98/214.15  |- skos__altLabel mesh__D040681 Homologs, 3-D, Protein
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Protein 3-D Homologies
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Protein 3-Dimensional Homology
% 213.98/214.15  |- mesh__recordOriginator mesh__D040681 nns
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 3 D Homologs, Protein
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D040681 2006
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 3 Dimensional Homology, Protein
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 3-D Homologies, Protein
% 213.98/214.15  |- mesh__dateCreated mesh__D040681 2002-07-03
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Protein Structural Homolog
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Protein 3-D Homolog
% 213.98/214.15  |- skos__broader mesh__D040681smesh__D040341
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Protein 3-Dimensional Homolog
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Homologies, Protein 3-D
% 213.98/214.15  |- skos__altLabel mesh__D040681 Structural Homologs, Protein
% 213.98/214.15  |- mesh__dateEstablished mesh__D040681 2003-01-01
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Homology, Protein Structural
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Homolog, Protein Structural
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Protein Structural Homologies
% 213.98/214.15  |- mesh__recordAuthorizer mesh__D040681 sjn
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 Homology, Protein 3-Dimensional
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 3 D Homology, Protein
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 3 Dimensional Homologs, Protein
% 213.98/214.15  |- skos__hiddenLabel mesh__D040681 3-Dimensional Homologies, Protein
% 213.98/214.15  |- skos__related mesh__D040681smesh__D017386
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D012990 2004
% 213.98/214.15  |- mesh__dateEstablished mesh__D012990 1991-01-01
% 213.98/214.15  |- mesh__publicMeSHNote mesh__D012990
% 213.98/214.15       91; was see under SOIL POLLUTANTS 1975-90   
% 213.98/214.15  |- rdf__type mesh__D012990sskos__Concept
% 213.98/214.15  |- mesh__recordMaintainer mesh__D012990 ssb
% 213.98/214.15  |- skos__hiddenLabel mesh__D012990 Radioactive Soil Pollutants
% 213.98/214.15  |- mesh__historyNote mesh__D012990
% 213.98/214.15       91%28%75%29%; was see under SOIL POLLUTANTS 1975-90   
% 213.98/214.15  |- mesh__recordAuthorizer mesh__D012990 sjn
% 213.98/214.15  |- skos__broader mesh__D012990smesh__D011848
% 213.98/214.15  |- mesh__dateRevised mesh__D012990 2003-07-09
% 213.98/214.15  |- skos__prefLabel mesh__D012990 Soil Pollutants, Radioactive
% 213.98/214.15  |- mesh__dateCreated mesh__D012990 1999-01-01
% 213.98/214.15  |- skos__hiddenLabel mesh__D012990 Pollutants, Radioactive Soil
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D012990 2006
% 213.98/214.15  |- mesh__recordOriginator mesh__D012990 NLM
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D012990 2005
% 213.98/214.15  |- skos__broader mesh__D012990smesh__D012989
% 213.98/214.15  |- skos__scopeNote mesh__D012990
% 213.98/214.15       Pollutants, present in soil, which exhibit radioactivity.%A%    
% 213.98/214.15  |- skos__annotation mesh__D012990
% 213.98/214.15       specify radiopollutant if pertinent %28%IM or NIM%29%   
% 213.98/214.15  |- skos__historyNote mesh__D012192 Virus Diseases %28%1966-1980%29%
% 213.98/214.15  |- skos__broader mesh__D012192smesh__D012327
% 213.98/214.15  |- mesh__recordMaintainer mesh__D012192 AGS
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D012192 1994
% 213.98/214.15  |- mesh__recordOriginator mesh__D012192 RC
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D012192 2006
% 213.98/214.15  |- skos__hiddenLabel mesh__D012192 Infection, Retroviridae
% 213.98/214.15  |- mesh__onlineNote mesh__D012192
% 213.98/214.15       use RETROVIRIDAE INFECTIONS to search RETROVIRUS INFECTIONS 1981-93%A%  
% 213.98/214.15  |- skos__hiddenLabel mesh__D012192 Retroviridae Infection
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D012192 2004
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D012192 1999
% 213.98/214.15  |- mesh__recordAuthorizer mesh__D012192 PLS
% 213.98/214.15  |- skos__altLabel mesh__D012192 Infections, Retroviridae
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D012192 1997
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D012192 2005
% 213.98/214.15  |- skos__hiddenLabel mesh__D012192 Retrovirus Infection
% 213.98/214.15  |- rdf__type mesh__D012192sskos__Concept
% 213.98/214.15  |- skos__historyNote mesh__D012192 Retroviridae %28%1966-1977%29%
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D012192 2001
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D012192 2003
% 213.98/214.15  |- mesh__dateRevised mesh__D012192 1993-06-04
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D012192 1998
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D012192 2000
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D012192 1996
% 213.98/214.15  |- skos__scopeNote mesh__D012192
% 213.98/214.15       Virus diseases caused by the RETROVIRIDAE.     
% 213.98/214.15  |- mesh__dateCreated mesh__D012192 1980-05-13
% 213.98/214.15  |- skos__annotation mesh__D012192 GEN or unspecified; prefer specifics   
% 213.98/214.15  |- skos__hiddenLabel mesh__D012192 Infection, Retrovirus
% 213.98/214.15  |- skos__altLabel mesh__D012192 Infections, Retrovirus
% 213.98/214.15  |- mesh__historyNote mesh__D012192 94; was RETROVIRUS INFECTIONS 1981-93   
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D012192 1995
% 213.98/214.15  |- mesh__publicMeSHNote mesh__D012192
% 213.98/214.15       94; was RETROVIRUS INFECTIONS 1981-93   
% 213.98/214.15  |- skos__prefLabel mesh__D012192 Retroviridae Infections
% 213.98/214.15  |- skos__altLabel mesh__D012192 Retrovirus Infections
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D012192 2002
% 213.98/214.15  |- mesh__dateEstablished mesh__D012192 1981-01-01
% 213.98/214.15  |- mesh__recordAuthorizer mesh__D006953 sjn
% 213.98/214.15  |- rdf__type mesh__D006953sskos__Concept
% 213.98/214.15  |- skos__hiddenLabel mesh__D006953 Familial Hypertriglyceridemia
% 213.98/214.15  |- skos__prefLabel mesh__D006953 Hyperlipoproteinemia Type IV
% 213.98/214.15  |- mesh__recordMaintainer mesh__D006953 lkt
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D006953 2006
% 213.98/214.15  |- mesh__dateRevised mesh__D006953 2005-06-30
% 213.98/214.15  |- skos__historyNote mesh__D006953 Hyperlipidemia %28%1966-1979%29%
% 213.98/214.15  |- skos__hiddenLabel mesh__D006953 Hyperprebetalipoproteinemias
% 213.98/214.15  |- mesh__recordOriginator mesh__D006953 VDK
% 213.98/214.15  |- skos__hiddenLabel mesh__D006953 Type IVs, Hyperlipoproteinemia
% 213.98/214.15  |- skos__hiddenLabel mesh__D006953 Familial Hypertriglyceridemias
% 213.98/214.15  |- skos__broader mesh__D006953smesh__D008052
% 213.98/214.15  |- skos__annotation mesh__D006953
% 213.98/214.15       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 213.98/214.15  |- skos__altLabel mesh__D006953 Hypertriglyceridemia, Familial
% 213.98/214.15  |- mesh__historyNote mesh__D006953 80   
% 213.98/214.15  |- skos__hiddenLabel mesh__D006953 IV, Hyperlipoproteinemia Type
% 213.98/214.15  |- skos__broader mesh__D006953smesh__D006950
% 213.98/214.15  |- skos__scopeNote mesh__D006953
% 213.98/214.15       A familial disorder characterized by an isolated elevation in the plasma level of endogenously synthesized triglyceride carried in VLDL. It is considered to be an autosomal dominant trait.%A%    
% 213.98/214.15  |- mesh__dateEstablished mesh__D006953 1980-01-01
% 213.98/214.15  |- skos__broader mesh__D006953smesh__D006951
% 213.98/214.15  |- mesh__publicMeSHNote mesh__D006953 80   
% 213.98/214.15  |- skos__hiddenLabel mesh__D006953 IVs, Hyperlipoproteinemia Type
% 213.98/214.15  |- skos__hiddenLabel mesh__D006953 Hypertriglyceridemias, Familial
% 213.98/214.15  |- mesh__dateCreated mesh__D006953 1979-04-23
% 213.98/214.15  |- skos__hiddenLabel mesh__D006953 Type IV, Hyperlipoproteinemia
% 213.98/214.15  |- skos__altLabel mesh__D006953 Hyperprebetalipoproteinemia
% 213.98/214.15  |- skos__hiddenLabel mesh__D006953 Hyperlipoproteinemia Type IVs
% 213.98/214.15  |- mesh__historyNote mesh__D020624 2000   
% 213.98/214.15  |- skos__historyNote mesh__D020624
% 213.98/214.15       Gram-Negative Anaerobic Bacteria %28%1996-1999%29%
% 213.98/214.15  |- mesh__publicMeSHNote mesh__D020624 2000   
% 213.98/214.15  |- skos__broader mesh__D020624smesh__D016965
% 213.98/214.15  |- mesh__recordOriginator mesh__D020624 ndw
% 213.98/214.15  |- mesh__recordMaintainer mesh__D020624 ags
% 213.98/214.15  |- mesh__recordAuthorizer mesh__D020624 ags
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D020624 2006A
% 213.98/214.15  |- skos__scopeNote mesh__D020624
% 213.98/214.15       The sole species of the genus Oxalobacter consisting of straight or curved gram-negative rods with rounded ends. Cells are nonmotile, nonsporing, and use oxylates as the only source of CARBON and energy, with formate and CARBON DIOXIDE as end products. They are isolated from lake sediments and from the rumen or large bowel of humans and animals. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 213.98/214.15  |- rdf__type mesh__D020624sskos__Concept
% 213.98/214.15  |- mesh__dateEstablished mesh__D020624 2000-01-01
% 213.98/214.15  |- mesh__dateCreated mesh__D020624 1999-11-03
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D020624 2006
% 213.98/214.15  |- skos__broader mesh__D020624smesh__D042802
% 213.98/214.15  |- skos__prefLabel mesh__D020624 Oxalobacter formigenes
% 213.98/214.15  |- mesh__dateRevised mesh__D020624 2005-07-22
% 213.98/214.15  |- skos__historyNote mesh__D006155
% 213.98/214.15       Nucleoside Diphosphate Sugars %28%1973-1974%29%
% 213.98/214.15  |- skos__hiddenLabel mesh__D006155 Diphosphomannose, Guanosine
% 213.98/214.15  |- skos__annotation mesh__D006155 /biosyn /physiol permitted   
% 213.98/214.15  |- mesh__activeMeSHYear mesh__D006155 2005
% 213.98/214.15  |- skos__hiddenLabel mesh__D006155 Mannose, Guanosine Diphosphate
% 213.98/214.15  |- rdf__type mesh__D006155sskos__Concept
% 213.98/214.15  |- skos__historyNote mesh__D006155 Guanine Nucleotides %28%1973-1974%29%
% 213.98/214.15  |- mesh__dateEstablished mesh__D006155 1991-01-01
% 213.98/214.15  |- mesh__dateCreated mesh__D006155 1974-11-19
% 213.98/214.15  |- mesh__historyNote mesh__D006155
% 213.98/214.15       91%28%75%29%; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90%A%  
% 213.98/214.15  |- skos__historyNote mesh__D006155 Mannose %28%1973-1974%29%
% 213.98/214.15  |- skos__prefLabel mesh__D006155 Guanosine Diphosphate Mannose
% 213.98/214.15  |- mesh__recordMaintainer mesh__D006155 ssb
% 213.98/214.15  |- skos__hiddenLabel mesh__D006155 Diphosphate Mannose, Guanosine
% 213.98/214.15  |- skos__altLabel mesh__D006155 Guanosine Pyrophosphate Mannose
% 213.98/214.15  |- skos__broader mesh__D006155smesh__D006156
% 213.98/214.15  |- skos__scopeNote mesh__D006155
% 213.98/214.15       A nucleoside diphosphate sugar which can be converted to the deoxy sugar GDPfucose, which provides fucose for lipopolysaccharides of bacterial cell walls. Also acts as mannose donor for glycolipid synthesis.%A%    
% 213.98/214.15  |- mesh__dateRevised mesh__D006155 2004-07-07
% 213.98/214.15  |- skos__altLabel mesh__D006155 GDP Mannose
% 213.98/214.15  |- mesh__recordAuthorizer mesh__D006155 sjn
% 213.98/214.15  |- mesh__publicMeSHNote mesh__D006155
% 213.98/214.15       91; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90   
% 213.98/214.15  |- skos__hiddenLabel mesh__D006155 Mannose, GDP
% 213.98/214.15  |- skos__altLabel mesh__D006155 Guanosine Diphosphomannose
% 213.98/214.16  |- mesh__recordOriginator mesh__D006155 NLM
% 213.98/214.16  |- skos__hiddenLabel mesh__D006155 Pyrophosphate Mannose, Guanosine
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006155 2006
% 213.98/214.16  |- skos__hiddenLabel mesh__D006155 Mannose, Guanosine Pyrophosphate
% 213.98/214.16  |- skos__hiddenLabel mesh__D011898 True Frog
% 213.98/214.16  |- mesh__dateCreated mesh__D011898 1999-01-01
% 213.98/214.16  |- skos__historyNote mesh__D011898 Anura %28%1966-1971%29%
% 213.98/214.16  |- mesh__dateRevised mesh__D011898 2003-07-09
% 213.98/214.16  |- mesh__publicMeSHNote mesh__D011898 81; was RANA 1972-80   
% 213.98/214.16  |- mesh__recordAuthorizer mesh__D011898 sjn
% 213.98/214.16  |- skos__broader mesh__D011898smesh__D001001
% 213.98/214.16  |- skos__scopeNote mesh__D011898
% 213.98/214.16       The family of true frogs of the order Anura. The family occurs worldwide except in Antarctica.%A%    
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D011898 2006
% 213.98/214.16  |- skos__hiddenLabel mesh__D011898 True Frogs
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D011898 2004
% 213.98/214.16  |- skos__annotation mesh__D011898
% 213.98/214.16       family of true frogs; GEN or unspecified; prefer specific genera; NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 213.98/214.16  |- skos__altLabel mesh__D011898 Frogs, True
% 213.98/214.16  |- mesh__recordOriginator mesh__D011898 NLM
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D011898 2005
% 213.98/214.16  |- rdf__type mesh__D011898sskos__Concept
% 213.98/214.16  |- skos__prefLabel mesh__D011898 Ranidae
% 213.98/214.16  |- mesh__onlineNote mesh__D011898 use RANIDAE to search RANA 1972-80   
% 213.98/214.16  |- mesh__recordMaintainer mesh__D011898 ags
% 213.98/214.16  |- skos__hiddenLabel mesh__D011898 Frog, True
% 213.98/214.16  |- mesh__dateEstablished mesh__D011898 1972-01-01
% 213.98/214.16  |- mesh__historyNote mesh__D011898 81; was RANA 1972-80   
% 213.98/214.16  |- skos__hiddenLabel mesh__D016583 Bovine Leukoses, Enzootic
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D016583 2005
% 213.98/214.16  |- skos__hiddenLabel mesh__D016583 Bovine Leukoses
% 213.98/214.16  |- skos__hiddenLabel mesh__D016583 Bovine Leukemias
% 213.98/214.16  |- skos__hiddenLabel mesh__D016583 Enzootic Bovine Leukoses
% 213.98/214.16  |- rdf__type mesh__D016583sskos__Concept
% 213.98/214.16  |- skos__hiddenLabel mesh__D016583 Leukoses, Enzootic Bovine
% 213.98/214.16  |- skos__hiddenLabel mesh__D016583 Bovine Lymphomas
% 213.98/214.16  |- skos__altLabel mesh__D016583 Bovine Leukosis
% 213.98/214.16  |- skos__hiddenLabel mesh__D016583 Lymphosarcomas, Bovine
% 213.98/214.16  |- mesh__recordOriginator mesh__D016583 AGS
% 213.98/214.16  |- skos__broader mesh__D016583smesh__D006800
% 213.98/214.16  |- skos__hiddenLabel mesh__D016583 Leukoses, Bovine
% 213.98/214.16  |- skos__annotation mesh__D016583
% 213.98/214.16       a specific dis caused by BOVINE LEUKEMIA VIRUS %28%see LEUKEMIA VIRUS, BOVINE%29%: do not confuse with the general group BLV INFECTIONS see DELTARETROVIRUS INFECTIONS; don%27%t forget also CATTLE %28%NIM%29% %26% check tag ANIMALS%A%  
% 213.98/214.16  |- skos__historyNote mesh__D016583 Cattle Diseases %28%1966-1991%29%
% 213.98/214.16  |- skos__historyNote mesh__D016583 Leukemia/veterinary %28%1966-1991%29%
% 213.98/214.16  |- skos__hiddenLabel mesh__D016583 Lymphomas, Bovine
% 213.98/214.16  |- mesh__dateCreated mesh__D016583 1991-01-25
% 213.98/214.16  |- skos__hiddenLabel mesh__D016583 Bovine Lymphosarcomas
% 213.98/214.16  |- skos__altLabel mesh__D016583 Bovine Lymphoma
% 213.98/214.16  |- mesh__dateEstablished mesh__D016583 1992-01-01
% 213.98/214.16  |- skos__prefLabel mesh__D016583 Enzootic Bovine Leukosis
% 213.98/214.16  |- skos__scopeNote mesh__D016583
% 213.98/214.16       A lymphoid neoplastic disease in cattle caused by the bovine leukemia virus. Enzootic bovine leukosis may take the form of lymphosarcoma, malignant lymphoma, or leukemia but the presence of malignant cells in the blood is not a consistent finding.%A%    
% 213.98/214.16  |- mesh__recordAuthorizer mesh__D016583 sjn
% 213.98/214.16  |- skos__altLabel mesh__D016583 Leukemia, Bovine
% 213.98/214.16  |- skos__hiddenLabel mesh__D016583 Bovine Leukosis, Enzootic
% 213.98/214.16  |- mesh__dateRevised mesh__D016583 2003-07-30
% 213.98/214.16  |- skos__broader mesh__D016583smesh__D007938
% 213.98/214.16  |- skos__altLabel mesh__D016583 Bovine Lymphosarcoma
% 213.98/214.16  |- skos__hiddenLabel mesh__D016583 Leukosis, Enzootic Bovine
% 213.98/214.16  |- skos__hiddenLabel mesh__D016583 Leukemias, Bovine
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D016583 2006
% 213.98/214.16  |- skos__broader mesh__D016583smesh__D002418
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D016583 2004
% 213.98/214.16  |- mesh__recordMaintainer mesh__D016583 ags
% 213.98/214.16  |- mesh__publicMeSHNote mesh__D016583 92   
% 213.98/214.16  |- skos__altLabel mesh__D016583 Leukosis, Bovine
% 213.98/214.16  |- mesh__historyNote mesh__D016583 92   
% 213.98/214.16  |- skos__related mesh__D002563smesh__D002565
% 213.98/214.16  |- mesh__recordMaintainer mesh__D002563 jmp
% 213.98/214.16  |- skos__broader mesh__D002563smesh__D028581
% 213.98/214.16  |- rdf__type mesh__D002563sskos__Concept
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D002563 2004
% 213.98/214.16  |- skos__annotation mesh__D002563 a rare earth metal; Ce-140   
% 213.98/214.16  |- mesh__dateCreated mesh__D002563 1999-01-01
% 213.98/214.16  |- mesh__recordOriginator mesh__D002563 NLM
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D002563 2003
% 213.98/214.16  |- skos__related mesh__D002563smesh__D002564
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D002563 2006
% 213.98/214.16  |- mesh__dateRevised mesh__D002563 2001-07-25
% 213.98/214.16  |- mesh__recordAuthorizer mesh__D002563 sjn
% 213.98/214.16  |- skos__prefLabel mesh__D002563 Cerium
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D002563 2002
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D002563 2005
% 213.98/214.16  |- skos__scopeNote mesh__D002563
% 213.98/214.16       An element of the rare earth family of metals. It has the atomic symbol Ce, atomic number 58, and atomic weight 140.12. Cerium is a malleable metal used in industrial applications.%A%    
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D012991 2003
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D012991 1998
% 213.98/214.16  |- skos__altLabel mesh__D012991 Solanum Alkaloids
% 213.98/214.16  |- mesh__onlineNote mesh__D012991
% 213.98/214.16       use SOLANACEOUS ALKALOIDS to search SOLANUM ALKALOIDS 1977-78%A%  
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D012991 2000
% 213.98/214.16  |- mesh__publicMeSHNote mesh__D012991 79; was SOLANUM ALKALOIDS 1977-78   
% 213.98/214.16  |- mesh__historyNote mesh__D012991 79; was SOLANUM ALKALOIDS 1977-78   
% 213.98/214.16  |- skos__hiddenLabel mesh__D012991 Alkaloids, Solanaceous
% 213.98/214.16  |- mesh__recordAuthorizer mesh__D012991 SJN
% 213.98/214.16  |- mesh__dateRevised mesh__D012991 1997-06-20
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D012991 2006
% 213.98/214.16  |- skos__scopeNote mesh__D012991
% 213.98/214.16       Alkaloids, mainly tropanes, elaborated by plants of the family Solanaceae, including Atropa, Hyoscyamus, Mandragora, Nicotiana, Solanum, etc. Some act as cholinergic antagonists; most are very toxic; many are used medicinally.%A%    
% 213.98/214.16  |- skos__historyNote mesh__D012991 Alkaloids %28%1966-1976%29%
% 213.98/214.16  |- mesh__dateCreated mesh__D012991 1976-05-19
% 213.98/214.16  |- skos__related mesh__D012991smesh__D010276
% 213.98/214.16  |- mesh__recordOriginator mesh__D012991 RLS
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D012991 2005
% 213.98/214.16  |- skos__broader mesh__D012991smesh__D000470
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D012991 2002
% 213.98/214.16  |- skos__historyNote mesh__D012991 Solanum Alkaloids %28%1977-1978%29%
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D012991 2004
% 213.98/214.16  |- mesh__recordMaintainer mesh__D012991 JLS
% 213.98/214.16  |- skos__prefLabel mesh__D012991 Solanaceous Alkaloids
% 213.98/214.16  |- mesh__dateEstablished mesh__D012991 1977-01-01
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D012991 1999
% 213.98/214.16  |- skos__hiddenLabel mesh__D012991 Alkaloids, Solanum
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D012991 2001
% 213.98/214.16  |- rdf__type mesh__D012991sskos__Concept
% 213.98/214.16  |- skos__hiddenLabel mesh__D012193 Reversal Learnings
% 213.98/214.16  |- mesh__recordOriginator mesh__D012193 NLM
% 213.98/214.16  |- skos__broader mesh__D012193smesh__D007858
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D012193 2005
% 213.98/214.16  |- mesh__recordMaintainer mesh__D012193 sjn
% 213.98/214.16  |- rdf__type mesh__D012193sskos__Concept
% 213.98/214.16  |- mesh__recordAuthorizer mesh__D012193 sjn
% 213.98/214.16  |- skos__annotation mesh__D012193 human %26% animal   
% 213.98/214.16  |- mesh__dateRevised mesh__D012193 2004-07-13
% 213.98/214.16  |- skos__scopeNote mesh__D012193
% 213.98/214.16       Any situation where an animal or human is trained to respond differentially to two stimuli %28%e.g., approach and avoidance%29% under reward and punishment conditions and subsequently trained under reversed reward values %28%i.e., the approach which was previously rewarded is punished and vice versa%29%.%A%    
% 213.98/214.16  |- skos__hiddenLabel mesh__D012193 Learnings, Reversal
% 213.98/214.16  |- skos__hiddenLabel mesh__D012193 Learning, Reversal
% 213.98/214.16  |- skos__prefLabel mesh__D012193 Reversal Learning
% 213.98/214.16  |- mesh__dateEstablished mesh__D012193 1966-01-01
% 213.98/214.16  |- mesh__publicMeSHNote mesh__D012193 66   
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D012193 2006
% 213.98/214.16  |- mesh__dateCreated mesh__D012193 1999-01-01
% 213.98/214.16  |- mesh__historyNote mesh__D012193 66%28%64%29%   
% 213.98/214.16  |- skos__hiddenLabel mesh__D006954 V, Hyperlipoproteinemia Type
% 213.98/214.16  |- mesh__publicMeSHNote mesh__D006954 80   
% 213.98/214.16  |- skos__hiddenLabel mesh__D006954 Mixed Hyperlipemias
% 213.98/214.16  |- skos__hiddenLabel mesh__D006954 Mixed Hyperlipemia
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006954 2006
% 213.98/214.16  |- mesh__recordAuthorizer mesh__D006954 sjn
% 213.98/214.16  |- skos__hiddenLabel mesh__D006954 Hyperlipoproteinemia Type Vs
% 213.98/214.16  |- skos__altLabel mesh__D006954 Hyperlipemia, Mixed
% 213.98/214.16  |- mesh__recordMaintainer mesh__D006954 lkt
% 213.98/214.16  |- skos__annotation mesh__D006954
% 213.98/214.16       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 213.98/214.16  |- mesh__historyNote mesh__D006954 80   
% 213.98/214.16  |- skos__broader mesh__D006954smesh__D006951
% 213.98/214.16  |- skos__prefLabel mesh__D006954 Hyperlipoproteinemia Type V
% 213.98/214.16  |- mesh__dateEstablished mesh__D006954 1980-01-01
% 213.98/214.16  |- mesh__dateRevised mesh__D006954 2005-06-30
% 213.98/214.16  |- skos__hiddenLabel mesh__D006954 Vs, Hyperlipoproteinemia Type
% 213.98/214.16  |- skos__historyNote mesh__D006954 Hyperlipidemia %28%1966-1979%29%
% 213.98/214.16  |- mesh__dateCreated mesh__D006954 1979-04-23
% 213.98/214.16  |- mesh__recordOriginator mesh__D006954 VDK
% 213.98/214.16  |- skos__scopeNote mesh__D006954
% 213.98/214.16       A severe familial adult-onset hypertriglyceridemia different from that due to lipoprotein lipase deficiency.%A%    
% 213.98/214.16  |- skos__broader mesh__D006954smesh__D008052
% 213.98/214.16  |- skos__hiddenLabel mesh__D006954 Type Vs, Hyperlipoproteinemia
% 213.98/214.16  |- rdf__type mesh__D006954sskos__Concept
% 213.98/214.16  |- skos__hiddenLabel mesh__D006954 Hyperlipemias, Mixed
% 213.98/214.16  |- skos__hiddenLabel mesh__D006954 Type V, Hyperlipoproteinemia
% 213.98/214.16  |- mesh__dateCreated mesh__D020625 1999-11-03
% 213.98/214.16  |- rdf__type mesh__D020625sskos__Concept
% 213.98/214.16  |- mesh__recordOriginator mesh__D020625 ndw
% 213.98/214.16  |- mesh__recordMaintainer mesh__D020625 SYSTEM
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D020625 2006
% 213.98/214.16  |- mesh__recordAuthorizer mesh__D020625 sjn
% 213.98/214.16  |- skos__annotation mesh__D020625
% 213.98/214.16       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 213.98/214.16  |- mesh__publicMeSHNote mesh__D020625 2000   
% 213.98/214.16  |- mesh__dateRevised mesh__D020625 2005-06-30
% 213.98/214.16  |- skos__broader mesh__D020625smesh__D042502
% 213.98/214.16  |- mesh__dateEstablished mesh__D020625 2000-01-01
% 213.98/214.16  |- mesh__historyNote mesh__D020625 2000   
% 213.98/214.16  |- skos__scopeNote mesh__D020625
% 213.98/214.16       A species of bacteria which is comprised of gram-negative rods which often approach a spherical shape. They are nonmotile and microaerophilic. They are considered parasites of horses and are pathogenic for mares. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 213.98/214.16  |- skos__prefLabel mesh__D020625 Taylorella equigenitalis
% 213.98/214.16  |- skos__historyNote mesh__D020625 Haemophilus %28%1986-1999%29%
% 213.98/214.16  |- mesh__recordOriginator mesh__D006156 NLM
% 213.98/214.16  |- rdf__type mesh__D006156sskos__Concept
% 213.98/214.16  |- mesh__historyNote mesh__D006156
% 213.98/214.16       91%28%75%29%; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90%A%  
% 213.98/214.16  |- skos__historyNote mesh__D006156
% 213.98/214.16       Nucleoside Diphosphate Sugars %28%1973-1974%29%
% 213.98/214.16  |- skos__prefLabel mesh__D006156 Guanosine Diphosphate Sugars
% 213.98/214.16  |- skos__historyNote mesh__D006156 Guanine Nucleotides %28%1973-1974%29%
% 213.98/214.16  |- skos__hiddenLabel mesh__D006156 Sugars, GDP
% 213.98/214.16  |- mesh__dateEstablished mesh__D006156 1991-01-01
% 213.98/214.16  |- skos__broader mesh__D006156smesh__D009702
% 213.98/214.16  |- skos__scopeNote mesh__D006156
% 213.98/214.16       Esters formed between the aldehydic carbon of sugars and the terminal phosphate of guanosine diphosphate.%A%    
% 213.98/214.16  |- skos__hiddenLabel mesh__D006156 Sugars, Guanosine Diphosphate
% 213.98/214.16  |- mesh__dateCreated mesh__D006156 1974-11-19
% 213.98/214.16  |- mesh__dateRevised mesh__D006156 2004-07-07
% 213.98/214.16  |- mesh__recordMaintainer mesh__D006156 ssb
% 213.98/214.16  |- skos__hiddenLabel mesh__D006156 Diphosphate Sugars, Guanosine
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006156 2006
% 213.98/214.16  |- skos__broader mesh__D006156smesh__D006153
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006156 2005
% 213.98/214.16  |- mesh__publicMeSHNote mesh__D006156
% 213.98/214.16       91; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90   
% 213.98/214.16  |- skos__altLabel mesh__D006156 GDP Sugars
% 213.98/214.16  |- skos__annotation mesh__D006156 /biosyn /physiol permitted   
% 213.98/214.16  |- mesh__recordAuthorizer mesh__D006156 sjn
% 213.98/214.16  |- skos__hiddenLabel mesh__D011899 Hydrochloride, Ranitidine
% 213.98/214.16  |- skos__hiddenLabel mesh__D011899 AH19065
% 213.98/214.16  |- skos__altLabel mesh__D011899
% 213.98/214.16       N %28%2-%28%%28%%28%5-%28%%28%Dimethylamino%29%methyl%29%-2-furanyl%29%methyl%29%thio%29%ethyl%29%-N%27%-methyl-2-nitro-1,1-ethenediamine
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D011899 2002
% 213.98/214.16  |- mesh__historyNote mesh__D011899 84   
% 213.98/214.16  |- mesh__dateEstablished mesh__D011899 1984-01-01
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D011899 2006
% 213.98/214.16  |- mesh__recordMaintainer mesh__D011899 TWD
% 213.98/214.16  |- skos__historyNote mesh__D011899 Furans %28%1966-1983%29%
% 213.98/214.16  |- skos__scopeNote mesh__D011899
% 213.98/214.16       A non-imidazole blocker of those histamine receptors that mediate gastric secretion %28%H2 receptors%29%. It is used to treat gastrointestinal ulcers.%A%    
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D011899 2004
% 213.98/214.16  |- mesh__dateCreated mesh__D011899 1983-06-13
% 213.98/214.16  |- skos__broader mesh__D011899smesh__D005663
% 213.98/214.16  |- skos__hiddenLabel mesh__D011899 AH 19065
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D011899 2005
% 213.98/214.16  |- skos__altLabel mesh__D011899 Ranitidin
% 213.98/214.16  |- rdf__type mesh__D011899sskos__Concept
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D011899 2001
% 213.98/214.16  |- mesh__recordOriginator mesh__D011899 SH
% 213.98/214.16  |- mesh__recordAuthorizer mesh__D011899 sjn
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D011899 2003
% 213.98/214.16  |- skos__prefLabel mesh__D011899 Ranitidine
% 213.98/214.16  |- mesh__dateRevised mesh__D011899 2000-06-21
% 213.98/214.16  |- mesh__publicMeSHNote mesh__D011899 84   
% 213.98/214.16  |- skos__scopeNote mesh__D016584
% 213.98/214.16       A type of anxiety disorder characterized by unexpected panic attacks that last minutes or, rarely, hours. Panic attacks begin with intense apprehension, fear or terror and, often, a feeling of impending doom. Symptoms experienced during a panic attack include dyspnea or sensations of being smothered; dizziness, loss of balance or faintness; choking sensations; palpitations or accelerated heart rate; shakiness; sweating; nausea or other form of abdominal distress; depersonalization or derealization; paresthesias; hot flashes or chills; chest discomfort or pain; fear of dying and fear of not being in control of oneself or going crazy. Agoraphobia may also develop. Similar to other anxiety disorders, it may be inherited as an autosomal dominant trait.%A%    
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D016584 2002
% 213.98/214.16  |- mesh__publicMeSHNote mesh__D016584 92   
% 213.98/214.16  |- skos__historyNote mesh__D016584 Anxiety Disorders %28%1978-1991%29%
% 213.98/214.16  |- skos__hiddenLabel mesh__D016584 Panic Attack
% 213.98/214.16  |- skos__hiddenLabel mesh__D016584 Panic Disorders
% 213.98/214.16  |- skos__hiddenLabel mesh__D016584 Disorders, Panic
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D016584 1999
% 213.98/214.16  |- mesh__recordAuthorizer mesh__D016584 SJN
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D016584 2006
% 213.98/214.16  |- skos__hiddenLabel mesh__D016584 Attacks, Panic
% 213.98/214.16  |- skos__historyNote mesh__D016584 Panic %28%1978-1991%29%
% 213.98/214.16  |- mesh__recordMaintainer mesh__D016584 JLS
% 213.98/214.16  |- mesh__historyNote mesh__D016584 92   
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D016584 1998
% 213.98/214.16  |- skos__hiddenLabel mesh__D016584 Attack, Panic
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D016584 2005
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D016584 2004
% 213.98/214.16  |- mesh__dateEstablished mesh__D016584 1992-01-01
% 213.98/214.16  |- skos__broader mesh__D016584smesh__D001008
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D016584 2001
% 213.98/214.16  |- skos__historyNote mesh__D016584 Fear %28%1978-1991%29%
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D016584 2003
% 213.98/214.16  |- skos__annotation mesh__D016584
% 213.98/214.16       note category: do not confuse with PANIC %28%Cat F1%29%   
% 213.98/214.16  |- skos__prefLabel mesh__D016584 Panic Disorder
% 213.98/214.16  |- mesh__dateRevised mesh__D016584 1997-06-20
% 213.98/214.16  |- mesh__recordOriginator mesh__D016584 MXR
% 213.98/214.16  |- rdf__type mesh__D016584sskos__Concept
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D016584 2000
% 213.98/214.16  |- skos__hiddenLabel mesh__D016584 Disorder, Panic
% 213.98/214.16  |- mesh__dateCreated mesh__D016584 1991-01-25
% 213.98/214.16  |- rdf__type mesh__D002564sskos__Concept
% 213.98/214.16  |- mesh__recordMaintainer mesh__D002564 nns
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D002564 2004
% 213.98/214.16  |- mesh__dateCreated mesh__D002564 1999-01-01
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D002564 2003
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D002564 2001
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D002564 2006
% 213.98/214.16  |- skos__annotation mesh__D002564 Ce-136, 138, 142; NIM   
% 213.98/214.16  |- skos__broader mesh__D002564smesh__D007554
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D002564 2005
% 213.98/214.16  |- skos__prefLabel mesh__D002564 Cerium Isotopes
% 213.98/214.16  |- mesh__recordOriginator mesh__D002564 NLM
% 213.98/214.16  |- mesh__dateRevised mesh__D002564 2000-06-22
% 213.98/214.16  |- skos__scopeNote mesh__D002564
% 213.98/214.16       Stable cerium atoms that have the same atomic number as the element cerium, but differ in atomic weight. Ce-136, 138, and 142 are stable cerium isotopes.%A%    
% 213.98/214.16  |- skos__hiddenLabel mesh__D002564 Isotopes, Cerium
% 213.98/214.16  |- mesh__recordAuthorizer mesh__D002564 sjn
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D002564 2002
% 213.98/214.16  |- skos__annotation mesh__D029701
% 213.98/214.16       coordinate IM with specific protein %28%IM%29%   
% 213.98/214.16  |- mesh__recordOriginator mesh__D029701 jmp
% 213.98/214.16  |- skos__altLabel mesh__D029701 Baker%27%s Yeast Proteins
% 213.98/214.16  |- skos__historyNote mesh__D029701 Fungal Proteins %28%1973-2001%29%
% 213.98/214.16  |- mesh__dateCreated mesh__D029701 2001-07-25
% 213.98/214.16  |- skos__altLabel mesh__D029701 S cerevisiae Proteins
% 213.98/214.16  |- skos__related mesh__D029701smesh__D012441
% 213.98/214.16  |- mesh__publicMeSHNote mesh__D029701 2002   
% 213.98/214.16  |- mesh__historyNote mesh__D029701 2002   
% 213.98/214.16  |- skos__scopeNote mesh__D029701
% 213.98/214.16       Proteins obtained from the species SACCHAROMYCES CEREVISIAE. The function of specific proteins from this organism are the subject of intense scientific interest and have been used to derive basic understanding of the functioning similar proteins in higher eukaryotes.%A%    
% 213.98/214.16  |- mesh__dateEstablished mesh__D029701 2002-01-01
% 213.98/214.16  |- mesh__recordMaintainer mesh__D029701 SYSTEM
% 213.98/214.16  |- skos__broader mesh__D029701smesh__D005656
% 213.98/214.16  |- mesh__recordAuthorizer mesh__D029701 sjn
% 213.98/214.16  |- mesh__dateRevised mesh__D029701 2005-06-30
% 213.98/214.16  |- skos__prefLabel mesh__D029701 Saccharomyces cerevisiae Proteins
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D029701 2006
% 213.98/214.16  |- rdf__type mesh__D029701sskos__Concept
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D012992 2006
% 213.98/214.16  |- skos__broader mesh__D012992smesh__D013261
% 213.98/214.16  |- mesh__dateRevised mesh__D012992 2004-07-07
% 213.98/214.16  |- skos__hiddenLabel mesh__D012992 Alpha Solanine
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D012992 2005
% 213.98/214.16  |- skos__broader mesh__D012992smesh__D012503
% 213.98/214.16  |- mesh__recordOriginator mesh__D012992 NLM
% 213.98/214.16  |- skos__broader mesh__D012992smesh__D012991
% 213.98/214.16  |- rdf__type mesh__D012992sskos__Concept
% 213.98/214.16  |- mesh__recordMaintainer mesh__D012992 ssb
% 213.98/214.16  |- skos__prefLabel mesh__D012992 Solanine
% 213.98/214.16  |- mesh__dateCreated mesh__D012992 1999-01-01
% 213.98/214.16  |- mesh__recordAuthorizer mesh__D012992 sjn
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D012194 2004
% 213.98/214.16  |- skos__altLabel mesh__D012194 DNA Polymerase, RNA-Directed
% 213.98/214.16  |- mesh__recordMaintainer mesh__D012194 ssb
% 213.98/214.16  |- skos__hiddenLabel mesh__D012194 RNA Directed DNA Polymerase
% 213.98/214.16  |- skos__historyNote mesh__D012194
% 213.98/214.16       DNA Nucleotidyltransferases %28%1968-1971%29%
% 213.98/214.16  |- skos__hiddenLabel mesh__D012194 RNA Dependent DNA Polymerase
% 213.98/214.16  |- rdf__type mesh__D012194sskos__Concept
% 213.98/214.16  |- skos__altLabel mesh__D012194 Revertase
% 213.98/214.16  |- mesh__dateRevised mesh__D012194 2003-07-09
% 213.98/214.16  |- skos__altLabel mesh__D012194 Reverse Transcriptase
% 213.98/214.16  |- skos__hiddenLabel mesh__D012194 DNA Polymerase, RNA Directed
% 213.98/214.16  |- skos__prefLabel mesh__D012194 RNA-Directed DNA Polymerase
% 213.98/214.16  |- skos__scopeNote mesh__D012194
% 213.98/214.16       An enzyme that synthesizes DNA on an RNA template. It is encoded by the pol gene of retroviruses and by certain retrovirus-like elements. EC 2.7.7.49.%A%    
% 213.98/214.16  |- mesh__recordOriginator mesh__D012194 NLM
% 213.98/214.16  |- mesh__historyNote mesh__D012194
% 213.98/214.16       96; was REVERSE TRANSCRIPTASE 1972-95 %28%Prov 1972%29%   
% 213.98/214.16  |- skos__altLabel mesh__D012194 RNA Transcriptase
% 213.98/214.16  |- mesh__dateEstablished mesh__D012194 1973-01-01
% 213.98/214.16  |- mesh__dateCreated mesh__D012194 1999-01-01
% 213.98/214.16  |- mesh__recordAuthorizer mesh__D012194 sjn
% 213.98/214.16  |- skos__broader mesh__D012194smesh__D015684
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D012194 2005
% 213.98/214.16  |- mesh__publicMeSHNote mesh__D012194
% 213.98/214.16       96; was REVERSE TRANSCRIPTASE 1973-95   
% 213.98/214.16  |- skos__altLabel mesh__D012194 RNA-Dependent DNA Polymerase
% 213.98/214.16  |- skos__broader mesh__D012194smesh__D004259
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D012194 2006
% 213.98/214.16  |- skos__hiddenLabel mesh__D012194 DNA Polymerase, RNA-Dependent
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006955 2004
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006955 1998
% 213.98/214.16  |- skos__broader mesh__D006955smesh__D014883
% 213.98/214.16  |- rdf__type mesh__D006955sskos__Concept
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006955 2000
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006955 1994
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006955 2003
% 213.98/214.16  |- skos__annotation mesh__D006955
% 213.98/214.16       high blood sodium levels; do not confuse with HYPONATREMIA%A%  
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006955 2006
% 213.98/214.16  |- mesh__recordAuthorizer mesh__D006955 PLS
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006955 2002
% 213.98/214.16  |- mesh__dateCreated mesh__D006955 1999-01-01
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006955 1997
% 213.98/214.16  |- mesh__recordMaintainer mesh__D006955 TGC
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006955 2005
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006955 1996
% 213.98/214.16  |- skos__hiddenLabel mesh__D006955 Hypernatremias
% 213.98/214.16  |- mesh__recordOriginator mesh__D006955 NLM
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006955 1999
% 213.98/214.16  |- mesh__dateRevised mesh__D006955 1993-06-02
% 213.98/214.16  |- skos__prefLabel mesh__D006955 Hypernatremia
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006955 2001
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006955 1995
% 213.98/214.16  |- skos__scopeNote mesh__D006955
% 213.98/214.16       Excessive amount of sodium in the blood. %28%Dorland, 27th ed%29%%A%    
% 213.98/214.16  |- mesh__recordMaintainer mesh__D020626 SYSTEM
% 213.98/214.16  |- rdf__type mesh__D020626sskos__Concept
% 213.98/214.16  |- skos__scopeNote mesh__D020626
% 213.98/214.16       Transforming proteins coded by myb oncogenes. Transformation of cells by v-myb in conjunction with v-ets is seen in the avian E26 leukemia virus.%A%    
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D020626 2006
% 213.98/214.16  |- skos__prefLabel mesh__D020626 Oncogene Proteins v-myb
% 213.98/214.16  |- mesh__dateCreated mesh__D020626 1999-11-03
% 213.98/214.16  |- skos__historyNote mesh__D020626
% 213.98/214.16       Retroviridae Proteins, Oncogenic %28%1990-1999%29%
% 213.98/214.16  |- skos__hiddenLabel mesh__D020626 myb, Oncogene Proteins
% 213.98/214.16  |- skos__altLabel mesh__D020626 v-myb Proteins
% 213.98/214.16  |- mesh__dateEstablished mesh__D020626 2000-01-01
% 213.98/214.16  |- mesh__recordOriginator mesh__D020626 ags
% 213.98/214.16  |- skos__hiddenLabel mesh__D020626 myb, Oncogene Protein
% 213.98/214.16  |- skos__altLabel mesh__D020626 p48%28%v-myb%29%
% 213.98/214.16  |- skos__hiddenLabel mesh__D020626 v-myb, Oncogene Products
% 213.98/214.16  |- skos__hiddenLabel mesh__D020626 v-myb, Oncogene Proteins
% 213.98/214.16  |- skos__broader mesh__D020626smesh__D015682
% 213.98/214.16  |- skos__altLabel mesh__D020626 Oncogene Protein myb
% 213.98/214.16  |- skos__hiddenLabel mesh__D020626 v myb Proteins
% 213.98/214.16  |- skos__hiddenLabel mesh__D020626 Oncogene Products v myb
% 213.98/214.16  |- mesh__publicMeSHNote mesh__D020626
% 213.98/214.16       2000; ONCOGENE PROTEINS MYB was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-1999 %26% RETROVIRIDAE PROTEINS 1986-1989%A%  
% 213.98/214.16  |- skos__hiddenLabel mesh__D020626 Oncogene Proteins, myb
% 213.98/214.16  |- skos__altLabel mesh__D020626 myb Oncogene Proteins
% 213.98/214.16  |- mesh__recordAuthorizer mesh__D020626 sjn
% 213.98/214.16  |- skos__historyNote mesh__D020626 Retroviridae Proteins %28%1986-1989%29%
% 213.98/214.16  |- skos__altLabel mesh__D020626 Oncogene Products v-myb
% 213.98/214.16  |- mesh__dateRevised mesh__D020626 2005-06-30
% 213.98/214.16  |- mesh__historyNote mesh__D020626
% 213.98/214.16       2000; use ONCOGENE PROTEINS V-MYB %28%NM%29% 1986-1999   
% 213.98/214.16  |- skos__altLabel mesh__D020626 v-myb Protein
% 213.98/214.16  |- skos__hiddenLabel mesh__D020626 v myb Protein
% 213.98/214.16  |- skos__hiddenLabel mesh__D020626 Oncogene Proteins v myb
% 213.98/214.16  |- skos__altLabel mesh__D020626 Oncogene Proteins myb
% 213.98/214.16  |- mesh__dateCreated mesh__D006157 1999-01-01
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006157 1997
% 213.98/214.16  |- mesh__publicMeSHNote mesh__D006157
% 213.98/214.16       94; was GUANOSINE MONOPHOSPHATE 1978-93 %28%see under GUANINE NUCLEOTIDES 1978-90%29%; was GUANYLIC ACIDS see under GUANINE NUCEOTIDES 1963-77; GUANYLIC ACID was see GUANOSINE MONOPHOSPHATE 1978-93%A%  
% 213.98/214.16  |- skos__altLabel mesh__D006157 Guanosine 5%27%-Monophosphate
% 213.98/214.16  |- mesh__historyNote mesh__D006157
% 213.98/214.16       94; was GUANOSINE MONOPHOSPHATE 1978-93 %28%see under GUANINE NUCLEOTIDES 1978-90%29%; was GUANYLIC ACIDS see under GUANINE NUCEOTIDES 1963-77; GUANYLIC ACID was see GUANOSINE MONOPOSPHATE 1978-93%A%  
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006157 1996
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006157 2006
% 213.98/214.16  |- skos__hiddenLabel mesh__D006157 Monophosphate, Guanosine
% 213.98/214.16  |- mesh__recordMaintainer mesh__D006157 AGS
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006157 1995
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006157 2002
% 213.98/214.16  |- skos__scopeNote mesh__D006157
% 213.98/214.16       Guanosine 5%27%-monophosphate. A guanine nucleotide containing one phosphate group esterified to the sugar moiety and found widely in nature.%A%    
% 213.98/214.16  |- skos__hiddenLabel mesh__D006157 Acids, Guanylic
% 213.98/214.16  |- mesh__recordOriginator mesh__D006157 NLM
% 213.98/214.16  |- skos__hiddenLabel mesh__D006157 5%27%-Monophosphate, Guanosine
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006157 2005
% 213.98/214.16  |- skos__historyNote mesh__D006157 Guanine Nucleotides %28%1966-1974%29%
% 213.98/214.16  |- skos__altLabel mesh__D006157 5%27%-GMP
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006157 2001
% 213.98/214.16  |- mesh__dateRevised mesh__D006157 1994-05-12
% 213.98/214.16  |- mesh__recordAuthorizer mesh__D006157 PLS
% 213.98/214.16  |- skos__broader mesh__D006157smesh__D006150
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006157 1999
% 213.98/214.16  |- skos__annotation mesh__D006157 /biosyn /physiol permitted   
% 213.98/214.16  |- mesh__onlineNote mesh__D006157
% 213.98/214.16       use 5%27%-GUANYLIC ACID to search GUANOSINE MONOPHOSPHATE %26% GUANYLIC ACID 1978-93; use GUANINE NUCLEOTIDES 1966-77%A%  
% 213.98/214.16  |- skos__altLabel mesh__D006157 Guanosine Monophosphate
% 213.98/214.16  |- mesh__activeMeSHYear mesh__D006157 2004
% 213.98/214.17  |- rdf__type mesh__D006157sskos__Concept
% 213.98/214.17  |- skos__hiddenLabel mesh__D006157 Acid, 5%27%-Guanylic
% 213.98/214.17  |- skos__prefLabel mesh__D006157 5%27%-Guanylic Acid
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006157 2000
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006157 1998
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006157 2003
% 213.98/214.17  |- skos__altLabel mesh__D006157 Guanylic Acids
% 213.98/214.17  |- skos__hiddenLabel mesh__D006157 Guanosine 5%27% Monophosphate
% 213.98/214.17  |- mesh__dateEstablished mesh__D006157 1991-01-01
% 213.98/214.17  |- skos__hiddenLabel mesh__D006157 5%27% Guanylic Acid
% 213.98/214.17  |- skos__broader mesh__D016585smesh__D001424
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D016585 2000
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D016585 1999
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D016585 2006
% 213.98/214.17  |- mesh__historyNote mesh__D016585 92   
% 213.98/214.17  |- skos__historyNote mesh__D016585 Vaginitis %28%1983-1991%29%
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D016585 1998
% 213.98/214.17  |- skos__historyNote mesh__D016585 Bacterial Infections %28%1983-1991%29%
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D016585 2005
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D016585 2004
% 213.98/214.17  |- skos__prefLabel mesh__D016585 Vaginosis, Bacterial
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D016585 2002
% 213.98/214.17  |- mesh__publicMeSHNote mesh__D016585 92   
% 213.98/214.17  |- skos__annotation mesh__D016585
% 213.98/214.17       coord IM with specific bacterium/infections heading %28%IM%29% or specific bacterium %28%IM%29% if no precoord bact/infect term exists; DF: VAGINOSIS BACT%A%  
% 213.98/214.17  |- skos__altLabel mesh__D016585 Bacterial Vaginoses
% 213.98/214.17  |- skos__altLabel mesh__D016585 Vaginitis, Nonspecific
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D016585 2003
% 213.98/214.17  |- mesh__recordAuthorizer mesh__D016585 SJN
% 213.98/214.17  |- skos__hiddenLabel mesh__D016585 Nonspecific Vaginitis
% 213.98/214.17  |- skos__altLabel mesh__D016585 Vaginitides, Bacterial
% 213.98/214.17  |- skos__broader mesh__D016585smesh__D014627
% 213.98/214.17  |- skos__altLabel mesh__D016585 Vaginoses, Bacterial
% 213.98/214.17  |- rdf__type mesh__D016585sskos__Concept
% 213.98/214.17  |- mesh__dateEstablished mesh__D016585 1992-01-01
% 213.98/214.17  |- mesh__recordMaintainer mesh__D016585 TGC
% 213.98/214.17  |- mesh__recordOriginator mesh__D016585 AGS
% 213.98/214.17  |- mesh__dateCreated mesh__D016585 1991-01-25
% 213.98/214.17  |- skos__altLabel mesh__D016585 Vaginitis, Bacterial
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D016585 2001
% 213.98/214.17  |- skos__altLabel mesh__D016585 Bacterial Vaginitis
% 213.98/214.17  |- skos__scopeNote mesh__D016585
% 213.98/214.17       Polymicrobial, nonspecific vaginitis associated with positive cultures of Gardnerella vaginalis and other anaerobic organisms and a decrease in lactobacilli. It remains unclear whether the initial pathogenic event is caused by the growth of anaerobes or a primary decrease in lactobacilli.%A%    
% 213.98/214.17  |- skos__altLabel mesh__D016585 Bacterial Vaginosis
% 213.98/214.17  |- mesh__dateRevised mesh__D016585 1997-06-20
% 213.98/214.17  |- skos__altLabel mesh__D016585 Bacterial Vaginitides
% 213.98/214.17  |- mesh__dateCreated mesh__D002565 1974-11-11
% 213.98/214.17  |- skos__historyNote mesh__D002565 Isotopes %28%1966-1974%29%
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D002565 2006
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D002565 1997
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D002565 2000
% 213.98/214.17  |- mesh__recordMaintainer mesh__D002565 TPW
% 213.98/214.17  |- mesh__recordOriginator mesh__D002565 NLM
% 213.98/214.17  |- skos__scopeNote mesh__D002565
% 213.98/214.17       Unstable isotopes of cerium that decay or disintegrate emitting radiation. Ce atoms with atomic weights 132-135, 137, 139, and 141-148 are radioactive cerium isotopes.%A%    
% 213.98/214.17  |- mesh__onlineNote mesh__D002565 search CERIUM ISOTOPES 1966-74   
% 213.98/214.17  |- mesh__publicMeSHNote mesh__D002565 75   
% 213.98/214.17  |- mesh__historyNote mesh__D002565 75   
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D002565 1996
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D002565 2005
% 213.98/214.17  |- skos__broader mesh__D002565smesh__D011868
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D002565 1999
% 213.98/214.17  |- mesh__dateEstablished mesh__D002565 1975-09-01
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D002565 2002
% 213.98/214.17  |- mesh__dateRevised mesh__D002565 1993-06-01
% 213.98/214.17  |- mesh__recordAuthorizer mesh__D002565 PLS
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D002565 1995
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D002565 1998
% 213.98/214.17  |- skos__broader mesh__D002565smesh__D002564
% 213.98/214.17  |- skos__hiddenLabel mesh__D002565 Radioisotopes, Cerium
% 213.98/214.17  |- skos__historyNote mesh__D002565 Radioisotopes %28%1966-1974%29%
% 213.98/214.17  |- rdf__type mesh__D002565sskos__Concept
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D002565 1994
% 213.98/214.17  |- skos__historyNote mesh__D002565 Cerium %28%1966-1974%29%
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D002565 2004
% 213.98/214.17  |- skos__annotation mesh__D002565
% 213.98/214.17       Ce-132-135, 137, 139, 141-148; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D002565 2001
% 213.98/214.17  |- skos__prefLabel mesh__D002565 Cerium Radioisotopes
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D002565 2003
% 213.98/214.17  |- mesh__dateRevised mesh__D029702 2005-06-30
% 213.98/214.17  |- skos__annotation mesh__D029702
% 213.98/214.17       coord IM with specific protein %28%IM%29%   
% 213.98/214.17  |- mesh__publicMeSHNote mesh__D029702 2002   
% 213.98/214.17  |- mesh__recordOriginator mesh__D029702 jmp
% 213.98/214.17  |- skos__scopeNote mesh__D029702
% 213.98/214.17       Proteins obtained from the species Schizosaccharomyces pombe. The function of specific proteins from this organism are the subject of intense scientific interest and have been used to derive basic understanding of the functioning similar proteins in higher eukaryotes.%A%    
% 213.98/214.17  |- skos__historyNote mesh__D029702 Fungal Proteins %28%1973-2001%29%
% 213.98/214.17  |- mesh__dateEstablished mesh__D029702 2002-01-01
% 213.98/214.17  |- mesh__recordMaintainer mesh__D029702 SYSTEM
% 213.98/214.17  |- mesh__dateCreated mesh__D029702 2001-07-25
% 213.98/214.17  |- skos__broader mesh__D029702smesh__D005656
% 213.98/214.17  |- skos__altLabel mesh__D029702 S pombe Proteins
% 213.98/214.17  |- mesh__historyNote mesh__D029702 2002   
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D029702 2006
% 213.98/214.17  |- skos__altLabel mesh__D029702 Fission Yeast Proteins
% 213.98/214.17  |- rdf__type mesh__D029702sskos__Concept
% 213.98/214.17  |- skos__prefLabel mesh__D029702 Schizosaccharomyces pombe Proteins
% 213.98/214.17  |- mesh__recordAuthorizer mesh__D029702 sjn
% 213.98/214.17  |- mesh__dateEstablished mesh__D007250 1991-01-01
% 213.98/214.17  |- mesh__publicMeSHNote mesh__D007250
% 213.98/214.17       91; was see under ECONOMICS 1980-90   
% 213.98/214.17  |- skos__altLabel mesh__D007250 Inflation
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D007250 2006
% 213.98/214.17  |- mesh__recordAuthorizer mesh__D007250 sjn
% 213.98/214.17  |- skos__altLabel mesh__D007250 Economic Inflation
% 213.98/214.17  |- mesh__recordOriginator mesh__D007250 EC
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D007250 2005
% 213.98/214.17  |- skos__prefLabel mesh__D007250 Inflation, Economic
% 213.98/214.17  |- mesh__historyNote mesh__D007250
% 213.98/214.17       91%28%80%29%; was see under ECONOMICS 1980-90   
% 213.98/214.17  |- rdf__type mesh__D007250sskos__Concept
% 213.98/214.17  |- mesh__dateCreated mesh__D007250 1979-06-01
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D007250 2004
% 213.98/214.17  |- mesh__recordMaintainer mesh__D007250 sjn
% 213.98/214.17  |- skos__scopeNote mesh__D007250
% 213.98/214.17       An increase in the volume of money and credit relative to available goods resulting in a substantial and continuing rise in the general price level.%A%    
% 213.98/214.17  |- mesh__dateRevised mesh__D007250 2002-07-18
% 213.98/214.17  |- skos__broader mesh__D007250smesh__D004467
% 213.98/214.17  |- skos__annotation mesh__D007250 specify geog if pertinent   
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D007250 2003
% 213.98/214.17  |- skos__broader mesh__D012993smesh__D004736
% 213.98/214.17  |- mesh__dateRevised mesh__D012993 2005-06-30
% 213.98/214.17  |- mesh__recordAuthorizer mesh__D012993 sjn
% 213.98/214.17  |- rdf__type mesh__D012993sskos__Concept
% 213.98/214.17  |- mesh__recordMaintainer mesh__D012993 nns
% 213.98/214.17  |- skos__altLabel mesh__D012993 Solar Power
% 213.98/214.17  |- skos__historyNote mesh__D012993 Sunlight %28%1966-1981%29%
% 213.98/214.17  |- mesh__dateCreated mesh__D012993 1981-05-19
% 213.98/214.17  |- mesh__dateEstablished mesh__D012993 1991-01-01
% 213.98/214.17  |- mesh__recordOriginator mesh__D012993 EC
% 213.98/214.17  |- skos__hiddenLabel mesh__D012993 Energies, Solar
% 213.98/214.17  |- skos__scopeNote mesh__D012993
% 213.98/214.17       Energy transmitted from the sun in the form of electromagnetic radiation.%A%    
% 213.98/214.17  |- mesh__historyNote mesh__D012993
% 213.98/214.17       91%28%82%29%; was see under ENERGY-GENERATING RESOURCES 1982-90%A%  
% 213.98/214.17  |- skos__hiddenLabel mesh__D012993 Solar Energies
% 213.98/214.17  |- skos__hiddenLabel mesh__D012993 Power, Solar
% 213.98/214.17  |- skos__prefLabel mesh__D012993 Solar Energy
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D012993 2006
% 213.98/214.17  |- skos__hiddenLabel mesh__D012993 Energy, Solar
% 213.98/214.17  |- mesh__publicMeSHNote mesh__D012993
% 213.98/214.17       91; was see under ENERGY-GENERATING RESOURCES 1982-90   
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006956 2000
% 213.98/214.17  |- skos__scopeNote mesh__D006956
% 213.98/214.17       A refractive error in which rays of light entering the eye parallel to the optic axis are brought to a focus behind the retina, as a result of the eyeball being too short from front to back. It is also called farsightedness because the near point is more distant than it is in emmetropia with an equal amplitude of accommodation. %28%Dorland, 27th ed%29%%A%    
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006956 2004
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006956 1995
% 213.98/214.17  |- mesh__recordAuthorizer mesh__D006956 PLS
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006956 2003
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006956 1994
% 213.98/214.17  |- skos__annotation mesh__D006956 refractive error; note X ref   
% 213.98/214.17  |- mesh__dateCreated mesh__D006956 1999-01-01
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006956 1997
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006956 2002
% 213.98/214.17  |- mesh__recordMaintainer mesh__D006956 PLS
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006956 2006
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006956 1996
% 213.98/214.17  |- skos__altLabel mesh__D006956 Farsightedness
% 213.98/214.17  |- mesh__recordOriginator mesh__D006956 NLM
% 213.98/214.17  |- skos__prefLabel mesh__D006956 Hyperopia
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006956 2005
% 213.98/214.17  |- mesh__dateRevised mesh__D006956 1993-06-02
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006956 1999
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006956 2001
% 213.98/214.17  |- skos__broader mesh__D006956smesh__D012030
% 213.98/214.17  |- skos__altLabel mesh__D006956 Hypermetropia
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006956 1998
% 213.98/214.17  |- rdf__type mesh__D006956sskos__Concept
% 213.98/214.17  |- mesh__recordAuthorizer mesh__D020627 sjn
% 213.98/214.17  |- mesh__dateRevised mesh__D020627 2005-06-30
% 213.98/214.17  |- skos__scopeNote mesh__D020627
% 213.98/214.17       A genus of gram-negative, facultatively anaerobic bacteria including species which are often associated with grasses %28%POACEAE%29% and which fix nitrogen as well as species which anaerobically degrade toluene and other mono-aromatic hydrocarbons.%A%    
% 213.98/214.17  |- skos__broader mesh__D020627smesh__D006092
% 213.98/214.17  |- rdf__type mesh__D020627sskos__Concept
% 213.98/214.17  |- skos__historyNote mesh__D020627
% 213.98/214.17       Gram-Negative Facultatively Anaerobic Rods %28%1994-1999%29%
% 213.98/214.17  |- skos__prefLabel mesh__D020627 Azoarcus
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D020627 2006
% 213.98/214.17  |- mesh__recordMaintainer mesh__D020627 SYSTEM
% 213.98/214.17  |- mesh__dateEstablished mesh__D020627 2000-01-01
% 213.98/214.17  |- mesh__recordOriginator mesh__D020627 ndw
% 213.98/214.17  |- mesh__publicMeSHNote mesh__D020627 2000   
% 213.98/214.17  |- mesh__dateCreated mesh__D020627 1999-11-03
% 213.98/214.17  |- mesh__historyNote mesh__D020627 2000   
% 213.98/214.17  |- skos__broader mesh__D020627smesh__D043362
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006158 2000
% 213.98/214.17  |- mesh__recordMaintainer mesh__D006158 NLM
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006158 1996
% 213.98/214.17  |- skos__hiddenLabel mesh__D006158
% 213.98/214.17       Guanosine 3%27% Diphosphate 5%27% Triphosphate
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006158 2006
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006158 1995
% 213.98/214.17  |- skos__historyNote mesh__D006158 Guanine Nucleotides %28%1966-1977%29%
% 213.98/214.17  |- mesh__dateRevised mesh__D006158 1990-04-13
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006158 2005
% 213.98/214.17  |- skos__annotation mesh__D006158 /biosyn /physiol permitted; DF: PPPGPP   
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006158 1994
% 213.98/214.17  |- skos__prefLabel mesh__D006158 Guanosine Pentaphosphate
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006158 1999
% 213.98/214.17  |- rdf__type mesh__D006158sskos__Concept
% 213.98/214.17  |- skos__hiddenLabel mesh__D006158 Pentaphosphate, Guanosine
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006158 2004
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006158 1993
% 213.98/214.17  |- skos__scopeNote mesh__D006158
% 213.98/214.17       Guanosine 5%27%-triphosphate 2%27%%28%3%27%%29%-diphosphate. A guanine nucleotide containing five phosphate groups. Three phosphate groups are esterified to the sugar moiety in the 5%27% position and the other two in the 2%27% or 3%27% position. This nucleotide serves as a messenger to turn off the synthesis of ribosomal RNA when amino acids are not available for protein synthesis. Synonym: magic spot II.%A%    
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006158 2002
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006158 1991
% 213.98/214.17  |- mesh__dateCreated mesh__D006158 1977-04-22
% 213.98/214.17  |- skos__hiddenLabel mesh__D006158
% 213.98/214.17       5%27%-Triphosphate, Guanosine 3%27%-Diphosphate
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006158 1998
% 213.98/214.17  |- skos__altLabel mesh__D006158
% 213.98/214.17       Guanosine 3%27%-Diphosphate 5%27%-Triphosphate
% 213.98/214.17  |- mesh__publicMeSHNote mesh__D006158
% 213.98/214.17       91; was see under GUANINE NUCLEOTIDES 1978-90   
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006158 2003
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006158 1992
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006158 2001
% 213.98/214.17  |- skos__broader mesh__D006158smesh__D006150
% 213.98/214.17  |- mesh__dateEstablished mesh__D006158 1991-01-01
% 213.98/214.17  |- mesh__recordAuthorizer mesh__D006158 PLS
% 213.98/214.17  |- mesh__recordOriginator mesh__D006158 RLS
% 213.98/214.17  |- skos__hiddenLabel mesh__D006158
% 213.98/214.17       3%27%-Diphosphate 5%27%-Triphosphate, Guanosine
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006158 1997
% 213.98/214.17  |- mesh__historyNote mesh__D006158
% 213.98/214.17       91%28%78%29%; was see under GUANINE NUCLEOTIDES 1978-90   
% 213.98/214.17  |- mesh__recordMaintainer mesh__D016586 KEV
% 213.98/214.17  |- mesh__dateRevised mesh__D016586 1995-06-08
% 213.98/214.17  |- skos__hiddenLabel mesh__D016586 Cell Tumor, Granular
% 213.98/214.17  |- skos__broader mesh__D016586smesh__D009379
% 213.98/214.17  |- skos__scopeNote mesh__D016586
% 213.98/214.17       Unusual tumor affecting any site of the body, but most often encountered in the head and neck. Considerable debate has surrounded the histogenesis of this neoplasm; however, it is considered to be a myoblastoma of, usually, a benign nature. It affects women more often than men. When it develops beneath the epidermis or mucous membrane, it can lead to proliferation of the squamous cells and mimic squamous cell carcinoma.%A%    
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D016586 2000
% 213.98/214.17  |- skos__hiddenLabel mesh__D016586 Cell Myoblastoma, Granular
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D016586 1996
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D016586 2003
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D016586 1999
% 213.98/214.17  |- skos__hiddenLabel mesh__D016586 Cell Tumors, Granular
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D016586 2006
% 213.98/214.17  |- skos__hiddenLabel mesh__D016586 Myoblastomas, Granular Cell
% 213.98/214.17  |- skos__hiddenLabel mesh__D016586 Granular Cell Tumors
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D016586 2001
% 213.98/214.17  |- skos__hiddenLabel mesh__D016586 Tumors, Granular Cell
% 213.98/214.17  |- mesh__historyNote mesh__D016586 92   
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D016586 1997
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D016586 2004
% 213.98/214.17  |- skos__altLabel mesh__D016586 Myoblastoma, Granular Cell
% 213.98/214.17  |- mesh__dateCreated mesh__D016586 1991-01-25
% 213.98/214.17  |- mesh__recordOriginator mesh__D016586 MXR
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D016586 2002
% 213.98/214.17  |- skos__hiddenLabel mesh__D016586 Cell Myoblastomas, Granular
% 213.98/214.17  |- skos__hiddenLabel mesh__D016586 Tumor, Granular Cell
% 213.98/214.17  |- rdf__type mesh__D016586sskos__Concept
% 213.98/214.17  |- skos__annotation mesh__D016586
% 213.98/214.17       benign or malignant; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; do not confuse with GRANULOSA CELL TUMOR, an ovarian neopl%A%  
% 213.98/214.17  |- skos__historyNote mesh__D016586 Myoblastoma %28%1966-1991%29%
% 213.98/214.17  |- mesh__recordAuthorizer mesh__D016586 PLS
% 213.98/214.17  |- mesh__publicMeSHNote mesh__D016586 92   
% 213.98/214.17  |- skos__altLabel mesh__D016586 Granular Cell Myoblastoma
% 213.98/214.17  |- skos__prefLabel mesh__D016586 Granular Cell Tumor
% 213.98/214.17  |- skos__hiddenLabel mesh__D016586 Granular Cell Myoblastomas
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D016586 1998
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D016586 2005
% 213.98/214.17  |- mesh__dateEstablished mesh__D016586 1992-01-01
% 213.98/214.17  |- mesh__publicMeSHNote mesh__D002566 91; was see under PIGMENTS 1975-90   
% 213.98/214.17  |- mesh__recordMaintainer mesh__D002566 ssb
% 213.98/214.17  |- skos__annotation mesh__D002566 a lipid pigment   
% 213.98/214.17  |- skos__historyNote mesh__D002566 Pigments %28%1970-1974%29%
% 213.98/214.17  |- mesh__recordOriginator mesh__D002566 NLM
% 213.98/214.17  |- mesh__dateCreated mesh__D002566 1974-11-19
% 213.98/214.17  |- rdf__type mesh__D002566sskos__Concept
% 213.98/214.17  |- mesh__recordAuthorizer mesh__D002566 sjn
% 213.98/214.17  |- mesh__dateRevised mesh__D002566 2005-06-30
% 213.98/214.17  |- mesh__dateEstablished mesh__D002566 1991-01-01
% 213.98/214.17  |- skos__scopeNote mesh__D002566
% 213.98/214.17       A naturally occurring lipid pigment with histochemical characteristics similar to lipofuscin. It accumulates in various tissues in certain experimental and pathological conditions.%A%    
% 213.98/214.17  |- skos__broader mesh__D002566smesh__D010860
% 213.98/214.17  |- skos__broader mesh__D002566smesh__D008055
% 213.98/214.17  |- skos__prefLabel mesh__D002566 Ceroid
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D002566 2006
% 213.98/214.17  |- mesh__historyNote mesh__D002566
% 213.98/214.17       91%28%75%29%; was see under PIGMENTS 1975-90   
% 213.98/214.17  |- skos__hiddenLabel mesh__D007251 Human Influenzas
% 213.98/214.17  |- mesh__publicMeSHNote mesh__D007251 2006; see INFLUENZA 1963-2005   
% 213.98/214.17  |- skos__hiddenLabel mesh__D007251 Flu, Human
% 213.98/214.17  |- mesh__dateCreated mesh__D007251 1999-01-01
% 213.98/214.17  |- mesh__recordMaintainer mesh__D007251 ags
% 213.98/214.17  |- skos__hiddenLabel mesh__D007251 Influenza in Human
% 213.98/214.17  |- skos__scopeNote mesh__D007251
% 213.98/214.17       An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.%A%    
% 213.98/214.17  |- skos__hiddenLabel mesh__D007251 Influenzas, Human
% 213.98/214.17  |- skos__hiddenLabel mesh__D007251 Influenzas
% 213.98/214.17  |- skos__altLabel mesh__D007251 Influenza
% 213.98/214.17  |- skos__altLabel mesh__D007251 Human Influenza
% 213.98/214.17  |- skos__annotation mesh__D007251
% 213.98/214.17       coordinate IM with specific influenza virus %28%IM%29% if pertinent; note specific subtypes of INFLUENZA A VIRUS are available%A%  
% 213.98/214.17  |- rdf__type mesh__D007251sskos__Concept
% 213.98/214.17  |- skos__altLabel mesh__D007251 Influenza in Humans
% 213.98/214.17  |- skos__altLabel mesh__D007251 Grippe
% 213.98/214.17  |- mesh__dateRevised mesh__D007251 2005-11-09
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D007251 2006A
% 213.98/214.17  |- skos__broader mesh__D007251smesh__D009976
% 213.98/214.17  |- skos__altLabel mesh__D007251 Human Flu
% 213.98/214.17  |- skos__prefLabel mesh__D007251 Influenza, Human
% 213.98/214.17  |- mesh__historyNote mesh__D007251 2006 %28%1963%29%   
% 213.98/214.17  |- skos__broader mesh__D007251smesh__D012141
% 213.98/214.17  |- mesh__recordAuthorizer mesh__D007251 ags
% 213.98/214.17  |- mesh__recordOriginator mesh__D007251 NLM
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D007251 2006
% 213.98/214.17  |- mesh__recordAuthorizer mesh__D048668 sjn
% 213.98/214.17  |- mesh__dateCreated mesh__D048668 2004-07-07
% 213.98/214.17  |- skos__broader mesh__D048668smesh__D007778
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D048668 2006
% 213.98/214.17  |- skos__scopeNote mesh__D048668
% 213.98/214.17       A species of gram-positive, rod-shaped, facultatively anaerobic bacteria. capable of producing LACTIC ACID.  It is important in the manufacture of fermented dairy products.%A%    
% 213.98/214.17  |- skos__prefLabel mesh__D048668 Lactobacillus delbrueckii
% 213.98/214.17  |- mesh__historyNote mesh__D048668 2005   
% 213.98/214.17  |- rdf__type mesh__D048668sskos__Concept
% 213.98/214.17  |- mesh__recordOriginator mesh__D048668 ags
% 213.98/214.17  |- skos__historyNote mesh__D048668 Lactobacillus %28%1970-2004%29%
% 213.98/214.17  |- mesh__recordMaintainer mesh__D048668 SYSTEM
% 213.98/214.17  |- mesh__dateRevised mesh__D048668 2005-06-30
% 213.98/214.17  |- mesh__dateEstablished mesh__D048668 2005-01-01
% 213.98/214.17  |- mesh__publicMeSHNote mesh__D048668 2005   
% 213.98/214.17  |- skos__altLabel mesh__D012994 Dental Welding
% 213.98/214.17  |- mesh__publicMeSHNote mesh__D012994 95; was SOLDERING, DENTAL 1973-94   
% 213.98/214.17  |- mesh__recordOriginator mesh__D012994 NLM
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D012994 2003
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D012994 1998
% 213.98/214.17  |- skos__annotation mesh__D012994
% 213.98/214.17       includes soldering %26% solders; do not use /util except by MeSH definition; DF: DENT SOLDERING%A%  
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D012994 2004
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D012994 1999
% 213.98/214.17  |- mesh__dateCreated mesh__D012994 1999-01-01
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D012994 2002
% 213.98/214.17  |- rdf__type mesh__D012994sskos__Concept
% 213.98/214.17  |- skos__scopeNote mesh__D012994
% 213.98/214.17       The joining of pieces of metal through the use of an alloy which has a lower melting point, usually at least 100 degrees Celsius below the fusion temperature of the parts being soldered. In dentistry, soldering is used for joining components of a dental appliance, as in assembling a bridge, joining metals to orthodontic bands, or adding to the bulk of certain structures, such as the establishment of proper contact areas on inlays and crowns with adjacent teeth. %28%Illustrated Dictionary of Dentistry, 1982%29%%A%    
% 213.98/214.17  |- mesh__recordAuthorizer mesh__D012994 PLS
% 213.98/214.17  |- skos__hiddenLabel mesh__D012994 Weldings, Dental
% 213.98/214.17  |- skos__historyNote mesh__D012994 Welding %28%1966-1972%29%
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D012994 1996
% 213.98/214.17  |- mesh__dateRevised mesh__D012994 1994-04-16
% 213.98/214.17  |- skos__prefLabel mesh__D012994 Dental Soldering
% 213.98/214.17  |- skos__hiddenLabel mesh__D012994 Dental Weldings
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D012994 2005
% 213.98/214.17  |- mesh__historyNote mesh__D012994 95; was SOLDERING, DENTAL 1973-94   
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D012994 1997
% 213.98/214.17  |- mesh__onlineNote mesh__D012994
% 213.98/214.17       use DENTAL SOLDERING to search SOLDERING, DENTAL 1973-94   
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D012994 2000
% 213.98/214.17  |- mesh__dateEstablished mesh__D012994 1973-01-01
% 213.98/214.17  |- skos__altLabel mesh__D012994 Welding, Dental
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D012994 2006
% 213.98/214.17  |- skos__broader mesh__D012994smesh__D013674
% 213.98/214.17  |- mesh__recordMaintainer mesh__D012994 TGC
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D012994 2001
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D012994 1995
% 213.98/214.17  |- skos__altLabel mesh__D012994 Soldering, Dental
% 213.98/214.17  |- mesh__dateRevised mesh__D012196 2001-07-25
% 213.98/214.17  |- skos__hiddenLabel mesh__D012196 State of the Art Review
% 213.98/214.17  |- skos__hiddenLabel mesh__D012196 Review, State-of-the-Art
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D012196 2005
% 213.98/214.17  |- skos__scopeNote mesh__D012196
% 213.98/214.17       Published materials which provide an examination of recent or current literature. Review articles can cover a wide range of subject matter at various levels of completeness and comprehensiveness based on analyses of literature that may include research findings. The review may reflect the state of the art. It also includes reviews as a literary form.%A%    
% 213.98/214.17  |- skos__prefLabel mesh__D012196 Review Literature
% 213.98/214.17  |- skos__hiddenLabel mesh__D012196 Reviews, State-of-the-Art
% 213.98/214.17  |- skos__hiddenLabel mesh__D012196 Review Literatures
% 213.98/214.17  |- skos__broader mesh__D012196smesh__D011642
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D012196 2006
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D012196 2003
% 213.98/214.17  |- mesh__recordAuthorizer mesh__D012196 sjn
% 213.98/214.17  |- mesh__recordMaintainer mesh__D012196 jls
% 213.98/214.17  |- mesh__recordOriginator mesh__D012196 NW
% 213.98/214.17  |- skos__altLabel mesh__D012196 Literature, Review
% 213.98/214.17  |- mesh__dateCreated mesh__D012196 1987-05-13
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D012196 2004
% 213.98/214.17  |- mesh__historyNote mesh__D012196
% 213.98/214.17       88; for both the publication type %26% the main heading 1988-90; main heading only 1991 forward%A%  
% 213.98/214.17  |- skos__hiddenLabel mesh__D012196 Literatures, Review
% 213.98/214.17  |- rdf__type mesh__D012196sskos__Concept
% 213.98/214.17  |- mesh__dateEstablished mesh__D012196 1988-01-01
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D012196 2002
% 213.98/214.17  |- skos__related mesh__D012196smesh__D015201
% 213.98/214.17  |- skos__hiddenLabel mesh__D012196 State of the Art Reviews
% 213.98/214.17  |- skos__altLabel mesh__D012196 State-of-the-Art Reviews
% 213.98/214.17  |- skos__annotation mesh__D012196
% 213.98/214.17       IM; no qualif; for review books or review articles as a form of literature; when IM for review as a literary form, do not fill in REVIEW in Field 17; Manual section 12; TN L for amplification; do not confuse with REVIEW, a publication type; note X ref; DF: REV LIT or STATE OF THE ART%A%  
% 213.98/214.17  |- mesh__publicMeSHNote mesh__D012196 88   
% 213.98/214.17  |- mesh__onlineNote mesh__D006957
% 213.98/214.17       use HYPEROSTOSIS FRONTALIS INTERNA to search LEONTIASIS OSSIUM 1966-84%A%  
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006957 2001
% 213.98/214.17  |- skos__altLabel mesh__D006957 Morgagni-Stewart-Morel Syndrome
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006957 2003
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006957 1994
% 213.98/214.17  |- mesh__dateCreated mesh__D006957 1999-01-01
% 213.98/214.17  |- skos__hiddenLabel mesh__D006957 Morgagni Stewart Morel Syndrome
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006957 1997
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006957 2000
% 213.98/214.17  |- mesh__publicMeSHNote mesh__D006957
% 213.98/214.17       LEONTIASIS OSSIUM was heading 1963-84   
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006957 2006
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006957 1996
% 213.98/214.17  |- mesh__recordAuthorizer mesh__D006957 PLS
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006957 2005
% 213.98/214.17  |- skos__hiddenLabel mesh__D006957 Syndrome, Morgagni-Stewart-Morel
% 213.98/214.17  |- skos__broader mesh__D006957smesh__D010009
% 213.98/214.17  |- skos__prefLabel mesh__D006957 Hyperostosis Frontalis Interna
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006957 1999
% 213.98/214.17  |- skos__broader mesh__D006957smesh__D015576
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006957 2002
% 213.98/214.17  |- mesh__historyNote mesh__D006957 LEONTIASIS OSSIUM was heading 1963-84   
% 213.98/214.17  |- skos__annotation mesh__D006957
% 213.98/214.17       frontalis refers to frontal bone of skull   
% 213.98/214.17  |- skos__scopeNote mesh__D006957
% 213.98/214.17       Thickening of the inner table of the frontal bone, which may be associated with hypertrichosis and obesity. It most commonly affects women near menopause.%A%    
% 213.98/214.17  |- mesh__recordMaintainer mesh__D006957 PLS
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006957 1998
% 213.98/214.17  |- rdf__type mesh__D006957sskos__Concept
% 213.98/214.17  |- mesh__recordOriginator mesh__D006957 NLM
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006957 2004
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D006957 1995
% 213.98/214.17  |- mesh__dateRevised mesh__D006957 1993-06-02
% 213.98/214.17  |- skos__broader mesh__D020628smesh__D016965
% 213.98/214.17  |- mesh__dateCreated mesh__D020628 1999-11-03
% 213.98/214.17  |- rdf__type mesh__D020628sskos__Concept
% 213.98/214.17  |- mesh__activeMeSHYear mesh__D020628 2006
% 213.98/214.17  |- mesh__recordMaintainer mesh__D020628 SYSTEM
% 213.98/214.17  |- mesh__dateEstablished mesh__D020628 2000-01-01
% 213.98/214.17  |- mesh__recordAuthorizer mesh__D020628 sjn
% 213.98/214.17  |- mesh__dateRevised mesh__D020628 2005-06-30
% 213.98/214.18  |- mesh__recordOriginator mesh__D020628 ndw
% 213.98/214.18  |- skos__scopeNote mesh__D020628
% 213.98/214.18       A genus of gram-negative, rod-shaped bacteria able to anaerobically oxidize and degrade toluene.%A%    
% 213.98/214.18  |- skos__prefLabel mesh__D020628 Thauera
% 213.98/214.18  |- skos__broader mesh__D020628smesh__D043362
% 213.98/214.18  |- mesh__historyNote mesh__D020628 2000   
% 213.98/214.18  |- mesh__publicMeSHNote mesh__D020628 2000   
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006159 2000
% 213.98/214.18  |- mesh__publicMeSHNote mesh__D006159
% 213.98/214.18       91; was see under GUANINE NUCLEOTIDES 1978-90   
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006159 2006
% 213.98/214.18  |- skos__hiddenLabel mesh__D006159
% 213.98/214.18       5%27%-Diphosphate 3%27%-Diphosphate, Guanosine
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006159 2001
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006159 1995
% 213.98/214.18  |- skos__hiddenLabel mesh__D006159
% 213.98/214.18       Guanosine 5%27% Diphosphate 3%27% Diphosphate
% 213.98/214.18  |- mesh__dateEstablished mesh__D006159 1991-01-01
% 213.98/214.18  |- mesh__dateRevised mesh__D006159 1990-04-13
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006159 1998
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006159 2003
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006159 1992
% 213.98/214.18  |- mesh__recordOriginator mesh__D006159 RLS
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006159 1999
% 213.98/214.18  |- skos__hiddenLabel mesh__D006159 Tetraphosphate, Guanosine
% 213.98/214.18  |- rdf__type mesh__D006159sskos__Concept
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006159 2004
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006159 1993
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006159 2002
% 213.98/214.18  |- mesh__dateCreated mesh__D006159 1977-04-22
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006159 1991
% 213.98/214.18  |- skos__hiddenLabel mesh__D006159
% 213.98/214.18       5%27%-Diphosphate, Guanosine 3%27%-Diphosphate
% 213.98/214.18  |- skos__prefLabel mesh__D006159 Guanosine Tetraphosphate
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006159 1996
% 213.98/214.18  |- skos__hiddenLabel mesh__D006159
% 213.98/214.18       Guanosine 3%27% Diphosphate 5%27% Diphosphate
% 213.98/214.18  |- mesh__recordAuthorizer mesh__D006159 PLS
% 213.98/214.18  |- skos__historyNote mesh__D006159 Guanine Nucleotides %28%1966-1977%29%
% 213.98/214.18  |- skos__hiddenLabel mesh__D006159
% 213.98/214.18       3%27%-Diphosphate, Guanosine 5%27%-Diphosphate
% 213.98/214.18  |- mesh__recordMaintainer mesh__D006159 NLM
% 213.98/214.18  |- skos__hiddenLabel mesh__D006159
% 213.98/214.18       3%27%-Diphosphate 5%27%-Diphosphate, Guanosine
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006159 2005
% 213.98/214.18  |- skos__scopeNote mesh__D006159
% 213.98/214.18       Guanosine 5%27%-diphosphate 2%27%%28%3%27%%29%-diphosphate. A guanine nucleotide containing four phosphate groups. Two phosphate groups are esterified to the sugar moiety in the 5%27% position and the other two in the 2%27% or 3%27% position. This nucleotide serves as a messenger to turn off the synthesis of ribosomal RNA when amino acids are not available for protein synthesis. Synonym: magic spot I.%A%    
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006159 1997
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006159 1994
% 213.98/214.18  |- skos__altLabel mesh__D006159
% 213.98/214.18       Guanosine 3%27%-Diphosphate 5%27%-Diphosphate
% 213.98/214.18  |- skos__annotation mesh__D006159 /biosyn /physiol permitted; DF: PPGPP   
% 213.98/214.18  |- mesh__historyNote mesh__D006159
% 213.98/214.18       91%28%78%29%; was see under GUANINE NUCLEOTIDES 1978-90   
% 213.98/214.18  |- skos__broader mesh__D006159smesh__D006150
% 213.98/214.18  |- skos__altLabel mesh__D006159
% 213.98/214.18       Guanosine 5%27%-Diphosphate 3%27%-Diphosphate
% 213.98/214.18  |- skos__altLabel mesh__D016587 Antimutagens
% 213.98/214.18  |- mesh__publicMeSHNote mesh__D016587 92   
% 213.98/214.18  |- mesh__historyNote mesh__D016587 92   
% 213.98/214.18  |- skos__related mesh__D016587smesh__D016588
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D016587 2004
% 213.98/214.18  |- mesh__dateRevised mesh__D016587 2003-07-09
% 213.98/214.18  |- mesh__dateEstablished mesh__D016587 1992-01-01
% 213.98/214.18  |- skos__prefLabel mesh__D016587 Antimutagenic Agents
% 213.98/214.18  |- mesh__recordMaintainer mesh__D016587 ssb
% 213.98/214.18  |- mesh__dateCreated mesh__D016587 1991-01-24
% 213.98/214.18  |- rdf__type mesh__D016587sskos__Concept
% 213.98/214.18  |- skos__annotation mesh__D016587 D25-26 qualif   
% 213.98/214.18  |- skos__scopeNote mesh__D016587
% 213.98/214.18       Agents that reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved.%A%    
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D016587 2005
% 213.98/214.18  |- skos__historyNote mesh__D016587 Mutation %28%1966-1991%29%
% 213.98/214.18  |- mesh__recordAuthorizer mesh__D016587 sjn
% 213.98/214.18  |- skos__hiddenLabel mesh__D016587 Anti Mutagenic Agents
% 213.98/214.18  |- skos__hiddenLabel mesh__D016587 Agents, Antimutagenic
% 213.98/214.18  |- mesh__recordOriginator mesh__D016587 RLS
% 213.98/214.18  |- skos__broader mesh__D016587smesh__D020011
% 213.98/214.18  |- skos__altLabel mesh__D016587 Anti-Mutagenic Agents
% 213.98/214.18  |- skos__hiddenLabel mesh__D016587 Agents, Anti-Mutagenic
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D016587 2006
% 213.98/214.18  |- skos__broader mesh__D035741smesh__D019659
% 213.98/214.18  |- skos__annotation mesh__D035741
% 213.98/214.18       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.98/214.18  |- mesh__historyNote mesh__D035741 2003   
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D035741 2003
% 213.98/214.18  |- mesh__publicMeSHNote mesh__D035741 2003   
% 213.98/214.18  |- rdf__type mesh__D035741sskos__Concept
% 213.98/214.18  |- skos__prefLabel mesh__D035741 Vernonia
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D035741 2006
% 213.98/214.18  |- mesh__dateCreated mesh__D035741 2002-07-03
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D035741 2005
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D035741 2004
% 213.98/214.18  |- mesh__dateEstablished mesh__D035741 2003-01-01
% 213.98/214.18  |- skos__scopeNote mesh__D035741
% 213.98/214.18       A plant genus of the family ASTERACEAE. Members contain germacrane and sesquiterpene LACTONES.%A%    
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D002567 2006
% 213.98/214.18  |- skos__prefLabel mesh__D002567 Certificate of Need
% 213.98/214.18  |- mesh__publicMeSHNote mesh__D002567
% 213.98/214.18       91; was see under REGIONAL HEALTH PLANNING Aug 1977-90   
% 213.98/214.18  |- mesh__recordMaintainer mesh__D002567 kle
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D002567 2000
% 213.98/214.18  |- skos__annotation mesh__D002567
% 213.98/214.18       regional or area needs, not personal or financial need; specify geog%A%  
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D002567 2005
% 213.98/214.18  |- mesh__historyNote mesh__D002567
% 213.98/214.18       91%28%Aug 77%29%; was see under REGIONAL HEALTH PLANNING 1977-90%A%  
% 213.98/214.18  |- rdf__type mesh__D002567sskos__Concept
% 213.98/214.18  |- mesh__recordAuthorizer mesh__D002567 sjn
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D002567 2002
% 213.98/214.18  |- mesh__dateEstablished mesh__D002567 1991-01-01
% 213.98/214.18  |- skos__broader mesh__D002567smesh__D012040
% 213.98/214.18  |- skos__hiddenLabel mesh__D002567 Need Certificate
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D002567 2004
% 213.98/214.18  |- skos__scopeNote mesh__D002567
% 213.98/214.18       A certificate issued by a governmental body to an individual or organization proposing to construct or modify a health facility, or to offer a new or different service. The process of issuing the certificate is also included.%A%    
% 213.98/214.18  |- mesh__dateCreated mesh__D002567 1977-05-12
% 213.98/214.18  |- skos__hiddenLabel mesh__D002567 Need Certificates
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D002567 2003
% 213.98/214.18  |- mesh__dateRevised mesh__D002567 1999-11-03
% 213.98/214.18  |- mesh__recordOriginator mesh__D002567 EC
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D002567 2001
% 213.98/214.18  |- skos__broader mesh__D021721smesh__D006489
% 213.98/214.18  |- mesh__historyNote mesh__D021721 2001   
% 213.98/214.18  |- mesh__recordOriginator mesh__D021721 jmp
% 213.98/214.18  |- skos__scopeNote mesh__D021721
% 213.98/214.18       Use of a balloon catheter to block the flow of blood through an artery or vein.%A%    
% 213.98/214.18  |- skos__hiddenLabel mesh__D021721 Embolization, Balloon
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D021721 2002
% 213.98/214.18  |- skos__annotation mesh__D021721 coord IM with dis /ther not /surg   
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D021721 2001
% 213.98/214.18  |- rdf__type mesh__D021721sskos__Concept
% 213.98/214.18  |- skos__hiddenLabel mesh__D021721 Occlusions, Balloon
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D021721 2004
% 213.98/214.18  |- mesh__recordMaintainer mesh__D021721 jmp
% 213.98/214.18  |- skos__hiddenLabel mesh__D021721 Embolizations, Balloon
% 213.98/214.18  |- skos__hiddenLabel mesh__D021721 Balloon Occlusions
% 213.98/214.18  |- skos__historyNote mesh__D021721 Balloon Dilatation %28%1988-2000%29%
% 213.98/214.18  |- skos__historyNote mesh__D021721
% 213.98/214.18       Embolization, Therapeutic %28%1975-2000%29%
% 213.98/214.18  |- skos__broader mesh__D021721smesh__D002404
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D021721 2006
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D021721 2003
% 213.98/214.18  |- mesh__dateEstablished mesh__D021721 2001-01-01
% 213.98/214.18  |- mesh__recordAuthorizer mesh__D021721 sjn
% 213.98/214.18  |- mesh__dateCreated mesh__D021721 2000-06-27
% 213.98/214.18  |- skos__related mesh__D021721smesh__D001451
% 213.98/214.18  |- mesh__publicMeSHNote mesh__D021721 2001   
% 213.98/214.18  |- skos__related mesh__D021721smesh__D019917
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D021721 2005
% 213.98/214.18  |- skos__hiddenLabel mesh__D021721 Balloon Embolizations
% 213.98/214.18  |- skos__hiddenLabel mesh__D021721 Occlusion, Balloon
% 213.98/214.18  |- skos__prefLabel mesh__D021721 Balloon Occlusion
% 213.98/214.18  |- skos__altLabel mesh__D007252 Influenza Vaccine
% 213.98/214.18  |- mesh__recordMaintainer mesh__D007252 ags
% 213.98/214.18  |- skos__prefLabel mesh__D007252 Influenza Vaccines
% 213.98/214.18  |- skos__broader mesh__D007252smesh__D014765
% 213.98/214.18  |- mesh__historyNote mesh__D007252 2005 %28%1963%29%   
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D007252 2006A
% 213.98/214.18  |- skos__scopeNote mesh__D007252
% 213.98/214.18       Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed or attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The vaccine is usually bivalent or trivalent, containing one or two INFLUENZAVIRUS A strains and one INFLUENZAVIRUS B strain.%A%    
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D007252 2006B
% 213.98/214.18  |- mesh__dateRevised mesh__D007252 2005-11-14
% 213.98/214.18  |- mesh__publicMeSHNote mesh__D007252
% 213.98/214.18       2005; see INFLUENZA VACCINE 1963-2004; TRIVALENT LIVE INFLUENZA VACCINE was indexed under INFLUENZA VACCINES 2003-2004%A%  
% 213.98/214.18  |- rdf__type mesh__D007252sskos__Concept
% 213.98/214.18  |- mesh__recordOriginator mesh__D007252 NLM
% 213.98/214.18  |- mesh__recordAuthorizer mesh__D007252 ags
% 213.98/214.18  |- skos__hiddenLabel mesh__D007252 vaccine, LAIV
% 213.98/214.18  |- skos__annotation mesh__D007252
% 213.98/214.18       coordinate IM with specific influenza virus or virus subtype /immunol %28%IM%29%; not for Haemophilus influenzae vaccine %28% = HAEMOPHILUS VACCINES%29%%A%  
% 213.98/214.18  |- skos__hiddenLabel mesh__D007252 Vaccine, Influenza
% 213.98/214.18  |- skos__altLabel mesh__D007252 CAIV-T vaccine
% 213.98/214.18  |- mesh__dateCreated mesh__D007252 1999-01-01
% 213.98/214.18  |- skos__altLabel mesh__D007252 LAIV vaccine
% 213.98/214.18  |- skos__hiddenLabel mesh__D007252 Vaccines, Influenza
% 213.98/214.18  |- skos__altLabel mesh__D007252
% 213.98/214.18       MedImmune Vaccines Brand of Trivalent Live Attenuated Influenza Vaccine
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D007252 2006
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D048669 2005
% 213.98/214.18  |- mesh__historyNote mesh__D048669 2005%28%1996%29%   
% 213.98/214.18  |- skos__hiddenLabel mesh__D048669 Stress Activated Protein Kinase Kinase 3
% 213.98/214.18  |- skos__altLabel mesh__D048669 MKK6c Protein Kinase
% 213.98/214.18  |- skos__altLabel mesh__D048669 MEK6c Protein Kinase
% 213.98/214.18  |- skos__hiddenLabel mesh__D048669 Protein Kinase, MEK6c
% 213.98/214.18  |- skos__hiddenLabel mesh__D048669 Protein Kinase, MEK6
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D048669 2006
% 213.98/214.18  |- skos__broader mesh__D048669smesh__D020929
% 213.98/214.18  |- rdf__type mesh__D048669sskos__Concept
% 213.98/214.18  |- skos__altLabel mesh__D048669 SAPKK3 Protein Kinase
% 213.98/214.18  |- mesh__publicMeSHNote mesh__D048669
% 213.98/214.18       2005; MAP KINASE KINASE 6 was indexed under CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1996-2004%A%  
% 213.98/214.18  |- skos__hiddenLabel mesh__D048669 Protein Kinase, MEK6b
% 213.98/214.18  |- skos__altLabel mesh__D048669 Stress-Activated Protein Kinase Kinase-3
% 213.98/214.18  |- mesh__recordAuthorizer mesh__D048669 sjn
% 213.98/214.18  |- skos__hiddenLabel mesh__D048669 Protein Kinase, SAPKK3
% 213.98/214.18  |- skos__altLabel mesh__D048669 MKK6b Protein Kinase
% 213.98/214.18  |- mesh__recordOriginator mesh__D048669 jmp
% 213.98/214.18  |- mesh__recordMaintainer mesh__D048669 jmp
% 213.98/214.18  |- skos__historyNote mesh__D048669
% 213.98/214.18       Ca%28%2+%29%-Calmodulin Dependent Protein Kinase %28%1996-2004%29%
% 213.98/214.18  |- skos__altLabel mesh__D048669 MEK6 MAP Kinase Kinase
% 213.98/214.18  |- skos__scopeNote mesh__D048669
% 213.98/214.18       A mitogen-activated protein kinase kinase with specificity for P38 MITOGEN-ACTIVATED PROTEIN KINASES.%A%    
% 213.98/214.18  |- skos__hiddenLabel mesh__D048669 Protein Kinase, MKK6c
% 213.98/214.18  |- skos__altLabel mesh__D048669 Mitogen-Activated Protein Kinase Kinase 6
% 213.98/214.18  |- skos__prefLabel mesh__D048669 MAP Kinase Kinase 6
% 213.98/214.18  |- skos__altLabel mesh__D048669 MEK6 Protein Kinase
% 213.98/214.18  |- mesh__dateEstablished mesh__D048669 2005-01-01
% 213.98/214.18  |- mesh__dateCreated mesh__D048669 2004-07-07
% 213.98/214.18  |- skos__hiddenLabel mesh__D048669
% 213.98/214.18       Mitogen Activated Protein Kinase Kinase 6
% 213.98/214.18  |- skos__hiddenLabel mesh__D048669 Protein Kinase, MKK6b
% 213.98/214.18  |- skos__altLabel mesh__D048669 MAP Kinase Kinase MEK6
% 213.98/214.18  |- skos__altLabel mesh__D048669 MEK6b Protein Kinase
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D012995 1998
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D012995 2003
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D012995 1995
% 213.98/214.18  |- skos__prefLabel mesh__D012995 Solubility
% 213.98/214.18  |- mesh__dateCreated mesh__D012995 1999-01-01
% 213.98/214.18  |- skos__hiddenLabel mesh__D012995 Solubilities
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D012995 1999
% 213.98/214.18  |- rdf__type mesh__D012995sskos__Concept
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D012995 2004
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D012995 2002
% 213.98/214.18  |- mesh__recordMaintainer mesh__D012995 TAP
% 213.98/214.18  |- mesh__recordAuthorizer mesh__D012995 PLS
% 213.98/214.18  |- mesh__publicMeSHNote mesh__D012995 65   
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D012995 1996
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D012995 1993
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D012995 1997
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D012995 2000
% 213.98/214.18  |- mesh__dateEstablished mesh__D012995 1965-01-01
% 213.98/214.18  |- skos__annotation mesh__D012995 NIM   
% 213.98/214.18  |- mesh__historyNote mesh__D012995 65%28%64%29%   
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D012995 2005
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D012995 2001
% 213.98/214.18  |- skos__broader mesh__D012995smesh__D002627
% 213.98/214.18  |- mesh__recordOriginator mesh__D012995 NLM
% 213.98/214.18  |- mesh__dateRevised mesh__D012995 1992-05-18
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D012995 1994
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D012995 2006
% 213.98/214.18  |- mesh__recordMaintainer mesh__D020629 SYSTEM
% 213.98/214.18  |- skos__broader mesh__D020629smesh__D042762
% 213.98/214.18  |- mesh__dateEstablished mesh__D020629 2000-01-01
% 213.98/214.18  |- mesh__dateCreated mesh__D020629 1999-11-03
% 213.98/214.18  |- mesh__historyNote mesh__D020629 2000   
% 213.98/214.18  |- mesh__recordOriginator mesh__D020629 ndw
% 213.98/214.18  |- mesh__publicMeSHNote mesh__D020629 2000   
% 213.98/214.18  |- skos__prefLabel mesh__D020629 Methylophilus
% 213.98/214.18  |- rdf__type mesh__D020629sskos__Concept
% 213.98/214.18  |- mesh__recordAuthorizer mesh__D020629 sjn
% 213.98/214.18  |- skos__scopeNote mesh__D020629
% 213.98/214.18       A genus of straight or slightly curved gram-negative rods occurring singly or in pairs and isolated from sludge, mud, and river and pond water. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 213.98/214.18  |- mesh__dateRevised mesh__D020629 2005-06-30
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D020629 2006
% 213.98/214.18  |- skos__hiddenLabel mesh__D006958 Hyperostosis, Congenital Cortical
% 213.98/214.18  |- skos__altLabel mesh__D006958 Cortical Congenital Hyperostosis
% 213.98/214.18  |- skos__scopeNote mesh__D006958
% 213.98/214.18       A disease of young infants characterized by soft tissue swellings over the affected bones, fever, and irritability, and marked by periods of remission and exacerbation. %28%Dorland, 27th ed%29%%A%    
% 213.98/214.18  |- mesh__dateCreated mesh__D006958 1999-01-01
% 213.98/214.18  |- skos__broader mesh__D006958smesh__D010009
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006958 2005
% 213.98/214.18  |- skos__hiddenLabel mesh__D006958 Infantile Cortical Hyperostoses
% 213.98/214.18  |- rdf__type mesh__D006958sskos__Concept
% 213.98/214.18  |- skos__hiddenLabel mesh__D006958 Hyperostoses, Cortical Congenital
% 213.98/214.18  |- skos__prefLabel mesh__D006958 Hyperostosis, Cortical, Congenital
% 213.98/214.18  |- mesh__publicMeSHNote mesh__D006958
% 213.98/214.18       91; was HYPEROSTOSIS, CORTICAL CONGENITAL 1964-90   
% 213.98/214.18  |- skos__broader mesh__D006958smesh__D007232
% 213.98/214.18  |- skos__hiddenLabel mesh__D006958 Congenital Hyperostoses, Cortical
% 213.98/214.18  |- mesh__dateEstablished mesh__D006958 1964-01-01
% 213.98/214.18  |- skos__hiddenLabel mesh__D006958 Caffey De Toni Silvermann Syndrome
% 213.98/214.18  |- skos__hiddenLabel mesh__D006958 Cortical Congenital Hyperostoses
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006958 2006
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006958 2002
% 213.98/214.18  |- skos__hiddenLabel mesh__D006958 Hyperostoses, Congenital Cortical
% 213.98/214.18  |- skos__annotation mesh__D006958
% 213.98/214.18       cortical refers to cortex of bone; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 213.98/214.18  |- skos__altLabel mesh__D006958 Cortical Hyperostosis, Congenital
% 213.98/214.18  |- skos__altLabel mesh__D006958 Caffey-De Toni-Silvermann Syndrome
% 213.98/214.18  |- skos__hiddenLabel mesh__D006958 Congenital Cortical Hyperostoses
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006958 2003
% 213.98/214.18  |- skos__hiddenLabel mesh__D006958 Syndrome, Caffey-De Toni-Silvermann
% 213.98/214.18  |- skos__hiddenLabel mesh__D006958 Congenital Cortical Hyperostosis
% 213.98/214.18  |- mesh__recordAuthorizer mesh__D006958 sjn
% 213.98/214.18  |- mesh__onlineNote mesh__D006958
% 213.98/214.18       use HYPEROSTOSIS, CORTICAL, CONGENITAL to search HYPEROSTOSIS, CORTICAL CONGENITAL 1966-90%A%  
% 213.98/214.18  |- skos__hiddenLabel mesh__D006958 Cortical Hyperostoses, Infantile
% 213.98/214.18  |- mesh__dateRevised mesh__D006958 1999-11-03
% 213.98/214.18  |- mesh__recordOriginator mesh__D006958 NLM
% 213.98/214.18  |- skos__hiddenLabel mesh__D006958 Cortical Hyperostosis, Infantile
% 213.98/214.18  |- skos__hiddenLabel mesh__D006958 Hyperostosis, Infantile Cortical
% 213.98/214.18  |- skos__broader mesh__D006958smesh__D015576
% 213.98/214.18  |- skos__hiddenLabel mesh__D006958 Hyperostoses, Infantile Cortical
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006958 2004
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006958 2000
% 213.98/214.18  |- mesh__historyNote mesh__D006958
% 213.98/214.18       91; was HYPEROSTOSIS, CORTICAL CONGENITAL 1964-90   
% 213.98/214.18  |- mesh__recordMaintainer mesh__D006958 kle
% 213.98/214.18  |- skos__hiddenLabel mesh__D006958 Cortical Hyperostoses, Congenital
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D006958 2001
% 213.98/214.18  |- skos__altLabel mesh__D006958 Congenital Hyperostosis, Cortical
% 213.98/214.18  |- skos__altLabel mesh__D006958 Infantile Cortical Hyperostosis
% 213.98/214.18  |- skos__hiddenLabel mesh__D006958 Hyperostosis, Cortical Congenital
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D017680 1999
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D017680 2003
% 213.98/214.18  |- skos__broader mesh__D017680smesh__D007287
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D017680 2000
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D017680 1996
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D017680 2004
% 213.98/214.18  |- mesh__dateCreated mesh__D017680 1993-06-04
% 213.98/214.18  |- mesh__historyNote mesh__D017680 94   
% 213.98/214.18  |- skos__historyNote mesh__D017680 Potassium %28%1966-1993%29%
% 213.98/214.18  |- skos__annotation mesh__D017680
% 213.98/214.18       inorganic; GEN or unspecified; prefer specifics; DF: POTASSIUM CPDS%A%  
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D017680 1997
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D017680 2001
% 213.98/214.18  |- mesh__publicMeSHNote mesh__D017680 94   
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D017680 1994
% 213.98/214.18  |- skos__hiddenLabel mesh__D017680 Compounds, Potassium
% 213.98/214.18  |- skos__scopeNote mesh__D017680
% 213.98/214.18       Inorganic compounds that contain potassium as an integral part of the molecule.%A%    
% 213.98/214.18  |- mesh__dateEstablished mesh__D017680 1994-01-01
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D017680 1995
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D017680 2005
% 213.98/214.18  |- rdf__type mesh__D017680sskos__Concept
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D017680 2002
% 213.98/214.18  |- skos__prefLabel mesh__D017680 Potassium Compounds
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D017680 1998
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D017680 2006
% 213.98/214.18  |- skos__scopeNote mesh__D003660
% 213.98/214.18       Computer-based systems that enable management to interrogate the computer on an ad hoc basis for various kinds of information in the organization, which predict the effect of potential decisions.%A%    
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D003660 1995
% 213.98/214.18  |- mesh__dateRevised mesh__D003660 1992-05-14
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D003660 2004
% 213.98/214.18  |- mesh__recordOriginator mesh__D003660 EC
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D003660 2002
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D003660 2006
% 213.98/214.18  |- skos__annotation mesh__D003660 IM   
% 213.98/214.18  |- mesh__recordAuthorizer mesh__D003660 PLS
% 213.98/214.18  |- mesh__dateEstablished mesh__D003660 1991-01-01
% 213.98/214.18  |- skos__broader mesh__D003660smesh__D008331
% 213.98/214.18  |- mesh__dateCreated mesh__D003660 1986-06-17
% 213.98/214.18  |- mesh__publicMeSHNote mesh__D003660
% 213.98/214.18       91; was see under MANAGEMENT INFORMATION SYSTEMS 1987-90   
% 213.98/214.18  |- mesh__recordMaintainer mesh__D003660 TGC
% 213.98/214.18  |- skos__prefLabel mesh__D003660 Decision Support Systems, Management
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D003660 2000
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D003660 1996
% 213.98/214.18  |- rdf__type mesh__D003660sskos__Concept
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D003660 1998
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D003660 2001
% 213.98/214.18  |- mesh__historyNote mesh__D003660
% 213.98/214.18       91%28%87%29%; was see under MANAGEMENT INFORMATION SYSTEMS 1987-90%A%  
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D003660 1997
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D003660 1994
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D003660 2003
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D003660 1999
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D003660 2005
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D003660 1993
% 213.98/214.18  |- rdf__type mesh__D016588sskos__Concept
% 213.98/214.18  |- skos__hiddenLabel mesh__D016588 Drugs, Anticarcinogenic
% 213.98/214.18  |- skos__altLabel mesh__D016588 Anti-Carcinogenic Agents
% 213.98/214.18  |- skos__hiddenLabel mesh__D016588 Anti Carcinogenic Agents
% 213.98/214.18  |- skos__hiddenLabel mesh__D016588 Drugs, Anti-Carcinogenic
% 213.98/214.18  |- mesh__recordOriginator mesh__D016588 RLS
% 213.98/214.18  |- skos__altLabel mesh__D016588 Anti-Carcinogenic Drugs
% 213.98/214.18  |- skos__hiddenLabel mesh__D016588 Agents, Anti-Carcinogenic
% 213.98/214.18  |- mesh__recordAuthorizer mesh__D016588 sjn
% 213.98/214.18  |- skos__annotation mesh__D016588
% 213.98/214.18       do not confuse with ANTINEOPLASTIC AGENTS which treat or affect cancer already developed while ANTICARCINOGENIC AGENTS prevent or reduce the development of cancer%A%  
% 213.98/214.18  |- skos__scopeNote mesh__D016588
% 213.98/214.18       Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. They differ from antineoplastic agents in that they prevent neoplasms from forming. The anticarcinogenic substances can be divided into three categories. The first consists of compounds that prevent the formation of carcinogens from precursor substances. The second group consists of %22%blocking agents%22% which inhibit carcinogenesis by preventing carcinogenic agents from reaching or reacting with critical target sites in the tissues. The third group is the %22%suppressor agents%22% which act by suppression of expression of neoplasia in cells previously exposed to carcinogens that would otherwise cause neoplasms.%A%    
% 213.98/214.18  |- mesh__dateEstablished mesh__D016588 1992-01-01
% 213.98/214.18  |- mesh__publicMeSHNote mesh__D016588 92   
% 213.98/214.18  |- skos__related mesh__D016588smesh__D000970
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D016588 2006
% 213.98/214.18  |- skos__broader mesh__D016588smesh__D000970
% 213.98/214.18  |- skos__prefLabel mesh__D016588 Anticarcinogenic Agents
% 213.98/214.18  |- mesh__historyNote mesh__D016588 92   
% 213.98/214.18  |- mesh__recordMaintainer mesh__D016588 ssb
% 213.98/214.18  |- skos__altLabel mesh__D016588 Anticarcinogens
% 213.98/214.18  |- skos__hiddenLabel mesh__D016588 Agents, Anticarcinogenic
% 213.98/214.18  |- skos__related mesh__D016588smesh__D016587
% 213.98/214.18  |- mesh__dateCreated mesh__D016588 1991-04-29
% 213.98/214.18  |- skos__altLabel mesh__D016588 Anticarcinogenic Drugs
% 213.98/214.18  |- mesh__dateRevised mesh__D016588 2005-06-30
% 213.98/214.18  |- skos__hiddenLabel mesh__D016588 Anti Carcinogenic Drugs
% 213.98/214.18  |- skos__broader mesh__D035742smesh__D019659
% 213.98/214.18  |- skos__annotation mesh__D035742
% 213.98/214.18       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 213.98/214.18  |- mesh__dateCreated mesh__D035742 2002-07-03
% 213.98/214.18  |- mesh__publicMeSHNote mesh__D035742 2003   
% 213.98/214.18  |- mesh__dateEstablished mesh__D035742 2003-01-01
% 213.98/214.18  |- rdf__type mesh__D035742sskos__Concept
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D035742 2005
% 213.98/214.18  |- skos__altLabel mesh__D035742 Guaco
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D035742 2006
% 213.98/214.18  |- skos__scopeNote mesh__D035742
% 213.98/214.18       A plant genus of the family ASTERACEAE. Members contain scandenolide %28%a sesquiterpene lactone%29% and germacranolides.%A%    
% 213.98/214.18  |- mesh__historyNote mesh__D035742 2003   
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D035742 2003
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D035742 2004
% 213.98/214.18  |- skos__prefLabel mesh__D035742 Mikania
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D002568 2006
% 213.98/214.18  |- skos__annotation mesh__D002568
% 213.98/214.18       by the profession; certif by various bds can go here but consider also LICENSURE; coord IM with specialty or discipline %28%IM%29%; specify geog%A%  
% 213.98/214.18  |- mesh__publicMeSHNote mesh__D002568 68   
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D002568 2000
% 213.98/214.18  |- mesh__dateCreated mesh__D002568 1999-01-01
% 213.98/214.18  |- mesh__dateEstablished mesh__D002568 1968-01-01
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D002568 2001
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D002568 2003
% 213.98/214.18  |- mesh__dateRevised mesh__D002568 1999-11-03
% 213.98/214.18  |- rdf__type mesh__D002568sskos__Concept
% 213.98/214.18  |- skos__historyNote mesh__D002568 Accreditation %28%1966-1967%29%
% 213.98/214.18  |- skos__related mesh__D002568smesh__D000068
% 213.98/214.18  |- skos__hiddenLabel mesh__D002568 Certifications
% 213.98/214.18  |- mesh__recordMaintainer mesh__D002568 kle
% 213.98/214.18  |- mesh__recordOriginator mesh__D002568 NLM
% 213.98/214.18  |- skos__hiddenLabel mesh__D002568 Level, Certification
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D002568 2002
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D002568 2004
% 213.98/214.18  |- skos__prefLabel mesh__D002568 Certification
% 213.98/214.18  |- skos__broader mesh__D002568smesh__D003406
% 213.98/214.18  |- skos__hiddenLabel mesh__D002568 Levels, Certification
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D002568 2005
% 213.98/214.18  |- mesh__recordAuthorizer mesh__D002568 sjn
% 213.98/214.18  |- skos__scopeNote mesh__D002568
% 213.98/214.18       Compliance with a set of standards defined by non-governmental organizations. Certification is applied for by individuals on a voluntary basis and represents a professional status when achieved, e.g., certification for a medical specialty.%A%    
% 213.98/214.18  |- skos__hiddenLabel mesh__D002568 Certification Levels
% 213.98/214.18  |- mesh__historyNote mesh__D002568 68   
% 213.98/214.18  |- skos__related mesh__D002568smesh__D008004
% 213.98/214.18  |- skos__related mesh__D002568smesh__D013044
% 213.98/214.18  |- skos__hiddenLabel mesh__D013290 Streptococcal Infection
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D013290 2000
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D013290 1994
% 213.98/214.18  |- skos__hiddenLabel mesh__D013290 Infection, Streptococcal
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D013290 2001
% 213.98/214.18  |- mesh__recordMaintainer mesh__D013290 TAP
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D013290 1995
% 213.98/214.18  |- rdf__type mesh__D013290sskos__Concept
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D013290 1998
% 213.98/214.18  |- skos__altLabel mesh__D013290 Infections, Streptococcal
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D013290 2005
% 213.98/214.18  |- mesh__recordOriginator mesh__D013290 NLM
% 213.98/214.18  |- skos__broader mesh__D013290smesh__D016908
% 213.98/214.18  |- mesh__activeMeSHYear mesh__D013290 1999
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D013290 2006
% 213.98/214.19  |- mesh__dateCreated mesh__D013290 1999-01-01
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D013290 2002
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D013290 1996
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D013290 2003
% 213.98/214.19  |- mesh__recordAuthorizer mesh__D013290 PLS
% 213.98/214.19  |- skos__scopeNote mesh__D013290
% 213.98/214.19       Infections with bacteria of the genus STREPTOCOCCUS.     
% 213.98/214.19  |- mesh__dateRevised mesh__D013290 1993-06-03
% 213.98/214.19  |- skos__prefLabel mesh__D013290 Streptococcal Infections
% 213.98/214.19  |- skos__annotation mesh__D013290
% 213.98/214.19       gram-pos bact infect; coord IM with species %28%IM%29%; DF: STREP INFECT%A%  
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D013290 1997
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D013290 2004
% 213.98/214.19  |- skos__hiddenLabel mesh__D007253 Center, Information
% 213.98/214.19  |- skos__hiddenLabel mesh__D007253 Centers, Information
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007253 2003
% 213.98/214.19  |- rdf__type mesh__D007253sskos__Concept
% 213.98/214.19  |- mesh__dateEstablished mesh__D007253 1976-01-01
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007253 2004
% 213.98/214.19  |- mesh__dateCreated mesh__D007253 1975-07-25
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007253 2000
% 213.98/214.19  |- skos__scopeNote mesh__D007253
% 213.98/214.19       Facilities for collecting and organizing information. They may be specialized by subject field, type of source material, persons served, location, or type of services.%A%    
% 213.98/214.19  |- mesh__publicMeSHNote mesh__D007253 76   
% 213.98/214.19  |- skos__hiddenLabel mesh__D007253 Information Center
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007253 2005
% 213.98/214.19  |- mesh__dateRevised mesh__D007253 1999-11-03
% 213.98/214.19  |- skos__prefLabel mesh__D007253 Information Centers
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007253 2001
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007253 2006
% 213.98/214.19  |- skos__annotation mesh__D007253
% 213.98/214.19       med inform cent: do not coord with MEDICINE   
% 213.98/214.19  |- mesh__recordMaintainer mesh__D007253 kle
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007253 2002
% 213.98/214.19  |- skos__broader mesh__D007253smesh__D007254
% 213.98/214.19  |- mesh__historyNote mesh__D007253 76; was NON MESH before 1976   
% 213.98/214.19  |- skos__historyNote mesh__D007253 Information Services %28%1966-1975%29%
% 213.98/214.19  |- mesh__recordAuthorizer mesh__D007253 sjn
% 213.98/214.19  |- mesh__recordOriginator mesh__D007253 SMH
% 213.98/214.19  |- rdf__type mesh__D012996sskos__Concept
% 213.98/214.19  |- mesh__recordOriginator mesh__D012996 NLM
% 213.98/214.19  |- skos__prefLabel mesh__D012996 Solutions
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D012996 2004
% 213.98/214.19  |- mesh__recordMaintainer mesh__D012996 ssb
% 213.98/214.19  |- skos__broader mesh__D012996smesh__D004364
% 213.98/214.19  |- mesh__dateRevised mesh__D012996 2003-07-09
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D012996 2005
% 213.98/214.19  |- mesh__recordAuthorizer mesh__D012996 sjn
% 213.98/214.19  |- skos__scopeNote mesh__D012996
% 213.98/214.19       The homogeneous mixtures formed by the mixing of a solid, liquid, or gaseous substance %28%solute%29% with a liquid %28%the solvent%29%, from which the dissolved substances can be recovered by physical processes. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 213.98/214.19  |- skos__related mesh__D012996smesh__D019999
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D012996 2006
% 213.98/214.19  |- skos__annotation mesh__D012996
% 213.98/214.19       IM for general only, qualif permitted; NIM %28%no qualif%29% when substance in solution is IM %28%with qualif%29%; /adv eff permitted but be careful: it may be the adv eff of the substance in solution, not the %22%solution%22%%A%  
% 213.98/214.19  |- mesh__dateCreated mesh__D012996 1999-01-01
% 213.98/214.19  |- mesh__recordOriginator mesh__D006959 VDK
% 213.98/214.19  |- rdf__type mesh__D006959sskos__Concept
% 213.98/214.19  |- skos__annotation mesh__D006959
% 213.98/214.19       HYPEROXALURIA, PRIMARY is also available   
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D006959 2002
% 213.98/214.19  |- skos__altLabel mesh__D006959 Oxaluria
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D006959 2004
% 213.98/214.19  |- mesh__dateEstablished mesh__D006959 1987-01-01
% 213.98/214.19  |- mesh__recordAuthorizer mesh__D006959 sjn
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D006959 2003
% 213.98/214.19  |- skos__historyNote mesh__D006959 Oxalates/urine %28%1966-1986%29%
% 213.98/214.19  |- mesh__publicMeSHNote mesh__D006959 87   
% 213.98/214.19  |- mesh__dateRevised mesh__D006959 2001-07-25
% 213.98/214.19  |- mesh__historyNote mesh__D006959 87   
% 213.98/214.19  |- skos__scopeNote mesh__D006959
% 213.98/214.19       Excretion of an excessive amount of oxalate in the urine.%A%    
% 213.98/214.19  |- skos__broader mesh__D006959smesh__D008659
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D006959 2006
% 213.98/214.19  |- mesh__dateCreated mesh__D006959 1986-04-18
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D006959 2005
% 213.98/214.19  |- mesh__recordMaintainer mesh__D006959 nns
% 213.98/214.19  |- skos__prefLabel mesh__D006959 Hyperoxaluria
% 213.98/214.19  |- skos__hiddenLabel mesh__D017681 Syndromes, Idiopathic Hypereosinophilic
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D017681 1997
% 213.98/214.19  |- skos__prefLabel mesh__D017681 Hypereosinophilic Syndrome
% 213.98/214.19  |- skos__hiddenLabel mesh__D017681 Hypereosinophilic Syndromes
% 213.98/214.19  |- skos__historyNote mesh__D017681 Eosinophilia %28%1966-1993%29%
% 213.98/214.19  |- skos__altLabel mesh__D017681 Endocarditis, Loeffler%27%s
% 213.98/214.19  |- skos__hiddenLabel mesh__D017681 Loefflers Endocarditis
% 213.98/214.19  |- skos__hiddenLabel mesh__D017681 Endocarditis, Loefflers
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D017681 1994
% 213.98/214.19  |- skos__hiddenLabel mesh__D017681 Syndrome, Hypereosinophilic
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D017681 2002
% 213.98/214.19  |- skos__hiddenLabel mesh__D017681 Hypereosinophilic Syndrome, Idiopathic
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D017681 1995
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D017681 2005
% 213.98/214.19  |- rdf__type mesh__D017681sskos__Concept
% 213.98/214.19  |- skos__hiddenLabel mesh__D017681 Loeffler Endocarditis
% 213.98/214.19  |- mesh__dateCreated mesh__D017681 1992-12-28
% 213.98/214.19  |- skos__hiddenLabel mesh__D017681 Syndromes, Hypereosinophilic
% 213.98/214.19  |- skos__hiddenLabel mesh__D017681 Idiopathic Hypereosinophilic Syndromes
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D017681 1998
% 213.98/214.19  |- skos__hiddenLabel mesh__D017681 Eosinophilic Leukemias
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D017681 2006
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D017681 2000
% 213.98/214.19  |- skos__hiddenLabel mesh__D017681 Eosinophilic Leukemia
% 213.98/214.19  |- skos__scopeNote mesh__D017681
% 213.98/214.19       A heterogeneous group of disorders with the common feature of prolonged eosinophilia of unknown cause and associated organ system dysfunction, including the heart, central nervous system, kidneys, lungs, gastrointestinal tract, and skin. There is a massive increase in the number of eosinophils in the blood, mimicking leukemia, and extensive eosinophilic infiltration of the various organs. It is often referred to as idiopathic.%A%    
% 213.98/214.19  |- skos__annotation mesh__D017681
% 213.98/214.19       do not confuse X ref LOEFFLER%27%S ENDOCARDITIS with LOEFFLER SYNDROME see PULMONARY EOSINOPHILIA%A%  
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D017681 1999
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D017681 2003
% 213.98/214.19  |- skos__hiddenLabel mesh__D017681 Hypereosinophilic Syndromes, Idiopathic
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D017681 2001
% 213.98/214.19  |- mesh__publicMeSHNote mesh__D017681 94   
% 213.98/214.19  |- skos__broader mesh__D017681smesh__D004802
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D017681 1996
% 213.98/214.19  |- skos__hiddenLabel mesh__D017681 Leukemias, Eosinophilic
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D017681 2004
% 213.98/214.19  |- skos__hiddenLabel mesh__D017681 Syndrome, Idiopathic Hypereosinophilic
% 213.98/214.19  |- mesh__dateEstablished mesh__D017681 1994-01-01
% 213.98/214.19  |- mesh__historyNote mesh__D017681 94   
% 213.98/214.19  |- skos__hiddenLabel mesh__D017681 Endocarditis, Loeffler
% 213.98/214.19  |- skos__prefLabel mesh__D003661 Decision Support Techniques
% 213.98/214.19  |- mesh__recordAuthorizer mesh__D003661 sjn
% 213.98/214.19  |- skos__hiddenLabel mesh__D003661 Decision Support Technique
% 213.98/214.19  |- mesh__dateCreated mesh__D003661 1987-04-06
% 213.98/214.19  |- skos__hiddenLabel mesh__D003661 Techniques, Decision Support
% 213.98/214.19  |- mesh__onlineNote mesh__D003661
% 213.98/214.19       use DECISION SUPPORT TECHNIQUES to search DECISION SUPPORT TECHNICS 1988-90%A%  
% 213.98/214.19  |- mesh__publicMeSHNote mesh__D003661
% 213.98/214.19       91; was DECISION SUPPORT TECHNICS 1988-90   
% 213.98/214.19  |- skos__scopeNote mesh__D003661
% 213.98/214.19       Mathematical or statistical procedures used as aids in making a decision. They are frequently used in medical decision-making.%A%    
% 213.98/214.19  |- skos__hiddenLabel mesh__D003661 Decision Support Technic
% 213.98/214.19  |- mesh__recordOriginator mesh__D003661 EC
% 213.98/214.19  |- skos__hiddenLabel mesh__D003661 Decision Analyses
% 213.98/214.19  |- skos__hiddenLabel mesh__D003661 Aid, Decision
% 213.98/214.19  |- skos__annotation mesh__D003661 IM; no qualif   
% 213.98/214.19  |- skos__altLabel mesh__D003661 Analysis, Decision
% 213.98/214.19  |- skos__hiddenLabel mesh__D003661 Analyses, Decision
% 213.98/214.19  |- rdf__type mesh__D003661sskos__Concept
% 213.98/214.19  |- mesh__historyNote mesh__D003661
% 213.98/214.19       91; was DECISION SUPPORT TECHNICS 1988-90   
% 213.98/214.19  |- skos__related mesh__D003661smesh__D019317
% 213.98/214.19  |- mesh__recordMaintainer mesh__D003661 jls
% 213.98/214.19  |- skos__hiddenLabel mesh__D003661 Decision Aid
% 213.98/214.19  |- skos__hiddenLabel mesh__D003661 Model, Decision Support
% 213.98/214.19  |- skos__hiddenLabel mesh__D003661 Aids, Decision
% 213.98/214.19  |- mesh__dateRevised mesh__D003661 2004-07-07
% 213.98/214.19  |- skos__hiddenLabel mesh__D003661 Technics, Decision Support
% 213.98/214.19  |- skos__hiddenLabel mesh__D003661 Technic, Decision Support
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D003661 2005
% 213.98/214.19  |- skos__hiddenLabel mesh__D003661 Decision Support Models
% 213.98/214.19  |- skos__hiddenLabel mesh__D003661 Technique, Decision Support
% 213.98/214.19  |- skos__hiddenLabel mesh__D003661 Modeling, Decision
% 213.98/214.19  |- skos__hiddenLabel mesh__D003661 Decision Support Model
% 213.98/214.19  |- skos__broader mesh__D003661smesh__D008432
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D003661 2006
% 213.98/214.19  |- mesh__dateEstablished mesh__D003661 1988-01-01
% 213.98/214.19  |- skos__altLabel mesh__D003661 Decision Support Technics
% 213.98/214.19  |- skos__altLabel mesh__D016589 Medinsa Brand of Astemizole
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 R 43 512
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 Astemizole McNeil Brand
% 213.98/214.19  |- skos__altLabel mesh__D016589 Alacan Brand of Astemizole
% 213.98/214.19  |- skos__altLabel mesh__D016589 Diba Brand of Astemizole
% 213.98/214.19  |- skos__altLabel mesh__D016589 Fustery Brand of Astemizole
% 213.98/214.19  |- skos__altLabel mesh__D016589 Reig Jofre Brand of Astemizole
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 Astemizole Septa Brand
% 213.98/214.19  |- skos__altLabel mesh__D016589 Janssen Brand of Astemizole
% 213.98/214.19  |- skos__altLabel mesh__D016589 Urbion Brand of Astemizole
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 Alonga, Astemizol
% 213.98/214.19  |- skos__altLabel mesh__D016589 McNeil Brand of Astemizole
% 213.98/214.19  |- rdf__type mesh__D016589sskos__Concept
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 Astemizole Fustery Brand
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D016589 2006
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 Astemizole Merck Brand
% 213.98/214.19  |- mesh__dateRevised mesh__D016589 2004-07-07
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 R43512
% 213.98/214.19  |- mesh__publicMeSHNote mesh__D016589
% 213.98/214.19       92; ASTEMIZOLE was indexed under BENZIMIDAZOLES 1981-91   
% 213.98/214.19  |- mesh__onlineNote mesh__D016589
% 213.98/214.19       use ASTEMIZOLE %28%NM%29% to search ASTEMIZOLE 1981-91   
% 213.98/214.19  |- skos__broader mesh__D016589smesh__D001562
% 213.98/214.19  |- skos__scopeNote mesh__D016589
% 213.98/214.19       A long-acting, non-sedative antihistaminic used in the treatment of seasonal allergic rhinitis, asthma, allergic conjunctivitis, and chronic idiopathic urticaria. The drug is well tolerated and has no anticholinergic side effects.%A%    
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 Astemizole Urbion Brand
% 213.98/214.19  |- skos__altLabel mesh__D016589 Elfar Brand of Astemizole
% 213.98/214.19  |- skos__altLabel mesh__D016589 Septa Brand of Astemizole
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 Astemizole ICN Brand
% 213.98/214.19  |- skos__altLabel mesh__D016589 Vita Brand of Astemizole
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 Astemizole Janssen Brand
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 Astemizole Byk Brand
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D016589 2005
% 213.98/214.19  |- skos__altLabel mesh__D016589 Lesvi Brand of Astemizole
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 Astemizole Medinsa Brand
% 213.98/214.19  |- skos__altLabel mesh__D016589 Byk Brand of Astemizole
% 213.98/214.19  |- skos__prefLabel mesh__D016589 Astemizole
% 213.98/214.19  |- skos__altLabel mesh__D016589 Senosiain Brand of Astemizole
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 Astemizole Lesvi Brand
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 Astemizole Diba Brand
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 ratiopharm, Astemizol
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 Astemizole Alacan Brand
% 213.98/214.19  |- mesh__historyNote mesh__D016589 92; was ASTEMIZOLE %28%NM%29% 1981-91   
% 213.98/214.19  |- skos__altLabel mesh__D016589 Merck Brand of Astemizole
% 213.98/214.19  |- skos__altLabel mesh__D016589 Alonga Brand of Astemizole
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 Astemizole Elfar Brand
% 213.98/214.19  |- skos__altLabel mesh__D016589 Smaller Brand of Astemizole
% 213.98/214.19  |- skos__historyNote mesh__D016589 Benzimidazoles %28%1966-1991%29%
% 213.98/214.19  |- mesh__dateEstablished mesh__D016589 1992-01-01
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 Astemizole Smaller Brand
% 213.98/214.19  |- mesh__dateCreated mesh__D016589 1991-01-24
% 213.98/214.19  |- skos__altLabel mesh__D016589 ratiopharm Brand of Astemizole
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 Astemizole Senosiain Brand
% 213.98/214.19  |- skos__altLabel mesh__D016589 Esteve Brand of Astemizole
% 213.98/214.19  |- skos__historyNote mesh__D016589
% 213.98/214.19       Histamine H1 Receptor Blockaders %28%1966-1991%29%
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 Astemizole Vita Brand
% 213.98/214.19  |- skos__altLabel mesh__D016589 ICN Brand of Astemizole
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 Astemizole Esteve Brand
% 213.98/214.19  |- mesh__recordMaintainer mesh__D016589 mdb
% 213.98/214.19  |- mesh__recordAuthorizer mesh__D016589 sjn
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 Astemizole ratiopharm Brand
% 213.98/214.19  |- mesh__recordOriginator mesh__D016589 RLS
% 213.98/214.19  |- skos__hiddenLabel mesh__D016589 Astemizole Alonga Brand
% 213.98/214.19  |- mesh__recordAuthorizer mesh__D002569 sjn
% 213.98/214.19  |- skos__broader mesh__D002569smesh__D000577
% 213.98/214.19  |- skos__annotation mesh__D002569
% 213.98/214.19       do not confuse with CERULEIN see CAERULEIN   
% 213.98/214.19  |- rdf__type mesh__D002569sskos__Concept
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D002569 2003
% 213.98/214.19  |- skos__altLabel mesh__D002569 2,3-Epoxy-4-oxo-7,10-dodecadienoylamide
% 213.98/214.19  |- mesh__recordMaintainer mesh__D002569 ssb
% 213.98/214.19  |- skos__historyNote mesh__D002569
% 213.98/214.19       Antibiotics, Antifungal %28%1973-1974%29%
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D002569 2004
% 213.98/214.19  |- skos__prefLabel mesh__D002569 Cerulenin
% 213.98/214.19  |- mesh__dateRevised mesh__D002569 2002-07-03
% 213.98/214.19  |- skos__historyNote mesh__D002569 Fatty Acids, Unsaturated %28%1974%29%
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D002569 2005
% 213.98/214.19  |- mesh__recordOriginator mesh__D002569 NLM
% 213.98/214.19  |- skos__historyNote mesh__D002569 Ethers, Cyclic %28%1973-1974%29%
% 213.98/214.19  |- mesh__dateEstablished mesh__D002569 1991-01-01
% 213.98/214.19  |- mesh__publicMeSHNote mesh__D002569
% 213.98/214.19       91; was see under ANTIBIOTICS, ANTIFUNGAL 1975-90   
% 213.98/214.19  |- mesh__dateCreated mesh__D002569 1974-11-19
% 213.98/214.19  |- mesh__historyNote mesh__D002569
% 213.98/214.19       91%28%75%29%; was see under ANTIBIOTICS, ANTIFUNGAL 1975-90   
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D002569 2006
% 213.98/214.19  |- skos__scopeNote mesh__D002569
% 213.98/214.19       Antifungal antibiotic isolated from several species, including Acremonium %28%Cephalosporium%29%, Acrocylindrum, and Helicoceras. It inhibits the biosynthesis of several lipids by interfering with enzyme function and is used as a biochemical tool.%A%    
% 213.98/214.19  |- mesh__dateCreated mesh__D013291 1999-01-01
% 213.98/214.19  |- skos__scopeNote mesh__D013291
% 213.98/214.19       A genus of gram-positive, coccoid bacteria whose organisms occur in pairs or chains. No endospores are produced. Many species exist as commensals or parasites on man or animals with some being highly pathogenic. A few species are saprophytes and occur in the natural environment.%A%    
% 213.98/214.19  |- skos__annotation mesh__D013291
% 213.98/214.19       GEN or unspecified; prefer specifics; hemolytic streptococci = STREPTOCOCCUS unless specified in text as S. pyogenes, S. agalactiae, etc.; group A = STREPTOCOCCUS PYOGENES; B = STREPTOCOCCUS AGALACTIAE; D = ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; STREPTOCOCCUS BOVIS; S. equinus %28%index under STREPTOCOCCUS%29%; N = LACTOCOCCUS LACTIS; groups E, L, M, O, R, S go under STREPTOCOCCUS; infection = STREPTOCOCCAL INFECTIONS; DF: STREP%A%  
% 213.98/214.19  |- mesh__recordAuthorizer mesh__D013291 sjn
% 213.98/214.19  |- rdf__type mesh__D013291sskos__Concept
% 213.98/214.19  |- skos__prefLabel mesh__D013291 Streptococcus
% 213.98/214.19  |- skos__broader mesh__D013291smesh__D013289
% 213.98/214.19  |- mesh__recordMaintainer mesh__D013291 SYSTEM
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D013291 2006
% 213.98/214.19  |- mesh__recordOriginator mesh__D013291 NLM
% 213.98/214.19  |- mesh__dateRevised mesh__D013291 2005-06-30
% 213.98/214.19  |- skos__prefLabel mesh__D007254 Information Science
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007254 2001
% 213.98/214.19  |- mesh__dateCreated mesh__D007254 1999-01-01
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007254 1996
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007254 2005
% 213.98/214.19  |- skos__annotation mesh__D007254 SPEC: SPEC qualif   
% 213.98/214.19  |- mesh__dateEstablished mesh__D007254 1993-01-01
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007254 2002
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007254 1997
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007254 2006
% 213.98/214.19  |- skos__hiddenLabel mesh__D007254 Information Sciences
% 213.98/214.19  |- skos__historyNote mesh__D007254 Information Services %28%1966-1992%29%
% 213.98/214.19  |- skos__hiddenLabel mesh__D007254 Sciences, Information
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007254 1993
% 213.98/214.19  |- mesh__publicMeSHNote mesh__D007254 93   
% 213.98/214.19  |- skos__hiddenLabel mesh__D007254 Science, Information
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007254 1998
% 213.98/214.19  |- mesh__recordMaintainer mesh__D007254 ags
% 213.98/214.19  |- mesh__historyNote mesh__D007254
% 213.98/214.19       93; was INFORMATION SCIENCE %28%NON MESH%29% 1974-92   
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007254 2006A
% 213.98/214.19  |- mesh__dateRevised mesh__D007254 2005-07-12
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007254 1994
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007254 2003
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007254 1999
% 213.98/214.19  |- mesh__runningHead mesh__D007254
% 213.98/214.19       L1 - INFORMATION SCIENCES-COMMUNICATION TECHNIQUES AND SERVICES%A%  
% 213.98/214.19  |- rdf__type mesh__D007254sskos__Concept
% 213.98/214.19  |- skos__historyNote mesh__D007254 Information Systems %28%1966-1992%29%
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007254 2000
% 213.98/214.19  |- skos__scopeNote mesh__D007254
% 213.98/214.19       The field of knowledge, theory, and technology dealing with the collection of facts and figures, and the processes and methods involved in their manipulation, storage, dissemination, publication, and retrieval. It includes the fields of COMMUNICATION; PUBLISHING; LIBRARY SCIENCE; and informatics.%A%    
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007254 1995
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007254 2004
% 213.98/214.19  |- mesh__recordAuthorizer mesh__D007254 ags
% 213.98/214.19  |- mesh__recordOriginator mesh__D007254 NLM
% 213.98/214.19  |- mesh__recordAuthorizer mesh__D012997 sjn
% 213.98/214.19  |- skos__scopeNote mesh__D012997
% 213.98/214.19       Liquids that dissolve other substances %28%solutes%29%, generally solids, without any change in chemical composition, as, water containing sugar. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 213.98/214.19  |- skos__prefLabel mesh__D012997 Solvents
% 213.98/214.19  |- mesh__dateRevised mesh__D012997 2003-07-09
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D012997 2005
% 213.98/214.19  |- skos__broader mesh__D012997smesh__D020313
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D012997 2006
% 213.98/214.19  |- mesh__recordOriginator mesh__D012997 NLM
% 213.98/214.19  |- mesh__recordMaintainer mesh__D012997 ssb
% 213.98/214.19  |- mesh__dateCreated mesh__D012997 1999-01-01
% 213.98/214.19  |- rdf__type mesh__D012997sskos__Concept
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D012997 2004
% 213.98/214.19  |- skos__annotation mesh__D012997 D25-26 qualif   
% 213.98/214.19  |- skos__historyNote mesh__D017682 Myocardial Reperfusion %28%1989-1993%29%
% 213.98/214.19  |- skos__hiddenLabel mesh__D017682 Stunning, Myocardial
% 213.98/214.19  |- mesh__publicMeSHNote mesh__D017682 94   
% 213.98/214.19  |- mesh__dateRevised mesh__D017682 2005-06-30
% 213.98/214.19  |- skos__hiddenLabel mesh__D017682 Myocardium, Stunned
% 213.98/214.19  |- mesh__dateEstablished mesh__D017682 1994-01-01
% 213.98/214.19  |- rdf__type mesh__D017682sskos__Concept
% 213.98/214.19  |- skos__prefLabel mesh__D017682 Myocardial Stunning
% 213.98/214.19  |- mesh__recordOriginator mesh__D017682 TGC
% 213.98/214.19  |- skos__altLabel mesh__D017682 Myocardial Hibernation
% 213.98/214.19  |- skos__scopeNote mesh__D017682
% 213.98/214.19       Prolonged dysfunction of the myocardium after a brief episode of severe ischemia, with gradual return of contractile activity. It occurs frequently, both in the experimental laboratory and in clinical medicine. Since stunned myocardium occurs adjacent to necrotic tissue after prolonged coronary occlusion, many myocardial infarcts may be a mixture of necrotic and stunned tissue. %28%Braunwald, Heart Disease, 1992, p1176%29%%A%    
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D017682 2006
% 213.98/214.19  |- mesh__recordMaintainer mesh__D017682 ssb
% 213.98/214.19  |- skos__broader mesh__D017682smesh__D009203
% 213.98/214.19  |- mesh__historyNote mesh__D017682 94   
% 213.98/214.19  |- skos__broader mesh__D017682smesh__D017202
% 213.98/214.19  |- skos__annotation mesh__D017682
% 213.98/214.19       a type of myocardial ischemia, often caused by myocardial reperfusion%A%  
% 213.98/214.19  |- skos__historyNote mesh__D017682
% 213.98/214.19       Myocardial Reperfusion Injury %28%1989-1993%29%
% 213.98/214.19  |- mesh__dateCreated mesh__D017682 1993-06-02
% 213.98/214.19  |- skos__historyNote mesh__D017682 Myocardial Contraction %28%1984-1993%29%
% 213.98/214.19  |- mesh__recordAuthorizer mesh__D017682 sjn
% 213.98/214.19  |- skos__prefLabel mesh__D003662 Decision Theory
% 213.98/214.19  |- skos__broader mesh__D003662smesh__D003661
% 213.98/214.19  |- rdf__type mesh__D003662sskos__Concept
% 213.98/214.19  |- skos__annotation mesh__D003662 no qualif   
% 213.98/214.19  |- skos__hiddenLabel mesh__D003662 Theories, Decision
% 213.98/214.19  |- mesh__dateRevised mesh__D003662 2004-07-07
% 213.98/214.19  |- skos__scopeNote mesh__D003662
% 213.98/214.19       A theoretical technique utilizing a group of related constructs to describe or prescribe how individuals or groups of people choose a course of action when faced with several alternatives and a variable amount of knowledge about the determinants of the outcomes of those alternatives.%A%    
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D003662 2005
% 213.98/214.19  |- mesh__recordAuthorizer mesh__D003662 sjn
% 213.98/214.19  |- mesh__recordOriginator mesh__D003662 EC
% 213.98/214.19  |- mesh__historyNote mesh__D003662 80   
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D003662 2006
% 213.98/214.19  |- mesh__publicMeSHNote mesh__D003662 80   
% 213.98/214.19  |- skos__hiddenLabel mesh__D003662 Decision Theories
% 213.98/214.19  |- mesh__recordMaintainer mesh__D003662 jls
% 213.98/214.19  |- skos__hiddenLabel mesh__D003662 Theory, Decision
% 213.98/214.19  |- mesh__dateEstablished mesh__D003662 1980-01-01
% 213.98/214.19  |- mesh__dateCreated mesh__D003662 1979-05-31
% 213.98/214.19  |- skos__broader mesh__D008829Q000379smesh__D008829
% 213.98/214.19  |- mesh__preferredCombination mesh__D008829Q000379smesh__D008828
% 213.98/214.19  |- rdf__type mesh__D008829Q000379smesh__CompoundConcept
% 213.98/214.19  |- skos__related mesh__D041781smesh__D002780
% 213.98/214.19  |- skos__hiddenLabel mesh__D041781 Obstructive Jaundice
% 213.98/214.19  |- mesh__recordAuthorizer mesh__D041781 sjn
% 213.98/214.19  |- mesh__publicMeSHNote mesh__D041781 2004; see CHOLESTASIS 1980-2003   
% 213.98/214.19  |- skos__prefLabel mesh__D041781 Jaundice, Obstructive
% 213.98/214.19  |- mesh__historyNote mesh__D041781 2004; use CHOLESTASIS 1980-2003   
% 213.98/214.19  |- mesh__dateEstablished mesh__D041781 2004-01-01
% 213.98/214.19  |- skos__altLabel mesh__D041781 Jaundice, Mechanical
% 213.98/214.19  |- mesh__recordMaintainer mesh__D041781 lkt
% 213.98/214.19  |- skos__related mesh__D041781smesh__D002779
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D041781 2004
% 213.98/214.19  |- skos__scopeNote mesh__D041781
% 213.98/214.19       JAUNDICE, the condition with yellowish staining of the skin and mucous membranes, that is due to impaired BILE flow in the BILIARY TRACT, such as INTRAHEPATIC CHOLESTASIS, or EXTRAHEPATIC CHOLESTASIS.%A%    
% 213.98/214.19  |- mesh__dateCreated mesh__D041781 2003-07-09
% 213.98/214.19  |- mesh__recordOriginator mesh__D041781 lkt
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D041781 2006
% 213.98/214.19  |- skos__related mesh__D041781smesh__D001651
% 213.98/214.19  |- skos__historyNote mesh__D041781 Cholestasis %28%1965-2003%29%
% 213.98/214.19  |- skos__broader mesh__D041781smesh__D007565
% 213.98/214.19  |- skos__hiddenLabel mesh__D041781 Cholestatic Jaundice
% 213.98/214.19  |- rdf__type mesh__D041781sskos__Concept
% 213.98/214.19  |- skos__altLabel mesh__D041781 Jaundice, Cholestatic
% 213.98/214.19  |- skos__hiddenLabel mesh__D041781 Mechanical Jaundice
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D041781 2005
% 213.98/214.19  |- skos__historyNote mesh__D013292 Streptococcus %28%1966-1971%29%
% 213.98/214.19  |- mesh__recordOriginator mesh__D013292 NLM
% 213.98/214.19  |- mesh__dateRevised mesh__D013292 2005-06-30
% 213.98/214.19  |- mesh__historyNote mesh__D013292 74%28%72%29%   
% 213.98/214.19  |- rdf__type mesh__D013292sskos__Concept
% 213.98/214.19  |- skos__altLabel mesh__D013292 Streptococcus Group B
% 213.98/214.19  |- skos__scopeNote mesh__D013292
% 213.98/214.19       A bacterium which causes mastitis in cattle and occasionally in man.%A%    
% 213.98/214.19  |- mesh__recordMaintainer mesh__D013292 SYSTEM
% 213.98/214.19  |- mesh__recordAuthorizer mesh__D013292 sjn
% 213.98/214.19  |- skos__broader mesh__D013292smesh__D013291
% 213.98/214.19  |- skos__annotation mesh__D013292
% 213.98/214.19       infection: coord IM with STREPTOCOCCAL INFECTIONS %28%IM%29%; DF: STREP AGALACTIAE%A%  
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D013292 2006
% 213.98/214.19  |- mesh__publicMeSHNote mesh__D013292 74   
% 213.98/214.19  |- mesh__dateCreated mesh__D013292 1999-01-01
% 213.98/214.19  |- skos__prefLabel mesh__D013292 Streptococcus agalactiae
% 213.98/214.19  |- mesh__dateEstablished mesh__D013292 1974-01-01
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007255 2006
% 213.98/214.19  |- mesh__recordOriginator mesh__D007255 NLM
% 213.98/214.19  |- mesh__historyNote mesh__D007255 66   
% 213.98/214.19  |- skos__hiddenLabel mesh__D007255 Information Network
% 213.98/214.19  |- skos__broader mesh__D007255smesh__D007254
% 213.98/214.19  |- skos__prefLabel mesh__D007255 Information Services
% 213.98/214.19  |- skos__annotation mesh__D007255
% 213.98/214.19       med inform serv: do not coord with MEDICINE; DRUG INFORMATION SERVICES is available; DF: INFORMATION SERV%A%  
% 213.98/214.19  |- skos__hiddenLabel mesh__D007255 Networks, Information
% 213.98/214.19  |- skos__hiddenLabel mesh__D007255 Information Specialist
% 213.98/214.19  |- mesh__publicMeSHNote mesh__D007255 66   
% 213.98/214.19  |- mesh__dateRevised mesh__D007255 2002-07-03
% 213.98/214.19  |- mesh__dateEstablished mesh__D007255 1966-01-01
% 213.98/214.19  |- skos__hiddenLabel mesh__D007255 Specialists, Information
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007255 2003
% 213.98/214.19  |- mesh__recordAuthorizer mesh__D007255 sjn
% 213.98/214.19  |- rdf__type mesh__D007255sskos__Concept
% 213.98/214.19  |- skos__related mesh__D007255smesh__D007990
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007255 2004
% 213.98/214.19  |- mesh__recordMaintainer mesh__D007255 jrf
% 213.98/214.19  |- skos__scopeNote mesh__D007255
% 213.98/214.19       Organized services to provide information on any questions an individual might have using databases and other sources. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 213.98/214.19  |- skos__related mesh__D007255smesh__D033181
% 213.98/214.19  |- skos__hiddenLabel mesh__D007255 Network, Information
% 213.98/214.19  |- skos__hiddenLabel mesh__D007255 Information Service
% 213.98/214.19  |- skos__hiddenLabel mesh__D007255 Specialist, Information
% 213.98/214.19  |- skos__altLabel mesh__D007255 Services, Information
% 213.98/214.19  |- skos__hiddenLabel mesh__D007255 Service, Information
% 213.98/214.19  |- mesh__dateCreated mesh__D007255 1999-01-01
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D007255 2005
% 213.98/214.19  |- skos__prefLabel mesh__D012998 Somalia
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D012998 2002
% 213.98/214.19  |- mesh__recordAuthorizer mesh__D012998 PLS
% 213.98/214.19  |- mesh__activeMeSHYear mesh__D012998 2006
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D012998 1998
% 213.98/214.20  |- mesh__dateRevised mesh__D012998 1995-02-21
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D012998 2003
% 213.98/214.20  |- skos__broader mesh__D012998smesh__D000351
% 213.98/214.20  |- mesh__dateCreated mesh__D012998 1999-01-01
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D012998 2000
% 213.98/214.20  |- mesh__recordMaintainer mesh__D012998 TGC
% 213.98/214.20  |- rdf__type mesh__D012998sskos__Concept
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D012998 1999
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D012998 2004
% 213.98/214.20  |- skos__annotation mesh__D012998
% 213.98/214.20       a republic in eastern Africa at the Gulf of Aden %26% Indian Ocean%A%  
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D012998 1996
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D012998 2001
% 213.98/214.20  |- mesh__recordOriginator mesh__D012998 NLM
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D012998 1997
% 213.98/214.20  |- skos__scopeNote mesh__D012998
% 213.98/214.20       A republic in eastern Africa bounded by the Gulf of Aden and the Indian Ocean. Its capital is Mogadishu. In 1960 it was constituted as an independent republic by the union of British Somaliland with the Trust Territory of Somalia %28%formerly Italian Somaliland%29%, both flourishing in the 19th century. Many derivations are posed for its name taken from the indigenous people: from a Cushitic word meaning dark or black with reference to their skin; from soo mal, a local phrase meaning go and milk with reference to the hospitable people offering milk to guests; from the name of a tribal chieftain; or from the Arabic zamla, cattle, with reference to the many herds there. %28%From Webster%27%s New Geographical Dictionary, 1988, p1130 %26% Room, Brewer%27%s Dictionary of Names, 1992, p512%29%%A%    
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D012998 2005
% 213.98/214.20  |- mesh__dateRevised mesh__D017683 2003-07-09
% 213.98/214.20  |- mesh__historyNote mesh__D017683 94; was see SALMON 1987-93   
% 213.98/214.20  |- mesh__publicMeSHNote mesh__D017683 94; was see SALMON 1987-93   
% 213.98/214.20  |- skos__prefLabel mesh__D017683 Oncorhynchus
% 213.98/214.20  |- skos__annotation mesh__D017683
% 213.98/214.20       GEN or unspecified; prefer specifics; salmon %26% trout belong to this genus; check specific ONCORHYNCHUS headings, their X refs %26% text carefully; IM; qualif permitted%A%  
% 213.98/214.20  |- mesh__dateCreated mesh__D017683 1992-12-28
% 213.98/214.20  |- mesh__recordAuthorizer mesh__D017683 sjn
% 213.98/214.20  |- skos__historyNote mesh__D017683 Salmonidae %28%1968-1972%29%
% 213.98/214.20  |- mesh__dateEstablished mesh__D017683 1994-01-01
% 213.98/214.20  |- rdf__type mesh__D017683sskos__Concept
% 213.98/214.20  |- mesh__recordMaintainer mesh__D017683 ags
% 213.98/214.20  |- skos__historyNote mesh__D017683 Salmon %28%1973-1993%29%
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D017683 2006
% 213.98/214.20  |- skos__scopeNote mesh__D017683
% 213.98/214.20       A genus of the family SALMONIDAE %28%salmons and trouts%29%. They are named for their hooked %28%onco%29% nose %28%rhynchus%29%. They are usually anadromous and occasionally inhabit freshwater. They can be found in North Pacific coastal areas from Japan to California and adjacent parts of the Arctic Ocean. Salmon and trout are popular game and food fish. Various species figure heavily in genetic, metabolism, and hormone research.%A%    
% 213.98/214.20  |- skos__broader mesh__D017683smesh__D014337
% 213.98/214.20  |- skos__historyNote mesh__D017683 Fishes %28%1966-1967%29%
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D017683 2004
% 213.98/214.20  |- mesh__onlineNote mesh__D017683
% 213.98/214.20       use SALMON to search ONCORHYNCHUS 1987-93   
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D017683 2005
% 213.98/214.20  |- mesh__recordOriginator mesh__D017683 TGC
% 213.98/214.20  |- skos__broader mesh__D017683smesh__D012474
% 213.98/214.20  |- mesh__dateRevised mesh__D003663 2004-07-07
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D003663 2005
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D003663 2006
% 213.98/214.20  |- mesh__dateEstablished mesh__D003663 1988-01-01
% 213.98/214.20  |- skos__broader mesh__D003663smesh__D003662
% 213.98/214.20  |- mesh__dateCreated mesh__D003663 1987-04-06
% 213.98/214.20  |- mesh__publicMeSHNote mesh__D003663 88   
% 213.98/214.20  |- mesh__recordAuthorizer mesh__D003663 sjn
% 213.98/214.20  |- skos__scopeNote mesh__D003663
% 213.98/214.20       A graphic device used in decision analysis, series of decision options are represented as branches %28%hierarchical%29%.%A%    
% 213.98/214.20  |- skos__prefLabel mesh__D003663 Decision Trees
% 213.98/214.20  |- mesh__recordOriginator mesh__D003663 EC
% 213.98/214.20  |- skos__hiddenLabel mesh__D003663 Tree, Decision
% 213.98/214.20  |- skos__hiddenLabel mesh__D003663 Decision Tree
% 213.98/214.20  |- skos__broader mesh__D003663smesh__D003661
% 213.98/214.20  |- skos__hiddenLabel mesh__D003663 Trees, Decision
% 213.98/214.20  |- rdf__type mesh__D003663sskos__Concept
% 213.98/214.20  |- mesh__historyNote mesh__D003663 88   
% 213.98/214.20  |- skos__annotation mesh__D003663 no qualif   
% 213.98/214.20  |- mesh__recordMaintainer mesh__D003663 jls
% 213.98/214.20  |- skos__scopeNote mesh__D013293
% 213.98/214.20       A species of gram-positive, coccoid bacteria commonly isolated from clinical specimens and the human intestinal tract. Most strains are nonhemolytic.%A%    
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D013293 2006
% 213.98/214.20  |- mesh__recordMaintainer mesh__D013293 SYSTEM
% 213.98/214.20  |- skos__altLabel mesh__D013293 Streptococcus faecalis
% 213.98/214.20  |- mesh__dateCreated mesh__D013293 1999-01-01
% 213.98/214.20  |- mesh__historyNote mesh__D013293
% 213.98/214.20       92; was STREPTOCOCCUS FAECALIS 1963-91   
% 213.98/214.20  |- mesh__recordOriginator mesh__D013293 NLM
% 213.98/214.20  |- skos__altLabel mesh__D013293 Streptococcus Group D
% 213.98/214.20  |- mesh__dateRevised mesh__D013293 2005-06-30
% 213.98/214.20  |- mesh__publicMeSHNote mesh__D013293
% 213.98/214.20       92; was STREPTOCOCCUS FAECALIS 1963-91   
% 213.98/214.20  |- mesh__onlineNote mesh__D013293
% 213.98/214.20       use ENTEROCOCCUS FAECALIS to search STREPTOCOCCUS FAECALIS 1966-91%A%  
% 213.98/214.20  |- skos__annotation mesh__D013293
% 213.98/214.20       infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS %28%IM%29%; do not confuse with ENTEROCOCCUS FAECIUM%A%  
% 213.98/214.20  |- skos__broader mesh__D013293smesh__D016983
% 213.98/214.20  |- rdf__type mesh__D013293sskos__Concept
% 213.98/214.20  |- skos__prefLabel mesh__D013293 Enterococcus faecalis
% 213.98/214.20  |- mesh__recordAuthorizer mesh__D013293 sjn
% 213.98/214.20  |- skos__broader mesh__D015510Q000941smesh__D015510
% 213.98/214.20  |- mesh__preferredCombination mesh__D015510Q000941smesh__D026690
% 213.98/214.20  |- rdf__type mesh__D015510Q000941smesh__CompoundConcept
% 213.98/214.20  |- mesh__recordAuthorizer mesh__D007256 SJN
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D007256 2002
% 213.98/214.20  |- skos__broader mesh__D007256smesh__D008491
% 213.98/214.20  |- skos__hiddenLabel mesh__D007256 Systems, Information
% 213.98/214.20  |- skos__hiddenLabel mesh__D007256 Information Retrieval System
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D007256 2006
% 213.98/214.20  |- skos__scopeNote mesh__D007256
% 213.98/214.20       Integrated set of files, procedures, and equipment for the storage, manipulation, and retrieval of information.%A%    
% 213.98/214.20  |- skos__hiddenLabel mesh__D007256 Ancillary Information System
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D007256 2001
% 213.98/214.20  |- mesh__dateRevised mesh__D007256 1997-06-20
% 213.98/214.20  |- mesh__onlineNote mesh__D007256
% 213.98/214.20       use INFORMATION SYSTEMS to search INFORMATION RETRIEVAL SYSTEMS 1966-81; use EMERGENCY MEDICAL SERVICE COMMUNICATION SYSTEMS to search EMERGENCY CARE INFORMATION SYSTEMS 1987-91%A%  
% 213.98/214.20  |- skos__hiddenLabel mesh__D007256 Systems, Data
% 213.98/214.20  |- skos__hiddenLabel mesh__D007256 System, Ancillary Information
% 213.98/214.20  |- skos__hiddenLabel mesh__D007256 Information System, Ancillary
% 213.98/214.20  |- skos__hiddenLabel mesh__D007256 Data System
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D007256 2005
% 213.98/214.20  |- mesh__recordMaintainer mesh__D007256 JLS
% 213.98/214.20  |- skos__hiddenLabel mesh__D007256 Information System
% 213.98/214.20  |- mesh__recordOriginator mesh__D007256 NLM
% 213.98/214.20  |- skos__hiddenLabel mesh__D007256 System, Information Retrieval
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D007256 2000
% 213.98/214.20  |- skos__hiddenLabel mesh__D007256 Information Systems, Ancillary
% 213.98/214.20  |- skos__hiddenLabel mesh__D007256 Systems, Information Retrieval
% 213.98/214.20  |- skos__hiddenLabel mesh__D007256 Systems, Ancillary Information
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D007256 1999
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D007256 2004
% 213.98/214.20  |- skos__prefLabel mesh__D007256 Information Systems
% 213.98/214.20  |- mesh__historyNote mesh__D007256
% 213.98/214.20       82; was INFORMATION RETRIEVAL SYSTEMS 1966-81; EMERGENCY CARE INFORMATION SYSTEMS was see EMERGENCY MEDICAL SERVICE COMMUNICATION SYSTEMS 1987-91%A%  
% 213.98/214.20  |- skos__hiddenLabel mesh__D007256 System, Data
% 213.98/214.20  |- mesh__dateCreated mesh__D007256 1999-01-01
% 213.98/214.20  |- rdf__type mesh__D007256sskos__Concept
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D007256 1998
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D007256 2003
% 213.98/214.20  |- skos__hiddenLabel mesh__D007256 System, Information
% 213.98/214.20  |- mesh__dateEstablished mesh__D007256 1966-01-01
% 213.98/214.20  |- skos__annotation mesh__D007256
% 213.98/214.20       for automated systems do not coord with AUTOMATIC DATA PROCESSING; for medical information systems do not coord with MEDICINE%A%  
% 213.98/214.20  |- mesh__publicMeSHNote mesh__D007256
% 213.98/214.20       82; was INFORMATION RETRIEVAL SYSTEMS 1966-81; EMERGENCY CARE INFORMATION SYSTEMS was see EMERGENCY MEDICAL SERVICE COMMUNICATION SYSTEMS 1987-91%A%  
% 213.98/214.20  |- mesh__recordOriginator mesh__D012999 NLM
% 213.98/214.20  |- mesh__dateRevised mesh__D012999 2000-06-22
% 213.98/214.20  |- skos__hiddenLabel mesh__D012999 Methylphosphonofluoridate, Pinacolyl
% 213.98/214.20  |- mesh__dateEstablished mesh__D012999 1986-01-01
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D012999 2001
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D012999 2006
% 213.98/214.20  |- skos__altLabel mesh__D012999 Pinacolyl Methylphosphonofluoridate
% 213.98/214.20  |- skos__historyNote mesh__D012999 Organophosphorus Compounds %28%1971%29%
% 213.98/214.20  |- skos__historyNote mesh__D012999
% 213.98/214.20       Cholinesterase Inhibitors %28%1966-1971%29%
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D012999 2004
% 213.98/214.20  |- mesh__recordAuthorizer mesh__D012999 sjn
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D012999 2005
% 213.98/214.20  |- mesh__historyNote mesh__D012999
% 213.98/214.20       86%28%72%29%; was see under ORGANOPHOSPHORUS COMPOUNDS 1975-85, was Prov 1972-74%A%  
% 213.98/214.20  |- rdf__type mesh__D012999sskos__Concept
% 213.98/214.20  |- mesh__dateCreated mesh__D012999 1999-01-01
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D012999 2003
% 213.98/214.20  |- skos__broader mesh__D012999smesh__D009943
% 213.98/214.20  |- skos__prefLabel mesh__D012999 Soman
% 213.98/214.20  |- mesh__recordMaintainer mesh__D012999 CCR
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D012999 2002
% 213.98/214.20  |- mesh__publicMeSHNote mesh__D012999
% 213.98/214.20       86; was see under ORGANOPHOSPHORUS COMPOUNDS 1972-85   
% 213.98/214.20  |- skos__scopeNote mesh__D012999
% 213.98/214.20       An organophosphorus compound that inhibits cholinesterase. It causes seizures and has been used as a chemical warfare agent.%A%    
% 213.98/214.20  |- mesh__dateCreated mesh__D017684 1992-12-28
% 213.98/214.20  |- skos__historyNote mesh__D017684 Salmon %28%1972-1993%29%
% 213.98/214.20  |- skos__annotation mesh__D017684 a salmon; IM; qualif permitted   
% 213.98/214.20  |- mesh__recordOriginator mesh__D017684 TGC
% 213.98/214.20  |- skos__prefLabel mesh__D017684 Oncorhynchus kisutch
% 213.98/214.20  |- mesh__recordMaintainer mesh__D017684 ags
% 213.98/214.20  |- skos__scopeNote mesh__D017684
% 213.98/214.20       An anadromous species of SALMON ranging from the Arctic and Pacific Oceans to Monterey Bay, California and inhabiting ocean and coastal streams. It is familiarly known as the coho or silver salmon. It is relatively small but its light-colored flesh is of good flavor.%A%    
% 213.98/214.20  |- rdf__type mesh__D017684sskos__Concept
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D017684 2006
% 213.98/214.20  |- skos__historyNote mesh__D017684 Fishes %28%1966-1967%29%
% 213.98/214.20  |- skos__hiddenLabel mesh__D017684 Coho Salmon
% 213.98/214.20  |- skos__hiddenLabel mesh__D017684 Silver Salmon
% 213.98/214.20  |- skos__altLabel mesh__D017684 Salmon, Coho
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D017684 2005
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D017684 2004
% 213.98/214.20  |- mesh__dateEstablished mesh__D017684 1994-01-01
% 213.98/214.20  |- mesh__recordAuthorizer mesh__D017684 sjn
% 213.98/214.20  |- skos__altLabel mesh__D017684 Salmon, Silver
% 213.98/214.20  |- mesh__publicMeSHNote mesh__D017684 94   
% 213.98/214.20  |- skos__historyNote mesh__D017684 Salmonidae %28%1968-1971%29%
% 213.98/214.20  |- mesh__dateRevised mesh__D017684 2003-07-09
% 213.98/214.20  |- skos__broader mesh__D017684smesh__D017683
% 213.98/214.20  |- mesh__historyNote mesh__D017684 94   
% 213.98/214.20  |- skos__prefLabel mesh__D003664 Decompression
% 213.98/214.20  |- rdf__type mesh__D003664sskos__Concept
% 213.98/214.20  |- mesh__recordOriginator mesh__D003664 NLM
% 213.98/214.20  |- mesh__recordMaintainer mesh__D003664 lkt
% 213.98/214.20  |- mesh__dateRevised mesh__D003664 2005-06-30
% 213.98/214.20  |- skos__scopeNote mesh__D003664
% 213.98/214.20       Decompression external to the body, most often the slow lessening of external pressure on the whole body %28%especially in caisson workers, deep sea divers, and persons who ascend to great heights%29% to prevent DECOMPRESSION SICKNESS. It includes also sudden accidental decompression, but not surgical %28%local%29% decompression or decompression applied through body openings.%A%    
% 213.98/214.20  |- mesh__publicMeSHNote mesh__D003664 80; see PRESSURE 1975-79   
% 213.98/214.20  |- skos__broader mesh__D003664smesh__D013812
% 213.98/214.20  |- skos__broader mesh__D003664smesh__D011312
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D003664 2006
% 213.98/214.20  |- mesh__dateEstablished mesh__D003664 1980-01-01
% 213.98/214.20  |- skos__annotation mesh__D003664
% 213.98/214.20       restrict to %22%decompression external to the body%22%: not for surg decompression %28% = DECOMPRESSION, SURGICAL%29%%A%  
% 213.98/214.20  |- mesh__historyNote mesh__D003664 80%28%75%29%   
% 213.98/214.20  |- mesh__recordAuthorizer mesh__D003664 sjn
% 213.98/214.20  |- mesh__dateCreated mesh__D003664 1974-11-11
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D013294 2006
% 213.98/214.20  |- mesh__recordMaintainer mesh__D013294 SYSTEM
% 213.98/214.20  |- skos__scopeNote mesh__D013294
% 213.98/214.20       A non-pathogenic species of LACTOCOCCUS found in DAIRY PRODUCTS and responsible for the souring of MILK and the production of LACTIC ACID.%A%    
% 213.98/214.20  |- mesh__recordAuthorizer mesh__D013294 sjn
% 213.98/214.20  |- mesh__dateCreated mesh__D013294 1999-01-01
% 213.98/214.20  |- skos__altLabel mesh__D013294 Streptococcus lactis
% 213.98/214.20  |- mesh__dateEstablished mesh__D013294 1974-01-01
% 213.98/214.20  |- mesh__publicMeSHNote mesh__D013294
% 213.98/214.20       92; was STREPTOCOCCUS LACTIS 1974-91   
% 213.98/214.20  |- skos__historyNote mesh__D013294 Streptococcus %28%1966-1971%29%
% 213.98/214.20  |- skos__prefLabel mesh__D013294 Lactococcus lactis
% 213.98/214.20  |- mesh__historyNote mesh__D013294
% 213.98/214.20       92%28%72%29%; was STREPTOCOCCUS LACTIS 1972-91 %28%Prov 1972-73%29%   
% 213.98/214.20  |- skos__broader mesh__D013294smesh__D017045
% 213.98/214.20  |- mesh__recordOriginator mesh__D013294 NLM
% 213.98/214.20  |- rdf__type mesh__D013294sskos__Concept
% 213.98/214.20  |- mesh__dateRevised mesh__D013294 2005-06-30
% 213.98/214.20  |- mesh__onlineNote mesh__D013294
% 213.98/214.20       use LACTOCOCCUS LACTIS to search STREPTOCOCCUS LACTIS 1972-91 %28%as Prov 1972-73%29%%A%  
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D007257 2006
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D007257 2005
% 213.98/214.20  |- skos__hiddenLabel mesh__D007257 Information Theories
% 213.98/214.20  |- mesh__recordAuthorizer mesh__D007257 SJN
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D007257 2002
% 213.98/214.20  |- mesh__publicMeSHNote mesh__D007257 65   
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D007257 1999
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D007257 2004
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D007257 2001
% 213.98/214.20  |- mesh__dateRevised mesh__D007257 1997-06-20
% 213.98/214.20  |- mesh__dateCreated mesh__D007257 1999-01-01
% 213.98/214.20  |- rdf__type mesh__D007257sskos__Concept
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D007257 1998
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D007257 2003
% 213.98/214.20  |- skos__hiddenLabel mesh__D007257 Theories, Information
% 213.98/214.20  |- mesh__recordOriginator mesh__D007257 NLM
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D007257 2000
% 213.98/214.20  |- mesh__dateEstablished mesh__D007257 1965-01-01
% 213.98/214.20  |- skos__hiddenLabel mesh__D007257 Theory, Information
% 213.98/214.20  |- skos__broader mesh__D007257smesh__D007254
% 213.98/214.20  |- skos__scopeNote mesh__D007257
% 213.98/214.20       An interdisciplinary study dealing with the transmission of messages or signals, or the communication of information. Information theory does not directly deal with meaning or content, but with physical representations that have meaning or content. It overlaps considerably with communication theory and CYBERNETICS.%A%    
% 213.98/214.20  |- skos__prefLabel mesh__D007257 Information Theory
% 213.98/214.20  |- mesh__historyNote mesh__D007257 65%28%64%29%   
% 213.98/214.20  |- mesh__recordMaintainer mesh__D007257 PXP
% 213.98/214.20  |- mesh__recordAuthorizer mesh__D017685 sjn
% 213.98/214.20  |- skos__historyNote mesh__D017685 Fishes %28%1966-1967%29%
% 213.98/214.20  |- skos__hiddenLabel mesh__D017685 Chum Salmon
% 213.98/214.20  |- mesh__publicMeSHNote mesh__D017685 94   
% 213.98/214.20  |- mesh__recordMaintainer mesh__D017685 ags
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D017685 2005
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D017685 2004
% 213.98/214.20  |- mesh__dateRevised mesh__D017685 2003-07-09
% 213.98/214.20  |- mesh__historyNote mesh__D017685 94   
% 213.98/214.20  |- skos__historyNote mesh__D017685 Salmon %28%1972-1993%29%
% 213.98/214.20  |- skos__historyNote mesh__D017685 Salmonidae %28%1968-1971%29%
% 213.98/214.20  |- mesh__recordOriginator mesh__D017685 TGC
% 213.98/214.20  |- skos__altLabel mesh__D017685 Salmon, Chum
% 213.98/214.20  |- skos__scopeNote mesh__D017685
% 213.98/214.20       An anadromous species of SALMON found in the streams of the Pacific coast from Sacramento north, and also common in Japan. It is used frequently in genetic and other medical research.%A%    
% 213.98/214.20  |- skos__altLabel mesh__D017685 Salmon, Dog
% 213.98/214.20  |- mesh__dateCreated mesh__D017685 1992-12-28
% 213.98/214.20  |- skos__annotation mesh__D017685 a salmon; IM; qualif permitted   
% 213.98/214.20  |- skos__prefLabel mesh__D017685 Oncorhynchus keta
% 213.98/214.20  |- mesh__dateEstablished mesh__D017685 1994-01-01
% 213.98/214.20  |- skos__hiddenLabel mesh__D017685 Dog Salmon
% 213.98/214.20  |- skos__broader mesh__D017685smesh__D017683
% 213.98/214.20  |- rdf__type mesh__D017685sskos__Concept
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D017685 2006
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D003665 2004
% 213.98/214.20  |- mesh__recordMaintainer mesh__D003665 ags
% 213.98/214.20  |- skos__hiddenLabel mesh__D003665 Caisson Diseases
% 213.98/214.20  |- skos__scopeNote mesh__D003665
% 213.98/214.20       A condition occurring as a result of exposure to a rapid fall in ambient pressure. Gases, nitrogen in particular, come out of solution and form bubbles in body fluid and blood. These gas bubbles accumulate in joint spaces and the peripheral circulation impairing tissue oxygenation causing disorientation, severe pain, and potentially death.%A%    
% 213.98/214.20  |- skos__prefLabel mesh__D003665 Decompression Sickness
% 213.98/214.20  |- mesh__dateRevised mesh__D003665 1999-11-24
% 213.98/214.20  |- skos__broader mesh__D003665smesh__D001469
% 213.98/214.20  |- skos__altLabel mesh__D003665 Bends
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D003665 2003
% 213.98/214.20  |- mesh__recordOriginator mesh__D003665 NLM
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D003665 2001
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D003665 2006
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D003665 2000
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D003665 2005
% 213.98/214.20  |- skos__hiddenLabel mesh__D003665 Disease, Caisson
% 213.98/214.20  |- skos__hiddenLabel mesh__D003665 Sickness, Decompression
% 213.98/214.20  |- mesh__recordAuthorizer mesh__D003665 ags
% 213.98/214.20  |- skos__hiddenLabel mesh__D003665 Diseases, Caisson
% 213.98/214.20  |- skos__altLabel mesh__D003665 Caisson Disease
% 213.98/214.20  |- rdf__type mesh__D003665sskos__Concept
% 213.98/214.20  |- mesh__dateCreated mesh__D003665 1999-01-01
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D003665 2002
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D003665 2000A
% 213.98/214.20  |- mesh__recordMaintainer mesh__D008350 TGC
% 213.98/214.20  |- skos__broader mesh__D008350smesh__D002170
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D008350 2002
% 213.98/214.20  |- mesh__dateCreated mesh__D008350 1999-01-01
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D008350 2004
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D008350 1997
% 213.98/214.20  |- mesh__dateRevised mesh__D008350 1995-02-21
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D008350 2003
% 213.98/214.20  |- skos__annotation mesh__D008350 a province of Canada   
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D008350 1996
% 213.98/214.20  |- mesh__recordAuthorizer mesh__D008350 PLS
% 213.98/214.20  |- mesh__recordOriginator mesh__D008350 NLM
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D008350 2001
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D008350 2006
% 213.98/214.20  |- skos__prefLabel mesh__D008350 Manitoba
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D008350 1999
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D008350 2000
% 213.98/214.20  |- skos__scopeNote mesh__D008350
% 213.98/214.20       A province of Canada, lying between the provinces of Saskatchewan and Ontario. Its capital is Winnipeg. Taking its name from Lake Manitoba, itself named for one of its islands, the name derived from Algonquian Manitou, great spirit. %28%From Webster%27%s New Geographical Dictionary, 1988, p724 %26% Room, Brewer%27%s Dictionary of Names, 1992, p332%29%%A%    
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D008350 2005
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D008350 1998
% 213.98/214.20  |- rdf__type mesh__D008350sskos__Concept
% 213.98/214.20  |- skos__altLabel mesh__D022021 FK506 Binding Protein
% 213.98/214.20  |- mesh__recordAuthorizer mesh__D022021 sjn
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D022021 2004
% 213.98/214.20  |- skos__hiddenLabel mesh__D022021 Protein, FK-506-Binding
% 213.98/214.20  |- mesh__dateEstablished mesh__D022021 2001-01-01
% 213.98/214.20  |- skos__altLabel mesh__D022021 FK506-Binding Protein
% 213.98/214.20  |- skos__historyNote mesh__D022021 Carrier Proteins %28%1991-1998%29%
% 213.98/214.20  |- skos__historyNote mesh__D022021 Immunophilins %28%1999-2000%29%
% 213.98/214.20  |- skos__prefLabel mesh__D022021 Tacrolimus Binding Proteins
% 213.98/214.20  |- skos__altLabel mesh__D022021 FK506 Binding Proteins
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D022021 2006
% 213.98/214.20  |- skos__historyNote mesh__D022021 Heat-Shock Proteins %28%1991-1998%29%
% 213.98/214.20  |- mesh__recordOriginator mesh__D022021 jmp
% 213.98/214.20  |- mesh__recordMaintainer mesh__D022021 jmp
% 213.98/214.20  |- skos__altLabel mesh__D022021 FK-506-Binding Protein
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D022021 2005
% 213.98/214.20  |- skos__scopeNote mesh__D022021
% 213.98/214.20       A family of immunophilin proteins that bind to the immunosuppressive drugs TACROLIMUS %28%also known as FK506%29% and SIROLIMUS. EC 5.2.1.-%A%    
% 213.98/214.20  |- skos__altLabel mesh__D022021 FKBP Rotamase
% 213.98/214.20  |- mesh__publicMeSHNote mesh__D022021
% 213.98/214.20       2001; FK 506 BINDING PROTEIN %28%now TACROLIMUS BINDING PROTEINS%29% was indexed under IMMUNOPHILINS 1999-2000 %26% under CARRIER PROTEINS, DNA-BINDING PROTEINS, %26% HEAT SHOCK PROTEINS 1991-1998%A%  
% 213.98/214.20  |- rdf__type mesh__D022021sskos__Concept
% 213.98/214.20  |- skos__hiddenLabel mesh__D022021 Proteins, Rapamycin-Binding
% 213.98/214.20  |- skos__broader mesh__D022021smesh__D020104
% 213.98/214.20  |- mesh__dateRevised mesh__D022021 2003-07-09
% 213.98/214.20  |- skos__historyNote mesh__D022021 DNA-Binding Proteins %28%1991-1998%29%
% 213.98/214.20  |- skos__hiddenLabel mesh__D022021 Binding Proteins, Rapamycin
% 213.98/214.20  |- mesh__dateCreated mesh__D022021 2000-06-22
% 213.98/214.20  |- skos__hiddenLabel mesh__D022021 Rotamase, FKBP
% 213.98/214.20  |- skos__hiddenLabel mesh__D022021 Protein, FK506-Binding
% 213.98/214.20  |- mesh__historyNote mesh__D022021
% 213.98/214.20       2001; use TACROLIMUS BINDING PROTEINS %28%NM%29% 1991-2000   
% 213.98/214.20  |- skos__altLabel mesh__D022021 Rapamycin-Binding Proteins
% 213.98/214.20  |- skos__hiddenLabel mesh__D022021 FK 506 Binding Protein
% 213.98/214.20  |- skos__altLabel mesh__D022021 FKBP
% 213.98/214.20  |- skos__broader mesh__D002248Q000506smesh__D002248
% 213.98/214.20  |- mesh__preferredCombination mesh__D002248Q000506smesh__D002249
% 213.98/214.20  |- rdf__type mesh__D002248Q000506smesh__CompoundConcept
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D013295 2006
% 213.98/214.20  |- mesh__recordOriginator mesh__D013295 JW
% 213.98/214.20  |- skos__broader mesh__D013295smesh__D034363
% 213.98/214.20  |- skos__historyNote mesh__D013295 Streptococcus %28%1966-1975%29%
% 213.98/214.20  |- mesh__dateEstablished mesh__D013295 1978-01-01
% 213.98/214.20  |- mesh__dateRevised mesh__D013295 2005-06-30
% 213.98/214.20  |- mesh__recordMaintainer mesh__D013295 SYSTEM
% 213.98/214.20  |- skos__prefLabel mesh__D013295 Streptococcus mutans
% 213.98/214.20  |- mesh__recordAuthorizer mesh__D013295 sjn
% 213.98/214.20  |- mesh__publicMeSHNote mesh__D013295
% 213.98/214.20       78; was see under STREPTOCOCCUS 1976-77   
% 213.98/214.20  |- skos__annotation mesh__D013295
% 213.98/214.20       found in dental plaque; DF: STREP MUTANS   
% 213.98/214.20  |- rdf__type mesh__D013295sskos__Concept
% 213.98/214.20  |- skos__scopeNote mesh__D013295
% 213.98/214.20       A polysaccharide-producing species of STREPTOCOCCUS isolated from human dental plaque.%A%    
% 213.98/214.20  |- mesh__dateCreated mesh__D013295 1975-07-21
% 213.98/214.20  |- mesh__historyNote mesh__D013295
% 213.98/214.20       78%28%76%29%; was see under STREPTOCOCCUS 1976-77   
% 213.98/214.20  |- skos__broader mesh__D007258smesh__D007603
% 213.98/214.20  |- skos__historyNote mesh__D007258
% 213.98/214.20       Physician-Patient Relations %28%1966-1970%29%
% 213.98/214.20  |- mesh__dateRevised mesh__D007258 2003-07-09
% 213.98/214.20  |- mesh__historyNote mesh__D007258 73%28%71%29%   
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D007258 2004
% 213.98/214.20  |- mesh__recordOriginator mesh__D007258 NLM
% 213.98/214.20  |- skos__related mesh__D007258smesh__D016312
% 213.98/214.20  |- skos__broader mesh__D007258smesh__D028701
% 213.98/214.20  |- mesh__dateCreated mesh__D007258 1999-01-01
% 213.98/214.20  |- skos__annotation mesh__D007258
% 213.98/214.20       competency to consent: coord IM with MENTAL COMPETENCY %28%IM%29%%A%  
% 213.98/214.20  |- rdf__type mesh__D007258sskos__Concept
% 213.98/214.20  |- skos__scopeNote mesh__D007258
% 213.98/214.20       Voluntary authorization, by a patient or research subject, with full comprehension of the risks involved, for diagnostic or investigative procedures, and for medical and surgical treatment.%A%    
% 213.98/214.20  |- skos__related mesh__D007258smesh__D030881
% 213.98/214.20  |- mesh__recordMaintainer mesh__D007258 jls
% 213.98/214.20  |- skos__hiddenLabel mesh__D007258 Consent, Informed
% 213.98/214.20  |- mesh__recordAuthorizer mesh__D007258 sjn
% 213.98/214.20  |- mesh__dateEstablished mesh__D007258 1973-01-01
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D007258 2006
% 213.98/214.20  |- mesh__publicMeSHNote mesh__D007258 73   
% 213.98/214.20  |- skos__prefLabel mesh__D007258 Informed Consent
% 213.98/214.20  |- skos__related mesh__D007258smesh__D016743
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D007258 2005
% 213.98/214.20  |- skos__historyNote mesh__D007258 Jurisprudence %28%1966-1970%29%
% 213.98/214.20  |- mesh__dateEstablished mesh__D017686 1994-01-01
% 213.98/214.20  |- skos__hiddenLabel mesh__D017686 Rainbow Trout
% 213.98/214.20  |- skos__broader mesh__D017686smesh__D017683
% 213.98/214.20  |- skos__historyNote mesh__D017686 Trout %28%1975-1993%29%
% 213.98/214.20  |- skos__historyNote mesh__D017686 Salmonidae %28%1968-1974%29%
% 213.98/214.20  |- mesh__dateRevised mesh__D017686 2003-07-09
% 213.98/214.20  |- skos__hiddenLabel mesh__D017686 Steelheads
% 213.98/214.20  |- mesh__recordAuthorizer mesh__D017686 sjn
% 213.98/214.20  |- mesh__historyNote mesh__D017686
% 213.98/214.20       94; SALMO GAIRDNERI was see TROUT 1987-93   
% 213.98/214.20  |- mesh__onlineNote mesh__D017686
% 213.98/214.20       use TROUT to search SALMO GAIRDNERI 1987-93   
% 213.98/214.20  |- mesh__publicMeSHNote mesh__D017686
% 213.98/214.20       94; SALMO GAIRDNERI was see TROUT 1987-93   
% 213.98/214.20  |- skos__annotation mesh__D017686
% 213.98/214.20       a trout; IM; qualif permitted; do not confuse X ref SALMO GAIRDNERI with SALMON%A%  
% 213.98/214.20  |- mesh__dateCreated mesh__D017686 1992-12-28
% 213.98/214.20  |- skos__altLabel mesh__D017686 Trout, Rainbow
% 213.98/214.20  |- skos__hiddenLabel mesh__D017686 Redband Trout
% 213.98/214.20  |- rdf__type mesh__D017686sskos__Concept
% 213.98/214.20  |- mesh__recordOriginator mesh__D017686 TGC
% 213.98/214.20  |- skos__altLabel mesh__D017686 Salmo gairdneri
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D017686 2006
% 213.98/214.20  |- skos__scopeNote mesh__D017686
% 213.98/214.20       A large stout-bodied, sometimes anadromous, TROUT found in still and flowing waters of the Pacific coast from southern California to Alaska. It has a greenish back, a whitish belly, and pink, red, or lavender stripes on the sides, with usually a sprinkling of black dots. It is highly regarded as a sport and food fish. Its former name was Salmo gairdneri. The sea-run rainbow trouts are often called steelheads. Redband trouts refer to interior populations of rainbows.%A%    
% 213.98/214.20  |- mesh__recordMaintainer mesh__D017686 ags
% 213.98/214.20  |- skos__prefLabel mesh__D017686 Oncorhynchus mykiss
% 213.98/214.20  |- skos__historyNote mesh__D017686 Fishes %28%1966-1967%29%
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D017686 2005
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D017686 2004
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D003666 2005
% 213.98/214.20  |- mesh__recordMaintainer mesh__D003666 adp
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D003666 2002
% 213.98/214.20  |- skos__prefLabel mesh__D003666 Decontamination
% 213.98/214.20  |- rdf__type mesh__D003666sskos__Concept
% 213.98/214.20  |- skos__scopeNote mesh__D003666
% 213.98/214.20       The removal of contaminating material, such as radioactive materials, biological materials, or CHEMICAL WARFARE AGENTS, from a person or object.%A%    
% 213.98/214.20  |- mesh__dateCreated mesh__D003666 1999-01-01
% 213.98/214.20  |- mesh__recordAuthorizer mesh__D003666 sjn
% 213.98/214.20  |- skos__broader mesh__D003666smesh__D015980
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D003666 2004
% 213.98/214.20  |- mesh__recordOriginator mesh__D003666 NLM
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D003666 2001
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D003666 2003
% 213.98/214.20  |- mesh__dateRevised mesh__D003666 2000-06-22
% 213.98/214.20  |- mesh__activeMeSHYear mesh__D003666 2006
% 213.98/214.20  |- mesh__recordOriginator mesh__D008351 NLM
% 213.98/214.20  |- skos__altLabel mesh__D008351 Mannan
% 213.98/214.20  |- mesh__recordAuthorizer mesh__D008351 sjn
% 213.98/214.21  |- mesh__publicMeSHNote mesh__D008351
% 213.98/214.21       84; was see under POLYSACCHARIDES 1975-83   
% 213.98/214.21  |- mesh__recordMaintainer mesh__D008351 ssb
% 213.98/214.21  |- skos__historyNote mesh__D008351 Mannose %28%1971-1974%29%
% 213.98/214.21  |- mesh__dateEstablished mesh__D008351 1984-01-01
% 213.98/214.21  |- mesh__activeMeSHYear mesh__D008351 2006
% 213.98/214.21  |- skos__broader mesh__D008351smesh__D011134
% 213.98/214.21  |- mesh__activeMeSHYear mesh__D008351 2005
% 213.98/214.21  |- rdf__type mesh__D008351sskos__Concept
% 213.98/214.21  |- mesh__dateCreated mesh__D008351 1974-11-19
% 213.98/214.21  |- mesh__dateRevised mesh__D008351 2004-07-07
% 213.98/214.21  |- mesh__historyNote mesh__D008351
% 213.98/214.21       84%28%75%29%; was see under POLYSACCHARIDES 1975-83   
% 213.98/214.21  |- skos__historyNote mesh__D008351 Polysaccharides %28%1971-1974%29%
% 213.98/214.21  |- skos__prefLabel mesh__D008351 Mannans
% 213.98/214.21  |- skos__scopeNote mesh__D008351
% 213.98/214.21       Polysaccharides consisting of mannose units.     
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D022022 2005
% 214.07/214.21  |- rdf__type mesh__D022022sskos__Concept
% 214.07/214.21  |- skos__hiddenLabel mesh__D022022 Pore, Nuclear
% 214.07/214.21  |- mesh__historyNote mesh__D022022 2001; use NUCLEAR ENVELOPE 1977-2000   
% 214.07/214.21  |- skos__historyNote mesh__D022022 Nuclear Membrane %28%1977-2000%29%
% 214.07/214.21  |- mesh__dateRevised mesh__D022022 2003-07-09
% 214.07/214.21  |- skos__historyNote mesh__D022022 Cell Nucleus %28%1970-1976%29%
% 214.07/214.21  |- mesh__publicMeSHNote mesh__D022022
% 214.07/214.21       2001; see NUCLEAR MEMBRANE 1977-2000   
% 214.07/214.21  |- skos__hiddenLabel mesh__D022022 Pores, Nuclear
% 214.07/214.21  |- skos__hiddenLabel mesh__D022022 Nuclear Pores
% 214.07/214.21  |- skos__prefLabel mesh__D022022 Nuclear Pore
% 214.07/214.21  |- mesh__dateCreated mesh__D022022 2000-06-22
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D022022 2004
% 214.07/214.21  |- skos__scopeNote mesh__D022022
% 214.07/214.21       An opening through the NUCLEAR ENVELOPE formed by the nuclear pore complex which transports nuclear proteins or RNA into or out of the CELL NUCLEUS and which, under some conditions, acts as an ion channel.%A%    
% 214.07/214.21  |- mesh__dateEstablished mesh__D022022 2001-01-01
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D022022 2006
% 214.07/214.21  |- skos__broader mesh__D022022smesh__D009685
% 214.07/214.21  |- skos__annotation mesh__D013296
% 214.07/214.21       infection = PNEUMOCOCCAL INFECTIONS %26% do not coord with STREPTOCOCCUS PNEUMONIAE; consider also PNEUMONIA, PNEUMOCOCCAL; DF: STREP PNEUMONIAE%A%  
% 214.07/214.21  |- mesh__historyNote mesh__D013296
% 214.07/214.21       76; was DIPLOCOCCUS PNEUMONIAE 1963-75   
% 214.07/214.21  |- skos__related mesh__D013296smesh__D011008
% 214.07/214.21  |- mesh__recordMaintainer mesh__D013296 SYSTEM
% 214.07/214.21  |- mesh__onlineNote mesh__D013296
% 214.07/214.21       use STREPTOCOCCUS PNEUMONIAE to search DIPLOCOCCUS PNEUMONIAE 1966-75%A%  
% 214.07/214.21  |- mesh__recordOriginator mesh__D013296 JW
% 214.07/214.21  |- mesh__dateRevised mesh__D013296 2005-06-30
% 214.07/214.21  |- rdf__type mesh__D013296sskos__Concept
% 214.07/214.21  |- mesh__dateCreated mesh__D013296 1975-07-23
% 214.07/214.21  |- mesh__publicMeSHNote mesh__D013296
% 214.07/214.21       76; was DIPLOCOCCUS PNEUMONIAE 1963-75   
% 214.07/214.21  |- mesh__dateEstablished mesh__D013296 1976-01-01
% 214.07/214.21  |- skos__scopeNote mesh__D013296
% 214.07/214.21       A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals.%A%    
% 214.07/214.21  |- skos__broader mesh__D013296smesh__D013291
% 214.07/214.21  |- skos__altLabel mesh__D013296 Pneumococcus
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D013296 2006
% 214.07/214.21  |- skos__altLabel mesh__D013296 Diplococcus pneumoniae
% 214.07/214.21  |- mesh__recordAuthorizer mesh__D013296 sjn
% 214.07/214.21  |- skos__prefLabel mesh__D013296 Streptococcus pneumoniae
% 214.07/214.21  |- mesh__dateCreated mesh__D007259 1999-01-01
% 214.07/214.21  |- rdf__type mesh__D007259sskos__Concept
% 214.07/214.21  |- mesh__recordMaintainer mesh__D007259 TAP
% 214.07/214.21  |- skos__broader mesh__D007259smesh__D011840
% 214.07/214.21  |- skos__hiddenLabel mesh__D007259 Wave, Heat
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D007259 1998
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D007259 2003
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D007259 2001
% 214.07/214.21  |- skos__altLabel mesh__D007259 Heat Waves
% 214.07/214.21  |- skos__hiddenLabel mesh__D007259 Infrared Ray
% 214.07/214.21  |- mesh__recordAuthorizer mesh__D007259 PLS
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D007259 1997
% 214.07/214.21  |- mesh__recordOriginator mesh__D007259 NLM
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D007259 2000
% 214.07/214.21  |- skos__scopeNote mesh__D007259
% 214.07/214.21       That portion of the electromagnetic spectrum usually sensed as heat. Infrared wavelengths are longer than those of visible light, extending into the microwave frequencies. They are used therapeutically as heat, and also to warm food in restaurants.%A%    
% 214.07/214.21  |- skos__hiddenLabel mesh__D007259 Ray, Infrared
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D007259 2006
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D007259 2005
% 214.07/214.21  |- skos__prefLabel mesh__D007259 Infrared Rays
% 214.07/214.21  |- skos__hiddenLabel mesh__D007259 Heat Wave
% 214.07/214.21  |- skos__broader mesh__D007259smesh__D013472
% 214.07/214.21  |- skos__annotation mesh__D007259
% 214.07/214.21       non-ionizing; radiation policy: Manual 28.11+; black light goes here or under ULTRAVIOLET RAYS depending on text but unspecified index under ULTRAVIOLET RAYS%A%  
% 214.07/214.21  |- mesh__dateRevised mesh__D007259 1996-06-10
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D007259 1999
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D007259 2004
% 214.07/214.21  |- skos__hiddenLabel mesh__D007259 Waves, Heat
% 214.07/214.21  |- skos__hiddenLabel mesh__D007259 Rays, Infrared
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D007259 2002
% 214.07/214.21  |- skos__historyNote mesh__D017687 Lead %28%1981-1992%29%
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D017687 2002
% 214.07/214.21  |- skos__scopeNote mesh__D017687
% 214.07/214.21       Short-lived radioactive decay products of radon that include 216-Po, 214-Pb, 214-Bi, and 214-Po. They have an effective half-life of about 30 minutes and are solids that can deposit on the bronchial airways during inhalation and exhalation. This results in exposure of the respiratory airways to alpha radiation and can lead to diseases of the respiratory system, including lung cancer. %28%From Casarett and Doull%27%s Toxicology, 4th ed, p740%29%%A%    
% 214.07/214.21  |- mesh__dateRevised mesh__D017687 1995-06-08
% 214.07/214.21  |- mesh__recordMaintainer mesh__D017687 JRT
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D017687 1997
% 214.07/214.21  |- mesh__recordOriginator mesh__D017687 TPW
% 214.07/214.21  |- mesh__onlineNote mesh__D017687
% 214.07/214.21       use RADON DAUGHTERS %28%NM%29% to search RADON DAUGHTERS 1981-93%A%  
% 214.07/214.21  |- mesh__dateEstablished mesh__D017687 1994-01-01
% 214.07/214.21  |- mesh__historyNote mesh__D017687
% 214.07/214.21       94; was RADON DAUGHTERS %28%NM%29% 1981-93   
% 214.07/214.21  |- skos__historyNote mesh__D017687 Radon %28%1993%29%
% 214.07/214.21  |- mesh__recordAuthorizer mesh__D017687 PLS
% 214.07/214.21  |- skos__hiddenLabel mesh__D017687 Daughters, Thoron
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D017687 2005
% 214.07/214.21  |- mesh__publicMeSHNote mesh__D017687
% 214.07/214.21       94; RADON DAUGHTERS was indexed under RADON 1993 %26% BISMUTH, LEAD %26% POLONIUM 1981-92%A%  
% 214.07/214.21  |- skos__historyNote mesh__D017687 Polonium %28%1981-1992%29%
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D017687 2000
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D017687 1998
% 214.07/214.21  |- skos__annotation mesh__D017687
% 214.07/214.21       short-lived radioactive decay products of radon   
% 214.07/214.21  |- rdf__type mesh__D017687sskos__Concept
% 214.07/214.21  |- skos__broader mesh__D017687smesh__D011886
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D017687 2003
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D017687 2006
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D017687 2001
% 214.07/214.21  |- skos__historyNote mesh__D017687 Bismuth %28%1981-1992%29%
% 214.07/214.21  |- mesh__dateCreated mesh__D017687 1993-06-04
% 214.07/214.21  |- skos__prefLabel mesh__D017687 Radon Daughters
% 214.07/214.21  |- skos__hiddenLabel mesh__D017687 Daughters, Radon
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D017687 1996
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D017687 1999
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D017687 2004
% 214.07/214.21  |- skos__hiddenLabel mesh__D036841 Poisonings, Ciguatera
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D036841 2006
% 214.07/214.21  |- mesh__historyNote mesh__D036841 2003; see CIGUATOXINS 1978-2002   
% 214.07/214.21  |- mesh__publicMeSHNote mesh__D036841 2003; use CIGUATOXIN 1978-2002   
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D036841 2005
% 214.07/214.21  |- skos__hiddenLabel mesh__D036841 Poisoning, Ciguatera
% 214.07/214.21  |- mesh__dateEstablished mesh__D036841 2003-01-01
% 214.07/214.21  |- skos__hiddenLabel mesh__D036841 Ciguatera Poisonings
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D036841 2004
% 214.07/214.21  |- skos__prefLabel mesh__D036841 Ciguatera Poisoning
% 214.07/214.21  |- skos__scopeNote mesh__D036841
% 214.07/214.21       Poisoning caused by ingestion of SEAFOOD containing microgram levels of CIGUATOXINS.  The poisoning is characterized by gastrointestinal, neurological and cardiovascular disturbances.%A%    
% 214.07/214.21  |- skos__broader mesh__D036841smesh__D005517
% 214.07/214.21  |- rdf__type mesh__D036841sskos__Concept
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D036841 2003
% 214.07/214.21  |- skos__historyNote mesh__D036841 Ciguatoxins %28%1978-2002%29%
% 214.07/214.21  |- mesh__dateCreated mesh__D036841 2002-07-03
% 214.07/214.21  |- skos__altLabel mesh__D036841 Ciguatera
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D003667 2006
% 214.07/214.21  |- skos__historyNote mesh__D003667 Quinolines %28%1972-1974%29%
% 214.07/214.21  |- rdf__type mesh__D003667sskos__Concept
% 214.07/214.21  |- mesh__recordAuthorizer mesh__D003667 sjn
% 214.07/214.21  |- mesh__recordMaintainer mesh__D003667 exl
% 214.07/214.21  |- mesh__dateEstablished mesh__D003667 1991-01-01
% 214.07/214.21  |- skos__broader mesh__D003667smesh__D006912
% 214.07/214.21  |- mesh__recordOriginator mesh__D003667 NLM
% 214.07/214.21  |- mesh__publicMeSHNote mesh__D003667
% 214.07/214.21       91; was see under HYDROXYQUINOLINES 1975-90   
% 214.07/214.21  |- skos__historyNote mesh__D003667 Carboxylic Acids %28%1972-1974%29%
% 214.07/214.21  |- mesh__dateCreated mesh__D003667 1974-11-19
% 214.07/214.21  |- skos__prefLabel mesh__D003667 Decoquinate
% 214.07/214.21  |- skos__historyNote mesh__D003667 Ethers %28%1972-1974%29%
% 214.07/214.21  |- skos__scopeNote mesh__D003667 A coccidiostat for poultry.     
% 214.07/214.21  |- mesh__dateRevised mesh__D003667 2005-06-30
% 214.07/214.21  |- mesh__historyNote mesh__D003667
% 214.07/214.21       91%28%75%29%; was see under HYDROXYQUINOLINES 1975-90   
% 214.07/214.21  |- skos__altLabel mesh__D003667
% 214.07/214.21       Ethyl-6-%28%Decycloxy%29%-7-ethoxy-4-hydroxy-3-quinolinecarboxylate
% 214.07/214.21  |- skos__hiddenLabel mesh__D022821 Acceptor Site, Splice
% 214.07/214.21  |- mesh__dateEstablished mesh__D022821 2001-01-01
% 214.07/214.21  |- skos__hiddenLabel mesh__D022821 Splice Site, 5%27%
% 214.07/214.21  |- skos__hiddenLabel mesh__D022821 Splice Donor Sites
% 214.07/214.21  |- mesh__dateRevised mesh__D022821 2005-08-01
% 214.07/214.21  |- skos__hiddenLabel mesh__D022821 Splice Site, 3%27%
% 214.07/214.21  |- skos__hiddenLabel mesh__D022821 Donor Sites, Splice
% 214.07/214.21  |- skos__hiddenLabel mesh__D022821 Splice Acceptor Sites
% 214.07/214.21  |- skos__hiddenLabel mesh__D022821 Acceptor Sites, Splice
% 214.07/214.21  |- skos__broader mesh__D022821smesh__D012333
% 214.07/214.21  |- skos__hiddenLabel mesh__D022821 Splice Sites, 5%27%
% 214.07/214.21  |- rdf__type mesh__D022821sskos__Concept
% 214.07/214.21  |- skos__broader mesh__D022821smesh__D040461
% 214.07/214.21  |- skos__hiddenLabel mesh__D022821 Donor Site, Splice
% 214.07/214.21  |- mesh__publicMeSHNote mesh__D022821 2001   
% 214.07/214.21  |- skos__scopeNote mesh__D022821
% 214.07/214.21       Nucleotide sequences located at the ends of exons and recognized in pre-messenger RNA by SPLICESOMES. They are joined during the RNA SPLICING reaction, forming the junctions between exons.%A%    
% 214.07/214.21  |- skos__hiddenLabel mesh__D022821 Splice Site, RNA
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D022821 2006A
% 214.07/214.21  |- skos__prefLabel mesh__D022821 RNA Splice Sites
% 214.07/214.21  |- skos__broader mesh__D022821smesh__D038621
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D022821 2006
% 214.07/214.21  |- skos__hiddenLabel mesh__D022821 Splice Sites, 3%27%
% 214.07/214.21  |- skos__hiddenLabel mesh__D022821 3%27% Splice Sites
% 214.07/214.21  |- mesh__historyNote mesh__D022821 2001   
% 214.07/214.21  |- skos__altLabel mesh__D022821 3%27% Splice Site
% 214.07/214.21  |- mesh__recordAuthorizer mesh__D022821 ags
% 214.07/214.21  |- mesh__dateCreated mesh__D022821 2000-06-23
% 214.07/214.21  |- skos__hiddenLabel mesh__D022821 RNA Splice Site
% 214.07/214.21  |- skos__altLabel mesh__D022821 5%27% Splice Site
% 214.07/214.21  |- skos__hiddenLabel mesh__D022821 Splice Sites, RNA
% 214.07/214.21  |- skos__hiddenLabel mesh__D022821 5%27% Splice Sites
% 214.07/214.21  |- mesh__recordMaintainer mesh__D022821 ags
% 214.07/214.21  |- mesh__recordOriginator mesh__D022821 nns
% 214.07/214.21  |- skos__historyNote mesh__D022821 RNA Splicing %28%1982-2000%29%
% 214.07/214.21  |- skos__broader mesh__D004194Q000473smesh__D004194
% 214.07/214.21  |- mesh__preferredCombination mesh__D004194Q000473smesh__D010336
% 214.07/214.21  |- rdf__type mesh__D004194Q000473smesh__CompoundConcept
% 214.07/214.21  |- skos__historyNote mesh__D008352 Amines %28%1966-1976%29%
% 214.07/214.21  |- skos__broader mesh__D008352smesh__D000588
% 214.07/214.21  |- mesh__dateCreated mesh__D008352 1976-05-19
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D008352 2006
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D008352 1999
% 214.07/214.21  |- mesh__recordAuthorizer mesh__D008352 PLS
% 214.07/214.21  |- mesh__dateRevised mesh__D008352 1992-05-18
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D008352 2001
% 214.07/214.21  |- skos__hiddenLabel mesh__D008352 Bases, Mannich
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D008352 1995
% 214.07/214.21  |- mesh__publicMeSHNote mesh__D008352 91; was see under AMINES 1977-90   
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D008352 2005
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D008352 2000
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D008352 1998
% 214.07/214.21  |- mesh__recordOriginator mesh__D008352 RLS
% 214.07/214.21  |- rdf__type mesh__D008352sskos__Concept
% 214.07/214.21  |- skos__prefLabel mesh__D008352 Mannich Bases
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D008352 1994
% 214.07/214.21  |- skos__scopeNote mesh__D008352
% 214.07/214.21       Ketonic amines prepared from the condensation of a ketone with formaldehyde and ammonia or a primary or secondary amine. A Mannich base can act as the equivalent of an alpha,beta unsaturated ketone in synthesis or can be reduced to form physiologically active amino alcohols.%A%    
% 214.07/214.21  |- skos__broader mesh__D008352smesh__D007659
% 214.07/214.21  |- mesh__dateEstablished mesh__D008352 1991-01-01
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D008352 2004
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D008352 1997
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D008352 2002
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D008352 1993
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D008352 2003
% 214.07/214.21  |- mesh__historyNote mesh__D008352
% 214.07/214.21       91%28%77%29%; was see under AMINES 1977-90   
% 214.07/214.21  |- skos__annotation mesh__D008352 IM general only   
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D008352 1996
% 214.07/214.21  |- mesh__recordMaintainer mesh__D008352 TAP
% 214.07/214.21  |- skos__altLabel mesh__D013297 Flesh-Eating Bacteria
% 214.07/214.21  |- rdf__type mesh__D013297sskos__Concept
% 214.07/214.21  |- mesh__recordAuthorizer mesh__D013297 sjn
% 214.07/214.21  |- mesh__dateCreated mesh__D013297 1999-01-01
% 214.07/214.21  |- skos__annotation mesh__D013297
% 214.07/214.21       infection: coordinate IM with STREPTOCOCCAL INFECTIONS %28%IM%29%; note entry term BACTERIA, FLESH-EATING: consider also FASCIITIS, NECROTIZING; DF: STREP PYOGENES%A%  
% 214.07/214.21  |- mesh__recordMaintainer mesh__D013297 ssb
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D013297 2006
% 214.07/214.21  |- skos__scopeNote mesh__D013297
% 214.07/214.21       A species of gram-positive, coccoid bacteria isolated from skin lesions, blood, inflammatory exudates, and the upper respiratory tract of humans. It is a group A hemolytic Streptococcus that can cause SCARLET FEVER and RHEUMATIC FEVER.%A%    
% 214.07/214.21  |- skos__prefLabel mesh__D013297 Streptococcus pyogenes
% 214.07/214.21  |- mesh__recordOriginator mesh__D013297 NLM
% 214.07/214.21  |- skos__related mesh__D013297smesh__D013301
% 214.07/214.21  |- mesh__dateRevised mesh__D013297 2005-06-30
% 214.07/214.21  |- skos__altLabel mesh__D013297 Streptococcus Group A
% 214.07/214.21  |- skos__related mesh__D013297smesh__D010844
% 214.07/214.21  |- skos__broader mesh__D013297smesh__D013291
% 214.07/214.21  |- mesh__publicMeSHNote mesh__D018780 95   
% 214.07/214.21  |- mesh__recordAuthorizer mesh__D018780 SJN
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D018780 2006
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D018780 1999
% 214.07/214.21  |- skos__historyNote mesh__D018780 Electrocardiography %28%1966-1994%29%
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D018780 2001
% 214.07/214.21  |- skos__hiddenLabel mesh__D018780 Body Surface Mappings
% 214.07/214.21  |- skos__broader mesh__D018780smesh__D004562
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D018780 2003
% 214.07/214.21  |- mesh__dateCreated mesh__D018780 1994-05-31
% 214.07/214.21  |- skos__scopeNote mesh__D018780
% 214.07/214.21       Recording of regional electrophysiological information by analysis of surface potentials to give a complete picture of the effects of the currents from the heart on the body surface. It has been applied to the diagnosis of old inferior myocardial infarction, localization of the bypass pathway in Wolff-Parkinson-White syndrome, recognition of ventricular hypertrophy, estimation of the size of a myocardial infarct, and the effects of different interventions designed to reduce infarct size. The limiting factor at present is the complexity of the recording and analysis, which requires 100 or more electrodes, sophisticated instrumentation, and dedicated personnel. %28%Braunwald, Heart Disease, 4th ed%29%%A%    
% 214.07/214.21  |- skos__hiddenLabel mesh__D018780 Surface Mappings, Body
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D018780 2004
% 214.07/214.21  |- skos__hiddenLabel mesh__D018780 Mappings, Body Surface
% 214.07/214.21  |- rdf__type mesh__D018780sskos__Concept
% 214.07/214.21  |- mesh__recordOriginator mesh__D018780 TGC
% 214.07/214.21  |- skos__historyNote mesh__D018780 Vectorcardiography %28%1978-1994%29%
% 214.07/214.21  |- skos__annotation mesh__D018780
% 214.07/214.21       an ECG %26% vectorcardiogr technique: do not confuse with BODY SURFACE AREA, an anthropometric method%A%  
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D018780 2002
% 214.07/214.21  |- mesh__dateEstablished mesh__D018780 1995-01-01
% 214.07/214.21  |- mesh__historyNote mesh__D018780 95   
% 214.07/214.21  |- skos__prefLabel mesh__D018780 Body Surface Potential Mapping
% 214.07/214.21  |- skos__broader mesh__D018780smesh__D014672
% 214.07/214.21  |- skos__hiddenLabel mesh__D018780 Mapping, Body Surface
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D018780 2005
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D018780 2000
% 214.07/214.21  |- mesh__recordMaintainer mesh__D018780 PXP
% 214.07/214.21  |- mesh__dateRevised mesh__D018780 1997-06-20
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D018780 1998
% 214.07/214.21  |- skos__altLabel mesh__D018780 Body Surface Mapping
% 214.07/214.21  |- skos__hiddenLabel mesh__D018780 Surface Mapping, Body
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D004760 2004
% 214.07/214.21  |- mesh__dateCreated mesh__D004760 1984-04-06
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D004760 2006
% 214.07/214.21  |- mesh__recordAuthorizer mesh__D004760 sjn
% 214.07/214.21  |- skos__historyNote mesh__D004760 Colitis %28%1966-1984%29%
% 214.07/214.21  |- mesh__dateEstablished mesh__D004760 1985-01-01
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D004760 2005
% 214.07/214.21  |- skos__annotation mesh__D004760 note specifics   
% 214.07/214.21  |- skos__hiddenLabel mesh__D004760 Enterocolitides
% 214.07/214.21  |- mesh__publicMeSHNote mesh__D004760 85   
% 214.07/214.21  |- skos__scopeNote mesh__D004760
% 214.07/214.21       Inflammation of the MUCOSA of both the SMALL INTESTINE and the LARGE INTESTINE. Etiology includes ISCHEMIA, infections, allergic, and immune responses.%A%    
% 214.07/214.21  |- skos__broader mesh__D004760smesh__D005759
% 214.07/214.21  |- mesh__recordOriginator mesh__D004760 RC
% 214.07/214.21  |- rdf__type mesh__D004760sskos__Concept
% 214.07/214.21  |- mesh__recordMaintainer mesh__D004760 lkt
% 214.07/214.21  |- skos__broader mesh__D004760smesh__D007410
% 214.07/214.21  |- skos__prefLabel mesh__D004760 Enterocolitis
% 214.07/214.21  |- mesh__historyNote mesh__D004760 85   
% 214.07/214.21  |- mesh__dateRevised mesh__D004760 2003-07-09
% 214.07/214.21  |- skos__historyNote mesh__D004760 Enteritis %28%1966-1984%29%
% 214.07/214.21  |- mesh__historyNote mesh__D017688 94   
% 214.07/214.21  |- skos__altLabel mesh__D017688 Cholera, Summer
% 214.07/214.21  |- mesh__dateCreated mesh__D017688 1992-12-28
% 214.07/214.21  |- skos__hiddenLabel mesh__D017688 Choleras, Summer
% 214.07/214.21  |- skos__annotation mesh__D017688
% 214.07/214.21       an old name for a type of gastroenteritis: do not confuse with classical CHOLERA%A%  
% 214.07/214.21  |- mesh__recordOriginator mesh__D017688 TGC
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D017688 2005
% 214.07/214.21  |- mesh__recordMaintainer mesh__D017688 lkt
% 214.07/214.21  |- mesh__dateEstablished mesh__D017688 1994-01-01
% 214.07/214.21  |- rdf__type mesh__D017688sskos__Concept
% 214.07/214.21  |- skos__scopeNote mesh__D017688
% 214.07/214.21       An old term that is no longer used in the scientific literature. Cholera morbus refers to acute GASTROENTERITIS occurring in summer or autumn; characterized by severe cramps, diarrhea, and vomiting.%A%    
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D017688 2006
% 214.07/214.21  |- skos__broader mesh__D017688smesh__D005759
% 214.07/214.21  |- skos__hiddenLabel mesh__D017688 Summer Cholera
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D017688 2004
% 214.07/214.21  |- skos__prefLabel mesh__D017688 Cholera Morbus
% 214.07/214.21  |- mesh__recordAuthorizer mesh__D017688 sjn
% 214.07/214.21  |- mesh__publicMeSHNote mesh__D017688 94   
% 214.07/214.21  |- mesh__dateRevised mesh__D017688 2003-07-09
% 214.07/214.21  |- skos__hiddenLabel mesh__D017688 Summer Choleras
% 214.07/214.21  |- mesh__recordAuthorizer mesh__D042081 sjn
% 214.07/214.21  |- skos__historyNote mesh__D042081 Azospirillum %28%1978-2003%29%
% 214.07/214.21  |- mesh__dateCreated mesh__D042081 2003-07-09
% 214.07/214.21  |- mesh__dateEstablished mesh__D042081 2004-01-01
% 214.07/214.21  |- rdf__type mesh__D042081sskos__Concept
% 214.07/214.21  |- skos__broader mesh__D042081smesh__D016949
% 214.07/214.21  |- mesh__recordOriginator mesh__D042081 ags
% 214.07/214.21  |- mesh__publicMeSHNote mesh__D042081 2004   
% 214.07/214.21  |- mesh__historyNote mesh__D042081 2004   
% 214.07/214.21  |- mesh__dateRevised mesh__D042081 2005-06-30
% 214.07/214.21  |- mesh__recordMaintainer mesh__D042081 ags
% 214.07/214.21  |- skos__scopeNote mesh__D042081
% 214.07/214.21       A species of gram-negative to gram-variable, nitrogen-fixing bacteria. They are free-living in SOIL or found in association with PLANT ROOTS. It is the type species of the genus AZOSPIRILLUM.%A%    
% 214.07/214.21  |- skos__prefLabel mesh__D042081 Azospirillum lipoferum
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D042081 2006
% 214.07/214.21  |- skos__hiddenLabel mesh__D003668 Ulcer, Decubitus
% 214.07/214.21  |- skos__hiddenLabel mesh__D003668 Decubitus Ulcers
% 214.07/214.21  |- skos__broader mesh__D003668smesh__D012883
% 214.07/214.21  |- skos__altLabel mesh__D003668 Bed Sores
% 214.07/214.21  |- mesh__dateRevised mesh__D003668 2005-06-30
% 214.07/214.21  |- rdf__type mesh__D003668sskos__Concept
% 214.07/214.21  |- mesh__dateCreated mesh__D003668 1999-01-01
% 214.07/214.21  |- skos__hiddenLabel mesh__D003668 Sores, Pressure
% 214.07/214.21  |- skos__hiddenLabel mesh__D003668 Bedsores
% 214.07/214.21  |- skos__hiddenLabel mesh__D003668 Sores, Bed
% 214.07/214.21  |- skos__hiddenLabel mesh__D003668 Bed Sore
% 214.07/214.21  |- skos__altLabel mesh__D003668 Decubitus Ulcer
% 214.07/214.21  |- skos__altLabel mesh__D003668 Bedsore
% 214.07/214.21  |- skos__scopeNote mesh__D003668
% 214.07/214.21       An ulceration caused by prolonged pressure on the SKIN and TISSUES when one stay in one position for a long period of time, such as lying in bed. The bony areas of the body are the most frequently affected sites which become ischemic %28%ISCHEMIA%29% under sustained and constant pressure.%A%    
% 214.07/214.21  |- skos__hiddenLabel mesh__D003668 Ulcer, Pressure
% 214.07/214.21  |- skos__hiddenLabel mesh__D003668 Sore, Pressure
% 214.07/214.21  |- skos__hiddenLabel mesh__D003668 Pressure Ulcers
% 214.07/214.21  |- mesh__historyNote mesh__D003668 2006 %28%1963%29%   
% 214.07/214.21  |- skos__hiddenLabel mesh__D003668 Sore, Bed
% 214.07/214.21  |- skos__prefLabel mesh__D003668 Pressure Ulcer
% 214.07/214.21  |- mesh__recordAuthorizer mesh__D003668 sjn
% 214.07/214.21  |- skos__hiddenLabel mesh__D003668 Ulcers, Pressure
% 214.07/214.21  |- mesh__recordOriginator mesh__D003668 NLM
% 214.07/214.21  |- skos__hiddenLabel mesh__D003668 Ulcers, Decubitus
% 214.07/214.21  |- skos__altLabel mesh__D003668 Pressure Sore
% 214.07/214.21  |- mesh__recordMaintainer mesh__D003668 lkt
% 214.07/214.21  |- mesh__publicMeSHNote mesh__D003668
% 214.07/214.21       2006; see DECUBITUS ULCER 1963-2005   
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D003668 2006
% 214.07/214.21  |- skos__hiddenLabel mesh__D003668 Pressure Sores
% 214.07/214.21  |- skos__altLabel mesh__D014390 Tuberculosis Meningitis
% 214.07/214.21  |- skos__hiddenLabel mesh__D014390
% 214.07/214.21       Tuberculous Hypertrophic Pachymeningitides
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D014390 2006
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D014390 2000
% 214.07/214.21  |- mesh__dateRevised mesh__D014390 1999-11-03
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D014390 2003
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D014390 2001
% 214.07/214.21  |- skos__hiddenLabel mesh__D014390 Tuberculous Meningitis
% 214.07/214.21  |- mesh__recordAuthorizer mesh__D014390 sjn
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D014390 2004
% 214.07/214.21  |- skos__altLabel mesh__D014390 Meningitis, Tuberculous
% 214.07/214.21  |- skos__scopeNote mesh__D014390
% 214.07/214.21       A form of bacterial meningitis caused by MYCOBACTERIUM TUBERCULOSIS or rarely MYCOBACTERIUM BOVIS. The organism seeds the meninges and forms microtuberculomas which subsequently rupture. The clinical course tends to be subacute, with progressions occurring over a period of several days or longer. Headache and meningeal irritation may be followed by SEIZURES, cranial neuropathies, focal neurologic deficits, somnolence, and eventually COMA.  The illness may occur in immunocompetent individuals or as an OPPORTUNISTIC INFECTION in the ACQUIRED IMMUNODEFICIENCY SYNDROME and other immunodeficiency syndromes. %28%From Adams et al., Principles of Neurology, 6th ed, pp717-9%29%%A%    
% 214.07/214.21  |- skos__hiddenLabel mesh__D014390 Meningitis, Tuberculosis
% 214.07/214.21  |- rdf__type mesh__D014390sskos__Concept
% 214.07/214.21  |- skos__broader mesh__D014390smesh__D016920
% 214.07/214.21  |- skos__hiddenLabel mesh__D014390
% 214.07/214.21       Pachymeningitis, Tuberculous Hypertrophic
% 214.07/214.21  |- mesh__recordOriginator mesh__D014390 NLM
% 214.07/214.21  |- skos__hiddenLabel mesh__D014390
% 214.07/214.21       Pachymeningitides, Tuberculous Hypertrophic
% 214.07/214.21  |- skos__hiddenLabel mesh__D014390 Meningeal Tuberculosis
% 214.07/214.21  |- skos__prefLabel mesh__D014390 Tuberculosis, Meningeal
% 214.07/214.21  |- skos__hiddenLabel mesh__D014390 Tuberculosis Meningitides
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D014390 2002
% 214.07/214.21  |- skos__hiddenLabel mesh__D014390 Meningitides, Tuberculosis
% 214.07/214.21  |- mesh__dateCreated mesh__D014390 1999-01-01
% 214.07/214.21  |- skos__hiddenLabel mesh__D014390
% 214.07/214.21       Hypertrophic Pachymeningitis, Tuberculous
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D014390 2005
% 214.07/214.21  |- skos__broader mesh__D014390smesh__D020306
% 214.07/214.21  |- mesh__recordMaintainer mesh__D014390 KEV
% 214.07/214.21  |- skos__hiddenLabel mesh__D014390
% 214.07/214.21       Hypertrophic Pachymeningitides, Tuberculous
% 214.07/214.21  |- mesh__dateRevised mesh__D008353 2004-07-07
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D008353 2006
% 214.07/214.21  |- mesh__dateCreated mesh__D008353 1999-01-01
% 214.07/214.21  |- skos__prefLabel mesh__D008353 Mannitol
% 214.07/214.21  |- skos__scopeNote mesh__D008353
% 214.07/214.21       A diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity.%A%    
% 214.07/214.21  |- mesh__recordMaintainer mesh__D008353 ssb
% 214.07/214.21  |- rdf__type mesh__D008353sskos__Concept
% 214.07/214.21  |- mesh__recordAuthorizer mesh__D008353 sjn
% 214.07/214.21  |- mesh__recordOriginator mesh__D008353 NLM
% 214.07/214.21  |- skos__broader mesh__D008353smesh__D013402
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D008353 2005
% 214.07/214.21  |- mesh__activeMeSHYear mesh__D000370 2003
% 214.07/214.21  |- skos__broader mesh__D000370smesh__D013651
% 214.07/214.22  |- skos__scopeNote mesh__D000370
% 214.07/214.22       Complete or severe loss of the subjective sense of taste, frequently accompanied by OLFACTION DISORDERS.%A%    
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000370 2005
% 214.07/214.22  |- mesh__dateRevised mesh__D000370 1999-11-04
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000370 2000
% 214.07/214.22  |- mesh__dateCreated mesh__D000370 1999-01-01
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000370 2004
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000370 2001
% 214.07/214.22  |- skos__hiddenLabel mesh__D000370 Hysterical Ageusia
% 214.07/214.22  |- mesh__recordAuthorizer mesh__D000370 sjn
% 214.07/214.22  |- skos__annotation mesh__D000370
% 214.07/214.22       do not confuse with DYSGEUSIA, distortion of sense of taste%A%  
% 214.07/214.22  |- skos__hiddenLabel mesh__D000370 Ageusias, Hysterical
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000370 2006
% 214.07/214.22  |- mesh__recordOriginator mesh__D000370 NLM
% 214.07/214.22  |- skos__hiddenLabel mesh__D000370 Hysterical Ageusias
% 214.07/214.22  |- mesh__recordMaintainer mesh__D000370 KEV
% 214.07/214.22  |- skos__hiddenLabel mesh__D000370 Hypogeusias
% 214.07/214.22  |- skos__prefLabel mesh__D000370 Ageusia
% 214.07/214.22  |- skos__hiddenLabel mesh__D000370 Taste Blindness
% 214.07/214.22  |- mesh__publicMeSHNote mesh__D000370
% 214.07/214.22       1991; see TASTE DISORDERS 1975-1990   
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000370 2002
% 214.07/214.22  |- mesh__dateEstablished mesh__D000370 1991-01-01
% 214.07/214.22  |- rdf__type mesh__D000370sskos__Concept
% 214.07/214.22  |- mesh__historyNote mesh__D000370 1991%28%1975%29%   
% 214.07/214.22  |- skos__annotation mesh__D013298
% 214.07/214.22       infection: coord IM with STREPTOCOCCAL INFECTIONS %28%IM%29%; DF: STREP SANGUIS%A%  
% 214.07/214.22  |- mesh__dateEstablished mesh__D013298 1976-01-01
% 214.07/214.22  |- mesh__dateRevised mesh__D013298 2005-06-30
% 214.07/214.22  |- skos__scopeNote mesh__D013298
% 214.07/214.22       A gram-positive organism found in dental plaque, in blood, on heart valves in subacute endocarditis, and infrequently in saliva and throat specimens. L-forms are associated with recurrent aphthous stomatitis.%A%    
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D013298 2006
% 214.07/214.22  |- mesh__publicMeSHNote mesh__D013298 76   
% 214.07/214.22  |- skos__broader mesh__D013298smesh__D034363
% 214.07/214.22  |- skos__prefLabel mesh__D013298 Streptococcus sanguis
% 214.07/214.22  |- mesh__recordAuthorizer mesh__D013298 sjn
% 214.07/214.22  |- mesh__historyNote mesh__D013298 76   
% 214.07/214.22  |- mesh__dateCreated mesh__D013298 1975-07-21
% 214.07/214.22  |- skos__historyNote mesh__D013298 Streptococcus %28%1966-1975%29%
% 214.07/214.22  |- mesh__recordMaintainer mesh__D013298 SYSTEM
% 214.07/214.22  |- mesh__recordOriginator mesh__D013298 JW
% 214.07/214.22  |- rdf__type mesh__D013298sskos__Concept
% 214.07/214.22  |- skos__hiddenLabel mesh__D018781 Psychogenic Headaches
% 214.07/214.22  |- mesh__recordMaintainer mesh__D018781 lkt
% 214.07/214.22  |- skos__altLabel mesh__D018781 Stress Headache
% 214.07/214.22  |- skos__hiddenLabel mesh__D018781 Headache, Tension-Type
% 214.07/214.22  |- skos__prefLabel mesh__D018781 Tension-Type Headache
% 214.07/214.22  |- skos__hiddenLabel mesh__D018781 Headaches, Tension-Vascular
% 214.07/214.22  |- skos__hiddenLabel mesh__D018781 Headaches, Psychogenic
% 214.07/214.22  |- mesh__recordAuthorizer mesh__D018781 sjn
% 214.07/214.22  |- skos__hiddenLabel mesh__D018781 Headache, Tension-Vascular
% 214.07/214.22  |- skos__broader mesh__D018781smesh__D051270
% 214.07/214.22  |- skos__hiddenLabel mesh__D018781 Tension-Type Headaches
% 214.07/214.22  |- skos__hiddenLabel mesh__D018781 Tension Headaches
% 214.07/214.22  |- rdf__type mesh__D018781sskos__Concept
% 214.07/214.22  |- skos__altLabel mesh__D018781 Idiopathic Headache
% 214.07/214.22  |- skos__altLabel mesh__D018781 Tension Headache
% 214.07/214.22  |- skos__scopeNote mesh__D018781
% 214.07/214.22       A common primary headache disorder, characterized by a dull, non-pulsatile, diffuse, band-like %28%or vice-like%29% PAIN of mild to moderate intensity in the HEAD; SCALP; or NECK. The subtypes are classified by frequency and severity of symptoms. There is no clear cause even though it has been associated with MUSCLE CONTRACTION and STRESS. %28%International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1%29%%A%    
% 214.07/214.22  |- skos__hiddenLabel mesh__D018781 Tension Type Headache
% 214.07/214.22  |- skos__hiddenLabel mesh__D018781 Headaches, Stress
% 214.07/214.22  |- skos__hiddenLabel mesh__D018781 Tension Vascular Headache
% 214.07/214.22  |- mesh__dateCreated mesh__D018781 1994-05-31
% 214.07/214.22  |- skos__hiddenLabel mesh__D018781 Headaches, Tension
% 214.07/214.22  |- skos__hiddenLabel mesh__D018781 Headache, Stress
% 214.07/214.22  |- mesh__dateRevised mesh__D018781 2005-06-30
% 214.07/214.22  |- skos__hiddenLabel mesh__D018781 Idiopathic Headaches
% 214.07/214.22  |- skos__hiddenLabel mesh__D018781 Headaches, Tension-Type
% 214.07/214.22  |- skos__altLabel mesh__D018781 Psychogenic Headache
% 214.07/214.22  |- mesh__recordOriginator mesh__D018781 TGC
% 214.07/214.22  |- skos__historyNote mesh__D018781 Headache %28%1966-1994%29%
% 214.07/214.22  |- mesh__publicMeSHNote mesh__D018781
% 214.07/214.22       2006; see TENSION HEADACHE 1995-2005   
% 214.07/214.22  |- mesh__historyNote mesh__D018781 2006 %28%1995%29%   
% 214.07/214.22  |- skos__hiddenLabel mesh__D018781 Tension-Vascular Headaches
% 214.07/214.22  |- skos__altLabel mesh__D018781 Headache, Tension
% 214.07/214.22  |- skos__hiddenLabel mesh__D018781 Stress Headaches
% 214.07/214.22  |- skos__hiddenLabel mesh__D018781 Headache, Psychogenic
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D018781 2006
% 214.07/214.22  |- mesh__dateEstablished mesh__D018781 1995-01-01
% 214.07/214.22  |- skos__hiddenLabel mesh__D018781 Headache, Idiopathic
% 214.07/214.22  |- skos__hiddenLabel mesh__D018781 Headaches, Idiopathic
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D004761 2004
% 214.07/214.22  |- skos__hiddenLabel mesh__D004761 Colitis, Antibiotic-Associated
% 214.07/214.22  |- skos__hiddenLabel mesh__D004761 Antibiotic Associated Colitis
% 214.07/214.22  |- mesh__dateCreated mesh__D004761 1999-01-01
% 214.07/214.22  |- skos__altLabel mesh__D004761 Pseudomembranous Colitis
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D004761 2006
% 214.07/214.22  |- mesh__historyNote mesh__D004761 85; was ENTEROCOLITIS, ACUTE 1963-84   
% 214.07/214.22  |- mesh__recordMaintainer mesh__D004761 lkt
% 214.07/214.22  |- mesh__recordOriginator mesh__D004761 NLM
% 214.07/214.22  |- mesh__onlineNote mesh__D004761
% 214.07/214.22       use ENTEROCOLITIS, PSEUDOMEMBRANOUS to search ENTEROCOLITIS, ACUTE 1966-84%A%  
% 214.07/214.22  |- skos__broader mesh__D004761smesh__D003015
% 214.07/214.22  |- skos__broader mesh__D004761smesh__D004760
% 214.07/214.22  |- skos__annotation mesh__D004761
% 214.07/214.22       coord IM with specific Clostridium species %28%IM%29%   
% 214.07/214.22  |- mesh__recordAuthorizer mesh__D004761 sjn
% 214.07/214.22  |- rdf__type mesh__D004761sskos__Concept
% 214.07/214.22  |- skos__altLabel mesh__D004761 Pseudomembranous Enterocolitis
% 214.07/214.22  |- mesh__publicMeSHNote mesh__D004761
% 214.07/214.22       85; was ENTEROCOLITIS, ACUTE 1963-84   
% 214.07/214.22  |- mesh__dateRevised mesh__D004761 2003-07-09
% 214.07/214.22  |- skos__scopeNote mesh__D004761
% 214.07/214.22       An acute inflammation of the INTESTINAL MUCOSA that is characterized by the presence of pseudomembranes or plaques in the SMALL INTESTINE %28%pseudomembranous enteritis%29% and the LARGE INTESTINE %28%pseudomembranous colitis%29%. It is commonly associated with antibiotic therapy and CLOSTRIDIUM DIFFICILE colonization.%A%    
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D004761 2005
% 214.07/214.22  |- skos__altLabel mesh__D004761 Pseudomembranous Enteritis
% 214.07/214.22  |- skos__prefLabel mesh__D004761 Enterocolitis, Pseudomembranous
% 214.07/214.22  |- skos__historyNote mesh__D017689 Toes/abnormalities %28%1966-1993%29%
% 214.07/214.22  |- skos__broader mesh__D017689smesh__D017880
% 214.07/214.22  |- rdf__type mesh__D017689sskos__Concept
% 214.07/214.22  |- skos__hiddenLabel mesh__D017689 Polydactylias
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D017689 2006
% 214.07/214.22  |- mesh__recordAuthorizer mesh__D017689 sjn
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D017689 2003
% 214.07/214.22  |- skos__annotation mesh__D017689
% 214.07/214.22       do not confuse with SYNDACTYLY; coord IM with FINGERS /abnorm %28%IM%29% or TOES /abnorm %28%IM%29%; SHORT RIB-POLYDACTYLY SYNDROME is also available%A%  
% 214.07/214.22  |- mesh__publicMeSHNote mesh__D017689 94   
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D017689 2004
% 214.07/214.22  |- skos__historyNote mesh__D017689 Fingers/abnormalities %28%1966-1993%29%
% 214.07/214.22  |- skos__related mesh__D017689smesh__D013576
% 214.07/214.22  |- skos__scopeNote mesh__D017689
% 214.07/214.22       A congenital anomaly of the hand or foot, marked by the presence of supernumerary digits.%A%    
% 214.07/214.22  |- mesh__recordMaintainer mesh__D017689 lkt
% 214.07/214.22  |- mesh__dateEstablished mesh__D017689 1994-01-01
% 214.07/214.22  |- mesh__historyNote mesh__D017689 94   
% 214.07/214.22  |- mesh__recordOriginator mesh__D017689 TGC
% 214.07/214.22  |- skos__altLabel mesh__D017689 Hyperdactyly
% 214.07/214.22  |- skos__hiddenLabel mesh__D017689 Polydactylisms
% 214.07/214.22  |- skos__prefLabel mesh__D017689 Polydactyly
% 214.07/214.22  |- mesh__dateCreated mesh__D017689 1992-12-28
% 214.07/214.22  |- skos__altLabel mesh__D017689 Polydactylia
% 214.07/214.22  |- mesh__dateRevised mesh__D017689 2002-07-03
% 214.07/214.22  |- skos__hiddenLabel mesh__D017689 Polydactylies
% 214.07/214.22  |- skos__altLabel mesh__D017689 Polydactylism
% 214.07/214.22  |- skos__hiddenLabel mesh__D017689 Hyperdactylies
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D017689 2005
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D042082 2006
% 214.07/214.22  |- mesh__dateCreated mesh__D042082 2003-07-09
% 214.07/214.22  |- skos__scopeNote mesh__D042082
% 214.07/214.22       A family of gram-negative bacteria in the order Rhizobiales. Genera include METHYLOBACTERIUM, Protomonas, and Roseomonas.%A%    
% 214.07/214.22  |- mesh__recordMaintainer mesh__D042082 DRC
% 214.07/214.22  |- mesh__recordAuthorizer mesh__D042082 sjn
% 214.07/214.22  |- rdf__type mesh__D042082sskos__Concept
% 214.07/214.22  |- mesh__publicMeSHNote mesh__D042082 2004   
% 214.07/214.22  |- mesh__recordOriginator mesh__D042082 ags
% 214.07/214.22  |- skos__prefLabel mesh__D042082 Methylobacteriaceae
% 214.07/214.22  |- skos__broader mesh__D042082smesh__D020561
% 214.07/214.22  |- mesh__historyNote mesh__D042082 2004   
% 214.07/214.22  |- mesh__dateEstablished mesh__D042082 2004-01-01
% 214.07/214.22  |- mesh__dateRevised mesh__D042082 2005-06-30
% 214.07/214.22  |- skos__broader mesh__D042082smesh__D016946
% 214.07/214.22  |- skos__annotation mesh__D003669 DF: DEDUCTIBLES   
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D003669 1997
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D003669 2000
% 214.07/214.22  |- rdf__type mesh__D003669sskos__Concept
% 214.07/214.22  |- mesh__recordOriginator mesh__D003669 NLM
% 214.07/214.22  |- mesh__publicMeSHNote mesh__D003669 68   
% 214.07/214.22  |- mesh__historyNote mesh__D003669 68   
% 214.07/214.22  |- skos__scopeNote mesh__D003669
% 214.07/214.22       Cost-sharing mechanisms that provide for payment by the insured of some portion of covered expenses. Deductibles are the amounts paid by the insured under a health insurance contract before benefits become payable; coinsurance is the provision under which the insured pays part of the medical bill, usually according to a fixed percentage, when benefits become payable.%A%    
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D003669 1998
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D003669 2001
% 214.07/214.22  |- mesh__recordAuthorizer mesh__D003669 NLM
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D003669 2003
% 214.07/214.22  |- skos__historyNote mesh__D003669 Insurance, Health %28%1966-1967%29%
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D003669 1999
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D003669 2002
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D003669 2004
% 214.07/214.22  |- mesh__dateRevised mesh__D003669 1993-09-16
% 214.07/214.22  |- mesh__recordMaintainer mesh__D003669 PLS
% 214.07/214.22  |- skos__prefLabel mesh__D003669 Deductibles and Coinsurance
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D003669 2005
% 214.07/214.22  |- mesh__dateCreated mesh__D003669 1999-01-01
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D003669 1995
% 214.07/214.22  |- skos__altLabel mesh__D003669 Coinsurance and Deductibles
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D003669 1996
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D003669 2006
% 214.07/214.22  |- skos__broader mesh__D003669smesh__D017047
% 214.07/214.22  |- mesh__dateEstablished mesh__D003669 1968-01-01
% 214.07/214.22  |- skos__hiddenLabel mesh__D014391 Miliary Tuberculoses
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014391 1997
% 214.07/214.22  |- mesh__recordAuthorizer mesh__D014391 PLS
% 214.07/214.22  |- skos__scopeNote mesh__D014391
% 214.07/214.22       An acute form of TUBERCULOSIS in which minute tubercles are formed in a number of organs of the body due to dissemination of the bacilli through the blood stream.%A%    
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014391 2004
% 214.07/214.22  |- skos__hiddenLabel mesh__D014391 Miliary Tuberculosis
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014391 1994
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014391 2000
% 214.07/214.22  |- rdf__type mesh__D014391sskos__Concept
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014391 1995
% 214.07/214.22  |- mesh__dateRevised mesh__D014391 1991-06-12
% 214.07/214.22  |- mesh__recordMaintainer mesh__D014391 PXP
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014391 2001
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014391 1992
% 214.07/214.22  |- mesh__dateCreated mesh__D014391 1999-01-01
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014391 1998
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014391 2005
% 214.07/214.22  |- skos__hiddenLabel mesh__D014391 Tuberculoses, Miliary
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014391 1993
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014391 1999
% 214.07/214.22  |- skos__broader mesh__D014391smesh__D014376
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014391 2006
% 214.07/214.22  |- mesh__recordOriginator mesh__D014391 NLM
% 214.07/214.22  |- skos__prefLabel mesh__D014391 Tuberculosis, Miliary
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014391 1996
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014391 2002
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014391 2003
% 214.07/214.22  |- mesh__dateCreated mesh__D008354 1999-01-01
% 214.07/214.22  |- skos__hiddenLabel mesh__D008354 Dehydrogenase, Mannitol
% 214.07/214.22  |- skos__broader mesh__D008354smesh__D013401
% 214.07/214.22  |- rdf__type mesh__D008354sskos__Concept
% 214.07/214.22  |- skos__prefLabel mesh__D008354 Mannitol Dehydrogenase
% 214.07/214.22  |- mesh__dateEstablished mesh__D008354 1965-01-01
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D008354 2004
% 214.07/214.22  |- mesh__publicMeSHNote mesh__D008354 65   
% 214.07/214.22  |- mesh__recordMaintainer mesh__D008354 ssb
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D008354 2005
% 214.07/214.22  |- mesh__dateRevised mesh__D008354 2003-07-09
% 214.07/214.22  |- mesh__recordOriginator mesh__D008354 NLM
% 214.07/214.22  |- mesh__recordAuthorizer mesh__D008354 sjn
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D008354 2006
% 214.07/214.22  |- mesh__historyNote mesh__D008354 65   
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000371 2006
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000371 2002
% 214.07/214.22  |- mesh__recordMaintainer mesh__D000371 ags
% 214.07/214.22  |- rdf__type mesh__D000371sskos__Concept
% 214.07/214.22  |- skos__broader mesh__D000371smesh__D000937
% 214.07/214.22  |- mesh__dateRevised mesh__D000371 1999-11-03
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000371 2000
% 214.07/214.22  |- skos__prefLabel mesh__D000371 Agglutination
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000371 2003
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000371 2001
% 214.07/214.22  |- mesh__recordAuthorizer mesh__D000371 sjn
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000371 2005
% 214.07/214.22  |- mesh__recordOriginator mesh__D000371 NLM
% 214.07/214.22  |- skos__hiddenLabel mesh__D000371 Agglutinations
% 214.07/214.22  |- mesh__dateCreated mesh__D000371 1999-01-01
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000371 2004
% 214.07/214.22  |- skos__annotation mesh__D000371
% 214.07/214.22       NIM, no qualif; when IM, qualif permitted   
% 214.07/214.22  |- skos__broader mesh__D010300Q000139smesh__D010300
% 214.07/214.22  |- mesh__preferredCombination mesh__D010300Q000139smesh__D010302Q000139
% 214.07/214.22  |- rdf__type mesh__D010300Q000139smesh__CompoundConcept
% 214.07/214.22  |- skos__hiddenLabel mesh__D013299 Streptokinase and Streptodornase
% 214.07/214.22  |- skos__prefLabel mesh__D013299 Streptodornase and Streptokinase
% 214.07/214.22  |- rdf__type mesh__D013299sskos__Concept
% 214.07/214.22  |- mesh__recordOriginator mesh__D013299 NLM
% 214.07/214.22  |- mesh__publicMeSHNote mesh__D013299
% 214.07/214.22       FIBRINOKINASE %26% PLASMINOKINASE were see STREPTODORNASE AND STREPTOKINASE 1963-93%A%  
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D013299 2006
% 214.07/214.22  |- mesh__dateRevised mesh__D013299 2005-06-30
% 214.07/214.22  |- skos__broader mesh__D013299smesh__D013300
% 214.07/214.22  |- skos__broader mesh__D013299smesh__D003850
% 214.07/214.22  |- mesh__recordMaintainer mesh__D013299 ssb
% 214.07/214.22  |- mesh__historyNote mesh__D013299
% 214.07/214.22       FIBRINOKINASE %26% PLASMINOKINASE were see STREPTODORNASE AND STREPTOKINASE 1963-93%A%  
% 214.07/214.22  |- mesh__recordAuthorizer mesh__D013299 sjn
% 214.07/214.22  |- skos__scopeNote mesh__D013299
% 214.07/214.22       A mixture of the enzymes %28%streptokinase and streptodornase%29% produced by hemolytic streptococci. It is used topically on surface lesions and by instillation in closed body cavities to remove clotted blood or fibrinous or purulent accumulations. It is also used as a skin test antigen in evaluating generalized cell-mediated immunodeficiency. %28%Dorland, 27th ed%29% EC 3.-.%A%    
% 214.07/214.22  |- mesh__onlineNote mesh__D013299
% 214.07/214.22       use STREPTODORNASE AND STREPTOKINASE to search FIBRINOKINASE %26% PLASMINOKINASE 1963-93%A%  
% 214.07/214.22  |- mesh__dateCreated mesh__D013299 1999-01-01
% 214.07/214.22  |- skos__annotation mesh__D013299
% 214.07/214.22       a pharm prep as ther agent combining both enzymes in a single dosage form; do not confuse with STREPTODORNASE see DEOXYRIBONUCLEASE I nor with STREPTOKINASE%A%  
% 214.07/214.22  |- skos__hiddenLabel mesh__D018782 Maze Learnings
% 214.07/214.22  |- mesh__recordOriginator mesh__D018782 TGC
% 214.07/214.22  |- mesh__dateEstablished mesh__D018782 1995-01-01
% 214.07/214.22  |- mesh__historyNote mesh__D018782 95   
% 214.07/214.22  |- skos__historyNote mesh__D018782
% 214.07/214.22       Discrimination Learning %28%1966-1994%29%
% 214.07/214.22  |- skos__hiddenLabel mesh__D018782 Learnings, Maze
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D018782 2005
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D018782 2006
% 214.07/214.22  |- skos__annotation mesh__D018782 human %26% animal   
% 214.07/214.22  |- mesh__recordAuthorizer mesh__D018782 sjn
% 214.07/214.22  |- mesh__dateRevised mesh__D018782 2004-07-13
% 214.07/214.22  |- mesh__publicMeSHNote mesh__D018782 95   
% 214.07/214.22  |- skos__prefLabel mesh__D018782 Maze Learning
% 214.07/214.22  |- skos__broader mesh__D018782smesh__D007858
% 214.07/214.22  |- skos__scopeNote mesh__D018782
% 214.07/214.22       Learning the correct route through a maze to obtain reinforcement. It is used for human or animal populations. %28%Thesaurus of Psychological Index Terms, 6th ed%29%%A%    
% 214.07/214.22  |- skos__historyNote mesh__D018782 Learning %28%1966-1994%29%
% 214.07/214.22  |- skos__hiddenLabel mesh__D018782 Learning, Maze
% 214.07/214.22  |- mesh__recordMaintainer mesh__D018782 sjn
% 214.07/214.22  |- rdf__type mesh__D018782sskos__Concept
% 214.07/214.22  |- mesh__dateCreated mesh__D018782 1994-05-31
% 214.07/214.22  |- mesh__recordMaintainer mesh__D042083 SYSTEM
% 214.07/214.22  |- mesh__historyNote mesh__D042083 2004   
% 214.07/214.22  |- mesh__dateEstablished mesh__D042083 2004-01-01
% 214.07/214.22  |- mesh__dateRevised mesh__D042083 2005-06-30
% 214.07/214.22  |- rdf__type mesh__D042083sskos__Concept
% 214.07/214.22  |- mesh__publicMeSHNote mesh__D042083 2004   
% 214.07/214.22  |- skos__broader mesh__D042083smesh__D020561
% 214.07/214.22  |- mesh__recordAuthorizer mesh__D042083 sjn
% 214.07/214.22  |- skos__scopeNote mesh__D042083
% 214.07/214.22       A family of gram-negative methanotrophs in the order Rhizobiales, distantly related to the nitrogen-fixing and phototrophic bacteria.%A%    
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D042083 2006
% 214.07/214.22  |- mesh__recordOriginator mesh__D042083 ags
% 214.07/214.22  |- mesh__dateCreated mesh__D042083 2003-07-09
% 214.07/214.22  |- skos__prefLabel mesh__D042083 Methylocystaceae
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014392 2006
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014392 1997
% 214.07/214.22  |- mesh__recordAuthorizer mesh__D014392 PLS
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014392 2004
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014392 2001
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014392 1998
% 214.07/214.22  |- mesh__dateRevised mesh__D014392 1991-06-12
% 214.07/214.22  |- mesh__recordOriginator mesh__D014392 NLM
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014392 2005
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014392 2000
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014392 1996
% 214.07/214.22  |- skos__hiddenLabel mesh__D014392 Tuberculoses, Ocular
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014392 2003
% 214.07/214.22  |- skos__hiddenLabel mesh__D014392 Ocular Tuberculoses
% 214.07/214.22  |- mesh__recordMaintainer mesh__D014392 PXP
% 214.07/214.22  |- skos__prefLabel mesh__D014392 Tuberculosis, Ocular
% 214.07/214.22  |- rdf__type mesh__D014392sskos__Concept
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014392 1995
% 214.07/214.22  |- skos__scopeNote mesh__D014392
% 214.07/214.22       Tuberculous infection of the eye, primarily the iris, ciliary body, and choroid.%A%    
% 214.07/214.22  |- skos__broader mesh__D014392smesh__D015818
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014392 1993
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014392 2002
% 214.07/214.22  |- skos__broader mesh__D014392smesh__D014376
% 214.07/214.22  |- skos__annotation mesh__D014392
% 214.07/214.22       IM; coord IM with specific eye heading %28%IM%29% or eye dis heading %28%IM%29%%A%  
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014392 1994
% 214.07/214.22  |- skos__altLabel mesh__D014392 Ocular Tuberculosis
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014392 1992
% 214.07/214.22  |- mesh__dateCreated mesh__D014392 1999-01-01
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D014392 1999
% 214.07/214.22  |- skos__prefLabel mesh__D008355 Mannitol Phosphates
% 214.07/214.22  |- mesh__historyNote mesh__D008355
% 214.07/214.22       91%28%78%29%; was see under SUGAR PHOSPHATES 1978-90   
% 214.07/214.22  |- skos__broader mesh__D008355smesh__D013403
% 214.07/214.22  |- skos__scopeNote mesh__D008355 Phosphoric acid esters of mannitol.     
% 214.07/214.22  |- skos__historyNote mesh__D008355 Mannitol %28%1966-1977%29%
% 214.07/214.22  |- mesh__recordAuthorizer mesh__D008355 sjn
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D008355 2005
% 214.07/214.22  |- mesh__recordOriginator mesh__D008355 RLS
% 214.07/214.22  |- mesh__publicMeSHNote mesh__D008355
% 214.07/214.22       91; was see under SUGAR PHOSPHATES 1978-90   
% 214.07/214.22  |- mesh__dateRevised mesh__D008355 2004-07-07
% 214.07/214.22  |- mesh__dateCreated mesh__D008355 1977-04-15
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D008355 2006
% 214.07/214.22  |- mesh__dateEstablished mesh__D008355 1991-01-01
% 214.07/214.22  |- rdf__type mesh__D008355sskos__Concept
% 214.07/214.22  |- skos__broader mesh__D008355smesh__D008353
% 214.07/214.22  |- skos__hiddenLabel mesh__D008355 Phosphates, Mannitol
% 214.07/214.22  |- skos__historyNote mesh__D008355 Sugar Phosphates %28%1974-1977%29%
% 214.07/214.22  |- mesh__recordMaintainer mesh__D008355 ssb
% 214.07/214.22  |- mesh__recordOriginator mesh__D000372 NLM
% 214.07/214.22  |- mesh__dateEstablished mesh__D000372 1966-01-01
% 214.07/214.22  |- skos__scopeNote mesh__D000372
% 214.07/214.22       Tests that are dependent on the clumping of cells, microorganisms, or particles when mixed with specific antiserum. %28%From Stedman, 26th ed%29%%A%    
% 214.07/214.22  |- skos__hiddenLabel mesh__D000372 Test, Agglutination
% 214.07/214.22  |- mesh__recordMaintainer mesh__D000372 PXP
% 214.07/214.22  |- rdf__type mesh__D000372sskos__Concept
% 214.07/214.22  |- mesh__historyNote mesh__D000372 66   
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000372 2002
% 214.07/214.22  |- skos__hiddenLabel mesh__D000372 Agglutination Test
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000372 2003
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000372 1998
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000372 2005
% 214.07/214.22  |- mesh__recordAuthorizer mesh__D000372 SJN
% 214.07/214.22  |- skos__hiddenLabel mesh__D000372 Tests, Agglutination
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000372 2004
% 214.07/214.22  |- mesh__dateCreated mesh__D000372 1999-01-01
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000372 1999
% 214.07/214.22  |- skos__prefLabel mesh__D000372 Agglutination Tests
% 214.07/214.22  |- mesh__dateRevised mesh__D000372 1997-06-20
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000372 2006
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000372 2000
% 214.07/214.22  |- mesh__publicMeSHNote mesh__D000372 66   
% 214.07/214.22  |- skos__annotation mesh__D000372 NIM   
% 214.07/214.22  |- skos__broader mesh__D000372smesh__D012698
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D000372 2001
% 214.07/214.22  |- skos__historyNote mesh__D018783 Penis/blood supply %28%1985-1994%29%
% 214.07/214.22  |- skos__hiddenLabel mesh__D018783 Venogenic Impotence
% 214.07/214.22  |- skos__hiddenLabel mesh__D018783 Vasculogenic Impotence
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D018783 2005
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D018783 1998
% 214.07/214.22  |- skos__hiddenLabel mesh__D018783 Leakage, Penile Venous
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D018783 2006
% 214.07/214.22  |- mesh__recordOriginator mesh__D018783 TGC
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D018783 1999
% 214.07/214.22  |- mesh__dateEstablished mesh__D018783 1995-01-01
% 214.07/214.22  |- mesh__recordMaintainer mesh__D018783 JLS
% 214.07/214.22  |- skos__historyNote mesh__D018783 Impotence %28%1985-1994%29%
% 214.07/214.22  |- skos__hiddenLabel mesh__D018783 Arteriogenic Impotence
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D018783 2002
% 214.07/214.22  |- skos__broader mesh__D018783smesh__D007172
% 214.07/214.22  |- skos__prefLabel mesh__D018783 Impotence, Vasculogenic
% 214.07/214.22  |- mesh__dateCreated mesh__D018783 1994-06-03
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D018783 2003
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D018783 2004
% 214.07/214.22  |- rdf__type mesh__D018783sskos__Concept
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D018783 2000
% 214.07/214.22  |- mesh__dateRevised mesh__D018783 1997-06-20
% 214.07/214.22  |- mesh__publicMeSHNote mesh__D018783 95   
% 214.07/214.22  |- mesh__recordAuthorizer mesh__D018783 SJN
% 214.07/214.22  |- skos__scopeNote mesh__D018783
% 214.07/214.22       Impotence caused by a diminution of blood flow to the penis. Arteries involved can be the terminal aorta, hypogastric, pudendal, penile, and cavernous arteries. Ectopic drainage of the corpora cavernosa via large superficial dorsal veins or abnormally large cavernous and crural veins can cause venogenic impotence. %28%From Walsh, et al., Campbell%27%s Urology, 6th ed, p720%29%. The expression %22%venous leakage%22% is seen often in international literature. Leakage refers to the failure of the blood to reach the penile erectile tissues.%A%    
% 214.07/214.22  |- mesh__historyNote mesh__D018783 95   
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D018783 2001
% 214.07/214.22  |- skos__annotation mesh__D018783
% 214.07/214.22       do not coord with PENIS /blood supply + specific artery or vein unless the vasc heading is particularly discussed %28%probably NIM%29%%A%  
% 214.07/214.22  |- skos__hiddenLabel mesh__D018783 Penile Venous Leakage
% 214.07/214.22  |- skos__hiddenLabel mesh__D004763 Peptides, Glucagon-Like
% 214.07/214.22  |- skos__hiddenLabel mesh__D004763 Glucagon Like Polypeptides
% 214.07/214.22  |- mesh__recordMaintainer mesh__D004763 ssb
% 214.07/214.22  |- mesh__recordAuthorizer mesh__D004763 sjn
% 214.07/214.22  |- mesh__historyNote mesh__D004763
% 214.07/214.22       1991%28%1979%29%; was see under GASTROINTESTINAL HORMONES 1979-1990%A%  
% 214.07/214.22  |- skos__historyNote mesh__D004763
% 214.07/214.22       Gastrointestinal Hormones %28%1966-1978%29%
% 214.07/214.22  |- mesh__dateCreated mesh__D004763 1977-12-09
% 214.07/214.22  |- skos__hiddenLabel mesh__D004763 Glucagon Like Peptides
% 214.07/214.22  |- skos__related mesh__D004763smesh__D005765
% 214.07/214.22  |- skos__altLabel mesh__D004763 Enteroglucagon
% 214.07/214.22  |- mesh__recordOriginator mesh__D004763 RLS
% 214.07/214.22  |- skos__hiddenLabel mesh__D004763 Glucagon, Gut
% 214.07/214.22  |- skos__broader mesh__D004763smesh__D052336
% 214.07/214.22  |- mesh__activeMeSHYear mesh__D004763 2006
% 214.07/214.22  |- skos__altLabel mesh__D004763 Glucagon-Like Peptides
% 214.07/214.22  |- skos__prefLabel mesh__D004763 Enteroglucagons
% 214.07/214.22  |- mesh__dateRevised mesh__D004763 2005-06-30
% 214.07/214.23  |- skos__scopeNote mesh__D004763
% 214.07/214.23       Peptide products of proglucagon in the GI TRACT which have different processing and activity than GLUCAGON.%A%    
% 214.07/214.23  |- skos__historyNote mesh__D004763 Peptides %28%1966-1978%29%
% 214.07/214.23  |- skos__altLabel mesh__D004763 Glucagon-Like Polypeptides
% 214.07/214.23  |- mesh__dateEstablished mesh__D004763 1991-01-01
% 214.07/214.23  |- skos__hiddenLabel mesh__D004763 Polypeptides, Glucagon-Like
% 214.07/214.23  |- mesh__publicMeSHNote mesh__D004763
% 214.07/214.23       1991; was under GASTROINTESTINAL HORMONES 1979-1990; see ENTEROGLUCAGON 1991-2005%A%  
% 214.07/214.23  |- rdf__type mesh__D004763sskos__Concept
% 214.07/214.23  |- skos__altLabel mesh__D004763 Gut Glucagon
% 214.07/214.23  |- skos__broader mesh__D042882smesh__D002137
% 214.07/214.23  |- mesh__historyNote mesh__D042882 2004; use CHOLELITHIASIS 1975-2003   
% 214.07/214.23  |- skos__scopeNote mesh__D042882
% 214.07/214.23       Solid crystalline precipitates in the BILIARY TRACT, usually formed in the GALLBLADDER. Gallstones, derived from the BILE, consist mainly of calcium, cholesterol, or bilirubin.%A%    
% 214.07/214.23  |- mesh__recordMaintainer mesh__D042882 lkt
% 214.07/214.23  |- skos__hiddenLabel mesh__D042882 Calculi, Biliary
% 214.07/214.23  |- mesh__publicMeSHNote mesh__D042882
% 214.07/214.23       2004; see CHOLELITHIASIS 1975-2003; for COMMON BILE DUCT CALCULI see COMMON BILE DUCT CALCULI 1963-2003%A%  
% 214.07/214.23  |- skos__hiddenLabel mesh__D042882 Gallstone
% 214.07/214.23  |- skos__altLabel mesh__D042882 Gallstones, Common Bile Duct
% 214.07/214.23  |- skos__altLabel mesh__D042882 Gall Stones
% 214.07/214.23  |- skos__historyNote mesh__D042882 Cholelithiasis %28%1965-2003%29%
% 214.07/214.23  |- skos__historyNote mesh__D042882
% 214.07/214.23       Common Bile Duct Calculi %28%1965-2003%29%
% 214.07/214.23  |- rdf__type mesh__D042882sskos__Concept
% 214.07/214.23  |- mesh__recordAuthorizer mesh__D042882 sjn
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D042882 2005
% 214.07/214.23  |- skos__altLabel mesh__D042882 Common Bile Duct Gallstones
% 214.07/214.23  |- skos__annotation mesh__D042882
% 214.07/214.23       consider also CHOLELITHIASIS and its specifics   
% 214.07/214.23  |- skos__altLabel mesh__D042882 Gall Stone
% 214.07/214.23  |- mesh__dateEstablished mesh__D042882 2004-01-01
% 214.07/214.23  |- mesh__recordOriginator mesh__D042882 lkt
% 214.07/214.23  |- skos__altLabel mesh__D042882 Common Bile Duct Gall Stones
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D042882 2006
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D042882 2004
% 214.07/214.23  |- skos__prefLabel mesh__D042882 Gallstones
% 214.07/214.23  |- skos__altLabel mesh__D042882 Biliary Calculi
% 214.07/214.23  |- skos__altLabel mesh__D042882 Gall Stones, Common Bile Duct
% 214.07/214.23  |- mesh__dateCreated mesh__D042882 2003-07-09
% 214.07/214.23  |- skos__altLabel mesh__D042882 Biliary Calculi, Common Bile Duct
% 214.07/214.23  |- mesh__publicMeSHNote mesh__D042084 2004   
% 214.07/214.23  |- mesh__recordAuthorizer mesh__D042084 sjn
% 214.07/214.23  |- mesh__recordOriginator mesh__D042084 ags
% 214.07/214.23  |- mesh__dateEstablished mesh__D042084 2004-01-01
% 214.07/214.23  |- skos__prefLabel mesh__D042084 Paracoccus pantotrophus
% 214.07/214.23  |- skos__altLabel mesh__D042084 Thiosphaera pantotropha
% 214.07/214.23  |- mesh__historyNote mesh__D042084 2004   
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D042084 2006
% 214.07/214.23  |- mesh__dateCreated mesh__D042084 2003-07-09
% 214.07/214.23  |- mesh__dateRevised mesh__D042084 2005-06-30
% 214.07/214.23  |- skos__broader mesh__D042084smesh__D010230
% 214.07/214.23  |- mesh__recordMaintainer mesh__D042084 SYSTEM
% 214.07/214.23  |- skos__scopeNote mesh__D042084
% 214.07/214.23       A species of gram-negative, coccoid, mostly chemolithoautotrophic bacteria, in the family RHODOBACTERACEAE. Some strains can grow anaerobically.%A%    
% 214.07/214.23  |- skos__historyNote mesh__D042084 Paracoccus %28%1999-2003%29%
% 214.07/214.23  |- rdf__type mesh__D042084sskos__Concept
% 214.07/214.23  |- skos__hiddenLabel mesh__D014393 Tuberculoses, Oral
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D014393 2005
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D014393 1996
% 214.07/214.23  |- skos__historyNote mesh__D014393 Mouth Diseases %28%1966-1971%29%
% 214.07/214.23  |- skos__historyNote mesh__D014393 specific oral disease %28%1966-1971%29%
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D014393 2003
% 214.07/214.23  |- mesh__recordAuthorizer mesh__D014393 PLS
% 214.07/214.23  |- rdf__type mesh__D014393sskos__Concept
% 214.07/214.23  |- skos__historyNote mesh__D014393 Tuberculosis %28%1966-1971%29%
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D014393 2001
% 214.07/214.23  |- mesh__historyNote mesh__D014393
% 214.07/214.23       91%28%72%29%; was see under TUBERCULOSIS 1972-90   
% 214.07/214.23  |- mesh__dateEstablished mesh__D014393 1991-01-01
% 214.07/214.23  |- mesh__dateRevised mesh__D014393 1991-06-12
% 214.07/214.23  |- mesh__recordOriginator mesh__D014393 NLM
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D014393 1995
% 214.07/214.23  |- skos__annotation mesh__D014393
% 214.07/214.23       %22%tuberc of the mouth, tongue %26% salivary glands%22%; IM; coord IM with specific mouth, tongue or salivary gland heading %28%IM%29% or mouth, tongue or salivary dis heading %28%IM%29%%A%  
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D014393 2000
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D014393 1993
% 214.07/214.23  |- skos__broader mesh__D014393smesh__D014376
% 214.07/214.23  |- skos__scopeNote mesh__D014393
% 214.07/214.23       Tuberculosis of the mouth, tongue, and salivary glands.%A%    
% 214.07/214.23  |- skos__prefLabel mesh__D014393 Tuberculosis, Oral
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D014393 1994
% 214.07/214.23  |- mesh__recordMaintainer mesh__D014393 PXP
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D014393 1992
% 214.07/214.23  |- mesh__dateCreated mesh__D014393 1999-01-01
% 214.07/214.23  |- skos__broader mesh__D014393smesh__D009059
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D014393 1999
% 214.07/214.23  |- skos__hiddenLabel mesh__D014393 Oral Tuberculoses
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D014393 2006
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D014393 1997
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D014393 2002
% 214.07/214.23  |- skos__hiddenLabel mesh__D014393 Oral Tuberculosis
% 214.07/214.23  |- mesh__publicMeSHNote mesh__D014393
% 214.07/214.23       91; was see under TUBERCULOSIS 1972-90   
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D014393 2004
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D014393 1998
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D008356 2005
% 214.07/214.23  |- skos__broader mesh__D008356smesh__D006539
% 214.07/214.23  |- mesh__recordMaintainer mesh__D008356 ssb
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D008356 2006
% 214.07/214.23  |- mesh__dateRevised mesh__D008356 2004-07-07
% 214.07/214.23  |- skos__altLabel mesh__D008356 Mannoketoheptose
% 214.07/214.23  |- skos__broader mesh__D008356smesh__D007661
% 214.07/214.23  |- skos__historyNote mesh__D008356 Ketoses %28%1974%29%
% 214.07/214.23  |- mesh__dateEstablished mesh__D008356 1991-01-01
% 214.07/214.23  |- mesh__recordOriginator mesh__D008356 NLM
% 214.07/214.23  |- skos__scopeNote mesh__D008356
% 214.07/214.23       A 7-carbon keto sugar having the mannose configuration.%A%    
% 214.07/214.23  |- mesh__recordAuthorizer mesh__D008356 sjn
% 214.07/214.23  |- mesh__dateCreated mesh__D008356 1974-11-19
% 214.07/214.23  |- skos__prefLabel mesh__D008356 Mannoheptulose
% 214.07/214.23  |- rdf__type mesh__D008356sskos__Concept
% 214.07/214.23  |- mesh__publicMeSHNote mesh__D008356 91; was see under HEPTOSES 1975-90   
% 214.07/214.23  |- mesh__historyNote mesh__D008356
% 214.07/214.23       91%28%75%29%; was see under HEPTOSES 1975-90   
% 214.07/214.23  |- skos__historyNote mesh__D008356 Heptoses %28%1972-1974%29%
% 214.07/214.23  |- skos__historyNote mesh__D000373 Antibodies %28%1966-1972%29%
% 214.07/214.23  |- skos__prefLabel mesh__D000373 Agglutinins
% 214.07/214.23  |- mesh__historyNote mesh__D000373 73   
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D000373 2006
% 214.07/214.23  |- mesh__dateCreated mesh__D000373 1999-01-01
% 214.07/214.23  |- mesh__recordMaintainer mesh__D000373 ssb
% 214.07/214.23  |- skos__broader mesh__D000373smesh__D007155
% 214.07/214.23  |- mesh__dateEstablished mesh__D000373 1973-01-01
% 214.07/214.23  |- mesh__recordAuthorizer mesh__D000373 sjn
% 214.07/214.23  |- mesh__recordOriginator mesh__D000373 NLM
% 214.07/214.23  |- rdf__type mesh__D000373sskos__Concept
% 214.07/214.23  |- mesh__publicMeSHNote mesh__D000373 73   
% 214.07/214.23  |- mesh__dateRevised mesh__D000373 2005-06-30
% 214.07/214.23  |- skos__scopeNote mesh__D000373
% 214.07/214.23       Substances, usually of biological origin, that cause cells or other organic particles to aggregate and stick to each other. They include those ANTIBODIES which cause aggregation or agglutination of particulate or insoluble ANTIGENS.%A%    
% 214.07/214.23  |- skos__historyNote mesh__D018784 Abscess %28%1966-1994%29%
% 214.07/214.23  |- skos__hiddenLabel mesh__D018784 Intra-Abdominal Abscesses
% 214.07/214.23  |- skos__hiddenLabel mesh__D018784 Abdominal Abscesses
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D018784 2002
% 214.07/214.23  |- mesh__historyNote mesh__D018784 95   
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D018784 1995
% 214.07/214.23  |- skos__hiddenLabel mesh__D018784 Abscesses, Intra-Abdominal
% 214.07/214.23  |- skos__altLabel mesh__D018784 Abscess, Abdominal
% 214.07/214.23  |- mesh__publicMeSHNote mesh__D018784 95   
% 214.07/214.23  |- skos__altLabel mesh__D018784 Abscess, Intra-Abdominal
% 214.07/214.23  |- skos__prefLabel mesh__D018784 Abdominal Abscess
% 214.07/214.23  |- skos__scopeNote mesh__D018784
% 214.07/214.23       An abscess located in the abdominal cavity, i.e., the cavity between the diaphragm above and the pelvis below. %28%From Dorland, 27th ed%29%%A%    
% 214.07/214.23  |- mesh__dateCreated mesh__D018784 1994-06-03
% 214.07/214.23  |- skos__historyNote mesh__D018784 Abdomen %28%1966-1994%29%
% 214.07/214.23  |- skos__annotation mesh__D018784 for coord read note on ABSCESS   
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D018784 2006
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D018784 1999
% 214.07/214.23  |- skos__broader mesh__D018784smesh__D000038
% 214.07/214.23  |- skos__hiddenLabel mesh__D018784 Intra-Abdominal Abscess
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D018784 2001
% 214.07/214.23  |- skos__hiddenLabel mesh__D018784 Abscesses, Abdominal
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D018784 2005
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D018784 1998
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D018784 2004
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D018784 1997
% 214.07/214.23  |- skos__hiddenLabel mesh__D018784 Abscess, Intra Abdominal
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D018784 2000
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D018784 2003
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D018784 1996
% 214.07/214.23  |- mesh__dateEstablished mesh__D018784 1995-01-01
% 214.07/214.23  |- rdf__type mesh__D018784sskos__Concept
% 214.07/214.23  |- skos__historyNote mesh__D004764 Bile %28%1966-1974%29%
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D004764 2001
% 214.07/214.23  |- skos__broader mesh__D004764smesh__D008660
% 214.07/214.23  |- mesh__historyNote mesh__D004764 75   
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D004764 1996
% 214.07/214.23  |- skos__hiddenLabel mesh__D004764 Entero-Hepatic Circulations
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D004764 2006
% 214.07/214.23  |- skos__prefLabel mesh__D004764 Enterohepatic Circulation
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D004764 2000
% 214.07/214.23  |- skos__historyNote mesh__D004764 Intestines %28%1966-1974%29%
% 214.07/214.23  |- mesh__recordAuthorizer mesh__D004764 PLS
% 214.07/214.23  |- skos__scopeNote mesh__D004764
% 214.07/214.23       Recycling through liver by excretion in bile, reabsorption from intestines into portal circulation, passage back into liver, and re-excretion in bile.%A%    
% 214.07/214.23  |- mesh__dateCreated mesh__D004764 1974-11-11
% 214.07/214.23  |- skos__hiddenLabel mesh__D004764 Entero Hepatic Circulation
% 214.07/214.23  |- skos__historyNote mesh__D004764 Liver Circulation %28%1966-1974%29%
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D004764 2005
% 214.07/214.23  |- skos__hiddenLabel mesh__D004764 Enterohepatic Circulations
% 214.07/214.23  |- skos__hiddenLabel mesh__D004764 Circulations, Entero-Hepatic
% 214.07/214.23  |- skos__annotation mesh__D004764
% 214.07/214.23       a metab concept, not a hemodynamic circ concept; bile-to-intestines-to-portal circ-to-liver-to-bile; DF: ENTEROHEPATIC CIRC%A%  
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D004764 2004
% 214.07/214.23  |- skos__historyNote mesh__D004764 Bile Acids and Salts %28%1966-1974%29%
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D004764 1995
% 214.07/214.23  |- mesh__dateRevised mesh__D004764 1993-06-04
% 214.07/214.23  |- skos__historyNote mesh__D004764 Intestine, Small %28%1966-1974%29%
% 214.07/214.23  |- rdf__type mesh__D004764sskos__Concept
% 214.07/214.23  |- mesh__recordOriginator mesh__D004764 NLM
% 214.07/214.23  |- skos__historyNote mesh__D004764 Intestinal Absorption %28%1966-1974%29%
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D004764 2002
% 214.07/214.23  |- skos__historyNote mesh__D004764 Liver %28%1966-1974%29%
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D004764 2003
% 214.07/214.23  |- skos__altLabel mesh__D004764 Entero-Hepatic Circulation
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D004764 1999
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D004764 1994
% 214.07/214.23  |- skos__altLabel mesh__D004764 Circulation, Enterohepatic
% 214.07/214.23  |- mesh__recordMaintainer mesh__D004764 JLS
% 214.07/214.23  |- mesh__dateEstablished mesh__D004764 1975-09-01
% 214.07/214.23  |- skos__hiddenLabel mesh__D004764 Circulations, Enterohepatic
% 214.07/214.23  |- skos__hiddenLabel mesh__D004764 Circulation, Entero-Hepatic
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D004764 1998
% 214.07/214.23  |- mesh__publicMeSHNote mesh__D004764 75   
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D004764 1997
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D042883 2006
% 214.07/214.23  |- skos__scopeNote mesh__D042883
% 214.07/214.23       Presence or formation of GALLSTONES in the COMMON BILE DUCT.%A%    
% 214.07/214.23  |- skos__broader mesh__D042883smesh__D002769
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D042883 2005
% 214.07/214.23  |- skos__historyNote mesh__D042883
% 214.07/214.23       Common Bile Duct Calculi %28%1964-2003%29%
% 214.07/214.23  |- skos__prefLabel mesh__D042883 Choledocholithiasis
% 214.07/214.23  |- mesh__dateEstablished mesh__D042883 2004-01-01
% 214.07/214.23  |- rdf__type mesh__D042883sskos__Concept
% 214.07/214.23  |- mesh__historyNote mesh__D042883
% 214.07/214.23       2004; use COMMON BILE DUCT CALCULI 1980-2003   
% 214.07/214.23  |- mesh__publicMeSHNote mesh__D042883
% 214.07/214.23       2004; see COMMON BILE DUCT CALCULI 1980-2003   
% 214.07/214.23  |- skos__broader mesh__D042883smesh__D003137
% 214.07/214.23  |- mesh__dateCreated mesh__D042883 2003-07-09
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D042883 2004
% 214.07/214.23  |- skos__historyNote mesh__D042883 Cholelithiasis %28%1965-2003%29%
% 214.07/214.23  |- skos__altLabel mesh__D042883 Cholelithiasis, Common Bile Duct
% 214.07/214.23  |- mesh__recordMaintainer mesh__D014394 PXP
% 214.07/214.23  |- skos__scopeNote mesh__D014394 Tuberculosis of the bones or joints.     
% 214.07/214.23  |- skos__hiddenLabel mesh__D014394 Tuberculoses, Joint
% 214.07/214.23  |- skos__broader mesh__D014394smesh__D014376
% 214.07/214.23  |- skos__hiddenLabel mesh__D014394 Tuberculoses, Osteoarticular
% 214.07/214.23  |- mesh__dateCreated mesh__D014394 1999-01-01
% 214.07/214.23  |- skos__prefLabel mesh__D014394 Tuberculosis, Osteoarticular
% 214.07/214.23  |- skos__hiddenLabel mesh__D014394 Joint Tuberculoses
% 214.07/214.23  |- skos__hiddenLabel mesh__D014394 Tuberculosis, Bone
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D014394 2006
% 214.07/214.23  |- mesh__recordAuthorizer mesh__D014394 sjn
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D014394 2004
% 214.07/214.23  |- skos__hiddenLabel mesh__D014394 Tuberculoses, Bone
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D014394 2005
% 214.07/214.23  |- skos__broader mesh__D014394smesh__D001850
% 214.07/214.23  |- skos__hiddenLabel mesh__D014394 Osteoarticular Tuberculosis
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D014394 2003
% 214.07/214.23  |- skos__hiddenLabel mesh__D014394 Osteoarticular Tuberculoses
% 214.07/214.23  |- mesh__recordOriginator mesh__D014394 NLM
% 214.07/214.23  |- rdf__type mesh__D014394sskos__Concept
% 214.07/214.23  |- skos__hiddenLabel mesh__D014394 Bone Tuberculoses
% 214.07/214.23  |- skos__annotation mesh__D014394
% 214.07/214.23       IM; may be osteo- or artic; coord IM with specific bone or joint %28%IM%29% or bone or joint dis %28%IM%29%%A%  
% 214.07/214.23  |- skos__hiddenLabel mesh__D014394 Tuberculosis, Joint
% 214.07/214.23  |- mesh__dateRevised mesh__D014394 2002-07-02
% 214.07/214.23  |- skos__hiddenLabel mesh__D008357 Nitrogen Mustard, Mannitol
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D008357 2003
% 214.07/214.23  |- skos__altLabel mesh__D008357 Mannitol Mustard
% 214.07/214.23  |- skos__scopeNote mesh__D008357
% 214.07/214.23       Nitrogen mustard derivative alkylating agent used as antineoplastic. It causes severe bone marrow depression and is a powerful vesicant.%A%    
% 214.07/214.23  |- mesh__recordMaintainer mesh__D008357 CCR
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D008357 2002
% 214.07/214.23  |- mesh__dateCreated mesh__D008357 1999-01-01
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D008357 2006
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D008357 2001
% 214.07/214.23  |- skos__prefLabel mesh__D008357 Mannomustine
% 214.07/214.23  |- skos__altLabel mesh__D008357 Mannitol Nitrogen Mustard
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D008357 2005
% 214.07/214.23  |- skos__hiddenLabel mesh__D008357 Mustard, Mannitol Nitrogen
% 214.07/214.23  |- mesh__dateRevised mesh__D008357 2000-06-22
% 214.07/214.23  |- rdf__type mesh__D008357sskos__Concept
% 214.07/214.23  |- mesh__recordOriginator mesh__D008357 NLM
% 214.07/214.23  |- skos__broader mesh__D008357smesh__D009588
% 214.07/214.23  |- mesh__recordAuthorizer mesh__D008357 sjn
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D008357 2004
% 214.07/214.23  |- skos__hiddenLabel mesh__D008357 Mustard, Mannitol
% 214.07/214.23  |- skos__altLabel mesh__D008357 Mannitlost
% 214.07/214.23  |- skos__broader mesh__D000374smesh__D001526
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D000374 2005
% 214.07/214.23  |- mesh__recordMaintainer mesh__D000374 TPW
% 214.07/214.23  |- skos__scopeNote mesh__D000374
% 214.07/214.23       A form of behavior which leads to self-assertion; it may arise from innate drives and/or a response to frustration; may be manifested by destructive and attacking behavior, by covert attitudes of hostility and obstructionism, or by healthy self-expressive drive to mastery. %28%Dorland 27th ed%29%%A%    
% 214.07/214.23  |- skos__broader mesh__D000374smesh__D012919
% 214.07/214.23  |- mesh__dateRevised mesh__D000374 2002-07-02
% 214.07/214.23  |- rdf__type mesh__D000374sskos__Concept
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D000374 2004
% 214.07/214.23  |- skos__hiddenLabel mesh__D000374 Aggressions
% 214.07/214.23  |- mesh__recordAuthorizer mesh__D000374 sjn
% 214.07/214.23  |- mesh__recordOriginator mesh__D000374 NLM
% 214.07/214.23  |- skos__prefLabel mesh__D000374 Aggression
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D000374 2003
% 214.07/214.23  |- skos__annotation mesh__D000374
% 214.07/214.23       human %26% animal; %22%agression%22% in French is translated %22%stress%22% %26% indexed under a STRESS heading; %22%agressologie%22% = STRESS%A%  
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D000374 2006
% 214.07/214.23  |- mesh__dateCreated mesh__D000374 1999-01-01
% 214.07/214.23  |- mesh__dateCreated mesh__D018785 1994-05-23
% 214.07/214.23  |- skos__scopeNote mesh__D018785
% 214.07/214.23       Absence of the orifice between the right atrium and ventricle, with the presence of an atrial defect through which all the systemic venous return reaches the left heart. As a result, there is left ventricular hypertrophy %28%HYPERTROPHY, LEFT VENTRICULAR%29% because the right ventricle is absent or not functional.%A%    
% 214.07/214.23  |- mesh__dateEstablished mesh__D018785 1995-01-01
% 214.07/214.23  |- skos__hiddenLabel mesh__D018785 Valve Atresias, Tricuspid
% 214.07/214.23  |- skos__hiddenLabel mesh__D018785 Tricuspid Atresias
% 214.07/214.23  |- skos__related mesh__D018785smesh__D018729
% 214.07/214.23  |- skos__annotation mesh__D018785
% 214.07/214.23       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 214.07/214.23  |- skos__hiddenLabel mesh__D018785 Atresias, Tricuspid Valve
% 214.07/214.23  |- skos__hiddenLabel mesh__D018785 Atresia, Tricuspid Valve
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D018785 2006
% 214.07/214.23  |- mesh__recordMaintainer mesh__D018785 kle
% 214.07/214.23  |- skos__prefLabel mesh__D018785 Tricuspid Atresia
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D018785 2002
% 214.07/214.23  |- mesh__publicMeSHNote mesh__D018785 95   
% 214.07/214.23  |- mesh__recordAuthorizer mesh__D018785 sjn
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D018785 2005
% 214.07/214.23  |- skos__altLabel mesh__D018785 Atresia, Tricuspid
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D018785 2004
% 214.07/214.23  |- skos__broader mesh__D018785smesh__D006330
% 214.07/214.23  |- skos__historyNote mesh__D018785
% 214.07/214.23       Tricuspid Valve/abnormalities %28%1966-1994%29%
% 214.07/214.23  |- skos__hiddenLabel mesh__D018785 Tricuspid Valve Atresias
% 214.07/214.23  |- skos__broader mesh__D018785smesh__D006349
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D018785 2003
% 214.07/214.23  |- skos__hiddenLabel mesh__D018785 Valve Atresia, Tricuspid
% 214.07/214.23  |- skos__hiddenLabel mesh__D018785 Atresias, Tricuspid
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D018785 2001
% 214.07/214.23  |- skos__altLabel mesh__D018785 Tricuspid Valve Atresia
% 214.07/214.23  |- rdf__type mesh__D018785sskos__Concept
% 214.07/214.23  |- mesh__recordOriginator mesh__D018785 PXP
% 214.07/214.23  |- mesh__dateRevised mesh__D018785 1999-11-03
% 214.07/214.23  |- mesh__historyNote mesh__D018785 95   
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D018785 2000
% 214.07/214.23  |- mesh__dateRevised mesh__D004765 2003-07-09
% 214.07/214.23  |- mesh__dateEstablished mesh__D004765 1991-01-01
% 214.07/214.23  |- skos__altLabel mesh__D004765 Enterokinase
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D004765 2004
% 214.07/214.23  |- mesh__recordMaintainer mesh__D004765 ssb
% 214.07/214.23  |- mesh__historyNote mesh__D004765
% 214.07/214.23       91%28%73%29%; was see under SERINE ENDOPEPTIDASES 1973-90   
% 214.07/214.23  |- mesh__recordOriginator mesh__D004765 NLM
% 214.07/214.23  |- mesh__publicMeSHNote mesh__D004765
% 214.07/214.23       91; was see under SERINE PROTEINASES 1973-90   
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D004765 2006
% 214.07/214.23  |- mesh__dateCreated mesh__D004765 1999-01-01
% 214.07/214.23  |- mesh__recordAuthorizer mesh__D004765 sjn
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D004765 2005
% 214.07/214.23  |- skos__prefLabel mesh__D004765 Enteropeptidase
% 214.07/214.23  |- skos__scopeNote mesh__D004765
% 214.07/214.23       A specialized proteolytic enzyme secreted by intestinal cells. It converts TRYPSINOGEN into its active form TRYPSIN by removing the N-terminal peptide. EC 3.4.21.9.%A%    
% 214.07/214.23  |- skos__broader mesh__D004765smesh__D012697
% 214.07/214.23  |- rdf__type mesh__D004765sskos__Concept
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D037141 2004
% 214.07/214.23  |- skos__hiddenLabel mesh__D037141 Program, Mandatory
% 214.07/214.23  |- skos__prefLabel mesh__D037141 Mandatory Programs
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D037141 2005
% 214.07/214.23  |- skos__hiddenLabel mesh__D037141 Programs, Mandatory
% 214.07/214.23  |- skos__broader mesh__D037141smesh__D009934
% 214.07/214.23  |- rdf__type mesh__D037141sskos__Concept
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D037141 2003
% 214.07/214.23  |- mesh__dateCreated mesh__D037141 2002-07-03
% 214.07/214.23  |- skos__hiddenLabel mesh__D037141 Mandatory Program
% 214.07/214.23  |- skos__scopeNote mesh__D037141
% 214.07/214.23       Programs in which participation is required.     
% 214.07/214.23  |- mesh__publicMeSHNote mesh__D037141 2003   
% 214.07/214.23  |- skos__related mesh__D037141smesh__D035141
% 214.07/214.23  |- skos__broader mesh__D037141smesh__D012926
% 214.07/214.23  |- mesh__dateEstablished mesh__D037141 2003-01-01
% 214.07/214.23  |- mesh__historyNote mesh__D037141 2003   
% 214.07/214.23  |- skos__related mesh__D037141smesh__D003068
% 214.07/214.23  |- skos__annotation mesh__D037141
% 214.07/214.23       coord with geographical term and type of program if pertinent%A%  
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D037141 2006
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D009450 1994
% 214.07/214.23  |- skos__hiddenLabel mesh__D009450 Localized Neurodermatitis
% 214.07/214.23  |- skos__hiddenLabel mesh__D009450 Localized Neurodermatitides
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D009450 2001
% 214.07/214.23  |- skos__hiddenLabel mesh__D009450 Circumscribed Neurodermatitis
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D009450 2004
% 214.07/214.23  |- skos__altLabel mesh__D009450 Neurodermatitis, Circumscribed
% 214.07/214.23  |- mesh__recordAuthorizer mesh__D009450 PLS
% 214.07/214.23  |- mesh__recordMaintainer mesh__D009450 PLS
% 214.07/214.23  |- rdf__type mesh__D009450sskos__Concept
% 214.07/214.23  |- skos__broader mesh__D009450smesh__D003872
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D009450 2000
% 214.07/214.23  |- skos__altLabel mesh__D009450 Neurodermatitis, Localized
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D009450 1997
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D009450 2003
% 214.07/214.23  |- skos__prefLabel mesh__D009450 Neurodermatitis
% 214.07/214.23  |- skos__hiddenLabel mesh__D009450 Neurodermatitides
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D009450 1996
% 214.07/214.23  |- mesh__recordOriginator mesh__D009450 NLM
% 214.07/214.23  |- skos__scopeNote mesh__D009450
% 214.07/214.23       An extremely variable eczematous skin disease that is presumed to be a response to prolonged vigorous scratching, rubbing, or pinching to relieve intense pruritus. It varies in intensity, severity, course, and morphologic expression in different individuals. Neurodermatitis is believed by some to be psychogenic. The circumscribed or localized form is often referred to as lichen simplex chronicus.%A%    
% 214.07/214.23  |- skos__hiddenLabel mesh__D009450 Neurodermatitides, Circumscribed
% 214.07/214.23  |- skos__hiddenLabel mesh__D009450 Circumscribed Neurodermatitides
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D009450 2006
% 214.07/214.23  |- mesh__dateCreated mesh__D009450 1999-01-01
% 214.07/214.23  |- skos__annotation mesh__D009450
% 214.07/214.23       eczematous skin dis with intense itching   
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D009450 2002
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D009450 1999
% 214.07/214.23  |- skos__hiddenLabel mesh__D009450 Neurodermatitides, Localized
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D009450 2005
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D009450 1995
% 214.07/214.23  |- skos__broader mesh__D009450smesh__D017443
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D009450 1998
% 214.07/214.23  |- mesh__dateRevised mesh__D009450 1993-06-03
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D023121 2001
% 214.07/214.23  |- skos__altLabel mesh__D023121 Masked Messenger RNA
% 214.07/214.23  |- skos__hiddenLabel mesh__D023121 RNA, Masked Messenger
% 214.07/214.23  |- skos__hiddenLabel mesh__D023121 Messenger RNA, Masked
% 214.07/214.23  |- skos__annotation mesh__D023121
% 214.07/214.23       do not confuse with RNA, UNTRANSLATED; DF: STORED MRNA   
% 214.07/214.23  |- skos__hiddenLabel mesh__D023121 mRNA, Maternal
% 214.07/214.23  |- mesh__historyNote mesh__D023121 2001   
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D023121 2004
% 214.07/214.23  |- skos__hiddenLabel mesh__D023121 mRNA, Stored
% 214.07/214.23  |- skos__altLabel mesh__D023121 Stored Messenger RNA
% 214.07/214.23  |- skos__broader mesh__D023121smesh__D012333
% 214.07/214.23  |- skos__altLabel mesh__D023121 Maternal mRNA
% 214.07/214.23  |- skos__altLabel mesh__D023121 Paternal mRNA
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D023121 2003
% 214.07/214.23  |- skos__altLabel mesh__D023121 Paternal Messenger RNA
% 214.07/214.23  |- skos__hiddenLabel mesh__D023121 mRNA, Paternal
% 214.07/214.23  |- skos__hiddenLabel mesh__D023121 RNA, Maternal Messenger
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D023121 2006
% 214.07/214.23  |- skos__scopeNote mesh__D023121
% 214.07/214.23       Messenger RNA that is stored in a masked state for translation at a later time. Distinguish from RNA, UNTRANSLATED which refers to non-messenger RNA, i.e. RNA that does not code for protein.%A%    
% 214.07/214.23  |- mesh__dateCreated mesh__D023121 2000-06-22
% 214.07/214.23  |- skos__prefLabel mesh__D023121 RNA, Messenger, Stored
% 214.07/214.23  |- rdf__type mesh__D023121sskos__Concept
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D023121 2002
% 214.07/214.23  |- skos__historyNote mesh__D023121 RNA, Messenger %28%1966-2000%29%
% 214.07/214.23  |- skos__hiddenLabel mesh__D023121 RNA, Stored Messenger
% 214.07/214.23  |- mesh__activeMeSHYear mesh__D023121 2005
% 214.07/214.23  |- skos__hiddenLabel mesh__D023121 Messenger RNA, Maternal
% 214.07/214.23  |- skos__hiddenLabel mesh__D023121 mRNA, Masked
% 214.07/214.23  |- skos__hiddenLabel mesh__D023121 Messenger RNA, Paternal
% 214.07/214.23  |- mesh__publicMeSHNote mesh__D023121 2001   
% 214.07/214.23  |- skos__hiddenLabel mesh__D023121 Messenger RNA, Stored
% 214.07/214.23  |- skos__altLabel mesh__D023121 Masked mRNA
% 214.07/214.23  |- skos__hiddenLabel mesh__D023121 RNA, Paternal Messenger
% 214.07/214.24  |- skos__altLabel mesh__D023121 Stored mRNA
% 214.07/214.24  |- skos__altLabel mesh__D023121 Maternal Messenger RNA
% 214.07/214.24  |- skos__altLabel mesh__D023121 RNA, Messenger, Masked
% 214.07/214.24  |- mesh__dateEstablished mesh__D023121 2001-01-01
% 214.07/214.24  |- mesh__recordOriginator mesh__D014395 NLM
% 214.07/214.24  |- skos__altLabel mesh__D014395 Tuberculosis, Peritoneal
% 214.07/214.24  |- skos__scopeNote mesh__D014395
% 214.07/214.24       A form of PERITONITIS seen in patients with TUBERCULOSIS, characterized by lesion either as a miliary form or as a pelvic mass on the peritoneal surfaces. Most patients have ASCITES, abdominal swelling, ABDOMINAL PAIN, and other systemic symptoms such as FEVER; WEIGHT LOSS; and ANEMIA.%A%    
% 214.07/214.24  |- mesh__dateCreated mesh__D014395 1999-01-01
% 214.07/214.24  |- mesh__publicMeSHNote mesh__D014395
% 214.07/214.24       2005; see TUBERCULOSIS, PERITONEAL 1966-2004   
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D014395 2006
% 214.07/214.24  |- skos__broader mesh__D014395smesh__D010538
% 214.07/214.24  |- skos__prefLabel mesh__D014395 Peritonitis, Tuberculous
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D014395 2005
% 214.07/214.24  |- skos__hiddenLabel mesh__D014395 Tuberculous Peritonitis
% 214.07/214.24  |- skos__hiddenLabel mesh__D014395 Peritoneal Tuberculosis
% 214.07/214.24  |- mesh__recordMaintainer mesh__D014395 lkt
% 214.07/214.24  |- mesh__historyNote mesh__D014395 2005 %28%1966%29%   
% 214.07/214.24  |- mesh__dateRevised mesh__D014395 2004-07-07
% 214.07/214.24  |- mesh__recordAuthorizer mesh__D014395 sjn
% 214.07/214.24  |- rdf__type mesh__D014395sskos__Concept
% 214.07/214.24  |- skos__broader mesh__D014395smesh__D014376
% 214.07/214.24  |- skos__altLabel mesh__D008358 Mannopyranoside
% 214.07/214.24  |- skos__hiddenLabel mesh__D008358 D Mannose
% 214.07/214.24  |- mesh__recordOriginator mesh__D008358 NLM
% 214.07/214.24  |- mesh__recordAuthorizer mesh__D008358 sjn
% 214.07/214.24  |- mesh__dateCreated mesh__D008358 1999-01-01
% 214.07/214.24  |- skos__prefLabel mesh__D008358 Mannose
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D008358 2006
% 214.07/214.24  |- mesh__recordMaintainer mesh__D008358 ssb
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D008358 2005
% 214.07/214.24  |- mesh__dateRevised mesh__D008358 2004-07-07
% 214.07/214.24  |- skos__altLabel mesh__D008358 Mannopyranose
% 214.07/214.24  |- rdf__type mesh__D008358sskos__Concept
% 214.07/214.24  |- skos__altLabel mesh__D008358 D-Mannose
% 214.07/214.24  |- skos__broader mesh__D008358smesh__D006601
% 214.07/214.24  |- skos__scopeNote mesh__D008358
% 214.07/214.24       A hexose or fermentable monosaccharide and isomer of glucose from manna, the ash Fraxinus ornus and related plants. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed %26% Random House Unabridged Dictionary, 2d ed%29%%A%    
% 214.07/214.24  |- mesh__recordOriginator mesh__D000375 NLM
% 214.07/214.24  |- skos__related mesh__D000375smesh__D015595
% 214.07/214.24  |- mesh__dateRevised mesh__D000375 2004-07-07
% 214.07/214.24  |- skos__scopeNote mesh__D000375
% 214.07/214.24       The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.%A%    
% 214.07/214.24  |- skos__broader mesh__D000375smesh__D048788
% 214.07/214.24  |- skos__altLabel mesh__D000375 Aging, Biological
% 214.07/214.24  |- mesh__recordMaintainer mesh__D000375 nns
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D000375 2006
% 214.07/214.24  |- mesh__dateCreated mesh__D000375 1999-01-01
% 214.07/214.24  |- skos__related mesh__D000375smesh__D016922
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D000375 2005
% 214.07/214.24  |- skos__prefLabel mesh__D000375 Aging
% 214.07/214.24  |- skos__annotation mesh__D000375
% 214.07/214.24       human %26% animal; IM; aging process anywhere between birth %26% old age; differentiation from other age-related terms: Manual 28.16, 34.10; %22%aging%22% of lower organisms, cultures, drugs, etc. is probably TIME FACTORS; AGING, PREMATURE is also available%A%  
% 214.07/214.24  |- rdf__type mesh__D000375sskos__Concept
% 214.07/214.24  |- mesh__recordAuthorizer mesh__D000375 sjn
% 214.07/214.24  |- mesh__dateCreated mesh__D019080 1995-06-05
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D019080 2006
% 214.07/214.24  |- skos__hiddenLabel mesh__D019080 Spot, Cafe-au-Lait
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D019080 2002
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D019080 2004
% 214.07/214.24  |- mesh__publicMeSHNote mesh__D019080 96   
% 214.07/214.24  |- mesh__dateEstablished mesh__D019080 1996-01-01
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D019080 2005
% 214.07/214.24  |- skos__broader mesh__D019080smesh__D012877
% 214.07/214.24  |- skos__hiddenLabel mesh__D019080 Cafe au Lait Spots
% 214.07/214.24  |- skos__hiddenLabel mesh__D019080 Spots, Cafe-au-Lait
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D019080 2003
% 214.07/214.24  |- mesh__recordOriginator mesh__D019080 JLS
% 214.07/214.24  |- mesh__historyNote mesh__D019080 96   
% 214.07/214.24  |- mesh__dateRevised mesh__D019080 2001-08-13
% 214.07/214.24  |- skos__annotation mesh__D019080
% 214.07/214.24       a pigmentation disord; spell in titles %26% translations with hyphens %26% accent: caf%C3%%A9%-au-lait%A%  
% 214.07/214.24  |- skos__prefLabel mesh__D019080 Cafe-au-Lait Spots
% 214.07/214.24  |- skos__broader mesh__D019080smesh__D010859
% 214.07/214.24  |- mesh__recordMaintainer mesh__D019080 jls
% 214.07/214.24  |- mesh__recordAuthorizer mesh__D019080 sjn
% 214.07/214.24  |- skos__scopeNote mesh__D019080
% 214.07/214.24       Light brown pigmented macules associated with NEUROFIBROMATOSIS and Albright%27%s syndrome %28%see FIBROUS DYSPLASIA, POLYOSTOTIC%29%.%A%    
% 214.07/214.24  |- skos__hiddenLabel mesh__D019080 Cafe-au-Lait Spot
% 214.07/214.24  |- skos__historyNote mesh__D019080 Pigmentation Disorders %28%1966-1995%29%
% 214.07/214.24  |- rdf__type mesh__D019080sskos__Concept
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005060 2001
% 214.07/214.24  |- skos__broader mesh__D005060smesh__D005842
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005060 2003
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005060 1993
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005060 1996
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005060 2000
% 214.07/214.24  |- skos__prefLabel mesh__D005060 Europe
% 214.07/214.24  |- mesh__recordAuthorizer mesh__D005060 PLS
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005060 1992
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005060 2006
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005060 1999
% 214.07/214.24  |- mesh__recordMaintainer mesh__D005060 PLS
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005060 2005
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005060 1995
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005060 1998
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005060 2002
% 214.07/214.24  |- mesh__dateRevised mesh__D005060 1991-11-09
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005060 1994
% 214.07/214.24  |- skos__annotation mesh__D005060
% 214.07/214.24       each European country is available as a heading   
% 214.07/214.24  |- rdf__type mesh__D005060sskos__Concept
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005060 2004
% 214.07/214.24  |- mesh__dateCreated mesh__D005060 1999-01-01
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005060 1997
% 214.07/214.24  |- mesh__recordOriginator mesh__D005060 NLM
% 214.07/214.24  |- skos__annotation mesh__D018786
% 214.07/214.24       IM; coord with specific bone %28%IM%29% if relevant + substitute material %28%IM%29% if significant%A%  
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D018786 2005
% 214.07/214.24  |- mesh__dateRevised mesh__D018786 1998-06-10
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D018786 2004
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D018786 2001
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D018786 2003
% 214.07/214.24  |- mesh__dateEstablished mesh__D018786 1995-01-01
% 214.07/214.24  |- rdf__type mesh__D018786sskos__Concept
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D018786 2000
% 214.07/214.24  |- skos__altLabel mesh__D018786 Replacement Materials, Bone
% 214.07/214.24  |- skos__hiddenLabel mesh__D018786 Materials, Bone Replacement
% 214.07/214.24  |- skos__altLabel mesh__D018786 Substitutes, Bone
% 214.07/214.24  |- skos__hiddenLabel mesh__D018786 Material, Bone Replacement
% 214.07/214.24  |- mesh__recordAuthorizer mesh__D018786 SJN
% 214.07/214.24  |- mesh__historyNote mesh__D018786 95   
% 214.07/214.24  |- mesh__dateCreated mesh__D018786 1994-05-31
% 214.07/214.24  |- mesh__recordOriginator mesh__D018786 TGC
% 214.07/214.24  |- skos__scopeNote mesh__D018786
% 214.07/214.24       Synthetic or natural materials for the replacement of bones or bone tissue. They include hard tissue replacement polymers, natural coral, hydroxyapatite, beta-tricalcium phosphate, and various other biomaterials. The bone substitutes as inert materials can be incorporated into surrounding tissue or gradually replaced by original tissue.%A%    
% 214.07/214.24  |- skos__broader mesh__D018786smesh__D001672
% 214.07/214.24  |- skos__altLabel mesh__D018786 Replacement Material, Bone
% 214.07/214.24  |- skos__hiddenLabel mesh__D018786 Substitute, Bone
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D018786 2002
% 214.07/214.24  |- skos__altLabel mesh__D018786 Bone Substitute
% 214.07/214.24  |- skos__altLabel mesh__D018786 Bone Replacement Material
% 214.07/214.24  |- mesh__publicMeSHNote mesh__D018786 95   
% 214.07/214.24  |- skos__altLabel mesh__D018786 Bone Replacement Materials
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D018786 2006
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D018786 1999
% 214.07/214.24  |- skos__prefLabel mesh__D018786 Bone Substitutes
% 214.07/214.24  |- mesh__recordMaintainer mesh__D018786 ADP
% 214.07/214.24  |- mesh__recordAuthorizer mesh__D004766 SJN
% 214.07/214.24  |- mesh__dateRevised mesh__D004766 1997-06-20
% 214.07/214.24  |- mesh__publicMeSHNote mesh__D004766 88   
% 214.07/214.24  |- skos__scopeNote mesh__D004766
% 214.07/214.24       Creation of an artificial external opening or fistula in the intestines.%A%    
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D004766 2003
% 214.07/214.24  |- skos__hiddenLabel mesh__D004766 Enterostomies
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D004766 2001
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D004766 2006
% 214.07/214.24  |- mesh__dateCreated mesh__D004766 1987-03-18
% 214.07/214.24  |- mesh__recordMaintainer mesh__D004766 PXP
% 214.07/214.24  |- skos__annotation mesh__D004766
% 214.07/214.24       GEN only: prefer specific intestinal -ostomy; do not use /util except by MeSH definition%A%  
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D004766 2000
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D004766 2005
% 214.07/214.24  |- skos__historyNote mesh__D004766 Ileostomy %28%1966-1987%29%
% 214.07/214.24  |- skos__broader mesh__D004766smesh__D010030
% 214.07/214.24  |- rdf__type mesh__D004766sskos__Concept
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D004766 1999
% 214.07/214.24  |- mesh__recordOriginator mesh__D004766 SCD
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D004766 2002
% 214.07/214.24  |- mesh__historyNote mesh__D004766 88   
% 214.07/214.24  |- skos__historyNote mesh__D004766 Colostomy %28%1966-1987%29%
% 214.07/214.24  |- skos__broader mesh__D004766smesh__D013505
% 214.07/214.24  |- skos__prefLabel mesh__D004766 Enterostomy
% 214.07/214.24  |- mesh__dateEstablished mesh__D004766 1988-01-01
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D004766 1998
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D004766 2004
% 214.07/214.24  |- mesh__historyNote mesh__D037142 2003   
% 214.07/214.24  |- mesh__publicMeSHNote mesh__D037142 2003   
% 214.07/214.24  |- skos__annotation mesh__D037142
% 214.07/214.24       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D037142 2006
% 214.07/214.24  |- skos__prefLabel mesh__D037142 Flaveria
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D037142 2004
% 214.07/214.24  |- mesh__dateCreated mesh__D037142 2002-07-03
% 214.07/214.24  |- skos__broader mesh__D037142smesh__D019659
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D037142 2005
% 214.07/214.24  |- skos__scopeNote mesh__D037142
% 214.07/214.24       A plant genus of the family ASTERACEAE that is used for experiments in molecular genetic studies in plant physiology and development.%A%    
% 214.07/214.24  |- rdf__type mesh__D037142sskos__Concept
% 214.07/214.24  |- mesh__dateEstablished mesh__D037142 2003-01-01
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D037142 2003
% 214.07/214.24  |- skos__hiddenLabel mesh__D009451 Junctions, Neuroeffector
% 214.07/214.24  |- mesh__publicMeSHNote mesh__D009451 68   
% 214.07/214.24  |- rdf__type mesh__D009451sskos__Concept
% 214.07/214.24  |- skos__prefLabel mesh__D009451 Neuroeffector Junction
% 214.07/214.24  |- skos__scopeNote mesh__D009451
% 214.07/214.24       The synapse between a neuron %28%presynaptic%29% and an effector cell other than another neuron %28%postsynaptic%29%. Neuroeffector junctions include synapses onto muscles and onto secretory cells.%A%    
% 214.07/214.24  |- skos__hiddenLabel mesh__D009451 Junction, Neuroeffector
% 214.07/214.24  |- skos__broader mesh__D009451smesh__D013569
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D009451 2003
% 214.07/214.24  |- mesh__dateEstablished mesh__D009451 1968-01-01
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D009451 2001
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D009451 2006
% 214.07/214.24  |- mesh__dateCreated mesh__D009451 1999-01-01
% 214.07/214.24  |- skos__historyNote mesh__D009451 Nerve Endings %28%1966-1967%29%
% 214.07/214.24  |- mesh__historyNote mesh__D009451 68   
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D009451 2005
% 214.07/214.24  |- mesh__dateRevised mesh__D009451 2000-06-22
% 214.07/214.24  |- skos__hiddenLabel mesh__D009451 Neuroeffector Junctions
% 214.07/214.24  |- mesh__recordAuthorizer mesh__D009451 sjn
% 214.07/214.24  |- mesh__recordOriginator mesh__D009451 NLM
% 214.07/214.24  |- mesh__recordMaintainer mesh__D009451 TGC
% 214.07/214.24  |- skos__broader mesh__D009451smesh__D009411
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D009451 2002
% 214.07/214.24  |- skos__annotation mesh__D009451
% 214.07/214.24       a synapse between a neuron %26% an effector cell   
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D009451 2004
% 214.07/214.24  |- skos__hiddenLabel mesh__D014396 Pleural Tuberculosis
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D014396 1996
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D014396 1999
% 214.07/214.24  |- skos__altLabel mesh__D014396 Pleurisy, Tuberculous
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D014396 2000
% 214.07/214.24  |- skos__prefLabel mesh__D014396 Tuberculosis, Pleural
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D014396 2003
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D014396 2006
% 214.07/214.24  |- mesh__recordMaintainer mesh__D014396 PXP
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D014396 2001
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D014396 1997
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D014396 2004
% 214.07/214.24  |- mesh__recordOriginator mesh__D014396 NLM
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D014396 2002
% 214.07/214.24  |- mesh__dateRevised mesh__D014396 1991-05-30
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D014396 1994
% 214.07/214.24  |- skos__hiddenLabel mesh__D014396 Tuberculoses, Pleural
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D014396 1992
% 214.07/214.24  |- skos__broader mesh__D014396smesh__D012141
% 214.07/214.24  |- skos__scopeNote mesh__D014396
% 214.07/214.24       Tuberculosis of the serous membrane lining the thoracic cavity and surrounding the lungs.%A%    
% 214.07/214.24  |- skos__hiddenLabel mesh__D014396 Tuberculous Pleurisy
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D014396 1995
% 214.07/214.24  |- mesh__dateCreated mesh__D014396 1999-01-01
% 214.07/214.24  |- rdf__type mesh__D014396sskos__Concept
% 214.07/214.24  |- skos__hiddenLabel mesh__D014396 Tuberculous Pleurisies
% 214.07/214.24  |- skos__broader mesh__D014396smesh__D010995
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D014396 1998
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D014396 1993
% 214.07/214.24  |- mesh__recordAuthorizer mesh__D014396 PLS
% 214.07/214.24  |- skos__broader mesh__D014396smesh__D014376
% 214.07/214.24  |- skos__hiddenLabel mesh__D014396 Pleurisies, Tuberculous
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D014396 2005
% 214.07/214.24  |- skos__hiddenLabel mesh__D014396 Pleural Tuberculoses
% 214.07/214.24  |- skos__scopeNote mesh__D008359
% 214.07/214.24       An enzyme that catalyzes the reversible isomerization of D-mannose-6-phosphate to form D-fructose-6-phosphate, an important step in glycolysis. EC 5.3.1.8.%A%    
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D008359 2005
% 214.07/214.24  |- mesh__dateRevised mesh__D008359 2003-07-09
% 214.07/214.24  |- skos__hiddenLabel mesh__D008359 Isomerase, Mannose-6-Phosphate
% 214.07/214.24  |- mesh__recordOriginator mesh__D008359 RLS
% 214.07/214.24  |- rdf__type mesh__D008359sskos__Concept
% 214.07/214.24  |- skos__altLabel mesh__D008359 Mannosephosphate Isomerase
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D008359 2004
% 214.07/214.24  |- skos__hiddenLabel mesh__D008359 Mannose 6 Phosphate Isomerase
% 214.07/214.24  |- skos__altLabel mesh__D008359 Phosphomannose Isomerase
% 214.07/214.24  |- skos__broader mesh__D008359smesh__D019747
% 214.07/214.24  |- mesh__dateEstablished mesh__D008359 1991-01-01
% 214.07/214.24  |- mesh__recordAuthorizer mesh__D008359 sjn
% 214.07/214.24  |- mesh__publicMeSHNote mesh__D008359
% 214.07/214.24       98; see MANNOSEPHOSPHATE ISOMERASE 1991-97, see CARBOHYDRATE ISOMERASES 1978-90; for MANNOSE-6-PHOSPHATE ISOMERASE see MANNOSEPHOSPHATE ISOMERASE 1978-97%A%  
% 214.07/214.24  |- mesh__dateCreated mesh__D008359 1977-04-15
% 214.07/214.24  |- mesh__historyNote mesh__D008359 98%28%78%29%   
% 214.07/214.24  |- skos__hiddenLabel mesh__D008359 Isomerase, Phosphomannose
% 214.07/214.24  |- skos__prefLabel mesh__D008359 Mannose-6-Phosphate Isomerase
% 214.07/214.24  |- mesh__recordMaintainer mesh__D008359 ssb
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D008359 2006
% 214.07/214.24  |- skos__historyNote mesh__D008359
% 214.07/214.24       Carbohydrate Isomerases %28%1973-1977%29%
% 214.07/214.24  |- skos__hiddenLabel mesh__D008359 Isomerase, Mannosephosphate
% 214.07/214.24  |- mesh__historyNote mesh__D000376
% 214.07/214.24       91%28%75%29%; was see under GUANIDINES 1975-90   
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D000376 2003
% 214.07/214.24  |- mesh__dateRevised mesh__D000376 2000-06-21
% 214.07/214.24  |- mesh__recordAuthorizer mesh__D000376 sjn
% 214.07/214.24  |- mesh__recordOriginator mesh__D000376 NLM
% 214.07/214.24  |- mesh__dateEstablished mesh__D000376 1991-01-01
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D000376 2006
% 214.07/214.24  |- skos__broader mesh__D000376smesh__D006146
% 214.07/214.24  |- skos__scopeNote mesh__D000376
% 214.07/214.24       Decarboxylated arginine, isolated from several plant and animal sources, e.g., pollen, ergot, herring sperm, octopus muscle.%A%    
% 214.07/214.24  |- skos__altLabel mesh__D000376 4-%28%Aminobutyl%29%guanidine
% 214.07/214.24  |- mesh__publicMeSHNote mesh__D000376
% 214.07/214.24       91; was see under GUANIDINES 1975-90   
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D000376 2001
% 214.07/214.24  |- mesh__dateCreated mesh__D000376 1974-11-19
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D000376 2005
% 214.07/214.24  |- skos__historyNote mesh__D000376 Butylamines %28%1973-1974%29%
% 214.07/214.24  |- rdf__type mesh__D000376sskos__Concept
% 214.07/214.24  |- skos__hiddenLabel mesh__D000376 1 Amino 4 guanidinobutane
% 214.07/214.24  |- skos__historyNote mesh__D000376 Guanidines %28%1968-1974%29%
% 214.07/214.24  |- skos__prefLabel mesh__D000376 Agmatine
% 214.07/214.24  |- skos__altLabel mesh__D000376 1-Amino-4-guanidinobutane
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D000376 2004
% 214.07/214.24  |- mesh__recordMaintainer mesh__D000376 CCR
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D000376 2002
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D019081 2006
% 214.07/214.24  |- skos__hiddenLabel mesh__D019081 O Specific Polysaccharides
% 214.07/214.24  |- mesh__onlineNote mesh__D019081
% 214.07/214.24       use O ANTIGENS %28%NM%29% to search O ANTIGEN, BACTERIAL 1981-95%A%  
% 214.07/214.24  |- skos__altLabel mesh__D019081 O Antigen, Bacterial
% 214.07/214.24  |- mesh__recordAuthorizer mesh__D019081 sjn
% 214.07/214.24  |- skos__broader mesh__D019081smesh__D008070
% 214.07/214.24  |- mesh__recordOriginator mesh__D019081 AGS
% 214.07/214.24  |- skos__historyNote mesh__D019081 Antigens, Bacterial %28%1981-1992%29%
% 214.07/214.24  |- skos__altLabel mesh__D019081 O-Specific Polysaccharide
% 214.07/214.24  |- skos__scopeNote mesh__D019081
% 214.07/214.24       The lipopolysaccharide-protein somatic antigens, usually from gram-negative bacteria, important in the serological classification of enteric bacilli. The O-specific chains determine the specificity of the O antigens of a given serotype. O antigens are the immunodominant part of the lipopolysaccharide molecule in the intact bacterial cell. %28%From Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed%29%%A%    
% 214.07/214.24  |- mesh__dateRevised mesh__D019081 2005-06-30
% 214.07/214.24  |- skos__historyNote mesh__D019081
% 214.07/214.24       Polysaccharides, Bacterial %28%1993-1995%29%
% 214.07/214.24  |- mesh__publicMeSHNote mesh__D019081
% 214.07/214.24       96; O ANTIGEN, BACTERIAL was indexed under POLYSACCHARIDES, BACTERIAL 1993-95 %26% ANTIGENS, BACTERIAL 1981-92%A%  
% 214.07/214.24  |- skos__hiddenLabel mesh__D019081 Antigen, O
% 214.07/214.24  |- skos__altLabel mesh__D019081 O-Antigens
% 214.07/214.24  |- skos__hiddenLabel mesh__D019081 O Specific Polysaccharide
% 214.07/214.24  |- mesh__dateEstablished mesh__D019081 1996-01-01
% 214.07/214.24  |- mesh__dateCreated mesh__D019081 1995-06-05
% 214.07/214.24  |- skos__hiddenLabel mesh__D019081 Polysaccharides, O-Specific
% 214.07/214.24  |- skos__hiddenLabel mesh__D019081 Polysaccharide, O-Specific
% 214.07/214.24  |- skos__prefLabel mesh__D019081 O Antigens
% 214.07/214.24  |- skos__altLabel mesh__D019081 O-Specific Polysaccharides
% 214.07/214.24  |- mesh__recordMaintainer mesh__D019081 ssb
% 214.07/214.24  |- mesh__historyNote mesh__D019081
% 214.07/214.24       96; was O ANTIGEN, BACTERIAL %28%NM%29% 1981-95   
% 214.07/214.24  |- skos__hiddenLabel mesh__D019081 Antigen, Bacterial O
% 214.07/214.24  |- skos__hiddenLabel mesh__D019081 Bacterial O Antigen
% 214.07/214.24  |- skos__altLabel mesh__D019081 O Antigen
% 214.07/214.24  |- skos__hiddenLabel mesh__D019081 Antigens, O
% 214.07/214.24  |- rdf__type mesh__D019081sskos__Concept
% 214.07/214.24  |- skos__broader mesh__D005061smesh__D005060
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005061 2006
% 214.07/214.24  |- mesh__dateRevised mesh__D005061 1992-05-08
% 214.07/214.24  |- mesh__recordOriginator mesh__D005061 NLM
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005061 1999
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005061 2001
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005061 2005
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005061 1995
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005061 1998
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005061 2000
% 214.07/214.24  |- mesh__recordAuthorizer mesh__D005061 PLS
% 214.07/214.24  |- skos__prefLabel mesh__D005061 Europe, Eastern
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005061 1994
% 214.07/214.24  |- skos__annotation mesh__D005061
% 214.07/214.24       in translations of historical articles use spelling: People%27%s Republic, not Peoples%27% nor Peoples%A%  
% 214.07/214.24  |- mesh__recordMaintainer mesh__D005061 PLS
% 214.07/214.24  |- rdf__type mesh__D005061sskos__Concept
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005061 2004
% 214.07/214.24  |- mesh__dateCreated mesh__D005061 1999-01-01
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005061 1997
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005061 2002
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005061 2003
% 214.07/214.24  |- skos__altLabel mesh__D005061 Eastern Europe
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005061 1993
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D005061 1996
% 214.07/214.24  |- skos__altLabel mesh__D018787 Radiology, Therapeutic
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D018787 2003
% 214.07/214.24  |- skos__altLabel mesh__D018787 Oncology, Radiation
% 214.07/214.24  |- rdf__type mesh__D018787sskos__Concept
% 214.07/214.24  |- skos__historyNote mesh__D018787 Neoplasms/radiotherapy %28%1975-1994%29%
% 214.07/214.24  |- skos__broader mesh__D018787smesh__D008495
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D018787 2001
% 214.07/214.24  |- mesh__historyNote mesh__D018787 95   
% 214.07/214.24  |- skos__annotation mesh__D018787
% 214.07/214.24       SPEC: SPEC qualif; do not confuse X ref THERAPEUTIC RADIOLOGY %28%a specialty%29% with RADIOTHERAPY %28%a ther technique%29%; DF: RAD ONCOL%A%  
% 214.07/214.24  |- skos__broader mesh__D018787smesh__D011871
% 214.07/214.24  |- mesh__recordMaintainer mesh__D018787 PXP
% 214.07/214.24  |- mesh__dateEstablished mesh__D018787 1995-01-01
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D018787 2000
% 214.07/214.24  |- mesh__dateRevised mesh__D018787 1997-06-20
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D018787 2006
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D018787 1999
% 214.07/214.24  |- mesh__recordAuthorizer mesh__D018787 SJN
% 214.07/214.24  |- mesh__dateCreated mesh__D018787 1994-05-31
% 214.07/214.24  |- mesh__recordOriginator mesh__D018787 TGC
% 214.07/214.24  |- skos__historyNote mesh__D018787 Medical Oncology %28%1979-1994%29%
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D018787 2005
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D018787 1998
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D018787 2004
% 214.07/214.24  |- skos__prefLabel mesh__D018787 Radiation Oncology
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D018787 2002
% 214.07/214.24  |- skos__scopeNote mesh__D018787
% 214.07/214.24       A subspecialty of medical oncology and radiology concerned with the radiotherapy of cancer.%A%    
% 214.07/214.24  |- mesh__publicMeSHNote mesh__D018787 95   
% 214.07/214.24  |- skos__hiddenLabel mesh__D037941 Silencer Element
% 214.07/214.24  |- mesh__dateCreated mesh__D037941 2002-07-03
% 214.07/214.24  |- mesh__dateRevised mesh__D037941 2005-08-03
% 214.07/214.24  |- mesh__recordMaintainer mesh__D037941 ags
% 214.07/214.24  |- skos__broader mesh__D037941smesh__D012045
% 214.07/214.24  |- skos__altLabel mesh__D037941 Transcriptional Silencer Elements
% 214.07/214.24  |- skos__altLabel mesh__D037941 Silencer Elements
% 214.07/214.24  |- skos__hiddenLabel mesh__D037941 Element, Silencer
% 214.07/214.24  |- skos__hiddenLabel mesh__D037941 Elements, Silencing
% 214.07/214.24  |- mesh__historyNote mesh__D037941 2003   
% 214.07/214.24  |- mesh__recordAuthorizer mesh__D037941 ags
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D037941 2006
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D037941 2006B
% 214.07/214.24  |- skos__hiddenLabel mesh__D037941 Transcriptional Silencer Element
% 214.07/214.24  |- skos__hiddenLabel mesh__D037941 Silencer Element, Transcriptional
% 214.07/214.24  |- mesh__recordOriginator mesh__D037941 nns
% 214.07/214.24  |- skos__hiddenLabel mesh__D037941 Silencing Element
% 214.07/214.24  |- skos__hiddenLabel mesh__D037941 Elements, Silencer
% 214.07/214.24  |- skos__prefLabel mesh__D037941 Silencer Elements, Transcriptional
% 214.07/214.24  |- mesh__dateEstablished mesh__D037941 2003-01-01
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D037941 2006A
% 214.07/214.24  |- skos__scopeNote mesh__D037941
% 214.07/214.24       Nucleic acid sequences that are involved in the negative regulation of GENETIC TRANSCRIPTION by chromatin silencing.%A%    
% 214.07/214.24  |- skos__broader mesh__D037941smesh__D040481
% 214.07/214.24  |- skos__hiddenLabel mesh__D037941 Elements, Transcriptional Silencer
% 214.07/214.24  |- skos__hiddenLabel mesh__D037941 Element, Silencing
% 214.07/214.24  |- mesh__publicMeSHNote mesh__D037941 2003   
% 214.07/214.24  |- skos__altLabel mesh__D037941 Silencing Elements
% 214.07/214.24  |- rdf__type mesh__D037941sskos__Concept
% 214.07/214.24  |- skos__hiddenLabel mesh__D037941 Element, Transcriptional Silencer
% 214.07/214.24  |- mesh__publicMeSHNote mesh__D004767
% 214.07/214.24       91; was see under CLOSTRIDIUM INFECTIONS 1969-90   
% 214.07/214.24  |- skos__scopeNote mesh__D004767
% 214.07/214.24       Disease caused by the liberation of exotoxins of CLOSTRIDIUM PERFRINGENS in the intestines of sheep, goats, cattle, foals, and piglets. Type B enterotoxemia in lambs is lamb dysentery; type C enterotoxemia in mature sheep produces %22%struck%22%, and in calves, lambs and piglets it produces hemorrhagic enterotoxemia; type D enterotoxemia in sheep and goats is pulpy-kidney disease or overeating disease.%A%    
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D004767 2004
% 214.07/214.24  |- mesh__historyNote mesh__D004767
% 214.07/214.24       91%28%69%29%; was see under CLOSTRIDIUM INFECTIONS 1969-90   
% 214.07/214.24  |- mesh__dateCreated mesh__D004767 1999-01-01
% 214.07/214.24  |- mesh__recordAuthorizer mesh__D004767 meshuser
% 214.07/214.24  |- skos__annotation mesh__D004767
% 214.07/214.24       Clostridium infect; animal only; check tag ANIMALS; coord IM with precoord animal/dis term %28%IM%29% + animal %28%NIM%29% or with animal %28%IM%29% in absence of precoord%A%  
% 214.07/214.24  |- skos__hiddenLabel mesh__D004767 Enterotoxemias
% 214.07/214.24  |- mesh__dateRevised mesh__D004767 2003-07-30
% 214.07/214.24  |- mesh__recordOriginator mesh__D004767 NLM
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D004767 2006
% 214.07/214.24  |- skos__historyNote mesh__D004767
% 214.07/214.24       Clostridium Infections/veterinary %28%1966-1968%29%
% 214.07/214.24  |- mesh__recordMaintainer mesh__D004767 meshuser
% 214.07/214.24  |- rdf__type mesh__D004767sskos__Concept
% 214.07/214.24  |- mesh__activeMeSHYear mesh__D004767 2005
% 214.07/214.24  |- mesh__dateEstablished mesh__D004767 1991-01-01
% 214.07/214.24  |- skos__broader mesh__D004767smesh__D003015
% 214.07/214.24  |- skos__prefLabel mesh__D004767 Enterotoxemia
% 214.07/214.24  |- skos__broader mesh__D004767smesh__D000820
% 214.07/214.25  |- skos__scopeNote mesh__D023921
% 214.07/214.25       Narrowing or constriction of a coronary artery.     
% 214.07/214.25  |- skos__broader mesh__D023921smesh__D003327
% 214.07/214.25  |- skos__altLabel mesh__D023921 Coronary Stenoses
% 214.07/214.25  |- mesh__dateEstablished mesh__D023921 2002-01-01
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D023921 2002
% 214.07/214.25  |- skos__hiddenLabel mesh__D023921 Coronary Artery Stenoses
% 214.07/214.25  |- skos__hiddenLabel mesh__D023921 Artery Stenoses, Coronary
% 214.07/214.25  |- skos__prefLabel mesh__D023921 Coronary Stenosis
% 214.07/214.25  |- skos__related mesh__D023921smesh__D003251
% 214.07/214.25  |- skos__hiddenLabel mesh__D023921 Stenosis, Coronary
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D023921 2005
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D023921 2003
% 214.07/214.25  |- mesh__dateCreated mesh__D023921 2001-07-25
% 214.07/214.25  |- skos__hiddenLabel mesh__D023921 Stenoses, Coronary
% 214.07/214.25  |- mesh__publicMeSHNote mesh__D023921
% 214.07/214.25       2002; see CORONARY DISEASE 1995-2001   
% 214.07/214.25  |- skos__hiddenLabel mesh__D023921 Stenoses, Coronary Artery
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D023921 2006
% 214.07/214.25  |- skos__hiddenLabel mesh__D023921 Stenosis, Coronary Artery
% 214.07/214.25  |- skos__historyNote mesh__D023921 Coronary Disease %28%1965-2001%29%
% 214.07/214.25  |- rdf__type mesh__D023921sskos__Concept
% 214.07/214.25  |- skos__altLabel mesh__D023921 Coronary Artery Stenosis
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D023921 2004
% 214.07/214.25  |- skos__hiddenLabel mesh__D023921 Artery Stenosis, Coronary
% 214.07/214.25  |- mesh__historyNote mesh__D023921 2002; use CORONARY DISEASE 1995-2001   
% 214.07/214.25  |- skos__annotation mesh__D009452
% 214.07/214.25       SPEC only, SPEC qualif; not for coord of NERVOUS SYSTEM + ENDOCRINE GLANDS nor for ENDOCRINE GLANDS /innerv; DF: NEUROENDOCRINOL%A%  
% 214.07/214.25  |- mesh__recordMaintainer mesh__D009452 jls
% 214.07/214.25  |- mesh__recordAuthorizer mesh__D009452 sjn
% 214.07/214.25  |- skos__broader mesh__D009452smesh__D009488
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D009452 2005
% 214.07/214.25  |- mesh__historyNote mesh__D009452 86   
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D009452 2002
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D009452 2004
% 214.07/214.25  |- mesh__publicMeSHNote mesh__D009452 86   
% 214.07/214.25  |- rdf__type mesh__D009452sskos__Concept
% 214.07/214.25  |- mesh__dateCreated mesh__D009452 1985-06-06
% 214.07/214.25  |- mesh__dateRevised mesh__D009452 2001-07-25
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D009452 2003
% 214.07/214.25  |- skos__scopeNote mesh__D009452
% 214.07/214.25       The study of the anatomical and functional relationships between the nervous system and the endocrine system.%A%    
% 214.07/214.25  |- mesh__dateEstablished mesh__D009452 1986-01-01
% 214.07/214.25  |- skos__prefLabel mesh__D009452 Neuroendocrinology
% 214.07/214.25  |- skos__broader mesh__D009452smesh__D004704
% 214.07/214.25  |- mesh__recordOriginator mesh__D009452 EC
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D009452 2006
% 214.07/214.25  |- skos__scopeNote mesh__D014397 Tuberculosis of the lungs.     
% 214.07/214.25  |- mesh__dateRevised mesh__D014397 2005-06-30
% 214.07/214.25  |- skos__altLabel mesh__D014397 Pulmonary Tuberculosis
% 214.07/214.25  |- skos__altLabel mesh__D014397 Pulmonary Tuberculoses
% 214.07/214.25  |- mesh__historyNote mesh__D014397
% 214.07/214.25       TUBERCULOSIS IN CHILDHOOD was heading 1963-89   
% 214.07/214.25  |- skos__altLabel mesh__D014397 Tuberculoses, Pulmonary
% 214.07/214.25  |- skos__related mesh__D014397smesh__D011013
% 214.07/214.25  |- mesh__recordAuthorizer mesh__D014397 sjn
% 214.07/214.25  |- skos__broader mesh__D014397smesh__D012141
% 214.07/214.25  |- skos__related mesh__D014397smesh__D003096
% 214.07/214.25  |- skos__annotation mesh__D014397
% 214.07/214.25       tuberculosis unspecified probably goes here, check text; atypical mycobacterial infections of the lung = TUBERCULOSIS, PULMONARY + MYCOBACTERIUM INFECTIONS, ATYPICAL %28%IM%29%; DF: TUBERCULOSIS PULM%A%  
% 214.07/214.25  |- rdf__type mesh__D014397sskos__Concept
% 214.07/214.25  |- mesh__dateCreated mesh__D014397 1999-01-01
% 214.07/214.25  |- mesh__recordOriginator mesh__D014397 NLM
% 214.07/214.25  |- skos__prefLabel mesh__D014397 Tuberculosis, Pulmonary
% 214.07/214.25  |- skos__broader mesh__D014397smesh__D014376
% 214.07/214.25  |- skos__altLabel mesh__D014397 Phthisis
% 214.07/214.25  |- skos__related mesh__D014397smesh__D008400
% 214.07/214.25  |- mesh__recordMaintainer mesh__D014397 ags
% 214.07/214.25  |- mesh__onlineNote mesh__D014397
% 214.07/214.25       use TUBERCULOSIS, PULMONARY to search TUBERCULOSIS IN CHILDHOOD 1966-89%A%  
% 214.07/214.25  |- skos__broader mesh__D014397smesh__D008171
% 214.07/214.25  |- mesh__publicMeSHNote mesh__D014397
% 214.07/214.25       TUBERCULOSIS IN CHILDHOOD was heading 1963-89   
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D014397 2006
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D019880 2006
% 214.07/214.25  |- mesh__dateEstablished mesh__D019880 1998-01-01
% 214.07/214.25  |- skos__prefLabel mesh__D019880 Aldehyde-Ketone Transferases
% 214.07/214.25  |- rdf__type mesh__D019880sskos__Concept
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D019880 2005
% 214.07/214.25  |- mesh__publicMeSHNote mesh__D019880 98   
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D019880 2004
% 214.07/214.25  |- mesh__dateCreated mesh__D019880 1997-06-20
% 214.07/214.25  |- mesh__dateRevised mesh__D019880 2003-07-09
% 214.07/214.25  |- skos__broader mesh__D019880smesh__D014166
% 214.07/214.25  |- mesh__historyNote mesh__D019880 98   
% 214.07/214.25  |- skos__hiddenLabel mesh__D019880 Transferases, Aldehyde-Ketone
% 214.07/214.25  |- skos__historyNote mesh__D019880 Transferases %28%1971-1997%29%
% 214.07/214.25  |- skos__scopeNote mesh__D019880
% 214.07/214.25       Enzymes that catalyze the transfer of aldehyde or ketone residues. EC 2.2.%A%    
% 214.07/214.25  |- skos__hiddenLabel mesh__D019880 Aldehyde Ketone Transferases
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosias, Auditory
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosia, Topographical
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosia, Congenital Auditory
% 214.07/214.25  |- skos__altLabel mesh__D000377 Olfactory Agnosia
% 214.07/214.25  |- mesh__recordMaintainer mesh__D000377 KEV
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D000377 2003
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosias, Sensory
% 214.07/214.25  |- mesh__recordAuthorizer mesh__D000377 sjn
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Tactile Agnosias
% 214.07/214.25  |- rdf__type mesh__D000377sskos__Concept
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D000377 2002
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Finger Agnosias
% 214.07/214.25  |- mesh__dateCreated mesh__D000377 1999-01-01
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosia for Tastes
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosia, Sensory
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Auditory Agnosias
% 214.07/214.25  |- mesh__recordOriginator mesh__D000377 NLM
% 214.07/214.25  |- skos__annotation mesh__D000377
% 214.07/214.25       coord IM with type of stimulus that is not recognized %28%IM%29%%A%  
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Syndromes, Visual Disorientation
% 214.07/214.25  |- skos__prefLabel mesh__D000377 Agnosia
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosia, Ideational
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosia, Position
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosia, Developmental
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosia, Tactile
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosia, Finger
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosias, Time
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosia, Time
% 214.07/214.25  |- skos__altLabel mesh__D000377 Visual Disorientation Syndrome
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Body-Image Agnosias
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosias, Topographical
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosias, Visual
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D000377 2001
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosia, Visuospatial
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosias, Congenital Auditory
% 214.07/214.25  |- skos__altLabel mesh__D000377 Congenital Auditory Agnosia
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosia, Auditory
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D000377 2006
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosia, Visual
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosia, Body-Image
% 214.07/214.25  |- skos__broader mesh__D000377smesh__D010468
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Developmental Agnosias
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Somatosensory Agnosias
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosias, Visuospatial
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosias, Body-Image
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosias, Developmental
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D000377 2000
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Visual Agnosias
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosias, Olfactory
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Visual Disorientation Syndromes
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosias
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D000377 2005
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosia, Olfactory
% 214.07/214.25  |- skos__scopeNote mesh__D000377
% 214.07/214.25       Loss of the ability to comprehend the meaning or recognize the importance of various forms of stimulation that cannot be attributed to impairment of a primary sensory modality. Tactile agnosia is characterized by an inability to perceive the shape and nature of an object by touch alone, despite unimpaired sensation to light touch, position, and other primary sensory modalities.%A%    
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Time Agnosias
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Body Image Agnosia
% 214.07/214.25  |- mesh__dateRevised mesh__D000377 1999-11-08
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Congenital Auditory Agnosias
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Auditory Agnosias, Congenital
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Ideational Agnosias
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Position Agnosias
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Syndrome, Visual Disorientation
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosias, Tactile
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosias, Finger
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Topographical Agnosias
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Sensory Agnosias
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosia, Somatosensory
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Olfactory Agnosias
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Visuospatial Agnosias
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosias, Somatosensory
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosias, Ideational
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D000377 2004
% 214.07/214.25  |- skos__hiddenLabel mesh__D000377 Agnosias, Position
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D019082 2004
% 214.07/214.25  |- skos__hiddenLabel mesh__D019082 Smith Lemli Opitz Syndrome, Type I
% 214.07/214.25  |- mesh__historyNote mesh__D019082 96   
% 214.07/214.25  |- mesh__recordAuthorizer mesh__D019082 sjn
% 214.07/214.25  |- skos__hiddenLabel mesh__D019082 Smith Lemli Opitz Syndrome, Type II
% 214.07/214.25  |- skos__hiddenLabel mesh__D019082 RSH SLO Syndrome
% 214.07/214.25  |- mesh__dateCreated mesh__D019082 1995-06-05
% 214.07/214.25  |- mesh__recordOriginator mesh__D019082 AGS
% 214.07/214.25  |- mesh__dateRevised mesh__D019082 2003-07-09
% 214.07/214.25  |- skos__annotation mesh__D019082
% 214.07/214.25       an inborn error of lipid metab; the syndrome is named for the authors first describing it, the X ref RSH SYNDROME refers to the initials of the surnames of the first 3 patients%A%  
% 214.07/214.25  |- skos__prefLabel mesh__D019082 Smith-Lemli-Opitz Syndrome
% 214.07/214.25  |- skos__hiddenLabel mesh__D019082 RSH Syndromes
% 214.07/214.25  |- skos__altLabel mesh__D019082 RSH-SLO Syndrome
% 214.07/214.25  |- mesh__dateEstablished mesh__D019082 1996-01-01
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D019082 2005
% 214.07/214.25  |- skos__historyNote mesh__D019082
% 214.07/214.25       Abnormalities, Multiple %28%1967-1995%29%
% 214.07/214.25  |- mesh__recordMaintainer mesh__D019082 jmp
% 214.07/214.25  |- skos__hiddenLabel mesh__D019082 Smith Lemli Opitz Syndrome
% 214.07/214.25  |- rdf__type mesh__D019082sskos__Concept
% 214.07/214.25  |- skos__scopeNote mesh__D019082
% 214.07/214.25       Autosomal recessive disorder characterized by multiple congenital anomalies including microcephaly, mental retardation, unusual facies, and genital abnormalities. The biochemical defect is a lack of 7-dehydrocholesterol-delta-7-reductase, resulting in abnormally high levels of 7-dehydrocholesterol and low levels of cholesterol.%A%    
% 214.07/214.25  |- skos__broader mesh__D019082smesh__D008052
% 214.07/214.25  |- mesh__publicMeSHNote mesh__D019082 96   
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D019082 2006
% 214.07/214.25  |- skos__hiddenLabel mesh__D019082 RSH-SLO Syndromes
% 214.07/214.25  |- skos__broader mesh__D019082smesh__D043202
% 214.07/214.25  |- skos__broader mesh__D019082smesh__D000015
% 214.07/214.25  |- skos__altLabel mesh__D019082 RSH Syndrome
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005860 2002
% 214.07/214.25  |- mesh__recordAuthorizer mesh__D005860 ags
% 214.07/214.25  |- skos__annotation mesh__D005860
% 214.07/214.25       for West Germany 23 May 1949-3 Oct 1990; Manual 36.11; BERLIN is also available; in German texts as BRD %28%Bundesrepublik Deutschland%29%%A%  
% 214.07/214.25  |- skos__altLabel mesh__D005860 Germany, Federal Republic of
% 214.07/214.25  |- skos__altLabel mesh__D005860 Federal Republic of Germany
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005860 2001
% 214.07/214.25  |- skos__broader mesh__D005860smesh__D005858
% 214.07/214.25  |- mesh__dateCreated mesh__D005860 1999-01-01
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005860 2004
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005860 2000
% 214.07/214.25  |- mesh__dateRevised mesh__D005860 1999-12-01
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005860 2006
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005860 2003
% 214.07/214.25  |- skos__prefLabel mesh__D005860 Germany, West
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005860 2000A
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005860 2005
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005860 1997
% 214.07/214.25  |- mesh__recordMaintainer mesh__D005860 ags
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005860 1999
% 214.07/214.25  |- mesh__recordOriginator mesh__D005860 NLM
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005860 1996
% 214.07/214.25  |- rdf__type mesh__D005860sskos__Concept
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005860 1995
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005860 1998
% 214.07/214.25  |- mesh__dateEstablished mesh__D005062 1976-01-01
% 214.07/214.25  |- mesh__dateRevised mesh__D005062 2005-10-31
% 214.07/214.25  |- skos__altLabel mesh__D005062 European Common Market
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005062 2006A
% 214.07/214.25  |- mesh__dateCreated mesh__D005062 1975-07-18
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005062 2006
% 214.07/214.25  |- skos__historyNote mesh__D005062 Economics %28%1966-1975%29%
% 214.07/214.25  |- mesh__historyNote mesh__D005062 98%28%76%29%   
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005062 2006B
% 214.07/214.25  |- skos__altLabel mesh__D005062 Economic Community, European
% 214.07/214.25  |- mesh__publicMeSHNote mesh__D005062
% 214.07/214.25       98; see EUROPEAN ECONOMIC COMMUNITY 1976-97   
% 214.07/214.25  |- mesh__recordMaintainer mesh__D005062 jls
% 214.07/214.25  |- rdf__type mesh__D005062sskos__Concept
% 214.07/214.25  |- skos__altLabel mesh__D005062 European Economic Community
% 214.07/214.25  |- skos__altLabel mesh__D005062 European Community
% 214.07/214.25  |- skos__prefLabel mesh__D005062 European Union
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005062 2004
% 214.07/214.25  |- skos__annotation mesh__D005062
% 214.07/214.25       name specific European country if pertinent     CATALOG: Use NAF entry%A%  
% 214.07/214.25  |- mesh__recordAuthorizer mesh__D005062 jls
% 214.07/214.25  |- skos__historyNote mesh__D005062
% 214.07/214.25       International Cooperation %28%1966-1975%29%
% 214.07/214.25  |- skos__broader mesh__D005062smesh__D019049
% 214.07/214.25  |- skos__altLabel mesh__D005062 Community, European Economic
% 214.07/214.25  |- skos__scopeNote mesh__D005062
% 214.07/214.25       The collective designation of three organizations with common membership: the European Economic Community %28%Common Market%29%, the European Coal and Steel Community, and the European Atomic Energy Community %28%Euratom%29%. It was known as the European Community until 1994. It is primarily an economic union with the principal objectives of free movement of goods, capital, and labor. Professional services, social, medical and paramedical, are subsumed under labor. The constituent countries are Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Netherlands, Portugal, Spain, Sweden, and the United Kingdom. %28%The World Almanac and Book of Facts 1997, p842%29%%A%    
% 214.07/214.25  |- skos__altLabel mesh__D005062 EEC
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005062 2005
% 214.07/214.25  |- skos__broader mesh__D005062smesh__D017516
% 214.07/214.25  |- mesh__recordOriginator mesh__D005062 EC
% 214.07/214.25  |- skos__scopeNote mesh__D018788
% 214.07/214.25       Accidental dispersal of radioactive materials from a radiation source. Accidents at nuclear reactors can involve large groups of the population from dispersion of radioactivity into the environment and through fallout or a few individuals with high injurious doses.%A%    
% 214.07/214.25  |- skos__broader mesh__D018788smesh__D000059
% 214.07/214.25  |- skos__historyNote mesh__D018788 Radiation Injuries %28%1966-1994%29%
% 214.07/214.25  |- skos__hiddenLabel mesh__D018788 Accident, Nuclear Reactor
% 214.07/214.25  |- skos__hiddenLabel mesh__D018788 Reactor Accidents, Nuclear
% 214.07/214.25  |- skos__annotation mesh__D018788
% 214.07/214.25       usually accidents %26% exposure at nuclear reactors so do not index also under NUCLEAR REACTORS; specify other rad source %28%IM%29%; IM; coord with specific inj or med aspect %28%IM%29%; do not index here for rad inj during radiother or radiodiag: index under specific radiother or radiodiag heading; specify geog; DF: ACCIDENTS RAD%A%  
% 214.07/214.25  |- mesh__dateEstablished mesh__D018788 1995-01-01
% 214.07/214.25  |- rdf__type mesh__D018788sskos__Concept
% 214.07/214.25  |- mesh__recordOriginator mesh__D018788 TGC
% 214.07/214.25  |- skos__altLabel mesh__D018788 Accidents, Nuclear Reactor
% 214.07/214.25  |- mesh__recordMaintainer mesh__D018788 kle
% 214.07/214.25  |- skos__historyNote mesh__D018788 Accidents %28%1967-1994%29%
% 214.07/214.25  |- mesh__historyNote mesh__D018788 95   
% 214.07/214.25  |- skos__altLabel mesh__D018788 Radiation Accidents
% 214.07/214.25  |- mesh__publicMeSHNote mesh__D018788 95   
% 214.07/214.25  |- mesh__dateCreated mesh__D018788 1994-06-30
% 214.07/214.25  |- mesh__recordAuthorizer mesh__D018788 sjn
% 214.07/214.25  |- skos__historyNote mesh__D018788 Nuclear Reactors %28%1967-1994%29%
% 214.07/214.25  |- skos__broader mesh__D018788smesh__D000062
% 214.07/214.25  |- skos__hiddenLabel mesh__D018788 Nuclear Accident
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D018788 2005
% 214.07/214.25  |- skos__hiddenLabel mesh__D018788 Reactor Accident, Nuclear
% 214.07/214.25  |- skos__related mesh__D018788smesh__D011832
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D018788 2000
% 214.07/214.25  |- skos__altLabel mesh__D018788 Accidents, Nuclear
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D018788 2006
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D018788 2003
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D018788 2001
% 214.07/214.25  |- skos__hiddenLabel mesh__D018788 Accident, Nuclear
% 214.07/214.25  |- skos__hiddenLabel mesh__D018788 Nuclear Reactor Accident
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D018788 2004
% 214.07/214.25  |- skos__altLabel mesh__D018788 Accident, Radiation
% 214.07/214.25  |- mesh__dateRevised mesh__D018788 1999-11-03
% 214.07/214.25  |- skos__prefLabel mesh__D018788 Accidents, Radiation
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D018788 2002
% 214.07/214.25  |- skos__altLabel mesh__D018788 Radiation Accident
% 214.07/214.25  |- skos__scopeNote mesh__D004768
% 214.07/214.25       Substances that are toxic to the intestinal tract causing vomiting, diarrhea, etc.; most common enterotoxins are produced by bacteria.%A%    
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D004768 2006
% 214.07/214.25  |- mesh__recordAuthorizer mesh__D004768 sjn
% 214.07/214.25  |- rdf__type mesh__D004768sskos__Concept
% 214.07/214.25  |- skos__related mesh__D004768smesh__D013202
% 214.07/214.25  |- mesh__dateEstablished mesh__D004768 1968-01-01
% 214.07/214.25  |- skos__broader mesh__D004768smesh__D014118
% 214.07/214.25  |- skos__annotation mesh__D004768
% 214.07/214.25       /antag permitted but consider also ANTITOXINS; coord IM with specific bacterium %28%IM or NIM%29%%A%  
% 214.07/214.25  |- mesh__publicMeSHNote mesh__D004768 68   
% 214.07/214.25  |- mesh__onlineNote mesh__D004768
% 214.07/214.25       use ENTEROTOXINS to search ENTEROTOXIN 1966-67 %28%as Prov%29%   
% 214.07/214.25  |- mesh__historyNote mesh__D004768
% 214.07/214.25       68; was ENTEROTOXIN 1964-67 %28%Prov%29%   
% 214.07/214.25  |- skos__altLabel mesh__D004768 Enterotoxin
% 214.07/214.25  |- mesh__recordMaintainer mesh__D004768 ssb
% 214.07/214.25  |- mesh__recordOriginator mesh__D004768 NLM
% 214.07/214.25  |- skos__prefLabel mesh__D004768 Enterotoxins
% 214.07/214.25  |- mesh__dateRevised mesh__D004768 2005-06-30
% 214.07/214.25  |- mesh__dateCreated mesh__D004768 1999-01-01
% 214.07/214.25  |- skos__prefLabel mesh__D015490 HTLV-I Infections
% 214.07/214.25  |- mesh__publicMeSHNote mesh__D015490 89   
% 214.07/214.25  |- mesh__dateRevised mesh__D015490 2001-07-25
% 214.07/214.25  |- skos__altLabel mesh__D015490 Infections, HTLV-I
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D015490 2006
% 214.07/214.25  |- skos__annotation mesh__D015490
% 214.07/214.25       GEN or unspecified; consider also LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED %26% PARAPARESIS, TROPICAL SPASTIC; DF: HTLV I INFECT%A%  
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D015490 2003
% 214.07/214.25  |- skos__related mesh__D015490smesh__D015493
% 214.07/214.25  |- skos__hiddenLabel mesh__D015490 Infections, HTLV I
% 214.07/214.25  |- skos__broader mesh__D015490smesh__D006800
% 214.07/214.25  |- mesh__recordAuthorizer mesh__D015490 sjn
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D015490 2004
% 214.07/214.25  |- mesh__dateEstablished mesh__D015490 1989-01-01
% 214.07/214.25  |- skos__hiddenLabel mesh__D015490 HTLV I Infections
% 214.07/214.25  |- rdf__type mesh__D015490sskos__Concept
% 214.07/214.25  |- mesh__recordMaintainer mesh__D015490 ags
% 214.07/214.25  |- mesh__historyNote mesh__D015490 89   
% 214.07/214.25  |- skos__hiddenLabel mesh__D015490 Infection, HTLV-I
% 214.07/214.25  |- skos__hiddenLabel mesh__D015490 HTLV-I Infection
% 214.07/214.25  |- skos__historyNote mesh__D015490 HTLV Infections %28%1987-1988%29%
% 214.07/214.25  |- skos__historyNote mesh__D015490 Retrovirus Infections %28%1985-1986%29%
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D015490 2005
% 214.07/214.25  |- mesh__dateCreated mesh__D015490 1988-06-10
% 214.07/214.25  |- skos__historyNote mesh__D015490
% 214.07/214.25       Human T-Cell Leukemia Virus %28%1985-1987%29%
% 214.07/214.25  |- mesh__recordOriginator mesh__D015490 TC
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D015490 2002
% 214.07/214.25  |- skos__prefLabel mesh__D014398 Tuberculosis, Renal
% 214.07/214.25  |- rdf__type mesh__D014398sskos__Concept
% 214.07/214.25  |- mesh__dateCreated mesh__D014398 1999-01-01
% 214.07/214.25  |- skos__hiddenLabel mesh__D014398 Renal Tuberculoses
% 214.07/214.25  |- skos__scopeNote mesh__D014398
% 214.07/214.25       Infection of the KIDNEY with species of MYCOBACTERIUM.     
% 214.07/214.25  |- skos__hiddenLabel mesh__D014398 Tuberculoses, Renal
% 214.07/214.25  |- mesh__dateRevised mesh__D014398 2005-06-30
% 214.07/214.25  |- mesh__recordMaintainer mesh__D014398 lkt
% 214.07/214.25  |- skos__hiddenLabel mesh__D014398 Renal Tuberculosis
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D014398 2006
% 214.07/214.25  |- skos__broader mesh__D014398smesh__D014401
% 214.07/214.25  |- mesh__recordAuthorizer mesh__D014398 sjn
% 214.07/214.25  |- skos__broader mesh__D014398smesh__D007674
% 214.07/214.25  |- mesh__recordOriginator mesh__D014398 NLM
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D019881 2006
% 214.07/214.25  |- mesh__recordMaintainer mesh__D019881 ssb
% 214.07/214.25  |- mesh__recordAuthorizer mesh__D019881 sjn
% 214.07/214.25  |- skos__historyNote mesh__D019881 Acyltransferases %28%1967-1997%29%
% 214.07/214.25  |- rdf__type mesh__D019881sskos__Concept
% 214.07/214.25  |- mesh__recordOriginator mesh__D019881 KEV
% 214.07/214.25  |- mesh__dateEstablished mesh__D019881 1998-01-01
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D019881 2004
% 214.07/214.25  |- mesh__dateCreated mesh__D019881 1997-06-20
% 214.07/214.25  |- mesh__dateRevised mesh__D019881 2003-07-09
% 214.07/214.25  |- skos__broader mesh__D019881smesh__D000217
% 214.07/214.25  |- mesh__historyNote mesh__D019881 98   
% 214.07/214.25  |- skos__prefLabel mesh__D019881 Aminoacyltransferases
% 214.07/214.25  |- mesh__publicMeSHNote mesh__D019881 98   
% 214.07/214.25  |- skos__scopeNote mesh__D019881
% 214.07/214.25       Enzymes that catalyze the transfer of an aminoacyl group from donor to acceptor resulting in the formation of an ester or amide linkage. EC 2.3.2.%A%    
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D019881 2005
% 214.07/214.25  |- skos__hiddenLabel mesh__D000378 Behaviors, Agonistic
% 214.07/214.25  |- skos__scopeNote mesh__D000378
% 214.07/214.25       Any behavior associated with conflict between two individuals.%A%    
% 214.07/214.25  |- skos__prefLabel mesh__D000378 Agonistic Behavior
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D000378 2005
% 214.07/214.25  |- mesh__recordMaintainer mesh__D000378 JLS
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D000378 2006
% 214.07/214.25  |- mesh__recordAuthorizer mesh__D000378 sjn
% 214.07/214.25  |- mesh__recordOriginator mesh__D000378 NLM
% 214.07/214.25  |- mesh__dateEstablished mesh__D000378 1991-01-01
% 214.07/214.25  |- rdf__type mesh__D000378sskos__Concept
% 214.07/214.25  |- skos__hiddenLabel mesh__D000378 Behavior, Agonistic
% 214.07/214.25  |- skos__hiddenLabel mesh__D000378 Agonistic Behaviors
% 214.07/214.25  |- mesh__publicMeSHNote mesh__D000378
% 214.07/214.25       91; was see under AGGRESSION 1975-90   
% 214.07/214.25  |- mesh__dateCreated mesh__D000378 1999-01-01
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D000378 2003
% 214.07/214.25  |- mesh__historyNote mesh__D000378
% 214.07/214.25       91%28%75%29%; was see under AGGRESSION 1975-90   
% 214.07/214.25  |- mesh__onlineNote mesh__D000378 search AGGRESSION 1968-74   
% 214.07/214.25  |- skos__broader mesh__D000378smesh__D000374
% 214.07/214.25  |- mesh__dateRevised mesh__D000378 2002-07-02
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D000378 2004
% 214.07/214.25  |- mesh__dateCreated mesh__D019083 1995-06-05
% 214.07/214.25  |- skos__prefLabel mesh__D019083 Mediterranean Region
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D019083 1997
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D019083 2005
% 214.07/214.25  |- rdf__type mesh__D019083sskos__Concept
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D019083 2000
% 214.07/214.25  |- skos__broader mesh__D019083smesh__D005060
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D019083 2006
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D019083 2003
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D019083 2001
% 214.07/214.25  |- skos__scopeNote mesh__D019083
% 214.07/214.25       The MEDITERRANEAN SEA, the MEDITERRANEAN ISLANDS, and the countries bordering on the sea collectively.%A%    
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D019083 2004
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D019083 2002
% 214.07/214.25  |- skos__annotation mesh__D019083
% 214.07/214.25       the countries %26% people of the region in general or unspecified; prefer specific islands or countries%A%  
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D019083 1998
% 214.07/214.25  |- mesh__dateEstablished mesh__D019083 1996-01-01
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D019083 1999
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D019083 1996
% 214.07/214.25  |- mesh__historyNote mesh__D019083 96   
% 214.07/214.25  |- mesh__recordOriginator mesh__D005861 NLM
% 214.07/214.25  |- mesh__recordAuthorizer mesh__D005861 sjn
% 214.07/214.25  |- skos__prefLabel mesh__D005861 Germine Acetates
% 214.07/214.25  |- skos__scopeNote mesh__D005861
% 214.07/214.25       Germine derivatives acetylated on any one or more of the hydroxy groups. These compounds are present in many polyester alkaloids which occur in Veratrum and Zygadenus species. They are used as antihypertensive agents, and in some cases, exhibit curare-like activity.%A%    
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005861 2004
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005861 2002
% 214.07/214.25  |- skos__hiddenLabel mesh__D005861 Germine 3 monoacetate
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005861 2006
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005861 2003
% 214.07/214.25  |- mesh__dateRevised mesh__D005861 2000-06-21
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005861 2001
% 214.07/214.25  |- mesh__activeMeSHYear mesh__D005861 2005
% 214.07/214.25  |- skos__historyNote mesh__D005861 Veratrum %28%1972-1974%29%
% 214.07/214.25  |- mesh__publicMeSHNote mesh__D005861 91; was see under CEVANES 1975-90   
% 214.07/214.25  |- skos__broader mesh__D005861smesh__D002595
% 214.07/214.25  |- rdf__type mesh__D005861sskos__Concept
% 214.07/214.25  |- skos__hiddenLabel mesh__D005861 Acetates, Germine
% 214.07/214.25  |- mesh__historyNote mesh__D005861
% 214.07/214.25       91%28%75%29%; was see under CEVANES 1975-90   
% 214.07/214.25  |- mesh__recordMaintainer mesh__D005861 TWD
% 214.07/214.25  |- mesh__dateCreated mesh__D005861 1974-11-19
% 214.07/214.25  |- mesh__dateEstablished mesh__D005861 1991-01-01
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005063 2002
% 214.07/214.26  |- mesh__dateRevised mesh__D005063 2001-07-25
% 214.07/214.26  |- skos__annotation mesh__D005063
% 214.07/214.26       a rare earth metal; Eu-153; Eu-151 = EUROPIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Eu-144-150, 152, 154-160 = EUROPIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 214.07/214.26  |- mesh__dateCreated mesh__D005063 1999-01-01
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005063 2003
% 214.07/214.26  |- skos__scopeNote mesh__D005063
% 214.07/214.26       Europium. An element of the rare earth family of metals. It has the atomic symbol Eu, atomic number 63, and atomic weight 152. Europium is used in the form of its salts as coatings for cathode ray tubes and in the form of its organic derivatives as shift reagents in NMR spectroscopy.%A%    
% 214.07/214.26  |- rdf__type mesh__D005063sskos__Concept
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005063 2004
% 214.07/214.26  |- skos__broader mesh__D005063smesh__D028581
% 214.07/214.26  |- skos__prefLabel mesh__D005063 Europium
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005063 2005
% 214.07/214.26  |- mesh__recordMaintainer mesh__D005063 jmp
% 214.07/214.26  |- mesh__recordOriginator mesh__D005063 NLM
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005063 2006
% 214.07/214.26  |- mesh__recordAuthorizer mesh__D005063 sjn
% 214.07/214.26  |- skos__broader mesh__D014465Q000627smesh__D014465
% 214.07/214.26  |- mesh__preferredCombination mesh__D014465Q000627smesh__D014464
% 214.07/214.26  |- rdf__type mesh__D014465Q000627smesh__CompoundConcept
% 214.07/214.26  |- skos__altLabel mesh__D043182 Ali-esterase
% 214.07/214.26  |- skos__altLabel mesh__D043182 Carboxylate Esterase
% 214.07/214.26  |- skos__hiddenLabel mesh__D043182 Esterase, Non-specific
% 214.07/214.26  |- skos__altLabel mesh__D043182 CAP-hydrolyzing Enzyme
% 214.07/214.26  |- skos__hiddenLabel mesh__D043182 CAP hydrolyzing Enzyme
% 214.07/214.26  |- skos__hiddenLabel mesh__D043182 Esterase, Naproxen
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D043182 2005
% 214.07/214.26  |- skos__hiddenLabel mesh__D043182 Esterase, Procaine
% 214.07/214.26  |- skos__altLabel mesh__D043182 Carboxylesterase B
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D043182 2004
% 214.07/214.26  |- skos__altLabel mesh__D043182 Carboxylester Lipase
% 214.07/214.26  |- mesh__recordAuthorizer mesh__D043182 sjn
% 214.07/214.26  |- skos__hiddenLabel mesh__D043182 Esterase, Nonspecific
% 214.07/214.26  |- skos__hiddenLabel mesh__D043182 Enzyme, Capsaicin-Hydrolyzing
% 214.07/214.26  |- mesh__recordMaintainer mesh__D043182 jmp
% 214.07/214.26  |- skos__hiddenLabel mesh__D043182 Enzyme, CAP-hydrolyzing
% 214.07/214.26  |- skos__hiddenLabel mesh__D043182 Hydrolase, Carboxylic Ester
% 214.07/214.26  |- rdf__type mesh__D043182sskos__Concept
% 214.07/214.26  |- skos__altLabel mesh__D043182 Non-specific Esterase
% 214.07/214.26  |- skos__hiddenLabel mesh__D043182 Ester Hydrolase, Carboxylic
% 214.07/214.26  |- skos__broader mesh__D043182smesh__D002265
% 214.07/214.26  |- skos__altLabel mesh__D043182 B-esterase
% 214.07/214.26  |- skos__hiddenLabel mesh__D043182 ES-1A, Esterase
% 214.07/214.26  |- skos__scopeNote mesh__D043182
% 214.07/214.26       Carboxylesterase is a serine-dependent esterase with wide substrate specificity. The enzyme is involved in the detoxification of XENOBIOTICS and the activation of ester and of amide PRODRUGS.%A%    
% 214.07/214.26  |- skos__altLabel mesh__D043182 Carboxylic Ester Hydrolase
% 214.07/214.26  |- skos__hiddenLabel mesh__D043182 Lipase, Carboxylester
% 214.07/214.26  |- skos__hiddenLabel mesh__D043182 Carboxylesterase, Non-specific
% 214.07/214.26  |- skos__hiddenLabel mesh__D043182 Non specific Esterase
% 214.07/214.26  |- skos__hiddenLabel mesh__D043182 Ali esterase
% 214.07/214.26  |- mesh__dateCreated mesh__D043182 2003-07-09
% 214.07/214.26  |- skos__altLabel mesh__D043182 Non-specific Carboxylesterase
% 214.07/214.26  |- skos__hiddenLabel mesh__D043182 Non specific Carboxylesterase
% 214.07/214.26  |- skos__hiddenLabel mesh__D043182 Capsaicin Hydrolyzing Enzyme
% 214.07/214.26  |- skos__prefLabel mesh__D043182 Carboxylesterase
% 214.07/214.26  |- skos__hiddenLabel mesh__D043182 Esterase ES 1A
% 214.07/214.26  |- skos__altLabel mesh__D043182 Naproxen Esterase
% 214.07/214.26  |- skos__altLabel mesh__D043182 Procaine Esterase
% 214.07/214.26  |- skos__hiddenLabel mesh__D043182 amidase, Isocarboxazid
% 214.07/214.26  |- mesh__historyNote mesh__D043182
% 214.07/214.26       2004; use CARBOXYLESTERASE %28%NM%29% 1981 - 2003   
% 214.07/214.26  |- skos__altLabel mesh__D043182 Nonspecific Esterase
% 214.07/214.26  |- skos__altLabel mesh__D043182 Carboxyesterase
% 214.07/214.26  |- mesh__recordOriginator mesh__D043182 AKE
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D043182 2006
% 214.07/214.26  |- skos__altLabel mesh__D043182 Capsaicin-Hydrolyzing Enzyme
% 214.07/214.26  |- skos__altLabel mesh__D043182 Isocarboxazid amidase
% 214.07/214.26  |- mesh__dateEstablished mesh__D043182 2004-01-01
% 214.07/214.26  |- skos__hiddenLabel mesh__D043182 Esterase, Carboxylate
% 214.07/214.26  |- mesh__publicMeSHNote mesh__D043182
% 214.07/214.26       2004; CARBOXYLESTERASE was indexed under CARBOXYLIC ACID ESTERASES 1981-2003%A%  
% 214.07/214.26  |- skos__historyNote mesh__D043182
% 214.07/214.26       Carboxylic Ester Hydrolases %28%1981-2003%29%
% 214.07/214.26  |- skos__hiddenLabel mesh__D043182 B esterase
% 214.07/214.26  |- mesh__recordAuthorizer mesh__D004769 PLS
% 214.07/214.26  |- rdf__type mesh__D004769sskos__Concept
% 214.07/214.26  |- mesh__recordOriginator mesh__D004769 NLM
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D004769 2005
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D004769 1999
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D004769 1998
% 214.07/214.26  |- mesh__recordMaintainer mesh__D004769 PLS
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D004769 2002
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D004769 2004
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D004769 1995
% 214.07/214.26  |- skos__annotation mesh__D004769 caused by a picornavirus   
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D004769 2003
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D004769 1994
% 214.07/214.26  |- skos__broader mesh__D004769smesh__D010850
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D004769 1997
% 214.07/214.26  |- mesh__dateCreated mesh__D004769 1999-01-01
% 214.07/214.26  |- skos__hiddenLabel mesh__D004769 Infection, Enterovirus
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D004769 2001
% 214.07/214.26  |- skos__prefLabel mesh__D004769 Enterovirus Infections
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D004769 1996
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D004769 2006
% 214.07/214.26  |- mesh__dateRevised mesh__D004769 1993-05-27
% 214.07/214.26  |- skos__altLabel mesh__D004769 Infections, Enterovirus
% 214.07/214.26  |- skos__hiddenLabel mesh__D004769 Enterovirus Infection
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D004769 2000
% 214.07/214.26  |- skos__hiddenLabel mesh__D015491 HTLV-II Infection
% 214.07/214.26  |- mesh__dateEstablished mesh__D015491 1989-01-01
% 214.07/214.26  |- rdf__type mesh__D015491sskos__Concept
% 214.07/214.26  |- skos__hiddenLabel mesh__D015491 Infection, HTLV-II
% 214.07/214.26  |- skos__hiddenLabel mesh__D015491 Infections, HTLV II
% 214.07/214.26  |- skos__historyNote mesh__D015491 HTLV Infections %28%1987-1988%29%
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D015491 2002
% 214.07/214.26  |- mesh__recordMaintainer mesh__D015491 ags
% 214.07/214.26  |- mesh__recordOriginator mesh__D015491 TC
% 214.07/214.26  |- skos__historyNote mesh__D015491 Leukemia, Hairy Cell %28%1986-1988%29%
% 214.07/214.26  |- mesh__dateRevised mesh__D015491 2001-07-25
% 214.07/214.26  |- skos__altLabel mesh__D015491 Infections, HTLV-II
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D015491 2005
% 214.07/214.26  |- mesh__dateCreated mesh__D015491 1988-06-10
% 214.07/214.26  |- skos__prefLabel mesh__D015491 HTLV-II Infections
% 214.07/214.26  |- mesh__publicMeSHNote mesh__D015491 89   
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D015491 2006
% 214.07/214.26  |- mesh__recordAuthorizer mesh__D015491 sjn
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D015491 2003
% 214.07/214.26  |- skos__annotation mesh__D015491
% 214.07/214.26       GEN or unspecified; consider also LEUKEMIA, T-CELL, HTLV-II-ASSOCIATED; DF: HTLV II INFECT%A%  
% 214.07/214.26  |- skos__broader mesh__D015491smesh__D006800
% 214.07/214.26  |- mesh__historyNote mesh__D015491 89   
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D015491 2004
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D009454 2004
% 214.07/214.26  |- mesh__dateCreated mesh__D009454 1999-01-01
% 214.07/214.26  |- rdf__type mesh__D009454sskos__Concept
% 214.07/214.26  |- mesh__historyNote mesh__D009454 65   
% 214.07/214.26  |- skos__broader mesh__D009454smesh__D003599
% 214.07/214.26  |- skos__scopeNote mesh__D009454
% 214.07/214.26       The delicate interlacing threads, formed by aggregations of neurofilaments and neurotubules, coursing through the cytoplasm of the body of a neuron and extending from one dendrite into another or into the axon.%A%    
% 214.07/214.26  |- mesh__dateEstablished mesh__D009454 1965-01-01
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D009454 2005
% 214.07/214.26  |- skos__hiddenLabel mesh__D009454 Neurofibril
% 214.07/214.26  |- skos__annotation mesh__D009454
% 214.07/214.26       A 11 qualif except /cytol; /genet permitted; do not confuse with NERVE FIBERS%A%  
% 214.07/214.26  |- mesh__recordAuthorizer mesh__D009454 sjn
% 214.07/214.26  |- mesh__dateRevised mesh__D009454 2003-07-09
% 214.07/214.26  |- mesh__recordMaintainer mesh__D009454 nns
% 214.07/214.26  |- skos__broader mesh__D009454smesh__D009474
% 214.07/214.26  |- mesh__publicMeSHNote mesh__D009454 65   
% 214.07/214.26  |- mesh__recordOriginator mesh__D009454 NLM
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D009454 2006
% 214.07/214.26  |- skos__prefLabel mesh__D009454 Neurofibrils
% 214.07/214.26  |- skos__related mesh__D009454smesh__D016229
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D001471 2005
% 214.07/214.26  |- mesh__historyNote mesh__D001471
% 214.07/214.26       89%28%81%29%; was see under ESOPHAGEAL DISEASES 1981-88   
% 214.07/214.26  |- mesh__recordMaintainer mesh__D001471 lkt
% 214.07/214.26  |- mesh__recordAuthorizer mesh__D001471 sjn
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D001471 2004
% 214.07/214.26  |- skos__hiddenLabel mesh__D001471 Syndrome, Barrett
% 214.07/214.26  |- skos__hiddenLabel mesh__D001471 Barretts Syndrome
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D001471 2006
% 214.07/214.26  |- skos__prefLabel mesh__D001471 Barrett Esophagus
% 214.07/214.26  |- skos__historyNote mesh__D001471 Esophagitis, Peptic %28%1966-1980%29%
% 214.07/214.26  |- skos__broader mesh__D001471smesh__D004065
% 214.07/214.26  |- mesh__dateRevised mesh__D001471 2003-07-09
% 214.07/214.26  |- skos__broader mesh__D001471smesh__D004935
% 214.07/214.26  |- mesh__dateCreated mesh__D001471 1980-04-04
% 214.07/214.26  |- skos__historyNote mesh__D001471 Esophageal Stenosis %28%1966-1980%29%
% 214.07/214.26  |- skos__scopeNote mesh__D001471
% 214.07/214.26       A condition with damage to the lining of the lower ESOPHAGUS resulting from chronic acid reflux %28%ESOPHAGITIS, REFLUX%29%. Through the process of metaplasia, the squamous cells are replaced by a columnar epithelium with cells resembling those of the INTESTINE or the salmon-pink mucosa of the STOMACH. Barrett%27%s columnar epithelium is a marker for severe reflux and precursor to ADENOCARCINOMA of the esophagus.%A%    
% 214.07/214.26  |- skos__altLabel mesh__D001471 Barrett%27%s Syndrome
% 214.07/214.26  |- rdf__type mesh__D001471sskos__Concept
% 214.07/214.26  |- skos__altLabel mesh__D001471 Esophagus, Barrett
% 214.07/214.26  |- skos__altLabel mesh__D001471 Barrett Syndrome
% 214.07/214.26  |- skos__hiddenLabel mesh__D001471 Syndrome, Barrett%27%s
% 214.07/214.26  |- skos__hiddenLabel mesh__D001471 Barretts Esophagus
% 214.07/214.26  |- skos__hiddenLabel mesh__D001471 Epithelium, Barrett
% 214.07/214.26  |- skos__altLabel mesh__D001471 Barrett%27%s Esophagus
% 214.07/214.26  |- mesh__recordOriginator mesh__D001471 RC
% 214.07/214.26  |- mesh__dateEstablished mesh__D001471 1989-01-01
% 214.07/214.26  |- mesh__publicMeSHNote mesh__D001471
% 214.07/214.26       89; was see under ESOPHAGEAL DISEASES 1981-88   
% 214.07/214.26  |- skos__annotation mesh__D001471
% 214.07/214.26       note category; do not coord with INFANT, NEWBORN, DISEASES%A%  
% 214.07/214.26  |- skos__hiddenLabel mesh__D001471 Esophagus, Barrett%27%s
% 214.07/214.26  |- skos__altLabel mesh__D014399 Pott Disease
% 214.07/214.26  |- skos__broader mesh__D014399smesh__D014394
% 214.07/214.26  |- skos__broader mesh__D014399smesh__D013166
% 214.07/214.26  |- skos__scopeNote mesh__D014399
% 214.07/214.26       Osteitis or caries of the vertebrae, usually occurring as a complication of tuberculosis of the lungs.%A%    
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D014399 2005
% 214.07/214.26  |- skos__hiddenLabel mesh__D014399 Spinal Tuberculosis
% 214.07/214.26  |- mesh__recordOriginator mesh__D014399 NLM
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D014399 2006
% 214.07/214.26  |- skos__prefLabel mesh__D014399 Tuberculosis, Spinal
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D014399 2003
% 214.07/214.26  |- mesh__dateRevised mesh__D014399 2002-07-03
% 214.07/214.26  |- mesh__recordMaintainer mesh__D014399 ags
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D014399 2004
% 214.07/214.26  |- skos__hiddenLabel mesh__D014399 Tuberculoses, Spinal
% 214.07/214.26  |- skos__hiddenLabel mesh__D014399 Spinal Tuberculoses
% 214.07/214.26  |- skos__annotation mesh__D014399
% 214.07/214.26       IM; coord IM with specific vertebra %28%IM%29%   
% 214.07/214.26  |- skos__hiddenLabel mesh__D014399 Disease, Pott%27%s
% 214.07/214.26  |- skos__hiddenLabel mesh__D014399 Potts Disease
% 214.07/214.26  |- skos__hiddenLabel mesh__D014399 Disease, Pott
% 214.07/214.26  |- mesh__recordAuthorizer mesh__D014399 sjn
% 214.07/214.26  |- mesh__dateCreated mesh__D014399 1999-01-01
% 214.07/214.26  |- rdf__type mesh__D014399sskos__Concept
% 214.07/214.26  |- skos__altLabel mesh__D014399 Pott%27%s Disease
% 214.07/214.26  |- rdf__type mesh__D019882sskos__Concept
% 214.07/214.26  |- skos__broader mesh__D019882smesh__D013508
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D019882 2000
% 214.07/214.26  |- skos__hiddenLabel mesh__D019882 Blepharoplasties
% 214.07/214.26  |- skos__broader mesh__D019882smesh__D019651
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D019882 2004
% 214.07/214.26  |- skos__historyNote mesh__D019882 Blepharoptosis %28%1966-1997%29%
% 214.07/214.26  |- skos__historyNote mesh__D019882 Eyelids/surgery %28%1966-1997%29%
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D019882 2001
% 214.07/214.26  |- mesh__historyNote mesh__D019882 98   
% 214.07/214.26  |- skos__related mesh__D019882smesh__D001763
% 214.07/214.26  |- mesh__dateEstablished mesh__D019882 1998-01-01
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D019882 1998
% 214.07/214.26  |- mesh__dateCreated mesh__D019882 1997-06-20
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D019882 2005
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D019882 1999
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D019882 2002
% 214.07/214.26  |- skos__scopeNote mesh__D019882
% 214.07/214.26       Plastic surgery of the eyelid. %28%Cline et al., Dictionary of Visual Science, 4th ed%29%%A%    
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D019882 2006
% 214.07/214.26  |- skos__annotation mesh__D019882
% 214.07/214.26       do not use /util except by MeSH definition   
% 214.07/214.26  |- skos__prefLabel mesh__D019882 Blepharoplasty
% 214.07/214.26  |- mesh__publicMeSHNote mesh__D019882 98   
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D019882 2003
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D000379 2005
% 214.07/214.26  |- skos__prefLabel mesh__D000379 Agoraphobia
% 214.07/214.26  |- skos__hiddenLabel mesh__D000379 Agoraphobias
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D000379 2002
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D000379 2006
% 214.07/214.26  |- mesh__publicMeSHNote mesh__D000379
% 214.07/214.26       90; was see under PHOBIC DISORDERS 1981-89; was see under PHOBIAS 1968-80%A%  
% 214.07/214.26  |- skos__broader mesh__D000379smesh__D001008
% 214.07/214.26  |- rdf__type mesh__D000379sskos__Concept
% 214.07/214.26  |- mesh__historyNote mesh__D000379
% 214.07/214.26       90%28%75%29%; was see under PHOBIC DISORDERS 1981-89; was see under PHOBIAS 1968-80%A%  
% 214.07/214.26  |- mesh__recordAuthorizer mesh__D000379 SJN
% 214.07/214.26  |- mesh__dateEstablished mesh__D000379 1990-01-01
% 214.07/214.26  |- mesh__recordMaintainer mesh__D000379 JLS
% 214.07/214.26  |- mesh__dateCreated mesh__D000379 1999-01-01
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D000379 2003
% 214.07/214.26  |- skos__scopeNote mesh__D000379
% 214.07/214.26       Obsessive, persistent, intense fear of open places.     
% 214.07/214.26  |- mesh__dateRevised mesh__D000379 1997-06-20
% 214.07/214.26  |- mesh__recordOriginator mesh__D000379 NLM
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D000379 2000
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D000379 1998
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D000379 2004
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D000379 2001
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D000379 1999
% 214.07/214.26  |- skos__altLabel mesh__D019084 Indirect Fluorescent Antibody Technique
% 214.07/214.26  |- skos__hiddenLabel mesh__D019084 Indirect Immunofluorescence Technics
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D019084 2001
% 214.07/214.26  |- mesh__historyNote mesh__D019084 96   
% 214.07/214.26  |- skos__altLabel mesh__D019084 Fluorescent Antibody Technic, Indirect
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D019084 2005
% 214.07/214.26  |- skos__altLabel mesh__D019084 Immunofluorescence Technique, Indirect
% 214.07/214.26  |- skos__hiddenLabel mesh__D019084 Immunofluorescence Techniques, Indirect
% 214.07/214.26  |- skos__annotation mesh__D019084
% 214.07/214.26       NIM; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT is also available; DF: IFAT%A%  
% 214.07/214.26  |- skos__altLabel mesh__D019084 Immunofluorescence Technic, Indirect
% 214.07/214.26  |- mesh__dateEstablished mesh__D019084 1996-01-01
% 214.07/214.26  |- mesh__dateCreated mesh__D019084 1995-06-05
% 214.07/214.26  |- skos__altLabel mesh__D019084 Indirect Fluorescent Antibody Technic
% 214.07/214.26  |- mesh__recordMaintainer mesh__D019084 kle
% 214.07/214.26  |- mesh__dateRevised mesh__D019084 2000-06-21
% 214.07/214.26  |- mesh__recordOriginator mesh__D019084 AGS
% 214.07/214.26  |- skos__altLabel mesh__D019084 Indirect Immunofluorescence Assay
% 214.07/214.26  |- skos__hiddenLabel mesh__D019084 Indirect Immunofluorescence Technic
% 214.07/214.26  |- skos__hiddenLabel mesh__D019084 Indirect Immunofluorescence Techniques
% 214.07/214.26  |- skos__hiddenLabel mesh__D019084 Assay, Indirect Immunofluorescence
% 214.07/214.26  |- skos__hiddenLabel mesh__D019084 Indirect Immunofluorescences
% 214.07/214.26  |- skos__altLabel mesh__D019084 Immunofluorescence Antibody Test, Indirect
% 214.07/214.26  |- skos__hiddenLabel mesh__D019084 Immunofluorescence Technics, Indirect
% 214.07/214.26  |- mesh__recordAuthorizer mesh__D019084 sjn
% 214.07/214.26  |- skos__hiddenLabel mesh__D019084 Immunofluorescence Assay, Indirect
% 214.07/214.26  |- skos__hiddenLabel mesh__D019084 Immunofluorescences, Indirect
% 214.07/214.26  |- skos__hiddenLabel mesh__D019084 Assays, Indirect Immunofluorescence
% 214.07/214.26  |- skos__prefLabel mesh__D019084 Fluorescent Antibody Technique, Indirect
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D019084 2004
% 214.07/214.26  |- skos__hiddenLabel mesh__D019084 Immunofluorescence, Indirect
% 214.07/214.26  |- rdf__type mesh__D019084sskos__Concept
% 214.07/214.26  |- skos__broader mesh__D019084smesh__D005455
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D019084 2002
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D019084 2003
% 214.07/214.26  |- skos__hiddenLabel mesh__D019084 Immunofluorescence Assays, Indirect
% 214.07/214.26  |- skos__historyNote mesh__D019084
% 214.07/214.26       Fluorescent Antibody Technique %28%1966-1995%29%
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D019084 2006
% 214.07/214.26  |- skos__scopeNote mesh__D019084
% 214.07/214.26       A form of fluorescent antibody technique commonly used to detect serum antibodies and immune complexes in tissues and microorganisms in specimens from patients with infectious diseases. The technique involves formation of an antigen-antibody complex which is labeled with fluorescein-conjugated anti-immunoglobulin antibody. %28%From Bennington, Saunders Dictionary %26% Encyclopedia of Laboratory Medicine and Technology, 1984%29%%A%    
% 214.07/214.26  |- mesh__publicMeSHNote mesh__D019084 96   
% 214.07/214.26  |- skos__hiddenLabel mesh__D019084 Indirect Immunofluorescence Assays
% 214.07/214.26  |- skos__hiddenLabel mesh__D019084 Indirect Immunofluorescence Technique
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005862 2003
% 214.07/214.26  |- skos__broader mesh__D005862smesh__D000377
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005862 2005
% 214.07/214.26  |- skos__hiddenLabel mesh__D005862 Syndrome, Acquired Gerstmann
% 214.07/214.26  |- skos__hiddenLabel mesh__D005862 Gerstmann%27%s Syndrome, Developmental
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005862 2004
% 214.07/214.26  |- skos__hiddenLabel mesh__D005862 Syndrome, Acquired Gerstmann%27%s
% 214.07/214.26  |- skos__altLabel mesh__D005862 Acquired Gerstmann%27%s Syndrome
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005862 2002
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005862 2006
% 214.07/214.26  |- skos__annotation mesh__D005862
% 214.07/214.26       do not confuse with GERSTMANN-STRAUSSLER SYNDROME, a slow virus dis%A%  
% 214.07/214.26  |- mesh__recordMaintainer mesh__D005862 KEV
% 214.07/214.26  |- skos__hiddenLabel mesh__D005862 Syndrome, Developmental Gerstmann
% 214.07/214.26  |- skos__altLabel mesh__D005862 Gerstmann%27%s Syndrome
% 214.07/214.26  |- mesh__recordOriginator mesh__D005862 NLM
% 214.07/214.26  |- mesh__recordAuthorizer mesh__D005862 sjn
% 214.07/214.26  |- skos__hiddenLabel mesh__D005862 Gerstmann Syndrome, Acquired
% 214.07/214.26  |- skos__hiddenLabel mesh__D005862
% 214.07/214.26       Finger-Agnosia-Left-Right-Confusion-Acalculia-Agraphias
% 214.07/214.26  |- skos__hiddenLabel mesh__D005862 Gerstmann%27%s Syndrome, Acquired
% 214.07/214.26  |- skos__hiddenLabel mesh__D005862 Gerstmann Syndrome, Developmental
% 214.07/214.26  |- skos__altLabel mesh__D005862
% 214.07/214.26       Finger-Agnosia-Left-Right-Confusion-Acalculia-Agraphia
% 214.07/214.26  |- skos__prefLabel mesh__D005862 Gerstmann Syndrome
% 214.07/214.26  |- rdf__type mesh__D005862sskos__Concept
% 214.07/214.26  |- mesh__publicMeSHNote mesh__D005862
% 214.07/214.26       2000; see Gerstmann%27%s Syndrome 1966-1999   
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005862 2000
% 214.07/214.26  |- skos__hiddenLabel mesh__D005862 Syndrome, Gerstmann
% 214.07/214.26  |- skos__scopeNote mesh__D005862
% 214.07/214.26       A disorder of cognition characterized by the tetrad of finger agnosia, dysgraphia, dyscalculia, and right-left disorientation. The syndrome may be developmental or acquired. Acquired Gerstmann syndrome is associated with lesions in the dominant %28%usually left%29% PARIETAL LOBE which involve the angular gyrus or subjacent white matter. %28%From Adams et al., Principles of Neurology, 6th ed, p457%29%%A%    
% 214.07/214.26  |- mesh__dateRevised mesh__D005862 1999-11-05
% 214.07/214.26  |- mesh__dateCreated mesh__D005862 1999-01-01
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005862 2001
% 214.07/214.26  |- skos__hiddenLabel mesh__D005862 Developmental Gerstmanns Syndrome
% 214.07/214.26  |- mesh__historyNote mesh__D005862 2000%28%1966%29%   
% 214.07/214.26  |- skos__altLabel mesh__D005862 Developmental Gerstmann Syndrome
% 214.07/214.26  |- rdf__type mesh__D005064sskos__Concept
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005064 2004
% 214.07/214.26  |- mesh__recordAuthorizer mesh__D005064 PLS
% 214.07/214.26  |- mesh__recordMaintainer mesh__D005064 TGC
% 214.07/214.26  |- skos__broader mesh__D005064smesh__D004432
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005064 1992
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005064 1997
% 214.07/214.26  |- skos__hiddenLabel mesh__D005064 Tube, Eustachian
% 214.07/214.26  |- mesh__dateRevised mesh__D005064 1991-01-07
% 214.07/214.26  |- mesh__recordOriginator mesh__D005064 NLM
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005064 2001
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005064 1993
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005064 2005
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005064 1998
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005064 2002
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005064 2006
% 214.07/214.26  |- skos__hiddenLabel mesh__D005064 Tubes, Auditory
% 214.07/214.26  |- skos__hiddenLabel mesh__D005064 Tube, Auditory
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005064 1999
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005064 1994
% 214.07/214.26  |- skos__altLabel mesh__D005064 Auditory Tube
% 214.07/214.26  |- skos__prefLabel mesh__D005064 Eustachian Tube
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005064 1995
% 214.07/214.26  |- mesh__dateCreated mesh__D005064 1999-01-01
% 214.07/214.26  |- skos__hiddenLabel mesh__D005064 Tubes, Eustachian
% 214.07/214.26  |- skos__hiddenLabel mesh__D005064 Auditory Tubes
% 214.07/214.26  |- skos__hiddenLabel mesh__D005064 Eustachian Tubes
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005064 2003
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005064 1996
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D005064 2000
% 214.07/214.26  |- skos__annotation mesh__D005064
% 214.07/214.26       %22%eustachian%22% is not capitalized in titles or translations%A%  
% 214.07/214.26  |- mesh__dateCreated mesh__D043183 2003-07-09
% 214.07/214.26  |- skos__hiddenLabel mesh__D043183 Syndromes, Irritable Bowel
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D043183 2005
% 214.07/214.26  |- rdf__type mesh__D043183sskos__Concept
% 214.07/214.26  |- skos__broader mesh__D043183smesh__D003109
% 214.07/214.26  |- skos__hiddenLabel mesh__D043183 Mucous Colitides
% 214.07/214.26  |- skos__altLabel mesh__D043183 Colon, Irritable
% 214.07/214.26  |- mesh__publicMeSHNote mesh__D043183
% 214.07/214.26       2004; see COLONIC DISEASES, FUNCTIONAL 1979-2003   
% 214.07/214.26  |- skos__hiddenLabel mesh__D043183 Irritable Colon
% 214.07/214.26  |- skos__hiddenLabel mesh__D043183 Mucous Colitis
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D043183 2004
% 214.07/214.26  |- skos__historyNote mesh__D043183
% 214.07/214.26       Colonic Diseases, Functional %28%1970-2003%29%
% 214.07/214.26  |- skos__altLabel mesh__D043183 Colitis, Mucous
% 214.07/214.26  |- mesh__historyNote mesh__D043183
% 214.07/214.26       2004; use COLONIC DISEASES, FUNCTIONAL 1979-2003   
% 214.07/214.26  |- skos__historyNote mesh__D043183 Colonic Diseases %28%1967-1970%29%
% 214.07/214.26  |- skos__hiddenLabel mesh__D043183 Irritable Bowel Syndromes
% 214.07/214.26  |- skos__hiddenLabel mesh__D043183 Syndrome, Irritable Bowel
% 214.07/214.26  |- skos__prefLabel mesh__D043183 Irritable Bowel Syndrome
% 214.07/214.26  |- skos__scopeNote mesh__D043183
% 214.07/214.26       A disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION.%A%    
% 214.07/214.26  |- skos__hiddenLabel mesh__D043183 Colitides, Mucous
% 214.07/214.26  |- mesh__dateEstablished mesh__D043183 2004-01-01
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D043183 2006
% 214.07/214.26  |- skos__historyNote mesh__D015492 HTLV-III/immunology %28%1987%29%
% 214.07/214.26  |- mesh__recordOriginator mesh__D015492 SCD
% 214.07/214.26  |- skos__prefLabel mesh__D015492 AIDS Serodiagnosis
% 214.07/214.26  |- skos__annotation mesh__D015492
% 214.07/214.26       used with AIDS patients %26% HIV-seropositive or -negative persons; do not use /util except by MeSH definition; DF: AIDS SERODIAG%A%  
% 214.07/214.26  |- skos__hiddenLabel mesh__D015492 Serology, HTLV III
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D015492 2005
% 214.07/214.26  |- skos__historyNote mesh__D015492
% 214.07/214.26       Human T-Cell Leukemia Virus/immunology %28%1984-1987%29%
% 214.07/214.26  |- mesh__recordAuthorizer mesh__D015492 sjn
% 214.07/214.26  |- skos__historyNote mesh__D015492 HIV/immunology %28%1988%29%
% 214.07/214.26  |- skos__historyNote mesh__D015492 Antibodies, Viral %28%1983-1988%29%
% 214.07/214.26  |- rdf__type mesh__D015492sskos__Concept
% 214.07/214.26  |- skos__hiddenLabel mesh__D015492 Serodiagnoses, HTLV-III
% 214.07/214.26  |- mesh__publicMeSHNote mesh__D015492 89   
% 214.07/214.26  |- mesh__dateRevised mesh__D015492 2001-07-25
% 214.07/214.26  |- skos__altLabel mesh__D015492 HTLV-III Serodiagnosis
% 214.07/214.26  |- skos__hiddenLabel mesh__D015492 Serodiagnosis, HTLV III
% 214.07/214.26  |- skos__altLabel mesh__D015492 Serodiagnosis, HTLV-III
% 214.07/214.26  |- skos__hiddenLabel mesh__D015492 Serodiagnoses, HIV
% 214.07/214.26  |- skos__hiddenLabel mesh__D015492 AIDS Serodiagnoses
% 214.07/214.26  |- skos__related mesh__D015492smesh__D015528
% 214.07/214.26  |- skos__hiddenLabel mesh__D015492 HIV Serodiagnoses
% 214.07/214.26  |- skos__altLabel mesh__D015492 Serodiagnosis, AIDS
% 214.07/214.26  |- skos__broader mesh__D015492smesh__D012698
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D015492 2004
% 214.07/214.26  |- skos__altLabel mesh__D015492 Serology, AIDS
% 214.07/214.26  |- skos__hiddenLabel mesh__D015492 HTLV-III Serodiagnoses
% 214.07/214.26  |- skos__altLabel mesh__D015492 Serology, HTLV-III
% 214.07/214.26  |- skos__altLabel mesh__D015492 HIV Serodiagnosis
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D015492 2002
% 214.07/214.26  |- skos__altLabel mesh__D015492 Serodiagnosis, HIV
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D015492 2003
% 214.07/214.26  |- skos__altLabel mesh__D015492 HTLV-III Serology
% 214.07/214.26  |- mesh__dateEstablished mesh__D015492 1989-01-01
% 214.07/214.26  |- skos__hiddenLabel mesh__D015492 HTLV III Serology
% 214.07/214.26  |- mesh__dateCreated mesh__D015492 1988-06-10
% 214.07/214.26  |- skos__altLabel mesh__D015492 AIDS Serology
% 214.07/214.26  |- skos__hiddenLabel mesh__D015492 Serodiagnoses, AIDS
% 214.07/214.26  |- skos__scopeNote mesh__D015492
% 214.07/214.26       Immunologic tests for identification of HIV %28%HTLV-III/LAV%29% antibodies. They include assays for HIV SEROPOSITIVITY and HIV SERONEGATIVITY; %28%ELISA, immunofluorescence, immunoblot, etc.%29% that have been developed for screening persons carrying the viral antibody from patients with overt symptoms of AIDS or AIDS-RELATED COMPLEX.%A%    
% 214.07/214.26  |- skos__historyNote mesh__D015492
% 214.07/214.26       Acquired Immunodeficiency Syndrome %28%1984-1988%29%
% 214.07/214.26  |- mesh__activeMeSHYear mesh__D015492 2006
% 214.07/214.26  |- mesh__historyNote mesh__D015492 89   
% 214.07/214.26  |- mesh__recordMaintainer mesh__D015492 mdb
% 214.07/214.26  |- skos__hiddenLabel mesh__D015492 HTLV III Serodiagnosis
% 214.07/214.27  |- skos__prefLabel mesh__D009455 Neurofibroma
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D009455 2004
% 214.07/214.27  |- mesh__dateCreated mesh__D009455 1999-01-01
% 214.07/214.27  |- rdf__type mesh__D009455sskos__Concept
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D009455 2000
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D009455 2005
% 214.07/214.27  |- skos__annotation mesh__D009455
% 214.07/214.27       solitary; multiple = NEUROFIBROMATOSES but see MeSH definition; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 214.07/214.27  |- skos__hiddenLabel mesh__D009455 Neurofibromas
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D009455 2001
% 214.07/214.27  |- skos__broader mesh__D009455smesh__D018317
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D009455 2006
% 214.07/214.27  |- skos__scopeNote mesh__D009455
% 214.07/214.27       A moderately firm, benign, encapsulated tumor resulting from proliferation of SCHWANN CELLS and FIBROBLASTS that includes portions of nerve fibers. The tumors usually develop along peripheral or cranial nerves and are a central feature of NEUROFIBROMATOSIS 1, where they may occur intracranially or involve spinal roots. Pathologic features include fusiform enlargement of the involved nerve. Microscopic examination reveals a disorganized and loose cellular pattern with elongated nuclei intermixed with fibrous strands. %28%From Adams et al., Principles of Neurology, 6th ed, p1016%29%%A%    
% 214.07/214.27  |- mesh__dateRevised mesh__D009455 1999-11-03
% 214.07/214.27  |- mesh__recordMaintainer mesh__D009455 KEV
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D009455 2002
% 214.07/214.27  |- mesh__recordAuthorizer mesh__D009455 sjn
% 214.07/214.27  |- mesh__recordOriginator mesh__D009455 NLM
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D009455 2003
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D001472 2002
% 214.07/214.27  |- skos__scopeNote mesh__D001472
% 214.07/214.27       Mucus-secreting glands situated on the posterior and lateral aspect of the vestibule of the vagina.%A%    
% 214.07/214.27  |- rdf__type mesh__D001472sskos__Concept
% 214.07/214.27  |- skos__hiddenLabel mesh__D001472 Glands, Bartholin%27%s
% 214.07/214.27  |- skos__hiddenLabel mesh__D001472 Bartholins Glands
% 214.07/214.27  |- skos__broader mesh__D001472smesh__D005088
% 214.07/214.27  |- skos__broader mesh__D001472smesh__D014844
% 214.07/214.27  |- mesh__dateRevised mesh__D001472 1999-11-03
% 214.07/214.27  |- skos__hiddenLabel mesh__D001472 Bartholin Glands
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D001472 2000
% 214.07/214.27  |- mesh__recordAuthorizer mesh__D001472 sjn
% 214.07/214.27  |- mesh__dateCreated mesh__D001472 1999-01-01
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D001472 2003
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D001472 2001
% 214.07/214.27  |- mesh__recordMaintainer mesh__D001472 KEV
% 214.07/214.27  |- skos__prefLabel mesh__D001472 Bartholin%27%s Glands
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D001472 2005
% 214.07/214.27  |- mesh__recordOriginator mesh__D001472 NLM
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D001472 2004
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D001472 2006
% 214.07/214.27  |- skos__broader mesh__D011575Q000266smesh__D011575
% 214.07/214.27  |- mesh__preferredCombination mesh__D011575Q000266smesh__D011572Q000266
% 214.07/214.27  |- rdf__type mesh__D011575Q000266smesh__CompoundConcept
% 214.07/214.27  |- skos__scopeNote mesh__D019883
% 214.07/214.27       A somewhat heterogeneous class of enzymes that catalyze the transfer of alkyl or related groups %28%excluding methyl groups%29%. EC 2.5.%A%    
% 214.07/214.27  |- skos__prefLabel mesh__D019883 Alkyl and Aryl Transferases
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D019883 2005
% 214.07/214.27  |- mesh__publicMeSHNote mesh__D019883 98   
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D019883 2006
% 214.07/214.27  |- rdf__type mesh__D019883sskos__Concept
% 214.07/214.27  |- mesh__dateEstablished mesh__D019883 1998-01-01
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D019883 2004
% 214.07/214.27  |- mesh__dateRevised mesh__D019883 2003-07-09
% 214.07/214.27  |- skos__broader mesh__D019883smesh__D014166
% 214.07/214.27  |- skos__historyNote mesh__D019883 Transferases %28%1976-1997%29%
% 214.07/214.27  |- mesh__historyNote mesh__D019883 98   
% 214.07/214.27  |- mesh__dateCreated mesh__D019883 1997-06-20
% 214.07/214.27  |- skos__altLabel mesh__D019085 Direct Immunofluorescence Assay
% 214.07/214.27  |- mesh__recordMaintainer mesh__D019085 kle
% 214.07/214.27  |- skos__hiddenLabel mesh__D019085 Direct Immunofluorescences
% 214.07/214.27  |- skos__hiddenLabel mesh__D019085 Immunofluorescence Technics, Direct
% 214.07/214.27  |- skos__altLabel mesh__D019085 Immunofluorescence Technic, Direct
% 214.07/214.27  |- mesh__dateCreated mesh__D019085 1995-06-05
% 214.07/214.27  |- skos__altLabel mesh__D019085 Immunofluorescence Technique, Direct
% 214.07/214.27  |- mesh__dateRevised mesh__D019085 2000-06-21
% 214.07/214.27  |- skos__hiddenLabel mesh__D019085 Immunofluorescence Assay, Direct
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D019085 2005
% 214.07/214.27  |- skos__hiddenLabel mesh__D019085 Direct Immunofluorescence Technics
% 214.07/214.27  |- mesh__historyNote mesh__D019085 96   
% 214.07/214.27  |- skos__altLabel mesh__D019085 Direct Fluorescent Antibody Technic
% 214.07/214.27  |- mesh__dateEstablished mesh__D019085 1996-01-01
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D019085 2001
% 214.07/214.27  |- mesh__recordOriginator mesh__D019085 AGS
% 214.07/214.27  |- skos__altLabel mesh__D019085 Immunofluorescence Antibody Test, Direct
% 214.07/214.27  |- skos__hiddenLabel mesh__D019085 Immunofluorescence Assays, Direct
% 214.07/214.27  |- skos__hiddenLabel mesh__D019085 Direct Immunofluorescence Assays
% 214.07/214.27  |- skos__broader mesh__D019085smesh__D005455
% 214.07/214.27  |- skos__altLabel mesh__D019085 Direct Fluorescent Antibody Technique
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D019085 2006
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D019085 2003
% 214.07/214.27  |- skos__hiddenLabel mesh__D019085 Assays, Direct Immunofluorescence
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D019085 2002
% 214.07/214.27  |- skos__scopeNote mesh__D019085
% 214.07/214.27       A form of fluorescent antibody technique utilizing a fluorochrome conjugated to an antibody, which is added directly to a tissue or cell suspension for the detection of a specific antigen. %28%Bennington, Saunders Dictionary %26% Encyclopedia of Laboratory Medicine and Technology, 1984%29%%A%    
% 214.07/214.27  |- skos__annotation mesh__D019085
% 214.07/214.27       NIM; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT is also available; DF: DFAT%A%  
% 214.07/214.27  |- skos__hiddenLabel mesh__D019085 Direct Immunofluorescence Technique
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D019085 2004
% 214.07/214.27  |- mesh__recordAuthorizer mesh__D019085 sjn
% 214.07/214.27  |- skos__hiddenLabel mesh__D019085 Direct Immunofluorescence Technic
% 214.07/214.27  |- skos__prefLabel mesh__D019085 Fluorescent Antibody Technique, Direct
% 214.07/214.27  |- skos__hiddenLabel mesh__D019085 Immunofluorescence, Direct
% 214.07/214.27  |- skos__hiddenLabel mesh__D019085 Immunofluorescences, Direct
% 214.07/214.27  |- mesh__publicMeSHNote mesh__D019085 96   
% 214.07/214.27  |- skos__hiddenLabel mesh__D019085 Assay, Direct Immunofluorescence
% 214.07/214.27  |- skos__historyNote mesh__D019085
% 214.07/214.27       Fluorescent Antibody Technique %28%1966-1995%29%
% 214.07/214.27  |- skos__hiddenLabel mesh__D019085 Immunofluorescence Techniques, Direct
% 214.07/214.27  |- skos__altLabel mesh__D019085 Fluorescent Antibody Technic, Direct
% 214.07/214.27  |- rdf__type mesh__D019085sskos__Concept
% 214.07/214.27  |- skos__hiddenLabel mesh__D019085 Direct Immunofluorescence Techniques
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D005863 2001
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D005863 2006
% 214.07/214.27  |- mesh__dateEstablished mesh__D005863 1991-01-01
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D005863 1996
% 214.07/214.27  |- skos__hiddenLabel mesh__D005863 Gestalt Theories
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D005863 1998
% 214.07/214.27  |- mesh__recordMaintainer mesh__D005863 TAP
% 214.07/214.27  |- mesh__historyNote mesh__D005863
% 214.07/214.27       91%28%75%29%; was see under PSYCHOLOGICAL THEORY 1975-90   
% 214.07/214.27  |- skos__hiddenLabel mesh__D005863 Theories, Gestalt
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D005863 1997
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D005863 1994
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D005863 1999
% 214.07/214.27  |- skos__hiddenLabel mesh__D005863 Theory, Gestalt
% 214.07/214.27  |- skos__scopeNote mesh__D005863
% 214.07/214.27       A system which emphasizes that experience and behavior contain basic patterns and relationships which cannot be reduced to simpler components; that is, the whole is greater than the sum of its parts.%A%    
% 214.07/214.27  |- skos__prefLabel mesh__D005863 Gestalt Theory
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D005863 2002
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D005863 1993
% 214.07/214.27  |- mesh__recordAuthorizer mesh__D005863 PLS
% 214.07/214.27  |- rdf__type mesh__D005863sskos__Concept
% 214.07/214.27  |- mesh__publicMeSHNote mesh__D005863
% 214.07/214.27       91; was see under PSYCHOLOGICAL THEORY 1975-90   
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D005863 1995
% 214.07/214.27  |- mesh__dateCreated mesh__D005863 1999-01-01
% 214.07/214.27  |- skos__broader mesh__D005863smesh__D011582
% 214.07/214.27  |- mesh__onlineNote mesh__D005863 search PSYCHOLOGICAL THEORY 1969-74   
% 214.07/214.27  |- mesh__recordOriginator mesh__D005863 NLM
% 214.07/214.27  |- mesh__dateRevised mesh__D005863 1992-05-18
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D005863 2003
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D005863 2000
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D005863 2005
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D005863 2004
% 214.07/214.27  |- skos__broader mesh__D005065smesh__D013727
% 214.07/214.27  |- skos__hiddenLabel mesh__D005065 Mercy Killings
% 214.07/214.27  |- skos__related mesh__D005065smesh__D017236
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D005065 2005
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D005065 2003A
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D005065 2003B
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D005065 2006
% 214.07/214.27  |- skos__annotation mesh__D005065
% 214.07/214.27       HUMAN only; EUTHANASIA, ANIMAL is available for animals; EUTHANASIA, ACTIVE and EUTHANASIA, PASSIVE are also available%A%  
% 214.07/214.27  |- skos__altLabel mesh__D005065 Mercy Killing
% 214.07/214.27  |- mesh__recordOriginator mesh__D005065 NLM
% 214.07/214.27  |- mesh__dateRevised mesh__D005065 2002-11-06
% 214.07/214.27  |- skos__hiddenLabel mesh__D005065 Killings, Mercy
% 214.07/214.27  |- mesh__dateCreated mesh__D005065 1999-01-01
% 214.07/214.27  |- skos__related mesh__D005065smesh__D026688
% 214.07/214.27  |- mesh__recordAuthorizer mesh__D005065 sjn
% 214.07/214.27  |- skos__altLabel mesh__D005065 Euthanasia, Involuntary
% 214.07/214.27  |- skos__related mesh__D005065smesh__D012297
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D005065 2003
% 214.07/214.27  |- mesh__recordMaintainer mesh__D005065 sjn
% 214.07/214.27  |- skos__scopeNote mesh__D005065
% 214.07/214.27       The act or practice of killing or allowing death from natural causes, for reasons of mercy, i.e., in order to release a person from incurable disease, intolerable suffering, or undignified death. %28%from Beauchamp and Walters, Contemporary Issues in Bioethics, 5th ed%29%%A%    
% 214.07/214.27  |- rdf__type mesh__D005065sskos__Concept
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D005065 2004
% 214.07/214.27  |- skos__prefLabel mesh__D005065 Euthanasia
% 214.07/214.27  |- skos__broader mesh__D005065smesh__D006708
% 214.07/214.27  |- skos__hiddenLabel mesh__D005065 Killing, Mercy
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D043982 2004
% 214.07/214.27  |- skos__annotation mesh__D043982
% 214.07/214.27       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.07/214.27  |- mesh__dateCreated mesh__D043982 2003-07-09
% 214.07/214.27  |- skos__broader mesh__D043982smesh__D019684
% 214.07/214.27  |- skos__prefLabel mesh__D043982 Rhizophoraceae
% 214.07/214.27  |- skos__altLabel mesh__D043982 Mangrove, American
% 214.07/214.27  |- skos__scopeNote mesh__D043982
% 214.07/214.27       A plant family of the order Rhizophorales, subclass Rosidae, class Magnoliopsida, that includes mangrove trees.%A%    
% 214.07/214.27  |- mesh__historyNote mesh__D043982 2004   
% 214.07/214.27  |- mesh__publicMeSHNote mesh__D043982 2004   
% 214.07/214.27  |- skos__altLabel mesh__D043982 Mangrove, Red
% 214.07/214.27  |- rdf__type mesh__D043982sskos__Concept
% 214.07/214.27  |- mesh__dateEstablished mesh__D043982 2004-01-01
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D043982 2005
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D043982 2006
% 214.07/214.27  |- rdf__type mesh__D051616sskos__Concept
% 214.07/214.27  |- skos__altLabel mesh__D051616 NAIP %28%Spinal Muscular Atrophy%29%
% 214.07/214.27  |- mesh__recordAuthorizer mesh__D051616 sjn
% 214.07/214.27  |- skos__broader mesh__D051616smesh__D009419
% 214.07/214.27  |- skos__hiddenLabel mesh__D051616 Apoptosis-Inhibitory Protein, Neuronal
% 214.07/214.27  |- mesh__dateCreated mesh__D051616 2005-06-30
% 214.07/214.27  |- mesh__publicMeSHNote mesh__D051616
% 214.07/214.27       2006; NEURONAL APOPTOSIS-INHIBITORY PROTEIN  was indexed under NERVE TISSUE PROTEINS 1995-2005%A%  
% 214.07/214.27  |- mesh__recordMaintainer mesh__D051616 DRC
% 214.07/214.27  |- skos__scopeNote mesh__D051616
% 214.07/214.27       An inhibitor of apoptosis protein that was initially identified during analysis of CHROMOSOME DELETIONS associated with SPINAL MUSCULAR ATROPHY. Naip contains a nucleotide binding oligomerization domain and a carboxy-terminal LEUCINE rich repeat.%A%    
% 214.07/214.27  |- skos__altLabel mesh__D051616 NAIP Protein
% 214.07/214.27  |- mesh__dateEstablished mesh__D051616 2006-01-01
% 214.07/214.27  |- skos__hiddenLabel mesh__D051616 Neuronal Apoptosis Inhibitory Protein
% 214.07/214.27  |- mesh__activeMeSHYear mesh__D051616 2006
% 214.15/214.35  |- skos__broader mesh__D051616smesh__D051034
% 214.15/214.35  |- mesh__historyNote mesh__D051616 2006%28%1995%29%   
% 214.15/214.35  |- mesh__recordOriginator mesh__D051616 DRC
% 214.15/214.35  |- skos__prefLabel mesh__D051616 Neuronal Apoptosis-Inhibitory Protein
% 214.15/214.35  |- skos__hiddenLabel mesh__D015493 Parapareses, Tropical Spastic
% 214.15/214.35  |- mesh__recordMaintainer mesh__D015493 ags
% 214.15/214.35  |- skos__altLabel mesh__D015493 Myelopathies, HTLV I Associated
% 214.15/214.35  |- mesh__recordAuthorizer mesh__D015493 ags
% 214.15/214.35  |- skos__hiddenLabel mesh__D015493 Spastic Paraparesis, Tropical
% 214.15/214.35  |- mesh__dateCreated mesh__D015493 1988-06-10
% 214.15/214.35  |- skos__prefLabel mesh__D015493 Paraparesis, Tropical Spastic
% 214.15/214.35  |- mesh__dateRevised mesh__D015493 2005-07-18
% 214.15/214.35  |- skos__historyNote mesh__D015493
% 214.15/214.35       Human T-Cell Leukemia Virus %28%1985-1988%29%
% 214.15/214.35  |- skos__hiddenLabel mesh__D015493 Myelopathy, HTLV-I-Associated
% 214.15/214.35  |- skos__hiddenLabel mesh__D015493 HTLV I Associated Myelopathy
% 214.15/214.35  |- skos__hiddenLabel mesh__D015493 Tropical Spastic Paraplegia
% 214.15/214.35  |- mesh__publicMeSHNote mesh__D015493 1989   
% 214.15/214.35  |- skos__hiddenLabel mesh__D015493
% 214.15/214.35       HTLV I Associated Myelopathy Tropical Spastic Paraparesis
% 214.15/214.35  |- skos__hiddenLabel mesh__D015493 Paraplegias, Tropical Spastic
% 214.15/214.35  |- skos__hiddenLabel mesh__D015493
% 214.15/214.35       Myelopathy, Human T Lymphotropic Virus Type 1 Associated
% 214.15/214.35  |- skos__historyNote mesh__D015493 HTLV Infections %28%1987-1988%29%
% 214.15/214.35  |- skos__hiddenLabel mesh__D015493 Tropical Spastic Parapareses
% 214.15/214.35  |- skos__altLabel mesh__D015493
% 214.15/214.35       HTLV-I-Associated Myelopathy-Tropical Spastic Paraparesis
% 214.15/214.35  |- skos__broader mesh__D015493smesh__D015490
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D015493 2005
% 214.15/214.35  |- skos__hiddenLabel mesh__D015493 Myelopathies, HTLV-I-Associated
% 214.15/214.35  |- skos__hiddenLabel mesh__D015493 Spastic Parapareses, Tropical
% 214.15/214.35  |- skos__altLabel mesh__D015493
% 214.15/214.35       Human T-Lymphotropic Virus Type 1 Associated Myelopathy
% 214.15/214.35  |- skos__broader mesh__D015493smesh__D009187
% 214.15/214.35  |- skos__historyNote mesh__D015493 Paralysis %28%1984-1988%29%
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D015493 2006
% 214.15/214.35  |- mesh__dateEstablished mesh__D015493 1989-01-01
% 214.15/214.35  |- skos__scopeNote mesh__D015493
% 214.15/214.35       A subacute paralytic myeloneuropathy occurring endemically in tropical areas such as the Caribbean, Colombia, India, and Africa, as well as in the southwestern region of Japan; associated with infection by HUMAN T-CELL LEUKEMIA VIRUS I. Clinical manifestations include a slowly progressive spastic weakness of the legs, increased reflexes, Babinski signs, incontinence, and loss of vibratory and position sensation. On pathologic examination inflammatory, demyelination, and necrotic lesions may be found in the spinal cord. %28%Adams et al., Principles of Neurology, 6th ed, p1239%29%%A%    
% 214.15/214.35  |- skos__historyNote mesh__D015493 Retrovirus Infections %28%1985-1986%29%
% 214.15/214.35  |- skos__altLabel mesh__D015493 Paraplegia, Tropical Spastic
% 214.15/214.35  |- skos__hiddenLabel mesh__D015493
% 214.15/214.35       Human T Lymphotropic Virus Type 1 Associated Myelopathy
% 214.15/214.35  |- mesh__historyNote mesh__D015493 1989   
% 214.15/214.35  |- skos__hiddenLabel mesh__D015493 Spastic Paraplegias, Tropical
% 214.15/214.35  |- skos__altLabel mesh__D015493
% 214.15/214.35       Myelopathy, Human T-Lymphotropic Virus Type 1 Associated
% 214.15/214.35  |- skos__hiddenLabel mesh__D015493 Tropical Spastic Paraplegias
% 214.15/214.35  |- skos__historyNote mesh__D015493 Paraplegia %28%1983-1988%29%
% 214.15/214.35  |- skos__altLabel mesh__D015493 HTLV-I-Associated Myelopathy
% 214.15/214.35  |- mesh__recordOriginator mesh__D015493 SCD
% 214.15/214.35  |- skos__hiddenLabel mesh__D015493 Spastic Paraplegia, Tropical
% 214.15/214.35  |- skos__altLabel mesh__D015493 HTLV I Associated Myelopathies
% 214.15/214.35  |- rdf__type mesh__D015493sskos__Concept
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D015493 2006A
% 214.15/214.35  |- skos__altLabel mesh__D015493 Tropical Spastic Paraparesis
% 214.15/214.35  |- skos__hiddenLabel mesh__D015493 HTLV-I-Associated Myelopathies
% 214.15/214.35  |- skos__altLabel mesh__D009456 Neurofibromatosis Type I
% 214.15/214.35  |- skos__altLabel mesh__D009456 Neurofibromatosis Type 1
% 214.15/214.35  |- mesh__recordOriginator mesh__D009456 NLM
% 214.15/214.35  |- skos__hiddenLabel mesh__D009456 Syndrome, Watson
% 214.15/214.35  |- mesh__historyNote mesh__D009456
% 214.15/214.35       1992%28%1966%29%; for NEUROFIBROMATOSIS, PERIPHERAL, NF1 use NEUROFIBROMATOSIS 1989-1991%A%  
% 214.15/214.35  |- skos__hiddenLabel mesh__D009456 Type 1, Neurofibromatosis
% 214.15/214.35  |- mesh__recordMaintainer mesh__D009456 ags
% 214.15/214.35  |- skos__hiddenLabel mesh__D009456 Neurofibromatoses, Type I
% 214.15/214.35  |- skos__related mesh__D009456smesh__D025542
% 214.15/214.35  |- skos__altLabel mesh__D009456 Neurofibromatosis, Type I
% 214.15/214.35  |- rdf__type mesh__D009456sskos__Concept
% 214.15/214.35  |- skos__prefLabel mesh__D009456 Neurofibromatosis 1
% 214.15/214.35  |- skos__altLabel mesh__D009456 Recklinghausen Disease of Nerve
% 214.15/214.35  |- skos__hiddenLabel mesh__D009456 I, Neurofibromatosis Type
% 214.15/214.35  |- skos__altLabel mesh__D009456 Neurofibromatosis I
% 214.15/214.35  |- skos__annotation mesh__D009456
% 214.15/214.35       do not confuse with NEUROFIBROMATOSIS 2; coord IM with precoord organ/neopl term %28%IM%29% if relevant%A%  
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D009456 2006
% 214.15/214.35  |- skos__altLabel mesh__D009456 Neurofibromatosis, Peripheral, NF 1
% 214.15/214.35  |- skos__broader mesh__D009456smesh__D010523
% 214.15/214.35  |- skos__altLabel mesh__D009456 von Recklinghausen%27%s Disease
% 214.15/214.35  |- skos__altLabel mesh__D009456 NF1 %28%Neurofibromatosis 1%29%
% 214.15/214.35  |- skos__altLabel mesh__D009456 Neurofibromatosis, Type 1
% 214.15/214.35  |- skos__altLabel mesh__D009456 von Recklinghausen Disease
% 214.15/214.35  |- skos__hiddenLabel mesh__D009456 Recklinghausen Disease, Nerve
% 214.15/214.35  |- skos__related mesh__D009456smesh__D016514
% 214.15/214.35  |- skos__altLabel mesh__D009456 Recklinghausen%27%s Disease of Nerve
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D009456 2005
% 214.15/214.35  |- mesh__recordAuthorizer mesh__D009456 ags
% 214.15/214.35  |- mesh__publicMeSHNote mesh__D009456
% 214.15/214.35       1992; see NEUROFIBROMATOSIS 1966-91; for NEUROFIBROMATOSIS, PERIPHERAL, NF1 see NEUROFIBROMATOSIS 1989-1991%A%  
% 214.15/214.35  |- mesh__dateCreated mesh__D009456 1999-01-01
% 214.15/214.35  |- skos__hiddenLabel mesh__D009456 Neurofibromatosis, Peripheral
% 214.15/214.35  |- mesh__dateRevised mesh__D009456 2005-07-27
% 214.15/214.35  |- skos__related mesh__D009456smesh__D044542
% 214.15/214.35  |- skos__altLabel mesh__D009456 Neurofibromatosis, Peripheral, NF1
% 214.15/214.35  |- skos__hiddenLabel mesh__D009456 Neurofibromatoses, Peripheral
% 214.15/214.35  |- skos__hiddenLabel mesh__D009456 Type I Neurofibromatoses
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D009456 2006B
% 214.15/214.35  |- skos__scopeNote mesh__D009456
% 214.15/214.35       An autosomal dominant inherited disorder %28%with a high frequency of spontaneous mutations%29% that features developmental changes in the nervous system, muscles, bones, and skin, most notably in tissue derived from the embryonic NEURAL CREST. Multiple hyperpigmented skin lesions and subcutaneous tumors are the hallmark of this disease. Peripheral and central nervous system neoplasms occur frequently, especially OPTIC NERVE GLIOMA and NEUROFIBROSARCOMA. NF1 is caused by mutations which inactivate the NF1 gene %28%GENES, NEUROFIBROMATOSIS 1%29% on chromosome 17q. The incidence of learning disabilities is also elevated in this condition. %28%From Adams et al., Principles of Neurology, 6th ed, pp1014-18%29% There is overlap of clinical features with NOONAN SYNDROME in a syndrome called neurofibromatosis-Noonan syndrome. Both the PTPN11 and NF1 gene products are involved in the SIGNAL TRANSDUCTION pathway of Ras %28%RAS PROTEINS%29%.%A%    
% 214.15/214.35  |- skos__hiddenLabel mesh__D009456 von Recklinghausens Disease
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D009456 2004
% 214.15/214.35  |- skos__hiddenLabel mesh__D009456 Peripheral Neurofibromatoses
% 214.15/214.35  |- skos__hiddenLabel mesh__D009456 Type 1 Neurofibromatosis
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D009456 2006A
% 214.15/214.35  |- skos__broader mesh__D009456smesh__D017253
% 214.15/214.35  |- skos__altLabel mesh__D009456 Recklinghausens Disease of Nerve
% 214.15/214.35  |- skos__hiddenLabel mesh__D009456 Type I, Neurofibromatosis
% 214.15/214.35  |- skos__related mesh__D009456smesh__D009634
% 214.15/214.35  |- skos__altLabel mesh__D009456 Peripheral Neurofibromatosis
% 214.15/214.35  |- rdf__type mesh__D001473sskos__Concept
% 214.15/214.35  |- mesh__recordMaintainer mesh__D001473 SYSTEM
% 214.15/214.35  |- skos__altLabel mesh__D001473 Rochalimaea
% 214.15/214.35  |- mesh__historyNote mesh__D001473 ROCHALIMAEA was heading 1995   
% 214.15/214.35  |- skos__scopeNote mesh__D001473
% 214.15/214.35       A genus of gram-negative bacteria characteristically appearing in chains of several segmenting organisms. It occurs in man and arthropod vectors and is found only in the Andes region of South America. This genus is the etiologic agent of human bartonellosis. The genus Rochalimaea, once considered a separate genus, has recently been combined with the genus Bartonella as a result of high levels of relatedness in 16S rRNA sequence data and DNA hybridization data.%A%    
% 214.15/214.35  |- mesh__dateCreated mesh__D001473 1999-01-01
% 214.15/214.35  |- mesh__publicMeSHNote mesh__D001473 ROCHALIMAEA was heading 1995   
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D001473 2006
% 214.15/214.35  |- mesh__recordAuthorizer mesh__D001473 sjn
% 214.15/214.35  |- mesh__dateRevised mesh__D001473 2005-06-30
% 214.15/214.35  |- skos__broader mesh__D001473smesh__D001475
% 214.15/214.35  |- skos__prefLabel mesh__D001473 Bartonella
% 214.15/214.35  |- skos__annotation mesh__D001473 infection = BARTONELLA INFECTIONS   
% 214.15/214.35  |- mesh__recordOriginator mesh__D001473 NLM
% 214.15/214.35  |- mesh__dateCreated mesh__D019884 1997-06-20
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D019884 2006
% 214.15/214.35  |- rdf__type mesh__D019884sskos__Concept
% 214.15/214.35  |- mesh__dateRevised mesh__D019884 2003-07-09
% 214.15/214.35  |- skos__scopeNote mesh__D019884
% 214.15/214.35       Enzymes that catalyze the transfer of nitrogenous groups, primarily amino groups, from a donor, generally an amino acid, to an acceptor, usually a 2-oxoacid. EC 2.6.%A%    
% 214.15/214.35  |- mesh__publicMeSHNote mesh__D019884 98   
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D019884 2004
% 214.15/214.35  |- skos__prefLabel mesh__D019884 Nitrogenous Group Transferases
% 214.15/214.35  |- skos__broader mesh__D019884smesh__D014166
% 214.15/214.35  |- mesh__historyNote mesh__D019884 98   
% 214.15/214.35  |- skos__hiddenLabel mesh__D019884 Group Transferases, Nitrogenous
% 214.15/214.35  |- skos__hiddenLabel mesh__D019884 Transferases, Nitrogenous Group
% 214.15/214.35  |- mesh__recordMaintainer mesh__D019884 ssb
% 214.15/214.35  |- mesh__dateEstablished mesh__D019884 1998-01-01
% 214.15/214.35  |- mesh__recordAuthorizer mesh__D019884 sjn
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D019884 2005
% 214.15/214.35  |- skos__annotation mesh__D019884 DF: N GROUP TRANSFERASES   
% 214.15/214.35  |- mesh__recordOriginator mesh__D019884 KEV
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D019086 2002
% 214.15/214.35  |- mesh__dateRevised mesh__D019086 1997-07-10
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D019086 2004
% 214.15/214.35  |- mesh__dateCreated mesh__D019086 1995-06-08
% 214.15/214.35  |- skos__altLabel mesh__D019086 Heterocyclic Bicyclo Compounds
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D019086 1998
% 214.15/214.35  |- skos__broader mesh__D019086smesh__D006572
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D019086 2001
% 214.15/214.35  |- skos__hiddenLabel mesh__D019086 Cpds, Bicyclic Heterocyclic
% 214.15/214.35  |- skos__annotation mesh__D019086 DF: BICYCLO CPDS HETEROCYCLIC   
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D019086 2003
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D019086 2006
% 214.15/214.35  |- rdf__type mesh__D019086sskos__Concept
% 214.15/214.35  |- skos__historyNote mesh__D019086 Bicyclo Compounds %28%1975-1995%29%
% 214.15/214.35  |- mesh__recordMaintainer mesh__D019086 WDJ
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D019086 2000
% 214.15/214.35  |- mesh__recordAuthorizer mesh__D019086 SJN
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D019086 2005
% 214.15/214.35  |- skos__broader mesh__D019086smesh__D006574
% 214.15/214.35  |- skos__broader mesh__D019086smesh__D001643
% 214.15/214.35  |- skos__hiddenLabel mesh__D019086 Bicyclic Heterocyclic Cpds
% 214.15/214.35  |- mesh__publicMeSHNote mesh__D019086 96   
% 214.15/214.35  |- skos__hiddenLabel mesh__D019086 Compounds, Heterocyclic Bicyclo
% 214.15/214.35  |- skos__altLabel mesh__D019086 Bicyclic Heterocyclic Compounds
% 214.15/214.35  |- skos__hiddenLabel mesh__D019086 Compounds, Bicyclic Heterocyclic
% 214.15/214.35  |- skos__scopeNote mesh__D019086
% 214.15/214.35       A class of saturated compounds consisting of two rings only, having two or more atoms in common, containing at least one hetero atom, and that take the name of an open chain hydrocarbon containing the same total number of atoms. %28%From Riguady et al., Nomenclature of Organic Chemistry, 1979, p31%29%%A%    
% 214.15/214.35  |- skos__altLabel mesh__D019086 Heterocyclic Cpds, Bicyclic
% 214.15/214.35  |- skos__hiddenLabel mesh__D019086 Heterocyclic Compounds, Bicyclic
% 214.15/214.35  |- mesh__dateEstablished mesh__D019086 1996-01-01
% 214.15/214.35  |- mesh__historyNote mesh__D019086 96   
% 214.15/214.35  |- mesh__recordOriginator mesh__D019086 JRT
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D019086 1999
% 214.15/214.35  |- skos__prefLabel mesh__D019086 Bicyclo Compounds, Heterocyclic
% 214.15/214.35  |- mesh__recordOriginator mesh__D005864 NLM
% 214.15/214.35  |- rdf__type mesh__D005864sskos__Concept
% 214.15/214.35  |- skos__broader mesh__D005864smesh__D011613
% 214.15/214.35  |- mesh__dateCreated mesh__D005864 1999-01-01
% 214.15/214.35  |- mesh__activeMeSHYear mesh__D005864 2000
% 214.15/214.36  |- mesh__dateRevised mesh__D005864 1995-05-31
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005864 2003
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005864 2001
% 214.15/214.36  |- skos__scopeNote mesh__D005864
% 214.15/214.36       A form of psychotherapy with emphasis on the interplay of organism and environment. Basic to this therapy is the development of awareness and maturity, as well as self-confidence.%A%    
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005864 2005
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005864 2004
% 214.15/214.36  |- mesh__publicMeSHNote mesh__D005864
% 214.15/214.36       91; was see under PSYCHOTHERAPY 1973-90   
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005864 2006
% 214.15/214.36  |- mesh__recordMaintainer mesh__D005864 TGC
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005864 1996
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005864 1998
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005864 2002
% 214.15/214.36  |- mesh__recordAuthorizer mesh__D005864 PLS
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005864 1997
% 214.15/214.36  |- mesh__dateEstablished mesh__D005864 1991-01-01
% 214.15/214.36  |- mesh__historyNote mesh__D005864
% 214.15/214.36       91%28%73%29%; was see under PSYCHOTHERAPY 1973-90   
% 214.15/214.36  |- skos__annotation mesh__D005864
% 214.15/214.36       a psychother technique; DF: GESTALT THER   
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005864 1999
% 214.15/214.36  |- skos__prefLabel mesh__D005864 Gestalt Therapy
% 214.15/214.36  |- skos__altLabel mesh__D005864 Therapy, Gestalt
% 214.15/214.36  |- skos__altLabel mesh__D005066 Passive Euthanasia
% 214.15/214.36  |- rdf__type mesh__D005066sskos__Concept
% 214.15/214.36  |- skos__scopeNote mesh__D005066
% 214.15/214.36       Failing to prevent death from natural causes, for reasons of mercy by the withdrawal or withholding of life-prolonging treatment.%A%    
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005066 2003
% 214.15/214.36  |- mesh__dateCreated mesh__D005066 1977-04-22
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005066 2003B
% 214.15/214.36  |- mesh__historyNote mesh__D005066
% 214.15/214.36       90%28%78%29%; was see under EUTHANASIA 1978-89   
% 214.15/214.36  |- skos__annotation mesh__D005066
% 214.15/214.36       human only; differentiate X ref ALLOWING TO DIE from RIGHT TO DIE%A%  
% 214.15/214.36  |- skos__historyNote mesh__D005066 Ethics, Medical %28%1966-1977%29%
% 214.15/214.36  |- mesh__dateEstablished mesh__D005066 1990-01-01
% 214.15/214.36  |- skos__historyNote mesh__D005066 Euthanasia %28%1966-1977%29%
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005066 2002
% 214.15/214.36  |- skos__prefLabel mesh__D005066 Euthanasia, Passive
% 214.15/214.36  |- skos__altLabel mesh__D005066 Euthanasia, Negative
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005066 2006
% 214.15/214.36  |- mesh__dateRevised mesh__D005066 2002-11-06
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005066 2003A
% 214.15/214.36  |- skos__related mesh__D005066smesh__D016414
% 214.15/214.36  |- skos__altLabel mesh__D005066 Negative Euthanasia
% 214.15/214.36  |- mesh__recordMaintainer mesh__D005066 sjn
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005066 2005
% 214.15/214.36  |- mesh__publicMeSHNote mesh__D005066
% 214.15/214.36       90; was see under EUTHANASIA 1978-89   
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005066 2004
% 214.15/214.36  |- skos__broader mesh__D005066smesh__D028761
% 214.15/214.36  |- skos__broader mesh__D005066smesh__D005065
% 214.15/214.36  |- skos__altLabel mesh__D005066 Allowing to Die
% 214.15/214.36  |- mesh__recordAuthorizer mesh__D005066 sjn
% 214.15/214.36  |- skos__related mesh__D005066smesh__D028761
% 214.15/214.36  |- mesh__recordOriginator mesh__D005066 EC
% 214.15/214.36  |- skos__annotation mesh__D010200
% 214.15/214.36       note category: do not confuse with PANIC DISORDER %28%Cat F3%29%%A%  
% 214.15/214.36  |- mesh__publicMeSHNote mesh__D010200 91; was see under FEAR 1975-90   
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010200 1999
% 214.15/214.36  |- rdf__type mesh__D010200sskos__Concept
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010200 1993
% 214.15/214.36  |- mesh__recordMaintainer mesh__D010200 TAP
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010200 2005
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010200 2002
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010200 1996
% 214.15/214.36  |- skos__broader mesh__D010200smesh__D005239
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010200 2006
% 214.15/214.36  |- mesh__recordAuthorizer mesh__D010200 PLS
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010200 1997
% 214.15/214.36  |- skos__prefLabel mesh__D010200 Panic
% 214.15/214.36  |- mesh__onlineNote mesh__D010200 search FEAR 1972-74   
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010200 1994
% 214.15/214.36  |- mesh__recordOriginator mesh__D010200 NLM
% 214.15/214.36  |- skos__hiddenLabel mesh__D010200 Panics
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010200 2003
% 214.15/214.36  |- mesh__dateEstablished mesh__D010200 1991-01-01
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010200 1995
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010200 2000
% 214.15/214.36  |- mesh__dateCreated mesh__D010200 1999-01-01
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010200 2004
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010200 2001
% 214.15/214.36  |- mesh__historyNote mesh__D010200
% 214.15/214.36       91%28%75%29%; was see under FEAR 1975-90   
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010200 1998
% 214.15/214.36  |- skos__scopeNote mesh__D010200
% 214.15/214.36       A state of extreme acute, intense anxiety and unreasoning fear accompanied by disorganization of personality function.%A%    
% 214.15/214.36  |- mesh__dateRevised mesh__D010200 1992-05-15
% 214.15/214.36  |- skos__hiddenLabel mesh__D015494 Salivary Gland Stone
% 214.15/214.36  |- skos__historyNote mesh__D015494 Calculi %28%1966-1988%29%
% 214.15/214.36  |- skos__altLabel mesh__D015494 Sialoliths
% 214.15/214.36  |- skos__hiddenLabel mesh__D015494 Gland Calculi, Salivary
% 214.15/214.36  |- skos__hiddenLabel mesh__D015494 Gland Stones, Salivary
% 214.15/214.36  |- skos__scopeNote mesh__D015494
% 214.15/214.36       Calculi occurring in a salivary gland. Most salivary gland calculi occur in the submandibular gland, but can also occur in the parotid gland and in the sublingual and minor salivary glands.%A%    
% 214.15/214.36  |- skos__hiddenLabel mesh__D015494 Stones, Salivary Gland
% 214.15/214.36  |- skos__altLabel mesh__D015494 Salivary Gland Stones
% 214.15/214.36  |- skos__hiddenLabel mesh__D015494 Stone, Salivary Gland
% 214.15/214.36  |- skos__hiddenLabel mesh__D015494 Gland Calculus, Salivary
% 214.15/214.36  |- skos__annotation mesh__D015494
% 214.15/214.36       chem composition of calculi: use /chem; /ultrastruct permitted; coord IM with specific precoord salivary gland dis term %28%IM%29%; do not confuse with SALIVARY DUCT CALCULI%A%  
% 214.15/214.36  |- skos__hiddenLabel mesh__D015494 Calculus, Salivary Gland
% 214.15/214.36  |- skos__historyNote mesh__D015494 Salivary Duct Calculi %28%1966-1988%29%
% 214.15/214.36  |- skos__altLabel mesh__D015494 Sialolithiasis
% 214.15/214.36  |- skos__broader mesh__D015494smesh__D012466
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D015494 2006
% 214.15/214.36  |- mesh__recordAuthorizer mesh__D015494 sjn
% 214.15/214.36  |- skos__prefLabel mesh__D015494 Salivary Gland Calculi
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D015494 2002
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D015494 2004
% 214.15/214.36  |- skos__hiddenLabel mesh__D015494 Calculi, Salivary Gland
% 214.15/214.36  |- mesh__dateEstablished mesh__D015494 1989-01-01
% 214.15/214.36  |- mesh__historyNote mesh__D015494
% 214.15/214.36       89; SIALOLITHIASIS was see SALIVARY DUCT CALCULI 1966-88   
% 214.15/214.36  |- skos__hiddenLabel mesh__D015494 Gland Stone, Salivary
% 214.15/214.36  |- mesh__onlineNote mesh__D015494
% 214.15/214.36       use SALIVARY DUCT CALCULI to search SIALOLITHIASIS 1966-88; to search for chem composition of salivary duct calculi, use SALIVARY DUCT CALCULI/anal 1987-90 %26% SALIVARY DUCT CALCULI/metab 1966-86%A%  
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D015494 2005
% 214.15/214.36  |- mesh__dateCreated mesh__D015494 1988-06-10
% 214.15/214.36  |- skos__broader mesh__D015494smesh__D020792
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D015494 2003
% 214.15/214.36  |- skos__historyNote mesh__D015494
% 214.15/214.36       Salivary Gland Diseases %28%1966-1988%29%
% 214.15/214.36  |- skos__hiddenLabel mesh__D015494 Salivary Gland Calculus
% 214.15/214.36  |- mesh__recordOriginator mesh__D015494 EJB
% 214.15/214.36  |- mesh__dateRevised mesh__D015494 2001-07-25
% 214.15/214.36  |- rdf__type mesh__D015494sskos__Concept
% 214.15/214.36  |- skos__hiddenLabel mesh__D015494 Sialolith
% 214.15/214.36  |- mesh__publicMeSHNote mesh__D015494
% 214.15/214.36       89; SIALOLITHIASIS was see SALIVARY DUCT CALCULI 1966-88   
% 214.15/214.36  |- mesh__recordMaintainer mesh__D015494 ags
% 214.15/214.36  |- skos__hiddenLabel mesh__D009457 Neuroglial Cell
% 214.15/214.36  |- skos__broader mesh__D009457smesh__D002477
% 214.15/214.36  |- skos__altLabel mesh__D009457 Glial Cells
% 214.15/214.36  |- mesh__recordMaintainer mesh__D009457 nns
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D009457 2002
% 214.15/214.36  |- skos__hiddenLabel mesh__D009457 Cells, Neuroglial
% 214.15/214.36  |- skos__broader mesh__D009457smesh__D009420
% 214.15/214.36  |- skos__hiddenLabel mesh__D009457 Cells, Glial
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D009457 2003
% 214.15/214.36  |- mesh__recordAuthorizer mesh__D009457 sjn
% 214.15/214.36  |- mesh__recordOriginator mesh__D009457 NLM
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D009457 2004
% 214.15/214.36  |- mesh__dateRevised mesh__D009457 2001-07-25
% 214.15/214.36  |- skos__altLabel mesh__D009457 Neuroglial Cells
% 214.15/214.36  |- mesh__dateCreated mesh__D009457 1999-01-01
% 214.15/214.36  |- rdf__type mesh__D009457sskos__Concept
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D009457 2005
% 214.15/214.36  |- skos__hiddenLabel mesh__D009457 Glial Cell
% 214.15/214.36  |- skos__hiddenLabel mesh__D009457 Cell, Neuroglial
% 214.15/214.36  |- skos__hiddenLabel mesh__D009457 Cell, Glial
% 214.15/214.36  |- skos__altLabel mesh__D009457 Glia
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D009457 2006
% 214.15/214.36  |- skos__prefLabel mesh__D009457 Neuroglia
% 214.15/214.36  |- skos__scopeNote mesh__D009457
% 214.15/214.36       The non-neuronal cells of the nervous system. They not only provide physical support, but also respond to injury, regulate the ionic and chemical composition of the extracellular milieu, participate in the BLOOD-BRAIN BARRIER and BLOOD-RETINAL BARRIER, form the myelin insulation of nervous pathways, guide neuronal migration during development, and exchange metabolites with neurons. Neuroglia have high-affinity transmitter uptake systems, voltage-dependent and transmitter-gated ion channels, and can release transmitters, but their role in signaling %28%as in many other functions%29% is unclear.%A%    
% 214.15/214.36  |- skos__hiddenLabel mesh__D001474 Bartonella Infection
% 214.15/214.36  |- skos__hiddenLabel mesh__D001474 Bartonelloses
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D001474 2005
% 214.15/214.36  |- mesh__recordAuthorizer mesh__D001474 sjn
% 214.15/214.36  |- rdf__type mesh__D001474sskos__Concept
% 214.15/214.36  |- skos__altLabel mesh__D001474 Bartonellosis
% 214.15/214.36  |- skos__annotation mesh__D001474 gram-neg bact infect   
% 214.15/214.36  |- skos__hiddenLabel mesh__D001474 Disease, Carrion%27%s
% 214.15/214.36  |- skos__hiddenLabel mesh__D001474 Disease, Carrion
% 214.15/214.36  |- skos__altLabel mesh__D001474 Infections, Bartonella
% 214.15/214.36  |- skos__hiddenLabel mesh__D001474 Rochalimaea Infection
% 214.15/214.36  |- skos__hiddenLabel mesh__D001474 Infection, Rochalimaea
% 214.15/214.36  |- mesh__publicMeSHNote mesh__D001474
% 214.15/214.36       ROCHALIMAEA INFECTIONS was heading 1995   
% 214.15/214.36  |- mesh__recordOriginator mesh__D001474 NLM
% 214.15/214.36  |- skos__hiddenLabel mesh__D001474 Infection, Bartonella
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D001474 2004
% 214.15/214.36  |- mesh__recordMaintainer mesh__D001474 ags
% 214.15/214.36  |- skos__altLabel mesh__D001474 Carrion%27%s Disease
% 214.15/214.36  |- mesh__dateCreated mesh__D001474 1999-01-01
% 214.15/214.36  |- skos__broader mesh__D001474smesh__D001476
% 214.15/214.36  |- skos__hiddenLabel mesh__D001474 Fever, Oroya
% 214.15/214.36  |- skos__altLabel mesh__D001474 Infections, Rochalimaea
% 214.15/214.36  |- skos__altLabel mesh__D001474 Carrion Disease
% 214.15/214.36  |- skos__scopeNote mesh__D001474
% 214.15/214.36       Infections by the genus BARTONELLA. Bartonella bacilliformis can cause acute febrile anemia, designated Oroya fever, and a benign skin eruption, called verruga peruana. BARTONELLA QUINTANA causes TRENCH FEVER, while BARTONELLA HENSELAE is the etiologic agent of bacillary angiomatosis %28%ANGIOMATOSIS, BACILLARY%29% and is also one of the causes of CAT-SCRATCH DISEASE in immunocompetent patients.%A%    
% 214.15/214.36  |- mesh__historyNote mesh__D001474
% 214.15/214.36       ROCHALIMAEA INFECTIONS was heading 1995   
% 214.15/214.36  |- skos__prefLabel mesh__D001474 Bartonella Infections
% 214.15/214.36  |- mesh__dateRevised mesh__D001474 2003-07-09
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D001474 2006
% 214.15/214.36  |- skos__hiddenLabel mesh__D001474 Carrions Disease
% 214.15/214.36  |- skos__altLabel mesh__D001474 Rochalimaea Infections
% 214.15/214.36  |- mesh__historyNote mesh__D019885 98   
% 214.15/214.36  |- skos__scopeNote mesh__D019885
% 214.15/214.36       Enzymes that catalyze the transfer of sulfur atoms %28%2.8.1%29%, sulfur groups %28%2.8.2%29% or coenzyme A %28%2.8.3%29%. EC 2.8.%A%    
% 214.15/214.36  |- mesh__dateEstablished mesh__D019885 1998-01-01
% 214.15/214.36  |- mesh__dateCreated mesh__D019885 1997-06-20
% 214.15/214.36  |- skos__prefLabel mesh__D019885 Sulfur Group Transferases
% 214.15/214.36  |- skos__hiddenLabel mesh__D019885 Group Transferases, Sulfur
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D019885 2006
% 214.15/214.36  |- mesh__dateRevised mesh__D019885 2003-07-09
% 214.15/214.36  |- skos__historyNote mesh__D019885 Transferases %28%1970-1997%29%
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D019885 2005
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D019885 2004
% 214.15/214.36  |- skos__broader mesh__D019885smesh__D014166
% 214.15/214.36  |- rdf__type mesh__D019885sskos__Concept
% 214.15/214.36  |- skos__hiddenLabel mesh__D019885 Transferases, Sulfur Group
% 214.15/214.36  |- mesh__publicMeSHNote mesh__D019885 98   
% 214.15/214.36  |- mesh__publicMeSHNote mesh__D019087 96   
% 214.15/214.36  |- skos__broader mesh__D019087smesh__D015815
% 214.15/214.36  |- mesh__dateEstablished mesh__D019087 1996-01-01
% 214.15/214.36  |- skos__broader mesh__D019087smesh__D037102
% 214.15/214.36  |- mesh__recordMaintainer mesh__D019087 ssb
% 214.15/214.36  |- skos__annotation mesh__D019087
% 214.15/214.36       cell adhesion molecules; GEN or unspecified; prefer specifics%A%  
% 214.15/214.36  |- mesh__historyNote mesh__D019087 96   
% 214.15/214.36  |- mesh__recordOriginator mesh__D019087 AGS
% 214.15/214.36  |- skos__historyNote mesh__D019087
% 214.15/214.36       Cell Adhesion Molecules %28%1990-1995%29%
% 214.15/214.36  |- mesh__dateCreated mesh__D019087 1995-05-26
% 214.15/214.36  |- skos__prefLabel mesh__D019087 Selectins
% 214.15/214.36  |- skos__scopeNote mesh__D019087
% 214.15/214.36       Family of cell adhesion molecules consisting of a lectin-like domain, an epidermal growth factor-like domain, and a variable number of domains that encode proteins homologous to complement-binding proteins. Selectins mediate the binding of leukocytes to the vascular endothelium. %28%From Dorland, 28th ed%29%%A%    
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D019087 2006
% 214.15/214.36  |- rdf__type mesh__D019087sskos__Concept
% 214.15/214.36  |- mesh__dateRevised mesh__D019087 2005-06-30
% 214.15/214.36  |- mesh__recordAuthorizer mesh__D019087 sjn
% 214.15/214.36  |- skos__related mesh__D005865smesh__D047929
% 214.15/214.36  |- mesh__dateRevised mesh__D005865 2004-07-07
% 214.15/214.36  |- skos__historyNote mesh__D005865 Embryo %28%1966-1967%29%
% 214.15/214.36  |- skos__annotation mesh__D005865 mammalian only; for fetus not mother   
% 214.15/214.36  |- mesh__dateEstablished mesh__D005865 1970-01-01
% 214.15/214.36  |- skos__related mesh__D005865smesh__D007234
% 214.15/214.36  |- skos__hiddenLabel mesh__D005865 Ages, Gestational
% 214.15/214.36  |- skos__altLabel mesh__D005865 Fetal Age
% 214.15/214.36  |- mesh__recordAuthorizer mesh__D005865 sjn
% 214.15/214.36  |- skos__altLabel mesh__D005865 Chronologic Fetal Maturity
% 214.15/214.36  |- mesh__recordOriginator mesh__D005865 NLM
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005865 2005
% 214.15/214.36  |- skos__related mesh__D005865smesh__D018568
% 214.15/214.36  |- skos__altLabel mesh__D005865 Maturity, Chronologic Fetal
% 214.15/214.36  |- skos__hiddenLabel mesh__D005865 Age, Fetal
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005865 2006
% 214.15/214.36  |- skos__hiddenLabel mesh__D005865 Fetal Ages
% 214.15/214.36  |- skos__altLabel mesh__D005865 Fetal Maturity, Chronologic
% 214.15/214.36  |- skos__historyNote mesh__D005865 Infant, Premature %28%1966-1967%29%
% 214.15/214.36  |- skos__prefLabel mesh__D005865 Gestational Age
% 214.15/214.36  |- skos__scopeNote mesh__D005865
% 214.15/214.36       The age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated as the time from the last day of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization.%A%    
% 214.15/214.36  |- mesh__publicMeSHNote mesh__D005865 70   
% 214.15/214.36  |- skos__hiddenLabel mesh__D005865 Ages, Fetal
% 214.15/214.36  |- skos__broader mesh__D005865smesh__D047109
% 214.15/214.36  |- mesh__recordMaintainer mesh__D005865 lkt
% 214.15/214.36  |- rdf__type mesh__D005865sskos__Concept
% 214.15/214.36  |- skos__historyNote mesh__D005865 Fetus %28%1966-1967%29%
% 214.15/214.36  |- skos__hiddenLabel mesh__D005865 Age, Gestational
% 214.15/214.36  |- mesh__historyNote mesh__D005865 70%28%68%29%   
% 214.15/214.36  |- skos__hiddenLabel mesh__D005865 Gestational Ages
% 214.15/214.36  |- mesh__dateCreated mesh__D005865 1999-01-01
% 214.15/214.36  |- mesh__dateRevised mesh__D005067 2005-08-02
% 214.15/214.36  |- skos__altLabel mesh__D005067 Sick Euthyroid Syndrome
% 214.15/214.36  |- skos__hiddenLabel mesh__D005067 Euthyroid Sick Syndrome
% 214.15/214.36  |- skos__altLabel mesh__D005067 Non-Thyroidal Illness Syndrome
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005067 2006
% 214.15/214.36  |- skos__hiddenLabel mesh__D005067 Syndrome, Sick Euthyroid
% 214.15/214.36  |- skos__hiddenLabel mesh__D005067 Low T3 Low T4 Syndrome
% 214.15/214.36  |- mesh__recordAuthorizer mesh__D005067 ags
% 214.15/214.36  |- skos__hiddenLabel mesh__D005067 Syndrome, Non-Thyroidal Illness
% 214.15/214.36  |- skos__broader mesh__D005067smesh__D013959
% 214.15/214.36  |- skos__annotation mesh__D005067
% 214.15/214.36       differentiate from THYROID HORMONE RESISTANCE SYNDROME where no other disease is present%A%  
% 214.15/214.36  |- skos__altLabel mesh__D005067 Low T3 and Low T4 Syndrome
% 214.15/214.36  |- mesh__recordMaintainer mesh__D005067 ags
% 214.15/214.36  |- mesh__historyNote mesh__D005067 87   
% 214.15/214.36  |- skos__related mesh__D005067smesh__D018382
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005067 2006B
% 214.15/214.36  |- mesh__publicMeSHNote mesh__D005067 87   
% 214.15/214.36  |- mesh__dateEstablished mesh__D005067 1987-01-01
% 214.15/214.36  |- skos__altLabel mesh__D005067 Low T3 High T4 Syndrome
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D005067 2006A
% 214.15/214.36  |- skos__hiddenLabel mesh__D005067 Syndromes, Non-Thyroidal Illness
% 214.15/214.36  |- skos__hiddenLabel mesh__D005067 High T4 Syndromes
% 214.15/214.36  |- skos__scopeNote mesh__D005067
% 214.15/214.36       Conditions of abnormal THYROID HORMONES release in patients with apparently normal THYROID GLAND during severe systemic illness, physical TRAUMA, and psychiatric disturbances. It can be caused by the loss of endogenous hypothalamic input or by exogenous drug effects. The most common abnormality results in low T3 THYROID HORMONE with progressive decrease in THYROXINE; %28%T4%29% and TSH. Elevated T4 with normal T3 may be seen in diseases in which THYROXINE-BINDING GLOBULIN synthesis and release are increased.%A%    
% 214.15/214.36  |- skos__hiddenLabel mesh__D005067 Non Thyroidal Illness Syndrome
% 214.15/214.36  |- mesh__dateCreated mesh__D005067 1986-04-18
% 214.15/214.36  |- rdf__type mesh__D005067sskos__Concept
% 214.15/214.36  |- mesh__recordOriginator mesh__D005067 VDK
% 214.15/214.36  |- skos__prefLabel mesh__D005067 Euthyroid Sick Syndromes
% 214.15/214.36  |- skos__scopeNote mesh__D024221
% 214.15/214.36       Clinical protocols used to inhibit the growth or spread of NEOPLASMS.%A%    
% 214.15/214.36  |- skos__hiddenLabel mesh__D024221 Protocol, Cancer Treatment
% 214.15/214.36  |- skos__hiddenLabel mesh__D024221 Protocols, Antineoplastic
% 214.15/214.36  |- mesh__publicMeSHNote mesh__D024221 2002   
% 214.15/214.36  |- skos__hiddenLabel mesh__D024221 Protocols, Cancer Treatment
% 214.15/214.36  |- mesh__dateCreated mesh__D024221 2001-07-25
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D024221 2002
% 214.15/214.36  |- skos__historyNote mesh__D024221
% 214.15/214.36       Antineoplastic Combined Chemotherapy Protocols %28%1983-2001%29%
% 214.15/214.36  |- mesh__historyNote mesh__D024221 2002   
% 214.15/214.36  |- skos__annotation mesh__D024221
% 214.15/214.36       coord with COMBINED MODALITY THERAPY if pertinent   
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D024221 2003
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D024221 2005
% 214.15/214.36  |- mesh__recordMaintainer mesh__D024221 jmp
% 214.15/214.36  |- skos__hiddenLabel mesh__D024221 Protocol, Antineoplastic
% 214.15/214.36  |- skos__prefLabel mesh__D024221 Antineoplastic Protocols
% 214.15/214.36  |- skos__broader mesh__D024221smesh__D002985
% 214.15/214.36  |- skos__hiddenLabel mesh__D024221 Treatment Protocol, Cancer
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D024221 2004
% 214.15/214.36  |- skos__hiddenLabel mesh__D024221 Antineoplastic Protocol
% 214.15/214.36  |- rdf__type mesh__D024221sskos__Concept
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D024221 2006
% 214.15/214.36  |- skos__hiddenLabel mesh__D024221 Cancer Treatment Protocol
% 214.15/214.36  |- skos__altLabel mesh__D024221 Cancer Treatment Protocols
% 214.15/214.36  |- mesh__recordOriginator mesh__D024221 jmp
% 214.15/214.36  |- skos__hiddenLabel mesh__D024221 Treatment Protocols, Cancer
% 214.15/214.36  |- mesh__recordAuthorizer mesh__D024221 sjn
% 214.15/214.36  |- skos__broader mesh__D024221smesh__D004358
% 214.15/214.36  |- mesh__dateEstablished mesh__D024221 2002-01-01
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010201 1999
% 214.15/214.36  |- mesh__publicMeSHNote mesh__D010201 65; was PANNICULITIS 1963-64   
% 214.15/214.36  |- mesh__historyNote mesh__D010201 65; was PANNICULITIS 1963-64   
% 214.15/214.36  |- mesh__dateRevised mesh__D010201 1992-05-22
% 214.15/214.36  |- skos__scopeNote mesh__D010201
% 214.15/214.36       A form of panniculitis characterized by recurrent episodes of fever accompanied by the eruption of single or multiple erythematous subcutaneous nodules on the lower extremities. They normally resolve, but tend to leave depressions in the skin. The condition is most often seen in women, alone or in association with other disorders.%A%    
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010201 1996
% 214.15/214.36  |- skos__broader mesh__D010201smesh__D015434
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010201 1993
% 214.15/214.36  |- skos__prefLabel mesh__D010201 Panniculitis, Nodular Nonsuppurative
% 214.15/214.36  |- skos__altLabel mesh__D010201 Weber-Christian Disease
% 214.15/214.36  |- mesh__recordMaintainer mesh__D010201 PLS
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010201 2002
% 214.15/214.36  |- skos__hiddenLabel mesh__D010201 Disease, Weber-Christian
% 214.15/214.36  |- mesh__recordAuthorizer mesh__D010201 PLS
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010201 2005
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010201 1997
% 214.15/214.36  |- mesh__recordOriginator mesh__D010201 NLM
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010201 2006
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010201 2000
% 214.15/214.36  |- skos__hiddenLabel mesh__D010201 Weber Christian Disease
% 214.15/214.36  |- mesh__dateCreated mesh__D010201 1999-01-01
% 214.15/214.36  |- skos__hiddenLabel mesh__D010201 Panniculitides, Nodular Nonsuppurative
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010201 1994
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010201 2003
% 214.15/214.36  |- skos__hiddenLabel mesh__D010201 Nonsuppurative Panniculitis, Nodular
% 214.15/214.36  |- mesh__dateEstablished mesh__D010201 1965-01-01
% 214.15/214.36  |- skos__hiddenLabel mesh__D010201 Nodular Nonsuppurative Panniculitides
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010201 2001
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010201 1998
% 214.15/214.36  |- skos__hiddenLabel mesh__D010201 Nonsuppurative Panniculitides, Nodular
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010201 1995
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D010201 2004
% 214.15/214.36  |- rdf__type mesh__D010201sskos__Concept
% 214.15/214.36  |- skos__hiddenLabel mesh__D010201 Nodular Nonsuppurative Panniculitis
% 214.15/214.36  |- mesh__dateRevised mesh__D009458 1993-06-03
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D009458 2002
% 214.15/214.36  |- skos__scopeNote mesh__D009458
% 214.15/214.36       A form of analgesia accompanied by general quiescence and psychic indifference to environmental stimuli, without loss of consciousness, and produced by the combined administration of a major tranquilizer %28%neuroleptic%29% and a narcotic.%A%    
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D009458 1994
% 214.15/214.36  |- skos__prefLabel mesh__D009458 Neuroleptanalgesia
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D009458 2006
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D009458 2001
% 214.15/214.36  |- mesh__onlineNote mesh__D009458
% 214.15/214.36       use NEUROLEPTANALGESIA to search NEUROLEPTOANALGESIA 1966-78 %28%as Prov 1966-67%29%%A%  
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D009458 1999
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D009458 2005
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D009458 2000
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D009458 1998
% 214.15/214.36  |- mesh__dateCreated mesh__D009458 1999-01-01
% 214.15/214.36  |- skos__broader mesh__D009458smesh__D000698
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D009458 2004
% 214.15/214.36  |- skos__annotation mesh__D009458
% 214.15/214.36       do not use /util except by MeSH definition   
% 214.15/214.36  |- skos__altLabel mesh__D009458 Neuroleptoanalgesia
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D009458 1997
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D009458 2003
% 214.15/214.36  |- mesh__recordMaintainer mesh__D009458 PLS
% 214.15/214.36  |- mesh__recordAuthorizer mesh__D009458 PLS
% 214.15/214.36  |- mesh__historyNote mesh__D009458
% 214.15/214.36       79; was NEUROLEPTOANALGESIA 1966-78 %28%Prov 1966-67%29%   
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D009458 1996
% 214.15/214.36  |- rdf__type mesh__D009458sskos__Concept
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D009458 1995
% 214.15/214.36  |- mesh__publicMeSHNote mesh__D009458
% 214.15/214.36       79; was NEUROLEPTOANALGESIA 1968-78   
% 214.15/214.36  |- mesh__recordOriginator mesh__D009458 NLM
% 214.15/214.36  |- mesh__dateEstablished mesh__D009458 1968-01-01
% 214.15/214.36  |- rdf__type mesh__D001475sskos__Concept
% 214.15/214.36  |- mesh__publicMeSHNote mesh__D001475 75   
% 214.15/214.36  |- mesh__recordAuthorizer mesh__D001475 sjn
% 214.15/214.36  |- mesh__dateRevised mesh__D001475 2005-06-30
% 214.15/214.36  |- mesh__recordMaintainer mesh__D001475 SYSTEM
% 214.15/214.36  |- mesh__dateCreated mesh__D001475 1999-01-01
% 214.15/214.36  |- skos__scopeNote mesh__D001475
% 214.15/214.36       A family of small gram-negative bacteria whose organisms are parasites of erythrocytes in man and other vertebrates and the etiologic agents of several diseases.%A%    
% 214.15/214.36  |- skos__broader mesh__D001475smesh__D006090
% 214.15/214.36  |- mesh__recordOriginator mesh__D001475 NLM
% 214.15/214.36  |- skos__broader mesh__D001475smesh__D020561
% 214.15/214.36  |- skos__prefLabel mesh__D001475 Bartonellaceae
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D001475 2006
% 214.15/214.36  |- mesh__dateEstablished mesh__D001475 1975-01-01
% 214.15/214.36  |- mesh__historyNote mesh__D001475 75   
% 214.15/214.36  |- skos__historyNote mesh__D001475 Bacteria %28%1966-1974%29%
% 214.15/214.36  |- rdf__type mesh__D006160sskos__Concept
% 214.15/214.36  |- mesh__dateCreated mesh__D006160 1999-01-01
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D006160 2002
% 214.15/214.36  |- skos__historyNote mesh__D006160 Guanine Nucleotides %28%1966-1971%29%
% 214.15/214.36  |- mesh__recordOriginator mesh__D006160 NLM
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D006160 1995
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D006160 1998
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D006160 2004
% 214.15/214.36  |- skos__broader mesh__D006160smesh__D006150
% 214.15/214.36  |- mesh__recordAuthorizer mesh__D006160 NLM
% 214.15/214.36  |- skos__prefLabel mesh__D006160 Guanosine Triphosphate
% 214.15/214.36  |- mesh__publicMeSHNote mesh__D006160 72   
% 214.15/214.36  |- skos__hiddenLabel mesh__D006160 Triphosphate, Guanosine
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D006160 1994
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D006160 2003
% 214.15/214.36  |- mesh__recordMaintainer mesh__D006160 PLS
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D006160 2001
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D006160 1997
% 214.15/214.36  |- mesh__dateRevised mesh__D006160 1990-05-30
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D006160 2006
% 214.15/214.36  |- skos__scopeNote mesh__D006160
% 214.15/214.36       Guanosine 5%27%-%28%tetrahydrogen triphosphate%29%. A guanine nucleotide containing three phosphate groups esterified to the sugar moiety.%A%    
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D006160 1991
% 214.15/214.36  |- mesh__dateEstablished mesh__D006160 1972-01-01
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D006160 2000
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D006160 1996
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D006160 1993
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D006160 2005
% 214.15/214.36  |- skos__annotation mesh__D006160 /biosyn /physiol permitted   
% 214.15/214.36  |- mesh__historyNote mesh__D006160 72   
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D006160 1992
% 214.15/214.36  |- skos__altLabel mesh__D006160 GTP
% 214.15/214.36  |- mesh__activeMeSHYear mesh__D006160 1999
% 214.15/214.36  |- skos__historyNote mesh__D019886 Peptides %28%1978-1997%29%
% 214.15/214.36  |- mesh__recordOriginator mesh__D019886 AGS
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D019886 2006
% 214.15/214.37  |- mesh__publicMeSHNote mesh__D019886
% 214.15/214.37       98; GASTRIN RELEASING PEPTIDE was indexed under PEPTIDES 1978-97%A%  
% 214.15/214.37  |- mesh__recordMaintainer mesh__D019886 sjn
% 214.15/214.37  |- mesh__dateEstablished mesh__D019886 1998-01-01
% 214.15/214.37  |- mesh__dateCreated mesh__D019886 1997-06-20
% 214.15/214.37  |- skos__hiddenLabel mesh__D019886 Gastrin Releasing Peptide
% 214.15/214.37  |- mesh__historyNote mesh__D019886
% 214.15/214.37       98; use GASTRIN-RELEASING PEPTIDE %28%NM%29% 1980-97   
% 214.15/214.37  |- rdf__type mesh__D019886sskos__Concept
% 214.15/214.37  |- mesh__recordAuthorizer mesh__D019886 sjn
% 214.15/214.37  |- skos__scopeNote mesh__D019886
% 214.15/214.37       Neuropeptide and gut hormone that helps regulate GASTRIC ACID secretion and motor function. Once released from nerves in the antrum of the STOMACH, the neuropeptide stimulates release of GASTRIN from the GASTRIN-SECRETING CELLS.%A%    
% 214.15/214.37  |- skos__broader mesh__D019886smesh__D009479
% 214.15/214.37  |- mesh__dateRevised mesh__D019886 2005-07-01
% 214.15/214.37  |- skos__broader mesh__D019886smesh__D005768
% 214.15/214.37  |- skos__prefLabel mesh__D019886 Gastrin-Releasing Peptide
% 214.15/214.37  |- skos__altLabel mesh__D019886 Gastrin-Releasing Peptide %28%1-27%29%
% 214.15/214.37  |- skos__scopeNote mesh__D005866
% 214.15/214.37       A long-acting potent progestogen structurally related to PROGESTERONE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1185%29%%A%    
% 214.15/214.37  |- skos__prefLabel mesh__D005866 Gestonorone Caproate
% 214.15/214.37  |- skos__hiddenLabel mesh__D005866 Caproate, Gestonorone
% 214.15/214.37  |- mesh__dateRevised mesh__D005866 2005-06-30
% 214.15/214.37  |- skos__altLabel mesh__D005866 Primostat
% 214.15/214.37  |- skos__historyNote mesh__D005866 Pregnanes %28%1971%29%
% 214.15/214.37  |- rdf__type mesh__D005866sskos__Concept
% 214.15/214.37  |- skos__altLabel mesh__D005866 Schering Brand of Gestonorone Caproate
% 214.15/214.37  |- mesh__publicMeSHNote mesh__D005866 73   
% 214.15/214.37  |- mesh__dateCreated mesh__D005866 1999-01-01
% 214.15/214.37  |- skos__hiddenLabel mesh__D005866 Hexanoate, Gestronol
% 214.15/214.37  |- skos__altLabel mesh__D005866 Gestronol Hexanoate
% 214.15/214.37  |- mesh__dateEstablished mesh__D005866 1973-01-01
% 214.15/214.37  |- mesh__recordAuthorizer mesh__D005866 sjn
% 214.15/214.37  |- skos__broader mesh__D005866smesh__D011282
% 214.15/214.37  |- mesh__recordOriginator mesh__D005866 NLM
% 214.15/214.37  |- mesh__historyNote mesh__D005866 73%28%72%29%   
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D005866 2006
% 214.15/214.37  |- mesh__recordMaintainer mesh__D005866 CCR
% 214.15/214.37  |- skos__broader mesh__D005866smesh__D009652
% 214.15/214.37  |- mesh__dateCreated mesh__D005068 1975-07-23
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D005068 1993
% 214.15/214.37  |- skos__hiddenLabel mesh__D005068 Eutrophications
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D005068 2005
% 214.15/214.37  |- skos__hiddenLabel mesh__D005068 Blooms, Algal
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D005068 2001
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D005068 1998
% 214.15/214.37  |- skos__broader mesh__D005068smesh__D001686
% 214.15/214.37  |- skos__hiddenLabel mesh__D005068 Algal Blooms
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D005068 2004
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D005068 2000
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D005068 1997
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D005068 2003
% 214.15/214.37  |- rdf__type mesh__D005068sskos__Concept
% 214.15/214.37  |- mesh__dateEstablished mesh__D005068 1976-01-01
% 214.15/214.37  |- skos__scopeNote mesh__D005068
% 214.15/214.37       Growth of a superabundance of algae and other microscopic plant life usually from an enrichment of a natural body of water by the addition of dissolved nutrients, especially nitrogen and phosphorus. It may be natural, induced %28%water pollution%29%, or controlled %28%harvesting phytoplankton for food in an aquaculture system%29%.%A%    
% 214.15/214.37  |- mesh__historyNote mesh__D005068 76   
% 214.15/214.37  |- skos__hiddenLabel mesh__D005068 Bloom, Algal
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D005068 1996
% 214.15/214.37  |- skos__historyNote mesh__D005068 Water Pollution, Chemical %28%1975%29%
% 214.15/214.37  |- skos__historyNote mesh__D005068 Water Microbiology %28%1966-1975%29%
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D005068 1995
% 214.15/214.37  |- mesh__publicMeSHNote mesh__D005068 76   
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D005068 1994
% 214.15/214.37  |- skos__prefLabel mesh__D005068 Eutrophication
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D005068 2006
% 214.15/214.37  |- mesh__dateRevised mesh__D005068 1992-05-15
% 214.15/214.37  |- mesh__recordAuthorizer mesh__D005068 PLS
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D005068 2002
% 214.15/214.37  |- mesh__recordMaintainer mesh__D005068 TAP
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D005068 1999
% 214.15/214.37  |- mesh__recordOriginator mesh__D005068 SMH
% 214.15/214.37  |- mesh__dateRevised mesh__D010202 1996-06-13
% 214.15/214.37  |- skos__prefLabel mesh__D010202 Panophthalmitis
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D010202 2006
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D010202 2001
% 214.15/214.37  |- mesh__dateCreated mesh__D010202 1999-01-01
% 214.15/214.37  |- mesh__recordMaintainer mesh__D010202 PXP
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D010202 2003
% 214.15/214.37  |- skos__scopeNote mesh__D010202
% 214.15/214.37       Acute suppurative inflammation of the inner eye with necrosis of the sclera %28%and sometimes the cornea%29% and extension of the inflammation into the orbit. Pain may be severe and the globe may rupture. In endophthalmitis the globe does not rupture.%A%    
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D010202 1998
% 214.15/214.37  |- skos__broader mesh__D010202smesh__D015829
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D010202 2004
% 214.15/214.37  |- skos__hiddenLabel mesh__D010202 Panophthalmitides
% 214.15/214.37  |- rdf__type mesh__D010202sskos__Concept
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D010202 1999
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D010202 2002
% 214.15/214.37  |- mesh__recordAuthorizer mesh__D010202 PLS
% 214.15/214.37  |- skos__annotation mesh__D010202
% 214.15/214.37       inflamm of all struct of eye: a clin entity; do not use as a coord for inflamm of specific parts of eye: these are available as -ITIS headings in C11%A%  
% 214.15/214.37  |- mesh__recordOriginator mesh__D010202 NLM
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D010202 2005
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D010202 1997
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D010202 2000
% 214.15/214.37  |- skos__altLabel mesh__D048670 JNK Kinase
% 214.15/214.37  |- skos__hiddenLabel mesh__D048670 Kinase, JNKK1 Protein
% 214.15/214.37  |- mesh__dateCreated mesh__D048670 2004-07-07
% 214.15/214.37  |- skos__altLabel mesh__D048670 MEK4 Protein Kinase
% 214.15/214.37  |- skos__altLabel mesh__D048670 SAPK-ERK Kinase 1
% 214.15/214.37  |- skos__altLabel mesh__D048670 JNK-Activating Protein Kinase
% 214.15/214.37  |- skos__hiddenLabel mesh__D048670 SAPK ERK Kinase 1
% 214.15/214.37  |- mesh__historyNote mesh__D048670 2005%28%1995%29%   
% 214.15/214.37  |- skos__altLabel mesh__D048670 Stress-Activated Protein Kinase Kinase 1
% 214.15/214.37  |- skos__hiddenLabel mesh__D048670 JNK Activating Protein Kinase
% 214.15/214.37  |- skos__hiddenLabel mesh__D048670 Jun Amino Terminal Kinase Kinase
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D048670 2006
% 214.15/214.37  |- skos__altLabel mesh__D048670 JNKK1 Protein Kinase
% 214.15/214.37  |- skos__historyNote mesh__D048670
% 214.15/214.37       Protein-Serine-Threonine Kinases %28%1995-1999%29%
% 214.15/214.37  |- skos__hiddenLabel mesh__D048670 Protein Kinase, JNK-Activating
% 214.15/214.37  |- mesh__publicMeSHNote mesh__D048670
% 214.15/214.37       2005; MAP KINASE KINASE 4 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES %26% PROTEIN-TYROSINE KINASE 2000-2004, %26% under PROTEIN-SERINE-THREONINE KINASES 1995-1999;  JNK-ACTIVATING PROTEIN KINASE was indexed under JNK MITOGEN-ACTIVATED PROTEIN KINASES 2004-2005; under MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASES 2000-2005, %26% under PROTEIN KINASES 1995-1999%A%  
% 214.15/214.37  |- skos__prefLabel mesh__D048670 MAP Kinase Kinase 4
% 214.15/214.37  |- rdf__type mesh__D048670sskos__Concept
% 214.15/214.37  |- skos__hiddenLabel mesh__D048670
% 214.15/214.37       Mitogen Activated Protein Kinase Kinase 4
% 214.15/214.37  |- skos__altLabel mesh__D048670
% 214.15/214.37       SAP Kinase-Extracellular Signal-Regulated Kinase Kinase 1
% 214.15/214.37  |- skos__altLabel mesh__D048670 SAP Kinase Kinase 1
% 214.15/214.37  |- skos__hiddenLabel mesh__D048670 Protein Kinase, MEK4
% 214.15/214.37  |- skos__hiddenLabel mesh__D048670 Protein Kinase, JNKK1
% 214.15/214.37  |- skos__scopeNote mesh__D048670
% 214.15/214.37       A mitogen-activated protein kinase kinase with specificity for JNK MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES and the RETINOID X RECEPTORS. It takes part in a SIGNAL TRANSDUCTION pathway that is activated in response to cellular stress.%A%    
% 214.15/214.37  |- skos__hiddenLabel mesh__D048670
% 214.15/214.37       SAP Kinase Extracellular Signal Regulated Kinase Kinase 1
% 214.15/214.37  |- mesh__dateEstablished mesh__D048670 2005-01-01
% 214.15/214.37  |- mesh__dateRevised mesh__D048670 2005-07-29
% 214.15/214.37  |- skos__hiddenLabel mesh__D048670 Stress Activated Protein Kinase Kinase 1
% 214.15/214.37  |- skos__historyNote mesh__D048670
% 214.15/214.37       Protein-Tyrosine Kinase %28%2000-2004%29%
% 214.15/214.37  |- skos__altLabel mesh__D048670 Mitogen-Activated Protein Kinase Kinase 4
% 214.15/214.37  |- mesh__recordMaintainer mesh__D048670 ags
% 214.15/214.37  |- mesh__recordAuthorizer mesh__D048670 ags
% 214.15/214.37  |- skos__historyNote mesh__D048670
% 214.15/214.37       Mitogen-Activated Protein Kinases %28%2000-2004%29%
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D048670 2006A
% 214.15/214.37  |- skos__altLabel mesh__D048670 JN Kinase Kinase
% 214.15/214.37  |- mesh__recordOriginator mesh__D048670 jmp
% 214.15/214.37  |- skos__altLabel mesh__D048670 Jun Amino-Terminal Kinase Kinase
% 214.15/214.37  |- skos__hiddenLabel mesh__D048670 Protein Kinase, SEK1
% 214.15/214.37  |- skos__broader mesh__D048670smesh__D020929
% 214.15/214.37  |- skos__altLabel mesh__D048670 SEK1 Protein Kinase
% 214.15/214.37  |- mesh__onlineNote mesh__D015496
% 214.15/214.37       use CD4-POSITIVE T-LYMPHOCYTES to search T4 LYMPHOCYTES 1989-94%A%  
% 214.15/214.37  |- mesh__dateRevised mesh__D015496 2005-06-30
% 214.15/214.37  |- mesh__historyNote mesh__D015496 95; was T4 LYMPHOCYTES 1989-94   
% 214.15/214.37  |- skos__hiddenLabel mesh__D015496 T-Lymphocytes, CD4-Positive
% 214.15/214.37  |- skos__hiddenLabel mesh__D015496 T-Lymphocyte, CD4-Positive
% 214.15/214.37  |- mesh__recordAuthorizer mesh__D015496 sjn
% 214.15/214.37  |- skos__hiddenLabel mesh__D015496 CD4-Positive T-Lymphocyte
% 214.15/214.37  |- skos__prefLabel mesh__D015496 CD4-Positive T-Lymphocytes
% 214.15/214.37  |- skos__related mesh__D015496smesh__D018344
% 214.15/214.37  |- mesh__recordOriginator mesh__D015496 PLS
% 214.15/214.37  |- skos__historyNote mesh__D015496 T Lymphocytes %28%1986-1988%29%
% 214.15/214.37  |- mesh__publicMeSHNote mesh__D015496 95; was T4 LYMPHOCYTES 1989-94   
% 214.15/214.37  |- skos__broader mesh__D015496smesh__D013601
% 214.15/214.37  |- rdf__type mesh__D015496sskos__Concept
% 214.15/214.37  |- skos__hiddenLabel mesh__D015496 CD4 Positive T Lymphocytes
% 214.15/214.37  |- skos__altLabel mesh__D015496 CD4-Positive Lymphocytes
% 214.15/214.37  |- skos__hiddenLabel mesh__D015496 CD4-Positive Lymphocyte
% 214.15/214.37  |- skos__annotation mesh__D015496
% 214.15/214.37       subpopulations: index specifics if available or coordinate CD4-POSITIVE T-LYMPHOCYTES with T-LYMPHOCYTE SUBSETS;  count: coordinate IM with CD4 LYMPHOCYTE COUNT %28%NIM%29%%A%  
% 214.15/214.37  |- skos__related mesh__D015496smesh__D015704
% 214.15/214.37  |- skos__altLabel mesh__D015496 T4 Cells
% 214.15/214.37  |- mesh__dateCreated mesh__D015496 1988-07-01
% 214.15/214.37  |- mesh__recordMaintainer mesh__D015496 ags
% 214.15/214.37  |- skos__related mesh__D015496smesh__D016516
% 214.15/214.37  |- skos__scopeNote mesh__D015496
% 214.15/214.37       A critical subpopulation of  T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes.%A%    
% 214.15/214.37  |- skos__related mesh__D015496smesh__D000163
% 214.15/214.37  |- skos__hiddenLabel mesh__D015496 Lymphocyte, CD4-Positive
% 214.15/214.37  |- skos__altLabel mesh__D015496 T4 Lymphocytes
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D015496 2006
% 214.15/214.37  |- skos__hiddenLabel mesh__D015496 T4 Lymphocyte
% 214.15/214.37  |- skos__hiddenLabel mesh__D015496 T4 Cell
% 214.15/214.37  |- skos__hiddenLabel mesh__D015496 Lymphocytes, CD4-Positive
% 214.15/214.37  |- mesh__dateEstablished mesh__D015496 1989-01-01
% 214.15/214.37  |- skos__historyNote mesh__D009459 Malignant Hyperthermia %28%1973-1984%29%
% 214.15/214.37  |- mesh__recordAuthorizer mesh__D009459 ags
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D009459 2005
% 214.15/214.37  |- skos__broader mesh__D009459smesh__D020258
% 214.15/214.37  |- skos__annotation mesh__D009459
% 214.15/214.37       caused by tranquilizing agents so do not use /chem ind   
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D009459 2002
% 214.15/214.37  |- skos__hiddenLabel mesh__D009459 Syndromes, Neuroleptic Malignant
% 214.15/214.37  |- skos__hiddenLabel mesh__D009459
% 214.15/214.37       Neuroleptic Malignant Syndrome, Neuroleptic Induced
% 214.15/214.37  |- mesh__recordOriginator mesh__D009459 RC
% 214.15/214.37  |- skos__hiddenLabel mesh__D009459
% 214.15/214.37       Neuroleptic Induced Neuroleptic Malignant Syndrome
% 214.15/214.37  |- mesh__dateRevised mesh__D009459 1999-12-07
% 214.15/214.37  |- skos__historyNote mesh__D009459 Muscle Rigidity %28%1972-1984%29%
% 214.15/214.37  |- skos__scopeNote mesh__D009459
% 214.15/214.37       A potentially fatal syndrome associated primarily with the use of neuroleptic agents %28%see ANTIPSYCHOTIC AGENTS%29% which are in turn associated with dopaminergic receptor blockade %28%see RECEPTORS, DOPAMINE%29% in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. %28%From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49%28%9%29%:1163-72%29%%A%    
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D009459 2004
% 214.15/214.37  |- skos__prefLabel mesh__D009459 Neuroleptic Malignant Syndrome
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D009459 2001
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D009459 2000A
% 214.15/214.37  |- mesh__dateEstablished mesh__D009459 1986-01-01
% 214.15/214.37  |- mesh__publicMeSHNote mesh__D009459
% 214.15/214.37       1986; see BASAL GANGLIA DISEASES 1985   
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D009459 2003
% 214.15/214.37  |- skos__altLabel mesh__D009459
% 214.15/214.37       Neuroleptic-Malignant Syndrome, Neuroleptic Induced
% 214.15/214.37  |- skos__historyNote mesh__D009459 Fever %28%1966-1984%29%
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D009459 2000
% 214.15/214.37  |- skos__altLabel mesh__D009459 NMS %28%Neuroleptic Malignant Syndrome%29%
% 214.15/214.37  |- rdf__type mesh__D009459sskos__Concept
% 214.15/214.37  |- skos__hiddenLabel mesh__D009459
% 214.15/214.37       NMSs %28%Neuroleptic Malignant Syndrome%29%
% 214.15/214.37  |- skos__broader mesh__D009459smesh__D001480
% 214.15/214.37  |- mesh__recordMaintainer mesh__D009459 ags
% 214.15/214.37  |- skos__hiddenLabel mesh__D009459 Neuroleptic Malignant Syndromes
% 214.15/214.37  |- mesh__historyNote mesh__D009459 1986%28%1985%29%   
% 214.15/214.37  |- mesh__dateCreated mesh__D009459 1984-06-05
% 214.15/214.37  |- skos__historyNote mesh__D009459 Basal Ganglia Diseases %28%1979-1984%29%
% 214.15/214.37  |- skos__historyNote mesh__D009459
% 214.15/214.37       Tranquilizing Agents, Major %28%1975-1984%29%
% 214.15/214.37  |- skos__hiddenLabel mesh__D009459 Syndrome, Neuroleptic Malignant
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D009459 2006
% 214.15/214.37  |- skos__historyNote mesh__D001476 Rickettsial Infections %28%1966-1976%29%
% 214.15/214.37  |- mesh__dateEstablished mesh__D001476 1977-01-01
% 214.15/214.37  |- mesh__historyNote mesh__D001476 77   
% 214.15/214.37  |- mesh__recordMaintainer mesh__D001476 ags
% 214.15/214.37  |- skos__broader mesh__D001476smesh__D016905
% 214.15/214.37  |- mesh__dateRevised mesh__D001476 2003-07-09
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D001476 2006
% 214.15/214.37  |- skos__hiddenLabel mesh__D001476 Bartonellaceae Infection
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D001476 2005
% 214.15/214.37  |- skos__prefLabel mesh__D001476 Bartonellaceae Infections
% 214.15/214.37  |- skos__hiddenLabel mesh__D001476 Infection, Bartonellaceae
% 214.15/214.37  |- rdf__type mesh__D001476sskos__Concept
% 214.15/214.37  |- skos__annotation mesh__D001476 gram-neg bact infect   
% 214.15/214.37  |- mesh__publicMeSHNote mesh__D001476 77   
% 214.15/214.37  |- skos__historyNote mesh__D001476 Bartonella Infections %28%1966-1976%29%
% 214.15/214.37  |- mesh__recordAuthorizer mesh__D001476 sjn
% 214.15/214.37  |- mesh__recordOriginator mesh__D001476 FPG
% 214.15/214.37  |- skos__scopeNote mesh__D001476
% 214.15/214.37       Infections with bacteria of the family BARTONELLACEAE.     
% 214.15/214.37  |- mesh__dateCreated mesh__D001476 1976-04-27
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D001476 2004
% 214.15/214.37  |- skos__altLabel mesh__D001476 Infections, Bartonellaceae
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D020630 2006
% 214.15/214.37  |- mesh__publicMeSHNote mesh__D020630 2000   
% 214.15/214.37  |- mesh__recordOriginator mesh__D020630 ndw
% 214.15/214.37  |- skos__historyNote mesh__D020630
% 214.15/214.37       Gram-Negative Aerobic Rods and Cocci %28%1998-1999%29%
% 214.15/214.37  |- skos__prefLabel mesh__D020630 Methylophilus methylotrophus
% 214.15/214.37  |- skos__broader mesh__D020630smesh__D020629
% 214.15/214.37  |- skos__historyNote mesh__D020630 Gram-Negative Bacteria %28%1992-1997%29%
% 214.15/214.37  |- mesh__recordMaintainer mesh__D020630 SYSTEM
% 214.15/214.37  |- mesh__dateEstablished mesh__D020630 2000-01-01
% 214.15/214.37  |- mesh__historyNote mesh__D020630 2000   
% 214.15/214.37  |- skos__scopeNote mesh__D020630
% 214.15/214.37       A species of METHYLOPHILUS which is motile by single flagella. In addition to growth on methanol as a sole carbon source, growth also occurs on glucose. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 214.15/214.37  |- mesh__recordAuthorizer mesh__D020630 sjn
% 214.15/214.37  |- mesh__dateCreated mesh__D020630 1999-11-03
% 214.15/214.37  |- mesh__dateRevised mesh__D020630 2005-06-30
% 214.15/214.37  |- rdf__type mesh__D020630sskos__Concept
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D019887 2005
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D019887 2004
% 214.15/214.37  |- mesh__recordMaintainer mesh__D019887 jmp
% 214.15/214.37  |- rdf__type mesh__D019887sskos__Concept
% 214.15/214.37  |- mesh__publicMeSHNote mesh__D019887
% 214.15/214.37       98; PEANUT AGGLUTININ was indexed under LECTINS 1979-97   
% 214.15/214.37  |- skos__broader mesh__D019887smesh__D037121
% 214.15/214.37  |- skos__historyNote mesh__D019887 Lectins %28%1979-1997%29%
% 214.15/214.37  |- mesh__dateEstablished mesh__D019887 1998-01-01
% 214.15/214.37  |- mesh__recordOriginator mesh__D019887 AGS
% 214.15/214.37  |- skos__scopeNote mesh__D019887
% 214.15/214.37       Lectin purified from peanuts %28%ARACHIS HYPOGAEA%29%. It binds to poorly differentiated cells and terminally differentiated cells and is used in cell separation techniques.%A%    
% 214.15/214.37  |- skos__prefLabel mesh__D019887 Peanut Agglutinin
% 214.15/214.37  |- skos__hiddenLabel mesh__D019887 Lectin, Peanut
% 214.15/214.37  |- mesh__dateCreated mesh__D019887 1997-06-20
% 214.15/214.37  |- mesh__historyNote mesh__D019887
% 214.15/214.37       98; use PEANUT AGGLUTININ %28%NM%29% 1979-97   
% 214.15/214.37  |- skos__altLabel mesh__D019887 Peanut Lectin
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D019887 2006
% 214.15/214.37  |- mesh__dateRevised mesh__D019887 2003-07-09
% 214.15/214.37  |- skos__hiddenLabel mesh__D019887 Agglutinin, Peanut
% 214.15/214.37  |- mesh__recordAuthorizer mesh__D019887 sjn
% 214.15/214.37  |- skos__altLabel mesh__D019089 Steel Factor
% 214.15/214.37  |- skos__historyNote mesh__D019089
% 214.15/214.37       Hematopoietic Cell Growth Factors %28%1990-1995%29%
% 214.15/214.37  |- mesh__dateRevised mesh__D019089 2005-07-01
% 214.15/214.37  |- skos__scopeNote mesh__D019089
% 214.15/214.37       A hematopoietic growth factor and the ligand of the cell surface c-kit protein %28%PROTO-ONCOGENE PROTEINS C-KIT%29%. It is expressed during embryogenesis and is a growth factor for a number of cell types including the MAST CELLS and the MELANOCYTES in addition to the HEMATOPOIETIC STEM CELLS.%A%    
% 214.15/214.37  |- mesh__publicMeSHNote mesh__D019089
% 214.15/214.37       96; MAST CELL GROWTH FACTOR was indexed under HEMATOPOIETIC CELL GROWTH FACTORS 1990-95%A%  
% 214.15/214.37  |- skos__broader mesh__D019089smesh__D016298
% 214.15/214.37  |- mesh__recordMaintainer mesh__D019089 sjn
% 214.15/214.37  |- mesh__dateCreated mesh__D019089 1995-05-26
% 214.15/214.37  |- mesh__dateEstablished mesh__D019089 1996-01-01
% 214.15/214.37  |- mesh__recordAuthorizer mesh__D019089 sjn
% 214.15/214.37  |- skos__hiddenLabel mesh__D019089 c kit Ligand
% 214.15/214.37  |- skos__altLabel mesh__D019089 c-kit Ligand
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D019089 2006
% 214.15/214.37  |- skos__altLabel mesh__D019089 Mast Cell Growth Factor
% 214.15/214.37  |- rdf__type mesh__D019089sskos__Concept
% 214.15/214.37  |- skos__altLabel mesh__D019089 kit Ligand
% 214.15/214.37  |- mesh__onlineNote mesh__D019089
% 214.15/214.37       use STEM CELL FACTOR %28%NM%29% to search MAST CELL GROWTH FACTOR 1990-95%A%  
% 214.15/214.37  |- mesh__recordOriginator mesh__D019089 AGS
% 214.15/214.37  |- skos__prefLabel mesh__D019089 Stem Cell Factor
% 214.15/214.37  |- mesh__historyNote mesh__D019089
% 214.15/214.37       96; was MAST CELL GROWTH FACTOR %28%NM%29% 1990-95   
% 214.15/214.37  |- rdf__type mesh__D005867sskos__Concept
% 214.15/214.37  |- mesh__onlineNote mesh__D005867
% 214.15/214.37       use GESTRINONE to search R 2323 1979-87   
% 214.15/214.37  |- skos__historyNote mesh__D005867
% 214.15/214.37       Norgestrienone/analogs %26% derivatives %28%1975-1978%29%
% 214.15/214.37  |- mesh__dateRevised mesh__D005867 2005-06-30
% 214.15/214.37  |- mesh__dateCreated mesh__D005867 1977-12-15
% 214.15/214.37  |- mesh__historyNote mesh__D005867
% 214.15/214.37       91%28%88%29%; was see under NORPREGNATRIENES 1988-90; was R 2323 see under NORPREGNATRIENES 1979-87%A%  
% 214.15/214.37  |- mesh__recordOriginator mesh__D005867 RLS
% 214.15/214.37  |- mesh__recordAuthorizer mesh__D005867 sjn
% 214.15/214.37  |- skos__altLabel mesh__D005867 Hoechst Brand of Gestrinone
% 214.15/214.37  |- skos__hiddenLabel mesh__D005867 R 2323
% 214.15/214.37  |- skos__broader mesh__D005867smesh__D009645
% 214.15/214.37  |- skos__historyNote mesh__D005867 Gonanes %28%1968-1974%29%
% 214.15/214.37  |- skos__altLabel mesh__D005867 Dimetriose
% 214.15/214.37  |- mesh__recordMaintainer mesh__D005867 CCR
% 214.15/214.37  |- skos__scopeNote mesh__D005867
% 214.15/214.37       A non-estrogenic contraceptive which is a weak progestin with strong anti-progesterone properties. It is effective if used once a week orally or can also be used in intravaginal devices.%A%    
% 214.15/214.37  |- skos__altLabel mesh__D005867 R2323
% 214.15/214.37  |- skos__prefLabel mesh__D005867 Gestrinone
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D005867 2006
% 214.15/214.37  |- skos__altLabel mesh__D005867 Florizel Brand of Gestrinone
% 214.15/214.37  |- skos__altLabel mesh__D005867 Aventis Brand of Gestrinone
% 214.15/214.37  |- mesh__publicMeSHNote mesh__D005867
% 214.15/214.37       91; was see under NORPREGNATRIENES 1988-90; was R 2323 see under NORPREGNATRIENES 1979-87%A%  
% 214.15/214.37  |- mesh__dateEstablished mesh__D005867 1991-01-01
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Evaluations
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Studies, Evaluation
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Quantitative Evaluations
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Evaluation, Qualitative
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D005069 2002
% 214.15/214.37  |- mesh__recordOriginator mesh__D005069 NLM
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D005069 2003
% 214.15/214.37  |- mesh__recordAuthorizer mesh__D005069 sjn
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Evaluations, Quantitative
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Indexes, Evaluation
% 214.15/214.37  |- mesh__dateCreated mesh__D005069 1999-01-01
% 214.15/214.37  |- skos__broader mesh__D005069smesh__D008919
% 214.15/214.37  |- skos__scopeNote mesh__D005069
% 214.15/214.37       Studies determining the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. For drugs and devices, CLINICAL TRIALS; DRUG EVALUATION; and DRUG EVALUATION, PRECLINICAL are available.%A%    
% 214.15/214.37  |- skos__altLabel mesh__D005069 Evaluation Methodology
% 214.15/214.37  |- mesh__publicMeSHNote mesh__D005069 74   
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Research, Evaluation
% 214.15/214.37  |- skos__related mesh__D005069smesh__D015397
% 214.15/214.37  |- rdf__type mesh__D005069sskos__Concept
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D005069 2004
% 214.15/214.37  |- mesh__dateRevised mesh__D005069 2001-07-25
% 214.15/214.37  |- mesh__historyNote mesh__D005069 74%28%71%29%%28%66-67%29%   
% 214.15/214.37  |- mesh__recordMaintainer mesh__D005069 mdb
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Reports, Evaluation
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Evaluations, Qualitative
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D005069 2005
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Study, Evaluation
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Pre-Post Test
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Report, Evaluation
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Evaluation Reports
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Tests, Pre-Post
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Methodologies, Evaluation
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Critiques
% 214.15/214.37  |- skos__annotation mesh__D005069
% 214.15/214.37       do not use for evaluation of drugs %28% = probably DRUG EVALUATION or DRUG EVALUATION, PRECLINICAL or CLINICAL TRIALS terms%29%; do not use for evaluation of patient care %28% = probably terms indented under QUALITY OF HEALTH CARE%29%%A%  
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Test, Pre-Post
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D005069 2006
% 214.15/214.37  |- skos__broader mesh__D005069smesh__D017531
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Pre Post Tests
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Evaluation, Quantitative
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Effectiveness, Theoretical
% 214.15/214.37  |- skos__prefLabel mesh__D005069 Evaluation Studies
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Evaluation Study
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Use Effectiveness
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Qualitative Evaluations
% 214.15/214.37  |- mesh__dateEstablished mesh__D005069 1974-01-01
% 214.15/214.37  |- skos__hiddenLabel mesh__D005069 Evaluation Methodologies
% 214.15/214.37  |- skos__scopeNote mesh__D010203
% 214.15/214.37       A genus of cone-nosed bugs of the subfamily TRIATOMINAE. Its species are vectors of TRYPANOSOMA CRUZI.%A%    
% 214.15/214.37  |- mesh__dateCreated mesh__D010203 1999-01-01
% 214.15/214.37  |- skos__prefLabel mesh__D010203 Panstrongylus
% 214.15/214.37  |- mesh__publicMeSHNote mesh__D010203
% 214.15/214.37       91; was see under TRIATOMIDAE 1979-90; was see under TRIATOMINAE 1973-78%A%  
% 214.15/214.37  |- mesh__dateRevised mesh__D010203 2003-07-09
% 214.15/214.37  |- mesh__historyNote mesh__D010203
% 214.15/214.37       91%28%75%29%; was see under TRIATOMIDAE 1979-90; was see under TRIATOMINAE 1973-78%A%  
% 214.15/214.37  |- mesh__dateEstablished mesh__D010203 1991-01-01
% 214.15/214.37  |- mesh__onlineNote mesh__D010203 search TRIATOMINAE 1973-74   
% 214.15/214.37  |- mesh__recordAuthorizer mesh__D010203 sjn
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D010203 2004
% 214.15/214.37  |- rdf__type mesh__D010203sskos__Concept
% 214.15/214.37  |- mesh__recordMaintainer mesh__D010203 ags
% 214.15/214.37  |- skos__broader mesh__D010203smesh__D014225
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D010203 2005
% 214.15/214.37  |- skos__annotation mesh__D010203
% 214.15/214.37       do not use /drug eff for insecticides: TN 111   
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D010203 2006
% 214.15/214.37  |- mesh__recordOriginator mesh__D010203 NLM
% 214.15/214.37  |- mesh__historyNote mesh__D048671 2005%28%1995%29%   
% 214.15/214.37  |- skos__altLabel mesh__D048671 MAP2K5 Protein
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D048671 2005
% 214.15/214.37  |- skos__prefLabel mesh__D048671 MAP Kinase Kinase 5
% 214.15/214.37  |- skos__hiddenLabel mesh__D048671 MAPKK 5 Protein Kinase
% 214.15/214.37  |- rdf__type mesh__D048671sskos__Concept
% 214.15/214.37  |- mesh__dateCreated mesh__D048671 2004-07-07
% 214.15/214.37  |- mesh__publicMeSHNote mesh__D048671
% 214.15/214.37       2005; MITOGEN-ACTIVATED PROTEIN KINASE KINASE 5 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004, %26% under PROTEIN-TYROSINE KINASE %26% PROTEIN-SERINE-THREONINE KINASES 1995-1999%A%  
% 214.15/214.37  |- skos__altLabel mesh__D048671 MAPKK-5 Protein Kinase
% 214.15/214.37  |- mesh__recordOriginator mesh__D048671 jmp
% 214.15/214.37  |- mesh__recordAuthorizer mesh__D048671 sjn
% 214.15/214.37  |- skos__historyNote mesh__D048671
% 214.15/214.37       Protein-Serine-Threonine Kinases %28%1995-1999%29%
% 214.15/214.37  |- skos__altLabel mesh__D048671 Mitogen-Activated Protein Kinase Kinase 5
% 214.15/214.37  |- skos__historyNote mesh__D048671
% 214.15/214.37       Mitogen-Activated Protein Kinases %28%2000-2004%29%
% 214.15/214.37  |- skos__altLabel mesh__D048671 MAPK-ERK Kinase 5
% 214.15/214.37  |- skos__scopeNote mesh__D048671
% 214.15/214.37       A mitogen-activated protein kinase kinase with specificity for MITOGEN-ACTIVATED PROTEIN KINASE 7.%A%    
% 214.15/214.37  |- mesh__dateEstablished mesh__D048671 2005-01-01
% 214.15/214.37  |- skos__hiddenLabel mesh__D048671 MAPK ERK Kinase 5
% 214.15/214.37  |- mesh__recordMaintainer mesh__D048671 jmp
% 214.15/214.37  |- skos__broader mesh__D048671smesh__D020929
% 214.15/214.37  |- skos__altLabel mesh__D048671 MAPKK5 Protein Kinase
% 214.15/214.37  |- skos__historyNote mesh__D048671
% 214.15/214.37       Protein-Tyrosine Kinase %28%1995-1999%29%
% 214.15/214.37  |- skos__hiddenLabel mesh__D048671
% 214.15/214.37       Mitogen Activated Protein Kinase Kinase 5
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D048671 2006
% 214.15/214.37  |- skos__altLabel mesh__D015497 Human immunodeficiency virus 1
% 214.15/214.37  |- skos__altLabel mesh__D015497 Human Immunodeficiency Virus Type 1
% 214.15/214.37  |- skos__prefLabel mesh__D015497 HIV-1
% 214.15/214.37  |- skos__annotation mesh__D015497
% 214.15/214.37       infection: coord IM with HIV INFECTIONS %28%IM%29% or AIDS %28%IM%29% or their specifics %28%IM%29%%A%  
% 214.15/214.37  |- mesh__recordOriginator mesh__D015497 PLS
% 214.15/214.37  |- skos__altLabel mesh__D015497 Immunodeficiency Virus Type 1, Human
% 214.15/214.37  |- mesh__recordMaintainer mesh__D015497 ags
% 214.15/214.37  |- rdf__type mesh__D015497sskos__Concept
% 214.15/214.37  |- mesh__dateRevised mesh__D015497 2004-07-07
% 214.15/214.37  |- mesh__recordAuthorizer mesh__D015497 sjn
% 214.15/214.37  |- mesh__publicMeSHNote mesh__D015497 89   
% 214.15/214.37  |- skos__historyNote mesh__D015497 HIV %28%1987-1988%29%
% 214.15/214.37  |- mesh__dateCreated mesh__D015497 1988-07-01
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D015497 2005
% 214.15/214.37  |- skos__related mesh__D015497smesh__D000163
% 214.15/214.37  |- skos__altLabel mesh__D015497 HIV-I
% 214.15/214.37  |- skos__broader mesh__D015497smesh__D006678
% 214.15/214.37  |- mesh__activeMeSHYear mesh__D015497 2006
% 214.15/214.38  |- skos__scopeNote mesh__D015497
% 214.15/214.38       The type species of LENTIVIRUS and the etiologic agent of AIDS %28%ACQUIRED IMMUNODEFICIENCY SYNDROME%29%. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte.%A%    
% 214.15/214.38  |- mesh__historyNote mesh__D015497 89   
% 214.15/214.38  |- mesh__dateEstablished mesh__D015497 1989-01-01
% 214.15/214.38  |- skos__hiddenLabel mesh__D001477 Disease, Bartter
% 214.15/214.38  |- mesh__historyNote mesh__D001477 2005 %28%1975%29%   
% 214.15/214.38  |- skos__hiddenLabel mesh__D001477 Bartters Disease
% 214.15/214.38  |- skos__altLabel mesh__D001477 Barter Disease
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D001477 2006
% 214.15/214.38  |- mesh__recordOriginator mesh__D001477 NLM
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D001477 2005
% 214.15/214.38  |- skos__scopeNote mesh__D001477
% 214.15/214.38       A group of disorders caused by the defective salt reabsorption in the ascending LOOP OF HENLE. It is characterized by severe salt-wasting, HYPOKALEMIA, hypercalciuria, metabolic ALKALOSIS, and hyper-reninemic HYPERALDOSTERONISM without HYPERTENSION. There are several subtypes resulting from mutations of autosomal recessive genes for SODIUM-POTASSIUM-CHLORIDE COTRANSPORTERS.%A%    
% 214.15/214.38  |- skos__hiddenLabel mesh__D001477 Barters Disease
% 214.15/214.38  |- skos__prefLabel mesh__D001477 Bartter Syndrome
% 214.15/214.38  |- rdf__type mesh__D001477sskos__Concept
% 214.15/214.38  |- skos__altLabel mesh__D001477 Bartter%27%s Disease
% 214.15/214.38  |- mesh__dateEstablished mesh__D001477 1991-01-01
% 214.15/214.38  |- mesh__dateRevised mesh__D001477 2004-07-07
% 214.15/214.38  |- skos__hiddenLabel mesh__D001477 Syndrome, Bartter
% 214.15/214.38  |- skos__altLabel mesh__D001477 Barter%27%s Disease
% 214.15/214.38  |- mesh__publicMeSHNote mesh__D001477
% 214.15/214.38       2005; see BARTTER%27%S DISEASE 1991-2004, see HYPERALDOSTERONISM 1975-1990%A%  
% 214.15/214.38  |- mesh__recordMaintainer mesh__D001477 lkt
% 214.15/214.38  |- skos__hiddenLabel mesh__D001477 Disease, Barter
% 214.15/214.38  |- skos__hiddenLabel mesh__D001477 Disease, Barter%27%s
% 214.15/214.38  |- skos__broader mesh__D001477smesh__D006929
% 214.15/214.38  |- mesh__dateCreated mesh__D001477 1999-01-01
% 214.15/214.38  |- mesh__recordAuthorizer mesh__D001477 sjn
% 214.15/214.38  |- skos__hiddenLabel mesh__D001477 Disease, Bartter%27%s
% 214.15/214.38  |- skos__altLabel mesh__D001477 Bartter Disease
% 214.15/214.38  |- skos__broader mesh__D001477smesh__D015499
% 214.15/214.38  |- skos__hiddenLabel mesh__D006960 Primary Oxalurias
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D006960 2006
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D006960 2003
% 214.15/214.38  |- skos__annotation mesh__D006960
% 214.15/214.38       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D006960 2005
% 214.15/214.38  |- mesh__dateCreated mesh__D006960 1986-04-18
% 214.15/214.38  |- skos__broader mesh__D006960smesh__D007674
% 214.15/214.38  |- mesh__historyNote mesh__D006960
% 214.15/214.38       91%28%87%29%; was see under HYPEROXALURIA 1987-90   
% 214.15/214.38  |- mesh__dateRevised mesh__D006960 2004-07-28
% 214.15/214.38  |- mesh__recordAuthorizer mesh__D006960 jls
% 214.15/214.38  |- skos__hiddenLabel mesh__D006960 Primary Hyperoxalurias
% 214.15/214.38  |- skos__scopeNote mesh__D006960
% 214.15/214.38       Either of two genetic disorders characterized by urinary excretion of large amounts of oxalate, with nephrolithiasis, nephrocalcinosis, early onset of renal failure, and often a generalized deposit of calcium oxalate, resulting from a defect in glyoxylate metabolism.%A%    
% 214.15/214.38  |- skos__altLabel mesh__D006960 Oxaluria, Primary
% 214.15/214.38  |- mesh__recordOriginator mesh__D006960 VDK
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D006960 2005A
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D006960 2002
% 214.15/214.38  |- mesh__dateEstablished mesh__D006960 1991-01-01
% 214.15/214.38  |- skos__hiddenLabel mesh__D006960 Oxalurias, Primary
% 214.15/214.38  |- rdf__type mesh__D006960sskos__Concept
% 214.15/214.38  |- mesh__recordMaintainer mesh__D006960 jls
% 214.15/214.38  |- skos__broader mesh__D006960smesh__D006959
% 214.15/214.38  |- skos__broader mesh__D006960smesh__D002239
% 214.15/214.38  |- skos__hiddenLabel mesh__D006960 Hyperoxalurias, Primary
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D006960 2004
% 214.15/214.38  |- skos__prefLabel mesh__D006960 Hyperoxaluria, Primary
% 214.15/214.38  |- skos__altLabel mesh__D006960 Primary Hyperoxaluria
% 214.15/214.38  |- mesh__publicMeSHNote mesh__D006960
% 214.15/214.38       91; was see under HYPEROXALURIA 1987-90   
% 214.15/214.38  |- skos__scopeNote mesh__D020631
% 214.15/214.38       A genus of short, aerobic, gram-negative rods which are obligate methylotrophs, growing on one-carbon compounds other than methane. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 214.15/214.38  |- rdf__type mesh__D020631sskos__Concept
% 214.15/214.38  |- mesh__recordAuthorizer mesh__D020631 sjn
% 214.15/214.38  |- mesh__dateRevised mesh__D020631 2005-06-30
% 214.15/214.38  |- skos__prefLabel mesh__D020631 Methylobacillus
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D020631 2006
% 214.15/214.38  |- mesh__recordMaintainer mesh__D020631 SYSTEM
% 214.15/214.38  |- mesh__publicMeSHNote mesh__D020631 2000   
% 214.15/214.38  |- skos__broader mesh__D020631smesh__D042762
% 214.15/214.38  |- mesh__dateEstablished mesh__D020631 2000-01-01
% 214.15/214.38  |- mesh__recordOriginator mesh__D020631 ndw
% 214.15/214.38  |- mesh__dateCreated mesh__D020631 1999-11-03
% 214.15/214.38  |- mesh__historyNote mesh__D020631 2000   
% 214.15/214.38  |- skos__hiddenLabel mesh__D006162 Cyclase, Guanyl
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D006162 2006
% 214.15/214.38  |- skos__hiddenLabel mesh__D006162 Cyclase, Deoxyguanylate
% 214.15/214.38  |- skos__altLabel mesh__D006162 Inosinate Cyclase
% 214.15/214.38  |- mesh__dateRevised mesh__D006162 2005-06-30
% 214.15/214.38  |- skos__historyNote mesh__D006162
% 214.15/214.38       Nucleotidyltransferases %28%1966-1972%29%
% 214.15/214.38  |- mesh__dateEstablished mesh__D006162 1973-01-01
% 214.15/214.38  |- skos__hiddenLabel mesh__D006162 Cyclase, Guanylate
% 214.15/214.38  |- rdf__type mesh__D006162sskos__Concept
% 214.15/214.38  |- mesh__dateCreated mesh__D006162 1999-01-01
% 214.15/214.38  |- mesh__historyNote mesh__D006162 94; was GUANYL CYCLASE 1973-94   
% 214.15/214.38  |- skos__broader mesh__D006162smesh__D047908
% 214.15/214.38  |- mesh__recordMaintainer mesh__D006162 jmp
% 214.15/214.38  |- mesh__publicMeSHNote mesh__D006162 94; was GUANYL CYCLASE 1973-94   
% 214.15/214.38  |- skos__prefLabel mesh__D006162 Guanylate Cyclase
% 214.15/214.38  |- skos__scopeNote mesh__D006162
% 214.15/214.38       An enzyme that catalyzes the conversion of GTP to 3%27%,5%27%-cyclic GMP and pyrophosphate. It also acts on ITP and dGTP. %28%From Enzyme Nomenclature, 1992%29% EC 4.6.1.2.%A%    
% 214.15/214.38  |- mesh__recordAuthorizer mesh__D006162 sjn
% 214.15/214.38  |- skos__hiddenLabel mesh__D006162 Cyclase, Guanylyl
% 214.15/214.38  |- mesh__recordOriginator mesh__D006162 NLM
% 214.15/214.38  |- skos__broader mesh__D006162smesh__D019761
% 214.15/214.38  |- mesh__onlineNote mesh__D006162
% 214.15/214.38       use GUANYLATE CYCLASE to search GUANYL CYCLASE 1973-94   
% 214.15/214.38  |- skos__hiddenLabel mesh__D006162 Cyclase, Inosinate
% 214.15/214.38  |- skos__altLabel mesh__D006162 Guanyl Cyclase
% 214.15/214.38  |- skos__altLabel mesh__D006162 Guanylyl Cyclase
% 214.15/214.38  |- skos__altLabel mesh__D006162 Deoxyguanylate Cyclase
% 214.15/214.38  |- mesh__recordAuthorizer mesh__D019888 sjn
% 214.15/214.38  |- mesh__publicMeSHNote mesh__D019888
% 214.15/214.38       98; NELFINAVIR MESYLATE %28%now NELFINAVIR%29% was indexed under ISOQUINOLINES 1997; AG 1343 %28%now NELFINAVIR%29% was indexed under ISOQUINOLINES %26% SULFONIC ACIDS 1995-97%A%  
% 214.15/214.38  |- skos__historyNote mesh__D019888 Sulfonic Acids %28%1995-1997%29%
% 214.15/214.38  |- skos__altLabel mesh__D019888 Roche Brand of Nelfinavir Mesylate
% 214.15/214.38  |- skos__historyNote mesh__D019888 Isoquinolines %28%1995-1997%29%
% 214.15/214.38  |- skos__prefLabel mesh__D019888 Nelfinavir
% 214.15/214.38  |- skos__altLabel mesh__D019888 Agouron Brand of Nelfinavir Mesylate
% 214.15/214.38  |- skos__hiddenLabel mesh__D019888 Monomethane Sulfonate, Nelfinavir
% 214.15/214.38  |- mesh__dateRevised mesh__D019888 2005-06-30
% 214.15/214.38  |- skos__altLabel mesh__D019888 Nelfinavir Monomethane Sulfonate
% 214.15/214.38  |- mesh__historyNote mesh__D019888 98; use NELFINAVIR %28%NM%29% 1995-97   
% 214.15/214.38  |- skos__scopeNote mesh__D019888
% 214.15/214.38       A potent HIV protease inhibitor. It is used in combination with other antiviral drugs in the treatment of HIV in both adults and children.%A%    
% 214.15/214.38  |- mesh__recordMaintainer mesh__D019888 lkw
% 214.15/214.38  |- skos__broader mesh__D019888smesh__D007546
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D019888 2006
% 214.15/214.38  |- skos__hiddenLabel mesh__D019888 Mesylate, Nelfinavir
% 214.15/214.38  |- mesh__dateEstablished mesh__D019888 1998-01-01
% 214.15/214.38  |- skos__hiddenLabel mesh__D019888 Sulfonate, Nelfinavir Monomethane
% 214.15/214.38  |- mesh__recordOriginator mesh__D019888 AGS
% 214.15/214.38  |- skos__altLabel mesh__D019888 AG-1343
% 214.15/214.38  |- rdf__type mesh__D019888sskos__Concept
% 214.15/214.38  |- skos__altLabel mesh__D019888 AG1343
% 214.15/214.38  |- mesh__dateCreated mesh__D019888 1997-06-20
% 214.15/214.38  |- mesh__dateCreated mesh__D005868 1999-01-01
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D005868 2004
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D005868 2003
% 214.15/214.38  |- mesh__onlineNote mesh__D005868
% 214.15/214.38       search KINESICS 1968-74 %26% COMMUNICATION 1966-67   
% 214.15/214.38  |- skos__broader mesh__D005868smesh__D007697
% 214.15/214.38  |- mesh__dateRevised mesh__D005868 2002-07-03
% 214.15/214.38  |- mesh__historyNote mesh__D005868
% 214.15/214.38       91%28%75%29%; was see under KINESICS 1968-90; was see under COMMUNICATION 1963-67%A%  
% 214.15/214.38  |- skos__hiddenLabel mesh__D005868 Gesture
% 214.15/214.38  |- mesh__publicMeSHNote mesh__D005868
% 214.15/214.38       91; was see under KINESICS 1968-90; was see under COMMUNICATION 1963-67%A%  
% 214.15/214.38  |- skos__scopeNote mesh__D005868
% 214.15/214.38       Movement of a part of the body for the purpose of communication.%A%    
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D005868 2006
% 214.15/214.38  |- mesh__recordAuthorizer mesh__D005868 sjn
% 214.15/214.38  |- mesh__recordOriginator mesh__D005868 NLM
% 214.15/214.38  |- skos__prefLabel mesh__D005868 Gestures
% 214.15/214.38  |- mesh__recordMaintainer mesh__D005868 NLM
% 214.15/214.38  |- mesh__dateEstablished mesh__D005868 1991-01-01
% 214.15/214.38  |- rdf__type mesh__D005868sskos__Concept
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D005868 2005
% 214.15/214.38  |- skos__annotation mesh__D005868 no qualif   
% 214.15/214.38  |- mesh__dateRevised mesh__D016590 2000-06-21
% 214.15/214.38  |- mesh__publicMeSHNote mesh__D016590
% 214.15/214.38       92; APHIDICOLIN was indexed under DITERPENES 1974-91   
% 214.15/214.38  |- skos__historyNote mesh__D016590 Diterpenes %28%1974-1991%29%
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D016590 2006
% 214.15/214.38  |- mesh__dateEstablished mesh__D016590 1992-01-01
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D016590 2001
% 214.15/214.38  |- skos__hiddenLabel mesh__D016590 NSC 234714
% 214.15/214.38  |- skos__historyNote mesh__D016590 Antiviral Agents %28%1966-1991%29%
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D016590 2003
% 214.15/214.38  |- skos__hiddenLabel mesh__D016590 ICI69653
% 214.15/214.38  |- skos__scopeNote mesh__D016590
% 214.15/214.38       An antiviral antibiotic produced by Cephalosporium aphidicola and other fungi. It inhibits the growth of eukaryotic cells and certain animal viruses by selectively inhibiting the cellular replication of DNA polymerase II or the viral-induced DNA polymerases. The drug may be useful for controlling excessive cell proliferation in patients with cancer, psoriasis or other dermatitis with little or no adverse effect upon non-multiplying cells.%A%    
% 214.15/214.38  |- mesh__onlineNote mesh__D016590
% 214.15/214.38       use APHIDICOLIN %28%NM%29% to search APHIDICOLIN 1980-91   
% 214.15/214.38  |- skos__hiddenLabel mesh__D016590 ICI 69653
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D016590 2004
% 214.15/214.38  |- rdf__type mesh__D016590sskos__Concept
% 214.15/214.38  |- skos__historyNote mesh__D016590
% 214.15/214.38       DNA Polymerases/antagonists %26% inhibitors %28%1977-1991%29%
% 214.15/214.38  |- skos__hiddenLabel mesh__D016590 NSC234714
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D016590 2002
% 214.15/214.38  |- mesh__recordOriginator mesh__D016590 RLS
% 214.15/214.38  |- skos__hiddenLabel mesh__D016590 NSC351140
% 214.15/214.38  |- mesh__historyNote mesh__D016590
% 214.15/214.38       92; was APHIDICOLIN %28%NM%29% 1974-91   
% 214.15/214.38  |- mesh__recordAuthorizer mesh__D016590 sjn
% 214.15/214.38  |- skos__prefLabel mesh__D016590 Aphidicolin
% 214.15/214.38  |- mesh__dateCreated mesh__D016590 1991-01-24
% 214.15/214.38  |- skos__hiddenLabel mesh__D016590 NSC 351140
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D016590 2005
% 214.15/214.38  |- skos__broader mesh__D016590smesh__D004224
% 214.15/214.38  |- mesh__recordMaintainer mesh__D016590 CCR
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D030261 2006
% 214.15/214.38  |- skos__altLabel mesh__D030261 PTLV-1
% 214.15/214.38  |- skos__altLabel mesh__D030261 T-Lymphotropic Virus 1, Primate
% 214.15/214.38  |- skos__prefLabel mesh__D030261 Primate T-lymphotropic virus 1
% 214.15/214.38  |- skos__scopeNote mesh__D030261
% 214.15/214.38       A species in the family DELTARETROVIRUS comprising strains of different host species but arising from the same geographic origin. They include HUMAN T-LYMPHOTROPIC VIRUS 1 and SIMIAN T-LYMPHOTROPIC VIRUS 1.%A%    
% 214.15/214.38  |- skos__hiddenLabel mesh__D030261 T Lymphotropic Virus 1, Primate
% 214.15/214.38  |- mesh__publicMeSHNote mesh__D030261 2002   
% 214.15/214.38  |- mesh__recordOriginator mesh__D030261 ags
% 214.15/214.38  |- mesh__dateCreated mesh__D030261 2001-07-25
% 214.15/214.38  |- skos__hiddenLabel mesh__D030261 Primate T lymphotropic virus 1
% 214.15/214.38  |- mesh__recordMaintainer mesh__D030261 sjn
% 214.15/214.38  |- mesh__recordAuthorizer mesh__D030261 sjn
% 214.15/214.38  |- mesh__dateEstablished mesh__D030261 2002-01-01
% 214.15/214.38  |- skos__broader mesh__D030261smesh__D017977
% 214.15/214.38  |- skos__annotation mesh__D030261
% 214.15/214.38       infection: coord IM with DELTARETROVIRUS INFECTIONS + TUMOR VIRUS INFECTIONS %28%IM%29% if pertinent%A%  
% 214.15/214.38  |- rdf__type mesh__D030261sskos__Concept
% 214.15/214.38  |- mesh__historyNote mesh__D030261 2002   
% 214.15/214.38  |- mesh__dateRevised mesh__D030261 2004-07-13
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D030261 2005
% 214.15/214.38  |- skos__altLabel mesh__D002570 Ferroxidase
% 214.15/214.38  |- skos__annotation mesh__D002570 an alpha-globulin   
% 214.15/214.38  |- mesh__recordMaintainer mesh__D002570 ssb
% 214.15/214.38  |- mesh__dateRevised mesh__D002570 2003-07-09
% 214.15/214.38  |- skos__broader mesh__D002570smesh__D008667
% 214.15/214.38  |- skos__broader mesh__D002570smesh__D002352
% 214.15/214.38  |- skos__broader mesh__D002570smesh__D010088
% 214.15/214.38  |- mesh__recordOriginator mesh__D002570 NLM
% 214.15/214.38  |- rdf__type mesh__D002570sskos__Concept
% 214.15/214.38  |- skos__altLabel mesh__D002570 alpha%28%2%29%-Ceruloplasmin
% 214.15/214.38  |- skos__hiddenLabel mesh__D002570 Ferroxidase, Ceruloplasmin
% 214.15/214.38  |- skos__altLabel mesh__D002570 Caeruloplasmin
% 214.15/214.38  |- skos__broader mesh__D002570smesh__D000209
% 214.15/214.38  |- skos__broader mesh__D002570smesh__D000510
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D002570 2004
% 214.15/214.38  |- mesh__recordAuthorizer mesh__D002570 sjn
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D002570 2006
% 214.15/214.38  |- mesh__dateCreated mesh__D002570 1999-01-01
% 214.15/214.38  |- skos__altLabel mesh__D002570 Ceruloplasmin Oxidase
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D002570 2005
% 214.15/214.38  |- skos__altLabel mesh__D002570 Ceruloplasmin Ferroxidase
% 214.15/214.38  |- skos__prefLabel mesh__D002570 Ceruloplasmin
% 214.15/214.38  |- skos__hiddenLabel mesh__D002570 Oxidase, Ceruloplasmin
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D010204 2001
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D010204 2006
% 214.15/214.38  |- mesh__dateCreated mesh__D010204 1974-11-19
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D010204 2004
% 214.15/214.38  |- mesh__historyNote mesh__D010204
% 214.15/214.38       91%28%75%29%; was see under SULFHYDRYL COMPOUNDS 1975-90   
% 214.15/214.38  |- skos__historyNote mesh__D010204 Sulfhydryl Compounds %28%1972-1974%29%
% 214.15/214.38  |- skos__annotation mesh__D010204 do not confuse with pantethine   
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D010204 2005
% 214.15/214.38  |- mesh__recordOriginator mesh__D010204 NLM
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D010204 2003
% 214.15/214.38  |- rdf__type mesh__D010204sskos__Concept
% 214.15/214.38  |- mesh__dateEstablished mesh__D010204 1991-01-01
% 214.15/214.38  |- skos__broader mesh__D010204smesh__D013438
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D010204 2002
% 214.15/214.38  |- mesh__recordAuthorizer mesh__D010204 sjn
% 214.15/214.38  |- skos__historyNote mesh__D010204 Pantothenic Acid %28%1972-1974%29%
% 214.15/214.38  |- skos__scopeNote mesh__D010204
% 214.15/214.38       An intermediate in the pathway of coenzyme A formation in mammalian liver and some microorganisms.%A%    
% 214.15/214.38  |- mesh__dateRevised mesh__D010204 2000-06-22
% 214.15/214.38  |- skos__prefLabel mesh__D010204 Pantetheine
% 214.15/214.38  |- mesh__recordMaintainer mesh__D010204 CCR
% 214.15/214.38  |- mesh__publicMeSHNote mesh__D010204
% 214.15/214.38       91; was see under SULFHYDRYL COMPOUNDS 1975-90   
% 214.15/214.38  |- skos__annotation mesh__D015498
% 214.15/214.38       infection: coord IM with HIV INFECTIONS %28%IM%29% or AIDS %28%IM%29% or their specifics %28%IM%29%%A%  
% 214.15/214.38  |- mesh__recordOriginator mesh__D015498 PLS
% 214.15/214.38  |- skos__scopeNote mesh__D015498
% 214.15/214.38       An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker.%A%    
% 214.15/214.38  |- mesh__historyNote mesh__D015498 89   
% 214.15/214.38  |- mesh__recordMaintainer mesh__D015498 sjn
% 214.15/214.38  |- skos__altLabel mesh__D015498 HTLV-IV
% 214.15/214.38  |- rdf__type mesh__D015498sskos__Concept
% 214.15/214.38  |- skos__altLabel mesh__D015498 Immunodeficiency Virus Type 2, Human
% 214.15/214.38  |- skos__altLabel mesh__D015498 LAV-2
% 214.15/214.38  |- skos__altLabel mesh__D015498 Human T-Lymphotropic Virus Type IV
% 214.15/214.38  |- mesh__publicMeSHNote mesh__D015498 89   
% 214.15/214.38  |- mesh__dateCreated mesh__D015498 1988-07-01
% 214.15/214.38  |- skos__altLabel mesh__D015498 HIV-II
% 214.15/214.38  |- skos__broader mesh__D015498smesh__D006678
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D015498 2006
% 214.15/214.38  |- mesh__dateEstablished mesh__D015498 1989-01-01
% 214.15/214.38  |- mesh__recordAuthorizer mesh__D015498 sjn
% 214.15/214.38  |- skos__historyNote mesh__D015498 HIV %28%1987-1988%29%
% 214.15/214.38  |- skos__altLabel mesh__D015498 Human immunodeficiency virus 2
% 214.15/214.38  |- skos__prefLabel mesh__D015498 HIV-2
% 214.15/214.38  |- skos__altLabel mesh__D015498 Human Immunodeficiency Virus Type 2
% 214.15/214.38  |- mesh__dateRevised mesh__D015498 2005-07-01
% 214.15/214.38  |- skos__altLabel mesh__D015498 Human T Lymphotropic Virus Type IV
% 214.15/214.38  |- mesh__publicMeSHNote mesh__D001478
% 214.15/214.38       91; was see under CARCINOMA, BASAL CELL 1980-90   
% 214.15/214.38  |- skos__prefLabel mesh__D001478 Basal Cell Nevus Syndrome
% 214.15/214.38  |- skos__historyNote mesh__D001478 specific jaw disease %28%1967-1979%29%
% 214.15/214.38  |- skos__broader mesh__D001478smesh__D001848
% 214.15/214.38  |- skos__annotation mesh__D001478
% 214.15/214.38       coord IM with precoord organ/neopl %28%IM or NIM%29% only if pertinent; do not confuse X ref GORLIN SYNDROME %28%also called Gorlin-Goltz syndrome%29% with GOLTZ SYNDROME see FOCAL DERMAL HYPOPLASIA%A%  
% 214.15/214.38  |- skos__broader mesh__D001478smesh__D002280
% 214.15/214.38  |- skos__historyNote mesh__D001478 Skin Neoplasms %28%1967-1979%29%
% 214.15/214.38  |- mesh__historyNote mesh__D001478
% 214.15/214.38       91%28%80%29%; was see under CARCINOMA, BASAL CELL 1980-90   
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D001478 2006
% 214.15/214.38  |- skos__hiddenLabel mesh__D001478 Syndrome, Gorlin
% 214.15/214.38  |- rdf__type mesh__D001478sskos__Concept
% 214.15/214.38  |- mesh__dateEstablished mesh__D001478 1991-01-01
% 214.15/214.38  |- mesh__recordOriginator mesh__D001478 SMH
% 214.15/214.38  |- skos__altLabel mesh__D001478 Nevoid Basal Cell Carcinoma Syndrome
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D001478 2005
% 214.15/214.38  |- skos__broader mesh__D001478smesh__D009386
% 214.15/214.38  |- skos__historyNote mesh__D001478 Jaw Diseases %28%1967-1979%29%
% 214.15/214.38  |- skos__broader mesh__D001478smesh__D009807
% 214.15/214.38  |- skos__altLabel mesh__D001478 Nevus Syndrome, Basal Cell
% 214.15/214.38  |- skos__broader mesh__D001478smesh__D000015
% 214.15/214.38  |- skos__scopeNote mesh__D001478
% 214.15/214.38       Hereditary disorder consisting of multiple basal cell carcinomas, odontogenic keratocysts, and multiple skeletal defects, e.g., frontal and temporoparietal bossing, bifurcated and splayed ribs, kyphoscoliosis, fusion of vertebrae, and cervicothoracic spina bifida. Genetic transmission is autosomal dominant.%A%    
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D001478 2002
% 214.15/214.38  |- mesh__recordAuthorizer mesh__D001478 sjn
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D001478 2004
% 214.15/214.38  |- skos__altLabel mesh__D001478 Gorlin Syndrome
% 214.15/214.38  |- mesh__dateRevised mesh__D001478 2001-07-25
% 214.15/214.38  |- skos__historyNote mesh__D001478 specific jaw neoplasm %28%1967-1979%29%
% 214.15/214.38  |- skos__historyNote mesh__D001478 Bone Cyst %28%1966-1979%29%
% 214.15/214.38  |- skos__historyNote mesh__D001478 Syndrome %28%1972-1979%29%
% 214.15/214.38  |- skos__historyNote mesh__D001478 Carcinoma, Basal Cell %28%1966-1979%29%
% 214.15/214.38  |- mesh__recordMaintainer mesh__D001478 nns
% 214.15/214.38  |- mesh__dateCreated mesh__D001478 1979-04-25
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D001478 2003
% 214.15/214.38  |- skos__historyNote mesh__D001478 Jaw Neoplasms %28%1967-1979%29%
% 214.15/214.38  |- mesh__dateCreated mesh__D006961 1999-01-01
% 214.15/214.38  |- skos__scopeNote mesh__D006961
% 214.15/214.38       A condition of abnormally elevated output of PARATHYROID HORMONE %28%or PTH%29% triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.%A%    
% 214.15/214.38  |- skos__broader mesh__D006961smesh__D010279
% 214.15/214.38  |- mesh__recordOriginator mesh__D006961 NLM
% 214.15/214.38  |- mesh__recordAuthorizer mesh__D006961 sjn
% 214.15/214.38  |- mesh__recordMaintainer mesh__D006961 lkt
% 214.15/214.38  |- rdf__type mesh__D006961sskos__Concept
% 214.15/214.38  |- skos__related mesh__D006961smesh__D018761
% 214.15/214.38  |- skos__related mesh__D006961smesh__D010002
% 214.15/214.38  |- skos__prefLabel mesh__D006961 Hyperparathyroidism
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D006961 2006
% 214.15/214.38  |- skos__annotation mesh__D006961
% 214.15/214.38       general or unspecified; prefer specifics   
% 214.15/214.38  |- mesh__dateRevised mesh__D006961 2005-06-30
% 214.15/214.38  |- mesh__dateCreated mesh__D020632 1999-11-03
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D020632 2006
% 214.15/214.38  |- mesh__recordMaintainer mesh__D020632 SYSTEM
% 214.15/214.38  |- mesh__recordAuthorizer mesh__D020632 sjn
% 214.15/214.38  |- skos__prefLabel mesh__D020632 Halomonas
% 214.15/214.38  |- mesh__dateRevised mesh__D020632 2005-06-30
% 214.15/214.38  |- mesh__dateEstablished mesh__D020632 2000-01-01
% 214.15/214.38  |- skos__broader mesh__D020632smesh__D044129
% 214.15/214.38  |- mesh__recordOriginator mesh__D020632 ndw
% 214.15/214.38  |- mesh__historyNote mesh__D020632 2000   
% 214.15/214.38  |- mesh__publicMeSHNote mesh__D020632 2000   
% 214.15/214.38  |- skos__scopeNote mesh__D020632
% 214.15/214.38       A genus of gram-negative, rod-shaped or pleomorphic bacteria which are halotolerant. Members of this genus are capable of growth in sodium chloride concentrations of up to 20%25% or more. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 214.15/214.38  |- rdf__type mesh__D020632sskos__Concept
% 214.15/214.38  |- skos__scopeNote mesh__D006163
% 214.15/214.38       An enzyme catalyzing the endonucleolytic cleavage of RNA at the 3%27%-position of a guanylate residue. EC 3.1.27.3.%A%    
% 214.15/214.38  |- mesh__publicMeSHNote mesh__D006163
% 214.15/214.38       92; was GUANYLORIBONUCLEASE 1975-91 %28%see under ENDORIBONUCLEASES 1984-90 %26% see under RIBONUCLEASES 1975-83%29%%A%  
% 214.15/214.38  |- skos__altLabel mesh__D006163 T 1 RNase
% 214.15/214.38  |- mesh__onlineNote mesh__D006163
% 214.15/214.38       use RIBONUCLEASE T1 to search GUANYLORIBONUCLEASE 1975-91%A%  
% 214.15/214.38  |- skos__hiddenLabel mesh__D006163 Ribonuclease T 1
% 214.15/214.38  |- skos__hiddenLabel mesh__D006163 Ribonuclease, Aspergillus oryzae
% 214.15/214.38  |- mesh__dateRevised mesh__D006163 2003-07-09
% 214.15/214.38  |- mesh__recordMaintainer mesh__D006163 ssb
% 214.15/214.38  |- mesh__recordOriginator mesh__D006163 NLM
% 214.15/214.38  |- skos__altLabel mesh__D006163 RNase T1
% 214.15/214.38  |- skos__altLabel mesh__D006163 RNase ST
% 214.15/214.38  |- skos__altLabel mesh__D006163 RNase F1
% 214.15/214.38  |- skos__altLabel mesh__D006163 Guanyl-Specific RNase
% 214.15/214.38  |- rdf__type mesh__D006163sskos__Concept
% 214.15/214.38  |- skos__altLabel mesh__D006163 Guanyloribonuclease
% 214.15/214.38  |- skos__altLabel mesh__D006163 Aspergillus oryzae Ribonuclease
% 214.15/214.38  |- skos__historyNote mesh__D006163 Endonucleases %28%1974%29%
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D006163 2004
% 214.15/214.38  |- skos__hiddenLabel mesh__D006163 Guanyl Specific RNase
% 214.15/214.38  |- skos__historyNote mesh__D006163 Guanine Nucleotides %28%1974%29%
% 214.15/214.38  |- skos__broader mesh__D006163smesh__D004722
% 214.15/214.38  |- mesh__historyNote mesh__D006163
% 214.15/214.38       92; was GUANYLORIBONUCLEASE 1975-91 %28%was see under ENDORIBONUCLEASES 1984-90 %26% see under RIBONUCLEASES 1975-83%29%%A%  
% 214.15/214.38  |- skos__altLabel mesh__D006163 Ribonuclease N1
% 214.15/214.38  |- skos__hiddenLabel mesh__D006163 RNase, T 1
% 214.15/214.38  |- skos__prefLabel mesh__D006163 Ribonuclease T1
% 214.15/214.38  |- mesh__dateCreated mesh__D006163 1974-11-19
% 214.15/214.38  |- skos__historyNote mesh__D006163 Ribonucleases %28%1974%29%
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D006163 2005
% 214.15/214.38  |- skos__hiddenLabel mesh__D006163 RNase, Guanyl-Specific
% 214.15/214.38  |- mesh__recordAuthorizer mesh__D006163 sjn
% 214.15/214.38  |- skos__altLabel mesh__D006163 Ribonuclease T-1
% 214.15/214.38  |- mesh__dateEstablished mesh__D006163 1991-01-01
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D006163 2006
% 214.15/214.38  |- skos__hiddenLabel mesh__D044282 5 HT1A Receptor
% 214.15/214.38  |- mesh__dateEstablished mesh__D044282 2004-01-01
% 214.15/214.38  |- mesh__historyNote mesh__D044282
% 214.15/214.38       2004; use RECEPTOR SEROTONIN 5 HT1 SUBCLASS %28%NM%29% 1993-2003%A%  
% 214.15/214.38  |- mesh__recordOriginator mesh__D044282 jmp
% 214.15/214.38  |- mesh__dateRevised mesh__D044282 2005-06-30
% 214.15/214.38  |- skos__altLabel mesh__D044282 5-HT%28%1A%29% Receptor
% 214.15/214.38  |- skos__hiddenLabel mesh__D044282 5 Hydroxytryptamine 1A Receptor
% 214.15/214.38  |- skos__altLabel mesh__D044282 Serotonin 1A Receptor
% 214.15/214.38  |- mesh__publicMeSHNote mesh__D044282
% 214.15/214.38       2004; RECEPTOR, SEROTONIN 1A %28%now  RECEPTOR, SEROTONIN, 5-HT1A%29% was indexed under RECEPTORS, SEROTONIN 1993-2003%A%  
% 214.15/214.38  |- skos__broader mesh__D044282smesh__D044263
% 214.15/214.38  |- skos__hiddenLabel mesh__D044282 Serotonin, 5 HT1a Receptor
% 214.15/214.38  |- skos__hiddenLabel mesh__D044282 Receptor, Serotonin 1A
% 214.15/214.38  |- skos__hiddenLabel mesh__D044282 5-HT1a Receptor Serotonin
% 214.15/214.38  |- skos__hiddenLabel mesh__D044282 Serotonin Receptor, 5 HT1A
% 214.15/214.38  |- skos__altLabel mesh__D044282 5-Hydroxytryptamine 1A Receptor
% 214.15/214.38  |- skos__hiddenLabel mesh__D044282 1A Receptors, 5-Hydroxytryptamine
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D044282 2006
% 214.15/214.38  |- skos__hiddenLabel mesh__D044282 Receptor, 5-HT1A
% 214.15/214.38  |- skos__hiddenLabel mesh__D044282 Receptors, 5-Hydroxytryptamine 1A
% 214.15/214.38  |- skos__hiddenLabel mesh__D044282 Receptor, 5-HT1A Serotonin
% 214.15/214.38  |- skos__altLabel mesh__D044282 5-HT1A Receptor
% 214.15/214.38  |- rdf__type mesh__D044282sskos__Concept
% 214.15/214.38  |- skos__altLabel mesh__D044282 Serotonin Receptor, 5-HT1A
% 214.15/214.38  |- skos__altLabel mesh__D044282 5-Hydroxytryptamine 1A Receptors
% 214.15/214.38  |- skos__altLabel mesh__D044282 Serotonin, 5-HT1a Receptor
% 214.15/214.38  |- mesh__recordMaintainer mesh__D044282 jmp
% 214.15/214.38  |- skos__hiddenLabel mesh__D044282 5 Hydroxytryptamine 1A Receptors
% 214.15/214.38  |- skos__hiddenLabel mesh__D044282 1A Receptor, Serotonin
% 214.15/214.38  |- mesh__recordAuthorizer mesh__D044282 sjn
% 214.15/214.38  |- skos__scopeNote mesh__D044282
% 214.15/214.38       A serotonin receptor subtype found distributed through the CENTRAL NERVOUS SYSTEM where they are involved in neuroendocrine regulation of ACTH secretion. The fact that this serotonin receptor subtype is particularly sensitive to SEROTONIN AGONISTS such as BUSPIRONE suggests its role in the modulation of ANXIETY and DEPRESSION.%A%    
% 214.15/214.38  |- skos__hiddenLabel mesh__D044282 5-HT1A Serotonin Receptor
% 214.15/214.38  |- skos__hiddenLabel mesh__D044282 Receptor Serotonin, 5-HT1a
% 214.15/214.38  |- skos__hiddenLabel mesh__D044282 1A Receptor, 5-Hydroxytryptamine
% 214.15/214.38  |- skos__prefLabel mesh__D044282 Receptor, Serotonin, 5-HT1A
% 214.15/214.38  |- skos__historyNote mesh__D044282 Receptors, Serotonin %28%1993-2003%29%
% 214.15/214.38  |- mesh__dateCreated mesh__D044282 2003-07-09
% 214.15/214.38  |- skos__hiddenLabel mesh__D044282 Receptor, 5 Hydroxytryptamine 1A
% 214.15/214.38  |- skos__altLabel mesh__D044282 Receptor, 5-Hydroxytryptamine 1A
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D005869 2003
% 214.15/214.38  |- mesh__recordMaintainer mesh__D005869 TGC
% 214.15/214.38  |- mesh__recordOriginator mesh__D005869 NLM
% 214.15/214.38  |- skos__annotation mesh__D005869
% 214.15/214.38       a republic in western Africa; X ref GOLD COAST was its former name%A%  
% 214.15/214.38  |- mesh__recordAuthorizer mesh__D005869 SJN
% 214.15/214.38  |- skos__broader mesh__D005869smesh__D000354
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D005869 2006
% 214.15/214.38  |- rdf__type mesh__D005869sskos__Concept
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D005869 1999
% 214.15/214.38  |- mesh__activeMeSHYear mesh__D005869 2002
% 214.15/214.38  |- mesh__dateRevised mesh__D005869 1997-06-20
% 214.15/214.38  |- skos__scopeNote mesh__D005869
% 214.15/214.38       A republic in western Africa, south of BURKINA FASO and west of TOGO. Its capital is Accra. It was called the Gold Coast until 1957, from the gold discovered there by the Portuguese in the late 15th century. A center for slave trade, it was acquired by the British in the 19th century and became independent in 1957. Ghana took its name from a tribal leader that stands for king. %28%From Webster%27%s New Geographical Dictionary, 1988, p441 %26% Room, Brewer%27%s Dictionary of Names, 1992, p206%29%%A%    
% 214.24/214.38  |- mesh__activeMeSHYear mesh__D005869 2005
% 214.24/214.38  |- mesh__activeMeSHYear mesh__D005869 1998
% 214.24/214.38  |- mesh__dateCreated mesh__D005869 1999-01-01
% 214.24/214.38  |- skos__altLabel mesh__D005869 Gold Coast
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D005869 2001
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D005869 2004
% 214.24/214.39  |- skos__prefLabel mesh__D005869 Ghana
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D005869 2000
% 214.24/214.39  |- skos__scopeNote mesh__D016591
% 214.24/214.39       Methods of preparing cells or tissues for examination and study of their origin, structure, function, or pathology. The methods include preservation, fixation, sectioning, staining, replica, or other technique to allow for viewing using a microscope.%A%    
% 214.24/214.39  |- skos__altLabel mesh__D016591 Histocytological Preparation Technique
% 214.24/214.39  |- rdf__type mesh__D016591sskos__Concept
% 214.24/214.39  |- skos__prefLabel mesh__D016591 Histocytological Preparation Techniques
% 214.24/214.39  |- skos__altLabel mesh__D016591 Preparation Techniques, Cytohistologic
% 214.24/214.39  |- skos__altLabel mesh__D016591 Preparation Technique, Histocytologic
% 214.24/214.39  |- skos__altLabel mesh__D016591 Technics, Cytohistologic Preparation
% 214.24/214.39  |- skos__altLabel mesh__D016591 Preparation Technics, Histocytological
% 214.24/214.39  |- skos__altLabel mesh__D016591 Techniques, Histocytological Preparation
% 214.24/214.39  |- skos__altLabel mesh__D016591 Histocytologic Preparation Technic
% 214.24/214.39  |- skos__altLabel mesh__D016591 Preparation Technic, Histocytological
% 214.24/214.39  |- skos__altLabel mesh__D016591 Technics, Histocytological Preparation
% 214.24/214.39  |- skos__annotation mesh__D016591 DF: HISTOCYTOL PREP TECHNIQUES   
% 214.24/214.39  |- skos__altLabel mesh__D016591 Technic, Cytohistologic Preparation
% 214.24/214.39  |- mesh__recordAuthorizer mesh__D016591 sjn
% 214.24/214.39  |- mesh__dateEstablished mesh__D016591 1992-01-01
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D016591 2003
% 214.24/214.39  |- skos__altLabel mesh__D016591 Technic, Histocytologic Preparation
% 214.24/214.39  |- skos__altLabel mesh__D016591 Cytohistologic Preparation Technics
% 214.24/214.39  |- skos__altLabel mesh__D016591 Preparation Technic, Cytohistological
% 214.24/214.39  |- skos__altLabel mesh__D016591 Technique, Cytohistological Preparation
% 214.24/214.39  |- skos__altLabel mesh__D016591 Cytohistologic Preparation Techniques
% 214.24/214.39  |- skos__altLabel mesh__D016591 Preparation Technic, Cytohistologic
% 214.24/214.39  |- skos__altLabel mesh__D016591 Techniques, Histocytologic Preparation
% 214.24/214.39  |- skos__altLabel mesh__D016591 Cytohistological Preparation Technic
% 214.24/214.39  |- skos__altLabel mesh__D016591 Cytohistological Preparation Technics
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D016591 2002
% 214.24/214.39  |- skos__altLabel mesh__D016591 Cytohistological Preparation Techniques
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D016591 2006
% 214.24/214.39  |- skos__altLabel mesh__D016591 Histocytological Preparation Technic
% 214.24/214.39  |- skos__altLabel mesh__D016591 Techniques, Cytohistologic Preparation
% 214.24/214.39  |- mesh__dateCreated mesh__D016591 1991-01-25
% 214.24/214.39  |- skos__altLabel mesh__D016591 Preparation Technique, Histocytological
% 214.24/214.39  |- skos__altLabel mesh__D016591 Preparation Technics, Cytohistologic
% 214.24/214.39  |- skos__altLabel mesh__D016591 Technique, Histocytologic Preparation
% 214.24/214.39  |- skos__altLabel mesh__D016591 Preparation Techniques, Cytohistological
% 214.24/214.39  |- skos__altLabel mesh__D016591 Histocytologic Preparation Technics
% 214.24/214.39  |- mesh__dateRevised mesh__D016591 2000-06-22
% 214.24/214.39  |- skos__altLabel mesh__D016591 Preparation Technics, Cytohistological
% 214.24/214.39  |- mesh__recordMaintainer mesh__D016591 PLS
% 214.24/214.39  |- skos__altLabel mesh__D016591 Histocytologic Preparation Techniques
% 214.24/214.39  |- skos__altLabel mesh__D016591 Histocytological Preparation Technics
% 214.24/214.39  |- skos__altLabel mesh__D016591 Technics, Cytohistological Preparation
% 214.24/214.39  |- skos__hiddenLabel mesh__D016591 Cytohistologic Preparation Technic
% 214.24/214.39  |- skos__altLabel mesh__D016591 Techniques, Cytohistological Preparation
% 214.24/214.39  |- skos__altLabel mesh__D016591 Preparation Techniques, Histocytological
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D016591 2005
% 214.24/214.39  |- mesh__historyNote mesh__D016591 92   
% 214.24/214.39  |- skos__altLabel mesh__D016591 Histocytologic Preparation Technique
% 214.24/214.39  |- skos__altLabel mesh__D016591 Cytohistological Preparation Technique
% 214.24/214.39  |- skos__altLabel mesh__D016591 Preparation Technics, Histocytologic
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D016591 2001
% 214.24/214.39  |- skos__altLabel mesh__D016591 Preparation Technic, Histocytologic
% 214.24/214.39  |- skos__altLabel mesh__D016591 Cytohistologic Preparation Technique
% 214.24/214.39  |- skos__broader mesh__D016591smesh__D003584
% 214.24/214.39  |- skos__altLabel mesh__D016591 Technique, Cytohistologic Preparation
% 214.24/214.39  |- skos__altLabel mesh__D016591 Preparation Techniques, Histocytologic
% 214.24/214.39  |- skos__altLabel mesh__D016591 Technics, Histocytologic Preparation
% 214.24/214.39  |- skos__altLabel mesh__D016591 Preparation Technique, Cytohistologic
% 214.24/214.39  |- mesh__recordOriginator mesh__D016591 MXR
% 214.24/214.39  |- skos__altLabel mesh__D016591 Technic, Histocytological Preparation
% 214.24/214.39  |- mesh__publicMeSHNote mesh__D016591 92   
% 214.24/214.39  |- skos__altLabel mesh__D016591 Technic, Cytohistological Preparation
% 214.24/214.39  |- skos__broader mesh__D016591smesh__D006652
% 214.24/214.39  |- skos__altLabel mesh__D016591 Preparation Technique, Cytohistological
% 214.24/214.39  |- skos__altLabel mesh__D016591 Technique, Histocytological Preparation
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D016591 2004
% 214.24/214.39  |- skos__broader mesh__D030262smesh__D010940
% 214.24/214.39  |- mesh__recordOriginator mesh__D030262 jmp
% 214.24/214.39  |- skos__prefLabel mesh__D030262 Soybean Proteins
% 214.24/214.39  |- skos__related mesh__D030262smesh__D013025
% 214.24/214.39  |- skos__broader mesh__D030262smesh__D045730
% 214.24/214.39  |- skos__scopeNote mesh__D030262
% 214.24/214.39       Proteins which are present in or isolated from SOYBEANS.%A%    
% 214.24/214.39  |- skos__altLabel mesh__D030262 Soy Protein
% 214.24/214.39  |- skos__hiddenLabel mesh__D030262 Proteins, Soy
% 214.24/214.39  |- mesh__dateEstablished mesh__D030262 2002-01-01
% 214.24/214.39  |- skos__annotation mesh__D030262
% 214.24/214.39       coordinate IM with VEGETABLE PROTEINS if appropriate   
% 214.24/214.39  |- mesh__dateCreated mesh__D030262 2001-07-25
% 214.24/214.39  |- rdf__type mesh__D030262sskos__Concept
% 214.24/214.39  |- mesh__publicMeSHNote mesh__D030262
% 214.24/214.39       2002; see SOY PROTEINS %28%1997-2001%29%   
% 214.24/214.39  |- mesh__recordMaintainer mesh__D030262 SYSTEM
% 214.24/214.39  |- mesh__dateRevised mesh__D030262 2005-06-30
% 214.24/214.39  |- mesh__recordAuthorizer mesh__D030262 sjn
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D030262 2006
% 214.24/214.39  |- mesh__historyNote mesh__D030262 2002%28%1997%29%   
% 214.24/214.39  |- skos__altLabel mesh__D030262 Soy Proteins
% 214.24/214.39  |- skos__altLabel mesh__D030262 Soy Bean Proteins
% 214.24/214.39  |- mesh__recordAuthorizer mesh__D002571 sjn
% 214.24/214.39  |- skos__broader mesh__D002571smesh__D012634
% 214.24/214.39  |- mesh__dateRevised mesh__D002571 2001-07-25
% 214.24/214.39  |- skos__altLabel mesh__D002571 Ear Wax
% 214.24/214.39  |- skos__prefLabel mesh__D002571 Cerumen
% 214.24/214.39  |- skos__hiddenLabel mesh__D002571 Wax, Ear
% 214.24/214.39  |- mesh__dateCreated mesh__D002571 1999-01-01
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D002571 2003
% 214.24/214.39  |- rdf__type mesh__D002571sskos__Concept
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D002571 2005
% 214.24/214.39  |- skos__scopeNote mesh__D002571
% 214.24/214.39       The yellow or brown waxy secretions produced by vestigial apocrine sweat glands in the external ear canal.%A%    
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D002571 2004
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D002571 2002
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D002571 2006
% 214.24/214.39  |- mesh__recordOriginator mesh__D002571 NLM
% 214.24/214.39  |- mesh__recordMaintainer mesh__D002571 ags
% 214.24/214.39  |- mesh__recordMaintainer mesh__D010205 ssb
% 214.24/214.39  |- skos__broader mesh__D010205smesh__D015091
% 214.24/214.39  |- skos__broader mesh__D010205smesh__D007094
% 214.24/214.39  |- skos__hiddenLabel mesh__D010205 B5, Vitamin
% 214.24/214.39  |- skos__prefLabel mesh__D010205 Pantothenic Acid
% 214.24/214.39  |- mesh__dateCreated mesh__D010205 1999-01-01
% 214.24/214.39  |- skos__altLabel mesh__D010205 Vitamin B5
% 214.24/214.39  |- skos__hiddenLabel mesh__D010205 Pantothenate, Calcium
% 214.24/214.39  |- rdf__type mesh__D010205sskos__Concept
% 214.24/214.39  |- skos__scopeNote mesh__D010205
% 214.24/214.39       A butyryl-beta-alanine that can also be viewed as pantoic acid complexed with BETA ALANINE. It is incorporated into COENZYME A and protects cells against peroxidative damage by increasing the level of GLUTATHIONE.%A%    
% 214.24/214.39  |- skos__hiddenLabel mesh__D010205 B 5, Vitamin
% 214.24/214.39  |- skos__altLabel mesh__D010205 Vitamin B 5
% 214.24/214.39  |- skos__hiddenLabel mesh__D010205 Pantothenate, Zinc
% 214.24/214.39  |- mesh__recordOriginator mesh__D010205 NLM
% 214.24/214.39  |- mesh__dateRevised mesh__D010205 2005-06-30
% 214.24/214.39  |- mesh__recordAuthorizer mesh__D010205 sjn
% 214.24/214.39  |- skos__annotation mesh__D010205
% 214.24/214.39       deficiency: coordinate PANTOTHENIC ACID /defic %28%IM%29% with VITAMIN B DEFICIENCY %28%IM%29%; ther use: coordinate disease with /drug ther, not /diet ther%A%  
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D010205 2006
% 214.24/214.39  |- mesh__dateRevised mesh__D015499 2001-07-25
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D015499 2005
% 214.24/214.39  |- skos__scopeNote mesh__D015499
% 214.24/214.39       Genetically determined disorders of the reabsorptive functions of the kidney with regard to specific nephron segments responsible for specific transport functions, classifiable by proximal nephron function, loop of Henle function, and distal nephron function. The transport defects can be selective or nonselective. %28%From Cecil Textbook of Medicine, 19th ed, p584; Harrison%27%s Principles of Internal Medicine, 12th ed, p1140%29%%A%    
% 214.24/214.39  |- mesh__recordAuthorizer mesh__D015499 sjn
% 214.24/214.39  |- mesh__publicMeSHNote mesh__D015499 65   
% 214.24/214.39  |- skos__broader mesh__D015499smesh__D007674
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D015499 2006
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D015499 2003
% 214.24/214.39  |- skos__altLabel mesh__D015499 Renal Tubular Transport, Inborn Error
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D015499 2004
% 214.24/214.39  |- skos__prefLabel mesh__D015499 Renal Tubular Transport, Inborn Errors
% 214.24/214.39  |- skos__broader mesh__D015499smesh__D008661
% 214.24/214.39  |- mesh__recordOriginator mesh__D015499 NLM
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D015499 2002
% 214.24/214.39  |- mesh__recordMaintainer mesh__D015499 nns
% 214.24/214.39  |- skos__altLabel mesh__D015499 Renal Tubular Transport Errors
% 214.24/214.39  |- mesh__historyNote mesh__D015499 65   
% 214.24/214.39  |- rdf__type mesh__D015499sskos__Concept
% 214.24/214.39  |- skos__annotation mesh__D015499
% 214.24/214.39       GEN or unspecified; prefer specific; coord IM with specific metabolite /metab %28%IM%29%; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: RENAL TUB TRANSP INBORN ERR%A%  
% 214.24/214.39  |- skos__altLabel mesh__D015499 Kidney Tubular Transport, Inborn Errors
% 214.24/214.39  |- skos__altLabel mesh__D015499 Kidney Tubular Transport, Inborn Error
% 214.24/214.39  |- mesh__dateEstablished mesh__D015499 1965-01-01
% 214.24/214.39  |- mesh__dateCreated mesh__D015499 1964-07-01
% 214.24/214.39  |- skos__altLabel mesh__D001479 Ganglia, Basal
% 214.24/214.39  |- mesh__onlineNote mesh__D001479
% 214.24/214.39       use BASAL GANGLIA to search GANGLIA, BASAL 1966-81   
% 214.24/214.39  |- skos__prefLabel mesh__D001479 Basal Ganglia
% 214.24/214.39  |- skos__scopeNote mesh__D001479
% 214.24/214.39       Large subcortical nuclear masses derived from the telencephalon and located in the basal regions of the cerebral hemispheres.%A%    
% 214.24/214.39  |- mesh__recordAuthorizer mesh__D001479 sjn
% 214.24/214.39  |- skos__broader mesh__D001479smesh__D013687
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D001479 2006
% 214.24/214.39  |- rdf__type mesh__D001479sskos__Concept
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D001479 2000
% 214.24/214.39  |- mesh__dateCreated mesh__D001479 1999-01-01
% 214.24/214.39  |- mesh__recordOriginator mesh__D001479 NLM
% 214.24/214.39  |- skos__annotation mesh__D001479
% 214.24/214.39       dis = BASAL GANGLIA DISEASES; do not confuse X ref VENTRAL STRIATUM with CORPUS STRIATUM%A%  
% 214.24/214.39  |- skos__altLabel mesh__D001479 Ganglion, Basal
% 214.24/214.39  |- mesh__dateRevised mesh__D001479 1999-11-03
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D001479 2001
% 214.24/214.39  |- mesh__publicMeSHNote mesh__D001479 82; was GANGLIA, BASAL 1963-81   
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D001479 2003
% 214.24/214.39  |- skos__hiddenLabel mesh__D001479 Nuclei, Basal
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D001479 2002
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D001479 2004
% 214.24/214.39  |- mesh__recordMaintainer mesh__D001479 ags
% 214.24/214.39  |- skos__altLabel mesh__D001479 Basal Nuclei
% 214.24/214.39  |- skos__hiddenLabel mesh__D001479 Striatum, Ventral
% 214.24/214.39  |- mesh__historyNote mesh__D001479
% 214.24/214.39       82; was GANGLIA, BASAL 1963-81; CLAUSTRUM was see under GANGLIA, BASAL 1963-78%A%  
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D001479 2005
% 214.24/214.39  |- mesh__historyNote mesh__D006962 70   
% 214.24/214.39  |- skos__altLabel mesh__D006962 Secondary Hyperparathyroidism
% 214.24/214.39  |- rdf__type mesh__D006962sskos__Concept
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D006962 2006
% 214.24/214.39  |- skos__historyNote mesh__D006962 Hyperparathyroidism %28%1966-1969%29%
% 214.24/214.39  |- skos__prefLabel mesh__D006962 Hyperparathyroidism, Secondary
% 214.24/214.39  |- mesh__dateEstablished mesh__D006962 1970-01-01
% 214.24/214.39  |- mesh__recordOriginator mesh__D006962 NLM
% 214.24/214.39  |- mesh__recordAuthorizer mesh__D006962 sjn
% 214.24/214.39  |- mesh__recordMaintainer mesh__D006962 lkt
% 214.24/214.39  |- skos__hiddenLabel mesh__D006962 Secondary Hyperparathyroidisms
% 214.24/214.39  |- skos__scopeNote mesh__D006962
% 214.24/214.39       Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.%A%    
% 214.24/214.39  |- skos__broader mesh__D006962smesh__D006961
% 214.24/214.39  |- mesh__dateCreated mesh__D006962 1999-01-01
% 214.24/214.39  |- skos__hiddenLabel mesh__D006962 Hyperparathyroidisms, Secondary
% 214.24/214.39  |- mesh__dateRevised mesh__D006962 2005-06-30
% 214.24/214.39  |- mesh__publicMeSHNote mesh__D006962 70   
% 214.24/214.39  |- skos__broader mesh__D020633smesh__D011548
% 214.24/214.39  |- mesh__publicMeSHNote mesh__D020633 2000   
% 214.24/214.39  |- skos__prefLabel mesh__D020633 Cellvibrio
% 214.24/214.39  |- mesh__dateEstablished mesh__D020633 2000-01-01
% 214.24/214.39  |- mesh__historyNote mesh__D020633 2000   
% 214.24/214.39  |- skos__scopeNote mesh__D020633
% 214.24/214.39       A genus of aerobic, gram-negative, motile, slightly curved, rod-shaped bacteria. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 214.24/214.39  |- mesh__dateCreated mesh__D020633 1999-11-03
% 214.24/214.39  |- skos__broader mesh__D020633smesh__D016946
% 214.24/214.39  |- mesh__recordOriginator mesh__D020633 ndw
% 214.24/214.39  |- rdf__type mesh__D020633sskos__Concept
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D020633 2006
% 214.24/214.39  |- mesh__recordAuthorizer mesh__D020633 sjn
% 214.24/214.39  |- mesh__dateRevised mesh__D020633 2005-06-30
% 214.24/214.39  |- mesh__recordMaintainer mesh__D020633 SYSTEM
% 214.24/214.39  |- skos__altLabel mesh__D006164 Gutimine
% 214.24/214.39  |- skos__prefLabel mesh__D006164 Guanylthiourea
% 214.24/214.39  |- skos__broader mesh__D006164smesh__D013890
% 214.24/214.39  |- mesh__historyNote mesh__D006164
% 214.24/214.39       91%28%79%29%; was see under THIOUREA 1979-90   
% 214.24/214.39  |- mesh__recordAuthorizer mesh__D006164 sjn
% 214.24/214.39  |- skos__altLabel mesh__D006164 Guthimine
% 214.24/214.39  |- rdf__type mesh__D006164sskos__Concept
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D006164 2003
% 214.24/214.39  |- skos__scopeNote mesh__D006164
% 214.24/214.39       May protect against hypoxic damage; proposed for treatment of shock due to trauma or blood loss; also stimulates paretic gastrointestinal system.%A%    
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D006164 2004
% 214.24/214.39  |- mesh__dateCreated mesh__D006164 1978-02-07
% 214.24/214.39  |- skos__altLabel mesh__D006164 Guthymine
% 214.24/214.39  |- mesh__recordOriginator mesh__D006164 SH
% 214.24/214.39  |- mesh__recordMaintainer mesh__D006164 CCR
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D006164 2005
% 214.24/214.39  |- skos__historyNote mesh__D006164 Thiourea %28%1966-1978%29%
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D006164 2001
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D006164 2006
% 214.24/214.39  |- mesh__dateEstablished mesh__D006164 1991-01-01
% 214.24/214.39  |- mesh__dateRevised mesh__D006164 2000-06-22
% 214.24/214.39  |- skos__altLabel mesh__D006164 Gutimin
% 214.24/214.39  |- mesh__publicMeSHNote mesh__D006164 91; was see under THIOUREA 1979-90   
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D006164 2002
% 214.24/214.39  |- mesh__dateCreated mesh__D030263 2001-07-25
% 214.24/214.39  |- skos__broader mesh__D030263smesh__D017977
% 214.24/214.39  |- skos__annotation mesh__D030263
% 214.24/214.39       infection: coord IM with DELTARETROVIRUS INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% if pertinent%A%  
% 214.24/214.39  |- rdf__type mesh__D030263sskos__Concept
% 214.24/214.39  |- mesh__recordAuthorizer mesh__D030263 sjn
% 214.24/214.39  |- mesh__dateEstablished mesh__D030263 2002-01-01
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D030263 2005
% 214.24/214.39  |- skos__prefLabel mesh__D030263 Primate T-lymphotropic virus 2
% 214.24/214.39  |- mesh__dateRevised mesh__D030263 2004-07-13
% 214.24/214.39  |- mesh__historyNote mesh__D030263 2002   
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D030263 2006
% 214.24/214.39  |- skos__scopeNote mesh__D030263
% 214.24/214.39       A species in the family DELTARETROVIRUS, comprising strains from different host species but arising from the same geographic origin. They include HUMAN T-LYMPHOTROPIC VIRUS 2 and SIMIAN T-LYMPHOTROPIC VIRUS 2.%A%    
% 214.24/214.39  |- skos__altLabel mesh__D030263 PTLV-2
% 214.24/214.39  |- mesh__publicMeSHNote mesh__D030263 2002   
% 214.24/214.39  |- skos__hiddenLabel mesh__D030263 Primate T lymphotropic virus 2
% 214.24/214.39  |- mesh__recordOriginator mesh__D030263 ags
% 214.24/214.39  |- skos__hiddenLabel mesh__D030263 T Lymphotropic Virus 2, Primate
% 214.24/214.39  |- skos__altLabel mesh__D030263 T-Lymphotropic Virus 2, Primate
% 214.24/214.39  |- mesh__recordMaintainer mesh__D030263 sjn
% 214.24/214.39  |- mesh__recordOriginator mesh__D002572 NLM
% 214.24/214.39  |- mesh__dateRevised mesh__D002572 1993-06-18
% 214.24/214.39  |- rdf__type mesh__D002572sskos__Concept
% 214.24/214.39  |- mesh__dateCreated mesh__D002572 1999-01-01
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D002572 2003
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D002572 2005
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D002572 2000
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D002572 2004
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D002572 2001
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D002572 1996
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D002572 2006
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D002572 1998
% 214.24/214.39  |- skos__prefLabel mesh__D002572 Cervical Plexus
% 214.24/214.39  |- skos__broader mesh__D002572smesh__D013127
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D002572 1997
% 214.24/214.39  |- mesh__recordAuthorizer mesh__D002572 PLS
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D002572 1994
% 214.24/214.39  |- skos__annotation mesh__D002572 a network of spinal nerves   
% 214.24/214.39  |- mesh__recordMaintainer mesh__D002572 RAZ
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D002572 1999
% 214.24/214.39  |- skos__hiddenLabel mesh__D002572 Plexus, Cervical
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D002572 2002
% 214.24/214.39  |- skos__scopeNote mesh__D002572
% 214.24/214.39       A network of nerve fibers originating in the upper four cervical spinal cord segments. The cervical plexus distributes cutaneous nerves to parts of the neck, shoulders, and back of the head, and motor fibers to muscles of the cervical spinal column, infrahyoid muscles, and the diaphragm.%A%    
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D002572 1995
% 214.24/214.39  |- mesh__recordOriginator mesh__D010206 NLM
% 214.24/214.39  |- mesh__recordAuthorizer mesh__D010206 sjn
% 214.24/214.39  |- mesh__recordMaintainer mesh__D010206 ssb
% 214.24/214.39  |- skos__prefLabel mesh__D010206 Papain
% 214.24/214.39  |- mesh__dateRevised mesh__D010206 2003-07-09
% 214.24/214.39  |- skos__broader mesh__D010206smesh__D003546
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D010206 2006
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D010206 2004
% 214.24/214.39  |- skos__scopeNote mesh__D010206
% 214.24/214.39       A proteolytic enzyme obtained from Carica papaya. It is also the name used for a purified mixture of papain and CHYMOPAPAIN that is used as a topical enzymatic debriding agent. EC 3.4.22.2.%A%    
% 214.24/214.39  |- mesh__dateCreated mesh__D010206 1999-01-01
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D010206 2005
% 214.24/214.39  |- rdf__type mesh__D010206sskos__Concept
% 214.24/214.39  |- skos__historyNote mesh__D006963 Eating %28%1966-1980%29%
% 214.24/214.39  |- rdf__type mesh__D006963sskos__Concept
% 214.24/214.39  |- mesh__recordMaintainer mesh__D006963 lkt
% 214.24/214.39  |- mesh__publicMeSHNote mesh__D006963
% 214.24/214.39       89; was see under APPETITE DISORDERS 1981-88   
% 214.24/214.39  |- mesh__dateRevised mesh__D006963 2005-06-30
% 214.24/214.39  |- mesh__dateEstablished mesh__D006963 1989-01-01
% 214.24/214.39  |- skos__historyNote mesh__D006963 Feeding Behavior %28%1969-1980%29%
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D006963 2006
% 214.24/214.39  |- mesh__dateCreated mesh__D006963 1980-05-21
% 214.24/214.39  |- skos__broader mesh__D006963smesh__D012817
% 214.24/214.39  |- skos__historyNote mesh__D006963 Appetite Disorders %28%1966-1980%29%
% 214.24/214.39  |- mesh__historyNote mesh__D006963
% 214.24/214.39       89%28%81%29%; was see under APPETITE DISORDERS 1981-88   
% 214.24/214.39  |- mesh__recordOriginator mesh__D006963 EC
% 214.24/214.39  |- skos__related mesh__D006963smesh__D009765
% 214.24/214.39  |- skos__altLabel mesh__D006963 Overeating
% 214.24/214.39  |- skos__scopeNote mesh__D006963
% 214.24/214.39       Ingestion of a greater than optimal quantity of food.     
% 214.24/214.39  |- skos__prefLabel mesh__D006963 Hyperphagia
% 214.24/214.39  |- mesh__recordAuthorizer mesh__D006963 sjn
% 214.24/214.39  |- mesh__dateCreated mesh__D006165 1977-04-22
% 214.24/214.39  |- skos__altLabel mesh__D006165 GMP-P%28%NH%29%P
% 214.24/214.39  |- skos__altLabel mesh__D006165 Guanyl-5%27%-Imidodiphosphate
% 214.24/214.39  |- skos__altLabel mesh__D006165 Gpp%28%NH%29%p
% 214.24/214.39  |- mesh__dateRevised mesh__D006165 1998-06-10
% 214.24/214.39  |- skos__altLabel mesh__D006165 GMP-PNP
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D006165 2001
% 214.24/214.39  |- skos__historyNote mesh__D006165 Guanosine Triphosphate %28%1972-1977%29%
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D006165 2005
% 214.24/214.39  |- skos__annotation mesh__D006165 DF: GPPNHP   
% 214.24/214.39  |- skos__prefLabel mesh__D006165 Guanylyl Imidodiphosphate
% 214.24/214.39  |- skos__historyNote mesh__D006165 Guanine Nucleotides %28%1966-1977%29%
% 214.24/214.39  |- mesh__recordOriginator mesh__D006165 RLS
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D006165 2002
% 214.24/214.39  |- mesh__recordAuthorizer mesh__D006165 SJN
% 214.24/214.39  |- mesh__historyNote mesh__D006165
% 214.24/214.39       91%28%78%29%; was see under GUANOSINE TRIPHOSPHATE 1978-90   
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D006165 2006
% 214.24/214.39  |- skos__hiddenLabel mesh__D006165 Imidodiphosphate, Guanylyl
% 214.24/214.39  |- skos__altLabel mesh__D006165
% 214.24/214.39       Guanosine 5%27%-%28%Beta,Gamma-Imido%29%Triphosphate
% 214.24/214.39  |- skos__altLabel mesh__D006165 P%28%NH%29%PPG
% 214.24/214.39  |- mesh__dateEstablished mesh__D006165 1991-01-01
% 214.24/214.39  |- mesh__recordMaintainer mesh__D006165 ADP
% 214.24/214.39  |- mesh__publicMeSHNote mesh__D006165
% 214.24/214.39       91; was see under GUANOSINE TRIPHOSPHATE 1978-90   
% 214.24/214.39  |- skos__broader mesh__D006165smesh__D006160
% 214.24/214.39  |- rdf__type mesh__D006165sskos__Concept
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D006165 1999
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D006165 2003
% 214.24/214.39  |- skos__hiddenLabel mesh__D006165 Guanyl 5%27% Imidodiphosphate
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D006165 2000
% 214.24/214.39  |- skos__scopeNote mesh__D006165
% 214.24/214.39       A non-hydrolyzable analog of GTP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It binds tightly to G-protein in the presence of Mg2+. The nucleotide is a potent stimulator of adenylate cyclase.%A%    
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D006165 2004
% 214.24/214.39  |- mesh__onlineNote mesh__D016593
% 214.24/214.39       use TERFENADINE %28%NM%29% to search TERFENADINE 1980-91   
% 214.24/214.39  |- skos__broader mesh__D016593smesh__D010880
% 214.24/214.39  |- skos__historyNote mesh__D016593 Piperidines %28%1966-1991%29%
% 214.24/214.39  |- skos__hiddenLabel mesh__D016593 RMI 9918
% 214.24/214.39  |- skos__altLabel mesh__D016593 ratiopharm Brand of Terfenadine
% 214.24/214.39  |- skos__altLabel mesh__D016593
% 214.24/214.39       alpha-%28%4-%28%1,1-Dimethylethyl%29%phenyl%29%-4-%28%hydroxydiphenylmethyl%29%-1-piperdinebutanol
% 214.24/214.39  |- mesh__dateRevised mesh__D016593 2005-06-30
% 214.24/214.39  |- skos__altLabel mesh__D016593 Merck dura Brand of Terfenadine
% 214.24/214.39  |- mesh__recordOriginator mesh__D016593 RLS
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D016593 2006
% 214.24/214.39  |- skos__hiddenLabel mesh__D016593 Sigma Tau Brand of Terfenadine
% 214.24/214.39  |- skos__altLabel mesh__D016593 ct-Arzneimittel Brand of Terfenadine
% 214.24/214.39  |- skos__historyNote mesh__D016593 Benzhydryl Compounds %28%1975-1991%29%
% 214.24/214.39  |- skos__hiddenLabel mesh__D016593 ct Arzneimittel Brand of Terfenadine
% 214.24/214.39  |- mesh__recordAuthorizer mesh__D016593 sjn
% 214.24/214.39  |- skos__altLabel mesh__D016593 Dolorgiet Brand of Terfenadine
% 214.24/214.39  |- skos__altLabel mesh__D016593 Mundipharma Brand of Terfenadine
% 214.24/214.39  |- skos__altLabel mesh__D016593 Terfenidine
% 214.24/214.39  |- skos__altLabel mesh__D016593 Heumann Brand of Terfenadine
% 214.24/214.39  |- mesh__recordMaintainer mesh__D016593 CCR
% 214.24/214.39  |- skos__altLabel mesh__D016593 Aliud Brand of Terfenadine
% 214.24/214.39  |- mesh__publicMeSHNote mesh__D016593
% 214.24/214.39       92; TERFENADINE was indexed under BENZHYDRYL COMPOUNDS 1978-91%A%  
% 214.24/214.39  |- skos__prefLabel mesh__D016593 Terfenadine
% 214.24/214.39  |- rdf__type mesh__D016593sskos__Concept
% 214.24/214.39  |- skos__broader mesh__D016593smesh__D001559
% 214.24/214.39  |- mesh__dateCreated mesh__D016593 1991-01-25
% 214.24/214.39  |- skos__hiddenLabel mesh__D016593 RMI9918
% 214.24/214.39  |- mesh__dateEstablished mesh__D016593 1992-01-01
% 214.24/214.39  |- skos__altLabel mesh__D016593 Wolff Brand of Terfenadine
% 214.24/214.39  |- skos__altLabel mesh__D016593 Hoechst Brand of Terfenadine
% 214.24/214.39  |- skos__scopeNote mesh__D016593
% 214.24/214.39       A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug is used in the treatment of seasonal allergic rhinitis, asthma, allergic conjunctivitis, and chronic idiopathic urticaria.%A%    
% 214.24/214.39  |- skos__altLabel mesh__D016593 Stadapharm Brand of Terfenadine
% 214.24/214.39  |- skos__altLabel mesh__D016593 Teldane
% 214.24/214.39  |- skos__altLabel mesh__D016593 Sigma-Tau Brand of Terfenadine
% 214.24/214.39  |- skos__altLabel mesh__D016593 Cantabria Brand of Terfenadine
% 214.24/214.39  |- mesh__historyNote mesh__D016593
% 214.24/214.39       92; was TERFENADINE %28%NM%29% 1978-91   
% 214.24/214.39  |- skos__altLabel mesh__D016593 Triludan
% 214.24/214.39  |- skos__historyNote mesh__D016593
% 214.24/214.39       Histamine H1 Receptor Blockaders %28%1966-1991%29%
% 214.24/214.39  |- skos__altLabel mesh__D016593 Bial Brand of Terfenadine
% 214.24/214.39  |- skos__altLabel mesh__D002573 Naffziger%27%s Syndrome
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D002573 2004
% 214.24/214.39  |- mesh__recordMaintainer mesh__D002573 KEV
% 214.24/214.39  |- skos__hiddenLabel mesh__D002573 Syndrome, Cervical-Rib-Cervical-Band
% 214.24/214.39  |- skos__prefLabel mesh__D002573 Cervical Rib Syndrome
% 214.24/214.39  |- mesh__activeMeSHYear mesh__D002573 2006
% 214.24/214.39  |- skos__broader mesh__D002573smesh__D013901
% 214.24/214.39  |- skos__altLabel mesh__D002573 Anomalous Cervical Rib Syndrome
% 214.24/214.39  |- skos__hiddenLabel mesh__D002573 Syndrome, Naffziger%27%s
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D002573 2002
% 214.24/214.40  |- mesh__onlineNote mesh__D002573
% 214.24/214.40       search THORACIC OUTLET SYNDROME 1966-74   
% 214.24/214.40  |- skos__scopeNote mesh__D002573
% 214.24/214.40       A condition associated with compression of the BRACHIAL PLEXUS; SUBCLAVIAN ARTERY; and SUBCLAVIAN VEIN at the thoracic outlet and caused by a complete or incomplete anomalous cervical rib or fascial band connecting the tip of a cervical rib with the first thoracic rib. Clinical manifestations may include pain in the neck and shoulder which radiates into the upper extremity, PARESIS or PARALYSIS of brachial plexus innervated muscles; sensory loss; PARESTHESIAS; ISCHEMIA; and EDEMA. %28%Adams et al., Principles of Neurology, 6th ed, p214%29%%A%    
% 214.24/214.40  |- mesh__recordOriginator mesh__D002573 NLM
% 214.24/214.40  |- skos__hiddenLabel mesh__D002573 Naffziger%27%s Syndromes
% 214.24/214.40  |- skos__hiddenLabel mesh__D002573 Syndrome, Cervical Rib
% 214.24/214.40  |- skos__hiddenLabel mesh__D002573 Syndromes, Cervical Rib
% 214.24/214.40  |- mesh__dateEstablished mesh__D002573 1991-01-01
% 214.24/214.40  |- skos__hiddenLabel mesh__D002573 Syndrome, Naffziger
% 214.24/214.40  |- mesh__dateRevised mesh__D002573 1999-11-04
% 214.24/214.40  |- skos__hiddenLabel mesh__D002573 Naffziger Syndromes
% 214.24/214.40  |- skos__hiddenLabel mesh__D002573 Cervical Rib Syndromes
% 214.24/214.40  |- skos__hiddenLabel mesh__D002573 Cervical Rib Cervical Band Syndrome
% 214.24/214.40  |- mesh__recordAuthorizer mesh__D002573 sjn
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D002573 2000
% 214.24/214.40  |- skos__hiddenLabel mesh__D002573 Syndromes, Naffziger%27%s
% 214.24/214.40  |- skos__hiddenLabel mesh__D002573 Syndromes, Naffziger
% 214.24/214.40  |- rdf__type mesh__D002573sskos__Concept
% 214.24/214.40  |- mesh__publicMeSHNote mesh__D002573
% 214.24/214.40       1991; was see under THORACIC OUTLET SYNDROME 1983-90; was see under SCALENUS ANTICUS SYNDROME 1963-82%A%  
% 214.24/214.40  |- mesh__dateCreated mesh__D002573 1999-01-01
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D002573 2003
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D002573 2001
% 214.24/214.40  |- mesh__historyNote mesh__D002573
% 214.24/214.40       1991%28%1975%29%; was see under THORACIC OUTLET SYNDROME 1983-90; was see under SCALENUS ANTICUS SYNDROME 1963-82%A%  
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D002573 2005
% 214.24/214.40  |- mesh__historyNote mesh__D010207 1991%28%1986%29%1963   
% 214.24/214.40  |- mesh__publicMeSHNote mesh__D010207
% 214.24/214.40       1991, 1963-1985; see PLANTS, MEDICINAL 1986-1990   
% 214.24/214.40  |- skos__broader mesh__D010207smesh__D028101
% 214.24/214.40  |- mesh__recordOriginator mesh__D010207 NLM
% 214.24/214.40  |- skos__scopeNote mesh__D010207
% 214.24/214.40       A genus of Eurasian herbaceous plants, the poppies %28%family PAPAVERACEAE of the dicotyledon class Magnoliopsida%29%, that yield OPIUM from the latex of the unripe seed pods.%A%    
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D010207 2006
% 214.24/214.40  |- mesh__recordAuthorizer mesh__D010207 sjn
% 214.24/214.40  |- skos__related mesh__D010207smesh__D009892
% 214.24/214.40  |- skos__annotation mesh__D010207
% 214.24/214.40       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D010207 2004
% 214.24/214.40  |- mesh__dateCreated mesh__D010207 1999-01-01
% 214.24/214.40  |- skos__prefLabel mesh__D010207 Papaver
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D010207 2005
% 214.24/214.40  |- mesh__recordMaintainer mesh__D010207 ssb
% 214.24/214.40  |- skos__altLabel mesh__D010207 Poppy
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D010207 2003
% 214.24/214.40  |- mesh__dateRevised mesh__D010207 2002-07-03
% 214.24/214.40  |- rdf__type mesh__D010207sskos__Concept
% 214.24/214.40  |- mesh__dateEstablished mesh__D010207 1991-01-01
% 214.24/214.40  |- rdf__type mesh__D006964sskos__Concept
% 214.24/214.40  |- skos__altLabel mesh__D006964
% 214.24/214.40       Inappropriate Thyroid Stimulating Hormone Secretion
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006964 2005
% 214.24/214.40  |- skos__altLabel mesh__D006964 Inappropriate TSH Secretion Syndrome
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006964 2006
% 214.24/214.40  |- mesh__dateEstablished mesh__D006964 1967-01-01
% 214.24/214.40  |- mesh__recordAuthorizer mesh__D006964 sjn
% 214.24/214.40  |- mesh__dateCreated mesh__D006964 1999-01-01
% 214.24/214.40  |- mesh__publicMeSHNote mesh__D006964 1967   
% 214.24/214.40  |- mesh__dateRevised mesh__D006964 2004-07-07
% 214.24/214.40  |- skos__prefLabel mesh__D006964 Hyperpituitarism
% 214.24/214.40  |- mesh__recordOriginator mesh__D006964 NLM
% 214.24/214.40  |- skos__broader mesh__D006964smesh__D010900
% 214.24/214.40  |- mesh__historyNote mesh__D006964 1967%28%1965%29%   
% 214.24/214.40  |- skos__hiddenLabel mesh__D006964 LH Hypersecretion, Pituitary
% 214.24/214.40  |- mesh__recordMaintainer mesh__D006964 lkt
% 214.24/214.40  |- skos__hiddenLabel mesh__D006964 TSH Hypersecretion, Pituitary
% 214.24/214.40  |- skos__annotation mesh__D006964
% 214.24/214.40       coord with specific hormone/secret if pertinent   
% 214.24/214.40  |- skos__altLabel mesh__D006964 Inappropriate Luteinizing Hormone Secretion
% 214.24/214.40  |- skos__hiddenLabel mesh__D006964 Hypersecretion, Pituitary TSH
% 214.24/214.40  |- skos__hiddenLabel mesh__D006964 Hypersecretion, Pituitary FSH
% 214.24/214.40  |- skos__altLabel mesh__D006964
% 214.24/214.40       Follicle Stimulating Hormone, Inappropriate Secretion
% 214.24/214.40  |- skos__altLabel mesh__D006964
% 214.24/214.40       Luteinizing Hormone, Inappropriate Secretion
% 214.24/214.40  |- skos__altLabel mesh__D006964 Inappropriate FSH Secretion Syndrome
% 214.24/214.40  |- skos__hiddenLabel mesh__D006964 Hypersecretion, Pituitary LH
% 214.24/214.40  |- skos__altLabel mesh__D006964
% 214.24/214.40       Thyroid Stimulating Hormone, Inappropriate Secretion
% 214.24/214.40  |- skos__altLabel mesh__D006964
% 214.24/214.40       Inappropriate Follicle Stimulating Hormone Secretion
% 214.24/214.40  |- skos__scopeNote mesh__D006964
% 214.24/214.40       Disease of the glandular, anterior portion of the pituitary %28%PITUITARY GLAND, ANTERIOR%29% resulting in hypersecretion of ADENOHYPOPHYSEAL HORMONES such as GROWTH HORMONE; PROLACTIN; THYROTROPIN; LUTEINIZING HORMONE; FOLLICLE STIMULATING HORMONE ; and CORTICOTROPIN.  Hyperpituitarism usually is caused by a functional ADENOMA.%A%    
% 214.24/214.40  |- skos__altLabel mesh__D006964 Inappropriate LH Secretion Syndrome
% 214.24/214.40  |- skos__hiddenLabel mesh__D006964 FSH Hypersecretion, Pituitary
% 214.24/214.40  |- skos__broader mesh__D020635smesh__D006090
% 214.24/214.40  |- mesh__recordOriginator mesh__D020635 ndw
% 214.24/214.40  |- mesh__dateCreated mesh__D020635 1999-11-03
% 214.24/214.40  |- mesh__recordMaintainer mesh__D020635 SYSTEM
% 214.24/214.40  |- rdf__type mesh__D020635sskos__Concept
% 214.24/214.40  |- mesh__recordAuthorizer mesh__D020635 sjn
% 214.24/214.40  |- mesh__publicMeSHNote mesh__D020635 2000   
% 214.24/214.40  |- skos__prefLabel mesh__D020635 Buchnera
% 214.24/214.40  |- mesh__dateRevised mesh__D020635 2005-06-30
% 214.24/214.40  |- mesh__dateEstablished mesh__D020635 2000-01-01
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D020635 2006
% 214.24/214.40  |- skos__scopeNote mesh__D020635
% 214.24/214.40       A genus of gram-negative bacteria which are obligately intracellular endosymbionts of APHIDS. The bacteria are found within specialized cells in the aphid body cavity.%A%    
% 214.24/214.40  |- skos__historyNote mesh__D020635 Aphids/microbiology %28%1993-1999%29%
% 214.24/214.40  |- mesh__historyNote mesh__D020635 2000   
% 214.24/214.40  |- skos__broader mesh__D020635smesh__D020563
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006166 2005
% 214.24/214.40  |- mesh__recordMaintainer mesh__D006166 PLS
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006166 1991
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006166 2000
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006166 1997
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006166 1992
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006166 2006
% 214.24/214.40  |- mesh__dateCreated mesh__D006166 1999-01-01
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006166 1993
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006166 2001
% 214.24/214.40  |- mesh__recordAuthorizer mesh__D006166 PLS
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006166 1998
% 214.24/214.40  |- mesh__dateRevised mesh__D006166 1991-11-09
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006166 2002
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006166 1994
% 214.24/214.40  |- rdf__type mesh__D006166sskos__Concept
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006166 1999
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006166 2003
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006166 1995
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006166 2004
% 214.24/214.40  |- skos__broader mesh__D006166smesh__D002489
% 214.24/214.40  |- skos__prefLabel mesh__D006166 Guatemala
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006166 1990
% 214.24/214.40  |- mesh__recordOriginator mesh__D006166 NLM
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006166 1989
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006166 1996
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011300 2000
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011300 2006
% 214.24/214.40  |- skos__altLabel mesh__D011300 Procedures, Preoperative
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011300 2001
% 214.24/214.40  |- mesh__recordOriginator mesh__D011300 NLM
% 214.24/214.40  |- mesh__dateCreated mesh__D011300 1999-01-01
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011300 2003
% 214.24/214.40  |- skos__scopeNote mesh__D011300
% 214.24/214.40       Care given during the period prior to undergoing surgery when psychological and physical preparations are made according to the special needs of the individual patient. This period spans the time between admission to the hospital to the time the surgery begins. %28%From Dictionary of Health Services Management, 2d ed%29%%A%    
% 214.24/214.40  |- mesh__recordAuthorizer mesh__D011300 SJN
% 214.24/214.40  |- skos__broader mesh__D011300smesh__D013514
% 214.24/214.40  |- skos__broader mesh__D011300smesh__D005791
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011300 2004
% 214.24/214.40  |- skos__altLabel mesh__D011300 Procedure, Preoperative
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011300 2002
% 214.24/214.40  |- rdf__type mesh__D011300sskos__Concept
% 214.24/214.40  |- mesh__dateRevised mesh__D011300 1997-06-20
% 214.24/214.40  |- skos__annotation mesh__D011300
% 214.24/214.40       preop use of antibiotics for prev of infect: index under ANTIBIOTIC PROPHYLAXIS %26% not here; DF: PREOP CARE%A%  
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011300 1998
% 214.24/214.40  |- skos__altLabel mesh__D011300 Preoperative Procedures
% 214.24/214.40  |- skos__prefLabel mesh__D011300 Preoperative Care
% 214.24/214.40  |- mesh__recordMaintainer mesh__D011300 PXP
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011300 1999
% 214.24/214.40  |- skos__altLabel mesh__D011300 Care, Preoperative
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011300 2005
% 214.24/214.40  |- mesh__dateRevised mesh__D002574 1999-11-03
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D002574 2001
% 214.24/214.40  |- skos__annotation mesh__D002574
% 214.24/214.40       IM when discussed as bones or as coord with specific spinal disease %28%IM%29%; NIM when locational; inflammation = CERVICAL VERTEBRAE %28%IM%29% + SPONDYLITIS %28%IM%29%%A%  
% 214.24/214.40  |- mesh__recordMaintainer mesh__D002574 ags
% 214.24/214.40  |- skos__hiddenLabel mesh__D002574 Vertebrae, Cervical
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D002574 2002
% 214.24/214.40  |- rdf__type mesh__D002574sskos__Concept
% 214.24/214.40  |- mesh__dateCreated mesh__D002574 1999-01-01
% 214.24/214.40  |- skos__prefLabel mesh__D002574 Cervical Vertebrae
% 214.24/214.40  |- mesh__recordOriginator mesh__D002574 NLM
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D002574 2003
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D002574 2005
% 214.24/214.40  |- skos__broader mesh__D002574smesh__D013131
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D002574 2004
% 214.24/214.40  |- mesh__recordAuthorizer mesh__D002574 sjn
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D002574 2006
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D002574 2000
% 214.24/214.40  |- skos__prefLabel mesh__D010208 Papaverine
% 214.24/214.40  |- mesh__dateCreated mesh__D010208 1999-01-01
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D010208 2005
% 214.24/214.40  |- skos__scopeNote mesh__D010208
% 214.24/214.40       An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.%A%    
% 214.24/214.40  |- mesh__dateRevised mesh__D010208 2003-07-09
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D010208 2006
% 214.24/214.40  |- skos__hiddenLabel mesh__D010208 Hydrochloride, Papaverine
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D010208 2004
% 214.24/214.40  |- skos__broader mesh__D010208smesh__D044182
% 214.24/214.40  |- mesh__recordOriginator mesh__D010208 NLM
% 214.24/214.40  |- mesh__recordMaintainer mesh__D010208 ssb
% 214.24/214.40  |- rdf__type mesh__D010208sskos__Concept
% 214.24/214.40  |- mesh__recordAuthorizer mesh__D010208 sjn
% 214.24/214.40  |- skos__broader mesh__D010208smesh__D009892
% 214.24/214.40  |- mesh__publicMeSHNote mesh__D006965 1965   
% 214.24/214.40  |- skos__broader mesh__D006965smesh__D010335
% 214.24/214.40  |- skos__related mesh__D006965smesh__D011230
% 214.24/214.40  |- mesh__recordMaintainer mesh__D006965 nns
% 214.24/214.40  |- skos__related mesh__D006965smesh__D049109
% 214.24/214.40  |- mesh__recordAuthorizer mesh__D006965 sjn
% 214.24/214.40  |- skos__hiddenLabel mesh__D006965 Hyperplasias
% 214.24/214.40  |- rdf__type mesh__D006965sskos__Concept
% 214.24/214.40  |- mesh__recordOriginator mesh__D006965 NLM
% 214.24/214.40  |- skos__annotation mesh__D006965
% 214.24/214.40       general or unspecified; coordinate NIM with organ /pathol %28%IM%29%; many specific precoordinated hyperplasia terms are available; congen adrenal hyperplasia = ADRENAL HYPERPLASIA, CONGENITAL but non-congenital adrenal hyperplasia = ADRENAL GLANDS /pathol %28%IM%29% + HYPERPLASIA %28%NIM%29%%A%  
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006965 2005
% 214.24/214.40  |- mesh__historyNote mesh__D006965 1965   
% 214.24/214.40  |- mesh__dateEstablished mesh__D006965 1965-01-01
% 214.24/214.40  |- mesh__dateCreated mesh__D006965 1999-01-01
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006965 2006
% 214.24/214.40  |- mesh__dateRevised mesh__D006965 2004-07-07
% 214.24/214.40  |- skos__scopeNote mesh__D006965
% 214.24/214.40       An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.%A%    
% 214.24/214.40  |- skos__prefLabel mesh__D006965 Hyperplasia
% 214.24/214.40  |- skos__scopeNote mesh__D020636
% 214.24/214.40       A genus of gram-negative, facultatively anaerobic, straight rods which are motile by peritrichous flagella. Most strains produce a yellow pigment. This organism is isolated from plant surfaces, seeds, soil, and water, as well as from animals and human wounds, blood, and urine. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 214.24/214.40  |- rdf__type mesh__D020636sskos__Concept
% 214.24/214.40  |- mesh__dateEstablished mesh__D020636 2000-01-01
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D020636 2006
% 214.24/214.40  |- mesh__dateCreated mesh__D020636 1999-11-03
% 214.24/214.40  |- skos__broader mesh__D020636smesh__D004755
% 214.24/214.40  |- skos__prefLabel mesh__D020636 Pantoea
% 214.24/214.40  |- mesh__historyNote mesh__D020636 2000   
% 214.24/214.40  |- mesh__recordAuthorizer mesh__D020636 sjn
% 214.24/214.40  |- mesh__publicMeSHNote mesh__D020636 2000   
% 214.24/214.40  |- mesh__dateRevised mesh__D020636 2005-06-30
% 214.24/214.40  |- skos__annotation mesh__D020636
% 214.24/214.40       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 214.24/214.40  |- mesh__recordOriginator mesh__D020636 ndw
% 214.24/214.40  |- mesh__recordMaintainer mesh__D020636 SYSTEM
% 214.24/214.40  |- skos__prefLabel mesh__D039341 Receptors, Fibrinogen
% 214.24/214.40  |- mesh__dateEstablished mesh__D039341 2003-01-01
% 214.24/214.40  |- skos__historyNote mesh__D039341
% 214.24/214.40       Platelet Glycoprotein GPIIb-IIIa Complex %28%1996-2002%29%
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D039341 2004
% 214.24/214.40  |- mesh__dateCreated mesh__D039341 2002-07-03
% 214.24/214.40  |- mesh__dateRevised mesh__D039341 2003-07-09
% 214.24/214.40  |- rdf__type mesh__D039341sskos__Concept
% 214.24/214.40  |- skos__altLabel mesh__D039341 Fibrinogen Receptors
% 214.24/214.40  |- mesh__publicMeSHNote mesh__D039341
% 214.24/214.40       2003; see PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX 1996-2002%A%  
% 214.24/214.40  |- skos__broader mesh__D039341smesh__D016023
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D039341 2005
% 214.24/214.40  |- skos__scopeNote mesh__D039341
% 214.24/214.40       Receptors that bind FIBRINOGEN through distinct adhesive sequences on the fibrinogen molecule. Although MACROPHAGE-1 ANTIGEN is considered an important signaling molecule for fibrinogen interaction, a variety of INTEGRINS from all three major families, %28%beta1, beta2, and beta3%29% have been shown to bind fibrinogen.%A%    
% 214.24/214.40  |- mesh__historyNote mesh__D039341
% 214.24/214.40       2003; use PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX 1996-2002%A%  
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D039341 2006
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006167 1992
% 214.24/214.40  |- mesh__dateRevised mesh__D006167 1989-04-28
% 214.24/214.40  |- skos__scopeNote mesh__D006167
% 214.24/214.40       Subjective feeling of having committed an error, offense or sin; unpleasant feeling of self-criticism. These result from acts, impulses, or thoughts contrary to one%27%s personal conscience.%A%    
% 214.24/214.40  |- mesh__dateCreated mesh__D006167 1999-01-01
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006167 1997
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006167 2002
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006167 1991
% 214.24/214.40  |- skos__prefLabel mesh__D006167 Guilt
% 214.24/214.40  |- mesh__recordOriginator mesh__D006167 NLM
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006167 1996
% 214.24/214.40  |- mesh__recordMaintainer mesh__D006167 TGC
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006167 2006
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006167 2001
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006167 1995
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006167 1990
% 214.24/214.40  |- mesh__recordAuthorizer mesh__D006167 PLS
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006167 2005
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006167 1994
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006167 2000
% 214.24/214.40  |- skos__hiddenLabel mesh__D006167 Guilts
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006167 1999
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006167 2004
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006167 1993
% 214.24/214.40  |- rdf__type mesh__D006167sskos__Concept
% 214.24/214.40  |- skos__broader mesh__D006167smesh__D004644
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006167 1998
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D006167 2003
% 214.24/214.40  |- skos__annotation mesh__D006167 no qualif   
% 214.24/214.40  |- skos__broader mesh__D025321smesh__D013813
% 214.24/214.40  |- skos__scopeNote mesh__D025321
% 214.24/214.40       Surgical procedures conducted with the aid of computers. This is most frequently used in orthopedic and laparoscopic surgery for implant placement and instrument guidance. Image-guided surgery interactively combines prior CT scans or MRI images with real-time video.%A%    
% 214.24/214.40  |- skos__hiddenLabel mesh__D025321 Surgery, Computer Assisted
% 214.24/214.40  |- skos__altLabel mesh__D025321 Computer-Assisted Surgery
% 214.24/214.40  |- skos__historyNote mesh__D025321
% 214.24/214.40       Therapy, Computer-Assisted %28%1988-2001%29%
% 214.24/214.40  |- skos__hiddenLabel mesh__D025321 Computer-Aided Surgeries
% 214.24/214.40  |- mesh__dateEstablished mesh__D025321 2002-01-01
% 214.24/214.40  |- skos__hiddenLabel mesh__D025321 Computer-Assisted Surgeries
% 214.24/214.40  |- skos__related mesh__D025321smesh__D038361
% 214.24/214.40  |- mesh__recordOriginator mesh__D025321 ags
% 214.24/214.40  |- skos__hiddenLabel mesh__D025321 Computer Aided Surgery
% 214.24/214.40  |- mesh__dateRevised mesh__D025321 2004-08-02
% 214.24/214.40  |- mesh__historyNote mesh__D025321 2002   
% 214.24/214.40  |- skos__prefLabel mesh__D025321 Surgery, Computer-Assisted
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D025321 2003
% 214.24/214.40  |- skos__hiddenLabel mesh__D025321 Surgeries, Computer-Assisted
% 214.24/214.40  |- skos__hiddenLabel mesh__D025321 Computer Assisted Surgery
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D025321 2005
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D025321 2005A
% 214.24/214.40  |- mesh__dateCreated mesh__D025321 2001-07-25
% 214.24/214.40  |- skos__hiddenLabel mesh__D025321 Surgeries, Computer-Aided
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D025321 2004
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D025321 2006
% 214.24/214.40  |- mesh__recordMaintainer mesh__D025321 jls
% 214.24/214.40  |- mesh__publicMeSHNote mesh__D025321 2002   
% 214.24/214.40  |- rdf__type mesh__D025321sskos__Concept
% 214.24/214.40  |- skos__hiddenLabel mesh__D025321 Image-Guided Surgeries
% 214.24/214.40  |- skos__altLabel mesh__D025321 Computer-Aided Surgery
% 214.24/214.40  |- skos__hiddenLabel mesh__D025321 Surgery, Computer-Aided
% 214.24/214.40  |- skos__hiddenLabel mesh__D025321 Surgeries, Image-Guided
% 214.24/214.40  |- skos__hiddenLabel mesh__D025321 Surgery, Image Guided
% 214.24/214.40  |- skos__hiddenLabel mesh__D025321 Image Guided Surgery
% 214.24/214.40  |- mesh__recordAuthorizer mesh__D025321 jls
% 214.24/214.40  |- skos__altLabel mesh__D025321 Image-Guided Surgery
% 214.24/214.40  |- skos__hiddenLabel mesh__D011301 Area, Preoptic
% 214.24/214.40  |- mesh__recordOriginator mesh__D011301 NLM
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011301 2005
% 214.24/214.40  |- mesh__recordMaintainer mesh__D011301 TAP
% 214.24/214.40  |- mesh__dateRevised mesh__D011301 1992-05-18
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011301 2001
% 214.24/214.40  |- skos__hiddenLabel mesh__D011301 Preoptic Areas
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011301 1997
% 214.24/214.40  |- skos__scopeNote mesh__D011301
% 214.24/214.40       Region of hypothalamus between the anterior commissure and optic chiasm.%A%    
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011301 2006
% 214.24/214.40  |- skos__prefLabel mesh__D011301 Preoptic Area
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011301 2003
% 214.24/214.40  |- mesh__dateCreated mesh__D011301 1974-11-11
% 214.24/214.40  |- skos__hiddenLabel mesh__D011301 Areas, Preoptic
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011301 1994
% 214.24/214.40  |- rdf__type mesh__D011301sskos__Concept
% 214.24/214.40  |- mesh__dateEstablished mesh__D011301 1983-01-01
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011301 2002
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011301 2004
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011301 1998
% 214.24/214.40  |- mesh__publicMeSHNote mesh__D011301
% 214.24/214.40       83; was see under HYPOTHALAMUS 1975-82   
% 214.24/214.40  |- skos__broader mesh__D011301smesh__D007032
% 214.24/214.40  |- mesh__historyNote mesh__D011301
% 214.24/214.40       83%28%75%29%; was see under HYPOTHALAMUS 1975-82   
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011301 1995
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011301 1999
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011301 2000
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011301 1996
% 214.24/214.40  |- mesh__recordAuthorizer mesh__D011301 PLS
% 214.24/214.40  |- mesh__activeMeSHYear mesh__D011301 1993
% 214.24/214.40  |- skos__historyNote mesh__D016595
% 214.24/214.40       Alprostadil/analogs %26% derivatives %28%1975-1991%29%
% 214.24/214.40  |- skos__hiddenLabel mesh__D016595 Apo Misoprostol
% 214.24/214.40  |- mesh__recordAuthorizer mesh__D016595 sjn
% 214.24/214.40  |- skos__historyNote mesh__D016595
% 214.24/214.40       Abortifacient Agents, Non-Steroidal %28%1975-1991%29%
% 214.24/214.40  |- skos__prefLabel mesh__D016595 Misoprostol
% 214.24/214.40  |- skos__altLabel mesh__D016595 Pharmacia Brand of Misoprostol
% 214.26/214.40  |- skos__hiddenLabel mesh__D016595 Misoprostol Searle Brand
% 214.26/214.40  |- mesh__recordOriginator mesh__D016595 RLS
% 214.26/214.40  |- skos__scopeNote mesh__D016595
% 214.26/214.40       A synthetic analog of natural prostaglandin E1. It produces a dose-related inhibition of gastric acid and pepsin secretion, and enhances mucosal resistance to injury. It is an effective anti-ulcer agent and also has oxytocic properties.%A%    
% 214.26/214.40  |- mesh__activeMeSHYear mesh__D016595 2006
% 214.26/214.40  |- skos__hiddenLabel mesh__D016595 Misoprostol Novopharm Brand
% 214.26/214.40  |- skos__broader mesh__D016595smesh__D011459
% 214.26/214.40  |- skos__hiddenLabel mesh__D016595 SC29333
% 214.26/214.40  |- skos__altLabel mesh__D016595 Pharmacia Spain Brand of Misoprostol
% 214.26/214.40  |- skos__hiddenLabel mesh__D016595 Novo Misoprostol
% 214.26/214.40  |- skos__hiddenLabel mesh__D016595 SC30249
% 214.26/214.40  |- skos__historyNote mesh__D016595 Anti-Ulcer Agents %28%1977-1991%29%
% 214.26/214.40  |- skos__hiddenLabel mesh__D016595 Misoprostol Apotex Brand
% 214.26/214.40  |- skos__hiddenLabel mesh__D016595 SC 30249
% 214.26/214.40  |- skos__altLabel mesh__D016595 Heumann Brand of Misoprostol
% 214.26/214.40  |- skos__altLabel mesh__D016595 Novopharm Brand of Misoprostol
% 214.26/214.40  |- skos__altLabel mesh__D016595 Grunenthal Brand of Misoprostol
% 214.26/214.40  |- skos__hiddenLabel mesh__D016595 Misoprostol Heumann Brand
% 214.26/214.40  |- mesh__publicMeSHNote mesh__D016595
% 214.26/214.40       92; MISOPROSTOL was indexed under ALPROSTADIL/analogs %26% derivatives 1986-91, under PROSTAGLANDINS E, SYNTHETIC 1979-85 %26% under PROSTAGLANDINS, SYNTHETIC 1977-78%A%  
% 214.26/214.40  |- skos__hiddenLabel mesh__D016595 Misoprostol Grunenthal Brand
% 214.26/214.40  |- skos__hiddenLabel mesh__D016595 SC 29333
% 214.26/214.40  |- rdf__type mesh__D016595sskos__Concept
% 214.26/214.40  |- mesh__historyNote mesh__D016595
% 214.26/214.40       92; was MISOPROSTOL %28%NM%29% 1977-91   
% 214.26/214.40  |- mesh__dateCreated mesh__D016595 1991-01-25
% 214.26/214.40  |- mesh__dateEstablished mesh__D016595 1992-01-01
% 214.26/214.40  |- skos__altLabel mesh__D016595 Searle Brand of Misoprostol
% 214.26/214.40  |- mesh__dateRevised mesh__D016595 2005-06-30
% 214.26/214.40  |- mesh__onlineNote mesh__D016595
% 214.26/214.40       use MISOPROSTOL %28%NM%29% to search MISOPROSTOL 1980-91   
% 214.26/214.40  |- skos__altLabel mesh__D016595 Apotex Brand of Misoprostol
% 214.26/214.40  |- mesh__recordMaintainer mesh__D016595 ssb
% 214.26/214.40  |- skos__hiddenLabel mesh__D016595 Misoprostol Pharmacia Brand
% 214.26/214.40  |- mesh__recordOriginator mesh__D002575 NLM
% 214.26/214.40  |- skos__hiddenLabel mesh__D002575 Cervicitides, Uterine
% 214.26/214.40  |- mesh__recordMaintainer mesh__D002575 lkt
% 214.26/214.40  |- skos__broader mesh__D002575smesh__D002577
% 214.26/214.40  |- mesh__historyNote mesh__D002575 2006 %28%1963%29%   
% 214.26/214.40  |- skos__scopeNote mesh__D002575 Inflammation of the UTERINE CERVIX.     
% 214.26/214.40  |- mesh__activeMeSHYear mesh__D002575 2006
% 214.26/214.40  |- mesh__recordAuthorizer mesh__D002575 sjn
% 214.26/214.40  |- skos__hiddenLabel mesh__D002575 Uterine Cervicitides
% 214.26/214.40  |- mesh__dateRevised mesh__D002575 2005-06-30
% 214.26/214.40  |- skos__hiddenLabel mesh__D002575 Cervicitis, Uterine
% 214.26/214.40  |- skos__hiddenLabel mesh__D002575 Cervicitides
% 214.26/214.40  |- skos__prefLabel mesh__D002575 Uterine Cervicitis
% 214.26/214.40  |- mesh__publicMeSHNote mesh__D002575 2006; see CERVICITIS 1963-2005   
% 214.26/214.40  |- skos__altLabel mesh__D002575 Cervicitis
% 214.26/214.40  |- rdf__type mesh__D002575sskos__Concept
% 214.26/214.40  |- mesh__dateCreated mesh__D002575 1999-01-01
% 214.26/214.40  |- mesh__dateRevised mesh__D010209 1997-06-20
% 214.26/214.40  |- mesh__dateCreated mesh__D010209 1999-01-01
% 214.26/214.40  |- mesh__recordMaintainer mesh__D010209 JLS
% 214.26/214.40  |- mesh__activeMeSHYear mesh__D010209 2003
% 214.26/214.40  |- mesh__recordAuthorizer mesh__D010209 SJN
% 214.26/214.40  |- mesh__activeMeSHYear mesh__D010209 2006
% 214.26/214.40  |- skos__hiddenLabel mesh__D010209 Papers
% 214.26/214.40  |- mesh__activeMeSHYear mesh__D010209 2000
% 214.26/214.40  |- mesh__activeMeSHYear mesh__D010209 2004
% 214.26/214.40  |- mesh__activeMeSHYear mesh__D010209 2001
% 214.26/214.40  |- mesh__activeMeSHYear mesh__D010209 1998
% 214.26/214.40  |- mesh__activeMeSHYear mesh__D010209 2002
% 214.26/214.40  |- mesh__activeMeSHYear mesh__D010209 1999
% 214.26/214.40  |- rdf__type mesh__D010209sskos__Concept
% 214.26/214.40  |- skos__broader mesh__D010209smesh__D008420
% 214.26/214.40  |- skos__prefLabel mesh__D010209 Paper
% 214.26/214.40  |- skos__broader mesh__D010209smesh__D001870
% 214.26/214.40  |- mesh__recordOriginator mesh__D010209 NLM
% 214.26/214.40  |- mesh__activeMeSHYear mesh__D010209 2005
% 214.26/214.40  |- skos__hiddenLabel mesh__D007260 Pump, Infusion
% 214.26/214.40  |- skos__hiddenLabel mesh__D007260 Pump, External Infusion
% 214.26/214.40  |- mesh__activeMeSHYear mesh__D007260 2000
% 214.26/214.40  |- mesh__publicMeSHNote mesh__D007260 87   
% 214.26/214.40  |- skos__annotation mesh__D007260
% 214.26/214.40       /psychol permitted; coord IM with drug /admin %28%IM%29%; INFUSION PUMPS, IMPLANTABLE is also available%A%  
% 214.26/214.40  |- mesh__activeMeSHYear mesh__D007260 1997
% 214.26/214.40  |- skos__altLabel mesh__D007260 Infusors
% 214.26/214.40  |- mesh__activeMeSHYear mesh__D007260 2005
% 214.26/214.40  |- skos__hiddenLabel mesh__D007260 Infusion Systems, Drug
% 214.26/214.40  |- skos__hiddenLabel mesh__D007260 Infusor
% 214.26/214.40  |- mesh__historyNote mesh__D007260 87   
% 214.26/214.40  |- skos__prefLabel mesh__D007260 Infusion Pumps
% 214.26/214.41  |- mesh__recordAuthorizer mesh__D007260 PLS
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D007260 2001
% 214.26/214.41  |- skos__hiddenLabel mesh__D007260 External Infusion Pumps
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D007260 2006
% 214.26/214.41  |- skos__hiddenLabel mesh__D007260 Infusion System, Drug
% 214.26/214.41  |- mesh__dateRevised mesh__D007260 1996-06-10
% 214.26/214.41  |- skos__hiddenLabel mesh__D007260 Drug Infusion System
% 214.26/214.41  |- skos__hiddenLabel mesh__D007260 External Infusion Pump
% 214.26/214.41  |- skos__hiddenLabel mesh__D007260 System, Drug Infusion
% 214.26/214.41  |- skos__hiddenLabel mesh__D007260 Perfusion Pump
% 214.26/214.41  |- skos__scopeNote mesh__D007260
% 214.26/214.41       Fluid propulsion systems driven mechanically, electrically, or osmotically that are used to inject %28%or infuse%29% over time agents into a patient or experimental animal; used routinely in hospitals to maintain a patent intravenous line, to administer antineoplastic agents and other drugs in thromboembolism, heart disease, diabetes mellitus %28%INSULIN INFUSION SYSTEMS is also available%29%, and other disorders.%A%    
% 214.26/214.41  |- skos__hiddenLabel mesh__D007260 Pumps, Perfusion
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D007260 1998
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D007260 2003
% 214.26/214.41  |- skos__hiddenLabel mesh__D007260 Infusion Pump, External
% 214.26/214.41  |- skos__hiddenLabel mesh__D007260 Infusion Pump
% 214.26/214.41  |- skos__broader mesh__D007260smesh__D001187
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D007260 2002
% 214.26/214.41  |- rdf__type mesh__D007260sskos__Concept
% 214.26/214.41  |- skos__historyNote mesh__D007260 Perfusion, Regional %28%1978-1986%29%
% 214.26/214.41  |- mesh__dateCreated mesh__D007260 1986-06-04
% 214.26/214.41  |- mesh__recordMaintainer mesh__D007260 TGC
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D007260 1999
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D007260 2004
% 214.26/214.41  |- skos__hiddenLabel mesh__D007260 Systems, Drug Infusion
% 214.26/214.41  |- skos__historyNote mesh__D007260 Infusions, Parenteral %28%1966-1986%29%
% 214.26/214.41  |- skos__broader mesh__D007260smesh__D004864
% 214.26/214.41  |- mesh__dateEstablished mesh__D007260 1987-01-01
% 214.26/214.41  |- skos__historyNote mesh__D007260
% 214.26/214.41       Infusions, Intra-Arterial %28%1978-1986%29%
% 214.26/214.41  |- skos__hiddenLabel mesh__D007260 Pump, Perfusion
% 214.26/214.41  |- skos__altLabel mesh__D007260 Perfusion Pumps
% 214.26/214.41  |- mesh__recordOriginator mesh__D007260 SH
% 214.26/214.41  |- skos__hiddenLabel mesh__D007260 Pumps, External Infusion
% 214.26/214.41  |- skos__altLabel mesh__D007260 Pumps, Infusion
% 214.26/214.41  |- mesh__dateEstablished mesh__D006966 1986-01-01
% 214.26/214.41  |- mesh__publicMeSHNote mesh__D006966 1986   
% 214.26/214.41  |- mesh__dateRevised mesh__D006966 2005-06-30
% 214.26/214.41  |- skos__altLabel mesh__D006966 Prolactin, Inappropriate Secretion
% 214.26/214.41  |- skos__hiddenLabel mesh__D006966 Syndrome, Prolactin Hypersecretion
% 214.26/214.41  |- skos__prefLabel mesh__D006966 Hyperprolactinemia
% 214.26/214.41  |- skos__scopeNote mesh__D006966
% 214.26/214.41       Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic %28%non-pituitary%29% production of prolactin may also occur. %28%From Joynt, Clinical Neurology, 1992, Ch36, pp77-8%29%%A%    
% 214.26/214.41  |- mesh__recordOriginator mesh__D006966 VDK
% 214.26/214.41  |- skos__broader mesh__D006966smesh__D008659
% 214.26/214.41  |- skos__historyNote mesh__D006966 Prolactin/blood %28%1966-1985%29%
% 214.26/214.41  |- skos__altLabel mesh__D006966 Inappropriate Prolactin Secretion Syndrome
% 214.26/214.41  |- mesh__historyNote mesh__D006966 1986   
% 214.26/214.41  |- rdf__type mesh__D006966sskos__Concept
% 214.26/214.41  |- skos__altLabel mesh__D006966 Prolactin Hypersecretion Syndrome
% 214.26/214.41  |- skos__broader mesh__D006966smesh__D006964
% 214.26/214.41  |- skos__hiddenLabel mesh__D006966 Hyperprolactinemias
% 214.26/214.41  |- skos__hiddenLabel mesh__D006966 Hypersecretion Syndrome, Prolactin
% 214.26/214.41  |- skos__hiddenLabel mesh__D006966 Secretion, Inappropriate Prolactin
% 214.26/214.41  |- skos__hiddenLabel mesh__D006966 Prolactin Secretion, Inappropriate
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D006966 2006
% 214.26/214.41  |- skos__hiddenLabel mesh__D006966 Inappropriate Secretion Prolactin
% 214.26/214.41  |- skos__hiddenLabel mesh__D006966 Secretion Prolactin, Inappropriate
% 214.26/214.41  |- mesh__recordAuthorizer mesh__D006966 sjn
% 214.26/214.41  |- mesh__recordMaintainer mesh__D006966 lkt
% 214.26/214.41  |- mesh__dateCreated mesh__D006966 1985-03-11
% 214.26/214.41  |- skos__altLabel mesh__D006966 Inappropriate Prolactin Secretion
% 214.26/214.41  |- skos__prefLabel mesh__D020637 Photorhabdus
% 214.26/214.41  |- mesh__dateEstablished mesh__D020637 2000-01-01
% 214.26/214.41  |- skos__scopeNote mesh__D020637
% 214.26/214.41       A genus of gram-negative bacteria existing symbiotically with nematodes of the family Heterorhabditidae %28%see RHABDITOIDEA%29%. These nematodes infect a variety of soil-dwelling insects. Upon entering an insect host, the nematode releases Photorhabdus from its intestinal tract and the bacterium establishes a lethal septicemia in the insect.%A%    
% 214.26/214.41  |- mesh__historyNote mesh__D020637
% 214.26/214.41       2000; for XENORHABDUS LUMINESCENS use XENORHABDUS 2001-2002%A%  
% 214.26/214.41  |- mesh__dateRevised mesh__D020637 2005-06-30
% 214.26/214.41  |- skos__altLabel mesh__D020637 Xenorhabdus luminescens
% 214.26/214.41  |- mesh__dateCreated mesh__D020637 1999-11-03
% 214.26/214.41  |- mesh__recordOriginator mesh__D020637 ndw
% 214.26/214.41  |- mesh__recordMaintainer mesh__D020637 SYSTEM
% 214.26/214.41  |- rdf__type mesh__D020637sskos__Concept
% 214.26/214.41  |- skos__historyNote mesh__D020637 Enterobacteriaceae %28%1994-1999%29%
% 214.26/214.41  |- mesh__publicMeSHNote mesh__D020637
% 214.26/214.41       2000; for XENORHABDUS LUMINESCENS see XENORHABDUS 2001-2002%A%  
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D020637 2006
% 214.26/214.41  |- skos__broader mesh__D020637smesh__D004755
% 214.26/214.41  |- mesh__recordAuthorizer mesh__D020637 sjn
% 214.26/214.41  |- skos__hiddenLabel mesh__D006168 Pigs, Guinea
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D006168 2006
% 214.26/214.41  |- skos__broader mesh__D006168smesh__D012377
% 214.26/214.41  |- skos__prefLabel mesh__D006168 Guinea Pigs
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D006168 2005
% 214.26/214.41  |- mesh__recordAuthorizer mesh__D006168 sjn
% 214.26/214.41  |- skos__hiddenLabel mesh__D006168 Guinea Pig
% 214.26/214.41  |- mesh__recordOriginator mesh__D006168 NLM
% 214.26/214.41  |- skos__altLabel mesh__D006168 Cavia
% 214.26/214.41  |- rdf__type mesh__D006168sskos__Concept
% 214.26/214.41  |- mesh__recordMaintainer mesh__D006168 ags
% 214.26/214.41  |- skos__hiddenLabel mesh__D006168 Pig, Guinea
% 214.26/214.41  |- skos__scopeNote mesh__D006168
% 214.26/214.41       A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research.%A%    
% 214.26/214.41  |- mesh__dateCreated mesh__D006168 1999-01-01
% 214.26/214.41  |- skos__annotation mesh__D006168 check tag: no qualif   
% 214.26/214.41  |- mesh__dateRevised mesh__D006168 2004-07-07
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D011302 2006
% 214.26/214.41  |- skos__hiddenLabel mesh__D011302 Dehydratase, Prephenate
% 214.26/214.41  |- mesh__dateEstablished mesh__D011302 1991-01-01
% 214.26/214.41  |- skos__annotation mesh__D011302
% 214.26/214.41       do not confuse with PREPHENATE DEHYDROGENASE   
% 214.26/214.41  |- skos__historyNote mesh__D011302 Pyruvates %28%1970-1974%29%
% 214.26/214.41  |- skos__hiddenLabel mesh__D011302 Prephenate Hydro lyase
% 214.26/214.41  |- mesh__dateCreated mesh__D011302 1974-11-11
% 214.26/214.41  |- mesh__recordOriginator mesh__D011302 NLM
% 214.26/214.41  |- rdf__type mesh__D011302sskos__Concept
% 214.26/214.41  |- skos__broader mesh__D011302smesh__D006836
% 214.26/214.41  |- skos__hiddenLabel mesh__D011302
% 214.26/214.41       Dehydratase, Chorismate Mutase-Prephenate
% 214.26/214.41  |- skos__hiddenLabel mesh__D011302 Chorismate Mutase Prephenate Dehydratase
% 214.26/214.41  |- mesh__recordMaintainer mesh__D011302 ssb
% 214.26/214.41  |- mesh__dateRevised mesh__D011302 2003-07-09
% 214.26/214.41  |- skos__altLabel mesh__D011302 Prephenate Hydro-lyase
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D011302 2004
% 214.26/214.41  |- skos__scopeNote mesh__D011302
% 214.26/214.41       An enzyme that catalyzes the conversion of prephenate to phenylpyruvate with the elimination of water and carbon dioxide. In the enteric bacteria this enzyme also possesses chorismate mutase activity, thereby catalyzing the first two steps in the biosynthesis of phenylalanine. EC 4.2.1.51.%A%    
% 214.26/214.41  |- mesh__historyNote mesh__D011302
% 214.26/214.41       91%28%75%29%; was see under HYDRO-LYASES 1975-90   
% 214.26/214.41  |- mesh__publicMeSHNote mesh__D011302
% 214.26/214.41       91; was see under HYDRO-LYASES 1975-90   
% 214.26/214.41  |- skos__historyNote mesh__D011302 Hydro-Lyases %28%1970-1974%29%
% 214.26/214.41  |- skos__hiddenLabel mesh__D011302
% 214.26/214.41       Mutase-Prephenate Dehydratase, Chorismate
% 214.26/214.41  |- skos__hiddenLabel mesh__D011302 Hydro-lyase, Prephenate
% 214.26/214.41  |- skos__prefLabel mesh__D011302 Prephenate Dehydratase
% 214.26/214.41  |- mesh__recordAuthorizer mesh__D011302 sjn
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D011302 2005
% 214.26/214.41  |- skos__historyNote mesh__D011302 Cyclohexanes %28%1970-1974%29%
% 214.26/214.41  |- skos__broader mesh__D011302smesh__D002826
% 214.26/214.41  |- skos__prefLabel mesh__D049770 Genes, Mating Type, Fungal
% 214.26/214.41  |- skos__hiddenLabel mesh__D049770 Fungal Mating-Type Gene
% 214.26/214.41  |- skos__scopeNote mesh__D049770
% 214.26/214.41       Fungal genes that mostly encode TRANSCRIPTION FACTORS. In some FUNGI they also encode PHEROMONES and PHEROMONE RECEPTORS. The transcription factors control expression of specific proteins that give a cell its mating identity. Opposite mating type identities are required for mating.%A%    
% 214.26/214.41  |- skos__hiddenLabel mesh__D049770 Fungal Mating Types
% 214.26/214.41  |- skos__hiddenLabel mesh__D049770 Mating-Type Genes, Fungal
% 214.26/214.41  |- skos__broader mesh__D049770smesh__D005800
% 214.26/214.41  |- skos__hiddenLabel mesh__D049770 Fungal Mating Type Genes
% 214.26/214.41  |- skos__hiddenLabel mesh__D049770 Fungal Mating Type
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D049770 2006
% 214.26/214.41  |- mesh__dateCreated mesh__D049770 2005-06-30
% 214.26/214.41  |- mesh__recordOriginator mesh__D049770 nns
% 214.26/214.41  |- skos__hiddenLabel mesh__D049770 Gene, Fungal Mating-Type
% 214.26/214.41  |- skos__hiddenLabel mesh__D049770 Genes, Fungal Mating-Type
% 214.26/214.41  |- rdf__type mesh__D049770sskos__Concept
% 214.26/214.41  |- skos__hiddenLabel mesh__D049770 Mating Types, Fungal
% 214.26/214.41  |- mesh__recordMaintainer mesh__D049770 nns
% 214.26/214.41  |- skos__altLabel mesh__D049770 Fungal Mating-Type Genes
% 214.26/214.41  |- mesh__historyNote mesh__D049770 2006   
% 214.26/214.41  |- skos__hiddenLabel mesh__D049770 Type, Fungal Mating
% 214.26/214.41  |- mesh__dateEstablished mesh__D049770 2006-01-01
% 214.26/214.41  |- skos__hiddenLabel mesh__D049770 Mating-Type Gene, Fungal
% 214.26/214.41  |- mesh__recordAuthorizer mesh__D049770 sjn
% 214.26/214.41  |- skos__historyNote mesh__D049770 Genes, Fungal %28%1981-2005%29%
% 214.26/214.41  |- skos__hiddenLabel mesh__D049770 Types, Fungal Mating
% 214.26/214.41  |- skos__altLabel mesh__D049770 Genes, Fungal Mating Type
% 214.26/214.41  |- mesh__publicMeSHNote mesh__D049770 2006   
% 214.26/214.41  |- mesh__dateEstablished mesh__D016596 1992-01-01
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D016596 2005
% 214.26/214.41  |- skos__broader mesh__D016596smesh__D003598
% 214.26/214.41  |- skos__scopeNote mesh__D016596
% 214.26/214.41       A cytoskeletal protein associated with cell-cell and cell-matrix interactions. The amino acid sequence of human vinculin has been determined. The protein consists of 1066 amino acid residues and its gene has been assigned to chromosome 10.%A%    
% 214.26/214.41  |- mesh__dateRevised mesh__D016596 2004-07-13
% 214.26/214.41  |- skos__hiddenLabel mesh__D016596 alpha Vinculin
% 214.26/214.41  |- rdf__type mesh__D016596sskos__Concept
% 214.26/214.41  |- mesh__recordOriginator mesh__D016596 RLS
% 214.26/214.41  |- mesh__recordAuthorizer mesh__D016596 sjn
% 214.26/214.41  |- skos__prefLabel mesh__D016596 Vinculin
% 214.26/214.41  |- mesh__historyNote mesh__D016596 92; was VINCULIN %28%NM%29% 1980-91   
% 214.26/214.41  |- mesh__onlineNote mesh__D016596
% 214.26/214.41       use VINCULIN %28%NM%29% to search VINCULIN 1980-91   
% 214.26/214.41  |- mesh__publicMeSHNote mesh__D016596
% 214.26/214.41       92; VINCULIN was indexed under CYTOSKELETAL PROTEINS 1990-91 %26% under MUSCLE PROTEINS 1980-89%A%  
% 214.26/214.41  |- skos__historyNote mesh__D016596 Muscle Proteins %28%1980-1989%29%
% 214.26/214.41  |- skos__historyNote mesh__D016596 Cytoskeletal Proteins %28%1990-1991%29%
% 214.26/214.41  |- skos__annotation mesh__D016596
% 214.26/214.41       a cytoskeletal protein in cell-cell %26% cell-matrix interactions; /drug eff /ultrastruct permitted%A%  
% 214.26/214.41  |- mesh__recordMaintainer mesh__D016596 sjn
% 214.26/214.41  |- mesh__dateCreated mesh__D016596 1991-07-12
% 214.26/214.41  |- skos__hiddenLabel mesh__D016596 beta Vinculin
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D016596 2006
% 214.26/214.41  |- mesh__dateCreated mesh__D007261 1977-04-22
% 214.26/214.41  |- skos__hiddenLabel mesh__D007261 Intra-Arterial Infusions
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D007261 2006
% 214.26/214.41  |- mesh__dateRevised mesh__D007261 2005-06-30
% 214.26/214.41  |- skos__broader mesh__D007261smesh__D007263
% 214.26/214.41  |- skos__hiddenLabel mesh__D007261 Regional Arterial Infusion
% 214.26/214.41  |- skos__altLabel mesh__D007261 Infusions, Intraarterial
% 214.26/214.41  |- skos__hiddenLabel mesh__D007261 Arterial Infusion, Regional
% 214.26/214.41  |- skos__hiddenLabel mesh__D007261 Arterial Infusions, Regional
% 214.26/214.41  |- mesh__publicMeSHNote mesh__D007261 78   
% 214.26/214.41  |- skos__hiddenLabel mesh__D007261 Arterial Infusion, Intra
% 214.26/214.41  |- skos__hiddenLabel mesh__D007261 Intra Arterial Infusion
% 214.26/214.41  |- mesh__recordOriginator mesh__D007261 SMH
% 214.26/214.41  |- mesh__recordAuthorizer mesh__D007261 sjn
% 214.26/214.41  |- mesh__historyNote mesh__D007261 78   
% 214.26/214.41  |- skos__hiddenLabel mesh__D007261 Arterial Infusions, Intra
% 214.26/214.41  |- skos__historyNote mesh__D007261 Isolation Perfusion %28%1966-1977%29%
% 214.26/214.41  |- skos__hiddenLabel mesh__D007261 Infusion, Intra Arterial
% 214.26/214.41  |- rdf__type mesh__D007261sskos__Concept
% 214.26/214.41  |- mesh__dateEstablished mesh__D007261 1978-01-01
% 214.26/214.41  |- skos__prefLabel mesh__D007261 Infusions, Intra-Arterial
% 214.26/214.41  |- mesh__recordMaintainer mesh__D007261 nns
% 214.26/214.41  |- skos__hiddenLabel mesh__D007261 Infusion, Intraarterial
% 214.26/214.41  |- skos__hiddenLabel mesh__D007261 Regional Arterial Infusions
% 214.26/214.41  |- skos__altLabel mesh__D007261 Infusions, Intra Arterial
% 214.26/214.41  |- skos__scopeNote mesh__D007261
% 214.26/214.41       Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease.%A%    
% 214.26/214.41  |- skos__historyNote mesh__D007261
% 214.26/214.41       Injections, Intra-Arterial %28%1966-1977%29%
% 214.26/214.41  |- skos__hiddenLabel mesh__D007261 Infusion, Regional Arterial
% 214.26/214.41  |- skos__hiddenLabel mesh__D007261 Intraarterial Infusion
% 214.26/214.41  |- skos__historyNote mesh__D007261 Infusions, Parenteral %28%1966-1977%29%
% 214.26/214.41  |- skos__hiddenLabel mesh__D007261 Intraarterial Infusions
% 214.26/214.41  |- skos__hiddenLabel mesh__D007261 Intra-Arterial Infusion
% 214.26/214.41  |- skos__annotation mesh__D007261
% 214.26/214.41       do not confuse with CHEMOTHERAPY, CANCER, REGIONAL PERFUSION which is also used in cancer therapy or with INJECTIONS, INTRA-ARTERIAL%A%  
% 214.26/214.41  |- skos__hiddenLabel mesh__D007261 Intra Arterial Infusions
% 214.26/214.41  |- skos__hiddenLabel mesh__D007261 Infusion, Intra-Arterial
% 214.26/214.41  |- skos__hiddenLabel mesh__D006967 Hypersensitivities
% 214.26/214.41  |- skos__prefLabel mesh__D006967 Hypersensitivity
% 214.26/214.41  |- mesh__dateEstablished mesh__D006967 1966-01-01
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D006967 2002
% 214.26/214.41  |- skos__broader mesh__D006967smesh__D007154
% 214.26/214.41  |- rdf__type mesh__D006967sskos__Concept
% 214.26/214.41  |- mesh__dateRevised mesh__D006967 1999-11-03
% 214.26/214.41  |- skos__related mesh__D006967smesh__D018777
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D006967 2003
% 214.26/214.41  |- skos__related mesh__D006967smesh__D003888
% 214.26/214.41  |- mesh__historyNote mesh__D006967 66; was ALLERGY 1963-65   
% 214.26/214.41  |- mesh__dateCreated mesh__D006967 1999-01-01
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D006967 2000
% 214.26/214.41  |- skos__altLabel mesh__D006967 Allergy
% 214.26/214.41  |- skos__annotation mesh__D006967
% 214.26/214.41       IM; use qualif with caution; /drug ther: consider also ANTI-ALLERGIC AGENTS; atopic = HYPERSENSITIVITY, IMMEDIATE; to food = FOOD HYPERSENSITIVITY; to light = PHOTOSENSITIVITY DISORDERS; RESPIRATORY HYPERSENSITIVITY is also available; in occup or environ exposure MULTIPLE CHEMICAL SENSITIVITY is also available%A%  
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D006967 2005
% 214.26/214.41  |- skos__hiddenLabel mesh__D006967 Allergic Reactions
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D006967 2004
% 214.26/214.41  |- skos__hiddenLabel mesh__D006967 Reactions, Allergic
% 214.26/214.41  |- skos__hiddenLabel mesh__D006967 Reaction, Allergic
% 214.26/214.41  |- skos__hiddenLabel mesh__D006967 Allergies
% 214.26/214.41  |- mesh__recordAuthorizer mesh__D006967 sjn
% 214.26/214.41  |- mesh__recordOriginator mesh__D006967 NLM
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D006967 2001
% 214.26/214.41  |- skos__related mesh__D006967smesh__D018926
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D006967 2006
% 214.26/214.41  |- skos__scopeNote mesh__D006967
% 214.26/214.41       Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.%A%    
% 214.26/214.41  |- mesh__publicMeSHNote mesh__D006967 66; was ALLERGY 1963-65   
% 214.26/214.41  |- mesh__recordMaintainer mesh__D006967 kle
% 214.26/214.41  |- skos__annotation mesh__D020638
% 214.26/214.41       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 214.26/214.41  |- mesh__recordAuthorizer mesh__D020638 sjn
% 214.26/214.41  |- mesh__publicMeSHNote mesh__D020638 2000   
% 214.26/214.41  |- mesh__dateRevised mesh__D020638 2005-06-30
% 214.26/214.41  |- skos__prefLabel mesh__D020638 Rahnella
% 214.26/214.41  |- mesh__recordOriginator mesh__D020638 ndw
% 214.26/214.41  |- mesh__recordMaintainer mesh__D020638 SYSTEM
% 214.26/214.41  |- rdf__type mesh__D020638sskos__Concept
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D020638 2006
% 214.26/214.41  |- skos__scopeNote mesh__D020638
% 214.26/214.41       A genus of gram-negative, facultatively anaerobic, small, rod-shaped bacteria occurring in fresh water.%A%    
% 214.26/214.41  |- mesh__dateCreated mesh__D020638 1999-11-03
% 214.26/214.41  |- skos__broader mesh__D020638smesh__D006092
% 214.26/214.41  |- skos__broader mesh__D020638smesh__D004755
% 214.26/214.41  |- mesh__dateEstablished mesh__D020638 2000-01-01
% 214.26/214.41  |- mesh__historyNote mesh__D020638 2000   
% 214.26/214.41  |- skos__historyNote mesh__D020638 Enterobacteriaceae %28%1980-1999%29%
% 214.26/214.41  |- mesh__dateRevised mesh__D006169 1997-06-20
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D006169 2001
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D006169 1999
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D006169 2004
% 214.26/214.41  |- mesh__recordAuthorizer mesh__D006169 SJN
% 214.26/214.41  |- rdf__type mesh__D006169sskos__Concept
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D006169 2000
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D006169 1998
% 214.26/214.41  |- skos__annotation mesh__D006169
% 214.26/214.41       a republic in western Africa; do not confuse X ref PORTUGUESE GUINEA %28%its former name%29% with GUINEA %28%formerly French Guinea%29% or EQUATORIAL GUINEA %28%formerly Spanish Guinea%29%%A%  
% 214.26/214.41  |- skos__altLabel mesh__D006169 Guinea-Bissau, Republic of
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D006169 2003
% 214.26/214.41  |- mesh__dateCreated mesh__D006169 1999-01-01
% 214.26/214.41  |- skos__broader mesh__D006169smesh__D000354
% 214.26/214.41  |- skos__altLabel mesh__D006169 Guinea, Portuguese
% 214.26/214.41  |- skos__altLabel mesh__D006169 Portuguese Guinea
% 214.26/214.41  |- mesh__historyNote mesh__D006169 80   
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D006169 2006
% 214.26/214.41  |- skos__prefLabel mesh__D006169 Guinea-Bissau
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D006169 2002
% 214.26/214.41  |- mesh__recordOriginator mesh__D006169 NLM
% 214.26/214.41  |- mesh__recordMaintainer mesh__D006169 TGC
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D006169 2005
% 214.26/214.41  |- skos__scopeNote mesh__D006169
% 214.26/214.41       A republic in western Africa, south of SENEGAL and west of GUINEA. Its capital is Bissau. It was discovered by the Portuguese in 1446. In the 17th and 18th centuries it was active in slave trading. Its boundaries were established by convention with France in 1886 and 1902-05 and in 1974 it gained its independence. As a Portuguese overseas province, the country was called Portuguese Guinea; it was named Guinea-Bissau in 1974. The name Guinea is from the Tuareg word Aginaw, meaning black people. Bissau is from the native name of the people there, the Bijuga, whose meaning is uncertain. %28%From Webster%27%s New Geographical Dictionary, 1988, p975 %26% Room, Brewer%27%s Dictionary of Names, 1992, p222%29%%A%    
% 214.26/214.41  |- mesh__dateRevised mesh__D011303 2005-06-30
% 214.26/214.41  |- mesh__publicMeSHNote mesh__D011303
% 214.26/214.41       91; was see under OXIDOREDUCTASES 1975-90   
% 214.26/214.41  |- skos__hiddenLabel mesh__D011303
% 214.26/214.41       Mutase-Prephenate Dehydrogenase, Chorismate
% 214.26/214.41  |- skos__hiddenLabel mesh__D011303
% 214.26/214.41       Chorismate Mutase Prephenate Dehydrogenase
% 214.26/214.41  |- mesh__historyNote mesh__D011303
% 214.26/214.41       91%28%75%29%; was see under OXIDOREDUCTASES 1975-90   
% 214.26/214.41  |- mesh__recordAuthorizer mesh__D011303 sjn
% 214.26/214.41  |- skos__broader mesh__D011303smesh__D002826
% 214.26/214.41  |- skos__historyNote mesh__D011303 Oxidoreductases %28%1972-1974%29%
% 214.26/214.41  |- skos__hiddenLabel mesh__D011303 Dehydrogenase, Prephenate
% 214.26/214.41  |- skos__hiddenLabel mesh__D011303
% 214.26/214.41       Dehydrogenase, Chorismate Mutase-Prephenate
% 214.26/214.41  |- skos__scopeNote mesh__D011303
% 214.26/214.41       An enzyme that catalyzes the conversion of prephenate to p-hydroxyphenylpyruvate in the presence of NAD. In the enteric bacteria, this enzyme also possesses chorismate mutase activity, thereby catalyzing the first two steps in the biosynthesis of tyrosine. EC 1.3.1.12.%A%    
% 214.26/214.41  |- skos__historyNote mesh__D011303 Pyruvates %28%1972-1974%29%
% 214.26/214.41  |- skos__annotation mesh__D011303
% 214.26/214.41       do not confuse with PREPHENATE DEHYDRATASE   
% 214.26/214.41  |- skos__historyNote mesh__D011303 Cyclohexanes %28%1972-1974%29%
% 214.26/214.41  |- mesh__recordOriginator mesh__D011303 NLM
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D011303 2006
% 214.26/214.41  |- skos__broader mesh__D011303smesh__D044925
% 214.26/214.41  |- mesh__dateCreated mesh__D011303 1974-11-11
% 214.26/214.41  |- rdf__type mesh__D011303sskos__Concept
% 214.26/214.41  |- mesh__recordMaintainer mesh__D011303 jmp
% 214.26/214.41  |- mesh__dateEstablished mesh__D011303 1991-01-01
% 214.26/214.41  |- skos__prefLabel mesh__D011303 Prephenate Dehydrogenase
% 214.26/214.41  |- skos__broader mesh__D016597smesh__D011799
% 214.26/214.41  |- skos__historyNote mesh__D016597 Antineoplastic Agents %28%1966-1991%29%
% 214.26/214.41  |- skos__hiddenLabel mesh__D016597 Hydrate, Trimetrexate
% 214.26/214.41  |- skos__historyNote mesh__D016597 Folic Acid Antagonists %28%1966-1991%29%
% 214.26/214.41  |- mesh__onlineNote mesh__D016597
% 214.26/214.41       use TRIMETREXATE %28%NM%29% to search TRIMETREXATE 1980-91   
% 214.26/214.41  |- rdf__type mesh__D016597sskos__Concept
% 214.26/214.41  |- skos__hiddenLabel mesh__D016597 JB11
% 214.26/214.41  |- skos__hiddenLabel mesh__D016597 CI898
% 214.26/214.41  |- mesh__dateEstablished mesh__D016597 1992-01-01
% 214.26/214.41  |- mesh__dateCreated mesh__D016597 1991-01-25
% 214.26/214.41  |- skos__scopeNote mesh__D016597
% 214.26/214.41       A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against PNEUMOCYSTIS PNEUMONIA in AIDS patients. Myelosuppression is its dose-limiting toxic effect.%A%    
% 214.26/214.41  |- skos__hiddenLabel mesh__D016597 NSC 328564
% 214.26/214.41  |- mesh__historyNote mesh__D016597
% 214.26/214.41       92; was TRIMETREXATE %28%NM%29% 1979-91   
% 214.26/214.41  |- skos__hiddenLabel mesh__D016597 NSC249008
% 214.26/214.41  |- skos__prefLabel mesh__D016597 Trimetrexate
% 214.26/214.41  |- skos__hiddenLabel mesh__D016597 Monohydrate, Monoacetate Trimetrexate
% 214.26/214.41  |- skos__historyNote mesh__D016597 Quinazolines %28%1966-1991%29%
% 214.26/214.41  |- mesh__recordOriginator mesh__D016597 RLS
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D016597 2006
% 214.26/214.41  |- mesh__recordAuthorizer mesh__D016597 sjn
% 214.26/214.41  |- skos__hiddenLabel mesh__D016597 JB 11
% 214.26/214.41  |- skos__hiddenLabel mesh__D016597 CI 898
% 214.26/214.41  |- mesh__dateRevised mesh__D016597 2003-07-25
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D016597 2005
% 214.26/214.41  |- mesh__activeMeSHYear mesh__D016597 2004
% 214.26/214.41  |- skos__hiddenLabel mesh__D016597 NSC328564
% 214.26/214.41  |- mesh__publicMeSHNote mesh__D016597
% 214.26/214.41       92; TRIMETREXATE was indexed under QUINAZOLINES 1979-91   
% 214.26/214.41  |- mesh__recordMaintainer mesh__D016597 sjn
% 214.26/214.41  |- skos__hiddenLabel mesh__D016597 NSC 249008
% 214.26/214.41  |- skos__broader mesh__D020111Q000031smesh__D020111
% 214.26/214.41  |- mesh__preferredCombination mesh__D020111Q000031smesh__D001140
% 214.26/214.41  |- rdf__type mesh__D020111Q000031smesh__CompoundConcept
% 214.26/214.41  |- mesh__historyNote mesh__D002577 2006 %28%1966%29%   
% 214.26/214.41  |- skos__hiddenLabel mesh__D002577 Diseases, Cervix
% 214.26/214.41  |- skos__hiddenLabel mesh__D002577 Disease, Uterine Cervical
% 214.26/214.41  |- rdf__type mesh__D002577sskos__Concept
% 214.26/214.41  |- skos__scopeNote mesh__D002577
% 214.26/214.41       Pathological processes of the UTERINE CERVIX.     
% 214.26/214.41  |- skos__broader mesh__D002577smesh__D014591
% 214.26/214.41  |- skos__hiddenLabel mesh__D002577 Cervical Disease, Uterine
% 214.26/214.41  |- skos__hiddenLabel mesh__D002577 Cervical Diseases, Uterine
% 214.26/214.41  |- skos__prefLabel mesh__D002577 Uterine Cervical Diseases
% 214.26/214.41  |- mesh__dateCreated mesh__D002577 1999-01-01
% 214.26/214.41  |- skos__annotation mesh__D002577
% 214.26/214.41       inflammatory disease = UTERINE CERVICITIS   
% 214.26/214.41  |- mesh__recordMaintainer mesh__D002577 lkt
% 214.26/214.41  |- skos__altLabel mesh__D002577 Cervix Diseases
% 214.26/214.41  |- mesh__publicMeSHNote mesh__D002577
% 214.26/214.41       2006; see CERVIX DISEASES 1966-2005   
% 214.27/214.41  |- skos__hiddenLabel mesh__D002577 Diseases, Uterine Cervical
% 214.27/214.41  |- mesh__activeMeSHYear mesh__D002577 2006
% 214.27/214.41  |- skos__hiddenLabel mesh__D002577 Cervix Disease
% 214.27/214.41  |- mesh__recordOriginator mesh__D002577 NLM
% 214.27/214.41  |- skos__hiddenLabel mesh__D002577 Disease, Cervix
% 214.27/214.41  |- skos__hiddenLabel mesh__D002577 Uterine Cervical Disease
% 214.27/214.41  |- mesh__dateEstablished mesh__D002577 1966-01-01
% 214.27/214.41  |- mesh__recordAuthorizer mesh__D002577 sjn
% 214.27/214.41  |- mesh__dateRevised mesh__D002577 2005-06-30
% 214.27/214.41  |- mesh__historyNote mesh__D007262
% 214.27/214.41       87; was see INFUSIONS, PARENTERAL 1975-86   
% 214.27/214.41  |- skos__hiddenLabel mesh__D007262 Infusion, Drip
% 214.27/214.41  |- mesh__dateEstablished mesh__D007262 1987-01-01
% 214.27/214.41  |- mesh__recordOriginator mesh__D007262 SH
% 214.27/214.41  |- mesh__dateRevised mesh__D007262 1991-04-29
% 214.27/214.41  |- skos__altLabel mesh__D007262 Intravenous Infusions
% 214.27/214.41  |- mesh__activeMeSHYear mesh__D007262 1994
% 214.27/214.41  |- mesh__activeMeSHYear mesh__D007262 2004
% 214.27/214.41  |- skos__historyNote mesh__D007262 Infusions, Parenteral %28%1966-1986%29%
% 214.27/214.41  |- skos__annotation mesh__D007262
% 214.27/214.41       NIM; do not use /util except by MeSH definition; do not confuse with INJECTIONS, INTRAVENOUS%A%  
% 214.27/214.41  |- skos__hiddenLabel mesh__D007262 Infusion, Intravenous
% 214.27/214.41  |- skos__broader mesh__D007262smesh__D007263
% 214.27/214.41  |- skos__hiddenLabel mesh__D007262 Intravenous Infusion
% 214.27/214.41  |- mesh__activeMeSHYear mesh__D007262 2001
% 214.27/214.41  |- mesh__activeMeSHYear mesh__D007262 2003
% 214.27/214.41  |- mesh__activeMeSHYear mesh__D007262 1997
% 214.27/214.41  |- skos__hiddenLabel mesh__D007262 Drip, Intravenous
% 214.27/214.41  |- mesh__dateCreated mesh__D007262 1986-06-19
% 214.27/214.41  |- mesh__activeMeSHYear mesh__D007262 2000
% 214.27/214.41  |- mesh__activeMeSHYear mesh__D007262 1996
% 214.27/214.41  |- mesh__activeMeSHYear mesh__D007262 1993
% 214.27/214.41  |- mesh__publicMeSHNote mesh__D007262
% 214.27/214.41       87; was see INFUSIONS, PARENTERAL 1975-86   
% 214.27/214.41  |- mesh__recordMaintainer mesh__D007262 AGS
% 214.27/214.41  |- skos__altLabel mesh__D007262 Drip Infusions
% 214.27/214.41  |- skos__hiddenLabel mesh__D007262 Drip Infusion
% 214.27/214.41  |- mesh__activeMeSHYear mesh__D007262 2006
% 214.27/214.41  |- mesh__activeMeSHYear mesh__D007262 1992
% 214.27/214.41  |- mesh__recordAuthorizer mesh__D007262 PLS
% 214.27/214.41  |- skos__related mesh__D007262smesh__D016756
% 214.27/214.41  |- mesh__activeMeSHYear mesh__D007262 2005
% 214.27/214.41  |- mesh__activeMeSHYear mesh__D007262 1999
% 214.27/214.41  |- skos__hiddenLabel mesh__D007262 Infusions, Drip
% 214.27/214.41  |- mesh__onlineNote mesh__D007262 search INFUSIONS, PARENTERAL 1975-86   
% 214.27/214.41  |- rdf__type mesh__D007262sskos__Concept
% 214.27/214.41  |- mesh__activeMeSHYear mesh__D007262 2002
% 214.27/214.41  |- mesh__activeMeSHYear mesh__D007262 1995
% 214.27/214.41  |- skos__prefLabel mesh__D007262 Infusions, Intravenous
% 214.27/214.41  |- skos__scopeNote mesh__D007262
% 214.27/214.41       The long-term %28%minutes to hours%29% administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it.%A%    
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D007262 1998
% 214.27/214.42  |- skos__scopeNote mesh__D020639
% 214.27/214.42       A genus of gram-negative, obligate intracellular bacteria causing a proliferative enteritis in animals, especially pigs, deer, horses, and rabbits.%A%    
% 214.27/214.42  |- mesh__dateEstablished mesh__D020639 2000-01-01
% 214.27/214.42  |- mesh__dateCreated mesh__D020639 1999-11-05
% 214.27/214.42  |- mesh__publicMeSHNote mesh__D020639 2003; see LAWSONIA 2000-2003   
% 214.27/214.42  |- skos__broader mesh__D020639smesh__D006090
% 214.27/214.42  |- mesh__recordOriginator mesh__D020639 ndw
% 214.27/214.42  |- mesh__historyNote mesh__D020639 2003%28%2000%29%   
% 214.27/214.42  |- mesh__recordAuthorizer mesh__D020639 sjn
% 214.27/214.42  |- skos__historyNote mesh__D020639 Gram-Negative Bacteria %28%1996-1999%29%
% 214.27/214.42  |- skos__prefLabel mesh__D020639 Lawsonia Bacteria
% 214.27/214.42  |- mesh__dateRevised mesh__D020639 2005-06-30
% 214.27/214.42  |- skos__annotation mesh__D020639
% 214.27/214.42       infection: coord IM with DESULFOVIBRIONACEAE INFECTIONS %28%IM%29%%A%  
% 214.27/214.42  |- rdf__type mesh__D020639sskos__Concept
% 214.27/214.42  |- skos__broader mesh__D020639smesh__D020564
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D020639 2006
% 214.27/214.42  |- mesh__recordMaintainer mesh__D020639 SYSTEM
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D006968 2003
% 214.27/214.42  |- skos__altLabel mesh__D006968 Tuberculin-Type Hypersensitivity
% 214.27/214.42  |- skos__hiddenLabel mesh__D006968 Hypersensitivities, Delayed
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D006968 2002
% 214.27/214.42  |- skos__altLabel mesh__D006968 Hypersensitivity, Tuberculin-Type
% 214.27/214.42  |- skos__hiddenLabel mesh__D006968 Delayed Hypersensitivities
% 214.27/214.42  |- skos__hiddenLabel mesh__D006968 Type IV Hypersensitivities
% 214.27/214.42  |- mesh__recordMaintainer mesh__D006968 AGS
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D006968 1998
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D006968 2004
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D006968 1995
% 214.27/214.42  |- rdf__type mesh__D006968sskos__Concept
% 214.27/214.42  |- skos__hiddenLabel mesh__D006968 Tuberculin Type Hypersensitivity
% 214.27/214.42  |- skos__prefLabel mesh__D006968 Hypersensitivity, Delayed
% 214.27/214.42  |- skos__altLabel mesh__D006968 Hypersensitivity, Type IV
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D006968 1999
% 214.27/214.42  |- mesh__publicMeSHNote mesh__D006968 66   
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D006968 2000
% 214.27/214.42  |- skos__hiddenLabel mesh__D006968 Hypersensitivities, Tuberculin-Type
% 214.27/214.42  |- mesh__dateRevised mesh__D006968 1994-06-03
% 214.27/214.42  |- skos__scopeNote mesh__D006968
% 214.27/214.42       An increased reactivity to specific antigens mediated not by antibodies but by cells.%A%    
% 214.27/214.42  |- skos__altLabel mesh__D006968 Type IV Hypersensitivity
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D006968 1996
% 214.27/214.42  |- mesh__dateCreated mesh__D006968 1999-01-01
% 214.27/214.42  |- mesh__dateEstablished mesh__D006968 1966-01-01
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D006968 2005
% 214.27/214.42  |- skos__annotation mesh__D006968
% 214.27/214.42       IM; use qualif with caution; /chem ind: coord IM with DRUG HYPERSENSITIVITY or specifics %28%IM%29%%A%  
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D006968 2001
% 214.27/214.42  |- skos__related mesh__D006968smesh__D004673
% 214.27/214.42  |- mesh__recordOriginator mesh__D006968 NLM
% 214.27/214.42  |- skos__related mesh__D006968smesh__D002464
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D006968 1997
% 214.27/214.42  |- skos__hiddenLabel mesh__D006968 Hypersensitivities, Type IV
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D006968 2006
% 214.27/214.42  |- skos__hiddenLabel mesh__D006968 Delayed Hypersensitivity
% 214.27/214.42  |- mesh__historyNote mesh__D006968 66%28%65%29%   
% 214.27/214.42  |- skos__broader mesh__D006968smesh__D006967
% 214.27/214.42  |- skos__hiddenLabel mesh__D006968 Hypersensitivity, Tuberculin Type
% 214.27/214.42  |- skos__hiddenLabel mesh__D006968 Tuberculin-Type Hypersensitivities
% 214.27/214.42  |- mesh__recordAuthorizer mesh__D006968 PLS
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D017690 2004
% 214.27/214.42  |- mesh__historyNote mesh__D017690 94   
% 214.27/214.42  |- skos__hiddenLabel mesh__D017690 Transplantations, Cell
% 214.27/214.42  |- skos__prefLabel mesh__D017690 Cell Transplantation
% 214.27/214.42  |- mesh__dateRevised mesh__D017690 2002-07-03
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D017690 2003
% 214.27/214.42  |- skos__annotation mesh__D017690
% 214.27/214.42       GEN %26% unspecified only: prefer /transpl with specific cells except blood cells %28%index under BLOOD COMPONENT TRANSFUSION or specific indention%29% %28%Manual 19.7+, 19.8.75%29%; for transpl of cells of organs %28%lung cells%29%, coord IM with organ /cytol %28%IM%29% %28%LUNG /cytol%29%; available also are several types of technical transpl terms %28%e.g., TRANSPLANTATION, HETEROLOGOUS%29%; immunol of cell transpl = TRANSPLANTATION IMMUNOLOGY; DF: CELL TRANSPL%A%  
% 214.27/214.42  |- mesh__recordAuthorizer mesh__D017690 sjn
% 214.27/214.42  |- mesh__publicMeSHNote mesh__D017690 94   
% 214.27/214.42  |- skos__historyNote mesh__D017690 Cells/transplantation %28%1966-1993%29%
% 214.27/214.42  |- skos__altLabel mesh__D017690 Transplantation, Cell
% 214.27/214.42  |- skos__broader mesh__D017690smesh__D014180
% 214.27/214.42  |- rdf__type mesh__D017690sskos__Concept
% 214.27/214.42  |- mesh__recordOriginator mesh__D017690 TGC
% 214.27/214.42  |- mesh__dateCreated mesh__D017690 1992-12-28
% 214.27/214.42  |- mesh__recordMaintainer mesh__D017690 lkt
% 214.27/214.42  |- skos__scopeNote mesh__D017690
% 214.27/214.42       Transference of cells within an individual, between individuals of the same species, or between individuals of different species.%A%    
% 214.27/214.42  |- skos__hiddenLabel mesh__D017690 Cell Transplantations
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D017690 2006
% 214.27/214.42  |- skos__related mesh__D017690smesh__D014181
% 214.27/214.42  |- mesh__dateEstablished mesh__D017690 1994-01-01
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D017690 2005
% 214.27/214.42  |- skos__historyNote mesh__D017690
% 214.27/214.42       specific cell/transplantation %28%1966-1993%29%
% 214.27/214.42  |- skos__related mesh__D017690smesh__D016913
% 214.27/214.42  |- mesh__dateEstablished mesh__D031361 2003-01-01
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D031361 2006
% 214.27/214.42  |- skos__annotation mesh__D031361
% 214.27/214.42       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.27/214.42  |- mesh__historyNote mesh__D031361 2003   
% 214.27/214.42  |- skos__prefLabel mesh__D031361 Rabdosia
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D031361 2005
% 214.27/214.42  |- skos__scopeNote mesh__D031361
% 214.27/214.42       A plant genus of the family LAMIACEAE that contains macrocalin B.  R. japonica is an ingredient of PC-SPES, a treatment for prostate cancer.%A%    
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D031361 2004
% 214.27/214.42  |- skos__broader mesh__D031361smesh__D019686
% 214.27/214.42  |- mesh__dateCreated mesh__D031361 2002-07-03
% 214.27/214.42  |- rdf__type mesh__D031361sskos__Concept
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D031361 2003
% 214.27/214.42  |- mesh__publicMeSHNote mesh__D031361 2003   
% 214.27/214.42  |- mesh__dateRevised mesh__D003670 2003-07-09
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D003670 2005
% 214.27/214.42  |- skos__broader mesh__D003670smesh__D012418
% 214.27/214.42  |- mesh__publicMeSHNote mesh__D003670 68   
% 214.27/214.42  |- mesh__dateEstablished mesh__D003670 1968-01-01
% 214.27/214.42  |- rdf__type mesh__D003670sskos__Concept
% 214.27/214.42  |- skos__annotation mesh__D003670
% 214.27/214.42       includes elk, wapiti, moose, caribou, REINDEER %26% MUNTJACS; IM; qualif permitted%A%  
% 214.27/214.42  |- skos__prefLabel mesh__D003670 Deer
% 214.27/214.42  |- mesh__dateCreated mesh__D003670 1999-01-01
% 214.27/214.42  |- skos__historyNote mesh__D003670 Artiodactyla %28%1966-1967%29%
% 214.27/214.42  |- skos__scopeNote mesh__D003670
% 214.27/214.42       The family Cervidae of 17 genera and 45 species occurring nearly throughout North America, South America, and Eurasia, on most associated continental islands, and in northern Africa. Wild populations of deer have been established through introduction by people in Cuba, New Guinea, Australia, New Zealand, and other places where the family does not naturally occur. They are slim, long-legged and best characterized by the presence of antlers. Their habitat is forests, swamps, brush country, deserts, and arctic tundra. They are usually good swimmers; some migrate seasonally. %28%Walker%27%s Mammals of the World, 5th ed, p1362%29%%A%    
% 214.27/214.42  |- mesh__recordAuthorizer mesh__D003670 sjn
% 214.27/214.42  |- mesh__historyNote mesh__D003670 68   
% 214.27/214.42  |- skos__hiddenLabel mesh__D003670 Deers
% 214.27/214.42  |- mesh__recordMaintainer mesh__D003670 ags
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D003670 2004
% 214.27/214.42  |- mesh__recordOriginator mesh__D003670 NLM
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D003670 2006
% 214.27/214.42  |- skos__broader mesh__D011304smesh__D006319
% 214.27/214.42  |- skos__prefLabel mesh__D011304 Presbycusis
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D011304 2005
% 214.27/214.42  |- skos__historyNote mesh__D011304 Deafness %28%1966-1971%29%
% 214.27/214.42  |- skos__scopeNote mesh__D011304
% 214.27/214.42       Gradual bilateral hearing loss associated with aging that is due to progressive degeneration of cochlear structures and central auditory pathways. Hearing loss usually begins with the high frequencies then progresses to sounds of middle and low frequencies.%A%    
% 214.27/214.42  |- mesh__dateCreated mesh__D011304 1999-01-01
% 214.27/214.42  |- mesh__recordAuthorizer mesh__D011304 sjn
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D011304 2006
% 214.27/214.42  |- mesh__historyNote mesh__D011304
% 214.27/214.42       91%28%72%29%; was see under HEARING LOSS, SENSORINEURAL 1979-90; was see under DEAFNESS 1975-78%A%  
% 214.27/214.42  |- mesh__dateRevised mesh__D011304 2004-07-07
% 214.27/214.42  |- rdf__type mesh__D011304sskos__Concept
% 214.27/214.42  |- mesh__dateEstablished mesh__D011304 1991-01-01
% 214.27/214.42  |- mesh__publicMeSHNote mesh__D011304
% 214.27/214.42       91; was see under HEARING LOSS, SENSORINEURAL 1979-90; was see under DEAFNESS 1975-78%A%  
% 214.27/214.42  |- mesh__recordMaintainer mesh__D011304 lkt
% 214.27/214.42  |- mesh__recordOriginator mesh__D011304 NLM
% 214.27/214.42  |- skos__hiddenLabel mesh__D011304 Presbycuses
% 214.27/214.42  |- skos__prefLabel mesh__D002578 Uterine Cervical Dysplasia
% 214.27/214.42  |- mesh__dateRevised mesh__D002578 2005-06-30
% 214.27/214.42  |- rdf__type mesh__D002578sskos__Concept
% 214.27/214.42  |- mesh__dateEstablished mesh__D002578 1984-01-01
% 214.27/214.42  |- skos__broader mesh__D002578smesh__D011230
% 214.27/214.42  |- mesh__historyNote mesh__D002578
% 214.27/214.42       2006%28%1984%29%; use CERVIX NEOPLASMS 1977-1983   
% 214.27/214.42  |- skos__hiddenLabel mesh__D002578 Cervical Dysplasia, Uterine
% 214.27/214.42  |- skos__related mesh__D002578smesh__D018290
% 214.27/214.42  |- mesh__recordMaintainer mesh__D002578 lkt
% 214.27/214.42  |- mesh__dateCreated mesh__D002578 1977-12-06
% 214.27/214.42  |- skos__broader mesh__D002578smesh__D002577
% 214.27/214.42  |- skos__related mesh__D002578smesh__D002583
% 214.27/214.42  |- skos__altLabel mesh__D002578 Cervix Dysplasia
% 214.27/214.42  |- mesh__recordOriginator mesh__D002578 SMH
% 214.27/214.42  |- skos__historyNote mesh__D002578 Cervix Neoplasms %28%1966-1976%29%
% 214.27/214.42  |- skos__historyNote mesh__D002578 Cervix Diseases %28%1966-1976%29%
% 214.27/214.42  |- mesh__recordAuthorizer mesh__D002578 sjn
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D002578 2006
% 214.27/214.42  |- mesh__publicMeSHNote mesh__D002578
% 214.27/214.42       2006; see CERVIX DYSPLASIA 1984-2005, see CERVIX NEOPLASMS 1977-1983%A%  
% 214.27/214.42  |- skos__hiddenLabel mesh__D002578 Dysplasia, Cervix
% 214.27/214.42  |- skos__scopeNote mesh__D002578
% 214.27/214.42       Abnormal development of immature squamous EPITHELIAL CELLS of the UTERINE CERVIX, a term used to describe premalignant cytological changes in the cervical EPITHELIUM. These atypical cells do not penetrate the epithelial BASEMENT MEMBRANE.%A%    
% 214.27/214.42  |- skos__hiddenLabel mesh__D002578 Dysplasia, Uterine Cervical
% 214.27/214.42  |- skos__scopeNote mesh__D007263
% 214.27/214.42       The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping.%A%    
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D007263 2002
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D007263 1997
% 214.27/214.42  |- skos__hiddenLabel mesh__D007263 Peritoneal Infusion
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D007263 2003
% 214.27/214.42  |- mesh__dateRevised mesh__D007263 1996-06-10
% 214.27/214.42  |- mesh__recordMaintainer mesh__D007263 TGC
% 214.27/214.42  |- skos__hiddenLabel mesh__D007263 Intra-Abdominal Infusion
% 214.27/214.42  |- skos__hiddenLabel mesh__D007263 Intra Abdominal Infusions
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D007263 2006
% 214.27/214.42  |- mesh__dateCreated mesh__D007263 1999-01-01
% 214.27/214.42  |- skos__hiddenLabel mesh__D007263 Infusions, Intra-Abdominal
% 214.27/214.42  |- skos__annotation mesh__D007263
% 214.27/214.42       restrict to method of admin of drugs %26% chemicals; not for replacement of fluids %28% = FLUID THERAPY%29% nor for nourishment %28% = PARENTERAL FEEDING%29%; GEN or unspecified; prefer specifics; do not use /util except by MeSH definition%A%  
% 214.27/214.42  |- skos__hiddenLabel mesh__D007263 Infusions, Peritoneal
% 214.27/214.42  |- skos__hiddenLabel mesh__D007263 Infusion, Parenteral
% 214.27/214.42  |- skos__altLabel mesh__D007263 Parenteral Infusions
% 214.27/214.42  |- skos__hiddenLabel mesh__D007263 Infusion, Intra-Abdominal
% 214.27/214.42  |- skos__hiddenLabel mesh__D007263 Infusion, Peritoneal
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D007263 2001
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D007263 1999
% 214.27/214.42  |- skos__broader mesh__D007263smesh__D004333
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D007263 2005
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D007263 2000
% 214.27/214.42  |- rdf__type mesh__D007263sskos__Concept
% 214.27/214.42  |- skos__related mesh__D007263smesh__D005440
% 214.27/214.42  |- skos__hiddenLabel mesh__D007263 Intraperitoneal Infusion
% 214.27/214.42  |- skos__altLabel mesh__D007263 Peritoneal Infusions
% 214.27/214.42  |- skos__hiddenLabel mesh__D007263 Infusions, Intraperitoneal
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D007263 1998
% 214.27/214.42  |- mesh__recordOriginator mesh__D007263 SMH
% 214.27/214.42  |- skos__hiddenLabel mesh__D007263 Infusion, Intraperitoneal
% 214.27/214.42  |- skos__altLabel mesh__D007263 Intraperitoneal Infusions
% 214.27/214.42  |- skos__related mesh__D007263smesh__D018718
% 214.27/214.42  |- skos__hiddenLabel mesh__D007263 Parenteral Infusion
% 214.27/214.42  |- skos__prefLabel mesh__D007263 Infusions, Parenteral
% 214.27/214.42  |- mesh__recordAuthorizer mesh__D007263 PLS
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D007263 2004
% 214.27/214.42  |- mesh__recordAuthorizer mesh__D045382 sjn
% 214.27/214.42  |- mesh__historyNote mesh__D045382 2004   
% 214.27/214.42  |- rdf__type mesh__D045382sskos__Concept
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D045382 2006
% 214.27/214.42  |- skos__broader mesh__D045382smesh__D011010
% 214.27/214.42  |- mesh__publicMeSHNote mesh__D045382 2004   
% 214.27/214.42  |- mesh__dateCreated mesh__D045382 2003-07-09
% 214.27/214.42  |- mesh__recordMaintainer mesh__D045382 SYSTEM
% 214.27/214.42  |- skos__prefLabel mesh__D045382 Pneumocystis jiroveci
% 214.27/214.42  |- skos__annotation mesh__D045382
% 214.27/214.42       formerly called Pneumocystis carinii f. sp. Hominis; Pneumocystis carinii in humans goes here; infection: coord IM with probably PNEUMONIA, PNEUMOCYSTIS %28%IM%29% but if not of lungs, coord with PNEUMOCYSTIS INFECTIONS %28%IM%29% + precoord organ/dis term %28%IM%29%; coord with pre-coord fungal terms %28%ANTIGENS, FUNGAL, etc%29% if pertinent%A%  
% 214.27/214.42  |- mesh__dateEstablished mesh__D045382 2004-01-01
% 214.27/214.42  |- mesh__recordOriginator mesh__D045382 ags
% 214.27/214.42  |- mesh__dateRevised mesh__D045382 2005-06-30
% 214.27/214.42  |- skos__scopeNote mesh__D045382
% 214.27/214.42       A species of PNEUMOCYSTIS infecting humans and causing PNEUMOCYSTIS PNEUMONIA. It also occasionally causes extrapulmonary disease in immunocompromised patients. Its former name was Pneumocystis carinii f. sp. hominis.%A%    
% 214.27/214.42  |- skos__broader mesh__D005385Q000293smesh__D005385
% 214.27/214.42  |- mesh__preferredCombination mesh__D005385Q000293smesh__D005383
% 214.27/214.42  |- rdf__type mesh__D005385Q000293smesh__CompoundConcept
% 214.27/214.42  |- skos__hiddenLabel mesh__D006969 Hypersensitivities, Type I
% 214.27/214.42  |- skos__hiddenLabel mesh__D006969 Hypersensitivities, IgE-Mediated
% 214.27/214.42  |- skos__hiddenLabel mesh__D006969 Atopic Hypersensitivities
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D006969 2002
% 214.27/214.42  |- mesh__recordMaintainer mesh__D006969 NLM
% 214.27/214.42  |- skos__annotation mesh__D006969
% 214.27/214.42       /chem ind: coord with DRUG HYPERSENSITIVITY or specifics   
% 214.27/214.42  |- mesh__recordOriginator mesh__D006969 NLM
% 214.27/214.42  |- mesh__recordAuthorizer mesh__D006969 NLM
% 214.27/214.42  |- mesh__dateEstablished mesh__D006969 1966-01-01
% 214.27/214.42  |- skos__prefLabel mesh__D006969 Hypersensitivity, Immediate
% 214.27/214.42  |- rdf__type mesh__D006969sskos__Concept
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D006969 2004
% 214.27/214.42  |- skos__altLabel mesh__D006969 Hypersensitivity, Atopic
% 214.27/214.42  |- skos__hiddenLabel mesh__D006969 IgE Mediated Hypersensitivity
% 214.27/214.42  |- skos__hiddenLabel mesh__D006969 Hypersensitivities, Immediate
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D006969 2003
% 214.27/214.42  |- skos__altLabel mesh__D006969 IgE-Mediated Hypersensitivity
% 214.27/214.42  |- skos__related mesh__D006969smesh__D020315
% 214.27/214.42  |- mesh__dateCreated mesh__D006969 1999-01-01
% 214.27/214.42  |- skos__hiddenLabel mesh__D006969 Hypersensitivities, Atopic
% 214.27/214.42  |- skos__scopeNote mesh__D006969
% 214.27/214.42       Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability.%A%    
% 214.27/214.42  |- skos__hiddenLabel mesh__D006969 Type I Hypersensitivities
% 214.27/214.42  |- skos__altLabel mesh__D006969 Type I Hypersensitivity
% 214.27/214.42  |- mesh__dateRevised mesh__D006969 2001-08-14
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D006969 2006
% 214.27/214.42  |- mesh__historyNote mesh__D006969 66%28%65%29%   
% 214.27/214.42  |- skos__broader mesh__D006969smesh__D006967
% 214.27/214.42  |- skos__hiddenLabel mesh__D006969 IgE-Mediated Hypersensitivities
% 214.27/214.42  |- skos__hiddenLabel mesh__D006969 Immediate Hypersensitivities
% 214.27/214.42  |- skos__hiddenLabel mesh__D006969 Hypersensitivity, IgE-Mediated
% 214.27/214.42  |- mesh__publicMeSHNote mesh__D006969 66   
% 214.27/214.42  |- skos__altLabel mesh__D006969 Atopic Hypersensitivity
% 214.27/214.42  |- skos__altLabel mesh__D006969 Hypersensitivity, Type I
% 214.27/214.42  |- skos__hiddenLabel mesh__D006969 Immediate Hypersensitivity
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D006969 2005
% 214.27/214.42  |- mesh__historyNote mesh__D017691 94   
% 214.27/214.42  |- mesh__dateEstablished mesh__D017691 1994-01-01
% 214.27/214.42  |- mesh__recordAuthorizer mesh__D017691 PLS
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D017691 1997
% 214.27/214.42  |- skos__prefLabel mesh__D017691 Caribbean Region
% 214.27/214.42  |- mesh__dateRevised mesh__D017691 1995-06-08
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D017691 2002
% 214.27/214.42  |- skos__historyNote mesh__D017691 West Indies %28%1966-1993%29%
% 214.27/214.42  |- skos__altLabel mesh__D017691 Caribbean
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D017691 2000
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D017691 2005
% 214.27/214.42  |- mesh__dateCreated mesh__D017691 1993-05-26
% 214.27/214.42  |- rdf__type mesh__D017691sskos__Concept
% 214.27/214.42  |- skos__broader mesh__D017691smesh__D000569
% 214.27/214.42  |- skos__altLabel mesh__D017691 West Indies Region
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D017691 1998
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D017691 2006
% 214.27/214.42  |- skos__scopeNote mesh__D017691
% 214.27/214.42       The area that lies between continental North and South America and comprises the Caribbean Sea, the West Indies, and the adjacent mainland regions of southern Mexico, Central America, Colombia, and Venezuela.%A%    
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D017691 2001
% 214.27/214.42  |- mesh__recordMaintainer mesh__D017691 RAZ
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D017691 1999
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D017691 2003
% 214.27/214.42  |- skos__annotation mesh__D017691
% 214.27/214.42       GEN or unspecified for Caribbean Sea, region, islands or population; do not confuse X ref WEST INDIES REGION with WEST INDIES or any of its specific islands; DF: CARIBBEAN%A%  
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D017691 1996
% 214.27/214.42  |- skos__altLabel mesh__D017691 Caribbean Sea Region
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D017691 2004
% 214.27/214.42  |- mesh__recordOriginator mesh__D017691 TGC
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D031362 2005
% 214.27/214.42  |- mesh__dateCreated mesh__D031362 2002-07-03
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D031362 2006
% 214.27/214.42  |- skos__annotation mesh__D031362
% 214.27/214.42       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.27/214.42  |- mesh__dateEstablished mesh__D031362 2003-01-01
% 214.27/214.42  |- skos__broader mesh__D031362smesh__D019686
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D031362 2003
% 214.27/214.42  |- skos__scopeNote mesh__D031362
% 214.27/214.42       A plant genus of the family LAMIACEAE used to flavor food.%A%    
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D031362 2004
% 214.27/214.42  |- mesh__historyNote mesh__D031362 2003   
% 214.27/214.42  |- skos__altLabel mesh__D031362 Savory Plant
% 214.27/214.42  |- rdf__type mesh__D031362sskos__Concept
% 214.27/214.42  |- skos__prefLabel mesh__D031362 Satureja
% 214.27/214.42  |- mesh__publicMeSHNote mesh__D031362 2003   
% 214.27/214.42  |- skos__hiddenLabel mesh__D003671 R 209
% 214.27/214.42  |- skos__prefLabel mesh__D003671 DEET
% 214.27/214.42  |- skos__altLabel mesh__D003671 DET
% 214.27/214.42  |- rdf__type mesh__D003671sskos__Concept
% 214.27/214.42  |- skos__hiddenLabel mesh__D003671 R209
% 214.27/214.42  |- skos__altLabel mesh__D003671 N,N-Diethyltoluamide
% 214.27/214.42  |- mesh__historyNote mesh__D003671
% 214.27/214.42       91%28%72%29%; was see under BENZAMIDES 1972-90   
% 214.27/214.42  |- skos__hiddenLabel mesh__D003671 N,N Diethyl 3 methylbenzamide
% 214.27/214.42  |- mesh__dateEstablished mesh__D003671 1991-01-01
% 214.27/214.42  |- mesh__dateCreated mesh__D003671 1999-01-01
% 214.27/214.42  |- skos__historyNote mesh__D003671 Benzoates %28%1966-1971%29%
% 214.27/214.42  |- skos__broader mesh__D003671smesh__D001549
% 214.27/214.42  |- skos__hiddenLabel mesh__D003671 N,N Diethyltoluamide
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D003671 2004
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D003671 2002
% 214.27/214.42  |- mesh__publicMeSHNote mesh__D003671
% 214.27/214.42       91; was see under BENZAMIDES 1972-90   
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D003671 2006
% 214.27/214.42  |- skos__hiddenLabel mesh__D003671 N,N Diethyl m toluamide
% 214.27/214.42  |- skos__historyNote mesh__D003671 Insect Repellents %28%1966-1971%29%
% 214.27/214.42  |- skos__altLabel mesh__D003671 N,N-Diethyl-3-methylbenzamide
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D003671 2003
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D003671 2001
% 214.27/214.42  |- mesh__recordMaintainer mesh__D003671 CCR
% 214.27/214.42  |- skos__scopeNote mesh__D003671
% 214.27/214.42       A compound used as a topical insect repellent that may cause irritation to eyes and mucous membranes, but not to the skin.%A%    
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D003671 2005
% 214.27/214.42  |- mesh__dateRevised mesh__D003671 2000-06-22
% 214.27/214.42  |- skos__altLabel mesh__D003671 DETA
% 214.27/214.42  |- mesh__recordAuthorizer mesh__D003671 sjn
% 214.27/214.42  |- skos__altLabel mesh__D003671 N,N-Diethyl-m-toluamide
% 214.27/214.42  |- mesh__recordOriginator mesh__D003671 NLM
% 214.27/214.42  |- skos__scopeNote mesh__D011305
% 214.27/214.42       The normal decreasing elasticity of the crystalline lens that leads to loss of accommodation.%A%    
% 214.27/214.42  |- skos__hiddenLabel mesh__D011305 Presbyopias
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D011305 2002
% 214.27/214.42  |- mesh__recordOriginator mesh__D011305 NLM
% 214.27/214.42  |- mesh__dateRevised mesh__D011305 1999-11-03
% 214.27/214.42  |- skos__prefLabel mesh__D011305 Presbyopia
% 214.27/214.42  |- mesh__recordMaintainer mesh__D011305 KEV
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D011305 2001
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D011305 2006
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D011305 2000
% 214.27/214.42  |- mesh__dateCreated mesh__D011305 1999-01-01
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D011305 2004
% 214.27/214.42  |- skos__broader mesh__D011305smesh__D012030
% 214.27/214.42  |- mesh__recordAuthorizer mesh__D011305 sjn
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D011305 2005
% 214.27/214.42  |- rdf__type mesh__D011305sskos__Concept
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D011305 2003
% 214.27/214.42  |- skos__hiddenLabel mesh__D002579 Cervical Erosion, Uterine
% 214.27/214.42  |- mesh__dateCreated mesh__D002579 1999-01-01
% 214.27/214.42  |- skos__hiddenLabel mesh__D002579 Erosion, Uterine Cervix
% 214.27/214.42  |- mesh__dateRevised mesh__D002579 2005-06-30
% 214.27/214.42  |- skos__prefLabel mesh__D002579 Uterine Cervical Erosion
% 214.27/214.42  |- skos__broader mesh__D002579smesh__D002577
% 214.27/214.42  |- skos__hiddenLabel mesh__D002579 Erosion, Uterine Cervical
% 214.27/214.42  |- skos__altLabel mesh__D002579 Uterine Cervix Erosion
% 214.27/214.42  |- skos__scopeNote mesh__D002579
% 214.27/214.42       Loss or destruction of the epithelial lining of the UTERINE CERVIX.%A%    
% 214.27/214.42  |- mesh__historyNote mesh__D002579 2006 %28%1963%29%   
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D002579 2006
% 214.27/214.42  |- mesh__publicMeSHNote mesh__D002579 2006; see CERVIX EROSION 1963-2005   
% 214.27/214.42  |- skos__hiddenLabel mesh__D002579 Erosion, Cervix
% 214.27/214.42  |- skos__altLabel mesh__D002579 Cervix Erosion
% 214.27/214.42  |- skos__hiddenLabel mesh__D002579 Cervix Erosion, Uterine
% 214.27/214.42  |- mesh__recordMaintainer mesh__D002579 lkt
% 214.27/214.42  |- mesh__recordOriginator mesh__D002579 SMH
% 214.27/214.42  |- mesh__recordAuthorizer mesh__D002579 sjn
% 214.27/214.42  |- rdf__type mesh__D002579sskos__Concept
% 214.27/214.42  |- mesh__dateCreated mesh__D007264 1999-01-01
% 214.27/214.42  |- skos__prefLabel mesh__D007264 Inguinal Canal
% 214.27/214.42  |- skos__hiddenLabel mesh__D007264 Canal, Inguinal
% 214.27/214.42  |- mesh__recordAuthorizer mesh__D007264 sjn
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D007264 2005
% 214.27/214.42  |- skos__hiddenLabel mesh__D007264 Inguinal Canals
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D007264 2006
% 214.27/214.42  |- mesh__dateRevised mesh__D007264 2004-07-07
% 214.27/214.42  |- mesh__recordMaintainer mesh__D007264 lkt
% 214.27/214.42  |- skos__scopeNote mesh__D007264
% 214.27/214.42       The tunnel in the lower anterior ABDOMINAL WALL through which the SPERMATIC CORD, in the male; ROUND LIGAMENT, in the female; nerves; and vessels pass. Its internal end is at the deep inguinal ring and its external end is at the superficial inguinal ring.%A%    
% 214.27/214.42  |- skos__broader mesh__D007264smesh__D000005
% 214.27/214.42  |- rdf__type mesh__D007264sskos__Concept
% 214.27/214.42  |- skos__hiddenLabel mesh__D007264 Inguinal Rings
% 214.27/214.42  |- skos__annotation mesh__D007264
% 214.27/214.42       internal canal only: do not confuse with GROIN, external only%A%  
% 214.27/214.42  |- skos__hiddenLabel mesh__D007264 Canals, Inguinal
% 214.27/214.42  |- mesh__recordOriginator mesh__D007264 NLM
% 214.27/214.42  |- skos__hiddenLabel mesh__D007264 Rings, Inguinal
% 214.27/214.42  |- skos__hiddenLabel mesh__D007264 Ring, Inguinal
% 214.27/214.42  |- skos__prefLabel mesh__D031363 Scutellaria
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D031363 2006
% 214.27/214.42  |- skos__annotation mesh__D031363
% 214.27/214.42       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.27/214.42  |- skos__broader mesh__D031363smesh__D019686
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D031363 2003
% 214.27/214.42  |- skos__scopeNote mesh__D031363
% 214.27/214.42       A plant genus of the family LAMIACEAE used in folk medicine as a nervine.%A%    
% 214.27/214.42  |- mesh__dateCreated mesh__D031363 2002-07-03
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D031363 2004
% 214.27/214.42  |- mesh__dateEstablished mesh__D031363 2003-01-01
% 214.27/214.42  |- rdf__type mesh__D031363sskos__Concept
% 214.27/214.42  |- mesh__publicMeSHNote mesh__D031363 2003   
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D031363 2005
% 214.27/214.42  |- mesh__historyNote mesh__D031363 2003   
% 214.27/214.42  |- mesh__dateCreated mesh__D003672 1999-01-01
% 214.27/214.42  |- skos__scopeNote mesh__D003672
% 214.27/214.42       The normal process of elimination of fecal material from the RECTUM.%A%    
% 214.27/214.42  |- rdf__type mesh__D003672sskos__Concept
% 214.27/214.42  |- skos__related mesh__D003672smesh__D005242
% 214.27/214.42  |- mesh__activeMeSHYear mesh__D003672 2001
% 214.27/214.42  |- skos__prefLabel mesh__D003672 Defecation
% 214.27/214.42  |- mesh__dateRevised mesh__D003672 2000-06-22
% 214.27/214.42  |- mesh__recordAuthorizer mesh__D003672 sjn
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003672 2003
% 214.27/214.43  |- mesh__recordOriginator mesh__D003672 NLM
% 214.27/214.43  |- skos__broader mesh__D003672smesh__D004068
% 214.27/214.43  |- skos__related mesh__D003672smesh__D003967
% 214.27/214.43  |- skos__related mesh__D003672smesh__D003248
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003672 2005
% 214.27/214.43  |- mesh__recordMaintainer mesh__D003672 adp
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003672 2004
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003672 2002
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003672 2006
% 214.27/214.43  |- skos__related mesh__D003672smesh__D019841
% 214.27/214.43  |- skos__hiddenLabel mesh__D003672 Defecations
% 214.27/214.43  |- skos__related mesh__D003672smesh__D004688
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011306 1999
% 214.27/214.43  |- skos__broader mesh__D011306smesh__D005249
% 214.27/214.43  |- mesh__onlineNote mesh__D011306 search FEES, PHARMACEUTICAL 1968-74   
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011306 1997
% 214.27/214.43  |- skos__hiddenLabel mesh__D011306 Prescription Fee
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011306 1998
% 214.27/214.43  |- skos__altLabel mesh__D011306 Fees, Prescription
% 214.27/214.43  |- mesh__recordMaintainer mesh__D011306 PLS
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011306 2002
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011306 1996
% 214.27/214.43  |- skos__hiddenLabel mesh__D011306 Dispensing Fee
% 214.27/214.43  |- skos__broader mesh__D011306smesh__D005252
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011306 2006
% 214.27/214.43  |- mesh__recordOriginator mesh__D011306 NLM
% 214.27/214.43  |- mesh__historyNote mesh__D011306
% 214.27/214.43       91%28%75%29%; was see under FEES, PHARMACEUTICAL 1975-90   
% 214.27/214.43  |- mesh__recordAuthorizer mesh__D011306 NLM
% 214.27/214.43  |- skos__hiddenLabel mesh__D011306 Fees, Dispensing
% 214.27/214.43  |- mesh__dateCreated mesh__D011306 1999-01-01
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011306 2004
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011306 2005
% 214.27/214.43  |- rdf__type mesh__D011306sskos__Concept
% 214.27/214.43  |- skos__hiddenLabel mesh__D011306 Fee, Prescription
% 214.27/214.43  |- skos__altLabel mesh__D011306 Dispensing Fees
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011306 2001
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011306 2003
% 214.27/214.43  |- skos__scopeNote mesh__D011306
% 214.27/214.43       The charge levied on the consumer for drugs or therapy prescribed under written order of a physician or other health professional.%A%    
% 214.27/214.43  |- skos__prefLabel mesh__D011306 Prescription Fees
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011306 2000
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011306 1995
% 214.27/214.43  |- mesh__dateRevised mesh__D011306 1993-09-16
% 214.27/214.43  |- mesh__dateEstablished mesh__D011306 1991-01-01
% 214.27/214.43  |- skos__hiddenLabel mesh__D011306 Fee, Dispensing
% 214.27/214.43  |- skos__annotation mesh__D011306
% 214.27/214.43       for drug %26% non-drug prescriptions; costs to the patient or 3d-party payer: do not confuse with DRUG COSTS, which are costs to a health care facility or organiz%A%  
% 214.27/214.43  |- mesh__publicMeSHNote mesh__D011306
% 214.27/214.43       91; was see under FEES, PHARMACEUTICAL 1975-90   
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D007265 2005
% 214.27/214.43  |- skos__hiddenLabel mesh__D007265 Inhibin, Female
% 214.27/214.43  |- skos__historyNote mesh__D007265 Testicular Hormones %28%1975-1982%29%
% 214.27/214.43  |- skos__broader mesh__D007265smesh__D042341
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D007265 2006
% 214.27/214.43  |- skos__altLabel mesh__D007265 Inhibin-F
% 214.27/214.43  |- skos__hiddenLabel mesh__D007265 Inhibin F
% 214.27/214.43  |- skos__hiddenLabel mesh__D007265 Female Inhibins
% 214.27/214.43  |- skos__prefLabel mesh__D007265 Inhibins
% 214.27/214.43  |- skos__broader mesh__D007265smesh__D006023
% 214.27/214.43  |- skos__scopeNote mesh__D007265
% 214.27/214.43       Glycoproteins that inhibit pituitary FOLLICLE STIMULATING HORMONE secretion. Inhibins are secreted by the Sertoli cells of the testes, the granulosa cells of the ovarian follicles, the placenta, and other tissues. Inhibins and ACTIVINS are modulators of FOLLICLE STIMULATING HORMONE secretions; both groups belong to the TGF-beta superfamily, as the TRANSFORMING GROWTH FACTOR BETA. Inhibins consist of a disulfide-linked heterodimer with a unique alpha linked to either a beta A or a beta B subunit to form inhibin A or inhibin B, respectively%A%    
% 214.27/214.43  |- mesh__publicMeSHNote mesh__D007265 2002; see INHIBIN 1983-2001   
% 214.27/214.43  |- skos__hiddenLabel mesh__D007265 Inhibin, Ovarian
% 214.27/214.43  |- skos__altLabel mesh__D007265 Testicular Inhibin
% 214.27/214.43  |- skos__annotation mesh__D007265 /biosyn /physiol permitted   
% 214.27/214.43  |- mesh__recordAuthorizer mesh__D007265 sjn
% 214.27/214.43  |- mesh__dateRevised mesh__D007265 2003-07-09
% 214.27/214.43  |- mesh__historyNote mesh__D007265 2002; %28%1983%29%   
% 214.27/214.43  |- skos__historyNote mesh__D007265 Proteins %28%1966-1982%29%
% 214.27/214.43  |- rdf__type mesh__D007265sskos__Concept
% 214.27/214.43  |- skos__altLabel mesh__D007265 Inhibin
% 214.27/214.43  |- skos__hiddenLabel mesh__D007265 Testicular Inhibins
% 214.27/214.43  |- mesh__recordMaintainer mesh__D007265 lkt
% 214.27/214.43  |- mesh__dateEstablished mesh__D007265 1983-01-01
% 214.27/214.43  |- mesh__recordOriginator mesh__D007265 RLS
% 214.27/214.43  |- skos__broader mesh__D007265smesh__D036361
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D007265 2004
% 214.27/214.43  |- skos__hiddenLabel mesh__D007265 Inhibin, Testicular
% 214.27/214.43  |- skos__altLabel mesh__D007265 Ovarian Inhibin
% 214.27/214.43  |- mesh__dateCreated mesh__D007265 1982-05-11
% 214.27/214.43  |- skos__altLabel mesh__D007265 Female Inhibin
% 214.27/214.43  |- skos__altLabel mesh__D045384 Pregnancy-Associated alpha 2-Glycoproteins
% 214.27/214.43  |- skos__prefLabel mesh__D045384
% 214.27/214.43       Pregnancy-Associated alpha 2-Macroglobulins
% 214.27/214.43  |- mesh__dateEstablished mesh__D045384 2004-01-01
% 214.27/214.43  |- skos__altLabel mesh__D045384 PAAG
% 214.27/214.43  |- skos__scopeNote mesh__D045384
% 214.27/214.43       Large %28%%3E%160 kDa%29% glycoproteins with electrophoretic mobility of ALPHA-GLOBULINS, found in high concentration in the plasma of pregnant women but also in a number of species including mouse, rat, and others %28%ALPHA-MACROGLOBULINS%29%. In humans, they are always present in the circulation and are nonspecific inhibitors of PROTEINASES, similar to COMPLEMENT PROTEINS %28%C3; C4; C5%29%.%A%    
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D045384 2005
% 214.27/214.43  |- skos__hiddenLabel mesh__D045384 Pregnancy Associated alpha 2 Globulins
% 214.27/214.43  |- skos__hiddenLabel mesh__D045384 alpha2 PAG
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D045384 2004
% 214.27/214.43  |- rdf__type mesh__D045384sskos__Concept
% 214.27/214.43  |- skos__hiddenLabel mesh__D045384
% 214.27/214.43       Pregnancy Associated alpha 2 Macroglobulins
% 214.27/214.43  |- skos__broader mesh__D045384smesh__D011257
% 214.27/214.43  |- skos__altLabel mesh__D045384 alpha%28%2%29%-PAG
% 214.27/214.43  |- skos__hiddenLabel mesh__D045384 alpha 2-Globulins, Pregnancy-Associated
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D045384 2006
% 214.27/214.43  |- skos__hiddenLabel mesh__D045384
% 214.27/214.43       Pregnancy Associated alpha 2 Glycoproteins
% 214.27/214.43  |- mesh__historyNote mesh__D045384 2004   
% 214.27/214.43  |- skos__historyNote mesh__D045384 alpha-Macroglobulins %28%1976-2003%29%
% 214.27/214.43  |- skos__broader mesh__D045384smesh__D000511
% 214.27/214.43  |- mesh__dateCreated mesh__D045384 2003-07-09
% 214.27/214.43  |- skos__hiddenLabel mesh__D045384
% 214.27/214.43       alpha 2-Glycoproteins, Pregnancy-Associated
% 214.27/214.43  |- mesh__publicMeSHNote mesh__D045384
% 214.27/214.43       2004; see PREGNANCY ZONE PROTEINS 1980-2003   
% 214.27/214.43  |- skos__hiddenLabel mesh__D045384
% 214.27/214.43       alpha 2-Macroglobulins, Pregnancy-Associated
% 214.27/214.43  |- skos__altLabel mesh__D045384 alpha2-PAG
% 214.27/214.43  |- skos__altLabel mesh__D045384 Pregnancy-Associated alpha 2-Globulins
% 214.27/214.43  |- skos__related mesh__D017693smesh__D002021
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D017693 2006
% 214.27/214.43  |- skos__broader mesh__D017693smesh__D001639
% 214.27/214.43  |- mesh__recordAuthorizer mesh__D017693 sjn
% 214.27/214.43  |- skos__altLabel mesh__D017693 Baking Soda
% 214.27/214.43  |- mesh__dateCreated mesh__D017693 1993-06-04
% 214.27/214.43  |- skos__prefLabel mesh__D017693 Sodium Bicarbonate
% 214.27/214.43  |- mesh__onlineNote mesh__D017693
% 214.27/214.43       use SODIUM BICARBONATE %28%NM%29% to search SODIUM BICARBONATE 1980-93%A%  
% 214.27/214.43  |- skos__hiddenLabel mesh__D017693 Bicarbonate, Sodium
% 214.27/214.43  |- skos__altLabel mesh__D017693 Carbonic Acid Monosodium Salt
% 214.27/214.43  |- mesh__dateRevised mesh__D017693 2005-06-30
% 214.27/214.43  |- skos__historyNote mesh__D017693 Bicarbonates %28%1980-1993%29%
% 214.27/214.43  |- skos__historyNote mesh__D017693 Sodium %28%1980-1993%29%
% 214.27/214.43  |- skos__altLabel mesh__D017693 Sodium Hydrogen Carbonate
% 214.27/214.43  |- mesh__dateEstablished mesh__D017693 1994-01-01
% 214.27/214.43  |- skos__hiddenLabel mesh__D017693 Hydrogen Carbonate, Sodium
% 214.27/214.43  |- skos__hiddenLabel mesh__D017693 Soda, Baking
% 214.27/214.43  |- mesh__recordOriginator mesh__D017693 TPW
% 214.27/214.43  |- skos__broader mesh__D017693smesh__D017670
% 214.27/214.43  |- skos__scopeNote mesh__D017693
% 214.27/214.43       A white, crystalline powder that is commonly used as a pH buffering agent, an electrolyte replenisher, systemic alkalizer and in topical cleansing solutions.%A%    
% 214.27/214.43  |- mesh__historyNote mesh__D017693
% 214.27/214.43       94; was SODIUM BICARBONATE %28%NM%29% 1980-93   
% 214.27/214.43  |- mesh__publicMeSHNote mesh__D017693
% 214.27/214.43       94; SODIUM BICARBONATE was indexed under BICARBONATES %26% SODIUM 1980-93%A%  
% 214.27/214.43  |- mesh__recordMaintainer mesh__D017693 DRC
% 214.27/214.43  |- rdf__type mesh__D017693sskos__Concept
% 214.27/214.43  |- mesh__dateCreated mesh__D031364 2002-07-02
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D031364 2004
% 214.27/214.43  |- skos__broader mesh__D031364smesh__D031363
% 214.27/214.43  |- skos__altLabel mesh__D031364 Skullcap, Baikal
% 214.27/214.43  |- rdf__type mesh__D031364sskos__Concept
% 214.27/214.43  |- skos__prefLabel mesh__D031364 Scutellaria baicalensis
% 214.27/214.43  |- mesh__publicMeSHNote mesh__D031364 2003   
% 214.27/214.43  |- mesh__historyNote mesh__D031364 2003   
% 214.27/214.43  |- skos__altLabel mesh__D031364 Scutellariae radix
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D031364 2005
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D031364 2006
% 214.27/214.43  |- skos__annotation mesh__D031364
% 214.27/214.43       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.27/214.43  |- mesh__dateEstablished mesh__D031364 2003-01-01
% 214.27/214.43  |- skos__scopeNote mesh__D031364
% 214.27/214.43       A plant species of the genus SCUTELLARIA, family LAMIACEAE, that contains skullcapflavone and is used in CHINESE HERBAL DRUGS.%A%    
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D031364 2003
% 214.27/214.43  |- skos__altLabel mesh__D031364 Baikal Skullcap
% 214.27/214.43  |- skos__hiddenLabel mesh__D003673 Viruses, Incomplete
% 214.27/214.43  |- mesh__onlineNote mesh__D003673
% 214.27/214.43       use DEFECTIVE VIRUSES to search DEFECTIVE VIRUS 1967-74 %28%as Prov 1967-72%29% %26% INCOMPLETE VIRUS 1975-93%A%  
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003673 2006
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003673 2001
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003673 1996
% 214.27/214.43  |- mesh__recordAuthorizer mesh__D003673 PLS
% 214.27/214.43  |- mesh__recordMaintainer mesh__D003673 AGS
% 214.27/214.43  |- skos__prefLabel mesh__D003673 Defective Viruses
% 214.27/214.43  |- skos__hiddenLabel mesh__D003673 Particle, Defective Interfering
% 214.27/214.43  |- skos__hiddenLabel mesh__D003673 Hybrid, Defective
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003673 2005
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003673 2000
% 214.27/214.43  |- skos__altLabel mesh__D003673 Defective Interfering Viruses
% 214.27/214.43  |- skos__hiddenLabel mesh__D003673 Incomplete Virus
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003673 2004
% 214.27/214.43  |- skos__hiddenLabel mesh__D003673 Viruses, Defective Interfering
% 214.27/214.43  |- skos__hiddenLabel mesh__D003673 Hybrids, Defective
% 214.27/214.43  |- skos__scopeNote mesh__D003673
% 214.27/214.43       Viruses which lack a complete genome so that they cannot completely replicate or cannot form a protein coat. Some are host-dependent defectives, meaning they can replicate only in cell systems which provide the particular genetic function which they lack. Others, called SATELLITE VIRUSES, are able to replicate only when their genetic defect is complemented by a helper virus.%A%    
% 214.27/214.43  |- skos__hiddenLabel mesh__D003673 Defective Virus
% 214.27/214.43  |- mesh__dateCreated mesh__D003673 1999-01-01
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003673 1995
% 214.27/214.43  |- mesh__publicMeSHNote mesh__D003673
% 214.27/214.43       75; was DEFECTIVE VIRUS 1973-74; INCOMPLETE VIRUSES was INCOMPLETE VIRUS 1975-93%A%  
% 214.27/214.43  |- skos__broader mesh__D003673smesh__D014780
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003673 2003
% 214.27/214.43  |- skos__hiddenLabel mesh__D003673 Interfering Particles, Defective
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003673 1999
% 214.27/214.43  |- mesh__dateRevised mesh__D003673 1993-06-04
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003673 1994
% 214.27/214.43  |- skos__hiddenLabel mesh__D003673 Interfering Virus, Defective
% 214.27/214.43  |- skos__altLabel mesh__D003673 Incomplete Viruses
% 214.27/214.43  |- skos__annotation mesh__D003673
% 214.27/214.43       viruses lacking a complete genome %26% so unable to replicate completely or to form a protein coat%A%  
% 214.27/214.43  |- skos__hiddenLabel mesh__D003673 Virus, Incomplete
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003673 2002
% 214.27/214.43  |- rdf__type mesh__D003673sskos__Concept
% 214.27/214.43  |- mesh__dateEstablished mesh__D003673 1973-01-01
% 214.27/214.43  |- skos__hiddenLabel mesh__D003673 Defective Interfering Virus
% 214.27/214.43  |- skos__hiddenLabel mesh__D003673 Interfering Viruses, Defective
% 214.27/214.43  |- skos__hiddenLabel mesh__D003673 Virus, Defective
% 214.27/214.43  |- skos__hiddenLabel mesh__D003673 Interfering Particle, Defective
% 214.27/214.43  |- skos__hiddenLabel mesh__D003673 Defective Interfering Particle
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003673 1998
% 214.27/214.43  |- mesh__recordOriginator mesh__D003673 NLM
% 214.27/214.43  |- skos__hiddenLabel mesh__D003673 Viruses, Defective
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003673 1997
% 214.27/214.43  |- skos__altLabel mesh__D003673 Defective Hybrids
% 214.27/214.43  |- skos__hiddenLabel mesh__D003673 Defective Hybrid
% 214.27/214.43  |- skos__historyNote mesh__D003673 specific virus %28%1966%29%
% 214.27/214.43  |- skos__altLabel mesh__D003673 Defective Interfering Particles
% 214.27/214.43  |- skos__hiddenLabel mesh__D003673 Particles, Defective Interfering
% 214.27/214.43  |- skos__hiddenLabel mesh__D003673 Virus, Defective Interfering
% 214.27/214.43  |- mesh__historyNote mesh__D003673
% 214.27/214.43       75; was DEFECTIVE VIRUS 1967-74 %28%Prov 1967-72%29%; INCOMPLETE VIRUSES was INCOMPLETE VIRUS 1975-93%A%  
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011307 2006
% 214.27/214.43  |- mesh__publicMeSHNote mesh__D011307 78; was PRESCRIPTIONS 1963-77   
% 214.27/214.43  |- skos__hiddenLabel mesh__D011307 Drug Prescription
% 214.27/214.43  |- mesh__dateCreated mesh__D011307 1999-01-01
% 214.27/214.43  |- mesh__dateRevised mesh__D011307 2005-06-30
% 214.27/214.43  |- skos__hiddenLabel mesh__D011307 Drug Prescriptions
% 214.27/214.43  |- rdf__type mesh__D011307sskos__Concept
% 214.27/214.43  |- skos__hiddenLabel mesh__D011307 Prescription
% 214.27/214.43  |- skos__related mesh__D011307smesh__D007880
% 214.27/214.43  |- mesh__recordAuthorizer mesh__D011307 sjn
% 214.27/214.43  |- mesh__recordMaintainer mesh__D011307 ssb
% 214.27/214.43  |- skos__broader mesh__D011307smesh__D004358
% 214.27/214.43  |- mesh__onlineNote mesh__D011307
% 214.27/214.43       use PRESCRIPTIONS, DRUG to search PRESCRIPTIONS 1966-77   
% 214.27/214.43  |- mesh__historyNote mesh__D011307 78; was PRESCRIPTIONS 1963-77   
% 214.27/214.43  |- skos__scopeNote mesh__D011307
% 214.27/214.43       Directions written for the preparation and administration of a drug.%A%    
% 214.27/214.43  |- mesh__recordOriginator mesh__D011307 NLM
% 214.27/214.43  |- skos__hiddenLabel mesh__D011307 Prescription, Drug
% 214.27/214.43  |- skos__prefLabel mesh__D011307 Prescriptions, Drug
% 214.27/214.43  |- skos__annotation mesh__D011307
% 214.27/214.43       general; do not confuse the concept of %22%prescription%22% with the drug prescribed; do not index here routinely for every %22%prescribed%22% drug; do not confuse with DRUG COMPOUNDING: prescribing is by the MD, compounding is by the pharmacist or drug company%A%  
% 214.27/214.43  |- skos__scopeNote mesh__D007266
% 214.27/214.43       The interference with or prevention of a behavioral or verbal response even though the stimulus for that response is present; in psychoanalysis the unconscious restraining of an instinctual process.%A%    
% 214.27/214.43  |- mesh__dateEstablished mesh__D007266 1971-01-01
% 214.27/214.43  |- rdf__type mesh__D007266sskos__Concept
% 214.27/214.43  |- skos__annotation mesh__D007266
% 214.27/214.43       human %26% animal; no qualif; DF: INHIBITION   
% 214.27/214.43  |- skos__historyNote mesh__D007266 Learning %28%1966-1970%29%
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D007266 2003
% 214.27/214.43  |- mesh__recordMaintainer mesh__D007266 ags
% 214.27/214.43  |- skos__historyNote mesh__D007266 Psychoanalytic Theory %28%1966-1970%29%
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D007266 2004
% 214.27/214.43  |- skos__broader mesh__D007266smesh__D011574
% 214.27/214.43  |- mesh__dateCreated mesh__D007266 1999-01-01
% 214.27/214.43  |- skos__altLabel mesh__D007266 Inhibition
% 214.27/214.43  |- mesh__publicMeSHNote mesh__D007266 1971   
% 214.27/214.43  |- mesh__recordOriginator mesh__D007266 NLM
% 214.27/214.43  |- skos__broader mesh__D007266smesh__D007858
% 214.27/214.43  |- skos__broader mesh__D007266smesh__D001519
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D007266 2005
% 214.27/214.43  |- skos__prefLabel mesh__D007266 Inhibition %28%Psychology%29%
% 214.27/214.43  |- skos__historyNote mesh__D007266
% 214.27/214.43       Conditioning %28%Psychology%29% %28%1966-1970%29%
% 214.27/214.43  |- skos__hiddenLabel mesh__D007266 Inhibitions %28%Psychology%29%
% 214.27/214.43  |- skos__hiddenLabel mesh__D007266 Inhibitions
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D007266 2006
% 214.27/214.43  |- mesh__dateRevised mesh__D007266 2002-07-03
% 214.27/214.43  |- mesh__recordAuthorizer mesh__D007266 sjn
% 214.27/214.43  |- mesh__historyNote mesh__D007266 1971   
% 214.27/214.43  |- skos__broader mesh__D012106Q000941smesh__D012106
% 214.27/214.43  |- mesh__preferredCombination mesh__D012106Q000941smesh__D032984
% 214.27/214.43  |- rdf__type mesh__D012106Q000941smesh__CompoundConcept
% 214.27/214.43  |- mesh__dateEstablished mesh__D012400 1983-01-01
% 214.27/214.43  |- skos__annotation mesh__D012400 caused by a reovirus   
% 214.27/214.43  |- mesh__recordMaintainer mesh__D012400 sjn
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D012400 2006
% 214.27/214.43  |- mesh__dateCreated mesh__D012400 1982-04-28
% 214.27/214.43  |- mesh__historyNote mesh__D012400 83   
% 214.27/214.43  |- skos__scopeNote mesh__D012400
% 214.27/214.43       Infection with any of the rotaviruses. Specific infections include human infantile diarrhea, neonatal calf diarrhea, and epidemic diarrhea of infant mice.%A%    
% 214.27/214.43  |- skos__prefLabel mesh__D012400 Rotavirus Infections
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D012400 2005
% 214.27/214.43  |- rdf__type mesh__D012400sskos__Concept
% 214.27/214.43  |- mesh__recordOriginator mesh__D012400 RC
% 214.27/214.43  |- skos__broader mesh__D012400smesh__D012088
% 214.27/214.43  |- skos__historyNote mesh__D012400 Reovirus Infections %28%1968-1982%29%
% 214.27/214.43  |- skos__hiddenLabel mesh__D012400 Rotavirus Infection
% 214.27/214.43  |- skos__historyNote mesh__D012400 Rotaviruses %28%1981-1982%29%
% 214.27/214.43  |- skos__hiddenLabel mesh__D012400 Infections, Rotavirus
% 214.27/214.43  |- mesh__dateRevised mesh__D012400 2004-07-13
% 214.27/214.43  |- mesh__recordAuthorizer mesh__D012400 sjn
% 214.27/214.43  |- skos__historyNote mesh__D012400 Diarrhea %28%1966-1982%29%
% 214.27/214.43  |- skos__hiddenLabel mesh__D012400 Infection, Rotavirus
% 214.27/214.43  |- mesh__publicMeSHNote mesh__D012400 83   
% 214.27/214.43  |- skos__broader mesh__D017694smesh__D013812
% 214.27/214.43  |- skos__historyNote mesh__D017694 Heat/therapeutic use %28%1966-1993%29%
% 214.27/214.43  |- skos__historyNote mesh__D017694 Body Temperature %28%1967-1993%29%
% 214.27/214.43  |- mesh__historyNote mesh__D017694 94   
% 214.27/214.43  |- skos__prefLabel mesh__D017694 Rewarming
% 214.27/214.43  |- skos__scopeNote mesh__D017694
% 214.27/214.43       Application of heat to correct hypothermia, accidental or induced.%A%    
% 214.27/214.43  |- mesh__recordAuthorizer mesh__D017694 sjn
% 214.27/214.43  |- skos__annotation mesh__D017694
% 214.27/214.43       IM; usually in accidental or induced hypothermia; do not use /util except by MeSH definition%A%  
% 214.27/214.43  |- mesh__publicMeSHNote mesh__D017694 94   
% 214.27/214.43  |- skos__hiddenLabel mesh__D017694 Rewarmings
% 214.27/214.43  |- mesh__dateRevised mesh__D017694 2005-06-30
% 214.27/214.43  |- mesh__dateEstablished mesh__D017694 1994-01-01
% 214.27/214.43  |- rdf__type mesh__D017694sskos__Concept
% 214.27/214.43  |- mesh__recordOriginator mesh__D017694 TGC
% 214.27/214.43  |- mesh__dateCreated mesh__D017694 1992-12-28
% 214.27/214.43  |- mesh__recordMaintainer mesh__D017694 lkt
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D017694 2006
% 214.27/214.43  |- rdf__type mesh__D031365sskos__Concept
% 214.27/214.43  |- skos__prefLabel mesh__D031365 Sideritis
% 214.27/214.43  |- skos__altLabel mesh__D031365 Ironwort
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D031365 2004
% 214.27/214.43  |- mesh__publicMeSHNote mesh__D031365 2003   
% 214.27/214.43  |- mesh__historyNote mesh__D031365 2003   
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D031365 2005
% 214.27/214.43  |- skos__annotation mesh__D031365
% 214.27/214.43       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.27/214.43  |- skos__broader mesh__D031365smesh__D019686
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D031365 2006
% 214.27/214.43  |- skos__scopeNote mesh__D031365
% 214.27/214.43       A plant genus of the family LAMIACEAE that contains isoscutellarein-7-O-%28%allosyl%28%1-2%29%glucoside%29%.%A%    
% 214.27/214.43  |- mesh__dateCreated mesh__D031365 2002-07-03
% 214.27/214.43  |- mesh__dateEstablished mesh__D031365 2003-01-01
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D031365 2003
% 214.27/214.43  |- mesh__recordOriginator mesh__D003674 NLM
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003674 2006
% 214.27/214.43  |- skos__prefLabel mesh__D003674 Defense Mechanisms
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003674 2002
% 214.27/214.43  |- mesh__dateRevised mesh__D003674 1997-06-20
% 214.27/214.43  |- skos__broader mesh__D003674smesh__D001520
% 214.27/214.43  |- mesh__dateCreated mesh__D003674 1999-01-01
% 214.27/214.43  |- rdf__type mesh__D003674sskos__Concept
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003674 2000
% 214.27/214.43  |- skos__annotation mesh__D003674 no qualif   
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003674 1998
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003674 2003
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003674 2001
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003674 1999
% 214.27/214.43  |- skos__scopeNote mesh__D003674
% 214.27/214.43       Unconscious process used by an individual or a group of individuals in order to cope with impulses, feelings or ideas which are not acceptable at their conscious level; various types include reaction formation, projection and self reversal.%A%    
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003674 2005
% 214.27/214.43  |- mesh__recordAuthorizer mesh__D003674 SJN
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D003674 2004
% 214.27/214.43  |- mesh__recordMaintainer mesh__D003674 JLS
% 214.27/214.43  |- skos__hiddenLabel mesh__D003674 Mechanisms, Defense
% 214.27/214.43  |- mesh__recordOriginator mesh__D011308 SMH
% 214.27/214.43  |- skos__prefLabel mesh__D011308 Prescriptions, Non-Drug
% 214.27/214.43  |- mesh__recordMaintainer mesh__D011308 TAP
% 214.27/214.43  |- rdf__type mesh__D011308sskos__Concept
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011308 2005
% 214.27/214.43  |- skos__historyNote mesh__D011308 Eyeglasses %28%1966-1977%29%
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011308 2003
% 214.27/214.43  |- skos__broader mesh__D011308smesh__D013812
% 214.27/214.43  |- skos__historyNote mesh__D011308 Orthopedic Equipment %28%1966-1977%29%
% 214.27/214.43  |- skos__scopeNote mesh__D011308
% 214.27/214.43       Written directions for the preparation, administration, or application of a non-drug remedy. This includes prescriptions for corrective lenses, self-help and orthopedic devices, and physical therapy and rehabilitation measures.%A%    
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011308 1995
% 214.27/214.43  |- skos__historyNote mesh__D011308 Prescriptions %28%1966-1977%29%
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011308 1993
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011308 2001
% 214.27/214.43  |- skos__hiddenLabel mesh__D011308 Prescriptions, Non Drug
% 214.27/214.43  |- skos__hiddenLabel mesh__D011308 Non-Drug Prescription
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011308 1999
% 214.27/214.43  |- mesh__dateEstablished mesh__D011308 1978-01-01
% 214.27/214.43  |- skos__hiddenLabel mesh__D011308 Nondrug Prescription
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011308 2000
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011308 1994
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011308 1997
% 214.27/214.43  |- mesh__recordAuthorizer mesh__D011308 PLS
% 214.27/214.43  |- mesh__dateCreated mesh__D011308 1977-04-22
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011308 1998
% 214.27/214.43  |- skos__hiddenLabel mesh__D011308 Prescription, Nondrug
% 214.27/214.43  |- skos__hiddenLabel mesh__D011308 Prescription, Non-Drug
% 214.27/214.43  |- skos__hiddenLabel mesh__D011308 Non-Drug Prescriptions
% 214.27/214.43  |- skos__hiddenLabel mesh__D011308 Nondrug Prescriptions
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011308 1996
% 214.27/214.43  |- mesh__publicMeSHNote mesh__D011308 78   
% 214.27/214.43  |- skos__altLabel mesh__D011308 Prescriptions, Nondrug
% 214.27/214.43  |- mesh__historyNote mesh__D011308 78   
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011308 2006
% 214.27/214.43  |- mesh__dateRevised mesh__D011308 1992-05-18
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011308 2002
% 214.27/214.43  |- skos__historyNote mesh__D011308 Orthotic Devices %28%1972-1974%29%
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D011308 2004
% 214.27/214.43  |- rdf__type mesh__D007267sskos__Concept
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D007267 2003
% 214.27/214.43  |- skos__annotation mesh__D007267
% 214.27/214.43       GEN or unspecified; prefer specifics; NIM; do not use /util except by MeSH definition; periodontal ligament injection %28%PDLI%29% = PERIODONTAL LIGAMENT %28%IM%29% + ANESTHESIA, DENTAL %28%IM%29%; Manual 26.25; DF: INJECT%A%  
% 214.27/214.43  |- skos__hiddenLabel mesh__D007267 Injection
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D007267 2004
% 214.27/214.43  |- mesh__dateCreated mesh__D007267 1999-01-01
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D007267 2005
% 214.27/214.43  |- mesh__recordMaintainer mesh__D007267 TGC
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D007267 1997
% 214.27/214.43  |- mesh__dateRevised mesh__D007267 1996-06-10
% 214.27/214.43  |- skos__hiddenLabel mesh__D007267 Injectable
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D007267 1998
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D007267 2006
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D007267 2000
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D007267 2001
% 214.27/214.43  |- skos__prefLabel mesh__D007267 Injections
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D007267 1999
% 214.27/214.43  |- mesh__recordOriginator mesh__D007267 NLM
% 214.27/214.43  |- skos__broader mesh__D007267smesh__D004333
% 214.27/214.43  |- mesh__recordAuthorizer mesh__D007267 PLS
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D007267 2002
% 214.27/214.43  |- mesh__historyNote mesh__D026421 2002   
% 214.27/214.43  |- skos__annotation mesh__D026421 GEN or unspecified; prefer specifics   
% 214.27/214.43  |- skos__scopeNote mesh__D026421
% 214.27/214.43       Therapies using arts or directed at the senses.     
% 214.27/214.43  |- mesh__dateCreated mesh__D026421 2001-07-25
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D026421 2002
% 214.27/214.43  |- rdf__type mesh__D026421sskos__Concept
% 214.27/214.43  |- skos__hiddenLabel mesh__D026421 Art Therapies, Sensory
% 214.27/214.43  |- mesh__publicMeSHNote mesh__D026421 2002   
% 214.27/214.43  |- skos__hiddenLabel mesh__D026421 Therapies, Sensory Art
% 214.27/214.43  |- skos__prefLabel mesh__D026421 Sensory Art Therapies
% 214.27/214.43  |- mesh__dateEstablished mesh__D026421 2002-01-01
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D026421 2003
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D026421 2005
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D026421 2004
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D026421 2006
% 214.27/214.43  |- skos__broader mesh__D026421smesh__D000529
% 214.27/214.43  |- skos__related mesh__D026421smesh__D011613
% 214.27/214.43  |- skos__scopeNote mesh__D012401
% 214.27/214.43       A genus of REOVIRIDAE, causing acute gastroenteritis in BIRDS and MAMMALS, including humans. Transmission is horizontal and by environmental contamination. Seven species %28%Rotaviruses A thru G%29% are recognized.%A%    
% 214.27/214.43  |- mesh__dateEstablished mesh__D012401 1983-01-01
% 214.27/214.43  |- skos__annotation mesh__D012401 infection = ROTAVIRUS INFECTIONS   
% 214.27/214.43  |- mesh__recordMaintainer mesh__D012401 ags
% 214.27/214.43  |- skos__hiddenLabel mesh__D012401 Rotaviruses
% 214.27/214.43  |- skos__prefLabel mesh__D012401 Rotavirus
% 214.27/214.43  |- skos__broader mesh__D012401smesh__D012087
% 214.27/214.43  |- mesh__recordOriginator mesh__D012401 AEP
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D012401 2006
% 214.27/214.43  |- mesh__dateCreated mesh__D012401 1977-05-13
% 214.27/214.43  |- rdf__type mesh__D012401sskos__Concept
% 214.27/214.43  |- mesh__activeMeSHYear mesh__D012401 2005
% 214.27/214.44  |- mesh__publicMeSHNote mesh__D012401
% 214.27/214.44       94, 78-80; was ROTAVIRUSES 1981-93 %28%see under REOVIRIDAE 1981-82%29%; was see under RNA VIRUSES 1978-80%A%  
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D012401 2002
% 214.27/214.44  |- mesh__recordAuthorizer mesh__D012401 sjn
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D012401 2004
% 214.27/214.44  |- mesh__historyNote mesh__D012401
% 214.27/214.44       94, 78-80; was ROTAVIRUSES 1981-93 %28%see under REOVIRIDAE 1981-82%29%; was see under RNA VIRUSES 1978-80%A%  
% 214.27/214.44  |- skos__historyNote mesh__D012401 Reoviridae %28%1966-1977%29%
% 214.27/214.44  |- mesh__onlineNote mesh__D012401
% 214.27/214.44       use ROTAVIRUS to search ROTAVIRUSES 1978-93   
% 214.27/214.44  |- mesh__dateRevised mesh__D012401 2001-07-25
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D012401 2003
% 214.27/214.44  |- skos__broader mesh__D017695smesh__D014947
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D017695 1994
% 214.27/214.44  |- rdf__type mesh__D017695sskos__Concept
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D017695 2006
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D017695 2001
% 214.27/214.44  |- skos__historyNote mesh__D017695
% 214.27/214.44       specific region/injuries %28%1966-1993%29%
% 214.27/214.44  |- skos__annotation mesh__D017695
% 214.27/214.44       IM GEN or unspecified; coord NIM with specific organ or region /inj %28%IM%29%; DF: SOFT TISSUE INJ%A%  
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D017695 1999
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D017695 2005
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D017695 2004
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D017695 2000
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D017695 1998
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D017695 1997
% 214.27/214.44  |- skos__hiddenLabel mesh__D017695 Injury, Soft Tissue
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D017695 2003
% 214.27/214.44  |- skos__hiddenLabel mesh__D017695 Soft Tissue Injury
% 214.27/214.44  |- mesh__historyNote mesh__D017695 94   
% 214.27/214.44  |- skos__historyNote mesh__D017695
% 214.27/214.44       specific tissue/injuries %28%1966-1993%29%
% 214.27/214.44  |- skos__historyNote mesh__D017695
% 214.27/214.44       specific organ/injuries %28%1966-1993%29%
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D017695 1996
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D017695 2002
% 214.27/214.44  |- mesh__dateCreated mesh__D017695 1992-12-28
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D017695 1995
% 214.27/214.44  |- skos__altLabel mesh__D017695 Injuries, Soft Tissue
% 214.27/214.44  |- mesh__dateEstablished mesh__D017695 1994-01-01
% 214.27/214.44  |- mesh__publicMeSHNote mesh__D017695 94   
% 214.27/214.44  |- skos__prefLabel mesh__D017695 Soft Tissue Injuries
% 214.27/214.44  |- skos__scopeNote mesh__D017695
% 214.27/214.44       Injuries of tissue other than bone. The concept is usually general and does not customarily refer to internal organs or viscera. It is meaningful with reference to regions or organs where soft tissue %28%muscle, fat, skin%29% should be differentiated from bones or bone tissue, as %22%soft tissue injuries of the hand%22%.%A%    
% 214.27/214.44  |- mesh__dateEstablished mesh__D031366 2003-01-01
% 214.27/214.44  |- skos__altLabel mesh__D031366 Hedgenettle
% 214.27/214.44  |- mesh__dateCreated mesh__D031366 2002-07-02
% 214.27/214.44  |- skos__scopeNote mesh__D031366
% 214.27/214.44       A plant genus of the family LAMIACEAE that has a characteristic odor.%A%    
% 214.27/214.44  |- mesh__publicMeSHNote mesh__D031366 2003   
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D031366 2005
% 214.27/214.44  |- skos__annotation mesh__D031366
% 214.27/214.44       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.27/214.44  |- skos__prefLabel mesh__D031366 Stachys
% 214.27/214.44  |- skos__broader mesh__D031366smesh__D019686
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D031366 2006
% 214.27/214.44  |- skos__altLabel mesh__D031366 Betonica
% 214.27/214.44  |- mesh__historyNote mesh__D031366 2003   
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D031366 2003
% 214.27/214.44  |- rdf__type mesh__D031366sskos__Concept
% 214.27/214.44  |- skos__altLabel mesh__D031366 Nettle, Hedge
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D031366 2004
% 214.27/214.44  |- mesh__dateRevised mesh__D003675 1990-05-13
% 214.27/214.44  |- skos__hiddenLabel mesh__D003675 Defensive Practices
% 214.27/214.44  |- skos__prefLabel mesh__D003675 Defensive Medicine
% 214.27/214.44  |- mesh__publicMeSHNote mesh__D003675
% 214.27/214.44       91; was see under MALPRACTICE 1975-90   
% 214.27/214.44  |- mesh__dateCreated mesh__D003675 1974-11-11
% 214.27/214.44  |- mesh__dateEstablished mesh__D003675 1991-01-01
% 214.27/214.44  |- mesh__recordOriginator mesh__D003675 NLM
% 214.27/214.44  |- skos__altLabel mesh__D003675 Medicine, Defensive
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D003675 1991
% 214.27/214.44  |- rdf__type mesh__D003675sskos__Concept
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D003675 1996
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D003675 2002
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D003675 1998
% 214.27/214.44  |- mesh__recordAuthorizer mesh__D003675 PLS
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D003675 1992
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D003675 1997
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D003675 2003
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D003675 1994
% 214.27/214.44  |- mesh__historyNote mesh__D003675
% 214.27/214.44       91%28%75%29%; was see under MALPRACTICE 1975-90   
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D003675 1999
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D003675 2005
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D003675 1993
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D003675 2004
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D003675 1995
% 214.27/214.44  |- skos__altLabel mesh__D003675 Defensive Practice
% 214.27/214.44  |- skos__annotation mesh__D003675 SPEC; SPEC qualif; DF: DEFENSIVE MED   
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D003675 2006
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D003675 2000
% 214.27/214.44  |- mesh__recordMaintainer mesh__D003675 TAP
% 214.27/214.44  |- skos__broader mesh__D003675smesh__D008318
% 214.27/214.44  |- skos__scopeNote mesh__D003675
% 214.27/214.44       The alterations of modes of medical practice, induced by the threat of liability, for the principal purposes of forestalling lawsuits by patients as well as providing good legal defense in the event that such lawsuits are instituted.%A%    
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D003675 2001
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D011309 2004
% 214.27/214.44  |- mesh__recordAuthorizer mesh__D011309 sjn
% 214.27/214.44  |- rdf__type mesh__D011309sskos__Concept
% 214.27/214.44  |- skos__broader mesh__D011309smesh__D013048
% 214.27/214.44  |- mesh__recordMaintainer mesh__D011309 nns
% 214.27/214.44  |- skos__related mesh__D011309smesh__D003451
% 214.27/214.44  |- skos__broader mesh__D011309smesh__D008919
% 214.27/214.44  |- mesh__historyNote mesh__D011309 67%28%64%29%   
% 214.27/214.44  |- skos__prefLabel mesh__D011309 Preservation, Biological
% 214.27/214.44  |- mesh__recordOriginator mesh__D011309 NLM
% 214.27/214.44  |- mesh__dateEstablished mesh__D011309 1967-01-01
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D011309 2005
% 214.27/214.44  |- skos__hiddenLabel mesh__D011309 Biologic Preservation
% 214.27/214.44  |- mesh__dateCreated mesh__D011309 1999-01-01
% 214.27/214.44  |- mesh__publicMeSHNote mesh__D011309 67   
% 214.27/214.44  |- skos__altLabel mesh__D011309 Biological Preservation
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D011309 2003
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D011309 2006
% 214.27/214.44  |- skos__altLabel mesh__D011309 Preservation, Biologic
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D011309 2002
% 214.27/214.44  |- mesh__dateRevised mesh__D011309 2001-07-25
% 214.27/214.44  |- skos__annotation mesh__D011309
% 214.27/214.44       BLOOD PRESERVATION; ORGAN PRESERVATION and TISSUE PRESERVATION are also available; CRYOPRESERVATION is also available; DF: PRESERVATION BIOL%A%  
% 214.27/214.44  |- skos__related mesh__D011309smesh__D005404
% 214.27/214.44  |- mesh__recordMaintainer mesh__D008360 ssb
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D008360 2006
% 214.27/214.44  |- skos__scopeNote mesh__D008360 Phosphoric acid esters of mannose.     
% 214.27/214.44  |- mesh__publicMeSHNote mesh__D008360
% 214.27/214.44       91; was see under HEXOSEPHOSPHATES 1978-90   
% 214.27/214.44  |- skos__broader mesh__D008360smesh__D006600
% 214.27/214.44  |- mesh__dateEstablished mesh__D008360 1991-01-01
% 214.27/214.44  |- skos__prefLabel mesh__D008360 Mannosephosphates
% 214.27/214.44  |- mesh__dateRevised mesh__D008360 2004-07-07
% 214.27/214.44  |- mesh__recordOriginator mesh__D008360 RLS
% 214.27/214.44  |- mesh__dateCreated mesh__D008360 1977-04-15
% 214.27/214.44  |- skos__historyNote mesh__D008360 Mannose %28%1966-1977%29%
% 214.27/214.44  |- rdf__type mesh__D008360sskos__Concept
% 214.27/214.44  |- mesh__recordAuthorizer mesh__D008360 sjn
% 214.27/214.44  |- mesh__historyNote mesh__D008360
% 214.27/214.44       91%28%78%29%; was see under HEXOSEPHOSPHATES 1978-90   
% 214.27/214.44  |- skos__historyNote mesh__D008360 Hexosephosphates %28%1966-1977%29%
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D008360 2005
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007268 2001
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007268 1994
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007268 1991
% 214.27/214.44  |- skos__historyNote mesh__D007268 Epidural Space %28%1979-1986%29%
% 214.27/214.44  |- rdf__type mesh__D007268sskos__Concept
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007268 1999
% 214.27/214.44  |- skos__altLabel mesh__D007268 Epidural Injections
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007268 2003
% 214.27/214.44  |- skos__scopeNote mesh__D007268
% 214.27/214.44       The injection of drugs, most often analgesics, into the spinal canal without puncturing the dura mater.%A%    
% 214.27/214.44  |- skos__related mesh__D007268smesh__D000767
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007268 1993
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007268 2002
% 214.27/214.44  |- mesh__dateEstablished mesh__D007268 1987-01-01
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007268 1995
% 214.27/214.44  |- mesh__recordOriginator mesh__D007268 SH
% 214.27/214.44  |- skos__historyNote mesh__D007268 Injections %28%1966-1986%29%
% 214.27/214.44  |- skos__altLabel mesh__D007268 Extradural Injections
% 214.27/214.44  |- skos__altLabel mesh__D007268 Injections, Peridural
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007268 2004
% 214.27/214.44  |- mesh__publicMeSHNote mesh__D007268 87   
% 214.27/214.44  |- mesh__dateCreated mesh__D007268 1986-06-04
% 214.27/214.44  |- skos__prefLabel mesh__D007268 Injections, Epidural
% 214.27/214.44  |- skos__altLabel mesh__D007268 Injections, Extradural
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007268 1996
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007268 2005
% 214.27/214.44  |- mesh__recordMaintainer mesh__D007268 PLS
% 214.27/214.44  |- mesh__dateRevised mesh__D007268 1990-06-01
% 214.27/214.44  |- skos__hiddenLabel mesh__D007268 Extradural Injection
% 214.27/214.44  |- mesh__historyNote mesh__D007268 87   
% 214.27/214.44  |- mesh__recordAuthorizer mesh__D007268 PLS
% 214.27/214.44  |- skos__hiddenLabel mesh__D007268 Epidural Injection
% 214.27/214.44  |- skos__hiddenLabel mesh__D007268 Peridural Injection
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007268 1997
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007268 2006
% 214.27/214.44  |- skos__hiddenLabel mesh__D007268 Injection, Extradural
% 214.27/214.44  |- skos__annotation mesh__D007268
% 214.27/214.44       NIM; do not use /util except by MeSH definition; DF: INJECT EPIDURAL%A%  
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007268 2000
% 214.27/214.44  |- skos__hiddenLabel mesh__D007268 Injection, Peridural
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007268 1998
% 214.27/214.44  |- skos__altLabel mesh__D007268 Peridural Injections
% 214.27/214.44  |- skos__broader mesh__D007268smesh__D007278
% 214.27/214.44  |- skos__hiddenLabel mesh__D007268 Injection, Epidural
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007268 1992
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D026422 2003
% 214.27/214.44  |- mesh__dateEstablished mesh__D026422 2002-01-01
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D026422 2005
% 214.27/214.44  |- skos__historyNote mesh__D026422 Glutathione %28%1980-2001%29%
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D026422 2004
% 214.27/214.44  |- skos__historyNote mesh__D026422 Nitroso Compounds %28%1980-2001%29%
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D026422 2006
% 214.27/214.44  |- mesh__dateCreated mesh__D026422 2001-07-25
% 214.27/214.44  |- skos__broader mesh__D026422smesh__D005978
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D026422 2002
% 214.27/214.44  |- mesh__publicMeSHNote mesh__D026422
% 214.27/214.44       2002; S-NITROSOGLUTATHIONE was indexed under NITROSO COMPOUNDS 1980-2001, GLUTATHIONE 1980-2001%A%  
% 214.27/214.44  |- mesh__historyNote mesh__D026422
% 214.27/214.44       2002; use S-NITROSOGLUTATHIONE %28%NM%29% 1980-2001   
% 214.27/214.44  |- skos__scopeNote mesh__D026422
% 214.27/214.44       A sulfur-containing alkyl thionitrite that is one of the NITRIC OXIDE DONORS.%A%    
% 214.27/214.44  |- rdf__type mesh__D026422sskos__Concept
% 214.27/214.44  |- skos__altLabel mesh__D026422 S-Nitroso-GSH
% 214.27/214.44  |- skos__broader mesh__D026422smesh__D026403
% 214.27/214.44  |- skos__prefLabel mesh__D026422 S-Nitrosoglutathione
% 214.27/214.44  |- mesh__dateCreated mesh__D012402 1999-01-01
% 214.27/214.44  |- mesh__recordAuthorizer mesh__D012402 sjn
% 214.27/214.44  |- mesh__dateRevised mesh__D012402 2005-06-30
% 214.27/214.44  |- skos__scopeNote mesh__D012402
% 214.27/214.44       A botanical insecticide that is an inhibitor of mitochondrial electron transport.%A%    
% 214.27/214.44  |- skos__annotation mesh__D012402 TN 111 for eff on insects   
% 214.27/214.44  |- mesh__recordOriginator mesh__D012402 NLM
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D012402 2006
% 214.27/214.44  |- mesh__recordMaintainer mesh__D012402 ssb
% 214.27/214.44  |- rdf__type mesh__D012402sskos__Concept
% 214.27/214.44  |- skos__broader mesh__D012402smesh__D006576
% 214.27/214.44  |- skos__broader mesh__D012402smesh__D007529
% 214.27/214.44  |- skos__prefLabel mesh__D012402 Rotenone
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D017696 2005
% 214.27/214.44  |- skos__historyNote mesh__D017696 Muscle Hypotonia %28%1967-1993%29%
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D017696 2004
% 214.27/214.44  |- skos__hiddenLabel mesh__D017696 Myopathy, Rod Body
% 214.27/214.44  |- skos__altLabel mesh__D017696 Myopathy, Rod
% 214.27/214.44  |- mesh__recordMaintainer mesh__D017696 sjn
% 214.27/214.44  |- mesh__recordAuthorizer mesh__D017696 sjn
% 214.27/214.44  |- mesh__dateEstablished mesh__D017696 1994-01-01
% 214.27/214.44  |- mesh__historyNote mesh__D017696 2000%28%1994%29%   
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D017696 2003
% 214.27/214.44  |- skos__historyNote mesh__D017696 Muscular Diseases %28%1966-1993%29%
% 214.27/214.44  |- skos__altLabel mesh__D017696 Rod-Body Myopathy
% 214.27/214.44  |- skos__broader mesh__D017696smesh__D020914
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D017696 2001
% 214.27/214.44  |- skos__altLabel mesh__D017696 Childhood Onset Nemaline Myopathy
% 214.27/214.44  |- skos__altLabel mesh__D017696 Autosomal Recessive Nemaline Myopathy
% 214.27/214.44  |- skos__altLabel mesh__D017696 Nemaline Myopathy, Adult Onset
% 214.27/214.44  |- skos__altLabel mesh__D017696 Late Onset Nemaline Myopathy
% 214.27/214.44  |- skos__hiddenLabel mesh__D017696 Rod-Body Myopathies
% 214.27/214.44  |- mesh__dateRevised mesh__D017696 2000-06-21
% 214.27/214.44  |- skos__hiddenLabel mesh__D017696 Rod Myopathies
% 214.27/214.44  |- skos__hiddenLabel mesh__D017696 Nemaline Myopathy
% 214.27/214.44  |- skos__altLabel mesh__D017696 Rod Myopathy
% 214.27/214.44  |- skos__hiddenLabel mesh__D017696 Myopathies, Rod
% 214.27/214.44  |- skos__altLabel mesh__D017696 Autosomal Dominant Nemaline Myopathy
% 214.27/214.44  |- skos__altLabel mesh__D017696 Myopathy, Nemaline
% 214.27/214.44  |- mesh__recordOriginator mesh__D017696 TGC
% 214.27/214.44  |- skos__hiddenLabel mesh__D017696 Rod Body Myopathy
% 214.27/214.44  |- rdf__type mesh__D017696sskos__Concept
% 214.27/214.44  |- mesh__dateCreated mesh__D017696 1999-11-08
% 214.27/214.44  |- skos__scopeNote mesh__D017696
% 214.27/214.44       A group of inherited congenital myopathic conditions characterized clinically by weakness, hypotonia, and prominent hypoplasia of proximal muscles including the face. Muscle biopsy reveals large numbers of rod-shaped structures beneath the muscle fiber plasma membrane. This disorder is genetically heterogeneous and may occasionally present in adults. %28%Adams et al., Principles of Neurology, 6th ed, p1453%29%%A%    
% 214.27/214.44  |- skos__historyNote mesh__D017696 Neuromuscular Diseases %28%1971-1993%29%
% 214.27/214.44  |- skos__hiddenLabel mesh__D017696 Myopathies, Rod-Body
% 214.27/214.44  |- skos__prefLabel mesh__D017696 Myopathies, Nemaline
% 214.27/214.44  |- skos__altLabel mesh__D017696 Nemaline Myopathies
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D017696 2006
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D017696 2002
% 214.27/214.44  |- skos__altLabel mesh__D017696 Myopathy, Rod-Body
% 214.27/214.44  |- mesh__publicMeSHNote mesh__D017696
% 214.27/214.44       2000; see NEMALINE MYOPATHY 1994-1999   
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D031367 2005
% 214.27/214.44  |- mesh__dateEstablished mesh__D031367 2003-01-01
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D031367 2003
% 214.27/214.44  |- mesh__historyNote mesh__D031367 2003   
% 214.27/214.44  |- rdf__type mesh__D031367sskos__Concept
% 214.27/214.44  |- skos__broader mesh__D031367smesh__D019686
% 214.27/214.44  |- skos__annotation mesh__D031367
% 214.27/214.44       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.27/214.44  |- mesh__dateCreated mesh__D031367 2002-07-03
% 214.27/214.44  |- mesh__publicMeSHNote mesh__D031367 2003   
% 214.27/214.44  |- skos__prefLabel mesh__D031367 Teucrium
% 214.27/214.44  |- skos__altLabel mesh__D031367 Germander
% 214.27/214.44  |- skos__scopeNote mesh__D031367
% 214.27/214.44       A plant genus of the family LAMIACEAE. Members contain teuscordonin. There have been reports of hepatoxicity by this genus.%A%    
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D031367 2006
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D031367 2004
% 214.27/214.44  |- skos__altLabel mesh__D003676 Desferroxamine
% 214.27/214.44  |- skos__hiddenLabel mesh__D003676 Mesilate, Deferoxamine
% 214.27/214.44  |- skos__altLabel mesh__D003676 Deferoxamine B
% 214.27/214.44  |- skos__hiddenLabel mesh__D003676 B, Desferrioxamine
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D003676 2006
% 214.27/214.44  |- skos__broader mesh__D003676smesh__D006877
% 214.27/214.44  |- skos__hiddenLabel mesh__D003676 Mesylate, Desferrioxamine B
% 214.27/214.44  |- mesh__dateEstablished mesh__D003676 1965-01-01
% 214.27/214.44  |- skos__hiddenLabel mesh__D003676 B, Deferoxamine
% 214.27/214.44  |- skos__altLabel mesh__D003676 Deferoxamine Mesylate
% 214.27/214.44  |- skos__prefLabel mesh__D003676 Deferoxamine
% 214.27/214.44  |- skos__altLabel mesh__D003676 Desferrioxamine
% 214.27/214.44  |- mesh__recordMaintainer mesh__D003676 ssb
% 214.27/214.44  |- skos__scopeNote mesh__D003676
% 214.27/214.44       Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.%A%    
% 214.27/214.44  |- skos__hiddenLabel mesh__D003676 Methanesulfonate, Deferoxamine
% 214.27/214.44  |- mesh__historyNote mesh__D003676 65   
% 214.27/214.44  |- skos__altLabel mesh__D003676 Desferioximine
% 214.27/214.44  |- mesh__recordAuthorizer mesh__D003676 sjn
% 214.27/214.44  |- rdf__type mesh__D003676sskos__Concept
% 214.27/214.44  |- mesh__dateCreated mesh__D003676 1999-01-01
% 214.27/214.44  |- mesh__recordOriginator mesh__D003676 NLM
% 214.27/214.44  |- mesh__publicMeSHNote mesh__D003676 65   
% 214.27/214.44  |- skos__altLabel mesh__D003676 Deferoximine
% 214.27/214.44  |- skos__hiddenLabel mesh__D003676 Mesylate, Deferoxamine
% 214.27/214.44  |- skos__altLabel mesh__D003676 Desferrioxamine B
% 214.27/214.44  |- skos__altLabel mesh__D003676 Deferrioxamine B
% 214.27/214.44  |- mesh__dateRevised mesh__D003676 2005-06-30
% 214.27/214.44  |- skos__altLabel mesh__D003676 Deferoxamine Mesilate
% 214.27/214.44  |- skos__altLabel mesh__D003676 Deferoxamine Methanesulfonate
% 214.27/214.44  |- skos__historyNote mesh__D008361 Glycoside Hydrolases %28%1966-1974%29%
% 214.27/214.44  |- mesh__recordMaintainer mesh__D008361 jmp
% 214.27/214.44  |- skos__historyNote mesh__D008361 Mannose %28%1966-1974%29%
% 214.27/214.44  |- mesh__dateRevised mesh__D008361 2003-07-09
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D008361 2006
% 214.27/214.44  |- mesh__historyNote mesh__D008361
% 214.27/214.44       78%28%75%29%; was see under DISACCHARIDASES 1975-77   
% 214.27/214.44  |- mesh__publicMeSHNote mesh__D008361
% 214.27/214.44       78; was see under DISACCHARIDASES 1975-77   
% 214.27/214.44  |- skos__prefLabel mesh__D008361 Mannosidases
% 214.27/214.44  |- skos__scopeNote mesh__D008361
% 214.27/214.44       Glycoside hydrolases that catalyze the hydrolysis of alpha or beta linked MANNOSE.%A%    
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D008361 2005
% 214.27/214.44  |- mesh__dateEstablished mesh__D008361 1978-01-01
% 214.27/214.44  |- rdf__type mesh__D008361sskos__Concept
% 214.27/214.44  |- mesh__dateCreated mesh__D008361 1974-11-19
% 214.27/214.44  |- skos__annotation mesh__D008361
% 214.27/214.44       ALPHA-MANNOSIDASE and BETA-MANNOSIDASE are also available; /defic: consider also MANNOSIDASE DEFICIENCY DISEASES%A%  
% 214.27/214.44  |- skos__broader mesh__D008361smesh__D006026
% 214.27/214.44  |- mesh__recordOriginator mesh__D008361 NLM
% 214.27/214.44  |- mesh__recordAuthorizer mesh__D008361 sjn
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D008361 2004
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007269 1992
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007269 2004
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007269 2001
% 214.27/214.44  |- mesh__recordAuthorizer mesh__D007269 PLS
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007269 2003
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007269 1997
% 214.27/214.44  |- skos__hiddenLabel mesh__D007269 Injection, Intraarterial
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007269 2000
% 214.27/214.44  |- skos__broader mesh__D007269smesh__D007267
% 214.27/214.44  |- mesh__recordOriginator mesh__D007269 NLM
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007269 1996
% 214.27/214.44  |- skos__hiddenLabel mesh__D007269 Intraarterial Injection
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007269 1995
% 214.27/214.44  |- skos__hiddenLabel mesh__D007269 Intra-Arterial Injection
% 214.27/214.44  |- skos__altLabel mesh__D007269 Intraarterial Injections
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007269 2006
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007269 1994
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007269 1991
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007269 2005
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007269 1999
% 214.27/214.44  |- rdf__type mesh__D007269sskos__Concept
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007269 1993
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007269 2002
% 214.27/214.44  |- mesh__dateRevised mesh__D007269 1990-06-01
% 214.27/214.44  |- skos__prefLabel mesh__D007269 Injections, Intra-Arterial
% 214.27/214.44  |- skos__hiddenLabel mesh__D007269 Injection, Intra-Arterial
% 214.27/214.44  |- skos__annotation mesh__D007269
% 214.27/214.44       NIM; do not use /util except by MeSH definition; do not confuse with INFUSIONS, INTRA-ARTERIAL; DF: INJECT INTRA ARTERIAL%A%  
% 214.27/214.44  |- skos__altLabel mesh__D007269 Injections, Intraarterial
% 214.27/214.44  |- skos__hiddenLabel mesh__D007269 Injections, Intra Arterial
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D007269 1998
% 214.27/214.44  |- mesh__dateCreated mesh__D007269 1999-01-01
% 214.27/214.44  |- skos__hiddenLabel mesh__D007269 Intra Arterial Injections
% 214.27/214.44  |- mesh__recordMaintainer mesh__D007269 TGC
% 214.27/214.44  |- skos__altLabel mesh__D007269 Intra-Arterial Injections
% 214.27/214.44  |- skos__broader mesh__D019347Q000031smesh__D019347
% 214.27/214.44  |- mesh__preferredCombination mesh__D019347Q000031smesh__D000085
% 214.27/214.44  |- rdf__type mesh__D019347Q000031smesh__CompoundConcept
% 214.27/214.44  |- skos__altLabel mesh__D026423 S-NONAP
% 214.27/214.44  |- mesh__recordMaintainer mesh__D026423 ssb
% 214.27/214.44  |- skos__altLabel mesh__D026423 S-Nitrosylacetylpenicillamine
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D026423 2006
% 214.27/214.44  |- mesh__historyNote mesh__D026423
% 214.27/214.44       2002; use S-NITROSO-N-ACETYLPENICILLAMINE %28%NM%29% 1984-2001   
% 214.27/214.44  |- mesh__publicMeSHNote mesh__D026423
% 214.27/214.44       2002; S-NITROSO-N-ACETYLPENICILLAMINE was indexed under PENICILLAMINE 1984-2001%A%  
% 214.27/214.44  |- skos__altLabel mesh__D026423 N-Acetyl-S-Nitrosopenicillamine
% 214.27/214.44  |- skos__altLabel mesh__D026423 SNAP %28%NO donor%29%
% 214.27/214.44  |- skos__historyNote mesh__D026423 Penicillamine %28%1984-2001%29%
% 214.27/214.44  |- mesh__dateRevised mesh__D026423 2005-06-30
% 214.27/214.44  |- mesh__recordOriginator mesh__D026423 lkt
% 214.27/214.44  |- skos__prefLabel mesh__D026423 S-Nitroso-N-Acetylpenicillamine
% 214.27/214.44  |- rdf__type mesh__D026423sskos__Concept
% 214.27/214.44  |- skos__broader mesh__D026423smesh__D010396
% 214.27/214.44  |- mesh__dateCreated mesh__D026423 2001-07-25
% 214.27/214.44  |- skos__broader mesh__D026423smesh__D026403
% 214.27/214.44  |- skos__scopeNote mesh__D026423
% 214.27/214.44       A sulfur-containing alkyl thionitrite that is one of the NITRIC OXIDE DONORS.%A%    
% 214.27/214.44  |- mesh__recordAuthorizer mesh__D026423 sjn
% 214.27/214.44  |- mesh__dateEstablished mesh__D026423 2002-01-01
% 214.27/214.44  |- skos__historyNote mesh__D012403 Aschelminthes %28%1975-1976%29%
% 214.27/214.44  |- mesh__recordOriginator mesh__D012403 FPG
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D012403 2005
% 214.27/214.44  |- mesh__historyNote mesh__D012403 77   
% 214.27/214.44  |- skos__broader mesh__D012403smesh__D006376
% 214.27/214.44  |- mesh__dateEstablished mesh__D012403 1977-01-01
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D012403 2006
% 214.27/214.44  |- rdf__type mesh__D012403sskos__Concept
% 214.27/214.44  |- mesh__dateCreated mesh__D012403 1976-04-27
% 214.27/214.44  |- skos__prefLabel mesh__D012403 Rotifera
% 214.27/214.44  |- mesh__recordAuthorizer mesh__D012403 sjn
% 214.27/214.44  |- skos__scopeNote mesh__D012403
% 214.27/214.44       A class of minute animals of the phylum Aschelminthes.     
% 214.27/214.44  |- mesh__publicMeSHNote mesh__D012403 77   
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D012403 2004
% 214.27/214.44  |- skos__historyNote mesh__D012403 Invertebrates %28%1966-1974%29%
% 214.27/214.44  |- mesh__dateRevised mesh__D012403 2003-07-09
% 214.27/214.44  |- mesh__recordMaintainer mesh__D012403 ags
% 214.27/214.44  |- skos__annotation mesh__D012403 an aschelminth   
% 214.27/214.44  |- skos__historyNote mesh__D017697 Menopause %28%1969-1993%29%
% 214.27/214.44  |- skos__historyNote mesh__D017697 Climacteric %28%1969-1993%29%
% 214.27/214.44  |- mesh__recordOriginator mesh__D017697 TGC
% 214.27/214.44  |- skos__broader mesh__D017697smesh__D008593
% 214.27/214.44  |- mesh__dateCreated mesh__D017697 1992-12-28
% 214.27/214.44  |- mesh__dateEstablished mesh__D017697 1994-01-01
% 214.27/214.44  |- skos__altLabel mesh__D017697 Premenopausal Period
% 214.27/214.44  |- rdf__type mesh__D017697sskos__Concept
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D017697 2006
% 214.27/214.44  |- mesh__dateRevised mesh__D017697 2004-07-07
% 214.27/214.44  |- mesh__recordAuthorizer mesh__D017697 sjn
% 214.27/214.44  |- mesh__publicMeSHNote mesh__D017697 94   
% 214.27/214.44  |- skos__altLabel mesh__D017697 Pre-menopausal Period
% 214.27/214.44  |- mesh__activeMeSHYear mesh__D017697 2005
% 214.27/214.44  |- skos__hiddenLabel mesh__D017697 Period, Pre-menopausal
% 214.27/214.44  |- skos__altLabel mesh__D017697 Pre-Menopause
% 214.27/214.45  |- skos__prefLabel mesh__D017697 Premenopause
% 214.27/214.45  |- mesh__recordMaintainer mesh__D017697 lkt
% 214.27/214.45  |- skos__scopeNote mesh__D017697
% 214.27/214.45       The period before MENOPAUSE. In premenopausal women, the climacteric transition from full sexual maturity to cessation of ovarian cycle takes place between the age of late thirty and early fifty.%A%    
% 214.27/214.45  |- mesh__historyNote mesh__D017697 94   
% 214.27/214.45  |- skos__historyNote mesh__D017697 Menstruation %28%1966-1993%29%
% 214.27/214.45  |- skos__prefLabel mesh__D031368 Zoster Sine Herpete
% 214.27/214.45  |- skos__historyNote mesh__D031368
% 214.27/214.45       Herpes Zoster Ophthalmicus %28%1995-2002%29%
% 214.27/214.45  |- skos__broader mesh__D031368smesh__D006562
% 214.27/214.45  |- mesh__dateEstablished mesh__D031368 2003-01-01
% 214.27/214.45  |- skos__altLabel mesh__D031368 Zoster Sine Eruptione
% 214.27/214.45  |- mesh__publicMeSHNote mesh__D031368 2003   
% 214.27/214.45  |- mesh__historyNote mesh__D031368 2003   
% 214.27/214.45  |- skos__historyNote mesh__D031368 Herpes Zoster %28%1970-2002%29%
% 214.27/214.45  |- skos__scopeNote mesh__D031368
% 214.27/214.45       HERPES ZOSTER but without eruption of vesicles. Patients exhibit the characteristic pain minus the skin rash, sometimes making diagnosis difficult.%A%    
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D031368 2006
% 214.27/214.45  |- mesh__dateCreated mesh__D031368 2002-07-03
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D031368 2004
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D031368 2005
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D031368 2003
% 214.27/214.45  |- rdf__type mesh__D031368sskos__Concept
% 214.27/214.45  |- skos__broader mesh__D003677smesh__D044342
% 214.27/214.45  |- skos__scopeNote mesh__D003677
% 214.27/214.45       A condition produced by dietary or metabolic deficiency. The term includes all diseases caused by an insufficient supply of essential nutrients, i.e., protein %28%or amino acids%29%, vitamins, and minerals. It also includes an inadequacy of calories. %28%From Dorland, 27th ed; Stedman, 25th ed%29%%A%    
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D003677 2005
% 214.27/214.45  |- skos__hiddenLabel mesh__D003677 Diseases, Deficiency
% 214.27/214.45  |- skos__hiddenLabel mesh__D003677 Deficiency Disease
% 214.27/214.45  |- rdf__type mesh__D003677sskos__Concept
% 214.27/214.45  |- mesh__dateCreated mesh__D003677 1999-01-01
% 214.27/214.45  |- skos__prefLabel mesh__D003677 Deficiency Diseases
% 214.27/214.45  |- skos__annotation mesh__D003677
% 214.27/214.45       GEN only: prefer /defic with specific Cat D terms: Manual 19.7+, 19.8.21; also Manual 23.25+; do not confuse with NUTRITION DISORDERS: DEFICIENCY DISEASES results from deficient intake; TN 194: as NIM %26% differentiation from METABOLIC DISEASES or METABOLISM, INBORN ERRORS; DF: DEFIC DIS%A%  
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D003677 2004
% 214.27/214.45  |- mesh__recordAuthorizer mesh__D003677 sjn
% 214.27/214.45  |- mesh__recordOriginator mesh__D003677 NLM
% 214.27/214.45  |- mesh__dateRevised mesh__D003677 2003-07-09
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D003677 2006
% 214.27/214.45  |- skos__hiddenLabel mesh__D003677 Disease, Deficiency
% 214.27/214.45  |- mesh__recordMaintainer mesh__D003677 lkt
% 214.27/214.45  |- skos__scopeNote mesh__D008362
% 214.27/214.45       Glycosides formed by the reaction of the hydroxyl group on the anomeric carbon atom of mannose with an alcohol to form an acetal. They include both alpha- and beta-mannosides.%A%    
% 214.27/214.45  |- skos__historyNote mesh__D008362 Glycosides %28%1966-1974%29%
% 214.27/214.45  |- mesh__recordOriginator mesh__D008362 NLM
% 214.27/214.45  |- mesh__recordAuthorizer mesh__D008362 sjn
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D008362 2006
% 214.27/214.45  |- mesh__dateCreated mesh__D008362 1974-11-11
% 214.27/214.45  |- mesh__recordMaintainer mesh__D008362 ssb
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D008362 2005
% 214.27/214.45  |- mesh__historyNote mesh__D008362
% 214.27/214.45       91%28%75%29%; was see under GLYCOSIDES 1975-90   
% 214.27/214.45  |- rdf__type mesh__D008362sskos__Concept
% 214.27/214.45  |- skos__historyNote mesh__D008362 Mannose %28%1966-1974%29%
% 214.27/214.45  |- mesh__dateEstablished mesh__D008362 1991-01-01
% 214.27/214.45  |- mesh__dateRevised mesh__D008362 2004-07-07
% 214.27/214.45  |- skos__broader mesh__D008362smesh__D006027
% 214.27/214.45  |- skos__prefLabel mesh__D008362 Mannosides
% 214.27/214.45  |- mesh__publicMeSHNote mesh__D008362
% 214.27/214.45       91; was see under GLYCOSIDES 1975-90   
% 214.27/214.45  |- skos__prefLabel mesh__D032461 Chromosomes, Plant
% 214.27/214.45  |- skos__hiddenLabel mesh__D032461 Plant Chromosome
% 214.27/214.45  |- mesh__dateEstablished mesh__D032461 2003-01-01
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D032461 2006
% 214.27/214.45  |- skos__hiddenLabel mesh__D032461 Chromosome, Plant
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D032461 2005
% 214.27/214.45  |- mesh__publicMeSHNote mesh__D032461 2003   
% 214.27/214.45  |- skos__scopeNote mesh__D032461
% 214.27/214.45       Complex nucleoprotein structures which contain the genomic DNA and are part of the CELL NUCLEUS of PLANTS.%A%    
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D032461 2004
% 214.27/214.45  |- mesh__historyNote mesh__D032461 2003   
% 214.27/214.45  |- rdf__type mesh__D032461sskos__Concept
% 214.27/214.45  |- mesh__dateCreated mesh__D032461 2002-07-03
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D032461 2003
% 214.27/214.45  |- skos__historyNote mesh__D032461 Chromosomes %28%1973-2002%29%
% 214.27/214.45  |- skos__hiddenLabel mesh__D032461 Plant Chromosomes
% 214.27/214.45  |- skos__broader mesh__D032461smesh__D002875
% 214.27/214.45  |- mesh__recordAuthorizer mesh__D004770 ags
% 214.27/214.45  |- skos__broader mesh__D004770smesh__D010849
% 214.27/214.45  |- mesh__recordMaintainer mesh__D004770 ags
% 214.27/214.45  |- skos__scopeNote mesh__D004770
% 214.27/214.45       A genus of the family PICORNAVIRIDAE whose members preferentially inhabit the intestinal tract of a variety of hosts. The genus contains many species. Newly described members of human enteroviruses are assigned continuous numbers with the species designated %22%human enterovirus%22%.%A%    
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D004770 2006
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D004770 2006B
% 214.27/214.45  |- mesh__dateRevised mesh__D004770 2005-07-18
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D004770 2005
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D004770 2006A
% 214.27/214.45  |- mesh__publicMeSHNote mesh__D004770
% 214.27/214.45       94,63-74; was ENTEROVIRUSES 1975-93   
% 214.27/214.45  |- skos__annotation mesh__D004770
% 214.27/214.45       note X ref COXSACKIEVIRUSES: GEN only, prefer specific Coxsackievirus terms; infection = ENTEROVIRUS INFECTIONS or COXSACKIEVIRUS INFECTIONS, follow text%A%  
% 214.27/214.45  |- mesh__dateCreated mesh__D004770 1999-01-01
% 214.27/214.45  |- rdf__type mesh__D004770sskos__Concept
% 214.27/214.45  |- mesh__historyNote mesh__D004770 94,63-74; was ENTEROVIRUSES 1975-93   
% 214.27/214.45  |- mesh__onlineNote mesh__D004770
% 214.27/214.45       use ENTEROVIRUS to search ENTEROVIRUSES 1975-93   
% 214.27/214.45  |- mesh__recordOriginator mesh__D004770 NLM
% 214.27/214.45  |- skos__prefLabel mesh__D004770 Enterovirus
% 214.27/214.45  |- skos__altLabel mesh__D004770 Coxsackie Viruses
% 214.27/214.45  |- mesh__publicMeSHNote mesh__D012404
% 214.27/214.45       91; was see under ADNEXA UTERI 1975-90   
% 214.27/214.45  |- skos__hiddenLabel mesh__D012404 Ligaments, Round
% 214.27/214.45  |- skos__hiddenLabel mesh__D012404 Round Ligaments
% 214.27/214.45  |- skos__hiddenLabel mesh__D012404 Ligament, Round
% 214.27/214.45  |- skos__broader mesh__D012404smesh__D008022
% 214.27/214.45  |- skos__prefLabel mesh__D012404 Round Ligament
% 214.27/214.45  |- mesh__dateEstablished mesh__D012404 1991-01-01
% 214.27/214.45  |- mesh__dateRevised mesh__D012404 2004-07-07
% 214.27/214.45  |- mesh__dateCreated mesh__D012404 1999-01-01
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D012404 2005
% 214.27/214.45  |- mesh__historyNote mesh__D012404
% 214.27/214.45       91%28%75%29%; was see under ADNEXA UTERI 1975-90   
% 214.27/214.45  |- mesh__onlineNote mesh__D012404 search ADNEXA UTERI 1966-74   
% 214.27/214.45  |- skos__broader mesh__D012404smesh__D000290
% 214.27/214.45  |- mesh__recordAuthorizer mesh__D012404 sjn
% 214.27/214.45  |- mesh__recordMaintainer mesh__D012404 lkt
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D012404 2006
% 214.27/214.45  |- rdf__type mesh__D012404sskos__Concept
% 214.27/214.45  |- skos__scopeNote mesh__D012404
% 214.27/214.45       A fibromuscular band that attaches to the UTERUS and then passes along the BROAD LIGAMENT, out through the INGUINAL RING, and into the labium majus.%A%    
% 214.27/214.45  |- mesh__recordOriginator mesh__D012404 NLM
% 214.27/214.45  |- skos__altLabel mesh__D017698 Postmenopausal Period
% 214.27/214.45  |- mesh__recordMaintainer mesh__D017698 lkt
% 214.27/214.45  |- skos__historyNote mesh__D017698 Menstruation %28%1966-1993%29%
% 214.27/214.45  |- rdf__type mesh__D017698sskos__Concept
% 214.27/214.45  |- skos__altLabel mesh__D017698 Post-Menopause
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D017698 2006
% 214.27/214.45  |- mesh__recordOriginator mesh__D017698 TGC
% 214.27/214.45  |- mesh__dateRevised mesh__D017698 2004-07-07
% 214.27/214.45  |- skos__broader mesh__D017698smesh__D008593
% 214.27/214.45  |- skos__hiddenLabel mesh__D017698 Period, Post-menopausal
% 214.27/214.45  |- skos__hiddenLabel mesh__D017698 Period, Postmenopausal
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D017698 2005
% 214.27/214.45  |- skos__hiddenLabel mesh__D017698 Post-Menopauses
% 214.27/214.45  |- mesh__dateEstablished mesh__D017698 1994-01-01
% 214.27/214.45  |- skos__altLabel mesh__D017698 Post-menopausal Period
% 214.27/214.45  |- skos__scopeNote mesh__D017698
% 214.27/214.45       The physiological period following the MENOPAUSE, the permanent cessation of the menstrual life.%A%    
% 214.27/214.45  |- mesh__recordAuthorizer mesh__D017698 sjn
% 214.27/214.45  |- mesh__historyNote mesh__D017698 94   
% 214.27/214.45  |- skos__hiddenLabel mesh__D017698 Post menopausal Period
% 214.27/214.45  |- skos__hiddenLabel mesh__D017698 Post Menopause
% 214.27/214.45  |- mesh__publicMeSHNote mesh__D017698 94   
% 214.27/214.45  |- skos__historyNote mesh__D017698 Menopause %28%1969-1993%29%
% 214.27/214.45  |- skos__historyNote mesh__D017698 Climacteric %28%1969-1993%29%
% 214.27/214.45  |- mesh__dateCreated mesh__D017698 1992-12-28
% 214.27/214.45  |- skos__prefLabel mesh__D017698 Postmenopause
% 214.27/214.45  |- mesh__dateCreated mesh__D031369 2002-07-03
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D031369 2006
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D031369 2004
% 214.27/214.45  |- skos__prefLabel mesh__D031369 Cryptocarya
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D031369 2005
% 214.27/214.45  |- mesh__dateEstablished mesh__D031369 2003-01-01
% 214.27/214.45  |- rdf__type mesh__D031369sskos__Concept
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D031369 2003
% 214.27/214.45  |- skos__broader mesh__D031369smesh__D019770
% 214.27/214.45  |- mesh__historyNote mesh__D031369 2003   
% 214.27/214.45  |- skos__annotation mesh__D031369
% 214.27/214.45       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.27/214.45  |- mesh__publicMeSHNote mesh__D031369 2003   
% 214.27/214.45  |- skos__scopeNote mesh__D031369
% 214.27/214.45       A plant genus of the family LAURACEAE. Members contain cryptofolione, caryachine, grandisin and other compounds.  Some PEUMUS species have been reclassified as CRYPTOCARYA.%A%    
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D003678 2006
% 214.27/214.45  |- mesh__onlineNote mesh__D003678 search HERBICIDES 1969-74   
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D003678 2005
% 214.27/214.45  |- mesh__dateCreated mesh__D003678 1999-01-01
% 214.27/214.45  |- skos__broader mesh__D003678smesh__D006540
% 214.27/214.45  |- rdf__type mesh__D003678sskos__Concept
% 214.27/214.45  |- mesh__historyNote mesh__D003678
% 214.27/214.45       91%28%75%29%; was see under HERBICIDES 1975-90   
% 214.27/214.45  |- mesh__dateEstablished mesh__D003678 1991-01-01
% 214.27/214.45  |- skos__scopeNote mesh__D003678
% 214.27/214.45       Herbicides that remove leaves from trees and growing plants. They may be either organic or inorganic. Several of the more persistent types have been used in military operations and many are toxic. %28%From Hawley%27%s Condensed Chemical Dictionary, 11th ed%29%%A%    
% 214.27/214.45  |- mesh__recordMaintainer mesh__D003678 ssb
% 214.27/214.45  |- mesh__recordAuthorizer mesh__D003678 sjn
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D003678 2004
% 214.27/214.45  |- skos__prefLabel mesh__D003678 Defoliants, Chemical
% 214.27/214.45  |- mesh__recordOriginator mesh__D003678 NLM
% 214.27/214.45  |- mesh__publicMeSHNote mesh__D003678
% 214.27/214.45       91; was see under HERBICIDES 1975-90   
% 214.27/214.45  |- mesh__dateRevised mesh__D003678 2003-07-09
% 214.27/214.45  |- skos__altLabel mesh__D003678 Chemical Defoliants
% 214.27/214.45  |- skos__hiddenLabel mesh__D008363 alpha Mannosidosis
% 214.27/214.45  |- rdf__type mesh__D008363sskos__Concept
% 214.27/214.45  |- skos__hiddenLabel mesh__D008363 Deficiency, alpha-Mannosidase
% 214.27/214.45  |- skos__historyNote mesh__D008363 Mannose %28%1966-1984%29%
% 214.27/214.45  |- skos__related mesh__D008363smesh__D043323
% 214.27/214.45  |- mesh__publicMeSHNote mesh__D008363 2004; see MANNOSIDOSIS 1984-2003   
% 214.27/214.45  |- skos__hiddenLabel mesh__D008363 alpha-Mannosidase Deficiencies
% 214.27/214.45  |- skos__historyNote mesh__D008363 Mannosidases %28%1975-1984%29%
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D008363 2004
% 214.27/214.45  |- mesh__dateCreated mesh__D008363 1984-05-29
% 214.27/214.45  |- skos__broader mesh__D008363smesh__D044904
% 214.27/214.45  |- skos__altLabel mesh__D008363 alpha-Mannosidase Deficiency
% 214.27/214.45  |- skos__prefLabel mesh__D008363 alpha-Mannosidosis
% 214.27/214.45  |- skos__historyNote mesh__D008363
% 214.27/214.45       Carbohydrate Metabolism, Inborn Errors %28%1966-1984%29%
% 214.27/214.45  |- mesh__recordAuthorizer mesh__D008363 sjn
% 214.27/214.45  |- skos__hiddenLabel mesh__D008363 alpha-Mannosidoses
% 214.27/214.45  |- mesh__historyNote mesh__D008363 2004%28%1985%29%;   
% 214.27/214.45  |- skos__historyNote mesh__D008363
% 214.27/214.45       Metabolism, Inborn Errors %28%1966-1984%29%
% 214.27/214.45  |- skos__scopeNote mesh__D008363
% 214.27/214.45       An inborn error of metabolism marked by a defect in the lysosomal isoform of ALPHA-MANNOSIDASE activity that results in lysosomal accumulation of mannose-rich intermediate metabolites. Virtually all patients have psychomotor retardation, facial coarsening, and some degree of dysostosis multiplex. It is thought to be an autosomal recessive disorder.%A%    
% 214.27/214.45  |- mesh__dateRevised mesh__D008363 2003-07-09
% 214.27/214.45  |- skos__hiddenLabel mesh__D008363 Deficiencies, alpha-Mannosidase
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D008363 2006
% 214.27/214.45  |- skos__historyNote mesh__D008363 Mannosidosis %28%1985-2003%29%
% 214.27/214.45  |- skos__altLabel mesh__D008363 Mannosidosis, alpha B, Lysosomal
% 214.27/214.45  |- skos__hiddenLabel mesh__D008363 alpha Mannosidase Deficiency
% 214.27/214.45  |- mesh__recordOriginator mesh__D008363 VDK
% 214.27/214.45  |- mesh__recordMaintainer mesh__D008363 jmp
% 214.27/214.45  |- mesh__dateEstablished mesh__D008363 1985-01-01
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D008363 2005
% 214.27/214.45  |- mesh__recordAuthorizer mesh__D000380 ags
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D000380 2006A
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D000380 2002
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D000380 2006
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D000380 2003
% 214.27/214.45  |- mesh__recordOriginator mesh__D000380 NLM
% 214.27/214.45  |- skos__prefLabel mesh__D000380 Agranulocytosis
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D000380 2001
% 214.27/214.45  |- mesh__dateRevised mesh__D000380 2005-07-15
% 214.27/214.45  |- mesh__dateCreated mesh__D000380 1999-01-01
% 214.27/214.45  |- mesh__recordMaintainer mesh__D000380 ags
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D000380 2005
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D000380 2000
% 214.27/214.45  |- rdf__type mesh__D000380sskos__Concept
% 214.27/214.45  |- skos__scopeNote mesh__D000380
% 214.27/214.45       A decrease in the number of GRANULOCYTES; %28%BASOPHILS; EOSINOPHILS; and NEUTROPHILS%29%.%A%    
% 214.27/214.45  |- skos__broader mesh__D000380smesh__D007970
% 214.27/214.45  |- skos__hiddenLabel mesh__D000380 Agranulocytoses
% 214.27/214.45  |- skos__altLabel mesh__D000380 Granulocytopenia
% 214.27/214.45  |- skos__hiddenLabel mesh__D000380 Granulocytopenias
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D000380 2004
% 214.27/214.45  |- mesh__recordAuthorizer mesh__D018791 sjn
% 214.27/214.45  |- skos__altLabel mesh__D018791 T4 Lymphocyte Count
% 214.27/214.45  |- mesh__publicMeSHNote mesh__D018791 95   
% 214.27/214.45  |- mesh__recordOriginator mesh__D018791 AGS
% 214.27/214.45  |- skos__altLabel mesh__D018791 CD4+ Counts
% 214.27/214.45  |- mesh__historyNote mesh__D018791 95   
% 214.27/214.45  |- skos__altLabel mesh__D018791 CD4+ Cell Counts
% 214.27/214.45  |- skos__hiddenLabel mesh__D018791 T4 Lymphocyte Counts
% 214.27/214.45  |- skos__hiddenLabel mesh__D018791 CD4 Cell Count
% 214.27/214.45  |- mesh__dateEstablished mesh__D018791 1995-01-01
% 214.27/214.45  |- skos__hiddenLabel mesh__D018791 CD4 Lymphocyte Counts
% 214.27/214.45  |- skos__hiddenLabel mesh__D018791 Lymphocyte Counts, CD4
% 214.27/214.45  |- skos__altLabel mesh__D018791 CD4 Counts
% 214.27/214.45  |- skos__altLabel mesh__D018791 Lymphocyte Count, CD4
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D018791 2006
% 214.27/214.45  |- skos__hiddenLabel mesh__D018791 Counts, T4 Lymphocyte
% 214.27/214.45  |- skos__broader mesh__D018791smesh__D018655
% 214.27/214.45  |- skos__hiddenLabel mesh__D018791 Lymphocyte Counts, T4
% 214.27/214.45  |- skos__hiddenLabel mesh__D018791 CD4 Count
% 214.27/214.45  |- skos__hiddenLabel mesh__D018791 Lymphocyte Count, T4
% 214.27/214.45  |- skos__altLabel mesh__D018791 CD4 Cell Counts
% 214.27/214.45  |- skos__hiddenLabel mesh__D018791 CD4+ Cell Count
% 214.27/214.45  |- mesh__dateCreated mesh__D018791 1994-05-23
% 214.27/214.45  |- mesh__recordMaintainer mesh__D018791 nns
% 214.27/214.45  |- skos__hiddenLabel mesh__D018791 Count, T4 Lymphocyte
% 214.27/214.45  |- skos__prefLabel mesh__D018791 CD4 Lymphocyte Count
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D018791 2005
% 214.27/214.45  |- skos__scopeNote mesh__D018791
% 214.27/214.45       The number of CD4-POSITIVE T-LYMPHOCYTES per unit volume of BLOOD. Determination requires the use of a fluorescence-activated flow cytometer.%A%    
% 214.27/214.45  |- skos__historyNote mesh__D018791 Leukocyte Count %28%1988-1994%29%
% 214.27/214.45  |- rdf__type mesh__D018791sskos__Concept
% 214.27/214.45  |- skos__annotation mesh__D018791
% 214.27/214.45       usually NIM; coord with disease /immunol, not /physiopathol%A%  
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D018791 2004
% 214.27/214.45  |- skos__hiddenLabel mesh__D018791 CD4+ Count
% 214.27/214.45  |- mesh__dateRevised mesh__D018791 2003-07-09
% 214.27/214.45  |- skos__broader mesh__D032462smesh__D019681
% 214.27/214.45  |- mesh__recordAuthorizer mesh__D032462 sjn
% 214.27/214.45  |- skos__historyNote mesh__D032462 Gymnosperms %28%1998-2002%29%
% 214.27/214.45  |- mesh__publicMeSHNote mesh__D032462 2003; see GYMNOSPERMS 1998-2002   
% 214.27/214.45  |- mesh__recordOriginator mesh__D032462 ssb
% 214.27/214.45  |- mesh__historyNote mesh__D032462 2003; use GYMNOSPERMS 1998-2002   
% 214.27/214.45  |- mesh__dateEstablished mesh__D032462 2003-01-01
% 214.27/214.45  |- mesh__dateRevised mesh__D032462 2005-06-30
% 214.27/214.45  |- skos__annotation mesh__D032462
% 214.27/214.45       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.27/214.45  |- mesh__recordMaintainer mesh__D032462 ssb
% 214.27/214.45  |- skos__prefLabel mesh__D032462 Cycadophyta
% 214.27/214.45  |- rdf__type mesh__D032462sskos__Concept
% 214.27/214.45  |- skos__scopeNote mesh__D032462
% 214.27/214.45       A division of GYMNOSPERMS which look like palm trees %28%ARECACEAE%29% but are more closely related to PINUS. They have large cones and large pinnate leaves and are sometimes called cycads, a term which may also refer more narrowly to cycadales or CYCAS.%A%    
% 214.27/214.45  |- mesh__dateCreated mesh__D032462 2002-07-03
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D032462 2006
% 214.27/214.45  |- mesh__historyNote mesh__D004771
% 214.27/214.45       91%28%75%29%; was see under ENTEROVIRUSES 1975-90   
% 214.27/214.45  |- skos__annotation mesh__D004771
% 214.27/214.45       infection: coord IM with ENTEROVIRUS INFECTIONS %28%IM%29%   
% 214.27/214.45  |- skos__hiddenLabel mesh__D004771 Enterovirus, Porcine
% 214.27/214.45  |- mesh__recordOriginator mesh__D004771 NLM
% 214.27/214.45  |- skos__broader mesh__D004771smesh__D004770
% 214.27/214.45  |- skos__altLabel mesh__D004771 Teschen Disease Virus
% 214.27/214.45  |- rdf__type mesh__D004771sskos__Concept
% 214.27/214.45  |- skos__prefLabel mesh__D004771 Enteroviruses, Porcine
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D004771 2002
% 214.27/214.45  |- mesh__recordAuthorizer mesh__D004771 sjn
% 214.27/214.45  |- mesh__dateEstablished mesh__D004771 1991-01-01
% 214.27/214.45  |- mesh__dateCreated mesh__D004771 1974-12-12
% 214.27/214.45  |- skos__scopeNote mesh__D004771
% 214.27/214.45       Species of ENTEROVIRUS causing mild to severe neurological diseases among pigs especially in Eastern Europe. Mild strains are also present in Canada, U.S., and Australia. Specific species include Porcine enterovirus A and Porcine enterovirus B.%A%    
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D004771 2004
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D004771 2006
% 214.27/214.45  |- mesh__publicMeSHNote mesh__D004771
% 214.27/214.45       91; was see under ENTEROVIRUSES 1975-90   
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D004771 2003
% 214.27/214.45  |- mesh__dateRevised mesh__D004771 2001-07-25
% 214.27/214.45  |- skos__hiddenLabel mesh__D004771 Porcine Enterovirus
% 214.27/214.45  |- mesh__recordMaintainer mesh__D004771 ags
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D004771 2005
% 214.27/214.45  |- skos__altLabel mesh__D004771 Porcine Enteroviruses
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D012405 1999
% 214.27/214.45  |- skos__broader mesh__D012405smesh__D003051
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D012405 2001
% 214.27/214.45  |- mesh__dateEstablished mesh__D012405 1991-01-01
% 214.27/214.45  |- mesh__dateCreated mesh__D012405 1978-05-19
% 214.27/214.45  |- skos__hiddenLabel mesh__D012405 Round Windows
% 214.27/214.45  |- mesh__dateRevised mesh__D012405 1997-06-20
% 214.27/214.45  |- mesh__publicMeSHNote mesh__D012405 91; was see under COCHLEA 1979-90   
% 214.27/214.45  |- skos__annotation mesh__D012405
% 214.27/214.45       do not confuse with OVAL WINDOW in vestib appar   
% 214.27/214.45  |- skos__prefLabel mesh__D012405 Round Window
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D012405 2005
% 214.27/214.45  |- mesh__historyNote mesh__D012405
% 214.27/214.45       91%28%79%29%; was see under COCHLEA 1979-90   
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D012405 2002
% 214.27/214.45  |- skos__hiddenLabel mesh__D012405 Window, Round
% 214.27/214.45  |- skos__scopeNote mesh__D012405
% 214.27/214.45       Fenestra of the cochlea; an opening in the medial wall of the middle ear leading into the cochlea.%A%    
% 214.27/214.45  |- skos__hiddenLabel mesh__D012405 Windows, Round
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D012405 2006
% 214.27/214.45  |- rdf__type mesh__D012405sskos__Concept
% 214.27/214.45  |- mesh__recordOriginator mesh__D012405 RC
% 214.27/214.45  |- skos__historyNote mesh__D012405 Cochlea %28%1966-1978%29%
% 214.27/214.45  |- mesh__recordAuthorizer mesh__D012405 SJN
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D012405 2003
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D012405 2000
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D012405 1998
% 214.27/214.45  |- mesh__recordMaintainer mesh__D012405 TPW
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D012405 2004
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D017699 2005
% 214.27/214.45  |- mesh__recordAuthorizer mesh__D017699 sjn
% 214.27/214.45  |- skos__scopeNote mesh__D017699
% 214.27/214.45       Pain in the pelvic region of genital and non-genital origin and of organic or psychogenic etiology. Frequent causes of pain are distension or contraction of hollow viscera, rapid stretching of the capsule of a solid organ, chemical irritation, tissue ischemia, and neuritis secondary to inflammatory, neoplastic, or fibrotic processes in adjacent organs. %28%Kase, Weingold %26% Gershenson: Principles and Practice of Clinical Gynecology, 2d ed, pp479-508%29%%A%    
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D017699 2000
% 214.27/214.45  |- mesh__publicMeSHNote mesh__D017699 94   
% 214.27/214.45  |- rdf__type mesh__D017699sskos__Concept
% 214.27/214.45  |- skos__historyNote mesh__D017699 Pelvis %28%1966-1993%29%
% 214.27/214.45  |- skos__historyNote mesh__D017699 Pain %28%1966-1993%29%
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D017699 2006
% 214.27/214.45  |- mesh__dateRevised mesh__D017699 1999-11-03
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D017699 2003
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D017699 2001
% 214.27/214.45  |- skos__hiddenLabel mesh__D017699 Pain, Pelvic
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D017699 2004
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D017699 2002
% 214.27/214.45  |- skos__annotation mesh__D017699 refers to region, not pelvic bones   
% 214.27/214.45  |- mesh__recordMaintainer mesh__D017699 TAP
% 214.27/214.45  |- mesh__recordOriginator mesh__D017699 TGC
% 214.27/214.45  |- mesh__dateCreated mesh__D017699 1993-08-09
% 214.27/214.45  |- skos__prefLabel mesh__D017699 Pelvic Pain
% 214.27/214.45  |- mesh__historyNote mesh__D017699 94   
% 214.27/214.45  |- skos__hiddenLabel mesh__D017699 Pelvic Pains
% 214.27/214.45  |- mesh__dateEstablished mesh__D017699 1994-01-01
% 214.27/214.45  |- skos__hiddenLabel mesh__D017699 Pains, Pelvic
% 214.27/214.45  |- skos__broader mesh__D017699smesh__D010146
% 214.27/214.45  |- mesh__recordOriginator mesh__D003679 NLM
% 214.27/214.45  |- skos__prefLabel mesh__D003679 Deglutition
% 214.27/214.45  |- skos__broader mesh__D003679smesh__D004068
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D003679 1993
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D003679 2001
% 214.27/214.45  |- skos__altLabel mesh__D003679 Swallowing
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D003679 2004
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D003679 1999
% 214.27/214.45  |- skos__hiddenLabel mesh__D003679 Swallowings
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D003679 2000
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D003679 2003
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D003679 1998
% 214.27/214.45  |- mesh__dateRevised mesh__D003679 1992-05-14
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D003679 1995
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D003679 2006
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D003679 1994
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D003679 2002
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D003679 2005
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D003679 1997
% 214.27/214.45  |- mesh__recordMaintainer mesh__D003679 TAP
% 214.27/214.45  |- mesh__dateCreated mesh__D003679 1999-01-01
% 214.27/214.45  |- rdf__type mesh__D003679sskos__Concept
% 214.27/214.45  |- mesh__recordAuthorizer mesh__D003679 PLS
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D003679 1996
% 214.27/214.45  |- skos__hiddenLabel mesh__D003679 Deglutitions
% 214.27/214.45  |- skos__broader mesh__D008364smesh__D006602
% 214.27/214.45  |- mesh__dateEstablished mesh__D008364 1991-01-01
% 214.27/214.45  |- skos__historyNote mesh__D008364 Hexosyltransferases %28%1973-1974%29%
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D008364 2004
% 214.27/214.45  |- mesh__dateCreated mesh__D008364 1974-11-19
% 214.27/214.45  |- mesh__publicMeSHNote mesh__D008364
% 214.27/214.45       91; was see under HEXOSYLTRANSFERASES 1975-90   
% 214.27/214.45  |- mesh__dateRevised mesh__D008364 2003-07-09
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D008364 2006
% 214.27/214.45  |- skos__scopeNote mesh__D008364
% 214.27/214.45       Enzymes that catalyze the transfer of mannose from a nucleoside diphosphate mannose to an acceptor molecule which is frequently another carbohydrate. The group includes EC 2.4.1.32, EC 2.4.1.48, EC 2.4.1.54, and EC 2.4.1.57.%A%    
% 214.27/214.45  |- mesh__recordAuthorizer mesh__D008364 sjn
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D008364 2005
% 214.27/214.45  |- mesh__recordOriginator mesh__D008364 NLM
% 214.27/214.45  |- skos__historyNote mesh__D008364 Mannose %28%1973-1974%29%
% 214.27/214.45  |- mesh__recordMaintainer mesh__D008364 ssb
% 214.27/214.45  |- skos__prefLabel mesh__D008364 Mannosyltransferases
% 214.27/214.45  |- rdf__type mesh__D008364sskos__Concept
% 214.27/214.45  |- mesh__historyNote mesh__D008364
% 214.27/214.45       91%28%75%29%; was see under HEXOSYLTRANSFERASES 1975-90   
% 214.27/214.45  |- skos__hiddenLabel mesh__D000381 Developmental Dysgraphias
% 214.27/214.45  |- mesh__dateCreated mesh__D000381 1999-01-01
% 214.27/214.45  |- skos__hiddenLabel mesh__D000381 Agraphias, Developmental
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D000381 2004
% 214.27/214.45  |- mesh__dateRevised mesh__D000381 2000-06-21
% 214.27/214.45  |- skos__hiddenLabel mesh__D000381 Agraphias, Constructional
% 214.27/214.45  |- skos__altLabel mesh__D000381 Developmental Dysgraphia
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D000381 2002
% 214.27/214.45  |- skos__hiddenLabel mesh__D000381 Agraphias, Pure
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D000381 2006
% 214.27/214.45  |- skos__hiddenLabel mesh__D000381 Pure Agraphias
% 214.27/214.45  |- mesh__recordMaintainer mesh__D000381 ags
% 214.27/214.45  |- skos__hiddenLabel mesh__D000381 Dysgraphias, Acquired
% 214.27/214.45  |- skos__hiddenLabel mesh__D000381 Dysgraphias
% 214.27/214.45  |- skos__altLabel mesh__D000381 Acquired Dysgraphia
% 214.27/214.45  |- skos__hiddenLabel mesh__D000381 Agraphias
% 214.27/214.45  |- skos__hiddenLabel mesh__D000381 Developmental Agraphias
% 214.27/214.45  |- rdf__type mesh__D000381sskos__Concept
% 214.27/214.45  |- skos__hiddenLabel mesh__D000381 Agraphia, Constructional
% 214.27/214.45  |- mesh__activeMeSHYear mesh__D000381 2001
% 214.27/214.45  |- mesh__recordAuthorizer mesh__D000381 sjn
% 214.27/214.45  |- mesh__recordOriginator mesh__D000381 NLM
% 214.27/214.45  |- skos__prefLabel mesh__D000381 Agraphia
% 214.27/214.45  |- skos__scopeNote mesh__D000381
% 214.27/214.45       Loss or impairment of the ability to write %28%letters, syllables, words, or phrases%29% due to an injury to a specific cerebral area or occasionally due to emotional factors. This condition rarely occurs in isolation, and often accompanies APHASIA. %28%From Adams et al., Principles of Neurology, 6th ed, p485; APA, Thesaurus of Psychological Index Terms, 1994%29%%A%    
% 214.27/214.45  |- skos__hiddenLabel mesh__D000381 Acquired Dysgraphias
% 214.27/214.46  |- skos__hiddenLabel mesh__D000381 Constructional Agraphias
% 214.27/214.46  |- skos__hiddenLabel mesh__D000381 Agraphia, Pure
% 214.27/214.46  |- skos__hiddenLabel mesh__D000381 Agraphia, Developmental
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000381 2003
% 214.27/214.46  |- skos__hiddenLabel mesh__D000381 Dysgraphias, Developmental
% 214.27/214.46  |- skos__hiddenLabel mesh__D000381 Agraphias, Acquired
% 214.27/214.46  |- skos__hiddenLabel mesh__D000381 Agraphia, Acquired
% 214.27/214.46  |- skos__hiddenLabel mesh__D000381 Dysgraphia, Acquired
% 214.27/214.46  |- skos__hiddenLabel mesh__D000381 Acquired Agraphias
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000381 2005
% 214.27/214.46  |- skos__broader mesh__D000381smesh__D007806
% 214.27/214.46  |- skos__hiddenLabel mesh__D000381 Dysgraphia, Developmental
% 214.27/214.46  |- mesh__dateEstablished mesh__D018792 1995-01-01
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D018792 2002
% 214.27/214.46  |- skos__scopeNote mesh__D018792
% 214.27/214.46       Inflammation of brain parenchymal tissue as a result of viral infection. Encephalitis may occur as primary or secondary manifestation of TOGAVIRIDAE INFECTIONS; HERPESVIRIDAE INFECTIONS; ADENOVIRIDAE INFECTIONS; FLAVIVIRIDAE INFECTIONS; BUNYAVIRIDAE INFECTIONS; PICORNAVIRIDAE INFECTIONS; PARAMYXOVIRIDAE INFECTIONS; ORTHOMYXOVIRIDAE INFECTIONS; RETROVIRIDAE INFECTIONS; and ARENAVIRIDAE INFECTIONS.%A%    
% 214.27/214.46  |- mesh__historyNote mesh__D018792 1995   
% 214.27/214.46  |- skos__hiddenLabel mesh__D018792 Encephalomyelitis, Viral Infectious
% 214.27/214.46  |- skos__altLabel mesh__D018792 Encephalomyelitis, Infectious, Viral
% 214.27/214.46  |- mesh__recordOriginator mesh__D018792 AGS
% 214.27/214.46  |- mesh__dateRevised mesh__D018792 1999-12-13
% 214.27/214.46  |- mesh__recordAuthorizer mesh__D018792 ags
% 214.27/214.46  |- skos__historyNote mesh__D018792 Encephalitis %28%1966-1994%29%
% 214.27/214.46  |- skos__broader mesh__D018792smesh__D004660
% 214.27/214.46  |- skos__annotation mesh__D018792
% 214.27/214.46       coord IM with specific virus infection %28%IM%29%; DF: ENCEPH VIRAL%A%  
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D018792 2000
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D018792 2005
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D018792 2000A
% 214.27/214.46  |- skos__hiddenLabel mesh__D018792 Viral Infectious Encephalomyelitis
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D018792 2006
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D018792 2001
% 214.27/214.46  |- mesh__publicMeSHNote mesh__D018792 1995   
% 214.27/214.46  |- skos__broader mesh__D018792smesh__D014777
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D018792 2003
% 214.27/214.46  |- mesh__dateCreated mesh__D018792 1994-05-23
% 214.27/214.46  |- mesh__recordMaintainer mesh__D018792 ags
% 214.27/214.46  |- skos__altLabel mesh__D018792 Viral Encephalitis
% 214.27/214.46  |- rdf__type mesh__D018792sskos__Concept
% 214.27/214.46  |- skos__prefLabel mesh__D018792 Encephalitis, Viral
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D018792 2004
% 214.27/214.46  |- skos__altLabel mesh__D018792 Infectious Encephalomyelitis, Viral
% 214.27/214.46  |- mesh__recordMaintainer mesh__D004772 lkt
% 214.27/214.46  |- rdf__type mesh__D004772sskos__Concept
% 214.27/214.46  |- skos__prefLabel mesh__D004772 Entomology
% 214.27/214.46  |- skos__annotation mesh__D004772 SPEC: SPEC qualif; DF: ENTOMOL   
% 214.27/214.46  |- mesh__dateRevised mesh__D004772 2003-07-09
% 214.27/214.46  |- mesh__recordOriginator mesh__D004772 NLM
% 214.27/214.46  |- skos__broader mesh__D004772smesh__D015046
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D004772 2004
% 214.27/214.46  |- mesh__recordAuthorizer mesh__D004772 sjn
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D004772 2006
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D004772 2005
% 214.27/214.46  |- skos__scopeNote mesh__D004772
% 214.27/214.46       A discipline or occupation concerned with the study of INSECTS, including the biology and the control of insects.%A%    
% 214.27/214.46  |- mesh__dateCreated mesh__D004772 1999-01-01
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D012406 2005
% 214.27/214.46  |- mesh__recordMaintainer mesh__D012406 SYSTEM
% 214.27/214.46  |- skos__altLabel mesh__D012406 3-Nitro-4-Hydroxyphenylarsonic Acid
% 214.27/214.46  |- skos__scopeNote mesh__D012406
% 214.27/214.46       An arsenic derivative which has anticoccidial action and promotes growth in animals.%A%    
% 214.27/214.46  |- skos__historyNote mesh__D012406 Nitrophenols %28%1972-1974%29%
% 214.27/214.46  |- skos__hiddenLabel mesh__D012406 3 Nitro 4 Hydroxyphenylarsonic Acid
% 214.27/214.46  |- skos__historyNote mesh__D012406 Arsenicals %28%1970-1974%29%
% 214.27/214.46  |- mesh__dateRevised mesh__D012406 2003-07-30
% 214.27/214.46  |- mesh__dateEstablished mesh__D012406 1991-01-01
% 214.27/214.46  |- skos__hiddenLabel mesh__D012406 3Nitro10
% 214.27/214.46  |- skos__broader mesh__D012406smesh__D001152
% 214.27/214.46  |- skos__prefLabel mesh__D012406 Roxarsone
% 214.27/214.46  |- mesh__recordOriginator mesh__D012406 NLM
% 214.27/214.46  |- mesh__recordAuthorizer mesh__D012406 NLM
% 214.27/214.46  |- skos__hiddenLabel mesh__D012406 3 Nitro 10
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D012406 2006
% 214.27/214.46  |- mesh__publicMeSHNote mesh__D012406
% 214.27/214.46       91; was see under ARSENICALS 1975-90   
% 214.27/214.46  |- rdf__type mesh__D012406sskos__Concept
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D012406 2004
% 214.27/214.46  |- skos__hiddenLabel mesh__D012406 Acid, 3-Nitro-4-Hydroxyphenylarsonic
% 214.27/214.46  |- mesh__dateCreated mesh__D012406 1974-11-19
% 214.27/214.46  |- mesh__historyNote mesh__D012406
% 214.27/214.46       91%28%75%29%; was see under ARSENICALS 1975-90   
% 214.27/214.46  |- skos__scopeNote mesh__D008365
% 214.27/214.46       Measurement of the pressure or tension of liquids or gases with a manometer.%A%    
% 214.27/214.46  |- mesh__recordAuthorizer mesh__D008365 sjn
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D008365 2004
% 214.27/214.46  |- skos__prefLabel mesh__D008365 Manometry
% 214.27/214.46  |- mesh__recordOriginator mesh__D008365 NLM
% 214.27/214.46  |- skos__hiddenLabel mesh__D008365 Manometries
% 214.27/214.46  |- skos__broader mesh__D008365smesh__D008919
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D008365 2005
% 214.27/214.46  |- skos__annotation mesh__D008365
% 214.27/214.46       for measurement of intraocular pressure use TONOMETRY, OCULAR; NIM%A%  
% 214.27/214.46  |- mesh__recordMaintainer mesh__D008365 lkt
% 214.27/214.46  |- mesh__dateRevised mesh__D008365 2003-07-09
% 214.27/214.46  |- mesh__historyNote mesh__D008365
% 214.27/214.46       1963; for TONOMETRY use TONOMETRY 1963-2003   
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D008365 2006
% 214.27/214.46  |- mesh__dateCreated mesh__D008365 1999-01-01
% 214.27/214.46  |- mesh__publicMeSHNote mesh__D008365
% 214.27/214.46       1963; for TONOMETRY see TONOMETRY 1963-2003   
% 214.27/214.46  |- rdf__type mesh__D008365sskos__Concept
% 214.27/214.46  |- rdf__type mesh__D000382sskos__Concept
% 214.27/214.46  |- skos__hiddenLabel mesh__D000382 Agricultural Workers Diseases
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000382 2003
% 214.27/214.46  |- skos__hiddenLabel mesh__D000382 Disease, Agricultural Workers%27%
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000382 1995
% 214.27/214.46  |- skos__hiddenLabel mesh__D000382 Disease, Agricultural Worker%27%s
% 214.27/214.46  |- skos__altLabel mesh__D000382 Agricultural Worker%27%s Disease
% 214.27/214.46  |- mesh__dateCreated mesh__D000382 1999-01-01
% 214.27/214.46  |- skos__scopeNote mesh__D000382
% 214.27/214.46       Diseases in persons engaged in cultivating and tilling soil, growing plants, harvesting crops, raising livestock, or otherwise engaged in husbandry and farming. The diseases are not restricted to farmers in the sense of those who perform conventional farm chores: the heading applies also to those engaged in the individual activities named above, as in those only gathering harvest or in those only dusting crops.%A%    
% 214.27/214.46  |- skos__hiddenLabel mesh__D000382 Agricultural Worker%27%s Diseases
% 214.27/214.46  |- skos__hiddenLabel mesh__D000382 Workers%27% Diseases, Agricultural
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000382 2002
% 214.27/214.46  |- mesh__recordAuthorizer mesh__D000382 PLS
% 214.27/214.46  |- mesh__recordMaintainer mesh__D000382 TGC
% 214.27/214.46  |- mesh__dateRevised mesh__D000382 1993-02-16
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000382 1999
% 214.27/214.46  |- skos__hiddenLabel mesh__D000382 Worker%27%s Disease, Agricultural
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000382 1994
% 214.27/214.46  |- skos__altLabel mesh__D000382 Agricultural Worker Disease
% 214.27/214.46  |- skos__hiddenLabel mesh__D000382 Agricultural Workers Disease
% 214.27/214.46  |- skos__hiddenLabel mesh__D000382 Diseases, Agricultural Worker%27%s
% 214.27/214.46  |- skos__hiddenLabel mesh__D000382 Disease, Agricultural Worker
% 214.27/214.46  |- skos__prefLabel mesh__D000382 Agricultural Workers%27% Diseases
% 214.27/214.46  |- skos__hiddenLabel mesh__D000382 Worker Diseases, Agricultural
% 214.27/214.46  |- skos__hiddenLabel mesh__D000382 Worker%27%s Diseases, Agricultural
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000382 1998
% 214.27/214.46  |- skos__hiddenLabel mesh__D000382 Workers%27% Disease, Agricultural
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000382 1997
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000382 2006
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000382 2001
% 214.27/214.46  |- skos__hiddenLabel mesh__D000382 Worker Disease, Agricultural
% 214.27/214.46  |- skos__broader mesh__D000382smesh__D009784
% 214.27/214.46  |- mesh__recordOriginator mesh__D000382 NLM
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000382 1996
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000382 2005
% 214.27/214.46  |- skos__hiddenLabel mesh__D000382 Agricultural Workers%27% Disease
% 214.27/214.46  |- skos__hiddenLabel mesh__D000382 Diseases, Agricultural Workers%27%
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000382 2000
% 214.27/214.46  |- skos__hiddenLabel mesh__D000382 Agricultural Worker Diseases
% 214.27/214.46  |- skos__hiddenLabel mesh__D000382 Diseases, Agricultural Worker
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000382 2004
% 214.27/214.46  |- skos__annotation mesh__D000382
% 214.27/214.46       coord IM with specific dis %28%IM%29%; specify geog if pertinent%A%  
% 214.27/214.46  |- skos__broader mesh__D006615Q000293smesh__D006615
% 214.27/214.46  |- mesh__preferredCombination mesh__D006615Q000293smesh__D025981
% 214.27/214.46  |- rdf__type mesh__D006615Q000293smesh__CompoundConcept
% 214.27/214.46  |- mesh__dateEstablished mesh__D018793 1995-01-01
% 214.27/214.46  |- mesh__dateRevised mesh__D018793 2005-06-30
% 214.27/214.46  |- skos__altLabel mesh__D018793 IL-13
% 214.27/214.46  |- skos__broader mesh__D018793smesh__D007378
% 214.27/214.46  |- skos__altLabel mesh__D018793 IL 13
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D018793 2006
% 214.27/214.46  |- mesh__recordOriginator mesh__D018793 AGS
% 214.27/214.46  |- skos__prefLabel mesh__D018793 Interleukin-13
% 214.27/214.46  |- skos__historyNote mesh__D018793 Interleukins %28%1993-1994%29%
% 214.27/214.46  |- skos__altLabel mesh__D018793 Interleukin 13
% 214.27/214.46  |- skos__scopeNote mesh__D018793
% 214.27/214.46       T-lymphocyte-derived cytokine that produces proliferation, immunoglobulin isotype switching, and immunoglobulin production by immature B-lymphocytes. It appears to play a role in regulating inflammatory and immune responses.%A%    
% 214.27/214.46  |- mesh__onlineNote mesh__D018793
% 214.27/214.46       use INTERLEUKIN-13 %28%NM%29% to search INTERLEUKIN 13 1993-94   
% 214.27/214.46  |- skos__altLabel mesh__D018793 IL13
% 214.27/214.46  |- rdf__type mesh__D018793sskos__Concept
% 214.27/214.46  |- mesh__recordAuthorizer mesh__D018793 sjn
% 214.27/214.46  |- mesh__publicMeSHNote mesh__D018793
% 214.27/214.46       95; INTERLEUKIN 13 was indexed under INTERLEUKINS 1993-94%A%  
% 214.27/214.46  |- mesh__historyNote mesh__D018793
% 214.27/214.46       95; was INTERLEUKIN 13 %28%NM%29% 1993-94   
% 214.27/214.46  |- mesh__recordMaintainer mesh__D018793 ssb
% 214.27/214.46  |- skos__annotation mesh__D018793 DF: IL 13 or IL13   
% 214.27/214.46  |- mesh__dateCreated mesh__D018793 1994-05-23
% 214.27/214.46  |- mesh__recordAuthorizer mesh__D004773 sjn
% 214.27/214.46  |- rdf__type mesh__D004773sskos__Concept
% 214.27/214.46  |- mesh__historyNote mesh__D004773 91%28%75%29%   
% 214.27/214.46  |- skos__scopeNote mesh__D004773
% 214.27/214.46       A genus of fungi in the family Entomophthoraceae, order Entomorphthorales. They are primarily parasites of insects and spiders, but have been found to cause mycotic infections of the nose in man and horses.%A%    
% 214.27/214.46  |- mesh__publicMeSHNote mesh__D004773
% 214.27/214.46       91; see ZYGOMYCOTINA 1986-90, see ZYGOMYCETES 1979-85, see PHYCOMYCETES 1975-78%A%  
% 214.27/214.46  |- mesh__dateCreated mesh__D004773 1974-12-12
% 214.27/214.46  |- skos__broader mesh__D004773smesh__D020091
% 214.27/214.46  |- mesh__dateRevised mesh__D004773 2005-06-30
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D004773 2006
% 214.27/214.46  |- skos__annotation mesh__D004773
% 214.27/214.46       infection: coord IM with ZYGOMYCOSIS %28%IM%29%   
% 214.27/214.46  |- mesh__recordOriginator mesh__D004773 NLM
% 214.27/214.46  |- mesh__recordMaintainer mesh__D004773 SYSTEM
% 214.27/214.46  |- skos__prefLabel mesh__D004773 Entomophthora
% 214.27/214.46  |- mesh__dateEstablished mesh__D004773 1991-01-01
% 214.27/214.46  |- skos__historyNote mesh__D012407 RNA, Ribosomal %28%1977-1987%29%
% 214.27/214.46  |- skos__historyNote mesh__D012407 Operon %28%1977-1987%29%
% 214.27/214.46  |- skos__prefLabel mesh__D012407 rRNA Operon
% 214.27/214.46  |- skos__hiddenLabel mesh__D012407 Operon, rrnB
% 214.27/214.46  |- skos__broader mesh__D012407smesh__D009876
% 214.27/214.46  |- mesh__dateEstablished mesh__D012407 1991-01-01
% 214.27/214.46  |- mesh__dateCreated mesh__D012407 1987-05-09
% 214.27/214.46  |- skos__scopeNote mesh__D012407
% 214.27/214.46       Genetic loci which direct transcription of ribosomal RNA in bacterial operons. They are designated rrnB, rrnC, rrnD, etc. according to the structural position of the transcription unit in the DNA sequence.%A%    
% 214.27/214.46  |- mesh__recordAuthorizer mesh__D012407 sjn
% 214.27/214.46  |- skos__related mesh__D012407smesh__D020459
% 214.27/214.46  |- mesh__dateRevised mesh__D012407 2005-06-30
% 214.27/214.46  |- mesh__recordOriginator mesh__D012407 SCD
% 214.27/214.46  |- skos__hiddenLabel mesh__D012407 rrnB Operons
% 214.27/214.46  |- mesh__historyNote mesh__D012407
% 214.27/214.46       91%28%88%29%; was see under OPERON 1988-90   
% 214.27/214.46  |- skos__hiddenLabel mesh__D012407 Operons, rrnB
% 214.27/214.46  |- mesh__publicMeSHNote mesh__D012407 91; was see under OPERON 1988-90   
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D012407 2006
% 214.27/214.46  |- rdf__type mesh__D012407sskos__Concept
% 214.27/214.46  |- skos__historyNote mesh__D012407
% 214.27/214.46       Promoter Regions %28%Genetics%29% %28%1985-1987%29%
% 214.27/214.46  |- mesh__recordMaintainer mesh__D012407 nns
% 214.27/214.46  |- skos__altLabel mesh__D012407 Operon, rRNA
% 214.27/214.46  |- skos__hiddenLabel mesh__D012407 Operons, rRNA
% 214.27/214.46  |- skos__hiddenLabel mesh__D012407 rRNA Operons
% 214.27/214.46  |- mesh__historyNote mesh__D008366
% 214.27/214.46       MANSONELLA OZZARDI was heading 1975-96 %28%see under MANSONELLA 1979-90, was FILARIA OZZARDI see under MANSONELLA 1975-78%29%, was FILARIA OZZARDI see under MANSONELLA 1963-74; FILARIA DEMARQUAYI was see under MANSONELLA 1963-78, was see MANSONELLA OZZARDI 1979-96; FILARIA OZZARDI was see MANSONELLA OZZARDI 1979-96%A%  
% 214.27/214.46  |- skos__altLabel mesh__D008366 Tetrapetalonema
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D008366 2005
% 214.27/214.46  |- skos__altLabel mesh__D008366 Mansonella ozzardi
% 214.27/214.46  |- mesh__dateRevised mesh__D008366 2003-07-09
% 214.27/214.46  |- mesh__recordAuthorizer mesh__D008366 sjn
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D008366 2006
% 214.27/214.46  |- mesh__recordOriginator mesh__D008366 NLM
% 214.27/214.46  |- mesh__publicMeSHNote mesh__D008366
% 214.27/214.46       MANSONELLA OZZARDI was heading 1975-96 %28%see under MANSONELLA 1979-90, was FILARIA OZZARDI see under MANSONELLA 1975-78%29%, was FILARIA OZZARDI see under MANSONELLA 1963-74; FILARIA DEMARQUAYI was see under MANSONELLA 1963-78, was see MANSONELLA OZZARDI 1979-96; FILARIA OZZARDI was see MANSONELLA OZZARDI 1979-96%A%  
% 214.27/214.46  |- skos__prefLabel mesh__D008366 Mansonella
% 214.27/214.46  |- mesh__dateCreated mesh__D008366 1999-01-01
% 214.27/214.46  |- rdf__type mesh__D008366sskos__Concept
% 214.27/214.46  |- skos__broader mesh__D008366smesh__D005370
% 214.27/214.46  |- skos__annotation mesh__D008366
% 214.27/214.46       infection = MANSONELLIASIS; coord with specific helminth term %28%ANTIGENS, HELMINTH, etc%29% if pertinent; /drug eff: consider FILARICIDES%A%  
% 214.27/214.46  |- mesh__recordMaintainer mesh__D008366 ags
% 214.27/214.46  |- skos__altLabel mesh__D008366 Filaria ozzardi
% 214.27/214.46  |- skos__altLabel mesh__D008366 Acanthocheilonema perstans
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D008366 2004
% 214.27/214.46  |- skos__scopeNote mesh__D008366
% 214.27/214.46       A genus of parasitic nematodes whose organisms are distributed in Central and South America. Characteristics include a smooth cuticle and an enlarged anterior end.%A%    
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000383 2000
% 214.27/214.46  |- mesh__recordAuthorizer mesh__D000383 PLS
% 214.27/214.46  |- skos__hiddenLabel mesh__D000383 Supplies, Land
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000383 2003
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000383 1996
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000383 2001
% 214.27/214.46  |- mesh__recordOriginator mesh__D000383 NLM
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000383 2005
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000383 1998
% 214.27/214.46  |- skos__hiddenLabel mesh__D000383 Workers, Agricultural
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000383 1992
% 214.27/214.46  |- skos__hiddenLabel mesh__D000383 Development, Agricultural
% 214.27/214.46  |- mesh__dateCreated mesh__D000383 1999-01-01
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000383 2004
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000383 1997
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000383 1994
% 214.27/214.46  |- skos__hiddenLabel mesh__D000383 Agricultural Worker
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000383 2006
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000383 1999
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000383 1993
% 214.27/214.46  |- mesh__recordMaintainer mesh__D000383 PLS
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000383 1995
% 214.27/214.46  |- skos__broader mesh__D000383smesh__D013676
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D000383 2002
% 214.27/214.46  |- skos__prefLabel mesh__D000383 Agriculture
% 214.27/214.46  |- skos__hiddenLabel mesh__D000383 Worker, Agricultural
% 214.27/214.46  |- mesh__dateRevised mesh__D000383 1993-11-29
% 214.27/214.46  |- skos__hiddenLabel mesh__D000383 Supply, Land
% 214.27/214.46  |- skos__scopeNote mesh__D000383
% 214.27/214.46       The science of soil cultivation, crop production, and livestock raising.%A%    
% 214.27/214.46  |- skos__hiddenLabel mesh__D000383 Land Supplies
% 214.27/214.46  |- skos__annotation mesh__D000383 SPEC: SPEC qualif   
% 214.27/214.46  |- rdf__type mesh__D000383sskos__Concept
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D013500 1994
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D013500 2004
% 214.27/214.46  |- mesh__dateRevised mesh__D013500 1992-05-26
% 214.27/214.46  |- mesh__dateCreated mesh__D013500 1999-01-01
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D013500 2000
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D013500 1999
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D013500 1993
% 214.27/214.46  |- mesh__recordAuthorizer mesh__D013500 PLS
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D013500 2003
% 214.27/214.46  |- rdf__type mesh__D013500sskos__Concept
% 214.27/214.46  |- skos__prefLabel mesh__D013500 Surface Tension
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D013500 1998
% 214.27/214.46  |- skos__hiddenLabel mesh__D013500 Tensions, Surface
% 214.27/214.46  |- skos__broader mesh__D013500smesh__D013499
% 214.27/214.46  |- mesh__recordOriginator mesh__D013500 NLM
% 214.27/214.46  |- skos__hiddenLabel mesh__D013500 Tension, Surface
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D013500 1997
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D013500 2006
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D013500 2002
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D013500 1996
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D013500 1995
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D013500 2005
% 214.27/214.46  |- mesh__recordMaintainer mesh__D013500 TAP
% 214.27/214.46  |- skos__hiddenLabel mesh__D013500 Surface Tensions
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D013500 2001
% 214.27/214.46  |- skos__annotation mesh__D013500 NIM   
% 214.27/214.46  |- skos__altLabel mesh__D018794 Active Learning
% 214.27/214.46  |- skos__hiddenLabel mesh__D018794 Learning, Active
% 214.27/214.46  |- mesh__publicMeSHNote mesh__D018794 95   
% 214.27/214.46  |- mesh__dateCreated mesh__D018794 1994-06-01
% 214.27/214.46  |- skos__hiddenLabel mesh__D018794 Curricula, Problem-Based
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D018794 2003
% 214.27/214.46  |- skos__broader mesh__D018794smesh__D013663
% 214.27/214.46  |- skos__scopeNote mesh__D018794
% 214.27/214.46       Instructional use of examples or cases to teach using problem-solving skills and critical thinking.%A%    
% 214.27/214.46  |- rdf__type mesh__D018794sskos__Concept
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D018794 2001
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D018794 2004
% 214.27/214.46  |- mesh__recordOriginator mesh__D018794 JLS
% 214.27/214.46  |- mesh__recordMaintainer mesh__D018794 ags
% 214.27/214.46  |- skos__annotation mesh__D018794
% 214.27/214.46       a teaching method in the curriculum: do not confuse with PROBLEM SOLVING, a type of learning%A%  
% 214.27/214.46  |- skos__altLabel mesh__D018794 Problem-Based Curricula
% 214.27/214.46  |- skos__prefLabel mesh__D018794 Problem-Based Learning
% 214.27/214.46  |- mesh__dateEstablished mesh__D018794 1995-01-01
% 214.27/214.46  |- skos__hiddenLabel mesh__D018794 Problem-Based Curriculum
% 214.27/214.46  |- skos__historyNote mesh__D018794 Problem Solving %28%1975-1994%29%
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D018794 1998
% 214.27/214.46  |- mesh__recordAuthorizer mesh__D018794 ags
% 214.27/214.46  |- skos__hiddenLabel mesh__D018794 Problem Based Curricula
% 214.27/214.46  |- skos__hiddenLabel mesh__D018794 Problem Based Learning
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D018794 2002
% 214.27/214.46  |- mesh__historyNote mesh__D018794 95   
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D018794 2006A
% 214.27/214.46  |- skos__broader mesh__D018794smesh__D003479
% 214.27/214.46  |- skos__hiddenLabel mesh__D018794 Learning, Experiential
% 214.27/214.46  |- skos__historyNote mesh__D018794 Teaching %28%1975-1994%29%
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D018794 1999
% 214.27/214.46  |- mesh__dateRevised mesh__D018794 2005-07-27
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D018794 2005
% 214.27/214.46  |- skos__hiddenLabel mesh__D018794 Learning, Problem-Based
% 214.27/214.46  |- skos__historyNote mesh__D018794 Learning %28%1975-1994%29%
% 214.27/214.46  |- skos__hiddenLabel mesh__D018794 Curriculum, Problem Based
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D018794 2006
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D018794 2000
% 214.27/214.46  |- skos__broader mesh__D018794smesh__D007858
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D004774 2003
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D004774 2000
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D004774 2005
% 214.27/214.46  |- mesh__recordAuthorizer mesh__D004774 PLS
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D004774 2004
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D004774 2001
% 214.27/214.46  |- mesh__dateCreated mesh__D004774 1999-01-01
% 214.27/214.46  |- mesh__dateRevised mesh__D004774 1993-05-27
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D004774 2006
% 214.27/214.46  |- skos__scopeNote mesh__D004774
% 214.27/214.46       The turning inward %28%inversion%29% of the edge of the eyelid, with the tarsal cartilage turned inward toward the eyeball. %28%Dorland, 27th ed%29%%A%    
% 214.27/214.46  |- mesh__recordMaintainer mesh__D004774 TGC
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D004774 1996
% 214.27/214.46  |- skos__prefLabel mesh__D004774 Entropion
% 214.27/214.46  |- skos__hiddenLabel mesh__D004774 Entropions
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D004774 1998
% 214.27/214.46  |- skos__broader mesh__D004774smesh__D005141
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D004774 1997
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D004774 2002
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D004774 1994
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D004774 1999
% 214.27/214.46  |- rdf__type mesh__D004774sskos__Concept
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D004774 1995
% 214.27/214.46  |- mesh__recordOriginator mesh__D004774 NLM
% 214.27/214.46  |- skos__annotation mesh__D004774
% 214.27/214.46       inversion of eyelid: do not confuse with ECTROPION, eversion%A%  
% 214.27/214.46  |- mesh__recordMaintainer mesh__D012408 ags
% 214.27/214.46  |- mesh__dateCreated mesh__D012408 1999-01-01
% 214.27/214.46  |- skos__hiddenLabel mesh__D012408 Synthetic Rubbers
% 214.27/214.46  |- skos__related mesh__D012408smesh__D028482
% 214.27/214.46  |- mesh__recordOriginator mesh__D012408 NLM
% 214.27/214.46  |- skos__broader mesh__D012408smesh__D011108
% 214.27/214.46  |- skos__broader mesh__D012408smesh__D020724
% 214.27/214.46  |- rdf__type mesh__D012408sskos__Concept
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D012408 2006A
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D012408 2006
% 214.27/214.46  |- skos__related mesh__D012408smesh__D007840
% 214.27/214.46  |- mesh__dateRevised mesh__D012408 2005-07-15
% 214.27/214.46  |- mesh__onlineNote mesh__D012408
% 214.27/214.46       use RUBBER to search LATEX RUBBER 1968-80   
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D012408 2005
% 214.27/214.46  |- skos__prefLabel mesh__D012408 Rubber
% 214.27/214.46  |- skos__hiddenLabel mesh__D012408 Rubbers, Synthetic
% 214.27/214.46  |- mesh__recordAuthorizer mesh__D012408 ags
% 214.27/214.46  |- skos__broader mesh__D012408smesh__D001704
% 214.27/214.46  |- mesh__historyNote mesh__D012408
% 214.27/214.46       LATEX RUBBER was see under RUBBER 1968-80   
% 214.27/214.46  |- skos__altLabel mesh__D012408 Latex Rubber
% 214.27/214.46  |- skos__related mesh__D012408smesh__D020315
% 214.27/214.46  |- skos__hiddenLabel mesh__D012408 Rubber, Synthetic
% 214.27/214.46  |- skos__scopeNote mesh__D012408
% 214.27/214.46       A high-molecular-weight polymeric elastomer derived  from the milk juice %28%LATEX%29% of HEVEA brasiliensis and other trees and plants. It is a substance that can be stretched at room temperature to at least twice its original length and after releasing the stress, retractrapidly, and recover its original dimensions fully. Synthetic rubber is made from many different chemicals, including STYRENE; ACRYLONITRILE; ethylene; propylene; and isoprene.%A%    
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Cells, Kidney Mesangial
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Cell, Renal Mesangial
% 214.27/214.46  |- mesh__recordOriginator mesh__D050527 lkt
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Cell, Mesangial
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Renal Mesangial Cell
% 214.27/214.46  |- skos__broader mesh__D050527smesh__D005347
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Kidney Mesangial Cells
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Mesangial Cell, Glomerular
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Cells, Extraglomerular Mesangial
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Cell, Glomerular Mesangial
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Mesangial Cells, Glomerular
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Lacis Cell
% 214.27/214.46  |- mesh__historyNote mesh__D050527 2006   
% 214.27/214.46  |- mesh__recordMaintainer mesh__D050527 lkt
% 214.27/214.46  |- skos__altLabel mesh__D050527 Lacis Cells
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Mesangial Cells, Renal
% 214.27/214.46  |- skos__historyNote mesh__D050527 Kidney Glomerulus %28%1968-2005%29%
% 214.27/214.46  |- skos__prefLabel mesh__D050527 Mesangial Cells
% 214.27/214.46  |- mesh__dateEstablished mesh__D050527 2006-01-01
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Cells, Mesangial
% 214.27/214.46  |- skos__altLabel mesh__D050527 Renal Mesangial Cells
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Cells, Lacis
% 214.27/214.46  |- skos__broader mesh__D050527smesh__D007678
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Glomerular Mesangial Cell
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Cells, Renal Mesangial
% 214.27/214.46  |- skos__altLabel mesh__D050527 Mesangial Cells, Kidney
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Cell, Kidney Mesangial
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Mesangial Cell, Kidney
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Mesangial Cell, Renal
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Mesangial Cell
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Cells, Glomerular Mesangial
% 214.27/214.46  |- rdf__type mesh__D050527sskos__Concept
% 214.27/214.46  |- mesh__activeMeSHYear mesh__D050527 2006
% 214.27/214.46  |- skos__scopeNote mesh__D050527
% 214.27/214.46       Smooth muscle-like cells adhering to the wall of the small blood vessels of the KIDNEY at the glomerulus and along the vascular pole of the glomerulus in the JUXTAGLOMERULAR APPARATUS. They are myofibroblasts with contractile and phagocytic properties. These cells and their MESANGIAL EXTRACELLULAR MATRIX constitute the GLOMERULAR MESANGIUM.%A%    
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Kidney Mesangial Cell
% 214.27/214.46  |- mesh__recordAuthorizer mesh__D050527 sjn
% 214.27/214.46  |- skos__hiddenLabel mesh__D050527 Cell, Lacis
% 214.27/214.46  |- skos__altLabel mesh__D050527 Renal Glomerulus Mesangial Cells
% 214.27/214.46  |- mesh__dateCreated mesh__D050527 2005-06-30
% 214.27/214.46  |- mesh__publicMeSHNote mesh__D050527 2006   
% 214.27/214.47  |- skos__hiddenLabel mesh__D050527 Mesangial Cells, Extraglomerular
% 214.27/214.47  |- skos__hiddenLabel mesh__D050527 Cell, Extraglomerular Mesangial
% 214.27/214.47  |- skos__hiddenLabel mesh__D050527 Mesangial Cell, Extraglomerular
% 214.27/214.47  |- skos__hiddenLabel mesh__D050527 Extraglomerular Mesangial Cell
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D027521 2004
% 214.27/214.47  |- skos__scopeNote mesh__D027521
% 214.27/214.47       A genus of the LAMIACEAE family. It is known for its mild calming effect and for the way cats are attracted to the aroma.%A%    
% 214.27/214.47  |- mesh__publicMeSHNote mesh__D027521 2002; see LAMIACEAE 1998-2001   
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D027521 2002
% 214.27/214.47  |- skos__broader mesh__D027521smesh__D019686
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D027521 2006
% 214.27/214.47  |- skos__historyNote mesh__D027521 Phytotherapy %28%1969-2001%29%
% 214.27/214.47  |- skos__annotation mesh__D027521
% 214.27/214.47       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.27/214.47  |- rdf__type mesh__D027521sskos__Concept
% 214.27/214.47  |- mesh__dateCreated mesh__D027521 2001-07-25
% 214.27/214.47  |- skos__altLabel mesh__D027521 Catnip
% 214.27/214.47  |- mesh__dateEstablished mesh__D027521 2002-01-01
% 214.27/214.47  |- skos__prefLabel mesh__D027521 Nepeta
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D027521 2003
% 214.27/214.47  |- skos__historyNote mesh__D027521 Plants %28%1969-2001%29%
% 214.27/214.47  |- mesh__historyNote mesh__D027521 2002; use LAMIACEAE 1998-2001   
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D027521 2005
% 214.27/214.47  |- skos__hiddenLabel mesh__D013501 Active Agents, Surface
% 214.27/214.47  |- mesh__publicMeSHNote mesh__D013501
% 214.27/214.47       1963; TENSIDES was indexed under SURFACE ACTIVE AGENTS 1973-2004%A%  
% 214.27/214.47  |- rdf__type mesh__D013501sskos__Concept
% 214.27/214.47  |- skos__hiddenLabel mesh__D013501 Agents, Surface-Active
% 214.27/214.47  |- skos__hiddenLabel mesh__D013501 Agents, Amphiphilic
% 214.27/214.47  |- skos__prefLabel mesh__D013501 Surface-Active Agents
% 214.27/214.47  |- mesh__historyNote mesh__D013501 1963   
% 214.27/214.47  |- mesh__recordOriginator mesh__D013501 NLM
% 214.27/214.47  |- mesh__recordAuthorizer mesh__D013501 sjn
% 214.27/214.47  |- skos__related mesh__D013501smesh__D011663
% 214.27/214.47  |- skos__altLabel mesh__D013501 Surface Active Agents
% 214.27/214.47  |- skos__scopeNote mesh__D013501
% 214.27/214.47       Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics.%A%    
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D013501 2006
% 214.27/214.47  |- mesh__recordMaintainer mesh__D013501 ssb
% 214.27/214.47  |- skos__hiddenLabel mesh__D013501 Agents, Surface Active
% 214.27/214.47  |- skos__broader mesh__D013501smesh__D020313
% 214.27/214.47  |- mesh__dateRevised mesh__D013501 2004-07-07
% 214.27/214.47  |- mesh__dateCreated mesh__D013501 1999-01-01
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D013501 2005
% 214.27/214.47  |- skos__hiddenLabel mesh__D018795 Device Approval, New
% 214.27/214.47  |- skos__hiddenLabel mesh__D018795 Approval, Device
% 214.27/214.47  |- skos__historyNote mesh__D018795
% 214.27/214.47       Consumer Product Safety %28%1966-1994%29%
% 214.27/214.47  |- rdf__type mesh__D018795sskos__Concept
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D018795 2004
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D018795 1995
% 214.27/214.47  |- skos__broader mesh__D018795smesh__D003257
% 214.27/214.47  |- skos__hiddenLabel mesh__D018795 Processes, Device Approval
% 214.27/214.47  |- mesh__publicMeSHNote mesh__D018795 95   
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D018795 2000
% 214.27/214.47  |- skos__prefLabel mesh__D018795 Device Approval
% 214.27/214.47  |- mesh__dateCreated mesh__D018795 1994-06-01
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D018795 1998
% 214.27/214.47  |- skos__hiddenLabel mesh__D018795 Device Approval Processes
% 214.27/214.47  |- skos__hiddenLabel mesh__D018795 Approval Process, Device
% 214.27/214.47  |- skos__hiddenLabel mesh__D018795 Approval Processes, Device
% 214.27/214.47  |- skos__altLabel mesh__D018795 Device Approval Process
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D018795 2001
% 214.27/214.47  |- mesh__historyNote mesh__D018795 95   
% 214.27/214.47  |- skos__broader mesh__D018795smesh__D005069
% 214.27/214.47  |- skos__hiddenLabel mesh__D018795 New Device Approvals
% 214.27/214.47  |- skos__hiddenLabel mesh__D018795 Process, Device Approval
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D018795 1999
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D018795 2005
% 214.27/214.47  |- skos__hiddenLabel mesh__D018795 Approvals, New Device
% 214.27/214.47  |- skos__hiddenLabel mesh__D018795 Approval, New Device
% 214.27/214.47  |- skos__hiddenLabel mesh__D018795 Device Approvals
% 214.27/214.47  |- skos__hiddenLabel mesh__D018795 Approvals, Device
% 214.27/214.47  |- skos__scopeNote mesh__D018795
% 214.27/214.47       Process that is gone through in order for a device to receive approval by a government regulatory agency. This includes any required preclinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance. It is not restricted to FDA.%A%    
% 214.27/214.47  |- mesh__dateEstablished mesh__D018795 1995-01-01
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D018795 1996
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D018795 2006
% 214.27/214.47  |- skos__hiddenLabel mesh__D018795 Device Approvals, New
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D018795 2002
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D018795 1997
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D018795 2003
% 214.27/214.47  |- skos__annotation mesh__D018795
% 214.27/214.47       by a govt regulatory agency, not restricted to FDA   
% 214.27/214.47  |- skos__broader mesh__D004775smesh__D019960
% 214.27/214.47  |- mesh__recordMaintainer mesh__D004775 JLS
% 214.27/214.47  |- mesh__dateRevised mesh__D004775 2002-07-02
% 214.27/214.47  |- skos__scopeNote mesh__D004775
% 214.27/214.47       Involuntary discharge of urine after the age at which urinary control should have been achieved; often used alone with specific reference to involuntary discharge of urine occurring during sleep at night %28%bed-wetting; nocturnal enuresis%29%. %28%Dorland, 27th ed%29%%A%    
% 214.27/214.47  |- skos__broader mesh__D004775smesh__D014555
% 214.27/214.47  |- mesh__recordOriginator mesh__D004775 NLM
% 214.27/214.47  |- rdf__type mesh__D004775sskos__Concept
% 214.27/214.47  |- mesh__recordAuthorizer mesh__D004775 sjn
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D004775 2003
% 214.27/214.47  |- skos__broader mesh__D004775smesh__D001526
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D004775 2005
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D004775 2004
% 214.27/214.47  |- mesh__dateCreated mesh__D004775 1999-01-01
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D004775 2006
% 214.27/214.47  |- skos__prefLabel mesh__D004775 Enuresis
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D012409 2006
% 214.27/214.47  |- skos__broader mesh__D012409smesh__D018355
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D012409 2002
% 214.27/214.47  |- mesh__recordAuthorizer mesh__D012409 sjn
% 214.27/214.47  |- rdf__type mesh__D012409sskos__Concept
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D012409 2005
% 214.27/214.47  |- skos__altLabel mesh__D012409 Measles, German
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D012409 2004
% 214.27/214.47  |- skos__annotation mesh__D012409
% 214.27/214.47       caused by a rubivirus, RUBELLA VIRUS: do not confuse with RUBULAVIRUS, a paramyxovirus; do not confuse with RUBEOLA see MEASLES; French for rubella = rub%C3%%A9%ole, Ital for rubella = rubeola, Span for rubella = rub%C3%%A9%ola or ros%C3%%A9%ola epidemica;  /congen: consider also RUBELLA SYNDROME, CONGENITAL%A%  
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D012409 2003
% 214.27/214.47  |- skos__hiddenLabel mesh__D012409 German Measles
% 214.27/214.47  |- mesh__recordOriginator mesh__D012409 NLM
% 214.27/214.47  |- skos__scopeNote mesh__D012409
% 214.27/214.47       An acute, usually benign, infectious disease caused by the RUBELLA VIRUS and most often affecting children and nonimmune young adults, in which the virus enters the respiratory tract via droplet nuclei and spreads to the lymphatic system. %28%From Dorland, 27th edition%29%%A%    
% 214.27/214.47  |- mesh__recordMaintainer mesh__D012409 jls
% 214.27/214.47  |- skos__prefLabel mesh__D012409 Rubella
% 214.27/214.47  |- mesh__dateRevised mesh__D012409 2001-08-13
% 214.27/214.47  |- mesh__dateCreated mesh__D012409 1999-01-01
% 214.27/214.47  |- skos__hiddenLabel mesh__D012409 Rubellas
% 214.27/214.47  |- skos__hiddenLabel mesh__D009460 Examination, Neurological
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D009460 2006
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D009460 1998
% 214.27/214.47  |- mesh__recordMaintainer mesh__D009460 PXP
% 214.27/214.47  |- skos__altLabel mesh__D009460 Examination, Neurologic
% 214.27/214.47  |- skos__hiddenLabel mesh__D009460 Neurological Examinations
% 214.27/214.47  |- skos__hiddenLabel mesh__D009460 Examinations, Neurological
% 214.27/214.47  |- mesh__publicMeSHNote mesh__D009460 66   
% 214.27/214.47  |- mesh__dateRevised mesh__D009460 1997-06-20
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D009460 2002
% 214.27/214.47  |- skos__altLabel mesh__D009460 Neurological Examination
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D009460 1999
% 214.27/214.47  |- skos__prefLabel mesh__D009460 Neurologic Examination
% 214.27/214.47  |- mesh__historyNote mesh__D009460 66%28%64%29%   
% 214.27/214.47  |- mesh__dateEstablished mesh__D009460 1966-01-01
% 214.27/214.47  |- mesh__recordOriginator mesh__D009460 NLM
% 214.27/214.47  |- skos__hiddenLabel mesh__D009460 Examinations, Neurologic
% 214.27/214.47  |- skos__broader mesh__D009460smesh__D010808
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D009460 2000
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D009460 2003
% 214.27/214.47  |- skos__annotation mesh__D009460 NIM; DF: NEUROL EXAM   
% 214.27/214.47  |- mesh__recordAuthorizer mesh__D009460 SJN
% 214.27/214.47  |- rdf__type mesh__D009460sskos__Concept
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D009460 2001
% 214.27/214.47  |- skos__broader mesh__D009460smesh__D003943
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D009460 2005
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D009460 2004
% 214.27/214.47  |- mesh__dateCreated mesh__D009460 1999-01-01
% 214.27/214.47  |- skos__hiddenLabel mesh__D009460 Neurologic Examinations
% 214.27/214.47  |- skos__prefLabel mesh__D050528 Diet, Carbohydrate-Restricted
% 214.27/214.47  |- skos__hiddenLabel mesh__D050528 Diets, Carbohydrate-Restricted
% 214.27/214.47  |- mesh__recordAuthorizer mesh__D050528 sjn
% 214.27/214.47  |- mesh__recordMaintainer mesh__D050528 ssb
% 214.27/214.47  |- mesh__dateCreated mesh__D050528 2005-06-30
% 214.27/214.47  |- skos__hiddenLabel mesh__D050528 Low Carbohydrate Diet
% 214.27/214.47  |- skos__hiddenLabel mesh__D050528 Carbohydrate-Restricted Diets
% 214.27/214.47  |- skos__altLabel mesh__D050528 Diet, Low Carbohydrate
% 214.27/214.47  |- skos__hiddenLabel mesh__D050528 Carbohydrate-Restricted Diet
% 214.27/214.47  |- skos__hiddenLabel mesh__D050528 Carbohydrate Diets, Low
% 214.27/214.47  |- skos__hiddenLabel mesh__D050528 Diet, Atkins
% 214.27/214.47  |- skos__hiddenLabel mesh__D050528 Beach Diet, South
% 214.27/214.47  |- mesh__recordOriginator mesh__D050528 ssb
% 214.27/214.47  |- skos__hiddenLabel mesh__D050528 Diet, South Beach
% 214.27/214.47  |- mesh__dateEstablished mesh__D050528 2006-01-01
% 214.27/214.47  |- skos__hiddenLabel mesh__D050528 Diets, Low Carbohydrate
% 214.27/214.47  |- skos__hiddenLabel mesh__D050528 Diet, Carbohydrate Restricted
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D050528 2006
% 214.27/214.47  |- skos__historyNote mesh__D050528 Dietary Carbohydrates %28%1973-2005%29%
% 214.27/214.47  |- mesh__historyNote mesh__D050528 2006   
% 214.27/214.47  |- skos__hiddenLabel mesh__D050528 Carbohydrate Diet, Low
% 214.27/214.47  |- skos__broader mesh__D050528smesh__D004035
% 214.27/214.47  |- skos__historyNote mesh__D050528 Diet Therapy %28%1974-2005%29%
% 214.27/214.47  |- rdf__type mesh__D050528sskos__Concept
% 214.27/214.47  |- skos__scopeNote mesh__D050528
% 214.27/214.47       A diet that contains limited amounts of CARBOHYDRATES. This is in distinction to a regular DIET.%A%    
% 214.27/214.47  |- skos__hiddenLabel mesh__D050528 Low Carbohydrate Diets
% 214.27/214.47  |- mesh__publicMeSHNote mesh__D050528 2006   
% 214.27/214.47  |- mesh__recordOriginator mesh__D008368 NLM
% 214.27/214.47  |- skos__broader mesh__D008368smesh__D005368
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D008368 2002
% 214.27/214.47  |- skos__hiddenLabel mesh__D008368 Mansonelliases
% 214.27/214.47  |- rdf__type mesh__D008368sskos__Concept
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D008368 2003
% 214.27/214.47  |- mesh__onlineNote mesh__D008368 search FILARIASIS 1967-74   
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D008368 2004
% 214.27/214.47  |- skos__annotation mesh__D008368 /drug ther: consider FILARICIDES   
% 214.27/214.47  |- mesh__publicMeSHNote mesh__D008368
% 214.27/214.47       91; was see under FILARIASIS 1975-90   
% 214.27/214.47  |- skos__scopeNote mesh__D008368
% 214.27/214.47       Infection with nematodes of the genus MANSONELLA. Symptoms include pruritus, headache, and articular swelling.%A%    
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D008368 2005
% 214.27/214.47  |- mesh__recordAuthorizer mesh__D008368 SJN
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D008368 2006
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D008368 2000
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D008368 1999
% 214.27/214.47  |- mesh__recordMaintainer mesh__D008368 MSR
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D008368 2001
% 214.27/214.47  |- mesh__dateRevised mesh__D008368 1998-06-10
% 214.27/214.47  |- skos__prefLabel mesh__D008368 Mansonelliasis
% 214.27/214.47  |- mesh__dateEstablished mesh__D008368 1991-01-01
% 214.27/214.47  |- mesh__historyNote mesh__D008368
% 214.27/214.47       91%28%75%29%; was see under FILARIASIS 1975-90   
% 214.27/214.47  |- mesh__dateCreated mesh__D008368 1999-01-01
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D000385 2001
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D000385 2004
% 214.27/214.47  |- skos__hiddenLabel mesh__D000385 Allowances, Family
% 214.27/214.47  |- skos__hiddenLabel mesh__D000385 Family Allowance
% 214.27/214.47  |- skos__hiddenLabel mesh__D000385 Allowance, Family
% 214.27/214.47  |- mesh__dateEstablished mesh__D000385 1978-01-01
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D000385 2000
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D000385 2003
% 214.27/214.47  |- mesh__historyNote mesh__D000385
% 214.27/214.47       78%28%75%29%; was see under PUBLIC ASSISTANCE 1968-77   
% 214.27/214.47  |- skos__annotation mesh__D000385
% 214.27/214.47       treed under SOCIAL SECURITY; specify geog; DF: AFDC   
% 214.27/214.47  |- mesh__publicMeSHNote mesh__D000385
% 214.27/214.47       78; was see under PUBLIC ASSISTANCE 1968-77   
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D000385 2006
% 214.27/214.47  |- mesh__dateCreated mesh__D000385 1999-01-01
% 214.27/214.47  |- skos__prefLabel mesh__D000385 Aid to Families with Dependent Children
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D000385 2002
% 214.27/214.47  |- mesh__onlineNote mesh__D000385 search PUBLIC ASSISTANCE 1968-74   
% 214.27/214.47  |- mesh__recordMaintainer mesh__D000385 kle
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D000385 2005
% 214.27/214.47  |- skos__scopeNote mesh__D000385
% 214.27/214.47       Financial assistance provided by the government to indigent families with dependent children who meet certain requirements as defined by the Social Security Act, Title IV, in the U.S.%A%    
% 214.27/214.47  |- mesh__recordAuthorizer mesh__D000385 sjn
% 214.27/214.47  |- mesh__dateRevised mesh__D000385 1999-11-03
% 214.27/214.47  |- skos__broader mesh__D000385smesh__D012943
% 214.27/214.47  |- mesh__recordOriginator mesh__D000385 NLM
% 214.27/214.47  |- rdf__type mesh__D000385sskos__Concept
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D019090 2002
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D019090 1996
% 214.27/214.47  |- mesh__publicMeSHNote mesh__D019090 96   
% 214.27/214.47  |- mesh__dateCreated mesh__D019090 1995-05-26
% 214.27/214.47  |- rdf__type mesh__D019090sskos__Concept
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D019090 2006
% 214.27/214.47  |- skos__related mesh__D019090smesh__D008329
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D019090 2005
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D019090 2004
% 214.27/214.47  |- mesh__dateEstablished mesh__D019090 1996-01-01
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D019090 2001
% 214.27/214.47  |- skos__annotation mesh__D019090
% 214.27/214.47       all health professionals%27% activities to insure coord of services for the patient%A%  
% 214.27/214.47  |- skos__prefLabel mesh__D019090 Case Management
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D019090 2003
% 214.27/214.47  |- mesh__historyNote mesh__D019090 96   
% 214.27/214.47  |- skos__historyNote mesh__D019090 Patient Care Planning %28%1980-1995%29%
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D019090 2000
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D019090 1999
% 214.27/214.47  |- skos__historyNote mesh__D019090 Managed Care Programs %28%1988-1995%29%
% 214.27/214.47  |- skos__scopeNote mesh__D019090
% 214.27/214.47       A traditional term for all the activities which a physician or other health care professional normally performs to insure the coordination of the medical services required by a patient. It also, when used in connection with managed care, covers all the activities of evaluating the patient, planning treatment, referral, and follow-up so that care is continuous and comprehensive and payment for the care is obtained. %28%From Slee %26% Slee, Health Care Terms, 2nd ed%29%%A%    
% 214.27/214.47  |- skos__broader mesh__D019090smesh__D010347
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D019090 1998
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D019090 1997
% 214.27/214.47  |- rdf__type mesh__D027522sskos__Concept
% 214.27/214.47  |- skos__altLabel mesh__D027522 Horehound
% 214.27/214.47  |- mesh__dateRevised mesh__D027522 2002-07-03
% 214.27/214.47  |- mesh__recordOriginator mesh__D027522 ssb
% 214.27/214.47  |- skos__altLabel mesh__D027522 Horehound, Common
% 214.27/214.47  |- mesh__publicMeSHNote mesh__D027522 2002; see LAMIACEAE 1998-2001   
% 214.27/214.47  |- skos__prefLabel mesh__D027522 Marrubium
% 214.27/214.47  |- mesh__dateEstablished mesh__D027522 2002-01-01
% 214.27/214.47  |- skos__annotation mesh__D027522
% 214.27/214.47       X ref HOREHOUND: HOREHOUND, BLACK see BALLOTA and HOREHOUND, WATER see LYCOPUS are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.27/214.47  |- skos__historyNote mesh__D027522 Plants, Medicinal %28%1966-2001%29%
% 214.27/214.47  |- skos__scopeNote mesh__D027522
% 214.27/214.47       A plant genus of the LAMIACEAE family that contains marrubiin %28%a labdane diterpene%29%. It is known as a traditional medicinal for sore throat.%A%    
% 214.27/214.47  |- mesh__dateCreated mesh__D027522 2001-07-25
% 214.27/214.47  |- mesh__recordMaintainer mesh__D027522 ssb
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D027522 2003
% 214.27/214.47  |- mesh__historyNote mesh__D027522 2002; use LAMIACEAE 1998-2001   
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D027522 2005
% 214.27/214.47  |- skos__altLabel mesh__D027522 Horehound, Woolly
% 214.27/214.47  |- mesh__recordAuthorizer mesh__D027522 sjn
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D027522 2004
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D027522 2006
% 214.27/214.47  |- skos__broader mesh__D027522smesh__D019686
% 214.27/214.47  |- rdf__type mesh__D005070sskos__Concept
% 214.27/214.47  |- mesh__publicMeSHNote mesh__D005070
% 214.27/214.47       91; was see under AZO COMPOUNDS 1976-90; AZOVAN BLUE, AZOVANUM CAERULEUM, DIAZOBLEU %26% T-1824 were see EVANS BLUE 1976-93%A%  
% 214.27/214.47  |- skos__annotation mesh__D005070 D25-26 qualif   
% 214.27/214.47  |- skos__broader mesh__D005070smesh__D009282
% 214.27/214.47  |- skos__historyNote mesh__D005070 Naphthalenesulfonates %28%1974-1975%29%
% 214.27/214.47  |- skos__prefLabel mesh__D005070 Evans Blue
% 214.27/214.47  |- skos__altLabel mesh__D005070 Evan%27%s Blue
% 214.27/214.47  |- skos__broader mesh__D005070smesh__D001391
% 214.27/214.47  |- mesh__onlineNote mesh__D005070
% 214.27/214.47       use EVANS BLUE to search AZOVAN BLUE, AZOVANUM CAERULEUM, DIAZOBLEU, %26% T-1824 1976-93%A%  
% 214.27/214.47  |- mesh__historyNote mesh__D005070
% 214.27/214.47       91%28%76%29%; was see under AZO COMPOUNDS 1976-90; AZOVAN BLUE, AZOVANUM CAERULEUM, DIAZOBLEU %26% T-1824 were see EVANS BLUE 1976-93%A%  
% 214.27/214.47  |- mesh__dateCreated mesh__D005070 1975-07-18
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D005070 2006
% 214.27/214.47  |- mesh__dateRevised mesh__D005070 2005-07-06
% 214.27/214.47  |- skos__hiddenLabel mesh__D005070 Blue, Evan%27%s
% 214.27/214.47  |- skos__hiddenLabel mesh__D005070 Blue, Azovan
% 214.27/214.47  |- skos__historyNote mesh__D005070 Azo Compounds %28%1969-1975%29%
% 214.27/214.47  |- skos__hiddenLabel mesh__D005070 Evan Blue
% 214.27/214.47  |- mesh__recordMaintainer mesh__D005070 NLM
% 214.27/214.47  |- mesh__recordAuthorizer mesh__D005070 NLM
% 214.27/214.47  |- skos__scopeNote mesh__D005070
% 214.27/214.47       An azo dye used in blood volume and cardiac output measurement by the dye dilution method. It is very soluble, strongly bound to plasma albumin, and disappears very slowly.%A%    
% 214.27/214.47  |- mesh__recordOriginator mesh__D005070 SH
% 214.27/214.47  |- skos__altLabel mesh__D005070 Azovan Blue
% 214.27/214.47  |- skos__hiddenLabel mesh__D005070 Blue, Evans
% 214.27/214.47  |- mesh__dateEstablished mesh__D005070 1991-01-01
% 214.27/214.47  |- rdf__type mesh__D013502sskos__Concept
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D013502 2001
% 214.27/214.47  |- skos__broader mesh__D013502smesh__D013043
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D013502 2003
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D013502 1998
% 214.27/214.47  |- mesh__recordAuthorizer mesh__D013502 SJN
% 214.27/214.47  |- mesh__dateRevised mesh__D013502 1997-06-20
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D013502 2000
% 214.27/214.47  |- skos__scopeNote mesh__D013502
% 214.27/214.47       A specialty in which manual or operative procedures are used in the treatment of disease, injuries, or deformities.%A%    
% 214.27/214.47  |- skos__related mesh__D013502smesh__D013514
% 214.27/214.47  |- mesh__recordOriginator mesh__D013502 NLM
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D013502 2006
% 214.27/214.47  |- skos__annotation mesh__D013502
% 214.27/214.47       SPEC only: prefer /surg with organs %26% dis: Manual 19.7+, 19.8.70; the surgeon %26% specialty go here: the surgical patient = SURGICAL PROCEDURES, OPERATIVE: Manual 26.15+; /instrum = SURGICAL INSTRUMENTS or SURGICAL EQUIPMENT; military surgery = MILITARY MEDICINE %28%IM%29% + SURGERY %28%IM%29% if the specialty; DF: SURG%A%  
% 214.27/214.47  |- skos__related mesh__D013502smesh__D019024
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D013502 2005
% 214.27/214.47  |- mesh__dateCreated mesh__D013502 1999-01-01
% 214.27/214.47  |- mesh__recordMaintainer mesh__D013502 JLS
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D013502 2002
% 214.27/214.47  |- skos__prefLabel mesh__D013502 Surgery
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D013502 2004
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D013502 1999
% 214.27/214.47  |- skos__altLabel mesh__D018796 Radioimmunoconjugate
% 214.27/214.47  |- mesh__dateEstablished mesh__D018796 1995-01-01
% 214.27/214.47  |- mesh__dateCreated mesh__D018796 1994-05-23
% 214.27/214.47  |- mesh__dateRevised mesh__D018796 2005-06-30
% 214.27/214.47  |- rdf__type mesh__D018796sskos__Concept
% 214.27/214.47  |- skos__prefLabel mesh__D018796 Immunoconjugates
% 214.27/214.47  |- skos__scopeNote mesh__D018796
% 214.27/214.47       Combinations of diagnostic or therapeutic substances linked with specific immune substances such as IMMUNOGLOBULINS; MONOCLONAL ANTIBODIES; or ANTIGENS. Often the diagnostic or therapeutic substance is a radionuclide. These conjugates are useful tools for specific targeting of DRUGS and RADIOISOTOPES in the CHEMOTHERAPY and RADIOIMMUNOTHERAPY of certain cancers.%A%    
% 214.27/214.47  |- mesh__recordMaintainer mesh__D018796 ssb
% 214.27/214.47  |- mesh__publicMeSHNote mesh__D018796 95   
% 214.27/214.47  |- mesh__historyNote mesh__D018796 95   
% 214.27/214.47  |- mesh__recordAuthorizer mesh__D018796 sjn
% 214.27/214.47  |- mesh__recordOriginator mesh__D018796 AGS
% 214.27/214.47  |- skos__altLabel mesh__D018796 Immunoconjugate
% 214.27/214.47  |- skos__broader mesh__D018796smesh__D000906
% 214.27/214.47  |- skos__historyNote mesh__D018796 Immunotoxins %28%1987-1994%29%
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D018796 2006
% 214.27/214.47  |- mesh__onlineNote mesh__D004776
% 214.27/214.47       use ENVIOMYCIN to search TUBERACTINOMYCIN-N 1975-80   
% 214.27/214.47  |- mesh__dateCreated mesh__D004776 1974-11-19
% 214.27/214.47  |- mesh__dateEstablished mesh__D004776 1991-01-01
% 214.27/214.47  |- rdf__type mesh__D004776sskos__Concept
% 214.27/214.47  |- mesh__dateRevised mesh__D004776 2004-07-07
% 214.27/214.47  |- skos__altLabel mesh__D004776 Tuberactinomycin N
% 214.27/214.47  |- skos__altLabel mesh__D004776 Tuberactinomycin-N
% 214.27/214.47  |- mesh__recordOriginator mesh__D004776 NLM
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D004776 2005
% 214.27/214.47  |- skos__historyNote mesh__D004776 Antibiotics %28%1966-1974%29%
% 214.27/214.47  |- mesh__historyNote mesh__D004776
% 214.27/214.47       91%28%81%29%; was see under VIOMYCINS 1981-90; was TUBERACTINOMYCIN-N see under ANTIBIOTICS, ANTITUBERCULAR 1975-80%A%  
% 214.27/214.47  |- skos__historyNote mesh__D004776 Peptides %28%1966-1974%29%
% 214.27/214.47  |- skos__broader mesh__D004776smesh__D014756
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D004776 2006
% 214.27/214.47  |- mesh__recordAuthorizer mesh__D004776 sjn
% 214.27/214.47  |- mesh__recordMaintainer mesh__D004776 ssb
% 214.27/214.47  |- skos__scopeNote mesh__D004776
% 214.27/214.47       Cyclic basic peptide related to VIOMYCIN. It is isolated from an induced mutant of Streptomyces griseoverticillatus var. tuberacticus and acts as an antitubercular agent with less ototoxicity than tuberactinomycin.%A%    
% 214.27/214.47  |- mesh__publicMeSHNote mesh__D004776
% 214.27/214.47       91; was see under VIOMYCINS 1981-90; was TUBERACTINOMYCIN-N see under ANTIBIOTICS, ANTITUBERCULAR 1975-80%A%  
% 214.27/214.47  |- skos__prefLabel mesh__D004776 Enviomycin
% 214.27/214.47  |- skos__altLabel mesh__D009461 Manifestations, Neurological
% 214.27/214.47  |- mesh__recordMaintainer mesh__D009461 ags
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Dysfunctions, Neurologic
% 214.27/214.47  |- rdf__type mesh__D009461sskos__Concept
% 214.27/214.47  |- mesh__recordAuthorizer mesh__D009461 sjn
% 214.27/214.47  |- mesh__dateRevised mesh__D009461 2004-07-07
% 214.27/214.47  |- skos__altLabel mesh__D009461 Manifestations, Neurologic
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Findings, Neurologic
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Dysfunction, Neurologic
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Signs, Neurologic
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Manifestation, Neurological
% 214.27/214.47  |- skos__prefLabel mesh__D009461 Neurologic Manifestations
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Neurologic Symptom
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Deficit, Focal Neurologic
% 214.27/214.47  |- skos__scopeNote mesh__D009461
% 214.27/214.47       Clinical signs and symptoms caused by nervous system injury or dysfunction.%A%    
% 214.27/214.47  |- skos__broader mesh__D009461smesh__D012816
% 214.27/214.47  |- skos__altLabel mesh__D009461 Neurologic Manifestation
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Deficits, Neurologic
% 214.27/214.47  |- skos__altLabel mesh__D009461 Neurologic Signs and Symptoms
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Deficit, Neurologic
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Neurologic Deficit, Focal
% 214.27/214.47  |- mesh__recordOriginator mesh__D009461 NLM
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Deficits, Focal Neurologic
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D009461 2006
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Neurologic Sign
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Sign, Neurologic
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Symptom, Neurologic
% 214.27/214.47  |- skos__broader mesh__D009461smesh__D009422
% 214.27/214.47  |- mesh__dateCreated mesh__D009461 1999-01-01
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Neurologic Deficits, Focal
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Symptoms, Neurologic
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Focal Neurologic Deficit
% 214.27/214.47  |- skos__annotation mesh__D009461
% 214.27/214.47       not used for indexing since 1989; prior to 1989 used for neurol manifest of non-neural diseases%A%  
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D009461 2005
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Neurological Manifestation
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Neurologic Finding
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Finding, Neurologic
% 214.27/214.47  |- skos__altLabel mesh__D009461 Neurological Manifestations
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Neurologic Deficit
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Manifestation, Neurologic
% 214.27/214.47  |- skos__hiddenLabel mesh__D009461 Neurologic Dysfunctions
% 214.27/214.47  |- mesh__onlineNote mesh__D009461
% 214.27/214.47       pre-explosion = NEUROLOGIC MANIFESTATIONS %28%PX%29%   
% 214.27/214.47  |- mesh__publicMeSHNote mesh__D008369
% 214.27/214.47       74; SIGN LANGUAGE was heading 1963-65   
% 214.27/214.47  |- mesh__recordMaintainer mesh__D008369 TGC
% 214.27/214.47  |- skos__scopeNote mesh__D008369
% 214.27/214.47       Method of nonverbal communication utilizing hand movements as speech equivalents.%A%    
% 214.27/214.47  |- skos__broader mesh__D008369smesh__D012048
% 214.27/214.47  |- skos__hiddenLabel mesh__D008369 Manual Communications
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D008369 2005
% 214.27/214.47  |- skos__hiddenLabel mesh__D008369 Communications, Manual
% 214.27/214.47  |- rdf__type mesh__D008369sskos__Concept
% 214.27/214.47  |- skos__hiddenLabel mesh__D008369 Communication, Manual
% 214.27/214.47  |- mesh__dateRevised mesh__D008369 2002-07-03
% 214.27/214.47  |- mesh__recordOriginator mesh__D008369 NLM
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D008369 2004
% 214.27/214.47  |- mesh__recordAuthorizer mesh__D008369 sjn
% 214.27/214.47  |- mesh__dateEstablished mesh__D008369 1974-01-01
% 214.27/214.47  |- skos__historyNote mesh__D008369
% 214.27/214.47       Nonverbal Communication %28%1970-1971%29%
% 214.27/214.47  |- mesh__historyNote mesh__D008369 74%28%72%29%   
% 214.27/214.47  |- skos__broader mesh__D008369smesh__D009633
% 214.27/214.47  |- mesh__activeMeSHYear mesh__D008369 2003
% 214.27/214.47  |- skos__annotation mesh__D008369
% 214.27/214.47       no qualif; SIGN LANGUAGE %26% NONVERBAL COMMUNICATION are also available%A%  
% 214.27/214.47  |- skos__prefLabel mesh__D008369 Manual Communication
% 214.27/214.47  |- mesh__dateCreated mesh__D008369 1999-01-01
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D008369 2006
% 214.27/214.48  |- mesh__dateRevised mesh__D000386 2004-07-13
% 214.27/214.48  |- skos__broader mesh__D000386smesh__D012897
% 214.27/214.48  |- mesh__recordAuthorizer mesh__D000386 sjn
% 214.27/214.48  |- mesh__historyNote mesh__D000386 87   
% 214.27/214.48  |- skos__prefLabel mesh__D000386 AIDS-Related Complex
% 214.27/214.48  |- skos__hiddenLabel mesh__D000386 Lymphadenopathy Syndromes
% 214.27/214.48  |- skos__hiddenLabel mesh__D000386 AIDS Related Complex
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D000386 2006
% 214.27/214.48  |- skos__hiddenLabel mesh__D000386 Complex, AIDS-Related
% 214.27/214.48  |- skos__altLabel mesh__D000386 Lymphadenopathy Syndrome
% 214.27/214.48  |- skos__historyNote mesh__D000386
% 214.27/214.48       Acquired Immunodeficiency Syndrome %28%1983-1986%29%
% 214.27/214.48  |- mesh__recordOriginator mesh__D000386 SCD
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D000386 2005
% 214.27/214.48  |- mesh__publicMeSHNote mesh__D000386 87   
% 214.27/214.48  |- skos__broader mesh__D000386smesh__D015658
% 214.27/214.48  |- skos__altLabel mesh__D000386 ARC
% 214.27/214.48  |- mesh__dateCreated mesh__D000386 1986-06-18
% 214.27/214.48  |- rdf__type mesh__D000386sskos__Concept
% 214.27/214.48  |- mesh__recordMaintainer mesh__D000386 sjn
% 214.27/214.48  |- skos__scopeNote mesh__D000386
% 214.27/214.48       A prodromal phase of infection with the human immunodeficiency virus %28%HIV%29%. Laboratory criteria separating AIDS-related complex %28%ARC%29% from AIDS include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in AIDS; follicular or mixed hyperplasia in ARC lymph nodes, leading to lymphocyte degeneration and depletion more typical of AIDS; evolving succession of histopathological lesions such as localization of Kaposi%27%s sarcoma, signaling the transition to the full-blown AIDS.%A%    
% 214.27/214.48  |- skos__hiddenLabel mesh__D000386 Syndromes, Lymphadenopathy
% 214.27/214.48  |- skos__annotation mesh__D000386
% 214.27/214.48       coord IM with HIV-1 or HIV-2 %28%IM%29% if pertinent; DF: note short X ref%A%  
% 214.27/214.48  |- mesh__dateEstablished mesh__D000386 1987-01-01
% 214.27/214.48  |- skos__hiddenLabel mesh__D000386 Syndrome, Lymphadenopathy
% 214.27/214.48  |- skos__prefLabel mesh__D019091 Critical Pathways
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D019091 2000
% 214.27/214.48  |- skos__hiddenLabel mesh__D019091 Pathways, Critical
% 214.27/214.48  |- skos__hiddenLabel mesh__D019091 Clinical Path
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D019091 2003
% 214.27/214.48  |- skos__hiddenLabel mesh__D019091 Paths, Critical
% 214.27/214.48  |- mesh__historyNote mesh__D019091 96   
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D019091 1999
% 214.27/214.48  |- skos__broader mesh__D019091smesh__D010347
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D019091 2002
% 214.27/214.48  |- skos__hiddenLabel mesh__D019091 Pathway, Clinical
% 214.27/214.48  |- skos__hiddenLabel mesh__D019091 Path, Clinical
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D019091 1997
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D019091 1998
% 214.27/214.48  |- mesh__publicMeSHNote mesh__D019091 96   
% 214.27/214.48  |- skos__hiddenLabel mesh__D019091 Path, Critical
% 214.27/214.48  |- skos__hiddenLabel mesh__D019091 Critical Path
% 214.27/214.48  |- mesh__dateEstablished mesh__D019091 1996-01-01
% 214.27/214.48  |- skos__hiddenLabel mesh__D019091 Pathway, Critical
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D019091 1996
% 214.27/214.48  |- skos__altLabel mesh__D019091 Critical Paths
% 214.27/214.48  |- rdf__type mesh__D019091sskos__Concept
% 214.27/214.48  |- mesh__dateCreated mesh__D019091 1995-05-26
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D019091 2006
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D019091 2001
% 214.27/214.48  |- skos__historyNote mesh__D019091 Patient Care Planning %28%1991-1995%29%
% 214.27/214.48  |- skos__broader mesh__D019091smesh__D010346
% 214.27/214.48  |- skos__hiddenLabel mesh__D019091 Paths, Clinical
% 214.27/214.48  |- skos__scopeNote mesh__D019091
% 214.27/214.48       Schedules of medical and nursing procedures, including diagnostic tests, medications, and consultations designed to effect an efficient, coordinated program of treatment. %28%From Mosby%27%s Medical, Nursing %26% Allied Health Dictionary, 4th ed%29%%A%    
% 214.27/214.48  |- skos__hiddenLabel mesh__D019091 Clinical Pathway
% 214.27/214.48  |- skos__hiddenLabel mesh__D019091 Pathways, Clinical
% 214.27/214.48  |- skos__annotation mesh__D019091
% 214.27/214.48       schedules in patient care for coordinated treatment   
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D019091 2004
% 214.27/214.48  |- skos__hiddenLabel mesh__D019091 Critical Pathway
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D019091 2005
% 214.27/214.48  |- mesh__dateCreated mesh__D027523 2001-07-25
% 214.27/214.48  |- skos__historyNote mesh__D027523 Plants, Medicinal %28%1969-2001%29%
% 214.27/214.48  |- mesh__dateEstablished mesh__D027523 2002-01-01
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D027523 2003
% 214.27/214.48  |- mesh__historyNote mesh__D027523 2002; use LAMIACEAE 1998-2001   
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D027523 2005
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D027523 2004
% 214.27/214.48  |- skos__prefLabel mesh__D027523 Lavandula
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D027523 2006
% 214.27/214.48  |- mesh__publicMeSHNote mesh__D027523 2002; see LAMIACEAE 1998-2001   
% 214.27/214.48  |- skos__broader mesh__D027523smesh__D019686
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D027523 2002
% 214.27/214.48  |- skos__altLabel mesh__D027523 Lavender
% 214.27/214.48  |- rdf__type mesh__D027523sskos__Concept
% 214.27/214.48  |- skos__scopeNote mesh__D027523
% 214.27/214.48       A plant genus of the LAMIACEAE family.     
% 214.27/214.48  |- skos__annotation mesh__D027523
% 214.27/214.48       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.27/214.48  |- skos__prefLabel mesh__D005071 Evoked Potentials
% 214.27/214.48  |- mesh__recordOriginator mesh__D005071 NLM
% 214.27/214.48  |- mesh__publicMeSHNote mesh__D005071 68   
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005071 2001
% 214.27/214.48  |- skos__broader mesh__D005071smesh__D004594
% 214.27/214.48  |- skos__broader mesh__D005071smesh__D009424
% 214.27/214.48  |- skos__hiddenLabel mesh__D005071 Potential, Event-Related
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005071 2006
% 214.27/214.48  |- skos__hiddenLabel mesh__D005071 Potential, Evoked
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005071 1999
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005071 2000
% 214.27/214.48  |- skos__historyNote mesh__D005071 Electrophysiology %28%1966%29%
% 214.27/214.48  |- mesh__recordAuthorizer mesh__D005071 PLS
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005071 2005
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005071 1998
% 214.27/214.48  |- skos__hiddenLabel mesh__D005071 Antidromic Potential
% 214.27/214.48  |- skos__hiddenLabel mesh__D005071 Potentials, Evoked
% 214.27/214.48  |- skos__scopeNote mesh__D005071
% 214.27/214.48       The electric response evoked in the central nervous system by stimulation of sensory receptors or some point on the sensory pathway leading from the receptor to the cortex. The evoked stimulus can be auditory %28%EVOKED POTENTIALS, AUDITORY%29%, somatosensory %28%EVOKED POTENTIALS, SOMATOSENSORY%29%, or visual %28%EVOKED POTENTIALS, VISUAL%29%, although other modalities have been reported. Event-related potentials is sometimes used synonymously with evoked potentials but is often associated with the execution of a motor, cognitive, or psychophysiological task, as well as with the response to a stimulus.%A%    
% 214.27/214.48  |- skos__altLabel mesh__D005071 Event-Related Potentials
% 214.27/214.48  |- mesh__recordMaintainer mesh__D005071 TGC
% 214.27/214.48  |- skos__annotation mesh__D005071 GEN or unspecified; prefer specifics   
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005071 2002
% 214.27/214.48  |- mesh__dateEstablished mesh__D005071 1968-01-01
% 214.27/214.48  |- rdf__type mesh__D005071sskos__Concept
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005071 2004
% 214.27/214.48  |- mesh__historyNote mesh__D005071 68%28%67%29%   
% 214.27/214.48  |- mesh__dateRevised mesh__D005071 1996-06-10
% 214.27/214.48  |- skos__hiddenLabel mesh__D005071 Evoked Potential
% 214.27/214.48  |- mesh__dateCreated mesh__D005071 1999-01-01
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005071 1997
% 214.27/214.48  |- skos__hiddenLabel mesh__D005071 Potentials, Event Related
% 214.27/214.48  |- skos__hiddenLabel mesh__D005071 Potentials, Antidromic
% 214.27/214.48  |- skos__hiddenLabel mesh__D005071 Potential, Antidromic
% 214.27/214.48  |- skos__hiddenLabel mesh__D005071 Event-Related Potential
% 214.27/214.48  |- skos__hiddenLabel mesh__D005071 Event Related Potentials
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005071 2003
% 214.27/214.48  |- mesh__recordMaintainer mesh__D013503 lkt
% 214.27/214.48  |- skos__hiddenLabel mesh__D013503 Hospital Surgery Departments
% 214.27/214.48  |- mesh__recordAuthorizer mesh__D013503 sjn
% 214.27/214.48  |- skos__broader mesh__D013503smesh__D006748
% 214.27/214.48  |- mesh__dateCreated mesh__D013503 1977-05-19
% 214.27/214.48  |- mesh__historyNote mesh__D013503
% 214.27/214.48       91%28%Aug 77%29%; was see under HOSPITAL DEPARTMENTS 1977-90   
% 214.27/214.48  |- skos__prefLabel mesh__D013503 Surgery Department, Hospital
% 214.27/214.48  |- skos__scopeNote mesh__D013503
% 214.27/214.48       Hospital department which administers all departmental functions and the provision of surgical diagnostic and therapeutic services.%A%    
% 214.27/214.48  |- skos__hiddenLabel mesh__D013503 Departments, Hospital Surgery
% 214.27/214.48  |- mesh__dateRevised mesh__D013503 2002-07-03
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D013503 2005
% 214.27/214.48  |- mesh__publicMeSHNote mesh__D013503
% 214.27/214.48       91; was see under HOSPITAL DEPARTMENTS Aug 1977-90   
% 214.27/214.48  |- skos__altLabel mesh__D013503 Department, Hospital Surgery
% 214.27/214.48  |- skos__altLabel mesh__D013503 Surgery Departments, Hospital
% 214.27/214.48  |- mesh__dateEstablished mesh__D013503 1991-01-01
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D013503 2006
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D013503 2003
% 214.27/214.48  |- mesh__recordOriginator mesh__D013503 EC
% 214.27/214.48  |- skos__annotation mesh__D013503 DF: SURG DEP   
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D013503 2004
% 214.27/214.48  |- skos__altLabel mesh__D013503 Hospital Surgery Department
% 214.27/214.48  |- rdf__type mesh__D013503sskos__Concept
% 214.27/214.48  |- skos__related mesh__D018797smesh__D002453
% 214.27/214.48  |- skos__broader mesh__D018797smesh__D011506
% 214.27/214.48  |- rdf__type mesh__D018797sskos__Concept
% 214.27/214.48  |- skos__related mesh__D018797smesh__D010749
% 214.27/214.48  |- skos__related mesh__D018797smesh__D011494
% 214.27/214.48  |- skos__related mesh__D018797smesh__D018816
% 214.27/214.48  |- mesh__recordMaintainer mesh__D018797 SYSTEM
% 214.27/214.48  |- skos__historyNote mesh__D018797 Cell Cycle %28%1978-1994%29%
% 214.27/214.48  |- mesh__historyNote mesh__D018797 95   
% 214.27/214.48  |- mesh__dateEstablished mesh__D018797 1995-01-01
% 214.27/214.48  |- mesh__dateRevised mesh__D018797 2005-06-30
% 214.27/214.48  |- skos__scopeNote mesh__D018797
% 214.27/214.48       Proteins that control the CELL DIVISION CYCLE. This family of proteins includes a wide variety of classes, including CYCLIN-DEPENDENT KINASES, mitogen-activated kinases, CYCLINS, and phosphoprotein phosphatases %28%PHOSPHOPROTEIN PHOSPHATASE%29% as well as their putative substrates such as chromatin-associated proteins, CYTOSKELETAL PROTEINS, and TRANSCRIPTION FACTORS.%A%    
% 214.27/214.48  |- skos__altLabel mesh__D018797 cdc Proteins
% 214.27/214.48  |- skos__prefLabel mesh__D018797 Cell Cycle Proteins
% 214.27/214.48  |- mesh__dateCreated mesh__D018797 1994-05-31
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D018797 2006
% 214.27/214.48  |- skos__altLabel mesh__D018797 Cell Division Cycle Proteins
% 214.27/214.48  |- mesh__publicMeSHNote mesh__D018797 95   
% 214.27/214.48  |- mesh__recordOriginator mesh__D018797 AGS
% 214.27/214.48  |- mesh__recordAuthorizer mesh__D018797 sjn
% 214.27/214.48  |- skos__hiddenLabel mesh__D018797 Cell Cycle Regulatory Proteins
% 214.27/214.48  |- skos__altLabel mesh__D018797 Cell-Cycle Regulatory Proteins
% 214.27/214.48  |- skos__historyNote mesh__D018797 Cell Division %28%1966-1994%29%
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D004777 2006
% 214.27/214.48  |- skos__scopeNote mesh__D004777
% 214.27/214.48       The external elements and conditions which surround, influence, and affect the life and development of an organism or population.%A%    
% 214.27/214.48  |- skos__altLabel mesh__D004777 Environmental Policy
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D004777 2002
% 214.27/214.48  |- mesh__dateCreated mesh__D004777 1999-01-01
% 214.27/214.48  |- skos__related mesh__D004777smesh__D012931
% 214.27/214.48  |- mesh__recordAuthorizer mesh__D004777 sjn
% 214.27/214.48  |- skos__hiddenLabel mesh__D004777 Habitats
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D004777 2005
% 214.27/214.48  |- mesh__recordMaintainer mesh__D004777 adp
% 214.27/214.48  |- skos__altLabel mesh__D004777 Impact, Environmental
% 214.27/214.48  |- skos__hiddenLabel mesh__D004777 Environments
% 214.27/214.48  |- skos__altLabel mesh__D004777 Policy, Environmental
% 214.27/214.48  |- rdf__type mesh__D004777sskos__Concept
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D004777 2001
% 214.27/214.48  |- skos__altLabel mesh__D004777 Policies, Environmental
% 214.27/214.48  |- skos__broader mesh__D004777smesh__D004778
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D004777 2004
% 214.27/214.48  |- skos__altLabel mesh__D004777 Environmental Impact
% 214.27/214.48  |- skos__altLabel mesh__D004777 Environmental Impacts
% 214.27/214.48  |- skos__annotation mesh__D004777 no qualif; DF: ENVIR   
% 214.27/214.48  |- mesh__dateRevised mesh__D004777 2000-06-22
% 214.27/214.48  |- skos__related mesh__D004777smesh__D017753
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D004777 2003
% 214.27/214.48  |- mesh__recordOriginator mesh__D004777 NLM
% 214.27/214.48  |- skos__prefLabel mesh__D004777 Environment
% 214.27/214.48  |- skos__scopeNote mesh__D009462
% 214.27/214.48       A medical specialty concerned with the study of the structures, functions, and diseases of the nervous system.%A%    
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D009462 2006
% 214.27/214.48  |- mesh__dateCreated mesh__D009462 1999-01-01
% 214.27/214.48  |- skos__related mesh__D009462smesh__D009422
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D009462 2002
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D009462 2005
% 214.27/214.48  |- mesh__recordMaintainer mesh__D009462 PXP
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D009462 1999
% 214.27/214.48  |- mesh__dateRevised mesh__D009462 1997-06-20
% 214.27/214.48  |- skos__prefLabel mesh__D009462 Neurology
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D009462 1998
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D009462 2001
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D009462 2004
% 214.27/214.48  |- skos__broader mesh__D009462smesh__D013040
% 214.27/214.48  |- rdf__type mesh__D009462sskos__Concept
% 214.27/214.48  |- skos__annotation mesh__D009462 SPEC: SPEC qualif; DF: NEUROL   
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D009462 2000
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D009462 2003
% 214.27/214.48  |- mesh__recordAuthorizer mesh__D009462 SJN
% 214.27/214.48  |- mesh__recordOriginator mesh__D009462 NLM
% 214.27/214.48  |- mesh__dateEstablished mesh__D033561 2003-01-01
% 214.27/214.48  |- rdf__type mesh__D033561sskos__Concept
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D033561 2004
% 214.27/214.48  |- skos__scopeNote mesh__D033561
% 214.27/214.48       A family of CRUSTACEA, order DECAPODA, comprising the penaeid shrimp. Species of the genus Penaeus are the most important commercial shrimp throughout the world.%A%    
% 214.27/214.48  |- skos__altLabel mesh__D033561 Shrimp, Penaeid
% 214.27/214.48  |- mesh__dateRevised mesh__D033561 2003-07-09
% 214.27/214.48  |- mesh__dateCreated mesh__D033561 2002-07-03
% 214.27/214.48  |- skos__annotation mesh__D033561
% 214.27/214.48       as animal %26% food; as food coord IM with SHELLFISH %28%IM%29%; unspecified shrimp as food probably goes here but note several other shrimp terms in MeSH%A%  
% 214.27/214.48  |- skos__altLabel mesh__D033561 Penaeid Shrimp
% 214.27/214.48  |- mesh__historyNote mesh__D033561 2003   
% 214.27/214.48  |- mesh__publicMeSHNote mesh__D033561 2003   
% 214.27/214.48  |- skos__broader mesh__D033561smesh__D033364
% 214.27/214.48  |- skos__prefLabel mesh__D033561 Penaeidae
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D033561 2006
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D033561 2005
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D000387 2005
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D000387 2002
% 214.27/214.48  |- mesh__recordMaintainer mesh__D000387 ags
% 214.27/214.48  |- rdf__type mesh__D000387sskos__Concept
% 214.27/214.48  |- mesh__dateRevised mesh__D000387 1999-11-23
% 214.27/214.48  |- mesh__recordOriginator mesh__D000387 NLM
% 214.27/214.48  |- skos__scopeNote mesh__D000387
% 214.27/214.48       Spontaneous autoamputation of the fourth or fifth toe.     
% 214.27/214.48  |- skos__prefLabel mesh__D000387 Ainhum
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D000387 2004
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D000387 2000A
% 214.27/214.48  |- skos__broader mesh__D000387smesh__D001862
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D000387 2001
% 214.27/214.48  |- mesh__recordAuthorizer mesh__D000387 ags
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D000387 2003
% 214.27/214.48  |- skos__altLabel mesh__D000387 Dactylolysis Spontanea
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D000387 2000
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D000387 2006
% 214.27/214.48  |- mesh__dateCreated mesh__D000387 1999-01-01
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D019092 2001
% 214.27/214.48  |- mesh__recordOriginator mesh__D019092 JLS
% 214.27/214.48  |- mesh__historyNote mesh__D019092 96   
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D019092 2000
% 214.27/214.48  |- mesh__recordAuthorizer mesh__D019092 sjn
% 214.27/214.48  |- skos__hiddenLabel mesh__D019092 Conisations
% 214.27/214.48  |- skos__altLabel mesh__D019092 Conisation
% 214.27/214.48  |- rdf__type mesh__D019092sskos__Concept
% 214.27/214.48  |- mesh__dateCreated mesh__D019092 1995-05-26
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D019092 2006
% 214.27/214.48  |- skos__prefLabel mesh__D019092 Conization
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D019092 2002
% 214.27/214.48  |- mesh__dateRevised mesh__D019092 1999-11-03
% 214.27/214.48  |- skos__annotation mesh__D019092
% 214.27/214.48       not restricted to cervical biopsy; coord IM with organ /pathol %28%IM%29% or organ /surg %28%IM%29%%A%  
% 214.27/214.48  |- mesh__publicMeSHNote mesh__D019092 96   
% 214.27/214.48  |- skos__hiddenLabel mesh__D019092 Conizations
% 214.27/214.48  |- skos__historyNote mesh__D019092 Cervix Uteri/surgery %28%1966-1995%29%
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D019092 2004
% 214.27/214.48  |- skos__scopeNote mesh__D019092
% 214.27/214.48       The excision of a cone of tissue, especially of the CERVIX UTERI.%A%    
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D019092 2005
% 214.27/214.48  |- mesh__dateEstablished mesh__D019092 1996-01-01
% 214.27/214.48  |- mesh__recordMaintainer mesh__D019092 KEV
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D019092 2003
% 214.27/214.48  |- skos__broader mesh__D019092smesh__D001706
% 214.27/214.48  |- skos__annotation mesh__D005870
% 214.27/214.48       benign or malignant; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29% but GIANT CELL TUMOR OF BONE is available%A%  
% 214.27/214.48  |- skos__hiddenLabel mesh__D005870 Tumors, Giant Cell
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005870 2001
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005870 1998
% 214.27/214.48  |- skos__hiddenLabel mesh__D005870 Tumor, Giant Cell
% 214.27/214.48  |- mesh__recordMaintainer mesh__D005870 TGC
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005870 2000
% 214.27/214.48  |- mesh__recordAuthorizer mesh__D005870 SJN
% 214.27/214.48  |- skos__prefLabel mesh__D005870 Giant Cell Tumors
% 214.27/214.48  |- skos__broader mesh__D005870smesh__D009372
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005870 2004
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005870 2006
% 214.27/214.48  |- skos__hiddenLabel mesh__D005870 Giant Cell Tumor
% 214.27/214.48  |- mesh__dateCreated mesh__D005870 1999-01-01
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005870 2003
% 214.27/214.48  |- skos__hiddenLabel mesh__D005870 Cell Tumors, Giant
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005870 2005
% 214.27/214.48  |- skos__scopeNote mesh__D005870
% 214.27/214.48       Tumors of bone tissue or synovial or other soft tissue characterized by the presence of giant cells. The most common are giant cell tumor of tendon sheath and GIANT CELL TUMOR OF BONE.%A%    
% 214.27/214.48  |- skos__hiddenLabel mesh__D005870 Cell Tumor, Giant
% 214.27/214.48  |- mesh__recordOriginator mesh__D005870 NLM
% 214.27/214.48  |- mesh__dateRevised mesh__D005870 1997-06-20
% 214.27/214.48  |- rdf__type mesh__D005870sskos__Concept
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005870 2002
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005870 1999
% 214.27/214.48  |- mesh__recordAuthorizer mesh__D005072 PLS
% 214.27/214.48  |- mesh__recordMaintainer mesh__D005072 AGS
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005072 2006
% 214.27/214.48  |- mesh__dateEstablished mesh__D005072 1980-01-01
% 214.27/214.48  |- skos__hiddenLabel mesh__D005072 Evoked Potential, Auditory
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005072 1998
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005072 2002
% 214.27/214.48  |- mesh__dateRevised mesh__D005072 1995-02-23
% 214.27/214.48  |- skos__historyNote mesh__D005072 Acoustic Stimulation %28%1972-1979%29%
% 214.27/214.48  |- skos__altLabel mesh__D005072 Auditory Evoked Response
% 214.27/214.48  |- mesh__dateCreated mesh__D005072 1978-12-14
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005072 2003
% 214.27/214.48  |- rdf__type mesh__D005072sskos__Concept
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005072 1999
% 214.27/214.48  |- skos__historyNote mesh__D005072 Evoked Potentials %28%1967-1979%29%
% 214.27/214.48  |- skos__hiddenLabel mesh__D005072 Auditory Evoked Responses
% 214.27/214.48  |- skos__hiddenLabel mesh__D005072 Potential, Auditory Evoked
% 214.27/214.48  |- skos__historyNote mesh__D005072 Auditory Perception %28%1967-1979%29%
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005072 2004
% 214.27/214.48  |- mesh__historyNote mesh__D005072 80   
% 214.27/214.48  |- skos__hiddenLabel mesh__D005072 Evoked Responses, Auditory
% 214.27/214.48  |- skos__altLabel mesh__D005072 Auditory Evoked Potentials
% 214.27/214.48  |- skos__historyNote mesh__D005072 Sound %28%1966-1971%29%
% 214.27/214.48  |- skos__broader mesh__D005072smesh__D005071
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005072 1996
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005072 2000
% 214.27/214.48  |- skos__prefLabel mesh__D005072 Evoked Potentials, Auditory
% 214.27/214.48  |- skos__hiddenLabel mesh__D005072 Response, Auditory Evoked
% 214.27/214.48  |- skos__annotation mesh__D005072 IM   
% 214.27/214.48  |- skos__historyNote mesh__D005072 Electrophysiology %28%1966%29%
% 214.27/214.48  |- mesh__publicMeSHNote mesh__D005072 80   
% 214.27/214.48  |- mesh__recordOriginator mesh__D005072 RC
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005072 1997
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005072 2001
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D005072 2005
% 214.27/214.48  |- skos__hiddenLabel mesh__D005072 Potentials, Auditory Evoked
% 214.27/214.48  |- skos__hiddenLabel mesh__D005072 Responses, Auditory Evoked
% 214.27/214.48  |- skos__scopeNote mesh__D005072
% 214.27/214.48       The electric response evoked in the cerebral cortex by acoustic stimulation or stimulation of the auditory pathways.%A%    
% 214.27/214.48  |- skos__hiddenLabel mesh__D005072 Auditory Evoked Potential
% 214.27/214.48  |- skos__historyNote mesh__D005072 Hearing %28%1966%29%
% 214.27/214.48  |- skos__hiddenLabel mesh__D005072 Evoked Response, Auditory
% 214.27/214.48  |- skos__altLabel mesh__D013504 Procedures, Cardiovascular Surgical
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D013504 2002
% 214.27/214.48  |- mesh__recordMaintainer mesh__D013504 TGC
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D013504 2005
% 214.27/214.48  |- mesh__recordOriginator mesh__D013504 NLM
% 214.27/214.48  |- mesh__dateCreated mesh__D013504 1999-01-01
% 214.27/214.48  |- skos__scopeNote mesh__D013504
% 214.27/214.48       Surgery performed on the heart or blood vessels.     
% 214.27/214.48  |- skos__altLabel mesh__D013504 Procedure, Cardiovascular Surgical
% 214.27/214.48  |- skos__altLabel mesh__D013504 Surgical Procedure, Cardiovascular
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D013504 2006
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D013504 2000
% 214.27/214.48  |- mesh__dateRevised mesh__D013504 1997-06-20
% 214.27/214.48  |- mesh__recordAuthorizer mesh__D013504 SJN
% 214.27/214.48  |- skos__broader mesh__D013504smesh__D013514
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D013504 2003
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D013504 1998
% 214.27/214.48  |- mesh__historyNote mesh__D013504 98; use explode 1970-97   
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D013504 2001
% 214.27/214.48  |- mesh__dateEstablished mesh__D013504 1998-01-01
% 214.27/214.48  |- skos__related mesh__D013504smesh__D013903
% 214.27/214.48  |- skos__annotation mesh__D013504
% 214.27/214.48       GEN or unspecified; prefer specifics; consider also /surg with specific parts of the cardiovasc system; also CARDIOVASCULAR DISEASES /surg or /surg with specific cardiovasc dis; DF: CARDIOVASC SURG PROCEDURES%A%  
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D013504 2004
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D013504 1999
% 214.27/214.48  |- mesh__publicMeSHNote mesh__D013504 98   
% 214.27/214.48  |- rdf__type mesh__D013504sskos__Concept
% 214.27/214.48  |- skos__altLabel mesh__D013504 Surgical Procedures, Cardiovascular
% 214.27/214.48  |- skos__prefLabel mesh__D013504 Cardiovascular Surgical Procedures
% 214.27/214.48  |- skos__altLabel mesh__D013504 Cardiovascular Surgical Procedure
% 214.27/214.48  |- skos__altLabel mesh__D018798 Anemias, Iron-Deficiency
% 214.27/214.48  |- mesh__historyNote mesh__D018798
% 214.27/214.48       95; IRON DEFICIENCY ANEMIA was see ANEMIA, HYPOCHROMIC 1970-94%A%  
% 214.27/214.48  |- mesh__dateCreated mesh__D018798 1994-05-31
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D018798 2002
% 214.27/214.48  |- skos__historyNote mesh__D018798 Anemia, Hypochromic %28%1966-1994%29%
% 214.27/214.48  |- mesh__recordAuthorizer mesh__D018798 sjn
% 214.27/214.48  |- mesh__onlineNote mesh__D018798
% 214.27/214.48       use ANEMIA, HYPOCHROMIC to search IRON DEFICIENCY ANEMIA 1970-94%A%  
% 214.27/214.48  |- skos__hiddenLabel mesh__D018798 Iron Deficiency Anemias
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D018798 2006
% 214.27/214.48  |- skos__altLabel mesh__D018798 Iron-Deficiency Anemia
% 214.27/214.48  |- skos__broader mesh__D018798smesh__D019189
% 214.27/214.48  |- mesh__dateRevised mesh__D018798 1999-11-03
% 214.27/214.48  |- skos__scopeNote mesh__D018798
% 214.27/214.48       Anemia characterized by decreased or absent iron stores, low serum iron concentration, low transferrin saturation, and low hemoglobin concentration or hematocrit value. The erythrocytes are hypochromic and microcytic and the iron binding capacity is increased.%A%    
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D018798 2005
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D018798 2004
% 214.27/214.48  |- skos__hiddenLabel mesh__D018798 Anemias, Iron Deficiency
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D018798 2001
% 214.27/214.48  |- mesh__publicMeSHNote mesh__D018798
% 214.27/214.48       95; IRON DEFICIENCY ANEMIA was see ANEMIA, HYPOCHROMIC 1970-94%A%  
% 214.27/214.48  |- skos__hiddenLabel mesh__D018798 Anemia, Iron Deficiency
% 214.27/214.48  |- skos__broader mesh__D018798smesh__D000747
% 214.27/214.48  |- rdf__type mesh__D018798sskos__Concept
% 214.27/214.48  |- mesh__dateEstablished mesh__D018798 1995-01-01
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D018798 2003
% 214.27/214.48  |- skos__prefLabel mesh__D018798 Anemia, Iron-Deficiency
% 214.27/214.48  |- mesh__recordMaintainer mesh__D018798 KEV
% 214.27/214.48  |- mesh__recordOriginator mesh__D018798 TGC
% 214.27/214.48  |- skos__hiddenLabel mesh__D018798 Iron Deficiency Anemia
% 214.27/214.48  |- skos__altLabel mesh__D018798 Iron-Deficiency Anemias
% 214.27/214.48  |- skos__annotation mesh__D018798 DF: ANEMIA IRON DEFIC   
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D018798 2000
% 214.27/214.48  |- mesh__recordAuthorizer mesh__D004778 sjn
% 214.27/214.48  |- mesh__recordMaintainer mesh__D004778 ags
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D004778 2002
% 214.27/214.48  |- mesh__publicMeSHNote mesh__D004778 1998   
% 214.27/214.48  |- mesh__historyNote mesh__D004778 1998; use explode 1970-1997   
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D004778 2006
% 214.27/214.48  |- skos__prefLabel mesh__D004778 Environment and Public Health
% 214.27/214.48  |- mesh__dateEstablished mesh__D004778 1998-01-01
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D004778 2005
% 214.27/214.48  |- rdf__type mesh__D004778sskos__Concept
% 214.27/214.48  |- skos__scopeNote mesh__D004778
% 214.27/214.48       Natural and man-made environments and their impact on public health.%A%    
% 214.27/214.48  |- mesh__runningHead mesh__D004778 G3 - ENVIRONMENT AND PUBLIC HEALTH   
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D004778 2001
% 214.27/214.48  |- skos__annotation mesh__D004778
% 214.27/214.48       not used for indexing; CATALOG: do not use   
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D004778 2004
% 214.27/214.48  |- mesh__dateRevised mesh__D004778 2000-06-22
% 214.27/214.48  |- mesh__recordOriginator mesh__D004778 NLM
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D004778 2003
% 214.27/214.48  |- mesh__dateCreated mesh__D004778 1999-01-01
% 214.27/214.48  |- mesh__activeMeSHYear mesh__D009463 2005
% 214.27/214.48  |- mesh__recordAuthorizer mesh__D009463 SJN
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D009463 1999
% 214.27/214.49  |- skos__scopeNote mesh__D009463
% 214.27/214.49       A tumor made up of nerve cells and nerve fibers. %28%Dorland, 27th ed%29%%A%    
% 214.27/214.49  |- mesh__recordOriginator mesh__D009463 NLM
% 214.27/214.49  |- skos__broader mesh__D009463smesh__D018317
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D009463 1998
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D009463 2002
% 214.27/214.49  |- mesh__recordMaintainer mesh__D009463 TGC
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D009463 2004
% 214.27/214.49  |- skos__annotation mesh__D009463
% 214.27/214.49       /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 214.27/214.49  |- mesh__dateRevised mesh__D009463 1997-06-20
% 214.27/214.49  |- rdf__type mesh__D009463sskos__Concept
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D009463 2003
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D009463 2001
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D009463 2006
% 214.27/214.49  |- mesh__dateCreated mesh__D009463 1999-01-01
% 214.27/214.49  |- skos__prefLabel mesh__D009463 Neuroma
% 214.27/214.49  |- skos__hiddenLabel mesh__D009463 Neuromas
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D009463 2000
% 214.27/214.49  |- skos__hiddenLabel mesh__D001480 Basal Ganglia Disease
% 214.27/214.49  |- mesh__recordMaintainer mesh__D001480 ags
% 214.27/214.49  |- mesh__recordOriginator mesh__D001480 NLM
% 214.27/214.49  |- skos__historyNote mesh__D001480 Movement Disorders %28%1966-1971%29%
% 214.27/214.49  |- mesh__dateCreated mesh__D001480 1999-01-01
% 214.27/214.49  |- skos__historyNote mesh__D001480 specific anatomic site %28%1966-1971%29%
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D001480 2006
% 214.27/214.49  |- mesh__dateEstablished mesh__D001480 1974-01-01
% 214.27/214.49  |- skos__broader mesh__D001480smesh__D001927
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D001480 2003
% 214.27/214.49  |- mesh__recordAuthorizer mesh__D001480 ags
% 214.27/214.49  |- mesh__historyNote mesh__D001480
% 214.27/214.49       79; was EXTRAPYRAMIDAL DISORDERS 1972-78 %28%Prov 1972-73%29%   
% 214.27/214.49  |- mesh__publicMeSHNote mesh__D001480
% 214.27/214.49       79; was EXTRAPYRAMIDAL DISORDERS 1974-78   
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D001480 2006A
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D001480 2005
% 214.27/214.49  |- rdf__type mesh__D001480sskos__Concept
% 214.27/214.49  |- skos__scopeNote mesh__D001480
% 214.27/214.49       Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS %28%most notably involuntary movements and alterations of the rate of movement%29% represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.%A%    
% 214.27/214.49  |- skos__hiddenLabel mesh__D001480 Basal Ganglia Disorder
% 214.27/214.49  |- mesh__dateRevised mesh__D001480 2005-07-12
% 214.27/214.49  |- skos__hiddenLabel mesh__D001480 Lenticulostriate Disorder
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D001480 2002
% 214.27/214.49  |- skos__prefLabel mesh__D001480 Basal Ganglia Diseases
% 214.27/214.49  |- skos__altLabel mesh__D001480 Basal Ganglia Disorders
% 214.27/214.49  |- skos__annotation mesh__D001480
% 214.27/214.49       GEN: prefer specifics; coord IM with specific site %28%IM%29%   
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D001480 2004
% 214.27/214.49  |- skos__hiddenLabel mesh__D001480 Extrapyramidal Disorder
% 214.27/214.49  |- skos__broader mesh__D011454Q000031smesh__D011454
% 214.27/214.49  |- mesh__preferredCombination mesh__D011454Q000031smesh__D011455
% 214.27/214.49  |- rdf__type mesh__D011454Q000031smesh__CompoundConcept
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D019891 2004
% 214.27/214.49  |- mesh__dateRevised mesh__D019891 2003-07-09
% 214.27/214.49  |- skos__prefLabel mesh__D019891 Leukopoiesis
% 214.27/214.49  |- mesh__recordOriginator mesh__D019891 TGC
% 214.27/214.49  |- mesh__historyNote mesh__D019891 98   
% 214.27/214.49  |- skos__broader mesh__D019891smesh__D006410
% 214.27/214.49  |- mesh__dateEstablished mesh__D019891 1998-01-01
% 214.27/214.49  |- skos__historyNote mesh__D019891 Leukocytes %28%1966-1997%29%
% 214.27/214.49  |- mesh__publicMeSHNote mesh__D019891 98   
% 214.27/214.49  |- mesh__dateCreated mesh__D019891 1997-06-20
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D019891 2006
% 214.27/214.49  |- skos__historyNote mesh__D019891 Hematopoiesis %28%1966-1997%29%
% 214.27/214.49  |- mesh__recordMaintainer mesh__D019891 nns
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D019891 2005
% 214.27/214.49  |- skos__scopeNote mesh__D019891
% 214.27/214.49       The process of generating white blood cells %28%LEUKOCYTES%29% from the pluripotent HEMATOPOIETIC STEM CELLS of the BONE MARROW. There are two significant pathways to generate various types of leukocytes: MYELOPOIESIS, in which leukocytes in the blood are derived from MYELOID STEM CELLS, and LYMPHOPOIESIS, in which leukocytes of the lymphatic system %28%LYMPHOCYTES%29% are generated from lymphoid stem cells.%A%    
% 214.27/214.49  |- mesh__recordAuthorizer mesh__D019891 sjn
% 214.27/214.49  |- rdf__type mesh__D019891sskos__Concept
% 214.27/214.49  |- rdf__type mesh__D000388sskos__Concept
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D000388 2004
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D000388 2002
% 214.27/214.49  |- skos__broader mesh__D000388smesh__D001272
% 214.27/214.49  |- skos__annotation mesh__D000388
% 214.27/214.49       do not confuse with ATMOSPHERE or OXYGEN   
% 214.27/214.49  |- skos__scopeNote mesh__D000388
% 214.27/214.49       The mixture of gases present in the earth%27%s atmosphere consisting of oxygen, nitrogen, carbon dioxide, and small amounts of other gases.%A%    
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D000388 2003
% 214.27/214.49  |- mesh__recordAuthorizer mesh__D000388 sjn
% 214.27/214.49  |- mesh__dateRevised mesh__D000388 2000-06-21
% 214.27/214.49  |- mesh__recordOriginator mesh__D000388 NLM
% 214.27/214.49  |- skos__prefLabel mesh__D000388 Air
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D000388 2006
% 214.27/214.49  |- mesh__dateCreated mesh__D000388 1999-01-01
% 214.27/214.49  |- mesh__recordMaintainer mesh__D000388 adp
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D000388 2001
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D000388 2005
% 214.27/214.49  |- mesh__recordOriginator mesh__D019093 JLS
% 214.27/214.49  |- mesh__dateEstablished mesh__D019093 1996-01-01
% 214.27/214.49  |- skos__hiddenLabel mesh__D019093 Clitorectomies
% 214.27/214.49  |- mesh__historyNote mesh__D019093 96   
% 214.27/214.49  |- mesh__publicMeSHNote mesh__D019093 96   
% 214.27/214.49  |- skos__historyNote mesh__D019093 Circumcision %28%1990-1995%29%
% 214.27/214.49  |- skos__broader mesh__D019093smesh__D046289
% 214.27/214.49  |- skos__hiddenLabel mesh__D019093 Circumcisions, Female
% 214.27/214.49  |- skos__altLabel mesh__D019093 Female Circumcision
% 214.27/214.49  |- mesh__recordMaintainer mesh__D019093 nns
% 214.27/214.49  |- mesh__dateRevised mesh__D019093 2004-07-07
% 214.27/214.49  |- mesh__dateCreated mesh__D019093 1995-06-07
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D019093 2005
% 214.27/214.49  |- skos__scopeNote mesh__D019093
% 214.27/214.49       A general term encompassing three types of excision of the external female genitalia - Sunna, clitoridectomy, and infibulation. It is associated with severe health risks and has been declared illegal in many places, but continues to be widely practiced in a number of countries, particularly in Africa.%A%    
% 214.27/214.49  |- skos__hiddenLabel mesh__D019093 Infibulations
% 214.27/214.49  |- skos__hiddenLabel mesh__D019093 Clitoridectomies
% 214.27/214.49  |- skos__broader mesh__D019093smesh__D013509
% 214.27/214.49  |- rdf__type mesh__D019093sskos__Concept
% 214.27/214.49  |- skos__altLabel mesh__D019093 Clitorectomy
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D019093 2006
% 214.27/214.49  |- mesh__recordAuthorizer mesh__D019093 sjn
% 214.27/214.49  |- skos__prefLabel mesh__D019093 Circumcision, Female
% 214.27/214.49  |- skos__broader mesh__D019093smesh__D003469
% 214.27/214.49  |- skos__hiddenLabel mesh__D019093 Female Circumcisions
% 214.27/214.49  |- mesh__dateEstablished mesh__D005871 1987-01-01
% 214.27/214.49  |- skos__hiddenLabel mesh__D005871 Lymphoid Hyperplasia, Angiofollicular
% 214.27/214.49  |- skos__hiddenLabel mesh__D005871 Hyperplasia, Angiofollicular Lymphoid
% 214.27/214.49  |- skos__hiddenLabel mesh__D005871 Castlemans Disease
% 214.27/214.49  |- skos__altLabel mesh__D005871 Lymph Node Hyperplasia, Giant
% 214.27/214.49  |- skos__scopeNote mesh__D005871
% 214.27/214.49       Large benign, hyperplastic lymph nodes. The more common hyaline vascular subtype is characterized by small hyaline vascular follicles and interfollicular capillary proliferations. Plasma cells are often present and represent another subtype with the plasma cells containing IgM and IMMUNOGLOBULIN A.%A%    
% 214.27/214.49  |- skos__prefLabel mesh__D005871 Giant Lymph Node Hyperplasia
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D005871 2002
% 214.27/214.49  |- skos__hiddenLabel mesh__D005871 Hyperplasias, Angiofollicular Lymphoid
% 214.27/214.49  |- skos__hiddenLabel mesh__D005871 Lymphoid Hyperplasias, Angiofollicular
% 214.27/214.49  |- skos__hiddenLabel mesh__D005871 Castleman Tumor
% 214.27/214.49  |- skos__altLabel mesh__D005871 Castleman%27%s Disease
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D005871 2004
% 214.27/214.49  |- skos__historyNote mesh__D005871 Hyperplasia %28%1966-1986%29%
% 214.27/214.49  |- mesh__historyNote mesh__D005871 87   
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D005871 2006
% 214.27/214.49  |- skos__broader mesh__D005871smesh__D008232
% 214.27/214.49  |- skos__hiddenLabel mesh__D005871 Castlemans Tumor
% 214.27/214.49  |- skos__altLabel mesh__D005871 Castleman Disease
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D005871 2003
% 214.27/214.49  |- skos__annotation mesh__D005871 DF: note short X ref   
% 214.27/214.49  |- skos__altLabel mesh__D005871 GLNH
% 214.27/214.49  |- skos__altLabel mesh__D005871 Angiofollicular Lymphoid Hyperplasia
% 214.27/214.49  |- mesh__publicMeSHNote mesh__D005871 87   
% 214.27/214.49  |- mesh__dateRevised mesh__D005871 2001-08-03
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D005871 2005
% 214.27/214.49  |- skos__historyNote mesh__D005871 Lymph Nodes %28%1966-1986%29%
% 214.27/214.49  |- skos__hiddenLabel mesh__D005871 Angiofollicular Lymphoid Hyperplasias
% 214.27/214.49  |- skos__altLabel mesh__D005871 Castleman%27%s Tumor
% 214.27/214.49  |- mesh__dateCreated mesh__D005871 1986-06-24
% 214.27/214.49  |- rdf__type mesh__D005871sskos__Concept
% 214.27/214.49  |- mesh__recordMaintainer mesh__D005871 sjn
% 214.27/214.49  |- skos__altLabel mesh__D005871 Hyperplasia, Giant Lymph Node
% 214.27/214.49  |- skos__hiddenLabel mesh__D005871 Tumor, Castleman%27%s
% 214.27/214.49  |- mesh__recordOriginator mesh__D005871 VDK
% 214.27/214.49  |- mesh__recordAuthorizer mesh__D005871 sjn
% 214.27/214.49  |- skos__hiddenLabel mesh__D005073 Potentials, Somatosensory Evoked
% 214.27/214.49  |- skos__broader mesh__D005073smesh__D005071
% 214.27/214.49  |- skos__hiddenLabel mesh__D005073 Potential, Somatosensory Evoked
% 214.27/214.49  |- mesh__dateCreated mesh__D005073 1981-05-20
% 214.27/214.49  |- skos__historyNote mesh__D005073 Evoked Potentials %28%1967-1981%29%
% 214.27/214.49  |- skos__annotation mesh__D005073 IM   
% 214.27/214.49  |- rdf__type mesh__D005073sskos__Concept
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D005073 2004
% 214.27/214.49  |- mesh__dateRevised mesh__D005073 1995-02-23
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D005073 1997
% 214.27/214.49  |- mesh__historyNote mesh__D005073 82   
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D005073 2002
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D005073 2003
% 214.27/214.49  |- skos__scopeNote mesh__D005073
% 214.27/214.49       The electric response evoked in the cerebral cortex by stimulation of afferent pathways from peripheral nerves to cerebrum.%A%    
% 214.27/214.49  |- mesh__dateEstablished mesh__D005073 1982-01-01
% 214.27/214.49  |- mesh__recordMaintainer mesh__D005073 AGS
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D005073 1996
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D005073 2006
% 214.27/214.49  |- mesh__publicMeSHNote mesh__D005073 82   
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D005073 1999
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D005073 2001
% 214.27/214.49  |- mesh__recordOriginator mesh__D005073 RC
% 214.27/214.49  |- skos__altLabel mesh__D005073 Somatosensory Evoked Potentials
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D005073 2005
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D005073 1998
% 214.27/214.49  |- skos__prefLabel mesh__D005073 Evoked Potentials, Somatosensory
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D005073 2000
% 214.27/214.49  |- skos__hiddenLabel mesh__D005073 Evoked Potential, Somatosensory
% 214.27/214.49  |- skos__hiddenLabel mesh__D005073 Somatosensory Evoked Potential
% 214.27/214.49  |- mesh__recordAuthorizer mesh__D005073 PLS
% 214.27/214.49  |- skos__historyNote mesh__D005073 Somatosensory Cortex %28%1971-1981%29%
% 214.27/214.49  |- skos__scopeNote mesh__D013505
% 214.27/214.49       Surgery performed on the digestive system or its parts.%A%    
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D013505 2001
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D013505 2003
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D013505 1998
% 214.27/214.49  |- mesh__publicMeSHNote mesh__D013505 98   
% 214.27/214.49  |- skos__prefLabel mesh__D013505 Digestive System Surgical Procedures
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D013505 2004
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D013505 1999
% 214.27/214.49  |- skos__altLabel mesh__D013505 Procedure, Gastrointestinal Surgical
% 214.27/214.49  |- rdf__type mesh__D013505sskos__Concept
% 214.27/214.49  |- skos__altLabel mesh__D013505 Gastrointestinal Surgical Procedures
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D013505 2002
% 214.27/214.49  |- mesh__historyNote mesh__D013505 98; use explode 1970-74   
% 214.27/214.49  |- mesh__recordMaintainer mesh__D013505 PXP
% 214.27/214.49  |- mesh__recordOriginator mesh__D013505 NLM
% 214.27/214.49  |- skos__altLabel mesh__D013505 Procedure, Digestive System Surgical
% 214.27/214.49  |- skos__altLabel mesh__D013505 Procedures, Digestive System Surgical
% 214.27/214.49  |- skos__altLabel mesh__D013505 Surgical Procedures, Gastrointestinal
% 214.27/214.49  |- skos__altLabel mesh__D013505 Surgical Procedure, Digestive System
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D013505 2000
% 214.27/214.49  |- mesh__dateCreated mesh__D013505 1999-01-01
% 214.27/214.49  |- mesh__dateRevised mesh__D013505 1997-06-20
% 214.27/214.49  |- mesh__recordAuthorizer mesh__D013505 SJN
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D013505 2005
% 214.27/214.49  |- skos__altLabel mesh__D013505 Surgical Procedures, Digestive System
% 214.27/214.49  |- skos__annotation mesh__D013505
% 214.27/214.49       GEN or unspecified; prefer specifics; consider also /surg with specific parts of the digest syst; also /surg with specific digest dis; DF: DIGESTIVE SYSTEM SURG PROCEDURES%A%  
% 214.27/214.49  |- mesh__dateEstablished mesh__D013505 1998-01-01
% 214.27/214.49  |- skos__broader mesh__D013505smesh__D013514
% 214.27/214.49  |- skos__altLabel mesh__D013505 Procedures, Gastrointestinal Surgical
% 214.27/214.49  |- skos__altLabel mesh__D013505 Surgical Procedure, Gastrointestinal
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D013505 2006
% 214.27/214.49  |- skos__altLabel mesh__D013505 Digestive System Surgical Procedure
% 214.27/214.49  |- skos__scopeNote mesh__D018799
% 214.27/214.49       A cell-surface ligand involved in leukocyte adhesion and inflammation. Its production is induced by gamma-interferon and it is required for neutrophil migration into inflamed tissue.%A%    
% 214.27/214.49  |- mesh__publicMeSHNote mesh__D018799
% 214.27/214.49       95; INTERCELLULAR ADHESION MOLECULE 1 was indexed under CELL ADHESION MOLECULES 1989-94%A%  
% 214.27/214.49  |- mesh__onlineNote mesh__D018799
% 214.27/214.49       use INTERCELLULAR ADHESION MOLECULE-1 %28%NM%29% to search INTERCELLULAR ADHESION MOLECULE 1 1989-94%A%  
% 214.27/214.49  |- mesh__dateRevised mesh__D018799 2005-06-30
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D018799 2006
% 214.27/214.49  |- skos__broader mesh__D018799smesh__D015703
% 214.27/214.49  |- skos__hiddenLabel mesh__D018799 Intercellular Adhesion Molecule 1
% 214.27/214.49  |- mesh__dateCreated mesh__D018799 1994-05-31
% 214.27/214.49  |- mesh__recordMaintainer mesh__D018799 ssb
% 214.27/214.49  |- mesh__historyNote mesh__D018799
% 214.27/214.49       95; was INTERCELLULAR ADHESION MOLECULE 1 %28%NM%29% 1989-94   
% 214.27/214.49  |- mesh__recordAuthorizer mesh__D018799 sjn
% 214.27/214.49  |- skos__altLabel mesh__D018799 Antigens, CD54
% 214.27/214.49  |- mesh__recordOriginator mesh__D018799 AGS
% 214.27/214.49  |- rdf__type mesh__D018799sskos__Concept
% 214.27/214.49  |- skos__historyNote mesh__D018799
% 214.27/214.49       Cell Adhesion Molecules %28%1989-1994%29%
% 214.27/214.49  |- skos__altLabel mesh__D018799 CD54 Antigens
% 214.27/214.49  |- skos__altLabel mesh__D018799 CD54 Antigen
% 214.27/214.49  |- skos__altLabel mesh__D018799 ICAM-1
% 214.27/214.49  |- skos__hiddenLabel mesh__D018799 Antigen, CD54
% 214.27/214.49  |- skos__prefLabel mesh__D018799 Intercellular Adhesion Molecule-1
% 214.27/214.49  |- mesh__dateEstablished mesh__D018799 1995-01-01
% 214.27/214.49  |- skos__broader mesh__D018799smesh__D015815
% 214.27/214.49  |- mesh__historyNote mesh__D004779 74%28%72%29%   
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D004779 2005
% 214.27/214.49  |- skos__prefLabel mesh__D004779 Environment Design
% 214.27/214.49  |- rdf__type mesh__D004779sskos__Concept
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D004779 1999
% 214.27/214.49  |- skos__broader mesh__D004779smesh__D004777
% 214.27/214.49  |- skos__hiddenLabel mesh__D004779 Designs, Environment
% 214.27/214.49  |- mesh__dateEstablished mesh__D004779 1974-01-01
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D004779 2002
% 214.27/214.49  |- mesh__publicMeSHNote mesh__D004779 74   
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D004779 1998
% 214.27/214.49  |- skos__scopeNote mesh__D004779
% 214.27/214.49       The structuring of the environment to permit or promote specific patterns of behavior.%A%    
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D004779 2004
% 214.27/214.49  |- skos__altLabel mesh__D004779 Design, Environment
% 214.27/214.49  |- skos__broader mesh__D004779smesh__D012939
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D004779 2001
% 214.27/214.49  |- skos__historyNote mesh__D004779 Environment %28%1966-1971%29%
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D004779 2003
% 214.27/214.49  |- skos__hiddenLabel mesh__D004779 Environment Designs
% 214.27/214.49  |- mesh__recordMaintainer mesh__D004779 KEV
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D004779 1997
% 214.27/214.49  |- mesh__dateCreated mesh__D004779 1999-01-01
% 214.27/214.49  |- skos__broader mesh__D004779smesh__D012942
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D004779 2000
% 214.27/214.49  |- skos__annotation mesh__D004779 DF: ENVIR DESIGN   
% 214.27/214.49  |- mesh__dateRevised mesh__D004779 1995-05-19
% 214.27/214.49  |- mesh__recordAuthorizer mesh__D004779 PLS
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D004779 1996
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D004779 2006
% 214.27/214.49  |- mesh__recordOriginator mesh__D004779 NLM
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D009464 2005
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Acoustic Neurinoma
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Neuromas, Acoustic
% 214.27/214.49  |- skos__broader mesh__D009464smesh__D003390
% 214.27/214.49  |- skos__altLabel mesh__D009464 Acoustic Neuroma, Cerebellopontine Angle
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Acoustic Neurilemmomas
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Schwannomas, Vestibular
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Vestibular Schwannoma
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Schwannomas, Acoustic
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Acoustic Neurilemomas
% 214.27/214.49  |- skos__broader mesh__D009464smesh__D010039
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Vestibular Schwannomas
% 214.27/214.49  |- skos__altLabel mesh__D009464 Neurilemmoma, Acoustic
% 214.27/214.49  |- mesh__historyNote mesh__D009464 78   
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Melanocytic Vestibular Schwannomas
% 214.27/214.49  |- skos__scopeNote mesh__D009464
% 214.27/214.49       A schwannoma that arises from the vestibular division of the vestibulocochlear nerve and tends to present in the fifth or sixth decade of life. Clinical manifestations include loss of hearing, headache, vertigo, facial pain, tinnitus, and facial weakness. Bilateral acoustic neuromas are associated with NEUROFIBROMATOSIS 2. %28%From Adams et al., Principles of Neurology, 6th ed, p673%29%%A%    
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Acoustic Neuromas
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D009464 2006
% 214.27/214.49  |- skos__altLabel mesh__D009464 Schwannoma, Acoustic
% 214.27/214.49  |- skos__broader mesh__D009464smesh__D009423
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Vestibular Schwannoma, Melanocytic
% 214.27/214.49  |- skos__historyNote mesh__D009464 Acoustic Nerve %28%1966-1977%29%
% 214.27/214.49  |- skos__broader mesh__D009464smesh__D000160
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D009464 2002
% 214.27/214.49  |- mesh__recordOriginator mesh__D009464 VDK
% 214.27/214.49  |- mesh__recordAuthorizer mesh__D009464 ags
% 214.27/214.49  |- skos__altLabel mesh__D009464 Schwannoma, Vestibular
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D009464 2003
% 214.27/214.49  |- mesh__publicMeSHNote mesh__D009464 78   
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Acoustic Schwannomas
% 214.27/214.49  |- mesh__dateRevised mesh__D009464 1999-11-24
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Neurilemmomas, Acoustic
% 214.27/214.49  |- skos__historyNote mesh__D009464 Neurilemmoma %28%1966-1977%29%
% 214.27/214.49  |- skos__broader mesh__D009464smesh__D009442
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D009464 2000A
% 214.27/214.49  |- skos__prefLabel mesh__D009464 Neuroma, Acoustic
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D009464 2004
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Schwannoma, Melanocytic Vestibular
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Neurilemomas, Acoustic
% 214.27/214.49  |- skos__altLabel mesh__D009464 Neurilemoma, Acoustic
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D009464 2000
% 214.27/214.49  |- mesh__recordMaintainer mesh__D009464 ags
% 214.27/214.49  |- rdf__type mesh__D009464sskos__Concept
% 214.27/214.49  |- mesh__dateEstablished mesh__D009464 1978-01-01
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Acoustic Neurilemoma
% 214.27/214.49  |- mesh__dateCreated mesh__D009464 1977-04-27
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Acoustic Neurinomas
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Schwannomas, Melanocytic Vestibular
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Acoustic Neurilemmoma
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Neurinomas, Acoustic
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D009464 2001
% 214.27/214.49  |- skos__altLabel mesh__D009464 Neurinoma, Acoustic
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Acoustic Schwannoma
% 214.27/214.49  |- skos__hiddenLabel mesh__D009464 Vestibular Schwannomas, Melanocytic
% 214.27/214.49  |- skos__altLabel mesh__D009464 Acoustic Neuroma
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D001481 2003
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D001481 2001
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D001481 2005
% 214.27/214.49  |- mesh__recordAuthorizer mesh__D001481 SJN
% 214.27/214.49  |- skos__related mesh__D001481smesh__D002151
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D001481 1999
% 214.27/214.49  |- skos__altLabel mesh__D001481 Metabolism, Basal
% 214.27/214.49  |- skos__annotation mesh__D001481
% 214.27/214.49       resting state only; energy expenditure, energy cost = ENERGY METABOLISM%A%  
% 214.27/214.49  |- mesh__recordOriginator mesh__D001481 NLM
% 214.27/214.49  |- mesh__recordMaintainer mesh__D001481 PXP
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D001481 1998
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D001481 2000
% 214.27/214.49  |- skos__broader mesh__D001481smesh__D013960
% 214.27/214.49  |- rdf__type mesh__D001481sskos__Concept
% 214.27/214.49  |- skos__scopeNote mesh__D001481
% 214.27/214.49       Heat production, or its measurement, of an organism at the lowest level of cell chemistry in an inactive, awake, fasting state. It may be determined directly by means of a calorimeter or indirectly by calculating the heat production from an analysis of the end products of oxidation within the organism or from the amount of oxygen utilized.%A%    
% 214.27/214.49  |- skos__hiddenLabel mesh__D001481 Metabolic Rates, Basal
% 214.27/214.49  |- skos__prefLabel mesh__D001481 Basal Metabolism
% 214.27/214.49  |- skos__altLabel mesh__D001481 Metabolic Rate, Basal
% 214.27/214.49  |- skos__altLabel mesh__D001481 Basal Metabolic Rate
% 214.27/214.49  |- skos__hiddenLabel mesh__D001481 Rates, Basal Metabolic
% 214.27/214.49  |- skos__broader mesh__D001481smesh__D004734
% 214.27/214.49  |- mesh__dateRevised mesh__D001481 1997-06-20
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D001481 2004
% 214.27/214.49  |- skos__hiddenLabel mesh__D001481 Basal Metabolic Rates
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D001481 2002
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D001481 2006
% 214.27/214.49  |- skos__hiddenLabel mesh__D001481 Rate, Basal Metabolic
% 214.27/214.49  |- mesh__dateCreated mesh__D001481 1999-01-01
% 214.27/214.49  |- skos__broader mesh__D003576Q000172smesh__D003576
% 214.27/214.49  |- mesh__preferredCombination mesh__D003576Q000172smesh__D030401
% 214.27/214.49  |- rdf__type mesh__D003576Q000172smesh__CompoundConcept
% 214.27/214.49  |- mesh__dateEstablished mesh__D019892 1998-01-01
% 214.27/214.49  |- skos__altLabel mesh__D019892 TIK Kinase
% 214.27/214.49  |- mesh__publicMeSHNote mesh__D019892
% 214.27/214.49       98; EIF-2 KINASE was indexed under PROTEIN-SERINE-THREONINE KINASES 1993-97 %26% PROTEIN KINASES 1980-93%A%  
% 214.27/214.49  |- skos__altLabel mesh__D019892 Eukaryotic Initiation Factor 2alpha Kinase
% 214.27/214.49  |- skos__altLabel mesh__D019892 Hemin Controlled Repressor
% 214.27/214.49  |- skos__altLabel mesh__D019892 Protein Kinase PKR
% 214.27/214.49  |- skos__altLabel mesh__D019892 Heme Controlled Repressor
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 Controlled Repressor, Hemin
% 214.27/214.49  |- skos__altLabel mesh__D019892 DAI Protein Kinase
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 Hemin Controlled Translational Repressor
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 Repressor, Heme-Controlled Translational
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 eIF 2alpha Kinase
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 PKR, Protein Kinase
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 Kinase, DAI Protein
% 214.27/214.49  |- skos__broader mesh__D019892smesh__D047908
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892
% 214.27/214.49       Repressor, Hemin-Controlled Translational
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 Protein Kinase, DSRNA-Dep
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 Kinase PKR, Protein
% 214.27/214.49  |- skos__altLabel mesh__D019892 Heme-Controlled Inhibitor
% 214.27/214.49  |- skos__altLabel mesh__D019892
% 214.27/214.49       Double Stranded RNA-Dependent eIF-2 alpha Protein Kinase
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 Kinase, DSRNA-Dep Protein
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892
% 214.27/214.49       Double Stranded RNA Dependent eIF 2 alpha Protein Kinase
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 eIF-2alpha Kinase, Heme-Regulated
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D019892 2005
% 214.27/214.49  |- skos__prefLabel mesh__D019892 eIF-2 Kinase
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 Kinase, p68
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 dsRNA Activated Inhibitor
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 Kinase, p65
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 Heme Controlled Translational Repressor
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 Kinase, P68 Protein
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 Inhibitor, dsRNA-Activated
% 214.27/214.49  |- skos__altLabel mesh__D019892
% 214.27/214.49       Double Stranded RNA-Dependent Kinase %28%dsl%29%
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 Heme Controlled Inhibitor
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 Kinase, RNA-Dependent Protein
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 Kinase, TIK
% 214.27/214.49  |- mesh__recordOriginator mesh__D019892 KEV
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 DSRNA Dep Protein Kinase
% 214.27/214.49  |- skos__altLabel mesh__D019892 Protein Kinase, RNA Activated
% 214.27/214.49  |- skos__altLabel mesh__D019892 p68 Kinase
% 214.27/214.49  |- mesh__activeMeSHYear mesh__D019892 2006
% 214.27/214.49  |- skos__altLabel mesh__D019892 P68 Protein Kinase
% 214.27/214.49  |- skos__altLabel mesh__D019892 RNA-Dependent Protein Kinase
% 214.27/214.49  |- skos__altLabel mesh__D019892 eIF-2alpha Kinase
% 214.27/214.49  |- rdf__type mesh__D019892sskos__Concept
% 214.27/214.49  |- skos__scopeNote mesh__D019892
% 214.27/214.49       A dsRNA-activated cAMP-independent protein serine/threonine kinase that is induced by interferon. In the presence of dsRNA and ATP, the kinase autophosphorylates on several serine and threonine residues. The phosphorylated enzyme catalyzes the phosphorylation of the alpha subunit of EUKARYOTIC INITIATION FACTOR-2, leading to the inhibition of protein synthesis.%A%    
% 214.27/214.49  |- skos__altLabel mesh__D019892 Hemin-Controlled Translational Repressor
% 214.27/214.49  |- skos__historyNote mesh__D019892 Protein Kinases %28%1980-1993%29%
% 214.27/214.49  |- skos__altLabel mesh__D019892 dsRNA-Activated Inhibitor
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 Protein Kinase, P68
% 214.27/214.49  |- mesh__recordMaintainer mesh__D019892 ags
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 Kinase, Self-Phosphorylating Protein
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 Protein Kinase, DAI
% 214.27/214.49  |- mesh__historyNote mesh__D019892
% 214.27/214.49       98; use EIF-2 KINASE %28%NM%29% 1980-97   
% 214.27/214.49  |- mesh__dateCreated mesh__D019892 1997-07-02
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 RNA Dependent Protein Kinase
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 eRF, eIF 2 Recycling Factor
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892 Controlled Repressor, Heme
% 214.27/214.49  |- skos__broader mesh__D019892smesh__D017346
% 214.27/214.49  |- skos__hiddenLabel mesh__D019892
% 214.27/214.49       Translational Repressor, Hemin-Controlled
% 214.27/214.50  |- skos__hiddenLabel mesh__D019892 Self Phosphorylating Protein Kinase
% 214.27/214.50  |- skos__hiddenLabel mesh__D019892 Protein Kinase, Self-Phosphorylating
% 214.27/214.50  |- skos__altLabel mesh__D019892 DSRNA-Dep Protein Kinase
% 214.27/214.50  |- skos__altLabel mesh__D019892 Self-Phosphorylating Protein Kinase
% 214.27/214.50  |- skos__hiddenLabel mesh__D019892 Inhibitor, Heme-Controlled
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D019892 2006A
% 214.27/214.50  |- skos__hiddenLabel mesh__D019892 Heme Regulated eIF 2alpha Kinase
% 214.27/214.50  |- skos__hiddenLabel mesh__D019892 Kinase, eIF-2
% 214.27/214.50  |- skos__hiddenLabel mesh__D019892 Kinase, eIF-2alpha
% 214.27/214.50  |- skos__hiddenLabel mesh__D019892 Kinase, Heme-Regulated eIF-2alpha
% 214.27/214.50  |- skos__altLabel mesh__D019892 p65 Kinase
% 214.27/214.50  |- skos__hiddenLabel mesh__D019892 Repressor, Heme Controlled
% 214.27/214.50  |- skos__hiddenLabel mesh__D019892 Translational Repressor, Heme-Controlled
% 214.27/214.50  |- skos__hiddenLabel mesh__D019892 eIF 2 Kinase
% 214.27/214.50  |- skos__hiddenLabel mesh__D019892 Repressor, Hemin Controlled
% 214.27/214.50  |- skos__hiddenLabel mesh__D019892 Protein Kinase, RNA-Dependent
% 214.27/214.50  |- mesh__dateRevised mesh__D019892 2005-07-08
% 214.27/214.50  |- skos__altLabel mesh__D019892 eRF, eIF-2 Recycling Factor
% 214.27/214.50  |- skos__historyNote mesh__D019892
% 214.27/214.50       Protein-Serine-Threonine Kinases %28%1993-1997%29%
% 214.27/214.50  |- mesh__recordAuthorizer mesh__D019892 ags
% 214.27/214.50  |- skos__altLabel mesh__D019892 Heme-Regulated eIF-2alpha Kinase
% 214.27/214.50  |- skos__altLabel mesh__D019892 Heme-Controlled Translational Repressor
% 214.27/214.50  |- skos__broader mesh__D000389smesh__D004780
% 214.27/214.50  |- rdf__type mesh__D000389sskos__Concept
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D000389 1995
% 214.27/214.50  |- skos__hiddenLabel mesh__D000389 Revitalizations, Air
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D000389 2005
% 214.27/214.50  |- mesh__recordMaintainer mesh__D000389 JLS
% 214.27/214.50  |- skos__hiddenLabel mesh__D000389 Controls, Climate
% 214.27/214.50  |- skos__hiddenLabel mesh__D000389 Air Revitalizations
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D000389 1997
% 214.27/214.50  |- skos__hiddenLabel mesh__D000389 Revitalization, Air
% 214.27/214.50  |- skos__hiddenLabel mesh__D000389 Air Conditionings
% 214.27/214.50  |- skos__prefLabel mesh__D000389 Air Conditioning
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D000389 2002
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D000389 1996
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D000389 2004
% 214.27/214.50  |- mesh__recordOriginator mesh__D000389 NLM
% 214.27/214.50  |- mesh__dateRevised mesh__D000389 1994-05-24
% 214.27/214.50  |- skos__hiddenLabel mesh__D000389 Control, Climate
% 214.27/214.50  |- skos__scopeNote mesh__D000389
% 214.27/214.50       The maintenance of certain aspects of the environment within a defined space to facilitate the function of that space; aspects controlled include air temperature and motion, radiant heat level, moisture, and concentration of pollutants such as dust, microorganisms, and gases. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 214.27/214.50  |- mesh__dateCreated mesh__D000389 1999-01-01
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D000389 2003
% 214.27/214.50  |- skos__hiddenLabel mesh__D000389 Conditionings, Air
% 214.27/214.50  |- skos__hiddenLabel mesh__D000389 Conditioning, Air
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D000389 1999
% 214.27/214.50  |- skos__hiddenLabel mesh__D000389 Climate Controls
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D000389 2001
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D000389 1998
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D000389 2006
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D000389 2000
% 214.27/214.50  |- mesh__recordAuthorizer mesh__D000389 PLS
% 214.27/214.50  |- skos__hiddenLabel mesh__D019094 Implant Supported Dental Prosthesis
% 214.27/214.50  |- mesh__dateEstablished mesh__D019094 1996-01-01
% 214.27/214.50  |- skos__hiddenLabel mesh__D019094 Dental Prosthesis, Implant Supported
% 214.27/214.50  |- mesh__publicMeSHNote mesh__D019094 96   
% 214.27/214.50  |- skos__hiddenLabel mesh__D019094 Dentures, Implant-Supported
% 214.27/214.50  |- skos__hiddenLabel mesh__D019094 Denture, Implant Supported
% 214.27/214.50  |- skos__prefLabel mesh__D019094 Dental Prosthesis, Implant-Supported
% 214.27/214.50  |- skos__annotation mesh__D019094 DF: DENT PROSTHESIS IMPLANT SUP   
% 214.27/214.50  |- mesh__recordAuthorizer mesh__D019094 SJN
% 214.27/214.50  |- skos__hiddenLabel mesh__D019094 Implant-Supported Prosthesis Dentals
% 214.27/214.50  |- skos__historyNote mesh__D019094 Dental Implants %28%1990-1995%29%
% 214.27/214.50  |- skos__altLabel mesh__D019094 Implant-Supported Dental Prosthesis
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D019094 2004
% 214.27/214.50  |- mesh__historyNote mesh__D019094 96   
% 214.27/214.50  |- skos__hiddenLabel mesh__D019094 Implant-Supported Prosthesis Dental
% 214.27/214.50  |- mesh__recordOriginator mesh__D019094 JLS
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D019094 1999
% 214.27/214.50  |- mesh__dateCreated mesh__D019094 1995-06-29
% 214.27/214.50  |- skos__hiddenLabel mesh__D019094 Implant Supported Denture
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D019094 2003
% 214.27/214.50  |- mesh__recordMaintainer mesh__D019094 PXP
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D019094 2006
% 214.27/214.50  |- skos__broader mesh__D019094smesh__D017266
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D019094 2002
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D019094 1998
% 214.27/214.50  |- skos__altLabel mesh__D019094 Prosthesis Dental, Implant-Supported
% 214.27/214.50  |- skos__hiddenLabel mesh__D019094 Dental Prostheses, Implant-Supported
% 214.27/214.50  |- skos__hiddenLabel mesh__D019094 Prostheses, Implant-Supported Dental
% 214.27/214.50  |- skos__hiddenLabel mesh__D019094 Prosthesis Dentals, Implant-Supported
% 214.27/214.50  |- skos__hiddenLabel mesh__D019094 Implant-Supported Dental Prostheses
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D019094 2005
% 214.27/214.50  |- skos__altLabel mesh__D019094 Denture, Implant-Supported
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D019094 2001
% 214.27/214.50  |- skos__scopeNote mesh__D019094
% 214.27/214.50       A prosthesis that gains its support, stability, and retention from a substructure that is implanted under the soft tissues of the basal seat of the device and is in contact with bone. %28%From Boucher%27%s Clinical Dental Terminology, 4th ed%29%%A%    
% 214.27/214.50  |- skos__hiddenLabel mesh__D019094 Prosthesis Dental, Implant Supported
% 214.27/214.50  |- mesh__dateRevised mesh__D019094 1997-06-20
% 214.27/214.50  |- skos__hiddenLabel mesh__D019094 Implant-Supported Dentures
% 214.27/214.50  |- rdf__type mesh__D019094sskos__Concept
% 214.27/214.50  |- skos__hiddenLabel mesh__D019094 Dentals, Implant-Supported Prosthesis
% 214.27/214.50  |- skos__hiddenLabel mesh__D019094 Dental, Implant-Supported Prosthesis
% 214.27/214.50  |- skos__altLabel mesh__D019094 Implant-Supported Denture
% 214.27/214.50  |- skos__hiddenLabel mesh__D019094 Prosthesis, Implant-Supported Dental
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D019094 2000
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D005872 2006
% 214.27/214.50  |- skos__annotation mesh__D005872
% 214.27/214.50       infection = GIARDIASIS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 214.27/214.50  |- mesh__dateCreated mesh__D005872 1999-01-01
% 214.27/214.50  |- mesh__recordMaintainer mesh__D005872 ags
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D005872 2005
% 214.27/214.50  |- skos__scopeNote mesh__D005872
% 214.27/214.50       A genus of flagellate intestinal protozoa parasitic in various vertebrates, including humans. Characteristics include the presence of four pairs of flagella arising from a complicated system of axonemes and cysts that are ellipsoidal to ovoidal in shape.%A%    
% 214.27/214.50  |- rdf__type mesh__D005872sskos__Concept
% 214.27/214.50  |- skos__prefLabel mesh__D005872 Giardia
% 214.27/214.50  |- mesh__recordAuthorizer mesh__D005872 sjn
% 214.27/214.50  |- skos__broader mesh__D005872smesh__D016828
% 214.27/214.50  |- mesh__recordOriginator mesh__D005872 NLM
% 214.27/214.50  |- mesh__dateRevised mesh__D005872 2003-07-09
% 214.27/214.50  |- skos__altLabel mesh__D005872 Lamblia
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D005872 2004
% 214.27/214.50  |- skos__hiddenLabel mesh__D005074 Potential, Visual Evoked
% 214.27/214.50  |- skos__historyNote mesh__D005074 Visual Cortex %28%1968-1981%29%
% 214.27/214.50  |- skos__hiddenLabel mesh__D005074 Evoked Potential, Visual
% 214.27/214.50  |- skos__historyNote mesh__D005074 Evoked Potentials %28%1967-1981%29%
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D005074 2004
% 214.27/214.50  |- rdf__type mesh__D005074sskos__Concept
% 214.27/214.50  |- skos__hiddenLabel mesh__D005074 Visual Evoked Responses
% 214.27/214.50  |- mesh__recordAuthorizer mesh__D005074 sjn
% 214.27/214.50  |- skos__historyNote mesh__D005074 Visual Perception %28%1966-1981%29%
% 214.27/214.50  |- skos__broader mesh__D005074smesh__D005071
% 214.27/214.50  |- skos__hiddenLabel mesh__D005074 Visual Evoked Potentials
% 214.27/214.50  |- mesh__recordOriginator mesh__D005074 RC
% 214.27/214.50  |- skos__hiddenLabel mesh__D005074 Evoked Responses, Visual
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D005074 2005
% 214.27/214.50  |- skos__hiddenLabel mesh__D005074 Visual Evoked Potential
% 214.27/214.50  |- skos__historyNote mesh__D005074 Photic Stimulation %28%1972-1981%29%
% 214.27/214.50  |- skos__hiddenLabel mesh__D005074 Responses, Visual Evoked
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D005074 2006
% 214.27/214.50  |- skos__annotation mesh__D005074 IM   
% 214.27/214.50  |- mesh__dateEstablished mesh__D005074 1982-01-01
% 214.27/214.50  |- mesh__recordMaintainer mesh__D005074 nns
% 214.27/214.50  |- skos__prefLabel mesh__D005074 Evoked Potentials, Visual
% 214.27/214.50  |- skos__scopeNote mesh__D005074
% 214.27/214.50       The electric response evoked in the cerebral cortex by visual stimulation or stimulation of the visual pathways.%A%    
% 214.27/214.50  |- skos__altLabel mesh__D005074 Visual Evoked Response
% 214.27/214.50  |- skos__hiddenLabel mesh__D005074 Evoked Response, Visual
% 214.27/214.50  |- mesh__publicMeSHNote mesh__D005074 82   
% 214.27/214.50  |- skos__broader mesh__D005074smesh__D043722
% 214.27/214.50  |- mesh__historyNote mesh__D005074 82   
% 214.27/214.50  |- mesh__dateCreated mesh__D005074 1981-02-24
% 214.27/214.50  |- skos__hiddenLabel mesh__D005074 Potentials, Visual Evoked
% 214.27/214.50  |- skos__hiddenLabel mesh__D005074 Response, Visual Evoked
% 214.27/214.50  |- mesh__dateRevised mesh__D005074 2003-07-09
% 214.27/214.50  |- skos__scopeNote mesh__D013506
% 214.27/214.50       Surgery performed on the external, middle, or internal ear.%A%    
% 214.27/214.50  |- mesh__dateEstablished mesh__D013506 1998-01-01
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D013506 2004
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D013506 1999
% 214.27/214.50  |- skos__annotation mesh__D013506
% 214.27/214.50       GEN or unspecified; prefer specifics; consider also EAR /surg or /surg with specific ear terms; also EAR DISEASES /surg or /surg with specific ear dis; DF: OTOL SURG PROCEDURES%A%  
% 214.27/214.50  |- rdf__type mesh__D013506sskos__Concept
% 214.27/214.50  |- skos__altLabel mesh__D013506 Surgical Procedures, Otologic
% 214.27/214.50  |- skos__broader mesh__D013506smesh__D013517
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D013506 2001
% 214.27/214.50  |- mesh__publicMeSHNote mesh__D013506 98   
% 214.27/214.50  |- skos__altLabel mesh__D013506 Otologic Surgical Procedure
% 214.27/214.50  |- mesh__dateCreated mesh__D013506 1999-01-01
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D013506 2005
% 214.27/214.50  |- skos__altLabel mesh__D013506 Procedures, Otologic Surgical
% 214.27/214.50  |- skos__altLabel mesh__D013506 Procedure, Otologic Surgical
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D013506 2002
% 214.27/214.50  |- mesh__recordMaintainer mesh__D013506 TGC
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D013506 2006
% 214.27/214.50  |- skos__related mesh__D013506smesh__D010036
% 214.27/214.50  |- mesh__recordOriginator mesh__D013506 NLM
% 214.27/214.50  |- skos__altLabel mesh__D013506 Surgical Procedure, Otologic
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D013506 2003
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D013506 2000
% 214.27/214.50  |- skos__prefLabel mesh__D013506 Otologic Surgical Procedures
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D013506 1998
% 214.27/214.50  |- mesh__historyNote mesh__D013506 98; use explode 1976-97   
% 214.27/214.50  |- mesh__dateRevised mesh__D013506 1997-06-20
% 214.27/214.50  |- mesh__recordAuthorizer mesh__D013506 SJN
% 214.27/214.50  |- skos__hiddenLabel mesh__D009465 Agents, Neuromuscular
% 214.27/214.50  |- skos__broader mesh__D009465smesh__D018373
% 214.27/214.50  |- mesh__dateEstablished mesh__D009465 1995-01-01
% 214.27/214.50  |- skos__scopeNote mesh__D009465
% 214.27/214.50       Drugs used for their actions on skeletal muscle. Included are agents that act directly on skeletal muscle, those that alter neuromuscular transmission %28%NEUROMUSCULAR BLOCKING AGENTS%29%, and drugs that act centrally as skeletal muscle relaxants %28%MUSCLE RELAXANTS, CENTRAL%29%. Drugs used in the treatment of movement disorders are ANTI-DYSKINESIA AGENTS.%A%    
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D009465 2006
% 214.27/214.50  |- mesh__dateCreated mesh__D009465 1999-01-01
% 214.27/214.50  |- mesh__recordMaintainer mesh__D009465 ssb
% 214.27/214.50  |- mesh__dateRevised mesh__D009465 2005-06-30
% 214.27/214.50  |- skos__annotation mesh__D009465
% 214.27/214.50       GEN or unspecified; prefer specifics; consider also NEUROMUSCULAR JUNCTION /drug eff %26% MUSCLES, SKELETAL /drug eff%A%  
% 214.27/214.50  |- mesh__onlineNote mesh__D009465
% 214.27/214.50       use MUSCLE RELAXANTS, CENTRAL to search SKELETAL MUSCLE RELAXANTS 1977-94%A%  
% 214.27/214.50  |- mesh__historyNote mesh__D009465
% 214.27/214.50       95; was NON MESH 1974-94; SKELETAL MUSCLE RELAXANTS was see MUSCLE RELAXANTS, CENTRAL 1977-94%A%  
% 214.27/214.50  |- skos__prefLabel mesh__D009465 Neuromuscular Agents
% 214.27/214.50  |- skos__hiddenLabel mesh__D009465 Muscle Relaxants, Skeletal
% 214.27/214.50  |- mesh__recordAuthorizer mesh__D009465 sjn
% 214.27/214.50  |- mesh__recordOriginator mesh__D009465 NLM
% 214.27/214.50  |- mesh__publicMeSHNote mesh__D009465
% 214.27/214.50       95; SKELETAL MUSCLE RELAXANTS was see MUSCLE RELAXANTS, CENTRAL 1977-94%A%  
% 214.27/214.50  |- rdf__type mesh__D009465sskos__Concept
% 214.27/214.50  |- skos__hiddenLabel mesh__D009465 Relaxants, Skeletal Muscle
% 214.27/214.50  |- mesh__recordOriginator mesh__D001482 VDK
% 214.27/214.50  |- skos__hiddenLabel mesh__D001482 Composition, G+C
% 214.27/214.50  |- skos__scopeNote mesh__D001482
% 214.27/214.50       The relative amounts of the PURINES and PYRIMIDINES in a nucleic acid.%A%    
% 214.27/214.50  |- skos__hiddenLabel mesh__D001482 Contents, G+C
% 214.27/214.50  |- skos__related mesh__D001482smesh__D032085
% 214.27/214.50  |- skos__altLabel mesh__D001482 GC Content
% 214.27/214.50  |- skos__altLabel mesh__D001482 GC Composition
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D001482 2006
% 214.27/214.50  |- skos__hiddenLabel mesh__D001482 Compositions, GC
% 214.27/214.50  |- mesh__dateEstablished mesh__D001482 1980-01-01
% 214.27/214.50  |- skos__hiddenLabel mesh__D001482 Content, GC
% 214.27/214.50  |- skos__prefLabel mesh__D001482 Base Composition
% 214.27/214.50  |- skos__altLabel mesh__D001482 Guanine + Cytosine Content
% 214.27/214.50  |- skos__hiddenLabel mesh__D001482 Contents, GC
% 214.27/214.50  |- mesh__recordAuthorizer mesh__D001482 sjn
% 214.27/214.50  |- skos__hiddenLabel mesh__D001482 G+C Compositions
% 214.27/214.50  |- skos__hiddenLabel mesh__D001482 Base Compositions
% 214.27/214.50  |- skos__hiddenLabel mesh__D001482 Compositions, G+C
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D001482 2005
% 214.27/214.50  |- skos__hiddenLabel mesh__D001482 GC Compositions
% 214.27/214.50  |- skos__annotation mesh__D001482
% 214.27/214.50       IM general only; NIM with specific nucleic acid %28%IM%29%; do not confuse with BASE SEQUENCE: sequ = order in which arranged, comp = what components %26% how many%A%  
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D001482 2004
% 214.27/214.50  |- mesh__dateRevised mesh__D001482 2002-07-02
% 214.27/214.50  |- skos__hiddenLabel mesh__D001482 Content, G+C
% 214.27/214.50  |- mesh__historyNote mesh__D001482 80   
% 214.27/214.50  |- skos__altLabel mesh__D001482 G+C Content
% 214.27/214.50  |- mesh__dateCreated mesh__D001482 1979-05-24
% 214.27/214.50  |- mesh__publicMeSHNote mesh__D001482 80   
% 214.27/214.50  |- skos__altLabel mesh__D001482 Guanine + Cytosine Composition
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D001482 2003
% 214.27/214.50  |- skos__hiddenLabel mesh__D001482 GC Contents
% 214.27/214.50  |- mesh__recordMaintainer mesh__D001482 nns
% 214.27/214.50  |- skos__related mesh__D001482smesh__D020862
% 214.27/214.50  |- skos__hiddenLabel mesh__D001482 Composition, Base
% 214.27/214.50  |- skos__broader mesh__D001482smesh__D001669
% 214.27/214.50  |- skos__hiddenLabel mesh__D001482 Base Ratios
% 214.27/214.50  |- skos__related mesh__D001482smesh__D020856
% 214.27/214.50  |- skos__hiddenLabel mesh__D001482 Composition, GC
% 214.27/214.50  |- skos__related mesh__D001482smesh__D020029
% 214.27/214.50  |- skos__hiddenLabel mesh__D001482 Compositions, Base
% 214.27/214.50  |- skos__hiddenLabel mesh__D001482 G+C Contents
% 214.27/214.50  |- rdf__type mesh__D001482sskos__Concept
% 214.27/214.50  |- skos__hiddenLabel mesh__D001482 Ratio, Base
% 214.27/214.50  |- skos__hiddenLabel mesh__D001482 Ratios, Base
% 214.27/214.50  |- skos__altLabel mesh__D019893 S6-H4 Kinase
% 214.27/214.50  |- skos__broader mesh__D019893smesh__D047908
% 214.27/214.50  |- mesh__publicMeSHNote mesh__D019893
% 214.27/214.50       2003; see RIBOSOMAL PROTEIN S6 KINASE 1998-2002; RIBOSOMAL PROTEIN S6 KINASE was indexed under PROTEIN-SERINE-THREONINE KINASES 1993-1997 %26% PROTEIN KINASES 1985-1992%A%  
% 214.27/214.50  |- mesh__historyNote mesh__D019893
% 214.27/214.50       2003%28%1998%29%; use RIBOSOMAL PROTEIN S6 KINASES %28%NM%29% 1985-1997%A%  
% 214.27/214.50  |- skos__prefLabel mesh__D019893 Ribosomal Protein S6 Kinases
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D019893 2005
% 214.27/214.50  |- skos__altLabel mesh__D019893 Ribosomal Protein S6 Kinase
% 214.27/214.50  |- skos__altLabel mesh__D019893 S6 Kinase
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D019893 2005A
% 214.27/214.50  |- skos__scopeNote mesh__D019893
% 214.27/214.50       A family of protein serine/threonine kinases which act as intracellular signalling intermediates. Ribosomal protein S6 kinases are activated through phosphorylation in response to a variety of HORMONES and INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS. Phosphorylation of RIBOSOMAL PROTEIN S6 by enzymes in this class results in increased expression of 5%27% TOP MRNAS. Although specific for RIBOSOMAL PROTEIN S6 members of this class of kinases can act on a number of substrates within the cell. The immunosuppressant SIROLIMUS inhibits the activation of ribosomal protein S6 kinases.%A%    
% 214.27/214.50  |- skos__historyNote mesh__D019893
% 214.27/214.50       Protein-Serine-Threonine Kinases %28%1993-1997%29%
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D019893 2006
% 214.27/214.50  |- mesh__dateRevised mesh__D019893 2004-08-02
% 214.27/214.50  |- mesh__recordAuthorizer mesh__D019893 jls
% 214.27/214.50  |- skos__broader mesh__D019893smesh__D017346
% 214.27/214.50  |- mesh__recordMaintainer mesh__D019893 jls
% 214.27/214.50  |- rdf__type mesh__D019893sskos__Concept
% 214.27/214.50  |- mesh__dateEstablished mesh__D019893 1998-01-01
% 214.27/214.50  |- mesh__recordOriginator mesh__D019893 KEV
% 214.27/214.50  |- skos__related mesh__D019893smesh__D038601
% 214.27/214.50  |- skos__historyNote mesh__D019893 Protein Kinases %28%1985-1992%29%
% 214.27/214.50  |- skos__hiddenLabel mesh__D019893 S6 H4 Kinase
% 214.27/214.50  |- mesh__dateCreated mesh__D019893 1997-06-20
% 214.27/214.50  |- skos__hiddenLabel mesh__D019095 Bedside Technologies
% 214.27/214.50  |- skos__hiddenLabel mesh__D019095 Computings, Bedside
% 214.27/214.50  |- skos__hiddenLabel mesh__D019095 Technology Point, Care
% 214.27/214.50  |- skos__hiddenLabel mesh__D019095 Care Technology Point
% 214.27/214.50  |- mesh__dateRevised mesh__D019095 2005-06-30
% 214.27/214.50  |- mesh__recordAuthorizer mesh__D019095 sjn
% 214.27/214.50  |- skos__hiddenLabel mesh__D019095 Testings, Bedside
% 214.27/214.50  |- mesh__recordOriginator mesh__D019095 JLS
% 214.27/214.50  |- skos__scopeNote mesh__D019095
% 214.27/214.50       Laboratory and other services provided to patients at the bedside. These include diagnostic and laboratory testing using automated information entry.%A%    
% 214.27/214.50  |- mesh__recordMaintainer mesh__D019095 ags
% 214.27/214.50  |- skos__hiddenLabel mesh__D019095 Technology, Bedside
% 214.27/214.50  |- skos__hiddenLabel mesh__D019095 Care Technology Points
% 214.27/214.50  |- skos__hiddenLabel mesh__D019095 Computing, Bedside
% 214.27/214.50  |- mesh__dateEstablished mesh__D019095 1996-01-01
% 214.27/214.50  |- skos__hiddenLabel mesh__D019095 Testing, Bedside
% 214.27/214.50  |- mesh__historyNote mesh__D019095 96   
% 214.27/214.50  |- skos__hiddenLabel mesh__D019095 Bedside Computings
% 214.27/214.50  |- skos__hiddenLabel mesh__D019095 Point of Care Systems
% 214.27/214.50  |- skos__broader mesh__D019095smesh__D010346
% 214.27/214.50  |- skos__hiddenLabel mesh__D019095 Bedside Testings
% 214.27/214.50  |- skos__related mesh__D019095smesh__D050316
% 214.27/214.50  |- skos__hiddenLabel mesh__D019095 System, Point-of-Care
% 214.27/214.50  |- mesh__dateCreated mesh__D019095 1995-05-26
% 214.27/214.50  |- mesh__publicMeSHNote mesh__D019095 96   
% 214.27/214.50  |- skos__prefLabel mesh__D019095 Point-of-Care Systems
% 214.27/214.50  |- skos__hiddenLabel mesh__D019095 Point-of-Care System
% 214.27/214.50  |- skos__hiddenLabel mesh__D019095 Technology Points, Care
% 214.27/214.50  |- skos__hiddenLabel mesh__D019095 Systems, Point-of-Care
% 214.27/214.50  |- skos__hiddenLabel mesh__D019095 Technologies, Bedside
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D019095 2006
% 214.27/214.50  |- skos__broader mesh__D019095smesh__D006751
% 214.27/214.50  |- rdf__type mesh__D019095sskos__Concept
% 214.27/214.50  |- rdf__type mesh__D005873sskos__Concept
% 214.27/214.50  |- skos__hiddenLabel mesh__D005873 Lambliases
% 214.27/214.50  |- skos__hiddenLabel mesh__D005873 Giardiases
% 214.27/214.50  |- mesh__dateRevised mesh__D005873 2003-07-09
% 214.27/214.50  |- skos__altLabel mesh__D005873 Lambliasis
% 214.27/214.50  |- mesh__recordMaintainer mesh__D005873 lkt
% 214.27/214.50  |- skos__broader mesh__D005873smesh__D016772
% 214.27/214.50  |- skos__prefLabel mesh__D005873 Giardiasis
% 214.27/214.50  |- skos__broader mesh__D005873smesh__D007411
% 214.27/214.50  |- mesh__recordAuthorizer mesh__D005873 sjn
% 214.27/214.50  |- mesh__recordOriginator mesh__D005873 NLM
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D005873 2004
% 214.27/214.50  |- skos__scopeNote mesh__D005873
% 214.27/214.50       An infection of the SMALL INTESTINE caused by the flagellated protozoan GIARDIA LAMBLIA. It is spread via contaminated food and water and by direct person-to-person contact.%A%    
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D005873 2006
% 214.27/214.50  |- mesh__dateCreated mesh__D005873 1999-01-01
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D005873 2005
% 214.27/214.50  |- skos__broader mesh__D005075smesh__D001686
% 214.27/214.50  |- skos__annotation mesh__D005075
% 214.27/214.50       Man in the evolutionary process is HOMINIDAE; evolution at molec level of DNA seq is EVOLUTION, MOLECULAR%A%  
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D005075 2005
% 214.27/214.50  |- skos__prefLabel mesh__D005075 Evolution
% 214.27/214.50  |- mesh__recordOriginator mesh__D005075 NLM
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D005075 2006
% 214.27/214.50  |- skos__scopeNote mesh__D005075
% 214.27/214.50       The process of cumulative change over successive generations through which organisms acquire their distinguishing morphological and physiological characteristics.%A%    
% 214.27/214.50  |- mesh__recordAuthorizer mesh__D005075 sjn
% 214.27/214.50  |- mesh__dateCreated mesh__D005075 1999-01-01
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D005075 2003
% 214.27/214.50  |- skos__hiddenLabel mesh__D005075 Evolutions
% 214.27/214.50  |- skos__broader mesh__D005075smesh__D039361
% 214.27/214.50  |- skos__related mesh__D005075smesh__D035503
% 214.27/214.50  |- mesh__recordMaintainer mesh__D005075 hjn
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D005075 2004
% 214.27/214.50  |- mesh__dateRevised mesh__D005075 2002-07-03
% 214.27/214.50  |- rdf__type mesh__D005075sskos__Concept
% 214.27/214.50  |- skos__broader mesh__D013507smesh__D013514
% 214.27/214.50  |- mesh__recordOriginator mesh__D013507 NLM
% 214.27/214.50  |- skos__altLabel mesh__D013507 Procedure, Endocrine Surgical
% 214.27/214.50  |- skos__altLabel mesh__D013507 Surgical Procedures, Endocrine
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D013507 2005
% 214.27/214.50  |- mesh__dateEstablished mesh__D013507 1998-01-01
% 214.27/214.50  |- mesh__recordAuthorizer mesh__D013507 sjn
% 214.27/214.50  |- rdf__type mesh__D013507sskos__Concept
% 214.27/214.50  |- mesh__dateRevised mesh__D013507 2004-07-13
% 214.27/214.50  |- mesh__historyNote mesh__D013507 98; use explode 1975-97   
% 214.27/214.50  |- skos__altLabel mesh__D013507 Surgical Procedure, Endocrine
% 214.27/214.50  |- mesh__recordMaintainer mesh__D013507 sjn
% 214.27/214.50  |- skos__altLabel mesh__D013507 Procedures, Endocrine Surgical
% 214.27/214.50  |- mesh__publicMeSHNote mesh__D013507 98   
% 214.27/214.50  |- skos__annotation mesh__D013507
% 214.27/214.50        GEN or unspecified; prefer specifics; consider also ENDOCRINE GLANDS /surg or /surg with specific endocrine glands; also  ENDOCRINE SYSTEM DISEASES /surg or /surg with specific endocrine dis; DF: ENDOCRINE SURG PROCEDURES%A%  
% 214.27/214.50  |- skos__altLabel mesh__D013507 Endocrine Surgical Procedure
% 214.27/214.50  |- skos__prefLabel mesh__D013507 Endocrine Surgical Procedures
% 214.27/214.50  |- mesh__dateCreated mesh__D013507 1999-01-01
% 214.27/214.50  |- skos__scopeNote mesh__D013507
% 214.27/214.50       Surgery performed on any endocrine gland.     
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D013507 2006
% 214.27/214.50  |- skos__historyNote mesh__D009466 Autonomic Agents %28%1966-1974%29%
% 214.27/214.50  |- mesh__historyNote mesh__D009466
% 214.27/214.50       75; was see under CURARE-LIKE AGENTS %26% NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74%A%  
% 214.27/214.50  |- mesh__recordAuthorizer mesh__D009466 sjn
% 214.27/214.50  |- skos__hiddenLabel mesh__D009466 Agents, Neuromuscular Blocking
% 214.27/214.50  |- mesh__recordOriginator mesh__D009466 NLM
% 214.27/214.50  |- skos__historyNote mesh__D009466 Curare-Like Agents %28%1970-1974%29%
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D009466 2006
% 214.27/214.50  |- skos__scopeNote mesh__D009466
% 214.27/214.50       Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers %28%NEUROMUSCULAR NONDEPOLARIZING AGENTS%29% or noncompetitive, depolarizing agents %28%NEUROMUSCULAR DEPOLARIZING AGENTS%29%. Both prevent acetylcholine from triggering the muscle contraction and they are used as anesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc.%A%    
% 214.27/214.50  |- mesh__recordMaintainer mesh__D009466 ssb
% 214.27/214.50  |- skos__hiddenLabel mesh__D009466 Blocking Agents, Neuromuscular
% 214.27/214.50  |- skos__prefLabel mesh__D009466 Neuromuscular Blocking Agents
% 214.27/214.50  |- skos__broader mesh__D009466smesh__D009465
% 214.27/214.50  |- skos__annotation mesh__D009466
% 214.27/214.50       GEN or unspecified; prefer specifics; consider also NEUROMUSCULAR JUNCTION /drug eff%A%  
% 214.27/214.50  |- mesh__dateEstablished mesh__D009466 1975-01-01
% 214.27/214.50  |- skos__historyNote mesh__D009466
% 214.27/214.50       Neuromuscular Depolarizing Agents %28%1970-1974%29%
% 214.27/214.50  |- mesh__dateRevised mesh__D009466 2005-06-30
% 214.27/214.50  |- skos__altLabel mesh__D009466 Neuromuscular Blockers
% 214.27/214.50  |- mesh__dateCreated mesh__D009466 1999-01-01
% 214.27/214.50  |- mesh__publicMeSHNote mesh__D009466
% 214.27/214.50       75; was see under CURARE-LIKE AGENTS %26% NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74%A%  
% 214.27/214.50  |- mesh__onlineNote mesh__D009466
% 214.27/214.50       search CURARE-LIKE AGENTS %26% NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74%A%  
% 214.27/214.50  |- rdf__type mesh__D009466sskos__Concept
% 214.27/214.50  |- skos__hiddenLabel mesh__D009466 Blockers, Neuromuscular
% 214.27/214.50  |- skos__historyNote mesh__D001483 Nucleotides/analysis %28%1966-1970%29%
% 214.27/214.50  |- skos__hiddenLabel mesh__D001483 Sequence, Nucleotide
% 214.27/214.50  |- mesh__historyNote mesh__D001483
% 214.27/214.50       78%28%71%29%; was see under BIOCHEMISTRY 1975-77   
% 214.27/214.50  |- rdf__type mesh__D001483sskos__Concept
% 214.27/214.50  |- mesh__dateRevised mesh__D001483 2002-07-02
% 214.27/214.50  |- skos__hiddenLabel mesh__D001483 Sequence, Base
% 214.27/214.50  |- mesh__publicMeSHNote mesh__D001483
% 214.27/214.50       78; was see under BIOCHEMISTRY 1975-77   
% 214.27/214.50  |- mesh__recordMaintainer mesh__D001483 nns
% 214.27/214.50  |- skos__broader mesh__D001483smesh__D015394
% 214.27/214.50  |- mesh__dateEstablished mesh__D001483 1978-01-01
% 214.27/214.50  |- mesh__dateCreated mesh__D001483 1999-01-01
% 214.27/214.50  |- skos__annotation mesh__D001483
% 214.27/214.50       IM general only; coord with specific nucleic acid; do not confuse with BASE COMPOSITION: comp = what components %26% how many, sequ = order in which arranged; for base sequencing, use SEQUENCE ANALYSIS, DNA or SEQUENCE ANALYSIS, RNA; when to index with MOLECULAR SEQUENCE DATA: see note there; DF: BASE SEQ%A%  
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D001483 2003
% 214.27/214.50  |- skos__hiddenLabel mesh__D001483 Sequences, RNA
% 214.27/214.50  |- skos__hiddenLabel mesh__D001483 Base Sequences
% 214.27/214.50  |- skos__hiddenLabel mesh__D001483 RNA Sequences
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D001483 2005
% 214.27/214.50  |- skos__prefLabel mesh__D001483 Base Sequence
% 214.27/214.50  |- skos__hiddenLabel mesh__D001483 Sequences, DNA
% 214.27/214.50  |- skos__hiddenLabel mesh__D001483 Nucleotide Sequences
% 214.27/214.50  |- mesh__recordAuthorizer mesh__D001483 sjn
% 214.27/214.50  |- skos__historyNote mesh__D001483 specific nucleic acid %28%1966-1970%29%
% 214.27/214.50  |- skos__historyNote mesh__D001483 Polynucleotides %28%1966-1970%29%
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D001483 2004
% 214.27/214.50  |- skos__altLabel mesh__D001483 DNA Sequences
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D001483 2006
% 214.27/214.50  |- skos__hiddenLabel mesh__D001483 Sequences, Nucleotide
% 214.27/214.50  |- skos__altLabel mesh__D001483 Nucleotide Sequence
% 214.27/214.50  |- skos__hiddenLabel mesh__D001483 Sequence, RNA
% 214.27/214.50  |- skos__scopeNote mesh__D001483
% 214.27/214.50       The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.%A%    
% 214.27/214.50  |- skos__hiddenLabel mesh__D001483 Sequences, Base
% 214.27/214.50  |- skos__hiddenLabel mesh__D001483 Sequence, DNA
% 214.27/214.50  |- mesh__recordOriginator mesh__D001483 NLM
% 214.27/214.50  |- skos__broader mesh__D001483smesh__D008969
% 214.27/214.50  |- skos__broader mesh__D001483smesh__D040342
% 214.27/214.50  |- rdf__type mesh__D014600sskos__Concept
% 214.27/214.50  |- skos__prefLabel mesh__D014600 Utilization Review
% 214.27/214.50  |- mesh__activeMeSHYear mesh__D014600 1996
% 214.27/214.50  |- mesh__recordAuthorizer mesh__D014600 PLS
% 214.27/214.51  |- mesh__recordMaintainer mesh__D014600 KEV
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D014600 2006
% 214.27/214.51  |- mesh__dateCreated mesh__D014600 1999-01-01
% 214.27/214.51  |- skos__hiddenLabel mesh__D014600 Reviews, Utilization
% 214.27/214.51  |- mesh__dateRevised mesh__D014600 1995-05-23
% 214.27/214.51  |- skos__scopeNote mesh__D014600
% 214.27/214.51       An organized procedure carried out through committees to review admissions, duration of stay, professional services furnished, and to evaluate the medical necessity of those services and promote their most efficient use.%A%    
% 214.27/214.51  |- mesh__recordOriginator mesh__D014600 NLM
% 214.27/214.51  |- skos__hiddenLabel mesh__D014600 Utilization Reviews
% 214.27/214.51  |- skos__broader mesh__D014600smesh__D011785
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D014600 2005
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D014600 2002
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D014600 1999
% 214.27/214.51  |- mesh__publicMeSHNote mesh__D014600 68   
% 214.27/214.51  |- skos__altLabel mesh__D014600 Review, Utilization
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D014600 2004
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D014600 1998
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D014600 2001
% 214.27/214.51  |- skos__broader mesh__D014600smesh__D011787
% 214.27/214.51  |- skos__annotation mesh__D014600 DF: UTIL REV   
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D014600 2003
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D014600 2000
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D014600 1997
% 214.27/214.51  |- mesh__dateEstablished mesh__D014600 1968-01-01
% 214.27/214.51  |- mesh__historyNote mesh__D014600 68   
% 214.27/214.51  |- skos__related mesh__D014600smesh__D007345
% 214.27/214.51  |- mesh__dateCreated mesh__D019894 1997-06-20
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D019894 2005
% 214.27/214.51  |- skos__prefLabel mesh__D019894 Peptide YY
% 214.27/214.51  |- skos__hiddenLabel mesh__D019894 Peptide, PYY
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D019894 2006
% 214.27/214.51  |- mesh__historyNote mesh__D019894 98; use PEPTIDE YY %28%NM%29% 1982-97   
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D019894 2003
% 214.27/214.51  |- skos__historyNote mesh__D019894 Peptides %28%1982-1997%29%
% 214.27/214.51  |- rdf__type mesh__D019894sskos__Concept
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D019894 2004
% 214.27/214.51  |- skos__broader mesh__D019894smesh__D036361
% 214.27/214.51  |- skos__scopeNote mesh__D019894
% 214.27/214.51       A 36-amino acid peptide produced by the L cells of the distal small intestine and colon. Peptide YY inhibits gastric and pancreatic secretion.%A%    
% 214.27/214.51  |- mesh__dateRevised mesh__D019894 2002-07-03
% 214.27/214.51  |- skos__broader mesh__D019894smesh__D005768
% 214.27/214.51  |- skos__altLabel mesh__D019894 PYY Peptide
% 214.27/214.51  |- mesh__publicMeSHNote mesh__D019894
% 214.27/214.51       98; PEPTIDE YY was indexed under PEPTIDES 1982-97   
% 214.27/214.51  |- mesh__dateEstablished mesh__D019894 1998-01-01
% 214.27/214.51  |- skos__broader mesh__D019096smesh__D001798
% 214.27/214.51  |- skos__broader mesh__D019096smesh__D006023
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D019096 2000
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D019096 1998
% 214.27/214.51  |- skos__prefLabel mesh__D019096 Vitronectin
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D019096 1996
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D019096 2001
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D019096 1999
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D019096 2005
% 214.27/214.51  |- skos__annotation mesh__D019096 a glycoprotein   
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D019096 1997
% 214.27/214.51  |- mesh__historyNote mesh__D019096
% 214.27/214.51       96; was VITRONECTIN %28%NM%29% 1978-95   
% 214.27/214.51  |- mesh__dateCreated mesh__D019096 1995-05-26
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D019096 2002
% 214.27/214.51  |- mesh__activeMeSHYear mesh__D019096 2003
% 214.27/214.51  |- mesh__publicMeSHNote mesh__D019096
% 214.27/214.51       96; VITRONECTIN was indexed under GLYCOPROTEINS 1978-95   
% 214.37/214.51  |- skos__broader mesh__D019096smesh__D016326
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D019096 2006
% 214.37/214.51  |- skos__scopeNote mesh__D019096
% 214.37/214.51       A blood plasma glycoprotein that mediates cell adhesion and interacts with proteins of the complement, coagulation, and fibrinolytic cascade. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 214.37/214.51  |- mesh__dateEstablished mesh__D019096 1996-01-01
% 214.37/214.51  |- rdf__type mesh__D019096sskos__Concept
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D019096 2004
% 214.37/214.51  |- skos__historyNote mesh__D019096 Glycoproteins %28%1978-1995%29%
% 214.37/214.51  |- mesh__onlineNote mesh__D019096
% 214.37/214.51       use VITRONECTIN %28%NM%29% to search VITRONECTIN 1980-95   
% 214.37/214.51  |- rdf__type mesh__D005874sskos__Concept
% 214.37/214.51  |- skos__related mesh__D005874smesh__D005670
% 214.37/214.51  |- mesh__recordOriginator mesh__D005874 NLM
% 214.37/214.51  |- mesh__historyNote mesh__D005874 91%28%75%29%   
% 214.37/214.51  |- mesh__dateRevised mesh__D005874 2005-06-30
% 214.37/214.51  |- skos__prefLabel mesh__D005874 Gibberella
% 214.37/214.51  |- skos__scopeNote mesh__D005874
% 214.37/214.51       A genus of ascomycetous fungi of the family Hypocreaceae, order Hypocreales including several pathogens of grains and cereals. It is also the source of plant growth regulators such as gibberellin and gibberellic acid.%A%    
% 214.37/214.51  |- skos__annotation mesh__D005874
% 214.37/214.51       an ascomycete yielding gibberellin %26% gibberellic acid   
% 214.37/214.51  |- mesh__dateCreated mesh__D005874 1974-11-19
% 214.37/214.51  |- mesh__publicMeSHNote mesh__D005874 91; see HYPOCREALES 1975-90   
% 214.37/214.51  |- skos__broader mesh__D005874smesh__D006999
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D005874 2006
% 214.37/214.51  |- mesh__recordMaintainer mesh__D005874 SYSTEM
% 214.37/214.51  |- mesh__dateEstablished mesh__D005874 1991-01-01
% 214.37/214.51  |- mesh__recordAuthorizer mesh__D005874 sjn
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D005076 1999
% 214.37/214.51  |- mesh__recordAuthorizer mesh__D005076 SJN
% 214.37/214.51  |- mesh__dateCreated mesh__D005076 1999-01-01
% 214.37/214.51  |- skos__broader mesh__D005076smesh__D012871
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D005076 2003
% 214.37/214.51  |- skos__altLabel mesh__D005076 Skin Rash
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D005076 2000
% 214.37/214.51  |- mesh__recordMaintainer mesh__D005076 TGC
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D005076 2004
% 214.37/214.51  |- rdf__type mesh__D005076sskos__Concept
% 214.37/214.51  |- skos__scopeNote mesh__D005076
% 214.37/214.51       Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth %28%Duke%27%s disease%29%, fifth %28%ERYTHEMA INFECTIOSUM%29%, and sixth %28%EXANTHEMA SUBITUM%29% numeric designations survive as occasional synonyms in current terminology.%A%    
% 214.37/214.51  |- skos__related mesh__D005076smesh__D014924
% 214.37/214.51  |- skos__altLabel mesh__D005076 Rash
% 214.37/214.51  |- skos__annotation mesh__D005076
% 214.37/214.51       a skin eruption usually chem- or viral-induced; EXANTHEMA SUBITUM is also available%A%  
% 214.37/214.51  |- mesh__dateRevised mesh__D005076 1997-06-20
% 214.37/214.51  |- mesh__recordOriginator mesh__D005076 NLM
% 214.37/214.51  |- skos__prefLabel mesh__D005076 Exanthema
% 214.37/214.51  |- skos__altLabel mesh__D005076 Exanthem
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D005076 2001
% 214.37/214.51  |- skos__hiddenLabel mesh__D005076 Rash, Skin
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D005076 2005
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D005076 1998
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D005076 2002
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D005076 2006
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D013508 2005
% 214.37/214.51  |- skos__related mesh__D013508smesh__D009885
% 214.37/214.51  |- skos__altLabel mesh__D013508 Procedures, Ophthalmologic Surgical
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D013508 2001
% 214.37/214.51  |- skos__prefLabel mesh__D013508 Ophthalmologic Surgical Procedures
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D013508 2003
% 214.37/214.51  |- skos__altLabel mesh__D013508 Ophthalmological Surgical Procedures
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D013508 1999
% 214.37/214.51  |- rdf__type mesh__D013508sskos__Concept
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D013508 2000
% 214.37/214.51  |- skos__scopeNote mesh__D013508
% 214.37/214.51       Surgery performed on the eye or any of its parts.     
% 214.37/214.51  |- mesh__dateRevised mesh__D013508 1997-06-20
% 214.37/214.51  |- mesh__recordAuthorizer mesh__D013508 SJN
% 214.37/214.51  |- skos__altLabel mesh__D013508 Surgical Procedure, Ophthalmologic
% 214.37/214.51  |- skos__hiddenLabel mesh__D013508 Procedures, Ophthalmological Surgical
% 214.37/214.51  |- skos__altLabel mesh__D013508 Procedure, Ophthalmologic Surgical
% 214.37/214.51  |- mesh__recordMaintainer mesh__D013508 TGC
% 214.37/214.51  |- skos__broader mesh__D013508smesh__D013514
% 214.37/214.51  |- skos__hiddenLabel mesh__D013508 Procedure, Ophthalmological Surgical
% 214.37/214.51  |- mesh__historyNote mesh__D013508 98; use explode 1975-97   
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D013508 1998
% 214.37/214.51  |- mesh__recordOriginator mesh__D013508 NLM
% 214.37/214.51  |- mesh__dateEstablished mesh__D013508 1998-01-01
% 214.37/214.51  |- skos__annotation mesh__D013508
% 214.37/214.51       GEN or unspecified; prefer specifics; consider also /surg with specific parts of the eye; also EYE DISEASES /surg or /surg with specific eye dis; DF: OPHTHALMOL SURG PROCEDURES%A%  
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D013508 2002
% 214.37/214.51  |- skos__hiddenLabel mesh__D013508 Surgical Procedure, Ophthalmological
% 214.37/214.51  |- mesh__dateCreated mesh__D013508 1999-01-01
% 214.37/214.51  |- skos__hiddenLabel mesh__D013508 Ophthalmological Surgical Procedure
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D013508 2006
% 214.37/214.51  |- skos__altLabel mesh__D013508 Ophthalmologic Surgical Procedure
% 214.37/214.51  |- skos__altLabel mesh__D013508 Surgical Procedures, Ophthalmologic
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D013508 2004
% 214.37/214.51  |- skos__hiddenLabel mesh__D013508 Surgical Procedures, Ophthalmological
% 214.37/214.51  |- mesh__publicMeSHNote mesh__D013508 98   
% 214.37/214.51  |- mesh__recordMaintainer mesh__D010210 nns
% 214.37/214.51  |- skos__related mesh__D010210smesh__D002815
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D010210 2004
% 214.37/214.51  |- skos__broader mesh__D010210smesh__D006351
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D010210 2002
% 214.37/214.51  |- skos__hiddenLabel mesh__D010210 Muscle, Papillary
% 214.37/214.51  |- rdf__type mesh__D010210sskos__Concept
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D010210 2003
% 214.37/214.51  |- skos__hiddenLabel mesh__D010210 Papillary Muscle
% 214.37/214.51  |- skos__prefLabel mesh__D010210 Papillary Muscles
% 214.37/214.51  |- skos__annotation mesh__D010210
% 214.37/214.51       Manual 21.52 as test tissue; for dis of papillary muscles coord IM with MYOCARDIAL DISEASES; /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 214.37/214.51  |- mesh__recordAuthorizer mesh__D010210 sjn
% 214.37/214.51  |- mesh__dateCreated mesh__D010210 1999-01-01
% 214.37/214.51  |- skos__hiddenLabel mesh__D010210 Muscles, Papillary
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D010210 2006
% 214.37/214.51  |- skos__broader mesh__D010210smesh__D009206
% 214.37/214.51  |- skos__scopeNote mesh__D010210
% 214.37/214.51       Conical muscular projections from the walls of the cardiac ventricles, attached to the cusps of the atrioventricular valves by the chordae tendineae.%A%    
% 214.37/214.51  |- mesh__dateRevised mesh__D010210 2001-07-25
% 214.37/214.51  |- skos__broader mesh__D010210smesh__D006321
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D010210 2005
% 214.37/214.51  |- mesh__recordOriginator mesh__D010210 NLM
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D009467 2006
% 214.37/214.51  |- mesh__dateRevised mesh__D009467 2005-06-30
% 214.37/214.51  |- mesh__onlineNote mesh__D009467
% 214.37/214.51       use NEUROMUSCULAR DEPOLARIZING AGENTS to search LEPTOCURARES 1970-92; search MUSCLE RELAXANTS under CURARE-LIKE AGENTS %26% MUSCLE RELAXANTS, CENTRAL %26% NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74 %26% MUSCLES 1966-69%A%  
% 214.37/214.51  |- skos__prefLabel mesh__D009467 Neuromuscular Depolarizing Agents
% 214.37/214.51  |- skos__scopeNote mesh__D009467
% 214.37/214.51       Drugs that interrupt transmission at the skeletal neuromuscular junction by causing sustained depolarization of the motor end plate. These agents are primarily used as adjuvants in surgical anesthesia to cause skeletal muscle relaxation.%A%    
% 214.37/214.51  |- mesh__publicMeSHNote mesh__D009467
% 214.37/214.51       70; LEPTOCURARES was see NEUROMUSCULAR DEPOLARIZING AGENTS 1970-92; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS %26% MUSCLE RELAXANTS, CENTRAL %26% NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69%A%  
% 214.37/214.51  |- skos__altLabel mesh__D009467 Depolarizing Muscle Relaxants
% 214.37/214.51  |- skos__annotation mesh__D009467
% 214.37/214.51       GEN or unspecified; prefer specifics; consider also NEUROMUSCULAR JUNCTION /drug eff%A%  
% 214.37/214.51  |- skos__hiddenLabel mesh__D009467 Relaxants, Depolarizing Muscle
% 214.37/214.51  |- skos__historyNote mesh__D009467 Muscles %28%1966-1969%29%
% 214.37/214.51  |- mesh__recordAuthorizer mesh__D009467 sjn
% 214.37/214.51  |- mesh__dateEstablished mesh__D009467 1970-01-01
% 214.37/214.51  |- mesh__recordOriginator mesh__D009467 NLM
% 214.37/214.51  |- skos__hiddenLabel mesh__D009467 Blockers, Depolarizing
% 214.37/214.51  |- mesh__recordMaintainer mesh__D009467 ssb
% 214.37/214.51  |- skos__broader mesh__D009467smesh__D009466
% 214.37/214.51  |- mesh__dateCreated mesh__D009467 1999-01-01
% 214.37/214.51  |- skos__altLabel mesh__D009467 Depolarizing Blockers
% 214.37/214.51  |- rdf__type mesh__D009467sskos__Concept
% 214.37/214.51  |- skos__hiddenLabel mesh__D009467 Agents, Neuromuscular Depolarizing
% 214.37/214.51  |- skos__altLabel mesh__D009467 Muscle Relaxants, Depolarizing
% 214.37/214.51  |- skos__hiddenLabel mesh__D009467 Depolarizing Agents, Neuromuscular
% 214.37/214.51  |- mesh__historyNote mesh__D009467
% 214.37/214.51       70; LEPTOCURARES was see NEUROMUSCULAR DEPOLARIZING AGENTS 1970-92; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS %26% MUSCLE RELAXANTS, CENTRAL %26% NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69%A%  
% 214.37/214.51  |- skos__annotation mesh__D001484
% 214.37/214.51       /inj: coord IM with specific inj %28%IM%29%; /physiol permitted; Manual 30.15.1%A%  
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D001484 2003
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D001484 2001
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D001484 2005
% 214.37/214.51  |- mesh__dateCreated mesh__D001484 1976-05-19
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D001484 2004
% 214.37/214.51  |- mesh__recordAuthorizer mesh__D001484 PLS
% 214.37/214.51  |- skos__scopeNote mesh__D001484
% 214.37/214.51       A competitive nine-member team sport including softball.%A%    
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D001484 1998
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D001484 2006
% 214.37/214.51  |- mesh__historyNote mesh__D001484
% 214.37/214.51       90%28%77%29%; was see under SPORTS 1977-89   
% 214.37/214.51  |- mesh__publicMeSHNote mesh__D001484 90; was see under SPORTS 1977-89   
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D001484 1997
% 214.37/214.51  |- skos__broader mesh__D001484smesh__D013177
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D001484 2002
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D001484 1999
% 214.37/214.51  |- mesh__dateEstablished mesh__D001484 1990-01-01
% 214.37/214.51  |- mesh__recordOriginator mesh__D001484 EC
% 214.37/214.51  |- mesh__dateRevised mesh__D001484 1996-06-10
% 214.37/214.51  |- skos__historyNote mesh__D001484 Sports %28%1966-1976%29%
% 214.37/214.51  |- rdf__type mesh__D001484sskos__Concept
% 214.37/214.51  |- mesh__recordMaintainer mesh__D001484 TPW
% 214.37/214.51  |- skos__prefLabel mesh__D001484 Baseball
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D001484 2000
% 214.37/214.51  |- skos__prefLabel mesh__D014601 Utopias
% 214.37/214.51  |- mesh__dateCreated mesh__D014601 1999-01-01
% 214.37/214.51  |- skos__broader mesh__D014601smesh__D010684
% 214.37/214.51  |- mesh__recordOriginator mesh__D014601 NLM
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D014601 1995
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D014601 2006
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D014601 1999
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D014601 2002
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D014601 1994
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D014601 2005
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D014601 1998
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D014601 2001
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D014601 1993
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D014601 2004
% 214.37/214.51  |- mesh__recordMaintainer mesh__D014601 TAP
% 214.37/214.51  |- mesh__dateRevised mesh__D014601 1992-05-18
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D014601 1997
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D014601 2000
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D014601 2003
% 214.37/214.51  |- rdf__type mesh__D014601sskos__Concept
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D014601 1996
% 214.37/214.51  |- skos__hiddenLabel mesh__D014601 Utopia
% 214.37/214.51  |- mesh__recordAuthorizer mesh__D014601 PLS
% 214.37/214.51  |- skos__altLabel mesh__D019895 Transposase
% 214.37/214.51  |- mesh__historyNote mesh__D019895
% 214.37/214.51       2004%28%1998%29%; use TRANSPOSASE %28%NM%29% 1981-1997   
% 214.37/214.51  |- mesh__dateEstablished mesh__D019895 1998-01-01
% 214.37/214.51  |- rdf__type mesh__D019895sskos__Concept
% 214.37/214.51  |- mesh__recordOriginator mesh__D019895 KEV
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D019895 2004
% 214.37/214.51  |- mesh__dateRevised mesh__D019895 2005-07-18
% 214.37/214.51  |- mesh__recordMaintainer mesh__D019895 ags
% 214.37/214.51  |- mesh__dateCreated mesh__D019895 1997-06-20
% 214.37/214.51  |- mesh__recordAuthorizer mesh__D019895 ags
% 214.37/214.51  |- skos__historyNote mesh__D019895
% 214.37/214.51       Nucleotidyltransferases %28%1981-1995%29%
% 214.37/214.51  |- skos__broader mesh__D019895smesh__D009713
% 214.37/214.51  |- skos__broader mesh__D019895smesh__D019426
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D019895 2006A
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D019895 2005
% 214.37/214.51  |- skos__historyNote mesh__D019895
% 214.37/214.51       DNA Nucleotidyltransferases %28%1996-1997%29%
% 214.37/214.51  |- mesh__publicMeSHNote mesh__D019895
% 214.37/214.51       2004; TRANSPOSASE was indexed under DNA NUCLEOTIDYLTRANSFERASES 1996-1997 %26% NUCLEOTIDYLTRANSFERASES 1981-1995%A%  
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D019895 2006
% 214.37/214.51  |- skos__scopeNote mesh__D019895
% 214.37/214.51       Enzymes that recombine DNA segments by a process which involves the formation of a synapse between two DNA helices, the cleavage of single strands from each DNA helix and the ligation of a DNA strand from one DNA helix to the other. The resulting DNA structure is called a Holliday junction which can be resolved by DNA REPLICATION or by HOLLIDAY JUNCTION RESOLVASES.%A%    
% 214.37/214.51  |- skos__prefLabel mesh__D019895 Transposases
% 214.37/214.51  |- rdf__type mesh__D019097sskos__Concept
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D019097 2005
% 214.37/214.51  |- mesh__dateEstablished mesh__D019097 1996-01-01
% 214.37/214.51  |- skos__historyNote mesh__D019097
% 214.37/214.51       Electron Spin Resonance Spectroscopy %28%1975-1995%29%
% 214.37/214.51  |- skos__hiddenLabel mesh__D019097 Trapping, Spin
% 214.37/214.51  |- skos__historyNote mesh__D019097 Spin Labels %28%1975-1995%29%
% 214.37/214.51  |- skos__hiddenLabel mesh__D019097 Spin Trappings
% 214.37/214.51  |- mesh__dateCreated mesh__D019097 1995-06-05
% 214.37/214.51  |- skos__hiddenLabel mesh__D019097 Trappings, Spin
% 214.37/214.51  |- skos__historyNote mesh__D019097 Free Radicals %28%1977-1995%29%
% 214.37/214.51  |- mesh__historyNote mesh__D019097 96   
% 214.37/214.51  |- skos__scopeNote mesh__D019097
% 214.37/214.51       A technique for detecting short-lived reactive FREE RADICALS in biological systems by providing a nitrone or nitrose compound for an addition reaction to occur which produces an ELECTRON SPIN RESONANCE SPECTROSCOPY-detectable aminoxyl radical. In spin trapping, the compound trapping the radical is called the spin trap and the addition product of the radical is identified as the spin adduct. %28%Free Rad Res Comm 1990;9%28%3-6%29%:163%29%%A%    
% 214.37/214.51  |- mesh__recordMaintainer mesh__D019097 lkt
% 214.37/214.51  |- skos__annotation mesh__D019097 a method for detecting free radicals   
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D019097 2004
% 214.37/214.51  |- mesh__dateRevised mesh__D019097 2002-07-03
% 214.37/214.51  |- mesh__recordOriginator mesh__D019097 TGC
% 214.37/214.51  |- skos__broader mesh__D019097smesh__D002623
% 214.37/214.51  |- mesh__recordAuthorizer mesh__D019097 sjn
% 214.37/214.51  |- skos__prefLabel mesh__D019097 Spin Trapping
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D019097 2003
% 214.37/214.51  |- mesh__publicMeSHNote mesh__D019097 96   
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D019097 2006
% 214.37/214.51  |- mesh__recordMaintainer mesh__D005875 ssb
% 214.37/214.51  |- mesh__recordAuthorizer mesh__D005875 sjn
% 214.37/214.51  |- skos__prefLabel mesh__D005875 Gibberellins
% 214.37/214.51  |- mesh__dateCreated mesh__D005875 1999-01-01
% 214.37/214.51  |- mesh__recordOriginator mesh__D005875 NLM
% 214.37/214.51  |- mesh__dateRevised mesh__D005875 2005-06-30
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D005875 2006
% 214.37/214.51  |- skos__scopeNote mesh__D005875
% 214.37/214.51       A class of plant growth hormone isolated from cultures of Gibberella fujikuroi, a fungus causing Bakanae disease in rice. There are many different members of the family as well as mixtures of multiple members; all are diterpenoid acids based on the gibberellane skeleton.%A%    
% 214.37/214.51  |- rdf__type mesh__D005875sskos__Concept
% 214.37/214.51  |- skos__broader mesh__D005875smesh__D045786
% 214.37/214.51  |- mesh__dateCreated mesh__D005077 1999-01-01
% 214.37/214.51  |- mesh__recordAuthorizer mesh__D005077 sjn
% 214.37/214.51  |- skos__altLabel mesh__D005077 Sixth Disease
% 214.37/214.51  |- mesh__recordMaintainer mesh__D005077 sjn
% 214.37/214.51  |- skos__broader mesh__D005077smesh__D019349
% 214.37/214.51  |- skos__prefLabel mesh__D005077 Exanthema Subitum
% 214.37/214.51  |- rdf__type mesh__D005077sskos__Concept
% 214.37/214.51  |- skos__annotation mesh__D005077
% 214.37/214.51       acute short-lived viral dis of inf %26% young child caused by human herpesvirus 6%A%  
% 214.37/214.51  |- skos__hiddenLabel mesh__D005077 Disease, Sixth
% 214.37/214.51  |- mesh__dateRevised mesh__D005077 2004-07-13
% 214.37/214.51  |- skos__broader mesh__D005077smesh__D017193
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D005077 2005
% 214.37/214.51  |- skos__altLabel mesh__D005077 Roseola Infantum
% 214.37/214.51  |- skos__broader mesh__D005077smesh__D005076
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D005077 2006
% 214.37/214.51  |- skos__scopeNote mesh__D005077
% 214.37/214.51       An acute, short-lived, viral disease of infants and young children characterized by a high fever at onset that drops to normal after 3-4 days and the concomitant appearance of a macular or maculopapular rash that appears first on the trunk and then spreads to other areas. It is the sixth of the classical exanthematous diseases and is caused by HHV-6; %28%HERPESVIRUS 6, HUMAN%29%. %28%From Dorland, 27th ed%29%%A%    
% 214.37/214.51  |- mesh__recordOriginator mesh__D005077 NLM
% 214.37/214.51  |- skos__prefLabel mesh__D013509 Gynecologic Surgical Procedures
% 214.37/214.51  |- skos__related mesh__D013509smesh__D006176
% 214.37/214.51  |- mesh__publicMeSHNote mesh__D013509 98   
% 214.37/214.51  |- skos__hiddenLabel mesh__D013509 Surgical Procedures, Gynecological
% 214.37/214.51  |- skos__hiddenLabel mesh__D013509 Surgeries, Gynecological
% 214.37/214.51  |- skos__altLabel mesh__D013509 Surgical Procedure, Gynecologic
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D013509 1998
% 214.37/214.51  |- skos__altLabel mesh__D013509 Surgery, Gynecological
% 214.37/214.51  |- mesh__historyNote mesh__D013509 98; use explode 1970-97   
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D013509 2002
% 214.37/214.51  |- mesh__recordOriginator mesh__D013509 NLM
% 214.37/214.51  |- skos__hiddenLabel mesh__D013509 Surgical Procedure, Gynecological
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D013509 1999
% 214.37/214.51  |- skos__scopeNote mesh__D013509
% 214.37/214.51       Surgery performed on the female genitalia.     
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D013509 2003
% 214.37/214.51  |- mesh__dateRevised mesh__D013509 1997-06-20
% 214.37/214.51  |- mesh__recordMaintainer mesh__D013509 TGC
% 214.37/214.51  |- skos__hiddenLabel mesh__D013509 Gynecologic Surgeries
% 214.37/214.51  |- skos__hiddenLabel mesh__D013509 Procedure, Gynecological Surgical
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D013509 2004
% 214.37/214.51  |- skos__altLabel mesh__D013509 Procedures, Gynecologic Surgical
% 214.37/214.51  |- skos__hiddenLabel mesh__D013509 Procedures, Gynecological Surgical
% 214.37/214.51  |- mesh__dateCreated mesh__D013509 1999-01-01
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D013509 2005
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D013509 2000
% 214.37/214.51  |- skos__hiddenLabel mesh__D013509 Surgeries, Gynecologic
% 214.37/214.51  |- skos__hiddenLabel mesh__D013509 Gynecological Surgical Procedures
% 214.37/214.51  |- skos__altLabel mesh__D013509 Gynecologic Surgical Procedure
% 214.37/214.51  |- skos__altLabel mesh__D013509 Procedure, Gynecologic Surgical
% 214.37/214.51  |- skos__altLabel mesh__D013509 Surgical Procedures, Gynecologic
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D013509 2001
% 214.37/214.51  |- skos__altLabel mesh__D013509 Gynecological Surgical Procedure
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D013509 2006
% 214.37/214.51  |- skos__broader mesh__D013509smesh__D013519
% 214.37/214.51  |- skos__hiddenLabel mesh__D013509 Gynecological Surgery
% 214.37/214.51  |- skos__hiddenLabel mesh__D013509 Surgery, Gynecologic
% 214.37/214.51  |- mesh__recordAuthorizer mesh__D013509 SJN
% 214.37/214.51  |- skos__hiddenLabel mesh__D013509 Gynecological Surgeries
% 214.37/214.51  |- mesh__dateEstablished mesh__D013509 1998-01-01
% 214.37/214.51  |- rdf__type mesh__D013509sskos__Concept
% 214.37/214.51  |- skos__altLabel mesh__D013509 Gynecologic Surgery
% 214.37/214.51  |- skos__annotation mesh__D013509
% 214.37/214.51       GEN or unspecified; prefer specifics; consider also GENITALIA, FEMALE /surg or /surg with specific genital terms; also GENITAL DISEASES, FEMALE /surg or /surg with specific gynecol dis; check the tag FEMALE; DF: GYNECOL SURG PROCEDURES%A%  
% 214.37/214.51  |- skos__hiddenLabel mesh__D010211 Retinal Edemas
% 214.37/214.51  |- mesh__recordAuthorizer mesh__D010211 sjn
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D010211 2004
% 214.37/214.51  |- skos__hiddenLabel mesh__D010211 Edemas, Optic Papilla
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D010211 2002
% 214.37/214.51  |- skos__related mesh__D010211smesh__D009887
% 214.37/214.51  |- skos__altLabel mesh__D010211 Choked Disk
% 214.37/214.51  |- skos__hiddenLabel mesh__D010211 Choked Disks
% 214.37/214.51  |- rdf__type mesh__D010211sskos__Concept
% 214.37/214.51  |- mesh__dateCreated mesh__D010211 1999-01-01
% 214.37/214.51  |- mesh__recordOriginator mesh__D010211 NLM
% 214.37/214.51  |- skos__altLabel mesh__D010211 Optic Papilla Edema
% 214.37/214.51  |- skos__hiddenLabel mesh__D010211 Papilledemas
% 214.37/214.51  |- skos__broader mesh__D010211smesh__D009901
% 214.37/214.51  |- skos__prefLabel mesh__D010211 Papilledema
% 214.37/214.51  |- skos__hiddenLabel mesh__D010211 Optic Papillitis
% 214.37/214.51  |- skos__hiddenLabel mesh__D010211 Optic Disk Edemas
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D010211 2005
% 214.37/214.51  |- skos__scopeNote mesh__D010211
% 214.37/214.51       Swelling of the OPTIC DISK, usually in association with increased intracranial pressure, characterized by hyperemia, blurring of the disk margins, microhemorrhages, blind spot enlargement, and engorgement of retinal veins. Chronic papilledema may cause OPTIC ATROPHY and visual loss. %28%Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p175%29%%A%    
% 214.37/214.51  |- skos__altLabel mesh__D010211 Optic Disk Edema
% 214.37/214.51  |- skos__altLabel mesh__D010211
% 214.37/214.51       Increased Intracranial Pressure-Associated Papilledema
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D010211 2006
% 214.37/214.51  |- skos__hiddenLabel mesh__D010211 Optic Papilla Edemas
% 214.37/214.51  |- skos__hiddenLabel mesh__D010211 Disks, Choked
% 214.37/214.51  |- skos__hiddenLabel mesh__D010211 Edema, Optic Papilla
% 214.37/214.51  |- skos__altLabel mesh__D010211
% 214.37/214.51       Papilledema Associated with Decreased Intraocular Pressure
% 214.37/214.51  |- mesh__dateRevised mesh__D010211 2001-07-25
% 214.37/214.51  |- skos__hiddenLabel mesh__D010211 Disk, Choked
% 214.37/214.51  |- mesh__recordMaintainer mesh__D010211 ags
% 214.37/214.51  |- skos__hiddenLabel mesh__D010211 Edemas, Optic Disk
% 214.37/214.51  |- skos__hiddenLabel mesh__D010211
% 214.37/214.51       Increased Intracranial Pressure Associated Papilledema
% 214.37/214.51  |- skos__hiddenLabel mesh__D010211 Edemas, Retinal
% 214.37/214.51  |- skos__hiddenLabel mesh__D010211 Edema, Optic Disk
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D010211 2003
% 214.37/214.51  |- skos__hiddenLabel mesh__D010211 Edema, Retinal
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D009468 2006
% 214.37/214.51  |- mesh__recordOriginator mesh__D009468 NLM
% 214.37/214.51  |- mesh__historyNote mesh__D009468
% 214.37/214.51       1971; AMYOTONIA CONGENITA was heading 1963-96   
% 214.37/214.51  |- skos__hiddenLabel mesh__D009468 Fasciculation Cramp Syndrome, Benign
% 214.37/214.51  |- skos__hiddenLabel mesh__D009468 Benign Fasciculation-Cramp Syndromes
% 214.37/214.51  |- skos__broader mesh__D009468smesh__D009422
% 214.37/214.51  |- skos__hiddenLabel mesh__D009468 Syndrome, Cramp-Fasciculation
% 214.37/214.51  |- skos__annotation mesh__D009468
% 214.37/214.51       GEN; do not confuse xref AMYOTONIA CONGENITA with MYOTONIA CONGENITA%A%  
% 214.37/214.51  |- mesh__activeMeSHYear mesh__D009468 2005
% 214.37/214.52  |- skos__hiddenLabel mesh__D009468 Cramp Fasciculation Syndrome
% 214.37/214.52  |- mesh__dateCreated mesh__D009468 1999-01-01
% 214.37/214.52  |- skos__altLabel mesh__D009468 Amyotonia Congenita
% 214.37/214.52  |- skos__historyNote mesh__D009468 Muscular Diseases %28%1966-1970%29%
% 214.37/214.52  |- mesh__recordMaintainer mesh__D009468 jls
% 214.37/214.52  |- skos__scopeNote mesh__D009468
% 214.37/214.52       A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.%A%    
% 214.37/214.52  |- mesh__publicMeSHNote mesh__D009468
% 214.37/214.52       1971; AMYOTONIA CONGENITA was heading 1963-96; for MYATONIA CONGENITA %26% OPPENHEIM%27%S DISEASE see AMYOTONIA CONGENITA 1963-1996%A%  
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D009468 2004
% 214.37/214.52  |- skos__hiddenLabel mesh__D009468 Syndromes, Cramp-Fasciculation
% 214.37/214.52  |- mesh__dateEstablished mesh__D009468 1971-01-01
% 214.37/214.52  |- skos__historyNote mesh__D009468
% 214.37/214.52       Nervous System Diseases %28%1966-1970%29%
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D009468 2002
% 214.37/214.52  |- skos__hiddenLabel mesh__D009468 Benign Fasciculation-Cramp Syndrome
% 214.37/214.52  |- skos__hiddenLabel mesh__D009468 Neuromuscular Disease
% 214.37/214.52  |- mesh__dateRevised mesh__D009468 2004-07-29
% 214.37/214.52  |- rdf__type mesh__D009468sskos__Concept
% 214.37/214.52  |- skos__hiddenLabel mesh__D009468 Oppenheims Disease
% 214.37/214.52  |- skos__hiddenLabel mesh__D009468 Syndrome, Foley-Denny-Brown
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D009468 2003
% 214.37/214.52  |- skos__hiddenLabel mesh__D009468 Foley Denny Brown Syndrome
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D009468 2001
% 214.37/214.52  |- skos__hiddenLabel mesh__D009468 Cramp-Fasciculation Syndromes
% 214.37/214.52  |- skos__altLabel mesh__D009468 Fasciculation-Cramp Syndrome, Benign
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D009468 2000A
% 214.37/214.52  |- skos__altLabel mesh__D009468 Cramp-Fasciculation Syndrome
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D009468 2005A
% 214.37/214.52  |- skos__prefLabel mesh__D009468 Neuromuscular Diseases
% 214.37/214.52  |- skos__hiddenLabel mesh__D009468 Fasciculation-Cramp Syndromes, Benign
% 214.37/214.52  |- mesh__recordAuthorizer mesh__D009468 jls
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D009468 2000
% 214.37/214.52  |- skos__altLabel mesh__D009468 Oppenheim%27%s Disease
% 214.37/214.52  |- skos__hiddenLabel mesh__D001485 Laminas, Basal
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D001485 2006
% 214.37/214.52  |- mesh__recordAuthorizer mesh__D001485 sjn
% 214.37/214.52  |- skos__hiddenLabel mesh__D001485 Basement Laminas
% 214.37/214.52  |- skos__hiddenLabel mesh__D001485 Basal Laminas
% 214.37/214.52  |- mesh__dateRevised mesh__D001485 2005-06-30
% 214.37/214.52  |- skos__prefLabel mesh__D001485 Basement Membrane
% 214.37/214.52  |- skos__hiddenLabel mesh__D001485 Membrane, Basement
% 214.37/214.52  |- skos__altLabel mesh__D001485 Basement Lamina
% 214.37/214.52  |- mesh__publicMeSHNote mesh__D001485 67   
% 214.37/214.52  |- skos__scopeNote mesh__D001485
% 214.37/214.52       A darkly stained mat-like EXTRACELLULAR MATRIX %28%ECM%29% that separates cell layers, such as EPITHELIUM from ENDOTHELIUM or a layer of CONNECTIVE TISSUE. The ECM layer that supports an overlying EPITHELIUM or ENDOTHELIUM is called basal lamina. Basement membrane %28%BM%29% can be formed by the fusion of either two adjacent basal laminae or a basal lamina with an adjacent reticular lamina of connective tissue. BM, composed mainly of TYPE IV COLLAGEN; glycoprotein LAMININ; and PROTEOGLYCAN, provides barriers as well as channels between interacting cell layers.%A%    
% 214.37/214.52  |- mesh__recordOriginator mesh__D001485 NLM
% 214.37/214.52  |- rdf__type mesh__D001485sskos__Concept
% 214.37/214.52  |- skos__hiddenLabel mesh__D001485 Lamina, Basal
% 214.37/214.52  |- skos__hiddenLabel mesh__D001485 Membranes, Basement
% 214.37/214.52  |- skos__hiddenLabel mesh__D001485 Laminas, Basement
% 214.37/214.52  |- skos__hiddenLabel mesh__D001485 Basement Membranes
% 214.37/214.52  |- skos__broader mesh__D001485smesh__D008566
% 214.37/214.52  |- mesh__dateCreated mesh__D001485 1999-01-01
% 214.37/214.52  |- skos__broader mesh__D001485smesh__D004848
% 214.37/214.52  |- mesh__historyNote mesh__D001485 67%28%65%29%   
% 214.37/214.52  |- skos__annotation mesh__D001485
% 214.37/214.52       do not confuse X ref BASAL LAMINA with %22%lamina basalis%22%, the basal plate of the embryonic neural tube%A%  
% 214.37/214.52  |- mesh__dateEstablished mesh__D001485 1967-01-01
% 214.37/214.52  |- skos__hiddenLabel mesh__D001485 Lamina, Basement
% 214.37/214.52  |- mesh__recordMaintainer mesh__D001485 lkt
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D006170 2006
% 214.37/214.52  |- mesh__publicMeSHNote mesh__D006170
% 214.37/214.52       91; was see under POLYSACCHARIDES 1980-90   
% 214.37/214.52  |- mesh__dateCreated mesh__D006170 1979-04-30
% 214.37/214.52  |- skos__annotation mesh__D006170 D25-26 qualif   
% 214.37/214.52  |- skos__altLabel mesh__D006170 Acacia Gum
% 214.37/214.52  |- skos__prefLabel mesh__D006170 Gum Arabic
% 214.37/214.52  |- skos__broader mesh__D006170smesh__D011134
% 214.37/214.52  |- mesh__dateEstablished mesh__D006170 1991-01-01
% 214.37/214.52  |- skos__historyNote mesh__D006170 Polysaccharides %28%1966-1979%29%
% 214.37/214.52  |- rdf__type mesh__D006170sskos__Concept
% 214.37/214.52  |- skos__hiddenLabel mesh__D006170 Gum, Acacia
% 214.37/214.52  |- mesh__dateRevised mesh__D006170 2005-06-30
% 214.37/214.52  |- skos__altLabel mesh__D006170 Gum Acacia
% 214.37/214.52  |- mesh__historyNote mesh__D006170
% 214.37/214.52       91%28%80%29%; was see under POLYSACCHARIDES 1980-90   
% 214.37/214.52  |- mesh__recordMaintainer mesh__D006170 ssb
% 214.37/214.52  |- skos__broader mesh__D006170smesh__D010936
% 214.37/214.52  |- skos__broader mesh__D006170smesh__D001704
% 214.37/214.52  |- skos__hiddenLabel mesh__D006170 Acacia, Gum
% 214.37/214.52  |- mesh__recordAuthorizer mesh__D006170 sjn
% 214.37/214.52  |- mesh__recordOriginator mesh__D006170 SH
% 214.37/214.52  |- skos__scopeNote mesh__D006170
% 214.37/214.52       Powdered exudate from various Acacia species, especially A. senegal %28%Leguminosae%29%. It forms mucilage or syrup in water. Gum arabic is used as a suspending agent, excipient, and emulsifier in foods and pharmaceuticals.%A%    
% 214.37/214.52  |- skos__hiddenLabel mesh__D006170 Arabic, Gum
% 214.37/214.52  |- skos__historyNote mesh__D006170 Acacia %28%1966-1979%29%
% 214.37/214.52  |- mesh__recordAuthorizer mesh__D014602 sjn
% 214.37/214.52  |- mesh__recordMaintainer mesh__D014602 mdb
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D014602 2005
% 214.37/214.52  |- skos__scopeNote mesh__D014602
% 214.37/214.52       The pigmented vascular coat of the eyeball, consisting of the CHOROID; CILIARY BODY; and IRIS, which are continuous with each other. %28%Cline et al., Dictionary of Visual Science, 4th ed%29%%A%    
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D014602 2004
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D014602 2003
% 214.37/214.52  |- rdf__type mesh__D014602sskos__Concept
% 214.37/214.52  |- mesh__dateRevised mesh__D014602 2001-07-25
% 214.37/214.52  |- skos__prefLabel mesh__D014602 Uvea
% 214.37/214.52  |- mesh__recordOriginator mesh__D014602 NLM
% 214.37/214.52  |- skos__hiddenLabel mesh__D014602 Uveas
% 214.37/214.52  |- mesh__dateCreated mesh__D014602 1999-01-01
% 214.37/214.52  |- skos__annotation mesh__D014602
% 214.37/214.52       anterior uvea = IRIS + CILIARY BODY, posterior uvea = CHOROID; uveal neopl = UVEAL NEOPLASMS; anterior uveal neopl = UVEAL NEOPLASMS %28%IM%29% + CILIARY BODY %28%IM%29% + IRIS NEOPLASMS %28%IM%29%, posterior uveal neopl = CHOROID NEOPLASMS; inflammation = UVEITIS %26% many specifics%A%  
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D014602 2002
% 214.37/214.52  |- skos__broader mesh__D014602smesh__D005123
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D014602 2006
% 214.37/214.52  |- skos__hiddenLabel mesh__D019896 alpha 1 Antitrypsin Deficiency
% 214.37/214.52  |- rdf__type mesh__D019896sskos__Concept
% 214.37/214.52  |- mesh__publicMeSHNote mesh__D019896 98   
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D019896 2004
% 214.37/214.52  |- mesh__recordMaintainer mesh__D019896 MSR
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D019896 2000
% 214.37/214.52  |- mesh__historyNote mesh__D019896 98   
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D019896 2001
% 214.37/214.52  |- mesh__dateEstablished mesh__D019896 1998-01-01
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D019896 2005
% 214.37/214.52  |- skos__scopeNote mesh__D019896
% 214.37/214.52       Deficiency of the protease inhibitor ALPHA 1-ANTITRYPSIN, leading primarily to degradation of elastin of the alveolar walls, as well as other structural proteins of a variety of tissues. %28%From Scriver, Beaudet, Sly, %26% Valle, The Metabolic and Molecular Bases of Inherited Disease, 7th ed, p4125%29%%A%    
% 214.37/214.52  |- skos__historyNote mesh__D019896
% 214.37/214.52       alpha 1-Antitrypsin/deficiency %28%1975-1997%29%
% 214.37/214.52  |- skos__hiddenLabel mesh__D019896 Deficiency, alpha 1-Antitrypsin
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D019896 1999
% 214.37/214.52  |- skos__annotation mesh__D019896
% 214.37/214.52       Pi or PiZZ goes here + PHENOTYPE; DF: ALPHA 1 ANTITRYPSIN DEFIC%A%  
% 214.37/214.52  |- mesh__dateRevised mesh__D019896 1998-06-11
% 214.37/214.52  |- mesh__recordAuthorizer mesh__D019896 SJN
% 214.37/214.52  |- mesh__dateCreated mesh__D019896 1997-06-20
% 214.37/214.52  |- mesh__recordOriginator mesh__D019896 NDW
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D019896 2006
% 214.37/214.52  |- skos__broader mesh__D019896smesh__D003240
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D019896 2002
% 214.37/214.52  |- skos__hiddenLabel mesh__D019896 alpha 1-Antitrypsin Deficiencies
% 214.37/214.52  |- skos__hiddenLabel mesh__D019896 Deficiencies, alpha 1-Antitrypsin
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D019896 2003
% 214.37/214.52  |- skos__prefLabel mesh__D019896 alpha 1-Antitrypsin Deficiency
% 214.37/214.52  |- skos__historyNote mesh__D019896 alpha 1-Antitrypsin %28%1974%29%
% 214.37/214.52  |- mesh__recordAuthorizer mesh__D019098 sjn
% 214.37/214.52  |- skos__broader mesh__D019098smesh__D012194
% 214.37/214.52  |- mesh__publicMeSHNote mesh__D019098 96   
% 214.37/214.52  |- mesh__recordMaintainer mesh__D019098 sjn
% 214.37/214.52  |- mesh__dateRevised mesh__D019098 2004-07-13
% 214.37/214.52  |- skos__historyNote mesh__D019098
% 214.37/214.52       DNA Nucleotidylexotransferase %28%1989-1995%29%
% 214.37/214.52  |- mesh__dateCreated mesh__D019098 1995-06-05
% 214.37/214.52  |- mesh__dateEstablished mesh__D019098 1996-01-01
% 214.37/214.52  |- mesh__historyNote mesh__D019098 96   
% 214.37/214.52  |- mesh__recordOriginator mesh__D019098 AGS
% 214.37/214.52  |- skos__prefLabel mesh__D019098 Telomerase
% 214.37/214.52  |- skos__scopeNote mesh__D019098
% 214.37/214.52       Essential ribonucleoprotein reverse transcriptase that adds telomeric DNA to the ends of eukaryotic chromosomes. Telomerase appears to be repressed in normal human somatic tissues but reactivated in cancer, and thus may be necessary for malignant transformation. EC 2.7.7.-.%A%    
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D019098 2006
% 214.37/214.52  |- rdf__type mesh__D019098sskos__Concept
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D019098 2005
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005876 2005
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005876 2004
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005876 2006
% 214.37/214.52  |- skos__prefLabel mesh__D005876 Gibraltar
% 214.37/214.52  |- mesh__recordMaintainer mesh__D005876 PLS
% 214.37/214.52  |- mesh__dateRevised mesh__D005876 1991-11-09
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005876 1996
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005876 2002
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005876 1998
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005876 1992
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005876 1990
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005876 1997
% 214.37/214.52  |- rdf__type mesh__D005876sskos__Concept
% 214.37/214.52  |- mesh__recordAuthorizer mesh__D005876 PLS
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005876 1994
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005876 1999
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005876 1993
% 214.37/214.52  |- mesh__recordOriginator mesh__D005876 NLM
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005876 1995
% 214.37/214.52  |- skos__broader mesh__D005876smesh__D005060
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005876 2000
% 214.37/214.52  |- mesh__dateCreated mesh__D005876 1999-01-01
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005876 1991
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005876 1989
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005876 2003
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005876 2001
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005078 2001
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005078 1999
% 214.37/214.52  |- mesh__recordMaintainer mesh__D005078 TGC
% 214.37/214.52  |- mesh__historyNote mesh__D005078 81; was EXCHANGE TRANSFUSION 1963-80   
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005078 2005
% 214.37/214.52  |- skos__annotation mesh__D005078
% 214.37/214.52       do not use /util except by MeSH definition; do not confuse with PLASMA EXCHANGE %28%removal %26% replacement of plasma%29%; TN 186: differentiate from BLOOD TRANSFUSION, AUTOLOGOUS; DF: EXCHANGE TRANSFUSION%A%  
% 214.37/214.52  |- mesh__onlineNote mesh__D005078
% 214.37/214.52       use EXCHANGE TRANSFUSION, WHOLE BLOOD to search EXCHANGE TRANSFUSION 1966-80%A%  
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005078 1998
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005078 2000
% 214.37/214.52  |- skos__broader mesh__D005078smesh__D001803
% 214.37/214.52  |- mesh__recordOriginator mesh__D005078 NLM
% 214.37/214.52  |- skos__scopeNote mesh__D005078
% 214.37/214.52       Repetitive withdrawal of small amounts of blood and replacement with donor blood until a large proportion of the blood volume has been exchanged. Used in treatment of fetal erythroblastosis, hepatic coma, sickle cell anemia, disseminated intravascular coagulation, septicemia, burns, thrombotic thrombopenic purpura, and fulminant malaria.%A%    
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005078 2004
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005078 1997
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005078 2003
% 214.37/214.52  |- mesh__dateRevised mesh__D005078 1992-12-28
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005078 1996
% 214.37/214.52  |- rdf__type mesh__D005078sskos__Concept
% 214.37/214.52  |- skos__prefLabel mesh__D005078 Exchange Transfusion, Whole Blood
% 214.37/214.52  |- mesh__publicMeSHNote mesh__D005078
% 214.37/214.52       81; was EXCHANGE TRANSFUSION 1963-80   
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005078 1995
% 214.37/214.52  |- mesh__recordAuthorizer mesh__D005078 PLS
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005078 2002
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005078 1994
% 214.37/214.52  |- mesh__dateCreated mesh__D005078 1999-01-01
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005078 2006
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D010212 1999
% 214.37/214.52  |- skos__annotation mesh__D010212
% 214.37/214.52       /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; %22%laryngeal papilloma%22% = PAPILLOMA %28%IM%29% + LARYNGEAL NEOPLASMS %28%IM%29%; %22%choroid plexus papilloma%22% = GLIOMA %28%IM%29% + CHOROID PLEXUS NEOPLASMS %28%IM%29%%A%  
% 214.37/214.52  |- rdf__type mesh__D010212sskos__Concept
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D010212 2002
% 214.37/214.52  |- mesh__dateCreated mesh__D010212 1999-01-01
% 214.37/214.52  |- skos__broader mesh__D010212smesh__D018307
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D010212 2004
% 214.37/214.52  |- mesh__recordOriginator mesh__D010212 NLM
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D010212 1996
% 214.37/214.52  |- skos__scopeNote mesh__D010212
% 214.37/214.52       A circumscribed benign epithelial tumor projecting from the surrounding surface; more precisely, a benign epithelial neoplasm consisting of villous or arborescent outgrowths of fibrovascular stroma covered by neoplastic cells. %28%Stedman, 25th ed%29%%A%    
% 214.37/214.52  |- skos__hiddenLabel mesh__D010212 Squamous Cell Papilloma
% 214.37/214.52  |- skos__hiddenLabel mesh__D010212 Squamous Cell Papillomas
% 214.37/214.52  |- skos__hiddenLabel mesh__D010212 Papillomatoses
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D010212 1997
% 214.37/214.52  |- skos__hiddenLabel mesh__D010212 Papillomas, Squamous Cell
% 214.37/214.52  |- mesh__recordAuthorizer mesh__D010212 PLS
% 214.37/214.52  |- mesh__dateRevised mesh__D010212 1995-06-08
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D010212 2000
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D010212 2005
% 214.37/214.52  |- skos__related mesh__D010212smesh__D014860
% 214.37/214.52  |- skos__prefLabel mesh__D010212 Papilloma
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D010212 2001
% 214.37/214.52  |- mesh__recordMaintainer mesh__D010212 KEV
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D010212 2006
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D010212 1998
% 214.37/214.52  |- skos__hiddenLabel mesh__D010212 Papillomas
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D010212 2003
% 214.37/214.52  |- mesh__recordOriginator mesh__D009469 NLM
% 214.37/214.52  |- mesh__recordAuthorizer mesh__D009469 sjn
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D009469 2004
% 214.37/214.52  |- mesh__dateCreated mesh__D009469 1999-01-01
% 214.37/214.52  |- rdf__type mesh__D009469sskos__Concept
% 214.37/214.52  |- mesh__onlineNote mesh__D009469
% 214.37/214.52       use NEUROMUSCULAR JUNCTION to search MYONEURAL JUNCTION 1966-67%A%  
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D009469 2005
% 214.37/214.52  |- mesh__historyNote mesh__D009469 68; was MYONEURAL JUNCTION 1963-67   
% 214.37/214.52  |- skos__hiddenLabel mesh__D009469 Junction, Neuromuscular
% 214.37/214.52  |- skos__related mesh__D009469smesh__D009466
% 214.37/214.52  |- skos__hiddenLabel mesh__D009469 Junctions, Neuromuscular
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D009469 2006
% 214.37/214.52  |- mesh__dateRevised mesh__D009469 2000-06-22
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D009469 2001
% 214.37/214.52  |- skos__prefLabel mesh__D009469 Neuromuscular Junction
% 214.37/214.52  |- skos__related mesh__D009469smesh__D011950
% 214.37/214.52  |- mesh__recordMaintainer mesh__D009469 KEV
% 214.37/214.52  |- skos__hiddenLabel mesh__D009469 Myoneural Junctions
% 214.37/214.52  |- skos__hiddenLabel mesh__D009469 Nerve-Muscle Preparations
% 214.37/214.52  |- skos__hiddenLabel mesh__D009469 Nerve Muscle Preparation
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D009469 2002
% 214.37/214.52  |- skos__annotation mesh__D009469
% 214.37/214.52       /drug eff: consider also NEUROMUSCULAR BLOCKING AGENTS or NEUROMUSCULAR DEPOLARIZING AGENTS; neuromusc transm = NEUROMUSCULAR JUNCTION /physiol + NEURAL TRANSMISSION; dis = NEUROMUSCULAR JUNCTION DISEASES%A%  
% 214.37/214.52  |- skos__hiddenLabel mesh__D009469 Junction, Myoneural
% 214.37/214.52  |- mesh__publicMeSHNote mesh__D009469 68; was MYONEURAL JUNCTION 1963-67   
% 214.37/214.52  |- mesh__dateEstablished mesh__D009469 1968-01-01
% 214.37/214.52  |- skos__hiddenLabel mesh__D009469 Junctions, Myoneural
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D009469 2003
% 214.37/214.52  |- skos__scopeNote mesh__D009469
% 214.37/214.52       The synapse between a neuron and a muscle.     
% 214.37/214.52  |- skos__hiddenLabel mesh__D009469 Preparation, Nerve-Muscle
% 214.37/214.52  |- skos__hiddenLabel mesh__D009469 Preparations, Nerve-Muscle
% 214.37/214.52  |- skos__related mesh__D009469smesh__D009467
% 214.37/214.52  |- skos__broader mesh__D009469smesh__D009451
% 214.37/214.52  |- skos__hiddenLabel mesh__D009469 Neuromuscular Junctions
% 214.37/214.52  |- skos__altLabel mesh__D009469 Myoneural Junction
% 214.37/214.52  |- mesh__dateEstablished mesh__D001486 1975-01-01
% 214.37/214.52  |- skos__broader mesh__D001486smesh__D012426
% 214.37/214.52  |- skos__altLabel mesh__D001486 Bashkir Republic
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D001486 2000
% 214.37/214.52  |- mesh__dateCreated mesh__D001486 1999-01-01
% 214.37/214.52  |- skos__prefLabel mesh__D001486 Bashkiria
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D001486 2003
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D001486 2006
% 214.37/214.52  |- skos__altLabel mesh__D001486 Bashkortostan
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D001486 2002
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D001486 2005
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D001486 1999
% 214.37/214.52  |- mesh__historyNote mesh__D001486 75   
% 214.37/214.52  |- mesh__recordMaintainer mesh__D001486 JLS
% 214.37/214.52  |- mesh__dateRevised mesh__D001486 1998-06-10
% 214.37/214.52  |- skos__scopeNote mesh__D001486
% 214.37/214.52       A political subdivision of eastern RUSSIA located within Europe. It consists of a plateau and mountainous area of the Southern Urals. %28%From Webster%27%s New Geographical Dictionary, 1997%29%%A%    
% 214.37/214.52  |- rdf__type mesh__D001486sskos__Concept
% 214.37/214.52  |- mesh__recordOriginator mesh__D001486 NLM
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D001486 2001
% 214.37/214.52  |- mesh__recordAuthorizer mesh__D001486 SJN
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D001486 2004
% 214.37/214.52  |- rdf__type mesh__D020640sskos__Concept
% 214.37/214.52  |- mesh__recordOriginator mesh__D020640 ndw
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D020640 2006
% 214.37/214.52  |- skos__broader mesh__D020640smesh__D020565
% 214.37/214.52  |- skos__historyNote mesh__D020640 Campylobacter %28%1992-1999%29%
% 214.37/214.52  |- mesh__recordMaintainer mesh__D020640 SYSTEM
% 214.37/214.52  |- skos__broader mesh__D020640smesh__D006090
% 214.37/214.52  |- mesh__dateEstablished mesh__D020640 2000-01-01
% 214.37/214.52  |- skos__prefLabel mesh__D020640 Arcobacter
% 214.37/214.52  |- mesh__historyNote mesh__D020640 2000   
% 214.37/214.52  |- skos__annotation mesh__D020640
% 214.37/214.52       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 214.37/214.52  |- mesh__recordAuthorizer mesh__D020640 sjn
% 214.37/214.52  |- skos__scopeNote mesh__D020640
% 214.37/214.52       A genus of gram-negative, aerotolerant, spiral-shaped bacteria isolated from water and associated with diarrhea in humans and animals.%A%    
% 214.37/214.52  |- mesh__dateRevised mesh__D020640 2005-06-30
% 214.37/214.52  |- mesh__dateCreated mesh__D020640 1999-11-03
% 214.37/214.52  |- mesh__publicMeSHNote mesh__D020640 2000   
% 214.37/214.52  |- skos__broader mesh__D006171smesh__D012387
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D006171 2003
% 214.37/214.52  |- skos__scopeNote mesh__D006171
% 214.37/214.52       Coagulated exudate isolated from several species of the tropical tree Palaquium %28%Sapotaceae%29%. It is the trans-isomer of natural rubber and is used as a filling and impression material in dentistry and orthopedics and as an insulator in electronics. It has also been used as a rubber substitute.%A%    
% 214.37/214.52  |- mesh__publicMeSHNote mesh__D006171 65   
% 214.37/214.52  |- mesh__recordAuthorizer mesh__D006171 sjn
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D006171 2006
% 214.37/214.52  |- mesh__recordOriginator mesh__D006171 NLM
% 214.37/214.52  |- mesh__dateRevised mesh__D006171 2001-07-25
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D006171 2002
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D006171 2005
% 214.37/214.52  |- mesh__dateEstablished mesh__D006171 1965-01-01
% 214.37/214.52  |- skos__altLabel mesh__D006171 Guttapercha
% 214.37/214.52  |- skos__hiddenLabel mesh__D006171 Gutta Percha
% 214.37/214.52  |- mesh__dateCreated mesh__D006171 1999-01-01
% 214.37/214.52  |- rdf__type mesh__D006171sskos__Concept
% 214.37/214.52  |- mesh__historyNote mesh__D006171 65   
% 214.37/214.52  |- mesh__recordMaintainer mesh__D006171 ssb
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D006171 2004
% 214.37/214.52  |- skos__annotation mesh__D006171 D25-26 qualif   
% 214.37/214.52  |- skos__prefLabel mesh__D006171 Gutta-Percha
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D014603 1998
% 214.37/214.52  |- skos__hiddenLabel mesh__D014603 Disease, Uveal
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D014603 2002
% 214.37/214.52  |- skos__hiddenLabel mesh__D014603 Uveal Disease
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D014603 2004
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D014603 1997
% 214.37/214.52  |- skos__historyNote mesh__D014603 specific uveal disease
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D014603 2001
% 214.37/214.52  |- skos__annotation mesh__D014603 inflamm dis = UVEITIS %26% specifics   
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D014603 2003
% 214.37/214.52  |- rdf__type mesh__D014603sskos__Concept
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D014603 2000
% 214.37/214.52  |- mesh__recordMaintainer mesh__D014603 TGC
% 214.37/214.52  |- mesh__publicMeSHNote mesh__D014603 76   
% 214.37/214.52  |- skos__hiddenLabel mesh__D014603 Diseases, Uveal
% 214.37/214.52  |- mesh__dateEstablished mesh__D014603 1976-01-01
% 214.37/214.52  |- mesh__historyNote mesh__D014603 76; was NON MESH before 1976   
% 214.37/214.52  |- mesh__recordAuthorizer mesh__D014603 PLS
% 214.37/214.52  |- skos__broader mesh__D014603smesh__D005128
% 214.37/214.52  |- mesh__recordOriginator mesh__D014603 SMH
% 214.37/214.52  |- skos__prefLabel mesh__D014603 Uveal Diseases
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D014603 2006
% 214.37/214.52  |- mesh__dateRevised mesh__D014603 1996-06-10
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D014603 1999
% 214.37/214.52  |- mesh__dateCreated mesh__D014603 1975-07-25
% 214.37/214.52  |- skos__historyNote mesh__D014603 Uvea %28%1966-1975%29%
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D014603 2005
% 214.37/214.52  |- skos__scopeNote mesh__D014603 Diseases of the uvea.     
% 214.37/214.52  |- skos__scopeNote mesh__D019897
% 214.37/214.52       The space between the inner and outer membranes of a cell that is shared with the cell wall.%A%    
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D019897 2005
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D019897 2004
% 214.37/214.52  |- skos__hiddenLabel mesh__D019897 Periplasms
% 214.37/214.52  |- mesh__dateRevised mesh__D019897 2000-06-22
% 214.37/214.52  |- rdf__type mesh__D019897sskos__Concept
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D019897 2003
% 214.37/214.52  |- skos__altLabel mesh__D019897 Periplasmic Space
% 214.37/214.52  |- mesh__publicMeSHNote mesh__D019897 98   
% 214.37/214.52  |- mesh__historyNote mesh__D019897 98   
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D019897 2002
% 214.37/214.52  |- mesh__recordMaintainer mesh__D019897 KEV
% 214.37/214.52  |- skos__broader mesh__D019897smesh__D005110
% 214.37/214.52  |- mesh__dateEstablished mesh__D019897 1998-01-01
% 214.37/214.52  |- mesh__dateCreated mesh__D019897 1997-06-20
% 214.37/214.52  |- mesh__recordAuthorizer mesh__D019897 sjn
% 214.37/214.52  |- mesh__recordOriginator mesh__D019897 NDW
% 214.37/214.52  |- skos__hiddenLabel mesh__D019897 Spaces, Periplasmic
% 214.37/214.52  |- skos__hiddenLabel mesh__D019897 Periplasmic Spaces
% 214.37/214.52  |- skos__hiddenLabel mesh__D019897 Space, Periplasmic
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D019897 2006
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D019897 2001
% 214.37/214.52  |- skos__prefLabel mesh__D019897 Periplasm
% 214.37/214.52  |- mesh__dateRevised mesh__D005877 2005-06-30
% 214.37/214.52  |- skos__altLabel mesh__D005877 Pituitary Gigantism
% 214.37/214.52  |- skos__broader mesh__D005877smesh__D001848
% 214.37/214.52  |- rdf__type mesh__D005877sskos__Concept
% 214.37/214.52  |- skos__broader mesh__D005877smesh__D006964
% 214.37/214.52  |- mesh__recordMaintainer mesh__D005877 lkt
% 214.37/214.52  |- skos__hiddenLabel mesh__D005877 Gigantism, Pituitary
% 214.37/214.52  |- skos__broader mesh__D005877smesh__D001849
% 214.37/214.52  |- mesh__dateCreated mesh__D005877 1999-01-01
% 214.37/214.52  |- skos__scopeNote mesh__D005877
% 214.37/214.52       The condition of accelerated and excessive GROWTH in children or adolescents who are exposed to excess HUMAN GROWTH HORMONE before the closure of EPIPHYSES. It is usually caused by somatotroph hyperplasia or a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. These patients are of abnormally tall stature, more than 3 standard deviations above normal mean height for age.%A%    
% 214.37/214.52  |- mesh__recordAuthorizer mesh__D005877 sjn
% 214.37/214.52  |- skos__prefLabel mesh__D005877 Gigantism
% 214.37/214.52  |- skos__related mesh__D005877smesh__D001506
% 214.37/214.52  |- mesh__recordOriginator mesh__D005877 NLM
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005877 2006
% 214.37/214.52  |- skos__historyNote mesh__D005079 Pharmacy %28%1966-1967%29%
% 214.37/214.52  |- skos__historyNote mesh__D005079 Vehicles %28%1966-1974%29%
% 214.37/214.52  |- mesh__recordMaintainer mesh__D005079 ssb
% 214.37/214.52  |- mesh__onlineNote mesh__D005079 search PHARMACEUTIC AIDS 1968-74   
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005079 2004
% 214.37/214.52  |- mesh__dateRevised mesh__D005079 2003-07-09
% 214.37/214.52  |- skos__broader mesh__D005079smesh__D014677
% 214.37/214.52  |- skos__scopeNote mesh__D005079
% 214.37/214.52       Usually inert substances added to a prescription in order to provide suitable consistency to the dosage form. These include binders, matrix, base or diluent in pills, tablets, creams, salves, etc.%A%    
% 214.37/214.52  |- skos__historyNote mesh__D005079 Pharmaceutic Aids %28%1968-1974%29%
% 214.37/214.52  |- rdf__type mesh__D005079sskos__Concept
% 214.37/214.52  |- mesh__publicMeSHNote mesh__D005079
% 214.37/214.52       80; was see under VEHICLES 1975-79, was see under PHARMACEUTIC AIDS 1968-74%A%  
% 214.37/214.52  |- skos__hiddenLabel mesh__D005079 Agents, Stabilizing
% 214.37/214.52  |- mesh__recordOriginator mesh__D005079 NLM
% 214.37/214.52  |- skos__hiddenLabel mesh__D005079 Agents, Suspending
% 214.37/214.52  |- mesh__recordAuthorizer mesh__D005079 sjn
% 214.37/214.52  |- mesh__dateCreated mesh__D005079 1999-01-01
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005079 2006
% 214.37/214.52  |- mesh__dateEstablished mesh__D005079 1980-01-01
% 214.37/214.52  |- mesh__historyNote mesh__D005079
% 214.37/214.52       80%28%75%29%; was see under VEHICLES 1975-79, was see under PHARMACEUTIC AIDS 1968-74%A%  
% 214.37/214.52  |- mesh__activeMeSHYear mesh__D005079 2005
% 214.37/214.52  |- skos__prefLabel mesh__D005079 Excipients
% 214.37/214.52  |- skos__broader mesh__D010213smesh__D027383
% 214.37/214.52  |- mesh__onlineNote mesh__D010213
% 214.37/214.52       use PAPILLOMAVIRUS to search PAPILLOMAVIRUSES 1978-93, PAPILLOMA VIRUSES 1975-77, %26% PAPILLOMA VIRUS 1966-74%A%  
% 214.37/214.52  |- mesh__recordAuthorizer mesh__D010213 sjn
% 214.37/214.53  |- skos__hiddenLabel mesh__D010213 Papilloma Virus
% 214.37/214.53  |- skos__hiddenLabel mesh__D010213 Viruses, Papilloma
% 214.37/214.53  |- skos__hiddenLabel mesh__D010213 Virus, Papilloma
% 214.37/214.53  |- mesh__dateRevised mesh__D010213 2003-07-09
% 214.37/214.53  |- mesh__recordOriginator mesh__D010213 NLM
% 214.37/214.53  |- skos__scopeNote mesh__D010213
% 214.37/214.53       The sole genus of PAPILLOMAVIRIDAE causing proliferation of the EPITHELIUM, leading to BENIGN NEOPLASMS. Some lesions, induced by specific types of papillomaviruses are at high risk for malignant progression. A wide range of animals are infected including humans, chimpanzees, CATTLE; RABBITS; DOGS; and HORSES.%A%    
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D010213 2005
% 214.37/214.53  |- skos__annotation mesh__D010213
% 214.37/214.53       GEN or unspecified; prefer specifics; infection = PAPILLOMAVIRUS INFECTIONS%A%  
% 214.37/214.53  |- mesh__historyNote mesh__D010213
% 214.37/214.53       94; was PAPILLOMAVIRUSES 1978-93; was PAPILLOMA VIRUSES 1975-77; was PAPILLOMA VIRUS 1963-74%A%  
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D010213 2006
% 214.37/214.53  |- mesh__recordMaintainer mesh__D010213 ags
% 214.37/214.53  |- mesh__publicMeSHNote mesh__D010213
% 214.37/214.53       94; was PAPILLOMAVIRUSES 1978-93; was PAPILLOMA VIRUSES 1975-77; was PAPILLOMA VIRUS 1963-74%A%  
% 214.37/214.53  |- skos__hiddenLabel mesh__D010213 Papillomaviruses
% 214.37/214.53  |- skos__prefLabel mesh__D010213 Papillomavirus
% 214.37/214.53  |- rdf__type mesh__D010213sskos__Concept
% 214.37/214.53  |- skos__altLabel mesh__D010213 Papilloma Viruses
% 214.37/214.53  |- skos__related mesh__D010213smesh__D003218
% 214.37/214.53  |- mesh__dateCreated mesh__D010213 1999-01-01
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D010213 2004
% 214.37/214.53  |- skos__broader mesh__D001011Q000530smesh__D001011
% 214.37/214.53  |- mesh__preferredCombination mesh__D001011Q000530smesh__D001027
% 214.37/214.53  |- rdf__type mesh__D001011Q000530smesh__CompoundConcept
% 214.37/214.53  |- mesh__recordOriginator mesh__D001487 NLM
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D001487 2006
% 214.37/214.53  |- mesh__publicMeSHNote mesh__D001487 99; see BASIDIOMYCETES 1963-98   
% 214.37/214.53  |- skos__broader mesh__D001487smesh__D005658
% 214.37/214.53  |- rdf__type mesh__D001487sskos__Concept
% 214.37/214.53  |- skos__altLabel mesh__D001487 Basidiomycetes
% 214.37/214.53  |- mesh__historyNote mesh__D001487 99   
% 214.37/214.53  |- mesh__recordAuthorizer mesh__D001487 sjn
% 214.37/214.53  |- skos__prefLabel mesh__D001487 Basidiomycota
% 214.37/214.53  |- mesh__recordMaintainer mesh__D001487 SYSTEM
% 214.37/214.53  |- mesh__dateRevised mesh__D001487 2005-06-30
% 214.37/214.53  |- skos__scopeNote mesh__D001487
% 214.37/214.53       A phylum of fungi that produce their sexual spores %28%basidiospores%29% on the outside of the basidium. It includes forms commonly known as mushrooms, boletes, puffballs, earthstars, stinkhorns, bird%27%s-nest fungi, jelly fungi, bracket or shelf fungi, and rust and smut fungi.%A%    
% 214.37/214.53  |- mesh__dateCreated mesh__D001487 1999-01-01
% 214.37/214.53  |- skos__annotation mesh__D001487 GEN or unspecified; prefer specifics   
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006970 2000
% 214.37/214.53  |- skos__prefLabel mesh__D006970 Disorders of Excessive Somnolence
% 214.37/214.53  |- mesh__dateEstablished mesh__D006970 1991-01-01
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006970 2001
% 214.37/214.53  |- skos__hiddenLabel mesh__D006970 Hypersomnolence Disorder
% 214.37/214.53  |- skos__altLabel mesh__D006970 Secondary Hypersomnolence Disorders
% 214.37/214.53  |- skos__hiddenLabel mesh__D006970 Recurrent Hypersomnias
% 214.37/214.53  |- skos__broader mesh__D006970smesh__D020919
% 214.37/214.53  |- skos__hiddenLabel mesh__D006970 Secondary Hypersomnolence Disorder
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006970 2005
% 214.37/214.53  |- rdf__type mesh__D006970sskos__Concept
% 214.37/214.53  |- skos__hiddenLabel mesh__D006970 Primary Hypersomnolence Disorder
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006970 2002
% 214.37/214.53  |- skos__scopeNote mesh__D006970
% 214.37/214.53       Disorders characterized by hypersomnolence during normal waking hours that may impair cognitive functioning. Subtypes include primary hypersomnia disorders %28%e.g., IDIOPATHIC HYPERSOMNOLENCE; NARCOLEPSY; and KLEINE-LEVIN SYNDROME%29% and secondary hypersomnia disorders where excessive somnolence can be attributed to a known cause %28%e.g., drug affect, MENTAL DISORDERS, and SLEEP APNEA SYNDROME%29%. %28%From  J Neurol Sci 1998 Jan 8;153%28%2%29%:192-202; Thorpy, Principles and Practice of Sleep Medicine, 2nd ed, p320%29%%A%    
% 214.37/214.53  |- mesh__publicMeSHNote mesh__D006970
% 214.37/214.53       2000; see HYPERSOMNIA 1991-1999, see SLEEP DISORDERS 1975-1990%A%  
% 214.37/214.53  |- skos__hiddenLabel mesh__D006970 Somnolence Disorders, Excessive
% 214.37/214.53  |- skos__hiddenLabel mesh__D006970 Hypersomnolence Disorder, Secondary
% 214.37/214.53  |- skos__hiddenLabel mesh__D006970 Hypersomnias
% 214.37/214.53  |- skos__hiddenLabel mesh__D006970
% 214.37/214.53       DOESs %28%Disorders of Excessive Somnolence%29%
% 214.37/214.53  |- skos__altLabel mesh__D006970 Primary Hypersomnolence Disorders
% 214.37/214.53  |- skos__altLabel mesh__D006970
% 214.37/214.53       DOES %28%Disorders of Excessive Somnolence%29%
% 214.37/214.53  |- skos__altLabel mesh__D006970 Hypersomnolence Disorders
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006970 2003
% 214.37/214.53  |- mesh__recordMaintainer mesh__D006970 KEV
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006970 2006
% 214.37/214.53  |- mesh__dateRevised mesh__D006970 1999-11-08
% 214.37/214.53  |- mesh__dateCreated mesh__D006970 1974-11-19
% 214.37/214.53  |- skos__hiddenLabel mesh__D006970 Hypersomnolence Disorder, Primary
% 214.37/214.53  |- skos__hiddenLabel mesh__D006970 Hypersomnias, Recurrent
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006970 2004
% 214.37/214.53  |- skos__hiddenLabel mesh__D006970 Recurrent Hypersomnia
% 214.37/214.53  |- skos__altLabel mesh__D006970 Excessive Somnolence Disorders
% 214.37/214.53  |- skos__hiddenLabel mesh__D006970 Excessive Somnolence Disorder
% 214.37/214.53  |- mesh__historyNote mesh__D006970 2000%28%1975%29%   
% 214.37/214.53  |- mesh__recordAuthorizer mesh__D006970 sjn
% 214.37/214.53  |- mesh__recordOriginator mesh__D006970 NLM
% 214.37/214.53  |- skos__hiddenLabel mesh__D006970 Somnolence Disorder, Excessive
% 214.37/214.53  |- mesh__dateRevised mesh__D020641 2002-07-03
% 214.37/214.53  |- skos__hiddenLabel mesh__D020641 Nucleotide Polymorphism, Single
% 214.37/214.53  |- skos__hiddenLabel mesh__D020641 Polymorphisms, Single Nucleotide
% 214.37/214.53  |- mesh__dateCreated mesh__D020641 1999-11-03
% 214.37/214.53  |- skos__broader mesh__D020641smesh__D011110
% 214.37/214.53  |- skos__annotation mesh__D020641
% 214.37/214.53       do not confuse with POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL%A%  
% 214.37/214.53  |- skos__altLabel mesh__D020641 SNPs
% 214.37/214.53  |- mesh__dateEstablished mesh__D020641 2000-01-01
% 214.37/214.53  |- mesh__historyNote mesh__D020641 2000   
% 214.37/214.53  |- skos__historyNote mesh__D020641
% 214.37/214.53       Polymorphism %28%Genetics%29% %28%1991-1999%29%
% 214.37/214.53  |- skos__hiddenLabel mesh__D020641 Nucleotide Polymorphisms, Single
% 214.37/214.53  |- mesh__publicMeSHNote mesh__D020641 2000   
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D020641 2005
% 214.37/214.53  |- rdf__type mesh__D020641sskos__Concept
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D020641 2003
% 214.37/214.53  |- skos__hiddenLabel mesh__D020641 Single Nucleotide Polymorphisms
% 214.37/214.53  |- skos__altLabel mesh__D020641 Single Nucleotide Polymorphism
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D020641 2006
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D020641 2004
% 214.37/214.53  |- skos__scopeNote mesh__D020641
% 214.37/214.53       A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population.%A%    
% 214.37/214.53  |- skos__prefLabel mesh__D020641 Polymorphism, Single Nucleotide
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006172 2001
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006172 2006
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006172 2000
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006172 2005
% 214.37/214.53  |- skos__prefLabel mesh__D006172 Guyana
% 214.37/214.53  |- mesh__recordMaintainer mesh__D006172 TGC
% 214.37/214.53  |- skos__altLabel mesh__D006172 Guiana, British
% 214.37/214.53  |- mesh__dateRevised mesh__D006172 1997-06-20
% 214.37/214.53  |- rdf__type mesh__D006172sskos__Concept
% 214.37/214.53  |- mesh__dateCreated mesh__D006172 1999-01-01
% 214.37/214.53  |- mesh__recordOriginator mesh__D006172 NLM
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006172 1999
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006172 2002
% 214.37/214.53  |- skos__altLabel mesh__D006172 British Guiana
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006172 2004
% 214.37/214.53  |- mesh__recordAuthorizer mesh__D006172 SJN
% 214.37/214.53  |- skos__scopeNote mesh__D006172
% 214.37/214.53       A republic in the north of South America, east of BRAZIL. Its capital is Georgetown. It was formerly called British Guiana and its history is allied with that of the region of Guiana which comprised British Guiana, FRENCH GUIANA, and Dutch Guiana %28%now SURINAME%29%. It was founded about 1620 by the Dutch and settled in the 18th century by many non-Dutch, mainly British, to whom it was ceded in 1814. Guyana gained independence in 1966 and became a republic in 1970. The name is probably of Indian origin meaning respectable, but some derive it from the Guarani guai %28%born%29% + ana %28%kin%29%, implying a united and interrelated race of people. %28%From Webster%27%s New Geographical Dictionary, 1988, p477 %26% Room, Brewer%27%s Dictionary of Names, 1992, p223%29%%A%    
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006172 1998
% 214.37/214.53  |- skos__broader mesh__D006172smesh__D013020
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006172 2003
% 214.37/214.53  |- skos__annotation mesh__D006172
% 214.37/214.53       in So. Amer; X ref BRITISH GUIANA was its former name; do not confuse with FRENCH GUIANA nor with GUINEA in Africa%A%  
% 214.37/214.53  |- skos__hiddenLabel mesh__D047589 Reduction Procedure, Leukocyte
% 214.37/214.53  |- skos__broader mesh__D047589smesh__D001781
% 214.37/214.53  |- skos__hiddenLabel mesh__D047589 Removal Procedures, Leukocyte
% 214.37/214.53  |- skos__hiddenLabel mesh__D047589 Procedures, Leukocyte Depletion
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D047589 2006
% 214.37/214.53  |- skos__hiddenLabel mesh__D047589 Procedures, Leukocyte Removal
% 214.37/214.53  |- skos__altLabel mesh__D047589 Leukocyte Removal Procedures
% 214.37/214.53  |- mesh__recordOriginator mesh__D047589 nns
% 214.37/214.53  |- mesh__dateEstablished mesh__D047589 2005-01-01
% 214.37/214.53  |- skos__hiddenLabel mesh__D047589 Leukocyte Reduction Filtrations
% 214.37/214.53  |- mesh__dateCreated mesh__D047589 2004-07-07
% 214.37/214.53  |- skos__broader mesh__D047589smesh__D002469
% 214.37/214.53  |- mesh__historyNote mesh__D047589 2005   
% 214.37/214.53  |- skos__hiddenLabel mesh__D047589 Reduction Procedures, Leukocyte
% 214.37/214.53  |- rdf__type mesh__D047589sskos__Concept
% 214.37/214.53  |- skos__hiddenLabel mesh__D047589 Reduction Filtration, Leukocyte
% 214.37/214.53  |- skos__hiddenLabel mesh__D047589 Filtration, Leukocyte Reduction
% 214.37/214.53  |- skos__altLabel mesh__D047589 Leukocyte Depletion Procedures
% 214.37/214.53  |- mesh__dateRevised mesh__D047589 2005-06-30
% 214.37/214.53  |- mesh__recordAuthorizer mesh__D047589 sjn
% 214.37/214.53  |- skos__hiddenLabel mesh__D047589 Leukocyte Depletion Procedure
% 214.37/214.53  |- skos__hiddenLabel mesh__D047589 Leukocyte Removal Procedure
% 214.37/214.53  |- skos__prefLabel mesh__D047589 Leukocyte Reduction Procedures
% 214.37/214.53  |- mesh__recordMaintainer mesh__D047589 lkt
% 214.37/214.53  |- skos__hiddenLabel mesh__D047589 Depletion Procedures, Leukocyte
% 214.37/214.53  |- skos__hiddenLabel mesh__D047589 Procedures, Leukocyte Reduction
% 214.37/214.53  |- skos__scopeNote mesh__D047589
% 214.37/214.53       The removal of LEUKOCYTES from BLOOD to reduce BLOOD TRANSFUSION reactions and lower the chance of transmitting VIRUSES. This may be performed by FILTRATION or by CYTAPHERESIS.%A%    
% 214.37/214.53  |- skos__hiddenLabel mesh__D047589 Filtrations, Leukocyte Reduction
% 214.37/214.53  |- mesh__publicMeSHNote mesh__D047589 2005   
% 214.37/214.53  |- skos__hiddenLabel mesh__D047589 Procedure, Leukocyte Depletion
% 214.37/214.53  |- skos__hiddenLabel mesh__D047589 Procedure, Leukocyte Removal
% 214.37/214.53  |- skos__hiddenLabel mesh__D047589 Leukocyte Reduction Procedure
% 214.37/214.53  |- skos__hiddenLabel mesh__D047589 Removal Procedure, Leukocyte
% 214.37/214.53  |- skos__hiddenLabel mesh__D047589 Depletion Procedure, Leukocyte
% 214.37/214.53  |- skos__hiddenLabel mesh__D047589 Procedure, Leukocyte Reduction
% 214.37/214.53  |- skos__hiddenLabel mesh__D047589 Reduction Filtrations, Leukocyte
% 214.37/214.53  |- mesh__historyNote mesh__D014604 81   
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D014604 2002
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D014604 2004
% 214.37/214.53  |- mesh__dateCreated mesh__D014604 1980-04-09
% 214.37/214.53  |- rdf__type mesh__D014604sskos__Concept
% 214.37/214.53  |- skos__historyNote mesh__D014604 Eye Neoplasms %28%1966-1980%29%
% 214.37/214.53  |- skos__hiddenLabel mesh__D014604 Neoplasm, Uveal
% 214.37/214.53  |- mesh__dateEstablished mesh__D014604 1981-01-01
% 214.37/214.53  |- skos__hiddenLabel mesh__D014604 Uveal Neoplasm
% 214.37/214.53  |- skos__historyNote mesh__D014604 Uveal Diseases %28%1976-1980%29%
% 214.37/214.53  |- skos__broader mesh__D014604smesh__D014603
% 214.37/214.53  |- skos__prefLabel mesh__D014604 Uveal Neoplasms
% 214.37/214.53  |- skos__scopeNote mesh__D014604 Tumors or cancer of the UVEA.     
% 214.37/214.53  |- skos__historyNote mesh__D014604 Uvea %28%1966-1975%29%
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D014604 2005
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D014604 2001
% 214.37/214.53  |- mesh__publicMeSHNote mesh__D014604 81   
% 214.37/214.53  |- mesh__recordMaintainer mesh__D014604 nns
% 214.37/214.53  |- mesh__recordOriginator mesh__D014604 RC
% 214.37/214.53  |- mesh__recordAuthorizer mesh__D014604 sjn
% 214.37/214.53  |- skos__hiddenLabel mesh__D014604 Neoplasms, Uveal
% 214.37/214.53  |- skos__broader mesh__D014604smesh__D005134
% 214.37/214.53  |- skos__historyNote mesh__D014604 Iris %28%1966-1980%29%
% 214.37/214.53  |- skos__historyNote mesh__D014604 Ciliary Body %28%1966-1980%29%
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D014604 2006
% 214.37/214.53  |- mesh__dateRevised mesh__D014604 2000-06-22
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D014604 2003
% 214.37/214.53  |- skos__annotation mesh__D014604
% 214.37/214.53       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%; CHOROID NEOPLASMS %26% IRIS NEOPLASMS are also available%A%  
% 214.37/214.53  |- mesh__recordAuthorizer mesh__D019898 sjn
% 214.37/214.53  |- rdf__type mesh__D019898sskos__Concept
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D019898 2003
% 214.37/214.53  |- skos__hiddenLabel mesh__D019898 Communication, Autocrine
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D019898 2001
% 214.37/214.53  |- skos__broader mesh__D019898smesh__D002450
% 214.37/214.53  |- skos__scopeNote mesh__D019898
% 214.37/214.53       Mode of communication wherein a bound hormone affects the function of the cell type that produced the hormone.%A%    
% 214.37/214.53  |- mesh__historyNote mesh__D019898 98   
% 214.37/214.53  |- skos__hiddenLabel mesh__D019898 Autocrine Signalings
% 214.37/214.53  |- mesh__recordMaintainer mesh__D019898 adp
% 214.37/214.53  |- mesh__recordOriginator mesh__D019898 NDW
% 214.37/214.53  |- mesh__publicMeSHNote mesh__D019898 98   
% 214.37/214.53  |- skos__altLabel mesh__D019898 Autocrine Signaling
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D019898 2006
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D019898 2002
% 214.37/214.53  |- skos__hiddenLabel mesh__D019898 Signalings, Autocrine
% 214.37/214.53  |- mesh__dateRevised mesh__D019898 2000-06-21
% 214.37/214.53  |- mesh__dateEstablished mesh__D019898 1998-01-01
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D019898 2005
% 214.37/214.53  |- mesh__dateCreated mesh__D019898 1997-06-20
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D019898 2004
% 214.37/214.53  |- skos__hiddenLabel mesh__D019898 Autocrine Communications
% 214.37/214.53  |- skos__hiddenLabel mesh__D019898 Signaling, Autocrine
% 214.37/214.53  |- skos__prefLabel mesh__D019898 Autocrine Communication
% 214.37/214.53  |- skos__hiddenLabel mesh__D019898 Communications, Autocrine
% 214.37/214.53  |- rdf__type mesh__D005878sskos__Concept
% 214.37/214.53  |- mesh__dateEstablished mesh__D005878 1991-01-01
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D005878 2006
% 214.37/214.53  |- mesh__dateRevised mesh__D005878 2001-07-25
% 214.37/214.53  |- mesh__historyNote mesh__D005878 2000%28%1975%29%   
% 214.37/214.53  |- skos__scopeNote mesh__D005878
% 214.37/214.53       A benign familial disorder, transmitted as an autosomal dominant trait. It is characterized by low-grade chronic hyperbilirubinemia with considerable daily fluctuations of the bilirubin level.%A%    
% 214.37/214.53  |- skos__hiddenLabel mesh__D005878 Disease, Gilbert%27%s
% 214.37/214.53  |- mesh__dateCreated mesh__D005878 1999-01-01
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D005878 2002
% 214.37/214.53  |- skos__prefLabel mesh__D005878 Gilbert Disease
% 214.37/214.53  |- skos__broader mesh__D005878smesh__D006933
% 214.37/214.53  |- mesh__recordMaintainer mesh__D005878 nns
% 214.37/214.53  |- mesh__recordAuthorizer mesh__D005878 sjn
% 214.37/214.53  |- skos__altLabel mesh__D005878 Gilbert%27%s Disease
% 214.37/214.53  |- mesh__recordOriginator mesh__D005878 NLM
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D005878 2003
% 214.37/214.53  |- skos__hiddenLabel mesh__D005878 Gilberts Disease
% 214.37/214.53  |- skos__hiddenLabel mesh__D005878 Disease, Gilbert
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D005878 2005
% 214.37/214.53  |- mesh__publicMeSHNote mesh__D005878
% 214.37/214.53       2000; see GILBERT%27%S DISEASE 1991-1999, see HYPERBILIRUBINEMIA, HEREDITARY 1975-90%A%  
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D005878 2004
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D010214 2005
% 214.37/214.53  |- skos__prefLabel mesh__D010214 Papillon-Lefevre Disease
% 214.37/214.53  |- skos__broader mesh__D010214smesh__D007645
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D010214 2006
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D010214 2003
% 214.37/214.53  |- skos__hiddenLabel mesh__D010214 Syndrome, Papillon-Lefevre
% 214.37/214.53  |- skos__scopeNote mesh__D010214
% 214.37/214.53       Rare, autosomal recessive disorder occurring between the first and fifth years of life. It is characterized by palmoplantar keratoderma with periodontitis followed by the premature shedding of both deciduous and permanent teeth.%A%    
% 214.37/214.53  |- skos__hiddenLabel mesh__D010214 Papillon Lefevre Disease
% 214.37/214.53  |- mesh__dateRevised mesh__D010214 2001-07-25
% 214.37/214.53  |- mesh__recordAuthorizer mesh__D010214 sjn
% 214.37/214.53  |- rdf__type mesh__D010214sskos__Concept
% 214.37/214.53  |- mesh__dateCreated mesh__D010214 1999-01-01
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D010214 2004
% 214.37/214.53  |- mesh__recordMaintainer mesh__D010214 nns
% 214.37/214.53  |- mesh__dateEstablished mesh__D010214 1991-01-01
% 214.37/214.53  |- skos__annotation mesh__D010214
% 214.37/214.53       palmoplantar keratoderma with periodontitis   
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D010214 2002
% 214.37/214.53  |- mesh__recordOriginator mesh__D010214 NLM
% 214.37/214.53  |- skos__hiddenLabel mesh__D010214 Papillon Lefevre Syndrome
% 214.37/214.53  |- skos__hiddenLabel mesh__D010214 Disease, Papillon-Lefevre
% 214.37/214.53  |- mesh__historyNote mesh__D010214
% 214.37/214.53       91%28%75%29%; was see under KERATOSIS PALMARIS ET PLANTARIS 1975-90 %28%which became KERATODERMA, PALMOPLANTAR 1993%29%%A%  
% 214.37/214.53  |- mesh__publicMeSHNote mesh__D010214
% 214.37/214.53       91; was see under KERATOSIS PALMARIS ET PLANTARIS 1975-90 %28%which became KERATODERMA, PALMOPLANTAR 1993%29%%A%  
% 214.37/214.53  |- skos__altLabel mesh__D010214 Papillon-Lefevre Syndrome
% 214.37/214.53  |- mesh__onlineNote mesh__D010214 search KERATODERMA, PALMOPLANTAR 1974   
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D001488 2002
% 214.37/214.53  |- mesh__recordAuthorizer mesh__D001488 PLS
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D001488 1995
% 214.37/214.53  |- rdf__type mesh__D001488sskos__Concept
% 214.37/214.53  |- skos__hiddenLabel mesh__D001488 Arteries, Basilar
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D001488 1998
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D001488 1994
% 214.37/214.53  |- skos__prefLabel mesh__D001488 Basilar Artery
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D001488 2004
% 214.37/214.53  |- mesh__recordOriginator mesh__D001488 NLM
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D001488 2001
% 214.37/214.53  |- mesh__dateCreated mesh__D001488 1999-01-01
% 214.37/214.53  |- skos__scopeNote mesh__D001488
% 214.37/214.53       The artery formed by the union of the right and left vertebral arteries; it runs from the lower to the upper border of the pons, where it bifurcates into the two posterior cerebral arteries.%A%    
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D001488 1997
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D001488 2003
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D001488 2000
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D001488 2006
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D001488 1993
% 214.37/214.53  |- mesh__recordMaintainer mesh__D001488 TAP
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D001488 1996
% 214.37/214.53  |- skos__hiddenLabel mesh__D001488 Artery, Basilar
% 214.37/214.53  |- skos__hiddenLabel mesh__D001488 Basilar Arteries
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D001488 1999
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D001488 2005
% 214.37/214.53  |- skos__broader mesh__D001488smesh__D001158
% 214.37/214.53  |- mesh__dateRevised mesh__D001488 1992-05-26
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006971 2002
% 214.37/214.53  |- mesh__dateCreated mesh__D006971 1999-01-01
% 214.37/214.53  |- mesh__historyNote mesh__D006971
% 214.37/214.53       66; ANEMIA, SPLENIC was heading 1963-83, was see under HYPERSPLENISM 1982-83%A%  
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006971 1997
% 214.37/214.53  |- mesh__publicMeSHNote mesh__D006971
% 214.37/214.53       ANEMIA, SPLENIC was heading 1963-81   
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006971 2001
% 214.37/214.53  |- skos__annotation mesh__D006971
% 214.37/214.53       increase in splenic hemolytic function: do not confuse with SPLENOMEGALY, increase in spleen size%A%  
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006971 1999
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006971 1996
% 214.37/214.53  |- mesh__recordOriginator mesh__D006971 NLM
% 214.37/214.53  |- skos__hiddenLabel mesh__D006971 Anemias, Splenic
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006971 1995
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006971 1998
% 214.37/214.53  |- skos__hiddenLabel mesh__D006971 Splenic Anemia
% 214.37/214.53  |- mesh__onlineNote mesh__D006971
% 214.37/214.53       use HYPERSPLENISM to search ANEMIA, SPLENIC 1966-83   
% 214.37/214.53  |- mesh__dateRevised mesh__D006971 1993-06-02
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006971 2000
% 214.37/214.53  |- rdf__type mesh__D006971sskos__Concept
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006971 1994
% 214.37/214.53  |- skos__hiddenLabel mesh__D006971 Splenic Anemias
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006971 2004
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006971 2006
% 214.37/214.53  |- mesh__recordAuthorizer mesh__D006971 PLS
% 214.37/214.53  |- mesh__recordMaintainer mesh__D006971 PLS
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006971 2003
% 214.37/214.53  |- skos__broader mesh__D006971smesh__D013158
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006971 2005
% 214.37/214.53  |- skos__prefLabel mesh__D006971 Hypersplenism
% 214.37/214.53  |- skos__scopeNote mesh__D006971
% 214.37/214.53       Condition characterized by splenomegaly, some reduction in the number of circulating blood cells in the presence of a normal or hyperactive bone marrow, and the potential for reversal by splenectomy.%A%    
% 214.37/214.53  |- mesh__dateEstablished mesh__D020642 2000-01-01
% 214.37/214.53  |- mesh__historyNote mesh__D020642 2000   
% 214.37/214.53  |- skos__hiddenLabel mesh__D020642 Disease, Takahara
% 214.37/214.53  |- skos__altLabel mesh__D020642 Acatalasemia
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D020642 2002
% 214.37/214.53  |- skos__prefLabel mesh__D020642 Acatalasia
% 214.37/214.53  |- mesh__recordAuthorizer mesh__D020642 sjn
% 214.37/214.53  |- mesh__dateCreated mesh__D020642 1999-11-03
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D020642 2005
% 214.37/214.53  |- skos__broader mesh__D020642smesh__D018901
% 214.37/214.53  |- rdf__type mesh__D020642sskos__Concept
% 214.37/214.53  |- skos__altLabel mesh__D020642 Takahara%27%s Disease
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D020642 2003
% 214.37/214.53  |- skos__scopeNote mesh__D020642
% 214.37/214.53       A rare autosomal recessive disorder resulting from the absence of CATALASE activity. Though usually asymptomatic, a syndrome of oral ulcerations and gangrene may be present.%A%    
% 214.37/214.53  |- skos__altLabel mesh__D020642 Hypocatalasia
% 214.37/214.53  |- skos__hiddenLabel mesh__D020642 Disease, Takahara%27%s
% 214.37/214.53  |- skos__altLabel mesh__D020642 Takahara Disease
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D020642 2006
% 214.37/214.53  |- mesh__publicMeSHNote mesh__D020642 2000   
% 214.37/214.53  |- mesh__recordMaintainer mesh__D020642 nns
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D020642 2004
% 214.37/214.53  |- mesh__recordOriginator mesh__D020642 adp
% 214.37/214.53  |- skos__hiddenLabel mesh__D020642 Takaharas Disease
% 214.37/214.53  |- mesh__dateRevised mesh__D020642 2001-07-25
% 214.37/214.53  |- skos__historyNote mesh__D020642 Catalase %28%1965-1999%29%
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006173 2002
% 214.37/214.53  |- skos__hiddenLabel mesh__D006173 Gymnastic
% 214.37/214.53  |- mesh__dateRevised mesh__D006173 1999-11-03
% 214.37/214.53  |- skos__prefLabel mesh__D006173 Gymnastics
% 214.37/214.53  |- rdf__type mesh__D006173sskos__Concept
% 214.37/214.53  |- mesh__dateCreated mesh__D006173 1999-01-01
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006173 2004
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006173 2001
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006173 2003
% 214.37/214.53  |- mesh__recordMaintainer mesh__D006173 kle
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006173 2000
% 214.37/214.53  |- skos__broader mesh__D006173smesh__D013177
% 214.37/214.53  |- skos__scopeNote mesh__D006173
% 214.37/214.53       Systematic physical exercise. This includes calisthenics, a system of light gymnastics for promoting strength and grace of carriage.%A%    
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006173 2006
% 214.37/214.53  |- skos__hiddenLabel mesh__D006173 Calisthenic
% 214.37/214.53  |- mesh__onlineNote mesh__D006173
% 214.37/214.53       use GYMNASTICS to search CALISTHENICS 1966-82   
% 214.37/214.53  |- mesh__recordAuthorizer mesh__D006173 sjn
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D006173 2005
% 214.37/214.53  |- skos__annotation mesh__D006173
% 214.37/214.53       /inj: coord IM with specific inj %28%IM%29%; /physiol permitted; a systematic set of exercises; differentiate from PHYSICAL EDUCATION AND TRAINING: instruction in hygiene as well as systematic exerc usually in formal setting; %22%corrective gymnastics%22% is probably EXERCISE THERAPY%A%  
% 214.37/214.53  |- skos__broader mesh__D006173smesh__D010806
% 214.37/214.53  |- mesh__recordOriginator mesh__D006173 NLM
% 214.37/214.53  |- mesh__historyNote mesh__D006173
% 214.37/214.53       CALISTHENICS was see under GYMNASTICS 1963-82   
% 214.37/214.53  |- mesh__recordMaintainer mesh__D014605 TGC
% 214.37/214.53  |- rdf__type mesh__D014605sskos__Concept
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D014605 2002
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D014605 1994
% 214.37/214.53  |- skos__prefLabel mesh__D014605 Uveitis
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D014605 2005
% 214.37/214.53  |- mesh__recordOriginator mesh__D014605 NLM
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D014605 1998
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D014605 1995
% 214.37/214.53  |- skos__hiddenLabel mesh__D014605 Uveitides
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D014605 2006
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D014605 2000
% 214.37/214.53  |- skos__broader mesh__D014605smesh__D014603
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D014605 1999
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D014605 2003
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D014605 1996
% 214.37/214.53  |- mesh__recordAuthorizer mesh__D014605 PLS
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D014605 2001
% 214.37/214.53  |- mesh__dateCreated mesh__D014605 1999-01-01
% 214.37/214.53  |- mesh__dateRevised mesh__D014605 1993-06-03
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D014605 2004
% 214.37/214.53  |- skos__scopeNote mesh__D014605
% 214.37/214.53       Inflammation of part or all of the uvea, the middle %28%vascular%29% tunic of the eye, and commonly involving the other tunics %28%sclera and cornea, and the retina%29%. %28%Dorland, 27th ed%29%%A%    
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D014605 1997
% 214.37/214.53  |- skos__annotation mesh__D014605 inflamm of uvea; GEN: prefer specifics   
% 214.37/214.53  |- mesh__dateEstablished mesh__D019899 1998-01-01
% 214.37/214.53  |- mesh__publicMeSHNote mesh__D019899 98   
% 214.37/214.53  |- skos__hiddenLabel mesh__D019899 Signaling, Paracrine
% 214.37/214.53  |- mesh__dateRevised mesh__D019899 2004-07-30
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D019899 2005A
% 214.37/214.53  |- skos__prefLabel mesh__D019899 Paracrine Communication
% 214.37/214.53  |- mesh__dateCreated mesh__D019899 1997-06-20
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D019899 2006
% 214.37/214.53  |- skos__hiddenLabel mesh__D019899 Paracrine Signalings
% 214.37/214.53  |- skos__scopeNote mesh__D019899
% 214.37/214.53       Cellular signaling in which a factor secreted by a cell affects other cells in the local environment. This term is often used to denote the action of INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS on surrounding cells.%A%    
% 214.37/214.53  |- skos__related mesh__D019899smesh__D036341
% 214.37/214.53  |- mesh__recordOriginator mesh__D019899 NDW
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D019899 2004
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D019899 2005
% 214.37/214.53  |- mesh__recordAuthorizer mesh__D019899 jls
% 214.37/214.53  |- skos__hiddenLabel mesh__D019899 Signalings, Paracrine
% 214.37/214.53  |- skos__altLabel mesh__D019899 Paracrine Signaling
% 214.37/214.53  |- rdf__type mesh__D019899sskos__Concept
% 214.37/214.53  |- skos__hiddenLabel mesh__D019899 Communication, Paracrine
% 214.37/214.53  |- mesh__activeMeSHYear mesh__D019899 2003
% 214.37/214.53  |- skos__hiddenLabel mesh__D019899 Communications, Paracrine
% 214.37/214.53  |- skos__broader mesh__D019899smesh__D002450
% 214.37/214.53  |- mesh__historyNote mesh__D019899 98   
% 214.37/214.53  |- mesh__recordMaintainer mesh__D019899 jls
% 214.37/214.53  |- skos__hiddenLabel mesh__D019899 Paracrine Communications
% 214.37/214.54  |- skos__altLabel mesh__D005879 Tourette Disease
% 214.37/214.54  |- mesh__recordOriginator mesh__D005879 NLM
% 214.37/214.54  |- mesh__recordMaintainer mesh__D005879 lkt
% 214.37/214.54  |- mesh__dateEstablished mesh__D005879 1966-01-01
% 214.37/214.54  |- skos__scopeNote mesh__D005879
% 214.37/214.54       A neuropsychological disorder related to alterations in DOPAMINE metabolism and neurotransmission involving frontal-subcortical neuronal circuits. Both multiple motor and one or more vocal tics need to be present with TICS occurring many times a day, nearly daily, over a period of more than one year. The onset is before age 18 and the disturbance is not due to direct physiological effects of a substance or a general medical condition. The disturbance causes marked distress or significant impairment in social, occupational, or other important areas of functioning. %28%From DSM-IV, 1994; Neurol Clin 1997 May;15%28%2%29%:357-79%29%%A%    
% 214.37/214.54  |- skos__broader mesh__D005879smesh__D013981
% 214.37/214.54  |- skos__broader mesh__D005879smesh__D001480
% 214.37/214.54  |- skos__altLabel mesh__D005879 Tourette%27%s Disorder
% 214.37/214.54  |- skos__altLabel mesh__D005879 Gilles de la Tourette Syndrome
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D005879 2006
% 214.37/214.54  |- rdf__type mesh__D005879sskos__Concept
% 214.37/214.54  |- skos__hiddenLabel mesh__D005879 Tourettes Disorder
% 214.37/214.54  |- skos__altLabel mesh__D005879
% 214.37/214.54       Combined Multiple Motor and Vocal Tic Disorder
% 214.37/214.54  |- mesh__historyNote mesh__D005879 1989%28%1966%29%   
% 214.37/214.54  |- skos__altLabel mesh__D005879 Tourette%27%s Disease
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D005879 2005
% 214.37/214.54  |- skos__altLabel mesh__D005879
% 214.37/214.54       Multiple Motor and Vocal Tic Disorder, Combined
% 214.37/214.54  |- skos__altLabel mesh__D005879 Gilles de la Tourette%27%s Disease
% 214.37/214.54  |- mesh__dateRevised mesh__D005879 2003-07-09
% 214.37/214.54  |- mesh__publicMeSHNote mesh__D005879
% 214.37/214.54       1989; see GILLES DE LA TOURETTE%27%S DISEASE 1966-88   
% 214.37/214.54  |- skos__altLabel mesh__D005879
% 214.37/214.54       Combined Vocal and Multiple Motor Tic Disorder
% 214.37/214.54  |- skos__altLabel mesh__D005879 Tourette Disorder
% 214.37/214.54  |- skos__hiddenLabel mesh__D005879 Tourettes Syndrome
% 214.37/214.54  |- skos__altLabel mesh__D005879 Tourette%27%s Syndrome
% 214.37/214.54  |- skos__related mesh__D005879smesh__D020323
% 214.37/214.54  |- skos__hiddenLabel mesh__D005879 Syndrome, Tourette%27%s
% 214.37/214.54  |- mesh__dateCreated mesh__D005879 1999-01-01
% 214.37/214.54  |- skos__prefLabel mesh__D005879 Tourette Syndrome
% 214.37/214.54  |- skos__broader mesh__D005879smesh__D020271
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D005879 2004
% 214.37/214.54  |- skos__hiddenLabel mesh__D005879 Tourettes Disease
% 214.37/214.54  |- mesh__recordAuthorizer mesh__D005879 sjn
% 214.37/214.54  |- skos__altLabel mesh__D005879
% 214.37/214.54       Tic Disorder, Combined Vocal and Multiple Motor
% 214.37/214.54  |- rdf__type mesh__D002581sskos__Concept
% 214.37/214.54  |- skos__hiddenLabel mesh__D002581 Incompetence, Uterine Cervical
% 214.37/214.54  |- skos__hiddenLabel mesh__D002581 Cervix, Incompetent
% 214.37/214.54  |- skos__annotation mesh__D002581 check the tags FEMALE %26% PREGNANCY   
% 214.37/214.54  |- skos__hiddenLabel mesh__D002581 Incompetent Cervices
% 214.37/214.54  |- mesh__publicMeSHNote mesh__D002581
% 214.37/214.54       2006; see CERVIX INCOMPETENCE 1973-2005   
% 214.37/214.54  |- skos__scopeNote mesh__D002581
% 214.37/214.54       Incompetent UTERINE CERVIX is usually diagnosed in the second trimester of PREGNANCY. It is characterized by passive painless cervical dilation in the absence of UTERINE CONTRACTION; BLEEDING; INFECTION; and sometimes with the amniotic sac %28%AMNIOTIC MEMBRANE%29% bulging through the partially dilated cervix. Left untreated, this condition may lead to premature pregnancy loss, such as HABITUAL ABORTION.%A%    
% 214.37/214.54  |- skos__prefLabel mesh__D002581 Uterine Cervical Incompetence
% 214.37/214.54  |- skos__broader mesh__D002581smesh__D002577
% 214.37/214.54  |- mesh__historyNote mesh__D002581 2006 %28%1973%29%   
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D002581 2006
% 214.37/214.54  |- skos__hiddenLabel mesh__D002581 Cervices, Incompetent
% 214.37/214.54  |- skos__historyNote mesh__D002581 Abortion, Habitual %28%1966-1972%29%
% 214.37/214.54  |- skos__hiddenLabel mesh__D002581 Cervical Incompetence, Uterine
% 214.37/214.54  |- skos__hiddenLabel mesh__D002581 Incompetence, Cervix
% 214.37/214.54  |- skos__historyNote mesh__D002581 Cervix Diseases %28%1966-1972%29%
% 214.37/214.54  |- mesh__dateCreated mesh__D002581 1999-01-01
% 214.37/214.54  |- mesh__recordMaintainer mesh__D002581 lkt
% 214.37/214.54  |- skos__altLabel mesh__D002581 Cervix Incompetence
% 214.37/214.54  |- mesh__recordOriginator mesh__D002581 NLM
% 214.37/214.54  |- mesh__dateEstablished mesh__D002581 1973-01-01
% 214.37/214.54  |- skos__broader mesh__D002581smesh__D000026
% 214.37/214.54  |- mesh__recordAuthorizer mesh__D002581 sjn
% 214.37/214.54  |- skos__altLabel mesh__D002581 Incompetent Cervix
% 214.37/214.54  |- mesh__dateRevised mesh__D002581 2005-06-30
% 214.37/214.54  |- skos__annotation mesh__D010215
% 214.37/214.54       NIM with no qualifiers when experimental animal; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 214.37/214.54  |- skos__hiddenLabel mesh__D010215 Baboon, Savanna
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D010215 2006
% 214.37/214.54  |- mesh__dateRevised mesh__D010215 2005-06-30
% 214.37/214.54  |- skos__scopeNote mesh__D010215
% 214.37/214.54       A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of  five named species: PAPIO URSINUS %28%chacma baboon%29%, PAPIO CYNOCEPHALUS %28%yellow baboon%29%, PAPIO PAPIO %28%western baboon%29%, PAPIO ANUBIS %28%or olive baboon%29%, and PAPIO HAMADRYAS %28%hamadryas baboon%29%. Members of the Papio genus inhabit open woodland, savannahs, grassland, and rocky hill country. Some authors consider MANDRILLUS a subgenus of Papio.%A%    
% 214.37/214.54  |- mesh__historyNote mesh__D010215
% 214.37/214.54       81%28%75%29%; was see under BABOONS 1973-80; BABOONS was heading 1971-80 %28%Prov 1971-72%29%%A%  
% 214.37/214.54  |- skos__hiddenLabel mesh__D010215 Papios
% 214.37/214.54  |- mesh__recordMaintainer mesh__D010215 ags
% 214.37/214.54  |- skos__altLabel mesh__D010215 Baboons, Savanna
% 214.37/214.54  |- rdf__type mesh__D010215sskos__Concept
% 214.37/214.54  |- mesh__dateCreated mesh__D010215 1999-01-01
% 214.37/214.54  |- skos__hiddenLabel mesh__D010215 Savanna Baboon
% 214.37/214.54  |- skos__prefLabel mesh__D010215 Papio
% 214.37/214.54  |- skos__altLabel mesh__D010215 Baboons
% 214.37/214.54  |- skos__altLabel mesh__D010215 Savanna Baboons
% 214.37/214.54  |- skos__broader mesh__D010215smesh__D016663
% 214.37/214.54  |- mesh__recordAuthorizer mesh__D010215 sjn
% 214.37/214.54  |- mesh__onlineNote mesh__D010215
% 214.37/214.54       use PAPIO to search BABOONS 1971-80 %28%as Prov 1971-72%29%   
% 214.37/214.54  |- mesh__publicMeSHNote mesh__D010215
% 214.37/214.54       81; was see under BABOONS 1973-80; BABOONS was heading 1973-80%A%  
% 214.37/214.54  |- skos__hiddenLabel mesh__D010215 Baboon
% 214.37/214.54  |- mesh__dateEstablished mesh__D010215 1981-01-01
% 214.37/214.54  |- mesh__recordOriginator mesh__D010215 NLM
% 214.37/214.54  |- rdf__type mesh__D001489sskos__Concept
% 214.37/214.54  |- mesh__recordAuthorizer mesh__D001489 sjn
% 214.37/214.54  |- mesh__dateEstablished mesh__D001489 1991-01-01
% 214.37/214.54  |- skos__prefLabel mesh__D001489 Basilar Membrane
% 214.37/214.54  |- skos__broader mesh__D001489smesh__D003051
% 214.37/214.54  |- mesh__recordOriginator mesh__D001489 NLM
% 214.37/214.54  |- mesh__dateRevised mesh__D001489 2005-06-30
% 214.37/214.54  |- mesh__dateCreated mesh__D001489 1999-01-01
% 214.37/214.54  |- mesh__historyNote mesh__D001489
% 214.37/214.54       91%28%75%29%; was see under COCHLEA 1990; was see under LABYRINTH 1960-89%A%  
% 214.37/214.54  |- mesh__onlineNote mesh__D001489
% 214.37/214.54       use LABYRINTH to search BASILAR MEMBRANE 1966-74   
% 214.37/214.54  |- skos__broader mesh__D001489smesh__D001485
% 214.37/214.54  |- skos__hiddenLabel mesh__D001489 Membranes, Basilar
% 214.37/214.54  |- skos__hiddenLabel mesh__D001489 Membrane, Basilar
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D001489 2006
% 214.37/214.54  |- skos__hiddenLabel mesh__D001489 Basilar Membranes
% 214.37/214.54  |- skos__scopeNote mesh__D001489
% 214.37/214.54       A basement membrane in the cochlea that supports the HAIR CELLS of the ORGAN OF CORTI, consisting keratin-like fibrils. It stretches from the SPIRAL LAMINA to the basilar crest. The movement of fluid in the cochlea, induced by sound, causes displacement of the basilar membrane and subsequent stimulation of the attached hair cells which transform the mechanical signal into neural activity.%A%    
% 214.37/214.54  |- mesh__recordMaintainer mesh__D001489 lkt
% 214.37/214.54  |- mesh__publicMeSHNote mesh__D001489
% 214.37/214.54       91; was see under COCHLEA 1990; was see under LABYRINTH 1960-89%A%  
% 214.37/214.54  |- mesh__historyNote mesh__D006972
% 214.37/214.54       91%28%75%29%; was see under BONE DISEASES, DEVELOPMENTAL 1985-90; was see under CRANIOFACIAL DYSOSTOSIS 1963-84%A%  
% 214.37/214.54  |- mesh__dateRevised mesh__D006972 1999-11-03
% 214.37/214.54  |- skos__scopeNote mesh__D006972
% 214.37/214.54       Abnormal increase in the interorbital distance due to overdevelopment of the lesser wings of the sphenoid.%A%    
% 214.37/214.54  |- skos__broader mesh__D006972smesh__D003394
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D006972 2002
% 214.37/214.54  |- mesh__dateEstablished mesh__D006972 1991-01-01
% 214.37/214.54  |- rdf__type mesh__D006972sskos__Concept
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D006972 2004
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D006972 2001
% 214.37/214.54  |- skos__hiddenLabel mesh__D006972 Hypertelorisms
% 214.37/214.54  |- mesh__recordAuthorizer mesh__D006972 sjn
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D006972 2006
% 214.37/214.54  |- mesh__recordOriginator mesh__D006972 NLM
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D006972 2003
% 214.37/214.54  |- mesh__recordMaintainer mesh__D006972 kle
% 214.37/214.54  |- mesh__publicMeSHNote mesh__D006972
% 214.37/214.54       91; was see under BONE DISEASES, DEVELOPMENTAL 1985-90; was see under CRANIOFACIAL DYSOSTOSIS 1963-84%A%  
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D006972 2005
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D006972 2000
% 214.37/214.54  |- skos__annotation mesh__D006972
% 214.37/214.54       a form of craniofacial dysostosis; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 214.37/214.54  |- mesh__dateCreated mesh__D006972 1999-01-01
% 214.37/214.54  |- mesh__onlineNote mesh__D006972 search CRANIOFACIAL DYSOSTOSIS 1966-74   
% 214.37/214.54  |- skos__prefLabel mesh__D006972 Hypertelorism
% 214.37/214.54  |- skos__altLabel mesh__D020643 Anteroventral Nucleus
% 214.37/214.54  |- mesh__publicMeSHNote mesh__D020643 2000   
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D020643 2001
% 214.37/214.54  |- mesh__dateEstablished mesh__D020643 2000-01-01
% 214.37/214.54  |- skos__scopeNote mesh__D020643
% 214.37/214.54       Three nuclei located beneath the dorsal surface of the most rostral part of the thalamus. The group includes the anterodorsal nucleus, anteromedial nucleus, and anteroventral nucleus. All receive connections from the mamillary body and fornix, and project fibers to the cingulate body.%A%    
% 214.37/214.54  |- skos__historyNote mesh__D020643 Thalamic Nuclei %28%1971-1999%29%
% 214.37/214.54  |- skos__altLabel mesh__D020643 Anterodorsal Nucleus
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D020643 2000
% 214.37/214.54  |- skos__hiddenLabel mesh__D020643 Nucleus, Anteroventral Thalamic
% 214.37/214.54  |- skos__hiddenLabel mesh__D020643 Nucleus, Anteromedial Thalamic
% 214.37/214.54  |- mesh__dateCreated mesh__D020643 1999-11-03
% 214.37/214.54  |- skos__prefLabel mesh__D020643 Anterior Thalamic Nuclei
% 214.37/214.54  |- skos__hiddenLabel mesh__D020643 Thalamic Nucleus, Anteroventral
% 214.37/214.54  |- skos__hiddenLabel mesh__D020643 Thalamic Nucleus, Anterodorsal
% 214.37/214.54  |- skos__hiddenLabel mesh__D020643 Nuclei, Anterior Thalamic
% 214.37/214.54  |- skos__hiddenLabel mesh__D020643 Nucleus, Anteroventral
% 214.37/214.54  |- mesh__historyNote mesh__D020643 2000   
% 214.37/214.54  |- skos__hiddenLabel mesh__D020643 Nucleus, Anteromedial
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D020643 2004
% 214.37/214.54  |- skos__broader mesh__D020643smesh__D013787
% 214.37/214.54  |- rdf__type mesh__D020643sskos__Concept
% 214.37/214.54  |- skos__hiddenLabel mesh__D020643 Thalamic Nucleus, Anteromedial
% 214.37/214.54  |- skos__hiddenLabel mesh__D020643 Thalamic Nuclei, Anterior
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D020643 2003
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D020643 2006
% 214.37/214.54  |- skos__hiddenLabel mesh__D020643 Nucleus, Anterodorsal Thalamic
% 214.37/214.54  |- skos__hiddenLabel mesh__D020643 Nucleus, Anterodorsal
% 214.37/214.54  |- skos__altLabel mesh__D020643 Anterior Nuclear Group
% 214.37/214.54  |- skos__altLabel mesh__D020643 Anteromedial Nucleus
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D020643 2002
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D020643 2005
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014606 1998
% 214.37/214.54  |- mesh__publicMeSHNote mesh__D014606 86; was IRIDOCYCLITIS 1963-85   
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014606 1995
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014606 2006
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014606 1999
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014606 2001
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014606 1992
% 214.37/214.54  |- skos__hiddenLabel mesh__D014606 Anterior Uveitides
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014606 2003
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014606 1996
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014606 1993
% 214.37/214.54  |- mesh__historyNote mesh__D014606 86; was IRIDOCYCLITIS 1963-85   
% 214.37/214.54  |- skos__hiddenLabel mesh__D014606 Uveitides, Anterior
% 214.37/214.54  |- mesh__dateCreated mesh__D014606 1999-01-01
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014606 2004
% 214.37/214.54  |- mesh__recordMaintainer mesh__D014606 PLS
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014606 1997
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014606 1991
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014606 2002
% 214.37/214.54  |- skos__prefLabel mesh__D014606 Uveitis, Anterior
% 214.37/214.54  |- rdf__type mesh__D014606sskos__Concept
% 214.37/214.54  |- mesh__dateRevised mesh__D014606 1990-05-29
% 214.37/214.54  |- skos__broader mesh__D014606smesh__D015864
% 214.37/214.54  |- skos__hiddenLabel mesh__D014606 Anterior Uveitis
% 214.37/214.54  |- mesh__recordOriginator mesh__D014606 NLM
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014606 1994
% 214.37/214.54  |- skos__annotation mesh__D014606
% 214.37/214.54       inflammation of both the iris %26% ciliary body; of iris alone = IRITIS, of ciliary body alone = CILIARY BODY %28%IM%29% + UVEITIS, ANTERIOR %28%IM%29%%A%  
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014606 2000
% 214.37/214.54  |- mesh__recordAuthorizer mesh__D014606 NLM
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014606 2005
% 214.37/214.54  |- skos__scopeNote mesh__D014606
% 214.37/214.54       Inflammation of the anterior uvea comprising the iris, angle structures, and the ciliary body. Manifestations of this disorder include ciliary injection, exudation into the anterior chamber, iris changes, and adhesions between the iris and lens %28%posterior synechiae%29%. Intraocular pressure may be increased or reduced.%A%    
% 214.37/214.54  |- mesh__recordAuthorizer mesh__D002582 SJN
% 214.37/214.54  |- mesh__recordOriginator mesh__D002582 NLM
% 214.37/214.54  |- skos__broader mesh__D002582smesh__D009093
% 214.37/214.54  |- skos__hiddenLabel mesh__D002582 Reactions, Palm-Leaf
% 214.37/214.54  |- mesh__dateRevised mesh__D002582 1997-06-20
% 214.37/214.54  |- skos__hiddenLabel mesh__D002582 Test, Fern
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D002582 2004
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D002582 2002
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D002582 2006
% 214.37/214.54  |- skos__hiddenLabel mesh__D002582 Mucus, Cervix
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D002582 2003
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D002582 2001
% 214.37/214.54  |- skos__altLabel mesh__D002582 Cervical Mucus
% 214.37/214.54  |- skos__hiddenLabel mesh__D002582 Fern Tests
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D002582 2005
% 214.37/214.54  |- skos__hiddenLabel mesh__D002582 Palm-Leaf Reactions
% 214.37/214.54  |- mesh__dateCreated mesh__D002582 1999-01-01
% 214.37/214.54  |- skos__hiddenLabel mesh__D002582 Tests, Fern
% 214.37/214.54  |- skos__prefLabel mesh__D002582 Cervix Mucus
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D002582 1999
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D002582 2000
% 214.37/214.54  |- skos__hiddenLabel mesh__D002582 Reaction, Palm-Leaf
% 214.37/214.54  |- mesh__recordMaintainer mesh__D002582 TGC
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D002582 1998
% 214.37/214.54  |- skos__hiddenLabel mesh__D002582 Palm Leaf Reaction
% 214.37/214.54  |- rdf__type mesh__D002582sskos__Concept
% 214.37/214.54  |- skos__scopeNote mesh__D002582
% 214.37/214.54       A slightly alkaline secretion of the endocervical glands. The consistency and amount are dependent on the physiological hormone changes in the menstrual cycle. It contains the glycoprotein mucin, amino acids, sugar, enzymes, and electrolytes, with a water content up to 90%25%. The mucus is a useful protection against the ascent of bacteria and sperm into the uterus. %28%From Dictionary of Obstetrics and Gynecology, 1988%29%%A%    
% 214.37/214.54  |- skos__hiddenLabel mesh__D002582 Mucus, Cervical
% 214.37/214.54  |- skos__broader mesh__D013334Q000193smesh__D013334
% 214.37/214.54  |- mesh__preferredCombination mesh__D013334Q000193smesh__D004493
% 214.37/214.54  |- rdf__type mesh__D013334Q000193smesh__CompoundConcept
% 214.37/214.54  |- skos__annotation mesh__D034664 see SCR for specific hnRNP entries   
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D034664 2003
% 214.37/214.54  |- skos__hiddenLabel mesh__D034664
% 214.37/214.54       Heterogeneous Nuclear Ribonucleoprotein L
% 214.37/214.54  |- skos__hiddenLabel mesh__D034664
% 214.37/214.54       Ribonucleoprotein L, Heterogeneous-Nuclear
% 214.37/214.54  |- mesh__dateCreated mesh__D034664 2002-07-03
% 214.37/214.54  |- mesh__publicMeSHNote mesh__D034664
% 214.37/214.54       2003; HNRNP L was indexed under RIBONUCLEOPROTEINS 2000-2002%A%  
% 214.37/214.54  |- skos__altLabel mesh__D034664 hnRNP L
% 214.37/214.54  |- skos__prefLabel mesh__D034664 Heterogeneous-Nuclear Ribonucleoprotein L
% 214.37/214.54  |- skos__scopeNote mesh__D034664
% 214.37/214.54       A heterogenous-nuclear ribonucleoprotein found associated with most nascent transcripts, most notably those of the landmark giant loops of amphibian lampbrush chromosomes.%A%    
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D034664 2006
% 214.37/214.54  |- skos__broader mesh__D034664smesh__D034441
% 214.37/214.54  |- mesh__historyNote mesh__D034664
% 214.37/214.54       2003; for HNRNP L use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 2000-2002%A%  
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D034664 2005
% 214.37/214.54  |- rdf__type mesh__D034664sskos__Concept
% 214.37/214.54  |- mesh__dateEstablished mesh__D034664 2003-01-01
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D034664 2004
% 214.37/214.54  |- skos__historyNote mesh__D034664 Ribonucleoproteins %28%2000-2002%29%
% 214.37/214.54  |- skos__hiddenLabel mesh__D006973 Blood Pressures, High
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D006973 2006
% 214.37/214.54  |- skos__broader mesh__D006973smesh__D014652
% 214.37/214.54  |- skos__altLabel mesh__D006973 Blood Pressure, High
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D006973 2005
% 214.37/214.54  |- skos__annotation mesh__D006973
% 214.37/214.54       not for intracranial or intraocular pressure; relation to BLOOD PRESSURE: Manuel23.27; Goldblatt kidney or Goldblatt hypertension is HYPERTENSION, GOLDBLATT see HYPERTENSION, RENOVASCULAR; hypertension with kidney disease is probably HYPERTENSION, RENAL, not HYPERTENSION; venous hypertension: index under VENOUS PRESSURE %28%IM%29% %26% do not coordinate with HYPERTENSION%A%  
% 214.37/214.54  |- skos__prefLabel mesh__D006973 Hypertension
% 214.37/214.54  |- mesh__dateCreated mesh__D006973 1999-01-01
% 214.37/214.54  |- mesh__dateRevised mesh__D006973 2004-07-07
% 214.37/214.54  |- skos__related mesh__D006973smesh__D000959
% 214.37/214.54  |- skos__hiddenLabel mesh__D006973 High Blood Pressures
% 214.37/214.54  |- skos__scopeNote mesh__D006973
% 214.37/214.54       Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings %28%BLOOD PRESSURE DETERMINATION%29%, hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.%A%    
% 214.37/214.54  |- skos__related mesh__D006973smesh__D014655
% 214.37/214.54  |- skos__hiddenLabel mesh__D006973 High Blood Pressure
% 214.37/214.54  |- mesh__recordAuthorizer mesh__D006973 sjn
% 214.37/214.54  |- mesh__recordMaintainer mesh__D006973 lkt
% 214.37/214.54  |- mesh__recordOriginator mesh__D006973 NLM
% 214.37/214.54  |- rdf__type mesh__D006973sskos__Concept
% 214.37/214.54  |- skos__altLabel mesh__D020644 Rhomboid Nucleus
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Nucleus, Reuniens
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D020644 2004
% 214.37/214.54  |- skos__historyNote mesh__D020644 Thalamic Nuclei %28%1971-1999%29%
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Nucleus Reuniens Thalamus
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Nuclear Group, Midline
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Nucleus, Subfascicular Thalamic
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Thalamus Paraventricular Nucleus
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Nucleus, Reuniens Thalamic
% 214.37/214.54  |- skos__altLabel mesh__D020644 Paraventricular Nucleus of Thalamus
% 214.37/214.54  |- rdf__type mesh__D020644sskos__Concept
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Reuniens Thalami, Nucleus
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Nucleus, Paraventricular Thalamic
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Nucleus, Paratenial Thalamic
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Nucleus, Rhomboidal
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Thalamic Nucleus, Reuniens
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Thalamic Nucleus, Paraventricular
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Nucleus, Paratenial
% 214.37/214.54  |- skos__altLabel mesh__D020644 Periventricular Nuclei of Thalamus
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Nucleus, Midline Thalamic
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Thalamus, Nucleus Reuniens
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Nucleus, Subfascular
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Thalamic Nuclei, Midline
% 214.37/214.54  |- skos__broader mesh__D020644smesh__D013787
% 214.37/214.54  |- skos__scopeNote mesh__D020644
% 214.37/214.54       Small, nonspecific nerve cells scattered in the periventricular gray matter, separating the medial part of the thalamus from the ependyma of the third ventricle. The group includes the paraventricular nucleus, paratenial nucleus, reuniens nucleus, rhomboidal nucleus, and subfascicular nucleus.%A%    
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Thalamus Midline Nuclei
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Thalamic Nucleus, Midline
% 214.37/214.54  |- skos__altLabel mesh__D020644 Midline Nuclear Group
% 214.37/214.54  |- mesh__dateCreated mesh__D020644 1999-11-08
% 214.37/214.54  |- mesh__dateEstablished mesh__D020644 2000-01-01
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D020644 2000
% 214.37/214.54  |- skos__altLabel mesh__D020644 Subfascular Nucleus
% 214.37/214.54  |- skos__altLabel mesh__D020644 Midline Nuclei of Thalamus
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Nuclei, Midline Thalamic
% 214.37/214.54  |- skos__altLabel mesh__D020644 Nucleus Reuniens Thalami
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D020644 2005
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Thalamic Nucleus, Subfascicular
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Thalamus Periventricular Nuclei
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Thalamic Nucleus, Paratenial
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Nucleus, Rhomboid Thalamic
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Nucleus, Rhomboid
% 214.37/214.54  |- mesh__publicMeSHNote mesh__D020644 2000   
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Thalami, Nucleus Reuniens
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Thalamic Nucleus, Rhomboid
% 214.37/214.54  |- skos__altLabel mesh__D020644 Rhomboidal Nucleus
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Reuniens Thalamus, Nucleus
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D020644 2001
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D020644 2006
% 214.37/214.54  |- skos__altLabel mesh__D020644 Reuniens Nucleus
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D020644 2003
% 214.37/214.54  |- skos__altLabel mesh__D020644 Paratenial Nucleus
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Midline Thalamic Nucleus
% 214.37/214.54  |- mesh__historyNote mesh__D020644 2000   
% 214.37/214.54  |- skos__hiddenLabel mesh__D020644 Thalamus Midline Nucleus
% 214.37/214.54  |- skos__prefLabel mesh__D020644 Midline Thalamic Nuclei
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D020644 2002
% 214.37/214.54  |- mesh__dateRevised mesh__D006175 2005-06-30
% 214.37/214.54  |- skos__hiddenLabel mesh__D006175 Gynatresias
% 214.37/214.54  |- mesh__dateCreated mesh__D006175 1977-11-23
% 214.37/214.54  |- mesh__recordMaintainer mesh__D006175 lkt
% 214.37/214.54  |- skos__scopeNote mesh__D006175
% 214.37/214.54       Absence of a normal opening in the lumen of the female genital tract, from the FALLOPIAN TUBES to the VAGINA. This anomaly may be congenital or acquired due to injuries, diseases, or adhesions.%A%    
% 214.37/214.54  |- mesh__publicMeSHNote mesh__D006175 98   
% 214.37/214.54  |- skos__hiddenLabel mesh__D006175 Syndrome, Asherman
% 214.37/214.54  |- mesh__recordOriginator mesh__D006175 SMH
% 214.37/214.54  |- mesh__recordAuthorizer mesh__D006175 sjn
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D006175 2006
% 214.37/214.54  |- mesh__dateEstablished mesh__D006175 1998-01-01
% 214.37/214.54  |- mesh__historyNote mesh__D006175 98; use explode 1979-97   
% 214.37/214.54  |- skos__broader mesh__D006175smesh__D005831
% 214.37/214.54  |- skos__prefLabel mesh__D006175 Gynatresia
% 214.37/214.54  |- skos__annotation mesh__D006175
% 214.37/214.54       general or unspecified; prefer specifics   
% 214.37/214.54  |- rdf__type mesh__D006175sskos__Concept
% 214.37/214.54  |- skos__hiddenLabel mesh__D014607 Vogt Koyanagi Harada Syndrome
% 214.37/214.54  |- skos__hiddenLabel mesh__D014607 Syndrome, Uveomeningoencephalitic
% 214.37/214.54  |- skos__broader mesh__D014607smesh__D020274
% 214.37/214.54  |- skos__broader mesh__D014607smesh__D008590
% 214.37/214.54  |- skos__hiddenLabel mesh__D014607 Syndrome, VKH
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014607 2003
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014607 2000
% 214.37/214.54  |- skos__hiddenLabel mesh__D014607 Syndrome, Vogt-Koyanagi-Harada
% 214.37/214.54  |- skos__altLabel mesh__D014607 Syndrome, VKH %28%Vogt Koyanagi Harada%29%
% 214.37/214.54  |- mesh__dateCreated mesh__D014607 1999-01-01
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014607 2004
% 214.37/214.54  |- skos__hiddenLabel mesh__D014607
% 214.37/214.54       VKH Syndrome %28%Vogt Koyanagi Harada%29%
% 214.37/214.54  |- skos__altLabel mesh__D014607 Uveomeningoencephalitis
% 214.37/214.54  |- mesh__dateEstablished mesh__D014607 1991-01-01
% 214.37/214.54  |- skos__prefLabel mesh__D014607 Uveomeningoencephalitic Syndrome
% 214.37/214.54  |- mesh__recordAuthorizer mesh__D014607 sjn
% 214.37/214.54  |- mesh__dateRevised mesh__D014607 1999-11-08
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014607 2001
% 214.37/214.54  |- rdf__type mesh__D014607sskos__Concept
% 214.37/214.54  |- skos__hiddenLabel mesh__D014607 Vogt Koyanagi Harada Disease
% 214.37/214.54  |- mesh__historyNote mesh__D014607
% 214.37/214.54       1991%28%1965%29%; was see under UVEITIS 1965-1990   
% 214.37/214.54  |- mesh__publicMeSHNote mesh__D014607
% 214.37/214.54       1991; was see under UVEITIS 1965-1990   
% 214.37/214.54  |- skos__annotation mesh__D014607 DF: UVEOMENINGOENCEPH SYNDROME   
% 214.37/214.54  |- skos__altLabel mesh__D014607 VKH Syndrome
% 214.37/214.54  |- mesh__recordMaintainer mesh__D014607 KEV
% 214.37/214.54  |- skos__broader mesh__D014607smesh__D014605
% 214.37/214.54  |- skos__hiddenLabel mesh__D014607 Disease, Vogt-Koyanagi-Harada
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014607 2005
% 214.37/214.54  |- skos__scopeNote mesh__D014607
% 214.37/214.54       A syndrome characterized by bilateral granulomatous UVEITIS with IRITIS and secondary GLAUCOMA, premature ALOPECIA, symmetrical VITILIGO, poliosis circumscripta %28%a strand of depigmented hair%29%, HEARING DISORDERS, and meningeal signs %28%neck stiffness and headache%29%. Examination of the cerebrospinal fluid reveals a pattern consistent with MENINGITIS, ASEPTIC. %28%Adams et al., Principles of Neurology, 6th ed, p748; Surv Ophthalmol 1995 Jan;39%28%4%29%:265-292%29%%A%    
% 214.37/214.54  |- skos__hiddenLabel mesh__D014607 Uveomeningoencephalitides
% 214.37/214.54  |- skos__altLabel mesh__D014607 Vogt-Koyanagi-Harada Disease
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014607 2002
% 214.37/214.54  |- skos__altLabel mesh__D014607 Vogt-Koyanagi-Harada Syndrome
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D014607 2006
% 214.37/214.54  |- skos__altLabel mesh__D014607 VKH %28%Vogt Koyanagi Harada%29% Syndrome
% 214.37/214.54  |- skos__altLabel mesh__D014607 Syndrome, Vogt Koyanagi Harada
% 214.37/214.54  |- mesh__recordOriginator mesh__D014607 NLM
% 214.37/214.54  |- rdf__type mesh__D002583sskos__Concept
% 214.37/214.54  |- skos__altLabel mesh__D002583 Cancer of Cervix
% 214.37/214.54  |- skos__hiddenLabel mesh__D002583 Cervical Neoplasm, Uterine
% 214.37/214.54  |- skos__altLabel mesh__D002583 Neoplasms, Cervix
% 214.37/214.54  |- skos__annotation mesh__D002583
% 214.37/214.54       coordinate IM with histologic type of neoplasm %28%IM%29%   
% 214.37/214.54  |- skos__hiddenLabel mesh__D002583 Cancer, Cervix
% 214.37/214.54  |- skos__hiddenLabel mesh__D002583 Cervical Neoplasm
% 214.37/214.54  |- skos__hiddenLabel mesh__D002583 Neoplasms, Uterine Cervical
% 214.37/214.54  |- skos__altLabel mesh__D002583 Neoplasms, Cervical
% 214.37/214.54  |- skos__altLabel mesh__D002583 Uterine Cervical Cancer
% 214.37/214.54  |- skos__broader mesh__D002583smesh__D002577
% 214.37/214.54  |- mesh__historyNote mesh__D002583 2006 %28%1963%29%   
% 214.37/214.54  |- skos__altLabel mesh__D002583 Cancer of the Cervix
% 214.37/214.54  |- skos__hiddenLabel mesh__D002583 Cervical Cancers, Uterine
% 214.37/214.54  |- mesh__dateRevised mesh__D002583 2005-06-30
% 214.37/214.54  |- skos__related mesh__D002583smesh__D018290
% 214.37/214.54  |- skos__hiddenLabel mesh__D002583 Cancers, Cervix
% 214.37/214.54  |- skos__hiddenLabel mesh__D002583 Cancer, Uterine Cervical
% 214.37/214.54  |- skos__altLabel mesh__D002583 Cervix Neoplasms
% 214.37/214.54  |- skos__broader mesh__D002583smesh__D014594
% 214.37/214.54  |- skos__altLabel mesh__D002583 Cervix Cancer
% 214.37/214.54  |- skos__hiddenLabel mesh__D002583 Neoplasm, Uterine Cervical
% 214.37/214.54  |- skos__hiddenLabel mesh__D002583 Uterine Cervical Neoplasm
% 214.37/214.54  |- mesh__recordMaintainer mesh__D002583 lkt
% 214.37/214.54  |- skos__hiddenLabel mesh__D002583 Cervix Neoplasm
% 214.37/214.54  |- skos__hiddenLabel mesh__D002583 Cervical Cancer, Uterine
% 214.37/214.54  |- mesh__recordAuthorizer mesh__D002583 sjn
% 214.37/214.54  |- mesh__recordOriginator mesh__D002583 NLM
% 214.37/214.54  |- skos__hiddenLabel mesh__D002583 Cancers, Uterine Cervical
% 214.37/214.54  |- skos__prefLabel mesh__D002583 Uterine Cervical Neoplasms
% 214.37/214.54  |- mesh__activeMeSHYear mesh__D002583 2006
% 214.37/214.55  |- skos__hiddenLabel mesh__D002583 Uterine Cervical Cancers
% 214.37/214.55  |- mesh__publicMeSHNote mesh__D002583
% 214.37/214.55       2006; see CERVIX NEOPLASMS %28%1963-2005%29%   
% 214.37/214.55  |- skos__hiddenLabel mesh__D002583 Cervical Neoplasms, Uterine
% 214.37/214.55  |- skos__hiddenLabel mesh__D002583 Neoplasm, Cervix
% 214.37/214.55  |- skos__related mesh__D002583smesh__D002578
% 214.37/214.55  |- skos__altLabel mesh__D002583 Cervical Neoplasms
% 214.37/214.55  |- skos__hiddenLabel mesh__D002583 Neoplasm, Cervical
% 214.37/214.55  |- mesh__dateCreated mesh__D002583 1999-01-01
% 214.37/214.55  |- skos__scopeNote mesh__D002583
% 214.37/214.55       Tumors or cancer of the UTERINE CERVIX.     
% 214.37/214.55  |- skos__annotation mesh__D010217 caused by a bunyavirus   
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D010217 2006
% 214.37/214.55  |- mesh__onlineNote mesh__D010217
% 214.37/214.55       use PHLEBOTOMUS FEVER to search PAPPATACI FEVER 1966-91   
% 214.37/214.55  |- skos__altLabel mesh__D010217 Pappataci Fever
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D010217 2004
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D010217 1995
% 214.37/214.55  |- skos__prefLabel mesh__D010217 Phlebotomus Fever
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D010217 2005
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D010217 1999
% 214.37/214.55  |- rdf__type mesh__D010217sskos__Concept
% 214.37/214.55  |- mesh__recordMaintainer mesh__D010217 TGC
% 214.37/214.55  |- skos__scopeNote mesh__D010217
% 214.37/214.55       Influenza-like febrile viral disease caused by several members of the BUNYAVIRIDAE family and transmitted mostly by the bloodsucking sandfly Phlebotomus papatasii.%A%    
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D010217 2003
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D010217 2001
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D010217 1994
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D010217 1997
% 214.37/214.55  |- skos__broader mesh__D010217smesh__D002044
% 214.37/214.55  |- mesh__publicMeSHNote mesh__D010217
% 214.37/214.55       92; was PAPPATACI FEVER 1966-91; PHLEBOTOMUS FEVER was see PAPPATACI FEVER 1977-91%A%  
% 214.37/214.55  |- mesh__recordAuthorizer mesh__D010217 PLS
% 214.37/214.55  |- skos__altLabel mesh__D010217 Sandfly Fever
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D010217 2000
% 214.37/214.55  |- mesh__dateCreated mesh__D010217 1999-01-01
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D010217 1998
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D010217 1996
% 214.37/214.55  |- mesh__recordOriginator mesh__D010217 NLM
% 214.37/214.55  |- skos__broader mesh__D010217smesh__D001102
% 214.37/214.55  |- skos__hiddenLabel mesh__D010217 Phlebotomus Fevers
% 214.37/214.55  |- skos__hiddenLabel mesh__D010217 Sandfly Fevers
% 214.37/214.55  |- mesh__dateRevised mesh__D010217 1993-06-02
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D010217 2002
% 214.37/214.55  |- skos__hiddenLabel mesh__D010217 Pappataci Fevers
% 214.37/214.55  |- mesh__historyNote mesh__D010217
% 214.37/214.55       92; was PAPPATACI FEVER 1966-91; PHLEBOTOMUS FEVER was see PAPPATACI FEVER 1977-91%A%  
% 214.37/214.55  |- skos__altLabel mesh__D015700 gp41 Envelope Protein, HIV
% 214.37/214.55  |- skos__altLabel mesh__D015700 HIV-1 Envelope Protein gp41
% 214.37/214.55  |- mesh__dateRevised mesh__D015700 2005-06-30
% 214.37/214.55  |- skos__broader mesh__D015700smesh__D015488
% 214.37/214.55  |- mesh__recordMaintainer mesh__D015700 nns
% 214.37/214.55  |- skos__annotation mesh__D015700
% 214.37/214.55       IM; coord with HIV-1 %28%IM%29%; /drug eff /ultrastruct permitted; DF: GP41%A%  
% 214.37/214.55  |- skos__scopeNote mesh__D015700
% 214.37/214.55       Transmembrane envelope protein of the HUMAN IMMUNODEFICIENCY VIRUS which is encoded by the HIV env gene. It has a molecular weight of 41,000 and is glycosylated. The N-terminal part of gp41 is thought to be involved in CELL FUSION with the CD4 ANTIGENS of T4 LYMPHOCYTES, leading to syncytial formation. Gp41 is one of the most common HIV antigens detected by IMMUNOBLOTTING.%A%    
% 214.37/214.55  |- skos__broader mesh__D015700smesh__D014760
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D015700 2006
% 214.37/214.55  |- skos__hiddenLabel mesh__D015700 HIV 1 Envelope Protein gp41
% 214.37/214.55  |- mesh__dateEstablished mesh__D015700 1990-01-01
% 214.37/214.55  |- mesh__dateCreated mesh__D015700 1989-06-19
% 214.37/214.55  |- skos__altLabel mesh__D015700 env Protein gp41, HIV
% 214.37/214.55  |- skos__hiddenLabel mesh__D015700 HTLV III gp41
% 214.37/214.55  |- skos__prefLabel mesh__D015700 HIV Envelope Protein gp41
% 214.37/214.55  |- mesh__recordOriginator mesh__D015700 AGS
% 214.37/214.55  |- skos__altLabel mesh__D015700 HTLV-III gp41
% 214.37/214.55  |- mesh__recordAuthorizer mesh__D015700 sjn
% 214.37/214.55  |- skos__altLabel mesh__D015700 Envelope Protein gp41, HIV
% 214.37/214.55  |- skos__historyNote mesh__D015700 Retroviridae Proteins %28%1986-1989%29%
% 214.37/214.55  |- skos__altLabel mesh__D015700 gp41%28%HIV%29%
% 214.37/214.55  |- skos__altLabel mesh__D015700 HIV Transmembrane Protein gp41
% 214.37/214.55  |- mesh__historyNote mesh__D015700 90   
% 214.37/214.55  |- mesh__publicMeSHNote mesh__D015700 90   
% 214.37/214.55  |- skos__broader mesh__D015700smesh__D015686
% 214.37/214.55  |- skos__hiddenLabel mesh__D015700 gp41, HTLV-III
% 214.37/214.55  |- skos__historyNote mesh__D015700
% 214.37/214.55       Viral Envelope Proteins %28%1983-1989%29%
% 214.37/214.55  |- rdf__type mesh__D015700sskos__Concept
% 214.37/214.55  |- mesh__recordAuthorizer mesh__D006974 sjn
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D006974 2005
% 214.37/214.55  |- mesh__recordMaintainer mesh__D006974 lkt
% 214.37/214.55  |- mesh__recordOriginator mesh__D006974 NLM
% 214.37/214.55  |- mesh__dateCreated mesh__D006974 1999-01-01
% 214.37/214.55  |- mesh__dateRevised mesh__D006974 2004-07-07
% 214.37/214.55  |- skos__broader mesh__D006974smesh__D006973
% 214.37/214.55  |- skos__related mesh__D006974smesh__D020343
% 214.37/214.55  |- skos__altLabel mesh__D006974 Malignant Hypertension
% 214.37/214.55  |- skos__scopeNote mesh__D006974
% 214.37/214.55       A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.%A%    
% 214.37/214.55  |- skos__prefLabel mesh__D006974 Hypertension, Malignant
% 214.37/214.55  |- skos__annotation mesh__D006974
% 214.37/214.55       malignant does not refer to neoplasm: refers to severe hypertension with papilledema %26% arterial necrosis%A%  
% 214.37/214.55  |- rdf__type mesh__D006974sskos__Concept
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D006974 2006
% 214.37/214.55  |- skos__altLabel mesh__D020645 Mediodorsal Nucleus
% 214.37/214.55  |- rdf__type mesh__D020645sskos__Concept
% 214.37/214.55  |- skos__prefLabel mesh__D020645 Mediodorsal Thalamic Nucleus
% 214.37/214.55  |- skos__altLabel mesh__D020645 Dorsal Medial Nucleus
% 214.37/214.55  |- skos__historyNote mesh__D020645 Thalamus %28%1967-1973%29%
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D020645 2006
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D020645 2003
% 214.37/214.55  |- skos__broader mesh__D020645smesh__D013787
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D020645 2005
% 214.37/214.55  |- skos__altLabel mesh__D020645 Medial Dorsal Nucleus
% 214.37/214.55  |- skos__hiddenLabel mesh__D020645 Thalamic Nucleus, Mediodorsal
% 214.37/214.55  |- skos__hiddenLabel mesh__D020645 Nucleus, Mediodorsal Thalamic
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D020645 2002
% 214.37/214.55  |- skos__hiddenLabel mesh__D020645 Nucleus, Mediodorsal
% 214.37/214.55  |- skos__scopeNote mesh__D020645
% 214.37/214.55       The largest of the medial nuclei of the thalamus. It makes extensive connections with most of the other thalamic nuclei.%A%    
% 214.37/214.55  |- mesh__publicMeSHNote mesh__D020645 2000   
% 214.37/214.55  |- skos__hiddenLabel mesh__D020645 Nucleus, Dorsomedial
% 214.37/214.55  |- skos__hiddenLabel mesh__D020645 Nucleus, Medial Dorsal
% 214.37/214.55  |- mesh__dateEstablished mesh__D020645 2000-01-01
% 214.37/214.55  |- skos__hiddenLabel mesh__D020645 Nucleus, Dorsomedial Thalamic
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D020645 2001
% 214.37/214.55  |- skos__altLabel mesh__D020645 Dorsomedial Thalamic Nucleus
% 214.37/214.55  |- mesh__dateCreated mesh__D020645 1999-11-03
% 214.37/214.55  |- skos__hiddenLabel mesh__D020645 Nucleus, Dorsal Medial
% 214.37/214.55  |- skos__altLabel mesh__D020645 Dorsomedial Nucleus
% 214.37/214.55  |- mesh__historyNote mesh__D020645 2000   
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D020645 2000
% 214.37/214.55  |- skos__historyNote mesh__D020645 Thalamic Nuclei %28%1974-1999%29%
% 214.37/214.55  |- skos__hiddenLabel mesh__D020645 Thalamic Nucleus, Dorsomedial
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D020645 2004
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D006176 2005
% 214.37/214.55  |- mesh__dateRevised mesh__D006176 1997-06-20
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D006176 2001
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D006176 2006
% 214.37/214.55  |- skos__related mesh__D006176smesh__D018456
% 214.37/214.55  |- mesh__dateCreated mesh__D006176 1999-01-01
% 214.37/214.55  |- skos__related mesh__D006176smesh__D005831
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D006176 2002
% 214.37/214.55  |- skos__annotation mesh__D006176
% 214.37/214.55       SPEC: SPEC qualif; corresponding organ term is GENITALIA, FEMALE; DF: GYNECOL%A%  
% 214.37/214.55  |- mesh__recordMaintainer mesh__D006176 PXP
% 214.37/214.55  |- mesh__recordAuthorizer mesh__D006176 SJN
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D006176 1998
% 214.37/214.55  |- skos__related mesh__D006176smesh__D013509
% 214.37/214.55  |- rdf__type mesh__D006176sskos__Concept
% 214.37/214.55  |- skos__prefLabel mesh__D006176 Gynecology
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D006176 2003
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D006176 1999
% 214.37/214.55  |- mesh__recordOriginator mesh__D006176 NLM
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D006176 2004
% 214.37/214.55  |- skos__scopeNote mesh__D006176
% 214.37/214.55       A medical-surgical specialty concerned with the physiology and disorders primarily of the female genital tract, as well as female endocrinology and reproductive physiology.%A%    
% 214.37/214.55  |- skos__broader mesh__D006176smesh__D013043
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D006176 2000
% 214.37/214.55  |- mesh__dateRevised mesh__D014608 1999-11-03
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D014608 2001
% 214.37/214.55  |- skos__altLabel mesh__D014608 Heerfordt Syndrome
% 214.37/214.55  |- mesh__historyNote mesh__D014608
% 214.37/214.55       91%28%75%29%; was see under SARCOIDOSIS 1975-90   
% 214.37/214.55  |- skos__hiddenLabel mesh__D014608 Fevers, Uveoparotid
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D014608 2006
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D014608 2000
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D014608 2004
% 214.37/214.55  |- mesh__onlineNote mesh__D014608 search SARCOIDOSIS 1966-74   
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D014608 2005
% 214.37/214.55  |- mesh__recordOriginator mesh__D014608 NLM
% 214.37/214.55  |- skos__hiddenLabel mesh__D014608 Fever, Uveoparotid
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D014608 2003
% 214.37/214.55  |- skos__hiddenLabel mesh__D014608 Uveoparotid Fevers
% 214.37/214.55  |- skos__hiddenLabel mesh__D014608 Syndrome, Heerfordt
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D014608 2002
% 214.37/214.55  |- skos__scopeNote mesh__D014608
% 214.37/214.55       A manifestation of sarcoidosis marked by chronic inflammation of the parotid gland and the uvea.%A%    
% 214.37/214.55  |- mesh__dateCreated mesh__D014608 1999-01-01
% 214.37/214.55  |- mesh__recordMaintainer mesh__D014608 KEV
% 214.37/214.55  |- skos__broader mesh__D014608smesh__D012507
% 214.37/214.55  |- rdf__type mesh__D014608sskos__Concept
% 214.37/214.55  |- skos__altLabel mesh__D014608 Uveoparotitis
% 214.37/214.55  |- mesh__recordAuthorizer mesh__D014608 sjn
% 214.37/214.55  |- mesh__dateEstablished mesh__D014608 1991-01-01
% 214.37/214.55  |- mesh__publicMeSHNote mesh__D014608
% 214.37/214.55       91; was see under SARCOIDOSIS 1975-90   
% 214.37/214.55  |- skos__hiddenLabel mesh__D014608 Uveoparotitides
% 214.37/214.55  |- skos__prefLabel mesh__D014608 Uveoparotid Fever
% 214.37/214.55  |- skos__broader mesh__D006321Q000002smesh__D006321
% 214.37/214.55  |- mesh__preferredCombination mesh__D006321Q000002smesh__D006330
% 214.37/214.55  |- rdf__type mesh__D006321Q000002smesh__CompoundConcept
% 214.37/214.55  |- skos__scopeNote mesh__D011310
% 214.37/214.55       Substances added to pharmaceutical preparations to protect them from chemical change or microbial action. They include ANTI-BACTERIAL AGENTS and antioxidants.%A%    
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D011310 2005
% 214.37/214.55  |- skos__altLabel mesh__D011310 Preservative, Pharmaceutical
% 214.37/214.55  |- skos__altLabel mesh__D011310 Preservative, Pharmaceutic
% 214.37/214.55  |- skos__prefLabel mesh__D011310 Preservatives, Pharmaceutical
% 214.37/214.55  |- skos__annotation mesh__D011310 D25-26 qualif; DF: PRESERVATIVES PHARM   
% 214.37/214.55  |- skos__historyNote mesh__D011310 Pharmaceutic Aids %28%1968-1974%29%
% 214.37/214.55  |- mesh__recordOriginator mesh__D011310 NLM
% 214.37/214.55  |- skos__altLabel mesh__D011310 Preservatives, Pharmaceutic
% 214.37/214.55  |- mesh__onlineNote mesh__D011310 search PHARMACEUTIC AIDS 1968-74   
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D011310 2004
% 214.37/214.55  |- skos__broader mesh__D011310smesh__D010592
% 214.37/214.55  |- rdf__type mesh__D011310sskos__Concept
% 214.37/214.55  |- mesh__dateCreated mesh__D011310 1999-01-01
% 214.37/214.55  |- mesh__publicMeSHNote mesh__D011310
% 214.37/214.55       91; was see under PHARMACEUTIC AIDS 1975-90   
% 214.37/214.55  |- skos__related mesh__D011310smesh__D000975
% 214.37/214.55  |- skos__altLabel mesh__D011310 Pharmaceutic Preservative
% 214.37/214.55  |- skos__altLabel mesh__D011310 Pharmaceutical Preservative
% 214.37/214.55  |- skos__altLabel mesh__D011310 Pharmaceutic Aids %28%Preservatives%29%
% 214.37/214.55  |- mesh__dateRevised mesh__D011310 2003-07-25
% 214.37/214.55  |- skos__altLabel mesh__D011310 Pharmaceutical Preservatives
% 214.37/214.55  |- mesh__recordAuthorizer mesh__D011310 sjn
% 214.37/214.55  |- mesh__dateEstablished mesh__D011310 1991-01-01
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D011310 2006
% 214.37/214.55  |- skos__historyNote mesh__D011310 Pharmacy %28%1966-1967%29%
% 214.37/214.55  |- mesh__recordMaintainer mesh__D011310 sjn
% 214.37/214.55  |- skos__altLabel mesh__D011310 Pharmaceutic Preservatives
% 214.37/214.55  |- mesh__historyNote mesh__D011310
% 214.37/214.55       91%28%75%29%; was see under PHARMACEUTIC AIDS 1975-90   
% 214.37/214.55  |- skos__prefLabel mesh__D002584 Cervix Uteri
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D002584 2006
% 214.37/214.55  |- skos__related mesh__D002584smesh__D003127
% 214.37/214.55  |- skos__altLabel mesh__D002584 Uterine Cervix
% 214.37/214.55  |- mesh__onlineNote mesh__D002584
% 214.37/214.55       use CERVIX UTERI to search CERVIX HYPERTROPHY 1966-96   
% 214.37/214.55  |- skos__altLabel mesh__D002584 Cervixes
% 214.37/214.55  |- skos__broader mesh__D002584smesh__D014599
% 214.37/214.55  |- skos__annotation mesh__D002584
% 214.37/214.55       inflammation = CERVICITIS; conization = CERVIX UTERI /pathol %28%IM%29% + CONIZATION %28%IM%29%%A%  
% 214.37/214.55  |- skos__altLabel mesh__D002584 Cervix
% 214.37/214.55  |- mesh__publicMeSHNote mesh__D002584
% 214.37/214.55       CERVIX HYPERTROPHY was heading 1963-96   
% 214.37/214.55  |- skos__hiddenLabel mesh__D002584 Cervix, Uterine
% 214.37/214.55  |- mesh__historyNote mesh__D002584
% 214.37/214.55       CERVIX HYPERTROPHY was heading 1963-96   
% 214.37/214.55  |- mesh__dateRevised mesh__D002584 2003-07-09
% 214.37/214.55  |- mesh__recordOriginator mesh__D002584 NLM
% 214.37/214.55  |- rdf__type mesh__D002584sskos__Concept
% 214.37/214.55  |- mesh__recordMaintainer mesh__D002584 lkt
% 214.37/214.55  |- mesh__recordAuthorizer mesh__D002584 sjn
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D002584 2005
% 214.37/214.55  |- mesh__dateCreated mesh__D002584 1999-01-01
% 214.37/214.55  |- skos__scopeNote mesh__D002584
% 214.37/214.55       The neck portion of the UTERUS between the lower isthmus and the VAGINA forming the cervical canal.%A%    
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D002584 2004
% 214.37/214.55  |- skos__prefLabel mesh__D029721 Drosophila Proteins
% 214.37/214.55  |- skos__related mesh__D029721smesh__D004330
% 214.37/214.55  |- skos__annotation mesh__D029721
% 214.37/214.55       coord IM with specific protein %28%IM%29%   
% 214.37/214.55  |- mesh__dateCreated mesh__D029721 2001-08-03
% 214.37/214.55  |- mesh__publicMeSHNote mesh__D029721 2002   
% 214.37/214.55  |- skos__related mesh__D029721smesh__D004331
% 214.37/214.55  |- skos__broader mesh__D029721smesh__D019476
% 214.37/214.55  |- skos__scopeNote mesh__D029721
% 214.37/214.55       Proteins that originate from insect species belonging to the genus DROSOPHILA. The proteins from the most intensely studied species of Drosophila, DROSOPHILA MELANOGASTER, are the subject of much interest in the area of MORPHOGENESIS and development.%A%    
% 214.37/214.55  |- mesh__historyNote mesh__D029721 2002   
% 214.37/214.55  |- mesh__recordAuthorizer mesh__D029721 sjn
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D029721 2006
% 214.37/214.55  |- mesh__dateRevised mesh__D029721 2005-06-30
% 214.37/214.55  |- skos__historyNote mesh__D029721 Insect Proteins %28%1997-2001%29%
% 214.37/214.55  |- mesh__recordOriginator mesh__D029721 jmp
% 214.37/214.55  |- rdf__type mesh__D029721sskos__Concept
% 214.37/214.55  |- mesh__dateEstablished mesh__D029721 2002-01-01
% 214.37/214.55  |- mesh__recordMaintainer mesh__D029721 DRC
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D015701 2003
% 214.37/214.55  |- skos__historyNote mesh__D015701 Drowning %28%1966-1989%29%
% 214.37/214.55  |- skos__hiddenLabel mesh__D015701 Near Drownings
% 214.37/214.55  |- skos__broader mesh__D015701smesh__D004332
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D015701 2002
% 214.37/214.55  |- mesh__dateEstablished mesh__D015701 1990-01-01
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D015701 2001
% 214.37/214.55  |- skos__hiddenLabel mesh__D015701 Near-Drownings
% 214.37/214.55  |- skos__annotation mesh__D015701 only Cat C qualif if pertinent   
% 214.37/214.55  |- skos__hiddenLabel mesh__D015701 Drowning, Near
% 214.37/214.55  |- mesh__recordMaintainer mesh__D015701 jls
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D015701 2006
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D015701 2000
% 214.37/214.55  |- skos__prefLabel mesh__D015701 Near Drowning
% 214.37/214.55  |- mesh__dateRevised mesh__D015701 1999-11-03
% 214.37/214.55  |- mesh__recordAuthorizer mesh__D015701 sjn
% 214.37/214.55  |- skos__altLabel mesh__D015701 Near-Drowning
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D015701 2005
% 214.37/214.55  |- mesh__historyNote mesh__D015701 90   
% 214.37/214.55  |- mesh__publicMeSHNote mesh__D015701 90   
% 214.37/214.55  |- skos__scopeNote mesh__D015701
% 214.37/214.55       Non-fatal immersion or submersion in water. The subject is resuscitable.%A%    
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D015701 2004
% 214.37/214.55  |- rdf__type mesh__D015701sskos__Concept
% 214.37/214.55  |- mesh__dateCreated mesh__D015701 1989-05-25
% 214.37/214.55  |- skos__hiddenLabel mesh__D015701 Drownings, Near
% 214.37/214.55  |- mesh__recordOriginator mesh__D015701 TGC
% 214.37/214.55  |- skos__hiddenLabel mesh__D006975 Portal Hypertension
% 214.37/214.55  |- skos__hiddenLabel mesh__D006975 Portal Hypertensions
% 214.37/214.55  |- skos__prefLabel mesh__D006975 Hypertension, Portal
% 214.37/214.55  |- skos__broader mesh__D006975smesh__D008107
% 214.37/214.55  |- mesh__recordAuthorizer mesh__D006975 sjn
% 214.37/214.55  |- skos__hiddenLabel mesh__D006975 Hypertensions, Portal
% 214.37/214.55  |- skos__hiddenLabel mesh__D006975 Cruveilhier Baumgarten Syndrome
% 214.37/214.55  |- mesh__recordOriginator mesh__D006975 NLM
% 214.37/214.55  |- mesh__publicMeSHNote mesh__D006975
% 214.37/214.55       CRUVEILHIER-BAUMGARTEN SYNDROME was heading 1975-96 %28%see under HYPERTENSION, PORTAL 1979-90, see under LIVER CIRRHOSIS 1975-78%29%; was see under LIVER CIRRHOSIS 1963-74%A%  
% 214.37/214.55  |- skos__hiddenLabel mesh__D006975 Syndrome, Cruveilhier-Baumgarten
% 214.37/214.55  |- mesh__onlineNote mesh__D006975
% 214.37/214.55       use LIVER CIRRHOSIS to search CRUVEILHIER-BAUMGARTEN SYNDROME 1966-74%A%  
% 214.37/214.55  |- rdf__type mesh__D006975sskos__Concept
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D006975 2005
% 214.37/214.55  |- mesh__recordMaintainer mesh__D006975 lkt
% 214.37/214.55  |- mesh__dateCreated mesh__D006975 1999-01-01
% 214.37/214.55  |- mesh__historyNote mesh__D006975
% 214.37/214.55       CRUVEILHIER-BAUMGARTEN SYNDROME was heading 1975-96 %28%see under HYPERTENSION, PORTAL 1979-90, see under LIVER CIRRHOSIS 1975-78%29%; was see under LIVER CIRRHOSIS 1963-74%A%  
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D006975 2006
% 214.37/214.55  |- mesh__dateRevised mesh__D006975 2004-07-07
% 214.37/214.55  |- skos__related mesh__D006975smesh__D011170
% 214.37/214.55  |- skos__scopeNote mesh__D006975
% 214.37/214.55       Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.%A%    
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Nucleus, Paracentral Thalamic
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Nuclei, Rostral Intralaminar
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D020646 2004
% 214.37/214.55  |- skos__historyNote mesh__D020646 Thalamic Nuclei %28%1971-1999%29%
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Thalamic Nucleus, Centromedian
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Nucleus, Central Medial
% 214.37/214.55  |- rdf__type mesh__D020646sskos__Concept
% 214.37/214.55  |- skos__altLabel mesh__D020646 Central Dorsal Nucleus
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Nucleus, Central Dorsal
% 214.37/214.55  |- skos__broader mesh__D020646smesh__D013787
% 214.37/214.55  |- skos__altLabel mesh__D020646 Parafascicular Nucleus
% 214.37/214.55  |- skos__scopeNote mesh__D020646
% 214.37/214.55       Cell groups within the internal medullary lamina of the thalamus. They include a rostral division comprising the paracentral, central lateral, central dorsal, and central medial nuclei, and a caudal division composed of the centromedian and parafascicular nuclei.%A%    
% 214.37/214.55  |- mesh__dateEstablished mesh__D020646 2000-01-01
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D020646 2000
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Lateral Nucleus, Central
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Nuclei, Intralaminar Thalamic
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Thalamic Nucleus, Paracentral
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Nucleus, Centromedian Thalamic
% 214.37/214.55  |- mesh__publicMeSHNote mesh__D020646 2000   
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Thalamic Nuclei, Intralaminar
% 214.37/214.55  |- skos__altLabel mesh__D020646 Centromedian Nucleus
% 214.37/214.55  |- skos__historyNote mesh__D020646 Thalamus %28%1966-1970%29%
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Nucleus, Centromedian
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Nucleus, Parafascicular
% 214.37/214.55  |- skos__altLabel mesh__D020646 Intralaminar Nuclear Group
% 214.37/214.55  |- skos__prefLabel mesh__D020646 Intralaminar Thalamic Nuclei
% 214.37/214.55  |- skos__altLabel mesh__D020646 Paracentral Nucleus
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Nuclear Group, Intralaminar
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Thalamus Reticulate Nucleus
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D020646 2001
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D020646 2005
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Nucleus, Central Lateral
% 214.37/214.55  |- skos__altLabel mesh__D020646 Interlaminar Nuclei of Thalamus
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Thalamic Nucleus, Parafascicular
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Nucleus, Parafascicular Thalamic
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D020646 2002
% 214.37/214.55  |- skos__altLabel mesh__D020646 Central Lateral Nucleus
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Intralaminar Nuclei, Rostral
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D020646 2006
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Nucleus, Paracentral
% 214.37/214.55  |- skos__altLabel mesh__D020646 Central Medial Nucleus
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Nucleus, Intralaminar Thalamic
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D020646 2003
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Thalamic Nucleus, Intralaminar
% 214.37/214.55  |- mesh__dateCreated mesh__D020646 1999-11-03
% 214.37/214.55  |- skos__hiddenLabel mesh__D020646 Thalamus Interlaminar Nuclei
% 214.37/214.55  |- mesh__historyNote mesh__D020646 2000   
% 214.37/214.55  |- mesh__recordAuthorizer mesh__D006177 sjn
% 214.37/214.55  |- mesh__recordOriginator mesh__D006177 NLM
% 214.37/214.55  |- skos__altLabel mesh__D006177 Male Breast Enlargement
% 214.37/214.55  |- rdf__type mesh__D006177sskos__Concept
% 214.37/214.55  |- skos__altLabel mesh__D006177 Newborn Gynecomastia
% 214.37/214.55  |- mesh__recordMaintainer mesh__D006177 sjn
% 214.37/214.55  |- skos__hiddenLabel mesh__D006177 Gynecomastia, Adolescent
% 214.37/214.55  |- skos__broader mesh__D006177smesh__D001941
% 214.37/214.55  |- mesh__dateRevised mesh__D006177 2004-07-13
% 214.37/214.55  |- skos__hiddenLabel mesh__D006177 Breast Enlargement, Male
% 214.37/214.55  |- skos__hiddenLabel mesh__D006177 Gynecomastia, Newborn
% 214.37/214.55  |- skos__hiddenLabel mesh__D006177 Gynecomastia, Infant
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D006177 2005
% 214.37/214.55  |- skos__hiddenLabel mesh__D006177 Enlargement, Male Breast
% 214.37/214.55  |- skos__prefLabel mesh__D006177 Gynecomastia
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D006177 2006
% 214.37/214.55  |- mesh__dateCreated mesh__D006177 1999-01-01
% 214.37/214.55  |- skos__annotation mesh__D006177  check tags  HUMANS %26% MALE   
% 214.37/214.55  |- skos__scopeNote mesh__D006177
% 214.37/214.55       Enlargement of the BREAST in the males, caused by an excess of ESTROGENS. Physiological gynecomastia is normally observed in NEWBORNS; ADOLESCENT; and AGING males.%A%    
% 214.37/214.55  |- mesh__recordAuthorizer mesh__D014609 sjn
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D014609 2005
% 214.37/214.55  |- skos__hiddenLabel mesh__D014609 Uvulas
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D014609 2004
% 214.37/214.55  |- mesh__historyNote mesh__D014609
% 214.37/214.55       65%28%63%29%; was see under PALATE 1963-64   
% 214.37/214.55  |- skos__prefLabel mesh__D014609 Uvula
% 214.37/214.55  |- skos__broader mesh__D014609smesh__D010160
% 214.37/214.55  |- mesh__dateCreated mesh__D014609 1999-01-01
% 214.37/214.55  |- mesh__recordMaintainer mesh__D014609 lkt
% 214.37/214.55  |- rdf__type mesh__D014609sskos__Concept
% 214.37/214.55  |- mesh__dateRevised mesh__D014609 2003-07-09
% 214.37/214.55  |- mesh__recordOriginator mesh__D014609 NLM
% 214.37/214.55  |- mesh__dateEstablished mesh__D014609 1965-01-01
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D014609 2006
% 214.37/214.55  |- mesh__publicMeSHNote mesh__D014609 65; was see under PALATE 1963-64   
% 214.37/214.55  |- mesh__recordMaintainer mesh__D011311 RAZ
% 214.37/214.55  |- skos__prefLabel mesh__D011311 Pressoreceptors
% 214.37/214.55  |- mesh__recordOriginator mesh__D011311 NLM
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D011311 2001
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D011311 1996
% 214.37/214.55  |- skos__hiddenLabel mesh__D011311 Receptors, Vascular Stretch
% 214.37/214.55  |- skos__annotation mesh__D011311
% 214.37/214.55       mechanoreceptors of the vasomotor system; DF: PRESSORECEPT%A%  
% 214.37/214.55  |- skos__hiddenLabel mesh__D011311 Baroreceptor
% 214.37/214.55  |- skos__hiddenLabel mesh__D011311 Receptor, Arterial Stretch
% 214.37/214.55  |- mesh__dateCreated mesh__D011311 1999-01-01
% 214.37/214.55  |- rdf__type mesh__D011311sskos__Concept
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D011311 2002
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D011311 1997
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D011311 2003
% 214.37/214.55  |- skos__altLabel mesh__D011311 Receptors, Stretch, Arterial
% 214.37/214.55  |- mesh__recordAuthorizer mesh__D011311 PLS
% 214.37/214.55  |- skos__hiddenLabel mesh__D011311 Vascular Stretch Receptors
% 214.37/214.55  |- skos__altLabel mesh__D011311 Stretch Receptors, Arterial
% 214.37/214.55  |- mesh__historyNote mesh__D011311 65   
% 214.37/214.55  |- skos__hiddenLabel mesh__D011311 Stretch Receptor, Vascular
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D011311 1998
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D011311 2004
% 214.37/214.55  |- skos__broader mesh__D011311smesh__D008465
% 214.37/214.55  |- mesh__dateRevised mesh__D011311 1993-06-18
% 214.37/214.55  |- skos__hiddenLabel mesh__D011311 Receptors, Arterial Stretch
% 214.37/214.55  |- skos__hiddenLabel mesh__D011311 Arterial Stretch Receptor
% 214.37/214.55  |- mesh__publicMeSHNote mesh__D011311 65   
% 214.37/214.55  |- skos__hiddenLabel mesh__D011311 Pressoreceptor
% 214.37/214.55  |- skos__related mesh__D011311smesh__D017704
% 214.37/214.55  |- skos__altLabel mesh__D011311 Stretch Receptors, Vascular
% 214.37/214.55  |- skos__altLabel mesh__D011311 Receptors, Stretch, Vascular
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D011311 1994
% 214.37/214.55  |- skos__hiddenLabel mesh__D011311 Vascular Stretch Receptor
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D011311 1999
% 214.37/214.55  |- skos__hiddenLabel mesh__D011311 Stretch Receptor, Arterial
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D011311 2005
% 214.37/214.55  |- skos__hiddenLabel mesh__D011311 Receptor, Vascular Stretch
% 214.37/214.55  |- skos__scopeNote mesh__D011311
% 214.37/214.55       Receptors in the vascular system, particularly the aorta and carotid sinus, which are sensitive to stretch of the vessel walls.%A%    
% 214.37/214.55  |- skos__broader mesh__D011311smesh__D014666
% 214.37/214.55  |- mesh__activeMeSHYear mesh__D011311 1995
% 214.37/214.55  |- skos__altLabel mesh__D011311 Baroreceptors
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D011311 2000
% 214.37/214.56  |- mesh__dateEstablished mesh__D011311 1965-01-01
% 214.37/214.56  |- skos__hiddenLabel mesh__D011311 Arterial Stretch Receptors
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D011311 2006
% 214.37/214.56  |- skos__scopeNote mesh__D002585
% 214.37/214.56       Extraction of the FETUS by means of abdominal HYSTEROTOMY.%A%    
% 214.37/214.56  |- skos__altLabel mesh__D002585 C-Section %28%OB%29%
% 214.37/214.56  |- mesh__recordOriginator mesh__D002585 NLM
% 214.37/214.56  |- skos__altLabel mesh__D002585 Caesarean Section
% 214.37/214.56  |- mesh__dateRevised mesh__D002585 2004-07-07
% 214.37/214.56  |- skos__hiddenLabel mesh__D002585 Cesarean Sections
% 214.37/214.56  |- mesh__recordAuthorizer mesh__D002585 sjn
% 214.37/214.56  |- skos__hiddenLabel mesh__D002585 Caesarean Sections
% 214.37/214.56  |- skos__hiddenLabel mesh__D002585 C-Sections %28%OB%29%
% 214.37/214.56  |- rdf__type mesh__D002585sskos__Concept
% 214.37/214.56  |- skos__annotation mesh__D002585
% 214.37/214.56       check the tags FEMALE %26% PREGNANCY; anesthesia in cesareans: coord IM with ANESTHESIA, OBSTETRICAL %28%IM%29%%A%  
% 214.37/214.56  |- skos__hiddenLabel mesh__D002585 Abdominal Deliveries
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D002585 2005
% 214.37/214.56  |- mesh__dateCreated mesh__D002585 1999-01-01
% 214.37/214.56  |- skos__hiddenLabel mesh__D002585 Deliveries, Abdominal
% 214.37/214.56  |- skos__broader mesh__D002585smesh__D036861
% 214.37/214.56  |- skos__altLabel mesh__D002585 Delivery, Abdominal
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D002585 2006
% 214.37/214.56  |- skos__prefLabel mesh__D002585 Cesarean Section
% 214.37/214.56  |- skos__related mesh__D002585smesh__D016064
% 214.37/214.56  |- mesh__recordMaintainer mesh__D002585 lkt
% 214.37/214.56  |- skos__hiddenLabel mesh__D002585 C Section %28%OB%29%
% 214.37/214.56  |- skos__altLabel mesh__D002585 Abdominal Delivery
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D010219 1996
% 214.37/214.56  |- mesh__recordAuthorizer mesh__D010219 PLS
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D010219 2000
% 214.37/214.56  |- skos__broader mesh__D010219smesh__D008542
% 214.37/214.56  |- skos__altLabel mesh__D010219 New Guinea, East
% 214.37/214.56  |- skos__annotation mesh__D010219
% 214.37/214.56       read MeSH definition for hist %26% geog scope; Papuans are of NEGROID RACE unless otherwise specified%A%  
% 214.37/214.56  |- skos__scopeNote mesh__D010219
% 214.37/214.56       A country consisting of the eastern half of the island of New Guinea and adjacent islands, including New Britain, New Ireland, the Admiralty Islands, and New Hanover in the Bismarck Archipelago; Bougainville and Buka in the northern Solomon Islands; the D%27%Entrecasteaux and Trobriand Islands; Woodlark %28%Murua%29% Island; and the Louisiade Archipelago. It became independent on September 16, 1975. Formerly, the southern part was the Australian Territory of Papua, and the northern part was the UN Trust Territory of New Guinea, administered by Australia. They were administratively merged in 1949 and named Papua and New Guinea, and renamed Papua New Guinea in 1971.%A%    
% 214.37/214.56  |- mesh__dateRevised mesh__D010219 1993-06-02
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D010219 2006
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D010219 2002
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D010219 2004
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D010219 1995
% 214.37/214.56  |- mesh__dateEstablished mesh__D010219 1982-01-01
% 214.37/214.56  |- skos__altLabel mesh__D010219 New Guinea, Papua
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D010219 2005
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D010219 1999
% 214.37/214.56  |- rdf__type mesh__D010219sskos__Concept
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D010219 2003
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D010219 1997
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D010219 1994
% 214.37/214.56  |- mesh__recordOriginator mesh__D010219 SMH
% 214.37/214.56  |- mesh__historyNote mesh__D010219 82   
% 214.37/214.56  |- skos__prefLabel mesh__D010219 Papua New Guinea
% 214.37/214.56  |- mesh__dateCreated mesh__D010219 1981-03-02
% 214.37/214.56  |- mesh__recordMaintainer mesh__D010219 TGC
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D010219 1998
% 214.37/214.56  |- skos__historyNote mesh__D010219 New Guinea %28%1966-1981%29%
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D010219 2001
% 214.37/214.56  |- mesh__publicMeSHNote mesh__D007270 66   
% 214.37/214.56  |- rdf__type mesh__D007270sskos__Concept
% 214.37/214.56  |- skos__prefLabel mesh__D007270 Injections, Intra-Articular
% 214.37/214.56  |- skos__altLabel mesh__D007270 Intraarticular Injections
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007270 2000
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007270 1991
% 214.37/214.56  |- skos__altLabel mesh__D007270 Intra-Articular Injections
% 214.37/214.56  |- skos__hiddenLabel mesh__D007270 Injections, Intra Articular
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007270 2003
% 214.37/214.56  |- skos__hiddenLabel mesh__D007270 Injection, Intraarticular
% 214.37/214.56  |- skos__hiddenLabel mesh__D007270 Intra Articular Injections
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007270 2001
% 214.37/214.56  |- mesh__recordAuthorizer mesh__D007270 PLS
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007270 2005
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007270 1996
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007270 2004
% 214.37/214.56  |- skos__broader mesh__D007270smesh__D007267
% 214.37/214.56  |- mesh__dateCreated mesh__D007270 1999-01-01
% 214.37/214.56  |- skos__hiddenLabel mesh__D007270 Intraarticular Injection
% 214.37/214.56  |- skos__altLabel mesh__D007270 Injections, Intraarticular
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007270 2006
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007270 1992
% 214.37/214.56  |- mesh__historyNote mesh__D007270 66%28%64%29%   
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007270 1998
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007270 1997
% 214.37/214.56  |- mesh__recordOriginator mesh__D007270 NLM
% 214.37/214.56  |- skos__hiddenLabel mesh__D007270 Injection, Intra-Articular
% 214.37/214.56  |- mesh__dateRevised mesh__D007270 1990-06-01
% 214.37/214.56  |- mesh__dateEstablished mesh__D007270 1966-01-01
% 214.37/214.56  |- mesh__recordMaintainer mesh__D007270 TGC
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007270 1994
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007270 2002
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007270 1993
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007270 1999
% 214.37/214.56  |- skos__annotation mesh__D007270
% 214.37/214.56       NIM; do not use /util except by MeSH definition; INJECT INTRA ARTICULAR%A%  
% 214.37/214.56  |- skos__hiddenLabel mesh__D007270 Intra-Articular Injection
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007270 1995
% 214.37/214.56  |- skos__prefLabel mesh__D006976 Hypertension, Pulmonary
% 214.37/214.56  |- skos__scopeNote mesh__D006976
% 214.37/214.56       Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.%A%    
% 214.37/214.56  |- skos__hiddenLabel mesh__D006976 Syndrome, Ayerza-Arrilaga
% 214.37/214.56  |- skos__altLabel mesh__D006976 Ayerza%27%s Syndrome
% 214.37/214.56  |- skos__hiddenLabel mesh__D006976 Ayerza Arrilaga Syndrome
% 214.37/214.56  |- skos__altLabel mesh__D006976 Ayerza-Arrilaga Syndrome
% 214.37/214.56  |- skos__related mesh__D006976smesh__D011660
% 214.37/214.56  |- skos__hiddenLabel mesh__D006976 Syndrome, Ayerza
% 214.37/214.56  |- rdf__type mesh__D006976sskos__Concept
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D006976 2005
% 214.37/214.56  |- skos__broader mesh__D006976smesh__D008171
% 214.37/214.56  |- skos__hiddenLabel mesh__D006976 Ayerzas Syndrome
% 214.37/214.56  |- mesh__historyNote mesh__D006976
% 214.37/214.56       AYERZA%27%S SYNDROME was heading 1963-83   
% 214.37/214.56  |- mesh__onlineNote mesh__D006976
% 214.37/214.56       use HYPERTENSION, PULMONARY to search AYERZA%27%S SYNDROME 1966-83%A%  
% 214.37/214.56  |- mesh__recordAuthorizer mesh__D006976 sjn
% 214.37/214.56  |- mesh__dateCreated mesh__D006976 1999-01-01
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D006976 2006
% 214.37/214.56  |- mesh__dateRevised mesh__D006976 2004-07-07
% 214.37/214.56  |- mesh__recordOriginator mesh__D006976 NLM
% 214.37/214.56  |- skos__altLabel mesh__D006976 Pulmonary Hypertension
% 214.37/214.56  |- mesh__recordMaintainer mesh__D006976 lkt
% 214.37/214.56  |- skos__hiddenLabel mesh__D020647 Nucleus, Laterodorsal Thalamic
% 214.37/214.56  |- skos__historyNote mesh__D020647 Thalamic Nuclei %28%1971-1999%29%
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D020647 2000
% 214.37/214.56  |- skos__altLabel mesh__D020647 Laterodorsal Thalamic Nucleus
% 214.37/214.56  |- skos__hiddenLabel mesh__D020647 Nucleus, Lateral Thalamic
% 214.37/214.56  |- skos__altLabel mesh__D020647 Lateral Dorsal Nucleus
% 214.37/214.56  |- mesh__historyNote mesh__D020647 2000   
% 214.37/214.56  |- skos__altLabel mesh__D020647 Lateral Nuclear Group
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D020647 2001
% 214.37/214.56  |- skos__altLabel mesh__D020647 Lateral Posterior Nucleus
% 214.37/214.56  |- skos__hiddenLabel mesh__D020647 Nucleus, Lateral Posterior
% 214.37/214.56  |- mesh__dateCreated mesh__D020647 1999-11-08
% 214.37/214.56  |- skos__hiddenLabel mesh__D020647 Thalamic Nuclei, Lateral
% 214.37/214.56  |- skos__scopeNote mesh__D020647
% 214.37/214.56       A narrow strip of cell groups on the dorsomedial surface of the thalamus. It includes the lateral dorsal nucleus, lateral posterior nucleus, and the PULVINAR.%A%    
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D020647 2003
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D020647 2002
% 214.37/214.56  |- skos__hiddenLabel mesh__D020647 Nuclear Group, Lateral
% 214.37/214.56  |- skos__broader mesh__D020647smesh__D013787
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D020647 2004
% 214.37/214.56  |- rdf__type mesh__D020647sskos__Concept
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D020647 2005
% 214.37/214.56  |- skos__prefLabel mesh__D020647 Lateral Thalamic Nuclei
% 214.37/214.56  |- skos__hiddenLabel mesh__D020647 Nuclei, Lateral Thalamic
% 214.37/214.56  |- mesh__publicMeSHNote mesh__D020647 2000   
% 214.37/214.56  |- skos__hiddenLabel mesh__D020647 Nucleus, Lateral Dorsal
% 214.37/214.56  |- mesh__dateEstablished mesh__D020647 2000-01-01
% 214.37/214.56  |- skos__hiddenLabel mesh__D020647 Thalamic Nucleus, Laterodorsal
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D020647 2006
% 214.37/214.56  |- mesh__dateEstablished mesh__D006178 1991-01-01
% 214.37/214.56  |- skos__historyNote mesh__D006178 Ethnic Groups %28%1968-1978%29%
% 214.37/214.56  |- skos__broader mesh__D006178smesh__D005006
% 214.37/214.56  |- mesh__dateCreated mesh__D006178 1978-04-28
% 214.37/214.56  |- skos__altLabel mesh__D006178 Gipsies
% 214.37/214.56  |- mesh__recordOriginator mesh__D006178 SMH
% 214.37/214.56  |- rdf__type mesh__D006178sskos__Concept
% 214.37/214.56  |- skos__scopeNote mesh__D006178
% 214.37/214.56       Ethnic group originating in India and entering Europe in the 14th or 15th century.%A%    
% 214.37/214.56  |- skos__historyNote mesh__D006178 Caucasoid Race %28%1966-1978%29%
% 214.37/214.56  |- mesh__recordAuthorizer mesh__D006178 sjn
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D006178 2004
% 214.37/214.56  |- mesh__publicMeSHNote mesh__D006178
% 214.37/214.56       91; was see under ETHNIC GROUPS 1979-90   
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D006178 2005
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D006178 2006
% 214.37/214.56  |- skos__prefLabel mesh__D006178 Gypsies
% 214.37/214.56  |- skos__altLabel mesh__D006178 Romany
% 214.37/214.56  |- mesh__historyNote mesh__D006178
% 214.37/214.56       91%28%79%29%; was see under ETHNIC GROUPS 1979-90   
% 214.37/214.56  |- mesh__dateRevised mesh__D006178 2003-07-09
% 214.37/214.56  |- skos__annotation mesh__D006178
% 214.37/214.56       use this spelling in translations; specify geog   
% 214.37/214.56  |- skos__historyNote mesh__D006178 Ethnology %28%1966-1967%29%
% 214.37/214.56  |- mesh__recordMaintainer mesh__D006178 jls
% 214.37/214.56  |- rdf__type mesh__D011312sskos__Concept
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D011312 2002
% 214.37/214.56  |- skos__related mesh__D011312smesh__D001794
% 214.37/214.56  |- skos__related mesh__D011312smesh__D001274
% 214.37/214.56  |- mesh__dateCreated mesh__D011312 1999-01-01
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D011312 2004
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D011312 1995
% 214.37/214.56  |- mesh__recordOriginator mesh__D011312 NLM
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D011312 2001
% 214.37/214.56  |- mesh__historyNote mesh__D011312 68%28%64%29%   
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D011312 2003
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D011312 1999
% 214.37/214.56  |- mesh__dateEstablished mesh__D011312 1968-01-01
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D011312 1994
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D011312 2000
% 214.37/214.56  |- mesh__recordAuthorizer mesh__D011312 PLS
% 214.37/214.56  |- mesh__recordMaintainer mesh__D011312 TGC
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D011312 1998
% 214.37/214.56  |- mesh__dateRevised mesh__D011312 1992-12-28
% 214.37/214.56  |- skos__annotation mesh__D011312
% 214.37/214.56       NIM; spinal or cerebrospinal fluid pressure = CEREBROSPINAL FLUID PRESSURE; pressure within heart ventricles = VENTRICULAR PRESSURE%A%  
% 214.37/214.56  |- skos__related mesh__D011312smesh__D008365
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D011312 1997
% 214.37/214.56  |- mesh__publicMeSHNote mesh__D011312 68   
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D011312 2006
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D011312 1996
% 214.37/214.56  |- skos__broader mesh__D011312smesh__D010825
% 214.37/214.56  |- skos__hiddenLabel mesh__D011312 Pressures
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D011312 2005
% 214.37/214.56  |- skos__prefLabel mesh__D011312 Pressure
% 214.37/214.56  |- rdf__type mesh__D002586sskos__Concept
% 214.37/214.56  |- skos__broader mesh__D002586smesh__D019216
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D002586 2003
% 214.37/214.56  |- skos__broader mesh__D002586smesh__D008672
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D002586 2005
% 214.37/214.56  |- mesh__recordOriginator mesh__D002586 NLM
% 214.37/214.56  |- mesh__dateCreated mesh__D002586 1999-01-01
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D002586 2004
% 214.37/214.56  |- mesh__recordMaintainer mesh__D002586 ADP
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D002586 2006
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D002586 2000
% 214.37/214.56  |- skos__prefLabel mesh__D002586 Cesium
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D002586 2001
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D002586 1998
% 214.37/214.56  |- skos__scopeNote mesh__D002586
% 214.37/214.56       A member of the alkali metals. It has an atomic symbol Cs, atomic number 50, and atomic weight 132.91. Cesium has many industrial applications, including the construction of atomic clocks based on its atomic vibrational frequency.%A%    
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D002586 1999
% 214.37/214.56  |- mesh__recordAuthorizer mesh__D002586 SJN
% 214.37/214.56  |- skos__related mesh__D002586smesh__D002588
% 214.37/214.56  |- mesh__dateRevised mesh__D002586 1997-06-20
% 214.37/214.56  |- skos__annotation mesh__D002586 an alkali metal; Cs-133   
% 214.37/214.56  |- skos__related mesh__D002586smesh__D002587
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D002586 2002
% 214.37/214.56  |- skos__prefLabel mesh__D007271 Injections, Intradermal
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007271 2002
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007271 2003
% 214.37/214.56  |- mesh__recordMaintainer mesh__D007271 PLS
% 214.37/214.56  |- skos__broader mesh__D007271smesh__D007279
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007271 2005
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007271 1996
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007271 2004
% 214.37/214.56  |- mesh__dateCreated mesh__D007271 1999-01-01
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007271 2000
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007271 1991
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007271 1992
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007271 1998
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007271 2006
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007271 1997
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007271 2001
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007271 1994
% 214.37/214.56  |- skos__scopeNote mesh__D007271
% 214.37/214.56       The forcing into the skin of liquid medication, nutrient, or other fluid through a hollow needle, piercing the top skin layer.%A%    
% 214.37/214.56  |- skos__hiddenLabel mesh__D007271 Intradermal Injection
% 214.37/214.56  |- mesh__recordAuthorizer mesh__D007271 PLS
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007271 1993
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007271 1999
% 214.37/214.56  |- skos__annotation mesh__D007271
% 214.37/214.56       NIM; do not use /util except by MeSH definition; DF: INJECT INTRADERMAL%A%  
% 214.37/214.56  |- mesh__historyNote mesh__D007271
% 214.37/214.56       91%28%87%29%66%28%64%29%; was see under INJECTIONS, SUBCUTANEOUS 1987-90; was heading 1966-86; was Prov 1964-65%A%  
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D007271 1995
% 214.37/214.56  |- rdf__type mesh__D007271sskos__Concept
% 214.37/214.56  |- mesh__recordOriginator mesh__D007271 NLM
% 214.37/214.56  |- mesh__publicMeSHNote mesh__D007271
% 214.37/214.56       91,66-86; was see under INJECTIONS, SUBCUTANEOUS 1987-90; was heading 1966-86%A%  
% 214.37/214.56  |- skos__hiddenLabel mesh__D007271 Injection, Intradermal
% 214.37/214.56  |- skos__altLabel mesh__D007271 Intradermal Injections
% 214.37/214.56  |- mesh__dateRevised mesh__D007271 1990-06-01
% 214.37/214.56  |- mesh__dateEstablished mesh__D007271 1966-01-01
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D048688 2005
% 214.37/214.56  |- rdf__type mesh__D048688sskos__Concept
% 214.37/214.56  |- mesh__dateEstablished mesh__D048688 2005-01-01
% 214.37/214.56  |- skos__hiddenLabel mesh__D048688 Protein Kinase, MAPKK7
% 214.37/214.56  |- skos__altLabel mesh__D048688 Mitogen-Activated Protein Kinase Kinase 7
% 214.37/214.56  |- skos__altLabel mesh__D048688 MEK7 Protein Kinase
% 214.37/214.56  |- mesh__publicMeSHNote mesh__D048688
% 214.37/214.56       2005; MAP KINASE KINASE KINASE 7 was indexed under MITOGEN-ACTIVATED PROTEIN KINASE KINASES 2000-2004 %26% under PROTEIN KINASES 1997-1999%A%  
% 214.37/214.56  |- skos__hiddenLabel mesh__D048688 JNK Activating Kinase 2
% 214.37/214.56  |- mesh__recordAuthorizer mesh__D048688 sjn
% 214.37/214.56  |- mesh__recordOriginator mesh__D048688 jmp
% 214.37/214.56  |- skos__broader mesh__D048688smesh__D020929
% 214.37/214.56  |- skos__hiddenLabel mesh__D048688 Protein Kinase, SKK4
% 214.37/214.56  |- mesh__recordMaintainer mesh__D048688 jmp
% 214.37/214.56  |- skos__altLabel mesh__D048688 SEK2 Protein Kinase
% 214.37/214.56  |- skos__altLabel mesh__D048688 PRKMK7
% 214.37/214.56  |- skos__historyNote mesh__D048688
% 214.37/214.56       Mitogen-Activated Protein Kinase Kinases %28%2000-2004%29%
% 214.37/214.56  |- skos__altLabel mesh__D048688 SKK4 Protein Kinase
% 214.37/214.56  |- skos__altLabel mesh__D048688 JNK-Activating Kinase 2
% 214.37/214.56  |- skos__hiddenLabel mesh__D048688 Protein Kinase, SEK2
% 214.37/214.56  |- skos__historyNote mesh__D048688 Protein Kinases %28%1997-1999%29%
% 214.37/214.56  |- skos__altLabel mesh__D048688 MAPKK7 Protein Kinase
% 214.37/214.56  |- skos__hiddenLabel mesh__D048688
% 214.37/214.56       Mitogen Activated Protein Kinase Kinase 7
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D048688 2006
% 214.37/214.56  |- skos__hiddenLabel mesh__D048688 Protein Kinase, MEK7
% 214.37/214.56  |- mesh__dateCreated mesh__D048688 2004-07-07
% 214.37/214.56  |- skos__scopeNote mesh__D048688
% 214.37/214.56       A mitogen-activated protein kinase kinase with specificity for JNK MITOGEN-ACTIVATED PROTEIN KINASES. It takes part in a SIGNAL TRANSDUCTION pathway that is activated in response to CYTOKINES.%A%    
% 214.37/214.56  |- skos__prefLabel mesh__D048688 MAP Kinase Kinase 7
% 214.37/214.56  |- mesh__historyNote mesh__D048688 2005%28%1997%29%   
% 214.37/214.56  |- mesh__recordMaintainer mesh__D015703 ssb
% 214.37/214.56  |- skos__altLabel mesh__D015703 Differentiation Antigens, Leukocyte, Human
% 214.37/214.56  |- mesh__historyNote mesh__D015703 90   
% 214.37/214.56  |- skos__hiddenLabel mesh__D015703 CD Antigens
% 214.37/214.56  |- mesh__recordOriginator mesh__D015703 AGS
% 214.37/214.56  |- mesh__recordAuthorizer mesh__D015703 sjn
% 214.37/214.56  |- skos__historyNote mesh__D015703
% 214.37/214.56       Antigens, Differentiation, T-Lymphocyte %28%1988-1989%29%
% 214.37/214.56  |- rdf__type mesh__D015703sskos__Concept
% 214.37/214.56  |- mesh__dateCreated mesh__D015703 1989-05-15
% 214.37/214.56  |- mesh__publicMeSHNote mesh__D015703 90   
% 214.37/214.56  |- skos__historyNote mesh__D015703
% 214.37/214.56       Antigens, Differentiation %28%1988-1989%29%
% 214.37/214.56  |- skos__scopeNote mesh__D015703
% 214.37/214.56       Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation.%A%    
% 214.37/214.56  |- skos__prefLabel mesh__D015703 Antigens, CD
% 214.37/214.56  |- mesh__dateRevised mesh__D015703 2005-06-30
% 214.37/214.56  |- mesh__dateEstablished mesh__D015703 1990-01-01
% 214.37/214.56  |- skos__broader mesh__D015703smesh__D000943
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D015703 2006
% 214.37/214.56  |- mesh__recordAuthorizer mesh__D006977 sjn
% 214.37/214.56  |- rdf__type mesh__D006977sskos__Concept
% 214.37/214.56  |- skos__hiddenLabel mesh__D006977 Renal Hypertension
% 214.37/214.56  |- mesh__recordOriginator mesh__D006977 NLM
% 214.37/214.56  |- mesh__recordMaintainer mesh__D006977 lkt
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D006977 2005
% 214.37/214.56  |- skos__scopeNote mesh__D006977
% 214.37/214.56       Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN.%A%    
% 214.37/214.56  |- mesh__dateCreated mesh__D006977 1999-01-01
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D006977 2006
% 214.37/214.56  |- mesh__dateRevised mesh__D006977 2004-07-07
% 214.37/214.56  |- skos__broader mesh__D006977smesh__D007674
% 214.37/214.56  |- skos__hiddenLabel mesh__D006977 Renal Hypertensions
% 214.37/214.56  |- skos__prefLabel mesh__D006977 Hypertension, Renal
% 214.37/214.56  |- skos__hiddenLabel mesh__D006977 Hypertensions, Renal
% 214.37/214.56  |- skos__broader mesh__D006977smesh__D006973
% 214.37/214.56  |- skos__annotation mesh__D006977
% 214.37/214.56       coord IM with specific kidney dis %28%IM%29% if pertinent; Goldblatt hypertension or Goldblatt kidney is HYPERTENSION, GOLDBLATT see HYPERTENSION, RENOVASCULAR%A%  
% 214.37/214.56  |- skos__altLabel mesh__D020648 EF-1gamma
% 214.37/214.56  |- mesh__recordAuthorizer mesh__D020648 sjn
% 214.37/214.56  |- skos__hiddenLabel mesh__D020648 EF 1beta
% 214.37/214.56  |- skos__altLabel mesh__D020648 EF-1H
% 214.37/214.56  |- skos__altLabel mesh__D020648 EF-1delta
% 214.37/214.56  |- skos__altLabel mesh__D020648 EF-1beta
% 214.37/214.56  |- mesh__recordMaintainer mesh__D020648 ssb
% 214.37/214.56  |- skos__hiddenLabel mesh__D020648 EF 1H
% 214.37/214.56  |- mesh__publicMeSHNote mesh__D020648
% 214.37/214.56       2000; ELONGATION FACTOR 1 was indexed under PEPTIDE ELONGATION FACTORS 1980-1999; ELONGATION FACTOR 1GAMMA was indexed under PEPTIDE ELONGATION FACTORS 1994-1999%A%  
% 214.37/214.56  |- skos__historyNote mesh__D020648
% 214.37/214.56       Peptide Elongation Factors %28%1973-1999%29%
% 214.37/214.56  |- mesh__recordOriginator mesh__D020648 jmp
% 214.37/214.56  |- skos__altLabel mesh__D020648 EF-1
% 214.37/214.56  |- skos__hiddenLabel mesh__D020648 EF 1gamma
% 214.37/214.56  |- skos__hiddenLabel mesh__D020648 EF 1delta
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D020648 2005
% 214.37/214.56  |- skos__hiddenLabel mesh__D020648 EF 1alpha
% 214.37/214.56  |- skos__hiddenLabel mesh__D020648 1, EF
% 214.37/214.56  |- mesh__dateRevised mesh__D020648 2003-07-25
% 214.37/214.56  |- mesh__dateCreated mesh__D020648 1999-11-04
% 214.37/214.56  |- skos__broader mesh__D020648smesh__D020963
% 214.37/214.56  |- skos__altLabel mesh__D020648 Elongation Factor 1
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D020648 2004
% 214.37/214.56  |- skos__altLabel mesh__D020648 EF-1alpha
% 214.37/214.56  |- mesh__dateEstablished mesh__D020648 2000-01-01
% 214.37/214.56  |- rdf__type mesh__D020648sskos__Concept
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D020648 2006
% 214.37/214.56  |- skos__prefLabel mesh__D020648 Peptide Elongation Factor 1
% 214.37/214.56  |- mesh__historyNote mesh__D020648
% 214.37/214.56       2000; for ELONGATION FACTOR 1 use PEPTIDE ELONGATION FACTOR 1 %28%NM%29% 1980-1999; for ELONGATION FACTOR 1GAMMA use PEPTIDE ELONGATION FACTOR 1 %28%NM%29% 1994-1999%A%  
% 214.37/214.56  |- skos__scopeNote mesh__D020648
% 214.37/214.56       Peptide elongation factor 1 is a multisubunit protein that is responsible for the GTP-dependent binding of aminoacyl-tRNAs to eukaryotic ribosomes. The alpha subunit %28%EF-1alpha%29% binds aminoacyl-tRNA and transfers it to the ribosome in a process linked to GTP hydrolysis. The beta and delta subunits %28%EF-1beta, EF-1delta%29% are involved in exchanging GDP for GTP. The gamma subunit %28%EF-1gamma%29% is a structural component.%A%    
% 214.37/214.56  |- skos__altLabel mesh__D020648 EF 1
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D006179 2005
% 214.37/214.56  |- mesh__recordMaintainer mesh__D006179 TAP
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D006179 1994
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D006179 2000
% 214.37/214.56  |- skos__altLabel mesh__D006179 Gyrus, Cingulate
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D006179 2004
% 214.37/214.56  |- skos__altLabel mesh__D006179 Cingulate Gyrus
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D006179 1999
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D006179 1993
% 214.37/214.56  |- rdf__type mesh__D006179sskos__Concept
% 214.37/214.56  |- skos__scopeNote mesh__D006179
% 214.37/214.56       One of the convolutions on the medial surface of the cerebral hemisphere. It surrounds the rostral part of the brain and interhemispheric commissure and forms part of the limbic system.%A%    
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D006179 2003
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D006179 1998
% 214.37/214.56  |- mesh__dateCreated mesh__D006179 1999-01-01
% 214.37/214.56  |- mesh__dateRevised mesh__D006179 1992-05-15
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D006179 2002
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D006179 1997
% 214.37/214.56  |- mesh__recordOriginator mesh__D006179 NLM
% 214.37/214.56  |- skos__broader mesh__D006179smesh__D008032
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D006179 2006
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D006179 2001
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D006179 1996
% 214.37/214.56  |- mesh__recordAuthorizer mesh__D006179 PLS
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D006179 1995
% 214.37/214.56  |- skos__prefLabel mesh__D006179 Gyrus Cinguli
% 214.37/214.56  |- rdf__type mesh__D011313sskos__Concept
% 214.37/214.56  |- skos__scopeNote mesh__D011313
% 214.37/214.56       The branch of dentistry concerned with the prevention of disease and the maintenance and promotion of oral health.%A%    
% 214.37/214.56  |- skos__related mesh__D011313smesh__D003740
% 214.37/214.56  |- mesh__dateRevised mesh__D011313 2003-07-09
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D011313 2004
% 214.37/214.56  |- mesh__recordMaintainer mesh__D011313 nns
% 214.37/214.56  |- mesh__recordAuthorizer mesh__D011313 sjn
% 214.37/214.56  |- skos__annotation mesh__D011313
% 214.37/214.56       SPEC only: SPEC qualif; spec concerned with prev of tooth %26% mouth dis: do not confuse with TOOTH DISEASES /prev or MOUTH DISEASES /prev; see note under DENTAL CARE; for %22%see your dentist twice a year%22%; do not confuse with DENTAL PROPHYLAXIS %28%see note there%29% or ORAL HYGIENE %28%see note there%29%%A%  
% 214.37/214.56  |- mesh__historyNote mesh__D011313 65   
% 214.37/214.56  |- skos__hiddenLabel mesh__D011313 Dentistries, Preventive
% 214.37/214.56  |- skos__hiddenLabel mesh__D011313 Dentistry, Preventive
% 214.37/214.56  |- skos__broader mesh__D011313smesh__D003813
% 214.37/214.56  |- skos__hiddenLabel mesh__D011313 Preventive Dentistries
% 214.37/214.56  |- skos__related mesh__D011313smesh__D011322
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D011313 2005
% 214.37/214.56  |- mesh__recordOriginator mesh__D011313 NLM
% 214.37/214.56  |- mesh__dateCreated mesh__D011313 1999-01-01
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D011313 2006
% 214.37/214.56  |- mesh__publicMeSHNote mesh__D011313 65   
% 214.37/214.56  |- mesh__dateEstablished mesh__D011313 1965-01-01
% 214.37/214.56  |- skos__prefLabel mesh__D011313 Preventive Dentistry
% 214.37/214.56  |- skos__related mesh__D011313smesh__D006267
% 214.37/214.56  |- mesh__dateEstablished mesh__D035761 2003-01-01
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D035761 2003
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D035761 2004
% 214.37/214.56  |- skos__altLabel mesh__D035761 Slippery Slope Argument
% 214.37/214.56  |- rdf__type mesh__D035761sskos__Concept
% 214.37/214.56  |- skos__scopeNote mesh__D035761
% 214.37/214.56       An assertion that an action apparently unobjectionable in itself would set in motion a train of events leading ultimately to an undesirable outcome. %28%From Cambridge Dictionary of Philosophy, 1995%29%%A%    
% 214.37/214.56  |- skos__historyNote mesh__D035761 Ethics %28%1974-2002%29%
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D035761 2005
% 214.37/214.56  |- skos__broader mesh__D035761smesh__D026689
% 214.37/214.56  |- skos__prefLabel mesh__D035761 Wedge Argument
% 214.37/214.56  |- mesh__publicMeSHNote mesh__D035761 2003   
% 214.37/214.56  |- mesh__activeMeSHYear mesh__D035761 2006
% 214.37/214.57  |- skos__hiddenLabel mesh__D035761 Slippery Slope Arguments
% 214.37/214.57  |- skos__hiddenLabel mesh__D035761 Wedge Arguments
% 214.37/214.57  |- mesh__dateCreated mesh__D035761 2002-07-03
% 214.37/214.57  |- mesh__historyNote mesh__D035761 2003   
% 214.37/214.57  |- mesh__dateRevised mesh__D002587 2000-06-22
% 214.37/214.57  |- rdf__type mesh__D002587sskos__Concept
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002587 2001
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002587 2004
% 214.37/214.57  |- skos__scopeNote mesh__D002587
% 214.37/214.57       Stable cesium atoms that have the same atomic number as the element cesium, but differ in atomic weight. Cs-133 is a naturally occurring isotope.%A%    
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002587 2003
% 214.37/214.57  |- mesh__recordOriginator mesh__D002587 NLM
% 214.37/214.57  |- mesh__dateCreated mesh__D002587 1999-01-01
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002587 2006
% 214.37/214.57  |- skos__broader mesh__D002587smesh__D007554
% 214.37/214.57  |- skos__hiddenLabel mesh__D002587 Isotopes, Cesium
% 214.37/214.57  |- mesh__recordAuthorizer mesh__D002587 sjn
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002587 2002
% 214.37/214.57  |- skos__prefLabel mesh__D002587 Cesium Isotopes
% 214.37/214.57  |- skos__annotation mesh__D002587 Cs-133; NIM   
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002587 2005
% 214.37/214.57  |- mesh__recordMaintainer mesh__D002587 nns
% 214.37/214.57  |- mesh__dateEstablished mesh__D021741 2001-01-01
% 214.37/214.57  |- mesh__recordAuthorizer mesh__D021741 ags
% 214.37/214.57  |- mesh__publicMeSHNote mesh__D021741 2001   
% 214.37/214.57  |- rdf__type mesh__D021741sskos__Concept
% 214.37/214.57  |- skos__prefLabel mesh__D021741 Eimeriida
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D021741 2006A
% 214.37/214.57  |- skos__annotation mesh__D021741
% 214.37/214.57       infection: coord IM with COCCIDIOSIS %28%IM%29%; drug eff: consider COCCIDIOSTATS; coord with specific protozoan terms %28%ANTIGENS, PROTOZOAN, etc%29% if pertinent%A%  
% 214.37/214.57  |- mesh__dateRevised mesh__D021741 2005-07-12
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D021741 2005
% 214.37/214.57  |- mesh__recordMaintainer mesh__D021741 ags
% 214.37/214.57  |- mesh__recordOriginator mesh__D021741 ags
% 214.37/214.57  |- mesh__dateCreated mesh__D021741 2000-06-22
% 214.37/214.57  |- skos__broader mesh__D021741smesh__D003044
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D021741 2006
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D021741 2004
% 214.37/214.57  |- skos__scopeNote mesh__D021741
% 214.37/214.57       An order of parasitic PROTOZOA in the class COCCIDIA. Families include CRYPTOSPORIDIIDAE; EIMERIIDAE; and SARCOCYSTIDAE.%A%    
% 214.37/214.57  |- mesh__historyNote mesh__D021741 2001   
% 214.37/214.57  |- mesh__publicMeSHNote mesh__D007272 73   
% 214.37/214.57  |- skos__scopeNote mesh__D007272
% 214.37/214.57       Injections into the lymph nodes or the lymphatic system.%A%    
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007272 1998
% 214.37/214.57  |- rdf__type mesh__D007272sskos__Concept
% 214.37/214.57  |- skos__altLabel mesh__D007272 Injections, Endolymphatic
% 214.37/214.57  |- mesh__dateEstablished mesh__D007272 1973-01-01
% 214.37/214.57  |- skos__altLabel mesh__D007272 Intralymphatic Injections
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007272 2001
% 214.37/214.57  |- mesh__recordOriginator mesh__D007272 NLM
% 214.37/214.57  |- skos__annotation mesh__D007272
% 214.37/214.57       NIM; do not use /util except by MeSH definition; X ref INJECTIONS, ENDOLYMPHATIC is seen mostly in foreign lit: nothing to do with ENDOLYMPH; DF: INJECT INTRALYMPHATIC%A%  
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007272 2004
% 214.37/214.57  |- mesh__recordMaintainer mesh__D007272 TGC
% 214.37/214.57  |- skos__hiddenLabel mesh__D007272 Endolymphatic Injection
% 214.37/214.57  |- skos__altLabel mesh__D007272 Endolymphatic Injections
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007272 2000
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007272 2003
% 214.37/214.57  |- skos__hiddenLabel mesh__D007272 Injection, Endolymphatic
% 214.37/214.57  |- skos__prefLabel mesh__D007272 Injections, Intralymphatic
% 214.37/214.57  |- skos__hiddenLabel mesh__D007272 Intralymphatic Injection
% 214.37/214.57  |- mesh__historyNote mesh__D007272 73%28%64%29%   
% 214.37/214.57  |- mesh__recordAuthorizer mesh__D007272 SJN
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007272 2006
% 214.37/214.57  |- mesh__dateCreated mesh__D007272 1999-01-01
% 214.37/214.57  |- mesh__dateRevised mesh__D007272 1997-06-20
% 214.37/214.57  |- skos__hiddenLabel mesh__D007272 Injection, Intralymphatic
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007272 2002
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007272 2005
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007272 1999
% 214.37/214.57  |- skos__broader mesh__D007272smesh__D007267
% 214.37/214.57  |- skos__related mesh__D015704smesh__D015699
% 214.37/214.57  |- skos__historyNote mesh__D015704
% 214.37/214.57       Antigens, Differentiation, T-Lymphocyte %28%1988-1989%29%
% 214.37/214.57  |- skos__hiddenLabel mesh__D015704 CD4 Receptors, Surface
% 214.37/214.57  |- skos__altLabel mesh__D015704 CD4 Antigens
% 214.37/214.57  |- rdf__type mesh__D015704sskos__Concept
% 214.37/214.57  |- skos__altLabel mesh__D015704 CD4 Molecule
% 214.37/214.57  |- mesh__dateCreated mesh__D015704 1989-06-19
% 214.37/214.57  |- mesh__recordMaintainer mesh__D015704 ssb
% 214.37/214.57  |- mesh__recordOriginator mesh__D015704 AGS
% 214.37/214.57  |- skos__historyNote mesh__D015704
% 214.37/214.57       Receptors, Antigen, T-Cell %28%1980-1989%29%
% 214.37/214.57  |- mesh__recordAuthorizer mesh__D015704 sjn
% 214.37/214.57  |- skos__related mesh__D015704smesh__D016516
% 214.37/214.57  |- skos__hiddenLabel mesh__D015704 T4 Antigens, T Cell
% 214.37/214.57  |- skos__altLabel mesh__D015704 Surface CD4 Receptor
% 214.37/214.57  |- skos__altLabel mesh__D015704 Receptors, Surface CD4
% 214.37/214.57  |- skos__broader mesh__D015704smesh__D000945
% 214.37/214.57  |- mesh__publicMeSHNote mesh__D015704
% 214.37/214.57       90; was CD4 ANTIGENS see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1989%A%  
% 214.37/214.57  |- skos__hiddenLabel mesh__D015704 Antigens, T-Cell T4
% 214.37/214.57  |- mesh__onlineNote mesh__D015704
% 214.37/214.57       90; use ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE to search CD4 ANTIGENS 1989%A%  
% 214.37/214.57  |- skos__altLabel mesh__D015704 CD4 Antigen
% 214.37/214.57  |- skos__hiddenLabel mesh__D015704 CD4 Receptor, Surface
% 214.37/214.57  |- mesh__dateEstablished mesh__D015704 1990-01-01
% 214.37/214.57  |- skos__scopeNote mesh__D015704
% 214.37/214.57       55-kDa Glycoproteins originally defined as differentiation antigens on T-lymphocytes, but also found on other cells including monocytes/macrophages. CD4 antigens are members of the immunoglobulin supergene family and are implicated as associative recognition elements in MHC %28%Major Histocompatibility Complex%29% Class II-restricted immune responses. On T-lymphocytes they define the helper/inducer subset. CD4 antigens also serve as HIV receptors, binding directly to the envelope protein gp120 on HIV.%A%    
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D015704 2006
% 214.37/214.57  |- skos__historyNote mesh__D015704 Antigens, Surface %28%1979-1987%29%
% 214.37/214.57  |- skos__hiddenLabel mesh__D015704 T-Cell T4 Antigens
% 214.37/214.57  |- skos__broader mesh__D015704smesh__D015728
% 214.37/214.57  |- skos__annotation mesh__D015704
% 214.37/214.57       human differentiation antigens only: for mouse use ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; for hematodermic CD4/CD56 neoplasm use LYMPHOMA, NON-HODGKIN%A%  
% 214.37/214.57  |- mesh__historyNote mesh__D015704
% 214.37/214.57       90; was CD4 ANTIGENS see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1989%A%  
% 214.37/214.57  |- skos__hiddenLabel mesh__D015704 Surface CD4 Receptors
% 214.37/214.57  |- skos__hiddenLabel mesh__D015704 Antigen, CD4
% 214.37/214.57  |- skos__altLabel mesh__D015704 Receptors, CD4
% 214.37/214.57  |- skos__altLabel mesh__D015704 CD4 Receptors
% 214.37/214.57  |- skos__prefLabel mesh__D015704 Antigens, CD4
% 214.37/214.57  |- skos__historyNote mesh__D015704 Receptors, Virus %28%1979-1989%29%
% 214.37/214.57  |- skos__broader mesh__D015704smesh__D015703
% 214.37/214.57  |- mesh__dateRevised mesh__D015704 2005-06-30
% 214.37/214.57  |- rdf__type mesh__D006978sskos__Concept
% 214.37/214.57  |- skos__scopeNote mesh__D006978
% 214.37/214.57       Hypertension due to RENAL ARTERY OBSTRUCTION or compression.%A%    
% 214.37/214.57  |- mesh__dateEstablished mesh__D006978 1984-01-01
% 214.37/214.57  |- skos__hiddenLabel mesh__D006978 Syndrome, Goldblatt
% 214.37/214.57  |- mesh__recordMaintainer mesh__D006978 lkt
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D006978 2005
% 214.37/214.57  |- mesh__dateRevised mesh__D006978 2004-07-07
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D006978 2006
% 214.37/214.57  |- mesh__recordOriginator mesh__D006978 VDK
% 214.37/214.57  |- mesh__publicMeSHNote mesh__D006978
% 214.37/214.57       84; was see under HYPERTENSION, RENAL 1979-83   
% 214.37/214.57  |- skos__annotation mesh__D006978
% 214.37/214.57       do not routinely index also under RENAL ARTERY or RENAL ARTERY OBSTRUCTION%A%  
% 214.37/214.57  |- mesh__dateCreated mesh__D006978 1977-12-06
% 214.37/214.57  |- mesh__historyNote mesh__D006978
% 214.37/214.57       84%28%79%29%; was see under HYPERTENSION, RENAL 1979-83   
% 214.37/214.57  |- skos__historyNote mesh__D006978 Hypertension, Renal %28%1966-1978%29%
% 214.37/214.57  |- skos__prefLabel mesh__D006978 Hypertension, Renovascular
% 214.37/214.57  |- skos__altLabel mesh__D006978 Goldblatt Syndrome
% 214.37/214.57  |- skos__broader mesh__D006978smesh__D006977
% 214.37/214.57  |- mesh__recordAuthorizer mesh__D006978 sjn
% 214.37/214.57  |- skos__hiddenLabel mesh__D006978 Goldblatt Hypertension
% 214.37/214.57  |- skos__hiddenLabel mesh__D006978 Renovascular Hypertension
% 214.37/214.57  |- skos__hiddenLabel mesh__D020649 Nucleus, Oral Pulvinar
% 214.37/214.57  |- skos__hiddenLabel mesh__D020649 Nucleus, Medial Pulvinar
% 214.37/214.57  |- skos__scopeNote mesh__D020649
% 214.37/214.57       Large mass of nuclei forming the most caudal portion of the thalamus and overhanging the geniculate bodies and the dorsolateral surface of the midbrain. It is divided into four parts: the lateral, medial, inferior, and oral pulvinar nuclei.%A%    
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D020649 2003
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D020649 2005
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D020649 2004
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D020649 2002
% 214.37/214.57  |- rdf__type mesh__D020649sskos__Concept
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D020649 2006
% 214.37/214.57  |- skos__hiddenLabel mesh__D020649 Pulvinar Nucleus, Inferior
% 214.37/214.57  |- skos__historyNote mesh__D020649 Thalamic Nuclei %28%1971-1999%29%
% 214.37/214.57  |- skos__hiddenLabel mesh__D020649 Pulvinar Nucleus, Lateral
% 214.37/214.57  |- mesh__dateEstablished mesh__D020649 2000-01-01
% 214.37/214.57  |- skos__historyNote mesh__D020649 Thalamus %28%1965-1970%29%
% 214.37/214.57  |- skos__hiddenLabel mesh__D020649 Nucleus, Inferior Pulvinar
% 214.37/214.57  |- mesh__publicMeSHNote mesh__D020649 2000   
% 214.37/214.57  |- skos__hiddenLabel mesh__D020649 Pulvinar Nucleus, Oral
% 214.37/214.57  |- mesh__historyNote mesh__D020649 2000   
% 214.37/214.57  |- skos__hiddenLabel mesh__D020649 Nucleus, Lateral Pulvinar
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D020649 2000
% 214.37/214.57  |- skos__prefLabel mesh__D020649 Pulvinar
% 214.37/214.57  |- skos__hiddenLabel mesh__D020649 Pulvinars
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D020649 2001
% 214.37/214.57  |- skos__broader mesh__D020649smesh__D020647
% 214.37/214.57  |- skos__hiddenLabel mesh__D020649 Pulvinar Nucleus, Medial
% 214.37/214.57  |- mesh__dateCreated mesh__D020649 1999-11-03
% 214.37/214.57  |- mesh__dateRevised mesh__D003680 2004-07-07
% 214.37/214.57  |- skos__scopeNote mesh__D003680
% 214.37/214.57       Difficulty in SWALLOWING which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal dysphagia due to malfunction of the PHARYNX and UPPER ESOPHAGEAL SPHINCTER; and esophageal dysphagia due to malfunction of the ESOPHAGUS.%A%    
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D003680 2005
% 214.37/214.57  |- skos__altLabel mesh__D003680 Dysphagia
% 214.37/214.57  |- rdf__type mesh__D003680sskos__Concept
% 214.37/214.57  |- mesh__recordAuthorizer mesh__D003680 sjn
% 214.37/214.57  |- skos__broader mesh__D003680smesh__D004935
% 214.37/214.57  |- mesh__dateCreated mesh__D003680 1999-01-01
% 214.37/214.57  |- skos__hiddenLabel mesh__D003680 Swallowing Disorder
% 214.37/214.57  |- mesh__recordOriginator mesh__D003680 NLM
% 214.37/214.57  |- skos__hiddenLabel mesh__D003680 Deglutition Disorder
% 214.37/214.57  |- skos__hiddenLabel mesh__D003680 Dysphagia, Oropharyngeal
% 214.37/214.57  |- mesh__recordMaintainer mesh__D003680 lkt
% 214.37/214.57  |- skos__broader mesh__D003680smesh__D010608
% 214.37/214.57  |- skos__hiddenLabel mesh__D003680 Disorders, Deglutition
% 214.37/214.57  |- skos__hiddenLabel mesh__D003680 Dysphagia, Esophageal
% 214.37/214.57  |- skos__prefLabel mesh__D003680 Deglutition Disorders
% 214.37/214.57  |- skos__altLabel mesh__D003680 Swallowing Disorders
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D003680 2006
% 214.37/214.57  |- skos__altLabel mesh__D011314 Services, Preventive Health
% 214.37/214.57  |- skos__historyNote mesh__D011314 specific disease/PC %28%1966-1967%29%
% 214.37/214.57  |- skos__hiddenLabel mesh__D011314 Health Service, Preventive
% 214.37/214.57  |- skos__hiddenLabel mesh__D011314 Service, Preventive Health
% 214.37/214.57  |- skos__related mesh__D011314smesh__D011313
% 214.37/214.57  |- skos__related mesh__D011314smesh__D011322
% 214.37/214.57  |- mesh__recordMaintainer mesh__D011314 nns
% 214.37/214.57  |- mesh__recordAuthorizer mesh__D011314 sjn
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D011314 2005
% 214.37/214.57  |- skos__related mesh__D011314smesh__D011316
% 214.37/214.57  |- skos__related mesh__D011314smesh__D006293
% 214.37/214.57  |- skos__altLabel mesh__D011314 Health Services, Preventive
% 214.37/214.57  |- mesh__dateCreated mesh__D011314 1999-01-01
% 214.37/214.57  |- skos__annotation mesh__D011314 DF: PREV HEALTH SERV   
% 214.37/214.57  |- mesh__publicMeSHNote mesh__D011314 68   
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D011314 2006
% 214.37/214.57  |- skos__prefLabel mesh__D011314 Preventive Health Services
% 214.37/214.57  |- mesh__historyNote mesh__D011314 68   
% 214.37/214.57  |- skos__broader mesh__D011314smesh__D006296
% 214.37/214.57  |- skos__related mesh__D011314smesh__D011315
% 214.37/214.57  |- skos__scopeNote mesh__D011314
% 214.37/214.57       Services designed for HEALTH PROMOTION and prevention of disease.%A%    
% 214.37/214.57  |- mesh__dateEstablished mesh__D011314 1968-01-01
% 214.37/214.57  |- skos__hiddenLabel mesh__D011314 Preventive Health Service
% 214.37/214.57  |- mesh__recordOriginator mesh__D011314 NLM
% 214.37/214.57  |- rdf__type mesh__D011314sskos__Concept
% 214.37/214.57  |- skos__broader mesh__D011314smesh__D003153
% 214.37/214.57  |- mesh__dateRevised mesh__D011314 2003-07-09
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D011314 2004
% 214.37/214.57  |- skos__related mesh__D011314smesh__D007114
% 214.37/214.57  |- skos__hiddenLabel mesh__D002588 Radioisotopes, Cesium
% 214.37/214.57  |- rdf__type mesh__D002588sskos__Concept
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002588 1998
% 214.37/214.57  |- skos__broader mesh__D002588smesh__D011868
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002588 2004
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002588 1994
% 214.37/214.57  |- mesh__recordAuthorizer mesh__D002588 PLS
% 214.37/214.57  |- skos__broader mesh__D002588smesh__D002587
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002588 2003
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002588 2006
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002588 2001
% 214.37/214.57  |- skos__prefLabel mesh__D002588 Cesium Radioisotopes
% 214.37/214.57  |- mesh__dateCreated mesh__D002588 1974-11-11
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002588 1997
% 214.37/214.57  |- mesh__onlineNote mesh__D002588 search CESIUM ISOTOPES 1966-74   
% 214.37/214.57  |- mesh__dateEstablished mesh__D002588 1975-09-01
% 214.37/214.57  |- skos__scopeNote mesh__D002588
% 214.37/214.57       Unstable isotopes of cesium that decay or disintegrate emitting radiation. Cs atoms with atomic weights of 123, 125-132, and 134-145 are radioactive cesium isotopes.%A%    
% 214.37/214.57  |- mesh__recordMaintainer mesh__D002588 TPW
% 214.37/214.57  |- mesh__historyNote mesh__D002588 75   
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002588 2000
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002588 2005
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002588 1996
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002588 1999
% 214.37/214.57  |- mesh__recordOriginator mesh__D002588 NLM
% 214.37/214.57  |- skos__historyNote mesh__D002588 Cesium Isotopes %28%1966-1974%29%
% 214.37/214.57  |- mesh__publicMeSHNote mesh__D002588 75   
% 214.37/214.57  |- skos__historyNote mesh__D002588 Radioisotopes %28%1966-1974%29%
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002588 1995
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002588 2002
% 214.37/214.57  |- mesh__dateRevised mesh__D002588 1993-06-01
% 214.37/214.57  |- skos__annotation mesh__D002588
% 214.37/214.57       Cs-123,125-32,134-144; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D021742 2005
% 214.37/214.57  |- skos__prefLabel mesh__D021742 Cryptosporidiidae
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D021742 2006
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D021742 2004
% 214.37/214.57  |- mesh__dateCreated mesh__D021742 2000-06-22
% 214.37/214.57  |- skos__scopeNote mesh__D021742
% 214.37/214.57       A family of parasitic PROTOZOA in the order EIMERIIDA. CRYPTOSPORIDIUM is the most important genus.%A%    
% 214.37/214.57  |- skos__broader mesh__D021742smesh__D021741
% 214.37/214.57  |- mesh__historyNote mesh__D021742 2001   
% 214.37/214.57  |- mesh__publicMeSHNote mesh__D021742 2001   
% 214.37/214.57  |- skos__annotation mesh__D021742
% 214.37/214.57       infection: coord IM with COCCIDIOSIS %28%IM%29%; drug eff: consider COCCIDIOSTATS; coord with specific protozoan terms %28%ANTIGENS, PROTOZOAN, etc%29% if pertinent%A%  
% 214.37/214.57  |- mesh__dateEstablished mesh__D021742 2001-01-01
% 214.37/214.57  |- mesh__dateRevised mesh__D021742 2003-07-09
% 214.37/214.57  |- rdf__type mesh__D021742sskos__Concept
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007273 1994
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007273 2002
% 214.37/214.57  |- skos__prefLabel mesh__D007273 Injections, Intramuscular
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007273 2004
% 214.37/214.57  |- mesh__recordMaintainer mesh__D007273 TGC
% 214.37/214.57  |- skos__altLabel mesh__D007273 Intramuscular Injections
% 214.37/214.57  |- mesh__dateRevised mesh__D007273 1990-06-01
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007273 2003
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007273 1997
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007273 1991
% 214.37/214.57  |- skos__hiddenLabel mesh__D007273 Intramuscular Injection
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007273 2001
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007273 1996
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007273 1993
% 214.37/214.57  |- mesh__recordOriginator mesh__D007273 NLM
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007273 2006
% 214.37/214.57  |- mesh__dateCreated mesh__D007273 1999-01-01
% 214.37/214.57  |- skos__hiddenLabel mesh__D007273 Injection, Intramuscular
% 214.37/214.57  |- skos__annotation mesh__D007273
% 214.37/214.57       NIM; do not use /util except by MeSH definition; DF: INJECT INTRAMUSCULAR%A%  
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007273 2000
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007273 1992
% 214.37/214.57  |- skos__scopeNote mesh__D007273
% 214.37/214.57       Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it.%A%    
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007273 2005
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007273 1999
% 214.37/214.57  |- skos__broader mesh__D007273smesh__D007267
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007273 1995
% 214.37/214.57  |- mesh__recordAuthorizer mesh__D007273 PLS
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D007273 1998
% 214.37/214.57  |- rdf__type mesh__D007273sskos__Concept
% 214.37/214.57  |- skos__scopeNote mesh__D006979
% 214.37/214.57       Abnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation %28%heat waves, infra-red%29%, ultrasound, or drugs.%A%    
% 214.37/214.57  |- skos__altLabel mesh__D006979 Therapy, Fever
% 214.37/214.57  |- mesh__recordAuthorizer mesh__D006979 sjn
% 214.37/214.57  |- mesh__recordOriginator mesh__D006979 NLM
% 214.37/214.57  |- skos__altLabel mesh__D006979 Induced Hyperthermia
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D006979 2006
% 214.37/214.57  |- mesh__publicMeSHNote mesh__D006979 84; was FEVER THERAPY 1963-83   
% 214.37/214.57  |- skos__related mesh__D006979smesh__D006358
% 214.37/214.57  |- mesh__recordMaintainer mesh__D006979 lkt
% 214.37/214.57  |- skos__prefLabel mesh__D006979 Hyperthermia, Induced
% 214.37/214.57  |- skos__altLabel mesh__D006979 Therapeutic Hyperthermia
% 214.37/214.57  |- mesh__historyNote mesh__D006979 84; was FEVER THERAPY 1963-83   
% 214.37/214.57  |- skos__hiddenLabel mesh__D006979 Local Hyperthermia
% 214.37/214.57  |- skos__broader mesh__D006979smesh__D026741
% 214.37/214.57  |- mesh__dateRevised mesh__D006979 2005-06-30
% 214.37/214.57  |- skos__broader mesh__D006979smesh__D013812
% 214.37/214.57  |- skos__altLabel mesh__D006979 Thermotherapy
% 214.37/214.57  |- rdf__type mesh__D006979sskos__Concept
% 214.37/214.57  |- mesh__onlineNote mesh__D006979
% 214.37/214.57       use HYPERTHERMIA, INDUCED to search FEVER THERAPY 1966-83%A%  
% 214.37/214.57  |- skos__altLabel mesh__D006979 Hyperthermia, Therapeutic
% 214.37/214.57  |- skos__annotation mesh__D006979
% 214.37/214.57       differentiate X ref FEVER THERAPY from FEVER /ther %28% = treatment of fever%29%; coord IM with disease /ther %28%IM%29%; do not index under specific type of induction unless the point of the article %26% then probably only NIM%A%  
% 214.37/214.57  |- skos__altLabel mesh__D006979 Fever Therapy
% 214.37/214.57  |- mesh__dateCreated mesh__D006979 1999-01-01
% 214.37/214.57  |- skos__scopeNote mesh__D003681
% 214.37/214.57       The condition that results from excessive loss of water from a living organism.%A%    
% 214.37/214.57  |- mesh__dateRevised mesh__D003681 2005-07-22
% 214.37/214.57  |- skos__related mesh__D003681smesh__D013894
% 214.37/214.57  |- skos__related mesh__D003681smesh__D015532
% 214.37/214.57  |- mesh__recordAuthorizer mesh__D003681 ags
% 214.37/214.57  |- skos__prefLabel mesh__D003681 Dehydration
% 214.37/214.57  |- rdf__type mesh__D003681sskos__Concept
% 214.37/214.57  |- skos__related mesh__D003681smesh__D003890
% 214.37/214.57  |- skos__broader mesh__D003681smesh__D014883
% 214.37/214.57  |- mesh__recordMaintainer mesh__D003681 ags
% 214.37/214.57  |- mesh__dateCreated mesh__D003681 1999-01-01
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D003681 2004
% 214.37/214.57  |- skos__annotation mesh__D003681
% 214.37/214.57       differentiate from DESICCATION, a technique for removing  moisture from matter; /ther: coord with ORAL REHYDRATION THERAPY see FLUID THERAPY if pertinent; do not use X ref WATER STRESS for water stress test: consider IMMERSION; permitted %28%NIM%29% with microorganisms, lower animals and plants%A%  
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D003681 2006A
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D003681 2006
% 214.37/214.57  |- skos__hiddenLabel mesh__D003681 Stress, Water
% 214.37/214.57  |- skos__broader mesh__D003681smesh__D010335
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D003681 2003
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D003681 2005
% 214.37/214.57  |- mesh__recordOriginator mesh__D003681 NLM
% 214.37/214.57  |- skos__related mesh__D003681smesh__D005440
% 214.37/214.57  |- skos__related mesh__D011315smesh__D011634
% 214.37/214.57  |- mesh__dateCreated mesh__D011315 1999-01-01
% 214.37/214.57  |- mesh__recordOriginator mesh__D011315 NLM
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D011315 2006
% 214.37/214.57  |- skos__annotation mesh__D011315
% 214.37/214.57       SPEC only: SPEC qualif; for specific disease, use /prev: Manual 19.7+, 19.8.58; primary prev = PRIMARY PREVENTION, secondary prev = diag %26% ther, tertiary prev = REHABILITATION; DF: PREV MED%A%  
% 214.37/214.57  |- skos__altLabel mesh__D011315 Medicine, Preventive
% 214.37/214.57  |- skos__scopeNote mesh__D011315
% 214.37/214.57       A medical specialty primarily concerned with prevention of disease %28%PRIMARY PREVENTION%29% and the promotion and preservation of health in the individual.%A%    
% 214.37/214.57  |- rdf__type mesh__D011315sskos__Concept
% 214.37/214.57  |- mesh__dateRevised mesh__D011315 2003-07-09
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D011315 2004
% 214.37/214.57  |- mesh__recordMaintainer mesh__D011315 nns
% 214.37/214.57  |- skos__prefLabel mesh__D011315 Preventive Medicine
% 214.37/214.57  |- skos__related mesh__D011315smesh__D011314
% 214.37/214.57  |- skos__related mesh__D011315smesh__D006293
% 214.37/214.57  |- mesh__recordAuthorizer mesh__D011315 sjn
% 214.37/214.57  |- skos__broader mesh__D011315smesh__D013040
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D011315 2005
% 214.37/214.57  |- skos__hiddenLabel mesh__D016000 Cluster Analyses
% 214.37/214.57  |- mesh__recordAuthorizer mesh__D016000 PLS
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D016000 2004
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D016000 1999
% 214.37/214.57  |- mesh__historyNote mesh__D016000
% 214.37/214.57       90; CLUSTERING was see SPACE-TIME CLUSTERING 1978-89   
% 214.37/214.57  |- mesh__onlineNote mesh__D016000
% 214.37/214.57       use SPACE-TIME CLUSTERING to search CLUSTERING 1978-89   
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D016000 2000
% 214.37/214.57  |- skos__broader mesh__D016000smesh__D013223
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D016000 1996
% 214.37/214.57  |- skos__hiddenLabel mesh__D016000 Clusterings
% 214.37/214.57  |- rdf__type mesh__D016000sskos__Concept
% 214.37/214.57  |- skos__hiddenLabel mesh__D016000 Clustering, Disease
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D016000 1997
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D016000 2001
% 214.37/214.57  |- mesh__dateEstablished mesh__D016000 1990-01-01
% 214.37/214.57  |- skos__scopeNote mesh__D016000
% 214.37/214.57       A set of statistical methods used to group variables or observations into strongly inter-related subgroups. In epidemiology, it may be used to analyze a closely grouped series of events or cases of disease or other health-related phenomenon with well-defined distribution patterns in relation to time or place or both.%A%    
% 214.37/214.57  |- mesh__dateRevised mesh__D016000 1994-04-11
% 214.37/214.57  |- skos__hiddenLabel mesh__D016000 Analyses, Cluster
% 214.37/214.57  |- mesh__dateCreated mesh__D016000 1989-05-25
% 214.37/214.57  |- mesh__recordOriginator mesh__D016000 PLS
% 214.37/214.57  |- skos__prefLabel mesh__D016000 Cluster Analysis
% 214.37/214.57  |- skos__altLabel mesh__D016000 Clustering
% 214.37/214.57  |- skos__annotation mesh__D016000
% 214.37/214.57       IM GEN only; coord NIM with specific disease or other concept %28%IM%29%; no qualif%A%  
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D016000 2005
% 214.37/214.57  |- mesh__publicMeSHNote mesh__D016000
% 214.37/214.57       90; CLUSTERING was see SPACE-TIME CLUSTERING 1978-89   
% 214.37/214.57  |- skos__hiddenLabel mesh__D016000 Clusterings, Disease
% 214.37/214.57  |- skos__hiddenLabel mesh__D016000 Analysis, Cluster
% 214.37/214.57  |- skos__historyNote mesh__D016000 Statistics %28%1966-1989%29%
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D016000 1995
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D016000 2006
% 214.37/214.57  |- skos__hiddenLabel mesh__D016000 Disease Clusterings
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D016000 2002
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D016000 2003
% 214.37/214.57  |- mesh__recordMaintainer mesh__D016000 TGC
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D016000 1998
% 214.37/214.57  |- skos__prefLabel mesh__D002589 Cestoda
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002589 2004
% 214.37/214.57  |- skos__related mesh__D002589smesh__D000923
% 214.37/214.57  |- mesh__dateCreated mesh__D002589 1999-01-01
% 214.37/214.57  |- skos__altLabel mesh__D002589 Cestodes
% 214.37/214.57  |- mesh__publicMeSHNote mesh__D002589
% 214.37/214.57       65; was TAPEWORMS 1963-64; RAILLIETINA was see under CESTODA 1965-85, was see under TAPEWORMS 1963-64; SPIROMETRA was heading 1979-85, was indexed under CESTODA 1975-78%A%  
% 214.37/214.57  |- mesh__recordMaintainer mesh__D002589 ags
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002589 2006
% 214.37/214.57  |- mesh__recordOriginator mesh__D002589 NLM
% 214.37/214.57  |- skos__scopeNote mesh__D002589
% 214.37/214.57       A subclass of segmented worms comprising the tapeworms.%A%    
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D002589 2005
% 214.37/214.57  |- mesh__dateRevised mesh__D002589 2003-07-09
% 214.37/214.57  |- mesh__recordAuthorizer mesh__D002589 sjn
% 214.37/214.57  |- skos__altLabel mesh__D002589 Tapeworms
% 214.37/214.57  |- skos__annotation mesh__D002589
% 214.37/214.57       GEN; IM; infection = CESTODE INFECTIONS; /drug eff: consider also ANTICESTODAL AGENTS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 214.37/214.57  |- rdf__type mesh__D002589sskos__Concept
% 214.37/214.57  |- mesh__dateEstablished mesh__D002589 1965-01-01
% 214.37/214.57  |- skos__broader mesh__D002589smesh__D010986
% 214.37/214.57  |- mesh__onlineNote mesh__D002589
% 214.37/214.57       use CESTODA to search RAILLIETINA 1966-85   
% 214.37/214.57  |- mesh__historyNote mesh__D002589
% 214.37/214.57       65; was TAPEWORMS 1963-64; RAILLIETINA was see under CESTODA 1965-85, was see under TAPEWORMS 1963-64; SPIROMETRA was heading 1978-85%A%  
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D021743 2006
% 214.37/214.57  |- mesh__activeMeSHYear mesh__D021743 2004
% 214.37/214.57  |- mesh__dateCreated mesh__D021743 2000-06-22
% 214.37/214.57  |- skos__historyNote mesh__D021743 Coccidia %28%1980-2000%29%
% 214.37/214.57  |- mesh__historyNote mesh__D021743 2001   
% 214.37/214.57  |- skos__scopeNote mesh__D021743
% 214.37/214.57       A large family of parasitic PROTOZOA in the order EIMERIIDA. They cause COCCIDIOSIS in a number of vertebrates including humans.%A%    
% 214.37/214.57  |- skos__prefLabel mesh__D021743 Eimeriidae
% 214.37/214.57  |- mesh__dateEstablished mesh__D021743 2001-01-01
% 214.37/214.57  |- skos__broader mesh__D021743smesh__D021741
% 214.37/214.57  |- mesh__dateRevised mesh__D021743 2003-07-09
% 214.37/214.57  |- rdf__type mesh__D021743sskos__Concept
% 214.37/214.57  |- skos__annotation mesh__D021743
% 214.37/214.57       infection: coord IM with COCCIDIOSIS %28%IM%29%; drug eff: consider COCCIDIOSTATS; coord with specific protozoan terms %28%ANTIGENS, PROTOZOAN, etc%29% if pertinent%A%  
% 214.37/214.58  |- mesh__publicMeSHNote mesh__D021743 2001   
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D021743 2005
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007274 1993
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007274 1996
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007274 2006
% 214.37/214.58  |- mesh__dateCreated mesh__D007274 1999-01-01
% 214.37/214.58  |- skos__hiddenLabel mesh__D007274 Injection, Intraperitoneal
% 214.37/214.58  |- skos__altLabel mesh__D007274 Intraperitoneal Injections
% 214.37/214.58  |- mesh__recordAuthorizer mesh__D007274 PLS
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007274 1992
% 214.37/214.58  |- skos__scopeNote mesh__D007274
% 214.37/214.58       Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall.%A%    
% 214.37/214.58  |- skos__prefLabel mesh__D007274 Injections, Intraperitoneal
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007274 1999
% 214.37/214.58  |- mesh__dateEstablished mesh__D007274 1966-01-01
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007274 2005
% 214.37/214.58  |- skos__broader mesh__D007274smesh__D007267
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007274 2002
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007274 1995
% 214.37/214.58  |- mesh__publicMeSHNote mesh__D007274 66   
% 214.37/214.58  |- skos__hiddenLabel mesh__D007274 Intraperitoneal Injection
% 214.37/214.58  |- rdf__type mesh__D007274sskos__Concept
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007274 1998
% 214.37/214.58  |- mesh__dateRevised mesh__D007274 1990-06-01
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007274 1994
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007274 2004
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007274 1991
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007274 2001
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007274 1997
% 214.37/214.58  |- mesh__historyNote mesh__D007274 66%28%64%29%   
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007274 2003
% 214.37/214.58  |- mesh__recordOriginator mesh__D007274 NLM
% 214.37/214.58  |- skos__annotation mesh__D007274
% 214.37/214.58       NIM; do not use /util except by MeSH definition; DF: INJECT INTRAPERITONEAL%A%  
% 214.37/214.58  |- mesh__recordMaintainer mesh__D007274 TGC
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007274 2000
% 214.37/214.58  |- skos__scopeNote mesh__D015706
% 214.37/214.58       The use of statistical methods in the analysis of a body of literature to reveal the historical development of subject fields and patterns of authorship, publication, and use. Formerly called statistical bibliography. %28%from The ALA Glossary of Library and Information Science, 1983%29%%A%    
% 214.37/214.58  |- skos__altLabel mesh__D015706 Bibliometric Analysis
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D015706 1997
% 214.37/214.58  |- mesh__historyNote mesh__D015706 90   
% 214.37/214.58  |- skos__altLabel mesh__D015706 Bibliography, Statistical
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D015706 2002
% 214.37/214.58  |- skos__altLabel mesh__D015706 Analysis, Bibliometric
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D015706 2005
% 214.37/214.58  |- mesh__dateEstablished mesh__D015706 1990-01-01
% 214.37/214.58  |- mesh__recordOriginator mesh__D015706 TGC
% 214.37/214.58  |- skos__hiddenLabel mesh__D015706 Analyses, Bibliometric
% 214.37/214.58  |- skos__altLabel mesh__D015706 Bibliographies, Statistical
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D015706 2006
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D015706 2000
% 214.37/214.58  |- skos__altLabel mesh__D015706 Statistical Bibliography
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D015706 1998
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D015706 1995
% 214.37/214.58  |- mesh__dateCreated mesh__D015706 1989-06-19
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D015706 2003
% 214.37/214.58  |- skos__annotation mesh__D015706
% 214.37/214.58       IM; coord with subject %28%IM%29%; med bibliometrics: do not coordinate with MEDICINE%A%  
% 214.37/214.58  |- skos__hiddenLabel mesh__D015706 Bibliometric Analyses
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D015706 1999
% 214.37/214.58  |- mesh__publicMeSHNote mesh__D015706 90   
% 214.37/214.58  |- mesh__onlineNote mesh__D015706 90   
% 214.37/214.58  |- skos__historyNote mesh__D015706 Bibliography %28%1966-1989%29%
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D015706 2001
% 214.37/214.58  |- rdf__type mesh__D015706sskos__Concept
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D015706 2004
% 214.37/214.58  |- skos__prefLabel mesh__D015706 Bibliometrics
% 214.37/214.58  |- mesh__dateRevised mesh__D015706 1994-05-27
% 214.37/214.58  |- mesh__recordMaintainer mesh__D015706 TGC
% 214.37/214.58  |- mesh__recordAuthorizer mesh__D015706 PLS
% 214.37/214.58  |- skos__broader mesh__D015706smesh__D001634
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D015706 1996
% 214.37/214.58  |- skos__altLabel mesh__D015706 Statistical Bibliographies
% 214.37/214.58  |- mesh__dateEstablished mesh__D003682 1991-01-01
% 214.37/214.58  |- skos__scopeNote mesh__D003682
% 214.37/214.58       Catalyzes the hydrolysis of the gamma lactone, dehydroascorbate, to diketogulonate.%A%    
% 214.37/214.58  |- mesh__recordAuthorizer mesh__D003682 sjn
% 214.37/214.58  |- skos__historyNote mesh__D003682 Ketones %28%1972-1974%29%
% 214.37/214.58  |- skos__historyNote mesh__D003682 Esterases %28%1972-1974%29%
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D003682 2004
% 214.37/214.58  |- mesh__recordOriginator mesh__D003682 NLM
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D003682 2006
% 214.37/214.58  |- mesh__dateRevised mesh__D003682 2003-07-09
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D003682 2005
% 214.37/214.58  |- skos__broader mesh__D003682smesh__D002265
% 214.37/214.58  |- mesh__historyNote mesh__D003682
% 214.37/214.58       91%28%75%29%; was see under CARBOXYLIC ESTER HYDROLASES 1976-90; was see under ESTERASES 1975%A%  
% 214.37/214.58  |- skos__prefLabel mesh__D003682 Dehydroascorbatase
% 214.37/214.58  |- mesh__publicMeSHNote mesh__D003682
% 214.37/214.58       91; was see under CARBOXYLIC ESTER HYDROLASES 1976-90; was see under ESTERASES 1975%A%  
% 214.37/214.58  |- skos__historyNote mesh__D003682 Ascorbic Acid %28%1972-1974%29%
% 214.37/214.58  |- rdf__type mesh__D003682sskos__Concept
% 214.37/214.58  |- mesh__dateCreated mesh__D003682 1974-11-27
% 214.37/214.58  |- mesh__recordMaintainer mesh__D003682 ssb
% 214.37/214.58  |- mesh__publicMeSHNote mesh__D011316
% 214.37/214.58       91; was see under COMMUNITY PSYCHIATRY 1980-90; was see under PSYCHIATRY, COMMUNITY 1973-79%A%  
% 214.37/214.58  |- skos__broader mesh__D011316smesh__D011315
% 214.37/214.58  |- mesh__onlineNote mesh__D011316 search COMMUNITY PSYCHIATRY 1973-74   
% 214.37/214.58  |- skos__annotation mesh__D011316
% 214.37/214.58       specialty; do not confuse with MENTAL DISORDERS /prev or specific ment disord /prev or with MENTAL HEALTH%A%  
% 214.37/214.58  |- mesh__dateEstablished mesh__D011316 1991-01-01
% 214.37/214.58  |- rdf__type mesh__D011316sskos__Concept
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D011316 2004
% 214.37/214.58  |- mesh__dateRevised mesh__D011316 2003-07-09
% 214.37/214.58  |- mesh__historyNote mesh__D011316
% 214.37/214.58       91%28%75%29%; was see under COMMUNITY PSYCHIATRY 1980-90; was see under PSYCHIATRY, COMMUNITY 1973-79%A%  
% 214.37/214.58  |- skos__scopeNote mesh__D011316
% 214.37/214.58       A discipline concerned with the prevention of mental illness and the promotion of mental health.%A%    
% 214.37/214.58  |- mesh__recordOriginator mesh__D011316 NLM
% 214.37/214.58  |- skos__related mesh__D011316smesh__D011314
% 214.37/214.58  |- mesh__recordMaintainer mesh__D011316 nns
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D011316 2005
% 214.37/214.58  |- mesh__dateCreated mesh__D011316 1999-01-01
% 214.37/214.58  |- skos__prefLabel mesh__D011316 Preventive Psychiatry
% 214.37/214.58  |- skos__altLabel mesh__D011316 Psychiatry, Preventive
% 214.37/214.58  |- mesh__recordAuthorizer mesh__D011316 sjn
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D011316 2006
% 214.37/214.58  |- skos__broader mesh__D011316smesh__D003158
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016001 1995
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016001 2006
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016001 2001
% 214.37/214.58  |- mesh__recordAuthorizer mesh__D016001 PLS
% 214.37/214.58  |- skos__hiddenLabel mesh__D016001 Intervals, Confidence
% 214.37/214.58  |- skos__historyNote mesh__D016001
% 214.37/214.58       Data Interpretation, Statistical %28%1988-1989%29%
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016001 2005
% 214.37/214.58  |- skos__prefLabel mesh__D016001 Confidence Intervals
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016001 2004
% 214.37/214.58  |- skos__broader mesh__D016001smesh__D013223
% 214.37/214.58  |- mesh__dateRevised mesh__D016001 1994-04-11
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016001 2000
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016001 1999
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016001 2003
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016001 1998
% 214.37/214.58  |- mesh__publicMeSHNote mesh__D016001 91; was see under STATISTICS 1990   
% 214.37/214.58  |- skos__annotation mesh__D016001
% 214.37/214.58       IM GEN only; coord NIM with specific disease or other concept %28%IM%29%; no qualif%A%  
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016001 1997
% 214.37/214.58  |- mesh__recordOriginator mesh__D016001 PLS
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016001 2002
% 214.37/214.58  |- mesh__dateEstablished mesh__D016001 1991-01-01
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016001 1996
% 214.37/214.58  |- rdf__type mesh__D016001sskos__Concept
% 214.37/214.58  |- skos__hiddenLabel mesh__D016001 Interval, Confidence
% 214.37/214.58  |- skos__hiddenLabel mesh__D016001 Confidence Interval
% 214.37/214.58  |- mesh__recordMaintainer mesh__D016001 TGC
% 214.37/214.58  |- skos__scopeNote mesh__D016001
% 214.37/214.58       A range of values for a variable of interest, e.g., a rate, constructed so that this range has a specified probability of including the true value of the variable.%A%    
% 214.37/214.58  |- skos__historyNote mesh__D016001 Statistics %28%1972-1989%29%
% 214.37/214.58  |- mesh__historyNote mesh__D016001
% 214.37/214.58       91%28%90%29%; was see under STATISTICS 1990   
% 214.37/214.58  |- mesh__dateCreated mesh__D016001 1989-05-25
% 214.37/214.58  |- rdf__type mesh__D021744sskos__Concept
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D021744 2004
% 214.37/214.58  |- mesh__dateEstablished mesh__D021744 2001-01-01
% 214.37/214.58  |- mesh__dateRevised mesh__D021744 2003-07-09
% 214.37/214.58  |- mesh__historyNote mesh__D021744 2001   
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D021744 2006
% 214.37/214.58  |- skos__prefLabel mesh__D021744 Cyclospora
% 214.37/214.58  |- skos__historyNote mesh__D021744 Eucoccidiida %28%1990-2000%29%
% 214.37/214.58  |- mesh__recordOriginator mesh__D021744 ags
% 214.37/214.58  |- mesh__recordAuthorizer mesh__D021744 sjn
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D021744 2005
% 214.37/214.58  |- skos__annotation mesh__D021744
% 214.37/214.58       infection = CYCLOSPORIASIS %28%IM%29%; drug eff: consider COCCIDIOSTATS; coord with specific protozoan terms %28%ANTIGENS, PROTOZOAN, etc%29% if pertinent%A%  
% 214.37/214.58  |- skos__scopeNote mesh__D021744
% 214.37/214.58       A genus of coccidian parasites in the family EIMERIIDAE. Cyclospora cayetanensis is pathogenic in humans, probably transmitted via the fecal-oral route, and causes nausea and diarrhea.%A%    
% 214.37/214.58  |- mesh__recordMaintainer mesh__D021744 ags
% 214.37/214.58  |- skos__broader mesh__D021744smesh__D021743
% 214.37/214.58  |- mesh__publicMeSHNote mesh__D021744 2001   
% 214.37/214.58  |- mesh__dateCreated mesh__D021744 2000-06-22
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007275 1992
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007275 2001
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007275 1999
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007275 2005
% 214.37/214.58  |- mesh__recordOriginator mesh__D007275 NLM
% 214.37/214.58  |- skos__broader mesh__D007275smesh__D007267
% 214.37/214.58  |- skos__scopeNote mesh__D007275
% 214.37/214.58       Injections made into a vein for therapeutic or experimental purposes.%A%    
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007275 2000
% 214.37/214.58  |- skos__hiddenLabel mesh__D007275 Intravenous Injection
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007275 1995
% 214.37/214.58  |- rdf__type mesh__D007275sskos__Concept
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007275 1998
% 214.37/214.58  |- skos__hiddenLabel mesh__D007275 Injection, Intravenous
% 214.37/214.58  |- mesh__recordAuthorizer mesh__D007275 PLS
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007275 1994
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007275 2004
% 214.37/214.58  |- skos__prefLabel mesh__D007275 Injections, Intravenous
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007275 2002
% 214.37/214.58  |- skos__altLabel mesh__D007275 Intravenous Injections
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007275 1997
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007275 2003
% 214.37/214.58  |- mesh__recordMaintainer mesh__D007275 TGC
% 214.37/214.58  |- mesh__dateRevised mesh__D007275 1990-06-01
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007275 1993
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007275 1996
% 214.37/214.58  |- skos__annotation mesh__D007275
% 214.37/214.58       NIM; do not use /util except by MeSH definition; do not confuse with INFUSIONS, INTRAVENOUS %28% = %22%long-term %28%minutes to hours%29% admin%22%%29%; DF: INJECT INTRAVENOUS%A%  
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007275 2006
% 214.37/214.58  |- mesh__dateCreated mesh__D007275 1999-01-01
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007275 1991
% 214.37/214.58  |- skos__prefLabel mesh__D015707 HN Protein
% 214.37/214.58  |- skos__hiddenLabel mesh__D015707 Glycoprotein, HANA
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D015707 2006
% 214.37/214.58  |- mesh__dateEstablished mesh__D015707 1990-01-01
% 214.37/214.58  |- skos__hiddenLabel mesh__D015707
% 214.37/214.58       Glycoprotein, Hemagglutinin-Neuraminidase
% 214.37/214.58  |- skos__altLabel mesh__D015707 Hemagglutinin-Neuraminidase Glycoprotein
% 214.37/214.58  |- mesh__dateCreated mesh__D015707 1989-05-25
% 214.37/214.58  |- skos__broader mesh__D015707smesh__D006389
% 214.37/214.58  |- skos__annotation mesh__D015707
% 214.37/214.58       IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 214.37/214.58  |- mesh__historyNote mesh__D015707 90   
% 214.37/214.58  |- skos__historyNote mesh__D015707
% 214.37/214.58       Viral Envelope Proteins %28%1986-1989%29%
% 214.37/214.58  |- mesh__recordAuthorizer mesh__D015707 sjn
% 214.37/214.58  |- skos__broader mesh__D015707smesh__D014759
% 214.37/214.58  |- skos__historyNote mesh__D015707 Hemagglutinins, Viral %28%1972-1989%29%
% 214.37/214.58  |- skos__historyNote mesh__D015707 Viral Proteins %28%1972-1985%29%
% 214.37/214.58  |- rdf__type mesh__D015707sskos__Concept
% 214.37/214.58  |- skos__scopeNote mesh__D015707
% 214.37/214.58       Glycoprotein from Sendai, para-influenza, Newcastle Disease, and other viruses that participates in binding the virus to cell-surface receptors. The HN protein possesses both hemagglutinin and neuraminidase activity.%A%    
% 214.37/214.58  |- mesh__publicMeSHNote mesh__D015707 90   
% 214.37/214.58  |- mesh__recordMaintainer mesh__D015707 ssb
% 214.37/214.58  |- skos__hiddenLabel mesh__D015707 Protein, HN
% 214.37/214.58  |- skos__hiddenLabel mesh__D015707 Hemagglutinin Neuraminidase Glycoprotein
% 214.37/214.58  |- skos__altLabel mesh__D015707 HANA Glycoprotein
% 214.37/214.58  |- mesh__dateRevised mesh__D015707 2005-06-30
% 214.37/214.58  |- mesh__recordOriginator mesh__D015707 AGS
% 214.37/214.58  |- skos__scopeNote mesh__D003683
% 214.37/214.58       The reversibly oxidized form of ascorbic acid. It is the lactone of 2,3-DIKETOGULONIC ACID and has antiscorbutic activity in man on oral ingestion.%A%    
% 214.37/214.58  |- mesh__recordMaintainer mesh__D003683 ssb
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D003683 2006
% 214.37/214.58  |- skos__historyNote mesh__D003683 Ascorbic Acid %28%1969-1974%29%
% 214.37/214.58  |- mesh__recordAuthorizer mesh__D003683 sjn
% 214.37/214.58  |- skos__broader mesh__D003683smesh__D007783
% 214.37/214.58  |- skos__annotation mesh__D003683
% 214.37/214.58       deficiency: coordinate DEHYDROASCORBIC ACID/defic %28%IM%29% with ASCORBIC ACID DEFICIENCY %28%IM%29%%A%  
% 214.37/214.58  |- mesh__recordOriginator mesh__D003683 NLM
% 214.37/214.58  |- skos__prefLabel mesh__D003683 Dehydroascorbic Acid
% 214.37/214.58  |- mesh__dateCreated mesh__D003683 1974-11-19
% 214.37/214.58  |- mesh__historyNote mesh__D003683
% 214.37/214.58       91%28%75%29%; was see under ASCORBIC ACID 1975-90   
% 214.37/214.58  |- rdf__type mesh__D003683sskos__Concept
% 214.37/214.58  |- mesh__dateRevised mesh__D003683 2005-06-30
% 214.37/214.58  |- skos__hiddenLabel mesh__D003683 Acid, Dehydroascorbic
% 214.37/214.58  |- mesh__dateEstablished mesh__D003683 1991-01-01
% 214.37/214.58  |- mesh__publicMeSHNote mesh__D003683
% 214.37/214.58       91; was see under ASCORBIC ACID 1975-90   
% 214.37/214.58  |- skos__broader mesh__D003683smesh__D001205
% 214.37/214.58  |- skos__broader mesh__D011317smesh__D010409
% 214.37/214.58  |- skos__prefLabel mesh__D011317 Priapism
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D011317 2001
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D011317 2006
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D011317 2000
% 214.37/214.58  |- mesh__recordAuthorizer mesh__D011317 PLS
% 214.37/214.58  |- mesh__dateCreated mesh__D011317 1999-01-01
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D011317 2004
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D011317 2005
% 214.37/214.58  |- rdf__type mesh__D011317sskos__Concept
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D011317 2003
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D011317 1995
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D011317 2002
% 214.37/214.58  |- mesh__dateRevised mesh__D011317 1993-06-02
% 214.37/214.58  |- skos__scopeNote mesh__D011317
% 214.37/214.58       Persistent abnormal erection of the penis, usually without sexual desire, and accompanied by pain and tenderness. It is seen in diseases and injuries of the spinal cord, and may be caused by vesical calculus and certain injuries to the penis. %28%Dorland, 27th ed%29%%A%    
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D011317 1999
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D011317 1997
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D011317 1994
% 214.37/214.58  |- mesh__recordOriginator mesh__D011317 NLM
% 214.37/214.58  |- mesh__recordMaintainer mesh__D011317 TAP
% 214.37/214.58  |- skos__annotation mesh__D011317 persistent penile erection   
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D011317 1998
% 214.37/214.58  |- skos__hiddenLabel mesh__D011317 Priapisms
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D011317 1996
% 214.37/214.58  |- rdf__type mesh__D016800sskos__Concept
% 214.37/214.58  |- skos__scopeNote mesh__D016800
% 214.37/214.58       An order of ciliate protozoa in which the cytostome is usually situated at the base of an oral groove, the wall of which bears dense cilia.%A%    
% 214.37/214.58  |- mesh__recordOriginator mesh__D016800 PXP
% 214.37/214.58  |- mesh__recordAuthorizer mesh__D016800 sjn
% 214.37/214.58  |- mesh__dateCreated mesh__D016800 1991-05-02
% 214.37/214.58  |- skos__annotation mesh__D016800 an order of ciliate protozoa   
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016800 2005
% 214.37/214.58  |- skos__broader mesh__D016800smesh__D016799
% 214.37/214.58  |- mesh__recordMaintainer mesh__D016800 sjn
% 214.37/214.58  |- mesh__publicMeSHNote mesh__D016800 92   
% 214.37/214.58  |- mesh__dateRevised mesh__D016800 2004-07-13
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016800 2006
% 214.37/214.58  |- mesh__historyNote mesh__D016800 92   
% 214.37/214.58  |- skos__prefLabel mesh__D016800 Trichostomatida
% 214.37/214.58  |- mesh__dateEstablished mesh__D016800 1992-01-01
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016002 2004
% 214.37/214.58  |- skos__hiddenLabel mesh__D016002 Discriminant Analyses
% 214.37/214.58  |- mesh__recordMaintainer mesh__D016002 PLS
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016002 1999
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016002 2003
% 214.37/214.58  |- skos__hiddenLabel mesh__D016002 Analyses, Discriminant
% 214.37/214.58  |- mesh__publicMeSHNote mesh__D016002 90   
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016002 2001
% 214.37/214.58  |- mesh__recordAuthorizer mesh__D016002 PLS
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016002 1998
% 214.37/214.58  |- skos__annotation mesh__D016002
% 214.37/214.58       IM GEN only; coord NIM with specific disease or other concept %28%IM%29%; no qualif%A%  
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016002 1997
% 214.37/214.58  |- mesh__dateEstablished mesh__D016002 1990-01-01
% 214.37/214.58  |- mesh__recordOriginator mesh__D016002 PLS
% 214.37/214.58  |- skos__hiddenLabel mesh__D016002 Analysis, Discriminant
% 214.37/214.58  |- skos__historyNote mesh__D016002 Statistics %28%1966-1989%29%
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016002 1996
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016002 2000
% 214.37/214.58  |- rdf__type mesh__D016002sskos__Concept
% 214.37/214.58  |- mesh__historyNote mesh__D016002 90   
% 214.37/214.58  |- mesh__dateRevised mesh__D016002 1994-06-28
% 214.37/214.58  |- mesh__dateCreated mesh__D016002 1989-05-25
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016002 1995
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016002 2006
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016002 2002
% 214.37/214.58  |- skos__scopeNote mesh__D016002
% 214.37/214.58       A statistical analytic technique used with discrete dependent variables, concerned with separating sets of observed values and allocating new values. It is sometimes used instead of regression analysis.%A%    
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D016002 2005
% 214.37/214.58  |- skos__prefLabel mesh__D016002 Discriminant Analysis
% 214.37/214.58  |- skos__broader mesh__D016002smesh__D013223
% 214.37/214.58  |- mesh__dateRevised mesh__D021745 2003-07-09
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D021745 2006
% 214.37/214.58  |- skos__annotation mesh__D021745
% 214.37/214.58       infection: coord IM with COCCIDIOSIS %28%IM%29%; drug eff: consider COCCIDIOSTATS; coord with specific protozoan terms %28%ANTIGENS, PROTOZOAN, etc%29% if pertinent%A%  
% 214.37/214.58  |- skos__prefLabel mesh__D021745 Sarcocystidae
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D021745 2005
% 214.37/214.58  |- mesh__historyNote mesh__D021745
% 214.37/214.58       2001; for BESNOITIA use EIMERIIDA 1992-2000   
% 214.37/214.58  |- mesh__recordMaintainer mesh__D021745 ags
% 214.37/214.58  |- mesh__publicMeSHNote mesh__D021745
% 214.37/214.58       2001; for BESNOITIA see EIMERIINA 1992-2000   
% 214.37/214.58  |- skos__broader mesh__D021745smesh__D021741
% 214.37/214.58  |- mesh__dateCreated mesh__D021745 2000-06-22
% 214.37/214.58  |- mesh__recordOriginator mesh__D021745 ags
% 214.37/214.58  |- mesh__recordAuthorizer mesh__D021745 sjn
% 214.37/214.58  |- rdf__type mesh__D021745sskos__Concept
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D021745 2004
% 214.37/214.58  |- mesh__dateEstablished mesh__D021745 2001-01-01
% 214.37/214.58  |- skos__scopeNote mesh__D021745
% 214.37/214.58       A family of parasitic PROTOZOA in the order EIMERIIDAE. They form tissue-cysts in their intermediate hosts, ultimately leading to pathogenesis in the final hosts that includes various mammals %28%including humans%29% and birds. The most important genera include NEOSPORA; SARCOCYSTIS; and TOXOPLASMA.%A%    
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007276 1994
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007276 1999
% 214.37/214.58  |- mesh__dateRevised mesh__D007276 1993-06-02
% 214.37/214.58  |- skos__historyNote mesh__D007276 Cerebral Ventricles %28%1966-1975%29%
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007276 2000
% 214.37/214.58  |- skos__historyNote mesh__D007276 Injections %28%1966-1975%29%
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007276 1995
% 214.37/214.58  |- rdf__type mesh__D007276sskos__Concept
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007276 2003
% 214.37/214.58  |- skos__altLabel mesh__D007276 Intraventricular Injections
% 214.37/214.58  |- skos__prefLabel mesh__D007276 Injections, Intraventricular
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007276 2004
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007276 2001
% 214.37/214.58  |- mesh__recordAuthorizer mesh__D007276 PLS
% 214.37/214.58  |- skos__scopeNote mesh__D007276
% 214.37/214.58       Injections into the cerebral ventricles.     
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007276 1996
% 214.37/214.58  |- mesh__recordMaintainer mesh__D007276 TGC
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007276 2002
% 214.37/214.58  |- skos__annotation mesh__D007276
% 214.37/214.58       brain, not heart; NIM; do not use /util except by MeSH definition; DF: INJECT INTRAVENTRICULAR%A%  
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007276 1997
% 214.37/214.58  |- skos__hiddenLabel mesh__D007276 Intraventricular Injection
% 214.37/214.58  |- mesh__recordOriginator mesh__D007276 SMH
% 214.37/214.58  |- skos__broader mesh__D007276smesh__D007267
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007276 2005
% 214.37/214.58  |- mesh__dateCreated mesh__D007276 1975-07-18
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007276 2006
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D007276 1998
% 214.37/214.58  |- mesh__historyNote mesh__D007276 76   
% 214.37/214.58  |- skos__hiddenLabel mesh__D007276 Injection, Intraventricular
% 214.37/214.58  |- mesh__publicMeSHNote mesh__D007276 76   
% 214.37/214.58  |- mesh__dateEstablished mesh__D007276 1976-01-01
% 214.37/214.58  |- skos__hiddenLabel mesh__D012410 Rubella Syndromes, Congenital
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D012410 2003
% 214.37/214.58  |- mesh__dateRevised mesh__D012410 1999-11-03
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D012410 2000
% 214.37/214.58  |- skos__historyNote mesh__D012410 Syndrome %28%1972-1986%29%
% 214.37/214.58  |- skos__broader mesh__D012410smesh__D012409
% 214.37/214.58  |- skos__historyNote mesh__D012410 Rubella/congenital %28%1966-1986%29%
% 214.37/214.58  |- skos__annotation mesh__D012410
% 214.37/214.58       caused by a rubivirus; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; restrict to syndrome: see MeSH definition; otherwise RUBELLA /congen permitted%A%  
% 214.37/214.58  |- skos__hiddenLabel mesh__D012410 Congenital Rubella Syndromes
% 214.37/214.58  |- skos__altLabel mesh__D012410 Syndrome, Congenital Rubella
% 214.37/214.58  |- mesh__publicMeSHNote mesh__D012410 91; was see under RUBELLA 1987-90   
% 214.37/214.58  |- mesh__historyNote mesh__D012410
% 214.37/214.58       91%28%87%29%; was see under RUBELLA 1987-90   
% 214.37/214.58  |- skos__prefLabel mesh__D012410 Rubella Syndrome, Congenital
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D012410 2006
% 214.37/214.58  |- skos__altLabel mesh__D012410 Congenital Rubella Syndrome
% 214.37/214.58  |- mesh__dateEstablished mesh__D012410 1991-01-01
% 214.37/214.58  |- mesh__dateCreated mesh__D012410 1986-06-17
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D012410 2005
% 214.37/214.58  |- skos__broader mesh__D012410smesh__D000015
% 214.37/214.58  |- mesh__recordMaintainer mesh__D012410 kle
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D012410 2002
% 214.37/214.58  |- mesh__recordOriginator mesh__D012410 RC
% 214.37/214.58  |- rdf__type mesh__D012410sskos__Concept
% 214.37/214.58  |- mesh__recordAuthorizer mesh__D012410 sjn
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D012410 2004
% 214.37/214.58  |- skos__scopeNote mesh__D012410
% 214.37/214.58       Transplacental infection of the fetus with rubella usually in the first trimester of pregnancy, as a consequence of maternal infection, resulting in various developmental abnormalities in the newborn infant. They include cardiac and ocular lesions, deafness, microcephaly, mental retardation, and generalized growth retardation. %28%From Dorland, 27th ed%29%%A%    
% 214.37/214.58  |- skos__hiddenLabel mesh__D012410 Syndromes, Congenital Rubella
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D012410 2001
% 214.37/214.58  |- mesh__publicMeSHNote mesh__D003684
% 214.37/214.58       91; was see under CHOLESTADIENOLS 1978-90; DEHYDROCHOLESTEROL was see under VITAMIN D 3 1963-66%A%  
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D003684 2004
% 214.37/214.58  |- mesh__recordMaintainer mesh__D003684 ssb
% 214.37/214.58  |- skos__historyNote mesh__D003684 Cholestadienols %28%1974-1977%29%
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D003684 2006
% 214.37/214.58  |- skos__broader mesh__D003684smesh__D002784
% 214.37/214.58  |- mesh__historyNote mesh__D003684
% 214.37/214.58       91%28%78%29%; was see under CHOLESTADIENOLS 1978-90; DEHYDROCHOLESTEROL was see under VITAMIN D 3 1963-66%A%  
% 214.37/214.58  |- mesh__dateRevised mesh__D003684 2003-07-09
% 214.37/214.58  |- mesh__dateEstablished mesh__D003684 1991-01-01
% 214.37/214.58  |- skos__scopeNote mesh__D003684
% 214.37/214.58       Cholesterol derivatives having an additional double bond in any position. 24-Dehydrocholesterol is DESMOSTEROL. The other most prevalent dehydrocholesterol is the 7-isomer. This compound is a precursor of cholesterol and of vitamin D3.%A%    
% 214.37/214.58  |- mesh__onlineNote mesh__D003684
% 214.37/214.58       use CHOLECALCIFEROLS to search DEHYDROCHOLESTEROL 1966   
% 214.37/214.58  |- skos__annotation mesh__D003684
% 214.37/214.58       do not confuse with DIHYDROCHOLESTEROL see CHOLESTANOL; 24-DEHYDROCHOLESTEROL is see DESMOSTEROL%A%  
% 214.37/214.58  |- skos__broader mesh__D003684smesh__D002775
% 214.37/214.58  |- rdf__type mesh__D003684sskos__Concept
% 214.37/214.58  |- skos__historyNote mesh__D003684 Cholesterol %28%1966-1977%29%
% 214.37/214.58  |- mesh__dateCreated mesh__D003684 1977-04-15
% 214.37/214.58  |- mesh__recordAuthorizer mesh__D003684 sjn
% 214.37/214.58  |- mesh__recordOriginator mesh__D003684 RLS
% 214.37/214.58  |- skos__historyNote mesh__D003684 Cholecalciferols %28%1966%29%
% 214.37/214.58  |- mesh__activeMeSHYear mesh__D003684 2005
% 214.37/214.58  |- skos__prefLabel mesh__D003684 Dehydrocholesterols
% 214.37/214.58  |- mesh__dateCreated mesh__D011318 1999-01-01
% 214.37/214.58  |- skos__altLabel mesh__D011318 Astra Brand of Prilocaine Hydrochloride
% 214.37/214.58  |- rdf__type mesh__D011318sskos__Concept
% 214.37/214.58  |- mesh__dateRevised mesh__D011318 2005-06-30
% 214.37/214.58  |- mesh__recordAuthorizer mesh__D011318 sjn
% 214.37/214.58  |- mesh__dateEstablished mesh__D011318 1968-01-01
% 214.37/214.58  |- skos__hiddenLabel mesh__D011318 Hydrochloride, Prilocaine
% 214.37/214.58  |- skos__altLabel mesh__D011318 Inibsa Brand of Prilocaine Hydrochloride
% 214.37/214.59  |- mesh__recordMaintainer mesh__D011318 lkw
% 214.37/214.59  |- skos__altLabel mesh__D011318 Propitocaine
% 214.37/214.59  |- skos__historyNote mesh__D011318 Anesthetics, Local %28%1966%29%
% 214.37/214.59  |- skos__broader mesh__D011318smesh__D000813
% 214.37/214.59  |- skos__prefLabel mesh__D011318 Prilocaine
% 214.37/214.59  |- skos__altLabel mesh__D011318 Xylonest
% 214.37/214.59  |- mesh__historyNote mesh__D011318 68%28%67%29%   
% 214.37/214.59  |- skos__scopeNote mesh__D011318
% 214.37/214.59       A local anesthetic that is similar pharmacologically to LIDOCAINE. Currently, it is used most often for infiltration anesthesia in dentistry. %28%From AMA Drug Evaluations Annual, 1992, p165%29%%A%    
% 214.37/214.59  |- skos__altLabel mesh__D011318
% 214.37/214.59       AstraZeneca Brand of Prilocaine Hydrochloride
% 214.37/214.59  |- mesh__publicMeSHNote mesh__D011318 68   
% 214.37/214.59  |- mesh__recordOriginator mesh__D011318 NLM
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D011318 2006
% 214.37/214.59  |- mesh__dateEstablished mesh__D016801 1992-01-01
% 214.37/214.59  |- mesh__recordOriginator mesh__D016801 PXP
% 214.37/214.59  |- mesh__recordAuthorizer mesh__D016801 sjn
% 214.37/214.59  |- mesh__dateCreated mesh__D016801 1991-05-02
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D016801 2004
% 214.37/214.59  |- mesh__recordMaintainer mesh__D016801 ags
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D016801 2005
% 214.37/214.59  |- skos__broader mesh__D016801smesh__D016800
% 214.37/214.59  |- skos__annotation mesh__D016801 a suborder of ciliate protozoa   
% 214.37/214.59  |- skos__scopeNote mesh__D016801
% 214.37/214.59       A suborder of ciliate protozoa characterized by non-reduction of the somatic ciliature.%A%    
% 214.37/214.59  |- mesh__publicMeSHNote mesh__D016801 92   
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D016801 2006
% 214.37/214.59  |- mesh__dateRevised mesh__D016801 2003-07-09
% 214.37/214.59  |- skos__prefLabel mesh__D016801 Trichostomatina
% 214.37/214.59  |- mesh__historyNote mesh__D016801 92   
% 214.37/214.59  |- rdf__type mesh__D016801sskos__Concept
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D007277 1995
% 214.37/214.59  |- rdf__type mesh__D007277sskos__Concept
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D007277 2003
% 214.37/214.59  |- skos__hiddenLabel mesh__D007277 Jet Injection
% 214.37/214.59  |- skos__altLabel mesh__D007277 Jet Injections
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D007277 2004
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D007277 1996
% 214.37/214.59  |- mesh__dateRevised mesh__D007277 1993-06-02
% 214.37/214.59  |- skos__historyNote mesh__D007277 Injections %28%1966-1971%29%
% 214.37/214.59  |- mesh__recordMaintainer mesh__D007277 TGC
% 214.37/214.59  |- mesh__dateCreated mesh__D007277 1999-01-01
% 214.37/214.59  |- skos__scopeNote mesh__D007277
% 214.37/214.59       The injection of solutions into the skin by compressed air devices so that only the solution pierces the skin.%A%    
% 214.37/214.59  |- mesh__publicMeSHNote mesh__D007277 73   
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D007277 2000
% 214.37/214.59  |- skos__annotation mesh__D007277
% 214.37/214.59       NIM; do not use /util except by MeSH definition; DF: INJECT JET%A%  
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D007277 1997
% 214.37/214.59  |- skos__broader mesh__D007277smesh__D007279
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D007277 2005
% 214.37/214.59  |- mesh__dateEstablished mesh__D007277 1973-01-01
% 214.37/214.59  |- mesh__recordAuthorizer mesh__D007277 PLS
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D007277 2001
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D007277 2006
% 214.37/214.59  |- mesh__recordOriginator mesh__D007277 NLM
% 214.37/214.59  |- skos__hiddenLabel mesh__D007277 Injection, Jet
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D007277 1998
% 214.37/214.59  |- mesh__historyNote mesh__D007277 73%28%72%29%   
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D007277 2002
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D007277 1994
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D007277 1999
% 214.37/214.59  |- skos__prefLabel mesh__D007277 Injections, Jet
% 214.37/214.59  |- mesh__publicMeSHNote mesh__D015709
% 214.37/214.59       90; CORRESPONDENCE was see WRITING 1966-89   
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D015709 2006
% 214.37/214.59  |- skos__annotation mesh__D015709
% 214.37/214.59       IM; /hist permitted for correspondence between hist figures; coord with required biographical and historical headings %26% check tags; do not confuse LETTERS see CORRESPONDENCE with Publication Type LETTER or publication type collected correspondence%A%  
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D015709 2000
% 214.37/214.59  |- skos__altLabel mesh__D015709 Letters
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D015709 2005
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D015709 2004
% 214.37/214.59  |- skos__scopeNote mesh__D015709
% 214.37/214.59       Communication between persons or between institutions or organizations by an exchange of letters. Its use in indexing and cataloging will generally figure in historical and biographical material.%A%    
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D015709 2003
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D015709 2002
% 214.37/214.59  |- mesh__historyNote mesh__D015709
% 214.37/214.59       90; CORRESPONDENCE was see WRITING 1966-89   
% 214.37/214.59  |- rdf__type mesh__D015709sskos__Concept
% 214.37/214.59  |- mesh__dateCreated mesh__D015709 1989-06-22
% 214.37/214.59  |- mesh__recordOriginator mesh__D015709 TGC
% 214.37/214.59  |- mesh__recordMaintainer mesh__D015709 kle
% 214.37/214.59  |- skos__broader mesh__D015709smesh__D014956
% 214.37/214.59  |- skos__prefLabel mesh__D015709 Correspondence
% 214.37/214.59  |- mesh__dateRevised mesh__D015709 1999-11-03
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D015709 2001
% 214.37/214.59  |- mesh__dateEstablished mesh__D015709 1990-01-01
% 214.37/214.59  |- mesh__onlineNote mesh__D015709
% 214.37/214.59       use WRITING to search CORRESPONDENCE 1966-89   
% 214.37/214.59  |- mesh__recordAuthorizer mesh__D015709 sjn
% 214.37/214.59  |- rdf__type mesh__D040102sskos__Concept
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D040102 2004
% 214.37/214.59  |- skos__scopeNote mesh__D040102
% 214.37/214.59       Family of spider MITES, in the superfamily Tetranychoidea, suborder Trombidiformes.%A%    
% 214.37/214.59  |- mesh__publicMeSHNote mesh__D040102 2003   
% 214.37/214.59  |- mesh__dateEstablished mesh__D040102 2003-01-01
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D040102 2006
% 214.37/214.59  |- skos__historyNote mesh__D040102 Mites %28%1966-2002%29%
% 214.37/214.59  |- mesh__dateRevised mesh__D040102 2003-07-09
% 214.37/214.59  |- skos__altLabel mesh__D040102 Spider Mites
% 214.37/214.59  |- skos__prefLabel mesh__D040102 Tetranychidae
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D040102 2005
% 214.37/214.59  |- skos__broader mesh__D040102smesh__D008925
% 214.37/214.59  |- mesh__historyNote mesh__D040102 2003   
% 214.37/214.59  |- skos__altLabel mesh__D040102 Mites, Spider
% 214.37/214.59  |- mesh__dateCreated mesh__D040102 2002-07-03
% 214.37/214.59  |- mesh__dateRevised mesh__D012411 2005-06-30
% 214.37/214.59  |- skos__hiddenLabel mesh__D012411 Vaccine, Rubella
% 214.37/214.59  |- mesh__dateEstablished mesh__D012411 1973-01-01
% 214.37/214.59  |- mesh__recordAuthorizer mesh__D012411 sjn
% 214.37/214.59  |- skos__historyNote mesh__D012411 Viral Vaccines %28%1966-1968%29%
% 214.37/214.59  |- mesh__dateCreated mesh__D012411 1999-01-01
% 214.37/214.59  |- rdf__type mesh__D012411sskos__Concept
% 214.37/214.59  |- skos__scopeNote mesh__D012411
% 214.37/214.59       A live attenuated virus vaccine of duck embryo or human diploid cell tissue culture origin, used for routine immunization of children and for immunization of nonpregnant adolescent and adult females of childbearing age who are unimmunized and do not have serum antibodies to rubella. Children are usually immunized with measles-mumps-rubella combination vaccine. %28%Dorland, 28th ed%29%%A%    
% 214.37/214.59  |- mesh__recordOriginator mesh__D012411 NLM
% 214.37/214.59  |- mesh__publicMeSHNote mesh__D012411 73   
% 214.37/214.59  |- mesh__historyNote mesh__D012411 73%28%69%29%   
% 214.37/214.59  |- skos__prefLabel mesh__D012411 Rubella Vaccine
% 214.37/214.59  |- skos__historyNote mesh__D012411 Rubella Virus %28%1966-1968%29%
% 214.37/214.59  |- skos__broader mesh__D012411smesh__D014765
% 214.37/214.59  |- mesh__recordMaintainer mesh__D012411 ssb
% 214.37/214.59  |- mesh__activeMeSHYear mesh__D012411 2006
% 214.37/214.59  |- skos__broader mesh__D003685smesh__D002793
% 214.37/214.59  |- skos__altLabel mesh__D003685 Triketocholanic Acid
% 214.37/214.59  |- mesh__recordOriginator mesh__D003685 NLM
% 214.37/214.59  |- skos__altLabel mesh__D003685 Ciba Vision Brand of Dehydrocholic Acid
% 214.37/214.59  |- mesh__dateCreated mesh__D003685 1999-01-01
% 214.37/214.59  |- mesh__dateRevised mesh__D003685 2005-06-30
% 214.37/214.59  |- skos__altLabel mesh__D003685 Sodium Dehydrocholate
% 214.37/214.59  |- skos__altLabel mesh__D003685 Glaxo Wellcome Brand of Dehydrocholic Acid
% 214.37/214.59  |- skos__altLabel mesh__D003685
% 214.37/214.59       %28%5beta%29%-3,7,12-Trioxocholan-24-oic Acid
% 214.37/214.59  |- rdf__type mesh__D003685sskos__Concept
% 214.37/214.59  |- skos__hiddenLabel mesh__D003685 Dehydrocholate, Sodium
% 214.37/214.59  |- skos__altLabel mesh__D003685 Ketocholanic Acid
% 214.37/214.59  |- skos__altLabel mesh__D003685 Bayer Brand of Dehydrocholic Acid
% 214.37/214.59  |- mesh__recordMaintainer mesh__D003685 exl
% 214.37/214.59  |- skos__scopeNote mesh__D003685
% 214.37/214.59       A semisynthetic bile acid made from cholic acid. It is used as a cholagogue, hydrocholeretic, diuretic, and as a diagnostic aid.%A%    
% 214.37/214.59  |- skos__prefLabel mesh__D003685 Dehydrocholic Acid
% 214.37/214.59  |- skos__altLabel mesh__D003685 Trioxocholate
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D003685 2006
% 214.44/214.59  |- mesh__recordAuthorizer mesh__D003685 sjn
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D036061 2005
% 214.44/214.59  |- mesh__publicMeSHNote mesh__D036061 2003   
% 214.44/214.59  |- mesh__dateCreated mesh__D036061 2002-07-03
% 214.44/214.59  |- skos__prefLabel mesh__D036061 Solanum glaucophyllum
% 214.44/214.59  |- skos__broader mesh__D036061smesh__D032322
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D036061 2006
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D036061 2003
% 214.44/214.59  |- rdf__type mesh__D036061sskos__Concept
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D036061 2004
% 214.44/214.59  |- mesh__historyNote mesh__D036061 2003   
% 214.44/214.59  |- skos__scopeNote mesh__D036061
% 214.44/214.59       A plant species of the genus SOLANUM, family SOLANACEAE that causes CALCINOSIS in grazing livestock due to high levels of 1a,25-dihydroxy vitamin D3 %28%CALCITRIOL%29%.%A%    
% 214.44/214.59  |- skos__annotation mesh__D036061
% 214.44/214.59       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.44/214.59  |- mesh__dateEstablished mesh__D036061 2003-01-01
% 214.44/214.59  |- skos__broader mesh__D011319smesh__D000634
% 214.44/214.59  |- mesh__recordOriginator mesh__D011319 NLM
% 214.44/214.59  |- skos__scopeNote mesh__D011319
% 214.44/214.59       An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. %28%From Martindale, The Extra Pharmacopeia, 30th ed, p404%29%%A%    
% 214.44/214.59  |- skos__hiddenLabel mesh__D011319 Phosphate, Primaquine
% 214.44/214.59  |- skos__prefLabel mesh__D011319 Primaquine
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D011319 2006
% 214.44/214.59  |- mesh__dateCreated mesh__D011319 1999-01-01
% 214.44/214.59  |- mesh__recordMaintainer mesh__D011319 lkw
% 214.44/214.59  |- mesh__dateRevised mesh__D011319 2005-06-30
% 214.44/214.59  |- rdf__type mesh__D011319sskos__Concept
% 214.44/214.59  |- skos__altLabel mesh__D011319
% 214.44/214.59       Boucher %26% Muir Brand of Primaquine Phosphate
% 214.44/214.59  |- mesh__recordAuthorizer mesh__D011319 sjn
% 214.44/214.59  |- skos__hiddenLabel mesh__D011319 Diphosphate, Primaquine
% 214.44/214.59  |- mesh__publicMeSHNote mesh__D008370 74   
% 214.44/214.59  |- skos__historyNote mesh__D008370 Books %28%1966-1968%29%
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D008370 2005
% 214.44/214.59  |- skos__annotation mesh__D008370
% 214.44/214.59       for manuals as a subject; for actual manuals, consider HANDBOOKS %5B%PUBLICATION TYPE%5D%%A%  
% 214.44/214.59  |- skos__broader mesh__D008370smesh__D013664
% 214.44/214.59  |- mesh__dateEstablished mesh__D008370 1974-01-01
% 214.44/214.59  |- skos__scopeNote mesh__D008370
% 214.44/214.59       Books designed to give factual information or instructions.%A%    
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D008370 2006
% 214.44/214.59  |- skos__broader mesh__D008370smesh__D001877
% 214.44/214.59  |- mesh__dateRevised mesh__D008370 2005-07-15
% 214.44/214.59  |- skos__hiddenLabel mesh__D008370 Manual
% 214.44/214.59  |- rdf__type mesh__D008370sskos__Concept
% 214.44/214.59  |- skos__prefLabel mesh__D008370 Manuals
% 214.44/214.59  |- mesh__recordMaintainer mesh__D008370 ags
% 214.44/214.59  |- mesh__historyNote mesh__D008370 74%28%69%29%   
% 214.44/214.59  |- mesh__recordOriginator mesh__D008370 NLM
% 214.44/214.59  |- mesh__dateCreated mesh__D008370 1999-01-01
% 214.44/214.59  |- mesh__recordAuthorizer mesh__D008370 ags
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D008370 2006A
% 214.44/214.59  |- mesh__recordMaintainer mesh__D022041 jmp
% 214.44/214.59  |- rdf__type mesh__D022041sskos__Concept
% 214.44/214.59  |- mesh__dateCreated mesh__D022041 2000-06-22
% 214.44/214.59  |- skos__broader mesh__D022041smesh__D002843
% 214.44/214.59  |- skos__prefLabel mesh__D022041 Euchromatin
% 214.44/214.59  |- skos__historyNote mesh__D022041 Chromatin %28%1971-2000%29%
% 214.44/214.59  |- mesh__historyNote mesh__D022041
% 214.44/214.59       2001; use EUCHROMATIN %28%NM%29% 1981-2000   
% 214.44/214.59  |- skos__hiddenLabel mesh__D022041 Euchromatins
% 214.44/214.59  |- mesh__dateEstablished mesh__D022041 2001-01-01
% 214.44/214.59  |- mesh__recordOriginator mesh__D022041 nns
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D022041 2005
% 214.44/214.59  |- mesh__recordAuthorizer mesh__D022041 sjn
% 214.44/214.59  |- mesh__dateRevised mesh__D022041 2004-07-07
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D022041 2006
% 214.44/214.59  |- mesh__publicMeSHNote mesh__D022041
% 214.44/214.59       2001; EUCHROMATIN was indexed under CHROMATIN 1981-2000   
% 214.44/214.59  |- skos__scopeNote mesh__D022041
% 214.44/214.59       Chromosome regions that are loosely packaged and more accessible to RNA polymerases than HETEROCHROMATIN. These regions also stain differentially in CHROMOSOME BANDING preparations.%A%    
% 214.44/214.59  |- skos__broader mesh__D016802smesh__D016798
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D016802 2006
% 214.44/214.59  |- mesh__dateEstablished mesh__D016802 1992-01-01
% 214.44/214.59  |- mesh__historyNote mesh__D016802 92   
% 214.44/214.59  |- mesh__recordMaintainer mesh__D016802 ags
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D016802 2005
% 214.44/214.59  |- rdf__type mesh__D016802sskos__Concept
% 214.44/214.59  |- mesh__dateRevised mesh__D016802 2003-07-09
% 214.44/214.59  |- mesh__recordOriginator mesh__D016802 PXP
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D016802 2004
% 214.44/214.59  |- skos__annotation mesh__D016802 a class of ciliate protozoa   
% 214.44/214.59  |- mesh__publicMeSHNote mesh__D016802 92   
% 214.44/214.59  |- skos__prefLabel mesh__D016802 Oligohymenophorea
% 214.44/214.59  |- mesh__recordAuthorizer mesh__D016802 sjn
% 214.44/214.59  |- mesh__dateCreated mesh__D016802 1991-05-02
% 214.44/214.59  |- skos__scopeNote mesh__D016802
% 214.44/214.59       A class of ciliate protozoa. Characteristics include the presence of a well developed oral apparatus and oral cilia being clearly distinct from somatic cilia.%A%    
% 214.44/214.59  |- mesh__recordAuthorizer mesh__D007278 PLS
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007278 1995
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007278 2005
% 214.44/214.59  |- mesh__dateCreated mesh__D007278 1999-01-01
% 214.44/214.59  |- skos__related mesh__D007278smesh__D000775
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007278 1993
% 214.44/214.59  |- mesh__historyNote mesh__D007278
% 214.44/214.59       87; was INJECTIONS, INTRATHECAL 1963-86 %28%Prov 1963-65%29%   
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007278 1991
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007278 1999
% 214.44/214.59  |- mesh__onlineNote mesh__D007278
% 214.44/214.59       use INJECTIONS, SPINAL to search INJECTIONS, INTRATHECAL 1966-86%A%  
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007278 1994
% 214.44/214.59  |- skos__broader mesh__D007278smesh__D007267
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007278 2004
% 214.44/214.59  |- skos__related mesh__D007278smesh__D000767
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007278 1992
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007278 2002
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007278 1998
% 214.44/214.59  |- mesh__dateEstablished mesh__D007278 1966-01-01
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007278 2003
% 214.44/214.59  |- mesh__publicMeSHNote mesh__D007278
% 214.44/214.59       87; was INJECTIONS, INTRATHECAL 1966-86   
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007278 2001
% 214.44/214.59  |- mesh__dateRevised mesh__D007278 1990-06-01
% 214.44/214.59  |- skos__prefLabel mesh__D007278 Injections, Spinal
% 214.44/214.59  |- skos__hiddenLabel mesh__D007278 Injection, Intraspinal
% 214.44/214.59  |- skos__annotation mesh__D007278
% 214.44/214.59       NIM; do not use /util except by MeSH definition; DF: INJECT SPINAL%A%  
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007278 1997
% 214.44/214.59  |- skos__altLabel mesh__D007278 Injections, Intraspinal
% 214.44/214.59  |- mesh__recordMaintainer mesh__D007278 PLS
% 214.44/214.59  |- skos__hiddenLabel mesh__D007278 Intrathecal Injection
% 214.44/214.59  |- skos__hiddenLabel mesh__D007278 Injection, Intrathecal
% 214.44/214.59  |- skos__altLabel mesh__D007278 Spinal Injections
% 214.44/214.59  |- skos__hiddenLabel mesh__D007278 Spinal Injection
% 214.44/214.59  |- skos__hiddenLabel mesh__D007278 Intraspinal Injection
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007278 2000
% 214.44/214.59  |- skos__altLabel mesh__D007278 Intraspinal Injections
% 214.44/214.59  |- skos__altLabel mesh__D007278 Intrathecal Injections
% 214.44/214.59  |- mesh__recordOriginator mesh__D007278 NLM
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007278 1996
% 214.44/214.59  |- rdf__type mesh__D007278sskos__Concept
% 214.44/214.59  |- skos__hiddenLabel mesh__D007278 Injection, Spinal
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007278 2006
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D040901 2006
% 214.44/214.59  |- mesh__dateCreated mesh__D040901 2002-07-03
% 214.44/214.59  |- rdf__type mesh__D040901sskos__Concept
% 214.44/214.59  |- mesh__historyNote mesh__D040901 2003   
% 214.44/214.59  |- mesh__dateEstablished mesh__D040901 2003-01-01
% 214.44/214.59  |- skos__broader mesh__D040901smesh__D001671
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D040901 2005
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D040901 2004
% 214.44/214.59  |- skos__scopeNote mesh__D040901
% 214.44/214.59       The systematic study of the complete complement of proteins %28%PROTEOME%29% of organisms.%A%    
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D040901 2003
% 214.44/214.59  |- skos__related mesh__D040901smesh__D023281
% 214.44/214.59  |- skos__historyNote mesh__D040901 Proteome %28%2000-2002%29%
% 214.44/214.59  |- skos__broader mesh__D040901smesh__D023281
% 214.44/214.59  |- mesh__publicMeSHNote mesh__D040901 2003   
% 214.44/214.59  |- skos__prefLabel mesh__D040901 Proteomics
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D012412 2002
% 214.44/214.59  |- mesh__recordAuthorizer mesh__D012412 sjn
% 214.44/214.59  |- skos__prefLabel mesh__D012412 Rubella virus
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D012412 2006
% 214.44/214.59  |- mesh__dateCreated mesh__D012412 1999-01-01
% 214.44/214.59  |- rdf__type mesh__D012412sskos__Concept
% 214.44/214.59  |- mesh__recordOriginator mesh__D012412 NLM
% 214.44/214.59  |- skos__broader mesh__D012412smesh__D018132
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D012412 2005
% 214.44/214.59  |- skos__altLabel mesh__D012412 Measles Virus, German
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D012412 2004
% 214.44/214.59  |- mesh__publicMeSHNote mesh__D012412 66   
% 214.44/214.59  |- skos__scopeNote mesh__D012412
% 214.44/214.59       The type %28%and only%29% species of RUBIVIRUS causing acute infection in humans, primarily children and young adults. Humans are the only natural host. A live, attenuated vaccine is available for prophylaxis.%A%    
% 214.44/214.59  |- mesh__dateEstablished mesh__D012412 1966-01-01
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D012412 2003
% 214.44/214.59  |- mesh__recordMaintainer mesh__D012412 sjn
% 214.44/214.59  |- skos__annotation mesh__D012412
% 214.44/214.59       do not confuse with RUBULAVIRUS, a RESPIROVIRUS; infection = RUBELLA%A%  
% 214.44/214.59  |- skos__hiddenLabel mesh__D012412 German Measles Virus
% 214.44/214.59  |- mesh__historyNote mesh__D012412 66   
% 214.44/214.59  |- mesh__dateRevised mesh__D012412 2001-08-03
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D008371 2002
% 214.44/214.59  |- mesh__dateEstablished mesh__D008371 1991-01-01
% 214.44/214.59  |- rdf__type mesh__D008371sskos__Concept
% 214.44/214.59  |- mesh__onlineNote mesh__D008371 search STERNUM 1966-74   
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D008371 1995
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D008371 1991
% 214.44/214.59  |- mesh__recordAuthorizer mesh__D008371 PLS
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D008371 2000
% 214.44/214.59  |- mesh__recordMaintainer mesh__D008371 NLM
% 214.44/214.59  |- mesh__historyNote mesh__D008371
% 214.44/214.59       91%28%75%29%; was see under STERNUM 1975-90   
% 214.44/214.59  |- mesh__publicMeSHNote mesh__D008371 91; was see under STERNUM 1975-90   
% 214.44/214.59  |- mesh__dateCreated mesh__D008371 1999-01-01
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D008371 2003
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D008371 2001
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D008371 1996
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D008371 2005
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D008371 2004
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D008371 1992
% 214.44/214.59  |- skos__hiddenLabel mesh__D008371 Manubriums
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D008371 1998
% 214.44/214.59  |- skos__prefLabel mesh__D008371 Manubrium
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D008371 1997
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D008371 2006
% 214.44/214.59  |- mesh__dateRevised mesh__D008371 1990-04-13
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D008371 1994
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D008371 1993
% 214.44/214.59  |- skos__broader mesh__D008371smesh__D013249
% 214.44/214.59  |- mesh__recordOriginator mesh__D008371 NLM
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D008371 1999
% 214.44/214.59  |- mesh__dateRevised mesh__D016803 2003-07-09
% 214.44/214.59  |- mesh__recordOriginator mesh__D016803 PXP
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D016803 2004
% 214.44/214.59  |- mesh__dateEstablished mesh__D016803 1992-01-01
% 214.44/214.59  |- skos__broader mesh__D016803smesh__D016802
% 214.44/214.59  |- skos__scopeNote mesh__D016803
% 214.44/214.59       An order of ciliate protozoa. Characteristics include a ventral oral area and a well-defined buccal cavity. It comprises three suborders: TETRAHYMENINA, Ophryoglenina, and PENICULINA.%A%    
% 214.44/214.59  |- skos__annotation mesh__D016803 an order of ciliate protozoa   
% 214.44/214.59  |- mesh__publicMeSHNote mesh__D016803 92   
% 214.44/214.59  |- mesh__recordAuthorizer mesh__D016803 sjn
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D016803 2006
% 214.44/214.59  |- skos__prefLabel mesh__D016803 Hymenostomatida
% 214.44/214.59  |- mesh__recordMaintainer mesh__D016803 ags
% 214.44/214.59  |- mesh__historyNote mesh__D016803 92   
% 214.44/214.59  |- mesh__dateCreated mesh__D016803 1991-05-02
% 214.44/214.59  |- rdf__type mesh__D016803sskos__Concept
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D016803 2005
% 214.44/214.59  |- skos__broader mesh__D020723Q000031smesh__D020723
% 214.44/214.59  |- mesh__preferredCombination mesh__D020723Q000031smesh__D020722
% 214.44/214.59  |- rdf__type mesh__D020723Q000031smesh__CompoundConcept
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007279 1998
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007279 2006
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007279 2000
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007279 1993
% 214.44/214.59  |- mesh__publicMeSHNote mesh__D007279
% 214.44/214.59       INJECTIONS, INTRADERMAL was heading 1966-86   
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007279 2001
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007279 1994
% 214.44/214.59  |- skos__scopeNote mesh__D007279
% 214.44/214.59       Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin.%A%    
% 214.44/214.59  |- skos__prefLabel mesh__D007279 Injections, Subcutaneous
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007279 1999
% 214.44/214.59  |- mesh__recordAuthorizer mesh__D007279 PLS
% 214.44/214.59  |- mesh__recordOriginator mesh__D007279 NLM
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007279 2002
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007279 1995
% 214.44/214.59  |- skos__altLabel mesh__D007279 Subcutaneous Injections
% 214.44/214.59  |- skos__hiddenLabel mesh__D007279 Injection, Subcutaneous
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007279 2003
% 214.44/214.59  |- rdf__type mesh__D007279sskos__Concept
% 214.44/214.59  |- skos__hiddenLabel mesh__D007279 Subcutaneous Injection
% 214.44/214.59  |- mesh__dateRevised mesh__D007279 1990-06-01
% 214.44/214.59  |- skos__annotation mesh__D007279
% 214.44/214.59       NIM; do not use /util except by MeSH definition; DF: INJECT SUBCUTANEOUS%A%  
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007279 1996
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007279 2004
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007279 1991
% 214.44/214.59  |- mesh__dateCreated mesh__D007279 1999-01-01
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007279 2005
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007279 1992
% 214.44/214.59  |- mesh__recordMaintainer mesh__D007279 TGC
% 214.44/214.59  |- skos__broader mesh__D007279smesh__D007267
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D007279 1997
% 214.44/214.59  |- skos__broader mesh__D012834Q000506smesh__D012834
% 214.44/214.59  |- mesh__preferredCombination mesh__D012834Q000506smesh__D001129
% 214.44/214.59  |- rdf__type mesh__D012834Q000506smesh__CompoundConcept
% 214.44/214.59  |- rdf__type mesh__D012413sskos__Concept
% 214.44/214.59  |- mesh__dateRevised mesh__D012413 1997-06-20
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D012413 2005
% 214.44/214.59  |- skos__scopeNote mesh__D012413
% 214.44/214.59       An element that is an alkali metal. It has an atomic symbol Rb, atomic number 37, and atomic weight 85.47. It is used as a chemical reagent and in the manufacture of photoelectric cells.%A%    
% 214.44/214.59  |- skos__broader mesh__D012413smesh__D008672
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D012413 2002
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D012413 2004
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D012413 2001
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D012413 1999
% 214.44/214.59  |- skos__broader mesh__D012413smesh__D019216
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D012413 2003
% 214.44/214.59  |- mesh__recordOriginator mesh__D012413 NLM
% 214.44/214.59  |- mesh__recordAuthorizer mesh__D012413 SJN
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D012413 2000
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D012413 1998
% 214.44/214.59  |- skos__prefLabel mesh__D012413 Rubidium
% 214.44/214.59  |- skos__annotation mesh__D012413
% 214.44/214.59       an alkali metal; Rb-85; Rb-79-84, 86-95 = RUBIDIUM RADIOISOTOPES %28%IM%29%%A%  
% 214.44/214.59  |- mesh__recordMaintainer mesh__D012413 ADP
% 214.44/214.59  |- mesh__activeMeSHYear mesh__D012413 2006
% 214.44/214.59  |- mesh__dateCreated mesh__D012413 1999-01-01
% 214.44/214.60  |- skos__related mesh__D012413smesh__D012414
% 214.44/214.60  |- skos__broader mesh__D011506Q000652smesh__D011506
% 214.44/214.60  |- mesh__preferredCombination mesh__D011506Q000652smesh__D011507
% 214.44/214.60  |- rdf__type mesh__D011506Q000652smesh__CompoundConcept
% 214.44/214.60  |- skos__related mesh__D036861smesh__D001720
% 214.44/214.60  |- skos__hiddenLabel mesh__D036861 Obstetric Deliveries
% 214.44/214.60  |- skos__related mesh__D036861smesh__D004420
% 214.44/214.60  |- mesh__dateCreated mesh__D036861 2002-07-03
% 214.44/214.60  |- mesh__historyNote mesh__D036861 2003   
% 214.44/214.60  |- skos__historyNote mesh__D036861 Pregnancy %28%1967-1971%29%
% 214.44/214.60  |- skos__prefLabel mesh__D036861 Delivery, Obstetric
% 214.44/214.60  |- skos__altLabel mesh__D036861 Obstetric Delivery
% 214.44/214.60  |- rdf__type mesh__D036861sskos__Concept
% 214.44/214.60  |- skos__scopeNote mesh__D036861
% 214.44/214.60       Delivery of the FETUS and PLACENTA under the care of an obstetrician or a health worker. Obstetric deliveries may involve physical, psychological, medical, or surgical interventions.%A%    
% 214.44/214.60  |- mesh__dateEstablished mesh__D036861 2003-01-01
% 214.44/214.60  |- mesh__publicMeSHNote mesh__D036861 2003   
% 214.44/214.60  |- mesh__dateRevised mesh__D036861 2005-06-30
% 214.44/214.60  |- skos__hiddenLabel mesh__D036861 Deliveries, Obstetric
% 214.44/214.60  |- skos__historyNote mesh__D036861 Delivery %28%1972-2002%29%
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D036861 2006
% 214.44/214.60  |- mesh__recordOriginator mesh__D036861 lkt
% 214.44/214.60  |- skos__annotation mesh__D036861
% 214.44/214.60       %22%tokolysis%22%: translate as %22%tocolysis%22% %26% index as TOCOLYSIS%A%  
% 214.44/214.60  |- mesh__recordAuthorizer mesh__D036861 sjn
% 214.44/214.60  |- mesh__recordMaintainer mesh__D036861 lkt
% 214.44/214.60  |- skos__broader mesh__D036861smesh__D013513
% 214.44/214.60  |- skos__broader mesh__D003687smesh__D015068
% 214.44/214.60  |- skos__altLabel mesh__D003687 DHEA
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D003687 2005
% 214.44/214.60  |- skos__hiddenLabel mesh__D003687 5 Androsten 3 ol 17 one
% 214.44/214.60  |- skos__altLabel mesh__D003687 Dehydroisoandrosterone
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D003687 2004
% 214.44/214.60  |- skos__altLabel mesh__D003687 Prasterone
% 214.44/214.60  |- skos__hiddenLabel mesh__D003687 5 Androsten 3 beta hydroxy 17 one
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D003687 2006
% 214.44/214.60  |- skos__prefLabel mesh__D003687 Dehydroepiandrosterone
% 214.44/214.60  |- skos__scopeNote mesh__D003687
% 214.44/214.60       A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone %28%DHEA%29% can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated %28%DEHYDROEPIANDROSTERONE SULFATE%29% before secretion.%A%    
% 214.44/214.60  |- skos__altLabel mesh__D003687 5-Androsten-3-beta-hydroxy-17-one
% 214.44/214.60  |- mesh__dateRevised mesh__D003687 2003-07-09
% 214.44/214.60  |- mesh__recordAuthorizer mesh__D003687 sjn
% 214.44/214.60  |- skos__altLabel mesh__D003687 Androstenolone
% 214.44/214.60  |- mesh__recordMaintainer mesh__D003687 lkt
% 214.44/214.60  |- mesh__publicMeSHNote mesh__D003687
% 214.44/214.60       2004, 1963-1992; use PRASTERONE 1993-2003   
% 214.44/214.60  |- mesh__dateCreated mesh__D003687 1999-01-01
% 214.44/214.60  |- skos__broader mesh__D003687smesh__D045165
% 214.44/214.60  |- mesh__recordOriginator mesh__D003687 NLM
% 214.44/214.60  |- skos__hiddenLabel mesh__D003687 Prasterone, 3 alpha Isomer
% 214.44/214.60  |- mesh__historyNote mesh__D003687 2004, 1963-1992   
% 214.44/214.60  |- skos__broader mesh__D003687smesh__D000737
% 214.44/214.60  |- rdf__type mesh__D003687sskos__Concept
% 214.44/214.60  |- mesh__recordAuthorizer mesh__D008372 sjn
% 214.44/214.60  |- mesh__recordOriginator mesh__D008372 VDK
% 214.44/214.60  |- skos__annotation mesh__D008372 includes slurry   
% 214.44/214.60  |- mesh__dateEstablished mesh__D008372 1979-01-01
% 214.44/214.60  |- skos__related mesh__D008372smesh__D005243
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D008372 2005
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D008372 2004
% 214.44/214.60  |- mesh__recordMaintainer mesh__D008372 ssb
% 214.44/214.60  |- mesh__historyNote mesh__D008372 79   
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D008372 2006
% 214.44/214.60  |- skos__scopeNote mesh__D008372
% 214.44/214.60       Accumulations of solid or liquid animal excreta usually from stables and barnyards with or without litter material. Its chief application is as a fertilizer. %28%From Webster%27%s 3d ed%29%%A%    
% 214.44/214.60  |- skos__broader mesh__D008372smesh__D045424
% 214.44/214.60  |- mesh__dateCreated mesh__D008372 1977-12-06
% 214.44/214.60  |- skos__historyNote mesh__D008372 Feces %28%1966-1978%29%
% 214.44/214.60  |- rdf__type mesh__D008372sskos__Concept
% 214.44/214.60  |- skos__prefLabel mesh__D008372 Manure
% 214.44/214.60  |- mesh__publicMeSHNote mesh__D008372 79   
% 214.44/214.60  |- mesh__dateRevised mesh__D008372 2003-07-09
% 214.44/214.60  |- mesh__publicMeSHNote mesh__D016804 92   
% 214.44/214.60  |- mesh__recordAuthorizer mesh__D016804 sjn
% 214.44/214.60  |- mesh__dateCreated mesh__D016804 1991-05-02
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D016804 2006
% 214.44/214.60  |- mesh__dateEstablished mesh__D016804 1992-01-01
% 214.44/214.60  |- skos__prefLabel mesh__D016804 Peniculina
% 214.44/214.60  |- mesh__historyNote mesh__D016804 92   
% 214.44/214.60  |- skos__scopeNote mesh__D016804
% 214.44/214.60       A suborder of protozoa characterized by peniculi, which are often situated deep in the buccal cavity, and by fusiform trichocysts.%A%    
% 214.44/214.60  |- rdf__type mesh__D016804sskos__Concept
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D016804 2005
% 214.44/214.60  |- skos__annotation mesh__D016804 a suborder of ciliate protozoa   
% 214.44/214.60  |- mesh__dateRevised mesh__D016804 2003-07-09
% 214.44/214.60  |- mesh__recordMaintainer mesh__D016804 ags
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D016804 2004
% 214.44/214.60  |- skos__broader mesh__D016804smesh__D016803
% 214.44/214.60  |- mesh__recordOriginator mesh__D016804 PXP
% 214.44/214.60  |- rdf__type mesh__D004780sskos__Concept
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D004780 1996
% 214.44/214.60  |- skos__hiddenLabel mesh__D004780 Area, Laminar Air-Flow
% 214.44/214.60  |- skos__annotation mesh__D004780 no qualif; DF: ENVIR CONTROLLED   
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D004780 2000
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D004780 1999
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D004780 1997
% 214.44/214.60  |- skos__hiddenLabel mesh__D004780 Room, Clean
% 214.44/214.60  |- mesh__historyNote mesh__D004780 73   
% 214.44/214.60  |- mesh__dateCreated mesh__D004780 1999-01-01
% 214.44/214.60  |- skos__hiddenLabel mesh__D004780 Clean Room
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D004780 2001
% 214.44/214.60  |- skos__historyNote mesh__D004780 Environment %28%1966-1972%29%
% 214.44/214.60  |- skos__hiddenLabel mesh__D004780 Controlled Environments
% 214.44/214.60  |- skos__scopeNote mesh__D004780
% 214.44/214.60       A state in which the environs of hospitals, laboratories, domestic and animal housing, work places, spacecraft, and other surroundings are under technological control with regard to air conditioning, heating, lighting, humidity, ventilation, and other ambient features. The concept includes control of atmospheric composition. %28%From Jane%27%s Aerospace Dictionary, 3d ed%29%%A%    
% 214.44/214.60  |- mesh__dateRevised mesh__D004780 1995-05-19
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D004780 2005
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D004780 2002
% 214.44/214.60  |- mesh__publicMeSHNote mesh__D004780 73   
% 214.44/214.60  |- skos__related mesh__D004780smesh__D001273
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D004780 2003
% 214.44/214.60  |- mesh__recordAuthorizer mesh__D004780 PLS
% 214.44/214.60  |- mesh__recordOriginator mesh__D004780 NLM
% 214.44/214.60  |- mesh__dateEstablished mesh__D004780 1973-01-01
% 214.44/214.60  |- mesh__recordMaintainer mesh__D004780 KEV
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D004780 2006
% 214.44/214.60  |- skos__related mesh__D004780smesh__D007185
% 214.44/214.60  |- skos__hiddenLabel mesh__D004780 Laminar Air-Flow Area
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D004780 2004
% 214.44/214.60  |- skos__related mesh__D004780smesh__D010357
% 214.44/214.60  |- skos__altLabel mesh__D004780 Controlled Environment
% 214.44/214.60  |- skos__prefLabel mesh__D004780 Environment, Controlled
% 214.44/214.60  |- skos__broader mesh__D004780smesh__D004777
% 214.44/214.60  |- skos__hiddenLabel mesh__D004780 Laminar Air Flow Areas
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D004780 1998
% 214.44/214.60  |- skos__hiddenLabel mesh__D004780 Environments, Controlled
% 214.44/214.60  |- rdf__type mesh__D012414sskos__Concept
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D012414 2003
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D012414 1994
% 214.44/214.60  |- mesh__recordMaintainer mesh__D012414 TPW
% 214.44/214.60  |- skos__historyNote mesh__D012414 Rubidium %28%1966-1987%29%
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D012414 1998
% 214.44/214.60  |- mesh__dateRevised mesh__D012414 1993-06-02
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D012414 2002
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D012414 2004
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D012414 1995
% 214.44/214.60  |- skos__annotation mesh__D012414
% 214.44/214.60       Rb-79-84, 86-95; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 214.44/214.60  |- mesh__recordOriginator mesh__D012414 RLS
% 214.44/214.60  |- skos__hiddenLabel mesh__D012414 Radioisotopes, Rubidium
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D012414 1999
% 214.44/214.60  |- mesh__publicMeSHNote mesh__D012414 88   
% 214.44/214.60  |- mesh__historyNote mesh__D012414 88   
% 214.44/214.60  |- skos__prefLabel mesh__D012414 Rubidium Radioisotopes
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D012414 1996
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D012414 2000
% 214.44/214.60  |- mesh__dateEstablished mesh__D012414 1988-01-01
% 214.44/214.60  |- skos__scopeNote mesh__D012414
% 214.44/214.60       Unstable isotopes of rubidium that decay or disintegrate emitting radiation. Rb atoms with atomic weights 79-84, and 86-95 are radioactive rubidium isotopes.%A%    
% 214.44/214.60  |- skos__historyNote mesh__D012414 Radioisotopes %28%1966-1987%29%
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D012414 2005
% 214.44/214.60  |- mesh__recordAuthorizer mesh__D012414 PLS
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D012414 1997
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D012414 2001
% 214.44/214.60  |- skos__broader mesh__D012414smesh__D011868
% 214.44/214.60  |- mesh__dateCreated mesh__D012414 1987-04-08
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D012414 2006
% 214.44/214.60  |- skos__scopeNote mesh__D050533
% 214.44/214.60       The layer of EXTRACELLULAR MATRIX that lies between the ENDOTHELIUM of the glomerular capillaries and the PODOCYTES of the inner or visceral layer of the BOWMAN CAPSULE. It is the product of these two cell types. It acts as a physical barrier and an ion-selective filter.%A%    
% 214.44/214.60  |- skos__hiddenLabel mesh__D050533 Membranes, Glomerular Basement
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D050533 2006
% 214.44/214.60  |- skos__broader mesh__D050533smesh__D005109
% 214.44/214.60  |- mesh__historyNote mesh__D050533 2006   
% 214.44/214.60  |- rdf__type mesh__D050533sskos__Concept
% 214.44/214.60  |- skos__related mesh__D050533smesh__D019867
% 214.44/214.60  |- mesh__dateCreated mesh__D050533 2005-06-30
% 214.44/214.60  |- skos__hiddenLabel mesh__D050533 Basement Membranes, Glomerular
% 214.44/214.60  |- skos__historyNote mesh__D050533 Basement Membrane %28%1965-2005%29%
% 214.44/214.60  |- mesh__recordAuthorizer mesh__D050533 sjn
% 214.44/214.60  |- skos__prefLabel mesh__D050533 Glomerular Basement Membrane
% 214.44/214.60  |- skos__hiddenLabel mesh__D050533 Membrane, Glomerular Basement
% 214.44/214.60  |- skos__broader mesh__D050533smesh__D001485
% 214.44/214.60  |- skos__historyNote mesh__D050533 Kidney Glomerulus %28%1965-2005%29%
% 214.44/214.60  |- skos__hiddenLabel mesh__D050533 Glomerular Basement Membranes
% 214.44/214.60  |- mesh__recordOriginator mesh__D050533 lkt
% 214.44/214.60  |- skos__broader mesh__D050533smesh__D007678
% 214.44/214.60  |- mesh__recordMaintainer mesh__D050533 lkt
% 214.44/214.60  |- mesh__dateEstablished mesh__D050533 2006-01-01
% 214.44/214.60  |- mesh__publicMeSHNote mesh__D050533 2006   
% 214.44/214.60  |- skos__hiddenLabel mesh__D050533 Basement Membrane, Glomerular
% 214.44/214.60  |- skos__hiddenLabel mesh__D003688 Deinstitutionalized Person
% 214.44/214.60  |- skos__hiddenLabel mesh__D003688 Person, Deinstitutionalized
% 214.44/214.60  |- mesh__recordMaintainer mesh__D003688 PXP
% 214.44/214.60  |- rdf__type mesh__D003688sskos__Concept
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D003688 2001
% 214.44/214.60  |- mesh__historyNote mesh__D003688 79   
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D003688 2004
% 214.44/214.60  |- mesh__dateCreated mesh__D003688 1978-05-08
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D003688 2000
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D003688 1999
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D003688 2003
% 214.44/214.60  |- skos__scopeNote mesh__D003688
% 214.44/214.60       The practice of caring for individuals in the community, rather than in an institutional environment with resultant effects on the individual, the individual%27%s family, the community, and the health care system.%A%    
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D003688 2006
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D003688 1998
% 214.44/214.60  |- mesh__recordOriginator mesh__D003688 EC
% 214.44/214.60  |- mesh__recordAuthorizer mesh__D003688 SJN
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D003688 2002
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D003688 2005
% 214.44/214.60  |- skos__prefLabel mesh__D003688 Deinstitutionalization
% 214.44/214.60  |- mesh__publicMeSHNote mesh__D003688 79   
% 214.44/214.60  |- mesh__dateEstablished mesh__D003688 1979-01-01
% 214.44/214.60  |- skos__annotation mesh__D003688
% 214.44/214.60       %22%caring for individuals in the community, rather than in an institutional environment%22%%A%  
% 214.44/214.60  |- skos__hiddenLabel mesh__D003688 Persons, Deinstitutionalized
% 214.44/214.60  |- mesh__dateRevised mesh__D003688 1997-06-20
% 214.44/214.60  |- skos__broader mesh__D003688smesh__D007326
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D008373 2002
% 214.44/214.60  |- mesh__dateRevised mesh__D008373 1999-11-03
% 214.44/214.60  |- skos__annotation mesh__D008373
% 214.44/214.60       IM; includes books prepared by hand before invention of printing; also handwritten or typescript drafts of pre-print papers, correspondence, diaries, notebooks, memoranda, etc.; check century tag; Manual 33.12: relation to BOOKS%A%  
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D008373 2005
% 214.44/214.60  |- rdf__type mesh__D008373sskos__Concept
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D008373 2001
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D008373 2004
% 214.44/214.60  |- mesh__recordAuthorizer mesh__D008373 sjn
% 214.44/214.60  |- mesh__recordOriginator mesh__D008373 NLM
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D008373 2000
% 214.44/214.60  |- mesh__dateCreated mesh__D008373 1999-01-01
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D008373 2003
% 214.44/214.60  |- skos__prefLabel mesh__D008373 Manuscripts
% 214.44/214.60  |- skos__broader mesh__D008373smesh__D011642
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D008373 2006
% 214.44/214.60  |- skos__hiddenLabel mesh__D008373 Manuscript
% 214.44/214.60  |- skos__scopeNote mesh__D008373
% 214.44/214.60       Compositions written by hand, as one written before the invention or adoption of printing. A manuscript may also refer to a handwritten copy of an ancient author. A manuscript may be handwritten or typewritten as distinguished from a printed copy, especially the copy of a writer%27%s work from which printed copies are made. %28%Webster, 3d ed%29%%A%    
% 214.44/214.60  |- mesh__recordMaintainer mesh__D008373 kle
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D000390 2002
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D000390 2004
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D000390 1997
% 214.44/214.60  |- mesh__recordOriginator mesh__D000390 NLM
% 214.44/214.60  |- skos__broader mesh__D000390smesh__D002627
% 214.44/214.60  |- skos__hiddenLabel mesh__D000390 Ionization, Air
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D000390 2006
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D000390 2001
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D000390 1993
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D000390 1999
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D000390 2003
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D000390 1996
% 214.44/214.60  |- mesh__recordMaintainer mesh__D000390 TAP
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D000390 2000
% 214.44/214.60  |- mesh__recordAuthorizer mesh__D000390 PLS
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D000390 1995
% 214.44/214.60  |- mesh__dateRevised mesh__D000390 1992-03-25
% 214.44/214.60  |- mesh__dateCreated mesh__D000390 1999-01-01
% 214.44/214.60  |- skos__broader mesh__D000390smesh__D000388
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D000390 2005
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D000390 1998
% 214.44/214.60  |- skos__hiddenLabel mesh__D000390 Ionizations, Air
% 214.44/214.60  |- skos__hiddenLabel mesh__D000390 Air Ionizations
% 214.44/214.60  |- mesh__publicMeSHNote mesh__D000390 70   
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D000390 1994
% 214.44/214.60  |- rdf__type mesh__D000390sskos__Concept
% 214.44/214.60  |- mesh__historyNote mesh__D000390 70%28%65%29%   
% 214.44/214.60  |- skos__prefLabel mesh__D000390 Air Ionization
% 214.44/214.60  |- mesh__dateEstablished mesh__D000390 1970-01-01
% 214.44/214.60  |- skos__broader mesh__D016805smesh__D010247
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D016805 2006
% 214.44/214.60  |- skos__annotation mesh__D016805 used as a research tool   
% 214.44/214.60  |- mesh__historyNote mesh__D016805 92   
% 214.44/214.60  |- mesh__recordAuthorizer mesh__D016805 sjn
% 214.44/214.60  |- mesh__publicMeSHNote mesh__D016805 92   
% 214.44/214.60  |- skos__historyNote mesh__D016805 Paramecium %28%1976-1991%29%
% 214.44/214.60  |- rdf__type mesh__D016805sskos__Concept
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D016805 2005
% 214.44/214.60  |- mesh__dateRevised mesh__D016805 2003-07-09
% 214.44/214.60  |- mesh__recordMaintainer mesh__D016805 ags
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D016805 2004
% 214.44/214.60  |- mesh__dateCreated mesh__D016805 1991-05-02
% 214.44/214.60  |- mesh__dateEstablished mesh__D016805 1992-01-01
% 214.44/214.60  |- mesh__recordOriginator mesh__D016805 PXP
% 214.44/214.60  |- skos__prefLabel mesh__D016805 Paramecium tetraurelia
% 214.44/214.60  |- skos__scopeNote mesh__D016805
% 214.44/214.60       A species of ciliate protozoa. It is used in biomedical research.%A%    
% 214.44/214.60  |- mesh__recordOriginator mesh__D004781 NLM
% 214.44/214.60  |- mesh__publicMeSHNote mesh__D004781 74   
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D004781 2005
% 214.44/214.60  |- skos__related mesh__D004781smesh__D016273
% 214.44/214.60  |- skos__related mesh__D004781smesh__D004784
% 214.44/214.60  |- skos__related mesh__D004781smesh__D000394
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D004781 2002
% 214.44/214.60  |- mesh__dateCreated mesh__D004781 1999-01-01
% 214.44/214.60  |- mesh__dateRevised mesh__D004781 1999-11-03
% 214.44/214.60  |- skos__related mesh__D004781smesh__D018876
% 214.44/214.60  |- mesh__recordAuthorizer mesh__D004781 sjn
% 214.44/214.60  |- mesh__recordMaintainer mesh__D004781 kle
% 214.44/214.60  |- skos__annotation mesh__D004781
% 214.44/214.60       may or may not result in a disease; coord IM with specific substance %28%IM%29%; DF: ENVIR EXPOSURE%A%  
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D004781 2001
% 214.44/214.60  |- rdf__type mesh__D004781sskos__Concept
% 214.44/214.60  |- mesh__historyNote mesh__D004781 74%28%67%29%   
% 214.44/214.60  |- skos__broader mesh__D004781smesh__D004787
% 214.44/214.60  |- skos__related mesh__D004781smesh__D018923
% 214.44/214.60  |- skos__scopeNote mesh__D004781
% 214.44/214.60       The exposure to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals.%A%    
% 214.44/214.60  |- skos__hiddenLabel mesh__D004781 Exposures, Environmental
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D004781 2000
% 214.44/214.60  |- skos__altLabel mesh__D004781 Exposure, Environmental
% 214.44/214.60  |- skos__hiddenLabel mesh__D004781 Environmental Exposures
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D004781 2004
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D004781 2006
% 214.44/214.60  |- skos__related mesh__D004781smesh__D018777
% 214.44/214.60  |- mesh__dateEstablished mesh__D004781 1974-01-01
% 214.44/214.60  |- skos__prefLabel mesh__D004781 Environmental Exposure
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D004781 2003
% 214.44/214.60  |- mesh__recordOriginator mesh__D012415 NLM
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D012415 2004
% 214.44/214.60  |- skos__altLabel mesh__D012415 Rubinstein Syndrome
% 214.44/214.60  |- skos__hiddenLabel mesh__D012415 Broad Thumb-Hallux Syndromes
% 214.44/214.60  |- mesh__dateEstablished mesh__D012415 1991-01-01
% 214.44/214.60  |- skos__broader mesh__D012415smesh__D019465
% 214.44/214.60  |- mesh__historyNote mesh__D012415
% 214.44/214.60       91%28%72%29%; was see under ABNORMALITIES, MULTIPLE 1972-90   
% 214.44/214.60  |- skos__broader mesh__D012415smesh__D008607
% 214.44/214.60  |- skos__historyNote mesh__D012415
% 214.44/214.60       Abnormalities, Multiple %28%1968-1971%29%
% 214.44/214.60  |- skos__broader mesh__D012415smesh__D004413
% 214.44/214.60  |- skos__historyNote mesh__D012415 Mental Retardation %28%1966-1971%29%
% 214.44/214.60  |- skos__hiddenLabel mesh__D012415 Syndromes, Broad Thumb-Hallux
% 214.44/214.60  |- mesh__dateCreated mesh__D012415 1999-01-01
% 214.44/214.60  |- mesh__recordMaintainer mesh__D012415 nns
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D012415 2002
% 214.44/214.60  |- skos__hiddenLabel mesh__D012415 Broad Thumb Hallux Syndrome
% 214.44/214.60  |- skos__hiddenLabel mesh__D012415 Syndrome, Rubinstein
% 214.44/214.60  |- skos__hiddenLabel mesh__D012415 Rubinstein Taybi Syndrome
% 214.44/214.60  |- skos__hiddenLabel mesh__D012415 Syndrome, Rubinstein-Taybi
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D012415 2005
% 214.44/214.60  |- skos__broader mesh__D012415smesh__D025063
% 214.44/214.60  |- skos__altLabel mesh__D012415 Broad Thumb-Hallux Syndrome
% 214.44/214.60  |- mesh__dateRevised mesh__D012415 2001-07-25
% 214.44/214.60  |- skos__hiddenLabel mesh__D012415 Syndrome, Broad Thumb-Hallux
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D012415 2006
% 214.44/214.60  |- mesh__publicMeSHNote mesh__D012415
% 214.44/214.60       91; was see under ABNORMALITIES, MULTIPLE 1972-90   
% 214.44/214.60  |- skos__broader mesh__D012415smesh__D000015
% 214.44/214.60  |- rdf__type mesh__D012415sskos__Concept
% 214.44/214.60  |- skos__related mesh__D012415smesh__D008607
% 214.44/214.60  |- skos__prefLabel mesh__D012415 Rubinstein-Taybi Syndrome
% 214.44/214.60  |- mesh__recordAuthorizer mesh__D012415 sjn
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D012415 2003
% 214.44/214.60  |- skos__scopeNote mesh__D012415
% 214.44/214.60       A chromosomal disorder characterized by MENTAL RETARDATION, broad thumbs, webbing of fingers and toes, beaked nose, short upper lip, pouting lower lip, agenesis of corpus callosum, large foramen magnum, keloid formation, pulmonary stenosis, vertebral anomalies, chest wall anomalies, sleep apnea, and megacolon. The disease has an autosomal dominant pattern of inheritance and is associated with deletions of the short arm of chromosome 16 %28%16p13.3%29%.%A%    
% 214.44/214.60  |- rdf__type mesh__D017100sskos__Concept
% 214.44/214.60  |- mesh__recordMaintainer mesh__D017100 ags
% 214.44/214.60  |- mesh__dateCreated mesh__D017100 1992-05-07
% 214.44/214.60  |- skos__scopeNote mesh__D017100
% 214.44/214.60       A species of temperate bacteriophage in the genus P22-like Viruses, family PODOVIRIDAE, that infects Salmonella species. The genome consists of double-stranded DNA, terminally redundant, and circularly permuted.%A%    
% 214.44/214.60  |- skos__altLabel mesh__D017100 Phage P22
% 214.44/214.60  |- mesh__recordAuthorizer mesh__D017100 sjn
% 214.44/214.60  |- mesh__historyNote mesh__D017100 93   
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D017100 2002
% 214.44/214.60  |- skos__historyNote mesh__D017100 Salmonella Phages %28%1966-1992%29%
% 214.44/214.60  |- mesh__publicMeSHNote mesh__D017100 93   
% 214.44/214.60  |- skos__hiddenLabel mesh__D017100 Phage, P22
% 214.44/214.60  |- skos__hiddenLabel mesh__D017100 P22 Phages
% 214.44/214.60  |- skos__broader mesh__D017100smesh__D012483
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D017100 2005
% 214.44/214.60  |- mesh__recordOriginator mesh__D017100 AGS
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D017100 2006
% 214.44/214.60  |- skos__annotation mesh__D017100
% 214.44/214.60       coord IM with specific Salmonella /virol   
% 214.44/214.60  |- skos__broader mesh__D017100smesh__D017902
% 214.44/214.60  |- mesh__dateRevised mesh__D017100 2001-07-25
% 214.44/214.60  |- skos__hiddenLabel mesh__D017100 Phages, P22
% 214.44/214.60  |- skos__altLabel mesh__D017100 Enterobacteria phage P22
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D017100 2003
% 214.44/214.60  |- mesh__dateEstablished mesh__D017100 1993-01-01
% 214.44/214.60  |- skos__altLabel mesh__D017100 P22 Phage
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D017100 2004
% 214.44/214.60  |- skos__prefLabel mesh__D017100 Bacteriophage P22
% 214.44/214.60  |- mesh__publicMeSHNote mesh__D003689
% 214.44/214.60       2000; see DEITER%27%S NUCLEUS 1991-1999, see VESTIBULAR NUCLEI 1967-90%A%  
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D003689 2001
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D003689 2000
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D003689 2004
% 214.44/214.60  |- skos__hiddenLabel mesh__D003689 Deiters Nucleus
% 214.44/214.60  |- mesh__recordMaintainer mesh__D003689 ags
% 214.44/214.60  |- skos__altLabel mesh__D003689 Deiter%27%s Nucleus
% 214.44/214.60  |- skos__scopeNote mesh__D003689
% 214.44/214.60       Vestibular nucleus lying immediately superior to the inferior vestibular nucleus and composed of large multipolar nerve cells. Its upper end becomes continuous with the superior vestibular nucleus. %28%From Dorland, 28th ed%29%%A%    
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D003689 2003
% 214.44/214.60  |- skos__broader mesh__D003689smesh__D014726
% 214.44/214.60  |- skos__hiddenLabel mesh__D003689 Nucleus, Deiter%27%s
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D003689 2002
% 214.44/214.60  |- skos__prefLabel mesh__D003689 Vestibular Nucleus, Lateral
% 214.44/214.60  |- mesh__dateRevised mesh__D003689 1999-11-04
% 214.44/214.60  |- mesh__historyNote mesh__D003689
% 214.44/214.60       2000%28%1975%29%; use VESTIBULAR NUCLEI 1967-1974   
% 214.44/214.60  |- skos__altLabel mesh__D003689 Deiter Nucleus
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D003689 2006
% 214.44/214.60  |- skos__hiddenLabel mesh__D003689 Nucleus, Deiter
% 214.44/214.60  |- mesh__recordAuthorizer mesh__D003689 sjn
% 214.44/214.60  |- skos__hiddenLabel mesh__D003689 Nucleus, Lateral Vestibular
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D003689 2005
% 214.44/214.60  |- skos__altLabel mesh__D003689 Lateral Vestibular Nucleus
% 214.44/214.60  |- mesh__dateCreated mesh__D003689 1999-01-01
% 214.44/214.60  |- mesh__recordOriginator mesh__D003689 NLM
% 214.44/214.60  |- mesh__dateEstablished mesh__D003689 1991-01-01
% 214.44/214.60  |- rdf__type mesh__D003689sskos__Concept
% 214.44/214.60  |- skos__altLabel mesh__D008374 Medical Manuscripts
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D008374 2002
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D008374 2004
% 214.44/214.60  |- mesh__dateRevised mesh__D008374 1996-06-10
% 214.44/214.60  |- mesh__dateCreated mesh__D008374 1999-01-01
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D008374 1997
% 214.44/214.60  |- skos__prefLabel mesh__D008374 Manuscripts, Medical
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D008374 2003
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D008374 2001
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D008374 2006
% 214.44/214.60  |- mesh__recordAuthorizer mesh__D008374 PLS
% 214.44/214.60  |- skos__annotation mesh__D008374
% 214.44/214.60       see note on MANUSCRIPTS; DF: MANUSCRIPTS MED   
% 214.44/214.60  |- skos__altLabel mesh__D008374 Medical Manuscript
% 214.44/214.60  |- skos__altLabel mesh__D008374 Manuscript, Medical
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D008374 2000
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D008374 1999
% 214.44/214.60  |- mesh__recordOriginator mesh__D008374 NLM
% 214.44/214.60  |- rdf__type mesh__D008374sskos__Concept
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D008374 2005
% 214.44/214.60  |- mesh__recordMaintainer mesh__D008374 TGC
% 214.44/214.60  |- skos__broader mesh__D008374smesh__D008373
% 214.44/214.60  |- mesh__activeMeSHYear mesh__D008374 1998
% 214.44/214.61  |- mesh__dateCreated mesh__D000391 1999-01-01
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000391 2005
% 214.44/214.61  |- rdf__type mesh__D000391sskos__Concept
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000391 2002
% 214.44/214.61  |- mesh__recordAuthorizer mesh__D000391 sjn
% 214.44/214.61  |- skos__annotation mesh__D000391
% 214.44/214.61       IM; coord IM with specific bact, virus or fungus %28%IM%29%; DF: AIR MICROBIOL%A%  
% 214.44/214.61  |- mesh__dateRevised mesh__D000391 2001-07-25
% 214.44/214.61  |- mesh__recordOriginator mesh__D000391 NLM
% 214.44/214.61  |- skos__altLabel mesh__D000391 Microbiology, Air
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000391 2004
% 214.44/214.61  |- mesh__recordMaintainer mesh__D000391 jls
% 214.44/214.61  |- skos__broader mesh__D000391smesh__D004783
% 214.44/214.61  |- skos__scopeNote mesh__D000391
% 214.44/214.61       The presence of bacteria, viruses, and fungi in the air. This term is not restricted to pathogenic organisms.%A%    
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000391 2006
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000391 2003
% 214.44/214.61  |- skos__prefLabel mesh__D000391 Air Microbiology
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D016806 2005
% 214.44/214.61  |- skos__broader mesh__D016806smesh__D016803
% 214.44/214.61  |- mesh__recordOriginator mesh__D016806 PXP
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D016806 2006
% 214.44/214.61  |- mesh__historyNote mesh__D016806 92   
% 214.44/214.61  |- mesh__recordMaintainer mesh__D016806 ags
% 214.44/214.61  |- rdf__type mesh__D016806sskos__Concept
% 214.44/214.61  |- mesh__dateRevised mesh__D016806 2003-07-09
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D016806 2004
% 214.44/214.61  |- skos__prefLabel mesh__D016806 Tetrahymenina
% 214.44/214.61  |- skos__scopeNote mesh__D016806
% 214.44/214.61       A suborder of ciliate protozoa. Most organisms are free-living in fresh water and many species are used extensively for experimental studies.%A%    
% 214.44/214.61  |- mesh__dateCreated mesh__D016806 1991-05-02
% 214.44/214.61  |- mesh__recordAuthorizer mesh__D016806 sjn
% 214.44/214.61  |- mesh__publicMeSHNote mesh__D016806 92   
% 214.44/214.61  |- mesh__dateEstablished mesh__D016806 1992-01-01
% 214.44/214.61  |- skos__annotation mesh__D016806
% 214.44/214.61       a suborder of ciliate protozoa: do not confuse with genus TETRAHYMENA%A%  
% 214.44/214.61  |- mesh__recordAuthorizer mesh__D016008 SJN
% 214.44/214.61  |- mesh__dateCreated mesh__D016008 1989-05-25
% 214.44/214.61  |- mesh__recordOriginator mesh__D016008 PLS
% 214.44/214.61  |- mesh__historyNote mesh__D016008 98; use explode 1990-97   
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D016008 2001
% 214.44/214.61  |- rdf__type mesh__D016008sskos__Concept
% 214.44/214.61  |- skos__hiddenLabel mesh__D016008 Distributions, Statistical
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D016008 2005
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D016008 2002
% 214.44/214.61  |- mesh__dateEstablished mesh__D016008 1998-01-01
% 214.44/214.61  |- mesh__recordMaintainer mesh__D016008 TGC
% 214.44/214.61  |- skos__scopeNote mesh__D016008
% 214.44/214.61       The complete summaries of the frequencies of the values or categories of a measurement made on a group of items, a population, or other collection of data. The distribution tells either how many or what proportion of the group was found to have each value %28%or each range of values%29% out of all the possible values that the quantitative measure can have.%A%    
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D016008 2006
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D016008 2003
% 214.44/214.61  |- skos__hiddenLabel mesh__D016008 Distribution, Statistical
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D016008 1998
% 214.44/214.61  |- skos__annotation mesh__D016008
% 214.44/214.61       how many or what proportion of a group has a given value: read MeSH definition; GEN or unspecified: prefer specifics; IM; coord with subject of data /epidemiol or /statist %28%IM%29%; DF: STATIST DISTRIBUTIONS%A%  
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D016008 2004
% 214.44/214.61  |- skos__broader mesh__D016008smesh__D013223
% 214.44/214.61  |- mesh__dateRevised mesh__D016008 1997-06-20
% 214.44/214.61  |- skos__hiddenLabel mesh__D016008 Statistical Distribution
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D016008 1999
% 214.44/214.61  |- skos__prefLabel mesh__D016008 Statistical Distributions
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D016008 2000
% 214.44/214.61  |- mesh__publicMeSHNote mesh__D016008 98   
% 214.44/214.61  |- skos__hiddenLabel mesh__D004782 Healths, Environmental
% 214.44/214.61  |- mesh__dateCreated mesh__D004782 1999-01-01
% 214.44/214.61  |- skos__scopeNote mesh__D004782
% 214.44/214.61       The science of controlling or modifying those conditions, influences, or forces surrounding man which relate to promoting, establishing, and maintaining health.%A%    
% 214.44/214.61  |- mesh__dateRevised mesh__D004782 2005-06-30
% 214.44/214.61  |- skos__related mesh__D004782smesh__D004777
% 214.44/214.61  |- mesh__recordOriginator mesh__D004782 NLM
% 214.44/214.61  |- rdf__type mesh__D004782sskos__Concept
% 214.44/214.61  |- skos__hiddenLabel mesh__D004782 Health Sciences, Environmental
% 214.44/214.61  |- skos__hiddenLabel mesh__D004782 Environmental Health Sciences
% 214.44/214.61  |- skos__hiddenLabel mesh__D004782 Sciences, Environmental Health
% 214.44/214.61  |- skos__altLabel mesh__D004782 Environmental Health Science
% 214.44/214.61  |- skos__annotation mesh__D004782 index geographic term if pertinent   
% 214.44/214.61  |- skos__related mesh__D004782smesh__D004463
% 214.44/214.61  |- mesh__recordAuthorizer mesh__D004782 sjn
% 214.44/214.61  |- skos__broader mesh__D004782smesh__D006281
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D004782 2006
% 214.44/214.61  |- skos__prefLabel mesh__D004782 Environmental Health
% 214.44/214.61  |- skos__hiddenLabel mesh__D004782 Health Science, Environmental
% 214.44/214.61  |- skos__hiddenLabel mesh__D004782 Environmental Healths
% 214.44/214.61  |- mesh__recordMaintainer mesh__D004782 ssb
% 214.44/214.61  |- skos__altLabel mesh__D004782 Health, Environmental
% 214.44/214.61  |- skos__hiddenLabel mesh__D004782 Science, Environmental Health
% 214.44/214.61  |- mesh__historyNote mesh__D012416
% 214.44/214.61       91%28%73%29%; was see under FERREDOXINS 1973-90   
% 214.44/214.61  |- skos__prefLabel mesh__D012416 Rubredoxins
% 214.44/214.61  |- mesh__recordAuthorizer mesh__D012416 sjn
% 214.44/214.61  |- mesh__dateRevised mesh__D012416 2005-06-30
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D012416 2006
% 214.44/214.61  |- mesh__recordMaintainer mesh__D012416 SYSTEM
% 214.44/214.61  |- skos__broader mesh__D012416smesh__D005288
% 214.44/214.61  |- rdf__type mesh__D012416sskos__Concept
% 214.44/214.61  |- skos__scopeNote mesh__D012416
% 214.44/214.61       A class of iron-sulfur proteins that contains one iron coordinated to the sulfur atom of four cysteine residues. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%    
% 214.44/214.61  |- mesh__recordOriginator mesh__D012416 NLM
% 214.44/214.61  |- mesh__publicMeSHNote mesh__D012416
% 214.44/214.61       91; was see under FERREDOXINS 1973-90   
% 214.44/214.61  |- mesh__dateEstablished mesh__D012416 1991-01-01
% 214.44/214.61  |- mesh__dateCreated mesh__D012416 1999-01-01
% 214.44/214.61  |- skos__annotation mesh__D012416 a ferredoxin   
% 214.44/214.61  |- mesh__dateEstablished mesh__D017101 1993-01-01
% 214.44/214.61  |- skos__altLabel mesh__D017101 P1 Phage
% 214.44/214.61  |- skos__altLabel mesh__D017101 Enterobacteria phage P1
% 214.44/214.61  |- skos__hiddenLabel mesh__D017101 Phage, P1
% 214.44/214.61  |- skos__historyNote mesh__D017101 Coliphages %28%1966-1992%29%
% 214.44/214.61  |- mesh__historyNote mesh__D017101 93   
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D017101 2005
% 214.44/214.61  |- skos__broader mesh__D017101smesh__D017900
% 214.44/214.61  |- skos__altLabel mesh__D017101 Phage P1
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D017101 2006
% 214.44/214.61  |- skos__prefLabel mesh__D017101 Bacteriophage P1
% 214.44/214.61  |- skos__scopeNote mesh__D017101
% 214.44/214.61       A species of temperate bacteriophage in the genus P1-like Viruses, family MYOVIRIDAE which infects E. coli. It is the largest of the coliphages and consists of double-stranded DNA, terminally redundant, and circularly permuted.%A%    
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D017101 2002
% 214.44/214.61  |- mesh__recordAuthorizer mesh__D017101 sjn
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D017101 2003
% 214.44/214.61  |- mesh__recordOriginator mesh__D017101 AGS
% 214.44/214.61  |- mesh__publicMeSHNote mesh__D017101 93   
% 214.44/214.61  |- skos__hiddenLabel mesh__D017101 Phages, P1
% 214.44/214.61  |- skos__hiddenLabel mesh__D017101 P1 Phages
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D017101 2004
% 214.44/214.61  |- mesh__dateRevised mesh__D017101 2001-07-25
% 214.44/214.61  |- skos__broader mesh__D017101smesh__D003090
% 214.44/214.61  |- rdf__type mesh__D017101sskos__Concept
% 214.44/214.61  |- mesh__recordMaintainer mesh__D017101 ags
% 214.44/214.61  |- mesh__dateCreated mesh__D017101 1992-05-07
% 214.44/214.61  |- skos__altLabel mesh__D017101 Coliphage P1
% 214.44/214.61  |- skos__altLabel mesh__D008375 Maple Syrup Urine Disease, Intermediate
% 214.44/214.61  |- skos__altLabel mesh__D008375 MSUD %28%Maple Syrup Urine Disease%29%
% 214.44/214.61  |- skos__broader mesh__D008375smesh__D000592
% 214.44/214.61  |- skos__hiddenLabel mesh__D008375 Branched Chain Ketoaciduria
% 214.44/214.61  |- mesh__recordMaintainer mesh__D008375 jls
% 214.44/214.61  |- skos__altLabel mesh__D008375 Maple Syrup Urine Disease, Classical
% 214.44/214.61  |- mesh__recordOriginator mesh__D008375 NLM
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D008375 2006
% 214.44/214.61  |- skos__altLabel mesh__D008375 Classical Maple Syrup Urine Disease
% 214.44/214.61  |- skos__prefLabel mesh__D008375 Maple Syrup Urine Disease
% 214.44/214.61  |- rdf__type mesh__D008375sskos__Concept
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D008375 2005
% 214.44/214.61  |- skos__hiddenLabel mesh__D008375 Ketoaciduria, Branched-Chain
% 214.44/214.61  |- skos__broader mesh__D008375smesh__D020739
% 214.44/214.61  |- mesh__recordAuthorizer mesh__D008375 jls
% 214.44/214.61  |- skos__altLabel mesh__D008375 Maple Syrup Urine Disease, Classic
% 214.44/214.61  |- mesh__dateRevised mesh__D008375 2004-07-28
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D008375 2004
% 214.44/214.61  |- skos__scopeNote mesh__D008375
% 214.44/214.61       An autosomal recessive inherited disorder with multiple forms of phenotypic expression, caused by a defect in the oxidative decarboxylation of branched-chain amino acids %28%AMINO ACIDS, BRANCHED-CHAIN%29%. These metabolites accumulate in body fluids and render a %22%maple syrup%22% odor. The disease is divided into classic, intermediate, intermittent, and thiamine responsive subtypes. The classic form presents in the first week of life with ketoacidosis, hypoglycemia, emesis, neonatal seizures, and hypertonia. The intermediate and intermittent forms present in childhood or later with acute episodes of ataxia and vomiting. %28%From Adams et al., Principles of Neurology, 6th ed, p936%29%%A%    
% 214.44/214.61  |- skos__altLabel mesh__D008375 Branched-Chain Ketoaciduria
% 214.44/214.61  |- skos__altLabel mesh__D008375 Maple Syrup Urine Disease, Intermittent
% 214.44/214.61  |- skos__hiddenLabel mesh__D008375 Ketoacidurias, Branched-Chain
% 214.44/214.61  |- mesh__dateCreated mesh__D008375 1999-01-01
% 214.44/214.61  |- skos__altLabel mesh__D008375
% 214.44/214.61       Thiamine Responsive Maple Syrup Urine Disease
% 214.44/214.61  |- skos__hiddenLabel mesh__D008375 Branched-Chain Ketoacidurias
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D008375 2005A
% 214.44/214.61  |- mesh__recordMaintainer mesh__D000392 TGC
% 214.44/214.61  |- mesh__dateRevised mesh__D000392 1991-06-13
% 214.44/214.61  |- skos__annotation mesh__D000392
% 214.44/214.61       no qualif; WIND is also available but see note there   
% 214.44/214.61  |- mesh__publicMeSHNote mesh__D000392 74   
% 214.44/214.61  |- rdf__type mesh__D000392sskos__Concept
% 214.44/214.61  |- skos__hiddenLabel mesh__D000392 Movements, Air
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000392 2004
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000392 1997
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000392 2002
% 214.44/214.61  |- skos__historyNote mesh__D000392 Weather %28%1966-1971%29%
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000392 2006
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000392 1999
% 214.44/214.61  |- skos__prefLabel mesh__D000392 Air Movements
% 214.44/214.61  |- mesh__historyNote mesh__D000392 74%28%72%29%   
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000392 2003
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000392 1996
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000392 1993
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000392 2001
% 214.44/214.61  |- skos__hiddenLabel mesh__D000392 Air Movement
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000392 1995
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000392 2005
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000392 1998
% 214.44/214.61  |- mesh__recordOriginator mesh__D000392 NLM
% 214.44/214.61  |- skos__historyNote mesh__D000392 Air %28%1966-1971%29%
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000392 1992
% 214.44/214.61  |- mesh__dateCreated mesh__D000392 1999-01-01
% 214.44/214.61  |- skos__broader mesh__D000392smesh__D000388
% 214.44/214.61  |- skos__hiddenLabel mesh__D000392 Movement, Air
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000392 1994
% 214.44/214.61  |- mesh__dateEstablished mesh__D000392 1974-01-01
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000392 2000
% 214.44/214.61  |- mesh__recordAuthorizer mesh__D000392 PLS
% 214.44/214.61  |- mesh__dateEstablished mesh__D016009 1990-01-01
% 214.44/214.61  |- mesh__recordAuthorizer mesh__D016009 sjn
% 214.44/214.61  |- skos__scopeNote mesh__D016009
% 214.44/214.61       A distribution in which a variable is distributed like the sum of the squares of any given independent random variable, each of which has a normal distribution with mean of zero and variance of one. The chi-square test is a statistical test based on comparison of a test statistic to a chi-square distribution. The oldest of these tests are used to detect whether two or more population distributions differ from one another.%A%    
% 214.44/214.61  |- skos__hiddenLabel mesh__D016009 Distribution, Chi-Square
% 214.44/214.61  |- mesh__dateRevised mesh__D016009 2004-07-19
% 214.44/214.61  |- skos__hiddenLabel mesh__D016009 Chi Square Distribution
% 214.44/214.61  |- skos__broader mesh__D016009smesh__D016008
% 214.44/214.61  |- skos__annotation mesh__D016009
% 214.44/214.61       IM GEN only; coord NIM with specific disease or other concept %28%IM%29%; no qualif; specify geog if pertinent%A%  
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D016009 2005
% 214.44/214.61  |- skos__hiddenLabel mesh__D016009 Tests, Chi-Square
% 214.44/214.61  |- skos__hiddenLabel mesh__D016009 Distributions, Chi-Square
% 214.44/214.61  |- skos__hiddenLabel mesh__D016009 Chi-Square Distributions
% 214.44/214.61  |- mesh__recordMaintainer mesh__D016009 jls
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D016009 2006
% 214.44/214.61  |- skos__hiddenLabel mesh__D016009 Test, Chi-Square
% 214.44/214.61  |- skos__hiddenLabel mesh__D016009 Chi Square Test
% 214.44/214.61  |- skos__prefLabel mesh__D016009 Chi-Square Distribution
% 214.44/214.61  |- skos__hiddenLabel mesh__D016009 Chi-Square Tests
% 214.44/214.61  |- mesh__dateCreated mesh__D016009 1989-05-25
% 214.44/214.61  |- mesh__publicMeSHNote mesh__D016009 90   
% 214.44/214.61  |- mesh__recordOriginator mesh__D016009 PLS
% 214.44/214.61  |- rdf__type mesh__D016009sskos__Concept
% 214.44/214.61  |- mesh__historyNote mesh__D016009 90   
% 214.44/214.61  |- mesh__dateEstablished mesh__D004783 1985-01-01
% 214.44/214.61  |- mesh__publicMeSHNote mesh__D004783 85   
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D004783 2004
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D004783 2006
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D004783 2003
% 214.44/214.61  |- mesh__dateRevised mesh__D004783 2001-07-25
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D004783 2005
% 214.44/214.61  |- skos__broader mesh__D004783smesh__D011634
% 214.44/214.61  |- mesh__recordOriginator mesh__D004783 NLM
% 214.44/214.61  |- skos__scopeNote mesh__D004783
% 214.44/214.61       The study of microorganisms living in a variety of environments %28%air, soil, water, etc.%29% and their pathogenic relationship to other organisms including man.%A%    
% 214.44/214.61  |- skos__altLabel mesh__D004783 Microbiology, Environmental
% 214.44/214.61  |- skos__prefLabel mesh__D004783 Environmental Microbiology
% 214.44/214.61  |- mesh__dateCreated mesh__D004783 1999-01-01
% 214.44/214.61  |- rdf__type mesh__D004783sskos__Concept
% 214.44/214.61  |- mesh__recordMaintainer mesh__D004783 jls
% 214.44/214.61  |- skos__annotation mesh__D004783
% 214.44/214.61       GEN or unspecified; prefer specifics; IM; coord with specific microbe %28%IM%29%; DF: ENVIR MICROBIOL%A%  
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D004783 2002
% 214.44/214.61  |- mesh__historyNote mesh__D004783 85; was NON MESH before 1985   
% 214.44/214.61  |- skos__broader mesh__D004783smesh__D008829
% 214.44/214.61  |- mesh__recordAuthorizer mesh__D004783 sjn
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D012417 2006
% 214.44/214.61  |- rdf__type mesh__D012417sskos__Concept
% 214.44/214.61  |- skos__prefLabel mesh__D012417 Rumen
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D012417 2003
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D012417 2000
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D012417 1998
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D012417 2004
% 214.44/214.61  |- mesh__recordMaintainer mesh__D012417 TGC
% 214.44/214.61  |- mesh__recordAuthorizer mesh__D012417 PLS
% 214.44/214.61  |- skos__hiddenLabel mesh__D012417 Rumens
% 214.44/214.61  |- skos__broader mesh__D012417smesh__D013279
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D012417 1999
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D012417 2001
% 214.44/214.61  |- skos__scopeNote mesh__D012417
% 214.44/214.61       The first stomach of ruminants. It lies on the left side of the body, occupying the whole of the left side of the abdomen and even stretching across the median plane of the body to the right side. It is capacious, divided into an upper and a lower sac, each of which has a blind sac at its posterior extremity. The rumen is lined by mucous membrane containing no digestive glands, but mucus-secreting glands are present in large numbers. Coarse, partially chewed food is stored and churned in the rumen until the animal finds circumstances convenient for rumination. When this occurs, little balls of food are regurgitated through the esophagus into the mouth, and are subjected to a second more thorough mastication, swallowed, and passed on into other parts of the compound stomach. %28%From Black%27%s Veterinary Dictionary, 17th ed%29%%A%    
% 214.44/214.61  |- mesh__recordOriginator mesh__D012417 NLM
% 214.44/214.61  |- mesh__dateCreated mesh__D012417 1999-01-01
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D012417 1996
% 214.44/214.61  |- skos__annotation mesh__D012417
% 214.44/214.61       a ruminant%27%s 1st stomach; dis: coord IM with STOMACH DISEASES /vet %28%IM%29%; neopl: coord IM with STOMACH NEOPLASMS /vet %28%IM%29% + histol type /vet %28%IM%29%; ulcer: coord IM with STOMACH ULCER /vet %28%IM%29%%A%  
% 214.44/214.61  |- mesh__dateRevised mesh__D012417 1995-05-18
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D012417 1997
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D012417 2005
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D012417 2002
% 214.44/214.61  |- mesh__recordMaintainer mesh__D017900 ags
% 214.44/214.61  |- skos__broader mesh__D017900smesh__D017899
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D017900 2004
% 214.44/214.61  |- mesh__historyNote mesh__D017900 94   
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D017900 2005
% 214.44/214.61  |- mesh__dateRevised mesh__D017900 2001-07-25
% 214.44/214.61  |- skos__prefLabel mesh__D017900 Myoviridae
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D017900 2002
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D017900 2006
% 214.44/214.61  |- rdf__type mesh__D017900sskos__Concept
% 214.44/214.61  |- mesh__publicMeSHNote mesh__D017900 94   
% 214.44/214.61  |- skos__annotation mesh__D017900
% 214.44/214.61       coord with specific bacterium /virol or specific Archaea /virol%A%  
% 214.44/214.61  |- mesh__recordOriginator mesh__D017900 AGS
% 214.44/214.61  |- skos__historyNote mesh__D017900 Bacteriophages %28%1983-1993%29%
% 214.44/214.61  |- mesh__recordAuthorizer mesh__D017900 sjn
% 214.44/214.61  |- skos__scopeNote mesh__D017900
% 214.44/214.61       A family of BACTERIOPHAGES and ARCHAEAL VIRUSES which are characterized by complex contractile tails.%A%    
% 214.44/214.61  |- mesh__dateEstablished mesh__D017900 1994-01-01
% 214.44/214.61  |- skos__broader mesh__D017900smesh__D023641
% 214.44/214.61  |- mesh__dateCreated mesh__D017900 1993-07-06
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D017900 2003
% 214.44/214.61  |- skos__related mesh__D017102smesh__D002146
% 214.44/214.61  |- skos__annotation mesh__D017102
% 214.44/214.61       coord IM with type of fracture %28%IM%29% + bone injured %28%IM%29%   
% 214.44/214.61  |- mesh__publicMeSHNote mesh__D017102 93   
% 214.44/214.61  |- rdf__type mesh__D017102sskos__Concept
% 214.44/214.61  |- skos__scopeNote mesh__D017102
% 214.44/214.61       The physiological restoration of bone tissue and function after a fracture. It includes BONY CALLUS formation and normal replacement of bone tissue.%A%    
% 214.44/214.61  |- mesh__recordMaintainer mesh__D017102 KEV
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D017102 2002
% 214.44/214.61  |- mesh__historyNote mesh__D017102 93   
% 214.44/214.61  |- mesh__recordOriginator mesh__D017102 TGC
% 214.44/214.61  |- skos__hiddenLabel mesh__D017102 Healing, Fracture
% 214.44/214.61  |- skos__hiddenLabel mesh__D017102 Fracture Healings
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D017102 2006
% 214.44/214.61  |- skos__broader mesh__D017102smesh__D014945
% 214.44/214.61  |- mesh__dateCreated mesh__D017102 1992-05-20
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D017102 2001
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D017102 2005
% 214.44/214.61  |- skos__prefLabel mesh__D017102 Fracture Healing
% 214.44/214.61  |- mesh__dateRevised mesh__D017102 1999-11-03
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D017102 2004
% 214.44/214.61  |- mesh__dateEstablished mesh__D017102 1993-01-01
% 214.44/214.61  |- skos__historyNote mesh__D017102 Wound Healing %28%1966-1992%29%
% 214.44/214.61  |- mesh__recordAuthorizer mesh__D017102 sjn
% 214.44/214.61  |- skos__hiddenLabel mesh__D017102 Healings, Fracture
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D017102 2000
% 214.44/214.61  |- skos__historyNote mesh__D017102 Fractures %28%1966-1992%29%
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D017102 2003
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D050536 2006
% 214.44/214.61  |- skos__prefLabel mesh__D050536
% 214.44/214.61       Glycerol-3-Phosphate Dehydrogenase %28%NAD+%29%
% 214.44/214.61  |- skos__scopeNote mesh__D050536
% 214.44/214.61       An NAD-dependent enzyme that catalyzes the oxidation of sn-glycerol 3-phosphate to glycerone phosphate.%A%    
% 214.44/214.61  |- mesh__recordMaintainer mesh__D050536 AKE
% 214.44/214.61  |- skos__broader mesh__D050536smesh__D005993
% 214.44/214.61  |- rdf__type mesh__D050536sskos__Concept
% 214.44/214.61  |- mesh__recordOriginator mesh__D050536 AKE
% 214.44/214.61  |- skos__altLabel mesh__D050536 G3P Dehydrogenase %28%NAD+%29%
% 214.44/214.61  |- skos__altLabel mesh__D050536
% 214.44/214.61       Glycerol 3-Phosphate Dehydrogenase %28%NAD+%29%
% 214.44/214.61  |- mesh__recordAuthorizer mesh__D050536 sjn
% 214.44/214.61  |- mesh__publicMeSHNote mesh__D050536
% 214.44/214.61       2006; GLYCEROL-3-PHOSPHATE DEHYDROGENASE %28%NAD+%29% was indexed under GLYCEROLPHOSPHATE DEHYDROGENASE 1982-2005%A%  
% 214.44/214.61  |- skos__altLabel mesh__D050536
% 214.44/214.61       alpha Glycerol-3-Phosphate Dehydrogenase %28%NAD+%29%
% 214.44/214.61  |- mesh__dateCreated mesh__D050536 2005-06-30
% 214.44/214.61  |- skos__altLabel mesh__D050536 alphaGPDH
% 214.44/214.61  |- skos__historyNote mesh__D050536
% 214.44/214.61       Glycerolphosphate Dehydrogenase %28%1982-2005%29%
% 214.44/214.61  |- mesh__historyNote mesh__D050536 2006%28%1982%29%   
% 214.44/214.61  |- mesh__dateEstablished mesh__D050536 2006-01-01
% 214.44/214.61  |- skos__altLabel mesh__D008376
% 214.44/214.61       ratiopharm Brand of Maprotiline Hydrochloride
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D008376 2006
% 214.44/214.61  |- skos__altLabel mesh__D008376 Maprotilin
% 214.44/214.61  |- skos__hiddenLabel mesh__D008376 Novo Maprotiline
% 214.44/214.61  |- skos__altLabel mesh__D008376
% 214.44/214.61       neuraxpharm Brand of Maprotiline Hydrochloride
% 214.44/214.61  |- skos__altLabel mesh__D008376
% 214.44/214.61       Novopharm Brand of Maprotiline Hydrochloride
% 214.44/214.61  |- skos__prefLabel mesh__D008376 Maprotiline
% 214.44/214.61  |- mesh__recordAuthorizer mesh__D008376 sjn
% 214.44/214.61  |- rdf__type mesh__D008376sskos__Concept
% 214.44/214.61  |- skos__historyNote mesh__D008376 Anthracenes %28%1972-1974%29%
% 214.44/214.61  |- skos__hiddenLabel mesh__D008376 Mesylate, Maprotiline
% 214.44/214.61  |- skos__broader mesh__D008376smesh__D000873
% 214.44/214.61  |- skos__hiddenLabel mesh__D008376 Maprotilin ratiopharm
% 214.44/214.61  |- mesh__recordOriginator mesh__D008376 NLM
% 214.44/214.61  |- skos__altLabel mesh__D008376 Teva Brand of Maprotiline Hydrochloride
% 214.44/214.61  |- skos__altLabel mesh__D008376 Declimed Brand of Maprotiline Hydrochloride
% 214.44/214.61  |- mesh__historyNote mesh__D008376
% 214.44/214.61       91%28%75%29%; was see under ANTHRACENES 1975-90   
% 214.44/214.61  |- skos__altLabel mesh__D008376
% 214.44/214.61       ct-Arzneimittel Brand of Maprotiline Hydrochloride
% 214.44/214.61  |- skos__altLabel mesh__D008376
% 214.44/214.61       Dolorgiet Brand of Maprotiline Hydrochloride
% 214.44/214.61  |- skos__altLabel mesh__D008376 Holsten Brand of Maprotiline Hydrochloride
% 214.44/214.61  |- skos__hiddenLabel mesh__D008376 Maprotilin TEVA
% 214.44/214.61  |- skos__hiddenLabel mesh__D008376 Hydrochloride, Maprotiline
% 214.44/214.61  |- skos__altLabel mesh__D008376 Novartis Brand of Maprotiline Hydrochloride
% 214.44/214.61  |- skos__altLabel mesh__D008376 Dibencycladine
% 214.44/214.61  |- mesh__dateEstablished mesh__D008376 1991-01-01
% 214.44/214.61  |- skos__altLabel mesh__D008376 Hexal Brand of Maprotiline Mesylate
% 214.44/214.61  |- skos__scopeNote mesh__D008376
% 214.44/214.61       A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.%A%    
% 214.44/214.61  |- mesh__publicMeSHNote mesh__D008376
% 214.44/214.61       91; was see under ANTHRACENES 1975-90   
% 214.44/214.61  |- skos__hiddenLabel mesh__D008376 Ba34,276
% 214.44/214.61  |- mesh__dateRevised mesh__D008376 2005-06-30
% 214.44/214.61  |- skos__altLabel mesh__D008376
% 214.44/214.61       N-Methyl-9,10-ethanoanthracene-9%28%10H%29%-propylamine
% 214.44/214.61  |- mesh__dateCreated mesh__D008376 1974-11-19
% 214.44/214.61  |- skos__hiddenLabel mesh__D008376 Maprotilin neuraxpharm
% 214.44/214.61  |- skos__historyNote mesh__D008376 Propylamines %28%1972-1974%29%
% 214.44/214.61  |- mesh__recordMaintainer mesh__D008376 CCR
% 214.44/214.61  |- skos__altLabel mesh__D008376 Lundbeck Brand of Maprotiline Hydrochloride
% 214.44/214.61  |- rdf__type mesh__D000393sskos__Concept
% 214.44/214.61  |- mesh__publicMeSHNote mesh__D000393 75   
% 214.44/214.61  |- mesh__recordAuthorizer mesh__D000393 sjn
% 214.44/214.61  |- mesh__recordOriginator mesh__D000393 NLM
% 214.44/214.61  |- skos__historyNote mesh__D000393 Air Pollution %28%1966-1974%29%
% 214.44/214.61  |- mesh__recordMaintainer mesh__D000393 ssb
% 214.44/214.61  |- mesh__dateRevised mesh__D000393 2003-07-09
% 214.44/214.61  |- mesh__dateEstablished mesh__D000393 1975-09-01
% 214.44/214.61  |- skos__broader mesh__D000393smesh__D004785
% 214.44/214.61  |- skos__scopeNote mesh__D000393 Substances which pollute the air.     
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000393 2005
% 214.44/214.61  |- skos__annotation mesh__D000393
% 214.44/214.61       specify pollutant if pertinent %28%IM or NIM%29%   
% 214.44/214.61  |- mesh__dateCreated mesh__D000393 1999-01-01
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000393 2004
% 214.44/214.61  |- skos__hiddenLabel mesh__D000393 Pollutants, Air
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D000393 2006
% 214.44/214.61  |- mesh__historyNote mesh__D000393 75   
% 214.44/214.61  |- skos__prefLabel mesh__D000393 Air Pollutants
% 214.44/214.61  |- skos__scopeNote mesh__D016808
% 214.44/214.61       A species of ciliate protozoa used in genetic and cytological research.%A%    
% 214.44/214.61  |- mesh__dateCreated mesh__D016808 1991-05-02
% 214.44/214.61  |- mesh__dateEstablished mesh__D016808 1992-01-01
% 214.44/214.61  |- mesh__recordAuthorizer mesh__D016808 sjn
% 214.44/214.61  |- mesh__publicMeSHNote mesh__D016808 92   
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D016808 2005
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D016808 2006
% 214.44/214.61  |- skos__prefLabel mesh__D016808 Tetrahymena thermophila
% 214.44/214.61  |- mesh__recordOriginator mesh__D016808 PXP
% 214.44/214.61  |- mesh__historyNote mesh__D016808 92   
% 214.44/214.61  |- skos__annotation mesh__D016808
% 214.44/214.61       a protozoon used in genetic %26% cytol research   
% 214.44/214.61  |- skos__broader mesh__D016808smesh__D013768
% 214.44/214.61  |- rdf__type mesh__D016808sskos__Concept
% 214.44/214.61  |- skos__historyNote mesh__D016808 Tetrahymena %28%1978-1991%29%
% 214.44/214.61  |- mesh__dateRevised mesh__D016808 2003-07-09
% 214.44/214.61  |- mesh__recordMaintainer mesh__D016808 ags
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D016808 2004
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D041201 2004
% 214.44/214.61  |- mesh__dateCreated mesh__D041201 2002-07-03
% 214.44/214.61  |- skos__altLabel mesh__D041201 Tapeworm, Pork
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D041201 2006
% 214.44/214.61  |- skos__annotation mesh__D041201
% 214.44/214.61       infection = TAENIASIS;  larval form = CYSTICERCUS, its infection = CYSTICERCOSIS%A%  
% 214.44/214.61  |- mesh__historyNote mesh__D041201 2003   
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D041201 2005
% 214.44/214.61  |- skos__broader mesh__D041201smesh__D013621
% 214.44/214.61  |- skos__scopeNote mesh__D041201
% 214.44/214.61       Species of tapeworm in the genus TAENIA, that infects swine. It is acquired by humans through the ingestion of cured or undercooked pork.%A%    
% 214.44/214.61  |- skos__historyNote mesh__D041201 Taenia %28%1965-2002%29%
% 214.44/214.61  |- mesh__publicMeSHNote mesh__D041201 2003   
% 214.44/214.61  |- rdf__type mesh__D041201sskos__Concept
% 214.44/214.61  |- mesh__dateRevised mesh__D041201 2003-07-09
% 214.44/214.61  |- mesh__dateEstablished mesh__D041201 2003-01-01
% 214.44/214.61  |- skos__prefLabel mesh__D041201 Taenia solium
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D013510 2000
% 214.44/214.61  |- mesh__publicMeSHNote mesh__D013510 98   
% 214.44/214.61  |- mesh__dateRevised mesh__D013510 1997-06-20
% 214.44/214.61  |- mesh__recordAuthorizer mesh__D013510 SJN
% 214.44/214.61  |- skos__altLabel mesh__D013510 Surgical Procedures, Pulmonary
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D013510 2004
% 214.44/214.61  |- mesh__dateCreated mesh__D013510 1999-01-01
% 214.44/214.61  |- skos__altLabel mesh__D013510 Pulmonary Surgical Procedure
% 214.44/214.61  |- skos__scopeNote mesh__D013510 Surgery performed on the lung.     
% 214.44/214.61  |- mesh__activeMeSHYear mesh__D013510 1999
% 214.44/214.62  |- skos__broader mesh__D013510smesh__D019616
% 214.44/214.62  |- mesh__dateEstablished mesh__D013510 1998-01-01
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D013510 2003
% 214.44/214.62  |- rdf__type mesh__D013510sskos__Concept
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D013510 1998
% 214.44/214.62  |- mesh__recordOriginator mesh__D013510 NLM
% 214.44/214.62  |- mesh__recordMaintainer mesh__D013510 PXP
% 214.44/214.62  |- mesh__historyNote mesh__D013510 98; use explode 1975-97   
% 214.44/214.62  |- skos__prefLabel mesh__D013510 Pulmonary Surgical Procedures
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D013510 2002
% 214.44/214.62  |- skos__annotation mesh__D013510
% 214.44/214.62       GEN or unspecified; prefer specifics; consider also LUNG /surg %26% LUNG DISEASES /surg or /surg with specific lung dis; DF: PULM SURG PROCEDURES%A%  
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D013510 2006
% 214.44/214.62  |- skos__altLabel mesh__D013510 Surgical Procedure, Pulmonary
% 214.44/214.62  |- skos__altLabel mesh__D013510 Procedure, Pulmonary Surgical
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D013510 2001
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D013510 2005
% 214.44/214.62  |- skos__altLabel mesh__D013510 Procedures, Pulmonary Surgical
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D004784 2004
% 214.44/214.62  |- skos__scopeNote mesh__D004784
% 214.44/214.62       The monitoring of the level of toxins, chemical pollutants, microbial contaminants, or other harmful substances in the environment or workplace by measuring the amounts of these toxicants in the bodies of people and animals in that environment, among other methods. It also includes the measurement of ENVIRONMENTAL EXPOSURE. Levels in humans and animals are used as indicators of toxic levels of undesirable chemicals.%A%    
% 214.44/214.62  |- mesh__recordAuthorizer mesh__D004784 SJN
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D004784 2002
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D004784 2006
% 214.44/214.62  |- mesh__dateCreated mesh__D004784 1985-06-18
% 214.44/214.62  |- skos__altLabel mesh__D004784 Ecological Monitoring
% 214.44/214.62  |- skos__hiddenLabel mesh__D004784 Monitoring, Epidemiological
% 214.44/214.62  |- skos__altLabel mesh__D004784 Monitoring, Environmental
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D004784 2003
% 214.44/214.62  |- skos__broader mesh__D004784smesh__D004781
% 214.44/214.62  |- skos__altLabel mesh__D004784 Monitoring, Epidemiologic
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D004784 2001
% 214.44/214.62  |- skos__hiddenLabel mesh__D004784 Monitoring, Biologic
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D004784 2005
% 214.44/214.62  |- mesh__dateEstablished mesh__D004784 1986-01-01
% 214.44/214.62  |- mesh__dateRevised mesh__D004784 1998-06-10
% 214.44/214.62  |- skos__historyNote mesh__D004784 Environmental Exposure %28%1967-1985%29%
% 214.44/214.62  |- skos__broader mesh__D004784smesh__D015980
% 214.44/214.62  |- skos__altLabel mesh__D004784 Ecologic Monitoring
% 214.44/214.62  |- mesh__publicMeSHNote mesh__D004784 86   
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D004784 2000
% 214.44/214.62  |- skos__prefLabel mesh__D004784 Environmental Monitoring
% 214.44/214.62  |- skos__hiddenLabel mesh__D004784 Monitoring, Ecologic
% 214.44/214.62  |- skos__altLabel mesh__D004784 Monitoring, Ecological
% 214.44/214.62  |- rdf__type mesh__D004784sskos__Concept
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D004784 1999
% 214.44/214.62  |- skos__altLabel mesh__D004784 Monitoring, Biological
% 214.44/214.62  |- mesh__recordMaintainer mesh__D004784 JLS
% 214.44/214.62  |- skos__altLabel mesh__D004784 Epidemiologic Monitoring
% 214.44/214.62  |- skos__altLabel mesh__D004784 Biologic Monitoring
% 214.44/214.62  |- skos__annotation mesh__D004784 DF: ENVIR MONITORING   
% 214.44/214.62  |- mesh__recordOriginator mesh__D004784 SH
% 214.44/214.62  |- mesh__historyNote mesh__D004784 86   
% 214.44/214.62  |- skos__hiddenLabel mesh__D012418 Mountain Goats
% 214.44/214.62  |- skos__hiddenLabel mesh__D012418 Goat, Mountain
% 214.44/214.62  |- mesh__dateRevised mesh__D012418 2004-07-07
% 214.44/214.62  |- skos__altLabel mesh__D012418 Ruminantia
% 214.44/214.62  |- skos__prefLabel mesh__D012418 Ruminants
% 214.44/214.62  |- mesh__historyNote mesh__D012418 87   
% 214.44/214.62  |- skos__hiddenLabel mesh__D012418 Mountain Goat
% 214.44/214.62  |- skos__annotation mesh__D012418
% 214.44/214.62       general or unspecified; prefer specifics   
% 214.44/214.62  |- mesh__dateEstablished mesh__D012418 1987-01-01
% 214.44/214.62  |- skos__historyNote mesh__D012418 Artiodactyla %28%1966-1986%29%
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D012418 2006
% 214.44/214.62  |- skos__broader mesh__D012418smesh__D001188
% 214.44/214.62  |- rdf__type mesh__D012418sskos__Concept
% 214.44/214.62  |- mesh__publicMeSHNote mesh__D012418 87   
% 214.44/214.62  |- skos__altLabel mesh__D012418 Goats, Mountain
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D012418 2005
% 214.44/214.62  |- skos__hiddenLabel mesh__D012418 Ruminant
% 214.44/214.62  |- mesh__recordOriginator mesh__D012418 EC
% 214.44/214.62  |- mesh__dateCreated mesh__D012418 1986-04-18
% 214.44/214.62  |- mesh__recordAuthorizer mesh__D012418 sjn
% 214.44/214.62  |- skos__scopeNote mesh__D012418
% 214.44/214.62       A suborder of the order ARTIODACTYLA whose members have the distinguishing feature of a four-chambered stomach, including the capacious RUMEN. Horns or antlers are usually present, at least in males.%A%    
% 214.44/214.62  |- mesh__recordMaintainer mesh__D012418 ags
% 214.44/214.62  |- mesh__recordMaintainer mesh__D017901 ags
% 214.44/214.62  |- skos__broader mesh__D017901smesh__D017900
% 214.44/214.62  |- skos__hiddenLabel mesh__D017901 Phage, P2
% 214.44/214.62  |- skos__hiddenLabel mesh__D017901 P2, Coliphage
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017901 2004
% 214.44/214.62  |- mesh__historyNote mesh__D017901 94   
% 214.44/214.62  |- mesh__dateCreated mesh__D017901 1993-06-04
% 214.44/214.62  |- skos__historyNote mesh__D017901 Coliphages %28%1966-1993%29%
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017901 2002
% 214.44/214.62  |- skos__hiddenLabel mesh__D017901 Phages, P2
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017901 2005
% 214.44/214.62  |- rdf__type mesh__D017901sskos__Concept
% 214.44/214.62  |- mesh__dateRevised mesh__D017901 2001-07-25
% 214.44/214.62  |- skos__scopeNote mesh__D017901
% 214.44/214.62       A species of temperate bacteriophage in the genus P2-like Viruses, family MYOVIRIDAE, which infects E. coli. It consists of linear double-stranded DNA with 19-base sticky ends.%A%    
% 214.44/214.62  |- mesh__recordAuthorizer mesh__D017901 sjn
% 214.44/214.62  |- mesh__recordOriginator mesh__D017901 AGS
% 214.44/214.62  |- mesh__publicMeSHNote mesh__D017901 94   
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017901 2006
% 214.44/214.62  |- skos__hiddenLabel mesh__D017901 P2, Bacteriophage
% 214.44/214.62  |- skos__prefLabel mesh__D017901 Bacteriophage P2
% 214.44/214.62  |- skos__altLabel mesh__D017901 Enterobacteria phage P2
% 214.44/214.62  |- skos__altLabel mesh__D017901 Coliphage P2
% 214.44/214.62  |- skos__altLabel mesh__D017901 Phage P2
% 214.44/214.62  |- mesh__dateEstablished mesh__D017901 1994-01-01
% 214.44/214.62  |- skos__broader mesh__D017901smesh__D003090
% 214.44/214.62  |- skos__hiddenLabel mesh__D017901 P2 Phages
% 214.44/214.62  |- skos__altLabel mesh__D017901 P2 Phage
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017901 2003
% 214.44/214.62  |- skos__hiddenLabel mesh__D017901 P2, Phage
% 214.44/214.62  |- skos__historyNote mesh__D017103 Bacteriophages %28%1966-1992%29%
% 214.44/214.62  |- mesh__dateEstablished mesh__D017103 1993-01-01
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017103 1996
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017103 2000
% 214.44/214.62  |- skos__altLabel mesh__D017103 Bacteriophage phi 29
% 214.44/214.62  |- skos__altLabel mesh__D017103 Bacteriophage phi 105
% 214.44/214.62  |- mesh__historyNote mesh__D017103 93   
% 214.44/214.62  |- mesh__publicMeSHNote mesh__D017103 93   
% 214.44/214.62  |- skos__hiddenLabel mesh__D017103 Bacillus Phage
% 214.44/214.62  |- skos__scopeNote mesh__D017103
% 214.44/214.62       Viruses whose host is Bacillus. Frequently encountered Bacillus phages include bacteriophage phi 29 and bacteriophage phi 105.%A%    
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017103 1995
% 214.44/214.62  |- skos__annotation mesh__D017103
% 214.44/214.62       coord IM with specific Bacillus %28%NIM%29%   
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017103 2006
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017103 2002
% 214.44/214.62  |- skos__hiddenLabel mesh__D017103 Bacteriophages, Bacillus
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017103 1994
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017103 1993
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017103 2005
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017103 2004
% 214.44/214.62  |- skos__prefLabel mesh__D017103 Bacillus Phages
% 214.44/214.62  |- skos__broader mesh__D017103smesh__D001435
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017103 1999
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017103 2003
% 214.44/214.62  |- skos__altLabel mesh__D017103 Bacillus Bacteriophages
% 214.44/214.62  |- skos__hiddenLabel mesh__D017103 Bacillus Bacteriophage
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017103 2001
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017103 1998
% 214.44/214.62  |- rdf__type mesh__D017103sskos__Concept
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017103 1997
% 214.44/214.62  |- skos__hiddenLabel mesh__D017103 Bacteriophage, Bacillus
% 214.44/214.62  |- mesh__dateCreated mesh__D017103 1992-05-07
% 214.44/214.62  |- mesh__dateEstablished mesh__D050537 2006-01-01
% 214.44/214.62  |- skos__hiddenLabel mesh__D050537 Beta Hydroxypyruvate Reductase
% 214.44/214.62  |- skos__broader mesh__D050537smesh__D000429
% 214.44/214.62  |- mesh__recordOriginator mesh__D050537 AKE
% 214.44/214.62  |- skos__hiddenLabel mesh__D050537 Reductase, Beta-Hydroxypyruvate
% 214.44/214.62  |- skos__altLabel mesh__D050537 Beta-Hydroxypyruvate Reductase
% 214.44/214.62  |- mesh__publicMeSHNote mesh__D050537
% 214.44/214.62       2006; HYDROXYPYRUVATE DEHYDROGENASE was indexed under ALCOHOL OXIDOREDUCTASES 1980-2005 %26% under GLYCERIC ACIDS 1974-1980%A%  
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D050537 2006
% 214.44/214.62  |- skos__prefLabel mesh__D050537 Hydroxypyruvate Reductase
% 214.44/214.62  |- mesh__recordMaintainer mesh__D050537 AKE
% 214.44/214.62  |- rdf__type mesh__D050537sskos__Concept
% 214.44/214.62  |- mesh__recordAuthorizer mesh__D050537 sjn
% 214.44/214.62  |- skos__scopeNote mesh__D050537
% 214.44/214.62       An enzyme that catalyzes the oxidation of D-glycerate to hydroxypyruvate in the presence of NADP.%A%    
% 214.44/214.62  |- mesh__historyNote mesh__D050537
% 214.44/214.62       2006%28%1980%29%; use GLYCERIC ACIDS 1974-1980   
% 214.44/214.62  |- skos__hiddenLabel mesh__D050537 Reductase, Hydroxypyruvate
% 214.44/214.62  |- mesh__dateCreated mesh__D050537 2005-06-30
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D008377 2006
% 214.44/214.62  |- skos__broader mesh__D008377smesh__D001296
% 214.44/214.62  |- rdf__type mesh__D008377sskos__Concept
% 214.44/214.62  |- skos__scopeNote mesh__D008377
% 214.44/214.62       Representations, normally to scale and on a flat medium, of a selection of material or abstract features on the surface of the earth, the heavens, or  celestial bodies.%A%    
% 214.44/214.62  |- skos__annotation mesh__D008377
% 214.44/214.62       avoid: a cataloging term; possibly GEOGRAPHY might apply; no qualif; do not confuse with Publication Type MAPS%A%  
% 214.44/214.62  |- mesh__recordMaintainer mesh__D008377 ags
% 214.44/214.62  |- mesh__dateCreated mesh__D008377 1999-01-01
% 214.44/214.62  |- skos__hiddenLabel mesh__D008377 Map
% 214.44/214.62  |- mesh__recordAuthorizer mesh__D008377 sjn
% 214.44/214.62  |- skos__prefLabel mesh__D008377 Maps
% 214.44/214.62  |- mesh__recordOriginator mesh__D008377 NLM
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D008377 2005
% 214.44/214.62  |- mesh__dateRevised mesh__D008377 2004-07-07
% 214.44/214.62  |- mesh__dateRevised mesh__D000394 2003-07-09
% 214.44/214.62  |- mesh__dateEstablished mesh__D000394 1984-01-01
% 214.44/214.62  |- skos__annotation mesh__D000394
% 214.44/214.62       specify pollutant if pertinent %28%IM or NIM%29%; DF: AIR POLLUTANTS ENVIR%A%  
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D000394 2005
% 214.44/214.62  |- mesh__historyNote mesh__D000394
% 214.44/214.62       84%28%75%29%; was see under AIR POLLUTANTS 1975-83   
% 214.44/214.62  |- mesh__dateCreated mesh__D000394 1999-01-01
% 214.44/214.62  |- skos__altLabel mesh__D000394 Environmental Air Pollutants
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D000394 2004
% 214.44/214.62  |- mesh__recordAuthorizer mesh__D000394 sjn
% 214.44/214.62  |- mesh__recordOriginator mesh__D000394 NLM
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D000394 2006
% 214.44/214.62  |- mesh__recordMaintainer mesh__D000394 ssb
% 214.44/214.62  |- skos__hiddenLabel mesh__D000394 Pollutants, Environmental Air
% 214.44/214.62  |- skos__altLabel mesh__D000394 Environmental Pollutants, Air
% 214.44/214.62  |- skos__prefLabel mesh__D000394 Air Pollutants, Environmental
% 214.44/214.62  |- skos__hiddenLabel mesh__D000394 Air Environmental Pollutants
% 214.44/214.62  |- mesh__publicMeSHNote mesh__D000394
% 214.44/214.62       84; was see under AIR POLLUTANTS 1975-83   
% 214.44/214.62  |- skos__hiddenLabel mesh__D000394 Pollutants, Air Environmental
% 214.44/214.62  |- rdf__type mesh__D000394sskos__Concept
% 214.44/214.62  |- skos__scopeNote mesh__D000394
% 214.44/214.62       Air pollutants which affect environmental conditions.     
% 214.44/214.62  |- skos__broader mesh__D000394smesh__D000393
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D016809 2005
% 214.44/214.62  |- mesh__dateCreated mesh__D016809 1991-05-02
% 214.44/214.62  |- skos__scopeNote mesh__D016809
% 214.44/214.62       A class of ciliate protozoa characterized by a well-developed, conspicuous adoral zone of numerous buccal or peristomial organelles, often extending out onto the body surface.%A%    
% 214.44/214.62  |- skos__broader mesh__D016809smesh__D016798
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D016809 2006
% 214.44/214.62  |- mesh__dateEstablished mesh__D016809 1992-01-01
% 214.44/214.62  |- skos__prefLabel mesh__D016809 Polymenophorea
% 214.44/214.62  |- mesh__historyNote mesh__D016809 92   
% 214.44/214.62  |- mesh__publicMeSHNote mesh__D016809 92   
% 214.44/214.62  |- mesh__recordOriginator mesh__D016809 PXP
% 214.44/214.62  |- mesh__recordAuthorizer mesh__D016809 sjn
% 214.44/214.62  |- mesh__dateRevised mesh__D016809 2003-07-09
% 214.44/214.62  |- rdf__type mesh__D016809sskos__Concept
% 214.44/214.62  |- mesh__recordMaintainer mesh__D016809 ags
% 214.44/214.62  |- skos__annotation mesh__D016809 a class of ciliate protozoa   
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D016809 2004
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D041202 2006
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D041202 2005
% 214.44/214.62  |- mesh__dateEstablished mesh__D041202 2003-01-01
% 214.44/214.62  |- skos__broader mesh__D041202smesh__D013621
% 214.44/214.62  |- mesh__dateCreated mesh__D041202 2002-07-03
% 214.44/214.62  |- skos__historyNote mesh__D041202 Taenia %28%1965-2002%29%
% 214.44/214.62  |- mesh__historyNote mesh__D041202 2003   
% 214.44/214.62  |- skos__prefLabel mesh__D041202 Taenia saginata
% 214.44/214.62  |- mesh__publicMeSHNote mesh__D041202 2003   
% 214.44/214.62  |- skos__scopeNote mesh__D041202
% 214.44/214.62       Species of tapeworm in the genus TAENIA, that infects cattle. It is acquired by humans through the ingestion of raw or insufficiently cooked beef.%A%    
% 214.44/214.62  |- rdf__type mesh__D041202sskos__Concept
% 214.44/214.62  |- mesh__dateRevised mesh__D041202 2003-07-09
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D041202 2004
% 214.44/214.62  |- skos__annotation mesh__D041202
% 214.44/214.62       infection = TAENIASIS;  larval form = CYSTICERCUS bovis, its infection = CYSTICERCOSIS%A%  
% 214.44/214.62  |- skos__altLabel mesh__D041202 Tapeworm, Beef
% 214.44/214.62  |- skos__altLabel mesh__D013511 Procedure, Minor Surgical
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D013511 1999
% 214.44/214.62  |- skos__altLabel mesh__D013511 Minor Surgery
% 214.44/214.62  |- mesh__publicMeSHNote mesh__D013511 98; see SURGERY, MINOR 1963-97   
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D013511 2003
% 214.44/214.62  |- rdf__type mesh__D013511sskos__Concept
% 214.44/214.62  |- skos__annotation mesh__D013511
% 214.44/214.62       IM GEN only; do not use as NIM coord for surg in minor ailments; DF: SURG PROCEDURES MINOR%A%  
% 214.44/214.62  |- skos__prefLabel mesh__D013511 Surgical Procedures, Minor
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D013511 2000
% 214.44/214.62  |- skos__hiddenLabel mesh__D013511 Surgeries, Minor
% 214.44/214.62  |- mesh__dateRevised mesh__D013511 1997-06-20
% 214.44/214.62  |- mesh__recordAuthorizer mesh__D013511 SJN
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D013511 1998
% 214.44/214.62  |- skos__broader mesh__D013511smesh__D013514
% 214.44/214.62  |- skos__altLabel mesh__D013511 Minor Surgical Procedures
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D013511 2006
% 214.44/214.62  |- mesh__recordOriginator mesh__D013511 NLM
% 214.44/214.62  |- mesh__recordMaintainer mesh__D013511 PXP
% 214.44/214.62  |- skos__altLabel mesh__D013511 Surgical Procedure, Minor
% 214.44/214.62  |- skos__altLabel mesh__D013511 Minor Surgical Procedure
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D013511 2005
% 214.44/214.62  |- skos__hiddenLabel mesh__D013511 Minor Surgeries
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D013511 2002
% 214.44/214.62  |- skos__altLabel mesh__D013511 Procedures, Minor Surgical
% 214.44/214.62  |- skos__scopeNote mesh__D013511
% 214.44/214.62       Surgery restricted to the management of minor problems and injuries; surgical procedures of relatively slight extent and not in itself hazardous to life. %28%Dorland, 28th ed %26% Stedman, 25th ed%29%%A%    
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D013511 2004
% 214.44/214.62  |- mesh__historyNote mesh__D013511 98%28%63%29%   
% 214.44/214.62  |- mesh__dateCreated mesh__D013511 1999-01-01
% 214.44/214.62  |- skos__altLabel mesh__D013511 Surgery, Minor
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D013511 2001
% 214.44/214.62  |- mesh__dateCreated mesh__D004785 1999-01-01
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D004785 2006
% 214.44/214.62  |- skos__prefLabel mesh__D004785 Environmental Pollutants
% 214.44/214.62  |- skos__broader mesh__D004785smesh__D004786
% 214.44/214.62  |- mesh__historyNote mesh__D004785 75   
% 214.44/214.62  |- skos__annotation mesh__D004785
% 214.44/214.62       specify pollutant if pertinent %28%IM or NIM%29%; in addition to AIR POLLUTANTS; RADIOACTIVE POLLUTANTS; SOIL POLLUTANTS %26% WATER POLLUTANTS %26% their specifics, CARCINOGENS, ENVIRONMENTAL is also available; DF: ENVIR POLLUTANTS%A%  
% 214.44/214.62  |- mesh__recordOriginator mesh__D004785 NLM
% 214.44/214.62  |- mesh__publicMeSHNote mesh__D004785 75   
% 214.44/214.62  |- mesh__recordMaintainer mesh__D004785 ssb
% 214.44/214.62  |- mesh__recordAuthorizer mesh__D004785 sjn
% 214.44/214.62  |- rdf__type mesh__D004785sskos__Concept
% 214.44/214.62  |- skos__scopeNote mesh__D004785
% 214.44/214.62       Substances which pollute the environment. Use for environmental pollutants in general or for which there is no specific heading.%A%    
% 214.44/214.62  |- skos__historyNote mesh__D004785
% 214.44/214.62       Environmental Pollution %28%1971-1974%29%
% 214.44/214.62  |- mesh__dateRevised mesh__D004785 2003-07-09
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D004785 2005
% 214.44/214.62  |- skos__related mesh__D004785smesh__D002274
% 214.44/214.62  |- mesh__dateEstablished mesh__D004785 1975-09-01
% 214.44/214.62  |- skos__altLabel mesh__D004785 Pollutants, Environmental
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D004785 2004
% 214.44/214.62  |- mesh__dateEstablished mesh__D037161 2003-01-01
% 214.44/214.62  |- skos__altLabel mesh__D037161 beta-Galactoside Binding Lectin
% 214.44/214.62  |- skos__altLabel mesh__D037161 Galactose-Binding Lectin
% 214.44/214.62  |- skos__hiddenLabel mesh__D037161 beta Galactoside Binding Lectin
% 214.44/214.62  |- skos__altLabel mesh__D037161 S-Type Lectin
% 214.44/214.62  |- skos__hiddenLabel mesh__D037161 Lectin, beta-Galactoside Binding
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D037161 2006A
% 214.44/214.62  |- skos__scopeNote mesh__D037161
% 214.44/214.62       A class of animal lectins that bind specifically to beta-galactoside in a calcium-independent manner. Members of this class are distiguished from other lectins by the presence of a conserved carbohydrate recognition domain. The majority of proteins in this class bind to sugar molecules in a sulfhydryl-dependent manner and are often referred to as S-type lectins, however this property is not required for membership in this class.%A%    
% 214.44/214.62  |- skos__hiddenLabel mesh__D037161 Binding Lectin, beta-Galactoside
% 214.44/214.62  |- mesh__dateCreated mesh__D037161 2002-07-02
% 214.44/214.62  |- skos__altLabel mesh__D037161 D-Galactoside-Binding Lectin
% 214.44/214.62  |- skos__altLabel mesh__D037161 S-Type Lectins
% 214.44/214.62  |- skos__hiddenLabel mesh__D037161 Lectins, S Type
% 214.44/214.62  |- skos__hiddenLabel mesh__D037161 Lectin, S-Type
% 214.44/214.62  |- skos__hiddenLabel mesh__D037161 Lectin, Galactose-Binding
% 214.44/214.62  |- skos__hiddenLabel mesh__D037161 Lectin, beta-D-Galactosyl-Specific
% 214.44/214.62  |- skos__prefLabel mesh__D037161 Galectins
% 214.44/214.62  |- skos__altLabel mesh__D037161 Lectins, S-Type
% 214.44/214.62  |- skos__altLabel mesh__D037161 Galaptins
% 214.44/214.62  |- skos__broader mesh__D037161smesh__D037102
% 214.44/214.62  |- mesh__publicMeSHNote mesh__D037161
% 214.44/214.62       2003; GALAPTINS %28%now GALECTINS%29% was indexed under HEMAGGLUTININS 1978-2002%A%  
% 214.44/214.62  |- skos__historyNote mesh__D037161 Hemagglutinins %28%1978-2002%29%
% 214.44/214.62  |- skos__hiddenLabel mesh__D037161 beta D Galactosyl Specific Lectin
% 214.44/214.62  |- skos__hiddenLabel mesh__D037161 S Type Lectins
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D037161 2006
% 214.44/214.62  |- skos__annotation mesh__D037161
% 214.44/214.62       GALECTIN 1 through GALECTIN 4 are available   
% 214.44/214.62  |- mesh__recordMaintainer mesh__D037161 ags
% 214.44/214.62  |- skos__hiddenLabel mesh__D037161 Galactose Binding Lectin
% 214.44/214.62  |- skos__hiddenLabel mesh__D037161 S Type Lectin
% 214.44/214.62  |- mesh__historyNote mesh__D037161
% 214.44/214.62       2003; use GALECTINS %28%NM%29% 1978-2002   
% 214.44/214.62  |- skos__hiddenLabel mesh__D037161 Lectin, D-Galactoside-Binding
% 214.44/214.62  |- rdf__type mesh__D037161sskos__Concept
% 214.44/214.62  |- skos__altLabel mesh__D037161 Galectin
% 214.44/214.62  |- skos__hiddenLabel mesh__D037161 D Galactoside Binding Lectin
% 214.44/214.62  |- skos__altLabel mesh__D037161 beta-D-Galactosyl-Specific Lectin
% 214.44/214.62  |- mesh__recordOriginator mesh__D037161 jmp
% 214.44/214.62  |- mesh__recordAuthorizer mesh__D037161 ags
% 214.44/214.62  |- mesh__dateRevised mesh__D037161 2005-07-14
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D012419 2006
% 214.44/214.62  |- rdf__type mesh__D012419sskos__Concept
% 214.44/214.62  |- skos__broader mesh__D012419smesh__D012940
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D012419 2004
% 214.44/214.62  |- mesh__recordOriginator mesh__D012419 NLM
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D012419 2005
% 214.44/214.62  |- skos__scopeNote mesh__D012419
% 214.44/214.62       A behavioral response manifested by leaving home in order to escape from threatening situations. Children or adolescents leaving home without permission is usually implied.%A%    
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D012419 2001
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D012419 2003
% 214.44/214.62  |- mesh__recordAuthorizer mesh__D012419 SJN
% 214.44/214.62  |- skos__hiddenLabel mesh__D012419 Behavior, Runaway
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D012419 2000
% 214.44/214.62  |- skos__historyNote mesh__D012419
% 214.44/214.62       Child Behavior Disorders %28%1966-1968%29%
% 214.44/214.62  |- skos__prefLabel mesh__D012419 Runaway Behavior
% 214.44/214.62  |- mesh__dateEstablished mesh__D012419 1969-01-01
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D012419 1999
% 214.44/214.62  |- mesh__publicMeSHNote mesh__D012419 98; use RUNAWAY REACTION 1969-97   
% 214.44/214.62  |- mesh__dateRevised mesh__D012419 1998-06-11
% 214.44/214.62  |- mesh__historyNote mesh__D012419 98; see RUNAWAY REACTION 1969-97   
% 214.44/214.62  |- mesh__recordMaintainer mesh__D012419 JLS
% 214.44/214.62  |- mesh__dateCreated mesh__D012419 1999-01-01
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D012419 2002
% 214.44/214.62  |- skos__scopeNote mesh__D009470
% 214.44/214.62       Mechanoreceptors found between skeletal muscle fibers. Muscle spindles are arranged in parallel with muscle fibers and respond to the passive stretch of the muscle, but cease to discharge if the muscle contracts isotonically, thus signaling muscle length. The muscle spindles are the receptors responsible for the stretch or myotactic reflex %28%REFLEX, STRETCH%29%.%A%    
% 214.44/214.62  |- skos__altLabel mesh__D009470 Neuromuscular Spindles
% 214.44/214.62  |- skos__hiddenLabel mesh__D009470 Stretch Receptor, Muscle
% 214.44/214.62  |- skos__hiddenLabel mesh__D009470 Muscle Stretch Receptor
% 214.44/214.62  |- mesh__onlineNote mesh__D009470
% 214.44/214.62       use MUSCLE SPINDLES to search NEUROMUSCULAR SPINDLES 1966-92%A%  
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D009470 2001
% 214.44/214.62  |- skos__hiddenLabel mesh__D009470 Muscle Spindle
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D009470 1999
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D009470 1994
% 214.44/214.62  |- mesh__recordAuthorizer mesh__D009470 PLS
% 214.44/214.62  |- skos__hiddenLabel mesh__D009470 Receptors, Muscle Stretch
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D009470 2006
% 214.44/214.62  |- mesh__dateCreated mesh__D009470 1999-01-01
% 214.44/214.62  |- mesh__historyNote mesh__D009470
% 214.44/214.62       93; was NEUROMUSCULAR SPINDLES 1965-92; was see under NERVE ENDINGS 1963-64%A%  
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D009470 2000
% 214.44/214.62  |- skos__hiddenLabel mesh__D009470 Spindles, Neuromuscular
% 214.44/214.62  |- skos__hiddenLabel mesh__D009470 Spindles, Muscle
% 214.44/214.62  |- mesh__dateEstablished mesh__D009470 1965-01-01
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D009470 1998
% 214.44/214.62  |- mesh__publicMeSHNote mesh__D009470
% 214.44/214.62       93; was NEUROMUSCULAR SPINDLES 1965-92; was see under NERVE ENDINGS 1963-64%A%  
% 214.44/214.62  |- skos__hiddenLabel mesh__D009470 Spindle, Neuromuscular
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D009470 1997
% 214.44/214.62  |- rdf__type mesh__D009470sskos__Concept
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D009470 2005
% 214.44/214.62  |- skos__altLabel mesh__D009470 Receptors, Stretch, Muscle
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D009470 2004
% 214.44/214.62  |- skos__altLabel mesh__D009470 Muscle Stretch Receptors
% 214.44/214.62  |- skos__prefLabel mesh__D009470 Muscle Spindles
% 214.44/214.62  |- skos__hiddenLabel mesh__D009470 Receptor, Muscle Stretch
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D009470 1996
% 214.44/214.62  |- mesh__dateRevised mesh__D009470 1993-06-18
% 214.44/214.62  |- skos__related mesh__D009470smesh__D012026
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D009470 2003
% 214.44/214.62  |- skos__broader mesh__D009470smesh__D008465
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D009470 2002
% 214.44/214.62  |- mesh__recordMaintainer mesh__D009470 RAZ
% 214.44/214.62  |- skos__altLabel mesh__D009470 Stretch Receptors, Muscle
% 214.44/214.62  |- skos__hiddenLabel mesh__D009470 Spindle, Muscle
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D009470 1995
% 214.44/214.62  |- skos__hiddenLabel mesh__D009470 Neuromuscular Spindle
% 214.44/214.62  |- mesh__recordOriginator mesh__D009470 NLM
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D023141 2006
% 214.44/214.62  |- skos__historyNote mesh__D023141 Herpesvirus 1, Equid %28%1991-1993%29%
% 214.44/214.62  |- skos__altLabel mesh__D023141 Equine Herpesvirus 4
% 214.44/214.62  |- skos__broader mesh__D023141smesh__D018140
% 214.44/214.62  |- rdf__type mesh__D023141sskos__Concept
% 214.44/214.62  |- skos__altLabel mesh__D023141 EHV-4
% 214.44/214.62  |- skos__hiddenLabel mesh__D023141 Equine Rhinopneumonitis Viruses
% 214.44/214.62  |- mesh__recordMaintainer mesh__D023141 ags
% 214.44/214.62  |- skos__prefLabel mesh__D023141 Herpesvirus 4, Equid
% 214.44/214.62  |- skos__historyNote mesh__D023141 Varicellovirus %28%1994-2000%29%
% 214.44/214.62  |- skos__hiddenLabel mesh__D023141 Rhinopneumonitis Virus, Equine
% 214.44/214.62  |- skos__hiddenLabel mesh__D023141 Herpesvirus 4, Equine
% 214.44/214.62  |- mesh__recordOriginator mesh__D023141 ags
% 214.44/214.62  |- skos__altLabel mesh__D023141 Equid herpesvirus 4
% 214.44/214.62  |- mesh__publicMeSHNote mesh__D023141
% 214.44/214.62       2001; see VARICELLOVIRUS 1994-2000; for EQUINE RHINOPNEUMONITIS VIRUS see HERPESVIRUS 1, EQUID 1994-2000, EQUINE RHINOPNEUMONITIS VIRUS 1991-1993, HERPESVIRIDAE 1981-1990, %26% HERPESVIRUSES 1975-1980%A%  
% 214.44/214.62  |- mesh__dateRevised mesh__D023141 2001-07-25
% 214.44/214.62  |- skos__scopeNote mesh__D023141
% 214.44/214.62       A species of VARICELLOVIRUS and the chief cause of rhinopneumonitis in horses.%A%    
% 214.44/214.62  |- mesh__dateEstablished mesh__D023141 2001-01-01
% 214.44/214.62  |- skos__hiddenLabel mesh__D023141 Rhinopneumonitis Viruses, Equine
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D023141 2003
% 214.44/214.62  |- mesh__historyNote mesh__D023141
% 214.44/214.62       2001; use VARICELLOVIRUS 1994-2000; for EQUINE RHINOPNEUMONITIS VIRUS use HERPESVIRUS 1, EQUID 1994-2000, EQUINE RHINOPNEUMONITIS VIRUS 1973-1993%A%  
% 214.44/214.62  |- skos__annotation mesh__D023141
% 214.44/214.62       infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29%; DF: EHV 4%A%  
% 214.44/214.62  |- skos__historyNote mesh__D023141 Herpesviridae %28%1965-1990%29%
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D023141 2005
% 214.44/214.62  |- mesh__recordAuthorizer mesh__D023141 sjn
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D023141 2004
% 214.44/214.62  |- skos__altLabel mesh__D023141 Equine Rhinopneumonitis Virus
% 214.44/214.62  |- mesh__dateCreated mesh__D023141 2000-06-22
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D023141 2002
% 214.44/214.62  |- skos__altLabel mesh__D017902 Phages, T7-like
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017902 2005
% 214.44/214.62  |- rdf__type mesh__D017902sskos__Concept
% 214.44/214.62  |- skos__annotation mesh__D017902
% 214.44/214.62       coord with specific bacterium /virol; note X refs; BACTERIOPHAGE T7 is also available%A%  
% 214.44/214.62  |- mesh__dateCreated mesh__D017902 1993-06-04
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017902 2006
% 214.44/214.62  |- skos__scopeNote mesh__D017902
% 214.44/214.62       A family of bacteriophages which are characterized by short, non-contractile tails.%A%    
% 214.44/214.62  |- mesh__activeMeSHYear mesh__D017902 2002
% 214.44/214.63  |- skos__hiddenLabel mesh__D017902 Phages, T7 like
% 214.44/214.63  |- skos__hiddenLabel mesh__D017902 T7 like Phages
% 214.44/214.63  |- skos__prefLabel mesh__D017902 Podoviridae
% 214.44/214.63  |- mesh__dateRevised mesh__D017902 2001-07-25
% 214.44/214.63  |- skos__hiddenLabel mesh__D017902 Viruses, T7-like
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017902 2003
% 214.44/214.63  |- mesh__recordAuthorizer mesh__D017902 sjn
% 214.44/214.63  |- mesh__recordOriginator mesh__D017902 AGS
% 214.44/214.63  |- skos__hiddenLabel mesh__D017902 T7 like Viruses
% 214.44/214.63  |- mesh__publicMeSHNote mesh__D017902 94   
% 214.44/214.63  |- skos__historyNote mesh__D017902 Bacteriophages %28%1983-1993%29%
% 214.44/214.63  |- mesh__recordMaintainer mesh__D017902 ags
% 214.44/214.63  |- skos__altLabel mesh__D017902 T7-like Phages
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017902 2004
% 214.44/214.63  |- mesh__historyNote mesh__D017902 94   
% 214.44/214.63  |- mesh__dateEstablished mesh__D017902 1994-01-01
% 214.44/214.63  |- skos__broader mesh__D017902smesh__D017899
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017104 2006
% 214.44/214.63  |- skos__hiddenLabel mesh__D017104 M13, Coliphage
% 214.44/214.63  |- skos__historyNote mesh__D017104 Coliphages %28%1966-1992%29%
% 214.44/214.63  |- skos__hiddenLabel mesh__D017104 M13 Phages
% 214.44/214.63  |- skos__hiddenLabel mesh__D017104 Phages, fd
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017104 2005
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017104 2004
% 214.44/214.63  |- mesh__dateEstablished mesh__D017104 1993-01-01
% 214.44/214.63  |- skos__hiddenLabel mesh__D017104 fd Phages
% 214.44/214.63  |- skos__altLabel mesh__D017104 Enterobacteria phage M13
% 214.44/214.63  |- skos__hiddenLabel mesh__D017104 Phages, M13
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017104 2003
% 214.44/214.63  |- skos__altLabel mesh__D017104 Phage M13
% 214.44/214.63  |- skos__hiddenLabel mesh__D017104 Phage, fd
% 214.44/214.63  |- skos__altLabel mesh__D017104 M13 Phage
% 214.44/214.63  |- mesh__dateRevised mesh__D017104 2001-07-25
% 214.44/214.63  |- mesh__recordAuthorizer mesh__D017104 sjn
% 214.44/214.63  |- rdf__type mesh__D017104sskos__Concept
% 214.44/214.63  |- mesh__recordMaintainer mesh__D017104 ags
% 214.44/214.63  |- mesh__dateCreated mesh__D017104 1992-05-07
% 214.44/214.63  |- skos__altLabel mesh__D017104 Bacteriophage fd
% 214.44/214.63  |- skos__scopeNote mesh__D017104
% 214.44/214.63       Temperate bacteriophage of the genus INOVIRUS which infects enterobacteria, especially E. coli. It is a filamentous phage consisting of single-stranded DNA and is circularly permuted.%A%    
% 214.44/214.63  |- skos__altLabel mesh__D017104 Coliphage M13
% 214.44/214.63  |- skos__altLabel mesh__D017104 fd Phage
% 214.44/214.63  |- skos__hiddenLabel mesh__D017104 Phage, M13
% 214.44/214.63  |- skos__broader mesh__D017104smesh__D017912
% 214.44/214.63  |- mesh__publicMeSHNote mesh__D017104
% 214.44/214.63       1993; for PHAGE FD, FD PHAGE, BACTERIOPHAGE FD,  %26% COLIPHAGE FD see INOVIRUS 1994-2001%A%  
% 214.44/214.63  |- skos__altLabel mesh__D017104 Enterobacteria phage fd
% 214.44/214.63  |- skos__altLabel mesh__D017104 Coliphage fd
% 214.44/214.63  |- skos__broader mesh__D017104smesh__D003090
% 214.44/214.63  |- mesh__historyNote mesh__D017104
% 214.44/214.63       1993; for PHAGE FD, FD PHAGE, BACTERIOPHAGE FD,  %26% COLIPHAGE FD use INOVIRUS 1994-2001%A%  
% 214.44/214.63  |- skos__prefLabel mesh__D017104 Bacteriophage M13
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017104 2002
% 214.44/214.63  |- mesh__recordOriginator mesh__D017104 AGS
% 214.44/214.63  |- mesh__historyNote mesh__D050538 2006%28%1998%29%   
% 214.44/214.63  |- mesh__recordAuthorizer mesh__D050538 sjn
% 214.44/214.63  |- skos__prefLabel mesh__D050538 Malate Dehydrogenase %28%NADP+%29%
% 214.44/214.63  |- mesh__dateCreated mesh__D050538 2005-06-30
% 214.44/214.63  |- mesh__dateEstablished mesh__D050538 2006-01-01
% 214.44/214.63  |- skos__hiddenLabel mesh__D050538 Dehydrogenase, NADP-Malate
% 214.44/214.63  |- skos__scopeNote mesh__D050538
% 214.44/214.63       A light-activated enzyme that catalyzes the oxidation of %28%S%29%-malate to OXALOACETATE. It is involved in PYRUVATE metabolism and CARBON fixation.%A%    
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D050538 2006
% 214.44/214.63  |- skos__altLabel mesh__D050538 NADP-Malate Dehydrogenase
% 214.44/214.63  |- mesh__recordMaintainer mesh__D050538 AKE
% 214.44/214.63  |- skos__altLabel mesh__D050538 Malate Dehydrogenase %28%NADP%29%
% 214.44/214.63  |- skos__broader mesh__D050538smesh__D000429
% 214.44/214.63  |- rdf__type mesh__D050538sskos__Concept
% 214.44/214.63  |- skos__hiddenLabel mesh__D050538 NADP Malate Dehydrogenase
% 214.44/214.63  |- mesh__recordOriginator mesh__D050538 AKE
% 214.44/214.63  |- mesh__publicMeSHNote mesh__D050538
% 214.44/214.63       2006; MALATE DEHYDROGENASE %28%NADP+%29% was indexed under MALATE DEHYDROGENASE 1988-2005%A%  
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D000395 2006
% 214.44/214.63  |- mesh__dateEstablished mesh__D000395 1984-01-01
% 214.44/214.63  |- mesh__historyNote mesh__D000395
% 214.44/214.63       84%28%75%29%; was see under AIR POLLUTANTS 1975-83   
% 214.44/214.63  |- rdf__type mesh__D000395sskos__Concept
% 214.44/214.63  |- skos__broader mesh__D000395smesh__D000393
% 214.44/214.63  |- skos__related mesh__D000395smesh__D020378
% 214.44/214.63  |- mesh__dateRevised mesh__D000395 2003-07-09
% 214.44/214.63  |- skos__scopeNote mesh__D000395
% 214.44/214.63       Air pollutants found in the work area. They are usually produced by the specific nature of the occupation.%A%    
% 214.44/214.63  |- skos__altLabel mesh__D000395 Occupational Air Pollutants
% 214.44/214.63  |- mesh__recordAuthorizer mesh__D000395 sjn
% 214.44/214.63  |- skos__related mesh__D000395smesh__D015920
% 214.44/214.63  |- mesh__recordOriginator mesh__D000395 NLM
% 214.44/214.63  |- skos__prefLabel mesh__D000395 Air Pollutants, Occupational
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D000395 2005
% 214.44/214.63  |- skos__annotation mesh__D000395
% 214.44/214.63       specify pollutant or occup if pertinent %28%IM or NIM%29%; DF: AIR POLLUTANTS OCCUP%A%  
% 214.44/214.63  |- mesh__publicMeSHNote mesh__D000395
% 214.44/214.63       84; was see under AIR POLLUTANTS 1975-83   
% 214.44/214.63  |- mesh__recordMaintainer mesh__D000395 ssb
% 214.44/214.63  |- mesh__dateCreated mesh__D000395 1999-01-01
% 214.44/214.63  |- skos__hiddenLabel mesh__D000395 Pollutants, Occupational Air
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D000395 2004
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Tests, Step
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Ergometry Test, Bicycle
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Exercise Tests
% 214.44/214.63  |- mesh__dateEstablished mesh__D005080 1966-01-01
% 214.44/214.63  |- mesh__recordAuthorizer mesh__D005080 sjn
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Stress Tests
% 214.44/214.63  |- mesh__publicMeSHNote mesh__D005080 66   
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D005080 2006
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Arm Ergometry Tests
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Test, Treadmill
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Tests, Bicycle Ergometry
% 214.44/214.63  |- skos__prefLabel mesh__D005080 Exercise Test
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Test, Exercise
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Ergometry Tests, Bicycle
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Tests, Arm Ergometry
% 214.44/214.63  |- skos__broader mesh__D005080smesh__D012129
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Ergometry Test, Arm
% 214.44/214.63  |- skos__altLabel mesh__D005080 Stress Test
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D005080 2005
% 214.44/214.63  |- rdf__type mesh__D005080sskos__Concept
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Tests, Stress
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D005080 2004
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D005080 2002
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Test, Bicycle Ergometry
% 214.44/214.63  |- skos__broader mesh__D005080smesh__D006334
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Tests, Exercise
% 214.44/214.63  |- mesh__historyNote mesh__D005080 66%28%63%29%   
% 214.44/214.63  |- skos__scopeNote mesh__D005080
% 214.44/214.63       Controlled physical activity, more strenuous than at rest, which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal %28%most intense%29% exercise is usually required but submaximal exercise is also used. The intensity of exercise is often graded, using criteria such as rate of work done, oxygen consumption, and heart rate.%A%    
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Tests, Treadmill
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D005080 2003
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Test, Stress
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Step Tests
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Bicycle Ergometry Tests
% 214.44/214.63  |- mesh__dateCreated mesh__D005080 1999-01-01
% 214.44/214.63  |- skos__related mesh__D005080smesh__D025401
% 214.44/214.63  |- mesh__recordOriginator mesh__D005080 NLM
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Treadmill Tests
% 214.44/214.63  |- mesh__dateRevised mesh__D005080 2001-07-25
% 214.44/214.63  |- mesh__recordMaintainer mesh__D005080 ags
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Test, Arm Ergometry
% 214.44/214.63  |- skos__broader mesh__D005080smesh__D016552
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Ergometry Tests, Arm
% 214.44/214.63  |- skos__hiddenLabel mesh__D005080 Test, Step
% 214.44/214.63  |- mesh__recordMaintainer mesh__D004786 sjn
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D004786 2006A
% 214.44/214.63  |- skos__prefLabel mesh__D004786 Toxic Actions
% 214.44/214.63  |- mesh__dateEstablished mesh__D004786 1998-01-01
% 214.44/214.63  |- skos__annotation mesh__D004786
% 214.44/214.63       not used for indexing      CATALOG: do not use   
% 214.44/214.63  |- rdf__type mesh__D004786sskos__Concept
% 214.44/214.63  |- skos__broader mesh__D004786smesh__D020164
% 214.44/214.63  |- mesh__recordOriginator mesh__D004786 NLM
% 214.44/214.63  |- skos__hiddenLabel mesh__D004786 Actions, Toxic
% 214.44/214.63  |- mesh__publicMeSHNote mesh__D004786
% 214.44/214.63       2004; see ENVIRONMENTAL POLLUTANTS, NOXAE, AND PESTICIDES 1998-2003%A%  
% 214.44/214.63  |- mesh__recordAuthorizer mesh__D004786 sjn
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D004786 2005
% 214.44/214.63  |- mesh__historyNote mesh__D004786 2004%28%1998%29%   
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D004786 2004
% 214.44/214.63  |- mesh__dateCreated mesh__D004786 1999-01-01
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D004786 2006
% 214.44/214.63  |- mesh__dateRevised mesh__D004786 2005-08-15
% 214.44/214.63  |- skos__scopeNote mesh__D004786
% 214.44/214.63       A broad category of chemical actions with harmful or deadly effect on living organisms.%A%    
% 214.44/214.63  |- skos__hiddenLabel mesh__D009471 Devics Disease
% 214.44/214.63  |- mesh__recordAuthorizer mesh__D009471 ags
% 214.44/214.63  |- skos__broader mesh__D009471smesh__D009103
% 214.44/214.63  |- skos__altLabel mesh__D009471 Devic%27%s Disease
% 214.44/214.63  |- mesh__dateEstablished mesh__D009471 1991-01-01
% 214.44/214.63  |- skos__prefLabel mesh__D009471 Neuromyelitis Optica
% 214.44/214.63  |- skos__hiddenLabel mesh__D009471 Syndrome, Devic%27%s
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D009471 2002
% 214.44/214.63  |- mesh__recordMaintainer mesh__D009471 ags
% 214.44/214.63  |- mesh__onlineNote mesh__D009471
% 214.44/214.63       use MULTIPLE SCLEROSIS to search NEUROMYELITIS OPTICA 1966-74%A%  
% 214.44/214.63  |- skos__hiddenLabel mesh__D009471 Disease, Devic
% 214.44/214.63  |- skos__altLabel mesh__D009471 Devic%27%s Syndrome
% 214.44/214.63  |- mesh__publicMeSHNote mesh__D009471
% 214.44/214.63       1991; was see under DEMYELINATING DISEASES 1979-1990; was see under MULTIPLE SCLEROSIS 1967-1978; DEVIC DISEASE was DEVIC%27%S DISEASE 1997%A%  
% 214.44/214.63  |- skos__hiddenLabel mesh__D009471 Syndromes, Devic%27%s
% 214.44/214.63  |- mesh__historyNote mesh__D009471
% 214.44/214.63       1991%28%1975%29%; was see under DEMYELINATING DISEASES 1979-1990; was see under MULTIPLE SCLEROSIS 1963-1978 %28%Prov 1963-1966%29% ; DEVIC DISEASE was DEVIC%27%S DISEASE 1997%A%  
% 214.44/214.63  |- skos__hiddenLabel mesh__D009471 Syndrome, Devic
% 214.44/214.63  |- skos__hiddenLabel mesh__D009471 Devics Syndrome
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D009471 2003
% 214.44/214.63  |- mesh__recordOriginator mesh__D009471 NLM
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D009471 2000A
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D009471 2000
% 214.44/214.63  |- rdf__type mesh__D009471sskos__Concept
% 214.44/214.63  |- mesh__dateRevised mesh__D009471 1999-11-24
% 214.44/214.63  |- skos__scopeNote mesh__D009471
% 214.44/214.63       A syndrome characterized by acute OPTIC NEURITIS in combination with acute MYELITIS, TRANSVERSE. Demyelinating and/or necrotizing lesions form in one or both optic nerves and in the spinal cord. The onset of optic neuritis and myelitis may be simultaneous or separated by several months. %28%J Neurol Neurosurg Psychiatry 1996 Apr;60%28%4%29%:382-387%29%%A%    
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D009471 2005
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D009471 2004
% 214.44/214.63  |- skos__broader mesh__D009471smesh__D020278
% 214.44/214.63  |- skos__hiddenLabel mesh__D009471 Disease, Devic%27%s
% 214.44/214.63  |- skos__altLabel mesh__D009471 Devic Syndrome
% 214.44/214.63  |- mesh__dateCreated mesh__D009471 1999-01-01
% 214.44/214.63  |- skos__broader mesh__D009471smesh__D009902
% 214.44/214.63  |- skos__altLabel mesh__D009471 Devic Disease
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D009471 2001
% 214.44/214.63  |- skos__hiddenLabel mesh__D009471 Devic%27%s Syndromes
% 214.44/214.63  |- skos__broader mesh__D009471smesh__D009188
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D009471 2006
% 214.44/214.63  |- skos__altLabel mesh__D017903 Enterobacteria phage T3
% 214.44/214.63  |- skos__broader mesh__D017903smesh__D013604
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017903 2003
% 214.44/214.63  |- mesh__dateCreated mesh__D017903 1993-06-15
% 214.44/214.63  |- mesh__recordAuthorizer mesh__D017903 sjn
% 214.44/214.63  |- mesh__dateRevised mesh__D017903 2001-07-25
% 214.44/214.63  |- mesh__historyNote mesh__D017903 94   
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017903 2002
% 214.44/214.63  |- skos__hiddenLabel mesh__D017903 Phage, T3
% 214.44/214.63  |- skos__altLabel mesh__D017903 Phage T3
% 214.44/214.63  |- rdf__type mesh__D017903sskos__Concept
% 214.44/214.63  |- mesh__recordMaintainer mesh__D017903 ags
% 214.44/214.63  |- skos__altLabel mesh__D017903 Coliphage T3
% 214.44/214.63  |- mesh__recordOriginator mesh__D017903 AGS
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017903 2006
% 214.44/214.63  |- mesh__publicMeSHNote mesh__D017903 94   
% 214.44/214.63  |- skos__historyNote mesh__D017903 Coliphages %28%1966-1993%29%
% 214.44/214.63  |- skos__prefLabel mesh__D017903 Bacteriophage T3
% 214.44/214.63  |- mesh__dateEstablished mesh__D017903 1994-01-01
% 214.44/214.63  |- skos__hiddenLabel mesh__D017903 T3 Phages
% 214.44/214.63  |- skos__altLabel mesh__D017903 T3 Phage
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017903 2005
% 214.44/214.63  |- skos__scopeNote mesh__D017903
% 214.44/214.63       Bacteriophage in the genus T7-like Phages, of the family PODOVIRIDAE, which is very closely related to BACTERIOPHAGE T7.%A%    
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017903 2004
% 214.44/214.63  |- skos__hiddenLabel mesh__D017903 Phages, T3
% 214.44/214.63  |- skos__broader mesh__D017903smesh__D017902
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017105 2005
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017105 2002
% 214.44/214.63  |- skos__hiddenLabel mesh__D017105 Pseudomonas Bacteriophage
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017105 1999
% 214.44/214.63  |- skos__scopeNote mesh__D017105
% 214.44/214.63       Viruses whose host is Pseudomonas. A frequently encountered Pseudomonas phage is BACTERIOPHAGE PHI 6.%A%    
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017105 2003
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017105 1997
% 214.44/214.63  |- rdf__type mesh__D017105sskos__Concept
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017105 1998
% 214.44/214.63  |- skos__broader mesh__D017105smesh__D001435
% 214.44/214.63  |- mesh__dateEstablished mesh__D017105 1993-01-01
% 214.44/214.63  |- skos__hiddenLabel mesh__D017105 Bacteriophages, Pseudomonas
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017105 2001
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017105 1996
% 214.44/214.63  |- skos__altLabel mesh__D017105 Pseudomonas Bacteriophages
% 214.44/214.63  |- mesh__historyNote mesh__D017105 93   
% 214.44/214.63  |- mesh__dateCreated mesh__D017105 1992-05-26
% 214.44/214.63  |- skos__historyNote mesh__D017105 Bacteriophages %28%1966-1992%29%
% 214.44/214.63  |- skos__prefLabel mesh__D017105 Pseudomonas Phages
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017105 2000
% 214.44/214.63  |- skos__annotation mesh__D017105
% 214.44/214.63       coord IM with specific Pseudomonas %28%NIM%29%   
% 214.44/214.63  |- skos__hiddenLabel mesh__D017105 Pseudomonas Phage
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017105 1995
% 214.44/214.63  |- skos__hiddenLabel mesh__D017105 Bacteriophage, Pseudomonas
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017105 2006
% 214.44/214.63  |- mesh__publicMeSHNote mesh__D017105 93   
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017105 1993
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017105 1994
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D017105 2004
% 214.44/214.63  |- skos__broader mesh__D050539smesh__D000429
% 214.44/214.63  |- skos__hiddenLabel mesh__D050539 Dehydrogenase, beta-IPM
% 214.44/214.63  |- mesh__historyNote mesh__D050539
% 214.44/214.63       2006%28%1980%29%; use DICARBOXYLIC ACIDS 1970-1979   
% 214.44/214.63  |- skos__scopeNote mesh__D050539
% 214.44/214.63       An NAD+ dependent enzyme that catalyzes the oxidation of 3-carboxy-2-hydroxy-4-methylpentanoate to 3-carboxy-4-methyl-2-oxopentanoate. It is involved in the biosynthesis of VALINE; LEUCINE; and ISOLEUCINE.%A%    
% 214.44/214.63  |- skos__altLabel mesh__D050539 beta-IPM Dehydrogenase
% 214.44/214.63  |- skos__hiddenLabel mesh__D050539 beta IPM Dehydrogenase
% 214.44/214.63  |- mesh__recordOriginator mesh__D050539 AKE
% 214.44/214.63  |- skos__altLabel mesh__D050539 beta-Isopropylmalate Dehydrogenase
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D050539 2006
% 214.44/214.63  |- mesh__recordAuthorizer mesh__D050539 sjn
% 214.44/214.63  |- skos__hiddenLabel mesh__D050539 Dehydrogenase, 3-Isopropylmalate
% 214.44/214.63  |- mesh__publicMeSHNote mesh__D050539
% 214.44/214.63       2006; 3-ISOPROPYLMALATE DEHYDROGENASE was indexed under ALCOHOL OXIDOREDUCTASES 1981-2005, %26% under DICARBOXYLIC ACIDS 1970-1980%A%  
% 214.44/214.63  |- skos__hiddenLabel mesh__D050539 Dehydrogenase, beta-Isopropylmalate
% 214.44/214.63  |- mesh__dateCreated mesh__D050539 2005-06-30
% 214.44/214.63  |- skos__hiddenLabel mesh__D050539 beta Isopropylmalate Dehydrogenase
% 214.44/214.63  |- mesh__recordMaintainer mesh__D050539 AKE
% 214.44/214.63  |- rdf__type mesh__D050539sskos__Concept
% 214.44/214.63  |- skos__hiddenLabel mesh__D050539 3 Isopropylmalate Dehydrogenase
% 214.44/214.63  |- skos__prefLabel mesh__D050539 3-Isopropylmalate Dehydrogenase
% 214.44/214.63  |- mesh__dateEstablished mesh__D050539 2006-01-01
% 214.44/214.63  |- skos__prefLabel mesh__D008379 Marburg Virus Disease
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D008379 2004
% 214.44/214.63  |- mesh__dateCreated mesh__D008379 1974-11-11
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D008379 2005
% 214.44/214.63  |- mesh__recordAuthorizer mesh__D008379 sjn
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D008379 2002
% 214.44/214.63  |- skos__broader mesh__D008379smesh__D018702
% 214.44/214.63  |- skos__broader mesh__D008379smesh__D008992
% 214.44/214.63  |- mesh__recordOriginator mesh__D008379 NLM
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D008379 2006
% 214.44/214.63  |- skos__scopeNote mesh__D008379
% 214.44/214.63       An RNA virus infection of rhesus, vervet, and squirrel monkeys transmissible to man.%A%    
% 214.44/214.63  |- mesh__dateEstablished mesh__D008379 1975-09-01
% 214.44/214.63  |- mesh__historyNote mesh__D008379 75   
% 214.44/214.63  |- skos__broader mesh__D008379smesh__D006482
% 214.44/214.63  |- rdf__type mesh__D008379sskos__Concept
% 214.44/214.63  |- skos__historyNote mesh__D008379 Virus Diseases %28%1966-1974%29%
% 214.44/214.63  |- mesh__dateRevised mesh__D008379 2001-07-25
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D008379 2003
% 214.44/214.63  |- mesh__recordMaintainer mesh__D008379 ags
% 214.44/214.63  |- mesh__publicMeSHNote mesh__D008379 75   
% 214.44/214.63  |- mesh__recordOriginator mesh__D000396 NLM
% 214.44/214.63  |- mesh__recordMaintainer mesh__D000396 ssb
% 214.44/214.63  |- rdf__type mesh__D000396sskos__Concept
% 214.44/214.63  |- skos__hiddenLabel mesh__D000396 Pollutants, Radioactive Air
% 214.44/214.63  |- skos__annotation mesh__D000396
% 214.44/214.63       specify radiopollutant if pertinent %28%IM or NIM%29%   
% 214.44/214.63  |- skos__broader mesh__D000396smesh__D000393
% 214.44/214.63  |- mesh__publicMeSHNote mesh__D000396
% 214.44/214.63       91; was see under AIR POLLUTANTS 1975-90   
% 214.44/214.63  |- mesh__dateEstablished mesh__D000396 1991-01-01
% 214.44/214.63  |- mesh__dateRevised mesh__D000396 2003-07-09
% 214.44/214.63  |- skos__scopeNote mesh__D000396
% 214.44/214.63       Pollutants, present in air, which exhibit radioactivity.%A%    
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D000396 2005
% 214.44/214.63  |- mesh__dateCreated mesh__D000396 1999-01-01
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D000396 2004
% 214.44/214.63  |- skos__prefLabel mesh__D000396 Air Pollutants, Radioactive
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D000396 2006
% 214.44/214.63  |- skos__altLabel mesh__D000396 Radioactive Air Pollutants
% 214.44/214.63  |- skos__broader mesh__D000396smesh__D011848
% 214.44/214.63  |- mesh__historyNote mesh__D000396
% 214.44/214.63       91%28%75%29%; was see under AIR POLLUTANTS 1975-90   
% 214.44/214.63  |- mesh__recordAuthorizer mesh__D000396 sjn
% 214.44/214.63  |- skos__broader mesh__D005081smesh__D026741
% 214.44/214.63  |- mesh__recordOriginator mesh__D005081 NLM
% 214.44/214.63  |- rdf__type mesh__D005081sskos__Concept
% 214.44/214.63  |- mesh__recordAuthorizer mesh__D005081 sjn
% 214.44/214.63  |- skos__hiddenLabel mesh__D005081 Exercise Therapies
% 214.44/214.63  |- skos__prefLabel mesh__D005081 Exercise Therapy
% 214.44/214.63  |- mesh__dateCreated mesh__D005081 1999-01-01
% 214.44/214.63  |- mesh__recordMaintainer mesh__D005081 lkt
% 214.44/214.63  |- mesh__dateRevised mesh__D005081 2005-06-30
% 214.44/214.63  |- skos__broader mesh__D005081smesh__D012046
% 214.44/214.63  |- skos__broader mesh__D005081smesh__D026201
% 214.44/214.63  |- skos__scopeNote mesh__D005081
% 214.44/214.63       Motion of the body or its parts to relieve symptoms or to improve function, leading to PHYSICAL FITNESS, but not PHYSICAL EDUCATION AND TRAINING.%A%    
% 214.44/214.63  |- skos__annotation mesh__D005081
% 214.44/214.63       %22%exercise%22% is not %22%exercise therapy%22%: use EXERCISE; do not use /util except by MeSH definition%A%  
% 214.44/214.63  |- skos__altLabel mesh__D005081 Therapy, Exercise
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D005081 2006
% 214.44/214.63  |- skos__broader mesh__D005081smesh__D026241
% 214.44/214.63  |- skos__hiddenLabel mesh__D005081 Therapies, Exercise
% 214.44/214.63  |- skos__altLabel mesh__D013513 Surgical Procedures, Obstetric
% 214.44/214.63  |- skos__hiddenLabel mesh__D013513 Obstetric Surgery
% 214.44/214.63  |- mesh__historyNote mesh__D013513 98; use explode 1970-97   
% 214.44/214.63  |- skos__hiddenLabel mesh__D013513 Obstetrical Surgeries
% 214.44/214.63  |- mesh__recordMaintainer mesh__D013513 sjn
% 214.44/214.63  |- skos__hiddenLabel mesh__D013513 Surgeries, Obstetric
% 214.44/214.63  |- skos__hiddenLabel mesh__D013513 Obstetric Surgeries
% 214.44/214.63  |- skos__hiddenLabel mesh__D013513 Surgeries, Obstetrical
% 214.44/214.63  |- skos__annotation mesh__D013513
% 214.44/214.63       GEN or unspecified; prefer specifics; consider also PREGNANCY COMPLICATIONS /surg %26% OBSTETRIC LABOR COMPLICATIONS /surg or /surg with specific pregn %26% labor compl; check the tags FEMALE %26% PREGNANCY; DF: OBSTET SURG PROCEDURES%A%  
% 214.44/214.63  |- skos__related mesh__D013513smesh__D009774
% 214.44/214.63  |- skos__altLabel mesh__D013513 Surgery, Obstetric
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D013513 2006
% 214.44/214.63  |- mesh__dateRevised mesh__D013513 2005-07-01
% 214.44/214.63  |- skos__altLabel mesh__D013513 Procedure, Obstetric Surgical
% 214.44/214.63  |- skos__hiddenLabel mesh__D013513 Obstetrical Surgical Procedure
% 214.44/214.63  |- skos__altLabel mesh__D013513 Surgical Procedure, Obstetric
% 214.44/214.63  |- mesh__dateCreated mesh__D013513 1999-01-01
% 214.44/214.63  |- mesh__publicMeSHNote mesh__D013513 98   
% 214.44/214.63  |- skos__altLabel mesh__D013513 Procedures, Obstetric Surgical
% 214.44/214.63  |- skos__hiddenLabel mesh__D013513 Surgery, Obstetrical
% 214.44/214.63  |- mesh__dateEstablished mesh__D013513 1998-01-01
% 214.44/214.63  |- skos__altLabel mesh__D013513 Obstetrical Surgical Procedures
% 214.44/214.63  |- skos__altLabel mesh__D013513 Obstetric Surgical Procedure
% 214.44/214.63  |- skos__scopeNote mesh__D013513
% 214.44/214.63       Surgery performed on the pregnant woman for conditions associated with pregnancy, labor, or the puerperium. It does not include surgery of the newborn infant.%A%    
% 214.44/214.63  |- skos__prefLabel mesh__D013513 Obstetric Surgical Procedures
% 214.44/214.63  |- skos__broader mesh__D013513smesh__D013514
% 214.44/214.63  |- skos__hiddenLabel mesh__D013513 Surgical Procedure, Obstetrical
% 214.44/214.63  |- rdf__type mesh__D013513sskos__Concept
% 214.44/214.63  |- skos__hiddenLabel mesh__D013513 Procedure, Obstetrical Surgical
% 214.44/214.63  |- skos__hiddenLabel mesh__D013513 Procedures, Obstetrical Surgical
% 214.44/214.63  |- mesh__recordOriginator mesh__D013513 NLM
% 214.44/214.63  |- skos__hiddenLabel mesh__D013513 Surgical Procedures, Obstetrical
% 214.44/214.63  |- skos__altLabel mesh__D013513 Obstetrical Surgery
% 214.44/214.63  |- mesh__recordAuthorizer mesh__D013513 sjn
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D037961 2006
% 214.44/214.63  |- skos__prefLabel mesh__D037961 Frullania
% 214.44/214.63  |- skos__scopeNote mesh__D037961
% 214.44/214.63       A plant genus of the family Jubulaceae, subclass JUNGERMANNIAE. Members contain eudesmane-type sesquiterpene lactones and cause CONTACT DERMATITIS.%A%    
% 214.44/214.63  |- skos__annotation mesh__D037961
% 214.44/214.63       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.44/214.63  |- mesh__publicMeSHNote mesh__D037961 2003   
% 214.44/214.63  |- mesh__dateCreated mesh__D037961 2002-07-03
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D037961 2003
% 214.44/214.63  |- rdf__type mesh__D037961sskos__Concept
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D037961 2004
% 214.44/214.63  |- mesh__dateEstablished mesh__D037961 2003-01-01
% 214.44/214.63  |- mesh__historyNote mesh__D037961 2003   
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D037961 2005
% 214.44/214.63  |- skos__broader mesh__D037961smesh__D035926
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D004787 2000
% 214.44/214.63  |- mesh__recordMaintainer mesh__D004787 kle
% 214.44/214.63  |- mesh__recordAuthorizer mesh__D004787 sjn
% 214.44/214.63  |- skos__prefLabel mesh__D004787 Environmental Pollution
% 214.44/214.63  |- mesh__dateEstablished mesh__D004787 1974-01-01
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D004787 2003
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D004787 2001
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D004787 2005
% 214.44/214.63  |- skos__annotation mesh__D004787
% 214.44/214.63       IM; coord with source of pollution %28%IM%29%; specify geog if pertinent; DF: ENVIR POLLUTION%A%  
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D004787 2004
% 214.44/214.63  |- mesh__dateCreated mesh__D004787 1999-01-01
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D004787 2006
% 214.44/214.63  |- mesh__historyNote mesh__D004787 74%28%71%29%   
% 214.44/214.63  |- skos__historyNote mesh__D004787 Environment %28%1966-1970%29%
% 214.44/214.63  |- skos__hiddenLabel mesh__D004787 Degradation, Soil
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D004787 2002
% 214.44/214.63  |- skos__altLabel mesh__D004787 Pollution, Environmental
% 214.44/214.63  |- skos__broader mesh__D004787smesh__D011634
% 214.44/214.63  |- mesh__recordOriginator mesh__D004787 NLM
% 214.44/214.63  |- mesh__publicMeSHNote mesh__D004787 74   
% 214.44/214.63  |- mesh__dateRevised mesh__D004787 1999-11-03
% 214.44/214.63  |- rdf__type mesh__D004787sskos__Concept
% 214.44/214.63  |- skos__altLabel mesh__D009472 Lipofuscinosis, Neuronal Ceroid
% 214.44/214.63  |- skos__hiddenLabel mesh__D009472 Cerebroretinal Degeneration, Juvenile
% 214.44/214.63  |- skos__scopeNote mesh__D009472
% 214.44/214.63       An inherited degenerative disease characterized by neuronal cytoplasmic inclusions which stain positively for ceroid and lipofuscin. Affected individuals develop retinal degeneration, seizures, myoclonus, ataxia, rigidity, and progressive dementia. Clinically there are four subtypes, divided by age of onset of symptoms: infantile %28%Santavuori-Haltia type%29%, late infantile %28%Jansky-Bielschowsky type%29%, juvenile %28%Spielmeyer-Vogt type%29%, and adult %28%Kuf%27%s disease%29%. The late infantile and juvenile forms may both also be referred to as Batten Disease and Batten-Mayou Disease. %28%Adams et al., Principles of Neurology, 6th ed, p957%29%%A%    
% 214.44/214.63  |- skos__hiddenLabel mesh__D009472 Batten Mayou Disease
% 214.44/214.63  |- mesh__historyNote mesh__D009472 83   
% 214.44/214.63  |- skos__hiddenLabel mesh__D009472 Diseases, Batten-Mayou
% 214.44/214.63  |- mesh__dateEstablished mesh__D009472 1983-01-01
% 214.44/214.63  |- skos__historyNote mesh__D009472 Lipofuscin %28%1975-1982%29%
% 214.44/214.63  |- skos__hiddenLabel mesh__D009472 Batten Spielmeyer Vogt Disease
% 214.44/214.63  |- skos__historyNote mesh__D009472 Lipoidosis %28%1966-1982%29%
% 214.44/214.63  |- skos__hiddenLabel mesh__D009472 Neuronal Ceroid Lipofuscinosis
% 214.44/214.63  |- skos__hiddenLabel mesh__D009472 Neuronal Ceroid Lipofuscinoses
% 214.44/214.63  |- mesh__activeMeSHYear mesh__D009472 2006
% 214.44/214.63  |- skos__hiddenLabel mesh__D009472 Diseases, Batten
% 214.44/214.63  |- skos__hiddenLabel mesh__D009472 Batten-Mayou Diseases
% 214.44/214.64  |- skos__prefLabel mesh__D009472 Neuronal Ceroid-Lipofuscinosis
% 214.44/214.64  |- skos__historyNote mesh__D009472 Pigments %28%1966-1982%29%
% 214.44/214.64  |- skos__hiddenLabel mesh__D009472
% 214.44/214.64       Neuronal Ceroid Lipfuscinosis, Late Infantile
% 214.44/214.64  |- skos__broader mesh__D009472smesh__D020271
% 214.44/214.64  |- skos__altLabel mesh__D009472 Kufs Disease
% 214.44/214.64  |- rdf__type mesh__D009472sskos__Concept
% 214.44/214.64  |- skos__altLabel mesh__D009472 Spielmeyer-Vogt Disease
% 214.44/214.64  |- skos__altLabel mesh__D009472 Neuronal Ceroid Lipfuscinosis, Infantile
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D009472 2005
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D009472 2004
% 214.44/214.64  |- skos__altLabel mesh__D009472 Batten-Spielmeyer-Vogt Disease
% 214.44/214.64  |- skos__historyNote mesh__D009472 Ceroid %28%1975-1982%29%
% 214.44/214.64  |- skos__hiddenLabel mesh__D009472 Juvenile Cerebroretinal Degenerations
% 214.44/214.64  |- skos__altLabel mesh__D009472 Neuronal Ceroid Lipfuscinosis. Adult
% 214.44/214.64  |- skos__altLabel mesh__D009472 Batten Disease
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D009472 2002
% 214.44/214.64  |- skos__hiddenLabel mesh__D009472 Cerebroretinal Degenerations, Juvenile
% 214.44/214.64  |- skos__hiddenLabel mesh__D009472
% 214.44/214.64       Late Infantile Neuronal Ceroid Lipfuscinosis
% 214.44/214.64  |- skos__hiddenLabel mesh__D009472 Spielmeyer Vogt Disease
% 214.44/214.64  |- skos__hiddenLabel mesh__D009472 Batten Diseases
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D009472 2003
% 214.44/214.64  |- mesh__recordAuthorizer mesh__D009472 sjn
% 214.44/214.64  |- mesh__dateRevised mesh__D009472 2001-07-25
% 214.44/214.64  |- skos__broader mesh__D009472smesh__D008064
% 214.44/214.64  |- skos__altLabel mesh__D009472 Santavuori-Haltia Disease
% 214.44/214.64  |- skos__hiddenLabel mesh__D009472 Santavuori Haltia Disease
% 214.44/214.64  |- mesh__dateCreated mesh__D009472 1982-04-28
% 214.44/214.64  |- skos__altLabel mesh__D009472 Jansky-Bielschowsky Disease
% 214.44/214.64  |- skos__altLabel mesh__D009472 Ceroid-Lipofuscinosis, Neuronal
% 214.44/214.64  |- mesh__publicMeSHNote mesh__D009472 83   
% 214.44/214.64  |- mesh__recordOriginator mesh__D009472 RC
% 214.44/214.64  |- skos__altLabel mesh__D009472 Juvenile Cerebroretinal Degeneration
% 214.44/214.64  |- mesh__recordMaintainer mesh__D009472 nns
% 214.44/214.64  |- skos__hiddenLabel mesh__D009472 Spielmeyer-Vogt Diseases
% 214.44/214.64  |- skos__altLabel mesh__D009472 Batten-Mayou Disease
% 214.44/214.64  |- skos__hiddenLabel mesh__D009472 Ceroid Lipofuscinosis, Neuronal
% 214.44/214.64  |- skos__hiddenLabel mesh__D009472 Degenerations, Juvenile Cerebroretinal
% 214.44/214.64  |- skos__altLabel mesh__D009472
% 214.44/214.64       Neuronal Ceroid Lipfuscinosis, Late-Infantile
% 214.44/214.64  |- skos__altLabel mesh__D009472 Neuronal Ceroid Lipfuscinosis, Juvenile
% 214.44/214.64  |- skos__hiddenLabel mesh__D009472 Jansky Bielschowsky Disease
% 214.44/214.64  |- skos__hiddenLabel mesh__D009472 Degeneration, Juvenile Cerebroretinal
% 214.44/214.64  |- mesh__recordOriginator mesh__D017904 PXP
% 214.44/214.64  |- skos__broader mesh__D017904smesh__D000191
% 214.44/214.64  |- rdf__type mesh__D017904sskos__Concept
% 214.44/214.64  |- mesh__recordMaintainer mesh__D017904 ags
% 214.44/214.64  |- mesh__recordAuthorizer mesh__D017904 ags
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D017904 2006
% 214.44/214.64  |- skos__historyNote mesh__D017904 Bacteria, Anaerobic %28%1984-1993%29%
% 214.44/214.64  |- skos__prefLabel mesh__D017904 Mobiluncus
% 214.44/214.64  |- mesh__dateRevised mesh__D017904 2005-08-31
% 214.44/214.64  |- mesh__dateCreated mesh__D017904 1993-02-16
% 214.44/214.64  |- skos__annotation mesh__D017904
% 214.44/214.64       infection: coordinate IM with ACTINOMYCETALES INFECTIONS %28%IM%29%%A%  
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D017904 2006A
% 214.44/214.64  |- mesh__publicMeSHNote mesh__D017904 94   
% 214.44/214.64  |- mesh__dateEstablished mesh__D017904 1994-01-01
% 214.44/214.64  |- skos__scopeNote mesh__D017904
% 214.44/214.64       A genus of gram-negative, anaerobic, rod-shaped bacteria. Its organisms are found in the human vagina, particularly in association with Gardnerella vaginalis in cases of bacterial vaginosis.%A%    
% 214.44/214.64  |- mesh__historyNote mesh__D017904 94   
% 214.44/214.64  |- skos__hiddenLabel mesh__D000397 Pollution, Air
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D000397 2006
% 214.44/214.64  |- skos__annotation mesh__D000397
% 214.44/214.64       includes pollen in the air %28%coord with POLLEN%29%   
% 214.44/214.64  |- mesh__dateCreated mesh__D000397 1999-01-01
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D000397 2002
% 214.44/214.64  |- mesh__recordMaintainer mesh__D000397 kle
% 214.44/214.64  |- skos__broader mesh__D000397smesh__D004787
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D000397 2005
% 214.44/214.64  |- skos__hiddenLabel mesh__D000397 Pollutions, Air
% 214.44/214.64  |- mesh__recordAuthorizer mesh__D000397 sjn
% 214.44/214.64  |- skos__hiddenLabel mesh__D000397 Air Pollutions
% 214.44/214.64  |- mesh__dateRevised mesh__D000397 1999-11-03
% 214.44/214.64  |- mesh__recordOriginator mesh__D000397 NLM
% 214.44/214.64  |- rdf__type mesh__D000397sskos__Concept
% 214.44/214.64  |- skos__prefLabel mesh__D000397 Air Pollution
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D000397 2001
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D000397 2004
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D000397 2000
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D000397 2003
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005880 2003
% 214.44/214.64  |- mesh__dateEstablished mesh__D005880 1968-01-01
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005880 2006
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005880 2000
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005880 1995
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005880 1993
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005880 2004
% 214.44/214.64  |- skos__prefLabel mesh__D005880 Gills
% 214.44/214.64  |- rdf__type mesh__D005880sskos__Concept
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005880 1998
% 214.44/214.64  |- skos__historyNote mesh__D005880 Fishes %28%1966-1967%29%
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005880 1990
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005880 2001
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005880 1996
% 214.44/214.64  |- mesh__dateCreated mesh__D005880 1999-01-01
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005880 1989
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005880 1999
% 214.44/214.64  |- skos__historyNote mesh__D005880 Branchial Region %28%1966-1967%29%
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005880 2002
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005880 1991
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005880 1997
% 214.44/214.64  |- mesh__recordAuthorizer mesh__D005880 NLM
% 214.44/214.64  |- mesh__historyNote mesh__D005880 68   
% 214.44/214.64  |- skos__broader mesh__D005880smesh__D000825
% 214.44/214.64  |- mesh__dateRevised mesh__D005880 1978-10-25
% 214.44/214.64  |- mesh__recordOriginator mesh__D005880 NLM
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005880 2005
% 214.44/214.64  |- mesh__recordMaintainer mesh__D005880 HMM
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005880 1994
% 214.44/214.64  |- skos__hiddenLabel mesh__D005880 Gill
% 214.44/214.64  |- mesh__publicMeSHNote mesh__D005880 68   
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005880 1992
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005082 2005
% 214.44/214.64  |- skos__hiddenLabel mesh__D005082 Effort, Physical
% 214.44/214.64  |- mesh__recordMaintainer mesh__D005082 nns
% 214.44/214.64  |- skos__broader mesh__D005082smesh__D043702
% 214.44/214.64  |- skos__prefLabel mesh__D005082 Exertion
% 214.44/214.64  |- skos__hiddenLabel mesh__D005082 Efforts
% 214.44/214.64  |- mesh__dateRevised mesh__D005082 2003-07-09
% 214.44/214.64  |- skos__related mesh__D005082smesh__D014937
% 214.44/214.64  |- rdf__type mesh__D005082sskos__Concept
% 214.44/214.64  |- skos__hiddenLabel mesh__D005082 Physical Efforts
% 214.44/214.64  |- skos__hiddenLabel mesh__D005082 Exertions
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005082 2004
% 214.44/214.64  |- mesh__recordOriginator mesh__D005082 NLM
% 214.44/214.64  |- mesh__recordAuthorizer mesh__D005082 sjn
% 214.44/214.64  |- mesh__dateCreated mesh__D005082 1999-01-01
% 214.44/214.64  |- skos__related mesh__D005082smesh__D005221
% 214.44/214.64  |- skos__annotation mesh__D005082
% 214.44/214.64       TN 166: exertion as a control state, opposite %22%at rest%22%   
% 214.44/214.64  |- skos__altLabel mesh__D005082 Effort
% 214.44/214.64  |- skos__related mesh__D005082smesh__D015444
% 214.44/214.64  |- skos__scopeNote mesh__D005082
% 214.44/214.64       Expenditure of energy by skeletal muscles. Intensity of exertion may be measured by rate of oxygen consumption, heat produced, or heart rate. Perceived exertion, a psychological measure of exertion, is included.%A%    
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005082 2006
% 214.44/214.64  |- skos__hiddenLabel mesh__D005082 Efforts, Physical
% 214.44/214.64  |- skos__related mesh__D005082smesh__D013177
% 214.44/214.64  |- skos__hiddenLabel mesh__D013514 Procedure, Operative
% 214.44/214.64  |- skos__altLabel mesh__D013514 Procedure, Operative Surgical
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D013514 2006
% 214.44/214.64  |- mesh__recordOriginator mesh__D013514 NLM
% 214.44/214.64  |- skos__related mesh__D013514smesh__D009873
% 214.44/214.64  |- mesh__recordAuthorizer mesh__D013514 sjn
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D013514 2005
% 214.44/214.64  |- mesh__runningHead mesh__D013514
% 214.44/214.64       E4 - PROCEDURES AND TECHNIQUES-SURGICAL   
% 214.44/214.64  |- mesh__dateCreated mesh__D013514 1999-01-01
% 214.44/214.64  |- skos__altLabel mesh__D013514 Ghost Surgery
% 214.44/214.64  |- skos__hiddenLabel mesh__D013514 Operative Procedure
% 214.44/214.64  |- skos__altLabel mesh__D013514 Surgical Procedure, Operative
% 214.44/214.64  |- skos__altLabel mesh__D013514 Procedures, Operative Surgical
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D013514 2004
% 214.44/214.64  |- skos__scopeNote mesh__D013514
% 214.44/214.64       Operations carried out for the correction of deformities and defects, repair of injuries, and diagnosis and cure of certain diseases. %28%Taber, 18th ed.%29%%A%    
% 214.44/214.64  |- skos__related mesh__D013514smesh__D011183
% 214.44/214.64  |- skos__altLabel mesh__D013514 Operative Surgical Procedures
% 214.44/214.64  |- mesh__dateRevised mesh__D013514 2002-07-03
% 214.44/214.64  |- skos__related mesh__D013514smesh__D012086
% 214.44/214.64  |- rdf__type mesh__D013514sskos__Concept
% 214.44/214.64  |- mesh__onlineNote mesh__D013514
% 214.44/214.64       pre-explosion = SURGICAL PROCEDURES, OPERATIVE %28%PX%29%   
% 214.44/214.64  |- skos__altLabel mesh__D013514 Operative Surgical Procedure
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D013514 2003
% 214.44/214.64  |- mesh__historyNote mesh__D013514 98%28%63%29%   
% 214.44/214.64  |- skos__related mesh__D013514smesh__D007431
% 214.44/214.64  |- skos__hiddenLabel mesh__D013514 Procedures, Operative
% 214.44/214.64  |- mesh__publicMeSHNote mesh__D013514 98; see SURGERY, OPERATIVE 1963-97   
% 214.44/214.64  |- skos__related mesh__D013514smesh__D013502
% 214.44/214.64  |- skos__annotation mesh__D013514
% 214.44/214.64       not the field nor spec %28% = SURGERY%29%; only the surg patient or surg procedures; prefer /surg with organs or dis; /instrum = SURGICAL INSTRUMENTS or SURGICAL EQUIPMENT; surgical inj = SURGICAL INJURIES see INTRAOPERATIVE COMPLICATIONS: see TN 179; /hist = SURGERY /hist; differentiation from SURGERY: Manual 26.15+; unnecessary surgery = SURGERY, UNNECESSARY see UNNECESSARY PROCEDURES %28%IM%29% + specific surg procedure %28%IM%29%; SECOND-LOOK SURGERY see REOPERATION is also available%A%  
% 214.44/214.64  |- mesh__recordMaintainer mesh__D013514 nns
% 214.44/214.64  |- skos__altLabel mesh__D013514 Operative Procedures
% 214.44/214.64  |- skos__prefLabel mesh__D013514 Surgical Procedures, Operative
% 214.44/214.64  |- skos__broader mesh__D005952Q000172smesh__D005952
% 214.44/214.64  |- mesh__preferredCombination mesh__D005952Q000172smesh__D005953
% 214.44/214.64  |- rdf__type mesh__D005952Q000172smesh__CompoundConcept
% 214.44/214.64  |- skos__hiddenLabel mesh__D009473 Neuroplasticities
% 214.44/214.64  |- rdf__type mesh__D009473sskos__Concept
% 214.44/214.64  |- mesh__recordAuthorizer mesh__D009473 sjn
% 214.44/214.64  |- skos__historyNote mesh__D009473 Visual Pathways %28%1971-1981%29%
% 214.44/214.64  |- skos__altLabel mesh__D009473 Neuroplasticity
% 214.44/214.64  |- mesh__historyNote mesh__D009473 82   
% 214.44/214.64  |- skos__hiddenLabel mesh__D009473 Neuronal Plasticities
% 214.44/214.64  |- mesh__publicMeSHNote mesh__D009473 82   
% 214.44/214.64  |- skos__scopeNote mesh__D009473
% 214.44/214.64       The capacity of the NERVOUS SYSTEM to change its reactivity as the result of successive activations.%A%    
% 214.44/214.64  |- skos__altLabel mesh__D009473 Plasticity, Neuronal
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D009473 2006
% 214.44/214.64  |- skos__historyNote mesh__D009473 Synapses %28%1966-1981%29%
% 214.44/214.64  |- mesh__dateCreated mesh__D009473 1981-02-24
% 214.44/214.64  |- skos__hiddenLabel mesh__D009473 Plasticities, Neuronal
% 214.44/214.64  |- skos__historyNote mesh__D009473 Visual Cortex %28%1968-1981%29%
% 214.44/214.64  |- mesh__dateEstablished mesh__D009473 1982-01-01
% 214.44/214.64  |- mesh__recordMaintainer mesh__D009473 nns
% 214.44/214.64  |- skos__prefLabel mesh__D009473 Neuronal Plasticity
% 214.44/214.64  |- mesh__dateRevised mesh__D009473 2005-06-30
% 214.44/214.64  |- skos__historyNote mesh__D009473 Neurons %28%1966-1981%29%
% 214.44/214.64  |- mesh__recordOriginator mesh__D009473 RC
% 214.44/214.64  |- skos__broader mesh__D009473smesh__D009424
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D001490 2004
% 214.44/214.64  |- skos__historyNote mesh__D001490 Athletic Injuries %28%1968-1986%29%
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D001490 2006
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D001490 2003
% 214.44/214.64  |- mesh__recordAuthorizer mesh__D001490 PLS
% 214.44/214.64  |- mesh__dateRevised mesh__D001490 1996-06-10
% 214.44/214.64  |- mesh__dateEstablished mesh__D001490 1990-01-01
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D001490 1997
% 214.44/214.64  |- skos__historyNote mesh__D001490 Sports %28%1966-1986%29%
% 214.44/214.64  |- mesh__publicMeSHNote mesh__D001490 90; was see under SPORTS 1987-89   
% 214.44/214.64  |- mesh__historyNote mesh__D001490
% 214.44/214.64       90%28%87%29%; was see under SPORTS 1987-89   
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D001490 2005
% 214.44/214.64  |- skos__prefLabel mesh__D001490 Basketball
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D001490 1999
% 214.44/214.64  |- rdf__type mesh__D001490sskos__Concept
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D001490 2002
% 214.44/214.64  |- skos__scopeNote mesh__D001490
% 214.44/214.64       A competitive team sport played on a rectangular court having a raised basket at each end.%A%    
% 214.44/214.64  |- mesh__recordMaintainer mesh__D001490 TPW
% 214.44/214.64  |- skos__broader mesh__D001490smesh__D013177
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D001490 1998
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D001490 2001
% 214.44/214.64  |- mesh__recordOriginator mesh__D001490 EC
% 214.44/214.64  |- mesh__dateCreated mesh__D001490 1986-03-25
% 214.44/214.64  |- skos__annotation mesh__D001490
% 214.44/214.64       /inj: coord IM with specific inj %28%IM%29%; /physiol permitted; Manual 30.15.1%A%  
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D001490 2000
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D017905 2006
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D017905 1995
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D017905 2001
% 214.44/214.64  |- mesh__dateEstablished mesh__D017905 1994-01-01
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D017905 1999
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D017905 2000
% 214.44/214.64  |- skos__scopeNote mesh__D017905
% 214.44/214.64       Inorganic salts or organic esters of phosphorous acid that contain the %28%3-%29%PO3 radical. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D017905 2005
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D017905 1994
% 214.44/214.64  |- mesh__publicMeSHNote mesh__D017905 94   
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D017905 2004
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D017905 1998
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D017905 1997
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D017905 2003
% 214.44/214.64  |- skos__historyNote mesh__D017905 Phosphorous Acids %28%1968-1993%29%
% 214.44/214.64  |- mesh__historyNote mesh__D017905 94   
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D017905 1996
% 214.44/214.64  |- skos__prefLabel mesh__D017905 Phosphites
% 214.44/214.64  |- rdf__type mesh__D017905sskos__Concept
% 214.44/214.64  |- skos__broader mesh__D017905smesh__D000838
% 214.44/214.64  |- skos__historyNote mesh__D017905
% 214.44/214.64       Organophosphorus Compounds %28%1973-1993%29%
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D017905 2002
% 214.44/214.64  |- mesh__dateCreated mesh__D017905 1993-06-04
% 214.44/214.64  |- skos__broader mesh__D017905smesh__D010757
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D000398 2000
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D000398 2005
% 214.44/214.64  |- rdf__type mesh__D000398sskos__Concept
% 214.44/214.64  |- skos__broader mesh__D000398smesh__D000397
% 214.44/214.64  |- skos__hiddenLabel mesh__D000398 Radioactive Air Pollution
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D000398 2002
% 214.44/214.64  |- mesh__recordMaintainer mesh__D000398 kle
% 214.44/214.64  |- skos__hiddenLabel mesh__D000398 Air Pollutions, Radioactive
% 214.44/214.64  |- skos__hiddenLabel mesh__D000398 Pollution, Radioactive Air
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D000398 2004
% 214.44/214.64  |- skos__hiddenLabel mesh__D000398 Radioactive Air Pollutions
% 214.44/214.64  |- mesh__recordAuthorizer mesh__D000398 sjn
% 214.44/214.64  |- mesh__dateRevised mesh__D000398 1999-11-03
% 214.44/214.64  |- mesh__recordOriginator mesh__D000398 NLM
% 214.44/214.64  |- skos__prefLabel mesh__D000398 Air Pollution, Radioactive
% 214.44/214.64  |- skos__annotation mesh__D000398
% 214.44/214.64       IM; coord with specific source of radiation %28%IM%29%; specify geog if pertinent%A%  
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D000398 2003
% 214.44/214.64  |- skos__broader mesh__D000398smesh__D011870
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D000398 2001
% 214.44/214.64  |- skos__hiddenLabel mesh__D000398 Pollutions, Radioactive Air
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D000398 2006
% 214.44/214.64  |- mesh__dateCreated mesh__D000398 1999-01-01
% 214.44/214.64  |- skos__related mesh__D005881smesh__D005893
% 214.44/214.64  |- skos__annotation mesh__D005881
% 214.44/214.64       /surg: prefer GINGIVOPLASTY or GINGIVECTOMY; inflammation = GINGIVITIS; peripheral giant cell granuloma = GINGIVAL DISEASES %28%IM%29% + GRANULOMA, GIANT CELL %28%IM%29%, central giant cell granuloma = JAW DISEASES %28%IM%29% + GRANULOMA, GIANT CELL %28%IM%29%%A%  
% 214.44/214.64  |- rdf__type mesh__D005881sskos__Concept
% 214.44/214.64  |- skos__broader mesh__D005881smesh__D010519
% 214.44/214.64  |- mesh__dateCreated mesh__D005881 1999-01-01
% 214.44/214.64  |- mesh__recordMaintainer mesh__D005881 ssb
% 214.44/214.64  |- mesh__dateRevised mesh__D005881 2004-07-07
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005881 2005
% 214.44/214.64  |- skos__prefLabel mesh__D005881 Gingiva
% 214.44/214.64  |- skos__scopeNote mesh__D005881
% 214.44/214.64       Oral tissue surrounding and attached to TEETH.     
% 214.44/214.64  |- skos__related mesh__D005881smesh__D005890
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005881 2006
% 214.44/214.64  |- skos__altLabel mesh__D005881 Gums
% 214.44/214.64  |- mesh__recordAuthorizer mesh__D005881 sjn
% 214.44/214.64  |- skos__hiddenLabel mesh__D005881 Gum
% 214.44/214.64  |- mesh__recordOriginator mesh__D005881 NLM
% 214.44/214.64  |- skos__altLabel mesh__D005881 Papilla, Interdental
% 214.44/214.64  |- skos__prefLabel mesh__D005083 Exfoliatins
% 214.44/214.64  |- skos__scopeNote mesh__D005083
% 214.44/214.64       Protein exotoxins from Staphylococcus aureus, phage type II, which cause epidermal necrolysis. They are proteins with a molecular weight of 26,000 to 32,000. They cause a condition variously called scaled skin, Lyell or Ritter syndrome, epidermal exfoliative disease, toxic epidermal necrolysis, etc.%A%    
% 214.44/214.64  |- skos__hiddenLabel mesh__D005083 Toxin B, Exfoliative
% 214.44/214.64  |- skos__hiddenLabel mesh__D005083 Exfoliative Toxin, Staphylococcal
% 214.44/214.64  |- mesh__recordOriginator mesh__D005083 SH
% 214.44/214.64  |- skos__broader mesh__D005083smesh__D001427
% 214.44/214.64  |- skos__historyNote mesh__D005083 Toxins %28%1966-1976%29%
% 214.44/214.64  |- rdf__type mesh__D005083sskos__Concept
% 214.44/214.64  |- mesh__historyNote mesh__D005083
% 214.44/214.64       91%28%78%29%; was see under BACTERIAL TOXINS 1978-90   
% 214.44/214.64  |- skos__historyNote mesh__D005083 Bacterial Proteins %28%1966-1976%29%
% 214.44/214.64  |- skos__hiddenLabel mesh__D005083 Toxin, Staphylococcal Exfoliative
% 214.44/214.64  |- skos__hiddenLabel mesh__D005083 B, Exfoliative Toxin
% 214.44/214.64  |- mesh__dateEstablished mesh__D005083 1991-01-01
% 214.44/214.64  |- skos__hiddenLabel mesh__D005083 Toxin A, Exfoliatin
% 214.44/214.64  |- skos__hiddenLabel mesh__D005083 A, Exfoliatin Toxin
% 214.44/214.64  |- mesh__publicMeSHNote mesh__D005083
% 214.44/214.64       91; was see under BACTERIAL TOXINS 1978-90   
% 214.44/214.64  |- skos__altLabel mesh__D005083 Epidermolysins
% 214.44/214.64  |- skos__annotation mesh__D005083
% 214.44/214.64       /antag permitted but consider also ANTITOXINS   
% 214.44/214.64  |- skos__hiddenLabel mesh__D005083 Toxins, Exfoliative
% 214.44/214.64  |- skos__broader mesh__D005083smesh__D005098
% 214.44/214.64  |- skos__broader mesh__D005083smesh__D001426
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D005083 2006
% 214.44/214.64  |- skos__historyNote mesh__D005083 Bacterial Toxins %28%1977%29%
% 214.44/214.64  |- skos__historyNote mesh__D005083
% 214.44/214.64       Staphylococcal Infections %28%1966-1977%29%
% 214.44/214.64  |- mesh__dateCreated mesh__D005083 1977-04-22
% 214.44/214.64  |- skos__altLabel mesh__D005083 Staphylococcal Exfoliative Toxin
% 214.44/214.64  |- mesh__recordAuthorizer mesh__D005083 sjn
% 214.44/214.64  |- mesh__recordMaintainer mesh__D005083 ssb
% 214.44/214.64  |- skos__hiddenLabel mesh__D005083 Toxins, Epidermolytic
% 214.44/214.64  |- mesh__dateRevised mesh__D005083 2005-06-30
% 214.44/214.64  |- skos__altLabel mesh__D013515 Maxillofacial Surgery
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D013515 2006
% 214.44/214.64  |- skos__related mesh__D013515smesh__D003814
% 214.44/214.64  |- skos__scopeNote mesh__D013515
% 214.44/214.64       A dental specialty concerned with the diagnosis and surgical treatment of disease, injuries, and defects of the human oral and maxillofacial region.%A%    
% 214.44/214.64  |- skos__related mesh__D013515smesh__D019647
% 214.44/214.64  |- mesh__historyNote mesh__D013515
% 214.44/214.64       EXODONTICS was see TOOTH EXTRACTION 1965-97; was EXODONTIA see TEETH EXTRACTION 1963-64%A%  
% 214.44/214.64  |- skos__prefLabel mesh__D013515 Surgery, Oral
% 214.44/214.64  |- mesh__recordOriginator mesh__D013515 NLM
% 214.44/214.64  |- rdf__type mesh__D013515sskos__Concept
% 214.44/214.64  |- mesh__recordMaintainer mesh__D013515 sjn
% 214.44/214.64  |- mesh__recordAuthorizer mesh__D013515 sjn
% 214.44/214.64  |- skos__broader mesh__D013515smesh__D013039
% 214.44/214.64  |- skos__altLabel mesh__D013515 Oral Surgery
% 214.44/214.64  |- mesh__publicMeSHNote mesh__D013515
% 214.44/214.64       EXODONTICS was see TOOTH EXTRACTION 1965-97; was EXODONTIA see TEETH EXTRACTION 1963-64%A%  
% 214.44/214.64  |- mesh__dateRevised mesh__D013515 2004-07-13
% 214.44/214.64  |- skos__altLabel mesh__D013515 Surgery, Maxillofacial
% 214.44/214.64  |- mesh__dateCreated mesh__D013515 1999-01-01
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D013515 2005
% 214.44/214.64  |- skos__broader mesh__D013515smesh__D003813
% 214.44/214.64  |- skos__annotation mesh__D013515
% 214.44/214.64       SPEC of surg ther of dis, inj %26% defects of soft tissue of mouth %26% jaws; do not confuse with DENTISTRY, OPERATIVE: to restore tooth function; not a substitute for MOUTH /surg or /surg with specific related terms; SPEC qualif %26% /contra /nurs /psychol /rehabil /util%A%  
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D018200 2005
% 214.44/214.64  |- mesh__recordOriginator mesh__D018200 PLS
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D018200 2002
% 214.44/214.64  |- mesh__publicMeSHNote mesh__D018200 94   
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D018200 2006
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D018200 2003
% 214.44/214.64  |- rdf__type mesh__D018200sskos__Concept
% 214.44/214.64  |- skos__hiddenLabel mesh__D018200 Tumor, Mullerian Mixed
% 214.44/214.64  |- skos__broader mesh__D018200smesh__D018193
% 214.44/214.64  |- skos__annotation mesh__D018200
% 214.44/214.64       in titles %26% translations use diacrit: M%C3%%BC%llerian; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with probably UTERINE NEOPLASMS %28%IM%29%%A%  
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D018200 2004
% 214.44/214.64  |- mesh__dateEstablished mesh__D018200 1994-01-01
% 214.44/214.64  |- skos__prefLabel mesh__D018200 Mixed Tumor, Mullerian
% 214.44/214.64  |- skos__hiddenLabel mesh__D018200 Mullerian Mixed Tumor
% 214.44/214.64  |- mesh__recordAuthorizer mesh__D018200 sjn
% 214.44/214.64  |- skos__historyNote mesh__D018200
% 214.44/214.64       Neoplasms, Germ Cell and Embryonal %28%1968-1993%29%
% 214.44/214.64  |- mesh__recordMaintainer mesh__D018200 jls
% 214.44/214.64  |- mesh__dateRevised mesh__D018200 2001-08-13
% 214.44/214.64  |- skos__scopeNote mesh__D018200
% 214.44/214.64       A tumor, basically a carcinoma with a single sarcoma such as leiomyosarcoma or angiosarcoma or multiple sarcomas of uterine origin. The role of estrogen has been postulated as a possible etiological factor in this tumor. %28%Holland et al., Cancer Medicine, 3d ed, p1703%29%%A%    
% 214.44/214.64  |- mesh__dateCreated mesh__D018200 1993-06-25
% 214.44/214.64  |- mesh__historyNote mesh__D018200 94   
% 214.44/214.64  |- mesh__dateRevised mesh__D004789 2004-07-07
% 214.44/214.64  |- mesh__recordMaintainer mesh__D004789 wdj
% 214.44/214.64  |- mesh__dateCreated mesh__D004789 1999-01-01
% 214.44/214.64  |- mesh__recordAuthorizer mesh__D004789 sjn
% 214.44/214.64  |- skos__hiddenLabel mesh__D004789 Activations, Enzyme
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D004789 2005
% 214.44/214.64  |- skos__hiddenLabel mesh__D004789 Enzyme Activations
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D004789 2006
% 214.44/214.64  |- mesh__dateEstablished mesh__D004789 1976-01-01
% 214.44/214.64  |- skos__prefLabel mesh__D004789 Enzyme Activation
% 214.44/214.64  |- skos__hiddenLabel mesh__D004789 Activation, Enzyme
% 214.44/214.64  |- rdf__type mesh__D004789sskos__Concept
% 214.44/214.64  |- skos__broader mesh__D004789smesh__D008660
% 214.44/214.64  |- skos__scopeNote mesh__D004789
% 214.44/214.64       Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions %28%activators%29%; 2, activation by cofactors %28%coenzymes%29%; and 3, conversion of an enzyme precursor %28%proenzyme or zymogen%29% to an active enzyme.%A%    
% 214.44/214.64  |- mesh__historyNote mesh__D004789
% 214.44/214.64       76%28%69%29%; was see under BIOCHEMISTRY 1975   
% 214.44/214.64  |- skos__annotation mesh__D004789
% 214.44/214.64       IM for general only; NIM with specific enzyme %28%IM%29%; %22%enzyme reactivation%22%: coord IM with specific enzyme /metab %28%IM%29% + ENZYME REACTIVATORS %28%IM%29% if discussed %28%see note there%29%%A%  
% 214.44/214.64  |- mesh__publicMeSHNote mesh__D004789
% 214.44/214.64       76; was see under BIOCHEMISTRY 1975   
% 214.44/214.64  |- mesh__recordOriginator mesh__D004789 NLM
% 214.44/214.64  |- skos__broader mesh__D004789smesh__D001669
% 214.44/214.64  |- skos__broader mesh__D009474smesh__D002477
% 214.44/214.64  |- mesh__publicMeSHNote mesh__D009474
% 214.44/214.64       NERVE CELLS was see under NEUROGLIA %26% NEURONS 1963-74   
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D009474 2004
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D009474 2001
% 214.44/214.64  |- mesh__dateRevised mesh__D009474 1999-11-03
% 214.44/214.64  |- mesh__activeMeSHYear mesh__D009474 2000
% 214.44/214.64  |- rdf__type mesh__D009474sskos__Concept
% 214.44/214.65  |- skos__scopeNote mesh__D009474
% 214.44/214.65       The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.%A%    
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D009474 2003
% 214.44/214.65  |- skos__hiddenLabel mesh__D009474 Cells, Nerve
% 214.44/214.65  |- skos__hiddenLabel mesh__D009474 Neuron
% 214.44/214.65  |- skos__hiddenLabel mesh__D009474 Nerve Cell
% 214.44/214.65  |- mesh__recordAuthorizer mesh__D009474 sjn
% 214.44/214.65  |- skos__related mesh__D009474smesh__D009431
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D009474 2006
% 214.44/214.65  |- mesh__recordOriginator mesh__D009474 NLM
% 214.44/214.65  |- mesh__dateCreated mesh__D009474 1999-01-01
% 214.44/214.65  |- skos__altLabel mesh__D009474 Nerve Cells
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D009474 2002
% 214.44/214.65  |- skos__broader mesh__D009474smesh__D009420
% 214.44/214.65  |- skos__hiddenLabel mesh__D009474 Cell, Nerve
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D009474 2005
% 214.44/214.65  |- mesh__recordMaintainer mesh__D009474 KEV
% 214.44/214.65  |- mesh__onlineNote mesh__D009474
% 214.44/214.65       to search NERVE CELLS use NEUROGLIA %26% NEURONS 1966-74   
% 214.44/214.65  |- mesh__historyNote mesh__D009474
% 214.44/214.65       NERVE CELLS was see under NEUROGLIA %26% NEURONS 1963-74   
% 214.44/214.65  |- skos__annotation mesh__D009474
% 214.44/214.65       do not use as a substitute or synonym for BRAIN /cytol   
% 214.44/214.65  |- skos__prefLabel mesh__D009474 Neurons
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D001491 2006
% 214.44/214.65  |- mesh__recordOriginator mesh__D001491 NLM
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D001491 2005
% 214.44/214.65  |- mesh__dateRevised mesh__D001491 2003-07-09
% 214.44/214.65  |- skos__prefLabel mesh__D001491 Basophils
% 214.44/214.65  |- rdf__type mesh__D001491sskos__Concept
% 214.44/214.65  |- skos__broader mesh__D001491smesh__D006098
% 214.44/214.65  |- skos__annotation mesh__D001491
% 214.44/214.65       restrict to leukocytes: not for %22%basophilic%22% when referring only to staining %28% = STAINING%29%%A%  
% 214.44/214.65  |- skos__scopeNote mesh__D001491
% 214.44/214.65       Granular leukocytes characterized by a relatively pale-staining, lobate nucleus and cytoplasm containing coarse dark-staining granules of variable size and stainable by basic dyes.%A%    
% 214.44/214.65  |- mesh__recordAuthorizer mesh__D001491 sjn
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D001491 2004
% 214.44/214.65  |- skos__hiddenLabel mesh__D001491 Basophil
% 214.44/214.65  |- mesh__dateCreated mesh__D001491 1999-01-01
% 214.44/214.65  |- mesh__recordMaintainer mesh__D001491 nns
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017906 2005
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017906 2002
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017906 2004
% 214.44/214.65  |- mesh__dateCreated mesh__D017906 1993-06-04
% 214.44/214.65  |- skos__hiddenLabel mesh__D017906 lambda like Viruses
% 214.44/214.65  |- skos__hiddenLabel mesh__D017906 Phages, T5 like
% 214.44/214.65  |- mesh__dateEstablished mesh__D017906 1994-01-01
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017906 2003
% 214.44/214.65  |- mesh__recordOriginator mesh__D017906 AGS
% 214.44/214.65  |- skos__broader mesh__D017906smesh__D017899
% 214.44/214.65  |- skos__prefLabel mesh__D017906 Siphoviridae
% 214.44/214.65  |- skos__altLabel mesh__D017906 Phages, T5-like
% 214.44/214.65  |- skos__altLabel mesh__D017906 T5-like Phages
% 214.44/214.65  |- skos__scopeNote mesh__D017906
% 214.44/214.65       A family of BACTERIOPHAGES and ARCHAEAL VIRUSES which are characterized by long, non-contractile tails.%A%    
% 214.44/214.65  |- skos__broader mesh__D017906smesh__D023641
% 214.44/214.65  |- rdf__type mesh__D017906sskos__Concept
% 214.44/214.65  |- skos__altLabel mesh__D017906 Syphoviridae
% 214.44/214.65  |- skos__hiddenLabel mesh__D017906 T5 like Viruses
% 214.44/214.65  |- mesh__historyNote mesh__D017906 1994   
% 214.44/214.65  |- skos__historyNote mesh__D017906 Bacteriophages %28%1984-1993%29%
% 214.44/214.65  |- skos__hiddenLabel mesh__D017906 lambda Like Phages
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017906 2006
% 214.44/214.65  |- skos__annotation mesh__D017906
% 214.44/214.65       coord with specific bacterium /virol or specific Archaea /virol; note X refs; BACTERIOPHAGE LAMBDA is also available%A%  
% 214.44/214.65  |- skos__hiddenLabel mesh__D017906 phage BF23, Enterobacteria
% 214.44/214.65  |- mesh__recordMaintainer mesh__D017906 ags
% 214.44/214.65  |- mesh__publicMeSHNote mesh__D017906 1994   
% 214.44/214.65  |- skos__altLabel mesh__D017906 lambda-Like Phages
% 214.44/214.65  |- skos__altLabel mesh__D017906 Phages, lambda-Like
% 214.44/214.65  |- mesh__recordAuthorizer mesh__D017906 sjn
% 214.44/214.65  |- mesh__dateRevised mesh__D017906 2001-07-25
% 214.44/214.65  |- skos__hiddenLabel mesh__D017108 Streptococcal Phage
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017108 2005
% 214.44/214.65  |- skos__historyNote mesh__D017108 Bacteriophages %28%1966-1992%29%
% 214.44/214.65  |- skos__hiddenLabel mesh__D017108 Phage, Streptococcal
% 214.44/214.65  |- skos__hiddenLabel mesh__D017108 Streptococcus Phage
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017108 1995
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017108 2006
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017108 2003
% 214.44/214.65  |- skos__broader mesh__D017108smesh__D001435
% 214.44/214.65  |- skos__hiddenLabel mesh__D017108 Bacteriophages, Streptococcus
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017108 2000
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017108 1998
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017108 1993
% 214.44/214.65  |- skos__altLabel mesh__D017108 Streptococcal Phages
% 214.44/214.65  |- skos__annotation mesh__D017108
% 214.44/214.65       coord IM with specific Streptococcus %28%NIM%29%   
% 214.44/214.65  |- skos__altLabel mesh__D017108 Streptococcus Bacteriophages
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017108 2004
% 214.44/214.65  |- skos__scopeNote mesh__D017108 Viruses whose host is Streptococcus.     
% 214.44/214.65  |- mesh__dateEstablished mesh__D017108 1993-01-01
% 214.44/214.65  |- skos__hiddenLabel mesh__D017108 Bacteriophage, Streptococcus
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017108 2001
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017108 1999
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017108 1996
% 214.44/214.65  |- skos__hiddenLabel mesh__D017108 Phages, Streptococcal
% 214.44/214.65  |- skos__hiddenLabel mesh__D017108 Phage, Streptococcus
% 214.44/214.65  |- skos__prefLabel mesh__D017108 Streptococcus Phages
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017108 2002
% 214.44/214.65  |- rdf__type mesh__D017108sskos__Concept
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017108 1997
% 214.44/214.65  |- mesh__dateCreated mesh__D017108 1992-05-22
% 214.44/214.65  |- mesh__publicMeSHNote mesh__D017108 93   
% 214.44/214.65  |- skos__hiddenLabel mesh__D017108 Phages, Streptococcus
% 214.44/214.65  |- skos__hiddenLabel mesh__D017108 Streptococcus Bacteriophage
% 214.44/214.65  |- mesh__historyNote mesh__D017108 93   
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017108 1994
% 214.44/214.65  |- mesh__recordOriginator mesh__D000399 NLM
% 214.44/214.65  |- skos__broader mesh__D000399smesh__D001274
% 214.44/214.65  |- skos__prefLabel mesh__D000399 Air Pressure
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D000399 2004
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D000399 1997
% 214.44/214.65  |- skos__hiddenLabel mesh__D000399 Pressures, Air
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D000399 2001
% 214.44/214.65  |- skos__hiddenLabel mesh__D000399 Pressure, Air
% 214.44/214.65  |- skos__scopeNote mesh__D000399
% 214.44/214.65       The force per unit area that the air exerts on any surface in contact with it. Primarily used for articles pertaining to air pressure within a closed environment.%A%    
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D000399 1993
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D000399 2003
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D000399 1996
% 214.44/214.65  |- mesh__onlineNote mesh__D000399 search ATMOSPHERIC PRESSURE 1966-74   
% 214.44/214.65  |- mesh__dateRevised mesh__D000399 1990-04-13
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D000399 2000
% 214.44/214.65  |- mesh__recordAuthorizer mesh__D000399 PLS
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D000399 2006
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D000399 1999
% 214.44/214.65  |- mesh__dateCreated mesh__D000399 1999-01-01
% 214.44/214.65  |- mesh__dateEstablished mesh__D000399 1991-01-01
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D000399 1992
% 214.44/214.65  |- mesh__recordMaintainer mesh__D000399 NLM
% 214.44/214.65  |- mesh__historyNote mesh__D000399
% 214.44/214.65       91%28%75%29%; was see under ATMOSPHERIC PRESSURE 1975-90   
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D000399 1995
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D000399 2005
% 214.44/214.65  |- mesh__publicMeSHNote mesh__D000399
% 214.44/214.65       91; was see under ATMOSPHERIC PRESSURE 1975-90   
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D000399 1998
% 214.44/214.65  |- skos__annotation mesh__D000399 no qualif   
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D000399 2002
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D000399 1994
% 214.44/214.65  |- skos__hiddenLabel mesh__D000399 Air Pressures
% 214.44/214.65  |- rdf__type mesh__D000399sskos__Concept
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D000399 1991
% 214.44/214.65  |- mesh__historyNote mesh__D005882 65   
% 214.44/214.65  |- skos__hiddenLabel mesh__D005882 Gingivoses
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005882 2006
% 214.44/214.65  |- mesh__dateCreated mesh__D005882 1999-01-01
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005882 2003
% 214.44/214.65  |- skos__annotation mesh__D005882
% 214.44/214.65       inflamm dis = GINGIVITIS or PERICORONITIS; note X ref EPULIS: EPULIS /congen = EPULIS, CONGENITAL see GINGIVAL NEOPLASMS %26% is indexed GINGIVAL NEOPLASMS /congen%A%  
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005882 2005
% 214.44/214.65  |- mesh__recordOriginator mesh__D005882 NLM
% 214.44/214.65  |- mesh__dateRevised mesh__D005882 1997-06-20
% 214.44/214.65  |- rdf__type mesh__D005882sskos__Concept
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005882 2002
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005882 1999
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005882 2001
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005882 1998
% 214.44/214.65  |- skos__altLabel mesh__D005882 Epulis
% 214.44/214.65  |- skos__hiddenLabel mesh__D005882 Diseases, Gingival
% 214.44/214.65  |- mesh__dateEstablished mesh__D005882 1965-01-01
% 214.44/214.65  |- mesh__publicMeSHNote mesh__D005882 65   
% 214.44/214.65  |- skos__broader mesh__D005882smesh__D010510
% 214.44/214.65  |- skos__hiddenLabel mesh__D005882 Gingival Disease
% 214.44/214.65  |- skos__hiddenLabel mesh__D005882 Disease, Gingival
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005882 2000
% 214.44/214.65  |- mesh__recordMaintainer mesh__D005882 TPW
% 214.44/214.65  |- skos__prefLabel mesh__D005882 Gingival Diseases
% 214.44/214.65  |- mesh__recordAuthorizer mesh__D005882 SJN
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005882 2004
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005084 2001
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005084 2003
% 214.44/214.65  |- mesh__dateCreated mesh__D005084 1999-01-01
% 214.44/214.65  |- mesh__dateEstablished mesh__D005084 1991-01-01
% 214.44/214.65  |- mesh__recordOriginator mesh__D005084 NLM
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005084 2000
% 214.44/214.65  |- mesh__dateRevised mesh__D005084 1998-06-10
% 214.44/214.65  |- skos__scopeNote mesh__D005084
% 214.44/214.65       A disorder in which fantasies about or the act of exposing the genitals to an unsuspecting stranger produces sexual excitement with no attempt at further sexual activity with the stranger.%A%    
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005084 2006
% 214.44/214.65  |- mesh__historyNote mesh__D005084
% 214.44/214.65       91%28%75%29%; was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1968-80%A%  
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005084 1999
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005084 2005
% 214.44/214.65  |- mesh__recordMaintainer mesh__D005084 JLS
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005084 2002
% 214.44/214.65  |- skos__prefLabel mesh__D005084 Exhibitionism
% 214.44/214.65  |- mesh__onlineNote mesh__D005084 search PARAPHILIAS 1968-74   
% 214.44/214.65  |- mesh__recordAuthorizer mesh__D005084 SJN
% 214.44/214.65  |- rdf__type mesh__D005084sskos__Concept
% 214.44/214.65  |- mesh__publicMeSHNote mesh__D005084
% 214.44/214.65       91; was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1968-80%A%  
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005084 2004
% 214.44/214.65  |- skos__broader mesh__D005084smesh__D010262
% 214.44/214.65  |- skos__hiddenLabel mesh__D005084 Exhibitionisms
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D013516 1998
% 214.44/214.65  |- mesh__historyNote mesh__D013516
% 214.44/214.65       98; was SURGERY, ORAL, PREPROSTHETIC 1980-97; PREPROSTHETIC ORAL SURGICAL PROCEDURES was PREPROSTHETIC ORAL SURGERY 1980-97%A%  
% 214.44/214.65  |- skos__altLabel mesh__D013516 Surgical Procedures, Oral, Preprosthetic
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D013516 2001
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D013516 2004
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D013516 1999
% 214.44/214.65  |- skos__prefLabel mesh__D013516 Oral Surgical Procedures, Preprosthetic
% 214.44/214.65  |- rdf__type mesh__D013516sskos__Concept
% 214.44/214.65  |- skos__historyNote mesh__D013516
% 214.44/214.65       specific dental prosthesis %28%1966-1979%29%
% 214.44/214.65  |- skos__historyNote mesh__D013516
% 214.44/214.65       specific oral surgery heading %28%1966-1979%29%
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D013516 2002
% 214.44/214.65  |- skos__historyNote mesh__D013516 Surgery, Oral %28%1966-1979%29%
% 214.44/214.65  |- skos__historyNote mesh__D013516 Mouth/surgery %28%1966-1979%29%
% 214.44/214.65  |- skos__altLabel mesh__D013516 Oral Surgical Procedure, Preprosthetic
% 214.44/214.65  |- mesh__recordMaintainer mesh__D013516 PXP
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D013516 2005
% 214.44/214.65  |- skos__historyNote mesh__D013516 Dental Prosthesis %28%1966-1979%29%
% 214.44/214.65  |- skos__altLabel mesh__D013516 Preprosthetic Oral Surgical Procedure
% 214.44/214.65  |- mesh__dateEstablished mesh__D013516 1980-01-01
% 214.44/214.65  |- mesh__dateCreated mesh__D013516 1979-04-27
% 214.44/214.65  |- skos__scopeNote mesh__D013516
% 214.44/214.65       Surgery necessary for a denture to rest on a firm base, free from marked osseous protuberances or undercuts, and devoid of interfering muscle attachments, excess mucoperiosteum, hyperplasias, and fibrous or papillary growths.%A%    
% 214.44/214.65  |- mesh__publicMeSHNote mesh__D013516
% 214.44/214.65       98; was SURGERY, ORAL, PREPROSTHETIC 1980-97; PREPROSTHETIC ORAL SURGICAL PROCEDURES was PREPROSTHETIC ORAL SURGERY 1980-97%A%  
% 214.44/214.65  |- skos__altLabel mesh__D013516 Surgical Procedure, Oral, Preprosthetic
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D013516 2006
% 214.44/214.65  |- skos__altLabel mesh__D013516 Preprosthetic Oral Surgical Procedures
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D013516 2000
% 214.44/214.65  |- mesh__recordOriginator mesh__D013516 SMH
% 214.44/214.65  |- mesh__dateRevised mesh__D013516 1997-06-20
% 214.44/214.65  |- mesh__recordAuthorizer mesh__D013516 SJN
% 214.44/214.65  |- skos__broader mesh__D013516smesh__D019647
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D013516 2003
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D018201 2001
% 214.44/214.65  |- mesh__dateRevised mesh__D018201 2000-06-22
% 214.44/214.65  |- rdf__type mesh__D018201sskos__Concept
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D018201 2004
% 214.44/214.65  |- mesh__recordAuthorizer mesh__D018201 sjn
% 214.44/214.65  |- mesh__recordMaintainer mesh__D018201 jmp
% 214.44/214.65  |- skos__broader mesh__D018201smesh__D007680
% 214.44/214.65  |- skos__historyNote mesh__D018201 Nephroblastoma %28%1973-1993%29%
% 214.44/214.65  |- skos__hiddenLabel mesh__D018201 Nephromas, Mesoblastic
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D018201 2002
% 214.44/214.65  |- skos__scopeNote mesh__D018201
% 214.44/214.65       A malignant tumor of the kidney characterized by spindled myofibroblastic cells arranged in sheets or bundles with a tendency to infiltrate into the adjoining normal kidney and through the capsule into the perirenal tissues. %28%From Holland et al., Cancer Medicine, 3d ed, p2208%29%%A%    
% 214.44/214.65  |- skos__prefLabel mesh__D018201 Nephroma, Mesoblastic
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D018201 2005
% 214.44/214.65  |- mesh__historyNote mesh__D018201 94   
% 214.44/214.65  |- mesh__publicMeSHNote mesh__D018201 94   
% 214.44/214.65  |- skos__hiddenLabel mesh__D018201 Mesoblastic Nephroma
% 214.44/214.65  |- mesh__recordOriginator mesh__D018201 PLS
% 214.44/214.65  |- skos__broader mesh__D018201smesh__D018193
% 214.44/214.65  |- mesh__dateEstablished mesh__D018201 1994-01-01
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D018201 2006
% 214.44/214.65  |- mesh__dateCreated mesh__D018201 1993-06-28
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D018201 2003
% 214.44/214.65  |- skos__annotation mesh__D018201
% 214.44/214.65       coord IM with KIDNEY NEOPLASMS %28%IM%29%   
% 214.44/214.65  |- skos__related mesh__D009475smesh__D011984
% 214.44/214.65  |- mesh__dateRevised mesh__D009475 1997-06-20
% 214.44/214.65  |- rdf__type mesh__D009475sskos__Concept
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D009475 2003
% 214.44/214.65  |- skos__prefLabel mesh__D009475 Neurons, Afferent
% 214.44/214.65  |- skos__hiddenLabel mesh__D009475 Neuron, Afferent
% 214.44/214.65  |- skos__hiddenLabel mesh__D009475 Afferent Neurons
% 214.44/214.65  |- skos__hiddenLabel mesh__D009475 Sensory Neuron
% 214.44/214.65  |- skos__hiddenLabel mesh__D009475 Afferent Neuron
% 214.44/214.65  |- mesh__publicMeSHNote mesh__D009475 77   
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D009475 2001
% 214.44/214.65  |- skos__hiddenLabel mesh__D009475 Neuron, Sensory
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D009475 2006
% 214.44/214.65  |- mesh__dateCreated mesh__D009475 1999-01-01
% 214.44/214.65  |- skos__historyNote mesh__D009475 Neurons %28%1966-1968%29%
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D009475 2000
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D009475 2005
% 214.44/214.65  |- mesh__recordMaintainer mesh__D009475 AGS
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D009475 1999
% 214.44/214.65  |- mesh__dateEstablished mesh__D009475 1977-01-01
% 214.44/214.65  |- mesh__recordAuthorizer mesh__D009475 SJN
% 214.44/214.65  |- mesh__historyNote mesh__D009475 77%28%69%29%   
% 214.44/214.65  |- skos__annotation mesh__D009475
% 214.44/214.65       note X ref: do not confuse with NEURONS, EFFERENT which activate muscle %26% secretory cells; A 11 qualif%A%  
% 214.44/214.65  |- skos__hiddenLabel mesh__D009475 Sensory Neurons
% 214.44/214.65  |- mesh__recordOriginator mesh__D009475 NLM
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D009475 1998
% 214.44/214.65  |- skos__broader mesh__D009475smesh__D009474
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D009475 2002
% 214.44/214.65  |- skos__altLabel mesh__D009475 Neurons, Sensory
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D009475 2004
% 214.44/214.65  |- skos__scopeNote mesh__D009475
% 214.44/214.65       Neurons which convey sensory information centrally from the periphery.%A%    
% 214.44/214.65  |- rdf__type mesh__D001492sskos__Concept
% 214.44/214.65  |- mesh__dateEstablished mesh__D001492 1991-01-01
% 214.44/214.65  |- skos__altLabel mesh__D001492 Sea Bass
% 214.44/214.65  |- skos__scopeNote mesh__D001492
% 214.44/214.65       Common name for FISHES belonging to the order Perciformes and occurring in three different families.%A%    
% 214.44/214.65  |- skos__prefLabel mesh__D001492 Bass
% 214.44/214.65  |- mesh__publicMeSHNote mesh__D001492
% 214.44/214.65       91; was see under PERCIFORMES 1987-90   
% 214.44/214.65  |- mesh__recordOriginator mesh__D001492 EC
% 214.44/214.65  |- skos__hiddenLabel mesh__D001492 Basses, Sea
% 214.44/214.65  |- skos__hiddenLabel mesh__D001492 Bass, Sea
% 214.44/214.65  |- mesh__historyNote mesh__D001492
% 214.44/214.65       91%28%87%29%; was see under PERCIFORMES 1987-90   
% 214.44/214.65  |- skos__hiddenLabel mesh__D001492 Basses, Temperate
% 214.44/214.65  |- skos__historyNote mesh__D001492 Fishes %28%1966-1986%29%
% 214.44/214.65  |- mesh__recordMaintainer mesh__D001492 ags
% 214.44/214.65  |- skos__altLabel mesh__D001492 Temperate Basses
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D001492 2006
% 214.44/214.65  |- mesh__recordAuthorizer mesh__D001492 ags
% 214.44/214.65  |- skos__broader mesh__D001492smesh__D010473
% 214.44/214.65  |- mesh__dateRevised mesh__D001492 2005-07-14
% 214.44/214.65  |- skos__altLabel mesh__D001492 Sea Basses
% 214.44/214.65  |- skos__hiddenLabel mesh__D001492 Perch, White
% 214.44/214.65  |- mesh__dateCreated mesh__D001492 1986-04-15
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D001492 2006A
% 214.44/214.65  |- skos__altLabel mesh__D001492 White Perch
% 214.44/214.65  |- mesh__dateRevised mesh__D017907 2001-07-25
% 214.44/214.65  |- skos__annotation mesh__D017907 coord with specific bacterium /virol   
% 214.44/214.65  |- skos__scopeNote mesh__D017907
% 214.44/214.65       A family of bacteriophages that infects enterobacteria, CAULOBACTER, and PSEUDOMONAS. The genome consists of linear, positive-sense single-stranded RNA.%A%    
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017907 2002
% 214.44/214.65  |- skos__broader mesh__D017907smesh__D001435
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017907 2004
% 214.44/214.65  |- mesh__dateCreated mesh__D017907 1993-06-04
% 214.44/214.65  |- skos__hiddenLabel mesh__D017907 phage 7s, Pseudomonas
% 214.44/214.65  |- skos__broader mesh__D017907smesh__D012328
% 214.44/214.65  |- mesh__publicMeSHNote mesh__D017907
% 214.44/214.65       1994; for PHAGE MU 2 see RNA PHAGES 1980-2001   
% 214.44/214.65  |- mesh__recordAuthorizer mesh__D017907 sjn
% 214.44/214.65  |- mesh__recordOriginator mesh__D017907 AGS
% 214.44/214.65  |- mesh__historyNote mesh__D017907
% 214.44/214.65       1994; for PHAGE MU 2 use RNA PHAGES 1980-2001   
% 214.44/214.65  |- mesh__dateEstablished mesh__D017907 1994-01-01
% 214.44/214.65  |- rdf__type mesh__D017907sskos__Concept
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017907 2005
% 214.44/214.65  |- mesh__recordMaintainer mesh__D017907 ags
% 214.44/214.65  |- skos__broader mesh__D017907smesh__D012317
% 214.44/214.65  |- skos__broader mesh__D017907smesh__D003090
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017907 2006
% 214.44/214.65  |- skos__altLabel mesh__D017907 Enterobacteria phage Mu 2
% 214.44/214.65  |- skos__hiddenLabel mesh__D017907 Mu 2, Phage
% 214.44/214.65  |- skos__prefLabel mesh__D017907 Leviviridae
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017907 2003
% 214.44/214.65  |- skos__hiddenLabel mesh__D017109 Drug-Induced Acathisias
% 214.44/214.65  |- skos__hiddenLabel mesh__D017109 Tardive Akathisia
% 214.44/214.65  |- skos__hiddenLabel mesh__D017109 Acathisia, Drug Induced
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017109 2005
% 214.44/214.65  |- skos__prefLabel mesh__D017109 Akathisia, Drug-Induced
% 214.44/214.65  |- mesh__publicMeSHNote mesh__D017109 19   
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017109 2000
% 214.44/214.65  |- skos__scopeNote mesh__D017109
% 214.44/214.65       A condition associated with the use of certain medications and characterized by an internal sense of motor restlessness often described as an inability to resist the urge to move.%A%    
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017109 2003
% 214.44/214.65  |- skos__hiddenLabel mesh__D017109 Drug Induced Akathisia
% 214.44/214.65  |- skos__hiddenLabel mesh__D017109 Acathisias, Drug-Induced
% 214.44/214.65  |- mesh__historyNote mesh__D017109 1993   
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017109 2006
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017109 2001
% 214.44/214.65  |- skos__hiddenLabel mesh__D017109 Pseudoakathisias
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017109 2004
% 214.44/214.65  |- mesh__recordAuthorizer mesh__D017109 sjn
% 214.44/214.65  |- mesh__dateRevised mesh__D017109 1999-11-08
% 214.44/214.65  |- skos__hiddenLabel mesh__D017109 Drug-Induced Acathisia
% 214.44/214.65  |- rdf__type mesh__D017109sskos__Concept
% 214.44/214.65  |- mesh__dateEstablished mesh__D017109 1993-01-01
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D017109 2002
% 214.44/214.65  |- mesh__recordOriginator mesh__D017109 MXR
% 214.44/214.65  |- skos__broader mesh__D017109smesh__D011595
% 214.44/214.65  |- skos__historyNote mesh__D017109 Movement Disorders %28%1968-1977%29%
% 214.44/214.65  |- skos__related mesh__D017109smesh__D004409
% 214.44/214.65  |- skos__historyNote mesh__D017109 Psychomotor Agitation %28%1978-1992%29%
% 214.44/214.65  |- skos__hiddenLabel mesh__D017109 Akathisia, Drug Induced
% 214.44/214.65  |- skos__altLabel mesh__D017109 Drug-Induced Akathisia
% 214.44/214.65  |- mesh__recordMaintainer mesh__D017109 KEV
% 214.44/214.65  |- mesh__dateCreated mesh__D017109 1992-05-07
% 214.44/214.65  |- skos__altLabel mesh__D017109 Acathisia, Drug-Induced
% 214.44/214.65  |- skos__broader mesh__D017109smesh__D020258
% 214.44/214.65  |- skos__annotation mesh__D017109
% 214.44/214.65       shows %22%anxiety, restlessness %26% agitation%22%: do not confuse with DYSKINESIA, DRUG-INDUCED which shows repetitive movements%A%  
% 214.44/214.65  |- skos__hiddenLabel mesh__D005883 Gingival Exudates
% 214.44/214.65  |- skos__hiddenLabel mesh__D005883 Fluids, Gingival Crevicular
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005883 2005
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005883 2000
% 214.44/214.65  |- mesh__historyNote mesh__D005883
% 214.44/214.65       91%28%72%29%; was GINGIVAL EXUDATE see under GINGIVITIS 1972-90 %28%Prov 1972-74%29%; was in Cat A %26% C 1972-83, was in Cat C 1984-95%A%  
% 214.44/214.65  |- mesh__onlineNote mesh__D005883
% 214.44/214.65       use GINGIVAL CREVICULAR FLUID to search GINGIVAL EXUDATE 1972-90 %28%as Prov 1972-74%29%%A%  
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005883 1997
% 214.44/214.65  |- rdf__type mesh__D005883sskos__Concept
% 214.44/214.65  |- skos__hiddenLabel mesh__D005883 Gingival Crevicular Fluids
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005883 1999
% 214.44/214.65  |- skos__broader mesh__D005883smesh__D005122
% 214.44/214.65  |- skos__hiddenLabel mesh__D005883 Crevicular Fluid, Gingival
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005883 1996
% 214.44/214.65  |- mesh__dateEstablished mesh__D005883 1991-01-01
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005883 1998
% 214.44/214.65  |- skos__hiddenLabel mesh__D005883 Fluid, Gingival Crevicular
% 214.44/214.65  |- skos__altLabel mesh__D005883 Gingival Exudate
% 214.44/214.65  |- skos__hiddenLabel mesh__D005883 Exudates, Gingival
% 214.44/214.65  |- mesh__recordOriginator mesh__D005883 NLM
% 214.44/214.65  |- mesh__recordMaintainer mesh__D005883 TGC
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005883 2002
% 214.44/214.65  |- mesh__publicMeSHNote mesh__D005883
% 214.44/214.65       91; was GINGIVAL EXUDATE see under GINGIVITIS 1975-90; was in Cat A %26% C 1972-83, was in Cat C 1984-95%A%  
% 214.44/214.65  |- skos__hiddenLabel mesh__D005883 Crevicular Fluids, Gingival
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005883 2004
% 214.44/214.65  |- skos__prefLabel mesh__D005883 Gingival Crevicular Fluid
% 214.44/214.65  |- mesh__recordAuthorizer mesh__D005883 PLS
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005883 2001
% 214.44/214.65  |- skos__scopeNote mesh__D005883
% 214.44/214.65       A fluid occurring in minute amounts in the gingival crevice, believed by some authorities to be an inflammatory exudate and by others to cleanse material from the crevice, containing sticky plasma proteins which improve adhesions of the epithelial attachment, have antimicrobial properties, and exert antibody activity. %28%From Jablonski, Illustrated Dictionary of Dentistry, 1982%29%%A%    
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005883 2006
% 214.44/214.65  |- mesh__dateCreated mesh__D005883 1999-01-01
% 214.44/214.65  |- skos__hiddenLabel mesh__D005883 Exudate, Gingival
% 214.44/214.65  |- mesh__activeMeSHYear mesh__D005883 2003
% 214.44/214.65  |- mesh__dateRevised mesh__D005883 1995-06-08
% 214.44/214.65  |- skos__annotation mesh__D005883
% 214.44/214.65       note X ref; crevicular refers to the gingival crevice   
% 214.44/214.66  |- skos__historyNote mesh__D005883 Gingiva %28%1966-1972%29%
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D005085 2006
% 214.44/214.66  |- skos__annotation mesh__D005085 no qualif   
% 214.44/214.66  |- skos__prefLabel mesh__D005085 Exhibits
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D005085 2005
% 214.44/214.66  |- mesh__recordAuthorizer mesh__D005085 sjn
% 214.44/214.66  |- mesh__recordOriginator mesh__D005085 NLM
% 214.44/214.66  |- skos__hiddenLabel mesh__D005085 Exhibit
% 214.44/214.66  |- rdf__type mesh__D005085sskos__Concept
% 214.44/214.66  |- mesh__recordMaintainer mesh__D005085 ags
% 214.44/214.66  |- mesh__dateRevised mesh__D005085 2004-07-07
% 214.44/214.66  |- mesh__dateCreated mesh__D005085 1999-01-01
% 214.44/214.66  |- skos__broader mesh__D005085smesh__D001296
% 214.44/214.66  |- skos__hiddenLabel mesh__D013517
% 214.44/214.66       Otorhinolaryngological Surgical Procedure
% 214.44/214.66  |- skos__related mesh__D013517smesh__D010036
% 214.44/214.66  |- mesh__recordOriginator mesh__D013517 NLM
% 214.44/214.66  |- skos__hiddenLabel mesh__D013517
% 214.44/214.66       Surgical Procedure, Otorhinolaryngological
% 214.44/214.66  |- skos__altLabel mesh__D013517 Procedure, Otorhinolaryngologic Surgical
% 214.44/214.66  |- mesh__dateCreated mesh__D013517 1999-01-01
% 214.44/214.66  |- skos__scopeNote mesh__D013517
% 214.44/214.66       Surgery performed on the ear and its parts, the nose and nasal cavity, or the throat, including surgery of the adenoids, tonsils, pharynx, and trachea.%A%    
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D013517 2000
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D013517 2005
% 214.44/214.66  |- mesh__dateRevised mesh__D013517 1997-06-20
% 214.44/214.66  |- mesh__recordAuthorizer mesh__D013517 SJN
% 214.44/214.66  |- skos__altLabel mesh__D013517 Otorhinolaryngological Surgical Procedures
% 214.44/214.66  |- mesh__dateEstablished mesh__D013517 1998-01-01
% 214.44/214.66  |- mesh__recordMaintainer mesh__D013517 TGC
% 214.44/214.66  |- skos__broader mesh__D013517smesh__D013514
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D013517 2006
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D013517 2001
% 214.44/214.66  |- skos__altLabel mesh__D013517 Procedures, Otorhinolaryngologic Surgical
% 214.44/214.66  |- skos__hiddenLabel mesh__D013517
% 214.44/214.66       Procedures, Otorhinolaryngological Surgical
% 214.44/214.66  |- skos__altLabel mesh__D013517 Surgical Procedures, Otorhinolaryngologic
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D013517 2003
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D013517 1998
% 214.44/214.66  |- skos__hiddenLabel mesh__D013517
% 214.44/214.66       Procedure, Otorhinolaryngological Surgical
% 214.44/214.66  |- skos__altLabel mesh__D013517 Surgical Procedure, Otorhinolaryngologic
% 214.44/214.66  |- mesh__publicMeSHNote mesh__D013517 98   
% 214.44/214.66  |- skos__altLabel mesh__D013517 Otorhinolaryngologic Surgical Procedure
% 214.44/214.66  |- skos__prefLabel mesh__D013517 Otorhinolaryngologic Surgical Procedures
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D013517 2004
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D013517 1999
% 214.44/214.66  |- mesh__historyNote mesh__D013517 98; use explode 1970-97   
% 214.44/214.66  |- rdf__type mesh__D013517sskos__Concept
% 214.44/214.66  |- skos__annotation mesh__D013517
% 214.44/214.66       GEN or unspecified; prefer specifics; consider also EAR /surg, NOSE /surg, LARYNX /surg %26% /surg with specific parts of these organs; also OTORHINOLARYNGOLOGIC DISEASES /surg %26% /surg with specific ORL dis; DF: ORL SURG PROCEDURES%A%  
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D013517 2002
% 214.44/214.66  |- skos__hiddenLabel mesh__D013517
% 214.44/214.66       Surgical Procedures, Otorhinolaryngological
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D018202 2004
% 214.44/214.66  |- mesh__recordMaintainer mesh__D018202 jmp
% 214.44/214.66  |- skos__altLabel mesh__D018202 Pulmonary Blastomas
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D018202 2001
% 214.44/214.66  |- skos__broader mesh__D018202smesh__D008175
% 214.44/214.66  |- skos__prefLabel mesh__D018202 Pulmonary Blastoma
% 214.44/214.66  |- skos__annotation mesh__D018202
% 214.44/214.66       coord IM with LUNG NEOPLASMS %28%IM%29%   
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D018202 2005
% 214.44/214.66  |- mesh__historyNote mesh__D018202 94   
% 214.44/214.66  |- skos__altLabel mesh__D018202 Blastoma, Pulmonary
% 214.44/214.66  |- mesh__recordAuthorizer mesh__D018202 sjn
% 214.44/214.66  |- mesh__recordOriginator mesh__D018202 PLS
% 214.44/214.66  |- mesh__dateCreated mesh__D018202 1993-06-25
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D018202 2006
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D018202 2002
% 214.44/214.66  |- skos__scopeNote mesh__D018202
% 214.44/214.66       A malignant neoplasm of the lung composed chiefly or entirely of immature undifferentiated cells %28%i.e., blast forms%29% with little or virtually no stroma. %28%From Stedman, 25th ed%29%%A%    
% 214.44/214.66  |- mesh__publicMeSHNote mesh__D018202 94   
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D018202 2003
% 214.44/214.66  |- mesh__dateRevised mesh__D018202 2000-06-22
% 214.44/214.66  |- skos__historyNote mesh__D018202 Lung Neoplasms %28%1966-1993%29%
% 214.44/214.66  |- rdf__type mesh__D018202sskos__Concept
% 214.44/214.66  |- skos__broader mesh__D018202smesh__D018193
% 214.44/214.66  |- skos__altLabel mesh__D018202 Blastomas, Pulmonary
% 214.44/214.66  |- mesh__dateEstablished mesh__D018202 1994-01-01
% 214.44/214.66  |- rdf__type mesh__D051636sskos__Concept
% 214.44/214.66  |- skos__scopeNote mesh__D051636
% 214.44/214.66       An inhibitor of apoptosis protein that is translated by a rare cap-independent mechanism. It blocks caspase-mediated cellular destruction by inhibiting CASPASE 3; CASPASE 7; and CASPASE 9.%A%    
% 214.44/214.66  |- mesh__historyNote mesh__D051636 2006%28%1996%29%   
% 214.44/214.66  |- mesh__recordAuthorizer mesh__D051636 sjn
% 214.44/214.66  |- skos__altLabel mesh__D051636 X-Linked IAP Protein
% 214.44/214.66  |- skos__altLabel mesh__D051636 XIAP Protein
% 214.44/214.66  |- mesh__dateCreated mesh__D051636 2005-06-30
% 214.44/214.66  |- skos__prefLabel mesh__D051636 X-Linked Inhibitor of Apoptosis Protein
% 214.44/214.66  |- mesh__dateEstablished mesh__D051636 2006-01-01
% 214.44/214.66  |- mesh__publicMeSHNote mesh__D051636
% 214.44/214.66       2006; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN was indexed under PROTEINS 1996-2005%A%  
% 214.44/214.66  |- skos__hiddenLabel mesh__D051636 IAP Protein, X-Linked
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D051636 2006
% 214.44/214.66  |- skos__broader mesh__D051636smesh__D051034
% 214.44/214.66  |- skos__hiddenLabel mesh__D051636 X Linked Inhibitor of Apoptosis Protein
% 214.44/214.66  |- mesh__recordMaintainer mesh__D051636 DRC
% 214.44/214.66  |- mesh__recordOriginator mesh__D051636 DRC
% 214.44/214.66  |- skos__hiddenLabel mesh__D051636 X Linked IAP Protein
% 214.44/214.66  |- skos__hiddenLabel mesh__D009476 Neuron, Efferent
% 214.44/214.66  |- mesh__recordOriginator mesh__D009476 NLM
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D009476 2005
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D009476 1999
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D009476 2002
% 214.44/214.66  |- mesh__historyNote mesh__D009476 77%28%69%29%   
% 214.44/214.66  |- mesh__recordMaintainer mesh__D009476 AGS
% 214.44/214.66  |- skos__annotation mesh__D009476
% 214.44/214.66       activate musc %26% secretory cells: do not confuse with NEURONS, AFFERENT which are sensory neurons; A 11 qualif%A%  
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D009476 1998
% 214.44/214.66  |- mesh__dateRevised mesh__D009476 1997-06-20
% 214.44/214.66  |- skos__related mesh__D009476smesh__D009451
% 214.44/214.66  |- skos__scopeNote mesh__D009476
% 214.44/214.66       Neurons which send impulses peripherally to activate muscles or secretory cells.%A%    
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D009476 2004
% 214.44/214.66  |- skos__hiddenLabel mesh__D009476 Efferent Neurons
% 214.44/214.66  |- skos__hiddenLabel mesh__D009476 Efferent Neuron
% 214.44/214.66  |- skos__prefLabel mesh__D009476 Neurons, Efferent
% 214.44/214.66  |- skos__historyNote mesh__D009476 Neurons %28%1966-1968%29%
% 214.44/214.66  |- rdf__type mesh__D009476sskos__Concept
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D009476 2001
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D009476 2003
% 214.44/214.66  |- mesh__dateEstablished mesh__D009476 1977-01-01
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D009476 2000
% 214.44/214.66  |- mesh__publicMeSHNote mesh__D009476 77   
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D009476 2006
% 214.44/214.66  |- mesh__dateCreated mesh__D009476 1999-01-01
% 214.44/214.66  |- skos__broader mesh__D009476smesh__D009474
% 214.44/214.66  |- mesh__recordAuthorizer mesh__D009476 SJN
% 214.44/214.66  |- skos__prefLabel mesh__D001493 Bathing Beaches
% 214.44/214.66  |- skos__scopeNote mesh__D001493
% 214.44/214.66       Beaches, both natural and man-made, used for bathing and other activities.%A%    
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D001493 2004
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D001493 2006
% 214.44/214.66  |- mesh__dateRevised mesh__D001493 2002-07-02
% 214.44/214.66  |- mesh__dateCreated mesh__D001493 1999-01-01
% 214.44/214.66  |- mesh__recordAuthorizer mesh__D001493 sjn
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D001493 2003
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D001493 2005
% 214.44/214.66  |- mesh__recordMaintainer mesh__D001493 mdb
% 214.44/214.66  |- mesh__recordOriginator mesh__D001493 NLM
% 214.44/214.66  |- rdf__type mesh__D001493sskos__Concept
% 214.44/214.66  |- skos__hiddenLabel mesh__D001493 Beaches, Bathing
% 214.44/214.66  |- skos__broader mesh__D001493smesh__D011633
% 214.44/214.66  |- skos__prefLabel mesh__D017908 Allolevivirus
% 214.44/214.66  |- skos__hiddenLabel mesh__D017908 Q beta, Phage
% 214.44/214.66  |- mesh__publicMeSHNote mesh__D017908 94   
% 214.44/214.66  |- skos__hiddenLabel mesh__D017908 Q beta Phages
% 214.44/214.66  |- skos__hiddenLabel mesh__D017908 Alloleviviruses
% 214.44/214.66  |- mesh__historyNote mesh__D017908 94   
% 214.44/214.66  |- mesh__dateRevised mesh__D017908 2001-07-25
% 214.44/214.66  |- skos__hiddenLabel mesh__D017908 Q beta, Coliphage
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D017908 2002
% 214.44/214.66  |- skos__altLabel mesh__D017908 Q beta Phage
% 214.44/214.66  |- skos__broader mesh__D017908smesh__D017907
% 214.44/214.66  |- rdf__type mesh__D017908sskos__Concept
% 214.44/214.66  |- mesh__dateCreated mesh__D017908 1993-06-04
% 214.44/214.66  |- skos__altLabel mesh__D017908 Enterobacteria phage Q beta
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D017908 2005
% 214.44/214.66  |- mesh__recordMaintainer mesh__D017908 ags
% 214.44/214.66  |- skos__scopeNote mesh__D017908
% 214.44/214.66       A bacteriophage genus of the family LEVIVIRIDAE, whose viruses contain the longer version of the genome and have no separate cell lysis gene.%A%    
% 214.44/214.66  |- mesh__recordAuthorizer mesh__D017908 sjn
% 214.44/214.66  |- skos__hiddenLabel mesh__D017908 Phages, Q beta
% 214.44/214.66  |- mesh__recordOriginator mesh__D017908 AGS
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D017908 2006
% 214.44/214.66  |- skos__altLabel mesh__D017908 Phage Q beta
% 214.44/214.66  |- mesh__dateEstablished mesh__D017908 1994-01-01
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D017908 2003
% 214.44/214.66  |- skos__altLabel mesh__D017908 Coliphage Q beta
% 214.44/214.66  |- skos__annotation mesh__D017908 coord with specific bacterium /virol   
% 214.44/214.66  |- skos__hiddenLabel mesh__D017908 Q beta, Bacteriophage
% 214.44/214.66  |- skos__hiddenLabel mesh__D017908 Phage, Q beta
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D017908 2004
% 214.44/214.66  |- rdf__type mesh__D042301sskos__Concept
% 214.44/214.66  |- mesh__recordAuthorizer mesh__D042301 sjn
% 214.44/214.66  |- skos__prefLabel mesh__D042301 Sphingomonadaceae
% 214.44/214.66  |- mesh__historyNote mesh__D042301 2004   
% 214.44/214.66  |- mesh__dateCreated mesh__D042301 2003-07-09
% 214.44/214.66  |- mesh__recordMaintainer mesh__D042301 SYSTEM
% 214.44/214.66  |- mesh__recordOriginator mesh__D042301 ags
% 214.44/214.66  |- skos__scopeNote mesh__D042301
% 214.44/214.66       A family of gram-negative, asporogenous rods or ovoid cells, aerobic or facultative anaerobic chemoorganotrophs. They are commonly isolated from SOIL, activated sludge, or marine environments.%A%    
% 214.44/214.66  |- mesh__dateEstablished mesh__D042301 2004-01-01
% 214.44/214.66  |- mesh__dateRevised mesh__D042301 2005-06-30
% 214.44/214.66  |- mesh__publicMeSHNote mesh__D042301 2004   
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D042301 2006
% 214.44/214.66  |- skos__broader mesh__D042301smesh__D020561
% 214.44/214.66  |- skos__altLabel mesh__D014610 Uzbek S.S.R.
% 214.44/214.66  |- skos__altLabel mesh__D014610 Uzbek SSR
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D014610 1995
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D014610 2003
% 214.44/214.66  |- mesh__dateCreated mesh__D014610 1999-01-01
% 214.44/214.66  |- skos__broader mesh__D014610smesh__D017517
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D014610 2004
% 214.44/214.66  |- rdf__type mesh__D014610sskos__Concept
% 214.44/214.66  |- mesh__recordOriginator mesh__D014610 NLM
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D014610 2005
% 214.44/214.66  |- mesh__historyNote mesh__D014610
% 214.44/214.66       93; was UZBEK S.S.R. 1982-92; was heading 1963-81   
% 214.44/214.66  |- mesh__onlineNote mesh__D014610
% 214.44/214.66       use UZBEKISTAN to search UZBEK S.S.R. 1982-92   
% 214.44/214.66  |- mesh__recordMaintainer mesh__D014610 PLS
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D014610 1996
% 214.44/214.66  |- skos__broader mesh__D014610smesh__D014586
% 214.44/214.66  |- mesh__recordAuthorizer mesh__D014610 PLS
% 214.44/214.66  |- skos__broader mesh__D014610smesh__D001209
% 214.44/214.66  |- skos__prefLabel mesh__D014610 Uzbekistan
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D014610 2006
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D014610 2000
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D014610 1997
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D014610 2001
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D014610 1998
% 214.44/214.66  |- mesh__dateRevised mesh__D014610 1994-03-17
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D014610 2002
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D014610 1999
% 214.44/214.66  |- mesh__publicMeSHNote mesh__D005884
% 214.44/214.66       91; was see under ORAL HEMORRHAGE 1990; was see under HEMORRHAGE, ORAL 1967-89%A%  
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D005884 2002
% 214.44/214.66  |- skos__scopeNote mesh__D005884
% 214.44/214.66       The flowing of blood from the marginal gingival area, particularly the sulcus, seen in such conditions as GINGIVITIS, marginal PERIODONTITIS, injury, and ASCORBIC ACID DEFICIENCY.%A%    
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D005884 2006B
% 214.44/214.66  |- mesh__recordAuthorizer mesh__D005884 ags
% 214.44/214.66  |- mesh__dateEstablished mesh__D005884 1991-01-01
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D005884 2001
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D005884 2006A
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D005884 2004
% 214.44/214.66  |- skos__prefLabel mesh__D005884 Gingival Hemorrhage
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D005884 2000
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D005884 2006
% 214.44/214.66  |- mesh__dateCreated mesh__D005884 1999-01-01
% 214.44/214.66  |- skos__broader mesh__D005884smesh__D006472
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D005884 2003
% 214.44/214.66  |- mesh__recordMaintainer mesh__D005884 ags
% 214.44/214.66  |- skos__broader mesh__D005884smesh__D005882
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D005884 2005
% 214.44/214.66  |- skos__hiddenLabel mesh__D005884 Gingival Hemorrhages
% 214.44/214.66  |- skos__annotation mesh__D005884
% 214.44/214.66       do not confuse with BLEEDING ON PROBING, GINGIVAL see PERIODONTAL INDEX%A%  
% 214.44/214.66  |- rdf__type mesh__D005884sskos__Concept
% 214.44/214.66  |- mesh__historyNote mesh__D005884
% 214.44/214.66       91%28%75%29%; was see under ORAL HEMORRHAGE 1990; was see under HEMORRHAGE, ORAL 1967-89%A%  
% 214.44/214.66  |- mesh__dateRevised mesh__D005884 2005-07-22
% 214.44/214.66  |- skos__altLabel mesh__D005884 Hemorrhage, Gingival
% 214.44/214.66  |- mesh__onlineNote mesh__D005884
% 214.44/214.66       use ORAL HEMORRHAGE to search GINVIVAL HEMORRHAGE 1967-74%A%  
% 214.44/214.66  |- mesh__recordOriginator mesh__D005884 NLM
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D005086 2006
% 214.44/214.66  |- mesh__recordMaintainer mesh__D005086 sjn
% 214.44/214.66  |- mesh__historyNote mesh__D005086
% 214.44/214.66       EXISTENTIAL PSYCHOLOGY was see under EXISTENTIALISM 1974-78%A%  
% 214.44/214.66  |- mesh__dateRevised mesh__D005086 2004-07-13
% 214.44/214.66  |- mesh__onlineNote mesh__D005086
% 214.44/214.66       use EXISTENTIALISM to search EXISTENTIAL PSYCHOLOGY 1974-78%A%  
% 214.44/214.66  |- skos__prefLabel mesh__D005086 Existentialism
% 214.44/214.66  |- skos__scopeNote mesh__D005086
% 214.44/214.66       Philosophy based on the analysis of the individual%27%s existence in the world which holds that human existence cannot be completely described in scientific terms. Existentialism also stresses the freedom and responsibility of the individual as well as the uniqueness of religious and ethical experiences and the analysis of subjective phenomena such as anxiety, guilt, and suffering. %28%APA, Thesaurus of Psychological Index Terms, 8th ed.%29%%A%    
% 214.44/214.66  |- mesh__dateCreated mesh__D005086 1999-01-01
% 214.44/214.66  |- skos__broader mesh__D005086smesh__D011582
% 214.44/214.66  |- rdf__type mesh__D005086sskos__Concept
% 214.44/214.66  |- mesh__recordAuthorizer mesh__D005086 sjn
% 214.44/214.66  |- mesh__recordOriginator mesh__D005086 NLM
% 214.44/214.66  |- skos__altLabel mesh__D005086 Psychology, Existential
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D005086 2005
% 214.44/214.66  |- skos__broader mesh__D005086smesh__D010684
% 214.44/214.66  |- mesh__dateCreated mesh__D013518 1999-01-01
% 214.44/214.66  |- skos__hiddenLabel mesh__D013518 Esthetic Surgeries
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D013518 2005
% 214.44/214.66  |- mesh__recordMaintainer mesh__D013518 ndw
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D013518 2002
% 214.44/214.66  |- skos__prefLabel mesh__D013518 Surgery, Plastic
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D013518 2006
% 214.44/214.66  |- skos__related mesh__D013518smesh__D019651
% 214.44/214.66  |- mesh__recordOriginator mesh__D013518 NLM
% 214.44/214.66  |- skos__altLabel mesh__D013518 Plastic Surgery
% 214.44/214.66  |- mesh__recordAuthorizer mesh__D013518 sjn
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D013518 2003
% 214.44/214.66  |- skos__altLabel mesh__D013518 Cosmetic Surgery
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D013518 2000
% 214.44/214.66  |- mesh__dateRevised mesh__D013518 1999-11-03
% 214.44/214.66  |- skos__annotation mesh__D013518
% 214.44/214.66       SPEC; do not confuse with RECONSTRUCTIVE SURGICAL PROCEDURES, the technique; not for -plasty in internal surgery: Manual 26.18%A%  
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D013518 2004
% 214.44/214.66  |- skos__hiddenLabel mesh__D013518 Surgeries, Esthetic
% 214.44/214.66  |- rdf__type mesh__D013518sskos__Concept
% 214.44/214.66  |- skos__broader mesh__D013518smesh__D013043
% 214.44/214.66  |- skos__scopeNote mesh__D013518
% 214.44/214.66       The branch of surgery concerned with restoration, reconstruction, or improvement of defective, damaged, or missing structures.%A%    
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D013518 2001
% 214.44/214.66  |- skos__altLabel mesh__D013518 Surgery, Esthetic
% 214.44/214.66  |- skos__broader mesh__D019427Q000037smesh__D019427
% 214.44/214.66  |- mesh__preferredCombination mesh__D019427Q000037smesh__D019428
% 214.44/214.66  |- rdf__type mesh__D019427Q000037smesh__CompoundConcept
% 214.44/214.66  |- skos__historyNote mesh__D018203 Sarcoma %28%1967-1993%29%
% 214.44/214.66  |- skos__annotation mesh__D018203
% 214.44/214.66       coord IM with ENDOMETRIAL NEOPLASMS %28%IM%29%   
% 214.44/214.66  |- skos__hiddenLabel mesh__D018203 Stromal Sarcoma, Endometrial
% 214.44/214.66  |- rdf__type mesh__D018203sskos__Concept
% 214.44/214.66  |- skos__broader mesh__D018203smesh__D018193
% 214.44/214.66  |- skos__hiddenLabel mesh__D018203 Stromal Sarcomas, Endometrial
% 214.44/214.66  |- mesh__dateEstablished mesh__D018203 1994-01-01
% 214.44/214.66  |- mesh__publicMeSHNote mesh__D018203 94   
% 214.44/214.66  |- mesh__dateRevised mesh__D018203 2005-06-30
% 214.44/214.66  |- skos__prefLabel mesh__D018203 Sarcoma, Endometrial Stromal
% 214.44/214.66  |- skos__altLabel mesh__D018203 Endometrial Stromal Sarcoma
% 214.44/214.66  |- mesh__recordMaintainer mesh__D018203 lkt
% 214.44/214.66  |- skos__scopeNote mesh__D018203
% 214.44/214.66       A highly malignant subset of neoplasms arising from the endometrial stroma. Tumors in this group infiltrate the stroma with a wide range of atypia cells and numerous mitoses. They are capable of widespread metastases %28%NEOPLASM METASTASIS%29%.%A%    
% 214.44/214.66  |- mesh__recordOriginator mesh__D018203 PLS
% 214.44/214.66  |- skos__hiddenLabel mesh__D018203 Sarcomas, Endometrial Stromal
% 214.44/214.66  |- skos__broader mesh__D018203smesh__D036821
% 214.44/214.66  |- mesh__historyNote mesh__D018203 94   
% 214.44/214.66  |- skos__hiddenLabel mesh__D018203 Endometrial Stromal Sarcomas
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D018203 2006
% 214.44/214.66  |- mesh__recordAuthorizer mesh__D018203 sjn
% 214.44/214.66  |- skos__broader mesh__D018203smesh__D012509
% 214.44/214.66  |- mesh__dateCreated mesh__D018203 1993-06-25
% 214.44/214.66  |- skos__hiddenLabel mesh__D010220 Body, Para-Aortic
% 214.44/214.66  |- skos__altLabel mesh__D010220 Paraaortic Bodies
% 214.44/214.66  |- skos__broader mesh__D010220smesh__D002838
% 214.44/214.66  |- skos__hiddenLabel mesh__D010220 Zuckerkandl Organs
% 214.44/214.66  |- skos__hiddenLabel mesh__D010220 Body, Paraaortic
% 214.44/214.66  |- skos__prefLabel mesh__D010220 Para-Aortic Bodies
% 214.44/214.66  |- mesh__dateRevised mesh__D010220 2004-07-07
% 214.44/214.66  |- mesh__onlineNote mesh__D010220 search CHROMAFFIN SYSTEM 1966-74   
% 214.44/214.66  |- skos__hiddenLabel mesh__D010220 Para Aortic Bodies
% 214.44/214.66  |- skos__hiddenLabel mesh__D010220 Bodies, Paraaortic
% 214.44/214.66  |- rdf__type mesh__D010220sskos__Concept
% 214.44/214.66  |- skos__hiddenLabel mesh__D010220 Paraaortic Body
% 214.44/214.66  |- skos__hiddenLabel mesh__D010220 Para-Aortic Body
% 214.44/214.66  |- mesh__recordAuthorizer mesh__D010220 sjn
% 214.44/214.66  |- mesh__dateEstablished mesh__D010220 1991-01-01
% 214.44/214.66  |- skos__altLabel mesh__D010220 Organ of Zuckerkandl
% 214.44/214.66  |- mesh__publicMeSHNote mesh__D010220
% 214.44/214.66       91; was see under CHROMAFFIN SYSTEM 1975-90   
% 214.44/214.66  |- mesh__dateCreated mesh__D010220 1999-01-01
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D010220 2006
% 214.44/214.66  |- skos__scopeNote mesh__D010220
% 214.44/214.66       Small masses of chromaffin cells found near the SYMPATHETIC GANGLIA along the ABDOMINAL AORTA, beginning cranial to the superior mesenteric artery %28%MESENTERIC ARTERY, SUPERIOR%29% or renal arteries and extending to the level of the aortic bifurcation or just beyond. They are also called the organs of Zuckerkandl and sometimes called aortic bodies %28%not to be confused with AORTIC BODIES in the THORAX%29%. The para-aortic bodies are the dominant source of CATECHOLAMINES in the FETUS and normally regress after BIRTH.%A%    
% 214.44/214.66  |- skos__hiddenLabel mesh__D010220 Bodies, Para-Aortic
% 214.44/214.66  |- skos__annotation mesh__D010220 do not confuse with AORTIC BODIES   
% 214.44/214.66  |- mesh__historyNote mesh__D010220
% 214.44/214.66       91%28%75%29%; was see under CHROMAFFIN SYSTEM 1975-90   
% 214.44/214.66  |- mesh__recordOriginator mesh__D010220 NLM
% 214.44/214.66  |- skos__altLabel mesh__D010220 Organs of Zuckerkandl
% 214.44/214.66  |- skos__hiddenLabel mesh__D010220 Zuckerkandl Organ
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D010220 2005
% 214.44/214.66  |- mesh__recordMaintainer mesh__D010220 ags
% 214.44/214.66  |- skos__prefLabel mesh__D051637 Shaker Superfamily of Potassium Channels
% 214.44/214.66  |- mesh__publicMeSHNote mesh__D051637
% 214.44/214.66       2006; SHAKER POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS 1994-2005%A%  
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D051637 2006
% 214.44/214.66  |- mesh__recordAuthorizer mesh__D051637 sjn
% 214.44/214.66  |- skos__altLabel mesh__D051637 Kv1 Potassium Channels
% 214.44/214.66  |- mesh__dateCreated mesh__D051637 2005-06-30
% 214.44/214.66  |- skos__broader mesh__D051637smesh__D024642
% 214.44/214.66  |- mesh__dateEstablished mesh__D051637 2006-01-01
% 214.44/214.66  |- skos__scopeNote mesh__D051637
% 214.44/214.66       Voltage-gated potassium channels whose primary subunits contain six transmembrane segments and form tetramers to create a pore with a voltage sensor. They are related to their founding member, shaker protein, Drosophila.%A%    
% 214.44/214.66  |- mesh__recordOriginator mesh__D051637 DRC
% 214.44/214.66  |- rdf__type mesh__D051637sskos__Concept
% 214.44/214.66  |- mesh__recordMaintainer mesh__D051637 DRC
% 214.44/214.66  |- mesh__historyNote mesh__D051637 2006%28%1994%29%   
% 214.44/214.66  |- mesh__recordMaintainer mesh__D009477 ags
% 214.44/214.66  |- rdf__type mesh__D009477sskos__Concept
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D009477 2002
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D009477 2003
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 Type II, HSAN
% 214.44/214.66  |- skos__annotation mesh__D009477
% 214.44/214.66       do not confuse with HEREDITARY MOTOR AND SENSORY NEUROPATHIES; for X refs to HSAN types: HSAN TYPE III is see DYSAUTONOMIA, FAMILIAL%A%  
% 214.44/214.66  |- skos__broader mesh__D009477smesh__D009421
% 214.44/214.66  |- skos__prefLabel mesh__D009477
% 214.44/214.66       Hereditary Sensory and Autonomic Neuropathies
% 214.44/214.66  |- skos__altLabel mesh__D009477
% 214.44/214.66       Pain Insensitivity with Anhidrosis, Congenital
% 214.44/214.66  |- mesh__dateRevised mesh__D009477 2005-07-18
% 214.44/214.66  |- mesh__historyNote mesh__D009477
% 214.44/214.66       2000%28%1989%29%; use NEUROPATHY, HEREDITARY SENSORY 1979-1988   
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 HSAN Type Is
% 214.44/214.66  |- skos__historyNote mesh__D009477 Sensation %28%1966-1978%29%
% 214.44/214.66  |- skos__altLabel mesh__D009477
% 214.44/214.66       Insensitivity to Pain with Anhidrosis, Congenital
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D009477 2004
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 Neuropathies, Hereditary Sensory
% 214.44/214.66  |- skos__altLabel mesh__D009477
% 214.44/214.66       Hereditary Sensory Autonomic Neuropathy, Type 1
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 Type I, HSAN
% 214.44/214.66  |- skos__historyNote mesh__D009477 Peripheral Nerves %28%1966-1978%29%
% 214.44/214.66  |- skos__altLabel mesh__D009477
% 214.44/214.66       HSAN %28%Hereditary Sensory Autonomic Neuropathy%29%
% 214.44/214.66  |- skos__broader mesh__D009477smesh__D011115
% 214.44/214.66  |- skos__altLabel mesh__D009477
% 214.44/214.66       Congenital Insensitivity to Pain with Anhidrosis
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 Hereditary Sensory Neuropathies
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 HSN Type Is
% 214.44/214.66  |- mesh__dateCreated mesh__D009477 1999-11-08
% 214.44/214.66  |- skos__related mesh__D009477smesh__D000699
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 Is, HSAN Type
% 214.44/214.66  |- skos__altLabel mesh__D009477 HSAN Type II
% 214.44/214.66  |- skos__altLabel mesh__D009477
% 214.44/214.66       Hereditary Sensory Autonomic Neuropathy, Type 5
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 HSAN Type IIs
% 214.44/214.66  |- skos__altLabel mesh__D009477 HSAN Type I
% 214.44/214.66  |- skos__altLabel mesh__D009477
% 214.44/214.66       Hereditary Sensory Autonomic Neuropathy, Type 2
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 IIs, HSAN Type
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D009477 2006A
% 214.44/214.66  |- skos__historyNote mesh__D009477
% 214.44/214.66       Peripheral Nerve Diseases %28%1966-1978%29%
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 Type IIs, HSAN
% 214.44/214.66  |- skos__altLabel mesh__D009477
% 214.44/214.66       Neuropathies, Hereditary Sensory and Autonomic
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 Type Is, HSAN
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477
% 214.44/214.66       HSANs %28%Hereditary Sensory Autonomic Neuropathy%29%
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 Type II, HSN
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 Type IIs, HSN
% 214.44/214.66  |- mesh__dateEstablished mesh__D009477 1979-01-01
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 Is, HSN Type
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 IIs, HSN Type
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 Sensory Neuropathies, Hereditary
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 HSN Type IIs
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D009477 2005
% 214.44/214.66  |- mesh__recordAuthorizer mesh__D009477 ags
% 214.44/214.66  |- skos__broader mesh__D009477smesh__D011129
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 Neuropathy, Hereditary Sensory
% 214.44/214.66  |- skos__broader mesh__D009477smesh__D020271
% 214.44/214.66  |- skos__altLabel mesh__D009477 HSAN
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 Type V, HSAN
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 Hereditary Sensory Neuropathy
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D009477 2006
% 214.44/214.66  |- skos__altLabel mesh__D009477
% 214.44/214.66       Sensory and Autonomic Neuropathies, Hereditary
% 214.44/214.66  |- mesh__publicMeSHNote mesh__D009477
% 214.44/214.66       2000; see NEUROPATHIES, HEREDITARY SENSORY AND AUTONOMIC 1989-1999; see NEUROPATHY, HEREDITARY SENSORY 1979-1988%A%  
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 Type IV, HSAN
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 Type Is, HSN
% 214.44/214.66  |- skos__altLabel mesh__D009477
% 214.44/214.66       Hereditary Sensory Autonomic Neuropathy, Type 4
% 214.44/214.66  |- skos__scopeNote mesh__D009477
% 214.44/214.66       A group of inherited disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and clinically by loss of sensation and autonomic dysfunction. There are five subtypes. Type I features autosomal dominant inheritance and distal sensory involvement. Type II is characterized by autosomal inheritance and distal and proximal sensory loss. Type III is DYSAUTONOMIA, FAMILIAL. Type IV features insensitivity to pain, heat intolerance, and mental deficiency. Type V is characterized by a selective loss of pain with intact light touch and vibratory sensation. %28%From Joynt, Clinical Neurology, 1995, Ch51, pp142-4%29%%A%    
% 214.44/214.66  |- skos__hiddenLabel mesh__D009477 Type I, HSN
% 214.44/214.66  |- mesh__recordOriginator mesh__D009477 RC
% 214.44/214.66  |- skos__scopeNote mesh__D001494
% 214.44/214.66       The immersion or washing of the body or any of its parts in water or other medium for cleansing or medical treatment. It includes bathing for personal hygiene as well as for medical purposes with the addition of therapeutic agents, such as alkalines, antiseptics, oil, etc.%A%    
% 214.44/214.66  |- skos__hiddenLabel mesh__D001494 Bath
% 214.44/214.66  |- mesh__dateCreated mesh__D001494 1999-01-01
% 214.44/214.66  |- mesh__recordOriginator mesh__D001494 NLM
% 214.44/214.66  |- skos__broader mesh__D001494smesh__D001452
% 214.44/214.66  |- skos__annotation mesh__D001494
% 214.44/214.66       for personal hygiene or med treatment; at home or in hosp, often not plain water %28%see note on HYDROTHERAPY%29%, usually with additives; do not confuse with BALNEOLOGY %28%see note there%29%; general only or unspecified; prefer specifics; note MUD BATHS see MUD THERAPY %26% SAND BATHS see AMMOTHERAPY; bathing in seawater is probably THALASSOTHERAPY%A%  
% 214.44/214.66  |- mesh__activeMeSHYear mesh__D001494 2006
% 214.44/214.66  |- skos__prefLabel mesh__D001494 Baths
% 214.44/214.66  |- mesh__recordMaintainer mesh__D001494 lkt
% 214.44/214.66  |- rdf__type mesh__D001494sskos__Concept
% 214.44/214.67  |- mesh__recordAuthorizer mesh__D001494 sjn
% 214.44/214.67  |- mesh__dateRevised mesh__D001494 2005-06-30
% 214.44/214.67  |- skos__altLabel mesh__D017909 Bacteriophage MS2
% 214.44/214.67  |- rdf__type mesh__D017909sskos__Concept
% 214.44/214.67  |- skos__prefLabel mesh__D017909 Levivirus
% 214.44/214.67  |- skos__altLabel mesh__D017909 Enterobacteria phage MS2
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D017909 2006
% 214.44/214.67  |- skos__hiddenLabel mesh__D017909 phage f2, Enterobacteria
% 214.44/214.67  |- skos__scopeNote mesh__D017909
% 214.44/214.67       A bacteriophage genus of the family LEVIVIRIDAE, whose viruses contain the short version of the genome and have a separate gene for cell lysis.%A%    
% 214.44/214.67  |- mesh__recordMaintainer mesh__D017909 ags
% 214.44/214.67  |- skos__altLabel mesh__D017909 Coliphage MS2
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D017909 2003
% 214.44/214.67  |- skos__hiddenLabel mesh__D017909 MS2 Phages
% 214.44/214.67  |- skos__hiddenLabel mesh__D017909 Phage, MS2
% 214.44/214.67  |- skos__hiddenLabel mesh__D017909 Phages, MS2
% 214.44/214.67  |- skos__hiddenLabel mesh__D017909 Leviviruses
% 214.44/214.67  |- mesh__publicMeSHNote mesh__D017909 94   
% 214.44/214.67  |- mesh__dateRevised mesh__D017909 2001-07-25
% 214.44/214.67  |- skos__hiddenLabel mesh__D017909 MS2, Coliphage
% 214.44/214.67  |- skos__altLabel mesh__D017909 MS2 Phage
% 214.44/214.67  |- skos__hiddenLabel mesh__D017909 phage PP7, Pseudomonas
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D017909 2004
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D017909 2002
% 214.44/214.67  |- skos__annotation mesh__D017909 coord with specific bacterium /virol   
% 214.44/214.67  |- skos__hiddenLabel mesh__D017909 phage fr, Enterobacteria
% 214.44/214.67  |- skos__hiddenLabel mesh__D017909 phage R17, Enterobacteria
% 214.44/214.67  |- skos__hiddenLabel mesh__D017909 MS2, Phage
% 214.44/214.67  |- mesh__historyNote mesh__D017909 94   
% 214.44/214.67  |- mesh__dateCreated mesh__D017909 1993-06-04
% 214.44/214.67  |- skos__broader mesh__D017909smesh__D017907
% 214.44/214.67  |- mesh__recordOriginator mesh__D017909 AGS
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D017909 2005
% 214.44/214.67  |- mesh__dateEstablished mesh__D017909 1994-01-01
% 214.44/214.67  |- mesh__recordAuthorizer mesh__D017909 sjn
% 214.44/214.67  |- skos__hiddenLabel mesh__D017909 MS2, Bacteriophage
% 214.44/214.67  |- skos__prefLabel mesh__D014611 Vaccination
% 214.44/214.67  |- mesh__dateCreated mesh__D014611 1999-01-01
% 214.44/214.67  |- mesh__recordAuthorizer mesh__D014611 sjn
% 214.44/214.67  |- skos__broader mesh__D014611smesh__D016233
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D014611 2005
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D014611 2004
% 214.44/214.67  |- skos__broader mesh__D014611smesh__D007114
% 214.44/214.67  |- skos__scopeNote mesh__D014611
% 214.44/214.67       Administration of vaccines to stimulate the host%27%s immune response. This includes any preparation intended for active immunological prophylaxis.%A%    
% 214.44/214.67  |- mesh__recordMaintainer mesh__D014611 nns
% 214.44/214.67  |- skos__hiddenLabel mesh__D014611 Immunizations, Active
% 214.44/214.67  |- skos__hiddenLabel mesh__D014611 Active Immunizations
% 214.44/214.67  |- skos__hiddenLabel mesh__D014611 Active Immunization
% 214.44/214.67  |- rdf__type mesh__D014611sskos__Concept
% 214.44/214.67  |- skos__annotation mesh__D014611
% 214.44/214.67       do not use /util except by MeSH definition; Manual 26.22.2.2+; for prev only: coord IM with dis /prev %28%IM%29%; for ther, index under IMMUNOTHERAPY or specific vaccine /ther use%A%  
% 214.44/214.67  |- mesh__recordOriginator mesh__D014611 NLM
% 214.44/214.67  |- skos__hiddenLabel mesh__D014611 Vaccinations
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D014611 2006
% 214.44/214.67  |- mesh__dateRevised mesh__D014611 2003-07-09
% 214.44/214.67  |- skos__scopeNote mesh__D005885
% 214.44/214.67       Non-inflammatory enlargement of the gingivae produced by factors other than local irritation. It is characteristically due to an increase in the number of cells. %28%From Jablonski%27%s Dictionary of Dentistry, 1992, p400%29%%A%    
% 214.44/214.67  |- skos__annotation mesh__D005885
% 214.44/214.67       differentiate from GINGIVAL HYPERTROPHY   
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005885 2004
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005885 2002
% 214.44/214.67  |- mesh__recordOriginator mesh__D005885 NLM
% 214.44/214.67  |- mesh__recordMaintainer mesh__D005885 TGC
% 214.44/214.67  |- skos__hiddenLabel mesh__D005885 Gingival Hyperplasias
% 214.44/214.67  |- mesh__historyNote mesh__D005885 65   
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005885 2006
% 214.44/214.67  |- mesh__dateCreated mesh__D005885 1999-01-01
% 214.44/214.67  |- mesh__recordAuthorizer mesh__D005885 PLS
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005885 2003
% 214.44/214.67  |- mesh__dateEstablished mesh__D005885 1965-01-01
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005885 2001
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005885 2005
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005885 1997
% 214.44/214.67  |- skos__broader mesh__D005885smesh__D019214
% 214.44/214.67  |- mesh__publicMeSHNote mesh__D005885 65   
% 214.44/214.67  |- rdf__type mesh__D005885sskos__Concept
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005885 1999
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005885 2000
% 214.44/214.67  |- skos__hiddenLabel mesh__D005885 Hyperplasia, Gingival
% 214.44/214.67  |- skos__hiddenLabel mesh__D005885 Hyperplasias, Gingival
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005885 1998
% 214.44/214.67  |- skos__prefLabel mesh__D005885 Gingival Hyperplasia
% 214.44/214.67  |- mesh__dateRevised mesh__D005885 1996-06-10
% 214.44/214.67  |- mesh__recordMaintainer mesh__D038261 jls
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D038261 2005
% 214.44/214.67  |- mesh__publicMeSHNote mesh__D038261 2003   
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D038261 2006
% 214.44/214.67  |- mesh__dateRevised mesh__D038261 2004-07-19
% 214.44/214.67  |- mesh__dateCreated mesh__D038261 2002-07-02
% 214.44/214.67  |- skos__hiddenLabel mesh__D038261 Alexanders Disease
% 214.44/214.67  |- skos__scopeNote mesh__D038261
% 214.44/214.67       A rare inherited disorder of myelin formation. Alexander disease is a progressive leukoencephalopathy whose hallmark is the widespread accumulation of cytoplasmic inclusions called Rosenthal fibers. The fibers contain GLIAL FIBRILLARY ACIDIC PROTEIN in association with ALPHA-CRYSTALLIN B CHAIN. Rosenthal fibers are found predominantly in ASTROCYTES located in the subependymal, subpial, and periventricular areas of the BRAIN.%A%    
% 214.44/214.67  |- skos__broader mesh__D038261smesh__D020279
% 214.44/214.67  |- skos__broader mesh__D038261smesh__D020271
% 214.44/214.67  |- mesh__recordOriginator mesh__D038261 jmp
% 214.44/214.67  |- mesh__recordAuthorizer mesh__D038261 sjn
% 214.44/214.67  |- rdf__type mesh__D038261sskos__Concept
% 214.44/214.67  |- mesh__historyNote mesh__D038261 2003   
% 214.44/214.67  |- skos__altLabel mesh__D038261 Alexander%27%s Disease
% 214.44/214.67  |- skos__prefLabel mesh__D038261 Alexander Disease
% 214.44/214.67  |- mesh__dateEstablished mesh__D038261 2003-01-01
% 214.44/214.67  |- skos__hiddenLabel mesh__D005087 Exo 1,4 alpha Glucosidase
% 214.44/214.67  |- skos__scopeNote mesh__D005087
% 214.44/214.67       An enzyme that catalyzes the hydrolysis of terminal 1,4-linked alpha-D-glucose residues successively from non-reducing ends of polysaccharide chains with the release of beta-glucose. It is also able to hydrolyze 1,6-alpha-glucosidic bonds when the next bond in sequence is 1,4. EC 3.2.1.3.%A%    
% 214.44/214.67  |- skos__related mesh__D005087smesh__D006009
% 214.44/214.67  |- mesh__historyNote mesh__D005087
% 214.44/214.67       91%28%78%29%; was EXO-1,4-ALPHA-GLUCOSIDASE 1978-90; was EXO-1,4-ALPHA-GLUCOSIDASE see under GLUCOSIDASES 1978-88%A%  
% 214.44/214.67  |- mesh__dateCreated mesh__D005087 1977-04-15
% 214.44/214.67  |- skos__altLabel mesh__D005087 Glucoamylase
% 214.44/214.67  |- mesh__recordOriginator mesh__D005087 RLS
% 214.44/214.67  |- skos__altLabel mesh__D005087 Acid Maltase
% 214.44/214.67  |- rdf__type mesh__D005087sskos__Concept
% 214.44/214.67  |- skos__altLabel mesh__D005087 Amyloglucosidase
% 214.44/214.67  |- mesh__dateRevised mesh__D005087 2003-07-09
% 214.44/214.67  |- skos__altLabel mesh__D005087 Exo-1,4-alpha-Glucosidase
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005087 2004
% 214.44/214.67  |- skos__broader mesh__D005087smesh__D005959
% 214.44/214.67  |- skos__altLabel mesh__D005087 gamma-Amylase
% 214.44/214.67  |- skos__prefLabel mesh__D005087 Glucan 1,4-alpha-Glucosidase
% 214.44/214.67  |- skos__annotation mesh__D005087
% 214.44/214.67       /defic: consider also GLYCOGEN STORAGE DISEASE TYPE II; DF: note short X ref%A%  
% 214.44/214.67  |- skos__hiddenLabel mesh__D005087 Lysosomal alpha Glucosidase
% 214.44/214.67  |- skos__altLabel mesh__D005087 Lysosomal alpha-Glucosidase
% 214.44/214.67  |- skos__hiddenLabel mesh__D005087 Glucan 1,4 alpha Glucosidase
% 214.44/214.67  |- skos__hiddenLabel mesh__D005087 1,4-alpha-Glucosidase, Glucan
% 214.44/214.67  |- skos__historyNote mesh__D005087 Glucosidases %28%1966-1977%29%
% 214.44/214.67  |- mesh__recordMaintainer mesh__D005087 ssb
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005087 2005
% 214.44/214.67  |- mesh__publicMeSHNote mesh__D005087
% 214.44/214.67       91; was EXO-1,4-ALPHA-GLUCOSIDASE 1978-90; was EXO-1,4-ALPHA-GLUCOSIDASE see under GLUCOSIDASES 1978-88%A%  
% 214.44/214.67  |- skos__altLabel mesh__D005087 1,4-alpha-Glucosidase, Exo
% 214.44/214.67  |- mesh__onlineNote mesh__D005087
% 214.44/214.67       use GLUCAN 1,4-ALPHA-GLUCOSIDASE to search EXO-1,4-ALPHA-GLUCOSIDASE 1978-90%A%  
% 214.44/214.67  |- skos__hiddenLabel mesh__D005087 gamma Amylase
% 214.44/214.67  |- skos__hiddenLabel mesh__D005087 Maltase, Acid
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005087 2006
% 214.44/214.67  |- mesh__dateEstablished mesh__D005087 1989-01-01
% 214.44/214.67  |- skos__hiddenLabel mesh__D005087 alpha-Glucosidase, Lysosomal
% 214.44/214.67  |- mesh__recordAuthorizer mesh__D005087 sjn
% 214.44/214.67  |- skos__scopeNote mesh__D013519
% 214.44/214.67       Surgery performed on the urinary tract or its organs and on the male or female genitalia.%A%    
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D013519 1998
% 214.44/214.67  |- mesh__historyNote mesh__D013519 98; use explode 1975-97   
% 214.44/214.67  |- skos__prefLabel mesh__D013519 Urogenital Surgical Procedures
% 214.44/214.67  |- skos__altLabel mesh__D013519 Urogenital Surgical Procedure
% 214.44/214.67  |- mesh__publicMeSHNote mesh__D013519 98   
% 214.44/214.67  |- skos__altLabel mesh__D013519 Surgical Procedures, Urogenital
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D013519 2001
% 214.44/214.67  |- skos__annotation mesh__D013519
% 214.44/214.67       avoid: too inclusive; prefer GYNECOLOGIC SURGICAL PROCEDURES %26% specifics or UROLOGIC SURGICAL PROCEDURES %26% specifics or UROLOGIC SURGICAL PROCEDURES, MALE %26% specifics; consider also UROGENITAL SYSTEM /surg or /surg with specific urogenital syst terms; also UROLOGIC DISEASES /surg or /surg with specific urol dis; DF: UROGENITAL SURG PROCEDURES%A%  
% 214.44/214.67  |- mesh__dateCreated mesh__D013519 1999-01-01
% 214.44/214.67  |- skos__altLabel mesh__D013519 Surgical Procedure, Urogenital
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D013519 2006
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D013519 2000
% 214.44/214.67  |- mesh__dateRevised mesh__D013519 1997-06-20
% 214.44/214.67  |- mesh__recordAuthorizer mesh__D013519 SJN
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D013519 2004
% 214.44/214.67  |- skos__altLabel mesh__D013519 Procedures, Urogenital Surgical
% 214.44/214.67  |- skos__broader mesh__D013519smesh__D013514
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D013519 2005
% 214.44/214.67  |- mesh__recordOriginator mesh__D013519 NLM
% 214.44/214.67  |- skos__altLabel mesh__D013519 Procedure, Urogenital Surgical
% 214.44/214.67  |- mesh__dateEstablished mesh__D013519 1998-01-01
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D013519 2003
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D013519 1999
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D013519 2002
% 214.44/214.67  |- rdf__type mesh__D013519sskos__Concept
% 214.44/214.67  |- mesh__recordMaintainer mesh__D013519 TGC
% 214.44/214.67  |- mesh__dateRevised mesh__D024241 2004-07-07
% 214.44/214.67  |- skos__broader mesh__D024241smesh__D024001
% 214.44/214.67  |- rdf__type mesh__D024241sskos__Concept
% 214.44/214.67  |- skos__historyNote mesh__D024241 Nucleoproteins %28%1966-1981%29%
% 214.44/214.67  |- skos__altLabel mesh__D024241 HMGN1
% 214.44/214.67  |- skos__hiddenLabel mesh__D024241 Nonhistone Chromosomal Protein HMG 14
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D024241 2006
% 214.44/214.67  |- skos__altLabel mesh__D024241 HMG 14 Protein
% 214.44/214.67  |- mesh__recordMaintainer mesh__D024241 jmp
% 214.44/214.67  |- mesh__dateCreated mesh__D024241 2001-07-25
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D024241 2005
% 214.44/214.67  |- skos__altLabel mesh__D024241 HMG14 Protein
% 214.44/214.67  |- skos__historyNote mesh__D024241
% 214.44/214.67       High Mobility Group Proteins %28%1985-2001%29%
% 214.44/214.67  |- skos__prefLabel mesh__D024241 HMGN1 Protein
% 214.44/214.67  |- skos__altLabel mesh__D024241 HMG 14
% 214.44/214.67  |- skos__altLabel mesh__D024241 HMG14
% 214.44/214.67  |- mesh__recordOriginator mesh__D024241 jmp
% 214.44/214.67  |- mesh__recordAuthorizer mesh__D024241 sjn
% 214.44/214.67  |- mesh__historyNote mesh__D024241
% 214.44/214.67       2002; for HMG 14 PROTEIN use HIGH MOBILITY GROUP PROTEINS 1985-2001%A%  
% 214.44/214.67  |- skos__altLabel mesh__D024241
% 214.44/214.67       Nucleosomal Binding Protein 1, High Mobility Group
% 214.44/214.67  |- mesh__publicMeSHNote mesh__D024241
% 214.44/214.67       2002; for HMG 14 PROTEIN see HIGH MOBILITY GROUP PROTEINS 1985-2001%A%  
% 214.44/214.67  |- skos__scopeNote mesh__D024241
% 214.44/214.67       An evolutionarily-conserved 10-kDa nuclear protein that binds NUCLEOSOMES and may be involved in the process of CHROMATIN unfolding.%A%    
% 214.44/214.67  |- mesh__dateEstablished mesh__D024241 2002-01-01
% 214.44/214.67  |- skos__altLabel mesh__D024241 Nonhistone Chromosomal Protein HMG-14
% 214.44/214.67  |- skos__historyNote mesh__D024241
% 214.44/214.67       Chromosomal Proteins, Non-Histone %28%1977-1984%29%
% 214.44/214.67  |- skos__broader mesh__D018204smesh__D009370
% 214.44/214.67  |- mesh__recordAuthorizer mesh__D018204 sjn
% 214.44/214.67  |- mesh__dateCreated mesh__D018204 1993-08-26
% 214.44/214.67  |- mesh__dateRevised mesh__D018204 2004-07-13
% 214.44/214.67  |- mesh__recordOriginator mesh__D018204 PLS
% 214.44/214.67  |- skos__scopeNote mesh__D018204
% 214.44/214.67       Neoplasms developing from some structure of the connective and subcutaneous tissue. The concept does not refer to neoplasms located in connective or soft tissue.%A%    
% 214.44/214.67  |- skos__prefLabel mesh__D018204 Neoplasms, Connective and Soft Tissue
% 214.44/214.67  |- mesh__publicMeSHNote mesh__D018204 98   
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D018204 2006
% 214.44/214.67  |- mesh__historyNote mesh__D018204 98; use explode 1994-97   
% 214.44/214.67  |- skos__annotation mesh__D018204
% 214.44/214.67       neopl composed of connective or soft tissue, NOT neopl located in these sites; indexing policy: Manual section 24; also TN Suppl: Tumor Key for human %26% corresponding vet tumors %28%does not contain exper tumors%29%; TN 135: correct use of tissue type terms; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; NEOPLASMS, CONNECTIVE TISSUE is available for neopl composed of connective tissue but SOFT TISSUE NEOPLASMS is available for neopl located in soft tissue %28%see note there%29%; DF: NEOPL CONNECTIVE SOFT TISSUE%A%  
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D018204 2005
% 214.44/214.67  |- skos__altLabel mesh__D018204 Connective and Soft Tissue Neoplasms
% 214.44/214.67  |- mesh__recordMaintainer mesh__D018204 sjn
% 214.44/214.67  |- rdf__type mesh__D018204sskos__Concept
% 214.44/214.67  |- mesh__dateEstablished mesh__D018204 1998-01-01
% 214.44/214.67  |- skos__hiddenLabel mesh__D051638 Ether A Go Go Related Potassium Channels
% 214.44/214.67  |- skos__scopeNote mesh__D051638
% 214.44/214.67       A family of voltage-gated potassium channels that are characterized by long N-terminal and C-terminal intracellular tails. They are named from the  Drosophila protein whose mutation causes abnormal leg shaking under ether anesthesia. Their activation kinetics are dependent on extracellular MAGNESIUM and PROTON concentration.%A%    
% 214.44/214.67  |- mesh__recordMaintainer mesh__D051638 DRC
% 214.44/214.67  |- skos__broader mesh__D051638smesh__D024642
% 214.44/214.67  |- skos__hiddenLabel mesh__D051638 Potassium Channels, Eag
% 214.44/214.67  |- mesh__recordOriginator mesh__D051638 DRC
% 214.44/214.67  |- mesh__historyNote mesh__D051638 2006%28%1994%29%   
% 214.44/214.67  |- rdf__type mesh__D051638sskos__Concept
% 214.44/214.67  |- skos__hiddenLabel mesh__D051638 Eag Related Potassium Channels
% 214.44/214.67  |- skos__hiddenLabel mesh__D051638 Potassium Channels, Eag-Related
% 214.44/214.67  |- skos__hiddenLabel mesh__D051638 Potassium Channels, ERG
% 214.44/214.67  |- skos__altLabel mesh__D051638 ERG Potassium Channels
% 214.44/214.67  |- mesh__publicMeSHNote mesh__D051638
% 214.44/214.67       2006; ETHER-A-GO-GO POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS 1994-2005%A%  
% 214.44/214.67  |- mesh__recordAuthorizer mesh__D051638 sjn
% 214.44/214.67  |- skos__prefLabel mesh__D051638 Ether-A-Go-Go Potassium Channels
% 214.44/214.67  |- skos__altLabel mesh__D051638 Ether-A-Go-Go Related Potassium Channels
% 214.44/214.67  |- skos__altLabel mesh__D051638 Eag-Related Potassium Channels
% 214.44/214.67  |- mesh__dateEstablished mesh__D051638 2006-01-01
% 214.44/214.67  |- skos__hiddenLabel mesh__D051638 Ether A Go Go Potassium Channels
% 214.44/214.67  |- skos__altLabel mesh__D051638 Eag Potassium Channels
% 214.44/214.67  |- skos__hiddenLabel mesh__D051638 Potassium Channels, Ether-A-Go-Go
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D051638 2006
% 214.44/214.67  |- mesh__dateCreated mesh__D051638 2005-06-30
% 214.44/214.67  |- skos__broader mesh__D009478smesh__D009479
% 214.44/214.67  |- mesh__publicMeSHNote mesh__D009478 87   
% 214.44/214.67  |- skos__hiddenLabel mesh__D009478 Y, Neuropeptide
% 214.44/214.67  |- skos__altLabel mesh__D009478 Neuropeptide Y-Like Immunoreactive Peptide
% 214.44/214.67  |- skos__scopeNote mesh__D009478
% 214.44/214.67       A 36-amino acid peptide present in many organs and in many sympathetic noradrenergic neurons. It has vasoconstrictor and natriuretic activity and regulates local blood flow, glandular secretion, and smooth muscle activity. The peptide also stimulates feeding and drinking behavior and influences secretion of pituitary hormones.%A%    
% 214.44/214.67  |- skos__hiddenLabel mesh__D009478 Tyrosine, Neuropeptide
% 214.44/214.67  |- mesh__dateRevised mesh__D009478 2005-06-30
% 214.44/214.67  |- mesh__dateEstablished mesh__D009478 1987-01-01
% 214.44/214.67  |- mesh__dateCreated mesh__D009478 1986-04-14
% 214.44/214.67  |- rdf__type mesh__D009478sskos__Concept
% 214.44/214.67  |- skos__altLabel mesh__D009478 Neuropeptide Tyrosine
% 214.44/214.67  |- skos__annotation mesh__D009478
% 214.44/214.67       a neurotransmitter; /biosyn /physiol permitted   
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D009478 2006
% 214.44/214.67  |- mesh__recordAuthorizer mesh__D009478 sjn
% 214.44/214.67  |- mesh__recordOriginator mesh__D009478 RLS
% 214.44/214.67  |- skos__historyNote mesh__D009478 Nerve Tissue Proteins %28%1966-1986%29%
% 214.44/214.67  |- skos__prefLabel mesh__D009478 Neuropeptide Y
% 214.44/214.67  |- skos__related mesh__D009478smesh__D017476
% 214.44/214.67  |- mesh__historyNote mesh__D009478 87   
% 214.44/214.67  |- mesh__recordMaintainer mesh__D009478 ssb
% 214.44/214.67  |- skos__altLabel mesh__D006180 Proton-Translocating ATPase
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D006180 2006
% 214.44/214.67  |- skos__hiddenLabel mesh__D006180 F 1 ATPase
% 214.44/214.67  |- skos__hiddenLabel mesh__D006180 Complexes, Proton-Translocating ATPase
% 214.44/214.67  |- skos__altLabel mesh__D006180 F1 ATPase
% 214.44/214.67  |- skos__hiddenLabel mesh__D006180 ATPase, Proton-Translocating
% 214.44/214.67  |- skos__historyNote mesh__D006180
% 214.44/214.67       Adenosine Triphosphatase %28%1966-1982%29%
% 214.44/214.67  |- skos__hiddenLabel mesh__D006180 F 0 ATPase
% 214.44/214.67  |- skos__altLabel mesh__D006180 Proton-Translocating ATPase Complexes
% 214.44/214.67  |- skos__hiddenLabel mesh__D006180 F0 ATPase
% 214.44/214.67  |- skos__altLabel mesh__D006180 ATPase, F0
% 214.44/214.67  |- skos__altLabel mesh__D006180 H%28%+%29%-Transporting ATP Synthase
% 214.44/214.67  |- skos__altLabel mesh__D006180 F-1-ATPase
% 214.44/214.67  |- skos__broader mesh__D006180smesh__D017494
% 214.44/214.67  |- skos__hiddenLabel mesh__D006180 Proton Translocating ATPase
% 214.44/214.67  |- skos__altLabel mesh__D006180 H+ ATPase
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D006180 2005
% 214.44/214.67  |- skos__hiddenLabel mesh__D006180 Proton Translocating ATPase Complex
% 214.44/214.67  |- skos__hiddenLabel mesh__D006180 ATPase Complexes, Proton-Translocating
% 214.44/214.67  |- rdf__type mesh__D006180sskos__Concept
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D006180 2004
% 214.44/214.67  |- skos__altLabel mesh__D006180 H+-Translocating ATPase
% 214.44/214.67  |- skos__altLabel mesh__D006180 ATPase, F%28%1%29%F%28%0%29%
% 214.44/214.67  |- skos__hiddenLabel mesh__D006180 ATPase Complex, Proton-Translocating
% 214.44/214.67  |- skos__prefLabel mesh__D006180 Proton-Translocating ATPases
% 214.44/214.67  |- skos__altLabel mesh__D006180 H%28%+%29%ATPase Complex
% 214.44/214.67  |- skos__altLabel mesh__D006180 ATP Dependent Proton Translocase
% 214.44/214.67  |- skos__altLabel mesh__D006180 F1F0 ATPase Complex
% 214.44/214.67  |- skos__altLabel mesh__D006180 ATPase, H%28%+%29%
% 214.44/214.67  |- skos__altLabel mesh__D006180 H+ Transporting ATP Synthase
% 214.44/214.67  |- skos__altLabel mesh__D006180 F%28%1%29%F%28%0%29%-ATPase
% 214.44/214.67  |- skos__altLabel mesh__D006180 ATPase, F0F1
% 214.44/214.67  |- skos__hiddenLabel mesh__D006180 Proton Translocating ATPase Complexes
% 214.44/214.67  |- skos__scopeNote mesh__D006180
% 214.44/214.67       Multisubunit enzymes that reversibly synthesize ADENOSINE TRIPHOSPHATE. They are coupled to the transport of protons across a membrane.%A%    
% 214.44/214.67  |- skos__hiddenLabel mesh__D006180 ATPase, H+-Translocating
% 214.44/214.67  |- skos__hiddenLabel mesh__D006180 Triphosphatase Complex, Adenosine
% 214.44/214.67  |- mesh__recordAuthorizer mesh__D006180 sjn
% 214.44/214.67  |- skos__hiddenLabel mesh__D006180 Complex, Adenosine Triphosphatase
% 214.44/214.67  |- skos__hiddenLabel mesh__D006180 Proton Translocating ATPase, F1 Sector
% 214.44/214.67  |- mesh__dateRevised mesh__D006180 2003-07-09
% 214.44/214.67  |- skos__broader mesh__D006180smesh__D000251
% 214.44/214.67  |- skos__altLabel mesh__D006180 F0F1 ATPase
% 214.44/214.67  |- skos__altLabel mesh__D006180 H%28%+%29%-ATPase
% 214.44/214.67  |- skos__hiddenLabel mesh__D006180 ATPase, H+
% 214.44/214.67  |- skos__altLabel mesh__D006180 F%28%0%29%F%28%1%29%-ATP Synthase
% 214.44/214.67  |- mesh__recordOriginator mesh__D006180 RLS
% 214.44/214.67  |- skos__hiddenLabel mesh__D006180 H+ Translocating ATPase
% 214.44/214.67  |- mesh__dateEstablished mesh__D006180 1983-01-01
% 214.44/214.67  |- skos__annotation mesh__D006180
% 214.44/214.67       GEN or unspecified; prefer specifics; do not confuse with H%28%+%29%-K%28%+%29%-TRANSPORTING ATPASE see H%28%+%29%-K%28%+%29%-EXCHANGING ATPASE; DF: H ATPASE%A%  
% 214.44/214.67  |- skos__altLabel mesh__D006180 H%28%+%29%-Transporting ATPase
% 214.44/214.67  |- skos__altLabel mesh__D006180 Adenosinetriphosphatase F1
% 214.44/214.67  |- skos__altLabel mesh__D006180 F1-ATPase
% 214.44/214.67  |- mesh__historyNote mesh__D006180
% 214.44/214.67       2002%28%1983%29%; for F%28%1%29%F%28%0%29%-ATPASE use PROTON-TRANSLOCATING ATPASES %28%NM%29%%A%  
% 214.44/214.67  |- skos__hiddenLabel mesh__D006180 Proton Translocating ATPase, F0 Sector
% 214.44/214.67  |- mesh__dateCreated mesh__D006180 1982-05-11
% 214.44/214.67  |- mesh__publicMeSHNote mesh__D006180
% 214.44/214.67       2002; see H%28%+%29%-TRANSPORTING ATP SYNTHASE 1993-2001, H%28%+%29%-TRANSPORTING ATPASE 1984-92,  ADENOSINE TRIPHOSPHATASE F1 1983; for ATPASE, F0 see ATPASE F%28%0%29% 1984-1992; for ATPASE, F1 see ATPASE F1 1983-1992; for F1F0 ATPASE COMPLEX see H%28%+%29%-TRANSPORTING ATP SYNTHASE 1984-1993; F%28%1%29%F%28%0%29% ATPASE was indexed under ADENOSINE TRIPHOSPHATASE 1979-1985 %26% H%28%+%29%-TRANSPORTING ATP SYNTHASE 1986-1993%A%  
% 214.44/214.67  |- skos__altLabel mesh__D006180 Adenosine Triphosphatase Complex
% 214.44/214.67  |- mesh__recordMaintainer mesh__D006180 ssb
% 214.44/214.67  |- skos__altLabel mesh__D006180 F-0-ATPase
% 214.44/214.67  |- skos__altLabel mesh__D006180 Proton-Translocating ATPase Complex
% 214.44/214.67  |- skos__altLabel mesh__D006180 ATPase, F1
% 214.44/214.67  |- skos__broader mesh__D006180smesh__D025181
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D014612 2006
% 214.44/214.67  |- skos__scopeNote mesh__D014612
% 214.44/214.67       Suspensions of killed or attenuated microorganisms %28%bacteria, viruses, fungi, protozoa, or rickettsiae%29%, antigenic proteins derived from them, or synthetic constructs, administered for the prevention, amelioration, or treatment of infectious and other diseases.%A%    
% 214.44/214.67  |- mesh__recordMaintainer mesh__D014612 ssb
% 214.44/214.67  |- skos__broader mesh__D014612smesh__D001688
% 214.44/214.67  |- rdf__type mesh__D014612sskos__Concept
% 214.44/214.67  |- skos__prefLabel mesh__D014612 Vaccines
% 214.44/214.67  |- mesh__recordOriginator mesh__D014612 NLM
% 214.44/214.67  |- mesh__recordAuthorizer mesh__D014612 sjn
% 214.44/214.67  |- mesh__dateRevised mesh__D014612 2005-06-30
% 214.44/214.67  |- mesh__dateCreated mesh__D014612 1999-01-01
% 214.44/214.67  |- skos__annotation mesh__D014612
% 214.44/214.67       GEN: prefer specifics; prev use = VACCINES or specific vaccine %28%IM%29% + disease /prev %28%IM%29%; ther use = VACCINES or specific vaccine /ther use %28%IM%29% + DISEASE /drug ther %28%IM%29%%A%  
% 214.44/214.67  |- skos__hiddenLabel mesh__D005886 Gingival Hypertrophies
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005886 2005
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005886 2004
% 214.44/214.67  |- skos__broader mesh__D005886smesh__D019214
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005886 2002
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005886 2006
% 214.44/214.67  |- mesh__dateRevised mesh__D005886 1996-06-10
% 214.44/214.67  |- mesh__recordAuthorizer mesh__D005886 PLS
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005886 1998
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005886 1997
% 214.44/214.67  |- rdf__type mesh__D005886sskos__Concept
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005886 1999
% 214.44/214.67  |- mesh__recordOriginator mesh__D005886 NLM
% 214.44/214.67  |- mesh__publicMeSHNote mesh__D005886 65   
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005886 2000
% 214.44/214.67  |- skos__annotation mesh__D005886
% 214.44/214.67       differentiate from GINGIVAL HYPERPLASIA   
% 214.44/214.67  |- skos__prefLabel mesh__D005886 Gingival Hypertrophy
% 214.44/214.67  |- skos__hiddenLabel mesh__D005886 Hypertrophy, Gingival
% 214.44/214.67  |- skos__hiddenLabel mesh__D005886 Hypertrophies, Gingival
% 214.44/214.67  |- skos__scopeNote mesh__D005886
% 214.44/214.67       Abnormal enlargement or overgrowth of the gingivae brought about by enlargement of existing cells.%A%    
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005886 2001
% 214.44/214.67  |- mesh__historyNote mesh__D005886 65   
% 214.44/214.67  |- mesh__dateCreated mesh__D005886 1999-01-01
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005886 2003
% 214.44/214.67  |- mesh__dateEstablished mesh__D005886 1965-01-01
% 214.44/214.67  |- mesh__recordMaintainer mesh__D005886 TGC
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D038262 2006
% 214.44/214.67  |- skos__scopeNote mesh__D038262
% 214.44/214.67       Multi-channel hearing devices typically used for patients who have tumors on the COCHLEAR NERVE and are unable to benefit from COCHLEAR IMPLANTS after tumor surgery that severs the cochlear nerve. The device electrically stimulates the nerves of cochlea nucleus in the BRAIN STEM rather than the inner ear as in cochlear implants.%A%    
% 214.44/214.67  |- mesh__historyNote mesh__D038262 2003   
% 214.44/214.67  |- skos__hiddenLabel mesh__D038262 Implants, Auditory Brainstem
% 214.44/214.67  |- skos__altLabel mesh__D038262 Brain Stem Implants, Auditory
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D038262 2003
% 214.44/214.67  |- mesh__dateEstablished mesh__D038262 2003-01-01
% 214.44/214.67  |- skos__related mesh__D038262smesh__D038263
% 214.44/214.67  |- skos__broader mesh__D038262smesh__D006310
% 214.44/214.67  |- skos__hiddenLabel mesh__D038262 Brainstem Implant, Auditory
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D038262 2004
% 214.44/214.67  |- skos__historyNote mesh__D038262 Cochlear Implants %28%1992-2002%29%
% 214.44/214.67  |- skos__hiddenLabel mesh__D038262 Brainstem Implants, Auditory
% 214.44/214.67  |- skos__broader mesh__D038262smesh__D004567
% 214.44/214.67  |- mesh__dateCreated mesh__D038262 2002-07-02
% 214.44/214.67  |- skos__altLabel mesh__D038262 Auditory Brainstem Implants
% 214.44/214.67  |- rdf__type mesh__D038262sskos__Concept
% 214.44/214.67  |- skos__hiddenLabel mesh__D038262 Implant, Auditory Brainstem
% 214.44/214.67  |- skos__hiddenLabel mesh__D038262 Auditory Brainstem Implant
% 214.44/214.67  |- skos__prefLabel mesh__D038262 Auditory Brain Stem Implants
% 214.44/214.67  |- skos__broader mesh__D038262smesh__D019736
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D038262 2005
% 214.44/214.67  |- mesh__publicMeSHNote mesh__D038262 2003   
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005088 1996
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005088 2004
% 214.44/214.67  |- skos__annotation mesh__D005088 GEN: prefer specifics   
% 214.44/214.67  |- mesh__publicMeSHNote mesh__D005088 70   
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005088 1992
% 214.44/214.67  |- mesh__recordAuthorizer mesh__D005088 PLS
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005088 1997
% 214.44/214.67  |- skos__historyNote mesh__D005088 specific anatomic part %28%1966%29%
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005088 2001
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005088 2005
% 214.44/214.67  |- mesh__dateRevised mesh__D005088 1989-03-14
% 214.44/214.67  |- mesh__recordOriginator mesh__D005088 NLM
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005088 1993
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005088 2002
% 214.44/214.67  |- skos__historyNote mesh__D005088 specific animal %28%1966%29%
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005088 1998
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005088 2006
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005088 1990
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005088 1994
% 214.44/214.67  |- skos__hiddenLabel mesh__D005088 Glands, Exocrine
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005088 1999
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005088 1991
% 214.44/214.67  |- skos__hiddenLabel mesh__D005088 Gland, Exocrine
% 214.44/214.67  |- mesh__historyNote mesh__D005088 70%28%67%29%   
% 214.44/214.67  |- skos__prefLabel mesh__D005088 Exocrine Glands
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005088 1995
% 214.44/214.67  |- mesh__dateEstablished mesh__D005088 1970-01-01
% 214.44/214.67  |- skos__broader mesh__D005088smesh__D014024
% 214.44/214.67  |- mesh__dateCreated mesh__D005088 1999-01-01
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005088 2003
% 214.44/214.67  |- rdf__type mesh__D005088sskos__Concept
% 214.44/214.67  |- skos__hiddenLabel mesh__D005088 Exocrine Gland
% 214.44/214.67  |- mesh__recordMaintainer mesh__D005088 TGC
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D005088 2000
% 214.44/214.67  |- skos__historyNote mesh__D024242
% 214.44/214.67       High Mobility Group Proteins %28%1984-2001%29%
% 214.44/214.67  |- skos__scopeNote mesh__D024242
% 214.44/214.67       An evolutionarily conserved 9-KDa nuclear protein that binds NUCLEOSOMES and may be involved in the process of CHROMATIN unfolding.%A%    
% 214.44/214.67  |- rdf__type mesh__D024242sskos__Concept
% 214.44/214.67  |- skos__historyNote mesh__D024242 Nucleoproteins %28%1966-1981%29%
% 214.44/214.67  |- mesh__activeMeSHYear mesh__D024242 2006
% 214.44/214.67  |- mesh__recordOriginator mesh__D024242 jmp
% 214.44/214.68  |- mesh__recordAuthorizer mesh__D024242 sjn
% 214.44/214.68  |- mesh__dateCreated mesh__D024242 2001-07-25
% 214.44/214.68  |- skos__altLabel mesh__D024242 HMG17
% 214.44/214.68  |- mesh__dateEstablished mesh__D024242 2002-01-01
% 214.44/214.68  |- skos__altLabel mesh__D024242 HMGN2
% 214.44/214.68  |- mesh__publicMeSHNote mesh__D024242
% 214.44/214.68       2002; for HMG 17 %26% HMG 17 PROTEIN see HIGH MOBILITY GROUP PROTEINS 1985-2001%A%  
% 214.44/214.68  |- skos__altLabel mesh__D024242 HMG 17
% 214.44/214.68  |- skos__altLabel mesh__D024242
% 214.44/214.68       Nucleosomal Binding Protein 2, High Mobility Group
% 214.44/214.68  |- mesh__dateRevised mesh__D024242 2004-07-07
% 214.44/214.68  |- mesh__historyNote mesh__D024242
% 214.44/214.68       2002; for HMG 17 %26% HMG 17 PROTEIN use HIGH MOBILITY GROUP PROTEINS 1985-2001%A%  
% 214.44/214.68  |- skos__broader mesh__D024242smesh__D024001
% 214.44/214.68  |- skos__prefLabel mesh__D024242 HMGN2 Protein
% 214.44/214.68  |- skos__historyNote mesh__D024242
% 214.44/214.68       Chromosomal Proteins, Non-Histone %28%1977-1984%29%
% 214.44/214.68  |- skos__altLabel mesh__D024242 HMG17 Protein
% 214.44/214.68  |- mesh__activeMeSHYear mesh__D024242 2005
% 214.44/214.68  |- skos__altLabel mesh__D024242 HMG 17 Protein
% 214.44/214.68  |- mesh__recordMaintainer mesh__D024242 jmp
% 214.44/214.68  |- mesh__activeMeSHYear mesh__D018205 2002
% 214.44/214.68  |- mesh__historyNote mesh__D018205 94   
% 214.44/214.68  |- mesh__dateRevised mesh__D018205 1995-06-08
% 214.44/214.68  |- skos__historyNote mesh__D018205 Soft Tissue Neoplasms %28%1978-1993%29%
% 214.44/214.68  |- skos__broader mesh__D018205smesh__D018204
% 214.44/214.68  |- mesh__activeMeSHYear mesh__D018205 2006
% 214.44/214.68  |- skos__hiddenLabel mesh__D018205 Neoplasm, Adipose Tissue
% 214.44/214.68  |- mesh__activeMeSHYear mesh__D018205 2004
% 214.44/214.68  |- mesh__activeMeSHYear mesh__D018205 2005
% 214.44/214.68  |- mesh__activeMeSHYear mesh__D018205 1999
% 214.44/214.68  |- skos__hiddenLabel mesh__D018205 Adipose Tissue Neoplasm
% 214.44/214.68  |- mesh__recordAuthorizer mesh__D018205 PLS
% 214.44/214.68  |- mesh__activeMeSHYear mesh__D018205 2001
% 214.44/214.68  |- rdf__type mesh__D018205sskos__Concept
% 214.44/214.68  |- skos__historyNote mesh__D018205 Adipose Tissue %28%1967-1993%29%
% 214.44/214.68  |- mesh__activeMeSHYear mesh__D018205 2003
% 214.44/214.68  |- mesh__dateCreated mesh__D018205 1993-06-25
% 214.44/214.68  |- mesh__activeMeSHYear mesh__D018205 1997
% 214.44/214.68  |- skos__prefLabel mesh__D018205 Neoplasms, Adipose Tissue
% 214.44/214.68  |- mesh__dateEstablished mesh__D018205 1994-01-01
% 214.44/214.68  |- mesh__activeMeSHYear mesh__D018205 1998
% 214.44/214.68  |- mesh__activeMeSHYear mesh__D018205 2000
% 214.44/214.68  |- skos__altLabel mesh__D018205 Adipose Tissue Neoplasms
% 214.44/214.68  |- mesh__recordMaintainer mesh__D018205 KEV
% 214.44/214.68  |- skos__scopeNote mesh__D018205
% 214.44/214.68       Neoplasms composed of fatty tissue or connective tissue made up of fat cells in a meshwork of areolar tissue. The concept does not refer to neoplasms located in adipose tissue.%A%    
% 214.44/214.68  |- mesh__publicMeSHNote mesh__D018205 94   
% 214.44/214.68  |- mesh__activeMeSHYear mesh__D018205 1996
% 214.44/214.68  |- mesh__recordOriginator mesh__D018205 PLS
% 214.44/214.68  |- skos__annotation mesh__D018205
% 214.44/214.68       neoplasms composed of adipose or soft tissue, NOT neoplasms located in adipose or soft tissue: TN 135; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; restricted use: Manual 24.2.2.5; DF: NEOPL ADIPOSE TISSUE%A%  
% 214.44/214.68  |- mesh__recordAuthorizer mesh__D010222 sjn
% 214.44/214.68  |- mesh__dateCreated mesh__D010222 1999-01-01
% 214.44/214.68  |- skos__annotation mesh__D010222
% 214.44/214.68       infection: coord IM with RESPIROVIRUS INFECTIONS %28%IM%29%   
% 214.44/214.68  |- mesh__activeMeSHYear mesh__D010222 2006
% 214.44/214.68  |- skos__altLabel mesh__D010222 Para-Influenza Virus Type 1
% 214.44/214.68  |- mesh__dateEstablished mesh__D010222 1965-01-01
% 214.44/214.68  |- mesh__dateRevised mesh__D010222 2001-07-25
% 214.44/214.68  |- skos__hiddenLabel mesh__D010222 Para Influenza Virus Type 1
% 214.44/214.68  |- mesh__activeMeSHYear mesh__D010222 2005
% 214.44/214.68  |- skos__prefLabel mesh__D010222 Parainfluenza Virus 1, Human
% 214.44/214.68  |- mesh__historyNote mesh__D010222
% 214.44/214.68       97; was PARAINFLUENZA VIRUS TYPE 1 1994-96, was PARA-INFLUENZA VIRUS TYPE 1 1977-93, was SENDAI VIRUS 1964-76%A%  
% 214.44/214.68  |- mesh__onlineNote mesh__D010222
% 214.44/214.68       use PARAINFLUENZA VIRUS 1, HUMAN to search PARAINFLUENZA VIRUS TYPE 1 1994-96, PARA-INFLUENZA VIRUS TYPE 1 1977-93, %26% SENDAI VIRUS 1966-76%A%  
% 214.44/214.68  |- mesh__recordOriginator mesh__D010222 NLM
% 214.44/214.68  |- skos__altLabel mesh__D010222 Hemadsorption Virus 2
% 214.44/214.68  |- mesh__recordMaintainer mesh__D010222 ags
% 214.44/214.68  |- mesh__activeMeSHYear mesh__D010222 2004
% 214.44/214.68  |- skos__scopeNote mesh__D010222
% 214.44/214.68       A species of RESPIROVIRUS also called hemadsorption virus 2 %28%HA2%29%, which causes laryngotracheitis in humans, especially children.%A%    
% 214.44/214.68  |- mesh__activeMeSHYear mesh__D010222 2002
% 214.44/214.68  |- mesh__publicMeSHNote mesh__D010222
% 214.44/214.68       97; was PARAINFLUENZA VIRUS TYPE 1 1994-96, was PARA-INFLUENZA VIRUS TYPE 1 1977-93, was SENDAI VIRUS 1964-76%A%  
% 214.44/214.68  |- skos__broader mesh__D010222smesh__D018108
% 214.44/214.68  |- rdf__type mesh__D010222sskos__Concept
% 214.44/214.68  |- skos__altLabel mesh__D010222 Human parainfluenza virus 1
% 214.44/214.68  |- mesh__activeMeSHYear mesh__D010222 2003
% 214.44/214.68  |- skos__broader mesh__D051639smesh__D000383
% 214.44/214.68  |- mesh__publicMeSHNote mesh__D051639 2006   
% 214.44/214.68  |- mesh__activeMeSHYear mesh__D051639 2006A
% 214.44/214.68  |- mesh__dateCreated mesh__D051639 2005-06-30
% 214.44/214.68  |- mesh__recordAuthorizer mesh__D051639 ags
% 214.44/214.68  |- skos__broader mesh__D051639smesh__D011998
% 214.44/214.68  |- rdf__type mesh__D051639sskos__Concept
% 214.44/214.68  |- skos__prefLabel mesh__D051639 Gardening
% 214.44/214.68  |- mesh__historyNote mesh__D051639 2006   
% 214.44/214.68  |- mesh__recordMaintainer mesh__D051639 ags
% 214.44/214.68  |- skos__scopeNote mesh__D051639
% 214.44/214.68       Cultivation of PLANTS; %28%FRUIT; VEGETABLES; MEDICINAL HERBS%29% on small plots of ground or in containers.%A%    
% 214.44/214.68  |- mesh__dateRevised mesh__D051639 2005-07-27
% 214.44/214.68  |- mesh__activeMeSHYear mesh__D051639 2006
% 214.44/214.68  |- mesh__recordOriginator mesh__D051639 ssb
% 214.44/214.68  |- mesh__dateEstablished mesh__D051639 2006-01-01
% 214.44/214.68  |- skos__prefLabel mesh__D048690 Fruiting Bodies, Fungal
% 214.44/214.68  |- mesh__dateRevised mesh__D048690 2005-06-30
% 214.44/214.68  |- mesh__recordMaintainer mesh__D048690 SYSTEM
% 214.44/214.68  |- mesh__publicMeSHNote mesh__D048690 2005   
% 214.44/214.68  |- mesh__dateCreated mesh__D048690 2004-07-07
% 214.44/214.68  |- mesh__dateEstablished mesh__D048690 2005-01-01
% 214.44/214.68  |- mesh__historyNote mesh__D048690 2005   
% 214.44/214.68  |- mesh__recordOriginator mesh__D048690 ssb
% 214.44/214.68  |- skos__broader mesh__D048690smesh__D025281
% 214.54/214.68  |- skos__scopeNote mesh__D048690
% 214.54/214.68       The fruiting %27%heads%27% or %27%caps%27% of FUNGI, which as a food item are familiarly known as MUSHROOMS, that contain the FUNGAL SPORES.%A%    
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D048690 2006
% 214.54/214.68  |- rdf__type mesh__D048690sskos__Concept
% 214.54/214.68  |- mesh__recordAuthorizer mesh__D048690 sjn
% 214.54/214.68  |- skos__related mesh__D048690smesh__D000363
% 214.54/214.68  |- skos__annotation mesh__D009479 GEN or unspecified; prefer specifics   
% 214.54/214.68  |- skos__prefLabel mesh__D009479 Neuropeptides
% 214.54/214.68  |- mesh__recordMaintainer mesh__D009479 ssb
% 214.54/214.68  |- skos__scopeNote mesh__D009479
% 214.54/214.68       Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells.%A%    
% 214.54/214.68  |- mesh__publicMeSHNote mesh__D009479 87   
% 214.54/214.68  |- rdf__type mesh__D009479sskos__Concept
% 214.54/214.68  |- skos__related mesh__D009479smesh__D018013
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D009479 2006
% 214.54/214.68  |- mesh__dateRevised mesh__D009479 2005-06-30
% 214.54/214.68  |- skos__broader mesh__D009479smesh__D010455
% 214.54/214.68  |- skos__historyNote mesh__D009479 Nerve Tissue Proteins %28%1966-1986%29%
% 214.54/214.68  |- mesh__dateEstablished mesh__D009479 1987-01-01
% 214.54/214.68  |- mesh__historyNote mesh__D009479 87   
% 214.54/214.68  |- mesh__recordAuthorizer mesh__D009479 sjn
% 214.54/214.68  |- mesh__recordOriginator mesh__D009479 RLS
% 214.54/214.68  |- skos__altLabel mesh__D009479 Neuropeptide
% 214.54/214.68  |- mesh__dateCreated mesh__D009479 1986-04-11
% 214.54/214.68  |- skos__broader mesh__D009479smesh__D009419
% 214.54/214.68  |- mesh__publicMeSHNote mesh__D001496 74   
% 214.54/214.68  |- skos__broader mesh__D001496smesh__D000664
% 214.54/214.68  |- mesh__historyNote mesh__D001496 74   
% 214.54/214.68  |- skos__prefLabel mesh__D001496 Batrachotoxins
% 214.54/214.68  |- rdf__type mesh__D001496sskos__Concept
% 214.54/214.68  |- skos__scopeNote mesh__D001496
% 214.54/214.68       Batrachotoxin is the 20-alpha-bromobenzoate of batrachotoxin A; they are toxins from the venom of a small Colombian frog, Phyllobates aurotaenia, cause release of acetylcholine, destruction of synaptic vesicles and depolarization of nerve and muscle fibers.%A%    
% 214.54/214.68  |- mesh__dateEstablished mesh__D001496 1974-01-01
% 214.54/214.68  |- mesh__dateCreated mesh__D001496 1999-01-01
% 214.54/214.68  |- mesh__recordAuthorizer mesh__D001496 sjn
% 214.54/214.68  |- skos__annotation mesh__D001496
% 214.54/214.68       from frogs; /antag permitted but consider also ANTITOXINS%A%  
% 214.54/214.68  |- mesh__dateRevised mesh__D001496 2005-06-30
% 214.54/214.68  |- mesh__recordMaintainer mesh__D001496 ssb
% 214.54/214.68  |- mesh__recordOriginator mesh__D001496 NLM
% 214.54/214.68  |- skos__hiddenLabel mesh__D001496 B, Batrachotoxin
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D001496 2006
% 214.54/214.68  |- skos__altLabel mesh__D001496 Batrachotoxin B
% 214.54/214.68  |- skos__altLabel mesh__D020650 Chemistry Techniques, Combinatorial
% 214.54/214.68  |- skos__altLabel mesh__D020650 Combinatorial Chemistry Technic
% 214.54/214.68  |- skos__altLabel mesh__D020650 Technique, Combinatorial Chemistry
% 214.54/214.68  |- skos__altLabel mesh__D020650 Chemistry Technique, Combinatorial
% 214.54/214.68  |- skos__altLabel mesh__D020650 Combinatorial Chemistry Technique
% 214.54/214.68  |- mesh__dateEstablished mesh__D020650 2000-01-01
% 214.54/214.68  |- mesh__dateCreated mesh__D020650 1999-11-03
% 214.54/214.68  |- skos__annotation mesh__D020650
% 214.54/214.68       do not confuse with DRUG COMBINATIONS; DF: COMB CHEM   
% 214.54/214.68  |- skos__related mesh__D020650smesh__D019151
% 214.54/214.68  |- skos__altLabel mesh__D020650 Chemistry Technics, Combinatorial
% 214.54/214.68  |- skos__historyNote mesh__D020650 Drug Design %28%1992-1999%29%
% 214.54/214.68  |- skos__scopeNote mesh__D020650
% 214.54/214.68       A chemistry-based technology in which sets of reactions, for solution or solid-phase synthesis, are used to create molecular libraries for analysis of compounds on a large scale.%A%    
% 214.54/214.68  |- skos__broader mesh__D020650smesh__D013678
% 214.54/214.68  |- skos__altLabel mesh__D020650 Chemistry Technic, Combinatorial
% 214.54/214.68  |- skos__historyNote mesh__D020650
% 214.54/214.68       specific chemical /chemistry %28%1992-1999%29%
% 214.54/214.68  |- mesh__publicMeSHNote mesh__D020650 2000   
% 214.54/214.68  |- skos__altLabel mesh__D020650 Combinatorial Chemistry Technics
% 214.54/214.68  |- skos__altLabel mesh__D020650 Technic, Combinatorial Chemistry
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D020650 2005
% 214.54/214.68  |- mesh__historyNote mesh__D020650 2000   
% 214.54/214.68  |- skos__broader mesh__D020650smesh__D008919
% 214.54/214.68  |- skos__prefLabel mesh__D020650 Combinatorial Chemistry Techniques
% 214.54/214.68  |- skos__related mesh__D020650smesh__D015723
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D020650 2000
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D020650 2006
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D020650 2003
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D020650 2001
% 214.54/214.68  |- skos__altLabel mesh__D020650 Techniques, Combinatorial Chemistry
% 214.54/214.68  |- rdf__type mesh__D020650sskos__Concept
% 214.54/214.68  |- skos__historyNote mesh__D020650
% 214.54/214.68       specific chemical /chemical synthesis %28%1992-1999%29%
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D020650 2004
% 214.54/214.68  |- skos__altLabel mesh__D020650 Technics, Combinatorial Chemistry
% 214.54/214.68  |- skos__related mesh__D020650smesh__D020411
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D020650 2002
% 214.54/214.68  |- skos__historyNote mesh__D020650
% 214.54/214.68       Technology, Pharmaceutical %28%1992-1999%29%
% 214.54/214.68  |- mesh__dateEstablished mesh__D006181 1991-01-01
% 214.54/214.68  |- mesh__dateCreated mesh__D006181 1999-01-01
% 214.54/214.68  |- skos__broader mesh__D006181smesh__D012023
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D006181 1999
% 214.54/214.68  |- rdf__type mesh__D006181sskos__Concept
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D006181 2000
% 214.54/214.68  |- mesh__recordMaintainer mesh__D006181 RAZ
% 214.54/214.68  |- mesh__recordOriginator mesh__D006181 NLM
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D006181 2003
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D006181 2001
% 214.54/214.68  |- mesh__publicMeSHNote mesh__D006181
% 214.54/214.68       91; was see under REFLEX, MONOSYNAPTIC 1975-90   
% 214.54/214.68  |- skos__altLabel mesh__D006181 H-Reflexes
% 214.54/214.68  |- mesh__dateRevised mesh__D006181 1995-06-08
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D006181 2005
% 214.54/214.68  |- mesh__recordAuthorizer mesh__D006181 PLS
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D006181 2004
% 214.54/214.68  |- skos__prefLabel mesh__D006181 H-Reflex
% 214.54/214.68  |- mesh__onlineNote mesh__D006181 search REFLEX, MONOSYNAPTIC 1970-74   
% 214.54/214.68  |- skos__hiddenLabel mesh__D006181 H Reflexes
% 214.54/214.68  |- skos__hiddenLabel mesh__D006181 Reflex, H
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D006181 2006
% 214.54/214.68  |- mesh__historyNote mesh__D006181
% 214.54/214.68       91%28%75%29%; was see under REFLEX, MONOSYNAPTIC 1975-90   
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D006181 1996
% 214.54/214.68  |- skos__scopeNote mesh__D006181
% 214.54/214.68       A monosynaptic reflex elicited by stimulating a nerve, particularly the tibial nerve, with an electric shock.%A%    
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D006181 2002
% 214.54/214.68  |- skos__altLabel mesh__D006181 H Reflex
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D006181 1998
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D006181 1997
% 214.54/214.68  |- skos__prefLabel mesh__D014613 Vaccines, Attenuated
% 214.54/214.68  |- mesh__dateRevised mesh__D014613 2005-06-30
% 214.54/214.68  |- mesh__recordAuthorizer mesh__D014613 sjn
% 214.54/214.68  |- skos__scopeNote mesh__D014613
% 214.54/214.68       Live vaccines prepared from microorganisms which have undergone physical adaptation %28%e.g., by radiation or temperature conditioning%29% or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity.%A%    
% 214.54/214.68  |- skos__annotation mesh__D014613
% 214.54/214.68       live vaccine; coord NIM with specific vaccine %28%IM%29%   
% 214.54/214.68  |- skos__historyNote mesh__D014613 specific vaccine %28%1966-1972%29%
% 214.54/214.68  |- skos__broader mesh__D014613smesh__D014612
% 214.54/214.68  |- skos__hiddenLabel mesh__D014613 Attenuated Vaccines
% 214.54/214.68  |- rdf__type mesh__D014613sskos__Concept
% 214.54/214.68  |- mesh__recordMaintainer mesh__D014613 ssb
% 214.54/214.68  |- mesh__historyNote mesh__D014613 74%28%73%29%   
% 214.54/214.68  |- mesh__dateCreated mesh__D014613 1999-01-01
% 214.54/214.68  |- skos__historyNote mesh__D014613 Vaccines %28%1966-1972%29%
% 214.54/214.68  |- mesh__dateEstablished mesh__D014613 1974-01-01
% 214.54/214.68  |- mesh__recordOriginator mesh__D014613 NLM
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D014613 2006
% 214.54/214.68  |- mesh__publicMeSHNote mesh__D014613 74   
% 214.54/214.68  |- skos__broader mesh__D017470Q000819smesh__D017470
% 214.54/214.68  |- mesh__preferredCombination mesh__D017470Q000819smesh__D018690
% 214.54/214.68  |- rdf__type mesh__D017470Q000819smesh__CompoundConcept
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D005887 2001
% 214.54/214.68  |- mesh__historyNote mesh__D005887 74%28%71%29%   
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D005887 2006
% 214.54/214.68  |- skos__prefLabel mesh__D005887 Gingival Neoplasms
% 214.54/214.68  |- mesh__dateEstablished mesh__D005887 1974-01-01
% 214.54/214.68  |- skos__altLabel mesh__D005887 Neoplasms, Gingival
% 214.54/214.68  |- skos__historyNote mesh__D005887 Gingival Diseases %28%1966-1970%29%
% 214.54/214.68  |- skos__broader mesh__D005887smesh__D005882
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D005887 1998
% 214.54/214.68  |- skos__annotation mesh__D005887
% 214.54/214.68       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%; note X ref EPULIS, CONGENITAL: do not confuse with EPULIS see GINGIVAL DISEASES; index EPULIS, CONGENITAL under GINGIVAL NEOPLASMS /congen%A%  
% 214.54/214.68  |- skos__altLabel mesh__D005887 Congenital Epulis
% 214.54/214.68  |- rdf__type mesh__D005887sskos__Concept
% 214.54/214.68  |- mesh__dateRevised mesh__D005887 1997-06-20
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D005887 1999
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D005887 2002
% 214.54/214.68  |- skos__altLabel mesh__D005887 Epulis, Congenital
% 214.54/214.68  |- skos__hiddenLabel mesh__D005887 Neoplasm, Gingival
% 214.54/214.68  |- skos__broader mesh__D005887smesh__D009062
% 214.54/214.68  |- mesh__publicMeSHNote mesh__D005887 74   
% 214.54/214.68  |- mesh__dateCreated mesh__D005887 1999-01-01
% 214.54/214.68  |- skos__hiddenLabel mesh__D005887 Gingival Neoplasm
% 214.54/214.68  |- mesh__recordOriginator mesh__D005887 NLM
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D005887 2003
% 214.54/214.68  |- skos__altLabel mesh__D005887 Epulides, Congenital
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D005887 2000
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D005887 2005
% 214.54/214.68  |- mesh__recordMaintainer mesh__D005887 TPW
% 214.54/214.68  |- mesh__recordAuthorizer mesh__D005887 SJN
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D005887 2004
% 214.54/214.68  |- skos__historyNote mesh__D005887 Mouth Neoplasms %28%1966-1970%29%
% 214.54/214.68  |- skos__scopeNote mesh__D038263
% 214.54/214.68       Surgical insertion of an electronic hearing device %28%AUDITORY BRAIN STEM IMPLANTS%29% with electrodes to the cochlea nucleus in the BRAIN STEM rather than to the inner ear as in COCHLEAR IMPLANTATION.%A%    
% 214.54/214.68  |- skos__hiddenLabel mesh__D038263 Implantation, Auditory Brainstem
% 214.54/214.68  |- skos__altLabel mesh__D038263 Auditory Brainstem Implantation
% 214.54/214.68  |- rdf__type mesh__D038263sskos__Concept
% 214.54/214.68  |- skos__historyNote mesh__D038263 Cochlear Implantation %28%1992-2002%29%
% 214.54/214.68  |- mesh__dateEstablished mesh__D038263 2003-01-01
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D038263 2005
% 214.54/214.68  |- mesh__historyNote mesh__D038263 2003   
% 214.54/214.68  |- mesh__publicMeSHNote mesh__D038263 2003   
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D038263 2006
% 214.54/214.68  |- skos__broader mesh__D038263smesh__D019919
% 214.54/214.68  |- skos__hiddenLabel mesh__D038263 Auditory Brainstem Implantations
% 214.54/214.68  |- skos__related mesh__D038263smesh__D038262
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D038263 2003
% 214.54/214.68  |- skos__hiddenLabel mesh__D038263 Brainstem Implantations, Auditory
% 214.54/214.68  |- skos__prefLabel mesh__D038263 Auditory Brain Stem Implantation
% 214.54/214.68  |- skos__broader mesh__D038263smesh__D013506
% 214.54/214.68  |- mesh__dateCreated mesh__D038263 2002-07-02
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D038263 2004
% 214.54/214.68  |- skos__hiddenLabel mesh__D038263 Brainstem Implantation, Auditory
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D005089 2005
% 214.54/214.68  |- mesh__historyNote mesh__D005089
% 214.54/214.68       76%28%73%29%; was see under CELLS 1975   
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D005089 2006
% 214.54/214.68  |- mesh__dateRevised mesh__D005089 2000-06-22
% 214.54/214.68  |- mesh__publicMeSHNote mesh__D005089 76; was see under CELLS 1975   
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D005089 2001
% 214.54/214.68  |- skos__historyNote mesh__D005089 Cells/SE %28%1966-1972%29%
% 214.54/214.68  |- skos__scopeNote mesh__D005089
% 214.54/214.68       Cellular release of material within membrane-limited vesicles by fusion of the vesicles with the CELL MEMBRANE.%A%    
% 214.54/214.68  |- mesh__recordOriginator mesh__D005089 NLM
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D005089 2002
% 214.54/214.68  |- mesh__recordMaintainer mesh__D005089 nns
% 214.54/214.68  |- mesh__recordAuthorizer mesh__D005089 sjn
% 214.54/214.68  |- skos__broader mesh__D005089smesh__D002468
% 214.54/214.68  |- mesh__dateEstablished mesh__D005089 1976-01-01
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D005089 2003
% 214.54/214.68  |- mesh__dateCreated mesh__D005089 1999-01-01
% 214.54/214.68  |- skos__prefLabel mesh__D005089 Exocytosis
% 214.54/214.68  |- rdf__type mesh__D005089sskos__Concept
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D005089 2004
% 214.54/214.68  |- skos__altLabel mesh__D024243 Heparin-Binding Protein p30
% 214.54/214.68  |- mesh__dateEstablished mesh__D024243 2002-01-01
% 214.54/214.68  |- skos__hiddenLabel mesh__D024243 p30, Heparin-Binding Protein
% 214.54/214.68  |- skos__altLabel mesh__D024243 HMGB1
% 214.54/214.68  |- skos__altLabel mesh__D024243 HMG-1 Protein
% 214.54/214.68  |- skos__historyNote mesh__D024243
% 214.54/214.68       High Mobility Group Proteins %28%1984-2001%29%
% 214.54/214.68  |- skos__related mesh__D024243smesh__D024742
% 214.54/214.68  |- skos__altLabel mesh__D024243 HMG1
% 214.54/214.68  |- skos__historyNote mesh__D024243 Nucleoproteins %28%1966-1981%29%
% 214.54/214.68  |- mesh__recordOriginator mesh__D024243 jmp
% 214.54/214.68  |- mesh__recordAuthorizer mesh__D024243 sjn
% 214.54/214.68  |- skos__altLabel mesh__D024243 HMG 1 Protein
% 214.54/214.68  |- mesh__dateRevised mesh__D024243 2004-07-07
% 214.54/214.68  |- mesh__historyNote mesh__D024243
% 214.54/214.68       2002; for HMG 1 PROTEIN use HIGH MOBILITY GROUP PROTEINS 1985-2001; for HMG1 use HIGH MOBILITY GROUP PROTEINS 1992-2001; for AMPHOTERIN use HMGB1 PROTEIN %28%NM%29% 1991-2001%A%  
% 214.54/214.68  |- mesh__dateCreated mesh__D024243 2001-07-25
% 214.54/214.68  |- skos__scopeNote mesh__D024243
% 214.54/214.68       A 24-kDa HMGB protein that binds to and distorts the minor grove of DNA.%A%    
% 214.54/214.68  |- skos__historyNote mesh__D024243
% 214.54/214.68       Chromosomal Proteins, Non-Histone %28%1977-1984%29%
% 214.54/214.68  |- skos__hiddenLabel mesh__D024243 Heparin Binding Protein p30
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D024243 2005
% 214.54/214.68  |- skos__altLabel mesh__D024243 Amphoterin
% 214.54/214.68  |- mesh__publicMeSHNote mesh__D024243
% 214.54/214.68       2002; for HMG 1 PROTEIN see HIGH MOBILITY GROUP PROTEINS 1985-2001; for HMG1 use HIGH MOBILITY GROUP PROTEINS 1992-2001; AMPHOTERIN was indexed under HIGH MOBILITY GROUP PROTEINS 1991-2001 %26% CARRIER PROTEINS 1991-2001%A%  
% 214.54/214.68  |- mesh__recordMaintainer mesh__D024243 jmp
% 214.54/214.68  |- skos__prefLabel mesh__D024243 HMGB1 Protein
% 214.54/214.68  |- skos__altLabel mesh__D024243 FM1 Gene Product
% 214.54/214.68  |- skos__altLabel mesh__D024243 Box Protein 1, High Mobility Group
% 214.54/214.68  |- rdf__type mesh__D024243sskos__Concept
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D024243 2006
% 214.54/214.68  |- skos__broader mesh__D024243smesh__D024002
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D018206 2004
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D018206 2005
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D018206 1999
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D018206 2002
% 214.54/214.68  |- skos__broader mesh__D018206smesh__D018205
% 214.54/214.68  |- skos__historyNote mesh__D018206 Lipoma %28%1966-1993%29%
% 214.54/214.68  |- rdf__type mesh__D018206sskos__Concept
% 214.54/214.68  |- skos__hiddenLabel mesh__D018206 Angiolipomas
% 214.54/214.68  |- skos__prefLabel mesh__D018206 Angiolipoma
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D018206 2003
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D018206 1997
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D018206 1998
% 214.54/214.68  |- mesh__recordMaintainer mesh__D018206 KEV
% 214.54/214.68  |- skos__historyNote mesh__D018206 Hemangioma %28%1969-1993%29%
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D018206 1996
% 214.54/214.68  |- skos__scopeNote mesh__D018206
% 214.54/214.68       A benign neoplasm composed of a mixture of adipose tissue and blood vessels. %28%Dorland, 27th ed%29%%A%    
% 214.54/214.68  |- mesh__recordAuthorizer mesh__D018206 PLS
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D018206 2001
% 214.54/214.68  |- mesh__recordOriginator mesh__D018206 PLS
% 214.54/214.68  |- mesh__dateCreated mesh__D018206 1993-06-25
% 214.54/214.68  |- mesh__dateEstablished mesh__D018206 1994-01-01
% 214.54/214.68  |- mesh__dateRevised mesh__D018206 1995-06-08
% 214.54/214.68  |- mesh__historyNote mesh__D018206 94   
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D018206 2000
% 214.54/214.68  |- skos__annotation mesh__D018206
% 214.54/214.68       /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D018206 2006
% 214.54/214.68  |- mesh__publicMeSHNote mesh__D018206 94   
% 214.54/214.68  |- mesh__recordAuthorizer mesh__D010223 sjn
% 214.54/214.68  |- mesh__dateEstablished mesh__D010223 1991-01-01
% 214.54/214.68  |- skos__hiddenLabel mesh__D010223 Croup Associated Viruses
% 214.54/214.68  |- skos__altLabel mesh__D010223 Acute Laryngotracheobronchitis Virus
% 214.54/214.68  |- skos__altLabel mesh__D010223 Parainfluenza Virus Type 2
% 214.54/214.68  |- mesh__dateCreated mesh__D010223 1974-11-19
% 214.54/214.68  |- mesh__recordMaintainer mesh__D010223 sjn
% 214.54/214.68  |- skos__hiddenLabel mesh__D010223 Laryngotracheo-Bronchitis Viruses, Acute
% 214.54/214.68  |- mesh__recordOriginator mesh__D010223 NLM
% 214.54/214.68  |- skos__altLabel mesh__D010223 Virus, Croup-Associated
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D010223 2006
% 214.54/214.68  |- skos__altLabel mesh__D010223 Croup-Associated Virus
% 214.54/214.68  |- skos__hiddenLabel mesh__D010223 Laryngotracheobronchitis Virus, Acute
% 214.54/214.68  |- skos__altLabel mesh__D010223 Croup-Associated Viruses
% 214.54/214.68  |- skos__annotation mesh__D010223
% 214.54/214.68       do not confuse with PARAINFLUENZA VIRUS 1, HUMAN or PARAINFLUENZA VIRUS 3, HUMAN; infection: coord IM with CROUP %28%IM%29% if text confirms or RUBULAVIRUS INFECTIONS %28%IM%29% if not specified as CROUP or %22%acute laryngotracheobronchitis%22%%A%  
% 214.54/214.68  |- skos__altLabel mesh__D010223 Acute Laryngotracheo-Bronchitis Virus
% 214.54/214.68  |- skos__hiddenLabel mesh__D010223 Para Influenza Virus Type 2
% 214.54/214.68  |- mesh__activeMeSHYear mesh__D010223 2005
% 214.54/214.68  |- mesh__publicMeSHNote mesh__D010223
% 214.54/214.68       97; was PARAINFLUENZA VIRUS TYPE 2 1994-96, was PARA-INFLUENZA VIRUS TYPE 2 1977-93 %28%see under PARA-INFLUENZA VIRUSES 1977-90%29%; was ACUTE LARYNGOTRACHEO-BRONCHITIS VIRUS see under PARA-INFLUENZA VIRUSES 1975-76; ACUTE LARYNGOTRACHEOBRONCHITIS VIRUS was ACUTE LARYNGOTRACHEO-BRONCHITIS VIRUS see PARAINFLUENZA VIRUS TYPE 2 1977-93%A%  
% 214.54/214.68  |- skos__hiddenLabel mesh__D010223 Croup Associated Virus
% 214.54/214.68  |- skos__hiddenLabel mesh__D010223 Acute Laryngotracheobronchitis Viruses
% 214.54/214.68  |- skos__hiddenLabel mesh__D010223 Acute Laryngotracheo-Bronchitis Viruses
% 214.54/214.68  |- skos__altLabel mesh__D010223 Viruses, Croup-Associated
% 214.54/214.68  |- mesh__onlineNote mesh__D010223
% 214.54/214.68       use PARAINFLUENZA VIRUS 2, HUMAN to search PARAINFLUENZA VIRUS TYPE 2 1994-96, PARA-INFLUENZA VIRUS TYPE 2 1977-93, %26% ACUTE LARYNGOTRACHEO-BRONCHITIS VIRUS 1975-93%A%  
% 214.54/214.68  |- rdf__type mesh__D010223sskos__Concept
% 214.54/214.68  |- skos__prefLabel mesh__D010223 Parainfluenza Virus 2, Human
% 214.54/214.68  |- skos__hiddenLabel mesh__D010223 Laryngotracheobronchitis Viruses, Acute
% 214.54/214.68  |- skos__broader mesh__D010223smesh__D019213
% 214.54/214.68  |- mesh__historyNote mesh__D010223
% 214.54/214.68       97; was PARAINFLUENZA VIRUS TYPE 2 1994-96, was PARA-INFLUENZA VIRUS TYPE 2 1977-93 %28%see under PARA-INFLUENZA VIRUSES 1977-90%29%; was ACUTE LARYNGOTRACHEO-BRONCHITIS VIRUS see under PARA-INFLUENZA VIRUSES 1975-76; ACUTE LARYNGOTRACHEOBRONCHITIS VIRUS was ACUTE LARYNGOTRACHEO-BRONCHITIS VIRUS see PARAINFLUENZA VIRUS TYPE 2 1977-93%A%  
% 214.54/214.68  |- skos__hiddenLabel mesh__D010223 Laryngotracheo-Bronchitis Virus, Acute
% 214.55/214.68  |- mesh__dateRevised mesh__D010223 2004-07-13
% 214.55/214.68  |- skos__altLabel mesh__D010223 Human parainfluenza virus 2
% 214.55/214.68  |- skos__altLabel mesh__D010223 Para-Influenza Virus Type 2
% 214.55/214.68  |- skos__scopeNote mesh__D010223
% 214.55/214.68       A species of RUBULAVIRUS associated particularly with acute laryngotracheitis %28%CROUP%29% in children aged 6 months to 3 years.%A%    
% 214.55/214.68  |- mesh__recordMaintainer mesh__D048691 SYSTEM
% 214.55/214.68  |- mesh__recordAuthorizer mesh__D048691 sjn
% 214.55/214.68  |- mesh__publicMeSHNote mesh__D048691 2005   
% 214.55/214.68  |- mesh__dateCreated mesh__D048691 2004-07-07
% 214.55/214.69  |- mesh__dateRevised mesh__D048691 2005-06-30
% 214.55/214.69  |- skos__scopeNote mesh__D048691
% 214.55/214.69       A member of the AGARICALES known for edible MUSHROOMS.     
% 214.55/214.69  |- mesh__recordOriginator mesh__D048691 ssb
% 214.55/214.69  |- skos__broader mesh__D048691smesh__D000363
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D048691 2006
% 214.55/214.69  |- rdf__type mesh__D048691sskos__Concept
% 214.55/214.69  |- mesh__dateEstablished mesh__D048691 2005-01-01
% 214.55/214.69  |- skos__altLabel mesh__D048691 Maitake
% 214.55/214.69  |- mesh__historyNote mesh__D048691 2005   
% 214.55/214.69  |- skos__prefLabel mesh__D048691 Grifola
% 214.55/214.69  |- rdf__type mesh__D001497sskos__Concept
% 214.55/214.69  |- mesh__onlineNote mesh__D001497 search CHILD ABUSE 1966-74   
% 214.55/214.69  |- mesh__publicMeSHNote mesh__D001497
% 214.55/214.69       91; was see under CHILD ABUSE 1975-90   
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D001497 2002
% 214.55/214.69  |- skos__hiddenLabel mesh__D001497 Syndromes, Battered Child
% 214.55/214.69  |- skos__scopeNote mesh__D001497
% 214.55/214.69       Repeated physical injuries inflicted on the child by the parent, parents, or surrogate parent; often triggered by the child%27%s minor and normal irritating behavior.%A%    
% 214.55/214.69  |- mesh__dateCreated mesh__D001497 1999-01-01
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D001497 2003
% 214.55/214.69  |- mesh__dateRevised mesh__D001497 1990-04-13
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D001497 2005
% 214.55/214.69  |- skos__hiddenLabel mesh__D001497 Battered Child Syndromes
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D001497 2004
% 214.55/214.69  |- skos__hiddenLabel mesh__D001497 Child Syndromes, Battered
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D001497 2006
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D001497 1991
% 214.55/214.69  |- skos__annotation mesh__D001497 use Cat C qualif   
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D001497 2000
% 214.55/214.69  |- skos__hiddenLabel mesh__D001497 Syndrome, Battered Child
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D001497 1996
% 214.55/214.69  |- skos__broader mesh__D001497smesh__D002649
% 214.55/214.69  |- mesh__historyNote mesh__D001497
% 214.55/214.69       91%28%75%29%; was see under CHILD ABUSE 1975-90   
% 214.55/214.69  |- skos__hiddenLabel mesh__D001497 Child Syndrome, Battered
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D001497 1998
% 214.55/214.69  |- mesh__dateEstablished mesh__D001497 1991-01-01
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D001497 2001
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D001497 1992
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D001497 1997
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D001497 1994
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D001497 1999
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D001497 1993
% 214.55/214.69  |- mesh__recordAuthorizer mesh__D001497 PLS
% 214.55/214.69  |- mesh__recordOriginator mesh__D001497 NLM
% 214.55/214.69  |- skos__prefLabel mesh__D001497 Battered Child Syndrome
% 214.55/214.69  |- mesh__recordMaintainer mesh__D001497 NLM
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D001497 1995
% 214.55/214.69  |- mesh__recordMaintainer mesh__D006980 lkt
% 214.55/214.69  |- mesh__dateRevised mesh__D006980 2005-06-30
% 214.55/214.69  |- mesh__dateCreated mesh__D006980 1999-01-01
% 214.55/214.69  |- skos__annotation mesh__D006980
% 214.55/214.69       THYROTOXICOSIS %26% THYROID CRISIS are available: do not make a diagnosis: use term of author%A%  
% 214.55/214.69  |- rdf__type mesh__D006980sskos__Concept
% 214.55/214.69  |- skos__related mesh__D006980smesh__D008135
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D006980 2006
% 214.55/214.69  |- skos__broader mesh__D006980smesh__D013959
% 214.55/214.69  |- mesh__recordAuthorizer mesh__D006980 sjn
% 214.55/214.69  |- skos__scopeNote mesh__D006980
% 214.55/214.69       Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE.%A%    
% 214.55/214.69  |- mesh__recordOriginator mesh__D006980 NLM
% 214.55/214.69  |- skos__prefLabel mesh__D006980 Hyperthyroidism
% 214.55/214.69  |- skos__related mesh__D006980smesh__D013956
% 214.55/214.69  |- mesh__dateCreated mesh__D020651 1999-11-03
% 214.55/214.69  |- skos__hiddenLabel mesh__D020651 Ventral Nuclear Groups
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D020651 2001
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D020651 2005
% 214.55/214.69  |- skos__hiddenLabel mesh__D020651 Nucleus, Ventral Posteroinferior
% 214.55/214.69  |- skos__scopeNote mesh__D020651
% 214.55/214.69       A large group of nuclei lying between the internal medullary lamina and the internal capsule. It includes the ventral anterior, ventral lateral, and ventral posterior nuclei.%A%    
% 214.55/214.69  |- skos__altLabel mesh__D020651 Ventral Nuclear Group
% 214.55/214.69  |- skos__altLabel mesh__D020651 Ventrolateral Thalamic Nucleus
% 214.55/214.69  |- skos__hiddenLabel mesh__D020651 Group, Ventral Nuclear
% 214.55/214.69  |- skos__prefLabel mesh__D020651 Ventral Thalamic Nuclei
% 214.55/214.69  |- skos__hiddenLabel mesh__D020651 Nucleus, Ventrolateral Thalamic
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D020651 2000
% 214.55/214.69  |- skos__hiddenLabel mesh__D020651 Posteroinferior Nucleus, Ventral
% 214.55/214.69  |- rdf__type mesh__D020651sskos__Concept
% 214.55/214.69  |- skos__hiddenLabel mesh__D020651 Thalamic Nucleus, Ventral
% 214.55/214.69  |- mesh__publicMeSHNote mesh__D020651 2000   
% 214.55/214.69  |- skos__hiddenLabel mesh__D020651 Nucleus, Ventral Lateral
% 214.55/214.69  |- skos__hiddenLabel mesh__D020651 Ventral Thalamic Nucleus
% 214.55/214.69  |- skos__hiddenLabel mesh__D020651 Nucleus, Ventral Posterior
% 214.55/214.69  |- mesh__dateEstablished mesh__D020651 2000-01-01
% 214.55/214.69  |- skos__historyNote mesh__D020651 Thalamic Nuclei %28%1971-1999%29%
% 214.55/214.69  |- skos__hiddenLabel mesh__D020651 Posterior Nucleus, Ventral
% 214.55/214.69  |- skos__hiddenLabel mesh__D020651 Nuclear Group, Ventral
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D020651 2004
% 214.55/214.69  |- skos__hiddenLabel mesh__D020651 Nucleus, Ventral Thalamic
% 214.55/214.69  |- skos__altLabel mesh__D020651 Ventral Posterior Nucleus
% 214.55/214.69  |- skos__altLabel mesh__D020651 Ventral Nuclei of Thalamus
% 214.55/214.69  |- skos__historyNote mesh__D020651 Thalamus %28%1965-1970%29%
% 214.55/214.69  |- skos__hiddenLabel mesh__D020651 Thalamic Nucleus, Ventrolateral
% 214.55/214.69  |- skos__broader mesh__D020651smesh__D013787
% 214.55/214.69  |- skos__altLabel mesh__D020651 Ventral Posterolateral Nucleus
% 214.55/214.69  |- skos__hiddenLabel mesh__D020651 Nucleus, Ventral Posterolateral
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D020651 2003
% 214.55/214.69  |- skos__altLabel mesh__D020651 Ventral Posteroinferior Nucleus
% 214.55/214.69  |- skos__altLabel mesh__D020651 Ventral Lateral Nucleus
% 214.55/214.69  |- skos__hiddenLabel mesh__D020651 Thalamic Nuclei, Ventral
% 214.55/214.69  |- skos__hiddenLabel mesh__D020651 Posterolateral Nucleus, Ventral
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D020651 2002
% 214.55/214.69  |- skos__hiddenLabel mesh__D020651 Nucleus, Ventral Posteromedial
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D020651 2006
% 214.55/214.69  |- mesh__historyNote mesh__D020651 2000   
% 214.55/214.69  |- skos__hiddenLabel mesh__D020651 Nucleus, Ventral Anterior
% 214.55/214.69  |- skos__hiddenLabel mesh__D020651 Posteromedial Nucleus, Ventral
% 214.55/214.69  |- skos__hiddenLabel mesh__D020651 Nuclei, Ventral Thalamic
% 214.55/214.69  |- skos__altLabel mesh__D020651 Ventral Posteromedial Nucleus
% 214.55/214.69  |- skos__altLabel mesh__D020651 Ventral Anterior Nucleus
% 214.55/214.69  |- rdf__type mesh__D006182sskos__Concept
% 214.55/214.69  |- mesh__dateRevised mesh__D006182 2005-06-30
% 214.55/214.69  |- skos__altLabel mesh__D006182 HY Antigen
% 214.55/214.69  |- mesh__dateEstablished mesh__D006182 1979-01-01
% 214.55/214.69  |- skos__prefLabel mesh__D006182 H-Y Antigen
% 214.55/214.69  |- skos__hiddenLabel mesh__D006182 Antigen, HY
% 214.55/214.69  |- skos__historyNote mesh__D006182 Histocompatibility %28%1968-1972%29%
% 214.55/214.69  |- mesh__recordMaintainer mesh__D006182 ssb
% 214.55/214.69  |- mesh__recordAuthorizer mesh__D006182 sjn
% 214.55/214.69  |- mesh__recordOriginator mesh__D006182 SH
% 214.55/214.69  |- skos__annotation mesh__D006182 mammals only   
% 214.55/214.69  |- skos__scopeNote mesh__D006182
% 214.55/214.69       A sex-specific cell surface antigen produced by the sex-determining gene of the Y chromosome in mammals. It causes syngeneic grafts from males to females to be rejected and interacts with somatic elements of the embryologic undifferentiated gonad to produce testicular organogenesis.%A%    
% 214.55/214.69  |- mesh__dateCreated mesh__D006182 1978-03-17
% 214.55/214.69  |- skos__hiddenLabel mesh__D006182 H Y Antigen
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D006182 2006
% 214.55/214.69  |- mesh__publicMeSHNote mesh__D006182 79   
% 214.55/214.69  |- skos__broader mesh__D006182smesh__D015778
% 214.55/214.69  |- skos__historyNote mesh__D006182
% 214.55/214.69       Histocompatibility Antigens %28%1973-1978%29%
% 214.55/214.69  |- skos__hiddenLabel mesh__D006182 Antigen, H-Y
% 214.55/214.69  |- skos__altLabel mesh__D006182 GA-1 Germ Cell Antigen
% 214.55/214.69  |- skos__hiddenLabel mesh__D006182 GA 1 Germ Cell Antigen
% 214.55/214.69  |- mesh__historyNote mesh__D006182 79   
% 214.55/214.69  |- skos__prefLabel mesh__D014614 Vaccines, Synthetic
% 214.55/214.69  |- skos__hiddenLabel mesh__D014614 Recombinant Vaccines
% 214.55/214.69  |- skos__altLabel mesh__D014614 Synthetic Immunogens
% 214.55/214.69  |- mesh__historyNote mesh__D014614
% 214.55/214.69       91%28%87%29%; was see under VACCINES 1989-90; was see under ANTIGENS 1987-88%A%  
% 214.55/214.69  |- skos__altLabel mesh__D014614 Synthetic Antigens
% 214.55/214.69  |- skos__altLabel mesh__D014614 Synthetic Vaccines
% 214.55/214.69  |- skos__altLabel mesh__D014614 Immunogens, Synthetic
% 214.55/214.69  |- mesh__dateEstablished mesh__D014614 1991-01-01
% 214.55/214.69  |- skos__annotation mesh__D014614
% 214.55/214.69       IM general only; coord NIM with specific vaccine %28%IM%29%   
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D014614 2006
% 214.55/214.69  |- mesh__dateRevised mesh__D014614 2005-06-30
% 214.55/214.69  |- mesh__recordAuthorizer mesh__D014614 sjn
% 214.55/214.69  |- mesh__dateCreated mesh__D014614 1986-03-25
% 214.55/214.69  |- skos__broader mesh__D014614smesh__D011994
% 214.55/214.69  |- skos__broader mesh__D014614smesh__D014612
% 214.55/214.69  |- mesh__recordMaintainer mesh__D014614 ssb
% 214.55/214.69  |- skos__altLabel mesh__D014614 Chemical Vaccines
% 214.55/214.69  |- mesh__publicMeSHNote mesh__D014614
% 214.55/214.69       91; was see under VACCINES 1989-90; was see under ANTIGENS 1987-88%A%  
% 214.55/214.69  |- skos__altLabel mesh__D014614 Vaccines, Molecular
% 214.55/214.69  |- skos__historyNote mesh__D014614 Antigens %28%1966-1986%29%
% 214.55/214.69  |- rdf__type mesh__D014614sskos__Concept
% 214.55/214.69  |- skos__broader mesh__D014614smesh__D000941
% 214.55/214.69  |- skos__scopeNote mesh__D014614
% 214.55/214.69       Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified.%A%    
% 214.55/214.69  |- skos__altLabel mesh__D014614 Vaccines, Semisynthetic
% 214.55/214.69  |- skos__altLabel mesh__D014614 Vaccines, Chemical
% 214.55/214.69  |- mesh__recordOriginator mesh__D014614 SH
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D005888 1999
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D005888 1993
% 214.55/214.69  |- skos__broader mesh__D005888smesh__D005891
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D005888 1995
% 214.55/214.69  |- mesh__recordOriginator mesh__D005888 NLM
% 214.55/214.69  |- skos__hiddenLabel mesh__D005888 Pockets, Gingival
% 214.55/214.69  |- skos__altLabel mesh__D005888 Pocket, Gingival
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D005888 2000
% 214.55/214.69  |- mesh__dateCreated mesh__D005888 1999-01-01
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D005888 2003
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D005888 2001
% 214.55/214.69  |- skos__prefLabel mesh__D005888 Gingival Pocket
% 214.55/214.69  |- skos__scopeNote mesh__D005888
% 214.55/214.69       An abnormal extension of a gingival sulcus not accompanied by the apical migration of the epithelial attachment.%A%    
% 214.55/214.69  |- skos__related mesh__D005888smesh__D010514
% 214.55/214.69  |- mesh__historyNote mesh__D005888
% 214.55/214.69       91%28%75%29%; was see under GINGIVITIS 1979-90; was see under PERIODONTITIS 1968-78%A%  
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D005888 2005
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D005888 2004
% 214.55/214.69  |- skos__historyNote mesh__D005888 Periodontitis %28%1968-1974%29%
% 214.55/214.69  |- mesh__recordMaintainer mesh__D005888 TGC
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D005888 2006
% 214.55/214.69  |- skos__hiddenLabel mesh__D005888 Gingival Pockets
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D005888 1996
% 214.55/214.69  |- mesh__onlineNote mesh__D005888 search PERIODONTITIS 1968-74   
% 214.55/214.69  |- mesh__dateRevised mesh__D005888 1991-06-18
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D005888 2002
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D005888 1998
% 214.55/214.69  |- skos__annotation mesh__D005888
% 214.55/214.69       do not confuse with PERIODONTAL POCKET: read MeSH definition%A%  
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D005888 1997
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D005888 1992
% 214.55/214.69  |- mesh__dateEstablished mesh__D005888 1991-01-01
% 214.55/214.69  |- rdf__type mesh__D005888sskos__Concept
% 214.55/214.69  |- mesh__recordAuthorizer mesh__D005888 PLS
% 214.55/214.69  |- mesh__publicMeSHNote mesh__D005888
% 214.55/214.69       91; was see under GINGIVITIS 1979-90; was see under PERIODONTITIS 1968-78%A%  
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D005888 1994
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D030281 2005
% 214.55/214.69  |- skos__broader mesh__D030281smesh__D015301
% 214.55/214.69  |- mesh__publicMeSHNote mesh__D030281 2002   
% 214.55/214.69  |- skos__scopeNote mesh__D030281
% 214.55/214.69       A strain of PRIMATE T-LYMPHOTROPIC VIRUS 2 isolated from Congolese bonobos %28%PAN PANISCUS%29%.%A%    
% 214.55/214.69  |- skos__hiddenLabel mesh__D030281 Simian T lymphotropic virus 2
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D030281 2004
% 214.55/214.69  |- skos__broader mesh__D030281smesh__D030263
% 214.55/214.69  |- skos__historyNote mesh__D030281
% 214.55/214.69       Simian T-lymphotropic virus 1 %28%1998-2001%29%
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D030281 2003
% 214.55/214.69  |- mesh__dateCreated mesh__D030281 2001-07-25
% 214.55/214.69  |- skos__annotation mesh__D030281
% 214.55/214.69       infection: coord IM with DELTARETROVIRUS INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% if pertinent%A%  
% 214.55/214.69  |- rdf__type mesh__D030281sskos__Concept
% 214.55/214.69  |- mesh__historyNote mesh__D030281 2002   
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D030281 2002
% 214.55/214.69  |- skos__altLabel mesh__D030281 STLV-2
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D030281 2006
% 214.55/214.69  |- skos__prefLabel mesh__D030281 Simian T-lymphotropic virus 2
% 214.55/214.69  |- mesh__dateEstablished mesh__D030281 2002-01-01
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D002590 2001
% 214.55/214.69  |- skos__hiddenLabel mesh__D002590 Infection, Cestode
% 214.55/214.69  |- skos__scopeNote mesh__D002590
% 214.55/214.69       Infections with true tapeworms of the helminth subclass CESTODA.%A%    
% 214.55/214.69  |- skos__hiddenLabel mesh__D002590 Infection, Tapeworm
% 214.55/214.69  |- mesh__publicMeSHNote mesh__D002590
% 214.55/214.69       65; was TAPEWORM INFECTION 1963-64; CENURIASIS was heading 1968-81; DIPYLIDIASIS %26% RAILLIETINIASIS were headings 1968-85%A%  
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D002590 2005
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D002590 2002
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D002590 1994
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D002590 2003
% 214.55/214.69  |- mesh__historyNote mesh__D002590
% 214.55/214.69       65; was TAPEWORM INFECTION 1963-64; CENURIASIS was heading 1968-81; DIPYLIDIASIS %26% RAILLIETINIASIS were headings 1968-85%A%  
% 214.55/214.69  |- mesh__recordOriginator mesh__D002590 NLM
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D002590 2006
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D002590 1995
% 214.55/214.69  |- skos__annotation mesh__D002590
% 214.55/214.69       helminth infect; GEN only; prefer specifics; /drug ther: consider also ANTICESTODAL AGENTS%A%  
% 214.55/214.69  |- mesh__recordMaintainer mesh__D002590 JLS
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D002590 2004
% 214.55/214.69  |- skos__hiddenLabel mesh__D002590 Tapeworm Infections
% 214.55/214.69  |- skos__altLabel mesh__D002590 Tapeworm Infection
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D002590 1998
% 214.55/214.69  |- skos__hiddenLabel mesh__D002590 Infections, Tapeworm
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D002590 1996
% 214.55/214.69  |- skos__hiddenLabel mesh__D002590 Dipylidiases
% 214.55/214.69  |- mesh__dateRevised mesh__D002590 1993-06-04
% 214.55/214.69  |- skos__hiddenLabel mesh__D002590 Infections, Cestode
% 214.55/214.69  |- skos__hiddenLabel mesh__D002590 Cenuriases
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D002590 1999
% 214.55/214.69  |- rdf__type mesh__D002590sskos__Concept
% 214.55/214.69  |- mesh__onlineNote mesh__D002590
% 214.55/214.69       use CESTODE INFECTIONS to search DIPYLIDIASIS %26% RAILLIETINIASIS 1968-85 %26% CENURIASIS 1968-81%A%  
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D002590 2000
% 214.55/214.69  |- skos__hiddenLabel mesh__D002590 Coenuriases
% 214.55/214.69  |- mesh__recordAuthorizer mesh__D002590 PLS
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D002590 1997
% 214.55/214.69  |- skos__hiddenLabel mesh__D002590 Raillietiniases
% 214.55/214.69  |- skos__hiddenLabel mesh__D002590 Bertielliases
% 214.55/214.69  |- mesh__dateCreated mesh__D002590 1999-01-01
% 214.55/214.69  |- skos__broader mesh__D002590smesh__D006373
% 214.55/214.69  |- skos__related mesh__D002590smesh__D000923
% 214.55/214.69  |- skos__prefLabel mesh__D002590 Cestode Infections
% 214.55/214.69  |- skos__hiddenLabel mesh__D002590 Cestode Infection
% 214.55/214.69  |- mesh__dateEstablished mesh__D018207 1994-01-01
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D018207 1998
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D018207 2001
% 214.55/214.69  |- mesh__dateCreated mesh__D018207 1993-06-25
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D018207 2004
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D018207 1999
% 214.55/214.69  |- skos__broader mesh__D018207smesh__D018205
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D018207 1996
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D018207 2002
% 214.55/214.69  |- rdf__type mesh__D018207sskos__Concept
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D018207 1997
% 214.55/214.69  |- mesh__publicMeSHNote mesh__D018207 94   
% 214.55/214.69  |- mesh__recordMaintainer mesh__D018207 KEV
% 214.55/214.69  |- skos__prefLabel mesh__D018207 Angiomyolipoma
% 214.55/214.69  |- skos__scopeNote mesh__D018207
% 214.55/214.69       A benign tumor containing vascular, adipose, and muscle elements. It occurs most often in the kidney with smooth muscle elements %28%angiolipoleiomyoma%29% in association with tuberous sclerosis. %28%Dorland, 27th ed%29%%A%    
% 214.55/214.69  |- skos__historyNote mesh__D018207 Hemangioma %28%1967-1993%29%
% 214.55/214.69  |- skos__annotation mesh__D018207
% 214.55/214.69       /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 214.55/214.69  |- skos__historyNote mesh__D018207 Lipoma %28%1966-1993%29%
% 214.55/214.69  |- mesh__recordAuthorizer mesh__D018207 PLS
% 214.55/214.69  |- skos__hiddenLabel mesh__D018207 Angiomyolipomas
% 214.55/214.69  |- mesh__recordOriginator mesh__D018207 PLS
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D018207 2005
% 214.55/214.69  |- mesh__historyNote mesh__D018207 94   
% 214.55/214.69  |- mesh__dateRevised mesh__D018207 1995-06-08
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D018207 2000
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D018207 2006
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D018207 2003
% 214.55/214.69  |- skos__altLabel mesh__D010224 Para-Influenza Virus Type 3
% 214.55/214.69  |- skos__hiddenLabel mesh__D010224 Para Influenza Virus Type 3
% 214.55/214.69  |- mesh__onlineNote mesh__D010224
% 214.55/214.69       use PARAINFLUENZA VIRUS 3, HUMAN to search PARAINFLUENZA VIRUS TYPE 3 1994-96 %26% PARA-INFLUENZA VIRUS TYPE 3 1975-93%A%  
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D010224 2005
% 214.55/214.69  |- skos__altLabel mesh__D010224 Hemadsorption Virus 1
% 214.55/214.69  |- skos__altLabel mesh__D010224 Human parainfluenza virus 3
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D010224 2006
% 214.55/214.69  |- mesh__dateRevised mesh__D010224 2001-07-25
% 214.55/214.69  |- mesh__recordAuthorizer mesh__D010224 sjn
% 214.55/214.69  |- mesh__recordMaintainer mesh__D010224 ags
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D010224 2003
% 214.55/214.69  |- mesh__dateEstablished mesh__D010224 1991-01-01
% 214.55/214.69  |- skos__prefLabel mesh__D010224 Parainfluenza Virus 3, Human
% 214.55/214.69  |- mesh__dateCreated mesh__D010224 1974-12-12
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D010224 2002
% 214.55/214.69  |- rdf__type mesh__D010224sskos__Concept
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D010224 2004
% 214.55/214.69  |- mesh__recordOriginator mesh__D010224 NLM
% 214.55/214.69  |- mesh__historyNote mesh__D010224
% 214.55/214.69       97; was PARAINFLUENZA VIRUS TYPE 3 1994-96, was PARA-INFLUENZA VIRUS TYPE 3 1975-93 %28%see under PARA-INFLUENZA VIRUSES 1975-90%29%%A%  
% 214.55/214.69  |- skos__annotation mesh__D010224
% 214.55/214.69       infection: coord IM with RESPIROVIRUS INFECTIONS %28%IM%29%   
% 214.55/214.69  |- mesh__publicMeSHNote mesh__D010224
% 214.55/214.69       97; was PARAINFLUENZA VIRUS TYPE 3 1994-96, was PARA-INFLUENZA VIRUS TYPE 3 1975-93 %28%see under PARA-INFLUENZA VIRUSES 1975-90%29%%A%  
% 214.55/214.69  |- skos__broader mesh__D010224smesh__D018108
% 214.55/214.69  |- skos__scopeNote mesh__D010224
% 214.55/214.69       A species of RESPIROVIRUS frequently isolated from small children with pharyngitis, bronchitis, and pneumonia.%A%    
% 214.55/214.69  |- skos__hiddenLabel mesh__D001498 BayK8644
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D001498 2005
% 214.55/214.69  |- skos__annotation mesh__D001498 a calcium channel agonist   
% 214.55/214.69  |- mesh__recordAuthorizer mesh__D001498 sjn
% 214.55/214.69  |- skos__broader mesh__D001498smesh__D004095
% 214.55/214.69  |- skos__hiddenLabel mesh__D001498 BK 8644
% 214.55/214.69  |- skos__scopeNote mesh__D001498
% 214.55/214.69       A dihydropyridine derivative, which, in contrast to NIFEDIPINE, functions as a calcium channel agonist. The compound facilitates Ca2+ influx through partially activated voltage-dependent Ca2+ channels, thereby causing vasoconstrictor and positive inotropic effects. It is used primarily as a research tool.%A%    
% 214.55/214.69  |- mesh__publicMeSHNote mesh__D001498 87   
% 214.55/214.69  |- mesh__historyNote mesh__D001498 87   
% 214.55/214.69  |- skos__altLabel mesh__D001498 BK-8644
% 214.55/214.69  |- rdf__type mesh__D001498sskos__Concept
% 214.55/214.69  |- skos__altLabel mesh__D001498 Bay R5417
% 214.55/214.69  |- skos__hiddenLabel mesh__D001498 R5417, Bay
% 214.55/214.69  |- skos__altLabel mesh__D001498 Bay-K8644
% 214.55/214.69  |- mesh__dateRevised mesh__D001498 2004-07-07
% 214.55/214.69  |- skos__historyNote mesh__D001498
% 214.55/214.69       Nifedipine/analogs %26% derivatives %28%1975-1986%29%
% 214.55/214.69  |- mesh__recordOriginator mesh__D001498 RLS
% 214.55/214.69  |- skos__hiddenLabel mesh__D001498 Bay K 8644
% 214.55/214.69  |- mesh__recordMaintainer mesh__D001498 jmp
% 214.55/214.69  |- skos__prefLabel mesh__D001498
% 214.55/214.69       3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-%28%2-%28%trifluoromethyl%29%phenyl%29%-, Methyl ester
% 214.55/214.69  |- skos__hiddenLabel mesh__D001498 BK8644
% 214.55/214.69  |- mesh__dateEstablished mesh__D001498 1987-01-01
% 214.55/214.69  |- mesh__dateCreated mesh__D001498 1986-06-02
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D001498 2006
% 214.55/214.69  |- skos__hiddenLabel mesh__D001498 Bay R 5417
% 214.55/214.69  |- skos__broader mesh__D001498smesh__D009539
% 214.55/214.69  |- skos__hiddenLabel mesh__D001498 Bay K8644
% 214.55/214.69  |- skos__historyNote mesh__D001498 Pyridines %28%1966-1974%29%
% 214.55/214.69  |- skos__hiddenLabel mesh__D001498 BayR5417
% 214.55/214.69  |- rdf__type mesh__D006981sskos__Concept
% 214.55/214.69  |- skos__historyNote mesh__D006981 Thyroxine/blood %28%1966-1986%29%
% 214.55/214.69  |- skos__broader mesh__D006981smesh__D013959
% 214.55/214.69  |- skos__hiddenLabel mesh__D006981 Hyperthyroxinemias
% 214.55/214.69  |- skos__prefLabel mesh__D006981 Hyperthyroxinemia
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D006981 2006
% 214.55/214.69  |- mesh__recordAuthorizer mesh__D006981 sjn
% 214.55/214.69  |- mesh__recordMaintainer mesh__D006981 lkt
% 214.55/214.69  |- mesh__recordOriginator mesh__D006981 VDK
% 214.55/214.69  |- mesh__publicMeSHNote mesh__D006981 87   
% 214.55/214.69  |- mesh__dateRevised mesh__D006981 2005-06-30
% 214.55/214.69  |- mesh__dateEstablished mesh__D006981 1987-01-01
% 214.55/214.69  |- mesh__dateCreated mesh__D006981 1986-03-26
% 214.55/214.69  |- skos__scopeNote mesh__D006981
% 214.55/214.69       Abnormally elevated THYROXINE level in the BLOOD.     
% 214.55/214.69  |- mesh__historyNote mesh__D006981 87   
% 214.55/214.69  |- skos__altLabel mesh__D020652 EF-2
% 214.55/214.69  |- skos__hiddenLabel mesh__D020652 EF 2
% 214.55/214.69  |- mesh__dateCreated mesh__D020652 1999-11-03
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D020652 2005
% 214.55/214.69  |- rdf__type mesh__D020652sskos__Concept
% 214.55/214.69  |- skos__altLabel mesh__D020652 Elongation Factor 2
% 214.55/214.69  |- skos__altLabel mesh__D020652 NSP100
% 214.55/214.69  |- mesh__publicMeSHNote mesh__D020652
% 214.55/214.69       2000; ELONGATION FACTOR 2 was indexed under PEPTIDE ELONGATION FACTORS 1980-1999%A%  
% 214.55/214.69  |- skos__altLabel mesh__D020652 NSP 100
% 214.55/214.69  |- skos__scopeNote mesh__D020652
% 214.55/214.69       Peptide Elongation Factor 2 catalyzes the translocation of peptidyl-tRNA from the A site to the P site of eukaryotic ribosomes by a process linked to the hydrolysis of GTP to GDP.%A%    
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D020652 2006
% 214.55/214.69  |- skos__historyNote mesh__D020652
% 214.55/214.69       Peptide Elongation Factors %28%1980-1999%29%
% 214.55/214.69  |- skos__altLabel mesh__D020652 Cytoplasmic Elongation Factor 2
% 214.55/214.69  |- mesh__dateRevised mesh__D020652 2003-07-09
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D020652 2004
% 214.55/214.69  |- skos__prefLabel mesh__D020652 Peptide Elongation Factor 2
% 214.55/214.69  |- skos__broader mesh__D020652smesh__D020963
% 214.55/214.69  |- skos__hiddenLabel mesh__D020652 100, NSP
% 214.55/214.69  |- mesh__dateEstablished mesh__D020652 2000-01-01
% 214.55/214.69  |- mesh__historyNote mesh__D020652
% 214.55/214.69       2000; for ELONGATION FACTOR 2 use PEPTIDE ELONGATION FACTOR 2 %28%NM%29% 1980-1999%A%  
% 214.55/214.69  |- skos__historyNote mesh__D006183 Histocompatibility %28%1970-1972%29%
% 214.55/214.69  |- skos__historyNote mesh__D006183
% 214.55/214.69       Histocompatibility Antigens %28%1973-1977%29%
% 214.55/214.69  |- skos__annotation mesh__D006183 mouse only   
% 214.55/214.69  |- skos__historyNote mesh__D006183
% 214.55/214.69       Transplantation Immunology %28%1966-1969%29%
% 214.55/214.69  |- skos__prefLabel mesh__D006183 H-2 Antigens
% 214.55/214.69  |- rdf__type mesh__D006183sskos__Concept
% 214.55/214.69  |- mesh__recordMaintainer mesh__D006183 ssb
% 214.55/214.69  |- mesh__recordOriginator mesh__D006183 AEP
% 214.55/214.69  |- skos__scopeNote mesh__D006183
% 214.55/214.69       The major group of transplantation antigens in the mouse.%A%    
% 214.55/214.69  |- mesh__dateRevised mesh__D006183 2005-06-30
% 214.55/214.69  |- mesh__historyNote mesh__D006183 78   
% 214.55/214.69  |- skos__broader mesh__D006183smesh__D015395
% 214.55/214.69  |- skos__hiddenLabel mesh__D006183 H 2 Antigens
% 214.55/214.69  |- skos__altLabel mesh__D006183 H2 Antigens
% 214.55/214.69  |- mesh__recordAuthorizer mesh__D006183 sjn
% 214.55/214.69  |- skos__hiddenLabel mesh__D006183 Antigens, H2
% 214.55/214.69  |- mesh__activeMeSHYear mesh__D006183 2006
% 214.55/214.69  |- mesh__dateEstablished mesh__D006183 1978-01-01
% 214.55/214.69  |- skos__hiddenLabel mesh__D006183 Antigens, H-2
% 214.55/214.69  |- mesh__publicMeSHNote mesh__D006183 78   
% 214.55/214.69  |- mesh__dateCreated mesh__D006183 1977-03-29
% 214.55/214.70  |- mesh__dateCreated mesh__D014615 1999-01-01
% 214.55/214.70  |- mesh__recordAuthorizer mesh__D014615 PLS
% 214.55/214.70  |- skos__prefLabel mesh__D014615 Vaccinia
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D014615 2006
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D014615 1995
% 214.55/214.70  |- skos__scopeNote mesh__D014615
% 214.55/214.70       The cutaneous and occasional systemic reactions associated with vaccination using smallpox %28%variola%29% vaccine.%A%    
% 214.55/214.70  |- mesh__recordOriginator mesh__D014615 NLM
% 214.55/214.70  |- skos__broader mesh__D014615smesh__D011213
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D014615 1999
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D014615 2005
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D014615 1994
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D014615 2002
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D014615 1998
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D014615 2004
% 214.55/214.70  |- rdf__type mesh__D014615sskos__Concept
% 214.55/214.70  |- mesh__dateRevised mesh__D014615 1993-06-03
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D014615 2001
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D014615 1997
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D014615 2003
% 214.55/214.70  |- skos__annotation mesh__D014615
% 214.55/214.70       caused by a poxvirus after smallpox vaccination   
% 214.55/214.70  |- skos__hiddenLabel mesh__D014615 Vaccinias
% 214.55/214.70  |- mesh__recordMaintainer mesh__D014615 TGC
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D014615 2000
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D014615 1996
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D019300 2001
% 214.55/214.70  |- mesh__recordMaintainer mesh__D019300 JLS
% 214.55/214.70  |- skos__annotation mesh__D019300
% 214.55/214.70       IM; coord with specific dis or procedure %28%IM%29%; do not confuse with MALPRACTICE: read MeSH definition; DIAGNOSTIC ERRORS %26% MEDICATION ERRORS are also available; DF: MED ERR%A%  
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D019300 2003
% 214.55/214.70  |- skos__scopeNote mesh__D019300
% 214.55/214.70       Errors or mistakes committed by health professionals which result in harm to the patient. They include errors in diagnosis %28%DIAGNOSTIC ERRORS%29%, errors in the administration of drugs and other medications %28%MEDICATION ERRORS%29%, errors in the performance of surgical procedures, in the use of other types of therapy, in the use of equipment, and in the interpretation of laboratory findings. Medical errors are differentiated from MALPRACTICE in that the former are regarded as honest mistakes or accidents while the latter is the result of negligence, reprehensible ignorance, or criminal intent.%A%    
% 214.55/214.70  |- skos__altLabel mesh__D019300 Medical Mistakes
% 214.55/214.70  |- skos__altLabel mesh__D019300 Errors, Medical
% 214.55/214.70  |- skos__altLabel mesh__D019300 Errors, Surgical
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D019300 2004
% 214.55/214.70  |- skos__hiddenLabel mesh__D019300 Error, Medical
% 214.55/214.70  |- mesh__dateRevised mesh__D019300 1998-06-10
% 214.55/214.70  |- skos__broader mesh__D019300smesh__D006296
% 214.55/214.70  |- skos__hiddenLabel mesh__D019300 Error, Surgical
% 214.55/214.70  |- mesh__dateEstablished mesh__D019300 1997-01-01
% 214.55/214.70  |- skos__prefLabel mesh__D019300 Medical Errors
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D019300 2002
% 214.55/214.70  |- skos__altLabel mesh__D019300 Mistake, Medical
% 214.55/214.70  |- skos__related mesh__D019300smesh__D007049
% 214.55/214.70  |- mesh__dateCreated mesh__D019300 1996-06-10
% 214.55/214.70  |- mesh__recordAuthorizer mesh__D019300 SJN
% 214.55/214.70  |- skos__hiddenLabel mesh__D019300 Medical Error
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D019300 2000
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D019300 2005
% 214.55/214.70  |- skos__related mesh__D019300smesh__D008318
% 214.55/214.70  |- mesh__recordOriginator mesh__D019300 TGC
% 214.55/214.70  |- mesh__publicMeSHNote mesh__D019300 97   
% 214.55/214.70  |- rdf__type mesh__D019300sskos__Concept
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D019300 2006
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D019300 1999
% 214.55/214.70  |- skos__altLabel mesh__D019300 Mistakes, Medical
% 214.55/214.70  |- skos__altLabel mesh__D019300 Medical Mistake
% 214.55/214.70  |- mesh__historyNote mesh__D019300 97   
% 214.55/214.70  |- skos__altLabel mesh__D019300 Surgical Error
% 214.55/214.70  |- skos__hiddenLabel mesh__D005889 Recessions, Gingival
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D005889 2000
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D005889 1994
% 214.55/214.70  |- skos__prefLabel mesh__D005889 Gingival Recession
% 214.55/214.70  |- skos__hiddenLabel mesh__D005889 Gingival Recessions
% 214.55/214.70  |- mesh__dateCreated mesh__D005889 1984-05-01
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D005889 2001
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D005889 1995
% 214.55/214.70  |- mesh__historyNote mesh__D005889
% 214.55/214.70       91%28%85%29%; was see under GINGIVAL DISEASES 1985-90   
% 214.55/214.70  |- skos__scopeNote mesh__D005889
% 214.55/214.70       The exposure of root surface by an apical shift in the position of the gingiva.%A%    
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D005889 2003
% 214.55/214.70  |- mesh__recordOriginator mesh__D005889 RC
% 214.55/214.70  |- skos__hiddenLabel mesh__D005889 Recession, Gingival
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D005889 1996
% 214.55/214.70  |- mesh__dateRevised mesh__D005889 1993-05-28
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D005889 2005
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D005889 2004
% 214.55/214.70  |- mesh__publicMeSHNote mesh__D005889
% 214.55/214.70       91; was see under GINGIVAL DISEASES 1985-90   
% 214.55/214.70  |- skos__broader mesh__D005889smesh__D005882
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D005889 1998
% 214.55/214.70  |- mesh__recordMaintainer mesh__D005889 TGC
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D005889 2002
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D005889 1997
% 214.55/214.70  |- mesh__dateEstablished mesh__D005889 1991-01-01
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D005889 2006
% 214.55/214.70  |- mesh__recordAuthorizer mesh__D005889 PLS
% 214.55/214.70  |- rdf__type mesh__D005889sskos__Concept
% 214.55/214.70  |- skos__annotation mesh__D005889 exposure of root surface   
% 214.55/214.70  |- skos__historyNote mesh__D005889 Gingival Diseases %28%1966-1984%29%
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D005889 1999
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D030282 2004
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D030282 2003
% 214.55/214.70  |- skos__scopeNote mesh__D030282
% 214.55/214.70       A species of DELTARETROVIRUS comprising one strain: Simian T-lymphotropic virus 3.%A%    
% 214.55/214.70  |- skos__annotation mesh__D030282
% 214.55/214.70       infection: coord IM with DELTARETROVIRUS INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% if pertinent%A%  
% 214.55/214.70  |- skos__hiddenLabel mesh__D030282 Primate T lymphotropic virus 3
% 214.55/214.70  |- skos__prefLabel mesh__D030282 Primate T-lymphotropic virus 3
% 214.55/214.70  |- skos__hiddenLabel mesh__D030282 Simian T lymphotropic virus 3
% 214.55/214.70  |- rdf__type mesh__D030282sskos__Concept
% 214.55/214.70  |- skos__historyNote mesh__D030282
% 214.55/214.70       Simian T-lymphotropic virus 1 %28%1999-2001%29%
% 214.55/214.70  |- skos__altLabel mesh__D030282 STLV-3
% 214.55/214.70  |- skos__broader mesh__D030282smesh__D017977
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D030282 2006
% 214.55/214.70  |- mesh__dateEstablished mesh__D030282 2002-01-01
% 214.55/214.70  |- mesh__dateCreated mesh__D030282 2001-07-25
% 214.55/214.70  |- skos__altLabel mesh__D030282 PLTV-3
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D030282 2005
% 214.55/214.70  |- mesh__publicMeSHNote mesh__D030282 2002   
% 214.55/214.70  |- mesh__historyNote mesh__D030282 2002   
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D030282 2002
% 214.55/214.70  |- skos__broader mesh__D009420Q000002smesh__D009420
% 214.55/214.70  |- mesh__preferredCombination mesh__D009420Q000002smesh__D009421
% 214.55/214.70  |- rdf__type mesh__D009420Q000002smesh__CompoundConcept
% 214.55/214.70  |- skos__annotation mesh__D002591
% 214.55/214.70       general or unspecified; prefer DOLPHINS; PORPOISES; or WHALES; or specifics%A%  
% 214.55/214.70  |- rdf__type mesh__D002591sskos__Concept
% 214.55/214.70  |- mesh__dateRevised mesh__D002591 2005-07-14
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D002591 2006B
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D002591 2006
% 214.55/214.70  |- mesh__recordMaintainer mesh__D002591 ags
% 214.55/214.70  |- skos__broader mesh__D002591smesh__D008322
% 214.55/214.70  |- skos__hiddenLabel mesh__D002591 Cetaceas
% 214.55/214.70  |- mesh__recordAuthorizer mesh__D002591 ags
% 214.55/214.70  |- mesh__dateCreated mesh__D002591 1999-01-01
% 214.55/214.70  |- mesh__recordOriginator mesh__D002591 NLM
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D002591 2006A
% 214.55/214.70  |- skos__prefLabel mesh__D002591 Cetacea
% 214.55/214.70  |- skos__scopeNote mesh__D002591
% 214.55/214.70       An order of wholly aquatic MAMMALS occurring in all the OCEANS and adjoining seas of the world, as well as in certain river systems. They feed generally on FISHES, cephalopods, and crustaceans. Most are gregarious and most have a relatively long period of parental care and maturation. Included are DOLPHINS; PORPOISES; and WHALES. %28%From Walker%27%s Mammals of the World, 5th ed, pp969-70%29%%A%    
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D018208 1996
% 214.55/214.70  |- skos__historyNote mesh__D018208 Liposarcoma %28%1968-1993%29%
% 214.55/214.70  |- rdf__type mesh__D018208sskos__Concept
% 214.55/214.70  |- skos__hiddenLabel mesh__D018208 Myxoid Liposarcomas
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D018208 2000
% 214.55/214.70  |- skos__scopeNote mesh__D018208
% 214.55/214.70       A liposarcoma containing myxomatous tissue. %28%Dorland, 27th ed%29%%A%    
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D018208 1997
% 214.55/214.70  |- mesh__dateEstablished mesh__D018208 1994-01-01
% 214.55/214.70  |- mesh__recordMaintainer mesh__D018208 KEV
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D018208 2001
% 214.55/214.70  |- mesh__dateCreated mesh__D018208 1993-06-25
% 214.55/214.70  |- skos__hiddenLabel mesh__D018208 Myxoid Liposarcoma
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D018208 2002
% 214.55/214.70  |- skos__annotation mesh__D018208
% 214.55/214.70       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 214.55/214.70  |- mesh__recordOriginator mesh__D018208 PLS
% 214.55/214.70  |- skos__broader mesh__D018208smesh__D008080
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D018208 2005
% 214.55/214.70  |- mesh__publicMeSHNote mesh__D018208 94   
% 214.55/214.70  |- mesh__dateRevised mesh__D018208 1995-06-08
% 214.55/214.70  |- mesh__historyNote mesh__D018208 94   
% 214.55/214.70  |- skos__prefLabel mesh__D018208 Liposarcoma, Myxoid
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D018208 2006
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D018208 2003
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D018208 1998
% 214.55/214.70  |- mesh__recordAuthorizer mesh__D018208 PLS
% 214.55/214.70  |- skos__hiddenLabel mesh__D018208 Liposarcomas, Myxoid
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D018208 2004
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D018208 1999
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D001499 1995
% 214.55/214.70  |- mesh__recordMaintainer mesh__D001499 PLS
% 214.55/214.70  |- rdf__type mesh__D001499sskos__Concept
% 214.55/214.70  |- skos__altLabel mesh__D001499 Analysis, Bayesian
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D001499 1998
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D001499 2002
% 214.55/214.70  |- mesh__recordAuthorizer mesh__D001499 PLS
% 214.55/214.70  |- skos__hiddenLabel mesh__D001499 Theorem, Bayes
% 214.55/214.70  |- skos__hiddenLabel mesh__D001499 Prediction, Bayesian
% 214.55/214.70  |- skos__annotation mesh__D001499
% 214.55/214.70       IM GEN only; coord NIM with specific disease %28%IM%29%; no qualif; specify geog if pertinent%A%  
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D001499 2004
% 214.55/214.70  |- skos__historyNote mesh__D001499 Probability %28%1966-1974%29%
% 214.55/214.70  |- mesh__onlineNote mesh__D001499 search PROBABILITY 1968-74   
% 214.55/214.70  |- mesh__dateCreated mesh__D001499 1999-01-01
% 214.55/214.70  |- skos__hiddenLabel mesh__D001499 Method, Bayesian
% 214.55/214.70  |- skos__hiddenLabel mesh__D001499 Forecast, Bayesian
% 214.55/214.70  |- mesh__publicMeSHNote mesh__D001499
% 214.55/214.70       91; was see under PROBABILITY 1975-90   
% 214.55/214.70  |- mesh__historyNote mesh__D001499
% 214.55/214.70       91%28%75%29%; was see under PROBABILITY 1975-90   
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D001499 2003
% 214.55/214.70  |- mesh__recordOriginator mesh__D001499 NLM
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D001499 1997
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D001499 2001
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D001499 2006
% 214.55/214.70  |- skos__prefLabel mesh__D001499 Bayes Theorem
% 214.55/214.70  |- skos__broader mesh__D001499smesh__D011336
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D001499 1996
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D001499 2000
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D001499 2005
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D001499 1999
% 214.55/214.70  |- mesh__dateRevised mesh__D001499 1994-04-11
% 214.55/214.70  |- mesh__dateEstablished mesh__D001499 1991-01-01
% 214.55/214.70  |- skos__scopeNote mesh__D001499
% 214.55/214.70       A theorem in probability theory named for Thomas Bayes %28%1702-1761%29%. In epidemiology, it is used to obtain the probability of disease in a group of people with some characteristic on the basis of the overall rate of that disease and of the likelihoods of that characteristic in healthy and diseased individuals. The most familiar application is in clinical decision analysis where it is used for estimating the probability of a particular diagnosis given the appearance of some symptoms or test result.%A%    
% 214.55/214.70  |- skos__prefLabel mesh__D006982 Hypertonic Solutions
% 214.55/214.70  |- skos__scopeNote mesh__D006982
% 214.55/214.70       Solutions that have a greater osmotic pressure than a reference solution such as blood, plasma, or interstitial fluid.%A%    
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D006982 2004
% 214.55/214.70  |- mesh__recordAuthorizer mesh__D006982 sjn
% 214.55/214.70  |- mesh__recordOriginator mesh__D006982 NLM
% 214.55/214.70  |- mesh__recordMaintainer mesh__D006982 ssb
% 214.55/214.70  |- skos__broader mesh__D006982smesh__D012996
% 214.55/214.70  |- mesh__dateRevised mesh__D006982 2003-07-09
% 214.55/214.70  |- mesh__dateCreated mesh__D006982 1999-01-01
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D006982 2005
% 214.55/214.70  |- rdf__type mesh__D006982sskos__Concept
% 214.55/214.70  |- skos__annotation mesh__D006982
% 214.55/214.70       GEN; NIM; no qualif when NIM coord; SALINE SOLUTION, HYPERTONIC %26% GLUCOSE SOLUTION, HYPERTONIC are available; DF: HYPERTONIC SOL%A%  
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D006982 2006
% 214.55/214.70  |- skos__hiddenLabel mesh__D006982 Solutions, Hypertonic
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D020653 2005
% 214.55/214.70  |- mesh__historyNote mesh__D020653
% 214.55/214.70       2000; for ELONGATION FACTOR G use PEPTIDE ELONGATION FACTOR G %28%NM%29% 1980-1999%A%  
% 214.55/214.70  |- skos__altLabel mesh__D020653 fusA Protein
% 214.55/214.70  |- rdf__type mesh__D020653sskos__Concept
% 214.55/214.70  |- skos__broader mesh__D020653smesh__D020963
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D020653 2006
% 214.55/214.70  |- mesh__dateRevised mesh__D020653 2003-07-09
% 214.55/214.70  |- skos__altLabel mesh__D020653 Elongation Factor G
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D020653 2004
% 214.55/214.70  |- skos__prefLabel mesh__D020653 Peptide Elongation Factor G
% 214.55/214.70  |- mesh__dateCreated mesh__D020653 1999-11-03
% 214.55/214.70  |- skos__hiddenLabel mesh__D020653 EF G
% 214.55/214.70  |- mesh__publicMeSHNote mesh__D020653
% 214.55/214.70       2000; Elongation Factor G was indexed under PEPTIDE ELONGATION FACTORS 1980-1999%A%  
% 214.55/214.70  |- skos__altLabel mesh__D020653 fusA Gene Product
% 214.55/214.70  |- mesh__dateEstablished mesh__D020653 2000-01-01
% 214.55/214.70  |- skos__scopeNote mesh__D020653
% 214.55/214.70       Peptide Elongation Factor G catalyzes the translocation of peptidyl-tRNA from the A to the P site of bacterial ribosomes by a process linked to hydrolysis of GTP to GDP.%A%    
% 214.55/214.70  |- skos__altLabel mesh__D020653 EF-G
% 214.55/214.70  |- skos__historyNote mesh__D020653
% 214.55/214.70       Peptide Elongation Factors %28%1980-1999%29%
% 214.55/214.70  |- skos__annotation mesh__D006184
% 214.55/214.70       no qualif; do not use for %22%drug habit%22% %28% = SUBSTANCE ABUSE or SUBSTANCE DEPENDENCE%29% nor for %22%smoking habit%22% %28% = SMOKING or TOBACCO USE DISORDER%29%%A%  
% 214.55/214.70  |- rdf__type mesh__D006184sskos__Concept
% 214.55/214.70  |- mesh__recordOriginator mesh__D006184 NLM
% 214.55/214.70  |- mesh__publicMeSHNote mesh__D006184 69; was HABIT 1963-68   
% 214.55/214.70  |- mesh__dateEstablished mesh__D006184 1969-01-01
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D006184 2004
% 214.55/214.70  |- mesh__dateRevised mesh__D006184 2002-07-03
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D006184 2003
% 214.55/214.70  |- skos__hiddenLabel mesh__D006184 Habit
% 214.55/214.70  |- mesh__historyNote mesh__D006184 69; was HABIT 1963-68   
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D006184 2006
% 214.55/214.70  |- skos__prefLabel mesh__D006184 Habits
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D006184 2005
% 214.55/214.70  |- mesh__recordMaintainer mesh__D006184 JLS
% 214.55/214.70  |- mesh__onlineNote mesh__D006184 use HABITS to search HABIT 1966-68   
% 214.55/214.70  |- skos__broader mesh__D006184smesh__D001519
% 214.55/214.70  |- skos__scopeNote mesh__D006184
% 214.55/214.70       Acquired or learned responses which are regularly manifested.%A%    
% 214.55/214.70  |- mesh__recordAuthorizer mesh__D006184 sjn
% 214.55/214.70  |- skos__hiddenLabel mesh__D006184 Habit Disturbance
% 214.55/214.70  |- mesh__dateCreated mesh__D006184 1999-01-01
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D014616 2005
% 214.55/214.70  |- mesh__recordAuthorizer mesh__D014616 sjn
% 214.55/214.70  |- mesh__recordMaintainer mesh__D014616 sjn
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D014616 2006
% 214.55/214.70  |- skos__prefLabel mesh__D014616 Vaccinia virus
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D014616 2003
% 214.55/214.70  |- mesh__onlineNote mesh__D014616
% 214.55/214.70       use VACCINIA VIRUS to search RABBIT POX VIRUS %26% RABBIT PLAGUE VIRUS 1975-93%A%  
% 214.55/214.70  |- skos__scopeNote mesh__D014616
% 214.55/214.70       The type species of ORTHOPOXVIRUS, related to COWPOX VIRUS, but whose true origin is unknown. It has been used as a live vaccine against smallpox. It is also used as a vector for inserting foreign DNA into animals. Rabbitpox virus is a subspecies of VACCINIA VIRUS.%A%    
% 214.55/214.70  |- mesh__dateRevised mesh__D014616 2001-08-03
% 214.55/214.70  |- mesh__historyNote mesh__D014616
% 214.55/214.70       63; RABBIT POX VIRUS was heading 1975-93 %28%see under POXVIRIDAE 1981-90, see under POXVIRUSES 1975-80%29%; RABBIT PLAGUE VIRUS was see RABBIT POX VIRUS 1975-93%A%  
% 214.55/214.70  |- skos__hiddenLabel mesh__D014616 Rabbitpox viruses
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D014616 2002
% 214.55/214.70  |- skos__hiddenLabel mesh__D014616 Rabbit Pox Viruses
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D014616 2004
% 214.55/214.70  |- skos__broader mesh__D014616smesh__D018155
% 214.55/214.70  |- rdf__type mesh__D014616sskos__Concept
% 214.55/214.70  |- skos__altLabel mesh__D014616 Rabbit Pox Virus
% 214.55/214.70  |- mesh__publicMeSHNote mesh__D014616
% 214.55/214.70       63; RABBIT POX VIRUS was heading 1975-93 %28%see under POXVIRIDAE 1981-90, see under POXVIRUSES 1975-80%29%; RABBIT PLAGUE VIRUS was see RABBIT POX VIRUS 1975-93%A%  
% 214.55/214.70  |- mesh__dateCreated mesh__D014616 1999-01-01
% 214.55/214.70  |- mesh__recordOriginator mesh__D014616 NLM
% 214.55/214.70  |- skos__hiddenLabel mesh__D014616 Vaccinia viruses
% 214.55/214.70  |- skos__altLabel mesh__D014616 Poxvirus officinale
% 214.55/214.70  |- skos__annotation mesh__D014616 infection = VACCINIA   
% 214.55/214.70  |- skos__broader mesh__D019301smesh__D009829
% 214.55/214.70  |- skos__hiddenLabel mesh__D019301 Acid, Oleic
% 214.55/214.70  |- mesh__publicMeSHNote mesh__D019301
% 214.55/214.70       97; OLEIC ACID was indexed under OLEIC ACIDS 1981-96   
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D019301 2004
% 214.55/214.70  |- mesh__dateRevised mesh__D019301 2003-07-09
% 214.55/214.70  |- skos__prefLabel mesh__D019301 Oleic Acid
% 214.55/214.70  |- skos__scopeNote mesh__D019301
% 214.55/214.70       An unsaturated fatty acid that is the most widely distributed and abundant fatty acid in nature. It is used commercially in the preparation of oleates and lotions, and as a pharmaceutical solvent. %28%Stedman, 26th ed%29%%A%    
% 214.55/214.70  |- skos__altLabel mesh__D019301 9-Octadecenoic Acid
% 214.55/214.70  |- mesh__historyNote mesh__D019301 97; was OLEIC ACID %28%NM%29% 1981-96   
% 214.55/214.70  |- mesh__recordOriginator mesh__D019301 ADP
% 214.55/214.70  |- skos__hiddenLabel mesh__D019301 cis 9 Octadecenoic Acid
% 214.55/214.70  |- skos__altLabel mesh__D019301 cis-9-Octadecenoic Acid
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D019301 2005
% 214.55/214.70  |- skos__hiddenLabel mesh__D019301 Acid, cis-9-Octadecenoic
% 214.55/214.70  |- mesh__onlineNote mesh__D019301
% 214.55/214.70       use OLEIC ACID %28%NM%29% to search OLEIC ACID 1981-96   
% 214.55/214.70  |- mesh__dateEstablished mesh__D019301 1997-01-01
% 214.55/214.70  |- skos__hiddenLabel mesh__D019301 9 Octadecenoic Acid
% 214.55/214.70  |- skos__hiddenLabel mesh__D019301 Acid, 9-Octadecenoic
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D019301 2006
% 214.55/214.70  |- mesh__dateCreated mesh__D019301 1996-06-10
% 214.55/214.70  |- rdf__type mesh__D019301sskos__Concept
% 214.55/214.70  |- mesh__recordAuthorizer mesh__D019301 sjn
% 214.55/214.70  |- skos__annotation mesh__D019301 do not confuse with OLEIC ACIDS   
% 214.55/214.70  |- mesh__recordMaintainer mesh__D019301 ssb
% 214.55/214.70  |- skos__historyNote mesh__D019301 Oleic Acids %28%1981-1996%29%
% 214.55/214.70  |- skos__prefLabel mesh__D030283 Epsilonretrovirus
% 214.55/214.70  |- skos__altLabel mesh__D030283 WEHV-1
% 214.55/214.70  |- rdf__type mesh__D030283sskos__Concept
% 214.55/214.70  |- skos__altLabel mesh__D030283 WDSV
% 214.55/214.70  |- mesh__dateCreated mesh__D030283 2001-07-25
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D030283 2006
% 214.55/214.70  |- mesh__historyNote mesh__D030283 2002   
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D030283 2002
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D030283 2005
% 214.55/214.70  |- mesh__dateEstablished mesh__D030283 2002-01-01
% 214.55/214.70  |- skos__hiddenLabel mesh__D030283 Epsilonretroviruses
% 214.55/214.70  |- skos__annotation mesh__D030283
% 214.55/214.70       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS if pertinent + FISH DISEASES %28%IM%29% %28%see note there%29%%A%  
% 214.55/214.70  |- skos__historyNote mesh__D030283 Retroviridae %28%1995-2001%29%
% 214.55/214.70  |- mesh__publicMeSHNote mesh__D030283 2002   
% 214.55/214.70  |- skos__broader mesh__D030283smesh__D012190
% 214.55/214.70  |- skos__altLabel mesh__D030283 WEHV-2
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D030283 2004
% 214.55/214.70  |- skos__altLabel mesh__D030283 Epidermal Hyperplasia Virus 1, Walleye
% 214.55/214.70  |- skos__altLabel mesh__D030283 Sarcoma Virus, Walleye Dermal
% 214.55/214.70  |- mesh__activeMeSHYear mesh__D030283 2003
% 214.55/214.70  |- skos__altLabel mesh__D030283 Epidermal Hyperplasia Virus 2, Walleye
% 214.55/214.70  |- skos__scopeNote mesh__D030283
% 214.55/214.70       A genus in the family RETROVIRIDAE infecting fish. Species include Walleye dermal sarcoma virus, Walleye epidermal hyperplasia virus 1, and Walleye epidermal hyperplasia virus 2.%A%    
% 214.55/214.70  |- mesh__dateEstablished mesh__D002592 1991-01-01
% 214.55/214.70  |- skos__hiddenLabel mesh__D002592 Brij58
% 214.55/214.70  |- mesh__recordAuthorizer mesh__D002592 sjn
% 214.55/214.70  |- mesh__historyNote mesh__D002592
% 214.55/214.70       91%28%75%29%; was see under POLYETHYLENE GLYCOLS 1975-90   
% 214.56/214.70  |- skos__altLabel mesh__D002592 Brij 58
% 214.56/214.70  |- mesh__dateRevised mesh__D002592 2004-07-07
% 214.56/214.70  |- skos__scopeNote mesh__D002592
% 214.56/214.70       Non-ionic surfactant of the polyethylene glycol family. It is used as a solubilizer and emulsifying agent in foods, cosmetics, and pharmaceuticals, often as an ointment base, and also as a research tool.%A%    
% 214.56/214.70  |- mesh__activeMeSHYear mesh__D002592 2006
% 214.56/214.70  |- skos__altLabel mesh__D002592
% 214.56/214.70       alpha-Hexadecyl-omega-Hydroxypoly%28%oxy-1,2-Ethanediyl%29%
% 214.56/214.70  |- skos__historyNote mesh__D002592 Polyethylene Glycols %28%1974%29%
% 214.56/214.70  |- skos__altLabel mesh__D002592 Polyethylene Glycol Monohexadecyl Ether
% 214.56/214.70  |- skos__hiddenLabel mesh__D002592
% 214.56/214.70       n Hexadecane Polyoxyethylene Glycol Monether
% 214.56/214.70  |- mesh__activeMeSHYear mesh__D002592 2005
% 214.56/214.70  |- skos__altLabel mesh__D002592 Polyethylene Glycol Cetyl Ether
% 214.56/214.70  |- mesh__dateCreated mesh__D002592 1974-11-11
% 214.56/214.70  |- skos__broader mesh__D002592smesh__D011092
% 214.56/214.70  |- skos__annotation mesh__D002592 D25-26 qualif   
% 214.56/214.70  |- mesh__publicMeSHNote mesh__D002592
% 214.56/214.70       91; was see under POLYETHYLENE GLYCOLS 1975-90   
% 214.56/214.70  |- mesh__recordMaintainer mesh__D002592 jmp
% 214.56/214.70  |- skos__prefLabel mesh__D002592 Cetomacrogol
% 214.56/214.70  |- mesh__recordOriginator mesh__D002592 NLM
% 214.56/214.70  |- rdf__type mesh__D002592sskos__Concept
% 214.56/214.70  |- skos__altLabel mesh__D002592
% 214.56/214.70       n-Hexadecane Polyoxyethylene Glycol Monether
% 214.56/214.70  |- mesh__activeMeSHYear mesh__D018209 2004
% 214.56/214.70  |- mesh__activeMeSHYear mesh__D018209 1997
% 214.56/214.70  |- mesh__dateCreated mesh__D018209 1993-06-25
% 214.56/214.70  |- mesh__activeMeSHYear mesh__D018209 2001
% 214.56/214.70  |- skos__broader mesh__D018209smesh__D018205
% 214.56/214.70  |- mesh__dateEstablished mesh__D018209 1994-01-01
% 214.56/214.70  |- skos__hiddenLabel mesh__D018209 Myelolipomas
% 214.56/214.70  |- mesh__recordMaintainer mesh__D018209 KEV
% 214.56/214.70  |- mesh__recordOriginator mesh__D018209 PLS
% 214.56/214.70  |- skos__scopeNote mesh__D018209
% 214.56/214.70       A rare benign tumor of the adrenal gland, several centimeters in diameter, composed in varying proportions of adipose tissue, lymphocytes, and primitive myeloid cells, probably a developmental abnormality. %28%Dorland, 27th ed%29%%A%    
% 214.56/214.70  |- mesh__activeMeSHYear mesh__D018209 2002
% 214.56/214.70  |- skos__historyNote mesh__D018209 Myeloid Metaplasia %28%1971-1979%29%
% 214.56/214.70  |- mesh__dateRevised mesh__D018209 1995-06-08
% 214.56/214.70  |- skos__prefLabel mesh__D018209 Myelolipoma
% 214.56/214.70  |- skos__historyNote mesh__D018209 Lipoma %28%1971-1993%29%
% 214.56/214.70  |- mesh__publicMeSHNote mesh__D018209 94   
% 214.56/214.70  |- mesh__historyNote mesh__D018209 94   
% 214.56/214.70  |- mesh__activeMeSHYear mesh__D018209 2005
% 214.56/214.70  |- mesh__activeMeSHYear mesh__D018209 1998
% 214.56/214.70  |- mesh__recordAuthorizer mesh__D018209 PLS
% 214.56/214.70  |- mesh__activeMeSHYear mesh__D018209 2003
% 214.56/214.70  |- mesh__activeMeSHYear mesh__D018209 1996
% 214.56/214.70  |- skos__annotation mesh__D018209
% 214.56/214.70       /blood supply /chem /secret /ultrastruct permitted; coord IM with ADRENAL GLAND NEOPLASMS %28%IM%29%%A%  
% 214.56/214.70  |- skos__historyNote mesh__D018209
% 214.56/214.70       Adrenal Gland Neoplasms %28%1966-1993%29%
% 214.56/214.70  |- rdf__type mesh__D018209sskos__Concept
% 214.56/214.70  |- mesh__activeMeSHYear mesh__D018209 2006
% 214.56/214.70  |- mesh__activeMeSHYear mesh__D018209 1999
% 214.56/214.70  |- mesh__activeMeSHYear mesh__D018209 2000
% 214.56/214.70  |- rdf__type mesh__D010226sskos__Concept
% 214.56/214.70  |- mesh__recordAuthorizer mesh__D010226 SJN
% 214.56/214.70  |- mesh__dateCreated mesh__D010226 1999-01-01
% 214.56/214.70  |- skos__historyNote mesh__D010226 Benzoates %28%1966-1970%29%
% 214.56/214.70  |- mesh__activeMeSHYear mesh__D010226 2004
% 214.56/214.70  |- mesh__onlineNote mesh__D010226
% 214.56/214.70       use PARABENS to search METHYLPARABEN 1966-71   
% 214.56/214.70  |- skos__prefLabel mesh__D010226 Parabens
% 214.56/214.70  |- mesh__activeMeSHYear mesh__D010226 2002
% 214.56/214.70  |- mesh__recordOriginator mesh__D010226 NLM
% 214.56/214.70  |- skos__hiddenLabel mesh__D010226 Acids, 4-Hydroxybenzoic
% 214.56/214.70  |- mesh__dateEstablished mesh__D010226 1972-01-01
% 214.56/214.70  |- skos__altLabel mesh__D010226 para-Hydroxybenzoic Acids
% 214.56/214.70  |- skos__broader mesh__D010226smesh__D006883
% 214.56/214.70  |- skos__hiddenLabel mesh__D010226 4 Hydroxybenzoic Acids
% 214.56/214.70  |- mesh__activeMeSHYear mesh__D010226 2005
% 214.56/214.70  |- mesh__activeMeSHYear mesh__D010226 2000
% 214.56/214.70  |- mesh__recordMaintainer mesh__D010226 ADP
% 214.56/214.70  |- skos__hiddenLabel mesh__D010226 Acids, para-Hydroxybenzoic
% 214.56/214.70  |- mesh__activeMeSHYear mesh__D010226 2006
% 214.56/214.70  |- mesh__activeMeSHYear mesh__D010226 2001
% 214.56/214.70  |- skos__annotation mesh__D010226 D25-26 qualif   
% 214.56/214.70  |- mesh__publicMeSHNote mesh__D010226
% 214.56/214.70       72; METHYLPARABEN was heading 1963-71   
% 214.56/214.70  |- mesh__historyNote mesh__D010226
% 214.56/214.70       72%28%71%29%; METHYLPARABEN was heading 1963-71   
% 214.56/214.70  |- mesh__activeMeSHYear mesh__D010226 2003
% 214.56/214.70  |- skos__scopeNote mesh__D010226
% 214.56/214.70       Proprietary name for the methyl, propyl, butyl, and ethyl esters of p-hydroxybenzoic acid. They have been approved by the FDA as antimicrobial agents for foods and pharmaceuticals. %28%From Hawley%27%s Condensed Chemical Dictionary, 11th ed, p872%29%%A%    
% 214.56/214.70  |- skos__hiddenLabel mesh__D010226 para Hydroxybenzoic Acids
% 214.56/214.70  |- mesh__activeMeSHYear mesh__D010226 1999
% 214.56/214.70  |- mesh__dateRevised mesh__D010226 1998-06-10
% 214.56/214.71  |- skos__broader mesh__D008511Q000266smesh__D008511
% 214.56/214.71  |- mesh__preferredCombination mesh__D008511Q000266smesh__D006666
% 214.56/214.71  |- rdf__type mesh__D008511Q000266smesh__CompoundConcept
% 214.56/214.71  |- skos__broader mesh__D006983smesh__D006201
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006983 2005A
% 214.56/214.71  |- mesh__recordOriginator mesh__D006983 NLM
% 214.56/214.71  |- mesh__dateCreated mesh__D006983 1999-01-01
% 214.56/214.71  |- skos__related mesh__D006983smesh__D006628
% 214.56/214.71  |- rdf__type mesh__D006983sskos__Concept
% 214.56/214.71  |- mesh__dateRevised mesh__D006983 2004-07-28
% 214.56/214.71  |- mesh__recordMaintainer mesh__D006983 jls
% 214.56/214.71  |- skos__prefLabel mesh__D006983 Hypertrichosis
% 214.56/214.71  |- skos__hiddenLabel mesh__D006983 Hypertrichoses
% 214.56/214.71  |- mesh__recordAuthorizer mesh__D006983 jls
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006983 2006
% 214.56/214.71  |- skos__scopeNote mesh__D006983
% 214.56/214.71       Excessive hair growth at inappropriate locations, such as on the extremities, the head, and the back. It is caused by genetic or acquired factors, and is an androgen-independent process. This concept does not include HIRSUTISM which is an androgen-dependent excess hair growth in WOMEN and CHILDREN.%A%    
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006983 2005
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006185 2000
% 214.56/214.71  |- mesh__historyNote mesh__D006185 70%28%68%29%   
% 214.56/214.71  |- mesh__dateEstablished mesh__D006185 1970-01-01
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006185 2006
% 214.56/214.71  |- skos__scopeNote mesh__D006185
% 214.56/214.71       The disappearance of responsiveness to accustomed stimulation. It does not include drug habituation.%A%    
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006185 1997
% 214.56/214.71  |- mesh__recordAuthorizer mesh__D006185 PLS
% 214.56/214.71  |- skos__broader mesh__D006185smesh__D007858
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006185 2005
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006185 1996
% 214.56/214.71  |- skos__altLabel mesh__D006185 Habituation, Psychophysiological
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006185 2002
% 214.56/214.71  |- skos__broader mesh__D006185smesh__D011603
% 214.56/214.71  |- mesh__recordOriginator mesh__D006185 NLM
% 214.56/214.71  |- skos__broader mesh__D006185smesh__D009424
% 214.56/214.71  |- mesh__dateCreated mesh__D006185 1999-01-01
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006185 1999
% 214.56/214.71  |- rdf__type mesh__D006185sskos__Concept
% 214.56/214.71  |- skos__altLabel mesh__D006185 Psychophysiological Habituation
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006185 2004
% 214.56/214.71  |- skos__prefLabel mesh__D006185 Habituation %28%Psychophysiology%29%
% 214.56/214.71  |- mesh__dateRevised mesh__D006185 1993-06-04
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006185 1995
% 214.56/214.71  |- skos__altLabel mesh__D006185 Habituation, Psychophysiologic
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006185 1998
% 214.56/214.71  |- skos__historyNote mesh__D006185 Learning %28%1966-1967%29%
% 214.56/214.71  |- mesh__publicMeSHNote mesh__D006185 70   
% 214.56/214.71  |- skos__hiddenLabel mesh__D006185 Habituations %28%Psychophysiology%29%
% 214.56/214.71  |- skos__annotation mesh__D006185 DF: HABITUATION   
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006185 2001
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006185 2003
% 214.56/214.71  |- skos__altLabel mesh__D006185 Psychophysiologic Habituation
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006185 1994
% 214.56/214.71  |- mesh__recordMaintainer mesh__D006185 JLS
% 214.56/214.71  |- mesh__recordOriginator mesh__D014617 NLM
% 214.56/214.71  |- mesh__dateRevised mesh__D014617 2003-07-09
% 214.56/214.71  |- skos__hiddenLabel mesh__D014617 Vacuole
% 214.56/214.71  |- mesh__recordAuthorizer mesh__D014617 sjn
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D014617 2004
% 214.56/214.71  |- mesh__recordMaintainer mesh__D014617 nns
% 214.56/214.71  |- mesh__dateEstablished mesh__D014617 1989-01-01
% 214.56/214.71  |- rdf__type mesh__D014617sskos__Concept
% 214.56/214.71  |- skos__annotation mesh__D014617
% 214.56/214.71       A 11 qualif except /cytol; /genet permitted   
% 214.56/214.71  |- mesh__dateCreated mesh__D014617 1999-01-01
% 214.56/214.71  |- mesh__historyNote mesh__D014617
% 214.56/214.71       89%28%75%29%; was see under ORGANOIDS 1977-88; was see under CELLULAR INCLUSIONS 1974-76; was see under CYTOPLASM 1966-73%A%  
% 214.56/214.71  |- skos__prefLabel mesh__D014617 Vacuoles
% 214.56/214.71  |- mesh__onlineNote mesh__D014617
% 214.56/214.71       search CELLULAR INCLUSIONS 1974 %26% CYTOPLASM 1966-73   
% 214.56/214.71  |- skos__broader mesh__D014617smesh__D022162
% 214.56/214.71  |- mesh__publicMeSHNote mesh__D014617
% 214.56/214.71       89; was see under ORGANOIDS 1977-88; was see under CELLULAR INCLUSIONS 1974-76; was see under CYTOPLASM 1966-73%A%  
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D014617 2005
% 214.56/214.71  |- skos__scopeNote mesh__D014617
% 214.56/214.71       Any spaces or cavities within a cell. They may function in digestion, storage, secretion, or excretion.%A%    
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D014617 2006
% 214.56/214.71  |- skos__broader mesh__D019302smesh__D015686
% 214.56/214.71  |- skos__historyNote mesh__D019302 Protein Precursors %28%1990-1996%29%
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D019302 2005
% 214.56/214.71  |- mesh__onlineNote mesh__D019302
% 214.56/214.71       use HIV ENVELOPE PROTEIN GP160 %28%NM%29% to search HIV ENVELOPE PROTEIN GP160 1988-96%A%  
% 214.56/214.71  |- mesh__dateCreated mesh__D019302 1996-06-10
% 214.56/214.71  |- skos__hiddenLabel mesh__D019302 HIV 1 Envelope Protein gp160
% 214.56/214.71  |- mesh__recordAuthorizer mesh__D019302 sjn
% 214.56/214.71  |- skos__annotation mesh__D019302 DF: GP160   
% 214.56/214.71  |- mesh__publicMeSHNote mesh__D019302
% 214.56/214.71       97; HIV ENVELOPE PROTEIN GP160 was indexed under GENE PRODUCTS, ENV %26% PROTEIN PRECURSORS 1990-96 and RETROVIRIDAE PROTEINS %26% VIRAL ENVELOPE PROTEINS 1988-89%A%  
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D019302 2006
% 214.56/214.71  |- skos__altLabel mesh__D019302 env Protein gp160, HIV
% 214.56/214.71  |- skos__scopeNote mesh__D019302
% 214.56/214.71       An envelope protein of the human immunodeficiency virus that is encoded by the HIV env gene. It has a molecular weight of 160,000 kDa and contains numerous glycosylation sites. It serves as a precursor for both the HIV ENVELOPE PROTEIN GP120 and the HIV ENVELOPE PROTEIN GP41.%A%    
% 214.56/214.71  |- mesh__historyNote mesh__D019302
% 214.56/214.71       97; was HIV ENVELOPE PROTEIN GP160 %28%NM%29% 1988-96   
% 214.56/214.71  |- skos__altLabel mesh__D019302 Envelope Glycoprotein gp160, HIV
% 214.56/214.71  |- skos__altLabel mesh__D019302 gp160%28%HIV%29%
% 214.56/214.71  |- rdf__type mesh__D019302sskos__Concept
% 214.56/214.71  |- skos__historyNote mesh__D019302 Gene Products, env %28%1990-1996%29%
% 214.56/214.71  |- skos__altLabel mesh__D019302 HTLV-III gp160
% 214.56/214.71  |- skos__hiddenLabel mesh__D019302 HIV 2 Envelope Protein gp160
% 214.56/214.71  |- mesh__recordOriginator mesh__D019302 TPW
% 214.56/214.71  |- skos__prefLabel mesh__D019302 HIV Envelope Protein gp160
% 214.56/214.71  |- skos__hiddenLabel mesh__D019302 gp160, HTLV-III
% 214.56/214.71  |- skos__altLabel mesh__D019302 gp160 Envelope Glycoprotein, HIV
% 214.56/214.71  |- mesh__dateEstablished mesh__D019302 1997-01-01
% 214.56/214.71  |- mesh__dateRevised mesh__D019302 2004-07-13
% 214.56/214.71  |- skos__hiddenLabel mesh__D019302 HTLV III gp160
% 214.56/214.71  |- skos__historyNote mesh__D019302 Retroviridae Proteins %28%1988-1989%29%
% 214.56/214.71  |- skos__altLabel mesh__D019302 HIV Envelope Glycoprotein gp160
% 214.56/214.71  |- mesh__recordMaintainer mesh__D019302 sjn
% 214.56/214.71  |- skos__historyNote mesh__D019302
% 214.56/214.71       Viral Envelope Proteins %28%1988-1989%29%
% 214.56/214.71  |- skos__broader mesh__D002593smesh__D000644
% 214.56/214.71  |- mesh__dateCreated mesh__D002593 1974-11-11
% 214.56/214.71  |- skos__altLabel mesh__D002593 Cetyltrimethylammonium Compounds
% 214.56/214.71  |- skos__hiddenLabel mesh__D002593 Compounds, Cetrimonium
% 214.56/214.71  |- mesh__historyNote mesh__D002593
% 214.56/214.71       91%28%75%29%; was see under AMMONIUM COMPOUNDS 1975-90   
% 214.56/214.71  |- mesh__recordOriginator mesh__D002593 NLM
% 214.56/214.71  |- skos__broader mesh__D002593smesh__D050337
% 214.56/214.71  |- mesh__recordAuthorizer mesh__D002593 sjn
% 214.56/214.71  |- mesh__dateRevised mesh__D002593 2005-06-30
% 214.56/214.71  |- rdf__type mesh__D002593sskos__Concept
% 214.56/214.71  |- skos__hiddenLabel mesh__D002593 Compounds, Cetyltrimethylammonium
% 214.56/214.71  |- skos__prefLabel mesh__D002593 Cetrimonium Compounds
% 214.56/214.71  |- skos__historyNote mesh__D002593 Ammonium Compounds %28%1968-1974%29%
% 214.56/214.71  |- mesh__publicMeSHNote mesh__D002593
% 214.56/214.71       91; was see under AMMONIUM COMPOUNDS 1975-90   
% 214.56/214.71  |- mesh__dateEstablished mesh__D002593 1991-01-01
% 214.56/214.71  |- skos__historyNote mesh__D002593 Alkanes %28%1972-1974%29%
% 214.56/214.71  |- mesh__recordMaintainer mesh__D002593 ssb
% 214.56/214.71  |- skos__scopeNote mesh__D002593
% 214.56/214.71       Cetyltrimethylammonium compounds that have cationic detergent, antiseptic, and disinfectant activities. They are used in pharmaceuticals, foods, and cosmetics as preservatives; on skin, mucous membranes, etc., as antiseptics or cleansers, and also as emulsifiers. These compounds are toxic when used orally due to neuromuscular blockade.%A%    
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D002593 2006
% 214.56/214.71  |- skos__annotation mesh__D002593 D25-26 qualif; DF: CETRIMONIUM CPDS   
% 214.56/214.71  |- skos__broader mesh__D003813Q000331smesh__D003813
% 214.56/214.71  |- mesh__preferredCombination mesh__D003813Q000331smesh__D007879
% 214.56/214.71  |- rdf__type mesh__D003813Q000331smesh__CompoundConcept
% 214.56/214.71  |- mesh__historyNote mesh__D010227 was in Cat G only 1963-78   
% 214.56/214.71  |- skos__prefLabel mesh__D010227 Parabiosis
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D010227 1997
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D010227 2005
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D010227 2002
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D010227 1994
% 214.56/214.71  |- mesh__dateRevised mesh__D010227 1992-05-15
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D010227 2006
% 214.56/214.71  |- mesh__recordOriginator mesh__D010227 NLM
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D010227 1998
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D010227 1995
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D010227 2003
% 214.56/214.71  |- mesh__recordAuthorizer mesh__D010227 PLS
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D010227 2000
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D010227 1999
% 214.56/214.71  |- mesh__dateCreated mesh__D010227 1999-01-01
% 214.56/214.71  |- mesh__recordMaintainer mesh__D010227 TAP
% 214.56/214.71  |- skos__hiddenLabel mesh__D010227 Parabioses
% 214.56/214.71  |- rdf__type mesh__D010227sskos__Concept
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D010227 2004
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D010227 1996
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D010227 1993
% 214.56/214.71  |- skos__broader mesh__D010227smesh__D008919
% 214.56/214.71  |- skos__scopeNote mesh__D010227
% 214.56/214.71       The experimental joining of two individuals for the purpose of studying the effects of one on the other.%A%    
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D010227 2001
% 214.56/214.71  |- mesh__dateRevised mesh__D006984 2004-07-07
% 214.56/214.71  |- skos__hiddenLabel mesh__D006984 Hypertrophies
% 214.56/214.71  |- mesh__dateCreated mesh__D006984 1999-01-01
% 214.56/214.71  |- rdf__type mesh__D006984sskos__Concept
% 214.56/214.71  |- mesh__publicMeSHNote mesh__D006984
% 214.56/214.71       65; HYPERTROPHY AND HYPERPLASIA was heading 1963-64   
% 214.56/214.71  |- skos__broader mesh__D006984smesh__D020763
% 214.56/214.71  |- mesh__dateEstablished mesh__D006984 1965-01-01
% 214.56/214.71  |- mesh__recordOriginator mesh__D006984 NLM
% 214.56/214.71  |- skos__scopeNote mesh__D006984
% 214.56/214.71       General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells %28%HYPERPLASIA%29%.%A%    
% 214.56/214.71  |- skos__annotation mesh__D006984
% 214.56/214.71       NIM; general or unspecified:  many precoordinated organ/hypertrophy terms are available; do not confuse with HYPERPLASIA; coord with organ /pathol %28%IM%29%%A%  
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006984 2006
% 214.56/214.71  |- skos__prefLabel mesh__D006984 Hypertrophy
% 214.56/214.71  |- mesh__recordMaintainer mesh__D006984 nns
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006984 2005
% 214.56/214.71  |- skos__related mesh__D006984smesh__D049108
% 214.56/214.71  |- mesh__historyNote mesh__D006984
% 214.56/214.71       65; HYPERTROPHY AND HYPERPLASIA was heading 1963-64   
% 214.56/214.71  |- mesh__recordAuthorizer mesh__D006984 sjn
% 214.56/214.71  |- skos__annotation mesh__D014618 almost never IM; no qualif   
% 214.56/214.71  |- rdf__type mesh__D014618sskos__Concept
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D014618 1991
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D014618 1997
% 214.56/214.71  |- mesh__dateCreated mesh__D014618 1977-04-27
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D014618 2002
% 214.56/214.71  |- mesh__dateEstablished mesh__D014618 1991-01-01
% 214.56/214.71  |- skos__hiddenLabel mesh__D014618 Vacuums
% 214.56/214.71  |- mesh__historyNote mesh__D014618
% 214.56/214.71       91%28%78%29%; was see under ATMOSPHERIC PRESSURE 1978-90   
% 214.56/214.71  |- mesh__dateRevised mesh__D014618 1990-04-13
% 214.56/214.71  |- skos__broader mesh__D014618smesh__D001274
% 214.56/214.71  |- skos__scopeNote mesh__D014618
% 214.56/214.71       A space in which the pressure is far below atmospheric pressure so that the remaining gases do not affect processes being carried on in the space.%A%    
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D014618 2005
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D014618 2000
% 214.56/214.71  |- mesh__publicMeSHNote mesh__D014618
% 214.56/214.71       91; was see under ATMOSPHERIC PRESSURE 1978-90   
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D014618 1994
% 214.56/214.71  |- mesh__recordMaintainer mesh__D014618 NLM
% 214.56/214.71  |- skos__broader mesh__D014618smesh__D011312
% 214.56/214.71  |- skos__prefLabel mesh__D014618 Vacuum
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D014618 1998
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D014618 2006
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D014618 1995
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D014618 2001
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D014618 1992
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D014618 1999
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D014618 2003
% 214.56/214.71  |- mesh__recordAuthorizer mesh__D014618 PLS
% 214.56/214.71  |- mesh__recordOriginator mesh__D014618 VDK
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D014618 1993
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D014618 1996
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D014618 2004
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D019303 2006
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D019303 1999
% 214.56/214.71  |- skos__prefLabel mesh__D019303 Multilingualism
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D019303 2002
% 214.56/214.71  |- rdf__type mesh__D019303sskos__Concept
% 214.56/214.71  |- mesh__historyNote mesh__D019303 97   
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D019303 2003
% 214.56/214.71  |- mesh__dateCreated mesh__D019303 1996-06-10
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D019303 2004
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D019303 1997
% 214.56/214.71  |- skos__historyNote mesh__D019303 Language %28%1968-1996%29%
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D019303 2000
% 214.56/214.71  |- skos__broader mesh__D019303smesh__D007803
% 214.56/214.71  |- skos__scopeNote mesh__D019303
% 214.56/214.71       The ability to speak, read, or write several languages or many languages with some facility. Bilingualism is the most common form. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D019303 2001
% 214.56/214.71  |- mesh__publicMeSHNote mesh__D019303 97   
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D019303 2005
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D019303 1998
% 214.56/214.71  |- skos__annotation mesh__D019303
% 214.56/214.71       IM; do not coord with a Cat Z term to specify the languages, i.e., French-Italian bilingualism = MULTILINGUALISM only %26% not also FRANCE %26% ITALY%A%  
% 214.56/214.71  |- mesh__dateEstablished mesh__D019303 1997-01-01
% 214.56/214.71  |- skos__historyNote mesh__D011320
% 214.56/214.71       Comprehensive Health Care %28%1968-1971%29%
% 214.56/214.71  |- skos__hiddenLabel mesh__D011320 Care, Primary
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D011320 2005
% 214.56/214.71  |- mesh__historyNote mesh__D011320 74%28%72%29%   
% 214.56/214.71  |- mesh__recordOriginator mesh__D011320 NLM
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D011320 2000
% 214.56/214.71  |- mesh__dateEstablished mesh__D011320 1974-01-01
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D011320 2000A
% 214.56/214.71  |- skos__altLabel mesh__D011320 Primary Healthcare
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D011320 2004
% 214.56/214.71  |- rdf__type mesh__D011320sskos__Concept
% 214.56/214.71  |- skos__scopeNote mesh__D011320
% 214.56/214.71       Care which provides integrated, accessible health care services by clinicians who are accountable for addressing a large majority of personal health care needs, developing a sustained partnership with patients, and practicing in the context of family and community. %28%JAMA 1995;273%28%3%29%:192%29%%A%    
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D011320 2003
% 214.56/214.71  |- mesh__recordAuthorizer mesh__D011320 sjn
% 214.56/214.71  |- skos__hiddenLabel mesh__D011320 Care, Primary Health
% 214.56/214.71  |- mesh__dateCreated mesh__D011320 1999-01-01
% 214.56/214.71  |- skos__broader mesh__D011320smesh__D003191
% 214.56/214.71  |- skos__annotation mesh__D011320 IM   
% 214.56/214.71  |- skos__hiddenLabel mesh__D011320 Health Care, Primary
% 214.56/214.71  |- mesh__publicMeSHNote mesh__D011320
% 214.56/214.71       74; CONTINUITY OF PATIENT CARE was see under COMPREHENSIVE HEALTH CARE 1968-78%A%  
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D011320 2002
% 214.56/214.71  |- skos__altLabel mesh__D011320 Primary Care
% 214.56/214.71  |- skos__hiddenLabel mesh__D011320 Healthcare, Primary
% 214.56/214.71  |- skos__prefLabel mesh__D011320 Primary Health Care
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D011320 2006
% 214.56/214.71  |- mesh__dateRevised mesh__D011320 2000-06-14
% 214.56/214.71  |- mesh__recordMaintainer mesh__D011320 sjn
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D011320 2001
% 214.56/214.71  |- skos__altLabel mesh__D002594
% 214.56/214.71       Intra Veno Brand of Cetylpyridinium Chloride
% 214.56/214.71  |- skos__hiddenLabel mesh__D002594 Chloride, Ceepryn
% 214.56/214.71  |- skos__hiddenLabel mesh__D002594 Chloride, Cetylpyridinium
% 214.56/214.71  |- skos__historyNote mesh__D002594 Surface-Active Agents %28%1966-1971%29%
% 214.56/214.71  |- skos__broader mesh__D002594smesh__D011726
% 214.56/214.71  |- rdf__type mesh__D002594sskos__Concept
% 214.56/214.71  |- skos__altLabel mesh__D002594 Catamium
% 214.56/214.71  |- skos__altLabel mesh__D002594
% 214.56/214.71       UPSA Conseil Brand of Cetylpyridinium Chloride
% 214.56/214.71  |- mesh__recordOriginator mesh__D002594 NLM
% 214.56/214.71  |- skos__altLabel mesh__D002594 Hexadecylpyridinium
% 214.56/214.71  |- skos__altLabel mesh__D002594
% 214.56/214.71       Diviser Aquilea Brand of Cetylpyridinium Chloride
% 214.56/214.71  |- mesh__dateEstablished mesh__D002594 1991-01-01
% 214.56/214.71  |- skos__prefLabel mesh__D002594 Cetylpyridinium
% 214.56/214.71  |- mesh__recordAuthorizer mesh__D002594 sjn
% 214.56/214.71  |- skos__annotation mesh__D002594 an anti-infective; = Cepacol   
% 214.56/214.71  |- skos__historyNote mesh__D002594 Pyridinium Compounds %28%1968-1971%29%
% 214.56/214.71  |- mesh__dateRevised mesh__D002594 2005-06-30
% 214.56/214.71  |- mesh__publicMeSHNote mesh__D002594
% 214.56/214.71       91; was see under PYRIDINIUM COMPOUNDS 1972-90   
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D002594 2006
% 214.56/214.71  |- skos__altLabel mesh__D002594 Cetylpyridium
% 214.56/214.71  |- skos__scopeNote mesh__D002594
% 214.56/214.71       Cationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; and also as a component in mouthwash and lozenges.%A%    
% 214.56/214.71  |- skos__historyNote mesh__D002594
% 214.56/214.71       Anti-Infective Agents, Local %28%1966-1971%29%
% 214.56/214.71  |- mesh__historyNote mesh__D002594
% 214.56/214.71       91%28%72%29%; was see under PYRIDINIUM COMPOUNDS 1972-90   
% 214.56/214.71  |- skos__altLabel mesh__D002594 Boots Brand of Cetylpyridinium Chloride
% 214.56/214.71  |- skos__altLabel mesh__D002594
% 214.56/214.71       Aventis Pharma Brand of Cetylpyridinium Chloride
% 214.56/214.71  |- mesh__recordMaintainer mesh__D002594 lkw
% 214.56/214.71  |- mesh__dateCreated mesh__D002594 1999-01-01
% 214.56/214.71  |- skos__altLabel mesh__D043402 Serine Carboxypeptidase I
% 214.56/214.71  |- skos__broader mesh__D043402smesh__D002268
% 214.56/214.71  |- skos__scopeNote mesh__D043402
% 214.56/214.71       A carboxypeptidase that catalyzes the release of a C-terminal amino acid with a broad specificity. It also plays a role in the LYSOSOMES by protecting BETA-GALACTOSIDASE and NEURAMINIDASE from degradation. It was formerly classified as EC 3.4.12.1 and EC 3.4.21.13.%A%    
% 214.56/214.71  |- skos__altLabel mesh__D043402 Carboxypeptidase Y
% 214.56/214.71  |- skos__altLabel mesh__D043402 Lysosomal Protective Protein
% 214.56/214.71  |- skos__altLabel mesh__D043402 Beta-galactosidase Protective Protein
% 214.56/214.71  |- mesh__dateCreated mesh__D043402 2003-07-09
% 214.56/214.71  |- skos__historyNote mesh__D043402 Cathepsins %28%1965-2003%29%
% 214.56/214.71  |- mesh__recordAuthorizer mesh__D043402 sjn
% 214.56/214.71  |- mesh__recordMaintainer mesh__D043402 AKE
% 214.56/214.71  |- skos__prefLabel mesh__D043402 Carboxypeptidase C
% 214.56/214.71  |- mesh__publicMeSHNote mesh__D043402
% 214.56/214.71       2004; CARBOXYPEPTIDASE C was indexed under CARBOXYPEPTIDASES 1995-2003%A%  
% 214.56/214.71  |- mesh__dateEstablished mesh__D043402 2004-01-01
% 214.56/214.71  |- skos__hiddenLabel mesh__D043402 Protective Protein, Beta-galactosidase
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D043402 2005
% 214.56/214.71  |- skos__altLabel mesh__D043402 Acid Carboxypeptidase
% 214.56/214.71  |- skos__broader mesh__D043402smesh__D002403
% 214.56/214.71  |- skos__altLabel mesh__D043402 Cathepsin A
% 214.56/214.71  |- mesh__recordOriginator mesh__D043402 AKE
% 214.56/214.71  |- rdf__type mesh__D043402sskos__Concept
% 214.56/214.71  |- skos__hiddenLabel mesh__D043402 Beta galactosidase Protective Protein
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D043402 2006
% 214.56/214.71  |- skos__historyNote mesh__D043402 Carboxypeptidases %28%1968-2003%29%
% 214.56/214.71  |- skos__altLabel mesh__D043402 Endothelin Degradation Enzyme
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D043402 2004
% 214.56/214.71  |- mesh__historyNote mesh__D043402
% 214.56/214.71       2004; use CARBOXYPEPTIDASE C %28%NM%29% 1995-2003   
% 214.56/214.71  |- skos__altLabel mesh__D043402 BGPP
% 214.56/214.71  |- skos__broader mesh__D010228smesh__D003904
% 214.56/214.71  |- mesh__dateRevised mesh__D010228 2005-06-30
% 214.56/214.71  |- rdf__type mesh__D010228sskos__Concept
% 214.56/214.71  |- skos__altLabel mesh__D010228 Paracoccidioides brasiliensis
% 214.56/214.71  |- skos__scopeNote mesh__D010228
% 214.56/214.71       A mitosporic fungal genus. P. brasiliensis %28%previously Blastomyces brasiliensis%29% is the etiologic agent of PARACOCCIDIOIDOMYCOSIS.%A%    
% 214.56/214.71  |- mesh__dateCreated mesh__D010228 1999-01-01
% 214.56/214.71  |- mesh__dateEstablished mesh__D010228 1991-01-01
% 214.56/214.71  |- mesh__historyNote mesh__D010228 91%28%72%29%   
% 214.56/214.71  |- mesh__recordAuthorizer mesh__D010228 sjn
% 214.56/214.71  |- skos__prefLabel mesh__D010228 Paracoccidioides
% 214.56/214.71  |- mesh__publicMeSHNote mesh__D010228
% 214.56/214.71       91; see HYPHOMYCETES 1986-90, see PHYCOMYCETES 1975-85   
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D010228 2006
% 214.56/214.71  |- mesh__recordMaintainer mesh__D010228 SYSTEM
% 214.56/214.71  |- skos__annotation mesh__D010228 infection = PARACOCCIDIOIDOMYCOSIS   
% 214.56/214.71  |- mesh__recordOriginator mesh__D010228 NLM
% 214.56/214.71  |- skos__historyNote mesh__D010228 Phycomyces %28%1966-1971%29%
% 214.56/214.71  |- skos__prefLabel mesh__D006985 Hyperventilation
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006985 2004
% 214.56/214.71  |- mesh__publicMeSHNote mesh__D006985 64   
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006985 2000
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006985 2006
% 214.56/214.71  |- mesh__recordMaintainer mesh__D006985 KEV
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006985 2003
% 214.56/214.71  |- mesh__historyNote mesh__D006985 64   
% 214.56/214.71  |- mesh__recordAuthorizer mesh__D006985 sjn
% 214.56/214.71  |- mesh__dateRevised mesh__D006985 1999-11-03
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006985 2005
% 214.56/214.71  |- mesh__dateEstablished mesh__D006985 1964-01-01
% 214.56/214.71  |- skos__broader mesh__D006985smesh__D012120
% 214.56/214.71  |- skos__broader mesh__D006985smesh__D012818
% 214.56/214.71  |- skos__hiddenLabel mesh__D006985 Hyperventilations
% 214.56/214.71  |- mesh__activeMeSHYear mesh__D006985 2002
% 214.56/214.71  |- mesh__dateCreated mesh__D006985 1999-01-01
% 214.56/214.71  |- skos__related mesh__D006985smesh__D016857
% 214.56/214.71  |- rdf__type mesh__D006985sskos__Concept
% 214.56/214.71  |- skos__scopeNote mesh__D006985
% 214.56/214.71       A pulmonary ventilation rate faster than is metabolically necessary for the exchange of gases. It is the result of an increased frequency of breathing, an increased tidal volume, or a combination of both. It causes an excess intake of oxygen and the blowing off of carbon dioxide.%A%    
% 214.58/214.71  |- mesh__activeMeSHYear mesh__D006985 2001
% 214.58/214.71  |- mesh__recordOriginator mesh__D006985 NLM
% 214.58/214.71  |- skos__annotation mesh__D006985
% 214.58/214.71       respiratory, not environmental; hyperventilation syndrome: coord IM with /psychol + emotional aspect %28%IM or NIM%29%%A%  
% 214.58/214.71  |- skos__scopeNote mesh__D020656
% 214.58/214.71       A transitional diencephalic zone of the thalamus consisting of complex and varied cells lying caudal to the ventral posterolateral nucleus, medial to the rostal part of the pulvinar, and dorsal to the medial geniculate body. It contains the limitans, posterior, suprageniculate, and submedial nuclei.%A%    
% 214.58/214.71  |- mesh__activeMeSHYear mesh__D020656 2006
% 214.58/214.71  |- mesh__activeMeSHYear mesh__D020656 2003
% 214.58/214.71  |- skos__hiddenLabel mesh__D020656 Nuclei, Posterior Thalamic
% 214.58/214.71  |- skos__hiddenLabel mesh__D020656 Nuclear Complex, Posterior
% 214.58/214.71  |- skos__altLabel mesh__D020656 Posterior Thalamic Nuclear Group
% 214.58/214.71  |- skos__prefLabel mesh__D020656 Posterior Thalamic Nuclei
% 214.58/214.71  |- mesh__activeMeSHYear mesh__D020656 2005
% 214.58/214.71  |- skos__broader mesh__D020656smesh__D013787
% 214.58/214.71  |- skos__hiddenLabel mesh__D020656 Nucleus, Supergeniculate
% 214.58/214.71  |- skos__hiddenLabel mesh__D020656 Nucleus, Limitans
% 214.58/214.71  |- mesh__dateCreated mesh__D020656 1999-11-08
% 214.58/214.71  |- skos__altLabel mesh__D020656 Posterior Nuclear Complex
% 214.58/214.71  |- mesh__dateEstablished mesh__D020656 2000-01-01
% 214.58/214.71  |- skos__hiddenLabel mesh__D020656 Nucleus, Suprageniculate Thalamic
% 214.58/214.71  |- skos__hiddenLabel mesh__D020656 Nucleus, Submedial
% 214.58/214.71  |- skos__hiddenLabel mesh__D020656 Complices, Posterior Nuclear
% 214.58/214.71  |- skos__hiddenLabel mesh__D020656 Thalamic Nuclei, Posterior
% 214.58/214.71  |- skos__hiddenLabel mesh__D020656 Thalamic Nucleus, Posterior
% 214.58/214.71  |- mesh__activeMeSHYear mesh__D020656 2002
% 214.58/214.71  |- mesh__historyNote mesh__D020656 2000   
% 214.58/214.71  |- mesh__publicMeSHNote mesh__D020656 2000   
% 214.58/214.71  |- skos__hiddenLabel mesh__D020656 Thalamic Nucleus, Suprageniculate
% 214.58/214.71  |- skos__altLabel mesh__D020656 Supergeniculate Nucleus
% 214.58/214.71  |- mesh__activeMeSHYear mesh__D020656 2001
% 214.58/214.71  |- skos__historyNote mesh__D020656 Thalamic Nuclei %28%1973-1999%29%
% 214.58/214.71  |- mesh__activeMeSHYear mesh__D020656 2004
% 214.58/214.71  |- skos__hiddenLabel mesh__D020656 Posterior Nuclear Complices
% 214.58/214.71  |- skos__hiddenLabel mesh__D020656 Nuclear Complices, Posterior
% 214.58/214.71  |- mesh__activeMeSHYear mesh__D020656 2000
% 214.58/214.71  |- skos__hiddenLabel mesh__D020656 Thalamus Posterior Nucleus
% 214.58/214.71  |- rdf__type mesh__D020656sskos__Concept
% 214.58/214.71  |- skos__hiddenLabel mesh__D020656 Posterior Thalamic Nucleus
% 214.58/214.71  |- mesh__recordMaintainer mesh__D039361 nns
% 214.58/214.71  |- mesh__activeMeSHYear mesh__D039361 2004
% 214.58/214.71  |- mesh__dateCreated mesh__D039361 2002-07-03
% 214.58/214.71  |- skos__annotation mesh__D039361 GEN only; avoid: prefer specifics   
% 214.58/214.71  |- skos__prefLabel mesh__D039361 Genetic Processes
% 214.58/214.71  |- mesh__dateRevised mesh__D039361 2003-07-09
% 214.58/214.71  |- skos__related mesh__D039361smesh__D040341
% 214.58/214.71  |- mesh__dateEstablished mesh__D039361 2003-01-01
% 214.58/214.72  |- rdf__type mesh__D039361sskos__Concept
% 214.58/214.72  |- mesh__historyNote mesh__D039361 2003   
% 214.58/214.72  |- mesh__recordAuthorizer mesh__D039361 sjn
% 214.58/214.72  |- mesh__publicMeSHNote mesh__D039361 2003   
% 214.58/214.72  |- skos__related mesh__D039361smesh__D040342
% 214.58/214.72  |- skos__hiddenLabel mesh__D039361 Processes, Genetic
% 214.58/214.72  |- skos__hiddenLabel mesh__D039361 Process, Genetic
% 214.58/214.72  |- skos__scopeNote mesh__D039361
% 214.58/214.72       Those biological processes that are involved in the transmission of hereditary traits from one organism to another.%A%    
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D039361 2006
% 214.58/214.72  |- skos__related mesh__D039361smesh__D005823
% 214.58/214.72  |- mesh__runningHead mesh__D039361 G5 - GENETIC PROCESSES   
% 214.58/214.72  |- mesh__recordOriginator mesh__D039361 nns
% 214.58/214.72  |- skos__altLabel mesh__D039361 Genetic Process
% 214.58/214.72  |- skos__related mesh__D039361smesh__D005821
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D039361 2005
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Pump, Vacuum
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Foot-Operated Vacuum Pumps
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Vacuum Pump, Hand Operated
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Pump, Foot-Operated Vacuum
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Hand-Operated Vacuum Pump
% 214.58/214.72  |- mesh__dateRevised mesh__D014619 1997-06-20
% 214.58/214.72  |- mesh__dateEstablished mesh__D014619 1991-01-01
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Pump, Electrical Vacuum
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Vacuum Pumps, Electrical
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Vacuum Pump, Foot Operated
% 214.58/214.72  |- mesh__recordMaintainer mesh__D014619 PXP
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D014619 2004
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Aspirations, Vacuum
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Curettages, Suction
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Uterine Aspirators
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Pumps, Vacuum
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Electrical Vacuum Pumps
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D014619 2002
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Pumps, Hand-Operated Vacuum
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D014619 2003
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Pump, Hand-Operated Vacuum
% 214.58/214.72  |- mesh__recordAuthorizer mesh__D014619 SJN
% 214.58/214.72  |- mesh__dateCreated mesh__D014619 1975-02-04
% 214.58/214.72  |- skos__annotation mesh__D014619
% 214.58/214.72       do not use /util except by MeSH definition   
% 214.58/214.72  |- skos__altLabel mesh__D014619 Suction Curettage
% 214.58/214.72  |- skos__broader mesh__D014619smesh__D004107
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Vacuum Curettages
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Aspirator, Uterine
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D014619 1999
% 214.58/214.72  |- mesh__recordOriginator mesh__D014619 NLM
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D014619 2006
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Suction Curettages
% 214.58/214.72  |- mesh__historyNote mesh__D014619
% 214.58/214.72       91%28%75%29%; was see under DILATATION AND CURETTAGE 1975-90   
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Electrical Vacuum Pump
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D014619 2001
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Curettage, Suction
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Vacuum Pumps, Foot-Operated
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Aspiration, Vacuum
% 214.58/214.72  |- rdf__type mesh__D014619sskos__Concept
% 214.58/214.72  |- skos__altLabel mesh__D014619 Vacuum Aspiration
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Pumps, Foot-Operated Vacuum
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D014619 1998
% 214.58/214.72  |- mesh__publicMeSHNote mesh__D014619
% 214.58/214.72       91; was see under DILATATION AND CURETTAGE 1975-90   
% 214.58/214.72  |- skos__prefLabel mesh__D014619 Vacuum Curettage
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Vacuum Pumps
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Curettages, Vacuum
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D014619 2005
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Pumps, Electrical Vacuum
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Foot-Operated Vacuum Pump
% 214.58/214.72  |- skos__scopeNote mesh__D014619
% 214.58/214.72       Aspiration of the contents of the uterus with a vacuum curette.%A%    
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Vacuum Pumps, Hand-Operated
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Vacuum Aspirations
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Curettage, Vacuum
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D014619 2000
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Aspirators, Uterine
% 214.58/214.72  |- skos__hiddenLabel mesh__D014619 Hand-Operated Vacuum Pumps
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D025341 2002
% 214.58/214.72  |- mesh__historyNote mesh__D025341 2002   
% 214.58/214.72  |- skos__hiddenLabel mesh__D025341 Principal Component Analyses
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D025341 2004
% 214.58/214.72  |- rdf__type mesh__D025341sskos__Concept
% 214.58/214.72  |- skos__hiddenLabel mesh__D025341 Analysis, Principal Component
% 214.58/214.72  |- skos__prefLabel mesh__D025341 Principal Component Analysis
% 214.58/214.72  |- mesh__dateEstablished mesh__D025341 2002-01-01
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D025341 2006
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D025341 2003
% 214.58/214.72  |- mesh__publicMeSHNote mesh__D025341 2002   
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D025341 2005
% 214.58/214.72  |- skos__hiddenLabel mesh__D025341 Analyses, Principal Component
% 214.58/214.72  |- skos__broader mesh__D025341smesh__D013223
% 214.58/214.72  |- mesh__dateCreated mesh__D025341 2001-07-25
% 214.58/214.72  |- skos__scopeNote mesh__D025341
% 214.58/214.72       Mathematical procedure that transforms a number of possibly correlated variables into a smaller number of uncorrelated variables called principal components.%A%    
% 214.58/214.72  |- skos__scopeNote mesh__D019304
% 214.58/214.72       ETHINYL ESTRADIOL and NORGESTREL given in fixed proportions. It has proved to be an effective contraceptive %28%CONTRACEPTIVES, ORAL, COMBINED%29%.%A%    
% 214.58/214.72  |- mesh__publicMeSHNote mesh__D019304
% 214.58/214.72       97; STEDIRIL was indexed under NORGESTREL %26% ETHINYL ESTRADIOL 1972-96, CONTRACEPTIVES, ORAL, COMBINED 1976-82, %26% CONTRACEPTIVES, ORAL 1972-77%A%  
% 214.58/214.72  |- skos__historyNote mesh__D019304
% 214.58/214.72       Contraceptives, Oral, Combined %28%1976-1982%29%
% 214.58/214.72  |- mesh__recordMaintainer mesh__D019304 lkt
% 214.58/214.72  |- skos__historyNote mesh__D019304 Contraceptives, Oral %28%1972-1977%29%
% 214.58/214.72  |- skos__hiddenLabel mesh__D019304
% 214.58/214.72       Estradiol-Norgestrel Combination, Ethinyl
% 214.58/214.72  |- skos__hiddenLabel mesh__D019304 R, Trisistone
% 214.58/214.72  |- skos__hiddenLabel mesh__D019304
% 214.58/214.72       Estradiol Combination, Norgestrel-Ethinyl
% 214.58/214.72  |- mesh__historyNote mesh__D019304 97; was STEDIRIL %28%NM%29% 1972-96   
% 214.58/214.72  |- skos__hiddenLabel mesh__D019304 Oral Contraceptive, Pearl
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D019304 2006
% 214.58/214.72  |- skos__annotation mesh__D019304 DF: EEN COMBINATION   
% 214.58/214.72  |- skos__prefLabel mesh__D019304 Ethinyl Estradiol-Norgestrel Combination
% 214.58/214.72  |- mesh__recordOriginator mesh__D019304 ADP
% 214.58/214.72  |- skos__altLabel mesh__D019304 Norgestrel-Ethinyl Estradiol Combination
% 214.58/214.72  |- skos__hiddenLabel mesh__D019304 TrisistoneR
% 214.58/214.72  |- rdf__type mesh__D019304sskos__Concept
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D019304 2005
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D019304 2004
% 214.58/214.72  |- skos__hiddenLabel mesh__D019304
% 214.58/214.72       Combination, Ethinyl Estradiol-Norgestrel
% 214.58/214.72  |- skos__hiddenLabel mesh__D019304 Contraceptive, Pearl Oral
% 214.58/214.72  |- skos__broader mesh__D019304smesh__D009644
% 214.58/214.72  |- skos__altLabel mesh__D019304 Trisistone R
% 214.58/214.72  |- mesh__onlineNote mesh__D019304
% 214.58/214.72       use ETHINYL ESTRADIOL-NORGESTREL COMBINATION %28%NM%29% to search STEDIRIL 1980-96%A%  
% 214.58/214.72  |- skos__historyNote mesh__D019304 Norgestrel %28%1972-1996%29%
% 214.58/214.72  |- mesh__dateRevised mesh__D019304 2003-07-09
% 214.58/214.72  |- skos__broader mesh__D019304smesh__D004997
% 214.58/214.72  |- skos__hiddenLabel mesh__D019304
% 214.58/214.72       Combination, Norgestrel-Ethinyl Estradiol
% 214.58/214.72  |- skos__hiddenLabel mesh__D019304 Ethinyl Estradiol Norgestrel Combination
% 214.58/214.72  |- skos__hiddenLabel mesh__D019304 Norgestrel Ethinyl Estradiol Combination
% 214.58/214.72  |- mesh__dateEstablished mesh__D019304 1997-01-01
% 214.58/214.72  |- mesh__recordAuthorizer mesh__D019304 sjn
% 214.58/214.72  |- mesh__dateCreated mesh__D019304 1996-06-10
% 214.58/214.72  |- skos__historyNote mesh__D019304 Ethinyl Estradiol %28%1972-1996%29%
% 214.58/214.72  |- skos__prefLabel mesh__D011321 Primary Nursing Care
% 214.58/214.72  |- rdf__type mesh__D011321sskos__Concept
% 214.58/214.72  |- skos__historyNote mesh__D011321 Primary Health Care %28%1974-1976%29%
% 214.58/214.72  |- mesh__recordMaintainer mesh__D011321 TGC
% 214.58/214.72  |- skos__hiddenLabel mesh__D011321 Cares, Primary Nursing
% 214.58/214.72  |- skos__hiddenLabel mesh__D011321 Primary Nursing Cares
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D011321 2004
% 214.58/214.72  |- mesh__recordOriginator mesh__D011321 EC
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D011321 1996
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D011321 1995
% 214.58/214.72  |- skos__broader mesh__D011321smesh__D009732
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D011321 2001
% 214.58/214.72  |- skos__hiddenLabel mesh__D011321 Nursing Cares, Primary
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D011321 2003
% 214.58/214.72  |- skos__altLabel mesh__D011321 Care, Primary Nursing
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D011321 1994
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D011321 2000
% 214.58/214.72  |- mesh__dateEstablished mesh__D011321 1977-01-01
% 214.58/214.72  |- skos__altLabel mesh__D011321 Nursing Care, Primary
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D011321 1999
% 214.58/214.72  |- skos__historyNote mesh__D011321 Nursing Care %28%1974-1976%29%
% 214.58/214.72  |- skos__scopeNote mesh__D011321
% 214.58/214.72       The primary responsibility of one nurse for the planning, evaluation, and care of a patient throughout the course of illness, convalescence, and recovery.%A%    
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D011321 1993
% 214.58/214.72  |- mesh__dateCreated mesh__D011321 1976-05-19
% 214.58/214.72  |- mesh__recordAuthorizer mesh__D011321 PLS
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D011321 2006
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D011321 1998
% 214.58/214.72  |- mesh__historyNote mesh__D011321 77   
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D011321 2005
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D011321 1997
% 214.58/214.72  |- mesh__dateRevised mesh__D011321 1992-05-18
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D011321 2002
% 214.58/214.72  |- mesh__publicMeSHNote mesh__D011321 77   
% 214.58/214.72  |- skos__prefLabel mesh__D002595 Cevanes
% 214.58/214.72  |- skos__altLabel mesh__D002595 Cevane Alkaloids
% 214.58/214.72  |- mesh__recordAuthorizer mesh__D002595 sjn
% 214.58/214.72  |- mesh__dateRevised mesh__D002595 2000-06-21
% 214.58/214.72  |- mesh__recordMaintainer mesh__D002595 jmp
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D002595 2001
% 214.58/214.72  |- rdf__type mesh__D002595sskos__Concept
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D002595 2003
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D002595 2005
% 214.58/214.72  |- mesh__historyNote mesh__D002595 69   
% 214.58/214.72  |- mesh__dateCreated mesh__D002595 1999-01-01
% 214.58/214.72  |- mesh__dateEstablished mesh__D002595 1969-01-01
% 214.58/214.72  |- skos__broader mesh__D002595smesh__D006576
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D002595 2004
% 214.58/214.72  |- skos__broader mesh__D002595smesh__D014704
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D002595 2002
% 214.58/214.72  |- skos__historyNote mesh__D002595 Veratrum %28%1966-1968%29%
% 214.58/214.72  |- skos__scopeNote mesh__D002595
% 214.58/214.72       Structurally-related alkaloids that contain the cevane carbon backbone.%A%    
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D002595 2006
% 214.58/214.72  |- mesh__publicMeSHNote mesh__D002595 69   
% 214.58/214.72  |- mesh__recordOriginator mesh__D002595 NLM
% 214.58/214.72  |- skos__hiddenLabel mesh__D002595 Alkaloids, Cevane
% 214.58/214.72  |- skos__broader mesh__D010229smesh__D003881
% 214.58/214.72  |- mesh__recordOriginator mesh__D010229 NLM
% 214.58/214.72  |- mesh__onlineNote mesh__D010229 search BLASTOMYCOSIS 1966-74   
% 214.58/214.72  |- skos__altLabel mesh__D010229 Blastomycosis, South American
% 214.58/214.72  |- skos__broader mesh__D010229smesh__D009181
% 214.58/214.72  |- mesh__dateEstablished mesh__D010229 1977-01-01
% 214.58/214.72  |- skos__hiddenLabel mesh__D010229 South American Blastomycosis
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D010229 2002
% 214.58/214.72  |- mesh__recordAuthorizer mesh__D010229 SJN
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D010229 2006
% 214.58/214.72  |- mesh__publicMeSHNote mesh__D010229
% 214.58/214.72       77; was see under BLASTOMYCOSIS 1963-76   
% 214.58/214.72  |- mesh__recordMaintainer mesh__D010229 AGS
% 214.58/214.72  |- mesh__historyNote mesh__D010229
% 214.58/214.72       77%28%75%29%; was see under BLASTOMYCOSIS 1963-76   
% 214.58/214.72  |- skos__scopeNote mesh__D010229
% 214.58/214.72       A mycosis affecting the skin, mucous membranes, lymph nodes, and internal organs. It is caused by Paracoccidioides brasiliensis. It is also called paracoccidioidal granuloma. Superficial resemblance of P. brasiliensis to Blastomyces brasiliensis %28%BLASTOMYCES%29% may cause misdiagnosis.%A%    
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D010229 2004
% 214.58/214.72  |- skos__historyNote mesh__D010229 Blastomycosis %28%1966-1974%29%
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D010229 2005
% 214.58/214.72  |- mesh__dateRevised mesh__D010229 1998-06-10
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D010229 1999
% 214.58/214.72  |- skos__annotation mesh__D010229
% 214.58/214.72       fungus dis of skin caused by Paracoccidioides; do not confuse X ref BLASTOMYCOSIS, SOUTH AMERICAN with BLASTOMYCOSIS, NORTH AMERICAN see BLASTOMYCOSIS%A%  
% 214.58/214.72  |- rdf__type mesh__D010229sskos__Concept
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D010229 2001
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D010229 2003
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D010229 2000
% 214.58/214.72  |- skos__hiddenLabel mesh__D010229 Paracoccidioidomycoses
% 214.58/214.72  |- mesh__dateCreated mesh__D010229 1999-01-01
% 214.58/214.72  |- skos__prefLabel mesh__D010229 Paracoccidioidomycosis
% 214.58/214.72  |- rdf__type mesh__D007280sskos__Concept
% 214.58/214.72  |- skos__annotation mesh__D007280
% 214.58/214.72       not used for indexing      CATALOG: do not use   
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D007280 2001
% 214.58/214.72  |- skos__altLabel mesh__D007280
% 214.58/214.72       Injuries, Poisonings, and Occupational Diseases
% 214.58/214.72  |- mesh__dateRevised mesh__D007280 1999-11-03
% 214.58/214.72  |- mesh__recordOriginator mesh__D007280 NLM
% 214.58/214.72  |- mesh__runningHead mesh__D007280
% 214.58/214.72       C21 - DISORDERS OF ENVIRONMENTAL ORIGIN   
% 214.58/214.72  |- skos__scopeNote mesh__D007280
% 214.58/214.72       Disorders representing collectively the results of assault by external forces, rather than by organic or physiologic dysfunction or by pathogens.%A%    
% 214.58/214.72  |- mesh__recordMaintainer mesh__D007280 adp
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D007280 2003
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D007280 2002
% 214.58/214.72  |- mesh__dateCreated mesh__D007280 1999-01-01
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D007280 2005
% 214.58/214.72  |- mesh__historyNote mesh__D007280 2000%28%1997%29%; use explode 1970-97   
% 214.58/214.72  |- mesh__publicMeSHNote mesh__D007280
% 214.58/214.72       2000; see INJURIES, POISONINGS, AND OCCUPATIONAL DISEASES 1974-1999%A%  
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D007280 2004
% 214.58/214.72  |- mesh__recordAuthorizer mesh__D007280 sjn
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D007280 2006
% 214.58/214.72  |- skos__prefLabel mesh__D007280 Disorders of Environmental Origin
% 214.58/214.72  |- mesh__dateEstablished mesh__D007280 1998-01-01
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D007280 2000
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006986 2003
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006986 2001
% 214.58/214.72  |- mesh__dateEstablished mesh__D006986 1987-01-01
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006986 2005
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006986 1997
% 214.58/214.72  |- mesh__recordMaintainer mesh__D006986 PLS
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006986 1999
% 214.58/214.72  |- mesh__dateCreated mesh__D006986 1986-04-18
% 214.58/214.72  |- skos__annotation mesh__D006986 excessive intake of vitamin A   
% 214.58/214.72  |- skos__prefLabel mesh__D006986 Hypervitaminosis A
% 214.58/214.72  |- mesh__historyNote mesh__D006986 87   
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006986 2000
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006986 1996
% 214.58/214.72  |- mesh__recordOriginator mesh__D006986 VDK
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006986 1995
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006986 1998
% 214.58/214.72  |- skos__historyNote mesh__D006986 Vitamin A %28%1966-1986%29%
% 214.58/214.72  |- mesh__publicMeSHNote mesh__D006986 87   
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006986 1994
% 214.58/214.72  |- rdf__type mesh__D006986sskos__Concept
% 214.58/214.72  |- mesh__dateRevised mesh__D006986 1993-06-02
% 214.58/214.72  |- skos__scopeNote mesh__D006986
% 214.58/214.72       A symptom complex resulting from ingestion of excessive amounts of vitamin A.%A%    
% 214.58/214.72  |- mesh__recordAuthorizer mesh__D006986 PLS
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006986 2004
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006986 2002
% 214.58/214.72  |- skos__broader mesh__D006986smesh__D008659
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006986 2006
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006188 1998
% 214.58/214.72  |- skos__prefLabel mesh__D006188 Haemonchiasis
% 214.58/214.72  |- skos__hiddenLabel mesh__D006188 Haemonchiases
% 214.58/214.72  |- mesh__publicMeSHNote mesh__D006188
% 214.58/214.72       91; was see under TRICHOSTRONGYLOIDIASIS 1975-90   
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006188 2003
% 214.58/214.72  |- mesh__dateRevised mesh__D006188 1993-06-04
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006188 1994
% 214.58/214.72  |- rdf__type mesh__D006188sskos__Concept
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006188 1999
% 214.58/214.72  |- mesh__onlineNote mesh__D006188 search TRICHOSTRONGYLOIDIASIS 1968-74   
% 214.58/214.72  |- mesh__recordOriginator mesh__D006188 NLM
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006188 2004
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006188 1995
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006188 2000
% 214.58/214.72  |- mesh__historyNote mesh__D006188
% 214.58/214.72       91%28%75%29%; was see under TRICHOSTRONGYLOIDIASIS 1975-90   
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006188 2005
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006188 1996
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006188 2001
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006188 2006
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006188 1997
% 214.58/214.72  |- mesh__recordAuthorizer mesh__D006188 PLS
% 214.58/214.72  |- mesh__dateCreated mesh__D006188 1999-01-01
% 214.58/214.72  |- skos__broader mesh__D006188smesh__D014252
% 214.58/214.72  |- mesh__dateEstablished mesh__D006188 1991-01-01
% 214.58/214.72  |- skos__annotation mesh__D006188 nematode infect   
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D006188 2002
% 214.58/214.72  |- skos__scopeNote mesh__D006188
% 214.58/214.72       Infection with nematodes of the genus HAEMONCHUS, characterized by digestive abnormalities and anemia similar to that from hookworm infestation.%A%    
% 214.58/214.72  |- mesh__recordMaintainer mesh__D006188 JLS
% 214.58/214.72  |- mesh__recordAuthorizer mesh__D019305 ags
% 214.58/214.72  |- mesh__publicMeSHNote mesh__D019305 1997   
% 214.58/214.72  |- mesh__dateEstablished mesh__D019305 1997-01-01
% 214.58/214.72  |- skos__hiddenLabel mesh__D019305 Epilepsies, Rolandic
% 214.58/214.72  |- skos__altLabel mesh__D019305 Epilepsy, Centrotemporal
% 214.58/214.72  |- skos__hiddenLabel mesh__D019305 Rolandic Epilepsies
% 214.58/214.72  |- skos__hiddenLabel mesh__D019305 Epilepsies, Centrotemporal
% 214.58/214.72  |- skos__hiddenLabel mesh__D019305 Epilepsy, Centralopathic
% 214.58/214.72  |- skos__hiddenLabel mesh__D019305 Epilepsy, Sylvian
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D019305 2003
% 214.58/214.72  |- skos__altLabel mesh__D019305 Centralopathic Epilepsy
% 214.58/214.72  |- skos__hiddenLabel mesh__D019305 Epilepsies, Centralopathic
% 214.58/214.72  |- skos__scopeNote mesh__D019305
% 214.58/214.72       An autosomal dominant inherited partial epilepsy syndrome with onset between age 3 and 13 years. Seizures are characterized by PARESTHESIA and tonic or clonic activity of the lower face associated with drooling and dysarthria. The episodes tend to occur at night and may become secondarily generalized. In most cases, affected children are neurologically and developmentally normal. The electroencephalogram shows characteristic high-voltage sharp waves over the central temporal regions, which are more prominent during drowsiness and sleep. In general, seizures do not continue beyond mid-adolescence. %28%From Epilepsia 1998 39;Suppl 4:S32-S41%29%%A%    
% 214.58/214.72  |- skos__hiddenLabel mesh__D019305 Epilepsy, Benign Rolandic
% 214.58/214.72  |- skos__altLabel mesh__D019305 Rolands Epilepsy
% 214.58/214.72  |- skos__broader mesh__D019305smesh__D004828
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D019305 2002
% 214.58/214.72  |- skos__altLabel mesh__D019305 Benign Rolandic Epilepsy
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D019305 2004
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D019305 2005
% 214.58/214.72  |- rdf__type mesh__D019305sskos__Concept
% 214.58/214.72  |- skos__hiddenLabel mesh__D019305 Rolandic Epilepsy
% 214.58/214.72  |- mesh__dateRevised mesh__D019305 1999-12-13
% 214.58/214.72  |- skos__altLabel mesh__D019305 Sylvian Epilepsy
% 214.58/214.72  |- skos__hiddenLabel mesh__D019305 Centralopathic Epilepsies
% 214.58/214.72  |- mesh__historyNote mesh__D019305 1997   
% 214.58/214.72  |- mesh__recordMaintainer mesh__D019305 ags
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D019305 2006
% 214.58/214.72  |- skos__prefLabel mesh__D019305 Epilepsy, Rolandic
% 214.58/214.72  |- skos__altLabel mesh__D019305
% 214.58/214.72       Benign Childhood Epilepsy With Centro-Temporal Spikes
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D019305 2000A
% 214.58/214.72  |- skos__altLabel mesh__D019305
% 214.58/214.72       Benign Epilepsy, Childhood, Centrotemporal Spikes
% 214.58/214.72  |- skos__historyNote mesh__D019305 Epilepsy, Partial %28%1986-1996%29%
% 214.58/214.72  |- skos__hiddenLabel mesh__D019305 Centrotemporal Epilepsies
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D019305 2000
% 214.58/214.72  |- skos__altLabel mesh__D019305 Benign Rolandic Epilepsy of Childhood
% 214.58/214.72  |- mesh__dateCreated mesh__D019305 1996-06-13
% 214.58/214.72  |- mesh__recordOriginator mesh__D019305 JLS
% 214.58/214.72  |- skos__hiddenLabel mesh__D019305 Centrotemporal Epilepsy
% 214.58/214.72  |- skos__hiddenLabel mesh__D019305
% 214.58/214.72       Benign Childhood Epilepsy With Centro Temporal Spikes
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D019305 2001
% 214.58/214.72  |- skos__hiddenLabel mesh__D019305 Epilepsy, Rolands
% 214.58/214.72  |- skos__hiddenLabel mesh__D019305 Rolandic Epilepsy, Benign
% 214.58/214.72  |- skos__historyNote mesh__D011322
% 214.58/214.72       Preventive Health Services %28%1968-1978%29%
% 214.58/214.72  |- skos__related mesh__D011322smesh__D011314
% 214.58/214.72  |- skos__broader mesh__D011322smesh__D011314
% 214.58/214.72  |- mesh__dateEstablished mesh__D011322 1979-01-01
% 214.58/214.72  |- skos__related mesh__D011322smesh__D011315
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D011322 2006
% 214.58/214.72  |- skos__scopeNote mesh__D011322
% 214.58/214.72       Specific practices for the prevention of disease or mental disorders in susceptible individuals or populations. These include HEALTH PROMOTION, including mental health; protective procedures, such as COMMUNICABLE DISEASE CONTROL; and monitoring and regulation of ENVIRONMENTAL POLLUTANTS. Primary prevention is to be distinguished from secondary prevention, which is the prevention of complications or after-effects of a drug or surgical procedure, and tertiary prevention, the amelioration of the after-effects of a disease.%A%    
% 214.58/214.72  |- mesh__recordOriginator mesh__D011322 EC
% 214.58/214.72  |- skos__altLabel mesh__D011322 Prevention, Primary
% 214.58/214.72  |- mesh__publicMeSHNote mesh__D011322 79   
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D011322 2005
% 214.58/214.72  |- skos__prefLabel mesh__D011322 Primary Prevention
% 214.58/214.72  |- skos__related mesh__D011322smesh__D011316
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D011322 2005A
% 214.58/214.72  |- skos__historyNote mesh__D011322 Preventive Medicine %28%1966-1978%29%
% 214.58/214.72  |- mesh__historyNote mesh__D011322 79   
% 214.58/214.72  |- skos__broader mesh__D011322smesh__D015980
% 214.58/214.72  |- rdf__type mesh__D011322sskos__Concept
% 214.58/214.72  |- skos__historyNote mesh__D011322
% 214.58/214.72       specific disease/prevention %26% control %28%1966-1978%29%
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D011322 2004
% 214.58/214.72  |- mesh__dateCreated mesh__D011322 1978-05-09
% 214.58/214.72  |- skos__related mesh__D011322smesh__D011313
% 214.58/214.72  |- mesh__dateRevised mesh__D011322 2004-07-30
% 214.58/214.72  |- mesh__recordAuthorizer mesh__D011322 jls
% 214.58/214.72  |- mesh__recordMaintainer mesh__D011322 jls
% 214.58/214.72  |- skos__hiddenLabel mesh__D049790 NES Peptides
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D049790 2006
% 214.58/214.72  |- skos__hiddenLabel mesh__D049790 Peptide, NES
% 214.58/214.72  |- skos__broader mesh__D049790smesh__D021382
% 214.58/214.72  |- mesh__dateEstablished mesh__D049790 2006-01-01
% 214.58/214.72  |- rdf__type mesh__D049790sskos__Concept
% 214.58/214.72  |- skos__related mesh__D049790smesh__D021581
% 214.58/214.72  |- skos__historyNote mesh__D049790
% 214.58/214.72       Protein Sorting Signals %28%1994-2005%29%
% 214.58/214.72  |- skos__hiddenLabel mesh__D049790 Peptides, NES
% 214.58/214.72  |- skos__hiddenLabel mesh__D049790 Export Signals, Nuclear
% 214.58/214.72  |- mesh__recordMaintainer mesh__D049790 nns
% 214.58/214.72  |- skos__hiddenLabel mesh__D049790 Signal, Nuclear Export
% 214.58/214.72  |- skos__scopeNote mesh__D049790
% 214.58/214.72       Specific amino acid sequences present in the primary amino acid sequence of proteins which mediate their export from the CELL NUCLEUS. They are rich in hydrophobic residues, such as LEUCINE and ISOLEUCINE.%A%    
% 214.58/214.72  |- skos__altLabel mesh__D049790 Nuclear Export Signal Peptide
% 214.58/214.72  |- mesh__publicMeSHNote mesh__D049790 2006   
% 214.58/214.72  |- skos__hiddenLabel mesh__D049790 Export Signal, Nuclear
% 214.58/214.72  |- skos__hiddenLabel mesh__D049790 Signals, Nuclear Export
% 214.58/214.72  |- mesh__historyNote mesh__D049790 2006   
% 214.58/214.72  |- mesh__dateCreated mesh__D049790 2005-06-30
% 214.58/214.72  |- mesh__recordOriginator mesh__D049790 nns
% 214.58/214.72  |- skos__altLabel mesh__D049790 Nuclear Export Signal
% 214.58/214.72  |- skos__altLabel mesh__D049790 NES Peptide
% 214.58/214.72  |- skos__prefLabel mesh__D049790 Nuclear Export Signals
% 214.58/214.72  |- mesh__recordAuthorizer mesh__D049790 sjn
% 214.58/214.72  |- skos__scopeNote mesh__D002596
% 214.58/214.72       A republic in central Africa, west of SUDAN. Its capital is N%27%Djamena, called Fort-Lamy before 1973. Explored in 1891 by the French, it became part of French Equatorial Africa in 1910 and, after many changes of status, became independent in 1960. The republic is named from Lake Chad, from the Arabic tsad, a local word meaning large expanse of water %28%or lake%29%. %28%From Webster%27%s New Geographical Dictionary, 1988, p239, 407 %26% Room, Brewer%27%s Dictionary of Names, 1992, p104%29%%A%    
% 214.58/214.72  |- skos__prefLabel mesh__D002596 Chad
% 214.58/214.72  |- rdf__type mesh__D002596sskos__Concept
% 214.58/214.72  |- mesh__recordOriginator mesh__D002596 NLM
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D002596 2003
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D002596 2000
% 214.58/214.72  |- mesh__activeMeSHYear mesh__D002596 2005
% 214.58/214.72  |- mesh__dateCreated mesh__D002596 1999-01-01
% 214.58/214.72  |- skos__broader mesh__D002596smesh__D000350
% 214.58/214.72  |- mesh__dateRevised mesh__D002596 1995-02-17
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D002596 2004
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D002596 2001
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D002596 2006
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D002596 1996
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D002596 1998
% 214.58/214.73  |- skos__annotation mesh__D002596 a republic in central Africa   
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D002596 1997
% 214.58/214.73  |- mesh__recordMaintainer mesh__D002596 TGC
% 214.58/214.73  |- mesh__recordAuthorizer mesh__D002596 PLS
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D002596 1999
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D002596 2002
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007281 2003
% 214.58/214.73  |- skos__broader mesh__D007281smesh__D008420
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007281 2000
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007281 2005
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007281 2004
% 214.58/214.73  |- skos__prefLabel mesh__D007281 Ink
% 214.58/214.73  |- mesh__dateCreated mesh__D007281 1999-01-01
% 214.58/214.73  |- skos__broader mesh__D007281smesh__D001870
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007281 2001
% 214.58/214.73  |- skos__annotation mesh__D007281 no qualif   
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007281 2006
% 214.58/214.73  |- mesh__recordAuthorizer mesh__D007281 SJN
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007281 1998
% 214.58/214.73  |- mesh__dateRevised mesh__D007281 1997-06-20
% 214.58/214.73  |- mesh__recordOriginator mesh__D007281 NLM
% 214.58/214.73  |- mesh__recordMaintainer mesh__D007281 JLS
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007281 1999
% 214.58/214.73  |- skos__hiddenLabel mesh__D007281 Inks
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007281 2002
% 214.58/214.73  |- rdf__type mesh__D007281sskos__Concept
% 214.58/214.73  |- mesh__dateRevised mesh__D015713 1994-03-14
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015713 1995
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015713 2005
% 214.58/214.73  |- mesh__historyNote mesh__D015713 90   
% 214.58/214.73  |- mesh__publicMeSHNote mesh__D015713 90   
% 214.58/214.73  |- skos__hiddenLabel mesh__D015713 Publication, Duplicate
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015713 1999
% 214.58/214.73  |- skos__hiddenLabel mesh__D015713 Publications, Duplicate
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015713 2004
% 214.58/214.73  |- mesh__recordAuthorizer mesh__D015713 PLS
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015713 1998
% 214.58/214.73  |- rdf__type mesh__D015713sskos__Concept
% 214.58/214.73  |- mesh__dateCreated mesh__D015713 1989-05-26
% 214.58/214.73  |- mesh__recordOriginator mesh__D015713 TGC
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015713 2003
% 214.58/214.73  |- mesh__recordMaintainer mesh__D015713 PLS
% 214.58/214.73  |- skos__historyNote mesh__D015713 Publishing %28%1966-1989%29%
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015713 1997
% 214.58/214.73  |- skos__annotation mesh__D015713
% 214.58/214.73       IM only for dupl publ as a publishing or bibliothecal problem %26% for notices that an article has been published in duplicate; do not confuse with Publication Type DUPLICATE PUBLICATION used for an individual item identified as a duplicate publication; do not confuse with PLAGIARISM: read MeSH definition; no qualif; Manual 17.16+%A%  
% 214.58/214.73  |- skos__prefLabel mesh__D015713 Duplicate Publication
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015713 2002
% 214.58/214.73  |- skos__scopeNote mesh__D015713
% 214.58/214.73       Simultaneous or successive publishing of identical or near- identical material in two or more different sources without acknowledgment. It differs from reprinted publication in that a reprint cites sources. It differs from PLAGIARISM in that duplicate publication is the product of the same authorship while plagiarism publishes a work or parts of a work of another as one%27%s own.%A%    
% 214.58/214.73  |- skos__broader mesh__D015713smesh__D011643
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015713 1996
% 214.58/214.73  |- skos__hiddenLabel mesh__D015713 Duplicate Publications
% 214.58/214.73  |- mesh__dateEstablished mesh__D015713 1990-01-01
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015713 2001
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015713 2006
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015713 2000
% 214.58/214.73  |- skos__hiddenLabel mesh__D006987 Sensation, Impaired
% 214.58/214.73  |- skos__prefLabel mesh__D006987 Hypesthesia
% 214.58/214.73  |- skos__broader mesh__D006987smesh__D020886
% 214.58/214.73  |- skos__hiddenLabel mesh__D006987 Sensations, Impaired
% 214.58/214.73  |- skos__altLabel mesh__D006987 Hypesthesia, Tactile
% 214.58/214.73  |- skos__hiddenLabel mesh__D006987 Hypesthesias, Thermal
% 214.58/214.73  |- skos__hiddenLabel mesh__D006987 Impaired Sensations
% 214.58/214.73  |- mesh__dateRevised mesh__D006987 1999-11-03
% 214.58/214.73  |- mesh__dateCreated mesh__D006987 1999-01-01
% 214.58/214.73  |- skos__hiddenLabel mesh__D006987 Hypesthesias, Tactile
% 214.58/214.73  |- skos__hiddenLabel mesh__D006987 Sensations, Reduced
% 214.58/214.73  |- skos__hiddenLabel mesh__D006987 Thermal Hypesthesias
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D006987 2000
% 214.58/214.73  |- skos__scopeNote mesh__D006987
% 214.58/214.73       Absent or reduced sensitivity to cutaneous stimulation.%A%    
% 214.58/214.73  |- mesh__recordOriginator mesh__D006987 NLM
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D006987 2001
% 214.58/214.73  |- skos__hiddenLabel mesh__D006987 Thermal Hypesthesia
% 214.58/214.73  |- skos__hiddenLabel mesh__D006987 Tactile Hypesthesia
% 214.58/214.73  |- skos__hiddenLabel mesh__D006987 Sensation, Reduced
% 214.58/214.73  |- skos__hiddenLabel mesh__D006987 Hypoesthesias
% 214.58/214.73  |- skos__altLabel mesh__D006987 Numbness
% 214.58/214.73  |- rdf__type mesh__D006987sskos__Concept
% 214.58/214.73  |- skos__hiddenLabel mesh__D006987 Tactile Hypesthesias
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D006987 2003
% 214.58/214.73  |- skos__altLabel mesh__D006987 Reduced Sensation
% 214.58/214.73  |- skos__annotation mesh__D006987
% 214.58/214.73       do not confuse with HYPERESTHESIA, increased sensitivity; coord with TOUCH or HEAT if pertinent%A%  
% 214.58/214.73  |- skos__altLabel mesh__D006987 Hypoesthesia
% 214.58/214.73  |- skos__hiddenLabel mesh__D006987 Reduced Sensations
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D006987 2005
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D006987 2004
% 214.58/214.73  |- skos__hiddenLabel mesh__D006987 Hypesthesias
% 214.58/214.73  |- mesh__recordMaintainer mesh__D006987 KEV
% 214.58/214.73  |- mesh__recordAuthorizer mesh__D006987 sjn
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D006987 2002
% 214.58/214.73  |- skos__altLabel mesh__D006987 Impaired Sensation
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D006987 2006
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D006189 2005
% 214.58/214.73  |- skos__broader mesh__D006189smesh__D014251
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D006189 2006
% 214.58/214.73  |- skos__annotation mesh__D006189
% 214.58/214.73       a genus of nematodes; infection = HAEMONCHIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 214.58/214.73  |- skos__scopeNote mesh__D006189
% 214.58/214.73       A genus of parasitic nematode worms which infest the duodenum and stomach of domestic and wild herbivores, which ingest it with the grasses %28%POACEAE%29% they eat. Infestation of man is accidental.%A%    
% 214.58/214.73  |- mesh__dateCreated mesh__D006189 1999-01-01
% 214.58/214.73  |- mesh__dateRevised mesh__D006189 2003-07-09
% 214.58/214.73  |- mesh__recordAuthorizer mesh__D006189 sjn
% 214.58/214.73  |- mesh__publicMeSHNote mesh__D006189
% 214.58/214.73       91; was see under TRICHOSTRONGYLOIDEA 1975-90   
% 214.58/214.73  |- mesh__recordMaintainer mesh__D006189 ags
% 214.58/214.73  |- mesh__dateEstablished mesh__D006189 1991-01-01
% 214.58/214.73  |- mesh__recordOriginator mesh__D006189 NLM
% 214.58/214.73  |- mesh__onlineNote mesh__D006189 search TRICHOSTRONGYLOIDEA 1966-74   
% 214.58/214.73  |- skos__prefLabel mesh__D006189 Haemonchus
% 214.58/214.73  |- mesh__historyNote mesh__D006189
% 214.58/214.73       91%28%75%29%; was see under TRICHOSTRONGYLOIDEA 1975-90   
% 214.58/214.73  |- rdf__type mesh__D006189sskos__Concept
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D006189 2004
% 214.58/214.73  |- mesh__recordMaintainer mesh__D019306 ssb
% 214.58/214.73  |- mesh__dateRevised mesh__D019306 2005-06-30
% 214.58/214.73  |- skos__altLabel mesh__D019306 Tarragon Plant
% 214.58/214.73  |- mesh__dateEstablished mesh__D019306 1997-01-01
% 214.58/214.73  |- skos__altLabel mesh__D019306 Wormwood
% 214.58/214.73  |- skos__altLabel mesh__D019306 Wormseed, Levant
% 214.58/214.73  |- mesh__recordAuthorizer mesh__D019306 sjn
% 214.58/214.73  |- skos__altLabel mesh__D019306 Sagebrush
% 214.58/214.73  |- mesh__dateCreated mesh__D019306 1996-06-13
% 214.58/214.73  |- skos__scopeNote mesh__D019306
% 214.58/214.73       A plant genus of the family ASTERACEAE with strong-smelling foliage.  It is a source of SANTONIN and other cytotoxic TERPENES.%A%    
% 214.58/214.73  |- skos__altLabel mesh__D019306 Mugwort
% 214.58/214.73  |- skos__prefLabel mesh__D019306 Artemisia
% 214.58/214.73  |- skos__altLabel mesh__D019306 Southernwood
% 214.58/214.73  |- skos__broader mesh__D019306smesh__D019659
% 214.58/214.73  |- skos__altLabel mesh__D019306 Sagewort
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D019306 2006
% 214.58/214.73  |- mesh__publicMeSHNote mesh__D019306 97   
% 214.58/214.73  |- mesh__recordOriginator mesh__D019306 JLS
% 214.58/214.73  |- skos__annotation mesh__D019306
% 214.58/214.73       Wormseed see CHENOPODIUM AMBROSIOIDES is also available; coordinate with specific PLANT COMPONENTS term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.58/214.73  |- rdf__type mesh__D019306sskos__Concept
% 214.58/214.73  |- mesh__historyNote mesh__D019306 97   
% 214.58/214.73  |- mesh__recordAuthorizer mesh__D011323 sjn
% 214.58/214.73  |- mesh__recordMaintainer mesh__D011323 sjn
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D011323 2006
% 214.58/214.73  |- skos__broader mesh__D011323smesh__D008322
% 214.58/214.73  |- mesh__recordOriginator mesh__D011323 NLM
% 214.58/214.73  |- rdf__type mesh__D011323sskos__Concept
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D011323 2005
% 214.58/214.73  |- skos__annotation mesh__D011323
% 214.58/214.73       GEN or unspecified; prefer specific family, subfamily or genus; IM; qualif permitted; only human primate is HOMINIDAE%A%  
% 214.58/214.73  |- skos__prefLabel mesh__D011323 Primates
% 214.58/214.73  |- mesh__dateRevised mesh__D011323 2004-07-13
% 214.58/214.73  |- skos__hiddenLabel mesh__D011323 Primate
% 214.58/214.73  |- mesh__dateCreated mesh__D011323 1999-01-01
% 214.58/214.73  |- skos__scopeNote mesh__D002597
% 214.58/214.73       A genus of ascomycetous fungi of the family Chaetomiaceae, order SORDARIALES. Many members are cellulolytic and some mycotoxic. They occur naturally on paper and cotton fabric.%A%    
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D002597 2006
% 214.58/214.73  |- skos__broader mesh__D002597smesh__D020037
% 214.58/214.73  |- mesh__publicMeSHNote mesh__D002597 91; see ASCOMYCETES 1975-90   
% 214.58/214.73  |- mesh__recordMaintainer mesh__D002597 ags
% 214.58/214.73  |- mesh__dateRevised mesh__D002597 2005-07-29
% 214.58/214.73  |- mesh__recordOriginator mesh__D002597 NLM
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D002597 2006A
% 214.58/214.73  |- mesh__dateEstablished mesh__D002597 1991-01-01
% 214.58/214.73  |- rdf__type mesh__D002597sskos__Concept
% 214.58/214.73  |- mesh__recordAuthorizer mesh__D002597 ags
% 214.58/214.73  |- mesh__dateCreated mesh__D002597 1974-12-12
% 214.58/214.73  |- skos__prefLabel mesh__D002597 Chaetomium
% 214.58/214.73  |- mesh__historyNote mesh__D002597 91%28%75%29%   
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007282 1996
% 214.58/214.73  |- mesh__dateCreated mesh__D007282 1999-01-01
% 214.58/214.73  |- skos__hiddenLabel mesh__D007282 Tests, Ink Blot
% 214.58/214.73  |- mesh__dateEstablished mesh__D007282 1968-01-01
% 214.58/214.73  |- mesh__recordOriginator mesh__D007282 NLM
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007282 2006
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007282 1998
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007282 1997
% 214.58/214.73  |- skos__hiddenLabel mesh__D007282 Blot Tests, Ink
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007282 2002
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007282 1994
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007282 1993
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007282 1999
% 214.58/214.73  |- mesh__dateRevised mesh__D007282 1992-05-14
% 214.58/214.73  |- skos__broader mesh__D007282smesh__D011386
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007282 1995
% 214.58/214.73  |- rdf__type mesh__D007282sskos__Concept
% 214.58/214.73  |- skos__scopeNote mesh__D007282
% 214.58/214.73       Projective tests utilizing ink blots to which a subject responds. They are used in personality diagnosis.%A%    
% 214.58/214.73  |- skos__prefLabel mesh__D007282 Ink Blot Tests
% 214.58/214.73  |- mesh__publicMeSHNote mesh__D007282 68   
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007282 2000
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007282 2003
% 214.58/214.73  |- mesh__historyNote mesh__D007282 68%28%64%29%   
% 214.58/214.73  |- skos__hiddenLabel mesh__D007282 Ink Blot Test
% 214.58/214.73  |- skos__hiddenLabel mesh__D007282 Blot Test, Ink
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007282 2001
% 214.58/214.73  |- skos__hiddenLabel mesh__D007282 Test, Ink Blot
% 214.58/214.73  |- mesh__recordAuthorizer mesh__D007282 PLS
% 214.58/214.73  |- mesh__recordMaintainer mesh__D007282 TAP
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007282 2005
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007282 2004
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015714 1999
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015714 2001
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015714 2004
% 214.58/214.73  |- rdf__type mesh__D015714sskos__Concept
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015714 1998
% 214.58/214.73  |- skos__prefLabel mesh__D015714 Plagiarism
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015714 2000
% 214.58/214.73  |- mesh__dateCreated mesh__D015714 1989-05-26
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015714 2003
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015714 1997
% 214.58/214.73  |- mesh__historyNote mesh__D015714 90   
% 214.58/214.73  |- skos__annotation mesh__D015714
% 214.58/214.73       IM; do not confuse with DUPLICATE PUBLICATION: read MeSH definition; no qualif%A%  
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015714 1996
% 214.58/214.73  |- mesh__recordAuthorizer mesh__D015714 PLS
% 214.58/214.73  |- mesh__dateEstablished mesh__D015714 1990-01-01
% 214.58/214.73  |- mesh__recordOriginator mesh__D015714 TGC
% 214.58/214.73  |- mesh__recordMaintainer mesh__D015714 PLS
% 214.58/214.73  |- skos__scopeNote mesh__D015714
% 214.58/214.73       Passing off as one%27%s own the work of another without credit.%A%    
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015714 2006
% 214.58/214.73  |- mesh__dateRevised mesh__D015714 1994-03-14
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015714 2002
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015714 1995
% 214.58/214.73  |- skos__broader mesh__D015714smesh__D011643
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015714 2005
% 214.58/214.73  |- mesh__publicMeSHNote mesh__D015714 90   
% 214.58/214.73  |- skos__historyNote mesh__D015714 Fraud %28%1977-1989%29%
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D006988 2002
% 214.58/214.73  |- mesh__recordAuthorizer mesh__D006988 sjn
% 214.58/214.73  |- mesh__onlineNote mesh__D006988 use HYPHEMA to search HYPHEMIA 1966   
% 214.58/214.73  |- mesh__historyNote mesh__D006988 67; was HYPHEMIA 1966   
% 214.58/214.73  |- mesh__publicMeSHNote mesh__D006988 67; was HYPHEMIA 1966   
% 214.58/214.73  |- mesh__dateRevised mesh__D006988 1999-11-03
% 214.58/214.73  |- rdf__type mesh__D006988sskos__Concept
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D006988 2003
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D006988 2000
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D006988 2005
% 214.58/214.73  |- skos__broader mesh__D006988smesh__D005130
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D006988 2004
% 214.58/214.73  |- mesh__recordOriginator mesh__D006988 NLM
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D006988 2001
% 214.58/214.73  |- mesh__recordMaintainer mesh__D006988 KEV
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D006988 2006
% 214.58/214.73  |- skos__prefLabel mesh__D006988 Hyphema
% 214.58/214.73  |- skos__scopeNote mesh__D006988
% 214.58/214.73       Bleeding in the anterior chamber of the eye.     
% 214.58/214.73  |- skos__hiddenLabel mesh__D006988 Hyphemas
% 214.58/214.73  |- mesh__dateCreated mesh__D006988 1999-01-01
% 214.58/214.73  |- skos__hiddenLabel mesh__D020659 Interferon Alfa 2c
% 214.58/214.73  |- mesh__historyNote mesh__D020659
% 214.58/214.73       2000; use INTERFERON TYPE I, RECOMBINANT 1989-1999   
% 214.58/214.73  |- mesh__dateCreated mesh__D020659 1999-11-03
% 214.58/214.73  |- skos__prefLabel mesh__D020659 Interferon Alfa-2c
% 214.58/214.73  |- skos__historyNote mesh__D020659
% 214.58/214.73       Interferon Type I, Recombinant %28%1989-1999%29%
% 214.58/214.73  |- skos__hiddenLabel mesh__D020659 Recombinant Interferon Alfa 2c
% 214.58/214.73  |- skos__historyNote mesh__D020659 Recombinant Proteins %28%1986-1989%29%
% 214.58/214.73  |- skos__altLabel mesh__D020659 Recombinant Interferon alpha-2c
% 214.58/214.73  |- skos__hiddenLabel mesh__D020659 Recombinant Interferon alpha 2c
% 214.58/214.73  |- skos__hiddenLabel mesh__D020659 Interferon alpha-2c, Recombinant
% 214.58/214.73  |- mesh__publicMeSHNote mesh__D020659
% 214.58/214.73       2000; see INTERFERON ALFA, RECOMBINANT 1989-1999   
% 214.58/214.73  |- skos__altLabel mesh__D020659 Recombinant Interferon Alfa-2c
% 214.58/214.73  |- skos__broader mesh__D020659smesh__D015379
% 214.58/214.73  |- mesh__recordAuthorizer mesh__D020659 sjn
% 214.58/214.73  |- mesh__dateEstablished mesh__D020659 2000-01-01
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D020659 2006
% 214.58/214.73  |- rdf__type mesh__D020659sskos__Concept
% 214.58/214.73  |- skos__hiddenLabel mesh__D020659 Interferon Alfa-2c, Recombinant
% 214.58/214.73  |- mesh__recordMaintainer mesh__D020659 ssb
% 214.58/214.73  |- mesh__dateRevised mesh__D020659 2005-06-30
% 214.58/214.73  |- mesh__recordOriginator mesh__D020659 jmp
% 214.58/214.73  |- skos__broader mesh__D020659smesh__D016898
% 214.58/214.73  |- skos__scopeNote mesh__D020659
% 214.58/214.73       A recombinant alfa interferon consisting of 165 amino acids with arginine at positions 23 and 34. It is used extensively as an antiviral and antineoplastic agent.%A%    
% 214.58/214.73  |- skos__historyNote mesh__D020659 Interferon Type I %28%1983-1988%29%
% 214.58/214.73  |- mesh__dateEstablished mesh__D031381 2003-01-01
% 214.58/214.73  |- mesh__dateCreated mesh__D031381 2002-07-03
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D031381 2003
% 214.58/214.73  |- skos__prefLabel mesh__D031381 Lecythidaceae
% 214.58/214.73  |- skos__broader mesh__D031381smesh__D019684
% 214.58/214.73  |- rdf__type mesh__D031381sskos__Concept
% 214.58/214.73  |- mesh__publicMeSHNote mesh__D031381 2003   
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D031381 2004
% 214.58/214.73  |- skos__scopeNote mesh__D031381
% 214.58/214.73       A plant family of the order Lecythidales, subclass Dilleniidae, class Magnoliopsida.%A%    
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D031381 2005
% 214.58/214.73  |- skos__annotation mesh__D031381
% 214.58/214.73       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.58/214.73  |- mesh__historyNote mesh__D031381 2003   
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D031381 2006
% 214.58/214.73  |- skos__scopeNote mesh__D003690
% 214.58/214.73       A subjective feeling that an experience which is occurring for the first time has been experienced before.%A%    
% 214.58/214.73  |- mesh__recordMaintainer mesh__D003690 jls
% 214.58/214.73  |- mesh__publicMeSHNote mesh__D003690 68   
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D003690 2005
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D003690 2003
% 214.58/214.73  |- skos__annotation mesh__D003690
% 214.58/214.73       in translations use accents: d%C3%%A9%j%C3%%A0% vu   
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D003690 2006
% 214.58/214.73  |- mesh__recordAuthorizer mesh__D003690 sjn
% 214.58/214.73  |- mesh__dateCreated mesh__D003690 1999-01-01
% 214.58/214.73  |- mesh__dateEstablished mesh__D003690 1968-01-01
% 214.58/214.73  |- mesh__historyNote mesh__D003690 68   
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D003690 2004
% 214.58/214.73  |- mesh__dateRevised mesh__D003690 2001-08-13
% 214.58/214.73  |- skos__hiddenLabel mesh__D003690 Vu, Deja
% 214.58/214.73  |- mesh__recordOriginator mesh__D003690 NLM
% 214.58/214.73  |- skos__broader mesh__D003690smesh__D008568
% 214.58/214.73  |- skos__prefLabel mesh__D003690 Deja Vu
% 214.58/214.73  |- rdf__type mesh__D003690sskos__Concept
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D003690 2002
% 214.58/214.73  |- mesh__recordOriginator mesh__D019307 ADP
% 214.58/214.73  |- skos__prefLabel mesh__D019307
% 214.58/214.73       1-%28%5-Isoquinolinesulfonyl%29%-2-Methylpiperazine
% 214.58/214.73  |- mesh__recordMaintainer mesh__D019307 ssb
% 214.58/214.73  |- mesh__onlineNote mesh__D019307
% 214.58/214.73       use 1-%28%5-ISOQUINOLINESULFONYL%29%-2-METHYLPIPERAZINE %28%NM%29% to search 1-%28%5-ISOQUINOLINESULFONYL%29%-2-METHYLPIPERAZINE 1985-96%A%  
% 214.58/214.73  |- mesh__dateRevised mesh__D019307 2005-06-30
% 214.58/214.73  |- skos__broader mesh__D019307smesh__D013449
% 214.58/214.73  |- mesh__historyNote mesh__D019307
% 214.58/214.73       97; was 1-%28%5-ISOQUINOLINESULFONYL%29%-2-METHYLPIPERAZINE %28%NM%29% 1985-96%A%  
% 214.58/214.73  |- skos__scopeNote mesh__D019307
% 214.58/214.73       A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils %28%PMN%29% stimulated with phorbol myristate acetate or synthetic diacylglycerol.%A%    
% 214.58/214.73  |- mesh__dateEstablished mesh__D019307 1997-01-01
% 214.58/214.73  |- skos__broader mesh__D019307smesh__D007546
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D019307 2006
% 214.58/214.73  |- mesh__recordAuthorizer mesh__D019307 sjn
% 214.58/214.73  |- rdf__type mesh__D019307sskos__Concept
% 214.58/214.73  |- skos__altLabel mesh__D019307 H-7
% 214.58/214.73  |- mesh__publicMeSHNote mesh__D019307
% 214.58/214.73       97; 1-%28%5-ISOQUINOLINESULFONYL%29%-2-METHYLPIPERAZINE was indexed under ISOQUINOLINES %26% PIPERAZINES 1985-96%A%  
% 214.58/214.73  |- skos__hiddenLabel mesh__D019307 H 7
% 214.58/214.73  |- mesh__dateCreated mesh__D019307 1996-06-10
% 214.58/214.73  |- skos__broader mesh__D019307smesh__D010879
% 214.58/214.73  |- skos__historyNote mesh__D019307 Isoquinolines %28%1985-1996%29%
% 214.58/214.73  |- skos__historyNote mesh__D019307 Piperazines %28%1985-1996%29%
% 214.58/214.73  |- skos__annotation mesh__D019307 DF: IQSMP   
% 214.58/214.73  |- skos__altLabel mesh__D019307
% 214.58/214.73       1-%28%5-Isoquinolinylsulfonyl%29%-2-Methylpiperazine
% 214.58/214.73  |- skos__altLabel mesh__D011324 AstraZeneca Brand of Primidone
% 214.58/214.73  |- skos__altLabel mesh__D011324 Draxis Brand of Primidone
% 214.58/214.73  |- skos__altLabel mesh__D011324 Zeneca Brand of Primidone
% 214.58/214.73  |- skos__broader mesh__D011324smesh__D010634
% 214.58/214.73  |- skos__altLabel mesh__D011324 Mylepsinum
% 214.58/214.73  |- mesh__recordAuthorizer mesh__D011324 sjn
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D011324 2006
% 214.58/214.73  |- skos__altLabel mesh__D011324 Desoxyphenobarbital
% 214.58/214.73  |- skos__altLabel mesh__D011324 Apotex Brand of Primidone
% 214.58/214.73  |- rdf__type mesh__D011324sskos__Concept
% 214.58/214.73  |- skos__scopeNote mesh__D011324
% 214.58/214.73       An antiepileptic agent related to the barbiturates; it is partly metabolized to PHENOBARBITAL in the body and owes some of its actions to this metabolite. Adverse effects are reported to be more frequent than with PHENOBARBITAL. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p309%29%%A%    
% 214.58/214.73  |- skos__altLabel mesh__D011324 Xcel Brand of Primidone
% 214.58/214.73  |- skos__altLabel mesh__D011324 Desitin Brand of Primidone
% 214.58/214.73  |- skos__altLabel mesh__D011324 Holsten Brand of Primidone
% 214.58/214.73  |- skos__altLabel mesh__D011324 Sanofi-Synthelabo Brand of Primidone
% 214.58/214.73  |- skos__altLabel mesh__D011324 Astra Brand of Primidone
% 214.58/214.73  |- skos__altLabel mesh__D011324 Misodine
% 214.58/214.73  |- mesh__dateCreated mesh__D011324 1999-01-01
% 214.58/214.73  |- skos__prefLabel mesh__D011324 Primidone
% 214.58/214.73  |- mesh__recordOriginator mesh__D011324 NLM
% 214.58/214.73  |- mesh__recordMaintainer mesh__D011324 lkw
% 214.58/214.73  |- mesh__dateRevised mesh__D011324 2005-06-30
% 214.58/214.73  |- skos__altLabel mesh__D002598 Chagas%27% Cardiomyopathy
% 214.58/214.73  |- skos__prefLabel mesh__D002598 Chagas Cardiomyopathy
% 214.58/214.73  |- mesh__recordOriginator mesh__D002598 AEP
% 214.58/214.73  |- skos__altLabel mesh__D002598 Trypanosomiasis, Cardiovascular
% 214.58/214.73  |- skos__historyNote mesh__D002598 specific heart disease %28%1966-1980%29%
% 214.58/214.73  |- skos__broader mesh__D002598smesh__D014355
% 214.58/214.73  |- mesh__dateEstablished mesh__D002598 1981-01-01
% 214.58/214.73  |- skos__hiddenLabel mesh__D002598 Cardiomyopathy, Chagas%27%
% 214.58/214.73  |- mesh__dateRevised mesh__D002598 2004-07-19
% 214.58/214.73  |- skos__historyNote mesh__D002598 Heart Diseases %28%1966-1980%29%
% 214.58/214.73  |- rdf__type mesh__D002598sskos__Concept
% 214.58/214.73  |- mesh__publicMeSHNote mesh__D002598 81   
% 214.58/214.73  |- mesh__recordMaintainer mesh__D002598 lkt
% 214.58/214.73  |- skos__hiddenLabel mesh__D002598 Cardiovascular Trypanosomiasis
% 214.58/214.73  |- skos__altLabel mesh__D002598 Cardiomyopathy, Chagas
% 214.58/214.73  |- skos__historyNote mesh__D002598
% 214.58/214.73       Trypanosomiasis, South American %28%1966-1980%29%
% 214.58/214.73  |- mesh__historyNote mesh__D002598 81   
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D002598 2005
% 214.58/214.73  |- mesh__recordAuthorizer mesh__D002598 sjn
% 214.58/214.73  |- skos__broader mesh__D002598smesh__D009202
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D002598 2006
% 214.58/214.73  |- skos__scopeNote mesh__D002598
% 214.58/214.73       A disease of the CARDIAC MUSCLE developed subsequent to the initial protozoan infection by TRYPANOSOMA CRUZI. After infection, less than 10%25% develop acute illness such as MYOCARDITIS %28%mostly in children%29%. The disease then enters a latent phase without clinical symptoms until about 20 years later. Myocardial symptoms of advanced CHAGAS DISEASE include conduction defects %28%HEART BLOCK%29% and CARDIOMEGALY.%A%    
% 214.58/214.73  |- mesh__dateCreated mesh__D002598 1980-04-02
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007283 1998
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007283 1997
% 214.58/214.73  |- skos__hiddenLabel mesh__D007283 Casting Wax, Inlay
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007283 2001
% 214.58/214.73  |- mesh__recordMaintainer mesh__D007283 TGC
% 214.58/214.73  |- mesh__recordAuthorizer mesh__D007283 PLS
% 214.58/214.73  |- skos__hiddenLabel mesh__D007283 Wax, Inlay Casting
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007283 1999
% 214.58/214.73  |- skos__broader mesh__D007283smesh__D003760
% 214.58/214.73  |- skos__scopeNote mesh__D007283
% 214.58/214.73       A mixture of several dental waxes, usually containing paraffin wax, ceresin, beeswax, resins, and other natural and synthetic waxes. It is used for making patterns to determine the shape of the metallic framework and other parts of removable partial dentures. %28%From Jablonski%27%s Dictionary of Dentistry, 1992, p868%29%%A%    
% 214.58/214.73  |- mesh__recordOriginator mesh__D007283 NLM
% 214.58/214.73  |- rdf__type mesh__D007283sskos__Concept
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007283 2002
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007283 2003
% 214.58/214.73  |- mesh__historyNote mesh__D007283 65   
% 214.58/214.73  |- mesh__dateEstablished mesh__D007283 1965-01-01
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007283 2005
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007283 2004
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007283 1996
% 214.58/214.73  |- mesh__publicMeSHNote mesh__D007283 65   
% 214.58/214.73  |- mesh__dateRevised mesh__D007283 1995-03-17
% 214.58/214.73  |- mesh__dateCreated mesh__D007283 1999-01-01
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007283 2000
% 214.58/214.73  |- skos__annotation mesh__D007283
% 214.58/214.73       a dent impression material; D25-26 qualif   
% 214.58/214.73  |- skos__prefLabel mesh__D007283 Inlay Casting Wax
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D007283 2006
% 214.58/214.73  |- skos__hiddenLabel mesh__D015715 Edema, Corneal
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015715 1996
% 214.58/214.73  |- mesh__recordOriginator mesh__D015715 EGC
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015715 2002
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015715 2006
% 214.58/214.73  |- mesh__dateEstablished mesh__D015715 1990-01-01
% 214.58/214.73  |- mesh__dateRevised mesh__D015715 1994-03-14
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015715 2001
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015715 1995
% 214.58/214.73  |- skos__historyNote mesh__D015715 Cornea %28%1966-1989%29%
% 214.58/214.73  |- mesh__historyNote mesh__D015715 90   
% 214.58/214.73  |- mesh__activeMeSHYear mesh__D015715 2005
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015715 2000
% 214.58/214.74  |- skos__hiddenLabel mesh__D015715 Corneal Edemas
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015715 1999
% 214.58/214.74  |- skos__scopeNote mesh__D015715
% 214.58/214.74       An excessive amount of fluid in the cornea due to damage of the epithelium or endothelium causing decreased visual acuity.%A%    
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015715 2004
% 214.58/214.74  |- mesh__publicMeSHNote mesh__D015715 90   
% 214.58/214.74  |- skos__prefLabel mesh__D015715 Corneal Edema
% 214.58/214.74  |- skos__broader mesh__D015715smesh__D003316
% 214.58/214.74  |- rdf__type mesh__D015715sskos__Concept
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015715 1998
% 214.58/214.74  |- skos__historyNote mesh__D015715 Edema %28%1966-1989%29%
% 214.58/214.74  |- skos__hiddenLabel mesh__D015715 Edemas, Corneal
% 214.58/214.74  |- mesh__dateCreated mesh__D015715 1989-05-25
% 214.58/214.74  |- mesh__recordMaintainer mesh__D015715 PLS
% 214.58/214.74  |- skos__historyNote mesh__D015715 Corneal Diseases %28%1974-1989%29%
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015715 2003
% 214.58/214.74  |- mesh__recordAuthorizer mesh__D015715 PLS
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015715 1997
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D031382 2006
% 214.58/214.74  |- skos__annotation mesh__D031382
% 214.58/214.74       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.58/214.74  |- skos__broader mesh__D031382smesh__D031381
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D031382 2005
% 214.58/214.74  |- skos__scopeNote mesh__D031382
% 214.58/214.74       A plant genus of the family Lecythidaceae. Members contain nasimalun A and B %28%neo-clerodane diterpenoids%29%.%A%    
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D031382 2004
% 214.58/214.74  |- mesh__dateCreated mesh__D031382 2002-07-02
% 214.58/214.74  |- mesh__dateEstablished mesh__D031382 2003-01-01
% 214.58/214.74  |- skos__prefLabel mesh__D031382 Barringtonia
% 214.58/214.74  |- mesh__historyNote mesh__D031382 2003   
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D031382 2003
% 214.58/214.74  |- rdf__type mesh__D031382sskos__Concept
% 214.58/214.74  |- mesh__publicMeSHNote mesh__D031382 2003   
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D003691 1999
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D003691 2005
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D003691 2002
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D003691 2003
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D003691 2006
% 214.58/214.74  |- mesh__dateCreated mesh__D003691 1999-01-01
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D003691 2004
% 214.58/214.74  |- skos__broader mesh__D003691smesh__D008873
% 214.58/214.74  |- mesh__recordAuthorizer mesh__D003691 SJN
% 214.58/214.74  |- mesh__recordMaintainer mesh__D003691 PXP
% 214.58/214.74  |- skos__prefLabel mesh__D003691 Delaware
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D003691 2000
% 214.58/214.74  |- rdf__type mesh__D003691sskos__Concept
% 214.58/214.74  |- mesh__dateRevised mesh__D003691 1997-06-20
% 214.58/214.74  |- mesh__recordOriginator mesh__D003691 NLM
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D003691 1998
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D003691 2001
% 214.58/214.74  |- skos__broader mesh__D019308smesh__D010169
% 214.58/214.74  |- skos__hiddenLabel mesh__D019308 Palmitate, Calcium
% 214.58/214.74  |- skos__hiddenLabel mesh__D019308 Acid, Palmitic
% 214.58/214.74  |- skos__hiddenLabel mesh__D019308 Acid, Hexadecanoic
% 214.58/214.74  |- skos__scopeNote mesh__D019308
% 214.58/214.74       A common saturated fatty acid found in fats and waxes including olive oil, palm oil, and body lipids.%A%    
% 214.58/214.74  |- mesh__dateCreated mesh__D019308 1996-06-10
% 214.58/214.74  |- mesh__recordMaintainer mesh__D019308 ssb
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D019308 2005
% 214.58/214.74  |- mesh__publicMeSHNote mesh__D019308
% 214.58/214.74       97; PALMITIC ACID was indexed under PALMITIC ACIDS 1981-96; HEXADECANOIC ACID was see PALMITIC ACIDS 1975-96%A%  
% 214.58/214.74  |- skos__altLabel mesh__D019308 Hexadecanoic Acid
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D019308 2006
% 214.58/214.74  |- mesh__recordOriginator mesh__D019308 ADP
% 214.58/214.74  |- mesh__onlineNote mesh__D019308
% 214.58/214.74       use PALMITIC ACID %28%NM%29% to search PALMITIC ACIDS 1981-96; use PALMITIC ACIDS to search HEXADECANOIC ACID 1975-96%A%  
% 214.58/214.74  |- rdf__type mesh__D019308sskos__Concept
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D019308 2004
% 214.58/214.74  |- mesh__historyNote mesh__D019308
% 214.58/214.74       97; was PALMITIC ACID %28%NM%29% 1981-96; HEXADECANOIC ACID was see PALMITIC ACIDS 1975-96%A%  
% 214.58/214.74  |- skos__hiddenLabel mesh__D019308 Palmitate, Sodium
% 214.58/214.74  |- skos__annotation mesh__D019308 do not confuse with PALMITIC ACIDS   
% 214.58/214.74  |- mesh__dateRevised mesh__D019308 2003-07-09
% 214.58/214.74  |- skos__historyNote mesh__D019308 Palmitic Acids %28%1981-1996%29%
% 214.58/214.74  |- mesh__dateEstablished mesh__D019308 1997-01-01
% 214.58/214.74  |- skos__prefLabel mesh__D019308 Palmitic Acid
% 214.58/214.74  |- mesh__recordAuthorizer mesh__D019308 sjn
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011325 2005
% 214.58/214.74  |- mesh__recordAuthorizer mesh__D011325 PLS
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011325 2001
% 214.58/214.74  |- mesh__recordOriginator mesh__D011325 NLM
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011325 1997
% 214.58/214.74  |- skos__prefLabel mesh__D011325 Prince Edward Island
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011325 2006
% 214.58/214.74  |- skos__annotation mesh__D011325 a province of eastern Canada   
% 214.58/214.74  |- mesh__dateCreated mesh__D011325 1999-01-01
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011325 2003
% 214.58/214.74  |- rdf__type mesh__D011325sskos__Concept
% 214.58/214.74  |- skos__broader mesh__D011325smesh__D002170
% 214.58/214.74  |- skos__scopeNote mesh__D011325
% 214.58/214.74       An island in the Gulf of St. Lawrence constituting a province of Canada in the eastern part of the country. It is very irregular in shape with many deep inlets. Its capital is Charlottetown. Discovered by the French in 1534 and originally named Ile Saint-Jean, it was renamed in 1799 in honor of Prince Edward, fourth son of George III and future father of Queen Victoria. %28%From Webster%27%s New Geographical Dictionary, 1988, p981 %26% Room, Brewer%27%s Dictionary of Names, 1992, p433%29%%A%    
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011325 2002
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011325 2004
% 214.58/214.74  |- mesh__recordMaintainer mesh__D011325 TGC
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011325 1998
% 214.58/214.74  |- mesh__dateRevised mesh__D011325 1995-02-21
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011325 1999
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011325 2000
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011325 1996
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D016010 2003
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D016010 1998
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D016010 2000
% 214.58/214.74  |- mesh__recordMaintainer mesh__D016010 PLS
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D016010 2004
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D016010 1999
% 214.58/214.74  |- skos__hiddenLabel mesh__D016010 Binomial Distributions
% 214.58/214.74  |- skos__hiddenLabel mesh__D016010 Distributions, Negative Binomial
% 214.58/214.74  |- skos__hiddenLabel mesh__D016010 Binomial Distribution, Negative
% 214.58/214.74  |- skos__hiddenLabel mesh__D016010 Distributions, Binomial
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D016010 2001
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D016010 1996
% 214.58/214.74  |- mesh__dateRevised mesh__D016010 1994-04-11
% 214.58/214.74  |- mesh__dateEstablished mesh__D016010 1990-01-01
% 214.58/214.74  |- mesh__publicMeSHNote mesh__D016010 90   
% 214.58/214.74  |- rdf__type mesh__D016010sskos__Concept
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D016010 1997
% 214.58/214.74  |- mesh__historyNote mesh__D016010 90   
% 214.58/214.74  |- skos__scopeNote mesh__D016010
% 214.58/214.74       The probability distribution associated with two mutually exclusive outcomes; used to model cumulative incidence rates and prevalence rates. The Bernoulli distribution is a special case of binomial distribution.%A%    
% 214.58/214.74  |- skos__annotation mesh__D016010
% 214.58/214.74       IM GEN only, coord NIM with specific disease or other concept %28%IM%29%; no qualif; specify geog if pertinent%A%  
% 214.58/214.74  |- skos__hiddenLabel mesh__D016010 Distribution, Negative Binomial
% 214.58/214.74  |- skos__hiddenLabel mesh__D016010 Distribution, Bernoulli
% 214.58/214.74  |- skos__hiddenLabel mesh__D016010 Negative Binomial Distributions
% 214.58/214.74  |- skos__broader mesh__D016010smesh__D016008
% 214.58/214.74  |- mesh__dateCreated mesh__D016010 1989-05-25
% 214.58/214.74  |- mesh__recordOriginator mesh__D016010 PLS
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D016010 2005
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D016010 2002
% 214.58/214.74  |- skos__prefLabel mesh__D016010 Binomial Distribution
% 214.58/214.74  |- skos__hiddenLabel mesh__D016010 Distribution, Binomial
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D016010 2006
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D016010 1995
% 214.58/214.74  |- mesh__recordAuthorizer mesh__D016010 PLS
% 214.58/214.74  |- skos__hiddenLabel mesh__D016010 Binomial Distributions, Negative
% 214.58/214.74  |- skos__historyNote mesh__D002599 Propiophenones %28%1969-1974%29%
% 214.58/214.74  |- mesh__publicMeSHNote mesh__D002599
% 214.58/214.74       91; was see under PROPIOPHENONES 1975-90   
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D002599 2006
% 214.58/214.74  |- mesh__recordOriginator mesh__D002599 NLM
% 214.58/214.74  |- mesh__recordAuthorizer mesh__D002599 sjn
% 214.58/214.74  |- skos__altLabel mesh__D002599 Benzylideneacetophenone
% 214.58/214.74  |- mesh__dateRevised mesh__D002599 2005-06-30
% 214.58/214.74  |- skos__altLabel mesh__D002599 1,3-Diphenyl-2-Propen-1-One
% 214.58/214.74  |- skos__hiddenLabel mesh__D002599 1,3 Diphenyl 2 Propen 1 One
% 214.58/214.74  |- skos__prefLabel mesh__D002599 Chalcone
% 214.58/214.74  |- mesh__dateCreated mesh__D002599 1974-11-19
% 214.58/214.74  |- skos__historyNote mesh__D002599 Alkenes %28%1973-1974%29%
% 214.58/214.74  |- mesh__historyNote mesh__D002599
% 214.58/214.74       91%28%75%29%; was see under PROPIOPHENONES 1975-90   
% 214.58/214.74  |- rdf__type mesh__D002599sskos__Concept
% 214.58/214.74  |- skos__broader mesh__D002599smesh__D047188
% 214.58/214.74  |- skos__altLabel mesh__D002599 Chalkone
% 214.58/214.74  |- mesh__dateEstablished mesh__D002599 1991-01-01
% 214.58/214.74  |- mesh__recordMaintainer mesh__D002599 ssb
% 214.58/214.74  |- skos__altLabel mesh__D002599 Benzalacetophenone
% 214.58/214.74  |- skos__annotation mesh__D002599
% 214.58/214.74       do not confuse with CHALONES see GROWTH INHIBITORS   
% 214.58/214.74  |- skos__broader mesh__D007284smesh__D017266
% 214.58/214.74  |- skos__altLabel mesh__D007284 Dental Inlays
% 214.58/214.74  |- mesh__recordMaintainer mesh__D007284 PXP
% 214.58/214.74  |- skos__hiddenLabel mesh__D007284 Onlay
% 214.58/214.74  |- skos__altLabel mesh__D007284 Onlays, Dental
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D007284 2006
% 214.58/214.74  |- mesh__recordAuthorizer mesh__D007284 SJN
% 214.58/214.74  |- mesh__dateCreated mesh__D007284 1999-01-01
% 214.58/214.74  |- mesh__historyNote mesh__D007284
% 214.58/214.74       63; DENTAL ONLAYS %26% ONLAYS were see DENTURE, OVERLAY 1991-92; ONLAYS was see INLAYS 1984-90%A%  
% 214.58/214.74  |- mesh__dateRevised mesh__D007284 1997-06-20
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D007284 2002
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D007284 2005
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D007284 1999
% 214.58/214.74  |- skos__prefLabel mesh__D007284 Inlays
% 214.58/214.74  |- skos__hiddenLabel mesh__D007284 Inlay
% 214.58/214.74  |- skos__altLabel mesh__D007284 Onlay, Dental
% 214.58/214.74  |- skos__scopeNote mesh__D007284
% 214.58/214.74       Restorations of metal, porcelain, or plastic made to fit a cavity preparation, then cemented into the tooth. Onlays are restorations which fit into cavity preparations and overlay the occlusal surface of a tooth or teeth. Onlays are retained by frictional or mechanical factors.%A%    
% 214.58/214.74  |- rdf__type mesh__D007284sskos__Concept
% 214.58/214.74  |- skos__altLabel mesh__D007284 Onlays
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D007284 1998
% 214.58/214.74  |- skos__altLabel mesh__D007284 Dental Inlay
% 214.58/214.74  |- mesh__recordOriginator mesh__D007284 NLM
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D007284 2001
% 214.58/214.74  |- skos__annotation mesh__D007284
% 214.58/214.74       coord IM with specific tooth %28%IM%29% if pertinent + specific material %28%IM%29%%A%  
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D007284 2004
% 214.58/214.74  |- skos__altLabel mesh__D007284 Inlays, Dental
% 214.58/214.74  |- skos__broader mesh__D007284smesh__D003793
% 214.58/214.74  |- mesh__onlineNote mesh__D007284
% 214.58/214.74       use DENTURE, OVERLAY to search DENTAL ONLAYS %26% ONLAYS 1991-92; use INLAYS to search ONLAYS 1984-90%A%  
% 214.58/214.74  |- skos__altLabel mesh__D007284 Inlay, Dental
% 214.58/214.74  |- skos__altLabel mesh__D007284 Dental Onlays
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D007284 2000
% 214.58/214.74  |- skos__altLabel mesh__D007284 Dental Onlay
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D007284 2003
% 214.58/214.74  |- mesh__publicMeSHNote mesh__D007284
% 214.58/214.74       63; DENTAL ONLAYS %26% ONLAYS were see DENTURE, OVERLAY 1991-92; ONLAYS was see INLAYS 1984-90%A%  
% 214.58/214.74  |- skos__altLabel mesh__D015716 Dynamic Electrocardiography
% 214.58/214.74  |- mesh__dateCreated mesh__D015716 1989-07-05
% 214.58/214.74  |- skos__hiddenLabel mesh__D015716
% 214.58/214.74       Electrocardiographic Monitoring, Ambulatory
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015716 2006
% 214.58/214.74  |- skos__altLabel mesh__D015716 Electrocardiography, Holter
% 214.58/214.74  |- mesh__dateEstablished mesh__D015716 1990-01-01
% 214.58/214.74  |- skos__broader mesh__D015716smesh__D004562
% 214.58/214.74  |- skos__altLabel mesh__D015716 Electrocardiography, Dynamic
% 214.58/214.74  |- skos__historyNote mesh__D015716 Electrocardiography %28%1966-1989%29%
% 214.58/214.74  |- skos__hiddenLabel mesh__D015716
% 214.58/214.74       Monitoring, Ambulatory Electrocardiography
% 214.58/214.74  |- skos__altLabel mesh__D015716 Electrocardiography Monitoring, Ambulatory
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015716 2005
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015716 1999
% 214.58/214.74  |- mesh__recordAuthorizer mesh__D015716 SJN
% 214.58/214.74  |- skos__annotation mesh__D015716
% 214.58/214.74       /drug eff /rad effects permitted; do not use /util except by MeSH definition; DF: ECG AMBULATORY%A%  
% 214.58/214.74  |- skos__altLabel mesh__D015716 Ambulatory Electrocardiography Monitoring
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015716 2002
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015716 2004
% 214.58/214.74  |- rdf__type mesh__D015716sskos__Concept
% 214.58/214.74  |- skos__altLabel mesh__D015716 Holter Monitoring
% 214.58/214.74  |- skos__prefLabel mesh__D015716 Electrocardiography, Ambulatory
% 214.58/214.74  |- mesh__publicMeSHNote mesh__D015716 90   
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015716 1998
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015716 2001
% 214.58/214.74  |- mesh__dateRevised mesh__D015716 1997-06-20
% 214.58/214.74  |- skos__altLabel mesh__D015716 Monitoring, Holter
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015716 2003
% 214.58/214.74  |- skos__historyNote mesh__D015716
% 214.58/214.74       Monitoring, Physiologic %28%1966-1989%29%
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015716 2000
% 214.58/214.74  |- mesh__historyNote mesh__D015716 90   
% 214.58/214.74  |- skos__altLabel mesh__D015716 Ambulatory Electrocardiography
% 214.58/214.74  |- mesh__recordMaintainer mesh__D015716 PXP
% 214.58/214.74  |- mesh__recordOriginator mesh__D015716 AGS
% 214.58/214.74  |- skos__scopeNote mesh__D015716
% 214.58/214.74       Method in which prolonged electrocardiographic recordings are made on a portable tape recorder %28%Holter-type system%29% or solid-state device %28%%22%real-time%22% system%29%, while the patient undergoes normal daily activities. It is useful in the diagnosis and management of intermittent cardiac arrhythmias and transient myocardial ischemia.%A%    
% 214.58/214.74  |- skos__hiddenLabel mesh__D015716
% 214.58/214.74       Ambulatory Electrocardiographic Monitoring
% 214.58/214.74  |- skos__broader mesh__D015716smesh__D018670
% 214.58/214.74  |- skos__altLabel mesh__D015716 Monitoring, Ambulatory Electrocardiographic
% 214.58/214.74  |- skos__altLabel mesh__D031383 Brazil Nut Tree
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D031383 2005
% 214.58/214.74  |- skos__prefLabel mesh__D031383 Bertholletia
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D031383 2004
% 214.58/214.74  |- skos__scopeNote mesh__D031383
% 214.58/214.74       A plant genus of the family Lecythidaceae which is the source of edible Brazil nuts.%A%    
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D031383 2003
% 214.58/214.74  |- rdf__type mesh__D031383sskos__Concept
% 214.58/214.74  |- mesh__publicMeSHNote mesh__D031383 2003   
% 214.58/214.74  |- mesh__dateCreated mesh__D031383 2002-07-02
% 214.58/214.74  |- mesh__dateEstablished mesh__D031383 2003-01-01
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D031383 2006
% 214.58/214.74  |- mesh__historyNote mesh__D031383 2003   
% 214.58/214.74  |- skos__annotation mesh__D031383
% 214.58/214.74       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.58/214.74  |- skos__broader mesh__D031383smesh__D031381
% 214.58/214.74  |- mesh__dateCreated mesh__D003692 1999-01-01
% 214.58/214.74  |- skos__hiddenLabel mesh__D003692 Sustained-Release Preparation
% 214.58/214.74  |- mesh__recordAuthorizer mesh__D003692 sjn
% 214.58/214.74  |- skos__hiddenLabel mesh__D003692 Delayed Action Preparations
% 214.58/214.74  |- mesh__recordOriginator mesh__D003692 NLM
% 214.58/214.74  |- skos__hiddenLabel mesh__D003692 Controlled Release Preparations
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D003692 2004
% 214.58/214.74  |- skos__scopeNote mesh__D003692
% 214.58/214.74       Dosage forms of a drug that act over a period of time by controlled-release processes or technology.%A%    
% 214.58/214.74  |- skos__broader mesh__D003692smesh__D004304
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D003692 2006
% 214.58/214.74  |- skos__broader mesh__D003692smesh__D016503
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D003692 2005
% 214.58/214.74  |- skos__annotation mesh__D003692
% 214.58/214.74       IM general only; coord with specific drug   
% 214.58/214.74  |- mesh__dateRevised mesh__D003692 2003-07-09
% 214.58/214.74  |- skos__hiddenLabel mesh__D003692 Depot Preparation
% 214.58/214.74  |- skos__hiddenLabel mesh__D003692 Preparations, Controlled-Release
% 214.58/214.74  |- skos__hiddenLabel mesh__D003692 Preparation, Controlled-Release
% 214.58/214.74  |- skos__hiddenLabel mesh__D003692 Prolonged-Action Preparation
% 214.58/214.74  |- mesh__recordMaintainer mesh__D003692 ssb
% 214.58/214.74  |- skos__hiddenLabel mesh__D003692 Controlled-Release Preparation
% 214.58/214.74  |- skos__hiddenLabel mesh__D003692 Delayed-Action Preparation
% 214.58/214.74  |- skos__hiddenLabel mesh__D003692 Timed-Release Preparation
% 214.58/214.74  |- rdf__type mesh__D003692sskos__Concept
% 214.58/214.74  |- skos__hiddenLabel mesh__D003692 Timed Release Preparations
% 214.58/214.74  |- skos__prefLabel mesh__D003692 Delayed-Action Preparations
% 214.58/214.74  |- skos__altLabel mesh__D019309 EBV Nuclear Antigens
% 214.58/214.74  |- mesh__dateCreated mesh__D019309 1996-06-10
% 214.58/214.74  |- skos__altLabel mesh__D019309 Herpesvirus 4, Human Nuclear Antigens
% 214.58/214.74  |- skos__historyNote mesh__D019309 DNA-Binding Proteins %28%1993-1996%29%
% 214.58/214.74  |- mesh__recordMaintainer mesh__D019309 jmp
% 214.58/214.74  |- skos__broader mesh__D019309smesh__D034961
% 214.58/214.74  |- rdf__type mesh__D019309sskos__Concept
% 214.58/214.74  |- mesh__onlineNote mesh__D019309
% 214.58/214.74       use EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS %28%NM%29% to search EBV-ASSOCIATED NUCLEAR ANTIGEN 1980-96%A%  
% 214.58/214.74  |- mesh__recordOriginator mesh__D019309 AGS
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D019309 2006
% 214.58/214.74  |- skos__prefLabel mesh__D019309 Epstein-Barr Virus Nuclear Antigens
% 214.58/214.74  |- mesh__dateRevised mesh__D019309 2005-06-30
% 214.58/214.74  |- mesh__publicMeSHNote mesh__D019309
% 214.58/214.74       97; EBV-ASSOCIATED NUCLEAR ANTIGEN was indexed under ANTIGENS, VIRAL 1979-96 and DNA-BINDING PROTEINS 1993-96%A%  
% 214.58/214.74  |- mesh__historyNote mesh__D019309
% 214.58/214.74       97; was EBV-ASSOCIATED NUCLEAR ANTIGEN %28%NM%29% 1979-96   
% 214.58/214.74  |- skos__hiddenLabel mesh__D019309 Nuclear Antigens, EBV
% 214.58/214.74  |- mesh__recordAuthorizer mesh__D019309 sjn
% 214.58/214.74  |- skos__scopeNote mesh__D019309
% 214.58/214.74       Nuclear antigens encoded by VIRAL GENES found in HUMAN HERPESVIRUS 4. At least six nuclear antigens have been identified.%A%    
% 214.58/214.74  |- skos__hiddenLabel mesh__D019309 Epstein Barr Virus Nuclear Antigens
% 214.58/214.74  |- skos__altLabel mesh__D019309 Nuclear Antigens, Herpesvirus 4, Human
% 214.58/214.74  |- skos__broader mesh__D019309smesh__D000956
% 214.58/214.74  |- mesh__dateEstablished mesh__D019309 1997-01-01
% 214.58/214.74  |- skos__historyNote mesh__D019309 Antigens, Viral %28%1977-1996%29%
% 214.58/214.74  |- skos__hiddenLabel mesh__D011326 Printers%27% Mark
% 214.58/214.74  |- skos__hiddenLabel mesh__D011326 Mark, Printers%27%
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011326 2006
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011326 2000
% 214.58/214.74  |- rdf__type mesh__D011326sskos__Concept
% 214.58/214.74  |- mesh__dateCreated mesh__D011326 1999-01-01
% 214.58/214.74  |- skos__hiddenLabel mesh__D011326 Marks, Printers%27%
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011326 2003
% 214.58/214.74  |- skos__hiddenLabel mesh__D011326 Printers Marks
% 214.58/214.74  |- mesh__recordAuthorizer mesh__D011326 PLS
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011326 2001
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011326 1994
% 214.58/214.74  |- mesh__recordMaintainer mesh__D011326 TAP
% 214.58/214.74  |- mesh__recordOriginator mesh__D011326 NLM
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011326 2004
% 214.58/214.74  |- skos__hiddenLabel mesh__D011326 Printer Marks
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011326 1998
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011326 1995
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011326 1999
% 214.58/214.74  |- skos__prefLabel mesh__D011326 Printers%27% Marks
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011326 2002
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011326 1996
% 214.58/214.74  |- skos__broader mesh__D011326smesh__D001869
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011326 1993
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011326 2005
% 214.58/214.74  |- mesh__dateRevised mesh__D011326 1992-05-18
% 214.58/214.74  |- skos__hiddenLabel mesh__D011326 Printer%27%s Marks
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D011326 1997
% 214.58/214.74  |- skos__scopeNote mesh__D016011
% 214.58/214.74       Continuous frequency distribution of infinite range. Its properties are as follows: 1, continuous, symmetrical distribution with both tails extending to infinity; 2, arithmetic mean, mode, and median identical; and 3, shape completely determined by the mean and standard deviation.%A%    
% 214.58/214.74  |- skos__prefLabel mesh__D016011 Normal Distribution
% 214.58/214.74  |- mesh__recordAuthorizer mesh__D016011 sjn
% 214.58/214.74  |- rdf__type mesh__D016011sskos__Concept
% 214.58/214.74  |- skos__hiddenLabel mesh__D016011 Distributions, Normal
% 214.58/214.74  |- mesh__dateEstablished mesh__D016011 1990-01-01
% 214.58/214.74  |- skos__altLabel mesh__D016011 Gaussian Distribution
% 214.58/214.74  |- skos__broader mesh__D016011smesh__D016008
% 214.58/214.74  |- mesh__publicMeSHNote mesh__D016011 90   
% 214.58/214.74  |- mesh__dateCreated mesh__D016011 1989-05-25
% 214.58/214.74  |- mesh__recordOriginator mesh__D016011 PLS
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D016011 2005
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D016011 2006
% 214.58/214.74  |- mesh__dateRevised mesh__D016011 2004-07-07
% 214.58/214.74  |- skos__hiddenLabel mesh__D016011 Distribution, Gaussian
% 214.58/214.74  |- mesh__historyNote mesh__D016011 90   
% 214.58/214.74  |- mesh__recordMaintainer mesh__D016011 wdj
% 214.58/214.74  |- skos__hiddenLabel mesh__D016011 Normal Distributions
% 214.58/214.74  |- skos__annotation mesh__D016011
% 214.58/214.74       IM GEN only; coord NIM with specific disease or other concept %28%IM%29%; no qualif; specify geog if pertinent%A%  
% 214.58/214.74  |- skos__hiddenLabel mesh__D016011 Distribution, Normal
% 214.58/214.74  |- mesh__dateEstablished mesh__D015717 1990-01-01
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015717 2001
% 214.58/214.74  |- skos__prefLabel mesh__D015717 Peptide T
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015717 1994
% 214.58/214.74  |- mesh__recordAuthorizer mesh__D015717 PLS
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015717 2006
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015717 1998
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015717 1995
% 214.58/214.74  |- mesh__dateCreated mesh__D015717 1989-05-25
% 214.58/214.74  |- skos__broader mesh__D015717smesh__D009842
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015717 2003
% 214.58/214.74  |- skos__hiddenLabel mesh__D015717 Peptide T, HIV
% 214.58/214.74  |- mesh__publicMeSHNote mesh__D015717 90   
% 214.58/214.74  |- mesh__dateRevised mesh__D015717 1990-06-29
% 214.58/214.74  |- mesh__historyNote mesh__D015717 90   
% 214.58/214.74  |- mesh__recordMaintainer mesh__D015717 TAP
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015717 1999
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015717 1992
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015717 2002
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015717 2004
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015717 1991
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015717 1996
% 214.58/214.74  |- rdf__type mesh__D015717sskos__Concept
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015717 1993
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015717 1997
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015717 2000
% 214.58/214.74  |- skos__historyNote mesh__D015717 Oligopeptides %28%1987-1989%29%
% 214.58/214.74  |- skos__annotation mesh__D015717 /biosyn /drug eff /physiol permitted   
% 214.58/214.74  |- skos__historyNote mesh__D015717 Peptide Fragments %28%1987-1989%29%
% 214.58/214.74  |- mesh__recordOriginator mesh__D015717 AGS
% 214.58/214.74  |- skos__altLabel mesh__D015717 HIV Peptide T
% 214.58/214.74  |- skos__scopeNote mesh__D015717
% 214.58/214.74       N-%28%N-%28%N%28%2%29%-%28%N-%28%N-%28%N-%28%N-D-Alanyl L-seryl%29%-L-threonyl%29%-L-threonyl%29% L-threonyl%29%-L-asparaginyl%29%-L-tyrosyl%29% L-threonine. Octapeptide sharing sequence homology with HIV envelope protein gp120. It is potentially useful as antiviral agent in AIDS therapy. The core pentapeptide sequence, TTNYT, consisting of amino acids 4-8 in peptide T, is the HIV envelope sequence required for attachment to the CD4 receptor.%A%    
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D015717 2005
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D031384 2003
% 214.58/214.74  |- skos__altLabel mesh__D031384 Smilacina, False
% 214.58/214.74  |- rdf__type mesh__D031384sskos__Concept
% 214.58/214.74  |- skos__altLabel mesh__D031384 Solomon%27%s Seal
% 214.58/214.74  |- mesh__publicMeSHNote mesh__D031384 2003   
% 214.58/214.74  |- skos__broader mesh__D031384smesh__D019668
% 214.58/214.74  |- skos__altLabel mesh__D031384 False Smilacina
% 214.58/214.74  |- mesh__historyNote mesh__D031384 2003   
% 214.58/214.74  |- skos__altLabel mesh__D031384 Solomon Seal
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D031384 2006
% 214.58/214.74  |- skos__scopeNote mesh__D031384
% 214.58/214.74       A plant genus of the family LILIACEAE. Members contain benzoquinones, steroidal saponin, and ribosome-inactivating proteins.%A%    
% 214.58/214.74  |- mesh__dateCreated mesh__D031384 2002-07-03
% 214.58/214.74  |- skos__annotation mesh__D031384
% 214.58/214.74       note X refs: SOLOMON SEAL, FALSE see SMILACINA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D031384 2005
% 214.58/214.74  |- skos__altLabel mesh__D031384 Solomon%27%s-seal
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D031384 2004
% 214.58/214.74  |- skos__prefLabel mesh__D031384 Polygonatum
% 214.58/214.74  |- mesh__dateEstablished mesh__D031384 2003-01-01
% 214.58/214.74  |- skos__prefLabel mesh__D003693 Delirium
% 214.58/214.74  |- skos__broader mesh__D003693smesh__D003221
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D003693 2004
% 214.58/214.74  |- mesh__recordMaintainer mesh__D003693 jls
% 214.58/214.74  |- skos__hiddenLabel mesh__D003693 Mixed Origin Deliriums
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D003693 2006
% 214.58/214.74  |- mesh__recordAuthorizer mesh__D003693 sjn
% 214.58/214.74  |- skos__annotation mesh__D003693
% 214.58/214.74       this is not the French %22%d%C3%%A9%lire%22% %28% = DELUSIONS%29%   
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D003693 2003
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D003693 2005
% 214.58/214.74  |- skos__broader mesh__D003693smesh__D019965
% 214.58/214.74  |- mesh__recordOriginator mesh__D003693 NLM
% 214.58/214.74  |- skos__hiddenLabel mesh__D003693 Subacute Deliriums
% 214.58/214.74  |- skos__hiddenLabel mesh__D003693 Mixed Origin Delirium
% 214.58/214.74  |- skos__hiddenLabel mesh__D003693 Deliriums, Subacute
% 214.58/214.74  |- rdf__type mesh__D003693sskos__Concept
% 214.58/214.74  |- mesh__dateCreated mesh__D003693 1999-01-01
% 214.58/214.74  |- skos__hiddenLabel mesh__D003693 Delirium, Subacute
% 214.58/214.74  |- skos__scopeNote mesh__D003693
% 214.58/214.74       A disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. %28%From Adams et al., Principles of Neurology, 6th ed, pp411-2%29%%A%    
% 214.58/214.74  |- mesh__activeMeSHYear mesh__D003693 2002
% 214.58/214.75  |- mesh__dateRevised mesh__D003693 2001-08-13
% 214.58/214.75  |- skos__prefLabel mesh__D011327 Printing
% 214.58/214.75  |- mesh__publicMeSHNote mesh__D011327 LITHOGRAPHY was heading 1963-65   
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D011327 2002
% 214.58/214.75  |- skos__broader mesh__D011327smesh__D011643
% 214.58/214.75  |- mesh__recordAuthorizer mesh__D011327 sjn
% 214.58/214.75  |- mesh__historyNote mesh__D011327 LITHOGRAPHY was heading 1963-65   
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D011327 2000
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D011327 2005
% 214.58/214.75  |- skos__annotation mesh__D011327 IM   
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D011327 2006
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D011327 2001
% 214.58/214.75  |- mesh__dateRevised mesh__D011327 1999-11-03
% 214.58/214.75  |- mesh__dateCreated mesh__D011327 1999-01-01
% 214.58/214.75  |- rdf__type mesh__D011327sskos__Concept
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D011327 2003
% 214.58/214.75  |- mesh__recordOriginator mesh__D011327 NLM
% 214.58/214.75  |- mesh__recordMaintainer mesh__D011327 kle
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D011327 2004
% 214.58/214.75  |- skos__related mesh__D011327smesh__D004741
% 214.58/214.75  |- skos__prefLabel mesh__D016810 Hypotrichida
% 214.58/214.75  |- mesh__recordAuthorizer mesh__D016810 sjn
% 214.58/214.75  |- mesh__recordOriginator mesh__D016810 PXP
% 214.58/214.75  |- rdf__type mesh__D016810sskos__Concept
% 214.58/214.75  |- skos__scopeNote mesh__D016810
% 214.58/214.75       An order of ciliate protozoa. Characteristics include a dorsoventrally flattened, highly mobile body with a unique cursorial type of locomotion.%A%    
% 214.58/214.75  |- mesh__dateCreated mesh__D016810 1991-05-02
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016810 2004
% 214.58/214.75  |- skos__historyNote mesh__D016810 Ciliophora %28%1966-1991%29%
% 214.58/214.75  |- mesh__recordMaintainer mesh__D016810 ags
% 214.58/214.75  |- skos__annotation mesh__D016810 an order of ciliate protozoa   
% 214.58/214.75  |- mesh__publicMeSHNote mesh__D016810 92   
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016810 2005
% 214.58/214.75  |- skos__broader mesh__D016810smesh__D016809
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016810 2006
% 214.58/214.75  |- mesh__historyNote mesh__D016810 92   
% 214.58/214.75  |- mesh__dateRevised mesh__D016810 2003-07-09
% 214.58/214.75  |- mesh__dateEstablished mesh__D016810 1992-01-01
% 214.58/214.75  |- rdf__type mesh__D016012sskos__Concept
% 214.58/214.75  |- mesh__onlineNote mesh__D016012
% 214.58/214.75       use PROBABILITY to search POISSON DISTRIBUTION 1969-89   
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016012 1997
% 214.58/214.75  |- skos__annotation mesh__D016012
% 214.58/214.75       IM GEN only; coord NIM with specific disease or other concept %28%IM%29%; no qualif; specify geog if pertinent%A%  
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016012 2005
% 214.58/214.75  |- mesh__dateEstablished mesh__D016012 1990-01-01
% 214.58/214.75  |- mesh__dateCreated mesh__D016012 1989-05-25
% 214.58/214.75  |- skos__broader mesh__D016012smesh__D016008
% 214.58/214.75  |- mesh__recordOriginator mesh__D016012 PLS
% 214.58/214.75  |- skos__scopeNote mesh__D016012
% 214.58/214.75       A distribution function used to describe the occurrence of rare events or to describe the sampling distribution of isolated counts in a continuum of time or space.%A%    
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016012 1995
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016012 2006
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016012 2002
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016012 1998
% 214.58/214.75  |- mesh__recordMaintainer mesh__D016012 TGC
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016012 2003
% 214.58/214.75  |- skos__prefLabel mesh__D016012 Poisson Distribution
% 214.58/214.75  |- mesh__recordAuthorizer mesh__D016012 PLS
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016012 1999
% 214.58/214.75  |- mesh__publicMeSHNote mesh__D016012
% 214.58/214.75       90; was see PROBABILITY 1979-89; was see under PROBABILITY 1969-78%A%  
% 214.58/214.75  |- mesh__historyNote mesh__D016012
% 214.58/214.75       90; was see PROBABILITY 1979-89; was see under PROBABILITY 1969-78%A%  
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016012 2004
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016012 2000
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016012 1996
% 214.58/214.75  |- skos__hiddenLabel mesh__D016012 Distribution, Poisson
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016012 2001
% 214.58/214.75  |- mesh__dateRevised mesh__D016012 1994-04-11
% 214.58/214.75  |- skos__altLabel mesh__D015718 Fibrin Sealant
% 214.58/214.75  |- skos__scopeNote mesh__D015718
% 214.58/214.75       An autologous or commercial tissue adhesive containing FIBRINOGEN and THROMBIN. The commercial product is a two component system from human plasma that contains more than fibrinogen and thrombin. The first component contains highly concentrated fibrinogen, FACTOR VIII, fibronectin, and traces of other plasma proteins. The second component contains thrombin, calcium chloride, and antifibrinolytic agents such as APROTININ. Mixing of the two components promotes BLOOD CLOTTING and the formation and cross-linking of fibrin. The tissue adhesive is used for tissue sealing, HEMOSTASIS, and WOUND HEALING.%A%    
% 214.58/214.75  |- skos__broader mesh__D015718smesh__D005337
% 214.58/214.75  |- skos__historyNote mesh__D015718 Fibrinogen %28%1966-1969%29%
% 214.58/214.75  |- skos__hiddenLabel mesh__D015718 Tissue Adhesive, Fibrin
% 214.58/214.75  |- skos__hiddenLabel mesh__D015718 Human Fibrin Sealant
% 214.58/214.75  |- skos__hiddenLabel mesh__D015718 Sealant, Fibrin
% 214.58/214.75  |- mesh__publicMeSHNote mesh__D015718 90   
% 214.58/214.75  |- skos__prefLabel mesh__D015718 Fibrin Tissue Adhesive
% 214.58/214.75  |- rdf__type mesh__D015718sskos__Concept
% 214.58/214.75  |- skos__altLabel mesh__D015718 Fibrinogen Adhesive
% 214.58/214.75  |- skos__altLabel mesh__D015718 Fibrin Glue
% 214.58/214.75  |- skos__altLabel mesh__D015718 Fibrin Sealant System
% 214.58/214.75  |- skos__hiddenLabel mesh__D015718 Adhesive, Fibrinogen
% 214.58/214.75  |- skos__hiddenLabel mesh__D015718 Adhesive, Fibrin Tissue
% 214.58/214.75  |- mesh__recordAuthorizer mesh__D015718 sjn
% 214.58/214.75  |- skos__historyNote mesh__D015718 Thrombin %28%1966-1989%29%
% 214.58/214.75  |- skos__historyNote mesh__D015718 Factor VIII %28%1966-1989%29%
% 214.58/214.75  |- mesh__historyNote mesh__D015718 90   
% 214.58/214.75  |- mesh__recordMaintainer mesh__D015718 sjn
% 214.58/214.75  |- skos__historyNote mesh__D015718 Hemostatics %28%1966-1989%29%
% 214.58/214.75  |- skos__hiddenLabel mesh__D015718 Glue, Fibrin
% 214.58/214.75  |- skos__altLabel mesh__D015718 Fibrin Adhesive
% 214.58/214.75  |- skos__hiddenLabel mesh__D015718 Sealant, Human Fibrin
% 214.58/214.75  |- skos__altLabel mesh__D015718 Autologous Fibrin Tissue Adhesive
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D015718 2005
% 214.58/214.75  |- mesh__dateEstablished mesh__D015718 1990-01-01
% 214.58/214.75  |- skos__hiddenLabel mesh__D015718 Seal, Fibrin
% 214.58/214.75  |- mesh__dateRevised mesh__D015718 2004-07-13
% 214.58/214.75  |- skos__hiddenLabel mesh__D015718 Adhesive, Fibrin
% 214.58/214.75  |- mesh__recordOriginator mesh__D015718 RLS
% 214.58/214.75  |- skos__altLabel mesh__D015718 Tissel
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D015718 2006
% 214.58/214.75  |- mesh__dateCreated mesh__D015718 1989-05-15
% 214.58/214.75  |- skos__hiddenLabel mesh__D015718 Sealant System, Fibrin
% 214.58/214.75  |- mesh__dateEstablished mesh__D012420 1976-01-01
% 214.58/214.75  |- skos__broader mesh__D012420smesh__D009043
% 214.58/214.75  |- skos__annotation mesh__D012420
% 214.58/214.75       human %26% animal; /inj: coord IM with specific inj %28%IM%29%; /physiol permitted; differentiate from JOGGING: running is relatively faster; TRACK AND FIELD is also available; animals running in exercise wheel is probably MOTOR ACTIVITY or EXERTION%A%  
% 214.58/214.75  |- mesh__recordOriginator mesh__D012420 JW
% 214.58/214.75  |- mesh__historyNote mesh__D012420 76   
% 214.58/214.75  |- mesh__dateRevised mesh__D012420 2003-07-09
% 214.58/214.75  |- skos__broader mesh__D012420smesh__D013177
% 214.58/214.75  |- mesh__recordMaintainer mesh__D012420 nns
% 214.58/214.75  |- rdf__type mesh__D012420sskos__Concept
% 214.58/214.75  |- skos__historyNote mesh__D012420 Sports %28%1966-1975%29%
% 214.58/214.75  |- mesh__publicMeSHNote mesh__D012420 76   
% 214.58/214.75  |- skos__broader mesh__D012420smesh__D008124
% 214.58/214.75  |- skos__hiddenLabel mesh__D012420 Runnings
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D012420 2004
% 214.58/214.75  |- skos__prefLabel mesh__D012420 Running
% 214.58/214.75  |- mesh__recordAuthorizer mesh__D012420 sjn
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D012420 2005
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D012420 2006
% 214.58/214.75  |- mesh__dateCreated mesh__D012420 1975-07-21
% 214.58/214.75  |- skos__scopeNote mesh__D012420
% 214.58/214.75       An activity in which the body is propelled by moving the legs rapidly. Running is performed at a moderate to rapid pace and should be differentiated from JOGGING, which is performed at a much slower pace.%A%    
% 214.58/214.75  |- skos__broader mesh__D044502smesh__D045647
% 214.58/214.75  |- mesh__dateEstablished mesh__D044502 2004-01-01
% 214.58/214.75  |- skos__historyNote mesh__D044502 Endodeoxyribonucleases %28%1991-2003%29%
% 214.58/214.75  |- mesh__dateCreated mesh__D044502 2003-07-09
% 214.58/214.75  |- skos__altLabel mesh__D044502 Thymine Glycol DNA Glycosylase
% 214.58/214.75  |- skos__hiddenLabel mesh__D044502 Glycosylase, Thymine Glycol
% 214.58/214.75  |- skos__hiddenLabel mesh__D044502
% 214.58/214.75       G T Mismatch Specific Thymine DNA Glycosylase
% 214.58/214.75  |- mesh__historyNote mesh__D044502
% 214.58/214.75       2004; use THYMINE DNA GLYCOSYLASE %28%NM%29% 1991-2003   
% 214.58/214.75  |- skos__prefLabel mesh__D044502 Thymine DNA Glycosylase
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D044502 2005
% 214.58/214.75  |- rdf__type mesh__D044502sskos__Concept
% 214.58/214.75  |- skos__hiddenLabel mesh__D044502 Glycol Glycosylase, Thymine
% 214.58/214.75  |- skos__altLabel mesh__D044502
% 214.58/214.75       G-T Mismatch-Specific Thymine DNA Glycosylase
% 214.58/214.75  |- skos__hiddenLabel mesh__D044502 DNA Glycosylase, Thymine
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D044502 2006
% 214.58/214.75  |- mesh__publicMeSHNote mesh__D044502
% 214.58/214.75       2004; THYMIDINE DNA GLYCOSYLASE was indexed under ENDODEOXYRIBONUCLEASES 1991-2003%A%  
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D044502 2004
% 214.58/214.75  |- skos__scopeNote mesh__D044502
% 214.58/214.75       An enzyme that removes THYMINE and URACIL bases mispaired with GUANINE through hydrolysis of their N-glycosidic bond. These mispaired nucleotides generally occur through the hydrolytic DEAMINATION of 5-METHYLCYTOSINE to thymine.%A%    
% 214.58/214.75  |- skos__altLabel mesh__D044502 Thymine Glycol Glycosylase
% 214.58/214.75  |- skos__hiddenLabel mesh__D044502 Glycosylase, Thymine DNA
% 214.58/214.75  |- skos__historyNote mesh__D011328 PrPSc Proteins %28%1966-1985%29%
% 214.58/214.75  |- skos__scopeNote mesh__D011328
% 214.58/214.75       Small proteinaceous infectious particles which resist inactivation by procedures that modify NUCLEIC ACIDS and contain an abnormal isoform of a cellular protein which is a major and necessary component. The abnormal %28%scrapie%29% isoform is PrPSc %28%PRPSC PROTEINS%29% and the cellular isoform PrPC %28%PRPC PROTEINS%29%. The primary amino acid sequence of the two isoforms is identical. Human diseases caused by prions include CREUTZFELDT-JAKOB SYNDROME;  GERSTMANN-STRAUSSLER SYNDROME; and INSOMNIA, FATAL FAMILIAL.%A%    
% 214.58/214.75  |- mesh__dateCreated mesh__D011328 1985-05-10
% 214.58/214.75  |- mesh__publicMeSHNote mesh__D011328
% 214.58/214.75       86; MINK ENCEPHALOPATHY VIRUS was heading 1991-92, was see under VERTEBRATE VIRUSES, UNCLASSIFIED %28%now VIRUSES, UNCLASSIFIED%29% 1975-90; TRANSMISSIBLE ENCEPHALOPATHY VIRUS OF MINK was see MINK ENCEPHALOPATHY VIRUS 1975-92%A%  
% 214.58/214.75  |- mesh__dateRevised mesh__D011328 2005-06-30
% 214.58/214.75  |- skos__hiddenLabel mesh__D011328 Encephalopathy Virus, Mink
% 214.58/214.75  |- skos__prefLabel mesh__D011328 Prions
% 214.58/214.75  |- skos__annotation mesh__D011328 /pathogen permitted   
% 214.58/214.75  |- mesh__recordAuthorizer mesh__D011328 sjn
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D011328 2006
% 214.58/214.75  |- skos__altLabel mesh__D011328 Prion Proteins
% 214.58/214.75  |- mesh__recordOriginator mesh__D011328 RC
% 214.58/214.75  |- skos__broader mesh__D011328smesh__D011506
% 214.58/214.75  |- skos__altLabel mesh__D011328 PrP Proteins
% 214.58/214.75  |- rdf__type mesh__D011328sskos__Concept
% 214.58/214.75  |- mesh__dateEstablished mesh__D011328 1986-01-01
% 214.58/214.75  |- mesh__historyNote mesh__D011328
% 214.58/214.75       86; MINK ENCEPHALOPATHY VIRUS was heading 1991-92, was see under VERTEBRATE VIRUSES, UNCLASSIFIED %28%now VIRUSES, UNCLASSIFIED%29% 1975-90; TRANSMISSIBLE ENCEPHALOPATHY VIRUS OF MINK was see MINK ENCEPHALOPATHY VIRUS 1975-92%A%  
% 214.58/214.75  |- mesh__recordMaintainer mesh__D011328 SYSTEM
% 214.58/214.75  |- skos__historyNote mesh__D011328 Viral Proteins %28%1966-1985%29%
% 214.58/214.75  |- mesh__onlineNote mesh__D011328
% 214.58/214.75       use PRIONS to search MINK ENCEPHALOPATHY VIRUS %26% TRANSMISSIBLE ENCEPHALOPATHY VIRUS OF MINK 1975-92%A%  
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016811 2005
% 214.58/214.75  |- skos__scopeNote mesh__D016811
% 214.58/214.75       A suborder of ciliate protozoa having a body that is commonly oval to elliptical in shape. Most species are free-living in widely diverse habitats.%A%    
% 214.58/214.75  |- mesh__dateEstablished mesh__D016811 1992-01-01
% 214.58/214.75  |- mesh__recordMaintainer mesh__D016811 ags
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016811 2006
% 214.58/214.75  |- skos__annotation mesh__D016811 a suborder of ciliate protozoa   
% 214.58/214.75  |- mesh__historyNote mesh__D016811 92   
% 214.58/214.75  |- skos__prefLabel mesh__D016811 Sporadotrichina
% 214.58/214.75  |- mesh__dateRevised mesh__D016811 2003-07-09
% 214.58/214.75  |- mesh__recordAuthorizer mesh__D016811 sjn
% 214.58/214.75  |- mesh__dateCreated mesh__D016811 1991-05-02
% 214.58/214.75  |- rdf__type mesh__D016811sskos__Concept
% 214.58/214.75  |- mesh__publicMeSHNote mesh__D016811 92   
% 214.58/214.75  |- skos__broader mesh__D016811smesh__D016810
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016811 2004
% 214.58/214.75  |- mesh__recordOriginator mesh__D016811 PXP
% 214.58/214.75  |- skos__hiddenLabel mesh__D016013 Likelihood Function
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016013 1997
% 214.58/214.75  |- mesh__dateRevised mesh__D016013 1992-05-22
% 214.58/214.75  |- mesh__dateEstablished mesh__D016013 1990-01-01
% 214.58/214.75  |- skos__annotation mesh__D016013
% 214.58/214.75       IM GEN only; coord NIM with specific subject /statist %28%IM%29%; no qualif%A%  
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016013 2002
% 214.58/214.75  |- mesh__recordOriginator mesh__D016013 PLS
% 214.58/214.75  |- skos__hiddenLabel mesh__D016013 Maximum Likelihood Estimate
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016013 1996
% 214.58/214.75  |- rdf__type mesh__D016013sskos__Concept
% 214.58/214.75  |- mesh__recordMaintainer mesh__D016013 PLS
% 214.58/214.75  |- skos__hiddenLabel mesh__D016013 Functions, Likelihood
% 214.58/214.75  |- skos__hiddenLabel mesh__D016013 Estimates, Maximum Likelihood
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016013 1995
% 214.58/214.75  |- mesh__dateCreated mesh__D016013 1989-05-25
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016013 2006
% 214.58/214.75  |- skos__historyNote mesh__D016013 Probability %28%1966-1989%29%
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016013 2001
% 214.58/214.75  |- mesh__recordAuthorizer mesh__D016013 PLS
% 214.58/214.75  |- skos__broader mesh__D016013smesh__D011336
% 214.58/214.75  |- skos__scopeNote mesh__D016013
% 214.58/214.75       Functions constructed from a statistical model and a set of observed data which give the probability of that data for various values of the unknown model parameters. Those parameter values that maximize the probability are the maximum likelihood estimates of the parameters.%A%    
% 214.58/214.75  |- skos__hiddenLabel mesh__D016013 Estimate, Maximum Likelihood
% 214.58/214.75  |- skos__prefLabel mesh__D016013 Likelihood Functions
% 214.58/214.75  |- skos__hiddenLabel mesh__D016013 Function, Likelihood
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016013 1994
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016013 2005
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016013 1993
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016013 2004
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016013 2000
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016013 1999
% 214.58/214.75  |- mesh__historyNote mesh__D016013 90   
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016013 2003
% 214.58/214.75  |- skos__broader mesh__D016013smesh__D015233
% 214.58/214.75  |- mesh__publicMeSHNote mesh__D016013 90   
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D016013 1998
% 214.58/214.75  |- skos__broader mesh__D011163Q000172smesh__D011163
% 214.58/214.75  |- mesh__preferredCombination mesh__D011163Q000172smesh__D017118
% 214.58/214.75  |- rdf__type mesh__D011163Q000172smesh__CompoundConcept
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D007287 2002
% 214.58/214.75  |- mesh__runningHead mesh__D007287 D1 - INORGANIC CHEMICALS   
% 214.58/214.75  |- skos__hiddenLabel mesh__D007287 Chemicals, Inorganic
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D007287 2003
% 214.58/214.75  |- mesh__dateRevised mesh__D007287 2000-06-22
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D007287 2006
% 214.58/214.75  |- mesh__historyNote mesh__D007287 98; use explode 1975-97   
% 214.58/214.75  |- mesh__dateCreated mesh__D007287 1999-01-01
% 214.58/214.75  |- mesh__dateEstablished mesh__D007287 1998-01-01
% 214.58/214.75  |- mesh__recordOriginator mesh__D007287 NLM
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D007287 2001
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D007287 2005
% 214.58/214.75  |- skos__prefLabel mesh__D007287 Inorganic Chemicals
% 214.58/214.75  |- skos__annotation mesh__D007287
% 214.58/214.75       GEN or unspecified; prefer specific groups or specific chemicals%A%  
% 214.58/214.75  |- rdf__type mesh__D007287sskos__Concept
% 214.58/214.75  |- mesh__recordAuthorizer mesh__D007287 sjn
% 214.58/214.75  |- skos__scopeNote mesh__D007287
% 214.58/214.75       A broad class of substances encompassing all those that do not include carbon and its derivatives as their principal elements. However, carbides, carbonates, cyanides, cyanates, and carbon disulfide are included in this class.%A%    
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D007287 2004
% 214.58/214.75  |- mesh__publicMeSHNote mesh__D007287 98   
% 214.58/214.75  |- mesh__recordMaintainer mesh__D007287 jls
% 214.58/214.75  |- skos__broader mesh__D015719smesh__D004706
% 214.58/214.75  |- skos__historyNote mesh__D015719 Endonucleases %28%1973-1989%29%
% 214.58/214.75  |- skos__hiddenLabel mesh__D015719 Nuclease, Mung Bean
% 214.58/214.75  |- skos__hiddenLabel mesh__D015719 Nuclease S 1
% 214.58/214.75  |- mesh__recordOriginator mesh__D015719 RLS
% 214.58/214.75  |- skos__altLabel mesh__D015719 P1 Endonuclease
% 214.58/214.75  |- skos__altLabel mesh__D015719 Nuclease S-1
% 214.58/214.75  |- skos__hiddenLabel mesh__D015719 Endonuclease, Neurospora
% 214.58/214.75  |- mesh__recordMaintainer mesh__D015719 ssb
% 214.58/214.75  |- skos__broader mesh__D015719smesh__D004722
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D015719 2005
% 214.58/214.75  |- skos__hiddenLabel mesh__D015719 Endonuclease, P1
% 214.58/214.75  |- skos__hiddenLabel mesh__D015719 Nuclease, Neurospora
% 214.58/214.75  |- skos__hiddenLabel mesh__D015719 Aspergillus Endonuclease S1
% 214.58/214.75  |- mesh__dateRevised mesh__D015719 2003-07-09
% 214.58/214.75  |- skos__altLabel mesh__D015719 Endonuclease S-1
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D015719 2006
% 214.58/214.75  |- mesh__dateEstablished mesh__D015719 1990-01-01
% 214.58/214.75  |- mesh__dateCreated mesh__D015719 1989-07-14
% 214.58/214.75  |- skos__hiddenLabel mesh__D015719 Nuclease S1, Aspergillus
% 214.58/214.75  |- skos__scopeNote mesh__D015719
% 214.58/214.75       An enzyme that catalyzes endonucleolytic cleavage to 5-phosphomononucleotides and 5-phosphooligonucleotide end-products. It has a preference for single-stranded substrates but is active with either ribo- or deoxyribonucleic acids. %28%From Enzyme Nomenclature, 1992%29% EC 3.1.30.1.%A%    
% 214.58/214.75  |- mesh__historyNote mesh__D015719 90   
% 214.58/214.75  |- mesh__recordAuthorizer mesh__D015719 sjn
% 214.58/214.75  |- skos__historyNote mesh__D015719 Phosphodiesterases %28%1972%29%
% 214.58/214.75  |- skos__hiddenLabel mesh__D015719 Nuclease, S1
% 214.58/214.75  |- skos__hiddenLabel mesh__D015719 Endonuclease S 1
% 214.58/214.75  |- skos__altLabel mesh__D015719 Endonuclease S1, Aspergillus
% 214.58/214.75  |- skos__altLabel mesh__D015719 Deoxyribonuclease S1
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D015719 2004
% 214.58/214.75  |- rdf__type mesh__D015719sskos__Concept
% 214.58/214.75  |- skos__prefLabel mesh__D015719 Aspergillus Nuclease S1
% 214.58/214.75  |- mesh__publicMeSHNote mesh__D015719 90   
% 214.58/214.75  |- skos__altLabel mesh__D015719 S1 Nuclease
% 214.58/214.75  |- mesh__publicMeSHNote mesh__D026441 2002   
% 214.58/214.75  |- skos__broader mesh__D026441smesh__D000529
% 214.58/214.75  |- rdf__type mesh__D026441sskos__Concept
% 214.58/214.75  |- mesh__dateCreated mesh__D026441 2001-07-25
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D026441 2002
% 214.58/214.75  |- skos__scopeNote mesh__D026441
% 214.58/214.75       A group of healing methods which emphasize mind-body interactions with  intended benefits that include relaxation and emotional well being.%A%    
% 214.58/214.75  |- skos__annotation mesh__D026441 avoid: too general; prefer specifics   
% 214.58/214.75  |- skos__altLabel mesh__D026441 Mind-Body and Relaxation Technics
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D026441 2004
% 214.58/214.75  |- skos__related mesh__D026441smesh__D026443
% 214.58/214.75  |- skos__prefLabel mesh__D026441 Mind-Body and Relaxation Techniques
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D026441 2006
% 214.58/214.75  |- skos__altLabel mesh__D026441 Mind Body and Relaxation Techniques
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D026441 2003
% 214.58/214.75  |- mesh__dateEstablished mesh__D026441 2002-01-01
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D026441 2005
% 214.58/214.75  |- skos__related mesh__D026441smesh__D001521
% 214.58/214.75  |- mesh__historyNote mesh__D026441 2002   
% 214.58/214.75  |- skos__related mesh__D026441smesh__D010919
% 214.58/214.75  |- skos__altLabel mesh__D026441 Mind Body and Relaxation Technics
% 214.58/214.75  |- mesh__publicMeSHNote mesh__D012421 68   
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D012421 2006
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D012421 2001
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D012421 1997
% 214.58/214.75  |- mesh__recordMaintainer mesh__D012421 TGC
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D012421 2005
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D012421 2000
% 214.58/214.75  |- mesh__historyNote mesh__D012421 68%28%66%29%   
% 214.58/214.75  |- mesh__recordOriginator mesh__D012421 NLM
% 214.58/214.75  |- mesh__dateCreated mesh__D012421 1999-01-01
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D012421 1996
% 214.58/214.75  |- skos__broader mesh__D012421smesh__D014947
% 214.58/214.75  |- rdf__type mesh__D012421sskos__Concept
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D012421 2004
% 214.58/214.75  |- mesh__recordAuthorizer mesh__D012421 PLS
% 214.58/214.75  |- mesh__dateRevised mesh__D012421 1995-06-05
% 214.58/214.75  |- skos__prefLabel mesh__D012421 Rupture
% 214.58/214.75  |- mesh__dateEstablished mesh__D012421 1968-01-01
% 214.58/214.75  |- skos__annotation mesh__D012421
% 214.58/214.75       traumatic only: differentiate from RUPTURE, SPONTANEOUS; never IM: coord NIM with probably organ /inj %28%IM%29% or precoord inj term %28%IM%29%%A%  
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D012421 2003
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D012421 1999
% 214.58/214.75  |- skos__hiddenLabel mesh__D012421 Ruptures
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D012421 2002
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D012421 1998
% 214.58/214.75  |- skos__scopeNote mesh__D012421
% 214.58/214.75       Forcible or traumatic tear or break of an organ or other soft part of the body.%A%    
% 214.58/214.75  |- skos__prefLabel mesh__D050540 Ketol-Acid Reductoisomerase
% 214.58/214.75  |- rdf__type mesh__D050540sskos__Concept
% 214.58/214.75  |- mesh__recordMaintainer mesh__D050540 AKE
% 214.58/214.75  |- skos__hiddenLabel mesh__D050540 Ketol Acid Reductoisomerase
% 214.58/214.75  |- skos__hiddenLabel mesh__D050540 Isomeroreductase, Alpha-Acetohydroxyacid
% 214.58/214.75  |- mesh__historyNote mesh__D050540
% 214.58/214.75       2006%28%1980%29%; use VALERATES 1970-1979   
% 214.58/214.75  |- mesh__dateCreated mesh__D050540 2005-06-30
% 214.58/214.75  |- skos__hiddenLabel mesh__D050540 Isomeroreductase, Acetohydroxy Acid
% 214.58/214.75  |- skos__hiddenLabel mesh__D050540 Acid Isomeroreductase, Acetohydroxy
% 214.58/214.75  |- skos__altLabel mesh__D050540 Isomeroreductase
% 214.58/214.75  |- mesh__recordAuthorizer mesh__D050540 sjn
% 214.58/214.75  |- skos__scopeNote mesh__D050540
% 214.58/214.75       An enzyme that catalyzes the oxidation of %28%R%29%-2,3-dihydroxy-3-methylbutanoate to %28%S%29%-2-hydroxy-2-methyl-3-oxobutanoate in the presence of NADP. It is involved in the biosynthesis of VALINE; LEUCINE; ISOLEUCINE; pentothenate and COENZYME A. This enzyme was formerly classified as EC 1.1.1.89.%A%    
% 214.58/214.75  |- skos__hiddenLabel mesh__D050540 Reductoisomerase, Hydroxyacid
% 214.58/214.75  |- skos__altLabel mesh__D050540
% 214.58/214.75       Dihydroxyisovalerate Dehydrogenase %28%Isomerizing%29%
% 214.58/214.75  |- skos__altLabel mesh__D050540 Alpha-Acetohydroxyacid Isomeroreductase
% 214.58/214.75  |- skos__hiddenLabel mesh__D050540 Reductoisomerase, Ketol-Acid
% 214.58/214.75  |- skos__broader mesh__D050540smesh__D000429
% 214.58/214.75  |- mesh__recordOriginator mesh__D050540 AKE
% 214.58/214.75  |- skos__altLabel mesh__D050540 Acetohydroxy Acid Isomeroreductase
% 214.58/214.75  |- skos__hiddenLabel mesh__D050540 Alpha Acetohydroxyacid Isomeroreductase
% 214.58/214.75  |- skos__altLabel mesh__D050540 Hydroxyacid Reductoisomerase
% 214.58/214.75  |- mesh__dateEstablished mesh__D050540 2006-01-01
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D050540 2006
% 214.58/214.75  |- mesh__publicMeSHNote mesh__D050540
% 214.58/214.75       2006; KETOL-ACID REDUCTOISOMERASE was indexed under ALCOHOL OXODOREDUCTASES 1983-2000, %26% under VALERATES 1970-1982%A%  
% 214.58/214.75  |- skos__related mesh__D003695smesh__D003256
% 214.58/214.75  |- skos__altLabel mesh__D003695 Healthcare
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Distribution, Contraceptive
% 214.58/214.75  |- mesh__historyNote mesh__D003695 71   
% 214.58/214.75  |- mesh__dateEstablished mesh__D003695 1971-01-01
% 214.58/214.75  |- skos__altLabel mesh__D003695 Non-Clinical Distribution
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Distributions, Contraceptive
% 214.58/214.75  |- skos__annotation mesh__D003695 Public Law 91-515   
% 214.58/214.75  |- skos__altLabel mesh__D003695 Distribution, Non-Clinical
% 214.58/214.75  |- mesh__dateRevised mesh__D003695 2001-07-25
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Community Based Distribution
% 214.58/214.75  |- skos__prefLabel mesh__D003695 Delivery of Health Care
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Deliveries, Healthcare
% 214.58/214.75  |- skos__altLabel mesh__D003695 Dental Care Delivery
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Activity, Distributional
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Systems, Healthcare
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D003695 2005
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Distribution, Community-Based
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Delivery, Dental Care
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Care, Health
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 System, Healthcare
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Contraceptive Distributions
% 214.58/214.75  |- skos__historyNote mesh__D003695
% 214.58/214.75       Personal Health Services %28%1968-1970%29%
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Health Care System
% 214.58/214.75  |- skos__altLabel mesh__D003695 Healthcare Delivery
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 System, Health Care
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Distributions, Nonclinical
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Delivery, Health Care
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Healthcare Deliveries
% 214.58/214.75  |- skos__broader mesh__D003695smesh__D017530
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Distributions, Community-Based
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Distribution, Non Clinical
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D003695 2006
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D003695 2002
% 214.58/214.75  |- mesh__recordAuthorizer mesh__D003695 sjn
% 214.58/214.75  |- skos__broader mesh__D003695smesh__D010346
% 214.58/214.75  |- skos__scopeNote mesh__D003695
% 214.58/214.75       The concept concerned with all aspects of providing and distributing health services to a patient population.%A%    
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D003695 2003
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Distributional Activity
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Delivery, Healthcare
% 214.58/214.75  |- skos__altLabel mesh__D003695 Health Care Delivery
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Non-Clinical Distributions
% 214.58/214.75  |- mesh__recordMaintainer mesh__D003695 jls
% 214.58/214.75  |- skos__altLabel mesh__D003695 Healthcare Systems
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Community-Based Distributions
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Systems, Health Care
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Nonclinical Distributions
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Activities, Distributional
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Healthcare System
% 214.58/214.75  |- mesh__recordOriginator mesh__D003695 NLM
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Non Clinical Distribution
% 214.58/214.75  |- mesh__activeMeSHYear mesh__D003695 2004
% 214.58/214.75  |- skos__altLabel mesh__D003695 Distribution, Nonclinical
% 214.58/214.75  |- mesh__publicMeSHNote mesh__D003695 71; HEALTH CARE was heading 1997   
% 214.58/214.75  |- skos__altLabel mesh__D003695 Delivery of Healthcare
% 214.58/214.75  |- skos__hiddenLabel mesh__D003695 Distributions, Non-Clinical
% 214.58/214.75  |- mesh__dateCreated mesh__D003695 1999-01-01
% 214.58/214.75  |- rdf__type mesh__D003695sskos__Concept
% 214.58/214.75  |- mesh__historyNote mesh__D044503
% 214.58/214.75       2004; use 5-METHYLCYTOSINE %28%NM%29% 1980-2003   
% 214.58/214.75  |- mesh__dateEstablished mesh__D044503 2004-01-01
% 214.58/214.75  |- mesh__publicMeSHNote mesh__D044503
% 214.58/214.75       2004; 5-METHYLCYTOSINE was indexed under CYTOSINE/AA 1976-2003, under CYTOSINE 1970-1975%A%  
% 214.58/214.75  |- mesh__recordMaintainer mesh__D044503 ags
% 214.58/214.75  |- skos__broader mesh__D044503smesh__D003596
% 214.58/214.75  |- skos__scopeNote mesh__D044503
% 214.58/214.75       A methylated nucleotide base found in eukaryotic DNA. In ANIMALS, the DNA METHYLATION of CYTOSINE to form 5-methylcytosine is found primarily in the palindromic sequence CpG.  In PLANTS, the methylated sequence is CpNpGp, where N can be any base.%A%    
% 214.58/214.76  |- skos__prefLabel mesh__D044503 5-Methylcytosine
% 214.58/214.76  |- rdf__type mesh__D044503sskos__Concept
% 214.58/214.76  |- skos__historyNote mesh__D044503 Cytosine %28%1970-2003%29%
% 214.58/214.76  |- skos__hiddenLabel mesh__D044503 5 Methylcytosine
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D044503 2006
% 214.58/214.76  |- mesh__dateRevised mesh__D044503 2005-06-30
% 214.58/214.76  |- skos__hiddenLabel mesh__D044503 Monohydrochloride, 5-Methylcytosine
% 214.58/214.76  |- skos__hiddenLabel mesh__D044503 5 Methylcytosine Monohydrochloride
% 214.58/214.76  |- mesh__recordAuthorizer mesh__D044503 sjn
% 214.58/214.76  |- mesh__recordOriginator mesh__D044503 jmp
% 214.58/214.76  |- mesh__dateCreated mesh__D044503 2003-07-09
% 214.58/214.76  |- mesh__recordAuthorizer mesh__D011329 SJN
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D011329 2002
% 214.58/214.76  |- mesh__publicMeSHNote mesh__D011329 74   
% 214.58/214.76  |- skos__historyNote mesh__D011329 Prisons %28%1966-1972%29%
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D011329 1999
% 214.58/214.76  |- skos__hiddenLabel mesh__D011329 Hostage
% 214.58/214.76  |- skos__annotation mesh__D011329
% 214.58/214.76       differentiate from CRIMINAL PSYCHOLOGY; X ref HOSTAGES: coord with VIOLENCE only if particularly discussed%A%  
% 214.58/214.76  |- mesh__historyNote mesh__D011329 74%28%73%29%   
% 214.58/214.76  |- mesh__dateRevised mesh__D011329 1997-06-20
% 214.58/214.76  |- mesh__recordOriginator mesh__D011329 NLM
% 214.58/214.76  |- skos__broader mesh__D011329smesh__D009272
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D011329 1998
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D011329 2001
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D011329 2006
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D011329 2000
% 214.58/214.76  |- skos__hiddenLabel mesh__D011329 Prisoner
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D011329 2004
% 214.58/214.76  |- mesh__dateEstablished mesh__D011329 1974-01-01
% 214.58/214.76  |- rdf__type mesh__D011329sskos__Concept
% 214.58/214.76  |- mesh__recordMaintainer mesh__D011329 TGC
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D011329 2005
% 214.58/214.76  |- mesh__dateCreated mesh__D011329 1999-01-01
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D011329 2003
% 214.58/214.76  |- skos__prefLabel mesh__D011329 Prisoners
% 214.58/214.76  |- skos__hiddenLabel mesh__D008380 Fowl Paralyses
% 214.58/214.76  |- skos__altLabel mesh__D008380 Marek%27%s Disease
% 214.58/214.76  |- rdf__type mesh__D008380sskos__Concept
% 214.58/214.76  |- skos__annotation mesh__D008380
% 214.58/214.76       don%27%t forget also BIRDS or POULTRY %28%NIM%29% or specific bird or fowl %28%IM%29%; check tag ANIMALS%A%  
% 214.58/214.76  |- skos__historyNote mesh__D008380 Avian Leukosis %28%1966-1971%29%
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D008380 2005
% 214.58/214.76  |- skos__historyNote mesh__D008380 Poultry Diseases %28%1966-1971%29%
% 214.58/214.76  |- mesh__recordAuthorizer mesh__D008380 sjn
% 214.58/214.76  |- skos__broader mesh__D008380smesh__D008232
% 214.58/214.76  |- skos__hiddenLabel mesh__D008380 Paralyses, Fowl
% 214.58/214.76  |- mesh__recordOriginator mesh__D008380 NLM
% 214.58/214.76  |- mesh__dateEstablished mesh__D008380 1973-01-01
% 214.58/214.76  |- skos__altLabel mesh__D008380 Neurolymphomatosis
% 214.58/214.76  |- mesh__publicMeSHNote mesh__D008380 73   
% 214.58/214.76  |- skos__historyNote mesh__D008380 Herpesvirus Infections %28%1966-1971%29%
% 214.58/214.76  |- mesh__recordMaintainer mesh__D008380 ags
% 214.58/214.76  |- skos__broader mesh__D008380smesh__D014412
% 214.58/214.76  |- skos__hiddenLabel mesh__D008380 Mareks Disease
% 214.58/214.76  |- mesh__historyNote mesh__D008380 73%28%72%29%   
% 214.58/214.76  |- skos__scopeNote mesh__D008380
% 214.58/214.76       A transmissible viral disease of birds caused by avian herpesvirus 2 %28%HERPESVIRUS 2, GALLID%29% and other MAREK%27%S DISEASE-LIKE VIRUSES. There is lymphoid cell infiltration or lymphomatous tumor formation in the peripheral nerves and gonads, but may also involve visceral organs, skin, muscle, and the eye.%A%    
% 214.58/214.76  |- skos__prefLabel mesh__D008380 Marek Disease
% 214.58/214.76  |- skos__broader mesh__D008380smesh__D006566
% 214.58/214.76  |- skos__broader mesh__D008380smesh__D001715
% 214.58/214.76  |- mesh__dateRevised mesh__D008380 2003-07-30
% 214.58/214.76  |- mesh__dateCreated mesh__D008380 1999-01-01
% 214.58/214.76  |- skos__hiddenLabel mesh__D008380 Neurolymphomatoses
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D008380 2004
% 214.58/214.76  |- skos__hiddenLabel mesh__D008380 Paralysis, Fowl
% 214.58/214.76  |- skos__altLabel mesh__D008380 Fowl Paralysis
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D008380 2006
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D016812 2004
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D016812 2005
% 214.58/214.76  |- mesh__recordMaintainer mesh__D016812 ags
% 214.58/214.76  |- mesh__dateEstablished mesh__D016812 1992-01-01
% 214.58/214.76  |- mesh__recordAuthorizer mesh__D016812 sjn
% 214.58/214.76  |- skos__scopeNote mesh__D016812
% 214.58/214.76       A genus of ciliate protozoa having a dorsoventrally flattened body with widely spaced rows of short bristle-like cilia on the dorsal surface.%A%    
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D016812 2006
% 214.58/214.76  |- skos__annotation mesh__D016812 a genus of ciliate protozoa   
% 214.58/214.76  |- mesh__historyNote mesh__D016812 92   
% 214.58/214.76  |- skos__historyNote mesh__D016812 Ciliophora %28%1966-1991%29%
% 214.58/214.76  |- mesh__dateCreated mesh__D016812 1991-05-02
% 214.58/214.76  |- mesh__dateRevised mesh__D016812 2003-07-09
% 214.58/214.76  |- skos__prefLabel mesh__D016812 Euplotes
% 214.58/214.76  |- rdf__type mesh__D016812sskos__Concept
% 214.58/214.76  |- skos__broader mesh__D016812smesh__D016811
% 214.58/214.76  |- mesh__recordOriginator mesh__D016812 PXP
% 214.58/214.76  |- mesh__publicMeSHNote mesh__D016812 92   
% 214.58/214.76  |- skos__prefLabel mesh__D016014 Linear Models
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D016014 1994
% 214.58/214.76  |- mesh__publicMeSHNote mesh__D016014
% 214.58/214.76       90; LINEAR REGRESSION was see REGRESSION ANALYSIS 1990-93%A%  
% 214.58/214.76  |- skos__broader mesh__D016014smesh__D015233
% 214.58/214.76  |- skos__historyNote mesh__D016014 Regression Analysis %28%1966-1993%29%
% 214.58/214.76  |- mesh__recordMaintainer mesh__D016014 RAZ
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D016014 1999
% 214.58/214.76  |- mesh__onlineNote mesh__D016014
% 214.58/214.76       use REGRESSION ANALYSIS to search LINEAR REGRESSION 1990-93%A%  
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D016014 2003
% 214.58/214.76  |- skos__scopeNote mesh__D016014
% 214.58/214.76       Statistical models in which the value of a parameter for a given value of a factor is assumed to be equal to a + bx, where a and b are constants. The models predict a linear regression.%A%    
% 214.58/214.76  |- skos__annotation mesh__D016014
% 214.58/214.76       IM GEN only; coord NIM with specific subject /statist %28%IM%29%; no qualif%A%  
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D016014 1995
% 214.58/214.76  |- mesh__dateRevised mesh__D016014 1993-06-18
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D016014 2002
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D016014 2004
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D016014 2005
% 214.58/214.76  |- mesh__recordAuthorizer mesh__D016014 PLS
% 214.58/214.76  |- skos__hiddenLabel mesh__D016014 Model, Log-Linear
% 214.58/214.76  |- skos__hiddenLabel mesh__D016014 Regression, Linear
% 214.58/214.76  |- skos__hiddenLabel mesh__D016014 Log Linear Models
% 214.58/214.76  |- mesh__dateCreated mesh__D016014 1989-05-25
% 214.58/214.76  |- skos__hiddenLabel mesh__D016014 Linear Regressions
% 214.58/214.76  |- skos__hiddenLabel mesh__D016014 Regressions, Linear
% 214.58/214.76  |- rdf__type mesh__D016014sskos__Concept
% 214.58/214.76  |- skos__hiddenLabel mesh__D016014 Linear Model
% 214.58/214.76  |- mesh__historyNote mesh__D016014
% 214.58/214.76       90; LINEAR REGRESSION was see REGRESSION ANALYSIS 1990-93%A%  
% 214.58/214.76  |- skos__hiddenLabel mesh__D016014 Models, Log-Linear
% 214.58/214.76  |- skos__historyNote mesh__D016014 Models, Theoretical %28%1966-1989%29%
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D016014 2006
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D016014 1996
% 214.58/214.76  |- mesh__dateEstablished mesh__D016014 1990-01-01
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D016014 2000
% 214.58/214.76  |- skos__broader mesh__D016014smesh__D012044
% 214.58/214.76  |- skos__hiddenLabel mesh__D016014 Model, Linear
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D016014 1997
% 214.58/214.76  |- skos__hiddenLabel mesh__D016014 Log-Linear Model
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D016014 1998
% 214.58/214.76  |- mesh__recordOriginator mesh__D016014 PLS
% 214.58/214.76  |- skos__altLabel mesh__D016014 Models, Linear
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D016014 2001
% 214.58/214.76  |- skos__broader mesh__D007288smesh__D011684
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D007288 2002
% 214.58/214.76  |- skos__broader mesh__D007288smesh__D012263
% 214.58/214.76  |- mesh__recordMaintainer mesh__D007288 KEV
% 214.58/214.76  |- mesh__recordAuthorizer mesh__D007288 sjn
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D007288 2005
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D007288 2006
% 214.58/214.76  |- mesh__dateRevised mesh__D007288 1999-11-09
% 214.58/214.76  |- skos__prefLabel mesh__D007288 Inosine
% 214.58/214.76  |- mesh__historyNote mesh__D007288
% 214.58/214.76       73%28%71%29%; was see under NUCLEOSIDES 1963-71   
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D007288 2000
% 214.58/214.76  |- mesh__onlineNote mesh__D007288 search NUCLEOSIDES 1966-70   
% 214.58/214.76  |- rdf__type mesh__D007288sskos__Concept
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D007288 2003
% 214.58/214.76  |- skos__scopeNote mesh__D007288
% 214.58/214.76       A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. %28%Dorland, 28th ed%29%%A%    
% 214.58/214.76  |- mesh__publicMeSHNote mesh__D007288
% 214.58/214.76       73; was see under NUCLEOSIDES 1963-71   
% 214.58/214.76  |- skos__historyNote mesh__D007288 Nucleosides %28%1966-1970%29%
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D007288 2004
% 214.58/214.76  |- mesh__recordOriginator mesh__D007288 NLM
% 214.58/214.76  |- mesh__dateEstablished mesh__D007288 1973-01-01
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D007288 2001
% 214.58/214.76  |- mesh__dateCreated mesh__D007288 1999-01-01
% 214.58/214.76  |- skos__hiddenLabel mesh__D012422 Ruptures, Spontaneous
% 214.58/214.76  |- mesh__recordMaintainer mesh__D012422 KEV
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D012422 2005
% 214.58/214.76  |- skos__broader mesh__D012422smesh__D020763
% 214.58/214.76  |- mesh__dateRevised mesh__D012422 1999-11-08
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D012422 2002
% 214.58/214.76  |- mesh__dateCreated mesh__D012422 1999-01-01
% 214.58/214.76  |- skos__hiddenLabel mesh__D012422 Spontaneous Rupture
% 214.58/214.76  |- mesh__recordAuthorizer mesh__D012422 sjn
% 214.58/214.76  |- rdf__type mesh__D012422sskos__Concept
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D012422 2004
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D012422 2001
% 214.58/214.76  |- mesh__dateEstablished mesh__D012422 1968-01-01
% 214.58/214.76  |- mesh__historyNote mesh__D012422 68%28%65%29%   
% 214.58/214.76  |- skos__hiddenLabel mesh__D012422 Spontaneous Ruptures
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D012422 2003
% 214.58/214.76  |- mesh__recordOriginator mesh__D012422 NLM
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D012422 2000
% 214.58/214.76  |- skos__prefLabel mesh__D012422 Rupture, Spontaneous
% 214.58/214.76  |- skos__scopeNote mesh__D012422
% 214.58/214.76       Tear or break of an organ, vessel or other soft part of the body, occurring in the absence of external force.%A%    
% 214.58/214.76  |- mesh__publicMeSHNote mesh__D012422 68   
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D012422 2006
% 214.58/214.76  |- skos__annotation mesh__D012422
% 214.58/214.76       includes spontan rupt unexplained or as a result of dis: differentiate from RUPTURE, traumatic only; never IM: coord NIM with organ/diseases term %28%IM%29%%A%  
% 214.58/214.76  |- mesh__recordMaintainer mesh__D050541 lkt
% 214.58/214.76  |- mesh__recordOriginator mesh__D050541 lkt
% 214.58/214.76  |- skos__altLabel mesh__D050541 Bowman%27%s Membrane
% 214.58/214.76  |- mesh__dateEstablished mesh__D050541 2006-01-01
% 214.58/214.76  |- skos__hiddenLabel mesh__D050541 Membrane, Bowman%27%s
% 214.58/214.76  |- skos__historyNote mesh__D050541 Cornea %28%1965-2005%29%
% 214.58/214.76  |- mesh__publicMeSHNote mesh__D050541 2006   
% 214.58/214.76  |- skos__hiddenLabel mesh__D050541 Membranes, Bowman
% 214.58/214.76  |- skos__hiddenLabel mesh__D050541 Membrane, Bowman
% 214.58/214.76  |- skos__scopeNote mesh__D050541
% 214.58/214.76       A layer of acellular matrix that lies beneath the CORNEAL EPITHELIUM and above the CORNEAL STROMA. It consists of randomly arranged COLLAGEN fibers in a condensed bed of intercellular substance. It provides stability and strength to the cornea.%A%    
% 214.58/214.76  |- skos__hiddenLabel mesh__D050541 Membranes, Bowman%27%s
% 214.58/214.76  |- skos__prefLabel mesh__D050541 Bowman Membrane
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D050541 2006
% 214.58/214.76  |- skos__hiddenLabel mesh__D050541 Bowmans Membrane
% 214.58/214.76  |- skos__broader mesh__D050541smesh__D003315
% 214.58/214.76  |- mesh__historyNote mesh__D050541 2006   
% 214.58/214.76  |- rdf__type mesh__D050541sskos__Concept
% 214.58/214.76  |- skos__hiddenLabel mesh__D050541 Bowman Membranes
% 214.58/214.76  |- mesh__dateCreated mesh__D050541 2005-06-30
% 214.58/214.76  |- skos__hiddenLabel mesh__D050541 Bowman%27%s Membranes
% 214.58/214.76  |- mesh__recordAuthorizer mesh__D050541 sjn
% 214.58/214.76  |- skos__altLabel mesh__D003696 Centers, Hospital Birth
% 214.58/214.76  |- skos__altLabel mesh__D003696 Center, Hospital Birthing
% 214.58/214.76  |- skos__prefLabel mesh__D003696 Delivery Rooms
% 214.58/214.76  |- skos__altLabel mesh__D003696 Rooms, Delivery
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D003696 1997
% 214.58/214.76  |- skos__altLabel mesh__D003696 Hospital Birthing Centers
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D003696 1999
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D003696 2001
% 214.58/214.76  |- skos__hiddenLabel mesh__D003696 Hospital Birth Center
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D003696 2003
% 214.58/214.76  |- skos__hiddenLabel mesh__D003696 Birthing Center, Hospital
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D003696 2005
% 214.58/214.76  |- mesh__recordMaintainer mesh__D003696 KEV
% 214.58/214.76  |- mesh__recordAuthorizer mesh__D003696 PLS
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D003696 2004
% 214.58/214.76  |- mesh__dateEstablished mesh__D003696 1991-01-01
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D003696 2002
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D003696 2006
% 214.58/214.76  |- skos__altLabel mesh__D003696 Center, Hospital Birth
% 214.58/214.76  |- skos__altLabel mesh__D003696 Birth Centers, Hospital
% 214.58/214.76  |- mesh__recordOriginator mesh__D003696 EC
% 214.58/214.76  |- skos__scopeNote mesh__D003696
% 214.58/214.76       Hospital units equipped for childbirth.     
% 214.58/214.76  |- mesh__historyNote mesh__D003696
% 214.58/214.76       91%28%82%29%; was see under OPERATING ROOMS 1982-90   
% 214.58/214.76  |- skos__altLabel mesh__D003696 Room, Delivery
% 214.58/214.76  |- skos__altLabel mesh__D003696 Delivery Room
% 214.58/214.76  |- skos__annotation mesh__D003696
% 214.58/214.76       note X ref BIRTHING CENTERS, HOSPITAL: do not confuse with BIRTHING CENTERS, FREE-STANDING see BIRTHING CENTERS; check also tags PREGNANCY %26% INFANT, NEWBORN%A%  
% 214.58/214.76  |- skos__altLabel mesh__D003696 Hospital Birth Centers
% 214.58/214.76  |- skos__altLabel mesh__D003696 Birthing Centers, Hospital
% 214.58/214.76  |- skos__broader mesh__D003696smesh__D006757
% 214.58/214.76  |- mesh__dateRevised mesh__D003696 1996-06-10
% 214.58/214.76  |- mesh__publicMeSHNote mesh__D003696
% 214.58/214.76       91; was see under OPERATING ROOMS 1982-90   
% 214.58/214.76  |- skos__hiddenLabel mesh__D003696 Hospital Birthing Center
% 214.58/214.76  |- skos__altLabel mesh__D003696 Centers, Hospital Birthing
% 214.58/214.76  |- mesh__dateCreated mesh__D003696 1981-02-26
% 214.58/214.76  |- rdf__type mesh__D003696sskos__Concept
% 214.58/214.76  |- skos__hiddenLabel mesh__D003696 Birth Center, Hospital
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D003696 1998
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D003696 2000
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D044504 2005
% 214.58/214.76  |- mesh__recordOriginator mesh__D044504 lkt
% 214.58/214.76  |- mesh__dateEstablished mesh__D044504 2004-01-01
% 214.58/214.76  |- mesh__recordAuthorizer mesh__D044504 sjn
% 214.58/214.76  |- skos__broader mesh__D044504smesh__D004760
% 214.58/214.76  |- skos__hiddenLabel mesh__D044504 Syndrome, Ileocecal
% 214.58/214.76  |- mesh__recordMaintainer mesh__D044504 lkt
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D044504 2004
% 214.58/214.76  |- skos__altLabel mesh__D044504 Ileocecal Syndrome
% 214.58/214.76  |- skos__historyNote mesh__D044504
% 214.58/214.76       Enterocolitis, Pseudomembranous %28%1976-2003%29%
% 214.58/214.76  |- skos__altLabel mesh__D044504 Neutropenic Enterocolitis
% 214.58/214.76  |- skos__prefLabel mesh__D044504 Enterocolitis, Neutropenic
% 214.58/214.76  |- mesh__historyNote mesh__D044504 2004   
% 214.58/214.76  |- rdf__type mesh__D044504sskos__Concept
% 214.58/214.76  |- skos__scopeNote mesh__D044504
% 214.58/214.76       A syndrome characterized by inflammation in the ILEUM, the CECUM, and the ASCENDING COLON. It is observed in cancer patients with CHEMOTHERAPY-induced NEUTROPENIA or in other immunocompromised individuals %28%IMMUNOCOMPROMISED HOST%29%.%A%    
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D044504 2006
% 214.58/214.76  |- mesh__publicMeSHNote mesh__D044504 2004   
% 214.58/214.76  |- mesh__dateCreated mesh__D044504 2003-07-09
% 214.58/214.76  |- skos__hiddenLabel mesh__D008381 Fowl Paralysis Viruses
% 214.58/214.76  |- skos__hiddenLabel mesh__D008381 Neurolymphomatosis Viruses
% 214.58/214.76  |- skos__historyNote mesh__D008381 Herpesviridae %28%1966-1974%29%
% 214.58/214.76  |- mesh__dateRevised mesh__D008381 2001-07-25
% 214.58/214.76  |- rdf__type mesh__D008381sskos__Concept
% 214.58/214.76  |- mesh__dateCreated mesh__D008381 1974-11-19
% 214.58/214.76  |- mesh__historyNote mesh__D008381
% 214.58/214.76       94; was MAREK%27%S DISEASE VIRUS 1975-93; MAREK%27%S DISEASE HERPESVIRUS 1 was MAREK%27%S DISEASE VIRUS see HERPESVIRUS 2, GALLID 1994-96%A%  
% 214.58/214.76  |- mesh__recordMaintainer mesh__D008381 ags
% 214.58/214.76  |- mesh__publicMeSHNote mesh__D008381
% 214.58/214.76       94; was MAREK%27%S DISEASE VIRUS 1975-93; MAREK%27%S DISEASE HERPESVIRUS 1 was MAREK%27%S DISEASE VIRUS see HERPESVIRUS 2, GALLID 1994-96%A%  
% 214.58/214.76  |- skos__altLabel mesh__D008381 Gallid herpesvirus 2
% 214.58/214.76  |- skos__altLabel mesh__D008381 Herpesvirus 2 %28%gamma%29%, Gallid
% 214.58/214.76  |- skos__prefLabel mesh__D008381 Herpesvirus 2, Gallid
% 214.58/214.76  |- skos__altLabel mesh__D008381 Marek%27%s Disease Herpesvirus 1
% 214.58/214.76  |- skos__broader mesh__D008381smesh__D025922
% 214.58/214.76  |- skos__hiddenLabel mesh__D008381 Paralysis Viruses, Fowl
% 214.58/214.76  |- mesh__onlineNote mesh__D008381
% 214.58/214.76       use HERPESVIRUS 2, GALLID to search MAREK%27%S DISEASE VIRUS 1975-96%A%  
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D008381 2003
% 214.58/214.76  |- skos__altLabel mesh__D008381 Neurolymphomatosis Virus
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D008381 2005
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D008381 2004
% 214.58/214.76  |- mesh__recordAuthorizer mesh__D008381 sjn
% 214.58/214.76  |- skos__annotation mesh__D008381
% 214.58/214.76       do not confuse with HERPESVIRUS 1, GALLID; infection = MAREK DISEASE%A%  
% 214.58/214.76  |- skos__altLabel mesh__D008381 Fowl Paralysis Virus
% 214.58/214.76  |- skos__scopeNote mesh__D008381
% 214.58/214.76       The type species of the genus MAREK%27%S DISEASE-LIKE VIRUSES in the family HERPESVIRIDAE. It is the etiologic agent of MAREK DISEASE, infecting domestic fowl and wild birds.%A%    
% 214.58/214.76  |- mesh__dateEstablished mesh__D008381 1975-09-01
% 214.58/214.76  |- skos__hiddenLabel mesh__D008381 Paralysis Virus, Fowl
% 214.58/214.76  |- mesh__recordOriginator mesh__D008381 NLM
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D008381 2002
% 214.58/214.76  |- skos__altLabel mesh__D008381 Marek%27%s Disease Virus Serotype 1
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D008381 2006
% 214.58/214.76  |- skos__altLabel mesh__D008381 Marek Disease Herpesvirus 1
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D016813 2005
% 214.58/214.76  |- mesh__recordMaintainer mesh__D016813 ags
% 214.58/214.76  |- skos__historyNote mesh__D016813 Ciliophora %28%1973-1991%29%
% 214.58/214.76  |- mesh__publicMeSHNote mesh__D016813 92   
% 214.58/214.76  |- mesh__activeMeSHYear mesh__D016813 2006
% 214.58/214.76  |- skos__annotation mesh__D016813 a genus of ciliate protozoa   
% 214.58/214.76  |- mesh__historyNote mesh__D016813 92   
% 214.58/214.76  |- mesh__dateRevised mesh__D016813 2003-07-09
% 214.58/214.76  |- rdf__type mesh__D016813sskos__Concept
% 214.67/214.84  |- mesh__dateEstablished mesh__D016813 1992-01-01
% 214.67/214.84  |- skos__broader mesh__D016813smesh__D016811
% 214.67/214.84  |- mesh__recordAuthorizer mesh__D016813 sjn
% 214.67/214.84  |- mesh__recordOriginator mesh__D016813 PXP
% 214.67/214.84  |- mesh__dateCreated mesh__D016813 1991-05-02
% 214.67/214.84  |- skos__scopeNote mesh__D016813
% 214.67/214.84       A genus of ciliate protozoa having a unique cursorial type of locomotion.%A%    
% 214.67/214.84  |- skos__prefLabel mesh__D016813 Oxytricha
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D016813 2004
% 214.67/214.84  |- skos__broader mesh__D016015smesh__D012044
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D016015 2005
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D016015 2004
% 214.67/214.84  |- skos__historyNote mesh__D016015 Regression Analysis %28%1980-1993%29%
% 214.67/214.84  |- skos__hiddenLabel mesh__D016015 Logit Model
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D016015 2001
% 214.67/214.84  |- skos__historyNote mesh__D016015 Statistics %28%1974-1979%29%
% 214.67/214.84  |- skos__historyNote mesh__D016015 Models, Theoretical %28%1972-1989%29%
% 214.67/214.84  |- skos__hiddenLabel mesh__D016015 Models, Logit
% 214.67/214.84  |- mesh__dateRevised mesh__D016015 1997-06-20
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D016015 1999
% 214.67/214.84  |- mesh__historyNote mesh__D016015 90   
% 214.67/214.84  |- mesh__recordMaintainer mesh__D016015 TPW
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D016015 2003
% 214.67/214.84  |- skos__broader mesh__D016015smesh__D015233
% 214.67/214.84  |- skos__scopeNote mesh__D016015
% 214.67/214.84       Statistical models which describe the relationship between a qualitative dependent variable %28%that is, one which can take only certain discrete values, such as the presence or absence of a disease%29% and an independent variable. A common application is in epidemiology for estimating an individual%27%s risk %28%probability of a disease%29% as a function of a given risk factor.%A%    
% 214.67/214.84  |- skos__hiddenLabel mesh__D016015 Regression, Logistic
% 214.67/214.84  |- skos__hiddenLabel mesh__D016015 Regressions, Logistic
% 214.67/214.84  |- skos__hiddenLabel mesh__D016015 Model, Logit
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D016015 2000
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D016015 1998
% 214.67/214.84  |- skos__altLabel mesh__D016015 Models, Logistic
% 214.67/214.84  |- skos__hiddenLabel mesh__D016015 Logistic Regressions
% 214.67/214.84  |- mesh__publicMeSHNote mesh__D016015 90   
% 214.67/214.84  |- mesh__recordOriginator mesh__D016015 PLS
% 214.67/214.84  |- mesh__recordAuthorizer mesh__D016015 SJN
% 214.67/214.84  |- rdf__type mesh__D016015sskos__Concept
% 214.67/214.84  |- skos__altLabel mesh__D016015 Logistic Model
% 214.67/214.84  |- skos__annotation mesh__D016015
% 214.67/214.84       IM GEN only; coord NIM with specific subject /statist %28%IM%29%; no qualif%A%  
% 214.67/214.84  |- mesh__dateEstablished mesh__D016015 1990-01-01
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D016015 2002
% 214.67/214.84  |- skos__hiddenLabel mesh__D016015 Model, Logistic
% 214.67/214.84  |- skos__broader mesh__D016015smesh__D012306
% 214.67/214.84  |- mesh__dateCreated mesh__D016015 1989-05-25
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D016015 2006
% 214.67/214.84  |- skos__prefLabel mesh__D016015 Logistic Models
% 214.67/214.84  |- mesh__historyNote mesh__D007289
% 214.67/214.84       94; was INOSINE CYCLIC MONOPHOSPHATE 1980-93 %28%see under INOSINE NUCLEOTIDES 1980-90%29%, was INOSINE CYCLIC-3%27%,5%27%-MONOPHOSPHATE see under INOSINE NUCLEOTIDES 1975-79; CYCLIC IMP was see INOSINE CYCLIC MONOPHOSPHATE 1975-93; INOSINE CYCLIC 2%27%,3%27%-MONOPHOSPHATE was see INOSINE CYCLIC MONOPHOSPHATE 1980-93%A%  
% 214.67/214.84  |- skos__hiddenLabel mesh__D007289 Cyclic Monophosphate, Inosine
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D007289 2001
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D007289 1997
% 214.67/214.84  |- skos__annotation mesh__D007289
% 214.67/214.84       /biosyn /physiol permitted; DF: CYCL IMP   
% 214.67/214.84  |- skos__broader mesh__D007289smesh__D007292
% 214.67/214.84  |- skos__historyNote mesh__D007289 Inosine Nucleotides %28%1971-1974%29%
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D007289 2006
% 214.67/214.84  |- skos__hiddenLabel mesh__D007289 IMP, Cyclic
% 214.67/214.84  |- mesh__publicMeSHNote mesh__D007289
% 214.67/214.84       94; was INOSINE CYCLIC MONOPHOSPHATE 1980-93 %28%see under INOSINE NUCLEOTIDES 1980-90%29%, was INOSINE CYCLIC-3%27%,5%27%-MONOPHOSPHATE see under INOSINE NUCLEOTIDES 1975-79; CYCLIC IMP was see INOSINE CYCLIC MONOPHOSPHATE 1975-93; INOSINE CYCLIC 2%27%,3%27%-MONOPHOSPHATE was see INOSINE CYCLIC MONOPHOSPHATE 1980-93%A%  
% 214.67/214.84  |- mesh__recordOriginator mesh__D007289 NLM
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D007289 1998
% 214.67/214.84  |- mesh__recordAuthorizer mesh__D007289 PLS
% 214.67/214.84  |- skos__hiddenLabel mesh__D007289 Inosine Cyclic 3%27%,5%27% Monophosphate
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D007289 2002
% 214.67/214.84  |- skos__scopeNote mesh__D007289
% 214.67/214.84       Inosine cyclic 3%27%,5%27%-%28%hydrogen phosphate%29%. An inosine nucleotide which acts as a mild inhibitor of the hydrolysis of cyclic AMP and cyclic GMP and as an inhibitor of cat heart cyclic AMP phosphodiesterase.%A%    
% 214.67/214.84  |- skos__hiddenLabel mesh__D007289
% 214.67/214.84       Cyclic-3%27%,5%27%-Monophosphate, Inosine
% 214.67/214.84  |- mesh__dateRevised mesh__D007289 1993-06-03
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D007289 1994
% 214.67/214.84  |- mesh__dateEstablished mesh__D007289 1991-01-01
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D007289 1999
% 214.67/214.84  |- skos__broader mesh__D007289smesh__D009712
% 214.67/214.84  |- skos__historyNote mesh__D007289 Nucleotides, Cyclic %28%1974%29%
% 214.67/214.84  |- skos__altLabel mesh__D007289 Inosine Cyclic Monophosphate
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D007289 1995
% 214.67/214.84  |- mesh__onlineNote mesh__D007289
% 214.67/214.84       use CYCLIC IMP to search INOSINE CYCLIC MONOPHOSPHATE 1980-93 %26% INOSINE CYCLIC-3%27%,5%27%-MONOPHOSPHATE 1975-79%A%  
% 214.67/214.84  |- skos__altLabel mesh__D007289 Inosine Cyclic 3%27%,5%27%-Monophosphate
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D007289 2003
% 214.67/214.84  |- mesh__dateCreated mesh__D007289 1974-11-19
% 214.67/214.84  |- rdf__type mesh__D007289sskos__Concept
% 214.67/214.84  |- skos__hiddenLabel mesh__D007289
% 214.67/214.84       Cyclic 3%27%,5%27%-Monophosphate, Inosine
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D007289 2004
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D007289 1996
% 214.67/214.84  |- mesh__recordMaintainer mesh__D007289 PLS
% 214.67/214.84  |- skos__altLabel mesh__D007289 Inosine Cyclic-3%27%,5%27%-Monophosphate
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D007289 2005
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D007289 2000
% 214.67/214.84  |- skos__prefLabel mesh__D007289 Cyclic IMP
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D026443 2003
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D026443 2005
% 214.67/214.84  |- skos__scopeNote mesh__D026443
% 214.67/214.84       Mystical, religious, or spiritual practices performed for health benefit.%A%    
% 214.67/214.84  |- mesh__recordOriginator mesh__D026443 ssb
% 214.67/214.84  |- mesh__recordMaintainer mesh__D026443 ssb
% 214.67/214.84  |- mesh__dateEstablished mesh__D026443 2002-01-01
% 214.67/214.84  |- skos__annotation mesh__D026443 GEN or unspecified; prefer specifics   
% 214.67/214.84  |- rdf__type mesh__D026443sskos__Concept
% 214.67/214.84  |- skos__related mesh__D026443smesh__D029181
% 214.67/214.84  |- mesh__publicMeSHNote mesh__D026443 2002   
% 214.67/214.84  |- skos__prefLabel mesh__D026443 Spiritual Therapies
% 214.67/214.84  |- skos__related mesh__D026443smesh__D012067
% 214.67/214.84  |- mesh__historyNote mesh__D026443 2002   
% 214.67/214.84  |- skos__related mesh__D026443smesh__D026441
% 214.67/214.84  |- skos__broader mesh__D026443smesh__D000529
% 214.67/214.84  |- skos__related mesh__D026443smesh__D010268
% 214.67/214.84  |- mesh__recordAuthorizer mesh__D026443 sjn
% 214.67/214.84  |- mesh__dateCreated mesh__D026443 2001-07-25
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D026443 2004
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D026443 2002
% 214.67/214.84  |- skos__altLabel mesh__D026443 Therapies, Spiritual
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D026443 2006
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D012423 2006
% 214.67/214.84  |- mesh__dateCreated mesh__D012423 1999-01-01
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D012423 2002
% 214.67/214.84  |- mesh__recordMaintainer mesh__D012423 kle
% 214.67/214.84  |- skos__annotation mesh__D012423 specify geog   
% 214.67/214.84  |- mesh__recordAuthorizer mesh__D012423 sjn
% 214.67/214.84  |- rdf__type mesh__D012423sskos__Concept
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D012423 2005
% 214.67/214.84  |- skos__prefLabel mesh__D012423 Rural Health
% 214.67/214.84  |- skos__hiddenLabel mesh__D012423 Health, Rural
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D012423 2001
% 214.67/214.84  |- skos__broader mesh__D012423smesh__D006262
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D012423 2004
% 214.67/214.84  |- mesh__recordOriginator mesh__D012423 NLM
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D012423 2000
% 214.67/214.84  |- skos__scopeNote mesh__D012423
% 214.67/214.84       The status of health in rural populations.     
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D012423 2003
% 214.67/214.84  |- mesh__dateRevised mesh__D012423 1999-11-03
% 214.67/214.84  |- skos__related mesh__D012423smesh__D000382
% 214.67/214.84  |- skos__scopeNote mesh__D050542
% 214.67/214.84       An enzyme that plays a role in the PENTOSES and GLUCURONATES interconversion pathway by catalyzing the oxidation of XYLITOL to D-xylulose. This enzyme has been found to be specific for NAD+.%A%    
% 214.67/214.84  |- mesh__dateRevised mesh__D050542 2005-07-22
% 214.67/214.84  |- mesh__publicMeSHNote mesh__D050542
% 214.67/214.84       2006; D-XYLULOSE REDUCTASE was indexed under SUGAR ALCOHOL DEHYDROGENASES 1981-2005, ALCOHOL OXIDOREDUCTASES 1975-1980, XYLULOSE 1976-1980, %26% KETOSES %26% PENTOSES 1975-1976%A%  
% 214.67/214.84  |- mesh__historyNote mesh__D050542 2006%28%1980%29%   
% 214.67/214.84  |- skos__hiddenLabel mesh__D050542 D Xylulose Reductase
% 214.67/214.84  |- mesh__recordOriginator mesh__D050542 AKE
% 214.67/214.84  |- skos__hiddenLabel mesh__D050542 Dehydrogenase, NAD-Dependent Xylitol
% 214.67/214.84  |- mesh__dateEstablished mesh__D050542 2006-01-01
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D050542 2006
% 214.67/214.84  |- skos__hiddenLabel mesh__D050542 Reductase, D-Xylulose
% 214.67/214.84  |- rdf__type mesh__D050542sskos__Concept
% 214.67/214.84  |- skos__hiddenLabel mesh__D050542 NAD Dependent Xylitol Dehydrogenase
% 214.67/214.84  |- skos__prefLabel mesh__D050542 D-Xylulose Reductase
% 214.67/214.84  |- skos__altLabel mesh__D050542 NAD-Dependent Xylitol Dehydrogenase
% 214.67/214.84  |- skos__broader mesh__D050542smesh__D013401
% 214.67/214.84  |- mesh__recordMaintainer mesh__D050542 ags
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D050542 2006A
% 214.67/214.84  |- skos__hiddenLabel mesh__D050542 Xylitol Dehydrogenase, NAD-Dependent
% 214.67/214.84  |- skos__hiddenLabel mesh__D050542 Dehydrogenase, Xylitol
% 214.67/214.84  |- mesh__recordAuthorizer mesh__D050542 ags
% 214.67/214.84  |- mesh__dateCreated mesh__D050542 2005-06-30
% 214.67/214.84  |- skos__altLabel mesh__D050542 Xylitol Dehydrogenase
% 214.67/214.84  |- skos__broader mesh__D003697smesh__D011795
% 214.67/214.84  |- skos__scopeNote mesh__D003697
% 214.67/214.84       An iterative questionnaire designed to measure consensus among individual responses. In the classic Delphi approach, there is no interaction between responder and interviewer.%A%    
% 214.67/214.84  |- skos__altLabel mesh__D003697 Delphi Technic
% 214.67/214.84  |- mesh__historyNote mesh__D003697
% 214.67/214.84       91%28%80%29%; was DELPHI TECHNIC see under QUESTIONNAIRES 1980-90%A%  
% 214.67/214.84  |- skos__hiddenLabel mesh__D003697 Technique, Delphi
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D003697 1998
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D003697 1997
% 214.67/214.84  |- skos__hiddenLabel mesh__D003697 Techniques, Delphi
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D003697 1992
% 214.67/214.84  |- mesh__publicMeSHNote mesh__D003697
% 214.67/214.84       91; was DELPHI TECHNIC see under QUESTIONNAIRES 1980-90   
% 214.67/214.84  |- skos__hiddenLabel mesh__D003697 Delphi Technics
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D003697 2006
% 214.67/214.84  |- skos__annotation mesh__D003697 to measure consensus; no qualif   
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D003697 2001
% 214.67/214.84  |- mesh__dateEstablished mesh__D003697 1991-01-01
% 214.67/214.84  |- skos__hiddenLabel mesh__D003697 Delphi Techniques
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D003697 1996
% 214.67/214.84  |- skos__hiddenLabel mesh__D003697 Delphi Study
% 214.67/214.84  |- mesh__dateRevised mesh__D003697 1991-06-20
% 214.67/214.84  |- skos__hiddenLabel mesh__D003697 Studies, Delphi
% 214.67/214.84  |- skos__hiddenLabel mesh__D003697 Technic, Delphi
% 214.67/214.84  |- skos__historyNote mesh__D003697 Questionnaires %28%1973-1979%29%
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D003697 2005
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D003697 2000
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D003697 2004
% 214.67/214.84  |- rdf__type mesh__D003697sskos__Concept
% 214.67/214.84  |- mesh__recordAuthorizer mesh__D003697 PLS
% 214.67/214.84  |- mesh__recordOriginator mesh__D003697 EC
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D003697 1995
% 214.67/214.84  |- mesh__recordMaintainer mesh__D003697 PLS
% 214.67/214.84  |- skos__hiddenLabel mesh__D003697 Technics, Delphi
% 214.67/214.84  |- mesh__dateCreated mesh__D003697 1979-05-31
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D003697 2003
% 214.67/214.84  |- skos__prefLabel mesh__D003697 Delphi Technique
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D003697 1999
% 214.67/214.84  |- mesh__onlineNote mesh__D003697
% 214.67/214.84       use DELPHI TECHNIQUE to search DELPHI TECHNIC 1980-90   
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D003697 1994
% 214.67/214.84  |- skos__hiddenLabel mesh__D003697 Study, Delphi
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D003697 2002
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D003697 1993
% 214.67/214.84  |- mesh__recordOriginator mesh__D008382 NLM
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D008382 2002
% 214.67/214.84  |- mesh__onlineNote mesh__D008382
% 214.67/214.84       use MARFAN SYNDROME to search ARACHNODACTYLY 1966-84   
% 214.67/214.84  |- skos__broader mesh__D008382smesh__D006330
% 214.67/214.84  |- mesh__dateCreated mesh__D008382 1999-01-01
% 214.67/214.84  |- skos__hiddenLabel mesh__D008382 Syndrome, Marfan
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D008382 2003
% 214.67/214.84  |- mesh__dateRevised mesh__D008382 2001-07-25
% 214.67/214.84  |- skos__altLabel mesh__D008382 Marfan%27%s Syndrome
% 214.67/214.84  |- skos__broader mesh__D008382smesh__D030342
% 214.67/214.84  |- skos__hiddenLabel mesh__D008382 Marfans Syndrome
% 214.67/214.84  |- skos__hiddenLabel mesh__D008382 Arachnodactylies
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D008382 2005
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D008382 2004
% 214.67/214.84  |- skos__scopeNote mesh__D008382
% 214.67/214.84       A hereditary disorder of connective tissue characterized by tall stature, elongated extremities, subluxation of the lens, dilatation of the ascending aorta, and %22%pigeon breast.%22% It is inherited as an autosomal dominant trait.%A%    
% 214.67/214.84  |- skos__broader mesh__D008382smesh__D003240
% 214.67/214.84  |- skos__hiddenLabel mesh__D008382 Syndrome, Marfan%27%s
% 214.67/214.84  |- mesh__recordMaintainer mesh__D008382 nns
% 214.67/214.84  |- mesh__activeMeSHYear mesh__D008382 2006
% 214.67/214.84  |- mesh__publicMeSHNote mesh__D008382 85; was ARACHNODACTYLY 1963-84   
% 214.67/214.84  |- mesh__historyNote mesh__D008382 85; was ARACHNODACTYLY 1963-84   
% 214.67/214.84  |- mesh__recordAuthorizer mesh__D008382 sjn
% 214.67/214.84  |- skos__broader mesh__D008382smesh__D001848
% 214.67/214.84  |- rdf__type mesh__D008382sskos__Concept
% 214.67/214.84  |- skos__prefLabel mesh__D008382 Marfan Syndrome
% 214.67/214.84  |- skos__broader mesh__D008382smesh__D000015
% 214.67/214.84  |- mesh__dateRevised mesh__D016814 2005-10-27
% 214.67/214.84  |- mesh__recordAuthorizer mesh__D016814 ags
% 214.67/214.84  |- skos__annotation mesh__D016814
% 214.67/214.84       do not confuse with the class MICROSPOREA, the order MICROSPORIDA, or with MICROSPORUM, a dermatophyte; MICROSPORIDIA, UNCLASSIFIED is also available, see annotation there; infection = MICROSPORIDIOSIS; coordinate with specific fungal term %28%ANTIGENS, FUNGAL, etc%29% if pertinent%A%  
% 214.67/214.84  |- skos__prefLabel mesh__D016814 Microsporidia
% 214.67/214.84  |- mesh__dateCreated mesh__D016814 1991-05-02
% 214.67/214.84  |- skos__broader mesh__D016814smesh__D005658
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016814 2006C
% 214.67/214.85  |- mesh__historyNote mesh__D016814
% 214.67/214.85       2006 %28%1992%29%; use MICROSPORIDA 1991-2000   
% 214.67/214.85  |- mesh__dateEstablished mesh__D016814 1992-01-01
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016814 2006
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016814 2006B
% 214.67/214.85  |- mesh__recordMaintainer mesh__D016814 ags
% 214.67/214.85  |- rdf__type mesh__D016814sskos__Concept
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016814 2006A
% 214.67/214.85  |- mesh__publicMeSHNote mesh__D016814
% 214.67/214.85       2006; see MICROSPORA 1992-2005, see MICROSPORIDA 1991-2000%A%  
% 214.67/214.85  |- skos__altLabel mesh__D016814 Microspora
% 214.67/214.85  |- mesh__recordOriginator mesh__D016814 PXP
% 214.67/214.85  |- skos__scopeNote mesh__D016814
% 214.67/214.85       A phylum of fungi comprising minute intracellular PARASITES with FUNGAL SPORES of unicellular origin. It has two classes: Rudimicrosporea and MICROSPOREA.%A%    
% 214.67/214.85  |- skos__hiddenLabel mesh__D016016 Hazard Model, Proportional
% 214.67/214.85  |- mesh__recordOriginator mesh__D016016 PLS
% 214.67/214.85  |- skos__annotation mesh__D016016
% 214.67/214.85       IM GEN only; coord NIM with specific subject /statist %28%IM%29%; no qualif%A%  
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016016 1993
% 214.67/214.85  |- skos__broader mesh__D016016smesh__D011336
% 214.67/214.85  |- skos__altLabel mesh__D016016 Proportional Hazard Models
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016016 1994
% 214.67/214.85  |- skos__hiddenLabel mesh__D016016 Models, Cox
% 214.67/214.85  |- skos__broader mesh__D016016smesh__D015233
% 214.67/214.85  |- skos__hiddenLabel mesh__D016016 Model, Hazard
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016016 1999
% 214.67/214.85  |- skos__altLabel mesh__D016016 Hazard Models
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016016 2002
% 214.67/214.85  |- skos__hiddenLabel mesh__D016016 Hazards Model, Proportional
% 214.67/214.85  |- skos__altLabel mesh__D016016 Models, Proportional Hazards
% 214.67/214.85  |- skos__scopeNote mesh__D016016
% 214.67/214.85       Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time.%A%    
% 214.67/214.85  |- mesh__recordMaintainer mesh__D016016 PLS
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016016 2003
% 214.67/214.85  |- mesh__recordAuthorizer mesh__D016016 PLS
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016016 1995
% 214.67/214.85  |- skos__historyNote mesh__D016016 Models, Theoretical %28%1977-1989%29%
% 214.67/214.85  |- skos__hiddenLabel mesh__D016016 Models, Hazards
% 214.67/214.85  |- mesh__publicMeSHNote mesh__D016016 90   
% 214.67/214.85  |- skos__hiddenLabel mesh__D016016 Model, Hazards
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016016 2004
% 214.67/214.85  |- skos__hiddenLabel mesh__D016016 Hazards Model
% 214.67/214.85  |- skos__hiddenLabel mesh__D016016 Hazard Models, Proportional
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016016 2005
% 214.67/214.85  |- mesh__dateEstablished mesh__D016016 1990-01-01
% 214.67/214.85  |- mesh__dateCreated mesh__D016016 1989-05-25
% 214.67/214.85  |- rdf__type mesh__D016016sskos__Concept
% 214.67/214.85  |- skos__hiddenLabel mesh__D016016 Hazards Models, Proportional
% 214.67/214.85  |- skos__hiddenLabel mesh__D016016 Proportional Hazard Model
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016016 2000
% 214.67/214.85  |- skos__hiddenLabel mesh__D016016 Models, Proportional Hazard
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016016 2006
% 214.67/214.85  |- skos__hiddenLabel mesh__D016016 Models, Hazard
% 214.67/214.85  |- skos__prefLabel mesh__D016016 Proportional Hazards Models
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016016 1996
% 214.67/214.85  |- skos__hiddenLabel mesh__D016016 Model, Proportional Hazards
% 214.67/214.85  |- mesh__dateRevised mesh__D016016 1992-05-22
% 214.67/214.85  |- skos__hiddenLabel mesh__D016016 Hazard Model
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016016 2001
% 214.67/214.85  |- skos__hiddenLabel mesh__D016016 Model, Proportional Hazard
% 214.67/214.85  |- skos__broader mesh__D016016smesh__D012044
% 214.67/214.85  |- mesh__historyNote mesh__D016016 90   
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016016 1997
% 214.67/214.85  |- skos__hiddenLabel mesh__D016016 Proportional Hazards Model
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016016 1998
% 214.67/214.85  |- mesh__dateCreated mesh__D032481 2002-07-03
% 214.67/214.85  |- mesh__historyNote mesh__D032481 2003   
% 214.67/214.85  |- rdf__type mesh__D032481sskos__Concept
% 214.67/214.85  |- skos__annotation mesh__D032481
% 214.67/214.85       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.67/214.85  |- mesh__dateRevised mesh__D032481 2005-06-30
% 214.67/214.85  |- mesh__dateEstablished mesh__D032481 2003-01-01
% 214.67/214.85  |- mesh__recordOriginator mesh__D032481 ssb
% 214.67/214.85  |- skos__prefLabel mesh__D032481 Zamiaceae
% 214.67/214.85  |- skos__scopeNote mesh__D032481
% 214.67/214.85       A plant family of the order Cycadales, class Cycadopsida, division CYCADOPHYTA.%A%    
% 214.67/214.85  |- mesh__recordMaintainer mesh__D032481 ssb
% 214.67/214.85  |- skos__broader mesh__D032481smesh__D032462
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D032481 2006
% 214.67/214.85  |- mesh__publicMeSHNote mesh__D032481 2003   
% 214.67/214.85  |- mesh__recordAuthorizer mesh__D032481 sjn
% 214.67/214.85  |- skos__broader mesh__D004790smesh__D015971
% 214.67/214.85  |- rdf__type mesh__D004790sskos__Concept
% 214.67/214.85  |- skos__hiddenLabel mesh__D004790 Induction, Enzyme
% 214.67/214.85  |- mesh__dateRevised mesh__D004790 2002-07-03
% 214.67/214.85  |- mesh__recordMaintainer mesh__D004790 NDW
% 214.67/214.85  |- mesh__historyNote mesh__D004790 68%28%66%29%   
% 214.67/214.85  |- mesh__dateCreated mesh__D004790 1999-01-01
% 214.67/214.85  |- mesh__recordOriginator mesh__D004790 NLM
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D004790 2005
% 214.67/214.85  |- skos__prefLabel mesh__D004790 Enzyme Induction
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D004790 2003
% 214.67/214.85  |- skos__scopeNote mesh__D004790
% 214.67/214.85       An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis.%A%    
% 214.67/214.85  |- mesh__dateEstablished mesh__D004790 1968-01-01
% 214.67/214.85  |- skos__annotation mesh__D004790
% 214.67/214.85       IM for general only; NIM with specific enzyme /biosyn %28%IM%29%%A%  
% 214.67/214.85  |- mesh__recordAuthorizer mesh__D004790 sjn
% 214.67/214.85  |- mesh__publicMeSHNote mesh__D004790 68   
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D004790 2006
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D004790 2004
% 214.67/214.85  |- skos__broader mesh__D012424smesh__D011153
% 214.67/214.85  |- skos__hiddenLabel mesh__D012424 Rural Spatial Distributions
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012424 2003
% 214.67/214.85  |- mesh__dateEstablished mesh__D012424 1968-01-01
% 214.67/214.85  |- skos__prefLabel mesh__D012424 Rural Population
% 214.67/214.85  |- skos__annotation mesh__D012424
% 214.67/214.85       specify geog; RURAL HEALTH %26% RURAL HEALTH SERVICES are also available%A%  
% 214.67/214.85  |- skos__hiddenLabel mesh__D012424 Community, Rural
% 214.67/214.85  |- skos__hiddenLabel mesh__D012424 Distribution, Rural Spatial
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012424 2002
% 214.67/214.85  |- mesh__recordAuthorizer mesh__D012424 sjn
% 214.67/214.85  |- mesh__recordMaintainer mesh__D012424 kle
% 214.67/214.85  |- mesh__publicMeSHNote mesh__D012424 68   
% 214.67/214.85  |- skos__scopeNote mesh__D012424
% 214.67/214.85       The inhabitants of rural areas or of small towns classified as rural.%A%    
% 214.67/214.85  |- skos__hiddenLabel mesh__D012424 Population, Rural
% 214.67/214.85  |- skos__hiddenLabel mesh__D012424 Distributions, Rural Spatial
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012424 2006
% 214.67/214.85  |- mesh__dateCreated mesh__D012424 1999-01-01
% 214.67/214.85  |- skos__hiddenLabel mesh__D012424 Communities, Rural
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012424 2001
% 214.67/214.85  |- skos__hiddenLabel mesh__D012424 Populations, Rural
% 214.67/214.85  |- skos__hiddenLabel mesh__D012424 Rural Community
% 214.67/214.85  |- rdf__type mesh__D012424sskos__Concept
% 214.67/214.85  |- mesh__recordOriginator mesh__D012424 NLM
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012424 2005
% 214.67/214.85  |- mesh__historyNote mesh__D012424 68%28%65%29%   
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012424 2000
% 214.67/214.85  |- skos__hiddenLabel mesh__D012424 Rural Populations
% 214.67/214.85  |- mesh__dateRevised mesh__D012424 1999-11-03
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012424 2004
% 214.67/214.85  |- skos__broader mesh__D050543smesh__D002237
% 214.67/214.85  |- skos__altLabel mesh__D050543 3-Phosphoglycerate Dehydrogenase
% 214.67/214.85  |- skos__hiddenLabel mesh__D050543 3 Phosphoglycerate NAD+ 2 Oxidoreductase
% 214.67/214.85  |- skos__hiddenLabel mesh__D050543 D 3 Phosphoglycerate Dehydrogenase
% 214.67/214.85  |- skos__hiddenLabel mesh__D050543 Dehydrogenase, D-3-Phosphoglycerate
% 214.67/214.85  |- skos__prefLabel mesh__D050543 Phosphoglycerate Dehydrogenase
% 214.67/214.85  |- skos__hiddenLabel mesh__D050543 Oxidoreductase, Phosphoglycerate
% 214.67/214.85  |- skos__hiddenLabel mesh__D050543 3 Phosphoglycerate Dehydrogenase
% 214.67/214.85  |- mesh__dateCreated mesh__D050543 2005-06-30
% 214.67/214.85  |- skos__altLabel mesh__D050543 Phosphoglycerate Oxidoreductase
% 214.67/214.85  |- mesh__historyNote mesh__D050543 2006%28%1985%29%   
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D050543 2006
% 214.67/214.85  |- rdf__type mesh__D050543sskos__Concept
% 214.67/214.85  |- mesh__recordAuthorizer mesh__D050543 sjn
% 214.67/214.85  |- skos__hiddenLabel mesh__D050543
% 214.67/214.85       2-Oxidoreductase, 3-Phosphoglycerate-NAD+
% 214.67/214.85  |- mesh__recordMaintainer mesh__D050543 AKE
% 214.67/214.85  |- skos__altLabel mesh__D050543 D-3-Phosphoglycerate Dehydrogenase
% 214.67/214.85  |- mesh__publicMeSHNote mesh__D050543
% 214.67/214.85       2006; PHOSPHOGLYCERATE DEHYDROGENASE was indexed under CARBOHYDRATE DEHYSDROGENASES 1985-2005%A%  
% 214.67/214.85  |- skos__hiddenLabel mesh__D050543 Dehydrogenase, Phosphoglycerate
% 214.67/214.85  |- skos__hiddenLabel mesh__D050543 Dehydrogenase, 3-Phosphoglycerate
% 214.67/214.85  |- skos__altLabel mesh__D050543 3-Phosphoglycerate-NAD+ 2-Oxidoreductase
% 214.67/214.85  |- mesh__recordOriginator mesh__D050543 AKE
% 214.67/214.85  |- skos__scopeNote mesh__D050543
% 214.67/214.85       An enzyme that catalyzes the oxidation of 3-phosphoglycerate to 3-phosphohydroxypyruvate. It takes part in the L-SERINE biosynthesis pathway.%A%    
% 214.67/214.85  |- mesh__dateEstablished mesh__D050543 2006-01-01
% 214.67/214.85  |- mesh__dateRevised mesh__D003698 2001-07-25
% 214.67/214.85  |- skos__hiddenLabel mesh__D003698 Delta Virus, Hepatitis
% 214.67/214.85  |- skos__scopeNote mesh__D003698
% 214.67/214.85       A defective virus, containing particles of RNA nucleoprotein in virion-like form, present in patients with acute hepatitis B and chronic hepatitis. It requires the presence of a hepadnavirus for full replication. This is the lone species in the genus Deltavirus.%A%    
% 214.67/214.85  |- mesh__dateEstablished mesh__D003698 1986-01-01
% 214.67/214.85  |- mesh__publicMeSHNote mesh__D003698
% 214.67/214.85       98; see DELTA AGENT 1986-97; for HEPATITIS DELTA VIRUS see DELTA AGENT 1997%A%  
% 214.67/214.85  |- mesh__recordMaintainer mesh__D003698 ags
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D003698 2002
% 214.67/214.85  |- mesh__dateCreated mesh__D003698 1985-05-07
% 214.67/214.85  |- skos__altLabel mesh__D003698 Delta Agent
% 214.67/214.85  |- mesh__historyNote mesh__D003698 98%28%86%29%   
% 214.67/214.85  |- rdf__type mesh__D003698sskos__Concept
% 214.67/214.85  |- skos__historyNote mesh__D003698 Hepatitis B %28%1977-1985%29%
% 214.67/214.85  |- mesh__recordOriginator mesh__D003698 RC
% 214.67/214.85  |- skos__hiddenLabel mesh__D003698 Deltaviruses
% 214.67/214.85  |- skos__broader mesh__D003698smesh__D003673
% 214.67/214.85  |- skos__annotation mesh__D003698
% 214.67/214.85       infection = HEPATITIS D or HEPATITIS D, CHRONIC   
% 214.67/214.85  |- skos__hiddenLabel mesh__D003698 Hepatitis D Viruses
% 214.67/214.85  |- skos__prefLabel mesh__D003698 Hepatitis Delta Virus
% 214.67/214.85  |- skos__hiddenLabel mesh__D003698 Delta Viruses, Hepatitis
% 214.67/214.85  |- skos__hiddenLabel mesh__D003698 Delta Agents
% 214.67/214.85  |- skos__broader mesh__D003698smesh__D006518
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D003698 2003
% 214.67/214.85  |- skos__altLabel mesh__D003698 Hepatitis D Virus
% 214.67/214.85  |- skos__hiddenLabel mesh__D003698 Hepatitis Delta Viruses
% 214.67/214.85  |- skos__hiddenLabel mesh__D003698 Delta Viruses
% 214.67/214.85  |- skos__altLabel mesh__D003698 Delta Virus
% 214.67/214.85  |- mesh__recordAuthorizer mesh__D003698 sjn
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D003698 2005
% 214.67/214.85  |- skos__broader mesh__D003698smesh__D012328
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D003698 2004
% 214.67/214.85  |- skos__historyNote mesh__D003698 Hepatitis B Antigens %28%1977-1985%29%
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D003698 2006
% 214.67/214.85  |- skos__prefLabel mesh__D008383 Margarine
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D008383 2005
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D008383 2004
% 214.67/214.85  |- mesh__recordAuthorizer mesh__D008383 sjn
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D008383 2006
% 214.67/214.85  |- mesh__recordOriginator mesh__D008383 NLM
% 214.67/214.85  |- skos__scopeNote mesh__D008383
% 214.67/214.85       A butterlike product made of refined vegetable oils, sometimes blended with animal fats, and emulsified usually with water or milk. It is used as a butter substitute. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 214.67/214.85  |- rdf__type mesh__D008383sskos__Concept
% 214.67/214.85  |- mesh__dateRevised mesh__D008383 2003-07-09
% 214.67/214.85  |- skos__broader mesh__D008383smesh__D004041
% 214.67/214.85  |- skos__annotation mesh__D008383 a butter substitute   
% 214.67/214.85  |- mesh__recordMaintainer mesh__D008383 ssb
% 214.67/214.85  |- mesh__dateCreated mesh__D008383 1999-01-01
% 214.67/214.85  |- skos__broader mesh__D008383smesh__D003611
% 214.67/214.85  |- mesh__dateRevised mesh__D016815 2005-06-30
% 214.67/214.85  |- skos__scopeNote mesh__D016815
% 214.67/214.85       A class of parasitic FUNGI. Characteristics include spores that are spherical, oval, or tubular in shape and sporoplasm which is uninuclear or binuclear.%A%    
% 214.67/214.85  |- mesh__recordAuthorizer mesh__D016815 sjn
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016815 2006
% 214.67/214.85  |- mesh__historyNote mesh__D016815 1992   
% 214.67/214.85  |- skos__annotation mesh__D016815
% 214.67/214.85       do not confuse with fungal phylum MICROSPORA see MICROSPORIDIA; infection: coordinate IM with MICROSPORIDIOSIS %28%IM%29%; coordinate with specific fungal terms %28%ANTIGENS, FUNGAL, etc%29% if pertinent%A%  
% 214.67/214.85  |- mesh__recordMaintainer mesh__D016815 ags
% 214.67/214.85  |- mesh__dateCreated mesh__D016815 1991-05-02
% 214.67/214.85  |- rdf__type mesh__D016815sskos__Concept
% 214.67/214.85  |- mesh__recordOriginator mesh__D016815 PXP
% 214.67/214.85  |- mesh__publicMeSHNote mesh__D016815 1992   
% 214.67/214.85  |- mesh__dateEstablished mesh__D016815 1992-01-01
% 214.67/214.85  |- skos__prefLabel mesh__D016815 Microsporea
% 214.67/214.85  |- skos__broader mesh__D016815smesh__D016814
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016017 1996
% 214.67/214.85  |- skos__hiddenLabel mesh__D016017 Ratios, Risk
% 214.67/214.85  |- skos__scopeNote mesh__D016017
% 214.67/214.85       The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases.%A%    
% 214.67/214.85  |- skos__hiddenLabel mesh__D016017 Ratio, Cross-Product
% 214.67/214.85  |- skos__annotation mesh__D016017
% 214.67/214.85       IM GEN only; coord NIM with specific disease or other concept %28%IM%29%; no qualif%A%  
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016017 1997
% 214.67/214.85  |- skos__hiddenLabel mesh__D016017 Risk Ratios
% 214.67/214.85  |- skos__altLabel mesh__D016017 Risk Ratio
% 214.67/214.85  |- mesh__publicMeSHNote mesh__D016017 91; was see under PROBABILITY 1990   
% 214.67/214.85  |- mesh__historyNote mesh__D016017
% 214.67/214.85       91%28%90%29%; was see under PROBABILITY 1990   
% 214.67/214.85  |- skos__hiddenLabel mesh__D016017 Ratios, Cross-Product
% 214.67/214.85  |- mesh__dateCreated mesh__D016017 1989-05-25
% 214.67/214.85  |- mesh__recordOriginator mesh__D016017 PLS
% 214.67/214.85  |- mesh__recordAuthorizer mesh__D016017 PLS
% 214.67/214.85  |- skos__hiddenLabel mesh__D016017 Odds Ratios
% 214.67/214.85  |- skos__broader mesh__D016017smesh__D011336
% 214.67/214.85  |- mesh__recordMaintainer mesh__D016017 TGC
% 214.67/214.85  |- rdf__type mesh__D016017sskos__Concept
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016017 2005
% 214.67/214.85  |- mesh__dateRevised mesh__D016017 1994-04-11
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016017 2000
% 214.67/214.85  |- skos__hiddenLabel mesh__D016017 Ratio, Risk
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016017 1995
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016017 2006
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016017 2003
% 214.67/214.85  |- skos__historyNote mesh__D016017 Risk %28%1977-1989%29%
% 214.67/214.85  |- skos__hiddenLabel mesh__D016017 Cross-Product Ratios
% 214.67/214.85  |- skos__altLabel mesh__D016017 Relative Odds
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016017 2001
% 214.67/214.85  |- skos__prefLabel mesh__D016017 Odds Ratio
% 214.67/214.85  |- skos__hiddenLabel mesh__D016017 Odds, Relative
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016017 1998
% 214.67/214.85  |- skos__hiddenLabel mesh__D016017 Cross Product Ratio
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016017 2004
% 214.67/214.85  |- skos__altLabel mesh__D016017 Cross-Product Ratio
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016017 2002
% 214.67/214.85  |- mesh__dateEstablished mesh__D016017 1991-01-01
% 214.67/214.85  |- skos__historyNote mesh__D016017 Probability %28%1977-1989%29%
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016017 1999
% 214.67/214.85  |- mesh__historyNote mesh__D032482 2003; use GYMNOSPERMS 1998-2002   
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D032482 2004
% 214.67/214.85  |- mesh__dateCreated mesh__D032482 2002-07-03
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D032482 2005
% 214.67/214.85  |- skos__broader mesh__D032482smesh__D019681
% 214.67/214.85  |- skos__annotation mesh__D032482
% 214.67/214.85       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.67/214.85  |- skos__scopeNote mesh__D032482
% 214.67/214.85       A plant division of GYMNOSPERMS consisting of cone-bearing trees and shrubs.%A%    
% 214.67/214.85  |- mesh__dateEstablished mesh__D032482 2003-01-01
% 214.67/214.85  |- skos__prefLabel mesh__D032482 Coniferophyta
% 214.67/214.85  |- mesh__publicMeSHNote mesh__D032482 2003; see GYMNOSPERMS 1998-2002   
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D032482 2006
% 214.67/214.85  |- skos__historyNote mesh__D032482 Gymnosperms %28%1998-2002%29%
% 214.67/214.85  |- skos__altLabel mesh__D032482 Conifers
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D032482 2003
% 214.67/214.85  |- rdf__type mesh__D032482sskos__Concept
% 214.67/214.85  |- skos__broader mesh__D012137Q000002smesh__D012137
% 214.67/214.85  |- mesh__preferredCombination mesh__D012137Q000002smesh__D015619
% 214.67/214.85  |- rdf__type mesh__D012137Q000002smesh__CompoundConcept
% 214.67/214.85  |- mesh__dateCreated mesh__D004791 1999-01-01
% 214.67/214.85  |- mesh__historyNote mesh__D004791 75,64-67   
% 214.67/214.85  |- skos__historyNote mesh__D004791
% 214.67/214.85       Enzymes/antagonists %26% inhibitors %28%1968-1974%29%
% 214.67/214.85  |- mesh__recordAuthorizer mesh__D004791 sjn
% 214.67/214.85  |- mesh__onlineNote mesh__D004791
% 214.67/214.85       search ENZYMES /AI 1968-74 %26% ENZYMES 1966-67   
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D004791 2005
% 214.67/214.85  |- skos__hiddenLabel mesh__D004791 Inhibitors, Enzyme
% 214.67/214.85  |- skos__broader mesh__D004791smesh__D045504
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D004791 2006
% 214.67/214.85  |- skos__historyNote mesh__D004791 Enzymes %28%1966-1967%29%
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D004791 2004
% 214.67/214.85  |- skos__annotation mesh__D004791
% 214.67/214.85       GEN only; prefer /antag with specific enzyme; DF: ENZYME INHIB%A%  
% 214.67/214.85  |- mesh__publicMeSHNote mesh__D004791 75,64-67   
% 214.67/214.85  |- rdf__type mesh__D004791sskos__Concept
% 214.67/214.85  |- mesh__recordMaintainer mesh__D004791 ssb
% 214.67/214.85  |- mesh__recordOriginator mesh__D004791 NLM
% 214.67/214.85  |- skos__prefLabel mesh__D004791 Enzyme Inhibitors
% 214.67/214.85  |- mesh__dateRevised mesh__D004791 2003-07-09
% 214.67/214.85  |- mesh__dateEstablished mesh__D004791 1975-09-01
% 214.67/214.85  |- skos__scopeNote mesh__D004791
% 214.67/214.85       Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.%A%    
% 214.67/214.85  |- mesh__onlineNote mesh__D012425
% 214.67/214.85       use RUSSIA %28%PRE-1917%29% to search RUSSIA 1966; search RUSSIAN FEDERATION under RUSSIA %26% SIBERIA 1966%A%  
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012425 2000
% 214.67/214.85  |- skos__prefLabel mesh__D012425 Russia %28%Pre-1917%29%
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012425 1998
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012425 1993
% 214.67/214.85  |- skos__broader mesh__D012425smesh__D017516
% 214.67/214.85  |- mesh__recordMaintainer mesh__D012425 ags
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012425 1997
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012425 1996
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012425 2006
% 214.67/214.85  |- mesh__dateCreated mesh__D012425 1999-01-01
% 214.67/214.85  |- mesh__dateRevised mesh__D012425 1999-12-01
% 214.67/214.85  |- rdf__type mesh__D012425sskos__Concept
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012425 2005
% 214.67/214.85  |- mesh__historyNote mesh__D012425
% 214.67/214.85       67; RUSSIAN FEDERATION was heading 1966; RUSSIA was heading 1963-66%A%  
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012425 2000A
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012425 2002
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012425 2004
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012425 1995
% 214.67/214.85  |- skos__altLabel mesh__D012425 Russia %28%Pre 1917%29%
% 214.67/214.85  |- skos__annotation mesh__D012425 MOSCOW is also available; Manual 36.12   
% 214.67/214.85  |- mesh__recordAuthorizer mesh__D012425 ags
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012425 2001
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012425 1999
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012425 2003
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D012425 1994
% 214.67/214.85  |- mesh__recordOriginator mesh__D012425 NLM
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D017110 2004
% 214.67/214.85  |- mesh__recordAuthorizer mesh__D017110 sjn
% 214.67/214.85  |- mesh__recordMaintainer mesh__D017110 nns
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D017110 2002
% 214.67/214.85  |- mesh__publicMeSHNote mesh__D017110 93   
% 214.67/214.85  |- skos__historyNote mesh__D017110 Freeze Drying %28%1977-1992%29%
% 214.67/214.85  |- skos__hiddenLabel mesh__D017110 Substitution, Freeze
% 214.67/214.85  |- skos__prefLabel mesh__D017110 Freeze Substitution
% 214.67/214.85  |- skos__historyNote mesh__D017110 Cryopreservation %28%1989-1992%29%
% 214.67/214.85  |- skos__broader mesh__D017110smesh__D005612
% 214.67/214.85  |- skos__scopeNote mesh__D017110
% 214.67/214.85       A modification of the freeze-drying method in which the ice within the frozen tissue is replaced by alcohol or other solvent at a very low temperature.%A%    
% 214.67/214.85  |- mesh__historyNote mesh__D017110 93   
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D017110 2005
% 214.67/214.85  |- mesh__dateRevised mesh__D017110 2001-07-25
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D017110 2006
% 214.67/214.85  |- skos__annotation mesh__D017110
% 214.67/214.85       in freeze drying, replacement of ice by alcohol or other solvent%A%  
% 214.67/214.85  |- mesh__dateCreated mesh__D017110 1992-05-20
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D017110 2003
% 214.67/214.85  |- mesh__dateEstablished mesh__D017110 1993-01-01
% 214.67/214.85  |- mesh__recordOriginator mesh__D017110 MXR
% 214.67/214.85  |- skos__historyNote mesh__D017110 Freezing %28%1966-1992%29%
% 214.67/214.85  |- rdf__type mesh__D017110sskos__Concept
% 214.67/214.85  |- mesh__recordOriginator mesh__D050544 AKE
% 214.67/214.85  |- skos__hiddenLabel mesh__D050544 L Gulonooxidase
% 214.67/214.85  |- skos__hiddenLabel mesh__D050544 L Gulono Gamma Lactone Dehydrogenase
% 214.67/214.85  |- mesh__dateEstablished mesh__D050544 2006-01-01
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D050544 2006
% 214.67/214.85  |- rdf__type mesh__D050544sskos__Concept
% 214.67/214.85  |- mesh__historyNote mesh__D050544
% 214.67/214.85       2006%28%1980%29%; use ALCOHOL OXIDOREDUCTASES %26% GLUCONATES 1973-1979%A%  
% 214.67/214.85  |- mesh__recordMaintainer mesh__D050544 ags
% 214.67/214.85  |- skos__prefLabel mesh__D050544 L-Gulonolactone Oxidase
% 214.67/214.85  |- skos__hiddenLabel mesh__D050544 Oxidase, L-Gulono-Gamma-Lactone
% 214.67/214.85  |- mesh__recordAuthorizer mesh__D050544 ags
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D050544 2006A
% 214.67/214.85  |- skos__hiddenLabel mesh__D050544 L Gulono Gamma Lactone Oxidase
% 214.67/214.85  |- skos__broader mesh__D050544smesh__D013401
% 214.67/214.85  |- mesh__dateCreated mesh__D050544 2005-06-30
% 214.67/214.85  |- skos__altLabel mesh__D050544 L-Gulonooxidase
% 214.67/214.85  |- skos__hiddenLabel mesh__D050544 Oxidase, L-Gulonolactone
% 214.67/214.85  |- mesh__dateRevised mesh__D050544 2005-07-08
% 214.67/214.85  |- skos__scopeNote mesh__D050544
% 214.67/214.85       An enzyme involved in the metabolism of ASCORBIC ACID and aldarate. It catalyzes the oxidation of L-gulono-1,4-lactone to L-xylo-hex-3-ulonolactone.%A%    
% 214.67/214.85  |- mesh__publicMeSHNote mesh__D050544
% 214.67/214.85       2006; L-GULONOLACTONE OXIDASE was indexed under SUGAR ALCOHOL DEHYDROGENASES 1980-2005, ALCOHOL OXIDOREDUCTASES %26% GLUCONATES 1973-1979%A%  
% 214.67/214.85  |- skos__altLabel mesh__D050544 L-Gulono-Gamma-Lactone Dehydrogenase
% 214.67/214.85  |- skos__hiddenLabel mesh__D050544 Dehydrogenase, L-Gulono-Gamma-Lactone
% 214.67/214.85  |- skos__altLabel mesh__D050544 L-Gulono-Gamma-Lactone Oxidase
% 214.67/214.85  |- skos__hiddenLabel mesh__D050544 L Gulonolactone Oxidase
% 214.67/214.85  |- mesh__recordAuthorizer mesh__D003699 sjn
% 214.67/214.85  |- skos__altLabel mesh__D003699 Delta Superinfection
% 214.67/214.85  |- mesh__publicMeSHNote mesh__D003699
% 214.67/214.85       98; see DELTA INFECTION 1986-97; for HEPATITIS D see DELTA INFECTION 1986-97%A%  
% 214.67/214.85  |- skos__altLabel mesh__D003699 Delta Infection
% 214.67/214.85  |- mesh__dateCreated mesh__D003699 1985-05-07
% 214.67/214.85  |- skos__hiddenLabel mesh__D003699 Delta Superinfections
% 214.67/214.85  |- rdf__type mesh__D003699sskos__Concept
% 214.67/214.85  |- skos__prefLabel mesh__D003699 Hepatitis D
% 214.67/214.85  |- mesh__recordOriginator mesh__D003699 RC
% 214.67/214.85  |- skos__historyNote mesh__D003699
% 214.67/214.85       Hepatitis, Viral, Human %28%1977-1985%29%
% 214.67/214.85  |- mesh__dateEstablished mesh__D003699 1986-01-01
% 214.67/214.85  |- skos__altLabel mesh__D003699 Infection, Delta
% 214.67/214.85  |- skos__broader mesh__D003699smesh__D012327
% 214.67/214.85  |- skos__altLabel mesh__D003699 Delta Hepatitis
% 214.67/214.85  |- skos__altLabel mesh__D003699 Hepatitis, Delta
% 214.67/214.85  |- mesh__historyNote mesh__D003699 98%28%86%29%   
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D003699 2005
% 214.67/214.85  |- skos__hiddenLabel mesh__D003699 Infections, Delta
% 214.67/214.85  |- skos__hiddenLabel mesh__D003699 Hepatitides, Delta
% 214.67/214.85  |- skos__historyNote mesh__D003699 Hepatitis B %28%1977-1985%29%
% 214.67/214.85  |- skos__broader mesh__D003699smesh__D006525
% 214.67/214.85  |- skos__historyNote mesh__D003699 Hepatitis B Antigens %28%1977-1985%29%
% 214.67/214.85  |- mesh__dateRevised mesh__D003699 2004-07-07
% 214.67/214.85  |- skos__scopeNote mesh__D003699
% 214.67/214.85       INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with %28%coinfection%29% or subsequent to %28%superinfection%29% hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.%A%    
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D003699 2006
% 214.67/214.85  |- skos__hiddenLabel mesh__D003699 Superinfections, Delta
% 214.67/214.85  |- mesh__recordMaintainer mesh__D003699 lkt
% 214.67/214.85  |- skos__annotation mesh__D003699 HEPATITIS D, CHRONIC is also available   
% 214.67/214.85  |- rdf__type mesh__D016816sskos__Concept
% 214.67/214.85  |- skos__annotation mesh__D016816
% 214.67/214.85       do not confuse with the fungal phylum MICROSPORIDIA; infection: coordinate IM with MICROSPORIDIOSIS %28%IM%29%; coordinate with specific fungal terms %28%ANTIGENS, FUNGAL, etc%29% if pertinent%A%  
% 214.67/214.85  |- mesh__dateRevised mesh__D016816 2005-07-14
% 214.67/214.85  |- mesh__recordMaintainer mesh__D016816 ags
% 214.67/214.85  |- mesh__publicMeSHNote mesh__D016816 1992   
% 214.67/214.85  |- mesh__activeMeSHYear mesh__D016816 2006A
% 214.67/214.86  |- skos__prefLabel mesh__D016816 Microsporida
% 214.67/214.86  |- skos__historyNote mesh__D016816 Protozoa %28%1969-1991%29%
% 214.67/214.86  |- mesh__recordOriginator mesh__D016816 PXP
% 214.67/214.86  |- mesh__recordAuthorizer mesh__D016816 ags
% 214.67/214.86  |- skos__broader mesh__D016816smesh__D016815
% 214.67/214.86  |- skos__historyNote mesh__D016816 Sporozoea %28%1969-1991%29%
% 214.67/214.86  |- mesh__historyNote mesh__D016816 1992   
% 214.67/214.86  |- skos__scopeNote mesh__D016816
% 214.67/214.86       An order of parasitic FUNGI found mostly in ARTHROPODS; FISHES; and in some VERTEBRATES including humans. It comprises two suborders: Pansporoblastina and APANSPOROBLASTINA.%A%    
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D016816 2006
% 214.67/214.86  |- mesh__dateCreated mesh__D016816 1991-05-02
% 214.67/214.86  |- mesh__dateEstablished mesh__D016816 1992-01-01
% 214.67/214.86  |- mesh__dateRevised mesh__D016018 2004-07-28
% 214.67/214.86  |- skos__hiddenLabel mesh__D016018 Least Squares Analysis
% 214.67/214.86  |- mesh__dateCreated mesh__D016018 1989-05-25
% 214.67/214.86  |- mesh__recordOriginator mesh__D016018 PLS
% 214.67/214.86  |- rdf__type mesh__D016018sskos__Concept
% 214.67/214.86  |- skos__broader mesh__D016018smesh__D012044
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D016018 2005A
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D016018 2005
% 214.67/214.86  |- mesh__recordAuthorizer mesh__D016018 jls
% 214.67/214.86  |- skos__hiddenLabel mesh__D016018 Analyses, Least-Squares
% 214.67/214.86  |- skos__historyNote mesh__D016018 Regression Analysis %28%1973-1989%29%
% 214.67/214.86  |- skos__altLabel mesh__D016018 Least Squares
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D016018 2006
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D016018 2003
% 214.67/214.86  |- skos__altLabel mesh__D016018 Analysis, Least-Squares
% 214.67/214.86  |- skos__scopeNote mesh__D016018
% 214.67/214.86       A principle of estimation in which the estimates of a set of parameters in a statistical model are those quantities minimizing the sum of squared differences between the observed values of a dependent variable and the values predicted by the model.%A%    
% 214.67/214.86  |- skos__hiddenLabel mesh__D016018 Refinement, Rietveld
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D016018 2004
% 214.67/214.86  |- mesh__historyNote mesh__D016018
% 214.67/214.86       91%28%90%29%; was see under REGRESSION ANALYSIS 1990   
% 214.67/214.86  |- mesh__dateEstablished mesh__D016018 1991-01-01
% 214.67/214.86  |- skos__hiddenLabel mesh__D016018 Analysis, Least Squares
% 214.67/214.86  |- skos__annotation mesh__D016018
% 214.67/214.86       IM GEN only; coord NIM with specific disease or other concept %28%IM%29%;%A%  
% 214.67/214.86  |- mesh__recordMaintainer mesh__D016018 jls
% 214.67/214.86  |- skos__hiddenLabel mesh__D016018 Least-Squares Analyses
% 214.67/214.86  |- skos__prefLabel mesh__D016018 Least-Squares Analysis
% 214.67/214.86  |- mesh__publicMeSHNote mesh__D016018
% 214.67/214.86       91; was see under REGRESSION ANALYSIS 1990   
% 214.67/214.86  |- mesh__dateCreated mesh__D032483 2002-07-03
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D032483 2004
% 214.67/214.86  |- rdf__type mesh__D032483sskos__Concept
% 214.67/214.86  |- mesh__historyNote mesh__D032483 2003   
% 214.67/214.86  |- skos__altLabel mesh__D032483 Yew, Harrington Plum
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D032483 2003
% 214.67/214.86  |- skos__broader mesh__D032483smesh__D032482
% 214.67/214.86  |- skos__annotation mesh__D032483
% 214.67/214.86       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.67/214.86  |- skos__prefLabel mesh__D032483 Cephalotaxus
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D032483 2006
% 214.67/214.86  |- skos__scopeNote mesh__D032483
% 214.67/214.86       A plant genus of the family Cephalotaxaceae, order Pinales, class Pinopsida,  division CONIFEROPHYTA. Members contain homoharringtonine.%A%    
% 214.67/214.86  |- mesh__publicMeSHNote mesh__D032483 2003   
% 214.67/214.86  |- mesh__dateEstablished mesh__D032483 2003-01-01
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D032483 2005
% 214.67/214.86  |- mesh__recordOriginator mesh__D004792 NLM
% 214.67/214.86  |- mesh__recordMaintainer mesh__D004792 ssb
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D004792 2006
% 214.67/214.86  |- skos__broader mesh__D004792smesh__D045762
% 214.67/214.86  |- skos__annotation mesh__D004792
% 214.67/214.86       IM; coord with specific enzyme %28%IM%29%; zymogen granules: index under ZYMOGEN GRANULES see SECRETORY VESICLES %28%IM%29% + ENZYME PRECURSORS %28%IM%29%  + specific enzyme %28%IM%29%%A%  
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D004792 2004
% 214.67/214.86  |- mesh__recordAuthorizer mesh__D004792 sjn
% 214.67/214.86  |- mesh__dateRevised mesh__D004792 2003-07-09
% 214.67/214.86  |- rdf__type mesh__D004792sskos__Concept
% 214.67/214.86  |- skos__altLabel mesh__D004792 Zymogens
% 214.67/214.86  |- skos__prefLabel mesh__D004792 Enzyme Precursors
% 214.67/214.86  |- mesh__dateCreated mesh__D004792 1999-01-01
% 214.67/214.86  |- skos__hiddenLabel mesh__D004792 Precursors, Enzyme
% 214.67/214.86  |- skos__altLabel mesh__D004792 Proenzymes
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D004792 2005
% 214.67/214.86  |- skos__scopeNote mesh__D004792
% 214.67/214.86       Physiologically inactive substances that can be converted to active enzymes.%A%    
% 214.67/214.86  |- mesh__dateCreated mesh__D012426 1999-01-01
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D012426 2000
% 214.67/214.86  |- skos__altLabel mesh__D012426 Russian S.F.S.R.
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D012426 2005
% 214.67/214.86  |- mesh__recordAuthorizer mesh__D012426 PLS
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D012426 1997
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D012426 2001
% 214.67/214.86  |- mesh__historyNote mesh__D012426
% 214.67/214.86       93; was RUSSIAN S.F.S.R. 1982-92, was RUSSIAN FEDERATION %28%EUROPE%29% 1967-81, was RUSSIAN FEDERATION 1966; RUSSIA was heading 1963-66%A%  
% 214.67/214.86  |- mesh__onlineNote mesh__D012426
% 214.67/214.86       use RUSSIA to search RUSSIAN S.F.S.R. 1982-92 %26% RUSSIAN FEDERATION %28%EUROPE%29% 1967-81; use RUSSIA %26% SIBERIA to search RUSSIAN FEDERATION 1966; search RUSSIA under RUSSIA %28%PRE-1917%29% 1966%A%  
% 214.67/214.86  |- mesh__recordOriginator mesh__D012426 NLM
% 214.67/214.86  |- skos__broader mesh__D012426smesh__D014586
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D012426 2006
% 214.67/214.86  |- rdf__type mesh__D012426sskos__Concept
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D012426 2003
% 214.67/214.86  |- mesh__recordMaintainer mesh__D012426 TGC
% 214.67/214.86  |- skos__altLabel mesh__D012426 Russian SFSR
% 214.67/214.86  |- skos__annotation mesh__D012426
% 214.67/214.86       MOSCOW is also available; Manual 36.12; consider also RUSSIA %28%PRE-1917%29%; in historical articles when part of the former Soviet Union it may be called Russian S.F.S.R. or RSFSR %28%see other names in hist note%29%%A%  
% 214.67/214.86  |- skos__altLabel mesh__D012426 Russian Federation %28%Europe%29%
% 214.67/214.86  |- skos__broader mesh__D012426smesh__D017517
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D012426 1998
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D012426 2002
% 214.67/214.86  |- skos__prefLabel mesh__D012426 Russia
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D012426 2004
% 214.67/214.86  |- skos__broader mesh__D012426smesh__D005061
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D012426 1999
% 214.67/214.86  |- mesh__dateRevised mesh__D012426 1996-06-10
% 214.67/214.86  |- skos__altLabel mesh__D017111 Djungarian Hamsters
% 214.67/214.86  |- mesh__dateEstablished mesh__D017111 1993-01-01
% 214.67/214.86  |- mesh__dateCreated mesh__D017111 1992-05-22
% 214.67/214.86  |- skos__altLabel mesh__D017111 Djungarian
% 214.67/214.86  |- skos__annotation mesh__D017111
% 214.67/214.86       NIM; when IM, qualif permitted; don%27%t forget also check tags CRICETINAE and ANIMALS%A%  
% 214.67/214.86  |- mesh__recordAuthorizer mesh__D017111 sjn
% 214.67/214.86  |- skos__prefLabel mesh__D017111 Phodopus
% 214.67/214.86  |- skos__hiddenLabel mesh__D017111 sungorus campbellus, Phodopus
% 214.67/214.86  |- mesh__dateRevised mesh__D017111 2005-07-01
% 214.67/214.86  |- skos__hiddenLabel mesh__D017111 campbelli, Phodopus sungorus
% 214.67/214.86  |- mesh__onlineNote mesh__D017111
% 214.67/214.86       use HAMSTERS to search PHODOPUS and DJUNGARIAN 1982-92 and DJUNGARIAN HAMSTER 1984-92%A%  
% 214.67/214.86  |- skos__scopeNote mesh__D017111
% 214.67/214.86       A genus of hamsters characterized by small size, very short tail, and short, broad feet with hairy soles.%A%    
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D017111 2006
% 214.67/214.86  |- mesh__historyNote mesh__D017111
% 214.67/214.86       93; was see HAMSTERS 1982-92; DJUNGARIAN was see HAMSTERS 1982-92; DJUNGARIAN HAMSTERS was DJUNGARIAN HAMSTER see HAMSTERS 1984-92%A%  
% 214.67/214.86  |- mesh__publicMeSHNote mesh__D017111
% 214.67/214.86       93; was see HAMSTERS 1982-92; DJUNGARIAN was see HAMSTERS 1982-92; DJUNGARIAN HAMSTERS was DJUNGARIAN HAMSTER see HAMSTERS 1984-92%A%  
% 214.67/214.86  |- skos__hiddenLabel mesh__D017111 campbelli, Phodopus
% 214.67/214.86  |- mesh__recordMaintainer mesh__D017111 sjn
% 214.67/214.86  |- skos__hiddenLabel mesh__D017111 Hamster, Siberian
% 214.67/214.86  |- skos__broader mesh__D017111smesh__D006224
% 214.67/214.86  |- mesh__recordOriginator mesh__D017111 MXR
% 214.67/214.86  |- rdf__type mesh__D017111sskos__Concept
% 214.67/214.86  |- skos__hiddenLabel mesh__D017111 sungorus, Phodopus
% 214.67/214.86  |- skos__historyNote mesh__D017111 Hamsters %28%1970-1992%29%
% 214.67/214.86  |- skos__altLabel mesh__D017111 Siberian Hamster
% 214.67/214.86  |- skos__hiddenLabel mesh__D017111 sungorus campbelli, Phodopus
% 214.67/214.86  |- skos__hiddenLabel mesh__D017111 Siberian Hamsters
% 214.67/214.86  |- mesh__recordAuthorizer mesh__D050545 sjn
% 214.67/214.86  |- mesh__publicMeSHNote mesh__D050545
% 214.67/214.86       2006; CHOLINE DEHYDROGENASE was indexed under ALCOHOL OXIDOREDUCTASES 1982-2005, %26% under CHOLINE 1979-1981%A%  
% 214.67/214.86  |- mesh__recordOriginator mesh__D050545 AKE
% 214.67/214.86  |- mesh__dateEstablished mesh__D050545 2006-01-01
% 214.67/214.86  |- skos__scopeNote mesh__D050545
% 214.67/214.86       An enzyme bound to the inner mitochondrial membrane that catalyzes the oxidation of CHOLINE to BETAINE.%A%    
% 214.67/214.86  |- skos__broader mesh__D050545smesh__D000429
% 214.67/214.86  |- skos__prefLabel mesh__D050545 Choline Dehydrogenase
% 214.67/214.86  |- mesh__historyNote mesh__D050545 2006%28%1980%29%; use CHOLINE 1979   
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D050545 2006
% 214.67/214.86  |- rdf__type mesh__D050545sskos__Concept
% 214.67/214.86  |- mesh__dateCreated mesh__D050545 2005-06-30
% 214.67/214.86  |- skos__hiddenLabel mesh__D050545 Dehydrogenase, Choline
% 214.67/214.86  |- mesh__recordMaintainer mesh__D050545 AKE
% 214.67/214.86  |- mesh__dateCreated mesh__D008385 1987-03-02
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D008385 2003
% 214.67/214.86  |- mesh__dateRevised mesh__D008385 2002-07-03
% 214.67/214.86  |- mesh__historyNote mesh__D008385 88   
% 214.67/214.86  |- skos__prefLabel mesh__D008385 Marijuana Smoking
% 214.67/214.86  |- skos__annotation mesh__D008385 consider also MARIJUANA ABUSE   
% 214.67/214.86  |- mesh__recordMaintainer mesh__D008385 PXP
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D008385 2006
% 214.67/214.86  |- skos__broader mesh__D008385smesh__D012907
% 214.67/214.86  |- skos__hiddenLabel mesh__D008385 Smoking, Marijuana
% 214.67/214.86  |- skos__hiddenLabel mesh__D008385 Smoking, Cannabis
% 214.67/214.86  |- mesh__dateEstablished mesh__D008385 1988-01-01
% 214.67/214.86  |- skos__scopeNote mesh__D008385
% 214.67/214.86       Inhaling and exhaling the smoke from CANNABIS.     
% 214.67/214.86  |- skos__hiddenLabel mesh__D008385 Smoking, Marihuana
% 214.67/214.86  |- skos__hiddenLabel mesh__D008385 Smoking, Hashish
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D008385 2005
% 214.67/214.86  |- mesh__recordOriginator mesh__D008385 EC
% 214.67/214.86  |- rdf__type mesh__D008385sskos__Concept
% 214.67/214.86  |- skos__historyNote mesh__D008385 Cannabis %28%1966-1987%29%
% 214.67/214.86  |- mesh__publicMeSHNote mesh__D008385 88   
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D008385 2004
% 214.67/214.86  |- mesh__recordAuthorizer mesh__D008385 sjn
% 214.67/214.86  |- skos__altLabel mesh__D008385 Marihuana Smoking
% 214.67/214.86  |- mesh__recordMaintainer mesh__D016817 ags
% 214.67/214.86  |- skos__broader mesh__D016817smesh__D016816
% 214.67/214.86  |- mesh__dateEstablished mesh__D016817 1992-01-01
% 214.67/214.86  |- skos__annotation mesh__D016817
% 214.67/214.86       infection: coordinate IM with MICROSPORIDIOSIS %28%IM%29%   
% 214.67/214.86  |- mesh__dateCreated mesh__D016817 1991-05-02
% 214.67/214.86  |- mesh__publicMeSHNote mesh__D016817 1992   
% 214.67/214.86  |- skos__scopeNote mesh__D016817
% 214.67/214.86       A suborder of FUNGI in the phylum MICROSPORIDIA, commonly lacking a pansporoblastic membrane. The sporoblast is usually dinucleate.%A%    
% 214.67/214.86  |- mesh__recordOriginator mesh__D016817 PXP
% 214.67/214.86  |- mesh__dateRevised mesh__D016817 2005-06-30
% 214.67/214.86  |- skos__prefLabel mesh__D016817 Apansporoblastina
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D016817 2006
% 214.67/214.86  |- mesh__recordAuthorizer mesh__D016817 sjn
% 214.67/214.86  |- rdf__type mesh__D016817sskos__Concept
% 214.67/214.86  |- mesh__historyNote mesh__D016817 1992   
% 214.67/214.86  |- skos__hiddenLabel mesh__D016019 Survival Analyses
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D016019 1995
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D016019 2006
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D016019 2003
% 214.67/214.86  |- skos__annotation mesh__D016019
% 214.67/214.86       IM GEN only; coord NIM with specific disease %28%IM%29%; DF: SURVIVAL ANAL%A%  
% 214.67/214.86  |- mesh__dateRevised mesh__D016019 1994-04-11
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D016019 2000
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D016019 1998
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D016019 2004
% 214.67/214.86  |- skos__related mesh__D016019smesh__D016016
% 214.67/214.86  |- skos__broader mesh__D016019smesh__D013223
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D016019 2001
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D016019 1999
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D016019 1996
% 214.67/214.86  |- mesh__historyNote mesh__D016019 90   
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D016019 2002
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D016019 1997
% 214.67/214.86  |- skos__scopeNote mesh__D016019
% 214.67/214.86       A class of statistical procedures for estimating the survival function %28%function of time, starting with a population 100%25% well at a given time and providing the percentage of the population still well at later times%29%. The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.%A%    
% 214.67/214.86  |- mesh__publicMeSHNote mesh__D016019 90   
% 214.67/214.86  |- mesh__dateCreated mesh__D016019 1989-05-25
% 214.67/214.86  |- mesh__recordOriginator mesh__D016019 PLS
% 214.67/214.86  |- rdf__type mesh__D016019sskos__Concept
% 214.67/214.86  |- skos__hiddenLabel mesh__D016019 Analyses, Survival
% 214.67/214.86  |- skos__prefLabel mesh__D016019 Survival Analysis
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D016019 2005
% 214.67/214.86  |- mesh__dateEstablished mesh__D016019 1990-01-01
% 214.67/214.86  |- skos__altLabel mesh__D016019 Analysis, Survival
% 214.67/214.86  |- mesh__recordAuthorizer mesh__D016019 PLS
% 214.67/214.86  |- mesh__recordMaintainer mesh__D016019 TGC
% 214.67/214.86  |- mesh__dateEstablished mesh__D032484 2003-01-01
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D032484 2003
% 214.67/214.86  |- skos__broader mesh__D032484smesh__D032482
% 214.67/214.86  |- mesh__dateCreated mesh__D032484 2002-07-03
% 214.67/214.86  |- skos__scopeNote mesh__D032484
% 214.67/214.86       The redwood plant family of the order Pinales, class Pinopsida, division CONIFEROPHYTA %28%Conifers%29%.%A%    
% 214.67/214.86  |- mesh__historyNote mesh__D032484 2003   
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D032484 2006
% 214.67/214.86  |- mesh__publicMeSHNote mesh__D032484 2003   
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D032484 2005
% 214.67/214.86  |- skos__annotation mesh__D032484
% 214.67/214.86       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.67/214.86  |- skos__prefLabel mesh__D032484 Taxodiaceae
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D032484 2004
% 214.67/214.86  |- rdf__type mesh__D032484sskos__Concept
% 214.67/214.86  |- skos__historyNote mesh__D004793 Enzymes %28%1966-1974%29%
% 214.67/214.86  |- skos__hiddenLabel mesh__D004793 Reactivators, Enzyme
% 214.67/214.86  |- mesh__dateRevised mesh__D004793 2003-07-09
% 214.67/214.86  |- mesh__recordMaintainer mesh__D004793 ssb
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D004793 2004
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D004793 2006
% 214.67/214.86  |- skos__prefLabel mesh__D004793 Enzyme Reactivators
% 214.67/214.86  |- mesh__historyNote mesh__D004793 75   
% 214.67/214.86  |- mesh__recordOriginator mesh__D004793 NLM
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D004793 2005
% 214.67/214.86  |- mesh__publicMeSHNote mesh__D004793 75   
% 214.67/214.86  |- skos__scopeNote mesh__D004793
% 214.67/214.86       Compounds which restore enzymatic activity by removing an inhibitory group bound to the reactive site of the enzyme.%A%    
% 214.67/214.86  |- mesh__dateCreated mesh__D004793 1999-01-01
% 214.67/214.86  |- mesh__recordAuthorizer mesh__D004793 sjn
% 214.67/214.86  |- skos__annotation mesh__D004793
% 214.67/214.86       coord IM with specific enzyme %28%IM%29% but CHOLINESTERASE REACTIVATORS is available for reactivators of CHOLINESTERASES %26% ACETYLCHOLINESTERASE %28%see note there%29%%A%  
% 214.67/214.86  |- skos__broader mesh__D004793smesh__D045504
% 214.67/214.86  |- mesh__dateEstablished mesh__D004793 1975-01-01
% 214.67/214.86  |- rdf__type mesh__D004793sskos__Concept
% 214.67/214.86  |- skos__scopeNote mesh__D012427
% 214.67/214.86       A macrolide antibiotic of the oligomycin group, obtained from Streptomyces rutgersensis. It is used in cytochemistry as a tool to inhibit various ATPases and to uncouple oxidative phosphorylation from electron transport and also clinically as an antifungal agent.%A%    
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D012427 2005
% 214.67/214.86  |- skos__hiddenLabel mesh__D012427 RR32705
% 214.67/214.86  |- mesh__publicMeSHNote mesh__D012427
% 214.67/214.86       91; was see under OLIGOMYCINS 1982-90; was see under ANTIBIOTICS, ANTIFUNGAL 1975-81%A%  
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D012427 2006
% 214.67/214.86  |- skos__prefLabel mesh__D012427 Rutamycin
% 214.67/214.86  |- skos__hiddenLabel mesh__D012427 RR 32705
% 214.67/214.86  |- mesh__recordAuthorizer mesh__D012427 sjn
% 214.67/214.86  |- rdf__type mesh__D012427sskos__Concept
% 214.67/214.86  |- skos__hiddenLabel mesh__D012427 A 272
% 214.67/214.86  |- skos__hiddenLabel mesh__D012427 A272
% 214.67/214.86  |- skos__historyNote mesh__D012427
% 214.67/214.86       Antibiotics, Antifungal %28%1969-1974%29%
% 214.67/214.86  |- mesh__dateEstablished mesh__D012427 1991-01-01
% 214.67/214.86  |- mesh__recordMaintainer mesh__D012427 ssb
% 214.67/214.86  |- mesh__recordOriginator mesh__D012427 NLM
% 214.67/214.86  |- mesh__dateCreated mesh__D012427 1974-11-19
% 214.67/214.86  |- mesh__dateRevised mesh__D012427 2004-07-07
% 214.67/214.86  |- skos__altLabel mesh__D012427 Oligomycin D
% 214.67/214.86  |- mesh__historyNote mesh__D012427
% 214.67/214.86       91%28%75%29%; was see under OLIGOMYCINS 1982-90; was see under ANTIBIOTICS, ANTIFUNGAL 1975-81%A%  
% 214.67/214.86  |- skos__broader mesh__D012427smesh__D009840
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D017910 2003
% 214.67/214.86  |- mesh__publicMeSHNote mesh__D017910
% 214.67/214.86       1994; for CYSTOVIRUS see BACTERIOPHAGE PHI 6 1994-2001   
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D017910 2004
% 214.67/214.86  |- mesh__dateRevised mesh__D017910 2001-07-25
% 214.67/214.86  |- mesh__dateCreated mesh__D017910 1993-06-04
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D017910 2002
% 214.67/214.86  |- mesh__historyNote mesh__D017910
% 214.67/214.86       1994; for CYSTOVIRUS use BACTERIOPHAGE PHI 6 1994-2001   
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D017910 2005
% 214.67/214.86  |- skos__scopeNote mesh__D017910
% 214.67/214.86       A family of bacteriophages containing one genus %28%Cystovirus%29% with one member %28%BACTERIOPHAGE PHI 6%29%.%A%    
% 214.67/214.86  |- mesh__recordOriginator mesh__D017910 AGS
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D017910 2006
% 214.67/214.86  |- skos__annotation mesh__D017910 coord with specific bacterium /virol   
% 214.67/214.86  |- mesh__recordAuthorizer mesh__D017910 sjn
% 214.67/214.86  |- rdf__type mesh__D017910sskos__Concept
% 214.67/214.86  |- skos__broader mesh__D017910smesh__D012317
% 214.67/214.86  |- skos__prefLabel mesh__D017910 Cystoviridae
% 214.67/214.86  |- skos__broader mesh__D017910smesh__D001435
% 214.67/214.86  |- mesh__dateEstablished mesh__D017910 1994-01-01
% 214.67/214.86  |- mesh__recordMaintainer mesh__D017910 ags
% 214.67/214.86  |- skos__broader mesh__D017910smesh__D012328
% 214.67/214.86  |- mesh__recordAuthorizer mesh__D008386 sjn
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D008386 2006
% 214.67/214.86  |- mesh__dateRevised mesh__D008386 2001-07-25
% 214.67/214.86  |- skos__annotation mesh__D008386
% 214.67/214.86       SPEC: SPEC qualif; IM; marine = ocean or sea, not inland waterways, lakes, ponds %28% = FRESH WATER %28%IM%29% + organism %28%IM%29% %29%; DF: MARINE BIOL%A%  
% 214.67/214.86  |- skos__prefLabel mesh__D008386 Marine Biology
% 214.67/214.86  |- mesh__recordOriginator mesh__D008386 NLM
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D008386 2005
% 214.67/214.86  |- rdf__type mesh__D008386sskos__Concept
% 214.67/214.86  |- mesh__recordMaintainer mesh__D008386 jls
% 214.67/214.86  |- skos__related mesh__D008386smesh__D010933
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D008386 2002
% 214.67/214.86  |- skos__altLabel mesh__D008386 Biology, Marine
% 214.67/214.86  |- skos__broader mesh__D008386smesh__D001695
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D008386 2004
% 214.67/214.86  |- mesh__dateCreated mesh__D008386 1999-01-01
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D008386 2003
% 214.67/214.86  |- skos__prefLabel mesh__D016818 Nosema
% 214.67/214.86  |- mesh__publicMeSHNote mesh__D016818 1992   
% 214.67/214.86  |- mesh__dateCreated mesh__D016818 1991-05-02
% 214.67/214.86  |- mesh__recordAuthorizer mesh__D016818 sjn
% 214.67/214.86  |- skos__broader mesh__D016818smesh__D016817
% 214.67/214.86  |- skos__scopeNote mesh__D016818
% 214.67/214.86       A genus of parasitic FUNGI in the family Nosematidae. Some species are pathogenic for invertebrates of economic importance while others are being researched for possible roles in controlling pest INSECTS. They are also pathogenic in humans.%A%    
% 214.67/214.86  |- mesh__dateEstablished mesh__D016818 1992-01-01
% 214.67/214.86  |- mesh__historyNote mesh__D016818 1992   
% 214.67/214.86  |- skos__historyNote mesh__D016818 Protozoa %28%1968-1991%29%
% 214.67/214.86  |- skos__historyNote mesh__D016818 Sporozoea %28%1966-1991%29%
% 214.67/214.86  |- mesh__recordOriginator mesh__D016818 PXP
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D016818 2006
% 214.67/214.86  |- mesh__recordMaintainer mesh__D016818 ags
% 214.67/214.86  |- rdf__type mesh__D016818sskos__Concept
% 214.67/214.86  |- mesh__dateRevised mesh__D016818 2005-06-30
% 214.67/214.86  |- skos__annotation mesh__D016818
% 214.67/214.86       note NOSEMA CUNICULI see ENCEPHALITOZOON CUNICULI and NOSEMA CORNEUM see VITTAFORMA; infection: coordinate IM with MICROSPORIDIOSIS %28%IM%29%; coordinate with specific fungal terms %28%ANTIGENS, FUNGAL, etc%29% if pertinent%A%  
% 214.67/214.86  |- skos__altLabel mesh__D013520 Surgical Procedure, Urologic
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D013520 2002
% 214.67/214.86  |- skos__prefLabel mesh__D013520 Urologic Surgical Procedures
% 214.67/214.86  |- skos__hiddenLabel mesh__D013520 Surgical Procedures, Urological
% 214.67/214.86  |- skos__altLabel mesh__D013520 Urological Surgical Procedures
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D013520 2006
% 214.67/214.86  |- skos__hiddenLabel mesh__D013520 Procedure, Urological Surgical
% 214.67/214.86  |- skos__related mesh__D013520smesh__D014572
% 214.67/214.86  |- skos__altLabel mesh__D013520 Procedures, Urologic Surgical
% 214.67/214.86  |- mesh__dateRevised mesh__D013520 1997-06-20
% 214.67/214.86  |- mesh__recordOriginator mesh__D013520 NLM
% 214.67/214.86  |- mesh__recordAuthorizer mesh__D013520 SJN
% 214.67/214.86  |- mesh__dateEstablished mesh__D013520 1998-01-01
% 214.67/214.86  |- skos__annotation mesh__D013520
% 214.67/214.86       GEN or unspecified; prefer specifics; UROLOGIC SURGICAL PROCEDURES, MALE is also available; DF: UROL SURG PROCEDURES%A%  
% 214.67/214.86  |- skos__broader mesh__D013520smesh__D013519
% 214.67/214.86  |- mesh__recordMaintainer mesh__D013520 TGC
% 214.67/214.86  |- skos__hiddenLabel mesh__D013520 Procedures, Urological Surgical
% 214.67/214.86  |- skos__altLabel mesh__D013520 Surgical Procedures, Urologic
% 214.67/214.86  |- mesh__publicMeSHNote mesh__D013520 98   
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D013520 1998
% 214.67/214.86  |- skos__hiddenLabel mesh__D013520 Urological Surgical Procedure
% 214.67/214.86  |- skos__hiddenLabel mesh__D013520 Surgical Procedure, Urological
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D013520 2003
% 214.67/214.86  |- skos__altLabel mesh__D013520 Urologic Surgical Procedure
% 214.67/214.86  |- skos__altLabel mesh__D013520 Procedure, Urologic Surgical
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D013520 2000
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D013520 1999
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D013520 2004
% 214.67/214.86  |- skos__scopeNote mesh__D013520
% 214.67/214.86       Surgery performed on the urinary tract or its parts in the male or female. For surgery of the male genitalia, UROLOGIC SURGICAL PROCEDURES, MALE is available.%A%    
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D013520 2001
% 214.67/214.86  |- mesh__historyNote mesh__D013520 98; use explode 1970-97   
% 214.67/214.86  |- rdf__type mesh__D013520sskos__Concept
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D013520 2005
% 214.67/214.86  |- mesh__dateCreated mesh__D013520 1999-01-01
% 214.67/214.86  |- skos__broader mesh__D032485smesh__D032484
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D032485 2006
% 214.67/214.86  |- mesh__publicMeSHNote mesh__D032485 2003   
% 214.67/214.86  |- mesh__dateEstablished mesh__D032485 2003-01-01
% 214.67/214.86  |- skos__altLabel mesh__D032485 Cedar, Japanese
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D032485 2005
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D032485 2004
% 214.67/214.86  |- rdf__type mesh__D032485sskos__Concept
% 214.67/214.86  |- skos__scopeNote mesh__D032485
% 214.67/214.86       A plant genus of the family TAXODIACEAE. Its POLLEN is one of the major ALLERGENS.%A%    
% 214.67/214.86  |- skos__prefLabel mesh__D032485 Cryptomeria
% 214.67/214.86  |- mesh__dateCreated mesh__D032485 2002-07-03
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D032485 2003
% 214.67/214.86  |- mesh__historyNote mesh__D032485 2003   
% 214.67/214.86  |- skos__annotation mesh__D032485
% 214.67/214.86       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.67/214.86  |- skos__annotation mesh__D004794
% 214.67/214.86       IM for general only; NIM with specific enzyme /biosyn %28%IM%29%%A%  
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D004794 2004
% 214.67/214.86  |- skos__scopeNote mesh__D004794
% 214.67/214.86       The interference in synthesis of an enzyme due to the elevated level of an effector substance, usually a metabolite, whose presence would cause depression of the gene responsible for enzyme synthesis.%A%    
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D004794 2006
% 214.67/214.86  |- skos__broader mesh__D004794smesh__D015971
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D004794 2003
% 214.67/214.86  |- mesh__historyNote mesh__D004794 66%28%64%29%   
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D004794 2005
% 214.67/214.86  |- mesh__dateEstablished mesh__D004794 1966-01-01
% 214.67/214.86  |- mesh__dateRevised mesh__D004794 2002-07-03
% 214.67/214.86  |- mesh__dateCreated mesh__D004794 1999-01-01
% 214.67/214.86  |- mesh__publicMeSHNote mesh__D004794 66   
% 214.67/214.86  |- skos__prefLabel mesh__D004794 Enzyme Repression
% 214.67/214.86  |- mesh__recordMaintainer mesh__D004794 NDW
% 214.67/214.86  |- mesh__recordOriginator mesh__D004794 NLM
% 214.67/214.86  |- rdf__type mesh__D004794sskos__Concept
% 214.67/214.86  |- skos__hiddenLabel mesh__D004794 Repression, Enzyme
% 214.67/214.86  |- mesh__recordAuthorizer mesh__D004794 sjn
% 214.67/214.86  |- skos__broader mesh__D000437Q000151smesh__D000437
% 214.67/214.86  |- mesh__preferredCombination mesh__D000437Q000151smesh__D005310
% 214.67/214.86  |- rdf__type mesh__D000437Q000151smesh__CompoundConcept
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D045602 2005
% 214.67/214.86  |- skos__broader mesh__D045602smesh__D008286
% 214.67/214.86  |- rdf__type mesh__D045602sskos__Concept
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D045602 2006
% 214.67/214.86  |- mesh__historyNote mesh__D045602 2004; use CELIAC DISEASE 1975-2003   
% 214.67/214.86  |- skos__historyNote mesh__D045602 Celiac Disease %28%1964-2003%29%
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D045602 2004
% 214.67/214.86  |- skos__prefLabel mesh__D045602 Steatorrhea
% 214.67/214.86  |- mesh__publicMeSHNote mesh__D045602 2004; see CELIAC DISEASE 1975-2003   
% 214.67/214.86  |- mesh__dateEstablished mesh__D045602 2004-01-01
% 214.67/214.86  |- mesh__dateCreated mesh__D045602 2003-07-09
% 214.67/214.86  |- skos__scopeNote mesh__D045602
% 214.67/214.86       A condition that is characterized by chronic fatty DIARRHEA, a result of abnormal DIGESTION and/or INTESTINAL ABSORPTION of FATS.%A%    
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D012428 2004
% 214.67/214.86  |- skos__scopeNote mesh__D012428
% 214.67/214.86       A hard, brittle, grayish-white rare earth metal with an atomic symbol Ru, atomic number 44, and atomic weight 101.07. It is used as a catalyst and hardener for PLATINUM and PALLADIUM.%A%    
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D012428 2002
% 214.67/214.86  |- mesh__dateCreated mesh__D012428 1999-01-01
% 214.67/214.86  |- skos__broader mesh__D012428smesh__D028561
% 214.67/214.86  |- skos__prefLabel mesh__D012428 Ruthenium
% 214.67/214.86  |- mesh__dateRevised mesh__D012428 2001-07-25
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D012428 2005
% 214.67/214.86  |- skos__annotation mesh__D012428
% 214.67/214.86       Ru-102; Ru-96, 98-101, 104 = RUTHENIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Ru-93-95, 97, 103, 105-108 = RUTHENIUM RADIOISOTOPES %28%IM%29%%A%  
% 214.67/214.86  |- mesh__recordAuthorizer mesh__D012428 sjn
% 214.67/214.86  |- mesh__activeMeSHYear mesh__D012428 2006
% 214.67/214.86  |- rdf__type mesh__D012428sskos__Concept
% 214.67/214.87  |- mesh__recordMaintainer mesh__D012428 jmp
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D012428 2003
% 214.67/214.87  |- skos__broader mesh__D012428smesh__D019216
% 214.67/214.87  |- mesh__recordOriginator mesh__D012428 NLM
% 214.67/214.87  |- mesh__historyNote mesh__D017911 94   
% 214.67/214.87  |- skos__broader mesh__D017911smesh__D001435
% 214.67/214.87  |- mesh__dateEstablished mesh__D017911 1994-01-01
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D017911 2000
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D017911 2005
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D017911 1996
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D017911 2001
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D017911 2006
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D017911 1997
% 214.67/214.87  |- rdf__type mesh__D017911sskos__Concept
% 214.67/214.87  |- mesh__dateCreated mesh__D017911 1993-06-04
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D017911 2002
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D017911 1998
% 214.67/214.87  |- skos__broader mesh__D017911smesh__D004267
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D017911 1994
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D017911 1999
% 214.67/214.87  |- mesh__publicMeSHNote mesh__D017911 94   
% 214.67/214.87  |- skos__prefLabel mesh__D017911 Inoviridae
% 214.67/214.87  |- skos__historyNote mesh__D017911 Bacteriophages %28%1984-1993%29%
% 214.67/214.87  |- skos__annotation mesh__D017911 a family of bacteriophages   
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D017911 1995
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D017911 2003
% 214.67/214.87  |- skos__scopeNote mesh__D017911
% 214.67/214.87       A family of rod-shaped or filamentous bacteriophages consisting of single-stranded DNA. There are two genera: INOVIRUS and PLECTROVIRUS.%A%    
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D017911 2004
% 214.67/214.87  |- skos__prefLabel mesh__D050547 Plastoquinol-Plastocyanin Reductase
% 214.67/214.87  |- skos__broader mesh__D050547smesh__D045346
% 214.67/214.87  |- mesh__dateEstablished mesh__D050547 2006-01-01
% 214.67/214.87  |- mesh__publicMeSHNote mesh__D050547
% 214.67/214.87       2006; PLASTOQUINOL-PLASTOCYANIN REDUCTASE was indexed under OXIDOREDUCTASES 1981-2005%A%  
% 214.67/214.87  |- skos__hiddenLabel mesh__D050547 Reductase, Plastoquinol-Plastocyanin
% 214.67/214.87  |- skos__hiddenLabel mesh__D050547 Plastoquinol Plastocyanin Reductase
% 214.67/214.87  |- mesh__recordOriginator mesh__D050547 AKE
% 214.67/214.87  |- skos__broader mesh__D050547smesh__D010088
% 214.67/214.87  |- skos__historyNote mesh__D050547 Oxidoreductases %28%1981-2005%29%
% 214.67/214.87  |- skos__hiddenLabel mesh__D050547
% 214.67/214.87       Oxidoreductase, Plastoquinol-Plastocyanin
% 214.67/214.87  |- skos__hiddenLabel mesh__D050547 Plastoquinol Plastocyanin Oxidoreductase
% 214.67/214.87  |- skos__altLabel mesh__D050547 Plastoquinol-Plastocyanin Oxidoreductase
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D050547 2006
% 214.67/214.87  |- mesh__recordAuthorizer mesh__D050547 sjn
% 214.67/214.87  |- skos__scopeNote mesh__D050547
% 214.67/214.87       A component of the CYTOCHROME B6F COMPLEX, this enzyme catalyzes the oxidation of plastoquinol-1 to PLASTOQUINONE.%A%    
% 214.67/214.87  |- mesh__recordMaintainer mesh__D050547 AKE
% 214.67/214.87  |- mesh__dateCreated mesh__D050547 2005-06-30
% 214.67/214.87  |- rdf__type mesh__D050547sskos__Concept
% 214.67/214.87  |- mesh__historyNote mesh__D050547 2006%28%1981%29%   
% 214.67/214.87  |- skos__hiddenLabel mesh__D008387 Toxins, Marine
% 214.67/214.87  |- mesh__dateRevised mesh__D008387 2005-06-30
% 214.67/214.87  |- mesh__publicMeSHNote mesh__D008387 74   
% 214.67/214.87  |- skos__broader mesh__D008387smesh__D014118
% 214.67/214.87  |- mesh__dateCreated mesh__D008387 1999-01-01
% 214.67/214.87  |- skos__annotation mesh__D008387
% 214.67/214.87       /antag permitted but consider also ANTITOXINS; coordinate IM with specific source %28%IM with no qualifiers%29%; does not include venoms of sea snakes %28% = SEA SNAKE VENOMS%29%%A%  
% 214.67/214.87  |- mesh__recordAuthorizer mesh__D008387 sjn
% 214.67/214.87  |- mesh__recordMaintainer mesh__D008387 ssb
% 214.67/214.87  |- skos__scopeNote mesh__D008387
% 214.67/214.87       Toxic or poisonous substances elaborated by marine flora or fauna. They include also specific, characterized poisons or toxins for which there is no more specific heading, like those from poisonous FISHES.%A%    
% 214.67/214.87  |- skos__prefLabel mesh__D008387 Marine Toxins
% 214.67/214.87  |- mesh__recordOriginator mesh__D008387 NLM
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D008387 2006
% 214.67/214.87  |- mesh__dateEstablished mesh__D008387 1974-01-01
% 214.67/214.87  |- rdf__type mesh__D008387sskos__Concept
% 214.67/214.87  |- mesh__historyNote mesh__D008387 74   
% 214.67/214.87  |- mesh__dateCreated mesh__D016819 1991-06-21
% 214.67/214.87  |- mesh__dateRevised mesh__D016819 2005-06-30
% 214.67/214.87  |- mesh__recordAuthorizer mesh__D016819 sjn
% 214.67/214.87  |- mesh__recordOriginator mesh__D016819 PXP
% 214.67/214.87  |- skos__historyNote mesh__D016819 Sporozoea %28%1973-1991%29%
% 214.67/214.87  |- skos__broader mesh__D016819smesh__D016817
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D016819 2006
% 214.67/214.87  |- mesh__publicMeSHNote mesh__D016819 92   
% 214.67/214.87  |- mesh__dateEstablished mesh__D016819 1992-01-01
% 214.67/214.87  |- mesh__historyNote mesh__D016819 92   
% 214.67/214.87  |- mesh__recordMaintainer mesh__D016819 ags
% 214.67/214.87  |- skos__annotation mesh__D016819
% 214.67/214.87       infection = ENCEPHALITOZOONOSIS; coordinate with specific fungal terms %28%ANTIGENS, FUNGAL, etc%29% if pertinent%A%  
% 214.67/214.87  |- rdf__type mesh__D016819sskos__Concept
% 214.67/214.87  |- skos__historyNote mesh__D016819 Protozoa %28%1977-1991%29%
% 214.67/214.87  |- skos__prefLabel mesh__D016819 Encephalitozoon
% 214.67/214.87  |- skos__scopeNote mesh__D016819
% 214.67/214.87       A genus of FUNGI originally considered a member of the class SPOROZOEA but now recognized as part of the class MICROSPOREA.%A%    
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D027541 2005
% 214.67/214.87  |- mesh__historyNote mesh__D027541 2002; use LAMIACEAE 1998-2001   
% 214.67/214.87  |- skos__prefLabel mesh__D027541 Mentha
% 214.67/214.87  |- rdf__type mesh__D027541sskos__Concept
% 214.67/214.87  |- skos__broader mesh__D027541smesh__D019686
% 214.67/214.87  |- skos__historyNote mesh__D027541 Plants, Medicinal %28%1968-2001%29%
% 214.67/214.87  |- skos__historyNote mesh__D027541 Flavoring Agents %28%1966-2001%29%
% 214.67/214.87  |- mesh__recordAuthorizer mesh__D027541 sjn
% 214.67/214.87  |- mesh__dateRevised mesh__D027541 2004-07-07
% 214.67/214.87  |- skos__scopeNote mesh__D027541
% 214.67/214.87       Mentha is a genus of the mint family %28%LAMIACEAE%29%.  It is known for species having characteristic flavor and aroma.%A%    
% 214.67/214.87  |- skos__altLabel mesh__D027541 Mint
% 214.67/214.87  |- mesh__dateCreated mesh__D027541 2001-07-25
% 214.67/214.87  |- mesh__recordMaintainer mesh__D027541 ssb
% 214.67/214.87  |- mesh__recordOriginator mesh__D027541 ssb
% 214.67/214.87  |- skos__annotation mesh__D027541
% 214.67/214.87       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.67/214.87  |- mesh__dateEstablished mesh__D027541 2002-01-01
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D027541 2006
% 214.67/214.87  |- mesh__publicMeSHNote mesh__D027541 2002; see LAMIACEAE 1998-2001   
% 214.67/214.87  |- skos__broader mesh__D025782Q000037smesh__D025782
% 214.67/214.87  |- mesh__preferredCombination mesh__D025782Q000037smesh__D019161
% 214.67/214.87  |- rdf__type mesh__D025782Q000037smesh__CompoundConcept
% 214.67/214.87  |- mesh__recordAuthorizer mesh__D013521 SJN
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D013521 2006
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D013521 2000
% 214.67/214.87  |- skos__altLabel mesh__D013521 Male Urologic Surgical Procedure
% 214.67/214.87  |- skos__annotation mesh__D013521
% 214.67/214.87       surg of male genitalia; GEN or unspecified; prefer specifics; consider also GENITALIA, MALE /surg or /surg with specific genital terms; also GENITAL DISEASES, MALE /surg or /surg with specific male genital dis; check the tag MALE; DF: UROL SURG PROCEDURES MALE%A%  
% 214.67/214.87  |- skos__altLabel mesh__D013521 Urological Surgical Procedures, Male
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D013521 1998
% 214.67/214.87  |- skos__altLabel mesh__D013521 Procedure, Urological Surgical, Male
% 214.67/214.87  |- skos__altLabel mesh__D013521 Male Urologic Surgical Procedures
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D013521 2005
% 214.67/214.87  |- skos__altLabel mesh__D013521 Male Urological Surgical Procedures
% 214.67/214.87  |- mesh__dateCreated mesh__D013521 1999-01-01
% 214.67/214.87  |- mesh__recordOriginator mesh__D013521 NLM
% 214.67/214.87  |- skos__hiddenLabel mesh__D013521 Male Urological Surgery
% 214.67/214.87  |- skos__altLabel mesh__D013521 Procedures, Urologic Surgical, Male
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D013521 2004
% 214.67/214.87  |- skos__altLabel mesh__D013521 Surgical Procedure, Urological, Male
% 214.67/214.87  |- skos__altLabel mesh__D013521 Urologic Surgical Procedure, Male
% 214.67/214.87  |- mesh__dateRevised mesh__D013521 1997-06-20
% 214.67/214.87  |- skos__altLabel mesh__D013521 Male Urologic Surgery
% 214.67/214.87  |- skos__altLabel mesh__D013521 Male Urological Surgical Procedure
% 214.67/214.87  |- rdf__type mesh__D013521sskos__Concept
% 214.67/214.87  |- skos__altLabel mesh__D013521 Surgery, Male Urologic
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D013521 2002
% 214.67/214.87  |- skos__altLabel mesh__D013521 Urologic Surgery, Male
% 214.67/214.87  |- skos__altLabel mesh__D013521 Surgical Procedures, Urological, Male
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D013521 2003
% 214.67/214.87  |- mesh__recordMaintainer mesh__D013521 TGC
% 214.67/214.87  |- skos__scopeNote mesh__D013521
% 214.67/214.87       Surgery performed on the male genitalia.     
% 214.67/214.87  |- skos__altLabel mesh__D013521 Surgical Procedure, Urologic, Male
% 214.67/214.87  |- skos__altLabel mesh__D013521 Urological Surgical Procedure, Male
% 214.67/214.87  |- mesh__dateEstablished mesh__D013521 1998-01-01
% 214.67/214.87  |- mesh__publicMeSHNote mesh__D013521 98   
% 214.67/214.87  |- skos__hiddenLabel mesh__D013521 Surgery, Male Urological
% 214.67/214.87  |- skos__broader mesh__D013521smesh__D013520
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D013521 2001
% 214.67/214.87  |- skos__altLabel mesh__D013521 Surgical Procedures, Urologic, Male
% 214.67/214.87  |- skos__altLabel mesh__D013521 Procedures, Urological Surgical, Male
% 214.67/214.87  |- skos__altLabel mesh__D013521 Procedure, Urologic Surgical, Male
% 214.67/214.87  |- skos__altLabel mesh__D013521 Urological Surgery, Male
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D013521 1999
% 214.67/214.87  |- mesh__historyNote mesh__D013521 98; use explode 1974-97   
% 214.67/214.87  |- skos__prefLabel mesh__D013521 Urologic Surgical Procedures, Male
% 214.67/214.87  |- skos__broader mesh__D003127Q000295smesh__D003127
% 214.67/214.87  |- mesh__preferredCombination mesh__D003127Q000295smesh__D020681
% 214.67/214.87  |- rdf__type mesh__D003127Q000295smesh__CompoundConcept
% 214.67/214.87  |- mesh__publicMeSHNote mesh__D032486 2003   
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D032486 2005
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D032486 2004
% 214.67/214.87  |- rdf__type mesh__D032486sskos__Concept
% 214.67/214.87  |- mesh__dateEstablished mesh__D032486 2003-01-01
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D032486 2003
% 214.67/214.87  |- skos__scopeNote mesh__D032486
% 214.67/214.87       A plant genus of the family TAXODIACEAE. Members contain DITERPENES.%A%    
% 214.67/214.87  |- skos__prefLabel mesh__D032486 Cunninghamia
% 214.67/214.87  |- skos__annotation mesh__D032486
% 214.67/214.87       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.67/214.87  |- skos__altLabel mesh__D032486 Fir, Chinese
% 214.67/214.87  |- skos__broader mesh__D032486smesh__D032484
% 214.67/214.87  |- mesh__dateCreated mesh__D032486 2002-07-03
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D032486 2006
% 214.67/214.87  |- mesh__historyNote mesh__D032486 2003   
% 214.67/214.87  |- mesh__dateCreated mesh__D051640 2005-06-30
% 214.67/214.87  |- mesh__recordAuthorizer mesh__D051640 sjn
% 214.67/214.87  |- skos__hiddenLabel mesh__D051640
% 214.67/214.87       Small Conductance Calcium Activated Potassium Channels
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D051640 2006
% 214.67/214.87  |- mesh__dateEstablished mesh__D051640 2006-01-01
% 214.67/214.87  |- skos__prefLabel mesh__D051640
% 214.67/214.87       Small-Conductance Calcium-Activated Potassium Channels
% 214.67/214.87  |- skos__scopeNote mesh__D051640
% 214.67/214.87       A major class of calcium-activated potassium channels that are found primarily in excitable CELLS. They play important roles in the transmission of ACTION POTENTIALS and generate a long-lasting hyperpolarization known as the slow afterhyperpolarization.%A%    
% 214.67/214.87  |- mesh__recordOriginator mesh__D051640 DRC
% 214.67/214.87  |- mesh__recordMaintainer mesh__D051640 DRC
% 214.67/214.87  |- mesh__publicMeSHNote mesh__D051640
% 214.67/214.87       2006; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, CALCIUM-ACTIVATED 2004, %26% under POTASSIUM CHANNELS 1996-2004%A%  
% 214.67/214.87  |- mesh__historyNote mesh__D051640 2006%28%1996%29%   
% 214.67/214.87  |- rdf__type mesh__D051640sskos__Concept
% 214.67/214.87  |- skos__altLabel mesh__D051640 SK Potassium Channels
% 214.67/214.87  |- skos__hiddenLabel mesh__D051640 Potassium Channels, SK
% 214.67/214.87  |- skos__broader mesh__D051640smesh__D024681
% 214.67/214.87  |- mesh__dateRevised mesh__D004795 1992-05-15
% 214.67/214.87  |- skos__broader mesh__D004795smesh__D013678
% 214.67/214.87  |- skos__annotation mesh__D004795
% 214.67/214.87       IM for general only; NIM with specific enzyme %28%IM%29%   
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D004795 1997
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D004795 1999
% 214.67/214.87  |- rdf__type mesh__D004795sskos__Concept
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D004795 2002
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D004795 1996
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D004795 1993
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D004795 1995
% 214.67/214.87  |- skos__prefLabel mesh__D004795 Enzyme Stability
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D004795 1998
% 214.67/214.87  |- mesh__dateCreated mesh__D004795 1986-03-25
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D004795 2001
% 214.67/214.87  |- mesh__recordOriginator mesh__D004795 SH
% 214.67/214.87  |- skos__hiddenLabel mesh__D004795 Enzyme Stabilities
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D004795 1994
% 214.67/214.87  |- skos__historyNote mesh__D004795 Drug Stability %28%1966-1986%29%
% 214.67/214.87  |- skos__hiddenLabel mesh__D004795 Stabilities, Enzyme
% 214.67/214.87  |- skos__hiddenLabel mesh__D004795 Stability, Enzyme
% 214.67/214.87  |- skos__historyNote mesh__D004795 Temperature %28%1966-1986%29%
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D004795 2004
% 214.67/214.87  |- skos__historyNote mesh__D004795 Kinetics %28%1966-1986%29%
% 214.67/214.87  |- skos__historyNote mesh__D004795
% 214.67/214.87       Hydrogen-Ion Concentration %28%1966-1986%29%
% 214.67/214.87  |- skos__scopeNote mesh__D004795
% 214.67/214.87       The extent to which an enzyme retains its structural conformation or its activity when subjected to storage, isolation, and purification or various other physical or chemical manipulations, including proteolytic enzymes and heat.%A%    
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D004795 2000
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D004795 2006
% 214.67/214.87  |- mesh__recordMaintainer mesh__D004795 TAP
% 214.67/214.87  |- mesh__recordAuthorizer mesh__D004795 PLS
% 214.67/214.87  |- skos__broader mesh__D004795smesh__D001669
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D004795 2003
% 214.67/214.87  |- mesh__publicMeSHNote mesh__D004795 87   
% 214.67/214.87  |- mesh__historyNote mesh__D004795 87   
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D004795 2005
% 214.67/214.87  |- mesh__dateEstablished mesh__D004795 1987-01-01
% 214.67/214.87  |- skos__scopeNote mesh__D045603
% 214.67/214.87       A plant family of the order Violales, subclass Dilleniidae class Magnoliopsida. Members contain naphthylisoquinolines which inhibit PLASMODIUM.%A%    
% 214.67/214.87  |- mesh__dateCreated mesh__D045603 2003-07-09
% 214.67/214.87  |- mesh__publicMeSHNote mesh__D045603 2004   
% 214.67/214.87  |- mesh__dateEstablished mesh__D045603 2004-01-01
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D045603 2005
% 214.67/214.87  |- mesh__historyNote mesh__D045603 2004   
% 214.67/214.87  |- rdf__type mesh__D045603sskos__Concept
% 214.67/214.87  |- skos__prefLabel mesh__D045603 Dioncophyllaceae
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D045603 2006
% 214.67/214.87  |- skos__annotation mesh__D045603
% 214.67/214.87       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D045603 2004
% 214.67/214.87  |- skos__broader mesh__D045603smesh__D019684
% 214.67/214.87  |- mesh__dateCreated mesh__D012429 1987-04-08
% 214.67/214.87  |- skos__broader mesh__D012429smesh__D011868
% 214.67/214.87  |- skos__annotation mesh__D012429
% 214.67/214.87       Ru-93-95, 97, 103, 105-108; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D012429 1999
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D012429 2001
% 214.67/214.87  |- skos__historyNote mesh__D012429 Ruthenium %28%1966-1987%29%
% 214.67/214.87  |- mesh__publicMeSHNote mesh__D012429 88   
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D012429 1996
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D012429 1997
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D012429 2005
% 214.67/214.87  |- mesh__dateRevised mesh__D012429 1993-06-02
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D012429 2002
% 214.67/214.87  |- mesh__recordOriginator mesh__D012429 RLS
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D012429 2006
% 214.67/214.87  |- skos__prefLabel mesh__D012429 Ruthenium Radioisotopes
% 214.67/214.87  |- skos__historyNote mesh__D012429 Radioisotopes %28%1966-1987%29%
% 214.67/214.87  |- rdf__type mesh__D012429sskos__Concept
% 214.67/214.87  |- mesh__dateEstablished mesh__D012429 1988-01-01
% 214.67/214.87  |- mesh__historyNote mesh__D012429 88   
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D012429 2003
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D012429 1994
% 214.67/214.87  |- skos__scopeNote mesh__D012429
% 214.67/214.87       Unstable isotopes of ruthenium that decay or disintegrate emitting radiation. Ru atoms with atomic weights 93-95, 97, 103, and 105-108 are radioactive ruthenium isotopes.%A%    
% 214.67/214.87  |- mesh__recordMaintainer mesh__D012429 TPW
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D012429 2000
% 214.67/214.87  |- skos__hiddenLabel mesh__D012429 Radioisotopes, Ruthenium
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D012429 1998
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D012429 2004
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D012429 1995
% 214.67/214.87  |- mesh__recordAuthorizer mesh__D012429 PLS
% 214.67/214.87  |- mesh__historyNote mesh__D009480 86   
% 214.67/214.87  |- mesh__recordAuthorizer mesh__D009480 sjn
% 214.67/214.87  |- mesh__publicMeSHNote mesh__D009480 86   
% 214.67/214.87  |- mesh__dateRevised mesh__D009480 2001-07-25
% 214.67/214.87  |- mesh__dateEstablished mesh__D009480 1986-01-01
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D009480 2004
% 214.67/214.87  |- skos__broader mesh__D009480smesh__D010600
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D009480 2006
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D009480 2003
% 214.67/214.87  |- skos__hiddenLabel mesh__D009480 Neuropharmacologies
% 214.67/214.87  |- skos__annotation mesh__D009480
% 214.67/214.87       SPEC: SPEC qualif: not for NERVOUS SYSTEM /drug eff; DF: NEUROPHARMACOL%A%  
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D009480 2005
% 214.67/214.87  |- skos__broader mesh__D009480smesh__D009488
% 214.67/214.87  |- mesh__recordMaintainer mesh__D009480 jls
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D009480 2002
% 214.67/214.87  |- skos__scopeNote mesh__D009480
% 214.67/214.87       The branch of pharmacology dealing especially with the action of drugs upon various parts of the nervous system.%A%    
% 214.67/214.87  |- mesh__dateCreated mesh__D009480 1985-06-06
% 214.67/214.87  |- rdf__type mesh__D009480sskos__Concept
% 214.67/214.87  |- mesh__recordOriginator mesh__D009480 EC
% 214.67/214.87  |- skos__prefLabel mesh__D009480 Neuropharmacology
% 214.67/214.87  |- mesh__historyNote mesh__D017912 94   
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D017912 2004
% 214.67/214.87  |- mesh__dateEstablished mesh__D017912 1994-01-01
% 214.67/214.87  |- skos__annotation mesh__D017912 coord with specific bacterium /virol   
% 214.67/214.87  |- skos__broader mesh__D017912smesh__D017911
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D017912 2005
% 214.67/214.87  |- mesh__dateCreated mesh__D017912 1993-06-04
% 214.67/214.87  |- rdf__type mesh__D017912sskos__Concept
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D017912 2002
% 214.67/214.87  |- skos__hiddenLabel mesh__D017912 Filamentous Bacteriophage
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D017912 2006
% 214.67/214.87  |- mesh__recordAuthorizer mesh__D017912 ags
% 214.67/214.87  |- skos__prefLabel mesh__D017912 Inovirus
% 214.67/214.87  |- skos__hiddenLabel mesh__D017912 Inoviruses
% 214.67/214.87  |- mesh__recordOriginator mesh__D017912 AGS
% 214.67/214.87  |- mesh__publicMeSHNote mesh__D017912 94   
% 214.67/214.87  |- mesh__dateRevised mesh__D017912 2005-07-27
% 214.67/214.87  |- skos__historyNote mesh__D017912 Bacteriophages %28%1984-1993%29%
% 214.67/214.87  |- skos__altLabel mesh__D017912 Bacteriophages, Filamentous
% 214.67/214.87  |- mesh__recordMaintainer mesh__D017912 ags
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D017912 2003
% 214.67/214.87  |- skos__scopeNote mesh__D017912
% 214.67/214.87       A genus of filamentous bacteriophages of the family INOVIRIDAE. Organisms of this genus infect enterobacteria, PSEUDOMONAS; VIBRIO; and XANTHOMONAS.%A%    
% 214.67/214.87  |- skos__hiddenLabel mesh__D017912 Bacteriophage, Filamentous
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D017912 2006A
% 214.67/214.87  |- skos__altLabel mesh__D017912 Filamentous Bacteriophages
% 214.67/214.87  |- skos__broader mesh__D017114smesh__D017093
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D017114 2006
% 214.67/214.87  |- skos__hiddenLabel mesh__D017114 Fulminant Liver Failure
% 214.67/214.87  |- skos__hiddenLabel mesh__D017114 Fulminating Hepatic Failures
% 214.67/214.87  |- skos__hiddenLabel mesh__D017114 Liver Failures, Fulminant
% 214.67/214.87  |- skos__hiddenLabel mesh__D017114 Liver Failure, Fulminating
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D017114 2005
% 214.67/214.87  |- skos__hiddenLabel mesh__D017114 Fulminant Liver Failures
% 214.67/214.87  |- skos__hiddenLabel mesh__D017114 Hepatic Failures, Fulminant
% 214.67/214.87  |- mesh__dateEstablished mesh__D017114 1993-01-01
% 214.67/214.87  |- skos__hiddenLabel mesh__D017114 Fulminating Liver Failures
% 214.67/214.87  |- skos__hiddenLabel mesh__D017114 Fulminant Hepatic Failures
% 214.67/214.87  |- skos__historyNote mesh__D017114 Hepatic Encephalopathy %28%1967-1992%29%
% 214.67/214.87  |- mesh__recordAuthorizer mesh__D017114 sjn
% 214.67/214.87  |- skos__hiddenLabel mesh__D017114 Fulminant Hepatic Failure
% 214.67/214.87  |- skos__historyNote mesh__D017114 Hepatitis, Toxic %28%1969-1992%29%
% 214.67/214.87  |- rdf__type mesh__D017114sskos__Concept
% 214.67/214.87  |- skos__hiddenLabel mesh__D017114 Liver Failures, Fulminating
% 214.67/214.87  |- mesh__dateCreated mesh__D017114 1992-05-22
% 214.67/214.87  |- skos__hiddenLabel mesh__D017114 Failure, Acute Liver
% 214.67/214.87  |- mesh__publicMeSHNote mesh__D017114 93   
% 214.67/214.87  |- mesh__dateRevised mesh__D017114 2004-07-07
% 214.67/214.87  |- skos__hiddenLabel mesh__D017114 Failure, Acute Hepatic
% 214.67/214.87  |- skos__hiddenLabel mesh__D017114 Acute Hepatic Failure
% 214.67/214.87  |- skos__altLabel mesh__D017114 Liver Failure, Fulminant
% 214.67/214.87  |- skos__historyNote mesh__D017114 Liver Diseases %28%1966-1992%29%
% 214.67/214.87  |- skos__hiddenLabel mesh__D017114 Hepatic Failure, Fulminating
% 214.67/214.87  |- skos__altLabel mesh__D017114 Fulminating Liver Failure
% 214.67/214.87  |- skos__scopeNote mesh__D017114
% 214.67/214.87       A form of rapid-onset LIVER FAILURE, also known as fulminant hepatic failure, caused by severe liver injury or massive loss of HEPATOCYTES. It is characterized by sudden development of liver dysfunction and JAUNDICE. Acute liver failure may progress to exhibit cerebral dysfunction even HEPATIC COMA depending on the etiology that includes hepatic ISCHEMIA, drug toxicity, malignant infiltration, and viral hepatitis such as post-transfusion HEPATITIS B and HEPATITIS C.%A%    
% 214.67/214.87  |- skos__altLabel mesh__D017114 Hepatic Failure, Acute
% 214.67/214.87  |- mesh__recordMaintainer mesh__D017114 lkt
% 214.67/214.87  |- skos__altLabel mesh__D017114 Hepatic Failure, Fulminant
% 214.67/214.87  |- skos__hiddenLabel mesh__D017114 Acute Liver Failure
% 214.67/214.87  |- skos__hiddenLabel mesh__D017114 Hepatic Failures, Fulminating
% 214.67/214.87  |- mesh__recordOriginator mesh__D017114 TGC
% 214.67/214.87  |- skos__altLabel mesh__D017114 Fulminating Hepatic Failure
% 214.67/214.87  |- mesh__historyNote mesh__D017114 93   
% 214.67/214.87  |- skos__prefLabel mesh__D017114 Liver Failure, Acute
% 214.67/214.87  |- skos__scopeNote mesh__D050548
% 214.67/214.87       An enzyme that catalyzes the oxidation of catechol to muconic acid with the use of Fe3+ as a cofactor. This enzyme was formerly characterized as EC 1.13.1.1 and EC 1.99.2.2.%A%    
% 214.67/214.87  |- mesh__historyNote mesh__D050548
% 214.67/214.87       2006%28%1980%29%; use DIOXYGENASES 1975-1979 %26% CATECHOL 1973-1974%A%  
% 214.67/214.87  |- skos__hiddenLabel mesh__D050548 Catechol 1,2 Dioxygenase
% 214.67/214.87  |- mesh__dateCreated mesh__D050548 2005-06-30
% 214.67/214.87  |- skos__hiddenLabel mesh__D050548 Catechol 1,2 Oxygenase
% 214.67/214.87  |- skos__broader mesh__D050548smesh__D049308
% 214.67/214.87  |- skos__hiddenLabel mesh__D050548 1,2-Dioxygenase, Pyrocatechol
% 214.67/214.87  |- skos__altLabel mesh__D050548 Catechol 1,2-Oxygenase
% 214.67/214.87  |- skos__hiddenLabel mesh__D050548 1,2-Oxygenase, Catechol
% 214.67/214.87  |- skos__altLabel mesh__D050548 Pyrocatechol 1,2-Dioxygenase
% 214.67/214.87  |- mesh__dateEstablished mesh__D050548 2006-01-01
% 214.67/214.87  |- skos__hiddenLabel mesh__D050548 Pyrocatechol 1,2 Dioxygenase
% 214.67/214.87  |- skos__altLabel mesh__D050548 Catechol-1,2-Oxygenase
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D050548 2006
% 214.67/214.87  |- skos__prefLabel mesh__D050548 Catechol 1,2-Dioxygenase
% 214.67/214.87  |- mesh__recordMaintainer mesh__D050548 AKE
% 214.67/214.87  |- mesh__recordOriginator mesh__D050548 AKE
% 214.67/214.87  |- rdf__type mesh__D050548sskos__Concept
% 214.67/214.87  |- mesh__publicMeSHNote mesh__D050548
% 214.67/214.87       2006; CATECHOL 1,2-DIOXYGENASE was indexed under DIOXYGENASES 1975-2005, %26% under CATECHOL 1973-1974%A%  
% 214.67/214.87  |- skos__altLabel mesh__D050548 Pyrocatechase
% 214.67/214.87  |- mesh__recordAuthorizer mesh__D050548 sjn
% 214.67/214.87  |- skos__hiddenLabel mesh__D050548 1,2-Dioxygenase, Catechol
% 214.67/214.87  |- skos__broader mesh__D001659Q000601smesh__D001659
% 214.67/214.87  |- mesh__preferredCombination mesh__D001659Q000601smesh__D001662
% 214.67/214.87  |- rdf__type mesh__D001659Q000601smesh__CompoundConcept
% 214.67/214.87  |- skos__altLabel mesh__D008388 Therapy, Marriage
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D008388 2004
% 214.67/214.87  |- skos__related mesh__D008388smesh__D019546
% 214.67/214.87  |- mesh__recordOriginator mesh__D008388 EC
% 214.67/214.87  |- mesh__dateCreated mesh__D008388 1975-07-25
% 214.67/214.87  |- skos__altLabel mesh__D008388 Marriage Therapy
% 214.67/214.87  |- mesh__dateEstablished mesh__D008388 1976-01-01
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D008388 1997
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D008388 2002
% 214.67/214.87  |- mesh__recordMaintainer mesh__D008388 JLS
% 214.67/214.87  |- mesh__onlineNote mesh__D008388
% 214.67/214.87       use MARITAL THERAPY to search MARRIAGE THERAPY 1973-75   
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D008388 2003
% 214.67/214.87  |- mesh__historyNote mesh__D008388 76; was MARRIAGE THERAPY 1973-75   
% 214.67/214.87  |- skos__historyNote mesh__D008388 Marriage %28%1966-1972%29%
% 214.67/214.87  |- skos__hiddenLabel mesh__D008388 Therapies, Marriage
% 214.67/214.87  |- skos__annotation mesh__D008388
% 214.67/214.87       a psychother technique; DF: MARITAL THER   
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D008388 2006
% 214.67/214.87  |- skos__broader mesh__D008388smesh__D011615
% 214.67/214.87  |- skos__scopeNote mesh__D008388
% 214.67/214.87       A form of psychotherapy involving the husband and wife and directed to improving the marital relationship.%A%    
% 214.67/214.87  |- mesh__publicMeSHNote mesh__D008388 76; was MARRIAGE THERAPY 1973-75   
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D008388 1999
% 214.67/214.87  |- skos__prefLabel mesh__D008388 Marital Therapy
% 214.67/214.87  |- skos__altLabel mesh__D008388 Therapy, Marital
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D008388 2001
% 214.67/214.87  |- skos__hiddenLabel mesh__D008388 Therapies, Marital
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D008388 2005
% 214.67/214.87  |- mesh__recordAuthorizer mesh__D008388 PLS
% 214.67/214.87  |- rdf__type mesh__D008388sskos__Concept
% 214.67/214.87  |- skos__hiddenLabel mesh__D008388 Marriage Therapies
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D008388 2000
% 214.67/214.87  |- mesh__activeMeSHYear mesh__D008388 1998
% 214.67/214.87  |- mesh__dateRevised mesh__D008388 1996-06-13
% 214.67/214.87  |- skos__hiddenLabel mesh__D008388 Marital Therapies
% 214.67/214.87  |- rdf__type mesh__D027542sskos__Concept
% 214.67/214.87  |- skos__broader mesh__D027542smesh__D019686
% 214.67/214.87  |- mesh__publicMeSHNote mesh__D027542 2002; see LAMIACEAE 1998-2001   
% 214.67/214.87  |- skos__annotation mesh__D027542
% 214.67/214.87       coordinate with specific PLANT COMPONENTS term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.67/214.87  |- skos__prefLabel mesh__D027542 Rosmarinus
% 214.67/214.88  |- mesh__recordOriginator mesh__D027542 ssb
% 214.67/214.88  |- mesh__recordAuthorizer mesh__D027542 sjn
% 214.67/214.88  |- skos__scopeNote mesh__D027542
% 214.67/214.88       A plant genus of the LAMIACEAE family. It is known as a spice and medicinal plant.%A%    
% 214.67/214.88  |- mesh__dateRevised mesh__D027542 2005-06-30
% 214.67/214.88  |- mesh__dateEstablished mesh__D027542 2002-01-01
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D027542 2006
% 214.67/214.88  |- mesh__dateCreated mesh__D027542 2001-07-25
% 214.67/214.88  |- mesh__recordMaintainer mesh__D027542 ssb
% 214.67/214.88  |- skos__historyNote mesh__D027542 Plants, Medicinal %28%1967-2001%29%
% 214.67/214.88  |- skos__altLabel mesh__D027542 Rosemary Plant
% 214.67/214.88  |- mesh__historyNote mesh__D027542 2002; use LAMIACEAE 1998-2001   
% 214.67/214.88  |- skos__broader mesh__D005090smesh__D003851
% 214.67/214.88  |- skos__historyNote mesh__D005090 Phosphatases %28%1966-1972%29%
% 214.67/214.88  |- mesh__dateCreated mesh__D005090 1982-04-30
% 214.67/214.88  |- mesh__recordMaintainer mesh__D005090 jmp
% 214.67/214.88  |- skos__altLabel mesh__D005090 DNA Exonucleases
% 214.67/214.88  |- mesh__publicMeSHNote mesh__D005090 83   
% 214.67/214.88  |- rdf__type mesh__D005090sskos__Concept
% 214.67/214.88  |- skos__historyNote mesh__D005090 Exonucleases %28%1973-1982%29%
% 214.67/214.88  |- skos__prefLabel mesh__D005090 Exodeoxyribonucleases
% 214.67/214.88  |- skos__hiddenLabel mesh__D005090 Exonucleases, DNA
% 214.67/214.88  |- mesh__dateEstablished mesh__D005090 1983-01-01
% 214.67/214.88  |- mesh__historyNote mesh__D005090 83   
% 214.67/214.88  |- skos__broader mesh__D005090smesh__D005092
% 214.67/214.88  |- mesh__dateRevised mesh__D005090 2003-07-09
% 214.67/214.88  |- skos__historyNote mesh__D005090 Deoxyribonucleases %28%1966-1982%29%
% 214.67/214.88  |- skos__scopeNote mesh__D005090
% 214.67/214.88       A family of enzymes that catalyze the exonucleolytic cleavage of DNA. It includes members of the class EC 3.1.11 that produce 5%27%-phosphomonoesters as cleavage products.%A%    
% 214.67/214.88  |- mesh__recordAuthorizer mesh__D005090 sjn
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D005090 2005
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D005090 2004
% 214.67/214.88  |- mesh__recordOriginator mesh__D005090 RLS
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D005090 2006
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D013522 1998
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D013522 2002
% 214.67/214.88  |- skos__hiddenLabel mesh__D013522 Veterinary Surgeries
% 214.67/214.88  |- skos__broader mesh__D013522smesh__D014730
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D013522 2006
% 214.67/214.88  |- skos__hiddenLabel mesh__D013522 Surgeries, Veterinary
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D013522 1997
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D013522 2001
% 214.67/214.88  |- skos__altLabel mesh__D013522 Veterinary Surgery
% 214.67/214.88  |- mesh__historyNote mesh__D013522
% 214.67/214.88       91%28%75%29%; was see under VETERINARY MEDICINE 1975-90   
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D013522 2005
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D013522 1996
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D013522 2000
% 214.67/214.88  |- mesh__publicMeSHNote mesh__D013522
% 214.67/214.88       91; was see under VETERINARY MEDICINE 1975-90   
% 214.67/214.88  |- mesh__recordAuthorizer mesh__D013522 PLS
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D013522 2004
% 214.67/214.88  |- mesh__dateCreated mesh__D013522 1999-01-01
% 214.67/214.88  |- skos__prefLabel mesh__D013522 Surgery, Veterinary
% 214.67/214.88  |- skos__scopeNote mesh__D013522
% 214.67/214.88       A board-certified specialty of VETERINARY MEDICINE, requiring at least four years of special education, training, and practice of veterinary surgery after graduation from veterinary school. In the written, oral, and practical examinations candidates may choose either large or small animal surgery. %28%From AVMA Directory, 43d ed, p278%29%%A%    
% 214.67/214.88  |- mesh__onlineNote mesh__D013522 search VETERINARY MEDICINE 1966-74   
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D013522 1999
% 214.67/214.88  |- mesh__dateRevised mesh__D013522 1995-03-13
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D013522 2003
% 214.67/214.88  |- mesh__dateEstablished mesh__D013522 1991-01-01
% 214.67/214.88  |- mesh__recordOriginator mesh__D013522 NLM
% 214.67/214.88  |- skos__annotation mesh__D013522
% 214.67/214.88       SPEC: SPEC qualif; see note on VETERINARY MEDICINE; DF: SURG VET%A%  
% 214.67/214.88  |- rdf__type mesh__D013522sskos__Concept
% 214.67/214.88  |- mesh__recordMaintainer mesh__D013522 TGC
% 214.67/214.88  |- skos__broader mesh__D032487smesh__D032484
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D032487 2006
% 214.67/214.88  |- mesh__publicMeSHNote mesh__D032487 2003   
% 214.67/214.88  |- mesh__historyNote mesh__D032487 2003   
% 214.67/214.88  |- skos__annotation mesh__D032487
% 214.67/214.88       SEQUOIA, GIANT see SEQUOIADENDRON is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.67/214.88  |- skos__prefLabel mesh__D032487 Sequoia
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D032487 2005
% 214.67/214.88  |- rdf__type mesh__D032487sskos__Concept
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D032487 2004
% 214.67/214.88  |- skos__scopeNote mesh__D032487
% 214.67/214.88       A plant genus of the family TAXODIACEAE known for including some of the tallest trees.%A%    
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D032487 2003
% 214.67/214.88  |- mesh__dateEstablished mesh__D032487 2003-01-01
% 214.67/214.88  |- mesh__dateCreated mesh__D032487 2002-07-03
% 214.67/214.88  |- skos__broader mesh__D004796smesh__D019963
% 214.67/214.88  |- skos__hiddenLabel mesh__D004796 Test, Enzyme
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D004796 1999
% 214.67/214.88  |- rdf__type mesh__D004796sskos__Concept
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D004796 1998
% 214.67/214.88  |- mesh__recordOriginator mesh__D004796 NLM
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D004796 2004
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D004796 2002
% 214.67/214.88  |- mesh__recordAuthorizer mesh__D004796 SJN
% 214.67/214.88  |- skos__prefLabel mesh__D004796 Enzyme Tests
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D004796 2006
% 214.67/214.88  |- mesh__dateRevised mesh__D004796 1997-06-20
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D004796 2003
% 214.67/214.88  |- skos__hiddenLabel mesh__D004796 Enzyme Test
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D004796 2001
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D004796 2005
% 214.67/214.88  |- skos__hiddenLabel mesh__D004796 Tests, Enzyme
% 214.67/214.88  |- skos__annotation mesh__D004796
% 214.67/214.88       IM; see Manual 25.19.4 %26% 26.8 for definition; coord with specific enzyme %28%with pertinent qualif%29% %28%IM%29% + disease /diag %28%IM%29%, not disease /enzymol%A%  
% 214.67/214.88  |- mesh__recordMaintainer mesh__D004796 PXP
% 214.67/214.88  |- mesh__dateCreated mesh__D004796 1999-01-01
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D004796 2000
% 214.67/214.88  |- mesh__dateCreated mesh__D045604 2003-07-09
% 214.67/214.88  |- skos__historyNote mesh__D045604 Extracellular Space %28%1964-2003%29%
% 214.67/214.88  |- skos__hiddenLabel mesh__D045604 Fluids, Interstitial
% 214.67/214.88  |- skos__annotation mesh__D045604
% 214.67/214.88       do not confuse EXTRACELLULAR FLUID with BODY WATER   
% 214.67/214.88  |- mesh__publicMeSHNote mesh__D045604
% 214.67/214.88       2004; see EXTRACELLULAR SPACE 1975-2003, see BODY FLUIDS 1963-1974%A%  
% 214.67/214.88  |- skos__hiddenLabel mesh__D045604 Intercellular Fluids
% 214.67/214.88  |- skos__hiddenLabel mesh__D045604 Fluid, Intercellular
% 214.67/214.88  |- mesh__recordOriginator mesh__D045604 nns
% 214.67/214.88  |- mesh__dateRevised mesh__D045604 2004-07-27
% 214.67/214.88  |- skos__broader mesh__D045604smesh__D005110
% 214.67/214.88  |- skos__scopeNote mesh__D045604
% 214.67/214.88       The fluid of the body that is outside of CELLS. It is the external environment for the cells.%A%    
% 214.67/214.88  |- mesh__recordAuthorizer mesh__D045604 jls
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D045604 2005A
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D045604 2005
% 214.67/214.88  |- rdf__type mesh__D045604sskos__Concept
% 214.67/214.88  |- skos__altLabel mesh__D045604 Intercellular Fluid
% 214.67/214.88  |- skos__prefLabel mesh__D045604 Extracellular Fluid
% 214.67/214.88  |- skos__hiddenLabel mesh__D045604 Fluids, Extracellular
% 214.67/214.88  |- skos__broader mesh__D045604smesh__D001826
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D045604 2006
% 214.67/214.88  |- skos__hiddenLabel mesh__D045604 Fluid, Extracellular
% 214.67/214.88  |- skos__hiddenLabel mesh__D045604 Fluid, Interstitial
% 214.67/214.88  |- skos__hiddenLabel mesh__D045604 Extracellular Fluids
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D045604 2004
% 214.67/214.88  |- skos__hiddenLabel mesh__D045604 Interstitial Fluids
% 214.67/214.88  |- skos__hiddenLabel mesh__D045604 Fluids, Intercellular
% 214.67/214.88  |- mesh__dateEstablished mesh__D045604 2004-01-01
% 214.67/214.88  |- mesh__recordMaintainer mesh__D045604 jls
% 214.67/214.88  |- mesh__historyNote mesh__D045604
% 214.67/214.88       2004; use EXTRACELLULAR SPACE 1975-2003, use BODY FLUIDS 1963-1974%A%  
% 214.67/214.88  |- skos__hiddenLabel mesh__D009481 Neurophysin, Oxytocin-Associated
% 214.67/214.88  |- skos__hiddenLabel mesh__D009481 Oxytocin Associated Neurophysin
% 214.67/214.88  |- skos__hiddenLabel mesh__D009481 Vasopressin Associated Neurophysin
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D009481 2006
% 214.67/214.88  |- mesh__recordMaintainer mesh__D009481 ssb
% 214.67/214.88  |- mesh__publicMeSHNote mesh__D009481 73   
% 214.67/214.88  |- mesh__recordAuthorizer mesh__D009481 sjn
% 214.67/214.88  |- skos__scopeNote mesh__D009481
% 214.67/214.88       A group of small, soluble proteins secreted by the hypothalamus. They serve as binding proteins for oxytocin and vasopressin during their transport to the posterior pituitary. They are secreted with the hormones but have no known functions other than serving as a carrier.%A%    
% 214.67/214.88  |- skos__prefLabel mesh__D009481 Neurophysins
% 214.67/214.88  |- mesh__dateEstablished mesh__D009481 1973-01-01
% 214.67/214.88  |- mesh__historyNote mesh__D009481 73   
% 214.67/214.88  |- skos__historyNote mesh__D009481 Nerve Tissue Proteins %28%1966-1972%29%
% 214.67/214.88  |- mesh__dateRevised mesh__D009481 2005-06-30
% 214.67/214.88  |- skos__hiddenLabel mesh__D009481 I, Neurophysin
% 214.67/214.88  |- mesh__dateCreated mesh__D009481 1999-01-01
% 214.67/214.88  |- skos__annotation mesh__D009481
% 214.67/214.88       neurotransmitter proteins secreted by the hypothalamus; /biosyn /physiol permitted%A%  
% 214.67/214.88  |- skos__hiddenLabel mesh__D009481 III, Neurophysin
% 214.67/214.88  |- skos__hiddenLabel mesh__D009481 Neurophysin, Vasopressin-Associated
% 214.67/214.88  |- rdf__type mesh__D009481sskos__Concept
% 214.67/214.88  |- mesh__recordOriginator mesh__D009481 NLM
% 214.67/214.88  |- skos__broader mesh__D009481smesh__D002352
% 214.67/214.88  |- skos__hiddenLabel mesh__D009481 II, Neurophysin
% 214.67/214.88  |- skos__broader mesh__D009481smesh__D009479
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017913 1998
% 214.67/214.88  |- mesh__publicMeSHNote mesh__D017913 94   
% 214.67/214.88  |- skos__hiddenLabel mesh__D017913 Plectroviruses
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017913 2006
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017913 1999
% 214.67/214.88  |- mesh__dateEstablished mesh__D017913 1994-01-01
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017913 1994
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017913 2000
% 214.67/214.88  |- skos__annotation mesh__D017913
% 214.67/214.88       a bacteriophage genus of the family Inoviridae   
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017913 2003
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017913 2001
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017913 1995
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017913 1996
% 214.67/214.88  |- mesh__historyNote mesh__D017913 94   
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017913 2004
% 214.67/214.88  |- skos__prefLabel mesh__D017913 Plectrovirus
% 214.67/214.88  |- mesh__dateCreated mesh__D017913 1993-06-04
% 214.67/214.88  |- skos__scopeNote mesh__D017913
% 214.67/214.88       A genus of bacteriophages of the family INOVIRIDAE. Organisms of this genus infect Acholeplasma and Spiroplasma.%A%    
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017913 2002
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017913 1997
% 214.67/214.88  |- skos__broader mesh__D017913smesh__D017911
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017913 2005
% 214.67/214.88  |- rdf__type mesh__D017913sskos__Concept
% 214.67/214.88  |- skos__hiddenLabel mesh__D017115 Ablation, Percutaneous Catheter
% 214.67/214.88  |- mesh__onlineNote mesh__D017115
% 214.67/214.88       use ELECTROCOAGULATION to search ABLATION, TRANSVENOUS ELECTRIC and CATHETER ABLATION, ELECTRIC 1989-92%A%  
% 214.67/214.88  |- mesh__dateRevised mesh__D017115 1997-06-20
% 214.67/214.88  |- skos__hiddenLabel mesh__D017115 Transvenous Electrical Ablation
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017115 2001
% 214.67/214.88  |- mesh__publicMeSHNote mesh__D017115
% 214.67/214.88       93; ABLATION, TRANSVENOUS ELECTRIC and CATHETER ABLATION, ELECTRIC were see ELECTROCOAGULATION 1989-92%A%  
% 214.67/214.88  |- skos__altLabel mesh__D017115 Percutaneous Catheter Ablation
% 214.67/214.88  |- mesh__dateEstablished mesh__D017115 1993-01-01
% 214.67/214.88  |- skos__hiddenLabel mesh__D017115 Transvenous Electric Ablation
% 214.67/214.88  |- skos__hiddenLabel mesh__D017115 Electric Ablation, Transvenous
% 214.67/214.88  |- skos__altLabel mesh__D017115 Ablation, Catheter
% 214.67/214.88  |- skos__altLabel mesh__D017115 Ablation, Transvenous Electrical
% 214.67/214.88  |- skos__broader mesh__D017115smesh__D002404
% 214.67/214.88  |- skos__altLabel mesh__D017115 Electrical Catheter Ablation
% 214.67/214.88  |- skos__altLabel mesh__D017115 Transvenous Catheter Ablation
% 214.67/214.88  |- skos__hiddenLabel mesh__D017115 Ablation, Transvenous Catheter
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017115 2003
% 214.67/214.88  |- skos__prefLabel mesh__D017115 Catheter Ablation
% 214.67/214.88  |- skos__broader mesh__D017115smesh__D004564
% 214.67/214.88  |- mesh__dateCreated mesh__D017115 1992-05-07
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017115 2002
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017115 2004
% 214.67/214.88  |- skos__hiddenLabel mesh__D017115 Ablation, Radiofrequency Catheter
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017115 2005
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017115 1998
% 214.67/214.88  |- skos__hiddenLabel mesh__D017115 Electrical Ablation, Transvenous
% 214.67/214.88  |- mesh__recordAuthorizer mesh__D017115 SJN
% 214.67/214.88  |- skos__altLabel mesh__D017115 Catheter Ablation, Electrical
% 214.67/214.88  |- skos__historyNote mesh__D017115 Heart Catheterization %28%1981-1992%29%
% 214.67/214.88  |- skos__broader mesh__D017115smesh__D006328
% 214.67/214.88  |- skos__hiddenLabel mesh__D017115 Ablation, Electric Catheter
% 214.67/214.88  |- skos__historyNote mesh__D017115 Catheterization %28%1971-1980%29%
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017115 2006
% 214.67/214.88  |- mesh__recordMaintainer mesh__D017115 PXP
% 214.67/214.88  |- skos__hiddenLabel mesh__D017115 Ablation, Electrical Catheter
% 214.67/214.88  |- skos__scopeNote mesh__D017115
% 214.67/214.88       Removal of tissue with electrical current delivered via electrodes positioned at the distal end of a catheter. Energy sources are commonly direct current %28%DC-shock%29% or alternating current at radiofrequencies %28%usually 750 kHz%29%. The technique is used most often to ablate the AV junction and/or accessory pathways in order to interrupt AV conduction and produce AV block in the treatment of various tachyarrhythmias.%A%    
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017115 1999
% 214.67/214.88  |- rdf__type mesh__D017115sskos__Concept
% 214.67/214.88  |- skos__annotation mesh__D017115
% 214.67/214.88       removal of tissue by electrode-fitted catheter; used often in heart surg to treat tachycardia; coord organ or dis with /surg; DF: CATH ABLATION%A%  
% 214.67/214.88  |- mesh__recordOriginator mesh__D017115 MXR
% 214.67/214.88  |- skos__altLabel mesh__D017115 Electric Catheter Ablation
% 214.67/214.88  |- skos__altLabel mesh__D017115 Radiofrequency Catheter Ablation
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017115 2000
% 214.67/214.88  |- mesh__historyNote mesh__D017115
% 214.67/214.88       93; ABLATION, TRANSVENOUS ELECTRIC and CATHETER ABLATION, ELECTRIC were see ELECTROCOAGULATION 1989-92%A%  
% 214.67/214.88  |- mesh__recordMaintainer mesh__D008389 jls
% 214.67/214.88  |- skos__hiddenLabel mesh__D008389 Marketing Service, Health
% 214.67/214.88  |- skos__altLabel mesh__D008389 Services, Health Marketing
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D008389 2004
% 214.67/214.88  |- mesh__recordAuthorizer mesh__D008389 sjn
% 214.67/214.88  |- mesh__publicMeSHNote mesh__D008389
% 214.67/214.88       80; was see under HEALTH RESOURCES 1979   
% 214.67/214.88  |- skos__altLabel mesh__D008389 Marketing, Health Services
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D008389 2005
% 214.67/214.88  |- mesh__dateRevised mesh__D008389 2002-07-03
% 214.67/214.88  |- skos__broader mesh__D008389smesh__D006297
% 214.67/214.88  |- mesh__recordOriginator mesh__D008389 EC
% 214.67/214.88  |- skos__altLabel mesh__D008389 Marketing Services, Health
% 214.67/214.88  |- skos__hiddenLabel mesh__D008389 Health Marketing Service
% 214.67/214.88  |- skos__broader mesh__D008389smesh__D040541
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D008389 2006
% 214.67/214.88  |- skos__prefLabel mesh__D008389 Marketing of Health Services
% 214.67/214.88  |- skos__broader mesh__D008389smesh__D005376
% 214.67/214.88  |- skos__scopeNote mesh__D008389
% 214.67/214.88       Application of marketing principles and techniques to maximize the use of health care resources.%A%    
% 214.67/214.88  |- mesh__historyNote mesh__D008389
% 214.67/214.88       80%28%79%29%; was see under HEALTH RESOURCES 1979   
% 214.67/214.88  |- skos__altLabel mesh__D008389 Health Services Marketing
% 214.67/214.88  |- skos__hiddenLabel mesh__D008389 Health Marketing Services
% 214.67/214.88  |- rdf__type mesh__D008389sskos__Concept
% 214.67/214.88  |- skos__annotation mesh__D008389 DF: MARKETING HEALTH SERV   
% 214.67/214.88  |- mesh__dateEstablished mesh__D008389 1980-01-01
% 214.67/214.88  |- mesh__dateCreated mesh__D008389 1978-05-09
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D008389 2003
% 214.67/214.88  |- mesh__recordAuthorizer mesh__D027543 sjn
% 214.67/214.88  |- skos__historyNote mesh__D027543 Plants, Medicinal %28%1966-2001%29%
% 214.67/214.88  |- mesh__dateRevised mesh__D027543 2005-06-30
% 214.67/214.88  |- mesh__dateCreated mesh__D027543 2001-07-25
% 214.67/214.88  |- mesh__recordMaintainer mesh__D027543 ssb
% 214.67/214.88  |- mesh__recordOriginator mesh__D027543 ssb
% 214.67/214.88  |- skos__altLabel mesh__D027543 Sage Plant
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D027543 2006
% 214.67/214.88  |- mesh__publicMeSHNote mesh__D027543 2002; see LAMIACEAE 1998-2001   
% 214.67/214.88  |- skos__prefLabel mesh__D027543 Salvia officinalis
% 214.67/214.88  |- mesh__dateEstablished mesh__D027543 2002-01-01
% 214.67/214.88  |- mesh__historyNote mesh__D027543 2002; use LAMIACEAE 1998-2001   
% 214.67/214.88  |- rdf__type mesh__D027543sskos__Concept
% 214.67/214.88  |- skos__annotation mesh__D027543
% 214.67/214.88       coordinate with specific PLANT COMPONENTS term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.67/214.88  |- skos__scopeNote mesh__D027543
% 214.67/214.88       A plant species of the Salvia genus known as a spice and medicinal plant.%A%    
% 214.67/214.88  |- skos__broader mesh__D027543smesh__D027544
% 214.67/214.88  |- mesh__dateCreated mesh__D005091 1986-06-18
% 214.67/214.88  |- mesh__onlineNote mesh__D005091 search BASE SEQUENCE 1980-86   
% 214.67/214.88  |- mesh__dateEstablished mesh__D005091 1987-01-01
% 214.67/214.88  |- rdf__type mesh__D005091sskos__Concept
% 214.67/214.88  |- skos__historyNote mesh__D005091 Genes, Structural %28%1977-1986%29%
% 214.67/214.88  |- mesh__recordOriginator mesh__D005091 SCD
% 214.67/214.88  |- skos__prefLabel mesh__D005091 Exons
% 214.67/214.88  |- mesh__dateRevised mesh__D005091 2005-06-30
% 214.67/214.88  |- skos__historyNote mesh__D005091 Base Sequence %28%1977-1986%29%
% 214.67/214.88  |- skos__broader mesh__D005091smesh__D040461
% 214.67/214.88  |- skos__hiddenLabel mesh__D005091 Mini Exon
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D005091 2006
% 214.67/214.88  |- skos__scopeNote mesh__D005091
% 214.67/214.88       The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or structural RNA.%A%    
% 214.67/214.88  |- mesh__historyNote mesh__D005091 87; was see BASE SEQUENCE 1980-86   
% 214.67/214.88  |- skos__hiddenLabel mesh__D005091 Mini-Exons
% 214.67/214.88  |- skos__historyNote mesh__D005091 Genes %28%1977-1980%29%
% 214.67/214.88  |- skos__hiddenLabel mesh__D005091 Exon
% 214.67/214.88  |- mesh__publicMeSHNote mesh__D005091 87; was see BASE SEQUENCE 1980-86   
% 214.67/214.88  |- mesh__recordMaintainer mesh__D005091 nns
% 214.67/214.88  |- mesh__recordAuthorizer mesh__D005091 sjn
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D013523 2002
% 214.67/214.88  |- skos__scopeNote mesh__D013523
% 214.67/214.88       Nonexpendable apparatus used during surgical procedures. They are differentiated from SURGICAL INSTRUMENTS, usually hand-held and used in the immediate operative field.%A%    
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D013523 2001
% 214.67/214.88  |- mesh__recordMaintainer mesh__D013523 PXP
% 214.67/214.88  |- skos__altLabel mesh__D013523 Equipment, Surgical
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D013523 2006
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D013523 2000
% 214.67/214.88  |- mesh__dateRevised mesh__D013523 1997-06-20
% 214.67/214.88  |- mesh__recordAuthorizer mesh__D013523 SJN
% 214.67/214.88  |- skos__broader mesh__D013523smesh__D004864
% 214.67/214.88  |- skos__hiddenLabel mesh__D013523 Surgical Equipments
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D013523 2005
% 214.67/214.88  |- mesh__dateCreated mesh__D013523 1999-01-01
% 214.67/214.88  |- skos__annotation mesh__D013523
% 214.67/214.88       differentiate from SURGICAL INSTRUMENTS in that the instrument is for use in the immediate operative field, usually held in the hand%A%  
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D013523 2004
% 214.67/214.88  |- mesh__recordOriginator mesh__D013523 NLM
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D013523 1999
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D013523 2003
% 214.67/214.88  |- rdf__type mesh__D013523sskos__Concept
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D013523 1998
% 214.67/214.88  |- skos__prefLabel mesh__D013523 Surgical Equipment
% 214.67/214.88  |- skos__hiddenLabel mesh__D013523 Equipments, Surgical
% 214.67/214.88  |- skos__altLabel mesh__D032488 Sequoia, Giant
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D032488 2006
% 214.67/214.88  |- mesh__publicMeSHNote mesh__D032488 2003   
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D032488 2003
% 214.67/214.88  |- rdf__type mesh__D032488sskos__Concept
% 214.67/214.88  |- mesh__dateCreated mesh__D032488 2002-07-03
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D032488 2004
% 214.67/214.88  |- skos__annotation mesh__D032488
% 214.67/214.88       SEQUOIA genus is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.67/214.88  |- skos__scopeNote mesh__D032488
% 214.67/214.88       A plant genus of the family TAXODIACEAE known for tall trees like the SEQUOIA redwoods.%A%    
% 214.67/214.88  |- mesh__historyNote mesh__D032488 2003   
% 214.67/214.88  |- skos__broader mesh__D032488smesh__D032484
% 214.67/214.88  |- skos__prefLabel mesh__D032488 Sequoiadendron
% 214.67/214.88  |- mesh__dateEstablished mesh__D032488 2003-01-01
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D032488 2005
% 214.67/214.88  |- mesh__recordMaintainer mesh__D051642 ags
% 214.67/214.88  |- mesh__recordOriginator mesh__D051642 ags
% 214.67/214.88  |- skos__scopeNote mesh__D051642
% 214.67/214.88       A neoplasm containing HISTIOCYTES. Important forms include BENIGN FIBROUS HISTIOCYTOMA; and MALIGNANT FIBROUS HISTIOCYTOMA.%A%    
% 214.67/214.88  |- skos__broader mesh__D051642smesh__D018218
% 214.67/214.88  |- rdf__type mesh__D051642sskos__Concept
% 214.67/214.88  |- mesh__dateCreated mesh__D051642 2005-06-30
% 214.67/214.88  |- skos__historyNote mesh__D051642 Dermatofibroma %28%1964-2005%29%
% 214.67/214.88  |- skos__prefLabel mesh__D051642 Histiocytoma
% 214.67/214.88  |- mesh__historyNote mesh__D051642
% 214.67/214.88       2006, 1968-1993; use HISTIOCYTOMA, BENIGN FIBROUS 1994-2005%A%  
% 214.67/214.88  |- mesh__recordAuthorizer mesh__D051642 sjn
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D051642 2006
% 214.67/214.88  |- skos__hiddenLabel mesh__D051642 Histiocytomas
% 214.67/214.88  |- mesh__dateEstablished mesh__D051642 2006-01-01
% 214.67/214.88  |- mesh__publicMeSHNote mesh__D051642
% 214.67/214.88       2006; see DERMATOFIBROMA 1994-2005, see HISTIOCYTOMA 1968-1993%A%  
% 214.67/214.88  |- skos__annotation mesh__D051642
% 214.67/214.88       coordinate IM with precoordinated organ/neoplasm term %28%IM%29%%A%  
% 214.67/214.88  |- skos__broader mesh__D009729Q000191smesh__D009729
% 214.67/214.88  |- mesh__preferredCombination mesh__D009729Q000191smesh__D004471
% 214.67/214.88  |- rdf__type mesh__D009729Q000191smesh__CompoundConcept
% 214.67/214.88  |- mesh__dateEstablished mesh__D004797 1986-01-01
% 214.67/214.88  |- skos__hiddenLabel mesh__D004797 Immunosorbent Assays, Enzyme-Linked
% 214.67/214.88  |- skos__hiddenLabel mesh__D004797 Immunosorbent Assay, Enzyme-Linked
% 214.67/214.88  |- rdf__type mesh__D004797sskos__Concept
% 214.67/214.88  |- mesh__dateRevised mesh__D004797 2001-07-25
% 214.67/214.88  |- skos__altLabel mesh__D004797 ELISA
% 214.67/214.88  |- skos__broader mesh__D004797smesh__D007124
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D004797 2003
% 214.67/214.88  |- mesh__publicMeSHNote mesh__D004797
% 214.67/214.88       86; was see under IMMUNOENZYME TECHNIQUES 1977-85   
% 214.67/214.88  |- mesh__recordOriginator mesh__D004797 SMH
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D004797 2005
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D004797 2004
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D004797 2002
% 214.67/214.88  |- skos__hiddenLabel mesh__D004797 Enzyme Linked Immunosorbent Assay
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D004797 2006
% 214.67/214.88  |- skos__historyNote mesh__D004797 Immunoassay %28%1966-1976%29%
% 214.67/214.88  |- skos__annotation mesh__D004797 NIM; IMMUNOSORBENTS is also available   
% 214.67/214.88  |- skos__broader mesh__D004797smesh__D007163
% 214.67/214.88  |- skos__hiddenLabel mesh__D004797 Assays, Enzyme-Linked Immunosorbent
% 214.67/214.88  |- mesh__dateCreated mesh__D004797 1976-04-19
% 214.67/214.88  |- skos__hiddenLabel mesh__D004797 Assay, Enzyme-Linked Immunosorbent
% 214.67/214.88  |- skos__historyNote mesh__D004797 Serodiagnosis %28%1966-1976%29%
% 214.67/214.88  |- mesh__recordMaintainer mesh__D004797 nns
% 214.67/214.88  |- mesh__recordAuthorizer mesh__D004797 sjn
% 214.67/214.88  |- skos__scopeNote mesh__D004797
% 214.67/214.88       An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed.%A%    
% 214.67/214.88  |- skos__hiddenLabel mesh__D004797 Enzyme-Linked Immunosorbent Assays
% 214.67/214.88  |- mesh__historyNote mesh__D004797
% 214.67/214.88       86%28%77%29%; was see under IMMUNOENZYME TECHNIQUES 1977-85   
% 214.67/214.88  |- skos__prefLabel mesh__D004797 Enzyme-Linked Immunosorbent Assay
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D009482 2004
% 214.67/214.88  |- skos__prefLabel mesh__D009482 Neurophysiology
% 214.67/214.88  |- skos__scopeNote mesh__D009482
% 214.67/214.88       The scientific discipline concerned with the physiology of the nervous system.%A%    
% 214.67/214.88  |- skos__annotation mesh__D009482
% 214.67/214.88       SPEC only: not for NERVOUS SYSTEM PHYSIOLOGY;DF: NEUROPHYSIOL%A%  
% 214.67/214.88  |- skos__broader mesh__D009482smesh__D010827
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D009482 2002
% 214.67/214.88  |- mesh__recordMaintainer mesh__D009482 jls
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D009482 2006
% 214.67/214.88  |- mesh__historyNote mesh__D009482 65   
% 214.67/214.88  |- mesh__recordOriginator mesh__D009482 NLM
% 214.67/214.88  |- mesh__dateCreated mesh__D009482 1999-01-01
% 214.67/214.88  |- mesh__publicMeSHNote mesh__D009482 65   
% 214.67/214.88  |- skos__broader mesh__D009482smesh__D009488
% 214.67/214.88  |- mesh__dateRevised mesh__D009482 2001-07-25
% 214.67/214.88  |- mesh__recordAuthorizer mesh__D009482 sjn
% 214.67/214.88  |- mesh__dateEstablished mesh__D009482 1965-01-01
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D009482 2003
% 214.67/214.88  |- rdf__type mesh__D009482sskos__Concept
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D009482 2005
% 214.67/214.88  |- mesh__dateRevised mesh__D017914 2005-08-01
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017914 2002
% 214.67/214.88  |- skos__prefLabel mesh__D017914 Microviridae
% 214.67/214.88  |- mesh__recordOriginator mesh__D017914 AGS
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017914 2003
% 214.67/214.88  |- mesh__publicMeSHNote mesh__D017914 94   
% 214.67/214.88  |- mesh__recordMaintainer mesh__D017914 ags
% 214.67/214.88  |- skos__historyNote mesh__D017914 Bacteriophages %28%1983-1993%29%
% 214.67/214.88  |- skos__scopeNote mesh__D017914
% 214.67/214.88       A large family of lytic bacteriophages infecting enterobacteria; SPIROPLASMA; BDELLOVIBRIO; and CHLAMYDIA. It contains four genera: MICROVIRUS; Spiromicrovirus; Bdellomicrovirus; and Chlamydiamicrovirus.%A%    
% 214.67/214.88  |- mesh__historyNote mesh__D017914 94   
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017914 2004
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017914 2006A
% 214.67/214.88  |- mesh__dateEstablished mesh__D017914 1994-01-01
% 214.67/214.88  |- skos__broader mesh__D017914smesh__D001435
% 214.67/214.88  |- mesh__activeMeSHYear mesh__D017914 2005
% 214.67/214.88  |- rdf__type mesh__D017914sskos__Concept
% 214.67/214.88  |- skos__annotation mesh__D017914 coord with specific bacterium /virol   
% 214.67/214.89  |- skos__broader mesh__D017914smesh__D004267
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017914 2006
% 214.67/214.89  |- mesh__dateCreated mesh__D017914 1993-06-04
% 214.67/214.89  |- mesh__recordAuthorizer mesh__D017914 ags
% 214.67/214.89  |- mesh__dateRevised mesh__D017116 1999-12-09
% 214.67/214.89  |- skos__altLabel mesh__D017116 Lower Back Pain
% 214.67/214.89  |- skos__scopeNote mesh__D017116
% 214.67/214.89       Acute or chronic pain in the lumbar or sacral regions, which may be associated with musculo-ligamentous SPRAINS AND STRAINS; INTERVERTEBRAL DISK DISPLACEMENT; and other conditions.%A%    
% 214.67/214.89  |- mesh__recordMaintainer mesh__D017116 ags
% 214.67/214.89  |- mesh__recordOriginator mesh__D017116 TGC
% 214.67/214.89  |- skos__prefLabel mesh__D017116 Low Back Pain
% 214.67/214.89  |- mesh__dateEstablished mesh__D017116 1993-01-01
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017116 2000A
% 214.67/214.89  |- skos__hiddenLabel mesh__D017116 Back Aches, Low
% 214.67/214.89  |- skos__hiddenLabel mesh__D017116 Back Pain, Low
% 214.67/214.89  |- skos__hiddenLabel mesh__D017116 Pains, Lower Back
% 214.67/214.89  |- skos__altLabel mesh__D017116 Recurrent Low Back Pain
% 214.67/214.89  |- skos__historyNote mesh__D017116 Back Pain %28%1966-1992%29%
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017116 2002
% 214.67/214.89  |- skos__altLabel mesh__D017116 Low Back Ache
% 214.67/214.89  |- skos__hiddenLabel mesh__D017116 Back Pain, Lower
% 214.67/214.89  |- skos__hiddenLabel mesh__D017116 Backaches, Low
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017116 2003
% 214.67/214.89  |- skos__hiddenLabel mesh__D017116 Lower Back Pains
% 214.67/214.89  |- mesh__dateCreated mesh__D017116 1992-05-22
% 214.67/214.89  |- skos__hiddenLabel mesh__D017116 Low Back Aches
% 214.67/214.89  |- skos__hiddenLabel mesh__D017116 Pain, Lower Back
% 214.67/214.89  |- mesh__recordAuthorizer mesh__D017116 ags
% 214.67/214.89  |- skos__hiddenLabel mesh__D017116 Aches, Low Back
% 214.67/214.89  |- skos__related mesh__D017116smesh__D012585
% 214.67/214.89  |- skos__hiddenLabel mesh__D017116 Ache, Low Back
% 214.67/214.89  |- mesh__historyNote mesh__D017116
% 214.67/214.89       1993; use BACKACHE 1987-1992; for LUMBAGO use BACKACHE 1963-1992%A%  
% 214.67/214.89  |- skos__hiddenLabel mesh__D017116 Back Pains, Low
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017116 2004
% 214.67/214.89  |- skos__broader mesh__D017116smesh__D001416
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017116 2005
% 214.67/214.89  |- skos__altLabel mesh__D017116 Mechanical Low Back Pain
% 214.67/214.89  |- skos__hiddenLabel mesh__D017116 Low Backaches
% 214.67/214.89  |- skos__altLabel mesh__D017116 Postural Low Back Pain
% 214.67/214.89  |- skos__hiddenLabel mesh__D017116 Pains, Low Back
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017116 2000
% 214.67/214.89  |- skos__hiddenLabel mesh__D017116 Backache, Low
% 214.67/214.89  |- skos__annotation mesh__D017116
% 214.67/214.89       %22%lombo-sciatique%22% in French texts is indexed here %28%IM%29% + SCIATICA %28%IM%29%%A%  
% 214.67/214.89  |- skos__hiddenLabel mesh__D017116 Low Back Pains
% 214.67/214.89  |- mesh__publicMeSHNote mesh__D017116
% 214.67/214.89       1993; see BACKACHE 1987-1992; for LUMBAGO see BACKACHE 1963-1992%A%  
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017116 2006
% 214.67/214.89  |- skos__altLabel mesh__D017116 Low Backache
% 214.67/214.89  |- rdf__type mesh__D017116sskos__Concept
% 214.67/214.89  |- skos__hiddenLabel mesh__D017116 Pain, Low Back
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017116 2001
% 214.67/214.89  |- skos__hiddenLabel mesh__D017116 Back Ache, Low
% 214.67/214.89  |- skos__hiddenLabel mesh__D017116 Back Pains, Lower
% 214.67/214.89  |- skos__altLabel mesh__D017116 Lumbago
% 214.67/214.89  |- skos__prefLabel mesh__D033581 Stem Cell Transplantation
% 214.67/214.89  |- skos__hiddenLabel mesh__D033581 Stem Cell Transplantation, Adult Derived
% 214.67/214.89  |- skos__altLabel mesh__D033581 Transplantation, Stem Cell
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D033581 2005
% 214.67/214.89  |- mesh__dateCreated mesh__D033581 2002-07-02
% 214.67/214.89  |- skos__hiddenLabel mesh__D033581 Adult Derived Stem Cell Transplantation
% 214.67/214.89  |- skos__altLabel mesh__D033581 Stem Cell Transplantation, Adult-Derived
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D033581 2006
% 214.67/214.89  |- mesh__recordAuthorizer mesh__D033581 sjn
% 214.67/214.89  |- skos__altLabel mesh__D033581 Stem Cell Transplantation, Embryonic
% 214.67/214.89  |- skos__hiddenLabel mesh__D033581 Stem Cell Transplantations
% 214.67/214.89  |- skos__altLabel mesh__D033581 Transplantation, Adult-Derived Stem Cell
% 214.67/214.89  |- mesh__recordOriginator mesh__D033581 lkt
% 214.67/214.89  |- skos__altLabel mesh__D033581 Transplantation, Embryonic Stem Cell
% 214.67/214.89  |- rdf__type mesh__D033581sskos__Concept
% 214.67/214.89  |- skos__scopeNote mesh__D033581
% 214.67/214.89       The transfer of STEM CELLS from one individual to another within the same species %28%TRANSPLANTATION, HOMOLOGOUS%29% or between species %28%XENOTRANSPLANTATION%29%, or transfer within the same individual %28%TRANSPLANTATION, AUTOLOGOUS%29%. The source and location of the stem cells determines their potency or pluripotency to differentiate into various cell types.%A%    
% 214.67/214.89  |- mesh__recordMaintainer mesh__D033581 lkt
% 214.67/214.89  |- skos__altLabel mesh__D033581 Transplantation, Fetal Stem Cell
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D033581 2003
% 214.67/214.89  |- skos__altLabel mesh__D033581 Transplantation, Juvenile Stem Cell
% 214.67/214.89  |- mesh__publicMeSHNote mesh__D033581
% 214.67/214.89       2003; see HEMATOPOIETIC STEM CELL TRANSPLANTATION 1995-2002%A%  
% 214.67/214.89  |- skos__historyNote mesh__D033581
% 214.67/214.89       Hematopoietic Stem Cell Transplantation %28%1981-2002%29%
% 214.67/214.89  |- mesh__dateEstablished mesh__D033581 2003-01-01
% 214.67/214.89  |- skos__broader mesh__D033581smesh__D017690
% 214.67/214.89  |- mesh__historyNote mesh__D033581
% 214.67/214.89       2003; use HEMATOPOIETIC STEM CELL TRANSPLANTATION 1995-2002%A%  
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D033581 2004
% 214.67/214.89  |- skos__hiddenLabel mesh__D033581 Transplantations, Stem Cell
% 214.67/214.89  |- skos__hiddenLabel mesh__D033581 Transplantation, Adult Derived Stem Cell
% 214.67/214.89  |- skos__altLabel mesh__D033581 Stem Cell Transplantation, Juvenile
% 214.67/214.89  |- skos__altLabel mesh__D033581 Stem Cell Transplantation, Fetal
% 214.67/214.89  |- skos__hiddenLabel mesh__D005890 Gingivectomies
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005890 2003
% 214.67/214.89  |- skos__broader mesh__D005890smesh__D019647
% 214.67/214.89  |- skos__broader mesh__D005890smesh__D010517
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005890 2006
% 214.67/214.89  |- skos__scopeNote mesh__D005890
% 214.67/214.89       Surgical excision of the gingiva at the level of its attachment, thus creating new marginal gingiva. This procedure is used to eliminate gingival or periodontal pockets or to provide an approach for extensive surgical interventions, and to gain access necessary to remove calculus within the pocket. %28%Dorland, 28th ed%29%%A%    
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005890 2004
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005890 2001
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005890 1998
% 214.67/214.89  |- rdf__type mesh__D005890sskos__Concept
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005890 2002
% 214.67/214.89  |- skos__prefLabel mesh__D005890 Gingivectomy
% 214.67/214.89  |- mesh__publicMeSHNote mesh__D005890 65   
% 214.67/214.89  |- mesh__historyNote mesh__D005890 65   
% 214.67/214.89  |- mesh__dateCreated mesh__D005890 1999-01-01
% 214.67/214.89  |- mesh__recordAuthorizer mesh__D005890 SJN
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005890 1999
% 214.67/214.89  |- mesh__dateEstablished mesh__D005890 1965-01-01
% 214.67/214.89  |- skos__annotation mesh__D005890
% 214.67/214.89       do not use /util except by MeSH definition   
% 214.67/214.89  |- mesh__recordOriginator mesh__D005890 NLM
% 214.67/214.89  |- mesh__recordMaintainer mesh__D005890 PXP
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005890 2000
% 214.67/214.89  |- mesh__dateRevised mesh__D005890 1997-06-20
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005890 2005
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D027544 2004
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D027544 2002
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D027544 2006
% 214.67/214.89  |- skos__scopeNote mesh__D027544
% 214.67/214.89       A genus in the mint family %28%LAMIACEAE%29%.     
% 214.67/214.89  |- skos__historyNote mesh__D027544 Plants, Medicinal %28%1966-2001%29%
% 214.67/214.89  |- skos__annotation mesh__D027544
% 214.67/214.89       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D027544 2003
% 214.67/214.89  |- mesh__publicMeSHNote mesh__D027544 2002   
% 214.67/214.89  |- mesh__dateEstablished mesh__D027544 2002-01-01
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D027544 2005
% 214.67/214.89  |- mesh__dateCreated mesh__D027544 2001-07-25
% 214.67/214.89  |- rdf__type mesh__D027544sskos__Concept
% 214.67/214.89  |- skos__broader mesh__D027544smesh__D019686
% 214.67/214.89  |- skos__prefLabel mesh__D027544 Salvia
% 214.67/214.89  |- mesh__historyNote mesh__D027544 2002   
% 214.67/214.89  |- mesh__dateEstablished mesh__D005092 1973-01-01
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005092 2005
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005092 2004
% 214.67/214.89  |- skos__broader mesh__D005092smesh__D004950
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005092 2006
% 214.67/214.89  |- skos__hiddenLabel mesh__D005092 5%27% 3%27% Exonucleases
% 214.67/214.89  |- skos__historyNote mesh__D005092
% 214.67/214.89       Nucleotidyltransferases %28%1966-1972%29%
% 214.67/214.89  |- skos__prefLabel mesh__D005092 Exonucleases
% 214.67/214.89  |- mesh__recordOriginator mesh__D005092 NLM
% 214.67/214.89  |- mesh__recordAuthorizer mesh__D005092 sjn
% 214.67/214.89  |- mesh__publicMeSHNote mesh__D005092
% 214.67/214.89       1973; 3%27%-5%27%-EXONUCLEASE use EXODEOXYRIBONUCLEASE V %26% 5%27%-3%27%-EXONUCLEASE were indexed under EXODEORIBONUCLEASES 1992-2003%A%  
% 214.67/214.89  |- skos__altLabel mesh__D005092 3%27%-5%27%-Exonuclease
% 214.67/214.89  |- skos__historyNote mesh__D005092 Phosphatases %28%1966-1972%29%
% 214.67/214.89  |- mesh__recordMaintainer mesh__D005092 jmp
% 214.67/214.89  |- skos__hiddenLabel mesh__D005092 3%27% 5%27% Exonuclease
% 214.67/214.89  |- skos__altLabel mesh__D005092 5%27%-3%27%-Exonuclease
% 214.67/214.89  |- mesh__historyNote mesh__D005092
% 214.67/214.89       1973; for 3%27%-5%27%-EXONUCLEASE use EXODEOXYRIBONUCLEASE V %26% 5%27%-3%27%-EXONUCLEASE %28%NM%29% 1992-2003%A%  
% 214.67/214.89  |- rdf__type mesh__D005092sskos__Concept
% 214.67/214.89  |- skos__hiddenLabel mesh__D005092 5%27% 3%27% Exonuclease
% 214.67/214.89  |- skos__scopeNote mesh__D005092
% 214.67/214.89       Enzymes that catalyze the release of mononucleotides by the hydrolysis of the terminal bond of deoxyribonucleotide or ribonucleotide chains.%A%    
% 214.67/214.89  |- mesh__dateCreated mesh__D005092 1999-01-01
% 214.67/214.89  |- skos__hiddenLabel mesh__D005092 3%27% 5%27% Exonucleases
% 214.67/214.89  |- mesh__dateRevised mesh__D005092 2003-07-09
% 214.67/214.89  |- mesh__dateEstablished mesh__D013524 1980-01-01
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D013524 2006
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D013524 2002
% 214.67/214.89  |- mesh__recordOriginator mesh__D013524 RC
% 214.67/214.89  |- skos__hiddenLabel mesh__D013524 Flap, Island
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D013524 2005
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D013524 2001
% 214.67/214.89  |- mesh__historyNote mesh__D013524 80   
% 214.67/214.89  |- mesh__recordMaintainer mesh__D013524 PXP
% 214.67/214.89  |- skos__historyNote mesh__D013524
% 214.67/214.89       Transplantation, Autologous %28%1966-1979%29%
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D013524 2004
% 214.67/214.89  |- skos__altLabel mesh__D013524 Surgical Flap
% 214.67/214.89  |- mesh__publicMeSHNote mesh__D013524 80   
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D013524 2000
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D013524 1999
% 214.67/214.89  |- rdf__type mesh__D013524sskos__Concept
% 214.67/214.89  |- skos__annotation mesh__D013524
% 214.67/214.89       includes skin %26% muscle tissue but do not specify site or tissue unless particularly discussed; do not coord with TRANSPLANTATION, AUTOLOGOUS; pedicled grafts, rotation flaps, tube flaps, free tissue flaps, soft tissue flaps go here; note X ref ISLAND FLAPS%A%  
% 214.67/214.89  |- skos__altLabel mesh__D013524 Flap, Surgical
% 214.67/214.89  |- mesh__dateRevised mesh__D013524 1997-06-20
% 214.67/214.89  |- mesh__recordAuthorizer mesh__D013524 SJN
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D013524 2003
% 214.67/214.89  |- skos__altLabel mesh__D013524 Flaps, Surgical
% 214.67/214.89  |- skos__altLabel mesh__D013524 Flaps
% 214.67/214.89  |- mesh__dateCreated mesh__D013524 1978-12-14
% 214.67/214.89  |- skos__broader mesh__D013524smesh__D019738
% 214.67/214.89  |- skos__hiddenLabel mesh__D013524 Flaps, Island
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D013524 1998
% 214.67/214.89  |- skos__prefLabel mesh__D013524 Surgical Flaps
% 214.67/214.89  |- skos__hiddenLabel mesh__D013524 Island Flap
% 214.67/214.89  |- skos__historyNote mesh__D013524 Skin %28%1966-1979%29%
% 214.67/214.89  |- skos__hiddenLabel mesh__D013524 Flap
% 214.67/214.89  |- skos__altLabel mesh__D013524 Island Flaps
% 214.67/214.89  |- skos__scopeNote mesh__D013524
% 214.67/214.89       Tongues of tissue %28%skin and subcutaneous tissue, sometimes including muscle%29% cut away from the underlying parts but attached at one end. They retain their own blood supply during transfer to the new site. They are used in plastic surgery for filling a defect in a neighboring region. The concept includes pedicled flaps, rotation flaps, tube flaps, etc.%A%    
% 214.67/214.89  |- skos__historyNote mesh__D013524 Surgery, Plastic %28%1966-1979%29%
% 214.67/214.89  |- rdf__type mesh__D032489sskos__Concept
% 214.67/214.89  |- mesh__dateEstablished mesh__D032489 2003-01-01
% 214.67/214.89  |- skos__prefLabel mesh__D032489 Taxodium
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D032489 2004
% 214.67/214.89  |- skos__broader mesh__D032489smesh__D032484
% 214.67/214.89  |- skos__annotation mesh__D032489
% 214.67/214.89       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.67/214.89  |- skos__altLabel mesh__D032489 Bald Cypress
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D032489 2005
% 214.67/214.89  |- mesh__historyNote mesh__D032489 2003   
% 214.67/214.89  |- mesh__dateCreated mesh__D032489 2002-07-02
% 214.67/214.89  |- skos__altLabel mesh__D032489 Cypress, Bald
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D032489 2006
% 214.67/214.89  |- mesh__publicMeSHNote mesh__D032489 2003   
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D032489 2003
% 214.67/214.89  |- skos__scopeNote mesh__D032489
% 214.67/214.89       A plant genus of the family TAXODIACEAE. Members contain taxodione and taxodone, which are diterpenoid quinone methide tumor inhibitors.%A%    
% 214.67/214.89  |- skos__broader mesh__D004798smesh__D045762
% 214.67/214.89  |- mesh__dateRevised mesh__D004798 2005-07-13
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D004798 2005
% 214.67/214.89  |- skos__related mesh__D004798smesh__D013379
% 214.67/214.89  |- mesh__dateCreated mesh__D004798 1999-01-01
% 214.67/214.89  |- skos__annotation mesh__D004798
% 214.67/214.89       GEN only: avoid; prefer /enzymol: Manual 19.7+, 19.8.30; /defic permitted but specific enzyme /defic is more likely; /diag use: very unlikely: probably incorrect for ENZYME TESTS; Manual 23.25.1; policy: Manual 25.19+; index enzyme substrate as NIM without qualif; SUBSTRATE SPECIFICITY, restricted to enzymes, is also available; %22%enzyme activation%22% = ENZYME ACTIVATION; %22%enzyme reactivation%22%: coord ENZYME ACTIVATION %28%IM%29% + specific enzyme /metab %28%IM%29% + ENZYME REACTIVATORS %28%IM%29% if discussed %28%see note there%29%%A%  
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D004798 2006
% 214.67/214.89  |- mesh__recordMaintainer mesh__D004798 ags
% 214.67/214.89  |- skos__prefLabel mesh__D004798 Enzymes
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D004798 2006A
% 214.67/214.89  |- mesh__onlineNote mesh__D004798 pre-explosion = ENZYMES %28%PX%29%   
% 214.67/214.89  |- skos__scopeNote mesh__D004798
% 214.67/214.89       Biological molecules that possess catalytic activity. They may occur naturally or be synthetically created. Enzymes are usually proteins, however CATALYTIC RNA and CATALYTIC DNA molecules have also been identified.%A%    
% 214.67/214.89  |- mesh__recordAuthorizer mesh__D004798 ags
% 214.67/214.89  |- rdf__type mesh__D004798sskos__Concept
% 214.67/214.89  |- mesh__recordOriginator mesh__D004798 NLM
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D009483 1999
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D009483 2006
% 214.67/214.89  |- skos__broader mesh__D009483smesh__D011581
% 214.67/214.89  |- mesh__dateEstablished mesh__D009483 1985-01-01
% 214.67/214.89  |- skos__hiddenLabel mesh__D009483 Test, Neuropsychologic
% 214.67/214.89  |- mesh__dateCreated mesh__D009483 1999-01-01
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D009483 1995
% 214.67/214.89  |- mesh__onlineNote mesh__D009483
% 214.67/214.89       use NEUROPSYCHOLOGICAL TESTS to search APHASIA 1979-84 %26% MEMORY FOR DESIGNS TEST 1971-84 %28%as Prov 1971-72%29%%A%  
% 214.67/214.89  |- skos__altLabel mesh__D009483 Neuropsychologic Tests
% 214.67/214.89  |- skos__hiddenLabel mesh__D009483 Test, Aphasia
% 214.67/214.89  |- mesh__publicMeSHNote mesh__D009483
% 214.67/214.89       85; MEMORY FOR DESIGNS TEST was heading 1973-84; APHASIA TESTS was see under LANGUAGE TESTS 1979-84%A%  
% 214.67/214.89  |- mesh__historyNote mesh__D009483
% 214.67/214.89       85; was NON MESH before 1985; MEMORY FOR DESIGNS TEST was heading 1971-84 %28%Prov 1971-72%29%; APHASIA TESTS was see under LANGUAGE TESTS 1979-84%A%  
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D009483 2002
% 214.67/214.89  |- skos__hiddenLabel mesh__D009483 Tests, Neuropsychologic
% 214.67/214.89  |- skos__altLabel mesh__D009483 Tests, Neuropsychological
% 214.67/214.89  |- mesh__recordOriginator mesh__D009483 NLM
% 214.67/214.89  |- skos__hiddenLabel mesh__D009483 Neuropsychologic Test
% 214.67/214.89  |- skos__hiddenLabel mesh__D009483 Aphasia Test
% 214.67/214.89  |- skos__hiddenLabel mesh__D009483 Tests, Aphasia
% 214.67/214.89  |- skos__altLabel mesh__D009483 Neuropsychological Test
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D009483 1996
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D009483 2003
% 214.67/214.89  |- rdf__type mesh__D009483sskos__Concept
% 214.67/214.89  |- skos__scopeNote mesh__D009483
% 214.67/214.89       Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury.%A%    
% 214.67/214.89  |- skos__prefLabel mesh__D009483 Neuropsychological Tests
% 214.67/214.89  |- skos__altLabel mesh__D009483 Test, Neuropsychological
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D009483 2000
% 214.67/214.89  |- skos__annotation mesh__D009483 DF: NEUROPSYCHOL TESTS   
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D009483 1998
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D009483 2005
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D009483 1997
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D009483 2004
% 214.67/214.89  |- mesh__recordAuthorizer mesh__D009483 PLS
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D009483 1994
% 214.67/214.89  |- mesh__dateRevised mesh__D009483 1993-06-04
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D009483 2001
% 214.67/214.89  |- mesh__recordMaintainer mesh__D009483 JLS
% 214.67/214.89  |- skos__altLabel mesh__D017915 G4 Phage
% 214.67/214.89  |- skos__hiddenLabel mesh__D017915 Microviruses
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017915 2006
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017915 2000
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017915 1995
% 214.67/214.89  |- mesh__dateCreated mesh__D017915 1993-06-18
% 214.67/214.89  |- mesh__publicMeSHNote mesh__D017915 94   
% 214.67/214.89  |- mesh__dateEstablished mesh__D017915 1994-01-01
% 214.67/214.89  |- skos__hiddenLabel mesh__D017915 Phage, G4
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017915 1999
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017915 2005
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017915 1994
% 214.67/214.89  |- skos__prefLabel mesh__D017915 Microvirus
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017915 1998
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017915 2004
% 214.67/214.89  |- skos__broader mesh__D017915smesh__D017914
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017915 1997
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017915 2003
% 214.67/214.89  |- skos__scopeNote mesh__D017915
% 214.67/214.89       A genus of bacteriophages of the family MICROVIRIDAE. The genome consists of isometric single-stranded DNA.%A%    
% 214.67/214.89  |- mesh__historyNote mesh__D017915 94   
% 214.67/214.89  |- skos__annotation mesh__D017915
% 214.67/214.89       a genus of bacteriophages of the family Microviridae   
% 214.67/214.89  |- skos__altLabel mesh__D017915 Bacteriophage G4
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017915 1996
% 214.67/214.89  |- skos__hiddenLabel mesh__D017915 G4 Phages
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017915 2002
% 214.67/214.89  |- skos__hiddenLabel mesh__D017915 Phages, G4
% 214.67/214.89  |- rdf__type mesh__D017915sskos__Concept
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D017915 2001
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005891 2004
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005891 1993
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005891 1998
% 214.67/214.89  |- rdf__type mesh__D005891sskos__Concept
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005891 2000
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005891 1996
% 214.67/214.89  |- mesh__dateCreated mesh__D005891 1999-01-01
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005891 1999
% 214.67/214.89  |- mesh__recordMaintainer mesh__D005891 PLS
% 214.67/214.89  |- mesh__recordAuthorizer mesh__D005891 PLS
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005891 1997
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005891 2001
% 214.67/214.89  |- skos__prefLabel mesh__D005891 Gingivitis
% 214.67/214.89  |- skos__hiddenLabel mesh__D005891 Gingivitides
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005891 2002
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005891 2005
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005891 1994
% 214.67/214.89  |- skos__broader mesh__D005891smesh__D005882
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005891 2003
% 214.67/214.89  |- mesh__recordOriginator mesh__D005891 NLM
% 214.67/214.89  |- mesh__dateRevised mesh__D005891 1991-11-09
% 214.67/214.89  |- skos__related mesh__D005891smesh__D010497
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005891 1992
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005891 2006
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005891 1995
% 214.67/214.89  |- mesh__recordOriginator mesh__D005093 RC
% 214.67/214.89  |- skos__historyNote mesh__D005093 Hyphomycetes %28%1966-1985%29%
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D005093 2006
% 214.67/214.89  |- mesh__dateCreated mesh__D005093 1985-02-12
% 214.67/214.89  |- skos__broader mesh__D005093smesh__D003904
% 214.67/214.89  |- skos__scopeNote mesh__D005093
% 214.67/214.89       A normally saprophytic mitosporic Chaetothyriales fungal genus. Infections in humans include phaeohyphomycosis, peritonitis, and chromoblastomycosis. Exophiala jeanselmei %28%previously Phialophora jeanselmei%29% is an etiological agent of maduromycosis.%A%    
% 214.67/214.89  |- skos__historyNote mesh__D005093 Deuteromycetes %28%1966-1985%29%
% 214.67/214.89  |- skos__altLabel mesh__D005093 Exophiala jeanselmei
% 214.67/214.89  |- mesh__dateEstablished mesh__D005093 1991-01-01
% 214.67/214.89  |- mesh__historyNote mesh__D005093 91%28%86%29%   
% 214.67/214.89  |- mesh__recordAuthorizer mesh__D005093 sjn
% 214.67/214.89  |- rdf__type mesh__D005093sskos__Concept
% 214.67/214.89  |- skos__prefLabel mesh__D005093 Exophiala
% 214.67/214.89  |- skos__altLabel mesh__D005093 Phialophora jeanselmei
% 214.67/214.89  |- mesh__recordMaintainer mesh__D005093 SYSTEM
% 214.67/214.89  |- skos__annotation mesh__D005093
% 214.67/214.89       infection: coord IM with MYCOSES %28%IM%29% or specific mycosis %28%IM%29%%A%  
% 214.67/214.89  |- mesh__publicMeSHNote mesh__D005093 91; see HYPHOMYCETES 1986-90   
% 214.67/214.89  |- mesh__dateRevised mesh__D005093 2005-06-30
% 214.67/214.89  |- skos__altLabel mesh__D005093 Wangiella
% 214.67/214.89  |- skos__hiddenLabel mesh__D013525 Surgical Instrument
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D013525 2003
% 214.67/214.89  |- skos__altLabel mesh__D013525 Instrument, Surgical
% 214.67/214.89  |- mesh__recordMaintainer mesh__D013525 PXP
% 214.67/214.89  |- mesh__recordAuthorizer mesh__D013525 SJN
% 214.67/214.89  |- skos__hiddenLabel mesh__D013525 Instruments, Surgical
% 214.67/214.89  |- skos__scopeNote mesh__D013525
% 214.67/214.89       Hand-held tools or implements used by health professionals for the performance of surgical tasks.%A%    
% 214.67/214.89  |- rdf__type mesh__D013525sskos__Concept
% 214.67/214.89  |- skos__prefLabel mesh__D013525 Surgical Instruments
% 214.67/214.89  |- skos__hiddenLabel mesh__D013525 Clip, Tantalum
% 214.67/214.89  |- skos__altLabel mesh__D013525 Clamp, Surgical
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D013525 2004
% 214.67/214.89  |- skos__altLabel mesh__D013525 Plug, Surgical
% 214.67/214.89  |- mesh__dateCreated mesh__D013525 1999-01-01
% 214.67/214.89  |- skos__annotation mesh__D013525
% 214.67/214.89       GEN or unspecified; prefer /instrum with specialty or with surg technique; differentiate from SURGICAL EQUIPMENT on basis of size %28%instruments are holdable in the hand%29%; surg instrum left in the operative field: coord IM with FOREIGN BODIES %28%IM%29%%A%  
% 214.67/214.89  |- mesh__historyNote mesh__D013525 65   
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D013525 1998
% 214.67/214.89  |- skos__altLabel mesh__D013525 Surgical Clip
% 214.67/214.89  |- skos__altLabel mesh__D013525 Hook, Surgical
% 214.67/214.89  |- skos__altLabel mesh__D013525 Clips, Surgical
% 214.67/214.89  |- skos__altLabel mesh__D013525 Clamps, Surgical
% 214.67/214.89  |- skos__altLabel mesh__D013525 Plugs, Surgical
% 214.67/214.89  |- skos__altLabel mesh__D013525 Surgical Plug
% 214.67/214.89  |- skos__altLabel mesh__D013525 Scissors, Surgical
% 214.67/214.89  |- skos__altLabel mesh__D013525 Valve, Surgical
% 214.67/214.89  |- mesh__publicMeSHNote mesh__D013525 65   
% 214.67/214.89  |- skos__altLabel mesh__D013525 Hooks, Surgical
% 214.67/214.89  |- skos__hiddenLabel mesh__D013525 Tantalum Clip
% 214.67/214.89  |- skos__hiddenLabel mesh__D013525 Tantalum Clips
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D013525 2000
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D013525 2005
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D013525 1999
% 214.67/214.89  |- mesh__dateEstablished mesh__D013525 1965-01-01
% 214.67/214.89  |- mesh__dateRevised mesh__D013525 1997-06-20
% 214.67/214.89  |- skos__hiddenLabel mesh__D013525 Speculums
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D013525 2001
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D013525 2006
% 214.67/214.89  |- skos__hiddenLabel mesh__D013525 Trocars
% 214.67/214.89  |- skos__hiddenLabel mesh__D013525 Clip
% 214.67/214.89  |- skos__altLabel mesh__D013525 Surgical Clamp
% 214.67/214.89  |- skos__broader mesh__D013525smesh__D013523
% 214.67/214.89  |- skos__altLabel mesh__D013525 Surgical Hook
% 214.67/214.89  |- skos__hiddenLabel mesh__D013525 Forcep
% 214.67/214.89  |- mesh__activeMeSHYear mesh__D013525 2002
% 214.67/214.89  |- skos__altLabel mesh__D013525 Clip, Surgical
% 214.67/214.89  |- mesh__recordOriginator mesh__D013525 NLM
% 214.67/214.89  |- skos__altLabel mesh__D013525 Surgical Valve
% 214.67/214.89  |- skos__altLabel mesh__D013525 Surgical Valves
% 214.67/214.89  |- mesh__publicMeSHNote mesh__D018210 94   
% 214.67/214.90  |- skos__annotation mesh__D018210
% 214.67/214.90       multiple; solitary = CHONDROMA; do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018210 2005
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018210 1999
% 214.67/214.90  |- rdf__type mesh__D018210sskos__Concept
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018210 2004
% 214.67/214.90  |- skos__hiddenLabel mesh__D018210 Chondromatoses
% 214.67/214.90  |- skos__historyNote mesh__D018210 Synovial Membrane %28%1967-1993%29%
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018210 1998
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018210 2002
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018210 2003
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018210 1997
% 214.67/214.90  |- mesh__recordAuthorizer mesh__D018210 PLS
% 214.67/214.90  |- skos__historyNote mesh__D018210
% 214.67/214.90       Chondromatosis, Synovial %28%1990-1993%29%
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018210 2001
% 214.67/214.90  |- mesh__recordMaintainer mesh__D018210 KEV
% 214.67/214.90  |- mesh__dateEstablished mesh__D018210 1994-01-01
% 214.67/214.90  |- mesh__historyNote mesh__D018210 94   
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018210 1996
% 214.67/214.90  |- skos__scopeNote mesh__D018210
% 214.67/214.90       Multiple formation of chondromas. %28%Dorland, 27th ed%29%     
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018210 2000
% 214.67/214.90  |- skos__historyNote mesh__D018210 Synovitis %28%1966-1981%29%
% 214.67/214.90  |- mesh__dateCreated mesh__D018210 1993-06-25
% 214.67/214.90  |- mesh__recordOriginator mesh__D018210 PLS
% 214.67/214.90  |- skos__historyNote mesh__D018210 Chondroma %28%1966-1993%29%
% 214.67/214.90  |- skos__broader mesh__D018210smesh__D002812
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018210 2006
% 214.67/214.90  |- skos__prefLabel mesh__D018210 Chondromatosis
% 214.67/214.90  |- mesh__dateRevised mesh__D018210 1995-06-08
% 214.67/214.90  |- skos__broader mesh__D009729Q000193smesh__D009729
% 214.67/214.90  |- mesh__preferredCombination mesh__D009729Q000193smesh__D004506
% 214.67/214.90  |- rdf__type mesh__D009729Q000193smesh__CompoundConcept
% 214.67/214.90  |- mesh__dateRevised mesh__D009484 2001-07-25
% 214.67/214.90  |- mesh__dateCreated mesh__D009484 1984-05-01
% 214.67/214.90  |- skos__annotation mesh__D009484
% 214.67/214.90       SPEC: not for coord of NERVOUS SYSTEM DISEASES /psychol; IM, SPEC qualif; NIM coord, no qualif; DF: NEUROPSYCHOL%A%  
% 214.67/214.90  |- skos__scopeNote mesh__D009484
% 214.67/214.90       A branch of psychology which investigates the correlation between experience or behavior and the basic neurophysiological processes. The term neuropsychology stresses the dominant role of the nervous system. It is a more narrowly defined field than physiological psychology or psychophysiology.%A%    
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D009484 2003
% 214.67/214.90  |- rdf__type mesh__D009484sskos__Concept
% 214.67/214.90  |- mesh__dateEstablished mesh__D009484 1985-01-01
% 214.67/214.90  |- mesh__recordAuthorizer mesh__D009484 sjn
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D009484 2005
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D009484 2004
% 214.67/214.90  |- mesh__historyNote mesh__D009484 85   
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D009484 2006
% 214.67/214.90  |- mesh__publicMeSHNote mesh__D009484 85   
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D009484 2002
% 214.67/214.90  |- skos__broader mesh__D009484smesh__D011603
% 214.67/214.90  |- skos__prefLabel mesh__D009484 Neuropsychology
% 214.67/214.90  |- mesh__recordMaintainer mesh__D009484 ssb
% 214.67/214.90  |- skos__hiddenLabel mesh__D009484 Neuropsychologies
% 214.67/214.90  |- mesh__recordOriginator mesh__D009484 EC
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017916 1999
% 214.67/214.90  |- mesh__dateCreated mesh__D017916 1993-06-04
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017916 2005
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017916 1994
% 214.67/214.90  |- skos__scopeNote mesh__D017916
% 214.67/214.90       A family of lipid-containing bacteriophages with double capsids which infect both gram-negative and gram-positive bacteria. It has one genus, Tectivirus.%A%    
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017916 2001
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017916 2004
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017916 1998
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017916 2000
% 214.67/214.90  |- skos__broader mesh__D017916smesh__D004267
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017916 1997
% 214.67/214.90  |- mesh__publicMeSHNote mesh__D017916 94   
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017916 2003
% 214.67/214.90  |- mesh__dateEstablished mesh__D017916 1994-01-01
% 214.67/214.90  |- mesh__historyNote mesh__D017916 94   
% 214.67/214.90  |- skos__annotation mesh__D017916
% 214.67/214.90       a family of lipid-containing bacteriophages   
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017916 1996
% 214.67/214.90  |- skos__hiddenLabel mesh__D017916 Tectiviruses
% 214.67/214.90  |- skos__broader mesh__D017916smesh__D001435
% 214.67/214.90  |- rdf__type mesh__D017916sskos__Concept
% 214.67/214.90  |- skos__prefLabel mesh__D017916 Tectiviridae
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017916 2006
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017916 1995
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017916 2002
% 214.67/214.90  |- mesh__recordMaintainer mesh__D017118 lkt
% 214.67/214.90  |- skos__broader mesh__D017118smesh__D017094
% 214.67/214.90  |- skos__prefLabel mesh__D017118 Porphyria, Acute Intermittent
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017118 2005
% 214.67/214.90  |- mesh__historyNote mesh__D017118 93   
% 214.67/214.90  |- skos__altLabel mesh__D017118 Acute Porphyria
% 214.67/214.90  |- skos__hiddenLabel mesh__D017118 Acute Intermittent Porphyrias
% 214.67/214.90  |- skos__scopeNote mesh__D017118
% 214.67/214.90       An autosomal dominant porphyria that is due to a deficiency of HYDROXYMETHYLBILANE SYNTHASE in the LIVER, the third enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features are recurrent and life-threatening neurologic disturbances, ABDOMINAL PAIN, and elevated level of AMINOLEVULINIC ACID and PORPHOBILINOGEN in the urine.%A%    
% 214.67/214.90  |- skos__hiddenLabel mesh__D017118 Intermittent Porphyrias, Acute
% 214.67/214.90  |- skos__hiddenLabel mesh__D017118 Intermittent Porphyria, Acute
% 214.67/214.90  |- mesh__recordOriginator mesh__D017118 PXP
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017118 2006
% 214.67/214.90  |- skos__historyNote mesh__D017118 Porphyria %28%1966-1992%29%
% 214.67/214.90  |- skos__hiddenLabel mesh__D017118 Acute Intermittent Porphyria
% 214.67/214.90  |- skos__hiddenLabel mesh__D017118 Porphyrias, Acute
% 214.67/214.90  |- mesh__dateRevised mesh__D017118 2004-07-15
% 214.67/214.90  |- mesh__dateEstablished mesh__D017118 1993-01-01
% 214.67/214.90  |- mesh__recordAuthorizer mesh__D017118 sjn
% 214.67/214.90  |- rdf__type mesh__D017118sskos__Concept
% 214.67/214.90  |- skos__hiddenLabel mesh__D017118 Porphyrias, Acute Intermittent
% 214.67/214.90  |- mesh__dateCreated mesh__D017118 1992-05-22
% 214.67/214.90  |- mesh__publicMeSHNote mesh__D017118 93   
% 214.67/214.90  |- skos__hiddenLabel mesh__D017118 Acute Porphyrias
% 214.67/214.90  |- skos__hiddenLabel mesh__D017118 Porphyria, Acute
% 214.67/214.90  |- skos__prefLabel mesh__D005892 Gingivitis, Necrotizing Ulcerative
% 214.67/214.90  |- skos__altLabel mesh__D005892 Trench Mouth
% 214.67/214.90  |- skos__broader mesh__D005892smesh__D007239
% 214.67/214.90  |- mesh__recordAuthorizer mesh__D005892 sjn
% 214.67/214.90  |- skos__altLabel mesh__D005892 Vincent%27%s Infection
% 214.67/214.90  |- mesh__recordMaintainer mesh__D005892 ags
% 214.67/214.90  |- skos__broader mesh__D005892smesh__D005891
% 214.67/214.90  |- skos__hiddenLabel mesh__D005892 Vincents Infection
% 214.67/214.90  |- skos__altLabel mesh__D005892 Vincent Infection
% 214.67/214.90  |- mesh__recordOriginator mesh__D005892 NLM
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005892 2005
% 214.67/214.90  |- skos__hiddenLabel mesh__D005892 Ulcerative Stomatitides
% 214.67/214.90  |- skos__hiddenLabel mesh__D005892 Anginas, Vincent
% 214.67/214.90  |- skos__broader mesh__D005892smesh__D005674
% 214.67/214.90  |- skos__hiddenLabel mesh__D005892 Angina, Vincent
% 214.67/214.90  |- skos__hiddenLabel mesh__D005892 Stomatitides, Ulcerative
% 214.67/214.90  |- skos__hiddenLabel mesh__D005892 Infection, Vincent%27%s
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005892 2006
% 214.67/214.90  |- skos__hiddenLabel mesh__D005892 Ulcerative Stomatitis
% 214.67/214.90  |- skos__hiddenLabel mesh__D005892 Ulcerative Gingivitis, Necrotizing
% 214.67/214.90  |- mesh__historyNote mesh__D005892
% 214.67/214.90       73; was VINCENT%27%S INFECTIONS 1963-72   
% 214.67/214.90  |- skos__scopeNote mesh__D005892
% 214.67/214.90       An acute or chronic GINGIVITIS characterized by redness and swelling, NECROSIS extending from the interdental papillae along the gingival margins, PAIN; HEMORRHAGE, necrotic odor, and often a pseudomembrane. The condition may extend to the ORAL MUCOSA; TONGUE; PALATE; or PHARYNX. The etiology is somewhat unclear, but may involve a complex of FUSOBACTERIUM NUCLEATUM along with spirochetes BORRELIA or TREPONEMA.%A%    
% 214.67/214.90  |- skos__hiddenLabel mesh__D005892 Infection, Vincent
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005892 2004
% 214.67/214.90  |- mesh__dateEstablished mesh__D005892 1973-01-01
% 214.67/214.90  |- mesh__dateRevised mesh__D005892 2003-07-09
% 214.67/214.90  |- rdf__type mesh__D005892sskos__Concept
% 214.67/214.90  |- skos__hiddenLabel mesh__D005892 Mouth, Trench
% 214.67/214.90  |- mesh__publicMeSHNote mesh__D005892
% 214.67/214.90       73; was VINCENT%27%S INFECTION 1963-72   
% 214.67/214.90  |- mesh__onlineNote mesh__D005892
% 214.67/214.90       use GINGIVITIS, NECROTIZING ULCERATIVE to search VINCENT%27%S INFECTION 1966-72%A%  
% 214.67/214.90  |- skos__hiddenLabel mesh__D005892 Necrotizing Ulcerative Gingivitis
% 214.67/214.90  |- mesh__dateCreated mesh__D005892 1999-01-01
% 214.67/214.90  |- mesh__recordOriginator mesh__D005094 NLM
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005094 2000
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005094 1997
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005094 2003
% 214.67/214.90  |- mesh__dateCreated mesh__D005094 1999-01-01
% 214.67/214.90  |- skos__hiddenLabel mesh__D005094 Proptoses
% 214.67/214.90  |- skos__broader mesh__D005094smesh__D009916
% 214.67/214.90  |- skos__annotation mesh__D005094
% 214.67/214.90       protrusion of eye: do not confuse with ENOPHTHALMOS, recession%A%  
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005094 1996
% 214.67/214.90  |- mesh__recordAuthorizer mesh__D005094 PLS
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005094 2006
% 214.67/214.90  |- skos__scopeNote mesh__D005094
% 214.67/214.90       Abnormal protrusion of both eyes; may be caused by endocrine gland malfunction, malignancy, injury, or paralysis of the extrinsic muscles of the eye.%A%    
% 214.67/214.90  |- mesh__dateRevised mesh__D005094 1993-05-27
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005094 2002
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005094 1999
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005094 2005
% 214.67/214.90  |- skos__prefLabel mesh__D005094 Exophthalmos
% 214.67/214.90  |- mesh__recordMaintainer mesh__D005094 TGC
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005094 1995
% 214.67/214.90  |- skos__altLabel mesh__D005094 Proptosis
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005094 1998
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005094 1994
% 214.67/214.90  |- rdf__type mesh__D005094sskos__Concept
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005094 2001
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005094 2004
% 214.67/214.90  |- skos__broader mesh__D003933Q000379smesh__D003933
% 214.67/214.90  |- mesh__preferredCombination mesh__D003933Q000379smesh__D019937
% 214.67/214.90  |- rdf__type mesh__D003933Q000379smesh__CompoundConcept
% 214.67/214.90  |- rdf__type mesh__D013526sskos__Concept
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D013526 2003
% 214.67/214.90  |- skos__altLabel mesh__D013526 Surgical Meshes
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D013526 2003A
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D013526 1998
% 214.67/214.90  |- skos__prefLabel mesh__D013526 Surgical Mesh
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D013526 2000
% 214.67/214.90  |- skos__altLabel mesh__D013526 Meshes, Surgical
% 214.67/214.90  |- mesh__recordOriginator mesh__D013526 NLM
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D013526 2006
% 214.67/214.90  |- skos__scopeNote mesh__D013526
% 214.67/214.90       Any woven or knit material of open texture used in surgery for the repair, reconstruction, or substitution of tissue. The mesh is usually a synthetic fabric made of various polymers. It is occasionally made of metal.%A%    
% 214.67/214.90  |- skos__broader mesh__D013526smesh__D013523
% 214.67/214.90  |- mesh__recordAuthorizer mesh__D013526 sjn
% 214.67/214.90  |- skos__altLabel mesh__D013526 Mesh, Surgical
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D013526 2005
% 214.67/214.90  |- mesh__dateCreated mesh__D013526 1999-01-01
% 214.67/214.90  |- mesh__dateRevised mesh__D013526 2002-10-23
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D013526 2002
% 214.67/214.90  |- mesh__recordMaintainer mesh__D013526 sjn
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D013526 2004
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D013526 1999
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D013526 2001
% 214.67/214.90  |- skos__scopeNote mesh__D018211
% 214.67/214.90       A rare aggressive variant of chondrosarcoma, characterized by a biphasic histologic pattern of small compact cells intermixed with islands of cartilaginous matrix. Mesenchymal chondrosarcomas have a predilection for flat bones; long tubular bones are rarely affected. They tend to occur in the younger age group and are highly metastatic. %28%DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1456%29%%A%    
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018211 2003
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018211 1999
% 214.67/214.90  |- rdf__type mesh__D018211sskos__Concept
% 214.67/214.90  |- skos__prefLabel mesh__D018211 Chondrosarcoma, Mesenchymal
% 214.67/214.90  |- mesh__dateCreated mesh__D018211 1993-06-25
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018211 2004
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018211 1996
% 214.67/214.90  |- skos__historyNote mesh__D018211 Mesenchymoma %28%1966-1991%29%
% 214.67/214.90  |- skos__hiddenLabel mesh__D018211 Chondrosarcomas, Mesenchymal
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018211 2002
% 214.67/214.90  |- skos__broader mesh__D018211smesh__D002813
% 214.67/214.90  |- skos__annotation mesh__D018211
% 214.67/214.90       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS %28%IM%29% or specific precoord bone/neopl term %28%IM%29% or specific bone %28%IM%29% + BONE NEOPLASMS %28%IM%29%%A%  
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018211 1997
% 214.67/214.90  |- mesh__publicMeSHNote mesh__D018211 94   
% 214.67/214.90  |- mesh__recordAuthorizer mesh__D018211 PLS
% 214.67/214.90  |- mesh__recordMaintainer mesh__D018211 KEV
% 214.67/214.90  |- mesh__historyNote mesh__D018211 94   
% 214.67/214.90  |- skos__hiddenLabel mesh__D018211 Mesenchymal Chondrosarcoma
% 214.67/214.90  |- skos__hiddenLabel mesh__D018211 Mesenchymal Chondrosarcomas
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018211 2000
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018211 2005
% 214.67/214.90  |- mesh__recordOriginator mesh__D018211 PLS
% 214.67/214.90  |- mesh__dateEstablished mesh__D018211 1994-01-01
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018211 2006
% 214.67/214.90  |- mesh__dateRevised mesh__D018211 1995-06-08
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018211 1998
% 214.67/214.90  |- skos__historyNote mesh__D018211 Chondrosarcoma %28%1966-1993%29%
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018211 2001
% 214.67/214.90  |- skos__annotation mesh__D009485
% 214.67/214.90       GEN or technical only: not coord for specific nerve /radiogr; NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: NEURORADIOGR%A%  
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D009485 2003
% 214.67/214.90  |- mesh__recordAuthorizer mesh__D009485 SJN
% 214.67/214.90  |- mesh__recordMaintainer mesh__D009485 PXP
% 214.67/214.90  |- mesh__recordOriginator mesh__D009485 NLM
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D009485 2004
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D009485 1998
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D009485 2005
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D009485 2000
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D009485 1999
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D009485 2006
% 214.67/214.90  |- skos__hiddenLabel mesh__D009485 Neuroradiographies
% 214.67/214.90  |- mesh__dateCreated mesh__D009485 1999-01-01
% 214.67/214.90  |- mesh__publicMeSHNote mesh__D009485 73   
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D009485 2001
% 214.67/214.90  |- mesh__dateEstablished mesh__D009485 1973-01-01
% 214.67/214.90  |- mesh__historyNote mesh__D009485 73   
% 214.67/214.90  |- skos__broader mesh__D009485smesh__D011859
% 214.67/214.90  |- skos__scopeNote mesh__D009485
% 214.67/214.90       Radiography of the central nervous system.     
% 214.67/214.90  |- skos__prefLabel mesh__D009485 Neuroradiography
% 214.67/214.90  |- mesh__dateRevised mesh__D009485 1997-06-20
% 214.67/214.90  |- skos__historyNote mesh__D009485 Radiography %28%1966-1972%29%
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D009485 2002
% 214.67/214.90  |- skos__broader mesh__D009485smesh__D003943
% 214.67/214.90  |- rdf__type mesh__D009485sskos__Concept
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017917 2003
% 214.67/214.90  |- mesh__historyNote mesh__D017917 94   
% 214.67/214.90  |- skos__scopeNote mesh__D017917
% 214.67/214.90       A genus of HEPADNAVIRIDAE infecting birds but rarely causing clinical problems. Transmission is predominantly vertical. HEPATITIS B VIRUS, DUCK is the type species.%A%    
% 214.67/214.90  |- mesh__recordAuthorizer mesh__D017917 PLS
% 214.67/214.90  |- mesh__recordMaintainer mesh__D017917 AGS
% 214.67/214.90  |- rdf__type mesh__D017917sskos__Concept
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017917 2002
% 214.67/214.90  |- mesh__dateCreated mesh__D017917 1993-06-04
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017917 2006
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017917 2001
% 214.67/214.90  |- mesh__dateRevised mesh__D017917 1996-06-10
% 214.67/214.90  |- skos__prefLabel mesh__D017917 Avihepadnavirus
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017917 1999
% 214.67/214.90  |- mesh__recordOriginator mesh__D017917 AGS
% 214.67/214.90  |- mesh__dateEstablished mesh__D017917 1994-01-01
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017917 2000
% 214.67/214.90  |- skos__broader mesh__D017917smesh__D015613
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017917 2005
% 214.67/214.90  |- skos__annotation mesh__D017917
% 214.67/214.90       from AVIan HEPAtotropic DNA virus; a genus of the family Hepadnaviridae infecting birds; infection: coord IM with HEPADNAVIRIDAE INFECTIONS %28%IM%29%%A%  
% 214.67/214.90  |- mesh__publicMeSHNote mesh__D017917 94   
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017917 2004
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017917 1998
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017917 1997
% 214.67/214.90  |- skos__hiddenLabel mesh__D017917 Avihepadnaviruses
% 214.67/214.90  |- mesh__onlineNote mesh__D017119
% 214.67/214.90       use PORPHYRIA CUTANEA TARDA to search PORPHYRIA, CUTANEA TARDA 1993-94%A%  
% 214.67/214.90  |- mesh__recordOriginator mesh__D017119 PXP
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017119 2006
% 214.67/214.90  |- skos__prefLabel mesh__D017119 Porphyria Cutanea Tarda
% 214.67/214.90  |- mesh__recordMaintainer mesh__D017119 lkt
% 214.67/214.90  |- skos__broader mesh__D017119smesh__D017094
% 214.67/214.90  |- mesh__historyNote mesh__D017119
% 214.67/214.90       95; was PORPHYRIA, CUTANEA TARDA 1993-94   
% 214.67/214.90  |- rdf__type mesh__D017119sskos__Concept
% 214.67/214.90  |- mesh__publicMeSHNote mesh__D017119
% 214.67/214.90       95; was PORPHYRIA, CUTANEA TARDA 1993-94   
% 214.67/214.90  |- skos__historyNote mesh__D017119 Porphyria %28%1966-1992%29%
% 214.67/214.90  |- mesh__dateRevised mesh__D017119 2004-07-15
% 214.67/214.90  |- mesh__dateEstablished mesh__D017119 1993-01-01
% 214.67/214.90  |- mesh__recordAuthorizer mesh__D017119 sjn
% 214.67/214.90  |- mesh__dateCreated mesh__D017119 1992-05-22
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D017119 2005
% 214.67/214.90  |- skos__scopeNote mesh__D017119
% 214.67/214.90       An autosomal dominant or acquired porphyria due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in the LIVER. It is characterized by photosensitivity and cutaneous lesions with little or no neurologic symptoms. Type I is the acquired form and is strongly associated with liver diseases and hepatic toxicities caused by alcohol or estrogenic steroids. Type II is the familial form.%A%    
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005893 2005
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005893 2002
% 214.67/214.90  |- mesh__dateEstablished mesh__D005893 1965-01-01
% 214.67/214.90  |- skos__broader mesh__D005893smesh__D019647
% 214.67/214.90  |- mesh__publicMeSHNote mesh__D005893 65   
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005893 2003
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005893 2006
% 214.67/214.90  |- skos__prefLabel mesh__D005893 Gingivoplasty
% 214.67/214.90  |- mesh__recordAuthorizer mesh__D005893 SJN
% 214.67/214.90  |- skos__hiddenLabel mesh__D005893 Gingivoplasties
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005893 1998
% 214.67/214.90  |- mesh__recordOriginator mesh__D005893 NLM
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005893 2004
% 214.67/214.90  |- skos__broader mesh__D005893smesh__D010517
% 214.67/214.90  |- mesh__historyNote mesh__D005893 65   
% 214.67/214.90  |- rdf__type mesh__D005893sskos__Concept
% 214.67/214.90  |- skos__scopeNote mesh__D005893
% 214.67/214.90       Surgical reshaping of the gingivae and papillae for correction of deformities %28%particularly enlargements%29% and to provide the gingivae with a normal and functional form, the incision creating an external bevel. %28%Dorland, 28th ed%29%%A%    
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005893 1999
% 214.67/214.90  |- mesh__recordMaintainer mesh__D005893 PXP
% 214.67/214.90  |- mesh__dateCreated mesh__D005893 1999-01-01
% 214.67/214.90  |- skos__annotation mesh__D005893
% 214.67/214.90       do not use /util except by MeSH definition   
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005893 2000
% 214.67/214.90  |- mesh__dateRevised mesh__D005893 1997-06-20
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005893 2001
% 214.67/214.90  |- mesh__historyNote mesh__D005095 83   
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005095 2006
% 214.67/214.90  |- skos__scopeNote mesh__D005095
% 214.67/214.90       A family of enzymes that catalyze the exonucleolytic cleavage of RNA. It includes EC 3.1.13.-, EC 3.1.14.-, EC 3.1.15.-, and EC 3.1.16.-. EC 3.1.-%A%    
% 214.67/214.90  |- mesh__recordAuthorizer mesh__D005095 sjn
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005095 2005
% 214.67/214.90  |- mesh__recordMaintainer mesh__D005095 ssb
% 214.67/214.90  |- skos__broader mesh__D005095smesh__D005092
% 214.67/214.90  |- mesh__recordOriginator mesh__D005095 RLS
% 214.67/214.90  |- mesh__dateRevised mesh__D005095 2003-07-09
% 214.67/214.90  |- mesh__dateCreated mesh__D005095 1982-04-30
% 214.67/214.90  |- skos__historyNote mesh__D005095 Ribonucleases %28%1966-1982%29%
% 214.67/214.90  |- rdf__type mesh__D005095sskos__Concept
% 214.67/214.90  |- skos__historyNote mesh__D005095 Phosphatases %28%1966-1972%29%
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D005095 2004
% 214.67/214.90  |- skos__broader mesh__D005095smesh__D012260
% 214.67/214.90  |- skos__historyNote mesh__D005095 Exonucleases %28%1973-1982%29%
% 214.67/214.90  |- skos__prefLabel mesh__D005095 Exoribonucleases
% 214.67/214.90  |- mesh__publicMeSHNote mesh__D005095 83   
% 214.67/214.90  |- mesh__dateEstablished mesh__D005095 1983-01-01
% 214.67/214.90  |- rdf__type mesh__D013527sskos__Concept
% 214.67/214.90  |- skos__related mesh__D013527smesh__D016528
% 214.67/214.90  |- mesh__recordAuthorizer mesh__D013527 sjn
% 214.67/214.90  |- skos__altLabel mesh__D013527 Surgical Nursing
% 214.67/214.90  |- skos__annotation mesh__D013527
% 214.67/214.90       a nurs SPEC; OPERATING ROOM NURSING is also available; DF: PERIOP NURS%A%  
% 214.67/214.90  |- skos__altLabel mesh__D013527 Nursing, Surgical
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D013527 2000
% 214.67/214.90  |- mesh__onlineNote mesh__D013527
% 214.67/214.90       use PERIOPERATIVE NURSING to search SURGICAL NURSING 1968-95; use OPERATING ROOM NURSING to search PERIOPERATIVE NURSING 1988-95%A%  
% 214.67/214.90  |- skos__historyNote mesh__D013527
% 214.67/214.90       Surgical Procedures, Operative %28%1966-1967%29%
% 214.67/214.90  |- skos__scopeNote mesh__D013527
% 214.67/214.90       Nursing care of the surgical patient before, during, and after surgery.%A%    
% 214.67/214.90  |- mesh__dateCreated mesh__D013527 1999-01-01
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D013527 2005
% 214.67/214.90  |- mesh__dateRevised mesh__D013527 1999-11-03
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D013527 2001
% 214.67/214.90  |- skos__related mesh__D013527smesh__D009871
% 214.67/214.90  |- skos__broader mesh__D013527smesh__D013041
% 214.67/214.90  |- skos__broader mesh__D013527smesh__D009732
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D013527 2006
% 214.67/214.90  |- skos__historyNote mesh__D013527 Operating Rooms %28%1966-1967%29%
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D013527 2003
% 214.67/214.90  |- mesh__recordMaintainer mesh__D013527 ndw
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D013527 2002
% 214.67/214.90  |- skos__broader mesh__D013527smesh__D019990
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D013527 2004
% 214.67/214.90  |- mesh__publicMeSHNote mesh__D013527
% 214.67/214.90       96; was SURGICAL NURSING 1968-95; PERIOPERATIVE NURSING was see OPERATING ROOM NURSING 1988-95%A%  
% 214.67/214.90  |- skos__historyNote mesh__D013527 Nursing Care %28%1966-1967%29%
% 214.67/214.90  |- mesh__historyNote mesh__D013527
% 214.67/214.90       96; was SURGICAL NURSING 1968-95; PERIOPERATIVE NURSING was see OPERATING ROOM NURSING 1988-95%A%  
% 214.67/214.90  |- mesh__dateEstablished mesh__D013527 1968-01-01
% 214.67/214.90  |- mesh__recordOriginator mesh__D013527 NLM
% 214.67/214.90  |- skos__prefLabel mesh__D013527 Perioperative Nursing
% 214.67/214.90  |- skos__altLabel mesh__D013527 Nursing, Perioperative
% 214.67/214.90  |- rdf__type mesh__D018212sskos__Concept
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018212 2004
% 214.67/214.90  |- skos__prefLabel mesh__D018212 Giant Cell Tumor of Bone
% 214.67/214.90  |- mesh__dateCreated mesh__D018212 1993-07-02
% 214.67/214.90  |- mesh__dateEstablished mesh__D018212 1994-01-01
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018212 1996
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018212 2001
% 214.67/214.90  |- skos__broader mesh__D018212smesh__D005870
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018212 1997
% 214.67/214.90  |- skos__broader mesh__D018212smesh__D018213
% 214.67/214.90  |- skos__historyNote mesh__D018212 Bone Neoplasms %28%1966-1993%29%
% 214.67/214.90  |- skos__historyNote mesh__D018212 Giant Cell Tumors %28%1966-1993%29%
% 214.67/214.90  |- mesh__recordMaintainer mesh__D018212 KEV
% 214.67/214.90  |- mesh__activeMeSHYear mesh__D018212 2005
% 214.67/214.91  |- mesh__historyNote mesh__D018212 94   
% 214.67/214.91  |- mesh__activeMeSHYear mesh__D018212 2002
% 214.67/214.91  |- mesh__activeMeSHYear mesh__D018212 2006
% 214.67/214.91  |- mesh__recordOriginator mesh__D018212 PLS
% 214.67/214.91  |- mesh__activeMeSHYear mesh__D018212 1998
% 214.67/214.91  |- mesh__publicMeSHNote mesh__D018212 94   
% 214.67/214.91  |- mesh__recordAuthorizer mesh__D018212 PLS
% 214.67/214.91  |- mesh__dateRevised mesh__D018212 1995-06-08
% 214.67/214.91  |- skos__scopeNote mesh__D018212
% 214.67/214.91       A bone tumor composed of cellular spindle-cell stroma containing scattered multinucleated giant cells resembling osteoclasts. The tumors range from benign to frankly malignant lesions. The tumor occurs most frequently in an end of a long tubular bone in young adults. %28%From Dorland, 27th ed; Stedman, 25th ed%29%%A%    
% 214.67/214.91  |- mesh__activeMeSHYear mesh__D018212 2003
% 214.67/214.91  |- mesh__activeMeSHYear mesh__D018212 1999
% 214.67/214.91  |- skos__annotation mesh__D018212
% 214.67/214.91       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS %28%IM%29% or specific precoord bone/neopl term %28%IM%29% or specific bone %28%IM%29% + BONE NEOPLASMS %28%IM%29%; osteoblastoclastoma: coord IM with OSTEOBLASTOMA %28%IM%29% + organ/neopl coords %28%IM%29%%A%  
% 214.67/214.91  |- mesh__activeMeSHYear mesh__D018212 2000
% 214.67/214.91  |- rdf__type mesh__D017918sskos__Concept
% 214.67/214.91  |- mesh__activeMeSHYear mesh__D017918 2006
% 214.67/214.91  |- skos__prefLabel mesh__D017918 Orthohepadnavirus
% 214.67/214.91  |- mesh__recordAuthorizer mesh__D017918 sjn
% 214.67/214.91  |- mesh__activeMeSHYear mesh__D017918 2005
% 214.67/214.91  |- mesh__dateRevised mesh__D017918 2004-07-13
% 214.67/214.91  |- skos__scopeNote mesh__D017918
% 214.67/214.91        A genus of HEPADNAVIRIDAE causing hepatitis in humans, woodchucks %28% HEPATITIS B VIRUS, WOODCHUCK%29% and ground squirrels. hepatitis b virus is the type species.%A%    
% 214.67/214.91  |- mesh__dateCreated mesh__D017918 1993-06-04
% 214.67/214.91  |- skos__altLabel mesh__D017918 Ground squirrel hepatitis B virus
% 214.67/214.91  |- mesh__recordMaintainer mesh__D017918 sjn
% 214.67/214.91  |- skos__annotation mesh__D017918
% 214.67/214.91       infection: coord IM with HEPATITIS, VIRAL, HUMAN %28%IM%29% or HEPATITIS, VIRAL, ANIMAL %28%IM%29% + HEPADNAVIRIDAE INFECTIONS %28%IM%29%%A%  
% 214.67/214.91  |- mesh__recordOriginator mesh__D017918 AGS
% 214.67/214.91  |- skos__hiddenLabel mesh__D017918 Orthohepadnaviruses
% 214.67/214.91  |- mesh__dateEstablished mesh__D017918 1994-01-01
% 214.67/214.91  |- skos__broader mesh__D017918smesh__D015613
% 214.67/214.91  |- mesh__historyNote mesh__D017918 94   
% 214.67/214.91  |- mesh__publicMeSHNote mesh__D017918 94   
% 214.67/214.91  |- mesh__recordMaintainer mesh__D014620 PXP
% 214.67/214.91  |- skos__hiddenLabel mesh__D014620 Extraction, Obstetric Vacuum
% 214.67/214.91  |- skos__altLabel mesh__D014620 Delivery, Vacuum Extraction
% 214.67/214.91  |- skos__hiddenLabel mesh__D014620 Extraction Deliveries, Vacuum
% 214.67/214.91  |- skos__annotation mesh__D014620
% 214.67/214.91       removal of fetus from uterus at delivery; do not use /util except by MeSH definition%A%  
% 214.67/214.91  |- skos__hiddenLabel mesh__D014620 Extraction, Obstetrical Vacuum
% 214.67/214.91  |- mesh__activeMeSHYear mesh__D014620 2003
% 214.67/214.91  |- skos__hiddenLabel mesh__D014620 Vacuum Extraction Deliveries
% 214.67/214.91  |- mesh__dateCreated mesh__D014620 1999-01-01
% 214.67/214.91  |- mesh__recordOriginator mesh__D014620 NLM
% 214.67/214.91  |- mesh__dateEstablished mesh__D014620 1991-01-01
% 214.67/214.91  |- skos__broader mesh__D014620smesh__D005113
% 214.67/214.91  |- skos__hiddenLabel mesh__D014620 Obstetric Vacuum Extractions
% 214.67/214.91  |- mesh__activeMeSHYear mesh__D014620 2004
% 214.67/214.91  |- rdf__type mesh__D014620sskos__Concept
% 214.67/214.91  |- mesh__recordAuthorizer mesh__D014620 sjn
% 214.67/214.91  |- skos__hiddenLabel mesh__D014620 Obstetric Vacuum Extraction
% 214.67/214.91  |- mesh__activeMeSHYear mesh__D014620 2005
% 214.67/214.91  |- skos__altLabel mesh__D014620 Vacuum Extraction, Obstetric
% 214.67/214.91  |- skos__scopeNote mesh__D014620
% 214.67/214.91       Removal of the fetus from the uterus or vagina at or near the end of pregnancy with a metal traction cup that is attached to the fetus%27% head. Negative pressure is applied and traction is made on a chain passed through the suction tube. %28%From Stedman, 26th ed %26% Dorland, 28th ed%29%%A%    
% 214.67/214.91  |- skos__hiddenLabel mesh__D014620 Obstetrical Vacuum Extraction
% 214.67/214.91  |- mesh__onlineNote mesh__D014620 search EXTRACTION, OBSTETRICAL 1966-74   
% 214.67/214.91  |- skos__hiddenLabel mesh__D014620 Vacuum Extraction Delivery
% 214.67/214.91  |- skos__hiddenLabel mesh__D014620 Vacuum Extractions, Obstetrical
% 214.67/214.91  |- mesh__activeMeSHYear mesh__D014620 2006
% 214.67/214.91  |- mesh__publicMeSHNote mesh__D014620
% 214.67/214.91       91; was see under EXTRACTION, OBSTETRICAL 1975-90   
% 214.67/214.91  |- skos__hiddenLabel mesh__D014620 Obstetrical Vacuum Extractions
% 214.67/214.91  |- mesh__historyNote mesh__D014620
% 214.67/214.91       91%28%75%29%; was see under EXTRACTION, OBSTETRICAL 1975-90   
% 214.67/214.91  |- skos__hiddenLabel mesh__D014620 Extraction Delivery, Vacuum
% 214.67/214.91  |- skos__prefLabel mesh__D014620 Vacuum Extraction, Obstetrical
% 214.67/214.91  |- skos__hiddenLabel mesh__D014620 Deliveries, Vacuum Extraction
% 214.67/214.91  |- skos__hiddenLabel mesh__D014620 Extractions, Obstetrical Vacuum
% 214.67/214.91  |- skos__hiddenLabel mesh__D014620 Extractions, Obstetric Vacuum
% 214.76/214.91  |- mesh__dateRevised mesh__D014620 2002-07-03
% 214.76/214.91  |- skos__hiddenLabel mesh__D014620 Vacuum Extractions, Obstetric
% 214.76/214.91  |- skos__broader mesh__D000600smesh__D000596
% 214.76/214.91  |- mesh__publicMeSHNote mesh__D000600 74   
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D000600 2000
% 214.76/214.91  |- mesh__historyNote mesh__D000600 74   
% 214.76/214.91  |- rdf__type mesh__D000600sskos__Concept
% 214.76/214.91  |- skos__hiddenLabel mesh__D000600 Acids, Dicarboxylic Amino
% 214.76/214.91  |- mesh__recordOriginator mesh__D000600 NLM
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D000600 1995
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D000600 1993
% 214.76/214.91  |- mesh__dateRevised mesh__D000600 1992-05-07
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D000600 1999
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D000600 1994
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D000600 2006
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D000600 2002
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D000600 1997
% 214.76/214.91  |- skos__altLabel mesh__D000600 Dicarboxylic Amino Acids
% 214.76/214.91  |- mesh__recordMaintainer mesh__D000600 TAP
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D000600 2004
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D000600 1998
% 214.76/214.91  |- mesh__dateCreated mesh__D000600 1999-01-01
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D000600 2005
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D000600 1996
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D000600 2003
% 214.76/214.91  |- skos__prefLabel mesh__D000600 Amino Acids, Dicarboxylic
% 214.76/214.91  |- mesh__dateEstablished mesh__D000600 1974-01-01
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D000600 2001
% 214.76/214.91  |- mesh__recordAuthorizer mesh__D000600 PLS
% 214.76/214.91  |- skos__annotation mesh__D005894
% 214.76/214.91       do not confuse X ref GINSENG with SIBERIAN GINSENG see Eleutherococcus; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.76/214.91  |- skos__altLabel mesh__D005894 Jen Shen
% 214.76/214.91  |- skos__prefLabel mesh__D005894 Panax
% 214.76/214.91  |- mesh__dateRevised mesh__D005894 2001-07-25
% 214.76/214.91  |- skos__broader mesh__D005894smesh__D027481
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005894 2004
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005894 2006
% 214.76/214.91  |- mesh__dateCreated mesh__D005894 1999-01-01
% 214.76/214.91  |- skos__scopeNote mesh__D005894
% 214.76/214.91       An araliaceous genus of plants that contains a number of pharmacologically active agents used as stimulants, sedatives, and tonics, especially in traditional medicine.  Sometimes confused with Siberian ginseng %28%ELEUTHEROCOCCUS%29%.%A%    
% 214.76/214.91  |- skos__altLabel mesh__D005894 Ginseng
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005894 2003
% 214.76/214.91  |- mesh__recordAuthorizer mesh__D005894 sjn
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005894 2005
% 214.76/214.91  |- skos__altLabel mesh__D005894 Shinseng
% 214.76/214.91  |- mesh__recordOriginator mesh__D005894 NLM
% 214.76/214.91  |- skos__altLabel mesh__D005894 Renshen
% 214.76/214.91  |- rdf__type mesh__D005894sskos__Concept
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005894 2002
% 214.76/214.91  |- skos__altLabel mesh__D005894 Ninjin
% 214.76/214.91  |- skos__altLabel mesh__D005894 Schinseng
% 214.76/214.91  |- mesh__recordMaintainer mesh__D005894 ssb
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005096 2002
% 214.76/214.91  |- skos__scopeNote mesh__D005096
% 214.76/214.91       Benign hypertrophy that projects outward from the surface of bone, often containing a cartilaginous component.%A%    
% 214.76/214.91  |- mesh__recordMaintainer mesh__D005096 TGC
% 214.76/214.91  |- rdf__type mesh__D005096sskos__Concept
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005096 2004
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005096 2001
% 214.76/214.91  |- mesh__dateCreated mesh__D005096 1999-01-01
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005096 2003
% 214.76/214.91  |- skos__altLabel mesh__D005096 Exostosis
% 214.76/214.91  |- skos__annotation mesh__D005096
% 214.76/214.91       cartilaginous %26% osteocartilaginous exostoses: index under OSTEOCHONDROMA; EXOSTOSES, MULTIPLE HEREDITARY is also available%A%  
% 214.76/214.91  |- mesh__recordAuthorizer mesh__D005096 sjn
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005096 2000
% 214.76/214.91  |- mesh__recordOriginator mesh__D005096 NLM
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005096 2006
% 214.76/214.91  |- skos__prefLabel mesh__D005096 Exostoses
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005096 2005
% 214.76/214.91  |- mesh__dateRevised mesh__D005096 1999-11-03
% 214.76/214.91  |- skos__broader mesh__D005096smesh__D015576
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D013528 2002
% 214.76/214.91  |- skos__scopeNote mesh__D013528
% 214.76/214.91       Fastening devices composed of steel-tantalum alloys used to close operative wounds, especially of the skin, which minimizes infection by not introducing a foreign body that would connect external and internal regions of the body. %28%From Segen, Current Med Talk, 1995%29%%A%    
% 214.76/214.91  |- skos__altLabel mesh__D013528 Staplers, Surgical
% 214.76/214.91  |- mesh__dateCreated mesh__D013528 1999-01-01
% 214.76/214.91  |- skos__altLabel mesh__D013528 Stapler, Surgical
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D013528 2005
% 214.76/214.91  |- mesh__recordOriginator mesh__D013528 NLM
% 214.76/214.91  |- mesh__recordMaintainer mesh__D013528 PXP
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D013528 2006
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D013528 2000
% 214.76/214.91  |- mesh__dateRevised mesh__D013528 1997-06-20
% 214.76/214.91  |- mesh__dateEstablished mesh__D013528 1966-01-01
% 214.76/214.91  |- mesh__recordAuthorizer mesh__D013528 SJN
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D013528 2003
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D013528 1998
% 214.76/214.91  |- skos__broader mesh__D013528smesh__D013525
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D013528 2001
% 214.76/214.91  |- skos__prefLabel mesh__D013528 Surgical Staplers
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D013528 2004
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D013528 1999
% 214.76/214.91  |- mesh__publicMeSHNote mesh__D013528 66   
% 214.76/214.91  |- mesh__historyNote mesh__D013528 66%28%64%29%   
% 214.76/214.91  |- rdf__type mesh__D013528sskos__Concept
% 214.76/214.91  |- skos__altLabel mesh__D013528 Surgical Stapler
% 214.76/214.91  |- skos__hiddenLabel mesh__D018213 Bony Tissue Neoplasm
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D018213 2005
% 214.76/214.91  |- mesh__historyNote mesh__D018213 94   
% 214.76/214.91  |- mesh__publicMeSHNote mesh__D018213 94   
% 214.76/214.91  |- skos__hiddenLabel mesh__D018213 Tissue Neoplasm, Bony
% 214.76/214.91  |- skos__historyNote mesh__D018213 Bone Neoplasms %28%1966-1993%29%
% 214.76/214.91  |- mesh__recordAuthorizer mesh__D018213 PLS
% 214.76/214.91  |- skos__prefLabel mesh__D018213 Neoplasms, Bone Tissue
% 214.76/214.91  |- skos__hiddenLabel mesh__D018213 Tissue Neoplasms, Bony
% 214.76/214.91  |- skos__altLabel mesh__D018213 Bony Tissue Neoplasms
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D018213 2006
% 214.76/214.91  |- mesh__recordOriginator mesh__D018213 PLS
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D018213 1998
% 214.76/214.91  |- mesh__dateEstablished mesh__D018213 1994-01-01
% 214.76/214.91  |- skos__hiddenLabel mesh__D018213 Neoplasm, Bony Tissue
% 214.76/214.91  |- mesh__recordMaintainer mesh__D018213 TGC
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D018213 2000
% 214.76/214.91  |- skos__broader mesh__D018213smesh__D009372
% 214.76/214.91  |- skos__scopeNote mesh__D018213
% 214.76/214.91       Neoplasms composed of bony tissue, whether normal or of a soft tissue which has become ossified. The concept does not refer to neoplasms located in bones.%A%    
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D018213 2003
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D018213 1999
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D018213 2001
% 214.76/214.91  |- skos__hiddenLabel mesh__D018213 Tissue Neoplasm, Bone
% 214.76/214.91  |- rdf__type mesh__D018213sskos__Concept
% 214.76/214.91  |- skos__altLabel mesh__D018213 Neoplasms, Bony Tissue
% 214.76/214.91  |- skos__hiddenLabel mesh__D018213 Tissue Neoplasms, Bone
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D018213 2004
% 214.76/214.91  |- mesh__dateCreated mesh__D018213 1993-06-25
% 214.76/214.91  |- skos__altLabel mesh__D018213 Bone Tissue Neoplasms
% 214.76/214.91  |- skos__annotation mesh__D018213
% 214.76/214.91       neoplasms composed of bone tissue, NOT neoplasms located in bones %28% = BONE NEOPLASMS%29%: TN 135; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; restricted use: Manual 24.2.2.5; DF: NEOPL BONE TISSUE%A%  
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D018213 1997
% 214.76/214.91  |- mesh__dateRevised mesh__D018213 1996-06-10
% 214.76/214.91  |- skos__hiddenLabel mesh__D018213 Bone Tissue Neoplasm
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D018213 2002
% 214.76/214.91  |- skos__hiddenLabel mesh__D018213 Neoplasm, Bone Tissue
% 214.76/214.91  |- skos__scopeNote mesh__D010230
% 214.76/214.91       Gram-negative non-motile bacteria found in soil or brines.%A%    
% 214.76/214.91  |- mesh__publicMeSHNote mesh__D010230 76   
% 214.76/214.91  |- skos__broader mesh__D010230smesh__D016946
% 214.76/214.91  |- skos__broader mesh__D010230smesh__D041902
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D010230 2006
% 214.76/214.91  |- mesh__dateEstablished mesh__D010230 1976-01-01
% 214.76/214.91  |- mesh__recordOriginator mesh__D010230 JW
% 214.76/214.91  |- mesh__recordAuthorizer mesh__D010230 sjn
% 214.76/214.91  |- mesh__recordMaintainer mesh__D010230 SYSTEM
% 214.76/214.91  |- mesh__dateCreated mesh__D010230 1975-07-23
% 214.76/214.91  |- mesh__dateRevised mesh__D010230 2005-06-30
% 214.76/214.91  |- skos__historyNote mesh__D010230 Micrococcus %28%1966-1975%29%
% 214.76/214.91  |- mesh__historyNote mesh__D010230 76   
% 214.76/214.91  |- rdf__type mesh__D010230sskos__Concept
% 214.76/214.91  |- skos__prefLabel mesh__D010230 Paracoccus
% 214.76/214.91  |- skos__altLabel mesh__D017919 Woodchuck Hepatitis B Virus
% 214.76/214.91  |- mesh__dateEstablished mesh__D017919 1994-01-01
% 214.76/214.91  |- skos__annotation mesh__D017919
% 214.76/214.91       a member of the genus Orthohepadnavirus; infection: coord IM with HEPATITIS B %28%IM%29%%A%  
% 214.76/214.91  |- rdf__type mesh__D017919sskos__Concept
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D017919 2005
% 214.76/214.91  |- skos__broader mesh__D017919smesh__D017918
% 214.76/214.91  |- skos__scopeNote mesh__D017919
% 214.76/214.91       An ORTHOHEPADNAVIRUS causing chronic liver disease and hepatocellular carcinoma in woodchucks. It closely resembles the human hepatitis B virus.%A%    
% 214.76/214.91  |- skos__hiddenLabel mesh__D017919 Woodchuck Hepatitis Viruses
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D017919 2006
% 214.76/214.91  |- skos__historyNote mesh__D017919 Hepatitis Viruses %28%1979-1993%29%
% 214.76/214.91  |- skos__prefLabel mesh__D017919 Hepatitis B Virus, Woodchuck
% 214.76/214.91  |- skos__hiddenLabel mesh__D017919 Hepatitis Viruses, Woodchuck
% 214.76/214.91  |- skos__altLabel mesh__D017919 Hepatitis Virus, Woodchuck
% 214.76/214.91  |- mesh__historyNote mesh__D017919
% 214.76/214.91       97; was HEPATITIS VIRUS, WOODCHUCK 1994-96; HEPATITIS B VIRUS, WOODCHUCK was see HEPATITIS VIRUS, WOODCHUCK 1994-96%A%  
% 214.76/214.91  |- mesh__dateCreated mesh__D017919 1993-06-04
% 214.76/214.91  |- skos__hiddenLabel mesh__D017919 Viruses, Woodchuck Hepatitis
% 214.76/214.91  |- skos__hiddenLabel mesh__D017919 Virus, Woodchuck Hepatitis
% 214.76/214.91  |- mesh__recordAuthorizer mesh__D017919 sjn
% 214.76/214.91  |- mesh__recordOriginator mesh__D017919 AGS
% 214.76/214.91  |- mesh__publicMeSHNote mesh__D017919
% 214.76/214.91       97; was HEPATITIS VIRUS, WOODCHUCK 1994-96; HEPATITIS B VIRUS, WOODCHUCK was see HEPATITIS VIRUS, WOODCHUCK 1994-96%A%  
% 214.76/214.91  |- mesh__dateRevised mesh__D017919 2004-07-13
% 214.76/214.91  |- skos__altLabel mesh__D017919 Woodchuck Hepatitis Virus
% 214.76/214.91  |- mesh__recordMaintainer mesh__D017919 sjn
% 214.76/214.91  |- rdf__type mesh__D014621sskos__Concept
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D014621 2005
% 214.76/214.91  |- mesh__recordMaintainer mesh__D014621 lkt
% 214.76/214.91  |- skos__scopeNote mesh__D014621
% 214.76/214.91       The genital canal in the female, extending from the UTERUS to the VULVA. %28%Stedman, 25th ed%29%%A%    
% 214.76/214.91  |- mesh__considerAlso mesh__D014621 consider also terms at COLPO-   
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D014621 2006
% 214.76/214.91  |- skos__hiddenLabel mesh__D014621 Vaginas
% 214.76/214.91  |- mesh__recordOriginator mesh__D014621 NLM
% 214.76/214.91  |- skos__prefLabel mesh__D014621 Vagina
% 214.76/214.91  |- skos__broader mesh__D014621smesh__D005836
% 214.76/214.91  |- skos__related mesh__D014621smesh__D003127
% 214.76/214.91  |- mesh__dateCreated mesh__D014621 1999-01-01
% 214.76/214.91  |- mesh__dateRevised mesh__D014621 2004-07-07
% 214.76/214.91  |- mesh__recordAuthorizer mesh__D014621 sjn
% 214.76/214.91  |- skos__annotation mesh__D014621
% 214.76/214.91       %22%vaginal bleeding%22% is probably UTERINE HEMORRHAGE but check text; inflammation = VAGINITIS or specifics; surg: consider COLPOTOMY; %22%vaginal opening%22% %28%assessing SEXUAL MATURATION by repeated daily inspection of laboratory animals%29%: index SEXUAL MATURATION + VAGINA%A%  
% 214.76/214.91  |- mesh__dateEstablished mesh__D000601 1974-01-01
% 214.76/214.91  |- mesh__historyNote mesh__D000601 74   
% 214.76/214.91  |- rdf__type mesh__D000601sskos__Concept
% 214.76/214.91  |- mesh__recordAuthorizer mesh__D000601 sjn
% 214.76/214.91  |- skos__prefLabel mesh__D000601 Amino Acids, Essential
% 214.76/214.91  |- mesh__dateCreated mesh__D000601 1999-01-01
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D000601 2005
% 214.76/214.91  |- skos__altLabel mesh__D000601 Essential Amino Acids
% 214.76/214.91  |- mesh__publicMeSHNote mesh__D000601 74   
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D000601 2006
% 214.76/214.91  |- mesh__recordMaintainer mesh__D000601 sjn
% 214.76/214.91  |- mesh__recordOriginator mesh__D000601 NLM
% 214.76/214.91  |- skos__broader mesh__D000601smesh__D000596
% 214.76/214.91  |- mesh__dateRevised mesh__D000601 2004-07-13
% 214.76/214.91  |- skos__scopeNote mesh__D000601
% 214.76/214.91       Amino acids that are not synthesized by the human body in amounts sufficient to carry out physiological functions. They are obtained from dietary foodstuffs.%A%    
% 214.76/214.91  |- skos__hiddenLabel mesh__D000601 Acids, Essential Amino
% 214.76/214.91  |- mesh__recordOriginator mesh__D005895 NLM
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005895 2002
% 214.76/214.91  |- skos__prefLabel mesh__D005895 Gizzard
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005895 2004
% 214.76/214.91  |- mesh__recordAuthorizer mesh__D005895 PLS
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005895 2001
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005895 2006
% 214.76/214.91  |- mesh__dateCreated mesh__D005895 1999-01-01
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005895 2003
% 214.76/214.91  |- skos__historyNote mesh__D005895 Poultry %28%1966-1967%29%
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005895 2005
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005895 2000
% 214.76/214.91  |- mesh__recordMaintainer mesh__D005895 TAP
% 214.76/214.91  |- skos__broader mesh__D005895smesh__D013278
% 214.76/214.91  |- rdf__type mesh__D005895sskos__Concept
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005895 1997
% 214.76/214.91  |- mesh__dateEstablished mesh__D005895 1968-01-01
% 214.76/214.91  |- skos__historyNote mesh__D005895 Stomach %28%1966-1967%29%
% 214.76/214.91  |- skos__hiddenLabel mesh__D005895 Gizzards
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005895 1999
% 214.76/214.91  |- mesh__publicMeSHNote mesh__D005895 68   
% 214.76/214.91  |- skos__annotation mesh__D005895
% 214.76/214.91       dis: coord IM with STOMACH DISEASES /vet %28%IM%29%; neopl: coord IM with STOMACH NEOPLASMS /vet %28%IM%29% + histol type %28%IM%29%%A%  
% 214.76/214.91  |- mesh__dateRevised mesh__D005895 1996-06-10
% 214.76/214.91  |- skos__historyNote mesh__D005895 Birds %28%1966-1967%29%
% 214.76/214.91  |- mesh__historyNote mesh__D005895 68   
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005895 1998
% 214.76/214.91  |- mesh__recordMaintainer mesh__D005097 nns
% 214.76/214.91  |- skos__altLabel mesh__D005097 Exostosis, Familial
% 214.76/214.91  |- skos__altLabel mesh__D005097 Exostosis, Multiple Cartilaginous
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Multiple Osteochondroma
% 214.76/214.91  |- mesh__onlineNote mesh__D005097
% 214.76/214.91       use EXOSTOSES, MULTIPLE HEREDITARY to search EXOSTOSES, MULTIPLE 1968-89%A%  
% 214.76/214.91  |- mesh__publicMeSHNote mesh__D005097
% 214.76/214.91       90; was EXOSTOSES, MULTIPLE 1968-89   
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Multiple Cartilaginous Exostosis
% 214.76/214.91  |- skos__historyNote mesh__D005097 Exostoses %28%1966-1967%29%
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Multiple Cartilaginous Exostoses
% 214.76/214.91  |- skos__altLabel mesh__D005097 Exostoses, Multiple Cartilaginous
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Hereditary Exostoses, Multiple
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Multiple Hereditary Exostoses
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005097 2005
% 214.76/214.91  |- skos__altLabel mesh__D005097 Exostosis, Hereditary Multiple
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Multiple Osteochondromas
% 214.76/214.91  |- skos__scopeNote mesh__D005097
% 214.76/214.91       Hereditary disorder transmitted by an autosomal dominant gene and characterized by multiple exostoses %28%multiple osteochondromas%29% near the ends of long bones. The genetic abnormality results in a defect in the osteoclastic activity at the metaphyseal ends of the bone during the remodeling process in childhood or early adolescence. The metaphyses develop benign, bony outgrowths often capped by cartilage. A small number undergo neoplastic transformation.%A%    
% 214.76/214.91  |- skos__altLabel mesh__D005097 Exostoses, Hereditary Multiple
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Diaphyseal Aclases
% 214.76/214.91  |- skos__altLabel mesh__D005097 Chondrodysplasia, Hereditary Deforming
% 214.76/214.91  |- rdf__type mesh__D005097sskos__Concept
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Multiple Exostosis, Hereditary
% 214.76/214.91  |- skos__altLabel mesh__D005097 Exostoses, Familial
% 214.76/214.91  |- skos__altLabel mesh__D005097 Exostosis, Multiple
% 214.76/214.91  |- skos__broader mesh__D005097smesh__D009386
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005097 2006
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Familial Exostosis
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Familial Exostoses
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Hereditary Deforming Chondrodysplasia
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005097 2002
% 214.76/214.91  |- skos__altLabel mesh__D005097 Hereditary Multiple Exostosis
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Cartilaginous Exostoses, Multiple
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005097 2003
% 214.76/214.91  |- mesh__recordAuthorizer mesh__D005097 sjn
% 214.76/214.91  |- skos__prefLabel mesh__D005097 Exostoses, Multiple Hereditary
% 214.76/214.91  |- skos__altLabel mesh__D005097 Diaphyseal Aclasis
% 214.76/214.91  |- mesh__historyNote mesh__D005097 90; was EXOSTOSES, MULTIPLE 1968-89   
% 214.76/214.91  |- mesh__dateRevised mesh__D005097 2001-07-25
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Aclases, Diaphyseal
% 214.76/214.91  |- mesh__dateCreated mesh__D005097 1999-01-01
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Cartilaginous Exostosis, Multiple
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Chondrodysplasias, Hereditary Deforming
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Hereditary Deforming Chondrodysplasias
% 214.76/214.91  |- mesh__dateEstablished mesh__D005097 1968-01-01
% 214.76/214.91  |- skos__altLabel mesh__D005097 Exostoses, Multiple
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Multiple Exostoses, Hereditary
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D005097 2004
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Deforming Chondrodysplasias, Hereditary
% 214.76/214.91  |- skos__broader mesh__D005097smesh__D018216
% 214.76/214.91  |- skos__altLabel mesh__D005097 Osteochondromas, Multiple
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Aclasis, Diaphyseal
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Deforming Chondrodysplasia, Hereditary
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Multiple Exostosis
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Multiple Exostoses
% 214.76/214.91  |- skos__altLabel mesh__D005097 Hereditary Multiple Exostoses
% 214.76/214.91  |- skos__hiddenLabel mesh__D005097 Osteochondroma, Multiple
% 214.76/214.91  |- mesh__recordOriginator mesh__D005097 NLM
% 214.76/214.91  |- skos__broader mesh__D005097smesh__D005096
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D013529 2001
% 214.76/214.91  |- skos__scopeNote mesh__D013529
% 214.76/214.91       Pathologic process consisting of a partial or complete disruption of the layers of a surgical wound.%A%    
% 214.76/214.91  |- skos__prefLabel mesh__D013529 Surgical Wound Dehiscence
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D013529 2003
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D013529 2004
% 214.76/214.91  |- mesh__publicMeSHNote mesh__D013529 65   
% 214.76/214.91  |- rdf__type mesh__D013529sskos__Concept
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D013529 2002
% 214.76/214.91  |- skos__altLabel mesh__D013529 Wound Dehiscence, Surgical
% 214.76/214.91  |- skos__altLabel mesh__D013529 Dehiscence, Surgical Wound
% 214.76/214.91  |- mesh__dateEstablished mesh__D013529 1965-01-01
% 214.76/214.91  |- mesh__recordOriginator mesh__D013529 NLM
% 214.76/214.91  |- skos__broader mesh__D013529smesh__D011183
% 214.76/214.91  |- mesh__recordAuthorizer mesh__D013529 sjn
% 214.76/214.91  |- mesh__dateCreated mesh__D013529 1999-01-01
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D013529 2000
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D013529 2005
% 214.76/214.91  |- mesh__recordMaintainer mesh__D013529 KEV
% 214.76/214.91  |- mesh__dateRevised mesh__D013529 1999-11-03
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D013529 2006
% 214.76/214.91  |- mesh__historyNote mesh__D013529 65%28%64%29%   
% 214.76/214.91  |- mesh__recordOriginator mesh__D018214 PLS
% 214.76/214.91  |- mesh__dateCreated mesh__D018214 1993-06-25
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D018214 2006
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D018214 1998
% 214.76/214.91  |- skos__hiddenLabel mesh__D018214 Ossifying Fibromas
% 214.76/214.91  |- skos__scopeNote mesh__D018214
% 214.76/214.91       A benign, relatively slow-growing, central bone tumor, usually of the jaws %28%especially the mandible%29% which is composed of fibrous connective tissue within which bone is formed. %28%Dorland, 27th ed%29%%A%    
% 214.76/214.91  |- skos__annotation mesh__D018214
% 214.76/214.91       /blood supply /chem /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS %28%IM%29% or specific precoord bone/neopl term %28%IM%29% or specific bone %28%IM%29% + BONE NEOPLASMS %28%IM%29%%A%  
% 214.76/214.91  |- mesh__activeMeSHYear mesh__D018214 2002
% 214.76/214.91  |- mesh__dateRevised mesh__D018214 1995-06-08
% 214.76/214.92  |- skos__broader mesh__D018214smesh__D005350
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018214 2003
% 214.76/214.92  |- mesh__publicMeSHNote mesh__D018214 94   
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018214 1999
% 214.76/214.92  |- mesh__recordAuthorizer mesh__D018214 PLS
% 214.76/214.92  |- rdf__type mesh__D018214sskos__Concept
% 214.76/214.92  |- skos__hiddenLabel mesh__D018214 Ossifying Fibroma
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018214 2004
% 214.76/214.92  |- mesh__dateEstablished mesh__D018214 1994-01-01
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018214 1996
% 214.76/214.92  |- skos__prefLabel mesh__D018214 Fibroma, Ossifying
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018214 2000
% 214.76/214.92  |- skos__historyNote mesh__D018214
% 214.76/214.92       Ossification, Heterotopic %28%1968-1993%29%
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018214 2001
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018214 1997
% 214.76/214.92  |- skos__broader mesh__D018214smesh__D018213
% 214.76/214.92  |- skos__hiddenLabel mesh__D018214 Fibromas, Ossifying
% 214.76/214.92  |- mesh__recordMaintainer mesh__D018214 KEV
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018214 2005
% 214.76/214.92  |- mesh__historyNote mesh__D018214 94   
% 214.76/214.92  |- skos__historyNote mesh__D018214 Fibroma %28%1966-1993%29%
% 214.76/214.92  |- skos__broader mesh__D010231smesh__D010230
% 214.76/214.92  |- skos__altLabel mesh__D010231 Micrococcus denitrificans
% 214.76/214.92  |- mesh__historyNote mesh__D010231
% 214.76/214.92       76; was MICROCOCCUS DENITRIFICANS 1972-75   
% 214.76/214.92  |- rdf__type mesh__D010231sskos__Concept
% 214.76/214.92  |- skos__historyNote mesh__D010231 Micrococcus %28%1966-1971%29%
% 214.76/214.92  |- mesh__dateRevised mesh__D010231 2005-06-30
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D010231 2006
% 214.76/214.92  |- mesh__dateCreated mesh__D010231 1975-07-21
% 214.76/214.92  |- mesh__recordMaintainer mesh__D010231 SYSTEM
% 214.76/214.92  |- mesh__dateEstablished mesh__D010231 1976-01-01
% 214.76/214.92  |- mesh__publicMeSHNote mesh__D010231
% 214.76/214.92       76; was MICROCOCCUS DENITRIFICANS 1972-75   
% 214.76/214.92  |- skos__prefLabel mesh__D010231 Paracoccus denitrificans
% 214.76/214.92  |- skos__scopeNote mesh__D010231
% 214.76/214.92       A species of bacteria isolated from soil.     
% 214.76/214.92  |- mesh__recordAuthorizer mesh__D010231 sjn
% 214.76/214.92  |- mesh__onlineNote mesh__D010231
% 214.76/214.92       use PARACOCCUS DENITRIFICANS to search MICROCOCCUS DENITRIFICANS 1972-75%A%  
% 214.76/214.92  |- mesh__recordOriginator mesh__D010231 JW
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D009488 2005A
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D009488 2006
% 214.76/214.92  |- mesh__dateRevised mesh__D009488 2004-07-29
% 214.76/214.92  |- skos__broader mesh__D009488smesh__D001690
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D009488 2005
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D009488 2002
% 214.76/214.92  |- mesh__recordMaintainer mesh__D009488 jls
% 214.76/214.92  |- mesh__recordOriginator mesh__D009488 EC
% 214.76/214.92  |- skos__annotation mesh__D009488
% 214.76/214.92       GEN or unspecified; prefer specifics; SPEC: SPEC qualif   
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D009488 2004
% 214.76/214.92  |- mesh__publicMeSHNote mesh__D009488 86   
% 214.76/214.92  |- rdf__type mesh__D009488sskos__Concept
% 214.76/214.92  |- mesh__dateCreated mesh__D009488 1985-06-06
% 214.76/214.92  |- mesh__historyNote mesh__D009488 86   
% 214.76/214.92  |- skos__prefLabel mesh__D009488 Neurosciences
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D009488 2003
% 214.76/214.92  |- mesh__dateEstablished mesh__D009488 1986-01-01
% 214.76/214.92  |- mesh__recordAuthorizer mesh__D009488 jls
% 214.76/214.92  |- skos__scopeNote mesh__D009488
% 214.76/214.92       The scientific disciplines concerned with the embryology, anatomy, physiology, biochemistry, pharmacology, etc., of the nervous system.%A%    
% 214.76/214.92  |- skos__hiddenLabel mesh__D009488 Neuroscience
% 214.76/214.92  |- mesh__dateCreated mesh__D028642 2001-07-25
% 214.76/214.92  |- mesh__dateRevised mesh__D028642 2002-07-03
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D028642 2006
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D028642 2003
% 214.76/214.92  |- skos__broader mesh__D028642smesh__D006233
% 214.76/214.92  |- skos__hiddenLabel mesh__D028642 Persons, Mentally Ill
% 214.76/214.92  |- rdf__type mesh__D028642sskos__Concept
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D028642 2005
% 214.76/214.92  |- mesh__publicMeSHNote mesh__D028642 2002   
% 214.76/214.92  |- skos__prefLabel mesh__D028642 Mentally Ill Persons
% 214.76/214.92  |- mesh__recordOriginator mesh__D028642 jrf
% 214.76/214.92  |- mesh__historyNote mesh__D028642 2002   
% 214.76/214.92  |- mesh__recordAuthorizer mesh__D028642 sjn
% 214.76/214.92  |- skos__historyNote mesh__D028642 Mental Disorders %28%1974-2001%29%
% 214.76/214.92  |- skos__altLabel mesh__D028642 Mental Patients
% 214.76/214.92  |- skos__related mesh__D028642smesh__D003134
% 214.76/214.92  |- skos__hiddenLabel mesh__D028642 Person, Mentally Ill
% 214.76/214.92  |- mesh__recordMaintainer mesh__D028642 mdb
% 214.76/214.92  |- skos__hiddenLabel mesh__D028642 Mentally Ill Person
% 214.76/214.92  |- skos__altLabel mesh__D028642 Mentally Ill
% 214.76/214.92  |- skos__hiddenLabel mesh__D028642 Ill, Mentally
% 214.76/214.92  |- skos__scopeNote mesh__D028642
% 214.76/214.92       Persons with psychiatric illnesses or diseases, particularly psychotic and severe mood disorders.%A%    
% 214.76/214.92  |- mesh__dateEstablished mesh__D028642 2002-01-01
% 214.76/214.92  |- skos__related mesh__D028642smesh__D001523
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D028642 2004
% 214.76/214.92  |- rdf__type mesh__D006190sskos__Concept
% 214.76/214.92  |- skos__prefLabel mesh__D006190 Haemophilus
% 214.76/214.92  |- skos__broader mesh__D006190smesh__D015661
% 214.76/214.92  |- mesh__dateCreated mesh__D006190 1999-01-01
% 214.76/214.92  |- mesh__recordMaintainer mesh__D006190 SYSTEM
% 214.76/214.92  |- mesh__recordAuthorizer mesh__D006190 sjn
% 214.76/214.92  |- mesh__dateRevised mesh__D006190 2005-06-30
% 214.76/214.92  |- skos__altLabel mesh__D006190 Hemophilus
% 214.76/214.92  |- skos__scopeNote mesh__D006190
% 214.76/214.92       A genus of PASTEURELLACEAE that consists of several species occurring in animals and humans. Its organisms are described as gram-negative, facultatively anaerobic, coccobacillus or rod-shaped, and nonmotile.%A%    
% 214.76/214.92  |- mesh__recordOriginator mesh__D006190 NLM
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D006190 2006
% 214.76/214.92  |- skos__annotation mesh__D006190
% 214.76/214.92       use this spelling in translations; infection = HAEMOPHILUS INFECTIONS but check text for species %26% index by instructions on species%A%  
% 214.76/214.92  |- skos__hiddenLabel mesh__D014622 Gel, Vaginal
% 214.76/214.92  |- skos__hiddenLabel mesh__D014622 Jellies, Vaginal
% 214.76/214.92  |- skos__altLabel mesh__D014622 Vaginal Cream
% 214.76/214.92  |- mesh__recordAuthorizer mesh__D014622 sjn
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D014622 2006
% 214.76/214.92  |- skos__broader mesh__D014622smesh__D004304
% 214.76/214.92  |- mesh__historyNote mesh__D014622 1975   
% 214.76/214.92  |- skos__annotation mesh__D014622
% 214.76/214.92       IM GEN only; coord NIM with specific drug %28%IM%29%   
% 214.76/214.92  |- skos__hiddenLabel mesh__D014622 Tablet, Vaginal
% 214.76/214.92  |- skos__altLabel mesh__D014622 Vaginal Jellies
% 214.76/214.92  |- skos__hiddenLabel mesh__D014622 Cream, Vaginal
% 214.76/214.92  |- mesh__recordMaintainer mesh__D014622 lkt
% 214.76/214.92  |- skos__hiddenLabel mesh__D014622 Tablets, Vaginal
% 214.76/214.92  |- mesh__publicMeSHNote mesh__D014622 1975   
% 214.76/214.92  |- skos__prefLabel mesh__D014622 Vaginal Creams, Foams and Jellies
% 214.76/214.92  |- skos__related mesh__D014622smesh__D013089
% 214.76/214.92  |- mesh__dateEstablished mesh__D014622 1975-09-01
% 214.76/214.92  |- skos__altLabel mesh__D014622 Vaginal Gel
% 214.76/214.92  |- skos__hiddenLabel mesh__D014622 Creams, Vaginal
% 214.76/214.92  |- mesh__dateCreated mesh__D014622 1974-11-11
% 214.76/214.92  |- skos__altLabel mesh__D014622 Vaginal Tablets
% 214.76/214.92  |- skos__hiddenLabel mesh__D014622 Jelly, Vaginal
% 214.76/214.92  |- skos__hiddenLabel mesh__D014622 Foams, Vaginal
% 214.76/214.92  |- skos__hiddenLabel mesh__D014622 Foam, Vaginal
% 214.76/214.92  |- skos__altLabel mesh__D014622 Vaginal Foam
% 214.76/214.92  |- skos__historyNote mesh__D014622 Dosage Forms %28%1966-1974%29%
% 214.76/214.92  |- skos__scopeNote mesh__D014622
% 214.76/214.92       Medicated dosage forms for topical application in the vagina. A cream is a semisolid emulsion containing suspended or dissolved medication; a foam is a dispersion of a gas in a medicated liquid resulting in a light, frothy mass; a jelly is a colloidal semisolid mass of a water soluble medicated material, usually translucent.%A%    
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D014622 2004
% 214.76/214.92  |- rdf__type mesh__D014622sskos__Concept
% 214.76/214.92  |- mesh__recordOriginator mesh__D014622 NLM
% 214.76/214.92  |- mesh__dateRevised mesh__D014622 2003-07-09
% 214.76/214.92  |- skos__broader mesh__D014622smesh__D004364
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D014622 2005
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D000602 2005
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D000602 2006
% 214.76/214.92  |- mesh__runningHead mesh__D000602
% 214.76/214.92       D12 - AMINO ACIDS, PEPTIDES, AND PROTEINS   
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D000602 2004
% 214.76/214.92  |- mesh__recordAuthorizer mesh__D000602 sjn
% 214.76/214.92  |- skos__annotation mesh__D000602 not used for indexing or cataloging   
% 214.76/214.92  |- mesh__dateEstablished mesh__D000602 1998-01-01
% 214.76/214.92  |- mesh__dateRevised mesh__D000602 2003-07-09
% 214.76/214.92  |- mesh__publicMeSHNote mesh__D000602 98   
% 214.76/214.92  |- skos__prefLabel mesh__D000602 Amino Acids, Peptides, and Proteins
% 214.76/214.92  |- mesh__recordMaintainer mesh__D000602 ags
% 214.76/214.92  |- skos__scopeNote mesh__D000602
% 214.76/214.92       Amino acids and chains of amino acids connected by peptide linkages.%A%    
% 214.76/214.92  |- mesh__recordOriginator mesh__D000602 NLM
% 214.76/214.92  |- rdf__type mesh__D000602sskos__Concept
% 214.76/214.92  |- mesh__dateCreated mesh__D000602 1999-01-01
% 214.76/214.92  |- mesh__historyNote mesh__D000602 98; use explode   
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D005896 2005
% 214.76/214.92  |- mesh__recordMaintainer mesh__D005896 ags
% 214.76/214.92  |- mesh__recordAuthorizer mesh__D005896 sjn
% 214.76/214.92  |- rdf__type mesh__D005896sskos__Concept
% 214.76/214.92  |- mesh__recordOriginator mesh__D005896 NLM
% 214.76/214.92  |- mesh__dateRevised mesh__D005896 2003-07-09
% 214.76/214.92  |- skos__broader mesh__D005896smesh__D019121
% 214.76/214.92  |- skos__scopeNote mesh__D005896
% 214.76/214.92       A contagious disease of horses that can be transmitted to humans. It is caused by BURKHOLDERIA MALLEI and characterized by ulceration of the respiratory mucosa and an eruption of nodules on the skin.%A%    
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D005896 2004
% 214.76/214.92  |- skos__prefLabel mesh__D005896 Glanders
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D005896 2006
% 214.76/214.92  |- skos__broader mesh__D005896smesh__D006734
% 214.76/214.92  |- mesh__dateCreated mesh__D005896 1999-01-01
% 214.76/214.92  |- mesh__historyNote mesh__D005098 78   
% 214.76/214.92  |- skos__scopeNote mesh__D005098
% 214.76/214.92       Toxins produced, especially by bacterial or fungal cells, and released into the culture medium or environment.%A%    
% 214.76/214.92  |- rdf__type mesh__D005098sskos__Concept
% 214.76/214.92  |- mesh__recordAuthorizer mesh__D005098 sjn
% 214.76/214.92  |- mesh__publicMeSHNote mesh__D005098 78   
% 214.76/214.92  |- skos__prefLabel mesh__D005098 Exotoxins
% 214.76/214.92  |- mesh__dateEstablished mesh__D005098 1978-01-01
% 214.76/214.92  |- skos__altLabel mesh__D005098 Exotoxin
% 214.76/214.92  |- mesh__dateRevised mesh__D005098 2005-06-30
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D005098 2006
% 214.76/214.92  |- mesh__dateCreated mesh__D005098 1977-04-22
% 214.76/214.92  |- skos__historyNote mesh__D005098 Bacterial Toxins %28%1977%29%
% 214.76/214.92  |- skos__annotation mesh__D005098
% 214.76/214.92       bacterial or fungal toxins; /antag permitted but consider also ANTITOXINS: coord IM with source of exotoxin %28%IM or NIM%29%%A%  
% 214.76/214.92  |- skos__historyNote mesh__D005098 Toxins %28%1966-1977%29%
% 214.76/214.92  |- skos__broader mesh__D005098smesh__D014118
% 214.76/214.92  |- mesh__recordOriginator mesh__D005098 SH
% 214.76/214.92  |- mesh__recordMaintainer mesh__D005098 ssb
% 214.76/214.92  |- mesh__historyNote mesh__D018215
% 214.76/214.92       94; was see OSTEOMA, OSTEOID 1985-93; GIANT OSTEOID OSTEOMA was see OSTEOMA, OSTEOID 1985-93%A%  
% 214.76/214.92  |- mesh__recordOriginator mesh__D018215 PLS
% 214.76/214.92  |- skos__hiddenLabel mesh__D018215 Osteoid Osteoma, Giant
% 214.76/214.92  |- skos__hiddenLabel mesh__D018215 Osteoblastomas
% 214.76/214.92  |- skos__hiddenLabel mesh__D018215 Giant Osteoid Osteomas
% 214.76/214.92  |- skos__historyNote mesh__D018215 Osteoma, Osteoid %28%1966-1993%29%
% 214.76/214.92  |- mesh__publicMeSHNote mesh__D018215
% 214.76/214.92       94; was see OSTEOMA, OSTEOID 1985-93; GIANT OSTEOID OSTEOMA was see OSTEOMA, OSTEOID 1985-93%A%  
% 214.76/214.92  |- mesh__dateRevised mesh__D018215 1995-06-08
% 214.76/214.92  |- skos__prefLabel mesh__D018215 Osteoblastoma
% 214.76/214.92  |- mesh__onlineNote mesh__D018215
% 214.76/214.92       use OSTEOMA, OSTEOID to search OSTEOBLASTOMA %26% GIANT OSTEOID OSTEOMA 1985-93%A%  
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018215 2006
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018215 2001
% 214.76/214.92  |- skos__scopeNote mesh__D018215
% 214.76/214.92       A benign, painful, tumor of bone characterized by the formation of osteoid tissue, primitive bone and calcified tissue. It occurs frequently in the spine of young persons. %28%From Dorland, 27th ed; Stedman, 25th ed%29%%A%    
% 214.76/214.92  |- mesh__recordAuthorizer mesh__D018215 PLS
% 214.76/214.92  |- skos__hiddenLabel mesh__D018215 Osteomas, Giant Osteoid
% 214.76/214.92  |- mesh__dateCreated mesh__D018215 1993-07-02
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018215 2005
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018215 2004
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018215 1999
% 214.76/214.92  |- skos__altLabel mesh__D018215 Osteoma, Giant Osteoid
% 214.76/214.92  |- skos__altLabel mesh__D018215 Giant Osteoid Osteoma
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018215 2000
% 214.76/214.92  |- rdf__type mesh__D018215sskos__Concept
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018215 2003
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018215 1998
% 214.76/214.92  |- mesh__dateEstablished mesh__D018215 1994-01-01
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018215 1997
% 214.76/214.92  |- mesh__recordMaintainer mesh__D018215 KEV
% 214.76/214.92  |- skos__annotation mesh__D018215
% 214.76/214.92       /blood supply /chem /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS %28%IM%29% or specific precoord bone/neopl term %28%IM%29% or specific bone %28%IM%29% + BONE NEOPLASMS %28%IM%29%; osteoblastoclastoma = OSTEOBLASTOMA %28%IM%29% + GIANT CELL TUMOR OF BONE %28%IM%29% + precoord organ/neopl term %28%IM%29%%A%  
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018215 1996
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018215 2002
% 214.76/214.92  |- skos__hiddenLabel mesh__D018215 Osteoid Osteomas, Giant
% 214.76/214.92  |- skos__broader mesh__D018215smesh__D018213
% 214.76/214.92  |- mesh__recordAuthorizer mesh__D010232 sjn
% 214.76/214.92  |- mesh__recordMaintainer mesh__D010232 jmp
% 214.76/214.92  |- skos__annotation mesh__D010232 D25-26 qualif   
% 214.76/214.92  |- mesh__dateCreated mesh__D010232 1999-01-01
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D010232 2006
% 214.76/214.92  |- skos__prefLabel mesh__D010232 Paraffin
% 214.76/214.92  |- mesh__recordOriginator mesh__D010232 NLM
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D010232 2005
% 214.76/214.92  |- mesh__dateRevised mesh__D010232 1999-11-03
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D010232 2002
% 214.76/214.92  |- skos__broader mesh__D010232smesh__D006838
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D010232 2004
% 214.76/214.92  |- skos__scopeNote mesh__D010232
% 214.76/214.92       A mixture of solid hydrocarbons obtained from petroleum. It has a wide range of uses including as a stiffening agent in ointments, as a lubricant, and as a topical anti-inflammatory. It is also commonly used as an embedding material in histology.%A%    
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D010232 2001
% 214.76/214.92  |- mesh__historyNote mesh__D010232 was in Cat D only 1963-82   
% 214.76/214.92  |- rdf__type mesh__D010232sskos__Concept
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D010232 2003
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D010232 2000
% 214.76/214.92  |- mesh__publicMeSHNote mesh__D009489 65   
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D009489 1994
% 214.76/214.92  |- mesh__dateCreated mesh__D009489 1999-01-01
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D009489 2000
% 214.76/214.92  |- mesh__dateRevised mesh__D009489 1992-05-15
% 214.76/214.92  |- skos__prefLabel mesh__D009489 Neurosecretion
% 214.76/214.92  |- skos__related mesh__D009489smesh__D010906
% 214.76/214.92  |- mesh__recordAuthorizer mesh__D009489 PLS
% 214.76/214.92  |- mesh__recordOriginator mesh__D009489 NLM
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D009489 1997
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D009489 2004
% 214.76/214.92  |- skos__hiddenLabel mesh__D009489 Neurosecretions
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D009489 2002
% 214.76/214.92  |- rdf__type mesh__D009489sskos__Concept
% 214.76/214.92  |- mesh__recordMaintainer mesh__D009489 TAP
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D009489 1993
% 214.76/214.92  |- mesh__historyNote mesh__D009489 65%28%64%29%   
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D009489 1996
% 214.76/214.92  |- mesh__dateEstablished mesh__D009489 1965-01-01
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D009489 2003
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D009489 1999
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D009489 2006
% 214.76/214.92  |- skos__broader mesh__D009489smesh__D009424
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D009489 2001
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D009489 1995
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D009489 1998
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D009489 2005
% 214.76/214.92  |- skos__prefLabel mesh__D006191 Haemophilus ducreyi
% 214.76/214.92  |- mesh__dateRevised mesh__D006191 2005-06-30
% 214.76/214.92  |- rdf__type mesh__D006191sskos__Concept
% 214.76/214.92  |- mesh__recordOriginator mesh__D006191 NLM
% 214.76/214.92  |- skos__scopeNote mesh__D006191
% 214.76/214.92       A species of HAEMOPHILUS that appears to be the pathogen or causative agent of the sexually transmitted disease, CHANCROID.%A%    
% 214.76/214.92  |- skos__broader mesh__D006191smesh__D006190
% 214.76/214.92  |- skos__annotation mesh__D006191 infection = CHANCROID   
% 214.76/214.92  |- mesh__recordMaintainer mesh__D006191 SYSTEM
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D006191 2006
% 214.76/214.92  |- mesh__dateCreated mesh__D006191 1999-01-01
% 214.76/214.92  |- skos__altLabel mesh__D006191 Hemophilus ducreyi
% 214.76/214.92  |- mesh__recordAuthorizer mesh__D006191 sjn
% 214.76/214.92  |- skos__related mesh__D006191smesh__D002602
% 214.76/214.92  |- mesh__dateRevised mesh__D014623 2005-06-30
% 214.76/214.92  |- skos__prefLabel mesh__D014623 Vaginal Diseases
% 214.76/214.92  |- mesh__historyNote mesh__D014623 66   
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D014623 2006
% 214.76/214.92  |- mesh__dateEstablished mesh__D014623 1966-01-01
% 214.76/214.92  |- skos__scopeNote mesh__D014623 Pathological processes of the VAGINA.     
% 214.76/214.92  |- mesh__recordMaintainer mesh__D014623 lkt
% 214.76/214.92  |- skos__hiddenLabel mesh__D014623 Diseases, Vaginal
% 214.76/214.92  |- mesh__dateCreated mesh__D014623 1999-01-01
% 214.76/214.92  |- skos__annotation mesh__D014623 inflammatory disease = VAGINITIS   
% 214.76/214.92  |- skos__hiddenLabel mesh__D014623 Disease, Vaginal
% 214.76/214.92  |- mesh__recordOriginator mesh__D014623 NLM
% 214.76/214.92  |- rdf__type mesh__D014623sskos__Concept
% 214.76/214.92  |- skos__hiddenLabel mesh__D014623 Vaginal Disease
% 214.76/214.92  |- mesh__publicMeSHNote mesh__D014623 66   
% 214.76/214.92  |- skos__broader mesh__D014623smesh__D005831
% 214.76/214.92  |- mesh__recordAuthorizer mesh__D014623 sjn
% 214.76/214.92  |- skos__broader mesh__D000603smesh__D013457
% 214.76/214.92  |- skos__broader mesh__D000603smesh__D000596
% 214.76/214.92  |- mesh__publicMeSHNote mesh__D000603 74   
% 214.76/214.92  |- mesh__recordMaintainer mesh__D000603 ssb
% 214.76/214.92  |- mesh__recordOriginator mesh__D000603 NLM
% 214.76/214.92  |- skos__hiddenLabel mesh__D000603 Acids, Sulfur Amino
% 214.76/214.92  |- mesh__dateEstablished mesh__D000603 1974-01-01
% 214.76/214.92  |- mesh__historyNote mesh__D000603 74   
% 214.76/214.92  |- rdf__type mesh__D000603sskos__Concept
% 214.76/214.92  |- mesh__dateRevised mesh__D000603 2005-06-30
% 214.76/214.92  |- mesh__dateCreated mesh__D000603 1999-01-01
% 214.76/214.92  |- mesh__recordAuthorizer mesh__D000603 sjn
% 214.76/214.92  |- skos__altLabel mesh__D000603 Sulfur Amino Acids
% 214.76/214.92  |- skos__prefLabel mesh__D000603 Amino Acids, Sulfur
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D000603 2006
% 214.76/214.92  |- skos__historyNote mesh__D005897 Glycols %28%1972-1974%29%
% 214.76/214.92  |- mesh__historyNote mesh__D005897
% 214.76/214.92       95; was GLAPHENINE 1975-94 %28%see under ANTHRANILIC ACIDS 1975-90%29%; GLAFENINE was see GLAPHENINE 1978-94%A%  
% 214.76/214.92  |- rdf__type mesh__D005897sskos__Concept
% 214.76/214.92  |- mesh__dateRevised mesh__D005897 2000-06-22
% 214.76/214.92  |- skos__historyNote mesh__D005897 Quinolines %28%1972-1974%29%
% 214.76/214.92  |- skos__prefLabel mesh__D005897 Glafenine
% 214.76/214.92  |- mesh__dateCreated mesh__D005897 1974-11-19
% 214.76/214.92  |- mesh__recordMaintainer mesh__D005897 CCR
% 214.76/214.92  |- mesh__dateEstablished mesh__D005897 1991-01-01
% 214.76/214.92  |- mesh__onlineNote mesh__D005897
% 214.76/214.92       use GLAFENINE to search GLAPHENINE 1975-94   
% 214.76/214.92  |- mesh__recordAuthorizer mesh__D005897 sjn
% 214.76/214.92  |- skos__historyNote mesh__D005897 Anthranilic Acids %28%1970-1974%29%
% 214.76/214.92  |- skos__scopeNote mesh__D005897
% 214.76/214.92       An anthranilic acid derivative with analgesic properties used for the relief of all types of pain.%A%    
% 214.76/214.92  |- mesh__publicMeSHNote mesh__D005897
% 214.76/214.92       95; was GLAPHENINE 1975-94 %28%see under ANTHRANILIC ACIDS 1975-90%29%; GLAFENINE was see GLAPHENINE 1978-94%A%  
% 214.76/214.92  |- skos__altLabel mesh__D005897 Glaphenine
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D005897 2004
% 214.76/214.92  |- mesh__recordOriginator mesh__D005897 NLM
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D005897 2002
% 214.76/214.92  |- skos__altLabel mesh__D005897 Glycerylaminophenaquine
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D005897 2006
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D005897 2003
% 214.76/214.92  |- skos__broader mesh__D005897smesh__D000879
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D005897 2001
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D005897 2005
% 214.76/214.92  |- skos__altLabel mesh__D005897 Glafenin
% 214.76/214.92  |- skos__hiddenLabel mesh__D005099 Exotropia, Alternating
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D005099 2000
% 214.76/214.92  |- skos__hiddenLabel mesh__D005099 Exotropia, Primary
% 214.76/214.92  |- skos__altLabel mesh__D005099 Strabismus, Divergent
% 214.76/214.92  |- skos__prefLabel mesh__D005099 Exotropia
% 214.76/214.92  |- mesh__dateEstablished mesh__D005099 1990-01-01
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D005099 2005
% 214.76/214.92  |- skos__hiddenLabel mesh__D005099 Exodeviations
% 214.76/214.92  |- mesh__recordMaintainer mesh__D005099 KEV
% 214.76/214.92  |- mesh__recordOriginator mesh__D005099 RC
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D005099 2001
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D005099 2006
% 214.76/214.92  |- mesh__recordAuthorizer mesh__D005099 sjn
% 214.76/214.92  |- skos__hiddenLabel mesh__D005099 Exotropia, Monocular
% 214.76/214.92  |- mesh__dateCreated mesh__D005099 1982-04-28
% 214.76/214.92  |- mesh__historyNote mesh__D005099
% 214.76/214.92       90%28%83%29%; was see under STRABISMUS 1983-89   
% 214.76/214.92  |- skos__annotation mesh__D005099
% 214.76/214.92       do not confuse with ESOTROPIA, eye turning inward   
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D005099 2002
% 214.76/214.92  |- skos__broader mesh__D005099smesh__D013285
% 214.76/214.92  |- skos__historyNote mesh__D005099 Strabismus %28%1966-1982%29%
% 214.76/214.92  |- mesh__publicMeSHNote mesh__D005099
% 214.76/214.92       90; was see under STRABISMUS 1983-89   
% 214.76/214.92  |- skos__altLabel mesh__D005099 Exodeviation
% 214.76/214.92  |- skos__hiddenLabel mesh__D005099 Exotropia, Secondary
% 214.76/214.92  |- skos__altLabel mesh__D005099 Divergent Strabismus
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D005099 2003
% 214.76/214.92  |- skos__scopeNote mesh__D005099
% 214.76/214.92       A form of ocular misalignment where the visual axes diverge inappropriately. For example, medial rectus muscle weakness may produce this condition as the affected eye will deviate laterally upon attempted forward gaze. An exotropia occurs due to the relatively unopposed force exerted on the eye by the lateral rectus muscle, which pulls the eye in an outward direction.%A%    
% 214.76/214.92  |- rdf__type mesh__D005099sskos__Concept
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D005099 2004
% 214.76/214.92  |- mesh__dateRevised mesh__D005099 1999-11-03
% 214.76/214.92  |- skos__broader mesh__D018216smesh__D015831
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018216 2006
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018216 2002
% 214.76/214.92  |- skos__scopeNote mesh__D018216
% 214.76/214.92       A condition marked by the presence of multiple osteochondromas. %28%Dorland, 27th ed%29%%A%    
% 214.76/214.92  |- mesh__publicMeSHNote mesh__D018216
% 214.76/214.92       94; was see EXOSTOSES, MULTIPLE HEREDITARY 1990-93   
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018216 2005
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018216 2004
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018216 1999
% 214.76/214.92  |- skos__hiddenLabel mesh__D018216 Osteochondromatoses
% 214.76/214.92  |- skos__historyNote mesh__D018216
% 214.76/214.92       Exostoses, Multiple Hereditary %28%1985-1993%29%
% 214.76/214.92  |- skos__prefLabel mesh__D018216 Osteochondromatosis
% 214.76/214.92  |- rdf__type mesh__D018216sskos__Concept
% 214.76/214.92  |- skos__historyNote mesh__D018216
% 214.76/214.92       Chondromatosis, Synovial %28%1989-1990%29%
% 214.76/214.92  |- mesh__historyNote mesh__D018216
% 214.76/214.92       94; was see EXOSTOSES, MULTIPLE HEREDITARY 1990-93   
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018216 2003
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018216 1997
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018216 1998
% 214.76/214.92  |- skos__historyNote mesh__D018216 Synovial Membrane %28%1966-1971%29%
% 214.76/214.92  |- mesh__recordAuthorizer mesh__D018216 PLS
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018216 2001
% 214.76/214.92  |- mesh__recordMaintainer mesh__D018216 KEV
% 214.76/214.92  |- skos__annotation mesh__D018216
% 214.76/214.92       multiple; solitary = OSTEOCHONDROMA; do not use /blood supply /chem /second /secret /ultrastruct; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 214.76/214.92  |- mesh__dateCreated mesh__D018216 1993-06-25
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018216 1996
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D018216 2000
% 214.76/214.92  |- skos__historyNote mesh__D018216 Chondroma %28%1966-1974%29%
% 214.76/214.92  |- mesh__onlineNote mesh__D018216
% 214.76/214.92       use EXOSTOSES, MULTIPLE HEREDITARY to search OSTEOCHONDROMATOSIS 1990-93%A%  
% 214.76/214.92  |- mesh__recordOriginator mesh__D018216 PLS
% 214.76/214.92  |- mesh__dateEstablished mesh__D018216 1994-01-01
% 214.76/214.92  |- mesh__dateRevised mesh__D018216 1995-06-08
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D010233 1996
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D010233 1995
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D010233 1991
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D010233 2005
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D010233 2003A
% 214.76/214.92  |- skos__hiddenLabel mesh__D010233 Chromaffin Paraganglia
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D010233 2001
% 214.76/214.92  |- skos__prefLabel mesh__D010233 Paraganglia, Chromaffin
% 214.76/214.92  |- mesh__onlineNote mesh__D010233 search CHROMAFFIN SYSTEM 1966-74   
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D010233 1994
% 214.76/214.92  |- skos__scopeNote mesh__D010233
% 214.76/214.92       Small bodies containing chromaffin cells occurring outside of the adrenal medulla, most commonly near the sympathetic ganglia and in organs such as the kidney, liver, heart and gonads.%A%    
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D010233 2004
% 214.76/214.92  |- mesh__activeMeSHYear mesh__D010233 2000
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D010233 1999
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D010233 1993
% 214.76/214.93  |- mesh__recordAuthorizer mesh__D010233 sjn
% 214.76/214.93  |- mesh__recordMaintainer mesh__D010233 sjn
% 214.76/214.93  |- mesh__publicMeSHNote mesh__D010233
% 214.76/214.93       91; was see under CHROMAFFIN SYSTEM 1975-90   
% 214.76/214.93  |- rdf__type mesh__D010233sskos__Concept
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D010233 2003
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D010233 1998
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D010233 1992
% 214.76/214.93  |- mesh__recordOriginator mesh__D010233 NLM
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D010233 1997
% 214.76/214.93  |- mesh__dateRevised mesh__D010233 2002-10-24
% 214.76/214.93  |- mesh__historyNote mesh__D010233
% 214.76/214.93       91%28%75%29%; was see under CHROMAFFIN SYSTEM 1975-90   
% 214.76/214.93  |- mesh__dateCreated mesh__D010233 1999-01-01
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D010233 2006
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D010233 2002
% 214.76/214.93  |- skos__broader mesh__D010233smesh__D002838
% 214.76/214.93  |- mesh__dateEstablished mesh__D010233 1991-01-01
% 214.76/214.93  |- skos__scopeNote mesh__D034681
% 214.76/214.93       A plant genus of the family SCROPHULARIACEAE. Members contain bacopaside, bacopasaponins and other dammarane type jujubogenins.%A%    
% 214.76/214.93  |- skos__annotation mesh__D034681
% 214.76/214.93       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.76/214.93  |- rdf__type mesh__D034681sskos__Concept
% 214.76/214.93  |- mesh__dateCreated mesh__D034681 2002-07-02
% 214.76/214.93  |- mesh__dateEstablished mesh__D034681 2003-01-01
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D034681 2003
% 214.76/214.93  |- mesh__historyNote mesh__D034681 2003   
% 214.76/214.93  |- mesh__publicMeSHNote mesh__D034681 2003   
% 214.76/214.93  |- skos__broader mesh__D034681smesh__D028083
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D034681 2004
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D034681 2005
% 214.76/214.93  |- skos__prefLabel mesh__D034681 Bacopa
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D034681 2006
% 214.76/214.93  |- skos__broader mesh__D006990smesh__D026441
% 214.76/214.93  |- skos__broader mesh__D006990smesh__D011613
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006990 2005
% 214.76/214.93  |- skos__prefLabel mesh__D006990 Hypnosis
% 214.76/214.93  |- mesh__dateCreated mesh__D006990 1999-01-01
% 214.76/214.93  |- mesh__recordOriginator mesh__D006990 NLM
% 214.76/214.93  |- skos__hiddenLabel mesh__D006990 Hypnoses
% 214.76/214.93  |- skos__annotation mesh__D006990
% 214.76/214.93       human only; for animals use ANIMAL HYPNOSIS see IMMOBILITY RESPONSE, TONIC%A%  
% 214.76/214.93  |- mesh__onlineNote mesh__D006990
% 214.76/214.93       use HYPNOSIS to search MESMERISM 1966-78   
% 214.76/214.93  |- mesh__dateRevised mesh__D006990 2004-07-07
% 214.76/214.93  |- rdf__type mesh__D006990sskos__Concept
% 214.76/214.93  |- skos__scopeNote mesh__D006990
% 214.76/214.93       A state of increased receptivity to suggestion and direction, initially induced by the influence of another person.%A%    
% 214.76/214.93  |- mesh__recordMaintainer mesh__D006990 nns
% 214.76/214.93  |- mesh__recordAuthorizer mesh__D006990 sjn
% 214.76/214.93  |- mesh__historyNote mesh__D006990
% 214.76/214.93       MESMERISM was see under HYPNOSIS 1963-78   
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006990 2006
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006192 2002
% 214.76/214.93  |- skos__hiddenLabel mesh__D006192 Infection, Haemophilus
% 214.76/214.93  |- skos__hiddenLabel mesh__D006192 Hemophilus Infection
% 214.76/214.93  |- mesh__recordMaintainer mesh__D006192 TGC
% 214.76/214.93  |- skos__hiddenLabel mesh__D006192 Infection, Hemophilus
% 214.76/214.93  |- mesh__historyNote mesh__D006192 68   
% 214.76/214.93  |- skos__annotation mesh__D006192
% 214.76/214.93       gram-neg bact infect; check text for species %26% index by instructions on species; MENINGITIS, HAEMOPHILUS is also available%A%  
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006192 2003
% 214.76/214.93  |- skos__scopeNote mesh__D006192
% 214.76/214.93       Infections with bacteria of the genus HAEMOPHILUS.     
% 214.76/214.93  |- skos__hiddenLabel mesh__D006192 Haemophilus Infection
% 214.76/214.93  |- skos__prefLabel mesh__D006192 Haemophilus Infections
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006192 2000
% 214.76/214.93  |- mesh__dateRevised mesh__D006192 1996-06-10
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006192 2005
% 214.76/214.93  |- skos__altLabel mesh__D006192 Hemophilus Infections
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006192 2004
% 214.76/214.93  |- mesh__dateEstablished mesh__D006192 1968-01-01
% 214.76/214.93  |- mesh__recordAuthorizer mesh__D006192 PLS
% 214.76/214.93  |- mesh__recordOriginator mesh__D006192 NLM
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006192 2001
% 214.76/214.93  |- skos__altLabel mesh__D006192 Infections, Hemophilus
% 214.76/214.93  |- skos__broader mesh__D006192smesh__D016871
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006192 2006
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006192 1998
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006192 1997
% 214.76/214.93  |- mesh__dateCreated mesh__D006192 1999-01-01
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006192 1999
% 214.76/214.93  |- skos__historyNote mesh__D006192 Haemophilus %28%1966-1967%29%
% 214.76/214.93  |- rdf__type mesh__D006192sskos__Concept
% 214.76/214.93  |- skos__altLabel mesh__D006192 Infections, Haemophilus
% 214.76/214.93  |- mesh__publicMeSHNote mesh__D006192 68   
% 214.76/214.93  |- mesh__recordMaintainer mesh__D014624 lkt
% 214.76/214.93  |- mesh__recordOriginator mesh__D014624 NLM
% 214.76/214.93  |- skos__annotation mesh__D014624
% 214.76/214.93       fistula policy: Manual 23.19+; RECTOVAGINAL FISTULA %26% VESICOVAGINAL FISTULA are available%A%  
% 214.76/214.93  |- skos__hiddenLabel mesh__D014624 Fistula, Vaginal
% 214.76/214.93  |- skos__hiddenLabel mesh__D014624 Vaginal Fistulas
% 214.76/214.93  |- skos__prefLabel mesh__D014624 Vaginal Fistula
% 214.76/214.93  |- mesh__recordAuthorizer mesh__D014624 sjn
% 214.76/214.93  |- mesh__dateCreated mesh__D014624 1999-01-01
% 214.76/214.93  |- skos__broader mesh__D014624smesh__D014623
% 214.76/214.93  |- mesh__dateRevised mesh__D014624 2003-07-09
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D014624 2006
% 214.76/214.93  |- skos__scopeNote mesh__D014624
% 214.76/214.93       An abnormal anatomical passage that connects the VAGINA to other organs, such as the bladder %28%VESICOVAGINAL FISTULA%29% or the rectum %28%RECTOVAGINAL FISTULA%29%.%A%    
% 214.76/214.93  |- skos__hiddenLabel mesh__D014624 Fistulas, Vaginal
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D014624 2005
% 214.76/214.93  |- skos__broader mesh__D014624smesh__D005402
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D014624 2004
% 214.76/214.93  |- rdf__type mesh__D014624sskos__Concept
% 214.76/214.93  |- skos__broader mesh__D000604smesh__D019729
% 214.76/214.93  |- mesh__historyNote mesh__D000604
% 214.76/214.93       2005%28%1972%29%; use LIGASES 1966-1971   
% 214.76/214.93  |- skos__hiddenLabel mesh__D000604 Amino Acyl tRNA Ligases
% 214.76/214.93  |- skos__altLabel mesh__D000604 Aminoacyl-tRNA Synthetase
% 214.76/214.93  |- mesh__dateEstablished mesh__D000604 1972-01-01
% 214.76/214.93  |- skos__historyNote mesh__D000604 Ligases %28%1966-1971%29%
% 214.76/214.93  |- skos__hiddenLabel mesh__D000604 Synthetase, tRNA
% 214.76/214.93  |- skos__hiddenLabel mesh__D000604 Synthetase, Transfer RNA
% 214.76/214.93  |- rdf__type mesh__D000604sskos__Concept
% 214.76/214.93  |- mesh__publicMeSHNote mesh__D000604
% 214.76/214.93       2005; see AMINO ACYL-TRNA LIGASES 1998-2004, see AMINO ACYL T RNA SYNTHETASES 1972-1997%A%  
% 214.76/214.93  |- skos__altLabel mesh__D000604 Transfer RNA Synthetase
% 214.76/214.93  |- mesh__dateCreated mesh__D000604 1999-01-01
% 214.76/214.93  |- skos__altLabel mesh__D000604 tRNA Synthetase
% 214.76/214.93  |- mesh__recordOriginator mesh__D000604 NLM
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D000604 2005
% 214.76/214.93  |- skos__hiddenLabel mesh__D000604 Synthetase, Aminoacyl-tRNA
% 214.76/214.93  |- skos__related mesh__D000604smesh__D046249
% 214.76/214.93  |- skos__hiddenLabel mesh__D000604 Amino Acyl tRNA Synthetases
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D000604 2006
% 214.76/214.93  |- skos__prefLabel mesh__D000604 Amino Acyl-tRNA Synthetases
% 214.76/214.93  |- skos__hiddenLabel mesh__D000604 Ligases, Amino Acyl-tRNA
% 214.76/214.93  |- skos__hiddenLabel mesh__D000604 Aminoacyl tRNA Synthetase
% 214.76/214.93  |- skos__hiddenLabel mesh__D000604 Synthetases, Amino Acyl-tRNA
% 214.76/214.93  |- skos__hiddenLabel mesh__D000604 RNA Synthetase, Transfer
% 214.76/214.93  |- skos__hiddenLabel mesh__D000604 Acyl-tRNA Ligases, Amino
% 214.76/214.93  |- mesh__dateRevised mesh__D000604 2004-07-07
% 214.76/214.93  |- skos__scopeNote mesh__D000604
% 214.76/214.93       A subclass of enzymes that aminoacylate AMINO ACID-SPECIFIC TRANSFER RNA with their corresponding AMINO ACIDS.%A%    
% 214.76/214.93  |- skos__altLabel mesh__D000604 Aminoacyl Transfer RNA Synthetase
% 214.76/214.93  |- skos__hiddenLabel mesh__D000604 Acyl-tRNA Synthetases, Amino
% 214.76/214.93  |- mesh__recordMaintainer mesh__D000604 nns
% 214.76/214.93  |- mesh__recordAuthorizer mesh__D000604 sjn
% 214.76/214.93  |- skos__altLabel mesh__D000604 Amino Acyl-tRNA Ligases
% 214.76/214.93  |- skos__altLabel mesh__D000604 Amino Acyl T RNA Synthetases
% 214.76/214.93  |- skos__broader mesh__D005898smesh__D011108
% 214.76/214.93  |- mesh__recordOriginator mesh__D005898 NLM
% 214.76/214.93  |- skos__broader mesh__D005898smesh__D003252
% 214.76/214.93  |- rdf__type mesh__D005898sskos__Concept
% 214.76/214.93  |- mesh__recordMaintainer mesh__D005898 jmp
% 214.76/214.93  |- skos__annotation mesh__D005898 few qualif apply   
% 214.76/214.93  |- mesh__dateCreated mesh__D005898 1999-01-01
% 214.76/214.93  |- skos__prefLabel mesh__D005898 Glass
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D005898 2005
% 214.76/214.93  |- mesh__dateRevised mesh__D005898 2004-07-08
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D005898 2006
% 214.76/214.93  |- mesh__recordAuthorizer mesh__D005898 sjn
% 214.76/214.93  |- skos__scopeNote mesh__D005898
% 214.76/214.93       Hard, amorphous, brittle, inorganic, usually transparent, polymerous silicate of basic oxides, usually potassium or sodium. It is used in the form of hard sheets, vessels, tubing, fibers, ceramics, beads, etc.%A%    
% 214.76/214.93  |- rdf__type mesh__D018217sskos__Concept
% 214.76/214.93  |- mesh__dateCreated mesh__D018217 1993-06-25
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D018217 2003
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D018217 1997
% 214.76/214.93  |- skos__prefLabel mesh__D018217 Osteosarcoma, Juxtacortical
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D018217 1998
% 214.76/214.93  |- mesh__dateEstablished mesh__D018217 1994-01-01
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D018217 2000
% 214.76/214.93  |- mesh__recordMaintainer mesh__D018217 KEV
% 214.76/214.93  |- mesh__publicMeSHNote mesh__D018217 94   
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D018217 1996
% 214.76/214.93  |- skos__hiddenLabel mesh__D018217 Osteosarcomas, Juxtacortical
% 214.76/214.93  |- mesh__recordOriginator mesh__D018217 PLS
% 214.76/214.93  |- skos__scopeNote mesh__D018217
% 214.76/214.93       A form of osteogenic sarcoma of relatively low malignancy, probably arising from the periosteum and initially involving cortical bone and adjacent connective tissue. It occurs in middle-aged as well as young adults and most commonly affects the lower part of the femoral shaft. %28%Stedman, 25th ed%29%%A%    
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D018217 2002
% 214.76/214.93  |- mesh__historyNote mesh__D018217 94   
% 214.76/214.93  |- skos__hiddenLabel mesh__D018217 Juxtacortical Osteosarcoma
% 214.76/214.93  |- mesh__dateRevised mesh__D018217 1995-06-08
% 214.76/214.93  |- skos__broader mesh__D018217smesh__D012516
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D018217 2006
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D018217 2004
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D018217 2005
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D018217 1999
% 214.76/214.93  |- skos__annotation mesh__D018217
% 214.76/214.93       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS %28%IM%29% or specific precoord bone/neopl term %28%IM%29% or specific bone %28%IM%29% + BONE NEOPLASMS %28%IM%29%%A%  
% 214.76/214.93  |- skos__historyNote mesh__D018217 Osteosarcoma %28%1966-1993%29%
% 214.76/214.93  |- mesh__recordAuthorizer mesh__D018217 PLS
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D018217 2001
% 214.76/214.93  |- skos__hiddenLabel mesh__D018217 Juxtacortical Osteosarcomas
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D010234 2006
% 214.76/214.93  |- skos__prefLabel mesh__D010234 Paraganglia, Nonchromaffin
% 214.76/214.93  |- skos__broader mesh__D010234smesh__D002628
% 214.76/214.93  |- mesh__dateRevised mesh__D010234 2005-07-11
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D010234 2005
% 214.76/214.93  |- mesh__recordAuthorizer mesh__D010234 ags
% 214.76/214.93  |- mesh__recordMaintainer mesh__D010234 ags
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D010234 2004
% 214.76/214.93  |- rdf__type mesh__D010234sskos__Concept
% 214.76/214.93  |- skos__altLabel mesh__D010234 Paraganglia, Non-Chromaffin
% 214.76/214.93  |- mesh__recordOriginator mesh__D010234 NLM
% 214.76/214.93  |- mesh__dateCreated mesh__D010234 1999-01-01
% 214.76/214.93  |- skos__hiddenLabel mesh__D010234 Nonchromaffin Paraganglia
% 214.76/214.93  |- skos__scopeNote mesh__D010234
% 214.76/214.93       Several clusters of chemoreceptive and supporting cells associated with blood vessels and nerves %28%especially the glossopharyngeal and vagus%29%. The nonchromaffin paraganglia sense pH, carbon dioxide, and oxygen concentrations in the blood and participate in respiratory, and perhaps circulatory, control. They include the CAROTID BODY; AORTIC BODIES; the GLOMUS JUGULARE; and the GLOMUS TYMPANICUM.%A%    
% 214.76/214.93  |- skos__hiddenLabel mesh__D010234 Paraganglia, Non Chromaffin
% 214.76/214.93  |- skos__hiddenLabel mesh__D010234 Non-Chromaffin Paraganglia
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D010234 2006A
% 214.76/214.93  |- skos__hiddenLabel mesh__D034682
% 214.76/214.93       Church of Jesus Christ of Latter day Saints
% 214.76/214.93  |- skos__broader mesh__D034682smesh__D002835
% 214.76/214.93  |- rdf__type mesh__D034682sskos__Concept
% 214.76/214.93  |- mesh__recordOriginator mesh__D034682 tjk
% 214.76/214.93  |- skos__hiddenLabel mesh__D034682 Mormon
% 214.76/214.93  |- mesh__dateEstablished mesh__D034682 2003-01-01
% 214.76/214.93  |- mesh__recordAuthorizer mesh__D034682 sjn
% 214.76/214.93  |- mesh__publicMeSHNote mesh__D034682
% 214.76/214.93       2003; for MORMONS see CHRISTIANITY 1977-2002   
% 214.76/214.93  |- mesh__recordMaintainer mesh__D034682 jls
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D034682 2006
% 214.76/214.93  |- skos__hiddenLabel mesh__D034682 Church of Latter day Saints
% 214.76/214.93  |- mesh__dateRevised mesh__D034682 2005-06-30
% 214.76/214.93  |- skos__prefLabel mesh__D034682
% 214.76/214.93       Church of Jesus Christ of Latter-day Saints
% 214.76/214.93  |- mesh__dateCreated mesh__D034682 2002-07-12
% 214.76/214.93  |- skos__scopeNote mesh__D034682
% 214.76/214.93       A group of religious bodies tracing their origin to Joseph Smith in 1830 and accepting the Book of Mormon as divine revelation. %28%from Merriam-Webster%27%s Collegiate Dictionary, 10th ed%29%%A%    
% 214.76/214.93  |- skos__altLabel mesh__D034682 Church of Latter-day Saints
% 214.76/214.93  |- skos__hiddenLabel mesh__D034682 Latter-day Saints Church
% 214.76/214.93  |- mesh__historyNote mesh__D034682
% 214.76/214.93       2003; for MORMONS use CHRISTIANITY 1977-2002   
% 214.76/214.93  |- skos__prefLabel mesh__D006991 Hypnosis, Anesthetic
% 214.76/214.93  |- mesh__dateEstablished mesh__D006991 1965-01-01
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006991 1998
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006991 1991
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006991 1996
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006991 2002
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006991 1999
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006991 1997
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006991 1989
% 214.76/214.93  |- skos__hiddenLabel mesh__D006991 Hypnoses, Anesthetic
% 214.76/214.93  |- mesh__historyNote mesh__D006991 65   
% 214.76/214.93  |- rdf__type mesh__D006991sskos__Concept
% 214.76/214.93  |- skos__hiddenLabel mesh__D006991 Anesthetic Hypnoses
% 214.76/214.93  |- mesh__recordOriginator mesh__D006991 NLM
% 214.76/214.93  |- mesh__publicMeSHNote mesh__D006991 65   
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006991 2005
% 214.76/214.93  |- mesh__recordAuthorizer mesh__D006991 PLS
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006991 2000
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006991 1994
% 214.76/214.93  |- mesh__dateRevised mesh__D006991 1991-11-14
% 214.76/214.93  |- mesh__recordMaintainer mesh__D006991 PLS
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006991 1992
% 214.76/214.93  |- mesh__dateCreated mesh__D006991 1999-01-01
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006991 2003
% 214.76/214.93  |- skos__annotation mesh__D006991
% 214.76/214.93       do not use /util except by MeSH definition   
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006991 1995
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006991 2006
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006991 1993
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006991 1990
% 214.76/214.93  |- skos__broader mesh__D006991smesh__D000758
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006991 2004
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006991 2001
% 214.76/214.93  |- skos__hiddenLabel mesh__D006991 Anesthetic Hypnosis
% 214.76/214.93  |- skos__altLabel mesh__D020662 Guanine Nucleotide Releasing Factors
% 214.76/214.93  |- skos__hiddenLabel mesh__D020662 Factors, GDP Exchange
% 214.76/214.93  |- mesh__recordAuthorizer mesh__D020662 sjn
% 214.76/214.93  |- mesh__dateCreated mesh__D020662 1999-11-03
% 214.76/214.93  |- mesh__recordMaintainer mesh__D020662 SYSTEM
% 214.76/214.93  |- mesh__dateEstablished mesh__D020662 2000-01-01
% 214.76/214.93  |- skos__altLabel mesh__D020662 GDP Dissociation Stimulators
% 214.76/214.93  |- mesh__dateRevised mesh__D020662 2005-06-30
% 214.76/214.93  |- rdf__type mesh__D020662sskos__Concept
% 214.76/214.93  |- skos__altLabel mesh__D020662 GDP-GTP Reversing Factors
% 214.76/214.93  |- skos__hiddenLabel mesh__D020662 Guanine Nucleotide Releasing Factor
% 214.76/214.93  |- skos__prefLabel mesh__D020662 Guanine Nucleotide Exchange Factors
% 214.76/214.93  |- skos__historyNote mesh__D020662 G-Proteins %28%1994-1999%29%
% 214.76/214.93  |- skos__altLabel mesh__D020662 Guanine Nucleotide Exchange Factor
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D020662 2006
% 214.76/214.93  |- skos__altLabel mesh__D020662 GDP Exchange Factors
% 214.76/214.93  |- skos__hiddenLabel mesh__D020662 Exchange Factors, GDP
% 214.76/214.93  |- skos__broader mesh__D020662smesh__D020555
% 214.76/214.93  |- skos__hiddenLabel mesh__D020662 Reversing Factors, GDP-GTP
% 214.76/214.93  |- skos__hiddenLabel mesh__D020662 GDP GTP Reversing Factors
% 214.76/214.93  |- skos__hiddenLabel mesh__D020662 Factors, GDP-GTP Reversing
% 214.76/214.93  |- skos__historyNote mesh__D020662 Proteins %28%1978-1999%29%
% 214.76/214.93  |- skos__altLabel mesh__D020662 GDP-GTP Exchange Protein
% 214.76/214.93  |- skos__hiddenLabel mesh__D020662 GDP GTP Exchange Protein
% 214.76/214.93  |- mesh__historyNote mesh__D020662
% 214.76/214.93       2000; use GUANINE NUCLEOTIDE EXCHANGE FACTORS %28%NM%29% 1978-1999; for GDP-GTP EXCHANGE PROTEIN use RAB3 GTP-BINDING PROTEINS %28%NM%29% 1994-1999; for GDP DISSOCIATION FACTOR use RAP GTP-BINDING PROTEINS %28%NM%29% 1996-1999%A%  
% 214.76/214.93  |- skos__scopeNote mesh__D020662
% 214.76/214.93       Protein factors that promote the exchange of GTP for GDP bound to GTP-BINDING PROTEINS.%A%    
% 214.76/214.93  |- mesh__publicMeSHNote mesh__D020662
% 214.76/214.93       2000; GUANINE-NUCLEOTIDE-RELEASING FACTOR was indexed under PROTEINS 1978-1999; GDP-GTP EXCHANGE PROTEIN was indexed under G-PROTEINS 1994-1999; GDP DISSOCIATION FACTOR was indexed under G-PROTEINS 1996-1999%A%  
% 214.76/214.93  |- mesh__recordOriginator mesh__D020662 jmp
% 214.76/214.93  |- skos__altLabel mesh__D020662 GDP Dissociation Factor
% 214.76/214.93  |- skos__altLabel mesh__D020662 Guanine-Nucleotide-Releasing Factor
% 214.76/214.93  |- skos__prefLabel mesh__D006193 Haemophilus influenzae
% 214.76/214.93  |- skos__annotation mesh__D006193
% 214.76/214.93       infection: coord IM with HAEMOPHILUS INFECTIONS %28%IM%29%; vaccine = HAEMOPHILUS VACCINES%A%  
% 214.76/214.93  |- skos__broader mesh__D006193smesh__D006190
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D006193 2006
% 214.76/214.93  |- skos__scopeNote mesh__D006193
% 214.76/214.93       A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII.%A%    
% 214.76/214.93  |- skos__altLabel mesh__D006193 Hemophilus influenzae
% 214.76/214.93  |- mesh__dateCreated mesh__D006193 1999-01-01
% 214.76/214.93  |- mesh__recordMaintainer mesh__D006193 SYSTEM
% 214.76/214.93  |- mesh__dateRevised mesh__D006193 2005-06-30
% 214.76/214.93  |- rdf__type mesh__D006193sskos__Concept
% 214.76/214.93  |- mesh__recordAuthorizer mesh__D006193 sjn
% 214.76/214.93  |- mesh__recordOriginator mesh__D006193 NLM
% 214.76/214.93  |- skos__altLabel mesh__D014625 Vagina Cancer
% 214.76/214.93  |- skos__hiddenLabel mesh__D014625 Neoplasms, Vagina
% 214.76/214.93  |- skos__prefLabel mesh__D014625 Vaginal Neoplasms
% 214.76/214.93  |- skos__altLabel mesh__D014625 Vagina Neoplasms
% 214.76/214.93  |- skos__hiddenLabel mesh__D014625 Cancers, Vagina
% 214.76/214.93  |- skos__hiddenLabel mesh__D014625 Cancer, Vagina
% 214.76/214.93  |- mesh__dateCreated mesh__D014625 1999-01-01
% 214.76/214.93  |- mesh__recordMaintainer mesh__D014625 lkt
% 214.76/214.93  |- skos__hiddenLabel mesh__D014625 Vaginal Cancers
% 214.76/214.93  |- skos__altLabel mesh__D014625 Cancer of Vagina
% 214.76/214.93  |- skos__annotation mesh__D014625
% 214.76/214.93       coordinate IM with histologic type of neoplasm %28%IM%29%   
% 214.76/214.93  |- mesh__recordOriginator mesh__D014625 NLM
% 214.76/214.93  |- skos__hiddenLabel mesh__D014625 Vagina Cancers
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D014625 2006
% 214.76/214.93  |- skos__altLabel mesh__D014625 Cancer of the Vagina
% 214.76/214.93  |- skos__scopeNote mesh__D014625 Tumors or cancer of the VAGINA.     
% 214.76/214.93  |- skos__hiddenLabel mesh__D014625 Neoplasm, Vagina
% 214.76/214.93  |- skos__hiddenLabel mesh__D014625 Vagina Neoplasm
% 214.76/214.93  |- skos__broader mesh__D014625smesh__D014623
% 214.76/214.93  |- skos__hiddenLabel mesh__D014625 Vaginal Neoplasm
% 214.76/214.93  |- skos__altLabel mesh__D014625 Neoplasms, Vaginal
% 214.76/214.93  |- mesh__recordAuthorizer mesh__D014625 sjn
% 214.76/214.93  |- skos__hiddenLabel mesh__D014625 Neoplasm, Vaginal
% 214.76/214.93  |- mesh__dateRevised mesh__D014625 2005-06-30
% 214.76/214.93  |- rdf__type mesh__D014625sskos__Concept
% 214.76/214.93  |- skos__hiddenLabel mesh__D014625 Cancers, Vaginal
% 214.76/214.93  |- skos__broader mesh__D014625smesh__D005833
% 214.76/214.93  |- skos__hiddenLabel mesh__D014625 Cancer, Vaginal
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D000605 2002
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D000605 2005
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D000605 1998
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D000605 2001
% 214.76/214.93  |- mesh__dateCreated mesh__D000605 1999-01-01
% 214.76/214.93  |- mesh__recordAuthorizer mesh__D000605 SJN
% 214.76/214.93  |- skos__broader mesh__D000605smesh__D000588
% 214.76/214.93  |- skos__prefLabel mesh__D000605 Amino Alcohols
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D000605 2000
% 214.76/214.93  |- mesh__recordMaintainer mesh__D000605 ADP
% 214.76/214.93  |- skos__hiddenLabel mesh__D000605 Alcohols, Amino
% 214.76/214.93  |- rdf__type mesh__D000605sskos__Concept
% 214.76/214.93  |- skos__broader mesh__D000605smesh__D000438
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D000605 2004
% 214.76/214.93  |- mesh__recordOriginator mesh__D000605 NLM
% 214.76/214.93  |- mesh__dateRevised mesh__D000605 1997-06-20
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D000605 2006
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D000605 1999
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D000605 2003
% 214.76/214.93  |- skos__scopeNote mesh__D000605
% 214.76/214.93       Compounds possessing both a hydroxyl %28%-OH%29% and an amino group %28%-NH2%29%.%A%    
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D019310 2000
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D019310 1997
% 214.76/214.93  |- mesh__dateEstablished mesh__D019310 1997-01-01
% 214.76/214.93  |- skos__historyNote mesh__D019310
% 214.76/214.93       Lymphoma, Small Lymphocytic %28%1990-1996%29%
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D019310 2003
% 214.76/214.93  |- skos__historyNote mesh__D019310
% 214.76/214.93       Lymphoma, Non-Hodgkin%27%s %28%1967-1992%29%
% 214.76/214.93  |- mesh__onlineNote mesh__D019310
% 214.76/214.93       use LYMPHOMA, SMALL LYMPHOCYTIC to search LYMPHOCYTOMA 1991-96%A%  
% 214.76/214.93  |- skos__altLabel mesh__D019310 Lymphocytoma
% 214.76/214.93  |- skos__prefLabel mesh__D019310 Pseudolymphoma
% 214.76/214.93  |- skos__hiddenLabel mesh__D019310 Pseudolymphomas
% 214.76/214.93  |- mesh__dateCreated mesh__D019310 1996-06-10
% 214.76/214.93  |- skos__scopeNote mesh__D019310
% 214.76/214.93       A group of disorders having a benign course but exhibiting clinical and histological features suggestive of malignant lymphoma. Pseudolymphoma is characterized by a benign infiltration of lymphoid cells or histiocytes which microscopically resembles a malignant lymphoma. %28%From Dorland, 28th ed %26% Stedman, 26th ed%29%%A%    
% 214.76/214.93  |- mesh__publicMeSHNote mesh__D019310
% 214.76/214.93       97; LYMPHOCYTOMA was see LYMPHOMA, SMALL LYMPHOCYTIC 1991-96%A%  
% 214.76/214.93  |- skos__hiddenLabel mesh__D019310 Lymphocytomas
% 214.76/214.93  |- skos__altLabel mesh__D019310 Hyperplasia, Reactive Lymphoid
% 214.76/214.93  |- skos__historyNote mesh__D019310 Lymphoma %28%1966-1995%29%
% 214.76/214.93  |- skos__annotation mesh__D019310
% 214.76/214.93       non-neoplastic; coord IM with organ/dis %28%IM%29%   
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D019310 2006
% 214.76/214.93  |- skos__broader mesh__D019310smesh__D008206
% 214.76/214.93  |- rdf__type mesh__D019310sskos__Concept
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D019310 2002
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D019310 1999
% 214.76/214.93  |- mesh__historyNote mesh__D019310
% 214.76/214.93       97; LYMPHOCYTOMA was see LYMPHOMA, SMALL LYMPHOCYTIC 1991-96%A%  
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D019310 2005
% 214.76/214.93  |- skos__hiddenLabel mesh__D019310 Reactive Lymphoid Hyperplasia
% 214.76/214.93  |- skos__hiddenLabel mesh__D019310 Reactive Lymphoid Hyperplasias
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D019310 2001
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D019310 1998
% 214.76/214.93  |- skos__hiddenLabel mesh__D019310 Lymphoid Hyperplasias, Reactive
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D019310 2004
% 214.76/214.93  |- skos__hiddenLabel mesh__D019310 Hyperplasias, Reactive Lymphoid
% 214.76/214.93  |- skos__altLabel mesh__D019310 Lymphoid Hyperplasia, Reactive
% 214.76/214.93  |- skos__historyNote mesh__D005899 Dental Cements %28%1972-1979%29%
% 214.76/214.93  |- skos__hiddenLabel mesh__D005899 Cements, Glass Ionomer
% 214.76/214.93  |- skos__hiddenLabel mesh__D005899 Cements, Glass Polyalkenoate
% 214.76/214.93  |- skos__hiddenLabel mesh__D005899 Cements, Polyalkenoate
% 214.76/214.93  |- mesh__recordOriginator mesh__D005899 SH
% 214.76/214.93  |- skos__hiddenLabel mesh__D005899 Cement, Glass-Ionomer
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D005899 2003
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D005899 2000
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D005899 2005
% 214.76/214.93  |- skos__broader mesh__D005899smesh__D003738
% 214.76/214.93  |- skos__altLabel mesh__D005899 Glass-Ionomer Cement
% 214.76/214.93  |- mesh__recordAuthorizer mesh__D005899 SJN
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D005899 2004
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D005899 2001
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D005899 2006
% 214.76/214.93  |- skos__prefLabel mesh__D005899 Glass Ionomer Cements
% 214.76/214.93  |- skos__altLabel mesh__D005899 Polyalkenoate Cements
% 214.76/214.93  |- mesh__onlineNote mesh__D005899
% 214.76/214.93       use GLASS IONOMER CEMENTS to search ASPA CEMENT %26% SILICOPOLYACRYLATE CEMENT 1980-96%A%  
% 214.76/214.93  |- mesh__dateCreated mesh__D005899 1979-04-30
% 214.76/214.93  |- mesh__dateEstablished mesh__D005899 1991-01-01
% 214.76/214.93  |- mesh__historyNote mesh__D005899
% 214.76/214.93       91%28%80%29%; was see under DENTAL CEMENTS 1980-90; ASPA CEMENT %26% SILICOPOLYACRYLATE CEMENT were see GLASS IONOMER CEMENTS 1980-96%A%  
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D005899 1998
% 214.76/214.93  |- mesh__recordMaintainer mesh__D005899 ADP
% 214.76/214.93  |- skos__historyNote mesh__D005899 Cementation %28%1966-1971%29%
% 214.76/214.93  |- rdf__type mesh__D005899sskos__Concept
% 214.76/214.93  |- mesh__publicMeSHNote mesh__D005899
% 214.76/214.93       91; was see under DENTAL CEMENTS 1980-90; ASPA CEMENT %26% SILICOPOLYACRYLATE CEMENT were see GLASS IONOMER CEMENTS 1980-96%A%  
% 214.76/214.93  |- mesh__dateRevised mesh__D005899 1997-06-20
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D005899 2002
% 214.76/214.93  |- skos__annotation mesh__D005899 dent cements; D25-26 qualif   
% 214.76/214.93  |- skos__scopeNote mesh__D005899
% 214.76/214.93       A polymer obtained by reacting polyacrylic acid with a special anion-leachable glass %28%alumino-silicate%29%. The resulting cement is more durable and tougher than others in that the materials comprising the polymer backbone do not leach out.%A%    
% 214.76/214.93  |- skos__hiddenLabel mesh__D005899 Glass Ionomer Cement
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D005899 1999
% 214.76/214.93  |- skos__altLabel mesh__D005899 Glass Polyalkenoate Cements
% 214.76/214.93  |- mesh__activeMeSHYear mesh__D018218 1996
% 214.76/214.94  |- mesh__recordAuthorizer mesh__D018218 PLS
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D018218 2001
% 214.76/214.94  |- mesh__dateCreated mesh__D018218 1993-06-25
% 214.76/214.94  |- mesh__recordOriginator mesh__D018218 PLS
% 214.76/214.94  |- skos__scopeNote mesh__D018218
% 214.76/214.94       Neoplasms composed of fibrous tissue, the ordinary connective tissue of the body, made up largely of yellow or white fibers. The concept does not refer to neoplasms located in fibrous tissue.%A%    
% 214.76/214.94  |- mesh__dateEstablished mesh__D018218 1994-01-01
% 214.76/214.94  |- mesh__historyNote mesh__D018218 94   
% 214.76/214.94  |- skos__hiddenLabel mesh__D018218 Fibrous Tissue Neoplasm
% 214.76/214.94  |- mesh__dateRevised mesh__D018218 1995-06-08
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D018218 2000
% 214.76/214.94  |- skos__altLabel mesh__D018218 Fibrous Tissue Neoplasms
% 214.76/214.94  |- skos__broader mesh__D018218smesh__D009372
% 214.76/214.94  |- skos__annotation mesh__D018218
% 214.76/214.94       neoplasms composed of fibrous tissue, NOT neoplasms located in fibrous tissue: TN 135; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; restricted use: Manual 24.2.2.5; DF: NEOPL FIBROUS TISSUE%A%  
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D018218 2006
% 214.76/214.94  |- mesh__publicMeSHNote mesh__D018218 94   
% 214.76/214.94  |- skos__hiddenLabel mesh__D018218 Neoplasm, Fibrous Tissue
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D018218 2004
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D018218 2005
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D018218 1999
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D018218 2002
% 214.76/214.94  |- rdf__type mesh__D018218sskos__Concept
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D018218 2003
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D018218 1997
% 214.76/214.94  |- skos__prefLabel mesh__D018218 Neoplasms, Fibrous Tissue
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D018218 1998
% 214.76/214.94  |- mesh__recordMaintainer mesh__D018218 KEV
% 214.76/214.94  |- skos__hiddenLabel mesh__D010235 Paragangliomas, Gangliocytic
% 214.76/214.94  |- skos__scopeNote mesh__D010235
% 214.76/214.94       A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion, such as the carotid body, or medulla of the adrenal gland %28%usually called a chromaffinoma or pheochromocytoma%29%. It is more common in women than in men. %28%Stedman, 25th ed; from Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D010235 2002
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D010235 1999
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D010235 2004
% 214.76/214.94  |- rdf__type mesh__D010235sskos__Concept
% 214.76/214.94  |- skos__hiddenLabel mesh__D010235 Gangliocytic Paraganglioma
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D010235 2001
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D010235 1998
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D010235 2003
% 214.76/214.94  |- skos__prefLabel mesh__D010235 Paraganglioma
% 214.76/214.94  |- skos__broader mesh__D010235smesh__D018358
% 214.76/214.94  |- skos__hiddenLabel mesh__D010235 Gangliocytic Paragangliomas
% 214.76/214.94  |- mesh__recordAuthorizer mesh__D010235 PLS
% 214.76/214.94  |- skos__altLabel mesh__D010235 Paraganglioma, Gangliocytic
% 214.76/214.94  |- skos__annotation mesh__D010235
% 214.76/214.94       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl heading %28%IM%29%%A%  
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D010235 2000
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D010235 1997
% 214.76/214.94  |- mesh__dateRevised mesh__D010235 1995-06-08
% 214.76/214.94  |- mesh__dateCreated mesh__D010235 1999-01-01
% 214.76/214.94  |- skos__hiddenLabel mesh__D010235 Paragangliomas
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D010235 1996
% 214.76/214.94  |- mesh__recordOriginator mesh__D010235 NLM
% 214.76/214.94  |- mesh__recordMaintainer mesh__D010235 KEV
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D010235 2006
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D010235 2005
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006992 2001
% 214.76/214.94  |- skos__hiddenLabel mesh__D006992 Dental Hypnoses
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006992 1997
% 214.76/214.94  |- skos__prefLabel mesh__D006992 Hypnosis, Dental
% 214.76/214.94  |- skos__hiddenLabel mesh__D006992 Hypnoses, Dental
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006992 1991
% 214.76/214.94  |- mesh__dateEstablished mesh__D006992 1965-01-01
% 214.76/214.94  |- mesh__historyNote mesh__D006992 65   
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006992 2002
% 214.76/214.94  |- skos__broader mesh__D006992smesh__D000766
% 214.76/214.94  |- rdf__type mesh__D006992sskos__Concept
% 214.76/214.94  |- skos__broader mesh__D006992smesh__D006991
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006992 1994
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006992 2005
% 214.76/214.94  |- mesh__recordMaintainer mesh__D006992 TAP
% 214.76/214.94  |- skos__altLabel mesh__D006992 Dental Hypnosis
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006992 1992
% 214.76/214.94  |- skos__annotation mesh__D006992
% 214.76/214.94       do not use /util except by MeSH definition; DF: HYPNOSIS DENT%A%  
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006992 2003
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006992 1995
% 214.76/214.94  |- mesh__dateCreated mesh__D006992 1999-01-01
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006992 2006
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006992 1998
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006992 1993
% 214.76/214.94  |- mesh__dateRevised mesh__D006992 1990-05-29
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006992 2004
% 214.76/214.94  |- mesh__recordOriginator mesh__D006992 NLM
% 214.76/214.94  |- mesh__publicMeSHNote mesh__D006992 65   
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006992 1996
% 214.76/214.94  |- mesh__recordAuthorizer mesh__D006992 PLS
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006992 1999
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006992 2000
% 214.76/214.94  |- skos__broader mesh__D020663smesh__D020662
% 214.76/214.94  |- skos__altLabel mesh__D020663 ras-GEF
% 214.76/214.94  |- rdf__type mesh__D020663sskos__Concept
% 214.76/214.94  |- mesh__publicMeSHNote mesh__D020663
% 214.76/214.94       2000; RAS GUANINE NUCLEOTIDE EXCHANGE FACTOR was indexed under PROTEINS 1995-1999%A%  
% 214.76/214.94  |- mesh__recordOriginator mesh__D020663 jmp
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D020663 2006
% 214.76/214.94  |- skos__historyNote mesh__D020663 Proteins %28%1979-1999%29%
% 214.76/214.94  |- mesh__recordAuthorizer mesh__D020663 sjn
% 214.76/214.94  |- mesh__recordMaintainer mesh__D020663 SYSTEM
% 214.76/214.94  |- mesh__historyNote mesh__D020663
% 214.76/214.94       2000; for RAS GUANINE NUCLEOTIDE EXCHANGE FACTOR use RAS GUANINE NUCLEOTIDE EXCHANGE FACTORS %28%NM%29% 1995-1999%A%  
% 214.76/214.94  |- skos__hiddenLabel mesh__D020663 ras GEFs
% 214.76/214.94  |- mesh__dateEstablished mesh__D020663 2000-01-01
% 214.76/214.94  |- skos__altLabel mesh__D020663 rasGEFs
% 214.76/214.94  |- skos__altLabel mesh__D020663 ras-GEFs
% 214.76/214.94  |- mesh__dateRevised mesh__D020663 2005-06-30
% 214.76/214.94  |- skos__hiddenLabel mesh__D020663 ras GEF
% 214.76/214.94  |- mesh__dateCreated mesh__D020663 1999-11-03
% 214.76/214.94  |- skos__prefLabel mesh__D020663 ras Guanine Nucleotide Exchange Factors
% 214.76/214.94  |- skos__scopeNote mesh__D020663
% 214.76/214.94       A family of GUANINE NUCLEOTIDE EXCHANGE FACTORS that are specific for RAS PROTEINS.%A%    
% 214.76/214.94  |- skos__altLabel mesh__D020663 rasGEF
% 214.76/214.94  |- skos__altLabel mesh__D020663 ras Guanine Nucleotide Exchange Factor
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006194 2006
% 214.76/214.94  |- skos__annotation mesh__D006194
% 214.76/214.94       infection: coord IM with BACTERIAL INFECTIONS %28%IM%29% but consider also IM with VAGINOSIS, BACTERIAL %28%IM%29%%A%  
% 214.76/214.94  |- mesh__recordOriginator mesh__D006194 NLM
% 214.76/214.94  |- mesh__onlineNote mesh__D006194
% 214.76/214.94       use GARDNERELLA VAGINALIS to search HAEMOPHILUS VAGINALIS 1975-89 %26% CORYNEBACTERIUM VAGINALE 1983-91%A%  
% 214.76/214.94  |- mesh__recordMaintainer mesh__D006194 SYSTEM
% 214.76/214.94  |- skos__broader mesh__D006194smesh__D016975
% 214.76/214.94  |- rdf__type mesh__D006194sskos__Concept
% 214.76/214.94  |- mesh__dateEstablished mesh__D006194 1990-01-01
% 214.76/214.94  |- skos__altLabel mesh__D006194 Hemophilus vaginalis
% 214.76/214.94  |- mesh__dateCreated mesh__D006194 1974-12-12
% 214.76/214.94  |- mesh__dateRevised mesh__D006194 2005-06-30
% 214.76/214.94  |- mesh__publicMeSHNote mesh__D006194
% 214.76/214.94       90; was HAEMOPHILUS VAGINALIS see under HAEMOPHILUS 1975-89; CORYNEBACTERIUM VAGINALE was see GARDNERELLA VAGINALIS 1983-91%A%  
% 214.76/214.94  |- skos__scopeNote mesh__D006194
% 214.76/214.94       The only species in the genus GARDNERELLA, and previously classed as Haemophilus vaginalis. This bacterium, also isolated from the female genital tract of healthy women, is implicated in the cause of bacterial vaginosis %28%VAGINOSIS, BACTERIAL%29%. It occasionally causes postpartum bacteremia and bacteremia following a transurethral resection of the prostate.%A%    
% 214.76/214.94  |- mesh__recordAuthorizer mesh__D006194 sjn
% 214.76/214.94  |- mesh__historyNote mesh__D006194
% 214.76/214.94       90%28%75%29%; was HAEMOPHILUS VAGINALIS see under HAEMOPHILUS 1975-89; CORYNEBACTERIUM VAGINALE was see GARDNERELLA VAGINALIS 1983-91%A%  
% 214.76/214.94  |- skos__prefLabel mesh__D006194 Gardnerella vaginalis
% 214.76/214.94  |- skos__altLabel mesh__D006194 Corynebacterium vaginale
% 214.76/214.94  |- skos__altLabel mesh__D006194 Haemophilus vaginalis
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D014626 1999
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D014626 2005
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D014626 2000
% 214.76/214.94  |- skos__hiddenLabel mesh__D014626 Vaginal Smear
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D014626 1998
% 214.76/214.94  |- skos__annotation mesh__D014626
% 214.76/214.94       do not use /util except by MeSH definition; note X ref CERVICAL SMEARS: do not coord with CERVIX UTERI; X ref PAPANICOLAOU SMEAR: when called Pap smears, capitalize Pap in titles %26% translations%A%  
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D014626 2004
% 214.76/214.94  |- skos__hiddenLabel mesh__D014626 Smear, Papanicolaou
% 214.76/214.94  |- rdf__type mesh__D014626sskos__Concept
% 214.76/214.94  |- skos__hiddenLabel mesh__D014626 Smears, Vaginal
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D014626 2003
% 214.76/214.94  |- skos__altLabel mesh__D014626 Papanicolaou Smear
% 214.76/214.94  |- skos__broader mesh__D014626smesh__D013048
% 214.76/214.94  |- skos__broader mesh__D014626smesh__D003944
% 214.76/214.94  |- skos__hiddenLabel mesh__D014626 Smears, Cervical
% 214.76/214.94  |- mesh__recordOriginator mesh__D014626 NLM
% 214.76/214.94  |- mesh__recordAuthorizer mesh__D014626 SJN
% 214.76/214.94  |- skos__prefLabel mesh__D014626 Vaginal Smears
% 214.76/214.94  |- skos__broader mesh__D014626smesh__D003581
% 214.76/214.94  |- skos__hiddenLabel mesh__D014626 Cervical Smear
% 214.76/214.94  |- mesh__dateCreated mesh__D014626 1999-01-01
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D014626 2002
% 214.76/214.94  |- skos__hiddenLabel mesh__D014626 Smear, Cervical
% 214.76/214.94  |- skos__altLabel mesh__D014626 Papanicolaou Test
% 214.76/214.94  |- mesh__recordMaintainer mesh__D014626 PXP
% 214.76/214.94  |- skos__hiddenLabel mesh__D014626 Smear, Vaginal
% 214.76/214.94  |- skos__hiddenLabel mesh__D014626 Test, Papanicolaou
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D014626 2006
% 214.76/214.94  |- mesh__dateRevised mesh__D014626 1997-06-20
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D014626 2001
% 214.76/214.94  |- skos__scopeNote mesh__D014626
% 214.76/214.94       Collection of pooled secretions of the posterior vaginal fornix for cytologic examination.%A%    
% 214.76/214.94  |- mesh__recordOriginator mesh__D000606 NLM
% 214.76/214.94  |- skos__broader mesh__D000606smesh__D002241
% 214.76/214.94  |- skos__scopeNote mesh__D000606
% 214.76/214.94       SUGARS containing an amino group. GLYCOSYLATION of other compounds with these amino sugars results in AMINOGLYCOSIDES.%A%    
% 214.76/214.94  |- mesh__dateCreated mesh__D000606 1999-01-01
% 214.76/214.94  |- mesh__dateRevised mesh__D000606 2004-07-07
% 214.76/214.94  |- rdf__type mesh__D000606sskos__Concept
% 214.76/214.94  |- skos__prefLabel mesh__D000606 Amino Sugars
% 214.76/214.94  |- skos__hiddenLabel mesh__D000606 Sugars, Amino
% 214.76/214.94  |- mesh__recordAuthorizer mesh__D000606 sjn
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D000606 2006
% 214.76/214.94  |- mesh__recordMaintainer mesh__D000606 ssb
% 214.76/214.94  |- skos__related mesh__D000606smesh__D000617
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D000606 2005
% 214.76/214.94  |- mesh__dateEstablished mesh__D019311 1997-01-01
% 214.76/214.94  |- mesh__dateRevised mesh__D019311 2004-07-13
% 214.76/214.94  |- mesh__recordOriginator mesh__D019311 ADP
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D019311 2006
% 214.76/214.94  |- rdf__type mesh__D019311sskos__Concept
% 214.76/214.94  |- skos__historyNote mesh__D019311 Alkaloids %28%1977-1996%29%
% 214.76/214.94  |- mesh__onlineNote mesh__D019311
% 214.76/214.94       use STAUROSPORINE %28%NM%29% to search STAUROSPORINE 1980-96   
% 214.76/214.94  |- skos__scopeNote mesh__D019311
% 214.76/214.94       An indolocarbazole that is a potent PROTEIN KINASE C inhibitor which enhances cAMP-mediated responses in human neuroblastoma cells. %28%Biochem Biophys Res Commun 1995;214%28%3%29%:1114-20%29%%A%    
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D019311 2005
% 214.76/214.94  |- mesh__recordAuthorizer mesh__D019311 sjn
% 214.76/214.94  |- mesh__dateCreated mesh__D019311 1996-06-10
% 214.76/214.94  |- mesh__publicMeSHNote mesh__D019311
% 214.76/214.94       97; STAUROSPORINE was indexed under ALKALOIDS 1977-96   
% 214.76/214.94  |- skos__prefLabel mesh__D019311 Staurosporine
% 214.76/214.94  |- mesh__historyNote mesh__D019311
% 214.76/214.94       97; was STAUROSPORINE %28%NM%29% 1977-96   
% 214.76/214.94  |- skos__broader mesh__D019311smesh__D002227
% 214.76/214.94  |- skos__broader mesh__D019311smesh__D026121
% 214.76/214.94  |- mesh__recordMaintainer mesh__D019311 sjn
% 214.76/214.94  |- skos__hiddenLabel mesh__D046708 Parrot, Amazon
% 214.76/214.94  |- mesh__dateEstablished mesh__D046708 2005-01-01
% 214.76/214.94  |- mesh__dateCreated mesh__D046708 2004-07-07
% 214.76/214.94  |- skos__broader mesh__D046708smesh__D010311
% 214.76/214.94  |- rdf__type mesh__D046708sskos__Concept
% 214.76/214.94  |- mesh__recordAuthorizer mesh__D046708 sjn
% 214.76/214.94  |- mesh__recordMaintainer mesh__D046708 ags
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D046708 2006
% 214.76/214.94  |- skos__prefLabel mesh__D046708 Amazona
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D046708 2005
% 214.76/214.94  |- mesh__publicMeSHNote mesh__D046708 2005   
% 214.76/214.94  |- skos__historyNote mesh__D046708 Parrots %28%1989-2004%29%
% 214.76/214.94  |- mesh__recordOriginator mesh__D046708 ags
% 214.76/214.94  |- skos__altLabel mesh__D046708 Amazon Parrots
% 214.76/214.94  |- mesh__historyNote mesh__D046708 2005   
% 214.76/214.94  |- skos__scopeNote mesh__D046708
% 214.76/214.94       One of the largest genera of PARROTS, ranging from South American to Northern Mexico. Many species are commonly kept as house pets.%A%    
% 214.76/214.94  |- skos__hiddenLabel mesh__D046708 Amazon Parrot
% 214.76/214.94  |- skos__hiddenLabel mesh__D046708 Parrots, Amazon
% 214.76/214.94  |- mesh__dateRevised mesh__D018219 2005-06-30
% 214.76/214.94  |- skos__hiddenLabel mesh__D018219 Dermatofibromas
% 214.76/214.94  |- skos__altLabel mesh__D018219 Hemangioma, Sclerosing
% 214.76/214.94  |- skos__hiddenLabel mesh__D018219 Sclerosing Hemangioma
% 214.76/214.94  |- skos__scopeNote mesh__D018219
% 214.76/214.94       A benign tumor composed, wholly or in part, of cells with the morphologic characteristics of HISTIOCYTES and with various fibroblastic components.  Fibrous histiocytomas can occur anywhere in the body. When they occur in the skin, they are called dermatofibromas or sclerosing hemangiomas. %28%From DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 5th ed, p1747%29%%A%    
% 214.76/214.94  |- mesh__publicMeSHNote mesh__D018219
% 214.76/214.94       2006; see HISTIOCYTOMA, FIBROUS 1994-2005; for DERMATOFIBROMA see DERMATOFIBROMA 1994-2005, see ANGIOMA SCLEROSING 1963-1993%A%  
% 214.76/214.94  |- mesh__recordOriginator mesh__D018219 PLS
% 214.76/214.94  |- skos__hiddenLabel mesh__D018219 Fibrous Histiocytomas, Benign
% 214.76/214.94  |- skos__related mesh__D018219smesh__D047868
% 214.76/214.94  |- skos__annotation mesh__D018219
% 214.76/214.94       benign only; malignant = HISTIOCYTOMA, MALIGNANT FIBROUS; coordinate IM with precoordinated organ/neoplasm term %28%IM%29%%A%  
% 214.76/214.94  |- skos__hiddenLabel mesh__D018219 Histiocytomas, Cutaneous
% 214.76/214.94  |- skos__altLabel mesh__D018219 Histiocytoma, Cutaneous
% 214.76/214.94  |- skos__hiddenLabel mesh__D018219 Hemangiomas, Sclerosing
% 214.76/214.94  |- skos__hiddenLabel mesh__D018219 Fibrous Histiocytoma, Benign
% 214.76/214.94  |- skos__hiddenLabel mesh__D018219 Histiocytomas, Benign Fibrous
% 214.76/214.94  |- skos__hiddenLabel mesh__D018219 Benign Fibrous Histiocytomas
% 214.76/214.94  |- skos__altLabel mesh__D018219 Angioma, Sclerosing
% 214.76/214.94  |- skos__hiddenLabel mesh__D018219 Sclerosing Angiomas
% 214.76/214.94  |- skos__prefLabel mesh__D018219 Histiocytoma, Benign Fibrous
% 214.76/214.94  |- skos__hiddenLabel mesh__D018219 Fibrous Histiocytoma
% 214.76/214.94  |- skos__hiddenLabel mesh__D018219 Cutaneous Histiocytoma
% 214.76/214.94  |- mesh__recordAuthorizer mesh__D018219 sjn
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D018219 2006
% 214.76/214.94  |- skos__hiddenLabel mesh__D018219 Sclerosing Hemangiomas
% 214.76/214.94  |- skos__altLabel mesh__D018219 Benign Fibrous Histiocytoma
% 214.76/214.94  |- mesh__dateEstablished mesh__D018219 1994-01-01
% 214.76/214.94  |- skos__broader mesh__D018219smesh__D051642
% 214.76/214.94  |- skos__hiddenLabel mesh__D018219 Angiomas, Sclerosing
% 214.76/214.94  |- skos__altLabel mesh__D018219 Histiocytoma, Fibrous
% 214.76/214.94  |- mesh__dateCreated mesh__D018219 1993-06-25
% 214.76/214.94  |- skos__historyNote mesh__D018219 Dermatofibroma %28%1968-1993%29%
% 214.76/214.94  |- skos__hiddenLabel mesh__D018219 Cutaneous Histiocytomas
% 214.76/214.94  |- rdf__type mesh__D018219sskos__Concept
% 214.76/214.94  |- mesh__historyNote mesh__D018219 2006 %28%1994%29%   
% 214.76/214.94  |- skos__hiddenLabel mesh__D018219 Sclerosing Angioma
% 214.76/214.94  |- mesh__recordMaintainer mesh__D018219 ags
% 214.76/214.94  |- skos__hiddenLabel mesh__D018219 Fibrous Histiocytomas
% 214.76/214.94  |- skos__hiddenLabel mesh__D018219 Histiocytomas, Fibrous
% 214.76/214.94  |- mesh__onlineNote mesh__D010236
% 214.76/214.94       use PARAGANGLIOMA, EXTRA-ADRENAL to search PARAGANGLIOMA, NONCHROMAFFIN 1966-93%A%  
% 214.76/214.94  |- skos__scopeNote mesh__D010236
% 214.76/214.94       A relatively rare, usually benign neoplasm originating in the chemoreceptor tissue of the CAROTID BODY; GLOMUS JUGULARE; GLOMUS TYPANICUM;, and AORTIC BODIES. It consists histologically of rounded or ovoid hyperchromatic cells that tend to be grouped in an alveolus-like pattern within a scant to moderate amount of fibrous stroma and a few large thin-walled vascular channels. %28%From Stedman, 27th ed%29%%A%    
% 214.76/214.94  |- skos__hiddenLabel mesh__D010236 Non-Chromaffin Paragangliomas
% 214.76/214.94  |- mesh__dateCreated mesh__D010236 1999-01-01
% 214.76/214.94  |- mesh__recordOriginator mesh__D010236 NLM
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D010236 2004
% 214.76/214.94  |- rdf__type mesh__D010236sskos__Concept
% 214.76/214.94  |- skos__annotation mesh__D010236
% 214.76/214.94       coord IM with precoord organ/neopl term %28%IM%29%   
% 214.76/214.94  |- skos__altLabel mesh__D010236 Paraganglioma, Non-Chromaffin
% 214.76/214.94  |- skos__hiddenLabel mesh__D010236 Paragangliomas, Non-Chromaffin
% 214.76/214.94  |- skos__altLabel mesh__D010236 Paraganglioma, Nonchromaffin
% 214.76/214.94  |- mesh__dateRevised mesh__D010236 2005-07-11
% 214.76/214.94  |- skos__prefLabel mesh__D010236 Paraganglioma, Extra-Adrenal
% 214.76/214.94  |- skos__altLabel mesh__D010236 Chemodectoma
% 214.76/214.94  |- mesh__historyNote mesh__D010236
% 214.76/214.94       94; was PARAGANGLIOMA, NONCHROMAFFIN 1963-93   
% 214.76/214.94  |- skos__hiddenLabel mesh__D010236 Nonchromaffin Paragangliomas
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D010236 2006A
% 214.76/214.94  |- skos__hiddenLabel mesh__D010236 Paragangliomas, Extra-Adrenal
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D010236 2005
% 214.76/214.94  |- skos__hiddenLabel mesh__D010236 Paraganglioma, Extra Adrenal
% 214.76/214.94  |- skos__hiddenLabel mesh__D010236 Nonchromaffin Paraganglioma
% 214.76/214.94  |- mesh__recordAuthorizer mesh__D010236 ags
% 214.76/214.94  |- skos__hiddenLabel mesh__D010236 Extra-Adrenal Paragangliomas
% 214.76/214.94  |- skos__hiddenLabel mesh__D010236 Paraganglioma, Non Chromaffin
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D010236 2006
% 214.76/214.94  |- skos__hiddenLabel mesh__D010236 Non-Chromaffin Paraganglioma
% 214.76/214.94  |- skos__broader mesh__D010236smesh__D010235
% 214.76/214.94  |- skos__related mesh__D010236smesh__D005918
% 214.76/214.94  |- skos__hiddenLabel mesh__D010236 Paragangliomas, Nonchromaffin
% 214.76/214.94  |- skos__hiddenLabel mesh__D010236 Extra-Adrenal Paraganglioma
% 214.76/214.94  |- mesh__publicMeSHNote mesh__D010236
% 214.76/214.94       94; was PARAGANGLIOMA, NONCHROMAFFIN 1963-93   
% 214.76/214.94  |- mesh__recordMaintainer mesh__D010236 ags
% 214.76/214.94  |- skos__hiddenLabel mesh__D010236 Chemodectomas
% 214.76/214.94  |- skos__broader mesh__D006993smesh__D002492
% 214.76/214.94  |- skos__broader mesh__D006993smesh__D045505
% 214.76/214.94  |- skos__annotation mesh__D006993
% 214.76/214.94       CNS depressants; GEN: prefer specifics; DF: HYPNOTICS   
% 214.76/214.94  |- mesh__dateCreated mesh__D006993 1999-01-01
% 214.76/214.94  |- mesh__recordOriginator mesh__D006993 NLM
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006993 2006
% 214.76/214.94  |- skos__broader mesh__D006993smesh__D002491
% 214.76/214.94  |- skos__scopeNote mesh__D006993
% 214.76/214.94       Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.%A%    
% 214.76/214.94  |- skos__prefLabel mesh__D006993 Hypnotics and Sedatives
% 214.76/214.94  |- mesh__recordMaintainer mesh__D006993 ssb
% 214.76/214.94  |- skos__related mesh__D006993smesh__D006634
% 214.76/214.94  |- skos__altLabel mesh__D006993 Sedatives and Hypnotics
% 214.76/214.94  |- mesh__dateRevised mesh__D006993 2005-06-30
% 214.76/214.94  |- mesh__recordAuthorizer mesh__D006993 sjn
% 214.76/214.94  |- skos__related mesh__D006993smesh__D014149
% 214.76/214.94  |- rdf__type mesh__D006993sskos__Concept
% 214.76/214.94  |- rdf__type mesh__D020664sskos__Concept
% 214.76/214.94  |- skos__altLabel mesh__D020664 Son of Sevenless Protein
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D020664 2006
% 214.76/214.94  |- skos__prefLabel mesh__D020664 Son of Sevenless Proteins
% 214.76/214.94  |- mesh__recordMaintainer mesh__D020664 SYSTEM
% 214.76/214.94  |- mesh__dateEstablished mesh__D020664 2000-01-01
% 214.76/214.94  |- skos__annotation mesh__D020664
% 214.76/214.94       not for proteins involved in SOS RESPONSE %28%GENETICS%29%; SOS PROTEIN see SON OF SEVENLESS PROTEIN, DROSOPHILA is also available%A%  
% 214.76/214.94  |- skos__altLabel mesh__D020664 SOS Proteins
% 214.76/214.94  |- mesh__recordOriginator mesh__D020664 jmp
% 214.76/214.94  |- skos__broader mesh__D020664smesh__D020663
% 214.76/214.94  |- mesh__publicMeSHNote mesh__D020664
% 214.76/214.94       2000; SON OF SEVENLESS PROTEIN was indexed under MEMBRANE PROTEINS 1992-1999%A%  
% 214.76/214.94  |- mesh__recordAuthorizer mesh__D020664 sjn
% 214.76/214.94  |- skos__hiddenLabel mesh__D020664 Sevenless Protein Son
% 214.76/214.94  |- skos__scopeNote mesh__D020664
% 214.76/214.94       A class of RAS GUANINE NUCLEOTIDE EXCHANGE FACTORS that are genetically related to the Son of Sevenless gene from DROSOPHILA. Sevenless refers to genetic mutations in DROSOPHILA that cause loss of the R7 photoreceptor which is required to see UV light.%A%    
% 214.76/214.94  |- skos__historyNote mesh__D020664 Proteins %28%1978-1999%29%
% 214.76/214.94  |- mesh__dateRevised mesh__D020664 2005-06-30
% 214.76/214.94  |- skos__historyNote mesh__D020664 Membrane Proteins %28%1992-1999%29%
% 214.76/214.94  |- mesh__dateCreated mesh__D020664 1999-11-03
% 214.76/214.94  |- mesh__historyNote mesh__D020664
% 214.76/214.94       2000; use SON OF SEVENLESS PROTEINS %28%NM%29% 1992-1999   
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006195 2003
% 214.76/214.94  |- mesh__recordAuthorizer mesh__D006195 sjn
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006195 2006
% 214.76/214.94  |- mesh__recordMaintainer mesh__D006195 jmp
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006195 2002
% 214.76/214.94  |- skos__broader mesh__D006195smesh__D028561
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006195 2005
% 214.76/214.94  |- skos__broader mesh__D006195smesh__D019216
% 214.76/214.94  |- mesh__recordOriginator mesh__D006195 NLM
% 214.76/214.94  |- mesh__dateCreated mesh__D006195 1999-01-01
% 214.76/214.94  |- rdf__type mesh__D006195sskos__Concept
% 214.76/214.94  |- skos__annotation mesh__D006195
% 214.76/214.94       Hf-180; Hf-176-179 = HAFNIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Hf-168-175, 181-183 = HAFNIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 214.76/214.94  |- mesh__dateRevised mesh__D006195 2001-07-25
% 214.76/214.94  |- skos__prefLabel mesh__D006195 Hafnium
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D006195 2004
% 214.76/214.94  |- skos__scopeNote mesh__D006195
% 214.76/214.94       Hafnium. A metal element of atomic number 72 and atomic weight 178.49, symbol Hf. %28%From Dorland, 28th ed%29%%A%    
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D014627 2004
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D014627 1998
% 214.76/214.94  |- skos__prefLabel mesh__D014627 Vaginitis
% 214.76/214.94  |- mesh__dateRevised mesh__D014627 1997-06-20
% 214.76/214.94  |- skos__broader mesh__D014627smesh__D014623
% 214.76/214.94  |- rdf__type mesh__D014627sskos__Concept
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D014627 2001
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D014627 2003
% 214.76/214.94  |- skos__annotation mesh__D014627
% 214.76/214.94       TRICHOMONAS VAGINITIS is also available   
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D014627 2000
% 214.76/214.94  |- mesh__recordMaintainer mesh__D014627 TGC
% 214.76/214.94  |- skos__scopeNote mesh__D014627
% 214.76/214.94       Inflammation of the vagina characterized by pain and a purulent discharge.%A%    
% 214.76/214.94  |- mesh__dateCreated mesh__D014627 1999-01-01
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D014627 2006
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D014627 1999
% 214.76/214.94  |- skos__hiddenLabel mesh__D014627 Vaginitides
% 214.76/214.94  |- mesh__recordAuthorizer mesh__D014627 SJN
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D014627 2005
% 214.76/214.94  |- mesh__recordOriginator mesh__D014627 NLM
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D014627 2002
% 214.76/214.94  |- skos__scopeNote mesh__D000607 Cyanomethylamine.     
% 214.76/214.94  |- mesh__recordMaintainer mesh__D000607 CCR
% 214.76/214.94  |- skos__prefLabel mesh__D000607 Aminoacetonitrile
% 214.76/214.94  |- rdf__type mesh__D000607sskos__Concept
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D000607 2004
% 214.76/214.94  |- skos__historyNote mesh__D000607 Methylamines %28%1972-1974%29%
% 214.76/214.94  |- mesh__dateCreated mesh__D000607 1974-11-19
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D000607 2006
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D000607 2003
% 214.76/214.94  |- mesh__publicMeSHNote mesh__D000607
% 214.76/214.94       91; was see under ACETONITRILES 1975-90   
% 214.76/214.94  |- mesh__historyNote mesh__D000607
% 214.76/214.94       91%28%75%29%; was see under ACETONITRILES 1975-90   
% 214.76/214.94  |- skos__broader mesh__D000607smesh__D000097
% 214.76/214.94  |- mesh__recordOriginator mesh__D000607 NLM
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D000607 2005
% 214.76/214.94  |- skos__altLabel mesh__D000607 Glycinonitrile
% 214.76/214.94  |- skos__altLabel mesh__D000607 Cyanomethylamine
% 214.76/214.94  |- skos__historyNote mesh__D000607 Nitriles %28%1968-1974%29%
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D000607 2002
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D000607 2001
% 214.76/214.94  |- mesh__dateRevised mesh__D000607 2000-06-21
% 214.76/214.94  |- mesh__dateEstablished mesh__D000607 1991-01-01
% 214.76/214.94  |- mesh__recordAuthorizer mesh__D000607 sjn
% 214.76/214.94  |- skos__annotation mesh__D019312
% 214.76/214.94       NIM for electrostatic potentials, properties, interactions, fluctuations, etc. of specific substances %26% organisms %28%IM%29%%A%  
% 214.76/214.94  |- mesh__dateCreated mesh__D019312 1996-06-10
% 214.76/214.94  |- skos__prefLabel mesh__D019312 Electrostatics
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D019312 2005
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D019312 1998
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D019312 2000
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D019312 2006
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D019312 2001
% 214.76/214.94  |- skos__hiddenLabel mesh__D019312 Electricity, Static
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D019312 1999
% 214.76/214.94  |- skos__broader mesh__D019312smesh__D004560
% 214.76/214.94  |- skos__scopeNote mesh__D019312
% 214.76/214.94       The branch of physics dealing with electric phenomena not associated with electricity in motion, electric charges at rest, their electric fields, and potentials. %28%Random House Unabridged Dictionary, 2d ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%    
% 214.76/214.94  |- mesh__publicMeSHNote mesh__D019312 97   
% 214.76/214.94  |- mesh__historyNote mesh__D019312 97   
% 214.76/214.94  |- rdf__type mesh__D019312sskos__Concept
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D019312 2003
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D019312 2004
% 214.76/214.94  |- mesh__dateEstablished mesh__D019312 1997-01-01
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D019312 2002
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D019312 1997
% 214.76/214.94  |- rdf__type mesh__D046709sskos__Concept
% 214.76/214.94  |- skos__hiddenLabel mesh__D046709 Auditory Pattern Recognition
% 214.76/214.94  |- skos__broader mesh__D046709smesh__D010465
% 214.76/214.94  |- skos__scopeNote mesh__D046709
% 214.76/214.94       The analysis of a critical number of sensory stimuli or facts %28%the pattern%29% by physiological processes such as vision %28%PATTERN RECOGNITION, VISUAL%29%, touch, or hearing.%A%    
% 214.76/214.94  |- skos__prefLabel mesh__D046709 Pattern Recognition, Physiological
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D046709 2006
% 214.76/214.94  |- skos__hiddenLabel mesh__D046709 Physiological Pattern Recognition
% 214.76/214.94  |- mesh__recordOriginator mesh__D046709 lkt
% 214.76/214.94  |- mesh__dateEstablished mesh__D046709 2005-01-01
% 214.76/214.94  |- mesh__activeMeSHYear mesh__D046709 2005
% 214.76/214.95  |- mesh__publicMeSHNote mesh__D046709 2005   
% 214.76/214.95  |- mesh__recordMaintainer mesh__D046709 lkt
% 214.76/214.95  |- mesh__recordAuthorizer mesh__D046709 sjn
% 214.76/214.95  |- skos__hiddenLabel mesh__D046709 Recognition, Physiological Pattern
% 214.76/214.95  |- skos__hiddenLabel mesh__D046709 Recognition, Tactile Pattern
% 214.76/214.95  |- skos__hiddenLabel mesh__D046709 Tactile Pattern Recognition
% 214.76/214.95  |- mesh__historyNote mesh__D046709 2005   
% 214.76/214.95  |- skos__hiddenLabel mesh__D046709 Recognition, Auditory Pattern
% 214.76/214.95  |- mesh__dateCreated mesh__D046709 2004-07-07
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D010237 1996
% 214.76/214.95  |- skos__broader mesh__D010237smesh__D014201
% 214.76/214.95  |- skos__annotation mesh__D010237 trematode infect   
% 214.76/214.95  |- mesh__recordMaintainer mesh__D010237 TGC
% 214.76/214.95  |- mesh__dateRevised mesh__D010237 1993-06-02
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D010237 1997
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D010237 2002
% 214.76/214.95  |- mesh__recordOriginator mesh__D010237 NLM
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D010237 2005
% 214.76/214.95  |- skos__hiddenLabel mesh__D010237 Paragonimiases
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D010237 1994
% 214.76/214.95  |- mesh__recordAuthorizer mesh__D010237 PLS
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D010237 2006
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D010237 2000
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D010237 1998
% 214.76/214.95  |- skos__scopeNote mesh__D010237
% 214.76/214.95       Infection with trematodes of the genus PARAGONIMUS. %28%Dorland, 27th ed%29%%A%    
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D010237 2003
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D010237 1995
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D010237 2001
% 214.76/214.95  |- mesh__dateCreated mesh__D010237 1999-01-01
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D010237 1999
% 214.76/214.95  |- skos__prefLabel mesh__D010237 Paragonimiasis
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D010237 2004
% 214.76/214.95  |- rdf__type mesh__D010237sskos__Concept
% 214.76/214.95  |- skos__altLabel mesh__D015720 Uridylate 5%27%-Nucleotidase
% 214.76/214.95  |- skos__altLabel mesh__D015720 Inosinate Phosphatase
% 214.76/214.95  |- rdf__type mesh__D015720sskos__Concept
% 214.76/214.95  |- skos__altLabel mesh__D015720 Antigens, CD73
% 214.76/214.95  |- skos__altLabel mesh__D015720 5%27%-AMP Nucleotidase
% 214.76/214.95  |- skos__scopeNote mesh__D015720
% 214.76/214.95       A glycoprotein enzyme present in various organs and in many cells. The enzyme catalyzes the hydrolysis of a 5%27%-ribonucleotide to a ribonucleoside and orthophosphate in the presence of water. It is cation-dependent and exists in a membrane-bound and soluble form. EC 3.1.3.5.%A%    
% 214.76/214.95  |- skos__altLabel mesh__D015720 Cytidylate Phosphatase
% 214.76/214.95  |- mesh__dateCreated mesh__D015720 1989-05-16
% 214.76/214.95  |- skos__altLabel mesh__D015720 Thymidine Phosphatase
% 214.76/214.95  |- mesh__recordAuthorizer mesh__D015720 sjn
% 214.76/214.95  |- skos__broader mesh__D015720smesh__D015703
% 214.76/214.95  |- mesh__dateEstablished mesh__D015720 1990-01-01
% 214.76/214.95  |- skos__historyNote mesh__D015720 Nucleotidases %28%1966-1989%29%
% 214.76/214.95  |- skos__altLabel mesh__D015720 Adenylate Phosphatase
% 214.76/214.95  |- skos__hiddenLabel mesh__D015720 5%27% AMP Nucleotidase
% 214.76/214.95  |- skos__altLabel mesh__D015720 Antigen, CD73
% 214.76/214.95  |- skos__hiddenLabel mesh__D015720 5%27% Nucleotidase Phosphoribolase
% 214.76/214.95  |- skos__altLabel mesh__D015720 AMP Phosphatase
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D015720 2006
% 214.76/214.95  |- mesh__dateRevised mesh__D015720 2005-06-30
% 214.76/214.95  |- skos__prefLabel mesh__D015720 5%27%-Nucleotidase
% 214.76/214.95  |- skos__altLabel mesh__D015720 IMP Nucleotidase
% 214.76/214.95  |- mesh__recordMaintainer mesh__D015720 ssb
% 214.76/214.95  |- skos__altLabel mesh__D015720 CD73 Antigens
% 214.76/214.95  |- mesh__publicMeSHNote mesh__D015720
% 214.76/214.95       90; CD73 ANTIGENS was CD73 ANTIGEN 1992-93   
% 214.76/214.95  |- skos__hiddenLabel mesh__D015720 Uridylate 5%27% Nucleotidase
% 214.76/214.95  |- skos__hiddenLabel mesh__D015720 Ecto 5%27% Nucleotidase
% 214.76/214.95  |- skos__altLabel mesh__D015720 IMPase
% 214.76/214.95  |- skos__altLabel mesh__D015720 IMP Phosphatase
% 214.76/214.95  |- mesh__historyNote mesh__D015720
% 214.76/214.95       90; CD73 ANTIGENS was CD73 ANTIGEN 1992-93   
% 214.76/214.95  |- skos__altLabel mesh__D015720 Ecto-5%27%-Nucleotidase
% 214.76/214.95  |- skos__altLabel mesh__D015720 5%27%-Nucleotidase Phosphoribolase
% 214.76/214.95  |- skos__hiddenLabel mesh__D015720 5%27% Nucleotidase
% 214.76/214.95  |- mesh__recordOriginator mesh__D015720 RLS
% 214.76/214.95  |- skos__hiddenLabel mesh__D015720 Pyrimidine 5%27% Nucleotidase
% 214.76/214.95  |- skos__altLabel mesh__D015720 Pyrimidine 5%27%-Nucleotidase
% 214.76/214.95  |- skos__broader mesh__D015720smesh__D009708
% 214.76/214.95  |- skos__hiddenLabel mesh__D015720 CD73 Antigen
% 214.76/214.95  |- mesh__onlineNote mesh__D001700
% 214.76/214.95       use BIOMPHALARIA to search AUSTRALORBIS GLABRATUS 1972-78%A%  
% 214.76/214.95  |- mesh__dateRevised mesh__D001700 2005-06-30
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D001700 2006
% 214.76/214.95  |- skos__prefLabel mesh__D001700 Biomphalaria
% 214.76/214.95  |- rdf__type mesh__D001700sskos__Concept
% 214.76/214.95  |- mesh__dateEstablished mesh__D001700 1972-01-01
% 214.76/214.95  |- mesh__recordOriginator mesh__D001700 NLM
% 214.76/214.95  |- skos__historyNote mesh__D001700 Snails %28%1966-1971%29%
% 214.76/214.95  |- skos__broader mesh__D001700smesh__D012908
% 214.76/214.95  |- mesh__recordMaintainer mesh__D001700 ags
% 214.76/214.95  |- skos__scopeNote mesh__D001700
% 214.76/214.95       A genus of planorbid freshwater snails, species of which are intermediate hosts of Schistosoma mansoni.%A%    
% 214.76/214.95  |- mesh__dateCreated mesh__D001700 1999-01-01
% 214.76/214.95  |- mesh__publicMeSHNote mesh__D001700 72   
% 214.76/214.95  |- skos__annotation mesh__D001700
% 214.76/214.95       freshwater snail; /microbiol /parasitol /virol permitted   
% 214.76/214.95  |- mesh__recordAuthorizer mesh__D001700 sjn
% 214.76/214.95  |- mesh__historyNote mesh__D001700
% 214.76/214.95       72; AUSTRALORBIS GLABRATUS was see under BIOMPHALARIA 1972-78%A%  
% 214.76/214.95  |- skos__altLabel mesh__D001700 Australorbis
% 214.76/214.95  |- mesh__publicMeSHNote mesh__D006994 88   
% 214.76/214.95  |- skos__scopeNote mesh__D006994
% 214.76/214.95       A congenital or acquired condition of insufficient production of ALDOSTERONE by the ADRENAL CORTEX leading to diminished aldosterone-mediated synthesis of Na%28%+%29%-K%28%+%29%-EXCHANGING ATPASE in renal tubular cells. Clinical symptoms include HYPERKALEMIA, sodium-wasting, HYPOTENSION, and sometimes metabolic ACIDOSIS.%A%    
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D006994 2006
% 214.76/214.95  |- skos__hiddenLabel mesh__D006994 Hyporeninemic Hypoaldosteronism
% 214.76/214.95  |- skos__altLabel mesh__D006994 Renal Tubular Acidosis, Type IV
% 214.76/214.95  |- mesh__historyNote mesh__D006994 88   
% 214.76/214.95  |- mesh__dateRevised mesh__D006994 2004-07-07
% 214.76/214.95  |- skos__annotation mesh__D006994
% 214.76/214.95       do not confuse with HYPERALDOSTERONISM or PSEUDOHYPOALDOSTERONISM%A%  
% 214.76/214.95  |- skos__broader mesh__D006994smesh__D000309
% 214.76/214.95  |- skos__prefLabel mesh__D006994 Hypoaldosteronism
% 214.76/214.95  |- mesh__recordOriginator mesh__D006994 SCD
% 214.76/214.95  |- mesh__dateCreated mesh__D006994 1987-03-13
% 214.76/214.95  |- skos__historyNote mesh__D006994
% 214.76/214.95       Adrenal Gland Hypofunction %28%1966-1987%29%
% 214.76/214.95  |- skos__altLabel mesh__D006994 Type IV Renal Tubular Acidosis
% 214.76/214.95  |- skos__historyNote mesh__D006994 Aldosterone %28%1966-1987%29%
% 214.76/214.95  |- mesh__recordMaintainer mesh__D006994 lkt
% 214.76/214.95  |- rdf__type mesh__D006994sskos__Concept
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D006994 2005
% 214.76/214.95  |- skos__altLabel mesh__D006994 Acidosis, Renal Tubular Type IV
% 214.76/214.95  |- mesh__dateEstablished mesh__D006994 1988-01-01
% 214.76/214.95  |- mesh__recordAuthorizer mesh__D006994 sjn
% 214.76/214.95  |- mesh__dateCreated mesh__D020665 1999-11-03
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D020665 2006A
% 214.76/214.95  |- mesh__recordMaintainer mesh__D020665 ags
% 214.76/214.95  |- mesh__dateEstablished mesh__D020665 2000-01-01
% 214.76/214.95  |- skos__annotation mesh__D020665 SEPTUM PELLUCIDUM is also available   
% 214.76/214.95  |- mesh__historyNote mesh__D020665 2000   
% 214.76/214.95  |- skos__hiddenLabel mesh__D020665 Brain Septum
% 214.76/214.95  |- mesh__publicMeSHNote mesh__D020665 2000   
% 214.76/214.95  |- skos__broader mesh__D020665smesh__D013687
% 214.76/214.95  |- skos__hiddenLabel mesh__D020665 Brain Septums
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D020665 2005
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D020665 2000
% 214.76/214.95  |- skos__broader mesh__D020665smesh__D008032
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D020665 2003
% 214.76/214.95  |- rdf__type mesh__D020665sskos__Concept
% 214.76/214.95  |- mesh__dateRevised mesh__D020665 2005-07-29
% 214.76/214.95  |- skos__hiddenLabel mesh__D020665 Region, Septal
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D020665 2006
% 214.76/214.95  |- skos__prefLabel mesh__D020665 Septum of Brain
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D020665 2001
% 214.76/214.95  |- skos__hiddenLabel mesh__D020665 Area, Septal
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D020665 2004
% 214.76/214.95  |- mesh__recordOriginator mesh__D020665 ags
% 214.76/214.95  |- skos__historyNote mesh__D020665 Septum Pellucidum %28%1972-1999%29%
% 214.76/214.95  |- skos__historyNote mesh__D020665 Brain %28%1966-1999%29%
% 214.76/214.95  |- mesh__recordAuthorizer mesh__D020665 ags
% 214.76/214.95  |- skos__scopeNote mesh__D020665
% 214.76/214.95       Gray matter structures of the telencephalon and limbic system in the brain, but containing widely varying definitions among authors. Included here is the cortical septal area, subcortical SEPTAL NUCLEI, and the SEPTUM PELLUCIDUM. Many authorities consider the septal region to be made up of the septal area and the septal nuclei, but excluding the septum pellucidum. %28%Anthoney, Neuroanatomy and the Neurologic Exam, 1994, pp485-489; NeuroNames, http://rprcsgi.rprc.washington.edu/neuronames/index.html %28%November 18, 1998%29%%29%.%A%    
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D020665 2002
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D006196 2006
% 214.76/214.95  |- mesh__recordAuthorizer mesh__D006196 ags
% 214.76/214.95  |- mesh__dateRevised mesh__D006196 2005-07-20
% 214.76/214.95  |- skos__broader mesh__D006196smesh__D024561
% 214.76/214.95  |- skos__broader mesh__D006196smesh__D005399
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D006196 2005
% 214.76/214.95  |- mesh__dateEstablished mesh__D006196 1991-01-01
% 214.76/214.95  |- mesh__dateCreated mesh__D006196 1999-01-01
% 214.76/214.95  |- mesh__historyNote mesh__D006196 2002 %28%1975%29%   
% 214.76/214.95  |- mesh__recordMaintainer mesh__D006196 ags
% 214.76/214.95  |- rdf__type mesh__D006196sskos__Concept
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D006196 2004
% 214.76/214.95  |- mesh__publicMeSHNote mesh__D006196
% 214.76/214.95       2002;  see HAGFISH 1991-2001, see CYCLOSTOMES 1975-1990   
% 214.76/214.95  |- skos__altLabel mesh__D006196 Hagfish
% 214.76/214.95  |- mesh__recordOriginator mesh__D006196 NLM
% 214.76/214.95  |- skos__scopeNote mesh__D006196
% 214.76/214.95       Common name for a family of eel-shaped jawless fishes %28%Myxinidae%29%, the only family in the order MYXINIFORMES. They are not true vertebrates.%A%    
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D006196 2006A
% 214.76/214.95  |- skos__prefLabel mesh__D006196 Hagfishes
% 214.76/214.95  |- rdf__type mesh__D014628sskos__Concept
% 214.76/214.95  |- mesh__dateCreated mesh__D014628 1999-01-01
% 214.76/214.95  |- skos__prefLabel mesh__D014628 Vagotomy
% 214.76/214.95  |- mesh__recordOriginator mesh__D014628 NLM
% 214.76/214.95  |- skos__broader mesh__D014628smesh__D017764
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D014628 2005
% 214.76/214.95  |- mesh__recordAuthorizer mesh__D014628 sjn
% 214.76/214.95  |- mesh__recordMaintainer mesh__D014628 ags
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D014628 2006
% 214.76/214.95  |- skos__hiddenLabel mesh__D014628 Vagotomies
% 214.76/214.95  |- skos__annotation mesh__D014628
% 214.76/214.95       also called %22%hyperselective,%22% %22%superselective,%22% %22%supraselective,%22% %22%ultraselective%22% vagotomy%A%  
% 214.76/214.95  |- skos__scopeNote mesh__D014628
% 214.76/214.95       The interruption or removal of any part of the vagus %28%10th cranial%29% nerve. Vagotomy may be performed for research or for therapeutic purposes.%A%    
% 214.76/214.95  |- mesh__dateRevised mesh__D014628 2004-07-07
% 214.76/214.95  |- skos__broader mesh__D014628smesh__D003714
% 214.76/214.95  |- skos__altLabel mesh__D019313 BRCA1 Gene Product
% 214.76/214.95  |- mesh__dateRevised mesh__D019313 2005-06-30
% 214.76/214.95  |- skos__historyNote mesh__D019313 Transcription Factors %28%1994-1996%29%
% 214.76/214.95  |- skos__broader mesh__D019313smesh__D009687
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D019313 2006
% 214.76/214.95  |- mesh__dateCreated mesh__D019313 1996-06-10
% 214.76/214.95  |- mesh__recordAuthorizer mesh__D019313 sjn
% 214.76/214.95  |- mesh__onlineNote mesh__D019313
% 214.76/214.95       use BRCA1 PROTEIN %28%NM%29% to search BRCA1 PROTEIN 1994-96   
% 214.76/214.95  |- rdf__type mesh__D019313sskos__Concept
% 214.76/214.95  |- skos__broader mesh__D019313smesh__D014157
% 214.76/214.95  |- mesh__publicMeSHNote mesh__D019313
% 214.76/214.95       97; BCRA1 PROTEIN was indexed under NEOPLASM PROTEINS %26% TRANSCRIPTION FACTORS 1994-96%A%  
% 214.76/214.95  |- skos__scopeNote mesh__D019313
% 214.76/214.95       The phosphoprotein encoded by the BRCA1 gene %28%GENE, BRCA1%29%. In normal cells the BRCA1 protein is localized in the nucleus, whereas in the majority of breast cancer cell lines and in malignant pleural effusions from breast cancer patients, it is localized mainly in the cytoplasm. %28%Science 1995;270%28%5237%29%:713,789-91%29%%A%    
% 214.76/214.95  |- skos__prefLabel mesh__D019313 BRCA1 Protein
% 214.76/214.95  |- skos__altLabel mesh__D019313 Breast Cancer 1 Protein
% 214.76/214.95  |- mesh__recordMaintainer mesh__D019313 DRC
% 214.76/214.95  |- skos__altLabel mesh__D019313 Breast Cancer 1 Gene Product
% 214.76/214.95  |- skos__broader mesh__D019313smesh__D010750
% 214.76/214.95  |- skos__related mesh__D019313smesh__D019398
% 214.76/214.95  |- mesh__recordOriginator mesh__D019313 TPW
% 214.76/214.95  |- skos__broader mesh__D019313smesh__D025521
% 214.76/214.95  |- skos__historyNote mesh__D019313 Neoplasm Proteins %28%1994-1996%29%
% 214.76/214.95  |- mesh__historyNote mesh__D019313
% 214.76/214.95       97; was BRCA1 PROTEIN %28%NM%29% 1994-96   
% 214.76/214.95  |- mesh__dateEstablished mesh__D019313 1997-01-01
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D000608 2006
% 214.76/214.95  |- mesh__publicMeSHNote mesh__D000608 65; was AMINOACIDURIA 1963-64   
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D000608 2003
% 214.76/214.95  |- mesh__recordMaintainer mesh__D000608 nns
% 214.76/214.95  |- skos__broader mesh__D000608smesh__D000592
% 214.76/214.95  |- mesh__recordAuthorizer mesh__D000608 sjn
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D000608 2005
% 214.76/214.95  |- skos__scopeNote mesh__D000608
% 214.76/214.95       Impairment of renal tubular transport of amino acids.     
% 214.76/214.95  |- skos__broader mesh__D000608smesh__D015499
% 214.76/214.95  |- skos__annotation mesh__D000608
% 214.76/214.95       impairment of renal tubule transport of amino acids; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific amino acid /urine %28%IM%29%%A%  
% 214.76/214.95  |- mesh__historyNote mesh__D000608 65; was AMINOACIDURIA 1963-64   
% 214.76/214.95  |- mesh__dateCreated mesh__D000608 1999-01-01
% 214.76/214.95  |- mesh__recordOriginator mesh__D000608 NLM
% 214.76/214.95  |- skos__prefLabel mesh__D000608 Aminoaciduria, Renal
% 214.76/214.95  |- mesh__dateRevised mesh__D000608 2001-07-25
% 214.76/214.95  |- mesh__dateEstablished mesh__D000608 1965-01-01
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D000608 2002
% 214.76/214.95  |- skos__hiddenLabel mesh__D000608 Renal Aminoaciduria
% 214.76/214.95  |- rdf__type mesh__D000608sskos__Concept
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D000608 2004
% 214.76/214.95  |- skos__scopeNote mesh__D011330
% 214.76/214.95       Penal institutions, or places of confinement for war prisoners.%A%    
% 214.76/214.95  |- skos__broader mesh__D011330smesh__D012926
% 214.76/214.95  |- mesh__recordOriginator mesh__D011330 NLM
% 214.76/214.95  |- skos__hiddenLabel mesh__D011330 Prison
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D011330 2001
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D011330 2005
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D011330 2002
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D011330 2006
% 214.76/214.95  |- skos__annotation mesh__D011330 specify geog   
% 214.76/214.95  |- mesh__recordAuthorizer mesh__D011330 sjn
% 214.76/214.95  |- mesh__dateCreated mesh__D011330 1999-01-01
% 214.76/214.95  |- mesh__recordMaintainer mesh__D011330 kle
% 214.76/214.95  |- mesh__dateRevised mesh__D011330 1999-11-03
% 214.76/214.95  |- rdf__type mesh__D011330sskos__Concept
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D011330 2003
% 214.76/214.95  |- skos__prefLabel mesh__D011330 Prisons
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D011330 2000
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D011330 2004
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D029741 2005
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D029741 2003
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D029741 2006
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D029741 2004
% 214.76/214.95  |- skos__annotation mesh__D029741
% 214.76/214.95       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.76/214.95  |- rdf__type mesh__D029741sskos__Concept
% 214.76/214.95  |- skos__altLabel mesh__D029741 Rapeseed
% 214.76/214.95  |- mesh__dateCreated mesh__D029741 2001-07-25
% 214.76/214.95  |- mesh__dateEstablished mesh__D029741 2002-01-01
% 214.76/214.95  |- skos__prefLabel mesh__D029741 Brassica rapa
% 214.76/214.95  |- mesh__historyNote mesh__D029741
% 214.76/214.95       2002; for RAPESEED use BRASSICA 1977-2001   
% 214.76/214.95  |- mesh__dateRevised mesh__D029741 2002-07-02
% 214.76/214.95  |- mesh__publicMeSHNote mesh__D029741
% 214.76/214.95       2002; for RAPESEED see BRASSICA 1977-2001   
% 214.76/214.95  |- skos__historyNote mesh__D029741 Brassica %28%1977-2001%29%
% 214.76/214.95  |- skos__broader mesh__D029741smesh__D001937
% 214.76/214.95  |- skos__scopeNote mesh__D029741
% 214.76/214.95       A plant species cultivated for the seed used as animal feed and as a source of canola cooking oil.%A%    
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D010238 2005
% 214.76/214.95  |- skos__broader mesh__D010238smesh__D014322
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D010238 2006
% 214.76/214.95  |- mesh__dateRevised mesh__D010238 2004-07-07
% 214.76/214.95  |- skos__scopeNote mesh__D010238
% 214.76/214.95       A genus of lung flukes of the family Troglotrematidae infecting humans and animals. This genus consists of several species one of which is PARAGONIMUS WESTERMANI, a common lung fluke in humans.%A%    
% 214.76/214.95  |- mesh__recordAuthorizer mesh__D010238 sjn
% 214.76/214.95  |- mesh__dateCreated mesh__D010238 1999-01-01
% 214.76/214.95  |- mesh__recordMaintainer mesh__D010238 ags
% 214.76/214.95  |- rdf__type mesh__D010238sskos__Concept
% 214.76/214.95  |- skos__annotation mesh__D010238
% 214.76/214.95       infection = PARAGONIMIASIS; coordinate with specific helminth terms %28%for example, ANTIGENS, HELMINTH%29% if pertinent%A%  
% 214.76/214.95  |- mesh__recordOriginator mesh__D010238 NLM
% 214.76/214.95  |- skos__prefLabel mesh__D010238 Paragonimus
% 214.76/214.95  |- skos__hiddenLabel mesh__D015721 Vaccine, DPT
% 214.76/214.95  |- skos__broader mesh__D015721smesh__D010567
% 214.76/214.95  |- skos__hiddenLabel mesh__D015721 Di Te Per Vaccine
% 214.76/214.95  |- mesh__recordOriginator mesh__D015721 RLS
% 214.76/214.95  |- skos__hiddenLabel mesh__D015721 Vaccine, Diphtheria-Pertussis-Tetanus
% 214.76/214.95  |- skos__hiddenLabel mesh__D015721 Diphtheria Tetanus Pertussis Vaccine
% 214.76/214.95  |- mesh__dateEstablished mesh__D015721 1990-01-01
% 214.76/214.95  |- mesh__dateCreated mesh__D015721 1989-07-14
% 214.76/214.95  |- skos__hiddenLabel mesh__D015721 Vaccine, DTP
% 214.76/214.95  |- skos__broader mesh__D015721smesh__D017778
% 214.76/214.95  |- skos__historyNote mesh__D015721 Diphtheria Toxoid %28%1966-1989%29%
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D015721 2006
% 214.76/214.95  |- skos__historyNote mesh__D015721 Pertussis Vaccine %28%1966-1989%29%
% 214.76/214.95  |- skos__hiddenLabel mesh__D015721 Vaccine, Di-Te-Per
% 214.76/214.95  |- skos__hiddenLabel mesh__D015721 Diphtheria Pertussis Tetanus Vaccine
% 214.76/214.95  |- skos__prefLabel mesh__D015721 Diphtheria-Tetanus-Pertussis Vaccine
% 214.76/214.95  |- skos__scopeNote mesh__D015721
% 214.76/214.95       A vaccine consisting of DIPHTHERIA TOXOID; TETANUS TOXOID; and whole-cell PERTUSSIS VACCINE. The vaccine protects against diphtheria, tetanus, and whooping cough.%A%    
% 214.76/214.95  |- mesh__recordMaintainer mesh__D015721 ags
% 214.76/214.95  |- skos__broader mesh__D015721smesh__D013745
% 214.76/214.95  |- skos__altLabel mesh__D015721 DTwP Vaccine
% 214.76/214.95  |- skos__broader mesh__D015721smesh__D001428
% 214.76/214.95  |- skos__hiddenLabel mesh__D015721 Vaccine, Diphtheria-Tetanus-Pertussis
% 214.76/214.95  |- mesh__publicMeSHNote mesh__D015721 1990   
% 214.76/214.95  |- mesh__historyNote mesh__D015721 1990   
% 214.76/214.95  |- skos__hiddenLabel mesh__D015721 Vaccine, DTwP
% 214.76/214.95  |- skos__altLabel mesh__D015721 DTP Vaccine
% 214.76/214.95  |- skos__altLabel mesh__D015721 DPT Vaccine
% 214.76/214.95  |- skos__annotation mesh__D015721
% 214.76/214.95       DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES and DIPHTHERIA-TETANUS VACCINE are also available%A%  
% 214.76/214.95  |- rdf__type mesh__D015721sskos__Concept
% 214.76/214.95  |- skos__historyNote mesh__D015721 Tetanus Toxoid %28%1966-1989%29%
% 214.76/214.95  |- mesh__recordAuthorizer mesh__D015721 ags
% 214.76/214.95  |- skos__altLabel mesh__D015721 Diphtheria-Pertussis-Tetanus Vaccine
% 214.76/214.95  |- mesh__dateRevised mesh__D015721 2005-07-13
% 214.76/214.95  |- skos__altLabel mesh__D015721 Di-Te-Per Vaccine
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D015721 2006A
% 214.76/214.95  |- skos__broader mesh__D015721smesh__D004168
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D001701 2002
% 214.76/214.95  |- mesh__publicMeSHNote mesh__D001701 70   
% 214.76/214.95  |- rdf__type mesh__D001701sskos__Concept
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D001701 2004
% 214.76/214.95  |- mesh__dateRevised mesh__D001701 2001-07-25
% 214.76/214.95  |- mesh__dateEstablished mesh__D001701 1970-01-01
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D001701 2005
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D001701 2003
% 214.76/214.95  |- skos__annotation mesh__D001701
% 214.76/214.95       SPEC: SPEC qualif; no qualif when NIM coord   
% 214.76/214.95  |- mesh__recordMaintainer mesh__D001701 jls
% 214.76/214.95  |- mesh__dateCreated mesh__D001701 1999-01-01
% 214.76/214.95  |- skos__hiddenLabel mesh__D001701 Bionic
% 214.76/214.95  |- mesh__recordOriginator mesh__D001701 NLM
% 214.76/214.95  |- mesh__historyNote mesh__D001701 70%28%66%29%   
% 214.76/214.95  |- skos__related mesh__D001701smesh__D003491
% 214.76/214.95  |- skos__broader mesh__D001701smesh__D001703
% 214.76/214.95  |- skos__scopeNote mesh__D001701
% 214.76/214.95       The study of systems, particularly electronic systems, which function after the manner of, in a manner characteristic of, or resembling living systems. Also, the science of applying biological techniques and principles to the design of electronic systems.%A%    
% 214.76/214.95  |- skos__prefLabel mesh__D001701 Bionics
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D001701 2006
% 214.76/214.95  |- mesh__recordAuthorizer mesh__D001701 sjn
% 214.76/214.95  |- rdf__type mesh__D006995sskos__Concept
% 214.76/214.95  |- skos__hiddenLabel mesh__D006995 Hypobetalipoproteinemias
% 214.76/214.95  |- skos__scopeNote mesh__D006995
% 214.76/214.95       A disease in which the low density lipoprotein %28%beta-lipoprotein%29% concentrations are far below normal.%A%    
% 214.76/214.95  |- skos__historyNote mesh__D006995
% 214.76/214.95       Lipid Metabolism, Inborn Errors %28%1966-1977%29%
% 214.76/214.95  |- mesh__dateRevised mesh__D006995 2005-06-30
% 214.76/214.95  |- mesh__dateEstablished mesh__D006995 1991-01-01
% 214.76/214.95  |- mesh__recordOriginator mesh__D006995 VDK
% 214.76/214.95  |- mesh__recordAuthorizer mesh__D006995 sjn
% 214.76/214.95  |- mesh__publicMeSHNote mesh__D006995
% 214.76/214.95       91; was see under HYPOLIPOPROTEINEMIA 1980-90; was see under HYPOLIPOPROTEINEMIAS 1978-79%A%  
% 214.76/214.95  |- mesh__dateCreated mesh__D006995 1977-04-29
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D006995 2006
% 214.76/214.95  |- mesh__recordMaintainer mesh__D006995 lkt
% 214.76/214.95  |- mesh__historyNote mesh__D006995
% 214.76/214.95       91%28%78%29%; was see under HYPOLIPOPROTEINEMIA 1980-90; was see under HYPOLIPOPROTEINEMIAS 1978-79%A%  
% 214.76/214.95  |- skos__annotation mesh__D006995
% 214.76/214.95       low blood beta-lipoprotein levels; do not confuse with ABETALIPOPROTEINEMIA; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 214.76/214.95  |- skos__broader mesh__D006995smesh__D007009
% 214.76/214.95  |- skos__historyNote mesh__D006995 Lipoproteins %28%1966-1977%29%
% 214.76/214.95  |- skos__historyNote mesh__D006995 Lipoproteins, LDL %28%1972-1977%29%
% 214.76/214.95  |- skos__prefLabel mesh__D006995 Hypobetalipoproteinemia
% 214.76/214.95  |- skos__historyNote mesh__D006995
% 214.76/214.95       Blood Protein Disorders %28%1966-1977%29%
% 214.76/214.95  |- skos__hiddenLabel mesh__D020666 H GRF55 Protein
% 214.76/214.95  |- skos__altLabel mesh__D020666 H-GRF55 Protein
% 214.76/214.95  |- mesh__recordOriginator mesh__D020666 jmp
% 214.76/214.95  |- skos__altLabel mesh__D020666 ras Guanine Nucleotide Releasing Factor
% 214.76/214.95  |- mesh__recordAuthorizer mesh__D020666 sjn
% 214.76/214.95  |- skos__scopeNote mesh__D020666
% 214.76/214.95       A guanine nucleotide exchange factor that is expressed primarily in neuronal tissue and may be specific for the Ha-ras homolog of the RAS PROTEINS.%A%    
% 214.76/214.95  |- skos__broader mesh__D020666smesh__D020663
% 214.76/214.95  |- mesh__dateCreated mesh__D020666 1999-11-03
% 214.76/214.95  |- mesh__publicMeSHNote mesh__D020666
% 214.76/214.95       2000; RAS-GRF1 was indexed under CELL CYCLE PROTEINS 1996-1999 %26% under PROTEINS 1992-1995; RAS-GRF was indexed under PROTEINS 1995-1999%A%  
% 214.76/214.95  |- skos__hiddenLabel mesh__D020666 ras GRF1
% 214.76/214.95  |- skos__altLabel mesh__D020666 GRF1 Protein
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D020666 2005
% 214.76/214.95  |- rdf__type mesh__D020666sskos__Concept
% 214.76/214.95  |- skos__altLabel mesh__D020666 ras-GRF
% 214.76/214.95  |- skos__annotation mesh__D020666
% 214.76/214.95       note: GRF1 is an acronym for several proteins that are not Guanine Nucleotide Releasing Factors; do not confuse with CDC25 PHOSPHATASE%A%  
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D020666 2006
% 214.76/214.95  |- mesh__recordMaintainer mesh__D020666 jmp
% 214.76/214.95  |- skos__hiddenLabel mesh__D020666 Protein, H-GRF55
% 214.76/214.95  |- mesh__historyNote mesh__D020666
% 214.76/214.95       2000; use RAS-GRF1 %28%NM%29% 1992-1999; for RAS-GRF use RAS-GRF1 %28%NM%29% 1995-1999;%A%  
% 214.76/214.95  |- mesh__dateRevised mesh__D020666 2004-07-07
% 214.76/214.95  |- skos__altLabel mesh__D020666 cdc25Mm
% 214.76/214.95  |- skos__altLabel mesh__D020666 cdc25 Guanine Nucleotide Exchange Factor
% 214.76/214.95  |- skos__altLabel mesh__D020666 ras Guanine Nucleotide Releasing Factor 1
% 214.76/214.95  |- skos__historyNote mesh__D020666 Proteins %28%1981-1999%29%
% 214.76/214.95  |- skos__altLabel mesh__D020666 rasGRF1
% 214.76/214.95  |- skos__prefLabel mesh__D020666 ras-GRF1
% 214.76/214.95  |- skos__hiddenLabel mesh__D020666 ras GRF
% 214.76/214.95  |- skos__altLabel mesh__D020666 cdc25p
% 214.76/214.95  |- mesh__dateEstablished mesh__D020666 2000-01-01
% 214.76/214.95  |- skos__broader mesh__D006321Q000821smesh__D006321
% 214.76/214.95  |- rdf__type mesh__D006321Q000821smesh__CompoundConcept
% 214.76/214.95  |- skos__hiddenLabel mesh__D006197 Fetal Hairs
% 214.76/214.95  |- skos__altLabel mesh__D006197 Hair, Fetal
% 214.76/214.95  |- skos__hiddenLabel mesh__D006197 Hairs, Fetal
% 214.76/214.95  |- mesh__dateRevised mesh__D006197 2002-07-02
% 214.76/214.95  |- skos__annotation mesh__D006197
% 214.76/214.95       abnormally pulling at one%27%s hair = TRICHOTILLOMANIA; HAIR FOLLICLE is available%A%  
% 214.76/214.95  |- mesh__recordOriginator mesh__D006197 NLM
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D006197 2004
% 214.76/214.95  |- skos__prefLabel mesh__D006197 Hair
% 214.76/214.95  |- mesh__recordMaintainer mesh__D006197 nns
% 214.76/214.95  |- mesh__historyNote mesh__D006197 LANUGO was see under HAIR 1963-78   
% 214.76/214.95  |- skos__hiddenLabel mesh__D006197 Hairs
% 214.76/214.95  |- skos__hiddenLabel mesh__D006197 Fur, Animal
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D006197 2003
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D006197 2006
% 214.76/214.95  |- mesh__recordAuthorizer mesh__D006197 sjn
% 214.76/214.95  |- mesh__onlineNote mesh__D006197 use HAIR to search LANUGO 1966-78   
% 214.76/214.95  |- mesh__activeMeSHYear mesh__D006197 2005
% 214.76/214.95  |- mesh__dateCreated mesh__D006197 1999-01-01
% 214.76/214.95  |- skos__broader mesh__D006197smesh__D034582
% 214.76/214.95  |- skos__altLabel mesh__D006197 Fetal Hair
% 214.76/214.95  |- rdf__type mesh__D006197sskos__Concept
% 214.76/214.95  |- skos__scopeNote mesh__D006197
% 214.76/214.95       A  filament-like structure consisting of a shaft which projects to the surface of the SKIN from a root which is softer than the shaft and lodges in the cavity of a HAIR FOLLICLE. It is found on most surfaces of the body.%A%    
% 214.76/214.95  |- mesh__historyNote mesh__D014629
% 214.76/214.95       86%28%81%29%; was see under VAGOTOMY 1981-85   
% 214.76/214.95  |- skos__hiddenLabel mesh__D014629 Proximal Vagotomy, Selective
% 214.76/214.95  |- mesh__publicMeSHNote mesh__D014629 86; was see under VAGOTOMY 1981-85   
% 214.76/214.95  |- skos__scopeNote mesh__D014629
% 214.76/214.95       Vagal denervation of that part of the STOMACH lined with acid-secreting mucosa %28%GASTRIC MUCOSA%29% containing the GASTRIC PARIETAL CELLS. Since the procedure leaves the vagal branches to the antrum and PYLORUS intact, it circumvents gastric drainage required with truncal vagotomy techniques.%A%    
% 214.76/214.95  |- skos__historyNote mesh__D014629 Duodenal Ulcer/surgery %28%1966-1980%29%
% 214.76/214.95  |- skos__hiddenLabel mesh__D014629 Selective Vagotomies, Highly
% 214.76/214.95  |- skos__hiddenLabel mesh__D014629 Proximal Gastric Vagotomies
% 214.76/214.95  |- skos__hiddenLabel mesh__D014629 Proximal Vagotomies, Selective
% 214.76/214.95  |- skos__hiddenLabel mesh__D014629 Selective Proximal Vagotomy
% 214.76/214.95  |- mesh__recordAuthorizer mesh__D014629 ags
% 214.76/214.96  |- mesh__dateEstablished mesh__D014629 1986-01-01
% 214.76/214.96  |- skos__hiddenLabel mesh__D014629 Vagotomies, Parietal Cell
% 214.76/214.96  |- skos__hiddenLabel mesh__D014629 Vagotomies, Selective Proximal
% 214.76/214.96  |- skos__hiddenLabel mesh__D014629 Selective Proximal Vagotomies
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D014629 2005
% 214.76/214.96  |- mesh__recordMaintainer mesh__D014629 ags
% 214.76/214.96  |- skos__altLabel mesh__D014629 Vagotomy, Highly Selective
% 214.76/214.96  |- skos__historyNote mesh__D014629 Vagotomy %28%1966-1980%29%
% 214.76/214.96  |- skos__prefLabel mesh__D014629 Vagotomy, Proximal Gastric
% 214.76/214.96  |- skos__hiddenLabel mesh__D014629 Highly Selective Vagotomies
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D014629 2006
% 214.76/214.96  |- skos__hiddenLabel mesh__D014629 Vagotomies, Proximal Gastric
% 214.76/214.96  |- skos__altLabel mesh__D014629 Vagotomy, Parietal Cell
% 214.76/214.96  |- skos__hiddenLabel mesh__D014629 Vagotomies, Highly Selective
% 214.76/214.96  |- mesh__recordOriginator mesh__D014629 RC
% 214.76/214.96  |- skos__hiddenLabel mesh__D014629 Gastric Vagotomy, Proximal
% 214.76/214.96  |- skos__annotation mesh__D014629
% 214.76/214.96       do not use /util except by MeSH definition; also called %22%highly selective vagotomy%22%, %22%hyperselective%22%, %22%superselective%22%, %22%supraselective%22%, %22%ultraselective%22%%A%  
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D014629 2006A
% 214.76/214.96  |- skos__hiddenLabel mesh__D014629 Proximal Gastric Vagotomy
% 214.76/214.96  |- skos__hiddenLabel mesh__D014629 Parietal Cell Vagotomy
% 214.76/214.96  |- skos__hiddenLabel mesh__D014629 Highly Selective Vagotomy
% 214.76/214.96  |- skos__hiddenLabel mesh__D014629 Parietal Cell Vagotomies
% 214.76/214.96  |- mesh__dateRevised mesh__D014629 2005-07-22
% 214.76/214.96  |- skos__broader mesh__D014629smesh__D014628
% 214.76/214.96  |- skos__hiddenLabel mesh__D014629 Gastric Vagotomies, Proximal
% 214.76/214.96  |- rdf__type mesh__D014629sskos__Concept
% 214.76/214.96  |- mesh__dateCreated mesh__D014629 1980-04-09
% 214.76/214.96  |- mesh__publicMeSHNote mesh__D019314
% 214.76/214.96       97; DEHYDROEPIANDROSTERONE SULFATE was indexed under PRASTERONE/analogs %26% derivatives 1978-96 %26% SULFURIC ACIDS 1978-80%A%  
% 214.76/214.96  |- skos__altLabel mesh__D019314 Prasterone Sulfate
% 214.76/214.96  |- skos__altLabel mesh__D019314 DHEA Sulfate
% 214.76/214.96  |- skos__prefLabel mesh__D019314 Dehydroepiandrosterone Sulfate
% 214.76/214.96  |- skos__hiddenLabel mesh__D019314 Sulfate, Dehydroepiandrosterone
% 214.76/214.96  |- skos__historyNote mesh__D019314 Sulfuric Acids %28%1978-1980%29%
% 214.76/214.96  |- mesh__dateEstablished mesh__D019314 1997-01-01
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D019314 2004
% 214.76/214.96  |- skos__scopeNote mesh__D019314
% 214.76/214.96       The circulating form of a major C19 steroid produced primarily by the ADRENAL CORTEX. DHEA sulfate serves as a precursor for TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE.%A%    
% 214.76/214.96  |- skos__hiddenLabel mesh__D019314 Sulfate, DHA
% 214.76/214.96  |- skos__altLabel mesh__D019314 DHA Sulfate
% 214.76/214.96  |- mesh__dateRevised mesh__D019314 2003-07-09
% 214.76/214.96  |- skos__broader mesh__D019314smesh__D003687
% 214.76/214.96  |- skos__altLabel mesh__D019314 Dehydroisoandrosterone Sulfate
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D019314 2005
% 214.76/214.96  |- skos__hiddenLabel mesh__D019314 Sulfate, Dehydroisoandrosterone
% 214.76/214.96  |- skos__hiddenLabel mesh__D019314 Sulfate, Prasterone
% 214.76/214.96  |- skos__hiddenLabel mesh__D019314 Sulfate, DHEA
% 214.76/214.96  |- mesh__dateCreated mesh__D019314 1996-06-10
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D019314 2006
% 214.76/214.96  |- mesh__historyNote mesh__D019314
% 214.76/214.96       97; was DEHYDROEPIANDROSTERONE SULFATE %28%NM%29% 1978-96   
% 214.76/214.96  |- mesh__onlineNote mesh__D019314
% 214.76/214.96       use DEHYDROEPIANDROSTERONE SULFATE %28%NM%29% to search DEHYDROEPIANDROSTERONE SULFATE 1980-96%A%  
% 214.76/214.96  |- rdf__type mesh__D019314sskos__Concept
% 214.76/214.96  |- skos__historyNote mesh__D019314
% 214.76/214.96       Prasterone/analogs %26% derivatives %28%1978-1996%29%
% 214.76/214.96  |- mesh__historyNote mesh__D011331 73%28%69%29%   
% 214.76/214.96  |- mesh__dateRevised mesh__D011331 1994-05-05
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011331 1995
% 214.76/214.96  |- mesh__dateEstablished mesh__D011331 1973-01-01
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011331 2006
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011331 2000
% 214.76/214.96  |- skos__broader mesh__D011331smesh__D011364
% 214.76/214.96  |- skos__hiddenLabel mesh__D011331 Practices, Private
% 214.76/214.96  |- mesh__recordOriginator mesh__D011331 NLM
% 214.76/214.96  |- mesh__dateCreated mesh__D011331 1999-01-01
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011331 2001
% 214.76/214.96  |- skos__hiddenLabel mesh__D011331 Private Practices
% 214.76/214.96  |- skos__hiddenLabel mesh__D011331 Practice, Private
% 214.76/214.96  |- skos__prefLabel mesh__D011331 Private Practice
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011331 1996
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011331 2002
% 214.76/214.96  |- skos__historyNote mesh__D011331 Medicine %28%1966-1968%29%
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011331 1997
% 214.76/214.96  |- rdf__type mesh__D011331sskos__Concept
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011331 2003
% 214.76/214.96  |- mesh__publicMeSHNote mesh__D011331 73   
% 214.76/214.96  |- skos__scopeNote mesh__D011331
% 214.76/214.96       Practice of a health profession by an individual, offering services on a person-to-person basis, as opposed to group or partnership practice.%A%    
% 214.76/214.96  |- skos__historyNote mesh__D011331 Office Management %28%1966-1968%29%
% 214.76/214.96  |- skos__hiddenLabel mesh__D011331 Practices, Solo
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011331 1998
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011331 2004
% 214.76/214.96  |- skos__hiddenLabel mesh__D011331 Solo Practices
% 214.76/214.96  |- skos__historyNote mesh__D011331 specific discipline %28%1966-1968%29%
% 214.76/214.96  |- mesh__recordAuthorizer mesh__D011331 PLS
% 214.76/214.96  |- skos__hiddenLabel mesh__D011331 Practice, Solo
% 214.76/214.96  |- skos__historyNote mesh__D011331 specific specialty %28%1966-1968%29%
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011331 1999
% 214.76/214.96  |- skos__historyNote mesh__D011331 Professional Practice %28%1968%29%
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011331 2005
% 214.76/214.96  |- mesh__recordMaintainer mesh__D011331 TGC
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D000609 2006
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D000609 1999
% 214.76/214.96  |- skos__broader mesh__D000609smesh__D000166
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D000609 1994
% 214.76/214.96  |- skos__scopeNote mesh__D000609
% 214.76/214.96       Acridines which are substituted in any position by one or more amino groups or substituted amino groups.%A%    
% 214.76/214.96  |- mesh__dateEstablished mesh__D000609 1980-01-01
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D000609 2000
% 214.76/214.96  |- skos__historyNote mesh__D000609 Acridines %28%1966-1979%29%
% 214.76/214.96  |- mesh__recordMaintainer mesh__D000609 TAP
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D000609 1993
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D000609 2001
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D000609 1995
% 214.76/214.96  |- mesh__dateRevised mesh__D000609 1992-05-07
% 214.76/214.96  |- skos__prefLabel mesh__D000609 Aminoacridines
% 214.76/214.96  |- mesh__recordAuthorizer mesh__D000609 PLS
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D000609 2003
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D000609 1996
% 214.76/214.96  |- mesh__recordOriginator mesh__D000609 RLS
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D000609 2002
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D000609 2005
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D000609 1998
% 214.76/214.96  |- rdf__type mesh__D000609sskos__Concept
% 214.76/214.96  |- mesh__dateCreated mesh__D000609 1979-02-21
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D000609 2004
% 214.76/214.96  |- mesh__historyNote mesh__D000609 80   
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D000609 1997
% 214.76/214.96  |- mesh__publicMeSHNote mesh__D000609
% 214.76/214.96       80; ACRIFLAVINE was see under ACRIDINES 1963-81; NITRACRINE was see under ACRIDINES 1975-80; TACRINE was see under ACRIDINES 1975-83%A%  
% 214.76/214.96  |- skos__broader mesh__D011768Q000172smesh__D011768
% 214.76/214.96  |- mesh__preferredCombination mesh__D011768Q000172smesh__D015325
% 214.76/214.96  |- rdf__type mesh__D011768Q000172smesh__CompoundConcept
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D029742 2006
% 214.76/214.96  |- skos__prefLabel mesh__D029742 Caenorhabditis elegans Proteins
% 214.76/214.96  |- skos__related mesh__D029742smesh__D017173
% 214.76/214.96  |- mesh__publicMeSHNote mesh__D029742 2002   
% 214.76/214.96  |- skos__broader mesh__D029742smesh__D015801
% 214.76/214.96  |- mesh__recordMaintainer mesh__D029742 SYSTEM
% 214.76/214.96  |- rdf__type mesh__D029742sskos__Concept
% 214.76/214.96  |- skos__annotation mesh__D029742
% 214.76/214.96       coord IM with specific protein %28%IM%29%   
% 214.76/214.96  |- mesh__recordOriginator mesh__D029742 jmp
% 214.76/214.96  |- mesh__dateEstablished mesh__D029742 2002-01-01
% 214.76/214.96  |- mesh__historyNote mesh__D029742 2002   
% 214.76/214.96  |- skos__scopeNote mesh__D029742
% 214.76/214.96       Proteins from the nematode species CAENORHABDITIS ELEGANS. The proteins from this species are the subject of scientific interest in the area of multicellular organism MORPHOGENESIS.%A%    
% 214.76/214.96  |- skos__altLabel mesh__D029742 C elegans Proteins
% 214.76/214.96  |- mesh__recordAuthorizer mesh__D029742 sjn
% 214.76/214.96  |- mesh__dateCreated mesh__D029742 2001-07-25
% 214.76/214.96  |- mesh__dateRevised mesh__D029742 2005-06-30
% 214.76/214.96  |- skos__historyNote mesh__D029742 Helminth Proteins %28%1990-2001%29%
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D010239 1998
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D010239 2003
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D010239 1995
% 214.76/214.96  |- mesh__recordAuthorizer mesh__D010239 PLS
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D010239 2000
% 214.76/214.96  |- mesh__dateCreated mesh__D010239 1999-01-01
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D010239 1999
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D010239 2004
% 214.76/214.96  |- skos__prefLabel mesh__D010239 Paraguay
% 214.76/214.96  |- rdf__type mesh__D010239sskos__Concept
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D010239 1996
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D010239 2001
% 214.76/214.96  |- mesh__recordMaintainer mesh__D010239 PLS
% 214.76/214.96  |- skos__broader mesh__D010239smesh__D013020
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D010239 1997
% 214.76/214.96  |- mesh__dateRevised mesh__D010239 1993-06-03
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D010239 2005
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D010239 2002
% 214.76/214.96  |- mesh__recordOriginator mesh__D010239 NLM
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D010239 2006
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D010239 1994
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D007290 2001
% 214.76/214.96  |- skos__broader mesh__D007290smesh__D007292
% 214.76/214.96  |- skos__altLabel mesh__D007290 Riboxine
% 214.76/214.96  |- mesh__dateEstablished mesh__D007290 1991-01-01
% 214.76/214.96  |- skos__altLabel mesh__D007290 Riboxin
% 214.76/214.96  |- skos__prefLabel mesh__D007290 Inosine Diphosphate
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D007290 2000
% 214.76/214.96  |- skos__altLabel mesh__D007290 Inosine Pyrophosphate
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D007290 2004
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D007290 2006
% 214.76/214.96  |- skos__scopeNote mesh__D007290
% 214.76/214.96       An inosine nucleotide containing a pyrophosphate group  esterified to C5 of the sugar moiety.%A%    
% 214.76/214.96  |- skos__altLabel mesh__D007290 IDP
% 214.76/214.96  |- mesh__historyNote mesh__D007290
% 214.76/214.96       91%28%78%29%; was see under INOSINE NUCLEOTIDES 1978-90   
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D007290 2003
% 214.76/214.96  |- mesh__recordAuthorizer mesh__D007290 sjn
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D007290 2005
% 214.76/214.96  |- skos__hiddenLabel mesh__D007290 Pyrophosphate, Inosine
% 214.76/214.96  |- mesh__recordOriginator mesh__D007290 RLS
% 214.76/214.96  |- rdf__type mesh__D007290sskos__Concept
% 214.76/214.96  |- skos__hiddenLabel mesh__D007290 Diphosphate, Inosine
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D007290 2002
% 214.76/214.96  |- mesh__recordMaintainer mesh__D007290 adp
% 214.76/214.96  |- skos__historyNote mesh__D007290 Inosine Nucleotides %28%1971-1977%29%
% 214.76/214.96  |- mesh__dateCreated mesh__D007290 1977-04-22
% 214.76/214.96  |- mesh__publicMeSHNote mesh__D007290
% 214.76/214.96       91; was see under INOSINE NUCLEOTIDES 1978-90   
% 214.76/214.96  |- mesh__dateRevised mesh__D007290 1999-11-08
% 214.76/214.96  |- rdf__type mesh__D001702sskos__Concept
% 214.76/214.96  |- mesh__dateCreated mesh__D001702 1999-01-01
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D001702 2004
% 214.76/214.96  |- skos__broader mesh__D001702smesh__D002620
% 214.76/214.96  |- mesh__recordOriginator mesh__D001702 NLM
% 214.76/214.96  |- skos__historyNote mesh__D001702
% 214.76/214.96       Chemistry, Pharmaceutical %28%1966-1969%29%
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D001702 1994
% 214.76/214.96  |- skos__prefLabel mesh__D001702 Biopharmaceutics
% 214.76/214.96  |- skos__annotation mesh__D001702
% 214.76/214.96       SPEC; SPEC qualif; IM general only; NIM with no qualif, with specific drug /pharmacokin %28%IM%29%; DF: BIOPHARM%A%  
% 214.76/214.96  |- skos__historyNote mesh__D001702 Drugs %28%1966-1969%29%
% 214.76/214.96  |- mesh__recordMaintainer mesh__D001702 TGC
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D001702 1998
% 214.76/214.96  |- mesh__dateEstablished mesh__D001702 1970-01-01
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D001702 1995
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D001702 1996
% 214.76/214.96  |- mesh__publicMeSHNote mesh__D001702 70   
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D001702 1999
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D001702 2000
% 214.76/214.96  |- skos__scopeNote mesh__D001702
% 214.76/214.96       The study of the physical and chemical properties of a drug and its dosage form as related to the onset, duration, and intensity of its action.%A%    
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D001702 1997
% 214.76/214.96  |- mesh__historyNote mesh__D001702 70   
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D001702 2005
% 214.76/214.96  |- mesh__recordAuthorizer mesh__D001702 PLS
% 214.76/214.96  |- skos__historyNote mesh__D001702 Drug Compounding %28%1966-1969%29%
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D001702 2001
% 214.76/214.96  |- skos__related mesh__D001702smesh__D004339
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D001702 2003
% 214.76/214.96  |- mesh__dateRevised mesh__D001702 1993-05-13
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D001702 2006
% 214.76/214.96  |- skos__historyNote mesh__D001702 Pharmacology %28%1966-1969%29%
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D001702 2002
% 214.76/214.96  |- skos__hiddenLabel mesh__D006996 Hypocalcemias
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D006996 2001
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D006996 2006
% 214.76/214.96  |- mesh__recordOriginator mesh__D006996 NLM
% 214.76/214.96  |- skos__annotation mesh__D006996
% 214.76/214.96       low blood calcium levels; do not confuse with HYPERCALCEMIA%A%  
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D006996 2003
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D006996 2000
% 214.76/214.96  |- skos__broader mesh__D006996smesh__D002128
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D006996 2005
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D006996 1997
% 214.76/214.96  |- skos__broader mesh__D006996smesh__D014883
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D006996 1999
% 214.76/214.96  |- mesh__recordMaintainer mesh__D006996 TGC
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D006996 1996
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D006996 1995
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D006996 1998
% 214.76/214.96  |- mesh__dateRevised mesh__D006996 1993-06-02
% 214.76/214.96  |- mesh__dateCreated mesh__D006996 1999-01-01
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D006996 1994
% 214.76/214.96  |- mesh__recordAuthorizer mesh__D006996 PLS
% 214.76/214.96  |- skos__prefLabel mesh__D006996 Hypocalcemia
% 214.76/214.96  |- skos__scopeNote mesh__D006996
% 214.76/214.96       Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek%27%s sign, muscle and abdominal cramps, and carpopedal spasm. %28%Dorland, 27th ed%29%%A%    
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D006996 2002
% 214.76/214.96  |- rdf__type mesh__D006996sskos__Concept
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D006996 2004
% 214.76/214.96  |- skos__broader mesh__D020667smesh__D013687
% 214.76/214.96  |- rdf__type mesh__D020667sskos__Concept
% 214.76/214.96  |- skos__annotation mesh__D020667
% 214.76/214.96       do not confuse with NUCLEUS OF DIAGONAL BAND see SEPTAL NUCLEI%A%  
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D020667 2004
% 214.76/214.96  |- mesh__dateRevised mesh__D020667 2005-07-21
% 214.76/214.96  |- skos__prefLabel mesh__D020667 Diagonal Band of Broca
% 214.76/214.96  |- skos__scopeNote mesh__D020667
% 214.76/214.96       Cholinergic bundle of nerve fibers posterior to the anterior perforated substance. It interconnects the paraterminal gyrus in the septal area with the hippocampus and lateral olfactory area.%A%    
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D020667 2006
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D020667 2003
% 214.76/214.96  |- mesh__publicMeSHNote mesh__D020667 2000   
% 214.76/214.96  |- mesh__dateCreated mesh__D020667 1999-11-03
% 214.76/214.96  |- mesh__historyNote mesh__D020667 2000   
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D020667 2002
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D020667 2005
% 214.76/214.96  |- mesh__recordAuthorizer mesh__D020667 ags
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D020667 2006A
% 214.76/214.96  |- mesh__recordMaintainer mesh__D020667 ags
% 214.76/214.96  |- mesh__recordOriginator mesh__D020667 ags
% 214.76/214.96  |- mesh__dateEstablished mesh__D020667 2000-01-01
% 214.76/214.96  |- skos__hiddenLabel mesh__D020667 Broca Diagonal Band
% 214.76/214.96  |- mesh__recordAuthorizer mesh__D006198 sjn
% 214.76/214.96  |- skos__broader mesh__D006198smesh__D009925
% 214.76/214.96  |- mesh__dateEstablished mesh__D006198 1980-01-01
% 214.76/214.96  |- mesh__publicMeSHNote mesh__D006198
% 214.76/214.96       80; was see under MECHANORECEPTORS 1977-79   
% 214.76/214.96  |- mesh__dateCreated mesh__D006198 1976-04-27
% 214.76/214.96  |- mesh__recordOriginator mesh__D006198 MM
% 214.76/214.96  |- skos__hiddenLabel mesh__D006198 Hair Cell
% 214.76/214.96  |- skos__annotation mesh__D006198
% 214.76/214.96       mechanoreceptors in the cochlea: nothing to do with HAIR; use for hair cells unspecified but HAIR CELLS, INNER %26% HAIR CELLS, OUTER %26% HAIR CELLS, VESTIBULAR are available%A%  
% 214.76/214.96  |- skos__historyNote mesh__D006198 Organ of Corti %28%1966-1976%29%
% 214.76/214.96  |- mesh__historyNote mesh__D006198
% 214.76/214.96       80%28%77%29%; was see under MECHANORECEPTORS 1977-79   
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D006198 2006
% 214.76/214.96  |- skos__broader mesh__D006198smesh__D009475
% 214.76/214.96  |- mesh__dateRevised mesh__D006198 2004-07-07
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D006198 2005
% 214.76/214.96  |- skos__broader mesh__D006198smesh__D046569
% 214.76/214.96  |- rdf__type mesh__D006198sskos__Concept
% 214.76/214.96  |- skos__hiddenLabel mesh__D006198 Cell, Hair
% 214.76/214.96  |- skos__prefLabel mesh__D006198 Hair Cells
% 214.76/214.96  |- skos__scopeNote mesh__D006198
% 214.76/214.96       Mechanoreceptors located in the organ of Corti that are sensitive to auditory stimuli and in the vestibular apparatus that are sensitive to movement of the head. In each case the accessory sensory structures are arranged so that appropriate stimuli cause movement of the hair-like projections %28%stereocilia and kinocilia%29% which relay the information centrally in the nervous system.%A%    
% 214.76/214.96  |- mesh__recordMaintainer mesh__D006198 ags
% 214.76/214.96  |- skos__hiddenLabel mesh__D006198 Cells, Hair
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D019315 2004
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D019315 2000
% 214.76/214.96  |- mesh__dateRevised mesh__D019315 1999-12-28
% 214.76/214.96  |- mesh__recordMaintainer mesh__D019315 ags
% 214.76/214.96  |- mesh__recordOriginator mesh__D019315 TGC
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D019315 2001
% 214.76/214.96  |- mesh__publicMeSHNote mesh__D019315 97   
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D019315 2005
% 214.76/214.96  |- mesh__dateEstablished mesh__D019315 1997-01-01
% 214.76/214.96  |- skos__broader mesh__D019315smesh__D009916
% 214.76/214.96  |- skos__prefLabel mesh__D019315 Retrobulbar Hemorrhage
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D019315 2006
% 214.76/214.96  |- skos__scopeNote mesh__D019315
% 214.76/214.96       Hemorrhage within the orbital cavity, posterior to the eyeball.%A%    
% 214.76/214.96  |- skos__annotation mesh__D019315
% 214.76/214.96       do not confuse with EYE HEMORRHAGE or its specifics, hemorrh of eye tissue%A%  
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D019315 2002
% 214.76/214.96  |- skos__altLabel mesh__D019315 Hemorrhage, Retrobulbar
% 214.76/214.96  |- mesh__recordAuthorizer mesh__D019315 ags
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D019315 2000A
% 214.76/214.96  |- mesh__historyNote mesh__D019315 97   
% 214.76/214.96  |- rdf__type mesh__D019315sskos__Concept
% 214.76/214.96  |- skos__hiddenLabel mesh__D019315 Retrobulbar Hemorrhages
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D019315 2003
% 214.76/214.96  |- mesh__dateCreated mesh__D019315 1996-06-10
% 214.76/214.96  |- skos__broader mesh__D019315smesh__D006470
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011332 2003
% 214.76/214.96  |- skos__scopeNote mesh__D011332
% 214.76/214.96       Process of shifting publicly controlled services and/or facilities to the private sector.%A%    
% 214.76/214.96  |- mesh__dateEstablished mesh__D011332 1991-01-01
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011332 1999
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011332 2002
% 214.76/214.96  |- mesh__dateRevised mesh__D011332 1994-05-05
% 214.76/214.96  |- mesh__historyNote mesh__D011332
% 214.76/214.96       91%28%88%29%; was see under OWNERSHIP 1988-90   
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011332 2006
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011332 1998
% 214.76/214.96  |- mesh__recordOriginator mesh__D011332 EC
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011332 2001
% 214.76/214.96  |- skos__annotation mesh__D011332 med or non-med services or facilities   
% 214.76/214.96  |- skos__broader mesh__D011332smesh__D010067
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011332 2005
% 214.76/214.96  |- mesh__dateCreated mesh__D011332 1987-05-04
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011332 1997
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011332 2000
% 214.76/214.96  |- skos__prefLabel mesh__D011332 Privatization
% 214.76/214.96  |- skos__hiddenLabel mesh__D011332 Privatizations
% 214.76/214.96  |- mesh__recordMaintainer mesh__D011332 TGC
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011332 2004
% 214.76/214.96  |- rdf__type mesh__D011332sskos__Concept
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011332 1996
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D011332 1995
% 214.76/214.96  |- mesh__recordAuthorizer mesh__D011332 PLS
% 214.76/214.96  |- mesh__publicMeSHNote mesh__D011332
% 214.76/214.96       91; was see under OWNERSHIP 1988-90   
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D029743 2005
% 214.76/214.96  |- skos__annotation mesh__D029743
% 214.76/214.96       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.76/214.96  |- skos__altLabel mesh__D029743 Olibanum
% 214.76/214.96  |- skos__altLabel mesh__D029743 Frankincense
% 214.76/214.96  |- mesh__publicMeSHNote mesh__D029743 2002   
% 214.76/214.96  |- skos__broader mesh__D029743smesh__D029403
% 214.76/214.96  |- mesh__recordOriginator mesh__D029743 ssb
% 214.76/214.96  |- skos__prefLabel mesh__D029743 Boswellia
% 214.76/214.96  |- skos__scopeNote mesh__D029743
% 214.76/214.96       A plant genus of the family BURSERACEAE used medicinally since ancient times.  It is a source of salai guggal %28%the gum resin%29% and boswellic acid %28%ursane type TRITERPENES%29%.%A%    
% 214.76/214.96  |- mesh__dateCreated mesh__D029743 2001-07-25
% 214.76/214.96  |- mesh__historyNote mesh__D029743 2002   
% 214.76/214.96  |- mesh__recordMaintainer mesh__D029743 ssb
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D029743 2004
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D029743 2006
% 214.76/214.96  |- mesh__recordAuthorizer mesh__D029743 sjn
% 214.76/214.96  |- rdf__type mesh__D029743sskos__Concept
% 214.76/214.96  |- mesh__dateRevised mesh__D029743 2002-07-02
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D029743 2003
% 214.76/214.96  |- mesh__dateEstablished mesh__D029743 2002-01-01
% 214.76/214.96  |- skos__altLabel mesh__D007291 Ribosylhypoxanthine Monophosphate
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D007291 2002
% 214.76/214.96  |- mesh__publicMeSHNote mesh__D007291
% 214.76/214.96       91; was see under INOSINE NUCLEOTIDES 1978-90; was INOSINIC ACIDS see under INOSINE NUCLEOTIDES 1974-77%A%  
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D007291 2004
% 214.76/214.96  |- mesh__onlineNote mesh__D007291
% 214.76/214.96       to search INOSINIC ACIDS use INOSINE MONOPHOSPHATE 1975-77 %26% INOSINE NUCLEOTIDES 1974%A%  
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D007291 2001
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D007291 1997
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D007291 2006
% 214.76/214.96  |- skos__broader mesh__D007291smesh__D007292
% 214.76/214.96  |- mesh__recordMaintainer mesh__D007291 TAP
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D007291 1999
% 214.76/214.96  |- skos__hiddenLabel mesh__D007291 Monophosphate, Ribosylhypoxanthine
% 214.76/214.96  |- mesh__dateRevised mesh__D007291 1995-05-18
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D007291 2003
% 214.76/214.96  |- skos__hiddenLabel mesh__D007291 Inosinate, Sodium
% 214.76/214.96  |- mesh__dateCreated mesh__D007291 1999-01-01
% 214.76/214.96  |- skos__hiddenLabel mesh__D007291 Acids, Inosinic
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D007291 2000
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D007291 1996
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D007291 2005
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D007291 1998
% 214.76/214.96  |- mesh__historyNote mesh__D007291
% 214.76/214.96       91%28%78%29%; was see under INOSINE NUCLEOTIDES 1978-90; was INOSINIC ACIDS see under INOSINE NUCLEOTIDES 1974-77%A%  
% 214.76/214.96  |- mesh__recordOriginator mesh__D007291 NLM
% 214.76/214.96  |- rdf__type mesh__D007291sskos__Concept
% 214.76/214.96  |- skos__scopeNote mesh__D007291
% 214.76/214.96       Inosine 5%27%-Monophosphate. A purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety.%A%    
% 214.76/214.96  |- skos__historyNote mesh__D007291 Inosine Nucleotides %28%1971-1974%29%
% 214.76/214.96  |- mesh__recordAuthorizer mesh__D007291 PLS
% 214.76/214.96  |- skos__prefLabel mesh__D007291 Inosine Monophosphate
% 214.76/214.96  |- skos__hiddenLabel mesh__D007291 Monophosphate, Inosine
% 214.76/214.96  |- skos__altLabel mesh__D007291 Inosinic Acids
% 214.76/214.96  |- skos__annotation mesh__D007291 /biosyn /physiol permitted   
% 214.76/214.96  |- mesh__dateEstablished mesh__D007291 1991-01-01
% 214.76/214.96  |- skos__altLabel mesh__D007291 IMP
% 214.76/214.96  |- skos__hiddenLabel mesh__D007291 Acid, Inosinic
% 214.76/214.96  |- mesh__dateRevised mesh__D015723 2002-07-03
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D015723 2006
% 214.76/214.96  |- mesh__historyNote mesh__D015723 90   
% 214.76/214.96  |- skos__related mesh__D015723smesh__D030561
% 214.76/214.96  |- skos__broader mesh__D015723smesh__D040342
% 214.76/214.96  |- skos__hiddenLabel mesh__D015723 Libraries, cDNA
% 214.76/214.96  |- mesh__dateCreated mesh__D015723 1989-05-15
% 214.76/214.96  |- skos__scopeNote mesh__D015723
% 214.76/214.96       A large collection of DNA fragments cloned %28%CLONING, MOLECULAR%29% from a given organism, tissue, organ, or cell type. It may contain complete genomic sequences %28%GENOMIC LIBRARY%29% or complementary DNA sequences, the latter being formed from messenger RNA and lacking intron sequences.%A%    
% 214.76/214.96  |- mesh__recordOriginator mesh__D015723 PXP
% 214.76/214.96  |- skos__historyNote mesh__D015723 Base Sequence %28%1978-1989%29%
% 214.76/214.96  |- rdf__type mesh__D015723sskos__Concept
% 214.76/214.96  |- skos__hiddenLabel mesh__D015723 cDNA Libraries
% 214.76/214.96  |- mesh__activeMeSHYear mesh__D015723 2003
% 214.76/214.96  |- mesh__recordMaintainer mesh__D015723 nns
% 214.76/214.96  |- skos__related mesh__D015723smesh__D020650
% 214.76/214.97  |- skos__hiddenLabel mesh__D015723 Libraries, DNA
% 214.76/214.97  |- skos__historyNote mesh__D015723 Cloning, Molecular %28%1980-1989%29%
% 214.76/214.97  |- skos__hiddenLabel mesh__D015723 DNA Libraries
% 214.76/214.97  |- mesh__publicMeSHNote mesh__D015723 90   
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D015723 2004
% 214.76/214.97  |- skos__related mesh__D015723smesh__D004274
% 214.76/214.97  |- skos__hiddenLabel mesh__D015723 Libraries, Gene
% 214.76/214.97  |- skos__prefLabel mesh__D015723 Gene Library
% 214.76/214.97  |- mesh__recordAuthorizer mesh__D015723 sjn
% 214.76/214.97  |- mesh__dateEstablished mesh__D015723 1990-01-01
% 214.76/214.97  |- skos__annotation mesh__D015723 do not confuse with GENOMIC LIBRARY   
% 214.76/214.97  |- skos__historyNote mesh__D015723 Plasmids %28%1978-1985%29%
% 214.76/214.97  |- skos__hiddenLabel mesh__D015723 Library, cDNA
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D015723 2005
% 214.76/214.97  |- skos__hiddenLabel mesh__D015723 Library, Gene
% 214.76/214.97  |- skos__hiddenLabel mesh__D015723 Gene Libraries
% 214.76/214.97  |- skos__hiddenLabel mesh__D015723 Library, DNA
% 214.76/214.97  |- mesh__recordOriginator mesh__D001703 NLM
% 214.76/214.97  |- mesh__recordMaintainer mesh__D001703 sjn
% 214.76/214.97  |- mesh__recordAuthorizer mesh__D001703 sjn
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D001703 2005
% 214.76/214.97  |- mesh__dateRevised mesh__D001703 2004-07-13
% 214.76/214.97  |- skos__annotation mesh__D001703
% 214.76/214.97       principles of physics applied to human or animal biology; SPEC qualif as IM; no qualif when NIM coord; Manual 29.11%A%  
% 214.76/214.97  |- skos__prefLabel mesh__D001703 Biophysics
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D001703 2006
% 214.76/214.97  |- rdf__type mesh__D001703sskos__Concept
% 214.76/214.97  |- mesh__dateCreated mesh__D001703 1999-01-01
% 214.76/214.97  |- skos__broader mesh__D001703smesh__D001690
% 214.76/214.97  |- skos__broader mesh__D001703smesh__D010825
% 214.76/214.97  |- mesh__dateCreated mesh__D006997 1974-11-19
% 214.76/214.97  |- skos__historyNote mesh__D006997 Sodium Hypochlorite %28%1966-1974%29%
% 214.76/214.97  |- skos__broader mesh__D006997smesh__D000148
% 214.76/214.97  |- skos__broader mesh__D006997smesh__D010087
% 214.76/214.97  |- mesh__recordMaintainer mesh__D006997 ssb
% 214.76/214.97  |- rdf__type mesh__D006997sskos__Concept
% 214.76/214.97  |- skos__scopeNote mesh__D006997
% 214.76/214.97       An oxyacid of chlorine %28%HClO%29% containing monovalent chlorine that acts as an oxidizing or reducing agent.%A%    
% 214.76/214.97  |- mesh__publicMeSHNote mesh__D006997
% 214.76/214.97       94; was HYPOCHLOROUS ACIDS 1975-93 %28%see under ACIDS 1975-76%29%; HYPOCHLOROUS ACID was indexed under HYPOCHLOROUS ACIDS 1982-93%A%  
% 214.76/214.97  |- mesh__onlineNote mesh__D006997
% 214.76/214.97       use HYPOCHLOROUS ACID to search HYPOCHLOROUS ACIDS 1975-93%A%  
% 214.76/214.97  |- mesh__recordOriginator mesh__D006997 NLM
% 214.76/214.97  |- skos__prefLabel mesh__D006997 Hypochlorous Acid
% 214.76/214.97  |- mesh__historyNote mesh__D006997
% 214.76/214.97       94; was HYPOCHLOROUS ACIDS 1975-93 %28%see under ACIDS 1975-76%29%; HYPOCHLOROUS ACID was %28%NM%29% 1982-93%A%  
% 214.76/214.97  |- skos__broader mesh__D006997smesh__D017382
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D006997 2006
% 214.76/214.97  |- mesh__dateRevised mesh__D006997 2005-06-30
% 214.76/214.97  |- mesh__recordAuthorizer mesh__D006997 sjn
% 214.76/214.97  |- skos__broader mesh__D006997smesh__D017606
% 214.76/214.97  |- mesh__dateEstablished mesh__D006997 1977-01-01
% 214.76/214.97  |- mesh__historyNote mesh__D020668
% 214.76/214.97       2000; use RAP GTP-BINDING PROTEINS %28%NM%29% 1988-1999   
% 214.76/214.97  |- mesh__recordMaintainer mesh__D020668 jmp
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D020668 2006
% 214.76/214.97  |- skos__historyNote mesh__D020668 G-Proteins %28%1989-1999%29%
% 214.76/214.97  |- skos__hiddenLabel mesh__D020668 ras Related rap Proteins
% 214.76/214.97  |- skos__altLabel mesh__D020668 rap Protein, ras-Related
% 214.76/214.97  |- skos__hiddenLabel mesh__D020668 ras-Related rap Protein
% 214.76/214.97  |- mesh__publicMeSHNote mesh__D020668
% 214.76/214.97       2000; RAS-RELATED RAP PROTEINS %28%now RAP GTP-BINDING PROTEINS%29% was indexed under G-PROTEINS 1988-1999%A%  
% 214.76/214.97  |- skos__broader mesh__D020668smesh__D020559
% 214.76/214.97  |- skos__altLabel mesh__D020668 ras-Related rap Proteins
% 214.76/214.97  |- skos__hiddenLabel mesh__D020668 rap Protein, ras Related
% 214.76/214.97  |- skos__prefLabel mesh__D020668 rap GTP-Binding Proteins
% 214.76/214.97  |- mesh__recordAuthorizer mesh__D020668 sjn
% 214.76/214.97  |- mesh__dateRevised mesh__D020668 2005-06-30
% 214.76/214.97  |- skos__hiddenLabel mesh__D020668 rap Proteins, ras-Related
% 214.76/214.97  |- skos__hiddenLabel mesh__D020668 rap GTP Binding Proteins
% 214.76/214.97  |- mesh__dateEstablished mesh__D020668 2000-01-01
% 214.76/214.97  |- mesh__dateCreated mesh__D020668 1999-11-03
% 214.76/214.97  |- skos__hiddenLabel mesh__D020668 GTP-Binding Proteins, rap
% 214.76/214.97  |- rdf__type mesh__D020668sskos__Concept
% 214.76/214.97  |- skos__scopeNote mesh__D020668
% 214.76/214.97       A family of MONOMERIC GTP-BINDING PROTEINS that are related to RAS PROTEINS.This enzyme was formerly listed as EC 3.6.1.47.%A%    
% 214.76/214.97  |- mesh__recordOriginator mesh__D020668 jmp
% 214.76/214.97  |- skos__prefLabel mesh__D006199 Hair Cells, Inner
% 214.76/214.97  |- skos__broader mesh__D006199smesh__D006198
% 214.76/214.97  |- skos__hiddenLabel mesh__D006199 Cells, Inner Hair
% 214.76/214.97  |- mesh__dateRevised mesh__D006199 2004-07-07
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D006199 2005
% 214.76/214.97  |- mesh__dateEstablished mesh__D006199 1991-01-01
% 214.76/214.97  |- skos__hiddenLabel mesh__D006199 Inner Hair Cells
% 214.76/214.97  |- mesh__recordAuthorizer mesh__D006199 sjn
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D006199 2006
% 214.76/214.97  |- mesh__publicMeSHNote mesh__D006199
% 214.76/214.97       91; was see under HAIR CELLS 1980-90   
% 214.76/214.97  |- skos__historyNote mesh__D006199 Hair Cells %28%1977-1979%29%
% 214.76/214.97  |- skos__scopeNote mesh__D006199
% 214.76/214.97       Bulbous cells that are medially placed in one row in the organ of Corti. In contrast to the outer hair cells, the inner hair cells are fewer in number, have fewer sensory hairs, and are less differentiated.%A%    
% 214.76/214.97  |- mesh__recordOriginator mesh__D006199 RC
% 214.76/214.97  |- skos__annotation mesh__D006199 see note on HAIR CELLS   
% 214.76/214.97  |- skos__hiddenLabel mesh__D006199 Inner Hair Cell
% 214.76/214.97  |- skos__historyNote mesh__D006199 Mechanoreceptors %28%1977-1979%29%
% 214.76/214.97  |- mesh__recordMaintainer mesh__D006199 ags
% 214.76/214.97  |- rdf__type mesh__D006199sskos__Concept
% 214.76/214.97  |- skos__historyNote mesh__D006199 Organ of Corti %28%1966-1976%29%
% 214.76/214.97  |- mesh__historyNote mesh__D006199
% 214.76/214.97       91%28%80%29%; was see under HAIR CELLS 1980-90   
% 214.76/214.97  |- skos__hiddenLabel mesh__D006199 Hair Cell, Inner
% 214.76/214.97  |- skos__hiddenLabel mesh__D006199 Cell, Inner Hair
% 214.76/214.97  |- mesh__dateCreated mesh__D006199 1978-12-21
% 214.76/214.97  |- skos__broader mesh__D000728Q000037smesh__D000728
% 214.76/214.97  |- mesh__preferredCombination mesh__D000728Q000037smesh__D000726
% 214.76/214.97  |- rdf__type mesh__D000728Q000037smesh__CompoundConcept
% 214.76/214.97  |- skos__historyNote mesh__D019316 RNA Viruses %28%1993-1994%29%
% 214.76/214.97  |- mesh__dateRevised mesh__D019316 2004-07-07
% 214.76/214.97  |- skos__historyNote mesh__D019316 Togaviridae %28%1992%29%
% 214.76/214.97  |- mesh__dateEstablished mesh__D019316 1997-01-01
% 214.76/214.97  |- mesh__recordMaintainer mesh__D019316 ags
% 214.76/214.97  |- mesh__recordAuthorizer mesh__D019316 sjn
% 214.76/214.97  |- skos__broader mesh__D019316smesh__D018018
% 214.76/214.97  |- skos__scopeNote mesh__D019316
% 214.76/214.97       A species of ARTERIVIRUS causing reproductive and respiratory disease in pigs. The European strain is called Lelystad virus. Airborne transmission is common.%A%    
% 214.76/214.97  |- skos__annotation mesh__D019316
% 214.76/214.97       infection = PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME%A%  
% 214.76/214.97  |- mesh__recordOriginator mesh__D019316 AGS
% 214.76/214.97  |- skos__altLabel mesh__D019316
% 214.76/214.97       Swine Infertility Respiratory Syndrome Virus
% 214.76/214.97  |- mesh__dateCreated mesh__D019316 1996-06-10
% 214.76/214.97  |- skos__altLabel mesh__D019316 PRRSV
% 214.76/214.97  |- skos__altLabel mesh__D019316
% 214.76/214.97       Porcine Reproductive and Respiratory Syndrome Virus
% 214.76/214.97  |- mesh__historyNote mesh__D019316 2002 %28%1997%29%   
% 214.76/214.97  |- skos__prefLabel mesh__D019316
% 214.76/214.97       Porcine respiratory and reproductive syndrome virus
% 214.76/214.97  |- skos__altLabel mesh__D019316
% 214.76/214.97       Swine Infertility and Respiratory Syndrome Virus
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D019316 2006
% 214.76/214.97  |- mesh__publicMeSHNote mesh__D019316
% 214.76/214.97       2002; see SWINE INFERTILITY AND RESPIRATORY SYNDROME VIRUS 1997-2001%A%  
% 214.76/214.97  |- skos__historyNote mesh__D019316 Arenavirus %28%1993-1996%29%
% 214.76/214.97  |- rdf__type mesh__D019316sskos__Concept
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D019316 2005
% 214.76/214.97  |- mesh__publicMeSHNote mesh__D011333 85   
% 214.76/214.97  |- skos__scopeNote mesh__D011333
% 214.76/214.97       A precursor protein, MW 30,000, synthesized mainly in the anterior pituitary gland but also found in the hypothalamus, brain, and several peripheral tissues. It incorporates the amino acid sequences of ACTH and beta-lipotropin. These two hormones, in turn, contain the biologically active peptides MSH, corticotropin-like intermediate lobe peptide, alpha-lipotropin, endorphins, and methionine enkephalin.%A%    
% 214.76/214.97  |- skos__hiddenLabel mesh__D011333 Pro Opio Melanocortin
% 214.76/214.97  |- skos__historyNote mesh__D011333 Protein Precursors %28%1973-1984%29%
% 214.76/214.97  |- skos__altLabel mesh__D011333 ACTH-Endorphin Precursor
% 214.76/214.97  |- skos__altLabel mesh__D011333 Proopiomelanocortin
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D011333 2006
% 214.76/214.97  |- skos__altLabel mesh__D011333 Pro-Opiocortin
% 214.76/214.97  |- mesh__historyNote mesh__D011333 85   
% 214.76/214.97  |- mesh__dateRevised mesh__D011333 2002-07-02
% 214.76/214.97  |- mesh__recordAuthorizer mesh__D011333 sjn
% 214.76/214.97  |- skos__hiddenLabel mesh__D011333 Pro ACTH Endorphin
% 214.76/214.97  |- skos__altLabel mesh__D011333 Pro-ACTH-Endorphin
% 214.76/214.97  |- skos__prefLabel mesh__D011333 Pro-Opiomelanocortin
% 214.76/214.97  |- mesh__recordOriginator mesh__D011333 RLS
% 214.76/214.97  |- skos__altLabel mesh__D011333 Proopiocortin
% 214.76/214.97  |- skos__hiddenLabel mesh__D011333 ACTH Endorphin Precursor
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D011333 2005
% 214.76/214.97  |- skos__altLabel mesh__D011333 Endorphin-ACTH Precursor
% 214.76/214.97  |- skos__hiddenLabel mesh__D011333 ACTH beta Lipotropin Precursor
% 214.76/214.97  |- skos__hiddenLabel mesh__D011333 Pro Opiomelanocortin
% 214.76/214.97  |- mesh__recordMaintainer mesh__D011333 KEV
% 214.76/214.97  |- mesh__dateEstablished mesh__D011333 1985-01-01
% 214.76/214.97  |- skos__hiddenLabel mesh__D011333 Endorphin ACTH Precursor
% 214.76/214.97  |- skos__hiddenLabel mesh__D011333 Pro Opiocortin
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D011333 2004
% 214.76/214.97  |- rdf__type mesh__D011333sskos__Concept
% 214.76/214.97  |- skos__historyNote mesh__D011333
% 214.76/214.97       Pituitary Hormones, Anterior %28%1966-1984%29%
% 214.76/214.97  |- skos__hiddenLabel mesh__D011333 Corticotropin beta Lipotropin Precursor
% 214.76/214.97  |- skos__altLabel mesh__D011333 POMC
% 214.76/214.97  |- skos__altLabel mesh__D011333 Pro-Opio-Melanocortin
% 214.76/214.97  |- skos__broader mesh__D011333smesh__D010908
% 214.76/214.97  |- mesh__dateCreated mesh__D011333 1984-05-30
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D011333 2003
% 214.76/214.97  |- skos__altLabel mesh__D011333 ACTH-beta-Lipotropin Precursor
% 214.76/214.97  |- skos__altLabel mesh__D011333 Corticotropin-beta-Lipotropin Precursor
% 214.76/214.97  |- skos__annotation mesh__D011333
% 214.76/214.97       a protein precursor; /biosyn /physiol permitted; DF: note short X ref%A%  
% 214.76/214.97  |- skos__broader mesh__D011333smesh__D011498
% 214.76/214.97  |- mesh__recordMaintainer mesh__D035781 sjn
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D035781 2004
% 214.76/214.97  |- skos__historyNote mesh__D035781 Nuclear Family %28%1991-2002%29%
% 214.76/214.97  |- mesh__recordAuthorizer mesh__D035781 sjn
% 214.76/214.97  |- rdf__type mesh__D035781sskos__Concept
% 214.76/214.97  |- mesh__recordOriginator mesh__D035781 hjn
% 214.76/214.97  |- mesh__publicMeSHNote mesh__D035781 2003   
% 214.76/214.97  |- mesh__dateEstablished mesh__D035781 2003-01-01
% 214.76/214.97  |- skos__scopeNote mesh__D035781
% 214.76/214.97       Persons or animals having at least one parent in common. %28%American College Dictionary, 3d ed%29%%A%    
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D035781 2006
% 214.76/214.97  |- skos__broader mesh__D035781smesh__D009679
% 214.76/214.97  |- mesh__dateRevised mesh__D035781 2003-07-25
% 214.76/214.97  |- skos__hiddenLabel mesh__D035781 Sister
% 214.76/214.97  |- mesh__dateCreated mesh__D035781 2002-07-02
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D035781 2005
% 214.76/214.97  |- skos__hiddenLabel mesh__D035781 Brother
% 214.76/214.97  |- skos__hiddenLabel mesh__D035781 Sibling
% 214.76/214.97  |- skos__broader mesh__D035781smesh__D009272
% 214.76/214.97  |- skos__annotation mesh__D035781
% 214.76/214.97       use only when the subject of discussion   
% 214.76/214.97  |- skos__prefLabel mesh__D035781 Siblings
% 214.76/214.97  |- mesh__historyNote mesh__D035781 2003   
% 214.76/214.97  |- skos__historyNote mesh__D035781 Family %28%1965-2002%29%
% 214.76/214.97  |- mesh__recordAuthorizer mesh__D029744 sjn
% 214.76/214.97  |- mesh__publicMeSHNote mesh__D029744 2002   
% 214.76/214.97  |- mesh__dateRevised mesh__D029744 2002-07-02
% 214.76/214.97  |- skos__altLabel mesh__D029744 Gugulu
% 214.76/214.97  |- skos__broader mesh__D029744smesh__D029403
% 214.76/214.97  |- skos__altLabel mesh__D029744 Bisabol Myrrh
% 214.76/214.97  |- mesh__recordOriginator mesh__D029744 ssb
% 214.76/214.97  |- skos__prefLabel mesh__D029744 Commiphora
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D029744 2004
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D029744 2006
% 214.76/214.97  |- rdf__type mesh__D029744sskos__Concept
% 214.76/214.97  |- skos__altLabel mesh__D029744 Myrrh, Bisabol
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D029744 2003
% 214.76/214.97  |- mesh__dateEstablished mesh__D029744 2002-01-01
% 214.76/214.97  |- skos__scopeNote mesh__D029744
% 214.76/214.97       A plant genus of the family BURSERACEAE which is a source of gugulipid and guggulu extract. Balm of Gilead is a common name more often referring to POPULUS and sometimes to ABIES.%A%    
% 214.76/214.97  |- mesh__dateCreated mesh__D029744 2001-07-25
% 214.76/214.97  |- mesh__historyNote mesh__D029744 2002   
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D029744 2005
% 214.76/214.97  |- mesh__recordMaintainer mesh__D029744 ssb
% 214.76/214.97  |- skos__annotation mesh__D029744
% 214.76/214.97       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.76/214.97  |- skos__altLabel mesh__D029744 Guggulu
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D007292 2005
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D007292 2004
% 214.76/214.97  |- mesh__recordOriginator mesh__D007292 NLM
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D007292 1996
% 214.76/214.97  |- skos__prefLabel mesh__D007292 Inosine Nucleotides
% 214.76/214.97  |- mesh__dateCreated mesh__D007292 1999-01-01
% 214.76/214.97  |- mesh__recordMaintainer mesh__D007292 TGC
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D007292 2002
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D007292 2006
% 214.76/214.97  |- skos__hiddenLabel mesh__D007292 Nucleotides, Inosine
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D007292 1998
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D007292 1997
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D007292 1994
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D007292 1993
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D007292 1999
% 214.76/214.97  |- mesh__publicMeSHNote mesh__D007292 73   
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D007292 2000
% 214.76/214.97  |- skos__annotation mesh__D007292 /biosyn /physiol permitted   
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D007292 1995
% 214.76/214.97  |- skos__hiddenLabel mesh__D007292 Phosphates, Inosine
% 214.76/214.97  |- mesh__historyNote mesh__D007292 73%28%71%29%   
% 214.76/214.97  |- skos__broader mesh__D007292smesh__D012265
% 214.76/214.97  |- rdf__type mesh__D007292sskos__Concept
% 214.76/214.97  |- skos__altLabel mesh__D007292 Inosine Phosphates
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D007292 2001
% 214.76/214.97  |- skos__broader mesh__D007292smesh__D011685
% 214.76/214.97  |- mesh__recordAuthorizer mesh__D007292 PLS
% 214.76/214.97  |- mesh__dateEstablished mesh__D007292 1973-01-01
% 214.76/214.97  |- mesh__dateRevised mesh__D007292 1992-05-19
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D007292 2003
% 214.76/214.97  |- skos__historyNote mesh__D007292 Nucleotides %28%1966-1970%29%
% 214.76/214.97  |- skos__related mesh__D001704smesh__D012313
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D001704 2005
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D001704 2006
% 214.76/214.97  |- rdf__type mesh__D001704sskos__Concept
% 214.76/214.97  |- mesh__dateCreated mesh__D001704 1999-01-01
% 214.76/214.97  |- mesh__dateEstablished mesh__D001704 1991-01-01
% 214.76/214.97  |- skos__prefLabel mesh__D001704 Biopolymers
% 214.76/214.97  |- skos__scopeNote mesh__D001704
% 214.76/214.97       Polymers synthesized by living organisms. They play a role in the formation of macromolecular structures and are synthesized via the covalent linkage of biological molecules, especially AMINO ACIDS; NUCLEOTIDES; and CARBOHYDRATES.%A%    
% 214.76/214.97  |- mesh__recordOriginator mesh__D001704 NLM
% 214.76/214.97  |- mesh__publicMeSHNote mesh__D001704
% 214.76/214.97       1991; see MACROMOLECULAR SYSTEMS 1975-1990   
% 214.76/214.97  |- skos__broader mesh__D001704smesh__D011108
% 214.76/214.97  |- skos__historyNote mesh__D001704
% 214.76/214.97       Macromolecular Substances %28%1975-2004%29%
% 214.76/214.97  |- skos__annotation mesh__D001704 IM GEN only   
% 214.76/214.97  |- mesh__dateRevised mesh__D001704 2004-07-07
% 214.76/214.97  |- mesh__recordMaintainer mesh__D001704 nns
% 214.76/214.97  |- skos__related mesh__D001704smesh__D004247
% 214.76/214.97  |- mesh__recordAuthorizer mesh__D001704 sjn
% 214.76/214.97  |- skos__related mesh__D001704smesh__D011134
% 214.76/214.97  |- mesh__historyNote mesh__D001704
% 214.76/214.97       1991%28%1975%29%; use MACROMOLECULAR SUBSTANCES 1975-1990   
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D006998 1998
% 214.76/214.97  |- mesh__dateCreated mesh__D006998 1999-01-01
% 214.76/214.97  |- skos__hiddenLabel mesh__D006998 Hypochondriacal Neurosis
% 214.76/214.97  |- rdf__type mesh__D006998sskos__Concept
% 214.76/214.97  |- skos__prefLabel mesh__D006998 Hypochondriasis
% 214.76/214.97  |- mesh__historyNote mesh__D006998
% 214.76/214.97       NEUROSIS, HYPOCHONDRIACAL was HYPOCHONDRIACAL NEUROSES see HYPOCHONDRIASIS 1979-80, was HYPOCHONDRIACAL NEUROSES see under HYPOCHONDRIASIS 1969-78%A%  
% 214.76/214.97  |- skos__scopeNote mesh__D006998
% 214.76/214.97       Preoccupation with the fear of having, or the idea that one has, a serious disease based on the person%27%s misinterpretation of bodily symptoms. %28%APA, DSM-IV%29%%A%    
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D006998 2004
% 214.76/214.97  |- mesh__recordAuthorizer mesh__D006998 SJN
% 214.76/214.97  |- mesh__recordMaintainer mesh__D006998 JLS
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D006998 2002
% 214.76/214.97  |- skos__broader mesh__D006998smesh__D013001
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D006998 2006
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D006998 2003
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D006998 2001
% 214.76/214.97  |- mesh__recordOriginator mesh__D006998 NLM
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D006998 2005
% 214.76/214.97  |- mesh__dateRevised mesh__D006998 1997-06-20
% 214.76/214.97  |- skos__altLabel mesh__D006998 Neurosis, Hypochondriacal
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D006998 1999
% 214.76/214.97  |- mesh__onlineNote mesh__D006998
% 214.76/214.97       use HYPOCHONDRIASIS to search HYPOCHONDRIACAL NEUROSES 1969-80%A%  
% 214.76/214.97  |- skos__altLabel mesh__D006998 Hypochondriacal Neuroses
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D006998 2000
% 214.76/214.97  |- skos__hiddenLabel mesh__D020669 Fetoscope
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D020669 2002
% 214.76/214.97  |- skos__hiddenLabel mesh__D020669 Embryoscope
% 214.76/214.97  |- skos__broader mesh__D020669smesh__D019723
% 214.76/214.97  |- skos__historyNote mesh__D020669
% 214.76/214.97       Endoscopy/instrumentation %28%1966-1976%29%
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D020669 2001
% 214.76/214.97  |- mesh__dateEstablished mesh__D020669 2000-01-01
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D020669 2000
% 214.76/214.97  |- rdf__type mesh__D020669sskos__Concept
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D020669 2004
% 214.76/214.97  |- skos__hiddenLabel mesh__D020669 Amnioscope
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D020669 2006
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D020669 2003
% 214.76/214.97  |- skos__prefLabel mesh__D020669 Fetoscopes
% 214.76/214.97  |- skos__scopeNote mesh__D020669
% 214.76/214.97       Endoscopes for viewing the embryo, fetus and amniotic cavity.%A%    
% 214.76/214.97  |- mesh__dateCreated mesh__D020669 1999-11-03
% 214.76/214.97  |- mesh__historyNote mesh__D020669 2000   
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D020669 2005
% 214.76/214.97  |- mesh__publicMeSHNote mesh__D020669 2000   
% 214.76/214.97  |- skos__historyNote mesh__D020669
% 214.76/214.97       Fetoscopy/instrumentation %28%1977-1999%29%
% 214.76/214.97  |- skos__scopeNote mesh__D047008
% 214.76/214.97       A liverwort plant genus of the family Marchantiaceae, order Marchantiales, subclass MARCHANTIAE. Members contain brassinosteroids and DITERPENES.%A%    
% 214.76/214.97  |- mesh__dateCreated mesh__D047008 2004-07-07
% 214.76/214.97  |- mesh__recordAuthorizer mesh__D047008 sjn
% 214.76/214.97  |- skos__broader mesh__D047008smesh__D035926
% 214.76/214.97  |- mesh__recordOriginator mesh__D047008 ssb
% 214.76/214.97  |- skos__prefLabel mesh__D047008 Marchantia
% 214.76/214.97  |- mesh__recordMaintainer mesh__D047008 ssb
% 214.76/214.97  |- mesh__dateEstablished mesh__D047008 2005-01-01
% 214.76/214.97  |- rdf__type mesh__D047008sskos__Concept
% 214.76/214.97  |- mesh__historyNote mesh__D047008 2005   
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D047008 2006
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D047008 2005
% 214.76/214.97  |- skos__annotation mesh__D047008
% 214.76/214.97       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.76/214.97  |- mesh__publicMeSHNote mesh__D047008 2005   
% 214.76/214.97  |- mesh__recordOriginator mesh__D019317 TGC
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D019317 2001
% 214.76/214.97  |- skos__altLabel mesh__D019317 Medicine, Evidence-Based
% 214.76/214.97  |- mesh__recordMaintainer mesh__D019317 jls
% 214.76/214.97  |- skos__broader mesh__D019317smesh__D015510
% 214.76/214.97  |- mesh__dateEstablished mesh__D019317 1997-01-01
% 214.76/214.97  |- mesh__recordAuthorizer mesh__D019317 sjn
% 214.76/214.97  |- skos__hiddenLabel mesh__D019317 Evidence Based Medicine
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D019317 2006
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D019317 2002
% 214.76/214.97  |- skos__hiddenLabel mesh__D019317 Medicine, Evidence Based
% 214.76/214.97  |- mesh__dateCreated mesh__D019317 1996-06-10
% 214.76/214.97  |- mesh__historyNote mesh__D019317 97   
% 214.76/214.97  |- rdf__type mesh__D019317sskos__Concept
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D019317 2004
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D019317 2005
% 214.76/214.97  |- mesh__dateRevised mesh__D019317 2000-06-22
% 214.76/214.97  |- skos__scopeNote mesh__D019317
% 214.76/214.97       The process of systematically finding, appraising, and using contemporaneous research findings as the basis for clinical decisions. Evidence-based medicine asks questions, finds and appraises the relevant data, and harnesses that information for everyday clinical practice. Evidence-based medicine follows four steps: formulate a clear clinical question from a patient%27%s problem; search the literature for relevant clinical articles; evaluate %28%critically appraise%29% the evidence for its validity and usefulness; implement useful findings in clinical practice. The term %22%evidence based medicine%22% %28%no hyphen%29% was coined at McMaster Medical School in Canada in the 1980%27%s to label this clinical learning strategy, which people at the school had been developing for over a decade. %28%From BMJ 1995;310:1122%29%%A%    
% 214.76/214.97  |- mesh__publicMeSHNote mesh__D019317 97   
% 214.76/214.97  |- skos__prefLabel mesh__D019317 Evidence-Based Medicine
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D019317 2003
% 214.76/214.97  |- skos__annotation mesh__D019317
% 214.76/214.97       a type of clinical med; DF: EVIDENCE BASED MED   
% 214.76/214.97  |- mesh__onlineNote mesh__D011334
% 214.76/214.97       search INHIBITION %28%PSYCHOLOGY%29% 1971-74   
% 214.76/214.97  |- mesh__publicMeSHNote mesh__D011334
% 214.76/214.97       91; was see under INHIBITION %28%PSYCHOLOGY%29% 1975-90   
% 214.76/214.97  |- mesh__recordAuthorizer mesh__D011334 sjn
% 214.76/214.97  |- mesh__historyNote mesh__D011334
% 214.76/214.97       91%28%75%29%; was see under INHIBITION %28%PSYCHOLOGY%29% 1975-90   
% 214.76/214.97  |- skos__broader mesh__D011334smesh__D007266
% 214.76/214.97  |- skos__altLabel mesh__D011334 Inhibition, Proactive
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D011334 2006
% 214.76/214.97  |- skos__hiddenLabel mesh__D011334 Proactive Inhibitions
% 214.76/214.97  |- mesh__recordMaintainer mesh__D011334 NLM
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D011334 2005
% 214.76/214.97  |- rdf__type mesh__D011334sskos__Concept
% 214.76/214.97  |- skos__annotation mesh__D011334 no qualif   
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D011334 2004
% 214.76/214.97  |- skos__hiddenLabel mesh__D011334 Inhibitions, Proactive
% 214.76/214.97  |- mesh__recordOriginator mesh__D011334 NLM
% 214.76/214.97  |- mesh__dateRevised mesh__D011334 2002-07-03
% 214.76/214.97  |- skos__scopeNote mesh__D011334
% 214.76/214.97       The state or process hypothesized to account for poorer learning rate for elements later in a series as compared to the learning rate for elements coming earlier in a series.%A%    
% 214.76/214.97  |- mesh__dateCreated mesh__D011334 1999-01-01
% 214.76/214.97  |- mesh__dateEstablished mesh__D011334 1991-01-01
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D011334 2003
% 214.76/214.97  |- skos__prefLabel mesh__D011334 Proactive Inhibition
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D035782 2004
% 214.76/214.97  |- rdf__type mesh__D035782sskos__Concept
% 214.76/214.97  |- mesh__dateCreated mesh__D035782 2002-07-03
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D035782 2005
% 214.76/214.97  |- mesh__historyNote mesh__D035782 2003   
% 214.76/214.97  |- mesh__publicMeSHNote mesh__D035782 2003   
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D035782 2006
% 214.76/214.97  |- skos__annotation mesh__D035782
% 214.76/214.97       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.76/214.97  |- mesh__dateEstablished mesh__D035782 2003-01-01
% 214.76/214.97  |- skos__broader mesh__D035782smesh__D007887
% 214.76/214.97  |- skos__scopeNote mesh__D035782
% 214.76/214.97       A plant genus of the family FABACEAE. Members of this genus can cause CONTACT DERMATITIS.%A%    
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D035782 2003
% 214.76/214.97  |- skos__prefLabel mesh__D035782 Dalbergia
% 214.76/214.97  |- mesh__recordOriginator mesh__D029745 ssb
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D029745 2004
% 214.76/214.97  |- mesh__dateCreated mesh__D029745 2001-07-25
% 214.76/214.97  |- mesh__historyNote mesh__D029745 2002   
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D029745 2006
% 214.76/214.97  |- mesh__recordMaintainer mesh__D029745 ssb
% 214.76/214.97  |- rdf__type mesh__D029745sskos__Concept
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D029745 2003
% 214.76/214.97  |- skos__prefLabel mesh__D029745 Codonopsis
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D029745 2005
% 214.76/214.97  |- mesh__recordAuthorizer mesh__D029745 sjn
% 214.76/214.97  |- skos__annotation mesh__D029745
% 214.76/214.97       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.76/214.97  |- mesh__dateRevised mesh__D029745 2002-07-02
% 214.76/214.97  |- mesh__dateEstablished mesh__D029745 2002-01-01
% 214.76/214.97  |- skos__broader mesh__D029745smesh__D029422
% 214.76/214.97  |- mesh__publicMeSHNote mesh__D029745 2002   
% 214.76/214.97  |- skos__altLabel mesh__D029745 Bellflower
% 214.76/214.97  |- skos__altLabel mesh__D029745 Dangshen
% 214.76/214.97  |- skos__scopeNote mesh__D029745
% 214.76/214.97       A plant genus of the family CAMPANULACEAE.  The common name of bellflower may sometimes be confused with other plants in the family that have similar appearance.%A%    
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D007293 2006
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D007293 1992
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D007293 1998
% 214.76/214.97  |- skos__prefLabel mesh__D007293 Inosine Triphosphate
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D007293 1997
% 214.76/214.97  |- mesh__dateEstablished mesh__D007293 1991-01-01
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D007293 1994
% 214.76/214.97  |- skos__broader mesh__D007293smesh__D007292
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D007293 1993
% 214.76/214.97  |- mesh__activeMeSHYear mesh__D007293 1999
% 214.76/214.97  |- mesh__dateCreated mesh__D007293 1977-04-22
% 214.76/214.97  |- skos__scopeNote mesh__D007293
% 214.76/214.97       Inosine 5%27%-%28%tetrahydrogen triphosphate%29%. An inosine nucleotide containing three phosphate groups esterified to the sugar moiety. Synonym: IRPPP.%A%    
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D007293 2002
% 214.76/214.98  |- skos__annotation mesh__D007293 /biosyn /physiol permitted   
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D007293 1995
% 214.76/214.98  |- rdf__type mesh__D007293sskos__Concept
% 214.76/214.98  |- mesh__dateRevised mesh__D007293 1990-04-13
% 214.76/214.98  |- mesh__recordMaintainer mesh__D007293 NLM
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D007293 2003
% 214.76/214.98  |- mesh__recordOriginator mesh__D007293 RLS
% 214.76/214.98  |- skos__historyNote mesh__D007293 Inosine Nucleotides %28%1971-1977%29%
% 214.76/214.98  |- mesh__historyNote mesh__D007293
% 214.76/214.98       91%28%78%29%; was see under INOSINE NUCLEOTIDES 1978-90   
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D007293 2000
% 214.76/214.98  |- mesh__publicMeSHNote mesh__D007293
% 214.76/214.98       91; was see under INOSINE NUCLEOTIDES 1978-90   
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D007293 2005
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D007293 2004
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D007293 1991
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D007293 1996
% 214.76/214.98  |- skos__hiddenLabel mesh__D007293 Triphosphate, Inosine
% 214.76/214.98  |- skos__altLabel mesh__D007293 ITP
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D007293 2001
% 214.76/214.98  |- mesh__recordAuthorizer mesh__D007293 PLS
% 214.76/214.98  |- skos__altLabel mesh__D015725 ct-Arzneimittel Brand of Fluconazole
% 214.76/214.98  |- skos__altLabel mesh__D015725 Effik Brand of Fluconazole
% 214.76/214.98  |- skos__broader mesh__D015725smesh__D014230
% 214.76/214.98  |- rdf__type mesh__D015725sskos__Concept
% 214.76/214.98  |- skos__prefLabel mesh__D015725 Fluconazole
% 214.76/214.98  |- skos__altLabel mesh__D015725 Pfleger Brand of Fluconazole
% 214.76/214.98  |- skos__altLabel mesh__D015725 Triflucan
% 214.76/214.98  |- skos__altLabel mesh__D015725 Vita Brand of Fluconazole
% 214.76/214.98  |- skos__hiddenLabel mesh__D015725 Fluconazol Isis
% 214.76/214.98  |- mesh__dateRevised mesh__D015725 2005-06-30
% 214.76/214.98  |- skos__altLabel mesh__D015725 Aliud Brand of Fluconazole
% 214.76/214.98  |- skos__altLabel mesh__D015725 Stada Brand of Fluconazole
% 214.76/214.98  |- mesh__recordAuthorizer mesh__D015725 sjn
% 214.76/214.98  |- skos__altLabel mesh__D015725 Chemia Brand of Fluconazole
% 214.76/214.98  |- skos__altLabel mesh__D015725 Lichtenstein Brand of Fluconazole
% 214.76/214.98  |- mesh__recordOriginator mesh__D015725 AGS
% 214.76/214.98  |- skos__hiddenLabel mesh__D015725 Fluconazol ratiopharm
% 214.76/214.98  |- skos__hiddenLabel mesh__D015725 UK49858
% 214.76/214.98  |- mesh__dateEstablished mesh__D015725 1990-01-01
% 214.76/214.98  |- skos__altLabel mesh__D015725 Lesvi Brand of Fluconazole
% 214.76/214.98  |- skos__hiddenLabel mesh__D015725 ct Arzneimittel Brand of Fluconazole
% 214.76/214.98  |- mesh__historyNote mesh__D015725 90   
% 214.76/214.98  |- mesh__recordMaintainer mesh__D015725 ssb
% 214.76/214.98  |- mesh__dateCreated mesh__D015725 1989-05-15
% 214.76/214.98  |- skos__altLabel mesh__D015725 betapharm Brand of Fluconazole
% 214.76/214.98  |- skos__hiddenLabel mesh__D015725 Apo Fluconazole
% 214.76/214.98  |- skos__altLabel mesh__D015725 SAT Brand of Fluconazole
% 214.76/214.98  |- skos__altLabel mesh__D015725 Hexal Brand of Fluconazole
% 214.76/214.98  |- skos__altLabel mesh__D015725 Alpharma Brand of Fluconazole
% 214.76/214.98  |- skos__altLabel mesh__D015725 Mack Brand of Fluconazole
% 214.76/214.98  |- skos__altLabel mesh__D015725 Apotex Brand of Fluconazole
% 214.76/214.98  |- skos__altLabel mesh__D015725 Pfizer Brand of Fluconazole
% 214.76/214.98  |- mesh__publicMeSHNote mesh__D015725 90   
% 214.76/214.98  |- skos__altLabel mesh__D015725 AbZ Brand of Fluconazole
% 214.76/214.98  |- skos__altLabel mesh__D015725 Armstrong Brand of Fluconazole
% 214.76/214.98  |- skos__scopeNote mesh__D015725
% 214.76/214.98       Triazole antifungal agent that is used to treat oropharyngeal candidiasis and cryptococcal meningitis in AIDS.%A%    
% 214.76/214.98  |- skos__historyNote mesh__D015725 Triazoles %28%1985-1989%29%
% 214.76/214.98  |- skos__altLabel mesh__D015725 ratiopharm Brand of Fluconazole
% 214.76/214.98  |- skos__hiddenLabel mesh__D015725 UK 49858
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D015725 2006
% 214.76/214.98  |- skos__altLabel mesh__D015725 Silanes Brand of Fluconazole
% 214.76/214.98  |- skos__scopeNote mesh__D001705
% 214.76/214.98       Prosthesis, usually heart valve, composed of biological material and whose durability depends upon the stability of the material after pretreatment, rather than regeneration by host cell ingrowth. Durability is achieved 1, mechanically by the interposition of a cloth, usually polytetrafluoroethylene, between the host and the graft, and 2, chemically by stabilization of the tissue by intermolecular linking, usually with glutaraldehyde, after removal of antigenic components, or the use of reconstituted and restructured biopolymers.%A%    
% 214.76/214.98  |- mesh__dateCreated mesh__D001705 1978-05-03
% 214.76/214.98  |- skos__hiddenLabel mesh__D001705 Heterograft Bioprostheses
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D001705 2006
% 214.76/214.98  |- mesh__recordAuthorizer mesh__D001705 sjn
% 214.76/214.98  |- rdf__type mesh__D001705sskos__Concept
% 214.76/214.98  |- skos__hiddenLabel mesh__D001705 Bioprostheses, Xenograft
% 214.76/214.98  |- skos__hiddenLabel mesh__D001705 Xenograft Bioprostheses
% 214.76/214.98  |- skos__hiddenLabel mesh__D001705 Graft, Glutaraldehyde-Stabilized
% 214.76/214.98  |- mesh__recordOriginator mesh__D001705 SMH
% 214.76/214.98  |- skos__hiddenLabel mesh__D001705 Bioprosthesis, Xenograft
% 214.76/214.98  |- skos__hiddenLabel mesh__D001705 Grafts, Glutaraldehyde-Stabilized
% 214.76/214.98  |- skos__hiddenLabel mesh__D001705 Bioprosthesis, Heterograft
% 214.76/214.98  |- skos__hiddenLabel mesh__D001705 Porcine Xenograft Bioprostheses
% 214.76/214.98  |- skos__altLabel mesh__D001705 Xenograft Bioprosthesis
% 214.76/214.98  |- mesh__dateEstablished mesh__D001705 1979-01-01
% 214.76/214.98  |- mesh__recordMaintainer mesh__D001705 wdj
% 214.76/214.98  |- skos__hiddenLabel mesh__D001705 Bioprostheses, Heterograft
% 214.76/214.98  |- skos__historyNote mesh__D001705 Heart Valve Prosthesis %28%1966-1978%29%
% 214.76/214.98  |- mesh__dateRevised mesh__D001705 2004-07-07
% 214.76/214.98  |- skos__hiddenLabel mesh__D001705 Xenograft Bioprostheses, Porcine
% 214.76/214.98  |- mesh__publicMeSHNote mesh__D001705 79   
% 214.76/214.98  |- skos__prefLabel mesh__D001705 Bioprosthesis
% 214.76/214.98  |- skos__hiddenLabel mesh__D001705 Glutaraldehyde-Stabilized Graft
% 214.76/214.98  |- mesh__historyNote mesh__D001705 79   
% 214.76/214.98  |- skos__hiddenLabel mesh__D001705 Bioprostheses
% 214.76/214.98  |- skos__hiddenLabel mesh__D001705 Bioprostheses, Porcine Xenograft
% 214.76/214.98  |- skos__hiddenLabel mesh__D001705 Bioprosthesis, Porcine Xenograft
% 214.76/214.98  |- skos__broader mesh__D001705smesh__D019736
% 214.76/214.98  |- skos__annotation mesh__D001705
% 214.76/214.98       IM; coord IM with specific prosth term %28%IM%29%, as BIOPROSTHESIS + HEART VALVE PROSTHESIS; do not specify source of biol material unless especially discussed %26% do not coord with TRANSPLANTATION, HETEROLOGOUS; note X refs below%A%  
% 214.76/214.98  |- skos__hiddenLabel mesh__D001705 Glutaraldehyde Stabilized Grafts
% 214.76/214.98  |- skos__hiddenLabel mesh__D001705 Xenograft Bioprosthesis, Porcine
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D001705 2005
% 214.76/214.98  |- mesh__dateEstablished mesh__D006999 1975-01-01
% 214.76/214.98  |- mesh__publicMeSHNote mesh__D006999 75; see ASCOMYCETES 1963-74   
% 214.76/214.98  |- mesh__recordOriginator mesh__D006999 NLM
% 214.76/214.98  |- rdf__type mesh__D006999sskos__Concept
% 214.76/214.98  |- mesh__historyNote mesh__D006999 75%28%63%29%   
% 214.76/214.98  |- skos__prefLabel mesh__D006999 Hypocreales
% 214.76/214.98  |- skos__historyNote mesh__D006999 Ascomycetes %28%1966-1974%29%
% 214.76/214.98  |- mesh__dateRevised mesh__D006999 2005-06-30
% 214.76/214.98  |- skos__broader mesh__D006999smesh__D001203
% 214.76/214.98  |- mesh__recordAuthorizer mesh__D006999 sjn
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D006999 2006
% 214.76/214.98  |- skos__scopeNote mesh__D006999
% 214.76/214.98       An order of fungi in the phylum ASCOMYCOTA that includes a number of species which are parasitic on higher plants, insects, or fungi. Other species are saprotrophic.%A%    
% 214.76/214.98  |- mesh__dateCreated mesh__D006999 1999-01-01
% 214.76/214.98  |- mesh__recordMaintainer mesh__D006999 SYSTEM
% 214.76/214.98  |- skos__prefLabel mesh__D047009 Clostridium histolyticum
% 214.76/214.98  |- skos__annotation mesh__D047009
% 214.76/214.98       infection: coordinate IM with CLOSTRIDIUM INFECTIONS %28%IM%29% or GAS GANGRENE %28%IM%29% if appropriate%A%  
% 214.76/214.98  |- skos__historyNote mesh__D047009 Clostridium %28%1965-2004%29%
% 214.76/214.98  |- rdf__type mesh__D047009sskos__Concept
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D047009 2006
% 214.76/214.98  |- mesh__recordOriginator mesh__D047009 ags
% 214.76/214.98  |- skos__scopeNote mesh__D047009
% 214.76/214.98       A species of gram-positive, strongly proteolytic bacteria in the family Clostridiaceae. It contains several forms of COLLAGENASE whose action can lead to GAS GANGRENE in humans and HORSES.%A%    
% 214.76/214.98  |- mesh__publicMeSHNote mesh__D047009 2005   
% 214.76/214.98  |- mesh__dateRevised mesh__D047009 2005-06-30
% 214.76/214.98  |- mesh__dateEstablished mesh__D047009 2005-01-01
% 214.76/214.98  |- mesh__recordAuthorizer mesh__D047009 sjn
% 214.76/214.98  |- skos__broader mesh__D047009smesh__D003013
% 214.76/214.98  |- mesh__recordMaintainer mesh__D047009 SYSTEM
% 214.76/214.98  |- mesh__dateCreated mesh__D047009 2004-07-07
% 214.76/214.98  |- mesh__historyNote mesh__D047009 2005   
% 214.76/214.98  |- skos__annotation mesh__D019318 DF: note short X ref   
% 214.76/214.98  |- mesh__dateCreated mesh__D019318 1996-06-10
% 214.76/214.98  |- skos__altLabel mesh__D019318 Swine Infertility and Respiratory Syndrome
% 214.76/214.98  |- mesh__recordMaintainer mesh__D019318 jmp
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D019318 2006
% 214.76/214.98  |- mesh__publicMeSHNote mesh__D019318 97   
% 214.76/214.98  |- mesh__historyNote mesh__D019318 97   
% 214.76/214.98  |- rdf__type mesh__D019318sskos__Concept
% 214.76/214.98  |- skos__altLabel mesh__D019318 PRRS
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D019318 2005
% 214.76/214.98  |- skos__hiddenLabel mesh__D019318 Blue Eared Pig Disease
% 214.76/214.98  |- skos__altLabel mesh__D019318 Mystery Swine Disease
% 214.76/214.98  |- skos__broader mesh__D019318smesh__D018174
% 214.76/214.98  |- skos__historyNote mesh__D019318 Swine Diseases %28%1991-1996%29%
% 214.76/214.98  |- skos__scopeNote mesh__D019318
% 214.76/214.98       A syndrome characterized by outbreaks of late term abortions, high numbers of stillbirths and mummified or weak newborn piglets, and respiratory disease in young unweaned and weaned pigs. It is caused by PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS. %28%Radostits et al., Veterinary Medicine, 8th ed, p1048%29%%A%    
% 214.76/214.98  |- mesh__dateRevised mesh__D019318 2004-07-07
% 214.76/214.98  |- mesh__dateEstablished mesh__D019318 1997-01-01
% 214.76/214.98  |- skos__broader mesh__D019318smesh__D013553
% 214.76/214.98  |- skos__hiddenLabel mesh__D019318 Pig Disease, Blue-Eared
% 214.76/214.98  |- skos__altLabel mesh__D019318 Blue-Eared Pig Disease
% 214.76/214.98  |- skos__altLabel mesh__D019318
% 214.76/214.98       Porcine Epidemic Abortion and Respiratory Syndrome
% 214.76/214.98  |- skos__prefLabel mesh__D019318
% 214.76/214.98       Porcine Reproductive and Respiratory Syndrome
% 214.76/214.98  |- mesh__recordAuthorizer mesh__D019318 sjn
% 214.76/214.98  |- skos__hiddenLabel mesh__D019318 Swine Disease, Mystery
% 214.76/214.98  |- mesh__recordOriginator mesh__D019318 AGS
% 214.76/214.98  |- skos__hiddenLabel mesh__D011335 SK 525A
% 214.76/214.98  |- mesh__dateRevised mesh__D011335 2002-07-31
% 214.76/214.98  |- skos__altLabel mesh__D011335 Diethylaminoethyldiphenylpropyl Acetate
% 214.76/214.98  |- mesh__recordOriginator mesh__D011335 NLM
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D011335 2005
% 214.76/214.98  |- rdf__type mesh__D011335sskos__Concept
% 214.76/214.98  |- mesh__dateEstablished mesh__D011335 1966-01-01
% 214.76/214.98  |- skos__broader mesh__D011335smesh__D014631
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D011335 2004
% 214.76/214.98  |- skos__annotation mesh__D011335 D25-26 qualif   
% 214.76/214.98  |- skos__altLabel mesh__D011335 SKF-525-A
% 214.76/214.98  |- skos__hiddenLabel mesh__D011335 SKF525A
% 214.76/214.98  |- skos__hiddenLabel mesh__D011335 SKF 525 A
% 214.76/214.98  |- mesh__dateCreated mesh__D011335 1999-01-01
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D011335 2003
% 214.76/214.98  |- mesh__recordMaintainer mesh__D011335 ssb
% 214.76/214.98  |- mesh__recordAuthorizer mesh__D011335 sjn
% 214.76/214.98  |- skos__prefLabel mesh__D011335 Proadifen
% 214.76/214.98  |- skos__scopeNote mesh__D011335
% 214.76/214.98       An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.%A%    
% 214.76/214.98  |- mesh__publicMeSHNote mesh__D011335 66   
% 214.76/214.98  |- skos__hiddenLabel mesh__D011335 Hydrochloride, Proadifen
% 214.76/214.98  |- skos__hiddenLabel mesh__D011335 SK525A
% 214.76/214.98  |- skos__altLabel mesh__D011335 SK-525A
% 214.76/214.98  |- skos__altLabel mesh__D011335 SKF-525A
% 214.76/214.98  |- skos__hiddenLabel mesh__D011335 SK%26%F 525 A
% 214.76/214.98  |- skos__altLabel mesh__D011335 Propyladiphenin
% 214.76/214.98  |- skos__hiddenLabel mesh__D011335 Acetate, Diethylaminoethyldiphenylpropyl
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D011335 2006
% 214.76/214.98  |- skos__hiddenLabel mesh__D011335 SK%26%F525A
% 214.76/214.98  |- mesh__historyNote mesh__D011335 66%28%64%29%   
% 214.76/214.98  |- skos__historyNote mesh__D016020 Research %28%1966-1997%29%
% 214.76/214.98  |- mesh__recordMaintainer mesh__D016020 ags
% 214.76/214.98  |- skos__broader mesh__D016020smesh__D004812
% 214.76/214.98  |- rdf__type mesh__D016020sskos__Concept
% 214.76/214.98  |- mesh__publicMeSHNote mesh__D016020 98   
% 214.76/214.98  |- skos__historyNote mesh__D016020 Epidemiologic Methods %28%1966-1997%29%
% 214.76/214.98  |- skos__prefLabel mesh__D016020 Epidemiologic Study Characteristics
% 214.76/214.98  |- mesh__recordOriginator mesh__D016020 PLS
% 214.76/214.98  |- mesh__dateRevised mesh__D016020 2003-07-09
% 214.76/214.98  |- skos__hiddenLabel mesh__D016020 Study Characteristic, Epidemiologic
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D016020 2006
% 214.76/214.98  |- mesh__recordAuthorizer mesh__D016020 sjn
% 214.76/214.98  |- mesh__historyNote mesh__D016020 98; use explode 1990-97   
% 214.76/214.98  |- skos__broader mesh__D016020smesh__D017531
% 214.76/214.98  |- skos__hiddenLabel mesh__D016020 Study Characteristics, Epidemiologic
% 214.76/214.98  |- skos__scopeNote mesh__D016020
% 214.76/214.98       Types and formulations of studies used in epidemiological and clinical research.%A%    
% 214.76/214.98  |- mesh__dateEstablished mesh__D016020 1998-01-01
% 214.76/214.98  |- skos__hiddenLabel mesh__D016020 Characteristic, Epidemiologic Study
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D016020 2005
% 214.76/214.98  |- skos__annotation mesh__D016020 not used for indexing or cataloging   
% 214.76/214.98  |- mesh__dateCreated mesh__D016020 1989-05-25
% 214.76/214.98  |- skos__historyNote mesh__D016020 Epidemiology %28%1966-1997%29%
% 214.76/214.98  |- skos__hiddenLabel mesh__D016020 Characteristics, Epidemiologic Study
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D016020 2004
% 214.76/214.98  |- skos__hiddenLabel mesh__D016020 Epidemiologic Study Characteristic
% 214.76/214.98  |- skos__broader mesh__D001769Q000032smesh__D001769
% 214.76/214.98  |- mesh__preferredCombination mesh__D001769Q000032smesh__D001774
% 214.76/214.98  |- rdf__type mesh__D001769Q000032smesh__CompoundConcept
% 214.76/214.98  |- rdf__type mesh__D002000sskos__Concept
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D002000 2002
% 214.76/214.98  |- skos__prefLabel mesh__D002000 Bronchospirometry
% 214.76/214.98  |- mesh__recordMaintainer mesh__D002000 PXP
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D002000 2001
% 214.76/214.98  |- skos__broader mesh__D002000smesh__D013147
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D002000 2004
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D002000 2000
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D002000 2006
% 214.76/214.98  |- skos__annotation mesh__D002000 NIM   
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D002000 1999
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D002000 2003
% 214.76/214.98  |- mesh__recordOriginator mesh__D002000 NLM
% 214.76/214.98  |- mesh__recordAuthorizer mesh__D002000 SJN
% 214.76/214.98  |- mesh__dateCreated mesh__D002000 1999-01-01
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D002000 2005
% 214.76/214.98  |- mesh__dateRevised mesh__D002000 1997-06-20
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D002000 1998
% 214.76/214.98  |- skos__scopeNote mesh__D002000
% 214.76/214.98       Spirometric technique in which the volume of air breathed in the right and left lung is recorded separately.%A%    
% 214.76/214.98  |- skos__hiddenLabel mesh__D002000 Bronchospirometries
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D029746 2006
% 214.76/214.98  |- rdf__type mesh__D029746sskos__Concept
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D029746 2003
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D029746 2005
% 214.76/214.98  |- skos__annotation mesh__D029746
% 214.76/214.98       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.76/214.98  |- mesh__dateEstablished mesh__D029746 2002-01-01
% 214.76/214.98  |- mesh__dateCreated mesh__D029746 2001-07-25
% 214.76/214.98  |- mesh__historyNote mesh__D029746 2002   
% 214.76/214.98  |- skos__broader mesh__D029746smesh__D029422
% 214.76/214.98  |- mesh__publicMeSHNote mesh__D029746 2002   
% 214.76/214.98  |- skos__prefLabel mesh__D029746 Lobelia
% 214.76/214.98  |- skos__scopeNote mesh__D029746
% 214.76/214.98       A plant genus of the family CAMPANULACEAE used medicinally and is a source of LOBELINE.%A%    
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D029746 2004
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D029746 2002
% 214.76/214.98  |- skos__altLabel mesh__D007294 Myoinositol
% 214.76/214.98  |- rdf__type mesh__D007294sskos__Concept
% 214.76/214.98  |- skos__altLabel mesh__D007294 Chiro-Inositol
% 214.76/214.98  |- skos__broader mesh__D007294smesh__D013402
% 214.76/214.98  |- skos__scopeNote mesh__D007294
% 214.76/214.98       An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1379%29% Inositol phospholipids are important in signal transduction.%A%    
% 214.76/214.98  |- skos__altLabel mesh__D007294 Mesoinositol
% 214.76/214.98  |- mesh__recordMaintainer mesh__D007294 ssb
% 214.76/214.98  |- mesh__dateCreated mesh__D007294 1999-01-01
% 214.76/214.98  |- skos__prefLabel mesh__D007294 Inositol
% 214.76/214.98  |- mesh__recordOriginator mesh__D007294 NLM
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D007294 2006
% 214.76/214.98  |- skos__hiddenLabel mesh__D007294 Chiro Inositol
% 214.76/214.98  |- mesh__dateRevised mesh__D007294 2005-06-30
% 214.76/214.98  |- mesh__recordAuthorizer mesh__D007294 sjn
% 214.76/214.98  |- skos__annotation mesh__D015726 any very large cell; A 11 qualif   
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D015726 2005
% 214.76/214.98  |- skos__altLabel mesh__D015726 Polykaryocytes
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D015726 2001
% 214.76/214.98  |- mesh__dateCreated mesh__D015726 1989-04-07
% 214.76/214.98  |- rdf__type mesh__D015726sskos__Concept
% 214.76/214.98  |- skos__scopeNote mesh__D015726
% 214.76/214.98       Multinucleated masses produced by the fusion of many cells; often associated with viral infections. In AIDS, they are induced when the envelope glycoprotein of the HIV virus binds to the CD4 antigen of uninfected neighboring T4 cells. The resulting syncytium leads to cell death and thus may account for the cytopathic effect of the virus.%A%    
% 214.76/214.98  |- skos__hiddenLabel mesh__D015726 Giant Cell
% 214.76/214.98  |- skos__altLabel mesh__D015726 Multinucleated Giant Cells
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D015726 2004
% 214.76/214.98  |- mesh__dateRevised mesh__D015726 1996-06-10
% 214.76/214.98  |- skos__altLabel mesh__D015726 Syncytia
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D015726 2000
% 214.76/214.98  |- mesh__historyNote mesh__D015726 90   
% 214.76/214.98  |- mesh__recordOriginator mesh__D015726 AGS
% 214.76/214.98  |- mesh__recordAuthorizer mesh__D015726 PLS
% 214.76/214.98  |- skos__historyNote mesh__D015726 Cell Fusion %28%1972-1989%29%
% 214.76/214.98  |- mesh__dateEstablished mesh__D015726 1990-01-01
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D015726 2003
% 214.76/214.98  |- skos__hiddenLabel mesh__D015726 Cells, Multinucleated Giant
% 214.76/214.98  |- skos__hiddenLabel mesh__D015726 Multinucleated Giant Cell
% 214.76/214.98  |- mesh__publicMeSHNote mesh__D015726 90   
% 214.76/214.98  |- skos__hiddenLabel mesh__D015726 Polykaryocyte
% 214.76/214.98  |- skos__hiddenLabel mesh__D015726 Cells, Giant
% 214.76/214.98  |- skos__hiddenLabel mesh__D015726 Cell, Multinucleated Giant
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D015726 1999
% 214.76/214.98  |- skos__hiddenLabel mesh__D015726 Giant Cell, Multinucleated
% 214.76/214.98  |- skos__prefLabel mesh__D015726 Giant Cells
% 214.76/214.98  |- skos__altLabel mesh__D015726 Syncytium
% 214.76/214.98  |- skos__altLabel mesh__D015726 Giant Cells, Multinucleated
% 214.76/214.98  |- skos__broader mesh__D015726smesh__D002477
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D015726 1998
% 214.76/214.98  |- skos__hiddenLabel mesh__D015726 Cell, Giant
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D015726 2006
% 214.76/214.98  |- mesh__recordMaintainer mesh__D015726 TGC
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D015726 2002
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D015726 1997
% 214.76/214.98  |- skos__hiddenLabel mesh__D001706 Biopsies
% 214.76/214.98  |- skos__broader mesh__D001706smesh__D003949
% 214.76/214.98  |- mesh__dateCreated mesh__D001706 1999-01-01
% 214.76/214.98  |- mesh__recordMaintainer mesh__D001706 lkt
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D001706 2004
% 214.76/214.98  |- mesh__recordOriginator mesh__D001706 NLM
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D001706 2006
% 214.76/214.98  |- skos__prefLabel mesh__D001706 Biopsy
% 214.76/214.98  |- skos__broader mesh__D001706smesh__D013514
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D001706 2003
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D001706 2005
% 214.76/214.98  |- rdf__type mesh__D001706sskos__Concept
% 214.76/214.98  |- mesh__recordAuthorizer mesh__D001706 sjn
% 214.76/214.98  |- skos__broader mesh__D001706smesh__D003581
% 214.76/214.98  |- mesh__dateRevised mesh__D001706 2002-07-02
% 214.76/214.98  |- skos__annotation mesh__D001706
% 214.76/214.98       IM GEN only; NIM with specific organ /pathol %28%IM%29% + dis /pathol %28%IM%29%; coord with specific technique if appropriate%A%  
% 214.76/214.98  |- skos__scopeNote mesh__D001706
% 214.76/214.98       Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.%A%    
% 214.76/214.98  |- skos__broader mesh__D001706smesh__D013048
% 214.76/214.98  |- mesh__publicMeSHNote mesh__D047808
% 214.76/214.98       2005; see ADRENAL HYPERPLASIA, CONGENITAL 1980-2004   
% 214.76/214.98  |- mesh__historyNote mesh__D047808
% 214.76/214.98       2005; use ADRENAL HYPERPLASIA, CONGENITAL 1980-2004   
% 214.76/214.98  |- skos__broader mesh__D047808smesh__D012734
% 214.76/214.98  |- mesh__dateEstablished mesh__D047808 2005-01-01
% 214.76/214.98  |- skos__hiddenLabel mesh__D047808 Syndromes, Adrenogenital
% 214.76/214.98  |- mesh__recordOriginator mesh__D047808 lkt
% 214.76/214.98  |- skos__hiddenLabel mesh__D047808 Syndrome, Adrenogenital
% 214.76/214.98  |- mesh__dateRevised mesh__D047808 2005-07-29
% 214.76/214.98  |- rdf__type mesh__D047808sskos__Concept
% 214.76/214.98  |- mesh__recordAuthorizer mesh__D047808 ags
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D047808 2006
% 214.76/214.98  |- skos__historyNote mesh__D047808
% 214.76/214.98       Adrenal Hyperplasia, Congenital %28%1964-2004%29%
% 214.76/214.98  |- skos__hiddenLabel mesh__D047808 Adrenogenital Syndromes
% 214.76/214.98  |- mesh__recordMaintainer mesh__D047808 ags
% 214.76/214.98  |- skos__prefLabel mesh__D047808 Adrenogenital Syndrome
% 214.76/214.98  |- skos__scopeNote mesh__D047808
% 214.76/214.98       Abnormal SEX DIFFERENTIATION caused by disorders of the GONADS or the ADRENAL GLANDS, such as CONGENITAL ADRENAL HYPERPLASIA and ADRENAL CORTEX NEOPLASMS. Due to abnormal steroid biosynthesis, clinical features include VIRILISM in females; FEMINIZATION in males; or precocious sexual development in children.%A%    
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D047808 2005
% 214.76/214.98  |- skos__related mesh__D047808smesh__D000312
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D047808 2006A
% 214.76/214.98  |- mesh__dateCreated mesh__D047808 2004-07-07
% 214.76/214.98  |- skos__broader mesh__D008995Q000037smesh__D008995
% 214.76/214.98  |- mesh__preferredCombination mesh__D008995Q000037smesh__D008996
% 214.76/214.98  |- rdf__type mesh__D008995Q000037smesh__CompoundConcept
% 214.76/214.98  |- skos__hiddenLabel mesh__D019319 Acid, Okadaic
% 214.76/214.98  |- mesh__recordAuthorizer mesh__D019319 sjn
% 214.76/214.98  |- skos__altLabel mesh__D019319 Ocadaic Acid
% 214.76/214.98  |- rdf__type mesh__D019319sskos__Concept
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D019319 2005
% 214.76/214.98  |- mesh__dateCreated mesh__D019319 1996-06-10
% 214.76/214.98  |- mesh__onlineNote mesh__D019319
% 214.76/214.98       use OKADAIC ACID %28%NM%29% to search OKADAIC ACID 1982-96   
% 214.76/214.98  |- mesh__dateRevised mesh__D019319 2004-07-07
% 214.76/214.98  |- skos__scopeNote mesh__D019319
% 214.76/214.98       A specific inhibitor of phosphoserine/threonine protein phosphatase 1 and 2a. It is also a potent tumor promoter. %28%Thromb Res 1992;67%28%4%29%:345-54 %26% Cancer Res 1993;53%28%2%29%:239-41%29%%A%    
% 214.76/214.98  |- mesh__publicMeSHNote mesh__D019319
% 214.76/214.98       97; OKADAIC ACID was indexed under ETHERS, CYCLIC 1982-96%A%  
% 214.76/214.98  |- skos__prefLabel mesh__D019319 Okadaic Acid
% 214.76/214.98  |- skos__hiddenLabel mesh__D019319 Acid, Ocadaic
% 214.76/214.98  |- skos__broader mesh__D019319smesh__D004988
% 214.76/214.98  |- skos__historyNote mesh__D019319 Ethers, Cyclic %28%1982-1996%29%
% 214.76/214.98  |- mesh__recordMaintainer mesh__D019319 ssb
% 214.76/214.98  |- mesh__recordOriginator mesh__D019319 ADP
% 214.76/214.98  |- mesh__dateEstablished mesh__D019319 1997-01-01
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D019319 2006
% 214.76/214.98  |- mesh__historyNote mesh__D019319
% 214.76/214.98       97; was OKADAIC ACID %28%NM%29% 1982-96   
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D011336 2004
% 214.76/214.98  |- skos__scopeNote mesh__D011336
% 214.76/214.98       The study of chance processes or the relative frequency characterizing a chance process.%A%    
% 214.76/214.98  |- mesh__dateCreated mesh__D011336 1999-01-01
% 214.76/214.98  |- skos__annotation mesh__D011336
% 214.76/214.98       IM for probability as a statist concept; NIM as coord for relative frequency of occur of specific dis, physiol response, etc.; see note under RISK %26% RISK FACTORS; coord NIM with specific disease or other concept %28%IM%29%%A%  
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D011336 2003
% 214.76/214.98  |- mesh__recordOriginator mesh__D011336 NLM
% 214.76/214.98  |- mesh__historyNote mesh__D011336 68%28%64%29%   
% 214.76/214.98  |- skos__prefLabel mesh__D011336 Probability
% 214.76/214.98  |- mesh__dateRevised mesh__D011336 2002-07-03
% 214.76/214.98  |- mesh__dateEstablished mesh__D011336 1968-01-01
% 214.76/214.98  |- skos__broader mesh__D011336smesh__D013223
% 214.76/214.98  |- mesh__recordAuthorizer mesh__D011336 sjn
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D011336 2006
% 214.76/214.98  |- rdf__type mesh__D011336sskos__Concept
% 214.76/214.98  |- skos__hiddenLabel mesh__D011336 Probabilities
% 214.76/214.98  |- mesh__publicMeSHNote mesh__D011336 68   
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D011336 2005
% 214.76/214.98  |- mesh__recordMaintainer mesh__D011336 tjk
% 214.76/214.98  |- skos__prefLabel mesh__D016021 Epidemiologic Studies
% 214.76/214.98  |- mesh__recordMaintainer mesh__D016021 ags
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D016021 2002
% 214.76/214.98  |- skos__altLabel mesh__D016021 Studies, Epidemiologic
% 214.76/214.98  |- rdf__type mesh__D016021sskos__Concept
% 214.76/214.98  |- skos__annotation mesh__D016021
% 214.76/214.98       exam %26% anal of data leading to epidemiol conclusions: differentiate from EPIDEMIOLOGY, the specialty; GEN or unspecified; prefer specifics; DF: EPIDEMIOL STUDIES%A%  
% 214.76/214.98  |- skos__hiddenLabel mesh__D016021 Epidemiological Study
% 214.76/214.98  |- skos__hiddenLabel mesh__D016021 Study, Epidemiological
% 214.76/214.98  |- skos__hiddenLabel mesh__D016021 Study, Epidemiologic
% 214.76/214.98  |- skos__altLabel mesh__D016021 Epidemiological Studies
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D016021 2005
% 214.76/214.98  |- mesh__recordOriginator mesh__D016021 PLS
% 214.76/214.98  |- mesh__dateRevised mesh__D016021 2001-07-25
% 214.76/214.98  |- skos__hiddenLabel mesh__D016021 Epidemiologic Study
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D016021 2006
% 214.76/214.98  |- mesh__dateCreated mesh__D016021 1989-09-01
% 214.76/214.98  |- skos__historyNote mesh__D016021 Epidemiology %28%1967-1997%29%
% 214.76/214.98  |- mesh__activeMeSHYear mesh__D016021 2003
% 214.76/214.98  |- skos__hiddenLabel mesh__D016021 Studies, Epidemiological
% 214.76/214.98  |- skos__broader mesh__D016021smesh__D016020
% 214.76/214.98  |- mesh__publicMeSHNote mesh__D016021 98   
% 214.76/214.98  |- skos__scopeNote mesh__D016021
% 214.76/214.98       Studies designed to examine associations, commonly, hypothesized causal relations. They are usually concerned with identifying or measuring the effects of risk factors or exposures. The common types of analytic study are CASE-CONTROL STUDIES; COHORT STUDIES; and CROSS-SECTIONAL STUDIES.%A%    
% 214.76/214.99  |- mesh__historyNote mesh__D016021 98; use explode 1990-97   
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D016021 2004
% 214.76/214.99  |- mesh__dateEstablished mesh__D016021 1998-01-01
% 214.76/214.99  |- mesh__recordAuthorizer mesh__D016021 sjn
% 214.76/214.99  |- skos__altLabel mesh__D002001 Adipose Tissue, Brown
% 214.76/214.99  |- skos__hiddenLabel mesh__D002001 Gland, Hibernating
% 214.76/214.99  |- mesh__recordAuthorizer mesh__D002001 sjn
% 214.76/214.99  |- skos__scopeNote mesh__D002001
% 214.76/214.99       A thermogenic form of adipose tissue found in newborns of many species, including humans, and in hibernating mammals. The tissue is capable of rapid liberation of energy and seems to be important in the maintenance of body temperature immediately after birth and upon waking from hibernation.%A%    
% 214.76/214.99  |- skos__hiddenLabel mesh__D002001 Glands, Hibernating
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D002001 2004
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D002001 2002
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D002001 2006
% 214.76/214.99  |- skos__hiddenLabel mesh__D002001 Hibernating Glands
% 214.76/214.99  |- skos__hiddenLabel mesh__D002001 Tissue, Brown Adipose
% 214.76/214.99  |- mesh__recordMaintainer mesh__D002001 KEV
% 214.76/214.99  |- skos__hiddenLabel mesh__D002001 Brown Adipose Tissue
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D002001 2003
% 214.76/214.99  |- skos__hiddenLabel mesh__D002001 Adipose Tissues, Brown
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D002001 2001
% 214.76/214.99  |- mesh__dateCreated mesh__D002001 1999-01-01
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D002001 2005
% 214.76/214.99  |- skos__prefLabel mesh__D002001 Brown Fat
% 214.76/214.99  |- skos__broader mesh__D002001smesh__D000273
% 214.76/214.99  |- mesh__publicMeSHNote mesh__D002001 72   
% 214.76/214.99  |- mesh__historyNote mesh__D002001 72%28%68%29%   
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D002001 2000
% 214.76/214.99  |- mesh__dateRevised mesh__D002001 1999-11-03
% 214.76/214.99  |- skos__hiddenLabel mesh__D002001 Brown Adipose Tissues
% 214.76/214.99  |- mesh__recordOriginator mesh__D002001 NLM
% 214.76/214.99  |- rdf__type mesh__D002001sskos__Concept
% 214.76/214.99  |- skos__hiddenLabel mesh__D002001 Tissues, Brown Adipose
% 214.76/214.99  |- skos__historyNote mesh__D002001 Adipose Tissue %28%1966-1967%29%
% 214.76/214.99  |- mesh__dateEstablished mesh__D002001 1972-01-01
% 214.76/214.99  |- skos__altLabel mesh__D002001 Hibernating Gland
% 214.76/214.99  |- skos__hiddenLabel mesh__D002001 Fat, Brown
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D029747 2006
% 214.76/214.99  |- mesh__recordAuthorizer mesh__D029747 sjn
% 214.76/214.99  |- skos__prefLabel mesh__D029747 Opuntia
% 214.76/214.99  |- rdf__type mesh__D029747sskos__Concept
% 214.76/214.99  |- mesh__recordOriginator mesh__D029747 ssb
% 214.76/214.99  |- skos__annotation mesh__D029747
% 214.76/214.99       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.76/214.99  |- mesh__dateCreated mesh__D029747 2001-07-25
% 214.76/214.99  |- mesh__recordMaintainer mesh__D029747 ssb
% 214.76/214.99  |- mesh__publicMeSHNote mesh__D029747 2002   
% 214.76/214.99  |- mesh__dateRevised mesh__D029747 2002-07-03
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D029747 2003
% 214.76/214.99  |- mesh__dateEstablished mesh__D029747 2002-01-01
% 214.76/214.99  |- mesh__historyNote mesh__D029747 2002   
% 214.76/214.99  |- skos__broader mesh__D029747smesh__D029421
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D029747 2005
% 214.76/214.99  |- skos__scopeNote mesh__D029747
% 214.76/214.99       A plant genus of the family CACTACEAE. Species with cylindrical joints are called Cholla; flat jointed ones are Prickly-pear.%A%    
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D029747 2004
% 214.76/214.99  |- mesh__recordOriginator mesh__D007295 RLS
% 214.76/214.99  |- mesh__recordAuthorizer mesh__D007295 sjn
% 214.76/214.99  |- skos__broader mesh__D007295smesh__D013403
% 214.76/214.99  |- skos__historyNote mesh__D007295 Inositol %28%1966-1977%29%
% 214.76/214.99  |- skos__hiddenLabel mesh__D007295 Phosphates, Inositol
% 214.76/214.99  |- skos__historyNote mesh__D007295 Sugar Phosphates %28%1974-1977%29%
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D007295 2005
% 214.76/214.99  |- mesh__publicMeSHNote mesh__D007295
% 214.76/214.99       90; was see under SUGAR PHOSPHATES 1978-89   
% 214.76/214.99  |- skos__prefLabel mesh__D007295 Inositol Phosphates
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D007295 2006
% 214.76/214.99  |- mesh__dateEstablished mesh__D007295 1990-01-01
% 214.76/214.99  |- mesh__historyNote mesh__D007295
% 214.76/214.99       90%28%78%29%; was see under SUGAR PHOSPHATES 1978-89   
% 214.76/214.99  |- mesh__recordMaintainer mesh__D007295 ssb
% 214.76/214.99  |- skos__scopeNote mesh__D007295
% 214.76/214.99       Phosphoric acid esters of inositol. They include mono- and polyphosphoric acid esters, with the exception of inositol hexaphosphate which is PHYTIC ACID.%A%    
% 214.76/214.99  |- mesh__dateRevised mesh__D007295 2004-07-07
% 214.76/214.99  |- mesh__dateCreated mesh__D007295 1977-04-15
% 214.76/214.99  |- rdf__type mesh__D007295sskos__Concept
% 214.76/214.99  |- skos__broader mesh__D007295smesh__D007294
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D001707 2004
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D001707 2006
% 214.76/214.99  |- skos__hiddenLabel mesh__D001707 Needle Biopsies
% 214.76/214.99  |- skos__broader mesh__D001707smesh__D011677
% 214.76/214.99  |- mesh__dateEstablished mesh__D001707 1973-01-01
% 214.76/214.99  |- skos__broader mesh__D001707smesh__D001706
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D001707 2005
% 214.76/214.99  |- mesh__dateRevised mesh__D001707 2003-07-09
% 214.76/214.99  |- mesh__recordMaintainer mesh__D001707 lkt
% 214.76/214.99  |- rdf__type mesh__D001707sskos__Concept
% 214.76/214.99  |- skos__annotation mesh__D001707
% 214.76/214.99       usually NIM with specific organ /pathol %28%IM%29% + dis /pathol %28%IM%29%%A%  
% 214.76/214.99  |- skos__hiddenLabel mesh__D001707 Biopsy, Puncture
% 214.76/214.99  |- skos__altLabel mesh__D001707 Puncture Biopsy
% 214.76/214.99  |- skos__hiddenLabel mesh__D001707 Biopsies, Aspiration
% 214.76/214.99  |- skos__hiddenLabel mesh__D001707 Biopsies, Puncture
% 214.76/214.99  |- skos__prefLabel mesh__D001707 Biopsy, Needle
% 214.76/214.99  |- mesh__recordOriginator mesh__D001707 NLM
% 214.76/214.99  |- skos__hiddenLabel mesh__D001707 Biopsy, Aspiration
% 214.76/214.99  |- skos__historyNote mesh__D001707 Biopsy %28%1966-1972%29%
% 214.76/214.99  |- skos__scopeNote mesh__D001707
% 214.76/214.99       Removal and examination of tissue obtained through a transdermal needle inserted into the specific region, organ, or tissue being analyzed.%A%    
% 214.76/214.99  |- mesh__publicMeSHNote mesh__D001707 73   
% 214.76/214.99  |- mesh__historyNote mesh__D001707 73   
% 214.76/214.99  |- skos__hiddenLabel mesh__D001707 Puncture Biopsies
% 214.76/214.99  |- skos__hiddenLabel mesh__D001707 Biopsies, Needle
% 214.76/214.99  |- mesh__recordAuthorizer mesh__D001707 sjn
% 214.76/214.99  |- skos__hiddenLabel mesh__D001707 Needle Biopsy
% 214.76/214.99  |- mesh__dateCreated mesh__D001707 1999-01-01
% 214.76/214.99  |- skos__hiddenLabel mesh__D001707 Aspiration Biopsies
% 214.76/214.99  |- skos__annotation mesh__D011337 no qualif   
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D011337 2002
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D011337 1990
% 214.76/214.99  |- mesh__dateEstablished mesh__D011337 1969-01-01
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D011337 2004
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D011337 1998
% 214.76/214.99  |- mesh__recordMaintainer mesh__D011337 TGC
% 214.76/214.99  |- mesh__publicMeSHNote mesh__D011337 69   
% 214.76/214.99  |- skos__hiddenLabel mesh__D011337 Learning, Probability
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D011337 1995
% 214.76/214.99  |- mesh__dateRevised mesh__D011337 1989-05-16
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D011337 1992
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D011337 1999
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D011337 2000
% 214.76/214.99  |- skos__hiddenLabel mesh__D011337 Probability Learnings
% 214.76/214.99  |- skos__scopeNote mesh__D011337
% 214.76/214.99       Usually refers to the use of mathematical models in the prediction of learning to perform tasks based on the theory of probability applied to responses; it may also refer to the frequency of occurrence of the responses observed in the particular study.%A%    
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D011337 1996
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D011337 1991
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D011337 2005
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D011337 1993
% 214.76/214.99  |- mesh__recordAuthorizer mesh__D011337 PLS
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D011337 2001
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D011337 1997
% 214.76/214.99  |- mesh__recordOriginator mesh__D011337 NLM
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D011337 2006
% 214.76/214.99  |- skos__prefLabel mesh__D011337 Probability Learning
% 214.76/214.99  |- skos__broader mesh__D011337smesh__D007858
% 214.76/214.99  |- mesh__dateCreated mesh__D011337 1999-01-01
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D011337 2003
% 214.76/214.99  |- rdf__type mesh__D011337sskos__Concept
% 214.76/214.99  |- mesh__historyNote mesh__D011337 69%28%66%29%   
% 214.76/214.99  |- skos__hiddenLabel mesh__D011337 Learnings, Probability
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D011337 1994
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D016820 2004
% 214.76/214.99  |- mesh__recordAuthorizer mesh__D016820 sjn
% 214.76/214.99  |- mesh__dateEstablished mesh__D016820 1992-01-01
% 214.76/214.99  |- skos__prefLabel mesh__D016820 Sarcomastigophora
% 214.76/214.99  |- skos__broader mesh__D016820smesh__D011527
% 214.76/214.99  |- mesh__recordMaintainer mesh__D016820 ags
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D016820 2006
% 214.76/214.99  |- mesh__publicMeSHNote mesh__D016820 92   
% 214.76/214.99  |- mesh__recordOriginator mesh__D016820 PXP
% 214.76/214.99  |- mesh__historyNote mesh__D016820 92   
% 214.76/214.99  |- mesh__dateRevised mesh__D016820 2003-07-09
% 214.76/214.99  |- mesh__dateCreated mesh__D016820 1991-05-02
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D016820 2005
% 214.76/214.99  |- skos__annotation mesh__D016820
% 214.76/214.99       a phylum of protozoa; infection = SARCOMASTIGOPHORA INFECTIONS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 214.76/214.99  |- skos__scopeNote mesh__D016820
% 214.76/214.99       A phylum of protozoa with a single-type nucleus and locomotion by flagella, pseudopodia, or both types of locomotor organelles. It comprises the subphyla MASTIGOPHORA, Opalinata, and SARCODINA.%A%    
% 214.76/214.99  |- rdf__type mesh__D016820sskos__Concept
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Nested Case Control Studies
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Nested Case-Control Study
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Case-Control Study
% 214.76/214.99  |- mesh__dateRevised mesh__D016022 2001-07-25
% 214.76/214.99  |- skos__altLabel mesh__D016022 Case-Referrent Studies
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Study, Case-Referent
% 214.76/214.99  |- skos__broader mesh__D016022smesh__D016021
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Study, Nested Case-Control
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Studies, Case-Referrent
% 214.76/214.99  |- skos__annotation mesh__D016022
% 214.76/214.99       IM GEN only; coord NIM with specific disease %28%IM%29%; no qualif; specify geog if pertinent%A%  
% 214.76/214.99  |- rdf__type mesh__D016022sskos__Concept
% 214.76/214.99  |- skos__altLabel mesh__D016022 Case-Compeer Studies
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Case-Referent Study
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D016022 2004
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Case-Control Studies, Nested
% 214.76/214.99  |- skos__altLabel mesh__D016022 Case-Comparison Studies
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Case-Compeer Study
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Studies, Case-Comparison
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Case Base Studies
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Case-Control Study, Matched
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Studies, Case-Base
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Study, Case-Comparison
% 214.76/214.99  |- mesh__dateEstablished mesh__D016022 1990-01-01
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Study, Case-Control
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Study, Case-Compeer
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Studies, Case-Compeer
% 214.76/214.99  |- mesh__recordOriginator mesh__D016022 PLS
% 214.76/214.99  |- mesh__dateCreated mesh__D016022 1989-05-25
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Studies, Nested Case-Control
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D016022 2003
% 214.76/214.99  |- mesh__recordMaintainer mesh__D016022 ags
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Study, Matched Case-Control
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Studies, Case-Control
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Case-Control Studies, Matched
% 214.76/214.99  |- skos__altLabel mesh__D016022 Case-Base Studies
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Case-Base Study
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Matched Case Control Studies
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Case-Comparison Study
% 214.76/214.99  |- skos__altLabel mesh__D016022 Case-Referent Studies
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Case-Referrent Study
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Study, Case-Base
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Study, Case Control
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Case Compeer Studies
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D016022 2002
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D016022 2006
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Matched Case-Control Study
% 214.76/214.99  |- mesh__publicMeSHNote mesh__D016022 90   
% 214.76/214.99  |- skos__scopeNote mesh__D016022
% 214.76/214.99       Studies which start with the identification of persons with a disease of interest and a control %28%comparison, referent%29% group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.%A%    
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Studies, Case-Referent
% 214.76/214.99  |- skos__altLabel mesh__D016022 Case Control Studies
% 214.76/214.99  |- skos__prefLabel mesh__D016022 Case-Control Studies
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Study, Case-Referrent
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Studies, Case Control
% 214.76/214.99  |- mesh__recordAuthorizer mesh__D016022 sjn
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Case Referrent Studies
% 214.76/214.99  |- mesh__historyNote mesh__D016022 90   
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Case Referent Studies
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D016022 2005
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Case Control Study
% 214.76/214.99  |- skos__historyNote mesh__D016022 Epidemiologic Methods %28%1966-1989%29%
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Case-Control Study, Nested
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Case Comparison Studies
% 214.76/214.99  |- skos__hiddenLabel mesh__D016022 Studies, Matched Case-Control
% 214.76/214.99  |- mesh__historyNote mesh__D002800
% 214.76/214.99       65; CHOLINESTERASE INHIBITORS, IRREVERSIBLE %26% CHOLINESTERASE INHIBITORS, REVERSIBLE were see under CHOLINESTERASE INHIBITORS 1975-83, were Prov 1971-74; CHOLINESTERASE INHIBITORS, ORGANIC was see PHOSPHORUS POISONS, ORGANIC 1963-64 %28%PHOSPHORUS POISONS, ORGANIC deleted 1965%29%%A%  
% 214.76/214.99  |- skos__hiddenLabel mesh__D002800 Inhibitors, Irreversible Cholinesterase
% 214.76/214.99  |- mesh__onlineNote mesh__D002800
% 214.76/214.99       use CHOLINESTERASE INHIBITORS to search CHOLINESTERASE INHIBITORS, IRREVERSIBLE %26% CHOLINESTERASE INHIBITORS, REVERSIBLE 1971-83 %28%as Prov 1971-74%29%%A%  
% 214.76/214.99  |- skos__broader mesh__D002800smesh__D018678
% 214.76/214.99  |- mesh__dateEstablished mesh__D002800 1965-01-01
% 214.76/214.99  |- skos__altLabel mesh__D002800 Anticholinesterases
% 214.76/214.99  |- skos__hiddenLabel mesh__D002800 Inhibitors, Cholinesterase
% 214.76/214.99  |- skos__hiddenLabel mesh__D002800 Reversible Cholinesterase Inhibitors
% 214.76/214.99  |- skos__hiddenLabel mesh__D002800 Inhibitors, Reversible Cholinesterase
% 214.76/214.99  |- skos__altLabel mesh__D002800 Anticholinesterase Agents
% 214.76/214.99  |- mesh__dateCreated mesh__D002800 1999-01-01
% 214.76/214.99  |- rdf__type mesh__D002800sskos__Concept
% 214.76/214.99  |- skos__prefLabel mesh__D002800 Cholinesterase Inhibitors
% 214.76/214.99  |- skos__hiddenLabel mesh__D002800 Irreversible Cholinesterase Inhibitors
% 214.76/214.99  |- skos__hiddenLabel mesh__D002800 Inhibitors, Acetylcholinesterase
% 214.76/214.99  |- mesh__recordAuthorizer mesh__D002800 sjn
% 214.76/214.99  |- skos__altLabel mesh__D002800 Anticholinesterase Drugs
% 214.76/214.99  |- skos__scopeNote mesh__D002800
% 214.76/214.99       Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system.%A%    
% 214.76/214.99  |- skos__related mesh__D002800smesh__D007306
% 214.76/214.99  |- skos__annotation mesh__D002800 DF: CHOLINESTERASE INHIB   
% 214.76/214.99  |- mesh__recordOriginator mesh__D002800 NLM
% 214.76/214.99  |- skos__broader mesh__D002800smesh__D004791
% 214.76/214.99  |- mesh__publicMeSHNote mesh__D002800
% 214.76/214.99       65; CHOLINESTERASE INHIBITORS, IRREVERSIBLE %26% CHOLINESTERASE INHIBITORS, REVERSIBLE were see under CHOLINESTERASE INHIBITORS 1975-83; CHOLINESTERASE INHIBITORS, ORGANIC was see PHOSPHORUS POISONS, ORGANIC 1963-64 %28%PHOSPHORUS POISONS, ORGANIC deleted 1965%29%%A%  
% 214.76/214.99  |- mesh__recordMaintainer mesh__D002800 ssb
% 214.76/214.99  |- skos__hiddenLabel mesh__D002800 Drugs, Anticholinesterase
% 214.76/214.99  |- skos__hiddenLabel mesh__D002800 Anti Cholinesterases
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D002800 2006
% 214.76/214.99  |- mesh__dateRevised mesh__D002800 2005-06-30
% 214.76/214.99  |- skos__hiddenLabel mesh__D002800 Agents, Anticholinesterase
% 214.76/214.99  |- skos__altLabel mesh__D002800 Anti-Cholinesterases
% 214.76/214.99  |- mesh__dateCreated mesh__D002002 1999-01-01
% 214.76/214.99  |- mesh__dateRevised mesh__D002002 2005-06-30
% 214.76/214.99  |- mesh__recordOriginator mesh__D002002 NLM
% 214.76/214.99  |- mesh__recordMaintainer mesh__D002002 SYSTEM
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D002002 2006
% 214.76/214.99  |- skos__scopeNote mesh__D002002
% 214.76/214.99       A genus of gram-negative, aerobic bacteria that causes BRUCELLOSIS. Its cells are nonmotile coccobacilli and are animal parasites and pathogens. The bacterium is transmissible to humans through contact with infected dairy products or tissue.%A%    
% 214.76/214.99  |- skos__broader mesh__D002002smesh__D042021
% 214.76/214.99  |- mesh__recordAuthorizer mesh__D002002 sjn
% 214.76/214.99  |- skos__annotation mesh__D002002 infection = BRUCELLOSIS   
% 214.76/214.99  |- mesh__historyNote mesh__D002002 1963   
% 214.76/214.99  |- mesh__publicMeSHNote mesh__D002002 1963   
% 214.76/214.99  |- rdf__type mesh__D002002sskos__Concept
% 214.76/214.99  |- skos__prefLabel mesh__D002002 Brucella
% 214.76/214.99  |- skos__prefLabel mesh__D029748 Caryophyllaceae
% 214.76/214.99  |- skos__scopeNote mesh__D029748
% 214.76/214.99       A plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. The species are diverse in appearance and habitat; most have swollen leaf and stem joints.%A%    
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D029748 2006
% 214.76/214.99  |- skos__annotation mesh__D029748
% 214.76/214.99       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.76/214.99  |- mesh__recordMaintainer mesh__D029748 ssb
% 214.76/214.99  |- skos__altLabel mesh__D029748 Rupturewort
% 214.76/214.99  |- mesh__dateCreated mesh__D029748 2001-07-25
% 214.76/214.99  |- mesh__recordOriginator mesh__D029748 ssb
% 214.76/214.99  |- mesh__dateEstablished mesh__D029748 2002-01-01
% 214.76/214.99  |- mesh__publicMeSHNote mesh__D029748 2002   
% 214.76/214.99  |- skos__broader mesh__D029748smesh__D019684
% 214.76/214.99  |- skos__altLabel mesh__D029748 Chickweed, Mouse-ear
% 214.76/214.99  |- mesh__dateRevised mesh__D029748 2005-06-30
% 214.76/214.99  |- mesh__recordAuthorizer mesh__D029748 sjn
% 214.76/214.99  |- mesh__historyNote mesh__D029748 2002   
% 214.76/214.99  |- rdf__type mesh__D029748sskos__Concept
% 214.76/214.99  |- skos__historyNote mesh__D007296 Glucosephosphates %28%1973-1974%29%
% 214.76/214.99  |- skos__scopeNote mesh__D007296
% 214.76/214.99       An enzyme that catalyzes the formation of myo-inositol-1-phosphate from glucose-6-phosphate in the presence of NAD. EC 5.5.1.4.%A%    
% 214.76/214.99  |- rdf__type mesh__D007296sskos__Concept
% 214.76/214.99  |- mesh__dateRevised mesh__D007296 2004-07-07
% 214.76/214.99  |- mesh__dateEstablished mesh__D007296 1991-01-01
% 214.76/214.99  |- skos__prefLabel mesh__D007296 Myo-Inositol-1-Phosphate Synthase
% 214.76/214.99  |- mesh__dateCreated mesh__D007296 1974-11-19
% 214.76/214.99  |- mesh__recordOriginator mesh__D007296 NLM
% 214.76/214.99  |- skos__broader mesh__D007296smesh__D019753
% 214.76/214.99  |- skos__altLabel mesh__D007296 Inositol-1-Phosphate Synthase
% 214.76/214.99  |- skos__hiddenLabel mesh__D007296 Synthase, Inositol-1-Phosphate
% 214.76/214.99  |- skos__hiddenLabel mesh__D007296 Myo Inositol 1 Phosphate Synthase
% 214.76/214.99  |- skos__altLabel mesh__D007296 Inositol Cyclase
% 214.76/214.99  |- mesh__recordAuthorizer mesh__D007296 sjn
% 214.76/214.99  |- skos__hiddenLabel mesh__D007296 Synthase, Myo-Inositol-1-Phosphate
% 214.76/214.99  |- mesh__publicMeSHNote mesh__D007296
% 214.76/214.99       98; see INOSITOL-1-PHOSPHATE SYNTHASE 1991-97, see CARBOHYDRATE ISOMERASES 1975-90; for MYO-INOSITOL-1-PHOSPHATE SYNTHASE see INOSITOL-1-PHOSPHATE SYNTHASE 1975-97%A%  
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D007296 2006
% 214.76/214.99  |- skos__hiddenLabel mesh__D007296 Cyclase, Inositol
% 214.76/214.99  |- skos__annotation mesh__D007296 DF: note short X ref   
% 214.76/214.99  |- mesh__recordMaintainer mesh__D007296 ssb
% 214.76/214.99  |- skos__altLabel mesh__D007296 Cycloaldolase
% 214.76/214.99  |- mesh__historyNote mesh__D007296 98%28%75%29%   
% 214.76/214.99  |- skos__historyNote mesh__D007296
% 214.76/214.99       Carbohydrate Isomerases %28%1973-1974%29%
% 214.76/214.99  |- skos__hiddenLabel mesh__D007296 Inositol 1 Phosphate Synthase
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D007296 2005
% 214.76/214.99  |- skos__historyNote mesh__D007296 Inositol %28%1973-1974%29%
% 214.76/214.99  |- skos__altLabel mesh__D015728 HTLV-III Receptors
% 214.76/214.99  |- mesh__publicMeSHNote mesh__D015728 90   
% 214.76/214.99  |- skos__prefLabel mesh__D015728 Receptors, HIV
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D015728 2006
% 214.76/214.99  |- skos__scopeNote mesh__D015728
% 214.76/214.99       Cellular receptors that bind the human immunodeficiency virus that causes AIDS. Included are CD4 ANTIGENS, found on T4 lymphocytes, and monocytes/macrophages, which bind to the HIV ENVELOPE PROTEIN GP120.%A%    
% 214.76/214.99  |- skos__altLabel mesh__D015728 AIDS Virus Receptors
% 214.76/214.99  |- skos__hiddenLabel mesh__D015728 HTLV III Receptors
% 214.76/214.99  |- skos__altLabel mesh__D015728 HIV Receptors
% 214.76/214.99  |- skos__historyNote mesh__D015728 Receptors, Virus %28%1987-1989%29%
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D015728 2005
% 214.76/214.99  |- rdf__type mesh__D015728sskos__Concept
% 214.76/214.99  |- mesh__recordAuthorizer mesh__D015728 ags
% 214.76/214.99  |- skos__altLabel mesh__D015728 Receptors, HTLV-III
% 214.76/214.99  |- skos__altLabel mesh__D015728 Receptors, AIDS Virus
% 214.76/214.99  |- mesh__historyNote mesh__D015728 90   
% 214.76/214.99  |- skos__related mesh__D015728smesh__D015699
% 214.76/214.99  |- mesh__dateCreated mesh__D015728 1989-06-19
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D015728 2006A
% 214.76/214.99  |- mesh__dateRevised mesh__D015728 2005-07-18
% 214.76/214.99  |- skos__hiddenLabel mesh__D015728 Receptors, HTLV III
% 214.76/214.99  |- skos__broader mesh__D015728smesh__D011991
% 214.76/214.99  |- mesh__recordOriginator mesh__D015728 AGS
% 214.76/214.99  |- skos__hiddenLabel mesh__D015728 Virus Receptors, AIDS
% 214.76/214.99  |- mesh__dateEstablished mesh__D015728 1990-01-01
% 214.76/214.99  |- mesh__recordMaintainer mesh__D015728 ags
% 214.76/214.99  |- skos__annotation mesh__D015728
% 214.76/214.99       includes HIV-1 %26% HIV-2 receptors; DF: RECEPT HIV or HIV RECEPT%A%  
% 214.76/214.99  |- mesh__recordMaintainer mesh__D040121 MDJ
% 214.76/214.99  |- skos__altLabel mesh__D040121 Semaphorin D
% 214.76/214.99  |- skos__broader mesh__D040121smesh__D039961
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D040121 2006
% 214.76/214.99  |- skos__hiddenLabel mesh__D040121 Collapsin 1
% 214.76/214.99  |- mesh__publicMeSHNote mesh__D040121
% 214.76/214.99       2003; COLLAPSIN %28%now SEMAPHORIN 3A%29% was indexed under GLYCOPROTEINS 1993-2002%A%  
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D040121 2004
% 214.76/214.99  |- skos__scopeNote mesh__D040121
% 214.76/214.99       The prototypical and most well-studied member of the semaphorin family. Semaphorin-3A is an axon-repulsive guidance cue for migrating neurons in the developing nervous system. It has so far been found only in vertebrates, and binds to NEUROPILIN-1/plexin complex receptors on growth cones.  Like other class 3 semaphorins, it is a secreted protein.%A%    
% 214.76/214.99  |- skos__altLabel mesh__D040121 Semaphorin 3A
% 214.76/214.99  |- skos__altLabel mesh__D040121 Sema3A
% 214.76/214.99  |- skos__altLabel mesh__D040121 Sem D
% 214.76/214.99  |- mesh__historyNote mesh__D040121
% 214.76/214.99       2003; use SEMAPHORIN 3A %28%NM%29% 1994-2002   
% 214.76/214.99  |- skos__altLabel mesh__D040121 Collapsing Factor
% 214.76/214.99  |- skos__historyNote mesh__D040121 Glycoproteins %28%1993-2002%29%
% 214.76/214.99  |- skos__altLabel mesh__D040121 Collapsin-1
% 214.76/214.99  |- skos__altLabel mesh__D040121 Collapsin
% 214.76/214.99  |- skos__prefLabel mesh__D040121 Semaphorin-3A
% 214.76/214.99  |- mesh__recordOriginator mesh__D040121 MDJ
% 214.76/214.99  |- mesh__dateCreated mesh__D040121 2002-07-03
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D040121 2005
% 214.76/214.99  |- mesh__dateEstablished mesh__D040121 2003-01-01
% 214.76/214.99  |- mesh__recordAuthorizer mesh__D040121 sjn
% 214.76/214.99  |- rdf__type mesh__D040121sskos__Concept
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D040121 2003
% 214.76/214.99  |- skos__altLabel mesh__D001708
% 214.76/214.99       2-Amino-6-%28%1,2-dihydroxypropyl%29%-4%28%1H%29%-pteridinone
% 214.76/214.99  |- mesh__recordAuthorizer mesh__D001708 sjn
% 214.76/214.99  |- skos__historyNote mesh__D001708 Pteridines %28%1970-1974%29%
% 214.76/214.99  |- mesh__dateCreated mesh__D001708 1974-11-19
% 214.76/214.99  |- mesh__dateEstablished mesh__D001708 1987-01-01
% 214.76/214.99  |- mesh__dateRevised mesh__D001708 2004-07-07
% 214.76/214.99  |- mesh__publicMeSHNote mesh__D001708
% 214.76/214.99       87; was see under PTERIDINES 1975-86   
% 214.76/214.99  |- skos__broader mesh__D001708smesh__D003067
% 214.76/214.99  |- skos__prefLabel mesh__D001708 Biopterin
% 214.76/214.99  |- mesh__recordOriginator mesh__D001708 SJJ
% 214.76/214.99  |- skos__broader mesh__D001708smesh__D011622
% 214.76/214.99  |- skos__historyNote mesh__D001708 Propanediols %28%1972-1974%29%
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D001708 2006
% 214.76/214.99  |- skos__annotation mesh__D001708 /defic /physiol permitted   
% 214.76/214.99  |- mesh__historyNote mesh__D001708
% 214.76/214.99       87%28%75%29%; was see under PTERIDINES 1975-86   
% 214.76/214.99  |- mesh__recordMaintainer mesh__D001708 ssb
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D001708 2005
% 214.76/214.99  |- skos__scopeNote mesh__D001708
% 214.76/214.99       A natural product that has been considered as a growth factor for some insects.%A%    
% 214.76/214.99  |- rdf__type mesh__D001708sskos__Concept
% 214.76/214.99  |- mesh__historyNote mesh__D012430
% 214.76/214.99       91%28%75%29%; was see under RUTHENIUM 1975-90   
% 214.76/214.99  |- mesh__dateCreated mesh__D012430 1974-11-19
% 214.76/214.99  |- mesh__publicMeSHNote mesh__D012430
% 214.76/214.99       91; was see under RUTHENIUM 1975-90   
% 214.76/214.99  |- mesh__recordMaintainer mesh__D012430 NLM
% 214.76/214.99  |- rdf__type mesh__D012430sskos__Concept
% 214.76/214.99  |- skos__broader mesh__D012430smesh__D017975
% 214.76/214.99  |- mesh__dateRevised mesh__D012430 2005-07-06
% 214.76/214.99  |- skos__broader mesh__D012430smesh__D017606
% 214.76/214.99  |- mesh__dateEstablished mesh__D012430 1991-01-01
% 214.76/214.99  |- mesh__recordAuthorizer mesh__D012430 NLM
% 214.76/214.99  |- skos__altLabel mesh__D012430 Ammoniated Ruthenium Oxychloride
% 214.76/214.99  |- skos__hiddenLabel mesh__D012430 Oxychloride, Ammoniated Ruthenium
% 214.76/214.99  |- skos__prefLabel mesh__D012430 Ruthenium Red
% 214.76/214.99  |- skos__scopeNote mesh__D012430
% 214.76/214.99       An inorganic dye used in microscopy for differential staining and as a diagnostic reagent. In research this compound is used to study changes in cytoplasmic concentrations of calcium. Ruthenium red inhibits calcium transport through membrane channels.%A%    
% 214.76/214.99  |- skos__hiddenLabel mesh__D012430 Red, Ruthenium
% 214.76/214.99  |- skos__broader mesh__D012430smesh__D017672
% 214.76/214.99  |- skos__hiddenLabel mesh__D012430 Ruthenium Oxychloride, Ammoniated
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D012430 2006
% 214.76/214.99  |- skos__historyNote mesh__D012430 Ruthenium %28%1972-1974%29%
% 214.76/214.99  |- mesh__recordOriginator mesh__D012430 NLM
% 214.76/214.99  |- skos__broader mesh__D011338smesh__D009874
% 214.76/214.99  |- mesh__publicMeSHNote mesh__D011338
% 214.76/214.99       91; was see under OPERATIONS RESEARCH 1975-90   
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D011338 1999
% 214.76/214.99  |- mesh__onlineNote mesh__D011338 search OPERATIONS RESEARCH 1966-74   
% 214.76/214.99  |- mesh__historyNote mesh__D011338
% 214.76/214.99       91%28%75%29%; was see under OPERATIONS RESEARCH 1975-90   
% 214.76/214.99  |- skos__hiddenLabel mesh__D011338 Probability Theories
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D011338 2002
% 214.76/214.99  |- mesh__dateRevised mesh__D011338 1995-05-18
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D011338 1996
% 214.76/214.99  |- mesh__activeMeSHYear mesh__D011338 2005
% 214.76/214.99  |- skos__hiddenLabel mesh__D011338 Theory, Probability
% 214.76/215.00  |- mesh__activeMeSHYear mesh__D011338 1997
% 214.76/215.00  |- skos__scopeNote mesh__D011338
% 214.76/215.00       The branch of mathematics dealing with the purely logical properties of probability. Its theorems underlie most statistical methods. %28%Last, A Dictionary of Epidemiology, 2d ed%29%%A%    
% 214.76/215.00  |- mesh__activeMeSHYear mesh__D011338 2006
% 214.76/215.00  |- mesh__activeMeSHYear mesh__D011338 2000
% 214.76/215.00  |- mesh__dateCreated mesh__D011338 1999-01-01
% 214.76/215.00  |- mesh__dateEstablished mesh__D011338 1991-01-01
% 214.76/215.00  |- skos__hiddenLabel mesh__D011338 Theories, Probability
% 214.76/215.00  |- mesh__activeMeSHYear mesh__D011338 2003
% 214.76/215.00  |- rdf__type mesh__D011338sskos__Concept
% 214.76/215.00  |- mesh__recordAuthorizer mesh__D011338 PLS
% 214.76/215.00  |- mesh__activeMeSHYear mesh__D011338 2001
% 214.76/215.00  |- mesh__activeMeSHYear mesh__D011338 2004
% 214.76/215.00  |- skos__annotation mesh__D011338 no qualif   
% 214.76/215.00  |- skos__prefLabel mesh__D011338 Probability Theory
% 214.76/215.00  |- mesh__recordOriginator mesh__D011338 NLM
% 214.76/215.00  |- mesh__recordMaintainer mesh__D011338 TGC
% 214.76/215.00  |- mesh__activeMeSHYear mesh__D011338 1998
% 214.76/215.00  |- mesh__activeMeSHYear mesh__D016821 2004
% 214.76/215.00  |- mesh__recordMaintainer mesh__D016821 ags
% 214.76/215.00  |- mesh__activeMeSHYear mesh__D016821 2005
% 214.76/215.00  |- mesh__dateEstablished mesh__D016821 1992-01-01
% 214.76/215.00  |- skos__scopeNote mesh__D016821
% 214.76/215.00       A class of protozoa consisting of plantlike flagellates. Its organisms are free-living and have one or two flagella.%A%    
% 214.76/215.00  |- mesh__activeMeSHYear mesh__D016821 2006
% 214.76/215.00  |- mesh__recordAuthorizer mesh__D016821 sjn
% 214.76/215.00  |- mesh__historyNote mesh__D016821 92   
% 214.76/215.00  |- mesh__dateRevised mesh__D016821 2003-07-09
% 214.76/215.00  |- mesh__dateCreated mesh__D016821 1991-05-02
% 214.76/215.00  |- skos__annotation mesh__D016821 a class of protozoa   
% 214.76/215.00  |- skos__broader mesh__D016821smesh__D008412
% 214.76/215.00  |- mesh__publicMeSHNote mesh__D016821 92   
% 214.76/215.00  |- skos__prefLabel mesh__D016821 Phytomastigophorea
% 214.76/215.00  |- mesh__recordOriginator mesh__D016821 PXP
% 214.76/215.00  |- rdf__type mesh__D016821sskos__Concept
% 214.76/215.00  |- skos__related mesh__D016023smesh__D015815
% 214.86/215.00  |- mesh__recordOriginator mesh__D016023 RLS
% 214.86/215.00  |- skos__historyNote mesh__D016023 Receptors, Immunologic %28%1980-1989%29%
% 214.86/215.00  |- skos__broader mesh__D016023smesh__D011971
% 214.86/215.00  |- skos__scopeNote mesh__D016023
% 214.86/215.00       A family of transmembrane glycoproteins %28%MEMBRANE GLYCOPROTEINS%29% consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other cells, while their intracellular domains interact with the CYTOSKELETON. The integrins consist of at least three identified families: the cytoadhesin receptors%28%RECEPTORS, CYTOADHESIN%29%, the leukocyte adhesion receptors %28%RECEPTORS, LEUKOCYTE ADHESION%29%, and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit %28%INTEGRIN BETA CHAINS%29% combined with one or more distinct alpha-subunits %28%INTEGRIN ALPHA CHAINS%29%. These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation.%A%    
% 214.86/215.00  |- mesh__historyNote mesh__D016023 90   
% 214.86/215.00  |- skos__historyNote mesh__D016023 Membrane Glycoproteins %28%1988-1989%29%
% 214.86/215.00  |- mesh__recordAuthorizer mesh__D016023 ags
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D016023 2006A
% 214.86/215.00  |- skos__prefLabel mesh__D016023 Integrins
% 214.86/215.00  |- skos__historyNote mesh__D016023 Glycoproteins %28%1966-1987%29%
% 214.86/215.00  |- mesh__recordMaintainer mesh__D016023 ags
% 214.86/215.00  |- rdf__type mesh__D016023sskos__Concept
% 214.86/215.00  |- mesh__dateEstablished mesh__D016023 1990-01-01
% 214.86/215.00  |- skos__annotation mesh__D016023 prefer specifics   
% 214.86/215.00  |- mesh__dateRevised mesh__D016023 2005-07-18
% 214.86/215.00  |- mesh__publicMeSHNote mesh__D016023 90   
% 214.86/215.00  |- skos__historyNote mesh__D016023
% 214.86/215.00       Receptors, Endogenous Substances %28%1973-1989%29%
% 214.86/215.00  |- mesh__dateCreated mesh__D016023 1989-07-07
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D016023 2006
% 214.86/215.00  |- rdf__type mesh__D002801sskos__Concept
% 214.86/215.00  |- mesh__dateEstablished mesh__D002801 1972-01-01
% 214.86/215.00  |- skos__altLabel mesh__D002801 Insecticides, Organophosphate, Antagonists
% 214.86/215.00  |- mesh__recordOriginator mesh__D002801 NLM
% 214.86/215.00  |- skos__hiddenLabel mesh__D002801 Insecticide Antagonists, Organophosphate
% 214.86/215.00  |- skos__historyNote mesh__D002801 Acetylcholinesterase %28%1966-1970%29%
% 214.86/215.00  |- skos__annotation mesh__D002801 note X refs   
% 214.86/215.00  |- skos__altLabel mesh__D002801 Organothiophosphate Insecticide Antagonists
% 214.86/215.00  |- skos__broader mesh__D002801smesh__D004793
% 214.86/215.00  |- mesh__recordMaintainer mesh__D002801 ssb
% 214.86/215.00  |- mesh__dateRevised mesh__D002801 2005-06-30
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D002801 2006
% 214.86/215.00  |- skos__scopeNote mesh__D002801
% 214.86/215.00       Drugs used to reverse the inactivation of cholinesterase caused by organophosphates or sulfonates. They are an important component of therapy in agricultural, industrial, and military poisonings by organophosphates and sulfonates.%A%    
% 214.86/215.00  |- skos__hiddenLabel mesh__D002801
% 214.86/215.00       Antagonists, Organothiophosphate Insecticide
% 214.86/215.00  |- skos__historyNote mesh__D002801 Oximes %28%1966-1970%29%
% 214.86/215.00  |- skos__prefLabel mesh__D002801 Cholinesterase Reactivators
% 214.86/215.00  |- skos__hiddenLabel mesh__D002801
% 214.86/215.00       Insecticide Antagonists, Organothiophosphate
% 214.86/215.00  |- skos__historyNote mesh__D002801 Pyridines %28%1966-1970%29%
% 214.86/215.00  |- skos__broader mesh__D002801smesh__D018678
% 214.86/215.00  |- skos__hiddenLabel mesh__D002801 Reactivators, Cholinesterase
% 214.86/215.00  |- skos__historyNote mesh__D002801 Pralidoxime Compounds %28%1966-1970%29%
% 214.86/215.00  |- skos__historyNote mesh__D002801 Pyridinium Compounds %28%1968-1970%29%
% 214.86/215.00  |- skos__historyNote mesh__D002801 Cholinesterases %28%1966-1970%29%
% 214.86/215.00  |- mesh__historyNote mesh__D002801 72%28%71%29%   
% 214.86/215.00  |- mesh__publicMeSHNote mesh__D002801 72   
% 214.86/215.00  |- mesh__recordAuthorizer mesh__D002801 sjn
% 214.86/215.00  |- skos__hiddenLabel mesh__D002801 Antagonists, Organophosphate Insecticide
% 214.86/215.00  |- mesh__dateCreated mesh__D002801 1999-01-01
% 214.86/215.00  |- mesh__recordMaintainer mesh__D002003 SYSTEM
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D002003 2006
% 214.86/215.00  |- skos__prefLabel mesh__D002003 Brucella abortus
% 214.86/215.00  |- skos__altLabel mesh__D002003 Brucella melitensis biovar abortus
% 214.86/215.00  |- mesh__dateRevised mesh__D002003 2005-06-30
% 214.86/215.00  |- mesh__recordOriginator mesh__D002003 NLM
% 214.86/215.00  |- rdf__type mesh__D002003sskos__Concept
% 214.86/215.00  |- mesh__recordAuthorizer mesh__D002003 sjn
% 214.86/215.00  |- skos__scopeNote mesh__D002003
% 214.86/215.00       A species of the genus BRUCELLA whose natural hosts are cattle and other bovidae. Abortion and placentitis are frequently produced in the pregnant animal. Other mammals, including humans, may be infected.%A%    
% 214.86/215.00  |- skos__annotation mesh__D002003
% 214.86/215.00       infection = probably BRUCELLOSIS, BOVINE but for man or other animals coord IM with BRUCELLOSIS %28%IM%29%%A%  
% 214.86/215.00  |- mesh__dateCreated mesh__D002003 1999-01-01
% 214.86/215.00  |- skos__broader mesh__D002003smesh__D002002
% 214.86/215.00  |- mesh__recordAuthorizer mesh__D029749 sjn
% 214.86/215.00  |- mesh__historyNote mesh__D029749 2002   
% 214.86/215.00  |- skos__annotation mesh__D029749
% 214.86/215.00       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.86/215.00  |- mesh__recordOriginator mesh__D029749 ssb
% 214.86/215.00  |- mesh__dateEstablished mesh__D029749 2002-01-01
% 214.86/215.00  |- mesh__publicMeSHNote mesh__D029749 2002   
% 214.86/215.00  |- skos__broader mesh__D029749smesh__D029748
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D029749 2003
% 214.86/215.00  |- mesh__recordMaintainer mesh__D029749 ssb
% 214.86/215.00  |- mesh__dateCreated mesh__D029749 2001-07-25
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D029749 2005
% 214.86/215.00  |- rdf__type mesh__D029749sskos__Concept
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D029749 2004
% 214.86/215.00  |- skos__prefLabel mesh__D029749 Dianthus
% 214.86/215.00  |- mesh__dateRevised mesh__D029749 2002-07-03
% 214.86/215.00  |- skos__scopeNote mesh__D029749
% 214.86/215.00       A plant genus of the family CARYOPHYLLACEAE. Members contain dianthins, which are ribosome inactivating proteins.%A%    
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D029749 2006
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D007297 2004
% 214.86/215.00  |- skos__broader mesh__D007297smesh__D010361
% 214.86/215.00  |- mesh__historyNote mesh__D007297
% 214.86/215.00       91%28%80%29%; was see under PATIENTS 1980-90   
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D007297 1994
% 214.86/215.00  |- skos__prefLabel mesh__D007297 Inpatients
% 214.86/215.00  |- skos__hiddenLabel mesh__D007297 Inpatient
% 214.86/215.00  |- mesh__recordOriginator mesh__D007297 EC
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D007297 2003
% 214.86/215.00  |- mesh__recordMaintainer mesh__D007297 TAP
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D007297 1997
% 214.86/215.00  |- skos__historyNote mesh__D007297 Patients %28%1966-1979%29%
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D007297 2001
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D007297 2006
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D007297 1993
% 214.86/215.00  |- mesh__dateCreated mesh__D007297 1978-12-22
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D007297 1996
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D007297 2000
% 214.86/215.00  |- skos__annotation mesh__D007297
% 214.86/215.00       inpatients as people or as a social, sociol, psychol, etc., group; do not confuse with HOSPITALIZATION%A%  
% 214.86/215.00  |- mesh__publicMeSHNote mesh__D007297 91; was see under PATIENTS 1980-90   
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D007297 2005
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D007297 1999
% 214.86/215.00  |- mesh__recordAuthorizer mesh__D007297 PLS
% 214.86/215.00  |- skos__scopeNote mesh__D007297
% 214.86/215.00       Persons admitted to health facilities which provide board and room, for the purpose of observation, care, diagnosis or treatment.%A%    
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D007297 1995
% 214.86/215.00  |- rdf__type mesh__D007297sskos__Concept
% 214.86/215.00  |- skos__historyNote mesh__D007297 Hospitalization %28%1966-1979%29%
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D007297 1998
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D007297 2002
% 214.86/215.00  |- mesh__dateEstablished mesh__D007297 1991-01-01
% 214.86/215.00  |- mesh__dateRevised mesh__D007297 1992-05-14
% 214.86/215.00  |- mesh__dateCreated mesh__D001709 1986-03-27
% 214.86/215.00  |- skos__related mesh__D001709smesh__D005818
% 214.86/215.00  |- skos__broader mesh__D001709smesh__D001690
% 214.86/215.00  |- skos__annotation mesh__D001709 SPEC: SPEC qualif; DF: BIOTECHNOL   
% 214.86/215.00  |- skos__broader mesh__D001709smesh__D013672
% 214.86/215.00  |- mesh__recordAuthorizer mesh__D001709 sjn
% 214.86/215.00  |- skos__scopeNote mesh__D001709
% 214.86/215.00       Body of knowledge related to the use of organisms, cells or cell-derived constituents for the purpose of developing products which are technically, scientifically and clinically useful. Alteration of biologic function at the molecular level %28%i.e., GENETIC ENGINEERING%29% is a central focus; laboratory methods used include TRANSFECTION and CLONING technologies, sequence and structure analysis algorithms, computer DATABASES, and gene and protein structure function analysis and prediction.%A%    
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D001709 2004
% 214.86/215.00  |- skos__related mesh__D001709smesh__D011994
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D001709 2006
% 214.86/215.00  |- mesh__dateEstablished mesh__D001709 1987-01-01
% 214.86/215.00  |- mesh__historyNote mesh__D001709 87   
% 214.86/215.00  |- rdf__type mesh__D001709sskos__Concept
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D001709 2005
% 214.86/215.00  |- mesh__recordOriginator mesh__D001709 VDK
% 214.86/215.00  |- skos__hiddenLabel mesh__D001709 Biotechnologies
% 214.86/215.00  |- mesh__dateRevised mesh__D001709 2003-07-09
% 214.86/215.00  |- mesh__recordMaintainer mesh__D001709 lkt
% 214.86/215.00  |- mesh__publicMeSHNote mesh__D001709 87   
% 214.86/215.00  |- skos__prefLabel mesh__D001709 Biotechnology
% 214.86/215.00  |- mesh__dateRevised mesh__D012431 2005-06-30
% 214.86/215.00  |- mesh__dateCreated mesh__D012431 1999-01-01
% 214.86/215.00  |- skos__hiddenLabel mesh__D012431 Quercetin 3 Rutinoside
% 214.86/215.00  |- mesh__recordOriginator mesh__D012431 NLM
% 214.86/215.00  |- skos__broader mesh__D012431smesh__D044948
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D012431 2006
% 214.86/215.00  |- skos__scopeNote mesh__D012431
% 214.86/215.00       A flavonol glycoside found in many plants, including BUCKWHEAT; TOBACCO; FORSYTHIA; HYDRANGEA; VIOLA, etc. It has been used therapeutically to decrease capillary fragility.%A%    
% 214.86/215.00  |- skos__prefLabel mesh__D012431 Rutin
% 214.86/215.00  |- skos__altLabel mesh__D012431 Quercetin-3-Rutinoside
% 214.86/215.00  |- rdf__type mesh__D012431sskos__Concept
% 214.86/215.00  |- mesh__recordAuthorizer mesh__D012431 sjn
% 214.86/215.00  |- mesh__recordMaintainer mesh__D012431 ssb
% 214.86/215.00  |- skos__hiddenLabel mesh__D036081 Receptors, Eph
% 214.86/215.00  |- skos__altLabel mesh__D036081 Receptor, Ephrin B
% 214.86/215.00  |- rdf__type mesh__D036081sskos__Concept
% 214.86/215.00  |- mesh__recordOriginator mesh__D036081 jmp
% 214.86/215.00  |- mesh__recordAuthorizer mesh__D036081 sjn
% 214.86/215.00  |- skos__broader mesh__D036081smesh__D020794
% 214.86/215.00  |- skos__altLabel mesh__D036081 EphA Receptors
% 214.86/215.00  |- skos__prefLabel mesh__D036081 Receptors, Eph Family
% 214.86/215.00  |- skos__hiddenLabel mesh__D036081 Receptors, Ephrin
% 214.86/215.00  |- skos__altLabel mesh__D036081 Ephrin B Receptor
% 214.86/215.00  |- skos__altLabel mesh__D036081 EphB Receptor
% 214.86/215.00  |- skos__altLabel mesh__D036081 Eph Receptor Tyrosine Kinase
% 214.86/215.00  |- skos__hiddenLabel mesh__D036081 Receptors, EphB
% 214.86/215.00  |- mesh__dateRevised mesh__D036081 2005-06-30
% 214.86/215.00  |- skos__altLabel mesh__D036081 Ephrin Receptors
% 214.86/215.00  |- skos__altLabel mesh__D036081 Eph Receptors
% 214.86/215.00  |- skos__historyNote mesh__D036081
% 214.86/215.00       Protein-Tyrosine Kinase %28%1988-1993%29%
% 214.86/215.00  |- skos__altLabel mesh__D036081 Eph Family Receptors
% 214.86/215.00  |- mesh__publicMeSHNote mesh__D036081
% 214.86/215.00       2003; EPHRIN B RECEPTORS %28%now RECEPTORS, EPH FAMILY%29% was indexed under RECEPTOR PROTEIN TYROSINE KINASES 1999-2002, EPH RECEPTOR TYROSINE KINASE was indexed under RECEPTOR PROTEIN TYROSINE KINASES 1999-2002%A%  
% 214.86/215.00  |- skos__altLabel mesh__D036081 EphB Receptors
% 214.86/215.00  |- mesh__dateEstablished mesh__D036081 2003-01-01
% 214.86/215.00  |- mesh__recordMaintainer mesh__D036081 jmp
% 214.86/215.00  |- mesh__dateCreated mesh__D036081 2002-07-03
% 214.86/215.00  |- skos__scopeNote mesh__D036081
% 214.86/215.00       A large family of receptor protein-tyrosine kinases that are structurally-related. The name of this family of proteins derives from original protein Eph %28%now called the EPHA1 RECEPTOR%29%, which was named after the cell line it was first discovered in: Erythropoietin-Producing human Hepatocellular carcinoma cell line. Members of this family have been implicated in regulation of cell-cell interactions involved in nervous system patterning and development.%A%    
% 214.86/215.00  |- skos__historyNote mesh__D036081
% 214.86/215.00       Receptor Protein-Tyrosine Kinases %28%1994-2002%29%
% 214.86/215.00  |- mesh__historyNote mesh__D036081
% 214.86/215.00       2003; use RECEPTORS, EPH FAMILY  %28%NM%29% 1999-2002, for EPH RECEPTOR TYROSINE KINASE use EPHA1 RECEPTOR %28%NM%29% 1999-2002;%A%  
% 214.86/215.00  |- skos__hiddenLabel mesh__D036081 Receptors, Ephrin A
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D036081 2006
% 214.86/215.00  |- mesh__recordOriginator mesh__D022061 jmp
% 214.86/215.00  |- mesh__publicMeSHNote mesh__D022061
% 214.86/215.00       2001; FK 506 BINDING PROTEIN %28%now TACROLIMUS BINDING PROTEINS%29% was indexed under IMMUNOPHILINS 1999-2000 %26% under HEAT-SHOCK PROTEINS, DNA-BINDING PROTEINS, %26% CARRIER PROTEINS 1991-1998%A%  
% 214.86/215.00  |- mesh__recordMaintainer mesh__D022061 jls
% 214.86/215.00  |- mesh__dateRevised mesh__D022061 2004-08-02
% 214.86/215.00  |- skos__altLabel mesh__D022061 FK506-Binding Protein 1A
% 214.86/215.00  |- skos__altLabel mesh__D022061 FKBP-12
% 214.86/215.00  |- mesh__dateEstablished mesh__D022061 2001-01-01
% 214.86/215.00  |- skos__altLabel mesh__D022061 FK506-Binding Protein 1
% 214.86/215.00  |- mesh__historyNote mesh__D022061
% 214.86/215.00       2001; use TACROLIMUS BINDING PROTEINS %28%NM%29% 1991-2000   
% 214.86/215.00  |- skos__scopeNote mesh__D022061
% 214.86/215.00       A 12-KDa tacrolimus binding protein that is found associated with and may modulate the function of calcium release channels. It is a peptidyl-prolyl cis/trans isomerase which is inhibited by both tacrolimus %28%commonly called FK506%29% and SIROLIMUS.%A%    
% 214.86/215.00  |- skos__prefLabel mesh__D022061 Tacrolimus Binding Protein 1A
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D022061 2005A
% 214.86/215.00  |- skos__historyNote mesh__D022061 DNA-Binding Proteins %28%1991-1998%29%
% 214.86/215.00  |- skos__hiddenLabel mesh__D022061 Macrophilin 12
% 214.86/215.00  |- skos__hiddenLabel mesh__D022061 FK506 Binding Protein 1
% 214.86/215.00  |- skos__hiddenLabel mesh__D022061 FKBP 12
% 214.86/215.00  |- skos__altLabel mesh__D022061 Macrophilin-12
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D022061 2006
% 214.86/215.00  |- skos__hiddenLabel mesh__D022061 FK506 Binding Protein 1A
% 214.86/215.00  |- mesh__recordAuthorizer mesh__D022061 jls
% 214.86/215.00  |- skos__broader mesh__D022061smesh__D022021
% 214.86/215.00  |- rdf__type mesh__D022061sskos__Concept
% 214.86/215.00  |- skos__historyNote mesh__D022061 Immunophilins %28%1999-2000%29%
% 214.86/215.00  |- mesh__dateCreated mesh__D022061 2000-06-23
% 214.86/215.00  |- skos__historyNote mesh__D022061 Heat-Shock Proteins %28%1991-1998%29%
% 214.86/215.00  |- skos__historyNote mesh__D022061 Carrier Proteins %28%1991-1998%29%
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D022061 2005
% 214.86/215.00  |- skos__altLabel mesh__D022061 FKBP12
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D011339 2006
% 214.86/215.00  |- skos__scopeNote mesh__D011339
% 214.86/215.00       The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.%A%    
% 214.86/215.00  |- skos__altLabel mesh__D011339 Ophthalmic Brand of Probenecid
% 214.86/215.00  |- mesh__dateCreated mesh__D011339 1999-01-01
% 214.86/215.00  |- skos__altLabel mesh__D011339 Valdecasas Brand of Probenecid
% 214.86/215.00  |- rdf__type mesh__D011339sskos__Concept
% 214.86/215.00  |- mesh__recordOriginator mesh__D011339 NLM
% 214.86/215.00  |- skos__altLabel mesh__D011339 IDIS Brand of Probenecid
% 214.86/215.00  |- skos__altLabel mesh__D011339 Benuryl
% 214.86/215.00  |- skos__altLabel mesh__D011339 ICN Brand of Probenecid
% 214.86/215.00  |- mesh__dateRevised mesh__D011339 2005-06-30
% 214.86/215.00  |- skos__prefLabel mesh__D011339 Probenecid
% 214.86/215.00  |- mesh__recordAuthorizer mesh__D011339 sjn
% 214.86/215.00  |- skos__altLabel mesh__D011339 Merck Brand of Probenecid
% 214.86/215.00  |- skos__broader mesh__D011339smesh__D013449
% 214.86/215.00  |- mesh__recordMaintainer mesh__D011339 lkw
% 214.86/215.00  |- skos__altLabel mesh__D011339 Biokanol Brand of Probenecid
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D008390 2006
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D008390 2000
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D008390 1999
% 214.86/215.00  |- skos__altLabel mesh__D008390 Markov Chain
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D008390 2003
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D008390 1996
% 214.86/215.00  |- mesh__historyNote mesh__D008390
% 214.86/215.00       91%28%75%29%; was see under PROBABILITY 1975-90   
% 214.86/215.00  |- rdf__type mesh__D008390sskos__Concept
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D008390 2005
% 214.86/215.00  |- skos__prefLabel mesh__D008390 Markov Chains
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D008390 1998
% 214.86/215.00  |- mesh__publicMeSHNote mesh__D008390
% 214.86/215.00       91; was see under PROBABILITY 1975-90   
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D008390 1993
% 214.86/215.00  |- mesh__recordOriginator mesh__D008390 NLM
% 214.86/215.00  |- skos__hiddenLabel mesh__D008390 Markov Processes
% 214.86/215.00  |- skos__hiddenLabel mesh__D008390 Chain, Markov
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D008390 1995
% 214.86/215.00  |- mesh__dateEstablished mesh__D008390 1991-01-01
% 214.86/215.00  |- mesh__onlineNote mesh__D008390 search PROBABILITY 1968-74   
% 214.86/215.00  |- skos__altLabel mesh__D008390 Markov Process
% 214.86/215.00  |- mesh__dateRevised mesh__D008390 1992-05-22
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D008390 2002
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D008390 1994
% 214.86/215.00  |- skos__hiddenLabel mesh__D008390 Processes, Markov
% 214.86/215.00  |- mesh__recordMaintainer mesh__D008390 PLS
% 214.86/215.00  |- skos__annotation mesh__D008390 no qualif   
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D008390 2001
% 214.86/215.00  |- skos__hiddenLabel mesh__D008390 Chains, Markov
% 214.86/215.00  |- mesh__dateCreated mesh__D008390 1999-01-01
% 214.86/215.00  |- skos__broader mesh__D008390smesh__D011336
% 214.86/215.00  |- skos__broader mesh__D008390smesh__D013269
% 214.86/215.00  |- skos__hiddenLabel mesh__D008390 Process, Markov
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D008390 2004
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D008390 1997
% 214.86/215.00  |- mesh__recordAuthorizer mesh__D008390 PLS
% 214.86/215.00  |- skos__scopeNote mesh__D008390
% 214.86/215.00       A stochastic process such that the conditional probability distribution for a state at any future instant, given the present state, is unaffected by any additional knowledge of the past history of the system.%A%    
% 214.86/215.00  |- skos__broader mesh__D005145Q000254smesh__D005145
% 214.86/215.00  |- mesh__preferredCombination mesh__D005145Q000254smesh__D008445
% 214.86/215.00  |- rdf__type mesh__D005145Q000254smesh__CompoundConcept
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D016822 2005
% 214.86/215.00  |- skos__altLabel mesh__D016822 Euglenids
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D016822 2006
% 214.86/215.00  |- skos__altLabel mesh__D016822 Euglenophyta
% 214.86/215.00  |- mesh__historyNote mesh__D016822 92   
% 214.86/215.00  |- mesh__dateRevised mesh__D016822 2003-07-09
% 214.86/215.00  |- mesh__dateEstablished mesh__D016822 1992-01-01
% 214.86/215.00  |- mesh__recordAuthorizer mesh__D016822 sjn
% 214.86/215.00  |- mesh__recordOriginator mesh__D016822 PXP
% 214.86/215.00  |- rdf__type mesh__D016822sskos__Concept
% 214.86/215.00  |- mesh__dateCreated mesh__D016822 1991-05-02
% 214.86/215.00  |- skos__prefLabel mesh__D016822 Euglenida
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D016822 2004
% 214.86/215.00  |- skos__broader mesh__D016822smesh__D016821
% 214.86/215.00  |- skos__broader mesh__D016822smesh__D000456
% 214.86/215.00  |- skos__scopeNote mesh__D016822
% 214.86/215.00       A group of unicellular flagellates of ancient eukaryotic lineage with unclear taxonomy. Classification differs depending on what characteristics are used. Some authorities consider them to be an order of PROTOZOA. For others, they are classed as ALGAE due to the presence of CHLOROPLASTS in some genera. However, the origin of the chloroplasts is in dispute and they are missing from many of the genera. Euglenida lack a CELL WALL but are covered by a proteinaceous flexible coat, the pellicle, that allows the cell to change shape.%A%    
% 214.86/215.00  |- mesh__recordMaintainer mesh__D016822 ags
% 214.86/215.00  |- mesh__publicMeSHNote mesh__D016822 92   
% 214.86/215.00  |- skos__scopeNote mesh__D016024
% 214.86/215.00       A group of INTEGRINS that includes the platelet outer membrane glycoprotein GPIIb-IIIa %28%PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX%29% and the vitronectin receptor %28%RECEPTORS, VITRONECTIN%29%. They play a major role in cell adhesion and serve as receptors for fibronectin, von Willebrand factor, and vitronectin.%A%    
% 214.86/215.00  |- mesh__dateCreated mesh__D016024 1989-07-07
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D016024 2004
% 214.86/215.00  |- skos__broader mesh__D016024smesh__D016023
% 214.86/215.00  |- mesh__recordOriginator mesh__D016024 RLS
% 214.86/215.00  |- skos__annotation mesh__D016024
% 214.86/215.00       a group of integrins; DF: RECEPT CYTOADHESIN   
% 214.86/215.00  |- skos__historyNote mesh__D016024
% 214.86/215.00       Receptors, Cell Surface %28%1973-1989%29%
% 214.86/215.00  |- mesh__historyNote mesh__D016024 90   
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D016024 2005
% 214.86/215.00  |- rdf__type mesh__D016024sskos__Concept
% 214.86/215.00  |- mesh__dateEstablished mesh__D016024 1990-01-01
% 214.86/215.00  |- mesh__recordMaintainer mesh__D016024 jmp
% 214.86/215.00  |- mesh__dateRevised mesh__D016024 2003-07-09
% 214.86/215.00  |- mesh__publicMeSHNote mesh__D016024 90   
% 214.86/215.00  |- skos__altLabel mesh__D016024 Cytoadhesin Receptors
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D016024 2006
% 214.86/215.00  |- skos__altLabel mesh__D016024
% 214.86/215.00       Receptors, Extracellular Matrix Glycoprotein
% 214.86/215.00  |- mesh__recordAuthorizer mesh__D016024 sjn
% 214.86/215.00  |- skos__prefLabel mesh__D016024 Receptors, Cytoadhesin
% 214.86/215.00  |- mesh__recordAuthorizer mesh__D002802 sjn
% 214.86/215.00  |- skos__prefLabel mesh__D002802 Cholinesterases
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D002802 2006
% 214.86/215.00  |- mesh__onlineNote mesh__D002802
% 214.86/215.00       use CHOLINESTERASES to search CHOLINESTERASE 1966-74   
% 214.86/215.00  |- mesh__recordOriginator mesh__D002802 NLM
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D002802 2004
% 214.86/215.00  |- mesh__recordMaintainer mesh__D002802 ssb
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D002802 2005
% 214.86/215.00  |- skos__altLabel mesh__D002802 Acylcholineacylhydrolase
% 214.86/215.00  |- mesh__dateRevised mesh__D002802 2003-07-09
% 214.86/215.00  |- mesh__publicMeSHNote mesh__D002802 75; was CHOLINESTERASE 1963-74   
% 214.86/215.00  |- mesh__historyNote mesh__D002802 75; was CHOLINESTERASE 1963-74   
% 214.86/215.00  |- mesh__dateCreated mesh__D002802 1999-01-01
% 214.86/215.00  |- rdf__type mesh__D002802sskos__Concept
% 214.86/215.00  |- skos__altLabel mesh__D002802 Cholinesterase
% 214.86/215.00  |- skos__broader mesh__D002802smesh__D002265
% 214.86/215.00  |- skos__annotation mesh__D002802
% 214.86/215.00       reactivation: index under CHOLINESTERASE REACTIVATORS   
% 214.86/215.00  |- mesh__recordAuthorizer mesh__D002004 sjn
% 214.86/215.00  |- skos__scopeNote mesh__D002004
% 214.86/215.00       A bacterial vaccine for the prevention of brucellosis in man and animal. Brucella abortus vaccine is used for the immunization of cattle, sheep, and goats.%A%    
% 214.86/215.00  |- rdf__type mesh__D002004sskos__Concept
% 214.86/215.00  |- skos__prefLabel mesh__D002004 Brucella Vaccine
% 214.86/215.00  |- skos__annotation mesh__D002004
% 214.86/215.00       coord IM with specific Brucella /immunol %28%IM%29%   
% 214.86/215.00  |- mesh__dateCreated mesh__D002004 1999-01-01
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D002004 2006
% 214.86/215.00  |- mesh__dateRevised mesh__D002004 2005-06-30
% 214.86/215.00  |- skos__hiddenLabel mesh__D002004 Vaccine, Brucella
% 214.86/215.00  |- mesh__recordOriginator mesh__D002004 NLM
% 214.86/215.00  |- skos__broader mesh__D002004smesh__D001428
% 214.86/215.00  |- mesh__recordMaintainer mesh__D002004 ssb
% 214.86/215.00  |- skos__hiddenLabel mesh__D007298 Rule, McNaughton
% 214.86/215.00  |- skos__hiddenLabel mesh__D007298 Defense, Insanity
% 214.86/215.00  |- mesh__recordAuthorizer mesh__D007298 sjn
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D007298 2006
% 214.86/215.00  |- mesh__dateCreated mesh__D007298 1999-01-01
% 214.86/215.00  |- mesh__recordMaintainer mesh__D007298 lkt
% 214.86/215.00  |- skos__scopeNote mesh__D007298
% 214.86/215.00       A legal concept that an accused is not criminally responsible if, at the time of committing the act, the person was laboring under such a defect of reason from disease of the mind as not to know the nature and quality of the act done or if the act was known, to not have known that what was done was wrong. %28%From Black%27%s Law Dictionary, 6th ed%29%%A%    
% 214.86/215.00  |- mesh__publicMeSHNote mesh__D007298
% 214.86/215.00       91; was see under FORENSIC PSYCHIATRY 1985-90; was MCNAUGHTON RULE see under FORENSIC PSYCHIATRY 1969-84; was MCNAUGHTON RULE see under JURISPRUDENCE, PSYCHIATRIC 1968%A%  
% 214.86/215.00  |- mesh__activeMeSHYear mesh__D007298 2005
% 214.86/215.00  |- skos__broader mesh__D007298smesh__D005555
% 214.86/215.00  |- mesh__onlineNote mesh__D007298
% 214.86/215.00       use FORENSIC PSYCHIATRY to search MCNAUGHTON RULE 1969-84; use JURISPRUDENCE, PSYCHIATRIC to search MCNAUGHTON RULE 1968%A%  
% 214.86/215.00  |- skos__prefLabel mesh__D007298 Insanity Defense
% 214.86/215.00  |- mesh__dateRevised mesh__D007298 2003-07-09
% 214.86/215.00  |- skos__hiddenLabel mesh__D007298 Insanity, Criminal
% 214.86/215.00  |- rdf__type mesh__D007298sskos__Concept
% 214.86/215.00  |- skos__hiddenLabel mesh__D007298 Rule, M%27%Naghten
% 214.86/215.00  |- mesh__historyNote mesh__D007298
% 214.86/215.00       91%28%85%29%; was see under FORENSIC PSYCHIATRY 1985-90; was MCNAUGHTON RULE see under FORENSIC PSYCHIATRY 1969-84; was MCNAUGHTON RULE see under JURISPRUDENCE, PSYCHIATRIC 1968%A%  
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D007298 2004
% 214.86/215.01  |- skos__related mesh__D007298smesh__D016743
% 214.86/215.01  |- mesh__dateEstablished mesh__D007298 1991-01-01
% 214.86/215.01  |- mesh__recordOriginator mesh__D007298 NLM
% 214.86/215.01  |- skos__annotation mesh__D040921
% 214.86/215.01       STRESS DISORDERS, TRAUMATIC, ACUTE is also available   
% 214.86/215.01  |- mesh__recordMaintainer mesh__D040921 sjn
% 214.86/215.01  |- mesh__publicMeSHNote mesh__D040921 2003   
% 214.86/215.01  |- skos__broader mesh__D040921smesh__D001008
% 214.86/215.01  |- skos__hiddenLabel mesh__D040921 Stress Disorder
% 214.86/215.01  |- skos__hiddenLabel mesh__D040921 Traumatic Stress Disorder
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D040921 2005
% 214.86/215.01  |- skos__hiddenLabel mesh__D040921 Traumatic Stress Disorders
% 214.86/215.01  |- mesh__recordAuthorizer mesh__D040921 sjn
% 214.86/215.01  |- skos__hiddenLabel mesh__D040921 Stress Disorder, Traumatic
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D040921 2006
% 214.86/215.01  |- mesh__dateEstablished mesh__D040921 2003-01-01
% 214.86/215.01  |- mesh__recordOriginator mesh__D040921 lkt
% 214.86/215.01  |- skos__prefLabel mesh__D040921 Stress Disorders, Traumatic
% 214.86/215.01  |- skos__scopeNote mesh__D040921
% 214.86/215.01       Anxiety disorders manifested by the development of characteristic symptoms following a psychologically traumatic event that is outside the normal range of usual human experience. Symptoms include re-experiencing the traumatic event, increased arousal, and numbing of responsiveness to or reduced involvement with the external world. Traumatic stress disorders can be further classified by the time of onset and the duration of these symptoms.%A%    
% 214.86/215.01  |- rdf__type mesh__D040921sskos__Concept
% 214.86/215.01  |- skos__historyNote mesh__D040921 Stress, Psychological %28%1965-2002%29%
% 214.86/215.01  |- mesh__dateCreated mesh__D040921 2002-07-03
% 214.86/215.01  |- mesh__dateRevised mesh__D040921 2004-07-13
% 214.86/215.01  |- skos__altLabel mesh__D040921 Stress Disorders
% 214.86/215.01  |- skos__historyNote mesh__D040921
% 214.86/215.01       Stress Disorders, Post-Traumatic %28%1980-2002%29%
% 214.86/215.01  |- mesh__historyNote mesh__D040921 2003   
% 214.86/215.01  |- mesh__recordAuthorizer mesh__D012432 SJN
% 214.86/215.01  |- skos__altLabel mesh__D012432 Ruanda
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D012432 2005
% 214.86/215.01  |- skos__broader mesh__D012432smesh__D000351
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D012432 2006
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D012432 2000
% 214.86/215.01  |- skos__scopeNote mesh__D012432
% 214.86/215.01       A republic in eastern Africa, south of UGANDA and east of DEMOCRATIC REPUBLIC OF THE CONGO. It was originally called Ruanda. Its capital is Kigali. Formerly part of the Belgian trust territory of Ruanda-Urundi %28%now RWANDA and BURUNDI%29%, it became independent in 1962. The country has taken the name of the people, the Rwanda, but its meaning is unknown. %28%From Webster%27%s New Geographical Dictionary, 1988, p1038 %26% Room, Brewer%27%s Dictionary of Names, 1992, p469%29%%A%    
% 214.86/215.01  |- mesh__recordMaintainer mesh__D012432 AGS
% 214.86/215.01  |- mesh__dateRevised mesh__D012432 1997-06-20
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D012432 2001
% 214.86/215.01  |- mesh__recordOriginator mesh__D012432 NLM
% 214.86/215.01  |- skos__annotation mesh__D012432
% 214.86/215.01       a republic in eastern Africa; X ref RUANDA was its former name%A%  
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D012432 1998
% 214.86/215.01  |- rdf__type mesh__D012432sskos__Concept
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D012432 2002
% 214.86/215.01  |- skos__prefLabel mesh__D012432 Rwanda
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D012432 1999
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D012432 2003
% 214.86/215.01  |- mesh__dateCreated mesh__D012432 1999-01-01
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D012432 2004
% 214.86/215.01  |- skos__broader mesh__D036082smesh__D036081
% 214.86/215.01  |- mesh__dateEstablished mesh__D036082 2003-01-01
% 214.86/215.01  |- skos__altLabel mesh__D036082 EPHA1 Protein
% 214.86/215.01  |- mesh__dateCreated mesh__D036082 2002-07-03
% 214.86/215.01  |- skos__altLabel mesh__D036082 Eph Receptor
% 214.86/215.01  |- skos__altLabel mesh__D036082 EphA1 Receptor
% 214.86/215.01  |- skos__scopeNote mesh__D036082
% 214.86/215.01       The founding member of the Eph family receptors. It was first cloned from an erythropoietin-producing human hepatocellular carcinoma cell line and is highly conserved among many mammalian species. Overproduction of the EphA1 receptor is associated with tumors and tumor cells of epithelial origin. It is also expressed at high levels in LIVER; LUNG; and KIDNEY; which is in contrast to many other members of the Eph receptor that are found primarily in tissues of the nervous system.%A%    
% 214.86/215.01  |- skos__altLabel mesh__D036082 EPHA1 Receptor Tyrosine Kinase
% 214.86/215.01  |- mesh__recordOriginator mesh__D036082 jmp
% 214.86/215.01  |- mesh__recordAuthorizer mesh__D036082 ags
% 214.86/215.01  |- mesh__dateRevised mesh__D036082 2005-07-19
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D036082 2006A
% 214.86/215.01  |- skos__prefLabel mesh__D036082 Receptor, EphA1
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D036082 2006
% 214.86/215.01  |- mesh__recordMaintainer mesh__D036082 ags
% 214.86/215.01  |- skos__historyNote mesh__D036082
% 214.86/215.01       Receptor Protein-Tyrosine Kinases %28%1999-2002%29%
% 214.86/215.01  |- mesh__publicMeSHNote mesh__D036082
% 214.86/215.01       2003; EPHA1 PROTEIN %28%now RECEPTOR, EPHA1%29% were indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1999-2002%A%  
% 214.86/215.01  |- mesh__historyNote mesh__D036082
% 214.86/215.01       2003; use RECEPTOR, EPHA1 %28%NM%29% 1999-2002   
% 214.86/215.01  |- rdf__type mesh__D036082sskos__Concept
% 214.86/215.01  |- skos__hiddenLabel mesh__D022062 Cardiac Electrophysiologic Study
% 214.86/215.01  |- mesh__publicMeSHNote mesh__D022062 2001   
% 214.86/215.01  |- skos__hiddenLabel mesh__D022062 Studies, Cardiac Electrophysiologic
% 214.86/215.01  |- skos__hiddenLabel mesh__D022062
% 214.86/215.01       Electrophysiologic Studies, Transesophageal
% 214.86/215.01  |- skos__broader mesh__D022062smesh__D006334
% 214.86/215.01  |- mesh__dateCreated mesh__D022062 2000-06-22
% 214.86/215.01  |- skos__hiddenLabel mesh__D022062 Technique, Cardiac Electrophysiologic
% 214.86/215.01  |- skos__hiddenLabel mesh__D022062
% 214.86/215.01       Studies, Transesophageal Electrophysiologic
% 214.86/215.01  |- skos__hiddenLabel mesh__D022062 Electrostimulations, Programmed
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D022062 2004
% 214.86/215.01  |- mesh__dateEstablished mesh__D022062 2001-01-01
% 214.86/215.01  |- skos__broader mesh__D022062smesh__D004568
% 214.86/215.01  |- mesh__historyNote mesh__D022062 2001   
% 214.86/215.01  |- skos__hiddenLabel mesh__D022062 Cardiac Electrophysiologic Technique
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D022062 2006
% 214.86/215.01  |- skos__hiddenLabel mesh__D022062
% 214.86/215.01       Transesophageal Electrophysiologic Studies
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D022062 2003
% 214.86/215.01  |- skos__hiddenLabel mesh__D022062 Techniques, Cardiac Electrophysiologic
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D022062 2005
% 214.86/215.01  |- skos__hiddenLabel mesh__D022062 Study, Cardiac Electrophysiologic
% 214.86/215.01  |- skos__hiddenLabel mesh__D022062 Cardiac Electrophysiologic Studies
% 214.86/215.01  |- skos__historyNote mesh__D022062 Electrophysiology %28%1970-2000%29%
% 214.86/215.01  |- rdf__type mesh__D022062sskos__Concept
% 214.86/215.01  |- skos__hiddenLabel mesh__D022062 Programmed Electrostimulations
% 214.86/215.01  |- skos__hiddenLabel mesh__D022062 Electrophysiologic Technique, Cardiac
% 214.86/215.01  |- skos__prefLabel mesh__D022062 Electrophysiologic Techniques, Cardiac
% 214.86/215.01  |- skos__scopeNote mesh__D022062
% 214.86/215.01       Invasive procedures whereby tachyarrhythmias %28%TACHYCARDIA%29%, induced or spontaneous, are mapped via heart catheterization techniques for the investigation of electrical activities in the heart. In addition to diagnostic purposes, the techniques of intracardiac programmed electrostimulation are used therapeutically.%A%    
% 214.86/215.01  |- skos__hiddenLabel mesh__D022062 Electrostimulation, Programmed
% 214.86/215.01  |- skos__hiddenLabel mesh__D022062
% 214.86/215.01       Electrophysiologic Study, Transesophageal
% 214.86/215.01  |- skos__hiddenLabel mesh__D022062 Electrophysiologic Studies, Cardiac
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D022062 2002
% 214.86/215.01  |- skos__hiddenLabel mesh__D022062
% 214.86/215.01       Study, Transesophageal Electrophysiologic
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D022062 2001
% 214.86/215.01  |- skos__altLabel mesh__D022062 Cardiac Electrophysiologic Techniques
% 214.86/215.01  |- mesh__publicMeSHNote mesh__D016823 92   
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D016823 2005
% 214.86/215.01  |- skos__scopeNote mesh__D016823
% 214.86/215.01       An order of plantlike, flagellate protozoa commonly found in freshwater habitats. Characteristics include the presence of a cellulose wall and two-to-four equal, smooth, apical flagella.%A%    
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D016823 2006
% 214.86/215.01  |- skos__annotation mesh__D016823 an order of freshwater protozoa   
% 214.86/215.01  |- mesh__historyNote mesh__D016823 92   
% 214.86/215.01  |- mesh__dateRevised mesh__D016823 2003-07-09
% 214.86/215.01  |- skos__prefLabel mesh__D016823 Volvocida
% 214.86/215.01  |- mesh__recordAuthorizer mesh__D016823 sjn
% 214.86/215.01  |- mesh__recordOriginator mesh__D016823 PXP
% 214.86/215.01  |- rdf__type mesh__D016823sskos__Concept
% 214.86/215.01  |- mesh__dateEstablished mesh__D016823 1992-01-01
% 214.86/215.01  |- mesh__dateCreated mesh__D016823 1991-05-02
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D016823 2004
% 214.86/215.01  |- skos__broader mesh__D016823smesh__D016821
% 214.86/215.01  |- mesh__recordMaintainer mesh__D016823 ags
% 214.86/215.01  |- mesh__recordOriginator mesh__D016025 PXP
% 214.86/215.01  |- mesh__dateRevised mesh__D016025 2002-07-02
% 214.86/215.01  |- skos__altLabel mesh__D016025 Transplantation, Bone
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D016025 2005
% 214.86/215.01  |- skos__hiddenLabel mesh__D016025 Bone Transplantations
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D016025 2004
% 214.86/215.01  |- mesh__recordAuthorizer mesh__D016025 sjn
% 214.86/215.01  |- skos__hiddenLabel mesh__D016025 Graftings, Bone
% 214.86/215.01  |- skos__annotation mesh__D016025
% 214.86/215.01       may refer to a whole bone or a segment of bone; do not use /util except by MeSH definition; do not coord with TRANSPLANTATION, AUTOLOGOUS or TRANSPLANTATION, HETEROTOPIC unless particularly discussed%A%  
% 214.86/215.01  |- mesh__historyNote mesh__D016025
% 214.86/215.01       90; was BONE AND BONES/transplantation 1966-89; was heading 1963-65%A%  
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D016025 2003
% 214.86/215.01  |- mesh__recordMaintainer mesh__D016025 lkt
% 214.86/215.01  |- skos__broader mesh__D016025smesh__D016377
% 214.86/215.01  |- mesh__dateEstablished mesh__D016025 1990-01-01
% 214.86/215.01  |- skos__hiddenLabel mesh__D016025 Bone Grafting
% 214.86/215.01  |- skos__historyNote mesh__D016025
% 214.86/215.01       Bone and Bones/transplantation %28%1966-1989%29%
% 214.86/215.01  |- skos__hiddenLabel mesh__D016025 Transplantations, Bone
% 214.86/215.01  |- mesh__publicMeSHNote mesh__D016025
% 214.86/215.01       90; was BONE AND BONES/transplantation 1966-89; was heading 1963-65%A%  
% 214.86/215.01  |- skos__altLabel mesh__D016025 Grafting, Bone
% 214.86/215.01  |- rdf__type mesh__D016025sskos__Concept
% 214.86/215.01  |- skos__broader mesh__D016025smesh__D019637
% 214.86/215.01  |- skos__prefLabel mesh__D016025 Bone Transplantation
% 214.86/215.01  |- skos__hiddenLabel mesh__D016025 Bone Graftings
% 214.86/215.01  |- skos__scopeNote mesh__D016025
% 214.86/215.01       The grafting of bone from a donor site to a recipient site.%A%    
% 214.86/215.01  |- mesh__dateCreated mesh__D016025 1989-09-06
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D016025 2006
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D002803 2005
% 214.86/215.01  |- skos__hiddenLabel mesh__D002803 Chondro 4 Sulfatase
% 214.86/215.01  |- skos__prefLabel mesh__D002803 Chondro-4-Sulfatase
% 214.86/215.01  |- mesh__recordOriginator mesh__D002803 RLS
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D002803 2006
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D002803 2004
% 214.86/215.01  |- skos__broader mesh__D002803smesh__D002811
% 214.86/215.01  |- mesh__recordMaintainer mesh__D002803 ssb
% 214.86/215.01  |- skos__historyNote mesh__D002803 Chondroitin %28%1974-1975%29%
% 214.86/215.01  |- mesh__recordAuthorizer mesh__D002803 sjn
% 214.86/215.01  |- mesh__dateRevised mesh__D002803 2003-07-09
% 214.86/215.01  |- mesh__dateEstablished mesh__D002803 1991-01-01
% 214.86/215.01  |- mesh__historyNote mesh__D002803
% 214.86/215.01       91%28%76%29%; was see under SULFATASES 1976-90   
% 214.86/215.01  |- skos__historyNote mesh__D002803 Sulfatases %28%1974-1975%29%
% 214.86/215.01  |- rdf__type mesh__D002803sskos__Concept
% 214.86/215.01  |- mesh__dateCreated mesh__D002803 1975-07-25
% 214.86/215.01  |- skos__scopeNote mesh__D002803
% 214.86/215.01       An enzyme from the sulfuric ester hydrolase class that breaks down one of the products of the chondroitin lyase II reaction. EC 3.1.6.9.%A%    
% 214.86/215.01  |- mesh__publicMeSHNote mesh__D002803
% 214.86/215.01       91; was see under SULFATASES 1976-90   
% 214.86/215.01  |- skos__scopeNote mesh__D032490
% 214.86/215.01       A plant family of the order Taxales, class Pinopsida, division CONIFEROPHYTA.%A%    
% 214.86/215.01  |- skos__prefLabel mesh__D032490 Taxaceae
% 214.86/215.01  |- mesh__dateEstablished mesh__D032490 2003-01-01
% 214.86/215.01  |- rdf__type mesh__D032490sskos__Concept
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D032490 2004
% 214.86/215.01  |- mesh__dateCreated mesh__D032490 2002-07-03
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D032490 2003
% 214.86/215.01  |- skos__annotation mesh__D032490
% 214.86/215.01       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.86/215.01  |- mesh__historyNote mesh__D032490 2003   
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D032490 2006
% 214.86/215.01  |- mesh__publicMeSHNote mesh__D032490 2003   
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D032490 2005
% 214.86/215.01  |- skos__broader mesh__D032490smesh__D032482
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D007299 2001
% 214.86/215.01  |- mesh__recordOriginator mesh__D007299 NLM
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D007299 2005
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D007299 1999
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D007299 2000
% 214.86/215.01  |- skos__hiddenLabel mesh__D007299 Sting, Insect
% 214.86/215.01  |- skos__hiddenLabel mesh__D007299 Bite, Insect
% 214.86/215.01  |- skos__hiddenLabel mesh__D007299 Stings, Insect
% 214.86/215.01  |- rdf__type mesh__D007299sskos__Concept
% 214.86/215.01  |- skos__hiddenLabel mesh__D007299 Bites, Insect
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D007299 1998
% 214.86/215.01  |- skos__broader mesh__D007299smesh__D001733
% 214.86/215.01  |- skos__hiddenLabel mesh__D007299 Insect Sting
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D007299 2004
% 214.86/215.01  |- mesh__recordMaintainer mesh__D007299 TPW
% 214.86/215.01  |- mesh__recordAuthorizer mesh__D007299 SJN
% 214.86/215.01  |- mesh__dateRevised mesh__D007299 1997-06-20
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D007299 2002
% 214.86/215.01  |- skos__hiddenLabel mesh__D007299 Insect Bite
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D007299 2003
% 214.86/215.01  |- skos__prefLabel mesh__D007299 Insect Bites and Stings
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D007299 2006
% 214.86/215.01  |- mesh__dateCreated mesh__D007299 1999-01-01
% 214.86/215.01  |- skos__annotation mesh__D007299
% 214.86/215.01       coord IM with specific insect %28%IM%29%; DF: INSECT BITES   
% 214.86/215.01  |- skos__scopeNote mesh__D007299
% 214.86/215.01       Bites and stings inflicted by insects.     
% 214.86/215.01  |- skos__scopeNote mesh__D012433
% 214.86/215.01       Insecticidal alkaloid isolated from Ryania speciosa; proposed as a myocardial depressant.%A%    
% 214.86/215.01  |- mesh__historyNote mesh__D012433
% 214.86/215.01       91%28%75%29%; was see under ALKALOIDS 1975-90   
% 214.86/215.01  |- skos__broader mesh__D012433smesh__D000470
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D012433 2003
% 214.86/215.01  |- skos__historyNote mesh__D012433 Alkaloids %28%1970-1974%29%
% 214.86/215.01  |- mesh__dateEstablished mesh__D012433 1991-01-01
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D012433 2002
% 214.86/215.01  |- mesh__dateRevised mesh__D012433 2000-06-22
% 214.86/215.01  |- mesh__recordAuthorizer mesh__D012433 sjn
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D012433 2006
% 214.86/215.01  |- mesh__publicMeSHNote mesh__D012433
% 214.86/215.01       91; was see under ALKALOIDS 1975-90   
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D012433 2001
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D012433 2005
% 214.86/215.01  |- rdf__type mesh__D012433sskos__Concept
% 214.86/215.01  |- mesh__recordMaintainer mesh__D012433 TWD
% 214.86/215.01  |- mesh__dateCreated mesh__D012433 1974-11-19
% 214.86/215.01  |- mesh__recordOriginator mesh__D012433 NLM
% 214.86/215.01  |- skos__prefLabel mesh__D012433 Ryanodine
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D012433 2004
% 214.86/215.01  |- skos__altLabel mesh__D036881
% 214.86/215.01       Long-Term Depression %28%Neurophysiology%29%
% 214.86/215.01  |- skos__annotation mesh__D036881
% 214.86/215.01       note category: do not confuse with clinical DEPRESSION or DEPRESSIVE DISORDERS%A%  
% 214.86/215.01  |- skos__hiddenLabel mesh__D036881 Depression, Homosynaptic
% 214.86/215.01  |- rdf__type mesh__D036881sskos__Concept
% 214.86/215.01  |- skos__broader mesh__D036881smesh__D009473
% 214.86/215.01  |- skos__historyNote mesh__D036881 Neuronal Plasticity %28%1985-2002%29%
% 214.86/215.01  |- skos__hiddenLabel mesh__D036881
% 214.86/215.01       Long Term Depression %28%Neurophysiology%29%
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D036881 2004
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D036881 2003
% 214.86/215.01  |- skos__hiddenLabel mesh__D036881 Synaptic Depression, Long-Term
% 214.86/215.01  |- mesh__publicMeSHNote mesh__D036881 2003   
% 214.86/215.01  |- skos__prefLabel mesh__D036881 Long-Term Depression %28%Physiology%29%
% 214.86/215.01  |- skos__scopeNote mesh__D036881
% 214.86/215.01       A persistent activity-dependent decrease in synaptic efficacy between NEURONS. It typically occurs following repeated low-frequency afferent stimulation, but it can be induced by other methods. Long-term depression appears to play a role in MEMORY.%A%    
% 214.86/215.01  |- skos__hiddenLabel mesh__D036881 Long Term Synaptic Depression
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D036881 2006
% 214.86/215.01  |- mesh__dateEstablished mesh__D036881 2003-01-01
% 214.86/215.01  |- skos__altLabel mesh__D036881 Homosynaptic Depression
% 214.86/215.01  |- skos__altLabel mesh__D036881 Long-Term Synaptic Depression
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D036881 2005
% 214.86/215.01  |- skos__hiddenLabel mesh__D036881 Long Term Depression %28%Physiology%29%
% 214.86/215.01  |- mesh__historyNote mesh__D036881 2003   
% 214.86/215.01  |- mesh__dateCreated mesh__D036881 2002-07-03
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D036083 2004
% 214.86/215.01  |- skos__annotation mesh__D036083
% 214.86/215.01       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.86/215.01  |- mesh__dateEstablished mesh__D036083 2003-01-01
% 214.86/215.01  |- skos__scopeNote mesh__D036083
% 214.86/215.01       A plant genus of the family ASTERACEAE. Members contain ATRACTYLOSIDE which inhibits ADENINE NUCLEOTIDE TRANSLOCASE.%A%    
% 214.86/215.01  |- skos__broader mesh__D036083smesh__D019659
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D036083 2005
% 214.86/215.01  |- mesh__dateCreated mesh__D036083 2002-07-02
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D036083 2006
% 214.86/215.01  |- mesh__publicMeSHNote mesh__D036083 2003   
% 214.86/215.01  |- skos__prefLabel mesh__D036083 Atractylis
% 214.86/215.01  |- mesh__historyNote mesh__D036083 2003   
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D036083 2003
% 214.86/215.01  |- rdf__type mesh__D036083sskos__Concept
% 214.86/215.01  |- mesh__recordAuthorizer mesh__D022861 sjn
% 214.86/215.01  |- skos__broader mesh__D022861smesh__D016115
% 214.86/215.01  |- skos__prefLabel mesh__D022861 Hermanski-Pudlak Syndrome
% 214.86/215.01  |- skos__historyNote mesh__D022861
% 214.86/215.01       Albinism, Oculocutaneous %28%1990-2000%29%
% 214.86/215.01  |- skos__hiddenLabel mesh__D022861 Hermansky Pudlak Syndrome
% 214.86/215.01  |- mesh__publicMeSHNote mesh__D022861 2001   
% 214.86/215.01  |- mesh__dateCreated mesh__D022861 2000-06-22
% 214.86/215.01  |- rdf__type mesh__D022861sskos__Concept
% 214.86/215.01  |- mesh__recordMaintainer mesh__D022861 ags
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D022861 2006
% 214.86/215.01  |- skos__scopeNote mesh__D022861
% 214.86/215.01       Syndrome characterized by the triad of oculocutaneous albinism %28%ALBINISM, OCULOCUTANEOUS%29%; PLATELET STORAGE POOL DEFICIENCY; and lysosomal accumulation of ceroid lipofuscin.%A%    
% 214.86/215.01  |- skos__altLabel mesh__D022861 Hermansky-Pudlak Syndrome
% 214.86/215.01  |- skos__hiddenLabel mesh__D022861 Hermanski Pudlak Syndrome
% 214.86/215.01  |- skos__broader mesh__D022861smesh__D010981
% 214.86/215.01  |- mesh__historyNote mesh__D022861 2001   
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D022861 2004
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D022861 2005
% 214.86/215.01  |- mesh__dateRevised mesh__D022861 2002-07-03
% 214.86/215.01  |- mesh__dateEstablished mesh__D022861 2001-01-01
% 214.86/215.01  |- skos__broader mesh__D022861smesh__D025861
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D022861 2003
% 214.86/215.01  |- mesh__recordOriginator mesh__D022861 ags
% 214.86/215.01  |- mesh__dateEstablished mesh__D008392 1991-01-01
% 214.86/215.01  |- skos__annotation mesh__D008392
% 214.86/215.01       a genus of marmots or woodchucks: do not confuse with MARMOSETS see CALLITHRIX, a genus of monkey; IM; qualif permitted%A%  
% 214.86/215.01  |- skos__hiddenLabel mesh__D008392 Marmotas
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D008392 2004
% 214.86/215.01  |- skos__prefLabel mesh__D008392 Marmota
% 214.86/215.01  |- mesh__historyNote mesh__D008392
% 214.86/215.01       91%28%82%29%; was see under SCIURIDAE 1982-90; was MARMOTS see under RODENTS 1975-81%A%  
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D008392 2006
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D008392 2005
% 214.86/215.01  |- rdf__type mesh__D008392sskos__Concept
% 214.86/215.01  |- skos__scopeNote mesh__D008392
% 214.86/215.01       A genus of Sciuridae consisting of 14 species. They are shortlegged, burrowing rodents which hibernate in winter.%A%    
% 214.86/215.01  |- skos__altLabel mesh__D008392 Marmots
% 214.86/215.01  |- mesh__dateRevised mesh__D008392 2003-07-09
% 214.86/215.01  |- mesh__publicMeSHNote mesh__D008392
% 214.86/215.01       91; was see under SCIURIDAE 1982-90; was MARMOTS see under RODENTS 1975-81%A%  
% 214.86/215.01  |- mesh__dateCreated mesh__D008392 1974-12-12
% 214.86/215.01  |- mesh__recordAuthorizer mesh__D008392 sjn
% 214.86/215.01  |- skos__broader mesh__D008392smesh__D012589
% 214.86/215.01  |- mesh__onlineNote mesh__D008392 use MARMOTA to search MARMOTS 1975-81   
% 214.86/215.01  |- skos__hiddenLabel mesh__D008392 Marmot
% 214.86/215.01  |- mesh__recordOriginator mesh__D008392 NLM
% 214.86/215.01  |- mesh__recordMaintainer mesh__D008392 ags
% 214.86/215.01  |- skos__hiddenLabel mesh__D008392 Woodchuck
% 214.86/215.01  |- skos__annotation mesh__D016824
% 214.86/215.01       restrict to antigens expressed on only platelets: do not confuse with HLA %26% other antigens expressed on platelets or other blood cells%A%  
% 214.86/215.01  |- mesh__historyNote mesh__D016824 92   
% 214.86/215.01  |- skos__altLabel mesh__D016824 Platelet Alloantigens
% 214.86/215.01  |- skos__altLabel mesh__D016824 Human Platelet Antigens
% 214.86/215.01  |- skos__historyNote mesh__D016824 Isoantigens %28%1976-1991%29%
% 214.86/215.01  |- rdf__type mesh__D016824sskos__Concept
% 214.86/215.01  |- skos__prefLabel mesh__D016824 Antigens, Human Platelet
% 214.86/215.01  |- skos__historyNote mesh__D016824 Antigens %28%1966-1979%29%
% 214.86/215.01  |- skos__hiddenLabel mesh__D016824 Antigens, Platelet Specific
% 214.86/215.01  |- skos__hiddenLabel mesh__D016824 Platelet Antigens, Human
% 214.86/215.01  |- mesh__publicMeSHNote mesh__D016824 92   
% 214.86/215.01  |- skos__altLabel mesh__D016824 Platelet-Specific Antigens
% 214.86/215.01  |- mesh__recordMaintainer mesh__D016824 ssb
% 214.86/215.01  |- skos__hiddenLabel mesh__D016824 Alloantigens, Platelet
% 214.86/215.01  |- mesh__dateRevised mesh__D016824 2005-06-30
% 214.86/215.01  |- skos__broader mesh__D016824smesh__D007519
% 214.86/215.01  |- skos__scopeNote mesh__D016824
% 214.86/215.01       Human alloantigens expressed only on platelets, specifically on platelet membrane glycoproteins. These platelet-specific antigens are immunogenic and can result in pathological reactions to transfusion therapy.%A%    
% 214.86/215.01  |- mesh__dateEstablished mesh__D016824 1992-01-01
% 214.86/215.01  |- mesh__dateCreated mesh__D016824 1991-06-21
% 214.86/215.01  |- skos__hiddenLabel mesh__D016824 Platelet Specific Antigens
% 214.86/215.01  |- mesh__recordOriginator mesh__D016824 AGS
% 214.86/215.01  |- mesh__recordAuthorizer mesh__D016824 sjn
% 214.86/215.01  |- skos__altLabel mesh__D016824 Antigens, Platelet-Specific
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D016824 2006
% 214.86/215.01  |- skos__historyNote mesh__D016026
% 214.86/215.01       Bone Marrow/transplantation %28%1966-1989%29%
% 214.86/215.01  |- skos__related mesh__D016026smesh__D018380
% 214.86/215.01  |- skos__broader mesh__D016026smesh__D033581
% 214.86/215.01  |- skos__scopeNote mesh__D016026
% 214.86/215.01       The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION.%A%    
% 214.86/215.01  |- skos__related mesh__D016026smesh__D016465
% 214.86/215.01  |- mesh__dateRevised mesh__D016026 2004-07-13
% 214.86/215.01  |- mesh__historyNote mesh__D016026
% 214.86/215.01       90; was BONE MARROW/transplantation 1966-89; was heading 1964-65%A%  
% 214.86/215.01  |- skos__altLabel mesh__D016026 Transplantation, Bone Marrow
% 214.86/215.01  |- skos__hiddenLabel mesh__D016026 Bone Marrow Grafting
% 214.86/215.01  |- mesh__dateEstablished mesh__D016026 1990-01-01
% 214.86/215.01  |- mesh__recordAuthorizer mesh__D016026 sjn
% 214.86/215.01  |- skos__annotation mesh__D016026
% 214.86/215.01       do not coord with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; in treatment of dis, coord with dis /surg; conditioning before transpl of bone marrow: coord IM with TRANSPLANTATION CONDITIONING %28%IM%29%%A%  
% 214.86/215.01  |- rdf__type mesh__D016026sskos__Concept
% 214.86/215.01  |- mesh__recordMaintainer mesh__D016026 sjn
% 214.86/215.01  |- mesh__publicMeSHNote mesh__D016026
% 214.86/215.01       90; was BONE MARROW/transplantation 1966-89; was heading 1964-65%A%  
% 214.86/215.01  |- skos__altLabel mesh__D016026 Grafting, Bone Marrow
% 214.86/215.01  |- skos__broader mesh__D016026smesh__D016378
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D016026 2006
% 214.86/215.01  |- mesh__dateCreated mesh__D016026 1989-05-25
% 214.86/215.01  |- mesh__recordOriginator mesh__D016026 PXP
% 214.86/215.01  |- skos__prefLabel mesh__D016026 Bone Marrow Transplantation
% 214.86/215.01  |- skos__altLabel mesh__D016026 Transplantation, Bone Marrow Cell
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D016026 2005
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D002804 2006
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D002804 2000
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D002804 2004
% 214.86/215.01  |- mesh__dateCreated mesh__D002804 1999-01-01
% 214.86/215.01  |- skos__scopeNote mesh__D002804
% 214.86/215.01       A usually benign tumor composed of cells which arise from chondroblasts or their precursors and which tend to differentiate into cartilage cells. It occurs primarily in the epiphyses of adolescents. It is relatively rare and represents less than 2%25% of all primary bone tumors. The peak incidence is in the second decade of life; it is about twice as common in males as in females. %28%From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1846%29%%A%    
% 214.86/215.01  |- mesh__dateRevised mesh__D002804 1995-06-08
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D002804 2001
% 214.86/215.01  |- skos__prefLabel mesh__D002804 Chondroblastoma
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D002804 1998
% 214.86/215.01  |- mesh__recordAuthorizer mesh__D002804 PLS
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D002804 1996
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D002804 2002
% 214.86/215.01  |- rdf__type mesh__D002804sskos__Concept
% 214.86/215.01  |- skos__annotation mesh__D002804
% 214.86/215.01       benign or malignant; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS or precoord organ/neopl term %28%IM%29%%A%  
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D002804 1999
% 214.86/215.01  |- skos__hiddenLabel mesh__D002804 Chondroblastomas
% 214.86/215.01  |- mesh__recordMaintainer mesh__D002804 KEV
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D002804 1997
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D002804 2005
% 214.86/215.01  |- mesh__recordOriginator mesh__D002804 NLM
% 214.86/215.01  |- skos__broader mesh__D002804smesh__D009372
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D002804 2003
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D002006 2002
% 214.86/215.01  |- skos__altLabel mesh__D002006 Undulant Fever
% 214.86/215.01  |- mesh__dateCreated mesh__D002006 1999-01-01
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D002006 1996
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D002006 2003
% 214.86/215.01  |- skos__hiddenLabel mesh__D002006 Fevers, Undulant
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D002006 1998
% 214.86/215.01  |- mesh__dateRevised mesh__D002006 1993-06-02
% 214.86/215.01  |- skos__hiddenLabel mesh__D002006 Fever, Malta
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D002006 1997
% 214.86/215.01  |- skos__altLabel mesh__D002006 Malta Fever
% 214.86/215.01  |- mesh__activeMeSHYear mesh__D002006 2000
% 214.86/215.02  |- skos__scopeNote mesh__D002006
% 214.86/215.02       Infection caused by bacteria of the genus BRUCELLA mainly involving the reticuloendothelial system. This condition is characterized by fever, weakness, malaise, and weight loss.%A%    
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002006 2005
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002006 2004
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002006 1999
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002006 2001
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002006 1994
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002006 2006
% 214.86/215.02  |- skos__hiddenLabel mesh__D002006 Brucelloses
% 214.86/215.02  |- skos__prefLabel mesh__D002006 Brucellosis
% 214.86/215.02  |- mesh__recordMaintainer mesh__D002006 PLS
% 214.86/215.02  |- skos__hiddenLabel mesh__D002006 Undulant Fevers
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002006 1995
% 214.86/215.02  |- mesh__recordOriginator mesh__D002006 NLM
% 214.86/215.02  |- skos__annotation mesh__D002006 gram-neg bact infect   
% 214.86/215.02  |- rdf__type mesh__D002006sskos__Concept
% 214.86/215.02  |- mesh__recordAuthorizer mesh__D002006 PLS
% 214.86/215.02  |- skos__broader mesh__D002006smesh__D016905
% 214.86/215.02  |- skos__hiddenLabel mesh__D002006 Fever, Undulant
% 214.86/215.02  |- mesh__historyNote mesh__D032491 2003   
% 214.86/215.02  |- skos__prefLabel mesh__D032491 Dryopteridaceae
% 214.86/215.02  |- skos__broader mesh__D032491smesh__D029624
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D032491 2003
% 214.86/215.02  |- rdf__type mesh__D032491sskos__Concept
% 214.86/215.02  |- mesh__dateEstablished mesh__D032491 2003-01-01
% 214.86/215.02  |- skos__annotation mesh__D032491
% 214.86/215.02       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D032491 2004
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D032491 2005
% 214.86/215.02  |- skos__scopeNote mesh__D032491
% 214.86/215.02       The wood fern plant family of the order Polypodiales, class Filicopsida, division Pteridophyta.%A%    
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D032491 2006
% 214.86/215.02  |- mesh__publicMeSHNote mesh__D032491 2003   
% 214.86/215.02  |- mesh__dateCreated mesh__D032491 2002-07-03
% 214.86/215.02  |- skos__broader mesh__D048108smesh__D048088
% 214.86/215.02  |- mesh__publicMeSHNote mesh__D048108 2005   
% 214.86/215.02  |- skos__scopeNote mesh__D048108
% 214.86/215.02       The field of information science concerned with the analysis and dissemination of data through the application of computers applied to the field of nursing.%A%    
% 214.86/215.02  |- mesh__historyNote mesh__D048108 2005   
% 214.86/215.02  |- mesh__recordOriginator mesh__D048108 jls
% 214.86/215.02  |- rdf__type mesh__D048108sskos__Concept
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D048108 2006
% 214.86/215.02  |- mesh__dateEstablished mesh__D048108 2005-01-01
% 214.86/215.02  |- mesh__dateCreated mesh__D048108 2004-07-07
% 214.86/215.02  |- skos__prefLabel mesh__D048108 Nursing Informatics
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D048108 2005
% 214.86/215.02  |- skos__hiddenLabel mesh__D048108 Informatics, Nursing
% 214.86/215.02  |- mesh__recordAuthorizer mesh__D048108 sjn
% 214.86/215.02  |- mesh__recordMaintainer mesh__D048108 jls
% 214.86/215.02  |- skos__historyNote mesh__D048108 Information Systems %28%1980-2004%29%
% 214.86/215.02  |- skos__prefLabel mesh__D012434 Secale cereale
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D012434 2004
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D012434 2003
% 214.86/215.02  |- mesh__recordMaintainer mesh__D012434 sjn
% 214.86/215.02  |- mesh__dateEstablished mesh__D012434 1991-01-01
% 214.86/215.02  |- skos__broader mesh__D012434smesh__D002523
% 214.86/215.02  |- skos__broader mesh__D012434smesh__D006109
% 214.86/215.02  |- skos__annotation mesh__D012434
% 214.86/215.02       do not confuse X ref SECALE with Secale cornutum %28% = ERGOT FUNGUS see CLAVICEPS%29% nor X ref RYE with RYE GRASS see LOLIUM; the rye-wheat hybrid Triticale is TRITICALE see CEREALS; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.86/215.02  |- mesh__historyNote mesh__D012434 2003%28%1963%29%   
% 214.86/215.02  |- mesh__recordAuthorizer mesh__D012434 sjn
% 214.86/215.02  |- skos__broader mesh__D012434smesh__D000821
% 214.86/215.02  |- mesh__dateCreated mesh__D012434 1999-01-01
% 214.86/215.02  |- mesh__dateRevised mesh__D012434 2002-07-03
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D012434 2006
% 214.86/215.02  |- rdf__type mesh__D012434sskos__Concept
% 214.86/215.02  |- mesh__publicMeSHNote mesh__D012434
% 214.86/215.02       2003; see RYE 1991-2002, see CEREALS 1985-1990, see GRAIN 1963-1984%A%  
% 214.86/215.02  |- mesh__recordOriginator mesh__D012434 NLM
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D012434 2005
% 214.86/215.02  |- skos__scopeNote mesh__D012434
% 214.86/215.02       A hardy grain crop, rye, grown in northern climates. It is the most frequent host to ergot %28%CLAVICEPS%29%, the toxic fungus. Its hybrid with TRITICUM is TRITICALE, another grain.%A%    
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D036882 2004
% 214.86/215.02  |- mesh__historyNote mesh__D036882 2003   
% 214.86/215.02  |- mesh__dateCreated mesh__D036882 2002-07-03
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D036882 2003
% 214.86/215.02  |- mesh__publicMeSHNote mesh__D036882 2003   
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D036882 2006
% 214.86/215.02  |- skos__scopeNote mesh__D036882
% 214.86/215.02       A plant genus of the family ARALIACEAE. Members contain triterpene saponins.%A%    
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D036882 2005
% 214.86/215.02  |- skos__broader mesh__D036882smesh__D027481
% 214.86/215.02  |- mesh__dateEstablished mesh__D036882 2003-01-01
% 214.86/215.02  |- rdf__type mesh__D036882sskos__Concept
% 214.86/215.02  |- skos__annotation mesh__D036882
% 214.86/215.02       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.86/215.02  |- skos__prefLabel mesh__D036882 Kalopanax
% 214.86/215.02  |- skos__annotation mesh__D036084
% 214.86/215.02       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.86/215.02  |- mesh__historyNote mesh__D036084 2003   
% 214.86/215.02  |- skos__broader mesh__D036084smesh__D019659
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D036084 2005
% 214.86/215.02  |- skos__altLabel mesh__D036084 Impila
% 214.86/215.02  |- mesh__dateEstablished mesh__D036084 2003-01-01
% 214.86/215.02  |- mesh__publicMeSHNote mesh__D036084 2003   
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D036084 2006
% 214.86/215.02  |- mesh__dateCreated mesh__D036084 2002-07-03
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D036084 2003
% 214.86/215.02  |- rdf__type mesh__D036084sskos__Concept
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D036084 2004
% 214.86/215.02  |- skos__scopeNote mesh__D036084
% 214.86/215.02       A plant genus of the family ASTERACEAE. Members contain ATRACTYLOSIDE.%A%    
% 214.86/215.02  |- skos__prefLabel mesh__D036084 Callilepis
% 214.86/215.02  |- skos__related mesh__D008393smesh__D018454
% 214.86/215.02  |- skos__scopeNote mesh__D008393
% 214.86/215.02       The social institution involving legal and/or religious sanction whereby men and women are joined together for the purpose of founding a family unit.%A%    
% 214.86/215.02  |- skos__prefLabel mesh__D008393 Marriage
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Married, Currently
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D008393 2003
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Consensual Unions
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Marriages, Arranged
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D008393 1996
% 214.86/215.02  |- skos__annotation mesh__D008393
% 214.86/215.02       a sociol %26% anthropol concept: differentiate from MARITAL STATUS, a demographic %26% statist concept; SPOUSES is available for the husband or wife as a person%A%  
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D008393 2002
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Comparisons, Husband-Wife
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Postponement, Marriage
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Mate Selections
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Marriage Consummations
% 214.86/215.02  |- rdf__type mesh__D008393sskos__Concept
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Intermarriages
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Postponements, Marriage
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Selections, Mate
% 214.86/215.02  |- mesh__dateRevised mesh__D008393 1994-04-16
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Unions, Consensual
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Dowries
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Marriage, Arranged
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Remarriages
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Marriages, Multiple
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D008393 1995
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D008393 2001
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Marriage Ages
% 214.86/215.02  |- mesh__dateCreated mesh__D008393 1999-01-01
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Comparison, Husband-Wife
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Marriages
% 214.86/215.02  |- mesh__recordOriginator mesh__D008393 NLM
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Marital Relationships
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D008393 2006
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Marriage Consummation
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Arranged Marriages
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Marriage, Commonlaw
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D008393 1999
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D008393 2000
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Husband-Wife Comparison
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Union, Consensual
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Duration, Marriage
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Relationships, Marital
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Marriage Postponements
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Commonlaw Marriages
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Husband Wife Comparisons
% 214.86/215.02  |- skos__related mesh__D008393smesh__D011291
% 214.86/215.02  |- mesh__recordAuthorizer mesh__D008393 PLS
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D008393 2005
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Age, Marriage
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D008393 2004
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Selection, Mate
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Marriage Pattern
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D008393 1998
% 214.86/215.02  |- mesh__recordMaintainer mesh__D008393 TGC
% 214.86/215.02  |- skos__broader mesh__D008393smesh__D017533
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D008393 1997
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Marriages, Commonlaw
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Relationship, Marital
% 214.86/215.02  |- skos__hiddenLabel mesh__D008393 Ages, Marriage
% 214.86/215.02  |- rdf__type mesh__D016825sskos__Concept
% 214.86/215.02  |- skos__annotation mesh__D016825
% 214.86/215.02       considered both a protozoon %26% a green alga   
% 214.86/215.02  |- mesh__dateEstablished mesh__D016825 1992-01-01
% 214.86/215.02  |- mesh__recordAuthorizer mesh__D016825 sjn
% 214.86/215.02  |- mesh__recordOriginator mesh__D016825 PXP
% 214.86/215.02  |- mesh__dateCreated mesh__D016825 1991-05-02
% 214.86/215.02  |- skos__historyNote mesh__D016825 Algae, Green %28%1970-1971%29%
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D016825 2004
% 214.86/215.02  |- skos__altLabel mesh__D016825 Chlamydomonas reinhardii
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D016825 2005
% 214.86/215.02  |- mesh__recordMaintainer mesh__D016825 ags
% 214.86/215.02  |- skos__prefLabel mesh__D016825 Chlamydomonas reinhardtii
% 214.86/215.02  |- mesh__publicMeSHNote mesh__D016825 92   
% 214.86/215.02  |- skos__broader mesh__D016825smesh__D002696
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D016825 2006
% 214.86/215.02  |- skos__scopeNote mesh__D016825
% 214.86/215.02       An organism considered both a protozoon %28%Dorland, 27th ed%29% and an alga %28%Bold %26% Wynne, Introduction to the Algae, 2d ed, p84%29%. Delicate, hairlike appendages arise from the flagellar surface in these organisms.%A%    
% 214.86/215.02  |- skos__historyNote mesh__D016825 Chlamydomonas %28%1972-1991%29%
% 214.86/215.02  |- mesh__historyNote mesh__D016825 92   
% 214.86/215.02  |- mesh__dateRevised mesh__D016825 2003-07-09
% 214.86/215.02  |- skos__prefLabel mesh__D016027 Heart Transplantation
% 214.86/215.02  |- mesh__historyNote mesh__D016027 90; was HEART/transplantation 1966-89   
% 214.86/215.02  |- rdf__type mesh__D016027sskos__Concept
% 214.86/215.02  |- skos__hiddenLabel mesh__D016027 Transplantations, Cardiac
% 214.86/215.02  |- skos__hiddenLabel mesh__D016027 Cardiac Transplantations
% 214.86/215.02  |- mesh__dateEstablished mesh__D016027 1990-01-01
% 214.86/215.02  |- skos__altLabel mesh__D016027 Grafting, Heart
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D016027 2006
% 214.86/215.02  |- skos__scopeNote mesh__D016027
% 214.86/215.02       The transference of a heart from one human or animal to another.%A%    
% 214.86/215.02  |- mesh__dateCreated mesh__D016027 1989-05-25
% 214.86/215.02  |- skos__hiddenLabel mesh__D016027 Graftings, Heart
% 214.86/215.02  |- skos__historyNote mesh__D016027 Heart/transplantation %28%1966-1989%29%
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D016027 2005
% 214.86/215.02  |- skos__altLabel mesh__D016027 Cardiac Transplantation
% 214.86/215.02  |- mesh__recordOriginator mesh__D016027 PXP
% 214.86/215.02  |- skos__altLabel mesh__D016027 Transplantation, Heart
% 214.86/215.02  |- mesh__dateRevised mesh__D016027 2004-07-13
% 214.86/215.02  |- skos__altLabel mesh__D016027 Transplantation, Cardiac
% 214.86/215.02  |- skos__hiddenLabel mesh__D016027 Heart Transplantations
% 214.86/215.02  |- skos__broader mesh__D016027smesh__D006348
% 214.86/215.02  |- skos__hiddenLabel mesh__D016027 Heart Grafting
% 214.86/215.02  |- mesh__recordAuthorizer mesh__D016027 sjn
% 214.86/215.02  |- mesh__recordMaintainer mesh__D016027 sjn
% 214.86/215.02  |- skos__hiddenLabel mesh__D016027 Transplantations, Heart
% 214.86/215.02  |- mesh__publicMeSHNote mesh__D016027
% 214.86/215.02       90; was HEART/transplantation 1966-89   
% 214.86/215.02  |- skos__broader mesh__D016027smesh__D016377
% 214.86/215.02  |- skos__annotation mesh__D016027
% 214.86/215.02       do not use /util except by MeSH definition; do not coord with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; HEART-LUNG TRANSPLANTATION is also available%A%  
% 214.86/215.02  |- skos__hiddenLabel mesh__D016027 Heart Graftings
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002805 1998
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002805 1995
% 214.86/215.02  |- mesh__recordMaintainer mesh__D002805 TGC
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002805 1996
% 214.86/215.02  |- skos__historyNote mesh__D002805 Calcinosis %28%1966-1971%29%
% 214.86/215.02  |- mesh__publicMeSHNote mesh__D002805 72   
% 214.86/215.02  |- rdf__type mesh__D002805sskos__Concept
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002805 1999
% 214.86/215.02  |- mesh__dateRevised mesh__D002805 1994-01-25
% 214.86/215.02  |- skos__hiddenLabel mesh__D002805 Chondrocalcinoses
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002805 1997
% 214.86/215.02  |- mesh__recordOriginator mesh__D002805 NLM
% 214.86/215.02  |- skos__scopeNote mesh__D002805
% 214.86/215.02       Presence of calcium salts, especially calcium pyrophosphate, in the cartilaginous structures of one or more joints. When accompanied by attacks of goutlike symptoms, it is called pseudogout. %28%Dorland, 27th ed%29%%A%    
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002805 2000
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002805 2005
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002805 2003
% 214.86/215.02  |- skos__historyNote mesh__D002805 Joint Diseases %28%1966-1971%29%
% 214.86/215.02  |- skos__annotation mesh__D002805
% 214.86/215.02       a form of arthritis; note X ref: do not index under CALCIUM PYROPHOSPHATE unless particularly discussed%A%  
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002805 2006
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002805 2001
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002805 2004
% 214.86/215.02  |- mesh__dateCreated mesh__D002805 1999-01-01
% 214.86/215.02  |- skos__broader mesh__D002805smesh__D001168
% 214.86/215.02  |- mesh__dateEstablished mesh__D002805 1972-01-01
% 214.86/215.02  |- mesh__recordAuthorizer mesh__D002805 PLS
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002805 2002
% 214.86/215.02  |- skos__prefLabel mesh__D002805 Chondrocalcinosis
% 214.86/215.02  |- mesh__historyNote mesh__D002805 72   
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002007 2005
% 214.86/215.02  |- rdf__type mesh__D002007sskos__Concept
% 214.86/215.02  |- skos__scopeNote mesh__D002007
% 214.86/215.02       A disease of cattle caused by bacteria of the genus BRUCELLA leading to abortion in late pregnancy. BRUCELLA ABORTUS is the primary infective agent.%A%    
% 214.86/215.02  |- skos__broader mesh__D002007smesh__D002418
% 214.86/215.02  |- mesh__recordOriginator mesh__D002007 NLM
% 214.86/215.02  |- skos__altLabel mesh__D002007 Bang%27%s Disease
% 214.86/215.02  |- skos__annotation mesh__D002007
% 214.86/215.02       in cattle only: if transmitted to man, use BRUCELLOSIS for the human; don%27%t forget also CATTLE %28%NIM%29% %26% check tag ANIMALS%A%  
% 214.86/215.02  |- skos__altLabel mesh__D002007 Bang Disease
% 214.86/215.02  |- skos__broader mesh__D002007smesh__D002006
% 214.86/215.02  |- skos__hiddenLabel mesh__D002007 Bovine Brucelloses
% 214.86/215.02  |- mesh__dateRevised mesh__D002007 2003-07-30
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002007 2004
% 214.86/215.02  |- mesh__dateCreated mesh__D002007 1999-01-01
% 214.86/215.02  |- skos__prefLabel mesh__D002007 Brucellosis, Bovine
% 214.86/215.02  |- mesh__recordAuthorizer mesh__D002007 sjn
% 214.86/215.02  |- skos__broader mesh__D002007smesh__D000034
% 214.86/215.02  |- skos__hiddenLabel mesh__D002007 Brucelloses, Bovine
% 214.86/215.02  |- skos__hiddenLabel mesh__D002007 Bovine Brucellosis
% 214.86/215.02  |- skos__hiddenLabel mesh__D002007 Bangs Disease
% 214.86/215.02  |- skos__hiddenLabel mesh__D002007 Disease, Bang%27%s
% 214.86/215.02  |- skos__hiddenLabel mesh__D002007 Disease, Bang
% 214.86/215.02  |- mesh__recordMaintainer mesh__D002007 ags
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002007 2006
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D032492 2003
% 214.86/215.02  |- skos__annotation mesh__D032492
% 214.86/215.02       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.86/215.02  |- rdf__type mesh__D032492sskos__Concept
% 214.86/215.02  |- skos__altLabel mesh__D032492 Aspidium filix-mas
% 214.86/215.02  |- skos__scopeNote mesh__D032492
% 214.86/215.02       A plant genus of the family DRYOPTERIDACEAE. Members contain aspidin and filicic acid.%A%    
% 214.86/215.02  |- mesh__historyNote mesh__D032492 2003   
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D032492 2004
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D032492 2005
% 214.86/215.02  |- mesh__dateCreated mesh__D032492 2002-07-02
% 214.86/215.02  |- mesh__dateEstablished mesh__D032492 2003-01-01
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D032492 2006
% 214.86/215.02  |- skos__prefLabel mesh__D032492 Dryopteris
% 214.86/215.02  |- mesh__publicMeSHNote mesh__D032492 2003   
% 214.86/215.02  |- skos__altLabel mesh__D032492 Fern, Male
% 214.86/215.02  |- skos__altLabel mesh__D032492 Male Fern
% 214.86/215.02  |- skos__broader mesh__D032492smesh__D032491
% 214.86/215.02  |- mesh__dateEstablished mesh__D012435 1991-01-01
% 214.86/215.02  |- mesh__dateCreated mesh__D012435 1974-11-19
% 214.86/215.02  |- skos__historyNote mesh__D012435 Homocysteine %28%1972-1974%29%
% 214.86/215.02  |- skos__altLabel mesh__D012435 S Adenosylhomocysteine
% 214.86/215.02  |- skos__prefLabel mesh__D012435 S-Adenosylhomocysteine
% 214.86/215.02  |- mesh__recordMaintainer mesh__D012435 ssb
% 214.86/215.02  |- skos__broader mesh__D012435smesh__D006710
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D012435 2006
% 214.86/215.02  |- rdf__type mesh__D012435sskos__Concept
% 214.86/215.02  |- skos__hiddenLabel mesh__D012435 Adenosylhomocysteine, S
% 214.86/215.02  |- mesh__recordAuthorizer mesh__D012435 sjn
% 214.86/215.02  |- skos__scopeNote mesh__D012435
% 214.86/215.02       5%27%-S-%28%3-Amino-3-carboxypropyl%29%-5%27%-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions.%A%    
% 214.86/215.02  |- mesh__historyNote mesh__D012435
% 214.86/215.02       91%28%75%29%; was see under HOMOCYSTEINE 1975-90   
% 214.86/215.02  |- skos__broader mesh__D012435smesh__D000241
% 214.86/215.02  |- skos__historyNote mesh__D012435 Adenosine %28%1972-1974%29%
% 214.86/215.02  |- mesh__dateRevised mesh__D012435 2005-06-30
% 214.86/215.02  |- mesh__publicMeSHNote mesh__D012435
% 214.86/215.02       91; was see under HOMOCYSTEINE 1975-90   
% 214.86/215.02  |- mesh__recordOriginator mesh__D012435 NLM
% 214.86/215.02  |- skos__historyNote mesh__D017120 Nystagmus, Physiologic %28%1983-1992%29%
% 214.86/215.02  |- mesh__publicMeSHNote mesh__D017120 93   
% 214.86/215.02  |- mesh__historyNote mesh__D017120 93   
% 214.86/215.02  |- mesh__recordMaintainer mesh__D017120 nns
% 214.86/215.02  |- mesh__recordOriginator mesh__D017120 TGC
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D017120 2006
% 214.86/215.02  |- skos__prefLabel mesh__D017120 Nystagmus, Optokinetic
% 214.86/215.02  |- skos__scopeNote mesh__D017120
% 214.86/215.02       Normal nystagmus produced by looking at objects moving across the field of vision.%A%    
% 214.86/215.02  |- skos__broader mesh__D017120smesh__D009760
% 214.86/215.02  |- mesh__dateEstablished mesh__D017120 1993-01-01
% 214.86/215.02  |- skos__hiddenLabel mesh__D017120 Optokinetic Nystagmus
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D017120 2005
% 214.86/215.02  |- rdf__type mesh__D017120sskos__Concept
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D017120 2004
% 214.86/215.02  |- skos__historyNote mesh__D017120 Eye Movements %28%1966-1982%29%
% 214.86/215.02  |- mesh__dateCreated mesh__D017120 1992-05-22
% 214.86/215.02  |- mesh__dateRevised mesh__D017120 2003-07-09
% 214.86/215.02  |- mesh__recordAuthorizer mesh__D017120 sjn
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D003100 2006
% 214.86/215.02  |- rdf__type mesh__D003100sskos__Concept
% 214.86/215.02  |- mesh__historyNote mesh__D003100
% 214.86/215.02       91%28%75%29%; was see under RADIUS FRACTURES 1975-90   
% 214.86/215.02  |- skos__broader mesh__D003100smesh__D011885
% 214.86/215.02  |- skos__prefLabel mesh__D003100 Colles%27% Fracture
% 214.86/215.02  |- mesh__recordOriginator mesh__D003100 NLM
% 214.86/215.02  |- skos__scopeNote mesh__D003100
% 214.86/215.02       Fracture of the lower end of the radius in which the lower fragment is displaced posteriorly.%A%    
% 214.86/215.02  |- mesh__publicMeSHNote mesh__D003100
% 214.86/215.02       91; was see under RADIUS FRACTURES 1975-90   
% 214.86/215.02  |- skos__hiddenLabel mesh__D003100 Fracture, Colles%27%
% 214.86/215.02  |- mesh__dateRevised mesh__D003100 2005-06-30
% 214.86/215.02  |- skos__hiddenLabel mesh__D003100 Colles Fracture
% 214.86/215.02  |- mesh__dateEstablished mesh__D003100 1991-01-01
% 214.86/215.02  |- mesh__onlineNote mesh__D003100 search RADIUS FRACTURES 1966-74   
% 214.86/215.02  |- mesh__recordMaintainer mesh__D003100 ssb
% 214.86/215.02  |- skos__annotation mesh__D003100 a distal radius fracture   
% 214.86/215.02  |- mesh__dateCreated mesh__D003100 1999-01-01
% 214.86/215.02  |- mesh__recordAuthorizer mesh__D003100 sjn
% 214.86/215.02  |- skos__broader mesh__D012982Q000737smesh__D012982
% 214.86/215.02  |- mesh__preferredCombination mesh__D012982Q000737smesh__D012964Q000737
% 214.86/215.02  |- rdf__type mesh__D012982Q000737smesh__CompoundConcept
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D008394 2005
% 214.86/215.02  |- skos__altLabel mesh__D008394 Metatheria
% 214.86/215.02  |- skos__hiddenLabel mesh__D008394 Marsupial
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D008394 2006
% 214.86/215.02  |- skos__altLabel mesh__D008394 Marsupials
% 214.86/215.02  |- mesh__dateRevised mesh__D008394 2004-07-07
% 214.86/215.02  |- mesh__recordAuthorizer mesh__D008394 sjn
% 214.86/215.02  |- skos__broader mesh__D008394smesh__D008322
% 214.86/215.02  |- rdf__type mesh__D008394sskos__Concept
% 214.86/215.02  |- mesh__recordOriginator mesh__D008394 NLM
% 214.86/215.02  |- mesh__recordMaintainer mesh__D008394 ags
% 214.86/215.02  |- skos__prefLabel mesh__D008394 Marsupialia
% 214.86/215.02  |- mesh__dateCreated mesh__D008394 1999-01-01
% 214.86/215.02  |- skos__scopeNote mesh__D008394
% 214.86/215.02       An infraclass of MAMMALS, also called Metatheria, where the young are born at an early stage of development and continue to develop in a pouch %28%marsupium%29%. In contrast to Eutheria %28%placentals%29%, marsupials have an incomplete PLACENTA.%A%    
% 214.86/215.02  |- mesh__dateEstablished mesh__D016826 1992-01-01
% 214.86/215.02  |- mesh__recordMaintainer mesh__D016826 ags
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D016826 2005
% 214.86/215.02  |- mesh__publicMeSHNote mesh__D016826
% 214.86/215.02       92; CHILOMASTIX was see MASTIGOPHORA 1986-91, was heading 1963-85%A%  
% 214.86/215.02  |- rdf__type mesh__D016826sskos__Concept
% 214.86/215.02  |- skos__annotation mesh__D016826 a class of protozoa   
% 214.86/215.02  |- mesh__dateRevised mesh__D016826 2003-07-09
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D016826 2004
% 214.86/215.02  |- mesh__recordOriginator mesh__D016826 PXP
% 214.86/215.02  |- mesh__recordAuthorizer mesh__D016826 sjn
% 214.86/215.02  |- skos__scopeNote mesh__D016826
% 214.86/215.02       A class of protozoa consisting of animal-like flagellates. Its organisms are heterotrophic and have one-to-many flagella. This class includes one superorder, Parabasalidea, and six orders: Choanoflagellida, KINETOPLASTIDA, Proteromonadida, Retortamonadida, DIPLOMONADIDA, and Oxymonadida.%A%    
% 214.86/215.02  |- mesh__onlineNote mesh__D016826
% 214.86/215.02       use MASTIGOPHORA to search CHILOMASTIX 1966-91   
% 214.86/215.02  |- mesh__historyNote mesh__D016826
% 214.86/215.02       92; CHILOMASTIX was see MASTIGOPHORA 1986-91, was heading 1963-85%A%  
% 214.86/215.02  |- skos__broader mesh__D016826smesh__D008412
% 214.86/215.02  |- skos__prefLabel mesh__D016826 Zoomastigophora
% 214.86/215.02  |- mesh__dateCreated mesh__D016826 1991-05-02
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D016826 2006
% 214.86/215.02  |- skos__hiddenLabel mesh__D016028 Family, Leu-CAM Receptor
% 214.86/215.02  |- mesh__recordAuthorizer mesh__D016028 sjn
% 214.86/215.02  |- skos__related mesh__D016028smesh__D018370
% 214.86/215.02  |- mesh__dateEstablished mesh__D016028 1990-01-01
% 214.86/215.02  |- skos__hiddenLabel mesh__D016028 Leukocyte Adhesion Receptor Family
% 214.86/215.02  |- skos__prefLabel mesh__D016028 Receptors, Leukocyte-Adhesion
% 214.86/215.02  |- skos__hiddenLabel mesh__D016028 Leukocyte Adhesion Receptors
% 214.86/215.02  |- mesh__recordMaintainer mesh__D016028 jmp
% 214.86/215.02  |- skos__altLabel mesh__D016028 Leukocyte-Adhesion Receptor
% 214.86/215.02  |- skos__scopeNote mesh__D016028
% 214.86/215.02       Family of proteins associated with the capacity of LEUKOCYTES to adhere to each other and to certain substrata, e.g., the C3bi component of complement. Members of this family are the LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; %28%LFA-1%29%, the MACROPHAGE-1 ANTIGEN; %28%Mac-1%29%, and the INTEGRIN ALPHAXBETA2 or p150,95 leukocyte adhesion protein. They all share a common beta-subunit which is the CD18 antigen. All three of the above antigens are absent in inherited LEUKOCYTE-ADHESION DEFICIENCY SYNDROME, which is characterized by recurrent bacterial infections, impaired pus formation, and wound healing as well as abnormalities in a wide spectrum of adherence-dependent functions of granulocytes, monocytes, and lymphoid cells.%A%    
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D016028 2006
% 214.86/215.02  |- skos__historyNote mesh__D016028
% 214.86/215.02       Antigens, Differentiation %28%1988-1989%29%
% 214.86/215.02  |- skos__hiddenLabel mesh__D016028 Leu CAM Receptor Family
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D016028 2004
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D016028 2005
% 214.86/215.02  |- skos__broader mesh__D016028smesh__D016023
% 214.86/215.02  |- skos__hiddenLabel mesh__D016028 Receptor Family, Leu-CAM
% 214.86/215.02  |- skos__historyNote mesh__D016028 Antigens %28%1966-1987%29%
% 214.86/215.02  |- skos__altLabel mesh__D016028 Leukocyte-Adhesion Receptor Family
% 214.86/215.02  |- skos__annotation mesh__D016028
% 214.86/215.02       /defic: consider LEUKOCYTE-ADHESION DEFICIENCY SYNDROME; DF: RECEPT LEUKOCYTE ADHESION%A%  
% 214.86/215.02  |- skos__historyNote mesh__D016028 Receptors, Immunologic %28%1980-1989%29%
% 214.86/215.02  |- skos__hiddenLabel mesh__D016028 Receptor, Leukocyte-Adhesion
% 214.86/215.02  |- mesh__recordOriginator mesh__D016028 RLS
% 214.86/215.02  |- skos__altLabel mesh__D016028 Leukocyte-Adhesion Receptors
% 214.86/215.02  |- mesh__dateRevised mesh__D016028 2003-07-09
% 214.86/215.02  |- skos__altLabel mesh__D016028 Leu-CAM Receptor Family
% 214.86/215.02  |- mesh__publicMeSHNote mesh__D016028 90   
% 214.86/215.02  |- skos__hiddenLabel mesh__D016028 Receptors, Leukocyte Adhesion
% 214.86/215.02  |- mesh__historyNote mesh__D016028 90   
% 214.86/215.02  |- mesh__dateCreated mesh__D016028 1989-07-07
% 214.86/215.02  |- rdf__type mesh__D016028sskos__Concept
% 214.86/215.02  |- skos__historyNote mesh__D016028
% 214.86/215.02       Receptors, Cell Surface %28%1973-1989%29%
% 214.86/215.02  |- skos__hiddenLabel mesh__D016028 Leukocyte Adhesion Receptor
% 214.86/215.02  |- mesh__recordAuthorizer mesh__D002806 ags
% 214.86/215.02  |- mesh__dateRevised mesh__D002806 2005-07-18
% 214.86/215.02  |- rdf__type mesh__D002806sskos__Concept
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002806 2002
% 214.86/215.02  |- mesh__activeMeSHYear mesh__D002806 2006B
% 214.86/215.02  |- skos__altLabel mesh__D002806 Dysplasia Epiphysialis Punctata
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D002806 1997
% 214.86/215.03  |- skos__altLabel mesh__D002806 Chondrodystrophia Calcificans Congenita
% 214.86/215.03  |- mesh__historyNote mesh__D002806
% 214.86/215.03       85; was CHONDRODYSTROPHIA CALCIFICANS CONGENITA 1964-84 %28%Prov 1964-66%29%%A%  
% 214.86/215.03  |- skos__hiddenLabel mesh__D002806 Conradi Hunermann Syndrome
% 214.86/215.03  |- skos__hiddenLabel mesh__D002806 Syndrome, Conradi-Hunermann
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D002806 2005
% 214.86/215.03  |- skos__hiddenLabel mesh__D002806 Syndrome, Hunermann-Conradi
% 214.86/215.03  |- skos__altLabel mesh__D002806 Epiphyses, Stippled
% 214.86/215.03  |- mesh__recordMaintainer mesh__D002806 ags
% 214.86/215.03  |- mesh__onlineNote mesh__D002806
% 214.86/215.03       use CHONDRODYSPLASIA PUNCTATA to search CHONDRODYSTROPHIA CALCIFICANS CONGENITA 1966-84 %28%as Prov 1966%29%%A%  
% 214.86/215.03  |- skos__altLabel mesh__D002806 Stippled Epiphyses
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D002806 2003
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D002806 2006
% 214.86/215.03  |- mesh__dateEstablished mesh__D002806 1967-01-01
% 214.86/215.03  |- skos__prefLabel mesh__D002806 Chondrodysplasia Punctata
% 214.86/215.03  |- mesh__recordOriginator mesh__D002806 NLM
% 214.86/215.03  |- skos__annotation mesh__D002806
% 214.86/215.03       spell entry term name Hunermann with an umlaut in titles %26% translations; CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC is also available%A%  
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D002806 2004
% 214.86/215.03  |- mesh__dateCreated mesh__D002806 1999-01-01
% 214.86/215.03  |- skos__scopeNote mesh__D002806
% 214.86/215.03       A heterogeneous group of bone dysplasias, the common character of which is stippling of the epiphyses in infancy. The group includes a severe autosomal recessive form %28%CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC%29%, an autosomal dominant form %28%Conradi-Hunermann syndrome%29%, and a milder X-linked form. Metabolic defects associated with impaired peroxisomes are present only in the rhizomelic form.%A%    
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D002806 1998
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D002806 2000
% 214.86/215.03  |- mesh__publicMeSHNote mesh__D002806
% 214.86/215.03       85; was CHONDRODYSTROPHIA CALCIFICANS CONGENITA 1967-84   
% 214.86/215.03  |- skos__altLabel mesh__D002806 Conradi-Hunermann Syndrome
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D002806 2001
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D002806 2006A
% 214.86/215.03  |- skos__hiddenLabel mesh__D002806 Hunermann Conradi Syndrome
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D002806 1999
% 214.86/215.03  |- skos__broader mesh__D002806smesh__D010009
% 214.86/215.03  |- skos__altLabel mesh__D032493 Fern, Giant Holly
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D032493 2006
% 214.86/215.03  |- mesh__publicMeSHNote mesh__D032493 2003   
% 214.86/215.03  |- skos__broader mesh__D032493smesh__D032491
% 214.86/215.03  |- mesh__dateCreated mesh__D032493 2002-07-03
% 214.86/215.03  |- mesh__historyNote mesh__D032493 2003   
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D032493 2003
% 214.86/215.03  |- skos__annotation mesh__D032493
% 214.86/215.03       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.86/215.03  |- rdf__type mesh__D032493sskos__Concept
% 214.86/215.03  |- mesh__dateEstablished mesh__D032493 2003-01-01
% 214.86/215.03  |- skos__scopeNote mesh__D032493
% 214.86/215.03       A plant genus of the family DRYOPTERIDACEAE.     
% 214.86/215.03  |- skos__prefLabel mesh__D032493 Polystichum
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D032493 2004
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D032493 2005
% 214.86/215.03  |- skos__prefLabel mesh__D048908 Vibrio fischeri
% 214.86/215.03  |- rdf__type mesh__D048908sskos__Concept
% 214.86/215.03  |- mesh__historyNote mesh__D048908 2005   
% 214.86/215.03  |- mesh__publicMeSHNote mesh__D048908 2005   
% 214.86/215.03  |- mesh__recordOriginator mesh__D048908 ags
% 214.86/215.03  |- mesh__recordAuthorizer mesh__D048908 sjn
% 214.86/215.03  |- skos__historyNote mesh__D048908 Vibrio %28%1975-2004%29%
% 214.86/215.03  |- mesh__dateRevised mesh__D048908 2005-06-30
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D048908 2006
% 214.86/215.03  |- skos__scopeNote mesh__D048908
% 214.86/215.03       A species of gram-negative bacteria in the genus VIBRIO, which exhibits LUMINESCENCE. V. fischeri is found in a symbiotic relationship with the SQUID Euprymna scolopes.%A%    
% 214.86/215.03  |- mesh__recordMaintainer mesh__D048908 SYSTEM
% 214.86/215.03  |- mesh__dateCreated mesh__D048908 2004-07-07
% 214.86/215.03  |- mesh__dateEstablished mesh__D048908 2005-01-01
% 214.86/215.03  |- skos__broader mesh__D048908smesh__D014733
% 214.86/215.03  |- skos__hiddenLabel mesh__D012436 FO1561
% 214.86/215.03  |- mesh__historyNote mesh__D012436 73%28%71%29%   
% 214.86/215.03  |- rdf__type mesh__D012436sskos__Concept
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D012436 2006
% 214.86/215.03  |- skos__hiddenLabel mesh__D012436 Amet, S
% 214.86/215.03  |- skos__altLabel mesh__D012436
% 214.86/215.03       ASTA Medica Brand of Ademetionine Tosilate Disulfate
% 214.86/215.03  |- skos__annotation mesh__D012436
% 214.86/215.03       /biosyn /physiol permitted; DF: note short X ref   
% 214.86/215.03  |- mesh__dateRevised mesh__D012436 2005-06-30
% 214.86/215.03  |- skos__broader mesh__D012436smesh__D000241
% 214.86/215.03  |- skos__altLabel mesh__D012436
% 214.86/215.03       Knoll Brand of Brand of Ademetionine Tosilate Disulfate
% 214.86/215.03  |- skos__scopeNote mesh__D012436
% 214.86/215.03       Physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease. %28%From Merck, 11th ed%29%%A%    
% 214.86/215.03  |- mesh__dateEstablished mesh__D012436 1973-01-01
% 214.86/215.03  |- mesh__recordOriginator mesh__D012436 NLM
% 214.86/215.03  |- skos__historyNote mesh__D012436 Adenosine %28%1966-1970%29%
% 214.86/215.03  |- mesh__publicMeSHNote mesh__D012436 73   
% 214.86/215.03  |- skos__hiddenLabel mesh__D012436 Tosylate, S-Adenosylmethionine Sulfate
% 214.86/215.03  |- skos__hiddenLabel mesh__D012436 Ademetionine Europharma Brand
% 214.86/215.03  |- skos__altLabel mesh__D012436 AdoMet
% 214.86/215.03  |- skos__altLabel mesh__D012436 Europharma Brand of Ademetionine
% 214.86/215.03  |- skos__hiddenLabel mesh__D012436 S Adenosylmethionine
% 214.86/215.03  |- skos__prefLabel mesh__D012436 S-Adenosylmethionine
% 214.86/215.03  |- mesh__recordMaintainer mesh__D012436 ssb
% 214.86/215.03  |- skos__broader mesh__D012436smesh__D008715
% 214.86/215.03  |- skos__historyNote mesh__D012436 Methionine %28%1966-1970%29%
% 214.86/215.03  |- skos__altLabel mesh__D012436 Ademetionine
% 214.86/215.03  |- skos__hiddenLabel mesh__D012436 FO 1561
% 214.86/215.03  |- skos__hiddenLabel mesh__D012436 Sulfate Tosylate, S-Adenosylmethionine
% 214.86/215.03  |- mesh__dateCreated mesh__D012436 1999-01-01
% 214.86/215.03  |- skos__hiddenLabel mesh__D012436 S Adenosylmethionine Sulfate Tosylate
% 214.86/215.03  |- mesh__recordAuthorizer mesh__D012436 sjn
% 214.86/215.03  |- skos__broader mesh__D017121smesh__D017094
% 214.86/215.03  |- mesh__dateCreated mesh__D017121 1992-05-22
% 214.86/215.03  |- mesh__dateRevised mesh__D017121 2005-07-18
% 214.86/215.03  |- skos__annotation mesh__D017121
% 214.86/215.03        do not confuse with  PORPHYRIAS, HEPATIC or PORPHYRIA, ERYTHROPOIETIC%A%  
% 214.86/215.03  |- skos__prefLabel mesh__D017121 Porphyria, Hepatoerythropoietic
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D017121 2006
% 214.86/215.03  |- skos__altLabel mesh__D017121 Hepatoerythropoietic Porphyria
% 214.86/215.03  |- mesh__recordAuthorizer mesh__D017121 ags
% 214.86/215.03  |- skos__hiddenLabel mesh__D017121 Porphyrias, Erythrohepatic
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D017121 2005
% 214.86/215.03  |- skos__scopeNote mesh__D017121
% 214.86/215.03       An autosomal recessive cutaneous porphyria that is due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in both the LIVER and the BONE MARROW. Similar to PORPHYRIA CUTANEA TARDA, this disorder is caused by defects in the fifth enzyme in the 8-enzyme biosynthetic pathway of HEME, but is a homozygous enzyme deficiency with less than 10%25% of the normal enzyme activity. Cutaneous lesions are severe and mutilating.%A%    
% 214.86/215.03  |- rdf__type mesh__D017121sskos__Concept
% 214.86/215.03  |- skos__hiddenLabel mesh__D017121 Erythrohepatic Porphyrias
% 214.86/215.03  |- mesh__recordMaintainer mesh__D017121 ags
% 214.86/215.03  |- mesh__historyNote mesh__D017121 2005 %28%1993%29%   
% 214.86/215.03  |- skos__hiddenLabel mesh__D017121 Porphyrias, Hepatoerythropoietic
% 214.86/215.03  |- skos__altLabel mesh__D017121 Porphyria, Erythrohepatic
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D017121 2006A
% 214.86/215.03  |- mesh__publicMeSHNote mesh__D017121
% 214.86/215.03       2005; see PORPHYRIA, ERYTHROHEPATIC 1993-2004   
% 214.86/215.03  |- skos__hiddenLabel mesh__D017121 Erythrohepatic Porphyria
% 214.86/215.03  |- mesh__dateEstablished mesh__D017121 1993-01-01
% 214.86/215.03  |- skos__historyNote mesh__D017121 Porphyria %28%1966-1992%29%
% 214.86/215.03  |- mesh__recordOriginator mesh__D017121 PXP
% 214.86/215.03  |- skos__hiddenLabel mesh__D017121 Hepatoerythropoietic Porphyrias
% 214.86/215.03  |- rdf__type mesh__D003101sskos__Concept
% 214.86/215.03  |- skos__annotation mesh__D003101 a pharmaceutic aid; D25-26 qualif   
% 214.86/215.03  |- skos__altLabel mesh__D003101 Pyroxylin
% 214.86/215.03  |- mesh__recordAuthorizer mesh__D003101 sjn
% 214.86/215.03  |- mesh__dateCreated mesh__D003101 1999-01-01
% 214.86/215.03  |- skos__hiddenLabel mesh__D003101 Cotton, Collodion
% 214.86/215.03  |- skos__hiddenLabel mesh__D003101 Nitrate, Cellulose
% 214.86/215.03  |- skos__prefLabel mesh__D003101 Collodion
% 214.86/215.03  |- skos__altLabel mesh__D003101 Cellulose Nitrate
% 214.86/215.03  |- skos__scopeNote mesh__D003101
% 214.86/215.03       A nitrocellulose solution in ether and alcohol. Collodion has a wide range of uses in industry including applications in the manufacture of photographic film, in fibers, in lacquers, and in engraving and lithography. In medicine it is used as a drug solvent and a wound sealant.%A%    
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D003101 2006
% 214.86/215.03  |- mesh__recordMaintainer mesh__D003101 jmp
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D003101 2005
% 214.86/215.03  |- mesh__recordOriginator mesh__D003101 NLM
% 214.86/215.03  |- skos__broader mesh__D003101smesh__D002482
% 214.86/215.03  |- mesh__dateRevised mesh__D003101 2004-07-19
% 214.86/215.03  |- skos__broader mesh__D012812Q000295smesh__D012812
% 214.86/215.03  |- mesh__preferredCombination mesh__D012812Q000295smesh__D020694
% 214.86/215.03  |- rdf__type mesh__D012812Q000295smesh__CompoundConcept
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D008395 1999
% 214.86/215.03  |- rdf__type mesh__D008395sskos__Concept
% 214.86/215.03  |- skos__broader mesh__D008395smesh__D014900
% 214.86/215.03  |- mesh__historyNote mesh__D008395 75   
% 214.86/215.03  |- mesh__recordAuthorizer mesh__D008395 PLS
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D008395 2000
% 214.86/215.03  |- mesh__dateEstablished mesh__D008395 1975-01-01
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D008395 2003
% 214.86/215.03  |- skos__scopeNote mesh__D008395
% 214.86/215.03       An island in the Lesser Antilles, one of the Windward Islands. Its capital is Fort-de-France. It was discovered by Columbus in 1502 and from its settlement in 1635 by the French it passed into and out of Dutch and British hands. It was made a French overseas department in 1946. One account of the name tells of native women on the shore calling %22%Madinina%22% as Columbus approached the island. The meaning was never discovered but was entered on early charts as Martinique, influenced by the name of St. Martin. %28%From Webster%27%s New Geographical Dictionary, 1988, p734 %26% Room, Brewer%27%s Dictionary of Names, 1992, p339%29%%A%    
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D008395 2001
% 214.86/215.03  |- mesh__dateRevised mesh__D008395 1995-02-21
% 214.86/215.03  |- mesh__recordMaintainer mesh__D008395 TGC
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D008395 2005
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D008395 1996
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D008395 2004
% 214.86/215.03  |- skos__annotation mesh__D008395
% 214.86/215.03       an island in the Lesser Antilles in the West Indies   
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D008395 2006
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D008395 1998
% 214.86/215.03  |- skos__prefLabel mesh__D008395 Martinique
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D008395 1997
% 214.86/215.03  |- mesh__dateCreated mesh__D008395 1974-11-11
% 214.86/215.03  |- mesh__recordOriginator mesh__D008395 NLM
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D008395 2002
% 214.86/215.03  |- mesh__recordMaintainer mesh__D016827 ssb
% 214.86/215.03  |- rdf__type mesh__D016827sskos__Concept
% 214.86/215.03  |- mesh__onlineNote mesh__D016827
% 214.86/215.03       use ANTIGENS, CD8 %28%NM%29% to search CD8 ANTIGEN %28%NM%29% 1988-91%A%  
% 214.86/215.03  |- skos__broader mesh__D016827smesh__D015703
% 214.86/215.03  |- skos__hiddenLabel mesh__D016827 Antigen, CD8
% 214.86/215.03  |- mesh__recordOriginator mesh__D016827 AGS
% 214.86/215.03  |- mesh__dateEstablished mesh__D016827 1992-01-01
% 214.86/215.03  |- skos__annotation mesh__D016827 T-lymphocyte differentiation antigens   
% 214.86/215.03  |- skos__hiddenLabel mesh__D016827 Leu 2 Antigens
% 214.86/215.03  |- skos__prefLabel mesh__D016827 Antigens, CD8
% 214.86/215.03  |- skos__historyNote mesh__D016827 Antigens, Surface %28%1985-1991%29%
% 214.86/215.03  |- mesh__dateCreated mesh__D016827 1991-07-12
% 214.86/215.03  |- skos__altLabel mesh__D016827 CD8 Antigens
% 214.86/215.03  |- skos__related mesh__D016827smesh__D016516
% 214.86/215.03  |- skos__hiddenLabel mesh__D016827 T-Cell T8 Antigens
% 214.86/215.03  |- mesh__publicMeSHNote mesh__D016827
% 214.86/215.03       92; CD8 ANTIGEN was indexed under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-91%A%  
% 214.86/215.03  |- mesh__dateRevised mesh__D016827 2005-06-30
% 214.86/215.03  |- skos__scopeNote mesh__D016827
% 214.86/215.03       Differentiation antigens found on thymocytes and on cytotoxic and suppressor T-lymphocytes. CD8 antigens are members of the immunoglobulin supergene family and are associative recognition elements in MHC %28%Major Histocompatibility Complex%29% Class I-restricted interactions.%A%    
% 214.86/215.03  |- skos__historyNote mesh__D016827
% 214.86/215.03       Antigens, Differentiation, T-Lymphocyte %28%1986-1991%29%
% 214.86/215.03  |- skos__altLabel mesh__D016827 Leu-2 Antigens
% 214.86/215.03  |- mesh__recordAuthorizer mesh__D016827 sjn
% 214.86/215.03  |- skos__hiddenLabel mesh__D016827 T8 Antigens, T Cell
% 214.86/215.03  |- skos__hiddenLabel mesh__D016827 Antigens, T-Cell T8
% 214.86/215.03  |- skos__hiddenLabel mesh__D016827 Antigens, Leu-2
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D016827 2006
% 214.86/215.03  |- mesh__historyNote mesh__D016827
% 214.86/215.03       92; was CD8 ANTIGEN %28%NM%29% 1988-91   
% 214.86/215.03  |- skos__broader mesh__D016827smesh__D000945
% 214.86/215.03  |- skos__altLabel mesh__D016827 T8 Antigens, T-Cell
% 214.86/215.03  |- skos__altLabel mesh__D016827 CD8 Antigen
% 214.86/215.03  |- skos__hiddenLabel mesh__D016029 Protein Complex, VLA
% 214.86/215.03  |- skos__altLabel mesh__D016029 Very Late Antigen Receptors
% 214.86/215.03  |- skos__altLabel mesh__D016029 VLA Activation Antigens
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D016029 2006
% 214.86/215.03  |- mesh__dateCreated mesh__D016029 1989-07-07
% 214.86/215.03  |- skos__annotation mesh__D016029 DF: RECEPT VLA   
% 214.86/215.03  |- skos__hiddenLabel mesh__D016029 Antigens, VLA Differentiation
% 214.86/215.03  |- skos__altLabel mesh__D016029 Receptors, Very Late Activation Antigen
% 214.86/215.03  |- skos__altLabel mesh__D016029 Very Late Activation Antigen Receptors
% 214.86/215.03  |- skos__historyNote mesh__D016029 Receptors, Immunologic %28%1980-1989%29%
% 214.86/215.03  |- skos__altLabel mesh__D016029 VLA Receptors
% 214.86/215.03  |- skos__hiddenLabel mesh__D016029 Activation Antigens, VLA
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D016029 2004
% 214.86/215.03  |- skos__altLabel mesh__D016029 VLA Protein Complex
% 214.86/215.03  |- mesh__recordOriginator mesh__D016029 RLS
% 214.86/215.03  |- skos__hiddenLabel mesh__D016029 Antigens, VLA Activation
% 214.86/215.03  |- mesh__recordAuthorizer mesh__D016029 sjn
% 214.86/215.03  |- skos__altLabel mesh__D016029 Receptors, VLA
% 214.86/215.03  |- mesh__historyNote mesh__D016029 90   
% 214.86/215.03  |- skos__hiddenLabel mesh__D016029 Differentiation Antigens, VLA
% 214.86/215.03  |- skos__broader mesh__D016029smesh__D016023
% 214.86/215.03  |- skos__historyNote mesh__D016029 Antigens, Surface %28%1978-1989%29%
% 214.86/215.03  |- skos__scopeNote mesh__D016029
% 214.86/215.03       Members of the integrin family appearing late after T-cell activation. They are a family of proteins initially identified at the surface of stimulated T-cells, but now identified on a variety of cell types. At least six VLA antigens have been identified as heterodimeric adhesion receptors consisting of a single common beta-subunit and different alpha-subunits.%A%    
% 214.86/215.03  |- mesh__publicMeSHNote mesh__D016029 90   
% 214.86/215.03  |- skos__historyNote mesh__D016029
% 214.86/215.03       Antigens, Differentiation %28%1988-1989%29%
% 214.86/215.03  |- skos__altLabel mesh__D016029 VLA Differentiation Antigens
% 214.86/215.03  |- skos__prefLabel mesh__D016029 Receptors, Very Late Antigen
% 214.86/215.03  |- mesh__dateEstablished mesh__D016029 1990-01-01
% 214.86/215.03  |- mesh__dateRevised mesh__D016029 2003-07-09
% 214.86/215.03  |- mesh__recordMaintainer mesh__D016029 jmp
% 214.86/215.03  |- skos__historyNote mesh__D016029
% 214.86/215.03       Receptors, Endogenous Substances %28%1973-1989%29%
% 214.86/215.03  |- rdf__type mesh__D016029sskos__Concept
% 214.86/215.03  |- skos__altLabel mesh__D016029 Receptor, Very Late Antigen
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D016029 2005
% 214.86/215.03  |- mesh__recordOriginator mesh__D002807 NLM
% 214.86/215.03  |- rdf__type mesh__D002807sskos__Concept
% 214.86/215.03  |- skos__annotation mesh__D002807
% 214.86/215.03       /biosyn /physiol permitted; CHONDROITIN SULFATE B see DERMATAN SULFATE is available%A%  
% 214.86/215.03  |- mesh__recordMaintainer mesh__D002807 ssb
% 214.86/215.03  |- skos__prefLabel mesh__D002807 Chondroitin
% 214.86/215.03  |- mesh__dateRevised mesh__D002807 2004-07-07
% 214.86/215.03  |- skos__scopeNote mesh__D002807
% 214.86/215.03       A mucopolysaccharide constituent of chondrin. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 214.86/215.03  |- mesh__dateCreated mesh__D002807 1999-01-01
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D002807 2006
% 214.86/215.03  |- skos__broader mesh__D002807smesh__D006025
% 214.86/215.03  |- mesh__recordAuthorizer mesh__D002807 sjn
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D002807 2005
% 214.86/215.03  |- mesh__recordAuthorizer mesh__D002009 sjn
% 214.86/215.03  |- skos__annotation mesh__D002009
% 214.86/215.03       infection: check text for probable lymphatic involvement %26% coord IM with ELEPHANTIASIS, FILARIAL %28%IM%29%; coord with specific helminth term %28%ANTIGENS, HELMINTH, etc%29% if pertinent; /drug eff: consider FILARICIDES%A%  
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D002009 2006
% 214.86/215.03  |- skos__prefLabel mesh__D002009 Brugia
% 214.86/215.03  |- mesh__dateRevised mesh__D002009 2003-07-09
% 214.86/215.03  |- mesh__onlineNote mesh__D002009 search FILARIOIDEA 1969-74   
% 214.86/215.03  |- mesh__recordMaintainer mesh__D002009 ags
% 214.86/215.03  |- skos__scopeNote mesh__D002009
% 214.86/215.03       A filarial worm of Southeast Asia, producing filariasis and elephantiasis in various mammals including man. It was formerly included in the genus WUCHERERIA.%A%    
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D002009 2005
% 214.86/215.03  |- mesh__dateEstablished mesh__D002009 1986-01-01
% 214.86/215.03  |- rdf__type mesh__D002009sskos__Concept
% 214.86/215.03  |- mesh__publicMeSHNote mesh__D002009
% 214.86/215.03       86; was see under FILARIOIDEA 1969-85   
% 214.86/215.03  |- skos__broader mesh__D002009smesh__D005370
% 214.86/215.03  |- mesh__recordOriginator mesh__D002009 NLM
% 214.86/215.03  |- mesh__historyNote mesh__D002009
% 214.86/215.03       86%28%75%29%; was see under FILARIOIDEA 1969-85   
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D002009 2004
% 214.86/215.03  |- mesh__dateCreated mesh__D002009 1999-01-01
% 214.86/215.03  |- mesh__publicMeSHNote mesh__D032494 2003   
% 214.86/215.03  |- skos__broader mesh__D032494smesh__D029621
% 214.86/215.03  |- skos__altLabel mesh__D032494 Fern, Licorice
% 214.86/215.03  |- skos__prefLabel mesh__D032494 Polypodium
% 214.86/215.03  |- skos__annotation mesh__D032494
% 214.86/215.03       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D032494 2003
% 214.86/215.03  |- rdf__type mesh__D032494sskos__Concept
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D032494 2004
% 214.86/215.03  |- mesh__dateCreated mesh__D032494 2002-07-03
% 214.86/215.03  |- skos__altLabel mesh__D032494 Fern, Calaguala
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D032494 2005
% 214.86/215.03  |- mesh__historyNote mesh__D032494 2003   
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D032494 2006
% 214.86/215.03  |- mesh__dateEstablished mesh__D032494 2003-01-01
% 214.86/215.03  |- skos__scopeNote mesh__D032494
% 214.86/215.03       A plant genus of the family POLYPODIACEAE. Members contain polypodoside.%A%    
% 214.86/215.03  |- skos__prefLabel mesh__D048909 Diabetes Complications
% 214.86/215.03  |- skos__altLabel mesh__D048909 Diabetic Complications
% 214.86/215.03  |- mesh__publicMeSHNote mesh__D048909 2005   
% 214.86/215.03  |- mesh__dateEstablished mesh__D048909 2005-01-01
% 214.86/215.03  |- skos__hiddenLabel mesh__D048909 Diabetes Mellitus Complication
% 214.86/215.03  |- skos__historyNote mesh__D048909
% 214.86/215.03       Diabetes Mellitus/complications %28%1965-2004%29%
% 214.86/215.03  |- skos__broader mesh__D048909smesh__D003920
% 214.86/215.03  |- skos__hiddenLabel mesh__D048909 Diabetes-Related Complication
% 214.86/215.03  |- skos__hiddenLabel mesh__D048909 Diabetic Complication
% 214.86/215.03  |- skos__altLabel mesh__D048909 Diabetes-Related Complications
% 214.86/215.03  |- skos__annotation mesh__D048909
% 214.86/215.03       general only; prefer /compl with specific type of diabetes + specific complication: Manual 23.25.3.1%A%  
% 214.86/215.03  |- mesh__historyNote mesh__D048909 2005   
% 214.86/215.03  |- mesh__recordMaintainer mesh__D048909 lkt
% 214.86/215.03  |- skos__scopeNote mesh__D048909
% 214.86/215.03       Conditions or pathological processes associated with the disease of diabetes mellitus. Due to the impaired control of BLOOD GLUCOSE level in diabetic patients, pathological processes develop in numerous tissues and organs including the EYE, the KIDNEY, the BLOOD VESSELS, and the NERVE TISSUE.%A%    
% 214.86/215.03  |- skos__altLabel mesh__D048909 Complications of Diabetes Mellitus
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D048909 2006
% 214.86/215.03  |- skos__hiddenLabel mesh__D048909 Diabetes Mellitus Complications
% 214.86/215.03  |- skos__hiddenLabel mesh__D048909 Diabetes Complication
% 214.86/215.03  |- mesh__dateCreated mesh__D048909 2004-07-07
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D048909 2005
% 214.86/215.03  |- rdf__type mesh__D048909sskos__Concept
% 214.86/215.03  |- mesh__recordAuthorizer mesh__D048909 sjn
% 214.86/215.03  |- skos__hiddenLabel mesh__D048909 Diabetes Related Complications
% 214.86/215.03  |- mesh__recordOriginator mesh__D048909 lkt
% 214.86/215.03  |- skos__historyNote mesh__D012437 S-Adenosylmethionine %28%1972-1974%29%
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D012437 2005
% 214.86/215.03  |- skos__hiddenLabel mesh__D012437 Decarboxylase, S-Adenosylmethionine
% 214.86/215.03  |- mesh__recordAuthorizer mesh__D012437 sjn
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D012437 2004
% 214.86/215.03  |- mesh__publicMeSHNote mesh__D012437
% 214.86/215.03       98; see S-ADENOSYLMETHIONINE DECARBOXYLASE 1991-97, see CARBOXY-LYASES 1975-90%A%  
% 214.86/215.03  |- skos__broader mesh__D012437smesh__D002262
% 214.86/215.03  |- mesh__dateCreated mesh__D012437 1974-11-19
% 214.86/215.03  |- skos__altLabel mesh__D012437 S-Adenosylmethionine Decarboxylase
% 214.86/215.03  |- mesh__dateRevised mesh__D012437 2003-07-09
% 214.86/215.03  |- mesh__recordOriginator mesh__D012437 NLM
% 214.86/215.03  |- skos__historyNote mesh__D012437 Carboxy-Lyases %28%1970-1974%29%
% 214.86/215.03  |- mesh__dateEstablished mesh__D012437 1991-01-01
% 214.86/215.03  |- mesh__historyNote mesh__D012437 98%28%75%29%   
% 214.86/215.03  |- skos__hiddenLabel mesh__D012437 S Adenosylmethionine Decarboxylase
% 214.86/215.03  |- skos__hiddenLabel mesh__D012437 Decarboxylase, Adenosylmethionine
% 214.86/215.03  |- skos__scopeNote mesh__D012437
% 214.86/215.03       An enzyme that catalyzes the decarboxylation of S-adenosyl-L-methionine to yield 5%27%-deoxy-%28%5%27%-%29%,3-aminopropyl-%28%1%29%, methylsulfonium salt. It is one of the enzymes responsible for the synthesis of spermidine from putrescine. EC 4.1.1.50.%A%    
% 214.86/215.03  |- mesh__recordMaintainer mesh__D012437 ssb
% 214.86/215.03  |- rdf__type mesh__D012437sskos__Concept
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D012437 2006
% 214.86/215.03  |- skos__prefLabel mesh__D012437 Adenosylmethionine Decarboxylase
% 214.86/215.03  |- skos__hiddenLabel mesh__D017920 Exchange Proteins, Anion
% 214.86/215.03  |- skos__altLabel mesh__D017920 Cation Exchangers %28%Proteins%29%
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D017920 2006
% 214.86/215.03  |- skos__broader mesh__D017920smesh__D008562
% 214.86/215.03  |- skos__hiddenLabel mesh__D017920 Exchange Proteins, Cation
% 214.86/215.03  |- skos__historyNote mesh__D017920 Carrier Proteins %28%1979-1993%29%
% 214.86/215.03  |- skos__scopeNote mesh__D017920
% 214.86/215.03       Membrane transporters that co-transport two or more dissimilar molecules in the opposite direction across a membrane. Usually the transport of one ion or molecule is against its electrochemical gradient and is %22%powered%22% by the movement of another ion or molecule with its electrochemical gradient.%A%    
% 214.86/215.03  |- rdf__type mesh__D017920sskos__Concept
% 214.86/215.03  |- mesh__recordAuthorizer mesh__D017920 sjn
% 214.86/215.03  |- skos__historyNote mesh__D017920 Biological Transport %28%1974-1981%29%
% 214.86/215.03  |- skos__prefLabel mesh__D017920 Antiporters
% 214.86/215.03  |- skos__broader mesh__D017920smesh__D016623
% 214.86/215.03  |- mesh__dateCreated mesh__D017920 1993-02-16
% 214.86/215.03  |- mesh__recordMaintainer mesh__D017920 jmp
% 214.86/215.03  |- mesh__recordOriginator mesh__D017920 PXP
% 214.86/215.03  |- mesh__publicMeSHNote mesh__D017920
% 214.86/215.03       1994; ANTIPORTERS was indexed under CARRIER PROTEINS 1980-1993%A%  
% 214.86/215.03  |- mesh__historyNote mesh__D017920
% 214.86/215.03       1994; use ANTIPORTERS %28%NM%29% 1980-1993   
% 214.86/215.03  |- skos__altLabel mesh__D017920 Anion Exchangers %28%Proteins%29%
% 214.86/215.03  |- mesh__dateRevised mesh__D017920 2005-06-30
% 214.86/215.03  |- mesh__dateEstablished mesh__D017920 1994-01-01
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D017122 2005
% 214.86/215.03  |- skos__scopeNote mesh__D017122
% 214.86/215.03       Virulent bacteriophage and type species of the genus T4-Like Phages, in the family MYOVIRIDAE.  It infects E. coli and is the best known of the T-even phages.  Its virion contains linear double-stranded DNA, terminally redundant and circularly permuted.%A%    
% 214.86/215.03  |- skos__altLabel mesh__D017122 T4 Phage
% 214.86/215.03  |- skos__altLabel mesh__D017122 Phage T2
% 214.86/215.03  |- mesh__dateRevised mesh__D017122 2001-07-25
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D017122 2006
% 214.86/215.03  |- skos__broader mesh__D017122smesh__D013604
% 214.86/215.03  |- skos__hiddenLabel mesh__D017122 Phages, T4
% 214.86/215.03  |- skos__prefLabel mesh__D017122 Bacteriophage T4
% 214.86/215.03  |- skos__altLabel mesh__D017122 Coliphage T4
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D017122 2003
% 214.86/215.03  |- mesh__recordMaintainer mesh__D017122 ags
% 214.86/215.03  |- mesh__dateEstablished mesh__D017122 1993-01-01
% 214.86/215.03  |- skos__altLabel mesh__D017122 Coliphage T2
% 214.86/215.03  |- skos__hiddenLabel mesh__D017122 Phage, T2
% 214.86/215.03  |- skos__historyNote mesh__D017122 Coliphages %28%1966-1979%29%
% 214.86/215.03  |- skos__hiddenLabel mesh__D017122 phage T2, Enterobacteria
% 214.86/215.03  |- rdf__type mesh__D017122sskos__Concept
% 214.86/215.03  |- mesh__publicMeSHNote mesh__D017122
% 214.86/215.03       1993; for BACTERIOPHAGE T2 see MYOVIRIDAE 1994-2001   
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D017122 2004
% 214.86/215.03  |- skos__altLabel mesh__D017122 Enterobacteria phage T2
% 214.86/215.03  |- mesh__recordAuthorizer mesh__D017122 sjn
% 214.86/215.03  |- skos__historyNote mesh__D017122 T-Phages %28%1980-1992%29%
% 214.86/215.03  |- mesh__dateCreated mesh__D017122 1992-05-07
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D017122 2002
% 214.86/215.03  |- skos__altLabel mesh__D017122 Phage T4
% 214.86/215.03  |- mesh__historyNote mesh__D017122
% 214.86/215.03       1993; for BACTERIOPHAGE T2 use MYOVIRIDAE 1994-2001   
% 214.86/215.03  |- skos__broader mesh__D017122smesh__D017900
% 214.86/215.03  |- skos__hiddenLabel mesh__D017122 Phages, T2
% 214.86/215.03  |- skos__altLabel mesh__D017122 Enterobacteria phage T4
% 214.86/215.03  |- skos__hiddenLabel mesh__D017122 Phage, T4
% 214.86/215.03  |- skos__hiddenLabel mesh__D017122 T2 Phages
% 214.86/215.03  |- mesh__recordOriginator mesh__D017122 AGS
% 214.86/215.03  |- skos__hiddenLabel mesh__D017122 T4 Phages
% 214.86/215.03  |- skos__hiddenLabel mesh__D017122 T2, Enterobacteria phage
% 214.86/215.03  |- skos__altLabel mesh__D017122 T2 Phage
% 214.86/215.03  |- mesh__recordMaintainer mesh__D003900 exl
% 214.86/215.03  |- skos__prefLabel mesh__D003900 Desoxycorticosterone
% 214.86/215.03  |- skos__altLabel mesh__D003900 21-Hydroxyprogesterone
% 214.86/215.03  |- skos__altLabel mesh__D003900 Desoxycortone
% 214.86/215.03  |- skos__altLabel mesh__D003900 21-Hydroxy-4-pregnene-3,20-dione
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D003900 2006
% 214.86/215.03  |- mesh__recordAuthorizer mesh__D003900 sjn
% 214.86/215.03  |- skos__broader mesh__D003900smesh__D011282
% 214.86/215.03  |- skos__scopeNote mesh__D003900
% 214.86/215.03       21-Hydroxypregn-4-ene-3,20-dione. Mineralocorticoid. Desoxycorticosterone acetate %28%DOCA%29% is used as replacement therapy in Addison%27%s Disease.%A%    
% 214.86/215.03  |- skos__hiddenLabel mesh__D003900 11 Decorticosterone
% 214.86/215.03  |- mesh__dateRevised mesh__D003900 2005-06-30
% 214.86/215.03  |- mesh__dateCreated mesh__D003900 1999-01-01
% 214.86/215.03  |- skos__altLabel mesh__D003900 11-Decorticosterone
% 214.86/215.03  |- skos__hiddenLabel mesh__D003900 21 Hydroxyprogesterone
% 214.86/215.03  |- skos__altLabel mesh__D003900 Cortexone
% 214.86/215.03  |- rdf__type mesh__D003900sskos__Concept
% 214.86/215.03  |- skos__altLabel mesh__D003900 Deoxycorticosterone
% 214.86/215.03  |- mesh__recordOriginator mesh__D003900 NLM
% 214.86/215.03  |- skos__broader mesh__D003900smesh__D006889
% 214.86/215.03  |- skos__annotation mesh__D003900
% 214.86/215.03       do not coord with ACETATES for DOCA; /biosyn /physiol permitted; do not confuse trade name Decortin %28%Schieffelin%29% with PREDNISONE trade name Decortin %28%Merck%29%%A%  
% 214.86/215.03  |- skos__hiddenLabel mesh__D003900 21 Hydroxy 4 pregnene 3,20 dione
% 214.86/215.03  |- skos__annotation mesh__D050556 see SCR for organism-specific terms   
% 214.86/215.03  |- skos__hiddenLabel mesh__D050556 Liver Fatty Acid Binding Protein
% 214.86/215.03  |- skos__hiddenLabel mesh__D050556
% 214.86/215.03       Fatty Acid Binding Protein, Cardiac Myocyte
% 214.86/215.03  |- skos__scopeNote mesh__D050556
% 214.86/215.03       Intracellular proteins that reversibly bind hydrophobic ligands including: saturated and unsaturated FATTY ACIDS; EICOSANOIDS; and RETINOIDS.  They are considered a highly conserved and ubiquitously expressed family of proteins that may play a role in the metabolism of LIPIDS.%A%    
% 214.86/215.03  |- skos__altLabel mesh__D050556 Myocardial Fatty Acid-Binding Protein
% 214.86/215.03  |- skos__hiddenLabel mesh__D050556 Lipid-Binding Proteins, Cytosolic
% 214.86/215.03  |- skos__altLabel mesh__D050556 Intestinal Fatty Acid-Binding Protein
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D050556 2006A
% 214.86/215.03  |- skos__altLabel mesh__D050556 Adipocyte Lipid Binding Protein
% 214.86/215.03  |- skos__hiddenLabel mesh__D050556
% 214.86/215.03       Fatty Acid Binding Proteins, Cytosolic Specific
% 214.86/215.03  |- mesh__activeMeSHYear mesh__D050556 2006
% 214.86/215.03  |- skos__hiddenLabel mesh__D050556 Intestinal Fatty Acid Binding Protein
% 214.86/215.03  |- skos__altLabel mesh__D050556 Fatty Acid-Binding Protein, Myocardial
% 214.86/215.03  |- mesh__publicMeSHNote mesh__D050556
% 214.86/215.03       2006; FATTY ACID-BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-2000%A%  
% 214.86/215.03  |- skos__altLabel mesh__D050556 Liver Fatty Acid-Binding Protein
% 214.86/215.03  |- skos__hiddenLabel mesh__D050556 Brain Type Fatty Acid Binding Protein
% 214.86/215.03  |- mesh__dateRevised mesh__D050556 2005-07-19
% 214.86/215.04  |- skos__altLabel mesh__D050556 Brain-Type Fatty Acid-Binding Protein
% 214.86/215.04  |- skos__hiddenLabel mesh__D050556 Fatty Acid Binding Protein, Myocardial
% 214.86/215.04  |- skos__prefLabel mesh__D050556 Fatty Acid-Binding Proteins
% 214.86/215.04  |- skos__hiddenLabel mesh__D050556
% 214.86/215.04       Fatty Acid Binding Proteins, Myocardial Specific
% 214.86/215.04  |- skos__hiddenLabel mesh__D050556 Cytosolic Lipid Binding Proteins
% 214.86/215.04  |- skos__hiddenLabel mesh__D050556
% 214.86/215.04       Plasma Membrane Fatty Acid Binding Protein
% 214.86/215.04  |- skos__historyNote mesh__D050556 Carrier Proteins %28%1980-2005%29%
% 214.86/215.04  |- skos__altLabel mesh__D050556 Cytosolic Lipid-Binding Proteins
% 214.86/215.04  |- mesh__recordAuthorizer mesh__D050556 ags
% 214.86/215.04  |- rdf__type mesh__D050556sskos__Concept
% 214.86/215.04  |- skos__hiddenLabel mesh__D050556
% 214.86/215.04       Fatty Acid Binding Proteins, Adipocyte Specific
% 214.86/215.04  |- mesh__dateCreated mesh__D050556 2005-06-30
% 214.86/215.04  |- skos__broader mesh__D050556smesh__D002352
% 214.86/215.04  |- skos__altLabel mesh__D050556 Fatty Acid-Binding Protein, Cardiac Myocyte
% 214.86/215.04  |- skos__hiddenLabel mesh__D050556
% 214.86/215.04       Fatty Acid Binding Proteins, Plasma Membrane Specific
% 214.86/215.04  |- skos__hiddenLabel mesh__D050556 Fatty Acid Binding Proteins
% 214.86/215.04  |- skos__hiddenLabel mesh__D050556
% 214.86/215.04       Fatty Acid Binding Proteins, Liver Specific
% 214.86/215.04  |- mesh__historyNote mesh__D050556 2006   
% 214.86/215.04  |- mesh__recordMaintainer mesh__D050556 ags
% 214.86/215.04  |- skos__hiddenLabel mesh__D050556 Myocardial Fatty Acid Binding Protein
% 214.86/215.04  |- skos__hiddenLabel mesh__D050556
% 214.86/215.04       Adipocyte Specific Fatty Acid Binding Protein
% 214.86/215.04  |- skos__hiddenLabel mesh__D050556
% 214.86/215.04       Fatty Acid Binding Proteins, Intestinal Specific
% 214.86/215.04  |- skos__hiddenLabel mesh__D050556
% 214.86/215.04       Fatty Acid Binding Proteins, Brain Specific
% 214.86/215.04  |- mesh__dateEstablished mesh__D050556 2006-01-01
% 214.86/215.04  |- mesh__recordOriginator mesh__D050556 jmp
% 214.86/215.04  |- skos__altLabel mesh__D050556
% 214.86/215.04       Adipocyte-Specific Fatty Acid-Binding Protein
% 214.86/215.04  |- skos__altLabel mesh__D050556 Plasma Membrane Fatty Acid-Binding Protein
% 214.86/215.04  |- mesh__dateRevised mesh__D003102 2003-07-09
% 214.86/215.04  |- mesh__recordOriginator mesh__D003102 NLM
% 214.86/215.04  |- skos__hiddenLabel mesh__D003102 Colloid
% 214.86/215.04  |- skos__broader mesh__D003102smesh__D002627
% 214.86/215.04  |- mesh__dateCreated mesh__D003102 1999-01-01
% 214.86/215.04  |- skos__prefLabel mesh__D003102 Colloids
% 214.86/215.04  |- skos__hiddenLabel mesh__D003102 Hydrocolloid
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D003102 2004
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D003102 2006
% 214.86/215.04  |- mesh__recordMaintainer mesh__D003102 ssb
% 214.86/215.04  |- mesh__recordAuthorizer mesh__D003102 sjn
% 214.86/215.04  |- skos__broader mesh__D003102smesh__D004304
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D003102 2005
% 214.86/215.04  |- skos__annotation mesh__D003102
% 214.86/215.04       IM for general only; NIM with specific drug IM, no qualif%A%  
% 214.86/215.04  |- rdf__type mesh__D003102sskos__Concept
% 214.86/215.04  |- skos__scopeNote mesh__D003102
% 214.86/215.04       Two-phase systems in which one is uniformly dispersed in another as particles small enough so they cannot be filtered or will not settle out. The dispersing or continuous phase or medium envelops the particles of the discontinuous phase. All three states of matter can form colloids among each other.%A%    
% 214.86/215.04  |- skos__broader mesh__D012876Q000188smesh__D012876
% 214.86/215.04  |- mesh__preferredCombination mesh__D012876Q000188smesh__D000977
% 214.86/215.04  |- rdf__type mesh__D012876Q000188smesh__CompoundConcept
% 214.86/215.04  |- skos__annotation mesh__D008396 BALTIMORE is also available   
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D008396 2002
% 214.86/215.04  |- mesh__dateCreated mesh__D008396 1999-01-01
% 214.86/215.04  |- mesh__recordOriginator mesh__D008396 NLM
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D008396 2003
% 214.86/215.04  |- mesh__recordAuthorizer mesh__D008396 SJN
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D008396 2004
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D008396 2005
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D008396 2000
% 214.86/215.04  |- skos__prefLabel mesh__D008396 Maryland
% 214.86/215.04  |- skos__broader mesh__D008396smesh__D001061
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D008396 2006
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D008396 1998
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D008396 2001
% 214.86/215.04  |- mesh__recordMaintainer mesh__D008396 PXP
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D008396 1999
% 214.86/215.04  |- mesh__dateRevised mesh__D008396 1997-06-20
% 214.86/215.04  |- rdf__type mesh__D008396sskos__Concept
% 214.86/215.04  |- skos__broader mesh__D008396smesh__D008873
% 214.86/215.04  |- mesh__recordAuthorizer mesh__D016828 sjn
% 214.86/215.04  |- mesh__publicMeSHNote mesh__D016828 92   
% 214.86/215.04  |- skos__annotation mesh__D016828 an order of protozoa   
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D016828 2006
% 214.86/215.04  |- mesh__dateCreated mesh__D016828 1991-05-02
% 214.86/215.04  |- mesh__dateEstablished mesh__D016828 1992-01-01
% 214.86/215.04  |- mesh__historyNote mesh__D016828 92   
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D016828 2005
% 214.86/215.04  |- rdf__type mesh__D016828sskos__Concept
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D016828 2004
% 214.86/215.04  |- skos__scopeNote mesh__D016828
% 214.86/215.04       An order of protozoa characterized by the presence of one or two karyomastigonts and either two-fold rotational or mirror symmetry.%A%    
% 214.86/215.04  |- mesh__dateRevised mesh__D016828 2003-07-09
% 214.86/215.04  |- mesh__recordMaintainer mesh__D016828 ags
% 214.86/215.04  |- skos__broader mesh__D016828smesh__D016826
% 214.86/215.04  |- skos__prefLabel mesh__D016828 Diplomonadida
% 214.86/215.04  |- mesh__recordOriginator mesh__D016828 PXP
% 214.86/215.04  |- skos__broader mesh__D041221smesh__D002175
% 214.86/215.04  |- mesh__recordMaintainer mesh__D041221 SYSTEM
% 214.86/215.04  |- mesh__recordOriginator mesh__D041221 ags
% 214.86/215.04  |- skos__historyNote mesh__D041221 Candida %28%1967-2002%29%
% 214.86/215.04  |- skos__prefLabel mesh__D041221 Candida glabrata
% 214.86/215.04  |- mesh__publicMeSHNote mesh__D041221 2003   
% 214.86/215.04  |- skos__annotation mesh__D041221
% 214.86/215.04       infection: coord with CANDIDIASIS %28%IM%29% or its indentions %28%IM%29%%A%  
% 214.86/215.04  |- mesh__dateCreated mesh__D041221 2002-07-03
% 214.86/215.04  |- rdf__type mesh__D041221sskos__Concept
% 214.86/215.04  |- mesh__recordAuthorizer mesh__D041221 sjn
% 214.86/215.04  |- mesh__historyNote mesh__D041221 2003   
% 214.86/215.04  |- skos__scopeNote mesh__D041221
% 214.86/215.04       A species of MITOSPORIC FUNGI commonly found on the body surface. It causes opportunistic infections especially in immunocompromised patients.%A%    
% 214.86/215.04  |- skos__altLabel mesh__D041221 Torulopsis glabrata
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D041221 2006
% 214.86/215.04  |- mesh__dateRevised mesh__D041221 2005-06-30
% 214.86/215.04  |- mesh__dateEstablished mesh__D041221 2003-01-01
% 214.86/215.04  |- mesh__dateRevised mesh__D002808 2003-07-09
% 214.86/215.04  |- skos__hiddenLabel mesh__D002808 Chondroitinase AC II
% 214.86/215.04  |- skos__historyNote mesh__D002808 Polysaccharide-Lyases %28%1975%29%
% 214.86/215.04  |- mesh__recordOriginator mesh__D002808 RLS
% 214.86/215.04  |- skos__hiddenLabel mesh__D002808 Eliminase, Chondroitin
% 214.86/215.04  |- mesh__publicMeSHNote mesh__D002808
% 214.86/215.04       91; was see under CHONDROITINASES 1976-90   
% 214.86/215.04  |- skos__hiddenLabel mesh__D002808 Sulfate Lyase, Chondroitin
% 214.86/215.04  |- mesh__dateEstablished mesh__D002808 1991-01-01
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D002808 2004
% 214.86/215.04  |- skos__historyNote mesh__D002808 Lyases %28%1970-1974%29%
% 214.86/215.04  |- skos__historyNote mesh__D002808 Chondroitin %28%1970-1975%29%
% 214.86/215.04  |- skos__hiddenLabel mesh__D002808 Lyase, Chondroitin Sulfate
% 214.86/215.04  |- skos__hiddenLabel mesh__D002808 Lyase, Chondroitin AC
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D002808 2006
% 214.86/215.04  |- mesh__recordMaintainer mesh__D002808 ssb
% 214.86/215.04  |- skos__broader mesh__D002808smesh__D002810
% 214.86/215.04  |- mesh__historyNote mesh__D002808
% 214.86/215.04       91%28%76%29%; was see under CHONDROITINASES 1976-90   
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D002808 2005
% 214.86/215.04  |- skos__annotation mesh__D002808
% 214.86/215.04       do not confuse with CHONDROITIN ABC LYASE   
% 214.86/215.04  |- skos__scopeNote mesh__D002808
% 214.86/215.04       Enzymes which catalyze the elimination of delta-4,5-D-glucuronate residues from polysaccharides containing 1,4-beta-hexosaminyl and 1,3-beta-D-glucuronosyl or 1,3-alpha-L-iduronosyl linkages thereby bringing about depolymerization. EC 4.2.2.4 acts on chondroitin sulfate A and C as well as on dermatan sulfate and slowly on hyaluronate. EC 4.2.2.5 acts on chondroitin sulfate A and C.%A%    
% 214.86/215.04  |- skos__hiddenLabel mesh__D002808 Lyase, Chondroitin B
% 214.86/215.04  |- skos__prefLabel mesh__D002808 Chondroitin Lyases
% 214.86/215.04  |- skos__hiddenLabel mesh__D002808 Lyases, Chondroitin
% 214.86/215.04  |- rdf__type mesh__D002808sskos__Concept
% 214.86/215.04  |- mesh__dateCreated mesh__D002808 1975-08-01
% 214.86/215.04  |- mesh__recordAuthorizer mesh__D002808 sjn
% 214.86/215.04  |- skos__altLabel mesh__D002808 Chondroitin AC Lyase
% 214.86/215.04  |- skos__broader mesh__D013530smesh__D014946
% 214.86/215.04  |- rdf__type mesh__D013530sskos__Concept
% 214.86/215.04  |- mesh__recordMaintainer mesh__D013530 lkt
% 214.86/215.04  |- mesh__dateCreated mesh__D013530 1999-01-01
% 214.86/215.04  |- skos__hiddenLabel mesh__D013530 Wound Infections, Postoperative
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D013530 2006
% 214.86/215.04  |- skos__prefLabel mesh__D013530 Surgical Wound Infection
% 214.86/215.04  |- mesh__recordOriginator mesh__D013530 NLM
% 214.86/215.04  |- skos__altLabel mesh__D013530 Postoperative Wound Infection
% 214.86/215.04  |- skos__hiddenLabel mesh__D013530 Infections, Surgical Wound
% 214.86/215.04  |- mesh__recordAuthorizer mesh__D013530 sjn
% 214.86/215.04  |- skos__altLabel mesh__D013530 Infection, Postoperative Wound
% 214.86/215.04  |- skos__hiddenLabel mesh__D013530 Wound Infections, Surgical
% 214.86/215.04  |- skos__hiddenLabel mesh__D013530 Surgical Wound Infections
% 214.86/215.04  |- skos__altLabel mesh__D013530 Wound Infection, Postoperative
% 214.86/215.04  |- skos__hiddenLabel mesh__D013530 Infections, Postoperative Wound
% 214.86/215.04  |- skos__altLabel mesh__D013530 Infection, Surgical Wound
% 214.86/215.04  |- skos__annotation mesh__D013530
% 214.86/215.04       coordinate IM with specific infection term %28%IM%29%; do not coordinate with POSTOPERATIVE COMPLICATIONS%A%  
% 214.86/215.04  |- skos__scopeNote mesh__D013530
% 214.86/215.04       Infection occurring at the site of a surgical incision.%A%    
% 214.86/215.04  |- skos__broader mesh__D013530smesh__D011183
% 214.86/215.04  |- skos__altLabel mesh__D013530 Wound Infection, Surgical
% 214.86/215.04  |- skos__hiddenLabel mesh__D013530 Postoperative Wound Infections
% 214.86/215.04  |- mesh__dateRevised mesh__D013530 2005-06-30
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D032495 2006
% 214.86/215.04  |- skos__annotation mesh__D032495
% 214.86/215.04       do not X ref confuse FERN, BRAKE with FERN, BRACKEN see PTERIDIUM; PTERIS AQUILINA and PTERIS ESCULENTUM see PTERIDIUM are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.86/215.04  |- mesh__publicMeSHNote mesh__D032495 2003   
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D032495 2005
% 214.86/215.04  |- mesh__dateEstablished mesh__D032495 2003-01-01
% 214.86/215.04  |- mesh__dateCreated mesh__D032495 2002-07-03
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D032495 2004
% 214.86/215.04  |- skos__prefLabel mesh__D032495 Pteris
% 214.86/215.04  |- rdf__type mesh__D032495sskos__Concept
% 214.86/215.04  |- mesh__historyNote mesh__D032495 2003   
% 214.86/215.04  |- skos__broader mesh__D032495smesh__D029625
% 214.86/215.04  |- skos__scopeNote mesh__D032495
% 214.86/215.04       A plant genus of the family PTERIDACEAE. Members contain entkaurane DITERPENES. The name is similar to bracken fern %28%PTERIDIUM%29%.%A%    
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D032495 2003
% 214.86/215.04  |- skos__altLabel mesh__D032495 Fern, Brake
% 214.86/215.04  |- mesh__dateEstablished mesh__D012438 1991-01-01
% 214.86/215.04  |- skos__altLabel mesh__D012438 Saccadic Eye Movements
% 214.86/215.04  |- skos__hiddenLabel mesh__D012438 Saccadic Eye Movement
% 214.86/215.04  |- skos__hiddenLabel mesh__D012438 Saccadic Pursuits
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D012438 2004
% 214.86/215.04  |- skos__altLabel mesh__D012438 Pursuit, Saccadic
% 214.86/215.04  |- skos__hiddenLabel mesh__D012438 Saccadic Pursuit
% 214.86/215.04  |- mesh__dateCreated mesh__D012438 1974-11-11
% 214.86/215.04  |- skos__hiddenLabel mesh__D012438 Saccade
% 214.86/215.04  |- skos__hiddenLabel mesh__D012438 Eye Movement, Saccadic
% 214.86/215.04  |- skos__hiddenLabel mesh__D012438 Movement, Saccadic Eye
% 214.86/215.04  |- mesh__recordMaintainer mesh__D012438 nns
% 214.86/215.04  |- skos__scopeNote mesh__D012438
% 214.86/215.04       An abrupt voluntary shift in ocular fixation from one point to another, as occurs in reading.%A%    
% 214.86/215.04  |- mesh__dateRevised mesh__D012438 2003-07-09
% 214.86/215.04  |- mesh__recordAuthorizer mesh__D012438 sjn
% 214.86/215.04  |- skos__hiddenLabel mesh__D012438 Eye Movements, Saccadic
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D012438 2005
% 214.86/215.04  |- skos__hiddenLabel mesh__D012438 Pursuits, Saccadic
% 214.86/215.04  |- skos__hiddenLabel mesh__D012438 Movements, Saccadic Eye
% 214.86/215.04  |- skos__broader mesh__D012438smesh__D005133
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D012438 2006
% 214.86/215.04  |- rdf__type mesh__D012438sskos__Concept
% 214.86/215.04  |- mesh__historyNote mesh__D012438
% 214.86/215.04       91%28%75%29%; was see under EYE MOVEMENTS 1975-90   
% 214.86/215.04  |- skos__prefLabel mesh__D012438 Saccades
% 214.86/215.04  |- mesh__publicMeSHNote mesh__D012438
% 214.86/215.04       91; was see under EYE MOVEMENTS 1975-90   
% 214.86/215.04  |- mesh__recordOriginator mesh__D012438 NLM
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D017921 2006
% 214.86/215.04  |- mesh__recordOriginator mesh__D017921 AGS
% 214.86/215.04  |- skos__annotation mesh__D017921
% 214.86/215.04       infection: coord IM with ADENOVIRIDAE INFECTIONS %28%IM%29%   
% 214.86/215.04  |- skos__scopeNote mesh__D017921
% 214.86/215.04       A genus of ADENOVIRIDAE that infects MAMMALS including humans and causes a wide range of diseases. The type species is Human adenovirus C %28%see ADENOVIRUSES, HUMAN%29%.%A%    
% 214.86/215.04  |- rdf__type mesh__D017921sskos__Concept
% 214.86/215.04  |- mesh__dateEstablished mesh__D017921 1994-01-01
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D017921 2005
% 214.86/215.04  |- skos__prefLabel mesh__D017921 Mastadenovirus
% 214.86/215.04  |- mesh__dateRevised mesh__D017921 2004-07-13
% 214.86/215.04  |- skos__historyNote mesh__D017921 Adenoviridae %28%1983-1993%29%
% 214.86/215.04  |- skos__hiddenLabel mesh__D017921 Mastadenoviruses
% 214.86/215.04  |- mesh__publicMeSHNote mesh__D017921 94   
% 214.86/215.04  |- skos__historyNote mesh__D017921 Adenoviruses, Human %28%1983-1993%29%
% 214.86/215.04  |- mesh__dateCreated mesh__D017921 1993-06-04
% 214.86/215.04  |- mesh__recordAuthorizer mesh__D017921 sjn
% 214.86/215.04  |- mesh__historyNote mesh__D017921 94   
% 214.86/215.04  |- mesh__recordMaintainer mesh__D017921 sjn
% 214.86/215.04  |- skos__broader mesh__D017921smesh__D000256
% 214.86/215.04  |- mesh__publicMeSHNote mesh__D017123 93   
% 214.86/215.04  |- skos__hiddenLabel mesh__D017123 T7 Phages
% 214.86/215.04  |- skos__hiddenLabel mesh__D017123 Phages, T7
% 214.86/215.04  |- skos__altLabel mesh__D017123 Coliphage T7
% 214.86/215.04  |- mesh__recordOriginator mesh__D017123 AGS
% 214.86/215.04  |- skos__altLabel mesh__D017123 T7 Phage
% 214.86/215.04  |- skos__broader mesh__D017123smesh__D017902
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D017123 2003
% 214.86/215.04  |- skos__altLabel mesh__D017123 Enterobacteria phage T7
% 214.86/215.04  |- mesh__recordMaintainer mesh__D017123 ags
% 214.86/215.04  |- mesh__dateRevised mesh__D017123 2001-07-25
% 214.86/215.04  |- rdf__type mesh__D017123sskos__Concept
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D017123 2004
% 214.86/215.04  |- skos__broader mesh__D017123smesh__D013604
% 214.86/215.04  |- mesh__dateCreated mesh__D017123 1992-05-07
% 214.86/215.04  |- mesh__dateEstablished mesh__D017123 1993-01-01
% 214.86/215.04  |- skos__altLabel mesh__D017123 Phage T7
% 214.86/215.04  |- skos__hiddenLabel mesh__D017123 Phage, T7
% 214.86/215.04  |- skos__historyNote mesh__D017123 Coliphages %28%1966-1979%29%
% 214.86/215.04  |- skos__annotation mesh__D017123
% 214.86/215.04       T7-LIKE PHAGES see PODOVIRIDAE is also available   
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D017123 2005
% 214.86/215.04  |- skos__prefLabel mesh__D017123 Bacteriophage T7
% 214.86/215.04  |- mesh__historyNote mesh__D017123 93   
% 214.86/215.04  |- skos__historyNote mesh__D017123 T-Phages %28%1980-1992%29%
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D017123 2002
% 214.86/215.04  |- mesh__recordAuthorizer mesh__D017123 sjn
% 214.86/215.04  |- skos__scopeNote mesh__D017123
% 214.86/215.04       Virulent bacteriophage and type species of the genus T7-like Phages, in the family PODOVIRIDAE, that infects E. coli. It consists of linear double-stranded DNA, terminally redundant, and non-permuted.%A%    
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D017123 2006
% 214.86/215.04  |- mesh__recordOriginator mesh__D003901 NLM
% 214.86/215.04  |- skos__broader mesh__D003901smesh__D020564
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D003901 2006
% 214.86/215.04  |- skos__scopeNote mesh__D003901
% 214.86/215.04       A genus of gram-negative, anaerobic, rod-shaped bacteria capable of reducing sulfur compounds to hydrogen sulfide. Organisms are isolated from anaerobic mud of fresh and salt water, animal intestines, manure, and feces.%A%    
% 214.86/215.04  |- mesh__dateCreated mesh__D003901 1999-01-01
% 214.86/215.04  |- rdf__type mesh__D003901sskos__Concept
% 214.86/215.04  |- mesh__recordMaintainer mesh__D003901 SYSTEM
% 214.86/215.04  |- skos__prefLabel mesh__D003901 Desulfovibrio
% 214.86/215.04  |- mesh__recordAuthorizer mesh__D003901 sjn
% 214.86/215.04  |- mesh__dateRevised mesh__D003901 2005-06-30
% 214.86/215.04  |- skos__annotation mesh__D003901
% 214.86/215.04       infection: coord IM with DESULFOVIBRIONACEAE INFECTIONS %28%IM%29%%A%  
% 214.86/215.04  |- skos__broader mesh__D003901smesh__D016999
% 214.86/215.04  |- skos__broader mesh__D003901smesh__D016965
% 214.86/215.04  |- skos__hiddenLabel mesh__D050557 2,3-Dioxygenase, Catechol
% 214.86/215.04  |- skos__hiddenLabel mesh__D050557 Pyrocatechol 2,3 Oxygenase
% 214.86/215.04  |- skos__hiddenLabel mesh__D050557 2,3-Dioxygenase, 3-Sulfocatechol
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D050557 2006
% 214.86/215.04  |- rdf__type mesh__D050557sskos__Concept
% 214.86/215.04  |- mesh__dateCreated mesh__D050557 2005-06-30
% 214.86/215.04  |- skos__altLabel mesh__D050557 Pyrocatechol-2,3-Oxygenase
% 214.86/215.04  |- skos__altLabel mesh__D050557 Catechol-2,3-Dioxygenase
% 214.86/215.04  |- skos__altLabel mesh__D050557 Metapyrocatechase
% 214.86/215.04  |- mesh__recordMaintainer mesh__D050557 AKE
% 214.86/215.04  |- skos__scopeNote mesh__D050557
% 214.86/215.04       Catalyzes the oxidation of catechol to 2-hydroxymuconate semialdehyde in the CARBAZOLE and BENZOATE degradation via HYDROXYLATION pathways. It also catalyzes the conversion of 3-methylcatechol to cis, cis-2-hydroxy-6-oxohept-2,4-dienoate in the TOLUENE and XYLENE degradation pathway. This enzyme was formerly characterized as EC 1.13.1.2.%A%    
% 214.86/215.04  |- skos__hiddenLabel mesh__D050557 3 Sulfocatechol 2,3 Dioxygenase
% 214.86/215.04  |- skos__broader mesh__D050557smesh__D049308
% 214.86/215.04  |- skos__hiddenLabel mesh__D050557 Catechol 2,3 Dioxygenase
% 214.86/215.04  |- mesh__recordAuthorizer mesh__D050557 sjn
% 214.86/215.04  |- skos__prefLabel mesh__D050557 Catechol 2,3-Dioxygenase
% 214.86/215.04  |- mesh__publicMeSHNote mesh__D050557
% 214.86/215.04       2006; CATECHOL 2,3,-DIOXYGENASE was indexed under DIOXYGENASES 1981-2005, under CATECHOLS 1975-1980, %26% under CATECHOL 1973-1974%A%  
% 214.86/215.04  |- mesh__recordOriginator mesh__D050557 AKE
% 214.86/215.04  |- mesh__dateEstablished mesh__D050557 2006-01-01
% 214.86/215.04  |- skos__altLabel mesh__D050557 3-Sulfocatechol 2,3-Dioxygenase
% 214.86/215.04  |- mesh__historyNote mesh__D050557 2006%28%1981%29%   
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D003103 2001
% 214.86/215.04  |- mesh__publicMeSHNote mesh__D003103 73   
% 214.86/215.04  |- mesh__recordMaintainer mesh__D003103 kle
% 214.86/215.04  |- mesh__historyNote mesh__D003103 73%28%65%29%   
% 214.86/215.04  |- skos__broader mesh__D003103smesh__D005124
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D003103 2003
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D003103 2005
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D003103 2004
% 214.86/215.04  |- skos__scopeNote mesh__D003103
% 214.86/215.04       Congenital anomaly in which some of the structures of the eye are absent due to incomplete fusion of the fetal intraocular fissure during gestation.%A%    
% 214.86/215.04  |- mesh__dateEstablished mesh__D003103 1973-01-01
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D003103 2002
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D003103 2006
% 214.86/215.04  |- mesh__recordOriginator mesh__D003103 NLM
% 214.86/215.04  |- skos__hiddenLabel mesh__D003103 Colobomas
% 214.86/215.04  |- mesh__dateRevised mesh__D003103 1999-11-03
% 214.86/215.04  |- rdf__type mesh__D003103sskos__Concept
% 214.86/215.04  |- skos__prefLabel mesh__D003103 Coloboma
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D003103 2000
% 214.86/215.04  |- mesh__dateCreated mesh__D003103 1999-01-01
% 214.86/215.04  |- mesh__recordAuthorizer mesh__D003103 sjn
% 214.86/215.04  |- skos__annotation mesh__D003103
% 214.86/215.04       eye abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific site in eye /abnorm %28%IM%29%%A%  
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D008397 2005
% 214.86/215.04  |- skos__prefLabel mesh__D008397 Masks
% 214.86/215.04  |- mesh__dateRevised mesh__D008397 1999-11-08
% 214.86/215.04  |- rdf__type mesh__D008397sskos__Concept
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D008397 2004
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D008397 2001
% 214.86/215.04  |- mesh__recordAuthorizer mesh__D008397 sjn
% 214.86/215.04  |- skos__hiddenLabel mesh__D008397 Mask
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D008397 2000
% 214.86/215.04  |- mesh__dateCreated mesh__D008397 1999-01-01
% 214.86/215.04  |- skos__broader mesh__D008397smesh__D011482
% 214.86/215.04  |- mesh__recordOriginator mesh__D008397 NLM
% 214.86/215.04  |- mesh__recordMaintainer mesh__D008397 adp
% 214.86/215.04  |- skos__annotation mesh__D008397
% 214.86/215.04       includes surgical masks; GAS MASKS see RESPIRATORY PROTECTIVE DEVICES is available%A%  
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D008397 2003
% 214.86/215.04  |- skos__scopeNote mesh__D008397
% 214.86/215.04       Devices that cover the nose and mouth to maintain aseptic conditions or to administer inhaled anesthetics or other gases. %28%UMDNS, 1999%29%%A%    
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D008397 2006
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D008397 2002
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D016829 2006
% 214.86/215.04  |- skos__scopeNote mesh__D016829
% 214.86/215.04       A species of parasitic protozoa that attaches itself to the intestinal mucosa and feeds on mucous secretions. The organism is roughly pear-shaped and motility is somewhat erratic, with a slow oscillation about the long axis. Considered for many years to be non-pathogenic and often found in completely asymptomatic individuals, there is presently strong evidence for its pathogenic potential.%A%    
% 214.86/215.04  |- skos__related mesh__D016829smesh__D019198
% 214.86/215.04  |- mesh__historyNote mesh__D016829 92   
% 214.86/215.04  |- mesh__recordAuthorizer mesh__D016829 sjn
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D016829 2005
% 214.86/215.04  |- rdf__type mesh__D016829sskos__Concept
% 214.86/215.04  |- mesh__publicMeSHNote mesh__D016829 92   
% 214.86/215.04  |- skos__altLabel mesh__D016829 Lamblia intestinalis
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D016829 2004
% 214.86/215.04  |- mesh__dateRevised mesh__D016829 2003-07-09
% 214.86/215.04  |- skos__historyNote mesh__D016829 Giardia %28%1967-1991%29%
% 214.86/215.04  |- mesh__recordMaintainer mesh__D016829 ags
% 214.86/215.04  |- skos__prefLabel mesh__D016829 Giardia lamblia
% 214.86/215.04  |- skos__broader mesh__D016829smesh__D005872
% 214.86/215.04  |- mesh__dateCreated mesh__D016829 1991-05-02
% 214.86/215.04  |- mesh__dateEstablished mesh__D016829 1992-01-01
% 214.86/215.04  |- mesh__recordOriginator mesh__D016829 PXP
% 214.86/215.04  |- skos__annotation mesh__D016829
% 214.86/215.04       infection = GIARDIASIS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN; a virus infecting Giardia lamblia is named GIARDIAVIRUS: read MeSH definition there%A%  
% 214.86/215.04  |- skos__altLabel mesh__D016829 Giardia intestinalis
% 214.86/215.04  |- skos__hiddenLabel mesh__D002809 Chondroitin Sulfate, Sodium
% 214.86/215.04  |- skos__historyNote mesh__D002809 Sulfuric Acids %28%1971-1975%29%
% 214.86/215.04  |- skos__altLabel mesh__D002809 Chondroitin Sulfate
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D002809 2006
% 214.86/215.04  |- skos__hiddenLabel mesh__D002809 Chondroitin 6 Sulfate, Potassium Salt
% 214.86/215.04  |- skos__hiddenLabel mesh__D002809 Sulfate, Sodium Chondroitin
% 214.86/215.04  |- skos__hiddenLabel mesh__D002809 Chondroitin 6 Sulfate, Sodium Salt
% 214.86/215.04  |- mesh__dateEstablished mesh__D002809 1991-01-01
% 214.86/215.04  |- skos__altLabel mesh__D002809 Chondroitin Sulfate C
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D002809 2005
% 214.86/215.04  |- skos__broader mesh__D002809smesh__D002807
% 214.86/215.04  |- mesh__recordOriginator mesh__D002809 RLS
% 214.86/215.04  |- mesh__recordAuthorizer mesh__D002809 sjn
% 214.86/215.04  |- skos__hiddenLabel mesh__D002809 Chondroitin 4 Sulfate, Potassium Salt
% 214.86/215.04  |- skos__prefLabel mesh__D002809 Chondroitin Sulfates
% 214.86/215.04  |- skos__altLabel mesh__D002809 Sodium Chondroitin Sulfate
% 214.86/215.04  |- skos__hiddenLabel mesh__D002809 Chondroitin 4 Sulfate
% 214.86/215.04  |- skos__hiddenLabel mesh__D002809 Sulfates, Chondroitin
% 214.86/215.04  |- rdf__type mesh__D002809sskos__Concept
% 214.86/215.04  |- skos__scopeNote mesh__D002809
% 214.86/215.04       Derivatives of chondroitin which have a sulfate moiety esterified to the galactosamine moiety of chondroitin. Chondroitin sulfate A, or chondroitin 4-sulfate, and chondroitin sulfate C, or chondroitin 6-sulfate, have the sulfate esterified in the 4- and 6-positions, respectively. Chondroitin sulfate B %28%beta heparin; DERMATAN SULFATE%29% is a misnomer and this compound is not a true chondroitin sulfate.%A%    
% 214.86/215.04  |- skos__hiddenLabel mesh__D002809 Sulfate, Chondroitin
% 214.86/215.04  |- skos__altLabel mesh__D002809 Chondroitin Sulfate A
% 214.86/215.04  |- mesh__publicMeSHNote mesh__D002809
% 214.86/215.04       1991; see CHONDROITIN 1976-90; TRANSLAGEN was indexed under CHONDROITIN SULFATES, COLLAGEN %26% HEPARIN 1991-2000%A%  
% 214.86/215.04  |- skos__historyNote mesh__D002809 Chondroitin %28%1971-1975%29%
% 214.86/215.04  |- skos__hiddenLabel mesh__D002809
% 214.86/215.04       Chondroitin Sulfate 4 Sulfate, Sodium Salt
% 214.86/215.04  |- mesh__dateCreated mesh__D002809 1975-07-23
% 214.86/215.04  |- mesh__recordMaintainer mesh__D002809 ssb
% 214.86/215.04  |- mesh__historyNote mesh__D002809
% 214.86/215.04       1991%28%1976%29%; for TRANSLAGEN use CHONDROITIN SULFATE %28%NM%29% 1991-2000%A%  
% 214.86/215.04  |- mesh__dateRevised mesh__D002809 2004-07-07
% 214.86/215.04  |- skos__hiddenLabel mesh__D002809 Chondroitin 6 Sulfate
% 214.86/215.04  |- skos__hiddenLabel mesh__D002809 Chondroitin 4 Sulfate, Aluminum Salt
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D013531 2006
% 214.86/215.04  |- mesh__publicMeSHNote mesh__D013531
% 214.86/215.04       78; was see under HOSPITALS, SPECIAL 1975-77   
% 214.86/215.04  |- mesh__recordMaintainer mesh__D013531 TGC
% 214.86/215.04  |- skos__broader mesh__D013531smesh__D006782
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D013531 1996
% 214.86/215.04  |- skos__hiddenLabel mesh__D013531 Surgicenter
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D013531 2002
% 214.86/215.04  |- mesh__dateRevised mesh__D013531 1992-05-18
% 214.86/215.04  |- skos__historyNote mesh__D013531 Hospitals, Special %28%1968-1971%29%
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D013531 1997
% 214.86/215.04  |- skos__historyNote mesh__D013531 Surgery, Minor %28%1966-1971%29%
% 214.86/215.04  |- mesh__recordOriginator mesh__D013531 NLM
% 214.86/215.04  |- mesh__recordAuthorizer mesh__D013531 PLS
% 214.86/215.04  |- mesh__historyNote mesh__D013531
% 214.86/215.04       78%28%72%29%; was see under HOSPITALS, SPECIAL 1975-77   
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D013531 1998
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D013531 1993
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D013531 2003
% 214.86/215.04  |- skos__broader mesh__D013531smesh__D000554
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D013531 1994
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D013531 1999
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D013531 2004
% 214.86/215.04  |- mesh__dateEstablished mesh__D013531 1978-01-01
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D013531 1995
% 214.86/215.04  |- skos__scopeNote mesh__D013531
% 214.86/215.04       Facilities designed to serve patients who require surgical treatment exceeding the capabilities of usual physician%27%s office yet not of such proportion as to require hospitalization.%A%    
% 214.86/215.04  |- skos__prefLabel mesh__D013531 Surgicenters
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D013531 2000
% 214.86/215.04  |- rdf__type mesh__D013531sskos__Concept
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D013531 2005
% 214.86/215.04  |- mesh__dateCreated mesh__D013531 1999-01-01
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D013531 2001
% 214.86/215.04  |- mesh__publicMeSHNote mesh__D032496 2003   
% 214.86/215.04  |- skos__prefLabel mesh__D032496 Satellite Cells, Skeletal Muscle
% 214.86/215.04  |- skos__altLabel mesh__D032496 Skeletal Muscle Satellite Cells
% 214.86/215.04  |- skos__historyNote mesh__D032496
% 214.86/215.04       Muscle, Skeletal/cytology %28%1994-2002%29%
% 214.86/215.04  |- mesh__activeMeSHYear mesh__D032496 2005
% 214.86/215.04  |- skos__scopeNote mesh__D032496
% 214.86/215.04       Elongated, spindle-shaped, quiescent myoblasts lying in close contact with adult skeletal muscle. They are thought to play a role in muscle repair and regeneration.%A%    
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D032496 2004
% 214.86/215.05  |- rdf__type mesh__D032496sskos__Concept
% 214.86/215.05  |- skos__hiddenLabel mesh__D032496 Satellite Cell, Myogenic
% 214.86/215.05  |- skos__altLabel mesh__D032496 Satellite Cells, Myogenic
% 214.86/215.05  |- mesh__dateEstablished mesh__D032496 2003-01-01
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D032496 2003
% 214.86/215.05  |- skos__hiddenLabel mesh__D032496 Myogenic Satellite Cells
% 214.86/215.05  |- skos__broader mesh__D032496smesh__D032448
% 214.86/215.05  |- mesh__dateCreated mesh__D032496 2002-07-03
% 214.86/215.05  |- skos__hiddenLabel mesh__D032496 Cells, Myogenic Satellite
% 214.86/215.05  |- skos__hiddenLabel mesh__D032496 Cell, Myogenic Satellite
% 214.86/215.05  |- mesh__historyNote mesh__D032496 2003   
% 214.86/215.05  |- skos__historyNote mesh__D032496 Muscles/cytology %28%1965-1994%29%
% 214.86/215.05  |- skos__hiddenLabel mesh__D032496 Myogenic Satellite Cell
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D032496 2006
% 214.86/215.05  |- skos__prefLabel mesh__D037181 Lectins, C-Type
% 214.86/215.05  |- mesh__recordMaintainer mesh__D037181 jmp
% 214.86/215.05  |- skos__hiddenLabel mesh__D037181 Lectin, C Type
% 214.86/215.05  |- skos__altLabel mesh__D037181 Lectin, C-Type
% 214.86/215.05  |- mesh__publicMeSHNote mesh__D037181
% 214.86/215.05       2003; C-TYPE LECTIN %28%now LECTINS, C-TYPE%29% was indexed under LECTINS 1997-2002%A%  
% 214.86/215.05  |- mesh__dateEstablished mesh__D037181 2003-01-01
% 214.86/215.05  |- skos__broader mesh__D037181smesh__D037102
% 214.86/215.05  |- skos__scopeNote mesh__D037181
% 214.86/215.05       A class of animal lectins that bind to carbohydrate in a calcium-dependent manner. They share a common carbohydrate-binding domain that is structurally distinct from other classes of lectins.%A%    
% 214.86/215.05  |- skos__hiddenLabel mesh__D037181 Receptors, C Type Lectin
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D037181 2006
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D037181 2005
% 214.86/215.05  |- mesh__recordAuthorizer mesh__D037181 sjn
% 214.86/215.05  |- mesh__recordOriginator mesh__D037181 jmp
% 214.86/215.05  |- skos__altLabel mesh__D037181 C-Type Lectin
% 214.86/215.05  |- rdf__type mesh__D037181sskos__Concept
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D037181 2004
% 214.86/215.05  |- skos__hiddenLabel mesh__D037181 C Type Lectins
% 214.86/215.05  |- skos__hiddenLabel mesh__D037181 Lectins, C Type
% 214.86/215.05  |- mesh__historyNote mesh__D037181
% 214.86/215.05       2003; use LECTINS, C-TYPE %28%NM%29% 1997-2002   
% 214.86/215.05  |- skos__altLabel mesh__D037181 C-Type Lectins
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D037181 2003
% 214.86/215.05  |- skos__hiddenLabel mesh__D037181 C Type Lectin
% 214.86/215.05  |- mesh__dateCreated mesh__D037181 2002-07-03
% 214.86/215.05  |- skos__hiddenLabel mesh__D037181 Lectin Receptors, C-Type
% 214.86/215.05  |- skos__hiddenLabel mesh__D037181 C-Type Lectin Receptors
% 214.86/215.05  |- skos__scopeNote mesh__D012439
% 214.86/215.05       Flavoring agent and non-nutritive sweetener.     
% 214.86/215.05  |- mesh__recordMaintainer mesh__D012439 ssb
% 214.86/215.05  |- mesh__dateEstablished mesh__D012439 1971-01-01
% 214.86/215.05  |- mesh__dateRevised mesh__D012439 2005-06-30
% 214.86/215.05  |- mesh__dateCreated mesh__D012439 1999-01-01
% 214.86/215.05  |- skos__annotation mesh__D012439 D25-26 qualif   
% 214.86/215.05  |- mesh__recordOriginator mesh__D012439 NLM
% 214.86/215.05  |- mesh__onlineNote mesh__D012439 search SWEETENING AGENTS 1966-69   
% 214.86/215.05  |- skos__broader mesh__D012439smesh__D052160
% 214.86/215.05  |- skos__hiddenLabel mesh__D012439 Calcium, Saccharin
% 214.86/215.05  |- skos__broader mesh__D012439smesh__D013844
% 214.86/215.05  |- mesh__publicMeSHNote mesh__D012439
% 214.86/215.05       71; was see under SWEETENING AGENTS 1963-70   
% 214.86/215.05  |- skos__historyNote mesh__D012439 Sweetening Agents %28%1966-1969%29%
% 214.86/215.05  |- mesh__historyNote mesh__D012439
% 214.86/215.05       71%28%70%29%; was see under SWEETENING AGENTS 1963-70   
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D012439 2006
% 214.86/215.05  |- rdf__type mesh__D012439sskos__Concept
% 214.86/215.05  |- skos__prefLabel mesh__D012439 Saccharin
% 214.86/215.05  |- mesh__recordAuthorizer mesh__D012439 sjn
% 214.86/215.05  |- skos__hiddenLabel mesh__D009490 Systems, Neurosecretory
% 214.86/215.05  |- rdf__type mesh__D009490sskos__Concept
% 214.86/215.05  |- skos__hiddenLabel mesh__D009490 System, Neuroendocrine
% 214.86/215.05  |- skos__hiddenLabel mesh__D009490 Neurohemal Organs
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D009490 2000
% 214.86/215.05  |- skos__hiddenLabel mesh__D009490 System, Neurosecretory
% 214.86/215.05  |- skos__prefLabel mesh__D009490 Neurosecretory Systems
% 214.86/215.05  |- skos__hiddenLabel mesh__D009490 Organs, Neurohemal
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D009490 1999
% 214.86/215.05  |- skos__scopeNote mesh__D009490
% 214.86/215.05       A system of neurons that has the specialized function to produce and secrete hormones, and that constitutes, in whole or in part, an endocrine organ or system.%A%    
% 214.86/215.05  |- mesh__onlineNote mesh__D009490
% 214.86/215.05       use NEUROSECRETORY SYSTEMS to search NEUROHEMAL ORGAN 1970-83%A%  
% 214.86/215.05  |- skos__altLabel mesh__D009490 Neuroendocrine System
% 214.86/215.05  |- skos__broader mesh__D009490smesh__D004703
% 214.86/215.05  |- skos__related mesh__D009490smesh__D015213
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D009490 2004
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D009490 2006
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D009490 1998
% 214.86/215.05  |- mesh__publicMeSHNote mesh__D009490 70   
% 214.86/215.05  |- mesh__recordOriginator mesh__D009490 NLM
% 214.86/215.05  |- mesh__dateRevised mesh__D009490 1997-06-20
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D009490 2003
% 214.86/215.05  |- skos__hiddenLabel mesh__D009490 Systems, Neuroendocrine
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D009490 2002
% 214.86/215.05  |- skos__historyNote mesh__D009490 Neurosecretion %28%1966-1969%29%
% 214.86/215.05  |- skos__hiddenLabel mesh__D009490 Neuroendocrine Systems
% 214.86/215.05  |- mesh__recordMaintainer mesh__D009490 TPW
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D009490 2005
% 214.86/215.05  |- skos__related mesh__D009490smesh__D009489
% 214.86/215.05  |- mesh__historyNote mesh__D009490
% 214.86/215.05       70; NEUROHEMAL ORGAN was see under NEUROSECRETORY SYSTEMS 1970-83%A%  
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D009490 2001
% 214.86/215.05  |- mesh__recordAuthorizer mesh__D009490 SJN
% 214.86/215.05  |- mesh__dateCreated mesh__D009490 1999-01-01
% 214.86/215.05  |- mesh__dateEstablished mesh__D009490 1970-01-01
% 214.86/215.05  |- skos__hiddenLabel mesh__D009490 Organ, Neurohemal
% 214.86/215.05  |- skos__hiddenLabel mesh__D009490 Neurosecretory System
% 214.86/215.05  |- skos__annotation mesh__D009490
% 214.86/215.05       /secret = probably /physiol or NEUROSECRETION   
% 214.86/215.05  |- skos__broader mesh__D009490smesh__D009420
% 214.86/215.05  |- skos__related mesh__D017124smesh__D016384
% 214.86/215.05  |- mesh__recordOriginator mesh__D017124 PXP
% 214.86/215.05  |- mesh__historyNote mesh__D017124 93; was see BASE SEQUENCE 1988-92   
% 214.86/215.05  |- skos__broader mesh__D017124smesh__D015394
% 214.86/215.05  |- mesh__onlineNote mesh__D017124
% 214.86/215.05       use BASE SEQUENCE to search CONSERVED SEQUENCE 1988-92   
% 214.86/215.05  |- mesh__recordAuthorizer mesh__D017124 sjn
% 214.86/215.05  |- skos__historyNote mesh__D017124 Base Sequence %28%1973-1992%29%
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D017124 2005
% 214.86/215.05  |- skos__prefLabel mesh__D017124 Conserved Sequence
% 214.86/215.05  |- mesh__dateRevised mesh__D017124 2002-07-03
% 214.86/215.05  |- skos__historyNote mesh__D017124 Amino Acid Sequence %28%1977-1992%29%
% 214.86/215.05  |- skos__hiddenLabel mesh__D017124 Conserved Sequences
% 214.86/215.05  |- mesh__publicMeSHNote mesh__D017124 93; was see BASE SEQUENCE 1988-92   
% 214.86/215.05  |- skos__hiddenLabel mesh__D017124 Sequences, Conserved
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D017124 2006
% 214.86/215.05  |- mesh__dateCreated mesh__D017124 1992-05-13
% 214.86/215.05  |- mesh__dateEstablished mesh__D017124 1993-01-01
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D017124 2003
% 214.86/215.05  |- skos__scopeNote mesh__D017124
% 214.86/215.05       A sequence of amino acids in a polypeptide or of nucleotides in DNA or RNA that is similar across multiple species. A known set of conserved sequences is represented by a CONSENSUS SEQUENCE. AMINO ACID MOTIFS are often composed of conserved sequences.%A%    
% 214.86/215.05  |- skos__related mesh__D017124smesh__D020816
% 214.86/215.05  |- rdf__type mesh__D017124sskos__Concept
% 214.86/215.05  |- skos__annotation mesh__D017124
% 214.86/215.05       coord with AMINO ACID SEQUENCE %28%NIM%29% or BASE SEQUENCE %28%NIM%29%%A%  
% 214.86/215.05  |- skos__hiddenLabel mesh__D017124 Sequence, Conserved
% 214.86/215.05  |- mesh__recordMaintainer mesh__D017124 nns
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D017124 2004
% 214.86/215.05  |- skos__scopeNote mesh__D003902
% 214.86/215.05       Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing %28%oil-dissolving%29% and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties.%A%    
% 214.86/215.05  |- mesh__recordMaintainer mesh__D003902 ssb
% 214.86/215.05  |- skos__hiddenLabel mesh__D003902 Agents, Cleansing
% 214.86/215.05  |- skos__broader mesh__D003902smesh__D006795
% 214.86/215.05  |- skos__hiddenLabel mesh__D003902 Agent, Cleansing
% 214.86/215.05  |- mesh__dateEstablished mesh__D003902 1963-01-01
% 214.86/215.05  |- mesh__historyNote mesh__D003902
% 214.86/215.05       91%28%81%29%63; was see under SURFACE-ACTIVE AGENTS 1981-90; was heading 1963-80%A%  
% 214.86/215.05  |- skos__prefLabel mesh__D003902 Detergents
% 214.86/215.05  |- mesh__recordOriginator mesh__D003902 NLM
% 214.86/215.05  |- skos__hiddenLabel mesh__D003902 Detergent
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003902 2006
% 214.86/215.05  |- skos__broader mesh__D003902smesh__D013501
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003902 2004
% 214.86/215.05  |- mesh__dateRevised mesh__D003902 2003-07-09
% 214.86/215.05  |- skos__annotation mesh__D003902 D25-26 qualif   
% 214.86/215.05  |- mesh__publicMeSHNote mesh__D003902
% 214.86/215.05       91; was see under SURFACE-ACTIVE AGENTS 1981-90; was heading 1963-80%A%  
% 214.86/215.05  |- mesh__dateCreated mesh__D003902 1999-01-01
% 214.86/215.05  |- skos__hiddenLabel mesh__D003902 Cleansing Agent
% 214.86/215.05  |- mesh__recordAuthorizer mesh__D003902 sjn
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003902 2005
% 214.86/215.05  |- rdf__type mesh__D003902sskos__Concept
% 214.86/215.05  |- mesh__dateEstablished mesh__D050558 2006-01-01
% 214.86/215.05  |- rdf__type mesh__D050558sskos__Concept
% 214.86/215.05  |- mesh__historyNote mesh__D050558
% 214.86/215.05       2006%28%1980%29%; use CYSTEINE 1973-1979   
% 214.86/215.05  |- mesh__publicMeSHNote mesh__D050558
% 214.86/215.05       2006; CYSTEINE DIOXYGENASE was indexed under DIOXYGENASES 1981-2005, %26% under CYSTEINE 1973-1980%A%  
% 214.86/215.05  |- skos__scopeNote mesh__D050558
% 214.86/215.05       An enzyme that catalyzes the conversion of L-CYSTEINE to 3-sulfinoalanine %28%3-sulfino-L-alanine%29% in the CYSTEINE metabolism and TAURINE and hypotaurine metabolic pathways.%A%    
% 214.86/215.05  |- mesh__recordMaintainer mesh__D050558 AKE
% 214.86/215.05  |- skos__altLabel mesh__D050558 Cysteine Dioxygenase Type I
% 214.86/215.05  |- skos__prefLabel mesh__D050558 Cysteine Dioxygenase
% 214.86/215.05  |- mesh__dateCreated mesh__D050558 2005-06-30
% 214.86/215.05  |- skos__hiddenLabel mesh__D050558 Dioxygenase, Cysteine
% 214.86/215.05  |- skos__hiddenLabel mesh__D050558 Oxidase, Cysteine
% 214.86/215.05  |- skos__broader mesh__D050558smesh__D049308
% 214.86/215.05  |- mesh__recordAuthorizer mesh__D050558 sjn
% 214.86/215.05  |- skos__altLabel mesh__D050558 Cysteine Oxidase
% 214.86/215.05  |- mesh__recordOriginator mesh__D050558 AKE
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D050558 2006
% 214.86/215.05  |- skos__altLabel mesh__D003104 Monkey, Colobus
% 214.86/215.05  |- skos__scopeNote mesh__D003104
% 214.86/215.05       A genus of Old World monkeys, subfamily COLOBINAE, family CERCOPITHECIDAE, that inhabits the forests of Africa. It consists of eight species: C. angolensis %28%Angolan colobus%29%, C. badius or C. rufomitratus %28%Red or Bay colobus%29%, C. guereza %28%Guereza or Eastern black-and-white colobus%29%, C. kirkii %28%Kirk%27%s colobus%29%, C. polykomos %28%King colobus or Western black-and-white colobus%29%, C. satanas %28%Black colobus%29%, and C. verus %28%Olive colobus%29%. Some authors recognize Procolobus as a separate genus and then the olive colobus is recognized as the species P. verus.%A%    
% 214.86/215.05  |- mesh__recordAuthorizer mesh__D003104 sjn
% 214.86/215.05  |- skos__prefLabel mesh__D003104 Colobus
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003104 2006
% 214.86/215.05  |- mesh__recordMaintainer mesh__D003104 ags
% 214.86/215.05  |- skos__hiddenLabel mesh__D003104 Colobus Monkey
% 214.86/215.05  |- skos__hiddenLabel mesh__D003104 Colobus Monkeys
% 214.86/215.05  |- skos__hiddenLabel mesh__D003104 Monkeys, Colobus
% 214.86/215.05  |- skos__broader mesh__D003104smesh__D016673
% 214.86/215.05  |- mesh__dateCreated mesh__D003104 1974-11-11
% 214.86/215.05  |- rdf__type mesh__D003104sskos__Concept
% 214.86/215.05  |- mesh__dateEstablished mesh__D003104 1991-01-01
% 214.86/215.05  |- skos__annotation mesh__D003104
% 214.86/215.05       Old World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 214.86/215.05  |- mesh__recordOriginator mesh__D003104 NLM
% 214.86/215.05  |- mesh__historyNote mesh__D003104
% 214.86/215.05       91%28%75%29%; was see under CERCOPITHECIDAE 1981-90; was see under MONKEYS 1975-80%A%  
% 214.86/215.05  |- mesh__publicMeSHNote mesh__D003104
% 214.86/215.05       91; was see under CERCOPITHECIDAE 1981-90; was see under MONKEYS 1975-80%A%  
% 214.86/215.05  |- mesh__dateRevised mesh__D003104 2005-06-30
% 214.86/215.05  |- skos__hiddenLabel mesh__D008398 Masochisms
% 214.86/215.05  |- skos__hiddenLabel mesh__D008398 Masochisms, Sexual
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D008398 2002
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D008398 2004
% 214.86/215.05  |- skos__hiddenLabel mesh__D008398 Masochism, Sexual
% 214.86/215.05  |- mesh__recordMaintainer mesh__D008398 JLS
% 214.86/215.05  |- mesh__dateCreated mesh__D008398 1999-01-01
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D008398 2003
% 214.86/215.05  |- skos__prefLabel mesh__D008398 Masochism
% 214.86/215.05  |- mesh__recordAuthorizer mesh__D008398 SJN
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D008398 2001
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D008398 2006
% 214.86/215.05  |- skos__hiddenLabel mesh__D008398 Sexual Masochisms
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D008398 2000
% 214.86/215.05  |- mesh__recordOriginator mesh__D008398 NLM
% 214.86/215.05  |- mesh__dateRevised mesh__D008398 1998-06-10
% 214.86/215.05  |- skos__broader mesh__D008398smesh__D010262
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D008398 1999
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D008398 2005
% 214.86/215.05  |- rdf__type mesh__D008398sskos__Concept
% 214.86/215.05  |- skos__scopeNote mesh__D008398
% 214.86/215.05       Pleasure derived from being physically or psychologically abused, whether inflicted by oneself or by others. Masochism includes sexual masochism.%A%    
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D013532 1998
% 214.86/215.05  |- skos__prefLabel mesh__D013532 Suriname
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D013532 2003
% 214.86/215.05  |- skos__scopeNote mesh__D013532
% 214.86/215.05       A republic in the north of South America, bordered on the west by GUYANA %28%British Guiana%29% and on the east by FRENCH GUIANA. Its capital is Paramaribo. It was formerly called Netherlands Guiana or Dutch Guiana or Surinam. Suriname was first settled by the English in 1651 but was ceded to the Dutch by treaty in 1667. It became an autonomous territory under the Dutch crown in 1954 and gained independence in 1975. The country was named for the Surinam River but the meaning of that name is uncertain. %28%From Webster%27%s New Geographical Dictionary, 1988, p1167 %26% Room, Brewer%27%s Dictionary of Names, 1992, p526%29%%A%    
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D013532 2000
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D013532 1999
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D013532 2004
% 214.86/215.05  |- mesh__onlineNote mesh__D013532 use SURINAME to search SURINAM 1966-80   
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D013532 2001
% 214.86/215.05  |- rdf__type mesh__D013532sskos__Concept
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D013532 2005
% 214.86/215.05  |- mesh__dateCreated mesh__D013532 1999-01-01
% 214.86/215.05  |- skos__altLabel mesh__D013532 Surinam
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D013532 2002
% 214.86/215.05  |- skos__altLabel mesh__D013532 Netherlands Guiana
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D013532 2006
% 214.86/215.05  |- skos__altLabel mesh__D013532 Dutch Guiana
% 214.86/215.05  |- skos__broader mesh__D013532smesh__D013020
% 214.86/215.05  |- mesh__historyNote mesh__D013532 81; was SURINAM 1963-80   
% 214.86/215.05  |- mesh__recordOriginator mesh__D013532 NLM
% 214.86/215.05  |- mesh__dateRevised mesh__D013532 1997-06-20
% 214.86/215.05  |- mesh__recordAuthorizer mesh__D013532 SJN
% 214.86/215.05  |- mesh__recordMaintainer mesh__D013532 TGC
% 214.86/215.05  |- skos__annotation mesh__D013532
% 214.86/215.05       in So. Amer; X refs NETHERLANDS GUIANA %26% DUTCH GUIANA were former names; in translations use American spelling Suriname, not Surinam%A%  
% 214.86/215.05  |- skos__scopeNote mesh__D032497
% 214.86/215.05       The bracken fern plant family of the order Polypodiales, class Filicopsida, division Pteridophyta.%A%    
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D032497 2004
% 214.86/215.05  |- rdf__type mesh__D032497sskos__Concept
% 214.86/215.05  |- mesh__dateCreated mesh__D032497 2002-07-03
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D032497 2003
% 214.86/215.05  |- mesh__historyNote mesh__D032497 2003   
% 214.86/215.05  |- skos__annotation mesh__D032497
% 214.86/215.05       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D032497 2006
% 214.86/215.05  |- mesh__publicMeSHNote mesh__D032497 2003   
% 214.86/215.05  |- skos__prefLabel mesh__D032497 Dennstaedtiaceae
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D032497 2005
% 214.86/215.05  |- mesh__dateEstablished mesh__D032497 2003-01-01
% 214.86/215.05  |- skos__broader mesh__D032497smesh__D029624
% 214.86/215.05  |- skos__hiddenLabel mesh__D037182 Specificity, T-Cell
% 214.86/215.05  |- skos__hiddenLabel mesh__D037182 T Cell Receptor Specificity
% 214.86/215.05  |- skos__hiddenLabel mesh__D037182 T Cell Immunologic Specificity
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D037182 2005
% 214.86/215.05  |- skos__prefLabel mesh__D037182 T-Cell Antigen Receptor Specificity
% 214.86/215.05  |- skos__hiddenLabel mesh__D037182 Specificity, T-Cell Receptor
% 214.86/215.05  |- mesh__recordMaintainer mesh__D037182 ags
% 214.86/215.05  |- mesh__recordOriginator mesh__D037182 ags
% 214.86/215.05  |- skos__scopeNote mesh__D037182
% 214.86/215.05       The property of the T-CELL RECEPTOR which enables it to react with some antigens and not others. The specificity is derived from the structure of the receptor%27%s variable region which has the ability to recognize certain antigens in conjunction with the MAJOR HISTOCOMPATIBILITY COMPLEX molecule.%A%    
% 214.86/215.05  |- skos__hiddenLabel mesh__D037182 T Cell Antigen Receptor Specificity
% 214.86/215.05  |- rdf__type mesh__D037182sskos__Concept
% 214.86/215.05  |- skos__altLabel mesh__D037182 T-Cell Immunologic Specificity
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D037182 2004
% 214.86/215.05  |- mesh__dateCreated mesh__D037182 2002-07-03
% 214.86/215.05  |- mesh__dateRevised mesh__D037182 2005-07-20
% 214.86/215.05  |- skos__hiddenLabel mesh__D037182 Specificity, T-Cell Immunologic
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D037182 2006A
% 214.86/215.05  |- skos__broader mesh__D037182smesh__D007109
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D037182 2003
% 214.86/215.05  |- mesh__dateEstablished mesh__D037182 2003-01-01
% 214.86/215.05  |- skos__related mesh__D037182smesh__D000918
% 214.86/215.05  |- skos__annotation mesh__D037182 T-cell cross-reactivity goes here   
% 214.86/215.05  |- mesh__publicMeSHNote mesh__D037182 2003   
% 214.86/215.05  |- mesh__historyNote mesh__D037182 2003   
% 214.86/215.05  |- skos__altLabel mesh__D037182 T-Cell Receptor Specificity
% 214.86/215.05  |- mesh__recordAuthorizer mesh__D037182 ags
% 214.86/215.05  |- skos__hiddenLabel mesh__D037182 T Cell Specificity
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D037182 2006
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D037182 2005A
% 214.86/215.05  |- skos__hiddenLabel mesh__D037182 Immunologic Specificity, T-Cell
% 214.86/215.05  |- skos__broader mesh__D009491smesh__D020037
% 214.86/215.05  |- mesh__recordAuthorizer mesh__D009491 sjn
% 214.86/215.05  |- skos__scopeNote mesh__D009491
% 214.86/215.05       A genus of ascomycetous fungi, family Sordariaceae, order SORDARIALES, comprising bread molds. They are capable of converting tryptophan to nicotinic acid and are used extensively in genetic and enzyme research. %28%Dorland, 27th ed%29%%A%    
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D009491 2006
% 214.86/215.05  |- mesh__recordMaintainer mesh__D009491 SYSTEM
% 214.86/215.05  |- mesh__dateRevised mesh__D009491 2005-06-30
% 214.86/215.05  |- mesh__dateCreated mesh__D009491 1999-01-01
% 214.86/215.05  |- skos__annotation mesh__D009491
% 214.86/215.05       an ascomycete much used in genetic %26% enzyme research; do not confuse with NEOSPORA, a protozoon%A%  
% 214.86/215.05  |- mesh__recordOriginator mesh__D009491 NLM
% 214.86/215.05  |- skos__prefLabel mesh__D009491 Neurospora
% 214.86/215.05  |- rdf__type mesh__D009491sskos__Concept
% 214.86/215.05  |- rdf__type mesh__D017923sskos__Concept
% 214.86/215.05  |- skos__hiddenLabel mesh__D017923 Antiporter, Sodium-Proton
% 214.86/215.05  |- skos__altLabel mesh__D017923 Sodium-Proton Antiporter
% 214.86/215.05  |- mesh__onlineNote mesh__D017923
% 214.86/215.05       use SODIUM-HYDROGEN ANTIPORTER %28%NM%29% to search SODIUM-HYDROGEN ANTIPORTER 1980-93%A%  
% 214.86/215.05  |- skos__historyNote mesh__D017923 Carrier Proteins %28%1980-1993%29%
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D017923 2006
% 214.86/215.05  |- mesh__publicMeSHNote mesh__D017923
% 214.86/215.05       94; SODIUM-HYDROGEN ANTIPORTER was indexed under CARRIER PROTEINS 1980-93%A%  
% 214.86/215.05  |- mesh__recordMaintainer mesh__D017923 jmp
% 214.86/215.05  |- skos__prefLabel mesh__D017923 Sodium-Hydrogen Antiporter
% 214.86/215.05  |- mesh__dateCreated mesh__D017923 1993-02-16
% 214.86/215.05  |- mesh__dateEstablished mesh__D017923 1994-01-01
% 214.86/215.05  |- skos__hiddenLabel mesh__D017923 Exchanger, Sodium-Hydrogen
% 214.86/215.05  |- skos__hiddenLabel mesh__D017923 Antiporter, Sodium-Hydrogen
% 214.86/215.05  |- skos__scopeNote mesh__D017923
% 214.86/215.05       A plasma membrane exchange glycoprotein transporter that functions in intracellular pH regulation, cell volume regulation, and cellular response to many different hormones and mitogens.%A%    
% 214.86/215.05  |- skos__annotation mesh__D017923 a carrier protein   
% 214.86/215.05  |- mesh__dateRevised mesh__D017923 2005-06-30
% 214.86/215.05  |- skos__altLabel mesh__D017923 Na%28%+%29%-H%28%+%29%-Antiporter
% 214.86/215.05  |- skos__altLabel mesh__D017923 Sodium-Hydrogen Exchanger
% 214.86/215.05  |- skos__broader mesh__D017923smesh__D017920
% 214.86/215.05  |- skos__historyNote mesh__D017923
% 214.86/215.05       Biological Transport, Active %28%1976-1982%29%
% 214.86/215.05  |- skos__altLabel mesh__D017923 Na%28%+%29%-H%28%+%29%-Exchanger
% 214.86/215.05  |- mesh__historyNote mesh__D017923
% 214.86/215.05       94; was SODIUM-HYDROGEN ANTIPORTER %28%NM%29% 1980-93   
% 214.86/215.05  |- mesh__recordOriginator mesh__D017923 PXP
% 214.86/215.05  |- skos__hiddenLabel mesh__D017923 Sodium Hydrogen Antiporter
% 214.86/215.05  |- mesh__recordAuthorizer mesh__D017923 sjn
% 214.86/215.05  |- skos__hiddenLabel mesh__D017923 Sodium Proton Antiporter
% 214.86/215.05  |- skos__hiddenLabel mesh__D017923 Sodium Hydrogen Exchanger
% 214.86/215.05  |- skos__broader mesh__D017125smesh__D018503
% 214.86/215.05  |- skos__scopeNote mesh__D017125
% 214.86/215.05       The functional hereditary units of PROTOZOA.     
% 214.86/215.05  |- mesh__dateRevised mesh__D017125 2005-06-30
% 214.86/215.05  |- mesh__dateCreated mesh__D017125 1992-05-20
% 214.86/215.05  |- mesh__recordMaintainer mesh__D017125 nns
% 214.86/215.05  |- mesh__historyNote mesh__D017125 93   
% 214.86/215.05  |- skos__hiddenLabel mesh__D017125 Gene, Protozoan
% 214.86/215.05  |- skos__prefLabel mesh__D017125 Genes, Protozoan
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D017125 2006
% 214.86/215.05  |- skos__broader mesh__D017125smesh__D005796
% 214.86/215.05  |- skos__related mesh__D017125smesh__D018503
% 214.86/215.05  |- skos__historyNote mesh__D017125 specific protozoa %28%1966-1992%29%
% 214.86/215.05  |- mesh__recordAuthorizer mesh__D017125 sjn
% 214.86/215.05  |- mesh__publicMeSHNote mesh__D017125 93   
% 214.86/215.05  |- skos__altLabel mesh__D017125 Protozoan Genes
% 214.86/215.05  |- skos__annotation mesh__D017125
% 214.86/215.05       coordinate IM with specific protozoon /genet %28%IM%29%   
% 214.86/215.05  |- rdf__type mesh__D017125sskos__Concept
% 214.86/215.05  |- mesh__recordOriginator mesh__D017125 PXP
% 214.86/215.05  |- skos__hiddenLabel mesh__D017125 Protozoan Gene
% 214.86/215.05  |- skos__historyNote mesh__D017125 Genes %28%1966-1992%29%
% 214.86/215.05  |- mesh__dateEstablished mesh__D017125 1993-01-01
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003903 2000
% 214.86/215.05  |- skos__annotation mesh__D003903
% 214.86/215.05       heavy hydrogen; HEAVY WATER see DEUTERIUM OXIDE is also available%A%  
% 214.86/215.05  |- skos__scopeNote mesh__D003903
% 214.86/215.05       Deuterium. The stable isotope of hydrogen. It has one neutron and one proton in the nucleus.%A%    
% 214.86/215.05  |- skos__broader mesh__D003903smesh__D007554
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003903 1998
% 214.86/215.05  |- mesh__recordAuthorizer mesh__D003903 PLS
% 214.86/215.05  |- skos__broader mesh__D003903smesh__D006859
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003903 2006
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003903 2002
% 214.86/215.05  |- mesh__recordMaintainer mesh__D003903 TGC
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003903 2004
% 214.86/215.05  |- mesh__dateCreated mesh__D003903 1999-01-01
% 214.86/215.05  |- mesh__recordOriginator mesh__D003903 NLM
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003903 2005
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003903 2003
% 214.86/215.05  |- skos__prefLabel mesh__D003903 Deuterium
% 214.86/215.05  |- rdf__type mesh__D003903sskos__Concept
% 214.86/215.05  |- mesh__dateRevised mesh__D003903 1996-06-10
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003903 1999
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003903 2001
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003903 1997
% 214.86/215.05  |- skos__altLabel mesh__D050559 beta, beta-Carotene-15,15%27%-Dioxygenase
% 214.86/215.05  |- skos__hiddenLabel mesh__D050559 Dioxygenase, Carotene
% 214.86/215.05  |- skos__hiddenLabel mesh__D050559 beta Carotene Cleaving Enzyme
% 214.86/215.05  |- skos__altLabel mesh__D050559 beta-Carotene Cleaving Enzyme
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D050559 2006
% 214.86/215.05  |- mesh__recordAuthorizer mesh__D050559 sjn
% 214.86/215.05  |- skos__hiddenLabel mesh__D050559 15,15%27%-Dioxygenase, beta-Carotene
% 214.86/215.05  |- rdf__type mesh__D050559sskos__Concept
% 214.86/215.05  |- mesh__dateCreated mesh__D050559 2005-06-30
% 214.86/215.05  |- skos__broader mesh__D050559smesh__D044943
% 214.86/215.05  |- mesh__recordMaintainer mesh__D050559 AKE
% 214.86/215.05  |- skos__altLabel mesh__D050559 Carotene Dioxygenase
% 214.86/215.05  |- skos__altLabel mesh__D050559 beta, beta-Carotene-15,15%27%-Monooxygenase
% 214.86/215.05  |- skos__hiddenLabel mesh__D050559 beta Carotene 15,15%27% Monooxygenase
% 214.86/215.05  |- skos__hiddenLabel mesh__D050559 15,15%27%-Monooxygenase, beta-Carotene
% 214.86/215.05  |- mesh__dateEstablished mesh__D050559 2006-01-01
% 214.86/215.05  |- mesh__historyNote mesh__D050559
% 214.86/215.05       2006%28%1980%29%; use OXYGENASES 1969-1979   
% 214.86/215.05  |- skos__prefLabel mesh__D050559 beta-Carotene 15,15%27%-Monooxygenase
% 214.86/215.05  |- skos__hiddenLabel mesh__D050559 beta Carotene 15,15%27% Dioxygenase
% 214.86/215.05  |- skos__altLabel mesh__D050559 beta-Carotene 15,15%27%-Dioxygenase
% 214.86/215.05  |- skos__hiddenLabel mesh__D050559 Cleaving Enzyme, beta-Carotene
% 214.86/215.05  |- skos__scopeNote mesh__D050559
% 214.86/215.05       A monooxygenase that catalyzes the conversion of BETA-CAROTENE into two molecules of RETINAL. It was formerly characterized as EC 1.13.11.21 and EC 1.18.3.1.%A%    
% 214.86/215.05  |- mesh__publicMeSHNote mesh__D050559
% 214.86/215.05       2006; BETA-CAROTENE 15,15%27%-MONOOXYGENASE was indexed under OXYGENASES 1969-2005%A%  
% 214.86/215.05  |- mesh__recordOriginator mesh__D050559 AKE
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003105 2002
% 214.86/215.05  |- mesh__recordOriginator mesh__D003105 NLM
% 214.86/215.05  |- mesh__recordAuthorizer mesh__D003105 PLS
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003105 1991
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003105 1989
% 214.86/215.05  |- rdf__type mesh__D003105sskos__Concept
% 214.86/215.05  |- mesh__dateCreated mesh__D003105 1999-01-01
% 214.86/215.05  |- skos__prefLabel mesh__D003105 Colombia
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003105 2000
% 214.86/215.05  |- skos__broader mesh__D003105smesh__D013020
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003105 2003
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003105 1996
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003105 2001
% 214.86/215.05  |- mesh__dateRevised mesh__D003105 1991-11-04
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003105 2005
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003105 1998
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003105 2004
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003105 1992
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003105 1990
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003105 1997
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003105 1994
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003105 2006
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003105 1999
% 214.86/215.05  |- mesh__activeMeSHYear mesh__D003105 1993
% 214.86/215.05  |- mesh__recordMaintainer mesh__D003105 PLS
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D003105 1995
% 214.86/215.06  |- mesh__dateRevised mesh__D008399 2002-07-02
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D008399 2003
% 214.86/215.06  |- skos__hiddenLabel mesh__D008399 Behaviors, Mass
% 214.86/215.06  |- mesh__recordOriginator mesh__D008399 NLM
% 214.86/215.06  |- skos__broader mesh__D008399smesh__D012919
% 214.86/215.06  |- mesh__dateEstablished mesh__D008399 1974-01-01
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D008399 2006
% 214.86/215.06  |- skos__related mesh__D008399smesh__D012305
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D008399 2005
% 214.86/215.06  |- rdf__type mesh__D008399sskos__Concept
% 214.86/215.06  |- mesh__recordMaintainer mesh__D008399 JLS
% 214.86/215.06  |- mesh__historyNote mesh__D008399 74   
% 214.86/215.06  |- skos__hiddenLabel mesh__D008399 Mass Behaviors
% 214.86/215.06  |- skos__related mesh__D008399smesh__D002960
% 214.86/215.06  |- skos__scopeNote mesh__D008399
% 214.86/215.06       Collective behavior of an aggregate of individuals giving the appearance of unity of attitude, feeling, and motivation.%A%    
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D008399 2004
% 214.86/215.06  |- mesh__publicMeSHNote mesh__D008399 74   
% 214.86/215.06  |- skos__prefLabel mesh__D008399 Mass Behavior
% 214.86/215.06  |- skos__annotation mesh__D008399
% 214.86/215.06       differentiate from GROUP PROCESSES: mass will probably be on a civil or pathol or mob level; no qualif%A%  
% 214.86/215.06  |- mesh__dateCreated mesh__D008399 1999-01-01
% 214.86/215.06  |- skos__hiddenLabel mesh__D008399 Behavior, Mass
% 214.86/215.06  |- mesh__recordAuthorizer mesh__D008399 sjn
% 214.86/215.06  |- skos__hiddenLabel mesh__D013533 Surrogate Mother
% 214.86/215.06  |- skos__hiddenLabel mesh__D013533 Mothers, Host
% 214.86/215.06  |- mesh__recordOriginator mesh__D013533 EC
% 214.86/215.06  |- mesh__dateCreated mesh__D013533 1985-03-20
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013533 2004
% 214.86/215.06  |- mesh__recordAuthorizer mesh__D013533 sjn
% 214.86/215.06  |- skos__hiddenLabel mesh__D013533 Mother, Surrogate
% 214.86/215.06  |- skos__altLabel mesh__D013533 Gestational Mothers
% 214.86/215.06  |- skos__hiddenLabel mesh__D013533 Carriers, Gestational
% 214.86/215.06  |- rdf__type mesh__D013533sskos__Concept
% 214.86/215.06  |- mesh__dateRevised mesh__D013533 2001-07-25
% 214.86/215.06  |- mesh__publicMeSHNote mesh__D013533 90; was see under MOTHERS 1986-89   
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013533 2005
% 214.86/215.06  |- mesh__dateEstablished mesh__D013533 1990-01-01
% 214.86/215.06  |- skos__historyNote mesh__D013533 Ethics, Medical %28%1966-1985%29%
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013533 2006
% 214.86/215.06  |- skos__hiddenLabel mesh__D013533 Gestational Carrier
% 214.86/215.06  |- skos__prefLabel mesh__D013533 Surrogate Mothers
% 214.86/215.06  |- skos__altLabel mesh__D013533 Mothers, Surrogate
% 214.86/215.06  |- skos__hiddenLabel mesh__D013533 Gestational Mother
% 214.86/215.06  |- skos__hiddenLabel mesh__D013533 Mother, Gestational
% 214.86/215.06  |- skos__hiddenLabel mesh__D013533 Host Mother
% 214.86/215.06  |- skos__hiddenLabel mesh__D013533 Carrier, Gestational
% 214.86/215.06  |- skos__scopeNote mesh__D013533
% 214.86/215.06       Women who allow themselves to be impregnated with the understanding that the offspring are to be given over to the parents who have commissioned the surrogate.%A%    
% 214.86/215.06  |- skos__historyNote mesh__D013533
% 214.86/215.06       Insemination, Artificial, Heterologous %28%1975-1985%29%
% 214.86/215.06  |- skos__altLabel mesh__D013533 Gestational Carriers
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013533 2002
% 214.86/215.06  |- mesh__recordMaintainer mesh__D013533 mdb
% 214.86/215.06  |- skos__historyNote mesh__D013533
% 214.86/215.06       Insemination, Artificial %28%1966-1985%29%
% 214.86/215.06  |- skos__altLabel mesh__D013533 Mothers, Gestational
% 214.86/215.06  |- skos__annotation mesh__D013533
% 214.86/215.06       human only; check tags HUMAN; FEMALE %26% PREGNANCY   
% 214.86/215.06  |- mesh__historyNote mesh__D013533
% 214.86/215.06       90%28%86%29%; was see under MOTHERS 1986-89   
% 214.86/215.06  |- skos__hiddenLabel mesh__D013533 Mother, Host
% 214.86/215.06  |- skos__altLabel mesh__D013533 Host Mothers
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013533 2003
% 214.86/215.06  |- skos__broader mesh__D013533smesh__D010290
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D032498 2004
% 214.86/215.06  |- skos__altLabel mesh__D032498 Fern, Bracken
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D032498 2003
% 214.86/215.06  |- skos__prefLabel mesh__D032498 Pteridium
% 214.86/215.06  |- mesh__dateRevised mesh__D032498 2005-07-13
% 214.86/215.06  |- mesh__historyNote mesh__D032498 2003   
% 214.86/215.06  |- mesh__recordMaintainer mesh__D032498 ags
% 214.86/215.06  |- skos__annotation mesh__D032498
% 214.86/215.06       do not confuse X ref FERN, BRACKEN with FERN, BRAKE see PTERIS; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.86/215.06  |- skos__altLabel mesh__D032498 Pteris aquilina
% 214.86/215.06  |- skos__altLabel mesh__D032498 Brackenfern
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D032498 2006A
% 214.86/215.06  |- skos__scopeNote mesh__D032498
% 214.86/215.06       A plant genus of the family DENNSTAEDTIACEAE. Members contain ptaquiloside, braxin A1, and braxin B. The name is similar to brake fern %28%PTERIS%29%.%A%    
% 214.86/215.06  |- skos__altLabel mesh__D032498 Pteridium esculentum
% 214.86/215.06  |- skos__broader mesh__D032498smesh__D032497
% 214.86/215.06  |- skos__altLabel mesh__D032498 Pteris esculentum
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D032498 2006
% 214.86/215.06  |- mesh__dateCreated mesh__D032498 2002-07-02
% 214.86/215.06  |- mesh__publicMeSHNote mesh__D032498 2003   
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D032498 2005
% 214.86/215.06  |- mesh__recordOriginator mesh__D032498 ssb
% 214.86/215.06  |- mesh__dateEstablished mesh__D032498 2003-01-01
% 214.86/215.06  |- rdf__type mesh__D032498sskos__Concept
% 214.86/215.06  |- mesh__recordAuthorizer mesh__D032498 ags
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D037981 2005
% 214.86/215.06  |- skos__hiddenLabel mesh__D037981 Radical Neck Dissections
% 214.86/215.06  |- skos__historyNote mesh__D037981
% 214.86/215.06       Radical Neck Dissection %28%1965-2002%29%
% 214.86/215.06  |- skos__annotation mesh__D037981
% 214.86/215.06       usually for cancer; do not use /util except by MeSH definition%A%  
% 214.86/215.06  |- skos__prefLabel mesh__D037981 Neck Dissection
% 214.86/215.06  |- mesh__recordMaintainer mesh__D037981 lkt
% 214.86/215.06  |- mesh__dateEstablished mesh__D037981 2003-01-01
% 214.86/215.06  |- skos__hiddenLabel mesh__D037981 Neck Dissection, Radical
% 214.86/215.06  |- rdf__type mesh__D037981sskos__Concept
% 214.86/215.06  |- skos__scopeNote mesh__D037981
% 214.86/215.06       Dissection in the neck to remove all disease tissues including cervical LYMPH NODES and to leave an adequate margin of normal tissue. This type of surgery is usually used in tumors or cervical metastases in the head and neck. The prototype of neck dissection is the radical neck dissection described by Crile in 1906.%A%    
% 214.86/215.06  |- mesh__dateCreated mesh__D037981 2002-07-03
% 214.86/215.06  |- mesh__historyNote mesh__D037981
% 214.86/215.06       2003; for RADICAL NECK DISSECTION use RADICAL NECK DISSECTION 1965-2002%A%  
% 214.86/215.06  |- mesh__recordAuthorizer mesh__D037981 sjn
% 214.86/215.06  |- skos__hiddenLabel mesh__D037981 Dissection, Neck
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D037981 2004
% 214.86/215.06  |- mesh__recordOriginator mesh__D037981 lkt
% 214.86/215.06  |- skos__hiddenLabel mesh__D037981 Neck Dissections, Radical
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D037981 2003
% 214.86/215.06  |- mesh__publicMeSHNote mesh__D037981
% 214.86/215.06       2003; for RADICAL NECK DISSECTION see RADICAL NECK DISSECTION 1965-2002%A%  
% 214.86/215.06  |- skos__hiddenLabel mesh__D037981 Neck Dissections
% 214.86/215.06  |- skos__hiddenLabel mesh__D037981 Dissection, Radical Neck
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D037981 2006
% 214.86/215.06  |- skos__broader mesh__D037981smesh__D013517
% 214.86/215.06  |- skos__broader mesh__D037981smesh__D008197
% 214.86/215.06  |- skos__historyNote mesh__D037981 Lymph Node Dissection %28%1966-2002%29%
% 214.86/215.06  |- skos__hiddenLabel mesh__D037981 Dissections, Neck
% 214.86/215.06  |- skos__hiddenLabel mesh__D037981 Dissections, Radical Neck
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D023961 2004
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D023961 2005
% 214.86/215.06  |- skos__broader mesh__D023961smesh__D006059
% 214.86/215.06  |- rdf__type mesh__D023961sskos__Concept
% 214.86/215.06  |- skos__scopeNote mesh__D023961
% 214.86/215.06       The 46,XX gonadal dysgenesis may be sporadic or familial. Familial XX gonadal dysgenesis is transmitted as an autosomal recessive trait and its locus was mapped to chromosome 2. Mutation in the gene for the FSH receptor %28%RECEPTORS, FSH%29% was detected.  Sporadic XX gonadal dysgenesis is heterogeneous and has been associated with trisomy-13 and trisomy-18. These phenotypic females are characterized by a normal stature, sexual infantilism, bilateral streak gonads, amenorrhea, elevated plasma LUTEINIZING HORMONE and FSH concentration. The syndrome is sometimes called %22%pure gonadal dysgenesis,%22% but this designation may also refer to gonadal dysgenesis with a 46,XY karyotype %28%GONADAL DYSGENESIS, 46,XY%29%.%A%    
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D023961 2003
% 214.86/215.06  |- mesh__dateCreated mesh__D023961 2001-08-03
% 214.86/215.06  |- mesh__recordOriginator mesh__D023961 lkt
% 214.86/215.06  |- skos__prefLabel mesh__D023961 Gonadal Dysgenesis, 46,XX
% 214.86/215.06  |- skos__historyNote mesh__D023961 Gonadal Dysgenesis %28%1980-2001%29%
% 214.86/215.06  |- mesh__publicMeSHNote mesh__D023961 2002   
% 214.86/215.06  |- mesh__dateRevised mesh__D023961 2002-07-03
% 214.86/215.06  |- mesh__recordAuthorizer mesh__D023961 sjn
% 214.86/215.06  |- skos__historyNote mesh__D023961
% 214.86/215.06       Sex Differentiation Disorders %28%1966-1979%29%
% 214.86/215.06  |- mesh__historyNote mesh__D023961 2002   
% 214.86/215.06  |- mesh__recordMaintainer mesh__D023961 sjn
% 214.86/215.06  |- mesh__dateEstablished mesh__D023961 2002-01-01
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D023961 2006
% 214.86/215.06  |- mesh__publicMeSHNote mesh__D009492 91; see NEUROSPORA 1972-90   
% 214.86/215.06  |- mesh__recordMaintainer mesh__D009492 ags
% 214.86/215.06  |- skos__broader mesh__D009492smesh__D009491
% 214.86/215.06  |- mesh__recordOriginator mesh__D009492 NLM
% 214.86/215.06  |- skos__historyNote mesh__D009492 Neurospora %28%1966-1971%29%
% 214.86/215.06  |- mesh__dateRevised mesh__D009492 2005-08-01
% 214.86/215.06  |- mesh__dateCreated mesh__D009492 1999-01-01
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D009492 2006A
% 214.86/215.06  |- mesh__recordAuthorizer mesh__D009492 ags
% 214.86/215.06  |- rdf__type mesh__D009492sskos__Concept
% 214.86/215.06  |- skos__annotation mesh__D009492
% 214.86/215.06       do not confuse with NEOSPORA, a protozoan; DF: N CRASSA   
% 214.86/215.06  |- mesh__historyNote mesh__D009492 91%28%72%29%   
% 214.86/215.06  |- skos__prefLabel mesh__D009492 Neurospora crassa
% 214.86/215.06  |- skos__scopeNote mesh__D009492
% 214.86/215.06       A species of ascomycetous fungi of the family Sordariaceae, order SORDARIALES, much used in biochemical, genetic, and physiologic studies.%A%    
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D009492 2006
% 214.86/215.06  |- mesh__dateEstablished mesh__D009492 1991-01-01
% 214.86/215.06  |- skos__hiddenLabel mesh__D017924 Polyhedrosis Viruses, Nuclear
% 214.86/215.06  |- skos__annotation mesh__D017924
% 214.86/215.06       a genus of insect viruses of the family Baculoviridae; coord IM with specific insect /virol %28%IM%29%%A%  
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D017924 1999
% 214.86/215.06  |- mesh__recordOriginator mesh__D017924 AGS
% 214.86/215.06  |- skos__hiddenLabel mesh__D017924 Viruses, Nuclear Polyhedrosis
% 214.86/215.06  |- skos__broader mesh__D017924smesh__D016367
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D017924 2003
% 214.86/215.06  |- mesh__historyNote mesh__D017924
% 214.86/215.06       97; was NUCLEAR POLYHEDROSIS VIRUS 1994-96, was NUCLEAR POLYHEDROSIS VIRUSES see BACULOVIRIDAE 1991-93, was see POLYHEDROSIS VIRUSES 1975-90; POLYHEDROSIS VIRUSES was heading 1978-90, was see under INSECT VIRUSES 1973-77 %28%Prov 1973-74%29%%A%  
% 214.86/215.06  |- skos__prefLabel mesh__D017924 Nucleopolyhedrovirus
% 214.86/215.06  |- mesh__onlineNote mesh__D017924
% 214.86/215.06       use NUCLEOPOLYHEDROVIRUS to search NUCLEAR POLYHEDROSIS VIRUS 1994-96; use BACULOVIRIDAE to search NUCLEAR POLYHEDROSIS VIRUSES 1973-93%A%  
% 214.86/215.06  |- skos__hiddenLabel mesh__D017924 Nucleopolyhedroviruses
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D017924 2000
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D017924 2004
% 214.86/215.06  |- mesh__publicMeSHNote mesh__D017924
% 214.86/215.06       97; was NUCLEAR POLYHEDROSIS VIRUS 1994-96, was NUCLEAR POLYHEDROSIS VIRUSES see BACULOVIRIDAE 1991-93, was see POLYHEDROSIS VIRUSES 1975-90; POLYHEDROSIS VIRUSES was heading 1978-90, was see under INSECT VIRUSES 1973-77%A%  
% 214.86/215.06  |- mesh__recordAuthorizer mesh__D017924 PLS
% 214.86/215.06  |- mesh__dateEstablished mesh__D017924 1994-01-01
% 214.86/215.06  |- mesh__recordMaintainer mesh__D017924 AGS
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D017924 2001
% 214.86/215.06  |- skos__scopeNote mesh__D017924
% 214.86/215.06       A genus of the family BACULOVIRIDAE, subfamily Eubaculovirinae, characterized by the formation of crystalline, polyhedral occlusion bodies in the host cell nucleus. The type species is Autographa californica nucleopolyhedrovirus.%A%    
% 214.86/215.06  |- skos__altLabel mesh__D017924 Nuclear Polyhedrosis Virus
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D017924 2005
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D017924 1997
% 214.86/215.06  |- mesh__dateRevised mesh__D017924 1996-06-10
% 214.86/215.06  |- rdf__type mesh__D017924sskos__Concept
% 214.86/215.06  |- skos__hiddenLabel mesh__D017924 Virus, Nuclear Polyhedrosis
% 214.86/215.06  |- mesh__dateCreated mesh__D017924 1993-06-15
% 214.86/215.06  |- skos__historyNote mesh__D017924 Baculoviridae %28%1973-1993%29%
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D017924 2002
% 214.86/215.06  |- skos__hiddenLabel mesh__D017924 Nuclear Polyhedrosis Viruses
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D017924 2006
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D017924 1998
% 214.86/215.06  |- skos__hiddenLabel mesh__D017924 Polyhedrosis Virus, Nuclear
% 214.86/215.06  |- mesh__publicMeSHNote mesh__D017126 93   
% 214.86/215.06  |- mesh__dateCreated mesh__D017126 1992-05-07
% 214.86/215.06  |- skos__prefLabel mesh__D017126 Bacteriophage phi 6
% 214.86/215.06  |- skos__altLabel mesh__D017126 phi 6 Phage
% 214.86/215.06  |- skos__hiddenLabel mesh__D017126 phi 6, Phage
% 214.86/215.06  |- skos__historyNote mesh__D017126 Bacteriophages %28%1966-1992%29%
% 214.86/215.06  |- skos__hiddenLabel mesh__D017126 Phages, phi 6
% 214.86/215.06  |- mesh__historyNote mesh__D017126 93   
% 214.86/215.06  |- mesh__recordOriginator mesh__D017126 AGS
% 214.86/215.06  |- skos__scopeNote mesh__D017126
% 214.86/215.06       Virulent bacteriophage and sole member of the genus Cystovirus that infects Pseudomonas species. The virion has a segmented genome consisting of three pieces of doubled-stranded DNA and also a unique lipid-containing envelope.%A%    
% 214.86/215.06  |- mesh__dateRevised mesh__D017126 2005-06-30
% 214.86/215.06  |- skos__annotation mesh__D017126
% 214.86/215.06       coord IM with specific Pseudomonas /virol   
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D017126 2006
% 214.86/215.06  |- skos__altLabel mesh__D017126 Phage phi 6
% 214.86/215.06  |- skos__broader mesh__D017126smesh__D017105
% 214.86/215.06  |- skos__altLabel mesh__D017126 Pseudomonas phage phi 6
% 214.86/215.06  |- skos__broader mesh__D017126smesh__D017910
% 214.86/215.06  |- skos__hiddenLabel mesh__D017126 phi 6 Phages
% 214.86/215.06  |- skos__hiddenLabel mesh__D017126 Phage, phi 6
% 214.86/215.06  |- mesh__dateEstablished mesh__D017126 1993-01-01
% 214.86/215.06  |- mesh__recordMaintainer mesh__D017126 ags
% 214.86/215.06  |- mesh__recordAuthorizer mesh__D017126 sjn
% 214.86/215.06  |- rdf__type mesh__D017126sskos__Concept
% 214.86/215.06  |- mesh__recordOriginator mesh__D003904 NLM
% 214.86/215.06  |- mesh__publicMeSHNote mesh__D003904
% 214.86/215.06       99; see DEUTEROMYCETES 1973-98; for HYPHOMYCETES see HYPHOMYCETES 1986-98, see MONILIALES 1963-85; for MADURELLA %26% GLIOCLADIUM see HYPHOMYCETES 1986-98%A%  
% 214.86/215.06  |- skos__altLabel mesh__D003904 Fungi, Mitosporic
% 214.86/215.06  |- mesh__dateCreated mesh__D003904 1999-01-01
% 214.86/215.06  |- skos__scopeNote mesh__D003904
% 214.86/215.06       A large and heterogenous group of fungi whose common characteristic is the absence of a sexual state. Many of the pathogenic fungi in humans belong to this group.%A%    
% 214.86/215.06  |- skos__altLabel mesh__D003904 Deuteromycetes
% 214.86/215.06  |- skos__broader mesh__D003904smesh__D005658
% 214.86/215.06  |- skos__annotation mesh__D003904
% 214.86/215.06       GEN or unspecified; prefer specifics; infection = MYCOSES or specific mycosis %28%IM%29%%A%  
% 214.86/215.06  |- mesh__dateEstablished mesh__D003904 1973-01-01
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D003904 2006
% 214.86/215.06  |- mesh__recordAuthorizer mesh__D003904 sjn
% 214.86/215.06  |- mesh__recordMaintainer mesh__D003904 SYSTEM
% 214.86/215.06  |- mesh__dateRevised mesh__D003904 2005-06-30
% 214.86/215.06  |- rdf__type mesh__D003904sskos__Concept
% 214.86/215.06  |- skos__historyNote mesh__D003904 Fungi %28%1966-1972%29%
% 214.86/215.06  |- mesh__historyNote mesh__D003904 99%28%73%29%   
% 214.86/215.06  |- skos__altLabel mesh__D003904 Fungi imperfecti
% 214.86/215.06  |- skos__prefLabel mesh__D003904 Mitosporic Fungi
% 214.86/215.06  |- skos__altLabel mesh__D003904 Deuteromycota
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D003106 2006
% 214.86/215.06  |- skos__prefLabel mesh__D003106 Colon
% 214.86/215.06  |- rdf__type mesh__D003106sskos__Concept
% 214.86/215.06  |- mesh__dateCreated mesh__D003106 1999-01-01
% 214.86/215.06  |- skos__related mesh__D003106smesh__D003082
% 214.86/215.06  |- skos__scopeNote mesh__D003106
% 214.86/215.06       The segment of LARGE INTESTINE between the CECUM and the RECTUM. It includes the ASCENDING COLON; the TRANSVERSE COLON; the DESCENDING COLON; and the SIGMOID COLON.%A%    
% 214.86/215.06  |- skos__altLabel mesh__D003106 Omental Appendices
% 214.86/215.06  |- skos__related mesh__D003106smesh__D003113
% 214.86/215.06  |- mesh__recordAuthorizer mesh__D003106 sjn
% 214.86/215.06  |- skos__related mesh__D003106smesh__D003125
% 214.86/215.06  |- skos__hiddenLabel mesh__D003106 Appendices, Omental
% 214.86/215.06  |- skos__broader mesh__D003106smesh__D007420
% 214.86/215.06  |- mesh__dateRevised mesh__D003106 2003-07-09
% 214.86/215.06  |- skos__hiddenLabel mesh__D003106 Appendix, Omental
% 214.86/215.06  |- mesh__recordMaintainer mesh__D003106 lkt
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D003106 2005
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D003106 2004
% 214.86/215.06  |- skos__altLabel mesh__D003106 Omental Appendix
% 214.86/215.06  |- skos__annotation mesh__D003106
% 214.86/215.06       X ref TAENIA COLI: do not confuse with Taenia, a genus of tapeworm; inflammation = COLITIS; /surg: do not confuse with specialty COLORECTAL SURGERY %26% consider also COLECTOMY or COLOSTOMY; note X refs: coord with specific tissue type if appropriate%A%  
% 214.86/215.06  |- mesh__recordOriginator mesh__D003106 NLM
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013534 1999
% 214.86/215.06  |- skos__prefLabel mesh__D013534 Survival
% 214.86/215.06  |- rdf__type mesh__D013534sskos__Concept
% 214.86/215.06  |- mesh__dateCreated mesh__D013534 1999-01-01
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013534 1994
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013534 2004
% 214.86/215.06  |- skos__scopeNote mesh__D013534
% 214.86/215.06       Continuance of life or existence especially under adverse conditions; includes methods and philosophy of survival.%A%    
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013534 2000
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013534 1995
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013534 1996
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013534 2005
% 214.86/215.06  |- skos__broader mesh__D013534smesh__D006802
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013534 2001
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013534 1997
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013534 2006
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013534 2002
% 214.86/215.06  |- mesh__dateRevised mesh__D013534 1992-05-18
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013534 1998
% 214.86/215.06  |- skos__annotation mesh__D013534
% 214.86/215.06       survival after disasters, plane crashes, shipwrecks, mountain-slides, etc; TN 180: definition %26% use%A%  
% 214.86/215.06  |- mesh__recordMaintainer mesh__D013534 TGC
% 214.86/215.06  |- mesh__recordOriginator mesh__D013534 NLM
% 214.86/215.06  |- mesh__recordAuthorizer mesh__D013534 PLS
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013534 2003
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013534 1993
% 214.86/215.06  |- skos__hiddenLabel mesh__D009493 Neurosurgeries
% 214.86/215.06  |- skos__broader mesh__D009493smesh__D013043
% 214.86/215.06  |- mesh__dateCreated mesh__D009493 1999-01-01
% 214.86/215.06  |- skos__annotation mesh__D009493 SPEC: SPEC qualif   
% 214.86/215.06  |- rdf__type mesh__D009493sskos__Concept
% 214.86/215.06  |- skos__scopeNote mesh__D009493
% 214.86/215.06       A surgical specialty concerned with the treatment of diseases and disorders of the brain, spinal cord, and peripheral and sympathetic nervous system.%A%    
% 214.86/215.06  |- mesh__recordOriginator mesh__D009493 NLM
% 214.86/215.06  |- mesh__dateRevised mesh__D009493 1997-06-20
% 214.86/215.06  |- skos__prefLabel mesh__D009493 Neurosurgery
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D009493 2004
% 214.86/215.06  |- skos__related mesh__D009493smesh__D019635
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D009493 2002
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D009493 2003
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D009493 1999
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D009493 2006
% 214.86/215.06  |- mesh__recordAuthorizer mesh__D009493 SJN
% 214.86/215.06  |- mesh__recordMaintainer mesh__D009493 PXP
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D009493 2001
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D009493 1998
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D009493 2005
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D009493 2000
% 214.86/215.06  |- skos__prefLabel mesh__D017925 Circovirus
% 214.86/215.06  |- mesh__recordMaintainer mesh__D017925 ags
% 214.86/215.06  |- mesh__dateCreated mesh__D017925 1993-06-04
% 214.86/215.06  |- skos__hiddenLabel mesh__D017925 Porcine Circoviruses
% 214.86/215.06  |- mesh__historyNote mesh__D017925 94   
% 214.86/215.06  |- skos__broader mesh__D017925smesh__D018136
% 214.86/215.06  |- skos__altLabel mesh__D017925 Circovirus, Porcine
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D017925 2005
% 214.86/215.06  |- mesh__dateRevised mesh__D017925 2004-07-07
% 214.86/215.06  |- rdf__type mesh__D017925sskos__Concept
% 214.86/215.06  |- skos__annotation mesh__D017925
% 214.86/215.06       infection: coord IM with CIRCOVIRIDAE INFECTIONS %28%IM%29%   
% 214.86/215.06  |- mesh__recordAuthorizer mesh__D017925 sjn
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D017925 2006
% 214.86/215.06  |- mesh__publicMeSHNote mesh__D017925 94   
% 214.86/215.06  |- mesh__recordOriginator mesh__D017925 AGS
% 214.86/215.06  |- skos__historyNote mesh__D017925 DNA Viruses %28%1986-1993%29%
% 214.86/215.06  |- skos__hiddenLabel mesh__D017925 Circoviruses, Porcine
% 214.86/215.06  |- skos__scopeNote mesh__D017925
% 214.86/215.06       A genus of the family CIRCOVIRIDAE that infects SWINE; PSITTACINES; and non-psittacine BIRDS. Species include Beak and feather disease virus causing a fatal disease in psittacine birds, and Porcine circovirus causing postweaning multisystemic wasting syndrome in pigs.%A%    
% 214.86/215.06  |- mesh__dateEstablished mesh__D017925 1994-01-01
% 214.86/215.06  |- mesh__recordAuthorizer mesh__D017127 sjn
% 214.86/215.06  |- skos__altLabel mesh__D017127 Glycation End Products, Advanced
% 214.86/215.06  |- mesh__recordMaintainer mesh__D017127 CCR
% 214.86/215.06  |- mesh__publicMeSHNote mesh__D017127 93   
% 214.86/215.06  |- mesh__historyNote mesh__D017127 93   
% 214.86/215.06  |- skos__prefLabel mesh__D017127 Glycosylation End Products, Advanced
% 214.86/215.06  |- skos__broader mesh__D017127smesh__D009930
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D017127 2006
% 214.86/215.06  |- mesh__dateRevised mesh__D017127 2000-06-21
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D017127 2002
% 214.86/215.06  |- skos__historyNote mesh__D017127 Glycosylation %28%1988-1992%29%
% 214.86/215.06  |- skos__annotation mesh__D017127 DF: GEPA   
% 214.86/215.06  |- skos__altLabel mesh__D017127 Advanced Glycosylation End Products
% 214.86/215.06  |- skos__scopeNote mesh__D017127
% 214.86/215.06       Products derived from the nonenzymatic reaction of glucose and proteins in vivo that exhibit a yellow-brown pigmentation and an ability to participate in protein-protein cross-linking. These substances are involved in biological processes relating to protein turnover and it is believed that their excessive accumulation contributes to the chronic complications of diabetes mellitus.%A%    
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D017127 2004
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D017127 2005
% 214.86/215.06  |- mesh__dateCreated mesh__D017127 1992-05-20
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D017127 2003
% 214.86/215.06  |- rdf__type mesh__D017127sskos__Concept
% 214.86/215.06  |- mesh__recordOriginator mesh__D017127 PXP
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D017127 2001
% 214.86/215.06  |- skos__altLabel mesh__D017127 Advanced Glycation End Products
% 214.86/215.06  |- mesh__dateEstablished mesh__D017127 1993-01-01
% 214.86/215.06  |- mesh__publicMeSHNote mesh__D003905
% 214.86/215.06       91; was see under PORPHYRINS 1975-90   
% 214.86/215.06  |- mesh__recordOriginator mesh__D003905 NLM
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D003905 2006
% 214.86/215.06  |- mesh__dateCreated mesh__D003905 1974-11-19
% 214.86/215.06  |- skos__annotation mesh__D003905 pigments   
% 214.86/215.06  |- mesh__recordMaintainer mesh__D003905 ssb
% 214.86/215.06  |- skos__hiddenLabel mesh__D003905 Deuteroporphyrin, Cobalt
% 214.86/215.06  |- mesh__dateEstablished mesh__D003905 1991-01-01
% 214.86/215.06  |- rdf__type mesh__D003905sskos__Concept
% 214.86/215.06  |- skos__prefLabel mesh__D003905 Deuteroporphyrins
% 214.86/215.06  |- skos__historyNote mesh__D003905 Porphyrins %28%1970-1974%29%
% 214.86/215.06  |- mesh__recordAuthorizer mesh__D003905 sjn
% 214.86/215.06  |- mesh__dateRevised mesh__D003905 2005-06-30
% 214.86/215.06  |- skos__scopeNote mesh__D003905
% 214.86/215.06       Porphyrins with four methyl and two propionic acid side chains attached to the pyrrole rings.%A%    
% 214.86/215.06  |- skos__broader mesh__D003905smesh__D011166
% 214.86/215.06  |- mesh__historyNote mesh__D003905
% 214.86/215.06       91%28%75%29%; was see under PORPHYRINS 1975-90   
% 214.86/215.06  |- skos__altLabel mesh__D003107 Specialty, Rectal Surgery
% 214.86/215.06  |- skos__altLabel mesh__D003107 Surgery, Colorectal
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D003107 2001
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D003107 1999
% 214.86/215.06  |- mesh__recordMaintainer mesh__D003107 TGC
% 214.86/215.06  |- skos__altLabel mesh__D003107 Rectal Surgery Specialty
% 214.86/215.06  |- mesh__recordOriginator mesh__D003107 NLM
% 214.86/215.06  |- skos__altLabel mesh__D003107 Colon and Rectal Surgery Specialty
% 214.86/215.06  |- skos__altLabel mesh__D003107 Colon Surgery %28%Specialty%29%
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D003107 2000
% 214.86/215.06  |- mesh__dateRevised mesh__D003107 1997-06-20
% 214.86/215.06  |- skos__hiddenLabel mesh__D003107 Rectal Surgeries %28%Specialty%29%
% 214.86/215.06  |- skos__annotation mesh__D003107
% 214.86/215.06       GEN only: do not confuse with COLON /surg %26% RECTUM /surg; SPEC: SPEC qualif      DF: COLORECTAL SURG%A%  
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D003107 1998
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D003107 2006
% 214.86/215.06  |- skos__altLabel mesh__D003107 Colon Surgery Specialty
% 214.86/215.06  |- skos__hiddenLabel mesh__D003107 Surgeries, Colon %28%Specialty%29%
% 214.86/215.06  |- mesh__onlineNote mesh__D003107
% 214.86/215.06       use COLON AND RECTAL SURGERY %28%SPECIALTY%29% to search PROCTOLOGY 1966-79%A%  
% 214.86/215.06  |- skos__altLabel mesh__D003107 Specialty, Colon Surgery
% 214.86/215.06  |- skos__altLabel mesh__D003107 Colon and Rectal Surgery %28%Specialty%29%
% 214.86/215.06  |- mesh__historyNote mesh__D003107
% 214.86/215.06       98; was COLON AND RECTAL SURGERY %28%SPECIALTY%29% 1980-97; was PROCTOLOGY 1963-79%A%  
% 214.86/215.06  |- mesh__publicMeSHNote mesh__D003107
% 214.86/215.06       98; was COLON AND RECTAL SURGERY %28%SPECIALTY%29% 1980-97; was PROCTOLOGY 1963-79%A%  
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D003107 2005
% 214.86/215.06  |- mesh__recordAuthorizer mesh__D003107 SJN
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D003107 2004
% 214.86/215.06  |- skos__altLabel mesh__D003107 Rectal Surgery %28%Specialty%29%
% 214.86/215.06  |- skos__hiddenLabel mesh__D003107 Colon Surgeries %28%Specialty%29%
% 214.86/215.06  |- skos__altLabel mesh__D003107 Surgery, Colon and Rectal %28%Specialty%29%
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D003107 2002
% 214.86/215.06  |- skos__scopeNote mesh__D003107
% 214.86/215.06       A surgical specialty concerned with the diagnosis and treatment of disorders and abnormalities of the colon, rectum, and anal canal.%A%    
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D003107 2003
% 214.86/215.06  |- skos__broader mesh__D003107smesh__D013043
% 214.86/215.06  |- skos__prefLabel mesh__D003107 Colorectal Surgery
% 214.86/215.06  |- skos__hiddenLabel mesh__D003107 Surgery, Rectal %28%Specialty%29%
% 214.86/215.06  |- skos__hiddenLabel mesh__D003107 Surgeries, Rectal %28%Specialty%29%
% 214.86/215.06  |- skos__altLabel mesh__D003107 Surgery Specialty, Colon and Rectal
% 214.86/215.06  |- skos__altLabel mesh__D003107 Surgery Specialty, Rectal
% 214.86/215.06  |- mesh__dateCreated mesh__D003107 1999-01-01
% 214.86/215.06  |- rdf__type mesh__D003107sskos__Concept
% 214.86/215.06  |- skos__hiddenLabel mesh__D003107 Surgery, Colon %28%Specialty%29%
% 214.86/215.06  |- mesh__recordAuthorizer mesh__D013535 ags
% 214.86/215.06  |- skos__broader mesh__D013535smesh__D003102
% 214.86/215.06  |- skos__scopeNote mesh__D013535
% 214.86/215.06       Colloids with liquid continuous phase and solid dispersed phase; the term is used loosely also for solid-in-gas %28%AEROSOLS%29% and other colloidal systems; water-insoluble drugs may be given as suspensions.%A%    
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013535 2004
% 214.86/215.06  |- mesh__recordOriginator mesh__D013535 NLM
% 214.86/215.06  |- mesh__dateRevised mesh__D013535 2005-07-07
% 214.86/215.06  |- rdf__type mesh__D013535sskos__Concept
% 214.86/215.06  |- skos__annotation mesh__D013535
% 214.86/215.06       IM for general only, qualif permitted; NIM %28%no qualif%29% with specific drug IM %28%with qualif%29%; /adv eff permitted but be careful: it may be the adv eff of the drug in suspension, not the %22%suspension%22%%A%  
% 214.86/215.06  |- mesh__recordMaintainer mesh__D013535 ags
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013535 2006
% 214.86/215.06  |- skos__prefLabel mesh__D013535 Suspensions
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013535 2005
% 214.86/215.06  |- mesh__activeMeSHYear mesh__D013535 2006A
% 214.86/215.07  |- mesh__dateCreated mesh__D013535 1999-01-01
% 214.86/215.07  |- skos__hiddenLabel mesh__D018220 Fibromas, Desmoplastic
% 214.86/215.07  |- skos__hiddenLabel mesh__D018220 Desmoplastic Fibroma
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018220 2001
% 214.86/215.07  |- mesh__recordMaintainer mesh__D018220 KEV
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018220 2003
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018220 2000
% 214.86/215.07  |- skos__broader mesh__D018220smesh__D005350
% 214.86/215.07  |- mesh__historyNote mesh__D018220 94   
% 214.86/215.07  |- skos__historyNote mesh__D018220 Fibroma %28%1966-1993%29%
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018220 1999
% 214.86/215.07  |- mesh__recordOriginator mesh__D018220 PLS
% 214.86/215.07  |- skos__scopeNote mesh__D018220
% 214.86/215.07       A extremely rare bone tumor characterized by abundant collagen formation and a fibrous stroma, without evidence of mitosis or pleomorphism. It appears on x-rays as an osteolytic lesion with well-defined margins and must be differentiated from primary fibrosarcoma of bone. %28%DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1441%29%%A%    
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018220 1998
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018220 2006
% 214.86/215.07  |- mesh__recordAuthorizer mesh__D018220 PLS
% 214.86/215.07  |- mesh__dateRevised mesh__D018220 1995-06-08
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018220 1997
% 214.86/215.07  |- rdf__type mesh__D018220sskos__Concept
% 214.86/215.07  |- skos__annotation mesh__D018220
% 214.86/215.07       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS %28%IM%29% or specific precoord bone/neopl term %28%IM%29% or specific bone %28%IM%29% + BONE NEOPLASMS %28%IM%29%%A%  
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018220 2005
% 214.86/215.07  |- mesh__publicMeSHNote mesh__D018220 94   
% 214.86/215.07  |- skos__hiddenLabel mesh__D018220 Desmoplastic Fibromas
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018220 2002
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018220 1996
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018220 2004
% 214.86/215.07  |- mesh__dateCreated mesh__D018220 1993-06-25
% 214.86/215.07  |- skos__prefLabel mesh__D018220 Fibroma, Desmoplastic
% 214.86/215.07  |- mesh__dateEstablished mesh__D018220 1994-01-01
% 214.86/215.07  |- skos__hiddenLabel mesh__D004200 Diseases in Twin
% 214.86/215.07  |- skos__prefLabel mesh__D004200 Diseases in Twins
% 214.86/215.07  |- skos__hiddenLabel mesh__D004200 in Twin, Diseases
% 214.86/215.07  |- skos__annotation mesh__D004200
% 214.86/215.07       human only; the disease may be in only one or in both twins; Manual 34.14; DF: DIS IN TWINS%A%  
% 214.86/215.07  |- mesh__recordAuthorizer mesh__D004200 sjn
% 214.86/215.07  |- skos__hiddenLabel mesh__D004200 Twins, Diseases in
% 214.86/215.07  |- mesh__dateRevised mesh__D004200 2004-07-07
% 214.86/215.07  |- skos__broader mesh__D004200smesh__D020969
% 214.86/215.07  |- rdf__type mesh__D004200sskos__Concept
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D004200 2006
% 214.86/215.07  |- skos__scopeNote mesh__D004200
% 214.86/215.07       Disorders affecting TWINS, one or both, at any age.     
% 214.86/215.07  |- skos__hiddenLabel mesh__D004200 in Twins, Diseases
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D004200 2005
% 214.86/215.07  |- mesh__recordOriginator mesh__D004200 NLM
% 214.86/215.07  |- skos__hiddenLabel mesh__D004200 Twin, Diseases in
% 214.86/215.07  |- mesh__dateCreated mesh__D004200 1999-01-01
% 214.86/215.07  |- skos__related mesh__D004200smesh__D014427
% 214.86/215.07  |- mesh__recordMaintainer mesh__D004200 nns
% 214.86/215.07  |- skos__altLabel mesh__D009494 General Paresis of the Insane
% 214.86/215.07  |- skos__hiddenLabel mesh__D009494 Pareses, Juvenile
% 214.86/215.07  |- skos__hiddenLabel mesh__D009494 General Paralyses
% 214.86/215.07  |- mesh__dateRevised mesh__D009494 2003-07-25
% 214.86/215.07  |- skos__hiddenLabel mesh__D009494 Asymptomatic Neurosyphilis
% 214.86/215.07  |- mesh__recordAuthorizer mesh__D009494 sjn
% 214.86/215.07  |- skos__altLabel mesh__D009494 General Paresis
% 214.86/215.07  |- rdf__type mesh__D009494sskos__Concept
% 214.86/215.07  |- skos__hiddenLabel mesh__D009494 Neurosyphilis, Paretic
% 214.86/215.07  |- skos__hiddenLabel mesh__D009494 Juvenile Neurosyphilis
% 214.86/215.07  |- skos__altLabel mesh__D009494 Secondary Neurosyphilis
% 214.86/215.07  |- skos__altLabel mesh__D009494 Paretic Neurosyphilis
% 214.86/215.07  |- mesh__historyNote mesh__D009494
% 214.86/215.07       1963; for GENERAL PARALYSIS %26% PARALYSIS, GENERAL use PARESIS 1963-93%A%  
% 214.86/215.07  |- skos__hiddenLabel mesh__D009494 General Pareses
% 214.86/215.07  |- skos__prefLabel mesh__D009494 Neurosyphilis
% 214.86/215.07  |- skos__altLabel mesh__D009494 Central Nervous System Syphilis
% 214.86/215.07  |- skos__scopeNote mesh__D009494
% 214.86/215.07       Infections of the central nervous system caused by TREPONEMA PALLIDUM which present with a variety of clinical syndromes. The initial phase of infection usually causes a mild or asymptomatic meningeal reaction. The meningovascular form may present acutely as BRAIN INFARCTION. The infection may also remain subclinical for several years. Late syndromes include general paresis; TABES DORSALIS; meningeal syphilis; syphilitic OPTIC ATROPHY; and spinal syphilis. General paresis is characterized by progressive DEMENTIA; DYSARTHRIA; TREMOR; MYOCLONUS; SEIZURES; and Argyll-Robertson pupils. %28%Adams et al., Principles of Neurology, 6th ed, pp722-8%29%%A%    
% 214.86/215.07  |- skos__broader mesh__D009494smesh__D013587
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D009494 2005
% 214.86/215.07  |- skos__hiddenLabel mesh__D009494 Pareses, General
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D009494 2004
% 214.86/215.07  |- mesh__publicMeSHNote mesh__D009494
% 214.86/215.07       1966; for GENERAL PARALYSIS %26% PARALYSIS, GENERAL see PARESIS 1963-93%A%  
% 214.86/215.07  |- skos__hiddenLabel mesh__D009494 Paresis, General
% 214.86/215.07  |- skos__hiddenLabel mesh__D009494 Gummatous Neurosyphilis
% 214.86/215.07  |- skos__hiddenLabel mesh__D009494 Juvenile Pareses
% 214.86/215.07  |- skos__altLabel mesh__D009494 Paralysis, General
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D009494 2006
% 214.86/215.07  |- skos__altLabel mesh__D009494 Syphilis, Central Nervous System
% 214.86/215.07  |- mesh__recordOriginator mesh__D009494 NLM
% 214.86/215.07  |- mesh__dateCreated mesh__D009494 1999-01-01
% 214.86/215.07  |- mesh__recordMaintainer mesh__D009494 sjn
% 214.86/215.07  |- skos__broader mesh__D009494smesh__D020806
% 214.86/215.07  |- skos__hiddenLabel mesh__D009494 Paralyses, General
% 214.86/215.07  |- skos__hiddenLabel mesh__D009494 Paresis, Juvenile
% 214.86/215.07  |- skos__altLabel mesh__D009494 Syphilis, CNS
% 214.86/215.07  |- skos__hiddenLabel mesh__D017128 Embolectomies
% 214.86/215.07  |- mesh__recordOriginator mesh__D017128 AGS
% 214.86/215.07  |- skos__annotation mesh__D017128
% 214.86/215.07       removal of an embolus transported from its origin: differentiate from THROMBECTOMY, removal of clot at its original site; do not use /util except by MeSH definition%A%  
% 214.86/215.07  |- mesh__dateRevised mesh__D017128 1997-06-20
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D017128 2004
% 214.86/215.07  |- mesh__dateEstablished mesh__D017128 1993-01-01
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D017128 2005
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D017128 2001
% 214.86/215.07  |- mesh__recordMaintainer mesh__D017128 PXP
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D017128 1999
% 214.86/215.07  |- skos__scopeNote mesh__D017128
% 214.86/215.07       Surgical removal of an obstructing clot or foreign material which has been transported from a distant vessel by the bloodstream. Removal of a clot at its original site is called THROMBECTOMY.%A%    
% 214.86/215.07  |- mesh__recordAuthorizer mesh__D017128 SJN
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D017128 2003
% 214.86/215.07  |- rdf__type mesh__D017128sskos__Concept
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D017128 2000
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D017128 1998
% 214.86/215.07  |- mesh__publicMeSHNote mesh__D017128 93   
% 214.86/215.07  |- mesh__dateCreated mesh__D017128 1992-05-08
% 214.86/215.07  |- skos__historyNote mesh__D017128
% 214.86/215.07       specific embolism/surgery %28%1966-1992%29%
% 214.86/215.07  |- skos__broader mesh__D017128smesh__D014656
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D017128 2002
% 214.86/215.07  |- mesh__historyNote mesh__D017128 93   
% 214.86/215.07  |- skos__prefLabel mesh__D017128 Embolectomy
% 214.86/215.07  |- skos__related mesh__D017128smesh__D017131
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D017128 2006
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Country, Developing
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Third-World Nation
% 214.86/215.07  |- mesh__recordMaintainer mesh__D003906 sjn
% 214.86/215.07  |- skos__altLabel mesh__D003906 Third-World Nations
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Under-Developed Nation
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Nations, Developing
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D003906 2005
% 214.86/215.07  |- skos__scopeNote mesh__D003906
% 214.86/215.07       Countries in the process of change directed toward economic growth, that is, an increase in production, per capita consumption, and income. The process of economic growth involves better utilization of natural and human resources, which results in a change in the social, political, and economic structures.%A%    
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Nation, Developing
% 214.86/215.07  |- skos__altLabel mesh__D003906 Third-World Countries
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Third-World Country
% 214.86/215.07  |- skos__altLabel mesh__D003906 Under-Developed Nations
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Nation, Third-World
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Country, Third-World
% 214.86/215.07  |- mesh__dateCreated mesh__D003906 1999-01-01
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Countries, Developing
% 214.86/215.07  |- mesh__publicMeSHNote mesh__D003906 71   
% 214.86/215.07  |- skos__altLabel mesh__D003906 Less-Developed Nations
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Less Developed Nations
% 214.86/215.07  |- mesh__recordAuthorizer mesh__D003906 sjn
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Developing Nation
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Countries, Less-Developed
% 214.86/215.07  |- skos__historyNote mesh__D003906
% 214.86/215.07       International Cooperation %28%1966-1970%29%
% 214.86/215.07  |- skos__historyNote mesh__D003906 specific country %28%1966-1970%29%
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Less Developed Countries
% 214.86/215.07  |- skos__altLabel mesh__D003906 Less-Developed Countries
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Under Developed Nations
% 214.86/215.07  |- mesh__recordOriginator mesh__D003906 NLM
% 214.86/215.07  |- rdf__type mesh__D003906sskos__Concept
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Under Developed Countries
% 214.86/215.07  |- skos__altLabel mesh__D003906 Under-Developed Countries
% 214.86/215.07  |- skos__broader mesh__D003906smesh__D007391
% 214.86/215.07  |- mesh__dateEstablished mesh__D003906 1971-01-01
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Nations, Third-World
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Nation, Under-Developed
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Under-Developed Country
% 214.86/215.07  |- skos__annotation mesh__D003906
% 214.86/215.07       do not confuse with DEVELOPED COUNTRIES; IM; specify country or countries if relevant%A%  
% 214.86/215.07  |- mesh__dateRevised mesh__D003906 2004-07-13
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Nations, Under-Developed
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Third World Countries
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Countries, Third-World
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Developing Country
% 214.86/215.07  |- skos__prefLabel mesh__D003906 Developing Countries
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Country, Under-Developed
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Nations, Less-Developed
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Country, Less-Developed
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Third World Nations
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Less-Developed Country
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D003906 2006
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Less-Developed Nation
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Countries, Under-Developed
% 214.86/215.07  |- skos__hiddenLabel mesh__D003906 Nation, Less-Developed
% 214.86/215.07  |- skos__altLabel mesh__D003906 Developing Nations
% 214.86/215.07  |- mesh__historyNote mesh__D003906 71   
% 214.86/215.07  |- mesh__recordAuthorizer mesh__D003108 sjn
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D003108 2006
% 214.86/215.07  |- rdf__type mesh__D003108sskos__Concept
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D003108 2005
% 214.86/215.07  |- mesh__dateRevised mesh__D003108 2003-07-09
% 214.86/215.07  |- mesh__dateCreated mesh__D003108 1999-01-01
% 214.86/215.07  |- skos__annotation mesh__D003108 inflamm dis = COLITIS   
% 214.86/215.07  |- skos__hiddenLabel mesh__D003108 Disease, Colonic
% 214.86/215.07  |- skos__scopeNote mesh__D003108
% 214.86/215.07       Pathological processes in the COLON region of the large intestine %28%INTESTINE, LARGE%29%.%A%    
% 214.86/215.07  |- mesh__recordOriginator mesh__D003108 NLM
% 214.86/215.07  |- mesh__recordMaintainer mesh__D003108 lkt
% 214.86/215.07  |- skos__prefLabel mesh__D003108 Colonic Diseases
% 214.86/215.07  |- skos__broader mesh__D003108smesh__D007410
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D003108 2004
% 214.86/215.07  |- skos__hiddenLabel mesh__D003108 Diseases, Colonic
% 214.86/215.07  |- skos__hiddenLabel mesh__D003108 Colonic Disease
% 214.86/215.07  |- mesh__publicMeSHNote mesh__D046710 2005   
% 214.86/215.07  |- skos__broader mesh__D046710smesh__D010311
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D046710 2005
% 214.86/215.07  |- mesh__recordMaintainer mesh__D046710 ags
% 214.86/215.07  |- mesh__recordOriginator mesh__D046710 ags
% 214.86/215.07  |- skos__hiddenLabel mesh__D046710 Lovebird
% 214.86/215.07  |- mesh__dateCreated mesh__D046710 2004-07-07
% 214.86/215.07  |- skos__altLabel mesh__D046710 Lovebirds
% 214.86/215.07  |- mesh__dateEstablished mesh__D046710 2005-01-01
% 214.86/215.07  |- skos__scopeNote mesh__D046710
% 214.86/215.07       A genus comprised of nine species of small PARROTS from Africa. They are noted for showing affection for their mates.%A%    
% 214.86/215.07  |- skos__prefLabel mesh__D046710 Agapornis
% 214.86/215.07  |- rdf__type mesh__D046710sskos__Concept
% 214.86/215.07  |- mesh__historyNote mesh__D046710 2005   
% 214.86/215.07  |- mesh__recordAuthorizer mesh__D046710 sjn
% 214.86/215.07  |- skos__historyNote mesh__D046710 Parrots %28%1977-2004%29%
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D046710 2006
% 214.86/215.07  |- skos__annotation mesh__D013536
% 214.86/215.07       do not use /util except by MeSH definition   
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D013536 2000
% 214.86/215.07  |- skos__altLabel mesh__D013536 Suture Technics
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D013536 2003
% 214.86/215.07  |- skos__broader mesh__D013536smesh__D013514
% 214.86/215.07  |- rdf__type mesh__D013536sskos__Concept
% 214.86/215.07  |- skos__hiddenLabel mesh__D013536 Suture Technique
% 214.86/215.07  |- mesh__recordMaintainer mesh__D013536 kle
% 214.86/215.07  |- mesh__onlineNote mesh__D013536
% 214.86/215.07       use SUTURE TECHNIQUES to search SUTURE TECHNICS 1966-90   
% 214.86/215.07  |- skos__hiddenLabel mesh__D013536 Technic, Suture
% 214.86/215.07  |- skos__hiddenLabel mesh__D013536 Suture Technic
% 214.86/215.07  |- mesh__recordOriginator mesh__D013536 NLM
% 214.86/215.07  |- mesh__publicMeSHNote mesh__D013536 91; was SUTURE TECHNICS 1963-90   
% 214.86/215.07  |- mesh__recordAuthorizer mesh__D013536 sjn
% 214.86/215.07  |- skos__prefLabel mesh__D013536 Suture Techniques
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D013536 2006
% 214.86/215.07  |- skos__hiddenLabel mesh__D013536 Techniques, Suture
% 214.86/215.07  |- mesh__historyNote mesh__D013536 91; was SUTURE TECHNICS 1963-90   
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D013536 2002
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D013536 2005
% 214.86/215.07  |- mesh__dateCreated mesh__D013536 1999-01-01
% 214.86/215.07  |- skos__hiddenLabel mesh__D013536 Technique, Suture
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D013536 2001
% 214.86/215.07  |- mesh__dateRevised mesh__D013536 1999-11-03
% 214.86/215.07  |- skos__hiddenLabel mesh__D013536 Technics, Suture
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D013536 2004
% 214.86/215.07  |- skos__broader mesh__D017546Q000295smesh__D017546
% 214.86/215.07  |- mesh__preferredCombination mesh__D017546Q000295smesh__D020677
% 214.86/215.07  |- rdf__type mesh__D017546Q000295smesh__CompoundConcept
% 214.86/215.07  |- mesh__recordAuthorizer mesh__D018221 PLS
% 214.86/215.07  |- skos__hiddenLabel mesh__D018221 Fibromatoses, Abdominal
% 214.86/215.07  |- skos__scopeNote mesh__D018221
% 214.86/215.07       A relatively large mass of unusually firm scarlike connective tissue resulting from active participation of fibroblasts, occurring most frequently in the abdominal muscles of women who have borne children. The fibroblasts infiltrate surrounding muscle and fascia. %28%Stedman, 25th ed%29%%A%    
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018221 1998
% 214.86/215.07  |- mesh__dateEstablished mesh__D018221 1994-01-01
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018221 2006
% 214.86/215.07  |- mesh__publicMeSHNote mesh__D018221 94   
% 214.86/215.07  |- skos__hiddenLabel mesh__D018221 Abdominal Fibromatosis
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018221 2002
% 214.86/215.07  |- mesh__dateRevised mesh__D018221 1995-06-08
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018221 1997
% 214.86/215.07  |- rdf__type mesh__D018221sskos__Concept
% 214.86/215.07  |- mesh__dateCreated mesh__D018221 1993-06-25
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018221 2005
% 214.86/215.07  |- skos__broader mesh__D018221smesh__D005350
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018221 2001
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018221 1996
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018221 2004
% 214.86/215.07  |- skos__prefLabel mesh__D018221 Fibromatosis, Abdominal
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018221 2000
% 214.86/215.07  |- skos__hiddenLabel mesh__D018221 Abdominal Fibromatoses
% 214.86/215.07  |- mesh__recordMaintainer mesh__D018221 KEV
% 214.86/215.07  |- skos__historyNote mesh__D018221 Fibroma %28%1967-1993%29%
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018221 2003
% 214.86/215.07  |- skos__annotation mesh__D018221
% 214.86/215.07       abdom refers to the abdom muscles; multiple; solitary = probably FIBROMA; do not use /blood supply /chem /second /secret /ultrastruct; do not coord with ABDOMINAL MUSCLES or ABDOMINAL NEOPLASMS %28%see note there%29%%A%  
% 214.86/215.07  |- mesh__historyNote mesh__D018221 94   
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D018221 1999
% 214.86/215.07  |- mesh__recordOriginator mesh__D018221 PLS
% 214.86/215.07  |- mesh__recordAuthorizer mesh__D017927 sjn
% 214.86/215.07  |- skos__broader mesh__D017927smesh__D029342
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D017927 2003
% 214.86/215.07  |- skos__scopeNote mesh__D017927
% 214.86/215.07       A species of the genus VESIVIRUS infecting cats. Transmission occurs via air and mechanical contact.%A%    
% 214.86/215.07  |- skos__annotation mesh__D017927
% 214.86/215.07       infection: coord IM with CALICIVIRIDAE INFECTIONS %28%IM%29%   
% 214.86/215.07  |- mesh__dateRevised mesh__D017927 2001-07-25
% 214.86/215.07  |- skos__historyNote mesh__D017927 Picornaviridae %28%1972-1975%29%
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D017927 2002
% 214.86/215.07  |- mesh__dateCreated mesh__D017927 1993-06-04
% 214.86/215.07  |- rdf__type mesh__D017927sskos__Concept
% 214.86/215.07  |- skos__prefLabel mesh__D017927 Calicivirus, Feline
% 214.86/215.07  |- mesh__historyNote mesh__D017927
% 214.86/215.07       94; FELINE CALICIVIRUSES was see CALICIVIRIDAE 1978-92; FELINE CALICIVIRUS was see under CALICIVIRUSES 1975-78%A%  
% 214.86/215.07  |- skos__historyNote mesh__D017927 Caliciviridae %28%1975-1993%29%
% 214.86/215.07  |- mesh__recordMaintainer mesh__D017927 ags
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D017927 2006
% 214.86/215.07  |- mesh__recordOriginator mesh__D017927 AGS
% 214.86/215.07  |- mesh__onlineNote mesh__D017927
% 214.86/215.07       use CALICIVIRIDAE to search FELINE CALICIVIRUSES 1978-92 %26% FELINE CALICIVIRUS 1975-78%A%  
% 214.86/215.07  |- mesh__publicMeSHNote mesh__D017927
% 214.86/215.07       94; FELINE CALICIVIRUSES was see CALICIVIRIDAE 1978-92; FELINE CALICIVIRUS was see under CALICIVIRUSES 1975-78%A%  
% 214.86/215.07  |- mesh__dateEstablished mesh__D017927 1994-01-01
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D017927 2005
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D017927 2004
% 214.86/215.07  |- skos__altLabel mesh__D017927 Feline calicivirus
% 214.86/215.07  |- mesh__recordMaintainer mesh__D017129 sjn
% 214.86/215.07  |- rdf__type mesh__D017129sskos__Concept
% 214.86/215.07  |- skos__broader mesh__D017129smesh__D017191
% 214.86/215.07  |- mesh__dateCreated mesh__D017129 1992-05-07
% 214.86/215.07  |- mesh__recordOriginator mesh__D017129 PXP
% 214.86/215.07  |- mesh__dateEstablished mesh__D017129 1993-01-01
% 214.86/215.07  |- skos__historyNote mesh__D017129 Nematode Infections %28%1967-1992%29%
% 214.86/215.07  |- skos__broader mesh__D017129smesh__D007411
% 214.86/215.07  |- mesh__historyNote mesh__D017129 93   
% 214.86/215.07  |- mesh__recordAuthorizer mesh__D017129 sjn
% 214.86/215.07  |- skos__scopeNote mesh__D017129
% 214.86/215.07       Infection with roundworms of the genus ANISAKIS. Human infection results from the consumption of fish harboring roundworm larvae. The worms may cause acute NAUSEA; VOMITING; or penetrate into the wall of the DIGESTIVE TRACT where they give rise to EOSINOPHILIC GRANULOMA in the STOMACH; INTESTINES; or the OMENTUM.%A%    
% 214.86/215.07  |- skos__hiddenLabel mesh__D017129 Anisakiases
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D017129 2006
% 214.86/215.07  |- mesh__dateRevised mesh__D017129 2004-07-13
% 214.86/215.07  |- mesh__publicMeSHNote mesh__D017129 93   
% 214.86/215.07  |- skos__prefLabel mesh__D017129 Anisakiasis
% 214.86/215.07  |- mesh__activeMeSHYear mesh__D017129 2005
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexagrin
% 214.86/215.07  |- skos__altLabel mesh__D003907 Cortam%C3%%A9%thasone
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 Isopto Dex
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 Intensol, Dexamethasone
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexagel
% 214.86/215.07  |- skos__altLabel mesh__D003907 Decadron
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 Dexa Sine
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dekasol
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexamethason FNA
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 DexaEffekton
% 214.86/215.07  |- skos__altLabel mesh__D003907 ratio-Dexamethasone
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 ratio Dexamethasone
% 214.86/215.07  |- skos__altLabel mesh__D003907 Colvasone
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 Inyectable, Dalamon
% 214.86/215.07  |- skos__altLabel mesh__D003907 Voren
% 214.86/215.07  |- skos__altLabel mesh__D003907 DexaEDO
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 Jenapharm, Dexamethason
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 Dexamethasonmp
% 214.86/215.07  |- skos__altLabel mesh__D003907 Solurex
% 214.86/215.07  |- skos__altLabel mesh__D003907 Decaspray
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexa-Sine
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexadreson
% 214.86/215.07  |- skos__altLabel mesh__D003907 Decadronal
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 Dekasol L.A.
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 dexaclinit
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 Azupharma, Dexamethason
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexason
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 L.A., Dexone
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexapos
% 214.86/215.07  |- mesh__dateCreated mesh__D003907 1999-01-01
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 Dexamethason mp
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexa Jenapharm
% 214.86/215.07  |- skos__altLabel mesh__D003907 Solupen
% 214.86/215.07  |- mesh__recordMaintainer mesh__D003907 exl
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 Dexa Phlogont
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexamethason Azupharma
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexa-Allvoran
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dibasona
% 214.86/215.07  |- skos__broader mesh__D003907smesh__D013259
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexa-Pos
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 dexa clinit
% 214.86/215.07  |- skos__altLabel mesh__D003907 Decaject-L.A.
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dalamon Inyectable
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexamedium
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexpak
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexahexal
% 214.86/215.07  |- mesh__dateRevised mesh__D003907 2005-06-30
% 214.86/215.07  |- skos__altLabel mesh__D003907 Decameth
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexatad
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 Belmac, Dexametasona
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexaflam
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexazone
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 PMS Dexamethasone Injection
% 214.86/215.07  |- mesh__recordAuthorizer mesh__D003907 sjn
% 214.86/215.07  |- rdf__type mesh__D003907sskos__Concept
% 214.86/215.07  |- skos__altLabel mesh__D003907 D%C3%%A9%socort
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 DexaSine
% 214.86/215.07  |- skos__altLabel mesh__D003907 dexa-clinit
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexafort
% 214.86/215.07  |- skos__altLabel mesh__D003907 Indarzona
% 214.86/215.07  |- skos__altLabel mesh__D003907 Solud%C3%%A9%cadron
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexone
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexabeta
% 214.86/215.07  |- skos__altLabel mesh__D003907 Oft Cusi Dexametasona
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexa Loscon
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexabene
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexamethason-Rotexmedica
% 214.86/215.07  |- skos__altLabel mesh__D003907 PMS-Dexamethasone Injection
% 214.86/215.07  |- mesh__recordOriginator mesh__D003907 NLM
% 214.86/215.07  |- skos__altLabel mesh__D003907 Isopto-Dex
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dectancyl
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexagalen
% 214.86/215.07  |- skos__altLabel mesh__D003907 Hexadecadrol
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexavene
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 von ct, dexa
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexaphos
% 214.86/215.07  |- skos__altLabel mesh__D003907 dexa von ct
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexamethason LAW
% 214.86/215.07  |- skos__prefLabel mesh__D003907 Dexamethasone
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 IsoptoDex
% 214.86/215.07  |- skos__altLabel mesh__D003907 Solutio cordes Dexa N
% 214.86/215.07  |- skos__altLabel mesh__D003907 Hexadreson
% 214.86/215.07  |- skos__altLabel mesh__D003907 PMS-Dexamethasone
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexametasona Belmac
% 214.86/215.07  |- skos__altLabel mesh__D003907 Methylfluorprednisolone
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 Dexametasona, Oft Cusi
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexa-Effekton
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 PMS Dexamethasone
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexsone
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 PredniFTablinen
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 Jenapharm, Dexa
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 DecajectL.A.
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 FNA, Dexamethason
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 Monofree, Dexamethason
% 214.86/215.07  |- skos__altLabel mesh__D003907 Methasone
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 Dexa Allvoran
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 Siozwo, Dexa
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 Loscon, Dexa
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexachel
% 214.86/215.07  |- skos__altLabel mesh__D003907 Solurex L.A.
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 Dexa Effekton
% 214.86/215.07  |- skos__altLabel mesh__D003907 Dexa-ratiopharm
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 LAW, Dexamethason
% 214.86/215.07  |- skos__hiddenLabel mesh__D003907 GALEN, Dexamethason
% 214.86/215.08  |- skos__altLabel mesh__D003907 Dexamethason-mp
% 214.86/215.08  |- skos__altLabel mesh__D003907 Cortidexason
% 214.86/215.08  |- skos__altLabel mesh__D003907 Dexamethasone Intensol
% 214.86/215.08  |- skos__hiddenLabel mesh__D003907 PMSDexamethasone Injection
% 214.86/215.08  |- skos__altLabel mesh__D003907 Cortisumman
% 214.86/215.08  |- skos__altLabel mesh__D003907 Dexamethason GALEN
% 214.86/215.08  |- skos__hiddenLabel mesh__D003907 Predni F Tablinen
% 214.86/215.08  |- skos__hiddenLabel mesh__D003907 ratioDexamethasone
% 214.86/215.08  |- skos__altLabel mesh__D003907 Dekasol-L.A.
% 214.86/215.08  |- skos__hiddenLabel mesh__D003907 Dexamethason Rotexmedica
% 214.86/215.08  |- skos__hiddenLabel mesh__D003907 ct, dexa von
% 214.86/215.08  |- skos__hiddenLabel mesh__D003907 Dexaratiopharm
% 214.86/215.08  |- skos__altLabel mesh__D003907 Dexamethason Monofree
% 214.86/215.08  |- skos__hiddenLabel mesh__D003907 DexaPhlogont
% 214.86/215.08  |- skos__altLabel mesh__D003907 Dexa Siozwo
% 214.86/215.08  |- skos__hiddenLabel mesh__D003907 Cusi Dexametasona, Oft
% 214.86/215.08  |- skos__hiddenLabel mesh__D003907 Decaject L.A.
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D003907 2006
% 214.86/215.08  |- skos__hiddenLabel mesh__D003907 DexaAllvoran
% 214.86/215.08  |- skos__hiddenLabel mesh__D003907 Dexa ratiopharm
% 214.86/215.08  |- skos__altLabel mesh__D003907 Noriplon
% 214.86/215.08  |- skos__altLabel mesh__D003907 Fortecortin Oral
% 214.86/215.08  |- skos__altLabel mesh__D003907 Maxidex
% 214.86/215.08  |- skos__altLabel mesh__D003907 Lipotalon
% 214.86/215.08  |- skos__altLabel mesh__D003907 Dexasel
% 214.86/215.08  |- skos__altLabel mesh__D003907 Totocortin
% 214.86/215.08  |- skos__hiddenLabel mesh__D003907 DekasolL.A.
% 214.86/215.08  |- skos__hiddenLabel mesh__D003907 Dexa Pos
% 214.86/215.08  |- skos__hiddenLabel mesh__D003907 L.A., Solurex
% 214.86/215.08  |- skos__altLabel mesh__D003907 Dexair
% 214.86/215.08  |- skos__altLabel mesh__D003907 Dexoral
% 214.86/215.08  |- skos__altLabel mesh__D003907 Dexone L.A.
% 214.86/215.08  |- skos__scopeNote mesh__D003907
% 214.86/215.08       An anti-inflammatory 9-fluoro-glucocorticoid.     
% 214.86/215.08  |- skos__altLabel mesh__D003907 Dexapent
% 214.86/215.08  |- skos__broader mesh__D003907smesh__D011246
% 214.86/215.08  |- skos__hiddenLabel mesh__D003907 PMSDexamethasone
% 214.86/215.08  |- skos__altLabel mesh__D003907 Dexmethsone
% 214.86/215.08  |- skos__altLabel mesh__D003907 Decaject
% 214.86/215.08  |- skos__hiddenLabel mesh__D003907 DexamethasonRotexmedica
% 214.86/215.08  |- skos__altLabel mesh__D003907 Dexamethason Jenapharm
% 214.86/215.08  |- skos__altLabel mesh__D003907 Dexamethason
% 214.86/215.08  |- skos__altLabel mesh__D003907 Dexa-Phlogont
% 214.86/215.08  |- skos__hiddenLabel mesh__D003907 Oral, Fortecortin
% 214.86/215.08  |- skos__altLabel mesh__D003907 Dexalone
% 214.86/215.08  |- skos__altLabel mesh__D003907 Predni-F-Tablinen
% 214.86/215.08  |- skos__altLabel mesh__D003907 Dexamonozon
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D003109 2005
% 214.86/215.08  |- skos__hiddenLabel mesh__D003109 Disease, Functional Colonic
% 214.86/215.08  |- mesh__dateCreated mesh__D003109 1999-01-01
% 214.86/215.08  |- mesh__dateRevised mesh__D003109 2003-07-09
% 214.86/215.08  |- mesh__historyNote mesh__D003109
% 214.86/215.08       65; was COLITIS, MUCOUS 1963-64; COLITIS, MUCOUS was see under COLONIC DISEASES, FUNCTIONAL 1965-78%A%  
% 214.86/215.08  |- mesh__dateEstablished mesh__D003109 1965-01-01
% 214.86/215.08  |- mesh__recordAuthorizer mesh__D003109 sjn
% 214.86/215.08  |- skos__altLabel mesh__D003109 Functional Colonic Diseases
% 214.86/215.08  |- skos__prefLabel mesh__D003109 Colonic Diseases, Functional
% 214.86/215.08  |- mesh__onlineNote mesh__D003109
% 214.86/215.08       use COLONIC DISEASES, FUNCTIONAL to search COLITIS, MUCOUS 1966-78%A%  
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D003109 2004
% 214.86/215.08  |- skos__hiddenLabel mesh__D003109 Colonic Disease, Functional
% 214.86/215.08  |- skos__hiddenLabel mesh__D003109 Functional Colonic Disease
% 214.86/215.08  |- skos__hiddenLabel mesh__D003109 Diseases, Functional Colonic
% 214.86/215.08  |- skos__broader mesh__D003109smesh__D003108
% 214.86/215.08  |- mesh__recordOriginator mesh__D003109 NLM
% 214.86/215.08  |- mesh__recordMaintainer mesh__D003109 lkt
% 214.86/215.08  |- skos__scopeNote mesh__D003109
% 214.86/215.08       Chronic or recurrent colonic disorders without an identifiable structural or biochemical explanation. The widely recognized IRRITABLE BOWEL SYNDROME falls into this category.%A%    
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D003109 2006
% 214.86/215.08  |- rdf__type mesh__D003109sskos__Concept
% 214.86/215.08  |- mesh__publicMeSHNote mesh__D003109 65; was COLITIS, MUCOUS 1963-64   
% 214.86/215.08  |- skos__broader mesh__D017470Q000037smesh__D017470
% 214.86/215.08  |- mesh__preferredCombination mesh__D017470Q000037smesh__D018691
% 214.86/215.08  |- rdf__type mesh__D017470Q000037smesh__CompoundConcept
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013537 2002
% 214.86/215.08  |- skos__hiddenLabel mesh__D013537 Suture
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013537 2006
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013537 2001
% 214.86/215.08  |- mesh__recordMaintainer mesh__D013537 PXP
% 214.86/215.08  |- skos__annotation mesh__D013537
% 214.86/215.08       /adv eff permitted but do not confuse adv eff of the suture with the adv eff of the material of which suture is made or the adv eff of the suture method%A%  
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013537 2005
% 214.86/215.08  |- mesh__dateCreated mesh__D013537 1999-01-01
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013537 2000
% 214.86/215.08  |- mesh__dateRevised mesh__D013537 1997-06-20
% 214.86/215.08  |- mesh__recordAuthorizer mesh__D013537 SJN
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013537 2004
% 214.86/215.08  |- skos__prefLabel mesh__D013537 Sutures
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013537 1999
% 214.86/215.08  |- skos__altLabel mesh__D013537 Surgical Staples
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013537 2003
% 214.86/215.08  |- rdf__type mesh__D013537sskos__Concept
% 214.86/215.08  |- skos__altLabel mesh__D013537 Surgical Staple
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013537 1998
% 214.86/215.08  |- mesh__recordOriginator mesh__D013537 NLM
% 214.86/215.08  |- skos__altLabel mesh__D013537 Staples, Surgical
% 214.86/215.08  |- skos__scopeNote mesh__D013537
% 214.86/215.08       Materials used in closing a surgical or traumatic wound. %28%From Dorland, 28th ed%29%%A%    
% 214.86/215.08  |- skos__broader mesh__D013537smesh__D013523
% 214.86/215.08  |- skos__broader mesh__D010758Q000172smesh__D010758
% 214.86/215.08  |- rdf__type mesh__D010758Q000172smesh__CompoundConcept
% 214.86/215.08  |- skos__altLabel mesh__D018222 Desmoid
% 214.86/215.08  |- mesh__dateRevised mesh__D018222 1995-06-08
% 214.86/215.08  |- mesh__historyNote mesh__D018222 94; DESMOID was see FIBROMA 1991-93   
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018222 1997
% 214.86/215.08  |- rdf__type mesh__D018222sskos__Concept
% 214.86/215.08  |- skos__prefLabel mesh__D018222 Fibromatosis, Aggressive
% 214.86/215.08  |- skos__hiddenLabel mesh__D018222 Aggressive Fibromatoses
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018222 2005
% 214.86/215.08  |- mesh__recordAuthorizer mesh__D018222 PLS
% 214.86/215.08  |- skos__hiddenLabel mesh__D018222 Desmoids
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018222 1996
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018222 2004
% 214.86/215.08  |- mesh__dateEstablished mesh__D018222 1994-01-01
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018222 2002
% 214.86/215.08  |- mesh__recordMaintainer mesh__D018222 KEV
% 214.86/215.08  |- mesh__onlineNote mesh__D018222 use FIBROMA to search DESMOID 1991-93   
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018222 2003
% 214.86/215.08  |- mesh__dateCreated mesh__D018222 1993-06-25
% 214.86/215.08  |- skos__historyNote mesh__D018222 Fibroma %28%1969-1993%29%
% 214.86/215.08  |- skos__hiddenLabel mesh__D018222 Fibromatoses, Aggressive
% 214.86/215.08  |- skos__broader mesh__D018222smesh__D005350
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018222 2001
% 214.86/215.08  |- skos__scopeNote mesh__D018222
% 214.86/215.08       A childhood counterpart of abdominal or extra-abdominal desmoid tumors, characterized by firm subcutaneous nodules that grow rapidly in any part of the body but do not metastasize. The adult form of abdominal fibromatosis is FIBROMATOSIS, ABDOMINAL. %28%Stedman, 25th ed%29%%A%    
% 214.86/215.08  |- skos__annotation mesh__D018222
% 214.86/215.08       in children; do not use /blood supply /chem /second /secret /ultrastruct; coord IM with precoord organ/neopl term if specified %28%IM%29%%A%  
% 214.86/215.08  |- skos__hiddenLabel mesh__D018222 Aggressive Fibromatosis
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018222 1999
% 214.86/215.08  |- mesh__publicMeSHNote mesh__D018222
% 214.86/215.08       94; DESMOID was see FIBROMA 1991-93   
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018222 2000
% 214.86/215.08  |- mesh__recordOriginator mesh__D018222 PLS
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018222 1998
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018222 2006
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D051656 2006
% 214.86/215.08  |- skos__hiddenLabel mesh__D051656 Potassium Channels, KCNQ
% 214.86/215.08  |- mesh__dateEstablished mesh__D051656 2006-01-01
% 214.86/215.08  |- mesh__historyNote mesh__D051656 2006%28%1996%29%   
% 214.86/215.08  |- skos__prefLabel mesh__D051656 KCNQ Potassium Channels
% 214.86/215.08  |- mesh__publicMeSHNote mesh__D051656
% 214.86/215.08       2006; KCNQ POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005 %26% under POTASSIUM CHANNELS 1996-2004%A%  
% 214.86/215.08  |- skos__hiddenLabel mesh__D051656 Potassium Channels, KvLQT
% 214.86/215.08  |- skos__broader mesh__D051656smesh__D051668
% 214.86/215.08  |- rdf__type mesh__D051656sskos__Concept
% 214.86/215.08  |- skos__altLabel mesh__D051656 KvLQT Potassium Channels
% 214.86/215.08  |- skos__scopeNote mesh__D051656
% 214.86/215.08       A family of delayed rectifier voltage-gated potassium channels that share homology with their founding member, KCNQ1 PROTEIN. KCNQ potassium channels have been implicated in a variety of diseases including LONG QT SYNDROME; DEAFNESS; and EPILEPSY.%A%    
% 214.86/215.08  |- mesh__dateCreated mesh__D051656 2005-06-30
% 214.86/215.08  |- mesh__recordAuthorizer mesh__D051656 sjn
% 214.86/215.08  |- mesh__recordMaintainer mesh__D051656 DRC
% 214.86/215.08  |- mesh__recordOriginator mesh__D051656 DRC
% 214.86/215.08  |- mesh__recordMaintainer mesh__D004202 ssb
% 214.86/215.08  |- skos__broader mesh__D004202smesh__D000890
% 214.86/215.08  |- skos__broader mesh__D004202smesh__D020313
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D004202 2005
% 214.86/215.08  |- skos__prefLabel mesh__D004202 Disinfectants
% 214.86/215.08  |- skos__scopeNote mesh__D004202
% 214.86/215.08       Substances used on inanimate objects that destroy harmful microorganisms or inhibit their activity. Disinfectants are classed as complete, destroying spores as well as vegetative forms of microorganisms, or incomplete, destroying only vegetative forms of the organisms. They are distinguished from antiseptics, which are local anti-infective agents used on humans and other animals. %28%From Hawley%27%s Condensed Chemical Dictionary, 11th ed%29%%A%    
% 214.86/215.08  |- skos__historyNote mesh__D004202
% 214.86/215.08       Anti-Infective Agents, Local %28%1966%29%
% 214.86/215.08  |- mesh__dateCreated mesh__D004202 1999-01-01
% 214.86/215.08  |- mesh__dateRevised mesh__D004202 2003-07-09
% 214.86/215.08  |- mesh__recordOriginator mesh__D004202 NLM
% 214.86/215.08  |- mesh__publicMeSHNote mesh__D004202 67; was see ANTISEPTICS 1963-66   
% 214.86/215.08  |- mesh__onlineNote mesh__D004202
% 214.86/215.08       search ANTI-INFECTIVE AGENTS, LOCAL 1966   
% 214.86/215.08  |- rdf__type mesh__D004202sskos__Concept
% 214.86/215.08  |- mesh__historyNote mesh__D004202 67; was see ANTISEPTICS 1963-66   
% 214.86/215.08  |- mesh__recordAuthorizer mesh__D004202 sjn
% 214.86/215.08  |- skos__annotation mesh__D004202
% 214.86/215.08       do not confuse with antiseptics %28% = ANTI-INFECTIVE AGENTS, LOCAL%29% for use against organisms in man %26% animal%A%  
% 214.86/215.08  |- mesh__dateEstablished mesh__D004202 1967-01-01
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D004202 2004
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D004202 2006
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D009496 2006
% 214.86/215.08  |- mesh__dateRevised mesh__D009496 2005-06-30
% 214.86/215.08  |- skos__prefLabel mesh__D009496 Neurotensin
% 214.86/215.08  |- skos__scopeNote mesh__D009496
% 214.86/215.08       A biologically active tridecapeptide isolated from the hypothalamus. It has been shown to induce hypotension in the rat, to stimulate contraction of guinea pig ileum and rat uterus, and to cause relaxation of rat duodenum. There is also evidence that it acts as both a peripheral and a central nervous system neurotransmitter.%A%    
% 214.86/215.08  |- skos__historyNote mesh__D009496 Peptides %28%1966-1977%29%
% 214.86/215.08  |- skos__historyNote mesh__D009496 Nerve Tissue Proteins %28%1966-1977%29%
% 214.86/215.08  |- mesh__publicMeSHNote mesh__D009496 78   
% 214.86/215.08  |- mesh__historyNote mesh__D009496 78   
% 214.86/215.08  |- mesh__recordMaintainer mesh__D009496 ssb
% 214.86/215.08  |- mesh__dateEstablished mesh__D009496 1978-01-01
% 214.86/215.08  |- skos__broader mesh__D009496smesh__D009479
% 214.86/215.08  |- skos__annotation mesh__D009496
% 214.86/215.08       a neurotransmitter isolated from the hypothalamus; /biosyn /physiol permitted%A%  
% 214.86/215.08  |- mesh__dateCreated mesh__D009496 1977-05-23
% 214.86/215.08  |- rdf__type mesh__D009496sskos__Concept
% 214.86/215.08  |- mesh__recordOriginator mesh__D009496 RLS
% 214.86/215.08  |- mesh__recordAuthorizer mesh__D009496 sjn
% 214.86/215.08  |- skos__related mesh__D009496smesh__D018028
% 214.86/215.08  |- skos__historyNote mesh__D009496 Kinins %28%1966-1977%29%
% 214.86/215.08  |- skos__annotation mesh__D017928
% 214.86/215.08       infection in swine = VESICULAR EXANTHEMA OF SWINE; infection in other animals: coord IM with CALICIVIRIDAE INFECTIONS %28%IM%29%%A%  
% 214.86/215.08  |- skos__historyNote mesh__D017928 Picornaviridae %28%1966-1978%29%
% 214.86/215.08  |- mesh__publicMeSHNote mesh__D017928
% 214.86/215.08       1994; see CALICIVIRIDAE 1993; for SAN MIGUEL SEA LION VIRUSES use CALICIVIRUS 1994-2001%A%  
% 214.86/215.08  |- rdf__type mesh__D017928sskos__Concept
% 214.86/215.08  |- mesh__recordAuthorizer mesh__D017928 ags
% 214.86/215.08  |- mesh__recordMaintainer mesh__D017928 ags
% 214.86/215.08  |- skos__broader mesh__D017928smesh__D029342
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D017928 2006
% 214.86/215.08  |- skos__prefLabel mesh__D017928 Vesicular exanthema of swine virus
% 214.86/215.08  |- mesh__dateRevised mesh__D017928 2005-07-11
% 214.86/215.08  |- skos__historyNote mesh__D017928 Caliciviridae %28%1978-1993%29%
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D017928 2002
% 214.86/215.08  |- mesh__historyNote mesh__D017928
% 214.86/215.08       1994; use CALICIVIRIDAE 1993; for SAN MIGUEL SEA LION VIRUSES use CALICIVIRIDAE 1994-2001%A%  
% 214.86/215.08  |- mesh__dateCreated mesh__D017928 1993-06-04
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D017928 2005
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D017928 2004
% 214.86/215.08  |- skos__altLabel mesh__D017928 Swine Vesicular Exanthema Virus
% 214.86/215.08  |- skos__scopeNote mesh__D017928
% 214.86/215.08       The type species of the genus VESIVIRUS infecting pigs. The resulting infection is an acute febrile disease which is clinically indistinguishable from FOOT AND MOUTH DISEASE. Transmission is by contaminated food.%A%    
% 214.86/215.08  |- skos__altLabel mesh__D017928 VESV
% 214.86/215.08  |- mesh__recordOriginator mesh__D017928 AGS
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D017928 2006A
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D017928 2003
% 214.86/215.08  |- mesh__dateEstablished mesh__D017928 1994-01-01
% 214.86/215.08  |- skos__prefLabel mesh__D042321 Anaplasma centrale
% 214.86/215.08  |- skos__scopeNote mesh__D042321
% 214.86/215.08       A species of gram-negative bacteria causing mild ANAPLASMOSIS in CATTLE. It also can infect SHEEP and GOATS. It is transmitted by TICKS.%A%    
% 214.86/215.08  |- skos__broader mesh__D042321smesh__D000709
% 214.86/215.08  |- mesh__historyNote mesh__D042321 2004   
% 214.86/215.08  |- mesh__recordOriginator mesh__D042321 ags
% 214.86/215.08  |- mesh__dateEstablished mesh__D042321 2004-01-01
% 214.86/215.08  |- mesh__dateRevised mesh__D042321 2005-06-30
% 214.86/215.08  |- mesh__publicMeSHNote mesh__D042321 2004   
% 214.86/215.08  |- mesh__recordMaintainer mesh__D042321 SYSTEM
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D042321 2006
% 214.86/215.08  |- rdf__type mesh__D042321sskos__Concept
% 214.86/215.08  |- skos__historyNote mesh__D042321 Anaplasma %28%1966-2003%29%
% 214.86/215.08  |- mesh__recordAuthorizer mesh__D042321 sjn
% 214.86/215.08  |- mesh__dateCreated mesh__D042321 2003-07-09
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D003908 2005
% 214.86/215.08  |- mesh__recordMaintainer mesh__D003908 ssb
% 214.86/215.08  |- mesh__dateRevised mesh__D003908 2003-07-09
% 214.86/215.08  |- skos__hiddenLabel mesh__D003908 Isonicotinate, Dexamethasone
% 214.86/215.08  |- skos__broader mesh__D003908smesh__D003907
% 214.86/215.08  |- rdf__type mesh__D003908sskos__Concept
% 214.86/215.08  |- skos__historyNote mesh__D003908
% 214.86/215.08       Dexamethasone %28%1972-1974%29% /analogs %26% derivatives %28%1975%29%
% 214.86/215.08  |- skos__hiddenLabel mesh__D003908 HE 111
% 214.86/215.08  |- mesh__publicMeSHNote mesh__D003908
% 214.86/215.08       91; was see under DEXAMETHASONE 1976-90   
% 214.86/215.08  |- mesh__dateEstablished mesh__D003908 1991-01-01
% 214.86/215.08  |- skos__prefLabel mesh__D003908 Dexamethasone Isonicotinate
% 214.86/215.08  |- mesh__historyNote mesh__D003908
% 214.86/215.08       91%28%76%29%; was see under DEXAMETHASONE 1976-90   
% 214.86/215.08  |- skos__historyNote mesh__D003908 Isonicotinic Acids %28%1972-1975%29%
% 214.86/215.08  |- mesh__recordAuthorizer mesh__D003908 sjn
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D003908 2004
% 214.86/215.08  |- mesh__recordOriginator mesh__D003908 SH
% 214.86/215.08  |- mesh__dateCreated mesh__D003908 1975-07-18
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D003908 2006
% 214.86/215.08  |- skos__hiddenLabel mesh__D003908 HE111
% 214.86/215.08  |- skos__scopeNote mesh__D003908
% 214.86/215.08       An anti-inflammatory, anti-allergic glucocorticoid that can be administered orally, by inhalation, locally, and parenterally. It may cause water and salt retention.%A%    
% 214.86/215.08  |- skos__broader mesh__D014630smesh__D010275
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D014630 2004
% 214.86/215.08  |- mesh__recordMaintainer mesh__D014630 ags
% 214.86/215.08  |- skos__hiddenLabel mesh__D014630 Nerve, Pneumogastric
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D014630 2002
% 214.86/215.08  |- mesh__dateRevised mesh__D014630 1999-11-03
% 214.86/215.08  |- mesh__recordOriginator mesh__D014630 NLM
% 214.86/215.08  |- skos__broader mesh__D014630smesh__D017776
% 214.86/215.08  |- rdf__type mesh__D014630sskos__Concept
% 214.86/215.08  |- skos__broader mesh__D014630smesh__D003391
% 214.86/215.08  |- skos__scopeNote mesh__D014630
% 214.86/215.08       The 10th cranial nerve. The vagus is a mixed nerve which contains somatic afferents %28%from skin in back of the ear and the external auditory meatus%29%, visceral afferents %28%from the pharynx, larynx, thorax, and abdomen%29%, parasympathetic efferents %28%to the thorax and abdomen%29%, and efferents to striated muscle %28%of the larynx and pharynx%29%.%A%    
% 214.86/215.08  |- skos__prefLabel mesh__D014630 Vagus Nerve
% 214.86/215.08  |- skos__hiddenLabel mesh__D014630 X, Cranial Nerve
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D014630 2003
% 214.86/215.08  |- skos__hiddenLabel mesh__D014630 Nerves, Pneumogastric
% 214.86/215.08  |- mesh__dateCreated mesh__D014630 1999-01-01
% 214.86/215.08  |- skos__hiddenLabel mesh__D014630 Nerves, Vagus
% 214.86/215.08  |- skos__hiddenLabel mesh__D014630 Pneumogastric Nerves
% 214.86/215.08  |- skos__hiddenLabel mesh__D014630 Nerve X, Cranial
% 214.86/215.08  |- mesh__recordAuthorizer mesh__D014630 sjn
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D014630 2006
% 214.86/215.08  |- skos__hiddenLabel mesh__D014630 Nerves, Tenth Cranial
% 214.86/215.08  |- skos__hiddenLabel mesh__D014630 Cranial Nerve, Tenth
% 214.86/215.08  |- skos__altLabel mesh__D014630 Tenth Cranial Nerve
% 214.86/215.08  |- skos__hiddenLabel mesh__D014630 Nerve, Tenth Cranial
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D014630 2001
% 214.86/215.08  |- skos__hiddenLabel mesh__D014630 Nerve, Vagus
% 214.86/215.08  |- skos__altLabel mesh__D014630 Cranial Nerve X
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D014630 2005
% 214.86/215.08  |- skos__hiddenLabel mesh__D014630 Vagus Nerves
% 214.86/215.08  |- skos__hiddenLabel mesh__D014630 Cranial Nerves, Tenth
% 214.86/215.08  |- skos__altLabel mesh__D014630 Pneumogastric Nerve
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D014630 2000
% 214.86/215.08  |- skos__related mesh__D014630smesh__D014628
% 214.86/215.08  |- skos__annotation mesh__D014630
% 214.86/215.08       neopl = VAGUS NERVE DISEASES %28%IM%29% + CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%; /surg: probably VAGOTOMY%A%  
% 214.86/215.08  |- skos__hiddenLabel mesh__D014630 Tenth Cranial Nerves
% 214.86/215.08  |- skos__broader mesh__D009369Q000556smesh__D009369
% 214.86/215.08  |- mesh__preferredCombination mesh__D009369Q000556smesh__D009362
% 214.86/215.08  |- rdf__type mesh__D009369Q000556smesh__CompoundConcept
% 214.86/215.08  |- skos__altLabel mesh__D000610
% 214.86/215.08       Llorens Brand of Aminobenzoic Acid Sodium Salt
% 214.86/215.08  |- skos__scopeNote mesh__D000610
% 214.86/215.08       BENZOIC ACID substituted with an amino group. They can either be mono-, di-, or tri- substituted. Para-aminobenzoic acid %28%see 4-AMINOBENZOIC ACID%29% is considered a member of the vitamin b complex.%A%    
% 214.86/215.08  |- mesh__onlineNote mesh__D000610
% 214.86/215.08       use AMINOBENZOIC ACIDS to search AMINOBENZOIC ACID 1966-74%A%  
% 214.86/215.08  |- mesh__recordOriginator mesh__D000610 NLM
% 214.86/215.08  |- skos__broader mesh__D000610smesh__D020185
% 214.86/215.08  |- skos__prefLabel mesh__D000610 Aminobenzoic Acids
% 214.86/215.08  |- rdf__type mesh__D000610sskos__Concept
% 214.86/215.08  |- mesh__historyNote mesh__D000610 75; was AMINOBENZOIC ACID 1965-74   
% 214.86/215.08  |- skos__altLabel mesh__D000610 Llorens Brand of Aminobenzoic Acid
% 214.86/215.08  |- mesh__publicMeSHNote mesh__D000610 75; was AMINOBENZOIC ACID 1965-74;   
% 214.86/215.08  |- skos__altLabel mesh__D000610 Medea Brand of Aminobenzoic Acid
% 214.86/215.08  |- skos__hiddenLabel mesh__D000610 Vit, Epit
% 214.86/215.08  |- mesh__recordMaintainer mesh__D000610 ssb
% 214.86/215.08  |- mesh__dateRevised mesh__D000610 2005-06-30
% 214.86/215.08  |- skos__hiddenLabel mesh__D000610 Acids, Aminobenzoic
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D000610 2006
% 214.86/215.08  |- skos__altLabel mesh__D000610 Paraminan
% 214.86/215.08  |- mesh__recordAuthorizer mesh__D000610 sjn
% 214.86/215.08  |- mesh__dateCreated mesh__D000610 1999-01-01
% 214.86/215.08  |- skos__altLabel mesh__D000610 Jumer Brand of Aminobenzoic Acid
% 214.86/215.08  |- skos__altLabel mesh__D000610 Owen Brand of Aminobenzoic Acid
% 214.86/215.08  |- mesh__dateEstablished mesh__D000610 1965-01-01
% 214.86/215.08  |- skos__altLabel mesh__D000610 Westwood Squibb Brand of Aminobenzoic Acid
% 214.86/215.08  |- skos__annotation mesh__D000610
% 214.86/215.08       deficiency: coordinate AMINOBENZOIC ACIDS /defic %28%IM%29% with VITAMIN B DEFICIENCY %28%IM%29%%A%  
% 214.86/215.08  |- skos__altLabel mesh__D000610
% 214.86/215.08       Torlan Brand of Aminobenzoic Acid Potassium Salt
% 214.86/215.08  |- mesh__dateEstablished mesh__D013538 1975-01-01
% 214.86/215.08  |- mesh__recordMaintainer mesh__D013538 TGC
% 214.86/215.08  |- mesh__recordOriginator mesh__D013538 NLM
% 214.86/215.08  |- skos__prefLabel mesh__D013538 Svalbard
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013538 2005
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013538 2002
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013538 1995
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013538 2004
% 214.86/215.08  |- mesh__dateRevised mesh__D013538 1991-06-11
% 214.86/215.08  |- mesh__dateCreated mesh__D013538 1974-11-11
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013538 1999
% 214.86/215.08  |- skos__broader mesh__D013538smesh__D009664
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013538 2001
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013538 1994
% 214.86/215.08  |- rdf__type mesh__D013538sskos__Concept
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013538 2003
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013538 2000
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013538 1993
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013538 1998
% 214.86/215.08  |- mesh__recordAuthorizer mesh__D013538 PLS
% 214.86/215.08  |- mesh__historyNote mesh__D013538 75   
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013538 1997
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013538 1992
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013538 1996
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D013538 2006
% 214.86/215.08  |- skos__annotation mesh__D018223
% 214.86/215.08       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with SKIN NEOPLASMS %28%IM%29%%A%  
% 214.86/215.08  |- mesh__dateRevised mesh__D018223 1995-06-08
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018223 2003
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018223 1997
% 214.86/215.08  |- skos__prefLabel mesh__D018223 Dermatofibrosarcoma
% 214.86/215.08  |- rdf__type mesh__D018223sskos__Concept
% 214.86/215.08  |- skos__historyNote mesh__D018223 Skin Neoplasms %28%1966-1993%29%
% 214.86/215.08  |- mesh__recordAuthorizer mesh__D018223 PLS
% 214.86/215.08  |- skos__historyNote mesh__D018223 Fibrosarcoma %28%1966-1993%29%
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018223 2004
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018223 2002
% 214.86/215.08  |- mesh__recordMaintainer mesh__D018223 KEV
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018223 1998
% 214.86/215.08  |- skos__scopeNote mesh__D018223
% 214.86/215.08       A fibrosarcoma of the skin, beginning most often as an indurated nodule that grows slowly and hence is often ignored until it grows large. Dermatofibrosarcomas show an extremely aggressive tendency to invade local surrounding tissue. They do not metastasize, however, even after multiple recurrences. About 50%25% will recur after simple incision; hence wide excision should be resorted to. %28%DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1356%29%%A%    
% 214.86/215.08  |- mesh__dateEstablished mesh__D018223 1994-01-01
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018223 2005
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018223 1999
% 214.86/215.08  |- mesh__historyNote mesh__D018223 94   
% 214.86/215.08  |- mesh__publicMeSHNote mesh__D018223 94   
% 214.86/215.08  |- mesh__recordOriginator mesh__D018223 PLS
% 214.86/215.08  |- skos__broader mesh__D018223smesh__D005354
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018223 2000
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018223 2006
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018223 1996
% 214.86/215.08  |- mesh__dateCreated mesh__D018223 1993-06-25
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D018223 2001
% 214.86/215.08  |- skos__hiddenLabel mesh__D018223 Dermatofibrosarcomas
% 214.86/215.08  |- rdf__type mesh__D010240sskos__Concept
% 214.86/215.08  |- mesh__recordMaintainer mesh__D010240 ags
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D010240 2005
% 214.86/215.08  |- skos__prefLabel mesh__D010240 Parakeets
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D010240 2006
% 214.86/215.08  |- mesh__recordAuthorizer mesh__D010240 sjn
% 214.86/215.08  |- mesh__historyNote mesh__D010240
% 214.86/215.08       91%28%75%29%; was see under PSITTACINES 1975-90   
% 214.86/215.08  |- mesh__publicMeSHNote mesh__D010240
% 214.86/215.08       91; was see under PSITTACINES 1975-90   
% 214.86/215.08  |- skos__broader mesh__D010240smesh__D010311
% 214.86/215.08  |- mesh__onlineNote mesh__D010240 search PSITTACINES 1968-74   
% 214.86/215.08  |- skos__hiddenLabel mesh__D010240 Parakeet
% 214.86/215.08  |- mesh__recordOriginator mesh__D010240 NLM
% 214.86/215.08  |- skos__scopeNote mesh__D010240
% 214.86/215.08       Common name for one of five species of small PARROTS, containing long tails.%A%    
% 214.86/215.08  |- mesh__dateCreated mesh__D010240 1999-01-01
% 214.86/215.08  |- mesh__dateRevised mesh__D010240 2004-07-07
% 214.86/215.08  |- mesh__dateEstablished mesh__D010240 1991-01-01
% 214.86/215.08  |- skos__altLabel mesh__D051657 KCNQ1 Protein
% 214.86/215.08  |- mesh__recordAuthorizer mesh__D051657 sjn
% 214.86/215.08  |- skos__broader mesh__D051657smesh__D051656
% 214.86/215.08  |- mesh__recordMaintainer mesh__D051657 DRC
% 214.86/215.08  |- skos__hiddenLabel mesh__D051657 Potassium Channel, KCNQ1
% 214.86/215.08  |- skos__altLabel mesh__D051657 KVLQT1 Protein
% 214.86/215.08  |- skos__hiddenLabel mesh__D051657 Voltage Gated K+ Channel KCNQ1
% 214.86/215.08  |- mesh__historyNote mesh__D051657 2006%28%1996%29%   
% 214.86/215.08  |- mesh__dateEstablished mesh__D051657 2006-01-01
% 214.86/215.08  |- skos__altLabel mesh__D051657 Voltage-Gated K+ Channel KCNQ1
% 214.86/215.08  |- rdf__type mesh__D051657sskos__Concept
% 214.86/215.08  |- skos__prefLabel mesh__D051657 KCNQ1 Potassium Channel
% 214.86/215.08  |- mesh__publicMeSHNote mesh__D051657
% 214.86/215.08       2006; KCNQ1 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1996-2004%A%  
% 214.86/215.08  |- skos__altLabel mesh__D051657 Kv7.1 Potassium Channel
% 214.86/215.08  |- mesh__recordOriginator mesh__D051657 DRC
% 214.86/215.08  |- skos__scopeNote mesh__D051657
% 214.86/215.08       A voltage-gated potassium channel that is expressed primarily in the HEART.%A%    
% 214.86/215.08  |- skos__hiddenLabel mesh__D051657 Potassium Channel, Kv7.1
% 214.86/215.08  |- mesh__activeMeSHYear mesh__D051657 2006
% 214.86/215.08  |- mesh__dateCreated mesh__D051657 2005-06-30
% 214.86/215.09  |- mesh__publicMeSHNote mesh__D004203
% 214.86/215.09       91,63-66; was see under STERILIZATION 1967-90; was heading 1963-66%A%  
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004203 2000
% 214.86/215.09  |- mesh__dateCreated mesh__D004203 1999-01-01
% 214.86/215.09  |- skos__scopeNote mesh__D004203
% 214.86/215.09       Rendering pathogens harmless through the use of heat, antiseptics, antibacterial agents, etc.%A%    
% 214.86/215.09  |- mesh__dateRevised mesh__D004203 1994-05-05
% 214.86/215.09  |- mesh__recordMaintainer mesh__D004203 TGC
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004203 1997
% 214.86/215.09  |- skos__annotation mesh__D004203
% 214.86/215.09       differentiate from STERILIZATION: DISINFECTION renders matter free of pathogens, STERILIZATION destroys all microbes; if in doubt, use the word of the text; disinfection of needles using household bleach Clorox, as by intravenous drug users, is indexed under DISINFECTION + NEEDLES + SODIUM HYPOCHLORITE%A%  
% 214.86/215.09  |- rdf__type mesh__D004203sskos__Concept
% 214.86/215.09  |- mesh__onlineNote mesh__D004203
% 214.86/215.09       use STERILIZATION to search DISINFECTION 1966-74   
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004203 1999
% 214.86/215.09  |- skos__broader mesh__D004203smesh__D013242
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004203 2004
% 214.86/215.09  |- mesh__recordAuthorizer mesh__D004203 PLS
% 214.86/215.09  |- mesh__recordOriginator mesh__D004203 NLM
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004203 1996
% 214.86/215.09  |- mesh__dateEstablished mesh__D004203 1991-01-01
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004203 1995
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004203 2002
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004203 2006
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004203 1998
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004203 2003
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004203 2001
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004203 2005
% 214.86/215.09  |- skos__prefLabel mesh__D004203 Disinfection
% 214.86/215.09  |- mesh__historyNote mesh__D004203
% 214.86/215.09       91%28%75%29%63-66; was see under STERILIZATION 1967-90; was heading 1963-66%A%  
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D009497 2001
% 214.86/215.09  |- skos__prefLabel mesh__D009497 Neurotic Disorders
% 214.86/215.09  |- skos__hiddenLabel mesh__D009497 Neurotic Disorder
% 214.86/215.09  |- skos__hiddenLabel mesh__D009497 Disorder, Neurotic
% 214.86/215.09  |- mesh__publicMeSHNote mesh__D009497 81; was NEUROSES 1963-80   
% 214.86/215.09  |- mesh__dateRevised mesh__D009497 1997-06-20
% 214.86/215.09  |- skos__hiddenLabel mesh__D009497 Disorders, Neurotic
% 214.86/215.09  |- mesh__historyNote mesh__D009497 81; was NEUROSES 1963-80   
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D009497 2002
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D009497 2003
% 214.86/215.09  |- rdf__type mesh__D009497sskos__Concept
% 214.86/215.09  |- mesh__recordAuthorizer mesh__D009497 SJN
% 214.86/215.09  |- skos__altLabel mesh__D009497 Neuroses
% 214.86/215.09  |- skos__altLabel mesh__D009497 Psychoneuroses
% 214.86/215.09  |- mesh__recordOriginator mesh__D009497 NLM
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D009497 2004
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D009497 1998
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D009497 2005
% 214.86/215.09  |- skos__broader mesh__D009497smesh__D001523
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D009497 2000
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D009497 1999
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D009497 2006
% 214.86/215.09  |- skos__scopeNote mesh__D009497
% 214.86/215.09       Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.%A%    
% 214.86/215.09  |- mesh__onlineNote mesh__D009497
% 214.86/215.09       use NEUROTIC DISORDERS to search NEUROSES 1966-80   
% 214.86/215.09  |- mesh__recordMaintainer mesh__D009497 JLS
% 214.86/215.09  |- mesh__dateCreated mesh__D009497 1999-01-01
% 214.86/215.09  |- mesh__recordMaintainer mesh__D017929 ags
% 214.86/215.09  |- mesh__publicMeSHNote mesh__D017929
% 214.86/215.09       94; RABBIT HEMORRHAGIC DISEASE VIRUS was see CALICIVIRIDAE 1993%A%  
% 214.86/215.09  |- mesh__dateEstablished mesh__D017929 1994-01-01
% 214.86/215.09  |- mesh__recordOriginator mesh__D017929 AGS
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D017929 2005
% 214.86/215.09  |- skos__altLabel mesh__D017929 Rabbit Haemorrhagic Disease Virus
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D017929 2004
% 214.86/215.09  |- skos__scopeNote mesh__D017929
% 214.86/215.09       A  species in the genus LAGOVIRUS which causes hemorrhagic disease, including hemorrhagic septicemia, in rabbits.%A%    
% 214.86/215.09  |- skos__prefLabel mesh__D017929 Hemorrhagic Disease Virus, Rabbit
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D017929 2003
% 214.86/215.09  |- skos__annotation mesh__D017929
% 214.86/215.09       infection: coord IM with CALICIVIRIDAE INFECTIONS %28%IM%29%   
% 214.86/215.09  |- mesh__historyNote mesh__D017929
% 214.86/215.09       94; RABBIT HEMORRHAGIC DISEASE VIRUS was see CALICIVIRIDAE 1993%A%  
% 214.86/215.09  |- skos__historyNote mesh__D017929 Caliciviridae %28%1991-1993%29%
% 214.86/215.09  |- mesh__onlineNote mesh__D017929
% 214.86/215.09       use CALICIVIRIDAE to search RABBIT HEMORRHAGIC DISEASE VIRUS 1993%A%  
% 214.86/215.09  |- skos__altLabel mesh__D017929 Rabbit hemorrhagic disease virus
% 214.86/215.09  |- mesh__recordAuthorizer mesh__D017929 sjn
% 214.86/215.09  |- mesh__dateRevised mesh__D017929 2001-07-25
% 214.86/215.09  |- rdf__type mesh__D017929sskos__Concept
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D017929 2002
% 214.86/215.09  |- mesh__dateCreated mesh__D017929 1993-06-04
% 214.86/215.09  |- skos__broader mesh__D017929smesh__D029321
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D017929 2006
% 214.86/215.09  |- mesh__recordMaintainer mesh__D042322 SYSTEM
% 214.86/215.09  |- skos__prefLabel mesh__D042322 Anaplasma marginale
% 214.86/215.09  |- mesh__recordAuthorizer mesh__D042322 sjn
% 214.86/215.09  |- skos__scopeNote mesh__D042322
% 214.86/215.09       A species of gram-negative bacteria and causative agent of severe bovine ANAPLASMOSIS. It is the most pathogenic of the ANAPLASMA species.%A%    
% 214.86/215.09  |- mesh__publicMeSHNote mesh__D042322 2004   
% 214.86/215.09  |- mesh__historyNote mesh__D042322 2004   
% 214.86/215.09  |- skos__broader mesh__D042322smesh__D000709
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D042322 2006
% 214.86/215.09  |- mesh__recordOriginator mesh__D042322 ags
% 214.86/215.09  |- rdf__type mesh__D042322sskos__Concept
% 214.86/215.09  |- mesh__dateRevised mesh__D042322 2005-06-30
% 214.86/215.09  |- skos__historyNote mesh__D042322 Anaplasma %28%1964-2003%29%
% 214.86/215.09  |- mesh__dateEstablished mesh__D042322 2004-01-01
% 214.86/215.09  |- mesh__dateCreated mesh__D042322 2003-07-09
% 214.86/215.09  |- mesh__dateRevised mesh__D003909 2005-06-30
% 214.86/215.09  |- rdf__type mesh__D003909sskos__Concept
% 214.86/215.09  |- skos__altLabel mesh__D003909 dextro-Benzetimide
% 214.86/215.09  |- skos__hiddenLabel mesh__D003909 dextro Benzetimide
% 214.86/215.09  |- skos__annotation mesh__D003909 an antiparkinson agent   
% 214.86/215.09  |- mesh__dateCreated mesh__D003909 1974-11-19
% 214.86/215.09  |- mesh__publicMeSHNote mesh__D003909
% 214.86/215.09       91; was see under PIPERIDINES 1975-90   
% 214.86/215.09  |- mesh__dateEstablished mesh__D003909 1991-01-01
% 214.86/215.09  |- mesh__recordOriginator mesh__D003909 NLM
% 214.86/215.09  |- skos__hiddenLabel mesh__D003909 R 16470
% 214.86/215.09  |- mesh__recordMaintainer mesh__D003909 exl
% 214.86/215.09  |- skos__altLabel mesh__D003909 Dexbenzetimid
% 214.86/215.09  |- skos__broader mesh__D003909smesh__D010881
% 214.86/215.09  |- skos__altLabel mesh__D003909 Dexbenzetimide
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D003909 2006
% 214.86/215.09  |- skos__historyNote mesh__D003909 Benzyl Compounds %28%1972-1974%29%
% 214.86/215.09  |- skos__historyNote mesh__D003909 Piperidones %28%1972-1974%29%
% 214.86/215.09  |- mesh__recordAuthorizer mesh__D003909 sjn
% 214.86/215.09  |- mesh__historyNote mesh__D003909
% 214.86/215.09       91%28%75%29%; was see under PIPERIDINES 1975-90   
% 214.86/215.09  |- skos__hiddenLabel mesh__D003909 R16470
% 214.86/215.09  |- skos__altLabel mesh__D003909 Janssen Brand of Benzetimide Hydrochloride
% 214.86/215.09  |- skos__prefLabel mesh__D003909 Dexetimide
% 214.86/215.09  |- skos__scopeNote mesh__D003909
% 214.86/215.09       A muscarinic antagonist that has been used to treat neuroleptic-induced parkinsonism. Benzetimide is the %28%-%29%-enantimorph of dexetimide.%A%    
% 214.86/215.09  |- skos__broader mesh__D014631smesh__D005232
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D014631 2004
% 214.86/215.09  |- mesh__publicMeSHNote mesh__D014631 66   
% 214.86/215.09  |- rdf__type mesh__D014631sskos__Concept
% 214.86/215.09  |- skos__prefLabel mesh__D014631 Valerates
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D014631 2005
% 214.86/215.09  |- mesh__dateRevised mesh__D014631 2003-07-09
% 214.86/215.09  |- mesh__dateEstablished mesh__D014631 1966-01-01
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D014631 2006
% 214.86/215.09  |- mesh__recordMaintainer mesh__D014631 ssb
% 214.86/215.09  |- skos__annotation mesh__D014631
% 214.86/215.09       2-propylvalerate, 2-propylvaleric acid = VALPROATE   
% 214.86/215.09  |- mesh__recordOriginator mesh__D014631 NLM
% 214.86/215.09  |- skos__broader mesh__D014631smesh__D000144
% 214.86/215.09  |- mesh__historyNote mesh__D014631 66   
% 214.86/215.09  |- skos__altLabel mesh__D014631 Pentanoates
% 214.86/215.09  |- mesh__recordAuthorizer mesh__D014631 sjn
% 214.86/215.09  |- mesh__dateCreated mesh__D014631 1999-01-01
% 214.86/215.09  |- mesh__historyNote mesh__D000611 75   
% 214.86/215.09  |- mesh__publicMeSHNote mesh__D000611 75   
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D000611 1995
% 214.86/215.09  |- skos__hiddenLabel mesh__D000611 Compounds, Aminobiphenyl
% 214.86/215.09  |- mesh__dateRevised mesh__D000611 1992-05-07
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D000611 1993
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D000611 2006
% 214.86/215.09  |- skos__historyNote mesh__D000611 Biphenyl Compounds %28%1972-1974%29%
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D000611 1999
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D000611 2001
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D000611 1994
% 214.86/215.09  |- mesh__recordAuthorizer mesh__D000611 PLS
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D000611 2004
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D000611 1997
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D000611 2005
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D000611 1998
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D000611 2000
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D000611 2003
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D000611 1996
% 214.86/215.09  |- mesh__recordOriginator mesh__D000611 NLM
% 214.86/215.09  |- mesh__dateCreated mesh__D000611 1974-11-11
% 214.86/215.09  |- skos__broader mesh__D000611smesh__D001713
% 214.86/215.09  |- skos__altLabel mesh__D000611 Biphenylamines
% 214.86/215.09  |- skos__prefLabel mesh__D000611 Aminobiphenyl Compounds
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D000611 2002
% 214.86/215.09  |- skos__scopeNote mesh__D000611
% 214.86/215.09       Biphenyl compounds substituted in any position by one or more amino groups. Permitted are any substituents except fused rings.%A%    
% 214.86/215.09  |- rdf__type mesh__D000611sskos__Concept
% 214.86/215.09  |- mesh__recordMaintainer mesh__D000611 TGC
% 214.86/215.09  |- mesh__dateEstablished mesh__D000611 1975-09-01
% 214.86/215.09  |- skos__annotation mesh__D000611 DF: AMINOBIPHENYL CPDS   
% 214.86/215.09  |- skos__related mesh__D038281smesh__D037761
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D038281 2006
% 214.86/215.09  |- skos__altLabel mesh__D038281
% 214.86/215.09       Silent Information Regulator Proteins, S cerevisiae
% 214.86/215.09  |- skos__scopeNote mesh__D038281
% 214.86/215.09       A set of nuclear proteins in SACCHAROMYCES CEREVISIAE that are required for the transcriptional repression of the silent mating type loci. They mediate the formation of silenced CHROMATIN and repress both transcription and recombination at other loci as well. They are comprised of 4 non-homologous, interacting proteins, Sir1p, Sir2p, Sir3p, and Sir4p. Sir2p, an NAD-dependent HISTONE DEACETYLASE, is the founding member of the family of SIRTUINS.%A%    
% 214.86/215.09  |- skos__broader mesh__D038281smesh__D029701
% 214.86/215.09  |- mesh__dateEstablished mesh__D038281 2003-01-01
% 214.86/215.09  |- mesh__dateRevised mesh__D038281 2005-06-30
% 214.86/215.09  |- mesh__recordAuthorizer mesh__D038281 sjn
% 214.86/215.09  |- rdf__type mesh__D038281sskos__Concept
% 214.86/215.09  |- skos__altLabel mesh__D038281 SIR Proteins, S cerevisiae
% 214.86/215.09  |- mesh__historyNote mesh__D038281 2003   
% 214.86/215.09  |- skos__broader mesh__D038281smesh__D009687
% 214.86/215.09  |- skos__prefLabel mesh__D038281
% 214.86/215.09       Silent Information Regulator Proteins, Saccharomyces cerevisiae
% 214.86/215.09  |- mesh__recordMaintainer mesh__D038281 SYSTEM
% 214.86/215.09  |- mesh__publicMeSHNote mesh__D038281 2003   
% 214.86/215.09  |- mesh__dateCreated mesh__D038281 2002-07-03
% 214.86/215.09  |- mesh__recordOriginator mesh__D038281 nns
% 214.86/215.09  |- mesh__publicMeSHNote mesh__D013539
% 214.86/215.09       2001; see POLYOMAVIRUS MACACAE 1994-2001, see SV40 VIRUS 1965-1993%A%  
% 214.86/215.09  |- skos__altLabel mesh__D013539 Vacuolating Agent
% 214.86/215.09  |- skos__broader mesh__D013539smesh__D011120
% 214.86/215.09  |- mesh__recordOriginator mesh__D013539 NLM
% 214.86/215.09  |- rdf__type mesh__D013539sskos__Concept
% 214.86/215.09  |- mesh__recordAuthorizer mesh__D013539 sjn
% 214.86/215.09  |- skos__hiddenLabel mesh__D013539 SV 40 Viruses
% 214.86/215.09  |- skos__prefLabel mesh__D013539 Simian virus 40
% 214.86/215.09  |- mesh__dateEstablished mesh__D013539 1965-01-01
% 214.86/215.09  |- mesh__recordMaintainer mesh__D013539 sjn
% 214.86/215.09  |- skos__altLabel mesh__D013539 Polyomavirus macacae
% 214.86/215.09  |- skos__annotation mesh__D013539
% 214.86/215.09       X ref SV40 VIRUS is from Simian Vacuolating virus; infection: coord IM with POLYOMAVIRUS INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%%A%  
% 214.86/215.09  |- mesh__historyNote mesh__D013539 2001 %28%1965%29%   
% 214.86/215.09  |- skos__hiddenLabel mesh__D013539 virus 40, Simian
% 214.86/215.09  |- mesh__dateCreated mesh__D013539 1999-01-01
% 214.86/215.09  |- skos__scopeNote mesh__D013539
% 214.86/215.09       A species of POLYOMAVIRUS originally isolated from Rhesus monkey kidney tissue. It produces malignancy in human and newborn hamster kidney cell cultures.%A%    
% 214.86/215.09  |- mesh__dateRevised mesh__D013539 2004-07-13
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D013539 2005
% 214.86/215.09  |- skos__hiddenLabel mesh__D013539 SV40 Viruses
% 214.86/215.09  |- skos__hiddenLabel mesh__D013539 Vacuolating Agents
% 214.86/215.09  |- skos__altLabel mesh__D013539 SV40 Virus
% 214.86/215.09  |- skos__altLabel mesh__D013539 SV 40 Virus
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D013539 2006
% 214.86/215.09  |- skos__altLabel mesh__D024261 HMG 2 Protein
% 214.86/215.09  |- skos__related mesh__D024261smesh__D024742
% 214.86/215.09  |- mesh__recordOriginator mesh__D024261 jmp
% 214.86/215.09  |- skos__broader mesh__D024261smesh__D024002
% 214.86/215.09  |- skos__historyNote mesh__D024261
% 214.86/215.09       Chromosomal Proteins, Non-Histone %28%1977-1984%29%
% 214.86/215.09  |- mesh__historyNote mesh__D024261
% 214.86/215.09       2002; for HMG 2 PROTEIN  use HIGH MOBILITY GROUP PROTEINS 1985-2001; for HMG 2 %26% HMG2 use HIGH MOBILITY GROUP PROTEINS 1992-2001%A%  
% 214.86/215.09  |- mesh__dateCreated mesh__D024261 2001-07-25
% 214.86/215.09  |- mesh__publicMeSHNote mesh__D024261
% 214.86/215.09       2002; for HMG 2 PROTEIN see HIGH MOBILITY GROUP PROTEINS 1985-2001; for HMG 2 %26% HMG2 see HIGH MOBILITY GROUP PROTEINS 1992-2001%A%  
% 214.86/215.09  |- skos__altLabel mesh__D024261 HMG 2
% 214.86/215.09  |- skos__altLabel mesh__D024261
% 214.86/215.09       High-Mobility Group %28%Nonhistone Chromosomal%29% Protein 2
% 214.86/215.09  |- mesh__dateRevised mesh__D024261 2004-07-07
% 214.86/215.09  |- skos__altLabel mesh__D024261 Box Protein 2, High Mobility Group
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D024261 2005
% 214.86/215.09  |- mesh__dateEstablished mesh__D024261 2002-01-01
% 214.86/215.09  |- mesh__recordAuthorizer mesh__D024261 sjn
% 214.86/215.09  |- rdf__type mesh__D024261sskos__Concept
% 214.86/215.09  |- mesh__recordMaintainer mesh__D024261 jmp
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D024261 2006
% 214.86/215.09  |- skos__historyNote mesh__D024261
% 214.86/215.09       High Mobility Group Proteins %28%1984-2001%29%
% 214.86/215.09  |- skos__prefLabel mesh__D024261 HMGB2 Protein
% 214.86/215.09  |- skos__altLabel mesh__D024261 HMGB2
% 214.86/215.09  |- skos__historyNote mesh__D024261 Nucleoproteins %28%1966-1981%29%
% 214.86/215.09  |- skos__scopeNote mesh__D024261
% 214.86/215.09       A 23-kDa HMG-box protein that binds to and distorts the minor grove of DNA.%A%    
% 214.86/215.09  |- skos__altLabel mesh__D024261 HMG2
% 214.86/215.09  |- mesh__publicMeSHNote mesh__D018224 94   
% 214.86/215.09  |- skos__scopeNote mesh__D018224
% 214.86/215.09       A condition characterized by multiple formations of myofibromas %28%LEIOMYOMA%29%.%A%    
% 214.86/215.09  |- skos__hiddenLabel mesh__D018224 Myofibromatoses
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D018224 2000
% 214.86/215.09  |- mesh__dateCreated mesh__D018224 1993-06-25
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D018224 2004
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D018224 2001
% 214.86/215.09  |- skos__historyNote mesh__D018224 Leiomyoma %28%1984-1993%29%
% 214.86/215.09  |- mesh__recordMaintainer mesh__D018224 KEV
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D018224 1998
% 214.86/215.09  |- skos__historyNote mesh__D018224 Fibroma %28%1981-1993%29%
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D018224 2005
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D018224 1999
% 214.86/215.09  |- skos__prefLabel mesh__D018224 Myofibromatosis
% 214.86/215.09  |- mesh__recordAuthorizer mesh__D018224 PLS
% 214.86/215.09  |- mesh__historyNote mesh__D018224 94   
% 214.86/215.09  |- skos__broader mesh__D018224smesh__D018218
% 214.86/215.09  |- mesh__recordOriginator mesh__D018224 PLS
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D018224 2002
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D018224 1996
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D018224 2006
% 214.86/215.09  |- mesh__dateEstablished mesh__D018224 1994-01-01
% 214.86/215.09  |- skos__annotation mesh__D018224
% 214.86/215.09       do not use /blood supply /chem /second /secret /ultrastruct; coord IM with organ/neopl term %28%IM%29%%A%  
% 214.86/215.09  |- mesh__dateRevised mesh__D018224 1995-06-08
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D018224 1997
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D018224 2003
% 214.86/215.09  |- rdf__type mesh__D018224sskos__Concept
% 214.86/215.09  |- mesh__recordOriginator mesh__D010241 NLM
% 214.86/215.09  |- mesh__recordMaintainer mesh__D010241 PLS
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D010241 1997
% 214.86/215.09  |- mesh__publicMeSHNote mesh__D010241
% 214.86/215.09       91; was see under KERATOSIS 1975-90   
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D010241 1998
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D010241 1993
% 214.86/215.09  |- mesh__dateCreated mesh__D010241 1999-01-01
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D010241 1994
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D010241 2003
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D010241 1999
% 214.86/215.09  |- skos__scopeNote mesh__D010241
% 214.86/215.09       Persistence of the nuclei of the keratinocytes into the stratum corneum of the skin. This is a normal state only in the epithelium of true mucous membranes in the mouth and vagina. %28%Dorland, 27th ed%29%%A%    
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D010241 2000
% 214.86/215.09  |- mesh__onlineNote mesh__D010241 search KERATOSIS 1968-74   
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D010241 1995
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D010241 2004
% 214.86/215.09  |- rdf__type mesh__D010241sskos__Concept
% 214.86/215.09  |- mesh__dateEstablished mesh__D010241 1991-01-01
% 214.86/215.09  |- mesh__historyNote mesh__D010241
% 214.86/215.09       91%28%75%29%; was see under KERATOSIS 1975-90   
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D010241 2001
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D010241 2005
% 214.86/215.09  |- skos__broader mesh__D010241smesh__D007642
% 214.86/215.09  |- skos__prefLabel mesh__D010241 Parakeratosis
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D010241 2002
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D010241 2006
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D010241 1996
% 214.86/215.09  |- skos__annotation mesh__D010241 do not confuse with POROKERATOSIS   
% 214.86/215.09  |- mesh__dateRevised mesh__D010241 1992-05-22
% 214.86/215.09  |- skos__hiddenLabel mesh__D010241 Parakeratoses
% 214.86/215.09  |- mesh__recordAuthorizer mesh__D010241 PLS
% 214.86/215.09  |- rdf__type mesh__D051658sskos__Concept
% 214.86/215.09  |- skos__altLabel mesh__D051658 KCNQ2 Protein
% 214.86/215.09  |- mesh__historyNote mesh__D051658 2006%28%1998%29%   
% 214.86/215.09  |- skos__hiddenLabel mesh__D051658 Voltage Gated K+ Channel KCNQ2
% 214.86/215.09  |- mesh__dateCreated mesh__D051658 2005-06-30
% 214.86/215.09  |- mesh__recordOriginator mesh__D051658 DRC
% 214.86/215.09  |- mesh__recordMaintainer mesh__D051658 DRC
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D051658 2006
% 214.86/215.09  |- skos__scopeNote mesh__D051658
% 214.86/215.09       A very slow opening and closing voltage-gated potassium channel that is expressed in NEURONS and is commonly mutated in BENIGN FAMILIAL NEONATAL CONVULSIONS.%A%    
% 214.86/215.09  |- mesh__recordAuthorizer mesh__D051658 sjn
% 214.86/215.09  |- skos__broader mesh__D051658smesh__D051656
% 214.86/215.09  |- skos__altLabel mesh__D051658 Voltage-Gated K+ Channel KCNQ2
% 214.86/215.09  |- mesh__dateEstablished mesh__D051658 2006-01-01
% 214.86/215.09  |- mesh__publicMeSHNote mesh__D051658
% 214.86/215.09       2006; KCNQ2 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1998-2004%A%  
% 214.86/215.09  |- skos__hiddenLabel mesh__D051658 Potassium Channel, KCNQ2
% 214.86/215.09  |- skos__prefLabel mesh__D051658 KCNQ2 Potassium Channel
% 214.86/215.09  |- skos__hiddenLabel mesh__D051658 Potassium Channel, Kv7.2
% 214.86/215.09  |- skos__altLabel mesh__D051658 Kv7.2 Potassium Channel
% 214.86/215.09  |- skos__prefLabel mesh__D004204 Dislocations
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004204 2000
% 214.86/215.09  |- mesh__recordMaintainer mesh__D004204 TGC
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004204 1996
% 214.86/215.09  |- skos__hiddenLabel mesh__D004204 Dislocation
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004204 2001
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004204 1998
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004204 1997
% 214.86/215.09  |- rdf__type mesh__D004204sskos__Concept
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004204 2003
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004204 1994
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004204 1999
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004204 2005
% 214.86/215.09  |- mesh__dateRevised mesh__D004204 1992-06-25
% 214.86/215.09  |- skos__broader mesh__D004204smesh__D014947
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004204 1993
% 214.86/215.09  |- skos__annotation mesh__D004204
% 214.86/215.09       bones %26% joints only: not for lens %28% = LENS DISLOCATION AND SUBLUXATION%29%, testis, etc.; IM; luxation %26% subluxation go here; coord IM with joint %28%IM%29%, not bone%A%  
% 214.86/215.09  |- mesh__recordAuthorizer mesh__D004204 PLS
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004204 2004
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004204 1995
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004204 2002
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D004204 2006
% 214.86/215.09  |- mesh__dateCreated mesh__D004204 1999-01-01
% 214.86/215.09  |- mesh__recordOriginator mesh__D004204 NLM
% 214.86/215.09  |- skos__related mesh__D009498smesh__D018377
% 214.86/215.09  |- skos__historyNote mesh__D009498 Toxins %28%1966-1977%29%
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D009498 2006
% 214.86/215.09  |- skos__broader mesh__D009498smesh__D009676
% 214.86/215.09  |- skos__altLabel mesh__D009498 Excitotoxin
% 214.86/215.09  |- skos__altLabel mesh__D009498 Excitatory Neurotoxins
% 214.86/215.09  |- mesh__recordAuthorizer mesh__D009498 sjn
% 214.86/215.09  |- skos__hiddenLabel mesh__D009498 Neurotoxins, Excitatory
% 214.86/215.09  |- mesh__publicMeSHNote mesh__D009498 78   
% 214.86/215.09  |- mesh__dateCreated mesh__D009498 1977-04-22
% 214.86/215.09  |- mesh__historyNote mesh__D009498 78   
% 214.86/215.09  |- mesh__recordMaintainer mesh__D009498 ssb
% 214.86/215.09  |- mesh__recordOriginator mesh__D009498 SH
% 214.86/215.09  |- mesh__dateRevised mesh__D009498 2005-06-30
% 214.86/215.09  |- rdf__type mesh__D009498sskos__Concept
% 214.86/215.09  |- skos__annotation mesh__D009498
% 214.86/215.09       /antag permitted but consider also ANTITOXINS; coordinate IM with toxin or venom heading which is the source of the neurotoxin %28%IM or NIM%29%; do not use for neurotoxicity of various chemicals %26% drugs %28% = NERVOUS SYSTEM /drug eff or specific nervous system term /drug eff or nervous system disease heading /chem ind + Category D term /adv eff-pois-tox%29%%A%  
% 214.86/215.09  |- skos__hiddenLabel mesh__D009498 Alpha Neurotoxins
% 214.86/215.09  |- skos__prefLabel mesh__D009498 Neurotoxins
% 214.86/215.09  |- mesh__dateEstablished mesh__D009498 1978-01-01
% 214.86/215.09  |- skos__scopeNote mesh__D009498
% 214.86/215.09       Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept.%A%    
% 214.86/215.09  |- mesh__dateRevised mesh__D042323 2005-06-30
% 214.86/215.09  |- mesh__dateEstablished mesh__D042323 2004-01-01
% 214.86/215.09  |- skos__scopeNote mesh__D042323
% 214.86/215.09       A species of gram-negative bacteria producing mild to severe ANAPLASMOSIS in SHEEP and GOATS, and mild or inapparent infections in DEER and CATTLE.%A%    
% 214.86/215.09  |- skos__prefLabel mesh__D042323 Anaplasma ovis
% 214.86/215.09  |- mesh__publicMeSHNote mesh__D042323 2004   
% 214.86/215.09  |- skos__broader mesh__D042323smesh__D000709
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D042323 2006
% 214.86/215.09  |- mesh__recordAuthorizer mesh__D042323 sjn
% 214.86/215.09  |- rdf__type mesh__D042323sskos__Concept
% 214.86/215.09  |- mesh__historyNote mesh__D042323 2004   
% 214.86/215.09  |- skos__historyNote mesh__D042323 Anaplasma %28%1968-2003%29%
% 214.86/215.09  |- mesh__dateCreated mesh__D042323 2003-07-09
% 214.86/215.09  |- mesh__recordOriginator mesh__D042323 ags
% 214.86/215.09  |- mesh__recordMaintainer mesh__D042323 SYSTEM
% 214.86/215.09  |- mesh__recordAuthorizer mesh__D014632 sjn
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D014632 2005
% 214.86/215.09  |- mesh__historyNote mesh__D014632
% 214.86/215.09       91%28%86%29%63; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85%A%  
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D014632 2006
% 214.86/215.09  |- skos__scopeNote mesh__D014632
% 214.86/215.09       A plant genus of the family VALERIANACEAE, order Dipsacales, subclass Asteridae, class Magnoliopsida.  It is best known for the sedative use and valepotriate content of the roots.  It is sometimes called Garden Heliotrope but is unrelated to true Heliotrope %28%HELIOTROPIUM%29%.%A%    
% 214.86/215.09  |- skos__altLabel mesh__D014632 Valeriana
% 214.86/215.09  |- mesh__dateRevised mesh__D014632 2002-07-03
% 214.86/215.09  |- skos__prefLabel mesh__D014632 Valerian
% 214.86/215.09  |- skos__broader mesh__D014632smesh__D028161
% 214.86/215.09  |- mesh__recordMaintainer mesh__D014632 ssb
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D014632 2003
% 214.86/215.09  |- mesh__recordOriginator mesh__D014632 NLM
% 214.86/215.09  |- mesh__dateCreated mesh__D014632 1999-01-01
% 214.86/215.09  |- skos__annotation mesh__D014632
% 214.86/215.09       do not confuse X ref HELIOTROPE, GARDEN with HELIOTROPIUM; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D014632 2004
% 214.86/215.09  |- mesh__dateEstablished mesh__D014632 1991-01-01
% 214.86/215.09  |- rdf__type mesh__D014632sskos__Concept
% 214.86/215.09  |- mesh__publicMeSHNote mesh__D014632
% 214.86/215.09       91,63-85; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85%A%  
% 214.86/215.09  |- skos__broader mesh__D000612smesh__D000637
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D000612 2004
% 214.86/215.09  |- mesh__recordMaintainer mesh__D000612 ssb
% 214.86/215.09  |- mesh__dateCreated mesh__D000612 1974-11-19
% 214.86/215.09  |- mesh__historyNote mesh__D000612 98%28%75%29%   
% 214.86/215.09  |- mesh__activeMeSHYear mesh__D000612 2005
% 214.86/215.09  |- skos__hiddenLabel mesh__D000612 Transaminase, GABA
% 214.86/215.09  |- mesh__dateRevised mesh__D000612 2003-07-09
% 214.86/215.09  |- skos__hiddenLabel mesh__D000612
% 214.86/215.09       Aminotransferase, GABA-alpha-Ketoglutarate
% 214.86/215.09  |- skos__altLabel mesh__D000612 GABA Transaminase
% 214.86/215.09  |- mesh__recordAuthorizer mesh__D000612 sjn
% 214.86/215.09  |- skos__hiddenLabel mesh__D000612
% 214.86/215.09       Ketoglutarate Aminotransferase, beta-Alanine
% 214.86/215.09  |- skos__hiddenLabel mesh__D000612 Transaminase, 4-Aminobutyrate
% 214.86/215.09  |- skos__historyNote mesh__D000612 Aminotransferases %28%1974%29%
% 214.86/215.09  |- skos__altLabel mesh__D000612 GABA Aminotransferase
% 214.86/215.09  |- skos__hiddenLabel mesh__D000612
% 214.86/215.09       Aminotransferase, beta-Alanine Ketoglutarate
% 214.86/215.09  |- skos__hiddenLabel mesh__D000612 Aminotransferase, Aminobutyrate
% 214.86/215.09  |- skos__altLabel mesh__D000612 GABA-alpha-Ketoglutarate Aminotransferase
% 214.86/215.09  |- skos__hiddenLabel mesh__D000612
% 214.86/215.09       GABA alpha Ketoglutarate Aminotransferase
% 214.86/215.09  |- skos__scopeNote mesh__D000612
% 214.86/215.09       An enzyme that converts brain gamma-aminobutyric acid %28%GAMMA-AMINOBUTYRIC ACID%29% into succinate semialdehyde, which can be converted to succinic acid and enter the citric acid cycle. It also acts on beta-alanine. EC 2.6.1.19.%A%    
% 214.86/215.09  |- rdf__type mesh__D000612sskos__Concept
% 214.86/215.09  |- mesh__recordOriginator mesh__D000612 NLM
% 214.86/215.09  |- mesh__dateEstablished mesh__D000612 1984-01-01
% 214.86/215.09  |- skos__altLabel mesh__D000612 beta-Alanine Ketoglutarate Aminotransferase
% 214.86/215.09  |- skos__hiddenLabel mesh__D000612 4 Aminobutyrate Transaminase
% 214.86/215.10  |- skos__hiddenLabel mesh__D000612
% 214.86/215.10       beta Alanine Ketoglutarate Aminotransferase
% 214.86/215.10  |- skos__altLabel mesh__D000612 Aminobutyrate Aminotransferase
% 214.86/215.10  |- skos__historyNote mesh__D000612 Aminobutyric Acid %28%1974%29%
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D000612 2006
% 214.86/215.10  |- skos__prefLabel mesh__D000612 4-Aminobutyrate Transaminase
% 214.86/215.10  |- mesh__publicMeSHNote mesh__D000612
% 214.86/215.10       98; see AMINOBUTYRATE AMINOTRANSFERASE 1984-97, see AMINOTRANSFERASES 1975-83%A%  
% 214.86/215.10  |- skos__hiddenLabel mesh__D000612 Aminotransferase, GABA
% 214.86/215.10  |- skos__hiddenLabel mesh__D018225 Fibroepithelial Neoplasm
% 214.86/215.10  |- mesh__dateEstablished mesh__D018225 1994-01-01
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018225 2002
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018225 2005
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018225 1999
% 214.86/215.10  |- mesh__historyNote mesh__D018225 94   
% 214.86/215.10  |- skos__broader mesh__D018225smesh__D018218
% 214.86/215.10  |- skos__annotation mesh__D018225
% 214.86/215.10       neoplasms composed of fibrous %26% epithelial elements, NOT neoplasms located in fibrous or epithelial tissue: TN 135; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; restricted use: Manual 24.2.2.5; DF: NEOPL FIBROEPITHELIAL%A%  
% 214.86/215.10  |- mesh__recordOriginator mesh__D018225 PLS
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018225 1996
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018225 2006
% 214.86/215.10  |- skos__broader mesh__D018225smesh__D009375
% 214.86/215.10  |- mesh__publicMeSHNote mesh__D018225 94   
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018225 2000
% 214.86/215.10  |- rdf__type mesh__D018225sskos__Concept
% 214.86/215.10  |- mesh__dateRevised mesh__D018225 1995-06-08
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018225 2003
% 214.86/215.10  |- mesh__dateCreated mesh__D018225 1993-06-25
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018225 1997
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018225 2001
% 214.86/215.10  |- skos__altLabel mesh__D018225 Fibroepithelial Neoplasms
% 214.86/215.10  |- skos__prefLabel mesh__D018225 Neoplasms, Fibroepithelial
% 214.86/215.10  |- skos__scopeNote mesh__D018225
% 214.86/215.10       Neoplasms composed of fibrous and epithelial tissue. The concept does not refer to neoplasms located in fibrous tissue or epithelium.%A%    
% 214.86/215.10  |- skos__hiddenLabel mesh__D018225 Neoplasm, Fibroepithelial
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018225 2004
% 214.86/215.10  |- mesh__recordMaintainer mesh__D018225 KEV
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018225 1998
% 214.86/215.10  |- mesh__recordAuthorizer mesh__D018225 PLS
% 214.86/215.10  |- mesh__dateCreated mesh__D010242 1999-01-01
% 214.86/215.10  |- mesh__dateRevised mesh__D010242 2003-07-09
% 214.86/215.10  |- skos__prefLabel mesh__D010242 Paraldehyde
% 214.86/215.10  |- mesh__recordOriginator mesh__D010242 NLM
% 214.86/215.10  |- skos__broader mesh__D010242smesh__D000079
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D010242 2004
% 214.86/215.10  |- rdf__type mesh__D010242sskos__Concept
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D010242 2005
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D010242 2006
% 214.86/215.10  |- mesh__recordMaintainer mesh__D010242 ssb
% 214.86/215.10  |- mesh__recordAuthorizer mesh__D010242 sjn
% 214.86/215.10  |- skos__scopeNote mesh__D010242
% 214.86/215.10       A hypnotic and sedative with anticonvulsant effects. However, because of the hazards associated with its administration, its tendency to react with plastic, and the risks associated with its deterioration, it has largely been superseded by other agents. It is still occasionally used to control status epilepticus resistant to conventional treatment. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p608-9%29%%A%    
% 214.86/215.10  |- mesh__historyNote mesh__D051659 2006%28%1998%29%   
% 214.86/215.10  |- mesh__publicMeSHNote mesh__D051659
% 214.86/215.10       2006; KCNQ3 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1998-2004%A%  
% 214.86/215.10  |- skos__altLabel mesh__D051659 Voltage-Gated K+ Channel KCNQ3
% 214.86/215.10  |- mesh__recordOriginator mesh__D051659 DRC
% 214.86/215.10  |- skos__altLabel mesh__D051659 Kv7.3 Potassium Channel
% 214.86/215.10  |- skos__hiddenLabel mesh__D051659 Potassium Channel, KCNQ3
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D051659 2006
% 214.86/215.10  |- skos__hiddenLabel mesh__D051659 Voltage Gated K+ Channel KCNQ3
% 214.86/215.10  |- skos__prefLabel mesh__D051659 KCNQ3 Potassium Channel
% 214.86/215.10  |- skos__scopeNote mesh__D051659
% 214.86/215.10       A very slow opening and closing voltage-gated potassium channel that is expressed in NEURONS and is closely related to KCNQ2 POTASSIUM CHANNEL. It is commonly mutated in BENIGN FAMILIAL NEONATAL CONVULSIONS.%A%    
% 214.86/215.10  |- mesh__dateCreated mesh__D051659 2005-06-30
% 214.86/215.10  |- mesh__recordMaintainer mesh__D051659 DRC
% 214.86/215.10  |- skos__broader mesh__D051659smesh__D051656
% 214.86/215.10  |- mesh__recordAuthorizer mesh__D051659 sjn
% 214.86/215.10  |- skos__hiddenLabel mesh__D051659 Potassium Channel, Kv7.3
% 214.86/215.10  |- skos__altLabel mesh__D051659 KCNQ3 Protein
% 214.86/215.10  |- mesh__dateEstablished mesh__D051659 2006-01-01
% 214.86/215.10  |- rdf__type mesh__D051659sskos__Concept
% 214.86/215.10  |- skos__scopeNote mesh__D004205
% 214.86/215.10       A chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack.%A%    
% 214.86/215.10  |- skos__hiddenLabel mesh__D004205 Cromoglycate, Disodium
% 214.86/215.10  |- mesh__recordOriginator mesh__D004205 NLM
% 214.86/215.10  |- mesh__dateEstablished mesh__D004205 1973-01-01
% 214.86/215.10  |- rdf__type mesh__D004205sskos__Concept
% 214.86/215.10  |- skos__prefLabel mesh__D004205 Cromolyn Sodium
% 214.86/215.10  |- mesh__recordMaintainer mesh__D004205 ssb
% 214.86/215.10  |- skos__altLabel mesh__D004205 Disodium Cromoglycate
% 214.86/215.10  |- skos__hiddenLabel mesh__D004205 Cromoglycate, Sodium
% 214.86/215.10  |- skos__historyNote mesh__D004205 Chromones %28%1966-1970%29%
% 214.86/215.10  |- mesh__dateCreated mesh__D004205 1999-01-01
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D004205 2006
% 214.86/215.10  |- skos__hiddenLabel mesh__D004205 FPL 670
% 214.86/215.10  |- skos__altLabel mesh__D004205 Cromoglycic Acid
% 214.86/215.10  |- mesh__recordAuthorizer mesh__D004205 sjn
% 214.86/215.10  |- mesh__onlineNote mesh__D004205
% 214.86/215.10       use CROMOLYN SODIUM to search DISODIUM CROMOGLYCATE 1971-91 %28%as Prov 1971-72%29%%A%  
% 214.86/215.10  |- skos__hiddenLabel mesh__D004205 FPL670
% 214.86/215.10  |- mesh__dateRevised mesh__D004205 2005-06-30
% 214.86/215.10  |- mesh__publicMeSHNote mesh__D004205
% 214.86/215.10       92; was DISODIUM CROMOGLYCATE 1973-91; CROMOLYN SODIUM was see DISODIUM CROMOGLYCATE 1973-91%A%  
% 214.86/215.10  |- skos__broader mesh__D004205smesh__D002867
% 214.86/215.10  |- mesh__historyNote mesh__D004205
% 214.86/215.10       92; was DISODIUM CROMOGLYCATE 1971-91 %28%Prov 1971-72%29%; CROMOLYN SODIUM was see DISODIUM CROMOGLYCATE 1973-91%A%  
% 214.86/215.10  |- skos__altLabel mesh__D004205 Sodium Cromoglycate
% 214.86/215.10  |- skos__altLabel mesh__D004205 Cromoglicic Acid
% 214.86/215.10  |- mesh__recordMaintainer mesh__D009499 NLM
% 214.86/215.10  |- skos__hiddenLabel mesh__D009499 Red, Toluylene
% 214.86/215.10  |- skos__scopeNote mesh__D009499
% 214.86/215.10       A vital dye used as an indicator and biological stain. Various adverse effects have been observed in biological systems.%A%    
% 214.86/215.10  |- mesh__recordOriginator mesh__D009499 NLM
% 214.86/215.10  |- mesh__dateCreated mesh__D009499 1974-11-11
% 214.86/215.10  |- skos__historyNote mesh__D009499 Phenazines %28%1969-1974%29%
% 214.86/215.10  |- skos__altLabel mesh__D009499 Toluylene Red
% 214.86/215.10  |- skos__altLabel mesh__D009499 Nuclear Fast Red %28%Basic Dye%29%
% 214.86/215.10  |- rdf__type mesh__D009499sskos__Concept
% 214.86/215.10  |- mesh__dateRevised mesh__D009499 2005-07-06
% 214.86/215.10  |- mesh__historyNote mesh__D009499
% 214.86/215.10       91%28%75%29%; was see under PHENAZINES 1975-90   
% 214.86/215.10  |- skos__hiddenLabel mesh__D009499 Red, Neutral
% 214.86/215.10  |- skos__annotation mesh__D009499 D25-26 qualif   
% 214.86/215.10  |- skos__historyNote mesh__D009499 Dimethylamines %28%1973-1974%29%
% 214.86/215.10  |- mesh__dateEstablished mesh__D009499 1991-01-01
% 214.86/215.10  |- skos__broader mesh__D009499smesh__D010619
% 214.86/215.10  |- mesh__recordAuthorizer mesh__D009499 NLM
% 214.86/215.10  |- skos__prefLabel mesh__D009499 Neutral Red
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D009499 2006
% 214.86/215.10  |- mesh__publicMeSHNote mesh__D009499
% 214.86/215.10       91; was see under PHENAZINES 1975-90   
% 214.86/215.10  |- skos__hiddenLabel mesh__D020670 Calleja Islands
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D020670 2006
% 214.86/215.10  |- mesh__dateCreated mesh__D020670 1999-11-08
% 214.86/215.10  |- skos__broader mesh__D020670smesh__D013687
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D020670 2001
% 214.86/215.10  |- rdf__type mesh__D020670sskos__Concept
% 214.86/215.10  |- skos__scopeNote mesh__D020670
% 214.86/215.10       Discrete clusters of pyramidal and polymorphic cells in the caudal part of the anterior perforated substance. The morphology, connections, and neurotransmitters associated with these cells suggest they are part of the striatopallidal system.%A%    
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D020670 2004
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D020670 2005
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D020670 2000
% 214.86/215.10  |- skos__altLabel mesh__D020670 Islets of Calleja
% 214.86/215.10  |- skos__hiddenLabel mesh__D020670 Calleja Islets
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D020670 2003
% 214.86/215.10  |- skos__historyNote mesh__D020670 Olfactory Pathways %28%1973-1999%29%
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D020670 2002
% 214.86/215.10  |- skos__prefLabel mesh__D020670 Islands of Calleja
% 214.86/215.10  |- mesh__historyNote mesh__D020670 2000   
% 214.86/215.10  |- mesh__publicMeSHNote mesh__D020670 2000   
% 214.86/215.10  |- skos__broader mesh__D020670smesh__D009833
% 214.86/215.10  |- mesh__dateEstablished mesh__D020670 2000-01-01
% 214.86/215.10  |- mesh__recordMaintainer mesh__D014633 adp
% 214.86/215.10  |- skos__hiddenLabel mesh__D014633 L Valine
% 214.86/215.10  |- mesh__recordOriginator mesh__D014633 NLM
% 214.86/215.10  |- mesh__dateRevised mesh__D014633 1999-11-03
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D014633 2003
% 214.86/215.10  |- mesh__dateCreated mesh__D014633 1999-01-01
% 214.86/215.10  |- skos__broader mesh__D014633smesh__D000597
% 214.86/215.10  |- mesh__recordAuthorizer mesh__D014633 sjn
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D014633 2000
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D014633 2004
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D014633 2001
% 214.86/215.10  |- rdf__type mesh__D014633sskos__Concept
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D014633 2005
% 214.86/215.10  |- skos__prefLabel mesh__D014633 Valine
% 214.86/215.10  |- skos__broader mesh__D014633smesh__D000601
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D014633 2002
% 214.86/215.10  |- skos__altLabel mesh__D014633 L-Valine
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D014633 2006
% 214.86/215.10  |- skos__scopeNote mesh__D014633
% 214.86/215.10       A branched-chain essential amino acid that has stimulant activity. It promotes muscle growth and tissue repair. It is a precursor in the penicillin biosynthetic pathway.%A%    
% 214.86/215.10  |- skos__annotation mesh__D014633 /biosyn /defic /physiol permitted   
% 214.86/215.10  |- skos__annotation mesh__D000613 GEN or unspecified; prefer specifics   
% 214.86/215.10  |- mesh__recordOriginator mesh__D000613 NLM
% 214.86/215.10  |- skos__related mesh__D000613smesh__D011963
% 214.86/215.10  |- mesh__historyNote mesh__D000613 75; was AMINOBUTYRIC ACID 1963-74   
% 214.86/215.10  |- skos__altLabel mesh__D000613 Made Brand of Aminobutric Acid
% 214.86/215.10  |- skos__broader mesh__D000613smesh__D000596
% 214.86/215.10  |- skos__hiddenLabel mesh__D000613 Acids, Aminobutyric
% 214.86/215.10  |- skos__hiddenLabel mesh__D000613 Acid, Aminobutyric
% 214.86/215.10  |- mesh__recordMaintainer mesh__D000613 DRC
% 214.86/215.10  |- skos__scopeNote mesh__D000613
% 214.86/215.10       Aliphatic four carbon acids substituted in any position%28%s%29% with amino group%28%s%29%. They are found in most living things. The best known is GAMMA-AMINOBUTYRIC ACID.%A%    
% 214.86/215.10  |- mesh__dateRevised mesh__D000613 2005-06-30
% 214.86/215.10  |- mesh__recordAuthorizer mesh__D000613 sjn
% 214.86/215.10  |- rdf__type mesh__D000613sskos__Concept
% 214.86/215.10  |- mesh__dateCreated mesh__D000613 1999-01-01
% 214.86/215.10  |- mesh__publicMeSHNote mesh__D000613 75; was AMINOBUTYRIC ACID 1963-74   
% 214.86/215.10  |- mesh__onlineNote mesh__D000613
% 214.86/215.10       use AMINOBUTYRIC ACIDS to search AMINOBUTYRIC ACID 1966-74%A%  
% 214.86/215.10  |- skos__broader mesh__D000613smesh__D002088
% 214.86/215.10  |- skos__prefLabel mesh__D000613 Aminobutyric Acids
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D000613 2006
% 214.86/215.10  |- mesh__recordOriginator mesh__D018226 PLS
% 214.86/215.10  |- skos__hiddenLabel mesh__D018226 Fibroadenomas
% 214.86/215.10  |- mesh__recordAuthorizer mesh__D018226 PLS
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018226 1996
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018226 2006
% 214.86/215.10  |- mesh__dateEstablished mesh__D018226 1994-01-01
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018226 2002
% 214.86/215.10  |- mesh__dateRevised mesh__D018226 1995-06-08
% 214.86/215.10  |- rdf__type mesh__D018226sskos__Concept
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018226 1997
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018226 2003
% 214.86/215.10  |- skos__historyNote mesh__D018226 Breast Neoplasms %28%1966-1993%29%
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018226 2004
% 214.86/215.10  |- skos__prefLabel mesh__D018226 Fibroadenoma
% 214.86/215.10  |- skos__broader mesh__D018226smesh__D018225
% 214.86/215.10  |- mesh__publicMeSHNote mesh__D018226 94   
% 214.86/215.10  |- mesh__recordMaintainer mesh__D018226 KEV
% 214.86/215.10  |- skos__historyNote mesh__D018226 Adenofibroma %28%1966-1993%29%
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018226 2000
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018226 1998
% 214.86/215.10  |- mesh__dateCreated mesh__D018226 1993-06-25
% 214.86/215.10  |- skos__scopeNote mesh__D018226
% 214.86/215.10       An adenoma containing fibrous tissue. It should be differentiated from ADENOFIBROMA which is a tumor composed of connective tissue %28%fibroma%29% containing glandular %28%adeno-%29% structures. %28%From Dorland, 27th ed%29%%A%    
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018226 2001
% 214.86/215.10  |- skos__annotation mesh__D018226
% 214.86/215.10       do not confuse with ADENOFIBROMA; /blood supply /chem /secret /ultrastruct permitted; coord IM with organ/neopl term %28%IM%29%%A%  
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018226 2005
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D018226 1999
% 214.86/215.10  |- mesh__historyNote mesh__D018226 94   
% 214.86/215.10  |- skos__annotation mesh__D010243
% 214.86/215.10       severe loss of motor function as compared with PARESIS, a slight loss; GENERAL PARALYSIS see NEUROSYPHILIS does not mean %22%generalized paralysis%22% %28% = PARALYSIS%29%; spastic paralysis = PARALYSIS %28%IM%29% + MUSCLE SPASTICITY %28%NIM%29%; flaccid paralysis = PARALYSIS %28%IM%29% + MUSCLE FLACCIDITY %28%NIM%29%%A%  
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D010243 2001
% 214.86/215.10  |- skos__hiddenLabel mesh__D010243 Paralyses
% 214.86/215.10  |- mesh__recordMaintainer mesh__D010243 KEV
% 214.86/215.10  |- skos__altLabel mesh__D010243 Palsy
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D010243 2005
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D010243 2000
% 214.86/215.10  |- skos__scopeNote mesh__D010243
% 214.86/215.10       A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. %28%From Adams et al., Principles of Neurology, 6th ed, p45%29%%A%    
% 214.86/215.10  |- mesh__recordAuthorizer mesh__D010243 sjn
% 214.86/215.10  |- skos__hiddenLabel mesh__D010243 Paralysis, Todd%27%s
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D010243 2004
% 214.86/215.10  |- mesh__publicMeSHNote mesh__D010243
% 214.86/215.10       PARALYSIS, SPASTIC was heading 1963-78   
% 214.86/215.10  |- skos__prefLabel mesh__D010243 Paralysis
% 214.86/215.10  |- skos__broader mesh__D010243smesh__D009461
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D010243 2003
% 214.86/215.10  |- rdf__type mesh__D010243sskos__Concept
% 214.86/215.10  |- skos__hiddenLabel mesh__D010243 Paralysis, Todd
% 214.86/215.10  |- mesh__onlineNote mesh__D010243
% 214.86/215.10       search PARALYSIS, SPASTIC under MUSCLE SPASTICITY 1966-78%A%  
% 214.86/215.10  |- mesh__recordOriginator mesh__D010243 NLM
% 214.86/215.10  |- skos__hiddenLabel mesh__D010243 Palsies
% 214.86/215.10  |- skos__hiddenLabel mesh__D010243 Todds Paralysis
% 214.86/215.10  |- skos__hiddenLabel mesh__D010243 Plegias
% 214.86/215.10  |- skos__altLabel mesh__D010243 Plegia
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D010243 2002
% 214.86/215.10  |- mesh__dateRevised mesh__D010243 1999-11-03
% 214.86/215.10  |- mesh__historyNote mesh__D010243
% 214.86/215.10       PARALYSIS, SPASTIC was heading 1963-78   
% 214.86/215.10  |- skos__altLabel mesh__D010243 Todd%27%s Paralysis
% 214.86/215.10  |- mesh__dateCreated mesh__D010243 1999-01-01
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D010243 2006
% 214.86/215.10  |- mesh__recordOriginator mesh__D004206 NLM
% 214.86/215.10  |- mesh__historyNote mesh__D004206
% 214.86/215.10       84%28%72%29%; was see under PYRIDINES 1972-83 %28%Prov 1972-74%29%   
% 214.86/215.10  |- skos__hiddenLabel mesh__D004206 Monohydrochloride, Disopyramide
% 214.86/215.10  |- skos__hiddenLabel mesh__D004206 Phosphate, Disopyramide
% 214.86/215.10  |- rdf__type mesh__D004206sskos__Concept
% 214.86/215.10  |- skos__hiddenLabel mesh__D004206 SC13957
% 214.86/215.10  |- skos__historyNote mesh__D004206 Anti-Arrhythmia Agents %28%1966-1971%29%
% 214.86/215.10  |- mesh__publicMeSHNote mesh__D004206
% 214.86/215.10       84; was see under PYRIDINES 1975-83   
% 214.86/215.10  |- skos__historyNote mesh__D004206 Pyridines %28%1966-1971%29%
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D004206 2003
% 214.86/215.10  |- mesh__dateRevised mesh__D004206 2001-07-25
% 214.86/215.10  |- mesh__dateCreated mesh__D004206 1999-01-01
% 214.86/215.10  |- skos__hiddenLabel mesh__D004206 SC 13957
% 214.86/215.10  |- skos__altLabel mesh__D004206 Rythmilen
% 214.86/215.10  |- mesh__recordAuthorizer mesh__D004206 sjn
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D004206 2005
% 214.86/215.10  |- skos__altLabel mesh__D004206 Disopyramide Phosphate %28%1:1%29%
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D004206 2004
% 214.86/215.10  |- skos__altLabel mesh__D004206 Diisopyramide
% 214.86/215.10  |- mesh__dateEstablished mesh__D004206 1984-01-01
% 214.86/215.10  |- skos__altLabel mesh__D004206 Palpitine
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D004206 2006
% 214.86/215.10  |- skos__prefLabel mesh__D004206 Disopyramide
% 214.86/215.10  |- skos__scopeNote mesh__D004206
% 214.86/215.10       A class I anti-arrhythmic agent %28%one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent%29% with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.%A%    
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D004206 2002
% 214.86/215.10  |- skos__broader mesh__D004206smesh__D011725
% 214.86/215.10  |- mesh__recordMaintainer mesh__D004206 jmp
% 214.86/215.10  |- skos__hiddenLabel mesh__D020671 Neuron, Posterior Horn
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D020671 2004
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D020671 2005
% 214.86/215.10  |- mesh__publicMeSHNote mesh__D020671 2000   
% 214.86/215.10  |- skos__hiddenLabel mesh__D020671 Dorsal Horn Cell
% 214.86/215.10  |- skos__hiddenLabel mesh__D020671 Posterior Horn Neurons
% 214.86/215.10  |- skos__hiddenLabel mesh__D020671 Posterior Horn Cell
% 214.86/215.10  |- skos__hiddenLabel mesh__D020671 Cells, Posterior Horn
% 214.86/215.10  |- skos__hiddenLabel mesh__D020671 Cells, Dorsal Horn
% 214.86/215.10  |- skos__hiddenLabel mesh__D020671 Cell, Posterior Horn
% 214.86/215.10  |- skos__altLabel mesh__D020671 Neurons, Posterior Horn
% 214.86/215.10  |- mesh__dateCreated mesh__D020671 1999-11-03
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D020671 2003
% 214.86/215.10  |- skos__altLabel mesh__D020671 Dorsal Horn Neurons
% 214.86/215.10  |- skos__broader mesh__D020671smesh__D013116
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D020671 2001
% 214.86/215.10  |- skos__altLabel mesh__D020671 Neurons, Dorsal Horn
% 214.86/215.10  |- skos__hiddenLabel mesh__D020671 Posterior Horn Neuron
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D020671 2000
% 214.86/215.10  |- mesh__historyNote mesh__D020671 2000   
% 214.86/215.10  |- skos__hiddenLabel mesh__D020671 Dorsal Horn Neuron
% 214.86/215.10  |- skos__broader mesh__D020671smesh__D009475
% 214.86/215.10  |- skos__hiddenLabel mesh__D020671 Neuron, Dorsal Horn
% 214.86/215.10  |- mesh__dateEstablished mesh__D020671 2000-01-01
% 214.86/215.10  |- skos__scopeNote mesh__D020671
% 214.86/215.10       Neurons in the posterior %28%dorsal%29% horn of the spinal cord whose cell bodies and processes are confined entirely to the central nervous system. They receive collateral or direct terminations of dorsal root fibers. They send their axons either directly to ANTERIOR HORN CELLS or to the white matter ascending and descending longitudinal fibers.%A%    
% 214.86/215.10  |- skos__altLabel mesh__D020671 Dorsal Horn Cells
% 214.86/215.10  |- skos__historyNote mesh__D020671 Spinal Cord %28%1967-1999%29%
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D020671 2006
% 214.86/215.10  |- skos__hiddenLabel mesh__D020671 Cell, Dorsal Horn
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D020671 2002
% 214.86/215.10  |- rdf__type mesh__D020671sskos__Concept
% 214.86/215.10  |- skos__prefLabel mesh__D020671 Posterior Horn Cells
% 214.86/215.10  |- skos__scopeNote mesh__D014634
% 214.86/215.10       A cyclododecadepsipeptide ionophore antibiotic produced by Streptomyces fulvissimus and related to the enniatins. It is composed of 3 moles each of L-valine, D-alpha-hydroxyisovaleric acid, D-valine, and L-lactic acid linked alternately to form a 36-membered ring. %28%From Merck Index, 11th ed%29% Valinomycin is a potassium selective ionophore and is commonly used as a tool in biochemical studies.%A%    
% 214.86/215.10  |- mesh__dateEstablished mesh__D014634 1973-01-01
% 214.86/215.10  |- mesh__dateCreated mesh__D014634 1999-01-01
% 214.86/215.10  |- mesh__recordAuthorizer mesh__D014634 sjn
% 214.86/215.10  |- skos__historyNote mesh__D014634 Antibiotics %28%1966-1970%29%
% 214.86/215.10  |- mesh__dateRevised mesh__D014634 2004-07-07
% 214.86/215.10  |- rdf__type mesh__D014634sskos__Concept
% 214.86/215.10  |- skos__prefLabel mesh__D014634 Valinomycin
% 214.86/215.10  |- mesh__historyNote mesh__D014634 73%28%71%29%   
% 214.86/215.10  |- mesh__publicMeSHNote mesh__D014634 73   
% 214.86/215.10  |- skos__broader mesh__D014634smesh__D047630
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D014634 2005
% 214.86/215.10  |- mesh__recordMaintainer mesh__D014634 ssb
% 214.86/215.10  |- mesh__recordOriginator mesh__D014634 NLM
% 214.86/215.10  |- mesh__activeMeSHYear mesh__D014634 2006
% 214.86/215.10  |- mesh__dateEstablished mesh__D047010 2005-01-01
% 214.86/215.10  |- mesh__publicMeSHNote mesh__D047010 2005   
% 214.86/215.10  |- mesh__dateRevised mesh__D047010 2005-06-30
% 214.86/215.10  |- mesh__historyNote mesh__D047010 2005   
% 214.86/215.10  |- skos__scopeNote mesh__D047010
% 214.86/215.10       A species of gram-positive bacteria in the family Clostridiaceae. It is distinctive for its ability to ferment ETHANOL to caproic acid.%A%    
% 214.86/215.10  |- mesh__recordAuthorizer mesh__D047010 sjn
% 214.96/215.10  |- mesh__dateCreated mesh__D047010 2004-07-07
% 214.96/215.10  |- mesh__activeMeSHYear mesh__D047010 2006
% 214.96/215.10  |- skos__broader mesh__D047010smesh__D003013
% 214.96/215.10  |- skos__prefLabel mesh__D047010 Clostridium kluyveri
% 214.96/215.10  |- skos__historyNote mesh__D047010 Clostridium %28%1965-2004%29%
% 214.96/215.10  |- rdf__type mesh__D047010sskos__Concept
% 214.96/215.10  |- mesh__recordOriginator mesh__D047010 ags
% 214.96/215.10  |- mesh__recordMaintainer mesh__D047010 SYSTEM
% 214.96/215.10  |- skos__broader mesh__D000614smesh__D000596
% 214.96/215.10  |- skos__scopeNote mesh__D000614
% 214.96/215.10       A group of compounds that are derivatives of aminohexanoic acids.%A%    
% 214.96/215.10  |- skos__hiddenLabel mesh__D000614 Acids, Aminocaproic
% 214.96/215.10  |- skos__broader mesh__D000614smesh__D002208
% 214.96/215.10  |- mesh__recordOriginator mesh__D000614 NLM
% 214.96/215.10  |- skos__prefLabel mesh__D000614 Aminocaproic Acids
% 214.96/215.10  |- skos__hiddenLabel mesh__D000614 Berlin Chemie Brand of Aminocaproic Acid
% 214.96/215.10  |- skos__altLabel mesh__D000614 Delagrange Brand of Aminocaproic Acid
% 214.96/215.10  |- skos__altLabel mesh__D000614 Aminocaproic Acid
% 214.96/215.10  |- rdf__type mesh__D000614sskos__Concept
% 214.96/215.10  |- mesh__dateCreated mesh__D000614 1999-01-01
% 214.96/215.10  |- mesh__historyNote mesh__D000614
% 214.96/215.10       75; was AMINOCAPROIC ACID 1963-74 %28%Prov 1963%29%   
% 214.96/215.10  |- skos__hiddenLabel mesh__D000614 Acid, Aminocaproic
% 214.96/215.10  |- skos__altLabel mesh__D000614 Leurquin Brand of Aminocaproic Acid
% 214.96/215.10  |- skos__altLabel mesh__D000614 Rottapharm Brand of Aminocaproic Acid
% 214.96/215.10  |- skos__altLabel mesh__D000614 Berlin-Chemie Brand of Aminocaproic Acid
% 214.96/215.10  |- mesh__recordMaintainer mesh__D000614 CCR
% 214.96/215.10  |- mesh__publicMeSHNote mesh__D000614 75; was AMINOCAPROIC ACID 1964-74   
% 214.96/215.10  |- mesh__onlineNote mesh__D000614
% 214.96/215.10       use AMINOCAPROIC ACIDS to search AMINOCAPROIC ACID 1966-74%A%  
% 214.96/215.10  |- mesh__dateRevised mesh__D000614 2005-06-30
% 214.96/215.10  |- mesh__activeMeSHYear mesh__D000614 2006
% 214.96/215.10  |- mesh__dateEstablished mesh__D000614 1964-01-01
% 214.96/215.10  |- mesh__recordAuthorizer mesh__D000614 sjn
% 214.96/215.10  |- skos__altLabel mesh__D000614 Sanofi Winthrop Brand of Aminocaproic Acid
% 214.96/215.10  |- skos__altLabel mesh__D000614 Pharmachemie Brand of Aminocaproic Acid
% 214.96/215.10  |- skos__altLabel mesh__D000614 Capramol
% 214.96/215.10  |- mesh__publicMeSHNote mesh__D018227 94   
% 214.96/215.10  |- mesh__recordOriginator mesh__D018227 PLS
% 214.96/215.10  |- mesh__recordAuthorizer mesh__D018227 PLS
% 214.96/215.10  |- mesh__activeMeSHYear mesh__D018227 1999
% 214.96/215.10  |- skos__altLabel mesh__D018227 Melanoma, Malignant, of Soft Parts
% 214.96/215.10  |- mesh__dateCreated mesh__D018227 1993-06-25
% 214.96/215.10  |- mesh__historyNote mesh__D018227 94   
% 214.96/215.10  |- mesh__dateRevised mesh__D018227 1995-06-08
% 214.96/215.10  |- skos__hiddenLabel mesh__D018227 Sarcomas, Clear Cell
% 214.96/215.10  |- mesh__activeMeSHYear mesh__D018227 1997
% 214.96/215.10  |- mesh__activeMeSHYear mesh__D018227 1998
% 214.96/215.10  |- mesh__activeMeSHYear mesh__D018227 2006
% 214.96/215.10  |- skos__scopeNote mesh__D018227
% 214.96/215.10       A sarcoma of young, often female, adults of the lower extremities and acral regions, intimately bound to tendons as circumscribed but unencapsulated melanin-bearing tumors of neuroectodermal origin. An ultrastructural finding simulates flattened and curved barrel staves, corresponding to the internal structures of premelanosomes. There is a 45-60%25% mortality in clear cell sarcoma. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 214.96/215.10  |- mesh__activeMeSHYear mesh__D018227 2001
% 214.96/215.10  |- mesh__dateEstablished mesh__D018227 1994-01-01
% 214.96/215.10  |- skos__annotation mesh__D018227
% 214.96/215.10       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 214.96/215.10  |- skos__hiddenLabel mesh__D018227 Clear Cell Sarcoma
% 214.96/215.10  |- mesh__activeMeSHYear mesh__D018227 1996
% 214.96/215.10  |- mesh__activeMeSHYear mesh__D018227 2004
% 214.96/215.10  |- mesh__activeMeSHYear mesh__D018227 2005
% 214.96/215.10  |- rdf__type mesh__D018227sskos__Concept
% 214.96/215.10  |- mesh__recordMaintainer mesh__D018227 KEV
% 214.96/215.10  |- mesh__activeMeSHYear mesh__D018227 2000
% 214.96/215.10  |- skos__historyNote mesh__D018227 Sarcoma %28%1966-1993%29%
% 214.96/215.10  |- skos__broader mesh__D018227smesh__D012509
% 214.96/215.10  |- mesh__activeMeSHYear mesh__D018227 2003
% 214.96/215.10  |- skos__prefLabel mesh__D018227 Sarcoma, Clear Cell
% 214.96/215.10  |- skos__hiddenLabel mesh__D018227 Clear Cell Sarcomas
% 214.96/215.10  |- mesh__activeMeSHYear mesh__D018227 2002
% 214.96/215.10  |- skos__broader mesh__D018227smesh__D009372
% 214.96/215.10  |- skos__hiddenLabel mesh__D010244 Progressive Bulbar Palsies
% 214.96/215.10  |- skos__hiddenLabel mesh__D010244 Palsy, Bulbar
% 214.96/215.10  |- mesh__publicMeSHNote mesh__D010244
% 214.96/215.10       2000; see PARALYSIS, BULBAR 1966-1999   
% 214.96/215.10  |- skos__scopeNote mesh__D010244
% 214.96/215.10       A motor neuron disease marked by progressive weakness of the muscles innervated by cranial nerves of the lower brain stem. Clinical manifestations include dysarthria, dysphagia, facial weakness, tongue weakness, and fasciculations of the tongue and facial muscles. The adult form of the disease is marked initially by bulbar weakness which progresses to involve motor neurons throughout the neuroaxis. Eventually this condition may become indistinguishable from AMYOTROPHIC LATERAL SCLEROSIS. Fazio-Londe syndrome is an inherited form of this illness which occurs in children and young adults. %28%Adams et al., Principles of Neurology, 6th ed, p1091; Brain 1992 Dec;115%28%Pt 6%29%:1889-1900%29%%A%    
% 214.96/215.10  |- skos__altLabel mesh__D010244 Bulbar Palsy
% 214.96/215.10  |- mesh__dateRevised mesh__D010244 2004-07-19
% 214.96/215.10  |- skos__broader mesh__D010244smesh__D016472
% 214.96/215.10  |- skos__hiddenLabel mesh__D010244 Palsies, Progressive Bulbar
% 214.96/215.10  |- skos__hiddenLabel mesh__D010244 Syndrome, Fazio-Londe
% 214.96/215.10  |- rdf__type mesh__D010244sskos__Concept
% 214.96/215.10  |- skos__hiddenLabel mesh__D010244 Fazio Londe Syndrome
% 214.96/215.10  |- skos__hiddenLabel mesh__D010244 Bulbar Palsies, Progressive
% 214.96/215.10  |- mesh__recordAuthorizer mesh__D010244 sjn
% 214.96/215.10  |- mesh__historyNote mesh__D010244 2000%28%1966%29%   
% 214.96/215.10  |- mesh__recordMaintainer mesh__D010244 jls
% 214.96/215.11  |- skos__hiddenLabel mesh__D010244 Progressive Bulbar Palsy
% 214.96/215.11  |- mesh__dateCreated mesh__D010244 1999-01-01
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D010244 2006
% 214.96/215.11  |- skos__hiddenLabel mesh__D010244 Palsies, Bulbar
% 214.96/215.11  |- skos__hiddenLabel mesh__D010244 Bulbar Palsies
% 214.96/215.11  |- mesh__recordOriginator mesh__D010244 NLM
% 214.96/215.11  |- skos__altLabel mesh__D010244 Paralysis, Bulbar
% 214.96/215.11  |- skos__hiddenLabel mesh__D010244 Bulbar Paralysis
% 214.96/215.11  |- skos__hiddenLabel mesh__D010244 Palsy, Progressive Bulbar
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D010244 2005
% 214.96/215.11  |- skos__altLabel mesh__D010244 Progressive Bulbar Palsy of Childhood
% 214.96/215.11  |- skos__hiddenLabel mesh__D010244 Bulbar Paralyses
% 214.96/215.11  |- skos__prefLabel mesh__D010244 Bulbar Palsy, Progressive
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004207 1994
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004207 2005
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004207 1993
% 214.96/215.11  |- mesh__recordAuthorizer mesh__D004207 PLS
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004207 2004
% 214.96/215.11  |- mesh__dateRevised mesh__D004207 1992-05-14
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004207 1995
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004207 2002
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004207 2006
% 214.96/215.11  |- mesh__recordOriginator mesh__D004207 NLM
% 214.96/215.11  |- skos__broader mesh__D004207smesh__D012013
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004207 1996
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004207 2000
% 214.96/215.11  |- skos__hiddenLabel mesh__D004207 Dispensatory
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004207 1998
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004207 1997
% 214.96/215.11  |- skos__prefLabel mesh__D004207 Dispensatories
% 214.96/215.11  |- mesh__recordMaintainer mesh__D004207 TAP
% 214.96/215.11  |- rdf__type mesh__D004207sskos__Concept
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004207 2001
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004207 1999
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004207 2003
% 214.96/215.11  |- mesh__dateCreated mesh__D004207 1999-01-01
% 214.96/215.11  |- skos__scopeNote mesh__D020672
% 214.96/215.11       A family of inhibitory proteins which bind to the REL PROTO-ONCOGENE PROTEINS and modulate their activity. In the CYTOPLASM, I-kappa B proteins bind to the transcription factor NF-KAPPA B. Cell stimulation causes its dissociation and translocation of active NF-kappa B to the nucleus.%A%    
% 214.96/215.11  |- mesh__dateRevised mesh__D020672 2005-06-30
% 214.96/215.11  |- mesh__publicMeSHNote mesh__D020672
% 214.96/215.11       2000; see I KAPPA B 2000-2005, I KAPPA B PROTEINS was indexed under PROTO-ONCOGENE PROTEINS 1993-1998 %26% DNA-BINDING PROTEINS 1998-1999%A%  
% 214.96/215.11  |- skos__related mesh__D020672smesh__D016328
% 214.96/215.11  |- skos__hiddenLabel mesh__D020672 I kappa B Proteins
% 214.96/215.11  |- skos__altLabel mesh__D020672 I kappa B
% 214.96/215.11  |- mesh__recordAuthorizer mesh__D020672 sjn
% 214.96/215.11  |- skos__prefLabel mesh__D020672 I-kappa B Proteins
% 214.96/215.11  |- mesh__historyNote mesh__D020672 2006%28%2000%29%   
% 214.96/215.11  |- skos__broader mesh__D020672smesh__D004268
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D020672 2006
% 214.96/215.11  |- skos__historyNote mesh__D020672
% 214.96/215.11       Proto-Oncogene Proteins %28%1993-1998%29%
% 214.96/215.11  |- mesh__recordOriginator mesh__D020672 ags
% 214.96/215.11  |- skos__altLabel mesh__D020672 I-kappa B
% 214.96/215.11  |- rdf__type mesh__D020672sskos__Concept
% 214.96/215.11  |- mesh__dateEstablished mesh__D020672 2000-01-01
% 214.96/215.11  |- skos__related mesh__D020672smesh__D020569
% 214.96/215.11  |- mesh__dateCreated mesh__D020672 1999-11-04
% 214.96/215.11  |- skos__altLabel mesh__D020672 IkB DNA-Binding Proteins
% 214.96/215.11  |- skos__related mesh__D020672smesh__D051550
% 214.96/215.11  |- skos__broader mesh__D020672smesh__D047908
% 214.96/215.11  |- skos__historyNote mesh__D020672 DNA-Binding Proteins %28%1998-1999%29%
% 214.96/215.11  |- mesh__recordMaintainer mesh__D020672 jmp
% 214.96/215.11  |- skos__hiddenLabel mesh__D020672 IkB DNA Binding Proteins
% 214.96/215.11  |- skos__broader mesh__D020672smesh__D014157
% 214.96/215.11  |- skos__broader mesh__D014635smesh__D010421
% 214.96/215.11  |- skos__altLabel mesh__D014635 Valproic Acid, Sodium Salt %28%2:1%29%
% 214.96/215.11  |- skos__altLabel mesh__D014635 Depakine
% 214.96/215.11  |- mesh__recordMaintainer mesh__D014635 ssb
% 214.96/215.11  |- mesh__dateCreated mesh__D014635 1974-11-11
% 214.96/215.11  |- mesh__publicMeSHNote mesh__D014635
% 214.96/215.11       91; was VALPROATE 1979-90; was DIPROPYL ACETATE see under VALERATES 1975-78%A%  
% 214.96/215.11  |- skos__hiddenLabel mesh__D014635 Valproate, Magnesium
% 214.96/215.11  |- skos__historyNote mesh__D014635 Valerates %28%1966-1974%29%
% 214.96/215.11  |- mesh__recordOriginator mesh__D014635 NLM
% 214.96/215.11  |- skos__altLabel mesh__D014635 2-Propylpentanoic Acid
% 214.96/215.11  |- skos__hiddenLabel mesh__D014635 Sodium, Divalproex
% 214.96/215.11  |- skos__altLabel mesh__D014635 Divalproex
% 214.96/215.11  |- rdf__type mesh__D014635sskos__Concept
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D014635 2004
% 214.96/215.11  |- skos__hiddenLabel mesh__D014635 Sodium, Valproate
% 214.96/215.11  |- skos__hiddenLabel mesh__D014635 Acid, Valproic
% 214.96/215.11  |- skos__hiddenLabel mesh__D014635 Valproate, Semisodium
% 214.96/215.11  |- skos__altLabel mesh__D014635 Semisodium Valproate
% 214.96/215.11  |- skos__hiddenLabel mesh__D014635 Valproate, Sodium
% 214.96/215.11  |- mesh__recordAuthorizer mesh__D014635 sjn
% 214.96/215.11  |- mesh__dateEstablished mesh__D014635 1979-01-01
% 214.96/215.11  |- skos__hiddenLabel mesh__D014635 Valproate, Calcium
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D014635 2005
% 214.96/215.11  |- mesh__dateRevised mesh__D014635 2003-07-09
% 214.96/215.11  |- skos__scopeNote mesh__D014635
% 214.96/215.11       A fatty acid with anticonvulsant properties used in the treatment of epilepsy. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of voltage dependent sodium channels.%A%    
% 214.96/215.11  |- skos__hiddenLabel mesh__D014635 2 Propylpentanoic Acid
% 214.96/215.11  |- skos__altLabel mesh__D014635 Valproate Sodium
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D014635 2006
% 214.96/215.11  |- skos__prefLabel mesh__D014635 Valproic Acid
% 214.96/215.11  |- mesh__onlineNote mesh__D014635
% 214.96/215.11       use VALPROIC ACID to search VALPROATE 1979-90 %26% DIPROPYL ACETATE 1975-90%A%  
% 214.96/215.11  |- mesh__historyNote mesh__D014635
% 214.96/215.11       91; was VALPROATE 1979-90; was DIPROPYL ACETATE see under VALERATES 1975-78%A%  
% 214.96/215.11  |- skos__hiddenLabel mesh__D014635 Acetate, Dipropyl
% 214.96/215.11  |- mesh__recordMaintainer mesh__D047011 jls
% 214.96/215.11  |- skos__prefLabel mesh__D047011 Silk
% 214.96/215.11  |- skos__broader mesh__D047011smesh__D011506
% 214.96/215.11  |- mesh__dateRevised mesh__D047011 2004-08-02
% 214.96/215.11  |- skos__scopeNote mesh__D047011
% 214.96/215.11       A continuous protein fiber consisting primarily of FIBROINS. It is synthesized by a variety of INSECTS and ARACHNIDS.%A%    
% 214.96/215.11  |- skos__related mesh__D047011smesh__D013537
% 214.96/215.11  |- skos__broader mesh__D047011smesh__D001704
% 214.96/215.11  |- skos__historyNote mesh__D047011 Proteins %28%1975-1997%29%
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D047011 2006
% 214.96/215.11  |- mesh__dateCreated mesh__D047011 2004-07-15
% 214.96/215.11  |- mesh__dateEstablished mesh__D047011 2005-01-01
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D047011 2005
% 214.96/215.11  |- skos__historyNote mesh__D047011 Insect Proteins %28%1998-2004%29%
% 214.96/215.11  |- rdf__type mesh__D047011sskos__Concept
% 214.96/215.11  |- mesh__publicMeSHNote mesh__D047011
% 214.96/215.11       2005; SILK was indexed under INSECT PROTEINS 1998-2004 %26% PROTEINS 1975-1997%A%  
% 214.96/215.11  |- mesh__recordOriginator mesh__D047011 jmp
% 214.96/215.11  |- skos__related mesh__D047011smesh__D012831
% 214.96/215.11  |- skos__related mesh__D047011smesh__D013784
% 214.96/215.11  |- mesh__historyNote mesh__D047011 2005; use SILK %28%NM%29% 1980 -2004   
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D047011 2005A
% 214.96/215.11  |- mesh__recordAuthorizer mesh__D047011 jls
% 214.96/215.11  |- rdf__type mesh__D000615sskos__Concept
% 214.96/215.11  |- skos__historyNote mesh__D000615 Phosphonic Acids %28%1973-1974%29%
% 214.96/215.11  |- skos__historyNote mesh__D000615 Ethylamines %28%1973-1974%29%
% 214.96/215.11  |- mesh__historyNote mesh__D000615
% 214.96/215.11       91%28%75%29%; was see under ORGANOPHOSPHORUS COMPOUNDS 1975-90   
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D000615 2005
% 214.96/215.11  |- mesh__recordAuthorizer mesh__D000615 sjn
% 214.96/215.11  |- skos__historyNote mesh__D000615
% 214.96/215.11       Organophosphorus Compounds %28%1973-1974%29%
% 214.96/215.11  |- mesh__publicMeSHNote mesh__D000615
% 214.96/215.11       91; was see under ORGANOPHOSPHORUS COMPOUNDS 1975-90   
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D000615 2006
% 214.96/215.11  |- skos__hiddenLabel mesh__D000615 Acid, 2-Aminoethylphosphonic
% 214.96/215.11  |- skos__broader mesh__D000615smesh__D009943
% 214.96/215.11  |- skos__hiddenLabel mesh__D000615 2 Aminoethylphosphonic Acid
% 214.96/215.11  |- mesh__dateEstablished mesh__D000615 1991-01-01
% 214.96/215.11  |- mesh__recordMaintainer mesh__D000615 sjn
% 214.96/215.11  |- mesh__recordOriginator mesh__D000615 NLM
% 214.96/215.11  |- skos__altLabel mesh__D000615 2-Aminoethylphosphonic Acid
% 214.96/215.11  |- skos__altLabel mesh__D000615 Ciliatine
% 214.96/215.11  |- skos__prefLabel mesh__D000615 Aminoethylphosphonic Acid
% 214.96/215.11  |- mesh__dateCreated mesh__D000615 1974-11-19
% 214.96/215.11  |- skos__scopeNote mesh__D000615
% 214.96/215.11       An organophosphorus compound isolated from human and animal tissues.%A%    
% 214.96/215.11  |- skos__hiddenLabel mesh__D000615 Acid, Aminoethylphosphonic
% 214.96/215.11  |- mesh__dateRevised mesh__D000615 2004-07-13
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D019320 2004
% 214.96/215.11  |- skos__hiddenLabel mesh__D019320 Embolisms, Paradoxical
% 214.96/215.11  |- skos__historyNote mesh__D019320 specific embolisms %28%1975-1996%29%
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D019320 1997
% 214.96/215.11  |- mesh__dateEstablished mesh__D019320 1997-01-01
% 214.96/215.11  |- skos__historyNote mesh__D019320 Embolism %28%1975-1996%29%
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D019320 2003
% 214.96/215.11  |- mesh__dateCreated mesh__D019320 1996-06-10
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D019320 2002
% 214.96/215.11  |- skos__hiddenLabel mesh__D019320 Paradoxical Embolisms
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D019320 2006
% 214.96/215.11  |- mesh__publicMeSHNote mesh__D019320 97   
% 214.96/215.11  |- mesh__historyNote mesh__D019320 97   
% 214.96/215.11  |- skos__scopeNote mesh__D019320
% 214.96/215.11       Blockage of a systemic artery by a thrombus originating in a systemic vein, which has passed through a defect that permits direct communication between the right and the left side of the heart, notably an open foramen ovale. It is also called crossed embolism. %28%Dorland, 28th ed%29%%A%    
% 214.96/215.11  |- skos__historyNote mesh__D019320 Thromboembolism %28%1976-1996%29%
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D019320 1999
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D019320 2001
% 214.96/215.11  |- skos__broader mesh__D019320smesh__D013923
% 214.96/215.11  |- rdf__type mesh__D019320sskos__Concept
% 214.96/215.11  |- skos__prefLabel mesh__D019320 Embolism, Paradoxical
% 214.96/215.11  |- skos__annotation mesh__D019320
% 214.96/215.11       IM; coord with specific vessels or vasc dis %28%IM%29%, often PULMONARY EMBOLISM or HEART SEPTAL DEFECTS, ATRIAL for patent foramen ovale%A%  
% 214.96/215.11  |- skos__hiddenLabel mesh__D019320 Paradoxical Embolism
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D019320 2000
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D019320 2005
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D019320 1998
% 214.96/215.11  |- skos__hiddenLabel mesh__D005300 Female Fertility Agents
% 214.96/215.11  |- mesh__dateEstablished mesh__D005300 1975-01-01
% 214.96/215.11  |- skos__hiddenLabel mesh__D005300 Agents, Female Infertility
% 214.96/215.11  |- skos__altLabel mesh__D005300 Infertility Agents, Female
% 214.96/215.11  |- skos__altLabel mesh__D005300 Infertility Drugs, Female
% 214.96/215.11  |- skos__hiddenLabel mesh__D005300 Agents, Female Fertility
% 214.96/215.11  |- rdf__type mesh__D005300sskos__Concept
% 214.96/215.11  |- mesh__recordAuthorizer mesh__D005300 sjn
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D005300 2006
% 214.96/215.11  |- skos__broader mesh__D005300smesh__D005299
% 214.96/215.11  |- skos__historyNote mesh__D005300 Fertility Agents %28%1973-1974%29%
% 214.96/215.11  |- skos__scopeNote mesh__D005300
% 214.96/215.11       Compounds which increase the capacity to conceive in females.%A%    
% 214.96/215.11  |- mesh__recordOriginator mesh__D005300 NLM
% 214.96/215.11  |- mesh__onlineNote mesh__D005300
% 214.96/215.11       use FERTILITY AGENTS, FEMALE to search FERTILITY AGENTS, FEMALE, HORMONAL %26% FERTILITY AGENTS, FEMALE, SYNTHETIC 1975-91%A%  
% 214.96/215.11  |- skos__hiddenLabel mesh__D005300 Drugs, Female Infertility
% 214.96/215.11  |- skos__prefLabel mesh__D005300 Fertility Agents, Female
% 214.96/215.11  |- skos__altLabel mesh__D005300 Synthetic Female Fertility Agents
% 214.96/215.11  |- mesh__dateRevised mesh__D005300 2005-06-30
% 214.96/215.11  |- mesh__historyNote mesh__D005300
% 214.96/215.11       75; FERTILITY AGENTS, FEMALE, HORMONAL %26% FERTILITY AGENTS, FEMALE, SYNTHETIC were headings 1975-91 %28%see under FERTILITY AGENTS, FEMALE 1975-90%29%%A%  
% 214.96/215.11  |- skos__hiddenLabel mesh__D005300 Female Infertility Agents
% 214.96/215.11  |- mesh__dateCreated mesh__D005300 1999-01-01
% 214.96/215.11  |- mesh__recordMaintainer mesh__D005300 ssb
% 214.96/215.11  |- skos__hiddenLabel mesh__D005300 Female Infertility Drugs
% 214.96/215.11  |- skos__altLabel mesh__D005300 Fertility Agents, Female, Synthetic
% 214.96/215.11  |- mesh__publicMeSHNote mesh__D005300
% 214.96/215.11       75; FERTILITY AGENTS, FEMALE, HORMONAL %26% FERTILITY AGENTS, FEMALE, SYNTHETIC were headings 1991, were see under FERTILITY AGENTS, FEMALE 1975-90%A%  
% 214.96/215.11  |- mesh__dateRevised mesh__D018228 1995-06-08
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D018228 1997
% 214.96/215.11  |- skos__prefLabel mesh__D018228 Sarcoma, Small Cell
% 214.96/215.11  |- skos__annotation mesh__D018228
% 214.96/215.11       /blood supply /chem/ second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D018228 1998
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D018228 2006
% 214.96/215.11  |- skos__hiddenLabel mesh__D018228 Cell Sarcomas, Small
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D018228 2002
% 214.96/215.11  |- skos__broader mesh__D018228smesh__D009372
% 214.96/215.11  |- mesh__publicMeSHNote mesh__D018228 94   
% 214.96/215.11  |- mesh__recordAuthorizer mesh__D018228 PLS
% 214.96/215.11  |- skos__historyNote mesh__D018228 Sarcoma %28%1972-1993%29%
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D018228 1996
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D018228 2004
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D018228 2005
% 214.96/215.11  |- rdf__type mesh__D018228sskos__Concept
% 214.96/215.11  |- skos__hiddenLabel mesh__D018228 Small Cell Sarcomas
% 214.96/215.11  |- skos__hiddenLabel mesh__D018228 Sarcomas, Small Cell
% 214.96/215.11  |- mesh__recordMaintainer mesh__D018228 KEV
% 214.96/215.11  |- skos__broader mesh__D018228smesh__D012509
% 214.96/215.11  |- skos__hiddenLabel mesh__D018228 Small Cell Sarcoma
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D018228 2003
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D018228 2001
% 214.96/215.11  |- mesh__dateEstablished mesh__D018228 1994-01-01
% 214.96/215.11  |- skos__hiddenLabel mesh__D018228 Cell Sarcoma, Small
% 214.96/215.11  |- mesh__recordOriginator mesh__D018228 PLS
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D018228 2000
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D018228 1999
% 214.96/215.11  |- mesh__dateCreated mesh__D018228 1993-06-28
% 214.96/215.11  |- skos__scopeNote mesh__D018228
% 214.96/215.11       A sarcoma characterized by the presence of small cells, cells measuring 9-14 micrometers with a faint or indistinct rim of cytoplasm and an oval-to-elongated nucleus with relatively dense chromatin. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 214.96/215.11  |- skos__historyNote mesh__D018228 Sarcoma, Ewing%27%s %28%1986-1993%29%
% 214.96/215.11  |- mesh__historyNote mesh__D018228 94   
% 214.96/215.11  |- skos__altLabel mesh__D010245 Familial Periodic Paralysis
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D010245 2005
% 214.96/215.11  |- skos__hiddenLabel mesh__D010245 Paralysis, Familial Periodic
% 214.96/215.11  |- skos__hiddenLabel mesh__D010245 Periodic Paralysis, Normokalemic
% 214.96/215.11  |- skos__hiddenLabel mesh__D010245 Periodic Paralyses, Normokalemic
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D010245 2004
% 214.96/215.11  |- mesh__recordMaintainer mesh__D010245 mdb
% 214.96/215.11  |- skos__annotation mesh__D010245
% 214.96/215.11       a specific disease entity: see MeSH definition   
% 214.96/215.11  |- mesh__dateRevised mesh__D010245 2002-07-03
% 214.96/215.11  |- rdf__type mesh__D010245sskos__Concept
% 214.96/215.11  |- mesh__historyNote mesh__D010245 2000%28%1966%29%   
% 214.96/215.11  |- mesh__recordAuthorizer mesh__D010245 sjn
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D010245 2003
% 214.96/215.11  |- skos__broader mesh__D010245smesh__D008664
% 214.96/215.11  |- skos__hiddenLabel mesh__D010245 Paralyses, Normokalemic Periodic
% 214.96/215.11  |- skos__scopeNote mesh__D010245
% 214.96/215.11       A heterogenous group of inherited disorders characterized by recurring attacks of rapidly progressive flaccid paralysis or myotonia. These conditions have in common a mutation of the gene encoding the alpha subunit of the sodium channel in skeletal muscle. They are frequently associated with fluctuations in serum potassium levels. Periodic paralysis may also occur as a non-familial process secondary to THYROTOXICOSIS and other conditions. %28%From Adams et al., Principles of Neurology, 6th ed, p1481%29%%A%    
% 214.96/215.11  |- skos__hiddenLabel mesh__D010245 Normokalemic Periodic Paralyses
% 214.96/215.11  |- skos__hiddenLabel mesh__D010245 Periodic Paralyses, Familial
% 214.96/215.11  |- skos__altLabel mesh__D010245 Periodic Paralysis, Familial
% 214.96/215.11  |- mesh__dateCreated mesh__D010245 1999-01-01
% 214.96/215.11  |- mesh__recordOriginator mesh__D010245 NLM
% 214.96/215.11  |- skos__prefLabel mesh__D010245 Paralyses, Familial Periodic
% 214.96/215.11  |- skos__broader mesh__D010245smesh__D009135
% 214.96/215.11  |- skos__hiddenLabel mesh__D010245 Paralysis, Normokalemic Periodic
% 214.96/215.11  |- mesh__publicMeSHNote mesh__D010245
% 214.96/215.11       2000; see PARALYSIS, FAMILIAL PERIODIC 1966-1999   
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D010245 2006
% 214.96/215.11  |- skos__hiddenLabel mesh__D010245 Familial Periodic Paralyses
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004208 2001
% 214.96/215.11  |- skos__broader mesh__D004208smesh__D003674
% 214.96/215.11  |- skos__altLabel mesh__D004208 Displacement
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004208 2006
% 214.96/215.11  |- mesh__dateRevised mesh__D004208 1997-06-20
% 214.96/215.11  |- skos__historyNote mesh__D004208
% 214.96/215.11       Psychoanalytic Interpretation %28%1966-1967%29%
% 214.96/215.11  |- mesh__recordAuthorizer mesh__D004208 SJN
% 214.96/215.11  |- mesh__dateEstablished mesh__D004208 1968-01-01
% 214.96/215.11  |- skos__prefLabel mesh__D004208 Displacement %28%Psychology%29%
% 214.96/215.11  |- skos__scopeNote mesh__D004208
% 214.96/215.11       The process by which an emotional or behavioral response that is appropriate for one situation appears in another situation for which it is inappropriate.%A%    
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004208 2002
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004208 1998
% 214.96/215.11  |- skos__historyNote mesh__D004208 Behavior %28%1966-1967%29%
% 214.96/215.11  |- skos__hiddenLabel mesh__D004208 Displacements %28%Psychology%29%
% 214.96/215.11  |- rdf__type mesh__D004208sskos__Concept
% 214.96/215.11  |- mesh__recordOriginator mesh__D004208 NLM
% 214.96/215.11  |- mesh__publicMeSHNote mesh__D004208 68   
% 214.96/215.11  |- skos__annotation mesh__D004208 no qualif; DF: DISPLACEMENT   
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004208 2003
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004208 1999
% 214.96/215.11  |- mesh__recordMaintainer mesh__D004208 JLS
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004208 2000
% 214.96/215.11  |- mesh__dateCreated mesh__D004208 1999-01-01
% 214.96/215.11  |- mesh__historyNote mesh__D004208 68   
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004208 2005
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D004208 2004
% 214.96/215.11  |- skos__prefLabel mesh__D020673 Protein Renaturation
% 214.96/215.11  |- mesh__historyNote mesh__D020673 2000   
% 214.96/215.11  |- skos__hiddenLabel mesh__D020673 Renaturations, Protein
% 214.96/215.11  |- skos__hiddenLabel mesh__D020673 Protein Renaturations
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D020673 2002
% 214.96/215.11  |- skos__broader mesh__D020673smesh__D001669
% 214.96/215.11  |- mesh__publicMeSHNote mesh__D020673 2000   
% 214.96/215.11  |- rdf__type mesh__D020673sskos__Concept
% 214.96/215.11  |- skos__historyNote mesh__D020673 Protein Folding %28%1993-1999%29%
% 214.96/215.11  |- mesh__dateCreated mesh__D020673 1999-11-03
% 214.96/215.11  |- mesh__dateEstablished mesh__D020673 2000-01-01
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D020673 2006
% 214.96/215.11  |- skos__historyNote mesh__D020673 Protein Conformation %28%1971-1999%29%
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D020673 2001
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D020673 2004
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D020673 2005
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D020673 2000
% 214.96/215.11  |- skos__altLabel mesh__D020673 Renaturation, Protein
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D020673 2003
% 214.96/215.11  |- skos__scopeNote mesh__D020673
% 214.96/215.11       The reconstitution of a protein%27%s activity following denaturation.%A%    
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D014636 2006
% 214.96/215.11  |- skos__hiddenLabel mesh__D014636 Maneuver, Valsalva%27%s
% 214.96/215.11  |- skos__scopeNote mesh__D014636
% 214.96/215.11       Forced expiratory effort against a closed GLOTTIS.     
% 214.96/215.11  |- mesh__recordMaintainer mesh__D014636 nns
% 214.96/215.11  |- skos__broader mesh__D014636smesh__D044702
% 214.96/215.11  |- skos__hiddenLabel mesh__D014636 Valsalva Maneuvers
% 214.96/215.11  |- rdf__type mesh__D014636sskos__Concept
% 214.96/215.11  |- mesh__publicMeSHNote mesh__D014636
% 214.96/215.11       2004; see VALSALVA%27%S MANEUVER 1963-2003   
% 214.96/215.11  |- mesh__recordOriginator mesh__D014636 NLM
% 214.96/215.11  |- skos__broader mesh__D014636smesh__D006334
% 214.96/215.11  |- skos__hiddenLabel mesh__D014636 Maneuver, Valsalva
% 214.96/215.11  |- skos__broader mesh__D014636smesh__D045472
% 214.96/215.11  |- skos__broader mesh__D014636smesh__D012129
% 214.96/215.11  |- mesh__historyNote mesh__D014636 2004%28%1963%29%   
% 214.96/215.11  |- skos__prefLabel mesh__D014636 Valsalva Maneuver
% 214.96/215.11  |- skos__altLabel mesh__D014636 Valsalva%27%s Maneuver
% 214.96/215.11  |- mesh__recordAuthorizer mesh__D014636 sjn
% 214.96/215.11  |- mesh__dateCreated mesh__D014636 1999-01-01
% 214.96/215.11  |- skos__hiddenLabel mesh__D014636 Maneuvers, Valsalva
% 214.96/215.11  |- mesh__dateRevised mesh__D014636 2005-06-30
% 214.96/215.11  |- skos__annotation mesh__D014636
% 214.96/215.11       for Valsalva Maneuver headache coordinate with PRIMARY COUGH HEADACHE %28%see HEADACHE DISORDERS, PRIMARY%29%%A%  
% 214.96/215.11  |- mesh__dateEstablished mesh__D014636 1967-01-01
% 214.96/215.11  |- skos__scopeNote mesh__D000616
% 214.96/215.11       An aromatase inhibitor that produces a state of %22%medical%22% adrenalectomy by blocking the production of adrenal steroids. It also blocks the conversion of androgens to estrogens. Aminoglutethimide has been used in the treatment of advanced breast and prostate cancer. It was formerly used for its weak anticonvulsant properties. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p454%29%%A%    
% 214.96/215.11  |- skos__altLabel mesh__D000616 Novartis Brand of Aminoglutethimide
% 214.96/215.11  |- mesh__publicMeSHNote mesh__D000616 73   
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D000616 2006
% 214.96/215.11  |- skos__altLabel mesh__D000616 Orimeten
% 214.96/215.11  |- mesh__dateRevised mesh__D000616 2005-06-30
% 214.96/215.11  |- skos__annotation mesh__D000616 an aromatase inhib   
% 214.96/215.11  |- mesh__recordMaintainer mesh__D000616 lkw
% 214.96/215.11  |- mesh__recordAuthorizer mesh__D000616 sjn
% 214.96/215.11  |- mesh__historyNote mesh__D000616 73%28%66%29%   
% 214.96/215.11  |- skos__altLabel mesh__D000616 Ciba Vision Brand of Aminoglutethimide
% 214.96/215.11  |- skos__broader mesh__D000616smesh__D005984
% 214.96/215.11  |- mesh__dateEstablished mesh__D000616 1973-01-01
% 214.96/215.11  |- rdf__type mesh__D000616sskos__Concept
% 214.96/215.11  |- mesh__dateCreated mesh__D000616 1999-01-01
% 214.96/215.11  |- mesh__recordOriginator mesh__D000616 NLM
% 214.96/215.11  |- skos__prefLabel mesh__D000616 Aminoglutethimide
% 214.96/215.11  |- mesh__recordOriginator mesh__D019321 TPW
% 214.96/215.11  |- mesh__dateRevised mesh__D019321 2005-06-30
% 214.96/215.11  |- mesh__dateEstablished mesh__D019321 1997-01-01
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D019321 2006
% 214.96/215.11  |- skos__prefLabel mesh__D019321 Erythropoietin, Recombinant
% 214.96/215.11  |- mesh__recordAuthorizer mesh__D019321 sjn
% 214.96/215.11  |- mesh__historyNote mesh__D019321 97   
% 214.96/215.11  |- rdf__type mesh__D019321sskos__Concept
% 214.96/215.11  |- skos__historyNote mesh__D019321 Erythropoietin %28%1986-1996%29%
% 214.96/215.11  |- skos__broader mesh__D019321smesh__D004921
% 214.96/215.11  |- mesh__dateCreated mesh__D019321 1996-06-10
% 214.96/215.11  |- skos__broader mesh__D019321smesh__D011994
% 214.96/215.11  |- skos__scopeNote mesh__D019321
% 214.96/215.11       ERYTHROPOIETIN prepared by recombinant DNA technology.     
% 214.96/215.11  |- skos__historyNote mesh__D019321 Recombinant Proteins %28%1986-1996%29%
% 214.96/215.11  |- mesh__recordMaintainer mesh__D019321 ssb
% 214.96/215.11  |- mesh__publicMeSHNote mesh__D019321 97   
% 214.96/215.11  |- skos__altLabel mesh__D019321 Recombinant Erythropoietin
% 214.96/215.11  |- mesh__recordMaintainer mesh__D018229 KEV
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D018229 2001
% 214.96/215.11  |- skos__prefLabel mesh__D018229 Angiomyoma
% 214.96/215.11  |- mesh__recordAuthorizer mesh__D018229 sjn
% 214.96/215.11  |- skos__historyNote mesh__D018229 Hemangioma %28%1975-1993%29%
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D018229 2003
% 214.96/215.11  |- skos__hiddenLabel mesh__D018229 Angioleiomyomas
% 214.96/215.11  |- skos__annotation mesh__D018229
% 214.96/215.11       coord IM with organ/neopl term %28%IM%29%   
% 214.96/215.11  |- skos__hiddenLabel mesh__D018229 Vascular Leiomyoma
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D018229 2000
% 214.96/215.11  |- mesh__recordOriginator mesh__D018229 PLS
% 214.96/215.11  |- skos__altLabel mesh__D018229 Leiomyoma, Vascular
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D018229 2002
% 214.96/215.11  |- mesh__historyNote mesh__D018229 94   
% 214.96/215.11  |- mesh__publicMeSHNote mesh__D018229 94   
% 214.96/215.11  |- skos__historyNote mesh__D018229 Leiomyoma %28%1975-1993%29%
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D018229 2006
% 214.96/215.11  |- mesh__dateCreated mesh__D018229 1993-06-25
% 214.96/215.11  |- skos__broader mesh__D018229smesh__D007889
% 214.96/215.11  |- skos__scopeNote mesh__D018229
% 214.96/215.11       A benign tumor consisting of vascular and smooth muscle elements.%A%    
% 214.96/215.11  |- skos__hiddenLabel mesh__D018229 Vascular Leiomyomas
% 214.96/215.11  |- skos__hiddenLabel mesh__D018229 Angiomyomas
% 214.96/215.11  |- skos__altLabel mesh__D018229 Angioleiomyoma
% 214.96/215.11  |- mesh__dateEstablished mesh__D018229 1994-01-01
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D018229 2004
% 214.96/215.11  |- mesh__dateRevised mesh__D018229 1999-11-03
% 214.96/215.11  |- rdf__type mesh__D018229sskos__Concept
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D018229 2005
% 214.96/215.11  |- skos__hiddenLabel mesh__D018229 Leiomyomas, Vascular
% 214.96/215.11  |- mesh__activeMeSHYear mesh__D010246 2003
% 214.96/215.11  |- skos__hiddenLabel mesh__D010246 Obstetric Paralysis
% 214.96/215.11  |- mesh__recordMaintainer mesh__D010246 kle
% 214.96/215.11  |- mesh__recordOriginator mesh__D010246 NLM
% 214.96/215.11  |- mesh__dateCreated mesh__D010246 1999-01-01
% 214.96/215.11  |- skos__hiddenLabel mesh__D010246 Paralyses, Obstetric
% 214.96/215.11  |- skos__annotation mesh__D010246
% 214.96/215.11       refers to neonate; coord IM with specific paralysis or birth inj %28%IM%29%; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 214.96/215.12  |- skos__hiddenLabel mesh__D010246 Obstetrical Paralysis
% 214.96/215.12  |- skos__altLabel mesh__D010246 Paralysis, Obstetrical
% 214.96/215.12  |- skos__hiddenLabel mesh__D010246 Obstetrical Paralyses
% 214.96/215.12  |- mesh__dateRevised mesh__D010246 1999-11-03
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D010246 2002
% 214.96/215.12  |- skos__hiddenLabel mesh__D010246 Obstetric Paralyses
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D010246 2006
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D010246 2001
% 214.96/215.12  |- skos__hiddenLabel mesh__D010246 Paralyses, Obstetrical
% 214.96/215.12  |- skos__broader mesh__D010246smesh__D001720
% 214.96/215.12  |- skos__scopeNote mesh__D010246
% 214.96/215.12       Paralysis of an infant resulting from injury received at birth. %28%From Dorland, 27th ed%29%%A%    
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D010246 2005
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D010246 2000
% 214.96/215.12  |- mesh__recordAuthorizer mesh__D010246 sjn
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D010246 2004
% 214.96/215.12  |- rdf__type mesh__D010246sskos__Concept
% 214.96/215.12  |- skos__prefLabel mesh__D010246 Paralysis, Obstetric
% 214.96/215.12  |- mesh__recordOriginator mesh__D004209 NLM
% 214.96/215.12  |- mesh__historyNote mesh__D004209 66   
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D004209 2003
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D004209 1998
% 214.96/215.12  |- mesh__dateRevised mesh__D004209 1997-06-20
% 214.96/215.12  |- mesh__dateCreated mesh__D004209 1999-01-01
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D004209 2002
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D004209 2006
% 214.96/215.12  |- mesh__dateEstablished mesh__D004209 1966-01-01
% 214.96/215.12  |- mesh__recordMaintainer mesh__D004209 PXP
% 214.96/215.12  |- mesh__recordAuthorizer mesh__D004209 SJN
% 214.96/215.12  |- skos__altLabel mesh__D004209 Equipment, Disposable
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D004209 2005
% 214.96/215.12  |- skos__scopeNote mesh__D004209
% 214.96/215.12       Apparatus, devices, or supplies intended for one-time or temporary use.%A%    
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D004209 2001
% 214.96/215.12  |- skos__broader mesh__D004209smesh__D004864
% 214.96/215.12  |- mesh__publicMeSHNote mesh__D004209 66   
% 214.96/215.12  |- skos__prefLabel mesh__D004209 Disposable Equipment
% 214.96/215.12  |- rdf__type mesh__D004209sskos__Concept
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D004209 2000
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D004209 2004
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D004209 1999
% 214.96/215.12  |- skos__broader mesh__D014637smesh__D000604
% 214.96/215.12  |- mesh__recordAuthorizer mesh__D014637 sjn
% 214.96/215.12  |- skos__historyNote mesh__D014637
% 214.96/215.12       Amino Acyl T RNA Synthetases %28%1972-1974%29%
% 214.96/215.12  |- skos__hiddenLabel mesh__D014637 Valyl tRNA Synthetase
% 214.96/215.12  |- skos__historyNote mesh__D014637 Valine %28%1972-1974%29%
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D014637 2004
% 214.96/215.12  |- skos__hiddenLabel mesh__D014637 Ligase, Val-tRNA
% 214.96/215.12  |- mesh__recordMaintainer mesh__D014637 ssb
% 214.96/215.12  |- rdf__type mesh__D014637sskos__Concept
% 214.96/215.12  |- skos__hiddenLabel mesh__D014637 Ligase, Valine-tRNA
% 214.96/215.12  |- skos__altLabel mesh__D014637 Valyl-tRNA Synthetase
% 214.96/215.12  |- skos__hiddenLabel mesh__D014637 Synthetase, Valyl-tRNA
% 214.96/215.12  |- mesh__dateCreated mesh__D014637 1974-11-19
% 214.96/215.12  |- skos__hiddenLabel mesh__D014637 Val tRNA Ligase
% 214.96/215.12  |- mesh__dateEstablished mesh__D014637 1991-01-01
% 214.96/215.12  |- skos__altLabel mesh__D014637 Val-tRNA Ligase
% 214.96/215.12  |- skos__altLabel mesh__D014637 Valyl T RNA Synthetase
% 214.96/215.12  |- mesh__recordOriginator mesh__D014637 NLM
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D014637 2006
% 214.96/215.12  |- skos__scopeNote mesh__D014637
% 214.96/215.12       An enzyme that activates valine with its specific transfer RNA. EC 6.1.1.9%A%    
% 214.96/215.12  |- skos__prefLabel mesh__D014637 Valine-tRNA Ligase
% 214.96/215.12  |- mesh__dateRevised mesh__D014637 2003-07-09
% 214.96/215.12  |- mesh__historyNote mesh__D014637 98%28%75%29%   
% 214.96/215.12  |- mesh__publicMeSHNote mesh__D014637
% 214.96/215.12       98; see VALYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A%  
% 214.96/215.12  |- skos__hiddenLabel mesh__D014637 Valine tRNA Ligase
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D014637 2005
% 214.96/215.12  |- mesh__historyNote mesh__D047013 2005   
% 214.96/215.12  |- mesh__recordAuthorizer mesh__D047013 sjn
% 214.96/215.12  |- mesh__publicMeSHNote mesh__D047013 2005   
% 214.96/215.12  |- skos__scopeNote mesh__D047013
% 214.96/215.12       Subtype of CLOSTRIDIUM BOTULINUM that produces BOTULINUM TOXIN TYPE A which is neurotoxic to humans and animals.%A%    
% 214.96/215.12  |- skos__annotation mesh__D047013
% 214.96/215.12       infection: coordinate IM with BOTULISM %28%IM%29%   
% 214.96/215.12  |- mesh__recordMaintainer mesh__D047013 SYSTEM
% 214.96/215.12  |- skos__broader mesh__D047013smesh__D003014
% 214.96/215.12  |- skos__prefLabel mesh__D047013 Clostridium botulinum type A
% 214.96/215.12  |- skos__altLabel mesh__D047013 Clostridium botulinum A
% 214.96/215.12  |- mesh__recordOriginator mesh__D047013 ags
% 214.96/215.12  |- mesh__dateCreated mesh__D047013 2004-07-07
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D047013 2006
% 214.96/215.12  |- mesh__dateEstablished mesh__D047013 2005-01-01
% 214.96/215.12  |- skos__historyNote mesh__D047013 Clostridium botulinum %28%1966-2004%29%
% 214.96/215.12  |- mesh__dateRevised mesh__D047013 2005-06-30
% 214.96/215.12  |- rdf__type mesh__D047013sskos__Concept
% 214.96/215.12  |- rdf__type mesh__D000617sskos__Concept
% 214.96/215.12  |- mesh__historyNote mesh__D000617 74   
% 214.96/215.12  |- mesh__publicMeSHNote mesh__D000617 74   
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D000617 2006
% 214.96/215.12  |- mesh__recordOriginator mesh__D000617 NLM
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D000617 2005
% 214.96/215.12  |- skos__related mesh__D000617smesh__D000606
% 214.96/215.12  |- mesh__dateEstablished mesh__D000617 1974-01-01
% 214.96/215.12  |- mesh__dateCreated mesh__D000617 1999-01-01
% 214.96/215.12  |- skos__broader mesh__D000617smesh__D006027
% 214.96/215.12  |- mesh__dateRevised mesh__D000617 2004-07-19
% 214.96/215.12  |- mesh__recordAuthorizer mesh__D000617 sjn
% 214.96/215.12  |- skos__prefLabel mesh__D000617 Aminoglycosides
% 214.96/215.12  |- skos__scopeNote mesh__D000617
% 214.96/215.12       Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS.%A%    
% 214.96/215.12  |- mesh__recordMaintainer mesh__D000617 ssb
% 214.96/215.12  |- mesh__dateCreated mesh__D019322 1996-06-10
% 214.96/215.12  |- skos__broader mesh__D019322smesh__D019321
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D019322 2006
% 214.96/215.12  |- mesh__historyNote mesh__D019322 97   
% 214.96/215.12  |- rdf__type mesh__D019322sskos__Concept
% 214.96/215.12  |- mesh__publicMeSHNote mesh__D019322 97   
% 214.96/215.12  |- mesh__recordMaintainer mesh__D019322 ssb
% 214.96/215.12  |- mesh__recordOriginator mesh__D019322 TPW
% 214.96/215.12  |- skos__historyNote mesh__D019322 Recombinant Proteins %28%1989-1996%29%
% 214.96/215.12  |- mesh__dateEstablished mesh__D019322 1997-01-01
% 214.96/215.12  |- skos__scopeNote mesh__D019322
% 214.96/215.12       This recombinant erythropoetin, a 165-amino acid glycoprotein %28%about 62%25% protein and 38%25% carbohydrate%29%, regulates red blood cell production. Epoetin alfa is produced by Chinese hamster ovary cells into which the human erythropoetin gene has been inserted. %28%USP Dictionary of USAN and International Drug Names, 1996%29%.%A%    
% 214.96/215.12  |- mesh__dateRevised mesh__D019322 2005-06-30
% 214.96/215.12  |- skos__historyNote mesh__D019322 Erythropoietin %28%1989-1996%29%
% 214.96/215.12  |- mesh__recordAuthorizer mesh__D019322 sjn
% 214.96/215.12  |- skos__prefLabel mesh__D019322 Epoetin Alfa
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D029750 2004
% 214.96/215.12  |- skos__broader mesh__D029750smesh__D029748
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D029750 2005
% 214.96/215.12  |- mesh__dateCreated mesh__D029750 2001-07-25
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D029750 2003
% 214.96/215.12  |- mesh__recordMaintainer mesh__D029750 ssb
% 214.96/215.12  |- mesh__dateRevised mesh__D029750 2002-07-03
% 214.96/215.12  |- mesh__recordOriginator mesh__D029750 ssb
% 214.96/215.12  |- mesh__historyNote mesh__D029750 2002   
% 214.96/215.12  |- skos__prefLabel mesh__D029750 Saponaria
% 214.96/215.12  |- mesh__dateEstablished mesh__D029750 2002-01-01
% 214.96/215.12  |- skos__scopeNote mesh__D029750
% 214.96/215.12       A plant species of the family CARYOPHYLLACEAE. It is a source of SAPONINS. The common name %22%Soapwort%22% is also used with VACCARIA. The common name of %22%Bouncing Bet%22% is occasionally used with VIOLA.%A%    
% 214.96/215.12  |- mesh__recordAuthorizer mesh__D029750 sjn
% 214.96/215.12  |- skos__annotation mesh__D029750
% 214.96/215.12       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.96/215.12  |- rdf__type mesh__D029750sskos__Concept
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D029750 2006
% 214.96/215.12  |- mesh__publicMeSHNote mesh__D029750 2002   
% 214.96/215.12  |- skos__broader mesh__D010247smesh__D016804
% 214.96/215.12  |- skos__prefLabel mesh__D010247 Paramecium
% 214.96/215.12  |- mesh__recordOriginator mesh__D010247 NLM
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D010247 2006
% 214.96/215.12  |- skos__scopeNote mesh__D010247
% 214.96/215.12       A genus of ciliate protozoa that is often large enough to be seen by the naked eye. Paramecia are commonly used in genetic, cytological, and other research.%A%    
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D010247 2005
% 214.96/215.12  |- mesh__recordMaintainer mesh__D010247 ags
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D010247 2004
% 214.96/215.12  |- rdf__type mesh__D010247sskos__Concept
% 214.96/215.12  |- skos__annotation mesh__D010247
% 214.96/215.12       research protozoon often large enough to be seen by naked eye%A%  
% 214.96/215.12  |- mesh__recordAuthorizer mesh__D010247 sjn
% 214.96/215.12  |- mesh__dateRevised mesh__D010247 2003-07-09
% 214.96/215.12  |- mesh__dateCreated mesh__D010247 1999-01-01
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D015730 1996
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D015730 2003
% 214.96/215.12  |- skos__altLabel mesh__D015730 French Somaliland
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D015730 2000
% 214.96/215.12  |- skos__prefLabel mesh__D015730 Djibouti
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D015730 1999
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D015730 2006
% 214.96/215.12  |- mesh__dateEstablished mesh__D015730 1990-01-01
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D015730 1998
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D015730 2005
% 214.96/215.12  |- skos__scopeNote mesh__D015730
% 214.96/215.12       A republic in eastern Africa, on the Gulf of Aden at the entrance to the Red Sea. Djibouti is also the name of its capital. It was formerly the French Territory of Afars and Issas and later French Somaliland, in French hands from 1862 to 1977 when it became independent. The republic was named from the capital, which is said to derive from an Afar word gabouri, plate, with reference to a plate woven from doum palm used in ceremonies. %28%From Webster%27%s New Geographical Dictionary, 1988, p10, 335 %26% Room, Brewer%27%s Dictionary of Names, 1992, p149%29%%A%    
% 214.96/215.12  |- mesh__dateCreated mesh__D015730 1989-10-13
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D015730 2002
% 214.96/215.12  |- mesh__historyNote mesh__D015730 90   
% 214.96/215.12  |- mesh__recordMaintainer mesh__D015730 TGC
% 214.96/215.12  |- mesh__recordAuthorizer mesh__D015730 PLS
% 214.96/215.12  |- skos__annotation mesh__D015730
% 214.96/215.12       a republic in eastern Africa; the name of the country %26% the capital%A%  
% 214.96/215.12  |- skos__altLabel mesh__D015730 Somaliland, French
% 214.96/215.12  |- skos__broader mesh__D015730smesh__D000351
% 214.96/215.12  |- rdf__type mesh__D015730sskos__Concept
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D015730 1997
% 214.96/215.12  |- skos__historyNote mesh__D015730 Africa, Eastern %28%1966-1989%29%
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D015730 2004
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D015730 2001
% 214.96/215.12  |- mesh__dateRevised mesh__D015730 1995-02-22
% 214.96/215.12  |- mesh__recordOriginator mesh__D015730 TGC
% 214.96/215.12  |- skos__hiddenLabel mesh__D001710 Hermes, Biotin
% 214.96/215.12  |- skos__hiddenLabel mesh__D001710 Roche, Biotine
% 214.96/215.12  |- skos__altLabel mesh__D001710 Simons Brand of Biotin
% 214.96/215.12  |- skos__hiddenLabel mesh__D001710 Biotin Medopharm Brand
% 214.96/215.12  |- mesh__dateRevised mesh__D001710 2005-06-30
% 214.96/215.12  |- skos__hiddenLabel mesh__D001710 Gelfert, Biotin
% 214.96/215.12  |- skos__hiddenLabel mesh__D001710 Biotin ratiopharm
% 214.96/215.12  |- mesh__recordMaintainer mesh__D001710 ssb
% 214.96/215.12  |- skos__hiddenLabel mesh__D001710 Biotin Dermapharm Brand
% 214.96/215.12  |- skos__altLabel mesh__D001710 Roche Brand of Biotin
% 214.96/215.12  |- skos__prefLabel mesh__D001710 Biotin
% 214.96/215.12  |- skos__related mesh__D001710smesh__D009100
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D001710 2006
% 214.96/215.12  |- mesh__dateCreated mesh__D001710 1999-01-01
% 214.96/215.12  |- skos__altLabel mesh__D001710 Strathmann Brand of Biotin
% 214.96/215.12  |- skos__broader mesh__D001710smesh__D007093
% 214.96/215.12  |- mesh__recordOriginator mesh__D001710 NLM
% 214.96/215.12  |- skos__related mesh__D001710smesh__D028922
% 214.96/215.12  |- skos__altLabel mesh__D001710 e+b Pharma Brand of Biotin
% 214.96/215.12  |- skos__altLabel mesh__D001710 Vitamin H
% 214.96/215.12  |- skos__altLabel mesh__D001710 Medea Brand of Biotin Sodium Salt
% 214.96/215.12  |- skos__scopeNote mesh__D001710
% 214.96/215.12       A water-soluble, enzyme co-factor present in minute amounts in every living cell. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk.%A%    
% 214.96/215.12  |- skos__altLabel mesh__D001710 ratiopharm Brand of Biotin
% 214.96/215.12  |- skos__related mesh__D001710smesh__D028921
% 214.96/215.12  |- skos__hiddenLabel mesh__D001710 Biotin Simons Brand
% 214.96/215.12  |- skos__altLabel mesh__D001710 Biocur Brand of Biotin
% 214.96/215.12  |- mesh__recordAuthorizer mesh__D001710 sjn
% 214.96/215.12  |- skos__hiddenLabel mesh__D001710 Biotin ratiopharm Brand
% 214.96/215.12  |- skos__annotation mesh__D001710
% 214.96/215.12       /ther use: coordinate disease with /drug ther, not /diet ther; deficiency: coordinate BIOTIN /defic %28%IM%29% with VITAMIN B DEFICIENCY %28%IM%29%%A%  
% 214.96/215.12  |- skos__hiddenLabel mesh__D001710 Biotin Strathmann Brand
% 214.96/215.12  |- skos__altLabel mesh__D001710 Ziethen Brand of Biotin
% 214.96/215.12  |- skos__hiddenLabel mesh__D001710 H, Vitamin
% 214.96/215.12  |- skos__hiddenLabel mesh__D001710 Biotin Roche Brand
% 214.96/215.12  |- skos__hiddenLabel mesh__D001710 Biotin Hermes Brand
% 214.96/215.12  |- skos__hiddenLabel mesh__D001710 Biotin Ziethen Brand
% 214.96/215.12  |- skos__hiddenLabel mesh__D001710 Biotin Biocur Brand
% 214.96/215.12  |- skos__related mesh__D001710smesh__D001360
% 214.96/215.12  |- skos__altLabel mesh__D001710 Medopharm Brand of Biotin
% 214.96/215.12  |- skos__altLabel mesh__D001710 Dermapharm Brand of Biotin
% 214.96/215.12  |- skos__broader mesh__D001710smesh__D003067
% 214.96/215.12  |- skos__hiddenLabel mesh__D001710 Biotinratiopharm
% 214.96/215.12  |- skos__altLabel mesh__D001710 Hermes Brand of Biotin
% 214.96/215.12  |- rdf__type mesh__D001710sskos__Concept
% 214.96/215.12  |- skos__historyNote mesh__D020675 Microbodies %28%1975-1999%29%
% 214.96/215.12  |- mesh__dateRevised mesh__D020675 2003-07-09
% 214.96/215.12  |- rdf__type mesh__D020675sskos__Concept
% 214.96/215.12  |- skos__hiddenLabel mesh__D020675 Peroxisome
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D020675 2005
% 214.96/215.12  |- mesh__dateCreated mesh__D020675 1999-11-03
% 214.96/215.12  |- mesh__publicMeSHNote mesh__D020675 2000; see MICROBODIES 1976-1999   
% 214.96/215.12  |- mesh__historyNote mesh__D020675 2000; use MICROBODIES 1976-1999   
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D020675 2006
% 214.96/215.12  |- skos__prefLabel mesh__D020675 Peroxisomes
% 214.96/215.12  |- skos__scopeNote mesh__D020675
% 214.96/215.12       Microbodies which occur in animal and plant cells and in certain fungi and protozoa. They contain peroxidase, catalase, and allied enzymes. %28%From Singleton and Sainsbury, Dictionary of Microbiology and Molecular Biology, 2nd ed%29%%A%    
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D020675 2004
% 214.96/215.12  |- skos__related mesh__D020675smesh__D018901
% 214.96/215.12  |- skos__broader mesh__D020675smesh__D008830
% 214.96/215.12  |- mesh__dateEstablished mesh__D020675 2000-01-01
% 214.96/215.12  |- skos__related mesh__D020675smesh__D020025
% 214.96/215.12  |- mesh__publicMeSHNote mesh__D014638 88   
% 214.96/215.12  |- mesh__recordOriginator mesh__D014638 RLS
% 214.96/215.12  |- skos__historyNote mesh__D014638 Vanadium %28%1966-1987%29%
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D014638 1996
% 214.96/215.12  |- mesh__historyNote mesh__D014638 88   
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D014638 2002
% 214.96/215.12  |- skos__prefLabel mesh__D014638 Vanadates
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D014638 2006
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D014638 2001
% 214.96/215.12  |- mesh__dateRevised mesh__D014638 1993-06-03
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D014638 1995
% 214.96/215.12  |- skos__broader mesh__D014638smesh__D017968
% 214.96/215.12  |- mesh__dateCreated mesh__D014638 1987-05-04
% 214.96/215.12  |- mesh__dateEstablished mesh__D014638 1988-01-01
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D014638 2005
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D014638 2000
% 214.96/215.12  |- skos__annotation mesh__D014638 enzyme inhib   
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D014638 1999
% 214.96/215.12  |- skos__altLabel mesh__D014638 Vanadate
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D014638 1994
% 214.96/215.12  |- skos__scopeNote mesh__D014638
% 214.96/215.12       Oxyvanadium ions in various states of oxidation. They act primarily as ion transport inhibitors due to their inhibition of Na%28%+%29%-, K%28%+%29%-, and Ca%28%+%29%-ATPase transport systems. They also have insulin-like action, positive inotropic action on cardiac ventricular muscle, and other metabolic effects.%A%    
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D014638 2004
% 214.96/215.12  |- skos__broader mesh__D014638smesh__D000838
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D014638 1998
% 214.96/215.12  |- skos__hiddenLabel mesh__D014638 Vanadate, Sodium
% 214.96/215.12  |- rdf__type mesh__D014638sskos__Concept
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D014638 2003
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D014638 1997
% 214.96/215.12  |- mesh__recordMaintainer mesh__D014638 TPW
% 214.96/215.12  |- mesh__recordAuthorizer mesh__D014638 PLS
% 214.96/215.12  |- mesh__recordOriginator mesh__D047014 ags
% 214.96/215.12  |- skos__annotation mesh__D047014
% 214.96/215.12       infection: coordinate IM with BOTULISM %28%IM%29%   
% 214.96/215.12  |- mesh__dateCreated mesh__D047014 2004-07-07
% 214.96/215.12  |- mesh__dateRevised mesh__D047014 2005-06-30
% 214.96/215.12  |- mesh__publicMeSHNote mesh__D047014 2005   
% 214.96/215.12  |- skos__historyNote mesh__D047014 Clostridium botulinum %28%1966-2004%29%
% 214.96/215.12  |- skos__broader mesh__D047014smesh__D003014
% 214.96/215.12  |- skos__scopeNote mesh__D047014
% 214.96/215.12       Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type B which is neurotoxic to humans and animals.%A%    
% 214.96/215.12  |- mesh__recordAuthorizer mesh__D047014 sjn
% 214.96/215.12  |- mesh__historyNote mesh__D047014 2005   
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D047014 2006
% 214.96/215.12  |- mesh__recordMaintainer mesh__D047014 SYSTEM
% 214.96/215.12  |- mesh__dateEstablished mesh__D047014 2005-01-01
% 214.96/215.12  |- skos__prefLabel mesh__D047014 Clostridium botulinum type B
% 214.96/215.12  |- rdf__type mesh__D047014sskos__Concept
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D019323 2005
% 214.96/215.12  |- rdf__type mesh__D019323sskos__Concept
% 214.96/215.12  |- skos__altLabel mesh__D019323 N%28%G%29%-Monomethyl-D-Arginine
% 214.96/215.12  |- skos__broader mesh__D019323smesh__D001120
% 214.96/215.12  |- skos__hiddenLabel mesh__D019323 omega N Methylarginine
% 214.96/215.12  |- skos__altLabel mesh__D019323 NG-Monomethyl-L-Arginine
% 214.96/215.12  |- skos__altLabel mesh__D019323 L-NG-Monomethyl Arginine
% 214.96/215.12  |- skos__altLabel mesh__D019323 D-NMMA
% 214.96/215.12  |- mesh__recordAuthorizer mesh__D019323 sjn
% 214.96/215.12  |- mesh__dateCreated mesh__D019323 1996-06-10
% 214.96/215.12  |- skos__altLabel mesh__D019323 L-NMMA
% 214.96/215.12  |- skos__hiddenLabel mesh__D019323 Arginine, L-NG-Monomethyl
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D019323 2004
% 214.96/215.12  |- mesh__historyNote mesh__D019323
% 214.96/215.12       97; was OMEGA-N-METHYLARGININE 1979-96   
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D019323 2002
% 214.96/215.12  |- mesh__onlineNote mesh__D019323
% 214.96/215.12       use OMEGA-N-METHYLARGININE to search OMEGA-N-METHYLARGININE 1980-96%A%  
% 214.96/215.12  |- skos__hiddenLabel mesh__D019323 L Monomethylarginine
% 214.96/215.12  |- skos__altLabel mesh__D019323 N%28%omega%29%-Monomethyl-L-Arginine
% 214.96/215.12  |- skos__altLabel mesh__D019323 N%28%G%29%-Monomethylarginine
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D019323 2003
% 214.96/215.12  |- mesh__dateRevised mesh__D019323 2001-07-25
% 214.96/215.12  |- skos__altLabel mesh__D019323 L-Monomethylarginine
% 214.96/215.12  |- mesh__publicMeSHNote mesh__D019323
% 214.96/215.12       97; OMEGA-N-METHYLARGININE was indexed under ARGININE/analogs %26% derivatives 1979-96%A%  
% 214.96/215.12  |- skos__prefLabel mesh__D019323 omega-N-Methylarginine
% 214.96/215.12  |- skos__historyNote mesh__D019323
% 214.96/215.12       Arginine/analogs %26% derivatives %28%1979-1996%29%
% 214.96/215.12  |- skos__hiddenLabel mesh__D019323 L NG Monomethyl Arginine
% 214.96/215.12  |- skos__altLabel mesh__D019323 N%28%G%29%-Methylarginine
% 214.96/215.12  |- mesh__recordMaintainer mesh__D019323 nns
% 214.96/215.12  |- mesh__dateEstablished mesh__D019323 1997-01-01
% 214.96/215.12  |- skos__scopeNote mesh__D019323
% 214.96/215.12       A competitive inhibitor of nitric oxide synthetase.     
% 214.96/215.12  |- mesh__recordOriginator mesh__D019323 ADP
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D019323 2006
% 214.96/215.12  |- skos__hiddenLabel mesh__D019323 NG Monomethyl L Arginine
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D000618 2004
% 214.96/215.12  |- mesh__recordAuthorizer mesh__D000618 SJN
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D000618 2000
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D000618 2006
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D000618 1999
% 214.96/215.12  |- mesh__historyNote mesh__D000618 77; was AMINOHIPPURIC ACID 1965-76   
% 214.96/215.12  |- skos__prefLabel mesh__D000618 Aminohippuric Acids
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D000618 2003
% 214.96/215.12  |- mesh__onlineNote mesh__D000618
% 214.96/215.12       use AMINOHIPPURIC ACIDS to search AMINOHIPPURIC ACID 1966-76%A%  
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D000618 2005
% 214.96/215.12  |- skos__broader mesh__D000618smesh__D006626
% 214.96/215.12  |- skos__broader mesh__D000618smesh__D001549
% 214.96/215.12  |- mesh__recordOriginator mesh__D000618 NLM
% 214.96/215.12  |- mesh__dateCreated mesh__D000618 1999-01-01
% 214.96/215.12  |- mesh__dateRevised mesh__D000618 1998-06-10
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D000618 2002
% 214.96/215.12  |- mesh__recordMaintainer mesh__D000618 ADP
% 214.96/215.12  |- skos__hiddenLabel mesh__D000618 Acids, Aminohippuric
% 214.96/215.12  |- mesh__dateEstablished mesh__D000618 1965-01-01
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D000618 2001
% 214.96/215.12  |- mesh__publicMeSHNote mesh__D000618 77; was AMINOHIPPURIC ACID 1965-76   
% 214.96/215.12  |- skos__scopeNote mesh__D000618
% 214.96/215.12       A group of glycine amides of aminobenzoic acids.     
% 214.96/215.12  |- rdf__type mesh__D000618sskos__Concept
% 214.96/215.12  |- mesh__dateRevised mesh__D011340 1992-05-18
% 214.96/215.12  |- skos__broader mesh__D011340smesh__D013850
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D011340 2004
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D011340 1998
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D011340 1993
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D011340 2002
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D011340 2005
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D011340 1994
% 214.96/215.12  |- skos__prefLabel mesh__D011340 Problem Solving
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D011340 1999
% 214.96/215.12  |- skos__scopeNote mesh__D011340
% 214.96/215.12       A learning situation involving more than one alternative from which a selection is made in order to attain a specific goal.%A%    
% 214.96/215.12  |- skos__annotation mesh__D011340 human %26% animal   
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D011340 2006
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D011340 1995
% 214.96/215.12  |- mesh__recordAuthorizer mesh__D011340 PLS
% 214.96/215.12  |- mesh__dateCreated mesh__D011340 1999-01-01
% 214.96/215.12  |- skos__related mesh__D011340smesh__D003657
% 214.96/215.12  |- skos__broader mesh__D011340smesh__D007858
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D011340 1996
% 214.96/215.12  |- mesh__recordMaintainer mesh__D011340 TAP
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D011340 2000
% 214.96/215.12  |- mesh__recordOriginator mesh__D011340 NLM
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D011340 2003
% 214.96/215.12  |- rdf__type mesh__D011340sskos__Concept
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D011340 2001
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D011340 1997
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D005303 2006
% 214.96/215.12  |- skos__prefLabel mesh__D005303 Fertility Agents, Male
% 214.96/215.12  |- mesh__dateCreated mesh__D005303 1999-01-01
% 214.96/215.12  |- skos__hiddenLabel mesh__D005303 Male Fertility Agents
% 214.96/215.12  |- skos__hiddenLabel mesh__D005303 Agents, Male Fertility
% 214.96/215.12  |- skos__altLabel mesh__D005303 Fertility Agents, Male, Synthetic
% 214.96/215.12  |- mesh__recordAuthorizer mesh__D005303 sjn
% 214.96/215.12  |- mesh__historyNote mesh__D005303
% 214.96/215.12       75; FERTILITY AGENTS, MALE, HORMONAL %26% FERTILITY AGENTS, MALE, SYNTHETIC were headings 1975-91 %28%see under FERTILITY AGENTS, MALE 1975-90%29%%A%  
% 214.96/215.12  |- mesh__recordMaintainer mesh__D005303 ssb
% 214.96/215.12  |- mesh__publicMeSHNote mesh__D005303
% 214.96/215.12       75; FERTILITY AGENTS, MALE, HORMONAL %26% FERTILITY AGENTS, MALE, SYNTHETIC were headings 1991, were see under FERTILITY AGENTS, MALE 1975-90%A%  
% 214.96/215.12  |- mesh__dateRevised mesh__D005303 2005-06-30
% 214.96/215.12  |- skos__altLabel mesh__D005303 Synthetic Male Fertility Agents
% 214.96/215.12  |- mesh__dateEstablished mesh__D005303 1975-01-01
% 214.96/215.12  |- mesh__recordOriginator mesh__D005303 NLM
% 214.96/215.12  |- skos__broader mesh__D005303smesh__D005299
% 214.96/215.12  |- rdf__type mesh__D005303sskos__Concept
% 214.96/215.12  |- skos__scopeNote mesh__D005303
% 214.96/215.12       Compounds which increase the capacity of the male to induce conception.%A%    
% 214.96/215.12  |- mesh__onlineNote mesh__D005303
% 214.96/215.12       use FERTILITY AGENTS, MALE to search FERTILITY AGENTS, MALE, HORMONAL %26% FERTILITY AGENTS, MALE, SYNTHETIC 1975-91%A%  
% 214.96/215.12  |- skos__historyNote mesh__D005303 Fertility Agents %28%1973-1974%29%
% 214.96/215.12  |- rdf__type mesh__D029751sskos__Concept
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D029751 2004
% 214.96/215.12  |- skos__prefLabel mesh__D029751 Silene
% 214.96/215.12  |- mesh__dateEstablished mesh__D029751 2002-01-01
% 214.96/215.12  |- mesh__dateCreated mesh__D029751 2001-07-25
% 214.96/215.12  |- mesh__recordAuthorizer mesh__D029751 sjn
% 214.96/215.12  |- mesh__recordMaintainer mesh__D029751 ssb
% 214.96/215.12  |- skos__broader mesh__D029751smesh__D029748
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D029751 2005
% 214.96/215.12  |- mesh__dateRevised mesh__D029751 2002-07-03
% 214.96/215.12  |- skos__scopeNote mesh__D029751
% 214.96/215.12       A plant genus of the family CARYOPHYLLACEAE. The common name of campion is also used with LYCHNIS. The common name of %27%pink%27% can be confused with other plants.%A%    
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D029751 2003
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D029751 2006
% 214.96/215.12  |- mesh__publicMeSHNote mesh__D029751 2002   
% 214.96/215.12  |- skos__annotation mesh__D029751
% 214.96/215.12       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.96/215.12  |- mesh__recordOriginator mesh__D029751 ssb
% 214.96/215.12  |- mesh__historyNote mesh__D029751 2002   
% 214.96/215.12  |- mesh__dateCreated mesh__D043422 2003-07-09
% 214.96/215.12  |- skos__altLabel mesh__D043422 PCPA2 Enzyme
% 214.96/215.12  |- mesh__recordMaintainer mesh__D043422 jmp
% 214.96/215.12  |- skos__scopeNote mesh__D043422
% 214.96/215.12       Carboxypeptidases that are primarily found the DIGESTIVE SYSTEM that catalyze the release of C-terminal amino acids. Carboxypeptidases A have little or no activity for hydrolysis of C-terminal ASPARTIC ACID; GLUTAMIC ACID; ARGININE; LYSINE; or PROLINE. This enzyme requires ZINC as a cofactor and was formerly listed as EC 3.4.2.1 and EC 3.4.12.2.%A%    
% 214.96/215.12  |- mesh__dateEstablished mesh__D043422 2004-01-01
% 214.96/215.12  |- mesh__publicMeSHNote mesh__D043422
% 214.96/215.12       2004; CARBOXYPEPTIDASES A was indexed under CARBOXYPEPTIDASES 1974-2003; PROCARBOXYPEPTIDASE A was indexed under CARBOXYPEPTIDASES %26% ENZYME PRECUSORS 1981-2003; PROCARBOXYPEPTIDASE A1 was indexed under CARBOXYPEPTIDASES %26% ENZYME PRECUSORS 1998-2003; PROCARBOXYPEPTIDASE A2 was indexed under CARBOXYPEPTIDASES %26% ENZYME PRECUSORS 1998-2003%A%  
% 214.96/215.12  |- mesh__recordOriginator mesh__D043422 AKE
% 214.96/215.12  |- mesh__activeMeSHYear mesh__D043422 2006
% 214.96/215.12  |- rdf__type mesh__D043422sskos__Concept
% 214.96/215.13  |- skos__historyNote mesh__D043422 Carboxypeptidases %28%1974-2003%29%
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D043422 2004
% 214.96/215.13  |- mesh__historyNote mesh__D043422
% 214.96/215.13       2004; use CARBOXYPEPTIDASES A %28%NM%29% 1980-2003, for PROCARBOXYPEPTIDASE A use CARBOXYPEPTIDASE A %28%NM%29% 1981-2003; for PROCARBOXYPEPTIDASE A1 use CARBOXYPEPTIDASES A 1998-2003; for PROCARBOXYPEPTIDASES A2 use CARBOXYPEPTIDASES A %28%NM%29% 1998-2003%A%  
% 214.96/215.13  |- skos__altLabel mesh__D043422 PCPA1 Enzyme
% 214.96/215.13  |- skos__prefLabel mesh__D043422 Carboxypeptidases A
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D043422 2005
% 214.96/215.13  |- skos__broader mesh__D043422smesh__D045727
% 214.96/215.13  |- skos__broader mesh__D043422smesh__D002268
% 214.96/215.13  |- skos__altLabel mesh__D043422 Carboxypeptidase A
% 214.96/215.13  |- mesh__recordAuthorizer mesh__D043422 sjn
% 214.96/215.13  |- skos__broader mesh__D010248smesh__D011246
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D010248 2005
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D010248 2006
% 214.96/215.13  |- mesh__recordAuthorizer mesh__D010248 sjn
% 214.96/215.13  |- mesh__recordMaintainer mesh__D010248 ssb
% 214.96/215.13  |- mesh__dateCreated mesh__D010248 1999-01-01
% 214.96/215.13  |- mesh__historyNote mesh__D010248 65%28%63%29%   
% 214.96/215.13  |- mesh__dateEstablished mesh__D010248 1965-01-01
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D010248 2004
% 214.96/215.13  |- mesh__recordOriginator mesh__D010248 NLM
% 214.96/215.13  |- rdf__type mesh__D010248sskos__Concept
% 214.96/215.13  |- mesh__publicMeSHNote mesh__D010248 65   
% 214.96/215.13  |- skos__scopeNote mesh__D010248
% 214.96/215.13       A glucocorticoid with the general properties of corticosteroids. It has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than HYDROCORTISONE with supplementary FLUDROCORTISONE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p737%29%%A%    
% 214.96/215.13  |- skos__broader mesh__D010248smesh__D013259
% 214.96/215.13  |- mesh__dateRevised mesh__D010248 2003-07-09
% 214.96/215.13  |- skos__prefLabel mesh__D010248 Paramethasone
% 214.96/215.13  |- skos__broader mesh__D014965Q000176smesh__D014965
% 214.96/215.13  |- mesh__preferredCombination mesh__D014965Q000176smesh__D011859
% 214.96/215.13  |- rdf__type mesh__D014965Q000176smesh__CompoundConcept
% 214.96/215.13  |- skos__prefLabel mesh__D001711 Biotransformation
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D001711 2006
% 214.96/215.13  |- rdf__type mesh__D001711sskos__Concept
% 214.96/215.13  |- mesh__dateRevised mesh__D001711 2005-06-30
% 214.96/215.13  |- mesh__recordMaintainer mesh__D001711 ssb
% 214.96/215.13  |- mesh__dateEstablished mesh__D001711 1970-01-01
% 214.96/215.13  |- skos__scopeNote mesh__D001711
% 214.96/215.13       The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.%A%    
% 214.96/215.13  |- mesh__dateCreated mesh__D001711 1999-01-01
% 214.96/215.13  |- mesh__recordOriginator mesh__D001711 NLM
% 214.96/215.13  |- skos__broader mesh__D001711smesh__D010599
% 214.96/215.13  |- skos__hiddenLabel mesh__D001711 Activations, Metabolic
% 214.96/215.13  |- skos__hiddenLabel mesh__D001711 Metabolic Activations
% 214.96/215.13  |- skos__hiddenLabel mesh__D001711 Biotransformations
% 214.96/215.13  |- mesh__recordAuthorizer mesh__D001711 sjn
% 214.96/215.13  |- skos__altLabel mesh__D001711 Metabolic Activation
% 214.96/215.13  |- mesh__historyNote mesh__D001711 70%28%66%29%   
% 214.96/215.13  |- mesh__publicMeSHNote mesh__D001711 70   
% 214.96/215.13  |- skos__annotation mesh__D001711
% 214.96/215.13       restrict to chemical changes of exogenous substances; IM general only; coordinate NIM with specific drug /pharmacokin %28%IM%29%; or /metab %28%for microorganisms%29%; do not confuse with BIODEGRADATION: reduction of %22%pollutant chemicals, organic wastes, pesticides %26% implantable materials%22%%A%  
% 214.96/215.13  |- rdf__type mesh__D020676sskos__Concept
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D020676 2005
% 214.96/215.13  |- skos__prefLabel mesh__D020676 Glyoxysomes
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D020676 2006
% 214.96/215.13  |- mesh__historyNote mesh__D020676 2000   
% 214.96/215.13  |- skos__scopeNote mesh__D020676
% 214.96/215.13       Microbodies which occur in plant cells, and in some eukaryotic microorganisms, and which contain enzymes of the glyoxylate cycle. %28%Singleton and Stainsbury, Dictionary of Microbiology and Molecular Biology, 2nd ed%29%%A%    
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D020676 2004
% 214.96/215.13  |- skos__broader mesh__D020676smesh__D008830
% 214.96/215.13  |- mesh__dateCreated mesh__D020676 1999-11-03
% 214.96/215.13  |- skos__hiddenLabel mesh__D020676 Glyoxysome
% 214.96/215.13  |- mesh__dateEstablished mesh__D020676 2000-01-01
% 214.96/215.13  |- mesh__publicMeSHNote mesh__D020676 2000   
% 214.96/215.13  |- skos__historyNote mesh__D020676 Microbodies %28%1982-1999%29%
% 214.96/215.13  |- mesh__dateRevised mesh__D020676 2003-07-09
% 214.96/215.13  |- skos__hiddenLabel mesh__D039381 Cap Binding Protein Complex
% 214.96/215.13  |- mesh__dateEstablished mesh__D039381 2003-01-01
% 214.96/215.13  |- skos__altLabel mesh__D039381 RNA Cap Binding Proteins
% 214.96/215.13  |- skos__broader mesh__D039381smesh__D016601
% 214.96/215.13  |- skos__altLabel mesh__D039381 Cap Binding Proteins
% 214.96/215.13  |- mesh__recordMaintainer mesh__D039381 ssb
% 214.96/215.13  |- mesh__dateRevised mesh__D039381 2005-06-30
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D039381 2006
% 214.96/215.13  |- mesh__recordAuthorizer mesh__D039381 sjn
% 214.96/215.13  |- mesh__historyNote mesh__D039381
% 214.96/215.13       2003; use RNA CAP-BINDING PROTEINS %28%NM%29% 1981-2002   
% 214.96/215.13  |- mesh__recordOriginator mesh__D039381 jmp
% 214.96/215.13  |- skos__altLabel mesh__D039381 mRNA Cap Binding Proteins
% 214.96/215.13  |- skos__historyNote mesh__D039381 RNA-Binding Proteins %28%1981-2002%29%
% 214.96/215.13  |- skos__hiddenLabel mesh__D039381 Binding Proteins, Cap
% 214.96/215.13  |- mesh__publicMeSHNote mesh__D039381
% 214.96/215.13       2003; RNA CAP-BINDING PROTEINS was indexed under RNA-BINDING PROTEINS 1981-2002%A%  
% 214.96/215.13  |- skos__altLabel mesh__D039381 Cap Binding Protein
% 214.96/215.13  |- skos__hiddenLabel mesh__D039381 Binding Protein, Cap
% 214.96/215.13  |- skos__prefLabel mesh__D039381 RNA Cap-Binding Proteins
% 214.96/215.13  |- rdf__type mesh__D039381sskos__Concept
% 214.96/215.13  |- mesh__dateCreated mesh__D039381 2002-07-02
% 214.96/215.13  |- skos__scopeNote mesh__D039381
% 214.96/215.13       Proteins that specifically bind to RNA CAPS and form nuclear cap binding protein complexes. In addition to stabilizing the 5%27% end of mRNAs, they serve a diverse array of functions such as enhancing mRNA transport out of the CELL NUCLEUS and regulating MRNA TRANSLATION in the CYTOPLASM.%A%    
% 214.96/215.13  |- skos__hiddenLabel mesh__D039381 Cap-Binding Proteins, RNA
% 214.96/215.13  |- mesh__dateCreated mesh__D014639 1999-01-01
% 214.96/215.13  |- skos__broader mesh__D014639smesh__D028561
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D014639 2006
% 214.96/215.13  |- mesh__recordOriginator mesh__D014639 NLM
% 214.96/215.13  |- skos__scopeNote mesh__D014639
% 214.96/215.13       A metallic element with the atomic symbol V, atomic number 23, and atomic weight 50.94. It is used in the manufacture of vanadium steel. Prolonged exposure can lead to chronic intoxication caused by absorption usually via the lungs.%A%    
% 214.96/215.13  |- skos__broader mesh__D014639smesh__D019216
% 214.96/215.13  |- mesh__recordAuthorizer mesh__D014639 sjn
% 214.96/215.13  |- rdf__type mesh__D014639sskos__Concept
% 214.96/215.13  |- mesh__dateRevised mesh__D014639 2005-06-30
% 214.96/215.13  |- skos__annotation mesh__D014639
% 214.96/215.13       V-51; V-50 = VANADIUM %28%IM%29% + ISOTOPES %28%NIM%29%; V-46-49, 52-54 = VANADIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 214.96/215.13  |- mesh__recordMaintainer mesh__D014639 ssb
% 214.96/215.13  |- skos__prefLabel mesh__D014639 Vanadium
% 214.96/215.13  |- skos__broader mesh__D006321Q000033smesh__D006321
% 214.96/215.13  |- rdf__type mesh__D006321Q000033smesh__CompoundConcept
% 214.96/215.13  |- skos__broader mesh__D025361smesh__D010456
% 214.96/215.13  |- mesh__dateCreated mesh__D025361 2001-07-25
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D025361 2006
% 214.96/215.13  |- mesh__dateEstablished mesh__D025361 2002-01-01
% 214.96/215.13  |- mesh__dateRevised mesh__D025361 2004-07-07
% 214.96/215.13  |- skos__historyNote mesh__D025361 Virginiamycin %28%1992-2001%29%
% 214.96/215.13  |- mesh__recordOriginator mesh__D025361 jmp
% 214.96/215.13  |- skos__prefLabel mesh__D025361 Streptogramins
% 214.96/215.13  |- skos__altLabel mesh__D025361 Streptogramin
% 214.96/215.13  |- mesh__historyNote mesh__D025361
% 214.96/215.13       2002, 1981-1993; use VIRGINIAMYCIN 1994-2001   
% 214.96/215.13  |- skos__scopeNote mesh__D025361
% 214.96/215.13       A class of natural cyclic peptide antibiotics produced by certain subspecies of STREPTOMYCES. They include two structurally unrelated components, STREPTOGRAMIN GROUP A and STREPTOGRAMIN GROUP B, which generally act synergistically to inhibit bacterial growth.%A%    
% 214.96/215.13  |- mesh__recordAuthorizer mesh__D025361 sjn
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D025361 2005
% 214.96/215.13  |- rdf__type mesh__D025361sskos__Concept
% 214.96/215.13  |- mesh__publicMeSHNote mesh__D025361
% 214.96/215.13       2002; see VIRGINIAMYCIN 1994-2001, see STREPTOGRAMINS 1981-1993%A%  
% 214.96/215.13  |- mesh__recordMaintainer mesh__D025361 ssb
% 214.96/215.13  |- mesh__historyNote mesh__D019324
% 214.96/215.13       97; was BETA-NAPHTHOFLAVONE %28%NM%29% 1973-96   
% 214.96/215.13  |- rdf__type mesh__D019324sskos__Concept
% 214.96/215.13  |- skos__scopeNote mesh__D019324
% 214.96/215.13       A polyaromatic hydrocarbon inducer of P4501A1 and P4501A2 cytochromes. %28%Proc Soc Exp Biol Med 1994 Dec:207%28%3%29%:302-308%29%%A%    
% 214.96/215.13  |- mesh__recordOriginator mesh__D019324 ADP
% 214.96/215.13  |- skos__altLabel mesh__D019324 5,6-Benzoflavone
% 214.96/215.13  |- mesh__dateEstablished mesh__D019324 1997-01-01
% 214.96/215.13  |- mesh__dateRevised mesh__D019324 2005-06-30
% 214.96/215.13  |- mesh__publicMeSHNote mesh__D019324
% 214.96/215.13       97; BETA-NAPHTHOFLAVONE was indexed under BENZOFLAVONES 1981-96, NAPHTHALENES 1973-80, %26% FLAVONES 1973-80%A%  
% 214.96/215.13  |- skos__hiddenLabel mesh__D019324 5,6 Benzoflavone
% 214.96/215.13  |- skos__historyNote mesh__D019324 Naphthalenes %28%1973-1980%29%
% 214.96/215.13  |- mesh__dateCreated mesh__D019324 1996-06-10
% 214.96/215.13  |- mesh__recordAuthorizer mesh__D019324 sjn
% 214.96/215.13  |- mesh__recordMaintainer mesh__D019324 ssb
% 214.96/215.13  |- skos__historyNote mesh__D019324 Benzoflavones %28%1981-1996%29%
% 214.96/215.13  |- skos__hiddenLabel mesh__D019324 beta Naphthoflavone
% 214.96/215.13  |- skos__broader mesh__D019324smesh__D001571
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D019324 2006
% 214.96/215.13  |- skos__prefLabel mesh__D019324 beta-Naphthoflavone
% 214.96/215.13  |- skos__historyNote mesh__D019324 Flavones %28%1973-1980%29%
% 214.96/215.13  |- mesh__onlineNote mesh__D019324
% 214.96/215.13       use BETA-NAPHTHOFLAVONE %28%NM%29% to search BETA-NAPHTHOFLAVONE 1980-96%A%  
% 214.96/215.13  |- mesh__dateCreated mesh__D000619 1999-01-01
% 214.96/215.13  |- mesh__dateRevised mesh__D000619 2003-07-09
% 214.96/215.13  |- skos__broader mesh__D000619smesh__D006867
% 214.96/215.13  |- mesh__recordAuthorizer mesh__D000619 sjn
% 214.96/215.13  |- mesh__recordMaintainer mesh__D000619 ssb
% 214.96/215.13  |- rdf__type mesh__D000619sskos__Concept
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D000619 2004
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D000619 2006
% 214.96/215.13  |- skos__prefLabel mesh__D000619 Aminohydrolases
% 214.96/215.13  |- mesh__recordOriginator mesh__D000619 NLM
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D000619 2005
% 214.96/215.13  |- mesh__recordOriginator mesh__D011341 NLM
% 214.96/215.13  |- mesh__historyNote mesh__D011341
% 214.96/215.13       91%28%73%29%; was see under PHENOLS 1973-90   
% 214.96/215.13  |- mesh__dateRevised mesh__D011341 2005-06-30
% 214.96/215.13  |- skos__broader mesh__D011341smesh__D010636
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D011341 2006
% 214.96/215.13  |- skos__scopeNote mesh__D011341
% 214.96/215.13       A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p993%29%.%A%    
% 214.96/215.13  |- skos__hiddenLabel mesh__D011341 DH581
% 214.96/215.13  |- mesh__dateCreated mesh__D011341 1999-01-01
% 214.96/215.13  |- mesh__recordMaintainer mesh__D011341 lkw
% 214.96/215.13  |- mesh__recordAuthorizer mesh__D011341 sjn
% 214.96/215.13  |- mesh__publicMeSHNote mesh__D011341 91; was see under PHENOLS 1973-90   
% 214.96/215.13  |- skos__historyNote mesh__D011341 Phenols %28%1966-1972%29%
% 214.96/215.13  |- skos__altLabel mesh__D011341 Almirall Brand of Probucol
% 214.96/215.13  |- skos__hiddenLabel mesh__D011341 DH 581
% 214.96/215.13  |- mesh__dateEstablished mesh__D011341 1991-01-01
% 214.96/215.13  |- rdf__type mesh__D011341sskos__Concept
% 214.96/215.13  |- skos__altLabel mesh__D011341 Hoechst Brand of Probucol
% 214.96/215.13  |- skos__historyNote mesh__D011341
% 214.96/215.13       Anticholesteremic Agents %28%1966-1972%29%
% 214.96/215.13  |- skos__altLabel mesh__D011341 Aventis Brand of Probucol
% 214.96/215.13  |- skos__prefLabel mesh__D011341 Probucol
% 214.96/215.13  |- skos__broader mesh__D004364Q000506smesh__D004364
% 214.96/215.13  |- mesh__preferredCombination mesh__D004364Q000506smesh__D011041
% 214.96/215.13  |- rdf__type mesh__D004364Q000506smesh__CompoundConcept
% 214.96/215.13  |- skos__prefLabel mesh__D029752 Stellaria
% 214.96/215.13  |- mesh__historyNote mesh__D029752 2002   
% 214.96/215.13  |- skos__scopeNote mesh__D029752
% 214.96/215.13       A plant genus of the family CARYOPHYLLACEAE.     
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D029752 2002
% 214.96/215.13  |- mesh__dateCreated mesh__D029752 2001-07-25
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D029752 2005
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D029752 2003
% 214.96/215.13  |- skos__broader mesh__D029752smesh__D029748
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D029752 2006
% 214.96/215.13  |- mesh__publicMeSHNote mesh__D029752 2002   
% 214.96/215.13  |- skos__annotation mesh__D029752
% 214.96/215.13       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.96/215.13  |- rdf__type mesh__D029752sskos__Concept
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D029752 2004
% 214.96/215.13  |- mesh__dateEstablished mesh__D029752 2002-01-01
% 214.96/215.13  |- mesh__dateCreated mesh__D043423 2003-07-09
% 214.96/215.13  |- skos__broader mesh__D043423smesh__D043484
% 214.96/215.13  |- mesh__recordOriginator mesh__D043423 AKE
% 214.96/215.13  |- mesh__publicMeSHNote mesh__D043423
% 214.96/215.13       2004; CARBOXYPETIDASE H was indexed under CARBOXYPEPTIDASES 1982-2003%A%  
% 214.96/215.13  |- skos__scopeNote mesh__D043423
% 214.96/215.13       A ZINC-containing exopeptidase primarily found in SECRETORY VESICLES of endocrine and neuroendocrine cells. It catalyzes the cleavage of  C-terminal ARGININE or LYSINE residues from polypeptides and is active in processing precursors of PEPTIDE HORMONES and other bioactive peptides.%A%    
% 214.96/215.13  |- skos__hiddenLabel mesh__D043423
% 214.96/215.13       Carboxypeptidase, Enkephalin-Synthesizing
% 214.96/215.13  |- mesh__historyNote mesh__D043423
% 214.96/215.13       2004; use CARBOXYPEPTIDASE H %28%NM%29% 1982-2003   
% 214.96/215.13  |- skos__altLabel mesh__D043423 Enkephalin Convertase
% 214.96/215.13  |- skos__hiddenLabel mesh__D043423 Carboxypeptidase, Enkephalin-Forming
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D043423 2005
% 214.96/215.13  |- mesh__recordAuthorizer mesh__D043423 sjn
% 214.96/215.13  |- mesh__dateRevised mesh__D043423 2004-07-19
% 214.96/215.13  |- skos__altLabel mesh__D043423 Carboxypeptidase E
% 214.96/215.13  |- skos__hiddenLabel mesh__D043423 Enkephalin Forming Carboxypeptidase
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D043423 2006
% 214.96/215.13  |- rdf__type mesh__D043423sskos__Concept
% 214.96/215.13  |- skos__prefLabel mesh__D043423 Carboxypeptidase H
% 214.96/215.13  |- skos__hiddenLabel mesh__D043423 Convertase, Enkephalin
% 214.96/215.13  |- mesh__recordMaintainer mesh__D043423 jls
% 214.96/215.13  |- skos__altLabel mesh__D043423 Enkephalin-Synthesizing Carboxypeptidase
% 214.96/215.13  |- skos__broader mesh__D043423smesh__D045727
% 214.96/215.13  |- skos__altLabel mesh__D043423 Enkephalin-Forming Carboxypeptidase
% 214.96/215.13  |- skos__broader mesh__D043423smesh__D002268
% 214.96/215.13  |- skos__hiddenLabel mesh__D043423 Enkephalin Synthesizing Carboxypeptidase
% 214.96/215.13  |- mesh__dateEstablished mesh__D043423 2004-01-01
% 214.96/215.13  |- skos__historyNote mesh__D043423 Carboxypeptidases %28%1982-2003%29%
% 214.96/215.13  |- skos__scopeNote mesh__D010249
% 214.96/215.13       Inflammation of the parametrium, the connective tissue of the pelvic floor, extending from the subserous coat of the uterus laterally between the layers of the BROAD LIGAMENT.%A%    
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D010249 2006
% 214.96/215.13  |- skos__hiddenLabel mesh__D010249 Pelvic Cellulitis
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D010249 2003
% 214.96/215.13  |- skos__hiddenLabel mesh__D010249 Cellulitides, Pelvic
% 214.96/215.13  |- mesh__recordMaintainer mesh__D010249 jls
% 214.96/215.13  |- mesh__dateCreated mesh__D010249 1999-01-01
% 214.96/215.13  |- skos__hiddenLabel mesh__D010249 Parametritides
% 214.96/215.13  |- skos__annotation mesh__D010249
% 214.96/215.13       %22%pelvic%22% in X ref refers to pelvic floor   
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D010249 2004
% 214.96/215.13  |- rdf__type mesh__D010249sskos__Concept
% 214.96/215.13  |- skos__hiddenLabel mesh__D010249 Pelvic Cellulitides
% 214.96/215.13  |- skos__altLabel mesh__D010249 Cellulitis, Pelvic
% 214.96/215.13  |- skos__broader mesh__D010249smesh__D000292
% 214.96/215.13  |- skos__prefLabel mesh__D010249 Parametritis
% 214.96/215.13  |- mesh__dateRevised mesh__D010249 2004-07-30
% 214.96/215.13  |- mesh__recordOriginator mesh__D010249 NLM
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D010249 2005
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D010249 2005A
% 214.96/215.13  |- mesh__recordAuthorizer mesh__D010249 jls
% 214.96/215.13  |- mesh__historyNote mesh__D001712
% 214.96/215.13       91%28%66%29%; was see under PIPERIDINES 1966-90   
% 214.96/215.13  |- mesh__dateCreated mesh__D001712 1999-01-01
% 214.96/215.13  |- mesh__dateEstablished mesh__D001712 1991-01-01
% 214.96/215.13  |- skos__broader mesh__D001712smesh__D010880
% 214.96/215.13  |- skos__broader mesh__D001712smesh__D001643
% 214.96/215.13  |- mesh__publicMeSHNote mesh__D001712
% 214.96/215.13       91; was see under PIPERIDINES 1966-90   
% 214.96/215.13  |- mesh__recordAuthorizer mesh__D001712 sjn
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D001712 2002
% 214.96/215.13  |- skos__hiddenLabel mesh__D001712 Hydrochloride, Biperiden
% 214.96/215.13  |- mesh__recordMaintainer mesh__D001712 CCR
% 214.96/215.13  |- skos__prefLabel mesh__D001712 Biperiden
% 214.96/215.13  |- skos__scopeNote mesh__D001712
% 214.96/215.13       A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.%A%    
% 214.96/215.13  |- skos__altLabel mesh__D001712
% 214.96/215.13       alpha-Bicyclo%28%2.2.1%29%hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D001712 2006
% 214.96/215.13  |- mesh__dateRevised mesh__D001712 2000-06-21
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D001712 2001
% 214.96/215.13  |- skos__altLabel mesh__D001712 Biperidene
% 214.96/215.13  |- rdf__type mesh__D001712sskos__Concept
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D001712 2004
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D001712 2005
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D001712 2003
% 214.96/215.13  |- mesh__recordOriginator mesh__D001712 NLM
% 214.96/215.13  |- skos__historyNote mesh__D020677
% 214.96/215.13       Angioscopy/instrumentation %28%1993-1999%29%
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D020677 2002
% 214.96/215.13  |- mesh__publicMeSHNote mesh__D020677 2000   
% 214.96/215.13  |- skos__prefLabel mesh__D020677 Angioscopes
% 214.96/215.13  |- mesh__dateEstablished mesh__D020677 2000-01-01
% 214.96/215.13  |- skos__broader mesh__D020677smesh__D019723
% 214.96/215.13  |- skos__historyNote mesh__D020677 Endoscopes %28%1998-1999%29%
% 214.96/215.13  |- rdf__type mesh__D020677sskos__Concept
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D020677 2000
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D020677 2005
% 214.96/215.13  |- skos__scopeNote mesh__D020677
% 214.96/215.13       Endoscopes used for viewing the interior of blood vessels.%A%    
% 214.96/215.13  |- skos__hiddenLabel mesh__D020677 Angioscope
% 214.96/215.13  |- mesh__dateCreated mesh__D020677 1999-11-03
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D020677 2003
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D020677 2006
% 214.96/215.13  |- mesh__historyNote mesh__D020677 2000   
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D020677 2001
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D020677 2004
% 214.96/215.13  |- rdf__type mesh__D039382sskos__Concept
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D039382 2003
% 214.96/215.13  |- mesh__historyNote mesh__D039382 2003; use NUTRITION 1979-2002   
% 214.96/215.13  |- mesh__publicMeSHNote mesh__D039382 2003; see NUTRITION 1979-2002   
% 214.96/215.13  |- skos__prefLabel mesh__D039382 Maternal Nutrition
% 214.96/215.13  |- skos__annotation mesh__D039382 PRENATAL NUTRITION is also available   
% 214.96/215.13  |- mesh__dateCreated mesh__D039382 2002-07-03
% 214.96/215.13  |- skos__scopeNote mesh__D039382
% 214.96/215.13       Nutrition of a mother which affects the health of the FETUS and INFANT as well as herself.%A%    
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D039382 2006
% 214.96/215.13  |- mesh__dateEstablished mesh__D039382 2003-01-01
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D039382 2005
% 214.96/215.13  |- skos__historyNote mesh__D039382 Nutrition %28%1979-2002%29%
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D039382 2004
% 214.96/215.13  |- skos__hiddenLabel mesh__D039382 Nutrition, Maternal
% 214.96/215.13  |- skos__broader mesh__D039382smesh__D009747
% 214.96/215.13  |- mesh__dateRevised mesh__D025362 2004-07-07
% 214.96/215.13  |- skos__hiddenLabel mesh__D025362 Group A, Streptogramin
% 214.96/215.13  |- mesh__recordAuthorizer mesh__D025362 sjn
% 214.96/215.13  |- mesh__historyNote mesh__D025362 2002   
% 214.96/215.13  |- skos__altLabel mesh__D025362 Streptogramins, Group A
% 214.96/215.13  |- mesh__dateCreated mesh__D025362 2001-07-25
% 214.96/215.13  |- mesh__recordMaintainer mesh__D025362 ssb
% 214.96/215.13  |- skos__altLabel mesh__D025362 Group A Streptogramin
% 214.96/215.13  |- skos__prefLabel mesh__D025362 Streptogramin Group A
% 214.96/215.13  |- skos__broader mesh__D025362smesh__D025361
% 214.96/215.13  |- mesh__publicMeSHNote mesh__D025362 2002   
% 214.96/215.13  |- mesh__recordOriginator mesh__D025362 jmp
% 214.96/215.13  |- skos__scopeNote mesh__D025362
% 214.96/215.13       A structural subclass of streptogramins that includes molecules containing unsaturated macrocyclic lactones with approximate molecular weight of 500 KDa.%A%    
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D025362 2005
% 214.96/215.13  |- skos__annotation mesh__D025362 STREPTOGRAMIN A is also available   
% 214.96/215.13  |- skos__hiddenLabel mesh__D025362 Streptogramin, Group A
% 214.96/215.13  |- skos__hiddenLabel mesh__D025362 Group A Streptogramins
% 214.96/215.13  |- rdf__type mesh__D025362sskos__Concept
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D025362 2006
% 214.96/215.13  |- skos__historyNote mesh__D025362 Virginiamycin %28%1986-2001%29%
% 214.96/215.13  |- mesh__dateEstablished mesh__D025362 2002-01-01
% 214.96/215.13  |- skos__historyNote mesh__D019325 Methylglucosides %28%1981-1996%29%
% 214.96/215.13  |- skos__broader mesh__D019325smesh__D008757
% 214.96/215.13  |- skos__scopeNote mesh__D019325
% 214.96/215.13       A non-metabolizable glucose analogue that is not phosphorylated by hexokinase. 3-O-Methylglucose is used as a marker to assess glucose transport by evaluating its uptake within various cells and organ systems. %28%J Neurochem 1993;60%28%4%29%:1498-504%29%%A%    
% 214.96/215.13  |- skos__prefLabel mesh__D019325 3-O-Methylglucose
% 214.96/215.13  |- mesh__recordOriginator mesh__D019325 ADP
% 214.96/215.13  |- skos__hiddenLabel mesh__D019325 3 O Methyl D Glucose
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D019325 2005
% 214.96/215.13  |- mesh__dateEstablished mesh__D019325 1997-01-01
% 214.96/215.13  |- skos__altLabel mesh__D019325 3-O-Methyl-D-Glucose
% 214.96/215.13  |- skos__hiddenLabel mesh__D019325 3 O Methylglucose
% 214.96/215.13  |- mesh__onlineNote mesh__D019325
% 214.96/215.13       use 3-O-METHYLGLUCOSE %28%NM%29% to search 3-O-METHYLGLUCOSE 1981-96%A%  
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D019325 2006
% 214.96/215.13  |- mesh__historyNote mesh__D019325
% 214.96/215.13       97; was 3-O-METHYLGLUCOSE %28%NM%29% 1981-96   
% 214.96/215.13  |- mesh__publicMeSHNote mesh__D019325
% 214.96/215.13       97; 3-O-METHYLGLUCOSE was indexed under METHYLGLUCOSIDES 1981-96%A%  
% 214.96/215.13  |- mesh__dateCreated mesh__D019325 1996-06-10
% 214.96/215.13  |- mesh__recordAuthorizer mesh__D019325 sjn
% 214.96/215.13  |- mesh__recordMaintainer mesh__D019325 ssb
% 214.96/215.13  |- rdf__type mesh__D019325sskos__Concept
% 214.96/215.13  |- mesh__dateRevised mesh__D019325 2004-07-07
% 214.96/215.13  |- skos__hiddenLabel mesh__D011342 Amide, Procaine
% 214.96/215.13  |- skos__altLabel mesh__D011342 Apotex Brand of Procainamide Hydrochloride
% 214.96/215.13  |- skos__altLabel mesh__D011342
% 214.96/215.13       Apothecon Brand of Procainamide Hydrochloride
% 214.96/215.13  |- skos__altLabel mesh__D011342 Uriach Brand of Procainamide Hydrochloride
% 214.96/215.13  |- skos__altLabel mesh__D011342 Procaine Amide
% 214.96/215.13  |- skos__broader mesh__D011342smesh__D010129
% 214.96/215.13  |- skos__altLabel mesh__D011342 Pfizer Brand of Procainamide Hydrochloride
% 214.96/215.13  |- rdf__type mesh__D011342sskos__Concept
% 214.96/215.13  |- skos__broader mesh__D011342smesh__D001549
% 214.96/215.13  |- skos__prefLabel mesh__D011342 Procainamide
% 214.96/215.13  |- mesh__publicMeSHNote mesh__D011342 79; see PROCAINE AMIDE 1963-78   
% 214.96/215.13  |- mesh__recordOriginator mesh__D011342 NLM
% 214.96/215.13  |- mesh__dateRevised mesh__D011342 2005-06-30
% 214.96/215.13  |- skos__altLabel mesh__D011342 Procan SR
% 214.96/215.13  |- skos__altLabel mesh__D011342 Monarch Brand of Procainamide Hydrochloride
% 214.96/215.13  |- mesh__recordMaintainer mesh__D011342 lkw
% 214.96/215.13  |- skos__scopeNote mesh__D011342
% 214.96/215.13       A derivative of PROCAINE with less CNS action.     
% 214.96/215.13  |- mesh__historyNote mesh__D011342 79%28%63%29%   
% 214.96/215.13  |- skos__altLabel mesh__D011342
% 214.96/215.13       Parke Davis Brand of Procainamide Hydrochloride
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D011342 2006
% 214.96/215.13  |- skos__hiddenLabel mesh__D011342 Hydrochloride, Procainamide
% 214.96/215.13  |- skos__altLabel mesh__D011342 Sidmark Brand of Procainamide Hydrochloride
% 214.96/215.13  |- skos__altLabel mesh__D011342
% 214.96/215.13       Bristol-Myers Squibb Brand of Procainamide Hydrochloride
% 214.96/215.13  |- mesh__recordAuthorizer mesh__D011342 sjn
% 214.96/215.13  |- mesh__dateCreated mesh__D011342 1999-01-01
% 214.96/215.13  |- skos__scopeNote mesh__D029753
% 214.96/215.13       A plant family of the order Celastrales, subclass Rosidae, class Magnoliopsida.%A%    
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D029753 2005
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D029753 2006
% 214.96/215.13  |- mesh__publicMeSHNote mesh__D029753 2002   
% 214.96/215.13  |- skos__prefLabel mesh__D029753 Celastraceae
% 214.96/215.13  |- rdf__type mesh__D029753sskos__Concept
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D029753 2004
% 214.96/215.13  |- mesh__recordOriginator mesh__D029753 ssb
% 214.96/215.13  |- mesh__historyNote mesh__D029753 2002   
% 214.96/215.13  |- skos__annotation mesh__D029753
% 214.96/215.13       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.96/215.13  |- skos__broader mesh__D029753smesh__D019684
% 214.96/215.13  |- mesh__dateEstablished mesh__D029753 2002-01-01
% 214.96/215.13  |- mesh__recordAuthorizer mesh__D029753 sjn
% 214.96/215.13  |- mesh__dateCreated mesh__D029753 2001-07-25
% 214.96/215.13  |- mesh__dateRevised mesh__D029753 2003-07-09
% 214.96/215.13  |- mesh__recordMaintainer mesh__D029753 ssb
% 214.96/215.13  |- skos__broader mesh__D043424smesh__D045727
% 214.96/215.13  |- skos__scopeNote mesh__D043424
% 214.96/215.13       A ZINC-dependent carboxypeptidase primary found in the DIGESTIVE SYSTEM. The enzyme catalyzes the preferential cleavage of a C-terminal peptidyl-L-lysine or arginine. It was formerly classified as EC 3.4.2.2 and EC 3.4.12.3.%A%    
% 214.96/215.13  |- mesh__dateEstablished mesh__D043424 2004-01-01
% 214.96/215.13  |- mesh__historyNote mesh__D043424
% 214.96/215.13       2004; use CARBOXYPEPTIDASE B %28%NM%29% 1980-2003; for PROCARBOXYPEPTIDASE B use CARBOXYPEPTIDASE B %28%NM%29% 1985-2003%A%  
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D043424 2005
% 214.96/215.13  |- mesh__publicMeSHNote mesh__D043424
% 214.96/215.13       2004; CARBOXYPEPTIDASE B was indexed under CARBOXYPEPTIDASES 1974-2003; PROCARBOXYPEPTIDASE B was indexed under CARBOXYPEPTIDASES %26% ENZYME PRECURSORS 1985-2003%A%  
% 214.96/215.13  |- mesh__dateRevised mesh__D043424 2004-07-19
% 214.96/215.13  |- mesh__recordOriginator mesh__D043424 AKE
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D043424 2006
% 214.96/215.13  |- rdf__type mesh__D043424sskos__Concept
% 214.96/215.13  |- mesh__recordAuthorizer mesh__D043424 sjn
% 214.96/215.13  |- skos__broader mesh__D043424smesh__D002268
% 214.96/215.13  |- mesh__dateCreated mesh__D043424 2003-07-09
% 214.96/215.13  |- skos__altLabel mesh__D043424 Protaminase
% 214.96/215.13  |- skos__historyNote mesh__D043424 Carboxypeptidases %28%1974-2003%29%
% 214.96/215.13  |- skos__prefLabel mesh__D043424 Carboxypeptidase B
% 214.96/215.13  |- mesh__recordMaintainer mesh__D043424 jls
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D001713 1999
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D001713 2000
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D001713 1994
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D001713 1997
% 214.96/215.13  |- mesh__recordOriginator mesh__D001713 NLM
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D001713 1998
% 214.96/215.13  |- skos__hiddenLabel mesh__D001713 Compounds, Biphenyl
% 214.96/215.13  |- mesh__recordAuthorizer mesh__D001713 PLS
% 214.96/215.13  |- mesh__recordMaintainer mesh__D001713 TAP
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D001713 1996
% 214.96/215.13  |- skos__prefLabel mesh__D001713 Biphenyl Compounds
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D001713 2006
% 214.96/215.13  |- mesh__activeMeSHYear mesh__D001713 2002
% 214.96/215.13  |- mesh__dateRevised mesh__D001713 1992-05-08
% 214.96/215.14  |- skos__broader mesh__D001713smesh__D001555
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D001713 2004
% 214.96/215.14  |- rdf__type mesh__D001713sskos__Concept
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D001713 2005
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D001713 2003
% 214.96/215.14  |- skos__annotation mesh__D001713 DF: BIPHENYL CPDS   
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D001713 1995
% 214.96/215.14  |- mesh__dateCreated mesh__D001713 1999-01-01
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D001713 2001
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D001713 1993
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D020678 2001
% 214.96/215.14  |- mesh__dateEstablished mesh__D020678 2000-01-01
% 214.96/215.14  |- skos__prefLabel mesh__D020678 Microscopic Angioscopy
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D020678 2002
% 214.96/215.14  |- skos__historyNote mesh__D020678 Angioscopy %28%1993-1999%29%
% 214.96/215.14  |- skos__hiddenLabel mesh__D020678 Angioscopies, Microscopic
% 214.96/215.14  |- mesh__publicMeSHNote mesh__D020678 2000   
% 214.96/215.14  |- skos__altLabel mesh__D020678 Capillaroscopy
% 214.96/215.14  |- rdf__type mesh__D020678sskos__Concept
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D020678 2005
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D020678 2003
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D020678 2006
% 214.96/215.14  |- mesh__historyNote mesh__D020678 2000   
% 214.96/215.14  |- skos__broader mesh__D020678smesh__D003935
% 214.96/215.14  |- skos__hiddenLabel mesh__D020678 Microscopic Angioscopies
% 214.96/215.14  |- skos__hiddenLabel mesh__D020678 Capillaroscopies
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D020678 2004
% 214.96/215.14  |- skos__scopeNote mesh__D020678
% 214.96/215.14       The noninvasive microscopic examination of the microcirculation, commonly done in the nailbed or conjunctiva. In addition to the capillaries themselves, observations can be made of passing blood cells or intravenously injected substances. This is not the same as endoscopic examination of blood vessels %28%ANGIOSCOPY%29%.%A%    
% 214.96/215.14  |- skos__hiddenLabel mesh__D020678 Angioscopy, Microscopic
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D020678 2000
% 214.96/215.14  |- mesh__dateCreated mesh__D020678 1999-11-03
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D025363 2006
% 214.96/215.14  |- rdf__type mesh__D025363sskos__Concept
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D025363 2003
% 214.96/215.14  |- skos__scopeNote mesh__D025363
% 214.96/215.14       Technique for measuring air pressure and the rate of airflow in the nasal cavity during respiration.%A%    
% 214.96/215.14  |- mesh__publicMeSHNote mesh__D025363 2002   
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D025363 2005
% 214.96/215.14  |- skos__broader mesh__D025363smesh__D003948
% 214.96/215.14  |- mesh__dateCreated mesh__D025363 2001-07-25
% 214.96/215.14  |- skos__historyNote mesh__D025363 Manometry %28%1970-2001%29%
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D025363 2002
% 214.96/215.14  |- mesh__historyNote mesh__D025363 2002   
% 214.96/215.14  |- skos__broader mesh__D025363smesh__D008365
% 214.96/215.14  |- mesh__dateEstablished mesh__D025363 2002-01-01
% 214.96/215.14  |- skos__prefLabel mesh__D025363 Rhinomanometry
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D025363 2004
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D019326 2005
% 214.96/215.14  |- skos__scopeNote mesh__D019326
% 214.96/215.14       A metabolite of PROGESTERONE with a hydroxyl group at the 17-alpha position. It serves as an intermediate in the biosynthesis of HYDROCORTISONE and GONADAL STEROID HORMONES.%A%    
% 214.96/215.14  |- mesh__recordAuthorizer mesh__D019326 sjn
% 214.96/215.14  |- mesh__dateCreated mesh__D019326 1996-06-10
% 214.96/215.14  |- mesh__recordMaintainer mesh__D019326 lkt
% 214.96/215.14  |- skos__hiddenLabel mesh__D019326 17 Hydroxyprogesterone
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D019326 2006
% 214.96/215.14  |- mesh__publicMeSHNote mesh__D019326
% 214.96/215.14       2004; see 17-HYDROXYPROGESTERONE 1997-2003; 17-HYDROXYPROGESTERONE was indexed under HYDROXYPROGESTERONES 1982-1996, under HYDROXYPROGESTERONES 1975-1982%A%  
% 214.96/215.14  |- rdf__type mesh__D019326sskos__Concept
% 214.96/215.14  |- skos__broader mesh__D019326smesh__D006908
% 214.96/215.14  |- skos__altLabel mesh__D019326
% 214.96/215.14       17-Hydroxyprogesterone, %28%17 alpha%29%-Isomer
% 214.96/215.14  |- skos__historyNote mesh__D019326 Hydroxyprogesterones %28%1975-1996%29%
% 214.96/215.14  |- skos__hiddenLabel mesh__D019326 17 alpha Hydroxyprogesterone
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D019326 2004
% 214.96/215.14  |- mesh__dateEstablished mesh__D019326 1997-01-01
% 214.96/215.14  |- mesh__recordOriginator mesh__D019326 ADP
% 214.96/215.14  |- skos__prefLabel mesh__D019326 17-alpha-Hydroxyprogesterone
% 214.96/215.14  |- skos__altLabel mesh__D019326 17 alpha-Hydroxyprogesterone
% 214.96/215.14  |- mesh__dateRevised mesh__D019326 2003-07-09
% 214.96/215.14  |- mesh__historyNote mesh__D019326
% 214.96/215.14       2004 %28%1997%29%; use 17-HYDROXYPROGESTERONE %28%NM%29% 1982-1996, use HYDROXYPROGESTERONES 1975-1982%A%  
% 214.96/215.14  |- skos__altLabel mesh__D019326 17-Hydroxyprogesterone
% 214.96/215.14  |- skos__altLabel mesh__D011343
% 214.96/215.14       Chaix et du Marais Brand of Procaine Hydrochloride
% 214.96/215.14  |- skos__altLabel mesh__D011343 Braun Brand of Procaine Hydrochloride
% 214.96/215.14  |- rdf__type mesh__D011343sskos__Concept
% 214.96/215.14  |- mesh__recordAuthorizer mesh__D011343 sjn
% 214.96/215.14  |- skos__altLabel mesh__D011343 Jenapharm Brand of Procaine Hydrochloride
% 214.96/215.14  |- skos__altLabel mesh__D011343 Aventis Brand of Procaine Hydrochloride
% 214.96/215.14  |- skos__hiddenLabel mesh__D011343 Hydrochloride, Procaine
% 214.96/215.14  |- skos__broader mesh__D011343smesh__D010129
% 214.96/215.14  |- skos__altLabel mesh__D011343 Hevert Brand of Procaine Hydrochloride
% 214.96/215.14  |- skos__altLabel mesh__D011343 Pharmakon Brand of Procaine Hydrochloride
% 214.96/215.14  |- skos__altLabel mesh__D011343 Abbott Brand of Procaine Hydrochloride
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D011343 2006
% 214.96/215.14  |- skos__altLabel mesh__D011343 Procain R%C3%%B6%dler
% 214.96/215.14  |- skos__scopeNote mesh__D011343
% 214.96/215.14       A local anesthetic of the ester type that has a slow onset and a short duration of action. It is mainly used for infiltration anesthesia, peripheral nerve block, and spinal block. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1016%29%.%A%    
% 214.96/215.14  |- skos__altLabel mesh__D011343 Steigerwald Brand of Procaine Hydrochloride
% 214.96/215.14  |- skos__altLabel mesh__D011343 curasan Brand of Procaine Hydrochloride
% 214.96/215.14  |- skos__altLabel mesh__D011343
% 214.96/215.14       Serra Pamies Brand of Procaine Hydrochloride
% 214.96/215.14  |- skos__altLabel mesh__D011343 Loges Brand of Procaine Hydrochloride
% 214.96/215.14  |- mesh__recordOriginator mesh__D011343 NLM
% 214.96/215.14  |- skos__altLabel mesh__D011343 Lomapharm Brand of Procaine Hydrochloride
% 214.96/215.14  |- mesh__dateCreated mesh__D011343 1999-01-01
% 214.96/215.14  |- mesh__dateRevised mesh__D011343 2005-06-30
% 214.96/215.14  |- skos__prefLabel mesh__D011343 Procaine
% 214.96/215.14  |- mesh__recordMaintainer mesh__D011343 lkw
% 214.96/215.14  |- skos__hiddenLabel mesh__D005306 Polyspermic Fertilizations
% 214.96/215.14  |- mesh__onlineNote mesh__D005306
% 214.96/215.14       use FERTILIZATION to search FERTILIZATION, DELAYED %26% FERTILIZATION, POLYSPERMIC 1975-84%A%  
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D005306 2006
% 214.96/215.14  |- skos__related mesh__D005306smesh__D037022
% 214.96/215.14  |- mesh__recordOriginator mesh__D005306 NLM
% 214.96/215.14  |- mesh__historyNote mesh__D005306
% 214.96/215.14       FERTILIZATION, DELAYED %26% FERTILIZATION, POLYSPERMIC were see under FERTILIZATION 1975-84%A%  
% 214.96/215.14  |- skos__hiddenLabel mesh__D005306 Conceptions
% 214.96/215.14  |- mesh__dateCreated mesh__D005306 1999-01-01
% 214.96/215.14  |- rdf__type mesh__D005306sskos__Concept
% 214.96/215.14  |- skos__hiddenLabel mesh__D005306 Fertilizations, Polyspermic
% 214.96/215.14  |- skos__hiddenLabel mesh__D005306 Fertilizations
% 214.96/215.14  |- skos__hiddenLabel mesh__D005306 Delayed Fertilizations
% 214.96/215.14  |- skos__hiddenLabel mesh__D005306 Delayed Fertilization
% 214.96/215.14  |- skos__scopeNote mesh__D005306
% 214.96/215.14       The fusion of a spermatozoon %28%SPERMATOZOA%29% with an OVUM thus resulting in the formation of a ZYGOTE.%A%    
% 214.96/215.14  |- skos__broader mesh__D005306smesh__D012098
% 214.96/215.14  |- mesh__dateRevised mesh__D005306 2004-07-07
% 214.96/215.14  |- mesh__recordAuthorizer mesh__D005306 sjn
% 214.96/215.14  |- mesh__recordMaintainer mesh__D005306 lkt
% 214.96/215.14  |- skos__hiddenLabel mesh__D005306 Fertilizations, Delayed
% 214.96/215.14  |- skos__related mesh__D005306smesh__D015181
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D005306 2005
% 214.96/215.14  |- skos__annotation mesh__D005306
% 214.96/215.14       physiol fertilization only: FERTILIZATION IN VITRO %28%Cat E2 and E5%29% is also available%A%  
% 214.96/215.14  |- skos__hiddenLabel mesh__D005306 Polyspermic Fertilization
% 214.96/215.14  |- skos__prefLabel mesh__D005306 Fertilization
% 214.96/215.14  |- mesh__dateCreated mesh__D029754 2001-07-25
% 214.96/215.14  |- mesh__recordAuthorizer mesh__D029754 sjn
% 214.96/215.14  |- mesh__publicMeSHNote mesh__D029754
% 214.96/215.14       2002; MIRAA was indexed under PLANT EXTRACTS 1981-2002   
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D029754 2006
% 214.96/215.14  |- skos__annotation mesh__D029754
% 214.96/215.14       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.96/215.14  |- mesh__recordMaintainer mesh__D029754 ssb
% 214.96/215.14  |- rdf__type mesh__D029754sskos__Concept
% 214.96/215.14  |- skos__scopeNote mesh__D029754
% 214.96/215.14       A plant genus of the family CELASTRACEAE.  The leafy stems of khat are chewed by some individuals for stimulating effect. Members contain %28%%28%+%29%-norpseudoephedrine%29%, cathionine, cathedulin, cathinine %26% cathidine.%A%    
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D029754 2004
% 214.96/215.14  |- mesh__recordOriginator mesh__D029754 ssb
% 214.96/215.14  |- skos__altLabel mesh__D029754 Mairungi
% 214.96/215.14  |- mesh__dateEstablished mesh__D029754 2002-01-01
% 214.96/215.14  |- skos__broader mesh__D029754smesh__D029753
% 214.96/215.14  |- mesh__dateRevised mesh__D029754 2003-07-09
% 214.96/215.14  |- skos__prefLabel mesh__D029754 Catha
% 214.96/215.14  |- skos__altLabel mesh__D029754 Miraa
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D029754 2005
% 214.96/215.14  |- skos__altLabel mesh__D029754 Khat
% 214.96/215.14  |- skos__altLabel mesh__D029754 Qat Plant
% 214.96/215.14  |- mesh__historyNote mesh__D029754
% 214.96/215.14       2002; for MIRAA use MIRAA %28%NM%29% 1981-2002   
% 214.96/215.14  |- skos__altLabel mesh__D043425 NAALADase
% 214.96/215.14  |- skos__altLabel mesh__D043425 NAALADase II
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D043425 2004
% 214.96/215.14  |- skos__hiddenLabel mesh__D043425 N Acetylaspartylglutamate Peptidase
% 214.96/215.14  |- skos__hiddenLabel mesh__D043425
% 214.96/215.14       Dipeptidase, N-Acetylated-alpha-Linked Acidic
% 214.96/215.14  |- skos__altLabel mesh__D043425 FOLH1 Protein
% 214.96/215.14  |- skos__altLabel mesh__D043425 NAALADase L
% 214.96/215.14  |- skos__hiddenLabel mesh__D043425
% 214.96/215.14       Acidic Dipeptidase, N-Acetylated-alpha-Linked
% 214.96/215.14  |- skos__altLabel mesh__D043425 NAAG Peptidase
% 214.96/215.14  |- skos__historyNote mesh__D043425 Dipeptidases %28%1988-1998%29%
% 214.96/215.14  |- skos__historyNote mesh__D043425 Carboxypeptidases %28%1999-2003%29%
% 214.96/215.14  |- skos__broader mesh__D043425smesh__D002268
% 214.96/215.14  |- skos__prefLabel mesh__D043425 Glutamate Carboxypeptidase II
% 214.96/215.14  |- mesh__dateEstablished mesh__D043425 2004-01-01
% 214.96/215.14  |- mesh__publicMeSHNote mesh__D043425
% 214.96/215.14       2004; GLUTAMATE CARBOXYPEPTIDASE II was indexed under CARBOXYPEPTIDASES 1999-2003 %26% under DIPEPTIDASES 1988-1998%A%  
% 214.96/215.14  |- mesh__historyNote mesh__D043425
% 214.96/215.14       2004; use GLUTAMATE CARBOXYPEPTIDASE II %28%NM%29% 1988-2003   
% 214.96/215.14  |- skos__hiddenLabel mesh__D043425 Peptidase, N-Acetylaspartylglutamate
% 214.96/215.14  |- mesh__dateCreated mesh__D043425 2003-07-09
% 214.96/215.14  |- skos__broader mesh__D043425smesh__D045727
% 214.96/215.14  |- skos__altLabel mesh__D043425 Folate Hydrolase I
% 214.96/215.14  |- skos__altLabel mesh__D043425
% 214.96/215.14       N-Acetylated-alpha-Linked Acidic Dipeptidase
% 214.96/215.14  |- skos__altLabel mesh__D043425 N-Acetylaspartylglutamate Peptidase
% 214.96/215.14  |- mesh__recordOriginator mesh__D043425 AKE
% 214.96/215.14  |- skos__hiddenLabel mesh__D043425 Carboxypeptidase II, Glutamate
% 214.96/215.14  |- mesh__recordMaintainer mesh__D043425 jmp
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D043425 2005
% 214.96/215.14  |- skos__scopeNote mesh__D043425
% 214.96/215.14       A metallocarboxypeptidase that is predominantly expressed as a membrane-bound enzyme. It catalyzes the hydrolysis of an unsubstituted, C-terminal glutamyl residue, typically from PTEROYLPOLYGLUTAMIC ACIDS. It was formerly classified as EC 3.4.19.8.%A%    
% 214.96/215.14  |- skos__hiddenLabel mesh__D043425 Hydrolase I, Folate
% 214.96/215.14  |- skos__hiddenLabel mesh__D043425
% 214.96/215.14       N Acetylated alpha Linked Acidic Dipeptidase
% 214.96/215.14  |- mesh__recordAuthorizer mesh__D043425 sjn
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D043425 2006
% 214.96/215.14  |- rdf__type mesh__D043425sskos__Concept
% 214.96/215.14  |- skos__altLabel mesh__D001714 Psychosis, Manic-Depressive
% 214.96/215.14  |- skos__hiddenLabel mesh__D001714 Manic-Depressive Psychoses
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D001714 2003
% 214.96/215.14  |- skos__hiddenLabel mesh__D001714 Manias
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D001714 2002
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D001714 2006
% 214.96/215.14  |- skos__hiddenLabel mesh__D001714 States, Manic
% 214.96/215.14  |- mesh__recordOriginator mesh__D001714 NLM
% 214.96/215.14  |- skos__hiddenLabel mesh__D001714 Manic Disorders
% 214.96/215.14  |- skos__hiddenLabel mesh__D001714 State, Manic
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D001714 2001
% 214.96/215.14  |- skos__hiddenLabel mesh__D001714 Psychosis, Manic Depressive
% 214.96/215.14  |- skos__hiddenLabel mesh__D001714 Psychoses, Manic Depressive
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D001714 2005
% 214.96/215.14  |- skos__hiddenLabel mesh__D001714 Psychosis, Bipolar Affective
% 214.96/215.14  |- skos__hiddenLabel mesh__D001714 Manic Depressive Psychosis
% 214.96/215.14  |- mesh__publicMeSHNote mesh__D001714
% 214.96/215.14       81; see PSYCHOSES, MANIC-DEPRESSIVE 1963-80; see MANIC DISORDER 1984-97; for MANIC DISORDER see AFFECTIVE DISORDERS, PSYCHOTIC 1981-83%A%  
% 214.96/215.14  |- skos__hiddenLabel mesh__D001714 Disorder, Manic
% 214.96/215.14  |- skos__hiddenLabel mesh__D001714 Manic States
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D001714 2000
% 214.96/215.14  |- mesh__historyNote mesh__D001714 81%28%63%29%   
% 214.96/215.14  |- skos__prefLabel mesh__D001714 Bipolar Disorder
% 214.96/215.14  |- skos__altLabel mesh__D001714 Manic-Depressive Psychosis
% 214.96/215.14  |- mesh__dateCreated mesh__D001714 1999-01-01
% 214.96/215.14  |- skos__broader mesh__D001714smesh__D000341
% 214.96/215.14  |- skos__hiddenLabel mesh__D001714 Disorder, Bipolar
% 214.96/215.14  |- mesh__recordAuthorizer mesh__D001714 SJN
% 214.96/215.14  |- skos__hiddenLabel mesh__D001714 Bipolar Depression
% 214.96/215.14  |- mesh__dateRevised mesh__D001714 1997-06-20
% 214.96/215.14  |- rdf__type mesh__D001714sskos__Concept
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D001714 1999
% 214.96/215.14  |- skos__altLabel mesh__D001714 Psychoses, Manic-Depressive
% 214.96/215.14  |- skos__hiddenLabel mesh__D001714 Bipolar Disorders
% 214.96/215.14  |- mesh__recordMaintainer mesh__D001714 JLS
% 214.96/215.14  |- skos__altLabel mesh__D001714 Manic State
% 214.96/215.14  |- skos__altLabel mesh__D001714 Affective Psychosis, Bipolar
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D001714 2004
% 214.96/215.14  |- skos__scopeNote mesh__D001714
% 214.96/215.14       A major affective disorder marked by severe mood swings %28%manic or major depressive episodes%29% and a tendency to remission and recurrence.%A%    
% 214.96/215.14  |- skos__hiddenLabel mesh__D001714 Psychoses, Bipolar Affective
% 214.96/215.14  |- skos__hiddenLabel mesh__D001714 Bipolar Affective Psychosis
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D001714 1998
% 214.96/215.14  |- skos__prefLabel mesh__D020679 Arthroscopes
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D020679 2005
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D020679 2001
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D020679 2000
% 214.96/215.14  |- mesh__dateEstablished mesh__D020679 2000-01-01
% 214.96/215.14  |- skos__broader mesh__D020679smesh__D019723
% 214.96/215.14  |- skos__historyNote mesh__D020679 Endoscopes %28%1998-1999%29%
% 214.96/215.14  |- rdf__type mesh__D020679sskos__Concept
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D020679 2004
% 214.96/215.14  |- skos__hiddenLabel mesh__D020679 Arthroscope
% 214.96/215.14  |- skos__historyNote mesh__D020679
% 214.96/215.14       Arthroscopy/instrumentation %28%1982-1999%29%
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D020679 2006
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D020679 2003
% 214.96/215.14  |- mesh__publicMeSHNote mesh__D020679 2000   
% 214.96/215.14  |- skos__scopeNote mesh__D020679
% 214.96/215.14       Endoscopes for visualizing the interior of a joint.     
% 214.96/215.14  |- mesh__historyNote mesh__D020679 2000   
% 214.96/215.14  |- mesh__dateCreated mesh__D020679 1999-11-03
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D020679 2002
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D025364 2005
% 214.96/215.14  |- skos__broader mesh__D025364smesh__D014769
% 214.96/215.14  |- skos__broader mesh__D025364smesh__D025362
% 214.96/215.14  |- skos__altLabel mesh__D025364 Staphylomycin M1
% 214.96/215.14  |- mesh__dateRevised mesh__D025364 2004-07-07
% 214.96/215.14  |- skos__prefLabel mesh__D025364 Streptogramin A
% 214.96/215.14  |- mesh__recordMaintainer mesh__D025364 ssb
% 214.96/215.14  |- skos__scopeNote mesh__D025364
% 214.96/215.14       A specific streptogramin group A antibiotic produced by Streptomyces graminofaciens and other bacteria.%A%    
% 214.96/215.14  |- skos__altLabel mesh__D025364 Pristinamycin IIA
% 214.96/215.14  |- mesh__historyNote mesh__D025364
% 214.96/215.14       2002; use VIRGINIAMYCIN 1991-2001; for STAPHYLOMYCIN M1, PRISTAMYCIN IIA %26% VIRGINIAMYCIN FACTOR M1 use VIRGINIAMYCIN 1991-2001%A%  
% 214.96/215.14  |- mesh__dateCreated mesh__D025364 2001-07-25
% 214.96/215.14  |- skos__historyNote mesh__D025364 Virginiamycin %28%1991-2001%29%
% 214.96/215.14  |- mesh__publicMeSHNote mesh__D025364
% 214.96/215.14       2002; see VIRGINIAMYCIN 1991-2001; for STAPHYLOMYCIN M1, PRISTAMYCIN IIA %26% VIRGINIAMYCIN FACTOR M1 see VIRGINIAMYCIN 1991-2001%A%  
% 214.96/215.14  |- mesh__recordOriginator mesh__D025364 jmp
% 214.96/215.14  |- skos__altLabel mesh__D025364 Virginiamycin IIB
% 214.96/215.14  |- mesh__recordAuthorizer mesh__D025364 sjn
% 214.96/215.14  |- skos__altLabel mesh__D025364 Virginiamycin Factor M1
% 214.96/215.14  |- skos__altLabel mesh__D025364 Staphylomycin M
% 214.96/215.14  |- skos__altLabel mesh__D025364 Ostreogrycin G
% 214.96/215.14  |- mesh__dateEstablished mesh__D025364 2002-01-01
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D025364 2006
% 214.96/215.14  |- rdf__type mesh__D025364sskos__Concept
% 214.96/215.14  |- skos__altLabel mesh__D025364 Virginiamycin M1
% 214.96/215.14  |- skos__historyNote mesh__D019327 Copper %28%1969-1996%29%
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D019327 2006
% 214.96/215.14  |- mesh__recordOriginator mesh__D019327 ADP
% 214.96/215.14  |- skos__altLabel mesh__D019327 Cupric Sulfate
% 214.96/215.14  |- skos__broader mesh__D019327smesh__D013431
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D019327 2002
% 214.96/215.14  |- mesh__onlineNote mesh__D019327
% 214.96/215.14       use COPPER SULFATE %28%NM%29% to search COPPER SULFATE 1980-96   
% 214.96/215.14  |- rdf__type mesh__D019327sskos__Concept
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D019327 2003
% 214.96/215.14  |- mesh__dateCreated mesh__D019327 1996-06-10
% 214.96/215.14  |- mesh__dateRevised mesh__D019327 2000-06-22
% 214.96/215.14  |- mesh__recordAuthorizer mesh__D019327 sjn
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D019327 2004
% 214.96/215.14  |- skos__hiddenLabel mesh__D019327 Sulfate, Copper
% 214.96/215.14  |- skos__hiddenLabel mesh__D019327 Sulfate, Cupric
% 214.96/215.14  |- skos__prefLabel mesh__D019327 Copper Sulfate
% 214.96/215.14  |- skos__historyNote mesh__D019327 Sulfates %28%1969-1982%29%
% 214.96/215.14  |- mesh__historyNote mesh__D019327
% 214.96/215.14       97; was COPPER SULFATE %28%NM%29% 1969-96   
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D019327 2001
% 214.96/215.14  |- mesh__recordMaintainer mesh__D019327 adp
% 214.96/215.14  |- skos__scopeNote mesh__D019327
% 214.96/215.14       A sulfate salt of copper. It is a potent emetic and is used as an antidote for poisoning by phosphorus. It also can be used to prevent the growth of algae.%A%    
% 214.96/215.14  |- skos__altLabel mesh__D019327 Blue Vitriol
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D019327 2005
% 214.96/215.14  |- mesh__dateEstablished mesh__D019327 1997-01-01
% 214.96/215.14  |- mesh__publicMeSHNote mesh__D019327
% 214.96/215.14       97; COPPER SULFATE was indexed under COPPER 1969-96 %26% SULFATES 1969-82%A%  
% 214.96/215.14  |- skos__hiddenLabel mesh__D019327 Vitriol, Blue
% 214.96/215.14  |- mesh__dateRevised mesh__D011344 2000-06-22
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D011344 2005
% 214.96/215.14  |- mesh__historyNote mesh__D011344 74%28%71%29%   
% 214.96/215.14  |- mesh__recordOriginator mesh__D011344 NLM
% 214.96/215.14  |- mesh__dateEstablished mesh__D011344 1974-01-01
% 214.96/215.14  |- mesh__recordMaintainer mesh__D011344 CCR
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D011344 2004
% 214.96/215.14  |- skos__hiddenLabel mesh__D011344 Monohydrochloride, Procarbazine
% 214.96/215.14  |- skos__broader mesh__D011344smesh__D001549
% 214.96/215.14  |- rdf__type mesh__D011344sskos__Concept
% 214.96/215.14  |- skos__historyNote mesh__D011344 Benzoates %28%1966-1970%29%
% 214.96/215.14  |- skos__hiddenLabel mesh__D011344 Monohydrobromide, Procarbazine
% 214.96/215.14  |- skos__altLabel mesh__D011344 Procarbazine Monohydrochloride
% 214.96/215.14  |- mesh__publicMeSHNote mesh__D011344 74   
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D011344 2003
% 214.96/215.14  |- mesh__recordAuthorizer mesh__D011344 sjn
% 214.96/215.14  |- mesh__dateCreated mesh__D011344 1999-01-01
% 214.96/215.14  |- skos__historyNote mesh__D011344 Antineoplastic Agents %28%1966-1970%29%
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D011344 2002
% 214.96/215.14  |- skos__prefLabel mesh__D011344 Procarbazine
% 214.96/215.14  |- skos__hiddenLabel mesh__D011344 Hydrochloride, Procarbazine
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D011344 2006
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D011344 2001
% 214.96/215.14  |- skos__scopeNote mesh__D011344
% 214.96/215.14       An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone %28%the MOPP protocol%29% in the treatment of Hodgkin%27%s disease.%A%    
% 214.96/215.14  |- skos__hiddenLabel mesh__D005307 In Vitro Fertilizations
% 214.96/215.14  |- skos__annotation mesh__D005307
% 214.96/215.14       do not check the tags IN VITRO; PREGNANCY; or FEMALE   
% 214.96/215.14  |- skos__hiddenLabel mesh__D005307 Baby, Test-Tube
% 214.96/215.14  |- skos__related mesh__D005307smesh__D016471
% 214.96/215.14  |- skos__historyNote mesh__D005307 Ectogenesis %28%1975-1979%29%
% 214.96/215.14  |- skos__hiddenLabel mesh__D005307 Test Tube Fertilization
% 214.96/215.14  |- skos__hiddenLabel mesh__D005307 Test-Tube Baby
% 214.96/215.14  |- mesh__historyNote mesh__D005307
% 214.96/215.14       79; TEST-TUBE FERTILIZATION was TEST TUBE BABIES see FERTILIZATION IN VITRO Apr-Dec 1979, was TEST TUBE BABIES see ECTOGENESIS 1978-Mar 79%A%  
% 214.96/215.14  |- rdf__type mesh__D005307sskos__Concept
% 214.96/215.14  |- mesh__recordAuthorizer mesh__D005307 ags
% 214.96/215.14  |- mesh__recordMaintainer mesh__D005307 ags
% 214.96/215.14  |- mesh__dateRevised mesh__D005307 2005-07-18
% 214.96/215.14  |- skos__related mesh__D005307smesh__D004477
% 214.96/215.14  |- skos__hiddenLabel mesh__D005307 Fertilization, Test-Tube
% 214.96/215.14  |- skos__hiddenLabel mesh__D005307 Test Tube Babies
% 214.96/215.14  |- mesh__dateEstablished mesh__D005307 1979-01-01
% 214.96/215.14  |- skos__altLabel mesh__D005307 In Vitro Fertilization
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D005307 2005
% 214.96/215.14  |- skos__hiddenLabel mesh__D005307 Test-Tube Fertilizations
% 214.96/215.14  |- skos__related mesh__D005307smesh__D004624
% 214.96/215.14  |- skos__scopeNote mesh__D005307
% 214.96/215.14       An assisted reproductive technique that includes the direct handling and manipulation of oocytes and sperm to achieve fertilization in vitro.%A%    
% 214.96/215.14  |- skos__historyNote mesh__D005307 Fertilization %28%1966-1979%29%
% 214.96/215.14  |- mesh__dateCreated mesh__D005307 1978-11-22
% 214.96/215.14  |- mesh__recordOriginator mesh__D005307 SMH
% 214.96/215.14  |- skos__altLabel mesh__D005307 Fertilizations in Vitro
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D005307 2006A
% 214.96/215.14  |- skos__broader mesh__D005307smesh__D027724
% 214.96/215.14  |- skos__hiddenLabel mesh__D005307 Fertilizations, Test-Tube
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D005307 2006
% 214.96/215.14  |- skos__hiddenLabel mesh__D005307 Babies, Test-Tube
% 214.96/215.14  |- skos__altLabel mesh__D005307 Test-Tube Fertilization
% 214.96/215.14  |- skos__prefLabel mesh__D005307 Fertilization in Vitro
% 214.96/215.14  |- mesh__onlineNote mesh__D005307
% 214.96/215.14       use FERTILIZATION IN VITRO to search TEST TUBE BABIES Apr 1979, use ECTOGENESIS 1978-Mar 79%A%  
% 214.96/215.14  |- mesh__publicMeSHNote mesh__D005307
% 214.96/215.14       Apr 79; TEST-TUBE FERTILIZATION was TEST TUBE BABIES see FERTILIZATION IN VITRO Apr-Dec 1979, was TEST TUBE BABIES see  ECTOGENESIS 1978-Mar 79%A%  
% 214.96/215.14  |- mesh__dateCreated mesh__D029755 2001-07-25
% 214.96/215.14  |- mesh__historyNote mesh__D029755 2002   
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D029755 2004
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D029755 2006
% 214.96/215.14  |- skos__broader mesh__D029755smesh__D029753
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D029755 2003
% 214.96/215.14  |- rdf__type mesh__D029755sskos__Concept
% 214.96/215.14  |- skos__prefLabel mesh__D029755 Maytenus
% 214.96/215.14  |- mesh__dateEstablished mesh__D029755 2002-01-01
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D029755 2005
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D029755 2002
% 214.96/215.14  |- skos__annotation mesh__D029755
% 214.96/215.14       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.96/215.14  |- mesh__publicMeSHNote mesh__D029755 2002   
% 214.96/215.14  |- skos__scopeNote mesh__D029755
% 214.96/215.14       A plant genus of the family CELASTRACEAE.     
% 214.96/215.14  |- skos__hiddenLabel mesh__D015735 R 38486
% 214.96/215.14  |- skos__altLabel mesh__D015735 R38486
% 214.96/215.14  |- skos__altLabel mesh__D015735 Exelgyn Brand of Mifepristone
% 214.96/215.14  |- mesh__recordMaintainer mesh__D015735 CCR
% 214.96/215.14  |- mesh__publicMeSHNote mesh__D015735 90   
% 214.96/215.14  |- skos__hiddenLabel mesh__D015735 Mifepristone Exelgyn Brand
% 214.96/215.14  |- mesh__dateCreated mesh__D015735 1989-09-06
% 214.96/215.14  |- mesh__recordAuthorizer mesh__D015735 sjn
% 214.96/215.14  |- mesh__dateEstablished mesh__D015735 1990-01-01
% 214.96/215.14  |- skos__hiddenLabel mesh__D015735 RU 38486
% 214.96/215.14  |- skos__hiddenLabel mesh__D015735 RU486
% 214.96/215.14  |- skos__altLabel mesh__D015735 RU-38486
% 214.96/215.14  |- skos__altLabel mesh__D015735 Contragest Brand of Mifepristone
% 214.96/215.14  |- skos__altLabel mesh__D015735 RU-486
% 214.96/215.14  |- skos__prefLabel mesh__D015735 Mifepristone
% 214.96/215.14  |- skos__historyNote mesh__D015735
% 214.96/215.14       Abortifacient Agents, Steroidal %28%1975-1989%29%
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D015735 2006
% 214.96/215.14  |- mesh__historyNote mesh__D015735 90   
% 214.96/215.14  |- skos__hiddenLabel mesh__D015735 Mifepristone Danco Brand
% 214.96/215.14  |- skos__hiddenLabel mesh__D015735 Mifepristone Contragest Brand
% 214.96/215.14  |- skos__altLabel mesh__D015735 Mif%C3%%A9%gyne
% 214.96/215.14  |- skos__broader mesh__D015735smesh__D004963
% 214.96/215.14  |- skos__scopeNote mesh__D015735
% 214.96/215.14       A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary CUSHING SYNDROME.%A%    
% 214.96/215.14  |- skos__historyNote mesh__D015735
% 214.96/215.14       Glucocorticoids/antagonists %26% inhibitors %28%1967-1989%29%
% 214.96/215.14  |- mesh__dateRevised mesh__D015735 2005-06-30
% 214.96/215.14  |- skos__historyNote mesh__D015735 Estrenes %28%1975-1989%29%
% 214.96/215.14  |- skos__altLabel mesh__D015735 Danco Brand of Mifepristone
% 214.96/215.14  |- skos__hiddenLabel mesh__D015735 ZK 98296
% 214.96/215.14  |- rdf__type mesh__D015735sskos__Concept
% 214.96/215.14  |- skos__hiddenLabel mesh__D015735 RU38486
% 214.96/215.14  |- skos__historyNote mesh__D015735
% 214.96/215.14       Contraceptives, Oral, Synthetic %28%1975-1989%29%
% 214.96/215.14  |- skos__altLabel mesh__D015735 ZK98296
% 214.96/215.14  |- mesh__recordOriginator mesh__D015735 RLS
% 214.96/215.14  |- skos__hiddenLabel mesh__D015735 RU 486
% 214.96/215.14  |- skos__scopeNote mesh__D001715
% 214.96/215.14       Diseases of birds not considered poultry, therefore usually found in zoos, parks, and the wild. The concept is differentiated from POULTRY DISEASES which is for birds raised as a source of meat or eggs for human consumption, and usually found in barnyards, hatcheries, etc.%A%    
% 214.96/215.14  |- skos__hiddenLabel mesh__D001715 Bird Disease
% 214.96/215.14  |- mesh__recordAuthorizer mesh__D001715 sjn
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D001715 2005
% 214.96/215.14  |- mesh__dateRevised mesh__D001715 2004-07-13
% 214.96/215.14  |- mesh__activeMeSHYear mesh__D001715 2006
% 214.96/215.14  |- mesh__dateCreated mesh__D001715 1999-01-01
% 214.96/215.14  |- rdf__type mesh__D001715sskos__Concept
% 214.96/215.14  |- skos__altLabel mesh__D001715 Avian Diseases
% 214.96/215.14  |- skos__broader mesh__D001715smesh__D000820
% 214.96/215.14  |- skos__hiddenLabel mesh__D001715 Avian Disease
% 214.96/215.14  |- skos__hiddenLabel mesh__D001715 Diseases, Avian
% 214.96/215.14  |- skos__hiddenLabel mesh__D001715 Disease, Bird
% 214.96/215.15  |- skos__hiddenLabel mesh__D001715 Disease, Avian
% 214.96/215.15  |- mesh__recordMaintainer mesh__D001715 sjn
% 214.96/215.15  |- mesh__recordOriginator mesh__D001715 NLM
% 214.96/215.15  |- skos__prefLabel mesh__D001715 Bird Diseases
% 214.96/215.15  |- skos__hiddenLabel mesh__D001715 Diseases, Bird
% 214.96/215.15  |- skos__annotation mesh__D001715
% 214.96/215.15       IM GEN or unspecified; coord IM with specific dis /vet %28%IM%29% or specific bird dis %28%IM%29%; coord IM with specific bird %28%IM%29%; for abnormalities or injuries, index under BIRDS /abnorm or BIRDS /inj; don%27%t forget also BIRDS %28%NIM%29% if no specific bird is indexed; also check tag ANIMALS; differentiate from POULTRY DISEASES on basis of distinction between BIRDS %26% POULTRY shown under BIRDS; DF: BIRD DIS%A%  
% 214.96/215.15  |- skos__hiddenLabel mesh__D006400 Hematocrits
% 214.96/215.15  |- skos__hiddenLabel mesh__D006400 Volume, Packed Red-Cell
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D006400 2006
% 214.96/215.15  |- skos__hiddenLabel mesh__D006400 Erythrocyte Volumes, Packed
% 214.96/215.15  |- mesh__dateRevised mesh__D006400 2003-07-09
% 214.96/215.15  |- skos__hiddenLabel mesh__D006400 Volumes, Packed Red-Cell
% 214.96/215.15  |- skos__hiddenLabel mesh__D006400 Volume, Packed Erythrocyte
% 214.96/215.15  |- skos__altLabel mesh__D006400 Packed Red-Cell Volume
% 214.96/215.15  |- mesh__recordOriginator mesh__D006400 NLM
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D006400 2004
% 214.96/215.15  |- mesh__dateCreated mesh__D006400 1999-01-01
% 214.96/215.15  |- skos__altLabel mesh__D006400 Erythrocyte Volume, Packed
% 214.96/215.15  |- skos__broader mesh__D006400smesh__D045122
% 214.96/215.15  |- skos__broader mesh__D006400smesh__D006403
% 214.96/215.15  |- skos__hiddenLabel mesh__D006400 Packed Red-Cell Volumes
% 214.96/215.15  |- skos__hiddenLabel mesh__D006400 Red-Cell Volumes, Packed
% 214.96/215.15  |- skos__scopeNote mesh__D006400
% 214.96/215.15       The volume of packed RED BLOOD CELLS in a blood specimen. The volume is measured by centrifugation in a tube with graduated markings, or with automated blood cell counters. It is an indicator of erythrocyte status in disease. For example, ANEMIA shows a low value; POLYCYTHEMIA, a high value.%A%    
% 214.96/215.15  |- skos__hiddenLabel mesh__D006400 Packed Erythrocyte Volume
% 214.96/215.15  |- skos__annotation mesh__D006400 usually NIM   
% 214.96/215.15  |- skos__hiddenLabel mesh__D006400 Packed Erythrocyte Volumes
% 214.96/215.15  |- rdf__type mesh__D006400sskos__Concept
% 214.96/215.15  |- skos__hiddenLabel mesh__D006400 Volumes, Packed Erythrocyte
% 214.96/215.15  |- mesh__recordAuthorizer mesh__D006400 sjn
% 214.96/215.15  |- skos__prefLabel mesh__D006400 Hematocrit
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D006400 2005
% 214.96/215.15  |- skos__hiddenLabel mesh__D006400 Red-Cell Volume, Packed
% 214.96/215.15  |- skos__hiddenLabel mesh__D006400 Packed Red Cell Volume
% 214.96/215.15  |- mesh__recordMaintainer mesh__D006400 nns
% 214.96/215.15  |- mesh__publicMeSHNote mesh__D019328
% 214.96/215.15       97; BUTHIONINE SULFOXIMINE was indexed under METHIONINE SULFOXIMINE 1979-96%A%  
% 214.96/215.15  |- mesh__historyNote mesh__D019328
% 214.96/215.15       97: was BUTHIONINE SULFOXIMINE %28%NM%29% 1979-96   
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D019328 2006
% 214.96/215.15  |- mesh__recordMaintainer mesh__D019328 ssb
% 214.96/215.15  |- mesh__recordOriginator mesh__D019328 ADP
% 214.96/215.15  |- rdf__type mesh__D019328sskos__Concept
% 214.96/215.15  |- skos__prefLabel mesh__D019328 Buthionine Sulfoximine
% 214.96/215.15  |- mesh__dateRevised mesh__D019328 2005-06-30
% 214.96/215.15  |- skos__historyNote mesh__D019328 Methionine Sulfoximine %28%1979-1996%29%
% 214.96/215.15  |- skos__hiddenLabel mesh__D019328 Sulfoximine, Buthionine
% 214.96/215.15  |- skos__scopeNote mesh__D019328
% 214.96/215.15       A synthetic amino acid that depletes glutathione by irreversibly inhibiting gamma-glutamylcysteine synthetase. Inhibition of this enzyme is a critical step in glutathione biosynthesis. It has been shown to inhibit the proliferative response in human T-lymphocytes and inhibit macrophage activation. %28%J Biol Chem 1995;270%28%33%29%:1945-7%29%%A%    
% 214.96/215.15  |- mesh__onlineNote mesh__D019328
% 214.96/215.15       use BUTHIONINE SULFOXIMINE %28%NM%29% to search BUTHIONINE SULFOXIMINE 1980-96%A%  
% 214.96/215.15  |- skos__broader mesh__D019328smesh__D008717
% 214.96/215.15  |- mesh__dateEstablished mesh__D019328 1997-01-01
% 214.96/215.15  |- mesh__recordAuthorizer mesh__D019328 sjn
% 214.96/215.15  |- mesh__dateCreated mesh__D019328 1996-06-10
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 LF 178
% 214.96/215.15  |- skos__altLabel mesh__D011345 Azupharma Brand of Procetofen
% 214.96/215.15  |- skos__historyNote mesh__D011345 Propionates %28%1966-1979%29%
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 Nu Fenofibrate
% 214.96/215.15  |- skos__altLabel mesh__D011345 Q-Pharm Brand of Procetofen
% 214.96/215.15  |- skos__altLabel mesh__D011345 Pharmascience Brand of Procetofen
% 214.96/215.15  |- mesh__publicMeSHNote mesh__D011345
% 214.96/215.15       91; was see under PROPIONATES 1980-90   
% 214.96/215.15  |- skos__altLabel mesh__D011345 Heumann Brand of Procetofen
% 214.96/215.15  |- skos__altLabel mesh__D011345 Apotex Brand of Procetofen
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 MTW Fenofibrat
% 214.96/215.15  |- skos__altLabel mesh__D011345 Aliud Brand of Procetofen
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 Stada, Fenofibrat
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 Heumann, Fenofibrat
% 214.96/215.15  |- skos__altLabel mesh__D011345 Merck dura Brand of Procetofen
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 Gen Fenofibrate
% 214.96/215.15  |- skos__altLabel mesh__D011345 betapharm Brand of Procetofen
% 214.96/215.15  |- skos__altLabel mesh__D011345 Supralip
% 214.96/215.15  |- mesh__recordOriginator mesh__D011345 RLS
% 214.96/215.15  |- skos__altLabel mesh__D011345 Schering-Plough Brand of Procetofen
% 214.96/215.15  |- skos__altLabel mesh__D011345 Procetofene
% 214.96/215.15  |- skos__prefLabel mesh__D011345 Procetofen
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 PMS Fenofibrate Micro
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 Novo Fenofibrate
% 214.96/215.15  |- skos__altLabel mesh__D011345 Fenofibrat FPh
% 214.96/215.15  |- mesh__dateEstablished mesh__D011345 1991-01-01
% 214.96/215.15  |- skos__broader mesh__D011345smesh__D002995
% 214.96/215.15  |- skos__altLabel mesh__D011345 Bouchara Brand of Procetofen
% 214.96/215.15  |- mesh__historyNote mesh__D011345
% 214.96/215.15       91%28%80%29%; was see under PROPIONATES 1980-90   
% 214.96/215.15  |- skos__altLabel mesh__D011345 Knoll Brand of Procetofen
% 214.96/215.15  |- skos__altLabel mesh__D011345 ct-Arzneimittel Brand of Procetofen
% 214.96/215.15  |- skos__altLabel mesh__D011345 F%C3%%A9%nofibrate Debat
% 214.96/215.15  |- mesh__dateRevised mesh__D011345 2005-06-30
% 214.96/215.15  |- skos__altLabel mesh__D011345 Stadapharm Brand of Procetofen
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 Debat, F%C3%%A9%nofibrate
% 214.96/215.15  |- skos__altLabel mesh__D011345 Fenofibrate
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 Nu Pharm Brand of Procetofen
% 214.96/215.15  |- skos__altLabel mesh__D011345 Secalip
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 Apo Fenofibrate
% 214.96/215.15  |- skos__scopeNote mesh__D011345
% 214.96/215.15       An antilipemic agent which reduces both CHOLESTEROL and TRIGLYCERIDES in the blood.%A%    
% 214.96/215.15  |- rdf__type mesh__D011345sskos__Concept
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 Q Pharm Brand of Procetofen
% 214.96/215.15  |- skos__altLabel mesh__D011345 Lipidil
% 214.96/215.15  |- mesh__recordAuthorizer mesh__D011345 sjn
% 214.96/215.15  |- mesh__dateCreated mesh__D011345 1979-05-23
% 214.96/215.15  |- skos__altLabel mesh__D011345 GNR-Pharma Brand of Procetofen
% 214.96/215.15  |- mesh__recordMaintainer mesh__D011345 ssb
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 LF178
% 214.96/215.15  |- skos__altLabel mesh__D011345 Hexal Brand of Procetofen
% 214.96/215.15  |- skos__historyNote mesh__D011345 Antilipemic Agents %28%1966-1979%29%
% 214.96/215.15  |- skos__altLabel mesh__D011345 ratiopharm Brand of Procetofen
% 214.96/215.15  |- skos__altLabel mesh__D011345 Novopharm Brand of Procetofen
% 214.96/215.15  |- skos__altLabel mesh__D011345 Reliant Brand of Procetofen
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 Apo Feno Micro
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 Procetofen Reliant Brand
% 214.96/215.15  |- skos__altLabel mesh__D011345 Apo-Fenofibrate
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 Procetofen, Antara Micronized
% 214.96/215.15  |- skos__altLabel mesh__D011345 United Drug Brand of Procetofen
% 214.96/215.15  |- skos__altLabel mesh__D011345 Normalip
% 214.96/215.15  |- skos__altLabel mesh__D011345 Lichtenstein Brand of Procetofen
% 214.96/215.15  |- skos__altLabel mesh__D011345 Nu-Pharm Brand of Procetofen
% 214.96/215.15  |- skos__broader mesh__D011345smesh__D011422
% 214.96/215.15  |- skos__altLabel mesh__D011345 Lipantil
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 Lipidil Ter
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 Fenofibrat ratiopharm
% 214.96/215.15  |- skos__altLabel mesh__D011345 Abbott Brand of Procetofen
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 AZU, Fenofibrat
% 214.96/215.15  |- skos__altLabel mesh__D011345 Genpharm Brand of Procetofen
% 214.96/215.15  |- skos__altLabel mesh__D011345 Lipidil-Ter
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 GNR Pharma Brand of Procetofen
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 Schering Plough Brand of Procetofen
% 214.96/215.15  |- skos__altLabel mesh__D011345 Phenofibrate
% 214.96/215.15  |- skos__altLabel mesh__D011345 Novartis Brand of Procetofen
% 214.96/215.15  |- skos__altLabel mesh__D011345 Gate Brand of Procetofen
% 214.96/215.15  |- skos__altLabel mesh__D011345 Anto Brand of Procetofen
% 214.96/215.15  |- skos__altLabel mesh__D011345 Fournier Brand of Procetofen
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 Micronized Procetofen, Antara
% 214.96/215.15  |- skos__altLabel mesh__D011345 MTW Brand of Procetofen
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 ct Arzneimittel Brand of Procetofen
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D011345 2006
% 214.96/215.15  |- skos__altLabel mesh__D011345 AbZ Brand of Procetofen
% 214.96/215.15  |- skos__hiddenLabel mesh__D011345 Hexal, Fenofibrat
% 214.96/215.15  |- skos__prefLabel mesh__D005308 Fertilizers
% 214.96/215.15  |- mesh__recordMaintainer mesh__D005308 ssb
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D005308 2005
% 214.96/215.15  |- mesh__dateRevised mesh__D005308 2003-07-09
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D005308 2004
% 214.96/215.15  |- mesh__recordAuthorizer mesh__D005308 sjn
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D005308 2006
% 214.96/215.15  |- skos__scopeNote mesh__D005308
% 214.96/215.15       Substances or mixtures that are added to the soil to supply nutrients or to make available nutrients already present in the soil, in order to increase plant growth and productivity.%A%    
% 214.96/215.15  |- mesh__recordOriginator mesh__D005308 NLM
% 214.96/215.15  |- skos__broader mesh__D005308smesh__D016573
% 214.96/215.15  |- mesh__dateCreated mesh__D005308 1999-01-01
% 214.96/215.15  |- rdf__type mesh__D005308sskos__Concept
% 214.96/215.15  |- skos__altLabel mesh__D016030 Transplantation, Renal
% 214.96/215.15  |- skos__prefLabel mesh__D016030 Kidney Transplantation
% 214.96/215.15  |- skos__historyNote mesh__D016030 Kidney/transplantation %28%1966-1989%29%
% 214.96/215.15  |- skos__altLabel mesh__D016030 Grafting, Kidney
% 214.96/215.15  |- skos__altLabel mesh__D016030 Renal Transplantation
% 214.96/215.15  |- mesh__dateEstablished mesh__D016030 1990-01-01
% 214.96/215.15  |- mesh__dateRevised mesh__D016030 2004-07-13
% 214.96/215.15  |- mesh__publicMeSHNote mesh__D016030
% 214.96/215.15       90; was KIDNEY/transplantation 1966-89; was heading 1963-65%A%  
% 214.96/215.15  |- skos__broader mesh__D016030smesh__D017582
% 214.96/215.15  |- skos__broader mesh__D016030smesh__D016377
% 214.96/215.15  |- rdf__type mesh__D016030sskos__Concept
% 214.96/215.15  |- skos__annotation mesh__D016030
% 214.96/215.15       do not use /util except by MeSH definition; do not coord with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed%A%  
% 214.96/215.15  |- mesh__recordAuthorizer mesh__D016030 sjn
% 214.96/215.15  |- skos__broader mesh__D016030smesh__D013520
% 214.96/215.15  |- skos__hiddenLabel mesh__D016030 Renal Transplantations
% 214.96/215.15  |- skos__scopeNote mesh__D016030
% 214.96/215.15       The transference of a kidney from one human or animal to another.%A%    
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D016030 2006
% 214.96/215.15  |- skos__hiddenLabel mesh__D016030 Kidney Transplantations
% 214.96/215.15  |- skos__hiddenLabel mesh__D016030 Kidney Grafting
% 214.96/215.15  |- mesh__recordMaintainer mesh__D016030 sjn
% 214.96/215.15  |- mesh__historyNote mesh__D016030
% 214.96/215.15       90; was KIDNEY/transplantation 1966-89; was heading 1963-65%A%  
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D016030 2005
% 214.96/215.15  |- mesh__dateCreated mesh__D016030 1989-05-25
% 214.96/215.15  |- mesh__recordOriginator mesh__D016030 PXP
% 214.96/215.15  |- skos__hiddenLabel mesh__D016030 Transplantations, Renal
% 214.96/215.15  |- skos__hiddenLabel mesh__D016030 Transplantations, Kidney
% 214.96/215.15  |- skos__altLabel mesh__D016030 Transplantation, Kidney
% 214.96/215.15  |- skos__broader mesh__D002010smesh__D001210
% 214.96/215.15  |- rdf__type mesh__D002010sskos__Concept
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D002010 2001
% 214.96/215.15  |- mesh__recordAuthorizer mesh__D002010 PLS
% 214.96/215.15  |- skos__scopeNote mesh__D002010
% 214.96/215.15       An independent sultanate on the northeast coast of Borneo. Its chief products are oil and natural gas. Its name is Hindi, coming from the Sanskrit bhumi, land or region. It gave its name Brunei to Borneo. %28%From Webster%27%s New Geographical Dictionary, 1988, p183 %26% Room, Brewer%27%s Dictionary of Names, 1992, p82%29%%A%    
% 214.96/215.15  |- mesh__dateEstablished mesh__D002010 1975-01-01
% 214.96/215.15  |- mesh__recordMaintainer mesh__D002010 TGC
% 214.96/215.15  |- skos__prefLabel mesh__D002010 Brunei
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D002010 2000
% 214.96/215.15  |- skos__annotation mesh__D002010
% 214.96/215.15       a sultanate on the northeast coast of Borneo   
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D002010 2004
% 214.96/215.15  |- mesh__dateRevised mesh__D002010 1995-02-17
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D002010 2006
% 214.96/215.15  |- mesh__dateCreated mesh__D002010 1974-11-11
% 214.96/215.15  |- mesh__recordOriginator mesh__D002010 NLM
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D002010 1997
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D002010 2003
% 214.96/215.15  |- mesh__historyNote mesh__D002010 75   
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D002010 1999
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D002010 2005
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D002010 1996
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D002010 1998
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D002010 2002
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D029756 2004
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D029756 2006
% 214.96/215.15  |- skos__broader mesh__D029756smesh__D029753
% 214.96/215.15  |- rdf__type mesh__D029756sskos__Concept
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D029756 2003
% 214.96/215.15  |- skos__annotation mesh__D029756
% 214.96/215.15       distinguish from BURNINGBUSH %28%BASSIA%29%; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.96/215.15  |- mesh__dateCreated mesh__D029756 2001-07-25
% 214.96/215.15  |- mesh__dateEstablished mesh__D029756 2002-01-01
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D029756 2005
% 214.96/215.15  |- mesh__historyNote mesh__D029756 2002   
% 214.96/215.15  |- skos__altLabel mesh__D029756 Burningbush %28%Euonymus%29%
% 214.96/215.15  |- mesh__publicMeSHNote mesh__D029756 2002   
% 214.96/215.15  |- skos__prefLabel mesh__D029756 Euonymus
% 214.96/215.15  |- skos__scopeNote mesh__D029756
% 214.96/215.15       A plant genus of the family CELASTRACEAE.     
% 214.96/215.15  |- skos__altLabel mesh__D029756 Spindletree
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D029756 2002
% 214.96/215.15  |- skos__altLabel mesh__D015736 Alpharma Brand of Felodipine
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D015736 2006
% 214.96/215.15  |- mesh__dateEstablished mesh__D015736 1990-01-01
% 214.96/215.15  |- skos__altLabel mesh__D015736 BC Brand of Felodipine
% 214.96/215.15  |- skos__hiddenLabel mesh__D015736 ct Arzneimittel Brand of Felodipine
% 214.96/215.15  |- skos__altLabel mesh__D015736 Flodil
% 214.96/215.15  |- skos__altLabel mesh__D015736 Azupharma Brand of Felodipine
% 214.96/215.15  |- skos__altLabel mesh__D015736 Hexal Brand of Felodipine
% 214.96/215.15  |- skos__hiddenLabel mesh__D015736 H 15482
% 214.96/215.15  |- skos__altLabel mesh__D015736 Pharmacia Spain Brand of Felodipine
% 214.96/215.15  |- skos__altLabel mesh__D015736 Aventis Brand of Felodipine
% 214.96/215.15  |- mesh__recordAuthorizer mesh__D015736 sjn
% 214.96/215.15  |- skos__altLabel mesh__D015736 Stadapharm Brand of Felodipine
% 214.96/215.15  |- skos__altLabel mesh__D015736 TheraPharm Brand of Felodipine
% 214.96/215.15  |- skos__hiddenLabel mesh__D015736 Heumann, Felodipin
% 214.96/215.15  |- skos__hiddenLabel mesh__D015736 Felo Puren
% 214.96/215.15  |- skos__altLabel mesh__D015736 ratiopharm Brand of Felodipine
% 214.96/215.15  |- skos__scopeNote mesh__D015736
% 214.96/215.15       A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.%A%    
% 214.96/215.15  |- skos__altLabel mesh__D015736 ct-Arzneimittel Brand of Felodipine
% 214.96/215.15  |- skos__historyNote mesh__D015736 Pyridines %28%1966-1980%29%
% 214.96/215.15  |- skos__altLabel mesh__D015736 Heumann Brand of Felodipine
% 214.96/215.15  |- skos__altLabel mesh__D015736 betapharm Brand of Felodipine
% 214.96/215.15  |- skos__altLabel mesh__D015736 Promed Brand of Felodipine
% 214.96/215.15  |- skos__historyNote mesh__D015736
% 214.96/215.15       Nifedipine/analogs %26% derivatives %28%1981-1986%29%
% 214.96/215.15  |- skos__hiddenLabel mesh__D015736 H 154 82
% 214.96/215.15  |- skos__hiddenLabel mesh__D015736 Felodipin ratiopharm
% 214.96/215.15  |- skos__historyNote mesh__D015736
% 214.96/215.15       Nitrendipine/analogs %26% derivatives %28%1987-1989%29%
% 214.96/215.15  |- skos__altLabel mesh__D015736 W%C3%%B6%rwag Brand of Felodipine
% 214.96/215.15  |- skos__altLabel mesh__D015736 Merck dura Brand of Felodipine
% 214.96/215.15  |- skos__prefLabel mesh__D015736 Felodipine
% 214.96/215.15  |- skos__altLabel mesh__D015736 Alphapharm Brand of Felodipine
% 214.96/215.15  |- skos__altLabel mesh__D015736 1A Brand of Felodipine
% 214.96/215.15  |- mesh__recordMaintainer mesh__D015736 CCR
% 214.96/215.15  |- skos__altLabel mesh__D015736 Astra Brand of Felodipine
% 214.96/215.15  |- skos__altLabel mesh__D015736 Munobal
% 214.96/215.15  |- skos__altLabel mesh__D015736 Modip
% 214.96/215.15  |- skos__altLabel mesh__D015736 Hoechst Brand of Felodipine
% 214.96/215.15  |- mesh__historyNote mesh__D015736 90   
% 214.96/215.15  |- skos__altLabel mesh__D015736 AstraZeneca Brand of Felodipine
% 214.96/215.15  |- skos__altLabel mesh__D015736 Aliud Brand of Felodipine
% 214.96/215.15  |- mesh__dateRevised mesh__D015736 2005-06-30
% 214.96/215.15  |- mesh__publicMeSHNote mesh__D015736 90   
% 214.96/215.15  |- rdf__type mesh__D015736sskos__Concept
% 214.96/215.15  |- skos__altLabel mesh__D015736 AbZ Brand of Felodipine
% 214.96/215.15  |- skos__altLabel mesh__D015736 Pharmaceutica Astra Brand of Felodipine
% 214.96/215.15  |- mesh__dateCreated mesh__D015736 1989-09-06
% 214.96/215.15  |- mesh__recordOriginator mesh__D015736 RLS
% 214.96/215.15  |- skos__broader mesh__D015736smesh__D004095
% 214.96/215.15  |- skos__hiddenLabel mesh__D001716 Bird Fancier%27%s Lungs
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D001716 2002
% 214.96/215.15  |- skos__scopeNote mesh__D001716
% 214.96/215.15       A respiratory disorder due to an acquired hypersensitivity to the dust of bird droppings.%A%    
% 214.96/215.15  |- skos__broader mesh__D001716smesh__D000542
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D001716 1995
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D001716 1998
% 214.96/215.15  |- skos__altLabel mesh__D001716 Pneumonitis, Hypersensitivity, Avian
% 214.96/215.15  |- skos__hiddenLabel mesh__D001716 Hypersensitivity Pneumonitides, Avian
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D001716 2003
% 214.96/215.15  |- skos__historyNote mesh__D001716
% 214.96/215.15       Respiratory Hypersensitivity %28%1966-1976%29%
% 214.96/215.15  |- skos__hiddenLabel mesh__D001716 Pigeon Breeders Lung
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D001716 2001
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D001716 2006
% 214.96/215.15  |- skos__hiddenLabel mesh__D001716 Avian Hypersensitivity Pneumonitides
% 214.96/215.15  |- mesh__recordAuthorizer mesh__D001716 PLS
% 214.96/215.15  |- skos__altLabel mesh__D001716 Avian Hypersensitivity Pneumonitis
% 214.96/215.15  |- skos__hiddenLabel mesh__D001716 Bird Fancier Lung
% 214.96/215.15  |- skos__historyNote mesh__D001716 Farmer%27%s Lung %28%1966-1976%29%
% 214.96/215.15  |- skos__hiddenLabel mesh__D001716 Budgerigar Fancier Lung
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D001716 2000
% 214.96/215.15  |- mesh__historyNote mesh__D001716
% 214.96/215.15       91%28%77%29%; was see under ALVEOLITIS, EXTRINSIC ALLERGIC 1977-90%A%  
% 214.96/215.15  |- skos__hiddenLabel mesh__D001716 Lung, Budgerigar Fancier%27%s
% 214.96/215.15  |- skos__hiddenLabel mesh__D001716 Lung, Bird Fancier%27%s
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D001716 2005
% 214.96/215.15  |- skos__hiddenLabel mesh__D001716 Bird Fanciers Lung
% 214.96/215.15  |- skos__altLabel mesh__D001716 Pneumonitis, Avian Hypersensitivity
% 214.96/215.15  |- skos__broader mesh__D001716smesh__D009784
% 214.96/215.15  |- skos__altLabel mesh__D001716 Hypersensitivity Pneumonitis, Avian
% 214.96/215.15  |- skos__hiddenLabel mesh__D001716 Pigeon Breeder Lung
% 214.96/215.15  |- mesh__publicMeSHNote mesh__D001716
% 214.96/215.15       91; was see under ALVEOLITIS, EXTRINSIC ALLERGIC 1977-90   
% 214.96/215.15  |- skos__hiddenLabel mesh__D001716 Pigeon Breeder%27%s Lungs
% 214.96/215.15  |- mesh__dateRevised mesh__D001716 1994-04-16
% 214.96/215.15  |- skos__annotation mesh__D001716
% 214.96/215.15       resp hypersensitivity to dust of bird droppings   
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D001716 1997
% 214.96/215.15  |- skos__hiddenLabel mesh__D001716 Pneumonitides, Avian Hypersensitivity
% 214.96/215.15  |- mesh__dateCreated mesh__D001716 1976-05-05
% 214.96/215.15  |- skos__prefLabel mesh__D001716 Bird Fancier%27%s Lung
% 214.96/215.15  |- skos__hiddenLabel mesh__D001716 Lung, Pigeon Breeder%27%s
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D001716 1996
% 214.96/215.15  |- mesh__dateEstablished mesh__D001716 1991-01-01
% 214.96/215.15  |- mesh__recordMaintainer mesh__D001716 TGC
% 214.96/215.15  |- rdf__type mesh__D001716sskos__Concept
% 214.96/215.15  |- skos__hiddenLabel mesh__D001716 Lungs, Budgerigar Fancier%27%s
% 214.96/215.15  |- skos__hiddenLabel mesh__D001716 Lungs, Bird Fancier%27%s
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D001716 1999
% 214.96/215.15  |- skos__hiddenLabel mesh__D001716 Budgerigar Fanciers Lung
% 214.96/215.15  |- skos__hiddenLabel mesh__D001716 Lungs, Pigeon Breeder%27%s
% 214.96/215.15  |- mesh__recordOriginator mesh__D001716 VDK
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D001716 2004
% 214.96/215.15  |- skos__hiddenLabel mesh__D001716 Budgerigar Fancier%27%s Lungs
% 214.96/215.15  |- mesh__recordAuthorizer mesh__D006401 sjn
% 214.96/215.15  |- mesh__dateCreated mesh__D006401 1999-01-01
% 214.96/215.15  |- mesh__recordMaintainer mesh__D006401 ssb
% 214.96/215.15  |- skos__broader mesh__D006401smesh__D045506
% 214.96/215.15  |- mesh__dateEstablished mesh__D006401 1998-01-01
% 214.96/215.15  |- skos__hiddenLabel mesh__D006401 Agents, Hematologic
% 214.96/215.15  |- mesh__recordOriginator mesh__D006401 NLM
% 214.96/215.15  |- skos__altLabel mesh__D006401 Hematological Agents
% 214.96/215.15  |- rdf__type mesh__D006401sskos__Concept
% 214.96/215.15  |- skos__annotation mesh__D006401
% 214.96/215.15       GEN; prefer specifics; used for mapping supplementary chemicals; consider also BLOOD COAGULATION /drug eff%A%  
% 214.96/215.15  |- mesh__historyNote mesh__D006401 98; use explode 1967-97   
% 214.96/215.15  |- skos__prefLabel mesh__D006401 Hematologic Agents
% 214.96/215.15  |- mesh__publicMeSHNote mesh__D006401 98   
% 214.96/215.15  |- skos__scopeNote mesh__D006401
% 214.96/215.15       Drugs that act on blood and blood-forming organs and those that affect the hemostatic system.%A%    
% 214.96/215.15  |- mesh__dateRevised mesh__D006401 2005-06-30
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D006401 2006
% 214.96/215.15  |- skos__hiddenLabel mesh__D006401 Agents, Hematological
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D019329 2006
% 214.96/215.15  |- skos__scopeNote mesh__D019329
% 214.96/215.15       An alpha%28%2%29%-adrenoceptor antagonist. It has been used experimentally to test the binding activity of other chemicals.%A%    
% 214.96/215.15  |- skos__historyNote mesh__D019329 Imidazoles %28%1982-1996%29%
% 214.96/215.15  |- skos__hiddenLabel mesh__D019329 RX781094
% 214.96/215.15  |- skos__broader mesh__D019329smesh__D004146
% 214.96/215.15  |- mesh__dateCreated mesh__D019329 1996-06-10
% 214.96/215.15  |- rdf__type mesh__D019329sskos__Concept
% 214.96/215.15  |- skos__hiddenLabel mesh__D019329 RX 781094
% 214.96/215.15  |- mesh__historyNote mesh__D019329 97; was IDAZOXAN %28%NM%29% 1982-96   
% 214.96/215.15  |- skos__broader mesh__D019329smesh__D007093
% 214.96/215.15  |- mesh__recordMaintainer mesh__D019329 ssb
% 214.96/215.15  |- mesh__recordOriginator mesh__D019329 ADP
% 214.96/215.15  |- mesh__dateRevised mesh__D019329 2005-06-30
% 214.96/215.15  |- skos__historyNote mesh__D019329 Dioxanes %28%1985-1996%29%
% 214.96/215.15  |- mesh__publicMeSHNote mesh__D019329
% 214.96/215.15       97; IDAZOXAN was indexed under DIOXANES %26% IMIDAZOLES 1982-96 and DIOXINS 1982-84%A%  
% 214.96/215.15  |- skos__historyNote mesh__D019329 Dioxins %28%1982-1984%29%
% 214.96/215.15  |- skos__prefLabel mesh__D019329 Idazoxan
% 214.96/215.15  |- mesh__onlineNote mesh__D019329
% 214.96/215.15       use IDAZOXAN %28%NM%29% to search IDAZOXAN 1982-96   
% 214.96/215.15  |- mesh__dateEstablished mesh__D019329 1997-01-01
% 214.96/215.15  |- mesh__recordAuthorizer mesh__D019329 sjn
% 214.96/215.15  |- rdf__type mesh__D011346sskos__Concept
% 214.96/215.15  |- skos__hiddenLabel mesh__D011346 Edisylate Salt, Prochlorperazine
% 214.96/215.15  |- mesh__recordOriginator mesh__D011346 NLM
% 214.96/215.15  |- skos__prefLabel mesh__D011346 Prochlorperazine
% 214.96/215.15  |- skos__altLabel mesh__D011346 Prochlorperazine Edisylate
% 214.96/215.15  |- mesh__dateCreated mesh__D011346 1999-01-01
% 214.96/215.15  |- mesh__dateRevised mesh__D011346 2005-06-30
% 214.96/215.15  |- skos__scopeNote mesh__D011346
% 214.96/215.15       A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p612%29%%A%    
% 214.96/215.15  |- mesh__recordMaintainer mesh__D011346 ssb
% 214.96/215.15  |- skos__hiddenLabel mesh__D011346 Maleate, Prochlorperazine
% 214.96/215.15  |- mesh__recordAuthorizer mesh__D011346 sjn
% 214.96/215.15  |- skos__hiddenLabel mesh__D011346 Salt, Prochlorperazine Edisylate
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D011346 2006
% 214.96/215.15  |- skos__hiddenLabel mesh__D011346 Edisylate, Prochlorperazine
% 214.96/215.15  |- skos__broader mesh__D011346smesh__D010640
% 214.96/215.15  |- skos__broader mesh__D005309smesh__D019661
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D005309 2005
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D005309 2004
% 214.96/215.15  |- skos__prefLabel mesh__D005309 Ferula
% 214.96/215.15  |- skos__scopeNote mesh__D005309
% 214.96/215.15       A plant genus of the family APIACEAE.  It contains pungent oils and resins.  It is used to flavor curries, as a carminative, and as cat and dog repellent.  The occasionally used common name of %27%giant fennel%27% should not be confused with true fennel %28%FOENICULUM%29%.%A%    
% 214.96/215.15  |- skos__altLabel mesh__D005309 Zallouh
% 214.96/215.15  |- mesh__historyNote mesh__D005309
% 214.96/215.15       91%28%86%29%63; was see under PLANTS, TOXIC 1986-90; was heading 1963-85%A%  
% 214.96/215.15  |- mesh__recordMaintainer mesh__D005309 ssb
% 214.96/215.15  |- skos__altLabel mesh__D005309 Asafetida
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D005309 2006
% 214.96/215.15  |- mesh__dateRevised mesh__D005309 2001-07-25
% 214.96/215.15  |- skos__altLabel mesh__D005309 Asa-foetida
% 214.96/215.15  |- mesh__recordAuthorizer mesh__D005309 sjn
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D005309 2002
% 214.96/215.15  |- mesh__dateCreated mesh__D005309 1999-01-01
% 214.96/215.15  |- rdf__type mesh__D005309sskos__Concept
% 214.96/215.15  |- skos__altLabel mesh__D005309 Ferula harmonis
% 214.96/215.15  |- skos__annotation mesh__D005309
% 214.96/215.15       distinguish from true Fennel = FOENICULUM; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.96/215.15  |- mesh__dateEstablished mesh__D005309 1991-01-01
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D005309 2003
% 214.96/215.15  |- mesh__recordOriginator mesh__D005309 NLM
% 214.96/215.15  |- mesh__publicMeSHNote mesh__D005309
% 214.96/215.15       91,63-85; was see under PLANTS, TOXIC 1986-90; was heading 1963-85%A%  
% 214.96/215.15  |- skos__broader mesh__D016031smesh__D016377
% 214.96/215.15  |- rdf__type mesh__D016031sskos__Concept
% 214.96/215.15  |- mesh__recordMaintainer mesh__D016031 sjn
% 214.96/215.15  |- skos__broader mesh__D016031smesh__D013505
% 214.96/215.15  |- mesh__dateEstablished mesh__D016031 1990-01-01
% 214.96/215.15  |- skos__hiddenLabel mesh__D016031 Liver Graftings
% 214.96/215.15  |- skos__broader mesh__D016031smesh__D016378
% 214.96/215.15  |- skos__hiddenLabel mesh__D016031 Hepatic Transplantations
% 214.96/215.15  |- mesh__activeMeSHYear mesh__D016031 2006
% 214.96/215.16  |- skos__hiddenLabel mesh__D016031 Liver Transplantations
% 214.96/215.16  |- skos__prefLabel mesh__D016031 Liver Transplantation
% 214.96/215.16  |- mesh__publicMeSHNote mesh__D016031
% 214.96/215.16       90; was LIVER/transplantation 1966-89   
% 214.96/215.16  |- skos__altLabel mesh__D016031 Transplantation, Hepatic
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D016031 2005
% 214.96/215.16  |- mesh__dateCreated mesh__D016031 1989-05-25
% 214.96/215.16  |- skos__altLabel mesh__D016031 Grafting, Liver
% 214.96/215.16  |- skos__hiddenLabel mesh__D016031 Graftings, Liver
% 214.96/215.16  |- skos__annotation mesh__D016031
% 214.96/215.16       do not use /util except by MeSH definition; do not coord with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed%A%  
% 214.96/215.16  |- skos__hiddenLabel mesh__D016031 Liver Grafting
% 214.96/215.16  |- mesh__recordOriginator mesh__D016031 PXP
% 214.96/215.16  |- mesh__dateRevised mesh__D016031 2004-07-13
% 214.96/215.16  |- skos__hiddenLabel mesh__D016031 Transplantations, Liver
% 214.96/215.16  |- skos__altLabel mesh__D016031 Hepatic Transplantation
% 214.96/215.16  |- mesh__historyNote mesh__D016031 90; was LIVER/transplantation 1966-89   
% 214.96/215.16  |- skos__altLabel mesh__D016031 Transplantation, Liver
% 214.96/215.16  |- skos__scopeNote mesh__D016031
% 214.96/215.16       The transference of a part of or an entire liver from one human or animal to another.%A%    
% 214.96/215.16  |- mesh__recordAuthorizer mesh__D016031 sjn
% 214.96/215.16  |- skos__historyNote mesh__D016031 Liver/transplantation%28%1966-1989%29%
% 214.96/215.16  |- skos__hiddenLabel mesh__D016031 Transplantations, Hepatic
% 214.96/215.16  |- skos__prefLabel mesh__D002011 Brunner Glands
% 214.96/215.16  |- skos__hiddenLabel mesh__D002011 Glands, Brunner%27%s
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D002011 2004
% 214.96/215.16  |- skos__altLabel mesh__D002011 Brunner%27%s Glands
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D002011 2006
% 214.96/215.16  |- skos__broader mesh__D002011smesh__D004386
% 214.96/215.16  |- skos__hiddenLabel mesh__D002011 Gland, Brunner
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D002011 2005
% 214.96/215.16  |- skos__scopeNote mesh__D002011
% 214.96/215.16       The abundant submucosal mucous glands in the DUODENUM. These glands secrete BICARBONATE IONS; GLYCOPROTEINS; and PEPSINOGEN II.%A%    
% 214.96/215.16  |- skos__hiddenLabel mesh__D002011 Brunners Glands
% 214.96/215.16  |- mesh__dateCreated mesh__D002011 1999-01-01
% 214.96/215.16  |- mesh__historyNote mesh__D002011 2004 %28%1991%29%   
% 214.96/215.16  |- skos__hiddenLabel mesh__D002011 Glands, Brunner
% 214.96/215.16  |- mesh__recordMaintainer mesh__D002011 lkt
% 214.96/215.16  |- mesh__dateRevised mesh__D002011 2003-07-09
% 214.96/215.16  |- rdf__type mesh__D002011sskos__Concept
% 214.96/215.16  |- mesh__recordOriginator mesh__D002011 NLM
% 214.96/215.16  |- mesh__publicMeSHNote mesh__D002011
% 214.96/215.16       2004; see BRUNNER%27%S GLANDS 1991-2003, see DUODENUM 1975-1990%A%  
% 214.96/215.16  |- mesh__dateEstablished mesh__D002011 1991-01-01
% 214.96/215.16  |- mesh__recordAuthorizer mesh__D002011 sjn
% 214.96/215.16  |- skos__altLabel mesh__D002011 Brunner Gland
% 214.96/215.16  |- skos__annotation mesh__D029757
% 214.96/215.16       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.96/215.16  |- mesh__dateEstablished mesh__D029757 2002-01-01
% 214.96/215.16  |- skos__prefLabel mesh__D029757 Tripterygium
% 214.96/215.16  |- mesh__historyNote mesh__D029757
% 214.96/215.16       2002; for TRIPTERYGIUM WILFORDII use TRIPTERYGIUM %28%NM%29% 1985-2002%A%  
% 214.96/215.16  |- mesh__publicMeSHNote mesh__D029757
% 214.96/215.16       2002; TRIPTERYGIUM was indexed under DRUGS, CHINESE HERBAL 1985-2001%A%  
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D029757 2002
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D029757 2004
% 214.96/215.16  |- skos__scopeNote mesh__D029757
% 214.96/215.16       A plant genus of the family CELASTRACEAE that is a source of triterpenoids and diterpene epoxides such as triptolide.%A%    
% 214.96/215.16  |- mesh__dateCreated mesh__D029757 2001-07-25
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D029757 2006
% 214.96/215.16  |- skos__broader mesh__D029757smesh__D029753
% 214.96/215.16  |- rdf__type mesh__D029757sskos__Concept
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D029757 2003
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D029757 2005
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D015737 2003
% 214.96/215.16  |- mesh__dateEstablished mesh__D015737 1990-01-01
% 214.96/215.16  |- mesh__publicMeSHNote mesh__D015737 90   
% 214.96/215.16  |- mesh__dateRevised mesh__D015737 2001-07-25
% 214.96/215.16  |- skos__prefLabel mesh__D015737 Nisoldipine
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D015737 2002
% 214.96/215.16  |- mesh__dateCreated mesh__D015737 1989-05-25
% 214.96/215.16  |- skos__historyNote mesh__D015737
% 214.96/215.16       Nifedipine/analogs %26% derivatives %28%1981-1989%29%
% 214.96/215.16  |- skos__historyNote mesh__D015737 Pyridines %28%1966-1980%29%
% 214.96/215.16  |- mesh__recordOriginator mesh__D015737 RLS
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D015737 2006
% 214.96/215.16  |- mesh__historyNote mesh__D015737 90   
% 214.96/215.16  |- skos__scopeNote mesh__D015737
% 214.96/215.16       A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.%A%    
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D015737 2005
% 214.96/215.16  |- mesh__recordMaintainer mesh__D015737 ssb
% 214.96/215.16  |- skos__broader mesh__D015737smesh__D004095
% 214.96/215.16  |- mesh__recordAuthorizer mesh__D015737 sjn
% 214.96/215.16  |- rdf__type mesh__D015737sskos__Concept
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D015737 2004
% 214.96/215.16  |- mesh__recordMaintainer mesh__D001717 ags
% 214.96/215.16  |- skos__related mesh__D001717smesh__D030161
% 214.96/215.16  |- mesh__dateRevised mesh__D001717 2004-07-07
% 214.96/215.16  |- skos__annotation mesh__D001717
% 214.96/215.16       General or unspecified; prefer specifics; differentiate from POULTRY: Manual 22.29%A%  
% 214.96/215.16  |- skos__hiddenLabel mesh__D001717 Bird
% 214.96/215.16  |- skos__scopeNote mesh__D001717
% 214.96/215.16       Warm-blooded VERTEBRATES possessing FEATHERS and belonging to the class Aves.%A%    
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D001717 2005
% 214.96/215.16  |- mesh__recordOriginator mesh__D001717 NLM
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D001717 2006
% 214.96/215.16  |- skos__prefLabel mesh__D001717 Birds
% 214.96/215.16  |- mesh__recordAuthorizer mesh__D001717 sjn
% 214.96/215.16  |- mesh__dateCreated mesh__D001717 1999-01-01
% 214.96/215.16  |- rdf__type mesh__D001717sskos__Concept
% 214.96/215.16  |- skos__altLabel mesh__D001717 Aves
% 214.96/215.16  |- skos__broader mesh__D001717smesh__D014714
% 214.96/215.16  |- skos__hiddenLabel mesh__D006402 Blood Disease
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D006402 2004
% 214.96/215.16  |- skos__broader mesh__D006402smesh__D006425
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D006402 2006
% 214.96/215.16  |- skos__scopeNote mesh__D006402
% 214.96/215.16       Disorders of the blood and blood forming tissues.     
% 214.96/215.16  |- mesh__dateRevised mesh__D006402 1999-11-03
% 214.96/215.16  |- skos__altLabel mesh__D006402 Hematologic Dis
% 214.96/215.16  |- mesh__publicMeSHNote mesh__D006402
% 214.96/215.16       65; was BLOOD DISEASES see under HEMATOLOGY 1963-64   
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D006402 2003
% 214.96/215.16  |- skos__hiddenLabel mesh__D006402 Hematologic Disease
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D006402 2005
% 214.96/215.16  |- mesh__recordAuthorizer mesh__D006402 sjn
% 214.96/215.16  |- skos__prefLabel mesh__D006402 Hematologic Diseases
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D006402 2002
% 214.96/215.16  |- skos__hiddenLabel mesh__D006402 Disease, Hematological
% 214.96/215.16  |- skos__hiddenLabel mesh__D006402 Disease, Hematologic
% 214.96/215.16  |- skos__altLabel mesh__D006402 Blood Diseases
% 214.96/215.16  |- mesh__dateEstablished mesh__D006402 1965-01-01
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D006402 2001
% 214.96/215.16  |- skos__hiddenLabel mesh__D006402 Diseases, Hematological
% 214.96/215.16  |- mesh__historyNote mesh__D006402
% 214.96/215.16       65; was BLOOD DISEASES see under HEMATOLOGY 1963-64   
% 214.96/215.16  |- skos__altLabel mesh__D006402 Hematological Diseases
% 214.96/215.16  |- rdf__type mesh__D006402sskos__Concept
% 214.96/215.16  |- skos__hiddenLabel mesh__D006402 Diseases, Hematologic
% 214.96/215.16  |- skos__hiddenLabel mesh__D006402 Hematological Disease
% 214.96/215.16  |- skos__hiddenLabel mesh__D006402 Disease, Blood
% 214.96/215.16  |- mesh__recordOriginator mesh__D006402 NLM
% 214.96/215.16  |- skos__hiddenLabel mesh__D006402 Diseases, Blood
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D006402 2000
% 214.96/215.16  |- mesh__dateCreated mesh__D006402 1999-01-01
% 214.96/215.16  |- mesh__recordMaintainer mesh__D006402 kle
% 214.96/215.16  |- skos__annotation mesh__D006402
% 214.96/215.16       GEN or unspecified: prefer specifics; DF: HEMATOL DIS   
% 214.96/215.16  |- mesh__recordMaintainer mesh__D011347 SYSTEM
% 214.96/215.16  |- skos__broader mesh__D011347smesh__D011498
% 214.96/215.16  |- mesh__recordOriginator mesh__D011347 RLS
% 214.96/215.16  |- skos__scopeNote mesh__D011347
% 214.96/215.16       A biosynthetic precursor of collagen containing additional amino acid sequences at the amino-terminal and carboxyl-terminal ends of the polypeptide chains.%A%    
% 214.96/215.16  |- mesh__historyNote mesh__D011347 77   
% 214.96/215.16  |- skos__broader mesh__D011347smesh__D003094
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D011347 2006
% 214.96/215.16  |- mesh__dateEstablished mesh__D011347 1977-01-01
% 214.96/215.16  |- rdf__type mesh__D011347sskos__Concept
% 214.96/215.16  |- mesh__dateCreated mesh__D011347 1976-04-27
% 214.96/215.16  |- skos__historyNote mesh__D011347 Collagen %28%1966-1976%29%
% 214.96/215.16  |- skos__prefLabel mesh__D011347 Procollagen
% 214.96/215.16  |- mesh__publicMeSHNote mesh__D011347 77   
% 214.96/215.16  |- mesh__dateRevised mesh__D011347 2005-06-30
% 214.96/215.16  |- skos__annotation mesh__D011347
% 214.96/215.16       coord IM with specific collagen %28%IM%29% if pertinent   
% 214.96/215.16  |- skos__historyNote mesh__D011347 Protein Precursors %28%1973-1976%29%
% 214.96/215.16  |- mesh__recordAuthorizer mesh__D011347 sjn
% 214.96/215.16  |- skos__annotation mesh__D016830 an order of protozoa   
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D016830 2004
% 214.96/215.16  |- mesh__recordMaintainer mesh__D016830 ags
% 214.96/215.16  |- mesh__publicMeSHNote mesh__D016830 92   
% 214.96/215.16  |- skos__broader mesh__D016830smesh__D016826
% 214.96/215.16  |- mesh__dateEstablished mesh__D016830 1992-01-01
% 214.96/215.16  |- skos__scopeNote mesh__D016830
% 214.96/215.16       An order of flagellate protozoa. Characteristics include the presence of one or two flagella arising from a depression in the cell body and a single mitochondrion that extends the length of the body.%A%    
% 214.96/215.16  |- mesh__recordOriginator mesh__D016830 PXP
% 214.96/215.16  |- mesh__dateCreated mesh__D016830 1991-05-02
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D016830 2006
% 214.96/215.16  |- mesh__dateRevised mesh__D016830 2003-07-09
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D016830 2005
% 214.96/215.16  |- mesh__historyNote mesh__D016830 92   
% 214.96/215.16  |- skos__prefLabel mesh__D016830 Kinetoplastida
% 214.96/215.16  |- rdf__type mesh__D016830sskos__Concept
% 214.96/215.16  |- mesh__recordAuthorizer mesh__D016830 sjn
% 214.96/215.16  |- mesh__publicMeSHNote mesh__D030501
% 214.96/215.16       2002; ANDROGEN-DEPENDENT EPIDIDYMAL SECRETORY PROTEIN was indexed under METALLOPROTEINS 1987-2001, TESTICULAR HORMONES 1987-2001%A%  
% 214.96/215.16  |- skos__altLabel mesh__D030501
% 214.96/215.16       Androgen-Dependent Epididymal Secretory Protein
% 214.96/215.16  |- mesh__recordAuthorizer mesh__D030501 sjn
% 214.96/215.16  |- skos__broader mesh__D030501smesh__D011506
% 214.96/215.16  |- rdf__type mesh__D030501sskos__Concept
% 214.96/215.16  |- mesh__recordOriginator mesh__D030501 lkt
% 214.96/215.16  |- mesh__dateEstablished mesh__D030501 2002-01-01
% 214.96/215.16  |- mesh__dateCreated mesh__D030501 2001-07-25
% 214.96/215.16  |- skos__altLabel mesh__D030501 ADESP
% 214.96/215.16  |- mesh__dateRevised mesh__D030501 2005-06-30
% 214.96/215.16  |- mesh__recordMaintainer mesh__D030501 SYSTEM
% 214.96/215.16  |- skos__scopeNote mesh__D030501
% 214.96/215.16       Proteins secreted by the epididymal epithelium. These proteins are both tissue- and species-specific. They are important molecular agents in the process of sperm maturation.%A%    
% 214.96/215.16  |- skos__historyNote mesh__D030501 Proteins %28%1968-2000%29%
% 214.96/215.16  |- skos__historyNote mesh__D030501 Glycoproteins %28%2000-2001%29%
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D030501 2006
% 214.96/215.16  |- mesh__historyNote mesh__D030501
% 214.96/215.16       2002; use EPIDIDYMAL SECRETORY PROTEINS %28%NM%29% 1987-2001   
% 214.96/215.16  |- skos__prefLabel mesh__D030501 Epididymal Secretory Proteins
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D016032 2006
% 214.96/215.16  |- skos__hiddenLabel mesh__D016032 Trial, Randomized Controlled
% 214.96/215.16  |- mesh__dateCreated mesh__D016032 1989-05-25
% 214.96/215.16  |- skos__scopeNote mesh__D016032
% 214.96/215.16       Clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.%A%    
% 214.96/215.16  |- skos__prefLabel mesh__D016032 Randomized Controlled Trials
% 214.96/215.16  |- skos__historyNote mesh__D016032 Clinical Trials %28%1966-1989%29%
% 214.96/215.16  |- skos__altLabel mesh__D016032 Randomized Clinical Trials
% 214.96/215.16  |- skos__broader mesh__D016032smesh__D018849
% 214.96/215.16  |- mesh__historyNote mesh__D016032 1990   
% 214.96/215.16  |- mesh__dateRevised mesh__D016032 2005-07-28
% 214.96/215.16  |- skos__hiddenLabel mesh__D016032 Controlled Trial, Randomized
% 214.96/215.16  |- mesh__recordMaintainer mesh__D016032 ags
% 214.96/215.16  |- rdf__type mesh__D016032sskos__Concept
% 214.96/215.16  |- skos__hiddenLabel mesh__D016032 Controlled Trials, Randomized
% 214.96/215.16  |- skos__annotation mesh__D016032
% 214.96/215.16       human %26% vet animals only; IM only as a method in med research: do not confuse with RANDOMIZED CONTROLLED TRIAL %5B%PUBLICATION TYPE%5D%; note X refs: do not confuse with CONTROLLED CLINICAL TRIALS; do not interpret trial design: use term of author; if in doubt, read MeSH definitions%A%  
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D016032 2006A
% 214.96/215.16  |- skos__hiddenLabel mesh__D016032 Trials, Randomized Controlled
% 214.96/215.16  |- mesh__dateEstablished mesh__D016032 1990-01-01
% 214.96/215.16  |- mesh__recordAuthorizer mesh__D016032 ags
% 214.96/215.16  |- mesh__publicMeSHNote mesh__D016032 90   
% 214.96/215.16  |- mesh__recordOriginator mesh__D016032 PLS
% 214.96/215.16  |- skos__altLabel mesh__D016032 Trials, Randomized Clinical
% 214.96/215.16  |- skos__historyNote mesh__D002810 Polysaccharide-Lyases %28%1975%29%
% 214.96/215.16  |- mesh__dateCreated mesh__D002810 1975-07-25
% 214.96/215.16  |- mesh__recordMaintainer mesh__D002810 ssb
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D002810 2005
% 214.96/215.16  |- skos__hiddenLabel mesh__D002810 Depolymerase, Chondroitin-4-Sulfate
% 214.96/215.16  |- skos__historyNote mesh__D002810 Sulfatases %28%1970-1975%29%
% 214.96/215.16  |- skos__broader mesh__D002810smesh__D011133
% 214.96/215.16  |- skos__scopeNote mesh__D002810
% 214.96/215.16       Enzymes which catalyze the elimination of glucuronate residues from chondroitin A,B, and C or which catalyze the hydrolysis of sulfate groups of the 2-acetamido-2-deoxy-D-galactose 6-sulfate units of chondroitin sulfate. EC 4.2.2.-.%A%    
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D002810 2006
% 214.96/215.16  |- mesh__recordAuthorizer mesh__D002810 sjn
% 214.96/215.16  |- skos__hiddenLabel mesh__D002810 Chondroitin 4 Sulfate Depolymerase
% 214.96/215.16  |- mesh__recordOriginator mesh__D002810 RLS
% 214.96/215.16  |- mesh__dateEstablished mesh__D002810 1976-01-01
% 214.96/215.16  |- skos__annotation mesh__D002810
% 214.96/215.16       CHONDROITIN LYASES is available; DF: CHONDROITINASES   
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D002810 2004
% 214.96/215.16  |- rdf__type mesh__D002810sskos__Concept
% 214.96/215.16  |- mesh__historyNote mesh__D002810 98%28%76%29%   
% 214.96/215.16  |- skos__historyNote mesh__D002810 Chondroitin %28%1970-1975%29%
% 214.96/215.16  |- skos__historyNote mesh__D002810 Lyases %28%1970-1974%29%
% 214.96/215.16  |- mesh__publicMeSHNote mesh__D002810 98; see CHONDROITINASES 1976-97   
% 214.96/215.16  |- mesh__dateRevised mesh__D002810 2003-07-09
% 214.96/215.16  |- skos__prefLabel mesh__D002810 Chondroitinases and Chondroitin Lyases
% 214.96/215.16  |- skos__broader mesh__D002810smesh__D013429
% 214.96/215.16  |- skos__hiddenLabel mesh__D002012 Disorders, Teeth Grinding
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D002012 2003
% 214.96/215.16  |- mesh__publicMeSHNote mesh__D002012
% 214.96/215.16       65; was see under MASTICATION 1963-64   
% 214.96/215.16  |- mesh__dateRevised mesh__D002012 2000-06-22
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D002012 2005
% 214.96/215.16  |- mesh__historyNote mesh__D002012 65; was see under MASTICATION 1963-64   
% 214.96/215.16  |- skos__broader mesh__D002012smesh__D014076
% 214.96/215.16  |- mesh__recordOriginator mesh__D002012 NLM
% 214.96/215.16  |- mesh__dateCreated mesh__D002012 1999-01-01
% 214.96/215.16  |- mesh__recordAuthorizer mesh__D002012 sjn
% 214.96/215.16  |- skos__altLabel mesh__D002012 Teeth Grinding Disorder
% 214.96/215.16  |- rdf__type mesh__D002012sskos__Concept
% 214.96/215.16  |- mesh__recordMaintainer mesh__D002012 tpw
% 214.96/215.16  |- skos__scopeNote mesh__D002012
% 214.96/215.16       A disorder characterized by grinding and clenching of the teeth.%A%    
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D002012 2002
% 214.96/215.16  |- skos__hiddenLabel mesh__D002012 Grinding Disorders, Teeth
% 214.96/215.16  |- skos__hiddenLabel mesh__D002012 Teeth Grinding Disorders
% 214.96/215.16  |- mesh__dateEstablished mesh__D002012 1965-01-01
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D002012 2001
% 214.96/215.16  |- skos__prefLabel mesh__D002012 Bruxism
% 214.96/215.16  |- skos__annotation mesh__D002012 SLEEP BRUXISM is also available   
% 214.96/215.16  |- skos__hiddenLabel mesh__D002012 Grinding Disorder, Teeth
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D002012 2004
% 214.96/215.16  |- skos__hiddenLabel mesh__D002012 Disorder, Teeth Grinding
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D002012 2006
% 214.96/215.16  |- mesh__recordMaintainer mesh__D029758 ssb
% 214.96/215.16  |- mesh__publicMeSHNote mesh__D029758 2002   
% 214.96/215.16  |- mesh__recordAuthorizer mesh__D029758 sjn
% 214.96/215.16  |- skos__prefLabel mesh__D029758 Cistus
% 214.96/215.16  |- mesh__recordOriginator mesh__D029758 ssb
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D029758 2004
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D029758 2006
% 214.96/215.16  |- skos__scopeNote mesh__D029758
% 214.96/215.16       A plant genus of the family CISTACEAE.  The common name of rock rose is also sometimes used with the closely related Helianthemum genus %28%CISTACEAE%29%.%A%    
% 214.96/215.16  |- rdf__type mesh__D029758sskos__Concept
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D029758 2003
% 214.96/215.16  |- mesh__dateRevised mesh__D029758 2002-07-03
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D029758 2005
% 214.96/215.16  |- skos__broader mesh__D029758smesh__D030601
% 214.96/215.16  |- skos__annotation mesh__D029758
% 214.96/215.16       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.96/215.16  |- mesh__dateCreated mesh__D029758 2001-07-25
% 214.96/215.16  |- mesh__dateEstablished mesh__D029758 2002-01-01
% 214.96/215.16  |- mesh__historyNote mesh__D029758 2002   
% 214.96/215.16  |- skos__hiddenLabel mesh__D015738 MK208
% 214.96/215.16  |- skos__scopeNote mesh__D015738
% 214.96/215.16       A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.%A%    
% 214.96/215.16  |- skos__historyNote mesh__D015738 Anti-Ulcer Agents %28%1977-1989%29%
% 214.96/215.16  |- skos__hiddenLabel mesh__D015738 MK 208
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D015738 2006
% 214.96/215.16  |- skos__prefLabel mesh__D015738 Famotidine
% 214.96/215.16  |- skos__hiddenLabel mesh__D015738 YM 11170
% 214.96/215.16  |- mesh__dateCreated mesh__D015738 1989-05-15
% 214.96/215.16  |- mesh__dateRevised mesh__D015738 2005-06-30
% 214.96/215.16  |- rdf__type mesh__D015738sskos__Concept
% 214.96/215.16  |- mesh__recordOriginator mesh__D015738 RLS
% 214.96/215.16  |- skos__historyNote mesh__D015738
% 214.96/215.16       Histamine H2 Receptor Blockaders %28%1977-1989%29%
% 214.96/215.16  |- skos__hiddenLabel mesh__D015738 YM11170
% 214.96/215.16  |- mesh__historyNote mesh__D015738 90   
% 214.96/215.16  |- skos__historyNote mesh__D015738 Thiazoles %28%1966-1989%29%
% 214.96/215.16  |- mesh__dateEstablished mesh__D015738 1990-01-01
% 214.96/215.16  |- skos__broader mesh__D015738smesh__D013844
% 214.96/215.16  |- mesh__recordMaintainer mesh__D015738 ssb
% 214.96/215.16  |- mesh__publicMeSHNote mesh__D015738 90   
% 214.96/215.16  |- mesh__recordAuthorizer mesh__D015738 sjn
% 214.96/215.16  |- skos__altLabel mesh__D001718 Double Refraction
% 214.96/215.16  |- mesh__recordMaintainer mesh__D001718 TGC
% 214.96/215.16  |- skos__scopeNote mesh__D001718
% 214.96/215.16       The property of nonisotropic media, such as crystals, whereby a single incident beam of light traverses the medium as two beams, each plane-polarized, the planes being at right angles to each other. %28%Cline et al., Dictionary of Visual Science, 4th ed%29%%A%    
% 214.96/215.16  |- rdf__type mesh__D001718sskos__Concept
% 214.96/215.16  |- mesh__historyNote mesh__D001718 68%28%64%29%   
% 214.96/215.16  |- skos__hiddenLabel mesh__D001718 Birefractions
% 214.96/215.16  |- skos__hiddenLabel mesh__D001718 Double Refractions
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D001718 2001
% 214.96/215.16  |- mesh__recordAuthorizer mesh__D001718 PLS
% 214.96/215.16  |- skos__broader mesh__D001718smesh__D009906
% 214.96/215.16  |- mesh__publicMeSHNote mesh__D001718 68   
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D001718 1997
% 214.96/215.16  |- skos__hiddenLabel mesh__D001718 Refraction, Double
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D001718 2000
% 214.96/215.16  |- skos__hiddenLabel mesh__D001718 Birefringences
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D001718 1999
% 214.96/215.16  |- mesh__dateEstablished mesh__D001718 1968-01-01
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D001718 1996
% 214.96/215.16  |- skos__prefLabel mesh__D001718 Birefringence
% 214.96/215.16  |- skos__annotation mesh__D001718 a principle of optics; NIM; no qualif   
% 214.96/215.16  |- mesh__dateCreated mesh__D001718 1999-01-01
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D001718 1998
% 214.96/215.16  |- mesh__recordOriginator mesh__D001718 NLM
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D001718 2004
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D001718 2006
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D001718 2003
% 214.96/215.16  |- skos__hiddenLabel mesh__D001718 Refractions, Double
% 214.96/215.16  |- skos__altLabel mesh__D001718 Birefraction
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D001718 2005
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D001718 2002
% 214.96/215.16  |- mesh__dateRevised mesh__D001718 1995-05-18
% 214.96/215.16  |- mesh__publicMeSHNote mesh__D012440 64; was see under YEASTS 1963   
% 214.96/215.16  |- skos__scopeNote mesh__D012440
% 214.96/215.16       A genus of ascomycetous fungi of the family Saccharomycetaceae, order SACCHAROMYCETALES.%A%    
% 214.96/215.16  |- skos__broader mesh__D012440smesh__D015003
% 214.96/215.16  |- skos__broader mesh__D012440smesh__D004718
% 214.96/215.16  |- mesh__recordAuthorizer mesh__D012440 sjn
% 214.96/215.16  |- mesh__dateCreated mesh__D012440 1999-01-01
% 214.96/215.16  |- mesh__recordMaintainer mesh__D012440 SYSTEM
% 214.96/215.16  |- mesh__dateRevised mesh__D012440 2005-06-30
% 214.96/215.16  |- skos__prefLabel mesh__D012440 Saccharomyces
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D012440 2006
% 214.96/215.16  |- skos__annotation mesh__D012440
% 214.96/215.16       there are many species but check Dorland for those wrongly called Saccharomyces%A%  
% 214.96/215.16  |- mesh__recordOriginator mesh__D012440 NLM
% 214.96/215.16  |- rdf__type mesh__D012440sskos__Concept
% 214.96/215.16  |- mesh__historyNote mesh__D012440 64; was see under YEASTS 1963   
% 214.96/215.16  |- skos__altLabel mesh__D006403 Test, Hematologic
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D006403 2003
% 214.96/215.16  |- mesh__recordOriginator mesh__D006403 NLM
% 214.96/215.16  |- skos__hiddenLabel mesh__D006403 Tests, Hematological
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D006403 2000
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D006403 2005
% 214.96/215.16  |- skos__altLabel mesh__D006403 Blood Tests
% 214.96/215.16  |- skos__prefLabel mesh__D006403 Hematologic Tests
% 214.96/215.16  |- skos__annotation mesh__D006403
% 214.96/215.16       GEN: prefer specifics; does not include BLOOD CHEMICAL ANALYSIS or SEROLOGIC TESTS; NIM; do not use /util except by MeSH definition; DF: HEMATOL TESTS%A%  
% 214.96/215.16  |- mesh__recordMaintainer mesh__D006403 PXP
% 214.96/215.16  |- skos__hiddenLabel mesh__D006403 Test, Hematological
% 214.96/215.16  |- mesh__historyNote mesh__D006403 78; was NON MESH before 1978   
% 214.96/215.16  |- mesh__dateRevised mesh__D006403 1997-06-20
% 214.96/215.16  |- mesh__publicMeSHNote mesh__D006403 78   
% 214.96/215.16  |- skos__hiddenLabel mesh__D006403 Test, Blood
% 214.96/215.16  |- skos__altLabel mesh__D006403 Hematologic Test
% 214.96/215.16  |- skos__broader mesh__D006403smesh__D003942
% 214.96/215.16  |- skos__hiddenLabel mesh__D006403 Tests, Blood
% 214.96/215.16  |- skos__altLabel mesh__D006403 Tests, Hematologic
% 214.96/215.16  |- skos__scopeNote mesh__D006403
% 214.96/215.16       Tests used in the analysis of the hemic system.     
% 214.96/215.16  |- skos__hiddenLabel mesh__D006403 Blood Test
% 214.96/215.16  |- mesh__dateEstablished mesh__D006403 1978-01-01
% 214.96/215.16  |- rdf__type mesh__D006403sskos__Concept
% 214.96/215.16  |- skos__altLabel mesh__D006403 Hematological Tests
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D006403 2002
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D006403 1999
% 214.96/215.16  |- skos__historyNote mesh__D006403 Hematology %28%1966-1977%29%
% 214.96/215.16  |- mesh__dateCreated mesh__D006403 1999-01-01
% 214.96/215.16  |- skos__hiddenLabel mesh__D006403 Hematological Test
% 214.96/215.16  |- mesh__recordAuthorizer mesh__D006403 SJN
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D006403 2004
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D006403 2001
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D006403 1998
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D006403 2006
% 214.96/215.16  |- mesh__dateCreated mesh__D044522 2003-07-09
% 214.96/215.16  |- mesh__recordOriginator mesh__D044522 ags
% 214.96/215.16  |- mesh__publicMeSHNote mesh__D044522 2004   
% 214.96/215.16  |- mesh__dateRevised mesh__D044522 2005-06-30
% 214.96/215.16  |- skos__historyNote mesh__D044522 Algae, Green %28%1973-2003%29%
% 214.96/215.16  |- mesh__recordAuthorizer mesh__D044522 sjn
% 214.96/215.16  |- skos__historyNote mesh__D044522 Plants %28%1968-1972%29%
% 214.96/215.16  |- skos__altLabel mesh__D044522 Stoneworts
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D044522 2006
% 214.96/215.16  |- rdf__type mesh__D044522sskos__Concept
% 214.96/215.16  |- skos__broader mesh__D044522smesh__D000456
% 214.96/215.16  |- skos__prefLabel mesh__D044522 Characeae
% 214.96/215.16  |- mesh__recordMaintainer mesh__D044522 SYSTEM
% 214.96/215.16  |- skos__altLabel mesh__D044522 Charophytes
% 214.96/215.16  |- skos__scopeNote mesh__D044522
% 214.96/215.16       Slender, threadlike family of ALGAE, in the order Charales, that are closely related to PLANTS. They differ from GREEN ALGAE in that they grow upright with branches off a central stand.%A%    
% 214.96/215.16  |- mesh__dateEstablished mesh__D044522 2004-01-01
% 214.96/215.16  |- mesh__historyNote mesh__D044522 2004   
% 214.96/215.16  |- skos__altLabel mesh__D011348 Procollagen Peptidase
% 214.96/215.16  |- skos__historyNote mesh__D011348
% 214.96/215.16       Peptide Peptidohydrolases %28%1966-1976%29%
% 214.96/215.16  |- skos__historyNote mesh__D011348 Protein Precursors %28%1973-1976%29%
% 214.96/215.16  |- mesh__recordAuthorizer mesh__D011348 sjn
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D011348 2006
% 214.96/215.16  |- skos__broader mesh__D011348smesh__D008666
% 214.96/215.16  |- mesh__historyNote mesh__D011348
% 214.96/215.16       97; was PROCOLLAGEN PEPTIDASE 1977-96 %28%see under ENDOPEPTIDASES 1977-90%29%%A%  
% 214.96/215.16  |- mesh__recordOriginator mesh__D011348 RLS
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D011348 2005
% 214.96/215.16  |- rdf__type mesh__D011348sskos__Concept
% 214.96/215.16  |- mesh__dateCreated mesh__D011348 1976-04-27
% 214.96/215.16  |- skos__historyNote mesh__D011348 Collagen %28%1966-1976%29%
% 214.96/215.16  |- skos__hiddenLabel mesh__D011348 Procollagen N Endopeptidase
% 214.96/215.16  |- mesh__activeMeSHYear mesh__D011348 2004
% 214.96/215.16  |- mesh__recordMaintainer mesh__D011348 jmp
% 214.96/215.16  |- skos__altLabel mesh__D011348 Procollagen N-Proteinase
% 214.96/215.16  |- skos__hiddenLabel mesh__D011348 Procollagen N Proteinase
% 214.96/215.16  |- mesh__dateRevised mesh__D011348 2003-07-09
% 214.96/215.16  |- skos__scopeNote mesh__D011348
% 214.96/215.16       An extracellular endopeptidase which excises a block of peptides at the amino terminal, nonhelical region of the procollagen molecule with the formation of collagen. Absence or deficiency of the enzyme causes accumulation of procollagen which results in the inherited connective tissue disorder--dermatosparaxis. EC 3.4.24.14.%A%    
% 214.96/215.16  |- skos__prefLabel mesh__D011348 Procollagen N-Endopeptidase
% 214.96/215.16  |- mesh__publicMeSHNote mesh__D011348
% 214.96/215.16       97; was PROCOLLAGEN PEPTIDASE 1977-96 %28%see under PEPTIDE PEPTIDOHYDROLASES 1977-90%29%%A%  
% 214.96/215.17  |- mesh__dateEstablished mesh__D011348 1991-01-01
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016831 2006
% 214.96/215.17  |- skos__prefLabel mesh__D016831 Crithidia fasciculata
% 214.96/215.17  |- skos__historyNote mesh__D016831 Mastigophora %28%1966-1978%29%
% 214.96/215.17  |- mesh__recordOriginator mesh__D016831 PXP
% 214.96/215.17  |- mesh__dateRevised mesh__D016831 2003-07-09
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016831 2005
% 214.96/215.17  |- mesh__historyNote mesh__D016831 92   
% 214.96/215.17  |- mesh__recordAuthorizer mesh__D016831 sjn
% 214.96/215.17  |- skos__historyNote mesh__D016831 Crithidia %28%1979-1991%29%
% 214.96/215.17  |- mesh__dateEstablished mesh__D016831 1992-01-01
% 214.96/215.17  |- rdf__type mesh__D016831sskos__Concept
% 214.96/215.17  |- mesh__publicMeSHNote mesh__D016831 92   
% 214.96/215.17  |- skos__annotation mesh__D016831
% 214.96/215.17       mastigophoran usually found in insects; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 214.96/215.17  |- skos__broader mesh__D016831smesh__D003421
% 214.96/215.17  |- skos__scopeNote mesh__D016831
% 214.96/215.17       A species of monogenetic, parasitic protozoa usually found in insects.%A%    
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016831 2004
% 214.96/215.17  |- mesh__dateCreated mesh__D016831 1991-05-02
% 214.96/215.17  |- mesh__recordMaintainer mesh__D016831 ags
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016033 2006
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016033 2003
% 214.96/215.17  |- skos__hiddenLabel mesh__D016033 Intervention Study
% 214.96/215.17  |- skos__broader mesh__D016033smesh__D016020
% 214.96/215.17  |- mesh__historyNote mesh__D016033 90   
% 214.96/215.17  |- skos__hiddenLabel mesh__D016033 Study, Intervention
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016033 2004
% 214.96/215.17  |- skos__prefLabel mesh__D016033 Intervention Studies
% 214.96/215.17  |- skos__annotation mesh__D016033
% 214.96/215.17       %22%intervention%22% refers to a modification of the research design, not surg or pharmacol intervention: read MeSH definition; IM GEN only; coord NIM with specific study %28%IM%29%; no qualif%A%  
% 214.96/215.17  |- mesh__recordAuthorizer mesh__D016033 sjn
% 214.96/215.17  |- mesh__recordMaintainer mesh__D016033 ags
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016033 2002
% 214.96/215.17  |- mesh__dateEstablished mesh__D016033 1990-01-01
% 214.96/215.17  |- mesh__publicMeSHNote mesh__D016033 90   
% 214.96/215.17  |- skos__scopeNote mesh__D016033
% 214.96/215.17       Epidemiologic investigations designed to test a hypothesized cause-effect relation by modifying the supposed causal factor%28%s%29% in the study population.%A%    
% 214.96/215.17  |- rdf__type mesh__D016033sskos__Concept
% 214.96/215.17  |- skos__hiddenLabel mesh__D016033 Studies, Intervention
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016033 2005
% 214.96/215.17  |- mesh__dateRevised mesh__D016033 2001-07-25
% 214.96/215.17  |- mesh__dateCreated mesh__D016033 1989-05-25
% 214.96/215.17  |- mesh__recordOriginator mesh__D016033 PLS
% 214.96/215.17  |- mesh__publicMeSHNote mesh__D002811
% 214.96/215.17       97; was CHONDROITINSULFATASE 1976-96 %28%see under CHONDROITINASES 1976-90%29%%A%  
% 214.96/215.17  |- mesh__recordMaintainer mesh__D002811 ssb
% 214.96/215.17  |- mesh__dateCreated mesh__D002811 1975-08-01
% 214.96/215.17  |- skos__historyNote mesh__D002811 Chondroitin %28%1970-1975%29%
% 214.96/215.17  |- mesh__recordOriginator mesh__D002811 RLS
% 214.96/215.17  |- mesh__historyNote mesh__D002811
% 214.96/215.17       97; was CHONDROITINSULFATASE 1976-96 %28%see under CHONDROITINASES 1976-90%29%%A%  
% 214.96/215.17  |- mesh__dateEstablished mesh__D002811 1991-01-01
% 214.96/215.17  |- skos__altLabel mesh__D002811 Chondroitin Sulfohydrolase
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D002811 2006
% 214.96/215.17  |- skos__scopeNote mesh__D002811
% 214.96/215.17       A group of enzymes that catalyze the hydrolysis of various sulfate bonds of chondroitin sulfate. EC 3.1.6.-.%A%    
% 214.96/215.17  |- skos__prefLabel mesh__D002811 Chondroitinsulfatases
% 214.96/215.17  |- skos__altLabel mesh__D002811 Chondroitinsulfatase
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D002811 2004
% 214.96/215.17  |- skos__broader mesh__D002811smesh__D002810
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D002811 2005
% 214.96/215.17  |- skos__hiddenLabel mesh__D002811 Sulfohydrolase, Chondroitin
% 214.96/215.17  |- mesh__recordAuthorizer mesh__D002811 sjn
% 214.96/215.17  |- skos__historyNote mesh__D002811 Sulfatases %28%1970-1975%29%
% 214.96/215.17  |- mesh__dateRevised mesh__D002811 2003-07-09
% 214.96/215.17  |- rdf__type mesh__D002811sskos__Concept
% 214.96/215.17  |- mesh__dateCreated mesh__D002013 1999-01-01
% 214.96/215.17  |- skos__annotation mesh__D002013
% 214.96/215.17       a phylum of tiny aquatic colonial animals; /microbiol /parasitol /virol permitted%A%  
% 214.96/215.17  |- mesh__dateRevised mesh__D002013 2003-07-09
% 214.96/215.17  |- rdf__type mesh__D002013sskos__Concept
% 214.96/215.17  |- skos__scopeNote mesh__D002013
% 214.96/215.17       A phylum of small sessile aquatic animals living as small tufted colonies. Some appear like hydroids or corals, but their internal structure is more advanced. Most bryozoans are matlike, forming thin encrustations on rocks, shells, or kelp. %28%Storer %26% Stebbins, General Zoology, 6th ed, p443%29%%A%    
% 214.96/215.17  |- mesh__recordOriginator mesh__D002013 NLM
% 214.96/215.17  |- skos__prefLabel mesh__D002013 Bryozoa
% 214.96/215.17  |- mesh__recordAuthorizer mesh__D002013 sjn
% 214.96/215.17  |- skos__altLabel mesh__D002013 Moss Animals
% 214.96/215.17  |- skos__altLabel mesh__D002013 Zoophytes
% 214.96/215.17  |- skos__broader mesh__D002013smesh__D007448
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D002013 2004
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D002013 2006
% 214.96/215.17  |- mesh__recordMaintainer mesh__D002013 ags
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D002013 2005
% 214.96/215.17  |- mesh__recordAuthorizer mesh__D029759 sjn
% 214.96/215.17  |- skos__broader mesh__D029759smesh__D028084
% 214.96/215.17  |- skos__prefLabel mesh__D029759 Calophyllum
% 214.96/215.17  |- mesh__historyNote mesh__D029759 2002   
% 214.96/215.17  |- mesh__publicMeSHNote mesh__D029759 2002   
% 214.96/215.17  |- skos__annotation mesh__D029759
% 214.96/215.17       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 214.96/215.17  |- skos__scopeNote mesh__D029759
% 214.96/215.17       A plant genus of the family CLUSIACEAE. Members contain costatolide, calanolides and 4-phenylfuranocoumarins %28%PSORALENS%29%.%A%    
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D029759 2004
% 214.96/215.17  |- rdf__type mesh__D029759sskos__Concept
% 214.96/215.17  |- mesh__recordOriginator mesh__D029759 ssb
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D029759 2003
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D029759 2006
% 214.96/215.17  |- mesh__dateEstablished mesh__D029759 2002-01-01
% 214.96/215.17  |- mesh__dateRevised mesh__D029759 2002-07-03
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D029759 2005
% 214.96/215.17  |- mesh__dateCreated mesh__D029759 2001-07-25
% 214.96/215.17  |- mesh__recordMaintainer mesh__D029759 ssb
% 214.96/215.17  |- skos__prefLabel mesh__D015739 Nocodazole
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D015739 2001
% 214.96/215.17  |- skos__scopeNote mesh__D015739
% 214.96/215.17       Nocodazole is an antineoplastic agent which exerts its effect by depolymerizing microtubules.%A%    
% 214.96/215.17  |- skos__broader mesh__D015739smesh__D001562
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D015739 2005
% 214.96/215.17  |- skos__altLabel mesh__D015739 Oncodazole
% 214.96/215.17  |- skos__hiddenLabel mesh__D015739 NSC 238159
% 214.96/215.17  |- rdf__type mesh__D015739sskos__Concept
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D015739 2004
% 214.96/215.17  |- mesh__recordAuthorizer mesh__D015739 sjn
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D015739 2003
% 214.96/215.17  |- mesh__recordMaintainer mesh__D015739 TWD
% 214.96/215.17  |- skos__altLabel mesh__D015739 R17934
% 214.96/215.17  |- mesh__dateCreated mesh__D015739 1989-05-25
% 214.96/215.17  |- mesh__dateEstablished mesh__D015739 1990-01-01
% 214.96/215.17  |- skos__historyNote mesh__D015739 Antineoplastic Agents %28%1966-1989%29%
% 214.96/215.17  |- mesh__publicMeSHNote mesh__D015739 90   
% 214.96/215.17  |- mesh__dateRevised mesh__D015739 2000-06-22
% 214.96/215.17  |- skos__historyNote mesh__D015739 Benzimidazoles %28%1966-1989%29%
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D015739 2002
% 214.96/215.17  |- skos__hiddenLabel mesh__D015739 R 17934
% 214.96/215.17  |- mesh__recordOriginator mesh__D015739 RLS
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D015739 2006
% 214.96/215.17  |- skos__hiddenLabel mesh__D015739 NSC238159
% 214.96/215.17  |- mesh__historyNote mesh__D015739 90   
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D026461 2003
% 214.96/215.17  |- mesh__publicMeSHNote mesh__D026461
% 214.96/215.17       2002; ECDYSTEROIDS was indexed under STEROIDS 1992-2001and INVERTEBRATE HORMONES 1976-1995%A%  
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D026461 2006
% 214.96/215.17  |- skos__broader mesh__D026461smesh__D002783
% 214.96/215.17  |- skos__historyNote mesh__D026461 Steroids %28%1992-2001%29%
% 214.96/215.17  |- mesh__dateCreated mesh__D026461 2001-07-25
% 214.96/215.17  |- skos__altLabel mesh__D026461 Ecdysteroid
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D026461 2004
% 214.96/215.17  |- skos__prefLabel mesh__D026461 Ecdysteroids
% 214.96/215.17  |- rdf__type mesh__D026461sskos__Concept
% 214.96/215.17  |- skos__broader mesh__D026461smesh__D007301
% 214.96/215.17  |- skos__broader mesh__D026461smesh__D010840
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D026461 2002
% 214.96/215.17  |- mesh__historyNote mesh__D026461
% 214.96/215.17       2002; use ECDYSTEROIDS %28%NM%29% 1976-2001   
% 214.96/215.17  |- skos__scopeNote mesh__D026461
% 214.96/215.17       Steroids that bring about MOLTING or ecdysis in insects. Ecdysteroids include the endogenous insect hormones %28%ECDYSONE and ECDYSTERONE%29% and the insect-molting hormones found in plants, the phytoecdysteroids. Phytoecdysteroids are natural insecticides.%A%    
% 214.96/215.17  |- skos__historyNote mesh__D026461 Invertebrate Hormones %28%1976-1995%29%
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D026461 2005
% 214.96/215.17  |- mesh__dateEstablished mesh__D026461 2002-01-01
% 214.96/215.17  |- mesh__recordMaintainer mesh__D001719 PLS
% 214.96/215.17  |- skos__hiddenLabel mesh__D001719 Birth Record
% 214.96/215.17  |- mesh__dateRevised mesh__D001719 1992-05-13
% 214.96/215.17  |- skos__scopeNote mesh__D001719
% 214.96/215.17       Official certifications by a physician recording the individual%27%s birth date, place of birth, parentage and other required identifying data which are filed with the local registrar of vital statistics.%A%    
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D001719 2002
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D001719 1997
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D001719 1999
% 214.96/215.17  |- skos__hiddenLabel mesh__D001719 Certificates, Birth
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D001719 2001
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D001719 1996
% 214.96/215.17  |- mesh__recordAuthorizer mesh__D001719 PLS
% 214.96/215.17  |- mesh__dateCreated mesh__D001719 1999-01-01
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D001719 1998
% 214.96/215.17  |- skos__hiddenLabel mesh__D001719 Records, Birth
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D001719 1993
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D001719 2004
% 214.96/215.17  |- skos__hiddenLabel mesh__D001719 Birth Certificate
% 214.96/215.17  |- skos__hiddenLabel mesh__D001719 Record, Birth
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D001719 2000
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D001719 1995
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D001719 2006
% 214.96/215.17  |- skos__prefLabel mesh__D001719 Birth Certificates
% 214.96/215.17  |- skos__broader mesh__D001719smesh__D011996
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D001719 2003
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D001719 1994
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D001719 2005
% 214.96/215.17  |- rdf__type mesh__D001719sskos__Concept
% 214.96/215.17  |- skos__hiddenLabel mesh__D001719 Certificate, Birth
% 214.96/215.17  |- skos__annotation mesh__D001719 IM   
% 214.96/215.17  |- mesh__recordOriginator mesh__D001719 NLM
% 214.96/215.17  |- skos__altLabel mesh__D012441 Baker Yeast
% 214.96/215.17  |- mesh__recordMaintainer mesh__D012441 SYSTEM
% 214.96/215.17  |- skos__broader mesh__D012441smesh__D012440
% 214.96/215.17  |- mesh__dateCreated mesh__D012441 1999-01-01
% 214.96/215.17  |- skos__altLabel mesh__D012441 S cerevisiae
% 214.96/215.17  |- skos__altLabel mesh__D012441 Yeast, Baker%27%s
% 214.96/215.17  |- mesh__recordOriginator mesh__D012441 NLM
% 214.96/215.17  |- skos__altLabel mesh__D012441 Yeast, Brewer%27%s
% 214.96/215.17  |- skos__altLabel mesh__D012441 Brewer%27%s Yeast
% 214.96/215.17  |- mesh__publicMeSHNote mesh__D012441 73   
% 214.96/215.17  |- mesh__dateEstablished mesh__D012441 1973-01-01
% 214.96/215.17  |- skos__scopeNote mesh__D012441
% 214.96/215.17       A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as %22%baker%27%s%22% or %22%brewer%27%s%22% yeast. The dried form is used as a dietary supplement.%A%    
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D012441 2006
% 214.96/215.17  |- skos__related mesh__D012441smesh__D015002
% 214.96/215.17  |- skos__historyNote mesh__D012441 Saccharomyces %28%1966-1971%29%
% 214.96/215.17  |- skos__prefLabel mesh__D012441 Saccharomyces cerevisiae
% 214.96/215.17  |- mesh__recordAuthorizer mesh__D012441 sjn
% 214.96/215.17  |- skos__annotation mesh__D012441
% 214.96/215.17       use YEAST, DRIED for brewer%27%s yeast or baker%27%s yeast used as a nutritional supplement or therapeutically%A%  
% 214.96/215.17  |- rdf__type mesh__D012441sskos__Concept
% 214.96/215.17  |- skos__altLabel mesh__D012441 Baker%27%s Yeast
% 214.96/215.17  |- mesh__dateRevised mesh__D012441 2005-06-30
% 214.96/215.17  |- mesh__historyNote mesh__D012441 73%28%72%29%   
% 214.96/215.17  |- skos__related mesh__D012441smesh__D029701
% 214.96/215.17  |- skos__broader mesh__D050560smesh__D049308
% 214.96/215.17  |- skos__altLabel mesh__D050560 Homogentisate Oxidase
% 214.96/215.17  |- skos__altLabel mesh__D050560 Homogentisate Dioxygenase
% 214.96/215.17  |- skos__hiddenLabel mesh__D050560 Dioxygenase, Homogentisate
% 214.96/215.17  |- mesh__dateCreated mesh__D050560 2005-06-30
% 214.96/215.17  |- skos__hiddenLabel mesh__D050560 Homogentisate 1,2 Dioxygenase
% 214.96/215.17  |- skos__hiddenLabel mesh__D050560 Oxygenase, Homogentisate
% 214.96/215.17  |- skos__hiddenLabel mesh__D050560 Oxidase, Homogentisic Acid
% 214.96/215.17  |- skos__altLabel mesh__D050560 Homogentisate Oxygenase
% 214.96/215.17  |- mesh__recordAuthorizer mesh__D050560 sjn
% 214.96/215.17  |- skos__hiddenLabel mesh__D050560 1,2-Dioxygenase, Homogentisate
% 214.96/215.17  |- skos__altLabel mesh__D050560 Homogentisic Acid Oxidase
% 214.96/215.17  |- mesh__historyNote mesh__D050560 2006%28%1969%29%   
% 214.96/215.17  |- skos__hiddenLabel mesh__D050560 Oxidase, Homogentisate
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D050560 2006
% 214.96/215.17  |- rdf__type mesh__D050560sskos__Concept
% 214.96/215.17  |- skos__hiddenLabel mesh__D050560 Acid Oxidase, Homogentisic
% 214.96/215.17  |- mesh__recordOriginator mesh__D050560 AKE
% 214.96/215.17  |- skos__prefLabel mesh__D050560 Homogentisate 1,2-Dioxygenase
% 214.96/215.17  |- skos__scopeNote mesh__D050560
% 214.96/215.17       A mononuclear Fe%28%II%29%-dependent oxygenase, this enzyme catalyzes the conversion of homogentisate to 4-maleylacetoacetate, the third step in the pathway for the catabolism of TYROSINE. Deficiency in the enzyme causes ALKAPTONURIA, an autosomal recessive disorder, characterized by homogentisic aciduria, OCHRONOSIS and ARTHRITIS. This enzyme was formerly characterized as EC 1.13.1.5 and EC 1.99.2.5.%A%    
% 214.96/215.17  |- skos__historyNote mesh__D050560 Dioxygenases %28%1969-2005%29%
% 214.96/215.17  |- mesh__dateEstablished mesh__D050560 2006-01-01
% 214.96/215.17  |- mesh__recordMaintainer mesh__D050560 AKE
% 214.96/215.17  |- mesh__publicMeSHNote mesh__D050560
% 214.96/215.17       2006; HOMOGENTISATE 1,2-DIOXYGENASE was indexed under DIOXYGENASES 1969-2005, OXYGENASES 1983-2004, %26% under HOMOGENTISIC ACID 1973-1982%A%  
% 214.96/215.17  |- mesh__publicMeSHNote mesh__D044523 2004   
% 214.96/215.17  |- mesh__dateEstablished mesh__D044523 2004-01-01
% 214.96/215.17  |- mesh__historyNote mesh__D044523 2004   
% 214.96/215.17  |- skos__hiddenLabel mesh__D044523 Algae, Golden Brown
% 214.96/215.17  |- rdf__type mesh__D044523sskos__Concept
% 214.96/215.17  |- mesh__recordOriginator mesh__D044523 ags
% 214.96/215.17  |- skos__altLabel mesh__D044523 Chrysophyta
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D044523 2006
% 214.96/215.17  |- mesh__recordMaintainer mesh__D044523 SYSTEM
% 214.96/215.17  |- mesh__dateRevised mesh__D044523 2005-06-30
% 214.96/215.17  |- mesh__recordAuthorizer mesh__D044523 sjn
% 214.96/215.17  |- skos__prefLabel mesh__D044523 Algae, Golden-Brown
% 214.96/215.17  |- skos__broader mesh__D044523smesh__D000456
% 214.96/215.17  |- mesh__dateCreated mesh__D044523 2003-07-09
% 214.96/215.17  |- skos__historyNote mesh__D044523 Algae %28%1969-2003%29%
% 214.96/215.17  |- skos__hiddenLabel mesh__D044523 Golden-Brown Algae
% 214.96/215.17  |- skos__scopeNote mesh__D044523
% 214.96/215.17       Microscopic fresh water algae in the family Chrysophyceae. They share many features with the BROWN ALGAE but are planktonic rather than benthic. Though most are photosynthetic, they are not considered truly autotrophic since they can become facultatively heterotrophic in the absence of adequate light. In this state they can feed on BACTERIA or DIATOMS.%A%    
% 214.96/215.17  |- skos__altLabel mesh__D044523 Chrysophyceae
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D011349 2005
% 214.96/215.17  |- mesh__recordOriginator mesh__D011349 NLM
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D011349 2006
% 214.96/215.17  |- mesh__recordMaintainer mesh__D011349 lkt
% 214.96/215.17  |- mesh__dateCreated mesh__D011349 1999-01-01
% 214.96/215.17  |- rdf__type mesh__D011349sskos__Concept
% 214.96/215.17  |- skos__scopeNote mesh__D011349
% 214.96/215.17       INFLAMMATION of the MUCOUS MEMBRANE of the RECTUM, the distal end of the large intestine %28%INTESTINE, LARGE%29%.%A%    
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D011349 2004
% 214.96/215.17  |- mesh__recordAuthorizer mesh__D011349 sjn
% 214.96/215.17  |- skos__broader mesh__D011349smesh__D012002
% 214.96/215.17  |- mesh__dateRevised mesh__D011349 2003-07-09
% 214.96/215.17  |- skos__broader mesh__D011349smesh__D005759
% 214.96/215.17  |- skos__hiddenLabel mesh__D011349 Proctitides
% 214.96/215.17  |- skos__prefLabel mesh__D011349 Proctitis
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016832 1997
% 214.96/215.17  |- mesh__recordOriginator mesh__D016832 TGC
% 214.96/215.17  |- mesh__recordAuthorizer mesh__D016832 PLS
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016832 2001
% 214.96/215.17  |- mesh__dateCreated mesh__D016832 1991-05-02
% 214.96/215.17  |- skos__broader mesh__D016832smesh__D012050
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016832 2005
% 214.96/215.17  |- mesh__historyNote mesh__D016832 92   
% 214.96/215.17  |- skos__prefLabel mesh__D016832 Employment, Supported
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016832 1993
% 214.96/215.17  |- skos__scopeNote mesh__D016832
% 214.96/215.17       Paid work for mentally or physically disabled persons, taking place in regular or normal work settings. It may be competitive employment %28%work that pays minimum wage%29% or employment with subminimal wages in individualized or group placement situations. It is intended for persons with severe disabilities who require a range of support services to maintain employment. Supported employment differs from SHELTERED WORKSHOPS in that work in the latter takes place in a controlled working environment. Federal regulations are authorized and administered by the U.S. Department of Education, Office of Special Education and Rehabilitative Services.%A%    
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016832 1996
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016832 2000
% 214.96/215.17  |- mesh__recordMaintainer mesh__D016832 TGC
% 214.96/215.17  |- rdf__type mesh__D016832sskos__Concept
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016832 1999
% 214.96/215.17  |- skos__annotation mesh__D016832
% 214.96/215.17       full or part-time employment program for the disabled   
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016832 1995
% 214.96/215.17  |- skos__broader mesh__D016832smesh__D004651
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016832 2004
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016832 1998
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016832 2002
% 214.96/215.17  |- mesh__dateEstablished mesh__D016832 1992-01-01
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016832 1994
% 214.96/215.17  |- mesh__dateRevised mesh__D016832 1992-05-08
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016832 2003
% 214.96/215.17  |- mesh__publicMeSHNote mesh__D016832 92   
% 214.96/215.17  |- skos__altLabel mesh__D016832 Supported Employment
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016832 2006
% 214.96/215.17  |- skos__historyNote mesh__D016832
% 214.96/215.17       Rehabilitation, Vocational %28%1988-1991%29%
% 214.96/215.17  |- mesh__dateCreated mesh__D002812 1999-01-01
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D002812 1997
% 214.96/215.17  |- mesh__recordMaintainer mesh__D002812 KEV
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D002812 1998
% 214.96/215.17  |- skos__hiddenLabel mesh__D002812 Chondromas
% 214.96/215.17  |- skos__prefLabel mesh__D002812 Chondroma
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D002812 2002
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D002812 1996
% 214.96/215.17  |- skos__hiddenLabel mesh__D002812 Enchondromas
% 214.96/215.17  |- mesh__recordOriginator mesh__D002812 NLM
% 214.96/215.17  |- mesh__recordAuthorizer mesh__D002812 PLS
% 214.96/215.17  |- skos__annotation mesh__D002812
% 214.96/215.17       solitary; multiple = CHONDROMATOSIS; /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; do not confuse X ref ENCHONDROMA with ENCHONDROMATOSIS%A%  
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D002812 2006
% 214.96/215.17  |- skos__broader mesh__D002812smesh__D009372
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D002812 2004
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D002812 2005
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D002812 2001
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D002812 2003
% 214.96/215.17  |- mesh__dateRevised mesh__D002812 1995-06-08
% 214.96/215.17  |- skos__scopeNote mesh__D002812
% 214.96/215.17       A benign neoplasm derived from mesodermal cells that form cartilage. It may remain within the substance of a cartilage or bone %28%true chondroma or enchondroma%29% or may develop on the surface of a cartilage %28%ecchondroma or ecchondrosis%29%. %28%Dorland, 27th ed; Stedman, 25th ed%29%%A%    
% 214.96/215.17  |- rdf__type mesh__D002812sskos__Concept
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D002812 2000
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D002812 1999
% 214.96/215.17  |- mesh__recordAuthorizer mesh__D012442 sjn
% 214.96/215.17  |- skos__broader mesh__D012442smesh__D015003
% 214.96/215.17  |- mesh__dateRevised mesh__D012442 2005-06-30
% 214.96/215.17  |- mesh__dateCreated mesh__D012442 1974-12-12
% 214.96/215.17  |- skos__scopeNote mesh__D012442
% 214.96/215.17       Yeast-like ascomycetous fungi of the family Saccharomycopsidaceae, order SACCHAROMYCETALES, isolated from the stomach of rabbits and some other animals.%A%    
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D012442 2006
% 214.96/215.17  |- mesh__recordOriginator mesh__D012442 NLM
% 214.96/215.17  |- skos__prefLabel mesh__D012442 Saccharomycopsis
% 214.96/215.17  |- rdf__type mesh__D012442sskos__Concept
% 214.96/215.17  |- mesh__publicMeSHNote mesh__D012442
% 214.96/215.17       91; see ENDOMYCETALES 1986-90, see ASCOMYCETES 1975-85   
% 214.96/215.17  |- mesh__dateEstablished mesh__D012442 1991-01-01
% 214.96/215.17  |- mesh__recordMaintainer mesh__D012442 SYSTEM
% 214.96/215.17  |- mesh__historyNote mesh__D012442 91%28%75%29%   
% 214.96/215.17  |- skos__broader mesh__D012442smesh__D004718
% 214.96/215.17  |- rdf__type mesh__D006405sskos__Concept
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D006405 1999
% 214.96/215.17  |- mesh__dateCreated mesh__D006405 1999-01-01
% 214.96/215.17  |- skos__related mesh__D006405smesh__D006402
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D006405 1996
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D006405 1995
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D006405 2004
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D006405 2002
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D006405 1998
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D006405 2006
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D006405 1994
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D006405 2003
% 214.96/215.17  |- mesh__recordMaintainer mesh__D006405 JLS
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D006405 2001
% 214.96/215.17  |- skos__prefLabel mesh__D006405 Hematology
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D006405 2005
% 214.96/215.17  |- mesh__recordOriginator mesh__D006405 NLM
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D006405 2000
% 214.96/215.17  |- skos__annotation mesh__D006405
% 214.96/215.17       SPEC: SPEC qualif; immunohematology is indexed under BLOOD GROUPS; DF: HEMATOL%A%  
% 214.96/215.17  |- mesh__dateRevised mesh__D006405 1993-06-04
% 214.96/215.17  |- skos__broader mesh__D006405smesh__D007388
% 214.96/215.17  |- skos__scopeNote mesh__D006405
% 214.96/215.17       A subspecialty of internal medicine concerned with morphology, physiology, and pathology of the blood and blood-forming tissues.%A%    
% 214.96/215.17  |- mesh__recordAuthorizer mesh__D006405 PLS
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D006405 1997
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D050561 2006
% 214.96/215.17  |- skos__altLabel mesh__D050561 3-HAA Oxygenase
% 214.96/215.17  |- rdf__type mesh__D050561sskos__Concept
% 214.96/215.17  |- skos__hiddenLabel mesh__D050561 Oxygenase, 3-HAA
% 214.96/215.17  |- skos__hiddenLabel mesh__D050561 3 Hydroxyanthranilic Acid Oxygenase
% 214.96/215.17  |- skos__scopeNote mesh__D050561
% 214.96/215.17       An enzyme that catalyzes the conversion of 3-hydroxyanthranilate to 2-amino-3-carboxymuconate semialdehyde. It was formerly characterized as EC 1.13.1.6.%A%    
% 214.96/215.17  |- skos__hiddenLabel mesh__D050561 3 Hydroxyanthranilate 3,4 Dioxygenase
% 214.96/215.17  |- skos__altLabel mesh__D050561 3-Hydroxyanthranilic Acid Oxygenase
% 214.96/215.17  |- mesh__recordMaintainer mesh__D050561 AKE
% 214.96/215.17  |- skos__broader mesh__D050561smesh__D049308
% 214.96/215.17  |- mesh__dateCreated mesh__D050561 2005-06-30
% 214.96/215.17  |- skos__hiddenLabel mesh__D050561 Oxygenase, 3-Hydroxyanthranilic Acid
% 214.96/215.17  |- skos__hiddenLabel mesh__D050561 3 HAA Oxygenase
% 214.96/215.17  |- mesh__recordAuthorizer mesh__D050561 sjn
% 214.96/215.17  |- skos__hiddenLabel mesh__D050561 3,4-Dioxygenase, 3-Hydroxyanthranilate
% 214.96/215.17  |- mesh__historyNote mesh__D050561
% 214.96/215.17       2006%28%1980%29%;  use ANTHRANILIC ACID 1974-1979   
% 214.96/215.17  |- skos__hiddenLabel mesh__D050561 Acid Oxygenase, 3-Hydroxyanthranilic
% 214.96/215.17  |- mesh__recordOriginator mesh__D050561 AKE
% 214.96/215.17  |- mesh__publicMeSHNote mesh__D050561
% 214.96/215.17       2006; 3-HYDROXYANTHRANILATE 3,4-DIOXYGENASE was indexed under DIOXYGENASES 1981-2005, %26% under ANTHRANILIC ACID 1974-1980%A%  
% 214.96/215.17  |- skos__prefLabel mesh__D050561 3-Hydroxyanthranilate 3,4-Dioxygenase
% 214.96/215.17  |- mesh__dateEstablished mesh__D050561 2006-01-01
% 214.96/215.17  |- mesh__dateRevised mesh__D016833 2003-07-09
% 214.96/215.17  |- mesh__dateCreated mesh__D016833 1991-05-02
% 214.96/215.17  |- skos__prefLabel mesh__D016833 Trypanosoma brucei rhodesiense
% 214.96/215.17  |- mesh__onlineNote mesh__D016833
% 214.96/215.17       use TRYPANOSOMA BRUCEI BRUCEI to search TRYPANOSOMA BRUCEI RHODESIENSE %26% TRYPANOSOMA RHODESIENSE 1987-91%A%  
% 214.96/215.17  |- rdf__type mesh__D016833sskos__Concept
% 214.96/215.17  |- skos__altLabel mesh__D016833 Trypanosoma rhodesiense
% 214.96/215.17  |- skos__historyNote mesh__D016833
% 214.96/215.17       Trypanosoma brucei brucei %28%1972-1991%29%
% 214.96/215.17  |- mesh__recordOriginator mesh__D016833 PXP
% 214.96/215.17  |- skos__broader mesh__D016833smesh__D014345
% 214.96/215.17  |- mesh__recordMaintainer mesh__D016833 ags
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016833 2004
% 214.96/215.17  |- skos__annotation mesh__D016833
% 214.96/215.17       causes Rhodesian sleeping sickness; infection: coord IM with TRYPANOSOMIASIS, AFRICAN %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016833 2005
% 214.96/215.17  |- skos__scopeNote mesh__D016833
% 214.96/215.17       A hemoflagellate subspecies of parasitic protozoa that causes Rhodesian sleeping sickness in humans. It is carried by Glossina pallidipes, G. morsitans and occasionally other species of game-attacking tsetse flies.%A%    
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016833 2006
% 214.96/215.17  |- mesh__dateEstablished mesh__D016833 1992-01-01
% 214.96/215.17  |- mesh__recordAuthorizer mesh__D016833 sjn
% 214.96/215.17  |- mesh__historyNote mesh__D016833
% 214.96/215.17       92; was see TRYPANOSOMA BRUCEI BRUCEI 1987-91; TRYPANOSOMA RHODESIENSE was see TRYPANOSOMA BRUCEI BRUCEI 1987-91%A%  
% 214.96/215.17  |- skos__historyNote mesh__D016833 Trypanosoma %28%1966-1986%29%
% 214.96/215.17  |- mesh__publicMeSHNote mesh__D016833
% 214.96/215.17       92; was see TRYPANOSOMA BRUCEI BRUCEI 1987-91; TRYPANOSOMA RHODESIENSE was see TRYPANOSOMA BRUCEI BRUCEI 1987-91%A%  
% 214.96/215.17  |- skos__annotation mesh__D016035
% 214.96/215.17       do not use /util except by MeSH definition; do not coord with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; in ther of diabetes mellitus, ISLETS OF LANGERHANS TRANSPLANTATION is probably the correct term: see note there%A%  
% 214.96/215.17  |- mesh__recordAuthorizer mesh__D016035 sjn
% 214.96/215.17  |- skos__hiddenLabel mesh__D016035 Transplantations, Pancreas
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016035 2005
% 214.96/215.17  |- skos__broader mesh__D016035smesh__D013505
% 214.96/215.17  |- rdf__type mesh__D016035sskos__Concept
% 214.96/215.17  |- mesh__dateEstablished mesh__D016035 1990-01-01
% 214.96/215.17  |- skos__altLabel mesh__D016035 Transplantation, Pancreas
% 214.96/215.17  |- mesh__historyNote mesh__D016035
% 214.96/215.17       90; was PANCREAS/transplantation 1966-89   
% 214.96/215.17  |- mesh__dateCreated mesh__D016035 1989-05-25
% 214.96/215.17  |- skos__hiddenLabel mesh__D016035 Pancreas Graftings
% 214.96/215.17  |- mesh__activeMeSHYear mesh__D016035 2006
% 214.96/215.17  |- skos__hiddenLabel mesh__D016035 Graftings, Pancreas
% 214.96/215.17  |- skos__altLabel mesh__D016035 Grafting, Pancreas
% 214.96/215.17  |- mesh__publicMeSHNote mesh__D016035
% 214.96/215.17       90; was PANCREAS/transplantation 1966-89   
% 214.96/215.17  |- mesh__recordOriginator mesh__D016035 PXP
% 214.96/215.17  |- mesh__recordMaintainer mesh__D016035 sjn
% 214.96/215.17  |- skos__prefLabel mesh__D016035 Pancreas Transplantation
% 214.96/215.18  |- skos__scopeNote mesh__D016035
% 214.96/215.18       The transference of a pancreas from one human or animal to another.%A%    
% 214.96/215.18  |- skos__hiddenLabel mesh__D016035 Pancreas Transplantations
% 214.96/215.18  |- skos__broader mesh__D016035smesh__D016377
% 214.96/215.18  |- skos__hiddenLabel mesh__D016035 Pancreas Grafting
% 214.96/215.18  |- mesh__dateRevised mesh__D016035 2004-07-13
% 214.96/215.18  |- skos__historyNote mesh__D016035
% 214.96/215.18       Pancreas/transplantation %28%1966-1989%29%
% 214.96/215.18  |- skos__broader mesh__D002813smesh__D012509
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002813 2001
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002813 2004
% 214.96/215.18  |- skos__prefLabel mesh__D002813 Chondrosarcoma
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002813 2000
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002813 2005
% 214.96/215.18  |- skos__hiddenLabel mesh__D002813 Chondrosarcomas
% 214.96/215.18  |- skos__annotation mesh__D002813
% 214.96/215.18       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS %28%IM%29% or specific precoord bone/neopl term %28%IM%29% or specific bone %28%IM%29% + BONE NEOPLASMS %28%IM%29%%A%  
% 214.96/215.18  |- mesh__dateRevised mesh__D002813 1995-06-08
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002813 2003
% 214.96/215.18  |- skos__scopeNote mesh__D002813
% 214.96/215.18       A slowly growing malignant neoplasm derived from cartilage cells, occurring most frequently in pelvic bones or near the ends of long bones, in middle-aged and old people. Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion or in patients with ENCHONDROMATOSIS. %28%Stedman, 25th ed%29%%A%    
% 214.96/215.18  |- rdf__type mesh__D002813sskos__Concept
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002813 1999
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002813 2002
% 214.96/215.18  |- mesh__dateCreated mesh__D002813 1999-01-01
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002813 1997
% 214.96/215.18  |- mesh__recordMaintainer mesh__D002813 KEV
% 214.96/215.18  |- mesh__recordAuthorizer mesh__D002813 PLS
% 214.96/215.18  |- skos__broader mesh__D002813smesh__D009372
% 214.96/215.18  |- mesh__recordOriginator mesh__D002813 NLM
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002813 1998
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002813 1996
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002813 2006
% 214.96/215.18  |- mesh__recordOriginator mesh__D002015 NLM
% 214.96/215.18  |- skos__altLabel mesh__D002015 Isobutylcyanoacrylate
% 214.96/215.18  |- skos__broader mesh__D002015smesh__D003487
% 214.96/215.18  |- mesh__recordAuthorizer mesh__D002015 sjn
% 214.96/215.18  |- skos__scopeNote mesh__D002015
% 214.96/215.18       Cyanoacrylate tissue adhesive also used to occlude blood vessels supplying neoplastic or other diseased tissue.%A%    
% 214.96/215.18  |- skos__altLabel mesh__D002015 Bucrilate
% 214.96/215.18  |- skos__broader mesh__D002015smesh__D004659
% 214.96/215.18  |- mesh__publicMeSHNote mesh__D002015
% 214.96/215.18       91; was see under CYANOACRYLATES 1980-90; was ISOBUTYLCYANOACRYLATE see under CYANOACRYLATES 1972-79%A%  
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002015 2005
% 214.96/215.18  |- mesh__dateCreated mesh__D002015 1999-01-01
% 214.96/215.18  |- skos__hiddenLabel mesh__D002015 Cyanoacrylate, Isobutyl
% 214.96/215.18  |- skos__altLabel mesh__D002015 Isobutyl-2-cyanoacrylate
% 214.96/215.18  |- mesh__onlineNote mesh__D002015
% 214.96/215.18       use BUCRYLATE to search ISOBUTYLCYANOACRYLATE 1975-79; use CYANOACRYLATES 1972-74%A%  
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002015 2006
% 214.96/215.18  |- skos__prefLabel mesh__D002015 Bucrylate
% 214.96/215.18  |- skos__hiddenLabel mesh__D002015 alpha-Cyanoacrylate, Isobutyl
% 214.96/215.18  |- mesh__dateEstablished mesh__D002015 1991-01-01
% 214.96/215.18  |- skos__altLabel mesh__D002015 Isobutyl Cyanoacrylate
% 214.96/215.18  |- skos__hiddenLabel mesh__D002015 Isobutyl alpha Cyanoacrylate
% 214.96/215.18  |- mesh__recordMaintainer mesh__D002015 jmp
% 214.96/215.18  |- skos__hiddenLabel mesh__D002015 Isobutyl 2 cyanoacrylate
% 214.96/215.18  |- skos__annotation mesh__D002015 D25-26 qualif   
% 214.96/215.18  |- mesh__historyNote mesh__D002015
% 214.96/215.18       91%28%80%29%; was see under CYANOACRYLATES 1980-90; was ISOBUTYLCYANOACRYLATE see under CYANOACRYLATES 1972-79%A%  
% 214.96/215.18  |- mesh__dateRevised mesh__D002015 2004-07-07
% 214.96/215.18  |- rdf__type mesh__D002015sskos__Concept
% 214.96/215.18  |- skos__altLabel mesh__D002015 Isobutyl alpha-Cyanoacrylate
% 214.96/215.18  |- skos__hiddenLabel mesh__D012443 Lysine Ketoglutarate Reductase
% 214.96/215.18  |- mesh__recordMaintainer mesh__D012443 jmp
% 214.96/215.18  |- skos__altLabel mesh__D012443 Lysine-2-Oxoglutarate Reductase
% 214.96/215.18  |- skos__broader mesh__D012443smesh__D000587
% 214.96/215.18  |- skos__hiddenLabel mesh__D012443 Dehydrogenases, Saccharopine
% 214.96/215.18  |- skos__hiddenLabel mesh__D012443 Reductase, Lysine-2-Oxoglutarate
% 214.96/215.18  |- rdf__type mesh__D012443sskos__Concept
% 214.96/215.18  |- skos__historyNote mesh__D012443 Lysine %28%1970-1974%29%
% 214.96/215.18  |- mesh__recordAuthorizer mesh__D012443 sjn
% 214.96/215.18  |- skos__related mesh__D012443smesh__D020167
% 214.96/215.18  |- skos__altLabel mesh__D012443 Lysine-Ketoglutarate Reductase
% 214.96/215.18  |- skos__historyNote mesh__D012443 Oxidoreductases %28%1970-1974%29%
% 214.96/215.18  |- skos__prefLabel mesh__D012443 Saccharopine Dehydrogenases
% 214.96/215.18  |- mesh__dateRevised mesh__D012443 2005-06-30
% 214.96/215.18  |- skos__hiddenLabel mesh__D012443 Reductase, Lysine-Ketoglutarate
% 214.96/215.18  |- mesh__historyNote mesh__D012443
% 214.96/215.18       91%28%75%29%; was see under AMINE OXIDOREDUCTASES 1975-90   
% 214.96/215.18  |- mesh__dateEstablished mesh__D012443 1991-01-01
% 214.96/215.18  |- skos__annotation mesh__D012443 /defic: consider also HYPERLYSINEMIAS   
% 214.96/215.18  |- mesh__publicMeSHNote mesh__D012443
% 214.96/215.18       91; was see under AMINE OXIDOREDUCTASES 1975-90   
% 214.96/215.18  |- mesh__dateCreated mesh__D012443 1974-11-19
% 214.96/215.18  |- mesh__recordOriginator mesh__D012443 NLM
% 214.96/215.18  |- skos__historyNote mesh__D012443 Ketoglutaric Acids %28%1972-1974%29%
% 214.96/215.18  |- skos__hiddenLabel mesh__D012443 Lysine 2 Oxoglutarate Reductase
% 214.96/215.18  |- skos__scopeNote mesh__D012443
% 214.96/215.18       Amine oxidoreductases that use either NAD+ %28%EC 1.5.1.7%29% or NADP+ %28%EC 1.5.1.8%29% as an acceptor to form L-LYSINE or NAD+ %28%EC 1.5.1.9%29% or NADP+ %28%EC 1.5.1.10%29% as an acceptor to form L-GLUTAMATE. Deficiency of this enzyme causes HYPERLYSINEMIAS.%A%    
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D012443 2006
% 214.96/215.18  |- mesh__dateCreated mesh__D006406 1999-01-01
% 214.96/215.18  |- mesh__recordAuthorizer mesh__D006406 sjn
% 214.96/215.18  |- skos__hiddenLabel mesh__D006406 Hematomas
% 214.96/215.18  |- skos__scopeNote mesh__D006406
% 214.96/215.18       An extravasation of blood localized in an organ, space, or tissue.%A%    
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D006406 2002
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D006406 2004
% 214.96/215.18  |- mesh__recordMaintainer mesh__D006406 KEV
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D006406 2001
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D006406 2003
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D006406 2006
% 214.96/215.18  |- mesh__recordOriginator mesh__D006406 NLM
% 214.96/215.18  |- skos__broader mesh__D006406smesh__D006470
% 214.96/215.18  |- skos__annotation mesh__D006406
% 214.96/215.18       IM; not a neoplasm: coord with organ /dis or organ /hemorrhage term %28%IM%29%%A%  
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D006406 2000
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D006406 2005
% 214.96/215.18  |- mesh__dateRevised mesh__D006406 1999-11-03
% 214.96/215.18  |- rdf__type mesh__D006406sskos__Concept
% 214.96/215.18  |- skos__prefLabel mesh__D006406 Hematoma
% 214.96/215.18  |- skos__broader mesh__D050562smesh__D019159
% 214.96/215.18  |- skos__hiddenLabel mesh__D050562 Oxygenase, Myo-Inositol
% 214.96/215.18  |- skos__broader mesh__D050562smesh__D010105
% 214.96/215.18  |- mesh__dateEstablished mesh__D050562 2006-01-01
% 214.96/215.18  |- mesh__recordMaintainer mesh__D050562 AKE
% 214.96/215.18  |- mesh__publicMeSHNote mesh__D050562
% 214.96/215.18       2006; INOSITOL OXYGENASE was indexed under OXYGENASES 1983-2005 %26% under INOSITOL 1979-1982%A%  
% 214.96/215.18  |- skos__altLabel mesh__D050562 Myo-Inositol Oxygenase
% 214.96/215.18  |- skos__scopeNote mesh__D050562
% 214.96/215.18       A non-heme IRON enzyme that catalyzes the conversion of MYOINOSITOL to D-glucuronic acid. The reaction is the first committed step in MYOINOSITOL catabolic pathway. This enzyme was formerly characterized as EC 1.13.1.11 and 1.99.2.6.%A%    
% 214.96/215.18  |- skos__hiddenLabel mesh__D050562 Myo Inositol Oxygenase
% 214.96/215.18  |- mesh__historyNote mesh__D050562 2006%28%1980%29%; use INOSITOL 1979   
% 214.96/215.18  |- skos__prefLabel mesh__D050562 Inositol Oxygenase
% 214.96/215.18  |- mesh__dateCreated mesh__D050562 2005-06-30
% 214.96/215.18  |- mesh__recordAuthorizer mesh__D050562 sjn
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D050562 2006
% 214.96/215.18  |- rdf__type mesh__D050562sskos__Concept
% 214.96/215.18  |- skos__hiddenLabel mesh__D050562 Oxygenase, Inositol
% 214.96/215.18  |- mesh__recordOriginator mesh__D050562 AKE
% 214.96/215.18  |- mesh__dateEstablished mesh__D016834 1992-01-01
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D016834 2006
% 214.96/215.18  |- skos__broader mesh__D016834smesh__D016826
% 214.96/215.18  |- skos__prefLabel mesh__D016834 Trichomonadida
% 214.96/215.18  |- rdf__type mesh__D016834sskos__Concept
% 214.96/215.18  |- mesh__dateRevised mesh__D016834 2003-07-09
% 214.96/215.18  |- mesh__historyNote mesh__D016834 92   
% 214.96/215.18  |- mesh__publicMeSHNote mesh__D016834 92   
% 214.96/215.18  |- mesh__recordOriginator mesh__D016834 PXP
% 214.96/215.18  |- mesh__recordMaintainer mesh__D016834 ags
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D016834 2004
% 214.96/215.18  |- skos__scopeNote mesh__D016834
% 214.96/215.18       An order of parasitic protozoa typically having four to six flagella. True cysts are known in very few species.%A%    
% 214.96/215.18  |- mesh__recordAuthorizer mesh__D016834 sjn
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D016834 2005
% 214.96/215.18  |- skos__annotation mesh__D016834 an order of protozoa   
% 214.96/215.18  |- mesh__dateCreated mesh__D016834 1991-05-02
% 214.96/215.18  |- skos__hiddenLabel mesh__D016036 Seroprevalences
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D016036 2005
% 214.96/215.18  |- mesh__publicMeSHNote mesh__D016036
% 214.96/215.18       99; see SEROEPIDEMIOLOGIC METHODS 1990-98   
% 214.96/215.18  |- rdf__type mesh__D016036sskos__Concept
% 214.96/215.18  |- mesh__dateEstablished mesh__D016036 1990-01-01
% 214.96/215.18  |- skos__scopeNote mesh__D016036
% 214.96/215.18       EPIDEMIOLOGIC STUDIES based on the detection through serological testing of characteristic change in the serum level of specific ANTIBODIES. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases.%A%    
% 214.96/215.18  |- skos__altLabel mesh__D016036 Studies, Seroepidemiologic
% 214.96/215.18  |- skos__prefLabel mesh__D016036 Seroepidemiologic Studies
% 214.96/215.18  |- mesh__recordOriginator mesh__D016036 PLS
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D016036 2006
% 214.96/215.18  |- skos__altLabel mesh__D016036 Seroepidemiologic Study
% 214.96/215.18  |- skos__hiddenLabel mesh__D016036 Seroepidemiological Studies
% 214.96/215.18  |- mesh__recordMaintainer mesh__D016036 lkt
% 214.96/215.18  |- skos__altLabel mesh__D016036 Study, Seroepidemiologic
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D016036 2002
% 214.96/215.18  |- mesh__recordAuthorizer mesh__D016036 sjn
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D016036 2003
% 214.96/215.18  |- skos__broader mesh__D016036smesh__D016021
% 214.96/215.18  |- skos__hiddenLabel mesh__D016036 Study, Seroepidemiological
% 214.96/215.18  |- mesh__historyNote mesh__D016036 99%28%90%29%   
% 214.96/215.18  |- skos__historyNote mesh__D016036 Epidemiologic Methods %28%1977-1989%29%
% 214.96/215.18  |- skos__annotation mesh__D016036
% 214.96/215.18       IM GEN only; coord NIM with specific disease %28%IM%29%; specify geog if pertinent; DF: SEROEPIDEMIOL STUDIES%A%  
% 214.96/215.18  |- mesh__dateRevised mesh__D016036 2001-07-25
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D016036 2004
% 214.96/215.18  |- mesh__dateCreated mesh__D016036 1989-07-06
% 214.96/215.18  |- skos__hiddenLabel mesh__D016036 Studies, Seroepidemiological
% 214.96/215.18  |- skos__altLabel mesh__D016036 Seroepidemiological Study
% 214.96/215.18  |- skos__broader mesh__D002814smesh__D005154
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002814 2003
% 214.96/215.18  |- skos__scopeNote mesh__D002814
% 214.96/215.18       A branch of the facial %28%7th cranial%29% nerve which passes through the middle ear and continues through the petrotympanic fissure. The chorda tympani nerve carries taste sensation from the anterior two-thirds of the tongue and conveys parasympathetic efferents to the salivary glands.%A%    
% 214.96/215.18  |- mesh__historyNote mesh__D002814 65%28%63%29%   
% 214.96/215.18  |- mesh__dateRevised mesh__D002814 1998-06-10
% 214.96/215.18  |- rdf__type mesh__D002814sskos__Concept
% 214.96/215.18  |- skos__hiddenLabel mesh__D002814 Nerve, Chorda Tympani
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002814 2001
% 214.96/215.18  |- mesh__dateEstablished mesh__D002814 1965-01-01
% 214.96/215.18  |- mesh__recordMaintainer mesh__D002814 MSR
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002814 2000
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002814 1999
% 214.96/215.18  |- skos__hiddenLabel mesh__D002814 Nerves, Chorda Tympani
% 214.96/215.18  |- mesh__dateCreated mesh__D002814 1999-01-01
% 214.96/215.18  |- skos__hiddenLabel mesh__D002814 Chorda Tympani Nerves
% 214.96/215.18  |- skos__hiddenLabel mesh__D002814 Tympani Nerves, Chorda
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002814 2006
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002814 2002
% 214.96/215.18  |- mesh__publicMeSHNote mesh__D002814 65   
% 214.96/215.18  |- mesh__recordAuthorizer mesh__D002814 SJN
% 214.96/215.18  |- skos__hiddenLabel mesh__D002814 Tympani Nerve, Chorda
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002814 2004
% 214.96/215.18  |- skos__annotation mesh__D002814
% 214.96/215.18       a branch of the facial %28%7th cranial%29% nerve; dis: coord IM with FACIAL NERVE DISEASES %28%IM%29%; neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 214.96/215.18  |- mesh__recordOriginator mesh__D002814 NLM
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002814 2005
% 214.96/215.18  |- skos__prefLabel mesh__D002814 Chorda Tympani Nerve
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002016 2004
% 214.96/215.18  |- mesh__dateCreated mesh__D002016 1999-01-01
% 214.96/215.18  |- mesh__dateRevised mesh__D002016 1999-11-03
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002016 2006
% 214.96/215.18  |- skos__annotation mesh__D002016 IM; specify geog if pertinent   
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002016 2002
% 214.96/215.18  |- skos__broader mesh__D002016smesh__D012067
% 214.96/215.18  |- mesh__recordMaintainer mesh__D002016 kle
% 214.96/215.18  |- skos__hiddenLabel mesh__D002016 Buddhist Ethic
% 214.96/215.18  |- mesh__recordOriginator mesh__D002016 NLM
% 214.96/215.18  |- mesh__recordAuthorizer mesh__D002016 sjn
% 214.96/215.18  |- rdf__type mesh__D002016sskos__Concept
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002016 2000
% 214.96/215.18  |- skos__hiddenLabel mesh__D002016 Ethics, Buddhist
% 214.96/215.18  |- skos__hiddenLabel mesh__D002016 Ethic, Buddhist
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002016 2003
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002016 2001
% 214.96/215.18  |- skos__scopeNote mesh__D002016
% 214.96/215.18       The teaching ascribed to Gautama Buddha %28%ca. 483 B.C.%29% holding that suffering is inherent in life and that one can escape it into nirvana by mental and moral self-purification. %28%Webster, 3d ed%29%%A%    
% 214.96/215.18  |- skos__prefLabel mesh__D002016 Buddhism
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002016 2005
% 214.96/215.18  |- skos__annotation mesh__D012444 DF: SACCULE   
% 214.96/215.18  |- skos__broader mesh__D012444smesh__D014722
% 214.96/215.18  |- rdf__type mesh__D012444sskos__Concept
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D012444 2002
% 214.96/215.18  |- skos__hiddenLabel mesh__D012444 Utricle and Saccule
% 214.96/215.18  |- mesh__publicMeSHNote mesh__D012444
% 214.96/215.18       83; SACCULE %26% UTRICLE were see under LABYRINTH 1966-82; MACULAE, ACOUSTIC was see under LABYRINTH 1979-82%A%  
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D012444 2003
% 214.96/215.18  |- mesh__dateEstablished mesh__D012444 1983-01-01
% 214.96/215.18  |- mesh__dateCreated mesh__D012444 1982-04-22
% 214.96/215.18  |- mesh__recordMaintainer mesh__D012444 ags
% 214.96/215.18  |- mesh__recordOriginator mesh__D012444 RC
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D012444 2004
% 214.96/215.18  |- skos__historyNote mesh__D012444 Utricle %28%1975-1982%29%
% 214.96/215.18  |- skos__historyNote mesh__D012444 Saccule %28%1975-1982%29%
% 214.96/215.18  |- skos__prefLabel mesh__D012444 Saccule and Utricle
% 214.96/215.18  |- mesh__recordAuthorizer mesh__D012444 sjn
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D012444 2005
% 214.96/215.18  |- skos__scopeNote mesh__D012444
% 214.96/215.18       Two membranous sacs within the vestibule of the inner ear. The smaller, the saccule, lies near the opening of the scala vestibuli. The larger, the utricle, is in the superoposterior part of the vestibule. Both receive filaments from the VESTIBULOCOCHLEAR NERVE.%A%    
% 214.96/215.18  |- mesh__historyNote mesh__D012444
% 214.96/215.18       83; SACCULE %26% UTRICLE were see under LABYRINTH 1966-82   
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D012444 2006
% 214.96/215.18  |- mesh__dateRevised mesh__D012444 1999-11-03
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D012444 2000
% 214.96/215.18  |- skos__hiddenLabel mesh__D012444 Utricles
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D012444 2001
% 214.96/215.18  |- skos__historyNote mesh__D012444 Labyrinth %28%1966-1974%29%
% 214.96/215.18  |- skos__hiddenLabel mesh__D012444 Saccules
% 214.96/215.18  |- mesh__onlineNote mesh__D012444
% 214.96/215.18       to search SACCULE %26% UTRICLE use SACCULE AND UTRICLE 1975-82; LABYRINTH 1966-74%A%  
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Epidural Hematomas, Intracranial
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Hematoma, Intracranial Epidural
% 214.96/215.18  |- skos__altLabel mesh__D006407 Hemorrhage, Cranial Epidural
% 214.96/215.18  |- skos__scopeNote mesh__D006407
% 214.96/215.18       Accumulation of blood in the cranial epidural space due to rupture of the middle meningeal artery or rarely the meningeal vein, often associated with a temporal or parietal bone fracture. The hematoma tends to expand rapidly, compressing the dura and underlying brain. Clinical features include the acute or subacute onset of HEADACHE; VOMITING; alterations of mentation, and HEMIPARESIS. The natural history of the process is progression to COMA and eventually DEATH. %28%Adams et al., Principles of Neurology, 6th ed, p885%29%%A%    
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Hemorrhages, Cranial Epidural
% 214.96/215.18  |- mesh__recordOriginator mesh__D006407 NLM
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Epidural Hematoma, Intracranial
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Hematomas, Cranial Extradural
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Cranial Extradural Hematomas
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Hematoma, Cranial Extradural
% 214.96/215.18  |- skos__altLabel mesh__D006407 Extradural Hematoma, Cranial
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Cranial Epidural Hemorrhage
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Hematomas, Intracranial Epidural
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Cranial Extradural Hemorrhages
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Epidural Hematoma, Cranial
% 214.96/215.18  |- skos__altLabel mesh__D006407 Cranial Epidural Hematoma
% 214.96/215.18  |- mesh__dateCreated mesh__D006407 1999-01-01
% 214.96/215.18  |- mesh__dateRevised mesh__D006407 2004-07-07
% 214.96/215.18  |- mesh__recordMaintainer mesh__D006407 ags
% 214.96/215.18  |- skos__broader mesh__D006407smesh__D006406
% 214.96/215.18  |- skos__altLabel mesh__D006407 Intracranial Epidural Hematoma
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Epidural Hemorrhages, Cranial
% 214.96/215.18  |- skos__broader mesh__D006407smesh__D020198
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Intracranial Epidural Hematomas
% 214.96/215.18  |- skos__altLabel mesh__D006407 Hematoma, Epidural, Intracranial
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D006407 2006
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Extradural Hematomas, Cranial
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Hemorrhages, Cranial Extradural
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Hematoma, Cranial Epidural
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Hemorrhage, Cranial Extradural
% 214.96/215.18  |- skos__altLabel mesh__D006407 Epidural Hemorrhage, Cranial
% 214.96/215.18  |- mesh__historyNote mesh__D006407 2005 %28%1966%29%   
% 214.96/215.18  |- mesh__publicMeSHNote mesh__D006407
% 214.96/215.18       2005; see HEMATOMA, EPIDURAL 1966-2004   
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Cranial Epidural Hematomas
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Epidural Hematomas, Cranial
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Hematomas, Cranial Epidural
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Cranial Epidural Hemorrhages
% 214.96/215.18  |- rdf__type mesh__D006407sskos__Concept
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Cranial Extradural Hematoma
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D006407 2005
% 214.96/215.18  |- skos__broader mesh__D006407smesh__D020300
% 214.96/215.18  |- mesh__recordAuthorizer mesh__D006407 sjn
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Cranial Extradural Hemorrhage
% 214.96/215.18  |- skos__altLabel mesh__D006407 Extradural Hemorrhage, Cranial
% 214.96/215.18  |- skos__prefLabel mesh__D006407 Hematoma, Epidural, Cranial
% 214.96/215.18  |- skos__hiddenLabel mesh__D006407 Extradural Hemorrhages, Cranial
% 214.96/215.18  |- skos__altLabel mesh__D050563 Trimethylaminobutyrate Hydroxylase
% 214.96/215.18  |- rdf__type mesh__D050563sskos__Concept
% 214.96/215.18  |- skos__hiddenLabel mesh__D050563
% 214.96/215.18       gamma Butyrobetaine, 2 Oxoglutarate Dioxygenase
% 214.96/215.18  |- skos__hiddenLabel mesh__D050563 gamma Butyrobetaine Dioxygenase
% 214.96/215.18  |- mesh__dateCreated mesh__D050563 2005-06-30
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D050563 2006
% 214.96/215.18  |- skos__hiddenLabel mesh__D050563 Hydroxylase, Butyrobetaine
% 214.96/215.18  |- skos__altLabel mesh__D050563
% 214.96/215.18       gamma-Butyrobetaine, 2-Oxoglutarate Dioxygenase
% 214.96/215.18  |- skos__hiddenLabel mesh__D050563
% 214.96/215.18       2-Oxoglutarate Dioxygenase gamma-Butyrobetaine
% 214.96/215.18  |- mesh__publicMeSHNote mesh__D050563
% 214.96/215.18       2006; GAMMA-BUTYROBETAINE DIOXYGENASE was indexed under MIXED FUNCTION OXYGENASES 1980-2005, KETOGLUTARIC ACID 1973-1974, BETAINE 1972-1980, BUTYRATES 1974-1979, %26% AMINOBUTYRIC ACID 1970-1974%A%  
% 214.96/215.18  |- skos__altLabel mesh__D050563 gamma-Butyrobetaine Hydroxylase
% 214.96/215.18  |- skos__prefLabel mesh__D050563 gamma-Butyrobetaine Dioxygenase
% 214.96/215.18  |- skos__hiddenLabel mesh__D050563 Dioxygenase, gamma-Butyrobetaine
% 214.96/215.18  |- mesh__recordAuthorizer mesh__D050563 sjn
% 214.96/215.18  |- skos__hiddenLabel mesh__D050563 Hydroxylase, gamma-Butyrobetaine
% 214.96/215.18  |- skos__broader mesh__D050563smesh__D006899
% 214.96/215.18  |- skos__hiddenLabel mesh__D050563 Hydroxylase, Trimethylaminobutyrate
% 214.96/215.18  |- mesh__historyNote mesh__D050563
% 214.96/215.18       2006%28%1980%29%; use KETOGLUTARIC ACID 1973-1974, BETAINE 1972-1979, BUTYRATES 1974-1979, %26% AMINOBUTYRIC ACID 1970-1974%A%  
% 214.96/215.18  |- mesh__recordMaintainer mesh__D050563 AKE
% 214.96/215.18  |- skos__hiddenLabel mesh__D050563
% 214.96/215.18       Dioxygenase, gamma-Butyrobetaine,2-Oxoglutarate
% 214.96/215.18  |- skos__hiddenLabel mesh__D050563
% 214.96/215.18       gamma Butyrobetaine,2 Oxoglutarate Dioxygenase
% 214.96/215.18  |- mesh__recordOriginator mesh__D050563 AKE
% 214.96/215.18  |- skos__hiddenLabel mesh__D050563 gamma Butyrobetaine Hydroxylase
% 214.96/215.18  |- skos__altLabel mesh__D050563
% 214.96/215.18       gamma-Butyrobetaine,2-Oxoglutarate Dioxygenase
% 214.96/215.18  |- skos__scopeNote mesh__D050563
% 214.96/215.18       An enzyme that catalyzes the HYDROXYLATION of gamma-butyrobetaine to L-CARNITINE. It is the last enzyme in the biosynthetic pathway of L-CARNITINE and is dependent on alpha-ketoglutarate; IRON; ASCORBIC ACID; and OXYGEN.%A%    
% 214.96/215.18  |- skos__hiddenLabel mesh__D050563
% 214.96/215.18       Dioxygenase gamma-Butyrobetaine, 2-Oxoglutarate
% 214.96/215.18  |- mesh__dateEstablished mesh__D050563 2006-01-01
% 214.96/215.18  |- skos__altLabel mesh__D050563 Butyrobetaine Hydroxylase
% 214.96/215.18  |- skos__altLabel mesh__D050563
% 214.96/215.18       4-Trimethylaminobutyrate, 2-Oxoglutarate Oxygen Oxidoreductase %28%3-Hydroxylating%29%
% 214.96/215.18  |- skos__broader mesh__D050768Q000172smesh__D050768
% 214.96/215.18  |- mesh__preferredCombination mesh__D050768Q000172smesh__D046350
% 214.96/215.18  |- rdf__type mesh__D050768Q000172smesh__CompoundConcept
% 214.96/215.18  |- mesh__historyNote mesh__D016835 92   
% 214.96/215.18  |- mesh__recordOriginator mesh__D016835 PXP
% 214.96/215.18  |- mesh__dateCreated mesh__D016835 1991-05-02
% 214.96/215.18  |- mesh__dateEstablished mesh__D016835 1992-01-01
% 214.96/215.18  |- mesh__recordMaintainer mesh__D016835 ags
% 214.96/215.18  |- skos__annotation mesh__D016835
% 214.96/215.18       causes bovine abortion; infection: coord IM with MASTIGOPHORA INFECTIONS %28%IM%29% %26% if pertinent ABORTION, VETERINARY %28%IM%29% %28%see note there%29% + CATTLE DISEASES %28%IM%29%%A%  
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D016835 2004
% 214.96/215.18  |- skos__historyNote mesh__D016835 Tritrichomonas %28%1972-1991%29%
% 214.96/215.18  |- mesh__publicMeSHNote mesh__D016835 92   
% 214.96/215.18  |- skos__scopeNote mesh__D016835
% 214.96/215.18       A species of flagellate parasitic protozoa. It possesses a long undulating membrane that is bordered on its outer margin by a flagellum that becomes free posteriorly. This organism causes infections in cows that could lead to temporary infertility or abortion.%A%    
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D016835 2005
% 214.96/215.18  |- skos__broader mesh__D016835smesh__D014318
% 214.96/215.18  |- skos__historyNote mesh__D016835 Mastigophora %28%1967-1971%29%
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D016835 2006
% 214.96/215.18  |- skos__prefLabel mesh__D016835 Tritrichomonas foetus
% 214.96/215.18  |- rdf__type mesh__D016835sskos__Concept
% 214.96/215.18  |- mesh__dateRevised mesh__D016835 2003-07-09
% 214.96/215.18  |- mesh__recordAuthorizer mesh__D016835 sjn
% 214.96/215.18  |- mesh__recordMaintainer mesh__D016037 ags
% 214.96/215.18  |- skos__annotation mesh__D016037
% 214.96/215.18       IM GEN only; coord NIM with specific disease %28%IM%29%; when pertinent add CLINICAL TRIAL %28%PT%29% or RANDOMIZED CONTROLLED TRIAL %28%PT%29%; do not index also under PLACEBOS unless particularly discussed; no qualif%A%  
% 214.96/215.18  |- skos__hiddenLabel mesh__D016037 Method, Single-Masked
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D016037 2002
% 214.96/215.18  |- skos__hiddenLabel mesh__D016037 Single-Blind Methods
% 214.96/215.18  |- skos__hiddenLabel mesh__D016037 Studies, Single-Blind
% 214.96/215.18  |- skos__hiddenLabel mesh__D016037 Single Masked Method
% 214.96/215.18  |- mesh__dateEstablished mesh__D016037 1990-01-01
% 214.96/215.18  |- mesh__recordOriginator mesh__D016037 PLS
% 214.96/215.18  |- skos__altLabel mesh__D016037 Single-Masked Method
% 214.96/215.18  |- skos__hiddenLabel mesh__D016037 Single-Blind Studies
% 214.96/215.18  |- skos__hiddenLabel mesh__D016037 Single Masked Study
% 214.96/215.18  |- skos__hiddenLabel mesh__D016037 Single Blind Method
% 214.96/215.18  |- skos__hiddenLabel mesh__D016037 Single-Masked Studies
% 214.96/215.18  |- rdf__type mesh__D016037sskos__Concept
% 214.96/215.18  |- skos__hiddenLabel mesh__D016037 Study, Single-Blind
% 214.96/215.18  |- skos__prefLabel mesh__D016037 Single-Blind Method
% 214.96/215.18  |- skos__broader mesh__D016037smesh__D015340
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D016037 2006
% 214.96/215.18  |- skos__hiddenLabel mesh__D016037 Methods, Single-Blind
% 214.96/215.18  |- skos__hiddenLabel mesh__D016037 Single-Masked Methods
% 214.96/215.18  |- skos__hiddenLabel mesh__D016037 Single Blind Study
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D016037 2005
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D016037 2004
% 214.96/215.18  |- mesh__dateRevised mesh__D016037 2001-07-25
% 214.96/215.18  |- skos__hiddenLabel mesh__D016037 Study, Single-Masked
% 214.96/215.18  |- skos__hiddenLabel mesh__D016037 Methods, Single-Masked
% 214.96/215.18  |- mesh__recordAuthorizer mesh__D016037 sjn
% 214.96/215.18  |- mesh__dateCreated mesh__D016037 1989-06-21
% 214.96/215.18  |- skos__hiddenLabel mesh__D016037 Studies, Single-Masked
% 214.96/215.18  |- mesh__historyNote mesh__D016037 90   
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D016037 2003
% 214.96/215.18  |- skos__scopeNote mesh__D016037
% 214.96/215.18       A method in which either the observer%28%s%29% or the subject%28%s%29% is kept ignorant of the group to which the subjects are assigned.%A%    
% 214.96/215.18  |- skos__hiddenLabel mesh__D016037 Method, Single-Blind
% 214.96/215.18  |- mesh__publicMeSHNote mesh__D016037 90   
% 214.96/215.18  |- mesh__dateCreated mesh__D002815 1999-01-01
% 214.96/215.18  |- mesh__recordAuthorizer mesh__D002815 sjn
% 214.96/215.18  |- rdf__type mesh__D002815sskos__Concept
% 214.96/215.18  |- mesh__dateRevised mesh__D002815 2005-06-30
% 214.96/215.18  |- skos__prefLabel mesh__D002815 Chordae Tendineae
% 214.96/215.18  |- mesh__recordOriginator mesh__D002815 NLM
% 214.96/215.18  |- skos__annotation mesh__D002815
% 214.96/215.18       for disease, coord IM with HEART VALVE DISEASES %28%IM%29%; PAPILLARY MUSCLES is also available but read MeSH definition; false tendons: index PURKINJE FIBERS but see note there%A%  
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002815 2006
% 214.96/215.18  |- skos__broader mesh__D002815smesh__D006351
% 214.96/215.18  |- skos__scopeNote mesh__D002815
% 214.96/215.18       The tendinous cords that connect each cusp of the two atrioventricular HEART VALVES to appropriate PAPILLARY MUSCLES in the HEART VENTRICLES, preventing the valves from reversing themselves when the ventricles contract.%A%    
% 214.96/215.18  |- mesh__recordMaintainer mesh__D002815 nns
% 214.96/215.18  |- skos__hiddenLabel mesh__D002815 Tendineae, Chordae
% 214.96/215.18  |- skos__hiddenLabel mesh__D002017 Budget
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002017 2005
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002017 2004
% 214.96/215.18  |- skos__prefLabel mesh__D002017 Budgets
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002017 1999
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002017 2002
% 214.96/215.18  |- skos__hiddenLabel mesh__D002017 Controls, Budgetary
% 214.96/215.18  |- skos__hiddenLabel mesh__D002017 Budgetary Controls
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002017 2006
% 214.96/215.18  |- skos__broader mesh__D002017smesh__D005376
% 214.96/215.18  |- mesh__recordOriginator mesh__D002017 EC
% 214.96/215.18  |- mesh__publicMeSHNote mesh__D002017
% 214.96/215.18       90; was see under FINANCIAL MANAGEMENT 1978-89   
% 214.96/215.18  |- rdf__type mesh__D002017sskos__Concept
% 214.96/215.18  |- mesh__activeMeSHYear mesh__D002017 2000
% 214.96/215.18  |- mesh__recordAuthorizer mesh__D002017 SJN
% 214.96/215.18  |- skos__scopeNote mesh__D002017
% 214.96/215.18       Detailed financial plans for carrying out specific activities for a certain period of time. They include proposed income and expenditures.%A%    
% 214.96/215.18  |- mesh__recordMaintainer mesh__D002017 JLS
% 214.96/215.18  |- mesh__historyNote mesh__D002017
% 214.96/215.18       90%28%78%29%; was see under FINANCIAL MANAGEMENT 1978-89   
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D002017 2001
% 214.96/215.19  |- mesh__dateCreated mesh__D002017 1977-05-05
% 214.96/215.19  |- skos__hiddenLabel mesh__D002017 Control, Budgetary
% 214.96/215.19  |- mesh__dateRevised mesh__D002017 1998-06-10
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D002017 2003
% 214.96/215.19  |- mesh__dateEstablished mesh__D002017 1990-01-01
% 214.96/215.19  |- skos__broader mesh__D007500smesh__D007499
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D007500 2002
% 214.96/215.19  |- skos__prefLabel mesh__D007500 Iritis
% 214.96/215.19  |- mesh__dateCreated mesh__D007500 1999-01-01
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D007500 1996
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D007500 1999
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D007500 2005
% 214.96/215.19  |- skos__hiddenLabel mesh__D007500 Iritides
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D007500 1997
% 214.96/215.19  |- mesh__recordOriginator mesh__D007500 NLM
% 214.96/215.19  |- mesh__dateRevised mesh__D007500 1993-06-04
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D007500 2003
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D007500 2006
% 214.96/215.19  |- mesh__recordMaintainer mesh__D007500 AGS
% 214.96/215.19  |- skos__scopeNote mesh__D007500
% 214.96/215.19       Inflammation of the iris characterized by circumcorneal injection, aqueous flare, keratotic precipitates, and constricted and sluggish pupil along with discoloration of the iris.%A%    
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D007500 2004
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D007500 1994
% 214.96/215.19  |- skos__broader mesh__D007500smesh__D014606
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D007500 2000
% 214.96/215.19  |- skos__annotation mesh__D007500 a type of anterior uveitis   
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D007500 1995
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D007500 2001
% 214.96/215.19  |- mesh__recordAuthorizer mesh__D007500 PLS
% 214.96/215.19  |- rdf__type mesh__D007500sskos__Concept
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D007500 1998
% 214.96/215.19  |- rdf__type mesh__D012445sskos__Concept
% 214.96/215.19  |- skos__hiddenLabel mesh__D012445 Coccygeal Regions
% 214.96/215.19  |- skos__broader mesh__D012445smesh__D001415
% 214.96/215.19  |- mesh__dateRevised mesh__D012445 1991-01-08
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012445 2002
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012445 1993
% 214.96/215.19  |- skos__hiddenLabel mesh__D012445 Region, Sacrococcygeal
% 214.96/215.19  |- mesh__recordAuthorizer mesh__D012445 PLS
% 214.96/215.19  |- mesh__dateCreated mesh__D012445 1999-01-01
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012445 1999
% 214.96/215.19  |- skos__prefLabel mesh__D012445 Sacrococcygeal Region
% 214.96/215.19  |- skos__hiddenLabel mesh__D012445 Sacral Regions
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012445 2003
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012445 1994
% 214.96/215.19  |- mesh__recordMaintainer mesh__D012445 TGC
% 214.96/215.19  |- skos__hiddenLabel mesh__D012445 Regions, Sacral
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012445 2004
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012445 1995
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012445 1996
% 214.96/215.19  |- skos__hiddenLabel mesh__D012445 Region, Sacral
% 214.96/215.19  |- skos__annotation mesh__D012445
% 214.96/215.19       not a substitute for the bones SACRUM %26% COCCYX; this is merely locational %26% usually NIM%A%  
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012445 2000
% 214.96/215.19  |- skos__hiddenLabel mesh__D012445 Region, Coccygeal
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012445 2005
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012445 1997
% 214.96/215.19  |- skos__hiddenLabel mesh__D012445 Sacrococcygeal Regions
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012445 2001
% 214.96/215.19  |- mesh__recordOriginator mesh__D012445 NLM
% 214.96/215.19  |- skos__hiddenLabel mesh__D012445 Regions, Sacrococcygeal
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012445 1992
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012445 2006
% 214.96/215.19  |- skos__hiddenLabel mesh__D012445 Regions, Coccygeal
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012445 1998
% 214.96/215.19  |- skos__scopeNote mesh__D006408
% 214.96/215.19       Extravasation and subsequent accumulation of blood in the subdural space between the dural and arachnoidal layers of the MENINGES. This condition primarily occurs over the surface of a cerebral hemisphere %28%HEMATOMA, SUBDURAL, INTRACRANIAL%29%, but may develop in the posterior fossa and spinal canal %28%HEMATOMA, SUBDURAL, SPINAL%29%. Acute %28%HEMATOMA, SUBDURAL, ACUTE%29% and chronic %28%HEMATOMA, SUBDURAL, CHRONIC%29% forms exist.%A%    
% 214.96/215.19  |- mesh__recordOriginator mesh__D006408 NLM
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D006408 2005
% 214.96/215.19  |- skos__prefLabel mesh__D006408 Hematoma, Subdural
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D006408 2006
% 214.96/215.19  |- skos__broader mesh__D006408smesh__D020198
% 214.96/215.19  |- skos__hiddenLabel mesh__D006408 Traumatic Subdural Hematomas
% 214.96/215.19  |- skos__hiddenLabel mesh__D006408 Hematomas, Traumatic Subdural
% 214.96/215.19  |- skos__hiddenLabel mesh__D006408 Traumatic Subdural Hematoma
% 214.96/215.19  |- skos__hiddenLabel mesh__D006408 Subdural Hematomas
% 214.96/215.19  |- mesh__dateCreated mesh__D006408 1999-01-01
% 214.96/215.19  |- skos__altLabel mesh__D006408 Hemorrhage, Subdural
% 214.96/215.19  |- skos__hiddenLabel mesh__D006408 Hematomas, Subdural
% 214.96/215.19  |- skos__hiddenLabel mesh__D006408 Subdural Hematomas, Traumatic
% 214.96/215.19  |- skos__altLabel mesh__D006408 Subdural Hematoma
% 214.96/215.19  |- mesh__dateRevised mesh__D006408 2004-07-07
% 214.96/215.19  |- mesh__recordAuthorizer mesh__D006408 sjn
% 214.96/215.19  |- rdf__type mesh__D006408sskos__Concept
% 214.96/215.19  |- skos__broader mesh__D006408smesh__D006406
% 214.96/215.19  |- skos__hiddenLabel mesh__D006408 Hemorrhages, Subdural
% 214.96/215.19  |- skos__broader mesh__D006408smesh__D020300
% 214.96/215.19  |- skos__hiddenLabel mesh__D006408 Subdural Hemorrhage
% 214.96/215.19  |- mesh__recordMaintainer mesh__D006408 ags
% 214.96/215.19  |- skos__hiddenLabel mesh__D006408 Subdural Hemorrhages
% 214.96/215.19  |- skos__hiddenLabel mesh__D006408 Hematoma, Traumatic Subdural
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D017130 2003
% 214.96/215.19  |- mesh__publicMeSHNote mesh__D017130 93   
% 214.96/215.19  |- skos__historyNote mesh__D017130 Angioplasty, Balloon %28%1982-1992%29%
% 214.96/215.19  |- skos__annotation mesh__D017130
% 214.96/215.19       coord IM with disease /surg %28%IM%29%; do not use /util except by MeSH definition%A%  
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D017130 1998
% 214.96/215.19  |- skos__hiddenLabel mesh__D017130 Repair, Endoluminal
% 214.96/215.19  |- skos__prefLabel mesh__D017130 Angioplasty
% 214.96/215.19  |- skos__hiddenLabel mesh__D017130 Endoluminal Repairs
% 214.96/215.19  |- mesh__historyNote mesh__D017130 93   
% 214.96/215.19  |- skos__scopeNote mesh__D017130
% 214.96/215.19       Endovascular reconstruction of an artery, which may include the removal of atheromatous plaque and/or the endothelial lining as well as simple dilatation. These are procedures performed by catheterization. When reconstruction of an artery is performed surgically, it is called ENDARTERECTOMY.%A%    
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D017130 2002
% 214.96/215.19  |- skos__broader mesh__D017130smesh__D014656
% 214.96/215.19  |- mesh__dateRevised mesh__D017130 1997-06-20
% 214.96/215.19  |- skos__historyNote mesh__D017130 Catheterization %28%1966-1981%29%
% 214.96/215.19  |- skos__related mesh__D017130smesh__D004691
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D017130 2006
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D017130 2001
% 214.96/215.19  |- mesh__recordAuthorizer mesh__D017130 SJN
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D017130 2000
% 214.96/215.19  |- mesh__dateEstablished mesh__D017130 1993-01-01
% 214.96/215.19  |- mesh__recordMaintainer mesh__D017130 PXP
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D017130 2005
% 214.96/215.19  |- mesh__recordOriginator mesh__D017130 AGS
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D017130 2004
% 214.96/215.19  |- rdf__type mesh__D017130sskos__Concept
% 214.96/215.19  |- skos__hiddenLabel mesh__D017130 Angioplasties
% 214.96/215.19  |- skos__broader mesh__D017130smesh__D002404
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D017130 1999
% 214.96/215.19  |- mesh__dateCreated mesh__D017130 1992-05-07
% 214.96/215.19  |- skos__hiddenLabel mesh__D017130 Repairs, Endoluminal
% 214.96/215.19  |- skos__hiddenLabel mesh__D050564 4-Hydroxylase, Cinnamate
% 214.96/215.19  |- skos__broader mesh__D050564smesh__D003577
% 214.96/215.19  |- skos__hiddenLabel mesh__D050564 4-Hydroxylase, Trans-Cinnamic Acid
% 214.96/215.19  |- skos__broader mesh__D050564smesh__D006899
% 214.96/215.19  |- skos__hiddenLabel mesh__D050564 CYP73, Trans-Cinnamate 4-Monooxygenase
% 214.96/215.19  |- mesh__recordMaintainer mesh__D050564 AKE
% 214.96/215.19  |- mesh__dateCreated mesh__D050564 2005-06-30
% 214.96/215.19  |- skos__hiddenLabel mesh__D050564 Trans Cinnamate 4 Monooxygenase CYP73
% 214.96/215.19  |- mesh__historyNote mesh__D050564
% 214.96/215.19       2006%28%1980%29%; use CINNAMATES 1974-1979   
% 214.96/215.19  |- skos__hiddenLabel mesh__D050564 4-Monooxygenase CYP73, Trans-Cinnamate
% 214.96/215.19  |- skos__hiddenLabel mesh__D050564 4-Monooxygenase, Trans-Cinnamate
% 214.96/215.19  |- mesh__recordAuthorizer mesh__D050564 sjn
% 214.96/215.19  |- skos__hiddenLabel mesh__D050564 Trans Cinnamic Acid 4 Hydroxylase
% 214.96/215.19  |- skos__altLabel mesh__D050564 Trans-Cinnamate 4-Monooxygenase CYP73
% 214.96/215.19  |- mesh__publicMeSHNote mesh__D050564
% 214.96/215.19       2006; TRANS-CINNAMATE 4-MONOOXYGENASE was indexed under CYTOCHROME P-450 ENZYME SYSTEM %26% MIXED FUNCTION OXYGENASES 1983-2005, %26% UNDER CINNAMATES 1974-1982%A%  
% 214.96/215.19  |- skos__hiddenLabel mesh__D050564 Cinnamate 4 Hydroxylase
% 214.96/215.19  |- skos__altLabel mesh__D050564 Trans-Cinnamic Acid 4-Hydroxylase
% 214.96/215.19  |- skos__scopeNote mesh__D050564
% 214.96/215.19       A member of the P450 superfamily, this enzyme catalyzes the first oxidative step of the phenylpropanoid pathway in higher PLANTS by transforming trans-cinnamate into p-coumarate.%A%    
% 214.96/215.19  |- skos__hiddenLabel mesh__D050564 Acid 4-Hydroxylase, Trans-Cinnamic
% 214.96/215.19  |- mesh__recordOriginator mesh__D050564 AKE
% 214.96/215.19  |- mesh__dateEstablished mesh__D050564 2006-01-01
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D050564 2006
% 214.96/215.19  |- skos__prefLabel mesh__D050564 Trans-Cinnamate 4-Monooxygenase
% 214.96/215.19  |- skos__hiddenLabel mesh__D050564 Trans Cinnamate 4 Monooxygenase
% 214.96/215.19  |- rdf__type mesh__D050564sskos__Concept
% 214.96/215.19  |- skos__altLabel mesh__D050564 Cinnamate 4-Hydroxylase
% 214.96/215.19  |- skos__altLabel mesh__D003110 Colonic Cancer
% 214.96/215.19  |- mesh__recordMaintainer mesh__D003110 lkt
% 214.96/215.19  |- skos__hiddenLabel mesh__D003110 Neoplasm, Colon
% 214.96/215.19  |- skos__annotation mesh__D003110
% 214.96/215.19       coord IM with histol type of neopl %28%IM%29%; note SIGMOID NEOPLASMS is available; familial: consider also ADENOMATOUS POLYPOSIS COLI %26% COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS%A%  
% 214.96/215.19  |- skos__hiddenLabel mesh__D003110 Colonic Cancers
% 214.96/215.19  |- skos__prefLabel mesh__D003110 Colonic Neoplasms
% 214.96/215.19  |- mesh__historyNote mesh__D003110 64   
% 214.96/215.19  |- skos__hiddenLabel mesh__D003110 Cancer, Colon
% 214.96/215.19  |- skos__altLabel mesh__D003110 Colon Neoplasms
% 214.96/215.19  |- skos__hiddenLabel mesh__D003110 Cancers, Colonic
% 214.96/215.19  |- skos__hiddenLabel mesh__D003110 Neoplasms, Colon
% 214.96/215.19  |- skos__hiddenLabel mesh__D003110 Colon Cancers
% 214.96/215.19  |- skos__hiddenLabel mesh__D003110 Cancer, Colonic
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D003110 2005
% 214.96/215.19  |- mesh__dateEstablished mesh__D003110 1964-01-01
% 214.96/215.19  |- skos__altLabel mesh__D003110 Cancer of the Colon
% 214.96/215.19  |- skos__hiddenLabel mesh__D003110 Colon Neoplasm
% 214.96/215.19  |- skos__hiddenLabel mesh__D003110 Colonic Neoplasm
% 214.96/215.19  |- mesh__recordOriginator mesh__D003110 NLM
% 214.96/215.19  |- mesh__publicMeSHNote mesh__D003110 64   
% 214.96/215.19  |- skos__scopeNote mesh__D003110 Tumors or cancer of the COLON.     
% 214.96/215.19  |- skos__hiddenLabel mesh__D003110 Cancers, Colon
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D003110 2006
% 214.96/215.19  |- skos__altLabel mesh__D003110 Colon Cancer
% 214.96/215.19  |- skos__altLabel mesh__D003110 Neoplasms, Colonic
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D003110 2004
% 214.96/215.19  |- mesh__dateCreated mesh__D003110 1999-01-01
% 214.96/215.19  |- mesh__dateRevised mesh__D003110 2003-07-09
% 214.96/215.19  |- skos__broader mesh__D003110smesh__D015179
% 214.96/215.19  |- mesh__recordAuthorizer mesh__D003110 sjn
% 214.96/215.19  |- skos__hiddenLabel mesh__D003110 Neoplasm, Colonic
% 214.96/215.19  |- rdf__type mesh__D003110sskos__Concept
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D016836 2004
% 214.96/215.19  |- mesh__recordMaintainer mesh__D016836 ags
% 214.96/215.19  |- skos__broader mesh__D016836smesh__D012506
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D016836 2005
% 214.96/215.19  |- skos__prefLabel mesh__D016836 Eumycetozoea
% 214.96/215.19  |- mesh__recordAuthorizer mesh__D016836 sjn
% 214.96/215.19  |- mesh__dateEstablished mesh__D016836 1992-01-01
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D016836 2006
% 214.96/215.19  |- rdf__type mesh__D016836sskos__Concept
% 214.96/215.19  |- mesh__dateCreated mesh__D016836 1991-05-02
% 214.96/215.19  |- mesh__dateRevised mesh__D016836 2003-07-09
% 214.96/215.19  |- mesh__historyNote mesh__D016836 92   
% 214.96/215.19  |- skos__annotation mesh__D016836 a class of protozoa   
% 214.96/215.19  |- mesh__publicMeSHNote mesh__D016836 92   
% 214.96/215.19  |- mesh__recordOriginator mesh__D016836 PXP
% 214.96/215.19  |- skos__scopeNote mesh__D016836
% 214.96/215.19       A class of protozoa comprising myxamoebae having filiform subpseudopodia. Aerial fruiting bodies are produced and the presence of a stalk tube in the fruiting body is observed in some species.%A%    
% 214.96/215.19  |- skos__altLabel mesh__D016038 Grafting, Skin
% 214.96/215.19  |- rdf__type mesh__D016038sskos__Concept
% 214.96/215.19  |- skos__related mesh__D016038smesh__D013524
% 214.96/215.19  |- mesh__recordMaintainer mesh__D016038 lkt
% 214.96/215.19  |- skos__historyNote mesh__D016038 Skin/transplantation %28%1966-1989%29%
% 214.96/215.19  |- skos__scopeNote mesh__D016038
% 214.96/215.19       The grafting of skin in humans or animals from one site to another to replace a lost portion of the body surface skin.%A%    
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D016038 2006
% 214.96/215.19  |- mesh__historyNote mesh__D016038
% 214.96/215.19       90; was SKIN/transplantation 1966-89; was heading 1963-65%A%  
% 214.96/215.19  |- skos__broader mesh__D016038smesh__D016378
% 214.96/215.19  |- mesh__dateCreated mesh__D016038 1989-05-25
% 214.96/215.19  |- mesh__recordOriginator mesh__D016038 PXP
% 214.96/215.19  |- skos__annotation mesh__D016038
% 214.96/215.19       do not use /util except by MeSH definition; do not coord with TRANSPLANTATION, AUTOLOGOUS or TRANSPLANTATION, HETEROTOPIC unless particularly discussed%A%  
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D016038 2004
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D016038 2005
% 214.96/215.19  |- skos__hiddenLabel mesh__D016038 Graftings, Skin
% 214.96/215.19  |- mesh__publicMeSHNote mesh__D016038
% 214.96/215.19       90; was SKIN/transplantation 1966-89; was heading 1963-65%A%  
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D016038 2003
% 214.96/215.19  |- skos__altLabel mesh__D016038 Transplantation, Skin
% 214.96/215.19  |- skos__hiddenLabel mesh__D016038 Dermatoplasties
% 214.96/215.19  |- skos__prefLabel mesh__D016038 Skin Transplantation
% 214.96/215.19  |- skos__hiddenLabel mesh__D016038 Skin Grafting
% 214.96/215.19  |- skos__hiddenLabel mesh__D016038 Transplantations, Skin
% 214.96/215.19  |- skos__hiddenLabel mesh__D016038 Skin Transplantations
% 214.96/215.19  |- skos__hiddenLabel mesh__D016038 Skin Graftings
% 214.96/215.19  |- mesh__recordAuthorizer mesh__D016038 sjn
% 214.96/215.19  |- skos__altLabel mesh__D016038 Dermatoplasty
% 214.96/215.19  |- mesh__dateEstablished mesh__D016038 1990-01-01
% 214.96/215.19  |- mesh__dateRevised mesh__D016038 2002-07-03
% 214.96/215.19  |- mesh__recordMaintainer mesh__D002816 ags
% 214.96/215.19  |- mesh__historyNote mesh__D002816 2000%28%1966%29%   
% 214.96/215.19  |- mesh__recordAuthorizer mesh__D002816 sjn
% 214.96/215.19  |- skos__scopeNote mesh__D002816
% 214.96/215.19       A portion of the animal phylum Chordata comprised of the subphyla Cephalochordata, UROCHORDATA, and HYPEROTRETI, but not including the Vertebrata %28%VERTEBRATES%29%. It includes nonvertebrate animals having a NOTOCHORD during some developmental stage.%A%    
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D002816 2005
% 214.96/215.19  |- skos__broader mesh__D002816smesh__D043344
% 214.96/215.19  |- mesh__recordOriginator mesh__D002816 NLM
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D002816 2006
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D002816 2004
% 214.96/215.19  |- mesh__publicMeSHNote mesh__D002816 2000; see CHORDATA 1966-1999   
% 214.96/215.19  |- mesh__dateCreated mesh__D002816 1999-01-01
% 214.96/215.19  |- skos__broader mesh__D002816smesh__D007448
% 214.96/215.19  |- skos__prefLabel mesh__D002816 Chordata, Nonvertebrate
% 214.96/215.19  |- mesh__dateRevised mesh__D002816 2003-07-09
% 214.96/215.19  |- rdf__type mesh__D002816sskos__Concept
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D002018 2001
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D002018 1999
% 214.96/215.19  |- mesh__dateRevised mesh__D002018 1993-06-03
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D002018 2006
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D002018 1994
% 214.96/215.19  |- mesh__dateEstablished mesh__D002018 1968-01-01
% 214.96/215.19  |- rdf__type mesh__D002018sskos__Concept
% 214.96/215.19  |- mesh__recordMaintainer mesh__D002018 PLS
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D002018 1995
% 214.96/215.19  |- mesh__recordOriginator mesh__D002018 NLM
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D002018 2002
% 214.96/215.19  |- skos__annotation mesh__D002018
% 214.96/215.19       includes bufenolides, bufadienolides, bufatrienolides   
% 214.96/215.19  |- mesh__recordAuthorizer mesh__D002018 PLS
% 214.96/215.19  |- mesh__historyNote mesh__D002018 68   
% 214.96/215.19  |- skos__prefLabel mesh__D002018 Bufanolides
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D002018 1996
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D002018 2003
% 214.96/215.19  |- mesh__dateCreated mesh__D002018 1999-01-01
% 214.96/215.19  |- mesh__publicMeSHNote mesh__D002018 68   
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D002018 2000
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D002018 1998
% 214.96/215.19  |- skos__scopeNote mesh__D002018
% 214.96/215.19       Steroids derived from various Bufo species and often possessing cardiotonic properties.%A%    
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D002018 1997
% 214.96/215.19  |- skos__broader mesh__D002018smesh__D013256
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D002018 2005
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D002018 2004
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D007501 2006
% 214.96/215.19  |- skos__related mesh__D007501smesh__D005290
% 214.96/215.19  |- mesh__historyNote mesh__D007501
% 214.96/215.19       /metabolism was IRON METABOLISM 1963-65   
% 214.96/215.19  |- skos__hiddenLabel mesh__D007501 Iron Level, Serum
% 214.96/215.19  |- skos__related mesh__D007501smesh__D007504
% 214.96/215.19  |- skos__related mesh__D007501smesh__D006486
% 214.96/215.19  |- mesh__publicMeSHNote mesh__D007501
% 214.96/215.19       /metabolism was IRON METABOLISM 1963-65   
% 214.96/215.19  |- skos__altLabel mesh__D007501 TIBC
% 214.96/215.19  |- mesh__dateRevised mesh__D007501 2005-06-30
% 214.96/215.19  |- rdf__type mesh__D007501sskos__Concept
% 214.96/215.19  |- skos__hiddenLabel mesh__D007501 Serum Total Iron Binding Capacity
% 214.96/215.19  |- skos__related mesh__D007501smesh__D007503
% 214.96/215.19  |- skos__scopeNote mesh__D007501
% 214.96/215.19       A metallic element found in certain minerals, in nearly all soils, and in mineral waters. It has the atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transport of oxygen to tissue %28%hemoglobin%29% and in cellular oxidation mechanisms. Depletion of iron stores may result in iron-deficiency anemia. Iron is used to build up the blood in anemia. %28%From Dorland, 27th ed%29%%A%    
% 214.96/215.19  |- mesh__recordAuthorizer mesh__D007501 sjn
% 214.96/215.19  |- skos__annotation mesh__D007501
% 214.96/215.19       Fe-56; Fe%28%II%29% = FERROUS COMPOUNDS, Fe%28%III%29% = FERRIC COMPOUNDS;  /defic: permitted but consider ANEMIA, IRON DEFICIENCY; pneumoconiosis caused by iron particles = SIDEROSIS; /metab: consider also IRON OVERLOAD; metabolic disorders = IRON METABOLISM DISORDERS%A%  
% 214.96/215.19  |- skos__broader mesh__D007501smesh__D028561
% 214.96/215.19  |- skos__hiddenLabel mesh__D007501 Level, Serum Iron
% 214.96/215.19  |- mesh__dateCreated mesh__D007501 1999-01-01
% 214.96/215.19  |- skos__related mesh__D007501smesh__D012806
% 214.96/215.19  |- skos__related mesh__D007501smesh__D014168
% 214.96/215.19  |- mesh__recordOriginator mesh__D007501 NLM
% 214.96/215.19  |- skos__prefLabel mesh__D007501 Iron
% 214.96/215.19  |- skos__broader mesh__D007501smesh__D019216
% 214.96/215.19  |- skos__related mesh__D007501smesh__D006485
% 214.96/215.19  |- skos__related mesh__D007501smesh__D005293
% 214.96/215.19  |- mesh__recordMaintainer mesh__D007501 ssb
% 214.96/215.19  |- skos__related mesh__D007501smesh__D005296
% 214.96/215.19  |- skos__scopeNote mesh__D012446
% 214.96/215.19       The immovable joint formed by the lateral surfaces of the SACRUM and ILIUM.%A%    
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012446 2001
% 214.96/215.19  |- mesh__dateCreated mesh__D012446 1999-01-01
% 214.96/215.19  |- skos__prefLabel mesh__D012446 Sacroiliac Joint
% 214.96/215.19  |- skos__hiddenLabel mesh__D012446 Joint, Sacroiliac
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012446 2006
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012446 2000
% 214.96/215.19  |- rdf__type mesh__D012446sskos__Concept
% 214.96/215.19  |- mesh__recordOriginator mesh__D012446 NLM
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012446 2005
% 214.96/215.19  |- skos__hiddenLabel mesh__D012446 Joints, Sacroiliac
% 214.96/215.19  |- mesh__dateRevised mesh__D012446 1999-11-03
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012446 2004
% 214.96/215.19  |- skos__broader mesh__D012446smesh__D007596
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012446 2003
% 214.96/215.19  |- skos__annotation mesh__D012446
% 214.96/215.19       sacroiliitis %28%note spelling%29%: coord IM with ARTHRITIS or specific indention %28%IM%29%%A%  
% 214.96/215.19  |- skos__hiddenLabel mesh__D012446 Sacroiliac Joints
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D012446 2002
% 214.96/215.19  |- mesh__recordAuthorizer mesh__D012446 sjn
% 214.96/215.19  |- mesh__recordMaintainer mesh__D012446 KEV
% 214.96/215.19  |- skos__scopeNote mesh__D006409 Blood-filled UTERUS.     
% 214.96/215.19  |- mesh__publicMeSHNote mesh__D006409
% 214.96/215.19       79; was see under UTERINE DISEASES 1975-78   
% 214.96/215.19  |- mesh__recordAuthorizer mesh__D006409 sjn
% 214.96/215.19  |- mesh__dateRevised mesh__D006409 2005-06-30
% 214.96/215.19  |- skos__annotation mesh__D006409 do not confuse with UTERINE HEMORRHAGE   
% 214.96/215.19  |- rdf__type mesh__D006409sskos__Concept
% 214.96/215.19  |- mesh__dateCreated mesh__D006409 1974-11-19
% 214.96/215.19  |- mesh__dateEstablished mesh__D006409 1979-01-01
% 214.96/215.19  |- skos__prefLabel mesh__D006409 Hematometra
% 214.96/215.19  |- skos__broader mesh__D006409smesh__D014591
% 214.96/215.19  |- mesh__recordOriginator mesh__D006409 NLM
% 214.96/215.19  |- skos__hiddenLabel mesh__D006409 Hematometras
% 214.96/215.19  |- skos__historyNote mesh__D006409 Uterine Diseases %28%1966-1974%29%
% 214.96/215.19  |- mesh__historyNote mesh__D006409
% 214.96/215.19       79%28%75%29%; was see under UTERINE DISEASES 1975-78   
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D006409 2006
% 214.96/215.19  |- mesh__recordMaintainer mesh__D006409 lkt
% 214.96/215.19  |- skos__hiddenLabel mesh__D017131 Thrombectomies
% 214.96/215.19  |- mesh__historyNote mesh__D017131 93   
% 214.96/215.19  |- skos__scopeNote mesh__D017131
% 214.96/215.19       Surgical removal of an obstructing clot or foreign material from a blood vessel at the point of its formation. Removal of a clot arising from a distant site is called EMBOLECTOMY.%A%    
% 214.96/215.19  |- mesh__publicMeSHNote mesh__D017131 93   
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D017131 2006
% 214.96/215.19  |- skos__related mesh__D017131smesh__D017128
% 214.96/215.19  |- skos__historyNote mesh__D017131
% 214.96/215.19       Thrombophlebitis/surgery %28%1966-1992%29%
% 214.96/215.19  |- skos__annotation mesh__D017131
% 214.96/215.19       removal of thrombus at its original site: differentiate from EMBOLECTOMY, removal of embolus transported from its origin; do not use /util except by MeSH definition%A%  
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D017131 2005
% 214.96/215.19  |- skos__historyNote mesh__D017131 Thrombosis/surgery %28%1966-1992%29%
% 214.96/215.19  |- skos__prefLabel mesh__D017131 Thrombectomy
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D017131 2002
% 214.96/215.19  |- skos__broader mesh__D017131smesh__D014656
% 214.96/215.19  |- mesh__dateRevised mesh__D017131 1997-06-20
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D017131 2004
% 214.96/215.19  |- rdf__type mesh__D017131sskos__Concept
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D017131 1999
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D017131 2001
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D017131 2003
% 214.96/215.19  |- mesh__recordAuthorizer mesh__D017131 SJN
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D017131 2000
% 214.96/215.19  |- mesh__dateEstablished mesh__D017131 1993-01-01
% 214.96/215.19  |- mesh__recordMaintainer mesh__D017131 PXP
% 214.96/215.19  |- mesh__recordOriginator mesh__D017131 AGS
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D017131 1998
% 214.96/215.19  |- mesh__dateCreated mesh__D017131 1992-05-22
% 214.96/215.19  |- mesh__recordOriginator mesh__D050565 AKE
% 214.96/215.19  |- skos__hiddenLabel mesh__D050565 4-Monooxygenase, Benzoate
% 214.96/215.19  |- skos__hiddenLabel mesh__D050565 4-Hydroxylase, Benzoate
% 214.96/215.19  |- mesh__dateEstablished mesh__D050565 2006-01-01
% 214.96/215.19  |- skos__hiddenLabel mesh__D050565 Benzoate Para Hydroxylase
% 214.96/215.19  |- skos__altLabel mesh__D050565 Benzoate 4-Hydroxylase
% 214.96/215.19  |- skos__scopeNote mesh__D050565
% 214.96/215.19       An enzyme that catalyzes the oxidation of BENZOATE to 4-HYDROXYBENZOATE. It requires IRON and tetrahydropteridine.%A%    
% 214.96/215.19  |- skos__hiddenLabel mesh__D050565 Benzoate 4 Monooxygenase
% 214.96/215.19  |- skos__hiddenLabel mesh__D050565 Benzoate 4 Hydroxylase
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D050565 2006
% 214.96/215.19  |- rdf__type mesh__D050565sskos__Concept
% 214.96/215.19  |- mesh__dateCreated mesh__D050565 2005-06-30
% 214.96/215.19  |- mesh__historyNote mesh__D050565
% 214.96/215.19       2006%28%1980%29%; use BENZOATES 1977-1979   
% 214.96/215.19  |- skos__broader mesh__D050565smesh__D006899
% 214.96/215.19  |- mesh__recordAuthorizer mesh__D050565 sjn
% 214.96/215.19  |- mesh__recordMaintainer mesh__D050565 AKE
% 214.96/215.19  |- mesh__publicMeSHNote mesh__D050565
% 214.96/215.19       2006; BENZOATE 4-MONOOXYGENASE was indexed under MIXED FUNCTION OXYGENASES 1982-2005, %26% under BENZOATES 1977-1981%A%  
% 214.96/215.19  |- skos__altLabel mesh__D050565 Benzoate-Para-Hydroxylase
% 214.96/215.19  |- skos__prefLabel mesh__D050565 Benzoate 4-Monooxygenase
% 214.96/215.19  |- mesh__historyNote mesh__D003111 84   
% 214.96/215.19  |- skos__hiddenLabel mesh__D003111 Polyps, Colonic
% 214.96/215.19  |- mesh__recordOriginator mesh__D003111 VDK
% 214.96/215.19  |- rdf__type mesh__D003111sskos__Concept
% 214.96/215.19  |- skos__scopeNote mesh__D003111
% 214.96/215.19       Discrete tissue masses that protrude into the lumen of the COLON. These POLYPS are connected to the wall of the colon either by a stalk, pedunculus, or by a broad base.%A%    
% 214.96/215.19  |- skos__hiddenLabel mesh__D003111 Colonic Polyp
% 214.96/215.19  |- skos__historyNote mesh__D003111 Intestinal Polyps %28%1968-1983%29%
% 214.96/215.19  |- mesh__recordAuthorizer mesh__D003111 sjn
% 214.96/215.19  |- mesh__dateRevised mesh__D003111 2003-07-09
% 214.96/215.19  |- skos__hiddenLabel mesh__D003111 Polyp, Colonic
% 214.96/215.19  |- skos__broader mesh__D003111smesh__D007417
% 214.96/215.19  |- mesh__dateEstablished mesh__D003111 1984-01-01
% 214.96/215.19  |- mesh__dateCreated mesh__D003111 1983-05-31
% 214.96/215.19  |- skos__historyNote mesh__D003111 Colonic Neoplasms %28%1966-1983%29%
% 214.96/215.19  |- mesh__recordMaintainer mesh__D003111 lkt
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D003111 2004
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D003111 2006
% 214.96/215.19  |- skos__prefLabel mesh__D003111 Colonic Polyps
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D003111 2005
% 214.96/215.19  |- mesh__publicMeSHNote mesh__D003111 84   
% 214.96/215.19  |- mesh__activeMeSHYear mesh__D016837 2005
% 214.96/215.20  |- skos__altLabel mesh__D016837 Slime Molds, Cellular
% 214.96/215.20  |- mesh__publicMeSHNote mesh__D016837 92   
% 214.96/215.20  |- skos__scopeNote mesh__D016837
% 214.96/215.20       An order of protozoa characterized by their ability to aggregate to form a multicellular pseudoplasmodium, which gives rise to a multispored fruiting body. A stalk tube is present.%A%    
% 214.96/215.20  |- skos__altLabel mesh__D016837 Dictyostelid Cellular Slime Molds
% 214.96/215.20  |- mesh__activeMeSHYear mesh__D016837 2006
% 214.96/215.20  |- rdf__type mesh__D016837sskos__Concept
% 214.96/215.20  |- mesh__dateRevised mesh__D016837 2003-07-09
% 214.96/215.20  |- mesh__historyNote mesh__D016837 92   
% 214.96/215.20  |- mesh__recordAuthorizer mesh__D016837 sjn
% 214.96/215.20  |- mesh__dateEstablished mesh__D016837 1992-01-01
% 215.06/215.20  |- mesh__recordOriginator mesh__D016837 PXP
% 215.06/215.20  |- skos__broader mesh__D016837smesh__D016836
% 215.06/215.20  |- mesh__dateCreated mesh__D016837 1991-05-02
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D016837 2004
% 215.06/215.20  |- skos__prefLabel mesh__D016837 Dictyosteliida
% 215.06/215.20  |- mesh__recordMaintainer mesh__D016837 ags
% 215.06/215.20  |- skos__broader mesh__D016039smesh__D013508
% 215.06/215.20  |- skos__altLabel mesh__D016039 Grafting, Corneal
% 215.06/215.20  |- skos__hiddenLabel mesh__D016039 Corneal Grafting
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D016039 2005
% 215.06/215.20  |- skos__altLabel mesh__D016039 Keratoplasty
% 215.06/215.20  |- skos__altLabel mesh__D016039 Cornea Transplantation
% 215.06/215.20  |- mesh__publicMeSHNote mesh__D016039
% 215.06/215.20       90; was CORNEA/transplantation 1966-89; was heading 1963-65%A%  
% 215.06/215.20  |- mesh__dateRevised mesh__D016039 2004-07-13
% 215.06/215.20  |- skos__prefLabel mesh__D016039 Corneal Transplantation
% 215.06/215.20  |- mesh__recordOriginator mesh__D016039 PXP
% 215.06/215.20  |- skos__related mesh__D016039smesh__D005125
% 215.06/215.20  |- skos__hiddenLabel mesh__D016039 Lamellar Keratoplasties
% 215.06/215.20  |- skos__altLabel mesh__D016039 Transplantation, Corneal
% 215.06/215.20  |- skos__hiddenLabel mesh__D016039 Transplantations, Cornea
% 215.06/215.20  |- skos__hiddenLabel mesh__D016039 Transplantations, Corneal
% 215.06/215.20  |- skos__hiddenLabel mesh__D016039 Corneal Graftings
% 215.06/215.20  |- mesh__historyNote mesh__D016039
% 215.06/215.20       90; was CORNEA/transplantation 1966-89; was heading 1963-65%A%  
% 215.06/215.20  |- mesh__recordAuthorizer mesh__D016039 sjn
% 215.06/215.20  |- skos__annotation mesh__D016039
% 215.06/215.20       do not use /util except by MeSH definition; do not coord with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed%A%  
% 215.06/215.20  |- mesh__recordMaintainer mesh__D016039 sjn
% 215.06/215.20  |- skos__hiddenLabel mesh__D016039 Cornea Transplantations
% 215.06/215.20  |- skos__historyNote mesh__D016039 Cornea/transplantation %28%1966-1989%29%
% 215.06/215.20  |- skos__hiddenLabel mesh__D016039 Graftings, Corneal
% 215.06/215.20  |- skos__hiddenLabel mesh__D016039 Lamellar Keratoplasty
% 215.06/215.20  |- skos__hiddenLabel mesh__D016039 Keratoplasties
% 215.06/215.20  |- rdf__type mesh__D016039sskos__Concept
% 215.06/215.20  |- skos__hiddenLabel mesh__D016039 Keratoplasties, Lamellar
% 215.06/215.20  |- mesh__dateEstablished mesh__D016039 1990-01-01
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D016039 2006
% 215.06/215.20  |- skos__altLabel mesh__D016039 Transplantation, Cornea
% 215.06/215.20  |- skos__broader mesh__D016039smesh__D016378
% 215.06/215.20  |- skos__hiddenLabel mesh__D016039 Corneal Transplantations
% 215.06/215.20  |- mesh__dateCreated mesh__D016039 1989-05-25
% 215.06/215.20  |- skos__scopeNote mesh__D016039
% 215.06/215.20       Partial or total replacement of the cornea from one human or animal to another.%A%    
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002817 2000
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002817 2003
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002817 2006
% 215.06/215.20  |- skos__prefLabel mesh__D002817 Chordoma
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002817 2001
% 215.06/215.20  |- skos__annotation mesh__D002817
% 215.06/215.20       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002817 2004
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002817 2002
% 215.06/215.20  |- skos__scopeNote mesh__D002817
% 215.06/215.20       A malignant tumor arising from the embryonic remains of the notochord. It is also called chordocarcinoma, chordoepithelioma, and notochordoma. %28%Dorland, 27th ed%29%%A%    
% 215.06/215.20  |- skos__hiddenLabel mesh__D002817 Chordomas
% 215.06/215.20  |- mesh__dateCreated mesh__D002817 1999-01-01
% 215.06/215.20  |- mesh__dateRevised mesh__D002817 1995-06-08
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002817 1998
% 215.06/215.20  |- mesh__recordAuthorizer mesh__D002817 PLS
% 215.06/215.20  |- rdf__type mesh__D002817sskos__Concept
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002817 1996
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002817 1999
% 215.06/215.20  |- mesh__recordMaintainer mesh__D002817 KEV
% 215.06/215.20  |- skos__broader mesh__D002817smesh__D009373
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002817 2005
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002817 1997
% 215.06/215.20  |- mesh__recordOriginator mesh__D002817 NLM
% 215.06/215.20  |- skos__hiddenLabel mesh__D002019 Bufexamac ratiopharm Brand
% 215.06/215.20  |- skos__broader mesh__D002019smesh__D006877
% 215.06/215.20  |- skos__altLabel mesh__D002019 Scheurich Brand of Bufexamac
% 215.06/215.20  |- skos__altLabel mesh__D002019 p-Butoxyphenylacethydroxamic Acid
% 215.06/215.20  |- skos__altLabel mesh__D002019 Whitehall Brand of Bufexamac
% 215.06/215.20  |- skos__altLabel mesh__D002019 ratiopharm Brand of Bufexamac
% 215.06/215.20  |- mesh__dateRevised mesh__D002019 2004-07-07
% 215.06/215.20  |- skos__hiddenLabel mesh__D002019 Bufexamac Scheurich Brand
% 215.06/215.20  |- skos__altLabel mesh__D002019 Merck dura Brand of Bufexamac
% 215.06/215.20  |- skos__broader mesh__D002019smesh__D044482
% 215.06/215.20  |- mesh__recordMaintainer mesh__D002019 mdb
% 215.06/215.20  |- skos__hiddenLabel mesh__D002019 Bufexamac GALENpharma Brand
% 215.06/215.20  |- mesh__historyNote mesh__D002019
% 215.06/215.20       91%28%75%29%; was see under HYDROXAMIC ACIDS 1975-90   
% 215.06/215.20  |- mesh__publicMeSHNote mesh__D002019
% 215.06/215.20       91; was see under HYDROXAMIC ACIDS 1975-90   
% 215.06/215.20  |- skos__altLabel mesh__D002019 Pharmacia Brand of Bufexamac
% 215.06/215.20  |- skos__hiddenLabel mesh__D002019 Bufexamac Pharmacia Brand
% 215.06/215.20  |- skos__altLabel mesh__D002019 GALENpharma Brand of Bufexamac
% 215.06/215.20  |- skos__hiddenLabel mesh__D002019 Bufexamac AHP Brand
% 215.06/215.20  |- skos__hiddenLabel mesh__D002019 Bufexamac ratiopharm
% 215.06/215.20  |- skos__hiddenLabel mesh__D002019 Bufexamac Bioglan Brand
% 215.06/215.20  |- skos__scopeNote mesh__D002019
% 215.06/215.20       A benzeneacetamide with anti-inflammatory, analgesic, and antipyretic action. It is administered topically, orally, or rectally.%A%    
% 215.06/215.20  |- skos__altLabel mesh__D002019 Pierre Fabre Brand of Bufexamac
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002019 2005
% 215.06/215.20  |- skos__historyNote mesh__D002019 Hydroxamic Acids %28%1971-1974%29%
% 215.06/215.20  |- skos__hiddenLabel mesh__D002019 Acid, p-Butoxyphenylacethydroxamic
% 215.06/215.20  |- skos__hiddenLabel mesh__D002019 Bufexamac Dermapharm Brand
% 215.06/215.20  |- skos__altLabel mesh__D002019 Dermapharm Brand of Bufexamac
% 215.06/215.20  |- skos__historyNote mesh__D002019 Phenylacetates %28%1971-1974%29%
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002019 2006
% 215.06/215.20  |- skos__hiddenLabel mesh__D002019 p Butoxyphenylacethydroxamic Acid
% 215.06/215.20  |- skos__altLabel mesh__D002019 AHP Brand of Bufexamac
% 215.06/215.20  |- mesh__recordOriginator mesh__D002019 NLM
% 215.06/215.20  |- skos__altLabel mesh__D002019 Parfenac
% 215.06/215.20  |- mesh__dateCreated mesh__D002019 1974-11-19
% 215.06/215.20  |- skos__prefLabel mesh__D002019 Bufexamac
% 215.06/215.20  |- skos__hiddenLabel mesh__D002019 Bufexamacratiopharm
% 215.06/215.20  |- mesh__dateEstablished mesh__D002019 1991-01-01
% 215.06/215.20  |- rdf__type mesh__D002019sskos__Concept
% 215.06/215.20  |- skos__altLabel mesh__D002019 Bioglan Brand of Bufexamac
% 215.06/215.20  |- skos__altLabel mesh__D002019 Paraderm
% 215.06/215.20  |- mesh__recordAuthorizer mesh__D002019 sjn
% 215.06/215.20  |- skos__hiddenLabel mesh__D002019 Bufexamac Whitehall Brand
% 215.06/215.20  |- mesh__recordOriginator mesh__D007502 NLM
% 215.06/215.20  |- mesh__dateRevised mesh__D007502 2003-07-09
% 215.06/215.20  |- skos__broader mesh__D007502smesh__D002614
% 215.06/215.20  |- mesh__recordMaintainer mesh__D007502 ssb
% 215.06/215.20  |- skos__annotation mesh__D007502 D25-26 qualif   
% 215.06/215.20  |- mesh__historyNote mesh__D007502 98%28%63%29%   
% 215.06/215.20  |- rdf__type mesh__D007502sskos__Concept
% 215.06/215.20  |- skos__scopeNote mesh__D007502
% 215.06/215.20       Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems.%A%    
% 215.06/215.20  |- skos__altLabel mesh__D007502 Iron Chelates
% 215.06/215.20  |- mesh__dateCreated mesh__D007502 1999-01-01
% 215.06/215.20  |- skos__hiddenLabel mesh__D007502 Chelating Agents, Iron
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D007502 2005
% 215.06/215.20  |- skos__prefLabel mesh__D007502 Iron Chelating Agents
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D007502 2006
% 215.06/215.20  |- mesh__recordAuthorizer mesh__D007502 sjn
% 215.06/215.20  |- mesh__publicMeSHNote mesh__D007502 98; see IRON CHELATES 1963-97   
% 215.06/215.20  |- skos__hiddenLabel mesh__D007502 Agents, Iron Chelating
% 215.06/215.20  |- skos__hiddenLabel mesh__D007502 Chelates, Iron
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D007502 2004
% 215.06/215.20  |- rdf__type mesh__D012447sskos__Concept
% 215.06/215.20  |- mesh__recordMaintainer mesh__D012447 TGC
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D012447 2002
% 215.06/215.20  |- skos__prefLabel mesh__D012447 Sacrum
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D012447 1995
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D012447 2005
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D012447 1991
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D012447 2001
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D012447 1999
% 215.06/215.20  |- mesh__dateRevised mesh__D012447 1990-06-05
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D012447 1994
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D012447 2004
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D012447 2000
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D012447 1998
% 215.06/215.20  |- mesh__recordAuthorizer mesh__D012447 PLS
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D012447 1993
% 215.06/215.20  |- skos__annotation mesh__D012447
% 215.06/215.20       a bone of the spine; do not confuse with LUMBOSACRAL REGION or SACROCOCCYGEAL REGION, both locational: use term in the text; coord IM with specific disease %28%IM%29%%A%  
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D012447 2003
% 215.06/215.20  |- mesh__recordOriginator mesh__D012447 NLM
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D012447 1997
% 215.06/215.20  |- skos__hiddenLabel mesh__D012447 Sacrums
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D012447 1992
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D012447 1996
% 215.06/215.20  |- mesh__dateCreated mesh__D012447 1999-01-01
% 215.06/215.20  |- skos__broader mesh__D012447smesh__D013131
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D012447 2006
% 215.06/215.20  |- mesh__historyNote mesh__D017930 1994   
% 215.06/215.20  |- mesh__dateEstablished mesh__D017930 1994-01-01
% 215.06/215.20  |- skos__broader mesh__D017930smesh__D005796
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D017930 2006
% 215.06/215.20  |- mesh__recordMaintainer mesh__D017930 nns
% 215.06/215.20  |- mesh__recordAuthorizer mesh__D017930 sjn
% 215.06/215.20  |- skos__hiddenLabel mesh__D017930 Gene, Reporter
% 215.06/215.20  |- skos__hiddenLabel mesh__D017930 Reporter Gene
% 215.06/215.20  |- rdf__type mesh__D017930sskos__Concept
% 215.06/215.20  |- mesh__recordOriginator mesh__D017930 PXP
% 215.06/215.20  |- skos__historyNote mesh__D017930
% 215.06/215.20       Promoter Regions %28%Genetics%29% %28%1987-1993%29%
% 215.06/215.20  |- mesh__dateCreated mesh__D017930 1993-02-16
% 215.06/215.20  |- skos__scopeNote mesh__D017930
% 215.06/215.20       Genes whose expression is easily detectable and therefore used to study promoter activity at many positions in a target genome. In recombinant DNA technology, these genes may be attached to a promoter region of interest.%A%    
% 215.06/215.20  |- mesh__dateRevised mesh__D017930 2005-06-30
% 215.06/215.20  |- skos__prefLabel mesh__D017930 Genes, Reporter
% 215.06/215.20  |- mesh__publicMeSHNote mesh__D017930 1994   
% 215.06/215.20  |- skos__altLabel mesh__D017930 Reporter Genes
% 215.06/215.20  |- skos__prefLabel mesh__D031601 Azadirachta
% 215.06/215.20  |- rdf__type mesh__D031601sskos__Concept
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D031601 2006A
% 215.06/215.20  |- mesh__recordMaintainer mesh__D031601 ags
% 215.06/215.20  |- mesh__recordOriginator mesh__D031601 ssb
% 215.06/215.20  |- skos__altLabel mesh__D031601 Neem Tree
% 215.06/215.20  |- mesh__historyNote mesh__D031601 2003   
% 215.06/215.20  |- mesh__dateCreated mesh__D031601 2002-07-02
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D031601 2003
% 215.06/215.20  |- skos__scopeNote mesh__D031601
% 215.06/215.20       A plant genus of the family MELIACEAE. Members contain azadirachtin A %28%a limonoid commonly referred to as azadirachtin%29% and other TRITERPENES. They have been used in PESTICIDES. The old name of Melia azadirachta is very similar to a related plant, MELIA AZEDARACH.%A%    
% 215.06/215.20  |- mesh__publicMeSHNote mesh__D031601 2003   
% 215.06/215.20  |- skos__altLabel mesh__D031601 Melia azadirachta
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D031601 2004
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D031601 2005
% 215.06/215.20  |- mesh__recordAuthorizer mesh__D031601 ags
% 215.06/215.20  |- skos__annotation mesh__D031601
% 215.06/215.20       X ref MELIA AZADIRACHTA: MELIA AZEDARACH is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D031601 2006
% 215.06/215.20  |- skos__broader mesh__D031601smesh__D029582
% 215.06/215.20  |- mesh__dateRevised mesh__D031601 2005-07-18
% 215.06/215.20  |- mesh__dateEstablished mesh__D031601 2003-01-01
% 215.06/215.20  |- skos__altLabel mesh__D017132 Job Site
% 215.06/215.20  |- skos__hiddenLabel mesh__D017132 Places, Work
% 215.06/215.20  |- skos__hiddenLabel mesh__D017132 Work Locations
% 215.06/215.20  |- skos__broader mesh__D017132smesh__D010559
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D017132 2002
% 215.06/215.20  |- mesh__dateEstablished mesh__D017132 1993-01-01
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D017132 1994
% 215.06/215.20  |- mesh__publicMeSHNote mesh__D017132 93   
% 215.06/215.20  |- skos__hiddenLabel mesh__D017132 Site, Job
% 215.06/215.20  |- rdf__type mesh__D017132sskos__Concept
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D017132 1999
% 215.06/215.20  |- skos__hiddenLabel mesh__D017132 Worksites
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D017132 2003
% 215.06/215.20  |- skos__hiddenLabel mesh__D017132 Job Sites
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D017132 1993
% 215.06/215.20  |- skos__hiddenLabel mesh__D017132 Workplaces
% 215.06/215.20  |- skos__altLabel mesh__D017132 Worksite
% 215.06/215.20  |- skos__scopeNote mesh__D017132
% 215.06/215.20       Place or physical location of work or employment.     
% 215.06/215.20  |- skos__hiddenLabel mesh__D017132 Place, Work
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D017132 1995
% 215.06/215.20  |- skos__altLabel mesh__D017132 Work Location
% 215.06/215.20  |- skos__hiddenLabel mesh__D017132 Location, Work
% 215.06/215.20  |- mesh__dateCreated mesh__D017132 1992-05-22
% 215.06/215.20  |- skos__altLabel mesh__D017132 Work-Site
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D017132 2004
% 215.06/215.20  |- skos__hiddenLabel mesh__D017132 Work Site
% 215.06/215.20  |- skos__broader mesh__D017132smesh__D004651
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D017132 1996
% 215.06/215.20  |- skos__prefLabel mesh__D017132 Workplace
% 215.06/215.20  |- skos__hiddenLabel mesh__D017132 Locations, Work
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D017132 2005
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D017132 2000
% 215.06/215.20  |- skos__hiddenLabel mesh__D017132 Sites, Job
% 215.06/215.20  |- skos__annotation mesh__D017132
% 215.06/215.20       NIM; coord with specific industry or occupation %28%IM%29% or specific milieu %28%as clinic, laboratory, hosp, school, etc.%29% %28%IM%29%%A%  
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D017132 1997
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D017132 2006
% 215.06/215.20  |- skos__hiddenLabel mesh__D017132 Work Places
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D017132 2001
% 215.06/215.20  |- skos__hiddenLabel mesh__D017132 Work-Sites
% 215.06/215.20  |- skos__altLabel mesh__D017132 Work Place
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D017132 1998
% 215.06/215.20  |- mesh__historyNote mesh__D017132 93   
% 215.06/215.20  |- mesh__dateRevised mesh__D003910 2003-07-09
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D003910 2004
% 215.06/215.20  |- rdf__type mesh__D003910sskos__Concept
% 215.06/215.20  |- mesh__publicMeSHNote mesh__D003910 73   
% 215.06/215.20  |- mesh__recordAuthorizer mesh__D003910 sjn
% 215.06/215.20  |- skos__hiddenLabel mesh__D003910 447-G, Glucanase
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D003910 2005
% 215.06/215.20  |- skos__hiddenLabel mesh__D003910 Endo Dextranase
% 215.06/215.20  |- skos__prefLabel mesh__D003910 Dextranase
% 215.06/215.20  |- skos__historyNote mesh__D003910 Glycoside Hydrolases %28%1966-1970%29%
% 215.06/215.20  |- mesh__dateEstablished mesh__D003910 1973-01-01
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D003910 2006
% 215.06/215.20  |- mesh__recordMaintainer mesh__D003910 ssb
% 215.06/215.20  |- mesh__recordOriginator mesh__D003910 NLM
% 215.06/215.20  |- mesh__dateCreated mesh__D003910 1999-01-01
% 215.06/215.20  |- skos__broader mesh__D003910smesh__D006026
% 215.06/215.20  |- mesh__historyNote mesh__D003910 73%28%71%29%   
% 215.06/215.20  |- skos__hiddenLabel mesh__D003910 Glucanase 447 G
% 215.06/215.20  |- skos__historyNote mesh__D003112
% 215.06/215.20       Intestinal Pseudo-Obstruction, Idiopathic %28%1981-1986%29%
% 215.06/215.20  |- mesh__dateRevised mesh__D003112 2003-07-09
% 215.06/215.20  |- skos__broader mesh__D003112smesh__D003109
% 215.06/215.20  |- mesh__historyNote mesh__D003112
% 215.06/215.20       91%28%87%29%; was see under INTESTINAL PSEUDO-OBSTRUCTION 1987-90%A%  
% 215.06/215.20  |- skos__altLabel mesh__D003112 Ogilvie Disease
% 215.06/215.20  |- mesh__dateEstablished mesh__D003112 1991-01-01
% 215.06/215.20  |- skos__scopeNote mesh__D003112
% 215.06/215.20       Functional obstruction of the COLON leading to MEGACOLON in the absence of obvious COLONIC DISEASES or mechanical obstruction. When this condition is acquired, acute, and coexisting with another medical condition %28%trauma, surgery, serious injuries or illness, or medication%29%, it is called Ogilvie%27%s syndrome.%A%    
% 215.06/215.20  |- skos__hiddenLabel mesh__D003112 Syndrome, Ogilvie
% 215.06/215.20  |- skos__hiddenLabel mesh__D003112 Colonic Pseudo Obstruction
% 215.06/215.20  |- mesh__recordAuthorizer mesh__D003112 sjn
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D003112 2004
% 215.06/215.20  |- skos__altLabel mesh__D003112 Pseudo-Obstruction, Colonic
% 215.06/215.20  |- skos__hiddenLabel mesh__D003112 Colonic Pseudoobstruction
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D003112 2006
% 215.06/215.20  |- skos__historyNote mesh__D003112 Intestinal Obstruction %28%1966-1986%29%
% 215.06/215.20  |- mesh__recordOriginator mesh__D003112 RC
% 215.06/215.20  |- mesh__publicMeSHNote mesh__D003112
% 215.06/215.20       91; was see under INTESTINAL PSEUDO-OBSTRUCTION 1987-90   
% 215.06/215.20  |- skos__altLabel mesh__D003112 Pseudoobstruction, Colonic
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D003112 2005
% 215.06/215.20  |- mesh__recordMaintainer mesh__D003112 lkt
% 215.06/215.20  |- skos__altLabel mesh__D003112 Ogilvie%27%s Syndrome
% 215.06/215.20  |- skos__prefLabel mesh__D003112 Colonic Pseudo-Obstruction
% 215.06/215.20  |- mesh__dateCreated mesh__D003112 1986-06-17
% 215.06/215.20  |- skos__broader mesh__D003112smesh__D007418
% 215.06/215.20  |- rdf__type mesh__D003112sskos__Concept
% 215.06/215.20  |- skos__historyNote mesh__D003112 Colonic Diseases %28%1966-1986%29%
% 215.06/215.20  |- mesh__dateCreated mesh__D016838 1991-05-02
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D016838 2006
% 215.06/215.20  |- skos__prefLabel mesh__D016838 Physarida
% 215.06/215.20  |- mesh__recordMaintainer mesh__D016838 ags
% 215.06/215.20  |- rdf__type mesh__D016838sskos__Concept
% 215.06/215.20  |- mesh__dateEstablished mesh__D016838 1992-01-01
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D016838 2005
% 215.06/215.20  |- mesh__historyNote mesh__D016838 92   
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D016838 2004
% 215.06/215.20  |- skos__broader mesh__D016838smesh__D016836
% 215.06/215.20  |- mesh__recordOriginator mesh__D016838 PXP
% 215.06/215.20  |- mesh__dateRevised mesh__D016838 2003-07-09
% 215.06/215.20  |- skos__broader mesh__D016838smesh__D009235
% 215.06/215.20  |- mesh__recordAuthorizer mesh__D016838 sjn
% 215.06/215.20  |- mesh__publicMeSHNote mesh__D016838 92   
% 215.06/215.20  |- skos__scopeNote mesh__D016838
% 215.06/215.20       An order of protozoa characterized by a peridium and capillitium that are calcareous and a spore mass that is usually dark-colored.%A%    
% 215.06/215.20  |- mesh__dateEstablished mesh__D002818 1966-01-01
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002818 2004
% 215.06/215.20  |- skos__hiddenLabel mesh__D002818 Chordotomies
% 215.06/215.20  |- skos__annotation mesh__D002818
% 215.06/215.20       do not use /util except by MeSH definition   
% 215.06/215.20  |- mesh__recordOriginator mesh__D002818 NLM
% 215.06/215.20  |- skos__scopeNote mesh__D002818
% 215.06/215.20       Any operation on the spinal cord. %28%Stedman, 26th ed%29%     
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002818 2000
% 215.06/215.20  |- mesh__dateCreated mesh__D002818 1999-01-01
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002818 1998
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002818 2001
% 215.06/215.20  |- mesh__onlineNote mesh__D002818
% 215.06/215.20       use CORDOTOMY to search CHORDOTOMY 1966-88   
% 215.06/215.20  |- mesh__historyNote mesh__D002818 89; was CHORDOTOMY 1966-88   
% 215.06/215.20  |- rdf__type mesh__D002818sskos__Concept
% 215.06/215.20  |- skos__prefLabel mesh__D002818 Cordotomy
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002818 1999
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002818 2002
% 215.06/215.20  |- skos__altLabel mesh__D002818 Chordotomy
% 215.06/215.20  |- mesh__recordAuthorizer mesh__D002818 SJN
% 215.06/215.20  |- skos__broader mesh__D002818smesh__D003714
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002818 2005
% 215.06/215.20  |- mesh__publicMeSHNote mesh__D002818 89; was CHORDOTOMY 1966-88   
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002818 2003
% 215.06/215.20  |- skos__hiddenLabel mesh__D002818 Cordotomies
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D002818 2006
% 215.06/215.20  |- mesh__recordMaintainer mesh__D002818 PXP
% 215.06/215.20  |- mesh__dateRevised mesh__D002818 1997-06-20
% 215.06/215.20  |- skos__historyNote mesh__D013540
% 215.06/215.20       Deficiency Diseases/veterinary %28%1966-1967%29%
% 215.06/215.20  |- skos__scopeNote mesh__D013540
% 215.06/215.20       Congenital locomotor ataxia of lambs, thought to be associated with copper deficiency. It is characterized clinically by progressive incoordination of the hind limbs and pathologically by disruption of neuron and myelin development in the central nervous system. It is caused by a deficiency of metabolizable copper in the ewe during the last half of her pregnancy. %28%Dorland, 28th ed; Stedman, 26th ed%29%%A%    
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D013540 2005
% 215.06/215.20  |- skos__annotation mesh__D013540
% 215.06/215.20       animal only: disease of sheep; check tag ANIMAL; don%27%t forget also SHEEP %28%NIM%29% but do not index under SHEEP DISEASES%A%  
% 215.06/215.20  |- mesh__recordOriginator mesh__D013540 NLM
% 215.06/215.20  |- mesh__recordAuthorizer mesh__D013540 sjn
% 215.06/215.20  |- skos__prefLabel mesh__D013540 Swayback
% 215.06/215.20  |- mesh__historyNote mesh__D013540
% 215.06/215.20       91%28%68%29%; was see under SHEEP DISEASES 1968-90   
% 215.06/215.20  |- skos__hiddenLabel mesh__D013540 Enzootic Ataxias
% 215.06/215.20  |- mesh__dateCreated mesh__D013540 1999-01-01
% 215.06/215.20  |- mesh__dateRevised mesh__D013540 2003-07-09
% 215.06/215.20  |- skos__historyNote mesh__D013540 Sheep Diseases %28%1966-1967%29%
% 215.06/215.20  |- skos__broader mesh__D013540smesh__D012757
% 215.06/215.20  |- skos__hiddenLabel mesh__D013540 Ataxia, Enzootic
% 215.06/215.20  |- skos__altLabel mesh__D013540 Enzootic Ataxia
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D013540 2004
% 215.06/215.20  |- rdf__type mesh__D013540sskos__Concept
% 215.06/215.20  |- skos__historyNote mesh__D013540 Demyelinating Diseases %28%1966-1967%29%
% 215.06/215.20  |- skos__broader mesh__D013540smesh__D003677
% 215.06/215.20  |- mesh__publicMeSHNote mesh__D013540
% 215.06/215.20       91; was see under SHEEP DISEASES 1968-90   
% 215.06/215.20  |- skos__hiddenLabel mesh__D013540 Ataxias, Enzootic
% 215.06/215.20  |- mesh__recordMaintainer mesh__D013540 lkt
% 215.06/215.20  |- mesh__dateEstablished mesh__D013540 1991-01-01
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D013540 2006
% 215.06/215.20  |- skos__broader mesh__D009206Q000469smesh__D009206
% 215.06/215.20  |- mesh__preferredCombination mesh__D009206Q000469smesh__D006321Q000469
% 215.06/215.20  |- rdf__type mesh__D009206Q000469smesh__CompoundConcept
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D007503 2006
% 215.06/215.20  |- mesh__recordMaintainer mesh__D007503 nns
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D007503 2003
% 215.06/215.20  |- mesh__recordAuthorizer mesh__D007503 sjn
% 215.06/215.20  |- skos__scopeNote mesh__D007503
% 215.06/215.20       Stable iron atoms that have the same atomic number as the element iron, but differ in atomic weight. Fe-54, 57, and 58 are stable iron isotopes.%A%    
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D007503 2005
% 215.06/215.20  |- skos__broader mesh__D007503smesh__D007554
% 215.06/215.20  |- skos__annotation mesh__D007503 Fe-54, 57, 58; NIM   
% 215.06/215.20  |- mesh__recordOriginator mesh__D007503 NLM
% 215.06/215.20  |- mesh__dateCreated mesh__D007503 1999-01-01
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D007503 2002
% 215.06/215.20  |- skos__prefLabel mesh__D007503 Iron Isotopes
% 215.06/215.20  |- rdf__type mesh__D007503sskos__Concept
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D007503 2001
% 215.06/215.20  |- skos__hiddenLabel mesh__D007503 Isotopes, Iron
% 215.06/215.20  |- mesh__dateRevised mesh__D007503 2000-06-22
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D007503 2004
% 215.06/215.20  |- mesh__activeMeSHYear mesh__D045622 2006
% 215.06/215.20  |- mesh__recordMaintainer mesh__D045622 SYSTEM
% 215.06/215.20  |- skos__altLabel mesh__D045622 Entomoplasma
% 215.06/215.20  |- mesh__historyNote mesh__D045622 2004   
% 215.06/215.20  |- mesh__dateCreated mesh__D045622 2003-07-09
% 215.06/215.20  |- mesh__dateEstablished mesh__D045622 2004-01-01
% 215.06/215.20  |- skos__broader mesh__D045622smesh__D008973
% 215.06/215.21  |- mesh__publicMeSHNote mesh__D045622 2004   
% 215.06/215.21  |- mesh__recordAuthorizer mesh__D045622 sjn
% 215.06/215.21  |- skos__scopeNote mesh__D045622
% 215.06/215.21       A family of gram-negative, nonhelical, arthropod-associated bacteria in the order Entomoplasmatales. It is comprised of two genera: Entomoplasma and Mesoplasma.%A%    
% 215.06/215.21  |- skos__prefLabel mesh__D045622 Entomoplasmataceae
% 215.06/215.21  |- rdf__type mesh__D045622sskos__Concept
% 215.06/215.21  |- mesh__dateRevised mesh__D045622 2005-06-30
% 215.06/215.21  |- mesh__recordOriginator mesh__D045622 ags
% 215.06/215.21  |- mesh__recordAuthorizer mesh__D012448 SJN
% 215.06/215.21  |- skos__prefLabel mesh__D012448 Sadism
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D012448 2003
% 215.06/215.21  |- skos__hiddenLabel mesh__D012448 Sexual Sadisms
% 215.06/215.21  |- mesh__dateRevised mesh__D012448 1998-06-11
% 215.06/215.21  |- mesh__recordMaintainer mesh__D012448 JLS
% 215.06/215.21  |- mesh__dateCreated mesh__D012448 1999-01-01
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D012448 2002
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D012448 2006
% 215.06/215.21  |- rdf__type mesh__D012448sskos__Concept
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D012448 2001
% 215.06/215.21  |- skos__hiddenLabel mesh__D012448 Sadisms, Sexual
% 215.06/215.21  |- skos__hiddenLabel mesh__D012448 Sadisms
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D012448 2005
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D012448 2000
% 215.06/215.21  |- skos__broader mesh__D012448smesh__D010262
% 215.06/215.21  |- skos__scopeNote mesh__D012448
% 215.06/215.21       A condition in which there is a derivation of pleasure from inflicting pain, discomfort or humiliation on another person or persons. The sexual significance of sadistic wishes or behavior may be conscious or unconscious.%A%    
% 215.06/215.21  |- skos__hiddenLabel mesh__D012448 Sadism, Sexual
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D012448 1999
% 215.06/215.21  |- mesh__recordOriginator mesh__D012448 NLM
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D012448 2004
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D017931 2006
% 215.06/215.21  |- skos__broader mesh__D017931smesh__D009838
% 215.06/215.21  |- rdf__type mesh__D017931sskos__Concept
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D017931 2005
% 215.06/215.21  |- mesh__dateEstablished mesh__D017931 1994-01-01
% 215.06/215.21  |- skos__hiddenLabel mesh__D017931 Primers, DNA
% 215.06/215.21  |- mesh__recordOriginator mesh__D017931 PXP
% 215.06/215.21  |- skos__prefLabel mesh__D017931 DNA Primers
% 215.06/215.21  |- skos__scopeNote mesh__D017931
% 215.06/215.21       Short sequences %28%generally about 10 base pairs%29% of DNA that are complementary to sequences of messenger RNA and allow reverse transcriptases to start copying the adjacent sequences of mRNA. Primers are used extensively in genetic and molecular biology techniques.%A%    
% 215.06/215.21  |- mesh__publicMeSHNote mesh__D017931 94   
% 215.06/215.21  |- skos__hiddenLabel mesh__D017931 Primers, Oligodeoxyribonucleotide
% 215.06/215.21  |- mesh__recordAuthorizer mesh__D017931 sjn
% 215.06/215.21  |- mesh__dateCreated mesh__D017931 1993-02-16
% 215.06/215.21  |- skos__broader mesh__D017931smesh__D015342
% 215.06/215.21  |- skos__historyNote mesh__D017931
% 215.06/215.21       Oligodeoxyribonucleotides %28%1976-1993%29%
% 215.06/215.21  |- skos__altLabel mesh__D017931 Oligodeoxyribonucleotide Primers
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D017931 2004
% 215.06/215.21  |- skos__annotation mesh__D017931
% 215.06/215.21       short DNA seq important in transcription   
% 215.06/215.21  |- skos__hiddenLabel mesh__D017931 Primers, Oligonucleotide
% 215.06/215.21  |- mesh__recordMaintainer mesh__D017931 ssb
% 215.06/215.21  |- mesh__historyNote mesh__D017931 94   
% 215.06/215.21  |- skos__historyNote mesh__D017931 DNA %28%1966-1993%29%
% 215.06/215.21  |- mesh__dateRevised mesh__D017931 2003-07-09
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D031602 2006
% 215.06/215.21  |- skos__annotation mesh__D031602
% 215.06/215.21       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D031602 2005
% 215.06/215.21  |- rdf__type mesh__D031602sskos__Concept
% 215.06/215.21  |- skos__scopeNote mesh__D031602
% 215.06/215.21       A plant genus of the family MELIACEAE. Members contain lariciresinol, pregnanes, insecticidal rocaglamide derivatives and other compounds.%A%    
% 215.06/215.21  |- mesh__dateCreated mesh__D031602 2002-07-02
% 215.06/215.21  |- skos__prefLabel mesh__D031602 Aglaia
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D031602 2004
% 215.06/215.21  |- mesh__publicMeSHNote mesh__D031602 2003   
% 215.06/215.21  |- skos__broader mesh__D031602smesh__D029582
% 215.06/215.21  |- mesh__historyNote mesh__D031602 2003   
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D031602 2003
% 215.06/215.21  |- mesh__dateEstablished mesh__D031602 2003-01-01
% 215.06/215.21  |- mesh__publicMeSHNote mesh__D003911 79; was DEXTRAN 1963-78   
% 215.06/215.21  |- skos__broader mesh__D003911smesh__D005936
% 215.06/215.21  |- skos__hiddenLabel mesh__D003911 Dextran B 1355
% 215.06/215.21  |- skos__hiddenLabel mesh__D003911 Dextran T 500
% 215.06/215.21  |- mesh__historyNote mesh__D003911 79; was DEXTRAN 1963-78   
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D003911 2005
% 215.06/215.21  |- mesh__recordAuthorizer mesh__D003911 sjn
% 215.06/215.21  |- mesh__dateRevised mesh__D003911 2004-07-07
% 215.06/215.21  |- skos__hiddenLabel mesh__D003911 Dextran T 40
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D003911 2006
% 215.06/215.21  |- skos__altLabel mesh__D003911 Dextran B-1355
% 215.06/215.21  |- mesh__dateCreated mesh__D003911 1999-01-01
% 215.06/215.21  |- mesh__recordMaintainer mesh__D003911 jmp
% 215.06/215.21  |- skos__hiddenLabel mesh__D003911 Dextran B 1355 S
% 215.06/215.21  |- skos__scopeNote mesh__D003911
% 215.06/215.21       A group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes.%A%    
% 215.06/215.21  |- mesh__onlineNote mesh__D003911 use DEXTRANS to search DEXTRAN 1966-78   
% 215.06/215.21  |- rdf__type mesh__D003911sskos__Concept
% 215.06/215.21  |- mesh__recordOriginator mesh__D003911 NLM
% 215.06/215.21  |- skos__prefLabel mesh__D003911 Dextrans
% 215.06/215.21  |- skos__historyNote mesh__D003113 Colonic Diseases %28%1966-1980%29%
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D003113 2004
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D003113 2000
% 215.06/215.21  |- skos__hiddenLabel mesh__D003113 Procedures, Colonoscopic Surgical
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D003113 2006
% 215.06/215.21  |- mesh__dateCreated mesh__D003113 1980-04-04
% 215.06/215.21  |- skos__scopeNote mesh__D003113
% 215.06/215.21       Endoscopic examination, therapy or surgery of the luminal surface of the colon.%A%    
% 215.06/215.21  |- skos__hiddenLabel mesh__D003113 Surgical Procedure, Colonoscopic
% 215.06/215.21  |- skos__hiddenLabel mesh__D003113 Colonoscopic Surgeries
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D003113 2003
% 215.06/215.21  |- mesh__recordOriginator mesh__D003113 RC
% 215.06/215.21  |- skos__hiddenLabel mesh__D003113 Surgeries, Colonoscopic
% 215.06/215.21  |- skos__historyNote mesh__D003113 Endoscopy %28%1966-1980%29%
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D003113 2005
% 215.06/215.21  |- mesh__dateRevised mesh__D003113 1999-11-03
% 215.06/215.21  |- skos__hiddenLabel mesh__D003113 Colonoscopic Surgical Procedure
% 215.06/215.21  |- skos__historyNote mesh__D003113 Colonic Neoplasms %28%1966-1980%29%
% 215.06/215.21  |- skos__prefLabel mesh__D003113 Colonoscopy
% 215.06/215.21  |- rdf__type mesh__D003113sskos__Concept
% 215.06/215.21  |- mesh__recordMaintainer mesh__D003113 nns
% 215.06/215.21  |- mesh__historyNote mesh__D003113 81   
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D003113 2002
% 215.06/215.21  |- mesh__dateEstablished mesh__D003113 1981-01-01
% 215.06/215.21  |- mesh__publicMeSHNote mesh__D003113 81   
% 215.06/215.21  |- skos__hiddenLabel mesh__D003113 Colonoscopies
% 215.06/215.21  |- skos__altLabel mesh__D003113 Colonoscopic Surgery
% 215.06/215.21  |- skos__altLabel mesh__D003113 Surgery, Colonoscopic
% 215.06/215.21  |- mesh__recordAuthorizer mesh__D003113 sjn
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D003113 2001
% 215.06/215.21  |- skos__hiddenLabel mesh__D003113 Procedure, Colonoscopic Surgical
% 215.06/215.21  |- skos__altLabel mesh__D003113 Surgical Procedures, Colonoscopic
% 215.06/215.21  |- skos__broader mesh__D003113smesh__D016099
% 215.06/215.21  |- mesh__recordAuthorizer mesh__D016839 sjn
% 215.06/215.21  |- mesh__publicMeSHNote mesh__D016839 92   
% 215.06/215.21  |- skos__scopeNote mesh__D016839
% 215.06/215.21       A protozoan, previously also considered a fungus. Characteristics include sporangia that are stalked and multilobed. It is widely used in biomedical research.%A%    
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D016839 2006
% 215.06/215.21  |- mesh__recordMaintainer mesh__D016839 ags
% 215.06/215.21  |- skos__prefLabel mesh__D016839 Physarum polycephalum
% 215.06/215.21  |- rdf__type mesh__D016839sskos__Concept
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D016839 2005
% 215.06/215.21  |- mesh__historyNote mesh__D016839 92   
% 215.06/215.21  |- mesh__dateCreated mesh__D016839 1991-05-02
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D016839 2004
% 215.06/215.21  |- skos__historyNote mesh__D016839 Physarum %28%1966-1991%29%
% 215.06/215.21  |- mesh__recordOriginator mesh__D016839 PXP
% 215.06/215.21  |- mesh__dateRevised mesh__D016839 2003-07-09
% 215.06/215.21  |- mesh__dateEstablished mesh__D016839 1992-01-01
% 215.06/215.21  |- skos__annotation mesh__D016839
% 215.06/215.21       a protozoan much used in biomed research   
% 215.06/215.21  |- skos__broader mesh__D016839smesh__D010804
% 215.06/215.21  |- mesh__dateCreated mesh__D027561 2001-08-03
% 215.06/215.21  |- skos__scopeNote mesh__D027561
% 215.06/215.21       A plant species which is known as an Oriental traditional medicinal plant.%A%    
% 215.06/215.21  |- mesh__recordAuthorizer mesh__D027561 sjn
% 215.06/215.21  |- skos__annotation mesh__D027561
% 215.06/215.21       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.06/215.21  |- mesh__publicMeSHNote mesh__D027561 2002   
% 215.06/215.21  |- skos__altLabel mesh__D027561 Danshen
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D027561 2005
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D027561 2003
% 215.06/215.21  |- skos__altLabel mesh__D027561 Dan-Shen
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D027561 2006
% 215.06/215.21  |- mesh__dateEstablished mesh__D027561 2002-01-01
% 215.06/215.21  |- skos__historyNote mesh__D027561 Plants, Medicinal %28%1977-2001%29%
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D027561 2004
% 215.06/215.21  |- mesh__recordOriginator mesh__D027561 ssb
% 215.06/215.21  |- skos__prefLabel mesh__D027561 Salvia miltiorrhiza
% 215.06/215.21  |- skos__historyNote mesh__D027561
% 215.06/215.21       Medicine, Chinese Traditional %28%1977-2001%29%
% 215.06/215.21  |- rdf__type mesh__D027561sskos__Concept
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D027561 2002
% 215.06/215.21  |- skos__broader mesh__D027561smesh__D027544
% 215.06/215.21  |- mesh__historyNote mesh__D027561 2002   
% 215.06/215.21  |- mesh__recordMaintainer mesh__D027561 jls
% 215.06/215.21  |- skos__hiddenLabel mesh__D002819 Movements, Choreic
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D002819 2004
% 215.06/215.21  |- mesh__recordMaintainer mesh__D002819 KEV
% 215.06/215.21  |- skos__broader mesh__D002819smesh__D020820
% 215.06/215.21  |- skos__hiddenLabel mesh__D002819 Movements, Choreiform
% 215.06/215.21  |- mesh__dateCreated mesh__D002819 1999-01-01
% 215.06/215.21  |- skos__hiddenLabel mesh__D002819 Choreas
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D002819 2006
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D002819 2003
% 215.06/215.21  |- mesh__recordAuthorizer mesh__D002819 sjn
% 215.06/215.21  |- skos__hiddenLabel mesh__D002819 Choreiform Movements
% 215.06/215.21  |- skos__hiddenLabel mesh__D002819 Movement, Choreiform
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D002819 2002
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D002819 2005
% 215.06/215.21  |- skos__altLabel mesh__D002819 Choreic Movement
% 215.06/215.21  |- skos__hiddenLabel mesh__D002819 Choreic Movements
% 215.06/215.21  |- skos__hiddenLabel mesh__D002819 Movement, Choreic
% 215.06/215.21  |- skos__annotation mesh__D002819
% 215.06/215.21       choreoathetosis = CHOREA %28%IM%29% + ATHETOSIS %28%IM%29%; MORVAN%27%S CHOREA see MYOKYMIA and CHOREATIC DISORDERS are also available%A%  
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D002819 2001
% 215.06/215.21  |- mesh__recordOriginator mesh__D002819 NLM
% 215.06/215.21  |- skos__prefLabel mesh__D002819 Chorea
% 215.06/215.21  |- skos__altLabel mesh__D002819 Choreiform Movement
% 215.06/215.21  |- rdf__type mesh__D002819sskos__Concept
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D002819 2000
% 215.06/215.21  |- mesh__dateRevised mesh__D002819 1999-11-03
% 215.06/215.21  |- skos__scopeNote mesh__D002819
% 215.06/215.21       Involuntary, forcible, rapid, jerky movements that may be subtle or become confluent, markedly altering normal patterns of movement. Hypotonia and pendular reflexes are often associated. Conditions which feature recurrent or persistent episodes of chorea as a primary manifestation of disease are referred to as CHOREATIC DISORDERS. Chorea is also a frequent manifestation of BASAL GANGLIA DISEASES.%A%    
% 215.06/215.21  |- skos__annotation mesh__D013541 a kingdom in southern Africa   
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D013541 1997
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D013541 2000
% 215.06/215.21  |- mesh__dateCreated mesh__D013541 1974-11-11
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D013541 1996
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D013541 2004
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D013541 1999
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D013541 2002
% 215.06/215.21  |- rdf__type mesh__D013541sskos__Concept
% 215.06/215.21  |- mesh__recordOriginator mesh__D013541 NLM
% 215.06/215.21  |- skos__scopeNote mesh__D013541
% 215.06/215.21       A kingdom in southern Africa, west of MOZAMBIQUE. Its capital is Mbabane. The area was settled by the Swazi branch of the Zulu nation in the early 1880%27%s, with its independence guaranteed by the British and Transvaal governments in 1881 and 1884. With limited self-government introduced in 1962, it became independent in 1968. Swazi is the Zulu name for the people who call themselves Swati, from Mswati, the name of a 16th century king, from a word meaning stick or rod. %28%From Webster%27%s New Geographical Dictionary, 1988, p1170 %26% Room, Brewer%27%s Dictionary of Names, 1992, p527%29%%A%    
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D013541 2003
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D013541 1998
% 215.06/215.21  |- skos__prefLabel mesh__D013541 Swaziland
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D013541 2006
% 215.06/215.21  |- mesh__dateRevised mesh__D013541 1995-02-21
% 215.06/215.21  |- mesh__dateEstablished mesh__D013541 1975-01-01
% 215.06/215.21  |- mesh__recordAuthorizer mesh__D013541 PLS
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D013541 2001
% 215.06/215.21  |- skos__broader mesh__D013541smesh__D000353
% 215.06/215.21  |- mesh__recordMaintainer mesh__D013541 TGC
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D013541 2005
% 215.06/215.21  |- mesh__historyNote mesh__D013541 75   
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D007504 1994
% 215.06/215.21  |- mesh__publicMeSHNote mesh__D007504 74   
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D007504 2005
% 215.06/215.21  |- skos__annotation mesh__D007504
% 215.06/215.21       Fe-52, 53, 55, 59-61; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 215.06/215.21  |- mesh__dateCreated mesh__D007504 1999-01-01
% 215.06/215.21  |- mesh__onlineNote mesh__D007504 search IRON ISOTOPES 1966-73   
% 215.06/215.21  |- rdf__type mesh__D007504sskos__Concept
% 215.06/215.21  |- skos__hiddenLabel mesh__D007504 Radioisotopes, Iron
% 215.06/215.21  |- skos__prefLabel mesh__D007504 Iron Radioisotopes
% 215.06/215.21  |- mesh__historyNote mesh__D007504 74   
% 215.06/215.21  |- mesh__recordOriginator mesh__D007504 NLM
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D007504 1997
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D007504 2002
% 215.06/215.21  |- mesh__dateRevised mesh__D007504 1993-06-04
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D007504 1999
% 215.06/215.21  |- mesh__recordAuthorizer mesh__D007504 PLS
% 215.06/215.21  |- skos__broader mesh__D007504smesh__D011868
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D007504 2004
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D007504 2001
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D007504 1996
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D007504 1995
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D007504 2006
% 215.06/215.21  |- skos__scopeNote mesh__D007504
% 215.06/215.21       Unstable isotopes of iron that decay or disintegrate emitting radiation. Fe atoms with atomic weights 52, 53, 55, and 59-61 are radioactive iron isotopes.%A%    
% 215.06/215.21  |- skos__broader mesh__D007504smesh__D007503
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D007504 1998
% 215.06/215.21  |- mesh__dateEstablished mesh__D007504 1974-01-01
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D007504 2003
% 215.06/215.21  |- mesh__recordMaintainer mesh__D007504 TPW
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D007504 2000
% 215.06/215.21  |- skos__hiddenLabel mesh__D051660
% 215.06/215.21       Intermediate Conductance Calcium Activated Potassium Channels
% 215.06/215.21  |- mesh__publicMeSHNote mesh__D051660
% 215.06/215.21       2006; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, CALCIUM-ACTIVATED 2005, %26% under POTASSIUM CHANNELS 1997-2004%A%  
% 215.06/215.21  |- mesh__dateEstablished mesh__D051660 2006-01-01
% 215.06/215.21  |- skos__broader mesh__D051660smesh__D024681
% 215.06/215.21  |- skos__scopeNote mesh__D051660
% 215.06/215.21       A major class of calcium-activated potassium channels that were originally discovered in ERYTHROCYTES. They are found primarily in non-excitable CELLS and set up electrical gradients for PASSIVE ION TRANSPORT.%A%    
% 215.06/215.21  |- skos__altLabel mesh__D051660 FIK Channel
% 215.06/215.21  |- rdf__type mesh__D051660sskos__Concept
% 215.06/215.21  |- skos__hiddenLabel mesh__D051660 Potassium Channels, IK
% 215.06/215.21  |- mesh__recordMaintainer mesh__D051660 DRC
% 215.06/215.21  |- mesh__dateCreated mesh__D051660 2005-06-30
% 215.06/215.21  |- skos__hiddenLabel mesh__D051660
% 215.06/215.21       Potassium Channels, Intermediate Conductance Calcium Activated
% 215.06/215.21  |- mesh__historyNote mesh__D051660 2006%28%1997%29%   
% 215.06/215.21  |- skos__altLabel mesh__D051660
% 215.06/215.21       Potassium Channels, Intermediate-Conductance Calcium-Activated
% 215.06/215.21  |- skos__altLabel mesh__D051660 IK Potassium Channels
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D051660 2006
% 215.06/215.21  |- mesh__recordOriginator mesh__D051660 DRC
% 215.06/215.21  |- mesh__recordAuthorizer mesh__D051660 sjn
% 215.06/215.21  |- skos__prefLabel mesh__D051660
% 215.06/215.21       Intermediate-Conductance Calcium-Activated Potassium Channels
% 215.06/215.21  |- mesh__publicMeSHNote mesh__D045623 2004   
% 215.06/215.21  |- skos__annotation mesh__D045623
% 215.06/215.21       infection: coord IM with PLEUROPNEUMONIA, CONTAGIOUS %28%IM%29%%A%  
% 215.06/215.21  |- mesh__dateRevised mesh__D045623 2005-06-30
% 215.06/215.21  |- skos__historyNote mesh__D045623 Mycoplasma %28%1974-2003%29%
% 215.06/215.21  |- mesh__recordOriginator mesh__D045623 ags
% 215.06/215.21  |- rdf__type mesh__D045623sskos__Concept
% 215.06/215.21  |- mesh__dateEstablished mesh__D045623 2004-01-01
% 215.06/215.21  |- skos__prefLabel mesh__D045623 Mycoplasma capricolum
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D045623 2006
% 215.06/215.21  |- mesh__historyNote mesh__D045623 2004   
% 215.06/215.21  |- skos__scopeNote mesh__D045623
% 215.06/215.21       A genus in the family ENTOMOPLASMATACEAE, order Entomoplasmatales. It is pathogenic to GOATS, causing caprine pleuropneumonia %28%PLEUROPNEUMONIA, CONTAGIOUS%29%.%A%    
% 215.06/215.21  |- mesh__dateCreated mesh__D045623 2003-07-09
% 215.06/215.21  |- mesh__recordMaintainer mesh__D045623 SYSTEM
% 215.06/215.21  |- skos__broader mesh__D045623smesh__D009174
% 215.06/215.21  |- mesh__recordAuthorizer mesh__D045623 sjn
% 215.06/215.21  |- mesh__dateEstablished mesh__D012449 1991-01-01
% 215.06/215.21  |- mesh__recordOriginator mesh__D012449 NLM
% 215.06/215.21  |- mesh__dateCreated mesh__D012449 1999-01-01
% 215.06/215.21  |- skos__scopeNote mesh__D012449
% 215.06/215.21       Freedom from exposure to danger and protection from the occurrence or risk of injury or loss. It suggests optimal precautions in the workplace, on the street, in the home, etc., and includes personal safety as well as the safety of property.%A%    
% 215.06/215.21  |- mesh__recordMaintainer mesh__D012449 sjn
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D012449 2006
% 215.06/215.21  |- skos__broader mesh__D012449smesh__D000056
% 215.06/215.21  |- rdf__type mesh__D012449sskos__Concept
% 215.06/215.21  |- mesh__publicMeSHNote mesh__D012449
% 215.06/215.21       91; was see under ACCIDENT PREVENTION 1975-90   
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D012449 2005
% 215.06/215.21  |- mesh__recordAuthorizer mesh__D012449 sjn
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D012449 2004
% 215.06/215.21  |- skos__prefLabel mesh__D012449 Safety
% 215.06/215.21  |- mesh__historyNote mesh__D012449
% 215.06/215.21       91%28%75%29%; was see under ACCIDENT PREVENTION 1975-90   
% 215.06/215.21  |- skos__hiddenLabel mesh__D012449 Safeties
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D012449 2003
% 215.06/215.21  |- mesh__onlineNote mesh__D012449 search ACCIDENT PREVENTION 1966-74   
% 215.06/215.21  |- mesh__dateRevised mesh__D012449 2002-07-03
% 215.06/215.21  |- skos__annotation mesh__D012449
% 215.06/215.21       IM in unspecified circumstances %28%%22%the economics of safety%22% = SAFETY /econ%29% or specified circumstances %28%%22%safety in coal mines%22% = SAFETY %28%IM%29% + COAL MINING %28%IM%29%%29%; CONSUMER PRODUCT SAFETY %26% EQUIPMENT SAFETY are also available%A%  
% 215.06/215.21  |- skos__annotation mesh__D031603
% 215.06/215.21       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.06/215.21  |- mesh__historyNote mesh__D031603 2003   
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D031603 2005
% 215.06/215.21  |- mesh__dateEstablished mesh__D031603 2003-01-01
% 215.06/215.21  |- rdf__type mesh__D031603sskos__Concept
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D031603 2004
% 215.06/215.21  |- skos__broader mesh__D031603smesh__D029583
% 215.06/215.21  |- mesh__publicMeSHNote mesh__D031603 2003   
% 215.06/215.21  |- skos__prefLabel mesh__D031603 Menispermum
% 215.06/215.21  |- skos__altLabel mesh__D031603 Parilla, Yellow
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D031603 2003
% 215.06/215.21  |- skos__altLabel mesh__D031603 Yellow Parilla
% 215.06/215.21  |- skos__scopeNote mesh__D031603
% 215.06/215.21       A plant genus of the family MENISPERMACEAE. Members contain dauricine and other ALKALOIDS.%A%    
% 215.06/215.21  |- mesh__dateCreated mesh__D031603 2002-07-03
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D031603 2006
% 215.06/215.21  |- skos__altLabel mesh__D031603 Moonseed
% 215.06/215.21  |- mesh__historyNote mesh__D003912
% 215.06/215.21       91%28%75%29%; was see under STARCH 1979-90; was see under POLYSACCHARIDES 1963-78%A%  
% 215.06/215.21  |- rdf__type mesh__D003912sskos__Concept
% 215.06/215.21  |- mesh__recordOriginator mesh__D003912 NLM
% 215.06/215.21  |- mesh__dateEstablished mesh__D003912 1991-01-01
% 215.06/215.21  |- mesh__onlineNote mesh__D003912 search POLYSACCHARIDES 1966-74   
% 215.06/215.21  |- mesh__recordMaintainer mesh__D003912 jmp
% 215.06/215.21  |- skos__prefLabel mesh__D003912 Dextrins
% 215.06/215.21  |- skos__broader mesh__D003912smesh__D013213
% 215.06/215.21  |- mesh__dateRevised mesh__D003912 2004-07-07
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D003912 2006
% 215.06/215.21  |- mesh__recordAuthorizer mesh__D003912 sjn
% 215.06/215.21  |- mesh__publicMeSHNote mesh__D003912
% 215.06/215.21       91; was see under STARCH 1979-90; was see under POLYSACCHARIDES 1963-78%A%  
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D003912 2005
% 215.06/215.21  |- mesh__dateCreated mesh__D003912 1999-01-01
% 215.06/215.21  |- skos__broader mesh__D003114smesh__D003584
% 215.06/215.21  |- mesh__recordAuthorizer mesh__D003114 sjn
% 215.06/215.21  |- skos__hiddenLabel mesh__D003114 Assay, Stem Cell
% 215.06/215.21  |- skos__annotation mesh__D003114
% 215.06/215.21       restricted to stem cells; do not use for microbial colony-forming units %28% = COLONY COUNT, MICROBIAL%29%; DF: CFU ASSAY%A%  
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D003114 2003
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D003114 2001
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D003114 2005
% 215.06/215.21  |- skos__prefLabel mesh__D003114 Colony-Forming Units Assay
% 215.06/215.21  |- mesh__recordMaintainer mesh__D003114 TAP
% 215.06/215.21  |- mesh__historyNote mesh__D003114 79   
% 215.06/215.21  |- skos__hiddenLabel mesh__D003114 Colony Forming Units Assay
% 215.06/215.21  |- skos__hiddenLabel mesh__D003114 Assay, Clonogenic Cell
% 215.06/215.21  |- skos__historyNote mesh__D003114 Bone Marrow %28%1966-1978%29%
% 215.06/215.21  |- rdf__type mesh__D003114sskos__Concept
% 215.06/215.21  |- skos__scopeNote mesh__D003114
% 215.06/215.21       A cytologic technique for measuring the functional capacity of stem cells by assaying their activity.%A%    
% 215.06/215.21  |- skos__hiddenLabel mesh__D003114 Assay, Colony-Forming Units
% 215.06/215.21  |- skos__historyNote mesh__D003114 Spleen %28%1966-1978%29%
% 215.06/215.21  |- skos__altLabel mesh__D003114 Stem Cell Assays
% 215.06/215.21  |- skos__altLabel mesh__D003114 Colony Forming Units Assays
% 215.06/215.21  |- skos__historyNote mesh__D003114 Hematopoiesis %28%1966-1978%29%
% 215.06/215.21  |- mesh__publicMeSHNote mesh__D003114 79   
% 215.06/215.21  |- skos__historyNote mesh__D003114 Erythropoiesis %28%1966-1978%29%
% 215.06/215.21  |- skos__historyNote mesh__D003114
% 215.06/215.21       Hematopoietic Stem Cells %28%1971-1978%29%
% 215.06/215.21  |- skos__altLabel mesh__D003114 Colony-Forming Units Assays
% 215.06/215.21  |- skos__altLabel mesh__D003114 Clonogenic Cell Assay
% 215.06/215.21  |- mesh__recordOriginator mesh__D003114 SMH
% 215.06/215.21  |- skos__hiddenLabel mesh__D003114 Assays, Clonogenic Cell
% 215.06/215.21  |- skos__altLabel mesh__D003114 Clonogenic Cell Assays
% 215.06/215.21  |- mesh__dateCreated mesh__D003114 1977-11-23
% 215.06/215.21  |- skos__hiddenLabel mesh__D003114 Assays, Colony-Forming Units
% 215.06/215.21  |- skos__hiddenLabel mesh__D003114 Assays, Stem Cell
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D003114 2004
% 215.06/215.21  |- mesh__dateEstablished mesh__D003114 1979-01-01
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D003114 2002
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D003114 2006
% 215.06/215.21  |- skos__altLabel mesh__D003114 Stem Cell Assay
% 215.06/215.21  |- mesh__dateRevised mesh__D003114 2000-06-21
% 215.06/215.21  |- skos__broader mesh__D013542smesh__D012634
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D013542 2000
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D013542 2003
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D013542 2001
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D013542 2004
% 215.06/215.21  |- skos__annotation mesh__D013542
% 215.06/215.21       TN 181: relation to SWEAT GLANDS %26% SWEATING   
% 215.06/215.21  |- rdf__type mesh__D013542sskos__Concept
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D013542 2002
% 215.06/215.21  |- skos__hiddenLabel mesh__D013542 Sweats
% 215.06/215.21  |- skos__scopeNote mesh__D013542
% 215.06/215.21       The fluid excreted by the SWEAT GLANDS. It consists of water containing sodium chloride, phosphate, urea, ammonia, and other waste products.%A%    
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D013542 2005
% 215.06/215.21  |- mesh__recordMaintainer mesh__D013542 KEV
% 215.06/215.21  |- skos__prefLabel mesh__D013542 Sweat
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D013542 2006
% 215.06/215.21  |- mesh__dateCreated mesh__D013542 1999-01-01
% 215.06/215.21  |- mesh__recordAuthorizer mesh__D013542 sjn
% 215.06/215.21  |- mesh__dateRevised mesh__D013542 1999-11-03
% 215.06/215.21  |- mesh__recordOriginator mesh__D013542 NLM
% 215.06/215.21  |- skos__altLabel mesh__D007505 Watson Brand of Iron-Dextran Complex
% 215.06/215.21  |- skos__altLabel mesh__D007505
% 215.06/215.21       GlaxoSmithKline Brand of Iron-Dextran Complex
% 215.06/215.21  |- skos__scopeNote mesh__D007505
% 215.06/215.21       A complex of ferric oxyhydroxide with dextrans of 5000 to 7000 daltons in a viscous solution containing 50 mg/ml of iron. It is supplied as a parenteral preparation and is used as a hematinic. %28%Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 8th ed, p1292%29%%A%    
% 215.06/215.21  |- skos__prefLabel mesh__D007505 Iron-Dextran Complex
% 215.06/215.21  |- skos__altLabel mesh__D007505 Ferridextran
% 215.06/215.21  |- skos__broader mesh__D007505smesh__D005290
% 215.06/215.21  |- mesh__recordMaintainer mesh__D007505 CCR
% 215.06/215.21  |- skos__altLabel mesh__D007505 Dextran-Iron Complex
% 215.06/215.21  |- skos__broader mesh__D007505smesh__D003911
% 215.06/215.21  |- skos__altLabel mesh__D007505 Vortech Brand of Iron-Dextran Complex
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D007505 2006
% 215.06/215.21  |- skos__altLabel mesh__D007505 Hawthron Brand of Iron-Dextran Complex
% 215.06/215.21  |- skos__hiddenLabel mesh__D007505 Iron Dextran Complex
% 215.06/215.21  |- mesh__dateRevised mesh__D007505 2005-06-30
% 215.06/215.21  |- skos__altLabel mesh__D007505 Goldline Brand of Iron-Dextran Complex
% 215.06/215.21  |- mesh__dateCreated mesh__D007505 1999-01-01
% 215.06/215.21  |- mesh__recordAuthorizer mesh__D007505 sjn
% 215.06/215.21  |- skos__hiddenLabel mesh__D007505 Dextran Iron Complex
% 215.06/215.21  |- skos__altLabel mesh__D007505
% 215.06/215.21       American Regent Brand of Iron-Dextran Complex
% 215.06/215.21  |- skos__altLabel mesh__D007505 Sanofi Brand of Iron-Dextran Complex
% 215.06/215.21  |- mesh__recordOriginator mesh__D007505 NLM
% 215.06/215.21  |- rdf__type mesh__D007505sskos__Concept
% 215.06/215.21  |- skos__altLabel mesh__D007505 Hauck Brand of Iron-Dextran Complex
% 215.06/215.21  |- mesh__publicMeSHNote mesh__D017933 94   
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D017933 1995
% 215.06/215.21  |- skos__hiddenLabel mesh__D017933 System, Peripheral Nervous
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D017933 1998
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D017933 2004
% 215.06/215.21  |- skos__hiddenLabel mesh__D017933 Nervous System, Peripheral
% 215.06/215.21  |- mesh__activeMeSHYear mesh__D017933 2002
% 215.06/215.22  |- skos__historyNote mesh__D017933 Peripheral Nerves %28%1966-1993%29%
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017933 1994
% 215.06/215.22  |- mesh__historyNote mesh__D017933 94   
% 215.06/215.22  |- mesh__dateCreated mesh__D017933 1993-06-30
% 215.06/215.22  |- skos__prefLabel mesh__D017933 Peripheral Nervous System
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017933 2003
% 215.06/215.22  |- skos__broader mesh__D017933smesh__D009420
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017933 2006
% 215.06/215.22  |- skos__scopeNote mesh__D017933
% 215.06/215.22       The nervous system outside of the brain and spinal cord. The peripheral nervous system has autonomic and somatic divisions. The autonomic nervous system includes the enteric, parasympathetic, and sympathetic subdivisions. The somatic nervous system includes the cranial and spinal nerves and their ganglia and the peripheral sensory receptors.%A%    
% 215.06/215.22  |- skos__hiddenLabel mesh__D017933 Nervous Systems, Peripheral
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017933 1997
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017933 2001
% 215.06/215.22  |- rdf__type mesh__D017933sskos__Concept
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017933 2005
% 215.06/215.22  |- mesh__dateEstablished mesh__D017933 1994-01-01
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017933 1996
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017933 2000
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017933 1999
% 215.06/215.22  |- skos__hiddenLabel mesh__D017933 Peripheral Nervous Systems
% 215.06/215.22  |- skos__related mesh__D017933smesh__D009434
% 215.06/215.22  |- skos__hiddenLabel mesh__D017933 Systems, Peripheral Nervous
% 215.06/215.22  |- mesh__publicMeSHNote mesh__D031604 2003   
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D031604 2004
% 215.06/215.22  |- mesh__dateEstablished mesh__D031604 2003-01-01
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D031604 2003
% 215.06/215.22  |- mesh__dateCreated mesh__D031604 2002-07-03
% 215.06/215.22  |- mesh__historyNote mesh__D031604 2003   
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D031604 2006
% 215.06/215.22  |- skos__scopeNote mesh__D031604
% 215.06/215.22       A plant genus of the family MENISPERMACEAE. Members contain bisbenzylisoquinoline alkaloids.%A%    
% 215.06/215.22  |- skos__broader mesh__D031604smesh__D029583
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D031604 2005
% 215.06/215.22  |- skos__annotation mesh__D031604
% 215.06/215.22       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.06/215.22  |- skos__prefLabel mesh__D031604 Cyclea
% 215.06/215.22  |- rdf__type mesh__D031604sskos__Concept
% 215.06/215.22  |- mesh__dateEstablished mesh__D017135 1993-01-01
% 215.06/215.22  |- mesh__dateRevised mesh__D017135 2005-06-30
% 215.06/215.22  |- skos__historyNote mesh__D017135 Norpregnenes %28%1979-1992%29%
% 215.06/215.22  |- mesh__recordAuthorizer mesh__D017135 sjn
% 215.06/215.22  |- skos__hiddenLabel mesh__D017135
% 215.06/215.22       13 Ethyl 11 methylene 18,19 dinor 17 alpha pregn 4 en 20 yn 17 ol
% 215.06/215.22  |- skos__hiddenLabel mesh__D017135
% 215.06/215.22       alpha-pregn-4-en-20-yn-17-ol, 13-Ethyl-11-methylene-18,19-dinor-17
% 215.06/215.22  |- mesh__recordOriginator mesh__D017135 PLS
% 215.06/215.22  |- skos__altLabel mesh__D017135
% 215.06/215.22       13-Ethyl-11-methylene-18,19-dinor-17 alpha-pregn-4-en-20-yn-17-ol
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017135 2006
% 215.06/215.22  |- skos__altLabel mesh__D017135 Organon Brand of Desogestrel
% 215.06/215.22  |- skos__scopeNote mesh__D017135
% 215.06/215.22       A synthetic progestational hormone used often as the progestogenic component of combined oral contraceptive agents.%A%    
% 215.06/215.22  |- skos__historyNote mesh__D017135
% 215.06/215.22       Progestational Hormones, Synthetic %28%1979-1992%29%
% 215.06/215.22  |- mesh__recordMaintainer mesh__D017135 exl
% 215.06/215.22  |- mesh__publicMeSHNote mesh__D017135
% 215.06/215.22       93; was indexed under NORPREGNENES 1979-92   
% 215.06/215.22  |- skos__broader mesh__D017135smesh__D009652
% 215.06/215.22  |- mesh__dateCreated mesh__D017135 1992-05-08
% 215.06/215.22  |- rdf__type mesh__D017135sskos__Concept
% 215.06/215.22  |- skos__hiddenLabel mesh__D017135 Org2969
% 215.06/215.22  |- skos__hiddenLabel mesh__D017135 Org 2969
% 215.06/215.22  |- skos__prefLabel mesh__D017135 Desogestrel
% 215.06/215.22  |- mesh__historyNote mesh__D017135
% 215.06/215.22       93; was DESOGESTREL %28%NM%29% 1977-92   
% 215.06/215.22  |- mesh__onlineNote mesh__D017135
% 215.06/215.22       use DESOGESTREL %28%NM%29% to search DESOGESTREL 1979-92   
% 215.06/215.22  |- mesh__dateRevised mesh__D003913 2005-06-30
% 215.06/215.22  |- skos__hiddenLabel mesh__D003913 Sulfate, Dextroamphetamine
% 215.06/215.22  |- mesh__publicMeSHNote mesh__D003913 77; was DEXTRO AMPHETAMINE 1963-76   
% 215.06/215.22  |- mesh__historyNote mesh__D003913 77; was DEXTRO AMPHETAMINE 1963-76   
% 215.06/215.22  |- skos__altLabel mesh__D003913
% 215.06/215.22       Mallinckrodt Brand of Dextroamphetamine Sulfate
% 215.06/215.22  |- mesh__onlineNote mesh__D003913
% 215.06/215.22       use DEXTROAMPHETAMINE to search DEXTRO AMPHETAMINE 1966-76%A%  
% 215.06/215.22  |- skos__altLabel mesh__D003913 dextro-Amphetamine
% 215.06/215.22  |- skos__broader mesh__D003913smesh__D000661
% 215.06/215.22  |- skos__altLabel mesh__D003913 d-Amphetamine
% 215.06/215.22  |- skos__prefLabel mesh__D003913 Dextroamphetamine
% 215.06/215.22  |- skos__altLabel mesh__D003913 Celltech Brand of Dextroamphetamine Sulfate
% 215.06/215.22  |- skos__altLabel mesh__D003913 Pasadena Brand of Dextroamphetamine
% 215.06/215.22  |- mesh__recordMaintainer mesh__D003913 exl
% 215.06/215.22  |- skos__hiddenLabel mesh__D003913 d Amphetamine Sulfate
% 215.06/215.22  |- skos__hiddenLabel mesh__D003913 dextro Amphetamine
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D003913 2006
% 215.06/215.22  |- skos__altLabel mesh__D003913 Vortech Brand of Dextroamphetamine Sulfate
% 215.06/215.22  |- skos__altLabel mesh__D003913 Dexamphetamine
% 215.06/215.22  |- mesh__recordOriginator mesh__D003913 NLM
% 215.06/215.22  |- skos__altLabel mesh__D003913 Dexamfetamine
% 215.06/215.22  |- mesh__dateCreated mesh__D003913 1999-01-01
% 215.06/215.22  |- skos__altLabel mesh__D003913
% 215.06/215.22       GlaxoSmithKline Brand of Dextroamphetamine Sulfate
% 215.06/215.22  |- skos__altLabel mesh__D003913 Dextro-Amphetamine Sulfate
% 215.06/215.22  |- skos__hiddenLabel mesh__D003913 Dextro Amphetamine Sulfate
% 215.06/215.22  |- skos__hiddenLabel mesh__D003913 d Amphetamine
% 215.06/215.22  |- rdf__type mesh__D003913sskos__Concept
% 215.06/215.22  |- skos__altLabel mesh__D003913 d-Amphetamine Sulfate
% 215.06/215.22  |- mesh__recordAuthorizer mesh__D003913 sjn
% 215.06/215.22  |- skos__scopeNote mesh__D003913
% 215.06/215.22       The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.%A%    
% 215.06/215.22  |- skos__altLabel mesh__D003913 Shire Brand of Dextroamphetamine Sulfate
% 215.06/215.22  |- mesh__dateCreated mesh__D003115 1975-07-18
% 215.06/215.22  |- mesh__recordOriginator mesh__D003115 RLS
% 215.06/215.22  |- skos__prefLabel mesh__D003115 Colony-Stimulating Factors
% 215.06/215.22  |- mesh__onlineNote mesh__D003115
% 215.06/215.22       use COLONY-STIMULATING FACTORS to search COLONY-STIMULATING FACTOR 1976-89%A%  
% 215.06/215.22  |- skos__altLabel mesh__D003115 Myeloid Cell-Growth Inducer
% 215.06/215.22  |- skos__historyNote mesh__D003115 Glycoproteins %28%1966-1975%29%
% 215.06/215.22  |- skos__historyNote mesh__D003115 Clone Cells %28%1968-1975%29%
% 215.06/215.22  |- mesh__dateRevised mesh__D003115 2005-06-30
% 215.06/215.22  |- rdf__type mesh__D003115sskos__Concept
% 215.06/215.22  |- skos__historyNote mesh__D003115 Cell Division %28%1966-1975%29%
% 215.06/215.22  |- skos__annotation mesh__D003115
% 215.06/215.22       /drug eff permitted; coord IM with colonized cell %28%IM or NIM%29% if pertinent%A%  
% 215.06/215.22  |- mesh__recordAuthorizer mesh__D003115 sjn
% 215.06/215.22  |- skos__historyNote mesh__D003115 Bone Marrow %28%1966-1975%29%
% 215.06/215.22  |- skos__hiddenLabel mesh__D003115 Cell-Growth Inducer, Myeloid
% 215.06/215.22  |- mesh__historyNote mesh__D003115
% 215.06/215.22       79%28%76%29%; was COLONY STIMULATING FACTOR see under GLYCOPROTEINS 1976-78; was COLONY-STIMULATING FACTOR 1979-89%A%  
% 215.06/215.22  |- skos__altLabel mesh__D003115 MGI-1
% 215.06/215.22  |- skos__altLabel mesh__D003115 Colony Stimulating Factor
% 215.06/215.22  |- skos__hiddenLabel mesh__D003115 Inducer, Myeloid Cell-Growth
% 215.06/215.22  |- skos__hiddenLabel mesh__D003115 Colony Stimulating Factors
% 215.06/215.22  |- skos__hiddenLabel mesh__D003115 Macrophage Granulocyte Inducer
% 215.06/215.22  |- skos__hiddenLabel mesh__D003115 Inducer, Macrophage-Granulocyte
% 215.06/215.22  |- skos__related mesh__D003115smesh__D016184
% 215.06/215.22  |- skos__hiddenLabel mesh__D003115 MGI, Protein Inducer
% 215.06/215.22  |- skos__hiddenLabel mesh__D003115 MGI 1 Protein
% 215.06/215.22  |- skos__broader mesh__D003115smesh__D016298
% 215.06/215.22  |- skos__hiddenLabel mesh__D003115 Myeloid Cell Growth Inducer
% 215.06/215.22  |- mesh__dateEstablished mesh__D003115 1979-01-01
% 215.06/215.22  |- skos__altLabel mesh__D003115 Colony-Stimulating Factor
% 215.06/215.22  |- skos__altLabel mesh__D003115 MGI-1 Protein
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D003115 2006
% 215.06/215.22  |- skos__broader mesh__D003115smesh__D006023
% 215.06/215.22  |- skos__scopeNote mesh__D003115
% 215.06/215.22       Glycoproteins found in a subfraction of normal mammalian plasma and urine. They stimulate the proliferation of bone marrow cells in agar cultures and the formation of colonies of granulocytes and/or macrophages. The factors include INTERLEUKIN-3; %28%IL-3%29%; GRANULOCYTE COLONY-STIMULATING FACTOR; %28%G-CSF%29%; MACROPHAGE COLONY-STIMULATING FACTOR; %28%M-CSF%29%; and GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; %28%GM-CSF%29%.%A%    
% 215.06/215.22  |- mesh__publicMeSHNote mesh__D003115
% 215.06/215.22       79; was COLONY STIMULATING FACTOR see under GLYCOPROTEINS 1976-78; was COLONY-STIMULATING FACTOR 1979-89%A%  
% 215.06/215.22  |- mesh__recordMaintainer mesh__D003115 ssb
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D013543 2003
% 215.06/215.22  |- mesh__publicMeSHNote mesh__D013543 76   
% 215.06/215.22  |- mesh__dateRevised mesh__D013543 2001-07-25
% 215.06/215.22  |- skos__annotation mesh__D013543 inflamm dis = HIDRADENITIS   
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D013543 2004
% 215.06/215.22  |- rdf__type mesh__D013543sskos__Concept
% 215.06/215.22  |- skos__broader mesh__D013543smesh__D012871
% 215.06/215.22  |- mesh__historyNote mesh__D013543 76; was NON MESH before 1976   
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D013543 2005
% 215.06/215.22  |- skos__historyNote mesh__D013543 Sweating %28%1966-1975%29%
% 215.06/215.22  |- skos__scopeNote mesh__D013543 Diseases of the SWEAT GLANDS.     
% 215.06/215.22  |- skos__hiddenLabel mesh__D013543 Diseases, Sweat Gland
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D013543 2006
% 215.06/215.22  |- skos__prefLabel mesh__D013543 Sweat Gland Diseases
% 215.06/215.22  |- skos__historyNote mesh__D013543 Sweat Glands %28%1966-1975%29%
% 215.06/215.22  |- skos__historyNote mesh__D013543
% 215.06/215.22       specific sweat gland disease %28%1966-1975%29%
% 215.06/215.22  |- skos__hiddenLabel mesh__D013543 Disease, Sweat Gland
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D013543 2002
% 215.06/215.22  |- skos__hiddenLabel mesh__D013543 Sweat Gland Disease
% 215.06/215.22  |- mesh__dateCreated mesh__D013543 1975-07-25
% 215.06/215.22  |- mesh__dateEstablished mesh__D013543 1976-01-01
% 215.06/215.22  |- mesh__recordMaintainer mesh__D013543 lkt
% 215.06/215.22  |- mesh__recordOriginator mesh__D013543 SMH
% 215.06/215.22  |- mesh__recordAuthorizer mesh__D013543 sjn
% 215.06/215.22  |- skos__hiddenLabel mesh__D007506 Proteins, Iron-Sulfur
% 215.06/215.22  |- skos__altLabel mesh__D007506 Iron Sulfur Proteins
% 215.06/215.22  |- skos__annotation mesh__D007506 /biosyn /physiol permitted   
% 215.06/215.22  |- mesh__publicMeSHNote mesh__D007506
% 215.06/215.22       91; was see under METALLOPROTEINS 1977-90   
% 215.06/215.22  |- skos__scopeNote mesh__D007506
% 215.06/215.22       A group of proteins possessing only the iron-sulfur complex as the prosthetic group. These proteins participate in all major pathways of electron transport: photosynthesis, respiration, hydroxylation and bacterial hydrogen and nitrogen fixation.%A%    
% 215.06/215.22  |- skos__historyNote mesh__D007506 Metalloproteins %28%1973-1976%29%
% 215.06/215.22  |- mesh__recordMaintainer mesh__D007506 SYSTEM
% 215.06/215.22  |- mesh__recordOriginator mesh__D007506 RLS
% 215.06/215.22  |- skos__historyNote mesh__D007506 Iron %28%1973-1976%29%
% 215.06/215.22  |- skos__historyNote mesh__D007506 Sulfur %28%1973-1976%29%
% 215.06/215.22  |- mesh__dateEstablished mesh__D007506 1991-01-01
% 215.06/215.22  |- mesh__historyNote mesh__D007506
% 215.06/215.22       91%28%77%29%; was see under METALLOPROTEINS 1977-90   
% 215.06/215.22  |- skos__hiddenLabel mesh__D007506 Proteins, Iron Sulfur
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D007506 2006
% 215.06/215.22  |- mesh__recordAuthorizer mesh__D007506 sjn
% 215.06/215.22  |- mesh__dateCreated mesh__D007506 1976-04-13
% 215.06/215.22  |- mesh__dateRevised mesh__D007506 2005-06-30
% 215.06/215.22  |- skos__broader mesh__D007506smesh__D019159
% 215.06/215.22  |- skos__hiddenLabel mesh__D007506 Sulfur Proteins, Iron
% 215.06/215.22  |- skos__prefLabel mesh__D007506 Iron-Sulfur Proteins
% 215.06/215.22  |- rdf__type mesh__D007506sskos__Concept
% 215.06/215.22  |- skos__altLabel mesh__D051662 Kv1.1alpha
% 215.06/215.22  |- mesh__dateCreated mesh__D051662 2005-06-30
% 215.06/215.22  |- skos__altLabel mesh__D051662 KCNA1 Potassium Channel
% 215.06/215.22  |- skos__scopeNote mesh__D051662
% 215.06/215.22       A delayed rectifier subtype of shaker potassium channels that is commonly mutated in human episodic ATAXIA and MYOKYMIA.%A%    
% 215.06/215.22  |- mesh__recordOriginator mesh__D051662 DRC
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D051662 2006
% 215.06/215.22  |- skos__broader mesh__D051662smesh__D051668
% 215.06/215.22  |- skos__prefLabel mesh__D051662 Kv1.1 Potassium Channel
% 215.06/215.22  |- mesh__publicMeSHNote mesh__D051662
% 215.06/215.22       2006; KV1.1 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1995-2004%A%  
% 215.06/215.22  |- skos__hiddenLabel mesh__D051662 Potassium Channel, Kv1.1
% 215.06/215.22  |- skos__hiddenLabel mesh__D051662 Potassium Channel, KCNA1
% 215.06/215.22  |- mesh__recordAuthorizer mesh__D051662 sjn
% 215.06/215.22  |- skos__altLabel mesh__D051662 Kv1.1beta
% 215.06/215.22  |- mesh__historyNote mesh__D051662 2006%28%1995%29%   
% 215.06/215.22  |- mesh__dateEstablished mesh__D051662 2006-01-01
% 215.06/215.22  |- skos__broader mesh__D051662smesh__D051637
% 215.06/215.22  |- rdf__type mesh__D051662sskos__Concept
% 215.06/215.22  |- mesh__recordMaintainer mesh__D051662 DRC
% 215.06/215.22  |- skos__annotation mesh__D017934 infection = CORONAVIRUS INFECTIONS   
% 215.06/215.22  |- mesh__publicMeSHNote mesh__D017934 94   
% 215.06/215.22  |- mesh__dateCreated mesh__D017934 1993-06-04
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017934 2002
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017934 2004
% 215.06/215.22  |- mesh__recordMaintainer mesh__D017934 ags
% 215.06/215.22  |- mesh__dateRevised mesh__D017934 2001-07-25
% 215.06/215.22  |- mesh__historyNote mesh__D017934 94   
% 215.06/215.22  |- skos__scopeNote mesh__D017934
% 215.06/215.22       A genus of the family CORONAVIRIDAE which causes respiratory or gastrointestinal disease in a variety of vertebrates.%A%    
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017934 2003
% 215.06/215.22  |- skos__altLabel mesh__D017934
% 215.06/215.22       Encephalomyelitis Virus, Porcine Hemagglutinating
% 215.06/215.22  |- mesh__recordOriginator mesh__D017934 AGS
% 215.06/215.22  |- rdf__type mesh__D017934sskos__Concept
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017934 2006
% 215.06/215.22  |- skos__hiddenLabel mesh__D017934 Rabbit Coronaviruses
% 215.06/215.22  |- mesh__dateEstablished mesh__D017934 1994-01-01
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017934 2005
% 215.06/215.22  |- skos__prefLabel mesh__D017934 Coronavirus
% 215.06/215.22  |- skos__altLabel mesh__D017934 Rabbit coronavirus
% 215.06/215.22  |- skos__broader mesh__D017934smesh__D003332
% 215.06/215.22  |- skos__hiddenLabel mesh__D017934 Coronaviruses, Rabbit
% 215.06/215.22  |- mesh__recordAuthorizer mesh__D017934 sjn
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D031605 2003
% 215.06/215.22  |- skos__scopeNote mesh__D031605
% 215.06/215.22       A plant genus of the family MENISPERMACEAE. Members contain sinococuline, coccuvine and other ALKALOIDS.%A%    
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D031605 2006
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D031605 2005
% 215.06/215.22  |- skos__annotation mesh__D031605
% 215.06/215.22       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.06/215.22  |- mesh__dateEstablished mesh__D031605 2003-01-01
% 215.06/215.22  |- mesh__dateCreated mesh__D031605 2002-07-03
% 215.06/215.22  |- mesh__historyNote mesh__D031605 2003   
% 215.06/215.22  |- rdf__type mesh__D031605sskos__Concept
% 215.06/215.22  |- skos__broader mesh__D031605smesh__D029583
% 215.06/215.22  |- skos__prefLabel mesh__D031605 Cocculus
% 215.06/215.22  |- mesh__publicMeSHNote mesh__D031605 2003   
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D031605 2004
% 215.06/215.22  |- mesh__recordOriginator mesh__D017136 AGS
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017136 2006
% 215.06/215.22  |- skos__related mesh__D017136smesh__D027981
% 215.06/215.22  |- skos__hiddenLabel mesh__D017136 Ion Transport, Passive
% 215.06/215.22  |- skos__related mesh__D017136smesh__D017920
% 215.06/215.22  |- mesh__dateRevised mesh__D017136 2005-07-27
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017136 2006A
% 215.06/215.22  |- mesh__dateEstablished mesh__D017136 1993-01-01
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017136 2003
% 215.06/215.22  |- skos__related mesh__D017136smesh__D016623
% 215.06/215.22  |- skos__scopeNote mesh__D017136
% 215.06/215.22       The movement of ions across energy-transducing cell membranes. Transport can be active, passive or facilitated.  Ions may travel by themselves %28%uniport%29%, or as a group of two or more ions in the same %28%symport%29% or opposite %28%antiport%29% directions.%A%    
% 215.06/215.22  |- skos__hiddenLabel mesh__D017136 Ion Transport, Facilitated
% 215.06/215.22  |- skos__broader mesh__D017136smesh__D001692
% 215.06/215.22  |- skos__annotation mesh__D017136
% 215.06/215.22       in biol systems: do not confuse with ION EXCHANGE, a physicochem process; coord NIM with endogenous substance /metab %28%IM%29% or with exogenous substance /pharmacokin %28%IM%29%; if active transport, coord with BIOLOGICAL TRANSPORT, ACTIVE%A%  
% 215.06/215.22  |- rdf__type mesh__D017136sskos__Concept
% 215.06/215.22  |- mesh__dateCreated mesh__D017136 1992-05-20
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017136 2004
% 215.06/215.22  |- skos__hiddenLabel mesh__D017136 Cotransport, Ion
% 215.06/215.22  |- mesh__recordMaintainer mesh__D017136 ags
% 215.06/215.22  |- skos__broader mesh__D017136smesh__D001669
% 215.06/215.22  |- skos__prefLabel mesh__D017136 Ion Transport
% 215.06/215.22  |- skos__hiddenLabel mesh__D017136 Exchange, Intracellular Ion
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017136 2002
% 215.06/215.22  |- skos__hiddenLabel mesh__D017136 Intracellular Ion Exchange
% 215.06/215.22  |- skos__altLabel mesh__D017136 Ion Cotransport
% 215.06/215.22  |- mesh__recordAuthorizer mesh__D017136 ags
% 215.06/215.22  |- skos__historyNote mesh__D017136 Ion Exchange %28%1966-1992%29%
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017136 2005
% 215.06/215.22  |- skos__hiddenLabel mesh__D017136 Ion Transport, Active
% 215.06/215.22  |- skos__hiddenLabel mesh__D017136 Transport, Active Ion
% 215.06/215.22  |- mesh__publicMeSHNote mesh__D017136 93   
% 215.06/215.22  |- skos__hiddenLabel mesh__D017136 Transport, Ion
% 215.06/215.22  |- mesh__historyNote mesh__D017136 93   
% 215.06/215.22  |- skos__scopeNote mesh__D003914
% 215.06/215.22       Location of the heart in the right hemithorax, with the apex directed to the right.%A%    
% 215.06/215.22  |- skos__prefLabel mesh__D003914 Dextrocardia
% 215.06/215.22  |- mesh__publicMeSHNote mesh__D003914
% 215.06/215.22       91; was see under HEART DEFECTS, CONGENITAL 1984-90; was heading 1963-83%A%  
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D003914 2006
% 215.06/215.22  |- skos__broader mesh__D003914smesh__D012857
% 215.06/215.22  |- skos__hiddenLabel mesh__D003914 Dextrocardias
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D003914 2004
% 215.06/215.22  |- mesh__dateCreated mesh__D003914 1999-01-01
% 215.06/215.22  |- mesh__recordAuthorizer mesh__D003914 sjn
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D003914 2005
% 215.06/215.22  |- skos__annotation mesh__D003914
% 215.06/215.22       heart in right hemithorax; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D003914 2003
% 215.06/215.22  |- rdf__type mesh__D003914sskos__Concept
% 215.06/215.22  |- mesh__dateRevised mesh__D003914 2001-07-25
% 215.06/215.22  |- mesh__recordMaintainer mesh__D003914 nns
% 215.06/215.22  |- mesh__historyNote mesh__D003914
% 215.06/215.22       91%28%84%29%63; was see under HEART DEFECTS, CONGENITAL 1984-90; was heading 1963-83%A%  
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D003914 2002
% 215.06/215.22  |- skos__broader mesh__D003914smesh__D006330
% 215.06/215.22  |- mesh__recordOriginator mesh__D003914 NLM
% 215.06/215.22  |- mesh__dateEstablished mesh__D003914 1991-01-01
% 215.06/215.22  |- skos__annotation mesh__D003116
% 215.06/215.22       NIM; when IM, /stand permitted; differentiate from PIGMENTATION in that PIGMENTATION is related to PIGMENTS, BIOLOGICAL%A%  
% 215.06/215.22  |- rdf__type mesh__D003116sskos__Concept
% 215.06/215.22  |- mesh__dateCreated mesh__D003116 1999-01-01
% 215.06/215.22  |- mesh__recordMaintainer mesh__D003116 sjn
% 215.06/215.22  |- mesh__recordOriginator mesh__D003116 NLM
% 215.06/215.22  |- mesh__dateRevised mesh__D003116 2005-07-01
% 215.06/215.22  |- skos__prefLabel mesh__D003116 Color
% 215.06/215.22  |- skos__hiddenLabel mesh__D003116 Colors
% 215.06/215.22  |- mesh__recordAuthorizer mesh__D003116 sjn
% 215.06/215.22  |- skos__broader mesh__D003116smesh__D008027
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D003116 2006
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D013544 2002
% 215.06/215.22  |- skos__broader mesh__D013544smesh__D012878
% 215.06/215.22  |- mesh__recordMaintainer mesh__D013544 lkt
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D013544 2006
% 215.06/215.22  |- mesh__dateCreated mesh__D013544 1999-01-01
% 215.06/215.22  |- mesh__historyNote mesh__D013544 68   
% 215.06/215.22  |- mesh__publicMeSHNote mesh__D013544 68   
% 215.06/215.22  |- skos__broader mesh__D013544smesh__D013543
% 215.06/215.22  |- skos__historyNote mesh__D013544 Sweat Glands %28%1966-1967%29%
% 215.06/215.22  |- mesh__recordAuthorizer mesh__D013544 sjn
% 215.06/215.22  |- mesh__recordOriginator mesh__D013544 NLM
% 215.06/215.22  |- mesh__dateRevised mesh__D013544 2001-07-25
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D013544 2003
% 215.06/215.22  |- skos__prefLabel mesh__D013544 Sweat Gland Neoplasms
% 215.06/215.22  |- mesh__dateEstablished mesh__D013544 1968-01-01
% 215.06/215.22  |- skos__altLabel mesh__D013544 Neoplasms, Sweat Gland
% 215.06/215.22  |- skos__historyNote mesh__D013544 Skin Neoplasms %28%1966-1967%29%
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D013544 2004
% 215.06/215.22  |- rdf__type mesh__D013544sskos__Concept
% 215.06/215.22  |- skos__hiddenLabel mesh__D013544 Sweat Gland Neoplasm
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D013544 2005
% 215.06/215.22  |- skos__annotation mesh__D013544
% 215.06/215.22       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%  
% 215.06/215.22  |- skos__hiddenLabel mesh__D013544 Neoplasm, Sweat Gland
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D007507 1999
% 215.06/215.22  |- skos__altLabel mesh__D007507 Douching
% 215.06/215.22  |- mesh__recordAuthorizer mesh__D007507 PLS
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D007507 2002
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D007507 1993
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D007507 1998
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D007507 2004
% 215.06/215.22  |- skos__hiddenLabel mesh__D007507 Lavages
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D007507 2001
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D007507 2003
% 215.06/215.22  |- mesh__recordMaintainer mesh__D007507 TAP
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D007507 1995
% 215.06/215.22  |- skos__hiddenLabel mesh__D007507 Douchings
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D007507 2006
% 215.06/215.22  |- mesh__dateCreated mesh__D007507 1999-01-01
% 215.06/215.22  |- skos__hiddenLabel mesh__D007507 Irrigations
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D007507 2000
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D007507 1994
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D007507 2005
% 215.06/215.22  |- rdf__type mesh__D007507sskos__Concept
% 215.06/215.22  |- skos__annotation mesh__D007507
% 215.06/215.22       IM only as general procedure; NIM for irrigation of specific organ or site; includes LAVAGE but GASTRIC LAVAGE %26% PERITONEAL LAVAGE are available as is BRONCHOALVEOLAR LAVAGE FLUID%A%  
% 215.06/215.22  |- skos__altLabel mesh__D007507 Lavage
% 215.06/215.22  |- skos__broader mesh__D007507smesh__D008919
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D007507 1997
% 215.06/215.22  |- mesh__dateRevised mesh__D007507 1992-05-14
% 215.06/215.22  |- skos__scopeNote mesh__D007507
% 215.06/215.22       The washing of a body cavity or surface by flowing solution which is inserted and then removed. Any drug in the irrigation solution may be absorbed.%A%    
% 215.06/215.22  |- skos__prefLabel mesh__D007507 Irrigation
% 215.06/215.22  |- mesh__recordOriginator mesh__D007507 NLM
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D007507 1996
% 215.06/215.22  |- mesh__recordOriginator mesh__D051663 DRC
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D051663 2006
% 215.06/215.22  |- mesh__recordMaintainer mesh__D051663 DRC
% 215.06/215.22  |- skos__broader mesh__D051663smesh__D051668
% 215.06/215.22  |- skos__hiddenLabel mesh__D051663 Potassium Channel, KCNA2
% 215.06/215.22  |- skos__scopeNote mesh__D051663
% 215.06/215.22       A delayed rectifier subtype of shaker potassium channels that is selectively inhibited by a variety of SCORPION VENOMS.%A%    
% 215.06/215.22  |- mesh__dateCreated mesh__D051663 2005-06-30
% 215.06/215.22  |- skos__broader mesh__D051663smesh__D051637
% 215.06/215.22  |- rdf__type mesh__D051663sskos__Concept
% 215.06/215.22  |- skos__altLabel mesh__D051663 KCNA2 Potassium Channel
% 215.06/215.22  |- mesh__recordAuthorizer mesh__D051663 sjn
% 215.06/215.22  |- mesh__historyNote mesh__D051663 2006%28%1995%29%   
% 215.06/215.22  |- mesh__dateEstablished mesh__D051663 2006-01-01
% 215.06/215.22  |- skos__prefLabel mesh__D051663 Kv1.2 Potassium Channel
% 215.06/215.22  |- skos__altLabel mesh__D051663 Kv1.2alpha
% 215.06/215.22  |- skos__hiddenLabel mesh__D051663 Potassium Channel, Kv1.2
% 215.06/215.22  |- mesh__publicMeSHNote mesh__D051663
% 215.06/215.22       2006; KV1.2 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1995-2004%A%  
% 215.06/215.22  |- skos__altLabel mesh__D051663 Kvbeta1.2
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D031606 2005
% 215.06/215.22  |- skos__scopeNote mesh__D031606
% 215.06/215.22       A plant genus of the family MENISPERMACEAE. Members contain eletefine %28%a stephaoxocane alkaloid%29% and tropoloisoquinoline and protoberberine ALKALOIDS.%A%    
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D031606 2006
% 215.06/215.22  |- skos__broader mesh__D031606smesh__D029583
% 215.06/215.22  |- skos__annotation mesh__D031606
% 215.06/215.22       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.06/215.22  |- rdf__type mesh__D031606sskos__Concept
% 215.06/215.22  |- mesh__dateEstablished mesh__D031606 2003-01-01
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D031606 2003
% 215.06/215.22  |- mesh__publicMeSHNote mesh__D031606 2003   
% 215.06/215.22  |- skos__prefLabel mesh__D031606 Cissampelos
% 215.06/215.22  |- mesh__dateCreated mesh__D031606 2002-07-03
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D031606 2004
% 215.06/215.22  |- mesh__historyNote mesh__D031606 2003   
% 215.06/215.22  |- mesh__publicMeSHNote mesh__D017137
% 215.06/215.22       94; was NONOXYNOLS 1993; NONOXYNOLS was indexed under POLYETHYLENE GLYCOLS 1974-92%A%  
% 215.06/215.22  |- skos__prefLabel mesh__D017137 Nonoxynol
% 215.06/215.22  |- mesh__onlineNote mesh__D017137
% 215.06/215.22       use NONOXYNOL to search NONOXYNOLS 1993; use NONOXYNOL %28%NM%29% to search NONOXYNOLS 1979-92%A%  
% 215.06/215.22  |- mesh__dateRevised mesh__D017137 2004-07-07
% 215.06/215.22  |- rdf__type mesh__D017137sskos__Concept
% 215.06/215.22  |- skos__broader mesh__D017137smesh__D011092
% 215.06/215.22  |- skos__hiddenLabel mesh__D017137 Nonoxynol 9
% 215.06/215.22  |- skos__annotation mesh__D017137 D25-26 qualif   
% 215.06/215.22  |- skos__altLabel mesh__D017137 Nonylphenoxypolyethoxyethanols
% 215.06/215.22  |- mesh__dateEstablished mesh__D017137 1993-01-01
% 215.06/215.22  |- skos__altLabel mesh__D017137 Nonoxinol
% 215.06/215.22  |- skos__altLabel mesh__D017137 Nonoxinols
% 215.06/215.22  |- skos__historyNote mesh__D017137 Polyethylene Glycols %28%1975-1992%29%
% 215.06/215.22  |- mesh__dateCreated mesh__D017137 1992-05-19
% 215.06/215.22  |- mesh__historyNote mesh__D017137
% 215.06/215.22       94; was NONOXYNOLS 1993; was NONOXYNOLS %28%NM%29% 1974-92   
% 215.06/215.22  |- mesh__recordMaintainer mesh__D017137 jmp
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017137 2005
% 215.06/215.22  |- mesh__recordOriginator mesh__D017137 PLS
% 215.06/215.22  |- skos__altLabel mesh__D017137 Nonoxynols
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D017137 2006
% 215.06/215.22  |- skos__altLabel mesh__D017137 Nonylphenoxypolyethoxyethanol
% 215.06/215.22  |- mesh__recordAuthorizer mesh__D017137 sjn
% 215.06/215.22  |- skos__scopeNote mesh__D017137
% 215.06/215.22       Nonionic surfactant mixtures varying in the number of repeating ethoxy %28%oxy-1,2-ethanediyl%29% groups. They are used as detergents, emulsifiers, wetting agents, defoaming agents, etc. Nonoxynol-9, the compound with 9 repeating ethoxy groups, is a spermatocide, formulated primarily as a component of vaginal foams and creams.%A%    
% 215.06/215.22  |- skos__scopeNote mesh__D003915
% 215.06/215.22       The d-isomer of the codeine analog of LEVORPHANOL. Dextromethorphan shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist %28%RECEPTORS, N-METHYL-D-ASPARTATE%29% and acts as a non-competitive channel blocker. It is one of the widely used ANTITUSSIVES, and is also used to study the involvement of glutamate receptors in neurotoxicity.%A%    
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D003915 2004
% 215.06/215.22  |- mesh__dateCreated mesh__D003915 1999-01-01
% 215.06/215.22  |- mesh__recordOriginator mesh__D003915 NLM
% 215.06/215.22  |- mesh__activeMeSHYear mesh__D003915 2005
% 215.06/215.22  |- skos__historyNote mesh__D003915 Antitussive Agents %28%1966-1971%29%
% 215.06/215.22  |- mesh__dateRevised mesh__D003915 2002-07-03
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D003915 2003
% 215.06/215.23  |- skos__altLabel mesh__D003915 d-Methorphan
% 215.06/215.23  |- rdf__type mesh__D003915sskos__Concept
% 215.06/215.23  |- mesh__publicMeSHNote mesh__D003915
% 215.06/215.23       91; was see under LEVORPHANOL 1972-90   
% 215.06/215.23  |- skos__hiddenLabel mesh__D003915 Hydrochloride, Dextromethorphan
% 215.06/215.23  |- mesh__historyNote mesh__D003915
% 215.06/215.23       91%28%72%29%; was see under LEVORPHANOL 1972-90   
% 215.06/215.23  |- mesh__recordAuthorizer mesh__D003915 sjn
% 215.06/215.23  |- skos__prefLabel mesh__D003915 Dextromethorphan
% 215.06/215.23  |- skos__historyNote mesh__D003915 Morphinans %28%1969-1971%29%
% 215.06/215.23  |- skos__hiddenLabel mesh__D003915 Hydrobromide, Dextromethorphan
% 215.06/215.23  |- mesh__recordMaintainer mesh__D003915 ssb
% 215.06/215.23  |- mesh__dateEstablished mesh__D003915 1991-01-01
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D003915 2006
% 215.06/215.23  |- skos__broader mesh__D003915smesh__D007981
% 215.06/215.23  |- skos__scopeNote mesh__D003117
% 215.06/215.23       Defects of color vision are mainly hereditary traits but can be secondary to acquired or developmental abnormalities in the CONES %28%RETINA%29%.  Severity of hereditary defects of color vision depends on the degree of mutation of the OPSIN genes %28%on X CHROMOSOME and CHROMOSOME 3%29% that code the photopigments for red, green and blue.%A%    
% 215.06/215.23  |- skos__hiddenLabel mesh__D003117 Vision Defect, Color
% 215.06/215.23  |- mesh__dateCreated mesh__D003117 1999-01-01
% 215.06/215.23  |- skos__hiddenLabel mesh__D003117 Defect, Deutan
% 215.06/215.23  |- mesh__recordOriginator mesh__D003117 NLM
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D003117 2002
% 215.06/215.23  |- skos__related mesh__D003117smesh__D017949
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D003117 2006A
% 215.06/215.23  |- skos__altLabel mesh__D003117 Tritan Defect
% 215.06/215.23  |- skos__related mesh__D003117smesh__D012164
% 215.06/215.23  |- skos__hiddenLabel mesh__D003117 Inherited Color Blindness
% 215.06/215.23  |- skos__hiddenLabel mesh__D003117 Blue Color Blindness
% 215.06/215.23  |- skos__altLabel mesh__D003117 Deutan Defect
% 215.06/215.23  |- mesh__dateRevised mesh__D003117 2005-07-12
% 215.06/215.23  |- skos__prefLabel mesh__D003117 Color Vision Defects
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D003117 2003
% 215.06/215.23  |- mesh__publicMeSHNote mesh__D003117 90; was COLOR BLINDNESS 1963-89   
% 215.06/215.23  |- skos__hiddenLabel mesh__D003117 Color Blindness, Red Green
% 215.06/215.23  |- mesh__onlineNote mesh__D003117
% 215.06/215.23       use COLOR VISION DEFECTS to search COLOR BLINDNESS 1966-89%A%  
% 215.06/215.23  |- skos__hiddenLabel mesh__D003117 Red Color Blindness
% 215.06/215.23  |- skos__hiddenLabel mesh__D003117 Defects, Color Vision
% 215.06/215.23  |- skos__hiddenLabel mesh__D003117 Red-Green Color Blindness
% 215.06/215.23  |- skos__hiddenLabel mesh__D003117 Blindness, Color
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D003117 2005
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D003117 2004
% 215.06/215.23  |- skos__broader mesh__D003117smesh__D014786
% 215.06/215.23  |- skos__altLabel mesh__D003117 Protan Defect
% 215.06/215.23  |- mesh__historyNote mesh__D003117 90; was COLOR BLINDNESS 1963-89   
% 215.06/215.23  |- mesh__recordMaintainer mesh__D003117 ags
% 215.06/215.23  |- skos__hiddenLabel mesh__D003117 Vision Defects, Color
% 215.06/215.23  |- skos__hiddenLabel mesh__D003117 Acquired Color Blindness
% 215.06/215.23  |- skos__hiddenLabel mesh__D003117 Defect, Color Vision
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D003117 2006
% 215.06/215.23  |- mesh__recordAuthorizer mesh__D003117 ags
% 215.06/215.23  |- skos__hiddenLabel mesh__D003117 Color Vision Defect
% 215.06/215.23  |- skos__hiddenLabel mesh__D003117 Green Color Blindness
% 215.06/215.23  |- rdf__type mesh__D003117sskos__Concept
% 215.06/215.23  |- mesh__publicMeSHNote mesh__D008600
% 215.06/215.23       94; was MENSTRUATION INDUCING AGENTS 1975-93   
% 215.06/215.23  |- rdf__type mesh__D008600sskos__Concept
% 215.06/215.23  |- skos__historyNote mesh__D008600
% 215.06/215.23       Menstruation/drug effects %28%1968-1974%29%
% 215.06/215.23  |- mesh__recordMaintainer mesh__D008600 ssb
% 215.06/215.23  |- mesh__historyNote mesh__D008600
% 215.06/215.23       94; was MENSTRUATION INDUCING AGENTS 1975-93   
% 215.06/215.23  |- skos__prefLabel mesh__D008600 Menstruation-Inducing Agents
% 215.06/215.23  |- skos__hiddenLabel mesh__D008600 Menstruation Inducing Agents
% 215.06/215.23  |- mesh__dateEstablished mesh__D008600 1975-09-01
% 215.06/215.23  |- skos__scopeNote mesh__D008600
% 215.06/215.23       Chemical compounds that induce menstruation either through direct action on the reproductive organs or through indirect action by relieving another condition of which amenorrhea is a secondary result. %28%From Dorland, 27th ed%29%%A%    
% 215.06/215.23  |- skos__altLabel mesh__D008600 Emmenagogues
% 215.06/215.23  |- skos__annotation mesh__D008600 consider also MENSTRUATION /drug eff   
% 215.06/215.23  |- mesh__recordOriginator mesh__D008600 NLM
% 215.06/215.23  |- mesh__dateCreated mesh__D008600 1974-11-11
% 215.06/215.23  |- mesh__dateRevised mesh__D008600 2005-06-30
% 215.06/215.23  |- skos__hiddenLabel mesh__D008600 Agents, Menstruation-Inducing
% 215.06/215.23  |- skos__broader mesh__D008600smesh__D012102
% 215.06/215.23  |- mesh__onlineNote mesh__D008600
% 215.06/215.23       use MENSTRUATION-INDUCING AGENTS to search MENSTRUATION INDUCING AGENTS 1975-93%A%  
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D008600 2006
% 215.06/215.23  |- skos__broader mesh__D008600smesh__D003271
% 215.06/215.23  |- mesh__recordAuthorizer mesh__D008600 sjn
% 215.06/215.23  |- skos__hiddenLabel mesh__D013545 Glands, Sweat
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D013545 2005
% 215.06/215.23  |- mesh__recordAuthorizer mesh__D013545 sjn
% 215.06/215.23  |- mesh__recordOriginator mesh__D013545 NLM
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D013545 2006
% 215.06/215.23  |- skos__broader mesh__D013545smesh__D005088
% 215.06/215.23  |- skos__scopeNote mesh__D013545
% 215.06/215.23       Sweat-producing structures that are embedded in the DERMIS. Each gland consists of a single tube, a coiled body, and a superficial duct.%A%    
% 215.06/215.23  |- skos__hiddenLabel mesh__D013545 Gland, Sweat
% 215.06/215.23  |- mesh__dateRevised mesh__D013545 2002-07-03
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D013545 2003
% 215.06/215.23  |- rdf__type mesh__D013545sskos__Concept
% 215.06/215.23  |- skos__hiddenLabel mesh__D013545 Sweat Gland
% 215.06/215.23  |- skos__prefLabel mesh__D013545 Sweat Glands
% 215.06/215.23  |- skos__annotation mesh__D013545
% 215.06/215.23       /secret: see also SWEAT or SWEATING; inflammation = HIDRADENITIS%A%  
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D013545 2004
% 215.06/215.23  |- skos__broader mesh__D013545smesh__D012867
% 215.06/215.23  |- mesh__dateCreated mesh__D013545 1999-01-01
% 215.06/215.23  |- mesh__recordMaintainer mesh__D013545 KEV
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D007508 1999
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D007508 2005
% 215.06/215.23  |- mesh__recordAuthorizer mesh__D007508 PLS
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D007508 1994
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D007508 2002
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D007508 1993
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D007508 2004
% 215.06/215.23  |- skos__prefLabel mesh__D007508 Irritable Mood
% 215.06/215.23  |- mesh__dateRevised mesh__D007508 1992-05-14
% 215.06/215.23  |- mesh__historyNote mesh__D007508
% 215.06/215.23       91%28%85%29%; was see under AFFECT 1988-90; was see under EMOTIONS 1985-87%A%  
% 215.06/215.23  |- mesh__recordOriginator mesh__D007508 EC
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D007508 1995
% 215.06/215.23  |- skos__broader mesh__D007508smesh__D000339
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D007508 2006
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D007508 2000
% 215.06/215.23  |- mesh__publicMeSHNote mesh__D007508
% 215.06/215.23       91; was see under AFFECT 1988-90; was see under EMOTIONS 1985-87%A%  
% 215.06/215.23  |- rdf__type mesh__D007508sskos__Concept
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D007508 1996
% 215.06/215.23  |- mesh__dateCreated mesh__D007508 1984-04-11
% 215.06/215.23  |- skos__scopeNote mesh__D007508
% 215.06/215.23       Abnormal or excessive excitability with easily triggered anger, annoyance, or impatience.%A%    
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D007508 2001
% 215.06/215.23  |- mesh__dateEstablished mesh__D007508 1991-01-01
% 215.06/215.23  |- mesh__recordMaintainer mesh__D007508 TAP
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D007508 1998
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D007508 1997
% 215.06/215.23  |- skos__altLabel mesh__D007508 Mood, Irritable
% 215.06/215.23  |- skos__hiddenLabel mesh__D007508 Moods, Irritable
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D007508 2003
% 215.06/215.23  |- skos__hiddenLabel mesh__D007508 Irritable Moods
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D018230 2006
% 215.06/215.23  |- skos__historyNote mesh__D018230 Leiomyoma %28%1966-1993%29%
% 215.06/215.23  |- skos__broader mesh__D018230smesh__D007889
% 215.06/215.23  |- rdf__type mesh__D018230sskos__Concept
% 215.06/215.23  |- skos__annotation mesh__D018230
% 215.06/215.23       /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D018230 2001
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D018230 1996
% 215.06/215.23  |- skos__hiddenLabel mesh__D018230 Epithelioid Leiomyoma
% 215.06/215.23  |- mesh__recordMaintainer mesh__D018230 KEV
% 215.06/215.23  |- skos__hiddenLabel mesh__D018230 Leiomyoblastomas
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D018230 2002
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D018230 1997
% 215.06/215.23  |- mesh__dateRevised mesh__D018230 1995-06-08
% 215.06/215.23  |- skos__hiddenLabel mesh__D018230 Leiomyomas, Epithelioid
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D018230 2003
% 215.06/215.23  |- mesh__dateEstablished mesh__D018230 1994-01-01
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D018230 2004
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D018230 1998
% 215.06/215.23  |- mesh__recordOriginator mesh__D018230 PLS
% 215.06/215.23  |- mesh__onlineNote mesh__D018230
% 215.06/215.23       use LEIOMYOMA to search LEIOMYOBLASTOMA 1992-93   
% 215.06/215.23  |- skos__altLabel mesh__D018230 Leiomyoblastoma
% 215.06/215.23  |- skos__scopeNote mesh__D018230
% 215.06/215.23       A relatively rare smooth muscle tumor found most frequently in the wall of the gastrointestinal tract, especially in the stomach. It is similar to other smooth muscle tumors but may become very large and hemorrhage and exhibit small cystic areas. Simple excision is almost always curative. %28%From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1354%29%%A%    
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D018230 1999
% 215.06/215.23  |- mesh__dateCreated mesh__D018230 1993-06-25
% 215.06/215.23  |- skos__hiddenLabel mesh__D018230 Epithelioid Leiomyomas
% 215.06/215.23  |- skos__prefLabel mesh__D018230 Leiomyoma, Epithelioid
% 215.06/215.23  |- mesh__historyNote mesh__D018230
% 215.06/215.23       94; LEIOMYOBLASTOMA was see LEIOMYOMA 1992-93   
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D018230 2005
% 215.06/215.23  |- mesh__publicMeSHNote mesh__D018230
% 215.06/215.23       94; LEIOMYOBLASTOMA was see LEIOMYOMA 1992-93   
% 215.06/215.23  |- mesh__recordAuthorizer mesh__D018230 PLS
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D018230 2000
% 215.06/215.23  |- skos__broader mesh__D051664smesh__D051668
% 215.06/215.23  |- mesh__recordAuthorizer mesh__D051664 sjn
% 215.06/215.23  |- skos__hiddenLabel mesh__D051664 Potassium Channel, Kv1.3
% 215.06/215.23  |- skos__scopeNote mesh__D051664
% 215.06/215.23       A delayed rectifier subtype of shaker potassium channels that is the predominant VOLTAGE-GATED POTASSIUM CHANNEL of T-LYMPHOCYTES.%A%    
% 215.06/215.23  |- mesh__historyNote mesh__D051664 2006%28%1994%29%   
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D051664 2006
% 215.06/215.23  |- mesh__dateEstablished mesh__D051664 2006-01-01
% 215.06/215.23  |- mesh__recordMaintainer mesh__D051664 DRC
% 215.06/215.23  |- mesh__recordOriginator mesh__D051664 DRC
% 215.06/215.23  |- mesh__publicMeSHNote mesh__D051664
% 215.06/215.23       2006; KV1.3 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1994-2004%A%  
% 215.06/215.23  |- skos__broader mesh__D051664smesh__D051637
% 215.06/215.23  |- mesh__dateCreated mesh__D051664 2005-06-30
% 215.06/215.23  |- rdf__type mesh__D051664sskos__Concept
% 215.06/215.23  |- skos__hiddenLabel mesh__D051664 Potassium Channel, KCNA3
% 215.06/215.23  |- skos__prefLabel mesh__D051664 Kv1.3 Potassium Channel
% 215.06/215.23  |- skos__altLabel mesh__D051664 KCNA3 Potassium Channel
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D004210 2006
% 215.06/215.23  |- skos__annotation mesh__D004210
% 215.06/215.23       %22%neck dissection%22% in cancer is probably LYMPH NODE EXCISION %28%IM%29% + NECK %28%NIM%29% if unspecified or RADICAL NECK DISSECTION if specified%A%  
% 215.06/215.23  |- mesh__recordAuthorizer mesh__D004210 sjn
% 215.06/215.23  |- skos__broader mesh__D004210smesh__D013048
% 215.06/215.23  |- skos__scopeNote mesh__D004210
% 215.06/215.23       The separation and isolation of tissues for surgical purposes, or for the analysis or study of their structures.%A%    
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D004210 2004
% 215.06/215.23  |- mesh__dateRevised mesh__D004210 2003-07-09
% 215.06/215.23  |- skos__prefLabel mesh__D004210 Dissection
% 215.06/215.23  |- mesh__recordMaintainer mesh__D004210 nns
% 215.06/215.23  |- skos__broader mesh__D004210smesh__D013514
% 215.06/215.23  |- mesh__recordOriginator mesh__D004210 NLM
% 215.06/215.23  |- skos__hiddenLabel mesh__D004210 Dissections
% 215.06/215.23  |- mesh__dateCreated mesh__D004210 1999-01-01
% 215.06/215.23  |- rdf__type mesh__D004210sskos__Concept
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D004210 2005
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D017936 2004
% 215.06/215.23  |- skos__altLabel mesh__D017936 Cytochromes, Heme a
% 215.06/215.23  |- mesh__dateEstablished mesh__D017936 1994-01-01
% 215.06/215.23  |- skos__annotation mesh__D017936
% 215.06/215.23       spell in titles %26% translations with lowercase a: cytochrome a; do not confuse with CYTOCHROMES A%A%  
% 215.06/215.23  |- skos__altLabel mesh__D017936 Cytochromes Type a
% 215.06/215.23  |- skos__hiddenLabel mesh__D017936 Heme a Cytochromes
% 215.06/215.23  |- mesh__dateRevised mesh__D017936 2003-07-09
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D017936 2005
% 215.06/215.23  |- rdf__type mesh__D017936sskos__Concept
% 215.06/215.23  |- mesh__publicMeSHNote mesh__D017936
% 215.06/215.23       2004; see CYTOCHROME A 1994-2003, see CYTOCHROMES 1979-2003%A%  
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D017936 2006
% 215.06/215.23  |- mesh__recordOriginator mesh__D017936 TPW
% 215.06/215.23  |- mesh__recordMaintainer mesh__D017936 jmp
% 215.06/215.23  |- mesh__recordAuthorizer mesh__D017936 sjn
% 215.06/215.23  |- mesh__dateCreated mesh__D017936 1993-02-16
% 215.06/215.23  |- skos__broader mesh__D017936smesh__D003580
% 215.06/215.23  |- skos__prefLabel mesh__D017936 Cytochrome a Group
% 215.06/215.23  |- skos__scopeNote mesh__D017936
% 215.06/215.23       Cytochromes %28%electron-transporting proteins%29% in which the heme prosthetic group is heme a, i.e., the iron chelate of cytoporphyrin IX. %28%From Enzyme Nomenclature, 1992, p539%29%%A%    
% 215.06/215.23  |- skos__historyNote mesh__D017936 Cytochromes %28%1979-1993%29%
% 215.06/215.23  |- mesh__historyNote mesh__D017936
% 215.06/215.23       2004%28%1994%29%; use CYTOCHROME A %28%NM%29% 1979-1993   
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D031607 2006
% 215.06/215.23  |- mesh__dateCreated mesh__D031607 2002-07-03
% 215.06/215.23  |- mesh__historyNote mesh__D031607 2003   
% 215.06/215.23  |- skos__annotation mesh__D031607
% 215.06/215.23       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.06/215.23  |- skos__prefLabel mesh__D031607 Stephania
% 215.06/215.23  |- rdf__type mesh__D031607sskos__Concept
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D031607 2003
% 215.06/215.23  |- skos__broader mesh__D031607smesh__D029583
% 215.06/215.23  |- skos__scopeNote mesh__D031607
% 215.06/215.23       A plant genus of the family MENISPERMACEAE. Members contain cycleanine.%A%    
% 215.06/215.23  |- mesh__publicMeSHNote mesh__D031607 2003   
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D031607 2004
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D031607 2005
% 215.06/215.23  |- mesh__dateEstablished mesh__D031607 2003-01-01
% 215.06/215.23  |- skos__scopeNote mesh__D003916
% 215.06/215.23       An opioid analgesic structurally related to METHADONE and used in the treatment of severe pain. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1070%29%%A%    
% 215.06/215.23  |- skos__prefLabel mesh__D003916 Dextromoramide
% 215.06/215.23  |- mesh__dateRevised mesh__D003916 2005-06-30
% 215.06/215.23  |- skos__altLabel mesh__D003916
% 215.06/215.23       ASTA Medica Brand of Dextromoramide Tartrate
% 215.06/215.23  |- rdf__type mesh__D003916sskos__Concept
% 215.06/215.23  |- skos__altLabel mesh__D003916 Pyrrolamidol
% 215.06/215.23  |- skos__altLabel mesh__D003916 D-Moramide
% 215.06/215.23  |- skos__hiddenLabel mesh__D003916 D Moramide
% 215.06/215.23  |- skos__hiddenLabel mesh__D003916 Tartrate, Dextromoramide
% 215.06/215.23  |- mesh__recordOriginator mesh__D003916 NLM
% 215.06/215.23  |- skos__altLabel mesh__D003916 Roche Brand of Dextromoramide Tartrate
% 215.06/215.23  |- mesh__dateCreated mesh__D003916 1999-01-01
% 215.06/215.23  |- mesh__recordMaintainer mesh__D003916 exl
% 215.06/215.23  |- skos__altLabel mesh__D003916 Antigen Brand of Dextromoramide Tartrate
% 215.06/215.23  |- skos__altLabel mesh__D003916 Faulding Brand of Dextromoramide Tartrate
% 215.06/215.23  |- skos__broader mesh__D003916smesh__D009025
% 215.06/215.23  |- mesh__recordAuthorizer mesh__D003916 sjn
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D003916 2006
% 215.06/215.23  |- skos__annotation mesh__D003916 an opioid analgesic   
% 215.06/215.23  |- skos__broader mesh__D003118smesh__D014796
% 215.06/215.23  |- skos__related mesh__D003118smesh__D003117
% 215.06/215.23  |- mesh__dateRevised mesh__D003118 2003-07-09
% 215.06/215.23  |- skos__prefLabel mesh__D003118 Color Perception
% 215.06/215.23  |- skos__hiddenLabel mesh__D003118 Perceptions, Color
% 215.06/215.23  |- skos__scopeNote mesh__D003118
% 215.06/215.23       The visual awareness of any particular hue or achromatic color.%A%    
% 215.06/215.23  |- skos__hiddenLabel mesh__D003118 Perception, Color
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D003118 2005
% 215.06/215.23  |- mesh__recordMaintainer mesh__D003118 nns
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D003118 2004
% 215.06/215.23  |- mesh__recordOriginator mesh__D003118 NLM
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D003118 2006
% 215.06/215.23  |- rdf__type mesh__D003118sskos__Concept
% 215.06/215.23  |- skos__hiddenLabel mesh__D003118 Color Visions
% 215.06/215.23  |- mesh__dateCreated mesh__D003118 1999-01-01
% 215.06/215.23  |- skos__hiddenLabel mesh__D003118 Visions, Color
% 215.06/215.23  |- skos__hiddenLabel mesh__D003118 Color Perceptions
% 215.06/215.23  |- skos__hiddenLabel mesh__D003118 Vision, Color
% 215.06/215.23  |- mesh__recordAuthorizer mesh__D003118 sjn
% 215.06/215.23  |- skos__scopeNote mesh__D013546
% 215.06/215.23       The process of exocrine secretion of the SWEAT GLANDS, including the aqueous sweat from the ECCRINE GLANDS and the complex viscous fluids of the APOCRINE GLANDS.%A%    
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D013546 2006
% 215.06/215.23  |- skos__broader mesh__D013546smesh__D001833
% 215.06/215.23  |- mesh__dateRevised mesh__D013546 2005-06-30
% 215.06/215.23  |- skos__related mesh__D013546smesh__D007007
% 215.06/215.23  |- skos__related mesh__D013546smesh__D006945
% 215.06/215.23  |- skos__broader mesh__D013546smesh__D012879
% 215.06/215.23  |- mesh__recordMaintainer mesh__D013546 lkt
% 215.06/215.23  |- mesh__recordAuthorizer mesh__D013546 sjn
% 215.06/215.23  |- mesh__recordOriginator mesh__D013546 NLM
% 215.06/215.23  |- skos__annotation mesh__D013546
% 215.06/215.23       PRICKLY HEAT see MILIARIA also available   
% 215.06/215.23  |- rdf__type mesh__D013546sskos__Concept
% 215.06/215.23  |- mesh__dateCreated mesh__D013546 1999-01-01
% 215.06/215.23  |- skos__related mesh__D013546smesh__D003550
% 215.06/215.23  |- skos__prefLabel mesh__D013546 Sweating
% 215.06/215.23  |- skos__broader mesh__D007509smesh__D009676
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D007509 2006
% 215.06/215.23  |- mesh__onlineNote mesh__D007509
% 215.06/215.23       use IRRITANTS to search RUBEFACIENTS %26% VESICANTS 1966-79   
% 215.06/215.23  |- skos__broader mesh__D007509smesh__D020313
% 215.06/215.23  |- rdf__type mesh__D007509sskos__Concept
% 215.06/215.23  |- skos__broader mesh__D007509smesh__D012304
% 215.06/215.23  |- mesh__recordAuthorizer mesh__D007509 sjn
% 215.06/215.23  |- skos__annotation mesh__D007509
% 215.06/215.23       note X ref COUNTERIRRITANTS but use no qualif with it %28%i.e., adv eff of a counterirritant is COUNTERIRRITANTS, not COUNTERIRRITANTS /adv eff since this would print as a misleading IRRITANTS /adv eff%29%%A%  
% 215.06/215.23  |- skos__scopeNote mesh__D007509
% 215.06/215.23       Drugs that act locally on cutaneous or mucosal surfaces to produce inflammation; those that cause redness due to hyperemia are rubefacients; those that raise blisters are vesicants and those that penetrate sebaceous glands and cause abscesses are pustulants; tear gases and mustard gases are also irritants.%A%    
% 215.06/215.23  |- mesh__recordOriginator mesh__D007509 NLM
% 215.06/215.23  |- mesh__dateRevised mesh__D007509 2003-07-09
% 215.06/215.23  |- mesh__dateCreated mesh__D007509 1999-01-01
% 215.06/215.23  |- skos__prefLabel mesh__D007509 Irritants
% 215.06/215.23  |- mesh__historyNote mesh__D007509
% 215.06/215.23       RUBEFACIENTS %26% VESICANTS were see under IRRITANTS 1963-79%A%  
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D007509 2005
% 215.06/215.23  |- mesh__recordMaintainer mesh__D007509 ssb
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D007509 2004
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D018231 1999
% 215.06/215.23  |- mesh__publicMeSHNote mesh__D018231 94   
% 215.06/215.23  |- mesh__recordOriginator mesh__D018231 PLS
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D018231 2002
% 215.06/215.23  |- mesh__dateCreated mesh__D018231 1993-06-25
% 215.06/215.23  |- skos__broader mesh__D018231smesh__D007889
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D018231 2006
% 215.06/215.23  |- skos__annotation mesh__D018231
% 215.06/215.23       multiple; solitary = LEIOMYOMA; coord IM with precoord organ/neopl term %28%IM%29% if relevant%A%  
% 215.06/215.23  |- mesh__dateEstablished mesh__D018231 1994-01-01
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D018231 2001
% 215.06/215.23  |- mesh__recordAuthorizer mesh__D018231 SJN
% 215.06/215.23  |- skos__historyNote mesh__D018231 Leiomyoma %28%1966-1993%29%
% 215.06/215.23  |- rdf__type mesh__D018231sskos__Concept
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D018231 2000
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D018231 2005
% 215.06/215.23  |- mesh__recordMaintainer mesh__D018231 ADP
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D018231 2004
% 215.06/215.23  |- skos__prefLabel mesh__D018231 Leiomyomatosis
% 215.06/215.23  |- skos__scopeNote mesh__D018231
% 215.06/215.23       The state of having multiple leiomyomas throughout the body. %28%Stedman, 25th ed%29%%A%    
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D018231 2003
% 215.06/215.23  |- mesh__dateRevised mesh__D018231 1998-06-10
% 215.06/215.23  |- skos__hiddenLabel mesh__D018231 Leiomyomatoses
% 215.06/215.23  |- mesh__historyNote mesh__D018231 94   
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D051665 2006
% 215.06/215.23  |- mesh__publicMeSHNote mesh__D051665
% 215.06/215.23       2006; KV1.4 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1995-2004%A%  
% 215.06/215.23  |- skos__altLabel mesh__D051665 KCNA4 Potassium Channel
% 215.06/215.23  |- mesh__recordOriginator mesh__D051665 DRC
% 215.06/215.23  |- mesh__recordAuthorizer mesh__D051665 sjn
% 215.06/215.23  |- skos__prefLabel mesh__D051665 Kv1.4 Potassium Channel
% 215.06/215.23  |- skos__hiddenLabel mesh__D051665 Potassium Channel, Kv1.4
% 215.06/215.23  |- skos__broader mesh__D051665smesh__D051637
% 215.06/215.23  |- rdf__type mesh__D051665sskos__Concept
% 215.06/215.23  |- mesh__dateEstablished mesh__D051665 2006-01-01
% 215.06/215.23  |- mesh__recordMaintainer mesh__D051665 DRC
% 215.06/215.23  |- skos__hiddenLabel mesh__D051665 Potassium Channel, KCNA4
% 215.06/215.23  |- mesh__historyNote mesh__D051665 2006%28%1995%29%   
% 215.06/215.23  |- skos__scopeNote mesh__D051665
% 215.06/215.23       A fast inactivating subtype of shaker potassium channels that contains two inactivation domains at its N terminus.%A%    
% 215.06/215.23  |- mesh__dateCreated mesh__D051665 2005-06-30
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D004211 2004
% 215.06/215.23  |- skos__hiddenLabel mesh__D004211 Disseminated Intravascular Coagulations
% 215.06/215.23  |- mesh__recordMaintainer mesh__D004211 NNS
% 215.06/215.23  |- skos__hiddenLabel mesh__D004211 Intravascular Disseminated Coagulations
% 215.06/215.23  |- skos__hiddenLabel mesh__D004211 Coagulopathy, Consumption
% 215.06/215.23  |- skos__altLabel mesh__D004211 Disseminated Coagulation, Intravascular
% 215.06/215.23  |- skos__hiddenLabel mesh__D004211 Coagulations, Intravascular Disseminated
% 215.06/215.23  |- skos__altLabel mesh__D004211 Consumption Coagulopathy
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D004211 2000
% 215.06/215.23  |- mesh__recordAuthorizer mesh__D004211 SJN
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D004211 2001
% 215.06/215.23  |- mesh__dateRevised mesh__D004211 1998-06-10
% 215.06/215.23  |- skos__annotation mesh__D004211
% 215.06/215.23       do not confuse with ERYTHROCYTE AGGREGATION, INTRAVASCULAR; DF: DISSEM INTRAVASC COAG%A%  
% 215.06/215.23  |- skos__altLabel mesh__D004211 Coagulation, Disseminated Intravascular
% 215.06/215.23  |- rdf__type mesh__D004211sskos__Concept
% 215.06/215.23  |- skos__scopeNote mesh__D004211
% 215.06/215.23       A disorder characterized by reduction in the elements involved in blood coagulation due to their utilization in widespread blood clotting within the vessels. The activation of the clotting mechanism may arise from any of a number of disorders. In the late stages, it is marked by profuse hemorrhaging. %28%Dorland, 27th ed%29%%A%    
% 215.06/215.23  |- skos__hiddenLabel mesh__D004211 Consumption Coagulopathies
% 215.06/215.23  |- skos__altLabel mesh__D004211 Intravascular Coagulation, Disseminated
% 215.06/215.23  |- mesh__dateCreated mesh__D004211 1999-01-01
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D004211 2005
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D004211 1999
% 215.06/215.23  |- mesh__historyNote mesh__D004211 72%28%70%29%   
% 215.06/215.23  |- skos__broader mesh__D004211smesh__D001778
% 215.06/215.23  |- skos__hiddenLabel mesh__D004211 Coagulopathies, Consumption
% 215.06/215.23  |- skos__altLabel mesh__D004211 Intravascular Disseminated Coagulation
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D004211 2002
% 215.06/215.23  |- mesh__publicMeSHNote mesh__D004211 72   
% 215.06/215.23  |- skos__hiddenLabel mesh__D004211 Disseminated Coagulations, Intravascular
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D004211 2003
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D004211 2006
% 215.06/215.23  |- skos__prefLabel mesh__D004211 Disseminated Intravascular Coagulation
% 215.06/215.23  |- skos__historyNote mesh__D004211
% 215.06/215.23       Blood Coagulation Disorders %28%1966-1969%29%
% 215.06/215.23  |- skos__broader mesh__D004211smesh__D019851
% 215.06/215.23  |- skos__hiddenLabel mesh__D004211 Coagulations, Disseminated Intravascular
% 215.06/215.23  |- mesh__recordOriginator mesh__D004211 NLM
% 215.06/215.23  |- skos__hiddenLabel mesh__D004211 Coagulation, Intravascular Disseminated
% 215.06/215.23  |- skos__hiddenLabel mesh__D004211 Intravascular Coagulations, Disseminated
% 215.06/215.23  |- skos__broader mesh__D004211smesh__D006474
% 215.06/215.23  |- mesh__dateEstablished mesh__D004211 1972-01-01
% 215.06/215.23  |- mesh__recordAuthorizer mesh__D017937 sjn
% 215.06/215.23  |- mesh__historyNote mesh__D017937 2004%28%1994%29%   
% 215.06/215.23  |- skos__annotation mesh__D017937
% 215.06/215.23       spell in titles %26% translations with lowercase d: cytochrome d%A%  
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D017937 2006
% 215.06/215.23  |- skos__historyNote mesh__D017937 Cytochromes %28%1979-1993%29%
% 215.06/215.23  |- mesh__publicMeSHNote mesh__D017937
% 215.06/215.23       2004; see CYTOCHROME D 1994-2003, see CYTOCHROMES 1979-1993%A%  
% 215.06/215.23  |- mesh__dateCreated mesh__D017937 1993-02-16
% 215.06/215.23  |- mesh__dateEstablished mesh__D017937 1994-01-01
% 215.06/215.23  |- mesh__recordMaintainer mesh__D017937 jmp
% 215.06/215.23  |- skos__scopeNote mesh__D017937
% 215.06/215.23       Cytochromes %28%electron-transporting proteins%29% with a tetrapyrrolic chelate of iron as a prosthetic group in which the degree of conjugation of double bonds is less than in porphyrin. %28%From Enzyme Nomenclature, 1992, p539%29%%A%    
% 215.06/215.23  |- skos__prefLabel mesh__D017937 Cytochrome d Group
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D017937 2004
% 215.06/215.23  |- mesh__recordOriginator mesh__D017937 TPW
% 215.06/215.23  |- skos__altLabel mesh__D017937 Cytochrome d
% 215.06/215.23  |- skos__altLabel mesh__D017937 Cytochromes d
% 215.06/215.23  |- mesh__dateRevised mesh__D017937 2003-07-09
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D017937 2005
% 215.06/215.23  |- skos__broader mesh__D017937smesh__D003580
% 215.06/215.23  |- rdf__type mesh__D017937sskos__Concept
% 215.06/215.23  |- skos__historyNote mesh__D031608 Cerebral Ventricles %28%1965-2001%29%
% 215.06/215.23  |- rdf__type mesh__D031608sskos__Concept
% 215.06/215.23  |- skos__historyNote mesh__D031608 Fourth Ventricle %28%2000-2002%29%
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D031608 2003
% 215.06/215.23  |- mesh__dateEstablished mesh__D031608 2003-01-01
% 215.06/215.23  |- mesh__recordMaintainer mesh__D031608 ags
% 215.06/215.23  |- mesh__recordOriginator mesh__D031608 ags
% 215.06/215.23  |- skos__scopeNote mesh__D031608
% 215.06/215.23       A small, rounded eminence on each side of the FOURTH VENTRICLE, which receives nerve fibers from the SOLITARY NUCLEUS; SPINAL CORD; and adjacent areas of the MEDULLA. The area postrema lies outside the BLOOD-BRAIN BARRIER and its functions include acting as an emetic chemoreceptor.%A%    
% 215.06/215.23  |- mesh__activeMeSHYear mesh__D031608 2004
% 215.06/215.23  |- mesh__publicMeSHNote mesh__D031608 2003   
% 215.06/215.23  |- skos__hiddenLabel mesh__D031608 Postrema, Area
% 215.06/215.24  |- skos__hiddenLabel mesh__D031608 Area Postremas
% 215.06/215.24  |- skos__broader mesh__D031608smesh__D008526
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D031608 2005
% 215.06/215.24  |- skos__prefLabel mesh__D031608 Area Postrema
% 215.06/215.24  |- skos__historyNote mesh__D031608 Medulla Oblongata %28%1966-2002%29%
% 215.06/215.24  |- mesh__recordAuthorizer mesh__D031608 ags
% 215.06/215.24  |- mesh__historyNote mesh__D031608 2003   
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D031608 2006
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D031608 2006A
% 215.06/215.24  |- mesh__dateCreated mesh__D031608 2002-07-02
% 215.06/215.24  |- mesh__dateRevised mesh__D031608 2005-07-29
% 215.06/215.24  |- mesh__onlineNote mesh__D003917
% 215.06/215.24       use DEXTRORPHAN to search DEXTRODROMORAN %26% D-DROMORAN 1977-94 %26% DESTRORPHANOLUM 1975-94%A%  
% 215.06/215.24  |- skos__historyNote mesh__D003917 Morphinans %28%1969-1974%29%
% 215.06/215.24  |- mesh__dateEstablished mesh__D003917 1991-01-01
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D003917 2002
% 215.06/215.24  |- mesh__dateRevised mesh__D003917 2000-06-22
% 215.06/215.24  |- rdf__type mesh__D003917sskos__Concept
% 215.06/215.24  |- mesh__publicMeSHNote mesh__D003917
% 215.06/215.24       91; was see under MORPHINANS 1975-90; DEXTRODROMORAN %26% D-DROMORAN were see DEXTRORPHAN 1977-94; DESTRORPHANOLUM was see DEXTRORPHAN 1975-94%A%  
% 215.06/215.24  |- mesh__historyNote mesh__D003917
% 215.06/215.24       91%28%75%29%; was see under MORPHINANS 1975-90; DEXTRODROMORAN %26% D-DROMORAN were see DEXTRORPHAN 1977-94; DESTRORPHANOLUM was see DEXTRORPHAN 1975-94%A%  
% 215.06/215.24  |- mesh__recordAuthorizer mesh__D003917 sjn
% 215.06/215.24  |- skos__scopeNote mesh__D003917
% 215.06/215.24       Dextro form of levorphanol. It acts as a noncompetitive NMDA receptor antagonist, among other effects, and has been proposed as a neuroprotective agent. It is also a metabolite of DEXTROMETHORPHAN.%A%    
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D003917 2005
% 215.06/215.24  |- skos__altLabel mesh__D003917 %28%+-%29%-17-Methylmorphinan-3-ol
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D003917 2003
% 215.06/215.24  |- skos__broader mesh__D003917smesh__D009019
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D003917 2006
% 215.06/215.24  |- mesh__recordMaintainer mesh__D003917 TWD
% 215.06/215.24  |- mesh__recordOriginator mesh__D003917 NLM
% 215.06/215.24  |- skos__prefLabel mesh__D003917 Dextrorphan
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D003917 2004
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D003917 2001
% 215.06/215.24  |- mesh__dateCreated mesh__D003917 1974-11-27
% 215.06/215.24  |- skos__broader mesh__D020358Q000031smesh__D020358
% 215.06/215.24  |- mesh__preferredCombination mesh__D020358Q000031smesh__D020355
% 215.06/215.24  |- rdf__type mesh__D020358Q000031smesh__CompoundConcept
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D003119 2000
% 215.06/215.24  |- mesh__recordMaintainer mesh__D003119 PXP
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D003119 2005
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D003119 1999
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D003119 2004
% 215.06/215.24  |- skos__hiddenLabel mesh__D003119 Perception Tests, Color
% 215.06/215.24  |- mesh__dateRevised mesh__D003119 1997-06-20
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D003119 2001
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D003119 2006
% 215.06/215.24  |- rdf__type mesh__D003119sskos__Concept
% 215.06/215.24  |- skos__hiddenLabel mesh__D003119 Tests, Color Perception
% 215.06/215.24  |- mesh__dateCreated mesh__D003119 1999-01-01
% 215.06/215.24  |- skos__hiddenLabel mesh__D003119 Perception Test, Color
% 215.06/215.24  |- skos__prefLabel mesh__D003119 Color Perception Tests
% 215.06/215.24  |- mesh__recordOriginator mesh__D003119 NLM
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D003119 2002
% 215.06/215.24  |- mesh__recordAuthorizer mesh__D003119 SJN
% 215.06/215.24  |- skos__hiddenLabel mesh__D003119 Test, Color Perception
% 215.06/215.24  |- skos__broader mesh__D003119smesh__D014787
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D003119 1998
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D003119 2003
% 215.06/215.24  |- skos__hiddenLabel mesh__D003119 Color Perception Test
% 215.06/215.24  |- skos__hiddenLabel mesh__D008602 Healing, Mental
% 215.06/215.24  |- mesh__dateRevised mesh__D008602 2001-07-25
% 215.06/215.24  |- mesh__recordOriginator mesh__D008602 NLM
% 215.06/215.24  |- skos__broader mesh__D008602smesh__D026441
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D008602 2006
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D008602 2003
% 215.06/215.24  |- skos__prefLabel mesh__D008602 Mental Healing
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D008602 2004
% 215.06/215.24  |- rdf__type mesh__D008602sskos__Concept
% 215.06/215.24  |- mesh__recordAuthorizer mesh__D008602 sjn
% 215.06/215.24  |- mesh__dateCreated mesh__D008602 1999-01-01
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D008602 2002
% 215.06/215.24  |- mesh__recordMaintainer mesh__D008602 ssb
% 215.06/215.24  |- skos__broader mesh__D008602smesh__D026443
% 215.06/215.24  |- skos__scopeNote mesh__D008602
% 215.06/215.24       The use of mind to cure disease, particularly physical illness.%A%    
% 215.06/215.24  |- skos__annotation mesh__D008602
% 215.06/215.24       do not confuse X ref SPIRITUAL HEALING with SPIRITUALISM   
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D008602 2005
% 215.06/215.24  |- skos__hiddenLabel mesh__D013547 Syndrome, Von Frey
% 215.06/215.24  |- skos__hiddenLabel mesh__D013547 Syndrome, Salivosudoriparous
% 215.06/215.24  |- mesh__recordOriginator mesh__D013547 NLM
% 215.06/215.24  |- skos__hiddenLabel mesh__D013547 Salivosudoriparous Syndromes
% 215.06/215.24  |- rdf__type mesh__D013547sskos__Concept
% 215.06/215.24  |- skos__hiddenLabel mesh__D013547 Syndromes, Salivosudoriparous
% 215.06/215.24  |- skos__broader mesh__D013547smesh__D001342
% 215.06/215.24  |- mesh__dateCreated mesh__D013547 1999-01-01
% 215.06/215.24  |- mesh__recordMaintainer mesh__D013547 lkt
% 215.06/215.24  |- skos__prefLabel mesh__D013547 Sweating, Gustatory
% 215.06/215.24  |- mesh__dateRevised mesh__D013547 2001-07-25
% 215.06/215.24  |- skos__hiddenLabel mesh__D013547 Von Freys Syndrome
% 215.06/215.24  |- skos__broader mesh__D013547smesh__D006945
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D013547 2003
% 215.06/215.24  |- mesh__onlineNote mesh__D013547
% 215.06/215.24       use SWEATING, GUSTATORY to search FREY%27%S SYNDROME 1966-73 %28%as Prov%29%%A%  
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D013547 2002
% 215.06/215.24  |- skos__hiddenLabel mesh__D013547 Syndrome, Frey%27%s
% 215.06/215.24  |- skos__altLabel mesh__D013547 Hyperhidrosis, Gustatory
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D013547 2004
% 215.06/215.24  |- skos__altLabel mesh__D013547 Frey%27%s Syndrome
% 215.06/215.24  |- skos__hiddenLabel mesh__D013547 Syndrome, Frey
% 215.06/215.24  |- mesh__recordAuthorizer mesh__D013547 sjn
% 215.06/215.24  |- mesh__historyNote mesh__D013547
% 215.06/215.24       74; was FREY%27%S SYNDROME 1965-73 %28%Prov%29%   
% 215.06/215.24  |- skos__hiddenLabel mesh__D013547 Syndrome, Auriculotemporal
% 215.06/215.24  |- skos__hiddenLabel mesh__D013547 Gustatory Hyperhidrosis
% 215.06/215.24  |- skos__altLabel mesh__D013547 Baillarger Syndrome
% 215.06/215.24  |- skos__altLabel mesh__D013547 Salivosudoriparous Syndrome
% 215.06/215.24  |- skos__scopeNote mesh__D013547
% 215.06/215.24       An autonomic disorder characterized by excessive sweating of the forehead, upper lip, perioral region, or sternum subsequent to gustatory stimuli. The auriculotemporal syndrome features facial flushing or sweating limited to the distribution of the auriculotemporal nerve and may develop after trauma to the parotid gland, in association with PAROTID NEOPLASMS, or following their surgical removal. %28%From Ann Neurol 1997 Dec;42%28%6%29%:973-5%29%%A%    
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D013547 2005
% 215.06/215.24  |- skos__altLabel mesh__D013547 Von Frey%27%s Syndrome
% 215.06/215.24  |- mesh__publicMeSHNote mesh__D013547 74   
% 215.06/215.24  |- skos__hiddenLabel mesh__D013547 Freys Syndrome
% 215.06/215.24  |- skos__altLabel mesh__D013547 Frey Syndrome
% 215.06/215.24  |- skos__altLabel mesh__D013547 Von Frey Syndrome
% 215.06/215.24  |- skos__hiddenLabel mesh__D013547 Gustatory Hyperhidroses
% 215.06/215.24  |- skos__hiddenLabel mesh__D013547 Hyperhidroses, Gustatory
% 215.06/215.24  |- skos__hiddenLabel mesh__D013547 Syndrome, Von Frey%27%s
% 215.06/215.24  |- skos__hiddenLabel mesh__D013547 Syndrome, Baillarger
% 215.06/215.24  |- skos__hiddenLabel mesh__D013547 Gustatory Sweating
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D013547 2006
% 215.06/215.24  |- skos__scopeNote mesh__D032701
% 215.06/215.24       An interdisciplinary field in materials science, ENGINEERING, and BIOLOGY, studying the use of biological principles for synthesis or fabrication of BIOMIMETIC MATERIALS.%A%    
% 215.06/215.24  |- skos__altLabel mesh__D032701 Mimetics, Biological
% 215.06/215.24  |- mesh__publicMeSHNote mesh__D032701 2003   
% 215.06/215.24  |- rdf__type mesh__D032701sskos__Concept
% 215.06/215.24  |- skos__hiddenLabel mesh__D032701 Mimetic, Biological
% 215.06/215.24  |- skos__hiddenLabel mesh__D032701 Biomimetic
% 215.06/215.24  |- mesh__dateEstablished mesh__D032701 2003-01-01
% 215.06/215.24  |- skos__annotation mesh__D032701 BIOMIMETIC MATERIALS is also available   
% 215.06/215.24  |- skos__hiddenLabel mesh__D032701 Biological Mimetics
% 215.06/215.24  |- skos__broader mesh__D032701smesh__D001709
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D032701 2003
% 215.06/215.24  |- mesh__dateCreated mesh__D032701 2002-07-02
% 215.06/215.24  |- skos__prefLabel mesh__D032701 Biomimetics
% 215.06/215.24  |- mesh__historyNote mesh__D032701 2003   
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D032701 2004
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D032701 2005
% 215.06/215.24  |- skos__hiddenLabel mesh__D032701 Biological Mimetic
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D032701 2006
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018232 1998
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018232 2006
% 215.06/215.24  |- mesh__recordAuthorizer mesh__D018232 PLS
% 215.06/215.24  |- skos__hiddenLabel mesh__D018232 Alveolar Rhabdomyosarcomas
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018232 1997
% 215.06/215.24  |- mesh__dateRevised mesh__D018232 1995-06-08
% 215.06/215.24  |- rdf__type mesh__D018232sskos__Concept
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018232 2005
% 215.06/215.24  |- mesh__publicMeSHNote mesh__D018232 94   
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018232 2002
% 215.06/215.24  |- skos__annotation mesh__D018232
% 215.06/215.24       %22%alveolar%22% has nothing to do with pulm alveoli: it refers to sac-like pathol of musc affected; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018232 1996
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018232 2004
% 215.06/215.24  |- mesh__dateCreated mesh__D018232 1993-06-25
% 215.06/215.24  |- skos__prefLabel mesh__D018232 Rhabdomyosarcoma, Alveolar
% 215.06/215.24  |- skos__hiddenLabel mesh__D018232 Alveolar Rhabdomyosarcoma
% 215.06/215.24  |- mesh__dateEstablished mesh__D018232 1994-01-01
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018232 2001
% 215.06/215.24  |- skos__historyNote mesh__D018232 Rhabdomyosarcoma %28%1968-1993%29%
% 215.06/215.24  |- mesh__recordMaintainer mesh__D018232 KEV
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018232 2003
% 215.06/215.24  |- skos__scopeNote mesh__D018232
% 215.06/215.24       A form of RHABDOMYOSARCOMA occurring mainly in adolescents and young adults, affecting muscles of the extremities, trunk, orbital region, etc. It is extremely malignant, metastasizing widely at an early stage. Few cures have been achieved and the prognosis is poor. %22%Alveolar%22% refers to its microscopic appearance simulating the cells of the respiratory alveolus. %28%Holland et al., Cancer Medicine, 3d ed, p2188%29%%A%    
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018232 2000
% 215.06/215.24  |- skos__broader mesh__D018232smesh__D012208
% 215.06/215.24  |- mesh__historyNote mesh__D018232 94   
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018232 1999
% 215.06/215.24  |- skos__hiddenLabel mesh__D018232 Rhabdomyosarcomas, Alveolar
% 215.06/215.24  |- mesh__recordOriginator mesh__D018232 PLS
% 215.06/215.24  |- mesh__historyNote mesh__D051666 2006%28%1995%29%   
% 215.06/215.24  |- rdf__type mesh__D051666sskos__Concept
% 215.06/215.24  |- skos__broader mesh__D051666smesh__D051637
% 215.06/215.24  |- mesh__dateCreated mesh__D051666 2005-06-30
% 215.06/215.24  |- skos__altLabel mesh__D051666 KCNA5 Potassium Channel
% 215.06/215.24  |- skos__hiddenLabel mesh__D051666 Potassium Channel, Kv1.5
% 215.06/215.24  |- skos__broader mesh__D051666smesh__D051668
% 215.06/215.24  |- mesh__publicMeSHNote mesh__D051666
% 215.06/215.24       2006; KV1.5 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1995-2004%A%  
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D051666 2006
% 215.06/215.24  |- mesh__recordAuthorizer mesh__D051666 sjn
% 215.06/215.24  |- skos__scopeNote mesh__D051666
% 215.06/215.24       A delayed rectifier subtype of shaker potassium channels that conducts a delayed rectifier current. It contributes to ACTION POTENTIAL repolarization of MYOCYTES in HEART ATRIA.%A%    
% 215.06/215.24  |- mesh__dateEstablished mesh__D051666 2006-01-01
% 215.06/215.24  |- mesh__recordMaintainer mesh__D051666 DRC
% 215.06/215.24  |- skos__prefLabel mesh__D051666 Kv1.5 Potassium Channel
% 215.06/215.24  |- mesh__recordOriginator mesh__D051666 DRC
% 215.06/215.24  |- skos__hiddenLabel mesh__D051666 Potassium Channel, KCNA5
% 215.06/215.24  |- skos__annotation mesh__D004212
% 215.06/215.24       do not confuse with Publication Type ACADEMIC DISSERTATIONS; DF: DISSERTATIONS ACAD%A%  
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D004212 2006
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D004212 1998
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D004212 2003
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D004212 2005
% 215.06/215.24  |- mesh__recordOriginator mesh__D004212 NLM
% 215.06/215.24  |- skos__scopeNote mesh__D004212
% 215.06/215.24       Dissertations embodying results of original research and especially substantiating a specific view, e.g., substantial papers written by candidates for an academic degree under the individual direction of a professor or papers written by undergraduates desirous of achieving honors or distinction.%A%    
% 215.06/215.24  |- mesh__recordAuthorizer mesh__D004212 PLS
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D004212 2002
% 215.06/215.24  |- mesh__dateRevised mesh__D004212 1996-06-10
% 215.06/215.24  |- mesh__dateCreated mesh__D004212 1999-01-01
% 215.06/215.24  |- mesh__historyNote mesh__D004212
% 215.06/215.24       THESES was see under DISSERTATIONS, ACADEMIC 1963-78   
% 215.06/215.24  |- skos__broader mesh__D004212smesh__D011642
% 215.06/215.24  |- skos__altLabel mesh__D004212 Thesis
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D004212 2001
% 215.06/215.24  |- mesh__recordMaintainer mesh__D004212 TGC
% 215.06/215.24  |- skos__prefLabel mesh__D004212 Dissertations, Academic
% 215.06/215.24  |- rdf__type mesh__D004212sskos__Concept
% 215.06/215.24  |- skos__altLabel mesh__D004212 Dissertation, Academic
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D004212 1997
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D004212 2000
% 215.06/215.24  |- mesh__onlineNote mesh__D004212
% 215.06/215.24       use DISSERTATIONS, ACADEMIC to search THESES 1966-78   
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D004212 1999
% 215.06/215.24  |- skos__altLabel mesh__D004212 Academic Dissertation
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D004212 2004
% 215.06/215.24  |- skos__altLabel mesh__D004212 Academic Dissertations
% 215.06/215.24  |- skos__broader mesh__D012987Q000821smesh__D012987
% 215.06/215.24  |- mesh__preferredCombination mesh__D012987Q000821smesh__D012988
% 215.06/215.24  |- rdf__type mesh__D012987Q000821smesh__CompoundConcept
% 215.06/215.24  |- skos__hiddenLabel mesh__D017938 Bovine Coronaviruses
% 215.06/215.24  |- mesh__dateRevised mesh__D017938 2001-07-25
% 215.06/215.24  |- mesh__recordAuthorizer mesh__D017938 sjn
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D017938 2003
% 215.06/215.24  |- mesh__publicMeSHNote mesh__D017938 94   
% 215.06/215.24  |- mesh__recordOriginator mesh__D017938 AGS
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D017938 2004
% 215.06/215.24  |- mesh__recordMaintainer mesh__D017938 ags
% 215.06/215.24  |- mesh__historyNote mesh__D017938 94   
% 215.06/215.24  |- mesh__dateEstablished mesh__D017938 1994-01-01
% 215.06/215.24  |- skos__altLabel mesh__D017938 Bovine coronavirus
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D017938 2005
% 215.06/215.24  |- skos__prefLabel mesh__D017938 Coronavirus, Bovine
% 215.06/215.24  |- rdf__type mesh__D017938sskos__Concept
% 215.06/215.24  |- skos__annotation mesh__D017938
% 215.06/215.24       infection: coord IM with CORONAVIRUS INFECTIONS %28%IM%29%   
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D017938 2006
% 215.06/215.24  |- mesh__dateCreated mesh__D017938 1993-06-04
% 215.06/215.24  |- skos__scopeNote mesh__D017938
% 215.06/215.24       A species of CORONAVIRUS infecting neonatal calves, presenting as acute diarrhea, and frequently leading to death.%A%    
% 215.06/215.24  |- skos__historyNote mesh__D017938 Coronaviridae %28%1977-1993%29%
% 215.06/215.24  |- skos__hiddenLabel mesh__D017938 Coronaviruses, Bovine
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D017938 2002
% 215.06/215.24  |- skos__broader mesh__D017938smesh__D017934
% 215.06/215.24  |- skos__broader mesh__D031609smesh__D031607
% 215.06/215.24  |- mesh__publicMeSHNote mesh__D031609 2003   
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D031609 2004
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D031609 2005
% 215.06/215.24  |- mesh__dateEstablished mesh__D031609 2003-01-01
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D031609 2006
% 215.06/215.24  |- skos__annotation mesh__D031609
% 215.06/215.24       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.06/215.24  |- mesh__dateCreated mesh__D031609 2002-07-03
% 215.06/215.24  |- skos__scopeNote mesh__D031609
% 215.06/215.24       A plant species of the genus STEPHANIA, family MENISPERMACEAE, that contains tetrandrine and bisbenzylisoquinoline alkaloids.%A%    
% 215.06/215.24  |- mesh__historyNote mesh__D031609 2003   
% 215.06/215.24  |- skos__prefLabel mesh__D031609 Stephania tetrandra
% 215.06/215.24  |- rdf__type mesh__D031609sskos__Concept
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D031609 2003
% 215.06/215.24  |- skos__broader mesh__D011595Q000139smesh__D011595
% 215.06/215.24  |- mesh__preferredCombination mesh__D011595Q000139smesh__D017109
% 215.06/215.24  |- rdf__type mesh__D011595Q000139smesh__CompoundConcept
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D003918 2005
% 215.06/215.24  |- skos__broader mesh__D003918smesh__D024322
% 215.06/215.24  |- skos__broader mesh__D003918smesh__D013963
% 215.06/215.24  |- mesh__recordOriginator mesh__D003918 NLM
% 215.06/215.24  |- mesh__dateCreated mesh__D003918 1999-01-01
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D003918 2006
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D003918 2003
% 215.06/215.24  |- mesh__historyNote mesh__D003918 65   
% 215.06/215.24  |- mesh__dateRevised mesh__D003918 2001-07-25
% 215.06/215.24  |- mesh__dateEstablished mesh__D003918 1965-01-01
% 215.06/215.24  |- mesh__recordMaintainer mesh__D003918 nns
% 215.06/215.24  |- skos__prefLabel mesh__D003918 Dextrothyroxine
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D003918 2004
% 215.06/215.24  |- mesh__publicMeSHNote mesh__D003918 65   
% 215.06/215.24  |- skos__altLabel mesh__D003918 D-T4 Thyroid Hormone
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D003918 2002
% 215.06/215.24  |- skos__scopeNote mesh__D003918
% 215.06/215.24       The dextrorotary isomer of the synthetic THYROXINE.     
% 215.06/215.24  |- mesh__recordAuthorizer mesh__D003918 sjn
% 215.06/215.24  |- skos__altLabel mesh__D003918 Sodium Dextrothyroxine
% 215.06/215.24  |- skos__altLabel mesh__D003918 D-Thyroxine
% 215.06/215.24  |- rdf__type mesh__D003918sskos__Concept
% 215.06/215.24  |- skos__hiddenLabel mesh__D003918 D Thyroxine
% 215.06/215.24  |- skos__hiddenLabel mesh__D014640 Hydrochloride, Vancomycin
% 215.06/215.24  |- skos__altLabel mesh__D014640 Abbott Brand of Vancomycin Hydrochloride
% 215.06/215.24  |- mesh__recordOriginator mesh__D014640 NLM
% 215.06/215.24  |- skos__altLabel mesh__D014640 Lilly Brand of Vancomycin Hydrochloride
% 215.06/215.24  |- skos__altLabel mesh__D014640 Combino Brand of Vancomycin Hydrochloride
% 215.06/215.24  |- skos__altLabel mesh__D014640
% 215.06/215.24       cell pharm Brand of Vancomycin Hydrochloride
% 215.06/215.24  |- skos__altLabel mesh__D014640 Eli Lilly Brand of Vancomycin Hydrochloride
% 215.06/215.24  |- mesh__dateRevised mesh__D014640 2005-06-30
% 215.06/215.24  |- skos__broader mesh__D014640smesh__D006020
% 215.06/215.24  |- skos__prefLabel mesh__D014640 Vancomycin
% 215.06/215.24  |- mesh__recordAuthorizer mesh__D014640 sjn
% 215.06/215.24  |- skos__altLabel mesh__D014640 Azupharma Brand of Vancomycin Hydrochloride
% 215.06/215.24  |- rdf__type mesh__D014640sskos__Concept
% 215.06/215.24  |- skos__altLabel mesh__D014640 Vancomycin Lilly
% 215.06/215.24  |- skos__altLabel mesh__D014640 curasan Brand of Vancomycin Hydrochloride
% 215.06/215.24  |- mesh__dateCreated mesh__D014640 1999-01-01
% 215.06/215.24  |- skos__altLabel mesh__D014640 Vancocine
% 215.06/215.24  |- skos__annotation mesh__D014640
% 215.06/215.24       do not confuse with trade name Vancomin, a vitamin B12 deriv%A%  
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D014640 2006
% 215.06/215.24  |- skos__altLabel mesh__D014640 Dakota Brand of Vancomycin Hydrochloride
% 215.06/215.24  |- skos__altLabel mesh__D014640 Vancocin HCl
% 215.06/215.24  |- skos__altLabel mesh__D014640 Dista Brand of Vancomycin Hydrochloride
% 215.06/215.24  |- skos__hiddenLabel mesh__D014640 Sulfate, Vancomycin
% 215.06/215.24  |- skos__altLabel mesh__D014640 MIP Brand of Vancomycin Hydrochloride
% 215.06/215.24  |- skos__altLabel mesh__D014640
% 215.06/215.24       ratiopharm Brand of Vancomycin Hydrochloride
% 215.06/215.24  |- skos__altLabel mesh__D014640 Hexal Brand of Vancomycin Hydrochloride
% 215.06/215.24  |- skos__altLabel mesh__D014640 Chiesi Brand of Vancomycin Hydrochloride
% 215.06/215.24  |- skos__altLabel mesh__D014640 Norman Brand of Vancomycin Hydrochloride
% 215.06/215.24  |- mesh__recordMaintainer mesh__D014640 lkw
% 215.06/215.24  |- skos__scopeNote mesh__D014640
% 215.06/215.24       Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.%A%    
% 215.06/215.24  |- skos__annotation mesh__D008603 no qualif   
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D008603 2004
% 215.06/215.24  |- mesh__historyNote mesh__D008603 67; was MENTAL HYGIENE 1963-66   
% 215.06/215.24  |- mesh__dateRevised mesh__D008603 1997-06-20
% 215.06/215.24  |- rdf__type mesh__D008603sskos__Concept
% 215.06/215.24  |- mesh__publicMeSHNote mesh__D008603 67; was MENTAL HYGIENE 1963-66   
% 215.06/215.24  |- skos__altLabel mesh__D008603 Mental Hygiene
% 215.06/215.24  |- skos__scopeNote mesh__D008603
% 215.06/215.24       The state wherein the person is well adjusted.     
% 215.06/215.24  |- mesh__recordOriginator mesh__D008603 NLM
% 215.06/215.24  |- mesh__recordAuthorizer mesh__D008603 SJN
% 215.06/215.24  |- mesh__dateCreated mesh__D008603 1999-01-01
% 215.06/215.24  |- mesh__dateEstablished mesh__D008603 1967-01-01
% 215.06/215.24  |- skos__broader mesh__D008603smesh__D011579
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D008603 2000
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D008603 1998
% 215.06/215.24  |- skos__hiddenLabel mesh__D008603 Hygiene, Mental
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D008603 2001
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D008603 1999
% 215.06/215.24  |- skos__hiddenLabel mesh__D008603 Health, Mental
% 215.06/215.24  |- mesh__onlineNote mesh__D008603
% 215.06/215.24       use MENTAL HEALTH to search MENTAL HYGIENE 1966   
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D008603 2005
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D008603 2002
% 215.06/215.24  |- skos__broader mesh__D008603smesh__D006262
% 215.06/215.24  |- skos__prefLabel mesh__D008603 Mental Health
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D008603 2006
% 215.06/215.24  |- mesh__recordMaintainer mesh__D008603 PXP
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D008603 2003
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D000620 2006
% 215.06/215.24  |- mesh__dateEstablished mesh__D000620 1991-01-01
% 215.06/215.24  |- mesh__historyNote mesh__D000620
% 215.06/215.24       91%28%78%29%; was see under IMIDAZOLES 1978-90   
% 215.06/215.24  |- skos__broader mesh__D000620smesh__D007093
% 215.06/215.24  |- mesh__publicMeSHNote mesh__D000620
% 215.06/215.24       91; was see under IMIDAZOLES 1978-90   
% 215.06/215.24  |- skos__prefLabel mesh__D000620 Aminoimidazole Carboxamide
% 215.06/215.24  |- mesh__dateRevised mesh__D000620 2005-06-30
% 215.06/215.24  |- mesh__recordAuthorizer mesh__D000620 sjn
% 215.06/215.24  |- mesh__dateCreated mesh__D000620 1977-04-15
% 215.06/215.24  |- mesh__recordOriginator mesh__D000620 RLS
% 215.06/215.24  |- rdf__type mesh__D000620sskos__Concept
% 215.06/215.24  |- mesh__recordMaintainer mesh__D000620 ssb
% 215.06/215.24  |- skos__hiddenLabel mesh__D000620 Carboxamide, Aminoimidazole
% 215.06/215.24  |- skos__scopeNote mesh__D000620
% 215.06/215.24       An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC. By itself, or as the ribonucleotide, it is used as a condensation agent in the preparation of nucleosides and nucleotides. Compounded with orotic acid, it is used to treat liver diseases.%A%    
% 215.06/215.24  |- skos__historyNote mesh__D000620 Imidazoles %28%1966-1977%29%
% 215.06/215.24  |- mesh__recordOriginator mesh__D013548 NLM
% 215.06/215.24  |- mesh__recordMaintainer mesh__D013548 KEV
% 215.06/215.24  |- mesh__dateRevised mesh__D013548 1995-05-23
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D013548 1996
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D013548 2006
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D013548 2002
% 215.06/215.24  |- skos__broader mesh__D013548smesh__D012537
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D013548 2005
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D013548 2001
% 215.06/215.24  |- skos__prefLabel mesh__D013548 Sweden
% 215.06/215.24  |- mesh__dateCreated mesh__D013548 1999-01-01
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D013548 2004
% 215.06/215.24  |- rdf__type mesh__D013548sskos__Concept
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D013548 2000
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D013548 2003
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D013548 1999
% 215.06/215.24  |- mesh__recordAuthorizer mesh__D013548 PLS
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D013548 1998
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D013548 1997
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018233 2004
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018233 2000
% 215.06/215.24  |- skos__hiddenLabel mesh__D018233 Embryonal Rhabdomyosarcomas
% 215.06/215.24  |- skos__broader mesh__D018233smesh__D012208
% 215.06/215.24  |- skos__historyNote mesh__D018233 Rhabdomyosarcoma %28%1966-1993%29%
% 215.06/215.24  |- mesh__recordMaintainer mesh__D018233 KEV
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018233 2003
% 215.06/215.24  |- mesh__historyNote mesh__D018233 94   
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018233 1999
% 215.06/215.24  |- mesh__recordOriginator mesh__D018233 PLS
% 215.06/215.24  |- mesh__recordAuthorizer mesh__D018233 PLS
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018233 1998
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018233 2006
% 215.06/215.24  |- mesh__publicMeSHNote mesh__D018233 94   
% 215.06/215.24  |- mesh__dateEstablished mesh__D018233 1994-01-01
% 215.06/215.24  |- skos__prefLabel mesh__D018233 Rhabdomyosarcoma, Embryonal
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018233 2002
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018233 1997
% 215.06/215.24  |- mesh__dateRevised mesh__D018233 1995-06-08
% 215.06/215.24  |- mesh__dateCreated mesh__D018233 1993-06-25
% 215.06/215.24  |- rdf__type mesh__D018233sskos__Concept
% 215.06/215.24  |- skos__hiddenLabel mesh__D018233 Rhabdomyosarcomas, Embryonal
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018233 2005
% 215.06/215.24  |- skos__hiddenLabel mesh__D018233 Embryonal Rhabdomyosarcoma
% 215.06/215.24  |- skos__scopeNote mesh__D018233
% 215.06/215.24       A form of RHABDOMYOSARCOMA arising primarily in the head and neck, especially the orbit, of children below the age of 10. The cells are smaller than those of other rhabdomyosarcomas and are of two basic cell types: spindle cells and round cells. This cancer is highly sensitive to chemotherapy and has a high cure rate with multi-modality therapy. %28%From Holland et al., Cancer Medicine, 3d ed, p2188%29%%A%    
% 215.06/215.24  |- skos__annotation mesh__D018233
% 215.06/215.24       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018233 2001
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D018233 1996
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D010250 2006
% 215.06/215.24  |- skos__altLabel mesh__D010250 Amphistomidae
% 215.06/215.24  |- mesh__historyNote mesh__D010250 82   
% 215.06/215.24  |- skos__annotation mesh__D010250
% 215.06/215.24       a family of trematodes; infection: coord IM with TREMATODE INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 215.06/215.24  |- mesh__activeMeSHYear mesh__D010250 2005
% 215.06/215.24  |- mesh__recordAuthorizer mesh__D010250 sjn
% 215.06/215.24  |- skos__prefLabel mesh__D010250 Paramphistomatidae
% 215.06/215.24  |- skos__historyNote mesh__D010250 Trematoda %28%1966-1981%29%
% 215.06/215.24  |- mesh__publicMeSHNote mesh__D010250 82   
% 215.06/215.24  |- mesh__dateRevised mesh__D010250 2003-07-09
% 215.06/215.25  |- rdf__type mesh__D010250sskos__Concept
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D010250 2004
% 215.06/215.25  |- mesh__dateEstablished mesh__D010250 1982-01-01
% 215.06/215.25  |- skos__broader mesh__D010250smesh__D014200
% 215.06/215.25  |- mesh__recordMaintainer mesh__D010250 ags
% 215.06/215.25  |- mesh__dateCreated mesh__D010250 1981-05-15
% 215.06/215.25  |- skos__scopeNote mesh__D010250
% 215.06/215.25       A family of flukes of the class Trematoda found in the intestinal tract and liver of animals and man. Some of the genera are Homalagaster, Gastrodiscus, Paramphistomum, Watsonius, Nilocotyle, Gigantocotyle, Gastrothylax, Macropotrema, Ceylonocotyle, Zygocotyle, Cotylophoron, and Calicophoron.%A%    
% 215.06/215.25  |- mesh__recordOriginator mesh__D010250 EC
% 215.06/215.25  |- mesh__publicMeSHNote mesh__D051667
% 215.06/215.25       2006; KV1.6 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2004-2005%A%  
% 215.06/215.25  |- skos__broader mesh__D051667smesh__D051637
% 215.06/215.25  |- mesh__historyNote mesh__D051667 2006%28%2004%29%   
% 215.06/215.25  |- skos__scopeNote mesh__D051667
% 215.06/215.25       A delayed rectifier subtype of shaker potassium channels that has been described in NEURONS and ASTROCYTES.%A%    
% 215.06/215.25  |- skos__broader mesh__D051667smesh__D051668
% 215.06/215.25  |- skos__altLabel mesh__D051667 HBK2 Potassium Channel
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D051667 2006
% 215.06/215.25  |- mesh__dateCreated mesh__D051667 2005-06-30
% 215.06/215.25  |- skos__altLabel mesh__D051667 KCNA6 Potassium Channel
% 215.06/215.25  |- skos__hiddenLabel mesh__D051667 Potassium Channel, HBK2
% 215.06/215.25  |- mesh__recordOriginator mesh__D051667 DRC
% 215.06/215.25  |- skos__prefLabel mesh__D051667 Kv1.6 Potassium Channel
% 215.06/215.25  |- skos__hiddenLabel mesh__D051667 Potassium Channel, Kv1.6
% 215.06/215.25  |- rdf__type mesh__D051667sskos__Concept
% 215.06/215.25  |- skos__altLabel mesh__D051667 RCK2 Potassium Channel
% 215.06/215.25  |- mesh__recordAuthorizer mesh__D051667 sjn
% 215.06/215.25  |- skos__hiddenLabel mesh__D051667 Potassium Channel, KCNA6
% 215.06/215.25  |- skos__hiddenLabel mesh__D051667 Potassium Channel, RCK2
% 215.06/215.25  |- mesh__recordMaintainer mesh__D051667 DRC
% 215.06/215.25  |- mesh__dateEstablished mesh__D051667 2006-01-01
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D004213 2005
% 215.06/215.25  |- skos__hiddenLabel mesh__D004213 Hysterias, Dissociative
% 215.06/215.25  |- skos__annotation mesh__D004213 use Cat F3 qualif   
% 215.06/215.25  |- mesh__dateCreated mesh__D004213 1999-01-01
% 215.06/215.25  |- skos__hiddenLabel mesh__D004213 Dissociative Disorder
% 215.06/215.25  |- skos__hiddenLabel mesh__D004213 Reaction, Dissociative
% 215.06/215.25  |- skos__hiddenLabel mesh__D004213 Reactions, Dissociative
% 215.06/215.25  |- mesh__onlineNote mesh__D004213
% 215.06/215.25       use DISSOCIATIVE DISORDERS to search DISSOCIATIVE REACTION 1969-80, FUGUE 1966-78, %26% DISSOCIATION 1969-78%A%  
% 215.06/215.25  |- skos__altLabel mesh__D004213 Fugue
% 215.06/215.25  |- mesh__dateRevised mesh__D004213 1997-06-20
% 215.06/215.25  |- skos__altLabel mesh__D004213 Dissociative Reaction
% 215.06/215.25  |- mesh__dateEstablished mesh__D004213 1968-01-01
% 215.06/215.25  |- skos__prefLabel mesh__D004213 Dissociative Disorders
% 215.06/215.25  |- mesh__recordOriginator mesh__D004213 NLM
% 215.06/215.25  |- skos__hiddenLabel mesh__D004213 Dissociative Reactions
% 215.06/215.25  |- skos__hiddenLabel mesh__D004213 Disorder, Dissociative
% 215.06/215.25  |- skos__hiddenLabel mesh__D004213 Disorders, Dissociative
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D004213 2002
% 215.06/215.25  |- skos__broader mesh__D004213smesh__D001523
% 215.06/215.25  |- mesh__recordAuthorizer mesh__D004213 SJN
% 215.06/215.25  |- rdf__type mesh__D004213sskos__Concept
% 215.06/215.25  |- mesh__publicMeSHNote mesh__D004213
% 215.06/215.25       81; was DISSOCIATIVE REACTION 1968-80; FUGUE was heading 1963-67%A%  
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D004213 1999
% 215.06/215.25  |- mesh__historyNote mesh__D004213
% 215.06/215.25       81; was DISSOCIATIVE REACTION 1968-80; DISSOCIATION was see under DISSOCIATIVE REACTION 1969-78; FUGUE was see under DISSOCIATIVE REACTION 1968-78, was heading 1963-67%A%  
% 215.06/215.25  |- skos__hiddenLabel mesh__D004213 Dissociative Hysteria
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D004213 2004
% 215.06/215.25  |- mesh__recordMaintainer mesh__D004213 JLS
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D004213 2001
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D004213 2006
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D004213 1998
% 215.06/215.25  |- skos__scopeNote mesh__D004213
% 215.06/215.25       Sudden temporary alterations in the normally integrative functions of consciousness.%A%    
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D004213 2003
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D004213 2000
% 215.06/215.25  |- mesh__recordMaintainer mesh__D017939 ags
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D017939 2006
% 215.06/215.25  |- mesh__recordOriginator mesh__D017939 AGS
% 215.06/215.25  |- mesh__publicMeSHNote mesh__D017939 94   
% 215.06/215.25  |- skos__scopeNote mesh__D017939
% 215.06/215.25       A species of CORONAVIRUS infecting dogs. Onset of symptoms is usually sudden and includes vomiting, diarrhea, and dehydration.%A%    
% 215.06/215.25  |- skos__hiddenLabel mesh__D017939 Coronaviruses, Canine
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D017939 2005
% 215.06/215.25  |- mesh__dateEstablished mesh__D017939 1994-01-01
% 215.06/215.25  |- skos__hiddenLabel mesh__D017939 Canine Coronaviruses
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D017939 2004
% 215.06/215.25  |- skos__annotation mesh__D017939
% 215.06/215.25       infection: coord IM with CORONAVIRUS INFECTIONS %28%IM%29%   
% 215.06/215.25  |- mesh__recordAuthorizer mesh__D017939 sjn
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D017939 2003
% 215.06/215.25  |- mesh__dateRevised mesh__D017939 2001-07-25
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D017939 2002
% 215.06/215.25  |- skos__historyNote mesh__D017939 Coronaviridae %28%1976-1993%29%
% 215.06/215.25  |- mesh__historyNote mesh__D017939 94   
% 215.06/215.25  |- skos__prefLabel mesh__D017939 Coronavirus, Canine
% 215.06/215.25  |- mesh__dateCreated mesh__D017939 1993-06-04
% 215.06/215.25  |- skos__altLabel mesh__D017939 Canine coronavirus
% 215.06/215.25  |- rdf__type mesh__D017939sskos__Concept
% 215.06/215.25  |- skos__broader mesh__D017939smesh__D017934
% 215.06/215.25  |- skos__scopeNote mesh__D028661
% 215.06/215.25       Association with or participation in an act that is, or is perceived to be, criminal or immoral.  One is complicitous when one promotes or unduly benefits from practices or institutions that are morally or legally suspect.%A%    
% 215.06/215.25  |- skos__prefLabel mesh__D028661 Complicity
% 215.06/215.25  |- skos__historyNote mesh__D028661 Morals %28%1992-2001%29%
% 215.06/215.25  |- skos__broader mesh__D028661smesh__D004989
% 215.06/215.25  |- mesh__dateCreated mesh__D028661 2001-07-25
% 215.06/215.25  |- mesh__dateEstablished mesh__D028661 2002-01-01
% 215.06/215.25  |- mesh__historyNote mesh__D028661
% 215.06/215.25       2002; for MORAL COMPLICITY use MORALS 1993-2001   
% 215.06/215.25  |- skos__related mesh__D028661smesh__D028743
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D028661 2006
% 215.06/215.25  |- rdf__type mesh__D028661sskos__Concept
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D028661 2004
% 215.06/215.25  |- mesh__publicMeSHNote mesh__D028661
% 215.06/215.25       2002; for MORAL COMPLICITY see MORALS 1993-2001   
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D028661 2005
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D028661 2002
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D028661 2003
% 215.06/215.25  |- skos__broader mesh__D003919smesh__D007674
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D003919 2006
% 215.06/215.25  |- mesh__recordMaintainer mesh__D003919 lkt
% 215.06/215.25  |- mesh__recordOriginator mesh__D003919 NLM
% 215.06/215.25  |- skos__prefLabel mesh__D003919 Diabetes Insipidus
% 215.06/215.25  |- rdf__type mesh__D003919sskos__Concept
% 215.06/215.25  |- mesh__recordAuthorizer mesh__D003919 sjn
% 215.06/215.25  |- skos__related mesh__D003919smesh__D003920
% 215.06/215.25  |- skos__broader mesh__D003919smesh__D010900
% 215.06/215.25  |- mesh__dateRevised mesh__D003919 2005-06-30
% 215.06/215.25  |- skos__scopeNote mesh__D003919
% 215.06/215.25       A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of ANTIDIURETIC HORMONE %28%also known as ADH or VASOPRESSIN%29% secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.%A%    
% 215.06/215.25  |- mesh__dateCreated mesh__D003919 1999-01-01
% 215.06/215.25  |- mesh__dateCreated mesh__D014641 1999-01-01
% 215.06/215.25  |- skos__hiddenLabel mesh__D014641 Acid, 4-Hydroxy-3-methoxybenzoic
% 215.06/215.25  |- skos__broader mesh__D014641smesh__D006883
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014641 2000
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014641 2006
% 215.06/215.25  |- mesh__publicMeSHNote mesh__D014641
% 215.06/215.25       91; was see under HYDROXYBENZOIC ACIDS 1975-90; was see under BENZOATES 1968-74%A%  
% 215.06/215.25  |- skos__altLabel mesh__D014641 p-Hydroxy-m-methoxy-benzoic Acid
% 215.06/215.25  |- skos__altLabel mesh__D014641 4-Hydroxy-3-methoxybenzoic Acid
% 215.06/215.25  |- mesh__recordAuthorizer mesh__D014641 SJN
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014641 2005
% 215.06/215.25  |- skos__hiddenLabel mesh__D014641 p Hydroxy m methoxy benzoic Acid
% 215.06/215.25  |- skos__hiddenLabel mesh__D014641 4 Hydroxy 3 methoxybenzoic Acid
% 215.06/215.25  |- mesh__dateEstablished mesh__D014641 1991-01-01
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014641 2002
% 215.06/215.25  |- skos__scopeNote mesh__D014641
% 215.06/215.25       A flavoring agent. It is the intermediate product in the two-step bioconversion of ferulic acid to vanillin. %28%J Biotechnol 1996;50%28%2-3%29%:107-13%29%.%A%    
% 215.06/215.25  |- mesh__recordOriginator mesh__D014641 NLM
% 215.06/215.25  |- mesh__dateRevised mesh__D014641 1998-06-11
% 215.06/215.25  |- skos__prefLabel mesh__D014641 Vanillic Acid
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014641 1999
% 215.06/215.25  |- mesh__historyNote mesh__D014641
% 215.06/215.25       91%28%75%29%; was see under HYDROXYBENZOIC ACIDS 1975-90; was see under BENZOATES 1968-74%A%  
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014641 2004
% 215.06/215.25  |- skos__hiddenLabel mesh__D014641 Acid, p-Hydroxy-m-methoxy-benzoic
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014641 2001
% 215.06/215.25  |- mesh__recordMaintainer mesh__D014641 ADP
% 215.06/215.25  |- rdf__type mesh__D014641sskos__Concept
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014641 2003
% 215.06/215.25  |- mesh__onlineNote mesh__D014641 search BENZOATES 1968-74   
% 215.06/215.25  |- skos__hiddenLabel mesh__D014641 Acid, Vanillic
% 215.06/215.25  |- mesh__historyNote mesh__D008604
% 215.06/215.25       94; was MENTAL HEALTH ASSOCIATION 1975-93 %28%see under VOLUNTARY HEALTH AGENCIES 1975-90%29%%A%  
% 215.06/215.25  |- skos__historyNote mesh__D008604
% 215.06/215.25       Community Mental Health Services %28%1967-1974%29%
% 215.06/215.25  |- mesh__recordAuthorizer mesh__D008604 sjn
% 215.06/215.25  |- mesh__dateEstablished mesh__D008604 1991-01-01
% 215.06/215.25  |- mesh__recordMaintainer mesh__D008604 kle
% 215.06/215.25  |- skos__hiddenLabel mesh__D008604 Health Association, Mental
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D008604 2004
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D008604 2006
% 215.06/215.25  |- mesh__dateCreated mesh__D008604 1999-01-01
% 215.06/215.25  |- skos__hiddenLabel mesh__D008604 Mental Health Association
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D008604 2003
% 215.06/215.25  |- skos__annotation mesh__D008604 specify geog; DF: MENTAL HEALTH ASSOC   
% 215.06/215.25  |- skos__altLabel mesh__D008604 Health Associations, Mental
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D008604 2005
% 215.06/215.25  |- skos__historyNote mesh__D008604 Mental Health %28%1966-1974%29%
% 215.06/215.25  |- skos__altLabel mesh__D008604 Associations, Mental Health
% 215.06/215.25  |- skos__historyNote mesh__D008604
% 215.06/215.25       Voluntary Health Agencies %28%1966-1974%29%
% 215.06/215.25  |- rdf__type mesh__D008604sskos__Concept
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D008604 2002
% 215.06/215.25  |- skos__prefLabel mesh__D008604 Mental Health Associations
% 215.06/215.25  |- mesh__publicMeSHNote mesh__D008604
% 215.06/215.25       94; was MENTAL HEALTH ASSOCIATION 1975-93 %28%see under VOLUNTARY HEALTH AGENCIES 1975-90%29%%A%  
% 215.06/215.25  |- mesh__dateRevised mesh__D008604 1999-11-03
% 215.06/215.25  |- mesh__recordOriginator mesh__D008604 NLM
% 215.06/215.25  |- skos__hiddenLabel mesh__D008604 Association, Mental Health
% 215.06/215.25  |- skos__broader mesh__D008604smesh__D014837
% 215.06/215.25  |- skos__scopeNote mesh__D008604
% 215.06/215.25       Voluntary organizations which support educational programs and research in psychiatry with the objective of the promotion of mental health. An early association in the United States was founded as the National Committee for Mental Hygiene in 1909, became the Mental Health Association in 1976 and later the National Mental Health Association in 1980. State and local mental health associations in this country are chartered by the national organization and affiliated with it.%A%    
% 215.06/215.25  |- mesh__onlineNote mesh__D008604
% 215.06/215.25       use MENTAL HEALTH ASSOCIATIONS to search MENTAL HEALTH ASSOCIATION 1975-93; search VOLUNTARY HEALTH AGENCIES 1967-74%A%  
% 215.06/215.25  |- skos__historyNote mesh__D008604 Mental Disorders %28%1966-1974%29%
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D008604 2001
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D008604 2000
% 215.06/215.25  |- rdf__type mesh__D000621sskos__Concept
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D000621 2001
% 215.06/215.25  |- mesh__dateRevised mesh__D000621 1998-06-10
% 215.06/215.25  |- skos__broader mesh__D000621smesh__D000613
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D000621 2006
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D000621 2000
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D000621 1999
% 215.06/215.25  |- skos__broader mesh__D000621smesh__D000597
% 215.06/215.25  |- skos__scopeNote mesh__D000621
% 215.06/215.25       A group of compounds that are derivatives of the amino acid 2-amino-2-methylpropanoic acid.%A%    
% 215.06/215.25  |- mesh__onlineNote mesh__D000621
% 215.06/215.25       use AMINOISOBUTYRIC ACIDS to search AMINOISOBUTYRIC ACID 1966-82%A%  
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D000621 2004
% 215.06/215.25  |- mesh__dateCreated mesh__D000621 1999-01-01
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D000621 2005
% 215.06/215.25  |- mesh__recordOriginator mesh__D000621 NLM
% 215.06/215.25  |- mesh__historyNote mesh__D000621 83; was AMINOISOBUTYRIC ACID 1963-82   
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D000621 2003
% 215.06/215.25  |- mesh__publicMeSHNote mesh__D000621
% 215.06/215.25       83; was AMINOISOBUTYRIC ACID 1963-82   
% 215.06/215.25  |- skos__prefLabel mesh__D000621 Aminoisobutyric Acids
% 215.06/215.25  |- mesh__recordAuthorizer mesh__D000621 SJN
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D000621 2002
% 215.06/215.25  |- mesh__recordMaintainer mesh__D000621 ADP
% 215.06/215.25  |- skos__hiddenLabel mesh__D000621 Acids, Aminoisobutyric
% 215.06/215.25  |- mesh__dateCreated mesh__D013549 1999-01-01
% 215.06/215.25  |- skos__hiddenLabel mesh__D013549 Agent, Sweetening
% 215.06/215.25  |- rdf__type mesh__D013549sskos__Concept
% 215.06/215.25  |- skos__hiddenLabel mesh__D013549 Substitute, Sugar
% 215.06/215.25  |- skos__hiddenLabel mesh__D013549 Artificial Sweetener
% 215.06/215.25  |- skos__hiddenLabel mesh__D013549 Sweetener
% 215.06/215.25  |- skos__broader mesh__D013549smesh__D005421
% 215.06/215.25  |- skos__hiddenLabel mesh__D013549 Substitutes, Sugar
% 215.06/215.25  |- skos__hiddenLabel mesh__D013549 Sweeteners, Artificial
% 215.06/215.25  |- skos__hiddenLabel mesh__D013549 Sweetener, Artificial
% 215.06/215.25  |- mesh__recordAuthorizer mesh__D013549 sjn
% 215.06/215.25  |- skos__hiddenLabel mesh__D013549 Agents, Sweetening
% 215.06/215.25  |- skos__annotation mesh__D013549 D25-26 qualif   
% 215.06/215.25  |- skos__scopeNote mesh__D013549
% 215.06/215.25       Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 215.06/215.25  |- mesh__recordOriginator mesh__D013549 NLM
% 215.06/215.25  |- skos__altLabel mesh__D013549 Sweeteners
% 215.06/215.25  |- skos__prefLabel mesh__D013549 Sweetening Agents
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D013549 2006
% 215.06/215.25  |- mesh__recordMaintainer mesh__D013549 ssb
% 215.06/215.25  |- mesh__dateRevised mesh__D013549 2004-07-07
% 215.06/215.25  |- skos__hiddenLabel mesh__D013549 Sugar Substitute
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D013549 2005
% 215.06/215.25  |- skos__broader mesh__D013549smesh__D020313
% 215.06/215.25  |- skos__hiddenLabel mesh__D013549 Sweetening Agent
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D018234 2003
% 215.06/215.25  |- mesh__dateCreated mesh__D018234 1993-06-25
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D018234 2001
% 215.06/215.25  |- skos__annotation mesh__D018234
% 215.06/215.25       %22%alveolar%22% has nothing to do with pulm alveoli: it refers to sac-like pathol of soft part; /blood /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D018234 1999
% 215.06/215.25  |- mesh__historyNote mesh__D018234 94   
% 215.06/215.25  |- skos__prefLabel mesh__D018234 Sarcoma, Alveolar Soft Part
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D018234 2000
% 215.06/215.25  |- mesh__recordOriginator mesh__D018234 PLS
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D018234 1998
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D018234 2006
% 215.06/215.25  |- skos__broader mesh__D018234smesh__D009379
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D018234 2005
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D018234 1997
% 215.06/215.25  |- mesh__dateRevised mesh__D018234 1995-06-08
% 215.06/215.25  |- skos__scopeNote mesh__D018234
% 215.06/215.25       A variety of sarcoma having a reticulated fibrous stroma enclosing groups of sarcoma cells, which resemble epithelial cells and are enclosed in alveoli walled with connective tissue. It is a rare tumor, usually occurring between 15 and 35 years of age. It appears in the muscles of the extremities in adults and most commonly in the head and neck region of children. Though slow-growing, it commonly metastasizes to the lungs, brain, bones, and lymph nodes. %28%From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1365%29%%A%    
% 215.06/215.25  |- rdf__type mesh__D018234sskos__Concept
% 215.06/215.25  |- mesh__recordAuthorizer mesh__D018234 PLS
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D018234 1996
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D018234 2004
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D018234 2002
% 215.06/215.25  |- mesh__publicMeSHNote mesh__D018234 94   
% 215.06/215.25  |- mesh__dateEstablished mesh__D018234 1994-01-01
% 215.06/215.25  |- skos__broader mesh__D018234smesh__D012509
% 215.06/215.25  |- skos__historyNote mesh__D018234 Soft Tissue Neoplasms %28%1976-1993%29%
% 215.06/215.25  |- mesh__recordMaintainer mesh__D018234 KEV
% 215.06/215.25  |- skos__historyNote mesh__D018234 Sarcoma %28%1966-1993%29%
% 215.06/215.25  |- rdf__type mesh__D051668sskos__Concept
% 215.06/215.25  |- mesh__historyNote mesh__D051668 2006%28%1994%29%   
% 215.06/215.25  |- skos__scopeNote mesh__D051668
% 215.06/215.25       A group of slow opening and closing voltage-gated potassium channels. Because of their delayed activation kinetics they play an important role in controlling ACTION POTENTIAL duration.%A%    
% 215.06/215.25  |- mesh__recordMaintainer mesh__D051668 DRC
% 215.06/215.25  |- mesh__recordOriginator mesh__D051668 DRC
% 215.06/215.25  |- mesh__publicMeSHNote mesh__D051668
% 215.06/215.25       2006; DELAYED RECTIFIER POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1994-2004%A%  
% 215.06/215.25  |- mesh__recordAuthorizer mesh__D051668 sjn
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D051668 2006
% 215.06/215.25  |- skos__prefLabel mesh__D051668 Delayed Rectifier Potassium Channels
% 215.06/215.25  |- mesh__dateEstablished mesh__D051668 2006-01-01
% 215.06/215.25  |- skos__broader mesh__D051668smesh__D024642
% 215.06/215.25  |- skos__altLabel mesh__D051668 Delayed Rectifying Potassium Channels
% 215.06/215.25  |- mesh__dateCreated mesh__D051668 2005-06-30
% 215.06/215.25  |- skos__broader mesh__D042601Q000254smesh__D042601
% 215.06/215.25  |- mesh__preferredCombination mesh__D042601Q000254smesh__D042583
% 215.06/215.25  |- rdf__type mesh__D042601Q000254smesh__CompoundConcept
% 215.06/215.25  |- skos__broader mesh__D001152Q000633smesh__D001152
% 215.06/215.25  |- mesh__preferredCombination mesh__D001152Q000633smesh__D020261
% 215.06/215.25  |- rdf__type mesh__D001152Q000633smesh__CompoundConcept
% 215.06/215.25  |- mesh__publicMeSHNote mesh__D004214 91; was see under PYRROLES 1975-90   
% 215.06/215.25  |- rdf__type mesh__D004214sskos__Concept
% 215.06/215.25  |- mesh__recordAuthorizer mesh__D004214 sjn
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D004214 2004
% 215.06/215.25  |- skos__historyNote mesh__D004214 Amidines %28%1972-1974%29%
% 215.06/215.25  |- mesh__dateEstablished mesh__D004214 1991-01-01
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D004214 2006
% 215.06/215.25  |- mesh__recordMaintainer mesh__D004214 ssb
% 215.06/215.25  |- skos__historyNote mesh__D004214 Oligopeptides %28%1973-1974%29%
% 215.06/215.25  |- mesh__historyNote mesh__D004214
% 215.06/215.25       91%28%75%29%; was see under PYRROLES 1975-90   
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D004214 2005
% 215.06/215.25  |- skos__scopeNote mesh__D004214
% 215.06/215.25       Oligopeptide antibiotics from Streptomyces distallicus. Their binding to DNA inhibits synthesis of nucleic acids.%A%    
% 215.06/215.25  |- mesh__dateCreated mesh__D004214 1974-11-11
% 215.06/215.25  |- skos__prefLabel mesh__D004214 Distamycins
% 215.06/215.25  |- skos__broader mesh__D004214smesh__D010455
% 215.06/215.25  |- skos__historyNote mesh__D004214 Pyrroles %28%1970-1974%29%
% 215.06/215.25  |- mesh__recordOriginator mesh__D004214 NLM
% 215.06/215.25  |- mesh__dateRevised mesh__D004214 2003-07-09
% 215.06/215.25  |- mesh__historyNote mesh__D028662 2002; use ETHICS 1999-2001   
% 215.06/215.25  |- skos__related mesh__D028662smesh__D028663
% 215.06/215.25  |- skos__hiddenLabel mesh__D028662 Principle-Based Ethic
% 215.06/215.25  |- skos__historyNote mesh__D028662 Ethics %28%1974-2001%29%
% 215.06/215.25  |- mesh__dateCreated mesh__D028662 2001-07-25
% 215.06/215.25  |- skos__broader mesh__D028662smesh__D004989
% 215.06/215.25  |- mesh__recordMaintainer mesh__D028662 tjk
% 215.06/215.25  |- mesh__recordAuthorizer mesh__D028662 sjn
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D028662 2005
% 215.06/215.25  |- skos__prefLabel mesh__D028662 Principle-Based Ethics
% 215.06/215.25  |- skos__hiddenLabel mesh__D028662 Ethics, Principle-Based
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D028662 2003
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D028662 2006
% 215.06/215.25  |- mesh__dateEstablished mesh__D028662 2002-01-01
% 215.06/215.25  |- skos__hiddenLabel mesh__D028662 Ethic, Principle-Based
% 215.06/215.25  |- mesh__recordOriginator mesh__D028662 jrf
% 215.06/215.25  |- rdf__type mesh__D028662sskos__Concept
% 215.06/215.25  |- skos__hiddenLabel mesh__D028662 Principle Based Ethics
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D028662 2004
% 215.06/215.25  |- skos__altLabel mesh__D028662 Principlism
% 215.06/215.25  |- mesh__dateRevised mesh__D028662 2002-07-03
% 215.06/215.25  |- mesh__publicMeSHNote mesh__D028662 2002; see ETHICS 1999-2001   
% 215.06/215.25  |- skos__scopeNote mesh__D028662
% 215.06/215.25       An approach to ethics that focuses on theories of the importance of general principles such as respect for autonomy, beneficence/nonmaleficence, and justice.%A%    
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014642 2001
% 215.06/215.25  |- mesh__recordMaintainer mesh__D014642 TAP
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014642 2005
% 215.06/215.25  |- skos__broader mesh__D014642smesh__D008333
% 215.06/215.25  |- skos__hiddenLabel mesh__D014642 Acid, Vanillylmandelic
% 215.06/215.25  |- mesh__recordAuthorizer mesh__D014642 PLS
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014642 1993
% 215.06/215.25  |- skos__altLabel mesh__D014642 4-Hydroxy-3-Methoxymandelic Acid
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014642 1996
% 215.06/215.25  |- mesh__historyNote mesh__D014642 72%28%68%29%   
% 215.06/215.25  |- mesh__publicMeSHNote mesh__D014642 72   
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014642 2000
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014642 1999
% 215.06/215.25  |- mesh__dateRevised mesh__D014642 1992-05-20
% 215.06/215.25  |- skos__hiddenLabel mesh__D014642 4 Hydroxy 3 Methoxymandelic Acid
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014642 1995
% 215.06/215.25  |- skos__hiddenLabel mesh__D014642 Acid, Vanilmandelic
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014642 1998
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014642 2004
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014642 2002
% 215.06/215.25  |- skos__historyNote mesh__D014642 Mandelic Acids %28%1966-1967%29%
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014642 1994
% 215.06/215.25  |- mesh__recordOriginator mesh__D014642 NLM
% 215.06/215.25  |- skos__hiddenLabel mesh__D014642 Acid, Methoxyhydroxymandelic
% 215.06/215.25  |- rdf__type mesh__D014642sskos__Concept
% 215.06/215.25  |- skos__hiddenLabel mesh__D014642 Acid, 4-Hydroxy-3-Methoxymandelic
% 215.06/215.25  |- skos__altLabel mesh__D014642 Vanillylmandelic Acid
% 215.06/215.25  |- skos__altLabel mesh__D014642 Methoxyhydroxymandelic Acid
% 215.06/215.25  |- skos__prefLabel mesh__D014642 Vanilmandelic Acid
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014642 2003
% 215.06/215.25  |- mesh__dateEstablished mesh__D014642 1972-01-01
% 215.06/215.25  |- mesh__dateCreated mesh__D014642 1999-01-01
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014642 2006
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D014642 1997
% 215.06/215.25  |- skos__hiddenLabel mesh__D008605 Mental Hygiene Service
% 215.06/215.25  |- skos__hiddenLabel mesh__D008605 Health Service, Mental
% 215.06/215.25  |- skos__altLabel mesh__D008605 Mental Hygiene Services
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D008605 2003
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D008605 2000
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D008605 2005
% 215.06/215.25  |- mesh__publicMeSHNote mesh__D008605
% 215.06/215.25       67; was MENTAL HYGIENE SERVICES 1963-66   
% 215.06/215.25  |- skos__altLabel mesh__D008605 Health Services, Mental
% 215.06/215.25  |- mesh__recordAuthorizer mesh__D008605 sjn
% 215.06/215.25  |- mesh__recordMaintainer mesh__D008605 kle
% 215.06/215.25  |- skos__broader mesh__D008605smesh__D004191
% 215.06/215.25  |- rdf__type mesh__D008605sskos__Concept
% 215.06/215.25  |- mesh__dateEstablished mesh__D008605 1967-01-01
% 215.06/215.25  |- skos__scopeNote mesh__D008605
% 215.06/215.25       Organized services to provide mental health care.     
% 215.06/215.25  |- mesh__onlineNote mesh__D008605
% 215.06/215.25       use MENTAL HEALTH SERVICES to search MENTAL HYGIENE SERVICES 1966%A%  
% 215.06/215.25  |- skos__hiddenLabel mesh__D008605 Mental Health Service
% 215.06/215.25  |- skos__hiddenLabel mesh__D008605 Service, Mental Health
% 215.06/215.25  |- skos__annotation mesh__D008605
% 215.06/215.25       COMMUNITY MENTAL HEALTH SERVICES %26% specifics are also available; Public Laws 89-105 %26% 89-164; DF: MENTAL HEALTH SERV%A%  
% 215.06/215.25  |- mesh__historyNote mesh__D008605
% 215.06/215.25       67; was MENTAL HYGIENE SERVICES 1963-66   
% 215.06/215.25  |- skos__altLabel mesh__D008605 Services, Mental Health
% 215.06/215.25  |- skos__broader mesh__D008605smesh__D006296
% 215.06/215.25  |- skos__altLabel mesh__D008605 Services, Mental Hygiene
% 215.06/215.25  |- skos__hiddenLabel mesh__D008605 Hygiene Service, Mental
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D008605 2002
% 215.06/215.25  |- skos__hiddenLabel mesh__D008605 Service, Mental Hygiene
% 215.06/215.25  |- mesh__dateRevised mesh__D008605 1999-11-03
% 215.06/215.25  |- mesh__recordOriginator mesh__D008605 NLM
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D008605 2004
% 215.06/215.25  |- skos__hiddenLabel mesh__D008605 Hygiene Services, Mental
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D008605 2006
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D008605 2001
% 215.06/215.25  |- skos__prefLabel mesh__D008605 Mental Health Services
% 215.06/215.25  |- mesh__dateCreated mesh__D008605 1999-01-01
% 215.06/215.25  |- mesh__publicMeSHNote mesh__D000622
% 215.06/215.25       91; see LEVULINIC ACIDS 1975-90; see LEVULINIC ACID 1973-74%A%  
% 215.06/215.25  |- mesh__dateRevised mesh__D000622 2005-06-30
% 215.06/215.25  |- mesh__activeMeSHYear mesh__D000622 2006
% 215.06/215.25  |- skos__hiddenLabel mesh__D000622 Delta Aminolevulinic Acid
% 215.06/215.25  |- skos__hiddenLabel mesh__D000622 Acid, Aminolevulinic
% 215.06/215.25  |- skos__hiddenLabel mesh__D000622 Hydrochloride, Aminolevulinic Acid
% 215.06/215.25  |- mesh__recordAuthorizer mesh__D000622 sjn
% 215.06/215.25  |- mesh__dateCreated mesh__D000622 1999-01-01
% 215.06/215.25  |- mesh__historyNote mesh__D000622 91%28%73%29%   
% 215.06/215.25  |- skos__altLabel mesh__D000622 5-Aminolevulinate
% 215.06/215.25  |- skos__hiddenLabel mesh__D000622 5 Aminolaevulinate
% 215.06/215.25  |- skos__broader mesh__D000622smesh__D007982
% 215.06/215.25  |- skos__scopeNote mesh__D000622
% 215.06/215.25       A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.%A%    
% 215.06/215.25  |- mesh__dateEstablished mesh__D000622 1991-01-01
% 215.06/215.25  |- skos__altLabel mesh__D000622 Delta-Aminolevulinic Acid
% 215.06/215.25  |- skos__hiddenLabel mesh__D000622 5 Aminolevulinate
% 215.06/215.25  |- skos__hiddenLabel mesh__D000622 Acid, Delta-Aminolevulinic
% 215.06/215.25  |- skos__prefLabel mesh__D000622 Aminolevulinic Acid
% 215.06/215.25  |- mesh__recordOriginator mesh__D000622 NLM
% 215.06/215.25  |- skos__broader mesh__D000622smesh__D000596
% 215.06/215.25  |- skos__hiddenLabel mesh__D000622 Acid Hydrochloride, Aminolevulinic
% 215.06/215.25  |- mesh__recordMaintainer mesh__D000622 lkw
% 215.06/215.25  |- rdf__type mesh__D000622sskos__Concept
% 215.06/215.25  |- skos__altLabel mesh__D000622
% 215.06/215.25       Bertek Brand of Aminolevulinic Acid Hydrochloride
% 215.06/215.25  |- skos__historyNote mesh__D018235 Muscle, Smooth %28%1969-1993%29%
% 215.06/215.25  |- mesh__dateEstablished mesh__D018235 1994-01-01
% 215.06/215.26  |- mesh__activeMeSHYear mesh__D018235 2005
% 215.06/215.26  |- mesh__activeMeSHYear mesh__D018235 1999
% 215.06/215.26  |- mesh__historyNote mesh__D018235 94   
% 215.06/215.26  |- skos__prefLabel mesh__D018235 Smooth Muscle Tumor
% 215.06/215.26  |- mesh__publicMeSHNote mesh__D018235 94   
% 215.06/215.26  |- skos__historyNote mesh__D018235
% 215.06/215.26       Muscle, Smooth, Vascular %28%1983-1993%29%
% 215.06/215.26  |- skos__hiddenLabel mesh__D018235 Smooth Muscle Tumors
% 215.06/215.26  |- mesh__recordOriginator mesh__D018235 PLS
% 215.06/215.26  |- mesh__activeMeSHYear mesh__D018235 2000
% 215.06/215.26  |- skos__historyNote mesh__D018235
% 215.06/215.26       Neoplasms, Muscle Tissue %28%1981-1993%29%
% 215.06/215.26  |- mesh__activeMeSHYear mesh__D018235 2006
% 215.06/215.26  |- mesh__activeMeSHYear mesh__D018235 1996
% 215.06/215.26  |- mesh__dateCreated mesh__D018235 1993-06-25
% 215.06/215.26  |- skos__historyNote mesh__D018235 Leiomyoma %28%1968-1993%29%
% 215.06/215.26  |- mesh__activeMeSHYear mesh__D018235 2001
% 215.06/215.26  |- skos__broader mesh__D018235smesh__D009379
% 215.06/215.26  |- mesh__activeMeSHYear mesh__D018235 1997
% 215.06/215.26  |- mesh__dateRevised mesh__D018235 1995-06-08
% 215.06/215.26  |- mesh__activeMeSHYear mesh__D018235 2003
% 215.06/215.26  |- skos__scopeNote mesh__D018235
% 215.06/215.26       A tumor composed of smooth muscle tissue, as opposed to leiomyoma, a tumor derived from smooth muscle.%A%    
% 215.06/215.26  |- skos__hiddenLabel mesh__D018235 Muscle Tumors, Smooth
% 215.06/215.26  |- rdf__type mesh__D018235sskos__Concept
% 215.06/215.26  |- skos__historyNote mesh__D018235 Leiomyosarcoma %28%1966-1993%29%
% 215.06/215.26  |- skos__hiddenLabel mesh__D018235 Muscle Tumor, Smooth
% 215.06/215.26  |- skos__hiddenLabel mesh__D018235 Tumors, Smooth Muscle
% 215.06/215.26  |- mesh__recordAuthorizer mesh__D018235 PLS
% 215.06/215.26  |- mesh__activeMeSHYear mesh__D018235 2004
% 215.06/215.26  |- skos__hiddenLabel mesh__D018235 Tumor, Smooth Muscle
% 215.06/215.26  |- mesh__activeMeSHYear mesh__D018235 2002
% 215.06/215.26  |- mesh__recordMaintainer mesh__D018235 KEV
% 215.06/215.26  |- skos__annotation mesh__D018235
% 215.06/215.26       a specific histol type: do not confuse with NEOPLASMS, MUSCLE TISSUE, a group histol term, or with LEIOMYOMA %28%see MeSH definition%29%; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; restricted use: Manual 24.2.2.5%A%  
% 215.06/215.26  |- mesh__activeMeSHYear mesh__D018235 1998
% 215.06/215.26  |- mesh__activeMeSHYear mesh__D010252 1997
% 215.06/215.26  |- skos__scopeNote mesh__D010252
% 215.06/215.26       A family of spherical viruses, of the order MONONEGAVIRALES, somewhat larger than the orthomyxoviruses, and containing single-stranded RNA. Subfamilies include PARAMYXOVIRINAE and PNEUMOVIRINAE.%A%    
% 215.06/215.26  |- mesh__onlineNote mesh__D010252
% 215.06/215.26       use PARAMYXOVIRIDAE to search PARAMYXOVIRUSES 1971-80 %28%as Prov 1971-72%29%%A%  
% 215.06/215.26  |- mesh__activeMeSHYear mesh__D010252 1998
% 215.06/215.26  |- mesh__recordAuthorizer mesh__D010252 PLS
% 215.06/215.26  |- mesh__recordOriginator mesh__D010252 NLM
% 215.06/215.26  |- mesh__activeMeSHYear mesh__D010252 2003
% 215.06/215.26  |- mesh__dateCreated mesh__D010252 1999-01-01
% 215.06/215.26  |- mesh__activeMeSHYear mesh__D010252 1994
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D010252 1999
% 215.14/215.33  |- rdf__type mesh__D010252sskos__Concept
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D010252 2004
% 215.14/215.33  |- skos__prefLabel mesh__D010252 Paramyxoviridae
% 215.14/215.33  |- skos__broader mesh__D010252smesh__D018096
% 215.14/215.33  |- mesh__historyNote mesh__D010252
% 215.14/215.33       81; was PARAMYXOVIRUSES 1971-80 %28%Prov 1971-72%29%   
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D010252 1995
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D010252 2000
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D010252 2005
% 215.14/215.33  |- mesh__dateEstablished mesh__D010252 1973-01-01
% 215.14/215.33  |- skos__historyNote mesh__D010252 Orthomyxoviridae %28%1966-1970%29%
% 215.14/215.33  |- skos__annotation mesh__D010252
% 215.14/215.33       a family of the order Mononegavirales; infection = PARAMYXOVIRIDAE INFECTIONS%A%  
% 215.14/215.33  |- mesh__dateRevised mesh__D010252 1993-06-04
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D010252 2001
% 215.14/215.33  |- mesh__publicMeSHNote mesh__D010252 81; was PARAMYXOVIRUSES 1973-80   
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D010252 2006
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D010252 1996
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D010252 2002
% 215.14/215.33  |- mesh__recordMaintainer mesh__D010252 AGS
% 215.14/215.33  |- mesh__recordOriginator mesh__D051669 DRC
% 215.14/215.33  |- skos__scopeNote mesh__D051669
% 215.14/215.33       A subfamily of shaker potassium channels that shares homology with its founding member, Shab protein, Drosophila. They regulate delayed rectifier currents in the NERVOUS SYSTEM of DROSOPHILA and in the SKELETAL MUSCLE and HEART of VERTEBRATES.%A%    
% 215.14/215.33  |- skos__hiddenLabel mesh__D051669 Potassium Channel, DRK1
% 215.14/215.33  |- mesh__dateCreated mesh__D051669 2005-06-30
% 215.14/215.33  |- skos__altLabel mesh__D051669 CDRK Potassium Channel
% 215.14/215.33  |- skos__hiddenLabel mesh__D051669 Potassium Channel, Kv2.2
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D051669 2006
% 215.14/215.33  |- skos__broader mesh__D051669smesh__D051637
% 215.14/215.33  |- skos__hiddenLabel mesh__D051669 Potassium Channel, KCNB2
% 215.14/215.33  |- skos__hiddenLabel mesh__D051669 Potassium Channel, Kv2.1
% 215.14/215.33  |- skos__altLabel mesh__D051669 KCNB2 Potassium Channel
% 215.14/215.33  |- mesh__recordMaintainer mesh__D051669 DRC
% 215.14/215.33  |- skos__hiddenLabel mesh__D051669 Potassium Channels, Shab
% 215.14/215.33  |- skos__hiddenLabel mesh__D051669 Potassium Channel, CDRK
% 215.14/215.33  |- mesh__publicMeSHNote mesh__D051669
% 215.14/215.33       2006; SHAB POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005%A%  
% 215.14/215.33  |- mesh__recordAuthorizer mesh__D051669 sjn
% 215.14/215.33  |- skos__prefLabel mesh__D051669 Shab Potassium Channels
% 215.14/215.33  |- skos__altLabel mesh__D051669 Kv2 Potassium Channels
% 215.14/215.33  |- rdf__type mesh__D051669sskos__Concept
% 215.14/215.33  |- skos__altLabel mesh__D051669 DRK1 Potassium Channel
% 215.14/215.33  |- mesh__dateEstablished mesh__D051669 2006-01-01
% 215.14/215.33  |- mesh__historyNote mesh__D051669 2006%28%2005%29%   
% 215.14/215.33  |- skos__hiddenLabel mesh__D051669 Potassium Channels, Kv2
% 215.14/215.33  |- skos__broader mesh__D051669smesh__D051668
% 215.14/215.33  |- rdf__type mesh__D004215sskos__Concept
% 215.14/215.33  |- mesh__recordOriginator mesh__D004215 NLM
% 215.14/215.33  |- mesh__recordMaintainer mesh__D004215 nns
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D004215 2004
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D004215 2006
% 215.14/215.33  |- mesh__dateEstablished mesh__D004215 1966-01-01
% 215.14/215.33  |- skos__scopeNote mesh__D004215
% 215.14/215.33       The act of knowing or the recognition of a distance by recollective thought, or by means of a sensory process which is under the influence of set and of prior experience.%A%    
% 215.14/215.33  |- skos__hiddenLabel mesh__D004215 Perception, Distance
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D004215 2005
% 215.14/215.33  |- skos__prefLabel mesh__D004215 Distance Perception
% 215.14/215.33  |- mesh__recordAuthorizer mesh__D004215 sjn
% 215.14/215.33  |- skos__hiddenLabel mesh__D004215 Perceptions, Distance
% 215.14/215.33  |- mesh__dateCreated mesh__D004215 1999-01-01
% 215.14/215.33  |- mesh__publicMeSHNote mesh__D004215 66   
% 215.14/215.33  |- skos__broader mesh__D004215smesh__D003867
% 215.14/215.33  |- mesh__historyNote mesh__D004215 66   
% 215.14/215.33  |- mesh__dateRevised mesh__D004215 2003-07-09
% 215.14/215.33  |- skos__hiddenLabel mesh__D004215 Distance Perceptions
% 215.14/215.33  |- skos__related mesh__D028663smesh__D028662
% 215.14/215.33  |- skos__hiddenLabel mesh__D028663 Theories, Ethical
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D028663 2002
% 215.14/215.33  |- skos__hiddenLabel mesh__D028663 Ethic, Deontological
% 215.14/215.33  |- skos__altLabel mesh__D028663 Normative Ethics
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D028663 2005
% 215.14/215.33  |- skos__hiddenLabel mesh__D028663 Ethical Theories
% 215.14/215.33  |- skos__altLabel mesh__D028663 Ethics, Deontological
% 215.14/215.33  |- mesh__historyNote mesh__D028663 2002; use ETHICS 1993-2001   
% 215.14/215.33  |- skos__hiddenLabel mesh__D028663 Ethics, Normative
% 215.14/215.33  |- skos__hiddenLabel mesh__D028663 Deontological Ethic
% 215.14/215.33  |- skos__broader mesh__D028663smesh__D004989
% 215.14/215.33  |- skos__scopeNote mesh__D028663
% 215.14/215.33       A philosophically coherent set of propositions %28%for example, utilitarianism%29% which attempts to provide general norms for the guidance and evaluation of moral conduct. %28%from Beauchamp and Childress, Principles of Biomedical Ethics, 4th ed%29%%A%    
% 215.14/215.33  |- skos__hiddenLabel mesh__D028663 Theory, Ethical
% 215.14/215.33  |- mesh__dateCreated mesh__D028663 2001-07-25
% 215.14/215.33  |- skos__hiddenLabel mesh__D028663 Ethic, Teleological
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D028663 2003
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D028663 2006
% 215.14/215.33  |- mesh__dateEstablished mesh__D028663 2002-01-01
% 215.14/215.33  |- skos__prefLabel mesh__D028663 Ethical Theory
% 215.14/215.33  |- rdf__type mesh__D028663sskos__Concept
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D028663 2004
% 215.14/215.33  |- skos__hiddenLabel mesh__D028663 Ethic, Normative
% 215.14/215.33  |- mesh__publicMeSHNote mesh__D028663 2002; see ETHICS 1993-2001   
% 215.14/215.33  |- skos__hiddenLabel mesh__D028663 Normative Ethic
% 215.14/215.33  |- skos__hiddenLabel mesh__D028663 Utilitarianisms
% 215.14/215.33  |- skos__altLabel mesh__D028663 Ethics, Teleological
% 215.14/215.33  |- skos__hiddenLabel mesh__D028663 Teleological Ethic
% 215.14/215.33  |- skos__historyNote mesh__D028663 Ethics %28%1974-2001%29%
% 215.14/215.33  |- mesh__historyNote mesh__D020680 2000   
% 215.14/215.33  |- skos__prefLabel mesh__D020680 Bronchoscopes
% 215.14/215.33  |- mesh__publicMeSHNote mesh__D020680 2000   
% 215.14/215.33  |- skos__broader mesh__D020680smesh__D019723
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D020680 2002
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D020680 2005
% 215.14/215.33  |- skos__historyNote mesh__D020680 Endoscopes %28%1998-1999%29%
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D020680 2006
% 215.14/215.33  |- mesh__dateEstablished mesh__D020680 2000-01-01
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D020680 2000
% 215.14/215.33  |- rdf__type mesh__D020680sskos__Concept
% 215.14/215.33  |- skos__hiddenLabel mesh__D020680 Bronchoscope
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D020680 2003
% 215.14/215.33  |- mesh__dateCreated mesh__D020680 1999-11-03
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D020680 2001
% 215.14/215.33  |- skos__scopeNote mesh__D020680
% 215.14/215.33       Endoscopes for the visualization of the interior of the bronchi.%A%    
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D020680 2004
% 215.14/215.33  |- skos__historyNote mesh__D020680
% 215.14/215.33       Bronchoscopy/instrumentation %28%1998-1999%29%
% 215.14/215.33  |- skos__broader mesh__D014643smesh__D000954
% 215.14/215.33  |- skos__scopeNote mesh__D014643
% 215.14/215.33       Glycoproteins attached to the surface coat of the trypanosome. Many of these glycoproteins show amino acid sequence diversity expressed as antigenic variations. This continuous development of antigenically distinct variants in the course of infection ensures that some trypanosomes always survive the development of immune response to propagate the infection.%A%    
% 215.14/215.33  |- mesh__recordOriginator mesh__D014643 RLS
% 215.14/215.33  |- skos__annotation mesh__D014643
% 215.14/215.33       /drug eff /ultrastruct permitted; DF: VSG TRYPAN   
% 215.14/215.33  |- mesh__historyNote mesh__D014643 88   
% 215.14/215.33  |- skos__altLabel mesh__D014643 SSP-4
% 215.14/215.33  |- mesh__dateCreated mesh__D014643 1987-05-05
% 215.14/215.33  |- mesh__dateRevised mesh__D014643 2005-06-30
% 215.14/215.33  |- skos__altLabel mesh__D014643
% 215.14/215.33       Trypanosoma Variant Surface Coat Glycoproteins
% 215.14/215.33  |- mesh__recordAuthorizer mesh__D014643 sjn
% 215.14/215.33  |- skos__prefLabel mesh__D014643 Variant Surface Glycoproteins, Trypanosoma
% 215.14/215.33  |- skos__broader mesh__D014643smesh__D000953
% 215.14/215.33  |- skos__broader mesh__D014643smesh__D008562
% 215.14/215.33  |- skos__altLabel mesh__D014643 Surface Variant Glycoproteins, Trypanosoma
% 215.14/215.33  |- skos__historyNote mesh__D014643 Membrane Proteins %28%1977-1987%29%
% 215.14/215.33  |- rdf__type mesh__D014643sskos__Concept
% 215.14/215.33  |- mesh__publicMeSHNote mesh__D014643 88   
% 215.14/215.33  |- skos__historyNote mesh__D014643 Glycoproteins %28%1966-1987%29%
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D014643 2006
% 215.14/215.33  |- mesh__recordMaintainer mesh__D014643 ssb
% 215.14/215.33  |- mesh__dateEstablished mesh__D014643 1988-01-01
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D008606 2000
% 215.14/215.33  |- skos__scopeNote mesh__D008606
% 215.14/215.33       Conceptual functions or thinking in all its forms.     
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D008606 2003
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D008606 2006
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D008606 1994
% 215.14/215.33  |- rdf__type mesh__D008606sskos__Concept
% 215.14/215.33  |- skos__altLabel mesh__D008606 Information Processing, Human
% 215.14/215.33  |- skos__prefLabel mesh__D008606 Mental Processes
% 215.14/215.33  |- mesh__dateRevised mesh__D008606 1992-05-15
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D008606 2005
% 215.14/215.33  |- mesh__recordAuthorizer mesh__D008606 PLS
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D008606 1997
% 215.14/215.33  |- skos__altLabel mesh__D008606 Human Information Processing
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D008606 1996
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D008606 1999
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D008606 2002
% 215.14/215.33  |- mesh__recordOriginator mesh__D008606 NLM
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D008606 1998
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D008606 1993
% 215.14/215.33  |- mesh__dateCreated mesh__D008606 1999-01-01
% 215.14/215.33  |- skos__broader mesh__D008606smesh__D011579
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D008606 2001
% 215.14/215.33  |- mesh__recordMaintainer mesh__D008606 TAP
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D008606 2004
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D008606 1995
% 215.14/215.33  |- mesh__publicMeSHNote mesh__D000623
% 215.14/215.33       98; see AMINOLEVULINIC ACID DEHYDRATASE 1978-97, see HYDRO-LYASES 1973-77%A%  
% 215.14/215.33  |- skos__hiddenLabel mesh__D000623 Dehydratase, delta-Aminolevulinate
% 215.14/215.33  |- skos__scopeNote mesh__D000623
% 215.14/215.33       An enzyme that catalyzes the formation of porphobilinogen from two molecules of 5-aminolevulinic acid. EC 4.2.1.24.%A%    
% 215.14/215.33  |- skos__hiddenLabel mesh__D000623 Acid Dehydratase, Aminolevulinic
% 215.14/215.33  |- skos__hiddenLabel mesh__D000623 Dehydratase, delta-Aminolevulinic Acid
% 215.14/215.33  |- rdf__type mesh__D000623sskos__Concept
% 215.14/215.33  |- skos__hiddenLabel mesh__D000623 delta Aminolevulinate Dehydratase
% 215.14/215.33  |- skos__hiddenLabel mesh__D000623 Synthase, Porphobilinogen
% 215.14/215.33  |- skos__annotation mesh__D000623 DF: ALA DEHYDRASE   
% 215.14/215.33  |- skos__hiddenLabel mesh__D000623 Hydro-Lyase, Aminolevulinate
% 215.14/215.33  |- skos__altLabel mesh__D000623 delta-Aminolevulinate Dehydratase
% 215.14/215.33  |- skos__altLabel mesh__D000623 delta-Aminolevulinic Acid Dehydratase
% 215.14/215.33  |- skos__hiddenLabel mesh__D000623 Dehydratase, Aminolevulinic Acid
% 215.14/215.33  |- skos__altLabel mesh__D000623 Aminolevulinic Acid Dehydratase
% 215.14/215.33  |- skos__altLabel mesh__D000623 Aminolevulinate Hydro-Lyase
% 215.14/215.33  |- mesh__recordMaintainer mesh__D000623 ssb
% 215.14/215.33  |- mesh__historyNote mesh__D000623 98%28%73%29%   
% 215.14/215.33  |- skos__prefLabel mesh__D000623 Porphobilinogen Synthase
% 215.14/215.33  |- mesh__recordAuthorizer mesh__D000623 sjn
% 215.14/215.33  |- mesh__dateEstablished mesh__D000623 1978-01-01
% 215.14/215.33  |- skos__hiddenLabel mesh__D000623 ALA Dehydrase
% 215.14/215.33  |- skos__altLabel mesh__D000623 ALA-Dehydrase
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D000623 2006
% 215.14/215.33  |- skos__historyNote mesh__D000623 Hydro-Lyases %28%1966-1972%29%
% 215.14/215.33  |- skos__broader mesh__D000623smesh__D006836
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D000623 2004
% 215.14/215.33  |- mesh__dateCreated mesh__D000623 1999-01-01
% 215.14/215.33  |- skos__hiddenLabel mesh__D000623 Aminolevulinate Hydro Lyase
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D000623 2005
% 215.14/215.33  |- skos__hiddenLabel mesh__D000623 delta Aminolevulinic Acid Dehydratase
% 215.14/215.33  |- skos__hiddenLabel mesh__D000623 Acid Dehydratase, delta-Aminolevulinic
% 215.14/215.33  |- mesh__dateRevised mesh__D000623 2003-07-09
% 215.14/215.33  |- mesh__recordOriginator mesh__D000623 NLM
% 215.14/215.33  |- mesh__recordAuthorizer mesh__D018236 PLS
% 215.14/215.33  |- mesh__historyNote mesh__D018236 94   
% 215.14/215.33  |- skos__annotation mesh__D018236
% 215.14/215.33       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with OVARIAN NEOPLASMS %28%IM%29% or TESTICULAR NEOPLASMS %28%IM%29% %26% appropriate check tags%A%  
% 215.14/215.33  |- mesh__recordOriginator mesh__D018236 PLS
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D018236 2002
% 215.14/215.33  |- skos__prefLabel mesh__D018236 Carcinoma, Embryonal
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D018236 1996
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D018236 2006
% 215.14/215.33  |- skos__historyNote mesh__D018236
% 215.14/215.33       Neoplasms, Germ Cell and Embryonal %28%1985-1993%29%
% 215.14/215.33  |- mesh__dateEstablished mesh__D018236 1994-01-01
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D018236 1997
% 215.14/215.33  |- mesh__dateRevised mesh__D018236 1995-06-08
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D018236 2003
% 215.14/215.33  |- skos__historyNote mesh__D018236 Carcinoma %28%1986-1993%29%
% 215.14/215.33  |- rdf__type mesh__D018236sskos__Concept
% 215.14/215.33  |- skos__broader mesh__D018236smesh__D009373
% 215.14/215.33  |- mesh__publicMeSHNote mesh__D018236 94   
% 215.14/215.33  |- skos__hiddenLabel mesh__D018236 Carcinomas, Embryonal
% 215.14/215.33  |- skos__historyNote mesh__D018236 Tumor Stem Cells %28%1985-1993%29%
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D018236 2000
% 215.14/215.33  |- mesh__dateCreated mesh__D018236 1993-06-25
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D018236 2004
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D018236 2001
% 215.14/215.33  |- skos__hiddenLabel mesh__D018236 Embryonal Carcinoma
% 215.14/215.33  |- mesh__recordMaintainer mesh__D018236 KEV
% 215.14/215.33  |- skos__hiddenLabel mesh__D018236 Embryonal Carcinomas
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D018236 1998
% 215.14/215.33  |- skos__historyNote mesh__D018236 Tumor Cells, Cultured %28%1987-1993%29%
% 215.14/215.33  |- skos__scopeNote mesh__D018236
% 215.14/215.33       A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20%25% of all testicular tumors. %28%From Dorland, 27th ed %26% Holland et al., Cancer Medicine, 3d ed, p1595%29%%A%    
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D018236 2005
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D018236 1999
% 215.14/215.33  |- skos__historyNote mesh__D010253
% 215.14/215.33       Orthomyxovirus Infections %28%1966-1976%29%
% 215.14/215.33  |- mesh__dateCreated mesh__D010253 1976-04-27
% 215.14/215.33  |- skos__prefLabel mesh__D010253 Respirovirus Infections
% 215.14/215.33  |- skos__altLabel mesh__D010253 Infections, Respirovirus
% 215.14/215.33  |- mesh__dateEstablished mesh__D010253 1977-01-01
% 215.14/215.33  |- mesh__recordAuthorizer mesh__D010253 sjn
% 215.14/215.33  |- mesh__recordMaintainer mesh__D010253 ags
% 215.14/215.33  |- mesh__publicMeSHNote mesh__D010253
% 215.14/215.33       2002; see PARAMYXOVIRUS INFECTIONS 1977-2001   
% 215.14/215.33  |- skos__broader mesh__D010253smesh__D018184
% 215.14/215.33  |- mesh__historyNote mesh__D010253 2002 %28%1977%29%   
% 215.14/215.33  |- mesh__activeMeSHYear mesh__D010253 2006
% 215.14/215.34  |- mesh__dateRevised mesh__D010253 2005-06-30
% 215.14/215.34  |- mesh__recordOriginator mesh__D010253 FPG
% 215.14/215.34  |- skos__scopeNote mesh__D010253
% 215.14/215.34       Infections with viruses of the genus RESPIROVIRUS, family PARAMYXOVIRIDAE. Host cell infection occurs by adsorption, via HEMAGGLUTININ, to the cell surface.%A%    
% 215.14/215.34  |- rdf__type mesh__D010253sskos__Concept
% 215.14/215.34  |- skos__annotation mesh__D004216
% 215.14/215.34       don%27%t forget also DOGS %28%NIM%29% or other animal + check tag ANIMALS but in cats = FELINE PANLEUKOPENIA %28%IM%29% + CATS %28%NIM%29% + check tag ANIMALS%A%  
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D004216 2005
% 215.14/215.34  |- skos__altLabel mesh__D004216 Distemper, Canine
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D004216 2004
% 215.14/215.34  |- skos__broader mesh__D004216smesh__D004283
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D004216 2006
% 215.14/215.34  |- mesh__dateCreated mesh__D004216 1999-01-01
% 215.14/215.34  |- skos__hiddenLabel mesh__D004216 Distempers
% 215.14/215.34  |- mesh__recordOriginator mesh__D004216 NLM
% 215.14/215.34  |- mesh__dateRevised mesh__D004216 2003-07-30
% 215.14/215.34  |- skos__hiddenLabel mesh__D004216 Distempers, Canine
% 215.14/215.34  |- skos__hiddenLabel mesh__D004216 Canine Distempers
% 215.14/215.34  |- skos__prefLabel mesh__D004216 Distemper
% 215.14/215.34  |- skos__broader mesh__D004216smesh__D018185
% 215.14/215.34  |- mesh__recordAuthorizer mesh__D004216 sjn
% 215.14/215.34  |- skos__scopeNote mesh__D004216
% 215.14/215.34       A name for several highly contagious viral diseases of animals, especially canine distemper. In dogs, it is caused by the canine distemper virus %28%DISTEMPER VIRUS, CANINE%29%. It is characterized by a diphasic fever, leukopenia, gastrointestinal and respiratory inflammation and sometimes, neurologic complications. In cats it is known as FELINE PANLEUKOPENIA.%A%    
% 215.14/215.34  |- mesh__recordMaintainer mesh__D004216 ags
% 215.14/215.34  |- rdf__type mesh__D004216sskos__Concept
% 215.14/215.34  |- skos__scopeNote mesh__D020681
% 215.14/215.34       Instruments inserted into the vagina for examination of the tissues of the vagina and cervix by means of a magnifying lens.%A%    
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D020681 2005
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D020681 2006
% 215.14/215.34  |- mesh__dateEstablished mesh__D020681 2000-01-01
% 215.14/215.34  |- mesh__publicMeSHNote mesh__D020681 2000   
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D020681 2002
% 215.14/215.34  |- skos__hiddenLabel mesh__D020681 Colposcope
% 215.14/215.34  |- rdf__type mesh__D020681sskos__Concept
% 215.14/215.34  |- skos__prefLabel mesh__D020681 Colposcopes
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D020681 2003
% 215.14/215.34  |- skos__historyNote mesh__D020681 Endoscopes %28%1998-1999%29%
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D020681 2004
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D020681 2000
% 215.14/215.34  |- mesh__historyNote mesh__D020681 2000   
% 215.14/215.34  |- skos__broader mesh__D020681smesh__D019723
% 215.14/215.34  |- skos__historyNote mesh__D020681 Colposcopy %28%1978-1999%29%
% 215.14/215.34  |- mesh__dateCreated mesh__D020681 1999-11-03
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D020681 2001
% 215.14/215.34  |- skos__broader mesh__D014644smesh__D040341
% 215.14/215.34  |- mesh__dateEstablished mesh__D014644 1968-01-01
% 215.14/215.34  |- skos__prefLabel mesh__D014644 Variation %28%Genetics%29%
% 215.14/215.34  |- mesh__dateCreated mesh__D014644 1999-01-01
% 215.14/215.34  |- mesh__recordOriginator mesh__D014644 NLM
% 215.14/215.34  |- skos__historyNote mesh__D014644 Genetics %28%1966-1967%29%
% 215.14/215.34  |- skos__historyNote mesh__D014644 Genetics, Population %28%1966-1967%29%
% 215.14/215.34  |- skos__altLabel mesh__D014644 Diversity, Genetic
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D014644 2004
% 215.14/215.34  |- mesh__recordAuthorizer mesh__D014644 sjn
% 215.14/215.34  |- rdf__type mesh__D014644sskos__Concept
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D014644 2005
% 215.14/215.34  |- mesh__dateRevised mesh__D014644 2003-07-09
% 215.14/215.34  |- skos__hiddenLabel mesh__D014644 Variations %28%Genetics%29%
% 215.14/215.34  |- mesh__publicMeSHNote mesh__D014644 68   
% 215.14/215.34  |- mesh__historyNote mesh__D014644 68   
% 215.14/215.34  |- skos__altLabel mesh__D014644 Genetic Diversity
% 215.14/215.34  |- mesh__recordMaintainer mesh__D014644 nns
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D014644 2006
% 215.14/215.34  |- skos__altLabel mesh__D014644 Genetic Variation
% 215.14/215.34  |- skos__scopeNote mesh__D014644
% 215.14/215.34       The phenotypic and genotypic differences among individuals in a population.%A%    
% 215.14/215.34  |- skos__related mesh__D008607smesh__D007849
% 215.14/215.34  |- skos__related mesh__D008607smesh__D003410
% 215.14/215.34  |- skos__related mesh__D008607smesh__D020788
% 215.14/215.34  |- skos__prefLabel mesh__D008607 Mental Retardation
% 215.14/215.34  |- skos__related mesh__D008607smesh__D018980
% 215.14/215.34  |- skos__related mesh__D008607smesh__D003635
% 215.14/215.34  |- skos__related mesh__D008607smesh__D004314
% 215.14/215.34  |- skos__related mesh__D008607smesh__D003409
% 215.14/215.34  |- skos__altLabel mesh__D008607 Mental Deficiency
% 215.14/215.34  |- skos__related mesh__D008607smesh__D019989
% 215.14/215.34  |- skos__scopeNote mesh__D008607
% 215.14/215.34       Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient %28%IQ%29% scores are commonly used to determine whether an individual is mentally retarded. IQ scores between 70 and 79 are in the borderline mentally retarded range. Scores below 67 are in the retarded range. %28%Joynt, Clinical Neurology, 1992, Ch55, p28%29%%A%    
% 215.14/215.34  |- mesh__historyNote mesh__D008607 1967%28%1963%29%   
% 215.14/215.34  |- mesh__dateCreated mesh__D008607 1999-01-01
% 215.14/215.34  |- skos__related mesh__D008607smesh__D015518
% 215.14/215.34  |- skos__related mesh__D008607smesh__D011218
% 215.14/215.34  |- skos__hiddenLabel mesh__D008607 Mental Retardations, Psychosocial
% 215.14/215.34  |- skos__related mesh__D008607smesh__D004495
% 215.14/215.34  |- skos__hiddenLabel mesh__D008607 Deficiencies, Mental
% 215.14/215.34  |- skos__broader mesh__D008607smesh__D019954
% 215.14/215.34  |- skos__hiddenLabel mesh__D008607 Retardations, Psychosocial Mental
% 215.14/215.34  |- mesh__recordMaintainer mesh__D008607 NLM
% 215.14/215.34  |- mesh__recordOriginator mesh__D008607 NLM
% 215.14/215.34  |- mesh__publicMeSHNote mesh__D008607
% 215.14/215.34       1967; see MENTAL DEFICIENCY 1963-1966; see IDIOCY 1963-1984; see MENTAL RETARDATION, PSYCHOSOCIAL 1969-1997%A%  
% 215.14/215.34  |- mesh__recordAuthorizer mesh__D008607 NLM
% 215.14/215.34  |- skos__hiddenLabel mesh__D008607 Psychosocial Mental Retardations
% 215.14/215.34  |- mesh__dateRevised mesh__D008607 2005-07-06
% 215.14/215.34  |- skos__related mesh__D008607smesh__D003057
% 215.14/215.34  |- skos__related mesh__D008607smesh__D005600
% 215.14/215.34  |- skos__related mesh__D008607smesh__D012415
% 215.14/215.34  |- mesh__dateEstablished mesh__D008607 1967-01-01
% 215.14/215.34  |- skos__related mesh__D008607smesh__D020739
% 215.14/215.34  |- skos__broader mesh__D008607smesh__D019952
% 215.14/215.34  |- rdf__type mesh__D008607sskos__Concept
% 215.14/215.34  |- skos__hiddenLabel mesh__D008607 Retardation, Psychosocial Mental
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D008607 2006
% 215.14/215.34  |- skos__altLabel mesh__D008607 Retardation, Mental
% 215.14/215.34  |- skos__annotation mesh__D008607
% 215.14/215.34       use Cat C qualif; /rehabil permitted: do not equate with EDUCATION OF MENTALLY RETARDED%A%  
% 215.14/215.34  |- skos__related mesh__D008607smesh__D017204
% 215.14/215.34  |- skos__hiddenLabel mesh__D008607 Psychosocial Mental Retardation
% 215.14/215.34  |- skos__hiddenLabel mesh__D008607 Mental Deficiencies
% 215.14/215.34  |- skos__related mesh__D008607smesh__D000015
% 215.14/215.34  |- skos__hiddenLabel mesh__D000624 Synthetase, 5-Aminolevulinate
% 215.14/215.34  |- skos__scopeNote mesh__D000624
% 215.14/215.34       An enzyme of the transferase class that catalyzes condensation of the succinyl group from succinyl coenzyme A with glycine to form delta-aminolevulinate. It is a pyridoxyal phosphate protein and the reaction occurs in mitochondria as the first step of the heme biosynthetic pathway. The enzyme is a key regulatory enzyme in heme biosynthesis. In liver feedback is inhibited by heme. EC 2.3.1.37.%A%    
% 215.14/215.34  |- skos__altLabel mesh__D000624 Aminolevulinic Acid Synthetase
% 215.14/215.34  |- rdf__type mesh__D000624sskos__Concept
% 215.14/215.34  |- skos__hiddenLabel mesh__D000624 Synthetase, delta-Aminolevulinic Acid
% 215.14/215.34  |- skos__hiddenLabel mesh__D000624 delta Aminolevulinic Acid Synthetase
% 215.14/215.34  |- mesh__recordOriginator mesh__D000624 NLM
% 215.14/215.34  |- skos__hiddenLabel mesh__D000624 Acid Synthetase, delta-Aminolevulinic
% 215.14/215.34  |- skos__hiddenLabel mesh__D000624 5 Aminolevulinate Synthetase
% 215.14/215.34  |- skos__hiddenLabel mesh__D000624 delta Aminolevulinate Synthase
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D000624 2006
% 215.14/215.34  |- skos__historyNote mesh__D000624 Acyltransferases %28%1966-1971%29%
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D000624 2006B
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D000624 2004
% 215.14/215.34  |- skos__prefLabel mesh__D000624 5-Aminolevulinate Synthetase
% 215.14/215.34  |- mesh__dateCreated mesh__D000624 1999-01-01
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D000624 2005
% 215.14/215.34  |- skos__hiddenLabel mesh__D000624 Synthase, delta-Aminolevulinate
% 215.14/215.34  |- skos__hiddenLabel mesh__D000624 Acid Synthetase, Aminolevulinic
% 215.14/215.34  |- mesh__recordAuthorizer mesh__D000624 jls
% 215.14/215.34  |- skos__broader mesh__D000624smesh__D000217
% 215.14/215.34  |- skos__hiddenLabel mesh__D000624 Synthetase, Aminolevulinic Acid
% 215.14/215.34  |- mesh__recordMaintainer mesh__D000624 jls
% 215.14/215.34  |- mesh__dateEstablished mesh__D000624 1973-01-01
% 215.14/215.34  |- mesh__historyNote mesh__D000624 98%28%72%29%   
% 215.14/215.34  |- skos__altLabel mesh__D000624 delta-Aminolevulinate Synthase
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D000624 2006A
% 215.14/215.34  |- mesh__dateRevised mesh__D000624 2005-07-29
% 215.14/215.34  |- mesh__publicMeSHNote mesh__D000624
% 215.14/215.34       98; see AMINOLEVULINIC ACID SYNTHETASE 1972-97   
% 215.14/215.34  |- skos__altLabel mesh__D000624 delta-Aminolevulinic Acid Synthetase
% 215.14/215.34  |- skos__broader mesh__D006761Q000331smesh__D006761
% 215.14/215.34  |- mesh__preferredCombination mesh__D006761Q000331smesh__D007882
% 215.14/215.34  |- rdf__type mesh__D006761Q000331smesh__CompoundConcept
% 215.14/215.34  |- skos__related mesh__D018237smesh__D013736
% 215.14/215.34  |- mesh__dateCreated mesh__D018237 1993-06-25
% 215.14/215.34  |- rdf__type mesh__D018237sskos__Concept
% 215.14/215.34  |- skos__annotation mesh__D018237
% 215.14/215.34       coordinate IM with precoordinated organ/neoplasm term %28%IM%29%%A%  
% 215.14/215.34  |- skos__historyNote mesh__D018237 Pinealoma %28%1966-1993%29%
% 215.14/215.34  |- skos__historyNote mesh__D018237 Teratoma %28%1966-1993%29%
% 215.14/215.34  |- mesh__recordAuthorizer mesh__D018237 sjn
% 215.14/215.34  |- skos__historyNote mesh__D018237 Dysgerminoma %28%1966-1993%29%
% 215.14/215.34  |- mesh__dateEstablished mesh__D018237 1994-01-01
% 215.14/215.34  |- skos__prefLabel mesh__D018237 Germinoma
% 215.14/215.34  |- mesh__historyNote mesh__D018237 94   
% 215.14/215.34  |- skos__broader mesh__D018237smesh__D009373
% 215.14/215.34  |- mesh__recordOriginator mesh__D018237 PLS
% 215.14/215.34  |- skos__scopeNote mesh__D018237
% 215.14/215.34       A malignant neoplasm of the germinal tissue of the GONADS; MEDIASTINUM; or pineal region. Germinomas are uniform in appearance, consisting of large, round cells with vesicular nuclei and clear or finely granular eosinophilic-staining cytoplasm. %28%Stedman, 265th ed; from DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, pp1642-3%29%%A%    
% 215.14/215.34  |- skos__related mesh__D018237smesh__D010051
% 215.14/215.34  |- skos__historyNote mesh__D018237
% 215.14/215.34       Neoplasms, Germ Cell and Embryonal %28%1972-1993%29%
% 215.14/215.34  |- mesh__dateRevised mesh__D018237 2005-06-30
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D018237 2006
% 215.14/215.34  |- mesh__publicMeSHNote mesh__D018237 94   
% 215.14/215.34  |- mesh__recordMaintainer mesh__D018237 ags
% 215.14/215.34  |- skos__hiddenLabel mesh__D018237 Germinomas
% 215.14/215.34  |- skos__hiddenLabel mesh__D010254 Diseases, Paranasal Sinus
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010254 2005
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010254 2006
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010254 2000
% 215.14/215.34  |- skos__hiddenLabel mesh__D010254 Disease, Paranasal Sinus
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010254 1996
% 215.14/215.34  |- skos__hiddenLabel mesh__D010254 Sinus Disease, Paranasal
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010254 2001
% 215.14/215.34  |- mesh__dateEstablished mesh__D010254 1977-01-01
% 215.14/215.34  |- skos__historyNote mesh__D010254 Paranasal Sinuses %28%1966-1976%29%
% 215.14/215.34  |- skos__hiddenLabel mesh__D010254 Sinus Diseases, Paranasal
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010254 1997
% 215.14/215.34  |- mesh__historyNote mesh__D010254 77; was NON MESH before 1977   
% 215.14/215.34  |- mesh__recordMaintainer mesh__D010254 PXP
% 215.14/215.34  |- mesh__publicMeSHNote mesh__D010254 77   
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010254 2002
% 215.14/215.34  |- skos__broader mesh__D010254smesh__D009668
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010254 1998
% 215.14/215.34  |- mesh__dateRevised mesh__D010254 1994-05-23
% 215.14/215.34  |- skos__prefLabel mesh__D010254 Paranasal Sinus Diseases
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010254 2003
% 215.14/215.34  |- mesh__dateCreated mesh__D010254 1999-01-01
% 215.14/215.34  |- skos__scopeNote mesh__D010254
% 215.14/215.34       Diseases affecting or involving the PARANASAL SINUSES and generally manifesting as inflammation, abscesses, cysts, or tumors.%A%    
% 215.14/215.34  |- rdf__type mesh__D010254sskos__Concept
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010254 1999
% 215.14/215.34  |- skos__hiddenLabel mesh__D010254 Paranasal Sinus Disease
% 215.14/215.34  |- mesh__recordAuthorizer mesh__D010254 PLS
% 215.14/215.34  |- mesh__recordOriginator mesh__D010254 NLM
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010254 2004
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010254 1995
% 215.14/215.34  |- mesh__dateCreated mesh__D004217 1999-01-01
% 215.14/215.34  |- skos__scopeNote mesh__D004217
% 215.14/215.34       A species of MORBILLIVIRUS causing distemper in dogs, wolves, foxes, raccoons, and ferrets. Pinnipeds have also been known to contract Canine distemper virus from contact with domestic dogs.%A%    
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D004217 2002
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D004217 2005
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D004217 2004
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D004217 2006A
% 215.14/215.34  |- mesh__recordOriginator mesh__D004217 NLM
% 215.14/215.34  |- skos__prefLabel mesh__D004217 Distemper Virus, Canine
% 215.14/215.34  |- mesh__dateEstablished mesh__D004217 1966-01-01
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D004217 2006
% 215.14/215.34  |- mesh__dateRevised mesh__D004217 2005-07-13
% 215.14/215.34  |- skos__annotation mesh__D004217
% 215.14/215.34       infection: coord IM with DISTEMPER %28%IM%29%; DISTEMPER VIRUS, PHOCINE is also available%A%  
% 215.14/215.34  |- mesh__publicMeSHNote mesh__D004217 66; was DISTEMPER VIRUS 1963-65   
% 215.14/215.34  |- skos__hiddenLabel mesh__D004217 Canine Distemper Viruses
% 215.14/215.34  |- skos__altLabel mesh__D004217 Canine distemper virus
% 215.14/215.34  |- skos__hiddenLabel mesh__D004217 Distemper Viruses, Canine
% 215.14/215.34  |- rdf__type mesh__D004217sskos__Concept
% 215.14/215.34  |- mesh__historyNote mesh__D004217 66; was DISTEMPER VIRUS 1963-65   
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D004217 2003
% 215.14/215.34  |- mesh__recordAuthorizer mesh__D004217 ags
% 215.14/215.34  |- mesh__recordMaintainer mesh__D004217 ags
% 215.14/215.34  |- skos__broader mesh__D004217smesh__D018103
% 215.14/215.34  |- rdf__type mesh__D009700sskos__Concept
% 215.14/215.34  |- mesh__historyNote mesh__D009700
% 215.14/215.34       75; was see under AMINOHYDROLASES 1974, was NUCLEOSIDE AND NUCLEOTIDE DEAMINASES see AMINOHYDROLASES 1963-73%A%  
% 215.14/215.34  |- mesh__dateCreated mesh__D009700 1999-01-01
% 215.14/215.34  |- mesh__dateRevised mesh__D009700 2003-07-09
% 215.14/215.34  |- mesh__recordAuthorizer mesh__D009700 sjn
% 215.14/215.34  |- mesh__recordOriginator mesh__D009700 NLM
% 215.14/215.34  |- mesh__publicMeSHNote mesh__D009700
% 215.14/215.34       75; was see under AMINOHYDROLASES 1974, was NUCLEOSIDE AND NUCLEOTIDE DEAMINASES see AMINOHYDROLASES 1963-73%A%  
% 215.14/215.34  |- skos__annotation mesh__D009700
% 215.14/215.34       do not confuse with NUCLEOTIDE DEAMINASES   
% 215.14/215.34  |- skos__scopeNote mesh__D009700
% 215.14/215.34       Catalyze the hydrolysis of nucleosides with the elimination of ammonia.%A%    
% 215.14/215.34  |- mesh__recordMaintainer mesh__D009700 ssb
% 215.14/215.34  |- skos__historyNote mesh__D009700 Aminohydrolases %28%1966-1974%29%
% 215.14/215.34  |- mesh__onlineNote mesh__D009700 search AMINOHYDROLASES 1966-74   
% 215.14/215.34  |- skos__broader mesh__D009700smesh__D000619
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D009700 2006
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D009700 2005
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D009700 2004
% 215.14/215.34  |- mesh__dateEstablished mesh__D009700 1975-01-01
% 215.14/215.34  |- skos__prefLabel mesh__D009700 Nucleoside Deaminases
% 215.14/215.34  |- skos__hiddenLabel mesh__D009700 Deaminases, Nucleoside
% 215.14/215.34  |- mesh__recordAuthorizer mesh__D020682 sjn
% 215.14/215.34  |- skos__historyNote mesh__D020682 Cephalosporins %28%1984-1985%29%
% 215.14/215.34  |- skos__altLabel mesh__D020682 FK 027
% 215.14/215.34  |- skos__hiddenLabel mesh__D020682 027, FK
% 215.14/215.34  |- skos__historyNote mesh__D020682
% 215.14/215.34       Cefotaxime/analogs %26% derivatives %28%1986-1999%29%
% 215.14/215.34  |- skos__hiddenLabel mesh__D020682 FR17027
% 215.14/215.34  |- skos__prefLabel mesh__D020682 Cefixime
% 215.14/215.34  |- mesh__recordMaintainer mesh__D020682 ssb
% 215.14/215.34  |- mesh__dateEstablished mesh__D020682 2000-01-01
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D020682 2006
% 215.14/215.34  |- mesh__dateCreated mesh__D020682 1999-11-03
% 215.14/215.34  |- skos__hiddenLabel mesh__D020682 FR 17027
% 215.14/215.34  |- skos__scopeNote mesh__D020682
% 215.14/215.34       A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.%A%    
% 215.14/215.34  |- rdf__type mesh__D020682sskos__Concept
% 215.14/215.34  |- mesh__historyNote mesh__D020682
% 215.14/215.34       2000; use CEFIXIME %28%NM%29% 1984-1999   
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D020682 2005
% 215.14/215.34  |- mesh__dateRevised mesh__D020682 2004-07-07
% 215.14/215.34  |- skos__broader mesh__D020682smesh__D002439
% 215.14/215.34  |- mesh__publicMeSHNote mesh__D020682
% 215.14/215.34       2000; FK 027 %28%now CEFIXIME%29% was indexed under CEFOTAXIME/*analogs %26% derivatives 1986-1999 %26% CEPHALOSPORINS 1984-1985%A%  
% 215.14/215.34  |- skos__hiddenLabel mesh__D020682 FK027
% 215.14/215.34  |- mesh__recordOriginator mesh__D020682 adp
% 215.14/215.34  |- skos__altLabel mesh__D014645 Herpes zoster Virus
% 215.14/215.34  |- skos__hiddenLabel mesh__D014645 Herpes zoster Viruses
% 215.14/215.34  |- skos__hiddenLabel mesh__D014645 VZ Viruses
% 215.14/215.34  |- skos__altLabel mesh__D014645 HHV-3
% 215.14/215.34  |- mesh__dateCreated mesh__D014645 1999-01-01
% 215.14/215.34  |- mesh__recordOriginator mesh__D014645 NLM
% 215.14/215.34  |- mesh__publicMeSHNote mesh__D014645
% 215.14/215.34       94; was VARICELLA-ZOSTER VIRUS 1963-93   
% 215.14/215.34  |- skos__scopeNote mesh__D014645
% 215.14/215.34       The type species of VARICELLOVIRUS causing CHICKENPOX %28%varicella%29% and HERPES ZOSTER %28%shingles%29% in humans.%A%    
% 215.14/215.34  |- skos__hiddenLabel mesh__D014645 Varicella-Zoster Viruses
% 215.14/215.34  |- skos__altLabel mesh__D014645 Chickenpox Virus
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D014645 2003
% 215.14/215.34  |- mesh__recordMaintainer mesh__D014645 ags
% 215.14/215.34  |- mesh__onlineNote mesh__D014645
% 215.14/215.34       use HERPESVIRUS 3, HUMAN to search VARICELLA-ZOSTER VIRUS 1966-93%A%  
% 215.14/215.34  |- mesh__recordAuthorizer mesh__D014645 sjn
% 215.14/215.34  |- skos__prefLabel mesh__D014645 Herpesvirus 3, Human
% 215.14/215.34  |- rdf__type mesh__D014645sskos__Concept
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D014645 2004
% 215.14/215.34  |- mesh__historyNote mesh__D014645
% 215.14/215.34       94; was VARICELLA-ZOSTER VIRUS 1963-93   
% 215.14/215.34  |- skos__hiddenLabel mesh__D014645 Varicella Zoster Virus
% 215.14/215.34  |- skos__altLabel mesh__D014645 Human herpesvirus 3
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D014645 2005
% 215.14/215.34  |- skos__annotation mesh__D014645
% 215.14/215.34       do not confuse with other numbered herpesviruses; infection = CHICKENPOX or HERPES ZOSTER; consider also ENCEPHALITIS, VARICELLA ZOSTER; DF: HHV 3%A%  
% 215.14/215.34  |- skos__broader mesh__D014645smesh__D018140
% 215.14/215.34  |- mesh__dateRevised mesh__D014645 2001-07-25
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D014645 2002
% 215.14/215.34  |- skos__altLabel mesh__D014645 Herpesvirus 3 %28%alpha%29%, Human
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D014645 2006
% 215.14/215.34  |- skos__altLabel mesh__D014645 Varicella-Zoster Virus
% 215.14/215.34  |- skos__altLabel mesh__D014645 Herpesvirus varicellae
% 215.14/215.34  |- skos__altLabel mesh__D014645 VZ Virus
% 215.14/215.34  |- skos__altLabel mesh__D014645 Ocular Herpes zoster Virus
% 215.14/215.34  |- skos__hiddenLabel mesh__D014645 Chickenpox Viruses
% 215.14/215.34  |- mesh__recordAuthorizer mesh__D000625 sjn
% 215.14/215.34  |- skos__hiddenLabel mesh__D000625 Acid, Aminooxyacetic
% 215.14/215.34  |- rdf__type mesh__D000625sskos__Concept
% 215.14/215.34  |- mesh__dateRevised mesh__D000625 2000-06-21
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D000625 2005
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D000625 2001
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D000625 2003
% 215.14/215.34  |- skos__scopeNote mesh__D000625
% 215.14/215.34       A compound that inhibits aminobutyrate aminotransferase activity in vivo, thereby raising the level of gamma-aminobutyric acid in tissues.%A%    
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D000625 2006
% 215.14/215.34  |- mesh__dateEstablished mesh__D000625 1991-01-01
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D000625 2002
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D000625 2004
% 215.14/215.34  |- skos__prefLabel mesh__D000625 Aminooxyacetic Acid
% 215.14/215.34  |- mesh__recordOriginator mesh__D000625 NLM
% 215.14/215.34  |- skos__altLabel mesh__D000625 Carboxymethoxyamine
% 215.14/215.34  |- skos__historyNote mesh__D000625 Hydroxylamines %28%1972-1974%29%
% 215.14/215.34  |- skos__broader mesh__D000625smesh__D000088
% 215.14/215.34  |- mesh__publicMeSHNote mesh__D000625
% 215.14/215.34       91; was see under ACETIC ACIDS 1975-90   
% 215.14/215.34  |- mesh__historyNote mesh__D000625
% 215.14/215.34       91%28%75%29%; was see under ACETIC ACIDS 1975-90   
% 215.14/215.34  |- skos__historyNote mesh__D000625 Acetic Acids %28%1972-1974%29%
% 215.14/215.34  |- mesh__dateCreated mesh__D000625 1974-11-19
% 215.14/215.34  |- mesh__recordMaintainer mesh__D000625 CCR
% 215.14/215.34  |- skos__broader mesh__D000625smesh__D006898
% 215.14/215.34  |- skos__hiddenLabel mesh__D033001 Organ Donations, Directed
% 215.14/215.34  |- skos__hiddenLabel mesh__D033001 Donation, Directed Gamete
% 215.14/215.34  |- skos__hiddenLabel mesh__D033001 Donations, Directed
% 215.14/215.34  |- mesh__recordMaintainer mesh__D033001 lkt
% 215.14/215.34  |- skos__hiddenLabel mesh__D033001 Donations, Directed Gamete
% 215.14/215.34  |- skos__broader mesh__D033001smesh__D009927
% 215.14/215.34  |- mesh__recordAuthorizer mesh__D033001 sjn
% 215.14/215.34  |- skos__hiddenLabel mesh__D033001 Directed Tissue Donations
% 215.14/215.34  |- skos__hiddenLabel mesh__D033001 Donation, Directed Tissue
% 215.14/215.34  |- skos__hiddenLabel mesh__D033001 Donation, Directed Organ
% 215.14/215.34  |- skos__related mesh__D033001smesh__D014019
% 215.14/215.34  |- skos__hiddenLabel mesh__D033001 Gamete Donations, Directed
% 215.14/215.34  |- skos__hiddenLabel mesh__D033001 Donations, Directed Tissue
% 215.14/215.34  |- skos__hiddenLabel mesh__D033001 Donations, Directed Organ
% 215.14/215.34  |- skos__altLabel mesh__D033001 Directed Donation
% 215.14/215.34  |- skos__hiddenLabel mesh__D033001 Directed Gamete Donations
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D033001 2005
% 215.14/215.34  |- skos__prefLabel mesh__D033001 Directed Tissue Donation
% 215.14/215.34  |- rdf__type mesh__D033001sskos__Concept
% 215.14/215.34  |- skos__related mesh__D033001smesh__D018587
% 215.14/215.34  |- skos__hiddenLabel mesh__D033001 Directed Donations
% 215.14/215.34  |- skos__scopeNote mesh__D033001
% 215.14/215.34       Tissue, organ, or gamete donation intended for a designated recipient.%A%    
% 215.14/215.34  |- skos__hiddenLabel mesh__D033001 Organ Donation, Directed
% 215.14/215.34  |- skos__hiddenLabel mesh__D033001 Donation, Directed
% 215.14/215.34  |- skos__hiddenLabel mesh__D033001 Tissue Donations, Directed
% 215.14/215.34  |- mesh__publicMeSHNote mesh__D033001
% 215.14/215.34       2003; see ORGAN PROCUREMENT 2002; see TISSUE DONORS 1992-2001%A%  
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D033001 2006
% 215.14/215.34  |- mesh__dateCreated mesh__D033001 2002-07-03
% 215.14/215.34  |- mesh__dateRevised mesh__D033001 2004-07-07
% 215.14/215.34  |- skos__hiddenLabel mesh__D033001 Gamete Donation, Directed
% 215.14/215.34  |- mesh__historyNote mesh__D033001
% 215.14/215.34       2003; use ORGAN PROCUREMENT 2002; use TISSUE DONORS 1992-2001%A%  
% 215.14/215.34  |- skos__hiddenLabel mesh__D033001 Directed Organ Donations
% 215.14/215.34  |- mesh__dateEstablished mesh__D033001 2003-01-01
% 215.14/215.34  |- skos__historyNote mesh__D033001 Organ Procurement %28%1990-2002%29%
% 215.14/215.34  |- skos__historyNote mesh__D033001 Tissue Donors %28%1990-2002%29%
% 215.14/215.34  |- mesh__recordOriginator mesh__D033001 jrf
% 215.14/215.34  |- skos__hiddenLabel mesh__D033001 Tissue Donation, Directed
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D005310 2006B
% 215.14/215.34  |- skos__broader mesh__D005310smesh__D005315
% 215.14/215.34  |- mesh__recordOriginator mesh__D005310 EC
% 215.14/215.34  |- skos__scopeNote mesh__D005310
% 215.14/215.34       A condition occurring in FETUS or NEWBORN due to in utero ETHANOL exposure when mother consumed alcohol during PREGNANCY. It is characterized by a cluster of irreversible BIRTH DEFECTS including abnormalities in physical, mental, and behavior development %28%such as FETAL GROWTH RETARDATION; MENTAL RETARDATION; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS%29% with varied degree of severity in an individual.%A%    
% 215.14/215.34  |- skos__broader mesh__D005310smesh__D020751
% 215.14/215.34  |- mesh__historyNote mesh__D005310 79; was in Cat C %26% F 1979-80   
% 215.14/215.34  |- mesh__publicMeSHNote mesh__D005310 79   
% 215.14/215.34  |- skos__hiddenLabel mesh__D005310 Fetal Alcohol Syndromes
% 215.14/215.34  |- rdf__type mesh__D005310sskos__Concept
% 215.14/215.34  |- mesh__dateRevised mesh__D005310 2005-07-15
% 215.14/215.34  |- skos__historyNote mesh__D005310 Alcoholism %28%1966-1978%29%
% 215.14/215.34  |- skos__prefLabel mesh__D005310 Fetal Alcohol Syndrome
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D005310 2006
% 215.14/215.34  |- mesh__dateEstablished mesh__D005310 1979-01-01
% 215.14/215.34  |- mesh__dateCreated mesh__D005310 1978-05-04
% 215.14/215.34  |- mesh__recordMaintainer mesh__D005310 ags
% 215.14/215.34  |- mesh__recordAuthorizer mesh__D005310 ags
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D005310 2006A
% 215.14/215.34  |- mesh__publicMeSHNote mesh__D018238 94   
% 215.14/215.34  |- skos__hiddenLabel mesh__D018238 Gonadoblastomas
% 215.14/215.34  |- skos__scopeNote mesh__D018238
% 215.14/215.34       A complex neoplasm composed of a mixture of gonadal elements, such as large primordial GERM CELLS, immature SERTOLI CELLS or GRANULOSA CELLS of the sex cord, and gonadal stromal cells. Gonadoblastomas are most often associated with abnormal chromosomal karyotype, GONADAL DYSGENESIS, and the presence of a Y CHROMOSOME.%A%    
% 215.14/215.34  |- mesh__dateCreated mesh__D018238 1993-06-25
% 215.14/215.34  |- mesh__recordMaintainer mesh__D018238 lkt
% 215.14/215.34  |- skos__annotation mesh__D018238
% 215.14/215.34       coordinate IM with OVARIAN NEOPLASMS %28%IM%29% or TESTICULAR NEOPLASMS %28%IM%29% %26% appropriate check tags%A%  
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D018238 2005
% 215.14/215.34  |- mesh__historyNote mesh__D018238 94   
% 215.14/215.34  |- mesh__recordOriginator mesh__D018238 PLS
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D018238 2006
% 215.14/215.34  |- skos__prefLabel mesh__D018238 Gonadoblastoma
% 215.14/215.34  |- mesh__recordAuthorizer mesh__D018238 sjn
% 215.14/215.34  |- mesh__dateRevised mesh__D018238 2004-07-07
% 215.14/215.34  |- skos__historyNote mesh__D018238 Dysgerminoma %28%1966-1993%29%
% 215.14/215.34  |- mesh__dateEstablished mesh__D018238 1994-01-01
% 215.14/215.34  |- skos__broader mesh__D018238smesh__D018309
% 215.14/215.34  |- rdf__type mesh__D018238sskos__Concept
% 215.14/215.34  |- skos__broader mesh__D018238smesh__D009373
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010255 1999
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010255 2003
% 215.14/215.34  |- skos__scopeNote mesh__D010255
% 215.14/215.34       Neoplasms or tumors of the paranasal sinuses. Malignant neoplasms are rare, comprising 3%25% of all head and neck neoplasms. The majority arise in the maxillary sinus with malignancies of the ethmoid sinus constituting virtually all the remaining tumors.%A%    
% 215.14/215.34  |- skos__prefLabel mesh__D010255 Paranasal Sinus Neoplasms
% 215.14/215.34  |- skos__altLabel mesh__D010255 Neoplasms, Paranasal Sinus
% 215.14/215.34  |- skos__broader mesh__D010255smesh__D010254
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010255 1998
% 215.14/215.34  |- mesh__recordOriginator mesh__D010255 NLM
% 215.14/215.34  |- skos__annotation mesh__D010255
% 215.14/215.34       coord IM with specific sinus %28%IM%29% + histol type of neopl %28%IM%29%; /blood supply /chem /second /secret /ultrastruct permitted; note that MAXILLARY SINUS NEOPLASMS is also available%A%  
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010255 2002
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010255 2006
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010255 1997
% 215.14/215.34  |- mesh__dateRevised mesh__D010255 1995-06-08
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010255 2001
% 215.14/215.34  |- mesh__dateCreated mesh__D010255 1999-01-01
% 215.14/215.34  |- skos__broader mesh__D010255smesh__D009669
% 215.14/215.34  |- skos__hiddenLabel mesh__D010255 Neoplasm, Paranasal Sinus
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010255 2005
% 215.14/215.34  |- mesh__recordMaintainer mesh__D010255 KEV
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010255 1996
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010255 2000
% 215.14/215.34  |- skos__hiddenLabel mesh__D010255 Sinus Neoplasm, Paranasal
% 215.14/215.34  |- mesh__recordAuthorizer mesh__D010255 PLS
% 215.14/215.34  |- mesh__activeMeSHYear mesh__D010255 2004
% 215.14/215.34  |- skos__hiddenLabel mesh__D010255 Paranasal Sinus Neoplasm
% 215.14/215.34  |- rdf__type mesh__D010255sskos__Concept
% 215.14/215.34  |- skos__hiddenLabel mesh__D010255 Sinus Neoplasms, Paranasal
% 215.14/215.34  |- skos__historyNote mesh__D009701 Phosphotransferases %28%1966-1973%29%
% 215.14/215.34  |- mesh__onlineNote mesh__D009701
% 215.14/215.34       use NUCLEOSIDE-DIPHOSPHATE KINASE to search NUCLEOSIDE DIPHOSPHATE KINASES 1977-93%A%  
% 215.14/215.35  |- rdf__type mesh__D009701sskos__Concept
% 215.14/215.35  |- skos__hiddenLabel mesh__D009701 Nucleoside Diphosphate Kinase
% 215.14/215.35  |- mesh__historyNote mesh__D009701
% 215.14/215.35       94; was NUCLEOSIDE DIPHOSPHATE KINASES 1977-93 %28%see under PHOSPHOTRANSFERASES, ATP 1977-90%29%%A%  
% 215.14/215.35  |- skos__hiddenLabel mesh__D009701 Kinase, Nucleoside-Diphosphate
% 215.14/215.35  |- skos__hiddenLabel mesh__D009701 Diphosphokinases, Nucleoside
% 215.14/215.35  |- mesh__dateRevised mesh__D009701 2003-07-09
% 215.14/215.35  |- skos__altLabel mesh__D009701 Deoxynucleoside Diphosphate Kinases
% 215.14/215.35  |- mesh__publicMeSHNote mesh__D009701
% 215.14/215.35       94; was NUCLEOSIDE DIPHOSPHATE KINASES 1977-93 %28%see under PHOSPHOTRANSFERASES, ATP 1977-90%29%%A%  
% 215.14/215.35  |- skos__hiddenLabel mesh__D009701 Kinases, Nucleoside-Diphosphate
% 215.14/215.35  |- skos__hiddenLabel mesh__D009701 Kinases, Deoxynucleoside Diphosphate
% 215.14/215.35  |- skos__hiddenLabel mesh__D009701 Diphosphate Kinases, Deoxynucleoside
% 215.14/215.35  |- skos__hiddenLabel mesh__D009701 Nucleoside Diphosphate Kinases
% 215.14/215.35  |- skos__altLabel mesh__D009701 Nucleoside-Diphosphate Kinases
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D009701 2005
% 215.14/215.35  |- mesh__dateEstablished mesh__D009701 1991-01-01
% 215.14/215.35  |- mesh__recordOriginator mesh__D009701 RLS
% 215.14/215.35  |- mesh__recordMaintainer mesh__D009701 ssb
% 215.14/215.35  |- skos__historyNote mesh__D009701
% 215.14/215.35       Phosphotransferases, ATP %28%1974-1976%29%
% 215.14/215.35  |- skos__historyNote mesh__D009701 Nucleotides %28%1966-1976%29%
% 215.14/215.35  |- skos__altLabel mesh__D009701 Nucleoside Diphosphokinases
% 215.14/215.35  |- mesh__recordAuthorizer mesh__D009701 sjn
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D009701 2006
% 215.14/215.35  |- skos__scopeNote mesh__D009701
% 215.14/215.35       An enzyme that is found in mitochondria and in the soluble cytoplasm of cells. It catalyzes reversible reactions of a nucleoside triphosphate, e.g., ATP, with a nucleoside diphosphate, e.g., UDP, to form ADP and UTP. Many nucleoside diphosphates can act as acceptor, while many ribo- and deoxyribonucleoside triphosphates can act as donor. EC 2.7.4.6.%A%    
% 215.14/215.35  |- skos__broader mesh__D009701smesh__D017856
% 215.14/215.35  |- mesh__dateCreated mesh__D009701 1976-05-19
% 215.14/215.35  |- skos__hiddenLabel mesh__D009701 Kinase, GDP
% 215.14/215.35  |- skos__prefLabel mesh__D009701 Nucleoside-Diphosphate Kinase
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D009701 2004
% 215.14/215.35  |- skos__altLabel mesh__D020683 Culdoscope
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D020683 2000
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D020683 2000B
% 215.14/215.35  |- skos__scopeNote mesh__D020683
% 215.14/215.35       Endoscopic instruments used for viewing the rectovaginal pouch and pelvic viscera.%A%    
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D020683 2000A
% 215.14/215.35  |- skos__historyNote mesh__D020683 Culdoscopy %28%1978-1999%29%
% 215.14/215.35  |- mesh__dateEstablished mesh__D020683 2000-01-01
% 215.14/215.35  |- mesh__recordMaintainer mesh__D020683 ags
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D020683 2006
% 215.14/215.35  |- skos__broader mesh__D020683smesh__D019723
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D020683 2002
% 215.14/215.35  |- skos__prefLabel mesh__D020683 Culdoscopes
% 215.14/215.35  |- mesh__recordAuthorizer mesh__D020683 ags
% 215.14/215.35  |- mesh__historyNote mesh__D020683
% 215.14/215.35       2000; for CULDOSCOPE use CULDOSCOPY 1979-1999   
% 215.14/215.35  |- rdf__type mesh__D020683sskos__Concept
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D020683 2004
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D020683 2005
% 215.14/215.35  |- mesh__publicMeSHNote mesh__D020683
% 215.14/215.35       2000; for CULDOSCOPE see CULDOSCOPY 1979-1999   
% 215.14/215.35  |- mesh__dateRevised mesh__D020683 1999-12-28
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D020683 2003
% 215.14/215.35  |- mesh__dateCreated mesh__D020683 1999-11-03
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D020683 2001
% 215.14/215.35  |- mesh__recordOriginator mesh__D020683 nns
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014646 2004
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014646 1995
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014646 1996
% 215.14/215.35  |- skos__prefLabel mesh__D014646 Varicocele
% 215.14/215.35  |- skos__scopeNote mesh__D014646
% 215.14/215.35       A varicose condition of the veins of the pampiniform plexus, forming a swelling that feels like a %22%bag of worms,%22% appearing bluish through the skin of the scrotum, and accompanied by a constant pulling, dragging, or dull pain in the scrotum. %28%Dorland, 27th ed%29%%A%    
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014646 2002
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014646 2005
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014646 1997
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014646 2006
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014646 1998
% 215.14/215.35  |- mesh__recordOriginator mesh__D014646 NLM
% 215.14/215.35  |- mesh__recordAuthorizer mesh__D014646 PLS
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014646 1999
% 215.14/215.35  |- mesh__dateCreated mesh__D014646 1999-01-01
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014646 2000
% 215.14/215.35  |- skos__hiddenLabel mesh__D014646 Varicoceles
% 215.14/215.35  |- skos__broader mesh__D014646smesh__D014652
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014646 1994
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014646 2003
% 215.14/215.35  |- skos__annotation mesh__D014646
% 215.14/215.35       abnorm dilat of veins of the spermatic cord   
% 215.14/215.35  |- skos__broader mesh__D014646smesh__D005832
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014646 2001
% 215.14/215.35  |- mesh__recordMaintainer mesh__D014646 TAP
% 215.14/215.35  |- rdf__type mesh__D014646sskos__Concept
% 215.14/215.35  |- mesh__dateRevised mesh__D014646 1993-06-03
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D008609 1999
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D008609 2003
% 215.14/215.35  |- skos__prefLabel mesh__D008609 Mental Status Schedule
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D008609 1994
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D008609 1993
% 215.14/215.35  |- skos__scopeNote mesh__D008609
% 215.14/215.35       Standardized clinical interview used to assess current psychopathology by scaling patient responses to the questions.%A%    
% 215.14/215.35  |- skos__broader mesh__D008609smesh__D011569
% 215.14/215.35  |- skos__hiddenLabel mesh__D008609 Mental Status Schedules
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D008609 2002
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D008609 2005
% 215.14/215.35  |- skos__hiddenLabel mesh__D008609 Schedule, Mental Status
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D008609 2004
% 215.14/215.35  |- skos__hiddenLabel mesh__D008609 Status Schedule, Mental
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D008609 1995
% 215.14/215.35  |- mesh__onlineNote mesh__D008609
% 215.14/215.35       search PSYCHIATRIC STATUS RATING SCALES 1969-74   
% 215.14/215.35  |- skos__hiddenLabel mesh__D008609 Schedules, Mental Status
% 215.14/215.35  |- mesh__publicMeSHNote mesh__D008609
% 215.14/215.35       91; was see under PSYCHIATRIC STATUS RATING SCALES 1975-90%A%  
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D008609 2006
% 215.14/215.35  |- rdf__type mesh__D008609sskos__Concept
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D008609 1996
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D008609 2000
% 215.14/215.35  |- mesh__recordOriginator mesh__D008609 NLM
% 215.14/215.35  |- mesh__dateEstablished mesh__D008609 1991-01-01
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D008609 2001
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D008609 1998
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D008609 1997
% 215.14/215.35  |- mesh__dateCreated mesh__D008609 1999-01-01
% 215.14/215.35  |- mesh__recordMaintainer mesh__D008609 TAP
% 215.14/215.35  |- mesh__historyNote mesh__D008609
% 215.14/215.35       91%28%75%29%; was see under PSYCHIATRIC STATUS RATING SCALES 1975-90%A%  
% 215.14/215.35  |- skos__hiddenLabel mesh__D008609 Status Schedules, Mental
% 215.14/215.35  |- mesh__dateRevised mesh__D008609 1992-05-15
% 215.14/215.35  |- mesh__recordAuthorizer mesh__D008609 PLS
% 215.14/215.35  |- skos__prefLabel mesh__D000626 Aminopeptidases
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D000626 2005
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D000626 2006
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D000626 2004
% 215.14/215.35  |- skos__scopeNote mesh__D000626
% 215.14/215.35       A subclass of EXOPEPTIDASES that act on the free N terminus end of a polypeptide liberating a single amino acid residue. EC 3.4.11.%A%    
% 215.14/215.35  |- mesh__recordAuthorizer mesh__D000626 sjn
% 215.14/215.35  |- mesh__dateRevised mesh__D000626 2003-07-09
% 215.14/215.35  |- skos__broader mesh__D000626smesh__D020689
% 215.14/215.35  |- mesh__recordMaintainer mesh__D000626 ssb
% 215.14/215.35  |- mesh__recordOriginator mesh__D000626 NLM
% 215.14/215.35  |- rdf__type mesh__D000626sskos__Concept
% 215.14/215.35  |- mesh__dateCreated mesh__D000626 1999-01-01
% 215.14/215.35  |- mesh__publicMeSHNote mesh__D019331
% 215.14/215.35       97; N%28%G%29%-NITROARGININE METHYL ESTER was indexed under ARGININE/analogs %26% derivatives 1990-96%A%  
% 215.14/215.35  |- skos__altLabel mesh__D019331 NG-Nitro-L-Arginine Methyl Ester
% 215.14/215.35  |- skos__altLabel mesh__D019331
% 215.14/215.35       N%28%omega%29%-Nitro-L-arginine Methyl Ester
% 215.14/215.35  |- skos__hiddenLabel mesh__D019331 Methyl Ester, NG-Nitro-L-Arginine
% 215.14/215.35  |- skos__altLabel mesh__D019331 N%28%G%29%-Nitroarginine Methyl Ester
% 215.14/215.35  |- mesh__dateCreated mesh__D019331 1996-06-10
% 215.14/215.35  |- skos__prefLabel mesh__D019331 NG-Nitroarginine Methyl Ester
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D019331 2002
% 215.14/215.35  |- skos__hiddenLabel mesh__D019331 Methyl Ester, NG-Nitroarginine
% 215.14/215.35  |- skos__altLabel mesh__D019331 L-NAME
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D019331 2003
% 215.14/215.35  |- mesh__onlineNote mesh__D019331
% 215.14/215.35       use NG-NITROARGININE METHYL ESTER %28%NM%29% to search N%28%G%29%-NITROARGININE METHYL ESTER 1990-96%A%  
% 215.14/215.35  |- mesh__recordAuthorizer mesh__D019331 sjn
% 215.14/215.35  |- skos__hiddenLabel mesh__D019331 NG Nitroarginine Methyl Ester
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D019331 2004
% 215.14/215.35  |- skos__altLabel mesh__D019331 N omega-Nitro-L-arginine Methyl Ester
% 215.14/215.35  |- mesh__recordOriginator mesh__D019331 ADP
% 215.14/215.35  |- skos__historyNote mesh__D019331
% 215.14/215.35       Arginine/analogs %26% derivatives %28%1990-1996%29%
% 215.14/215.35  |- skos__hiddenLabel mesh__D019331 NG Nitro L Arginine Methyl Ester
% 215.14/215.35  |- skos__annotation mesh__D019331 DF: note short X ref   
% 215.14/215.35  |- mesh__dateRevised mesh__D019331 2001-07-25
% 215.14/215.35  |- skos__altLabel mesh__D019331 N%28%G%29%-Nitro-L-arginine Methyl Ester
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D019331 2005
% 215.14/215.35  |- skos__hiddenLabel mesh__D019331
% 215.14/215.35       NG Nitroarginine Methyl Ester, D Orn Isomer
% 215.14/215.35  |- skos__hiddenLabel mesh__D019331 N omega Nitro L arginine Methyl Ester
% 215.14/215.35  |- mesh__recordMaintainer mesh__D019331 nns
% 215.14/215.35  |- skos__scopeNote mesh__D019331
% 215.14/215.35       A non-selective inhibitor of nitric oxide synthase. It has been used experimentally to induce hypertension.%A%    
% 215.14/215.35  |- skos__broader mesh__D019331smesh__D001120
% 215.14/215.35  |- rdf__type mesh__D019331sskos__Concept
% 215.14/215.35  |- mesh__dateEstablished mesh__D019331 1997-01-01
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D019331 2006
% 215.14/215.35  |- mesh__historyNote mesh__D019331
% 215.14/215.35       97; was N%28%G%29%-NITROARGININE METHYL ESTER %28%NM%29% 1990-96   
% 215.14/215.35  |- skos__broader mesh__D033002smesh__D007603
% 215.14/215.35  |- skos__hiddenLabel mesh__D033002 Recontact, Duty to
% 215.14/215.35  |- mesh__recordOriginator mesh__D033002 jrf
% 215.14/215.35  |- rdf__type mesh__D033002sskos__Concept
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D033002 2005
% 215.14/215.35  |- skos__scopeNote mesh__D033002
% 215.14/215.35       The ethical and/or legal obligation of a health provider or researcher to communicate with a former patient or research subject about advances in research relevant to a treatment or to a genetic or other diagnostic test provided earlier, or about proposed new uses of blood or tissue samples taken in the past for another purpose.%A%    
% 215.14/215.35  |- skos__hiddenLabel mesh__D033002 Recontacts
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D033002 2006
% 215.14/215.35  |- mesh__recordAuthorizer mesh__D033002 sjn
% 215.14/215.35  |- mesh__historyNote mesh__D033002 2003; use DISCLOSURE 2002   
% 215.14/215.35  |- skos__broader mesh__D033002smesh__D003142
% 215.14/215.35  |- mesh__dateRevised mesh__D033002 2003-07-25
% 215.14/215.35  |- mesh__publicMeSHNote mesh__D033002 2003; see DISCLOSURE 2002   
% 215.14/215.35  |- skos__related mesh__D033002smesh__D017007
% 215.14/215.35  |- skos__prefLabel mesh__D033002 Duty to Recontact
% 215.14/215.35  |- mesh__dateCreated mesh__D033002 2002-07-03
% 215.14/215.35  |- mesh__recordMaintainer mesh__D033002 sjn
% 215.14/215.35  |- mesh__dateEstablished mesh__D033002 2003-01-01
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D033002 2004
% 215.14/215.35  |- skos__prefLabel mesh__D005311 Fetal Hypoxia
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D005311 2006
% 215.14/215.35  |- mesh__recordMaintainer mesh__D005311 lkt
% 215.14/215.35  |- mesh__publicMeSHNote mesh__D005311 2006; see FETAL ANOXIA 1975-2005   
% 215.14/215.35  |- mesh__dateCreated mesh__D005311 1974-11-11
% 215.14/215.35  |- skos__altLabel mesh__D005311 Anoxia, Fetal
% 215.14/215.35  |- skos__annotation mesh__D005311
% 215.14/215.35       do not confuse with ASPHYXIA NEONATORUM   
% 215.14/215.35  |- skos__scopeNote mesh__D005311 Deficient oxygenation of FETAL BLOOD.     
% 215.14/215.35  |- mesh__historyNote mesh__D005311 2006 %28%1975%29%   
% 215.14/215.35  |- mesh__recordAuthorizer mesh__D005311 sjn
% 215.14/215.35  |- mesh__dateEstablished mesh__D005311 1975-09-01
% 215.14/215.35  |- skos__hiddenLabel mesh__D005311 Hypoxia, Fetal
% 215.14/215.35  |- skos__broader mesh__D005311smesh__D005315
% 215.14/215.35  |- mesh__dateRevised mesh__D005311 2005-06-30
% 215.14/215.35  |- rdf__type mesh__D005311sskos__Concept
% 215.14/215.35  |- skos__historyNote mesh__D005311 Fetal Diseases %28%1966-1974%29%
% 215.14/215.35  |- skos__related mesh__D005311smesh__D001238
% 215.14/215.35  |- mesh__recordOriginator mesh__D005311 NLM
% 215.14/215.35  |- mesh__recordAuthorizer mesh__D046728 sjn
% 215.14/215.35  |- mesh__publicMeSHNote mesh__D046728 2005   
% 215.14/215.35  |- skos__prefLabel mesh__D046728 Colitis, Microscopic
% 215.14/215.35  |- mesh__historyNote mesh__D046728 2005   
% 215.14/215.35  |- mesh__dateEstablished mesh__D046728 2005-01-01
% 215.14/215.35  |- skos__scopeNote mesh__D046728
% 215.14/215.35       A condition characterized by chronic watery DIARRHEA of unknown origin, a normal COLONOSCOPY but abnormal histopathology on BIOPSY. This syndrome was first described in 1980 by Read and associates. Subtypes include COLLAGENOUS COLITIS and LYMPHOCYTIC COLITIS. Both have similar clinical symptoms and are distinguishable only by histology.%A%    
% 215.14/215.35  |- mesh__recordOriginator mesh__D046728 lkt
% 215.14/215.35  |- rdf__type mesh__D046728sskos__Concept
% 215.14/215.35  |- skos__historyNote mesh__D046728 Colitis, Ulcerative %28%1965-2004%29%
% 215.14/215.35  |- skos__broader mesh__D046728smesh__D003092
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D046728 2005
% 215.14/215.35  |- mesh__dateCreated mesh__D046728 2004-07-07
% 215.14/215.35  |- skos__historyNote mesh__D046728 Colitis %28%1971-2004%29%
% 215.14/215.35  |- mesh__recordMaintainer mesh__D046728 lkt
% 215.14/215.35  |- skos__altLabel mesh__D046728 Microscopic Colitis
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D046728 2006
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D018239 1996
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D018239 2004
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D018239 2005
% 215.14/215.35  |- rdf__type mesh__D018239sskos__Concept
% 215.14/215.35  |- mesh__recordMaintainer mesh__D018239 KEV
% 215.14/215.35  |- skos__prefLabel mesh__D018239 Seminoma
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D018239 2000
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D018239 2003
% 215.14/215.35  |- skos__broader mesh__D018239smesh__D018237
% 215.14/215.35  |- skos__hiddenLabel mesh__D018239 Seminomas
% 215.14/215.35  |- skos__historyNote mesh__D018239 Dysgerminoma %28%1966-1993%29%
% 215.14/215.35  |- skos__annotation mesh__D018239
% 215.14/215.35       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with TESTICULAR NEOPLASMS %28%IM%29%%A%  
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D018239 2002
% 215.14/215.35  |- mesh__recordOriginator mesh__D018239 PLS
% 215.14/215.35  |- mesh__recordAuthorizer mesh__D018239 PLS
% 215.14/215.35  |- mesh__onlineNote mesh__D018239
% 215.14/215.35       use DYSGERMINOMA to search SEMINOMA 1979-93   
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D018239 1999
% 215.14/215.35  |- mesh__dateCreated mesh__D018239 1993-06-25
% 215.14/215.35  |- skos__scopeNote mesh__D018239
% 215.14/215.35       A radiosensitive, malignant neoplasm of the testis, thought to be derived from primordial germ cells of the sexually undifferentiated embryonic gonad. There are three variants: classical %28%typical%29%, the most common type; anaplastic; and spermatocytic. The classical seminoma is composed of fairly well differentiated sheets or cords of uniform polygonal or round cells %28%seminoma cells%29%, each cell having abundant clear cytoplasm, distinct cell membranes, a centrally placed round nucleus, and one or more nucleoli. In the female, a grossly and histologically identical neoplasm, known as dysgerminoma, occurs. %28%Dorland, 27th ed%29%%A%    
% 215.14/215.35  |- mesh__publicMeSHNote mesh__D018239 94; was see DYSGERMINOMA 1979-93   
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D018239 1997
% 215.14/215.35  |- mesh__dateRevised mesh__D018239 1995-06-08
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D018239 1998
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D018239 2006
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D018239 2001
% 215.14/215.35  |- mesh__dateEstablished mesh__D018239 1994-01-01
% 215.14/215.35  |- mesh__historyNote mesh__D018239 94; was see DYSGERMINOMA 1979-93   
% 215.14/215.35  |- skos__scopeNote mesh__D010256
% 215.14/215.35       Air-filled extensions of the respiratory part of the nasal cavity into the frontal, ethmoid, sphenoid, and maxillary cranial bones. They vary in size and form in different individuals and are lined by the ciliated mucous membranes of the nasal cavity.%A%    
% 215.14/215.35  |- skos__broader mesh__D010256smesh__D009666
% 215.14/215.35  |- mesh__recordOriginator mesh__D010256 NLM
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D010256 2003
% 215.14/215.35  |- skos__annotation mesh__D010256
% 215.14/215.35       GEN: prefer specifics; inflammation = SINUSITIS but do not add PARANASAL SINUSES for %22%paranasal%22% or %22%nasal%22% sinusitis%A%  
% 215.14/215.35  |- skos__prefLabel mesh__D010256 Paranasal Sinuses
% 215.14/215.35  |- skos__hiddenLabel mesh__D010256 Sinuses, Nasal
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D010256 1998
% 215.14/215.35  |- mesh__recordMaintainer mesh__D010256 PXP
% 215.14/215.35  |- skos__hiddenLabel mesh__D010256 Sinuses, Paranasal
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D010256 2002
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D010256 1997
% 215.14/215.35  |- mesh__dateCreated mesh__D010256 1999-01-01
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D010256 2001
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D010256 1996
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D010256 2006
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D010256 2000
% 215.14/215.35  |- skos__altLabel mesh__D010256 Nasal Sinuses
% 215.14/215.35  |- mesh__recordAuthorizer mesh__D010256 PLS
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D010256 2005
% 215.14/215.35  |- mesh__dateRevised mesh__D010256 1994-05-23
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D010256 1995
% 215.14/215.35  |- rdf__type mesh__D010256sskos__Concept
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D010256 2004
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D010256 1999
% 215.14/215.35  |- skos__altLabel mesh__D004219 Washington, D.C.
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D004219 2000
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D004219 1998
% 215.14/215.35  |- rdf__type mesh__D004219sskos__Concept
% 215.14/215.35  |- skos__prefLabel mesh__D004219 District of Columbia
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D004219 2001
% 215.14/215.35  |- skos__scopeNote mesh__D004219
% 215.14/215.35       A federal area located between Maryland and Virginia on the Potomac river; it is coextensive with Washington, D.C., which is the capital of the United States.%A%    
% 215.14/215.35  |- skos__broader mesh__D004219smesh__D002947
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D004219 2003
% 215.14/215.35  |- mesh__dateRevised mesh__D004219 1997-06-20
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D004219 1999
% 215.14/215.35  |- skos__altLabel mesh__D004219 Washington, DC
% 215.14/215.35  |- mesh__dateCreated mesh__D004219 1999-01-01
% 215.14/215.35  |- skos__broader mesh__D004219smesh__D008873
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D004219 2005
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D004219 2004
% 215.14/215.35  |- mesh__recordAuthorizer mesh__D004219 SJN
% 215.14/215.35  |- skos__annotation mesh__D004219
% 215.14/215.35       = the Federal district; city is Washington, D.C.   
% 215.14/215.35  |- mesh__recordMaintainer mesh__D004219 PXP
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D004219 2002
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D004219 2006
% 215.14/215.35  |- mesh__recordOriginator mesh__D004219 NLM
% 215.14/215.35  |- skos__broader mesh__D000059Q000517smesh__D000059
% 215.14/215.35  |- mesh__preferredCombination mesh__D000059Q000517smesh__D000056
% 215.14/215.35  |- rdf__type mesh__D000059Q000517smesh__CompoundConcept
% 215.14/215.35  |- skos__broader mesh__D009702smesh__D003854
% 215.14/215.35  |- skos__historyNote mesh__D009702 specific carbohydrate %28%1966-1972%29%
% 215.14/215.35  |- mesh__historyNote mesh__D009702 73%28%71%29%   
% 215.14/215.35  |- skos__broader mesh__D009702smesh__D012265
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D009702 2005
% 215.14/215.35  |- mesh__dateEstablished mesh__D009702 1973-01-01
% 215.14/215.35  |- skos__hiddenLabel mesh__D009702 Diphosphate Sugars, Nucleoside
% 215.14/215.35  |- skos__prefLabel mesh__D009702 Nucleoside Diphosphate Sugars
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D009702 2006
% 215.14/215.35  |- mesh__dateCreated mesh__D009702 1999-01-01
% 215.14/215.35  |- skos__broader mesh__D009702smesh__D009711
% 215.14/215.35  |- mesh__publicMeSHNote mesh__D009702 73   
% 215.14/215.35  |- mesh__dateRevised mesh__D009702 2004-07-07
% 215.14/215.35  |- mesh__recordMaintainer mesh__D009702 ssb
% 215.14/215.35  |- skos__historyNote mesh__D009702 specific nucleotide %28%1966-1972%29%
% 215.14/215.35  |- mesh__recordAuthorizer mesh__D009702 sjn
% 215.14/215.35  |- mesh__recordOriginator mesh__D009702 NLM
% 215.14/215.35  |- rdf__type mesh__D009702sskos__Concept
% 215.14/215.35  |- skos__hiddenLabel mesh__D009702 Sugars, Nucleoside Diphosphate
% 215.14/215.35  |- skos__hiddenLabel mesh__D020684 Cystoscope
% 215.14/215.35  |- mesh__historyNote mesh__D020684 2000; use ENDOSCOPES 1998-1999   
% 215.14/215.35  |- mesh__dateEstablished mesh__D020684 2000-01-01
% 215.14/215.35  |- rdf__type mesh__D020684sskos__Concept
% 215.14/215.35  |- mesh__publicMeSHNote mesh__D020684 2000; see ENDOSCOPES 1998-1999   
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D020684 2002
% 215.14/215.35  |- skos__historyNote mesh__D020684 Endoscopes %28%1998-1999%29%
% 215.14/215.35  |- skos__prefLabel mesh__D020684 Cystoscopes
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D020684 2006
% 215.14/215.35  |- skos__broader mesh__D020684smesh__D019723
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D020684 2004
% 215.14/215.35  |- skos__scopeNote mesh__D020684
% 215.14/215.35       Endoscopes for visual examination of the urinary bladder.%A%    
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D020684 2005
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D020684 2001
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D020684 2003
% 215.14/215.35  |- mesh__dateCreated mesh__D020684 1999-11-03
% 215.14/215.35  |- skos__historyNote mesh__D020684
% 215.14/215.35       Cystoscopy/instrumentation %28%1966-1999%29%
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D020684 2000
% 215.14/215.35  |- skos__broader mesh__D014647smesh__D007871
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014647 2005
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014647 1997
% 215.14/215.35  |- skos__hiddenLabel mesh__D014647 Ulcers, Stasis
% 215.14/215.35  |- skos__altLabel mesh__D014647 Venous Ulcer
% 215.14/215.35  |- mesh__recordMaintainer mesh__D014647 PLS
% 215.14/215.35  |- skos__hiddenLabel mesh__D014647 Ulcer, Varicose
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014647 2001
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014647 2006
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014647 1998
% 215.14/215.35  |- skos__hiddenLabel mesh__D014647 Stasis Ulcers
% 215.14/215.35  |- skos__hiddenLabel mesh__D014647 Ulcer, Venous
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014647 2002
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014647 1993
% 215.14/215.35  |- skos__broader mesh__D014647smesh__D014648
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014647 1999
% 215.14/215.35  |- mesh__dateCreated mesh__D014647 1999-01-01
% 215.14/215.35  |- skos__hiddenLabel mesh__D014647 Ulcers, Venous
% 215.14/215.35  |- skos__hiddenLabel mesh__D014647 Ulcer, Stasis
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014647 1994
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014647 2003
% 215.14/215.35  |- skos__hiddenLabel mesh__D014647 Venous Ulcers
% 215.14/215.35  |- mesh__recordOriginator mesh__D014647 NLM
% 215.14/215.35  |- skos__hiddenLabel mesh__D014647 Ulcers, Varicose
% 215.14/215.35  |- skos__prefLabel mesh__D014647 Varicose Ulcer
% 215.14/215.35  |- rdf__type mesh__D014647sskos__Concept
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014647 2004
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014647 1996
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014647 1995
% 215.14/215.35  |- mesh__recordAuthorizer mesh__D014647 PLS
% 215.14/215.35  |- skos__annotation mesh__D014647
% 215.14/215.35       assume to be of legs %26% do not coord with LEG ULCER   
% 215.14/215.35  |- skos__scopeNote mesh__D014647
% 215.14/215.35       Ulcer due to varicose veins. Chronic venous insufficiency in the deep veins of the legs leads to shunting the venous return into the superficial veins, in which pressure and flow rate, as well as oxygen content, are increased.%A%    
% 215.14/215.35  |- mesh__dateRevised mesh__D014647 1992-05-22
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D014647 2000
% 215.14/215.35  |- skos__hiddenLabel mesh__D014647 Varicose Ulcers
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D000627 2002
% 215.14/215.35  |- mesh__dateCreated mesh__D000627 1977-12-08
% 215.14/215.35  |- skos__historyNote mesh__D000627 Phenols %28%1966-1978%29%
% 215.14/215.35  |- mesh__recordOriginator mesh__D000627 RLS
% 215.14/215.35  |- skos__historyNote mesh__D000627 Aniline Compounds %28%1966-1978%29%
% 215.14/215.35  |- skos__broader mesh__D000627smesh__D000814
% 215.14/215.35  |- skos__broader mesh__D000627smesh__D010636
% 215.14/215.35  |- skos__prefLabel mesh__D000627 Aminophenols
% 215.14/215.35  |- skos__altLabel mesh__D000627 Hydroxyanilines
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D000627 1994
% 215.14/215.35  |- skos__scopeNote mesh__D000627
% 215.14/215.35       Phenols substituted in any position by an amino group.     
% 215.14/215.35  |- mesh__recordAuthorizer mesh__D000627 PLS
% 215.14/215.35  |- mesh__recordMaintainer mesh__D000627 TGC
% 215.14/215.35  |- rdf__type mesh__D000627sskos__Concept
% 215.14/215.35  |- mesh__dateEstablished mesh__D000627 1979-01-01
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D000627 2000
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D000627 2005
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D000627 1998
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D000627 1995
% 215.14/215.35  |- skos__historyNote mesh__D000627 Amines %28%1966-1978%29%
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D000627 2003
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D000627 1996
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D000627 1993
% 215.14/215.35  |- mesh__dateRevised mesh__D000627 1992-05-07
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D000627 2006
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D000627 1999
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D000627 2001
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D000627 2004
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D000627 1997
% 215.14/215.35  |- mesh__publicMeSHNote mesh__D000627
% 215.14/215.35       79; PHENETIDINE was see under ANILINE COMPOUNDS 1975-78   
% 215.14/215.35  |- mesh__historyNote mesh__D000627 79   
% 215.14/215.35  |- skos__hiddenLabel mesh__D019332 Big Endothelin 1
% 215.14/215.35  |- skos__scopeNote mesh__D019332
% 215.14/215.35       A 21-amino acid peptide produced in a variety of tissues including endothelial and vascular smooth-muscle cells, neurons and astrocytes in the central nervous system, and endometrial cells. It acts as a modulator of vasomotor tone, cell proliferation, and hormone production. %28%N Eng J Med 1995;333%28%6%29%:356-63%29%%A%    
% 215.14/215.35  |- rdf__type mesh__D019332sskos__Concept
% 215.14/215.35  |- mesh__historyNote mesh__D019332
% 215.14/215.35       2004%28%1997%29%; use ENDOTHELINS 1991-96; for BIG ENDOTHELIN use ENDOTHELIN-1 %28%NM%29% 1990-2003; for PREPROENDOLTHELIN use ENDOTHELINS-1 %28%NM%29% 1989-2003%A%  
% 215.14/215.35  |- skos__altLabel mesh__D019332 ET-1 %28%Endothelin-1%29%
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D019332 2006
% 215.14/215.35  |- skos__prefLabel mesh__D019332 Endothelin-1
% 215.14/215.35  |- skos__hiddenLabel mesh__D019332 Preproendothelin 1
% 215.14/215.35  |- skos__altLabel mesh__D019332 Preproendothelin
% 215.14/215.35  |- skos__altLabel mesh__D019332 Big Endothelin-1
% 215.14/215.35  |- skos__hiddenLabel mesh__D019332 Endothelin 1
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D019332 2005
% 215.14/215.35  |- skos__altLabel mesh__D019332 Big Endothelin
% 215.14/215.35  |- mesh__recordOriginator mesh__D019332 TPW
% 215.14/215.35  |- skos__historyNote mesh__D019332 Endothelins %28%1991-1996%29%
% 215.14/215.35  |- skos__hiddenLabel mesh__D019332 Proendothelin 1 Precursor
% 215.14/215.35  |- mesh__activeMeSHYear mesh__D019332 2004
% 215.14/215.35  |- skos__altLabel mesh__D019332 Proendothelin-1 Precursor
% 215.14/215.35  |- skos__broader mesh__D019332smesh__D016232
% 215.14/215.35  |- skos__hiddenLabel mesh__D019332 Endothelin-1, Big
% 215.14/215.36  |- mesh__dateEstablished mesh__D019332 1997-01-01
% 215.14/215.36  |- mesh__dateCreated mesh__D019332 1996-06-10
% 215.14/215.36  |- mesh__recordAuthorizer mesh__D019332 sjn
% 215.14/215.36  |- skos__altLabel mesh__D019332 Endothelin, Big
% 215.14/215.36  |- skos__hiddenLabel mesh__D019332 Precursor, Proendothelin-1
% 215.14/215.36  |- skos__altLabel mesh__D019332 Endothelin Type 1
% 215.14/215.36  |- mesh__dateRevised mesh__D019332 2003-07-09
% 215.14/215.36  |- mesh__publicMeSHNote mesh__D019332
% 215.14/215.36       2004; see ENDOTHELINS 1991-1996; BIG ENDOTHELIN was indexed under ENDTHELINS %26% PROTEIN PRECUSORS 1991-2003; under PEPTIDES 1990; PREPROENDOTHELIN was indexed under ENDOTHELINS %26% PROTEIN PRECUSORS 1989-2003%A%  
% 215.14/215.36  |- skos__annotation mesh__D019332 /drug eff permitted   
% 215.14/215.36  |- mesh__recordMaintainer mesh__D019332 jmp
% 215.14/215.36  |- mesh__recordOriginator mesh__D033003 jrf
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D033003 2003
% 215.14/215.36  |- mesh__historyNote mesh__D033003
% 215.14/215.36       2003; for EASTERN ORTHODOX ETHICS use CHRISTIANITY 1992-2002%A%  
% 215.14/215.36  |- mesh__dateCreated mesh__D033003 2002-07-02
% 215.14/215.36  |- skos__historyNote mesh__D033003 Christianity %28%1979-2002%29%
% 215.14/215.36  |- mesh__publicMeSHNote mesh__D033003 2003   
% 215.14/215.36  |- skos__prefLabel mesh__D033003 Eastern Orthodoxy
% 215.14/215.36  |- rdf__type mesh__D033003sskos__Concept
% 215.14/215.36  |- skos__hiddenLabel mesh__D033003 Orthodoxy, Russian
% 215.14/215.36  |- mesh__dateEstablished mesh__D033003 2003-01-01
% 215.14/215.36  |- skos__scopeNote mesh__D033003
% 215.14/215.36       The name given to the religion of the body of modern churches, including among others the Greek and Russian Orthodox, that is derived from the church of the Byzantine Empire, adheres to the Byzantine rite, and acknowledges the honorary primacy of the patriarch of Constantinople. %28%from American Heritage Dictionary of the English Language, 4th ed%29%%A%    
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D033003 2006
% 215.14/215.36  |- skos__hiddenLabel mesh__D033003 Orthodoxy, Eastern
% 215.14/215.36  |- skos__hiddenLabel mesh__D033003 Ethics, Eastern Orthodox
% 215.14/215.36  |- skos__hiddenLabel mesh__D033003 Orthodoxy, Syrian
% 215.14/215.36  |- skos__hiddenLabel mesh__D033003 Orthodoxy, Armenian
% 215.14/215.36  |- mesh__recordAuthorizer mesh__D033003 sjn
% 215.14/215.36  |- skos__hiddenLabel mesh__D033003 Orthodoxy, Serbian
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D033003 2005
% 215.14/215.36  |- skos__annotation mesh__D033003 specify geog if pertinent   
% 215.14/215.36  |- mesh__recordMaintainer mesh__D033003 jrf
% 215.14/215.36  |- skos__broader mesh__D033003smesh__D002835
% 215.14/215.36  |- skos__hiddenLabel mesh__D033003 Orthodoxy, Greek
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D033003 2004
% 215.14/215.36  |- skos__hiddenLabel mesh__D005312 Blood, Cord
% 215.14/215.36  |- skos__hiddenLabel mesh__D005312 Cord Bloods, Umbilical
% 215.14/215.36  |- skos__prefLabel mesh__D005312 Fetal Blood
% 215.14/215.36  |- mesh__dateRevised mesh__D005312 2005-06-30
% 215.14/215.36  |- skos__hiddenLabel mesh__D005312 Fetal Bloods
% 215.14/215.36  |- skos__hiddenLabel mesh__D005312 Umbilical Cord Bloods
% 215.14/215.36  |- skos__hiddenLabel mesh__D005312 Cord Blood, Umbilical
% 215.14/215.36  |- skos__hiddenLabel mesh__D005312 Bloods, Umbilical Cord
% 215.14/215.36  |- mesh__recordOriginator mesh__D005312 NLM
% 215.14/215.36  |- skos__hiddenLabel mesh__D005312 Blood, Umbilical Cord
% 215.14/215.36  |- mesh__recordMaintainer mesh__D005312 ags
% 215.14/215.36  |- skos__hiddenLabel mesh__D005312 Cord Bloods
% 215.14/215.36  |- mesh__publicMeSHNote mesh__D005312 75   
% 215.14/215.36  |- skos__hiddenLabel mesh__D005312 Bloods, Cord
% 215.14/215.36  |- skos__broader mesh__D005312smesh__D005333
% 215.14/215.36  |- skos__hiddenLabel mesh__D005312 Bloods, Fetal
% 215.14/215.36  |- skos__broader mesh__D005312smesh__D001769
% 215.14/215.36  |- mesh__dateEstablished mesh__D005312 1975-09-01
% 215.14/215.36  |- mesh__historyNote mesh__D005312 75   
% 215.14/215.36  |- rdf__type mesh__D005312sskos__Concept
% 215.14/215.36  |- skos__hiddenLabel mesh__D005312 Blood, Fetal
% 215.14/215.36  |- mesh__dateCreated mesh__D005312 1974-11-19
% 215.14/215.36  |- mesh__recordAuthorizer mesh__D005312 sjn
% 215.14/215.36  |- skos__annotation mesh__D005312
% 215.14/215.36       /transpl: consider also CORD BLOOD STEM CELL TRANSPLANTATION%A%  
% 215.14/215.36  |- skos__scopeNote mesh__D005312
% 215.14/215.36       Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels %28%UMBILICAL CORD%29% at the time of delivery.%A%    
% 215.14/215.36  |- skos__historyNote mesh__D005312 Umbilical Cord %28%1966-1974%29%
% 215.14/215.36  |- skos__altLabel mesh__D005312 Umbilical Cord Blood
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D005312 2006
% 215.14/215.36  |- mesh__recordMaintainer mesh__D046729 lkt
% 215.14/215.36  |- skos__broader mesh__D046729smesh__D046728
% 215.14/215.36  |- skos__prefLabel mesh__D046729 Colitis, Collagenous
% 215.14/215.36  |- mesh__recordOriginator mesh__D046729 lkt
% 215.14/215.36  |- mesh__recordAuthorizer mesh__D046729 sjn
% 215.14/215.36  |- mesh__historyNote mesh__D046729 2005   
% 215.14/215.36  |- rdf__type mesh__D046729sskos__Concept
% 215.14/215.36  |- skos__altLabel mesh__D046729 Collagenous Colitis
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D046729 2005
% 215.14/215.36  |- mesh__dateEstablished mesh__D046729 2005-01-01
% 215.14/215.36  |- mesh__dateCreated mesh__D046729 2004-07-07
% 215.14/215.36  |- skos__historyNote mesh__D046729 Colitis %28%1976-2004%29%
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D046729 2006
% 215.14/215.36  |- mesh__publicMeSHNote mesh__D046729 2005   
% 215.14/215.36  |- skos__scopeNote mesh__D046729
% 215.14/215.36       A subtype of MICROSCOPIC COLITIS, characterized by chronic watery DIARRHEA of unknown origin, a normal COLONOSCOPY but abnormal histopathology on BIOPSY. Microscopic examination of biopsy samples taken from the COLON show larger-than-normal band of subepithelial COLLAGEN.%A%    
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D029760 2006
% 215.14/215.36  |- rdf__type mesh__D029760sskos__Concept
% 215.14/215.36  |- mesh__dateCreated mesh__D029760 2001-07-25
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D029760 2002
% 215.14/215.36  |- mesh__publicMeSHNote mesh__D029760 2002   
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D029760 2004
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D029760 2005
% 215.14/215.36  |- skos__broader mesh__D029760smesh__D028084
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D029760 2003
% 215.14/215.36  |- skos__scopeNote mesh__D029760
% 215.14/215.36       A plant genus of the family CLUSIACEAE.     
% 215.14/215.36  |- skos__annotation mesh__D029760
% 215.14/215.36       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.14/215.36  |- mesh__historyNote mesh__D029760 2002   
% 215.14/215.36  |- mesh__dateEstablished mesh__D029760 2002-01-01
% 215.14/215.36  |- skos__prefLabel mesh__D029760 Garcinia
% 215.14/215.36  |- skos__annotation mesh__D010257
% 215.14/215.36       do not use /blood supply /chem /secret /ultrastruct   
% 215.14/215.36  |- mesh__dateRevised mesh__D010257 1999-11-05
% 215.14/215.36  |- skos__hiddenLabel mesh__D010257 Syndromes, Paraneoplastic
% 215.14/215.36  |- mesh__dateCreated mesh__D010257 1979-05-25
% 215.14/215.36  |- skos__hiddenLabel mesh__D010257 Paraneoplastic Syndrome
% 215.14/215.36  |- mesh__publicMeSHNote mesh__D010257 80   
% 215.14/215.36  |- skos__scopeNote mesh__D010257
% 215.14/215.36       In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products.%A%    
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D010257 2006
% 215.14/215.36  |- mesh__recordMaintainer mesh__D010257 KEV
% 215.14/215.36  |- mesh__historyNote mesh__D010257 80   
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D010257 2002
% 215.14/215.36  |- skos__hiddenLabel mesh__D010257 Syndrome, Paraneoplastic
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D010257 2005
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D010257 2001
% 215.14/215.36  |- rdf__type mesh__D010257sskos__Concept
% 215.14/215.36  |- mesh__dateEstablished mesh__D010257 1980-01-01
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D010257 2004
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D010257 2000
% 215.14/215.36  |- skos__broader mesh__D010257smesh__D009369
% 215.14/215.36  |- mesh__recordAuthorizer mesh__D010257 sjn
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D010257 2003
% 215.14/215.36  |- skos__prefLabel mesh__D010257 Paraneoplastic Syndromes
% 215.14/215.36  |- mesh__recordOriginator mesh__D010257 VDK
% 215.14/215.36  |- skos__historyNote mesh__D015740 Nerve Tissue Proteins %28%1966-1986%29%
% 215.14/215.36  |- mesh__recordAuthorizer mesh__D015740 sjn
% 215.14/215.36  |- skos__hiddenLabel mesh__D015740 Gene-Related Peptide, Calcitonin
% 215.14/215.36  |- mesh__dateEstablished mesh__D015740 1990-01-01
% 215.14/215.36  |- skos__annotation mesh__D015740 DF: CGRP   
% 215.14/215.36  |- mesh__dateCreated mesh__D015740 1989-05-15
% 215.14/215.36  |- skos__prefLabel mesh__D015740 Calcitonin Gene-Related Peptide
% 215.14/215.36  |- skos__scopeNote mesh__D015740
% 215.14/215.36       Calcitonin gene-related peptide. A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in neural tissue of the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator.%A%    
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D015740 2006
% 215.14/215.36  |- skos__related mesh__D015740smesh__D018015
% 215.14/215.36  |- mesh__dateRevised mesh__D015740 2005-06-30
% 215.14/215.36  |- skos__hiddenLabel mesh__D015740 beta CGRP
% 215.14/215.36  |- skos__hiddenLabel mesh__D015740 alpha CGRP
% 215.14/215.36  |- mesh__historyNote mesh__D015740 90   
% 215.14/215.36  |- skos__hiddenLabel mesh__D015740 Calcitonin Gene Related Peptide I
% 215.14/215.36  |- skos__hiddenLabel mesh__D015740 Peptide, Calcitonin Gene-Related
% 215.14/215.36  |- mesh__recordOriginator mesh__D015740 RLS
% 215.14/215.36  |- skos__hiddenLabel mesh__D015740 Calcitonin Gene Related Peptide II
% 215.14/215.36  |- mesh__recordMaintainer mesh__D015740 ssb
% 215.14/215.36  |- skos__historyNote mesh__D015740 Neuropeptides %28%1987-1989%29%
% 215.14/215.36  |- skos__broader mesh__D015740smesh__D009479
% 215.14/215.36  |- skos__hiddenLabel mesh__D015740 Calcitonin Gene Related Peptide
% 215.14/215.36  |- rdf__type mesh__D015740sskos__Concept
% 215.14/215.36  |- mesh__publicMeSHNote mesh__D015740 90   
% 215.14/215.36  |- mesh__onlineNote mesh__D009703
% 215.14/215.36       use NUCLEOSIDE-PHOSPHATE KINASE to search NUCLEOSIDE MONOPHOSPHATE KINASES 1977-93%A%  
% 215.14/215.36  |- skos__hiddenLabel mesh__D009703 Kinase, Nucleoside-Phosphate
% 215.14/215.36  |- skos__historyNote mesh__D009703 Nucleotides %28%1966-1976%29%
% 215.14/215.36  |- mesh__dateEstablished mesh__D009703 1991-01-01
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D009703 2006
% 215.14/215.36  |- mesh__recordMaintainer mesh__D009703 ssb
% 215.14/215.36  |- skos__scopeNote mesh__D009703
% 215.14/215.36       An enzyme that catalyzes reversible reactions of a nucleoside triphosphate, e.g., ATP, with a nucleoside monophosphate, e.g., UMP, to form ADP and UDP. Many nucleoside monophosphates can act as acceptor while many ribo- and deoxyribonucleoside triphosphates can act as donor. EC 2.7.4.4.%A%    
% 215.14/215.36  |- mesh__dateCreated mesh__D009703 1976-05-19
% 215.14/215.36  |- skos__hiddenLabel mesh__D009703 Kinases, Nucleoside Monophosphate
% 215.14/215.36  |- mesh__recordAuthorizer mesh__D009703 sjn
% 215.14/215.36  |- skos__hiddenLabel mesh__D009703 Monophosphate Kinases, Nucleoside
% 215.14/215.36  |- skos__broader mesh__D009703smesh__D017856
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D009703 2004
% 215.14/215.36  |- skos__altLabel mesh__D009703 Nucleoside Monophosphate Kinases
% 215.14/215.36  |- skos__hiddenLabel mesh__D009703 Nucleoside Phosphate Kinase
% 215.14/215.36  |- skos__historyNote mesh__D009703 Phosphotransferases %28%1966-1973%29%
% 215.14/215.36  |- mesh__historyNote mesh__D009703
% 215.14/215.36       94; was NUCLEOSIDE MONOPHOSPHATE KINASES 1977-93 %28%see under PHOSPHOTRANSFERASES, ATP 1977-90%29%%A%  
% 215.14/215.36  |- rdf__type mesh__D009703sskos__Concept
% 215.14/215.36  |- mesh__dateRevised mesh__D009703 2003-07-09
% 215.14/215.36  |- mesh__publicMeSHNote mesh__D009703
% 215.14/215.36       94; was NUCLEOSIDE MONOPHOSPHATE KINASES 1977-93 %28%see under PHOSPHOTRANSFERASES, ATP 1977-90%29%%A%  
% 215.14/215.36  |- skos__prefLabel mesh__D009703 Nucleoside-Phosphate Kinase
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D009703 2005
% 215.14/215.36  |- skos__historyNote mesh__D009703
% 215.14/215.36       Phosphotransferases, ATP %28%1974-1976%29%
% 215.14/215.36  |- mesh__recordOriginator mesh__D009703 RLS
% 215.14/215.36  |- mesh__dateCreated mesh__D001720 1999-01-01
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D001720 2004
% 215.14/215.36  |- skos__altLabel mesh__D001720 Injuries, Birth
% 215.14/215.36  |- skos__annotation mesh__D001720
% 215.14/215.36       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: BIRTH INJ%A%  
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D001720 2002
% 215.14/215.36  |- mesh__publicMeSHNote mesh__D001720 73; was BIRTH INJURY 1963-72   
% 215.14/215.36  |- skos__scopeNote mesh__D001720
% 215.14/215.36       Mechanical or anoxic trauma incurred by the infant during labor or delivery.%A%    
% 215.14/215.36  |- mesh__recordOriginator mesh__D001720 NLM
% 215.14/215.36  |- mesh__onlineNote mesh__D001720
% 215.14/215.36       use BIRTH INJURIES to search BIRTH INJURY 1966-72   
% 215.14/215.36  |- skos__broader mesh__D001720smesh__D007232
% 215.14/215.36  |- skos__hiddenLabel mesh__D001720 Injury, Birth
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D001720 2005
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D001720 2000
% 215.14/215.36  |- mesh__recordAuthorizer mesh__D001720 sjn
% 215.14/215.36  |- skos__hiddenLabel mesh__D001720 Birth Injury
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D001720 2006
% 215.14/215.36  |- skos__prefLabel mesh__D001720 Birth Injuries
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D001720 2001
% 215.14/215.36  |- mesh__dateRevised mesh__D001720 1999-11-03
% 215.14/215.36  |- skos__broader mesh__D001720smesh__D014947
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D001720 2003
% 215.14/215.36  |- mesh__recordMaintainer mesh__D001720 kle
% 215.14/215.36  |- rdf__type mesh__D001720sskos__Concept
% 215.14/215.36  |- mesh__dateEstablished mesh__D001720 1973-01-01
% 215.14/215.36  |- mesh__historyNote mesh__D001720 73; was BIRTH INJURY 1963-72   
% 215.14/215.36  |- mesh__dateEstablished mesh__D020685 2000-01-01
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D020685 2006
% 215.14/215.36  |- mesh__publicMeSHNote mesh__D020685 2000; see ENDOSCOPES 1998-1999   
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D020685 2001
% 215.14/215.36  |- skos__historyNote mesh__D020685
% 215.14/215.36       Colonoscopy/instrumentation %28%1966-1999%29%
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D020685 2004
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D020685 2005
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D020685 2000
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D020685 2003
% 215.14/215.36  |- skos__hiddenLabel mesh__D020685 Colonoscope
% 215.14/215.36  |- skos__scopeNote mesh__D020685
% 215.14/215.36       Specially designed endoscopes for visualizing the interior surface of the colon.%A%    
% 215.14/215.36  |- skos__broader mesh__D020685smesh__D020776
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D020685 2002
% 215.14/215.36  |- skos__historyNote mesh__D020685 Endoscopes %28%1998-1999%29%
% 215.14/215.36  |- mesh__historyNote mesh__D020685 2000; use ENDOSCOPES 1998-1999   
% 215.14/215.36  |- rdf__type mesh__D020685sskos__Concept
% 215.14/215.36  |- skos__prefLabel mesh__D020685 Colonoscopes
% 215.14/215.36  |- mesh__dateCreated mesh__D020685 1999-11-03
% 215.14/215.36  |- rdf__type mesh__D014648sskos__Concept
% 215.14/215.36  |- mesh__recordOriginator mesh__D014648 NLM
% 215.14/215.36  |- skos__related mesh__D014648smesh__D012597
% 215.14/215.36  |- skos__altLabel mesh__D014648 Varix
% 215.14/215.36  |- skos__related mesh__D014648smesh__D015911
% 215.14/215.36  |- skos__hiddenLabel mesh__D014648 Vein, Varicose
% 215.14/215.36  |- mesh__recordAuthorizer mesh__D014648 sjn
% 215.14/215.36  |- mesh__dateCreated mesh__D014648 1999-01-01
% 215.14/215.36  |- skos__broader mesh__D014648smesh__D014652
% 215.14/215.36  |- skos__hiddenLabel mesh__D014648 Veins, Varicose
% 215.14/215.36  |- skos__annotation mesh__D014648
% 215.14/215.36       assume to be of legs so do not coord with LEG; other sites: coord VARICOSE VEINS %28%IM%29% + organ /blood supply %28%IM%29%, not organ/dis, as orbit varix = VARICOSE VEINS %28%IM%29% + ORBIT /blood supply %28%IM%29% %28%not ORBITAL DISEASES%29%%A%  
% 215.14/215.36  |- skos__hiddenLabel mesh__D014648 Varicose Vein
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D014648 2006
% 215.14/215.36  |- skos__altLabel mesh__D014648 Varices
% 215.14/215.36  |- mesh__dateRevised mesh__D014648 2003-07-09
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D014648 2005
% 215.14/215.36  |- skos__scopeNote mesh__D014648 Enlarged and tortuous VEINS.     
% 215.14/215.36  |- skos__related mesh__D014648smesh__D004932
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D014648 2004
% 215.14/215.36  |- skos__prefLabel mesh__D014648 Varicose Veins
% 215.14/215.36  |- mesh__recordMaintainer mesh__D014648 lkt
% 215.14/215.36  |- skos__annotation mesh__D019333
% 215.14/215.36       /drug eff permitted; DF: note short X ref   
% 215.14/215.36  |- skos__scopeNote mesh__D019333
% 215.14/215.36       A 21-amino acid peptide produced predominantly within the kidney and intestine, with smaller amounts produced in the myocardium, placenta, and uterus, but the cells of origin are not clear. Endothelin-2 has no unique physiologic functions, as compared with endothelin-1. %28%N Eng J Med 1995;333%28%6%29%:356-63%29%%A%    
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D019333 2005
% 215.14/215.36  |- skos__historyNote mesh__D019333 Endothelins %28%1991-1996%29%
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D019333 2004
% 215.14/215.36  |- skos__broader mesh__D019333smesh__D016232
% 215.14/215.36  |- skos__prefLabel mesh__D019333 Endothelin-2
% 215.14/215.36  |- skos__altLabel mesh__D019333 ET-2
% 215.14/215.36  |- mesh__publicMeSHNote mesh__D019333 97; was see ENDOTHELINS 1991-96   
% 215.14/215.36  |- mesh__recordOriginator mesh__D019333 TPW
% 215.14/215.36  |- mesh__onlineNote mesh__D019333
% 215.14/215.36       use ENDOTHELINS to search ENDOTHELIN-2 1991-96   
% 215.14/215.36  |- mesh__dateRevised mesh__D019333 2003-07-09
% 215.14/215.36  |- mesh__recordMaintainer mesh__D019333 jmp
% 215.14/215.36  |- mesh__historyNote mesh__D019333 97; was see ENDOTHELINS 1991-96   
% 215.14/215.36  |- skos__hiddenLabel mesh__D019333 Endothelin 2
% 215.14/215.36  |- rdf__type mesh__D019333sskos__Concept
% 215.14/215.36  |- mesh__dateEstablished mesh__D019333 1997-01-01
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D019333 2006
% 215.14/215.36  |- mesh__dateCreated mesh__D019333 1996-06-10
% 215.14/215.36  |- mesh__recordAuthorizer mesh__D019333 sjn
% 215.14/215.36  |- skos__altLabel mesh__D000628 Clonmel Brand of Aminophylline
% 215.14/215.36  |- skos__altLabel mesh__D000628 Purdue Frederick Brand of Aminophylline
% 215.14/215.36  |- skos__altLabel mesh__D000628 G %26% W Brand of Aminophylline
% 215.14/215.36  |- skos__altLabel mesh__D000628 OPW Brand of Aminophylline
% 215.14/215.36  |- skos__altLabel mesh__D000628 Major Brand of Aminophylline
% 215.14/215.36  |- skos__altLabel mesh__D000628
% 215.14/215.36       Interstate Drug Exchange Brand of Aminophylline
% 215.14/215.36  |- skos__altLabel mesh__D000628 TVM Brand of Aminophylline
% 215.14/215.36  |- skos__altLabel mesh__D000628 Barre Brand of Aminophylline
% 215.14/215.36  |- skos__altLabel mesh__D000628 Mundiphyllin
% 215.14/215.36  |- skos__altLabel mesh__D000628 ratiopharm Brand of Aminophylline
% 215.14/215.36  |- skos__altLabel mesh__D000628 SmithKline Beecham Brand of Aminophylline
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D000628 2006
% 215.14/215.36  |- skos__altLabel mesh__D000628 Euphyllin
% 215.14/215.36  |- skos__altLabel mesh__D000628 Jenapharm Brand of Aminophylline
% 215.14/215.36  |- skos__altLabel mesh__D000628 Merck Brand of Aminophylline
% 215.14/215.36  |- skos__altLabel mesh__D000628 Theophyllamine
% 215.14/215.36  |- skos__altLabel mesh__D000628 Hamilton Brand of Aminophylline
% 215.14/215.36  |- skos__scopeNote mesh__D000628
% 215.14/215.36       A drug combination that contains THEOPHYLLINE and ethylenediamine. It is more soluble in water than theophylline but has similar pharmacologic actions. It%27%s most common use is in bronchial asthma, but it has been investigated for several other applications.%A%    
% 215.14/215.36  |- skos__altLabel mesh__D000628 Schein Brand of Aminophylline
% 215.14/215.36  |- skos__altLabel mesh__D000628 Byk Brand of Aminophylline
% 215.14/215.36  |- skos__altLabel mesh__D000628 Berlex Brand of Aminophylline
% 215.14/215.36  |- rdf__type mesh__D000628sskos__Concept
% 215.14/215.36  |- skos__broader mesh__D000628smesh__D005029
% 215.14/215.36  |- mesh__recordMaintainer mesh__D000628 jls
% 215.14/215.36  |- mesh__dateRevised mesh__D000628 2005-07-29
% 215.14/215.36  |- skos__altLabel mesh__D000628 Roxanne Brand of Aminophylline
% 215.14/215.36  |- skos__hiddenLabel mesh__D000628 Theophyllin EDAratiopharm
% 215.14/215.36  |- skos__altLabel mesh__D000628 United Research Brand of Aminophylline
% 215.14/215.36  |- skos__altLabel mesh__D000628 Napp Brand of Aminophylline
% 215.14/215.36  |- skos__broader mesh__D000628smesh__D013806
% 215.14/215.36  |- skos__altLabel mesh__D000628 Elmuquimica Brand of Aminophylline
% 215.14/215.36  |- skos__altLabel mesh__D000628 Searle Brand of Aminophylline
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D000628 2006A
% 215.14/215.36  |- skos__altLabel mesh__D000628 Ferndale Brand of Aminophylline
% 215.14/215.36  |- mesh__recordOriginator mesh__D000628 NLM
% 215.14/215.36  |- skos__altLabel mesh__D000628 Knoll Brand of Aminophylline
% 215.14/215.36  |- mesh__recordAuthorizer mesh__D000628 jls
% 215.14/215.36  |- skos__hiddenLabel mesh__D000628 Ethylenediamine, Theophylline
% 215.14/215.36  |- skos__altLabel mesh__D000628 Mundipharma Brand of Aminophylline
% 215.14/215.36  |- skos__altLabel mesh__D000628 Key Brand of Aminophylline
% 215.14/215.36  |- skos__hiddenLabel mesh__D000628 Theophyllin EDA ratiopharm
% 215.14/215.36  |- skos__altLabel mesh__D000628 Zafiro Brand of Aminophylline
% 215.14/215.36  |- skos__altLabel mesh__D000628 Rugby Brand of Aminophylline
% 215.14/215.36  |- skos__altLabel mesh__D000628 durachemie Brand of Aminophylline
% 215.14/215.36  |- mesh__dateCreated mesh__D000628 1999-01-01
% 215.14/215.36  |- skos__altLabel mesh__D000628 Carine
% 215.14/215.36  |- skos__prefLabel mesh__D000628 Aminophylline
% 215.14/215.36  |- skos__altLabel mesh__D000628 Theophylline Ethylenediamine
% 215.14/215.36  |- skos__altLabel mesh__D011350 Proctocolitis, Hemorrhagic
% 215.14/215.36  |- mesh__publicMeSHNote mesh__D011350
% 215.14/215.36       1991; see COLITIS 1963-1990; for RECTOCOLITIS, HEMORRHAGIC %26% RECTOCOLITIS, ULCERATIVE see COLITIS, ULCERATIVE 1979-2003%A%  
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D011350 2006
% 215.14/215.36  |- skos__broader mesh__D011350smesh__D011349
% 215.14/215.36  |- mesh__dateEstablished mesh__D011350 1991-01-01
% 215.14/215.36  |- skos__hiddenLabel mesh__D011350 Rectocolitides, Ulcerative
% 215.14/215.36  |- skos__altLabel mesh__D011350 Ulcerative Proctocolitis
% 215.14/215.36  |- skos__hiddenLabel mesh__D011350 Proctocolitides, Ulcerative
% 215.14/215.36  |- mesh__recordAuthorizer mesh__D011350 sjn
% 215.14/215.36  |- skos__hiddenLabel mesh__D011350 Ulcerative Rectocolitides
% 215.14/215.36  |- skos__altLabel mesh__D011350 Proctocolitis, Ulcerative
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D011350 2005
% 215.14/215.36  |- mesh__dateRevised mesh__D011350 2003-07-09
% 215.14/215.36  |- skos__broader mesh__D011350smesh__D003092
% 215.14/215.36  |- skos__hiddenLabel mesh__D011350 Ulcerative Rectocolitis
% 215.14/215.36  |- mesh__recordMaintainer mesh__D011350 lkt
% 215.14/215.36  |- skos__prefLabel mesh__D011350 Proctocolitis
% 215.14/215.36  |- skos__altLabel mesh__D011350 Rectosigmoiditis
% 215.14/215.36  |- skos__broader mesh__D011350smesh__D012810
% 215.14/215.36  |- mesh__dateCreated mesh__D011350 1999-01-01
% 215.14/215.36  |- rdf__type mesh__D011350sskos__Concept
% 215.14/215.36  |- mesh__historyNote mesh__D011350
% 215.14/215.36       1991%28%1963%29%; for RECTOCOLITIS, HEMORRHAGIC %26% RECTOCOLITIS, ULCERATIVE use COLITIS, ULCERATIVE 1979-2003%A%  
% 215.14/215.36  |- skos__hiddenLabel mesh__D011350 Hemorrhagic Rectocolitis
% 215.14/215.36  |- skos__hiddenLabel mesh__D011350 Ulcerative Proctocolitides
% 215.14/215.36  |- mesh__recordOriginator mesh__D011350 NLM
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D011350 2004
% 215.14/215.36  |- skos__altLabel mesh__D011350 Rectocolitis
% 215.14/215.36  |- skos__scopeNote mesh__D011350
% 215.14/215.36       Inflammation of the RECTUM and the distal portion of the COLON.%A%    
% 215.14/215.36  |- skos__altLabel mesh__D011350 Hemorrhagic Proctocolitis
% 215.14/215.36  |- skos__broader mesh__D018077Q000037smesh__D018077
% 215.14/215.36  |- mesh__preferredCombination mesh__D018077Q000037smesh__D020024
% 215.14/215.36  |- rdf__type mesh__D018077Q000037smesh__CompoundConcept
% 215.14/215.36  |- skos__hiddenLabel mesh__D005313 Death, Fetal
% 215.14/215.36  |- skos__prefLabel mesh__D005313 Fetal Death
% 215.14/215.36  |- skos__annotation mesh__D005313
% 215.14/215.36       do not confuse with FETAL MORTALITY, a statistical concept%A%  
% 215.14/215.36  |- mesh__recordAuthorizer mesh__D005313 sjn
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D005313 2006
% 215.14/215.36  |- mesh__dateCreated mesh__D005313 1999-01-01
% 215.14/215.36  |- skos__broader mesh__D005313smesh__D003643
% 215.14/215.36  |- mesh__dateRevised mesh__D005313 2005-06-30
% 215.14/215.36  |- skos__hiddenLabel mesh__D005313 Fetal Deaths
% 215.14/215.36  |- skos__scopeNote mesh__D005313
% 215.14/215.36       Death of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH.%A%    
% 215.14/215.36  |- skos__related mesh__D005313smesh__D011256
% 215.14/215.36  |- mesh__recordOriginator mesh__D005313 NLM
% 215.14/215.36  |- skos__related mesh__D005313smesh__D000026
% 215.14/215.36  |- skos__related mesh__D005313smesh__D005328
% 215.14/215.36  |- skos__broader mesh__D005313smesh__D011248
% 215.14/215.36  |- rdf__type mesh__D005313sskos__Concept
% 215.14/215.36  |- skos__related mesh__D005313smesh__D020964
% 215.14/215.36  |- mesh__recordMaintainer mesh__D005313 lkt
% 215.14/215.36  |- skos__scopeNote mesh__D029761
% 215.14/215.36       A plant species of the family CLUSIACEAE.  It is a source of hydroxycitric acid.%A%    
% 215.14/215.36  |- skos__altLabel mesh__D029761 Mangostana cambogia
% 215.14/215.36  |- skos__altLabel mesh__D029761 Citrin Fruit
% 215.14/215.36  |- mesh__dateEstablished mesh__D029761 2002-01-01
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D029761 2002
% 215.14/215.36  |- mesh__dateCreated mesh__D029761 2001-07-25
% 215.14/215.36  |- skos__broader mesh__D029761smesh__D029760
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D029761 2006
% 215.14/215.36  |- rdf__type mesh__D029761sskos__Concept
% 215.14/215.36  |- mesh__publicMeSHNote mesh__D029761 2002   
% 215.14/215.36  |- skos__annotation mesh__D029761
% 215.14/215.36       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D029761 2004
% 215.14/215.36  |- skos__prefLabel mesh__D029761 Garcinia cambogia
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D029761 2005
% 215.14/215.36  |- mesh__historyNote mesh__D029761 2002   
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D029761 2003
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D010258 2006
% 215.14/215.36  |- mesh__dateEstablished mesh__D010258 1979-01-01
% 215.14/215.36  |- mesh__publicMeSHNote mesh__D010258 79   
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D010258 2005
% 215.14/215.36  |- mesh__historyNote mesh__D010258 79   
% 215.14/215.36  |- skos__historyNote mesh__D010258
% 215.14/215.36       Paranoid Personality Disorder %28%1969-1978%29%
% 215.14/215.36  |- mesh__recordAuthorizer mesh__D010258 sjn
% 215.14/215.36  |- rdf__type mesh__D010258sskos__Concept
% 215.14/215.36  |- skos__hiddenLabel mesh__D010258 Paranoid Behaviors
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D010258 2004
% 215.14/215.36  |- mesh__recordMaintainer mesh__D010258 JLS
% 215.14/215.36  |- mesh__dateCreated mesh__D010258 1978-05-04
% 215.14/215.36  |- skos__hiddenLabel mesh__D010258 Behavior, Paranoid
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D010258 2003
% 215.14/215.36  |- skos__historyNote mesh__D010258 Paranoid Disorders %28%1966-1978%29%
% 215.14/215.36  |- mesh__recordOriginator mesh__D010258 EC
% 215.14/215.36  |- skos__scopeNote mesh__D010258
% 215.14/215.36       Behavior exhibited by individuals who are overly suspicious, but without the constellation of symptoms characteristic of paranoid personality disorder or paranoid type of schizophrenia.%A%    
% 215.14/215.36  |- skos__prefLabel mesh__D010258 Paranoid Behavior
% 215.14/215.36  |- skos__broader mesh__D010258smesh__D001526
% 215.14/215.36  |- mesh__dateRevised mesh__D010258 2002-07-02
% 215.14/215.36  |- skos__hiddenLabel mesh__D010258 Behaviors, Paranoid
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D015741 2006
% 215.14/215.36  |- mesh__recordMaintainer mesh__D015741 lkt
% 215.14/215.36  |- skos__hiddenLabel mesh__D015741 Ru1881
% 215.14/215.36  |- mesh__recordAuthorizer mesh__D015741 sjn
% 215.14/215.36  |- skos__historyNote mesh__D015741 Estranes %28%1968-1972%29%
% 215.14/215.36  |- mesh__activeMeSHYear mesh__D015741 2005
% 215.14/215.36  |- skos__altLabel mesh__D015741 R1881
% 215.14/215.36  |- skos__hiddenLabel mesh__D015741 Ru 1881
% 215.14/215.36  |- skos__historyNote mesh__D015741 Androgens, Synthetic %28%1975-1989%29%
% 215.14/215.36  |- skos__altLabel mesh__D015741 Ru-1881
% 215.14/215.36  |- skos__broader mesh__D015741smesh__D004963
% 215.14/215.36  |- skos__historyNote mesh__D015741 Estrenes %28%1973-1989%29%
% 215.14/215.36  |- skos__prefLabel mesh__D015741 Metribolone
% 215.14/215.36  |- mesh__dateRevised mesh__D015741 2003-07-09
% 215.14/215.36  |- skos__hiddenLabel mesh__D015741 R 1881
% 215.14/215.36  |- skos__altLabel mesh__D015741
% 215.14/215.36       17 beta-Hydroxy-17 alpha-methylestra-4,9,11-trien-3-one
% 215.14/215.36  |- skos__altLabel mesh__D015741 Methyltrienolone
% 215.14/215.37  |- rdf__type mesh__D015741sskos__Concept
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D015741 2004
% 215.14/215.37  |- skos__scopeNote mesh__D015741
% 215.14/215.37       A synthetic non-aromatizable androgen and anabolic steroid. It binds strongly to the androgen receptor and has therefore also been used as an affinity label for this receptor in the prostate and in prostatic tumors.%A%    
% 215.14/215.37  |- mesh__historyNote mesh__D015741 90   
% 215.14/215.37  |- mesh__publicMeSHNote mesh__D015741 90   
% 215.14/215.37  |- mesh__dateCreated mesh__D015741 1989-05-25
% 215.14/215.37  |- mesh__recordOriginator mesh__D015741 RLS
% 215.14/215.37  |- mesh__dateEstablished mesh__D015741 1990-01-01
% 215.14/215.37  |- mesh__dateRevised mesh__D009704 2001-07-25
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D009704 2004
% 215.14/215.37  |- skos__prefLabel mesh__D009704 Nucleoside Q
% 215.14/215.37  |- mesh__publicMeSHNote mesh__D009704
% 215.14/215.37       91; was see under GUANOSINE 1980-90   
% 215.14/215.37  |- mesh__recordOriginator mesh__D009704 RLS
% 215.14/215.37  |- skos__altLabel mesh__D009704 Q Nucleoside
% 215.14/215.37  |- rdf__type mesh__D009704sskos__Concept
% 215.14/215.37  |- mesh__recordMaintainer mesh__D009704 CCR
% 215.14/215.37  |- mesh__recordAuthorizer mesh__D009704 sjn
% 215.14/215.37  |- skos__broader mesh__D009704smesh__D006151
% 215.14/215.37  |- skos__altLabel mesh__D009704 Q-Ribonucleoside
% 215.14/215.37  |- skos__hiddenLabel mesh__D009704 Q Ribonucleoside
% 215.14/215.37  |- skos__scopeNote mesh__D009704
% 215.14/215.37       A modified nucleoside which is present in the first position of the anticodon of tRNA-tyrosine, tRNA-histidine, tRNA-asparagine and tRNA-aspartic acid of many organisms. It is believed to play a role in the regulatory function of tRNA. Nucleoside Q can be further modified to nucleoside Q*, which has a mannose or galactose moiety linked to position 4 of its cyclopentenediol moiety.%A%    
% 215.14/215.37  |- mesh__dateCreated mesh__D009704 1979-05-23
% 215.14/215.37  |- skos__altLabel mesh__D009704 Queuosine
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D009704 2005
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D009704 2002
% 215.14/215.37  |- skos__historyNote mesh__D009704 Nucleosides %28%1966-1971%29%
% 215.14/215.37  |- skos__annotation mesh__D009704 /biosyn /physiol permitted   
% 215.14/215.37  |- mesh__dateEstablished mesh__D009704 1991-01-01
% 215.14/215.37  |- skos__historyNote mesh__D009704
% 215.14/215.37       Guanosine %28%1972-1974%29%/analogs %26% derivatives %28%1975-1979%29%
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D009704 2006
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D009704 2003
% 215.14/215.37  |- mesh__historyNote mesh__D009704
% 215.14/215.37       91%28%80%29%; was see under GUANOSINE 1980-90   
% 215.14/215.37  |- mesh__onlineNote mesh__D001721
% 215.14/215.37       use BIRTH INTERVALS to search CHILD SPACING 1979-92   
% 215.14/215.37  |- skos__broader mesh__D001721smesh__D005191
% 215.14/215.37  |- mesh__historyNote mesh__D001721
% 215.14/215.37       80; CHILD SPACING was see BIRTH INTERVALS 1979-92   
% 215.14/215.37  |- mesh__recordOriginator mesh__D001721 SMH
% 215.14/215.37  |- mesh__recordMaintainer mesh__D001721 lkt
% 215.14/215.37  |- mesh__dateEstablished mesh__D001721 1980-01-01
% 215.14/215.37  |- skos__scopeNote mesh__D001721
% 215.14/215.37       The lengths of intervals between births to women in the population.%A%    
% 215.14/215.37  |- skos__hiddenLabel mesh__D001721 First Birth Interval
% 215.14/215.37  |- skos__prefLabel mesh__D001721 Birth Intervals
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D001721 2005
% 215.14/215.37  |- skos__hiddenLabel mesh__D001721 Birth Interval
% 215.14/215.37  |- mesh__dateCreated mesh__D001721 1978-12-19
% 215.14/215.37  |- skos__annotation mesh__D001721
% 215.14/215.37       human only; may be used in physiol or family planning context%A%  
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D001721 2006
% 215.14/215.37  |- skos__hiddenLabel mesh__D001721 Birth Spacings
% 215.14/215.37  |- rdf__type mesh__D001721sskos__Concept
% 215.14/215.37  |- skos__historyNote mesh__D001721 Family Planning %28%1968-1979%29%
% 215.14/215.37  |- skos__hiddenLabel mesh__D001721 Pregnancy Interval
% 215.14/215.37  |- mesh__dateRevised mesh__D001721 2003-07-09
% 215.14/215.37  |- mesh__recordAuthorizer mesh__D001721 sjn
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D001721 2004
% 215.14/215.37  |- skos__historyNote mesh__D001721 Family Characteristics %28%1968-1979%29%
% 215.14/215.37  |- mesh__publicMeSHNote mesh__D001721
% 215.14/215.37       80; CHILD SPACING was see BIRTH INTERVALS 1979-92   
% 215.14/215.37  |- skos__altLabel mesh__D001721 Birth Spacing
% 215.14/215.37  |- skos__broader mesh__D014649smesh__D005837
% 215.14/215.37  |- mesh__dateCreated mesh__D014649 1999-01-01
% 215.14/215.37  |- skos__altLabel mesh__D014649 Ductus Deferens
% 215.14/215.37  |- mesh__recordMaintainer mesh__D014649 KEV
% 215.14/215.37  |- skos__related mesh__D014649smesh__D014659
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D014649 2006
% 215.14/215.37  |- mesh__recordOriginator mesh__D014649 NLM
% 215.14/215.37  |- skos__hiddenLabel mesh__D014649 Deferens, Ductus
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D014649 2002
% 215.14/215.37  |- skos__annotation mesh__D014649 /surg: consider also VASECTOMY   
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D014649 2005
% 215.14/215.37  |- mesh__recordAuthorizer mesh__D014649 sjn
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D014649 2001
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D014649 2004
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D014649 2000
% 215.14/215.37  |- skos__related mesh__D014649smesh__D014669
% 215.14/215.37  |- mesh__dateRevised mesh__D014649 1999-11-03
% 215.14/215.37  |- rdf__type mesh__D014649sskos__Concept
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D014649 2003
% 215.14/215.37  |- skos__hiddenLabel mesh__D014649 Deferens, Vas
% 215.14/215.37  |- skos__scopeNote mesh__D014649
% 215.14/215.37       The excretory duct of the testes that carries SPERMATOZOA. It rises from the SCROTUM and joins the SEMINAL VESICLES to form the ejaculatory duct.%A%    
% 215.14/215.37  |- skos__prefLabel mesh__D014649 Vas Deferens
% 215.14/215.37  |- skos__broader mesh__D019334smesh__D016232
% 215.14/215.37  |- skos__scopeNote mesh__D019334
% 215.14/215.37       A 21-amino acid peptide that circulates in the plasma, but its source is not known. Endothelin-3 has been found in high concentrations in the brain and may regulate important functions in neurons and astrocytes, such as proliferation and development. It also is found throughout the gastrointestinal tract and in the lung and kidney. %28%N Eng J Med 1995;333%28%6%29%:356-63%29%%A%    
% 215.14/215.37  |- mesh__historyNote mesh__D019334
% 215.14/215.37       1997; use ENDOTHELINS 1991-1996; for BIG ENDOTHELIN 3 use ENDOTHELIN-3 %28%NM%29% 1993-2003%A%  
% 215.14/215.37  |- skos__hiddenLabel mesh__D019334 Endothelin-3, Big
% 215.14/215.37  |- skos__prefLabel mesh__D019334 Endothelin-3
% 215.14/215.37  |- mesh__dateEstablished mesh__D019334 1997-01-01
% 215.14/215.37  |- skos__hiddenLabel mesh__D019334 Endothelin 3
% 215.14/215.37  |- mesh__dateRevised mesh__D019334 2003-07-09
% 215.14/215.37  |- skos__annotation mesh__D019334
% 215.14/215.37       /drug eff permitted; DF: note short X ref   
% 215.14/215.37  |- mesh__dateCreated mesh__D019334 1996-06-10
% 215.14/215.37  |- mesh__recordAuthorizer mesh__D019334 sjn
% 215.14/215.37  |- skos__altLabel mesh__D019334 Big Endothelin-3
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D019334 2006
% 215.14/215.37  |- skos__hiddenLabel mesh__D019334 Endothelin 3, Big
% 215.14/215.37  |- mesh__publicMeSHNote mesh__D019334
% 215.14/215.37       1997; see ENDOTHELINS 1991-1996; BIG ENDOTHELIN 3 was indexed under ENDOTHELINS %26% PROTEIN PRECURSORS 1993-2003%A%  
% 215.14/215.37  |- mesh__recordMaintainer mesh__D019334 jmp
% 215.14/215.37  |- rdf__type mesh__D019334sskos__Concept
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D019334 2005
% 215.14/215.37  |- mesh__recordOriginator mesh__D019334 TPW
% 215.14/215.37  |- skos__historyNote mesh__D019334 Endothelins %28%1991-1996%29%
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D019334 2004
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D000629 1997
% 215.14/215.37  |- mesh__dateCreated mesh__D000629 1999-01-01
% 215.14/215.37  |- rdf__type mesh__D000629sskos__Concept
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D000629 1999
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D000629 1996
% 215.14/215.37  |- skos__altLabel mesh__D000629 BAPN
% 215.14/215.37  |- mesh__recordOriginator mesh__D000629 NLM
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D000629 2004
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D000629 1998
% 215.14/215.37  |- mesh__historyNote mesh__D000629 72%28%64%29%   
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D000629 2006
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D000629 1993
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D000629 2003
% 215.14/215.37  |- mesh__dateEstablished mesh__D000629 1972-01-01
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D000629 1995
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D000629 2002
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D000629 2005
% 215.14/215.37  |- mesh__recordMaintainer mesh__D000629 TGC
% 215.14/215.37  |- mesh__recordAuthorizer mesh__D000629 PLS
% 215.14/215.37  |- skos__broader mesh__D000629smesh__D009570
% 215.14/215.37  |- skos__scopeNote mesh__D000629
% 215.14/215.37       3-Aminopropanenitrile. Reagent used as an intermediate in the manufacture of beta-alanine and pantothenic acid.%A%    
% 215.14/215.37  |- skos__related mesh__D000629smesh__D007842
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D000629 1994
% 215.14/215.37  |- mesh__dateRevised mesh__D000629 1992-05-07
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D000629 2001
% 215.14/215.37  |- skos__prefLabel mesh__D000629 Aminopropionitrile
% 215.14/215.37  |- mesh__publicMeSHNote mesh__D000629 72   
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D000629 2000
% 215.14/215.37  |- skos__hiddenLabel mesh__D000629 beta Aminopropionitrile
% 215.14/215.37  |- mesh__recordOriginator mesh__D011351 NLM
% 215.14/215.37  |- skos__altLabel mesh__D011351 Surgical Procedures, Proctoscopic
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D011351 2001
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D011351 2005
% 215.14/215.37  |- skos__prefLabel mesh__D011351 Proctoscopy
% 215.14/215.37  |- skos__hiddenLabel mesh__D011351 Surgeries, Proctoscopic
% 215.14/215.37  |- skos__hiddenLabel mesh__D011351 Surgical Procedure, Proctoscopic
% 215.14/215.37  |- skos__hiddenLabel mesh__D011351 Procedure, Proctoscopic Surgical
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D011351 2000
% 215.14/215.37  |- skos__hiddenLabel mesh__D011351 Proctoscopies
% 215.14/215.37  |- skos__broader mesh__D011351smesh__D016099
% 215.14/215.37  |- mesh__recordAuthorizer mesh__D011351 sjn
% 215.14/215.37  |- skos__hiddenLabel mesh__D011351 Procedures, Proctoscopic Surgical
% 215.14/215.37  |- mesh__dateCreated mesh__D011351 1999-01-01
% 215.14/215.37  |- rdf__type mesh__D011351sskos__Concept
% 215.14/215.37  |- skos__scopeNote mesh__D011351
% 215.14/215.37       Endoscopic examination, therapy or surgery of the rectum.%A%    
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D011351 2004
% 215.14/215.37  |- skos__altLabel mesh__D011351 Proctoscopic Surgery
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D011351 2002
% 215.14/215.37  |- mesh__dateRevised mesh__D011351 1999-11-03
% 215.14/215.37  |- mesh__recordMaintainer mesh__D011351 nns
% 215.14/215.37  |- skos__hiddenLabel mesh__D011351 Proctoscopic Surgical Procedure
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D011351 2003
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D011351 2006
% 215.14/215.37  |- skos__altLabel mesh__D011351 Surgery, Proctoscopic
% 215.14/215.37  |- skos__hiddenLabel mesh__D011351 Proctoscopic Surgeries
% 215.14/215.37  |- skos__related mesh__D005314smesh__D015509
% 215.14/215.37  |- skos__scopeNote mesh__D005314
% 215.14/215.37       Morphological and physiological development of EMBRYOS or FETUSES.%A%    
% 215.14/215.37  |- mesh__dateRevised mesh__D005314 2004-11-15
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D005314 2005A
% 215.14/215.37  |- skos__historyNote mesh__D005314 Growth %28%1966-1984%29%
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D005314 2005
% 215.14/215.37  |- mesh__recordOriginator mesh__D005314 EC
% 215.14/215.37  |- skos__broader mesh__D005314smesh__D012098
% 215.14/215.37  |- mesh__recordMaintainer mesh__D005314 jls
% 215.14/215.37  |- mesh__dateCreated mesh__D005314 1984-06-11
% 215.14/215.37  |- skos__annotation mesh__D005314 not used for indexing or cataloging   
% 215.14/215.37  |- mesh__historyNote mesh__D005314 2005 %28%1985%29%   
% 215.14/215.37  |- skos__broader mesh__D005314smesh__D009024
% 215.14/215.37  |- mesh__dateEstablished mesh__D005314 1985-01-01
% 215.14/215.37  |- mesh__recordAuthorizer mesh__D005314 jls
% 215.14/215.37  |- skos__prefLabel mesh__D005314 Embryonic and Fetal Development
% 215.14/215.37  |- skos__related mesh__D005314smesh__D033421
% 215.14/215.37  |- rdf__type mesh__D005314sskos__Concept
% 215.14/215.37  |- mesh__publicMeSHNote mesh__D005314
% 215.14/215.37       2005; see EMBRYO AND FETAL DEVELOPMENT 2003-2004, see FETAL DEVELOPMENT 1985-2002%A%  
% 215.14/215.37  |- skos__historyNote mesh__D005314
% 215.14/215.37       specific organ/embryology %28%1966-1994%29%
% 215.14/215.37  |- skos__altLabel mesh__D005314 Embryo and Fetal Development
% 215.14/215.37  |- skos__historyNote mesh__D005314 Fetus/physiology %28%1966-1984%29%
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D005314 2006
% 215.14/215.37  |- mesh__historyNote mesh__D029762 2002   
% 215.14/215.37  |- skos__altLabel mesh__D029762 Mangosteen
% 215.14/215.37  |- mesh__dateEstablished mesh__D029762 2002-01-01
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D029762 2006
% 215.14/215.37  |- mesh__publicMeSHNote mesh__D029762 2002   
% 215.14/215.37  |- skos__annotation mesh__D029762
% 215.14/215.37       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.14/215.37  |- rdf__type mesh__D029762sskos__Concept
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D029762 2005
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D029762 2004
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D029762 2002
% 215.14/215.37  |- mesh__dateCreated mesh__D029762 2001-07-25
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D029762 2003
% 215.14/215.37  |- skos__scopeNote mesh__D029762
% 215.14/215.37       A plant genus of the family CLUSIACEAE.  It is the source of the mangosteen fruit.%A%    
% 215.14/215.37  |- skos__broader mesh__D029762smesh__D029760
% 215.14/215.37  |- skos__prefLabel mesh__D029762 Garcinia mangostana
% 215.14/215.37  |- skos__scopeNote mesh__D010259
% 215.14/215.37       Chronic mental disorders in which there has been an insidious development of a permanent and unshakeable delusional system %28%persecutory delusions or delusions of jealousy%29%, accompanied by preservation of clear and orderly thinking. Emotional responses and behavior are consistent with the delusional state.%A%    
% 215.14/215.37  |- rdf__type mesh__D010259sskos__Concept
% 215.14/215.37  |- skos__hiddenLabel mesh__D010259 Disorder, Paranoid
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D010259 2002
% 215.14/215.37  |- skos__altLabel mesh__D010259 Paranoia
% 215.14/215.37  |- mesh__dateRevised mesh__D010259 1997-06-20
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D010259 2004
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D010259 1999
% 215.14/215.37  |- mesh__historyNote mesh__D010259 81; was PARANOIA 1963-80   
% 215.14/215.37  |- skos__prefLabel mesh__D010259 Paranoid Disorders
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D010259 2001
% 215.14/215.37  |- skos__broader mesh__D010259smesh__D019967
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D010259 2003
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D010259 1998
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D010259 2000
% 215.14/215.37  |- skos__altLabel mesh__D010259 Paranoid Psychoses
% 215.14/215.37  |- skos__altLabel mesh__D010259 Psychoses, Paranoid
% 215.14/215.37  |- skos__hiddenLabel mesh__D010259 Disorders, Paranoid
% 215.14/215.37  |- mesh__recordMaintainer mesh__D010259 JLS
% 215.14/215.37  |- mesh__publicMeSHNote mesh__D010259 81; was PARANOIA 1963-80   
% 215.14/215.37  |- skos__hiddenLabel mesh__D010259 Paranoid Disorder
% 215.14/215.37  |- mesh__dateCreated mesh__D010259 1999-01-01
% 215.14/215.37  |- skos__hiddenLabel mesh__D010259 Paranoias
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D010259 2006
% 215.14/215.37  |- mesh__recordAuthorizer mesh__D010259 SJN
% 215.14/215.37  |- mesh__recordOriginator mesh__D010259 NLM
% 215.14/215.37  |- mesh__onlineNote mesh__D010259
% 215.14/215.37       use PARANOID DISORDERS to search PARANOIA 1966-80   
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D010259 2005
% 215.14/215.37  |- skos__hiddenLabel mesh__D015742 2,6 Diisopropylphenol
% 215.14/215.37  |- skos__altLabel mesh__D015742 Pisa Brand of Propofol
% 215.14/215.37  |- mesh__recordAuthorizer mesh__D015742 sjn
% 215.14/215.37  |- skos__altLabel mesh__D015742 Zeneca Brand of Propofol
% 215.14/215.37  |- skos__altLabel mesh__D015742 Disoprofol
% 215.14/215.37  |- skos__historyNote mesh__D015742 Anesthetics %28%1966-1989%29%
% 215.14/215.37  |- mesh__publicMeSHNote mesh__D015742 90   
% 215.14/215.37  |- skos__altLabel mesh__D015742 Fresenius Kabi Brand of Propofol
% 215.14/215.37  |- skos__altLabel mesh__D015742 Disoprivan
% 215.14/215.37  |- skos__hiddenLabel mesh__D015742 ICI 35,868
% 215.14/215.37  |- mesh__dateRevised mesh__D015742 2005-06-30
% 215.14/215.37  |- skos__altLabel mesh__D015742 Astra Brand of Propofol
% 215.14/215.37  |- skos__altLabel mesh__D015742 2,6-Bis%28%1-methylethyl%29%phenol
% 215.14/215.37  |- skos__altLabel mesh__D015742 Fresenius Brand of Propofol
% 215.14/215.37  |- skos__historyNote mesh__D015742
% 215.14/215.37       Sedatives, Nonbarbiturate %28%1975-1989%29%
% 215.14/215.37  |- mesh__recordOriginator mesh__D015742 RLS
% 215.14/215.37  |- skos__altLabel mesh__D015742 Alpha Brand of Propofol
% 215.14/215.37  |- mesh__recordMaintainer mesh__D015742 lkw
% 215.14/215.37  |- rdf__type mesh__D015742sskos__Concept
% 215.14/215.37  |- skos__hiddenLabel mesh__D015742 ICI35,868
% 215.14/215.37  |- skos__altLabel mesh__D015742 2,6-Diisopropylphenol
% 215.14/215.37  |- skos__broader mesh__D015742smesh__D010636
% 215.14/215.37  |- skos__altLabel mesh__D015742 Rovi Brand of Propofol
% 215.14/215.37  |- skos__altLabel mesh__D015742 Braun Brand of Propofol
% 215.14/215.37  |- skos__altLabel mesh__D015742 Schering Brand of Propofol
% 215.14/215.37  |- skos__historyNote mesh__D015742 Phenols %28%1966-1989%29%
% 215.14/215.37  |- mesh__historyNote mesh__D015742 90   
% 215.14/215.37  |- mesh__dateEstablished mesh__D015742 1990-01-01
% 215.14/215.37  |- skos__altLabel mesh__D015742 ICI-35868
% 215.14/215.37  |- skos__altLabel mesh__D015742 Parnell Brand of Propofol
% 215.14/215.37  |- skos__altLabel mesh__D015742 AstraZeneca Brand of Propofol
% 215.14/215.37  |- skos__altLabel mesh__D015742 Curamed Brand of Propofol
% 215.14/215.37  |- skos__altLabel mesh__D015742 Juste Brand of Propofol
% 215.14/215.37  |- skos__altLabel mesh__D015742 Propofol MCT
% 215.14/215.37  |- skos__hiddenLabel mesh__D015742 ICI 35868
% 215.14/215.37  |- skos__historyNote mesh__D015742 Analgesics, Narcotic %28%1975-1989%29%
% 215.14/215.37  |- skos__scopeNote mesh__D015742
% 215.14/215.37       An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. %28%From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206%29%%A%    
% 215.14/215.37  |- skos__hiddenLabel mesh__D015742 ICI35868
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D015742 2006
% 215.14/215.37  |- skos__altLabel mesh__D015742 Abbott Brand of Propofol
% 215.14/215.37  |- mesh__dateCreated mesh__D015742 1989-06-08
% 215.14/215.37  |- skos__prefLabel mesh__D015742 Propofol
% 215.14/215.37  |- mesh__recordAuthorizer mesh__D009705 sjn
% 215.14/215.37  |- rdf__type mesh__D009705sskos__Concept
% 215.14/215.37  |- mesh__dateRevised mesh__D009705 2004-07-07
% 215.14/215.37  |- skos__broader mesh__D009705smesh__D009706
% 215.14/215.37  |- mesh__recordOriginator mesh__D009705 NLM
% 215.14/215.37  |- skos__broader mesh__D009705smesh__D006027
% 215.14/215.37  |- skos__prefLabel mesh__D009705 Nucleosides
% 215.14/215.37  |- skos__scopeNote mesh__D009705
% 215.14/215.37       Purine or pyrimidine bases attached to a ribose or deoxyribose. %28%From King %26% Stansfield, A Dictionary of Genetics, 4th ed%29%%A%    
% 215.14/215.37  |- mesh__recordMaintainer mesh__D009705 ssb
% 215.14/215.37  |- mesh__dateCreated mesh__D009705 1999-01-01
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D009705 2006
% 215.14/215.37  |- skos__annotation mesh__D009705 nucleoside phosphates = NUCLEOTIDES   
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D009705 2005
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D001722 2003
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D001722 2002
% 215.14/215.37  |- mesh__dateCreated mesh__D001722 1999-01-01
% 215.14/215.37  |- skos__broader mesh__D001722smesh__D005190
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D001722 1995
% 215.14/215.37  |- skos__annotation mesh__D001722 IM   
% 215.14/215.37  |- skos__scopeNote mesh__D001722
% 215.14/215.37       The sequence in which children are born into the family.%A%    
% 215.14/215.37  |- skos__prefLabel mesh__D001722 Birth Order
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D001722 1993
% 215.14/215.37  |- skos__hiddenLabel mesh__D001722 First Births
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D001722 1999
% 215.14/215.37  |- skos__hiddenLabel mesh__D001722 Births, First
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D001722 1994
% 215.14/215.37  |- skos__hiddenLabel mesh__D001722 Birth, First
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D001722 1997
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D001722 1998
% 215.14/215.37  |- skos__broader mesh__D001722smesh__D005191
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D001722 2001
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D001722 1996
% 215.14/215.37  |- skos__hiddenLabel mesh__D001722 Birth Orders
% 215.14/215.37  |- mesh__recordMaintainer mesh__D001722 PLS
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D001722 2006
% 215.14/215.37  |- mesh__dateRevised mesh__D001722 1993-11-29
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D001722 2000
% 215.14/215.37  |- mesh__recordOriginator mesh__D001722 NLM
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D001722 2004
% 215.14/215.37  |- rdf__type mesh__D001722sskos__Concept
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D001722 2005
% 215.14/215.37  |- mesh__recordAuthorizer mesh__D001722 PLS
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D020687 2004
% 215.14/215.37  |- mesh__recordOriginator mesh__D020687 jmp
% 215.14/215.37  |- mesh__recordMaintainer mesh__D020687 ssb
% 215.14/215.37  |- skos__broader mesh__D020687smesh__D017027
% 215.14/215.37  |- skos__prefLabel mesh__D020687 cdc25 Phosphatase
% 215.14/215.37  |- mesh__recordAuthorizer mesh__D020687 sjn
% 215.14/215.37  |- skos__annotation mesh__D020687
% 215.14/215.37       do not confuse with CDC25 GUANINE NUCLEOTIDE EXCHANGE FACTOR%A%  
% 215.14/215.37  |- mesh__dateCreated mesh__D020687 1999-11-08
% 215.14/215.37  |- mesh__dateEstablished mesh__D020687 2000-01-01
% 215.14/215.37  |- skos__broader mesh__D020687smesh__D018797
% 215.14/215.37  |- mesh__historyNote mesh__D020687
% 215.14/215.37       2000; use CDC25 PHOSPHATASE %28%NM%29% 1995-1999   
% 215.14/215.37  |- skos__historyNote mesh__D020687 Cell Cycle Proteins %28%1996-1999%29%
% 215.14/215.37  |- mesh__dateRevised mesh__D020687 2003-07-09
% 215.14/215.37  |- skos__scopeNote mesh__D020687
% 215.14/215.37       A tyrosine phosphatase required for progression of the cell cycle. It is required for p34%28%cdc2%29% kinase activation.%A%    
% 215.14/215.37  |- skos__hiddenLabel mesh__D020687 Phosphatase, cdc25
% 215.14/215.37  |- mesh__publicMeSHNote mesh__D020687
% 215.14/215.37       2000; CDC25 PROTEIN %28%now CDC25 PHOSPHATASE%29% was indexed under CELL CYCLE PROTEINS 1995-1999 %26% PHOSPHOPROTEIN PHOSPHATASES 1996-1999%A%  
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D020687 2005
% 215.14/215.37  |- rdf__type mesh__D020687sskos__Concept
% 215.14/215.37  |- skos__historyNote mesh__D020687
% 215.14/215.37       Phosphoprotein Phosphatase %28%1996-1999%29%
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D020687 2006
% 215.14/215.37  |- skos__hiddenLabel mesh__D019335 omega-Nitro-L-Arginine, N
% 215.14/215.37  |- skos__altLabel mesh__D019335 NG-Nitroarginine
% 215.14/215.37  |- skos__altLabel mesh__D019335 N%28%omega%29%-Nitroarginine
% 215.14/215.37  |- mesh__recordMaintainer mesh__D019335 nns
% 215.14/215.37  |- mesh__recordOriginator mesh__D019335 ADP
% 215.14/215.37  |- skos__prefLabel mesh__D019335 Nitroarginine
% 215.14/215.37  |- mesh__dateEstablished mesh__D019335 1997-01-01
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D019335 2006
% 215.14/215.37  |- mesh__publicMeSHNote mesh__D019335
% 215.14/215.37       97; NITROARGININE was indexed under ARGININE/analogs %26% derivatives 1990-96%A%  
% 215.14/215.37  |- skos__annotation mesh__D019335 an enzyme inhib   
% 215.14/215.37  |- skos__historyNote mesh__D019335
% 215.14/215.37       Arginine/analogs %26% derivatives %28%1990-1996%29%
% 215.14/215.37  |- rdf__type mesh__D019335sskos__Concept
% 215.14/215.37  |- skos__altLabel mesh__D019335 NO2Arg
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D019335 2005
% 215.14/215.37  |- skos__broader mesh__D019335smesh__D001120
% 215.14/215.37  |- mesh__dateCreated mesh__D019335 1996-06-10
% 215.14/215.37  |- mesh__historyNote mesh__D019335
% 215.14/215.37       97; was NITROARGININE %28%NM%29% 1990-96   
% 215.14/215.37  |- skos__altLabel mesh__D019335 N omega-Nitro-L-Arginine
% 215.14/215.37  |- mesh__recordAuthorizer mesh__D019335 sjn
% 215.14/215.37  |- skos__altLabel mesh__D019335 NG-Nitro-L-Arginine
% 215.14/215.37  |- mesh__onlineNote mesh__D019335
% 215.14/215.37       use NITROARGININE %28%NM%29% to search NITROARGININE 1990-96   
% 215.14/215.37  |- skos__hiddenLabel mesh__D019335 NG Nitroarginine
% 215.14/215.37  |- skos__hiddenLabel mesh__D019335 NG Nitro L Arginine
% 215.14/215.37  |- skos__hiddenLabel mesh__D019335 N omega Nitro L Arginine
% 215.14/215.37  |- skos__altLabel mesh__D019335 NOARG
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D019335 2004
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D019335 2002
% 215.14/215.37  |- skos__scopeNote mesh__D019335
% 215.14/215.37       An inhibitor of nitric oxide synthetase which has been shown to prevent glutamate toxicity. Nitroarginine has been experimentally tested for its ability to prevent ammonia toxicity and ammonia-induced alterations in brain energy and ammonia metabolites. %28%Neurochem Res 1995:200%28%4%29%:451-6%29%%A%    
% 215.14/215.37  |- skos__altLabel mesh__D019335 N%28%G%29%-Nitroarginine
% 215.14/215.37  |- skos__altLabel mesh__D019335 omega-Nitroarginine
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D019335 2003
% 215.14/215.37  |- mesh__dateRevised mesh__D019335 2001-07-25
% 215.14/215.37  |- skos__hiddenLabel mesh__D019335 omega Nitroarginine
% 215.14/215.37  |- mesh__publicMeSHNote mesh__D011352
% 215.14/215.37       91; was see under PYRROLIDINES 1966-90   
% 215.14/215.37  |- mesh__dateCreated mesh__D011352 1999-01-01
% 215.14/215.37  |- skos__annotation mesh__D011352 a central muscle relaxant   
% 215.14/215.37  |- skos__hiddenLabel mesh__D011352 Hydrochloride, Procyclidine
% 215.14/215.37  |- skos__altLabel mesh__D011352 Opus Brand of Procyclidine Hydrochloride
% 215.14/215.37  |- skos__altLabel mesh__D011352
% 215.14/215.37       Glaxo Wellcome Brand of Procyclidine Hydrochloride
% 215.14/215.37  |- skos__altLabel mesh__D011352 Monarch Brand of Procyclidine Hydrochloride
% 215.14/215.37  |- skos__scopeNote mesh__D011352
% 215.14/215.37       A muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in parkinsonism.%A%    
% 215.14/215.37  |- mesh__dateEstablished mesh__D011352 1991-01-01
% 215.14/215.37  |- skos__prefLabel mesh__D011352 Procyclidine
% 215.14/215.37  |- skos__altLabel mesh__D011352
% 215.14/215.37       Rosemont Brand of Procyclidine Hydrochloride
% 215.14/215.37  |- rdf__type mesh__D011352sskos__Concept
% 215.14/215.37  |- skos__altLabel mesh__D011352 ICN Brand of Procyclidine Hydrochloride
% 215.14/215.37  |- mesh__recordOriginator mesh__D011352 NLM
% 215.14/215.37  |- skos__altLabel mesh__D011352 Osnervan
% 215.14/215.37  |- mesh__dateRevised mesh__D011352 2005-06-30
% 215.14/215.37  |- mesh__historyNote mesh__D011352
% 215.14/215.37       91%28%66%29%; was see under PYRROLIDINES 1966-90   
% 215.14/215.37  |- skos__altLabel mesh__D011352
% 215.14/215.37       GlaxoSmithKline Brand of Procyclidine Hydrochloride
% 215.14/215.37  |- mesh__recordMaintainer mesh__D011352 lkw
% 215.14/215.37  |- mesh__recordAuthorizer mesh__D011352 sjn
% 215.14/215.37  |- skos__broader mesh__D011352smesh__D011759
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D011352 2006
% 215.14/215.37  |- skos__altLabel mesh__D011352
% 215.14/215.37       Wellcome Brand of Procyclidine Hydrochloride
% 215.14/215.37  |- skos__related mesh__D005315smesh__D015193
% 215.14/215.37  |- mesh__dateRevised mesh__D005315 2005-06-30
% 215.14/215.37  |- mesh__onlineNote mesh__D005315
% 215.14/215.37       search PRENATAL INFLUENCES under PREGNANCY 1966-72   
% 215.14/215.37  |- skos__hiddenLabel mesh__D005315 Fetal Disease
% 215.14/215.37  |- mesh__publicMeSHNote mesh__D005315
% 215.14/215.37       PRENATAL INFLUENCES was heading 1963-72   
% 215.14/215.37  |- skos__hiddenLabel mesh__D005315 Embryopathy
% 215.14/215.37  |- mesh__recordOriginator mesh__D005315 NLM
% 215.14/215.37  |- rdf__type mesh__D005315sskos__Concept
% 215.14/215.37  |- mesh__recordMaintainer mesh__D005315 lkt
% 215.14/215.37  |- skos__scopeNote mesh__D005315
% 215.14/215.37       Pathophysiological conditions of the FETUS in the UTERUS. Some fetal diseases may be treated with FETAL THERAPIES.%A%    
% 215.14/215.37  |- mesh__historyNote mesh__D005315
% 215.14/215.37       PRENATAL INFLUENCES was heading 1963-72   
% 215.14/215.37  |- skos__broader mesh__D005315smesh__D011248
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D005315 2006
% 215.14/215.37  |- skos__broader mesh__D005315smesh__D009358
% 215.14/215.37  |- skos__hiddenLabel mesh__D005315 Diseases, Fetal
% 215.14/215.37  |- mesh__dateCreated mesh__D005315 1999-01-01
% 215.14/215.37  |- skos__hiddenLabel mesh__D005315 Disease, Fetal
% 215.14/215.37  |- skos__annotation mesh__D005315
% 215.14/215.37       GEN: prefer specifics; FETAL DISTRESS is available; anoxia = FETAL ANOXIA: do not confuse with ASPHYXIA NEONATORUM%A%  
% 215.14/215.37  |- mesh__recordAuthorizer mesh__D005315 sjn
% 215.14/215.37  |- skos__prefLabel mesh__D005315 Fetal Diseases
% 215.14/215.37  |- skos__related mesh__D005315smesh__D000013
% 215.14/215.37  |- skos__broader mesh__D029763smesh__D029760
% 215.14/215.37  |- skos__annotation mesh__D029763
% 215.14/215.37       for Kola or Cola see COLA, for Bitter Kola check if COLA or GARCINIA KOLA; for Gotu Kola use CENTELLA; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.14/215.37  |- skos__scopeNote mesh__D029763
% 215.14/215.37       A plant species of the family CLUSIACEAE.  The common name of %27%Bitter Kola%27% is sometimes also used to refer to COLA.%A%    
% 215.14/215.37  |- mesh__activeMeSHYear mesh__D029763 2005
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D029763 2003
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D029763 2006
% 215.14/215.38  |- mesh__publicMeSHNote mesh__D029763 2002   
% 215.14/215.38  |- mesh__historyNote mesh__D029763 2002   
% 215.14/215.38  |- rdf__type mesh__D029763sskos__Concept
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D029763 2004
% 215.14/215.38  |- skos__altLabel mesh__D029763 Kola, Bitter
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D029763 2002
% 215.14/215.38  |- skos__prefLabel mesh__D029763 Garcinia kola
% 215.14/215.38  |- mesh__dateEstablished mesh__D029763 2002-01-01
% 215.14/215.38  |- mesh__dateCreated mesh__D029763 2001-07-25
% 215.14/215.38  |- skos__altLabel mesh__D029763 Bitter Kola
% 215.14/215.38  |- mesh__publicMeSHNote mesh__D015743 91; was see under GIANT CELLS 1990   
% 215.14/215.38  |- skos__hiddenLabel mesh__D015743 Foreign-Body Giant Cells
% 215.14/215.38  |- rdf__type mesh__D015743sskos__Concept
% 215.14/215.38  |- skos__hiddenLabel mesh__D015743 Giant Cell, Foreign-Body
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D015743 2004
% 215.14/215.38  |- mesh__dateEstablished mesh__D015743 1991-01-01
% 215.14/215.38  |- skos__hiddenLabel mesh__D015743 Foreign-Body Giant Cell
% 215.14/215.38  |- mesh__dateCreated mesh__D015743 1989-04-07
% 215.14/215.38  |- mesh__historyNote mesh__D015743
% 215.14/215.38       91%28%90%29%; was see under GIANT CELLS 1990   
% 215.14/215.38  |- skos__historyNote mesh__D015743 Foreign Body Reaction %28%1972-1989%29%
% 215.14/215.38  |- skos__broader mesh__D015743smesh__D015726
% 215.14/215.38  |- skos__historyNote mesh__D015743 Macrophages %28%1966-1989%29%
% 215.14/215.38  |- skos__altLabel mesh__D015743 Foreign Body-Type Giant Cells
% 215.14/215.38  |- skos__annotation mesh__D015743 a type of macrophage; A 11 qualif   
% 215.14/215.38  |- skos__hiddenLabel mesh__D015743 Cells, Foreign-Body Giant
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D015743 2006
% 215.14/215.38  |- skos__scopeNote mesh__D015743
% 215.14/215.38       Multinucleated cells %28%fused macrophages%29%, characteristic of granulomatous inflammation, which form around exogenous material in the skin. They are similar in appearance to Langhans giant cells %28%GIANT CELLS, LANGHANS%29%, but foreign-body giant cells have more abundant chromatin and their nuclei are scattered in an irregular pattern in the cytoplasm.%A%    
% 215.14/215.38  |- skos__hiddenLabel mesh__D015743 Foreign Body Type Giant Cells
% 215.14/215.38  |- mesh__recordOriginator mesh__D015743 AGS
% 215.14/215.38  |- skos__hiddenLabel mesh__D015743 Giant Cells, Foreign Body
% 215.14/215.38  |- skos__altLabel mesh__D015743 Foreign Body Giant Cell
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D015743 2005
% 215.14/215.38  |- skos__prefLabel mesh__D015743 Giant Cells, Foreign-Body
% 215.14/215.38  |- skos__hiddenLabel mesh__D015743 Cell, Foreign-Body Giant
% 215.14/215.38  |- mesh__recordAuthorizer mesh__D015743 sjn
% 215.14/215.38  |- mesh__recordMaintainer mesh__D015743 nns
% 215.14/215.38  |- skos__broader mesh__D015743smesh__D008264
% 215.14/215.38  |- skos__altLabel mesh__D015743 Foreign Body Giant Cells
% 215.14/215.38  |- mesh__dateRevised mesh__D015743 2003-07-09
% 215.14/215.38  |- mesh__recordMaintainer mesh__D009706 mdb
% 215.14/215.38  |- mesh__historyNote mesh__D009706 98; use explode   
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D009706 2002
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D009706 2005
% 215.14/215.38  |- skos__annotation mesh__D009706
% 215.14/215.38       not used for indexing; NUCLEIC ACIDS; NUCLEOTIDES; %26% NUCLEOSIDES are available      CATALOG: do not use%A%  
% 215.14/215.38  |- mesh__runningHead mesh__D009706
% 215.14/215.38       D13 - NUCLEIC ACIDS, NUCLEOTIDES, AND NUCLEOSIDES   
% 215.14/215.38  |- mesh__recordOriginator mesh__D009706 NLM
% 215.14/215.38  |- mesh__dateRevised mesh__D009706 2001-07-25
% 215.14/215.38  |- mesh__dateCreated mesh__D009706 1999-01-01
% 215.14/215.38  |- mesh__publicMeSHNote mesh__D009706 98   
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D009706 2004
% 215.14/215.38  |- skos__scopeNote mesh__D009706
% 215.14/215.38       Complex compounds of high molecular weight occurring in living cells. These are basically of two types, ribonucleic %28%RNA%29% and deoxyribonucleic %28%DNA%29% acids, both of which consist of nucleotides %28%nucleoside phosphates linked together by phosphate bridges%29%.%A%    
% 215.14/215.38  |- mesh__recordAuthorizer mesh__D009706 sjn
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D009706 2003
% 215.14/215.38  |- mesh__dateEstablished mesh__D009706 1998-01-01
% 215.14/215.38  |- skos__prefLabel mesh__D009706
% 215.14/215.38       Nucleic Acids, Nucleotides, and Nucleosides
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D009706 2006
% 215.14/215.38  |- rdf__type mesh__D009706sskos__Concept
% 215.14/215.38  |- mesh__dateCreated mesh__D001723 1999-01-01
% 215.14/215.38  |- skos__hiddenLabel mesh__D001723 Rate, Fertility
% 215.14/215.38  |- skos__hiddenLabel mesh__D001723 Rates, Age-Specific Fertility
% 215.14/215.38  |- skos__hiddenLabel mesh__D001723 Rates, Age-Specific Birth
% 215.14/215.38  |- skos__hiddenLabel mesh__D001723 Age-Specific Birth Rates
% 215.14/215.38  |- skos__annotation mesh__D001723 specify geography if pertinent   
% 215.14/215.38  |- skos__hiddenLabel mesh__D001723 Age-Specific Fertility Rates
% 215.14/215.38  |- skos__hiddenLabel mesh__D001723 Rates, Birth
% 215.14/215.38  |- skos__hiddenLabel mesh__D001723 Rate, Age-Specific Birth
% 215.14/215.38  |- skos__hiddenLabel mesh__D001723 Fertility Rates
% 215.14/215.38  |- skos__scopeNote mesh__D001723
% 215.14/215.38       The number of births in a given population per year or other unit of time.%A%    
% 215.14/215.38  |- skos__hiddenLabel mesh__D001723 Fertility Rates, Age-Specific
% 215.14/215.38  |- skos__hiddenLabel mesh__D001723 Age Specific Birth Rate
% 215.14/215.38  |- mesh__dateEstablished mesh__D001723 1967-01-01
% 215.14/215.38  |- mesh__recordAuthorizer mesh__D001723 sjn
% 215.14/215.38  |- skos__hiddenLabel mesh__D001723 Age Specific Fertility Rate
% 215.14/215.38  |- skos__hiddenLabel mesh__D001723 Fertility Rate, Age-Specific
% 215.14/215.38  |- mesh__dateRevised mesh__D001723 2004-07-07
% 215.14/215.38  |- skos__hiddenLabel mesh__D001723 Birth Rates
% 215.14/215.38  |- mesh__historyNote mesh__D001723
% 215.14/215.38       1967: use POPULATION %26% VITAL STATISTICS 1963-1966; for AGE-SPECIFIC BIRTH RATE %26% AGE-SPECIFIC FERTILITY RATE use MATERNAL AGE 1980%A%  
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D001723 2006
% 215.14/215.38  |- mesh__publicMeSHNote mesh__D001723
% 215.14/215.38       1967: see POPULATION %26% VITAL STATISTICS 1963-1966; for AGE-SPECIFIC BIRTH RATE %26% AGE-SPECIFIC FERTILITY RATE see MATERNAL AGE 1980%A%  
% 215.14/215.38  |- skos__hiddenLabel mesh__D001723 Rate, Birth
% 215.14/215.38  |- rdf__type mesh__D001723sskos__Concept
% 215.14/215.38  |- skos__hiddenLabel mesh__D001723 Birth Rate, Age-Specific
% 215.14/215.38  |- skos__prefLabel mesh__D001723 Birth Rate
% 215.14/215.38  |- skos__broader mesh__D001723smesh__D018873
% 215.14/215.38  |- skos__hiddenLabel mesh__D001723 Birth Rates, Age-Specific
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D001723 2005
% 215.14/215.38  |- skos__hiddenLabel mesh__D001723 Rates, Fertility
% 215.14/215.38  |- skos__historyNote mesh__D001723 Vital Statistics %28%1966%29%
% 215.14/215.38  |- skos__historyNote mesh__D001723 Population %28%1966%29%
% 215.14/215.38  |- skos__hiddenLabel mesh__D001723 Rate, Age-Specific Fertility
% 215.14/215.38  |- mesh__recordMaintainer mesh__D001723 lkt
% 215.14/215.38  |- mesh__recordOriginator mesh__D001723 NLM
% 215.14/215.38  |- skos__prefLabel mesh__D019336 Cognitive Science
% 215.14/215.38  |- skos__broader mesh__D019336smesh__D011584
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D019336 2005
% 215.14/215.38  |- skos__annotation mesh__D019336 a branch of psychol; SPEC; SPEC qualif   
% 215.14/215.38  |- skos__scopeNote mesh__D019336
% 215.14/215.38       The study of the precise nature of different mental tasks and the operations of the brain that enable them to be performed, engaging branches of psychology, computer science, philosophy, and linguistics. %28%Random House Unabridged Dictionary, 2d ed%29%%A%    
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D019336 2000
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D019336 1998
% 215.14/215.38  |- skos__hiddenLabel mesh__D019336 Science, Cognitive
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D019336 2006
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D019336 2001
% 215.14/215.38  |- rdf__type mesh__D019336sskos__Concept
% 215.14/215.38  |- skos__hiddenLabel mesh__D019336 Sciences, Cognitive
% 215.14/215.38  |- mesh__historyNote mesh__D019336 97   
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D019336 1999
% 215.14/215.38  |- mesh__publicMeSHNote mesh__D019336 97   
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D019336 2003
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D019336 2004
% 215.14/215.38  |- skos__historyNote mesh__D019336 Cognition %28%1981-1996%29%
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D019336 2002
% 215.14/215.38  |- mesh__dateEstablished mesh__D019336 1997-01-01
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D019336 1997
% 215.14/215.38  |- skos__hiddenLabel mesh__D019336 Cognitive Sciences
% 215.14/215.38  |- mesh__dateCreated mesh__D019336 1996-06-10
% 215.14/215.38  |- mesh__publicMeSHNote mesh__D011353 73   
% 215.14/215.38  |- skos__scopeNote mesh__D011353
% 215.14/215.38       4-Methoxy-5-%28%%28%5-methyl-4-pentyl-2H-pyrrol-2-ylidene%29%methyl%29%- 2,2%27%-bi-1H-pyrrole. A toxic, bright red tripyrrole pigment from Serratia marcescens and others. It has antibacterial, anticoccidial, antimalarial, and antifungal activities, but is used mainly as a biochemical tool.%A%    
% 215.14/215.38  |- skos__broader mesh__D011353smesh__D011758
% 215.14/215.38  |- rdf__type mesh__D011353sskos__Concept
% 215.14/215.38  |- mesh__recordMaintainer mesh__D011353 ssb
% 215.14/215.38  |- skos__annotation mesh__D011353
% 215.14/215.38       an antibiotic from Serratia marcescens %26% others; do not confuse with PRODIGIOZAN, another antibiotic from same source; /biosyn permitted if by micro-organism%A%  
% 215.14/215.38  |- mesh__recordOriginator mesh__D011353 NLM
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D011353 2006
% 215.14/215.38  |- mesh__dateRevised mesh__D011353 2005-06-30
% 215.14/215.38  |- mesh__dateEstablished mesh__D011353 1973-01-01
% 215.14/215.38  |- mesh__historyNote mesh__D011353 73%28%63%29%   
% 215.14/215.38  |- mesh__dateCreated mesh__D011353 1999-01-01
% 215.14/215.38  |- skos__broader mesh__D011353smesh__D010860
% 215.14/215.38  |- skos__prefLabel mesh__D011353 Prodigiosin
% 215.14/215.38  |- mesh__recordAuthorizer mesh__D011353 sjn
% 215.14/215.38  |- skos__prefLabel mesh__D005316 Fetal Distress
% 215.14/215.38  |- rdf__type mesh__D005316sskos__Concept
% 215.14/215.38  |- skos__hiddenLabel mesh__D005316 Fetal Status, Nonreassuring
% 215.14/215.38  |- mesh__dateCreated mesh__D005316 1974-11-11
% 215.14/215.38  |- mesh__dateRevised mesh__D005316 2005-06-30
% 215.14/215.38  |- skos__historyNote mesh__D005316 Fetal Diseases %28%1966-1974%29%
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D005316 2006
% 215.14/215.38  |- mesh__recordOriginator mesh__D005316 NLM
% 215.14/215.38  |- mesh__publicMeSHNote mesh__D005316 1975   
% 215.14/215.38  |- mesh__recordMaintainer mesh__D005316 lkt
% 215.14/215.38  |- mesh__dateEstablished mesh__D005316 1975-09-01
% 215.14/215.38  |- mesh__historyNote mesh__D005316 1975   
% 215.14/215.38  |- skos__altLabel mesh__D005316 Nonreassuring Fetal Status
% 215.14/215.38  |- skos__annotation mesh__D005316
% 215.14/215.38       do not confuse with RESPIRATORY DISTRESS SYNDROME, NEWBORN %28%postnatal%29%%A%  
% 215.14/215.38  |- skos__broader mesh__D005316smesh__D012816
% 215.14/215.38  |- mesh__recordAuthorizer mesh__D005316 sjn
% 215.14/215.38  |- skos__scopeNote mesh__D005316
% 215.14/215.38       A nonreassuring fetal status %28%NRFS%29% indicating that the FETUS is compromised %28%American College of Obstetricians and Gynecologists 1988%29%. It can be identified by sub-optimal values in FETAL HEART RATE; oxygenation of FETAL BLOOD; and other parameters.%A%    
% 215.14/215.38  |- mesh__recordMaintainer mesh__D029764 ssb
% 215.14/215.38  |- skos__scopeNote mesh__D029764
% 215.14/215.38       A plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. They are mostly trees and shrubs growing in warm areas.%A%    
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D029764 2006
% 215.14/215.38  |- mesh__recordOriginator mesh__D029764 ssb
% 215.14/215.38  |- mesh__publicMeSHNote mesh__D029764 2002   
% 215.14/215.38  |- rdf__type mesh__D029764sskos__Concept
% 215.14/215.38  |- skos__annotation mesh__D029764
% 215.14/215.38       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D029764 2004
% 215.14/215.38  |- skos__prefLabel mesh__D029764 Combretaceae
% 215.14/215.38  |- mesh__dateEstablished mesh__D029764 2002-01-01
% 215.14/215.38  |- mesh__historyNote mesh__D029764 2002   
% 215.14/215.38  |- mesh__dateRevised mesh__D029764 2003-07-09
% 215.14/215.38  |- mesh__dateCreated mesh__D029764 2001-07-25
% 215.14/215.38  |- mesh__recordAuthorizer mesh__D029764 sjn
% 215.14/215.38  |- skos__broader mesh__D029764smesh__D019684
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D029764 2005
% 215.14/215.38  |- skos__hiddenLabel mesh__D015744 Giant Cells, Langhans-Type
% 215.14/215.38  |- mesh__recordMaintainer mesh__D015744 nns
% 215.14/215.38  |- rdf__type mesh__D015744sskos__Concept
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D015744 2004
% 215.14/215.38  |- skos__altLabel mesh__D015744 Langhans Giant Cells
% 215.14/215.38  |- skos__prefLabel mesh__D015744 Giant Cells, Langhans
% 215.14/215.38  |- skos__historyNote mesh__D015744 Macrophages %28%1966-1989%29%
% 215.14/215.38  |- mesh__recordAuthorizer mesh__D015744 sjn
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D015744 2005
% 215.14/215.38  |- mesh__historyNote mesh__D015744
% 215.14/215.38       91%28%90%29%; was see under GIANT CELLS 1990   
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D015744 2006
% 215.14/215.38  |- skos__broader mesh__D015744smesh__D015726
% 215.14/215.38  |- mesh__dateCreated mesh__D015744 1989-04-07
% 215.14/215.38  |- skos__broader mesh__D015744smesh__D008264
% 215.14/215.38  |- skos__hiddenLabel mesh__D015744 Cells, Langhans Giant
% 215.14/215.38  |- mesh__dateEstablished mesh__D015744 1991-01-01
% 215.14/215.38  |- skos__annotation mesh__D015744
% 215.14/215.38       a type of macrophage; do not confuse with LANGERHANS CELLS %28%cutaneous%29% nor with ISLETS OF LANGERHANS %28%pancreatic%29%; A 11 qualif%A%  
% 215.14/215.38  |- mesh__recordOriginator mesh__D015744 AGS
% 215.14/215.38  |- skos__hiddenLabel mesh__D015744 Cells, Langhans-Type Giant
% 215.14/215.38  |- skos__altLabel mesh__D015744 Langhans-Type Giant Cells
% 215.14/215.38  |- skos__hiddenLabel mesh__D015744 Langhans Type Giant Cells
% 215.14/215.38  |- mesh__publicMeSHNote mesh__D015744 91; was see under GIANT CELLS 1990   
% 215.14/215.38  |- skos__historyNote mesh__D015744 Granuloma, Giant Cell %28%1977-1989%29%
% 215.14/215.38  |- mesh__dateRevised mesh__D015744 2003-07-09
% 215.14/215.38  |- skos__scopeNote mesh__D015744
% 215.14/215.38       Multinucleated cells %28%fused macrophages%29% seen in granulomatous inflammations such as tuberculosis, syphilis, sarcoidosis, and deep fungal infections. They resemble foreign-body giant cells %28%GIANT CELLS, FOREIGN BODY%29% but Langhans giant cells contain less chromatin and their nuclei are arranged peripherally in a horseshoe-shaped pattern. Langhans giant cells occur frequently in delayed hypersensitivity.%A%    
% 215.14/215.38  |- mesh__publicMeSHNote mesh__D009707 80   
% 215.14/215.38  |- mesh__recordAuthorizer mesh__D009707 sjn
% 215.14/215.38  |- skos__broader mesh__D009707smesh__D002843
% 215.14/215.38  |- skos__hiddenLabel mesh__D009707 Polynucleosome
% 215.14/215.38  |- skos__historyNote mesh__D009707 Chromatin %28%1972-1979%29%
% 215.14/215.38  |- skos__prefLabel mesh__D009707 Nucleosomes
% 215.14/215.38  |- skos__hiddenLabel mesh__D009707 Nucleosome
% 215.14/215.38  |- skos__historyNote mesh__D009707 Cell Nucleus %28%1966-1979%29%
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D009707 2004
% 215.14/215.38  |- mesh__historyNote mesh__D009707 80   
% 215.14/215.38  |- rdf__type mesh__D009707sskos__Concept
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D009707 2006
% 215.14/215.38  |- mesh__dateRevised mesh__D009707 2003-07-09
% 215.14/215.38  |- skos__hiddenLabel mesh__D009707 Dinucleosome
% 215.14/215.38  |- skos__annotation mesh__D009707
% 215.14/215.38       A 11 qualif except /cytol; /genet permitted   
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D009707 2005
% 215.14/215.38  |- mesh__recordMaintainer mesh__D009707 nns
% 215.14/215.38  |- mesh__dateEstablished mesh__D009707 1980-01-01
% 215.14/215.38  |- mesh__dateCreated mesh__D009707 1978-12-20
% 215.14/215.38  |- skos__scopeNote mesh__D009707
% 215.14/215.38       The repeating structural units of chromatin, each consisting of approximately 200 base pairs of DNA wound around a protein core. This core is composed of the histones H2A, H2B, H3, and H4.%A%    
% 215.14/215.38  |- mesh__recordOriginator mesh__D009707 VDK
% 215.14/215.38  |- mesh__dateRevised mesh__D001724 2004-07-07
% 215.14/215.38  |- skos__scopeNote mesh__D001724
% 215.14/215.38       The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.%A%    
% 215.14/215.38  |- skos__prefLabel mesh__D001724 Birth Weight
% 215.14/215.38  |- skos__broader mesh__D001724smesh__D001835
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D001724 2006
% 215.14/215.38  |- mesh__recordMaintainer mesh__D001724 lkt
% 215.14/215.38  |- skos__hiddenLabel mesh__D001724 Weight, Birth
% 215.14/215.38  |- skos__hiddenLabel mesh__D001724 Birth Weights
% 215.14/215.38  |- rdf__type mesh__D001724sskos__Concept
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D001724 2005
% 215.14/215.38  |- mesh__recordOriginator mesh__D001724 NLM
% 215.14/215.38  |- skos__related mesh__D001724smesh__D007230
% 215.14/215.38  |- mesh__dateCreated mesh__D001724 1999-01-01
% 215.14/215.38  |- skos__related mesh__D001724smesh__D019102
% 215.14/215.38  |- mesh__recordAuthorizer mesh__D001724 sjn
% 215.14/215.38  |- skos__hiddenLabel mesh__D001724 Weights, Birth
% 215.14/215.38  |- skos__annotation mesh__D001724 IM   
% 215.14/215.38  |- mesh__dateRevised mesh__D020689 2003-07-09
% 215.14/215.38  |- mesh__publicMeSHNote mesh__D020689
% 215.14/215.38       2000; EXOPROTEASES %28%now EXOPEPTIDASES%29% was indexed under PEPTIDE HYDROLASES 1977-1999%A%  
% 215.14/215.38  |- rdf__type mesh__D020689sskos__Concept
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D020689 2005
% 215.14/215.38  |- skos__broader mesh__D020689smesh__D010447
% 215.14/215.38  |- skos__prefLabel mesh__D020689 Exopeptidases
% 215.14/215.38  |- mesh__dateCreated mesh__D020689 1999-11-03
% 215.14/215.38  |- skos__historyNote mesh__D020689 Peptide Hydrolases %28%1977-1999%29%
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D020689 2006
% 215.14/215.38  |- mesh__recordOriginator mesh__D020689 adp
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D020689 2004
% 215.14/215.38  |- mesh__historyNote mesh__D020689
% 215.14/215.38       2000; use EXOPEPTIDASES %28%NM%29% 1977-1999   
% 215.14/215.38  |- skos__altLabel mesh__D020689 Exoprotease
% 215.14/215.38  |- mesh__recordMaintainer mesh__D020689 ssb
% 215.14/215.38  |- mesh__recordAuthorizer mesh__D020689 sjn
% 215.14/215.38  |- skos__altLabel mesh__D020689 Exopeptidase
% 215.14/215.38  |- skos__scopeNote mesh__D020689
% 215.14/215.38       A sub-subclass of PEPTIDE HYDROLASES that act only near the ends of polypeptide chains. Exopeptidases are further divided into AMINOPEPTIDASES; EC 3.4.11; DIPEPTIDASES; EC 3.4.13; DIPEPTIDYL PEPTIDASES %26% tripeptidyl peptidases, EC 3.4.14; peptidyl-dipeptidases, EC 3.4.15; CARBOXYPEPTIDASES; EC 3.4.16 - EC 3.4.18, and omega peptidases, EC 3.4.19. EC 3.4.-.%A%    
% 215.14/215.38  |- mesh__dateEstablished mesh__D020689 2000-01-01
% 215.14/215.38  |- skos__altLabel mesh__D020689 Exoproteases
% 215.14/215.38  |- mesh__recordMaintainer mesh__D047028 ssb
% 215.14/215.38  |- skos__broader mesh__D047028smesh__D011083
% 215.14/215.38  |- mesh__dateCreated mesh__D047028 2004-07-07
% 215.14/215.38  |- mesh__publicMeSHNote mesh__D047028 2005   
% 215.14/215.38  |- skos__hiddenLabel mesh__D047028 Compounds, Macrocyclic
% 215.14/215.38  |- skos__annotation mesh__D047028
% 215.14/215.38       general or unspecified; prefer specific group or specific compound%A%  
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D047028 2005
% 215.14/215.38  |- mesh__recordOriginator mesh__D047028 ssb
% 215.14/215.38  |- skos__scopeNote mesh__D047028
% 215.14/215.38       Cyclic compounds with a ring size of approximately 1-4 dozen atoms.%A%    
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D047028 2006
% 215.14/215.38  |- mesh__recordAuthorizer mesh__D047028 sjn
% 215.14/215.38  |- mesh__historyNote mesh__D047028 2005   
% 215.14/215.38  |- skos__altLabel mesh__D047028 Macrocycle Compounds
% 215.14/215.38  |- skos__prefLabel mesh__D047028 Macrocyclic Compounds
% 215.14/215.38  |- mesh__dateEstablished mesh__D047028 2005-01-01
% 215.14/215.38  |- rdf__type mesh__D047028sskos__Concept
% 215.14/215.38  |- skos__hiddenLabel mesh__D047028 Compounds, Macrocycle
% 215.14/215.38  |- skos__hiddenLabel mesh__D019337 Neoplasm, Hematopoietic
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D019337 1997
% 215.14/215.38  |- mesh__dateCreated mesh__D019337 1996-06-10
% 215.14/215.38  |- skos__hiddenLabel mesh__D019337 Malignancies, Hematopoietic
% 215.14/215.38  |- skos__related mesh__D019337smesh__D007938
% 215.14/215.38  |- rdf__type mesh__D019337sskos__Concept
% 215.14/215.38  |- skos__hiddenLabel mesh__D019337 Neoplasm, Hematological
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D019337 2005
% 215.14/215.38  |- skos__altLabel mesh__D019337 Hematologic Malignancies
% 215.14/215.38  |- skos__hiddenLabel mesh__D019337 Malignancies, Hematological
% 215.14/215.38  |- skos__related mesh__D019337smesh__D008223
% 215.14/215.38  |- skos__altLabel mesh__D019337 Hematological Neoplasms
% 215.14/215.38  |- skos__hiddenLabel mesh__D019337 Hematologic Neoplasm
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D019337 2001
% 215.14/215.38  |- skos__altLabel mesh__D019337 Hematopoietic Malignancies
% 215.14/215.38  |- skos__hiddenLabel mesh__D019337 Neoplasms, Hematological
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D019337 1999
% 215.14/215.38  |- mesh__dateEstablished mesh__D019337 1997-01-01
% 215.14/215.38  |- skos__altLabel mesh__D019337 Hematologic Malignancy
% 215.14/215.38  |- mesh__publicMeSHNote mesh__D019337 97   
% 215.14/215.38  |- skos__hiddenLabel mesh__D019337 Hematological Malignancy
% 215.14/215.38  |- skos__hiddenLabel mesh__D019337 Hematopoietic Neoplasm
% 215.14/215.38  |- skos__broader mesh__D019337smesh__D009371
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D019337 2000
% 215.14/215.38  |- skos__altLabel mesh__D019337 Hematological Malignancies
% 215.14/215.38  |- skos__broader mesh__D019337smesh__D006402
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D019337 2004
% 215.14/215.38  |- skos__altLabel mesh__D019337 Malignancy, Hematologic
% 215.14/215.38  |- skos__hiddenLabel mesh__D019337 Hematopoietic Malignancy
% 215.14/215.38  |- skos__historyNote mesh__D019337 specific lymphomas %28%1968-1996%29%
% 215.14/215.38  |- skos__altLabel mesh__D019337 Neoplasms, Hematologic
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D019337 1998
% 215.14/215.38  |- skos__prefLabel mesh__D019337 Hematologic Neoplasms
% 215.14/215.38  |- skos__historyNote mesh__D019337 Neoplasms %28%1967-1996%29%
% 215.14/215.38  |- skos__annotation mesh__D019337
% 215.14/215.38       GEN or unspecified only; prefer LEUKEMIA or LYMPHOMA or their specifics; do not use /blood supply /second /secret; DF: HEMATOL NEOPL%A%  
% 215.14/215.38  |- skos__hiddenLabel mesh__D019337 Neoplasm, Hematologic
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D019337 2003
% 215.14/215.38  |- skos__altLabel mesh__D019337 Malignancies, Hematologic
% 215.14/215.38  |- skos__historyNote mesh__D019337 Hematologic Diseases %28%1969-1996%29%
% 215.14/215.38  |- skos__altLabel mesh__D019337 Neoplasms, Hematopoietic
% 215.14/215.38  |- skos__hiddenLabel mesh__D019337 Hematological Neoplasm
% 215.14/215.38  |- skos__historyNote mesh__D019337 specific leukemias %28%1968-1996%29%
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D019337 2002
% 215.14/215.38  |- skos__scopeNote mesh__D019337
% 215.14/215.38       Neoplasms located in the blood and blood-forming tissue %28%the bone marrow and lymphatic tissue%29%. The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.%A%    
% 215.14/215.38  |- mesh__historyNote mesh__D019337 97   
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D019337 2006
% 215.14/215.38  |- skos__hiddenLabel mesh__D019337 Malignancy, Hematopoietic
% 215.14/215.38  |- skos__hiddenLabel mesh__D019337 Malignancy, Hematological
% 215.14/215.38  |- skos__annotation mesh__D011354
% 215.14/215.38       Do not confuse with PRODIGIOSIN, an antibiotic from same source%A%  
% 215.14/215.38  |- skos__prefLabel mesh__D011354 Prodigiozan
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D011354 2005
% 215.14/215.38  |- mesh__publicMeSHNote mesh__D011354
% 215.14/215.38       91; was see under POLYSACCHARIDES, BACTERIAL 1979-90   
% 215.14/215.38  |- skos__historyNote mesh__D011354 Prodigiosin %28%1966-1978%29%
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D011354 2006
% 215.14/215.38  |- skos__altLabel mesh__D011354 Prodigiosan
% 215.14/215.38  |- mesh__recordAuthorizer mesh__D011354 sjn
% 215.14/215.38  |- mesh__recordOriginator mesh__D011354 RLS
% 215.14/215.38  |- mesh__recordMaintainer mesh__D011354 ssb
% 215.14/215.38  |- mesh__historyNote mesh__D011354
% 215.14/215.38       91%28%79%29%; was see under POLYSACCHARIDES, BACTERIAL 1979-90   
% 215.14/215.38  |- rdf__type mesh__D011354sskos__Concept
% 215.14/215.38  |- skos__historyNote mesh__D011354
% 215.14/215.38       Polysaccharides, Bacterial %28%1966-1978%29%
% 215.14/215.38  |- mesh__dateRevised mesh__D011354 2004-07-07
% 215.14/215.38  |- mesh__dateCreated mesh__D011354 1978-03-13
% 215.14/215.38  |- skos__scopeNote mesh__D011354
% 215.14/215.38       A polysaccharide extracted from Serratia marcescens and other bacteria. It activates enzymatic activity of macrophages and stimulates phagocytic processes.%A%    
% 215.14/215.38  |- skos__broader mesh__D011354smesh__D011135
% 215.14/215.38  |- mesh__dateEstablished mesh__D011354 1991-01-01
% 215.14/215.38  |- rdf__type mesh__D005317sskos__Concept
% 215.14/215.38  |- mesh__recordOriginator mesh__D005317 AEP
% 215.14/215.38  |- skos__broader mesh__D005317smesh__D005315
% 215.14/215.38  |- skos__altLabel mesh__D005317 Growth Retardation, Intrauterine
% 215.14/215.38  |- mesh__dateCreated mesh__D005317 1977-03-02
% 215.14/215.38  |- skos__prefLabel mesh__D005317 Fetal Growth Retardation
% 215.14/215.38  |- mesh__dateEstablished mesh__D005317 1978-01-01
% 215.14/215.38  |- mesh__dateRevised mesh__D005317 2005-06-30
% 215.14/215.38  |- skos__hiddenLabel mesh__D005317 Growth Retardation, Fetal
% 215.14/215.38  |- skos__historyNote mesh__D005317 Growth %28%1966-1971%29%
% 215.14/215.38  |- mesh__historyNote mesh__D005317 78   
% 215.14/215.38  |- skos__hiddenLabel mesh__D005317 Retardation, Fetal Growth
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D005317 2006
% 215.14/215.38  |- skos__historyNote mesh__D005317 Growth Disorders %28%1972-1977%29%
% 215.14/215.38  |- mesh__recordMaintainer mesh__D005317 lkt
% 215.14/215.38  |- skos__historyNote mesh__D005317 Fetal Diseases %28%1966-1977%29%
% 215.14/215.38  |- skos__altLabel mesh__D005317 Intrauterine Growth Retardation
% 215.14/215.38  |- skos__broader mesh__D005317smesh__D006130
% 215.14/215.38  |- mesh__publicMeSHNote mesh__D005317 78   
% 215.14/215.38  |- mesh__recordAuthorizer mesh__D005317 sjn
% 215.14/215.38  |- skos__scopeNote mesh__D005317
% 215.14/215.38       The failure of a FETUS to attain its expected FETAL GROWTH at any GESTATIONAL AGE.%A%    
% 215.14/215.38  |- skos__altLabel mesh__D005317 IUGR
% 215.14/215.38  |- skos__related mesh__D005317smesh__D007236
% 215.14/215.38  |- skos__hiddenLabel mesh__D005317 Retardation, Intrauterine Growth
% 215.14/215.38  |- mesh__historyNote mesh__D029765 2002   
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D029765 2002
% 215.14/215.38  |- mesh__dateEstablished mesh__D029765 2002-01-01
% 215.14/215.38  |- mesh__dateCreated mesh__D029765 2001-07-25
% 215.14/215.38  |- skos__prefLabel mesh__D029765 Combretum
% 215.14/215.38  |- skos__broader mesh__D029765smesh__D029764
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D029765 2005
% 215.14/215.38  |- skos__scopeNote mesh__D029765
% 215.14/215.38       A plant genus of the family COMBRETACEAE. Triterpenes and combretastatin have been identified in members of this genus.%A%    
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D029765 2003
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D029765 2006
% 215.14/215.38  |- skos__annotation mesh__D029765
% 215.14/215.38       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.14/215.38  |- mesh__publicMeSHNote mesh__D029765 2002   
% 215.14/215.38  |- rdf__type mesh__D029765sskos__Concept
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D029765 2004
% 215.14/215.38  |- skos__altLabel mesh__D021782 Multicystic Renal Dysplasia
% 215.14/215.38  |- skos__altLabel mesh__D021782 Multicystic Kidney Dysplasia
% 215.14/215.38  |- skos__prefLabel mesh__D021782 Multicystic Dysplastic Kidney
% 215.14/215.38  |- mesh__historyNote mesh__D021782 2001   
% 215.14/215.38  |- mesh__dateEstablished mesh__D021782 2001-01-01
% 215.14/215.38  |- rdf__type mesh__D021782sskos__Concept
% 215.14/215.38  |- mesh__dateRevised mesh__D021782 2005-07-28
% 215.14/215.38  |- skos__annotation mesh__D021782
% 215.14/215.38       do not confuse with POLYCYSTIC KIDNEY DISEASES, a genetic defect%A%  
% 215.14/215.38  |- skos__hiddenLabel mesh__D021782 Renal Dysplasias, Multicystic
% 215.14/215.38  |- skos__hiddenLabel mesh__D021782 Kidney Dysplasia, Multicystic
% 215.14/215.38  |- mesh__dateCreated mesh__D021782 2000-06-27
% 215.14/215.38  |- skos__hiddenLabel mesh__D021782 Multicystic Dysplastic Kidneys
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D021782 2006
% 215.14/215.38  |- skos__hiddenLabel mesh__D021782 Kidney Dysplasias, Multicystic
% 215.14/215.38  |- skos__hiddenLabel mesh__D021782 Renal Dysplasia, Multicystic
% 215.14/215.38  |- skos__hiddenLabel mesh__D021782 Multicystic Kidney Dysplasias
% 215.14/215.38  |- mesh__recordMaintainer mesh__D021782 ags
% 215.14/215.38  |- skos__broader mesh__D021782smesh__D052177
% 215.14/215.38  |- mesh__publicMeSHNote mesh__D021782 2001   
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D021782 2006A
% 215.14/215.38  |- skos__scopeNote mesh__D021782
% 215.14/215.38       A nongenetic defect due to malformation of the KIDNEY which appears as a bunch of grapes with multiple renal cysts but lacking the normal renal bean shape, and the collection drainage system. This condition can be detected in-utero with ULTRASONOGRAPHY.%A%    
% 215.14/215.38  |- skos__hiddenLabel mesh__D021782 Dysplasia, Multicystic Renal
% 215.14/215.38  |- skos__broader mesh__D021782smesh__D014564
% 215.14/215.38  |- skos__hiddenLabel mesh__D021782 Dysplasia, Multicystic Kidney
% 215.14/215.38  |- skos__hiddenLabel mesh__D021782 Multicystic Kidneys
% 215.14/215.38  |- skos__altLabel mesh__D021782 Multicystic Kidney
% 215.14/215.38  |- mesh__recordOriginator mesh__D021782 jmp
% 215.14/215.38  |- skos__hiddenLabel mesh__D021782 Dysplasias, Multicystic Kidney
% 215.14/215.38  |- mesh__recordAuthorizer mesh__D021782 ags
% 215.14/215.38  |- skos__hiddenLabel mesh__D021782 Multicystic Renal Dysplasias
% 215.14/215.38  |- skos__historyNote mesh__D021782
% 215.14/215.38       Polycystic Kidney Diseases %28%1966-2000%29%
% 215.14/215.38  |- skos__hiddenLabel mesh__D021782 Dysplasias, Multicystic Renal
% 215.14/215.38  |- skos__scopeNote mesh__D015745
% 215.14/215.38       Histiocytic, inflammatory response to a foreign body. It consists of modified macrophages with multinucleated giant cells, in this case foreign-body giant cells %28%GIANT CELLS, FOREIGN-BODY%29%, usually surrounded by lymphocytes.%A%    
% 215.14/215.38  |- skos__historyNote mesh__D015745 Granuloma %28%1966-1989%29%
% 215.14/215.38  |- skos__altLabel mesh__D015745 Foreign-Body Granuloma
% 215.14/215.38  |- mesh__recordAuthorizer mesh__D015745 sjn
% 215.14/215.38  |- mesh__dateRevised mesh__D015745 1999-11-03
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D015745 2002
% 215.14/215.38  |- mesh__activeMeSHYear mesh__D015745 2004
% 215.14/215.38  |- mesh__historyNote mesh__D015745
% 215.14/215.38       91%28%90%29%; was see under FOREIGN BODY REACTION 1990   
% 215.14/215.38  |- mesh__recordMaintainer mesh__D015745 KEV
% 215.14/215.39  |- skos__broader mesh__D015745smesh__D005549
% 215.14/215.39  |- skos__prefLabel mesh__D015745 Granuloma, Foreign-Body
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D015745 2005
% 215.14/215.39  |- skos__hiddenLabel mesh__D015745 Foreign Body Granuloma
% 215.14/215.39  |- skos__hiddenLabel mesh__D015745 Foreign-Body Granulomas
% 215.14/215.39  |- mesh__dateEstablished mesh__D015745 1991-01-01
% 215.14/215.39  |- mesh__publicMeSHNote mesh__D015745
% 215.14/215.39       91; was see under FOREIGN BODY REACTION 1990   
% 215.14/215.39  |- skos__historyNote mesh__D015745 Foreign Bodies %28%1966-1989%29%
% 215.14/215.39  |- mesh__recordOriginator mesh__D015745 AGS
% 215.14/215.39  |- skos__hiddenLabel mesh__D015745 Granuloma, Foreign Body
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D015745 2006
% 215.14/215.39  |- skos__broader mesh__D015745smesh__D006099
% 215.14/215.39  |- skos__hiddenLabel mesh__D015745 Granulomas, Foreign-Body
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D015745 2000
% 215.14/215.39  |- mesh__dateCreated mesh__D015745 1989-06-19
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D015745 2001
% 215.14/215.39  |- skos__historyNote mesh__D015745 Foreign Body Reaction %28%1972-1989%29%
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D015745 2003
% 215.14/215.39  |- rdf__type mesh__D015745sskos__Concept
% 215.14/215.39  |- mesh__dateCreated mesh__D009708 1999-01-01
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D009708 2004
% 215.14/215.39  |- mesh__recordMaintainer mesh__D009708 ssb
% 215.14/215.39  |- rdf__type mesh__D009708sskos__Concept
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D009708 2006
% 215.14/215.39  |- mesh__dateRevised mesh__D009708 2003-07-09
% 215.14/215.39  |- skos__scopeNote mesh__D009708
% 215.14/215.39       A class of enzymes that catalyze the conversion of a nucleotide and water to a nucleoside and orthophosphate. EC 3.1.3.-.%A%    
% 215.14/215.39  |- mesh__recordAuthorizer mesh__D009708 sjn
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D009708 2005
% 215.14/215.39  |- skos__broader mesh__D009708smesh__D010744
% 215.14/215.39  |- skos__prefLabel mesh__D009708 Nucleotidases
% 215.14/215.39  |- mesh__recordOriginator mesh__D009708 NLM
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D001725 2004
% 215.14/215.39  |- rdf__type mesh__D001725sskos__Concept
% 215.14/215.39  |- mesh__onlineNote mesh__D001725
% 215.14/215.39       use BIS%28%CHLOROMETHYL%29% ETHER to search DICHLOROMETHYL ETHER 1975-78%A%  
% 215.14/215.39  |- skos__historyNote mesh__D001725 Ethers %28%1966-1973%29%
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D001725 2005
% 215.14/215.39  |- mesh__dateRevised mesh__D001725 2000-06-22
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D001725 2003
% 215.14/215.39  |- skos__broader mesh__D001725smesh__D008738
% 215.14/215.39  |- mesh__recordOriginator mesh__D001725 SH
% 215.14/215.39  |- skos__altLabel mesh__D001725 Dichloromethyl Ether
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D001725 2001
% 215.14/215.39  |- skos__historyNote mesh__D001725 Methyl Ethers %28%1974%29%
% 215.14/215.39  |- mesh__dateEstablished mesh__D001725 1991-01-01
% 215.14/215.39  |- skos__historyNote mesh__D001725 Methyl Chloride %28%1966-1974%29%
% 215.14/215.39  |- skos__altLabel mesh__D001725 Chloromethyl Ether
% 215.14/215.39  |- skos__altLabel mesh__D001725 Bis%28%Chloromethyl%29%Ether
% 215.14/215.39  |- skos__hiddenLabel mesh__D001725 Ether, Chloromethyl
% 215.14/215.39  |- skos__scopeNote mesh__D001725
% 215.14/215.39       A substance that is an irritant to the eyes and respiratory tract and may be carcinogenic.%A%    
% 215.14/215.39  |- mesh__historyNote mesh__D001725
% 215.14/215.39       91%28%79%29%; was see under METHYL ETHERS 1979-90; was DICHLOROMETHYL ETHER see under METHYL ETHERS 1975-78%A%  
% 215.14/215.39  |- mesh__dateCreated mesh__D001725 1974-11-19
% 215.14/215.39  |- skos__prefLabel mesh__D001725 Bis%28%Chloromethyl%29% Ether
% 215.14/215.39  |- skos__hiddenLabel mesh__D001725 Ether, Dichloromethyl
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D001725 2006
% 215.14/215.39  |- mesh__recordAuthorizer mesh__D001725 sjn
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D001725 2002
% 215.14/215.39  |- mesh__publicMeSHNote mesh__D001725
% 215.14/215.39       91; was see under METHYL ETHERS 1979-90; was DICHLOROMETHYL ETHER see under METHYL ETHERS 1975-78%A%  
% 215.14/215.39  |- mesh__recordMaintainer mesh__D001725 CCR
% 215.14/215.39  |- mesh__dateRevised mesh__D034101 2005-06-30
% 215.14/215.39  |- skos__scopeNote mesh__D034101
% 215.14/215.39       The product of meiotic division of zygotes in parasitic PROTOZOA comprising haploid cells.  These infective cells invade the host and undergo asexual reproduction producing merozoites %28%or other forms%29% and ultimately gametocytes.%A%    
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D034101 2006
% 215.14/215.39  |- mesh__recordOriginator mesh__D034101 ags
% 215.14/215.39  |- mesh__recordAuthorizer mesh__D034101 sjn
% 215.14/215.39  |- mesh__dateEstablished mesh__D034101 2003-01-01
% 215.14/215.39  |- mesh__recordMaintainer mesh__D034101 SYSTEM
% 215.14/215.39  |- skos__prefLabel mesh__D034101 Sporozoites
% 215.14/215.39  |- mesh__historyNote mesh__D034101 2003   
% 215.14/215.39  |- skos__broader mesh__D034101smesh__D033761
% 215.14/215.39  |- mesh__dateCreated mesh__D034101 2002-07-03
% 215.14/215.39  |- rdf__type mesh__D034101sskos__Concept
% 215.14/215.39  |- mesh__publicMeSHNote mesh__D034101 2003   
% 215.14/215.39  |- skos__altLabel mesh__D006410 Haematopoiesis
% 215.14/215.39  |- mesh__recordMaintainer mesh__D006410 nns
% 215.14/215.39  |- mesh__recordOriginator mesh__D006410 NLM
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D006410 2006
% 215.14/215.39  |- mesh__dateRevised mesh__D006410 2003-07-09
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D006410 2004
% 215.14/215.39  |- mesh__dateCreated mesh__D006410 1999-01-01
% 215.14/215.39  |- skos__annotation mesh__D006410 GEN or unspecified; prefer specifics   
% 215.14/215.39  |- skos__scopeNote mesh__D006410
% 215.14/215.39       The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW %28%medullary%29% or outside the bone marrow %28%HEMATOPOIESIS, EXTRAMEDULLARY%29%.%A%    
% 215.14/215.39  |- skos__hiddenLabel mesh__D006410 Medullary Hematopoiesis
% 215.14/215.39  |- mesh__recordAuthorizer mesh__D006410 sjn
% 215.14/215.39  |- skos__broader mesh__D006410smesh__D002454
% 215.14/215.39  |- skos__broader mesh__D006410smesh__D045123
% 215.14/215.39  |- skos__prefLabel mesh__D006410 Hematopoiesis
% 215.14/215.39  |- rdf__type mesh__D006410sskos__Concept
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D006410 2005
% 215.14/215.39  |- mesh__recordMaintainer mesh__D047029 ssb
% 215.14/215.39  |- mesh__publicMeSHNote mesh__D047029
% 215.14/215.39       2005; ANSAMYCINS was indexed under ANTI-BACTERIAL AGENTS 1974-2004%A%  
% 215.14/215.39  |- mesh__dateCreated mesh__D047029 2004-07-07
% 215.14/215.39  |- mesh__historyNote mesh__D047029
% 215.14/215.39       2005; for ANSAMYCINS use LACTAMS, MACROCYCLIC 1974-2004   
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D047029 2005
% 215.14/215.39  |- mesh__recordAuthorizer mesh__D047029 sjn
% 215.14/215.39  |- skos__altLabel mesh__D047029 Macrocyclic Lactams
% 215.14/215.39  |- mesh__recordOriginator mesh__D047029 ssb
% 215.14/215.39  |- skos__scopeNote mesh__D047029
% 215.14/215.39       LACTAMS forming compounds with a ring size of approximately 1-3 dozen atoms.%A%    
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D047029 2006
% 215.14/215.39  |- rdf__type mesh__D047029sskos__Concept
% 215.14/215.39  |- skos__broader mesh__D047029smesh__D047028
% 215.14/215.39  |- mesh__dateEstablished mesh__D047029 2005-01-01
% 215.14/215.39  |- skos__altLabel mesh__D047029 Cyclams
% 215.14/215.39  |- skos__broader mesh__D047029smesh__D007769
% 215.14/215.39  |- skos__prefLabel mesh__D047029 Lactams, Macrocyclic
% 215.14/215.39  |- mesh__recordOriginator mesh__D019338 TGC
% 215.14/215.39  |- mesh__publicMeSHNote mesh__D019338 97   
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D019338 2004
% 215.14/215.39  |- skos__related mesh__D019338smesh__D004359
% 215.14/215.39  |- mesh__dateRevised mesh__D019338 1997-06-20
% 215.14/215.39  |- mesh__dateEstablished mesh__D019338 1997-01-01
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D019338 2002
% 215.14/215.39  |- mesh__dateCreated mesh__D019338 1996-06-10
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D019338 2005
% 215.14/215.39  |- skos__broader mesh__D019338smesh__D004358
% 215.14/215.39  |- mesh__recordAuthorizer mesh__D019338 SJN
% 215.14/215.39  |- skos__related mesh__D019338smesh__D004338
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D019338 2006
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D019338 1998
% 215.14/215.39  |- skos__prefLabel mesh__D019338 Polypharmacy
% 215.14/215.39  |- skos__scopeNote mesh__D019338
% 215.14/215.39       The use of multiple drugs administered to the same patient, most commonly seen in elderly patients. It includes also the administration of excessive medication. Since in the United States most drugs are dispensed as single-agent formulations, polypharmacy, though using many drugs administered to the same patient, must be differentiated from DRUG COMBINATIONS, single preparations containing two or more drugs as a fixed dose, and from DRUG THERAPY, COMBINATION, two or more drugs administered separately for a combined effect. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 215.14/215.39  |- skos__related mesh__D019338smesh__D004336
% 215.14/215.39  |- mesh__recordMaintainer mesh__D019338 TPW
% 215.14/215.39  |- rdf__type mesh__D019338sskos__Concept
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D019338 2000
% 215.14/215.39  |- mesh__historyNote mesh__D019338 97   
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D019338 1999
% 215.14/215.39  |- skos__annotation mesh__D019338
% 215.14/215.39       note category: a type of DRUG THERAPY, not a pharmacy specialty; multiple drugs given to the same patient; do not confuse with DRUG COMBINATIONS %28% = 2 or more drugs in a single dosage form%29% or with POLYCHEMOTHERAPY see DRUG THERAPY, COMBINATION %28% = 2 or more drugs given separately for a combined eff%29%; DF: POLYPHARM%A%  
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D019338 2003
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D019338 2001
% 215.14/215.39  |- mesh__activeMeSHYear mesh__D011355 2006
% 215.14/215.39  |- skos__altLabel mesh__D011355 Pro-Drugs
% 215.14/215.39  |- skos__altLabel mesh__D011355 Drug Precursors
% 215.14/215.39  |- skos__prefLabel mesh__D011355 Prodrugs
% 215.25/215.39  |- mesh__dateRevised mesh__D011355 2003-07-09
% 215.25/215.39  |- mesh__recordOriginator mesh__D011355 CC
% 215.25/215.39  |- mesh__dateCreated mesh__D011355 1987-05-04
% 215.25/215.39  |- skos__historyNote mesh__D011355
% 215.25/215.39       Delayed-Action Preparations %28%1966-1987%29%
% 215.25/215.39  |- mesh__recordAuthorizer mesh__D011355 sjn
% 215.25/215.39  |- mesh__historyNote mesh__D011355
% 215.25/215.39       89%28%88%29%; was see under DRUGS 1988   
% 215.25/215.39  |- skos__broader mesh__D011355smesh__D004364
% 215.25/215.39  |- rdf__type mesh__D011355sskos__Concept
% 215.25/215.39  |- skos__hiddenLabel mesh__D011355 Precursors, Drug
% 215.25/215.39  |- mesh__dateEstablished mesh__D011355 1989-01-01
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D011355 2004
% 215.25/215.39  |- skos__scopeNote mesh__D011355
% 215.25/215.39       A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.%A%    
% 215.25/215.39  |- skos__hiddenLabel mesh__D011355 Pro Drugs
% 215.25/215.39  |- mesh__recordMaintainer mesh__D011355 ssb
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D011355 2005
% 215.25/215.39  |- skos__annotation mesh__D011355
% 215.25/215.39       %22%a cpd that on admin must undergo chem conversion by metab processes before becoming the pharmacologically active drug for which it is a prodrug%22%; D25-26 qualif; coord IM with specific drug %28%IM%29%%A%  
% 215.25/215.39  |- mesh__publicMeSHNote mesh__D011355 89; was see under DRUGS 1988   
% 215.25/215.39  |- rdf__type mesh__D005318sskos__Concept
% 215.25/215.39  |- skos__scopeNote mesh__D005318
% 215.25/215.39       The heart of the fetus of any viviparous animal. It refers to the heart in the postembryonic period and is differentiated from the embryonic heart %28%HEART/embryology%29% only on the basis of time.%A%    
% 215.25/215.39  |- skos__annotation mesh__D005318
% 215.25/215.39       mammals only; use all pertinent qualif %28%except /blood supply%29% %26% do not coord with MYOCARDIUM for HEART; MYOCARDIUM restrictions; not for chick embryo heart %28% = CHICK EMBRYO + HEART /embryol%29%%A%  
% 215.25/215.39  |- mesh__recordAuthorizer mesh__D005318 ags
% 215.25/215.39  |- mesh__dateRevised mesh__D005318 2005-07-15
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D005318 2006A
% 215.25/215.39  |- mesh__recordMaintainer mesh__D005318 ags
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D005318 2003
% 215.25/215.39  |- skos__hiddenLabel mesh__D005318 Fetal Hearts
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D005318 2002
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D005318 2005
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D005318 2004
% 215.25/215.39  |- skos__broader mesh__D005318smesh__D005333
% 215.25/215.39  |- skos__broader mesh__D005318smesh__D006321
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D005318 1996
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D005318 2006
% 215.25/215.39  |- mesh__recordOriginator mesh__D005318 NLM
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D005318 2000
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D005318 1998
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D005318 1997
% 215.25/215.39  |- skos__hiddenLabel mesh__D005318 Heart, Fetal
% 215.25/215.39  |- skos__prefLabel mesh__D005318 Fetal Heart
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D005318 2001
% 215.25/215.39  |- skos__hiddenLabel mesh__D005318 Hearts, Fetal
% 215.25/215.39  |- mesh__dateCreated mesh__D005318 1999-01-01
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D005318 1999
% 215.25/215.39  |- skos__hiddenLabel mesh__D016040 Graftings, Lung
% 215.25/215.39  |- mesh__recordMaintainer mesh__D016040 sjn
% 215.25/215.39  |- skos__prefLabel mesh__D016040 Lung Transplantation
% 215.25/215.39  |- skos__broader mesh__D016040smesh__D013510
% 215.25/215.39  |- skos__hiddenLabel mesh__D016040 Lung Transplantations
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D016040 2006
% 215.25/215.39  |- skos__hiddenLabel mesh__D016040 Lung Graftings
% 215.25/215.39  |- skos__broader mesh__D016040smesh__D016377
% 215.25/215.39  |- mesh__recordAuthorizer mesh__D016040 sjn
% 215.25/215.39  |- mesh__publicMeSHNote mesh__D016040
% 215.25/215.39       90; was LUNG/transplantation 1966-89   
% 215.25/215.39  |- mesh__recordOriginator mesh__D016040 PXP
% 215.25/215.39  |- skos__annotation mesh__D016040
% 215.25/215.39       do not use /util except by MeSH definition; do not coord with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed%A%  
% 215.25/215.39  |- skos__hiddenLabel mesh__D016040 Transplantations, Lung
% 215.25/215.39  |- rdf__type mesh__D016040sskos__Concept
% 215.25/215.39  |- skos__scopeNote mesh__D016040
% 215.25/215.39       The transference of either one or both of the lungs from one human or animal to another.%A%    
% 215.25/215.39  |- skos__altLabel mesh__D016040 Grafting, Lung
% 215.25/215.39  |- mesh__dateCreated mesh__D016040 1989-05-25
% 215.25/215.39  |- mesh__dateRevised mesh__D016040 2004-07-13
% 215.25/215.39  |- mesh__dateEstablished mesh__D016040 1990-01-01
% 215.25/215.39  |- skos__hiddenLabel mesh__D016040 Lung Grafting
% 215.25/215.39  |- mesh__historyNote mesh__D016040 90; was LUNG/transplantation 1966-89   
% 215.25/215.39  |- skos__related mesh__D016040smesh__D016041
% 215.25/215.39  |- skos__historyNote mesh__D016040 Lung/transplantation %28%1966-1989%29%
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D016040 2005
% 215.25/215.39  |- skos__altLabel mesh__D016040 Transplantation, Lung
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D002020 2006
% 215.25/215.39  |- skos__annotation mesh__D002020
% 215.25/215.39       do not confuse with BUFFALO, AMERICAN see BISON; IM; qualif permitted%A%  
% 215.25/215.39  |- skos__altLabel mesh__D002020 Water Buffalo
% 215.25/215.39  |- mesh__dateEstablished mesh__D002020 1968-01-01
% 215.25/215.39  |- skos__altLabel mesh__D002020 Buffalo
% 215.25/215.39  |- mesh__dateRevised mesh__D002020 2003-07-09
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D002020 2004
% 215.25/215.39  |- skos__scopeNote mesh__D002020
% 215.25/215.39       Ruminants of the family Bovidae consisting of Bubalus arnee and Syncerus caffer. This concept is differentiated from BISON, which refers to Bison bison and Bison bonasus.%A%    
% 215.25/215.39  |- mesh__publicMeSHNote mesh__D002020 68   
% 215.25/215.39  |- rdf__type mesh__D002020sskos__Concept
% 215.25/215.39  |- skos__hiddenLabel mesh__D002020 Buffalo, Water
% 215.25/215.39  |- skos__broader mesh__D002020smesh__D012418
% 215.25/215.39  |- skos__historyNote mesh__D002020 Cattle %28%1966-1967%29%
% 215.25/215.39  |- mesh__historyNote mesh__D002020 68   
% 215.25/215.39  |- mesh__recordOriginator mesh__D002020 NLM
% 215.25/215.39  |- mesh__recordMaintainer mesh__D002020 ags
% 215.25/215.39  |- mesh__recordAuthorizer mesh__D002020 sjn
% 215.25/215.39  |- mesh__dateCreated mesh__D002020 1999-01-01
% 215.25/215.39  |- skos__prefLabel mesh__D002020 Buffaloes
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D002020 2005
% 215.25/215.39  |- skos__historyNote mesh__D002020 Artiodactyla %28%1966-1967%29%
% 215.25/215.39  |- mesh__dateEstablished mesh__D029766 2002-01-01
% 215.25/215.39  |- skos__annotation mesh__D029766
% 215.25/215.39       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.25/215.39  |- mesh__historyNote mesh__D029766 2002   
% 215.25/215.39  |- skos__broader mesh__D029766smesh__D029764
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D029766 2005
% 215.25/215.39  |- mesh__recordAuthorizer mesh__D029766 sjn
% 215.25/215.39  |- mesh__dateCreated mesh__D029766 2001-07-25
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D029766 2006
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D029766 2003
% 215.25/215.39  |- mesh__publicMeSHNote mesh__D029766 2002   
% 215.25/215.39  |- skos__scopeNote mesh__D029766
% 215.25/215.39       A plant genus of the family COMBRETACEAE. Members contain arjunin, an ellagitannin %28%TANNINS%29%.%A%    
% 215.25/215.39  |- mesh__recordMaintainer mesh__D029766 ssb
% 215.25/215.39  |- rdf__type mesh__D029766sskos__Concept
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D029766 2004
% 215.25/215.39  |- mesh__recordOriginator mesh__D029766 ssb
% 215.25/215.39  |- skos__prefLabel mesh__D029766 Terminalia
% 215.25/215.39  |- mesh__dateRevised mesh__D029766 2002-07-03
% 215.25/215.39  |- skos__historyNote mesh__D015746 Pain %28%1966-1989%29%
% 215.25/215.39  |- skos__hiddenLabel mesh__D015746 Abdominal Pains
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D015746 2005
% 215.25/215.39  |- skos__hiddenLabel mesh__D015746 Pains, Abdominal
% 215.25/215.39  |- skos__annotation mesh__D015746
% 215.25/215.39       do not confuse with ABDOMEN, ACUTE for abrupt abdom dis requiring emerg surg%A%  
% 215.25/215.39  |- mesh__recordAuthorizer mesh__D015746 sjn
% 215.25/215.39  |- mesh__recordMaintainer mesh__D015746 lkt
% 215.25/215.39  |- skos__scopeNote mesh__D015746
% 215.25/215.39       Sensation of discomfort, distress, or agony in the abdominal region; generally associated with functional disorders, tissue injuries, or diseases.%A%    
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D015746 2006
% 215.25/215.39  |- skos__related mesh__D015746smesh__D003085
% 215.25/215.39  |- mesh__dateCreated mesh__D015746 1989-05-25
% 215.25/215.39  |- skos__broader mesh__D015746smesh__D012817
% 215.25/215.39  |- mesh__recordOriginator mesh__D015746 PXP
% 215.25/215.39  |- skos__broader mesh__D015746smesh__D010146
% 215.25/215.39  |- skos__historyNote mesh__D015746 Abdomen %28%1966-1989%29%
% 215.25/215.39  |- skos__hiddenLabel mesh__D015746 Pain, Abdominal
% 215.25/215.39  |- rdf__type mesh__D015746sskos__Concept
% 215.25/215.39  |- mesh__historyNote mesh__D015746 90   
% 215.25/215.39  |- mesh__publicMeSHNote mesh__D015746 90   
% 215.25/215.39  |- mesh__dateRevised mesh__D015746 2003-07-09
% 215.25/215.39  |- skos__prefLabel mesh__D015746 Abdominal Pain
% 215.25/215.39  |- mesh__dateEstablished mesh__D015746 1990-01-01
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D015746 2004
% 215.25/215.39  |- skos__prefLabel mesh__D009709 Nucleotide Deaminases
% 215.25/215.39  |- rdf__type mesh__D009709sskos__Concept
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D009709 2006
% 215.25/215.39  |- mesh__dateRevised mesh__D009709 2003-07-09
% 215.25/215.39  |- mesh__recordOriginator mesh__D009709 NLM
% 215.25/215.39  |- skos__broader mesh__D009709smesh__D000619
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D009709 2005
% 215.25/215.39  |- mesh__recordMaintainer mesh__D009709 ssb
% 215.25/215.39  |- mesh__publicMeSHNote mesh__D009709
% 215.25/215.39       75; was see under AMINOHYDROLASES 1974, was NUCLEOSIDE AND NUCLEOTIDE DEAMINASES see AMINOHYDROLASES 1963-73%A%  
% 215.25/215.39  |- mesh__dateEstablished mesh__D009709 1975-01-01
% 215.25/215.39  |- mesh__onlineNote mesh__D009709 search AMINOHYDROLASES 1966-74   
% 215.25/215.39  |- skos__annotation mesh__D009709
% 215.25/215.39       do not confuse with NUCLEOSIDE DEAMINASES   
% 215.25/215.39  |- skos__historyNote mesh__D009709 Aminohydrolases %28%1966-1974%29%
% 215.25/215.39  |- mesh__recordAuthorizer mesh__D009709 sjn
% 215.25/215.39  |- mesh__historyNote mesh__D009709
% 215.25/215.39       75; was see under AMINOHYDROLASES 1974, was NUCLEOSIDE AND NUCLEOTIDE DEAMINASES see AMINOHYDROLASES 1963-73%A%  
% 215.25/215.39  |- mesh__dateCreated mesh__D009709 1999-01-01
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D009709 2004
% 215.25/215.39  |- skos__hiddenLabel mesh__D009709 Deaminases, Nucleotide
% 215.25/215.39  |- skos__scopeNote mesh__D009709
% 215.25/215.39       Catalyze the hydrolysis of nucleotides with the elimination of ammonia.%A%    
% 215.25/215.39  |- skos__altLabel mesh__D001726 Dulco-lax perles
% 215.25/215.39  |- skos__hiddenLabel mesh__D001726 Laxans ratiopharm
% 215.25/215.39  |- skos__scopeNote mesh__D001726
% 215.25/215.39       A diphenylmethane stimulant laxative used for the treatment of constipation and for bowel evacuation. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p871%29%%A%    
% 215.25/215.39  |- rdf__type mesh__D001726sskos__Concept
% 215.25/215.39  |- skos__altLabel mesh__D001726
% 215.25/215.39       Pfizer Consumer Healthcare Brand of Bisacodyl
% 215.25/215.39  |- skos__hiddenLabel mesh__D001726 Bisac Evac
% 215.25/215.39  |- skos__prefLabel mesh__D001726 Bisacodyl
% 215.25/215.39  |- skos__altLabel mesh__D001726 Schein Brand of Bisacodyl
% 215.25/215.39  |- skos__altLabel mesh__D001726 Richardson-Vicks Brand of Bisacodyl
% 215.25/215.39  |- mesh__recordAuthorizer mesh__D001726 sjn
% 215.25/215.39  |- mesh__recordOriginator mesh__D001726 NLM
% 215.25/215.39  |- mesh__dateRevised mesh__D001726 2005-06-30
% 215.25/215.39  |- mesh__dateCreated mesh__D001726 1999-01-01
% 215.25/215.39  |- skos__altLabel mesh__D001726 Upsher-Smith Brand of Bisacodyl
% 215.25/215.39  |- skos__altLabel mesh__D001726 Biscova Brand of Bisacodyl
% 215.25/215.39  |- skos__altLabel mesh__D001726 Wallace Brand of Bisacodyl
% 215.25/215.39  |- skos__hiddenLabel mesh__D001726 Bisco Zitron
% 215.25/215.39  |- skos__hiddenLabel mesh__D001726 ratio Bisacodyl
% 215.25/215.39  |- skos__altLabel mesh__D001726 Ratiopharm Brand of Bisacodyl
% 215.25/215.39  |- skos__hiddenLabel mesh__D001726 Dulco Lax
% 215.25/215.39  |- skos__altLabel mesh__D001726 Apotex Brand of Bisacodyl
% 215.25/215.39  |- mesh__historyNote mesh__D001726
% 215.25/215.39       91%28%72%29%; was see under CRESOLS 1972-90   
% 215.25/215.39  |- skos__hiddenLabel mesh__D001726 Tannex, Bisacodyl
% 215.25/215.39  |- skos__hiddenLabel mesh__D001726 Bisacodyl Upsher-Smith Brand
% 215.25/215.39  |- skos__hiddenLabel mesh__D001726 Apo Bisacodyl
% 215.25/215.39  |- skos__altLabel mesh__D001726 Schwarzhaupt Brand of Bisacodyl
% 215.25/215.39  |- skos__altLabel mesh__D001726 Boehringer Ingelheim Brand of Bisacodyl
% 215.25/215.39  |- skos__altLabel mesh__D001726 Ysatfabrik Brand of Bisacodyl
% 215.25/215.39  |- skos__altLabel mesh__D001726 ct-Arzneimittel Brand of Bisacodyl
% 215.25/215.39  |- skos__altLabel mesh__D001726 Novartis Brand of Bisacodyl
% 215.25/215.39  |- skos__altLabel mesh__D001726 G %26% W Brand of Bisacodyl
% 215.25/215.39  |- skos__altLabel mesh__D001726 roha Brand of Bisacodyl
% 215.25/215.39  |- skos__hiddenLabel mesh__D001726 Dulcolax perles
% 215.25/215.39  |- skos__altLabel mesh__D001726 Ulmer Brand of Bisacodyl
% 215.25/215.39  |- skos__altLabel mesh__D001726 Merckle Brand of Bisacodyl
% 215.25/215.39  |- skos__historyNote mesh__D001726 Cresols %28%1966-1971%29%
% 215.25/215.39  |- skos__hiddenLabel mesh__D001726 Bisacodyl, Bekunis
% 215.25/215.39  |- skos__historyNote mesh__D001726 Cathartics %28%1966-1971%29%
% 215.25/215.39  |- skos__altLabel mesh__D001726 ratio-Bisacodyl
% 215.25/215.39  |- skos__hiddenLabel mesh__D001726 Bisacodyl Richardson-Vicks Brand
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D001726 2006
% 215.25/215.39  |- skos__altLabel mesh__D001726 Numark Brand of Bisacodyl
% 215.25/215.39  |- mesh__recordMaintainer mesh__D001726 CCR
% 215.25/215.39  |- skos__hiddenLabel mesh__D001726 Bisco Lax
% 215.25/215.39  |- skos__altLabel mesh__D001726 Durolax
% 215.25/215.39  |- skos__hiddenLabel mesh__D001726 Dulco lax perles
% 215.25/215.39  |- skos__hiddenLabel mesh__D001726 Bisacodyl L%C3%%BC%nopharm Brand
% 215.25/215.39  |- skos__altLabel mesh__D001726 Fleet Brand of Bisacodyl
% 215.25/215.39  |- skos__hiddenLabel mesh__D001726 Uniserts, Bisacodyl
% 215.25/215.39  |- skos__altLabel mesh__D001726 L%C3%%BC%nopharm Brand of Bisacodyl
% 215.25/215.39  |- skos__hiddenLabel mesh__D001726 Bisacodyl, Fleet
% 215.25/215.39  |- mesh__dateEstablished mesh__D001726 1991-01-01
% 215.25/215.39  |- skos__altLabel mesh__D001726 Florisan N
% 215.25/215.39  |- skos__altLabel mesh__D001726 Aventis Brand of Bisacodyl
% 215.25/215.39  |- skos__altLabel mesh__D001726 Dulco-Lax
% 215.25/215.39  |- skos__broader mesh__D001726smesh__D003408
% 215.25/215.39  |- mesh__publicMeSHNote mesh__D001726 91; was see under CRESOLS 1972-90   
% 215.25/215.39  |- mesh__dateRevised mesh__D006411 2003-07-09
% 215.25/215.39  |- mesh__dateCreated mesh__D006411 1986-04-18
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D006411 2004
% 215.25/215.39  |- mesh__recordOriginator mesh__D006411 VDK
% 215.25/215.39  |- mesh__recordMaintainer mesh__D006411 nns
% 215.25/215.39  |- mesh__historyNote mesh__D006411 87   
% 215.25/215.39  |- skos__annotation mesh__D006411
% 215.25/215.39       for splenic, hepatic or lymphatic hematopoiesis do not coord with SPLEEN /physiol, LIVER /physiol or LYMPH NODES /physiol unless particularly discussed %26% then probably NIM%A%  
% 215.25/215.39  |- rdf__type mesh__D006411sskos__Concept
% 215.25/215.39  |- skos__prefLabel mesh__D006411 Hematopoiesis, Extramedullary
% 215.25/215.39  |- skos__hiddenLabel mesh__D006411 Extramedullary Hematopoieses
% 215.25/215.39  |- skos__scopeNote mesh__D006411
% 215.25/215.39       The formation and development of blood cells outside the BONE MARROW, as in the SPLEEN; LIVER; or LYMPH NODES.%A%    
% 215.25/215.39  |- skos__hiddenLabel mesh__D006411 Hematopoieses, Extramedullary
% 215.25/215.39  |- mesh__dateEstablished mesh__D006411 1987-01-01
% 215.25/215.39  |- mesh__publicMeSHNote mesh__D006411 87   
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D006411 2005
% 215.25/215.39  |- skos__hiddenLabel mesh__D006411 Extramedullary Hematopoiesis
% 215.25/215.39  |- skos__broader mesh__D006411smesh__D006410
% 215.25/215.39  |- skos__historyNote mesh__D006411
% 215.25/215.39       Hematopoietic Stem Cells %28%1971-1986%29%
% 215.25/215.39  |- skos__historyNote mesh__D006411 Hematopoiesis %28%1966-1986%29%
% 215.25/215.39  |- mesh__recordAuthorizer mesh__D006411 sjn
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D006411 2006
% 215.25/215.39  |- skos__hiddenLabel mesh__D047828 War, First World
% 215.25/215.39  |- skos__hiddenLabel mesh__D047828 First World Wars
% 215.25/215.39  |- skos__hiddenLabel mesh__D047828 Wars, 1914-1918 World
% 215.25/215.39  |- rdf__type mesh__D047828sskos__Concept
% 215.25/215.39  |- skos__hiddenLabel mesh__D047828 War, 1st World
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D047828 2005
% 215.25/215.39  |- skos__hiddenLabel mesh__D047828 World Wars, 1914-1918
% 215.25/215.39  |- skos__hiddenLabel mesh__D047828 World War, First
% 215.25/215.39  |- mesh__recordMaintainer mesh__D047828 jls
% 215.25/215.39  |- skos__hiddenLabel mesh__D047828 World Wars, 1st
% 215.25/215.39  |- skos__hiddenLabel mesh__D047828 Wars, 1st World
% 215.25/215.39  |- skos__hiddenLabel mesh__D047828 World War, 1914 1918
% 215.25/215.39  |- skos__hiddenLabel mesh__D047828 Great Wars
% 215.25/215.39  |- mesh__activeMeSHYear mesh__D047828 2006
% 215.25/215.39  |- skos__broader mesh__D047828smesh__D049673
% 215.25/215.39  |- skos__hiddenLabel mesh__D047828 1914-1918 World War
% 215.25/215.39  |- mesh__historyNote mesh__D047828 2005   
% 215.25/215.39  |- mesh__recordAuthorizer mesh__D047828 sjn
% 215.25/215.39  |- skos__hiddenLabel mesh__D047828 War, Great
% 215.25/215.39  |- skos__altLabel mesh__D047828 Great War
% 215.25/215.39  |- skos__hiddenLabel mesh__D047828 1st World Wars
% 215.25/215.39  |- mesh__dateEstablished mesh__D047828 2005-01-01
% 215.25/215.39  |- skos__hiddenLabel mesh__D047828 World War, 1st
% 215.25/215.39  |- skos__hiddenLabel mesh__D047828 Wars, Great
% 215.25/215.39  |- skos__hiddenLabel mesh__D047828 World Wars, First
% 215.25/215.39  |- skos__altLabel mesh__D047828 1st World War
% 215.25/215.39  |- mesh__publicMeSHNote mesh__D047828 2005   
% 215.25/215.39  |- skos__hiddenLabel mesh__D047828 Wars, First World
% 215.25/215.39  |- skos__prefLabel mesh__D047828 World War I
% 215.25/215.40  |- skos__scopeNote mesh__D047828
% 215.25/215.40       Global conflict primarily fought on European continent, that occurred between 1914 and 1918.%A%    
% 215.25/215.40  |- skos__altLabel mesh__D047828 World War, 1914-1918
% 215.25/215.40  |- skos__altLabel mesh__D047828 First World War
% 215.25/215.40  |- mesh__dateCreated mesh__D047828 2004-07-07
% 215.25/215.40  |- mesh__recordOriginator mesh__D047828 jls
% 215.25/215.40  |- skos__broader mesh__D019339smesh__D012868
% 215.25/215.40  |- mesh__recordOriginator mesh__D019339 TGC
% 215.25/215.40  |- skos__prefLabel mesh__D019339 Port-Wine Stain
% 215.25/215.40  |- mesh__publicMeSHNote mesh__D019339 97   
% 215.25/215.40  |- mesh__activeMeSHYear mesh__D019339 2005
% 215.25/215.40  |- skos__hiddenLabel mesh__D019339 Stains, Port-Wine
% 215.25/215.40  |- skos__hiddenLabel mesh__D019339 Port Wine Stain
% 215.25/215.40  |- mesh__dateEstablished mesh__D019339 1997-01-01
% 215.25/215.40  |- mesh__activeMeSHYear mesh__D019339 2006
% 215.25/215.40  |- skos__hiddenLabel mesh__D019339 Stain, Port-Wine
% 215.25/215.40  |- skos__altLabel mesh__D019339 Nevus Flammeus
% 215.25/215.40  |- mesh__activeMeSHYear mesh__D019339 2002
% 215.25/215.40  |- rdf__type mesh__D019339sskos__Concept
% 215.25/215.40  |- mesh__historyNote mesh__D019339 97   
% 215.25/215.40  |- mesh__dateCreated mesh__D019339 1996-06-10
% 215.25/215.40  |- skos__scopeNote mesh__D019339
% 215.25/215.40       A vascular malformation of developmental origin characterized pathologically by ectasia of superficial dermal capillaries, and clinically by persistent macular erythema. In the past, port wine stains have frequently been termed capillary hemangiomas, which they are not; unfortunately this confusing practice persists: HEMANGIOMA, CAPILLARY is neoplastic, a port-wine stain is non-neoplastic. Port-wine stains vary in color from fairly pale pink to deep red or purple and in size from a few millimeters to many centimeters in diameter. The face is the most frequently affected site and they are most often unilateral. %28%From Rook et al., Textbook of Dermatology, 5th ed, p483%29%%A%    
% 215.25/215.40  |- mesh__activeMeSHYear mesh__D019339 2003
% 215.25/215.40  |- mesh__dateRevised mesh__D019339 2001-07-25
% 215.25/215.40  |- mesh__recordAuthorizer mesh__D019339 sjn
% 215.25/215.40  |- skos__hiddenLabel mesh__D019339 Port-Wine Stains
% 215.25/215.40  |- skos__annotation mesh__D019339 distinguish from HEMANGIOMA, CAPILLARY   
% 215.25/215.40  |- mesh__activeMeSHYear mesh__D019339 2004
% 215.25/215.40  |- mesh__recordMaintainer mesh__D019339 nns
% 215.25/215.40  |- skos__scopeNote mesh__D011356
% 215.25/215.40       Use of written, printed, or graphic materials upon or accompanying a product or its container or wrapper. It includes purpose, effect, description, directions, hazards, warnings, and other relevant information.%A%    
% 215.25/215.40  |- mesh__activeMeSHYear mesh__D011356 2005
% 215.25/215.40  |- mesh__dateCreated mesh__D011356 1978-04-28
% 215.25/215.40  |- skos__broader mesh__D011356smesh__D019064
% 215.25/215.40  |- mesh__historyNote mesh__D011356 79   
% 215.25/215.40  |- mesh__publicMeSHNote mesh__D011356 79   
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D011356 2001
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D011356 2006
% 215.26/215.40  |- mesh__dateRevised mesh__D011356 1997-06-20
% 215.26/215.40  |- skos__hiddenLabel mesh__D011356 Inserts, Package
% 215.26/215.40  |- skos__prefLabel mesh__D011356 Product Labeling
% 215.26/215.40  |- skos__altLabel mesh__D011356 Labeling, Product
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D011356 2002
% 215.26/215.40  |- mesh__dateEstablished mesh__D011356 1979-01-01
% 215.26/215.40  |- skos__hiddenLabel mesh__D011356 Package Insert
% 215.26/215.40  |- rdf__type mesh__D011356sskos__Concept
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D011356 2003
% 215.26/215.40  |- skos__hiddenLabel mesh__D011356 Labelling, Product
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D011356 1998
% 215.26/215.40  |- mesh__recordMaintainer mesh__D011356 JLS
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D011356 2004
% 215.26/215.40  |- skos__hiddenLabel mesh__D011356 Insert, Package
% 215.26/215.40  |- mesh__recordOriginator mesh__D011356 SMH
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D011356 1999
% 215.26/215.40  |- mesh__recordAuthorizer mesh__D011356 SJN
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D011356 2000
% 215.26/215.40  |- skos__altLabel mesh__D011356 Product Labelling
% 215.26/215.40  |- skos__altLabel mesh__D005319 Hemoglobin F
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D005319 2001
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D005319 2005
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D005319 2004
% 215.26/215.40  |- mesh__dateRevised mesh__D005319 2000-06-22
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D005319 2006
% 215.26/215.40  |- mesh__recordAuthorizer mesh__D005319 sjn
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D005319 2002
% 215.26/215.40  |- skos__broader mesh__D005319smesh__D006454
% 215.26/215.40  |- skos__hiddenLabel mesh__D005319 Hemoglobin, Fetal
% 215.26/215.40  |- mesh__recordMaintainer mesh__D005319 adp
% 215.26/215.40  |- skos__scopeNote mesh__D005319
% 215.26/215.40       The major component of hemoglobin in the fetus. This HEMOGLOBIN has two alpha and two gamma polypeptide subunits in comparison to normal adult hemoglobin, which has two alpha and two beta polypeptide subunits. Fetal hemoglobin concentrations can be elevated %28%usually above 0.5%25%%29% in children and adults affected by LEUKEMIA and several types of ANEMIA.%A%    
% 215.26/215.40  |- mesh__dateCreated mesh__D005319 1999-01-01
% 215.26/215.40  |- skos__annotation mesh__D005319 DF: HBF   
% 215.26/215.40  |- rdf__type mesh__D005319sskos__Concept
% 215.26/215.40  |- mesh__recordOriginator mesh__D005319 NLM
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D005319 2003
% 215.26/215.40  |- skos__prefLabel mesh__D005319 Fetal Hemoglobin
% 215.26/215.40  |- skos__hiddenLabel mesh__D016041 Heart-Lung Grafting
% 215.26/215.40  |- mesh__recordMaintainer mesh__D016041 sjn
% 215.26/215.40  |- skos__hiddenLabel mesh__D016041 Transplantation, Heart Lung
% 215.26/215.40  |- skos__hiddenLabel mesh__D016041 Heart Lung Transplantation
% 215.26/215.40  |- skos__prefLabel mesh__D016041 Heart-Lung Transplantation
% 215.26/215.40  |- skos__hiddenLabel mesh__D016041 Heart-Lung Graftings
% 215.26/215.40  |- skos__hiddenLabel mesh__D016041 Grafting, Heart Lung
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D016041 2006
% 215.26/215.40  |- skos__broader mesh__D016041smesh__D016027
% 215.26/215.40  |- skos__hiddenLabel mesh__D016041 Graftings, Heart-Lung
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D016041 2005
% 215.26/215.40  |- skos__altLabel mesh__D016041 Grafting, Heart-Lung
% 215.26/215.40  |- skos__hiddenLabel mesh__D016041 Heart-Lung Transplantations
% 215.26/215.40  |- mesh__dateCreated mesh__D016041 1989-05-25
% 215.26/215.40  |- mesh__recordOriginator mesh__D016041 PXP
% 215.26/215.40  |- skos__scopeNote mesh__D016041
% 215.26/215.40       The simultaneous, or near simultaneous, transference of heart and lungs from one human or animal to another.%A%    
% 215.26/215.40  |- mesh__dateRevised mesh__D016041 2004-07-13
% 215.26/215.40  |- skos__broader mesh__D016041smesh__D016040
% 215.26/215.40  |- skos__historyNote mesh__D016041 Heart/transplantation %28%1966-1989%29%
% 215.26/215.40  |- mesh__recordAuthorizer mesh__D016041 sjn
% 215.26/215.40  |- mesh__historyNote mesh__D016041 90   
% 215.26/215.40  |- skos__annotation mesh__D016041
% 215.26/215.40       do not use /util except by MeSH definition; do not coord with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed%A%  
% 215.26/215.40  |- skos__hiddenLabel mesh__D016041 Transplantations, Heart-Lung
% 215.26/215.40  |- skos__altLabel mesh__D016041 Transplantation, Heart-Lung
% 215.26/215.40  |- mesh__dateEstablished mesh__D016041 1990-01-01
% 215.26/215.40  |- skos__historyNote mesh__D016041 Lung/transplantation %28%1966-1989%29%
% 215.26/215.40  |- mesh__publicMeSHNote mesh__D016041 90   
% 215.26/215.40  |- rdf__type mesh__D016041sskos__Concept
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D002021 2004
% 215.26/215.40  |- mesh__historyNote mesh__D002021 67%28%64%29%   
% 215.26/215.40  |- mesh__publicMeSHNote mesh__D002021 67   
% 215.26/215.40  |- skos__broader mesh__D002021smesh__D019995
% 215.26/215.40  |- rdf__type mesh__D002021sskos__Concept
% 215.26/215.40  |- skos__scopeNote mesh__D002021
% 215.26/215.40       A chemical system that functions to control the levels of specific ions in solution. When the level of hydrogen ion in solution is controlled the system is called a pH buffer.%A%    
% 215.26/215.40  |- mesh__recordMaintainer mesh__D002021 ssb
% 215.26/215.40  |- mesh__dateCreated mesh__D002021 1999-01-01
% 215.26/215.40  |- skos__annotation mesh__D002021 almost never IM   
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D002021 2005
% 215.26/215.40  |- mesh__recordOriginator mesh__D002021 NLM
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D002021 2006
% 215.26/215.40  |- mesh__dateEstablished mesh__D002021 1967-01-01
% 215.26/215.40  |- mesh__recordAuthorizer mesh__D002021 sjn
% 215.26/215.40  |- skos__prefLabel mesh__D002021 Buffers
% 215.26/215.40  |- mesh__dateRevised mesh__D002021 2003-07-09
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D029767 2005
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D029767 2006A
% 215.26/215.40  |- mesh__publicMeSHNote mesh__D029767 2002   
% 215.26/215.40  |- mesh__recordMaintainer mesh__D029767 ags
% 215.26/215.40  |- mesh__recordOriginator mesh__D029767 ssb
% 215.26/215.40  |- mesh__dateCreated mesh__D029767 2001-07-25
% 215.26/215.40  |- skos__prefLabel mesh__D029767 Cornaceae
% 215.26/215.40  |- mesh__recordAuthorizer mesh__D029767 ags
% 215.26/215.40  |- mesh__historyNote mesh__D029767 2002   
% 215.26/215.40  |- skos__annotation mesh__D029767
% 215.26/215.40       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.26/215.40  |- mesh__dateRevised mesh__D029767 2005-07-21
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D029767 2004
% 215.26/215.40  |- skos__broader mesh__D029767smesh__D019684
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D029767 2006
% 215.26/215.40  |- skos__scopeNote mesh__D029767
% 215.26/215.40       A plant family of the order Cornales, subclass Rosidae, class Magnoliopsida that is a loose grouping of woody ornamentals: 11 of its 14 genera have been placed in single families by some authorities.  Some botanists combine members of NYSSACEAE into this family.%A%    
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D029767 2003
% 215.26/215.40  |- rdf__type mesh__D029767sskos__Concept
% 215.26/215.40  |- mesh__dateEstablished mesh__D029767 2002-01-01
% 215.26/215.40  |- rdf__type mesh__D034901sskos__Concept
% 215.26/215.40  |- mesh__historyNote mesh__D034901 2003   
% 215.26/215.40  |- mesh__dateEstablished mesh__D034901 2003-01-01
% 215.26/215.40  |- mesh__dateCreated mesh__D034901 2002-07-02
% 215.26/215.40  |- skos__broader mesh__D034901smesh__D035961
% 215.26/215.40  |- skos__prefLabel mesh__D034901 Alismataceae
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D034901 2003
% 215.26/215.40  |- mesh__publicMeSHNote mesh__D034901 2003   
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D034901 2004
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D034901 2005
% 215.26/215.40  |- skos__annotation mesh__D034901
% 215.26/215.40       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D034901 2006
% 215.26/215.40  |- skos__scopeNote mesh__D034901
% 215.26/215.40       A plant family of the subclass ALISMATIDAE, class Liliopsida %28%monocotyledons%29% of aquatic plants. The flower parts are in threes with 3 green sepals and 3 white or yellow petals.%A%    
% 215.26/215.40  |- mesh__publicMeSHNote mesh__D001727 88   
% 215.26/215.40  |- mesh__recordMaintainer mesh__D001727 lkt
% 215.26/215.40  |- mesh__dateEstablished mesh__D001727 1988-01-01
% 215.26/215.40  |- skos__annotation mesh__D001727
% 215.26/215.40       note category: do not confuse with HERMAPHRODITISM, an endocrine dis%A%  
% 215.26/215.40  |- mesh__historyNote mesh__D001727 88   
% 215.26/215.40  |- mesh__dateRevised mesh__D001727 2004-07-07
% 215.26/215.40  |- skos__broader mesh__D001727smesh__D019529
% 215.26/215.40  |- skos__historyNote mesh__D001727 Sex Behavior %28%1966-1987%29%
% 215.26/215.40  |- skos__historyNote mesh__D001727 Homosexuality %28%1966-1987%29%
% 215.26/215.40  |- skos__hiddenLabel mesh__D001727 Bisexual
% 215.26/215.40  |- mesh__recordAuthorizer mesh__D001727 sjn
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D001727 2005
% 215.26/215.40  |- skos__scopeNote mesh__D001727
% 215.26/215.40       The sexual attraction or relationship between members of both the same and the opposite SEX.%A%    
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D001727 2006
% 215.26/215.40  |- rdf__type mesh__D001727sskos__Concept
% 215.26/215.40  |- skos__prefLabel mesh__D001727 Bisexuality
% 215.26/215.40  |- mesh__recordOriginator mesh__D001727 EC
% 215.26/215.40  |- mesh__dateCreated mesh__D001727 1987-04-30
% 215.26/215.40  |- skos__hiddenLabel mesh__D006412 Progenitor Cell, Hematopoietic
% 215.26/215.40  |- skos__hiddenLabel mesh__D006412 Hematopoietic Colony-Forming Unit
% 215.26/215.40  |- skos__hiddenLabel mesh__D006412 Colony-Forming Unit, Hematopoietic
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D006412 2002
% 215.26/215.40  |- skos__hiddenLabel mesh__D006412 Hematopoietic Colony-Forming Units
% 215.26/215.40  |- skos__hiddenLabel mesh__D006412 Unit, Hematopoietic Colony-Forming
% 215.26/215.40  |- skos__hiddenLabel mesh__D006412 Hematopoietic Stem Cell
% 215.26/215.40  |- skos__altLabel mesh__D006412 Stem Cells, Hematopoietic
% 215.26/215.40  |- skos__altLabel mesh__D006412 Progenitor Cells, Hematopoietic
% 215.26/215.40  |- skos__hiddenLabel mesh__D006412 Hematopoietic Progenitor Cell
% 215.26/215.40  |- rdf__type mesh__D006412sskos__Concept
% 215.26/215.40  |- skos__hiddenLabel mesh__D006412 Cell, Hematopoietic Stem
% 215.26/215.40  |- mesh__recordAuthorizer mesh__D006412 sjn
% 215.26/215.40  |- mesh__recordMaintainer mesh__D006412 adp
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D006412 2005
% 215.26/215.40  |- skos__hiddenLabel mesh__D006412 Units, Hematopoietic Colony-Forming
% 215.26/215.40  |- skos__hiddenLabel mesh__D006412 Cells, Hematopoietic Progenitor
% 215.26/215.40  |- skos__hiddenLabel mesh__D006412 Cells, Hematopoietic Stem
% 215.26/215.40  |- skos__broader mesh__D006412smesh__D013234
% 215.26/215.40  |- mesh__publicMeSHNote mesh__D006412 72   
% 215.26/215.40  |- skos__hiddenLabel mesh__D006412 Stem Cell, Hematopoietic
% 215.26/215.40  |- skos__prefLabel mesh__D006412 Hematopoietic Stem Cells
% 215.26/215.40  |- skos__historyNote mesh__D006412 Bone Marrow/cytology %28%1966-1970%29%
% 215.26/215.40  |- mesh__dateRevised mesh__D006412 2000-06-22
% 215.26/215.40  |- skos__annotation mesh__D006412
% 215.26/215.40       A 11 qualif; /transpl = HEMATOPOIETIC STEM CELL TRANSPLANTATION%A%  
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D006412 2003
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D006412 2006
% 215.26/215.40  |- skos__related mesh__D006412smesh__D003114
% 215.26/215.40  |- mesh__dateEstablished mesh__D006412 1972-01-01
% 215.26/215.40  |- skos__scopeNote mesh__D006412
% 215.26/215.40       Progenitor cells from which all blood cells derive.     
% 215.26/215.40  |- mesh__historyNote mesh__D006412 72%28%71%29%   
% 215.26/215.40  |- skos__broader mesh__D006412smesh__D001854
% 215.26/215.40  |- skos__hiddenLabel mesh__D006412 Cell, Hematopoietic Progenitor
% 215.26/215.40  |- mesh__recordOriginator mesh__D006412 NLM
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D006412 2004
% 215.26/215.40  |- mesh__dateCreated mesh__D006412 1999-01-01
% 215.26/215.40  |- skos__altLabel mesh__D006412 Hematopoietic Progenitor Cells
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D006412 2001
% 215.26/215.40  |- skos__hiddenLabel mesh__D006412 Colony Forming Units, Hematopoietic
% 215.26/215.40  |- skos__hiddenLabel mesh__D047829 Vietnamese Conflict, 1961 1975
% 215.26/215.40  |- skos__hiddenLabel mesh__D047829 Conflicts, 1961-1975 Vietnamese
% 215.26/215.40  |- skos__altLabel mesh__D047829 Vietnamese Conflict, 1961-1975
% 215.26/215.40  |- skos__hiddenLabel mesh__D047829 Conflict, 1961-1975 Vietnamese
% 215.26/215.40  |- skos__hiddenLabel mesh__D047829 Wars, Viet Nam
% 215.26/215.40  |- skos__hiddenLabel mesh__D047829 Conflict, Viet Nam
% 215.26/215.40  |- skos__prefLabel mesh__D047829 Vietnam Conflict
% 215.26/215.40  |- mesh__recordMaintainer mesh__D047829 jls
% 215.26/215.40  |- mesh__publicMeSHNote mesh__D047829 2005   
% 215.26/215.40  |- mesh__recordOriginator mesh__D047829 jls
% 215.26/215.40  |- mesh__dateCreated mesh__D047829 2004-07-07
% 215.26/215.40  |- skos__altLabel mesh__D047829 Viet Nam Conflict
% 215.26/215.40  |- skos__hiddenLabel mesh__D047829 Wars, Indochina
% 215.26/215.40  |- skos__altLabel mesh__D047829 Viet Nam War
% 215.26/215.40  |- skos__hiddenLabel mesh__D047829 Conflict, Vietnam
% 215.26/215.40  |- mesh__dateEstablished mesh__D047829 2005-01-01
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D047829 2005
% 215.26/215.40  |- skos__hiddenLabel mesh__D047829 Indochina Wars
% 215.26/215.40  |- skos__hiddenLabel mesh__D047829 1961-1975 Vietnamese Conflict
% 215.26/215.40  |- rdf__type mesh__D047829sskos__Concept
% 215.26/215.40  |- mesh__historyNote mesh__D047829 2005   
% 215.26/215.40  |- skos__hiddenLabel mesh__D047829 1961-1975 Vietnamese Conflicts
% 215.26/215.40  |- skos__scopeNote mesh__D047829
% 215.26/215.40       A conflict occurring from 1954 through 1975 within the Republic of Vietnam. It involved neighboring nations and the United States and other members of the Southeast Asia Treaty Organization.%A%    
% 215.26/215.40  |- mesh__recordAuthorizer mesh__D047829 sjn
% 215.26/215.40  |- skos__broader mesh__D047829smesh__D049673
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D047829 2006
% 215.26/215.40  |- skos__hiddenLabel mesh__D047829 War, Viet Nam
% 215.26/215.40  |- skos__hiddenLabel mesh__D047829 Vietnamese Conflicts, 1961-1975
% 215.26/215.40  |- skos__altLabel mesh__D047829 Indochina War
% 215.26/215.40  |- skos__hiddenLabel mesh__D047829 War, Indochina
% 215.26/215.40  |- skos__hiddenLabel mesh__D011357 Line Management, Product
% 215.26/215.40  |- mesh__dateRevised mesh__D011357 1999-11-05
% 215.26/215.40  |- mesh__dateEstablished mesh__D011357 1991-01-01
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D011357 2002
% 215.26/215.40  |- skos__hiddenLabel mesh__D011357 Product Line Managements
% 215.26/215.40  |- skos__hiddenLabel mesh__D011357 Managements, Product Line
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D011357 2001
% 215.26/215.40  |- mesh__recordMaintainer mesh__D011357 JLS
% 215.26/215.40  |- mesh__recordOriginator mesh__D011357 EC
% 215.26/215.40  |- skos__prefLabel mesh__D011357 Product Line Management
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D011357 2006
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D011357 2000
% 215.26/215.40  |- skos__scopeNote mesh__D011357
% 215.26/215.40       Management control systems for structuring health care delivery strategies around case types, as in DRGs, or specific clinical services.%A%    
% 215.26/215.40  |- mesh__dateCreated mesh__D011357 1987-05-04
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D011357 2005
% 215.26/215.40  |- skos__broader mesh__D011357smesh__D003695
% 215.26/215.40  |- skos__annotation mesh__D011357
% 215.26/215.40       restrict to Cat N: not for drug industry: read MeSH definition%A%  
% 215.26/215.40  |- skos__broader mesh__D011357smesh__D006739
% 215.26/215.40  |- rdf__type mesh__D011357sskos__Concept
% 215.26/215.40  |- mesh__historyNote mesh__D011357
% 215.26/215.40       91%28%88%29%; was see under HOSPITAL ADMINISTRATION 1988-90   
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D011357 2004
% 215.26/215.40  |- mesh__recordAuthorizer mesh__D011357 sjn
% 215.26/215.40  |- skos__hiddenLabel mesh__D011357 Line Managements, Product
% 215.26/215.40  |- mesh__publicMeSHNote mesh__D011357
% 215.26/215.40       91; was see under HOSPITAL ADMINISTRATION 1988-90   
% 215.26/215.40  |- skos__hiddenLabel mesh__D011357 Management, Product Line
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D011357 2003
% 215.26/215.40  |- mesh__publicMeSHNote mesh__D016840 92   
% 215.26/215.40  |- mesh__historyNote mesh__D016840 92   
% 215.26/215.40  |- skos__broader mesh__D016840smesh__D012506
% 215.26/215.40  |- mesh__dateRevised mesh__D016840 2003-07-09
% 215.26/215.40  |- rdf__type mesh__D016840sskos__Concept
% 215.26/215.40  |- mesh__dateEstablished mesh__D016840 1992-01-01
% 215.26/215.40  |- skos__scopeNote mesh__D016840
% 215.26/215.40       A class of ameboid protozoa that forms either filiform subpseudopodia or lobopodia. Characteristics include the absence of sorocarps, sporangia, or similar fruiting bodies.%A%    
% 215.26/215.40  |- skos__prefLabel mesh__D016840 Lobosea
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D016840 2005
% 215.26/215.40  |- mesh__dateCreated mesh__D016840 1991-05-02
% 215.26/215.40  |- mesh__recordMaintainer mesh__D016840 ags
% 215.26/215.40  |- skos__annotation mesh__D016840 a class of protozoa   
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D016840 2004
% 215.26/215.40  |- mesh__recordAuthorizer mesh__D016840 sjn
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D016840 2006
% 215.26/215.40  |- mesh__recordOriginator mesh__D016840 PXP
% 215.26/215.40  |- skos__historyNote mesh__D016042
% 215.26/215.40       Transplantation, Homologous %28%1966-1989%29%
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D016042 2006
% 215.26/215.40  |- skos__prefLabel mesh__D016042 Transplantation, Heterotopic
% 215.26/215.40  |- mesh__dateRevised mesh__D016042 2002-07-03
% 215.26/215.40  |- skos__scopeNote mesh__D016042
% 215.26/215.40       Transplantation of tissue typical of one area to a different recipient site. The tissue may be autologous, heterologous, or homologous.%A%    
% 215.26/215.40  |- mesh__recordMaintainer mesh__D016042 lkt
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D016042 2005
% 215.26/215.40  |- mesh__recordOriginator mesh__D016042 PXP
% 215.26/215.40  |- skos__hiddenLabel mesh__D016042 Heterotopic Transplantations
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D016042 2004
% 215.26/215.40  |- mesh__dateCreated mesh__D016042 1989-06-20
% 215.26/215.40  |- skos__hiddenLabel mesh__D016042 Transplantations, Heterotopic
% 215.26/215.40  |- mesh__dateEstablished mesh__D016042 1990-01-01
% 215.26/215.40  |- skos__altLabel mesh__D016042 Heterotopic Transplantation
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D016042 2003
% 215.26/215.40  |- mesh__publicMeSHNote mesh__D016042 90   
% 215.26/215.40  |- rdf__type mesh__D016042sskos__Concept
% 215.26/215.40  |- skos__annotation mesh__D016042
% 215.26/215.40       IM: TN 243; coord IM with organ /transpl %28%IM%29% or precoord organ/transpl term %28%IM%29% + implant site with no qualif %28%NIM%29%; no qualif when NIM coord; when IM, qualif permitted; do not confuse with TRANSPLANTATION, HETEROLOGOUS: heterotopic is for a graft of tissue typical of one site, removed to a different site, autol, homol or heterol; DF: TRANSPL HETEROTOPIC%A%  
% 215.26/215.40  |- skos__broader mesh__D016042smesh__D014180
% 215.26/215.40  |- mesh__recordAuthorizer mesh__D016042 sjn
% 215.26/215.40  |- mesh__historyNote mesh__D016042 90   
% 215.26/215.40  |- mesh__dateRevised mesh__D002820 2004-07-28
% 215.26/215.40  |- skos__scopeNote mesh__D002820
% 215.26/215.40       A uterine tumor derived from persistent gestational TROPHOBLASTS, most likely after a molar pregnancy %28%HYDATIDIFORM MOLE%29%. Invasive hyadatiform mole develops in about 15%25% of patients after evacuation of a complete mole and less frequently after other types of gestation. It may perforate the MYOMETRIUM and erode uterine vessels causing hemorrhage.%A%    
% 215.26/215.40  |- skos__hiddenLabel mesh__D002820 Mole, Invasive Hydatidiform
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D002820 2005
% 215.26/215.40  |- skos__hiddenLabel mesh__D002820 Mole, Invasive
% 215.26/215.40  |- skos__altLabel mesh__D002820 Invasive Mole
% 215.26/215.40  |- skos__annotation mesh__D002820
% 215.26/215.40       coord IM with UTERINE NEOPLASMS %28%IM%29%; check the tags FEMALE %26% PREGNANCY%A%  
% 215.26/215.40  |- skos__hiddenLabel mesh__D002820 Invasive Hydatidiform Mole
% 215.26/215.40  |- skos__altLabel mesh__D002820 Chorioadenoma
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D002820 2006
% 215.26/215.40  |- mesh__onlineNote mesh__D002820
% 215.26/215.40       use HYDATIDIFORM MOLE, INVASIVE to search CHORIOADENOMA 1966-93%A%  
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D002820 2005A
% 215.26/215.40  |- skos__hiddenLabel mesh__D002820 Invasive Moles
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D002820 2003
% 215.26/215.40  |- skos__hiddenLabel mesh__D002820 Chorioadenomas
% 215.26/215.40  |- skos__hiddenLabel mesh__D002820 Hydatidiform Moles, Invasive
% 215.26/215.40  |- skos__hiddenLabel mesh__D002820 Moles, Invasive
% 215.26/215.40  |- mesh__recordOriginator mesh__D002820 NLM
% 215.26/215.40  |- mesh__recordAuthorizer mesh__D002820 jls
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D002820 2004
% 215.26/215.40  |- skos__broader mesh__D002820smesh__D006828
% 215.26/215.40  |- skos__hiddenLabel mesh__D002820 Moles, Invasive Hydatidiform
% 215.26/215.40  |- mesh__recordMaintainer mesh__D002820 jls
% 215.26/215.40  |- rdf__type mesh__D002820sskos__Concept
% 215.26/215.40  |- mesh__dateCreated mesh__D002820 1999-01-01
% 215.26/215.40  |- skos__prefLabel mesh__D002820 Hydatidiform Mole, Invasive
% 215.26/215.40  |- mesh__historyNote mesh__D002820 94; was CHORIOADENOMA 1963-93   
% 215.26/215.40  |- skos__hiddenLabel mesh__D002820 Invasive Hydatidiform Moles
% 215.26/215.40  |- mesh__publicMeSHNote mesh__D002820 94; was CHORIOADENOMA 1963-93   
% 215.26/215.40  |- mesh__recordMaintainer mesh__D002022 ags
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D002022 2006
% 215.26/215.40  |- mesh__recordOriginator mesh__D002022 NLM
% 215.26/215.40  |- skos__broader mesh__D002022smesh__D002025
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D002022 2005
% 215.26/215.40  |- mesh__recordAuthorizer mesh__D002022 sjn
% 215.26/215.40  |- mesh__dateEstablished mesh__D002022 1972-01-01
% 215.26/215.40  |- skos__hiddenLabel mesh__D002022 Argentine Toad
% 215.26/215.40  |- mesh__dateCreated mesh__D002022 1999-01-01
% 215.26/215.40  |- mesh__dateRevised mesh__D002022 2003-07-09
% 215.26/215.40  |- mesh__historyNote mesh__D002022 72   
% 215.26/215.40  |- skos__prefLabel mesh__D002022 Bufo arenarum
% 215.26/215.40  |- skos__scopeNote mesh__D002022
% 215.26/215.40       A species of the true toads, Bufonidae, found in South America.%A%    
% 215.26/215.40  |- rdf__type mesh__D002022sskos__Concept
% 215.26/215.40  |- skos__altLabel mesh__D002022 Toad, Argentine
% 215.26/215.40  |- skos__annotation mesh__D002022
% 215.26/215.40       So. Amer. toad; NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 215.26/215.40  |- skos__hiddenLabel mesh__D002022 Argentine Toads
% 215.26/215.40  |- skos__historyNote mesh__D002022 Anura %28%1966-1971%29%
% 215.26/215.40  |- mesh__publicMeSHNote mesh__D002022 72   
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D002022 2004
% 215.26/215.40  |- skos__hiddenLabel mesh__D002022 Toads, Argentine
% 215.26/215.40  |- mesh__publicMeSHNote mesh__D029768 2002   
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D029768 2002
% 215.26/215.40  |- skos__scopeNote mesh__D029768
% 215.26/215.40       A plant genus of the family CORNACEAE.  It is widely cultivated for the attractive flowers.%A%    
% 215.26/215.40  |- skos__prefLabel mesh__D029768 Cornus
% 215.26/215.40  |- skos__annotation mesh__D029768
% 215.26/215.40       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D029768 2004
% 215.26/215.40  |- skos__broader mesh__D029768smesh__D029767
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D029768 2006
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D029768 2003
% 215.26/215.40  |- rdf__type mesh__D029768sskos__Concept
% 215.26/215.40  |- mesh__dateCreated mesh__D029768 2001-07-25
% 215.26/215.40  |- mesh__dateEstablished mesh__D029768 2002-01-01
% 215.26/215.40  |- mesh__activeMeSHYear mesh__D029768 2005
% 215.26/215.40  |- mesh__historyNote mesh__D029768 2002   
% 215.26/215.40  |- skos__historyNote mesh__D015748 Lyme Disease %28%1984-1989%29%
% 215.26/215.40  |- skos__scopeNote mesh__D015748
% 215.26/215.40       Gram-negative helical bacteria, in the genus BORRELIA, that are the etiologic agents of LYME DISEASE. The group comprises many specific species including Borrelia afzelii, Borellia garinii, and BORRELIA BURGDORFERI proper. These spirochetes are generally transmitted by several species of ixodid ticks.%A%    
% 215.26/215.40  |- mesh__recordOriginator mesh__D015748 PXP
% 215.26/215.40  |- skos__prefLabel mesh__D015748 Borrelia burgdorferi Group
% 215.26/215.40  |- rdf__type mesh__D015748sskos__Concept
% 215.26/215.40  |- mesh__publicMeSHNote mesh__D015748
% 215.26/215.40       2002; see BORRELIA BURGDORFERI 1990-2001   
% 215.26/215.40  |- mesh__recordMaintainer mesh__D015748 SYSTEM
% 215.26/215.40  |- skos__historyNote mesh__D015748 Borrelia %28%1984-1989%29%
% 215.26/215.40  |- mesh__dateRevised mesh__D015748 2005-06-30
% 215.26/215.40  |- skos__broader mesh__D015748smesh__D001898
% 215.26/215.40  |- skos__related mesh__D015748smesh__D008193
% 215.26/215.40  |- skos__altLabel mesh__D015748 Borrelia burgdorferi sensu lato
% 215.26/215.40  |- skos__annotation mesh__D015748
% 215.26/215.40       infection: coord IM with LYME DISEASE or specifics %28%IM%29%; BORRELIA BURGDORFERI is also available%A%  
% 215.26/215.41  |- mesh__dateEstablished mesh__D015748 1990-01-01
% 215.26/215.41  |- mesh__historyNote mesh__D015748 2002   
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D015748 2006
% 215.26/215.41  |- mesh__recordAuthorizer mesh__D015748 sjn
% 215.26/215.41  |- mesh__dateCreated mesh__D015748 1989-05-25
% 215.26/215.41  |- mesh__recordMaintainer mesh__D040141 SYSTEM
% 215.26/215.41  |- skos__broader mesh__D040141smesh__D006095
% 215.26/215.41  |- mesh__publicMeSHNote mesh__D040141 2003   
% 215.26/215.41  |- mesh__recordAuthorizer mesh__D040141 sjn
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D040141 2006
% 215.26/215.41  |- mesh__dateEstablished mesh__D040141 2003-01-01
% 215.26/215.41  |- rdf__type mesh__D040141sskos__Concept
% 215.26/215.41  |- skos__scopeNote mesh__D040141
% 215.26/215.41       Family of gram-positive, facultatively anaerobic bacteria, in the order Bacillales. Genera include Gemella, Macrococcus, Salinicoccus, and STAPHYLOCOCCUS.%A%    
% 215.26/215.41  |- skos__prefLabel mesh__D040141 Staphylococcaceae
% 215.26/215.41  |- mesh__recordOriginator mesh__D040141 ags
% 215.26/215.41  |- mesh__dateCreated mesh__D040141 2002-07-03
% 215.26/215.41  |- mesh__dateRevised mesh__D040141 2005-06-30
% 215.26/215.41  |- mesh__historyNote mesh__D040141 2003   
% 215.26/215.41  |- mesh__publicMeSHNote mesh__D034902 2003   
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D034902 2003
% 215.26/215.41  |- mesh__historyNote mesh__D034902 2003   
% 215.26/215.41  |- mesh__dateEstablished mesh__D034902 2003-01-01
% 215.26/215.41  |- mesh__dateCreated mesh__D034902 2002-07-02
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D034902 2004
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D034902 2005
% 215.26/215.41  |- skos__scopeNote mesh__D034902
% 215.26/215.41       A plant genus of the family ALISMATACEAE. The flowers have 3 green sepals, 3 yellow and white petals, 6 stamens, and several pistils.  Members contain TRITERPENES and SESQUITERPENES. Alisma is a component of tokishakuyakusan. Some species in this genus are called water plantain which is also a common name for other ALISMATACEAE plants.%A%    
% 215.26/215.41  |- skos__annotation mesh__D034902
% 215.26/215.41       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D034902 2006
% 215.26/215.41  |- rdf__type mesh__D034902sskos__Concept
% 215.26/215.41  |- skos__prefLabel mesh__D034902 Alisma
% 215.26/215.41  |- skos__broader mesh__D034902smesh__D034901
% 215.26/215.41  |- skos__scopeNote mesh__D001728
% 215.26/215.41       An oral anticoagulant that interferes with the metabolism of vitamin K. It is also used in biochemical experiments as an inhibitor of reductases.%A%    
% 215.26/215.41  |- mesh__historyNote mesh__D001728
% 215.26/215.41       96; was BISHYDROXYCOUMARIN 1963-95; DICUMAROL was see BISHYDROXYCOUMARIN 1963-95%A%  
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D001728 2006
% 215.26/215.41  |- mesh__dateRevised mesh__D001728 2005-06-30
% 215.26/215.41  |- mesh__publicMeSHNote mesh__D001728
% 215.26/215.41       96; was BISHYDROXYCOUMARIN 1963-95; DICUMAROL was see BISHYDROXYCOUMARIN 1963-95%A%  
% 215.26/215.41  |- mesh__dateCreated mesh__D001728 1999-01-01
% 215.26/215.41  |- skos__prefLabel mesh__D001728 Dicumarol
% 215.26/215.41  |- rdf__type mesh__D001728sskos__Concept
% 215.26/215.41  |- skos__altLabel mesh__D001728 Dicoumarol
% 215.26/215.41  |- mesh__recordOriginator mesh__D001728 NLM
% 215.26/215.41  |- skos__broader mesh__D001728smesh__D015110
% 215.26/215.41  |- skos__altLabel mesh__D001728 Bishydroxycoumarin
% 215.26/215.41  |- mesh__recordMaintainer mesh__D001728 ssb
% 215.26/215.41  |- mesh__recordAuthorizer mesh__D001728 sjn
% 215.26/215.41  |- skos__hiddenLabel mesh__D012450 Oils, Safflower
% 215.26/215.41  |- rdf__type mesh__D012450sskos__Concept
% 215.26/215.41  |- skos__broader mesh__D012450smesh__D010938
% 215.26/215.41  |- skos__hiddenLabel mesh__D012450 Safflower Oils
% 215.26/215.41  |- skos__hiddenLabel mesh__D012450 Oil, Safflower
% 215.26/215.41  |- mesh__onlineNote mesh__D012450 search FATTY ACIDS, ESSENTIAL 1966-74   
% 215.26/215.41  |- skos__broader mesh__D012450smesh__D004042
% 215.26/215.41  |- mesh__recordAuthorizer mesh__D012450 sjn
% 215.26/215.41  |- skos__annotation mesh__D012450 an unsaturated fat   
% 215.26/215.41  |- mesh__historyNote mesh__D012450
% 215.26/215.41       91%28%75%29%; was see under PLANT OILS 1975-90; was see under FATTY ACIDS, ESSENTIAL 1963-74%A%  
% 215.26/215.41  |- skos__scopeNote mesh__D012450
% 215.26/215.41       An oily liquid extracted from the seeds of the safflower, Carthamus tinctorius. It is used as a dietary supplement in the management of HYPERCHOLESTEROLEMIA. It is used also in cooking, as a salad oil, and as a vehicle for medicines, paints, varnishes, etc. %28%Dorland, 28th ed %26% Random House Unabridged Dictionary, 2d ed%29%%A%    
% 215.26/215.41  |- mesh__dateRevised mesh__D012450 2005-06-30
% 215.26/215.41  |- skos__broader mesh__D012450smesh__D005224
% 215.26/215.41  |- mesh__dateCreated mesh__D012450 1999-01-01
% 215.26/215.41  |- mesh__dateEstablished mesh__D012450 1991-01-01
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D012450 2006
% 215.26/215.41  |- mesh__recordOriginator mesh__D012450 NLM
% 215.26/215.41  |- mesh__recordMaintainer mesh__D012450 ssb
% 215.26/215.41  |- skos__prefLabel mesh__D012450 Safflower Oil
% 215.26/215.41  |- mesh__publicMeSHNote mesh__D012450
% 215.26/215.41       91; was see under PLANT OILS 1975-90; was see under FATTY ACIDS, ESSENTIAL 1963-74%A%  
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D006413 2001
% 215.26/215.41  |- skos__prefLabel mesh__D006413 Hematopoietic System
% 215.26/215.41  |- rdf__type mesh__D006413sskos__Concept
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D006413 1999
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D006413 1996
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D006413 2005
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D006413 2002
% 215.26/215.41  |- skos__annotation mesh__D006413 /physiol: consider also HEMATOPOIESIS   
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D006413 1997
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D006413 2006
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D006413 2003
% 215.26/215.41  |- mesh__recordMaintainer mesh__D006413 TGC
% 215.26/215.41  |- skos__hiddenLabel mesh__D006413 System, Hematopoietic
% 215.26/215.41  |- skos__hiddenLabel mesh__D006413 Hematopoietic Systems
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D006413 2004
% 215.26/215.41  |- mesh__dateCreated mesh__D006413 1999-01-01
% 215.26/215.41  |- skos__broader mesh__D006413smesh__D006424
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D006413 1994
% 215.26/215.41  |- mesh__recordAuthorizer mesh__D006413 PLS
% 215.26/215.41  |- skos__hiddenLabel mesh__D006413 Systems, Hematopoietic
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D006413 1995
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D006413 1992
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D006413 2000
% 215.26/215.41  |- mesh__dateRevised mesh__D006413 1991-06-27
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D006413 1998
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D006413 1993
% 215.26/215.41  |- mesh__recordOriginator mesh__D006413 NLM
% 215.26/215.41  |- skos__hiddenLabel mesh__D011358 Surveillances, Postmarketing Product
% 215.26/215.41  |- skos__hiddenLabel mesh__D011358 Surveillance, Postmarketing Drug
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D011358 2002
% 215.26/215.41  |- skos__prefLabel mesh__D011358 Product Surveillance, Postmarketing
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D011358 2004
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D011358 1995
% 215.26/215.41  |- skos__hiddenLabel mesh__D011358 Surveillance, Post-Marketing Product
% 215.26/215.41  |- skos__historyNote mesh__D011358 specific drug/AE %28%1966-1982%29%
% 215.26/215.41  |- skos__hiddenLabel mesh__D011358 Post-Marketing Product Surveillances
% 215.26/215.41  |- mesh__historyNote mesh__D011358
% 215.26/215.41       89%28%83%29%; was see under EVALUATION STUDIES 1983-88   
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D011358 1996
% 215.26/215.41  |- skos__hiddenLabel mesh__D011358 Postmarketing Drug Surveillances
% 215.26/215.41  |- skos__altLabel mesh__D011358 Evaluation Studies, Postmarketing
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D011358 2005
% 215.26/215.41  |- mesh__recordOriginator mesh__D011358 SH
% 215.26/215.41  |- skos__altLabel mesh__D011358 Postmarketing Product Surveillance
% 215.26/215.41  |- skos__hiddenLabel mesh__D011358 Post-Marketing Product Surveillance
% 215.26/215.41  |- skos__historyNote mesh__D011358 Clinical Trials %28%1966-1982%29%
% 215.26/215.41  |- skos__hiddenLabel mesh__D011358 Product Surveillances, Postmarketing
% 215.26/215.41  |- mesh__dateCreated mesh__D011358 1982-05-05
% 215.26/215.41  |- mesh__dateRevised mesh__D011358 1992-05-18
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D011358 1997
% 215.26/215.41  |- skos__hiddenLabel mesh__D011358 Surveillance, Postmarketing Product
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D011358 2006
% 215.26/215.41  |- skos__hiddenLabel mesh__D011358 Surveillances, Postmarketing Drug
% 215.26/215.41  |- skos__hiddenLabel mesh__D011358 Product Surveillance, Post Marketing
% 215.26/215.41  |- skos__historyNote mesh__D011358 Drug Therapy %28%1966-1982%29%
% 215.26/215.41  |- mesh__recordMaintainer mesh__D011358 TAP
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D011358 2000
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D011358 1993
% 215.26/215.41  |- skos__altLabel mesh__D011358 Product Surveillance, Post-Marketing
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D011358 1998
% 215.26/215.41  |- skos__hiddenLabel mesh__D011358 Postmarketing Evaluation Study
% 215.26/215.41  |- skos__broader mesh__D011358smesh__D005069
% 215.26/215.41  |- skos__hiddenLabel mesh__D011358 Surveillances, Post-Marketing Product
% 215.26/215.41  |- skos__hiddenLabel mesh__D011358 Evaluation Study, Postmarketing
% 215.26/215.41  |- skos__hiddenLabel mesh__D011358 Postmarketing Product Surveillances
% 215.26/215.41  |- rdf__type mesh__D011358sskos__Concept
% 215.26/215.41  |- mesh__publicMeSHNote mesh__D011358
% 215.26/215.41       89; was see under EVALUATION STUDIES 1983-88   
% 215.26/215.41  |- skos__annotation mesh__D011358
% 215.26/215.41       not restricted to drugs; surveillance after release for general sale%A%  
% 215.26/215.41  |- mesh__recordAuthorizer mesh__D011358 PLS
% 215.26/215.41  |- skos__hiddenLabel mesh__D011358 Studies, Postmarketing Evaluation
% 215.26/215.41  |- skos__hiddenLabel mesh__D011358 Study, Postmarketing Evaluation
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D011358 2001
% 215.26/215.41  |- skos__hiddenLabel mesh__D011358 Product Surveillances, Post-Marketing
% 215.26/215.41  |- skos__scopeNote mesh__D011358
% 215.26/215.41       Surveillance of drugs, devices, appliances, etc., for efficacy or adverse effects, after they have been released for general sale.%A%    
% 215.26/215.41  |- mesh__dateEstablished mesh__D011358 1989-01-01
% 215.26/215.41  |- skos__hiddenLabel mesh__D011358 Postmarketing Evaluation Studies
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D011358 2003
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D011358 1994
% 215.26/215.41  |- skos__hiddenLabel mesh__D011358 Drug Surveillances, Postmarketing
% 215.26/215.41  |- skos__hiddenLabel mesh__D011358 Postmarketing Drug Surveillance
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D011358 1999
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D016841 2006
% 215.26/215.41  |- mesh__recordOriginator mesh__D016841 PXP
% 215.26/215.41  |- skos__annotation mesh__D016841
% 215.26/215.41       an order of ameboid protozoa; usually nonpathogenic   
% 215.26/215.41  |- mesh__recordAuthorizer mesh__D016841 sjn
% 215.26/215.41  |- mesh__dateRevised mesh__D016841 2003-07-09
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D016841 2005
% 215.26/215.41  |- mesh__historyNote mesh__D016841 92   
% 215.26/215.41  |- mesh__publicMeSHNote mesh__D016841 92   
% 215.26/215.41  |- mesh__dateEstablished mesh__D016841 1992-01-01
% 215.26/215.41  |- rdf__type mesh__D016841sskos__Concept
% 215.26/215.41  |- skos__scopeNote mesh__D016841
% 215.26/215.41       An order of ameboid protozoa that is commonly uninucleate and possess mitochondria. Most organisms are nonpathogenic.%A%    
% 215.26/215.41  |- skos__prefLabel mesh__D016841 Amoebida
% 215.26/215.41  |- skos__altLabel mesh__D016841 Amebida
% 215.26/215.41  |- mesh__dateCreated mesh__D016841 1991-05-02
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D016841 2004
% 215.26/215.41  |- mesh__recordMaintainer mesh__D016841 ags
% 215.26/215.41  |- skos__broader mesh__D016841smesh__D016840
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D002821 2006
% 215.26/215.41  |- skos__hiddenLabel mesh__D002821 Amnionitides
% 215.26/215.41  |- skos__broader mesh__D002821smesh__D005315
% 215.26/215.41  |- mesh__recordMaintainer mesh__D002821 lkt
% 215.26/215.41  |- mesh__dateCreated mesh__D002821 1984-05-01
% 215.26/215.41  |- skos__historyNote mesh__D002821
% 215.26/215.41       Fetal Membranes, Premature Rupture %28%1975-1984%29%
% 215.26/215.41  |- skos__hiddenLabel mesh__D002821 Funisitides
% 215.26/215.41  |- skos__scopeNote mesh__D002821
% 215.26/215.41       INFLAMMATION of the placental membranes %28%CHORION; AMNION%29% and connected tissues such as fetal BLOOD VESSELS and UMBILICAL CORD. It is often associated with intrauterine ascending infections during PREGNANCY.%A%    
% 215.26/215.41  |- skos__historyNote mesh__D002821 Amnion %28%1966-1984%29%
% 215.26/215.41  |- rdf__type mesh__D002821sskos__Concept
% 215.26/215.41  |- mesh__historyNote mesh__D002821 85   
% 215.26/215.41  |- skos__historyNote mesh__D002821
% 215.26/215.41       Pregnancy Complications, Infectious %28%1966-1984%29%
% 215.26/215.41  |- skos__historyNote mesh__D002821 Chorion %28%1975-1984%29%
% 215.26/215.41  |- mesh__recordOriginator mesh__D002821 EC
% 215.26/215.41  |- skos__hiddenLabel mesh__D002821 Chorioamnionitides
% 215.26/215.41  |- skos__broader mesh__D002821smesh__D005322
% 215.26/215.41  |- mesh__recordAuthorizer mesh__D002821 sjn
% 215.26/215.41  |- skos__broader mesh__D002821smesh__D010922
% 215.26/215.41  |- mesh__dateEstablished mesh__D002821 1985-01-01
% 215.26/215.41  |- mesh__publicMeSHNote mesh__D002821 85   
% 215.26/215.41  |- skos__prefLabel mesh__D002821 Chorioamnionitis
% 215.26/215.41  |- mesh__dateRevised mesh__D002821 2005-06-30
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D002023 2005
% 215.26/215.41  |- mesh__dateCreated mesh__D002023 1999-01-01
% 215.26/215.41  |- skos__scopeNote mesh__D002023
% 215.26/215.41       A species of the true toads, Bufonidae, widely distributed in the United States and Europe.%A%    
% 215.26/215.41  |- skos__hiddenLabel mesh__D002023 Common Toads
% 215.26/215.41  |- mesh__dateRevised mesh__D002023 2003-07-09
% 215.26/215.41  |- mesh__historyNote mesh__D002023 72   
% 215.26/215.41  |- rdf__type mesh__D002023sskos__Concept
% 215.26/215.41  |- mesh__recordOriginator mesh__D002023 NLM
% 215.26/215.41  |- skos__prefLabel mesh__D002023 Bufo bufo
% 215.26/215.41  |- mesh__recordAuthorizer mesh__D002023 sjn
% 215.26/215.41  |- mesh__dateEstablished mesh__D002023 1972-01-01
% 215.26/215.41  |- skos__annotation mesh__D002023
% 215.26/215.41       common U.S. %26% European toad; NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 215.26/215.41  |- skos__hiddenLabel mesh__D002023 Toads, Common
% 215.26/215.41  |- skos__altLabel mesh__D002023 Toad, Common
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D002023 2004
% 215.26/215.41  |- mesh__recordMaintainer mesh__D002023 ags
% 215.26/215.41  |- skos__hiddenLabel mesh__D002023 Common Toad
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D002023 2006
% 215.26/215.41  |- skos__historyNote mesh__D002023 Anura %28%1966-1971%29%
% 215.26/215.41  |- skos__broader mesh__D002023smesh__D002025
% 215.26/215.41  |- mesh__publicMeSHNote mesh__D002023 72   
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D029769 2004
% 215.26/215.41  |- mesh__dateCreated mesh__D029769 2001-07-25
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D029769 2006
% 215.26/215.41  |- mesh__historyNote mesh__D029769 2002   
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D029769 2003
% 215.26/215.41  |- rdf__type mesh__D029769sskos__Concept
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D029769 2005
% 215.26/215.41  |- skos__prefLabel mesh__D029769 Camptotheca
% 215.26/215.41  |- skos__broader mesh__D029769smesh__D030701
% 215.26/215.41  |- mesh__dateEstablished mesh__D029769 2002-01-01
% 215.26/215.41  |- mesh__publicMeSHNote mesh__D029769 2002   
% 215.26/215.41  |- skos__annotation mesh__D029769
% 215.26/215.41       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.26/215.41  |- mesh__dateRevised mesh__D029769 2002-07-03
% 215.26/215.41  |- skos__scopeNote mesh__D029769
% 215.26/215.41       A plant genus of the family NYSSACEAE %28%sometimes classified in the CORNACEAE family%29%. It is a source of CAMPTOTHECIN.%A%    
% 215.26/215.41  |- skos__broader mesh__D040142smesh__D003352
% 215.26/215.41  |- skos__scopeNote mesh__D040142
% 215.26/215.41       A species in the genus CORYNEBACTERIUM, family Corynebacteriaceae, which is used for industrial production of the amino acid LYSINE. It is closely related to Corynebacterium glutamicum.%A%    
% 215.26/215.41  |- mesh__dateRevised mesh__D040142 2005-06-30
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D040142 2006
% 215.26/215.41  |- mesh__historyNote mesh__D040142 2003   
% 215.26/215.41  |- rdf__type mesh__D040142sskos__Concept
% 215.26/215.41  |- mesh__recordAuthorizer mesh__D040142 sjn
% 215.26/215.41  |- skos__prefLabel mesh__D040142 Brevibacterium flavum
% 215.26/215.41  |- mesh__dateEstablished mesh__D040142 2003-01-01
% 215.26/215.41  |- skos__annotation mesh__D040142
% 215.26/215.41       do not confuse with the genus BREVIBACTERIUM   
% 215.26/215.41  |- skos__historyNote mesh__D040142 Brevibacterium %28%1967-2002%29%
% 215.26/215.41  |- mesh__recordMaintainer mesh__D040142 SYSTEM
% 215.26/215.41  |- mesh__dateCreated mesh__D040142 2002-07-02
% 215.26/215.41  |- mesh__publicMeSHNote mesh__D040142 2003   
% 215.26/215.41  |- mesh__recordOriginator mesh__D040142 ags
% 215.26/215.41  |- skos__scopeNote mesh__D034903
% 215.26/215.41       A plant genus of the family ALISMATACEAE that grows in salty marshes and is used for phytoremediation of oil spills. The unisexual flowers have 3 sepals and 3 petals. Members contain trifoliones %28%DITERPENES%29%.%A%    
% 215.26/215.41  |- skos__altLabel mesh__D034903 Arrowhead
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D034903 2004
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D034903 2005
% 215.26/215.41  |- skos__prefLabel mesh__D034903 Sagittaria
% 215.26/215.41  |- skos__annotation mesh__D034903
% 215.26/215.41       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D034903 2006
% 215.26/215.41  |- skos__broader mesh__D034903smesh__D034901
% 215.26/215.41  |- rdf__type mesh__D034903sskos__Concept
% 215.26/215.41  |- mesh__dateEstablished mesh__D034903 2003-01-01
% 215.26/215.41  |- mesh__historyNote mesh__D034903 2003   
% 215.26/215.41  |- mesh__dateCreated mesh__D034903 2002-07-02
% 215.26/215.41  |- mesh__publicMeSHNote mesh__D034903 2003   
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D034903 2003
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D001729 2003
% 215.26/215.41  |- mesh__historyNote mesh__D001729
% 215.26/215.41       BISMUTH-ARSENIC COMPOUNDS was heading 1963-91   
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D001729 2006
% 215.26/215.41  |- mesh__onlineNote mesh__D001729
% 215.26/215.41       use BISMUTH to search BISMUTH-ARSENIC COMPOUNDS 1963-91   
% 215.26/215.41  |- mesh__recordAuthorizer mesh__D001729 sjn
% 215.26/215.41  |- skos__broader mesh__D001729smesh__D019216
% 215.26/215.41  |- mesh__dateCreated mesh__D001729 1999-01-01
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D001729 2004
% 215.26/215.41  |- rdf__type mesh__D001729sskos__Concept
% 215.26/215.41  |- mesh__publicMeSHNote mesh__D001729
% 215.26/215.41       BISMUTH-ARSENIC COMPOUNDS was heading 1963-91   
% 215.26/215.41  |- skos__prefLabel mesh__D001729 Bismuth
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D001729 2001
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D001729 2002
% 215.26/215.41  |- mesh__recordMaintainer mesh__D001729 adp
% 215.26/215.41  |- mesh__recordOriginator mesh__D001729 NLM
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D001729 2005
% 215.26/215.41  |- skos__scopeNote mesh__D001729
% 215.26/215.41       A metallic element that has the atomic symbol Bi, atomic number 83 and atomic weight 208.98.%A%    
% 215.26/215.41  |- skos__annotation mesh__D001729
% 215.26/215.41       Bi-209; Bi-199-208, 210-215 = BISMUTH %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 215.26/215.41  |- mesh__dateRevised mesh__D001729 2000-06-22
% 215.26/215.41  |- mesh__publicMeSHNote mesh__D012451 91; was see under DIOXOLES 1975-90   
% 215.26/215.41  |- mesh__recordOriginator mesh__D012451 NLM
% 215.26/215.41  |- mesh__recordMaintainer mesh__D012451 ssb
% 215.26/215.41  |- skos__hiddenLabel mesh__D012451 Safroles
% 215.26/215.41  |- skos__historyNote mesh__D012451 Allyl Compounds %28%1972-1974%29%
% 215.26/215.41  |- skos__hiddenLabel mesh__D012451 Safrols
% 215.26/215.41  |- skos__hiddenLabel mesh__D012451 4-Allyl-1,2-methylenedioxybenzenes
% 215.26/215.41  |- skos__altLabel mesh__D012451 4-Allyl-1,2-methylenedioxybenzene
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D012451 2006
% 215.26/215.41  |- skos__historyNote mesh__D012451 Dioxoles %28%1969-1974%29%
% 215.26/215.41  |- mesh__dateEstablished mesh__D012451 1991-01-01
% 215.26/215.41  |- skos__altLabel mesh__D012451 Safrol
% 215.26/215.41  |- skos__broader mesh__D012451smesh__D052117
% 215.26/215.41  |- mesh__dateCreated mesh__D012451 1974-11-19
% 215.26/215.41  |- skos__hiddenLabel mesh__D012451 4 Allyl 1,2 methylenedioxybenzene
% 215.26/215.41  |- skos__hiddenLabel mesh__D012451 Shikimols
% 215.26/215.41  |- rdf__type mesh__D012451sskos__Concept
% 215.26/215.41  |- skos__prefLabel mesh__D012451 Safrole
% 215.26/215.41  |- mesh__recordAuthorizer mesh__D012451 sjn
% 215.26/215.41  |- mesh__historyNote mesh__D012451
% 215.26/215.41       91%28%75%29%; was see under DIOXOLES 1975-90   
% 215.26/215.41  |- skos__scopeNote mesh__D012451
% 215.26/215.41       Constituent of several essential oils, notably sassafras. It has been used as a topical antiseptic and it is carcinogenic to the liver so it is no longer used as a flavoring agent in foods.%A%    
% 215.26/215.41  |- skos__broader mesh__D012451smesh__D005421
% 215.26/215.41  |- mesh__dateRevised mesh__D012451 2005-06-30
% 215.26/215.41  |- rdf__type mesh__D006414sskos__Concept
% 215.26/215.41  |- skos__altLabel mesh__D006414 Photoradiation, Hematoporphyrin
% 215.26/215.41  |- mesh__dateEstablished mesh__D006414 1991-01-01
% 215.26/215.41  |- skos__scopeNote mesh__D006414
% 215.26/215.41       Photochemotherapy using visible light, usually red, topically or delivered locally by fiberoptic probe to tissues sensitized with hematoporphyrins.%A%    
% 215.26/215.41  |- skos__altLabel mesh__D006414 Hematoporphyrin Photochemotherapy
% 215.26/215.41  |- skos__broader mesh__D006414smesh__D010778
% 215.26/215.41  |- mesh__historyNote mesh__D006414
% 215.26/215.41       91%28%86%29%; was see under PHOTOCHEMOTHERAPY 1986-90   
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D006414 2006
% 215.26/215.41  |- skos__prefLabel mesh__D006414 Hematoporphyrin Photoradiation
% 215.26/215.41  |- mesh__recordMaintainer mesh__D006414 lkt
% 215.26/215.41  |- mesh__publicMeSHNote mesh__D006414
% 215.26/215.41       91; was see under PHOTOCHEMOTHERAPY 1986-90   
% 215.26/215.41  |- mesh__dateCreated mesh__D006414 1985-06-07
% 215.26/215.41  |- mesh__recordOriginator mesh__D006414 SH
% 215.26/215.41  |- skos__historyNote mesh__D006414 Phototherapy %28%1981-1985%29%
% 215.26/215.41  |- skos__altLabel mesh__D006414 Photochemotherapy, Hematoporphyrin
% 215.26/215.41  |- skos__historyNote mesh__D006414 Photochemotherapy %28%1978-1985%29%
% 215.26/215.41  |- mesh__recordAuthorizer mesh__D006414 sjn
% 215.26/215.41  |- mesh__dateRevised mesh__D006414 2005-06-30
% 215.26/215.41  |- skos__annotation mesh__D006414
% 215.26/215.41       IM; coord with disease /drug ther %28%IM%29%, not /radiother   
% 215.26/215.41  |- skos__historyNote mesh__D006414 Hematoporphyrins %28%1980-1985%29%
% 215.26/215.41  |- mesh__recordOriginator mesh__D011359 NLM
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D011359 2005
% 215.26/215.41  |- rdf__type mesh__D011359sskos__Concept
% 215.26/215.41  |- mesh__publicMeSHNote mesh__D011359 91; was see under ESTRUS 1975-90   
% 215.26/215.41  |- mesh__recordAuthorizer mesh__D011359 sjn
% 215.26/215.41  |- mesh__dateRevised mesh__D011359 2004-07-07
% 215.26/215.41  |- skos__broader mesh__D011359smesh__D030762
% 215.26/215.41  |- mesh__dateCreated mesh__D011359 1974-11-11
% 215.26/215.41  |- mesh__historyNote mesh__D011359
% 215.26/215.41       91%28%75%29%; was see under ESTRUS 1975-90   
% 215.26/215.41  |- mesh__dateEstablished mesh__D011359 1991-01-01
% 215.26/215.41  |- skos__prefLabel mesh__D011359 Proestrus
% 215.26/215.41  |- skos__scopeNote mesh__D011359
% 215.26/215.41       A phase of the ESTROUS CYCLE that precedes ESTRUS. During proestrus, the Graafian follicles undergo maturation.%A%    
% 215.26/215.41  |- mesh__recordMaintainer mesh__D011359 lkt
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D011359 2006
% 215.26/215.41  |- skos__annotation mesh__D011359 non-primate mammals only   
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Projection, Cell Membrane
% 215.26/215.41  |- skos__altLabel mesh__D022081 Cell Membrane Projections
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Projection, Cell Surface
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Membrane Projections, Cell
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D022081 2003
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Surface Projection, Cell
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Membrane Protrusion, Cell
% 215.26/215.41  |- skos__prefLabel mesh__D022081 Cell Surface Extensions
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D022081 2006
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Extensions, Cell Membrane
% 215.26/215.41  |- skos__altLabel mesh__D022081 Cell Surface Protrusions
% 215.26/215.41  |- skos__broader mesh__D022081smesh__D022082
% 215.26/215.41  |- skos__scopeNote mesh__D022081
% 215.26/215.41       Specialized structures of the cell that extend the cell membrane and project out from the cell surface.%A%    
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D022081 2002
% 215.26/215.41  |- skos__altLabel mesh__D022081 Cell Membrane Extensions
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Extensions, Cell Surface
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Protrusions, Cell Surface
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Extension, Cell Membrane
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Surface Protrusions, Cell
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Projections, Cell Surface
% 215.26/215.41  |- mesh__publicMeSHNote mesh__D022081 2001   
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D022081 2005
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Protrusion, Cell Membrane
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Membrane Projection, Cell
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Membrane Protrusions, Cell
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Cell Membrane Protrusion
% 215.26/215.41  |- mesh__recordMaintainer mesh__D022081 nns
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Membrane Extension, Cell
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D022081 2001
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Membrane Extensions, Cell
% 215.26/215.41  |- skos__altLabel mesh__D022081 Cell Surface Projections
% 215.26/215.41  |- rdf__type mesh__D022081sskos__Concept
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Surface Projections, Cell
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Projections, Cell Membrane
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Protrusion, Cell Surface
% 215.26/215.41  |- mesh__recordAuthorizer mesh__D022081 sjn
% 215.26/215.41  |- skos__altLabel mesh__D022081 Cell Membrane Protrusions
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Surface Extensions, Cell
% 215.26/215.41  |- mesh__historyNote mesh__D022081 2001   
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Surface Extension, Cell
% 215.26/215.41  |- mesh__recordOriginator mesh__D022081 nns
% 215.26/215.41  |- skos__annotation mesh__D022081 GEN: avoid; prefer specifics   
% 215.26/215.41  |- mesh__dateCreated mesh__D022081 2000-06-27
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Extension, Cell Surface
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Protrusions, Cell Membrane
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D022081 2004
% 215.26/215.41  |- mesh__dateEstablished mesh__D022081 2001-01-01
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Surface Protrusion, Cell
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Cell Surface Extension
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Cell Surface Projection
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Cell Membrane Extension
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Cell Membrane Projection
% 215.26/215.41  |- skos__hiddenLabel mesh__D022081 Cell Surface Protrusion
% 215.26/215.41  |- skos__broader mesh__D016842smesh__D016841
% 215.26/215.41  |- mesh__dateRevised mesh__D016842 2003-07-09
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D016842 2005
% 215.26/215.41  |- mesh__historyNote mesh__D016842 92   
% 215.26/215.41  |- mesh__recordAuthorizer mesh__D016842 sjn
% 215.26/215.41  |- rdf__type mesh__D016842sskos__Concept
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D016842 2004
% 215.26/215.41  |- mesh__recordMaintainer mesh__D016842 ags
% 215.26/215.41  |- skos__annotation mesh__D016842 a suborder of protozoa   
% 215.26/215.41  |- mesh__publicMeSHNote mesh__D016842 92   
% 215.26/215.41  |- skos__scopeNote mesh__D016842
% 215.26/215.41       A suborder of ameboid protozoa. Characteristics include subpseudopodia that are more or less finely tipped, occasionally filiform, commonly furcate hyaline, and produced from a broad hyaline lobe. Cysts are usually formed and nuclear division is mesomitotic or metamitotic.%A%    
% 215.26/215.41  |- mesh__dateEstablished mesh__D016842 1992-01-01
% 215.26/215.41  |- skos__prefLabel mesh__D016842 Acanthopodina
% 215.26/215.41  |- mesh__activeMeSHYear mesh__D016842 2006
% 215.26/215.41  |- mesh__recordOriginator mesh__D016842 PXP
% 215.26/215.41  |- mesh__dateCreated mesh__D016842 1991-05-02
% 215.26/215.41  |- mesh__publicMeSHNote mesh__D016044
% 215.26/215.41       91; was BCR-ABL FUSION PROTEINS 1990   
% 215.26/215.42  |- rdf__type mesh__D016044sskos__Concept
% 215.26/215.42  |- skos__hiddenLabel mesh__D016044 Fusion Proteins, bcr abl
% 215.26/215.42  |- skos__historyNote mesh__D016044 Neoplasm Proteins %28%1986-1989%29%
% 215.26/215.42  |- skos__related mesh__D016044smesh__D010677
% 215.26/215.42  |- mesh__dateEstablished mesh__D016044 1990-01-01
% 215.26/215.42  |- mesh__onlineNote mesh__D016044
% 215.26/215.42       use FUSION PROTEINS, BCR-ABL to search BCR-ABL FUSION PROTEINS 1990%A%  
% 215.26/215.42  |- mesh__recordOriginator mesh__D016044 AGS
% 215.26/215.42  |- mesh__dateRevised mesh__D016044 2005-06-30
% 215.26/215.42  |- skos__altLabel mesh__D016044 bcr-abl Fusion Proteins
% 215.26/215.42  |- mesh__historyNote mesh__D016044 91; was BCR-ABL FUSION PROTEINS 1990   
% 215.26/215.42  |- skos__prefLabel mesh__D016044 Fusion Proteins, bcr-abl
% 215.26/215.42  |- mesh__recordAuthorizer mesh__D016044 sjn
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D016044 2006
% 215.26/215.42  |- mesh__recordMaintainer mesh__D016044 nns
% 215.26/215.42  |- skos__scopeNote mesh__D016044
% 215.26/215.42       Translation products of a fusion mRNA derived from the breakpoint cluster region %28%bcr%29% gene and a cellular abl %28%c-abl%29% gene translocated to chromosome 22. The p210%28%bcr-abl%29% fusion protein is found in patients with chronic myelogenous leukemia. The p190%28%bcr-abl%29% fusion protein is found in patients with acute lymphocytic leukemia. The activation of human c-abl by chromosomal translocation is essentially the same as the activation of murine c-abl by viral translocation in Abelson murine leukemia virus.%A%    
% 215.26/215.42  |- skos__hiddenLabel mesh__D016044 Proteins, bcr-abl Fusion
% 215.26/215.42  |- skos__annotation mesh__D016044
% 215.26/215.42       IM; found in various leukemias: coord IM with specific leukemia %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 215.26/215.42  |- skos__broader mesh__D016044smesh__D015514
% 215.26/215.42  |- mesh__dateCreated mesh__D016044 1989-05-25
% 215.26/215.42  |- skos__hiddenLabel mesh__D016044 bcr abl Fusion Proteins
% 215.26/215.42  |- skos__broader mesh__D016044smesh__D009363
% 215.26/215.42  |- skos__broader mesh__D002822smesh__D031901
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D002822 2004
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D002822 2006A
% 215.26/215.42  |- mesh__recordOriginator mesh__D002822 NLM
% 215.26/215.42  |- rdf__type mesh__D002822sskos__Concept
% 215.26/215.42  |- skos__annotation mesh__D002822
% 215.26/215.42       coord IM with UTERINE NEOPLASMS %28%IM%29% + FEMALE + PREGNANCY if in the female or TESTICULAR NEOPLASMS %28%IM%29% + MALE if in the male or other organ/neopl term applicable%A%  
% 215.26/215.42  |- mesh__dateCreated mesh__D002822 1999-01-01
% 215.26/215.42  |- skos__broader mesh__D002822smesh__D000230
% 215.26/215.42  |- mesh__recordAuthorizer mesh__D002822 ags
% 215.26/215.42  |- mesh__dateRevised mesh__D002822 2005-07-18
% 215.26/215.42  |- skos__scopeNote mesh__D002822
% 215.26/215.42       A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts %28%TROPHOBLASTS%29%. It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental %28%fetal%29% origin or  non-placental origin %28%CHORIOCARCINOMA, NON-GESTATIONAL%29%.%A%    
% 215.26/215.42  |- mesh__recordMaintainer mesh__D002822 ags
% 215.26/215.42  |- skos__prefLabel mesh__D002822 Choriocarcinoma
% 215.26/215.42  |- skos__broader mesh__D002822smesh__D014328
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D002822 2005
% 215.26/215.42  |- skos__hiddenLabel mesh__D002822 Choriocarcinomas
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D002822 2006
% 215.26/215.42  |- skos__related mesh__D002822smesh__D031954
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D002822 2003
% 215.26/215.42  |- skos__hiddenLabel mesh__D002024 Toads, Giant
% 215.26/215.42  |- skos__historyNote mesh__D002024 Anura %28%1966-1971%29%
% 215.26/215.42  |- skos__scopeNote mesh__D002024
% 215.26/215.42       A species of the true toads, Bufonidae, becoming fairly common in the southern United States and almost pantropical. The secretions from the skin glands of this species are very toxic to animals.%A%    
% 215.26/215.42  |- skos__altLabel mesh__D002024 Toad, Giant
% 215.26/215.42  |- skos__hiddenLabel mesh__D002024 Giant Toads
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D002024 2004
% 215.26/215.42  |- skos__prefLabel mesh__D002024 Bufo marinus
% 215.26/215.42  |- mesh__publicMeSHNote mesh__D002024 72   
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D002024 2006
% 215.26/215.42  |- skos__hiddenLabel mesh__D002024 Giant Toad
% 215.26/215.42  |- skos__broader mesh__D002024smesh__D002025
% 215.26/215.42  |- skos__hiddenLabel mesh__D002024 Marine Toad
% 215.26/215.42  |- mesh__recordMaintainer mesh__D002024 ags
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D002024 2005
% 215.26/215.42  |- skos__hiddenLabel mesh__D002024 Marine Toads
% 215.26/215.42  |- mesh__dateEstablished mesh__D002024 1972-01-01
% 215.26/215.42  |- mesh__dateCreated mesh__D002024 1999-01-01
% 215.26/215.42  |- mesh__recordOriginator mesh__D002024 NLM
% 215.26/215.42  |- mesh__recordAuthorizer mesh__D002024 sjn
% 215.26/215.42  |- skos__altLabel mesh__D002024 Toad, Marine
% 215.26/215.42  |- skos__annotation mesh__D002024
% 215.26/215.42       common southern U.S. toad; NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 215.26/215.42  |- mesh__dateRevised mesh__D002024 2003-07-09
% 215.26/215.42  |- mesh__historyNote mesh__D002024 72   
% 215.26/215.42  |- rdf__type mesh__D002024sskos__Concept
% 215.26/215.42  |- skos__hiddenLabel mesh__D002024 Toads, Marine
% 215.26/215.42  |- skos__broader mesh__D009206Q000473smesh__D009206
% 215.26/215.42  |- rdf__type mesh__D009206Q000473smesh__CompoundConcept
% 215.26/215.42  |- rdf__type mesh__D040941sskos__Concept
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D040941 2005
% 215.26/215.42  |- mesh__publicMeSHNote mesh__D040941
% 215.26/215.42       2003; see GENETICS %28%1974-2002%29%   
% 215.26/215.42  |- mesh__historyNote mesh__D040941 2003; use GENETICS %28%1974-2002%29%   
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D040941 2004
% 215.26/215.42  |- mesh__dateCreated mesh__D040941 2002-07-03
% 215.26/215.42  |- skos__annotation mesh__D040941
% 215.26/215.42       do not confuse with INHERITANCE see WILLS   
% 215.26/215.42  |- skos__scopeNote mesh__D040941
% 215.26/215.42       The transmission of traits encoded in GENES from parent to offspring.%A%    
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D040941 2003
% 215.26/215.42  |- mesh__dateEstablished mesh__D040941 2003-01-01
% 215.26/215.42  |- skos__prefLabel mesh__D040941 Heredity
% 215.26/215.42  |- skos__broader mesh__D040941smesh__D039361
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D040941 2006
% 215.26/215.42  |- mesh__recordMaintainer mesh__D040143 SYSTEM
% 215.26/215.42  |- skos__broader mesh__D040143smesh__D000192
% 215.26/215.42  |- mesh__publicMeSHNote mesh__D040143 2003   
% 215.26/215.42  |- rdf__type mesh__D040143sskos__Concept
% 215.26/215.42  |- mesh__dateCreated mesh__D040143 2002-07-03
% 215.26/215.42  |- mesh__dateRevised mesh__D040143 2005-06-30
% 215.26/215.42  |- skos__prefLabel mesh__D040143 Cellulomonas
% 215.26/215.42  |- mesh__historyNote mesh__D040143 2003   
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D040143 2006
% 215.26/215.42  |- mesh__recordAuthorizer mesh__D040143 sjn
% 215.26/215.42  |- skos__historyNote mesh__D040143 Actinomycetales %28%1974-2002%29%
% 215.26/215.42  |- mesh__dateEstablished mesh__D040143 2003-01-01
% 215.26/215.42  |- skos__scopeNote mesh__D040143
% 215.26/215.42       A genus of aerobic or facultatively anerobic BACTERIA, in the family Cellulomonadaceae. It is found in the SOIL and capable of hydrolyzing CELLULOSE.%A%    
% 215.26/215.42  |- mesh__recordOriginator mesh__D040143 ags
% 215.26/215.42  |- skos__scopeNote mesh__D034904
% 215.26/215.42       A subclass of developmentally regulated lamins having a neutral isoelectric point. They are found to disassociate from nuclear membranes during mitosis.%A%    
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D034904 2006
% 215.26/215.42  |- mesh__recordAuthorizer mesh__D034904 sjn
% 215.26/215.42  |- skos__altLabel mesh__D034904 Type A Lamins
% 215.26/215.42  |- mesh__historyNote mesh__D034904
% 215.26/215.42       2003; for LAMIN A use LAMINS %28%NM%29% 1991-2002   
% 215.26/215.42  |- rdf__type mesh__D034904sskos__Concept
% 215.26/215.42  |- skos__altLabel mesh__D034904 Lamin A
% 215.26/215.42  |- skos__hiddenLabel mesh__D034904 Lamins, Type A
% 215.26/215.42  |- skos__historyNote mesh__D034904 Nuclear Proteins %28%1991-2002%29%
% 215.26/215.42  |- mesh__dateRevised mesh__D034904 2005-06-30
% 215.26/215.42  |- mesh__publicMeSHNote mesh__D034904
% 215.26/215.42       2003; LAMIN A was indexed under NUCLEAR PROTEINS 1991-2002%A%  
% 215.26/215.42  |- mesh__recordOriginator mesh__D034904 jmp
% 215.26/215.42  |- skos__broader mesh__D034904smesh__D034882
% 215.26/215.42  |- mesh__dateEstablished mesh__D034904 2003-01-01
% 215.26/215.42  |- skos__prefLabel mesh__D034904 Lamin Type A
% 215.26/215.42  |- mesh__dateCreated mesh__D034904 2002-07-03
% 215.26/215.42  |- mesh__recordMaintainer mesh__D034904 SYSTEM
% 215.26/215.42  |- skos__altLabel mesh__D012452 Tamarins, Long-tusked
% 215.26/215.42  |- mesh__dateRevised mesh__D012452 2005-06-30
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D012452 2006
% 215.26/215.42  |- skos__prefLabel mesh__D012452 Saguinus
% 215.26/215.42  |- skos__altLabel mesh__D012452 Saguinus oedipus
% 215.26/215.42  |- skos__hiddenLabel mesh__D012452 Long-Tusked Marmosets
% 215.26/215.42  |- skos__historyNote mesh__D012452 Callithricidae %28%1975-1980%29%
% 215.26/215.42  |- mesh__dateEstablished mesh__D012452 1991-01-01
% 215.26/215.42  |- mesh__publicMeSHNote mesh__D012452
% 215.26/215.42       91; was see under CALLITHRICIDAE 1981-90   
% 215.26/215.42  |- mesh__recordOriginator mesh__D012452 EC
% 215.26/215.42  |- skos__hiddenLabel mesh__D012452 Long-tusked Tamarin
% 215.26/215.42  |- skos__hiddenLabel mesh__D012452 Long-Tusked Marmoset
% 215.26/215.42  |- skos__altLabel mesh__D012452 Marmoset, Long-Tusked
% 215.26/215.42  |- skos__hiddenLabel mesh__D012452 Marmoset, Long Tusked
% 215.26/215.42  |- rdf__type mesh__D012452sskos__Concept
% 215.26/215.42  |- mesh__historyNote mesh__D012452
% 215.26/215.42       91%28%81%29%; was see under CALLITHRICIDAE 1981-90   
% 215.26/215.42  |- skos__hiddenLabel mesh__D012452 Cotton-Top Marmoset
% 215.26/215.42  |- skos__hiddenLabel mesh__D012452 Marmoset, Cotton Top
% 215.26/215.42  |- mesh__dateCreated mesh__D012452 1980-05-07
% 215.26/215.42  |- skos__hiddenLabel mesh__D012452 Tamarin, Long-tusked
% 215.26/215.42  |- skos__hiddenLabel mesh__D012452 Cotton-Top Marmosets
% 215.26/215.42  |- mesh__recordMaintainer mesh__D012452 ags
% 215.26/215.42  |- skos__broader mesh__D012452smesh__D002143
% 215.26/215.42  |- skos__hiddenLabel mesh__D012452 Marmosets, Cotton-Top
% 215.26/215.42  |- skos__hiddenLabel mesh__D012452 Marmosets, Long-Tusked
% 215.26/215.42  |- skos__hiddenLabel mesh__D012452 Long-tusked Tamarins
% 215.26/215.42  |- skos__hiddenLabel mesh__D012452 Tamarins, Long tusked
% 215.26/215.42  |- skos__scopeNote mesh__D012452
% 215.26/215.42       A genus in the family CALLITRICHIDAE consisting of 12 species and found in Panama as well as South America. Species seen most frequently in the literature are S. oedipus %28%cotton-top marmoset%29%, S. nigricollis, and S. fusicollis.%A%    
% 215.26/215.42  |- mesh__recordAuthorizer mesh__D012452 sjn
% 215.26/215.42  |- skos__annotation mesh__D012452
% 215.26/215.42       diseases: coordinate IM with MONKEY DISEASES %28%IM%29%   
% 215.26/215.42  |- mesh__historyNote mesh__D006415
% 215.26/215.42       80; was HEMATOPORPHYRIN 1965-79 %28%Prov 1965-73%29%   
% 215.26/215.42  |- mesh__recordAuthorizer mesh__D006415 sjn
% 215.26/215.42  |- mesh__dateCreated mesh__D006415 1999-01-01
% 215.26/215.42  |- mesh__dateRevised mesh__D006415 2005-06-30
% 215.26/215.42  |- mesh__dateEstablished mesh__D006415 1974-01-01
% 215.26/215.42  |- skos__broader mesh__D006415smesh__D011166
% 215.26/215.42  |- mesh__publicMeSHNote mesh__D006415 80; was HEMATOPORPHYRIN 1974-79   
% 215.26/215.42  |- mesh__onlineNote mesh__D006415
% 215.26/215.42       use HEMATOPORPHYRINS to search HEMATOPORPHYRIN 1966-79 %28%as Prov 1966-73%29%%A%  
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D006415 2006
% 215.26/215.42  |- skos__scopeNote mesh__D006415
% 215.26/215.42       Iron-free derivatives of heme with 4 methyl groups, 2 hydroxyethyl groups and 2 propionic acid groups attached to the pyrrole rings. Some of these PHOTOSENSITIZING AGENTS are used in the PHOTOTHERAPY of malignant NEOPLASMS.%A%    
% 215.26/215.42  |- mesh__recordOriginator mesh__D006415 NLM
% 215.26/215.42  |- mesh__recordMaintainer mesh__D006415 ssb
% 215.26/215.42  |- skos__prefLabel mesh__D006415 Hematoporphyrins
% 215.26/215.42  |- rdf__type mesh__D006415sskos__Concept
% 215.26/215.42  |- rdf__type mesh__D022082sskos__Concept
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D022082 2001
% 215.26/215.42  |- mesh__publicMeSHNote mesh__D022082 2001   
% 215.26/215.42  |- mesh__historyNote mesh__D022082 2001   
% 215.26/215.42  |- mesh__dateEstablished mesh__D022082 2001-01-01
% 215.26/215.42  |- skos__annotation mesh__D022082 GEN: avoid; prefer specifics   
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D022082 2002
% 215.26/215.42  |- mesh__recordAuthorizer mesh__D022082 ags
% 215.26/215.42  |- skos__prefLabel mesh__D022082 Cellular Structures
% 215.26/215.42  |- skos__broader mesh__D022082smesh__D002477
% 215.26/215.42  |- skos__hiddenLabel mesh__D022082 Component, Cell
% 215.26/215.42  |- skos__hiddenLabel mesh__D022082 Structures, Cellular
% 215.26/215.42  |- skos__hiddenLabel mesh__D022082 Components, Cell
% 215.26/215.42  |- skos__scopeNote mesh__D022082 Components of a cell.     
% 215.26/215.42  |- skos__altLabel mesh__D022082 Cell Components
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D022082 2005
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D022082 2003
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D022082 2006
% 215.26/215.42  |- mesh__dateCreated mesh__D022082 2000-07-05
% 215.26/215.42  |- skos__hiddenLabel mesh__D022082 Cell Component
% 215.26/215.42  |- skos__hiddenLabel mesh__D022082 Cellular Structure
% 215.26/215.42  |- mesh__recordOriginator mesh__D022082 nns
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D022082 2004
% 215.26/215.42  |- mesh__recordMaintainer mesh__D022082 nns
% 215.26/215.42  |- skos__hiddenLabel mesh__D022082 Structure, Cellular
% 215.26/215.42  |- mesh__dateEstablished mesh__D016843 1992-01-01
% 215.26/215.42  |- rdf__type mesh__D016843sskos__Concept
% 215.26/215.42  |- mesh__publicMeSHNote mesh__D016843 92   
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D016843 2004
% 215.26/215.42  |- skos__annotation mesh__D016843 a suborder of protozoa   
% 215.26/215.42  |- skos__prefLabel mesh__D016843 Blastocystina
% 215.26/215.42  |- mesh__dateCreated mesh__D016843 1991-05-02
% 215.26/215.42  |- skos__scopeNote mesh__D016843
% 215.26/215.42       A suborder of protozoa of the class LOBOSEA.     
% 215.26/215.42  |- mesh__recordMaintainer mesh__D016843 ags
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D016843 2006
% 215.26/215.42  |- skos__broader mesh__D016843smesh__D016841
% 215.26/215.42  |- mesh__recordOriginator mesh__D016843 PXP
% 215.26/215.42  |- mesh__dateRevised mesh__D016843 2003-07-09
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D016843 2005
% 215.26/215.42  |- mesh__recordAuthorizer mesh__D016843 sjn
% 215.26/215.42  |- mesh__historyNote mesh__D016843 92   
% 215.26/215.42  |- skos__annotation mesh__D016045 CATALOG: use NAF entry   
% 215.26/215.42  |- mesh__recordAuthorizer mesh__D016045 sjn
% 215.26/215.42  |- skos__scopeNote mesh__D016045
% 215.26/215.42       A coordinated effort of researchers to map %28%CHROMOSOME MAPPING%29% and sequence %28%SEQUENCE ANALYSIS, DNA%29% the human GENOME.%A%    
% 215.26/215.42  |- skos__hiddenLabel mesh__D016045 Project, Human Genome
% 215.26/215.42  |- mesh__dateEstablished mesh__D016045 1990-01-01
% 215.26/215.42  |- mesh__publicMeSHNote mesh__D016045 90   
% 215.26/215.42  |- skos__hiddenLabel mesh__D016045 Genome Projects, Human
% 215.26/215.42  |- skos__hiddenLabel mesh__D016045 Projects, Human Genome
% 215.26/215.42  |- rdf__type mesh__D016045sskos__Concept
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D016045 2005
% 215.26/215.42  |- skos__prefLabel mesh__D016045 Human Genome Project
% 215.26/215.42  |- skos__altLabel mesh__D016045 Genome Project, Human
% 215.26/215.42  |- skos__broader mesh__D016045smesh__D036281
% 215.26/215.42  |- skos__hiddenLabel mesh__D016045 Human Genome Projects
% 215.26/215.42  |- skos__historyNote mesh__D016045 Base Sequence %28%1987-1989%29%
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D016045 2006
% 215.26/215.42  |- mesh__recordOriginator mesh__D016045 PXP
% 215.26/215.42  |- mesh__dateCreated mesh__D016045 1989-06-06
% 215.26/215.42  |- mesh__recordMaintainer mesh__D016045 sjn
% 215.26/215.42  |- skos__broader mesh__D016045smesh__D007255
% 215.26/215.42  |- skos__related mesh__D016045smesh__D023281
% 215.26/215.42  |- mesh__dateRevised mesh__D016045 2004-07-13
% 215.26/215.42  |- skos__historyNote mesh__D016045 Chromosomes, Human %28%1987-1989%29%
% 215.26/215.42  |- mesh__historyNote mesh__D016045 90   
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D002823 2006
% 215.26/215.42  |- skos__hiddenLabel mesh__D002823 Chorions
% 215.26/215.42  |- skos__related mesh__D002823smesh__D049033
% 215.26/215.42  |- mesh__historyNote mesh__D002823
% 215.26/215.42       78%28%75%29%; was see under FETAL MEMBRANES 1963-77   
% 215.26/215.42  |- skos__scopeNote mesh__D002823
% 215.26/215.42       The outermost extra-embryonic membrane surrounding the developing EMBRYO. In REPTILES and BIRDS, it adheres to the shell and allows exchange of gases between the egg and its environment. In MAMMALS, the chorion evolves into the fetal contribution of the PLACENTA.%A%    
% 215.26/215.42  |- mesh__recordAuthorizer mesh__D002823 sjn
% 215.26/215.42  |- rdf__type mesh__D002823sskos__Concept
% 215.26/215.42  |- skos__historyNote mesh__D002823 Fetal Membranes %28%1966-1974%29%
% 215.26/215.42  |- mesh__dateRevised mesh__D002823 2005-06-30
% 215.26/215.42  |- mesh__recordOriginator mesh__D002823 NLM
% 215.26/215.42  |- skos__broader mesh__D002823smesh__D005321
% 215.26/215.42  |- mesh__dateCreated mesh__D002823 1999-01-01
% 215.26/215.42  |- mesh__dateEstablished mesh__D002823 1978-01-01
% 215.26/215.42  |- mesh__onlineNote mesh__D002823 search FETAL MEMBRANES 1966-74   
% 215.26/215.42  |- skos__prefLabel mesh__D002823 Chorion
% 215.26/215.42  |- mesh__recordMaintainer mesh__D002823 lkt
% 215.26/215.42  |- mesh__publicMeSHNote mesh__D002823
% 215.26/215.42       78; was see under FETAL MEMBRANES 1963-77   
% 215.26/215.42  |- mesh__recordAuthorizer mesh__D002025 sjn
% 215.26/215.42  |- skos__hiddenLabel mesh__D002025 Bufos
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D002025 2004
% 215.26/215.42  |- skos__prefLabel mesh__D002025 Bufonidae
% 215.26/215.42  |- skos__altLabel mesh__D002025 Toads, True
% 215.26/215.42  |- mesh__historyNote mesh__D002025 81; was BUFO 1972-80   
% 215.26/215.42  |- skos__hiddenLabel mesh__D002025 Toad, True
% 215.26/215.42  |- skos__annotation mesh__D002025
% 215.26/215.42       toads including genera Bufo, Ansonia, Nectophrynoides %26% Atelopus; NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D002025 2006
% 215.26/215.42  |- skos__historyNote mesh__D002025 Anura %28%1966-1971%29%
% 215.26/215.42  |- skos__broader mesh__D002025smesh__D001001
% 215.26/215.42  |- skos__hiddenLabel mesh__D002025 True Toads
% 215.26/215.42  |- mesh__recordMaintainer mesh__D002025 ags
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D002025 2005
% 215.26/215.42  |- mesh__dateCreated mesh__D002025 1999-01-01
% 215.26/215.42  |- mesh__onlineNote mesh__D002025 use BUFONIDAE to search BUFO 1972-80   
% 215.26/215.42  |- mesh__dateRevised mesh__D002025 2003-07-09
% 215.26/215.42  |- rdf__type mesh__D002025sskos__Concept
% 215.26/215.42  |- skos__scopeNote mesh__D002025
% 215.26/215.42       The family of true toads belonging to the order Anura. The genera include Bufo, Ansonia, Nectophrynoides, and Atelopus.%A%    
% 215.26/215.42  |- skos__hiddenLabel mesh__D002025 True Toad
% 215.26/215.42  |- mesh__dateEstablished mesh__D002025 1972-01-01
% 215.26/215.42  |- mesh__recordOriginator mesh__D002025 NLM
% 215.26/215.42  |- mesh__publicMeSHNote mesh__D002025 81; was BUFO 1972-80   
% 215.26/215.42  |- skos__altLabel mesh__D012453 Monkey, Squirrel
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D012453 2006
% 215.26/215.42  |- mesh__onlineNote mesh__D012453
% 215.26/215.42       use SAIMIRI to search SQUIRREL MONKEYS 1975-80   
% 215.26/215.42  |- skos__hiddenLabel mesh__D012453 Monkeys, Squirrel
% 215.26/215.42  |- mesh__recordAuthorizer mesh__D012453 sjn
% 215.26/215.42  |- rdf__type mesh__D012453sskos__Concept
% 215.26/215.42  |- mesh__dateRevised mesh__D012453 2005-06-30
% 215.26/215.42  |- mesh__publicMeSHNote mesh__D012453
% 215.26/215.42       91; was see under CEBIDAE 1981-90; was SQUIRREL MONKEYS see under MONKEYS 1975-80%A%  
% 215.26/215.42  |- mesh__historyNote mesh__D012453
% 215.26/215.42       91%28%81%29%; was see under CEBIDAE 1981-90; was SQUIRREL MONKEYS see under MONKEYS 1975-80%A%  
% 215.26/215.42  |- mesh__recordMaintainer mesh__D012453 ags
% 215.26/215.42  |- skos__broader mesh__D012453smesh__D016648
% 215.26/215.42  |- skos__hiddenLabel mesh__D012453 Squirrel Monkeys
% 215.26/215.42  |- mesh__dateEstablished mesh__D012453 1991-01-01
% 215.26/215.42  |- mesh__dateCreated mesh__D012453 1974-11-11
% 215.26/215.42  |- skos__altLabel mesh__D012453 Squirrel Monkey
% 215.26/215.42  |- mesh__recordOriginator mesh__D012453 NLM
% 215.26/215.42  |- skos__scopeNote mesh__D012453
% 215.26/215.42       A genus of the family CEBIDAE consisting of four species: S. boliviensis, S. orstedii %28%red-backed squirrel monkey%29%, S. sciureus %28%common squirrel monkey%29%, and S. ustus. They inhabit tropical rain forests in Central and South America. S. sciureus is used extensively in research studies.%A%    
% 215.26/215.42  |- skos__hiddenLabel mesh__D012453 Saimirus
% 215.26/215.42  |- skos__annotation mesh__D012453
% 215.26/215.42       New World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 215.26/215.42  |- skos__prefLabel mesh__D012453 Saimiri
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D006416 2006
% 215.26/215.42  |- mesh__recordOriginator mesh__D006416 NLM
% 215.26/215.42  |- mesh__publicMeSHNote mesh__D006416
% 215.26/215.42       91; was see under BENZOPYRANS 1975-90   
% 215.26/215.42  |- mesh__recordMaintainer mesh__D006416 ssb
% 215.26/215.42  |- skos__altLabel mesh__D006416 Hemotoxylin
% 215.26/215.42  |- skos__annotation mesh__D006416 a dye; D25-26 qualif   
% 215.26/215.42  |- skos__historyNote mesh__D006416 Indenes %28%1973-1974%29%
% 215.26/215.42  |- skos__broader mesh__D006416smesh__D001578
% 215.26/215.42  |- mesh__recordAuthorizer mesh__D006416 sjn
% 215.26/215.42  |- mesh__dateRevised mesh__D006416 2005-06-30
% 215.26/215.42  |- skos__scopeNote mesh__D006416
% 215.26/215.42       A dye obtained from the heartwood of logwood %28%Haematoxylon campechianum Linn., Leguminosae%29% used as a stain in microscopy and in the manufacture of ink.%A%    
% 215.26/215.42  |- skos__altLabel mesh__D006416 Hydroxybrasilin
% 215.26/215.42  |- rdf__type mesh__D006416sskos__Concept
% 215.26/215.42  |- skos__altLabel mesh__D006416 Hematoxiline
% 215.26/215.42  |- skos__altLabel mesh__D006416 Hydroxybrazilin
% 215.26/215.42  |- skos__historyNote mesh__D006416 Benzopyrans %28%1969-1974%29%
% 215.26/215.42  |- mesh__dateCreated mesh__D006416 1974-11-19
% 215.26/215.42  |- mesh__historyNote mesh__D006416
% 215.26/215.42       91%28%75%29%; was see under BENZOPYRANS 1975-90   
% 215.26/215.42  |- skos__prefLabel mesh__D006416 Hematoxylin
% 215.26/215.42  |- mesh__dateEstablished mesh__D006416 1991-01-01
% 215.26/215.42  |- mesh__historyNote mesh__D022083 2001   
% 215.26/215.42  |- skos__broader mesh__D022083smesh__D003593
% 215.26/215.42  |- mesh__dateEstablished mesh__D022083 2001-01-01
% 215.26/215.42  |- skos__hiddenLabel mesh__D022083 Structures, Cytoplasmic
% 215.26/215.42  |- mesh__dateCreated mesh__D022083 2000-07-05
% 215.26/215.42  |- mesh__recordMaintainer mesh__D022083 nns
% 215.26/215.42  |- skos__prefLabel mesh__D022083 Cytoplasmic Structures
% 215.26/215.42  |- mesh__dateRevised mesh__D022083 2003-07-09
% 215.26/215.42  |- mesh__publicMeSHNote mesh__D022083 2001   
% 215.26/215.42  |- skos__annotation mesh__D022083 GEN: avoid; prefer specifics   
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D022083 2005
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D022083 2006
% 215.26/215.42  |- skos__hiddenLabel mesh__D022083 Structure, Cytoplasmic
% 215.26/215.42  |- skos__scopeNote mesh__D022083
% 215.26/215.42       Components of the cytoplasm excluding the CYTOSOL.     
% 215.26/215.42  |- mesh__recordOriginator mesh__D022083 nns
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D022083 2004
% 215.26/215.42  |- rdf__type mesh__D022083sskos__Concept
% 215.26/215.42  |- mesh__recordAuthorizer mesh__D022083 sjn
% 215.26/215.42  |- skos__hiddenLabel mesh__D022083 Cytoplasmic Structure
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D016844 2004
% 215.26/215.42  |- mesh__recordAuthorizer mesh__D016844 sjn
% 215.26/215.42  |- skos__broader mesh__D016844smesh__D016843
% 215.26/215.42  |- skos__historyNote mesh__D016844 Zygomycotina %28%1980-1985%29%
% 215.26/215.42  |- mesh__onlineNote mesh__D016844
% 215.26/215.42       use PROTOZOA to search BLASTOCYSTIS 1989-91   
% 215.26/215.42  |- mesh__dateEstablished mesh__D016844 1992-01-01
% 215.26/215.42  |- mesh__recordMaintainer mesh__D016844 ags
% 215.26/215.42  |- mesh__historyNote mesh__D016844 92; was see PROTOZOA 1989-91   
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D016844 2006
% 215.26/215.42  |- mesh__publicMeSHNote mesh__D016844 92; was see PROTOZOA 1989-91   
% 215.26/215.42  |- mesh__recordOriginator mesh__D016844 PXP
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D016844 2005
% 215.26/215.42  |- mesh__dateRevised mesh__D016844 2003-07-09
% 215.26/215.42  |- mesh__dateCreated mesh__D016844 1991-05-02
% 215.26/215.42  |- skos__prefLabel mesh__D016844 Blastocystis
% 215.26/215.42  |- skos__historyNote mesh__D016844 Phycomycetes %28%1971-1979%29%
% 215.26/215.42  |- rdf__type mesh__D016844sskos__Concept
% 215.26/215.42  |- skos__scopeNote mesh__D016844
% 215.26/215.42       A genus of protozoa of the suborder BLASTOCYSTINA. It was first classified as a yeast but further studies have shown it to be a protozoan.%A%    
% 215.26/215.42  |- skos__historyNote mesh__D016844 Protozoa %28%1986-1991%29%
% 215.26/215.42  |- skos__annotation mesh__D016844
% 215.26/215.42       do not confuse with BLASTOCYST %28%Cat A%29%; infection = BLASTOCYSTIS INFECTIONS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 215.26/215.42  |- mesh__recordMaintainer mesh__D002824 lkt
% 215.26/215.42  |- skos__hiddenLabel mesh__D002824 Villi, Placental
% 215.26/215.42  |- rdf__type mesh__D002824sskos__Concept
% 215.26/215.42  |- skos__hiddenLabel mesh__D002824 Villus, Placental
% 215.26/215.42  |- skos__hiddenLabel mesh__D002824 Placental Villus
% 215.26/215.42  |- skos__broader mesh__D002824smesh__D002823
% 215.26/215.42  |- skos__altLabel mesh__D002824 Placental Villi
% 215.26/215.42  |- skos__hiddenLabel mesh__D002824 Chorionic Villus
% 215.26/215.42  |- mesh__recordAuthorizer mesh__D002824 sjn
% 215.26/215.42  |- skos__hiddenLabel mesh__D002824 Villi, Chorionic
% 215.26/215.42  |- skos__broader mesh__D002824smesh__D010920
% 215.26/215.42  |- mesh__dateCreated mesh__D002824 1974-11-11
% 215.26/215.42  |- mesh__historyNote mesh__D002824
% 215.26/215.42       85%28%75%29%; was see under PLACENTA 1975-84   
% 215.26/215.42  |- skos__historyNote mesh__D002824 Fetal Membranes %28%1966-1974%29%
% 215.26/215.42  |- mesh__dateRevised mesh__D002824 2005-06-30
% 215.26/215.42  |- skos__scopeNote mesh__D002824
% 215.26/215.42       The threadlike, vascular projections of the chorion. Chorionic villi may be free or embedded within the DECIDUA forming the site for exchange of substances between fetal and maternal blood %28%PLACENTA%29%.%A%    
% 215.26/215.42  |- skos__historyNote mesh__D002824 Placenta %28%1966-1974%29%
% 215.26/215.42  |- skos__hiddenLabel mesh__D002824 Villus, Chorionic
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D002824 2006
% 215.26/215.42  |- mesh__recordOriginator mesh__D002824 NLM
% 215.26/215.42  |- mesh__publicMeSHNote mesh__D002824 85; was see under PLACENTA 1975-84   
% 215.26/215.42  |- mesh__dateEstablished mesh__D002824 1985-01-01
% 215.26/215.42  |- skos__prefLabel mesh__D002824 Chorionic Villi
% 215.26/215.42  |- skos__hiddenLabel mesh__D002026 Buformin Andromaco Brand
% 215.26/215.42  |- mesh__recordMaintainer mesh__D002026 mdb
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D002026 2005
% 215.26/215.42  |- skos__broader mesh__D002026smesh__D001645
% 215.26/215.42  |- skos__altLabel mesh__D002026 1-Butylbiguanide
% 215.26/215.42  |- mesh__publicMeSHNote mesh__D002026
% 215.26/215.42       91; was see under BIGUANIDES 1975-90   
% 215.26/215.42  |- skos__historyNote mesh__D002026 Butanes %28%1973-1974%29%
% 215.26/215.42  |- skos__altLabel mesh__D002026 Andromaco Brand of Buformin
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D002026 2006
% 215.26/215.42  |- mesh__recordOriginator mesh__D002026 NLM
% 215.26/215.42  |- mesh__dateEstablished mesh__D002026 1991-01-01
% 215.26/215.42  |- skos__prefLabel mesh__D002026 Buformin
% 215.26/215.42  |- mesh__recordAuthorizer mesh__D002026 sjn
% 215.26/215.42  |- skos__hiddenLabel mesh__D002026 1 Butylbiguanide
% 215.26/215.42  |- skos__hiddenLabel mesh__D002026 Retard, Silubin
% 215.26/215.42  |- skos__scopeNote mesh__D002026
% 215.26/215.42       An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.%A%    
% 215.26/215.42  |- mesh__dateRevised mesh__D002026 2004-07-07
% 215.26/215.42  |- skos__historyNote mesh__D002026 Biguanides %28%1968-1974%29%
% 215.26/215.42  |- rdf__type mesh__D002026sskos__Concept
% 215.26/215.42  |- skos__altLabel mesh__D002026 Grossmann Brand of Buformin Hydrochloride
% 215.26/215.42  |- mesh__historyNote mesh__D002026
% 215.26/215.42       91%28%75%29%; was see under BIGUANIDES 1975-90   
% 215.26/215.42  |- skos__altLabel mesh__D002026 Butylbiguanide
% 215.26/215.42  |- mesh__dateCreated mesh__D002026 1974-11-11
% 215.26/215.42  |- mesh__dateEstablished mesh__D048128 2005-01-01
% 215.26/215.42  |- mesh__recordMaintainer mesh__D048128 ags
% 215.26/215.42  |- skos__altLabel mesh__D048128 Casein Kinase I alpha
% 215.26/215.42  |- skos__scopeNote mesh__D048128
% 215.26/215.42       A casein kinase I isoenzyme that plays a role in intracellular signaling pathways including the CELL CYCLE, membrane trafficking, and RNA processing. In DROSOPHILA casein kinase Ialpha has been in regulation of Hedghog and Wingless signaling pathways. Multiple isoforms of casein kinase Ialpha exist and are due ALTERNATIVE SPLICING.%A%    
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D048128 2006B
% 215.26/215.42  |- skos__broader mesh__D048128smesh__D047389
% 215.26/215.42  |- skos__historyNote mesh__D048128 Protein Kinases %28%2000-2004%29%
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D048128 2005
% 215.26/215.42  |- mesh__historyNote mesh__D048128 2005%28%2000%29%   
% 215.26/215.42  |- skos__prefLabel mesh__D048128 Casein Kinase Ialpha
% 215.26/215.42  |- mesh__dateRevised mesh__D048128 2005-07-28
% 215.26/215.42  |- mesh__recordAuthorizer mesh__D048128 ags
% 215.26/215.42  |- mesh__activeMeSHYear mesh__D048128 2006
% 215.26/215.42  |- mesh__dateCreated mesh__D048128 2004-07-07
% 215.26/215.42  |- mesh__recordOriginator mesh__D048128 jmp
% 215.26/215.42  |- rdf__type mesh__D048128sskos__Concept
% 215.26/215.42  |- mesh__publicMeSHNote mesh__D048128
% 215.26/215.42       2005; CASEIN KINASE IALPHA was indexed under PROTEIN KINASES 2000-2004%A%  
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D048128 2006A
% 215.26/215.43  |- skos__hiddenLabel mesh__D012454 Salamandras
% 215.26/215.43  |- skos__historyNote mesh__D012454 Urodela %28%1966-1971%29%
% 215.26/215.43  |- skos__scopeNote mesh__D012454
% 215.26/215.43       A genus of European newts in the Salamandridae family. The two species of this genus are Salamandra salamandra %28%European %22%fire%22% salamander%29% and Salamandra atra %28%European alpine salamander%29%.%A%    
% 215.26/215.43  |- mesh__historyNote mesh__D012454 72   
% 215.26/215.43  |- rdf__type mesh__D012454sskos__Concept
% 215.26/215.43  |- mesh__publicMeSHNote mesh__D012454 72   
% 215.26/215.43  |- mesh__recordMaintainer mesh__D012454 ags
% 215.26/215.43  |- mesh__dateRevised mesh__D012454 2003-07-09
% 215.26/215.43  |- mesh__dateCreated mesh__D012454 1999-01-01
% 215.26/215.43  |- mesh__recordAuthorizer mesh__D012454 sjn
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D012454 2004
% 215.26/215.43  |- skos__annotation mesh__D012454
% 215.26/215.43       NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D012454 2005
% 215.26/215.43  |- skos__broader mesh__D012454smesh__D012455
% 215.26/215.43  |- skos__prefLabel mesh__D012454 Salamandra
% 215.26/215.43  |- mesh__dateEstablished mesh__D012454 1972-01-01
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D012454 2006
% 215.26/215.43  |- mesh__recordOriginator mesh__D012454 NLM
% 215.26/215.43  |- skos__hiddenLabel mesh__D006417 Hematurias
% 215.26/215.43  |- mesh__dateRevised mesh__D006417 1999-11-03
% 215.26/215.43  |- skos__prefLabel mesh__D006417 Hematuria
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D006417 2003
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D006417 2006
% 215.26/215.43  |- skos__broader mesh__D006417smesh__D014570
% 215.26/215.43  |- mesh__recordAuthorizer mesh__D006417 sjn
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D006417 2005
% 215.26/215.43  |- rdf__type mesh__D006417sskos__Concept
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D006417 2002
% 215.26/215.43  |- mesh__dateCreated mesh__D006417 1999-01-01
% 215.26/215.43  |- skos__scopeNote mesh__D006417 Presence of blood in the urine.     
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D006417 2001
% 215.26/215.43  |- mesh__recordMaintainer mesh__D006417 KEV
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D006417 2000
% 215.26/215.43  |- mesh__recordOriginator mesh__D006417 NLM
% 215.26/215.43  |- skos__broader mesh__D006417smesh__D006470
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D006417 2004
% 215.26/215.43  |- skos__historyNote mesh__D022882 Freons %28%1984-2000%29%
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D022882 2004
% 215.26/215.43  |- mesh__dateEstablished mesh__D022882 2001-01-01
% 215.26/215.43  |- mesh__recordAuthorizer mesh__D022882 sjn
% 215.26/215.43  |- mesh__recordMaintainer mesh__D022882 adp
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D022882 2002
% 215.26/215.43  |- mesh__publicMeSHNote mesh__D022882
% 215.26/215.43       2001; see CHLOROFLUOROCARBONS, METHANE 1984-2000   
% 215.26/215.43  |- skos__broader mesh__D022882smesh__D006846
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D022882 2005
% 215.26/215.43  |- mesh__historyNote mesh__D022882
% 215.26/215.43       2001; use CHLOROFLUOROCARBONS, METHANE 1984-2000   
% 215.26/215.43  |- mesh__dateCreated mesh__D022882 2000-06-22
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D022882 2006
% 215.26/215.43  |- skos__prefLabel mesh__D022882 Trihalomethanes
% 215.26/215.43  |- skos__altLabel mesh__D022882 Trihalomethane
% 215.26/215.43  |- rdf__type mesh__D022882sskos__Concept
% 215.26/215.43  |- skos__scopeNote mesh__D022882
% 215.26/215.43       Methanes substituted with three halogen atoms, which may be the same or different.%A%    
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D022882 2003
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D022882 2001
% 215.26/215.43  |- mesh__recordOriginator mesh__D022882 adp
% 215.26/215.43  |- skos__historyNote mesh__D016845 Zygomycotina %28%1980-1985%29%
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D016845 2004
% 215.26/215.43  |- mesh__recordMaintainer mesh__D016845 ags
% 215.26/215.43  |- skos__broader mesh__D016845smesh__D016844
% 215.26/215.43  |- mesh__dateEstablished mesh__D016845 1992-01-01
% 215.26/215.43  |- skos__scopeNote mesh__D016845
% 215.26/215.43       A species of parasitic protozoa found in the intestines of humans and other primates. It was classified as a yeast in 1912. Over the years, questions arose about this designation. In 1967, many physiological and morphological B. hominis characteristics were reported that fit a protozoan classification. Since that time, other papers have corroborated this work and the organism is now recognized as a protozoan parasite of humans causing intestinal disease with potentially disabling symptoms.%A%    
% 215.26/215.43  |- mesh__publicMeSHNote mesh__D016845 92   
% 215.26/215.43  |- mesh__recordOriginator mesh__D016845 PXP
% 215.26/215.43  |- mesh__dateCreated mesh__D016845 1991-05-02
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D016845 2006
% 215.26/215.43  |- mesh__dateRevised mesh__D016845 2003-07-09
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D016845 2005
% 215.26/215.43  |- rdf__type mesh__D016845sskos__Concept
% 215.26/215.43  |- skos__annotation mesh__D016845
% 215.26/215.43       infection: coord IM with BLASTOCYSTIS INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 215.26/215.43  |- mesh__historyNote mesh__D016845 92   
% 215.26/215.43  |- skos__historyNote mesh__D016845 Phycomyces %28%1971-1979%29%
% 215.26/215.43  |- skos__prefLabel mesh__D016845 Blastocystis hominis
% 215.26/215.43  |- skos__historyNote mesh__D016845 Protozoa %28%1986-1991%29%
% 215.26/215.43  |- mesh__recordAuthorizer mesh__D016845 sjn
% 215.26/215.43  |- skos__hiddenLabel mesh__D016047 NSC 606170
% 215.26/215.43  |- skos__altLabel mesh__D016047 Hoffman-La Roche Brand of Zalcitabine
% 215.26/215.43  |- skos__broader mesh__D016047smesh__D015224
% 215.26/215.43  |- mesh__dateRevised mesh__D016047 2005-06-30
% 215.26/215.43  |- skos__altLabel mesh__D016047 ddC %28%Antiviral%29%
% 215.26/215.43  |- skos__altLabel mesh__D016047 Dideoxycytidine
% 215.26/215.43  |- mesh__onlineNote mesh__D016047
% 215.26/215.43       use ZALCITABINE to search DIDEOXYCYTIDINE 1990-93   
% 215.26/215.43  |- skos__scopeNote mesh__D016047
% 215.26/215.43       A dideoxynucleoside compound in which the 3%27%-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication at low concentrations, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal toxic side effect is axonal degeneration resulting in peripheral neuropathy.%A%    
% 215.26/215.43  |- skos__historyNote mesh__D016047
% 215.26/215.43       Deoxycytidine/analogs %26% derivatives %28%1986-1989%29%
% 215.26/215.43  |- skos__hiddenLabel mesh__D016047 2%27%,3%27% Dideoxycytidine
% 215.26/215.43  |- skos__broader mesh__D016047smesh__D003841
% 215.26/215.43  |- mesh__recordAuthorizer mesh__D016047 sjn
% 215.26/215.43  |- rdf__type mesh__D016047sskos__Concept
% 215.26/215.43  |- mesh__recordMaintainer mesh__D016047 lkw
% 215.26/215.43  |- mesh__dateCreated mesh__D016047 1989-07-14
% 215.26/215.43  |- skos__hiddenLabel mesh__D016047 NSC606170
% 215.26/215.43  |- mesh__dateEstablished mesh__D016047 1990-01-01
% 215.26/215.43  |- skos__altLabel mesh__D016047 2%27%,3%27%-Dideoxycytidine
% 215.26/215.43  |- skos__altLabel mesh__D016047 Roche Brand of Zalcitabine
% 215.26/215.43  |- skos__altLabel mesh__D016047 HIVID Roche
% 215.26/215.43  |- mesh__publicMeSHNote mesh__D016047 94; was DIDEOXYCYTIDINE 1990-93   
% 215.26/215.43  |- mesh__recordOriginator mesh__D016047 AGS
% 215.26/215.43  |- skos__historyNote mesh__D016047 Dideoxynucleosides %28%1989%29%
% 215.26/215.43  |- skos__prefLabel mesh__D016047 Zalcitabine
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D016047 2006
% 215.26/215.43  |- mesh__historyNote mesh__D016047 94; was DIDEOXYCYTIDINE 1990-93   
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002825 1999
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002825 2002
% 215.26/215.43  |- mesh__dateCreated mesh__D002825 1999-01-01
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002825 1994
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002825 1997
% 215.26/215.43  |- mesh__recordAuthorizer mesh__D002825 PLS
% 215.26/215.43  |- skos__scopeNote mesh__D002825
% 215.26/215.43       Inflammation of the choroid in which the sensory retina becomes edematous and opaque. The inflammatory cells and exudate may burst through the sensory retina to cloud the vitreous body.%A%    
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002825 1998
% 215.26/215.43  |- mesh__recordOriginator mesh__D002825 NLM
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002825 1996
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002825 2006
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002825 2001
% 215.26/215.43  |- skos__prefLabel mesh__D002825 Chorioretinitis
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002825 2004
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002825 2000
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002825 2005
% 215.26/215.43  |- skos__annotation mesh__D002825 inflamm of choroid %26% retina   
% 215.26/215.43  |- skos__broader mesh__D002825smesh__D012173
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002825 2003
% 215.26/215.43  |- skos__hiddenLabel mesh__D002825 Chorioretinitides
% 215.26/215.43  |- skos__broader mesh__D002825smesh__D002833
% 215.26/215.43  |- mesh__dateRevised mesh__D002825 1993-05-26
% 215.26/215.43  |- mesh__recordMaintainer mesh__D002825 PLS
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002825 1995
% 215.26/215.43  |- rdf__type mesh__D002825sskos__Concept
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D035201 2003
% 215.26/215.43  |- skos__broader mesh__D035201smesh__D006109
% 215.26/215.43  |- rdf__type mesh__D035201sskos__Concept
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D035201 2004
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D035201 2005
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D035201 2006
% 215.26/215.43  |- skos__scopeNote mesh__D035201
% 215.26/215.43       A plant genus of the family POACEAE originating from the savanna of eastern Africa. It is widely grown for livestock forage.%A%    
% 215.26/215.43  |- skos__prefLabel mesh__D035201 Brachiaria
% 215.26/215.43  |- mesh__dateCreated mesh__D035201 2002-07-02
% 215.26/215.43  |- mesh__historyNote mesh__D035201 2003   
% 215.26/215.43  |- mesh__publicMeSHNote mesh__D035201 2003   
% 215.26/215.43  |- skos__annotation mesh__D035201
% 215.26/215.43       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.26/215.43  |- mesh__dateEstablished mesh__D035201 2003-01-01
% 215.26/215.43  |- skos__altLabel mesh__D002027 Bufotenine
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002027 2006
% 215.26/215.43  |- skos__altLabel mesh__D002027 N,N-Dimethyl-5-hydroxytryptamine
% 215.26/215.43  |- mesh__dateEstablished mesh__D002027 1991-01-01
% 215.26/215.43  |- skos__broader mesh__D002027smesh__D012701
% 215.26/215.43  |- skos__altLabel mesh__D002027 Mappin
% 215.26/215.43  |- mesh__dateRevised mesh__D002027 2005-06-30
% 215.26/215.43  |- skos__prefLabel mesh__D002027 Bufotenin
% 215.26/215.43  |- skos__annotation mesh__D002027
% 215.26/215.43       /biosyn permitted if by toads, mushrooms, etc.   
% 215.26/215.43  |- mesh__recordMaintainer mesh__D002027 ssb
% 215.26/215.43  |- skos__scopeNote mesh__D002027
% 215.26/215.43       A hallucinogenic serotonin analog found in frog or toad skins, mushrooms, higher plants, and mammals, especially in the brains, plasma, and urine of schizophrenics. Bufotenin has been used as a tool in CNS studies and misused as a psychedelic.%A%    
% 215.26/215.43  |- skos__broader mesh__D002027smesh__D000664
% 215.26/215.43  |- rdf__type mesh__D002027sskos__Concept
% 215.26/215.43  |- skos__altLabel mesh__D002027 5-Hydroxy-N,N-dimethyltryptamine
% 215.26/215.43  |- mesh__recordOriginator mesh__D002027 NLM
% 215.26/215.43  |- skos__hiddenLabel mesh__D002027 5 Hydroxy N,N dimethyltryptamine
% 215.26/215.43  |- mesh__recordAuthorizer mesh__D002027 sjn
% 215.26/215.43  |- skos__broader mesh__D002027smesh__D004130
% 215.26/215.43  |- skos__hiddenLabel mesh__D002027 N,N Dimethyl 5 hydroxytryptamine
% 215.26/215.43  |- mesh__publicMeSHNote mesh__D002027
% 215.26/215.43       91; was see under SEROTONIN 1975-90; was see under HALLUCINOGENS 1966-74%A%  
% 215.26/215.43  |- mesh__historyNote mesh__D002027
% 215.26/215.43       91%28%75%29%; was see under SEROTONIN 1975-90; was see under HALLUCINOGENS 1966-74%A%  
% 215.26/215.43  |- skos__altLabel mesh__D002027 Dimethylserotonin
% 215.26/215.43  |- mesh__onlineNote mesh__D002027 search HALLUCINOGENS 1966-74   
% 215.26/215.43  |- mesh__dateCreated mesh__D002027 1999-01-01
% 215.26/215.43  |- skos__altLabel mesh__D002027 Mappine
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D007510 2006
% 215.26/215.43  |- mesh__recordAuthorizer mesh__D007510 sjn
% 215.26/215.43  |- skos__prefLabel mesh__D007510 Isatin
% 215.26/215.43  |- mesh__dateCreated mesh__D007510 1999-01-01
% 215.26/215.43  |- mesh__recordOriginator mesh__D007510 NLM
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D007510 2005
% 215.26/215.43  |- skos__broader mesh__D007510smesh__D007211
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D007510 2004
% 215.26/215.43  |- mesh__dateEstablished mesh__D007510 1991-01-01
% 215.26/215.43  |- skos__altLabel mesh__D007510 2,3-Dioxoindoline
% 215.26/215.43  |- mesh__dateRevised mesh__D007510 2003-07-09
% 215.26/215.43  |- mesh__publicMeSHNote mesh__D007510 91; was see under INDOLES 1975-90   
% 215.26/215.43  |- skos__scopeNote mesh__D007510
% 215.26/215.43       An indole-dione that is obtained by oxidation of indigo blue. It is a MONOAMINE OXIDASE INHIBITOR and high levels have been found in urine of PARKINSONISM patients.%A%    
% 215.26/215.43  |- skos__annotation mesh__D007510 do not confuse with isatan   
% 215.26/215.43  |- mesh__historyNote mesh__D007510
% 215.26/215.43       91%28%75%29%; was see under INDOLES 1975-90   
% 215.26/215.43  |- skos__hiddenLabel mesh__D007510 2,3 Dioxoindoline
% 215.26/215.43  |- rdf__type mesh__D007510sskos__Concept
% 215.26/215.43  |- mesh__recordMaintainer mesh__D007510 ssb
% 215.26/215.43  |- mesh__onlineNote mesh__D007510 search INDOLES 1966-74   
% 215.26/215.43  |- mesh__dateCreated mesh__D012455 1999-01-01
% 215.26/215.43  |- mesh__recordMaintainer mesh__D012455 ags
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D012455 2004
% 215.26/215.43  |- mesh__historyNote mesh__D012455
% 215.26/215.43       81; was NEWTS see under SALAMANDERS 1972-80   
% 215.26/215.43  |- skos__annotation mesh__D012455
% 215.26/215.43       GEN: prefer specifics; NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D012455 2005
% 215.26/215.43  |- mesh__recordOriginator mesh__D012455 NLM
% 215.26/215.43  |- skos__hiddenLabel mesh__D012455 Tarichas
% 215.26/215.43  |- skos__scopeNote mesh__D012455
% 215.26/215.43       A family of Urodela consisting of 15 living genera and about 42 species and occurring in North America, Europe, Asia, and North Africa.%A%    
% 215.26/215.43  |- mesh__publicMeSHNote mesh__D012455
% 215.26/215.43       81; was NEWTS see under SALAMANDERS 1972-80   
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D012455 2006
% 215.26/215.43  |- skos__prefLabel mesh__D012455 Salamandridae
% 215.26/215.43  |- mesh__onlineNote mesh__D012455
% 215.26/215.43       use SALAMANDRIDAE to search NEWTS 1975-80; use URODELA 1972-74%A%  
% 215.26/215.43  |- skos__hiddenLabel mesh__D012455 Newt
% 215.26/215.43  |- mesh__dateEstablished mesh__D012455 1981-01-01
% 215.26/215.43  |- rdf__type mesh__D012455sskos__Concept
% 215.26/215.43  |- mesh__recordAuthorizer mesh__D012455 sjn
% 215.26/215.43  |- skos__broader mesh__D012455smesh__D014562
% 215.26/215.43  |- mesh__dateRevised mesh__D012455 2003-07-09
% 215.26/215.43  |- mesh__recordOriginator mesh__D006418 NLM
% 215.26/215.43  |- skos__broader mesh__D006418smesh__D008665
% 215.26/215.43  |- rdf__type mesh__D006418sskos__Concept
% 215.26/215.43  |- skos__altLabel mesh__D006418 Protoheme IX
% 215.26/215.43  |- mesh__recordMaintainer mesh__D006418 ssb
% 215.26/215.43  |- skos__prefLabel mesh__D006418 Heme
% 215.26/215.43  |- mesh__dateCreated mesh__D006418 1999-01-01
% 215.26/215.43  |- skos__altLabel mesh__D006418 Ferroprotoporphyrin
% 215.26/215.43  |- skos__altLabel mesh__D006418 Haem
% 215.26/215.43  |- skos__altLabel mesh__D006418 Heme b
% 215.26/215.43  |- mesh__recordAuthorizer mesh__D006418 sjn
% 215.26/215.43  |- skos__altLabel mesh__D006418 Protoheme
% 215.26/215.43  |- mesh__dateRevised mesh__D006418 2005-06-30
% 215.26/215.43  |- skos__scopeNote mesh__D006418
% 215.26/215.43       The color-furnishing portion of hemoglobin. It is found free in tissues and as the prosthetic group in many hemeproteins.%A%    
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D006418 2006
% 215.26/215.43  |- rdf__type mesh__D003120sskos__Concept
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D003120 2001
% 215.26/215.43  |- mesh__recordAuthorizer mesh__D003120 SJN
% 215.26/215.43  |- skos__broader mesh__D003120smesh__D015206
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D003120 2002
% 215.26/215.43  |- mesh__recordOriginator mesh__D003120 NLM
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D003120 2005
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D003120 1998
% 215.26/215.43  |- skos__prefLabel mesh__D003120 Colorado
% 215.26/215.43  |- mesh__dateRevised mesh__D003120 1997-06-20
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D003120 2003
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D003120 2006
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D003120 1999
% 215.26/215.43  |- mesh__recordMaintainer mesh__D003120 PXP
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D003120 2004
% 215.26/215.43  |- mesh__dateCreated mesh__D003120 1999-01-01
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D003120 2000
% 215.26/215.43  |- mesh__recordMaintainer mesh__D016846 ags
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D016846 2004
% 215.26/215.43  |- skos__scopeNote mesh__D016846
% 215.26/215.43       A suborder of ameboid protozoa characterized by a branched or unbranched cylindrical body and the absence of bidirectional cytoplasmic flow. Nuclear division is mesomitotic.%A%    
% 215.26/215.43  |- mesh__recordAuthorizer mesh__D016846 sjn
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D016846 2005
% 215.26/215.43  |- skos__prefLabel mesh__D016846 Tubulina
% 215.26/215.43  |- mesh__dateCreated mesh__D016846 1991-05-02
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D016846 2006
% 215.26/215.43  |- mesh__dateEstablished mesh__D016846 1992-01-01
% 215.26/215.43  |- skos__broader mesh__D016846smesh__D016841
% 215.26/215.43  |- skos__annotation mesh__D016846 a suborder of protozoa   
% 215.26/215.43  |- mesh__dateRevised mesh__D016846 2003-07-09
% 215.26/215.43  |- rdf__type mesh__D016846sskos__Concept
% 215.26/215.43  |- mesh__historyNote mesh__D016846 92   
% 215.26/215.43  |- mesh__publicMeSHNote mesh__D016846 92   
% 215.26/215.43  |- mesh__recordOriginator mesh__D016846 PXP
% 215.26/215.43  |- skos__altLabel mesh__D016048 ddA %28%Antiviral%29%
% 215.26/215.43  |- mesh__recordOriginator mesh__D016048 AGS
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D016048 2004
% 215.26/215.43  |- skos__annotation mesh__D016048 an antiviral; inhibits HIV replication   
% 215.26/215.43  |- mesh__recordAuthorizer mesh__D016048 PLS
% 215.26/215.43  |- skos__broader mesh__D016048smesh__D015224
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D016048 1999
% 215.26/215.43  |- skos__broader mesh__D016048smesh__D003839
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D016048 2000
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D016048 2001
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D016048 1996
% 215.26/215.43  |- rdf__type mesh__D016048sskos__Concept
% 215.26/215.43  |- skos__altLabel mesh__D016048 2%27%,3%27%-Dideoxyadenosine
% 215.26/215.43  |- mesh__dateCreated mesh__D016048 1989-07-14
% 215.26/215.43  |- skos__prefLabel mesh__D016048 Dideoxyadenosine
% 215.26/215.43  |- mesh__dateEstablished mesh__D016048 1990-01-01
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D016048 2005
% 215.26/215.43  |- mesh__dateRevised mesh__D016048 1995-06-08
% 215.26/215.43  |- mesh__publicMeSHNote mesh__D016048 90   
% 215.26/215.43  |- mesh__historyNote mesh__D016048 90   
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D016048 1997
% 215.26/215.43  |- mesh__recordMaintainer mesh__D016048 JRT
% 215.26/215.43  |- skos__historyNote mesh__D016048 Dideoxynucleosides %28%1989%29%
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D016048 2006
% 215.26/215.43  |- skos__scopeNote mesh__D016048
% 215.26/215.43       A dideoxynucleoside compound in which the 3%27%-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is an inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal side effect is nephrotoxicity. In vivo, dideoxyadenosine is rapidly metabolized to DIDANOSINE %28%ddI%29% by enzymatic deamination; ddI is then converted to dideoxyinosine monophosphate and ultimately to dideoxyadenosine triphosphate, the putative active metabolite.%A%    
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D016048 2002
% 215.26/215.43  |- skos__hiddenLabel mesh__D016048 2%27%,3%27% Dideoxyadenosine
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D016048 2003
% 215.26/215.43  |- skos__historyNote mesh__D016048
% 215.26/215.43       Deoxyadenosine/analogs %26% derivatives %28%1975-1989%29%
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D016048 1998
% 215.26/215.43  |- mesh__dateCreated mesh__D002826 1974-11-11
% 215.26/215.43  |- skos__altLabel mesh__D002826 Chorismate Pyruvatemutase
% 215.26/215.43  |- mesh__publicMeSHNote mesh__D002826
% 215.26/215.43       91; was see under ISOMERASES 1975-90   
% 215.26/215.43  |- mesh__recordAuthorizer mesh__D002826 sjn
% 215.26/215.43  |- skos__scopeNote mesh__D002826
% 215.26/215.43       An isomerase that catalyzes the conversion of chorismic acid to prephenic acid. EC 5.4.99.5.%A%    
% 215.26/215.43  |- mesh__dateEstablished mesh__D002826 1991-01-01
% 215.26/215.43  |- skos__broader mesh__D002826smesh__D019751
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002826 2006
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002826 2004
% 215.26/215.43  |- mesh__recordMaintainer mesh__D002826 ssb
% 215.26/215.43  |- skos__historyNote mesh__D002826 Isomerases %28%1969-1974%29%
% 215.26/215.43  |- mesh__recordOriginator mesh__D002826 NLM
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002826 2005
% 215.26/215.43  |- skos__historyNote mesh__D002826
% 215.26/215.43       Cyclohexanecarboxylic Acids %28%1969-1974%29%
% 215.26/215.43  |- mesh__historyNote mesh__D002826
% 215.26/215.43       91%28%75%29%; was see under ISOMERASES 1975-90   
% 215.26/215.43  |- skos__hiddenLabel mesh__D002826 Mutase, Chorismate
% 215.26/215.43  |- mesh__dateRevised mesh__D002826 2003-07-09
% 215.26/215.43  |- skos__prefLabel mesh__D002826 Chorismate Mutase
% 215.26/215.43  |- rdf__type mesh__D002826sskos__Concept
% 215.26/215.43  |- skos__historyNote mesh__D002826 Vinyl Compounds %28%1972-1974%29%
% 215.26/215.43  |- skos__hiddenLabel mesh__D002826 Pyruvatemutase, Chorismate
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002028 2004
% 215.26/215.43  |- skos__annotation mesh__D002028
% 215.26/215.43       coord IM with type of facility %28%IM%29%   
% 215.26/215.43  |- mesh__dateRevised mesh__D002028 1992-03-25
% 215.26/215.43  |- mesh__historyNote mesh__D002028
% 215.26/215.43       91%28%84%29%; was see under FACILITY DESIGN AND CONSTRUCTION 1984-90%A%  
% 215.26/215.43  |- skos__hiddenLabel mesh__D002028 Building Code
% 215.26/215.43  |- skos__historyNote mesh__D002028
% 215.26/215.43       Hospital Design and Construction %28%1966-1983%29%
% 215.26/215.43  |- mesh__dateCreated mesh__D002028 1983-06-06
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002028 1999
% 215.26/215.43  |- skos__broader mesh__D002028smesh__D005160
% 215.26/215.43  |- skos__hiddenLabel mesh__D002028 Codes, Building
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002028 2006
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002028 1994
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002028 1993
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002028 2002
% 215.26/215.43  |- rdf__type mesh__D002028sskos__Concept
% 215.26/215.43  |- skos__scopeNote mesh__D002028
% 215.26/215.43       Standards or regulations for construction which are designed to ensure safety against electrical hazards, fires, etc.%A%    
% 215.26/215.43  |- mesh__recordAuthorizer mesh__D002028 PLS
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002028 1995
% 215.26/215.43  |- skos__prefLabel mesh__D002028 Building Codes
% 215.26/215.43  |- skos__historyNote mesh__D002028 Safety %28%1975-1983%29%
% 215.26/215.43  |- skos__historyNote mesh__D002028
% 215.26/215.43       Facility Design and Construction %28%1967-1983%29%
% 215.26/215.43  |- skos__hiddenLabel mesh__D002028 Code, Building
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002028 2000
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002028 1996
% 215.26/215.43  |- mesh__recordOriginator mesh__D002028 EC
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002028 2003
% 215.26/215.43  |- mesh__recordMaintainer mesh__D002028 TGC
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002028 2001
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002028 1998
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002028 1997
% 215.26/215.43  |- mesh__publicMeSHNote mesh__D002028
% 215.26/215.43       91; was see under FACILITY DESIGN AND CONSTRUCTION 1984-90%A%  
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D002028 2005
% 215.26/215.43  |- mesh__dateEstablished mesh__D002028 1991-01-01
% 215.26/215.43  |- skos__broader mesh__D007511smesh__D014652
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D007511 2006
% 215.26/215.43  |- skos__prefLabel mesh__D007511 Ischemia
% 215.26/215.43  |- skos__scopeNote mesh__D007511
% 215.26/215.43       A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.%A%    
% 215.26/215.43  |- mesh__recordMaintainer mesh__D007511 nns
% 215.26/215.43  |- mesh__dateRevised mesh__D007511 2005-06-30
% 215.26/215.43  |- skos__hiddenLabel mesh__D007511 Ischemias
% 215.26/215.43  |- mesh__recordAuthorizer mesh__D007511 sjn
% 215.26/215.43  |- rdf__type mesh__D007511sskos__Concept
% 215.26/215.43  |- skos__annotation mesh__D007511
% 215.26/215.43       general or unspecified; prefer specifics; coordinate IM with specific organ /blood supply %28%IM%29%; for prevention and control, consider ISCHEMIC PRECONDITIONING%A%  
% 215.26/215.43  |- mesh__recordOriginator mesh__D007511 NLM
% 215.26/215.43  |- mesh__dateCreated mesh__D007511 1999-01-01
% 215.26/215.43  |- mesh__dateEstablished mesh__D048928 2005-01-01
% 215.26/215.43  |- skos__broader mesh__D048928smesh__D000458
% 215.26/215.43  |- skos__prefLabel mesh__D048928 Prochlorophytes
% 215.26/215.43  |- mesh__recordAuthorizer mesh__D048928 sjn
% 215.26/215.43  |- mesh__recordOriginator mesh__D048928 ags
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D048928 2006
% 215.26/215.43  |- mesh__historyNote mesh__D048928 2005   
% 215.26/215.43  |- rdf__type mesh__D048928sskos__Concept
% 215.26/215.43  |- mesh__dateRevised mesh__D048928 2005-06-30
% 215.26/215.43  |- mesh__recordMaintainer mesh__D048928 SYSTEM
% 215.26/215.43  |- mesh__publicMeSHNote mesh__D048928 2005   
% 215.26/215.43  |- mesh__dateCreated mesh__D048928 2004-07-07
% 215.26/215.43  |- skos__scopeNote mesh__D048928
% 215.26/215.43       An order of GRAM-NEGATIVE OXYGENIC PHOTOSYNTHETIC BACTERIA containing CHLOROPHYLL, a and b, but lacking PHYCOBILISOMES %28%light-harvesting antennae%29%. There are three genera: PROCHLORON;  PROCHLOROCOCCUS; and PROCHLOROTHRIX. This order was thought to be the missing link between CYANOBACTERIA and plant CHLOROPLASTS, hence the name.%A%    
% 215.26/215.43  |- skos__hiddenLabel mesh__D012456 Benefits, Paternity
% 215.26/215.43  |- skos__historyNote mesh__D012456 Income %28%1968-1977%29%
% 215.26/215.43  |- skos__hiddenLabel mesh__D012456 Wage
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D012456 2001
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D012456 2004
% 215.26/215.43  |- mesh__recordMaintainer mesh__D012456 KEV
% 215.26/215.43  |- skos__hiddenLabel mesh__D012456 Fringe Benefit
% 215.26/215.43  |- skos__broader mesh__D012456smesh__D007182
% 215.26/215.43  |- skos__scopeNote mesh__D012456
% 215.26/215.43       The remuneration paid or benefits granted to an employee.%A%    
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D012456 1996
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D012456 2002
% 215.26/215.43  |- skos__hiddenLabel mesh__D012456 Salary
% 215.26/215.43  |- skos__hiddenLabel mesh__D012456 Equity, Pay
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D012456 2005
% 215.26/215.43  |- mesh__dateCreated mesh__D012456 1977-05-12
% 215.26/215.43  |- mesh__recordAuthorizer mesh__D012456 PLS
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D012456 1997
% 215.26/215.43  |- skos__prefLabel mesh__D012456 Salaries and Fringe Benefits
% 215.26/215.43  |- skos__hiddenLabel mesh__D012456 Paternity Benefit
% 215.26/215.43  |- skos__hiddenLabel mesh__D012456 Benefit, Paternity
% 215.26/215.43  |- skos__hiddenLabel mesh__D012456 Benefit, Fringe
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D012456 2006
% 215.26/215.43  |- mesh__publicMeSHNote mesh__D012456 78   
% 215.26/215.43  |- rdf__type mesh__D012456sskos__Concept
% 215.26/215.43  |- skos__altLabel mesh__D012456 Salaries
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D012456 1998
% 215.26/215.43  |- skos__hiddenLabel mesh__D012456 Equities, Pay
% 215.26/215.43  |- mesh__recordOriginator mesh__D012456 EC
% 215.26/215.43  |- mesh__historyNote mesh__D012456 78   
% 215.26/215.43  |- skos__annotation mesh__D012456 DF: SALARIES   
% 215.26/215.43  |- skos__broader mesh__D012456smesh__D010559
% 215.26/215.43  |- skos__hiddenLabel mesh__D012456 Pay Equities
% 215.26/215.43  |- skos__hiddenLabel mesh__D012456 Benefits, Fringe
% 215.26/215.43  |- mesh__dateEstablished mesh__D012456 1978-01-01
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D012456 2000
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D012456 1999
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D012456 2003
% 215.26/215.43  |- mesh__dateRevised mesh__D012456 1995-05-23
% 215.26/215.43  |- mesh__activeMeSHYear mesh__D031610 2006
% 215.26/215.43  |- mesh__historyNote mesh__D031610 2003   
% 215.26/215.43  |- skos__broader mesh__D031610smesh__D029583
% 215.26/215.43  |- skos__prefLabel mesh__D031610 Tinospora
% 215.26/215.43  |- mesh__dateRevised mesh__D031610 2004-08-02
% 215.26/215.43  |- mesh__recordOriginator mesh__D031610 ssb
% 215.26/215.44  |- rdf__type mesh__D031610sskos__Concept
% 215.26/215.44  |- skos__scopeNote mesh__D031610
% 215.26/215.44       A plant genus of the family MENISPERMACEAE. Members have been used in AYURVEDIC MEDICINE. Hypoglycemic effect has been reported.%A%    
% 215.26/215.44  |- skos__annotation mesh__D031610
% 215.26/215.44       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D031610 2005A
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D031610 2003
% 215.26/215.44  |- mesh__publicMeSHNote mesh__D031610 2003   
% 215.26/215.44  |- mesh__dateEstablished mesh__D031610 2003-01-01
% 215.26/215.44  |- mesh__recordAuthorizer mesh__D031610 jls
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D031610 2005
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D031610 2004
% 215.26/215.44  |- mesh__recordMaintainer mesh__D031610 jls
% 215.26/215.44  |- mesh__dateCreated mesh__D031610 2002-07-03
% 215.26/215.44  |- mesh__dateEstablished mesh__D006419 1991-01-01
% 215.26/215.44  |- mesh__publicMeSHNote mesh__D006419
% 215.26/215.44       98; was HEME OXYGENASE 1980-97 %28%see under HYDROXYLASES 1980-90%29%%A%  
% 215.26/215.44  |- skos__altLabel mesh__D006419 Haem Oxygenase
% 215.26/215.44  |- rdf__type mesh__D006419sskos__Concept
% 215.26/215.44  |- mesh__recordMaintainer mesh__D006419 ssb
% 215.26/215.44  |- skos__hiddenLabel mesh__D006419 Oxygenase, Haem
% 215.26/215.44  |- skos__altLabel mesh__D006419 Heme Oxygenase
% 215.26/215.44  |- mesh__dateCreated mesh__D006419 1979-02-21
% 215.26/215.44  |- mesh__dateRevised mesh__D006419 2004-07-07
% 215.26/215.44  |- mesh__historyNote mesh__D006419
% 215.26/215.44       98; was HEME OXYGENASE 1980-97 %28%see under HYDROXYLASES 1980-90%29%%A%  
% 215.26/215.44  |- skos__prefLabel mesh__D006419 Heme Oxygenase %28%Decyclizing%29%
% 215.26/215.44  |- skos__historyNote mesh__D006419 Heme %28%1966-1979%29%
% 215.26/215.44  |- mesh__recordOriginator mesh__D006419 RLS
% 215.26/215.44  |- skos__broader mesh__D006419smesh__D006899
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D006419 2005
% 215.26/215.44  |- skos__hiddenLabel mesh__D006419 Oxygenase, Heme
% 215.26/215.44  |- skos__historyNote mesh__D006419 Hydroxylases %28%1966-1979%29%
% 215.26/215.44  |- skos__historyNote mesh__D006419 Oxygenases %28%1966-1979%29%
% 215.26/215.44  |- mesh__recordAuthorizer mesh__D006419 sjn
% 215.26/215.44  |- skos__scopeNote mesh__D006419
% 215.26/215.44       A mixed function oxidase enzyme which during hemoglobin catabolism catalyzes the degradation of heme to ferrous iron, carbon monoxide and biliverdin in the presence of molecular oxygen and reduced NADPH. The enzyme is induced by metals, particularly cobalt. EC 1.14.99.3.%A%    
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D006419 2006
% 215.26/215.44  |- mesh__publicMeSHNote mesh__D003121
% 215.26/215.44       91; was see under REOVIRUS INFECTIONS 1977-90; was see under ARBOVIRUS INFECTIONS 1975-76%A%  
% 215.26/215.44  |- mesh__dateRevised mesh__D003121 1993-05-26
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D003121 2003
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D003121 1996
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D003121 2006
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D003121 1999
% 215.26/215.44  |- mesh__recordMaintainer mesh__D003121 PLS
% 215.26/215.44  |- skos__annotation mesh__D003121 caused by a tick-transm reovirus   
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D003121 2000
% 215.26/215.44  |- mesh__onlineNote mesh__D003121
% 215.26/215.44       use ARBOVIRUS INFECTIONS to search COLORADO TICK FEVER 1966-74 %28%as Prov%29%%A%  
% 215.26/215.44  |- skos__hiddenLabel mesh__D003121 Fever, Colorado Tick
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D003121 2004
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D003121 1997
% 215.26/215.44  |- mesh__dateCreated mesh__D003121 1999-01-01
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D003121 2001
% 215.26/215.44  |- skos__prefLabel mesh__D003121 Colorado Tick Fever
% 215.26/215.44  |- skos__hiddenLabel mesh__D003121 Tick Fever, Colorado
% 215.26/215.44  |- mesh__recordAuthorizer mesh__D003121 PLS
% 215.26/215.44  |- skos__broader mesh__D003121smesh__D012088
% 215.26/215.44  |- skos__scopeNote mesh__D003121
% 215.26/215.44       A febrile illness characterized by chills, aches, vomiting, leukopenia, and sometimes encephalitis. It is caused by the COLORADO TICK FEVER VIRUS, a reovirus transmitted by the tick Dermacentor andersoni.%A%    
% 215.26/215.44  |- rdf__type mesh__D003121sskos__Concept
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D003121 2002
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D003121 1994
% 215.26/215.44  |- mesh__recordOriginator mesh__D003121 NLM
% 215.26/215.44  |- mesh__dateEstablished mesh__D003121 1991-01-01
% 215.26/215.44  |- skos__broader mesh__D003121smesh__D017282
% 215.26/215.44  |- mesh__historyNote mesh__D003121
% 215.26/215.44       91%28%66%29%; was see under REOVIRUS INFECTIONS 1977-90; was see under ARBOVIRUS INFECTIONS 1966-76 %28%Prov 1966-74%29%%A%  
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D003121 1995
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D003121 2005
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D003121 1998
% 215.26/215.44  |- mesh__publicMeSHNote mesh__D016847 92   
% 215.26/215.44  |- skos__scopeNote mesh__D016847
% 215.26/215.44       An order of ameboid protozoa commonly having a monopodial cylindrically shaped body. Nuclear division is promitotic and most species have a temporary flagellate stage.%A%    
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D016847 2005
% 215.26/215.44  |- skos__annotation mesh__D016847 an order of protozoa   
% 215.26/215.44  |- skos__prefLabel mesh__D016847 Schizopyrenida
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D016847 2006
% 215.26/215.44  |- skos__broader mesh__D016847smesh__D016840
% 215.26/215.44  |- mesh__dateRevised mesh__D016847 2003-07-09
% 215.26/215.44  |- rdf__type mesh__D016847sskos__Concept
% 215.26/215.44  |- mesh__recordAuthorizer mesh__D016847 sjn
% 215.26/215.44  |- mesh__historyNote mesh__D016847 92   
% 215.26/215.44  |- mesh__recordOriginator mesh__D016847 PXP
% 215.26/215.44  |- mesh__dateCreated mesh__D016847 1991-05-02
% 215.26/215.44  |- mesh__dateEstablished mesh__D016847 1992-01-01
% 215.26/215.44  |- mesh__recordMaintainer mesh__D016847 ags
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D016847 2004
% 215.26/215.44  |- skos__scopeNote mesh__D016049
% 215.26/215.44       A dideoxynucleoside compound in which the 3%27%-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate, its putative active metabolite.%A%    
% 215.26/215.44  |- skos__altLabel mesh__D016049 Bristol-Myers Squibb Brand of Didanosine
% 215.26/215.44  |- skos__altLabel mesh__D016049 2%27%,3%27%-Dideoxyinosine
% 215.26/215.44  |- mesh__recordAuthorizer mesh__D016049 sjn
% 215.26/215.44  |- mesh__publicMeSHNote mesh__D016049 92; was DIDEOXYINOSINE 1990-91   
% 215.26/215.44  |- skos__hiddenLabel mesh__D016049 Bristol Myers Brand of Didanosine
% 215.26/215.44  |- skos__altLabel mesh__D016049 ddI %28%Antiviral%29%
% 215.26/215.44  |- mesh__recordMaintainer mesh__D016049 exl
% 215.26/215.44  |- skos__historyNote mesh__D016049
% 215.26/215.44       Inosine/analogs %26% derivatives %28%1987-1989%29%
% 215.26/215.44  |- mesh__historyNote mesh__D016049 92; was DIDEOXYINOSINE 1990-91   
% 215.26/215.44  |- mesh__dateEstablished mesh__D016049 1990-01-01
% 215.26/215.44  |- skos__broader mesh__D016049smesh__D015224
% 215.26/215.44  |- skos__hiddenLabel mesh__D016049 NSC 612049
% 215.26/215.44  |- skos__hiddenLabel mesh__D016049 Bristol Myers Squibb Brand of Didanosine
% 215.26/215.44  |- rdf__type mesh__D016049sskos__Concept
% 215.26/215.44  |- mesh__onlineNote mesh__D016049
% 215.26/215.44       use DIDANOSINE to search DIDEOXYINOSINE 1990-91   
% 215.26/215.44  |- skos__prefLabel mesh__D016049 Didanosine
% 215.26/215.44  |- mesh__dateCreated mesh__D016049 1989-07-14
% 215.26/215.44  |- skos__altLabel mesh__D016049 Dideoxyinosine
% 215.26/215.44  |- skos__hiddenLabel mesh__D016049 2%27%,3%27% Dideoxyinosine
% 215.26/215.44  |- skos__altLabel mesh__D016049 Bristol-Myers Brand of Didanosine
% 215.26/215.44  |- skos__broader mesh__D016049smesh__D007288
% 215.26/215.44  |- skos__historyNote mesh__D016049 Dideoxynucleosides %28%1989%29%
% 215.26/215.44  |- mesh__recordOriginator mesh__D016049 AGS
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D016049 2006
% 215.26/215.44  |- skos__hiddenLabel mesh__D016049 NSC612049
% 215.26/215.44  |- mesh__dateRevised mesh__D016049 2005-06-30
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D002827 2005
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D002827 2001
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D002827 2003
% 215.26/215.44  |- skos__prefLabel mesh__D002827 Chorismic Acid
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D002827 2006
% 215.26/215.44  |- mesh__recordMaintainer mesh__D002827 CCR
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D002827 2002
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D002827 2004
% 215.26/215.44  |- mesh__publicMeSHNote mesh__D002827
% 215.26/215.44       91; was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90   
% 215.26/215.44  |- mesh__historyNote mesh__D002827
% 215.26/215.44       91%28%75%29%; was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90%A%  
% 215.26/215.44  |- mesh__recordAuthorizer mesh__D002827 sjn
% 215.26/215.44  |- skos__historyNote mesh__D002827
% 215.26/215.44       Cyclohexanecarboxylic Acids %28%1969-1974%29%
% 215.26/215.44  |- skos__hiddenLabel mesh__D002827 Acid, Chorismic
% 215.26/215.44  |- mesh__dateEstablished mesh__D002827 1991-01-01
% 215.26/215.44  |- rdf__type mesh__D002827sskos__Concept
% 215.26/215.44  |- skos__historyNote mesh__D002827 Vinyl Compounds %28%1972-1974%29%
% 215.26/215.44  |- skos__broader mesh__D002827smesh__D003509
% 215.26/215.44  |- mesh__dateRevised mesh__D002827 2000-06-21
% 215.26/215.44  |- mesh__recordOriginator mesh__D002827 NLM
% 215.26/215.44  |- mesh__dateCreated mesh__D002827 1974-11-19
% 215.26/215.44  |- skos__prefLabel mesh__D007512 Ischium
% 215.26/215.44  |- skos__broader mesh__D007512smesh__D010384
% 215.26/215.44  |- skos__hiddenLabel mesh__D007512 Ischiums
% 215.26/215.44  |- rdf__type mesh__D007512sskos__Concept
% 215.26/215.44  |- mesh__dateRevised mesh__D007512 2005-06-30
% 215.26/215.44  |- mesh__dateCreated mesh__D007512 1999-01-01
% 215.26/215.44  |- mesh__recordAuthorizer mesh__D007512 sjn
% 215.26/215.44  |- mesh__recordOriginator mesh__D007512 NLM
% 215.26/215.44  |- mesh__recordMaintainer mesh__D007512 ags
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D007512 2006
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D048929 2006
% 215.26/215.44  |- mesh__dateEstablished mesh__D048929 2005-01-01
% 215.26/215.44  |- skos__scopeNote mesh__D048929
% 215.26/215.44       A genus of marine planktonic CYANOBACTERIA in the order PROCHLOROPHYTES. They lack PHYCOBILISOMES and contain divinyl CHLOROPHYLL, a and b.%A%    
% 215.26/215.44  |- rdf__type mesh__D048929sskos__Concept
% 215.26/215.44  |- mesh__recordMaintainer mesh__D048929 SYSTEM
% 215.26/215.44  |- skos__historyNote mesh__D048929 Cyanobacteria %28%1995-2004%29%
% 215.26/215.44  |- mesh__recordOriginator mesh__D048929 ags
% 215.26/215.44  |- mesh__recordAuthorizer mesh__D048929 sjn
% 215.26/215.44  |- mesh__publicMeSHNote mesh__D048929 2005   
% 215.26/215.44  |- mesh__dateCreated mesh__D048929 2004-07-07
% 215.26/215.44  |- mesh__historyNote mesh__D048929 2005   
% 215.26/215.44  |- skos__prefLabel mesh__D048929 Prochlorococcus
% 215.26/215.44  |- mesh__dateRevised mesh__D048929 2005-06-30
% 215.26/215.44  |- skos__broader mesh__D048929smesh__D048928
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012457 2004
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012457 1995
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012457 1996
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012457 2000
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012457 2005
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012457 1997
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012457 2001
% 215.26/215.44  |- mesh__recordOriginator mesh__D012457 NLM
% 215.26/215.44  |- mesh__recordMaintainer mesh__D012457 RAZ
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012457 2006
% 215.26/215.44  |- rdf__type mesh__D012457sskos__Concept
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012457 1998
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012457 2002
% 215.26/215.44  |- skos__prefLabel mesh__D012457 Salicylamides
% 215.26/215.44  |- mesh__recordAuthorizer mesh__D012457 PLS
% 215.26/215.44  |- mesh__dateCreated mesh__D012457 1999-01-01
% 215.26/215.44  |- skos__scopeNote mesh__D012457 Amides of salicylic acid.     
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012457 1999
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012457 2003
% 215.26/215.44  |- mesh__dateRevised mesh__D012457 1994-05-24
% 215.26/215.44  |- skos__broader mesh__D012457smesh__D000577
% 215.26/215.44  |- skos__altLabel mesh__D031611 Boldea fragrans
% 215.26/215.44  |- mesh__dateEstablished mesh__D031611 2003-01-01
% 215.26/215.44  |- rdf__type mesh__D031611sskos__Concept
% 215.26/215.44  |- skos__broader mesh__D031611smesh__D029585
% 215.26/215.44  |- skos__scopeNote mesh__D031611
% 215.26/215.44       A plant genus of the family MONIMIACEAE. Members contain boldine ALKALOIDS. Some PEUMUS species have been reclassified as CRYPTOCARYA.%A%    
% 215.26/215.44  |- mesh__historyNote mesh__D031611 2003   
% 215.26/215.44  |- mesh__dateCreated mesh__D031611 2002-07-02
% 215.26/215.44  |- skos__annotation mesh__D031611
% 215.26/215.44       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D031611 2003
% 215.26/215.44  |- mesh__publicMeSHNote mesh__D031611 2003   
% 215.26/215.44  |- skos__prefLabel mesh__D031611 Peumus
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D031611 2004
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D031611 2005
% 215.26/215.44  |- skos__altLabel mesh__D031611 Boldo
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D031611 2006
% 215.26/215.44  |- skos__related mesh__D003920smesh__D003919
% 215.26/215.44  |- mesh__recordAuthorizer mesh__D003920 sjn
% 215.26/215.44  |- rdf__type mesh__D003920sskos__Concept
% 215.26/215.44  |- skos__related mesh__D003920smesh__D003927
% 215.26/215.44  |- skos__related mesh__D003920smesh__D018589
% 215.26/215.44  |- skos__broader mesh__D003920smesh__D044882
% 215.26/215.44  |- skos__scopeNote mesh__D003920
% 215.26/215.44       A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.%A%    
% 215.26/215.44  |- skos__related mesh__D003920smesh__D018149
% 215.26/215.44  |- skos__broader mesh__D003920smesh__D004700
% 215.26/215.44  |- skos__annotation mesh__D003920
% 215.26/215.44       GEN or unspecified; prefer specifics; pregnancy of diabetic patients  = PREGNANCY IN DIABETICS but do not confuse with DIABETES, GESTATIONAL: see note there; PREDIABETIC STATE is also available %26% includes subclinical diabetes; /diet ther: consider coord with DIABETIC DIET but see note there; alloxan- %26% streptozocin-induced diabetes: see note on DIABETES MELLITUS, EXPERIMENTAL%A%  
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D003920 2005
% 215.26/215.44  |- mesh__recordMaintainer mesh__D003920 lkt
% 215.26/215.44  |- mesh__dateCreated mesh__D003920 1999-01-01
% 215.26/215.44  |- skos__related mesh__D003920smesh__D017127
% 215.26/215.44  |- mesh__recordOriginator mesh__D003920 NLM
% 215.26/215.44  |- skos__prefLabel mesh__D003920 Diabetes Mellitus
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D003920 2006
% 215.26/215.44  |- mesh__dateRevised mesh__D003920 2004-07-07
% 215.26/215.44  |- skos__related mesh__D003920smesh__D012592
% 215.26/215.44  |- skos__related mesh__D003920smesh__D011236
% 215.26/215.44  |- mesh__recordOriginator mesh__D050576 nns
% 215.26/215.44  |- mesh__publicMeSHNote mesh__D050576 2006   
% 215.26/215.44  |- skos__annotation mesh__D050576
% 215.26/215.44       for chimeric membrane fusion proteins coordinate with RECOMBINANT FUSION PROTEINS, if resulting from ARTIFICIAL GENE FUSION,  or MUTANT CHIMERIC PROTEINS%A%  
% 215.26/215.44  |- skos__historyNote mesh__D050576 Membrane Fusion %28%1990-2005%29%
% 215.26/215.44  |- skos__historyNote mesh__D050576 Membrane Proteins %28%1983-2005%29%
% 215.26/215.44  |- mesh__dateEstablished mesh__D050576 2006-01-01
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D050576 2006
% 215.26/215.44  |- skos__hiddenLabel mesh__D050576 Proteins, Membrane Fusion
% 215.26/215.44  |- rdf__type mesh__D050576sskos__Concept
% 215.26/215.44  |- skos__prefLabel mesh__D050576 Membrane Fusion Proteins
% 215.26/215.44  |- skos__scopeNote mesh__D050576
% 215.26/215.44       Proteins that catalyze MEMBRANE FUSION.     
% 215.26/215.44  |- skos__broader mesh__D050576smesh__D008565
% 215.26/215.44  |- mesh__historyNote mesh__D050576 2006   
% 215.26/215.44  |- mesh__dateCreated mesh__D050576 2005-06-30
% 215.26/215.44  |- skos__hiddenLabel mesh__D050576 Fusion Proteins, Membrane
% 215.26/215.44  |- mesh__recordMaintainer mesh__D050576 nns
% 215.26/215.44  |- mesh__recordAuthorizer mesh__D050576 sjn
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D003122 2006
% 215.26/215.44  |- mesh__dateCreated mesh__D003122 1974-12-12
% 215.26/215.44  |- skos__prefLabel mesh__D003122 Colorado tick fever virus
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D003122 2004
% 215.26/215.44  |- skos__scopeNote mesh__D003122
% 215.26/215.44       A species of COLTIVIRUS transmitted by the tick DERMACENTOR andersonii and causing fever, chills, aching head and limbs, and often vomiting. It occurs in the northwestern United States, except the Pacific Coast.%A%    
% 215.26/215.44  |- mesh__publicMeSHNote mesh__D003122
% 215.26/215.44       91; was see under REOVIRIDAE 1981-90; was see under REOVIRUSES 1975-80%A%  
% 215.26/215.44  |- rdf__type mesh__D003122sskos__Concept
% 215.26/215.44  |- mesh__dateRevised mesh__D003122 2005-07-28
% 215.26/215.44  |- skos__broader mesh__D003122smesh__D018162
% 215.26/215.44  |- mesh__dateEstablished mesh__D003122 1991-01-01
% 215.26/215.44  |- skos__annotation mesh__D003122 infection = COLORADO TICK FEVER   
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D003122 2006A
% 215.26/215.44  |- mesh__recordMaintainer mesh__D003122 ags
% 215.26/215.44  |- mesh__recordAuthorizer mesh__D003122 ags
% 215.26/215.44  |- mesh__historyNote mesh__D003122
% 215.26/215.44       91%28%75%29%; was see under REOVIRIDAE 1981-90; was see under REOVIRUSES 1975-80%A%  
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D003122 2005
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D003122 2002
% 215.26/215.44  |- mesh__recordOriginator mesh__D003122 NLM
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D003122 2003
% 215.26/215.44  |- skos__prefLabel mesh__D016848 Naegleria fowleri
% 215.26/215.44  |- mesh__dateRevised mesh__D016848 2003-07-09
% 215.26/215.44  |- rdf__type mesh__D016848sskos__Concept
% 215.26/215.44  |- mesh__dateCreated mesh__D016848 1991-05-02
% 215.26/215.44  |- skos__broader mesh__D016848smesh__D009253
% 215.26/215.44  |- mesh__historyNote mesh__D016848 92   
% 215.26/215.44  |- mesh__publicMeSHNote mesh__D016848 92   
% 215.26/215.44  |- mesh__recordOriginator mesh__D016848 PXP
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D016848 2004
% 215.26/215.44  |- skos__historyNote mesh__D016848 Naegleria %28%1988-1991%29%
% 215.26/215.44  |- mesh__recordMaintainer mesh__D016848 ags
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D016848 2005
% 215.26/215.44  |- skos__historyNote mesh__D016848 Amoeba %28%1974-1987%29%
% 215.26/215.44  |- skos__scopeNote mesh__D016848
% 215.26/215.44       A species of parasitic protozoa having both an ameboid and flagellate stage in its life cycle. Infection with this pathogen produces primary amebic meningoencephalitis.%A%    
% 215.26/215.44  |- mesh__recordAuthorizer mesh__D016848 sjn
% 215.26/215.44  |- skos__annotation mesh__D016848
% 215.26/215.44       pathogenic ameba causing meningoencephalitis; infection: coord IM with AMEBIASIS %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D016848 2006
% 215.26/215.44  |- mesh__dateEstablished mesh__D016848 1992-01-01
% 215.26/215.44  |- skos__prefLabel mesh__D041241 Vibrio cholerae O1
% 215.26/215.44  |- skos__annotation mesh__D041241
% 215.26/215.44       infection: coord IM with CHOLERA %28%IM%29%   
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D041241 2006
% 215.26/215.44  |- rdf__type mesh__D041241sskos__Concept
% 215.26/215.44  |- skos__altLabel mesh__D041241 Vibrio cholerae Serogroup O1
% 215.26/215.44  |- mesh__recordOriginator mesh__D041241 ags
% 215.26/215.44  |- mesh__dateEstablished mesh__D041241 2003-01-01
% 215.26/215.44  |- mesh__dateCreated mesh__D041241 2002-07-03
% 215.26/215.44  |- skos__broader mesh__D041241smesh__D014734
% 215.26/215.44  |- mesh__historyNote mesh__D041241 2003   
% 215.26/215.44  |- mesh__recordAuthorizer mesh__D041241 sjn
% 215.26/215.44  |- skos__scopeNote mesh__D041241
% 215.26/215.44       Strains of VIBRIO CHOLERAE containing O ANTIGENS group 1. All are CHOLERA-causing strains %28%serotypes%29%. There are two biovars %28%biotypes%29%: cholerae and eltor %28%El Tor%29%.%A%    
% 215.26/215.44  |- mesh__publicMeSHNote mesh__D041241 2003   
% 215.26/215.44  |- mesh__dateRevised mesh__D041241 2005-06-30
% 215.26/215.44  |- mesh__recordMaintainer mesh__D041241 SYSTEM
% 215.26/215.44  |- skos__hiddenLabel mesh__D002828 Heterotopic Tissues
% 215.26/215.44  |- skos__broader mesh__D002828smesh__D020763
% 215.26/215.44  |- skos__annotation mesh__D002828
% 215.26/215.44       coord aberrant or heterotopic tissue of an organ under the organ without qualif, e.g., heterotopic pancreatic tissue in the duodenum = CHORISTOMA %28%IM%29% + DUODENAL DISEASES %28%IM%29% + PANCREAS %28%no qualif%29% %28%IM%29%%A%  
% 215.26/215.44  |- mesh__recordOriginator mesh__D002828 NLM
% 215.26/215.44  |- skos__hiddenLabel mesh__D002828 Tissues, Ectopic
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D002828 2000
% 215.26/215.44  |- skos__prefLabel mesh__D002828 Choristoma
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D002828 2004
% 215.26/215.44  |- skos__hiddenLabel mesh__D002828 Choristomas
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D002828 2001
% 215.26/215.44  |- skos__hiddenLabel mesh__D002828 Tissues, Aberrant
% 215.26/215.44  |- mesh__dateRevised mesh__D002828 1999-11-08
% 215.26/215.44  |- skos__hiddenLabel mesh__D002828 Tissue, Ectopic
% 215.26/215.44  |- skos__hiddenLabel mesh__D002828 Tissue, Heterotopic
% 215.26/215.44  |- skos__hiddenLabel mesh__D002828 Tissues, Heterotopic
% 215.26/215.44  |- mesh__dateCreated mesh__D002828 1999-01-01
% 215.26/215.44  |- skos__altLabel mesh__D002828 Heterotopic Tissue
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D002828 2002
% 215.26/215.44  |- skos__hiddenLabel mesh__D002828 Ectopic Tissues
% 215.26/215.44  |- skos__altLabel mesh__D002828 Ectopic Tissue
% 215.26/215.44  |- rdf__type mesh__D002828sskos__Concept
% 215.26/215.44  |- skos__scopeNote mesh__D002828
% 215.26/215.44       A mass of histologically normal tissue present in an abnormal location.%A%    
% 215.26/215.44  |- skos__hiddenLabel mesh__D002828 Aberrant Tissues
% 215.26/215.44  |- skos__hiddenLabel mesh__D002828 Tissue, Aberrant
% 215.26/215.44  |- mesh__recordMaintainer mesh__D002828 KEV
% 215.26/215.44  |- mesh__recordAuthorizer mesh__D002828 sjn
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D002828 2005
% 215.26/215.44  |- skos__altLabel mesh__D002828 Aberrant Tissue
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D002828 2003
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D002828 2006
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D013550 2006
% 215.26/215.44  |- mesh__recordMaintainer mesh__D013550 nns
% 215.26/215.44  |- mesh__recordAuthorizer mesh__D013550 sjn
% 215.26/215.44  |- skos__prefLabel mesh__D013550 Swimming
% 215.26/215.44  |- mesh__recordOriginator mesh__D013550 NLM
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D013550 2005
% 215.26/215.44  |- skos__scopeNote mesh__D013550
% 215.26/215.44       An activity in which the body is propelled through water by specific movement of the arms and/or the legs. Swimming as propulsion through water by the movement of limbs, tail, or fins of animals is often studied as a form of EXERTION or endurance.%A%    
% 215.26/215.44  |- skos__broader mesh__D013550smesh__D009043
% 215.26/215.44  |- mesh__dateCreated mesh__D013550 1999-01-01
% 215.26/215.44  |- mesh__dateRevised mesh__D013550 2003-07-09
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D013550 2004
% 215.26/215.44  |- skos__annotation mesh__D013550
% 215.26/215.44       human %26% animal; /inj: coord IM with specific inj %28%IM%29%; /physiol permitted; includes body-surfing, does not include surfboarding, windsurfing or water-skiing %28%index under SPORTS%29%; consider also DIVING; index NIM for swimming in animal experiments on EXERTION%A%  
% 215.26/215.44  |- rdf__type mesh__D013550sskos__Concept
% 215.26/215.44  |- skos__broader mesh__D013550smesh__D013177
% 215.26/215.44  |- skos__broader mesh__D013550smesh__D008124
% 215.26/215.44  |- mesh__recordAuthorizer mesh__D007513 sjn
% 215.26/215.44  |- mesh__recordMaintainer mesh__D007513 CCR
% 215.26/215.44  |- skos__historyNote mesh__D007513 Alkyl Sulfonates %28%1973-1974%29%
% 215.26/215.44  |- mesh__recordOriginator mesh__D007513 NLM
% 215.26/215.44  |- mesh__dateEstablished mesh__D007513 1991-01-01
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D007513 2005
% 215.26/215.44  |- skos__scopeNote mesh__D007513
% 215.26/215.44       A colorless, syrupy, strongly acidic liquid that can form detergents with oleic acid.%A%    
% 215.26/215.44  |- skos__hiddenLabel mesh__D007513 Acid, Isethionic
% 215.26/215.44  |- skos__altLabel mesh__D007513 Hydroxyethylsulfonic Acid
% 215.26/215.44  |- mesh__historyNote mesh__D007513
% 215.26/215.44       91%28%75%29%; was see under ALKYL SULFONATES 1975-90   
% 215.26/215.44  |- skos__hiddenLabel mesh__D007513 Acid, Hydroxyethylsulfonic
% 215.26/215.44  |- skos__hiddenLabel mesh__D007513 Isethionate, Sodium
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D007513 2006
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D007513 2003
% 215.26/215.44  |- mesh__dateCreated mesh__D007513 1974-11-19
% 215.26/215.44  |- mesh__dateRevised mesh__D007513 2000-06-21
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D007513 2004
% 215.26/215.44  |- skos__broader mesh__D007513smesh__D017738
% 215.26/215.44  |- mesh__publicMeSHNote mesh__D007513
% 215.26/215.44       91; was see under ALKYL SULFONATES 1975-90   
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D007513 2001
% 215.26/215.44  |- skos__historyNote mesh__D007513 Alcohol, Ethyl %28%1973-1974%29%
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D007513 2002
% 215.26/215.44  |- skos__prefLabel mesh__D007513 Isethionic Acid
% 215.26/215.44  |- rdf__type mesh__D007513sskos__Concept
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012458 2004
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012458 1994
% 215.26/215.44  |- mesh__dateCreated mesh__D012458 1976-04-27
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012458 2003
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012458 1993
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012458 1998
% 215.26/215.44  |- skos__altLabel mesh__D012458 N-Phenylsalicylamides
% 215.26/215.44  |- skos__broader mesh__D012458smesh__D012457
% 215.26/215.44  |- skos__broader mesh__D012458smesh__D000813
% 215.26/215.44  |- mesh__dateEstablished mesh__D012458 1991-01-01
% 215.26/215.44  |- skos__historyNote mesh__D012458 Salicylamides %28%1966-1976%29%
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012458 1997
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012458 2002
% 215.26/215.44  |- mesh__recordOriginator mesh__D012458 RLS
% 215.26/215.44  |- mesh__publicMeSHNote mesh__D012458
% 215.26/215.44       91; was see under SALICYLAMIDES 1977-90   
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012458 1996
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012458 2001
% 215.26/215.44  |- skos__hiddenLabel mesh__D012458 N Phenylsalicylamides
% 215.26/215.44  |- skos__prefLabel mesh__D012458 Salicylanilides
% 215.26/215.44  |- skos__annotation mesh__D012458 antifungals   
% 215.26/215.44  |- mesh__historyNote mesh__D012458
% 215.26/215.44       91%28%77%29%; was see under SALICYLAMIDES 1977-90   
% 215.26/215.44  |- mesh__recordMaintainer mesh__D012458 TAP
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012458 2006
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012458 2000
% 215.26/215.44  |- mesh__recordAuthorizer mesh__D012458 PLS
% 215.26/215.44  |- rdf__type mesh__D012458sskos__Concept
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012458 2005
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012458 1995
% 215.26/215.44  |- skos__scopeNote mesh__D012458
% 215.26/215.44       2-Hydroxy-N-phenylbenzamides. N-phenyl substituted salicylamides. Derivatives have been used as fungicides, anti-mildew agents and topical antifungal agents. In concentrated form may cause irritation of skin and mucous membranes.%A%    
% 215.26/215.44  |- mesh__dateRevised mesh__D012458 1992-05-20
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D012458 1999
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D017941 2002
% 215.26/215.44  |- mesh__historyNote mesh__D017941 94   
% 215.26/215.44  |- skos__prefLabel mesh__D017941 Coronavirus, Rat
% 215.26/215.44  |- mesh__dateRevised mesh__D017941 2001-07-25
% 215.26/215.44  |- mesh__recordOriginator mesh__D017941 AGS
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D017941 2003
% 215.26/215.44  |- skos__scopeNote mesh__D017941
% 215.26/215.44       A species of CORONAVIRUS causing pneumonia in newborn rats but a clinically inapparent infection in adults. It is separate but antigenically related to MURINE HEPATITIS VIRUS.%A%    
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D017941 2005
% 215.26/215.44  |- mesh__dateEstablished mesh__D017941 1994-01-01
% 215.26/215.44  |- mesh__recordAuthorizer mesh__D017941 sjn
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D017941 2004
% 215.26/215.44  |- mesh__recordMaintainer mesh__D017941 ags
% 215.26/215.44  |- skos__altLabel mesh__D017941 Rat coronavirus
% 215.26/215.44  |- mesh__activeMeSHYear mesh__D017941 2006
% 215.26/215.44  |- mesh__publicMeSHNote mesh__D017941 94   
% 215.26/215.44  |- rdf__type mesh__D017941sskos__Concept
% 215.26/215.44  |- skos__annotation mesh__D017941
% 215.26/215.44       infection: coord IM with CORONAVIRUS INFECTIONS %28%IM%29%   
% 215.26/215.44  |- skos__broader mesh__D017941smesh__D017934
% 215.26/215.44  |- skos__historyNote mesh__D017941 Coronaviridae %28%1977-1993%29%
% 215.26/215.44  |- mesh__dateCreated mesh__D017941 1993-06-04
% 215.26/215.44  |- skos__historyNote mesh__D017143 Models, Theoretical %28%1974-1992%29%
% 215.26/215.44  |- mesh__recordMaintainer mesh__D017143 jls
% 215.26/215.44  |- skos__prefLabel mesh__D017143 Fuzzy Logic
% 215.26/215.44  |- rdf__type mesh__D017143sskos__Concept
% 215.26/215.44  |- skos__altLabel mesh__D017143 Logic, Fuzzy
% 215.26/215.44  |- mesh__dateEstablished mesh__D017143 1993-01-01
% 215.26/215.45  |- skos__annotation mesh__D017143 no qualif   
% 215.26/215.45  |- mesh__recordOriginator mesh__D017143 AGS
% 215.26/215.45  |- skos__scopeNote mesh__D017143
% 215.26/215.45       Approximate, quantitative reasoning that is concerned with the linguistic ambiguity which exists in natural or synthetic language. At its core are variables such as good, bad, and young as well as modifiers such as more, less, and very. These ordinary terms represent fuzzy sets in a particular problem. Fuzzy logic plays a key role in many medical expert systems.%A%    
% 215.26/215.45  |- mesh__dateRevised mesh__D017143 2004-07-07
% 215.26/215.45  |- mesh__dateCreated mesh__D017143 1992-05-20
% 215.26/215.45  |- skos__broader mesh__D017143smesh__D008962
% 215.26/215.45  |- skos__broader mesh__D017143smesh__D001185
% 215.26/215.45  |- mesh__recordAuthorizer mesh__D017143 sjn
% 215.26/215.45  |- mesh__historyNote mesh__D017143 93   
% 215.26/215.45  |- skos__broader mesh__D017143smesh__D008128
% 215.26/215.45  |- mesh__publicMeSHNote mesh__D017143 93   
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017143 2006
% 215.26/215.45  |- skos__historyNote mesh__D017143 Logic %28%1977-1992%29%
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017143 2005
% 215.26/215.45  |- mesh__dateEstablished mesh__D003921 1978-01-01
% 215.26/215.45  |- skos__hiddenLabel mesh__D003921 Diabetes, Streptozocin
% 215.26/215.45  |- skos__altLabel mesh__D003921 Experimental Diabetes Mellitus
% 215.26/215.45  |- mesh__dateCreated mesh__D003921 1977-05-05
% 215.26/215.45  |- mesh__recordOriginator mesh__D003921 VDK
% 215.26/215.45  |- mesh__publicMeSHNote mesh__D003921
% 215.26/215.45       78; ALLOXAN DIABETES was heading 1963-77   
% 215.26/215.45  |- mesh__recordAuthorizer mesh__D003921 sjn
% 215.26/215.45  |- skos__annotation mesh__D003921
% 215.26/215.45       index alloxan or streptozocin diabetes as DIABETES MELLITUS, EXPERIMENTAL %28%IM%29% + ALLOXAN or STREPTOZOCIN %28%NIM%29% only if the chem are particularly discussed; probably in animal so do not use /vet but don%27%t forget check tag ANIMALS; DF: DIABETES MELLITUS EXPER%A%  
% 215.26/215.45  |- skos__hiddenLabel mesh__D003921 Diabetes, Streptozotocin
% 215.26/215.45  |- skos__altLabel mesh__D003921 Streptozocin Diabetes
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D003921 2005
% 215.26/215.45  |- skos__hiddenLabel mesh__D003921 Streptozocin Diabete
% 215.26/215.45  |- skos__broader mesh__D003921smesh__D004195
% 215.26/215.45  |- skos__hiddenLabel mesh__D003921 Diabetes, Alloxan
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D003921 2006
% 215.26/215.45  |- mesh__dateRevised mesh__D003921 2004-07-07
% 215.26/215.45  |- mesh__onlineNote mesh__D003921
% 215.26/215.45       use DIABETES MELLITUS, EXPERIMENTAL to search ALLOXAN DIABETES 1966-77%A%  
% 215.26/215.45  |- skos__historyNote mesh__D003921 Diabetes Mellitus %28%1966-1977%29%
% 215.26/215.45  |- skos__hiddenLabel mesh__D003921 Diabete, Streptozocin
% 215.26/215.45  |- mesh__historyNote mesh__D003921
% 215.26/215.45       78; ALLOXAN DIABETES was heading 1963-77   
% 215.26/215.45  |- mesh__recordMaintainer mesh__D003921 lkt
% 215.26/215.45  |- skos__scopeNote mesh__D003921
% 215.26/215.45       Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY.%A%    
% 215.26/215.45  |- skos__broader mesh__D003921smesh__D003920
% 215.26/215.45  |- skos__related mesh__D003921smesh__D016688
% 215.26/215.45  |- rdf__type mesh__D003921sskos__Concept
% 215.26/215.45  |- skos__prefLabel mesh__D003921 Diabetes Mellitus, Experimental
% 215.26/215.45  |- skos__hiddenLabel mesh__D050577 Convertase, C 3
% 215.26/215.45  |- rdf__type mesh__D050577sskos__Concept
% 215.26/215.45  |- skos__altLabel mesh__D050577 C5 Cleaving Enzyme
% 215.26/215.45  |- skos__scopeNote mesh__D050577
% 215.26/215.45       Serine proteases that cleave COMPLEMENT C3 into COMPLEMENT C3A and COMPLEMENT C3B, or cleave COMPLEMENT C5 into COMPLEMENT C5A and COMPLEMENT C5B. These include the different forms of C3/C5 convertases in the classical and the alternative pathways of COMPLEMENT ACTIVATION. Both cleavages take place at the C-terminal of an ARGININE residue.%A%    
% 215.26/215.45  |- skos__altLabel mesh__D050577 C3 Activator
% 215.26/215.45  |- skos__hiddenLabel mesh__D050577 Complement C3 C5 Convertases
% 215.26/215.45  |- mesh__dateCreated mesh__D050577 2005-06-30
% 215.26/215.45  |- mesh__recordMaintainer mesh__D050577 ags
% 215.26/215.45  |- skos__hiddenLabel mesh__D050577 C5 Convertases, Complement
% 215.26/215.45  |- skos__altLabel mesh__D050577 C3-C5 Convertase
% 215.26/215.45  |- skos__hiddenLabel mesh__D050577 Convertase, Complement 3
% 215.26/215.45  |- skos__altLabel mesh__D050577 C 3 Convertase
% 215.26/215.45  |- skos__hiddenLabel mesh__D050577 Convertases, Complement C5
% 215.26/215.45  |- skos__hiddenLabel mesh__D050577 Activator, C3
% 215.26/215.45  |- mesh__publicMeSHNote mesh__D050577
% 215.26/215.45       2006; for COMPLEMENT 3 CONVERTASE see COMPLEMENT 3 CONVERTASE 1991-2005, see COMPLEMENT ACTIVATING ENZYMES 1978-1990%A%  
% 215.26/215.45  |- skos__hiddenLabel mesh__D050577 C3 Convertases, Complement
% 215.26/215.45  |- skos__hiddenLabel mesh__D050577 C3-C5 Convertases, Complement
% 215.26/215.45  |- mesh__recordAuthorizer mesh__D050577 ags
% 215.26/215.45  |- skos__broader mesh__D050577smesh__D003166
% 215.26/215.45  |- mesh__dateRevised mesh__D050577 2005-07-11
% 215.26/215.45  |- skos__altLabel mesh__D050577 Complement 5 Convertase
% 215.26/215.45  |- mesh__recordOriginator mesh__D050577 lkt
% 215.26/215.45  |- mesh__dateEstablished mesh__D050577 2006-01-01
% 215.26/215.45  |- skos__hiddenLabel mesh__D050577 Convertase, C3-C5
% 215.26/215.45  |- mesh__historyNote mesh__D050577 2006 %28%1978%29%   
% 215.26/215.45  |- skos__hiddenLabel mesh__D050577 C3 C5 Convertase
% 215.26/215.45  |- skos__historyNote mesh__D050577 Complement C3 %28%1976-2005%29%
% 215.26/215.45  |- skos__historyNote mesh__D050577 Complement C5 %28%1976-2005%29%
% 215.26/215.45  |- skos__hiddenLabel mesh__D050577 Convertases, Complement C3-C5
% 215.26/215.45  |- skos__altLabel mesh__D050577 Complement 3 Convertase
% 215.26/215.45  |- skos__altLabel mesh__D050577 C5 Convertase
% 215.26/215.45  |- skos__altLabel mesh__D050577 C3 Convertase
% 215.26/215.45  |- skos__prefLabel mesh__D050577 Complement C3-C5 Convertases
% 215.26/215.45  |- skos__hiddenLabel mesh__D050577 Convertases, Complement C3
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D050577 2006A
% 215.26/215.45  |- skos__hiddenLabel mesh__D050577 Convertase, C3
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D050577 2006
% 215.26/215.45  |- skos__altLabel mesh__D003123
% 215.26/215.45       Hereditary Nonpolyposis Colorectal Neoplasms
% 215.26/215.45  |- mesh__recordOriginator mesh__D003123 VDK
% 215.26/215.45  |- skos__hiddenLabel mesh__D003123 Syndrome, Lynch
% 215.26/215.45  |- rdf__type mesh__D003123sskos__Concept
% 215.26/215.45  |- skos__broader mesh__D003123smesh__D009386
% 215.26/215.45  |- skos__scopeNote mesh__D003123
% 215.26/215.45       A group of autosomal-dominant inherited diseases in which COLON CANCER arises in discrete adenomas. Unlike FAMILIAL POLYPOSIS COLI with hundreds of polyps, hereditary nonpolyposis colorectal neoplasms occur much later, in the fourth and fifth decades. HNPCC has been associated with germline mutations in mismatch repair %28%MMR%29% genes.%A%    
% 215.26/215.45  |- mesh__dateRevised mesh__D003123 2005-06-30
% 215.26/215.45  |- skos__altLabel mesh__D003123 Lynch Syndrome
% 215.26/215.45  |- skos__altLabel mesh__D003123 Lynch Cancer Family Syndrome I
% 215.26/215.45  |- mesh__historyNote mesh__D003123 87   
% 215.26/215.45  |- skos__prefLabel mesh__D003123
% 215.26/215.45       Colorectal Neoplasms, Hereditary Nonpolyposis
% 215.26/215.45  |- mesh__dateCreated mesh__D003123 1986-06-24
% 215.26/215.45  |- mesh__dateEstablished mesh__D003123 1987-01-01
% 215.26/215.45  |- mesh__recordAuthorizer mesh__D003123 sjn
% 215.26/215.45  |- skos__broader mesh__D003123smesh__D049914
% 215.26/215.45  |- skos__broader mesh__D003123smesh__D015179
% 215.26/215.45  |- mesh__publicMeSHNote mesh__D003123 87   
% 215.26/215.45  |- skos__altLabel mesh__D003123 Lynch Syndrome I
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D003123 2006
% 215.26/215.45  |- mesh__recordMaintainer mesh__D003123 nns
% 215.26/215.45  |- skos__altLabel mesh__D003123 Colon Cancer, Familial Nonpolyposis
% 215.26/215.45  |- skos__annotation mesh__D003123 DF: HNPCC   
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D016849 2003
% 215.26/215.45  |- skos__broader mesh__D016849smesh__D015828
% 215.26/215.45  |- skos__altLabel mesh__D016849 Herpes Simplex Keratitis
% 215.26/215.45  |- mesh__recordAuthorizer mesh__D016849 PLS
% 215.26/215.45  |- mesh__dateEstablished mesh__D016849 1992-01-01
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D016849 2004
% 215.26/215.45  |- skos__hiddenLabel mesh__D016849 Herpes Simplex Keratitides
% 215.26/215.45  |- mesh__dateCreated mesh__D016849 1991-05-02
% 215.26/215.45  |- skos__altLabel mesh__D016849 Herpes Simplex, Ocular
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D016849 1996
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D016849 2000
% 215.26/215.45  |- skos__historyNote mesh__D016849 Keratitis, Dendritic %28%1966-1991%29%
% 215.26/215.45  |- mesh__dateRevised mesh__D016849 1995-06-08
% 215.26/215.45  |- mesh__recordMaintainer mesh__D016849 TAP
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D016849 2005
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D016849 1997
% 215.26/215.45  |- skos__broader mesh__D016849smesh__D007634
% 215.26/215.45  |- skos__hiddenLabel mesh__D016849 Keratitides, Herpetic
% 215.26/215.45  |- mesh__recordOriginator mesh__D016849 TGC
% 215.26/215.45  |- skos__hiddenLabel mesh__D016849 Keratitides, Herpes Simplex
% 215.26/215.45  |- mesh__onlineNote mesh__D016849
% 215.26/215.45       use KERATITIS, DENDRITIC to search HERPES SIMPLEX, OCULAR 1966-91 %26% OCULAR HERPES SIMPLEX 1990-91%A%  
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D016849 2001
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D016849 2006
% 215.26/215.45  |- skos__hiddenLabel mesh__D016849 Herpetic Keratitis
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D016849 1998
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D016849 2002
% 215.26/215.45  |- skos__broader mesh__D016849smesh__D006561
% 215.26/215.45  |- rdf__type mesh__D016849sskos__Concept
% 215.26/215.45  |- mesh__publicMeSHNote mesh__D016849
% 215.26/215.45       92; HERPES SIMPLEX, OCULAR was see KERATITIS, DENDRITIC 1963-91; OCULAR HERPES SIMPLEX was see KERATITIS, DENDRITIC 1990-91%A%  
% 215.26/215.45  |- skos__altLabel mesh__D016849 Ocular Herpes Simplex
% 215.26/215.45  |- skos__annotation mesh__D016849 herpes simplex of the cornea   
% 215.26/215.45  |- skos__hiddenLabel mesh__D016849 Keratitis, Herpes Simplex
% 215.26/215.45  |- skos__scopeNote mesh__D016849
% 215.26/215.45       A superficial, epithelial Herpesvirus hominis infection of the cornea, characterized by the presence of small vesicles which may break down and coalesce to form dendritic ulcers %28%KERATITIS, DENDRITIC%29%. %28%Dictionary of Visual Science, 3d ed%29%%A%    
% 215.26/215.45  |- mesh__historyNote mesh__D016849
% 215.26/215.45       92; HERPES SIMPLEX, OCULAR was see KERATITIS, DENDRITIC 1963-91; OCULAR HERPES SIMPLEX was see KERATITIS, DENDRITIC 1990-91%A%  
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D016849 1999
% 215.26/215.45  |- skos__hiddenLabel mesh__D016849 Herpetic Keratitides
% 215.26/215.45  |- skos__prefLabel mesh__D016849 Keratitis, Herpetic
% 215.26/215.45  |- skos__scopeNote mesh__D041242
% 215.26/215.45       Strains of VIBRIO CHOLERAE containing O ANTIGENS group 139. This strain emerged in India in 1992 and caused a CHOLERA epidemic.%A%    
% 215.26/215.45  |- mesh__dateRevised mesh__D041242 2005-06-30
% 215.26/215.45  |- mesh__publicMeSHNote mesh__D041242 2003   
% 215.26/215.45  |- skos__historyNote mesh__D041242 Vibrio cholerae %28%1993-2002%29%
% 215.26/215.45  |- mesh__dateEstablished mesh__D041242 2003-01-01
% 215.26/215.45  |- mesh__recordOriginator mesh__D041242 ags
% 215.26/215.45  |- mesh__recordMaintainer mesh__D041242 SYSTEM
% 215.26/215.45  |- mesh__dateCreated mesh__D041242 2002-07-03
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D041242 2006
% 215.26/215.45  |- skos__altLabel mesh__D041242 Vibrio cholerae Serogroup O139
% 215.26/215.45  |- rdf__type mesh__D041242sskos__Concept
% 215.26/215.45  |- skos__broader mesh__D041242smesh__D014734
% 215.26/215.45  |- skos__annotation mesh__D041242
% 215.26/215.45       infection: coord IM with CHOLERA %28%IM%29%   
% 215.26/215.45  |- mesh__historyNote mesh__D041242 2003   
% 215.26/215.45  |- mesh__recordAuthorizer mesh__D041242 sjn
% 215.26/215.45  |- skos__prefLabel mesh__D041242 Vibrio cholerae O139
% 215.26/215.45  |- skos__hiddenLabel mesh__D002829 Choroids
% 215.26/215.45  |- rdf__type mesh__D002829sskos__Concept
% 215.26/215.45  |- mesh__recordAuthorizer mesh__D002829 sjn
% 215.26/215.45  |- skos__prefLabel mesh__D002829 Choroid
% 215.26/215.45  |- skos__broader mesh__D002829smesh__D014602
% 215.26/215.45  |- mesh__recordMaintainer mesh__D002829 KEV
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D002829 2005
% 215.26/215.45  |- mesh__recordOriginator mesh__D002829 NLM
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D002829 2000
% 215.26/215.45  |- mesh__dateRevised mesh__D002829 1999-11-03
% 215.26/215.45  |- skos__scopeNote mesh__D002829
% 215.26/215.45       The thin, highly vascular membrane covering most of the posterior of the eye between the RETINA and SCLERA.%A%    
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D002829 2003
% 215.26/215.45  |- skos__annotation mesh__D002829
% 215.26/215.45       in the eye: do not confuse with CHOROID PLEXUS %28%in the brain%29%; inflammation = CHOROIDITIS or CHORIORETINITIS; /blood supply consider also CILIARY ARTERIES%A%  
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D002829 2006
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D002829 2001
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D002829 2004
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D002829 2002
% 215.26/215.45  |- mesh__dateCreated mesh__D002829 1999-01-01
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D013551 2000
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D013551 1997
% 215.26/215.45  |- mesh__dateCreated mesh__D013551 1999-01-01
% 215.26/215.45  |- skos__hiddenLabel mesh__D013551 Pools, Swimming
% 215.26/215.45  |- skos__broader mesh__D013551smesh__D011633
% 215.26/215.45  |- mesh__recordOriginator mesh__D013551 NLM
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D013551 2002
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D013551 1996
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D013551 1993
% 215.26/215.45  |- mesh__dateRevised mesh__D013551 1992-05-18
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D013551 2004
% 215.26/215.45  |- skos__hiddenLabel mesh__D013551 Pool, Swimming
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D013551 1999
% 215.26/215.45  |- skos__prefLabel mesh__D013551 Swimming Pools
% 215.26/215.45  |- rdf__type mesh__D013551sskos__Concept
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D013551 2003
% 215.26/215.45  |- mesh__recordMaintainer mesh__D013551 TAP
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D013551 1995
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D013551 1998
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D013551 2001
% 215.26/215.45  |- mesh__recordAuthorizer mesh__D013551 PLS
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D013551 2006
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D013551 1994
% 215.26/215.45  |- skos__hiddenLabel mesh__D013551 Swimming Pool
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D013551 2005
% 215.26/215.45  |- skos__annotation mesh__D007514 IM; specify geog if pertinent   
% 215.26/215.45  |- skos__hiddenLabel mesh__D007514 Ethics, Islamic
% 215.26/215.45  |- skos__scopeNote mesh__D007514
% 215.26/215.45       A monotheistic religion promulgated by the Prophet Mohammed with Allah as the deity.%A%    
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D007514 2005
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D007514 2002
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D007514 2006
% 215.26/215.45  |- mesh__recordAuthorizer mesh__D007514 sjn
% 215.26/215.45  |- mesh__dateEstablished mesh__D007514 1976-01-01
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D007514 2003
% 215.26/215.45  |- mesh__onlineNote mesh__D007514
% 215.26/215.45       use ISLAM to search MOHAMMEDANISM 1966-75   
% 215.26/215.45  |- skos__altLabel mesh__D007514 Mohammedanism
% 215.26/215.45  |- skos__hiddenLabel mesh__D007514 Islamic Ethic
% 215.26/215.45  |- skos__prefLabel mesh__D007514 Islam
% 215.26/215.45  |- skos__broader mesh__D007514smesh__D012067
% 215.26/215.45  |- skos__hiddenLabel mesh__D007514 Muslim
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D007514 2004
% 215.26/215.45  |- mesh__historyNote mesh__D007514 76; was MOHAMMEDANISM 1963-75   
% 215.26/215.45  |- skos__hiddenLabel mesh__D007514 Ethic, Islamic
% 215.26/215.45  |- mesh__recordOriginator mesh__D007514 EC
% 215.26/215.45  |- skos__related mesh__D007514smesh__D018912
% 215.26/215.45  |- mesh__dateCreated mesh__D007514 1975-07-18
% 215.26/215.45  |- mesh__dateRevised mesh__D007514 1999-11-08
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D007514 2000
% 215.26/215.45  |- rdf__type mesh__D007514sskos__Concept
% 215.26/215.45  |- mesh__recordMaintainer mesh__D007514 kle
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D007514 2001
% 215.26/215.45  |- mesh__publicMeSHNote mesh__D007514 76; was MOHAMMEDANISM 1963-75   
% 215.26/215.45  |- mesh__dateEstablished mesh__D051670 2006-01-01
% 215.26/215.45  |- skos__hiddenLabel mesh__D051670 Potassium Channel, Kv3.1
% 215.26/215.45  |- mesh__recordAuthorizer mesh__D051670 sjn
% 215.26/215.45  |- skos__prefLabel mesh__D051670 Shaw Potassium Channels
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D051670 2006
% 215.26/215.45  |- skos__broader mesh__D051670smesh__D051637
% 215.26/215.45  |- mesh__dateCreated mesh__D051670 2005-06-30
% 215.26/215.45  |- mesh__publicMeSHNote mesh__D051670
% 215.26/215.45       2006; SHAW POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1994-2004%A%  
% 215.26/215.45  |- skos__altLabel mesh__D051670 KCNC1 Potassium Channel
% 215.26/215.45  |- skos__altLabel mesh__D051670 KCNC2 Potassium Channel
% 215.26/215.45  |- skos__hiddenLabel mesh__D051670 Potassium Channel, KCNC2
% 215.26/215.45  |- skos__scopeNote mesh__D051670
% 215.26/215.45       A shaker subfamily that is prominently expressed in NEURONS and are necessary for high-frequency, repetitive firing of ACTION POTENTIALS.%A%    
% 215.26/215.45  |- skos__hiddenLabel mesh__D051670 Potassium Channel, KCNC1
% 215.26/215.45  |- skos__altLabel mesh__D051670 Shaw Potassium Channel Protein Family
% 215.26/215.45  |- skos__hiddenLabel mesh__D051670 Potassium Channel, Kv3.2
% 215.26/215.45  |- mesh__recordMaintainer mesh__D051670 DRC
% 215.26/215.45  |- skos__hiddenLabel mesh__D051670 Potassium Channels, Kv3
% 215.26/215.45  |- mesh__recordOriginator mesh__D051670 DRC
% 215.26/215.45  |- skos__hiddenLabel mesh__D051670 Potassium Channels, Shaw
% 215.26/215.45  |- mesh__historyNote mesh__D051670 2006%28%1994%29%   
% 215.26/215.45  |- skos__altLabel mesh__D051670 Kv3 Potassium Channels
% 215.26/215.45  |- rdf__type mesh__D051670sskos__Concept
% 215.26/215.45  |- skos__broader mesh__D012459smesh__D020156
% 215.26/215.45  |- mesh__recordMaintainer mesh__D012459 ssb
% 215.26/215.45  |- mesh__publicMeSHNote mesh__D012459 1963   
% 215.26/215.45  |- mesh__dateCreated mesh__D012459 1999-01-01
% 215.26/215.45  |- skos__scopeNote mesh__D012459
% 215.26/215.45       The salts, esters of salicylic acids, or salicylate esters of an organic acid. Some of these have analgesic, antipyretic, and anti-inflammatory activities by inhibiting prostaglandin synthesis.%A%    
% 215.26/215.45  |- mesh__historyNote mesh__D012459 1963   
% 215.26/215.45  |- skos__prefLabel mesh__D012459 Salicylates
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D012459 2006
% 215.26/215.45  |- rdf__type mesh__D012459sskos__Concept
% 215.26/215.45  |- mesh__recordAuthorizer mesh__D012459 sjn
% 215.26/215.45  |- mesh__recordOriginator mesh__D012459 NLM
% 215.26/215.45  |- mesh__dateRevised mesh__D012459 2005-06-30
% 215.26/215.45  |- skos__hiddenLabel mesh__D023181 Peptides, Antimicrobial Cationic
% 215.26/215.45  |- skos__hiddenLabel mesh__D023181 Cationic Proteins, Microbicidal
% 215.26/215.45  |- mesh__recordAuthorizer mesh__D023181 sjn
% 215.26/215.45  |- skos__scopeNote mesh__D023181
% 215.26/215.45       Small cationic peptides that are an important component, in most species, of early innate and induced defenses against invading microbes. In animals they are found on mucosal surfaces, within phagocytic granules, and on the surface of the body. They are also found in insects and plants.  Among others, this group includes the DEFENSINS, protegrins, tachyplesins, and thionins.%A%    
% 215.26/215.45  |- skos__broader mesh__D023181smesh__D010455
% 215.26/215.45  |- mesh__recordOriginator mesh__D023181 ags
% 215.26/215.45  |- mesh__dateRevised mesh__D023181 2005-06-30
% 215.26/215.45  |- skos__altLabel mesh__D023181 Microbicidal Cationic Proteins
% 215.26/215.45  |- mesh__recordMaintainer mesh__D023181 ssb
% 215.26/215.45  |- mesh__publicMeSHNote mesh__D023181
% 215.26/215.45       2001; MICROBICIDAL CATIONIC PROTEINS %28%now ANTIMICROBIAL CATIONIC PEPTIDES%29% was indexed under PROTEINS 1981-2000%A%  
% 215.26/215.45  |- skos__hiddenLabel mesh__D023181 Proteins, Microbicidal Cationic
% 215.26/215.45  |- mesh__dateCreated mesh__D023181 2000-06-21
% 215.26/215.45  |- skos__hiddenLabel mesh__D023181 Cationic Peptides, Antimicrobial
% 215.26/215.45  |- skos__prefLabel mesh__D023181 Antimicrobial Cationic Peptides
% 215.26/215.45  |- mesh__dateEstablished mesh__D023181 2001-01-01
% 215.26/215.45  |- mesh__historyNote mesh__D023181
% 215.26/215.45       2001; use ANTIMICROBIAL CATIONIC PEPTIDES %28%NM%29% to search MICROBICIDAL CATIONIC PROTEINS 1981-2000%A%  
% 215.26/215.45  |- skos__historyNote mesh__D023181 Proteins %28%1981-2000%29%
% 215.26/215.45  |- skos__related mesh__D023181smesh__D001770
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D023181 2006
% 215.26/215.45  |- rdf__type mesh__D023181sskos__Concept
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017942 1995
% 215.26/215.45  |- skos__historyNote mesh__D017942 Nitrates %28%1980-1993%29%
% 215.26/215.45  |- skos__scopeNote mesh__D017942
% 215.26/215.45       Nitric acid %28%HNO3%29%. A colorless liquid that is used in the manufacture of inorganic and organic nitrates and nitro compounds for fertilizers, dye intermediates, explosives, and many different organic chemicals. Continued exposure to vapor may cause chronic bronchitis; chemical pneumonitis may occur. %28%From Merck Index, 11th ed%29%%A%    
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017942 1998
% 215.26/215.45  |- mesh__publicMeSHNote mesh__D017942
% 215.26/215.45       94; NITRIC ACID was indexed under NITRATES 1980-93   
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017942 1994
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017942 2001
% 215.26/215.45  |- skos__broader mesh__D017942smesh__D017672
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017942 2004
% 215.26/215.45  |- skos__historyNote mesh__D017942 Acids %28%1974-1979%29%
% 215.26/215.45  |- skos__broader mesh__D017942smesh__D000148
% 215.26/215.45  |- skos__hiddenLabel mesh__D017942 Acid, Nitric
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017942 2000
% 215.26/215.45  |- skos__annotation mesh__D017942 do not confuse with NITROUS ACID   
% 215.26/215.45  |- mesh__dateEstablished mesh__D017942 1994-01-01
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017942 2003
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017942 1997
% 215.26/215.45  |- mesh__onlineNote mesh__D017942
% 215.26/215.45       use NITRIC ACID %28%NM%29% to search NITRIC ACID 1980-93   
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017942 2006
% 215.26/215.45  |- rdf__type mesh__D017942sskos__Concept
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017942 1996
% 215.26/215.45  |- mesh__historyNote mesh__D017942
% 215.26/215.45       94; was NITRIC ACID %28%NM%29% 1974-93   
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017942 2002
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017942 2005
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017942 1999
% 215.26/215.45  |- skos__prefLabel mesh__D017942 Nitric Acid
% 215.26/215.45  |- mesh__dateCreated mesh__D017942 1993-06-04
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017144 1998
% 215.26/215.45  |- skos__hiddenLabel mesh__D017144 Group, Focus
% 215.26/215.45  |- skos__broader mesh__D017144smesh__D007407
% 215.26/215.45  |- skos__hiddenLabel mesh__D017144 Groups, Focus
% 215.26/215.45  |- mesh__publicMeSHNote mesh__D017144 93   
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017144 1997
% 215.26/215.45  |- mesh__historyNote mesh__D017144 93   
% 215.26/215.45  |- skos__annotation mesh__D017144
% 215.26/215.45       a method of data collection %26% qualitative research   
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017144 1996
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017144 2006
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017144 2002
% 215.26/215.45  |- skos__prefLabel mesh__D017144 Focus Groups
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017144 1995
% 215.26/215.45  |- skos__historyNote mesh__D017144
% 215.26/215.45       Marketing of Health Services %28%1987-1992%29%
% 215.26/215.45  |- skos__scopeNote mesh__D017144
% 215.26/215.45       A method of data collection and a qualitative research tool in which a small group of individuals are brought together and allowed to interact in a discussion of their opinions about topics, issues, or questions.%A%    
% 215.26/215.45  |- skos__broader mesh__D017144smesh__D006126
% 215.26/215.45  |- mesh__dateEstablished mesh__D017144 1993-01-01
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017144 2005
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017144 2001
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017144 1994
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017144 2004
% 215.26/215.45  |- rdf__type mesh__D017144sskos__Concept
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017144 2000
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017144 1993
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017144 1999
% 215.26/215.45  |- mesh__dateCreated mesh__D017144 1992-05-20
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D017144 2003
% 215.26/215.45  |- skos__hiddenLabel mesh__D017144 Focus Group
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D003922 2005
% 215.26/215.45  |- skos__hiddenLabel mesh__D003922 Diabetes Mellitus, Sudden Onset
% 215.26/215.45  |- skos__hiddenLabel mesh__D003922 Autoimmune Diabete
% 215.26/215.45  |- skos__hiddenLabel mesh__D003922 Diabete, Autoimmune
% 215.26/215.45  |- mesh__dateCreated mesh__D003922 1999-01-01
% 215.26/215.45  |- skos__hiddenLabel mesh__D003922 Mellitus, Sudden-Onset Diabetes
% 215.26/215.45  |- skos__hiddenLabel mesh__D003922 Ketosis-Prone Diabetes Mellitus
% 215.26/215.45  |- mesh__historyNote mesh__D003922 2005 %28%1984%29%   
% 215.26/215.45  |- skos__hiddenLabel mesh__D003922 Sudden-Onset Diabetes Mellitus
% 215.26/215.45  |- skos__altLabel mesh__D003922 Type 1 Diabetes Mellitus
% 215.26/215.45  |- skos__altLabel mesh__D003922 Diabetes Mellitus, Ketosis-Prone
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D003922 2006
% 215.26/215.45  |- skos__broader mesh__D003922smesh__D003920
% 215.26/215.45  |- mesh__dateRevised mesh__D003922 2004-07-07
% 215.26/215.45  |- skos__hiddenLabel mesh__D003922 Diabetes Mellitus, Insulin Dependent
% 215.26/215.45  |- skos__altLabel mesh__D003922 Diabetes Mellitus, Sudden-Onset
% 215.26/215.45  |- skos__prefLabel mesh__D003922 Diabetes Mellitus, Type 1
% 215.26/215.45  |- mesh__recordOriginator mesh__D003922 NLM
% 215.26/215.45  |- skos__scopeNote mesh__D003922
% 215.26/215.45       A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.%A%    
% 215.26/215.45  |- skos__hiddenLabel mesh__D003922 Juvenile-Onset Diabetes Mellitus
% 215.26/215.45  |- skos__altLabel mesh__D003922 Diabetes Mellitus, Juvenile-Onset
% 215.26/215.45  |- skos__related mesh__D003922smesh__D016688
% 215.26/215.45  |- mesh__publicMeSHNote mesh__D003922
% 215.26/215.45       2005; see DIABETES MELLITUS, TYPE I 2004, see DIABETES MELLITUS, INSULIN-DEPENDENT 1984-2003, see DIABETES MELLITUS, JUVENILE 1966-1983%A%  
% 215.26/215.45  |- skos__hiddenLabel mesh__D003922 Insulin-Dependent Diabetes Mellitus
% 215.26/215.45  |- skos__altLabel mesh__D003922 Diabetes Mellitus, Insulin-Dependent
% 215.26/215.45  |- skos__altLabel mesh__D003922 IDDM
% 215.26/215.45  |- rdf__type mesh__D003922sskos__Concept
% 215.26/215.45  |- skos__hiddenLabel mesh__D003922 Brittle Diabetes Mellitus
% 215.26/215.45  |- skos__annotation mesh__D003922
% 215.26/215.45       MICE, INBRED NOD are a common model for this disease   
% 215.26/215.45  |- skos__altLabel mesh__D003922 Diabetes Mellitus, Type I
% 215.26/215.45  |- mesh__recordAuthorizer mesh__D003922 sjn
% 215.26/215.45  |- skos__altLabel mesh__D003922 Autoimmune Diabetes
% 215.26/215.45  |- skos__hiddenLabel mesh__D003922 Diabetes Mellitus, Juvenile Onset
% 215.26/215.45  |- skos__altLabel mesh__D003922 Diabetes Mellitus, Brittle
% 215.26/215.45  |- skos__broader mesh__D003922smesh__D001327
% 215.26/215.45  |- skos__hiddenLabel mesh__D003922 Diabetes Mellitus, Ketosis Prone
% 215.26/215.45  |- mesh__recordMaintainer mesh__D003922 lkt
% 215.26/215.45  |- skos__hiddenLabel mesh__D050578
% 215.26/215.45       Complement C3 C5 Convertases, Alternative Pathway
% 215.26/215.45  |- skos__scopeNote mesh__D050578
% 215.26/215.45       Important enzymes in the ALTERNATIVE COMPLEMENT ACTIVATION PATHWAY. They cleave COMPLEMENT C3 and COMPLEMENT C5.%A%    
% 215.26/215.45  |- skos__altLabel mesh__D050578 Alternative Pathway C3-C5 Convertases
% 215.26/215.45  |- mesh__recordOriginator mesh__D050578 lkt
% 215.26/215.45  |- mesh__historyNote mesh__D050578 2006   
% 215.26/215.45  |- mesh__dateCreated mesh__D050578 2005-06-30
% 215.26/215.45  |- skos__historyNote mesh__D050578 Esterases %28%1975-2005%29%
% 215.26/215.45  |- skos__hiddenLabel mesh__D050578 Alternative Pathway C3 C5 Convertases
% 215.26/215.45  |- skos__broader mesh__D050578smesh__D050577
% 215.26/215.45  |- mesh__publicMeSHNote mesh__D050578 2006   
% 215.26/215.45  |- mesh__recordAuthorizer mesh__D050578 sjn
% 215.26/215.45  |- mesh__dateEstablished mesh__D050578 2006-01-01
% 215.26/215.45  |- skos__prefLabel mesh__D050578
% 215.26/215.45       Complement C3-C5 Convertases, Alternative Pathway
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D050578 2006
% 215.26/215.45  |- rdf__type mesh__D050578sskos__Concept
% 215.26/215.45  |- skos__historyNote mesh__D050578 Complement C3 %28%1976-2005%29%
% 215.26/215.45  |- skos__historyNote mesh__D050578 Complement C5 %28%1976-2005%29%
% 215.26/215.45  |- mesh__recordMaintainer mesh__D050578 lkt
% 215.26/215.45  |- mesh__recordOriginator mesh__D003124 NLM
% 215.26/215.45  |- skos__broader mesh__D003124smesh__D017186
% 215.26/215.45  |- skos__scopeNote mesh__D003124
% 215.26/215.45       Any technique by which an unknown color is evaluated in terms of standard colors. The technique may be visual, photoelectric, or indirect by means of spectrophotometry. It is used in chemistry and physics. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 215.26/215.45  |- mesh__recordMaintainer mesh__D003124 lkt
% 215.26/215.45  |- mesh__dateRevised mesh__D003124 2002-07-03
% 215.26/215.45  |- skos__annotation mesh__D003124 an anal chem technique; NIM   
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D003124 2004
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D003124 2006
% 215.26/215.45  |- skos__prefLabel mesh__D003124 Colorimetry
% 215.26/215.45  |- mesh__dateCreated mesh__D003124 1999-01-01
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D003124 2003
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D003124 2005
% 215.26/215.45  |- mesh__recordAuthorizer mesh__D003124 sjn
% 215.26/215.45  |- rdf__type mesh__D003124sskos__Concept
% 215.26/215.45  |- mesh__recordMaintainer mesh__D013552 ags
% 215.26/215.45  |- mesh__activeMeSHYear mesh__D013552 2004
% 215.26/215.45  |- rdf__type mesh__D013552sskos__Concept
% 215.26/215.45  |- skos__altLabel mesh__D013552 Pigs
% 215.26/215.45  |- skos__altLabel mesh__D013552 Suidae
% 215.26/215.45  |- skos__hiddenLabel mesh__D013552 Hogs, Wart
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D013552 2006
% 215.26/215.46  |- skos__altLabel mesh__D013552 Phacochoerus
% 215.26/215.46  |- mesh__considerAlso mesh__D013552
% 215.26/215.46       consider also terms at HOG and PORCINE   
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D013552 2005
% 215.26/215.46  |- mesh__recordAuthorizer mesh__D013552 sjn
% 215.26/215.46  |- skos__prefLabel mesh__D013552 Swine
% 215.26/215.46  |- skos__broader mesh__D013552smesh__D001188
% 215.26/215.46  |- skos__scopeNote mesh__D013552
% 215.26/215.46       Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus %28%wart hogs%29%, and Sus, the latter containing the domestic pig %28%see SUS SCROFA%29%.%A%    
% 215.26/215.46  |- skos__hiddenLabel mesh__D013552 Hog, Wart
% 215.26/215.46  |- mesh__recordOriginator mesh__D013552 NLM
% 215.26/215.46  |- mesh__dateCreated mesh__D013552 1999-01-01
% 215.26/215.46  |- skos__annotation mesh__D013552
% 215.26/215.46       includes boars %26% wart hogs; PIG, DOMESTIC see SUS SCROFA is available; unspecified swine or pigs goes here%A%  
% 215.26/215.46  |- skos__hiddenLabel mesh__D013552 Wart Hog
% 215.26/215.46  |- skos__altLabel mesh__D013552 Wart Hogs
% 215.26/215.46  |- mesh__dateRevised mesh__D013552 2003-07-09
% 215.26/215.46  |- rdf__type mesh__D007515sskos__Concept
% 215.26/215.46  |- mesh__publicMeSHNote mesh__D007515
% 215.26/215.46       91; was ISLANDS OF LANGERHANS 1963-90   
% 215.26/215.46  |- skos__scopeNote mesh__D007515
% 215.26/215.46       Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini.  Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells %28%50-80%25%%29% secrete INSULIN. Alpha cells %28%5-20%25%%29% secrete GLUCAGON. PP cells %28%10-35%25%%29% secrete PANCREATIC POLYPEPTIDE. Delta cells %28%%7E%5%25%%29% secrete SOMATOSTATIN.%A%    
% 215.26/215.46  |- skos__broader mesh__D007515smesh__D004702
% 215.26/215.46  |- skos__altLabel mesh__D007515 Islands of Langerhans
% 215.26/215.46  |- skos__altLabel mesh__D007515 Pancreas, Endocrine
% 215.26/215.46  |- skos__hiddenLabel mesh__D007515 Langerhans Islets
% 215.26/215.46  |- skos__hiddenLabel mesh__D007515 Langerhans Islands
% 215.26/215.46  |- skos__hiddenLabel mesh__D007515 Cells, Islet
% 215.26/215.46  |- mesh__recordMaintainer mesh__D007515 lkt
% 215.26/215.46  |- skos__altLabel mesh__D007515 Pancreatic Islets
% 215.26/215.46  |- skos__hiddenLabel mesh__D007515 Pancreatic Islet
% 215.26/215.46  |- skos__hiddenLabel mesh__D007515 Islets, Pancreatic
% 215.26/215.46  |- skos__broader mesh__D007515smesh__D010179
% 215.26/215.46  |- skos__annotation mesh__D007515
% 215.26/215.46       do not confuse with LANGERHANS CELLS %28%skin%29%; neoplasms = ADENOMA, ISLET CELL or CARCINOMA, ISLET CELL or their specifics%A%  
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D007515 2006
% 215.26/215.46  |- mesh__dateRevised mesh__D007515 2005-06-30
% 215.26/215.46  |- skos__hiddenLabel mesh__D007515 Endocrine Pancreas
% 215.26/215.46  |- mesh__recordAuthorizer mesh__D007515 sjn
% 215.26/215.46  |- skos__prefLabel mesh__D007515 Islets of Langerhans
% 215.26/215.46  |- skos__hiddenLabel mesh__D007515 Nesidioblast
% 215.26/215.46  |- skos__hiddenLabel mesh__D007515 Islet Cell
% 215.26/215.46  |- skos__hiddenLabel mesh__D007515 Cell, Islet
% 215.26/215.46  |- mesh__dateCreated mesh__D007515 1999-01-01
% 215.26/215.46  |- mesh__recordOriginator mesh__D007515 NLM
% 215.26/215.46  |- skos__altLabel mesh__D007515 Nesidioblasts
% 215.26/215.46  |- mesh__historyNote mesh__D007515 91; was ISLANDS OF LANGERHANS 1963-90   
% 215.26/215.46  |- mesh__onlineNote mesh__D007515
% 215.26/215.46       use ISLETS OF LANGERHANS to search ISLANDS OF LANGERHANS 1966-90%A%  
% 215.26/215.46  |- skos__hiddenLabel mesh__D007515 Islet, Pancreatic
% 215.26/215.46  |- skos__altLabel mesh__D007515 Islet Cells
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017943 2002
% 215.26/215.46  |- mesh__historyNote mesh__D017943 94   
% 215.26/215.46  |- mesh__dateCreated mesh__D017943 1993-06-04
% 215.26/215.46  |- skos__hiddenLabel mesh__D017943 Cardioviruses
% 215.26/215.46  |- mesh__recordOriginator mesh__D017943 AGS
% 215.26/215.46  |- skos__historyNote mesh__D017943
% 215.26/215.46       Encephalomyocarditis Virus %28%1972-1993%29%
% 215.26/215.46  |- mesh__publicMeSHNote mesh__D017943 94   
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017943 2004
% 215.26/215.46  |- skos__annotation mesh__D017943
% 215.26/215.46       a genus of the family Picornaviridae; infection = CARDIOVIRUS INFECTIONS%A%  
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017943 1997
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017943 2003
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017943 2001
% 215.26/215.46  |- skos__broader mesh__D017943smesh__D010849
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017943 2006
% 215.26/215.46  |- skos__historyNote mesh__D017943 Picornaviridae %28%1978-1993%29%
% 215.26/215.46  |- skos__prefLabel mesh__D017943 Cardiovirus
% 215.26/215.46  |- rdf__type mesh__D017943sskos__Concept
% 215.26/215.46  |- mesh__recordMaintainer mesh__D017943 AGS
% 215.26/215.46  |- mesh__recordAuthorizer mesh__D017943 PLS
% 215.26/215.46  |- skos__scopeNote mesh__D017943
% 215.26/215.46       A genus of the family PICORNAVIRIDAE causing encephalitis and myocarditis in rodents. ENCEPHALOMYOCARDITIS VIRUS is the type species.%A%    
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017943 2000
% 215.26/215.46  |- mesh__dateRevised mesh__D017943 1996-06-10
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017943 1999
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017943 2005
% 215.26/215.46  |- mesh__dateEstablished mesh__D017943 1994-01-01
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017943 1998
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017145 2000
% 215.26/215.46  |- mesh__historyNote mesh__D017145 93   
% 215.26/215.46  |- skos__annotation mesh__D017145
% 215.26/215.46       no qualif; TN 128: application of MODELS, THEORETICAL; DF: MODELS EDUC%A%  
% 215.26/215.46  |- mesh__dateCreated mesh__D017145 1992-05-22
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017145 2006
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017145 1996
% 215.26/215.46  |- skos__historyNote mesh__D017145 Teaching %28%1966-1992%29%
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017145 1995
% 215.26/215.46  |- skos__altLabel mesh__D017145 Instructional Models
% 215.26/215.46  |- skos__hiddenLabel mesh__D017145 Instructional Model
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017145 2005
% 215.26/215.46  |- mesh__publicMeSHNote mesh__D017145 93   
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017145 1994
% 215.26/215.46  |- skos__altLabel mesh__D017145 Educational Models
% 215.26/215.46  |- skos__hiddenLabel mesh__D017145 Educational Model
% 215.26/215.46  |- skos__hiddenLabel mesh__D017145 Model, Educational
% 215.26/215.46  |- skos__prefLabel mesh__D017145 Models, Educational
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017145 2004
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017145 1999
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017145 2002
% 215.26/215.46  |- skos__scopeNote mesh__D017145
% 215.26/215.46       Theoretical models which propose methods of learning or teaching as a basis or adjunct to changes in attitude or behavior. These educational interventions are usually applied in the fields of health and patient education but are not restricted to patient care.%A%    
% 215.26/215.46  |- rdf__type mesh__D017145sskos__Concept
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017145 1993
% 215.26/215.46  |- skos__hiddenLabel mesh__D017145 Model, Instructional
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017145 2003
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017145 1998
% 215.26/215.46  |- mesh__dateEstablished mesh__D017145 1993-01-01
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017145 2001
% 215.26/215.46  |- skos__hiddenLabel mesh__D017145 Models, Instructional
% 215.26/215.46  |- skos__broader mesh__D017145smesh__D008962
% 215.26/215.46  |- skos__historyNote mesh__D017145 Models, Theoretical %28%1968-1992%29%
% 215.26/215.46  |- skos__broader mesh__D017145smesh__D013663
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017145 1997
% 215.26/215.46  |- mesh__dateRevised mesh__D003923 2004-07-19
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D003923 2006
% 215.26/215.46  |- skos__hiddenLabel mesh__D003923 Congenital Lipoatrophic Diabetes
% 215.26/215.46  |- skos__altLabel mesh__D003923 Lipoatrophic Diabetes
% 215.26/215.46  |- mesh__historyNote mesh__D003923 79   
% 215.26/215.46  |- skos__prefLabel mesh__D003923 Diabetes Mellitus, Lipoatrophic
% 215.26/215.46  |- mesh__recordMaintainer mesh__D003923 lkt
% 215.26/215.46  |- mesh__dateEstablished mesh__D003923 1979-01-01
% 215.26/215.46  |- skos__altLabel mesh__D003923 Koberling-Dunnigan Syndrome
% 215.26/215.46  |- rdf__type mesh__D003923sskos__Concept
% 215.26/215.46  |- skos__broader mesh__D003923smesh__D003924
% 215.26/215.46  |- skos__hiddenLabel mesh__D003923
% 215.26/215.46       Berardinelli Seip Congenital Lipodystrophy
% 215.26/215.46  |- skos__hiddenLabel mesh__D003923 Partial Lipodystrophy, Familial
% 215.26/215.46  |- skos__broader mesh__D003923smesh__D008060
% 215.26/215.46  |- skos__hiddenLabel mesh__D003923 Koberling Dunnigan Syndrome
% 215.26/215.46  |- skos__hiddenLabel mesh__D003923 Syndrome, Koberling-Dunnigan
% 215.26/215.46  |- skos__altLabel mesh__D003923 Berardinelli-Seip Congenital Lipodystrophy
% 215.26/215.46  |- skos__historyNote mesh__D003923 Diabetes Mellitus %28%1966-1978%29%
% 215.26/215.46  |- skos__hiddenLabel mesh__D003923 Syndrome, Dunnigan
% 215.26/215.46  |- mesh__recordOriginator mesh__D003923 VDK
% 215.26/215.46  |- skos__hiddenLabel mesh__D003923
% 215.26/215.46       Lipodystrophy, Berardinelli-Seip Congenital
% 215.26/215.46  |- mesh__dateCreated mesh__D003923 1978-05-19
% 215.26/215.46  |- skos__hiddenLabel mesh__D003923 Familial Partial Lipodystrophy
% 215.26/215.46  |- skos__hiddenLabel mesh__D003923 Diabetes, Congenital Lipoatrophic
% 215.26/215.46  |- skos__hiddenLabel mesh__D003923 Lipoatrophic Diabetes Mellitus
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D003923 2005
% 215.26/215.46  |- skos__historyNote mesh__D003923 Lipodystrophy %28%1966-1978%29%
% 215.26/215.46  |- skos__hiddenLabel mesh__D003923
% 215.26/215.46       Congenital Lipodystrophy, Berardinelli-Seip
% 215.26/215.46  |- mesh__publicMeSHNote mesh__D003923 79   
% 215.26/215.46  |- mesh__recordAuthorizer mesh__D003923 sjn
% 215.26/215.46  |- skos__scopeNote mesh__D003923
% 215.26/215.46       A type of diabetes mellitus that is characterized by a paucity of adipose tissue %28%LIPODYSTROPHY%29% and severe INSULIN RESISTANCE. There are several forms involving any one of a number of genes encoding nuclear protein LAMIN TYPE A; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; or other proteins.%A%    
% 215.26/215.46  |- skos__altLabel mesh__D003923 Lipoatrophic Diabetes, Congenital
% 215.26/215.46  |- skos__altLabel mesh__D003923 Dunnigan Syndrome
% 215.26/215.46  |- skos__hiddenLabel mesh__D003923 Partial Lipodystrophies, Familial
% 215.26/215.46  |- skos__broader mesh__D050579smesh__D050577
% 215.26/215.46  |- skos__scopeNote mesh__D050579
% 215.26/215.46       Important enzymes in the CLASSICAL COMPLEMENT ACTIVATION PATHWAY. They cleave COMPLEMENT C3 and COMPLEMENT C5.%A%    
% 215.26/215.46  |- skos__hiddenLabel mesh__D050579 Classical Pathway C3 C5 Convertases
% 215.26/215.46  |- skos__prefLabel mesh__D050579
% 215.26/215.46       Complement C3-C5 Convertases, Classical Pathway
% 215.26/215.46  |- skos__altLabel mesh__D050579 Classical Pathway C3-C5 Convertases
% 215.26/215.46  |- mesh__recordOriginator mesh__D050579 lkt
% 215.26/215.46  |- mesh__dateEstablished mesh__D050579 2006-01-01
% 215.26/215.46  |- mesh__publicMeSHNote mesh__D050579 2006   
% 215.26/215.46  |- mesh__recordMaintainer mesh__D050579 lkt
% 215.26/215.46  |- skos__hiddenLabel mesh__D050579
% 215.26/215.46       Complement C3 C5 Convertases, Classical Pathway
% 215.26/215.46  |- mesh__historyNote mesh__D050579 2006   
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D050579 2006
% 215.26/215.46  |- mesh__dateCreated mesh__D050579 2005-06-30
% 215.26/215.46  |- skos__historyNote mesh__D050579 Complement C3 %28%1976-2005%29%
% 215.26/215.46  |- skos__historyNote mesh__D050579 Complement C5 %28%1976-2005%29%
% 215.26/215.46  |- rdf__type mesh__D050579sskos__Concept
% 215.26/215.46  |- mesh__recordAuthorizer mesh__D050579 sjn
% 215.26/215.46  |- skos__hiddenLabel mesh__D003125 Colostomies
% 215.26/215.46  |- skos__broader mesh__D003125smesh__D004766
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D003125 2004
% 215.26/215.46  |- mesh__dateRevised mesh__D003125 1997-06-20
% 215.26/215.46  |- mesh__historyNote mesh__D003125
% 215.26/215.46       ANUS, ARTIFICIAL was see COLOSTOMY 1975-97   
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D003125 2000
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D003125 1998
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D003125 2006
% 215.26/215.46  |- mesh__recordMaintainer mesh__D003125 PXP
% 215.26/215.46  |- mesh__publicMeSHNote mesh__D003125
% 215.26/215.46       ANUS, ARTIFICIAL was see COLOSTOMY 1975-97   
% 215.26/215.46  |- mesh__dateCreated mesh__D003125 1999-01-01
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D003125 2003
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D003125 2005
% 215.26/215.46  |- mesh__recordOriginator mesh__D003125 NLM
% 215.26/215.46  |- mesh__recordAuthorizer mesh__D003125 SJN
% 215.26/215.46  |- skos__prefLabel mesh__D003125 Colostomy
% 215.26/215.46  |- rdf__type mesh__D003125sskos__Concept
% 215.26/215.46  |- skos__annotation mesh__D003125
% 215.26/215.46       do not use /util except by MeSH definition   
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D003125 2002
% 215.26/215.46  |- skos__scopeNote mesh__D003125
% 215.26/215.46       The surgical creation of an opening between the colon and the surface of the body. %28%From Dorland, 28th ed%29%%A%    
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D003125 2001
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D003125 1999
% 215.26/215.46  |- skos__broader mesh__D013553smesh__D000820
% 215.26/215.46  |- skos__scopeNote mesh__D013553
% 215.26/215.46       Diseases of domestic swine and of the wild boar of the genus Sus.%A%    
% 215.26/215.46  |- skos__hiddenLabel mesh__D013553 Disease, Swine
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D013553 2006
% 215.26/215.46  |- skos__hiddenLabel mesh__D013553 Swine Disease
% 215.26/215.46  |- skos__prefLabel mesh__D013553 Swine Diseases
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D013553 2005
% 215.26/215.46  |- mesh__dateCreated mesh__D013553 1999-01-01
% 215.26/215.46  |- skos__hiddenLabel mesh__D013553 Diseases, Swine
% 215.26/215.46  |- skos__annotation mesh__D013553
% 215.26/215.46       IM GEN or unspecified; coord IM with specific dis /vet %28%IM%29% or specific swine dis %28%IM%29%; for abnormalities or injuries, index under SWINE /abnorm or SWINE /inj; don%27%t forget also SWINE %28%NIM%29% %26% check tag ANIMALS; swine fever %26% swine plague = CLASSICAL SWINE FEVER; DF: SWINE DIS%A%  
% 215.26/215.46  |- mesh__dateRevised mesh__D013553 2003-07-30
% 215.26/215.46  |- mesh__recordMaintainer mesh__D013553 ags
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D013553 2004
% 215.26/215.46  |- mesh__recordAuthorizer mesh__D013553 sjn
% 215.26/215.46  |- rdf__type mesh__D013553sskos__Concept
% 215.26/215.46  |- mesh__recordOriginator mesh__D013553 NLM
% 215.26/215.46  |- mesh__recordOriginator mesh__D007516 NLM
% 215.26/215.46  |- skos__hiddenLabel mesh__D007516 Islet Cell Adenomas
% 215.26/215.46  |- skos__broader mesh__D007516smesh__D000236
% 215.26/215.46  |- skos__hiddenLabel mesh__D007516 Adenomas, Islet Cell
% 215.26/215.46  |- mesh__dateRevised mesh__D007516 2004-07-07
% 215.26/215.46  |- skos__hiddenLabel mesh__D007516 Island Cell Tumors
% 215.26/215.46  |- mesh__historyNote mesh__D007516 94; was ISLET CELL TUMOR 1963-93   
% 215.26/215.46  |- skos__broader mesh__D007516smesh__D010190
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D007516 2006
% 215.26/215.46  |- skos__altLabel mesh__D007516 Island Cell Tumor
% 215.26/215.46  |- skos__altLabel mesh__D007516 Nesidioblastoma
% 215.26/215.46  |- mesh__recordMaintainer mesh__D007516 lkt
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D007516 2005
% 215.26/215.46  |- skos__hiddenLabel mesh__D007516 Tumor, Islet Cell
% 215.26/215.46  |- mesh__publicMeSHNote mesh__D007516 94; was ISLET CELL TUMOR 1963-93   
% 215.26/215.46  |- mesh__dateCreated mesh__D007516 1999-01-01
% 215.26/215.46  |- skos__hiddenLabel mesh__D007516 Islet Cell Adenoma
% 215.26/215.46  |- skos__hiddenLabel mesh__D007516 Tumors, Island Cell
% 215.26/215.46  |- rdf__type mesh__D007516sskos__Concept
% 215.26/215.46  |- skos__scopeNote mesh__D007516
% 215.26/215.46       A benign tumor of the pancreatic ISLET CELLS. Usually it involves the INSULIN-producing PANCREATIC BETA CELLS, as in INSULINOMA, resulting in HYPERINSULINISM.%A%    
% 215.26/215.46  |- mesh__recordAuthorizer mesh__D007516 sjn
% 215.26/215.46  |- skos__hiddenLabel mesh__D007516 Tumors, Islet Cell
% 215.26/215.46  |- skos__hiddenLabel mesh__D007516 Tumor, Island Cell
% 215.26/215.46  |- skos__prefLabel mesh__D007516 Adenoma, Islet Cell
% 215.26/215.46  |- skos__annotation mesh__D007516
% 215.26/215.46       coord IM with PANCREATIC NEOPLASMS %28%IM%29%; ALPHA-CELL TUMOR see GLUCAGONOMA; BETA-CELL TUMOR see INSULINOMA and pancreatic delta-cell tumor see SOMATOSTATINOMA%A%  
% 215.26/215.46  |- mesh__onlineNote mesh__D007516
% 215.26/215.46       use ADENOMA, ISLET CELL to search ISLET CELL TUMOR 1966-93%A%  
% 215.26/215.46  |- skos__hiddenLabel mesh__D007516 Islet Cell Tumors
% 215.26/215.46  |- mesh__recordMaintainer mesh__D051672 DRC
% 215.26/215.46  |- skos__hiddenLabel mesh__D051672 Potassium Channel, KCND3
% 215.26/215.46  |- skos__scopeNote mesh__D051672
% 215.26/215.46       A shaker subfamily of potassium channels that participate in transient outward potassium currents by activating at subthreshold MEMBRANE POTENTIALS, inactivating rapidly, and recovering from inactivation quickly.%A%    
% 215.26/215.46  |- mesh__dateCreated mesh__D051672 2005-06-30
% 215.26/215.46  |- mesh__publicMeSHNote mesh__D051672
% 215.26/215.46       2006; SHAL POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1994-2004, %26% under INSECT HORMONES 1990-1993%A%  
% 215.26/215.46  |- skos__altLabel mesh__D051672 Kv4 Potassium Channels
% 215.26/215.46  |- skos__hiddenLabel mesh__D051672 Potassium Channel, Kv4.3
% 215.26/215.46  |- skos__prefLabel mesh__D051672 Shal Potassium Channels
% 215.26/215.46  |- skos__hiddenLabel mesh__D051672 Potassium Channel, Kv4.2
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D051672 2006
% 215.26/215.46  |- mesh__recordOriginator mesh__D051672 DRC
% 215.26/215.46  |- mesh__recordAuthorizer mesh__D051672 sjn
% 215.26/215.46  |- skos__altLabel mesh__D051672 KCND2 Potassium Channel
% 215.26/215.46  |- skos__hiddenLabel mesh__D051672 Potassium Channels, Kv4
% 215.26/215.46  |- skos__broader mesh__D051672smesh__D051637
% 215.26/215.46  |- mesh__historyNote mesh__D051672 2006%28%1990%29%   
% 215.26/215.46  |- mesh__dateEstablished mesh__D051672 2006-01-01
% 215.26/215.46  |- skos__hiddenLabel mesh__D051672 Potassium Channel, KCND2
% 215.26/215.46  |- skos__hiddenLabel mesh__D051672 Potassium Channels, Shal
% 215.26/215.46  |- skos__hiddenLabel mesh__D051672 Potassium Channel, Kv4.3L
% 215.26/215.46  |- rdf__type mesh__D051672sskos__Concept
% 215.26/215.46  |- skos__altLabel mesh__D051672 KCND1 Potassium Channel
% 215.26/215.46  |- skos__hiddenLabel mesh__D051672 Potassium Channel, Kv4.1
% 215.26/215.46  |- skos__altLabel mesh__D051672 KCND3 Potassium Channel
% 215.26/215.46  |- skos__hiddenLabel mesh__D051672 Potassium Channel, KCND1
% 215.26/215.46  |- mesh__dateEstablished mesh__D023981 2002-01-01
% 215.26/215.46  |- skos__prefLabel mesh__D023981 Sarcoma, Granulocytic
% 215.26/215.46  |- mesh__publicMeSHNote mesh__D023981 2002   
% 215.26/215.46  |- skos__broader mesh__D023981smesh__D012509
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D023981 2005
% 215.26/215.46  |- skos__hiddenLabel mesh__D023981 Chloromas
% 215.26/215.46  |- skos__altLabel mesh__D023981 Chloroma
% 215.26/215.46  |- skos__hiddenLabel mesh__D023981 Granulocytic Sarcoma
% 215.26/215.46  |- skos__altLabel mesh__D023981 Extramedullary Myeloid Cell Tumor
% 215.26/215.46  |- skos__broader mesh__D023981smesh__D007951
% 215.26/215.46  |- skos__related mesh__D023981smesh__D007950
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D023981 2006
% 215.26/215.46  |- skos__altLabel mesh__D023981 Myeloid Cell Tumor, Extramedullary
% 215.26/215.46  |- mesh__historyNote mesh__D023981 2002   
% 215.26/215.46  |- skos__historyNote mesh__D023981 Leukemia, Myeloid %28%1966-2001%29%
% 215.26/215.46  |- skos__hiddenLabel mesh__D023981 Sarcomas, Granulocytic
% 215.26/215.46  |- skos__hiddenLabel mesh__D023981 Granulocytic Sarcomas
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D023981 2003
% 215.26/215.46  |- mesh__dateCreated mesh__D023981 2001-07-25
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D023981 2004
% 215.26/215.46  |- rdf__type mesh__D023981sskos__Concept
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D023981 2002
% 215.26/215.46  |- skos__scopeNote mesh__D023981
% 215.26/215.46       An extramedullary tumor of immature myeloid cells. Granulocytic sarcoma usually occurs with or follows the onset of acute myeloid leukemia %28%LEUKEMIA, MYELOCYTIC, ACUTE%29%.%A%    
% 215.26/215.46  |- mesh__dateEstablished mesh__D017944 1994-01-01
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017944 2003
% 215.26/215.46  |- mesh__recordMaintainer mesh__D017944 ags
% 215.26/215.46  |- mesh__publicMeSHNote mesh__D017944
% 215.26/215.46       94; was COLUMBIA-SK VIRUSES see ENCEPHALOMYOCARDITIS VIRUSES 1979-93; was see under ENCEPHALOMYOCARDITIS VIRUSES 1965-78%A%  
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017944 2006
% 215.26/215.46  |- rdf__type mesh__D017944sskos__Concept
% 215.26/215.46  |- skos__hiddenLabel mesh__D017944 Columbia SK Viruses
% 215.26/215.46  |- skos__altLabel mesh__D017944 Columbia-SK Viruses
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017944 2005
% 215.26/215.46  |- mesh__recordAuthorizer mesh__D017944 sjn
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017944 2002
% 215.26/215.46  |- mesh__dateCreated mesh__D017944 1993-06-30
% 215.26/215.46  |- skos__prefLabel mesh__D017944 Columbia SK virus
% 215.26/215.46  |- skos__annotation mesh__D017944
% 215.26/215.46       infection: coord IM with CARDIOVIRUS INFECTIONS %28%IM%29%   
% 215.26/215.46  |- mesh__recordOriginator mesh__D017944 AGS
% 215.26/215.46  |- skos__broader mesh__D017944smesh__D004686
% 215.26/215.46  |- mesh__onlineNote mesh__D017944
% 215.26/215.46       use ENCEPHALOMYOCARDITIS VIRUS to search COLUMBIA-SK VIRUSES 1966-93%A%  
% 215.26/215.46  |- skos__scopeNote mesh__D017944
% 215.26/215.46       A strain of ENCEPHALOMYOCARDITIS VIRUS, a species of CARDIOVIRUS, that infects rodents.%A%    
% 215.26/215.46  |- mesh__historyNote mesh__D017944
% 215.26/215.46       94; was COLUMBIA-SK VIRUSES see ENCEPHALOMYOCARDITIS VIRUSES 1979-93; was see under ENCEPHALOMYOCARDITIS VIRUSES 1965-78%A%  
% 215.26/215.46  |- mesh__dateRevised mesh__D017944 2001-07-25
% 215.26/215.46  |- skos__hiddenLabel mesh__D017944 SK virus, Columbia
% 215.26/215.46  |- skos__historyNote mesh__D017944
% 215.26/215.46       Encephalomyocarditis Virus %28%1979-1993%29%
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017944 2004
% 215.26/215.46  |- mesh__historyNote mesh__D017146 93   
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017146 2000
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017146 2006
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017146 2001
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017146 1995
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017146 2003
% 215.26/215.46  |- mesh__dateEstablished mesh__D017146 1993-01-01
% 215.26/215.46  |- skos__altLabel mesh__D017146 Organizational Models
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017146 1998
% 215.26/215.46  |- skos__broader mesh__D017146smesh__D009934
% 215.26/215.46  |- skos__hiddenLabel mesh__D017146 Model, Organizational
% 215.26/215.46  |- skos__broader mesh__D017146smesh__D008962
% 215.26/215.46  |- mesh__dateCreated mesh__D017146 1992-05-22
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017146 2004
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017146 1999
% 215.26/215.46  |- skos__annotation mesh__D017146
% 215.26/215.46       no qualif; TN 128: application of MODELS, THEORETICAL; DF: MODELS ORGAN%A%  
% 215.26/215.46  |- skos__hiddenLabel mesh__D017146 Organizational Model
% 215.26/215.46  |- rdf__type mesh__D017146sskos__Concept
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017146 2002
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017146 1993
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017146 1996
% 215.26/215.46  |- mesh__publicMeSHNote mesh__D017146 93   
% 215.26/215.46  |- skos__scopeNote mesh__D017146
% 215.26/215.46       Theoretical representations and constructs that describe or explain the structure and hierarchy of relationships and interactions within or between formal organizational entities or informal social groups.%A%    
% 215.26/215.46  |- skos__historyNote mesh__D017146 Models, Theoretical %28%1968-1992%29%
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017146 2005
% 215.26/215.46  |- skos__prefLabel mesh__D017146 Models, Organizational
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017146 1997
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D017146 1994
% 215.26/215.46  |- skos__hiddenLabel mesh__D003924 Non-Insulin-Dependent Diabetes Mellitus
% 215.26/215.46  |- skos__hiddenLabel mesh__D003924 Slow-Onset Diabetes Mellitus
% 215.26/215.46  |- skos__altLabel mesh__D003924 Diabetes Mellitus, Type II
% 215.26/215.46  |- skos__altLabel mesh__D003924 Type 2 Diabetes Mellitus
% 215.26/215.46  |- skos__hiddenLabel mesh__D003924 Ketosis-Resistant Diabetes Mellitus
% 215.26/215.46  |- skos__hiddenLabel mesh__D003924 Diabetes Mellitus, Adult Onset
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D003924 2005
% 215.26/215.46  |- skos__hiddenLabel mesh__D003924 Diabetes Mellitus, Maturity Onset
% 215.26/215.46  |- skos__altLabel mesh__D003924 Diabetes Mellitus, Noninsulin Dependent
% 215.26/215.46  |- mesh__dateEstablished mesh__D003924 1984-01-01
% 215.26/215.46  |- skos__altLabel mesh__D003924 Diabetes Mellitus, Stable
% 215.26/215.46  |- skos__altLabel mesh__D003924 Diabetes Mellitus, Non Insulin Dependent
% 215.26/215.46  |- skos__hiddenLabel mesh__D003924 Diabetes Mellitus, Slow Onset
% 215.26/215.46  |- skos__hiddenLabel mesh__D003924 Maturity Onset Diabetes Mellitus
% 215.26/215.46  |- skos__broader mesh__D003924smesh__D003920
% 215.26/215.46  |- mesh__dateCreated mesh__D003924 1983-04-05
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D003924 2006
% 215.26/215.46  |- skos__altLabel mesh__D003924 MODY
% 215.26/215.46  |- skos__hiddenLabel mesh__D003924 Adult-Onset Diabetes Mellitus
% 215.26/215.46  |- skos__scopeNote mesh__D003924
% 215.26/215.46       A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent %28%NIDDM%29%. It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.%A%    
% 215.26/215.46  |- skos__hiddenLabel mesh__D003924 Diabetes Mellitus, Ketosis Resistant
% 215.26/215.46  |- mesh__publicMeSHNote mesh__D003924
% 215.26/215.46       2005; see DIABETES MELLITUS, TYPE I 2004, see DIABETES MELLITUS, NON-INSULIN-DEPENDENT 1984-2003%A%  
% 215.26/215.46  |- skos__related mesh__D003924smesh__D024821
% 215.26/215.46  |- mesh__dateRevised mesh__D003924 2004-07-07
% 215.26/215.46  |- rdf__type mesh__D003924sskos__Concept
% 215.26/215.46  |- skos__historyNote mesh__D003924 Diabetes Mellitus %28%1966-1983%29%
% 215.26/215.46  |- skos__altLabel mesh__D003924 Maturity-Onset Diabetes Mellitus
% 215.26/215.46  |- skos__altLabel mesh__D003924 Diabetes Mellitus, Non-Insulin-Dependent
% 215.26/215.46  |- skos__altLabel mesh__D003924 Diabetes Mellitus, Slow-Onset
% 215.26/215.46  |- skos__prefLabel mesh__D003924 Diabetes Mellitus, Type 2
% 215.26/215.46  |- skos__related mesh__D003924smesh__D020334
% 215.26/215.46  |- skos__altLabel mesh__D003924 NIDDM
% 215.26/215.46  |- skos__altLabel mesh__D003924 Diabetes Mellitus, Ketosis-Resistant
% 215.26/215.46  |- mesh__recordMaintainer mesh__D003924 lkt
% 215.26/215.46  |- mesh__recordOriginator mesh__D003924 VDK
% 215.26/215.46  |- mesh__historyNote mesh__D003924 2005 %28%1984%29%   
% 215.26/215.46  |- skos__hiddenLabel mesh__D003924 Stable Diabetes Mellitus
% 215.26/215.46  |- skos__altLabel mesh__D003924 Diabetes Mellitus, Adult-Onset
% 215.26/215.46  |- mesh__recordAuthorizer mesh__D003924 sjn
% 215.26/215.46  |- skos__altLabel mesh__D003924 Diabetes Mellitus, Maturity-Onset
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D003126 2006
% 215.26/215.46  |- mesh__dateCreated mesh__D003126 1999-01-01
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D003126 2003
% 215.26/215.46  |- skos__hiddenLabel mesh__D003126 Colostrums
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D003126 2001
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D003126 2005
% 215.26/215.46  |- skos__scopeNote mesh__D003126
% 215.26/215.46       The thin, yellow, serous fluid secreted by the mammary glands during pregnancy and immediately postpartum before lactation begins. It consists of immunologically active substances, white blood cells, water, protein, fat, and carbohydrates.%A%    
% 215.26/215.46  |- rdf__type mesh__D003126sskos__Concept
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D003126 2000
% 215.26/215.46  |- mesh__recordAuthorizer mesh__D003126 sjn
% 215.26/215.46  |- skos__broader mesh__D003126smesh__D012634
% 215.26/215.46  |- skos__annotation mesh__D003126 check the tags FEMALE %26% PREGNANCY   
% 215.26/215.46  |- mesh__recordOriginator mesh__D003126 NLM
% 215.26/215.46  |- mesh__dateRevised mesh__D003126 1999-11-03
% 215.26/215.46  |- mesh__recordMaintainer mesh__D003126 KEV
% 215.26/215.46  |- skos__prefLabel mesh__D003126 Colostrum
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D003126 2004
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D003126 2002
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D049228 2005
% 215.26/215.46  |- mesh__recordOriginator mesh__D049228 ags
% 215.26/215.46  |- skos__broader mesh__D049228smesh__D008331
% 215.26/215.46  |- mesh__recordAuthorizer mesh__D049228 jls
% 215.26/215.46  |- mesh__recordMaintainer mesh__D049228 jls
% 215.26/215.46  |- rdf__type mesh__D049228sskos__Concept
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D049228 2006
% 215.26/215.46  |- mesh__historyNote mesh__D049228 2005   
% 215.26/215.46  |- skos__prefLabel mesh__D049228 Healthcare Common Procedure Coding System
% 215.26/215.46  |- mesh__publicMeSHNote mesh__D049228 2005   
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D049228 2005A
% 215.26/215.46  |- mesh__dateRevised mesh__D049228 2004-11-19
% 215.26/215.46  |- mesh__dateEstablished mesh__D049228 2005-01-01
% 215.26/215.46  |- mesh__dateCreated mesh__D049228 2004-07-07
% 215.26/215.46  |- skos__broader mesh__D049228smesh__D018875
% 215.26/215.46  |- skos__scopeNote mesh__D049228
% 215.26/215.46       Uniform method for health care providers and medical suppliers to report professional services, procedures, and supplies. It consists of alphanumeric codes and modifiers for the use of all public and private health insurers. It is developed by the Centers for Medicare and Medicaid Services.%A%    
% 215.26/215.46  |- skos__altLabel mesh__D049228 HCPCS
% 215.26/215.46  |- skos__annotation mesh__D049228 CATALOG: use NAF entry   
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D013554 2005
% 215.26/215.46  |- skos__hiddenLabel mesh__D013554 Erysipelas, Swine
% 215.26/215.46  |- mesh__historyNote mesh__D013554
% 215.26/215.46       91%28%75%29%; was see under ERYSIPELOTHRIX INFECTIONS 1968-90; was see under ERYSIPELOID 1963-67%A%  
% 215.26/215.46  |- mesh__onlineNote mesh__D013554
% 215.26/215.46       search ERYSIPELOTHRIX INFECTIONS 1968-74 %26% ERYSIPELOID 1966-67%A%  
% 215.26/215.46  |- mesh__activeMeSHYear mesh__D013554 2006
% 215.26/215.46  |- mesh__dateCreated mesh__D013554 1999-01-01
% 215.26/215.46  |- mesh__recordAuthorizer mesh__D013554 sjn
% 215.26/215.46  |- mesh__recordOriginator mesh__D013554 NLM
% 215.26/215.46  |- mesh__dateRevised mesh__D013554 2003-07-30
% 215.26/215.47  |- skos__broader mesh__D013554smesh__D004889
% 215.26/215.47  |- mesh__dateEstablished mesh__D013554 1991-01-01
% 215.26/215.47  |- mesh__recordMaintainer mesh__D013554 ags
% 215.26/215.47  |- skos__scopeNote mesh__D013554
% 215.26/215.47       An acute and chronic contagious disease of young pigs caused by Erysipelothrix insidiosa.%A%    
% 215.26/215.47  |- skos__broader mesh__D013554smesh__D013553
% 215.26/215.47  |- mesh__publicMeSHNote mesh__D013554
% 215.26/215.47       91; was see under ERYSIPELOTHRIX INFECTIONS 1968-90; was see under ERYSIPELOID 1963-67%A%  
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D013554 2004
% 215.26/215.47  |- rdf__type mesh__D013554sskos__Concept
% 215.26/215.47  |- skos__annotation mesh__D013554
% 215.26/215.47       Erysipelothrix infect; don%27%t forget also SWINE %28%NIM%29% %26% check tag ANIMALS%A%  
% 215.26/215.47  |- skos__prefLabel mesh__D013554 Swine Erysipelas
% 215.26/215.47  |- skos__historyNote mesh__D007517 Polysaccharides %28%1974%29%
% 215.26/215.47  |- skos__broader mesh__D007517smesh__D006026
% 215.26/215.47  |- mesh__dateEstablished mesh__D007517 1991-01-01
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D007517 2004
% 215.26/215.47  |- mesh__dateCreated mesh__D007517 1974-11-19
% 215.26/215.47  |- mesh__historyNote mesh__D007517
% 215.26/215.47       91%28%75%29%; was see under GLYCOSIDE HYDROLASES 1975-90   
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D007517 2006
% 215.26/215.47  |- skos__historyNote mesh__D007517 Glycoside Hydrolases %28%1974%29%
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D007517 2005
% 215.26/215.47  |- skos__prefLabel mesh__D007517 Isoamylase
% 215.26/215.47  |- mesh__recordAuthorizer mesh__D007517 sjn
% 215.26/215.47  |- mesh__recordMaintainer mesh__D007517 ssb
% 215.26/215.47  |- skos__annotation mesh__D007517
% 215.26/215.47       do not confuse with amylase isoenzymes %28%index under AMYLASES %28%IM%29% + ISOENZYMES %28%IM%29% %29%%A%  
% 215.26/215.47  |- rdf__type mesh__D007517sskos__Concept
% 215.26/215.47  |- skos__scopeNote mesh__D007517
% 215.26/215.47       An enzyme that hydrolyzes 1,6-alpha-glucosidic branch linkages in glycogen, amylopectin, and their beta-limit dextrins. It is distinguished from pullulanase %28%EC 3.2.1.41%29% by its inability to attack pullulan and by the feeble action of alpha-limit dextrins. It is distinguished from amylopectin 6-glucanohydrolase %28%EC 3.2.1.69%29% by its action on glycogen. With EC 3.2.1.69, it produces the activity called %22%debranching enzyme%22%. EC 3.2.1.68.%A%    
% 215.26/215.47  |- mesh__recordOriginator mesh__D007517 NLM
% 215.26/215.47  |- mesh__publicMeSHNote mesh__D007517
% 215.26/215.47       91; was see under GLYCOSIDE HYDROLASES 1975-90   
% 215.26/215.47  |- mesh__dateRevised mesh__D007517 2003-07-09
% 215.26/215.47  |- mesh__dateRevised mesh__D017945 2004-07-13
% 215.26/215.47  |- mesh__dateEstablished mesh__D017945 1994-01-01
% 215.26/215.47  |- skos__altLabel mesh__D017945 Vilyuisk human encephalomyelitis virus
% 215.26/215.47  |- rdf__type mesh__D017945sskos__Concept
% 215.26/215.47  |- skos__altLabel mesh__D017945 Rat encephalomyelitis virus
% 215.26/215.47  |- skos__hiddenLabel mesh__D017945 Theilers Virus
% 215.26/215.47  |- skos__hiddenLabel mesh__D017945 Mouse Poliovirus
% 215.26/215.47  |- mesh__recordAuthorizer mesh__D017945 sjn
% 215.26/215.47  |- skos__altLabel mesh__D017945 Theiler%27%s murine encephalomyelitis virus
% 215.26/215.47  |- mesh__dateCreated mesh__D017945 1993-06-15
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D017945 2006
% 215.26/215.47  |- mesh__publicMeSHNote mesh__D017945
% 215.26/215.47       2002; see THEILER MURINE ENCEPHALOMYELITIS VIRUS 1999-2001, see THEILER%27%S MURINE ENCEPHALOMYELITIS VIRUS 1997-1998, see POLIOVIRUSES, MURINE 1994-1996; for THEILER%27%S VIRUS see ENCEPHALOMYELITIS VIRUS, MURINE 1992-1993%A%  
% 215.26/215.47  |- skos__altLabel mesh__D017945 TMEV
% 215.26/215.47  |- skos__broader mesh__D017945smesh__D017943
% 215.26/215.47  |- skos__historyNote mesh__D017945 Enterovirus %28%1975-1993%29%
% 215.26/215.47  |- skos__historyNote mesh__D017945
% 215.26/215.47       Encephalomyelitis Virus, Murine %28%1975-1993%29%
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D017945 2005
% 215.26/215.47  |- mesh__recordOriginator mesh__D017945 AGS
% 215.26/215.47  |- skos__hiddenLabel mesh__D017945 Theiloviruses
% 215.26/215.47  |- mesh__recordMaintainer mesh__D017945 sjn
% 215.26/215.47  |- skos__prefLabel mesh__D017945 Theilovirus
% 215.26/215.47  |- skos__altLabel mesh__D017945 Theilers Murine Encephalomyelitis Virus
% 215.26/215.47  |- skos__altLabel mesh__D017945 Theiler%27%s Virus
% 215.26/215.47  |- skos__scopeNote mesh__D017945
% 215.26/215.47       A species of CARDIOVIRUS which contains of three strains: Theiler%27%s murine encephalomyellitis virus, Vilyuisk human encephalomyelitis virus, and Rat encephalomyelitis virus.%A%    
% 215.26/215.47  |- skos__altLabel mesh__D017945 Mouse Polioviruses
% 215.26/215.47  |- skos__hiddenLabel mesh__D017945 Poliovirus, Mouse
% 215.26/215.47  |- skos__hiddenLabel mesh__D017945 Poliovirus, Murine
% 215.26/215.47  |- mesh__historyNote mesh__D017945
% 215.26/215.47       2002%28%1994%29%; for THEILER%27%S VIRUS use ENCEPHALOMYELITIS, MURINE 1992-1993%A%  
% 215.26/215.47  |- skos__altLabel mesh__D017945 Theiler Virus
% 215.26/215.47  |- skos__hiddenLabel mesh__D017945 Murine Poliovirus
% 215.26/215.47  |- skos__altLabel mesh__D017945 Theiler Murine Encephalomyelitis Virus
% 215.26/215.47  |- skos__altLabel mesh__D017945 Polioviruses, Murine
% 215.26/215.47  |- skos__annotation mesh__D017945
% 215.26/215.47       do not confuse x-Ref ENCEPHALOMYELITIS VIRUS, MURINE, THEILER with ENCEPHALOMYELITIS VIRUS, MURINE, also a Cardiovirus; infection: coord IM with CARDIOVIRUS INFECTIONS %28%IM%29% or POLIOMYELITIS %28%IM%29%; infection may also be a model for multiple sclerosis%A%  
% 215.26/215.47  |- skos__altLabel mesh__D017147 Implantable Cardioverter-Defibrillators
% 215.26/215.47  |- skos__prefLabel mesh__D017147 Defibrillators, Implantable
% 215.26/215.47  |- mesh__recordOriginator mesh__D017147 AGS
% 215.26/215.47  |- skos__broader mesh__D017147smesh__D047548
% 215.26/215.47  |- skos__hiddenLabel mesh__D017147 Implantable Defibrillator
% 215.26/215.47  |- skos__hiddenLabel mesh__D017147 Implantable Cardioverter-Defibrillator
% 215.26/215.47  |- skos__historyNote mesh__D017147
% 215.26/215.47       Electric Countershock/instrumentation %28%1980-1992%29%
% 215.26/215.47  |- skos__scopeNote mesh__D017147
% 215.26/215.47       Implantable devices which continuously monitor the electrical activity of the heart and automatically detect and terminate ventricular tachycardia %28%TACHYCARDIA, VENTRICULAR%29% and VENTRICULAR FIBRILLATION. They consist of an impulse generator, batteries, and electrodes.%A%    
% 215.26/215.47  |- mesh__dateRevised mesh__D017147 2004-07-07
% 215.26/215.47  |- skos__hiddenLabel mesh__D017147 Implantable Cardioverter Defibrillators
% 215.26/215.47  |- skos__broader mesh__D017147smesh__D019736
% 215.26/215.47  |- rdf__type mesh__D017147sskos__Concept
% 215.26/215.47  |- skos__broader mesh__D017147smesh__D004567
% 215.26/215.47  |- skos__hiddenLabel mesh__D017147 Cardioverter-Defibrillator, Implantable
% 215.26/215.47  |- skos__hiddenLabel mesh__D017147 Cardioverter Defibrillators, Implantable
% 215.26/215.47  |- mesh__dateEstablished mesh__D017147 1993-01-01
% 215.26/215.47  |- skos__historyNote mesh__D017147 Implants, Artificial %28%1982-1992%29%
% 215.26/215.47  |- mesh__dateCreated mesh__D017147 1992-05-20
% 215.26/215.47  |- skos__altLabel mesh__D017147 Cardioverter-Defibrillators, Implantable
% 215.26/215.47  |- skos__altLabel mesh__D017147 Implantable Defibrillators
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D017147 2005
% 215.26/215.47  |- mesh__recordMaintainer mesh__D017147 nns
% 215.26/215.47  |- skos__hiddenLabel mesh__D017147 Defibrillator, Implantable
% 215.26/215.47  |- skos__annotation mesh__D017147
% 215.26/215.47       coord dis with /ther, not /surg for treatment with this instrum%A%  
% 215.26/215.47  |- mesh__recordAuthorizer mesh__D017147 sjn
% 215.26/215.47  |- mesh__historyNote mesh__D017147 93   
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D017147 2006
% 215.26/215.47  |- mesh__publicMeSHNote mesh__D017147 93   
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D003925 2006
% 215.26/215.47  |- mesh__dateCreated mesh__D003925 1999-01-01
% 215.26/215.47  |- skos__hiddenLabel mesh__D003925 Vascular Complications, Diabetic
% 215.26/215.47  |- skos__hiddenLabel mesh__D003925 Diabetic Vascular Disease
% 215.26/215.47  |- skos__broader mesh__D003925smesh__D048909
% 215.26/215.47  |- skos__altLabel mesh__D003925 Diabetic Vascular Complications
% 215.26/215.47  |- mesh__recordOriginator mesh__D003925 NLM
% 215.26/215.47  |- mesh__dateRevised mesh__D003925 2004-07-07
% 215.26/215.47  |- skos__hiddenLabel mesh__D003925 Diabetic Microangiopathy
% 215.26/215.47  |- skos__prefLabel mesh__D003925 Diabetic Angiopathies
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D003925 2005
% 215.26/215.47  |- skos__annotation mesh__D003925
% 215.26/215.47       coord IM with specific vascular dis %28%IM%29% + specific type of diabetes%A%  
% 215.26/215.47  |- skos__hiddenLabel mesh__D003925 Diabetic Microangiopathies
% 215.26/215.47  |- rdf__type mesh__D003925sskos__Concept
% 215.26/215.47  |- skos__hiddenLabel mesh__D003925 Vascular Complication, Diabetic
% 215.26/215.47  |- skos__hiddenLabel mesh__D003925 Angiopathy, Diabetic
% 215.26/215.47  |- mesh__recordAuthorizer mesh__D003925 sjn
% 215.26/215.47  |- skos__scopeNote mesh__D003925
% 215.26/215.47       VASCULAR DISEASES that are associated with DIABETES MELLITUS.%A%    
% 215.26/215.47  |- skos__hiddenLabel mesh__D003925 Diabetic Angiopathy
% 215.26/215.47  |- skos__hiddenLabel mesh__D003925 Vascular Disease, Diabetic
% 215.26/215.47  |- skos__hiddenLabel mesh__D003925 Microangiopathies, Diabetic
% 215.26/215.47  |- skos__hiddenLabel mesh__D003925 Diabetic Vascular Complication
% 215.26/215.47  |- skos__hiddenLabel mesh__D003925 Vascular Diseases, Diabetic
% 215.26/215.47  |- skos__hiddenLabel mesh__D003925 Angiopathies, Diabetic
% 215.26/215.47  |- skos__altLabel mesh__D003925 Diabetic Vascular Diseases
% 215.26/215.47  |- skos__broader mesh__D003925smesh__D014652
% 215.26/215.47  |- mesh__recordMaintainer mesh__D003925 lkt
% 215.26/215.47  |- rdf__type mesh__D036301sskos__Concept
% 215.26/215.47  |- skos__prefLabel mesh__D036301 Qualitative Research
% 215.26/215.47  |- mesh__dateEstablished mesh__D036301 2003-01-01
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D036301 2004
% 215.26/215.47  |- skos__scopeNote mesh__D036301
% 215.26/215.47       Research that derives data from observation, interviews, or verbal interactions and focuses on the meanings and interpretations of the participants %28%From Holloway and Wheeler, %22%Ethical issues in qualitative nursing research,%22% Nursing Ethics, 1995 Sep; 2%28%3%29%: 223-232%29%.%A%    
% 215.26/215.47  |- skos__broader mesh__D036301smesh__D036262
% 215.26/215.47  |- mesh__publicMeSHNote mesh__D036301 2003   
% 215.26/215.47  |- mesh__historyNote mesh__D036301 2003   
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D036301 2003
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D036301 2006
% 215.26/215.47  |- mesh__dateCreated mesh__D036301 2002-07-03
% 215.26/215.47  |- skos__hiddenLabel mesh__D036301 Research, Qualitative
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D036301 2005
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D003127 2006
% 215.26/215.47  |- mesh__recordOriginator mesh__D003127 NLM
% 215.26/215.47  |- skos__hiddenLabel mesh__D003127 Surgical Procedure, Colposcopic
% 215.26/215.47  |- skos__prefLabel mesh__D003127 Colposcopy
% 215.26/215.47  |- skos__broader mesh__D003127smesh__D013509
% 215.26/215.47  |- skos__hiddenLabel mesh__D003127 Colposcopic Surgeries
% 215.26/215.47  |- skos__broader mesh__D003127smesh__D004724
% 215.26/215.47  |- skos__scopeNote mesh__D003127
% 215.26/215.47       The examination, therapy or surgery of the cervix and vagina by means of a specially designed endoscope introduced vaginally.%A%    
% 215.26/215.47  |- skos__hiddenLabel mesh__D003127 Procedures, Colposcopic Surgical
% 215.26/215.47  |- mesh__dateRevised mesh__D003127 2002-07-03
% 215.26/215.47  |- rdf__type mesh__D003127sskos__Concept
% 215.26/215.47  |- skos__broader mesh__D003127smesh__D013513
% 215.26/215.47  |- skos__altLabel mesh__D003127 Surgical Procedures, Colposcopic
% 215.26/215.47  |- skos__hiddenLabel mesh__D003127 Colposcopies
% 215.26/215.47  |- skos__altLabel mesh__D003127 Surgery, Colposcopic
% 215.26/215.47  |- skos__hiddenLabel mesh__D003127 Surgeries, Colposcopic
% 215.26/215.47  |- mesh__dateCreated mesh__D003127 1999-01-01
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D003127 2003
% 215.26/215.47  |- skos__altLabel mesh__D003127 Colposcopic Surgery
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D003127 2005
% 215.26/215.47  |- skos__hiddenLabel mesh__D003127 Procedure, Colposcopic Surgical
% 215.26/215.47  |- mesh__recordAuthorizer mesh__D003127 sjn
% 215.26/215.47  |- skos__broader mesh__D003127smesh__D003944
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D003127 2004
% 215.26/215.47  |- skos__hiddenLabel mesh__D003127 Colposcopic Surgical Procedure
% 215.26/215.47  |- mesh__recordMaintainer mesh__D003127 sjn
% 215.26/215.47  |- skos__broader mesh__D008610smesh__D003511
% 215.26/215.47  |- skos__scopeNote mesh__D008610
% 215.26/215.47       An alcohol produced from mint oils or prepared synthetically.%A%    
% 215.26/215.47  |- mesh__dateCreated mesh__D008610 1999-01-01
% 215.26/215.47  |- skos__broader mesh__D008610smesh__D039821
% 215.26/215.47  |- mesh__recordOriginator mesh__D008610 NLM
% 215.26/215.47  |- mesh__recordMaintainer mesh__D008610 ssb
% 215.26/215.47  |- mesh__dateRevised mesh__D008610 2003-07-09
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D008610 2006
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D008610 2005
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D008610 2004
% 215.26/215.47  |- mesh__recordAuthorizer mesh__D008610 sjn
% 215.26/215.47  |- rdf__type mesh__D008610sskos__Concept
% 215.26/215.47  |- skos__prefLabel mesh__D008610 Menthol
% 215.26/215.47  |- rdf__type mesh__D049229sskos__Concept
% 215.26/215.47  |- skos__historyNote mesh__D049229 Dendrites %28%1973-2004%29%
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D049229 2005
% 215.26/215.47  |- mesh__historyNote mesh__D049229 2005   
% 215.26/215.47  |- skos__scopeNote mesh__D049229
% 215.26/215.47       Spiny processes on DENDRITES, each of which receives excitatory input from one nerve ending %28%NERVE ENDINGS%29%.  They are commonly found on PURKINJE CELLS and PYRAMIDAL CELLS.%A%    
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D049229 2006
% 215.26/215.47  |- mesh__publicMeSHNote mesh__D049229 2005   
% 215.26/215.47  |- skos__hiddenLabel mesh__D049229 Spine, Dendritic
% 215.26/215.47  |- skos__hiddenLabel mesh__D049229 Spines, Dendritic
% 215.26/215.47  |- skos__prefLabel mesh__D049229 Dendritic Spines
% 215.26/215.47  |- mesh__recordAuthorizer mesh__D049229 sjn
% 215.26/215.47  |- mesh__dateEstablished mesh__D049229 2005-01-01
% 215.26/215.47  |- mesh__recordMaintainer mesh__D049229 ags
% 215.26/215.47  |- skos__hiddenLabel mesh__D049229 Dendritic Spine
% 215.26/215.47  |- skos__broader mesh__D049229smesh__D003712
% 215.26/215.47  |- mesh__dateCreated mesh__D049229 2004-07-07
% 215.26/215.47  |- mesh__recordOriginator mesh__D049229 ags
% 215.26/215.47  |- skos__hiddenLabel mesh__D013555 Vesicular Diseases, Swine
% 215.26/215.47  |- skos__hiddenLabel mesh__D013555 Vesicular Disease, Swine
% 215.26/215.47  |- mesh__dateCreated mesh__D013555 1974-11-11
% 215.26/215.47  |- mesh__recordMaintainer mesh__D013555 sjn
% 215.26/215.47  |- skos__scopeNote mesh__D013555
% 215.26/215.47       An enterovirus infection of swine clinically indistinguishable from FOOT-AND-MOUTH DISEASE, vesicular stomatitis, and VESICULAR EXANTHEMA OF SWINE. It is caused by a strain of HUMAN ENTEROVIRUS B.%A%    
% 215.26/215.47  |- skos__prefLabel mesh__D013555 Swine Vesicular Disease
% 215.26/215.47  |- skos__broader mesh__D013555smesh__D004769
% 215.26/215.47  |- mesh__dateRevised mesh__D013555 2004-07-13
% 215.26/215.47  |- mesh__dateEstablished mesh__D013555 1991-01-01
% 215.26/215.47  |- mesh__recordAuthorizer mesh__D013555 sjn
% 215.26/215.47  |- mesh__publicMeSHNote mesh__D013555
% 215.26/215.47       91; was see under ENTEROVIRUS INFECTIONS 1975-90   
% 215.26/215.47  |- mesh__recordOriginator mesh__D013555 NLM
% 215.26/215.47  |- skos__broader mesh__D013555smesh__D013553
% 215.26/215.47  |- rdf__type mesh__D013555sskos__Concept
% 215.26/215.47  |- skos__hiddenLabel mesh__D013555 Swine Vesicular Diseases
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D013555 2005
% 215.26/215.47  |- mesh__historyNote mesh__D013555
% 215.26/215.47       91%28%75%29%; was see under ENTEROVIRUS INFECTIONS 1975-90   
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D013555 2006
% 215.26/215.47  |- mesh__publicMeSHNote mesh__D007518 66   
% 215.26/215.47  |- mesh__recordAuthorizer mesh__D007518 sjn
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D007518 2006
% 215.26/215.47  |- mesh__dateCreated mesh__D007518 1999-01-01
% 215.26/215.47  |- mesh__recordMaintainer mesh__D007518 ssb
% 215.26/215.47  |- mesh__dateRevised mesh__D007518 2005-06-30
% 215.26/215.47  |- mesh__recordOriginator mesh__D007518 NLM
% 215.26/215.47  |- rdf__type mesh__D007518sskos__Concept
% 215.26/215.47  |- mesh__dateEstablished mesh__D007518 1966-01-01
% 215.26/215.47  |- skos__prefLabel mesh__D007518 Isoantibodies
% 215.26/215.47  |- skos__related mesh__D007518smesh__D001789
% 215.26/215.47  |- skos__broader mesh__D007518smesh__D000906
% 215.26/215.47  |- mesh__historyNote mesh__D007518 66%28%64%29%   
% 215.26/215.47  |- skos__scopeNote mesh__D007518
% 215.26/215.47       Antibodies from an ndividual that react with ISOANTIGENS of another individual of the same species.%A%    
% 215.26/215.47  |- skos__altLabel mesh__D007518 Alloantibodies
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D018240 2001
% 215.26/215.47  |- skos__historyNote mesh__D018240 Mesonephroma %28%1968-1993%29%
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D018240 2006
% 215.26/215.47  |- skos__broader mesh__D018240smesh__D008649
% 215.26/215.47  |- skos__annotation mesh__D018240
% 215.26/215.47       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 215.26/215.47  |- mesh__historyNote mesh__D018240
% 215.26/215.47       94; was see MESONEPHROMA 1979-93; YOLK SAC TUMOR was see MESONEPHROMA 1979-93%A%  
% 215.26/215.47  |- skos__hiddenLabel mesh__D018240 Yolk Sac Tumors
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D018240 2002
% 215.26/215.47  |- skos__hiddenLabel mesh__D018240 Tumor, Endodermal Sinus
% 215.26/215.47  |- skos__altLabel mesh__D018240 Yolk Sac Tumor
% 215.26/215.47  |- rdf__type mesh__D018240sskos__Concept
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D018240 1996
% 215.26/215.47  |- mesh__recordMaintainer mesh__D018240 KEV
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D018240 2003
% 215.26/215.47  |- mesh__onlineNote mesh__D018240
% 215.26/215.47       use MESONEPHROMA to search ENDODERMAL SINUS TUMOR %26% YOLK SAC TUMOR 1979-93%A%  
% 215.26/215.47  |- mesh__dateRevised mesh__D018240 1995-06-08
% 215.26/215.47  |- skos__hiddenLabel mesh__D018240 Tumors, Yolk Sac
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D018240 1997
% 215.26/215.47  |- skos__hiddenLabel mesh__D018240 Tumor, Yolk Sac
% 215.26/215.47  |- mesh__dateEstablished mesh__D018240 1994-01-01
% 215.26/215.47  |- mesh__dateCreated mesh__D018240 1993-06-25
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D018240 2004
% 215.26/215.47  |- mesh__recordOriginator mesh__D018240 PLS
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D018240 1998
% 215.26/215.47  |- skos__prefLabel mesh__D018240 Endodermal Sinus Tumor
% 215.26/215.47  |- mesh__recordAuthorizer mesh__D018240 PLS
% 215.26/215.47  |- mesh__publicMeSHNote mesh__D018240
% 215.26/215.47       94; was see MESONEPHROMA 1979-93; YOLK SAC TUMOR was see MESONEPHROMA 1979-93%A%  
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D018240 2000
% 215.26/215.47  |- skos__hiddenLabel mesh__D018240 Endodermal Sinus Tumors
% 215.26/215.47  |- skos__hiddenLabel mesh__D018240 Tumors, Endodermal Sinus
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D018240 2005
% 215.26/215.47  |- skos__scopeNote mesh__D018240
% 215.26/215.47       An unusual and aggressive tumor of germ-cell origin that reproduces the extraembryonic structures of the early embryo. It is the most common malignant germ cell tumor found in children. It is characterized by a labyrinthine glandular pattern of flat epithelial cells and rounded papillary processes with a central capillary %28%Schiller-Duval body%29%. The tumor is rarely bilateral. Before the use of combination chemotherapy, the tumor was almost invariably fatal. %28%From DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1189%29%%A%    
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D018240 1999
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D004220 2000
% 215.26/215.47  |- skos__broader mesh__D004220smesh__D013440
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D004220 2003
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D004220 2006
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D004220 2001
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D004220 1997
% 215.26/215.47  |- mesh__historyNote mesh__D004220 73%28%71%29%   
% 215.26/215.47  |- skos__prefLabel mesh__D004220 Disulfides
% 215.26/215.47  |- mesh__dateRevised mesh__D004220 1993-06-01
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D004220 2004
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D004220 2002
% 215.26/215.47  |- skos__historyNote mesh__D004220 Sulfides %28%1966-1970%29%
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D004220 1994
% 215.26/215.47  |- mesh__recordMaintainer mesh__D004220 TPW
% 215.26/215.47  |- skos__scopeNote mesh__D004220
% 215.26/215.47       Chemical groups containing the covalent disulfide bonds -S-S-. The sulfur atoms can be bound to inorganic or organic moieties.%A%    
% 215.26/215.47  |- mesh__recordOriginator mesh__D004220 NLM
% 215.26/215.47  |- mesh__publicMeSHNote mesh__D004220 73   
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D004220 1995
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D004220 1998
% 215.26/215.47  |- mesh__dateCreated mesh__D004220 1999-01-01
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D004220 2005
% 215.26/215.47  |- rdf__type mesh__D004220sskos__Concept
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D004220 1996
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D004220 1999
% 215.26/215.47  |- mesh__dateEstablished mesh__D004220 1973-01-01
% 215.26/215.47  |- mesh__recordAuthorizer mesh__D004220 PLS
% 215.26/215.47  |- skos__historyNote mesh__D017148 Infusions, Parenteral %28%1976-1992%29%
% 215.26/215.47  |- skos__prefLabel mesh__D017148 Infusions, Intraosseous
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D017148 1993
% 215.26/215.47  |- skos__hiddenLabel mesh__D017148 Intraosseous Infusions
% 215.26/215.47  |- mesh__recordMaintainer mesh__D017148 jls
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D017148 1996
% 215.26/215.47  |- skos__broader mesh__D017148smesh__D007263
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D017148 2002
% 215.26/215.47  |- skos__hiddenLabel mesh__D017148 Intraosseous Infusion
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D017148 2005A
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D017148 2005
% 215.26/215.47  |- mesh__dateRevised mesh__D017148 2004-07-28
% 215.26/215.47  |- mesh__recordAuthorizer mesh__D017148 jls
% 215.26/215.47  |- mesh__publicMeSHNote mesh__D017148 93   
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D017148 1997
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D017148 1994
% 215.26/215.47  |- skos__annotation mesh__D017148
% 215.26/215.47       admin of drugs or fluids via needle directly into bone marrow; do not use /util except by MeSH definition%A%  
% 215.26/215.47  |- mesh__historyNote mesh__D017148 93   
% 215.26/215.47  |- mesh__recordOriginator mesh__D017148 AGS
% 215.26/215.47  |- skos__altLabel mesh__D017148 Infusions, Intra-Osseous
% 215.26/215.47  |- skos__hiddenLabel mesh__D017148 Intra-Osseous Infusions
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D017148 2006
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D017148 1995
% 215.26/215.47  |- skos__hiddenLabel mesh__D017148 Infusions, Intra Osseous
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D017148 2000
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D017148 2003
% 215.26/215.47  |- mesh__dateEstablished mesh__D017148 1993-01-01
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D017148 1998
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D017148 2001
% 215.26/215.47  |- skos__hiddenLabel mesh__D017148 Intra-Osseous Infusion
% 215.26/215.47  |- skos__hiddenLabel mesh__D017148 Infusion, Intraosseous
% 215.26/215.47  |- skos__hiddenLabel mesh__D017148 Infusion, Intra-Osseous
% 215.26/215.47  |- rdf__type mesh__D017148sskos__Concept
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D017148 2004
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D017148 1999
% 215.26/215.47  |- skos__scopeNote mesh__D017148
% 215.26/215.47       The administration of medication or fluid through a needle directly into the bone marrow. The technique is especially useful in the management of pediatric emergencies when intravenous access to the systemic circulation is difficult.%A%    
% 215.26/215.47  |- mesh__dateCreated mesh__D017148 1992-05-20
% 215.26/215.47  |- skos__annotation mesh__D003926
% 215.26/215.47       coordinate IM with specific type of diabetes mellitus %28%IM%29% if pertinent%A%  
% 215.26/215.47  |- mesh__recordMaintainer mesh__D003926 lkt
% 215.26/215.47  |- skos__hiddenLabel mesh__D003926 Coma, Diabetic
% 215.26/215.47  |- mesh__recordOriginator mesh__D003926 NLM
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D003926 2006
% 215.26/215.47  |- mesh__dateCreated mesh__D003926 1999-01-01
% 215.26/215.47  |- skos__hiddenLabel mesh__D003926 Diabetic Comas
% 215.26/215.47  |- skos__prefLabel mesh__D003926 Diabetic Coma
% 215.26/215.47  |- mesh__dateRevised mesh__D003926 2004-07-07
% 215.26/215.47  |- skos__hiddenLabel mesh__D003926 Comas, Diabetic
% 215.26/215.47  |- skos__scopeNote mesh__D003926
% 215.26/215.47       A state of unconsciousness as a complication of diabetes mellitus. It occurs in cases of extreme HYPERGLYCEMIA or extreme HYPOGLYCEMIA as a complication of INSULIN therapy.%A%    
% 215.26/215.47  |- mesh__recordAuthorizer mesh__D003926 sjn
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D003926 2005
% 215.26/215.47  |- skos__broader mesh__D003926smesh__D048909
% 215.26/215.47  |- rdf__type mesh__D003926sskos__Concept
% 215.26/215.47  |- rdf__type mesh__D036302sskos__Concept
% 215.26/215.47  |- skos__scopeNote mesh__D036302
% 215.26/215.47       Human experimentation that is intended to benefit the subjects on whom it is performed.%A%    
% 215.26/215.47  |- mesh__recordAuthorizer mesh__D036302 jls
% 215.26/215.47  |- mesh__dateCreated mesh__D036302 2002-07-03
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D036302 2003
% 215.26/215.47  |- skos__prefLabel mesh__D036302 Therapeutic Human Experimentation
% 215.26/215.47  |- skos__historyNote mesh__D036302 Clinical Trials %28%1996-2002%29%
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D036302 2004
% 215.26/215.47  |- skos__altLabel mesh__D036302 Research, Therapeutic
% 215.26/215.47  |- mesh__recordOriginator mesh__D036302 hjn
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D036302 2005
% 215.26/215.47  |- mesh__publicMeSHNote mesh__D036302 2003   
% 215.26/215.47  |- mesh__dateEstablished mesh__D036302 2003-01-01
% 215.26/215.47  |- skos__related mesh__D036302smesh__D033281
% 215.26/215.47  |- skos__altLabel mesh__D036302 Therapeutic Research
% 215.26/215.47  |- skos__annotation mesh__D036302
% 215.26/215.47       use only when ethical, legal, psychological, or social issues are discussed%A%  
% 215.26/215.47  |- mesh__dateRevised mesh__D036302 2002-10-31
% 215.26/215.47  |- skos__broader mesh__D036302smesh__D006805
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D036302 2006
% 215.26/215.47  |- skos__hiddenLabel mesh__D036302 Experimentation, Therapeutic Human
% 215.26/215.47  |- skos__historyNote mesh__D036302 Research %28%1966-2002%29%
% 215.26/215.47  |- mesh__recordMaintainer mesh__D036302 jls
% 215.26/215.47  |- skos__altLabel mesh__D036302 Human Experimentation, Therapeutic
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D036302 2003A
% 215.26/215.47  |- mesh__historyNote mesh__D036302 2003   
% 215.26/215.47  |- skos__related mesh__D003128smesh__D002389
% 215.26/215.47  |- mesh__recordMaintainer mesh__D003128 sjn
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D003128 2006
% 215.26/215.47  |- rdf__type mesh__D003128sskos__Concept
% 215.26/215.47  |- skos__hiddenLabel mesh__D003128 Comas
% 215.26/215.47  |- skos__related mesh__D003128smesh__D018458
% 215.26/215.47  |- skos__hiddenLabel mesh__D003128 Pseudocomas
% 215.26/215.47  |- skos__altLabel mesh__D003128 Comatose
% 215.26/215.47  |- mesh__dateCreated mesh__D003128 1999-01-01
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D003128 2003A
% 215.26/215.47  |- mesh__dateRevised mesh__D003128 2002-08-09
% 215.26/215.47  |- skos__prefLabel mesh__D003128 Coma
% 215.26/215.47  |- skos__broader mesh__D003128smesh__D014474
% 215.26/215.47  |- mesh__recordAuthorizer mesh__D003128 sjn
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D003128 2003
% 215.26/215.47  |- skos__scopeNote mesh__D003128
% 215.26/215.47       A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.%A%    
% 215.26/215.47  |- mesh__recordOriginator mesh__D003128 NLM
% 215.26/215.47  |- skos__annotation mesh__D003128 check MeSH for specific coma terms   
% 215.26/215.47  |- skos__hiddenLabel mesh__D003128 Stupors
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D003128 2002
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D003128 2005
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D003128 2004
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D008611 1998
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D008611 1997
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D008611 2000
% 215.26/215.47  |- mesh__historyNote mesh__D008611 88   
% 215.26/215.47  |- skos__hiddenLabel mesh__D008611 Mentor
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D008611 2006
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D008611 1996
% 215.26/215.47  |- skos__scopeNote mesh__D008611
% 215.26/215.47       Senior professionals who provide guidance, direction and support to those persons desirous of improvement in academic positions, administrative positions or other career development situations.%A%    
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D008611 2005
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D008611 2004
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D008611 2002
% 215.26/215.47  |- mesh__dateEstablished mesh__D008611 1988-01-01
% 215.26/215.47  |- skos__prefLabel mesh__D008611 Mentors
% 215.26/215.47  |- rdf__type mesh__D008611sskos__Concept
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D008611 2003
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D008611 1995
% 215.26/215.47  |- skos__broader mesh__D008611smesh__D004493
% 215.26/215.47  |- skos__hiddenLabel mesh__D008611 Mentorship
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D008611 1994
% 215.26/215.47  |- mesh__recordMaintainer mesh__D008611 TGC
% 215.26/215.47  |- mesh__dateCreated mesh__D008611 1987-03-14
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D008611 1993
% 215.26/215.47  |- mesh__dateRevised mesh__D008611 1992-05-15
% 215.26/215.47  |- mesh__recordOriginator mesh__D008611 EC
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D008611 2001
% 215.26/215.47  |- mesh__publicMeSHNote mesh__D008611 88   
% 215.26/215.47  |- skos__broader mesh__D008611smesh__D009272
% 215.26/215.47  |- mesh__activeMeSHYear mesh__D008611 1999
% 215.26/215.48  |- mesh__recordAuthorizer mesh__D008611 PLS
% 215.26/215.48  |- rdf__type mesh__D046730sskos__Concept
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D046730 2006
% 215.26/215.48  |- mesh__dateCreated mesh__D046730 2004-07-07
% 215.26/215.48  |- mesh__publicMeSHNote mesh__D046730 2005   
% 215.26/215.48  |- skos__historyNote mesh__D046730 Colitis %28%1984-2004%29%
% 215.26/215.48  |- skos__broader mesh__D046730smesh__D046728
% 215.26/215.48  |- skos__prefLabel mesh__D046730 Colitis, Lymphocytic
% 215.26/215.48  |- skos__historyNote mesh__D046730 Colitis, Ulcerative %28%1980-2004%29%
% 215.26/215.48  |- mesh__recordMaintainer mesh__D046730 lkt
% 215.26/215.48  |- mesh__historyNote mesh__D046730 2005   
% 215.26/215.48  |- mesh__recordAuthorizer mesh__D046730 sjn
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D046730 2005
% 215.26/215.48  |- mesh__recordOriginator mesh__D046730 lkt
% 215.26/215.48  |- skos__scopeNote mesh__D046730
% 215.26/215.48       A subtype of MICROSCOPIC COLITIS, characterized by chronic watery DIARRHEA of unknown origin, a normal COLONOSCOPY but abnormal histopathology on BIOPSY. Microscopic examination of biopsy samples taken from the COLON show infiltration of LYMPHOCYTES in the superficial EPITHELIUM  and the underlying connective tissue %28%lamina propria%29%.%A%    
% 215.26/215.48  |- mesh__dateEstablished mesh__D046730 2005-01-01
% 215.26/215.48  |- skos__altLabel mesh__D046730 Lymphocytic Colitis
% 215.26/215.48  |- skos__broader mesh__D013502Q000266smesh__D013502
% 215.26/215.48  |- rdf__type mesh__D013502Q000266smesh__CompoundConcept
% 215.26/215.48  |- skos__altLabel mesh__D013556 Miniature Swine
% 215.26/215.48  |- skos__hiddenLabel mesh__D013556 Swines, Miniature
% 215.26/215.48  |- mesh__dateCreated mesh__D013556 1982-04-26
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D013556 2006
% 215.26/215.48  |- mesh__publicMeSHNote mesh__D013556 83   
% 215.26/215.48  |- mesh__dateRevised mesh__D013556 2003-07-30
% 215.26/215.48  |- mesh__recordAuthorizer mesh__D013556 sjn
% 215.26/215.48  |- mesh__recordMaintainer mesh__D013556 ags
% 215.26/215.48  |- skos__annotation mesh__D013556
% 215.26/215.48       IM; qualif permitted; don%27%t forget also SWINE %28%NIM%29% %26% check tag ANIMALS%A%  
% 215.26/215.48  |- mesh__dateEstablished mesh__D013556 1983-01-01
% 215.26/215.48  |- rdf__type mesh__D013556sskos__Concept
% 215.26/215.48  |- skos__scopeNote mesh__D013556
% 215.26/215.48       Genetically developed small pigs for use in biomedical research. There are several strains - Yucatan miniature, Sinclair miniature, and Minnesota miniature.%A%    
% 215.26/215.48  |- skos__historyNote mesh__D013556 Swine %28%1966-1982%29%
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D013556 2004
% 215.26/215.48  |- mesh__recordOriginator mesh__D013556 EC
% 215.26/215.48  |- skos__hiddenLabel mesh__D013556 Minipig
% 215.26/215.48  |- skos__altLabel mesh__D013556 Minipigs
% 215.26/215.48  |- skos__prefLabel mesh__D013556 Swine, Miniature
% 215.26/215.48  |- mesh__historyNote mesh__D013556 83   
% 215.26/215.48  |- skos__hiddenLabel mesh__D013556 Miniature Swines
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D013556 2005
% 215.26/215.48  |- skos__broader mesh__D013556smesh__D013552
% 215.26/215.48  |- skos__altLabel mesh__D007519 Isoantigen
% 215.26/215.48  |- mesh__publicMeSHNote mesh__D007519 67   
% 215.26/215.48  |- rdf__type mesh__D007519sskos__Concept
% 215.26/215.48  |- mesh__recordMaintainer mesh__D007519 ssb
% 215.26/215.48  |- mesh__recordAuthorizer mesh__D007519 sjn
% 215.26/215.48  |- mesh__dateRevised mesh__D007519 2005-06-30
% 215.26/215.48  |- mesh__historyNote mesh__D007519 67%28%64%29%   
% 215.26/215.48  |- mesh__recordOriginator mesh__D007519 NLM
% 215.26/215.48  |- mesh__dateEstablished mesh__D007519 1967-01-01
% 215.26/215.48  |- skos__prefLabel mesh__D007519 Isoantigens
% 215.26/215.48  |- skos__altLabel mesh__D007519 Alloantigen
% 215.26/215.48  |- skos__broader mesh__D007519smesh__D000941
% 215.26/215.48  |- skos__scopeNote mesh__D007519
% 215.26/215.48       Antigens that exist in alternative %28%allelic%29% forms in a single species. When an isoantigen is encountered by species members who lack it, an immune response is induced. Typical isoantigens are the BLOOD GROUP ANTIGENS.%A%    
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D007519 2006
% 215.26/215.48  |- mesh__dateCreated mesh__D007519 1999-01-01
% 215.26/215.48  |- skos__historyNote mesh__D018241
% 215.26/215.48       Neoplasms, Germ Cell and Embryonal %28%1984-1993%29%
% 215.26/215.48  |- mesh__recordMaintainer mesh__D018241 KEV
% 215.26/215.48  |- mesh__dateCreated mesh__D018241 1993-06-25
% 215.26/215.48  |- skos__hiddenLabel mesh__D018241 Tumor, Peripheral Neuroectodermal
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D018241 2003
% 215.26/215.48  |- skos__altLabel mesh__D018241 Neuroectodermal Tumor, Peripheral
% 215.26/215.48  |- mesh__historyNote mesh__D018241 2000%28%1994%29%   
% 215.26/215.48  |- skos__annotation mesh__D018241
% 215.26/215.48       coord IM with precoord organ/neopl term %28%IM%29%   
% 215.26/215.48  |- skos__historyNote mesh__D018241 Neuroblastoma %28%1985-1989%29%
% 215.26/215.48  |- skos__hiddenLabel mesh__D018241 Neuroepitheliomas
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D018241 2000
% 215.26/215.48  |- skos__scopeNote mesh__D018241
% 215.26/215.48       A group of highly cellular primitive round cell neoplasms which occur extracranially in soft tissue and bone and are derived from embryonal neural crest cells. These tumors occur primarily in children and adolescents and share a number of characteristics with Ewing%27%s Sarcoma %28%SARCOMA, EWING%27%S%29%. They may arise from the chest wall, skin, orbit, kidney, and other structures and tend to be locally invasive or metastasize, although relatively benign forms may occur. Characteristic histologic features include a tendency to form Homer-Wright rosettes and to stain positively with neuron-specific enolase and vimentin. %28%From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2113; J Clin Oncol 1998 Mar;16%28%3%29%:1150-7%29%%A%    
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D018241 2004
% 215.26/215.48  |- skos__altLabel mesh__D018241 Neuroectodermal Tumor, Peripheral Primitive
% 215.26/215.48  |- skos__related mesh__D018241smesh__D012512
% 215.26/215.48  |- skos__altLabel mesh__D018241 Peripheral Primitive Neuroectodermal Tumors
% 215.26/215.48  |- skos__altLabel mesh__D018241
% 215.26/215.48       Neuroectodermal Neoplasm, Peripheral Primitive
% 215.26/215.48  |- mesh__recordOriginator mesh__D018241 PLS
% 215.26/215.48  |- mesh__dateRevised mesh__D018241 1999-11-03
% 215.26/215.48  |- skos__hiddenLabel mesh__D018241 Neuroectodermal Tumors, Peripheral
% 215.26/215.48  |- skos__altLabel mesh__D018241
% 215.26/215.48       Primitive Neuroectodermal Tumor, Extracranial
% 215.26/215.48  |- mesh__recordAuthorizer mesh__D018241 sjn
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D018241 2001
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D018241 2005
% 215.26/215.48  |- skos__hiddenLabel mesh__D018241 Tumors, Peripheral Neuroectodermal
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D018241 2002
% 215.26/215.48  |- skos__hiddenLabel mesh__D018241 Peripheral Neuroectodermal Tumors
% 215.26/215.48  |- skos__historyNote mesh__D018241 Neuroepithelioma %28%1975-1989%29%
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D018241 2006
% 215.26/215.48  |- mesh__publicMeSHNote mesh__D018241
% 215.26/215.48       2000%28%1994%29%; see NEUROECTODERMAL TUMOR, PERIPHERAL 1994-1999; NEUROEPITHELIOMA was heading 1966-1999%A%  
% 215.26/215.48  |- skos__altLabel mesh__D018241
% 215.26/215.48       %28%pPNET%29% Peripheral Primitive Neuroectodermal Tumors
% 215.26/215.48  |- skos__hiddenLabel mesh__D018241 Peripheral Neuroectodermal Tumor
% 215.26/215.48  |- skos__altLabel mesh__D018241
% 215.26/215.48       Peripheral Primitive Neuroectodermal Neoplasm
% 215.26/215.48  |- skos__altLabel mesh__D018241
% 215.26/215.48       Extracranial Primitive Neuroectodermal Tumor
% 215.26/215.48  |- skos__broader mesh__D018241smesh__D018242
% 215.26/215.48  |- mesh__dateEstablished mesh__D018241 1994-01-01
% 215.26/215.48  |- skos__prefLabel mesh__D018241
% 215.26/215.48       Neuroectodermal Tumors, Primitive, Peripheral
% 215.26/215.48  |- rdf__type mesh__D018241sskos__Concept
% 215.26/215.48  |- skos__altLabel mesh__D004221 Tetraethylthiuram Disulfide
% 215.26/215.48  |- skos__altLabel mesh__D004221 Allphar Brand of Disulfiram
% 215.26/215.48  |- skos__broader mesh__D004221smesh__D004050
% 215.26/215.48  |- mesh__recordAuthorizer mesh__D004221 sjn
% 215.26/215.48  |- skos__altLabel mesh__D004221 Dumex Brand of Disulfiram
% 215.26/215.48  |- skos__prefLabel mesh__D004221 Disulfiram
% 215.26/215.48  |- skos__altLabel mesh__D004221 Altana Pharma Brand of Disulfiram
% 215.26/215.48  |- mesh__dateRevised mesh__D004221 2005-06-30
% 215.26/215.48  |- skos__altLabel mesh__D004221 Artu Brand of Disulfiram
% 215.26/215.48  |- skos__scopeNote mesh__D004221
% 215.26/215.48       A carbamate derivative used as an alcohol deterrent. It is a relatively nontoxic substance when administered alone, but markedly alters the intermediary metabolism of alcohol. When alcohol is ingested after administration of disulfiram, blood acetaldehyde concentrations are increased, followed by flushing, systemic vasodilation, respiratory difficulties, nausea, hypotension, and other symptoms %28%acetaldehyde syndrome%29%. It acts by inhibiting aldehyde dehydrogenase.%A%    
% 215.26/215.48  |- skos__altLabel mesh__D004221
% 215.26/215.48       Tetraethylthioperoxydicarbonic Diamide, %28%%28%H2N%29%C%28%S%29%%29%2S2
% 215.26/215.48  |- skos__altLabel mesh__D004221 Bohm Brand of Disulfiram
% 215.26/215.48  |- mesh__dateCreated mesh__D004221 1999-01-01
% 215.26/215.48  |- skos__altLabel mesh__D004221 Bis%28%diethylthiocarbamoyl%29% Disulfide
% 215.26/215.48  |- rdf__type mesh__D004221sskos__Concept
% 215.26/215.48  |- skos__broader mesh__D004221smesh__D004220
% 215.26/215.48  |- skos__altLabel mesh__D004221 Sanofi Synthelabo Brand of Disulfiram
% 215.26/215.48  |- mesh__recordOriginator mesh__D004221 NLM
% 215.26/215.48  |- skos__altLabel mesh__D004221 Odyssey Brand of Disulfiram
% 215.26/215.48  |- skos__hiddenLabel mesh__D004221 Disulfide, Tetraethylthiuram
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D004221 2006
% 215.26/215.48  |- skos__altLabel mesh__D004221 Orphan Brand of Disulfiram
% 215.26/215.48  |- mesh__recordMaintainer mesh__D004221 exl
% 215.26/215.48  |- mesh__recordAuthorizer mesh__D017149 ags
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D017149 2005
% 215.26/215.48  |- mesh__historyNote mesh__D017149 93   
% 215.26/215.48  |- skos__broader mesh__D017149smesh__D010067
% 215.26/215.48  |- mesh__dateCreated mesh__D017149 1992-05-22
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D017149 2006
% 215.26/215.48  |- mesh__recordOriginator mesh__D017149 JLS
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D017149 2002
% 215.26/215.48  |- skos__hiddenLabel mesh__D017149 Enterprises, Private
% 215.26/215.48  |- mesh__dateRevised mesh__D017149 1999-12-28
% 215.26/215.48  |- skos__hiddenLabel mesh__D017149 Enterprise, Private
% 215.26/215.48  |- mesh__publicMeSHNote mesh__D017149 93   
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D017149 2003
% 215.26/215.48  |- skos__historyNote mesh__D017149
% 215.26/215.48       Health Facilities, Proprietary %28%1979-1992%29%
% 215.26/215.48  |- skos__annotation mesh__D017149
% 215.26/215.48       IM; specify nature of private endeavor %28%IM%29%; specify geog if pertinent%A%  
% 215.26/215.48  |- skos__broader mesh__D017149smesh__D012942
% 215.26/215.48  |- skos__scopeNote mesh__D017149
% 215.26/215.48       That distinct portion of the institutional, industrial, or economic structure of a country that is controlled or owned by non-governmental, private interests.%A%    
% 215.26/215.48  |- skos__prefLabel mesh__D017149 Private Sector
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D017149 2004
% 215.26/215.48  |- rdf__type mesh__D017149sskos__Concept
% 215.26/215.48  |- skos__hiddenLabel mesh__D017149 Sector, Private
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D017149 2000
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D017149 2000A
% 215.26/215.48  |- skos__hiddenLabel mesh__D017149 Private Enterprises
% 215.26/215.48  |- mesh__recordMaintainer mesh__D017149 ags
% 215.26/215.48  |- mesh__dateEstablished mesh__D017149 1993-01-01
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D017149 2001
% 215.26/215.48  |- mesh__recordAuthorizer mesh__D003927 sjn
% 215.26/215.48  |- skos__prefLabel mesh__D003927 Diabetic Diet
% 215.26/215.48  |- skos__hiddenLabel mesh__D003927 Diabetic Diets
% 215.26/215.48  |- mesh__recordMaintainer mesh__D003927 lkt
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D003927 2006
% 215.26/215.48  |- mesh__dateCreated mesh__D003927 1999-01-01
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D003927 2004
% 215.26/215.48  |- skos__hiddenLabel mesh__D003927 Diets, Diabetic
% 215.26/215.48  |- mesh__dateRevised mesh__D003927 2003-07-09
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D003927 2005
% 215.26/215.48  |- rdf__type mesh__D003927sskos__Concept
% 215.26/215.48  |- skos__altLabel mesh__D003927 Diet, Diabetic
% 215.26/215.48  |- mesh__recordOriginator mesh__D003927 NLM
% 215.26/215.48  |- skos__annotation mesh__D003927
% 215.26/215.48       IM; a specific dietary regimen for diabetics: not all diet ther of diabetes is DIABETIC DIET; when specified by author as a diabetic diet, coord with DIABETES MELLITUS /diet ther %28%IM%29% or specific type of diabetes /diet ther %28%IM%29% + specific dietary element /ther use %28%IM%29%%A%  
% 215.26/215.48  |- skos__broader mesh__D003927smesh__D004035
% 215.26/215.48  |- skos__scopeNote mesh__D003927
% 215.26/215.48       A diet prescribed in the treatment of diabetes mellitus, usually limited in the amount of sugar or readily available carbohydrate. %28%Dorland, 27th ed%29%%A%    
% 215.26/215.48  |- mesh__recordOriginator mesh__D003129 NLM
% 215.26/215.48  |- skos__broader mesh__D003129smesh__D000825
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D003129 1996
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D003129 2002
% 215.26/215.48  |- mesh__dateRevised mesh__D003129 1991-01-07
% 215.26/215.48  |- skos__altLabel mesh__D003129 Wattles and Comb
% 215.26/215.48  |- skos__hiddenLabel mesh__D003129 Wattle
% 215.26/215.48  |- mesh__publicMeSHNote mesh__D003129 68   
% 215.26/215.48  |- mesh__recordMaintainer mesh__D003129 TGC
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D003129 1998
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D003129 1997
% 215.26/215.48  |- mesh__historyNote mesh__D003129 68   
% 215.26/215.48  |- mesh__dateCreated mesh__D003129 1999-01-01
% 215.26/215.48  |- skos__annotation mesh__D003129 DF: COMB   
% 215.26/215.48  |- mesh__recordAuthorizer mesh__D003129 PLS
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D003129 2000
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D003129 1992
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D003129 1999
% 215.26/215.48  |- skos__hiddenLabel mesh__D003129 Combs
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D003129 2003
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D003129 2001
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D003129 1994
% 215.26/215.48  |- skos__historyNote mesh__D003129 Poultry %28%1966-1967%29%
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D003129 1993
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D003129 2005
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D003129 2004
% 215.26/215.48  |- skos__prefLabel mesh__D003129 Comb and Wattles
% 215.26/215.48  |- mesh__dateEstablished mesh__D003129 1968-01-01
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D003129 1995
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D003129 2006
% 215.26/215.48  |- rdf__type mesh__D003129sskos__Concept
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D008612 2005
% 215.26/215.48  |- mesh__recordAuthorizer mesh__D008612 SJN
% 215.26/215.48  |- mesh__recordOriginator mesh__D008612 EC
% 215.26/215.48  |- skos__broader mesh__D008612smesh__D005521
% 215.26/215.48  |- mesh__dateCreated mesh__D008612 1977-05-11
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D008612 2000
% 215.26/215.48  |- skos__prefLabel mesh__D008612 Menu Planning
% 215.26/215.48  |- skos__annotation mesh__D008612
% 215.26/215.48       domestic, commercial, institutional, hosp, etc.   
% 215.26/215.48  |- skos__hiddenLabel mesh__D008612 Planning, Menu
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D008612 2003
% 215.26/215.48  |- mesh__publicMeSHNote mesh__D008612
% 215.26/215.48       91; was see under FOOD SERVICES Aug 1977-90   
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D008612 2006
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D008612 2001
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D008612 2004
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D008612 2002
% 215.26/215.48  |- rdf__type mesh__D008612sskos__Concept
% 215.26/215.48  |- skos__hiddenLabel mesh__D008612 Plannings, Menu
% 215.26/215.48  |- mesh__recordMaintainer mesh__D008612 JLS
% 215.26/215.48  |- skos__historyNote mesh__D008612
% 215.26/215.48       Food Service, Hospital %28%1966-Jul 1977%29%
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D008612 1998
% 215.26/215.48  |- mesh__dateEstablished mesh__D008612 1991-01-01
% 215.26/215.48  |- skos__hiddenLabel mesh__D008612 Menu Plannings
% 215.26/215.48  |- skos__broader mesh__D008612smesh__D005522
% 215.26/215.48  |- skos__historyNote mesh__D008612 Food Services %28%Jan-Jul 1977%29%
% 215.26/215.48  |- mesh__dateRevised mesh__D008612 1997-06-20
% 215.26/215.48  |- mesh__historyNote mesh__D008612
% 215.26/215.48       91%28%Aug 77%29%; was see under FOOD SERVICES 1977-90   
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D008612 1999
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D013557 1998
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D013557 2000
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D013557 2003
% 215.26/215.48  |- skos__broader mesh__D013557smesh__D005060
% 215.26/215.48  |- rdf__type mesh__D013557sskos__Concept
% 215.26/215.48  |- mesh__dateRevised mesh__D013557 1995-05-23
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D013557 1999
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D013557 2001
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D013557 2004
% 215.26/215.48  |- skos__prefLabel mesh__D013557 Switzerland
% 215.26/215.48  |- mesh__dateCreated mesh__D013557 1999-01-01
% 215.26/215.48  |- mesh__recordMaintainer mesh__D013557 KEV
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D013557 2002
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D013557 2005
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D013557 1996
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D013557 2006
% 215.26/215.48  |- mesh__recordOriginator mesh__D013557 NLM
% 215.26/215.48  |- mesh__recordAuthorizer mesh__D013557 PLS
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D013557 1997
% 215.26/215.48  |- skos__hiddenLabel mesh__D018242 Ependymoblastomas
% 215.26/215.48  |- skos__hiddenLabel mesh__D018242 Primitive Neuroepithelial Tumors
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D018242 2006A
% 215.26/215.48  |- skos__altLabel mesh__D018242 Primitive Neuroepithelial Neoplasms
% 215.26/215.48  |- skos__prefLabel mesh__D018242 Neuroectodermal Tumors, Primitive
% 215.26/215.48  |- skos__hiddenLabel mesh__D018242 Tumor, Primitive Neuroepithelial
% 215.26/215.48  |- mesh__dateRevised mesh__D018242 2005-07-21
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D018242 2001
% 215.26/215.48  |- mesh__recordMaintainer mesh__D018242 ags
% 215.26/215.48  |- mesh__recordOriginator mesh__D018242 PLS
% 215.26/215.48  |- mesh__historyNote mesh__D018242 2000%28%1994%29%   
% 215.26/215.48  |- mesh__dateEstablished mesh__D018242 1994-01-01
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D018242 2006
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D018242 2000
% 215.26/215.48  |- skos__altLabel mesh__D018242 Neoplasms, Primitive Neuroepithelial
% 215.26/215.48  |- skos__scopeNote mesh__D018242
% 215.26/215.48       A group of malignant tumors of the nervous system that feature primitive cells with elements of neuronal and/or glial differentiation. Use of this term is limited by some authors to central nervous system tumors and others include neoplasms of similar origin which arise extracranially %28%i.e., NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL%29%. This term is also occasionally used as a synonym for MEDULLOBLASTOMA. In general, these tumors arise in the first decade of life and tend to be highly malignant. %28%From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2059%29%%A%    
% 215.26/215.48  |- skos__hiddenLabel mesh__D018242 Primitive Neuroepithelial Neoplasm
% 215.26/215.48  |- skos__hiddenLabel mesh__D018242 Tumors, Primitive Neuroepithelial
% 215.26/215.48  |- skos__hiddenLabel mesh__D018242 Primitive Neuroectodermal Tumors
% 215.26/215.48  |- skos__altLabel mesh__D018242 PNET
% 215.26/215.48  |- skos__altLabel mesh__D018242 Neuroectodermal Tumor, Primitive
% 215.26/215.48  |- skos__altLabel mesh__D018242 Neuroepithelial Neoplasms, Primitive
% 215.26/215.48  |- skos__broader mesh__D018242smesh__D018302
% 215.26/215.48  |- mesh__publicMeSHNote mesh__D018242
% 215.26/215.48       2000; see NEUROECTODERMAL TUMOR, PRIMITIVE 1994-1999   
% 215.26/215.48  |- skos__hiddenLabel mesh__D018242 Primitive Neuroepithelial Tumor
% 215.26/215.48  |- skos__hiddenLabel mesh__D018242 Medulloepitheliomas
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D018242 2005
% 215.26/215.48  |- skos__hiddenLabel mesh__D018242 Neuroepithelial Neoplasm, Primitive
% 215.26/215.48  |- skos__annotation mesh__D018242
% 215.26/215.48       coord IM with BRAIN NEOPLASMS %28%IM%29% or specific precoord organ/neopl term %28%IM%29%; do not confuse with MEDULLOBLASTOMA%A%  
% 215.26/215.48  |- mesh__dateCreated mesh__D018242 1993-06-25
% 215.26/215.48  |- skos__hiddenLabel mesh__D018242 Spongioblastomas
% 215.26/215.48  |- skos__hiddenLabel mesh__D018242 Tumor, Primitive Neuroectodermal
% 215.26/215.48  |- skos__hiddenLabel mesh__D018242 PNETs
% 215.26/215.48  |- rdf__type mesh__D018242sskos__Concept
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D018242 2004
% 215.26/215.48  |- skos__altLabel mesh__D018242 Neuroepithelial Tumors, Primitive
% 215.26/215.48  |- skos__hiddenLabel mesh__D018242 Primitive Neuroectodermal Tumor
% 215.26/215.48  |- skos__hiddenLabel mesh__D018242 Neoplasm, Primitive Neuroepithelial
% 215.26/215.48  |- skos__hiddenLabel mesh__D018242 Tumors, Primitive Neuroectodermal
% 215.26/215.48  |- mesh__recordAuthorizer mesh__D018242 ags
% 215.26/215.48  |- skos__hiddenLabel mesh__D018242 Neuroepithelial Tumor, Primitive
% 215.26/215.48  |- skos__historyNote mesh__D018242
% 215.26/215.48       Neoplasms, Germ Cell and Embryonal %28%1979-1993%29%
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D018242 2002
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D018242 2003
% 215.26/215.48  |- mesh__recordOriginator mesh__D051676 DRC
% 215.26/215.48  |- skos__hiddenLabel mesh__D051676
% 215.26/215.48       G Protein Coupled Inwardly Rectifying Potassium Channel 4
% 215.26/215.48  |- skos__altLabel mesh__D051676 Kir3.1 Potassium Channel
% 215.26/215.48  |- skos__altLabel mesh__D051676 GIRK3 Potassium Channel
% 215.26/215.48  |- skos__hiddenLabel mesh__D051676 Potassium Channel, Kir3.4
% 215.26/215.48  |- mesh__dateCreated mesh__D051676 2005-06-30
% 215.26/215.48  |- rdf__type mesh__D051676sskos__Concept
% 215.26/215.48  |- skos__hiddenLabel mesh__D051676 Potassium Channel, GIRK3
% 215.26/215.48  |- skos__hiddenLabel mesh__D051676 Potassium Channel, GIRK4
% 215.26/215.48  |- skos__hiddenLabel mesh__D051676 Potassium Channel, Kir3.2
% 215.26/215.48  |- skos__hiddenLabel mesh__D051676
% 215.26/215.48       G Protein Coupled Inwardly Rectifying Potassium Channel 1
% 215.26/215.48  |- skos__hiddenLabel mesh__D051676
% 215.26/215.48       G Protein Coupled Inwardly Rectifying Potassium Channels
% 215.26/215.48  |- skos__altLabel mesh__D051676 Kir3.4 Potassium Channel
% 215.26/215.48  |- mesh__publicMeSHNote mesh__D051676
% 215.26/215.48       2006; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, INWARDLY RECTIFYING 2005, %26% under POTASSIUM CHANNELS 1995-2004, %26% under MEMBRANE PROTEINS 1993-1994; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNEL 1, G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNEL 2, G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNEL 3, %26% G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNEL 4 were indexed under POTASSIUM CHANNELS, INWARDLY RECTIFYING 2004-2005%A%  
% 215.26/215.48  |- mesh__historyNote mesh__D051676 2006%28%1993%29%   
% 215.26/215.48  |- skos__hiddenLabel mesh__D051676 Potassium Channel, Kir3.3
% 215.26/215.48  |- skos__hiddenLabel mesh__D051676
% 215.26/215.48       G Protein Coupled Inwardly Rectifying Potassium Channel 2
% 215.26/215.48  |- skos__altLabel mesh__D051676 Kir3.3 Potassium Channel
% 215.26/215.48  |- skos__prefLabel mesh__D051676
% 215.26/215.48       G Protein-Coupled Inwardly-Rectifying Potassium Channels
% 215.26/215.48  |- mesh__recordAuthorizer mesh__D051676 sjn
% 215.26/215.48  |- skos__altLabel mesh__D051676 GIRK1 Potassium Channel
% 215.26/215.48  |- skos__hiddenLabel mesh__D051676 Potassium Channel, GIRK1
% 215.26/215.48  |- skos__altLabel mesh__D051676 GIRK2 Potassium Channel
% 215.26/215.48  |- skos__hiddenLabel mesh__D051676 Potassium Channels, GIRK
% 215.26/215.48  |- skos__altLabel mesh__D051676 GIRK4 Potassium Channel
% 215.26/215.48  |- skos__altLabel mesh__D051676 Kir3 Potassium Channels
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D051676 2006
% 215.26/215.48  |- skos__hiddenLabel mesh__D051676 Potassium Channel, Kir3.1
% 215.26/215.48  |- skos__hiddenLabel mesh__D051676 Potassium Channel, GIRK2
% 215.26/215.48  |- skos__hiddenLabel mesh__D051676
% 215.26/215.48       G Protein Coupled Inwardly Rectifying Potassium Channel 3
% 215.26/215.48  |- mesh__dateEstablished mesh__D051676 2006-01-01
% 215.26/215.48  |- skos__altLabel mesh__D051676 Kir3.2 Potassium Channel
% 215.26/215.48  |- mesh__recordMaintainer mesh__D051676 DRC
% 215.26/215.48  |- skos__hiddenLabel mesh__D051676 G Protein Activated Potassium Channels
% 215.26/215.48  |- skos__altLabel mesh__D051676 GIRK Potassium Channels
% 215.26/215.48  |- skos__altLabel mesh__D051676 G Protein-Activated Potassium Channels
% 215.26/215.48  |- skos__broader mesh__D051676smesh__D024661
% 215.26/215.48  |- skos__scopeNote mesh__D051676
% 215.26/215.48       A family of inwardly-rectifying potassium channels that are activated by PERTUSSIS TOXIN sensitive G-PROTEIN-COUPLED RECEPTORS. GIRK potassium channels are primarily activated by the complex of GTP-BINDING PROTEIN BETA SUBUNITS and GTP-BINDING PROTEIN GAMMA SUBUNITS.%A%    
% 215.26/215.48  |- skos__hiddenLabel mesh__D051676 Potassium Channels, Kir3
% 215.26/215.48  |- skos__altLabel mesh__D004222 Disyston
% 215.26/215.48  |- mesh__dateEstablished mesh__D004222 1991-01-01
% 215.26/215.48  |- mesh__historyNote mesh__D004222
% 215.26/215.48       91%28%72%29%; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90%A%  
% 215.26/215.48  |- mesh__recordMaintainer mesh__D004222 ssb
% 215.26/215.48  |- mesh__recordOriginator mesh__D004222 NLM
% 215.26/215.48  |- skos__annotation mesh__D004222 TN 111 for eff on insects   
% 215.26/215.48  |- mesh__dateCreated mesh__D004222 1999-01-01
% 215.26/215.48  |- rdf__type mesh__D004222sskos__Concept
% 215.26/215.48  |- mesh__publicMeSHNote mesh__D004222
% 215.26/215.48       91; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90%A%  
% 215.26/215.48  |- skos__altLabel mesh__D004222 Thiodemeton
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D004222 2006
% 215.26/215.48  |- mesh__recordAuthorizer mesh__D004222 sjn
% 215.26/215.48  |- skos__hiddenLabel mesh__D004222 Di Syston
% 215.26/215.48  |- mesh__dateRevised mesh__D004222 2005-06-30
% 215.26/215.48  |- skos__historyNote mesh__D004222 Insecticides %28%1966-1971%29%
% 215.26/215.48  |- skos__prefLabel mesh__D004222 Disulfoton
% 215.26/215.48  |- skos__scopeNote mesh__D004222 An organothiophosphate insecticide.     
% 215.26/215.48  |- skos__broader mesh__D004222smesh__D009946
% 215.26/215.48  |- skos__hiddenLabel mesh__D017948 Rod Photoreceptor
% 215.26/215.48  |- skos__prefLabel mesh__D017948 Rods %28%Retina%29%
% 215.26/215.48  |- mesh__recordMaintainer mesh__D017948 NDW
% 215.26/215.48  |- skos__broader mesh__D017948smesh__D020419
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D017948 2003
% 215.26/215.48  |- mesh__historyNote mesh__D017948 94   
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D017948 2000
% 215.26/215.48  |- mesh__publicMeSHNote mesh__D017948 94   
% 215.26/215.48  |- skos__annotation mesh__D017948
% 215.26/215.48       photoreceptors in vertebrate retina; DF: RODS   
% 215.26/215.48  |- skos__scopeNote mesh__D017948
% 215.26/215.48       One of the two photoreceptor cell types of the vertebrate retina. In rods the photopigment is in stacks of membranous disks separate from the outer cell membrane. Rods are more sensitive to light than cones, but rod mediated vision has less spatial and temporal resolution than cone vision.%A%    
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D017948 2004
% 215.26/215.48  |- skos__hiddenLabel mesh__D017948 Photoreceptor, Rod
% 215.26/215.48  |- skos__hiddenLabel mesh__D017948 Rod %28%Retina%29%
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D017948 2001
% 215.26/215.48  |- mesh__dateCreated mesh__D017948 1993-06-16
% 215.26/215.48  |- mesh__dateEstablished mesh__D017948 1994-01-01
% 215.26/215.48  |- rdf__type mesh__D017948sskos__Concept
% 215.26/215.48  |- skos__altLabel mesh__D017948 Rod Photoreceptors
% 215.26/215.48  |- skos__altLabel mesh__D017948 Photoreceptors, Rod
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D017948 2005
% 215.26/215.48  |- mesh__dateRevised mesh__D017948 1998-06-11
% 215.26/215.48  |- mesh__recordAuthorizer mesh__D017948 SJN
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D017948 2002
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D017948 2006
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D017948 1999
% 215.26/215.48  |- mesh__recordOriginator mesh__D017948 RAZ
% 215.26/215.48  |- skos__historyNote mesh__D017948 Photoreceptors %28%1971-1993%29%
% 215.26/215.48  |- skos__historyNote mesh__D017948 Rods and Cones %28%1966-1993%29%
% 215.26/215.48  |- skos__hiddenLabel mesh__D042341 Hormones, Gonadal
% 215.26/215.48  |- mesh__recordAuthorizer mesh__D042341 sjn
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D042341 2006
% 215.26/215.48  |- mesh__historyNote mesh__D042341 2004   
% 215.26/215.48  |- mesh__publicMeSHNote mesh__D042341 2004   
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D042341 2004
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D042341 2005
% 215.26/215.48  |- skos__annotation mesh__D042341 GEN or unspecified; prefer specifics   
% 215.26/215.48  |- mesh__recordOriginator mesh__D042341 lkt
% 215.26/215.48  |- skos__prefLabel mesh__D042341 Gonadal Hormones
% 215.26/215.48  |- mesh__dateEstablished mesh__D042341 2004-01-01
% 215.26/215.48  |- rdf__type mesh__D042341sskos__Concept
% 215.26/215.48  |- mesh__recordMaintainer mesh__D042341 lkt
% 215.26/215.48  |- mesh__dateCreated mesh__D042341 2003-07-09
% 215.26/215.48  |- skos__broader mesh__D042341smesh__D006728
% 215.26/215.48  |- skos__scopeNote mesh__D042341
% 215.26/215.48       Hormones produced by the GONADS, including both steroid and peptide hormones. The major steroid hormones include ESTRADIOL and PROGESTERONE from the OVARY, and TESTOSTERONE from the TESTIS. The major peptide hormones include ACTIVINS and INHIBINS.%A%    
% 215.26/215.48  |- skos__broader mesh__D010455Q000096smesh__D010455
% 215.26/215.48  |- mesh__preferredCombination mesh__D010455Q000096smesh__D010452
% 215.26/215.48  |- rdf__type mesh__D010455Q000096smesh__CompoundConcept
% 215.26/215.48  |- mesh__publicMeSHNote mesh__D003928
% 215.26/215.48       65; KIMMELSTIEL-WILSON SYNDROME was heading 1963-76   
% 215.26/215.48  |- mesh__recordMaintainer mesh__D003928 lkt
% 215.26/215.48  |- skos__altLabel mesh__D003928 Diabetic Kidney Disease
% 215.26/215.48  |- skos__hiddenLabel mesh__D003928 Glomerulosclerosis, Nodular
% 215.26/215.48  |- mesh__dateCreated mesh__D003928 1999-01-01
% 215.26/215.48  |- skos__broader mesh__D003928smesh__D048909
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D003928 2005
% 215.26/215.48  |- mesh__recordOriginator mesh__D003928 NLM
% 215.26/215.48  |- skos__hiddenLabel mesh__D003928 Nephropathies, Diabetic
% 215.26/215.48  |- skos__altLabel mesh__D003928 Diabetic Nephropathy
% 215.26/215.48  |- mesh__dateRevised mesh__D003928 2004-07-07
% 215.26/215.48  |- skos__altLabel mesh__D003928 Kimmelstiel-Wilson Disease
% 215.26/215.48  |- mesh__activeMeSHYear mesh__D003928 2006
% 215.26/215.48  |- skos__altLabel mesh__D003928 Glomerulosclerosis, Diabetic
% 215.26/215.48  |- skos__hiddenLabel mesh__D003928 Kidney Diseases, Diabetic
% 215.26/215.48  |- mesh__historyNote mesh__D003928
% 215.26/215.48       65%28%64%29%; KIMMELSTIEL-WILSON SYNDROME was heading 1963-76   
% 215.26/215.48  |- skos__altLabel mesh__D003928 Intracapillary Glomerulosclerosis
% 215.26/215.48  |- skos__broader mesh__D003928smesh__D007674
% 215.26/215.48  |- skos__hiddenLabel mesh__D003928 Diabetic Kidney Diseases
% 215.26/215.48  |- mesh__recordAuthorizer mesh__D003928 sjn
% 215.26/215.48  |- mesh__dateEstablished mesh__D003928 1965-01-01
% 215.26/215.48  |- skos__hiddenLabel mesh__D003928 Kidney Disease, Diabetic
% 215.26/215.48  |- skos__annotation mesh__D003928
% 215.26/215.48       coord IM with specific kidney dis %28%IM%29%; do not confuse with DIABETES INSIPIDUS, NEPHROGENIC, a form of diabetes insipidus%A%  
% 215.26/215.48  |- skos__prefLabel mesh__D003928 Diabetic Nephropathies
% 215.26/215.49  |- mesh__onlineNote mesh__D003928
% 215.26/215.49       use DIABETIC NEPHROPATHIES to search KIMMELSTIEL-WILSON SYNDROME 1966-76%A%  
% 215.26/215.49  |- skos__hiddenLabel mesh__D003928 Syndrome, Kimmelstiel-Wilson
% 215.26/215.49  |- skos__scopeNote mesh__D003928
% 215.26/215.49       KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.%A%    
% 215.26/215.49  |- skos__altLabel mesh__D003928 Kimmelstiel-Wilson Syndrome
% 215.26/215.49  |- skos__hiddenLabel mesh__D003928 Kimmelstiel Wilson Syndrome
% 215.26/215.49  |- rdf__type mesh__D003928sskos__Concept
% 215.26/215.49  |- skos__hiddenLabel mesh__D003928 Nephropathy, Diabetic
% 215.26/215.49  |- skos__hiddenLabel mesh__D003928 Kimmelstiel Wilson Disease
% 215.26/215.49  |- skos__altLabel mesh__D003928 Nodular Glomerulosclerosis
% 215.26/215.49  |- mesh__recordMaintainer mesh__D014650 NLM
% 215.26/215.49  |- skos__hiddenLabel mesh__D014650 Nervorum, Vasa
% 215.26/215.49  |- skos__prefLabel mesh__D014650 Vasa Nervorum
% 215.26/215.49  |- mesh__publicMeSHNote mesh__D014650
% 215.26/215.49       91; was see under BLOOD VESSELS 1964-90   
% 215.26/215.49  |- skos__scopeNote mesh__D014650 Blood vessels supplying the nerves.     
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014650 2002
% 215.26/215.49  |- mesh__historyNote mesh__D014650
% 215.26/215.49       91%28%64%29%; was see under BLOOD VESSELS 1964-90   
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014650 1996
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014650 1991
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014650 2003
% 215.26/215.49  |- rdf__type mesh__D014650sskos__Concept
% 215.26/215.49  |- skos__hiddenLabel mesh__D014650 Vasa Nervorums
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014650 1998
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014650 2005
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014650 1992
% 215.26/215.49  |- mesh__dateRevised mesh__D014650 1990-04-13
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014650 1997
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014650 1994
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014650 2004
% 215.26/215.49  |- skos__broader mesh__D014650smesh__D001808
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014650 1999
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014650 2006
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014650 2000
% 215.26/215.49  |- mesh__dateCreated mesh__D014650 1999-01-01
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014650 1993
% 215.26/215.49  |- mesh__recordOriginator mesh__D014650 NLM
% 215.26/215.49  |- mesh__dateEstablished mesh__D014650 1991-01-01
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014650 2001
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014650 1995
% 215.26/215.49  |- mesh__recordAuthorizer mesh__D014650 PLS
% 215.26/215.49  |- skos__hiddenLabel mesh__D014650 Nervorums, Vasa
% 215.26/215.49  |- skos__broader mesh__D008613smesh__D011090
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D008613 2006
% 215.26/215.49  |- skos__altLabel mesh__D008613 Methylpartricin
% 215.26/215.49  |- skos__hiddenLabel mesh__D008613 SPA S 160
% 215.26/215.49  |- mesh__dateCreated mesh__D008613 1975-07-18
% 215.26/215.49  |- skos__broader mesh__D008613smesh__D018942
% 215.26/215.49  |- skos__historyNote mesh__D008613 Polyenes %28%1974-1975%29%
% 215.26/215.49  |- skos__altLabel mesh__D008613 Methyl Partricin
% 215.26/215.49  |- mesh__historyNote mesh__D008613
% 215.26/215.49       91%28%81%29%; was see under POLYENES 1981-90; was METHYL PARTRICIN see under POLYENES 1976-80%A%  
% 215.26/215.49  |- rdf__type mesh__D008613sskos__Concept
% 215.26/215.49  |- skos__scopeNote mesh__D008613
% 215.26/215.49       Polyene macrolide antibiotic with unknown composition. It is obtained from Streptomyces aureofaciens. It is used as an antifungal agent, an antiprotozoal agent, and in the treatment of BENIGN PROSTATIC HYPERTROPHY.%A%    
% 215.26/215.49  |- mesh__onlineNote mesh__D008613
% 215.26/215.49       use MEPARTRICIN to search METHYL PARTRICIN 1976-80   
% 215.26/215.49  |- skos__prefLabel mesh__D008613 Mepartricin
% 215.26/215.49  |- mesh__dateEstablished mesh__D008613 1991-01-01
% 215.26/215.49  |- mesh__dateRevised mesh__D008613 2004-07-07
% 215.26/215.49  |- mesh__recordAuthorizer mesh__D008613 sjn
% 215.26/215.49  |- mesh__publicMeSHNote mesh__D008613
% 215.26/215.49       91; was see under POLYENES 1981-90; was METHYL PARTRICIN see under POLYENES 1976-80%A%  
% 215.26/215.49  |- skos__hiddenLabel mesh__D008613 SPAS 160
% 215.26/215.49  |- mesh__recordMaintainer mesh__D008613 ssb
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D008613 2005
% 215.26/215.49  |- mesh__recordOriginator mesh__D008613 SH
% 215.26/215.49  |- rdf__type mesh__D000630sskos__Concept
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D000630 2006
% 215.26/215.49  |- skos__scopeNote mesh__D000630
% 215.26/215.49       A folic acid derivative used as a rodenticide that has been shown to be teratogenic.%A%    
% 215.26/215.49  |- skos__broader mesh__D000630smesh__D011622
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D000630 2003
% 215.26/215.49  |- skos__hiddenLabel mesh__D000630 Disodium Salt Aminopterin
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D000630 2004
% 215.26/215.49  |- skos__hiddenLabel mesh__D000630 Sodium, Aminopterin
% 215.26/215.49  |- skos__prefLabel mesh__D000630 Aminopterin
% 215.26/215.49  |- mesh__dateRevised mesh__D000630 2001-07-25
% 215.26/215.49  |- mesh__dateCreated mesh__D000630 1999-01-01
% 215.26/215.49  |- mesh__recordMaintainer mesh__D000630 ssb
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D000630 2002
% 215.26/215.49  |- mesh__recordOriginator mesh__D000630 NLM
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D000630 2005
% 215.26/215.49  |- mesh__recordAuthorizer mesh__D000630 sjn
% 215.26/215.49  |- mesh__onlineNote mesh__D013558 search OXADIAZOLES 1968-74   
% 215.26/215.49  |- rdf__type mesh__D013558sskos__Concept
% 215.26/215.49  |- skos__broader mesh__D013558smesh__D010069
% 215.26/215.49  |- skos__scopeNote mesh__D013558
% 215.26/215.49       OXADIAZOLES bearing an oxygen at the 5-position. They are mesoionic, with delocalized positive and negative charges.%A%    
% 215.26/215.49  |- mesh__dateCreated mesh__D013558 1999-01-01
% 215.26/215.49  |- mesh__historyNote mesh__D013558
% 215.26/215.49       91%28%75%29%; was see under OXADIAZOLES 1975-90   
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D013558 2006
% 215.26/215.49  |- skos__prefLabel mesh__D013558 Sydnones
% 215.26/215.49  |- mesh__recordMaintainer mesh__D013558 ssb
% 215.26/215.49  |- mesh__publicMeSHNote mesh__D013558
% 215.26/215.49       91; was see under OXADIAZOLES 1975-90   
% 215.26/215.49  |- mesh__dateRevised mesh__D013558 2005-06-30
% 215.26/215.49  |- mesh__dateEstablished mesh__D013558 1991-01-01
% 215.26/215.49  |- mesh__recordAuthorizer mesh__D013558 sjn
% 215.26/215.49  |- mesh__recordOriginator mesh__D013558 NLM
% 215.26/215.49  |- skos__scopeNote mesh__D018243
% 215.26/215.49       A malignant neoplasm consisting of elements of teratoma with those of embryonal carcinoma or choriocarcinoma, or both. It occurs most often in the testis. %28%Dorland, 27th ed%29%%A%    
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D018243 2004
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D018243 1996
% 215.26/215.49  |- skos__annotation mesh__D018243
% 215.26/215.49       /blood supply /chem /second /secret /ultrastruct; coord IM with probably TESTICULAR NEOPLASMS %28%IM%29%%A%  
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D018243 2003
% 215.26/215.49  |- mesh__recordMaintainer mesh__D018243 KEV
% 215.26/215.49  |- mesh__recordAuthorizer mesh__D018243 PLS
% 215.26/215.49  |- skos__broader mesh__D018243smesh__D009373
% 215.26/215.49  |- mesh__historyNote mesh__D018243 94   
% 215.26/215.49  |- mesh__publicMeSHNote mesh__D018243 94   
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D018243 1999
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D018243 2002
% 215.26/215.49  |- mesh__recordOriginator mesh__D018243 PLS
% 215.26/215.49  |- skos__hiddenLabel mesh__D018243 Teratocarcinomas
% 215.26/215.49  |- mesh__dateCreated mesh__D018243 1993-06-25
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D018243 2006
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D018243 1998
% 215.26/215.49  |- mesh__dateEstablished mesh__D018243 1994-01-01
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D018243 2001
% 215.26/215.49  |- skos__prefLabel mesh__D018243 Teratocarcinoma
% 215.26/215.49  |- mesh__dateRevised mesh__D018243 1995-06-08
% 215.26/215.49  |- skos__historyNote mesh__D018243 Teratoma %28%1967-1993%29%
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D018243 1997
% 215.26/215.49  |- rdf__type mesh__D018243sskos__Concept
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D018243 2000
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D018243 2005
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D010260 2001
% 215.26/215.49  |- skos__hiddenLabel mesh__D010260 Paranoid Personalities
% 215.26/215.49  |- skos__altLabel mesh__D010260 Personality Disorder, Paranoid
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D010260 2006
% 215.26/215.49  |- mesh__dateEstablished mesh__D010260 1991-01-01
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D010260 2005
% 215.26/215.49  |- mesh__recordAuthorizer mesh__D010260 SJN
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D010260 2000
% 215.26/215.49  |- skos__broader mesh__D010260smesh__D010554
% 215.26/215.49  |- skos__altLabel mesh__D010260 Paranoid Personality
% 215.26/215.49  |- skos__prefLabel mesh__D010260 Paranoid Personality Disorder
% 215.26/215.49  |- mesh__recordMaintainer mesh__D010260 JLS
% 215.26/215.49  |- mesh__recordOriginator mesh__D010260 NLM
% 215.26/215.49  |- mesh__dateRevised mesh__D010260 1997-06-20
% 215.26/215.49  |- skos__hiddenLabel mesh__D010260 Disorder, Paranoid Personality
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D010260 2002
% 215.26/215.49  |- skos__hiddenLabel mesh__D010260 Disorders, Paranoid Personality
% 215.26/215.49  |- mesh__publicMeSHNote mesh__D010260
% 215.26/215.49       91; was see under PERSONALITY DISORDERS 1979-90; was PARANOID PERSONALITY see under PARANOIA 1969-78%A%  
% 215.26/215.49  |- skos__hiddenLabel mesh__D010260 Personality, Paranoid
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D010260 1999
% 215.26/215.49  |- mesh__historyNote mesh__D010260
% 215.26/215.49       91%28%79%29%; was see under PERSONALITY DISORDERS 1979-90; was PARANOID PERSONALITY see under PARANOIA 1969-78%A%  
% 215.26/215.49  |- rdf__type mesh__D010260sskos__Concept
% 215.26/215.49  |- skos__hiddenLabel mesh__D010260 Paranoid Personality Disorders
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D010260 2004
% 215.26/215.49  |- skos__hiddenLabel mesh__D010260 Personality Disorders, Paranoid
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D010260 1998
% 215.26/215.49  |- mesh__onlineNote mesh__D010260
% 215.26/215.49       use PARANOID PERSONALITY DISORDER to search PARANOID PERSONALITY 1975-79; use PARANOID DISORDERS 1969-74%A%  
% 215.26/215.49  |- skos__hiddenLabel mesh__D010260 Personalities, Paranoid
% 215.26/215.49  |- skos__scopeNote mesh__D010260
% 215.26/215.49       A personality disorder characterized by the avoidance of accepting deserved blame and an unwarranted view of others as malevolent. The latter is expressed as suspiciousness, hypersensitivity, and mistrust.%A%    
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D010260 2003
% 215.26/215.49  |- mesh__dateCreated mesh__D010260 1999-01-01
% 215.26/215.49  |- rdf__type mesh__D051677sskos__Concept
% 215.26/215.49  |- skos__hiddenLabel mesh__D051677 Malignant Fibrous Histiocytomas
% 215.26/215.49  |- mesh__dateEstablished mesh__D051677 2006-01-01
% 215.26/215.49  |- skos__broader mesh__D051677smesh__D051642
% 215.26/215.49  |- skos__scopeNote mesh__D051677
% 215.26/215.49       The most commonly diagnosed soft tissue sarcoma. It is a neoplasm with a fibrohistiocytic appearance found chiefly in later adult life, with peak incidence in the 7th decade.%A%    
% 215.26/215.49  |- skos__historyNote mesh__D051677
% 215.26/215.49       Histiocytoma, Benign Fibrous %28%1972-2005%29%
% 215.26/215.49  |- mesh__recordOriginator mesh__D051677 ags
% 215.26/215.49  |- mesh__historyNote mesh__D051677 2006   
% 215.26/215.49  |- skos__hiddenLabel mesh__D051677 Fibrous Histiocytomas, Malignant
% 215.26/215.49  |- skos__broader mesh__D051677smesh__D012509
% 215.26/215.49  |- skos__prefLabel mesh__D051677 Histiocytoma, Malignant Fibrous
% 215.26/215.49  |- skos__hiddenLabel mesh__D051677 Histiocytomas, Malignant Fibrous
% 215.26/215.49  |- mesh__dateCreated mesh__D051677 2005-06-30
% 215.26/215.49  |- skos__altLabel mesh__D051677 Malignant Fibrous Histiocytoma
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D051677 2006
% 215.26/215.49  |- mesh__publicMeSHNote mesh__D051677 2006   
% 215.26/215.49  |- mesh__recordAuthorizer mesh__D051677 sjn
% 215.26/215.49  |- mesh__recordMaintainer mesh__D051677 ags
% 215.26/215.49  |- skos__annotation mesh__D051677
% 215.26/215.49       do not confuse with MALIGNANT HISTIOCYTOSIS, a lymphoma; coordinate IM with precoordinated organ/neoplasm term %28%IM%29%%A%  
% 215.26/215.49  |- skos__hiddenLabel mesh__D051677 Fibrous Histiocytoma, Malignant
% 215.26/215.49  |- skos__broader mesh__D017949smesh__D020419
% 215.26/215.49  |- skos__altLabel mesh__D017949 Photoreceptors, Cone
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D017949 2001
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D017949 2004
% 215.26/215.49  |- skos__prefLabel mesh__D017949 Cones %28%Retina%29%
% 215.26/215.49  |- skos__altLabel mesh__D017949 Cone Photoreceptors
% 215.26/215.49  |- mesh__recordAuthorizer mesh__D017949 SJN
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D017949 2002
% 215.26/215.49  |- rdf__type mesh__D017949sskos__Concept
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D017949 2005
% 215.26/215.49  |- mesh__recordOriginator mesh__D017949 RAZ
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D017949 2006
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D017949 1999
% 215.26/215.49  |- skos__historyNote mesh__D017949 Photoreceptors %28%1971-1993%29%
% 215.26/215.49  |- mesh__dateCreated mesh__D017949 1993-06-18
% 215.26/215.49  |- mesh__recordMaintainer mesh__D017949 NDW
% 215.26/215.49  |- mesh__dateRevised mesh__D017949 1998-06-10
% 215.26/215.49  |- skos__historyNote mesh__D017949 Rods and Cones %28%1966-1993%29%
% 215.26/215.49  |- skos__hiddenLabel mesh__D017949 Cone %28%Retina%29%
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D017949 2000
% 215.26/215.49  |- mesh__publicMeSHNote mesh__D017949 94   
% 215.26/215.49  |- mesh__dateEstablished mesh__D017949 1994-01-01
% 215.26/215.49  |- skos__hiddenLabel mesh__D017949 Photoreceptor, Cone
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D017949 2003
% 215.26/215.49  |- skos__annotation mesh__D017949
% 215.26/215.49       photoreceptors in vertebrate retina; DF: CONES   
% 215.26/215.49  |- mesh__historyNote mesh__D017949 94   
% 215.26/215.49  |- skos__scopeNote mesh__D017949
% 215.26/215.49       One of the two photoreceptor cell types in the vertebrate retina. In cones the photopigment is in invaginations of the cell membrane of the outer segment. Cones are less sensitive to light than rods, but they provide vision with higher spatial and temporal acuity, and the combination of signals from cones with different pigments allows color vision.%A%    
% 215.26/215.49  |- skos__hiddenLabel mesh__D017949 Cone Photoreceptor
% 215.26/215.49  |- skos__altLabel mesh__D003929 Diabetic Neuropathy, Painful
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Diabetic Polyneuropathies
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Diabetic Asymmetric Polyneuropathies
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Diabetic Autonomic Neuropathies
% 215.26/215.49  |- skos__annotation mesh__D003929
% 215.26/215.49       coord IM with specific neurol dis %28%IM%29% but do not coord with PERIPHERAL NERVOUS SYSTEM DISEASES for %22%diabetic peripheral neuropathy%22%%A%  
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D003929 2006
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Neuropathy, Painful Diabetic
% 215.26/215.49  |- skos__altLabel mesh__D003929 Mononeuropathy, Diabetic
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Neuropathies, Diabetic Autonomic
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Neuropathy, Diabetic Autonomic
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Diabetic Mononeuropathy Simplices
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Autonomic Neuropathy, Diabetic
% 215.26/215.49  |- skos__broader mesh__D003929smesh__D010523
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Diabetic Neuralgias
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Painful Diabetic Neuropathies
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D003929 2005
% 215.26/215.49  |- rdf__type mesh__D003929sskos__Concept
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Diabetic Mononeuropathies
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Mononeuropathy Simplices, Diabetic
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Neuropathies, Painful Diabetic
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Polyneuropathies, Diabetic Asymmetric
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Polyneuropathies, Diabetic
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Simplex, Diabetic Mononeuropathy
% 215.26/215.49  |- skos__broader mesh__D003929smesh__D048909
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Neuralgias, Diabetic
% 215.26/215.49  |- skos__altLabel mesh__D003929 Diabetic Mononeuropathy Simplex
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Polyneuropathy, Diabetic
% 215.26/215.49  |- mesh__recordOriginator mesh__D003929 NLM
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Amyotrophies, Diabetic
% 215.26/215.49  |- skos__prefLabel mesh__D003929 Diabetic Neuropathies
% 215.26/215.49  |- mesh__recordMaintainer mesh__D003929 lkt
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Painful Diabetic Neuropathy
% 215.26/215.49  |- skos__altLabel mesh__D003929 Neuralgia, Diabetic
% 215.26/215.49  |- mesh__dateRevised mesh__D003929 2004-07-07
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Asymmetric Polyneuropathies, Diabetic
% 215.26/215.49  |- mesh__dateCreated mesh__D003929 1999-01-01
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Diabetic Neuropathies, Painful
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Diabetic Amyotrophies
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Asymmetric Polyneuropathy, Diabetic
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Autonomic Neuropathies, Diabetic
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Mononeuropathies, Diabetic
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Neuropathies, Diabetic
% 215.26/215.49  |- mesh__recordAuthorizer mesh__D003929 sjn
% 215.26/215.49  |- skos__scopeNote mesh__D003929
% 215.26/215.49       Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves %28%VASA NERVORUM%29%. Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy %28%see OCULOMOTOR NERVE DISEASES%29%; MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. %28%From Adams et al., Principles of Neurology, 6th ed, p1325%29%%A%    
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Neuropathy, Diabetic
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Diabetic Neuropathy
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Simplices, Diabetic Mononeuropathy
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Mononeuropathy Simplex, Diabetic
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Polyneuropathy, Diabetic Asymmetric
% 215.26/215.49  |- skos__hiddenLabel mesh__D003929 Amyotrophy, Diabetic
% 215.26/215.49  |- mesh__recordOriginator mesh__D014651 NLM
% 215.26/215.49  |- mesh__publicMeSHNote mesh__D014651 74   
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014651 1994
% 215.26/215.49  |- mesh__dateRevised mesh__D014651 1992-05-18
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014651 2001
% 215.26/215.49  |- skos__scopeNote mesh__D014651
% 215.26/215.49       Nutrient blood vessels which supply the walls of large arteries or veins.%A%    
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014651 1997
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014651 2004
% 215.26/215.49  |- rdf__type mesh__D014651sskos__Concept
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014651 2000
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014651 1993
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014651 1996
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014651 2003
% 215.26/215.49  |- skos__hiddenLabel mesh__D014651 Vasorum, Vasa
% 215.26/215.49  |- skos__prefLabel mesh__D014651 Vasa Vasorum
% 215.26/215.49  |- skos__hiddenLabel mesh__D014651 Vasorums, Vasa
% 215.26/215.49  |- skos__hiddenLabel mesh__D014651 Vasa Vasorums
% 215.26/215.49  |- mesh__recordAuthorizer mesh__D014651 PLS
% 215.26/215.49  |- mesh__dateEstablished mesh__D014651 1974-01-01
% 215.26/215.49  |- mesh__recordMaintainer mesh__D014651 TAP
% 215.26/215.49  |- mesh__historyNote mesh__D014651 74%28%65%29%   
% 215.26/215.49  |- skos__broader mesh__D014651smesh__D001808
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014651 1999
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014651 2006
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014651 2002
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014651 1995
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014651 1998
% 215.26/215.49  |- mesh__dateCreated mesh__D014651 1999-01-01
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D014651 2005
% 215.26/215.49  |- mesh__dateCreated mesh__D008614 1999-01-01
% 215.26/215.49  |- mesh__publicMeSHNote mesh__D008614
% 215.26/215.49       OPERIDINE was see MEPERIDINE 1978-91   
% 215.26/215.49  |- skos__broader mesh__D008614smesh__D007540
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D008614 2002
% 215.26/215.49  |- skos__scopeNote mesh__D008614
% 215.26/215.49       A narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor. Prolonged use may lead to dependence of the morphine type; withdrawal symptoms appear more rapidly than with morphine and are of shorter duration.%A%    
% 215.26/215.49  |- mesh__historyNote mesh__D008614 OPERIDINE was see MEPERIDINE 1978-91   
% 215.26/215.49  |- mesh__recordMaintainer mesh__D008614 CCR
% 215.26/215.49  |- skos__altLabel mesh__D008614 Isonipecain
% 215.26/215.49  |- skos__hiddenLabel mesh__D008614 Operidine EPJ I
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D008614 2005
% 215.26/215.49  |- mesh__onlineNote mesh__D008614
% 215.26/215.49       use MEPERIDINE to search OPERIDINE 1978-91 %28%use PHENOPERIDINE 1992 forward%29%%A%  
% 215.26/215.49  |- skos__altLabel mesh__D008614 Pethidine
% 215.26/215.49  |- mesh__dateRevised mesh__D008614 2001-07-25
% 215.26/215.49  |- mesh__recordOriginator mesh__D008614 NLM
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D008614 2006
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D008614 2003
% 215.26/215.49  |- skos__altLabel mesh__D008614 Lydol
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D008614 2004
% 215.26/215.49  |- rdf__type mesh__D008614sskos__Concept
% 215.26/215.49  |- mesh__recordAuthorizer mesh__D008614 sjn
% 215.26/215.49  |- skos__prefLabel mesh__D008614 Meperidine
% 215.26/215.49  |- skos__broader mesh__D000631smesh__D000588
% 215.26/215.49  |- mesh__dateCreated mesh__D000631 1977-12-08
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D000631 2005
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D000631 1999
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D000631 2000
% 215.26/215.49  |- skos__annotation mesh__D000631 = pyridinamines %26% pyridylamines   
% 215.26/215.49  |- mesh__dateRevised mesh__D000631 1992-05-07
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D000631 1996
% 215.26/215.49  |- mesh__recordOriginator mesh__D000631 RLS
% 215.26/215.49  |- mesh__recordMaintainer mesh__D000631 TGC
% 215.26/215.49  |- mesh__recordAuthorizer mesh__D000631 PLS
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D000631 1993
% 215.26/215.49  |- skos__historyNote mesh__D000631 Pyridines %28%1966-1978%29%
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D000631 2006
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D000631 2001
% 215.26/215.49  |- mesh__publicMeSHNote mesh__D000631
% 215.26/215.49       79; METHAPYRILENE was see under PYRIDINES 1975-78, was see under ANTIHISTAMINICS 1963-74; PHENAZOPYRIDINE %26% PYRILAMINE were see under PYRIDINES 1975-78%A%  
% 215.26/215.49  |- mesh__historyNote mesh__D000631 79   
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D000631 2003
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D000631 1997
% 215.26/215.49  |- skos__prefLabel mesh__D000631 Aminopyridines
% 215.26/215.49  |- skos__broader mesh__D000631smesh__D011725
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D000631 2004
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D000631 1994
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D000631 2002
% 215.26/215.49  |- skos__historyNote mesh__D000631 Amines %28%1966-1978%29%
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D000631 1998
% 215.26/215.49  |- rdf__type mesh__D000631sskos__Concept
% 215.26/215.49  |- skos__scopeNote mesh__D000631
% 215.26/215.49       Pyridines substituted in any position with an amino group. May be hydrogenated, but must retain at least one double bond.%A%    
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D000631 1995
% 215.26/215.49  |- mesh__dateEstablished mesh__D000631 1979-01-01
% 215.26/215.49  |- mesh__dateCreated mesh__D013559 1999-01-01
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D013559 2004
% 215.26/215.49  |- rdf__type mesh__D013559sskos__Concept
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D013559 2003
% 215.26/215.49  |- skos__broader mesh__D013559smesh__D001686
% 215.26/215.49  |- mesh__recordAuthorizer mesh__D013559 sjn
% 215.26/215.49  |- mesh__recordOriginator mesh__D013559 NLM
% 215.26/215.49  |- skos__related mesh__D013559smesh__D038821
% 215.26/215.49  |- mesh__recordMaintainer mesh__D013559 ags
% 215.26/215.49  |- skos__scopeNote mesh__D013559
% 215.26/215.49       The living together of organisms of different species.     
% 215.26/215.49  |- mesh__dateRevised mesh__D013559 2002-07-03
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D013559 2006
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D013559 2005
% 215.26/215.49  |- skos__hiddenLabel mesh__D013559 Symbioses
% 215.26/215.49  |- skos__prefLabel mesh__D013559 Symbiosis
% 215.26/215.49  |- mesh__dateEstablished mesh__D018244 1994-01-01
% 215.26/215.49  |- skos__altLabel mesh__D018244 Yeast Artificial Chromosomes
% 215.26/215.49  |- skos__altLabel mesh__D018244 YACs %28%Chromosomes%29%
% 215.26/215.49  |- mesh__recordAuthorizer mesh__D018244 sjn
% 215.26/215.49  |- skos__altLabel mesh__D018244 Chromosomes, Yeast Artificial
% 215.26/215.49  |- mesh__recordMaintainer mesh__D018244 nns
% 215.26/215.49  |- mesh__publicMeSHNote mesh__D018244
% 215.26/215.49       2002; see CHROMOSOMES, YEAST ARTIFICIAL 1994-2001   
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D018244 2006
% 215.26/215.49  |- skos__broader mesh__D018244smesh__D015825
% 215.26/215.49  |- mesh__recordOriginator mesh__D018244 PXP
% 215.26/215.49  |- mesh__dateRevised mesh__D018244 2003-07-09
% 215.26/215.49  |- skos__altLabel mesh__D018244 YAC %28%Chromosome%29%
% 215.26/215.49  |- skos__prefLabel mesh__D018244 Chromosomes, Artificial, Yeast
% 215.26/215.49  |- skos__broader mesh__D018244smesh__D022201
% 215.26/215.49  |- skos__hiddenLabel mesh__D018244 Artificial Chromosome, Yeast
% 215.26/215.49  |- rdf__type mesh__D018244sskos__Concept
% 215.26/215.49  |- skos__annotation mesh__D018244
% 215.26/215.49       coord with specific yeast /genet only if particularly discussed; DF: note short X ref%A%  
% 215.26/215.49  |- skos__hiddenLabel mesh__D018244 Chromosome, Yeast Artificial
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D018244 2005
% 215.26/215.49  |- mesh__dateCreated mesh__D018244 1993-06-03
% 215.26/215.49  |- skos__historyNote mesh__D018244 Chromosomes, Fungal %28%1988-1993%29%
% 215.26/215.49  |- skos__hiddenLabel mesh__D018244 Yeast Artificial Chromosome
% 215.26/215.49  |- skos__scopeNote mesh__D018244
% 215.26/215.49       Chromosomes in which fragments of exogenous DNA ranging in length up to several hundred kilobase pairs have been cloned into yeast through ligation to vector sequences. These artificial chromosomes are used extensively in molecular biology for the construction of comprehensive genomic libraries of higher organisms.%A%    
% 215.26/215.49  |- skos__altLabel mesh__D018244 Artificial Chromosomes, Yeast
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D018244 2004
% 215.26/215.49  |- mesh__historyNote mesh__D018244 2002 %28%1994%29%   
% 215.26/215.49  |- skos__broader mesh__D010261smesh__D009943
% 215.26/215.49  |- skos__altLabel mesh__D010261 Diethyl-p-Nitrophenyl Phosphate
% 215.26/215.49  |- skos__hiddenLabel mesh__D010261 E 600
% 215.26/215.49  |- skos__historyNote mesh__D010261 Insecticides %28%1966-1971%29%
% 215.26/215.49  |- skos__annotation mesh__D010261 TN 111 for eff on insects   
% 215.26/215.49  |- mesh__historyNote mesh__D010261 74%28%72%29%   
% 215.26/215.49  |- rdf__type mesh__D010261sskos__Concept
% 215.26/215.49  |- skos__scopeNote mesh__D010261
% 215.26/215.49       An organophosphate cholinesterase inhibitor that is used as a pesticide.%A%    
% 215.26/215.49  |- mesh__publicMeSHNote mesh__D010261 74   
% 215.26/215.49  |- skos__prefLabel mesh__D010261 Paraoxon
% 215.26/215.49  |- mesh__dateRevised mesh__D010261 2004-07-07
% 215.26/215.49  |- mesh__recordAuthorizer mesh__D010261 sjn
% 215.26/215.49  |- skos__hiddenLabel mesh__D010261 Phosphate, Diethyl-p-Nitrophenyl
% 215.26/215.49  |- skos__hiddenLabel mesh__D010261 Diethyl p Nitrophenyl Phosphate
% 215.26/215.49  |- mesh__dateCreated mesh__D010261 1999-01-01
% 215.26/215.49  |- skos__hiddenLabel mesh__D010261 E600
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D010261 2006
% 215.26/215.49  |- mesh__dateEstablished mesh__D010261 1974-01-01
% 215.26/215.49  |- mesh__recordMaintainer mesh__D010261 ssb
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D010261 2005
% 215.26/215.49  |- mesh__recordOriginator mesh__D010261 NLM
% 215.26/215.49  |- skos__scopeNote mesh__D004224
% 215.26/215.49       Twenty-carbon compounds derived from MEVALONIC ACID or deoxyxylulose phosphate.%A%    
% 215.26/215.49  |- skos__hiddenLabel mesh__D004224 Cembrane Diterpenes
% 215.26/215.49  |- skos__altLabel mesh__D004224 Labdanes
% 215.26/215.49  |- mesh__dateRevised mesh__D004224 2003-07-09
% 215.26/215.49  |- skos__altLabel mesh__D004224 Cembranes
% 215.26/215.49  |- mesh__publicMeSHNote mesh__D004224
% 215.26/215.49       74; PHYTOL was see under TERPENES 1968-74   
% 215.26/215.49  |- skos__prefLabel mesh__D004224 Diterpenes
% 215.26/215.49  |- mesh__recordAuthorizer mesh__D004224 sjn
% 215.26/215.49  |- mesh__dateEstablished mesh__D004224 1974-01-01
% 215.26/215.49  |- skos__annotation mesh__D004224 GEN; prefer specifics   
% 215.26/215.49  |- rdf__type mesh__D004224sskos__Concept
% 215.26/215.49  |- mesh__recordMaintainer mesh__D004224 ssb
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D004224 2004
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D004224 2006
% 215.26/215.49  |- skos__altLabel mesh__D004224 Norditerpenoids
% 215.26/215.49  |- skos__altLabel mesh__D004224 Diterpenoids
% 215.26/215.49  |- mesh__activeMeSHYear mesh__D004224 2005
% 215.26/215.49  |- mesh__historyNote mesh__D004224 74   
% 215.26/215.49  |- mesh__recordOriginator mesh__D004224 NLM
% 215.26/215.49  |- skos__broader mesh__D004224smesh__D013729
% 215.26/215.50  |- skos__hiddenLabel mesh__D004224 Labdane Diterpenes
% 215.26/215.50  |- mesh__dateCreated mesh__D004224 1999-01-01
% 215.26/215.50  |- skos__broader mesh__D014652smesh__D002318
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D014652 2002
% 215.26/215.50  |- mesh__dateRevised mesh__D014652 2001-07-25
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D014652 2004
% 215.26/215.50  |- skos__prefLabel mesh__D014652 Vascular Diseases
% 215.26/215.50  |- mesh__recordOriginator mesh__D014652 NLM
% 215.26/215.50  |- rdf__type mesh__D014652sskos__Concept
% 215.26/215.50  |- mesh__onlineNote mesh__D014652
% 215.26/215.50       pre-explosion = VASCULAR DISEASES %28%PX%29%   
% 215.26/215.50  |- skos__hiddenLabel mesh__D014652 Diseases, Vascular
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D014652 2003
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D014652 2006
% 215.26/215.50  |- skos__annotation mesh__D014652
% 215.26/215.50       GEN or unspecified vasc dis but CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS %26% PERIPHERAL VASCULAR DISEASES are also available; inflamm vasc dis = VASCULITIS; vasc compression syndrome: see note on PERIPHERAL VASCULAR DISEASES%A%  
% 215.26/215.50  |- mesh__dateCreated mesh__D014652 1999-01-01
% 215.26/215.50  |- skos__hiddenLabel mesh__D014652 Disease, Vascular
% 215.26/215.50  |- mesh__recordMaintainer mesh__D014652 mdb
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D014652 2005
% 215.26/215.50  |- skos__hiddenLabel mesh__D014652 Vascular Disease
% 215.26/215.50  |- mesh__recordAuthorizer mesh__D014652 sjn
% 215.26/215.50  |- mesh__recordAuthorizer mesh__D008615 sjn
% 215.26/215.50  |- skos__prefLabel mesh__D008615 Mephenesin
% 215.26/215.50  |- mesh__recordMaintainer mesh__D008615 CCR
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D008615 2006
% 215.26/215.50  |- skos__altLabel mesh__D008615 Kade Brand of Mephenesin
% 215.26/215.50  |- skos__altLabel mesh__D008615 Sanofi Synthelabo OTC Brand of Mephenesin
% 215.26/215.50  |- rdf__type mesh__D008615sskos__Concept
% 215.26/215.50  |- skos__hiddenLabel mesh__D008615 Mephenesin Kade Brand
% 215.26/215.50  |- mesh__dateRevised mesh__D008615 2005-06-30
% 215.26/215.50  |- mesh__recordOriginator mesh__D008615 NLM
% 215.26/215.50  |- mesh__dateCreated mesh__D008615 1999-01-01
% 215.26/215.50  |- skos__scopeNote mesh__D008615
% 215.26/215.50       A centrally acting muscle relaxant with a short duration of action.%A%    
% 215.26/215.50  |- skos__broader mesh__D008615smesh__D011409
% 215.26/215.50  |- mesh__recordOriginator mesh__D000632 NLM
% 215.26/215.50  |- mesh__recordAuthorizer mesh__D000632 sjn
% 215.26/215.50  |- skos__hiddenLabel mesh__D000632 Berlin Chemie Brand of Aminophenazone
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D000632 2006
% 215.26/215.50  |- skos__hiddenLabel mesh__D000632 Dimethyl N aminoantipyrine
% 215.26/215.50  |- skos__altLabel mesh__D000632 Amidophen
% 215.26/215.50  |- skos__altLabel mesh__D000632 Aminophenazone
% 215.26/215.50  |- mesh__dateCreated mesh__D000632 1999-01-01
% 215.26/215.50  |- skos__altLabel mesh__D000632 Berlin-Chemie Brand of Aminophenazone
% 215.26/215.50  |- skos__broader mesh__D000632smesh__D047069
% 215.26/215.50  |- skos__altLabel mesh__D000632 Dimethylaminophenazone
% 215.26/215.50  |- skos__altLabel mesh__D000632 Dimethylaminoantipyrine
% 215.26/215.50  |- mesh__dateRevised mesh__D000632 2005-06-30
% 215.26/215.50  |- skos__prefLabel mesh__D000632 Aminopyrine
% 215.26/215.50  |- skos__annotation mesh__D000632
% 215.26/215.50       a non-steroidal anti-inflamm agent; do not confuse DIPYRINE %28%X ref%29% with DIPYRONE%A%  
% 215.26/215.50  |- skos__altLabel mesh__D000632 Dipyrine
% 215.26/215.50  |- skos__altLabel mesh__D000632 Dimethyl-N-aminoantipyrine
% 215.26/215.50  |- skos__hiddenLabel mesh__D000632 Aminophenazone Berlin-Chemie Brand
% 215.26/215.50  |- skos__altLabel mesh__D000632 Amidazophen
% 215.26/215.50  |- rdf__type mesh__D000632sskos__Concept
% 215.26/215.50  |- skos__altLabel mesh__D000632 Amidophenazon
% 215.26/215.50  |- skos__scopeNote mesh__D000632
% 215.26/215.50       A drug with analgesic, anti-inflammatory, and antipyretic properties but, owing to the risk of agranulocytosis, whose use is discouraged. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p3%29%%A%    
% 215.26/215.50  |- skos__altLabel mesh__D000632 Amidopyrine
% 215.26/215.50  |- mesh__recordMaintainer mesh__D000632 ssb
% 215.26/215.50  |- skos__altLabel mesh__D000632 Aminofenazone
% 215.26/215.50  |- skos__altLabel mesh__D024282 Gene, Sex-Determining Region Y
% 215.26/215.50  |- mesh__historyNote mesh__D024282 2002   
% 215.26/215.50  |- skos__hiddenLabel mesh__D024282 Gene, Sex-Related Y
% 215.26/215.50  |- skos__hiddenLabel mesh__D024282 sry Genes
% 215.26/215.50  |- mesh__dateEstablished mesh__D024282 2002-01-01
% 215.26/215.50  |- skos__hiddenLabel mesh__D024282 Y Gene, Sex-Related
% 215.26/215.50  |- skos__altLabel mesh__D024282 Genes, Sex-Related Y
% 215.26/215.50  |- rdf__type mesh__D024282sskos__Concept
% 215.26/215.50  |- skos__hiddenLabel mesh__D024282 Sex-Related Y Genes
% 215.26/215.50  |- skos__historyNote mesh__D024282 DNA-Binding Proteins %28%1991-2001%29%
% 215.26/215.50  |- skos__altLabel mesh__D024282 Gene, sry
% 215.26/215.50  |- skos__hiddenLabel mesh__D024282 Genes, Sex Related Y
% 215.26/215.50  |- skos__hiddenLabel mesh__D024282 Sex Determining Region Gene On Y
% 215.26/215.50  |- mesh__dateRevised mesh__D024282 2005-06-30
% 215.26/215.50  |- skos__hiddenLabel mesh__D024282 Y Genes, Sex-Related
% 215.26/215.50  |- skos__altLabel mesh__D024282 Sex-Determining Region Gene On Y
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D024282 2006
% 215.26/215.50  |- mesh__recordOriginator mesh__D024282 nns
% 215.26/215.50  |- skos__altLabel mesh__D024282 Sex-Related Gene On Y
% 215.26/215.50  |- mesh__recordMaintainer mesh__D024282 nns
% 215.26/215.50  |- skos__prefLabel mesh__D024282 Genes, sry
% 215.26/215.50  |- skos__historyNote mesh__D024282
% 215.26/215.50       Sex Determination %28%Genetics%29% %28%1998-2001%29%
% 215.26/215.50  |- mesh__publicMeSHNote mesh__D024282 2002   
% 215.26/215.50  |- mesh__dateCreated mesh__D024282 2001-07-25
% 215.26/215.50  |- mesh__recordAuthorizer mesh__D024282 sjn
% 215.26/215.50  |- skos__related mesh__D024282smesh__D019849
% 215.26/215.50  |- skos__hiddenLabel mesh__D024282 Sex Related Gene On Y
% 215.26/215.50  |- skos__broader mesh__D024282smesh__D005796
% 215.26/215.50  |- skos__hiddenLabel mesh__D024282 sry Gene
% 215.26/215.50  |- skos__historyNote mesh__D024282
% 215.26/215.50       Sex Determination %28%Analysis%29% %28%1991-2001%29%
% 215.26/215.50  |- skos__hiddenLabel mesh__D024282 Sex-Related Y Gene
% 215.26/215.50  |- skos__scopeNote mesh__D024282
% 215.26/215.50       The primary testis-determining gene in mammalians, located on the Y CHROMOSOME. It codes for a high mobility group box transcription factor %28%TRANSCRIPTION FACTORS%29% which initiates the development of the TESTES from the embryonic GONADS.%A%    
% 215.26/215.50  |- skos__hiddenLabel mesh__D024282 Gene, Sex Determining Region Y
% 215.26/215.50  |- skos__altLabel mesh__D018245 Placental-Site Trophoblastic Tumor
% 215.26/215.50  |- mesh__recordOriginator mesh__D018245 PLS
% 215.26/215.50  |- skos__annotation mesh__D018245
% 215.26/215.50       coord IM with UTERINE NEOPLASMS %28%IM%29%; check the tags FEMALE %26% PREGNANCY%A%  
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D018245 2006
% 215.26/215.50  |- skos__hiddenLabel mesh__D018245 Tumor, Placental Trophoblastic
% 215.26/215.50  |- skos__hiddenLabel mesh__D018245 Trophoblastic Tumor, Placental-Site
% 215.26/215.50  |- skos__hiddenLabel mesh__D018245 Trophoblastic Tumors, Placental-Site
% 215.26/215.50  |- mesh__publicMeSHNote mesh__D018245 94   
% 215.26/215.50  |- skos__hiddenLabel mesh__D018245 Trophoblastic Tumors, Placental
% 215.26/215.50  |- mesh__dateEstablished mesh__D018245 1994-01-01
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D018245 2005
% 215.26/215.50  |- mesh__dateCreated mesh__D018245 1993-06-25
% 215.26/215.50  |- skos__hiddenLabel mesh__D018245 Placental-Site Trophoblastic Tumors
% 215.26/215.50  |- skos__altLabel mesh__D018245 Trophoblastic Tumor, Placental
% 215.26/215.50  |- rdf__type mesh__D018245sskos__Concept
% 215.26/215.50  |- skos__hiddenLabel mesh__D018245 Tumors, Placental-Site Trophoblastic
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D018245 2004
% 215.26/215.50  |- skos__broader mesh__D018245smesh__D002822
% 215.26/215.50  |- mesh__dateRevised mesh__D018245 2002-07-03
% 215.26/215.50  |- skos__historyNote mesh__D018245
% 215.26/215.50       Trophoblastic Neoplasms %28%1980-1993%29%
% 215.26/215.50  |- skos__hiddenLabel mesh__D018245 Placental Trophoblastic Tumor
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D018245 2003
% 215.26/215.50  |- skos__prefLabel mesh__D018245 Trophoblastic Tumor, Placental Site
% 215.26/215.50  |- mesh__recordMaintainer mesh__D018245 KEV
% 215.26/215.50  |- mesh__recordAuthorizer mesh__D018245 sjn
% 215.26/215.50  |- skos__scopeNote mesh__D018245
% 215.26/215.50       An uncommon variant of CHORIOCARCINOMA. It is composed almost entirely of mononuclear cytotrophoblasts %28%TROPHOBLASTS%29%. Because its secretion of hCG %28%CHORIONIC GONADOTROPIN%29% is low, a large tumor may develop before the hCG can be detected.%A%    
% 215.26/215.50  |- skos__hiddenLabel mesh__D018245 Tumor, Placental-Site Trophoblastic
% 215.26/215.50  |- skos__hiddenLabel mesh__D018245 Placental Site Trophoblastic Tumor
% 215.26/215.50  |- skos__hiddenLabel mesh__D018245 Placental Trophoblastic Tumors
% 215.26/215.50  |- mesh__historyNote mesh__D018245 94   
% 215.26/215.50  |- skos__hiddenLabel mesh__D018245 Tumors, Placental Trophoblastic
% 215.26/215.50  |- skos__broader mesh__D010262smesh__D020018
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D010262 1999
% 215.26/215.50  |- rdf__type mesh__D010262sskos__Concept
% 215.26/215.50  |- mesh__onlineNote mesh__D010262
% 215.26/215.50       use PARAPHILIAS to search SEX DEVIATION 1966-80   
% 215.26/215.50  |- mesh__recordOriginator mesh__D010262 NLM
% 215.26/215.50  |- skos__hiddenLabel mesh__D010262 Paraphilia
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D010262 2004
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D010262 2002
% 215.26/215.50  |- skos__hiddenLabel mesh__D010262 Deviation, Sex
% 215.26/215.50  |- mesh__dateRevised mesh__D010262 1998-06-10
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D010262 2003
% 215.26/215.50  |- mesh__dateCreated mesh__D010262 1999-01-01
% 215.26/215.50  |- skos__prefLabel mesh__D010262 Paraphilias
% 215.26/215.50  |- mesh__publicMeSHNote mesh__D010262 81; was SEX DEVIATION 1963-80   
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D010262 2006
% 215.26/215.50  |- mesh__historyNote mesh__D010262 81; was SEX DEVIATION 1963-80   
% 215.26/215.50  |- skos__related mesh__D010262smesh__D012742
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D010262 2001
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D010262 2005
% 215.26/215.50  |- skos__scopeNote mesh__D010262
% 215.26/215.50       Disorders that include recurrent, intense sexually arousing fantasies, sexual urges, or behaviors generally involving nonhuman objects, suffering of oneself or partners, or children or other nonconsenting partners. %28%from DSM-IV, 1994%29%%A%    
% 215.26/215.50  |- mesh__recordMaintainer mesh__D010262 JLS
% 215.26/215.50  |- mesh__recordAuthorizer mesh__D010262 SJN
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D010262 2000
% 215.26/215.50  |- skos__hiddenLabel mesh__D010262 Deviations, Sex
% 215.26/215.50  |- skos__hiddenLabel mesh__D010262 Sex Deviation
% 215.26/215.50  |- skos__broader mesh__D004225smesh__D013844
% 215.26/215.50  |- skos__hiddenLabel mesh__D004225 Iodide, Dithiazanine
% 215.26/215.50  |- rdf__type mesh__D004225sskos__Concept
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D004225 2006
% 215.26/215.50  |- mesh__recordAuthorizer mesh__D004225 sjn
% 215.26/215.50  |- skos__hiddenLabel mesh__D004225 3,3%27% Diethylthiadicarbocyanine
% 215.26/215.50  |- mesh__dateRevised mesh__D004225 2005-06-30
% 215.26/215.50  |- skos__scopeNote mesh__D004225
% 215.26/215.50       3-Ethyl-2-%28%5-%28%3-ethyl-2-benzothiazolinylidene%29%-1,3- pentadienyl%29%benzothiazolium. A benzothiazole that was formerly used as an antinematodal agent and is currently used as a fluorescent dye.%A%    
% 215.26/215.50  |- mesh__recordMaintainer mesh__D004225 ssb
% 215.26/215.50  |- skos__annotation mesh__D004225 an antinematodal agent   
% 215.26/215.50  |- skos__broader mesh__D004225smesh__D052160
% 215.26/215.50  |- mesh__dateCreated mesh__D004225 1999-01-01
% 215.26/215.50  |- skos__prefLabel mesh__D004225 Dithiazanine
% 215.26/215.50  |- mesh__recordOriginator mesh__D004225 NLM
% 215.26/215.50  |- skos__altLabel mesh__D004225 3,3%27%-Diethylthiadicarbocyanine
% 215.26/215.50  |- skos__altLabel mesh__D020690 GTPase-Activating Protein
% 215.26/215.50  |- mesh__recordOriginator mesh__D020690 jmp
% 215.26/215.50  |- skos__scopeNote mesh__D020690
% 215.26/215.50       Proteins that activate the GTPase of specific GTP-BINDING PROTEINS.%A%    
% 215.26/215.50  |- mesh__historyNote mesh__D020690
% 215.26/215.50       2000; use GTPASE-ACTIVATING PROTEINS %28%NM%29% 1988-1999   
% 215.26/215.50  |- skos__altLabel mesh__D020690 GAP Proteins
% 215.26/215.50  |- skos__altLabel mesh__D020690 GAP Protein
% 215.26/215.50  |- mesh__dateRevised mesh__D020690 2005-06-30
% 215.26/215.50  |- skos__hiddenLabel mesh__D020690 GTPase Activating Proteins
% 215.26/215.50  |- skos__broader mesh__D020690smesh__D020555
% 215.26/215.50  |- mesh__dateEstablished mesh__D020690 2000-01-01
% 215.26/215.50  |- mesh__recordAuthorizer mesh__D020690 sjn
% 215.26/215.50  |- skos__hiddenLabel mesh__D020690 GTPase Activating Protein
% 215.26/215.50  |- mesh__publicMeSHNote mesh__D020690
% 215.26/215.50       2000; GTPASE-ACTIVATING PROTEIN %28%now GTPase-ACTIVATING PROTEINS%29% was indexed under PROTEINS 1988-1999%A%  
% 215.26/215.50  |- skos__prefLabel mesh__D020690 GTPase-Activating Proteins
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D020690 2006
% 215.26/215.50  |- skos__historyNote mesh__D020690 Proteins %28%1989-1999%29%
% 215.26/215.50  |- mesh__recordMaintainer mesh__D020690 SYSTEM
% 215.26/215.50  |- rdf__type mesh__D020690sskos__Concept
% 215.26/215.50  |- mesh__dateCreated mesh__D020690 1999-11-03
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D014653 2006
% 215.26/215.50  |- mesh__historyNote mesh__D014653
% 215.26/215.50       2000%28%1964%29%; use HEADACHE 1975-1977   
% 215.26/215.50  |- skos__altLabel mesh__D014653 Vascular Headache
% 215.26/215.50  |- skos__altLabel mesh__D014653 Headache, Vascular
% 215.26/215.50  |- mesh__dateCreated mesh__D014653 1999-01-01
% 215.26/215.50  |- skos__scopeNote mesh__D014653
% 215.26/215.50       Secondary headache disorders attributed to a variety of cranial or cervical vascular disorders, such as BRAIN ISCHEMIA; INTRACRANIAL HEMORRHAGES; and CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS.%A%    
% 215.26/215.50  |- skos__annotation mesh__D014653 general: prefer specifics   
% 215.26/215.50  |- mesh__recordAuthorizer mesh__D014653 sjn
% 215.26/215.50  |- skos__hiddenLabel mesh__D014653 Headaches, Vascular
% 215.26/215.50  |- mesh__recordMaintainer mesh__D014653 lkt
% 215.26/215.50  |- mesh__dateEstablished mesh__D014653 1978-01-01
% 215.26/215.50  |- skos__hiddenLabel mesh__D014653 Vascular Cephalgias
% 215.26/215.50  |- skos__hiddenLabel mesh__D014653 Vascular Cephalgia
% 215.26/215.50  |- mesh__dateRevised mesh__D014653 2005-06-30
% 215.26/215.50  |- mesh__recordOriginator mesh__D014653 NLM
% 215.26/215.50  |- skos__hiddenLabel mesh__D014653 Cephalgias, Vascular
% 215.26/215.50  |- mesh__publicMeSHNote mesh__D014653
% 215.26/215.50       2000; see VASCULAR  HEADACHE 1978-1999; see HEADACHE 1975-1977%A%  
% 215.26/215.50  |- skos__broader mesh__D014653smesh__D051271
% 215.26/215.50  |- skos__altLabel mesh__D014653 Cephalgia, Vascular
% 215.26/215.50  |- skos__prefLabel mesh__D014653 Vascular Headaches
% 215.26/215.50  |- rdf__type mesh__D014653sskos__Concept
% 215.26/215.50  |- skos__broader mesh__D014653smesh__D002561
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D008616 2002
% 215.26/215.50  |- rdf__type mesh__D008616sskos__Concept
% 215.26/215.50  |- skos__scopeNote mesh__D008616
% 215.26/215.50       A sympathomimetic agent with mainly indirect effects on adrenergic receptors. It is used to maintain blood pressure in hypotensive states, for example, following spinal anesthesia. Although the central stimulant effects of mephentermine are much less than those of amphetamine, its use may lead to amphetamine-type dependence. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1248%29%%A%    
% 215.26/215.50  |- mesh__recordOriginator mesh__D008616 NLM
% 215.26/215.50  |- skos__broader mesh__D008616smesh__D010645
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D008616 2001
% 215.26/215.50  |- skos__altLabel mesh__D008616 Mephentermine Sulfate %28%2:1%29%
% 215.26/215.50  |- skos__hiddenLabel mesh__D008616 Sulfate, Mephentermine
% 215.26/215.50  |- mesh__recordMaintainer mesh__D008616 CCR
% 215.26/215.50  |- mesh__recordAuthorizer mesh__D008616 sjn
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D008616 2004
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D008616 2006
% 215.26/215.50  |- mesh__dateRevised mesh__D008616 2000-06-22
% 215.26/215.50  |- mesh__dateCreated mesh__D008616 1999-01-01
% 215.26/215.50  |- skos__prefLabel mesh__D008616 Mephentermine
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D008616 2003
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D008616 2005
% 215.26/215.50  |- skos__broader mesh__D000633smesh__D010089
% 215.26/215.50  |- skos__hiddenLabel mesh__D000633 N-Demethylase, Aminopyrine
% 215.26/215.50  |- skos__altLabel mesh__D000633 Aminopyrine N Demethylase
% 215.26/215.50  |- skos__prefLabel mesh__D000633 Aminopyrine N-Demethylase
% 215.26/215.50  |- skos__hiddenLabel mesh__D000633 N Demethylase, Aminopyrine
% 215.26/215.50  |- mesh__recordMaintainer mesh__D000633 jmp
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D000633 2006
% 215.26/215.50  |- mesh__publicMeSHNote mesh__D000633 74   
% 215.26/215.50  |- mesh__recordOriginator mesh__D000633 NLM
% 215.26/215.50  |- mesh__recordAuthorizer mesh__D000633 sjn
% 215.26/215.50  |- skos__historyNote mesh__D000633 Oxidoreductases, N-Demethylating
% 215.26/215.50  |- mesh__dateCreated mesh__D000633 1999-01-01
% 215.26/215.50  |- mesh__historyNote mesh__D000633 74%28%72%29%   
% 215.26/215.50  |- skos__hiddenLabel mesh__D000633 Demethylase, Aminopyrine N
% 215.26/215.50  |- mesh__dateRevised mesh__D000633 2005-06-30
% 215.26/215.50  |- rdf__type mesh__D000633sskos__Concept
% 215.26/215.50  |- mesh__dateEstablished mesh__D000633 1974-01-01
% 215.26/215.50  |- skos__annotation mesh__D018246
% 215.26/215.50       coordinate IM with ADRENAL CORTEX NEOPLASMS; do not confuse X ref CONN DISEASE with CONN SYNDROME see HYPERALDOSTERONISM%A%  
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D018246 2005
% 215.26/215.50  |- skos__altLabel mesh__D018246 Adenoma, Adrenocortical
% 215.26/215.50  |- skos__altLabel mesh__D018246 Conn%27%s Disease
% 215.26/215.50  |- rdf__type mesh__D018246sskos__Concept
% 215.26/215.50  |- skos__hiddenLabel mesh__D018246 Conn Adenomas
% 215.26/215.50  |- skos__hiddenLabel mesh__D018246 Disease, Conn%27%s
% 215.26/215.50  |- skos__hiddenLabel mesh__D018246 Adrenal Cortical Adenomas
% 215.26/215.50  |- skos__hiddenLabel mesh__D018246 Conns Disease
% 215.26/215.50  |- skos__hiddenLabel mesh__D018246 Adenomas, Conn
% 215.26/215.50  |- mesh__dateRevised mesh__D018246 2004-07-07
% 215.26/215.50  |- skos__altLabel mesh__D018246 Adenoma, Adrenal Cortical
% 215.26/215.50  |- mesh__dateEstablished mesh__D018246 1994-01-01
% 215.26/215.50  |- skos__prefLabel mesh__D018246 Adrenocortical Adenoma
% 215.26/215.50  |- mesh__dateCreated mesh__D018246 1993-06-25
% 215.26/215.50  |- skos__altLabel mesh__D018246 Conn Disease
% 215.26/215.50  |- mesh__recordMaintainer mesh__D018246 lkt
% 215.26/215.50  |- skos__hiddenLabel mesh__D018246 Disease, Conn
% 215.26/215.50  |- mesh__publicMeSHNote mesh__D018246
% 215.26/215.50       2005; see ADENOMA, ADRENAL CORTICAL 1994-2004; for CONN%27%S DISEASE use HYPERALDOSTERONISM 1985-2004%A%  
% 215.26/215.50  |- skos__historyNote mesh__D018246 Adenoma %28%1966-1993%29%
% 215.26/215.50  |- skos__broader mesh__D018246smesh__D000306
% 215.26/215.50  |- skos__hiddenLabel mesh__D018246 Adrenal Cortical Adenoma
% 215.26/215.50  |- skos__scopeNote mesh__D018246
% 215.26/215.50       A benign neoplasm of the ADRENAL CORTEX. It is characterized by a well-defined nodular lesion, usually less than 2.5 cm. Most adrenocortical adenomas are nonfunctional. The functional ones are yellow and contain LIPIDS. Depending on the cell type or cortical zone involved, they may produce ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE.%A%    
% 215.26/215.50  |- skos__hiddenLabel mesh__D018246 Adenomas, Adrenocortical
% 215.26/215.50  |- skos__hiddenLabel mesh__D018246 Adrenocortical Adenomas
% 215.26/215.50  |- mesh__historyNote mesh__D018246
% 215.26/215.50       2005 %28%1994%29%; for CONN%27%S DISEASE use HYPERALDOSTERONISM 1985-2004%A%  
% 215.26/215.50  |- mesh__recordOriginator mesh__D018246 PLS
% 215.26/215.50  |- skos__hiddenLabel mesh__D018246 Adenoma, Conn
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D018246 2006
% 215.26/215.50  |- mesh__recordAuthorizer mesh__D018246 sjn
% 215.26/215.50  |- skos__hiddenLabel mesh__D018246 Adenomas, Adrenal Cortical
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D010263 1994
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D010263 2001
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D010263 1999
% 215.26/215.50  |- skos__annotation mesh__D010263 a penile dis   
% 215.26/215.50  |- mesh__dateEstablished mesh__D010263 1991-01-01
% 215.26/215.50  |- rdf__type mesh__D010263sskos__Concept
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D010263 2004
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D010263 1995
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D010263 2002
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D010263 2005
% 215.26/215.50  |- mesh__onlineNote mesh__D010263 search PHIMOSIS 1966-74   
% 215.26/215.50  |- mesh__historyNote mesh__D010263
% 215.26/215.50       91%28%75%29%; was see under PHIMOSIS 1975-90   
% 215.26/215.50  |- skos__hiddenLabel mesh__D010263 Paraphimoses
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D010263 2006
% 215.26/215.50  |- mesh__recordAuthorizer mesh__D010263 PLS
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D010263 1996
% 215.26/215.50  |- mesh__recordOriginator mesh__D010263 NLM
% 215.26/215.50  |- mesh__publicMeSHNote mesh__D010263 91; was see under PHIMOSIS 1975-90   
% 215.26/215.50  |- skos__broader mesh__D010263smesh__D010688
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D010263 1997
% 215.26/215.50  |- skos__prefLabel mesh__D010263 Paraphimosis
% 215.26/215.50  |- mesh__dateRevised mesh__D010263 1993-06-02
% 215.26/215.50  |- mesh__recordMaintainer mesh__D010263 TAP
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D010263 2000
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D010263 1998
% 215.26/215.50  |- skos__scopeNote mesh__D010263
% 215.26/215.50       Retraction of phimotic foreskin, causing a painful swelling of the glans that, if severe, may cause dry gangrene unless corrected. %28%Dorland, 27th ed%29%%A%    
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D010263 2003
% 215.26/215.50  |- mesh__dateCreated mesh__D010263 1999-01-01
% 215.26/215.50  |- mesh__historyNote mesh__D004226
% 215.26/215.50       91%28%75%29%; was see under DITHIOTHREITOL 1975-90   
% 215.26/215.50  |- mesh__publicMeSHNote mesh__D004226
% 215.26/215.50       91; was see under DITHIOTHREITOL 1975-90   
% 215.26/215.50  |- mesh__dateCreated mesh__D004226 1999-01-01
% 215.26/215.50  |- mesh__recordOriginator mesh__D004226 NLM
% 215.26/215.50  |- mesh__onlineNote mesh__D004226 search DITHIOTHREITOL 1972-74   
% 215.26/215.50  |- skos__broader mesh__D004226smesh__D013865
% 215.26/215.50  |- skos__prefLabel mesh__D004226 Dithioerythritol
% 215.26/215.50  |- rdf__type mesh__D004226sskos__Concept
% 215.26/215.50  |- skos__altLabel mesh__D004226 Dithioerythreitol
% 215.26/215.50  |- mesh__recordAuthorizer mesh__D004226 sjn
% 215.26/215.50  |- mesh__dateRevised mesh__D004226 2005-06-30
% 215.26/215.50  |- mesh__dateEstablished mesh__D004226 1991-01-01
% 215.26/215.50  |- mesh__activeMeSHYear mesh__D004226 2006
% 215.26/215.50  |- skos__broader mesh__D004226smesh__D013402
% 215.26/215.50  |- skos__scopeNote mesh__D004226
% 215.26/215.50       A compound that, along with its isomer, Cleland%27%s reagent %28%DITHIOTHREITOL%29%, is used for the protection of sulfhydryl groups against oxidation to disulfides and for the reduction of disulfides to sulfhydryl groups.%A%    
% 215.26/215.50  |- mesh__recordMaintainer mesh__D004226 ssb
% 215.26/215.50  |- skos__altLabel mesh__D020691 rab G-Proteins
% 215.26/215.50  |- mesh__historyNote mesh__D020691 2000   
% 215.36/215.50  |- mesh__dateEstablished mesh__D020691 2000-01-01
% 215.36/215.50  |- skos__scopeNote mesh__D020691
% 215.36/215.50       A large family of MONOMERIC GTP-BINDING PROTEINS that play a key role in cellular secretory and endocytic pathways. EC 3.6.1.-.%A%    
% 215.36/215.50  |- skos__prefLabel mesh__D020691 rab GTP-Binding Proteins
% 215.36/215.50  |- mesh__publicMeSHNote mesh__D020691 2000   
% 215.36/215.50  |- skos__altLabel mesh__D020691 rab GTPases
% 215.36/215.50  |- mesh__activeMeSHYear mesh__D020691 2006
% 215.36/215.50  |- skos__hiddenLabel mesh__D020691 G-Proteins, rab
% 215.36/215.50  |- mesh__recordOriginator mesh__D020691 jmp
% 215.36/215.50  |- mesh__dateRevised mesh__D020691 2005-06-30
% 215.36/215.50  |- skos__broader mesh__D020691smesh__D020559
% 215.36/215.50  |- skos__historyNote mesh__D020691 G-Proteins %28%1989-1999%29%
% 215.36/215.50  |- skos__hiddenLabel mesh__D020691 rab GTP Binding Proteins
% 215.36/215.50  |- rdf__type mesh__D020691sskos__Concept
% 215.36/215.50  |- mesh__recordMaintainer mesh__D020691 SYSTEM
% 215.36/215.50  |- mesh__recordAuthorizer mesh__D020691 sjn
% 215.36/215.50  |- mesh__dateCreated mesh__D020691 1999-11-04
% 215.36/215.50  |- skos__hiddenLabel mesh__D020691 rab G Proteins
% 215.36/215.50  |- skos__hiddenLabel mesh__D020691 GTPases, rab
% 215.36/215.50  |- skos__hiddenLabel mesh__D020691 GTP-Binding Proteins, rab
% 215.36/215.50  |- mesh__dateCreated mesh__D014654 1986-06-23
% 215.36/215.50  |- mesh__recordMaintainer mesh__D014654 nns
% 215.36/215.50  |- mesh__dateRevised mesh__D014654 2003-07-09
% 215.36/215.50  |- mesh__dateEstablished mesh__D014654 1987-01-01
% 215.36/215.50  |- skos__prefLabel mesh__D014654 Vascular Patency
% 215.36/215.50  |- skos__historyNote mesh__D014654
% 215.36/215.50       Graft Occlusion, Vascular %28%1985-1986%29%
% 215.36/215.50  |- mesh__activeMeSHYear mesh__D014654 2005
% 215.36/215.50  |- skos__broader mesh__D014654smesh__D045124
% 215.36/215.50  |- mesh__recordOriginator mesh__D014654 VDK
% 215.36/215.50  |- skos__scopeNote mesh__D014654
% 215.36/215.50       The degree to which BLOOD VESSELS are not blocked or obstructed.%A%    
% 215.36/215.50  |- mesh__recordAuthorizer mesh__D014654 sjn
% 215.36/215.50  |- mesh__activeMeSHYear mesh__D014654 2004
% 215.36/215.50  |- skos__related mesh__D014654smesh__D006083
% 215.36/215.50  |- mesh__historyNote mesh__D014654 87   
% 215.36/215.50  |- rdf__type mesh__D014654sskos__Concept
% 215.36/215.50  |- skos__hiddenLabel mesh__D014654 Vascular Patencies
% 215.36/215.50  |- skos__hiddenLabel mesh__D014654 Patencies, Vascular
% 215.36/215.50  |- skos__altLabel mesh__D014654 Patency, Vascular
% 215.36/215.50  |- mesh__publicMeSHNote mesh__D014654 87   
% 215.36/215.50  |- mesh__activeMeSHYear mesh__D014654 2006
% 215.36/215.50  |- mesh__activeMeSHYear mesh__D047030 2006
% 215.36/215.50  |- mesh__historyNote mesh__D047030 2005 %28%1974%29%   
% 215.36/215.50  |- skos__altLabel mesh__D047030 Sericin
% 215.36/215.50  |- mesh__publicMeSHNote mesh__D047030
% 215.36/215.50       2005; SERICINS was indexed under PEPTIDES, CYCLIC 1974-2004%A%  
% 215.36/215.50  |- mesh__recordAuthorizer mesh__D047030 sjn
% 215.36/215.50  |- mesh__recordOriginator mesh__D047030 lkt
% 215.36/215.50  |- mesh__dateEstablished mesh__D047030 2005-01-01
% 215.36/215.50  |- rdf__type mesh__D047030sskos__Concept
% 215.36/215.50  |- skos__broader mesh__D047030smesh__D047011
% 215.36/215.50  |- skos__scopeNote mesh__D047030
% 215.36/215.50       A serine-rich sticky protein secreted by MOTHS. Generally, the term refers to silkworm silk gum protein secreted in the middle section of silk gland cells of SILKWORMS, Bombyx mori. Sericin acts as a cement and coating for the two fibroin filaments in a silk strand and is readily soluble in mild alkaline solution.%A%    
% 215.36/215.50  |- skos__hiddenLabel mesh__D047030 Sericin 1
% 215.36/215.50  |- skos__altLabel mesh__D047030 Silk Gum Proteins
% 215.36/215.50  |- mesh__recordMaintainer mesh__D047030 DRC
% 215.36/215.50  |- skos__prefLabel mesh__D047030 Sericins
% 215.36/215.50  |- mesh__dateCreated mesh__D047030 2004-07-15
% 215.36/215.50  |- skos__hiddenLabel mesh__D047030 Proteins, Silk Gum
% 215.36/215.50  |- mesh__dateRevised mesh__D047030 2005-06-30
% 215.36/215.50  |- skos__historyNote mesh__D047030 Peptides, Cyclic %28%1980-2004%29%
% 215.36/215.50  |- skos__scopeNote mesh__D008617
% 215.36/215.50       An anticonvulsant effective in tonic-clonic epilepsy %28%EPILEPSY, TONIC-CLONIC%29%. It may cause blood dyscrasias.%A%    
% 215.36/215.50  |- skos__broader mesh__D008617smesh__D006827
% 215.36/215.50  |- mesh__historyNote mesh__D008617
% 215.36/215.50       91%28%75%29%; see HYDANTOINS 1975-90; for PHENANTION use PHENYTOIN 1978-97%A%  
% 215.36/215.50  |- skos__altLabel mesh__D008617 Mefenetoin
% 215.36/215.50  |- mesh__dateRevised mesh__D008617 2005-06-30
% 215.36/215.50  |- skos__altLabel mesh__D008617 Methoin
% 215.36/215.50  |- mesh__recordMaintainer mesh__D008617 ssb
% 215.36/215.50  |- mesh__dateCreated mesh__D008617 1974-11-19
% 215.36/215.50  |- skos__hiddenLabel mesh__D008617 5 Ethyl 3 Methyl 5 Phenylhydantoin
% 215.36/215.50  |- mesh__recordAuthorizer mesh__D008617 sjn
% 215.36/215.50  |- mesh__dateEstablished mesh__D008617 1991-01-01
% 215.36/215.50  |- skos__altLabel mesh__D008617 5-Ethyl-3-Methyl-5-Phenylhydantoin
% 215.36/215.50  |- mesh__publicMeSHNote mesh__D008617
% 215.36/215.50       91; see HYDANTOINS 1975-90; for PHENANTION use PHENYTOIN 1978-97%A%  
% 215.36/215.50  |- skos__hiddenLabel mesh__D008617 Phenetoin, Methyl
% 215.36/215.50  |- skos__altLabel mesh__D008617 Methyl Phenetoin
% 215.36/215.50  |- skos__prefLabel mesh__D008617 Mephenytoin
% 215.36/215.50  |- mesh__activeMeSHYear mesh__D008617 2006
% 215.36/215.50  |- rdf__type mesh__D008617sskos__Concept
% 215.36/215.50  |- mesh__recordOriginator mesh__D008617 NLM
% 215.36/215.50  |- skos__historyNote mesh__D008617 Hydantoins %28%1969-1974%29%
% 215.36/215.50  |- mesh__activeMeSHYear mesh__D000634 1997
% 215.36/215.50  |- mesh__activeMeSHYear mesh__D000634 1998
% 215.36/215.50  |- mesh__activeMeSHYear mesh__D000634 2006
% 215.36/215.50  |- mesh__activeMeSHYear mesh__D000634 1996
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D000634 2004
% 215.36/215.51  |- skos__historyNote mesh__D000634 Quinolines %28%1968-1974%29%
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D000634 2005
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D000634 2001
% 215.36/215.51  |- skos__prefLabel mesh__D000634 Aminoquinolines
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D000634 2003
% 215.36/215.51  |- mesh__recordMaintainer mesh__D000634 TAP
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D000634 2000
% 215.36/215.51  |- mesh__recordOriginator mesh__D000634 NLM
% 215.36/215.51  |- skos__scopeNote mesh__D000634
% 215.36/215.51       Quinolines substituted in any position by one or more amino groups.%A%    
% 215.36/215.51  |- mesh__dateEstablished mesh__D000634 1975-09-01
% 215.36/215.51  |- mesh__publicMeSHNote mesh__D000634 75   
% 215.36/215.51  |- mesh__recordAuthorizer mesh__D000634 PLS
% 215.36/215.51  |- mesh__dateCreated mesh__D000634 1974-11-11
% 215.36/215.51  |- rdf__type mesh__D000634sskos__Concept
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D000634 1995
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D000634 1993
% 215.36/215.51  |- skos__broader mesh__D000634smesh__D011804
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D000634 1999
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D000634 2002
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D000634 1994
% 215.36/215.51  |- mesh__dateRevised mesh__D000634 1992-05-07
% 215.36/215.51  |- mesh__historyNote mesh__D000634 75   
% 215.36/215.51  |- mesh__publicMeSHNote mesh__D018247
% 215.36/215.51       2001; see GASTROSPIRILLUM HOMINUS 1993-2000   
% 215.36/215.51  |- skos__prefLabel mesh__D018247 Helicobacter heilmannii
% 215.36/215.51  |- rdf__type mesh__D018247sskos__Concept
% 215.36/215.51  |- mesh__recordAuthorizer mesh__D018247 sjn
% 215.36/215.51  |- mesh__recordMaintainer mesh__D018247 SYSTEM
% 215.36/215.51  |- skos__altLabel mesh__D018247 Candidatus Helicobacter suis
% 215.36/215.51  |- skos__broader mesh__D018247smesh__D016998
% 215.36/215.51  |- skos__annotation mesh__D018247
% 215.36/215.51       infection: coord IM with HELICOBACTER INFECTIONS %28%IM%29%   
% 215.36/215.51  |- mesh__dateCreated mesh__D018247 1993-06-04
% 215.36/215.51  |- skos__scopeNote mesh__D018247
% 215.36/215.51       A species of gram-negative, spiral-shaped bacteria found in the gastric mucosa that is associated with chronic antral gastritis. This bacterium was first discovered in samples removed at endoscopy from patients investigated for HELICOBACTER PYLORI colonization.%A%    
% 215.36/215.51  |- mesh__dateEstablished mesh__D018247 1994-01-01
% 215.36/215.51  |- skos__altLabel mesh__D018247 Gastrospirillum suis
% 215.36/215.51  |- mesh__recordOriginator mesh__D018247 PXP
% 215.36/215.51  |- skos__historyNote mesh__D018247 Gram-Negative Bacteria %28%1989-1993%29%
% 215.36/215.51  |- mesh__dateRevised mesh__D018247 2005-06-30
% 215.36/215.51  |- skos__altLabel mesh__D018247 Gastrospirillum hominis
% 215.36/215.51  |- mesh__historyNote mesh__D018247
% 215.36/215.51       2001%28%1994%29%; for GASTROSPIRILLUM SUIS use GASTROSPIRILLUM 1993-2000%A%  
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D018247 2006
% 215.36/215.51  |- skos__altLabel mesh__D010264 Paralysis, Lower Limbs
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D010264 2004
% 215.36/215.51  |- mesh__historyNote mesh__D010264 1963   
% 215.36/215.51  |- skos__hiddenLabel mesh__D010264 Cerebral Paraplegias
% 215.36/215.51  |- mesh__dateRevised mesh__D010264 2000-01-03
% 215.36/215.51  |- skos__altLabel mesh__D010264 Spastic Paraplegia
% 215.36/215.51  |- skos__hiddenLabel mesh__D010264 Paraplegias, Spinal
% 215.36/215.51  |- skos__hiddenLabel mesh__D010264 Paraplegias, Cerebral
% 215.36/215.51  |- skos__hiddenLabel mesh__D010264 Ataxic Paraplegias
% 215.36/215.51  |- skos__hiddenLabel mesh__D010264 Paraplegias, Spastic
% 215.36/215.51  |- mesh__recordMaintainer mesh__D010264 ags
% 215.36/215.51  |- mesh__recordAuthorizer mesh__D010264 ags
% 215.36/215.51  |- mesh__recordOriginator mesh__D010264 NLM
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D010264 2003
% 215.36/215.51  |- skos__hiddenLabel mesh__D010264 Flaccid Paraplegias
% 215.36/215.51  |- skos__hiddenLabel mesh__D010264 Paraplegias, Ataxic
% 215.36/215.51  |- mesh__dateCreated mesh__D010264 1999-01-01
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D010264 2002
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D010264 2000B
% 215.36/215.51  |- skos__scopeNote mesh__D010264
% 215.36/215.51       Severe or complete loss of motor function in the lower extremities and lower portions of the trunk. This condition is most often associated with SPINAL CORD DISEASES, although BRAIN DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; and MUSCULAR DISEASES may also cause bilateral leg weakness.%A%    
% 215.36/215.51  |- skos__altLabel mesh__D010264 Paralysis, Legs
% 215.36/215.51  |- skos__altLabel mesh__D010264 Paralysis, Lower Extremities
% 215.36/215.51  |- skos__annotation mesh__D010264
% 215.36/215.51       also available is QUADRIPLEGIA; note X ref spastic paraplegia: SPASTIC PARAPLEGIA, HEREDITARY is also available%A%  
% 215.36/215.51  |- rdf__type mesh__D010264sskos__Concept
% 215.36/215.51  |- skos__hiddenLabel mesh__D010264 Cerebral Paraplegia
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D010264 2006
% 215.36/215.51  |- skos__prefLabel mesh__D010264 Paraplegia
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D010264 2001
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D010264 2000A
% 215.36/215.51  |- skos__hiddenLabel mesh__D010264 Paraplegias, Flaccid
% 215.36/215.51  |- skos__hiddenLabel mesh__D010264 Flaccid Paraplegia
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D010264 2005
% 215.36/215.51  |- mesh__publicMeSHNote mesh__D010264
% 215.36/215.51       1966; for PARALYSIS, SPASTIC see MUSCLE SPASTICITY 1966-78, see PARALYSIS, SPASTICITY 1963-78%A%  
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D010264 2000
% 215.36/215.51  |- skos__broader mesh__D010264smesh__D010243
% 215.36/215.51  |- skos__hiddenLabel mesh__D010264 Spinal Paraplegia
% 215.36/215.51  |- skos__hiddenLabel mesh__D010264 Ataxic Paraplegia
% 215.36/215.51  |- skos__hiddenLabel mesh__D010264 Spastic Paraplegias
% 215.36/215.51  |- skos__hiddenLabel mesh__D010264 Paraplegias
% 215.36/215.51  |- skos__hiddenLabel mesh__D010264 Spinal Paraplegias
% 215.36/215.51  |- rdf__type mesh__D037401sskos__Concept
% 215.36/215.51  |- skos__altLabel mesh__D037401 Chrysaora fuscescens
% 215.36/215.51  |- skos__historyNote mesh__D037401 Cnidaria %28%1971-2002%29%
% 215.36/215.51  |- skos__altLabel mesh__D037401 Jellyfish, True
% 215.36/215.51  |- skos__altLabel mesh__D037401 Moon Jelly
% 215.36/215.51  |- skos__annotation mesh__D037401
% 215.36/215.51       do not confuse the genus Aurelia with the species Paramecium aurelia%A%  
% 215.36/215.51  |- mesh__publicMeSHNote mesh__D037401 2003   
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D037401 2004
% 215.36/215.51  |- skos__prefLabel mesh__D037401 Scyphozoa
% 215.36/215.51  |- skos__broader mesh__D037401smesh__D003063
% 215.36/215.51  |- mesh__dateRevised mesh__D037401 2003-07-09
% 215.36/215.51  |- mesh__dateEstablished mesh__D037401 2003-01-01
% 215.36/215.51  |- mesh__historyNote mesh__D037401 2003   
% 215.36/215.51  |- skos__altLabel mesh__D037401 Jellyfish, Moon
% 215.36/215.51  |- skos__altLabel mesh__D037401 Sea Nettle, Pacific
% 215.36/215.51  |- skos__altLabel mesh__D037401 Moon Jellyfish
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D037401 2006
% 215.36/215.51  |- mesh__dateCreated mesh__D037401 2002-07-03
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D037401 2005
% 215.36/215.51  |- skos__scopeNote mesh__D037401
% 215.36/215.51       The class of true jellyfish, in the phylum CNIDARIA. They are mostly free-swimming marine organisms that go through five stages in their life cycle and exhibit two body forms: polyp and medusa.%A%    
% 215.36/215.51  |- skos__prefLabel mesh__D004227 Dithionite
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D004227 2000
% 215.36/215.51  |- mesh__dateCreated mesh__D004227 1999-01-01
% 215.36/215.51  |- mesh__recordMaintainer mesh__D004227 TPW
% 215.36/215.51  |- skos__altLabel mesh__D004227 Hyposulfite
% 215.36/215.51  |- skos__scopeNote mesh__D004227
% 215.36/215.51       Dithionite. The dithionous acid ion and its salts.     
% 215.36/215.51  |- skos__broader mesh__D004227smesh__D013447
% 215.36/215.51  |- mesh__publicMeSHNote mesh__D004227 91; was see under SULFITES 1975-90   
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D004227 1997
% 215.36/215.51  |- mesh__onlineNote mesh__D004227 search SULFITES 1973-74   
% 215.36/215.51  |- rdf__type mesh__D004227sskos__Concept
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D004227 1999
% 215.36/215.51  |- mesh__recordOriginator mesh__D004227 NLM
% 215.36/215.51  |- mesh__recordAuthorizer mesh__D004227 PLS
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D004227 2004
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D004227 2006
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D004227 2002
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D004227 1996
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D004227 1995
% 215.36/215.51  |- skos__hiddenLabel mesh__D004227 Dithionite, Sodium
% 215.36/215.51  |- mesh__dateEstablished mesh__D004227 1991-01-01
% 215.36/215.51  |- mesh__historyNote mesh__D004227
% 215.36/215.51       91%28%75%29%; was see under SULFITES 1975-90   
% 215.36/215.51  |- mesh__dateRevised mesh__D004227 1993-06-01
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D004227 1998
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D004227 2003
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D004227 2001
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D004227 2005
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D004227 1994
% 215.36/215.51  |- skos__hiddenLabel mesh__D009710 Fingerprint, Nucleotide
% 215.36/215.51  |- skos__hiddenLabel mesh__D009710 Nucleotide Mappings
% 215.36/215.51  |- skos__broader mesh__D009710smesh__D004590
% 215.36/215.51  |- mesh__publicMeSHNote mesh__D009710 87   
% 215.36/215.51  |- mesh__historyNote mesh__D009710 87   
% 215.36/215.51  |- skos__broader mesh__D009710smesh__D002623
% 215.36/215.51  |- skos__scopeNote mesh__D009710
% 215.36/215.51       Two-dimensional separation and analysis of nucleotides.%A%    
% 215.36/215.51  |- skos__prefLabel mesh__D009710 Nucleotide Mapping
% 215.36/215.51  |- skos__historyNote mesh__D009710 Chromatography, Paper %28%1966-1986%29%
% 215.36/215.51  |- mesh__recordAuthorizer mesh__D009710 sjn
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D009710 2006
% 215.36/215.51  |- skos__historyNote mesh__D009710 Electrophoresis, Paper %28%1973-1986%29%
% 215.36/215.51  |- skos__hiddenLabel mesh__D009710 Nucleotide Fingerprints
% 215.36/215.51  |- mesh__dateEstablished mesh__D009710 1987-01-01
% 215.36/215.51  |- skos__hiddenLabel mesh__D009710 Nucleotide Fingerprint
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D009710 2005
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D009710 2004
% 215.36/215.51  |- mesh__dateCreated mesh__D009710 1986-06-24
% 215.36/215.51  |- mesh__recordMaintainer mesh__D009710 lkt
% 215.36/215.51  |- rdf__type mesh__D009710sskos__Concept
% 215.36/215.51  |- skos__hiddenLabel mesh__D009710 Mapping, Nucleotide
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D009710 2003
% 215.36/215.51  |- skos__annotation mesh__D009710
% 215.36/215.51       2-dimensional separation %26% anal of nucleotides   
% 215.36/215.51  |- mesh__dateRevised mesh__D009710 2002-07-03
% 215.36/215.51  |- mesh__recordOriginator mesh__D009710 VDK
% 215.36/215.51  |- skos__broader mesh__D009710smesh__D002854
% 215.36/215.51  |- skos__hiddenLabel mesh__D009710 Mappings, Nucleotide
% 215.36/215.51  |- mesh__recordAuthorizer mesh__D020692 sjn
% 215.36/215.51  |- mesh__publicMeSHNote mesh__D020692
% 215.36/215.51       2000; RAB3 PROTEIN %28%now RAB3 GTP-BINDING PROTEINS%29% was indexd under G-PROTEINS %28%1990-1999%29%%A%  
% 215.36/215.51  |- skos__hiddenLabel mesh__D020692 rab3 GTP Binding Proteins
% 215.36/215.51  |- rdf__type mesh__D020692sskos__Concept
% 215.36/215.51  |- mesh__dateCreated mesh__D020692 1999-11-03
% 215.36/215.51  |- skos__hiddenLabel mesh__D020692 GTP-Binding Proteins, rab3
% 215.36/215.51  |- mesh__recordMaintainer mesh__D020692 jmp
% 215.36/215.51  |- skos__historyNote mesh__D020692 G-Proteins %28%1989-1999%29%
% 215.36/215.51  |- mesh__historyNote mesh__D020692
% 215.36/215.51       2000; use RAB3 GTP-BINDING PROTEIN %28%NM%29% 1990-1999   
% 215.36/215.51  |- skos__prefLabel mesh__D020692 rab3 GTP-Binding Proteins
% 215.36/215.51  |- skos__annotation mesh__D020692 DF: RAB3 PROTEIN   
% 215.36/215.51  |- skos__scopeNote mesh__D020692
% 215.36/215.51       A genetically related subfamily of RAB GTP-BINDING PROTEINS involved in calcium-dependent EXOCYTOSIS. This enzyme was formerly listed as EC 3.6.1.47.%A%    
% 215.36/215.51  |- skos__altLabel mesh__D020692 rab3 Proteins
% 215.36/215.51  |- mesh__recordOriginator mesh__D020692 jmp
% 215.36/215.51  |- skos__broader mesh__D020692smesh__D020691
% 215.36/215.51  |- mesh__dateRevised mesh__D020692 2005-06-30
% 215.36/215.51  |- skos__altLabel mesh__D020692 rab3 Protein
% 215.36/215.51  |- mesh__dateEstablished mesh__D020692 2000-01-01
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D020692 2006
% 215.36/215.51  |- skos__broader mesh__D014655smesh__D045472
% 215.36/215.51  |- skos__scopeNote mesh__D014655
% 215.36/215.51       The force that opposes the flow of BLOOD through a vascular bed. It is equal to the difference in BLOOD PRESSURE across the vascular bed divided by the CARDIAC OUTPUT.%A%    
% 215.36/215.51  |- skos__hiddenLabel mesh__D014655 Vascular Resistance, Systemic
% 215.36/215.51  |- mesh__dateEstablished mesh__D014655 1967-01-01
% 215.36/215.51  |- skos__prefLabel mesh__D014655 Vascular Resistance
% 215.36/215.51  |- skos__hiddenLabel mesh__D014655 Resistance, Systemic Vascular
% 215.36/215.51  |- skos__annotation mesh__D014655
% 215.36/215.51       do not confuse with VASCULAR CAPACITANCE, blood volume within a vessel%A%  
% 215.36/215.51  |- skos__related mesh__D014655smesh__D014661
% 215.36/215.51  |- skos__hiddenLabel mesh__D014655 Resistance, Pulmonary Vascular
% 215.36/215.51  |- mesh__recordOriginator mesh__D014655 NLM
% 215.36/215.51  |- mesh__dateRevised mesh__D014655 2005-06-30
% 215.36/215.51  |- mesh__recordMaintainer mesh__D014655 nns
% 215.36/215.51  |- skos__hiddenLabel mesh__D014655 Peripheral Resistance, Total
% 215.36/215.51  |- skos__hiddenLabel mesh__D014655 Resistance, Peripheral
% 215.36/215.51  |- skos__hiddenLabel mesh__D014655 Resistance, Vascular
% 215.36/215.51  |- mesh__historyNote mesh__D014655 67%28%64%29%   
% 215.36/215.51  |- skos__hiddenLabel mesh__D014655 Vascular Resistance, Pulmonary
% 215.36/215.51  |- rdf__type mesh__D014655sskos__Concept
% 215.36/215.51  |- mesh__dateCreated mesh__D014655 1999-01-01
% 215.36/215.51  |- skos__hiddenLabel mesh__D014655 Resistance, Total Peripheral
% 215.36/215.51  |- skos__related mesh__D014655smesh__D018924
% 215.36/215.51  |- skos__altLabel mesh__D014655 Systemic Vascular Resistance
% 215.36/215.51  |- skos__altLabel mesh__D014655 Peripheral Resistance
% 215.36/215.51  |- mesh__publicMeSHNote mesh__D014655
% 215.36/215.51       67; CAPILLARY RESISTANCE was heading 1963-85   
% 215.36/215.51  |- mesh__recordAuthorizer mesh__D014655 sjn
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D014655 2006
% 215.36/215.51  |- skos__altLabel mesh__D008618 Sanofi Brand of Mephobarbital
% 215.36/215.51  |- mesh__recordOriginator mesh__D008618 NLM
% 215.36/215.51  |- skos__altLabel mesh__D008618 Methylphenobarbital
% 215.36/215.51  |- skos__broader mesh__D008618smesh__D001463
% 215.36/215.51  |- mesh__dateCreated mesh__D008618 1999-01-01
% 215.36/215.51  |- mesh__publicMeSHNote mesh__D008618
% 215.36/215.51       73;  METHYLPHENOBARBITOL was see MEPHOBARBITOL 1973-94   
% 215.36/215.51  |- skos__prefLabel mesh__D008618 Mephobarbital
% 215.36/215.51  |- mesh__dateRevised mesh__D008618 2005-06-30
% 215.36/215.51  |- skos__altLabel mesh__D008618 N-Methylphenobarbital
% 215.36/215.51  |- mesh__dateEstablished mesh__D008618 1973-01-01
% 215.36/215.51  |- mesh__recordMaintainer mesh__D008618 CCR
% 215.36/215.51  |- skos__scopeNote mesh__D008618
% 215.36/215.51       A barbiturate that is metabolized to PHENOBARBITAL. It has been used for similar purposes, especially in EPILEPSY, but there is no evidence mephobarbital offers any advantage over PHENOBARBITAL.%A%    
% 215.36/215.51  |- mesh__recordAuthorizer mesh__D008618 sjn
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D008618 2006
% 215.36/215.51  |- mesh__onlineNote mesh__D008618
% 215.36/215.51       use MEPHOBARBITAL to search METHYLPHENOBARBITOL 1973-94   
% 215.36/215.51  |- rdf__type mesh__D008618sskos__Concept
% 215.36/215.51  |- skos__annotation mesh__D008618 do not confuse with mephebarbital   
% 215.36/215.51  |- mesh__historyNote mesh__D008618
% 215.36/215.51       73%28%63%29%; METHYLPHENOBARBITOL was see MEPHOBARBITOL 1973-94%A%  
% 215.36/215.51  |- skos__altLabel mesh__D008618 Sanofi Synthelabo Brand of Mephobarbital
% 215.36/215.51  |- skos__altLabel mesh__D008618 Methylphenobarbitone
% 215.36/215.51  |- mesh__recordOriginator mesh__D000635 NLM
% 215.36/215.51  |- skos__altLabel mesh__D000635 Aminoxaphen
% 215.36/215.51  |- skos__altLabel mesh__D000635 Aminoxafen
% 215.36/215.51  |- rdf__type mesh__D000635sskos__Concept
% 215.36/215.51  |- mesh__dateCreated mesh__D000635 1974-11-11
% 215.36/215.51  |- mesh__recordMaintainer mesh__D000635 ssb
% 215.36/215.51  |- mesh__dateEstablished mesh__D000635 1991-01-01
% 215.36/215.51  |- mesh__dateRevised mesh__D000635 2005-06-30
% 215.36/215.51  |- skos__historyNote mesh__D000635 Amines %28%1972-1974%29%
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D000635 2006
% 215.36/215.51  |- skos__prefLabel mesh__D000635 Aminorex
% 215.36/215.51  |- mesh__publicMeSHNote mesh__D000635 91; was see under OXAZOLES 1975-90   
% 215.36/215.51  |- skos__scopeNote mesh__D000635
% 215.36/215.51       An amphetamine-like anorectic agent. It may cause pulmonary hypertension.%A%    
% 215.36/215.51  |- skos__historyNote mesh__D000635 Oxazoles %28%1968-1974%29%
% 215.36/215.51  |- mesh__historyNote mesh__D000635
% 215.36/215.51       91%28%75%29%; was see under OXAZOLES 1975-90   
% 215.36/215.51  |- skos__broader mesh__D000635smesh__D010080
% 215.36/215.51  |- mesh__recordAuthorizer mesh__D000635 sjn
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D019340 2005
% 215.36/215.51  |- skos__annotation mesh__D019340
% 215.36/215.51       in maxillary surg; Le Fort I: coord IM with MAXILLA /surg %28%IM%29% for maxillary advancement; Le Fort II: coord IM with MAXILLARY FRACTURES /surg %28%IM%29%; Le Fort III: coord IM with MAXILLARY FRACTURES /surg %28%IM%29% or CRANIOFACIAL DYSTOSIS /surg %28%IM%29% or other related facial abnorm /surg %28%IM%29%; do not use /util except by MeSH definition%A%  
% 215.36/215.51  |- skos__scopeNote mesh__D019340
% 215.36/215.51       Transverse sectioning and repositioning of the maxilla. There are three types: Le Fort I osteotomy for maxillary advancement or the treatment of maxillary fractures; Le Fort II osteotomy for the treatment of maxillary fractures; Le Fort III osteotomy for the treatment of maxillary fractures with fracture of one or more facial bones. Le Fort III is often used also to correct craniofacial dysostosis and related facial abnormalities. %28%From Dorland, 28th ed, p1203 %26% p662%29%%A%    
% 215.36/215.51  |- skos__altLabel mesh__D019340 Osteotomy, LeFort
% 215.36/215.51  |- skos__historyNote mesh__D019340 Maxilla/surgery %28%1971-1996%29%
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D019340 1998
% 215.36/215.51  |- skos__prefLabel mesh__D019340 Osteotomy, Le Fort
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D019340 2006
% 215.36/215.51  |- rdf__type mesh__D019340sskos__Concept
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D019340 1999
% 215.36/215.51  |- skos__broader mesh__D019340smesh__D019647
% 215.36/215.51  |- mesh__recordMaintainer mesh__D019340 PXP
% 215.36/215.51  |- skos__historyNote mesh__D019340 Osteotomy %28%1971-1996%29%
% 215.36/215.51  |- skos__altLabel mesh__D019340 LeFort Osteotomy
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D019340 2000
% 215.36/215.51  |- mesh__dateRevised mesh__D019340 1997-06-20
% 215.36/215.51  |- mesh__publicMeSHNote mesh__D019340 97   
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D019340 2003
% 215.36/215.51  |- skos__broader mesh__D019340smesh__D010027
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D019340 2001
% 215.36/215.51  |- mesh__recordOriginator mesh__D019340 TGC
% 215.36/215.51  |- mesh__historyNote mesh__D019340 97   
% 215.36/215.51  |- skos__historyNote mesh__D019340
% 215.36/215.51       Maxillary Fractures/surgery %28%1971-1996%29%
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D019340 2004
% 215.36/215.51  |- mesh__dateEstablished mesh__D019340 1997-01-01
% 215.36/215.51  |- mesh__dateCreated mesh__D019340 1996-06-10
% 215.36/215.51  |- mesh__recordAuthorizer mesh__D019340 SJN
% 215.36/215.51  |- skos__hiddenLabel mesh__D019340 Le Fort Osteotomy
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D019340 2002
% 215.36/215.51  |- rdf__type mesh__D005320sskos__Concept
% 215.36/215.51  |- skos__broader mesh__D005320smesh__D016640
% 215.36/215.51  |- skos__altLabel mesh__D005320 Macrosomia, Fetal
% 215.36/215.51  |- mesh__recordAuthorizer mesh__D005320 sjn
% 215.36/215.51  |- skos__annotation mesh__D005320
% 215.36/215.51       do not confuse with INFANT, POSTMATURE %28%born after 42 wks of gestation%29%%A%  
% 215.36/215.51  |- skos__hiddenLabel mesh__D005320 Macrosomias, Fetal
% 215.36/215.51  |- mesh__dateCreated mesh__D005320 1986-06-18
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D005320 2006
% 215.36/215.51  |- skos__historyNote mesh__D005320
% 215.36/215.51       Infant, Newborn, Diseases %28%1966-1986%29%
% 215.36/215.51  |- skos__historyNote mesh__D005320 Fetal Diseases %28%1966-1986%29%
% 215.36/215.51  |- mesh__historyNote mesh__D005320 87   
% 215.36/215.51  |- skos__prefLabel mesh__D005320 Fetal Macrosomia
% 215.36/215.51  |- mesh__dateRevised mesh__D005320 2005-06-30
% 215.36/215.51  |- mesh__recordOriginator mesh__D005320 SCD
% 215.36/215.51  |- skos__broader mesh__D005320smesh__D001724
% 215.36/215.51  |- skos__broader mesh__D005320smesh__D048909
% 215.36/215.51  |- mesh__dateEstablished mesh__D005320 1987-01-01
% 215.36/215.51  |- skos__hiddenLabel mesh__D005320 Fetal Macrosomias
% 215.36/215.51  |- skos__historyNote mesh__D005320 Pregnancy in Diabetes %28%1966-1986%29%
% 215.36/215.51  |- mesh__recordMaintainer mesh__D005320 lkt
% 215.36/215.51  |- skos__broader mesh__D005320smesh__D011254
% 215.36/215.51  |- skos__scopeNote mesh__D005320
% 215.36/215.51       A condition of fetal overgrowth leading to a large-for-gestational-age FETUS. It is defined as BIRTH WEIGHT greater than 4,000 grams or above the 90th percentile for population and sex-specific growth curves. It is commonly seen in GESTATIONAL DIABETES; PROLONGED PREGNANCY; and pregnancies complicated by pre-existing diabetes mellitus.%A%    
% 215.36/215.51  |- skos__historyNote mesh__D005320 Birth Weight %28%1966-1986%29%
% 215.36/215.51  |- skos__broader mesh__D005320smesh__D005315
% 215.36/215.51  |- mesh__publicMeSHNote mesh__D005320 87   
% 215.36/215.51  |- skos__scopeNote mesh__D018248
% 215.36/215.51       A benign epithelial tumor of the LIVER.     
% 215.36/215.51  |- skos__hiddenLabel mesh__D018248 Liver Cell Adenomas
% 215.36/215.51  |- mesh__dateCreated mesh__D018248 1993-06-25
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D018248 2004
% 215.36/215.51  |- skos__hiddenLabel mesh__D018248 Liver Cell Adenoma
% 215.36/215.51  |- skos__historyNote mesh__D018248
% 215.36/215.51       Carcinoma, Hepatocellular %28%1966-1993%29%
% 215.36/215.51  |- skos__broader mesh__D018248smesh__D000236
% 215.36/215.51  |- mesh__recordMaintainer mesh__D018248 lkt
% 215.36/215.51  |- skos__hiddenLabel mesh__D018248 Hepatomas, Benign
% 215.36/215.51  |- skos__hiddenLabel mesh__D018248 Benign Hepatomas
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D018248 2005
% 215.36/215.51  |- skos__historyNote mesh__D018248 Adenoma %28%1966-1993%29%
% 215.36/215.51  |- mesh__recordAuthorizer mesh__D018248 sjn
% 215.36/215.51  |- mesh__historyNote mesh__D018248 94   
% 215.36/215.51  |- skos__hiddenLabel mesh__D018248 Benign Hepatoma
% 215.36/215.51  |- mesh__recordOriginator mesh__D018248 PLS
% 215.36/215.51  |- skos__broader mesh__D018248smesh__D008113
% 215.36/215.51  |- skos__hiddenLabel mesh__D018248 Hepatocellular Adenoma
% 215.36/215.51  |- skos__hiddenLabel mesh__D018248 Adenomas, Hepatocellular
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D018248 2006
% 215.36/215.51  |- mesh__dateRevised mesh__D018248 2003-07-09
% 215.36/215.51  |- skos__altLabel mesh__D018248 Adenoma, Hepatocellular
% 215.36/215.51  |- skos__hiddenLabel mesh__D018248 Hepatocellular Adenomas
% 215.36/215.51  |- skos__historyNote mesh__D018248 Liver Neoplasms %28%1966-1993%29%
% 215.36/215.51  |- skos__hiddenLabel mesh__D018248 Adenomas, Liver Cell
% 215.36/215.51  |- mesh__dateEstablished mesh__D018248 1994-01-01
% 215.36/215.51  |- skos__altLabel mesh__D018248 Hepatoma, Benign
% 215.36/215.51  |- skos__annotation mesh__D018248
% 215.36/215.51       coord IM with LIVER NEOPLASMS %28%IM%29%   
% 215.36/215.51  |- skos__prefLabel mesh__D018248 Adenoma, Liver Cell
% 215.36/215.51  |- rdf__type mesh__D018248sskos__Concept
% 215.36/215.51  |- mesh__publicMeSHNote mesh__D018248 94   
% 215.36/215.51  |- skos__broader mesh__D010265smesh__D001796
% 215.36/215.51  |- skos__hiddenLabel mesh__D010265 Paraproteinemia
% 215.36/215.51  |- mesh__dateCreated mesh__D010265 1975-07-25
% 215.36/215.51  |- skos__altLabel mesh__D010265 Paraimmunoglobulinemias
% 215.36/215.51  |- mesh__publicMeSHNote mesh__D010265 76   
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D010265 2003
% 215.36/215.51  |- mesh__dateRevised mesh__D010265 2002-07-03
% 215.36/215.51  |- skos__historyNote mesh__D010265
% 215.36/215.51       Blood Protein Disorders %28%1966-1975%29%
% 215.36/215.51  |- mesh__recordOriginator mesh__D010265 SMH
% 215.36/215.51  |- rdf__type mesh__D010265sskos__Concept
% 215.36/215.51  |- skos__historyNote mesh__D010265 Immunoglobulins %28%1970-1975%29%
% 215.36/215.51  |- mesh__dateEstablished mesh__D010265 1976-01-01
% 215.36/215.51  |- mesh__historyNote mesh__D010265 76   
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D010265 2004
% 215.36/215.51  |- skos__altLabel mesh__D010265 Monoclonal Gammopathies
% 215.36/215.51  |- mesh__recordMaintainer mesh__D010265 ssb
% 215.36/215.51  |- mesh__recordAuthorizer mesh__D010265 sjn
% 215.36/215.51  |- skos__hiddenLabel mesh__D010265 Paraimmunoglobulinemia
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D010265 2005
% 215.36/215.51  |- skos__prefLabel mesh__D010265 Paraproteinemias
% 215.36/215.51  |- skos__historyNote mesh__D010265
% 215.36/215.51       specific immunoglobulin %28%1971-1975%29%
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D010265 2006
% 215.36/215.51  |- skos__scopeNote mesh__D010265
% 215.36/215.51       A group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin %28%M-component%29% and/or an abnormal immunoglobulin.%A%    
% 215.36/215.51  |- skos__broader mesh__D010265smesh__D007160
% 215.36/215.51  |- skos__altLabel mesh__D010265 Monoclonal Gammapathies
% 215.36/215.51  |- skos__altLabel mesh__D010265 Gammapathy, Monoclonal
% 215.36/215.51  |- mesh__dateCreated mesh__D037402 2002-07-03
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D037402 2004
% 215.36/215.51  |- mesh__historyNote mesh__D037402
% 215.36/215.51       2003; use HYDRA 1997-2000, use CNIDARIA 2001-2002; for PHYSALIA %26% PORTUGESE MAN-OF-WAR use CNIDARIA 1998-2002%A%  
% 215.36/215.51  |- mesh__recordAuthorizer mesh__D037402 sjn
% 215.36/215.51  |- mesh__dateRevised mesh__D037402 2003-07-09
% 215.36/215.51  |- mesh__recordMaintainer mesh__D037402 ags
% 215.36/215.51  |- mesh__recordOriginator mesh__D037402 ags
% 215.36/215.51  |- skos__scopeNote mesh__D037402
% 215.36/215.51       A class in the phylum CNIDARIA which alternates between  polyp and medusa forms during their life cycle. There are over 2700 species in five orders.%A%    
% 215.36/215.51  |- skos__annotation mesh__D037402
% 215.36/215.51       do not confuse X ref LIRIOPE TETRAPHYLLA with LIRIOPE PLANT%A%  
% 215.36/215.51  |- skos__altLabel mesh__D037402 Hydrozoans
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D037402 2006
% 215.36/215.51  |- skos__historyNote mesh__D037402 Cnidaria %28%1986-2002%29%
% 215.36/215.51  |- skos__broader mesh__D037402smesh__D003063
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D037402 2005
% 215.36/215.51  |- skos__altLabel mesh__D037402 Physalia physalis
% 215.36/215.51  |- mesh__dateEstablished mesh__D037402 2003-01-01
% 215.36/215.51  |- skos__prefLabel mesh__D037402 Hydrozoa
% 215.36/215.51  |- mesh__publicMeSHNote mesh__D037402
% 215.36/215.51       2003; see HYDRA 1997-2000, see CNIDARIA 2001-2002; for PHYSALIA %26% PORTUGESE MAN-OF-WAR see JELLYFISH 1998-2002%A%  
% 215.36/215.51  |- rdf__type mesh__D037402sskos__Concept
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D004228 2005
% 215.36/215.51  |- mesh__historyNote mesh__D004228
% 215.36/215.51       91%28%75%29%; was see under NITROBENZOATES 1975-90   
% 215.36/215.51  |- mesh__recordMaintainer mesh__D004228 ssb
% 215.36/215.51  |- skos__broader mesh__D004228smesh__D009579
% 215.36/215.51  |- skos__altLabel mesh__D004228 Ellman%27%s Reagent
% 215.36/215.51  |- mesh__dateRevised mesh__D004228 2003-07-09
% 215.36/215.51  |- mesh__recordOriginator mesh__D004228 NLM
% 215.36/215.51  |- rdf__type mesh__D004228sskos__Concept
% 215.36/215.51  |- skos__altLabel mesh__D004228 DTNB
% 215.36/215.51  |- mesh__dateEstablished mesh__D004228 1991-01-01
% 215.36/215.51  |- skos__historyNote mesh__D004228 Nitro Compounds %28%1972-1974%29%
% 215.36/215.51  |- skos__hiddenLabel mesh__D004228 Ellman Reagent
% 215.36/215.51  |- skos__historyNote mesh__D004228 Benzoates %28%1969-1974%29%
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D004228 2004
% 215.36/215.51  |- skos__hiddenLabel mesh__D004228 Ellmans Reagent
% 215.36/215.51  |- mesh__publicMeSHNote mesh__D004228
% 215.36/215.51       91; was see under NITROBENZOATES 1975-90   
% 215.36/215.51  |- skos__hiddenLabel mesh__D004228 Reagent, Ellman%27%s
% 215.36/215.51  |- skos__scopeNote mesh__D004228
% 215.36/215.51       A standard reagent for the determination of reactive sulfhydryl groups by absorbance measurements. It is used primarily for the determination of sulfhydryl and disulfide groups in proteins. The color produced is due to the formation of a thio anion, 3-carboxyl-4-nitrothiophenolate.%A%    
% 215.36/215.51  |- mesh__recordAuthorizer mesh__D004228 sjn
% 215.36/215.51  |- skos__hiddenLabel mesh__D004228 Acid, Dithionitrobenzoic
% 215.36/215.51  |- mesh__activeMeSHYear mesh__D004228 2006
% 215.36/215.51  |- skos__prefLabel mesh__D004228 Dithionitrobenzoic Acid
% 215.36/215.51  |- mesh__dateCreated mesh__D004228 1974-11-14
% 215.36/215.51  |- skos__historyNote mesh__D004228 Disulfides %28%1972-1974%29%
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D009711 2006
% 215.36/215.52  |- skos__related mesh__D009711smesh__D001483
% 215.36/215.52  |- skos__broader mesh__D009711smesh__D006027
% 215.36/215.52  |- skos__scopeNote mesh__D009711
% 215.36/215.52       The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. %28%From King %26% Stansfield, A Dictionary of Genetics, 4th ed%29%%A%    
% 215.36/215.52  |- skos__prefLabel mesh__D009711 Nucleotides
% 215.36/215.52  |- mesh__recordMaintainer mesh__D009711 ssb
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D009711 2005
% 215.36/215.52  |- mesh__recordOriginator mesh__D009711 NLM
% 215.36/215.52  |- skos__annotation mesh__D009711
% 215.36/215.52       pyridine nucleotides are probably NAD or NADP; /anal: consider also NUCLEOTIDE MAPPING%A%  
% 215.36/215.52  |- rdf__type mesh__D009711sskos__Concept
% 215.36/215.52  |- skos__broader mesh__D009711smesh__D009706
% 215.36/215.52  |- mesh__recordAuthorizer mesh__D009711 sjn
% 215.36/215.52  |- mesh__dateCreated mesh__D009711 1999-01-01
% 215.36/215.52  |- mesh__dateRevised mesh__D009711 2004-07-07
% 215.36/215.52  |- skos__hiddenLabel mesh__D020693 rab2 GTP Binding Protein
% 215.36/215.52  |- mesh__recordOriginator mesh__D020693 jmp
% 215.36/215.52  |- skos__prefLabel mesh__D020693 rab2 GTP-Binding Protein
% 215.36/215.52  |- skos__scopeNote mesh__D020693
% 215.36/215.52       A protein involved in transport between the ENDOPLASMIC RETICULUM and the GOLGI APPARATUS. This enzyme was formerly listed as EC 3.6.1.47.%A%    
% 215.36/215.52  |- mesh__recordMaintainer mesh__D020693 jmp
% 215.36/215.52  |- mesh__dateRevised mesh__D020693 2005-06-30
% 215.36/215.52  |- mesh__recordAuthorizer mesh__D020693 sjn
% 215.36/215.52  |- mesh__historyNote mesh__D020693
% 215.36/215.52       2000; use RAB2 GTP-BINDING PROTEIN %28%NM%29% 1991-1999   
% 215.36/215.52  |- mesh__dateCreated mesh__D020693 1999-11-03
% 215.36/215.52  |- skos__altLabel mesh__D020693 rab2 Protein
% 215.36/215.52  |- mesh__publicMeSHNote mesh__D020693
% 215.36/215.52       2000; RAB2 PROTEIN %28%now RAB2 GTP-BINDING PROTEIN%29% was indexed under G-PROTEINS 1991-1999%A%  
% 215.36/215.52  |- skos__hiddenLabel mesh__D020693 GTP-Binding Protein, rab2
% 215.36/215.52  |- skos__broader mesh__D020693smesh__D020691
% 215.36/215.52  |- mesh__dateEstablished mesh__D020693 2000-01-01
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D020693 2006
% 215.36/215.52  |- skos__annotation mesh__D020693 DF: RAB2 PROTEIN   
% 215.36/215.52  |- skos__historyNote mesh__D020693 G-Proteins %28%1992-1999%29%
% 215.36/215.52  |- rdf__type mesh__D020693sskos__Concept
% 215.36/215.52  |- skos__hiddenLabel mesh__D047830 Shield, Operation Desert
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D047830 2005
% 215.36/215.52  |- mesh__dateCreated mesh__D047830 2004-07-07
% 215.36/215.52  |- rdf__type mesh__D047830sskos__Concept
% 215.36/215.52  |- mesh__dateEstablished mesh__D047830 2005-01-01
% 215.36/215.52  |- skos__altLabel mesh__D047830 Operation Desert Storm
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D047830 2006
% 215.36/215.52  |- skos__altLabel mesh__D047830 Operation Desert Shield
% 215.36/215.52  |- mesh__recordOriginator mesh__D047830 jls
% 215.36/215.52  |- mesh__historyNote mesh__D047830 2005   
% 215.36/215.52  |- mesh__recordAuthorizer mesh__D047830 sjn
% 215.36/215.52  |- skos__prefLabel mesh__D047830 Gulf War
% 215.36/215.52  |- skos__hiddenLabel mesh__D047830 Desert Shield, Operation
% 215.36/215.52  |- skos__broader mesh__D047830smesh__D049673
% 215.36/215.52  |- skos__hiddenLabel mesh__D047830 Desert Storm, Operation
% 215.36/215.52  |- mesh__publicMeSHNote mesh__D047830 2005   
% 215.36/215.52  |- skos__altLabel mesh__D047830 Persian Gulf War, 1991
% 215.36/215.52  |- skos__hiddenLabel mesh__D047830 War, Gulf
% 215.36/215.52  |- skos__hiddenLabel mesh__D047830 Storm, Operation Desert
% 215.36/215.52  |- skos__scopeNote mesh__D047830
% 215.36/215.52       United Nations%27% action to intervene in conflict between the nation of Kuwait and occupying Iraqi forces, occurring from 1990 through 1991.%A%    
% 215.36/215.52  |- mesh__recordMaintainer mesh__D047830 jls
% 215.36/215.52  |- skos__altLabel mesh__D014656 Procedure, Vascular Surgical
% 215.36/215.52  |- skos__scopeNote mesh__D014656
% 215.36/215.52       Operative procedures for the treatment of vascular disorders.%A%    
% 215.36/215.52  |- mesh__recordOriginator mesh__D014656 NLM
% 215.36/215.52  |- skos__altLabel mesh__D014656 Vascular Surgical Procedure
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014656 2006
% 215.36/215.52  |- skos__broader mesh__D014656smesh__D013504
% 215.36/215.52  |- skos__annotation mesh__D014656
% 215.36/215.52       GEN only: prefer specific blood vessel /surg; SPEC: SPEC qualif%A%  
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014656 2000
% 215.36/215.52  |- skos__prefLabel mesh__D014656 Vascular Surgical Procedures
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014656 2001
% 215.36/215.52  |- mesh__dateRevised mesh__D014656 1997-06-20
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014656 2003
% 215.36/215.52  |- rdf__type mesh__D014656sskos__Concept
% 215.36/215.52  |- mesh__dateCreated mesh__D014656 1999-01-01
% 215.36/215.52  |- mesh__recordMaintainer mesh__D014656 PXP
% 215.36/215.52  |- mesh__publicMeSHNote mesh__D014656 98; was VASCULAR SURGERY 1963-97   
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014656 2002
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014656 1998
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014656 2004
% 215.36/215.52  |- mesh__recordAuthorizer mesh__D014656 SJN
% 215.36/215.52  |- skos__altLabel mesh__D014656 Surgical Procedures, Vascular
% 215.36/215.52  |- mesh__historyNote mesh__D014656 98; was VASCULAR SURGERY 1963-97   
% 215.36/215.52  |- skos__altLabel mesh__D014656 Procedures, Vascular Surgical
% 215.36/215.52  |- skos__altLabel mesh__D014656 Surgical Procedure, Vascular
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014656 1999
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014656 2005
% 215.36/215.52  |- mesh__recordAuthorizer mesh__D008619 sjn
% 215.36/215.52  |- skos__altLabel mesh__D008619 Scandicaine
% 215.36/215.52  |- skos__hiddenLabel mesh__D008619 Hydrochloride, Mepivacaine
% 215.36/215.52  |- skos__hiddenLabel mesh__D008619 Mepivacain Injektopas
% 215.36/215.52  |- skos__altLabel mesh__D008619 Dentsply Brand of Mepivacaine Hydrochloride
% 215.36/215.52  |- skos__altLabel mesh__D008619 Carboca%C3%%AF%ne
% 215.36/215.52  |- skos__prefLabel mesh__D008619 Mepivacaine
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D008619 2006
% 215.36/215.52  |- skos__altLabel mesh__D008619 3M Brand of Mepivacaine Hydrochloride
% 215.36/215.52  |- rdf__type mesh__D008619sskos__Concept
% 215.36/215.52  |- skos__altLabel mesh__D008619 Astra Brand of Mepivacaine Hydrochloride
% 215.36/215.52  |- skos__scopeNote mesh__D008619
% 215.36/215.52       A local anesthetic that is chemically related to BUPIVACAINE but pharmacologically related to LIDOCAINE. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. %28%From AMA Drug Evaluations, 1994, p168%29%%A%    
% 215.36/215.52  |- skos__altLabel mesh__D008619 Clarben Brand of Mepivacaine Hydrochloride
% 215.36/215.52  |- skos__altLabel mesh__D008619
% 215.36/215.52       AstraZeneca Brand of Mepivacaine Hydrochloride
% 215.36/215.52  |- skos__altLabel mesh__D008619 curasan Brand of Mepivacaine Hydrochloride
% 215.36/215.52  |- skos__altLabel mesh__D008619 Inibsa Brand of Mepivacaine Hydrochloride
% 215.36/215.52  |- skos__hiddenLabel mesh__D008619 Braun, Mepivacaina
% 215.36/215.52  |- skos__altLabel mesh__D008619 Pascoe Brand of Mepivacaine Hydrochloride
% 215.36/215.52  |- mesh__recordOriginator mesh__D008619 NLM
% 215.36/215.52  |- skos__altLabel mesh__D008619 Hexal Brand of Mepivacaine Hydrochloride
% 215.36/215.52  |- skos__altLabel mesh__D008619 Mepivacaine Monohydrochloride
% 215.36/215.52  |- skos__altLabel mesh__D008619 Braun Brand of Mepivicaine Hydrochloride
% 215.36/215.52  |- skos__broader mesh__D008619smesh__D010880
% 215.36/215.52  |- skos__hiddenLabel mesh__D008619 Monohydrochloride, Mepivacaine
% 215.36/215.52  |- mesh__recordMaintainer mesh__D008619 CCR
% 215.36/215.52  |- skos__altLabel mesh__D008619 Abbott Brand of Mepivacaine Hydrochloride
% 215.36/215.52  |- skos__altLabel mesh__D008619 Novocol Brand of Mepivacaine Hydrochloride
% 215.36/215.52  |- skos__altLabel mesh__D008619 Aventis Brand of Mepivacaine Hydrochloride
% 215.36/215.52  |- skos__altLabel mesh__D008619 Polocaine
% 215.36/215.52  |- mesh__dateRevised mesh__D008619 2005-06-30
% 215.36/215.52  |- skos__altLabel mesh__D008619 Scandicain
% 215.36/215.52  |- skos__altLabel mesh__D008619 Sanofi Brand of Mepivacaine Hydrochloride
% 215.36/215.52  |- mesh__dateCreated mesh__D008619 1999-01-01
% 215.36/215.52  |- mesh__onlineNote mesh__D000636
% 215.36/215.52       use AMINOSALICYLIC ACIDS to search AMINOSALICYLIC ACID 1966-76%A%  
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D000636 2000
% 215.36/215.52  |- mesh__recordAuthorizer mesh__D000636 SJN
% 215.36/215.52  |- mesh__publicMeSHNote mesh__D000636
% 215.36/215.52       77; was AMINOSALICYLIC ACID 1963-76   
% 215.36/215.52  |- rdf__type mesh__D000636sskos__Concept
% 215.36/215.52  |- mesh__dateRevised mesh__D000636 1998-06-10
% 215.36/215.52  |- mesh__recordOriginator mesh__D000636 NLM
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D000636 1999
% 215.36/215.52  |- mesh__recordMaintainer mesh__D000636 ADP
% 215.36/215.52  |- skos__hiddenLabel mesh__D000636 Acid, Aminosalicylic
% 215.36/215.52  |- skos__prefLabel mesh__D000636 Aminosalicylic Acids
% 215.36/215.52  |- skos__scopeNote mesh__D000636
% 215.36/215.52       A group of 2-hydroxybenzoic acids that can be substituted by amino groups at any of the 3-, 4-, 5-, or 6-positions.%A%    
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D000636 2006
% 215.36/215.52  |- skos__annotation mesh__D000636
% 215.36/215.52       P-AMINOSALICYLIC ACID is also available   
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D000636 2002
% 215.36/215.52  |- mesh__historyNote mesh__D000636 77; was AMINOSALICYLIC ACID 1963-76   
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D000636 2004
% 215.36/215.52  |- skos__broader mesh__D000636smesh__D012461
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D000636 2005
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D000636 2003
% 215.36/215.52  |- mesh__dateCreated mesh__D000636 1999-01-01
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D000636 2001
% 215.36/215.52  |- skos__hiddenLabel mesh__D000636 Acids, Aminosalicylic
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D019341 2006
% 215.36/215.52  |- rdf__type mesh__D019341sskos__Concept
% 215.36/215.52  |- mesh__dateEstablished mesh__D019341 1997-01-01
% 215.36/215.52  |- skos__hiddenLabel mesh__D019341 Aroma Therapies
% 215.36/215.52  |- mesh__dateCreated mesh__D019341 1996-06-10
% 215.36/215.52  |- mesh__recordMaintainer mesh__D019341 ssb
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D019341 2002
% 215.36/215.52  |- skos__broader mesh__D019341smesh__D008517
% 215.36/215.52  |- skos__altLabel mesh__D019341 Aroma Therapy
% 215.36/215.52  |- mesh__recordAuthorizer mesh__D019341 sjn
% 215.36/215.52  |- skos__scopeNote mesh__D019341
% 215.36/215.52       The use of fragrances and essences from plants to affect or alter a person%27%s mood or behavior and to facilitate physical, mental, and emotional well-being. The chemicals comprising essential oils in plants has a host of therapeutic properties and has been used historically in Africa, Asia, and India. Its greatest application is in the field of alternative medicine. %28%From Random House Unabridged Dictionary, 2d ed; from Dr. Atiba Vheir, Dove Center, Washington, D.C.%29%%A%    
% 215.36/215.52  |- skos__historyNote mesh__D019341 Alternative Medicine %28%1990-1995%29%
% 215.36/215.52  |- skos__hiddenLabel mesh__D019341 Therapies, Aroma
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D019341 2003
% 215.36/215.52  |- skos__prefLabel mesh__D019341 Aromatherapy
% 215.36/215.52  |- mesh__historyNote mesh__D019341 97   
% 215.36/215.52  |- skos__annotation mesh__D019341
% 215.36/215.52       use of essential oils to treat dis in alternative med; coord IM with disease /ther %28%IM%29% %26% specific plant or essential oil /ther use %28%IM%29% if available %26% if pertinent; DF: AROMATHER%A%  
% 215.36/215.52  |- mesh__dateRevised mesh__D019341 2001-07-25
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D019341 2004
% 215.36/215.52  |- skos__altLabel mesh__D019341 Therapy, Aroma
% 215.36/215.52  |- skos__broader mesh__D019341smesh__D026441
% 215.36/215.52  |- skos__broader mesh__D019341smesh__D026421
% 215.36/215.52  |- skos__broader mesh__D019341smesh__D011613
% 215.36/215.52  |- skos__historyNote mesh__D019341 Odors %28%1986-1995%29%
% 215.36/215.52  |- skos__historyNote mesh__D019341 Oils, Volatile %28%1986-1996%29%
% 215.36/215.52  |- mesh__publicMeSHNote mesh__D019341 97   
% 215.36/215.52  |- skos__hiddenLabel mesh__D019341 Aromatherapies
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D019341 2005
% 215.36/215.52  |- mesh__recordOriginator mesh__D019341 TGC
% 215.36/215.52  |- rdf__type mesh__D005321sskos__Concept
% 215.36/215.52  |- skos__scopeNote mesh__D005321
% 215.36/215.52       The thin layers of tissue that surround the developing EMBRYO. There are four extra-embryonic membranes commonly found in VERTEBRATES, such as REPTILES; BIRDS; and MAMMALS. They are the YOLK SAC, the ALLANTOIS, the AMNION, and the CHORION. These membranes provide protection and means to transport nutrients and wastes.%A%    
% 215.36/215.52  |- skos__hiddenLabel mesh__D005321 Membranes, Extraembryonic
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D005321 2006A
% 215.36/215.52  |- skos__hiddenLabel mesh__D005321 Fetal Membrane
% 215.36/215.52  |- skos__hiddenLabel mesh__D005321 Membranes, Fetal
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D005321 2006
% 215.36/215.52  |- skos__hiddenLabel mesh__D005321 Membranes, Extra-Embryonic
% 215.36/215.52  |- skos__hiddenLabel mesh__D005321 Extra Embryonic Membranes
% 215.36/215.52  |- skos__hiddenLabel mesh__D005321 Membrane, Extraembryonic
% 215.36/215.52  |- skos__prefLabel mesh__D005321 Extraembryonic Membranes
% 215.36/215.52  |- mesh__dateRevised mesh__D005321 2005-07-18
% 215.36/215.52  |- skos__altLabel mesh__D005321 Extra-Embryonic Membranes
% 215.36/215.52  |- skos__hiddenLabel mesh__D005321 Extra-Embryonic Membrane
% 215.36/215.52  |- mesh__recordMaintainer mesh__D005321 ags
% 215.36/215.52  |- mesh__recordAuthorizer mesh__D005321 ags
% 215.36/215.52  |- skos__broader mesh__D005321smesh__D008566
% 215.36/215.52  |- skos__broader mesh__D005321smesh__D004622
% 215.36/215.52  |- skos__hiddenLabel mesh__D005321 Extraembryonic Membrane
% 215.36/215.52  |- mesh__dateCreated mesh__D005321 1999-01-01
% 215.36/215.52  |- skos__hiddenLabel mesh__D005321 Membrane, Extra-Embryonic
% 215.36/215.52  |- skos__hiddenLabel mesh__D005321 Membrane, Fetal
% 215.36/215.52  |- skos__annotation mesh__D005321
% 215.36/215.52       induced rupture = LABOR, INDUCED; premature rupture = FETAL MEMBRANES, PREMATURE RUPTURE; rupture in normal labor = EXTRAEMBRYONIC MEMBRANES %28%IM%29% + LABOR, OBSTETRIC %28%IM%29%%A%  
% 215.36/215.52  |- mesh__recordOriginator mesh__D005321 NLM
% 215.36/215.52  |- mesh__recordAuthorizer mesh__D018249 ags
% 215.36/215.52  |- skos__hiddenLabel mesh__D018249 Oxyphilic Adenoma
% 215.36/215.52  |- mesh__dateEstablished mesh__D018249 1994-01-01
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D018249 2005
% 215.36/215.52  |- mesh__historyNote mesh__D018249 94   
% 215.36/215.52  |- skos__annotation mesh__D018249
% 215.36/215.52       coord IM with precoord organ/neopl term %28%IM%29%; for X ref HURTHLE CELL TUMOR, coord IM with THYROID NEOPLASMS%A%  
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D018249 2006
% 215.36/215.52  |- mesh__recordOriginator mesh__D018249 PLS
% 215.36/215.52  |- skos__altLabel mesh__D018249 Huerthle Cell Tumor
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D018249 2006A
% 215.36/215.52  |- mesh__publicMeSHNote mesh__D018249 94   
% 215.36/215.52  |- skos__prefLabel mesh__D018249 Adenoma, Oxyphilic
% 215.36/215.52  |- mesh__recordMaintainer mesh__D018249 ags
% 215.36/215.52  |- mesh__dateCreated mesh__D018249 1993-06-25
% 215.36/215.52  |- rdf__type mesh__D018249sskos__Concept
% 215.36/215.52  |- skos__historyNote mesh__D018249 Adenoma %28%1967-1993%29%
% 215.36/215.52  |- skos__scopeNote mesh__D018249
% 215.36/215.52       A usually benign glandular tumor composed of oxyphil cells, large cells with small irregular nuclei and dense acidophilic granules due to the presence of abundant MITOCHONDRIA.  Oxyphil cells, also known as oncocytes, are found in oncocytomas of the kidney, salivary glands, and endocrine glands.  In the thyroid gland, oxyphil cells are known as Hurthle cells and Askanazy cells.%A%    
% 215.36/215.52  |- skos__broader mesh__D018249smesh__D000236
% 215.36/215.52  |- skos__altLabel mesh__D018249 Oncocytoma
% 215.36/215.52  |- mesh__dateRevised mesh__D018249 2005-07-12
% 215.36/215.52  |- mesh__dateCreated mesh__D010266 1975-07-25
% 215.36/215.52  |- skos__prefLabel mesh__D010266 Paraproteins
% 215.36/215.52  |- mesh__dateRevised mesh__D010266 2005-06-30
% 215.36/215.52  |- rdf__type mesh__D010266sskos__Concept
% 215.36/215.52  |- mesh__historyNote mesh__D010266 76; was see under GLOBULINS 1963-65   
% 215.36/215.52  |- mesh__recordOriginator mesh__D010266 RLS
% 215.36/215.52  |- skos__broader mesh__D010266smesh__D007136
% 215.36/215.52  |- skos__historyNote mesh__D010266
% 215.36/215.52       specific immunoglobulin %28%1966-1975%29%
% 215.36/215.52  |- skos__historyNote mesh__D010266
% 215.36/215.52       Blood Protein Disorders %28%1966-1975%29%
% 215.36/215.52  |- mesh__publicMeSHNote mesh__D010266
% 215.36/215.52       76; was see under GLOBULINS 1963-65   
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D010266 2006
% 215.36/215.52  |- skos__historyNote mesh__D010266 Immunoglobulins %28%1970-1975%29%
% 215.36/215.52  |- mesh__dateEstablished mesh__D010266 1976-01-01
% 215.36/215.52  |- mesh__recordMaintainer mesh__D010266 ssb
% 215.36/215.52  |- skos__scopeNote mesh__D010266
% 215.36/215.52       Abnormal immunoglobulins synthesized by atypical cells of the RETICULOENDOTHELIAL SYSTEM. Paraproteins containing only light chains lead to Bence Jones paraproteinemia, while the presence of only atypical heavy chains leads to heavy chain disease. Most of the paraproteins show themselves as an M-component %28%monoclonal gammopathy%29% in electrophoresis. Diclonal and polyclonal paraproteins are much less frequently encountered.%A%    
% 215.36/215.52  |- mesh__recordAuthorizer mesh__D010266 sjn
% 215.36/215.52  |- mesh__publicMeSHNote mesh__D004229 72   
% 215.36/215.52  |- mesh__recordMaintainer mesh__D004229 ssb
% 215.36/215.52  |- skos__scopeNote mesh__D004229
% 215.36/215.52       A reagent commonly used in biochemical studies as a protective agent to prevent the oxidation of SH %28%thiol%29% groups and for reducing disulphides to dithiols.%A%    
% 215.36/215.52  |- skos__hiddenLabel mesh__D004229 Reagent, Cleland%27%s
% 215.36/215.52  |- mesh__recordAuthorizer mesh__D004229 sjn
% 215.36/215.52  |- mesh__dateEstablished mesh__D004229 1972-01-01
% 215.36/215.52  |- rdf__type mesh__D004229sskos__Concept
% 215.36/215.52  |- skos__prefLabel mesh__D004229 Dithiothreitol
% 215.36/215.52  |- skos__broader mesh__D004229smesh__D013402
% 215.36/215.52  |- skos__hiddenLabel mesh__D004229 Reagent, Cleland
% 215.36/215.52  |- mesh__dateRevised mesh__D004229 2005-06-30
% 215.36/215.52  |- mesh__dateCreated mesh__D004229 1999-01-01
% 215.36/215.52  |- skos__historyNote mesh__D004229 Alcohols %28%1966-1971%29%
% 215.36/215.52  |- mesh__historyNote mesh__D004229 72   
% 215.36/215.52  |- skos__historyNote mesh__D004229 Tetroses %28%1966-1971%29%
% 215.36/215.52  |- skos__broader mesh__D004229smesh__D013865
% 215.36/215.52  |- mesh__recordOriginator mesh__D004229 NLM
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D004229 2006
% 215.36/215.52  |- skos__altLabel mesh__D004229 Cleland Reagent
% 215.36/215.52  |- skos__altLabel mesh__D004229 Cleland%27%s Reagent
% 215.36/215.52  |- skos__hiddenLabel mesh__D004229 Clelands Reagent
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D009712 2005
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D009712 2004
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D009712 1999
% 215.36/215.52  |- mesh__recordMaintainer mesh__D009712 TGC
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D009712 2002
% 215.36/215.52  |- rdf__type mesh__D009712sskos__Concept
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D009712 2003
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D009712 1998
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D009712 1997
% 215.36/215.52  |- skos__broader mesh__D009712smesh__D009711
% 215.36/215.52  |- mesh__recordAuthorizer mesh__D009712 PLS
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D009712 1996
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D009712 2001
% 215.36/215.52  |- mesh__recordOriginator mesh__D009712 NLM
% 215.36/215.52  |- mesh__dateEstablished mesh__D009712 1974-01-01
% 215.36/215.52  |- mesh__dateCreated mesh__D009712 1999-01-01
% 215.36/215.52  |- skos__prefLabel mesh__D009712 Nucleotides, Cyclic
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D009712 1995
% 215.36/215.52  |- mesh__publicMeSHNote mesh__D009712 74   
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D009712 2000
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D009712 2006
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D009712 1993
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D009712 1994
% 215.36/215.52  |- mesh__dateRevised mesh__D009712 1992-05-19
% 215.36/215.52  |- mesh__historyNote mesh__D009712 74   
% 215.36/215.52  |- skos__hiddenLabel mesh__D009712 Cyclic Nucleotides
% 215.36/215.52  |- mesh__historyNote mesh__D020694 2000; use ENDOSCOPY 1998-1999   
% 215.36/215.52  |- mesh__publicMeSHNote mesh__D020694 2000; see ENDOSCOPY 1998-1999   
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D020694 2006
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D020694 2001
% 215.36/215.52  |- rdf__type mesh__D020694sskos__Concept
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D020694 2004
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D020694 2005
% 215.36/215.52  |- skos__broader mesh__D020694smesh__D020685
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D020694 2000
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D020694 2003
% 215.36/215.52  |- skos__hiddenLabel mesh__D020694 Sigmoidoscope
% 215.36/215.52  |- skos__prefLabel mesh__D020694 Sigmoidoscopes
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D020694 2002
% 215.36/215.52  |- skos__historyNote mesh__D020694
% 215.36/215.52       Sigmoidoscopy/instrumentation %28%1966-1999%29%
% 215.36/215.52  |- skos__historyNote mesh__D020694 Endoscopes %28%1998-1999%29%
% 215.36/215.52  |- mesh__dateEstablished mesh__D020694 2000-01-01
% 215.36/215.52  |- skos__scopeNote mesh__D020694
% 215.36/215.52       Endoscopes for examining the interior of the sigmoid colon.%A%    
% 215.36/215.52  |- mesh__dateCreated mesh__D020694 1999-11-03
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D047831 2006
% 215.36/215.52  |- mesh__recordOriginator mesh__D047831 jls
% 215.36/215.52  |- skos__scopeNote mesh__D047831
% 215.36/215.52       1861-1865 conflict between the Union %28%Northern states%29% and the 11 Southern states that seceded and were organized as the Confederate States of America.%A%    
% 215.36/215.52  |- skos__hiddenLabel mesh__D047831 Civil War, American
% 215.36/215.52  |- mesh__recordMaintainer mesh__D047831 jls
% 215.36/215.52  |- skos__prefLabel mesh__D047831 American Civil War
% 215.36/215.52  |- skos__hiddenLabel mesh__D047831 War, American Civil
% 215.36/215.52  |- mesh__dateEstablished mesh__D047831 2005-01-01
% 215.36/215.52  |- skos__hiddenLabel mesh__D047831 Wars, American Civil
% 215.36/215.52  |- skos__altLabel mesh__D047831 War Between the States
% 215.36/215.52  |- skos__broader mesh__D047831smesh__D049672
% 215.36/215.52  |- mesh__publicMeSHNote mesh__D047831 2005   
% 215.36/215.52  |- mesh__historyNote mesh__D047831 2005   
% 215.36/215.52  |- skos__altLabel mesh__D047831 War of Secession
% 215.36/215.52  |- mesh__recordAuthorizer mesh__D047831 sjn
% 215.36/215.52  |- skos__hiddenLabel mesh__D047831 American Civil Wars
% 215.36/215.52  |- skos__altLabel mesh__D047831 U. S. Civil War, 1861-1865
% 215.36/215.52  |- skos__hiddenLabel mesh__D047831 U. S. Civil War, 1861 1865
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D047831 2005
% 215.36/215.52  |- skos__altLabel mesh__D047831 War of the Rebellion
% 215.36/215.52  |- skos__hiddenLabel mesh__D047831 Civil Wars, American
% 215.36/215.52  |- mesh__dateCreated mesh__D047831 2004-07-07
% 215.36/215.52  |- rdf__type mesh__D047831sskos__Concept
% 215.36/215.52  |- skos__hiddenLabel mesh__D014657 Angiitides
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014657 1996
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014657 1995
% 215.36/215.52  |- mesh__dateRevised mesh__D014657 1993-06-03
% 215.36/215.52  |- mesh__dateCreated mesh__D014657 1977-04-27
% 215.36/215.52  |- skos__altLabel mesh__D014657 Angiitis
% 215.36/215.52  |- mesh__recordOriginator mesh__D014657 VDK
% 215.36/215.52  |- skos__prefLabel mesh__D014657 Vasculitis
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014657 1997
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014657 2003
% 215.36/215.52  |- rdf__type mesh__D014657sskos__Concept
% 215.36/215.52  |- skos__historyNote mesh__D014657 Periarteritis Nodosa %28%1966-1977%29%
% 215.36/215.52  |- skos__historyNote mesh__D014657 Arteritis %28%1966-1977%29%
% 215.36/215.52  |- mesh__recordMaintainer mesh__D014657 TGC
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014657 2000
% 215.36/215.52  |- skos__scopeNote mesh__D014657 Inflammation of a blood vessel.     
% 215.36/215.52  |- skos__broader mesh__D014657smesh__D014652
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014657 1998
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014657 2004
% 215.36/215.52  |- mesh__recordAuthorizer mesh__D014657 PLS
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014657 2001
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014657 1999
% 215.36/215.52  |- mesh__publicMeSHNote mesh__D014657 78   
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014657 2005
% 215.36/215.52  |- skos__hiddenLabel mesh__D014657 Vasculitides
% 215.36/215.52  |- skos__annotation mesh__D014657
% 215.36/215.52       inflamm of blood vessels only; GEN or unspecified; consider ARTERITIS or PHLEBITIS %26% their indentions; hemorrhagic vasculitis = PURPURA, SCHOENLEIN-HENOCH%A%  
% 215.36/215.52  |- mesh__historyNote mesh__D014657 78   
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014657 1994
% 215.36/215.52  |- mesh__dateEstablished mesh__D014657 1978-01-01
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014657 2002
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D014657 2006
% 215.36/215.52  |- skos__scopeNote mesh__D000637
% 215.36/215.52       A subclass of enzymes of the transferase class that catalyze the transfer of an amino group from a donor %28%generally an amino acid%29% to an acceptor %28%generally a 2-keto acid%29%. Most of these enzymes are pyridoxyl phosphate proteins. %28%Dorland, 28th ed%29% EC 2.6.1.%A%    
% 215.36/215.52  |- rdf__type mesh__D000637sskos__Concept
% 215.36/215.52  |- mesh__dateRevised mesh__D000637 2003-07-09
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D000637 2005
% 215.36/215.52  |- skos__broader mesh__D000637smesh__D019884
% 215.36/215.52  |- mesh__dateCreated mesh__D000637 1999-01-01
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D000637 2006
% 215.36/215.52  |- mesh__historyNote mesh__D000637 98%28%63%29%   
% 215.36/215.52  |- skos__prefLabel mesh__D000637 Transaminases
% 215.36/215.52  |- mesh__recordAuthorizer mesh__D000637 sjn
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D000637 2004
% 215.36/215.52  |- mesh__recordOriginator mesh__D000637 NLM
% 215.36/215.52  |- mesh__recordMaintainer mesh__D000637 ssb
% 215.36/215.52  |- mesh__publicMeSHNote mesh__D000637
% 215.36/215.52       98; see AMINOTRANSFERASES 1963-97; for TRANSAMINASES see AMINOTRANSFERASES 1974-97%A%  
% 215.36/215.52  |- skos__altLabel mesh__D000637 Aminotransferases
% 215.36/215.52  |- mesh__publicMeSHNote mesh__D019342
% 215.36/215.52       97; ACETIC ACID GLACIAL was indexed under ACETIC ACIDS 1981-96%A%  
% 215.36/215.52  |- skos__broader mesh__D019342smesh__D000088
% 215.36/215.52  |- mesh__dateRevised mesh__D019342 2003-07-09
% 215.36/215.52  |- skos__hiddenLabel mesh__D019342 Acid Glacial, Acetic
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D019342 2004
% 215.36/215.52  |- skos__altLabel mesh__D019342 Acetic Acid Glacial
% 215.36/215.52  |- mesh__dateEstablished mesh__D019342 1997-01-01
% 215.36/215.52  |- skos__historyNote mesh__D019342 Acetic Acids %28%1981-1996%29%
% 215.36/215.52  |- skos__hiddenLabel mesh__D019342 Acid, Acetic
% 215.36/215.52  |- skos__prefLabel mesh__D019342 Acetic Acid
% 215.36/215.52  |- skos__hiddenLabel mesh__D019342 Acetic Acid, Glacial
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D019342 2005
% 215.36/215.52  |- mesh__dateCreated mesh__D019342 1996-06-10
% 215.36/215.52  |- mesh__recordMaintainer mesh__D019342 ssb
% 215.36/215.52  |- mesh__onlineNote mesh__D019342
% 215.36/215.52       use ACETIC ACID %28%NM%29% to search ACETIC ACID GLACIAL 1981-96%A%  
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D019342 2006
% 215.36/215.52  |- rdf__type mesh__D019342sskos__Concept
% 215.36/215.52  |- mesh__recordAuthorizer mesh__D019342 sjn
% 215.36/215.52  |- skos__hiddenLabel mesh__D019342 Glacial, Acetic Acid
% 215.36/215.52  |- mesh__historyNote mesh__D019342
% 215.36/215.52       97; was ACETIC ACID GLACIAL %28%NM%29% 1981-96   
% 215.36/215.52  |- skos__scopeNote mesh__D019342
% 215.36/215.52       Product of the oxidation of ethanol and of the destructive distillation of wood. It is used locally, occasionally internally, as a counterirritant and also as a reagent. %28%Stedman, 26th ed%29%%A%    
% 215.36/215.52  |- skos__hiddenLabel mesh__D019342 Acid, Glacial Acetic
% 215.36/215.52  |- skos__annotation mesh__D019342 do not confuse with ACETIC ACIDS   
% 215.36/215.52  |- mesh__recordOriginator mesh__D019342 ADP
% 215.36/215.52  |- skos__altLabel mesh__D019342 Glacial Acetic Acid
% 215.36/215.52  |- mesh__activeMeSHYear mesh__D005322 2006
% 215.36/215.52  |- skos__scopeNote mesh__D005322
% 215.36/215.52       Spontaneous tearing of the membranes surrounding the FETUS any time before the onset of OBSTETRIC LABOR. Preterm PROM is membrane rupture before 37 weeks of GESTATION.%A%    
% 215.36/215.52  |- mesh__recordOriginator mesh__D005322 NLM
% 215.36/215.52  |- mesh__dateCreated mesh__D005322 1974-11-11
% 215.36/215.52  |- mesh__publicMeSHNote mesh__D005322 75   
% 215.36/215.52  |- skos__altLabel mesh__D005322
% 215.36/215.52       Premature Rupture of Membrane %28%Pregnancy%29%
% 215.36/215.52  |- skos__hiddenLabel mesh__D005322
% 215.36/215.52       Membrane Premature Ruptures %28%Pregnancy%29%
% 215.36/215.52  |- mesh__dateEstablished mesh__D005322 1975-09-01
% 215.36/215.52  |- skos__altLabel mesh__D005322 Premature Rupture of Fetal Membranes
% 215.36/215.52  |- skos__annotation mesh__D005322 DF: PROM   
% 215.36/215.52  |- skos__historyNote mesh__D005322 Fetal Membranes %28%1966-1974%29%
% 215.36/215.52  |- mesh__recordMaintainer mesh__D005322 lkt
% 215.36/215.52  |- skos__altLabel mesh__D005322 PROM %28%Pregnancy%29%
% 215.36/215.52  |- mesh__historyNote mesh__D005322 75   
% 215.36/215.52  |- skos__hiddenLabel mesh__D005322
% 215.36/215.52       Membrane Premature Rupture %28%Pregnancy%29%
% 215.36/215.52  |- mesh__recordAuthorizer mesh__D005322 sjn
% 215.36/215.52  |- skos__hiddenLabel mesh__D005322 PROM, Preterm %28%Pregnancy%29%
% 215.36/215.52  |- rdf__type mesh__D005322sskos__Concept
% 215.36/215.53  |- skos__altLabel mesh__D005322 Preterm PROM %28%Pregnancy%29%
% 215.36/215.53  |- skos__broader mesh__D005322smesh__D007744
% 215.36/215.53  |- skos__prefLabel mesh__D005322 Fetal Membranes, Premature Rupture
% 215.36/215.53  |- mesh__dateRevised mesh__D005322 2005-06-30
% 215.36/215.53  |- skos__broader mesh__D029770smesh__D019862
% 215.36/215.53  |- skos__scopeNote mesh__D029770
% 215.36/215.53       A plant genus of the family Costaceae %28%sometimes classified in Zingiberaceae%29%, order Zingiberales, subclass Zingiberidae, class Liliopsida %28%monocotyledons%29%.  It is a source of SAPONINS and furostanol glycosides.%A%    
% 215.36/215.53  |- skos__prefLabel mesh__D029770 Costus
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D029770 2005
% 215.36/215.53  |- skos__annotation mesh__D029770
% 215.36/215.53       do not confuse with SAUSSUREA COSTUS see SAUSSUREA;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.36/215.53  |- mesh__dateCreated mesh__D029770 2001-07-25
% 215.36/215.53  |- mesh__historyNote mesh__D029770 2002   
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D029770 2006
% 215.36/215.53  |- mesh__publicMeSHNote mesh__D029770 2002   
% 215.36/215.53  |- rdf__type mesh__D029770sskos__Concept
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D029770 2002
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D029770 2003
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D029770 2004
% 215.36/215.53  |- mesh__dateEstablished mesh__D029770 2002-01-01
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D010267 1998
% 215.36/215.53  |- mesh__dateCreated mesh__D010267 1999-01-01
% 215.36/215.53  |- skos__hiddenLabel mesh__D010267 Erythrodermas, Maculopapular
% 215.36/215.53  |- mesh__onlineNote mesh__D010267
% 215.36/215.53       use PARAPSORIASIS to search PARAKERATOSIS VARIEGATA 1966-78%A%  
% 215.36/215.53  |- rdf__type mesh__D010267sskos__Concept
% 215.36/215.53  |- skos__hiddenLabel mesh__D010267 Parapsoriases
% 215.36/215.53  |- mesh__recordAuthorizer mesh__D010267 PLS
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D010267 2003
% 215.36/215.53  |- mesh__recordOriginator mesh__D010267 NLM
% 215.36/215.53  |- skos__hiddenLabel mesh__D010267 Maculopapular Erythroderma
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D010267 1999
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D010267 1994
% 215.36/215.53  |- skos__annotation mesh__D010267 a papulosquamous skin dis   
% 215.36/215.53  |- mesh__dateRevised mesh__D010267 1993-06-02
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D010267 2004
% 215.36/215.53  |- mesh__recordMaintainer mesh__D010267 TAP
% 215.36/215.53  |- skos__hiddenLabel mesh__D010267 Parapsoriasis en Plaque
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D010267 2000
% 215.36/215.53  |- mesh__historyNote mesh__D010267
% 215.36/215.53       PARAKERATOSIS VARIEGATA was see under PARAPSORIASIS 1963-78%A%  
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D010267 1995
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D010267 1996
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D010267 2005
% 215.36/215.53  |- skos__scopeNote mesh__D010267
% 215.36/215.53       The term applied to a group of relatively uncommon inflammatory, maculopapular, scaly eruptions of unknown etiology and resistant to conventional treatment. Eruptions are both psoriatic and lichenoid in appearance, but the diseases are distinct from psoriasis, lichen planus, or other recognized dermatoses. Proposed nomenclature divides parapsoriasis into two distinct subgroups, PITYRIASIS LICHENOIDES and parapsoriasis en plaques %28%small- and large-plaque parapsoriasis%29%.%A%    
% 215.36/215.53  |- skos__broader mesh__D010267smesh__D017444
% 215.36/215.53  |- skos__hiddenLabel mesh__D010267 Maculopapular Erythrodermas
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D010267 2001
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D010267 1997
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D010267 2006
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D010267 2002
% 215.36/215.53  |- skos__prefLabel mesh__D010267 Parapsoriasis
% 215.36/215.53  |- mesh__publicMeSHNote mesh__D015750
% 215.36/215.53       90; was GAG GENE see GENES, VIRAL 1987-89   
% 215.36/215.53  |- mesh__dateRevised mesh__D015750 2005-06-30
% 215.36/215.53  |- mesh__recordMaintainer mesh__D015750 nns
% 215.36/215.53  |- mesh__recordOriginator mesh__D015750 AGS
% 215.36/215.53  |- mesh__historyNote mesh__D015750
% 215.36/215.53       90; was GAG GENE see GENES, VIRAL 1987-89   
% 215.36/215.53  |- rdf__type mesh__D015750sskos__Concept
% 215.36/215.53  |- mesh__dateCreated mesh__D015750 1989-05-25
% 215.36/215.53  |- skos__broader mesh__D015750smesh__D005814
% 215.36/215.53  |- skos__altLabel mesh__D015750 gag Genes
% 215.36/215.53  |- mesh__onlineNote mesh__D015750
% 215.36/215.53       use GENES, VIRAL to search GAG GENE 1987-89   
% 215.36/215.53  |- skos__annotation mesh__D015750
% 215.36/215.53       gag stands for %22%Group-specific AntiGen%22%; coord IM with specific virus /genet %28%IM%29%%A%  
% 215.36/215.53  |- skos__historyNote mesh__D015750 Genes, Structural %28%1972-1989%29%
% 215.36/215.53  |- skos__altLabel mesh__D015750 gag Gene
% 215.36/215.53  |- skos__hiddenLabel mesh__D015750 Gene, gag
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D015750 2006
% 215.36/215.53  |- skos__scopeNote mesh__D015750
% 215.36/215.53       DNA sequences that form the coding region for proteins associated with the viral core in retroviruses. gag is short for group-specific antigen.%A%    
% 215.36/215.53  |- mesh__dateEstablished mesh__D015750 1990-01-01
% 215.36/215.53  |- skos__historyNote mesh__D015750 Genes, Viral %28%1977-1989%29%
% 215.36/215.53  |- mesh__recordAuthorizer mesh__D015750 sjn
% 215.36/215.53  |- skos__prefLabel mesh__D015750 Genes, gag
% 215.36/215.53  |- rdf__type mesh__D009713sskos__Concept
% 215.36/215.53  |- mesh__dateCreated mesh__D009713 1999-01-01
% 215.36/215.53  |- mesh__recordAuthorizer mesh__D009713 sjn
% 215.36/215.53  |- mesh__recordMaintainer mesh__D009713 ssb
% 215.36/215.53  |- mesh__publicMeSHNote mesh__D009713
% 215.36/215.53       68; was NUCLEOTIDYL TRANSFERASES 1963-67   
% 215.36/215.53  |- mesh__dateRevised mesh__D009713 2003-07-09
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D009713 2005
% 215.36/215.53  |- skos__scopeNote mesh__D009713
% 215.36/215.53       A class of enzymes that transfers nucleotidyl residues. EC 2.7.7.%A%    
% 215.36/215.53  |- mesh__dateEstablished mesh__D009713 1968-01-01
% 215.36/215.53  |- mesh__onlineNote mesh__D009713
% 215.36/215.53       use NUCLEOTIDYLTRANSFERASES to search NUCLEOTIDYL TRANSFERASES 1966-67%A%  
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D009713 2006
% 215.36/215.53  |- mesh__historyNote mesh__D009713
% 215.36/215.53       68; was NUCLEOTIDYL TRANSFERASES 1963-67   
% 215.36/215.53  |- skos__broader mesh__D009713smesh__D010770
% 215.36/215.53  |- mesh__recordOriginator mesh__D009713 NLM
% 215.36/215.53  |- skos__prefLabel mesh__D009713 Nucleotidyltransferases
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D009713 2004
% 215.36/215.53  |- skos__hiddenLabel mesh__D020695 GTP-Binding Protein, rab4A
% 215.36/215.53  |- mesh__dateCreated mesh__D020695 1999-11-03
% 215.36/215.53  |- rdf__type mesh__D020695sskos__Concept
% 215.36/215.53  |- mesh__publicMeSHNote mesh__D020695
% 215.36/215.53       2000; RAB4 PROTEIN %28%now RAB4 GTP-BINDING PROTEINS%29% was indexed under G-PROTEINS 1991-1999%A%  
% 215.36/215.53  |- mesh__recordMaintainer mesh__D020695 jmp
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D020695 2006
% 215.36/215.53  |- skos__broader mesh__D020695smesh__D020691
% 215.36/215.53  |- skos__annotation mesh__D020695 DF: RAB4 PROTEIN   
% 215.36/215.53  |- skos__hiddenLabel mesh__D020695 GTP-Binding Proteins, rab4
% 215.36/215.53  |- mesh__recordOriginator mesh__D020695 jmp
% 215.36/215.53  |- skos__hiddenLabel mesh__D020695 GTP-Binding Protein, rab4
% 215.36/215.53  |- skos__hiddenLabel mesh__D020695 rab4A GTP Binding Protein
% 215.36/215.53  |- mesh__recordAuthorizer mesh__D020695 sjn
% 215.36/215.53  |- skos__hiddenLabel mesh__D020695 rab4 GTP Binding Protein
% 215.36/215.53  |- mesh__dateRevised mesh__D020695 2005-06-30
% 215.36/215.53  |- skos__hiddenLabel mesh__D020695 rab4 GTP Binding Proteins
% 215.36/215.53  |- skos__prefLabel mesh__D020695 rab4 GTP-Binding Proteins
% 215.36/215.53  |- skos__historyNote mesh__D020695 G-Proteins %28%1992-1999%29%
% 215.36/215.53  |- skos__altLabel mesh__D020695 rab4 GTP-Binding Protein
% 215.36/215.53  |- mesh__historyNote mesh__D020695
% 215.36/215.53       2000; use RAB4 GTP-BINDING PROTEINS %28%NM%29% 1991-1999   
% 215.36/215.53  |- mesh__dateEstablished mesh__D020695 2000-01-01
% 215.36/215.53  |- skos__altLabel mesh__D020695 rab4A Protein
% 215.36/215.53  |- skos__altLabel mesh__D020695 rab4 Protein
% 215.36/215.53  |- skos__scopeNote mesh__D020695
% 215.36/215.53       A genetically related subfamily of RAB GTP-BINDING PROTEINS involved in recycling of proteins such as cell surface receptors from early endosomes to the cell surface. This enzyme was formerly listed as EC 3.6.1.47.%A%    
% 215.36/215.53  |- mesh__recordMaintainer mesh__D047832 jls
% 215.36/215.53  |- mesh__dateCreated mesh__D047832 2004-07-07
% 215.36/215.53  |- skos__hiddenLabel mesh__D047832 War, Spanish American
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D047832 2006
% 215.36/215.53  |- mesh__recordOriginator mesh__D047832 jls
% 215.36/215.53  |- mesh__dateEstablished mesh__D047832 2005-01-01
% 215.36/215.53  |- skos__hiddenLabel mesh__D047832 Spanish American Wars
% 215.36/215.53  |- mesh__recordAuthorizer mesh__D047832 sjn
% 215.36/215.53  |- skos__broader mesh__D047832smesh__D049672
% 215.36/215.53  |- skos__altLabel mesh__D047832 Spanish American War
% 215.36/215.53  |- mesh__publicMeSHNote mesh__D047832 2005   
% 215.36/215.53  |- mesh__historyNote mesh__D047832 2005   
% 215.36/215.53  |- skos__hiddenLabel mesh__D047832 Wars, Spanish American
% 215.36/215.53  |- skos__hiddenLabel mesh__D047832 American Wars, Spanish
% 215.36/215.53  |- skos__hiddenLabel mesh__D047832 American War, Spanish
% 215.36/215.53  |- rdf__type mesh__D047832sskos__Concept
% 215.36/215.53  |- skos__scopeNote mesh__D047832
% 215.36/215.53       Conflict between Spain and the United States, arising out of Spanish policies in Cuba.%A%    
% 215.36/215.53  |- skos__prefLabel mesh__D047832 Spanish-American War, 1898
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D047832 2005
% 215.36/215.53  |- mesh__historyNote mesh__D014658 78   
% 215.36/215.53  |- mesh__dateCreated mesh__D014658 1977-04-29
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D014658 2004
% 215.36/215.53  |- skos__historyNote mesh__D014658 Vascular Diseases %28%1966-1977%29%
% 215.36/215.53  |- skos__altLabel mesh__D014658 Allergic Cutaneous Vasculitis
% 215.36/215.53  |- skos__hiddenLabel mesh__D014658 Vasculitides, Allergic Cutaneous
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D014658 2002
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D014658 1997
% 215.36/215.53  |- skos__hiddenLabel mesh__D014658 Cutaneous Angiitis, Allergic
% 215.36/215.53  |- skos__hiddenLabel mesh__D014658 Cutaneous Vasculitis, Allergic
% 215.36/215.53  |- mesh__recordAuthorizer mesh__D014658 PLS
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D014658 2003
% 215.36/215.53  |- skos__historyNote mesh__D014658 Skin Diseases %28%1966-1977%29%
% 215.36/215.53  |- skos__altLabel mesh__D014658 Allergic Cutaneous Angiitis
% 215.36/215.53  |- skos__prefLabel mesh__D014658 Vasculitis, Allergic Cutaneous
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D014658 2001
% 215.36/215.53  |- mesh__recordMaintainer mesh__D014658 AGS
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D014658 1996
% 215.36/215.53  |- skos__scopeNote mesh__D014658
% 215.36/215.53       Vasculitis due to allergic reaction, marked by such cutaneous lesions as papules, macules, vesicles, urticarial wheals, purpura, and small ulcers, and accompanied by itching and usually a slight fever and malaise.%A%    
% 215.36/215.53  |- mesh__recordOriginator mesh__D014658 VDK
% 215.36/215.53  |- skos__altLabel mesh__D014658 Angiitis, Allergic Cutaneous
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D014658 2000
% 215.36/215.53  |- skos__hiddenLabel mesh__D014658 Allergic Cutaneous Vasculitides
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D014658 1995
% 215.36/215.53  |- mesh__publicMeSHNote mesh__D014658 78   
% 215.36/215.53  |- skos__historyNote mesh__D014658 Purpura %28%1966-1977%29%
% 215.36/215.53  |- skos__hiddenLabel mesh__D014658 Cutaneous Angiitides, Allergic
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D014658 2006
% 215.36/215.53  |- skos__broader mesh__D014658smesh__D017445
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D014658 1999
% 215.36/215.53  |- skos__historyNote mesh__D014658 Skin/blood supply %28%1966-1977%29%
% 215.36/215.53  |- skos__hiddenLabel mesh__D014658 Cutaneous Vasculitides, Allergic
% 215.36/215.53  |- mesh__dateRevised mesh__D014658 1994-02-08
% 215.36/215.53  |- rdf__type mesh__D014658sskos__Concept
% 215.36/215.53  |- skos__broader mesh__D014658smesh__D018366
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D014658 2005
% 215.36/215.53  |- skos__hiddenLabel mesh__D014658 Angiitides, Allergic Cutaneous
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D014658 1998
% 215.36/215.53  |- skos__hiddenLabel mesh__D014658 Allergic Cutaneous Angiitides
% 215.36/215.53  |- mesh__dateEstablished mesh__D014658 1978-01-01
% 215.36/215.53  |- skos__altLabel mesh__D000638
% 215.36/215.53       Pharma Investi Brand of Amiodarone Hydrochloride
% 215.36/215.53  |- skos__altLabel mesh__D000638 G Gam Brand of Amiodarone Hydrochloride
% 215.36/215.53  |- mesh__historyNote mesh__D000638
% 215.36/215.53       87%28%75%29%; was see under BENZOFURANS 1975-86   
% 215.36/215.53  |- skos__hiddenLabel mesh__D000638 L3428
% 215.36/215.53  |- mesh__dateEstablished mesh__D000638 1987-01-01
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D000638 2005
% 215.36/215.53  |- mesh__publicMeSHNote mesh__D000638
% 215.36/215.53       87; was see under BENZOFURANS 1975-86   
% 215.36/215.53  |- skos__altLabel mesh__D000638
% 215.36/215.53       Sanofi Winthrop Brand of Amiodarone Hydrochloride
% 215.36/215.53  |- skos__altLabel mesh__D000638 Armstrong Brand of Amiodarone Hydrochloride
% 215.36/215.53  |- skos__altLabel mesh__D000638
% 215.36/215.53       ASTA Medica Brand of Amiodarone Hydrochloride
% 215.36/215.53  |- mesh__dateCreated mesh__D000638 1974-11-19
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D000638 2006
% 215.36/215.53  |- skos__scopeNote mesh__D000638
% 215.36/215.53       An antianginal and antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting Na,K-activated myocardial adenosine triphosphatase. There is a resulting decrease in heart rate and in vascular resistance.%A%    
% 215.36/215.53  |- skos__historyNote mesh__D000638 Benzofurans %28%1968-1974%29%
% 215.36/215.53  |- skos__altLabel mesh__D000638 Cordarone
% 215.36/215.53  |- skos__altLabel mesh__D000638 Betapharm Brand of Amiodarone Hydrochloride
% 215.36/215.53  |- skos__altLabel mesh__D000638
% 215.36/215.53       Berenguer Infale Brand of Amiodarone Hydrochloride
% 215.36/215.53  |- mesh__recordMaintainer mesh__D000638 mdb
% 215.36/215.53  |- skos__historyNote mesh__D000638 Iodobenzoates %28%1973-1974%29%
% 215.36/215.53  |- skos__prefLabel mesh__D000638 Amiodarone
% 215.36/215.53  |- skos__altLabel mesh__D000638 Hexal Brand of Amiodarone Hydrochloride
% 215.36/215.53  |- skos__historyNote mesh__D000638 Diethylamines %28%1974%29%
% 215.36/215.53  |- mesh__dateRevised mesh__D000638 2004-07-07
% 215.36/215.53  |- skos__hiddenLabel mesh__D000638 L 3428
% 215.36/215.53  |- skos__altLabel mesh__D000638 Wyeth Brand of Amiodarone Hydrochloride
% 215.36/215.53  |- skos__altLabel mesh__D000638
% 215.36/215.53       Alphapharm Brand of Amiodarone Hydrochloride
% 215.36/215.53  |- mesh__recordAuthorizer mesh__D000638 sjn
% 215.36/215.53  |- mesh__recordOriginator mesh__D000638 NLM
% 215.36/215.53  |- skos__altLabel mesh__D000638 Leurquin Brand of Amiodarone Hydrochloride
% 215.36/215.53  |- skos__hiddenLabel mesh__D000638 SKF 33134 A
% 215.36/215.53  |- rdf__type mesh__D000638sskos__Concept
% 215.36/215.53  |- skos__altLabel mesh__D000638 Trangorex
% 215.36/215.53  |- skos__broader mesh__D000638smesh__D001572
% 215.36/215.53  |- skos__hiddenLabel mesh__D000638 SKF 33134A
% 215.36/215.53  |- skos__altLabel mesh__D000638 Cordarex
% 215.36/215.53  |- mesh__recordOriginator mesh__D019343 ADP
% 215.36/215.53  |- skos__hiddenLabel mesh__D019343 U, Uralyt
% 215.36/215.53  |- skos__annotation mesh__D019343
% 215.36/215.53       do not confuse X ref CITRATE with CITRATES   
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D019343 2005
% 215.36/215.53  |- mesh__dateRevised mesh__D019343 2000-06-21
% 215.36/215.53  |- mesh__publicMeSHNote mesh__D019343
% 215.36/215.53       97; CITRIC ACID was indexed under CITRATES 1979-96   
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D019343 2006
% 215.36/215.53  |- rdf__type mesh__D019343sskos__Concept
% 215.36/215.53  |- mesh__dateEstablished mesh__D019343 1997-01-01
% 215.36/215.53  |- mesh__historyNote mesh__D019343
% 215.36/215.53       97; was CITRIC ACID %28%NM%29% 1979-96   
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D019343 2001
% 215.36/215.53  |- mesh__dateCreated mesh__D019343 1996-06-10
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D019343 2002
% 215.36/215.53  |- skos__prefLabel mesh__D019343 Citric Acid
% 215.36/215.53  |- skos__hiddenLabel mesh__D019343 Acid, Citric
% 215.36/215.53  |- skos__historyNote mesh__D019343 Citrates %28%1979-1996%29%
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D019343 2003
% 215.36/215.53  |- mesh__recordAuthorizer mesh__D019343 sjn
% 215.36/215.53  |- skos__broader mesh__D019343smesh__D002951
% 215.36/215.53  |- mesh__onlineNote mesh__D019343
% 215.36/215.53       use CITRIC ACID %28%NM%29% to search CITRIC ACID 1979-96   
% 215.36/215.53  |- skos__scopeNote mesh__D019343
% 215.36/215.53       A key intermediate in metabolism.  It is an acid compound found in citrus fruits.  The salts of citric acid %28%citrates%29% can be used as anticoagulants due to their calcium chelating ability.%A%    
% 215.36/215.53  |- mesh__recordMaintainer mesh__D019343 CCR
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D019343 2004
% 215.36/215.53  |- skos__broader mesh__D005323smesh__D003944
% 215.36/215.53  |- skos__annotation mesh__D005323
% 215.36/215.53       during LABOR, OBSTETRIC or during prenatal maternal surg   
% 215.36/215.53  |- skos__scopeNote mesh__D005323
% 215.36/215.53       Physiologic or biochemical monitoring of the fetus. It is usually done during LABOR, OBSTETRIC and may be performed in conjunction with the monitoring of uterine activity. It may also be performed prenatally as when the mother is undergoing surgery.%A%    
% 215.36/215.53  |- skos__historyNote mesh__D005323 Labor %28%1966-1977%29%
% 215.36/215.53  |- mesh__recordAuthorizer mesh__D005323 sjn
% 215.36/215.53  |- skos__prefLabel mesh__D005323 Fetal Monitoring
% 215.36/215.53  |- mesh__dateCreated mesh__D005323 1977-04-27
% 215.36/215.53  |- skos__historyNote mesh__D005323 Fetal Heart %28%1966-1977%29%
% 215.36/215.53  |- skos__hiddenLabel mesh__D005323 Fetal Monitorings
% 215.36/215.53  |- mesh__publicMeSHNote mesh__D005323 78   
% 215.36/215.53  |- skos__historyNote mesh__D005323 Fetus %28%1966-1977%29%
% 215.36/215.53  |- rdf__type mesh__D005323sskos__Concept
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D005323 2005
% 215.36/215.53  |- skos__hiddenLabel mesh__D005323 Monitorings, Fetal
% 215.36/215.53  |- mesh__dateRevised mesh__D005323 2002-07-03
% 215.36/215.53  |- mesh__recordMaintainer mesh__D005323 sjn
% 215.36/215.53  |- skos__altLabel mesh__D005323 Monitoring, Fetal
% 215.36/215.53  |- skos__broader mesh__D005323smesh__D008991
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D005323 2003
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D005323 2006
% 215.36/215.53  |- skos__historyNote mesh__D005323
% 215.36/215.53       Monitoring, Physiologic %28%1966-1977%29%
% 215.36/215.53  |- mesh__historyNote mesh__D005323 78   
% 215.36/215.53  |- mesh__recordOriginator mesh__D005323 SMH
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D005323 2004
% 215.36/215.53  |- skos__related mesh__D005323smesh__D012815
% 215.36/215.53  |- mesh__dateEstablished mesh__D005323 1978-01-01
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D029771 2003
% 215.36/215.53  |- mesh__recordOriginator mesh__D029771 ssb
% 215.36/215.53  |- skos__prefLabel mesh__D029771 Rhodiola
% 215.36/215.53  |- mesh__dateEstablished mesh__D029771 2002-01-01
% 215.36/215.53  |- mesh__dateCreated mesh__D029771 2001-07-25
% 215.36/215.53  |- mesh__recordMaintainer mesh__D029771 ssb
% 215.36/215.53  |- mesh__dateRevised mesh__D029771 2002-07-03
% 215.36/215.53  |- skos__broader mesh__D029771smesh__D029627
% 215.36/215.53  |- skos__scopeNote mesh__D029771
% 215.36/215.53       A plant genus of the family CRASSULACEAE. Members contain rhodioloside.  This roseroot is unrelated to the familiar rose %28%ROSA%29%.  Some species in this genus are called stonecrop which is also a common name for SEDUM.%A%    
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D029771 2006
% 215.36/215.53  |- mesh__publicMeSHNote mesh__D029771 2002   
% 215.36/215.53  |- rdf__type mesh__D029771sskos__Concept
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D029771 2004
% 215.36/215.53  |- mesh__historyNote mesh__D029771 2002   
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D029771 2005
% 215.36/215.53  |- skos__altLabel mesh__D029771 Roseroot
% 215.36/215.53  |- mesh__recordAuthorizer mesh__D029771 sjn
% 215.36/215.53  |- skos__annotation mesh__D029771
% 215.36/215.53       do not confuse X ref ROSEROOT with ROSE see ROSA; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.36/215.53  |- skos__broader mesh__D010268smesh__D011579
% 215.36/215.53  |- mesh__historyNote mesh__D010268
% 215.36/215.53       CLAIRVOYANCE was see under PARAPSYCHOLOGY 1965-78; EXTRASENSORY PERCEPTION %26% PSYCHICAL RESEARCH were see under PARAPSYCHOLOGY 1963-78%A%  
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D010268 2006
% 215.36/215.53  |- mesh__recordAuthorizer mesh__D010268 sjn
% 215.36/215.53  |- skos__annotation mesh__D010268 DF: PARAPSYCHOL   
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D010268 2005
% 215.36/215.53  |- skos__prefLabel mesh__D010268 Parapsychology
% 215.36/215.53  |- skos__broader mesh__D010268smesh__D001525
% 215.36/215.53  |- rdf__type mesh__D010268sskos__Concept
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D010268 2004
% 215.36/215.53  |- mesh__onlineNote mesh__D010268
% 215.36/215.53       use PARAPSYCHOLOGY to search CLAIRVOYANCE, EXTRASENSORY PERCEPTION %26% PSYCHICAL RESEARCH 1966-78%A%  
% 215.36/215.53  |- mesh__dateRevised mesh__D010268 2001-07-25
% 215.36/215.53  |- skos__hiddenLabel mesh__D010268 Research, Psychical
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D010268 2003
% 215.36/215.53  |- skos__hiddenLabel mesh__D010268 Perception, Extrasensory
% 215.36/215.53  |- mesh__recordOriginator mesh__D010268 NLM
% 215.36/215.53  |- skos__related mesh__D010268smesh__D026443
% 215.36/215.53  |- skos__related mesh__D010268smesh__D013688
% 215.36/215.53  |- mesh__recordMaintainer mesh__D010268 ssb
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D010268 2002
% 215.36/215.53  |- skos__hiddenLabel mesh__D010268 Extrasensory Perceptions
% 215.36/215.53  |- skos__scopeNote mesh__D010268
% 215.36/215.53       Branch of psychology that deals with paranormal behavior and events such as telepathy, precognition, and clairvoyance, which are not explicable by present day %22%natural laws%22%.%A%    
% 215.36/215.53  |- mesh__dateCreated mesh__D010268 1999-01-01
% 215.36/215.53  |- skos__altLabel mesh__D010268 Psychic Research
% 215.36/215.53  |- skos__hiddenLabel mesh__D010268 Research, Psychic
% 215.36/215.53  |- skos__hiddenLabel mesh__D010268 Perceptions, Extrasensory
% 215.36/215.53  |- skos__historyNote mesh__D015751 Genes, Structural %28%1983-1989%29%
% 215.36/215.53  |- skos__annotation mesh__D015751
% 215.36/215.53       pol stands for %22%POLymerase%22%; coord IM with specific virus /genet %28%IM%29%%A%  
% 215.36/215.53  |- mesh__dateCreated mesh__D015751 1989-09-01
% 215.36/215.53  |- mesh__recordAuthorizer mesh__D015751 sjn
% 215.36/215.53  |- skos__prefLabel mesh__D015751 Genes, pol
% 215.36/215.53  |- rdf__type mesh__D015751sskos__Concept
% 215.36/215.53  |- mesh__onlineNote mesh__D015751
% 215.36/215.53       use GENES, VIRAL to search POL GENE 1987-89   
% 215.36/215.53  |- skos__scopeNote mesh__D015751
% 215.36/215.53       DNA sequences that form the coding region for retroviral enzymes including reverse transcriptase, protease, and endonuclease/integrase. %22%pol%22% is short for polymerase, the enzyme class of reverse transcriptase.%A%    
% 215.36/215.53  |- skos__altLabel mesh__D015751 pol Gene
% 215.36/215.53  |- mesh__dateRevised mesh__D015751 2005-06-30
% 215.36/215.53  |- mesh__recordMaintainer mesh__D015751 nns
% 215.36/215.53  |- mesh__recordOriginator mesh__D015751 AGS
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D015751 2006
% 215.36/215.53  |- skos__hiddenLabel mesh__D015751 Gene, pol
% 215.36/215.53  |- mesh__dateEstablished mesh__D015751 1990-01-01
% 215.36/215.53  |- skos__broader mesh__D015751smesh__D005814
% 215.36/215.53  |- skos__altLabel mesh__D015751 pol Genes
% 215.36/215.53  |- skos__historyNote mesh__D015751 Genes, Viral %28%1977-1989%29%
% 215.36/215.53  |- mesh__historyNote mesh__D015751
% 215.36/215.53       90; was POL GENE see GENES, VIRAL 1987-89   
% 215.36/215.53  |- mesh__publicMeSHNote mesh__D015751
% 215.36/215.53       90; was POL GENE see GENES, VIRAL 1987-89   
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D009714 2001
% 215.36/215.53  |- mesh__recordMaintainer mesh__D009714 ags
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D009714 2002
% 215.36/215.53  |- mesh__publicMeSHNote mesh__D009714
% 215.36/215.53       91; was see under SEPTAL NUCLEI 1978-90   
% 215.36/215.53  |- mesh__historyNote mesh__D009714
% 215.36/215.53       91%28%78%29%; was see under SEPTAL NUCLEI 1978-90   
% 215.36/215.53  |- skos__hiddenLabel mesh__D009714 Accumbens, Nucleus
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D009714 2005
% 215.36/215.53  |- skos__historyNote mesh__D009714 Septal Nuclei %28%1972-1977%29%
% 215.36/215.53  |- mesh__recordOriginator mesh__D009714 RC
% 215.36/215.53  |- mesh__recordAuthorizer mesh__D009714 sjn
% 215.36/215.53  |- mesh__dateEstablished mesh__D009714 1991-01-01
% 215.36/215.53  |- skos__prefLabel mesh__D009714 Nucleus Accumbens
% 215.36/215.53  |- skos__scopeNote mesh__D009714
% 215.36/215.53       Collection of pleomorphic cells in the caudal part of the anterior horn of the lateral ventricle, in the region of the olfactory tubercle, lying between the head of the caudate nucleus and the anterior perforated substance. It is part of the so-called ventral striatum, a composite structure considered part of the basal ganglia.%A%    
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D009714 2006
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D009714 2003
% 215.36/215.53  |- mesh__dateCreated mesh__D009714 1977-03-29
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D009714 2004
% 215.36/215.53  |- skos__historyNote mesh__D009714 Cerebral Ventricles %28%1966-1977%29%
% 215.36/215.53  |- rdf__type mesh__D009714sskos__Concept
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D009714 2000
% 215.36/215.53  |- mesh__dateRevised mesh__D009714 1999-11-03
% 215.36/215.53  |- skos__broader mesh__D009714smesh__D001479
% 215.36/215.53  |- skos__historyNote mesh__D001731
% 215.36/215.53       Diphosphoglyceric Acids %28%1973-1974%29%
% 215.36/215.53  |- skos__hiddenLabel mesh__D001731 Synthase, Bisphosphoglycerate
% 215.36/215.53  |- skos__scopeNote mesh__D001731
% 215.36/215.53       An enzyme that catalyzes the transfer of phosphate from C-3 of 1,3-diphosphoglycerate to C-2 of 3-phosphoglycerate, forming 2,3-diphosphoglycerate. EC 5.4.2.4.%A%    
% 215.36/215.53  |- mesh__onlineNote mesh__D001731
% 215.36/215.53       use BISPHOSPHOGLYCERATE MUTASE to search BISPHOSPHOGLYCEROMUTASE 1975-92%A%  
% 215.36/215.53  |- skos__prefLabel mesh__D001731 Bisphosphoglycerate Mutase
% 215.36/215.53  |- skos__altLabel mesh__D001731 Bisphosphoglyceromutase
% 215.36/215.53  |- skos__hiddenLabel mesh__D001731 Mutase, Bisphosphoglycerate
% 215.36/215.53  |- mesh__dateCreated mesh__D001731 1974-11-19
% 215.36/215.53  |- mesh__recordOriginator mesh__D001731 NLM
% 215.36/215.53  |- skos__broader mesh__D001731smesh__D017875
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D001731 2005
% 215.36/215.53  |- mesh__recordMaintainer mesh__D001731 ssb
% 215.36/215.53  |- skos__altLabel mesh__D001731 Bisphosphoglycerate Synthase
% 215.36/215.53  |- skos__altLabel mesh__D001731 Diphosphoglyceromutase
% 215.36/215.53  |- mesh__historyNote mesh__D001731
% 215.36/215.53       93; was BISPHOSPHOGLYCEROMUTASE 1975-92 %28%see under PHOSPHOTRANSFERASES%29%%A%  
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D001731 2006
% 215.36/215.53  |- mesh__dateEstablished mesh__D001731 1991-01-01
% 215.36/215.53  |- skos__altLabel mesh__D001731 Diphosphoglycerate Mutase
% 215.36/215.53  |- mesh__recordAuthorizer mesh__D001731 sjn
% 215.36/215.53  |- mesh__publicMeSHNote mesh__D001731
% 215.36/215.53       93; was BISPHOSPHOGLYCEROMUTASE 1975-92 %28%see under PHOSPHOTRANSFERASES 1975-90%29%%A%  
% 215.36/215.53  |- rdf__type mesh__D001731sskos__Concept
% 215.36/215.53  |- mesh__dateRevised mesh__D001731 2003-07-09
% 215.36/215.53  |- skos__historyNote mesh__D001731 Phosphotransferases %28%1973-1974%29%
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D001731 2004
% 215.36/215.53  |- skos__hiddenLabel mesh__D001731 Mutase, Diphosphoglycerate
% 215.36/215.53  |- skos__broader mesh__D020696smesh__D020691
% 215.36/215.53  |- skos__altLabel mesh__D020696 rab5 Protein
% 215.36/215.53  |- mesh__dateCreated mesh__D020696 1999-11-03
% 215.36/215.53  |- skos__hiddenLabel mesh__D020696 GTP-Binding Protein, rab5A
% 215.36/215.53  |- skos__hiddenLabel mesh__D020696 rab5A GTP Binding Protein
% 215.36/215.53  |- mesh__publicMeSHNote mesh__D020696
% 215.36/215.53       2000; RAB5 PROTEIN %28%now RAB5 GTP-BINDING PROTEINS%29% was indexed under G-PROTEINS 1991-1999%A%  
% 215.36/215.53  |- skos__prefLabel mesh__D020696 rab5 GTP-Binding Proteins
% 215.36/215.53  |- skos__hiddenLabel mesh__D020696 rab5 GTP Binding Protein
% 215.36/215.53  |- skos__altLabel mesh__D020696 rab5 GTP-Binding Protein
% 215.36/215.53  |- skos__annotation mesh__D020696 DF: RAB5 PROTEIN   
% 215.36/215.53  |- mesh__recordOriginator mesh__D020696 jmp
% 215.36/215.53  |- skos__hiddenLabel mesh__D020696 rab5 GTP Binding Proteins
% 215.36/215.53  |- skos__hiddenLabel mesh__D020696 GTP-Binding Proteins, rab5
% 215.36/215.53  |- mesh__recordAuthorizer mesh__D020696 sjn
% 215.36/215.53  |- mesh__dateEstablished mesh__D020696 2000-01-01
% 215.36/215.53  |- skos__hiddenLabel mesh__D020696 GTP-Binding Protein, rab5
% 215.36/215.53  |- mesh__dateRevised mesh__D020696 2005-06-30
% 215.36/215.53  |- rdf__type mesh__D020696sskos__Concept
% 215.36/215.53  |- skos__scopeNote mesh__D020696
% 215.36/215.53       A genetically related subfamily of RAB GTP-BINDING PROTEINS involved in transport from the cell membrane to early endosomes. This enzyme was formerly listed as EC 3.6.1.47.%A%    
% 215.36/215.53  |- mesh__historyNote mesh__D020696
% 215.36/215.53       2000; use RAB5 GTP-BINDING PROTEINS %28%NM%29% 1991-1999   
% 215.36/215.53  |- skos__altLabel mesh__D020696 rab5A Protein
% 215.36/215.53  |- skos__historyNote mesh__D020696 G-Proteins %28%1992-1999%29%
% 215.36/215.53  |- mesh__recordMaintainer mesh__D020696 jmp
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D020696 2006
% 215.36/215.53  |- skos__hiddenLabel mesh__D014659 Threads, Intravasal
% 215.36/215.53  |- mesh__recordOriginator mesh__D014659 NLM
% 215.36/215.53  |- skos__hiddenLabel mesh__D014659 Vasectomy Seeker
% 215.36/215.53  |- skos__hiddenLabel mesh__D014659 Seeker, Vasectomy
% 215.36/215.53  |- skos__hiddenLabel mesh__D014659 Occlusions, Vas
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D014659 2002
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D014659 2003
% 215.36/215.53  |- skos__hiddenLabel mesh__D014659 Refused Vasectomy Seeker
% 215.36/215.53  |- skos__hiddenLabel mesh__D014659 Vas Ligations
% 215.36/215.53  |- skos__hiddenLabel mesh__D014659 Seekers, Vasectomy
% 215.36/215.53  |- skos__broader mesh__D014659smesh__D013245
% 215.36/215.53  |- skos__annotation mesh__D014659
% 215.36/215.53       do not use /util except by MeSH definition   
% 215.36/215.53  |- skos__hiddenLabel mesh__D014659 Nonchemical Vas Occlusion
% 215.36/215.53  |- mesh__activeMeSHYear mesh__D014659 2001
% 215.36/215.53  |- skos__hiddenLabel mesh__D014659 Nonchemical Vas Occlusions
% 215.36/215.53  |- mesh__dateCreated mesh__D014659 1999-01-01
% 215.36/215.53  |- skos__hiddenLabel mesh__D014659 Vas Occlusions
% 215.36/215.53  |- skos__related mesh__D014659smesh__D013243
% 215.36/215.53  |- skos__hiddenLabel mesh__D014659 Vasectomy Seeker, Refused
% 215.36/215.54  |- mesh__recordMaintainer mesh__D014659 PXP
% 215.36/215.54  |- skos__hiddenLabel mesh__D014659 Thread, Intravasal
% 215.36/215.54  |- mesh__dateRevised mesh__D014659 1997-06-20
% 215.36/215.54  |- skos__scopeNote mesh__D014659
% 215.36/215.54       Surgical removal of the ductus deferens, or a portion of it. It is done in association with prostatectomy, or to induce infertility. %28%Dorland, 28th ed%29%%A%    
% 215.36/215.54  |- skos__hiddenLabel mesh__D014659 Vas Occlusions, Nonchemical
% 215.36/215.54  |- mesh__historyNote mesh__D014659 73   
% 215.36/215.54  |- mesh__dateEstablished mesh__D014659 1973-01-01
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D014659 2000
% 215.36/215.54  |- skos__prefLabel mesh__D014659 Vasectomy
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D014659 2006
% 215.36/215.54  |- skos__historyNote mesh__D014659 Vas Deferens/surgery %28%1966-1972%29%
% 215.36/215.54  |- skos__hiddenLabel mesh__D014659 Ligation, Vas
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D014659 1999
% 215.36/215.54  |- skos__hiddenLabel mesh__D014659 Intravasal Threads
% 215.36/215.54  |- mesh__publicMeSHNote mesh__D014659 73   
% 215.36/215.54  |- rdf__type mesh__D014659sskos__Concept
% 215.36/215.54  |- skos__hiddenLabel mesh__D014659 Occlusion, Nonchemical Vas
% 215.36/215.54  |- skos__hiddenLabel mesh__D014659 Occlusions, Nonchemical Vas
% 215.36/215.54  |- skos__hiddenLabel mesh__D014659 Seekers, Refused Vasectomy
% 215.36/215.54  |- skos__hiddenLabel mesh__D014659 Vasectomies
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D014659 2005
% 215.36/215.54  |- skos__broader mesh__D014659smesh__D013521
% 215.36/215.54  |- mesh__recordAuthorizer mesh__D014659 SJN
% 215.36/215.54  |- skos__hiddenLabel mesh__D014659 Ligations, Vas
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D014659 1998
% 215.36/215.54  |- skos__hiddenLabel mesh__D014659 Refused Vasectomy Seekers
% 215.36/215.54  |- skos__hiddenLabel mesh__D014659 Occlusion, Vas
% 215.36/215.54  |- skos__hiddenLabel mesh__D014659 Seeker, Refused Vasectomy
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D014659 2004
% 215.36/215.54  |- skos__altLabel mesh__D025381 Synergistin B
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D025381 2005
% 215.36/215.54  |- mesh__recordMaintainer mesh__D025381 ssb
% 215.36/215.54  |- mesh__dateCreated mesh__D025381 2001-07-25
% 215.36/215.54  |- mesh__publicMeSHNote mesh__D025381
% 215.36/215.54       2002; see VIRGINIAMYCIN 1991-2001; for PRISTINAMYCIN IA see VIRGINIAMYCIN 1991-2001%A%  
% 215.36/215.54  |- skos__prefLabel mesh__D025381 Streptogramin B
% 215.36/215.54  |- mesh__recordOriginator mesh__D025381 jmp
% 215.36/215.54  |- skos__altLabel mesh__D025381 Mikamycin B
% 215.36/215.54  |- skos__altLabel mesh__D025381 Osteogrycin B
% 215.36/215.54  |- mesh__dateEstablished mesh__D025381 2002-01-01
% 215.36/215.54  |- mesh__historyNote mesh__D025381
% 215.36/215.54       2002; use VIRGINIAMYCIN 1991-2001; for PRISTINAMYCIN IA use VIRGINIAMYCIN 1991-2001%A%  
% 215.36/215.54  |- mesh__dateRevised mesh__D025381 2004-07-07
% 215.36/215.54  |- skos__scopeNote mesh__D025381
% 215.36/215.54       A specific streptogramin group B antibiotic produced by Streptomyces graminofaciens and other bacteria.%A%    
% 215.36/215.54  |- skos__altLabel mesh__D025381 Pristinamycin IA
% 215.36/215.54  |- mesh__recordAuthorizer mesh__D025381 sjn
% 215.36/215.54  |- skos__broader mesh__D025381smesh__D025382
% 215.36/215.54  |- skos__altLabel mesh__D025381 Vernamycin Balpha
% 215.36/215.54  |- skos__altLabel mesh__D025381
% 215.36/215.54       4-%5B%4-%28%Dimethylamino%29%-N-methyl-L-phenylalanine%5D%virginiamycin S1
% 215.36/215.54  |- rdf__type mesh__D025381sskos__Concept
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D025381 2006
% 215.36/215.54  |- skos__historyNote mesh__D025381 Virginiamycin %28%1986-2001%29%
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D019344 1998
% 215.36/215.54  |- skos__hiddenLabel mesh__D019344 Acid, Lactic
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D019344 1997
% 215.36/215.54  |- skos__historyNote mesh__D019344 Lactates %28%1981-1996%29%
% 215.36/215.54  |- mesh__publicMeSHNote mesh__D019344
% 215.36/215.54       97; LACTIC ACID was indexed under LACTATES 1981-96   
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D019344 2003
% 215.36/215.54  |- mesh__dateEstablished mesh__D019344 1997-01-01
% 215.36/215.54  |- mesh__dateCreated mesh__D019344 1996-06-10
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D019344 2002
% 215.36/215.54  |- skos__prefLabel mesh__D019344 Lactic Acid
% 215.36/215.54  |- skos__annotation mesh__D019344
% 215.36/215.54       do not confuse X ref LACTATE with LACTATES   
% 215.36/215.54  |- skos__broader mesh__D019344smesh__D007773
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D019344 2006
% 215.36/215.54  |- rdf__type mesh__D019344sskos__Concept
% 215.36/215.54  |- skos__scopeNote mesh__D019344
% 215.36/215.54       A normal intermediate in the fermentation %28%oxidation, metabolism%29% of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. %28%From Stedman, 26th ed%29%%A%    
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D019344 2001
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D019344 1999
% 215.36/215.54  |- mesh__historyNote mesh__D019344
% 215.36/215.54       97; was LACTIC ACID %28%NM%29% 1981-96   
% 215.36/215.54  |- mesh__onlineNote mesh__D019344
% 215.36/215.54       use LACTIC ACID %28%NM%29% to search LACTIC ACID 1981-96   
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D019344 2000
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D019344 2005
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D019344 2004
% 215.36/215.54  |- skos__hiddenLabel mesh__D000639 Amitriptylinneuraxpharm
% 215.36/215.54  |- skos__altLabel mesh__D000639 Tryptanol
% 215.36/215.54  |- skos__altLabel mesh__D000639 DDSA Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- skos__hiddenLabel mesh__D000639 Desitin, Amitriptylin
% 215.36/215.54  |- skos__altLabel mesh__D000639
% 215.36/215.54       Lundbeck Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- skos__hiddenLabel mesh__D000639 Apo Amitriptyline
% 215.36/215.54  |- skos__altLabel mesh__D000639
% 215.36/215.54       Rh%C3%%B4%ne-Poulenc Rorer Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- skos__altLabel mesh__D000639
% 215.36/215.54       Psicofarma Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- mesh__dateCreated mesh__D000639 1999-11-08
% 215.36/215.54  |- skos__prefLabel mesh__D000639 Amitriptyline
% 215.36/215.54  |- mesh__dateRevised mesh__D000639 2004-07-19
% 215.36/215.54  |- skos__altLabel mesh__D000639
% 215.36/215.54       Merck Sharp %26% Dohme Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- skos__altLabel mesh__D000639
% 215.36/215.54       Douglas Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- skos__hiddenLabel mesh__D000639 RPh, Amitriptylin
% 215.36/215.54  |- skos__altLabel mesh__D000639 Protea Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- skos__altLabel mesh__D000639 Merck Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- skos__broader mesh__D000639smesh__D003986
% 215.36/215.54  |- skos__altLabel mesh__D000639
% 215.36/215.54       neuraxpharm Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- skos__altLabel mesh__D000639 Endep
% 215.36/215.54  |- skos__altLabel mesh__D000639
% 215.36/215.54       Betapharm Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- skos__altLabel mesh__D000639 Krewel Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- skos__altLabel mesh__D000639 Zeneca Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- skos__hiddenLabel mesh__D000639
% 215.36/215.54       Rh%C3%%B4%ne Poulenc Rorer Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- skos__altLabel mesh__D000639 Elavil
% 215.36/215.54  |- skos__scopeNote mesh__D000639
% 215.36/215.54       Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.%A%    
% 215.36/215.54  |- skos__altLabel mesh__D000639
% 215.36/215.54       Goldshield Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- skos__altLabel mesh__D000639
% 215.36/215.54       Cahill May Roberts Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- skos__altLabel mesh__D000639
% 215.36/215.54       Desitin Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- mesh__recordAuthorizer mesh__D000639 sjn
% 215.36/215.54  |- skos__hiddenLabel mesh__D000639 Amitriptylin neuraxpharm
% 215.36/215.54  |- mesh__publicMeSHNote mesh__D000639 64   
% 215.36/215.54  |- skos__altLabel mesh__D000639
% 215.36/215.54       Neuro Hexal Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D000639 2006
% 215.36/215.54  |- skos__altLabel mesh__D000639
% 215.36/215.54       Alphapharm Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- skos__altLabel mesh__D000639 Roche Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- skos__altLabel mesh__D000639
% 215.36/215.54       Cahill May Roberts Brand of Amitriptyline Embonate
% 215.36/215.54  |- mesh__dateEstablished mesh__D000639 1964-01-01
% 215.36/215.54  |- skos__altLabel mesh__D000639
% 215.36/215.54       Rodleben Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- skos__hiddenLabel mesh__D000639 ApoAmitriptyline
% 215.36/215.54  |- mesh__historyNote mesh__D000639 64%28%63%29%   
% 215.36/215.54  |- mesh__recordMaintainer mesh__D000639 jmp
% 215.36/215.54  |- skos__altLabel mesh__D000639 APS Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- skos__altLabel mesh__D000639
% 215.36/215.54       Merck Sharp %26% Dohme Brand of Amitriptyline Embonate
% 215.36/215.54  |- skos__altLabel mesh__D000639 Hexal Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- rdf__type mesh__D000639sskos__Concept
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D000639 2005
% 215.36/215.54  |- mesh__recordOriginator mesh__D000639 NLM
% 215.36/215.54  |- skos__hiddenLabel mesh__D000639 beta, Amitriptylin
% 215.36/215.54  |- skos__altLabel mesh__D000639 Apotex Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- skos__altLabel mesh__D000639
% 215.36/215.54       Parke Davis Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- skos__altLabel mesh__D000639 Amrad Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- skos__altLabel mesh__D000639 Bayer Brand of Amitriptyline Hydrochloride
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011361 2006
% 215.36/215.54  |- mesh__historyNote mesh__D011361 79   
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011361 2005
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011361 2000
% 215.36/215.54  |- skos__hiddenLabel mesh__D011361 Expertise Generalization
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011361 1997
% 215.36/215.54  |- mesh__recordOriginator mesh__D011361 EC
% 215.36/215.54  |- mesh__dateRevised mesh__D011361 1992-12-18
% 215.36/215.54  |- rdf__type mesh__D011361sskos__Concept
% 215.36/215.54  |- skos__scopeNote mesh__D011361
% 215.36/215.54       The capability to perform the duties of one%27%s profession generally, or to perform a particular professional task, with skill of an acceptable quality.%A%    
% 215.36/215.54  |- skos__altLabel mesh__D011361 Competence, Professional
% 215.36/215.54  |- mesh__dateCreated mesh__D011361 1978-05-09
% 215.36/215.54  |- skos__broader mesh__D011361smesh__D004521
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011361 1993
% 215.36/215.54  |- mesh__dateEstablished mesh__D011361 1979-01-01
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011361 1996
% 215.36/215.54  |- mesh__publicMeSHNote mesh__D011361 79   
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011361 2002
% 215.36/215.54  |- skos__hiddenLabel mesh__D011361 Expertise, Technical
% 215.36/215.54  |- mesh__recordMaintainer mesh__D011361 PLS
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011361 1999
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011361 2004
% 215.36/215.54  |- mesh__recordAuthorizer mesh__D011361 PLS
% 215.36/215.54  |- skos__annotation mesh__D011361
% 215.36/215.54       competence in any profession or discipline: differentiate from CLINICAL COMPETENCE which is restricted to competence in professional activities directly related to patient care%A%  
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011361 1995
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011361 1998
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011361 2003
% 215.36/215.54  |- skos__prefLabel mesh__D011361 Professional Competence
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011361 2001
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011361 1994
% 215.36/215.54  |- mesh__recordOriginator mesh__D005324 EC
% 215.36/215.54  |- skos__hiddenLabel mesh__D005324 Fetal Movements
% 215.36/215.54  |- skos__historyNote mesh__D005324 Fetus/PH %28%1966-1984%29%
% 215.36/215.54  |- rdf__type mesh__D005324sskos__Concept
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D005324 2005
% 215.36/215.54  |- mesh__recordAuthorizer mesh__D005324 sjn
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D005324 2006
% 215.36/215.54  |- mesh__dateRevised mesh__D005324 2004-07-07
% 215.36/215.54  |- skos__broader mesh__D005324smesh__D047109
% 215.36/215.54  |- skos__hiddenLabel mesh__D005324 Fetal Activities
% 215.36/215.54  |- skos__scopeNote mesh__D005324
% 215.36/215.54       Physical activity of the FETUS in utero. Gross or fine fetal body movement can be monitored by the mother, PALPATION, or ULTRASONOGRAPHY.%A%    
% 215.36/215.54  |- mesh__publicMeSHNote mesh__D005324 85   
% 215.36/215.54  |- mesh__dateEstablished mesh__D005324 1985-01-01
% 215.36/215.54  |- skos__prefLabel mesh__D005324 Fetal Movement
% 215.36/215.54  |- skos__altLabel mesh__D005324 Fetal Activity
% 215.36/215.54  |- skos__historyNote mesh__D005324 Movement %28%1966-1984%29%
% 215.36/215.54  |- mesh__recordMaintainer mesh__D005324 lkt
% 215.36/215.54  |- mesh__historyNote mesh__D005324 85   
% 215.36/215.54  |- mesh__dateCreated mesh__D005324 1984-04-06
% 215.36/215.54  |- mesh__historyNote mesh__D029772 2002   
% 215.36/215.54  |- mesh__dateEstablished mesh__D029772 2002-01-01
% 215.36/215.54  |- skos__scopeNote mesh__D029772
% 215.36/215.54       A plant genus of the family CUCURBITACEAE that is the source of bryodin 1 %28%a ribosome-inactivating protein%29%.%A%    
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D029772 2006
% 215.36/215.54  |- mesh__publicMeSHNote mesh__D029772 2002   
% 215.36/215.54  |- rdf__type mesh__D029772sskos__Concept
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D029772 2002
% 215.36/215.54  |- mesh__dateCreated mesh__D029772 2001-07-25
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D029772 2004
% 215.36/215.54  |- skos__broader mesh__D029772smesh__D019662
% 215.36/215.54  |- skos__annotation mesh__D029772
% 215.36/215.54       do not confuse X ref BRYONY with BLACK BRYONY see TAMUS; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D029772 2005
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D029772 2003
% 215.36/215.54  |- skos__prefLabel mesh__D029772 Bryonia
% 215.36/215.54  |- skos__historyNote mesh__D010269 Herbicides %28%1966-1970%29%
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D010269 2005
% 215.36/215.54  |- skos__altLabel mesh__D010269 Methyl Viologen
% 215.36/215.54  |- mesh__dateEstablished mesh__D010269 1973-01-01
% 215.36/215.54  |- rdf__type mesh__D010269sskos__Concept
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D010269 2004
% 215.36/215.54  |- skos__prefLabel mesh__D010269 Paraquat
% 215.36/215.54  |- mesh__historyNote mesh__D010269 73%28%71%29%   
% 215.36/215.54  |- mesh__recordAuthorizer mesh__D010269 sjn
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D010269 2003
% 215.36/215.54  |- skos__historyNote mesh__D010269 Pyridinium Compounds %28%1968-1970%29%
% 215.36/215.54  |- skos__broader mesh__D010269smesh__D011726
% 215.36/215.54  |- skos__scopeNote mesh__D010269
% 215.36/215.54       A poisonous dipyridilium compound used as contact herbicide. Contact with concentrated solutions causes irritation of the skin, cracking and shedding of the nails, and delayed healing of cuts and wounds.%A%    
% 215.36/215.54  |- mesh__dateCreated mesh__D010269 1999-01-01
% 215.36/215.54  |- skos__hiddenLabel mesh__D010269 Viologen, Methyl
% 215.36/215.54  |- mesh__dateRevised mesh__D010269 2001-07-25
% 215.36/215.54  |- mesh__recordOriginator mesh__D010269 NLM
% 215.36/215.54  |- mesh__publicMeSHNote mesh__D010269 73   
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D010269 2006
% 215.36/215.54  |- mesh__recordMaintainer mesh__D010269 ssb
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D010269 2002
% 215.36/215.54  |- skos__hiddenLabel mesh__D015752 HIV rev Responsive Element
% 215.36/215.54  |- skos__altLabel mesh__D015752 env Genes
% 215.36/215.54  |- skos__altLabel mesh__D015752 env Gene
% 215.36/215.54  |- skos__hiddenLabel mesh__D015752 Gene, env
% 215.36/215.54  |- skos__hiddenLabel mesh__D015752 rev-Responsive Element, HIV
% 215.36/215.54  |- skos__hiddenLabel mesh__D015752 rev-Responsive Elements, HIV
% 215.36/215.54  |- skos__annotation mesh__D015752
% 215.36/215.54       env stands for %22%envelope%22%; coord IM with specific virus /genet %28%IM%29%%A%  
% 215.36/215.54  |- skos__historyNote mesh__D015752 Genes, Structural %28%1983-1989%29%
% 215.36/215.54  |- mesh__recordOriginator mesh__D015752 AGS
% 215.36/215.54  |- mesh__historyNote mesh__D015752
% 215.36/215.54       90; was ENV GENE see GENES, VIRAL 1987-89   
% 215.36/215.54  |- skos__scopeNote mesh__D015752
% 215.36/215.54       DNA sequences that form the coding region for the viral envelope %28%env%29% proteins in retroviruses. The env genes contain a cis-acting RNA target sequence for the rev protein %28%= GENE PRODUCTS, REV%29%, termed the rev-responsive element %28%RRE%29%.%A%    
% 215.36/215.54  |- mesh__publicMeSHNote mesh__D015752
% 215.36/215.54       90; was ENV GENE see GENES, VIRAL 1987-89   
% 215.36/215.54  |- rdf__type mesh__D015752sskos__Concept
% 215.36/215.54  |- skos__historyNote mesh__D015752 Genes, Viral %28%1977-1989%29%
% 215.36/215.54  |- skos__hiddenLabel mesh__D015752 HIV rev-Responsive Elements
% 215.36/215.54  |- skos__hiddenLabel mesh__D015752 Elements, rev-Responsive
% 215.36/215.54  |- mesh__recordAuthorizer mesh__D015752 sjn
% 215.36/215.54  |- mesh__onlineNote mesh__D015752
% 215.36/215.54       use GENES, VIRAL to search ENV GENE 1987-89   
% 215.36/215.54  |- mesh__dateCreated mesh__D015752 1989-05-25
% 215.36/215.54  |- skos__hiddenLabel mesh__D015752 Element, HIV rev-Responsive
% 215.36/215.54  |- skos__broader mesh__D015752smesh__D005814
% 215.36/215.54  |- mesh__dateEstablished mesh__D015752 1990-01-01
% 215.36/215.54  |- skos__hiddenLabel mesh__D015752 rev Responsive Element
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D015752 2006
% 215.36/215.54  |- skos__hiddenLabel mesh__D015752 Element, rev-Responsive
% 215.36/215.54  |- mesh__recordMaintainer mesh__D015752 nns
% 215.36/215.54  |- skos__hiddenLabel mesh__D015752 rev-Responsive Elements
% 215.36/215.54  |- skos__prefLabel mesh__D015752 Genes, env
% 215.36/215.54  |- mesh__dateRevised mesh__D015752 2005-06-30
% 215.36/215.54  |- skos__hiddenLabel mesh__D015752 Elements, HIV rev-Responsive
% 215.36/215.54  |- skos__broader mesh__D014807Q000172smesh__D014807
% 215.36/215.54  |- mesh__preferredCombination mesh__D014807Q000172smesh__D014808
% 215.36/215.54  |- rdf__type mesh__D014807Q000172smesh__CompoundConcept
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D009715 2005
% 215.36/215.54  |- mesh__dateRevised mesh__D009715 1999-11-03
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D009715 2006
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D009715 2003
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D009715 2000
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D009715 2004
% 215.36/215.54  |- rdf__type mesh__D009715sskos__Concept
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D009715 2001
% 215.36/215.54  |- mesh__recordOriginator mesh__D009715 NLM
% 215.36/215.54  |- mesh__dateCreated mesh__D009715 1999-01-01
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D009715 2002
% 215.36/215.54  |- mesh__recordMaintainer mesh__D009715 jls
% 215.36/215.54  |- skos__scopeNote mesh__D009715
% 215.36/215.54       The practice of living unclothed for reasons of comfort or health.%A%    
% 215.36/215.54  |- skos__hiddenLabel mesh__D009715 Nudisms
% 215.36/215.54  |- skos__broader mesh__D009715smesh__D006802
% 215.36/215.54  |- mesh__recordAuthorizer mesh__D009715 sjn
% 215.36/215.54  |- skos__prefLabel mesh__D009715 Nudism
% 215.36/215.54  |- mesh__historyNote mesh__D001732
% 215.36/215.54       91%28%84%29%; was see under DENTAL OCCLUSION 1984-90   
% 215.36/215.54  |- mesh__dateRevised mesh__D001732 1990-04-13
% 215.36/215.54  |- mesh__dateEstablished mesh__D001732 1991-01-01
% 215.36/215.54  |- mesh__publicMeSHNote mesh__D001732
% 215.36/215.54       91; was see under DENTAL OCCLUSION 1984-90   
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D001732 1992
% 215.36/215.54  |- skos__historyNote mesh__D001732 Masticatory Muscles %28%1966-1983%29%
% 215.36/215.54  |- skos__historyNote mesh__D001732 Dental Occlusion %28%1966-1983%29%
% 215.36/215.54  |- rdf__type mesh__D001732sskos__Concept
% 215.36/215.54  |- skos__altLabel mesh__D001732 Masticatory Force
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D001732 1999
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D001732 2001
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D001732 2006
% 215.36/215.54  |- skos__hiddenLabel mesh__D001732 Forces, Occlusal
% 215.36/215.54  |- mesh__recordAuthorizer mesh__D001732 PLS
% 215.36/215.54  |- skos__annotation mesh__D001732 note category; no qualif   
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D001732 1995
% 215.36/215.54  |- skos__hiddenLabel mesh__D001732 Occlusal Forces
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D001732 1998
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D001732 2000
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D001732 2005
% 215.36/215.54  |- skos__hiddenLabel mesh__D001732 Force, Masticatory
% 215.36/215.54  |- skos__hiddenLabel mesh__D001732 Force, Occlusal
% 215.36/215.54  |- skos__historyNote mesh__D001732 Dental Stress Analysis %28%1968-1983%29%
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D001732 1994
% 215.36/215.54  |- skos__scopeNote mesh__D001732
% 215.36/215.54       The force applied by the masticatory muscles in dental occlusion.%A%    
% 215.36/215.54  |- mesh__recordOriginator mesh__D001732 RC
% 215.36/215.54  |- skos__historyNote mesh__D001732 Mastication %28%1966-1983%29%
% 215.36/215.54  |- skos__hiddenLabel mesh__D001732 Bite Forces
% 215.36/215.54  |- skos__hiddenLabel mesh__D001732 Forces, Masticatory
% 215.36/215.54  |- skos__broader mesh__D001732smesh__D003766
% 215.36/215.54  |- skos__prefLabel mesh__D001732 Bite Force
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D001732 1997
% 215.36/215.54  |- mesh__recordMaintainer mesh__D001732 NLM
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D001732 2004
% 215.36/215.54  |- mesh__dateCreated mesh__D001732 1983-06-15
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D001732 2002
% 215.36/215.54  |- skos__altLabel mesh__D001732 Occlusal Force
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D001732 1993
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D001732 1996
% 215.36/215.54  |- skos__hiddenLabel mesh__D001732 Force, Bite
% 215.36/215.54  |- skos__hiddenLabel mesh__D001732 Masticatory Forces
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D001732 1991
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D001732 2003
% 215.36/215.54  |- skos__hiddenLabel mesh__D001732 Forces, Bite
% 215.36/215.54  |- mesh__historyNote mesh__D025382 2002   
% 215.36/215.54  |- mesh__dateEstablished mesh__D025382 2002-01-01
% 215.36/215.54  |- skos__altLabel mesh__D025382 Streptogramins, Group B
% 215.36/215.54  |- skos__annotation mesh__D025382 STREPTOGRAMIN B is available   
% 215.36/215.54  |- skos__historyNote mesh__D025382 Virginiamycin %28%1986-2001%29%
% 215.36/215.54  |- mesh__dateRevised mesh__D025382 2004-07-07
% 215.36/215.54  |- skos__broader mesh__D025382smesh__D025361
% 215.36/215.54  |- skos__hiddenLabel mesh__D025382 Group B Streptogramins
% 215.36/215.54  |- skos__hiddenLabel mesh__D025382 Group B, Streptogramin
% 215.36/215.54  |- mesh__recordMaintainer mesh__D025382 ssb
% 215.36/215.54  |- mesh__publicMeSHNote mesh__D025382 2002   
% 215.36/215.54  |- skos__prefLabel mesh__D025382 Streptogramin Group B
% 215.36/215.54  |- mesh__dateCreated mesh__D025382 2001-07-25
% 215.36/215.54  |- mesh__recordOriginator mesh__D025382 jmp
% 215.36/215.54  |- rdf__type mesh__D025382sskos__Concept
% 215.36/215.54  |- skos__altLabel mesh__D025382 Group B Streptogramin
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D025382 2006
% 215.36/215.54  |- skos__hiddenLabel mesh__D025382 Streptogramin, Group B
% 215.36/215.54  |- mesh__recordAuthorizer mesh__D025382 sjn
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D025382 2005
% 215.36/215.54  |- skos__scopeNote mesh__D025382
% 215.36/215.54       A structural subclass of streptogramins. They are cyclic hexadepsipeptides with approximate molecular weight of 800 that contain a characteristic 3-hydroxy picolinoyl exocyclic component.%A%    
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D019345 2003
% 215.36/215.54  |- skos__scopeNote mesh__D019345
% 215.36/215.54       A salt produced by the reaction of zinc oxide with acetic acid and used as an astringent, styptic, and emetic.%A%    
% 215.36/215.54  |- mesh__recordOriginator mesh__D019345 ADP
% 215.36/215.54  |- skos__prefLabel mesh__D019345 Zinc Acetate
% 215.36/215.54  |- mesh__onlineNote mesh__D019345
% 215.36/215.54       use ACETIC ACID %28%NM%29% to search ZINC ACETATE 1981-96   
% 215.36/215.54  |- mesh__publicMeSHNote mesh__D019345
% 215.36/215.54       97; ZINC ACETATE was indexed under ACETIC ACIDS 1981-96   
% 215.36/215.54  |- mesh__recordMaintainer mesh__D019345 CCR
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D019345 2006
% 215.36/215.54  |- skos__broader mesh__D019345smesh__D000085
% 215.36/215.54  |- mesh__dateEstablished mesh__D019345 1997-01-01
% 215.36/215.54  |- mesh__dateCreated mesh__D019345 1996-06-10
% 215.36/215.54  |- skos__hiddenLabel mesh__D019345 Zinc Acetate, Anhydrous
% 215.36/215.54  |- mesh__recordAuthorizer mesh__D019345 sjn
% 215.36/215.54  |- rdf__type mesh__D019345sskos__Concept
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D019345 2005
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D019345 2002
% 215.36/215.54  |- mesh__dateRevised mesh__D019345 2000-06-21
% 215.36/215.54  |- mesh__historyNote mesh__D019345
% 215.36/215.54       97; ZINC ACETATE was SY to ACETIC ACID GLACIAL %28%NM%29% 1981-96%A%  
% 215.36/215.54  |- skos__hiddenLabel mesh__D019345 Acetate, Zinc
% 215.36/215.54  |- skos__historyNote mesh__D019345 Acetic Acids %28%1981-1996%29%
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D019345 2004
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D019345 2001
% 215.36/215.54  |- skos__historyNote mesh__D011362
% 215.36/215.54       Practice Management, Dental %28%1968-1978%29%
% 215.36/215.54  |- rdf__type mesh__D011362sskos__Concept
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011362 1996
% 215.36/215.54  |- mesh__recordAuthorizer mesh__D011362 PLS
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011362 1999
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011362 2004
% 215.36/215.54  |- skos__scopeNote mesh__D011362
% 215.36/215.54       Legally authorized corporations owned and managed by one or more professionals %28%medical, dental, legal%29% in which the income is ascribed primarily to the professional activities of the owners or stockholders.%A%    
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011362 2001
% 215.36/215.54  |- skos__annotation mesh__D011362
% 215.36/215.54       coord IM with PRACTICE MANAGEMENT, MEDICAL or PRACTICE MANAGEMENT, DENTAL %28%IM%29% for med or dent profess corp%A%  
% 215.36/215.54  |- skos__hiddenLabel mesh__D011362 Professional Corporation
% 215.36/215.54  |- skos__hiddenLabel mesh__D011362 Corporations, Professional
% 215.36/215.54  |- mesh__historyNote mesh__D011362
% 215.36/215.54       91%28%79%29%; was see under PROFESSIONAL PRACTICE 1979-90   
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011362 2003
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011362 1998
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011362 1995
% 215.36/215.54  |- mesh__recordMaintainer mesh__D011362 TGC
% 215.36/215.54  |- mesh__dateEstablished mesh__D011362 1991-01-01
% 215.36/215.54  |- mesh__publicMeSHNote mesh__D011362
% 215.36/215.54       91; was see under PROFESSIONAL PRACTICE 1979-90   
% 215.36/215.54  |- skos__hiddenLabel mesh__D011362 Corporate Practices
% 215.36/215.54  |- mesh__recordOriginator mesh__D011362 EC
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011362 2000
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011362 2006
% 215.36/215.54  |- mesh__dateCreated mesh__D011362 1978-05-09
% 215.36/215.54  |- skos__prefLabel mesh__D011362 Professional Corporations
% 215.36/215.54  |- skos__historyNote mesh__D011362
% 215.36/215.54       Practice Management, Medical %28%1968-1978%29%
% 215.36/215.54  |- skos__hiddenLabel mesh__D011362 Practices, Corporate
% 215.36/215.54  |- mesh__dateRevised mesh__D011362 1994-05-05
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011362 2005
% 215.36/215.54  |- skos__historyNote mesh__D011362 Professional Practice %28%1968-1978%29%
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011362 2002
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D011362 1997
% 215.36/215.54  |- skos__broader mesh__D011362smesh__D011364
% 215.36/215.54  |- skos__hiddenLabel mesh__D011362 Practice, Corporate
% 215.36/215.54  |- skos__hiddenLabel mesh__D011362 Corporation, Professional
% 215.36/215.54  |- skos__hiddenLabel mesh__D005325 Maturity, Fetal Organ
% 215.36/215.54  |- skos__historyNote mesh__D005325 Fetus %28%1966-1980%29%
% 215.36/215.54  |- skos__historyNote mesh__D005325
% 215.36/215.54       Respiratory Distress Syndrome %28%1966-1980%29%
% 215.36/215.54  |- skos__broader mesh__D005325smesh__D047109
% 215.36/215.54  |- skos__broader mesh__D005325smesh__D038081
% 215.36/215.54  |- mesh__publicMeSHNote mesh__D005325 81   
% 215.36/215.54  |- rdf__type mesh__D005325sskos__Concept
% 215.36/215.54  |- mesh__recordOriginator mesh__D005325 SMH
% 215.36/215.54  |- mesh__recordMaintainer mesh__D005325 lkt
% 215.36/215.54  |- mesh__dateCreated mesh__D005325 1980-05-13
% 215.36/215.54  |- mesh__dateEstablished mesh__D005325 1981-01-01
% 215.36/215.54  |- skos__prefLabel mesh__D005325 Fetal Organ Maturity
% 215.36/215.54  |- skos__hiddenLabel mesh__D005325 Maturity, Functional Fetal
% 215.36/215.54  |- mesh__recordAuthorizer mesh__D005325 sjn
% 215.36/215.54  |- skos__annotation mesh__D005325 coordinate with organ/embryol   
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D005325 2006
% 215.36/215.54  |- skos__hiddenLabel mesh__D005325 Organ Maturity, Fetal
% 215.36/215.54  |- mesh__dateRevised mesh__D005325 2004-07-07
% 215.36/215.54  |- skos__scopeNote mesh__D005325
% 215.36/215.54       Functional competence of specific organs or body systems of the FETUS in utero.%A%    
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D005325 2005
% 215.36/215.54  |- skos__altLabel mesh__D005325 Fetal Maturity, Functional
% 215.36/215.54  |- mesh__historyNote mesh__D005325 81   
% 215.36/215.54  |- skos__hiddenLabel mesh__D005325 Functional Fetal Maturity
% 215.36/215.54  |- skos__historyNote mesh__D005325 Amniotic Fluid %28%1966-1980%29%
% 215.36/215.54  |- skos__broader mesh__D029773smesh__D019662
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D029773 2006
% 215.36/215.54  |- mesh__publicMeSHNote mesh__D029773 2002   
% 215.36/215.54  |- skos__annotation mesh__D029773
% 215.36/215.54       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.36/215.54  |- skos__scopeNote mesh__D029773
% 215.36/215.54       A plant genus of the family CUCURBITACEAE known for the edible fruit.%A%    
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D029773 2005
% 215.36/215.54  |- rdf__type mesh__D029773sskos__Concept
% 215.36/215.54  |- mesh__activeMeSHYear mesh__D029773 2004
% 215.36/215.55  |- skos__prefLabel mesh__D029773 Citrullus
% 215.36/215.55  |- mesh__historyNote mesh__D029773 2002   
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D029773 2003
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D029773 2002
% 215.36/215.55  |- mesh__dateCreated mesh__D029773 2001-07-25
% 215.36/215.55  |- mesh__dateEstablished mesh__D029773 2002-01-01
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009716 2006
% 215.36/215.55  |- skos__scopeNote mesh__D009716
% 215.36/215.55       Computer-assisted study of methods for obtaining useful quantitative solutions to problems that have been expressed mathematically.%A%    
% 215.36/215.55  |- mesh__recordOriginator mesh__D009716 EC
% 215.36/215.55  |- skos__altLabel mesh__D009716 Computer-Assisted Numerical Analysis
% 215.36/215.55  |- mesh__dateEstablished mesh__D009716 1991-01-01
% 215.36/215.55  |- mesh__recordAuthorizer mesh__D009716 sjn
% 215.36/215.55  |- mesh__historyNote mesh__D009716
% 215.36/215.55       91%28%87%29%; was see under MATHEMATICAL COMPUTING 1987-90   
% 215.36/215.55  |- skos__hiddenLabel mesh__D009716 Analyses, Computer-Assisted Numerical
% 215.36/215.55  |- rdf__type mesh__D009716sskos__Concept
% 215.36/215.55  |- skos__hiddenLabel mesh__D009716 Numerical Analyses, Computer-Assisted
% 215.36/215.55  |- skos__altLabel mesh__D009716 Analysis, Computer-Assisted Numerical
% 215.36/215.55  |- skos__hiddenLabel mesh__D009716 Computer-Assisted Numerical Analyses
% 215.36/215.55  |- mesh__dateCreated mesh__D009716 1986-06-18
% 215.36/215.55  |- mesh__dateRevised mesh__D009716 2004-07-07
% 215.36/215.55  |- skos__hiddenLabel mesh__D009716 Analysis, Computer Assisted Numerical
% 215.36/215.55  |- skos__broader mesh__D009716smesh__D008432
% 215.36/215.55  |- mesh__publicMeSHNote mesh__D009716
% 215.36/215.55       91; was see under MATHEMATICAL COMPUTING 1987-90   
% 215.36/215.55  |- skos__annotation mesh__D009716 IM   
% 215.36/215.55  |- skos__hiddenLabel mesh__D009716 Computer Assisted Numerical Analysis
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009716 2005
% 215.36/215.55  |- mesh__recordMaintainer mesh__D009716 jls
% 215.36/215.55  |- skos__prefLabel mesh__D009716 Numerical Analysis, Computer-Assisted
% 215.36/215.55  |- skos__hiddenLabel mesh__D009716 Numerical Analysis, Computer Assisted
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001733 2006
% 215.36/215.55  |- skos__annotation mesh__D001733
% 215.36/215.55       snake bites = SNAKE BITES; spider bites = ARACHNIDISM; tick bites = TICKS %28%IM%29% + BITES AND STINGS %28%IM%29% %28%not TICK TOXICOSES unless paralysis or toxicosis results%29%; coord IM with biter %28%IM%29%; INSECT BITES AND STINGS is also available; DF: BITES%A%  
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001733 2003
% 215.36/215.55  |- rdf__type mesh__D001733sskos__Concept
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001733 2000
% 215.36/215.55  |- skos__broader mesh__D001733smesh__D011041
% 215.36/215.55  |- skos__prefLabel mesh__D001733 Bites and Stings
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001733 1994
% 215.36/215.55  |- mesh__dateCreated mesh__D001733 1999-01-01
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001733 2004
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001733 2001
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001733 1998
% 215.36/215.55  |- mesh__recordAuthorizer mesh__D001733 PLS
% 215.36/215.55  |- mesh__dateRevised mesh__D001733 1991-06-13
% 215.36/215.55  |- skos__broader mesh__D001733smesh__D014947
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001733 1995
% 215.36/215.55  |- skos__altLabel mesh__D001733 Stings and Bites
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001733 1992
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001733 1999
% 215.36/215.55  |- skos__hiddenLabel mesh__D001733 Sting
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001733 1996
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001733 2005
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001733 1993
% 215.36/215.55  |- mesh__recordMaintainer mesh__D001733 TGC
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001733 2002
% 215.36/215.55  |- mesh__recordOriginator mesh__D001733 NLM
% 215.36/215.55  |- skos__hiddenLabel mesh__D001733 Bite
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001733 1997
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D020698 2000
% 215.36/215.55  |- skos__prefLabel mesh__D020698 Duodenoscopes
% 215.36/215.55  |- rdf__type mesh__D020698sskos__Concept
% 215.36/215.55  |- mesh__dateEstablished mesh__D020698 2000-01-01
% 215.36/215.55  |- skos__scopeNote mesh__D020698
% 215.36/215.55       Endoscopes for examining the interior of the duodenum.     
% 215.36/215.55  |- skos__broader mesh__D020698smesh__D020776
% 215.36/215.55  |- skos__hiddenLabel mesh__D020698 Duodenoscope
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D020698 2006
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D020698 2002
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D020698 2004
% 215.36/215.55  |- skos__historyNote mesh__D020698 Endoscopes %28%1998-1999%29%
% 215.36/215.55  |- mesh__publicMeSHNote mesh__D020698 2000   
% 215.36/215.55  |- skos__historyNote mesh__D020698
% 215.36/215.55       Duodenoscopy/instrumentation %28%1981-1999%29%
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D020698 2005
% 215.36/215.55  |- mesh__dateCreated mesh__D020698 1999-11-03
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D020698 2003
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D020698 2001
% 215.36/215.55  |- mesh__historyNote mesh__D020698 2000   
% 215.36/215.55  |- skos__broader mesh__D019346smesh__D000085
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D019346 2006
% 215.36/215.55  |- skos__historyNote mesh__D019346 Acetic Acids %28%1981-1996%29%
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D019346 2002
% 215.36/215.55  |- rdf__type mesh__D019346sskos__Concept
% 215.36/215.55  |- mesh__onlineNote mesh__D019346
% 215.36/215.55       use ACETIC ACID %28%NM%29% to search SODIUM ACETATE 1981-96   
% 215.36/215.55  |- skos__hiddenLabel mesh__D019346 Anhydrous Sodium Acetate
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D019346 2005
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D019346 2001
% 215.36/215.55  |- skos__hiddenLabel mesh__D019346 Acetate, Sodium
% 215.36/215.55  |- skos__scopeNote mesh__D019346
% 215.36/215.55       The trihydrate sodium salt of acetic acid, which is used as a source of sodium ions in solutions for dialysis and as a systemic and urinary alkalizer, diuretic, and expectorant.%A%    
% 215.36/215.55  |- mesh__historyNote mesh__D019346
% 215.36/215.55       97; SODIUM ACETATE was SY to ACETIC ACID GLACIAL %28%NM%29% 1981-96%A%  
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D019346 2004
% 215.36/215.55  |- mesh__recordOriginator mesh__D019346 ADP
% 215.36/215.55  |- mesh__recordMaintainer mesh__D019346 CCR
% 215.36/215.55  |- mesh__publicMeSHNote mesh__D019346
% 215.36/215.55       97; SODIUM ACETATE was indexed under ACETIC ACIDS 1981-96%A%  
% 215.36/215.55  |- mesh__dateRevised mesh__D019346 2000-06-21
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D019346 2003
% 215.36/215.55  |- mesh__dateEstablished mesh__D019346 1997-01-01
% 215.36/215.55  |- skos__prefLabel mesh__D019346 Sodium Acetate
% 215.36/215.55  |- mesh__dateCreated mesh__D019346 1996-06-10
% 215.36/215.55  |- mesh__recordAuthorizer mesh__D019346 sjn
% 215.36/215.55  |- skos__historyNote mesh__D011363 Alcoholism %28%1966-1985%29%
% 215.36/215.55  |- skos__hiddenLabel mesh__D011363 Professional Impairments
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011363 1999
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011363 2004
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011363 2002
% 215.36/215.55  |- skos__hiddenLabel mesh__D011363 Impairments, Professional
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011363 1995
% 215.36/215.55  |- mesh__recordMaintainer mesh__D011363 TGC
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011363 1998
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011363 2003
% 215.36/215.55  |- mesh__historyNote mesh__D011363 86   
% 215.36/215.55  |- mesh__publicMeSHNote mesh__D011363 86   
% 215.36/215.55  |- mesh__recordAuthorizer mesh__D011363 PLS
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011363 2006
% 215.36/215.55  |- mesh__dateRevised mesh__D011363 1992-05-18
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011363 1994
% 215.36/215.55  |- mesh__dateCreated mesh__D011363 1985-03-15
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011363 2001
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011363 2005
% 215.36/215.55  |- skos__hiddenLabel mesh__D011363 Impairment, Professional
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011363 1997
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011363 2000
% 215.36/215.55  |- skos__prefLabel mesh__D011363 Professional Impairment
% 215.36/215.55  |- mesh__recordOriginator mesh__D011363 EC
% 215.36/215.55  |- rdf__type mesh__D011363sskos__Concept
% 215.36/215.55  |- skos__annotation mesh__D011363
% 215.36/215.55       for impairment see note on PHYSICIAN IMPAIRMENT; coord IM with specific impairment %28%IM%29% + specific profession %28%IM%29%%A%  
% 215.36/215.55  |- skos__historyNote mesh__D011363 Substance Dependence %28%1981-1985%29%
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011363 1993
% 215.36/215.55  |- skos__scopeNote mesh__D011363
% 215.36/215.55       The inability of a health professional to provide proper professional care of patients due to his or her physical and/or mental disability.%A%    
% 215.36/215.55  |- mesh__dateEstablished mesh__D011363 1986-01-01
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011363 1996
% 215.36/215.55  |- skos__broader mesh__D011363smesh__D008318
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D005326 1997
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D005326 1999
% 215.36/215.55  |- skos__broader mesh__D005326smesh__D011506
% 215.36/215.55  |- skos__hiddenLabel mesh__D005326 Globulins, Fetal
% 215.36/215.55  |- rdf__type mesh__D005326sskos__Concept
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D005326 2002
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D005326 1996
% 215.36/215.55  |- mesh__recordOriginator mesh__D005326 NLM
% 215.36/215.55  |- skos__historyNote mesh__D005326 Alpha Globulins %28%1966-1969%29%
% 215.36/215.55  |- skos__prefLabel mesh__D005326 Fetal Proteins
% 215.36/215.55  |- mesh__publicMeSHNote mesh__D005326 84; was FETAL GLOBULINS 1970-83   
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D005326 1998
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D005326 2004
% 215.36/215.55  |- mesh__recordAuthorizer mesh__D005326 PLS
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D005326 2001
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D005326 2006
% 215.36/215.55  |- mesh__dateRevised mesh__D005326 1995-05-18
% 215.36/215.55  |- mesh__dateCreated mesh__D005326 1999-01-01
% 215.36/215.55  |- skos__hiddenLabel mesh__D005326 Proteins, Fetal
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D005326 2003
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D005326 2000
% 215.36/215.55  |- skos__historyNote mesh__D005326 Serum Globulins %28%1966-1969%29%
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D005326 2005
% 215.36/215.55  |- mesh__onlineNote mesh__D005326
% 215.36/215.55       use FETAL PROTEINS to search FETAL GLOBULINS 1970-83   
% 215.36/215.55  |- mesh__recordMaintainer mesh__D005326 KEV
% 215.36/215.55  |- mesh__historyNote mesh__D005326 84; was FETAL GLOBULINS 1970-83   
% 215.36/215.55  |- mesh__dateEstablished mesh__D005326 1970-01-01
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D029774 2005
% 215.36/215.55  |- rdf__type mesh__D029774sskos__Concept
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D029774 2004
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D029774 2002
% 215.36/215.55  |- mesh__dateCreated mesh__D029774 2001-07-25
% 215.36/215.55  |- skos__broader mesh__D029774smesh__D019662
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D029774 2003
% 215.36/215.55  |- mesh__historyNote mesh__D029774 2002   
% 215.36/215.55  |- skos__prefLabel mesh__D029774 Gynostemma
% 215.36/215.55  |- skos__scopeNote mesh__D029774
% 215.36/215.55       A plant genus of the family CUCURBITACEAE. It is a source of gypenosides and triterpenoid SAPONINS.%A%    
% 215.36/215.55  |- mesh__dateEstablished mesh__D029774 2002-01-01
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D029774 2006
% 215.36/215.55  |- mesh__publicMeSHNote mesh__D029774 2002   
% 215.36/215.55  |- skos__annotation mesh__D029774
% 215.36/215.55       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.36/215.55  |- mesh__dateCreated mesh__D015754 1989-05-25
% 215.36/215.55  |- skos__annotation mesh__D015754
% 215.36/215.55       nef stands for %22%NEgative Factor%22%; coord IM with specific HIV /genet %28%IM%29%%A%  
% 215.36/215.55  |- skos__hiddenLabel mesh__D015754 Gene, nef
% 215.36/215.55  |- skos__hiddenLabel mesh__D015754 HIV-3%27%-orf Gene
% 215.36/215.55  |- mesh__recordAuthorizer mesh__D015754 sjn
% 215.36/215.55  |- skos__hiddenLabel mesh__D015754 HIV 3%27% orf Genes
% 215.36/215.55  |- mesh__recordMaintainer mesh__D015754 nns
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D015754 2006
% 215.36/215.55  |- skos__altLabel mesh__D015754 nef Genes
% 215.36/215.55  |- skos__broader mesh__D015754smesh__D005814
% 215.36/215.55  |- skos__broader mesh__D015754smesh__D005809
% 215.36/215.55  |- mesh__dateRevised mesh__D015754 2005-06-30
% 215.36/215.55  |- skos__hiddenLabel mesh__D015754 Gene, HIV-3%27%-orf
% 215.36/215.55  |- mesh__publicMeSHNote mesh__D015754
% 215.36/215.55       91; was see under GENES, VIRAL 1990   
% 215.36/215.55  |- mesh__historyNote mesh__D015754
% 215.36/215.55       91%28%90%29%; was see under GENES, VIRAL 1990   
% 215.36/215.55  |- skos__altLabel mesh__D015754 HIV-3%27%-orf Genes
% 215.36/215.55  |- skos__hiddenLabel mesh__D015754 nef Gene
% 215.36/215.55  |- skos__hiddenLabel mesh__D015754 Genes, HIV-3%27%-orf
% 215.36/215.55  |- skos__scopeNote mesh__D015754
% 215.36/215.55       DNA sequences that form the coding region for a protein that down-regulates the expression of human immunodeficiency virus %28%HIV%29%. nef is short for negative factor.%A%    
% 215.36/215.55  |- rdf__type mesh__D015754sskos__Concept
% 215.36/215.55  |- mesh__dateEstablished mesh__D015754 1991-01-01
% 215.36/215.55  |- skos__prefLabel mesh__D015754 Genes, nef
% 215.36/215.55  |- mesh__recordOriginator mesh__D015754 AGS
% 215.36/215.55  |- skos__historyNote mesh__D015754 Genes, Viral %28%1987-1989%29%
% 215.36/215.55  |- skos__prefLabel mesh__D009717 Numismatics
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009717 2003
% 215.36/215.55  |- skos__annotation mesh__D009717
% 215.36/215.55       SPEC: SPEC qualif; note X ref MEDALS: do not confuse a medal as a piece of metal %28%usually in the form of a coin%29% with a medal awarded for an accomplishment %28% = AWARDS AND PRIZES%29%; coin collecting as a hobby: coord IM with HOBBIES %28%IM%29%; indexing policy: TN 245%A%  
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009717 2006
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009717 1999
% 215.36/215.55  |- rdf__type mesh__D009717sskos__Concept
% 215.36/215.55  |- mesh__dateCreated mesh__D009717 1999-01-01
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009717 2004
% 215.36/215.55  |- mesh__historyNote mesh__D009717
% 215.36/215.55       was in Cat I 1975-82, was in Cat E 1963-74   
% 215.36/215.55  |- skos__scopeNote mesh__D009717
% 215.36/215.55       Study of coins, tokens, medals, etc. However, it usually refers to medals pertaining to the history of medicine.%A%    
% 215.36/215.55  |- skos__hiddenLabel mesh__D009717 Medal
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009717 2000
% 215.36/215.55  |- mesh__recordMaintainer mesh__D009717 TGC
% 215.36/215.55  |- skos__broader mesh__D009717smesh__D001154
% 215.36/215.55  |- mesh__recordOriginator mesh__D009717 NLM
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009717 2001
% 215.36/215.55  |- mesh__recordAuthorizer mesh__D009717 SJN
% 215.36/215.55  |- skos__hiddenLabel mesh__D009717 Coin
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009717 2002
% 215.36/215.55  |- mesh__dateRevised mesh__D009717 1997-06-20
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009717 2005
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009717 1998
% 215.36/215.55  |- skos__hiddenLabel mesh__D001734 Human Bites
% 215.36/215.55  |- mesh__publicMeSHNote mesh__D001734
% 215.36/215.55       91; was see under BITES AND STINGS 1972-90   
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001734 2006
% 215.36/215.55  |- mesh__recordOriginator mesh__D001734 NLM
% 215.36/215.55  |- rdf__type mesh__D001734sskos__Concept
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001734 2005
% 215.36/215.55  |- skos__historyNote mesh__D001734 Bites and Stings %28%1966-1971%29%
% 215.36/215.55  |- skos__prefLabel mesh__D001734 Bites, Human
% 215.36/215.55  |- mesh__historyNote mesh__D001734
% 215.36/215.55       91%28%72%29%; was see under BITES AND STINGS 1972-90   
% 215.36/215.55  |- skos__annotation mesh__D001734
% 215.36/215.55        the human is biting, not being bitten; don%27%t forget to check tag HUMANS%A%  
% 215.36/215.55  |- skos__broader mesh__D001734smesh__D001733
% 215.36/215.55  |- mesh__recordAuthorizer mesh__D001734 sjn
% 215.36/215.55  |- mesh__dateEstablished mesh__D001734 1991-01-01
% 215.36/215.55  |- mesh__dateRevised mesh__D001734 2004-07-13
% 215.36/215.55  |- mesh__dateCreated mesh__D001734 1999-01-01
% 215.36/215.55  |- skos__hiddenLabel mesh__D001734 Human Bite
% 215.36/215.55  |- mesh__recordMaintainer mesh__D001734 sjn
% 215.36/215.55  |- skos__hiddenLabel mesh__D001734 Bite, Human
% 215.36/215.55  |- skos__scopeNote mesh__D001734 Bites inflicted by humans.     
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D020699 2005
% 215.36/215.55  |- rdf__type mesh__D020699sskos__Concept
% 215.36/215.55  |- skos__scopeNote mesh__D020699
% 215.36/215.55       Endoscopes used for examining the interior of the stomach.%A%    
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D020699 2001
% 215.36/215.55  |- mesh__dateCreated mesh__D020699 1999-11-03
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D020699 2003
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D020699 2006
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D020699 2002
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D020699 2004
% 215.36/215.55  |- skos__prefLabel mesh__D020699 Gastroscopes
% 215.36/215.55  |- mesh__dateEstablished mesh__D020699 2000-01-01
% 215.36/215.55  |- skos__broader mesh__D020699smesh__D020776
% 215.36/215.55  |- mesh__historyNote mesh__D020699 2000; use ENDOSCOPES 1998-1999   
% 215.36/215.55  |- skos__historyNote mesh__D020699
% 215.36/215.55       Gastroscopy/instrumentation %28%1966-1999%29%
% 215.36/215.55  |- skos__historyNote mesh__D020699 Endoscopes %28%1998-1999%29%
% 215.36/215.55  |- mesh__publicMeSHNote mesh__D020699 2000; see ENDOSCOPES 1998-1999   
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D020699 2000
% 215.36/215.55  |- skos__hiddenLabel mesh__D020699 Gastroscope
% 215.36/215.55  |- mesh__dateCreated mesh__D019347 1996-06-10
% 215.36/215.55  |- mesh__publicMeSHNote mesh__D019347
% 215.36/215.55       97; POTASSIUM ACETATE was indexed under ACETIC ACIDS 1981-96%A%  
% 215.36/215.55  |- skos__historyNote mesh__D019347 Acetic Acids %28%1981-1996%29%
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D019347 2004
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D019347 2002
% 215.36/215.55  |- mesh__historyNote mesh__D019347
% 215.36/215.55       97; POTASSIUM ACETATE was SY to ACETIC ACID GLACIAL %28%NM%29% 1981-96%A%  
% 215.36/215.55  |- mesh__onlineNote mesh__D019347
% 215.36/215.55       use ACETIC ACID %28%NM%29% to search POTASSIUM ACETATE 1981-96   
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D019347 2003
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D019347 2001
% 215.36/215.55  |- skos__hiddenLabel mesh__D019347 Acetate, Potassium
% 215.36/215.55  |- skos__scopeNote mesh__D019347
% 215.36/215.55       An electrolyte replenisher, as well as a urinary and systemic alkalizer, which can be administered orally or by intravenous infusion. Formerly, it was used as a diuretic and expectorant. %28%From Dorland, 28th ed%29%%A%    
% 215.36/215.55  |- mesh__recordAuthorizer mesh__D019347 SJN
% 215.36/215.55  |- mesh__recordOriginator mesh__D019347 ADP
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D019347 2000
% 215.36/215.55  |- skos__prefLabel mesh__D019347 Potassium Acetate
% 215.36/215.55  |- skos__broader mesh__D019347smesh__D000085
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D019347 2006
% 215.36/215.55  |- mesh__dateEstablished mesh__D019347 1997-01-01
% 215.36/215.55  |- rdf__type mesh__D019347sskos__Concept
% 215.36/215.55  |- mesh__recordMaintainer mesh__D019347 ADP
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D019347 1999
% 215.36/215.55  |- mesh__dateRevised mesh__D019347 1998-06-10
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D019347 2005
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011364 1999
% 215.36/215.55  |- mesh__recordMaintainer mesh__D011364 TGC
% 215.36/215.55  |- mesh__recordOriginator mesh__D011364 NLM
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011364 2002
% 215.36/215.55  |- skos__broader mesh__D011364smesh__D009934
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011364 1995
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011364 2005
% 215.36/215.55  |- mesh__publicMeSHNote mesh__D011364 68   
% 215.36/215.55  |- skos__historyNote mesh__D011364 Office Management %28%1966-1967%29%
% 215.36/215.55  |- mesh__historyNote mesh__D011364 68   
% 215.36/215.55  |- skos__hiddenLabel mesh__D011364 Practices, Professional
% 215.36/215.55  |- mesh__recordAuthorizer mesh__D011364 PLS
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011364 2006
% 215.36/215.55  |- mesh__dateCreated mesh__D011364 1999-01-01
% 215.36/215.55  |- mesh__dateEstablished mesh__D011364 1968-01-01
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011364 1996
% 215.36/215.55  |- mesh__dateRevised mesh__D011364 1994-05-05
% 215.36/215.55  |- skos__related mesh__D011364smesh__D011216
% 215.36/215.55  |- skos__hiddenLabel mesh__D011364 Practice, Professional
% 215.36/215.55  |- skos__hiddenLabel mesh__D011364 Professional Practices
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011364 1997
% 215.36/215.55  |- skos__annotation mesh__D011364
% 215.36/215.55       /econ permitted but consider many specific economics terms available; do not confuse with PHYSICIAN%27%S PRACTICE PATTERNS: see note there%A%  
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011364 2000
% 215.36/215.55  |- rdf__type mesh__D011364sskos__Concept
% 215.36/215.55  |- skos__scopeNote mesh__D011364
% 215.36/215.55       The use of one%27%s knowledge in a particular profession. It includes, in the case of the field of biomedicine, professional activities related to health care and the actual performance of the duties related to the provision of health care.%A%    
% 215.36/215.55  |- skos__related mesh__D011364smesh__D011215
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011364 1998
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011364 2003
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011364 2001
% 215.36/215.55  |- skos__prefLabel mesh__D011364 Professional Practice
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D011364 2004
% 215.36/215.55  |- skos__scopeNote mesh__D038501
% 215.36/215.55       A group of telomere associated proteins that interact with TRF1 PROTEIN, contain ANKYRIN REPEATS and have poly%28%ADP-ribose%29% polymerase activity.%A%    
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D038501 2005
% 215.36/215.55  |- mesh__dateEstablished mesh__D038501 2003-01-01
% 215.36/215.55  |- mesh__historyNote mesh__D038501 2003   
% 215.36/215.55  |- mesh__dateRevised mesh__D038501 2003-07-09
% 215.36/215.55  |- mesh__dateCreated mesh__D038501 2002-07-03
% 215.36/215.55  |- skos__broader mesh__D038501smesh__D011065
% 215.36/215.55  |- rdf__type mesh__D038501sskos__Concept
% 215.36/215.55  |- mesh__publicMeSHNote mesh__D038501 2003   
% 215.36/215.55  |- skos__altLabel mesh__D038501
% 215.36/215.55       TRF-1 Interacting, Ankyrin-Related, ADP-Ribose Polymerases
% 215.36/215.55  |- skos__prefLabel mesh__D038501 Tankyrases
% 215.36/215.55  |- skos__historyNote mesh__D038501
% 215.36/215.55       Poly%28%ADP-ribose%29% Polymerases %28%1998-2002%29%
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D038501 2004
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D038501 2006
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D005327 2006
% 215.36/215.55  |- skos__related mesh__D005327smesh__D020964
% 215.36/215.55  |- mesh__recordOriginator mesh__D005327 CAB
% 215.36/215.55  |- mesh__recordAuthorizer mesh__D005327 sjn
% 215.36/215.55  |- skos__broader mesh__D005327smesh__D005313
% 215.36/215.55  |- mesh__dateCreated mesh__D005327 1975-07-25
% 215.36/215.55  |- skos__hiddenLabel mesh__D005327 Fetal Resorptions
% 215.36/215.55  |- skos__scopeNote mesh__D005327
% 215.36/215.55       The disintegration and assimilation of the dead FETUS in the UTERUS at any stage after the completion of organogenesis which, in humans, is after the 9th week of GESTATION. It does not include embryo resorption %28%see EMBRYO LOSS%29%.%A%    
% 215.36/215.55  |- skos__hiddenLabel mesh__D005327 Resorption, Fetal
% 215.36/215.55  |- skos__prefLabel mesh__D005327 Fetal Resorption
% 215.36/215.55  |- mesh__dateEstablished mesh__D005327 1991-01-01
% 215.36/215.55  |- mesh__dateRevised mesh__D005327 2005-06-30
% 215.36/215.55  |- mesh__historyNote mesh__D005327
% 215.36/215.55       91%28%76%29%; was see under FETAL DEATH 1976-90   
% 215.36/215.55  |- mesh__publicMeSHNote mesh__D005327
% 215.36/215.55       91; was see under FETAL DEATH 1976-90   
% 215.36/215.55  |- skos__historyNote mesh__D005327 Fetal Death %28%1966-1975%29%
% 215.36/215.55  |- skos__hiddenLabel mesh__D005327 Resorptions, Fetal
% 215.36/215.55  |- rdf__type mesh__D005327sskos__Concept
% 215.36/215.55  |- mesh__recordMaintainer mesh__D005327 lkt
% 215.36/215.55  |- skos__annotation mesh__D029775
% 215.36/215.55       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.36/215.55  |- mesh__historyNote mesh__D029775 2002   
% 215.36/215.55  |- rdf__type mesh__D029775sskos__Concept
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D029775 2004
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D029775 2002
% 215.36/215.55  |- mesh__dateCreated mesh__D029775 2001-07-25
% 215.36/215.55  |- mesh__dateEstablished mesh__D029775 2002-01-01
% 215.36/215.55  |- skos__prefLabel mesh__D029775 Momordica
% 215.36/215.55  |- skos__scopeNote mesh__D029775
% 215.36/215.55       A plant genus of the family CUCURBITACEAE.  It is a source of momordin.%A%    
% 215.36/215.55  |- skos__broader mesh__D029775smesh__D019662
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D029775 2005
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D029775 2003
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D029775 2006
% 215.36/215.55  |- mesh__publicMeSHNote mesh__D029775 2002   
% 215.36/215.55  |- mesh__recordAuthorizer mesh__D009718 ags
% 215.36/215.55  |- mesh__dateRevised mesh__D009718 1999-12-16
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009718 2004
% 215.36/215.55  |- skos__prefLabel mesh__D009718 Nurse Administrators
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009718 1997
% 215.36/215.55  |- skos__scopeNote mesh__D009718
% 215.36/215.55       Nurses professionally qualified in administration.     
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009718 2006
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009718 2003
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009718 1996
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009718 1999
% 215.36/215.55  |- mesh__recordMaintainer mesh__D009718 ags
% 215.36/215.55  |- skos__hiddenLabel mesh__D009718 Nurse Administrator
% 215.36/215.55  |- mesh__dateEstablished mesh__D009718 1991-01-01
% 215.36/215.55  |- rdf__type mesh__D009718sskos__Concept
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009718 2000A
% 215.36/215.55  |- mesh__publicMeSHNote mesh__D009718
% 215.36/215.55       91; was see under ADMINISTRATIVE PERSONNEL 1982-90   
% 215.36/215.55  |- skos__historyNote mesh__D009718
% 215.36/215.55       Nursing Service, Hospital %28%1968-1977%29%/organization %26% administration %28%1978-1981%29%
% 215.36/215.55  |- skos__hiddenLabel mesh__D009718 Administrators, Nurse
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009718 2005
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009718 2002
% 215.36/215.55  |- mesh__recordOriginator mesh__D009718 EC
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009718 1998
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009718 1993
% 215.36/215.55  |- skos__broader mesh__D009718smesh__D009726
% 215.36/215.55  |- skos__annotation mesh__D009718
% 215.36/215.55       do not confuse with HEAD NURSES see NURSING, SUPERVISORY; in British jrnls %22%matron%22% goes here but nursing %22%sisters%22% go under NURSING, SUPERVISORY%A%  
% 215.36/215.55  |- mesh__historyNote mesh__D009718
% 215.36/215.55       91%28%82%29%; was see under ADMINISTRATIVE PERSONNEL 1982-90   
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009718 2001
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009718 1995
% 215.36/215.55  |- skos__historyNote mesh__D009718
% 215.36/215.55       Administrative Personnel %28%1968-1981%29%
% 215.36/215.55  |- skos__broader mesh__D009718smesh__D000288
% 215.36/215.55  |- mesh__dateCreated mesh__D009718 1981-03-02
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009718 2000
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D009718 1994
% 215.36/215.55  |- skos__hiddenLabel mesh__D009718 Administrator, Nurse
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001735 2004
% 215.36/215.55  |- mesh__recordMaintainer mesh__D001735 CCR
% 215.36/215.55  |- mesh__dateRevised mesh__D001735 2000-06-22
% 215.36/215.55  |- skos__historyNote mesh__D001735 Phenols %28%1971-1974%29%
% 215.36/215.55  |- rdf__type mesh__D001735sskos__Concept
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001735 2005
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001735 2001
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001735 2003
% 215.36/215.55  |- skos__prefLabel mesh__D001735 Bithionol
% 215.36/215.55  |- mesh__recordOriginator mesh__D001735 SH
% 215.36/215.55  |- skos__scopeNote mesh__D001735
% 215.36/215.55       Halogenated anti-infective agent that is used against trematode and cestode infestations.%A%    
% 215.36/215.55  |- mesh__dateEstablished mesh__D001735 1991-01-01
% 215.36/215.55  |- mesh__historyNote mesh__D001735
% 215.36/215.55       91%28%75%29%; was see under PHENOLS 1975-90   
% 215.36/215.55  |- skos__historyNote mesh__D001735 Sulfides %28%1971-1974%29%
% 215.36/215.55  |- mesh__recordAuthorizer mesh__D001735 sjn
% 215.36/215.55  |- mesh__activeMeSHYear mesh__D001735 2002
% 215.36/215.55  |- skos__historyNote mesh__D001735 Chlorobenzenes %28%1974%29%
% 215.36/215.55  |- mesh__dateCreated mesh__D001735 1974-11-19
% 215.36/215.56  |- mesh__publicMeSHNote mesh__D001735 91; was see under PHENOLS 1975-90   
% 215.36/215.56  |- skos__broader mesh__D001735smesh__D010636
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D001735 2006
% 215.36/215.56  |- mesh__dateRevised mesh__D006420 1995-05-19
% 215.36/215.56  |- skos__historyNote mesh__D006420 Heme %28%1966-1972%29%
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D006420 2005
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D006420 2004
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D006420 2001
% 215.36/215.56  |- mesh__publicMeSHNote mesh__D006420 73   
% 215.36/215.56  |- mesh__recordOriginator mesh__D006420 NLM
% 215.36/215.56  |- skos__altLabel mesh__D006420 Heme Protein
% 215.36/215.56  |- skos__altLabel mesh__D006420 Heme Proteins
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D006420 2003
% 215.36/215.56  |- skos__prefLabel mesh__D006420 Hemeproteins
% 215.36/215.56  |- mesh__historyNote mesh__D006420 73   
% 215.36/215.56  |- mesh__dateCreated mesh__D006420 1999-01-01
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D006420 2000
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D006420 1999
% 215.36/215.56  |- rdf__type mesh__D006420sskos__Concept
% 215.36/215.56  |- mesh__recordMaintainer mesh__D006420 KEV
% 215.36/215.56  |- skos__hiddenLabel mesh__D006420 Protein, Heme
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D006420 1998
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D006420 1997
% 215.36/215.56  |- skos__historyNote mesh__D006420 Proteins %28%1966-1972%29%
% 215.36/215.56  |- skos__broader mesh__D006420smesh__D011506
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D006420 2002
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D006420 1996
% 215.36/215.56  |- skos__scopeNote mesh__D006420
% 215.36/215.56       Proteins that contain an iron-porphyrin, or heme, prosthetic group resembling that of hemoglobin. %28%From Lehninger, Principles of Biochemistry, 1982, p480%29%%A%    
% 215.36/215.56  |- skos__historyNote mesh__D006420 Blood Proteins %28%1966-1972%29%
% 215.36/215.56  |- mesh__dateEstablished mesh__D006420 1973-01-01
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D006420 2006
% 215.36/215.56  |- mesh__recordAuthorizer mesh__D006420 PLS
% 215.36/215.56  |- skos__hiddenLabel mesh__D006420 Proteins, Heme
% 215.36/215.56  |- mesh__publicMeSHNote mesh__D019348 97   
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D019348 2003
% 215.36/215.56  |- skos__scopeNote mesh__D019348
% 215.36/215.56       One of the principal schools of medical philosophy in ancient Greece and Rome. It developed in Alexandria between 270 and 220 B.C., the only one to have any success in reviving the essentials of the Hippocratic concept. The Empiricists declared that the search for ultimate causes of phenomena was vain, but they were active in endeavoring to discover immediate causes. The %22%tripod of the Empirics%22% was their own chance observations %28%experience%29%, learning obtained from contemporaries and predecessors %28%experience of others%29%, and, in the case of new diseases, the formation of conclusions from other diseases which they resembled %28%analogy%29%. Empiricism enjoyed sporadic continuing popularity in later centuries up to the nineteenth. %28%From Castiglioni, A History of Medicine, 2d ed, p186; Dr. James H. Cassedy, NLM History of Medicine Division%29%%A%    
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D019348 2004
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D019348 2002
% 215.36/215.56  |- mesh__dateEstablished mesh__D019348 1997-01-01
% 215.36/215.56  |- mesh__dateCreated mesh__D019348 1996-06-10
% 215.36/215.56  |- mesh__recordAuthorizer mesh__D019348 sjn
% 215.36/215.56  |- skos__broader mesh__D019348smesh__D010686
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D019348 2005
% 215.36/215.56  |- mesh__dateRevised mesh__D019348 1999-11-08
% 215.36/215.56  |- mesh__recordMaintainer mesh__D019348 jls
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D019348 2000
% 215.36/215.56  |- skos__prefLabel mesh__D019348 Empiricism
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D019348 2006
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D019348 2001
% 215.36/215.56  |- rdf__type mesh__D019348sskos__Concept
% 215.36/215.56  |- mesh__recordOriginator mesh__D019348 TGC
% 215.36/215.56  |- mesh__historyNote mesh__D019348 97   
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011365 2005
% 215.36/215.56  |- skos__prefLabel mesh__D011365 Professional Practice Location
% 215.36/215.56  |- mesh__recordMaintainer mesh__D011365 TAP
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011365 2001
% 215.36/215.56  |- mesh__recordOriginator mesh__D011365 EC
% 215.36/215.56  |- skos__hiddenLabel mesh__D011365 Practice Locations, Professional
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011365 2006
% 215.36/215.56  |- skos__hiddenLabel mesh__D011365 Professional Practice Locations
% 215.36/215.56  |- mesh__publicMeSHNote mesh__D011365
% 215.36/215.56       91; was see under PROFESSIONAL PRACTICE 1983-90   
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011365 2002
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011365 1996
% 215.36/215.56  |- skos__hiddenLabel mesh__D011365 Locations, Professional Practice
% 215.36/215.56  |- mesh__dateEstablished mesh__D011365 1991-01-01
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011365 1997
% 215.36/215.56  |- mesh__recordAuthorizer mesh__D011365 PLS
% 215.36/215.56  |- skos__broader mesh__D011365smesh__D011364
% 215.36/215.56  |- skos__hiddenLabel mesh__D011365 Practice Location, Professional
% 215.36/215.56  |- rdf__type mesh__D011365sskos__Concept
% 215.36/215.56  |- mesh__dateCreated mesh__D011365 1982-04-27
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011365 1993
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011365 1998
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011365 2003
% 215.36/215.56  |- skos__hiddenLabel mesh__D011365 Location, Professional Practice
% 215.36/215.56  |- mesh__dateRevised mesh__D011365 1992-05-18
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011365 1994
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011365 1999
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011365 2004
% 215.36/215.56  |- mesh__historyNote mesh__D011365
% 215.36/215.56       91%28%83%29%; was see under PROFESSIONAL PRACTICE 1983-90   
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011365 1995
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011365 2000
% 215.36/215.56  |- skos__scopeNote mesh__D011365
% 215.36/215.56       Geographic area in which a professional person practices; includes primarily physicians and dentists.%A%    
% 215.36/215.56  |- mesh__dateEstablished mesh__D005328 1978-01-01
% 215.36/215.56  |- skos__scopeNote mesh__D005328
% 215.36/215.56       The potential of the FETUS to survive outside the UTERUS after birth, natural or induced. Fetal viability depends largely on the FETAL ORGAN MATURITY, and environmental conditions.%A%    
% 215.36/215.56  |- mesh__recordAuthorizer mesh__D005328 sjn
% 215.36/215.56  |- skos__historyNote mesh__D005328 Fetus %28%1966-1977%29%
% 215.36/215.56  |- mesh__dateCreated mesh__D005328 1977-04-22
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D005328 2006
% 215.36/215.56  |- mesh__dateRevised mesh__D005328 2004-07-07
% 215.36/215.56  |- skos__hiddenLabel mesh__D005328 Viability, Fetal
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D005328 2005
% 215.36/215.56  |- mesh__publicMeSHNote mesh__D005328 78   
% 215.36/215.56  |- skos__prefLabel mesh__D005328 Fetal Viability
% 215.36/215.56  |- skos__broader mesh__D005328smesh__D047109
% 215.36/215.56  |- mesh__historyNote mesh__D005328 78   
% 215.36/215.56  |- rdf__type mesh__D005328sskos__Concept
% 215.36/215.56  |- skos__related mesh__D005328smesh__D005313
% 215.36/215.56  |- mesh__recordOriginator mesh__D005328 EC
% 215.36/215.56  |- mesh__recordMaintainer mesh__D005328 lkt
% 215.36/215.56  |- skos__hiddenLabel mesh__D002030 Glands, Cowper%27%s
% 215.36/215.56  |- skos__hiddenLabel mesh__D002030 Cowper Glands
% 215.36/215.56  |- mesh__recordMaintainer mesh__D002030 KEV
% 215.36/215.56  |- skos__hiddenLabel mesh__D002030 Bulbourethral Gland
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D002030 2003
% 215.36/215.56  |- skos__hiddenLabel mesh__D002030 Glands, Bulbourethral
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D002030 2006
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D002030 2004
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D002030 2001
% 215.36/215.56  |- skos__broader mesh__D002030smesh__D005837
% 215.36/215.56  |- skos__altLabel mesh__D002030 Cowper%27%s Glands
% 215.36/215.56  |- skos__broader mesh__D002030smesh__D005088
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D002030 2002
% 215.36/215.56  |- skos__scopeNote mesh__D002030
% 215.36/215.56       Glands situated on each side of the prostate that secrete a fluid component of the seminal fluid into the urethra.%A%    
% 215.36/215.56  |- mesh__recordOriginator mesh__D002030 NLM
% 215.36/215.56  |- mesh__dateRevised mesh__D002030 1999-11-03
% 215.36/215.56  |- mesh__recordAuthorizer mesh__D002030 sjn
% 215.36/215.56  |- rdf__type mesh__D002030sskos__Concept
% 215.36/215.56  |- mesh__dateCreated mesh__D002030 1999-01-01
% 215.36/215.56  |- skos__prefLabel mesh__D002030 Bulbourethral Glands
% 215.36/215.56  |- skos__hiddenLabel mesh__D002030 Cowpers Glands
% 215.36/215.56  |- skos__hiddenLabel mesh__D002030 Gland, Bulbourethral
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D002030 2000
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D002030 2005
% 215.36/215.56  |- mesh__dateEstablished mesh__D029776 2002-01-01
% 215.36/215.56  |- skos__altLabel mesh__D029776 Loofah
% 215.36/215.56  |- skos__annotation mesh__D029776
% 215.36/215.56       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.36/215.56  |- mesh__historyNote mesh__D029776 2002   
% 215.36/215.56  |- skos__prefLabel mesh__D029776 Luffa
% 215.36/215.56  |- skos__scopeNote mesh__D029776
% 215.36/215.56       A plant genus of the family CUCURBITACEAE known for the fruit which is the source of the luffa sponge and the seeds which contain luffin.%A%    
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D029776 2002
% 215.36/215.56  |- mesh__dateCreated mesh__D029776 2001-07-25
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D029776 2005
% 215.36/215.56  |- skos__broader mesh__D029776smesh__D019662
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D029776 2003
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D029776 2006
% 215.36/215.56  |- mesh__publicMeSHNote mesh__D029776 2002   
% 215.36/215.56  |- skos__altLabel mesh__D029776 Momordica luffa
% 215.36/215.56  |- rdf__type mesh__D029776sskos__Concept
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D029776 2004
% 215.36/215.56  |- skos__hiddenLabel mesh__D015756 Gene, tat
% 215.36/215.56  |- skos__altLabel mesh__D015756 tat Genes
% 215.36/215.56  |- mesh__recordOriginator mesh__D015756 AGS
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D015756 2006
% 215.36/215.56  |- skos__scopeNote mesh__D015756
% 215.36/215.56       DNA sequences that form the coding region for the protein responsible for trans-activation of transcription %28%tat%29% in human immunodeficiency virus %28%HIV%29%.%A%    
% 215.36/215.56  |- skos__historyNote mesh__D015756 Genes, Viral %28%1988-1989%29%
% 215.36/215.56  |- mesh__recordAuthorizer mesh__D015756 sjn
% 215.36/215.56  |- skos__broader mesh__D015756smesh__D005809
% 215.36/215.56  |- mesh__recordMaintainer mesh__D015756 nns
% 215.36/215.56  |- skos__broader mesh__D015756smesh__D005814
% 215.36/215.56  |- rdf__type mesh__D015756sskos__Concept
% 215.36/215.56  |- mesh__dateEstablished mesh__D015756 1991-01-01
% 215.36/215.56  |- skos__annotation mesh__D015756
% 215.36/215.56       tat stands for %22%Trans-Activation of Transcription%22%; coord IM with HIV /genet %28%IM%29%%A%  
% 215.36/215.56  |- mesh__dateCreated mesh__D015756 1989-05-25
% 215.36/215.56  |- mesh__publicMeSHNote mesh__D015756
% 215.36/215.56       91; was see under GENES, VIRAL 1990   
% 215.36/215.56  |- skos__prefLabel mesh__D015756 Genes, tat
% 215.36/215.56  |- skos__hiddenLabel mesh__D015756 tat Gene
% 215.36/215.56  |- mesh__dateRevised mesh__D015756 2005-06-30
% 215.36/215.56  |- mesh__historyNote mesh__D015756
% 215.36/215.56       91%28%90%29%; was see under GENES, VIRAL 1990   
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D009719 2004
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D009719 1997
% 215.36/215.56  |- skos__scopeNote mesh__D009719
% 215.36/215.56       Professional nurses who have completed postgraduate training in the administration of anesthetics and who function under the responsibility of the operating surgeon.%A%    
% 215.36/215.56  |- skos__hiddenLabel mesh__D009719 Nurse Anesthetist
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D009719 2000
% 215.36/215.56  |- mesh__publicMeSHNote mesh__D009719
% 215.36/215.56       77; was NURSE ANESTHETIST see under NURSES 1975-76   
% 215.36/215.56  |- mesh__recordOriginator mesh__D009719 NLM
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D009719 2006
% 215.36/215.56  |- skos__prefLabel mesh__D009719 Nurse Anesthetists
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D009719 2003
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D009719 1996
% 215.36/215.56  |- mesh__dateCreated mesh__D009719 1974-11-11
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D009719 1999
% 215.36/215.56  |- mesh__recordAuthorizer mesh__D009719 PLS
% 215.36/215.56  |- rdf__type mesh__D009719sskos__Concept
% 215.36/215.56  |- mesh__dateEstablished mesh__D009719 1977-01-01
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D009719 2005
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D009719 1998
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D009719 1993
% 215.36/215.56  |- skos__broader mesh__D009719smesh__D009726
% 215.36/215.56  |- skos__hiddenLabel mesh__D009719 Anesthetists, Nurse
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D009719 1995
% 215.36/215.56  |- mesh__historyNote mesh__D009719
% 215.36/215.56       77; was NURSE ANESTHETIST see under NURSES 1975-76   
% 215.36/215.56  |- mesh__recordMaintainer mesh__D009719 TAP
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D009719 1994
% 215.36/215.56  |- mesh__dateRevised mesh__D009719 1992-05-15
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D009719 2002
% 215.36/215.56  |- mesh__onlineNote mesh__D009719
% 215.36/215.56       use NURSE ANESTHETISTS to search NURSE ANESTHETIST 1975-76%A%  
% 215.36/215.56  |- skos__hiddenLabel mesh__D009719 Anesthetist, Nurse
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D009719 2001
% 215.36/215.56  |- mesh__recordAuthorizer mesh__D001736 PLS
% 215.36/215.56  |- skos__historyNote mesh__D001736 Hydrazines %28%1966-1967%29%
% 215.36/215.56  |- mesh__dateCreated mesh__D001736 1999-01-01
% 215.36/215.56  |- mesh__recordMaintainer mesh__D001736 TAP
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D001736 1995
% 215.36/215.56  |- skos__prefLabel mesh__D001736 Biureas
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D001736 1993
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D001736 2002
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D001736 1999
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D001736 1997
% 215.36/215.56  |- mesh__dateEstablished mesh__D001736 1968-01-01
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D001736 1994
% 215.36/215.56  |- mesh__historyNote mesh__D001736 68   
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D001736 1998
% 215.36/215.56  |- mesh__publicMeSHNote mesh__D001736 68   
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D001736 1996
% 215.36/215.56  |- skos__broader mesh__D001736smesh__D014508
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D001736 2006
% 215.36/215.56  |- mesh__dateRevised mesh__D001736 1992-05-08
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D001736 2001
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D001736 2004
% 215.36/215.56  |- rdf__type mesh__D001736sskos__Concept
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D001736 2000
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D001736 2005
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D001736 2003
% 215.36/215.56  |- mesh__recordOriginator mesh__D001736 NLM
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D019349 2004
% 215.36/215.56  |- skos__hiddenLabel mesh__D019349 Infection, Roseolovirus
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D019349 2001
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D019349 1997
% 215.36/215.56  |- skos__altLabel mesh__D019349 Infections, Roseolovirus
% 215.36/215.56  |- mesh__publicMeSHNote mesh__D019349 97   
% 215.36/215.56  |- skos__hiddenLabel mesh__D019349 Roseolovirus Infection
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D019349 2005
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D019349 2002
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D019349 1998
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D019349 2006
% 215.36/215.56  |- mesh__dateEstablished mesh__D019349 1997-01-01
% 215.36/215.56  |- mesh__dateCreated mesh__D019349 1996-06-10
% 215.36/215.56  |- skos__prefLabel mesh__D019349 Roseolovirus Infections
% 215.36/215.56  |- skos__broader mesh__D019349smesh__D006566
% 215.36/215.56  |- rdf__type mesh__D019349sskos__Concept
% 215.36/215.56  |- mesh__historyNote mesh__D019349 97   
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D019349 1999
% 215.36/215.56  |- skos__annotation mesh__D019349
% 215.36/215.56       caused by a genus of the family Herpesviridae   
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D019349 2003
% 215.36/215.56  |- skos__scopeNote mesh__D019349
% 215.36/215.56       Infection with ROSEOLOVIRUS, the most common in humans being EXANTHEMA SUBITUM, a benign disease of infants and young children.%A%    
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D019349 2000
% 215.36/215.56  |- skos__hiddenLabel mesh__D011366 Professional Review Organization
% 215.36/215.56  |- skos__broader mesh__D011366smesh__D011785
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011366 1997
% 215.36/215.56  |- rdf__type mesh__D011366sskos__Concept
% 215.36/215.56  |- mesh__onlineNote mesh__D011366
% 215.36/215.56       use PROFESSIONAL REVIEW ORGANIZATIONS to search PROFESSIONAL STANDARDS REVIEW ORGANIZATIONS 1974-85 %26% PSRO 1973 %28%as Prov%29%%A%  
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011366 1998
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011366 2003
% 215.36/215.56  |- skos__altLabel mesh__D011366 Organizations, Professional Review
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011366 2000
% 215.36/215.56  |- skos__altLabel mesh__D011366 PRO Professional Review Organizations
% 215.36/215.56  |- skos__altLabel mesh__D011366 Organizations, Peer Review
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011366 1999
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011366 2004
% 215.36/215.56  |- skos__hiddenLabel mesh__D011366 Peer Review Organization
% 215.36/215.56  |- mesh__dateEstablished mesh__D011366 1974-01-01
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011366 2001
% 215.36/215.56  |- skos__hiddenLabel mesh__D011366 Organization, Peer Review
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011366 1995
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011366 2005
% 215.36/215.56  |- mesh__recordMaintainer mesh__D011366 TGC
% 215.36/215.56  |- mesh__recordOriginator mesh__D011366 NLM
% 215.36/215.56  |- skos__prefLabel mesh__D011366 Professional Review Organizations
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011366 2002
% 215.36/215.56  |- skos__broader mesh__D011366smesh__D011787
% 215.36/215.56  |- mesh__historyNote mesh__D011366
% 215.36/215.56       86; was PROFESSIONAL STANDARDS REVIEW ORGANIZATIONS 1974-85, was PSRO 1973 %28%Prov%29%%A%  
% 215.36/215.56  |- skos__scopeNote mesh__D011366
% 215.36/215.56       Organizations representing designated geographic areas which have contracts under the PRO program to review the medical necessity, appropriateness, quality, and cost-effectiveness of care received by Medicare beneficiaries. Peer Review Improvement Act, PL 97-248, 1982.%A%    
% 215.36/215.56  |- skos__hiddenLabel mesh__D011366 Organization, Professional Review
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011366 2006
% 215.36/215.56  |- mesh__dateCreated mesh__D011366 1999-01-01
% 215.36/215.56  |- mesh__publicMeSHNote mesh__D011366
% 215.36/215.56       86; was PROFESSIONAL STANDARDS REVIEW ORGANIZATIONS 1974-85%A%  
% 215.36/215.56  |- skos__annotation mesh__D011366 DF: note short X ref   
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D011366 1996
% 215.36/215.56  |- mesh__recordAuthorizer mesh__D011366 PLS
% 215.36/215.56  |- skos__altLabel mesh__D011366 Review Organizations, Professional
% 215.36/215.56  |- skos__altLabel mesh__D011366 PSRO
% 215.36/215.56  |- mesh__dateRevised mesh__D011366 1994-05-05
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D005329 2003
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D005329 2006
% 215.36/215.56  |- mesh__dateEstablished mesh__D005329 1991-01-01
% 215.36/215.56  |- skos__broader mesh__D005329smesh__D010262
% 215.36/215.56  |- skos__scopeNote mesh__D005329
% 215.36/215.56       A condition in which inanimate objects are utilized as a preferred or exclusive method of stimulating erotic arousal.%A%    
% 215.36/215.56  |- skos__annotation mesh__D005329
% 215.36/215.56       belief in religious or magic fetishes goes under RELIGION; SUPERSTITION %26% its indentions, ANTHROPOLOGY, CULTURAL or other pertinent term; DF: FETISHISM%A%  
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D005329 2005
% 215.36/215.56  |- mesh__recordMaintainer mesh__D005329 mdb
% 215.36/215.56  |- mesh__recordAuthorizer mesh__D005329 sjn
% 215.36/215.56  |- mesh__dateRevised mesh__D005329 2001-07-25
% 215.36/215.56  |- rdf__type mesh__D005329sskos__Concept
% 215.36/215.56  |- mesh__recordOriginator mesh__D005329 NLM
% 215.36/215.56  |- skos__prefLabel mesh__D005329 Fetishism %28%Psychiatric%29%
% 215.36/215.56  |- mesh__historyNote mesh__D005329
% 215.36/215.56       91%28%75%29%; was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1968-80%A%  
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D005329 2002
% 215.36/215.56  |- mesh__dateCreated mesh__D005329 1999-01-01
% 215.36/215.56  |- mesh__publicMeSHNote mesh__D005329
% 215.36/215.56       91; was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1968-80%A%  
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D005329 2004
% 215.36/215.56  |- skos__hiddenLabel mesh__D005329 Fetishisms %28%Psychiatric%29%
% 215.36/215.56  |- mesh__onlineNote mesh__D005329 search PARAPHILIAS 1968-74   
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D002031 1996
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D002031 1999
% 215.36/215.56  |- mesh__recordMaintainer mesh__D002031 PLS
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D002031 2004
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D002031 2000
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D002031 1997
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D002031 2001
% 215.36/215.56  |- rdf__type mesh__D002031sskos__Concept
% 215.36/215.56  |- mesh__recordAuthorizer mesh__D002031 PLS
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D002031 1994
% 215.36/215.56  |- skos__prefLabel mesh__D002031 Bulgaria
% 215.36/215.56  |- skos__annotation mesh__D002031
% 215.36/215.56       in translations of historical articles use spelling People%27%s Republic, not Peoples%27% nor Peoples%A%  
% 215.36/215.56  |- mesh__dateRevised mesh__D002031 1992-05-07
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D002031 2002
% 215.36/215.56  |- mesh__dateCreated mesh__D002031 1999-01-01
% 215.36/215.56  |- mesh__recordOriginator mesh__D002031 NLM
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D002031 2005
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D002031 1995
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D002031 1998
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D002031 2003
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D002031 1993
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D002031 2006
% 215.36/215.56  |- skos__broader mesh__D002031smesh__D005061
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D029777 2005
% 215.36/215.56  |- skos__altLabel mesh__D029777 Gourd, Bitter
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D029777 2006
% 215.36/215.56  |- mesh__publicMeSHNote mesh__D029777 2002   
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D029777 2003
% 215.36/215.56  |- skos__annotation mesh__D029777
% 215.36/215.56       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.36/215.56  |- skos__prefLabel mesh__D029777 Momordica charantia
% 215.36/215.56  |- skos__broader mesh__D029777smesh__D029775
% 215.36/215.56  |- skos__altLabel mesh__D029777 Bitter Gourd
% 215.36/215.56  |- rdf__type mesh__D029777sskos__Concept
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D029777 2004
% 215.36/215.56  |- mesh__historyNote mesh__D029777 2002   
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D029777 2002
% 215.36/215.56  |- mesh__dateEstablished mesh__D029777 2002-01-01
% 215.36/215.56  |- mesh__dateCreated mesh__D029777 2001-07-25
% 215.36/215.56  |- skos__altLabel mesh__D029777 Karela
% 215.36/215.56  |- skos__scopeNote mesh__D029777
% 215.36/215.56       A plant species of the family CUCURBITACEAE.  It is a source of ribosome-inactivating proteins and triterpene glycosides.%A%    
% 215.36/215.56  |- skos__altLabel mesh__D015757 art-trs Genes
% 215.36/215.56  |- skos__broader mesh__D015757smesh__D005809
% 215.36/215.56  |- skos__scopeNote mesh__D015757
% 215.36/215.56       DNA sequences that form the coding region for a protein that regulates the expression of the viral structural and regulatory proteins in human immunodeficiency virus %28%HIV%29%. rev is short for regulator of virion.%A%    
% 215.36/215.56  |- skos__hiddenLabel mesh__D015757 rev Gene
% 215.36/215.56  |- mesh__recordOriginator mesh__D015757 AGS
% 215.36/215.56  |- skos__historyNote mesh__D015757 Genes, Viral %28%1986-1989%29%
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D015757 2006
% 215.36/215.56  |- mesh__dateRevised mesh__D015757 2005-06-30
% 215.36/215.56  |- skos__annotation mesh__D015757
% 215.36/215.56       rev stands for %22%REgulator of Virion%22%; coord IM with specific HIV /genet %28%IM%29%%A%  
% 215.36/215.56  |- skos__hiddenLabel mesh__D015757 Gene, art-trs
% 215.36/215.56  |- skos__hiddenLabel mesh__D015757 art-trs Gene
% 215.36/215.56  |- mesh__dateCreated mesh__D015757 1989-05-25
% 215.36/215.56  |- skos__hiddenLabel mesh__D015757 Genes, art-trs
% 215.36/215.56  |- skos__altLabel mesh__D015757 rev Genes
% 215.36/215.56  |- skos__broader mesh__D015757smesh__D005814
% 215.36/215.56  |- skos__hiddenLabel mesh__D015757 Genes, trs-art
% 215.36/215.56  |- skos__hiddenLabel mesh__D015757 Gene, rev
% 215.36/215.56  |- skos__prefLabel mesh__D015757 Genes, rev
% 215.36/215.56  |- mesh__recordMaintainer mesh__D015757 nns
% 215.36/215.56  |- rdf__type mesh__D015757sskos__Concept
% 215.36/215.56  |- skos__hiddenLabel mesh__D015757 Gene, trs-art
% 215.36/215.56  |- mesh__recordAuthorizer mesh__D015757 sjn
% 215.36/215.56  |- skos__hiddenLabel mesh__D015757 trs-art Gene
% 215.36/215.56  |- mesh__publicMeSHNote mesh__D015757
% 215.36/215.56       91; was see under GENES, VIRAL 1990   
% 215.36/215.56  |- skos__altLabel mesh__D015757 trs-art Genes
% 215.36/215.56  |- skos__hiddenLabel mesh__D015757 art trs Genes
% 215.36/215.56  |- skos__hiddenLabel mesh__D015757 trs art Genes
% 215.36/215.56  |- mesh__dateEstablished mesh__D015757 1991-01-01
% 215.36/215.56  |- mesh__historyNote mesh__D015757
% 215.36/215.56       91%28%90%29%; was see under GENES, VIRAL 1990   
% 215.36/215.56  |- mesh__dateEstablished mesh__D001737 1991-01-01
% 215.36/215.56  |- skos__annotation mesh__D001737 D25-26 qualif   
% 215.36/215.56  |- mesh__publicMeSHNote mesh__D001737 91; was see under UREA 1975-90   
% 215.36/215.56  |- mesh__dateCreated mesh__D001737 1974-11-19
% 215.36/215.56  |- skos__prefLabel mesh__D001737 Biuret
% 215.36/215.56  |- skos__altLabel mesh__D001737 Carbamylurea
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D001737 2006
% 215.36/215.56  |- mesh__recordAuthorizer mesh__D001737 sjn
% 215.36/215.56  |- mesh__historyNote mesh__D001737
% 215.36/215.56       91%28%75%29%; was see under UREA 1975-90   
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D001737 2002
% 215.36/215.56  |- mesh__recordMaintainer mesh__D001737 CCR
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D001737 2004
% 215.36/215.56  |- mesh__dateRevised mesh__D001737 2000-06-21
% 215.36/215.56  |- skos__altLabel mesh__D001737 Allophanamide
% 215.36/215.56  |- rdf__type mesh__D001737sskos__Concept
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D001737 2005
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D001737 2003
% 215.36/215.56  |- skos__historyNote mesh__D001737 Urea %28%1968-1974%29%
% 215.36/215.56  |- mesh__recordOriginator mesh__D001737 RLS
% 215.36/215.56  |- skos__broader mesh__D001737smesh__D014508
% 215.36/215.56  |- skos__historyNote mesh__D001737 Amides %28%1974%29%
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D001737 2001
% 215.36/215.56  |- skos__scopeNote mesh__D001737
% 215.36/215.56       Used as feed supplement for sheep and cattle since it is a good non-protein nitrogen source. In strongly alkaline solution biuret gives a violet color with copper sulfate.%A%    
% 215.36/215.56  |- skos__prefLabel mesh__D006422 Hemerythrin
% 215.36/215.56  |- mesh__dateRevised mesh__D006422 2002-07-03
% 215.36/215.56  |- mesh__recordAuthorizer mesh__D006422 sjn
% 215.36/215.56  |- rdf__type mesh__D006422sskos__Concept
% 215.36/215.56  |- mesh__recordMaintainer mesh__D006422 TAP
% 215.36/215.56  |- skos__broader mesh__D006422smesh__D019159
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D006422 2005
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D006422 2003
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D006422 2006
% 215.36/215.56  |- mesh__publicMeSHNote mesh__D006422
% 215.36/215.56       91; was see under METALLOPROTEINS 1975-90   
% 215.36/215.56  |- mesh__dateCreated mesh__D006422 1974-11-19
% 215.36/215.56  |- mesh__recordOriginator mesh__D006422 NLM
% 215.36/215.56  |- skos__historyNote mesh__D006422 Metalloproteins %28%1973-1974%29%
% 215.36/215.56  |- skos__historyNote mesh__D006422 Carrier Proteins %28%1973-1974%29%
% 215.36/215.56  |- mesh__activeMeSHYear mesh__D006422 2004
% 215.36/215.56  |- skos__scopeNote mesh__D006422
% 215.36/215.56       A non-heme iron protein consisting of eight apparently identical subunits each containing 2 iron atoms. It binds one molecule of oxygen per pair of iron atoms and functions as a respiratory protein.%A%    
% 215.36/215.56  |- mesh__historyNote mesh__D006422
% 215.36/215.56       91%28%75%29%; was see under METALLOPROTEINS 1975-90   
% 215.36/215.56  |- skos__annotation mesh__D006422 /biosyn /physiol permitted   
% 215.36/215.56  |- skos__historyNote mesh__D006422 Iron %28%1973-1974%29%
% 215.36/215.56  |- mesh__dateEstablished mesh__D006422 1991-01-01
% 215.36/215.56  |- skos__broader mesh__D011367smesh__D011785
% 215.36/215.57  |- mesh__dateEstablished mesh__D011367 1968-01-01
% 215.36/215.57  |- mesh__recordMaintainer mesh__D011367 jrf
% 215.36/215.57  |- rdf__type mesh__D011367sskos__Concept
% 215.36/215.57  |- skos__hiddenLabel mesh__D011367 Staff Committee, Professional
% 215.36/215.57  |- skos__related mesh__D011367smesh__D014600
% 215.36/215.57  |- skos__hiddenLabel mesh__D011367 Committee, Professional Staff
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D011367 2003
% 215.36/215.57  |- skos__broader mesh__D011367smesh__D011364
% 215.36/215.57  |- skos__hiddenLabel mesh__D011367 Staff Committees, Professional
% 215.36/215.57  |- mesh__recordOriginator mesh__D011367 NLM
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D011367 2004
% 215.36/215.57  |- skos__hiddenLabel mesh__D011367 Committees, Professional Staff
% 215.36/215.57  |- mesh__dateCreated mesh__D011367 1999-01-01
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D011367 2002
% 215.36/215.57  |- mesh__publicMeSHNote mesh__D011367 68   
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D011367 2005
% 215.36/215.57  |- mesh__recordAuthorizer mesh__D011367 sjn
% 215.36/215.57  |- skos__hiddenLabel mesh__D011367 Professional Staff Committee
% 215.36/215.57  |- skos__historyNote mesh__D011367
% 215.36/215.57       Hospital Administration %28%1966-1967%29%
% 215.36/215.57  |- skos__prefLabel mesh__D011367 Professional Staff Committees
% 215.36/215.57  |- skos__scopeNote mesh__D011367
% 215.36/215.57       Committees of professional personnel who have responsibility for determining policies, procedures, and controls related to professional matters in health facilities.%A%    
% 215.36/215.57  |- skos__historyNote mesh__D011367 Hospitals %28%1966-1967%29%
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D011367 2006
% 215.36/215.57  |- mesh__historyNote mesh__D011367 68   
% 215.36/215.57  |- mesh__dateRevised mesh__D011367 2001-07-25
% 215.36/215.57  |- skos__altLabel mesh__D016850 Sclerocorneal Limbus
% 215.36/215.57  |- skos__broader mesh__D016850smesh__D003315
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016850 2006
% 215.36/215.57  |- mesh__recordOriginator mesh__D016850 TGC
% 215.36/215.57  |- skos__hiddenLabel mesh__D016850 Corneoscleral Junctions
% 215.36/215.57  |- mesh__historyNote mesh__D016850 92   
% 215.36/215.57  |- skos__hiddenLabel mesh__D016850 Junctions, Corneoscleral
% 215.36/215.57  |- skos__altLabel mesh__D016850 Corneal Limbus
% 215.36/215.57  |- mesh__dateRevised mesh__D016850 1991-11-25
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016850 1996
% 215.36/215.57  |- skos__historyNote mesh__D016850 Cornea %28%1966-1991%29%
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016850 1998
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016850 2002
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016850 1992
% 215.36/215.57  |- mesh__recordMaintainer mesh__D016850 PLS
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016850 1997
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016850 1994
% 215.36/215.57  |- rdf__type mesh__D016850sskos__Concept
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016850 1999
% 215.36/215.57  |- skos__annotation mesh__D016850
% 215.36/215.57       a slight furrow between cornea %26% sclera: do not index under SCLERA unless sclera is particularly discussed; /transpl is unlikely: article will likely be on CORNEAL TRANSPLANTATION with anat or physiol ref to LIMBUS CORNEAE with pertinent qualif%A%  
% 215.36/215.57  |- mesh__recordAuthorizer mesh__D016850 PLS
% 215.36/215.57  |- skos__hiddenLabel mesh__D016850 Limbus, Sclerocorneal
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016850 1993
% 215.36/215.57  |- mesh__dateEstablished mesh__D016850 1992-01-01
% 215.36/215.57  |- mesh__dateCreated mesh__D016850 1991-05-02
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016850 2003
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016850 1995
% 215.36/215.57  |- skos__scopeNote mesh__D016850
% 215.36/215.57       An annular transitional zone, approximately 1 mm wide, between the cornea and the bulbar conjunctiva and sclera. It is highly vascular and is involved in the metabolism of the cornea. It is ophthalmologically significant in that it appears on the outer surface of the eyeball as a slight furrow, marking the line between the clear cornea and the sclera. %28%Dictionary of Visual Science, 3d ed%29%%A%    
% 215.36/215.57  |- skos__hiddenLabel mesh__D016850 Junction, Corneoscleral
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016850 2005
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016850 2000
% 215.36/215.57  |- skos__prefLabel mesh__D016850 Limbus Corneae
% 215.36/215.57  |- skos__altLabel mesh__D016850 Corneoscleral Junction
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016850 2004
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016850 2001
% 215.36/215.57  |- skos__hiddenLabel mesh__D016850 Limbus, Corneal
% 215.36/215.57  |- mesh__publicMeSHNote mesh__D016850 92   
% 215.36/215.57  |- skos__scopeNote mesh__D030521
% 215.36/215.57       A plant family of the order Zingiberales, subclass Zingiberidae, class Liliopsida. It includes plants which have both flavoring and medicinal properties such as GINGER; turmeric %28%CURCUMA%29%, and cardamom %28%ELETTARIA%29%.%A%    
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D030521 2003
% 215.36/215.57  |- mesh__historyNote mesh__D030521 2002; use ZINGIBERALES 1997-2001   
% 215.36/215.57  |- mesh__recordAuthorizer mesh__D030521 sjn
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D030521 2005
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D030521 2004
% 215.36/215.57  |- skos__annotation mesh__D030521
% 215.36/215.57       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D030521 2006
% 215.36/215.57  |- mesh__dateCreated mesh__D030521 2001-08-03
% 215.36/215.57  |- mesh__dateEstablished mesh__D030521 2002-01-01
% 215.36/215.57  |- mesh__recordMaintainer mesh__D030521 ssb
% 215.36/215.57  |- mesh__publicMeSHNote mesh__D030521 2002; see ZINGIBERALES 1997-2001   
% 215.36/215.57  |- skos__prefLabel mesh__D030521 Zingiberaceae
% 215.36/215.57  |- skos__historyNote mesh__D030521 Zingiberales %28%1997-2001%29%
% 215.36/215.57  |- rdf__type mesh__D030521sskos__Concept
% 215.36/215.57  |- mesh__recordOriginator mesh__D030521 ssb
% 215.36/215.57  |- mesh__dateRevised mesh__D030521 2002-07-02
% 215.36/215.57  |- skos__broader mesh__D030521smesh__D019862
% 215.36/215.57  |- mesh__publicMeSHNote mesh__D016052 91   
% 215.36/215.57  |- mesh__dateEstablished mesh__D016052 1991-01-01
% 215.36/215.57  |- mesh__recordMaintainer mesh__D016052 ssb
% 215.36/215.57  |- rdf__type mesh__D016052sskos__Concept
% 215.36/215.57  |- mesh__recordOriginator mesh__D016052 AGS
% 215.36/215.57  |- skos__broader mesh__D016052smesh__D014612
% 215.36/215.57  |- skos__historyNote mesh__D016052 Vaccines %28%1977-1990%29%
% 215.36/215.57  |- skos__prefLabel mesh__D016052 Protozoan Vaccines
% 215.36/215.57  |- skos__scopeNote mesh__D016052
% 215.36/215.57       Suspensions of attenuated or killed protozoa administered for the prevention or treatment of infectious protozoan disease.%A%    
% 215.36/215.57  |- mesh__historyNote mesh__D016052 91   
% 215.36/215.57  |- mesh__dateCreated mesh__D016052 1990-02-12
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016052 2006
% 215.36/215.57  |- mesh__dateRevised mesh__D016052 2005-06-30
% 215.36/215.57  |- skos__annotation mesh__D016052
% 215.36/215.57       coord IM with specific protozoon /immunol %28%IM%29%   
% 215.36/215.57  |- skos__hiddenLabel mesh__D016052 Vaccines, Protozoan
% 215.36/215.57  |- mesh__recordAuthorizer mesh__D016052 sjn
% 215.36/215.57  |- skos__historyNote mesh__D016052 specific Protozoa %28%1977-1990%29%
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D002830 2001
% 215.36/215.57  |- mesh__recordOriginator mesh__D002830 NLM
% 215.36/215.57  |- skos__broader mesh__D002830smesh__D015862
% 215.36/215.57  |- skos__annotation mesh__D002830
% 215.36/215.57       of the eye: do not confuse with neopl of CHOROID PLEXUS %28% = CHOROID PLEXUS NEOPLASMS%29%; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%  
% 215.36/215.57  |- skos__hiddenLabel mesh__D002830 Neoplasms, Choroidal
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D002830 2003
% 215.36/215.57  |- skos__hiddenLabel mesh__D002830 Choroid Neoplasm
% 215.36/215.57  |- skos__hiddenLabel mesh__D002830 Choroidal Neoplasm
% 215.36/215.57  |- skos__prefLabel mesh__D002830 Choroid Neoplasms
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D002830 2004
% 215.36/215.57  |- mesh__recordMaintainer mesh__D002830 TGC
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D002830 2002
% 215.36/215.57  |- skos__hiddenLabel mesh__D002830 Neoplasms, Choroid
% 215.36/215.57  |- skos__hiddenLabel mesh__D002830 Neoplasm, Choroid
% 215.36/215.57  |- rdf__type mesh__D002830sskos__Concept
% 215.36/215.57  |- mesh__dateCreated mesh__D002830 1999-01-01
% 215.36/215.57  |- mesh__recordAuthorizer mesh__D002830 sjn
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D002830 2005
% 215.36/215.57  |- skos__scopeNote mesh__D002830
% 215.36/215.57       Tumors of the choroid; most common intraocular tumors are malignant melanomas of the choroid. These usually occur after puberty and increase in incidence with advancing age. Most malignant melanomas of the uveal tract develop from benign melanomas %28%nevi%29%.%A%    
% 215.36/215.57  |- mesh__dateRevised mesh__D002830 2000-06-22
% 215.36/215.57  |- skos__hiddenLabel mesh__D002830 Neoplasm, Choroidal
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D002830 2006
% 215.36/215.57  |- skos__broader mesh__D002830smesh__D014604
% 215.36/215.57  |- skos__altLabel mesh__D002830 Choroidal Neoplasms
% 215.36/215.57  |- rdf__type mesh__D002032sskos__Concept
% 215.36/215.57  |- mesh__dateCreated mesh__D002032 1986-05-30
% 215.36/215.57  |- skos__prefLabel mesh__D002032 Bulimia
% 215.36/215.57  |- mesh__recordAuthorizer mesh__D002032 sjn
% 215.36/215.57  |- skos__annotation mesh__D002032 BULIMIA NERVOSA is also available   
% 215.36/215.57  |- skos__altLabel mesh__D002032 Binge Eating
% 215.36/215.57  |- skos__related mesh__D002032smesh__D052018
% 215.36/215.57  |- mesh__publicMeSHNote mesh__D002032 87; was see HYPERPHAGIA 1981-86   
% 215.36/215.57  |- mesh__onlineNote mesh__D002032 search HYPERPHAGIA 1981-86   
% 215.36/215.57  |- skos__hiddenLabel mesh__D002032 Eating, Binge
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D002032 2006
% 215.36/215.57  |- skos__broader mesh__D002032smesh__D006963
% 215.36/215.57  |- mesh__dateEstablished mesh__D002032 1987-01-01
% 215.36/215.57  |- mesh__recordOriginator mesh__D002032 EC
% 215.36/215.57  |- skos__historyNote mesh__D002032 Hyperphagia %28%1981-1986%29%
% 215.36/215.57  |- mesh__dateRevised mesh__D002032 2005-06-30
% 215.36/215.57  |- mesh__recordMaintainer mesh__D002032 lkt
% 215.36/215.57  |- mesh__historyNote mesh__D002032 87; was see HYPERPHAGIA 1981-86   
% 215.36/215.57  |- skos__scopeNote mesh__D002032
% 215.36/215.57       Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as %22%ox hunger%22%.%A%    
% 215.36/215.57  |- skos__hiddenLabel mesh__D002032 Bulimias
% 215.36/215.57  |- mesh__dateCreated mesh__D029778 2001-07-25
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D029778 2006
% 215.36/215.57  |- mesh__publicMeSHNote mesh__D029778 2002   
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D029778 2003
% 215.36/215.57  |- rdf__type mesh__D029778sskos__Concept
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D029778 2004
% 215.36/215.57  |- skos__scopeNote mesh__D029778
% 215.36/215.57       A plant species of the family CUCURBITACEAE that is a source of TRICHOSANTHIN %28%a ribosomal inhibitory protein%29%.%A%    
% 215.36/215.57  |- skos__altLabel mesh__D029778 Gourd, Snake
% 215.36/215.57  |- skos__prefLabel mesh__D029778 Trichosanthes
% 215.36/215.57  |- mesh__dateEstablished mesh__D029778 2002-01-01
% 215.36/215.57  |- skos__annotation mesh__D029778
% 215.36/215.57       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.36/215.57  |- mesh__historyNote mesh__D029778 2002   
% 215.36/215.57  |- skos__altLabel mesh__D029778 Snake Gourd
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D029778 2005
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D029778 2002
% 215.36/215.57  |- skos__broader mesh__D029778smesh__D019662
% 215.36/215.57  |- mesh__dateCreated mesh__D001738 1974-12-12
% 215.36/215.57  |- skos__prefLabel mesh__D001738 Biuret Reaction
% 215.36/215.57  |- skos__hiddenLabel mesh__D001738 Biuret Reactions
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D001738 2005
% 215.36/215.57  |- skos__annotation mesh__D001738
% 215.36/215.57       do not confuse with BIURET: biuret reaction or method no longer uses BIURET as signif reagent%A%  
% 215.36/215.57  |- skos__broader mesh__D001738smesh__D002623
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D001738 2003
% 215.36/215.57  |- skos__hiddenLabel mesh__D001738 Reactions, Biuret
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D001738 2006
% 215.36/215.57  |- mesh__recordMaintainer mesh__D001738 lkt
% 215.36/215.57  |- mesh__dateEstablished mesh__D001738 1991-01-01
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D001738 2004
% 215.36/215.57  |- mesh__recordOriginator mesh__D001738 NLM
% 215.36/215.57  |- rdf__type mesh__D001738sskos__Concept
% 215.36/215.57  |- skos__scopeNote mesh__D001738
% 215.36/215.57       A reaction characterized by a violet color upon the addition of copper sulfate to all compounds with two amide or peptide bonds linked directly or through an intermediate carbon atom. Used in the detection and estimation of proteins and peptides having more than two amino acids.%A%    
% 215.36/215.57  |- mesh__publicMeSHNote mesh__D001738
% 215.36/215.57       91; was see under CHEMISTRY, ANALYTICAL 1975-90   
% 215.36/215.57  |- mesh__historyNote mesh__D001738
% 215.36/215.57       91%28%75%29%; was see under CHEMISTRY, ANALYTICAL 1975-90   
% 215.36/215.57  |- mesh__recordAuthorizer mesh__D001738 sjn
% 215.36/215.57  |- skos__hiddenLabel mesh__D001738 Reaction, Biuret
% 215.36/215.57  |- mesh__dateRevised mesh__D001738 2002-07-02
% 215.36/215.57  |- skos__altLabel mesh__D012460 Salicylazosulfapyridine
% 215.36/215.57  |- skos__altLabel mesh__D012460 Ashbourne Brand of Sulfasalazine
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D012460 2006
% 215.36/215.57  |- skos__hiddenLabel mesh__D012460 Colo Pleon
% 215.36/215.57  |- skos__altLabel mesh__D012460 medac Brand of Sulfasalazine
% 215.36/215.57  |- mesh__recordAuthorizer mesh__D012460 sjn
% 215.36/215.57  |- skos__prefLabel mesh__D012460 Sulfasalazine
% 215.36/215.57  |- mesh__publicMeSHNote mesh__D012460
% 215.36/215.57       95; see SALICYLAZOSULFAPYRIDINE 1963-94; for SULFASALAZINE see SALICYLAZOSULFAPYRIDINE 1975-94%A%  
% 215.36/215.57  |- skos__hiddenLabel mesh__D012460 Sulfasalazin Heyl
% 215.36/215.57  |- skos__altLabel mesh__D012460 Ratiopharm Brand of Sulfasalazine
% 215.36/215.57  |- skos__altLabel mesh__D012460 Pharmacia Brand 1 of Sulfasalazine
% 215.36/215.57  |- skos__altLabel mesh__D012460 Pleon
% 215.36/215.57  |- skos__altLabel mesh__D012460 Azulfidine EN-tabs
% 215.36/215.57  |- skos__hiddenLabel mesh__D012460 ratio Sulfasalazine
% 215.36/215.57  |- skos__altLabel mesh__D012460 Henning Berlin Brand of Sulfasalazine
% 215.36/215.57  |- skos__altLabel mesh__D012460 Sulphasalazine
% 215.36/215.57  |- mesh__dateRevised mesh__D012460 2005-06-30
% 215.36/215.57  |- skos__altLabel mesh__D012460 Azulfadine
% 215.36/215.57  |- skos__broader mesh__D012460smesh__D013449
% 215.36/215.57  |- skos__altLabel mesh__D012460 Salazosulfapyridine
% 215.36/215.57  |- rdf__type mesh__D012460sskos__Concept
% 215.36/215.57  |- mesh__recordOriginator mesh__D012460 NLM
% 215.36/215.57  |- skos__altLabel mesh__D012460 FNA Brand of Sulfasalazine
% 215.36/215.57  |- skos__altLabel mesh__D012460 Sanofi Synthelabo Brand of Sulfasalazine
% 215.36/215.57  |- skos__scopeNote mesh__D012460
% 215.36/215.57       A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid %28%see MESALAMINE%29% released in the colon. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p907%29%%A%    
% 215.36/215.57  |- skos__altLabel mesh__D012460 Asulfidine
% 215.36/215.57  |- skos__altLabel mesh__D012460 Pyralin EN
% 215.36/215.57  |- skos__altLabel mesh__D012460 Heyl Brand of Sulfasalazine
% 215.36/215.57  |- mesh__recordMaintainer mesh__D012460 CCR
% 215.36/215.57  |- skos__altLabel mesh__D012460 Alphapharm Brand of Sulfasalazine
% 215.36/215.57  |- skos__altLabel mesh__D012460 Pharmacia Brand 2 of Sulfasalazine
% 215.36/215.57  |- skos__hiddenLabel mesh__D012460 Azulfidine EN tabs
% 215.36/215.57  |- mesh__historyNote mesh__D012460 95%28%63%29%   
% 215.36/215.57  |- mesh__dateCreated mesh__D012460 1999-01-01
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Hemianopias, Homonymous
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Hemianopsias, Homonymous
% 215.36/215.57  |- skos__altLabel mesh__D006423 Altitudinal Hemianopsia
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Hemianopia, Homonymous
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Altitudinal Hemianopsias
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Binasal Hemianopsias
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Binasal Hemianopias
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D006423 2004
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Hemianopia, Bitemporal
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Bitemporal Hemianopias
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Homonymous Hemianopias
% 215.36/215.57  |- skos__altLabel mesh__D006423 Hemianopsia, Bitemporal
% 215.36/215.57  |- mesh__dateRevised mesh__D006423 2001-07-25
% 215.36/215.57  |- mesh__recordMaintainer mesh__D006423 nns
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Hemianopsias, Altitudinal
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Hemianopsias, Binasal
% 215.36/215.57  |- mesh__recordAuthorizer mesh__D006423 sjn
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Hemianopia, Altidudinal
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Hemianopsia, Altitudinal
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D006423 2003
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Bitemporal Hemianopsias
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D006423 2006
% 215.36/215.57  |- skos__scopeNote mesh__D006423
% 215.36/215.57       Partial or complete loss of vision in one half of the visual field%28%s%29% of one or both eyes. Subtypes include altitudinal hemianopsia, characterized by a visual defect above or below the horizontal meridian of the visual field. Homonymous hemianopsia refers to a visual defect that affects both eyes equally, and occurs either to the left or right of the midline of the visual field. Binasal hemianopsia consists of loss of vision in the nasal hemifields of both eyes. Bitemporal hemianopsia is the bilateral loss of vision in the temporal fields. Quadrantanopsia refers to loss of vision in one quarter of the visual field in one or both eyes.%A%    
% 215.36/215.57  |- skos__broader mesh__D006423smesh__D001766
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Hemianopias, Binasal
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Hemianopsias, Bitemporal
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Homonymous Hemianopsia
% 215.36/215.57  |- mesh__recordOriginator mesh__D006423 NLM
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Quadrantanopias
% 215.36/215.57  |- skos__prefLabel mesh__D006423 Hemianopsia
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D006423 2002
% 215.36/215.57  |- skos__altLabel mesh__D006423 Hemianopsia, Binasal
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Altidudinal Hemianopias
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D006423 2005
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Hemianopsias
% 215.36/215.57  |- skos__broader mesh__D006423smesh__D014786
% 215.36/215.57  |- skos__altLabel mesh__D006423 Homonymous Hemianopia
% 215.36/215.57  |- rdf__type mesh__D006423sskos__Concept
% 215.36/215.57  |- mesh__dateCreated mesh__D006423 1999-01-01
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Binasal Hemianopsia
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Hemianopia, Binasal
% 215.36/215.57  |- skos__altLabel mesh__D006423 Quadrantanopia
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Homonymous Hemianopsias
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Hemianopias, Altidudinal
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Hemianopias
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Hemianopias, Bitemporal
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Bitemporal Hemianopsia
% 215.36/215.57  |- skos__hiddenLabel mesh__D006423 Quadrantanopsias
% 215.36/215.57  |- skos__altLabel mesh__D006423 Hemianopia
% 215.36/215.57  |- skos__broader mesh__D012867Q000002smesh__D012867
% 215.36/215.57  |- mesh__preferredCombination mesh__D012867Q000002smesh__D012868
% 215.36/215.57  |- rdf__type mesh__D012867Q000002smesh__CompoundConcept
% 215.36/215.57  |- skos__broader mesh__D044542smesh__D007911
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D044542 2004
% 215.36/215.57  |- skos__hiddenLabel mesh__D044542 Lentigines Syndromes, Multiple
% 215.36/215.57  |- skos__broader mesh__D044542smesh__D011666
% 215.36/215.57  |- skos__broader mesh__D044542smesh__D019465
% 215.36/215.57  |- skos__hiddenLabel mesh__D044542 Syndromes, Multiple Lentigines
% 215.36/215.57  |- skos__historyNote mesh__D044542 Syndrome %28%1971-2003%29%
% 215.36/215.57  |- skos__hiddenLabel mesh__D044542 Multiple Lentigines Syndromes
% 215.36/215.57  |- skos__related mesh__D044542smesh__D009456
% 215.36/215.57  |- mesh__dateCreated mesh__D044542 2003-07-09
% 215.36/215.57  |- mesh__historyNote mesh__D044542
% 215.36/215.57       2004; use NEUROFIBROMATOSIS 1 2002 -2003   
% 215.36/215.57  |- skos__scopeNote mesh__D044542
% 215.36/215.57       A syndrome characterized by Lentigines %28%LENTIGO%29%; Electrocardiographic conduction abnormalities; Ocular HYPERTELORISM; PULMONARY STENOSIS; Abnormal genitalia; Retardation of growth; and Deafness %28%HEARING LOSS, SENSORINEURAL%29%. It is caused by mutations of the PTPN11 gene which codes for non-receptor PROTEIN TYROSINE PHOSPHATASE, type 11. The clinical features of LEOPARD syndrome overlap those of NOONAN SYNDROME, also caused by mutations in PTPN11, as well as those of NEUROFIBROMATOSIS 1. The syndrome has also been associated with mutations in the NF1 gene %28%GENES, NEUROFIBROMATOSIS 1%29%. %28%J Med Genet 2002 Aug;39%28%8%29%:571-4%29%%A%    
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D044542 2005
% 215.36/215.57  |- skos__hiddenLabel mesh__D044542 Syndromes, LEOPARD
% 215.36/215.57  |- mesh__dateEstablished mesh__D044542 2004-01-01
% 215.36/215.57  |- skos__related mesh__D044542smesh__D009634
% 215.36/215.57  |- skos__hiddenLabel mesh__D044542 Syndrome, LEOPARD
% 215.36/215.57  |- skos__hiddenLabel mesh__D044542 Syndrome, Multiple Lentigines
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D044542 2006
% 215.36/215.57  |- skos__hiddenLabel mesh__D044542 LEOPARD Syndromes
% 215.36/215.57  |- skos__hiddenLabel mesh__D044542 Lentigines Syndrome, Multiple
% 215.36/215.57  |- skos__broader mesh__D044542smesh__D000015
% 215.36/215.57  |- skos__broader mesh__D044542smesh__D006330
% 215.36/215.57  |- skos__historyNote mesh__D044542 Lentigo %28%1970-2003%29%
% 215.36/215.57  |- mesh__publicMeSHNote mesh__D044542
% 215.36/215.57       2004; see NEUROFIBROMATOSIS 1 2002 -2003   
% 215.36/215.57  |- skos__altLabel mesh__D044542 Multiple Lentigines Syndrome
% 215.36/215.57  |- rdf__type mesh__D044542sskos__Concept
% 215.36/215.57  |- skos__prefLabel mesh__D044542 LEOPARD Syndrome
% 215.36/215.57  |- skos__broader mesh__D011368smesh__D007398
% 215.36/215.57  |- skos__hiddenLabel mesh__D011368 Relations, Professional-Family
% 215.36/215.57  |- skos__hiddenLabel mesh__D011368 Professional Family Relations
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D011368 2003
% 215.36/215.57  |- mesh__dateRevised mesh__D011368 2002-10-31
% 215.36/215.57  |- skos__annotation mesh__D011368
% 215.36/215.57       no qualif; DF: PROFESSIONAL FAMILY RELAT   
% 215.36/215.57  |- skos__hiddenLabel mesh__D011368 Relationship, Professional Family
% 215.36/215.57  |- skos__hiddenLabel mesh__D011368 Professional-Family Relation
% 215.36/215.57  |- skos__hiddenLabel mesh__D011368 Family Relationship, Professional
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D011368 1999
% 215.36/215.57  |- skos__hiddenLabel mesh__D011368 Professional Family Relationships
% 215.36/215.57  |- mesh__recordAuthorizer mesh__D011368 jls
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D011368 2004
% 215.36/215.57  |- mesh__dateEstablished mesh__D011368 1976-01-01
% 215.36/215.57  |- skos__historyNote mesh__D011368 Family %28%1966-1975%29%
% 215.36/215.57  |- mesh__dateCreated mesh__D011368 1975-07-25
% 215.36/215.57  |- mesh__publicMeSHNote mesh__D011368 76   
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D011368 2000
% 215.36/215.57  |- skos__hiddenLabel mesh__D011368 Family Relationships, Professional
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D011368 2005
% 215.36/215.57  |- mesh__recordOriginator mesh__D011368 EC
% 215.36/215.57  |- skos__hiddenLabel mesh__D011368 Relation, Professional-Family
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D011368 2003A
% 215.36/215.57  |- mesh__recordMaintainer mesh__D011368 jls
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D011368 2001
% 215.36/215.57  |- skos__hiddenLabel mesh__D011368 Relationships, Professional Family
% 215.36/215.57  |- skos__scopeNote mesh__D011368
% 215.36/215.57       The interactions between the professional person and the family.%A%    
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D011368 2006
% 215.36/215.57  |- skos__altLabel mesh__D011368 Professional Family Relationship
% 215.36/215.57  |- skos__prefLabel mesh__D011368 Professional-Family Relations
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D011368 2002
% 215.36/215.57  |- rdf__type mesh__D011368sskos__Concept
% 215.36/215.57  |- mesh__historyNote mesh__D011368 76   
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D011368 1998
% 215.36/215.57  |- skos__scopeNote mesh__D016851
% 215.36/215.57       A genus of the family BUNYAVIRIDAE containing over 150 viruses, most of which are transmitted by mosquitoes or flies. They are arranged in groups defined by serological criteria, each now named for the original reference species %28%previously called serogroups%29%. Many species have multiple serotypes or strains.%A%    
% 215.36/215.57  |- mesh__dateCreated mesh__D016851 1991-05-02
% 215.36/215.57  |- rdf__type mesh__D016851sskos__Concept
% 215.36/215.57  |- mesh__recordAuthorizer mesh__D016851 sjn
% 215.36/215.57  |- mesh__recordOriginator mesh__D016851 AGS
% 215.36/215.57  |- mesh__publicMeSHNote mesh__D016851
% 215.36/215.57       2005; see BUNYAVIRUS 1992-2004; for APEU VIRUS see APEU VIRUS 1991, see BUNYAVIRIDAE 1981-1990, see ARBOVIRUSES 1975-1980; for CATU VIRUS %26% GUAMA VIRUS see GUAMA GROUP VIRUSES 1975-1991%A%  
% 215.36/215.57  |- skos__altLabel mesh__D016851 Bunyavirus
% 215.36/215.57  |- mesh__historyNote mesh__D016851
% 215.36/215.57       2005 %28%1992%29%; for APEU VIRUS use APEU VIRUS 1991, use BUNYAVIRIDAE 1981-1990, use ARBOVIRUSES 1975-1980; for CATU VIRUS %26% GUAMA VIRUS use GUAMA GROUP VIRUSES 1975-1991%A%  
% 215.36/215.57  |- skos__historyNote mesh__D016851 Arboviruses %28%1973-1980%29%
% 215.36/215.57  |- skos__historyNote mesh__D016851 Bunyaviridae %28%1979-1991%29%
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016851 2005
% 215.36/215.57  |- mesh__recordMaintainer mesh__D016851 ags
% 215.36/215.57  |- skos__annotation mesh__D016851
% 215.36/215.57       infection: coord IM with BUNYAVIRIDAE INFECTIONS %28%IM%29%   
% 215.36/215.57  |- skos__prefLabel mesh__D016851 Orthobunyavirus
% 215.36/215.57  |- mesh__dateRevised mesh__D016851 2004-07-07
% 215.36/215.57  |- skos__broader mesh__D016851smesh__D002043
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016851 2006
% 215.36/215.57  |- skos__hiddenLabel mesh__D016851 Orthobunyaviruses
% 215.36/215.57  |- mesh__dateEstablished mesh__D016851 1992-01-01
% 215.36/215.57  |- skos__broader mesh__D016053smesh__D012313
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016053 2000
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016053 2005
% 215.36/215.57  |- mesh__recordOriginator mesh__D016053 AGS
% 215.36/215.57  |- mesh__dateCreated mesh__D016053 1990-02-12
% 215.36/215.57  |- mesh__recordMaintainer mesh__D016053 KEV
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016053 2004
% 215.36/215.57  |- mesh__historyNote mesh__D016053 91   
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016053 1999
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016053 2003
% 215.36/215.57  |- skos__historyNote mesh__D016053 specific protozoa %28%1966-1990%29%
% 215.36/215.57  |- rdf__type mesh__D016053sskos__Concept
% 215.36/215.57  |- mesh__publicMeSHNote mesh__D016053 91   
% 215.36/215.57  |- skos__scopeNote mesh__D016053
% 215.36/215.57       Ribonucleic acid in protozoa having regulatory and catalytic roles as well as involvement in protein synthesis.%A%    
% 215.36/215.57  |- mesh__dateEstablished mesh__D016053 1991-01-01
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016053 1998
% 215.36/215.57  |- mesh__dateRevised mesh__D016053 1995-06-08
% 215.36/215.57  |- skos__annotation mesh__D016053
% 215.36/215.57       IM; coord with specific protozoon %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016053 1997
% 215.36/215.57  |- skos__prefLabel mesh__D016053 RNA, Protozoan
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016053 2002
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016053 2006
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016053 1996
% 215.36/215.57  |- skos__historyNote mesh__D016053 RNA %28%1966-1990%29%
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D016053 2001
% 215.36/215.57  |- mesh__recordAuthorizer mesh__D016053 PLS
% 215.36/215.57  |- skos__altLabel mesh__D016053 Protozoan RNA
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D002831 2006
% 215.36/215.57  |- skos__prefLabel mesh__D002831 Choroid Plexus
% 215.36/215.57  |- mesh__dateRevised mesh__D002831 1999-11-08
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D002831 2003
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D002831 2002
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D002831 2004
% 215.36/215.57  |- mesh__recordMaintainer mesh__D002831 adp
% 215.36/215.57  |- skos__scopeNote mesh__D002831
% 215.36/215.57       A villous structure of tangled masses of BLOOD VESSELS contained within the third, lateral, and fourth ventricles of the BRAIN. It regulates part of the production and composition of CEREBROSPINAL FLUID.%A%    
% 215.36/215.57  |- rdf__type mesh__D002831sskos__Concept
% 215.36/215.57  |- mesh__dateCreated mesh__D002831 1999-01-01
% 215.36/215.57  |- mesh__recordAuthorizer mesh__D002831 sjn
% 215.36/215.57  |- skos__hiddenLabel mesh__D002831 Plexus, Choroid
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D002831 2000
% 215.36/215.57  |- skos__annotation mesh__D002831
% 215.36/215.57       in the brain: do not confuse with CHOROID %28%in the eye%29%; diseases: coord IM with BRAIN DISEASES %28%IM%29%; neopl = CHOROID PLEXUS NEOPLASMS; choroid plexus papilloma = GLIOMA %28%IM%29% + CHOROID PLEXUS NEOPLASMS %28%IM%29%; /radiogr: coord with CEREBRAL VENTRICULOGRAPHY%A%  
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D002831 2005
% 215.36/215.57  |- mesh__recordOriginator mesh__D002831 NLM
% 215.36/215.57  |- skos__broader mesh__D002831smesh__D002552
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D002831 2001
% 215.36/215.57  |- skos__scopeNote mesh__D002033
% 215.36/215.57       A genus of small freshwater snails of the order Pulmonata, found throughout Africa and the Middle East, where it is a vector of SCHISTOSOMA HAEMATOBIUM.%A%    
% 215.36/215.57  |- mesh__recordOriginator mesh__D002033 NLM
% 215.36/215.57  |- skos__broader mesh__D002033smesh__D012908
% 215.36/215.57  |- mesh__activeMeSHYear mesh__D002033 2006
% 215.36/215.57  |- mesh__recordAuthorizer mesh__D002033 sjn
% 215.36/215.57  |- skos__historyNote mesh__D002033 Snails %28%1966-1971%29%
% 215.36/215.57  |- mesh__historyNote mesh__D002033 72   
% 215.36/215.57  |- mesh__publicMeSHNote mesh__D002033 72   
% 215.36/215.57  |- rdf__type mesh__D002033sskos__Concept
% 215.36/215.57  |- mesh__dateEstablished mesh__D002033 1972-01-01
% 215.36/215.57  |- skos__prefLabel mesh__D002033 Bulinus
% 215.36/215.57  |- skos__annotation mesh__D002033
% 215.36/215.57       freshwater snail; /microbiol /parasitol /virol permitted   
% 215.36/215.57  |- mesh__dateRevised mesh__D002033 2005-06-30
% 215.36/215.57  |- mesh__recordMaintainer mesh__D002033 ags
% 215.36/215.57  |- mesh__dateCreated mesh__D002033 1999-01-01
% 215.36/215.58  |- mesh__dateCreated mesh__D029779 2001-07-25
% 215.36/215.58  |- skos__prefLabel mesh__D029779 Cupressaceae
% 215.36/215.58  |- skos__broader mesh__D029779smesh__D032482
% 215.36/215.58  |- mesh__recordMaintainer mesh__D029779 ssb
% 215.36/215.58  |- mesh__historyNote mesh__D029779 2002   
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D029779 2004
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D029779 2006
% 215.36/215.58  |- mesh__dateRevised mesh__D029779 2003-07-09
% 215.36/215.58  |- mesh__recordAuthorizer mesh__D029779 sjn
% 215.36/215.58  |- skos__scopeNote mesh__D029779
% 215.36/215.58       A plant family of the order Pinales, class Pinopsida, division Coniferophyta %28%conifers%29%.  They are mainly resinous, aromatic evergreen trees.%A%    
% 215.36/215.58  |- rdf__type mesh__D029779sskos__Concept
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D029779 2005
% 215.36/215.58  |- mesh__dateEstablished mesh__D029779 2002-01-01
% 215.36/215.58  |- mesh__publicMeSHNote mesh__D029779 2002   
% 215.36/215.58  |- skos__annotation mesh__D029779
% 215.36/215.58       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.36/215.58  |- mesh__recordOriginator mesh__D029779 ssb
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D015759 2004
% 215.36/215.58  |- mesh__publicMeSHNote mesh__D015759 90   
% 215.36/215.58  |- skos__scopeNote mesh__D015759
% 215.36/215.58       A divalent calcium ionophore that is widely used as a tool to investigate the role of intracellular calcium in cellular processes.%A%    
% 215.36/215.58  |- mesh__recordAuthorizer mesh__D015759 sjn
% 215.36/215.58  |- skos__hiddenLabel mesh__D015759 SQ23377
% 215.36/215.58  |- skos__prefLabel mesh__D015759 Ionomycin
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D015759 2005
% 215.36/215.58  |- mesh__dateEstablished mesh__D015759 1990-01-01
% 215.36/215.58  |- skos__hiddenLabel mesh__D015759 SQ 23377
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D015759 2006
% 215.36/215.58  |- mesh__recordMaintainer mesh__D015759 ssb
% 215.36/215.58  |- mesh__historyNote mesh__D015759 90   
% 215.36/215.58  |- skos__broader mesh__D015759smesh__D005231
% 215.36/215.58  |- mesh__dateCreated mesh__D015759 1989-05-15
% 215.36/215.58  |- skos__historyNote mesh__D015759 Ionophores %28%1976-1989%29%
% 215.36/215.58  |- rdf__type mesh__D015759sskos__Concept
% 215.36/215.58  |- skos__historyNote mesh__D015759 Ethers %28%1966-1989%29%
% 215.36/215.58  |- mesh__dateRevised mesh__D015759 2003-07-09
% 215.36/215.58  |- mesh__recordOriginator mesh__D015759 RLS
% 215.36/215.58  |- mesh__recordMaintainer mesh__D026481 lkt
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D026481 2004
% 215.36/215.58  |- skos__broader mesh__D026481smesh__D015336
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D026481 2005
% 215.36/215.58  |- skos__hiddenLabel mesh__D026481 Blots, Far-Western
% 215.36/215.58  |- skos__hiddenLabel mesh__D026481 Blottings, Far-Western
% 215.36/215.58  |- skos__altLabel mesh__D026481 Blotting, West-Western
% 215.36/215.58  |- skos__hiddenLabel mesh__D026481 West Western Blot
% 215.36/215.58  |- skos__historyNote mesh__D026481 Protein Binding %28%1996-2001%29%
% 215.36/215.58  |- skos__broader mesh__D026481smesh__D025941
% 215.36/215.58  |- skos__historyNote mesh__D026481 Binding Sites %28%1994-2001%29%
% 215.36/215.58  |- mesh__dateCreated mesh__D026481 2001-07-25
% 215.36/215.58  |- skos__hiddenLabel mesh__D026481 West-Western Blottings
% 215.36/215.58  |- mesh__publicMeSHNote mesh__D026481 2002   
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D026481 2006
% 215.36/215.58  |- skos__prefLabel mesh__D026481 Blotting, Far-Western
% 215.36/215.58  |- mesh__dateRevised mesh__D026481 2002-07-02
% 215.36/215.58  |- skos__hiddenLabel mesh__D026481 Blot, West Western
% 215.36/215.58  |- skos__hiddenLabel mesh__D026481 Blotting, West Western
% 215.36/215.58  |- skos__altLabel mesh__D026481 Blot, Far-Western
% 215.36/215.58  |- skos__hiddenLabel mesh__D026481 West-Western Blots
% 215.36/215.58  |- skos__altLabel mesh__D026481 West-Western Blot
% 215.36/215.58  |- skos__hiddenLabel mesh__D026481 Blot, Far Western
% 215.36/215.58  |- skos__hiddenLabel mesh__D026481 Far-Western Blottings
% 215.36/215.58  |- skos__hiddenLabel mesh__D026481 Far Western Blot
% 215.36/215.58  |- mesh__recordOriginator mesh__D026481 nns
% 215.36/215.58  |- mesh__dateEstablished mesh__D026481 2002-01-01
% 215.36/215.58  |- skos__related mesh__D026481smesh__D020798
% 215.36/215.58  |- skos__altLabel mesh__D026481 Far-Western Blotting
% 215.36/215.58  |- skos__altLabel mesh__D026481 Blot, West-Western
% 215.36/215.58  |- skos__historyNote mesh__D026481 Blotting, Western %28%1994-2001%29%
% 215.36/215.58  |- skos__hiddenLabel mesh__D026481 West-Western Blotting
% 215.36/215.58  |- rdf__type mesh__D026481sskos__Concept
% 215.36/215.58  |- skos__scopeNote mesh__D026481
% 215.36/215.58       A method that is derived from western blotting %28%BLOTTING, WESTERN%29% and is used to detect protein-protein interactions. The blotted proteins are probed with a non-antibody protein which can then be tagged with a labeled antibody.%A%    
% 215.36/215.58  |- skos__hiddenLabel mesh__D026481 Blotting, Far Western
% 215.36/215.58  |- skos__hiddenLabel mesh__D026481 Far Western Blotting
% 215.36/215.58  |- mesh__recordAuthorizer mesh__D026481 sjn
% 215.36/215.58  |- skos__broader mesh__D026481smesh__D015153
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D026481 2003
% 215.36/215.58  |- mesh__historyNote mesh__D026481 2002   
% 215.36/215.58  |- skos__hiddenLabel mesh__D026481 Blots, West-Western
% 215.36/215.58  |- skos__hiddenLabel mesh__D026481 Blottings, West-Western
% 215.36/215.58  |- skos__annotation mesh__D026481
% 215.36/215.58       %22%western%22% is not capitalized in titles or translations   
% 215.36/215.58  |- skos__hiddenLabel mesh__D026481 Far-Western Blots
% 215.36/215.58  |- skos__prefLabel mesh__D001739 BK Virus
% 215.36/215.58  |- mesh__recordAuthorizer mesh__D001739 sjn
% 215.36/215.58  |- skos__altLabel mesh__D001739 BK polyomavirus
% 215.36/215.58  |- skos__scopeNote mesh__D001739
% 215.36/215.58       A species of POLYOMAVIRUS apparently infecting over 90%25% of children but not clearly associated with any clinical illness in childhood. The virus remains latent in the body throughout life and can be reactivated under certain circumstances.%A%    
% 215.36/215.58  |- skos__altLabel mesh__D001739 Human Polyomavirus BK
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D001739 2003
% 215.36/215.58  |- mesh__historyNote mesh__D001739 2002, 1975-1993   
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D001739 2006
% 215.36/215.58  |- skos__altLabel mesh__D001739 Polyomavirus hominis 1
% 215.36/215.58  |- mesh__dateEstablished mesh__D001739 1991-01-01
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D001739 2004
% 215.36/215.58  |- mesh__publicMeSHNote mesh__D001739
% 215.36/215.58       2002; see POLYOMAVIRUS HOMINIS 1 1994-2001, see BK VIRUS 1991-1993, see POLYOMAVIRUSES 1978-1990, see POLYOMA VIRUS 1975-1977%A%  
% 215.36/215.58  |- rdf__type mesh__D001739sskos__Concept
% 215.36/215.58  |- mesh__recordMaintainer mesh__D001739 ags
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D001739 2002
% 215.36/215.58  |- mesh__dateCreated mesh__D001739 1974-11-19
% 215.36/215.58  |- mesh__dateRevised mesh__D001739 2001-07-25
% 215.36/215.58  |- skos__broader mesh__D001739smesh__D011120
% 215.36/215.58  |- skos__hiddenLabel mesh__D001739 Polyomavirus BK, Human
% 215.36/215.58  |- mesh__recordOriginator mesh__D001739 NLM
% 215.36/215.58  |- skos__altLabel mesh__D001739 Polyomavirus, BK
% 215.36/215.58  |- mesh__onlineNote mesh__D001739
% 215.36/215.58       use POLYOMAVIRUS HOMINIS 1 to search BK VIRUS 1975-93   
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D001739 2005
% 215.36/215.58  |- skos__annotation mesh__D001739
% 215.36/215.58       infection: coord IM with POLYOMAVIRUS INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%%A%  
% 215.36/215.58  |- mesh__recordOriginator mesh__D012461 NLM
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D012461 2004
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D012461 2000
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D012461 2003
% 215.36/215.58  |- mesh__dateCreated mesh__D012461 1999-01-01
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D012461 2006
% 215.36/215.58  |- skos__hiddenLabel mesh__D012461 Acids, Salicylic
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D012461 2002
% 215.36/215.58  |- mesh__onlineNote mesh__D012461
% 215.36/215.58       use SALICYLIC ACIDS to search SALICYLIC ACID 1966-74   
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D012461 2005
% 215.36/215.58  |- skos__broader mesh__D012461smesh__D006883
% 215.36/215.58  |- skos__scopeNote mesh__D012461
% 215.36/215.58       Derivatives and salts of SALICYLIC ACID.     
% 215.36/215.58  |- rdf__type mesh__D012461sskos__Concept
% 215.36/215.58  |- mesh__dateRevised mesh__D012461 1998-06-11
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D012461 2001
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D012461 1999
% 215.36/215.58  |- skos__prefLabel mesh__D012461 Salicylic Acids
% 215.36/215.58  |- mesh__publicMeSHNote mesh__D012461 75; was SALICYLIC ACID 1963-74   
% 215.36/215.58  |- skos__annotation mesh__D012461 SALICYLIC ACID is also available   
% 215.36/215.58  |- mesh__recordMaintainer mesh__D012461 ADP
% 215.36/215.58  |- mesh__recordAuthorizer mesh__D012461 SJN
% 215.36/215.58  |- mesh__historyNote mesh__D012461 75; was SALICYLIC ACID 1963-74   
% 215.36/215.58  |- skos__historyNote mesh__D006424 Blood %28%1966-1997%29%
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D006424 2006
% 215.36/215.58  |- mesh__historyNote mesh__D006424 1998; use explode   
% 215.36/215.58  |- mesh__dateCreated mesh__D006424 1999-01-01
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D006424 2004
% 215.36/215.58  |- mesh__dateRevised mesh__D006424 2003-07-09
% 215.36/215.58  |- skos__hiddenLabel mesh__D006424 System, Hemic
% 215.36/215.58  |- skos__historyNote mesh__D006424 Hematopoietic System %28%1966-1997%29%
% 215.36/215.58  |- mesh__recordOriginator mesh__D006424 NLM
% 215.36/215.58  |- mesh__recordMaintainer mesh__D006424 lkt
% 215.36/215.58  |- mesh__dateEstablished mesh__D006424 1998-01-01
% 215.36/215.58  |- skos__scopeNote mesh__D006424
% 215.36/215.58       Organs involved in the production of BLOOD, including the cellular and the molecular components essential in providing defense against foreign organisms or substances.%A%    
% 215.36/215.58  |- rdf__type mesh__D006424sskos__Concept
% 215.36/215.58  |- skos__annotation mesh__D006424
% 215.36/215.58       not used for indexing      CATALOG: do not use   
% 215.36/215.58  |- skos__prefLabel mesh__D006424 Hemic and Immune Systems
% 215.36/215.58  |- mesh__publicMeSHNote mesh__D006424
% 215.36/215.58       1998; for HEMIC SYSTEM see BLOOD 1995-2003   
% 215.36/215.58  |- mesh__recordAuthorizer mesh__D006424 sjn
% 215.36/215.58  |- skos__historyNote mesh__D006424 Immune System %28%1966-1997%29%
% 215.36/215.58  |- mesh__runningHead mesh__D006424
% 215.36/215.58       A15 - ANATOMY-HEMIC AND IMMUNE SYSTEMS   
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D006424 2005
% 215.36/215.58  |- skos__altLabel mesh__D050580 EAAT-3 Excitatory Amino Acid Transporter
% 215.36/215.58  |- skos__historyNote mesh__D050580
% 215.36/215.58       Amino Acid Transport System X-AG %28%1984-2005%29%
% 215.36/215.58  |- rdf__type mesh__D050580sskos__Concept
% 215.36/215.58  |- mesh__publicMeSHNote mesh__D050580
% 215.36/215.58       2006; EXCITATORY AMINO ACID TRANSPORTER 3 was indexed under AMINO ACID TRANSPORT SYSTEM X-AG %26% SYMPORTERS 2003-2005 %26% under CARRIER PROTEINS 1984-2002%A%  
% 215.36/215.58  |- mesh__dateCreated mesh__D050580 2005-06-30
% 215.36/215.58  |- skos__broader mesh__D050580smesh__D050491
% 215.36/215.58  |- mesh__recordOriginator mesh__D050580 DRC
% 215.36/215.58  |- skos__hiddenLabel mesh__D050580 EAAT 3 Excitatory Amino Acid Transporter
% 215.36/215.58  |- skos__historyNote mesh__D050580 Symporters %28%1984-2005%29%
% 215.36/215.58  |- mesh__historyNote mesh__D050580 2006%28%1984%29%   
% 215.36/215.58  |- mesh__recordAuthorizer mesh__D050580 sjn
% 215.36/215.58  |- mesh__dateEstablished mesh__D050580 2006-01-01
% 215.36/215.58  |- skos__scopeNote mesh__D050580
% 215.36/215.58       A neuronal and epithelial type glutamate plasma membrane transporter protein.%A%    
% 215.36/215.58  |- skos__hiddenLabel mesh__D050580 EAAC 1 Excitatory Amino Acid Carrier
% 215.36/215.58  |- skos__prefLabel mesh__D050580 Excitatory Amino Acid Transporter 3
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D050580 2006
% 215.36/215.58  |- mesh__recordMaintainer mesh__D050580 DRC
% 215.36/215.58  |- skos__hiddenLabel mesh__D050580 Transporter, SLC1A1
% 215.36/215.58  |- skos__altLabel mesh__D050580 EAAC-1 Excitatory Amino-Acid Carrier
% 215.36/215.58  |- skos__altLabel mesh__D050580 SLC1A1 Transporter
% 215.36/215.58  |- skos__hiddenLabel mesh__D011369 Professional Patient Relations
% 215.36/215.58  |- skos__hiddenLabel mesh__D011369 Professional-Patient Relation
% 215.36/215.58  |- skos__scopeNote mesh__D011369
% 215.36/215.58       Interactions between health personnel and patients.     
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D011369 1996
% 215.36/215.58  |- mesh__dateEstablished mesh__D011369 1968-01-01
% 215.36/215.58  |- mesh__publicMeSHNote mesh__D011369 68   
% 215.36/215.58  |- mesh__recordOriginator mesh__D011369 NLM
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D011369 2005
% 215.36/215.58  |- skos__hiddenLabel mesh__D011369 Relationship, Professional Patient
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D011369 1997
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D011369 2000
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D011369 2006
% 215.36/215.58  |- skos__hiddenLabel mesh__D011369 Relationships, Professional Patient
% 215.36/215.58  |- mesh__recordMaintainer mesh__D011369 jls
% 215.36/215.58  |- mesh__historyNote mesh__D011369 68   
% 215.36/215.58  |- mesh__recordAuthorizer mesh__D011369 jls
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D011369 1998
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D011369 2001
% 215.36/215.58  |- skos__altLabel mesh__D011369 Professional Patient Relationship
% 215.36/215.58  |- skos__hiddenLabel mesh__D011369 Client, Contacting
% 215.36/215.58  |- mesh__dateCreated mesh__D011369 1999-01-01
% 215.36/215.58  |- skos__related mesh__D011369smesh__D014342
% 215.36/215.58  |- rdf__type mesh__D011369sskos__Concept
% 215.36/215.58  |- skos__hiddenLabel mesh__D011369 Relation, Professional-Patient
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D011369 2003
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D011369 1994
% 215.36/215.58  |- skos__hiddenLabel mesh__D011369 Professional Patient Relationships
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D011369 1999
% 215.36/215.58  |- skos__hiddenLabel mesh__D011369 Clients, Contacting
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D011369 2002
% 215.36/215.58  |- skos__prefLabel mesh__D011369 Professional-Patient Relations
% 215.36/215.58  |- skos__broader mesh__D011369smesh__D007398
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D011369 1993
% 215.36/215.58  |- mesh__dateRevised mesh__D011369 2002-10-31
% 215.36/215.58  |- skos__broader mesh__D011369smesh__D003695
% 215.36/215.58  |- skos__annotation mesh__D011369
% 215.36/215.58       no qualif; DF: PROFESSIONAL PATIENT RELAT   
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D011369 2004
% 215.36/215.58  |- skos__hiddenLabel mesh__D011369 Relations, Professional-Patient
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D011369 2003A
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D011369 1995
% 215.36/215.58  |- skos__hiddenLabel mesh__D011369 Contacting Client
% 215.36/215.58  |- skos__historyNote mesh__D011369
% 215.36/215.58       Interpersonal Relations %28%1966-1967%29%
% 215.36/215.58  |- skos__annotation mesh__D016852
% 215.36/215.58       for the able-bodied: do not confuse with HOMES FOR THE AGED, med %26% nurs care for the aged sick%A%  
% 215.36/215.58  |- mesh__dateEstablished mesh__D016852 1992-01-01
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D016852 2003
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D016852 2005
% 215.36/215.58  |- skos__prefLabel mesh__D016852 Housing for the Elderly
% 215.36/215.58  |- mesh__dateCreated mesh__D016852 1991-05-02
% 215.36/215.58  |- skos__related mesh__D016852smesh__D006707
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D016852 2004
% 215.36/215.58  |- mesh__recordAuthorizer mesh__D016852 sjn
% 215.36/215.58  |- mesh__recordMaintainer mesh__D016852 kle
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D016852 2006
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D016852 2000
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D016852 2001
% 215.36/215.58  |- mesh__publicMeSHNote mesh__D016852 92   
% 215.36/215.58  |- mesh__historyNote mesh__D016852 92   
% 215.36/215.58  |- mesh__recordOriginator mesh__D016852 TGC
% 215.36/215.58  |- skos__historyNote mesh__D016852 Housing %28%1967-1991%29%
% 215.36/215.58  |- skos__broader mesh__D016852smesh__D006798
% 215.36/215.58  |- rdf__type mesh__D016852sskos__Concept
% 215.36/215.58  |- mesh__dateRevised mesh__D016852 1999-11-03
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D016852 2002
% 215.36/215.58  |- skos__scopeNote mesh__D016852
% 215.36/215.58       Housing arrangements for the elderly or aged, intended to foster independent living. The housing may take the form of group homes or small apartments. It is available to the economically self-supporting but the concept includes housing for the elderly with some physical limitations. The concept should be differentiated from HOMES FOR THE AGED which is restricted to long-term geriatric facilities providing supervised medical and nursing services.%A%    
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D016054 1999
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D016054 2001
% 215.36/215.58  |- mesh__recordAuthorizer mesh__D016054 PLS
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D016054 2003
% 215.36/215.58  |- skos__historyNote mesh__D016054 specific protozoa %28%1966-1990%29%
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D016054 2000
% 215.36/215.58  |- mesh__recordOriginator mesh__D016054 AGS
% 215.36/215.58  |- rdf__type mesh__D016054sskos__Concept
% 215.36/215.58  |- skos__historyNote mesh__D016054 DNA %28%1966-1990%29%
% 215.36/215.58  |- mesh__dateCreated mesh__D016054 1990-02-12
% 215.36/215.58  |- mesh__dateEstablished mesh__D016054 1991-01-01
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D016054 1998
% 215.36/215.58  |- mesh__dateRevised mesh__D016054 1995-06-08
% 215.36/215.58  |- skos__annotation mesh__D016054
% 215.36/215.58       IM; coord with specific protozoon %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 215.36/215.58  |- skos__broader mesh__D016054smesh__D004247
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D016054 1997
% 215.36/215.58  |- skos__altLabel mesh__D016054 Protozoan DNA
% 215.36/215.58  |- skos__prefLabel mesh__D016054 DNA, Protozoan
% 215.36/215.58  |- skos__scopeNote mesh__D016054
% 215.36/215.58       Deoxyribonucleic acid that makes up the genetic material of protozoa.%A%    
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D016054 2006
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D016054 1996
% 215.36/215.58  |- mesh__publicMeSHNote mesh__D016054 91   
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D016054 2005
% 215.36/215.58  |- mesh__recordMaintainer mesh__D016054 KEV
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D016054 2002
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D016054 2004
% 215.36/215.58  |- mesh__historyNote mesh__D016054 91   
% 215.36/215.58  |- skos__hiddenLabel mesh__D002832 Hemorrhage, Choroidal
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D002832 2003
% 215.36/215.58  |- skos__broader mesh__D002832smesh__D015862
% 215.36/215.58  |- mesh__onlineNote mesh__D002832
% 215.36/215.58       use CHOROID HEMORRHAGE to search CHOROIDAL HEMORRHAGE 1987-89%A%  
% 215.36/215.58  |- skos__altLabel mesh__D002832 Choroidal Hemorrhage
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D002832 2001
% 215.36/215.58  |- mesh__recordOriginator mesh__D002832 RC
% 215.36/215.58  |- skos__historyNote mesh__D002832 Choroid %28%1966-1986%29%
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D002832 2004
% 215.36/215.58  |- skos__historyNote mesh__D002832 Hemorrhage %28%1966-1986%29%
% 215.36/215.58  |- mesh__dateEstablished mesh__D002832 1991-01-01
% 215.36/215.58  |- skos__prefLabel mesh__D002832 Choroid Hemorrhage
% 215.36/215.58  |- rdf__type mesh__D002832sskos__Concept
% 215.36/215.58  |- mesh__dateRevised mesh__D002832 1999-11-03
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D002832 2002
% 215.36/215.58  |- skos__scopeNote mesh__D002832
% 215.36/215.58       Hemorrhage from the vessels of the choroid.     
% 215.36/215.58  |- skos__broader mesh__D002832smesh__D005130
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D002832 2005
% 215.36/215.58  |- mesh__publicMeSHNote mesh__D002832
% 215.36/215.58       91; was see under EYE HEMORRHAGE 1987-90; was CHOROIDAL HEMORRHAGE 1987-89%A%  
% 215.36/215.58  |- skos__altLabel mesh__D002832 Hemorrhage, Choroid
% 215.36/215.58  |- mesh__historyNote mesh__D002832
% 215.36/215.58       91%28%87%29%; was see under EYE HEMORRHAGE 1987-90; was CHOROIDAL HEMORRHAGE 1987-89%A%  
% 215.36/215.58  |- mesh__recordAuthorizer mesh__D002832 sjn
% 215.36/215.58  |- skos__annotation mesh__D002832 of the eye, not of the choroid plexus   
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D002832 2006
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D002832 2000
% 215.36/215.58  |- mesh__dateCreated mesh__D002832 1986-04-08
% 215.36/215.58  |- mesh__recordMaintainer mesh__D002832 KEV
% 215.36/215.58  |- skos__hiddenLabel mesh__D002832 Choroidal Hemorrhages
% 215.36/215.58  |- rdf__type mesh__D002034sskos__Concept
% 215.36/215.58  |- mesh__dateEstablished mesh__D002034 1991-01-01
% 215.36/215.58  |- skos__altLabel mesh__D002034 Roche Brand of Bumetanide
% 215.36/215.58  |- skos__scopeNote mesh__D002034 A sulfamyl diuretic.     
% 215.36/215.58  |- skos__hiddenLabel mesh__D002034 Bumetanide AstraZeneca Brand
% 215.36/215.58  |- skos__hiddenLabel mesh__D002034 Bumetanide Roche Brand
% 215.36/215.58  |- mesh__dateRevised mesh__D002034 2005-06-30
% 215.36/215.58  |- skos__broader mesh__D002034smesh__D013449
% 215.36/215.58  |- skos__historyNote mesh__D002034 Butylamines %28%1974%29%
% 215.36/215.58  |- skos__altLabel mesh__D002034 Farmacusi Brand of Bumetanide
% 215.36/215.58  |- skos__historyNote mesh__D002034 Diuretics, Sulfamyl %28%1974%29%
% 215.36/215.58  |- skos__altLabel mesh__D002034 Grossmann Brand of Bumetanide
% 215.36/215.58  |- skos__hiddenLabel mesh__D002034 Bumetanide Grossmann Brand
% 215.36/215.58  |- skos__hiddenLabel mesh__D002034 PF1593
% 215.36/215.58  |- skos__hiddenLabel mesh__D002034 Bumetanide Leo Brand
% 215.36/215.58  |- skos__hiddenLabel mesh__D002034 Bumetanide Farmacusi Brand
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D002034 2006
% 215.36/215.58  |- mesh__recordOriginator mesh__D002034 NLM
% 215.36/215.58  |- skos__altLabel mesh__D002034 AstraZeneca Brand of Bumetanide
% 215.36/215.58  |- skos__historyNote mesh__D002034 Phenyl Ethers %28%1974%29%
% 215.36/215.58  |- skos__hiddenLabel mesh__D002034 Bumetanide Senosiain Brand
% 215.36/215.58  |- skos__altLabel mesh__D002034 Leo Brand of Bumetanide
% 215.36/215.58  |- mesh__recordAuthorizer mesh__D002034 sjn
% 215.36/215.58  |- skos__altLabel mesh__D002034 Bumethanide
% 215.36/215.58  |- mesh__publicMeSHNote mesh__D002034
% 215.36/215.58       91; was see under DIURETICS, SULFAMYL 1975-90   
% 215.36/215.58  |- skos__historyNote mesh__D002034 Benzoates %28%1974%29%
% 215.36/215.58  |- skos__prefLabel mesh__D002034 Bumetanide
% 215.36/215.58  |- skos__altLabel mesh__D002034 Senosiain Brand of Bumetanide
% 215.36/215.58  |- mesh__recordMaintainer mesh__D002034 ssb
% 215.36/215.58  |- skos__broader mesh__D002034smesh__D020185
% 215.36/215.58  |- skos__altLabel mesh__D002034 Atlantis Brand of Bumetanide
% 215.36/215.58  |- skos__hiddenLabel mesh__D002034 PF 1593
% 215.36/215.58  |- skos__hiddenLabel mesh__D002034 Bumetanide Atlantis Brand
% 215.36/215.58  |- mesh__historyNote mesh__D002034
% 215.36/215.58       91%28%75%29%; was see under DIURETICS, SULFAMYL 1975-90   
% 215.36/215.58  |- mesh__dateCreated mesh__D002034 1974-11-19
% 215.36/215.58  |- mesh__publicMeSHNote mesh__D012462
% 215.36/215.58       90; was see under SODIUM CHLORIDE 1975-89   
% 215.36/215.58  |- mesh__dateCreated mesh__D012462 1974-11-11
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D012462 2006
% 215.36/215.58  |- mesh__recordOriginator mesh__D012462 NLM
% 215.36/215.58  |- mesh__recordMaintainer mesh__D012462 ssb
% 215.36/215.58  |- skos__altLabel mesh__D012462 Hypertonic Saline Solution
% 215.36/215.58  |- skos__hiddenLabel mesh__D012462 Saline Hypertonic Solutions
% 215.36/215.58  |- skos__annotation mesh__D012462
% 215.36/215.58       NIM, no qualif; when IM, use D25-26 qualif; DF: SALINE SOL HYPERTONIC%A%  
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D012462 2005
% 215.36/215.58  |- skos__altLabel mesh__D012462 Sodium Chloride Solutions, Hypertonic
% 215.36/215.58  |- skos__hiddenLabel mesh__D012462 Saline Hypertonic Solution
% 215.36/215.58  |- rdf__type mesh__D012462sskos__Concept
% 215.36/215.58  |- skos__historyNote mesh__D012462 Hypertonic Solutions %28%1966-1974%29%
% 215.36/215.58  |- skos__broader mesh__D012462smesh__D006982
% 215.36/215.58  |- skos__altLabel mesh__D012462 Sodium Chloride Solution, Hypertonic
% 215.36/215.58  |- skos__altLabel mesh__D012462 Hypertonic Saline Solutions
% 215.36/215.58  |- mesh__dateRevised mesh__D012462 2003-07-09
% 215.36/215.58  |- skos__scopeNote mesh__D012462
% 215.36/215.58       Hypertonic sodium chloride solution. A solution having an osmotic pressure greater than that of physiologic salt solution %28%0.9 g NaCl in 100 ml purified water%29%.%A%    
% 215.36/215.58  |- skos__hiddenLabel mesh__D012462 Solution, Saline Hypertonic
% 215.36/215.58  |- skos__hiddenLabel mesh__D012462 Solution, Hypertonic Saline
% 215.36/215.58  |- skos__altLabel mesh__D012462 Saline Solutions, Hypertonic
% 215.36/215.58  |- mesh__dateEstablished mesh__D012462 1990-01-01
% 215.36/215.58  |- mesh__recordAuthorizer mesh__D012462 sjn
% 215.36/215.58  |- mesh__historyNote mesh__D012462
% 215.36/215.58       90%28%75%29%; was see under SODIUM CHLORIDE 1975-89   
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D012462 2004
% 215.36/215.58  |- skos__hiddenLabel mesh__D012462 Solutions, Saline Hypertonic
% 215.36/215.58  |- skos__altLabel mesh__D012462 Hypertonic Solutions, Saline
% 215.36/215.58  |- skos__hiddenLabel mesh__D012462 Solutions, Hypertonic Saline
% 215.36/215.58  |- skos__altLabel mesh__D012462 Hypertonic Solution, Saline
% 215.36/215.58  |- skos__historyNote mesh__D012462 Sodium Chloride %28%1966-1974%29%
% 215.36/215.58  |- skos__prefLabel mesh__D012462 Saline Solution, Hypertonic
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D006425 2004
% 215.36/215.58  |- skos__scopeNote mesh__D006425
% 215.36/215.58       Hematologic diseases and diseases of the lymphatic system collectively. Hemic diseases include disorders involving the formed elements %28%e.g., ERYTHROCYTE AGGREGATION, INTRAVASCULAR%29% and chemical components %28%e.g., BLOOD PROTEIN DISORDERS%29%; lymphatic diseases include disorders relating to lymph, lymph nodes, and lymphocytes.%A%    
% 215.36/215.58  |- mesh__dateRevised mesh__D006425 1997-06-20
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D006425 1998
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D006425 2000
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D006425 1999
% 215.36/215.58  |- rdf__type mesh__D006425sskos__Concept
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D006425 2001
% 215.36/215.58  |- mesh__publicMeSHNote mesh__D006425 98   
% 215.36/215.58  |- mesh__recordOriginator mesh__D006425 NLM
% 215.36/215.58  |- skos__annotation mesh__D006425
% 215.36/215.58       avoid: too general; prefer HEMATOLOGIC DISEASES %26% its specifics or LYMPHATIC DISEASES %26% its specifics; DF: HEMIC LYMPHATIC DIS      CATALOG: do not use%A%  
% 215.36/215.58  |- skos__prefLabel mesh__D006425 Hemic and Lymphatic Diseases
% 215.36/215.58  |- mesh__dateEstablished mesh__D006425 1998-01-01
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D006425 2005
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D006425 2002
% 215.36/215.58  |- mesh__recordAuthorizer mesh__D006425 SJN
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D006425 2006
% 215.36/215.58  |- mesh__recordMaintainer mesh__D006425 TGC
% 215.36/215.58  |- mesh__runningHead mesh__D006425 C15 - DISEASES-HEMIC AND LYMPHATIC   
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D006425 2003
% 215.36/215.58  |- mesh__dateCreated mesh__D006425 1999-01-01
% 215.36/215.58  |- mesh__historyNote mesh__D006425 98; use explode 1971-97   
% 215.36/215.58  |- skos__broader mesh__D050581smesh__D050491
% 215.36/215.58  |- mesh__recordOriginator mesh__D050581 DRC
% 215.36/215.58  |- skos__altLabel mesh__D050581 SLC1A6 Transporter
% 215.36/215.58  |- skos__prefLabel mesh__D050581 Excitatory Amino Acid Transporter 4
% 215.36/215.58  |- mesh__historyNote mesh__D050581 2006%28%2005%29%   
% 215.36/215.58  |- mesh__dateCreated mesh__D050581 2005-06-30
% 215.36/215.58  |- skos__altLabel mesh__D050581 EAAT-4 Excitatory Amino Acid Transporter
% 215.36/215.58  |- mesh__activeMeSHYear mesh__D050581 2006
% 215.36/215.58  |- skos__hiddenLabel mesh__D050581 EAAT 4 Excitatory Amino Acid Transporter
% 215.36/215.58  |- mesh__publicMeSHNote mesh__D050581
% 215.36/215.58       2006; EXCITATORY AMINO ACID TRANSPORTER 4 was indexed under SYMPORTERS %26% AMINO ACID TRANSPORT SYSTEM X-AG %28%2005%29%%A%  
% 215.36/215.58  |- mesh__recordAuthorizer mesh__D050581 sjn
% 215.36/215.58  |- mesh__dateEstablished mesh__D050581 2006-01-01
% 215.36/215.58  |- rdf__type mesh__D050581sskos__Concept
% 215.36/215.58  |- skos__scopeNote mesh__D050581
% 215.36/215.58       A glutamate plasma membrane transporter protein that is primarily expressed in cerebellar PURKINJE CELLS on postsynaptic DENDRITIC SPINES.%A%    
% 215.36/215.58  |- skos__hiddenLabel mesh__D050581 Transporter, SLC1A6
% 215.36/215.58  |- mesh__recordMaintainer mesh__D050581 DRC
% 215.36/215.58  |- mesh__dateEstablished mesh__D016853 1992-01-01
% 215.36/215.58  |- mesh__onlineNote mesh__D016853
% 215.36/215.58       use MUROMONAB-CD3 %28%NM%29% to search MONOCLONAL ANTIBODY OKT3 %28%NM%29% 1987-91%A%  
% 215.36/215.58  |- skos__altLabel mesh__D016853 Monoclonal Antibody OKT3
% 215.36/215.58  |- skos__annotation mesh__D016853
% 215.36/215.58       do not coordinate with ANTIBODY FORMATION for biosyn   
% 215.36/215.58  |- rdf__type mesh__D016853sskos__Concept
% 215.36/215.58  |- skos__altLabel mesh__D016853 Ortho Brand of Muromonab-CD3
% 215.36/215.58  |- skos__hiddenLabel mesh__D016853 Cilag Brand of Muromonab CD3
% 215.36/215.58  |- skos__altLabel mesh__D016853 OKT3
% 215.36/215.58  |- skos__historyNote mesh__D016853 Antibodies, Monoclonal %28%1981-1991%29%
% 215.36/215.58  |- mesh__dateRevised mesh__D016853 2005-06-30
% 215.36/215.58  |- skos__broader mesh__D016853smesh__D000911
% 215.36/215.58  |- mesh__publicMeSHNote mesh__D016853
% 215.36/215.58       92; MONOCLONAL ANTIBODY OKT3 was indexed under ANTIBODIES, MONOCLONAL 1987-91%A%  
% 215.36/215.58  |- skos__prefLabel mesh__D016853 Muromonab-CD3
% 215.36/215.58  |- skos__altLabel mesh__D016853 Janssen Brand of Muromonab-CD3
% 215.36/215.58  |- mesh__historyNote mesh__D016853
% 215.36/215.58       92; MONOCLONAL ANTIBODY OKT3 was MONOCLONAL ANTIBODY OKT3, ORTHOCLONE %28%NM%29% 1987-91%A%  
% 215.36/215.58  |- skos__hiddenLabel mesh__D016853 Ortho Brand of Muromonab CD3
% 215.36/215.58  |- mesh__dateCreated mesh__D016853 1991-07-12
% 215.36/215.59  |- skos__scopeNote mesh__D016853
% 215.36/215.59       Anti-CD3 monoclonal antibody that exerts immunosuppressive effects by inducing peripheral T-cell depletion and modulation of the T-cell receptor complex %28%CD3/Ti%29%. This biochemically purified IMMUNOGLOBULIN G is obtained through the fusion of mouse myeloma cells to lymphocytes from immunized animals to produce hybridomas that secrete specific antibodies to the T3 %28%CD3%29% antigens of human T-lymphocytes. It is often used as an IMMUNOSUPPRESSIVE AGENTS in TRANSPLANTATION.%A%    
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D016853 2006
% 215.36/215.59  |- skos__altLabel mesh__D016853 Cilag Brand of Muromonab-CD3
% 215.36/215.59  |- mesh__recordOriginator mesh__D016853 MXR
% 215.36/215.59  |- skos__broader mesh__D016853smesh__D007074
% 215.36/215.59  |- mesh__recordAuthorizer mesh__D016853 sjn
% 215.36/215.59  |- mesh__recordMaintainer mesh__D016853 ssb
% 215.36/215.59  |- skos__hiddenLabel mesh__D016853 Muromonab CD3
% 215.36/215.59  |- skos__hiddenLabel mesh__D016853 Janssen Brand of Muromonab CD3
% 215.36/215.59  |- mesh__publicMeSHNote mesh__D016055 91   
% 215.36/215.59  |- skos__historyNote mesh__D016055 Urination Disorders %28%1966-1990%29%
% 215.36/215.59  |- mesh__dateEstablished mesh__D016055 1991-01-01
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D016055 2006
% 215.36/215.59  |- skos__hiddenLabel mesh__D016055 Retention, Urinary
% 215.36/215.59  |- mesh__dateRevised mesh__D016055 2003-07-09
% 215.36/215.59  |- skos__broader mesh__D016055smesh__D014555
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D016055 2005
% 215.36/215.59  |- skos__prefLabel mesh__D016055 Urinary Retention
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D016055 2004
% 215.36/215.59  |- mesh__historyNote mesh__D016055 91   
% 215.36/215.59  |- skos__annotation mesh__D016055
% 215.36/215.59       do not confuse with ANURIA, total suppression of urine secretion by the kidneys%A%  
% 215.36/215.59  |- mesh__recordOriginator mesh__D016055 AGS
% 215.36/215.59  |- skos__scopeNote mesh__D016055
% 215.36/215.59       Inability to urinate. The etiology of this disorder includes obstructive, neurogenic, pharmacologic, and psychogenic causes.%A%    
% 215.36/215.59  |- mesh__recordAuthorizer mesh__D016055 sjn
% 215.36/215.59  |- rdf__type mesh__D016055sskos__Concept
% 215.36/215.59  |- mesh__dateCreated mesh__D016055 1990-03-23
% 215.36/215.59  |- skos__related mesh__D016055smesh__D014546
% 215.36/215.59  |- mesh__recordMaintainer mesh__D016055 lkt
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002833 2002
% 215.36/215.59  |- mesh__dateCreated mesh__D002833 1999-01-01
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002833 1995
% 215.36/215.59  |- skos__scopeNote mesh__D002833 Inflammation of the choroid.     
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002833 1992
% 215.36/215.59  |- mesh__recordMaintainer mesh__D002833 TGC
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002833 1999
% 215.36/215.59  |- skos__hiddenLabel mesh__D002833 Choroiditides
% 215.36/215.59  |- mesh__publicMeSHNote mesh__D002833 66   
% 215.36/215.59  |- mesh__dateRevised mesh__D002833 1991-06-20
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002833 2005
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002833 1996
% 215.36/215.59  |- skos__prefLabel mesh__D002833 Choroiditis
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002833 2000
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002833 1993
% 215.36/215.59  |- mesh__dateEstablished mesh__D002833 1966-01-01
% 215.36/215.59  |- mesh__recordOriginator mesh__D002833 NLM
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002833 2006
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002833 1997
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002833 2001
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002833 2003
% 215.36/215.59  |- mesh__historyNote mesh__D002833 66%28%64%29%   
% 215.36/215.59  |- skos__broader mesh__D002833smesh__D015862
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002833 1994
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002833 2004
% 215.36/215.59  |- skos__related mesh__D002833smesh__D002825
% 215.36/215.59  |- mesh__recordAuthorizer mesh__D002833 PLS
% 215.36/215.59  |- skos__broader mesh__D002833smesh__D015866
% 215.36/215.59  |- skos__annotation mesh__D002833
% 215.36/215.59       of the eye, not of the choroid plexus; consider also CHORIORETINITIS%A%  
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002833 1998
% 215.36/215.59  |- rdf__type mesh__D002833sskos__Concept
% 215.36/215.59  |- skos__prefLabel mesh__D002035 Bunaftine
% 215.36/215.59  |- mesh__recordOriginator mesh__D002035 SH
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002035 2002
% 215.36/215.59  |- skos__historyNote mesh__D002035 Butylamines %28%1966-1977%29%
% 215.36/215.59  |- skos__altLabel mesh__D002035 Bunaphtide
% 215.36/215.59  |- skos__historyNote mesh__D002035 Naphthalenes %28%1966-1977%29%
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002035 2004
% 215.36/215.59  |- mesh__recordAuthorizer mesh__D002035 PLS
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002035 2001
% 215.36/215.59  |- skos__altLabel mesh__D002035 Bunaphtine
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002035 2006
% 215.36/215.59  |- mesh__dateRevised mesh__D002035 1995-06-08
% 215.36/215.59  |- skos__altLabel mesh__D002035 Bunaftide
% 215.36/215.59  |- mesh__historyNote mesh__D002035
% 215.36/215.59       91%28%78%29%; was see under NAPHTHALENES 1978-90   
% 215.36/215.59  |- mesh__dateCreated mesh__D002035 1977-04-22
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002035 2003
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002035 1997
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002035 2000
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002035 2005
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002035 1999
% 215.36/215.59  |- mesh__recordMaintainer mesh__D002035 JRT
% 215.36/215.59  |- skos__broader mesh__D002035smesh__D009281
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002035 1996
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002035 1998
% 215.36/215.59  |- rdf__type mesh__D002035sskos__Concept
% 215.36/215.59  |- mesh__publicMeSHNote mesh__D002035
% 215.36/215.59       91; was see under NAPHTHALENES 1978-90   
% 215.36/215.59  |- mesh__dateEstablished mesh__D002035 1991-01-01
% 215.36/215.59  |- skos__annotation mesh__D002035 an anti-arrhythmic   
% 215.36/215.59  |- skos__scopeNote mesh__D002035
% 215.36/215.59       N-Butyl-N-%28%2-%28%diethylamino%29%ethyl%29%-1-naphthamide. A proposed antiarrhythmic that prolongs myocardial refractory period and stabilizes cell membranes.%A%    
% 215.36/215.59  |- skos__prefLabel mesh__D012463 Saliva
% 215.36/215.59  |- skos__hiddenLabel mesh__D012463 Salivas
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D012463 2002
% 215.36/215.59  |- mesh__recordAuthorizer mesh__D012463 sjn
% 215.36/215.59  |- rdf__type mesh__D012463sskos__Concept
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D012463 2004
% 215.36/215.59  |- skos__broader mesh__D012463smesh__D012634
% 215.36/215.59  |- skos__annotation mesh__D012463
% 215.36/215.59       TN 169: relation to SALIVATION %26% SALIVARY GLANDS; %22%salivary IMMUNOGLOBULIN A%22%: index SALIVA %28%IM%29% + IMMUNOGLOBULIN A, SECRETORY %28%IM%29%%A%  
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D012463 2003
% 215.36/215.59  |- mesh__recordOriginator mesh__D012463 NLM
% 215.36/215.59  |- mesh__recordMaintainer mesh__D012463 sjn
% 215.36/215.59  |- mesh__dateCreated mesh__D012463 1999-01-01
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D012463 2006
% 215.36/215.59  |- mesh__dateRevised mesh__D012463 2001-08-03
% 215.36/215.59  |- skos__scopeNote mesh__D012463
% 215.36/215.59       The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin.%A%    
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D012463 2005
% 215.36/215.59  |- skos__broader mesh__D006426smesh__D000644
% 215.36/215.59  |- mesh__dateEstablished mesh__D006426 1972-01-01
% 215.36/215.59  |- skos__historyNote mesh__D006426 Morpholines %28%1966-1971%29%
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D006426 2006
% 215.36/215.59  |- skos__scopeNote mesh__D006426
% 215.36/215.59       A potent inhibitor of the high affinity uptake system for CHOLINE. It has less effect on the low affinity uptake system. Since choline is one of the components of ACETYLCHOLINE, treatment with hemicholinium can deplete acetylcholine from cholinergic terminals. Hemicholinium 3 is commonly used as a research tool in animal and in vitro experiments.%A%    
% 215.36/215.59  |- skos__prefLabel mesh__D006426 Hemicholinium 3
% 215.36/215.59  |- mesh__recordMaintainer mesh__D006426 ssb
% 215.36/215.59  |- mesh__publicMeSHNote mesh__D006426 72   
% 215.36/215.59  |- mesh__historyNote mesh__D006426 72   
% 215.36/215.59  |- mesh__recordAuthorizer mesh__D006426 sjn
% 215.36/215.59  |- mesh__dateRevised mesh__D006426 2005-06-30
% 215.36/215.59  |- skos__altLabel mesh__D006426 Hemicholinium
% 215.36/215.59  |- rdf__type mesh__D006426sskos__Concept
% 215.36/215.59  |- mesh__dateCreated mesh__D006426 1999-01-01
% 215.36/215.59  |- mesh__recordOriginator mesh__D006426 NLM
% 215.36/215.59  |- mesh__recordMaintainer mesh__D050582 DRC
% 215.36/215.59  |- skos__hiddenLabel mesh__D050582 Transporter, SLC1A7
% 215.36/215.59  |- skos__broader mesh__D050582smesh__D050491
% 215.36/215.59  |- skos__prefLabel mesh__D050582 Excitatory Amino Acid Transporter 5
% 215.36/215.59  |- mesh__historyNote mesh__D050582 2006%28%2005%29%   
% 215.36/215.59  |- mesh__publicMeSHNote mesh__D050582
% 215.36/215.59       2006; EXCITATORY AMINO ACID TRANSPORTER 5 was indexed under SYMPORTERS %26% AMINO ACID TRANSPORT SYSTEM X-AG %28%2005%29%%A%  
% 215.36/215.59  |- skos__scopeNote mesh__D050582
% 215.36/215.59       A glutamate plasma membrane transporter protein that is primarily expressed in the RETINA.%A%    
% 215.36/215.59  |- skos__hiddenLabel mesh__D050582 EAAT 5 Excitatory Amino Acid Transporter
% 215.36/215.59  |- skos__altLabel mesh__D050582 SLC1A7 Transporter
% 215.36/215.59  |- mesh__dateCreated mesh__D050582 2005-06-30
% 215.36/215.59  |- mesh__recordAuthorizer mesh__D050582 sjn
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D050582 2006
% 215.36/215.59  |- rdf__type mesh__D050582sskos__Concept
% 215.36/215.59  |- mesh__dateEstablished mesh__D050582 2006-01-01
% 215.36/215.59  |- skos__altLabel mesh__D050582 EAAT-5 Excitatory Amino Acid Transporter
% 215.36/215.59  |- mesh__recordOriginator mesh__D050582 DRC
% 215.36/215.59  |- mesh__recordAuthorizer mesh__D016854 SJN
% 215.36/215.59  |- skos__hiddenLabel mesh__D016854 Odontophobias
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D016854 2004
% 215.36/215.59  |- skos__prefLabel mesh__D016854 Dental Anxiety
% 215.36/215.59  |- skos__hiddenLabel mesh__D016854 Dental Phobias
% 215.36/215.59  |- mesh__publicMeSHNote mesh__D016854 92   
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D016854 1998
% 215.36/215.59  |- mesh__dateEstablished mesh__D016854 1992-01-01
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D016854 2003
% 215.36/215.59  |- skos__altLabel mesh__D016854 Fear, Dental
% 215.36/215.59  |- skos__historyNote mesh__D016854 Anxiety %28%1966-1991%29%
% 215.36/215.59  |- skos__broader mesh__D016854smesh__D001007
% 215.36/215.59  |- skos__altLabel mesh__D016854 Dental Phobia
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D016854 2001
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D016854 2006
% 215.36/215.59  |- skos__altLabel mesh__D016854 Odontophobia
% 215.36/215.59  |- mesh__recordOriginator mesh__D016854 TGC
% 215.36/215.59  |- mesh__dateCreated mesh__D016854 1991-05-02
% 215.36/215.59  |- skos__annotation mesh__D016854
% 215.36/215.59       abnormal fear of dent care or dent proced; use Cat F3 qualif; DF: DENT ANXIETY%A%  
% 215.36/215.59  |- skos__altLabel mesh__D016854 Anxiety, Dental
% 215.36/215.59  |- skos__historyNote mesh__D016854 Fear %28%1966-1991%29%
% 215.36/215.59  |- skos__hiddenLabel mesh__D016854 Fears, Dental
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D016854 2000
% 215.36/215.59  |- skos__broader mesh__D016854smesh__D005239
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D016854 2005
% 215.36/215.59  |- mesh__historyNote mesh__D016854 92   
% 215.36/215.59  |- skos__hiddenLabel mesh__D016854 Phobias, Dental
% 215.36/215.59  |- skos__hiddenLabel mesh__D016854 Dental Anxieties
% 215.36/215.59  |- skos__hiddenLabel mesh__D016854 Dental Fears
% 215.36/215.59  |- mesh__recordMaintainer mesh__D016854 TGC
% 215.36/215.59  |- skos__altLabel mesh__D016854 Phobia, Dental
% 215.36/215.59  |- skos__scopeNote mesh__D016854
% 215.36/215.59       Abnormal fear or dread of visiting the dentist for preventive care or therapy and unwarranted anxiety over dental procedures.%A%    
% 215.36/215.59  |- skos__altLabel mesh__D016854 Dental Fear
% 215.36/215.59  |- skos__hiddenLabel mesh__D016854 Anxieties, Dental
% 215.36/215.59  |- rdf__type mesh__D016854sskos__Concept
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D016854 2002
% 215.36/215.59  |- skos__historyNote mesh__D016854 Dental Care %28%1977-1991%29%
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D016854 1999
% 215.36/215.59  |- mesh__dateRevised mesh__D016854 1997-06-24
% 215.36/215.59  |- mesh__dateCreated mesh__D049230 2004-07-07
% 215.36/215.59  |- mesh__dateEstablished mesh__D049230 2005-01-01
% 215.36/215.59  |- mesh__historyNote mesh__D049230 2005   
% 215.36/215.59  |- rdf__type mesh__D049230sskos__Concept
% 215.36/215.59  |- skos__altLabel mesh__D049230 RXR beta Receptor
% 215.36/215.59  |- mesh__recordAuthorizer mesh__D049230 sjn
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D049230 2006
% 215.36/215.59  |- mesh__recordOriginator mesh__D049230 ssb
% 215.36/215.59  |- mesh__publicMeSHNote mesh__D049230 2005   
% 215.36/215.59  |- skos__hiddenLabel mesh__D049230 Receptor, RXR beta
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D049230 2005
% 215.36/215.59  |- skos__historyNote mesh__D049230
% 215.36/215.59       Receptors, Retinoic Acid %28%1993-2004%29%
% 215.36/215.59  |- skos__broader mesh__D049230smesh__D047488
% 215.36/215.59  |- skos__prefLabel mesh__D049230 Retinoid X Receptor beta
% 215.36/215.59  |- mesh__recordMaintainer mesh__D049230 ssb
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D016056 2006
% 215.36/215.59  |- skos__hiddenLabel mesh__D016056 Determinants, Immunodominant Antigenic
% 215.36/215.59  |- mesh__recordMaintainer mesh__D016056 ssb
% 215.36/215.59  |- skos__hiddenLabel mesh__D016056 Immunodominant Antigenic Determinants
% 215.36/215.59  |- mesh__dateCreated mesh__D016056 1990-06-06
% 215.36/215.59  |- skos__altLabel mesh__D016056 Antigenic Determinants, Immunodominant
% 215.36/215.59  |- mesh__recordAuthorizer mesh__D016056 sjn
% 215.36/215.59  |- skos__hiddenLabel mesh__D016056 Domains, Immunodominant
% 215.36/215.59  |- mesh__publicMeSHNote mesh__D016056 91   
% 215.36/215.59  |- skos__altLabel mesh__D016056 Immunodominant Determinants
% 215.36/215.59  |- mesh__historyNote mesh__D016056 91   
% 215.36/215.59  |- skos__broader mesh__D016056smesh__D000939
% 215.36/215.59  |- skos__prefLabel mesh__D016056 Immunodominant Epitopes
% 215.36/215.59  |- skos__hiddenLabel mesh__D016056 Sites, Immunodominant
% 215.36/215.59  |- skos__altLabel mesh__D016056 Immunodominant Domains
% 215.36/215.59  |- skos__altLabel mesh__D016056 Immunodominant Sites
% 215.36/215.59  |- skos__hiddenLabel mesh__D016056 Regions, Immunodominant
% 215.36/215.59  |- skos__altLabel mesh__D016056 Immunodominant Regions
% 215.36/215.59  |- skos__historyNote mesh__D016056 Antigenic Determinants %28%1966-1990%29%
% 215.36/215.59  |- skos__scopeNote mesh__D016056
% 215.36/215.59       Subunits of the antigenic determinant that are most easily recognized by the immune system and thus most influence the specificity of the induced antibody.%A%    
% 215.36/215.59  |- rdf__type mesh__D016056sskos__Concept
% 215.36/215.59  |- skos__annotation mesh__D016056
% 215.36/215.59       subunits of epitopes most easily recognized by the immune system%A%  
% 215.36/215.59  |- skos__hiddenLabel mesh__D016056 Immunodominant Antigens
% 215.36/215.59  |- mesh__recordOriginator mesh__D016056 AGS
% 215.36/215.59  |- skos__hiddenLabel mesh__D016056 Determinants, Immunodominant
% 215.36/215.59  |- mesh__dateRevised mesh__D016056 2005-06-30
% 215.36/215.59  |- mesh__dateEstablished mesh__D016056 1991-01-01
% 215.36/215.59  |- skos__altLabel mesh__D016056 Epitopes, Immunodominant
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002834 2005
% 215.36/215.59  |- skos__hiddenLabel mesh__D002834 Scientists, Christian
% 215.36/215.59  |- skos__hiddenLabel mesh__D002834 Christian Scientist
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002834 2002
% 215.36/215.59  |- mesh__recordMaintainer mesh__D002834 kle
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002834 2006
% 215.36/215.59  |- skos__scopeNote mesh__D002834
% 215.36/215.59       A religion discovered by Mary Baker Eddy in 1866 that was organized under the official name of the Church of Christ, Scientist, that derives its teachings from the Scriptures as understood by its adherents, and that includes a practice of spiritual healing based upon the teaching that cause and effect are mental, and that sin, sickness, and death will be destroyed by a full understanding of the divine principle of Jesus%27% teaching and healing. %28%Webster, 3d ed%29%%A%    
% 215.36/215.59  |- mesh__recordAuthorizer mesh__D002834 sjn
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002834 2003
% 215.36/215.59  |- skos__broader mesh__D002834smesh__D002835
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002834 2000
% 215.36/215.59  |- skos__annotation mesh__D002834 IM; specify geog if pertinent   
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002834 2004
% 215.36/215.59  |- mesh__recordOriginator mesh__D002834 NLM
% 215.36/215.59  |- skos__hiddenLabel mesh__D002834 Scientist, Christian
% 215.36/215.59  |- skos__prefLabel mesh__D002834 Christian Science
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002834 2001
% 215.36/215.59  |- rdf__type mesh__D002834sskos__Concept
% 215.36/215.59  |- mesh__dateCreated mesh__D002834 1999-01-01
% 215.36/215.59  |- mesh__dateRevised mesh__D002834 1999-11-03
% 215.36/215.59  |- skos__hiddenLabel mesh__D002834 Science, Christian
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002036 2003
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002036 1997
% 215.36/215.59  |- mesh__historyNote mesh__D002036
% 215.36/215.59       91%28%75%29%; was see under HEART CONDUCTION SYSTEM 1975-90   
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002036 2005
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002036 1999
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002036 1993
% 215.36/215.59  |- mesh__recordOriginator mesh__D002036 NLM
% 215.36/215.59  |- mesh__dateCreated mesh__D002036 1999-01-01
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002036 1996
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002036 1995
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002036 1998
% 215.36/215.59  |- skos__hiddenLabel mesh__D002036 Atrioventricular Bundles
% 215.36/215.59  |- skos__broader mesh__D002036smesh__D006329
% 215.36/215.59  |- rdf__type mesh__D002036sskos__Concept
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002036 2002
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002036 1994
% 215.36/215.59  |- skos__scopeNote mesh__D002036
% 215.36/215.59       Small band of specialized cardiac muscle fibers that originates in the atrioventricular node and extends into the membranous part of the interventricular septum.%A%    
% 215.36/215.59  |- skos__hiddenLabel mesh__D002036 Bundles, Atrioventricular
% 215.36/215.59  |- skos__hiddenLabel mesh__D002036 His Bundle
% 215.36/215.59  |- mesh__recordAuthorizer mesh__D002036 PLS
% 215.36/215.59  |- mesh__publicMeSHNote mesh__D002036
% 215.36/215.59       91; was see under HEART CONDUCTION SYSTEM 1975-90   
% 215.36/215.59  |- mesh__dateEstablished mesh__D002036 1991-01-01
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002036 2001
% 215.36/215.59  |- mesh__onlineNote mesh__D002036 search HEART CONDUCTION SYSTEM 1966-74   
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002036 2004
% 215.36/215.59  |- skos__hiddenLabel mesh__D002036 Bundle, Atrioventricular
% 215.36/215.59  |- skos__prefLabel mesh__D002036 Bundle of His
% 215.36/215.59  |- mesh__dateRevised mesh__D002036 1992-03-25
% 215.36/215.59  |- mesh__recordMaintainer mesh__D002036 TAP
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002036 2000
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D002036 2006
% 215.36/215.59  |- skos__altLabel mesh__D002036 Atrioventricular Bundle
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D012464 1999
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D012464 1992
% 215.36/215.59  |- mesh__dateCreated mesh__D012464 1983-04-22
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D012464 1995
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D012464 2004
% 215.36/215.59  |- skos__broader mesh__D012464smesh__D009067
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D012464 2002
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D012464 1998
% 215.36/215.59  |- mesh__dateRevised mesh__D012464 1991-06-28
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D012464 1994
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D012464 2003
% 215.36/215.59  |- mesh__recordAuthorizer mesh__D012464 PLS
% 215.36/215.59  |- skos__historyNote mesh__D012464 Saliva %28%1966-1983%29%
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D012464 2006
% 215.36/215.59  |- skos__scopeNote mesh__D012464
% 215.36/215.59       A solution used for irrigating the mouth in xerostomia and as a substitute for saliva.%A%    
% 215.36/215.59  |- mesh__recordOriginator mesh__D012464 RC
% 215.36/215.59  |- mesh__recordMaintainer mesh__D012464 TAP
% 215.36/215.59  |- mesh__dateEstablished mesh__D012464 1991-01-01
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D012464 2001
% 215.36/215.59  |- skos__hiddenLabel mesh__D012464 Artificial Saliva
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D012464 1997
% 215.36/215.59  |- skos__prefLabel mesh__D012464 Saliva, Artificial
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D012464 2005
% 215.36/215.59  |- skos__annotation mesh__D012464 D25-D26 qualif   
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D012464 2000
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D012464 1993
% 215.36/215.59  |- mesh__publicMeSHNote mesh__D012464
% 215.36/215.59       91; was see under MOUTHWASHES 1984-90   
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D012464 1996
% 215.36/215.59  |- mesh__historyNote mesh__D012464
% 215.36/215.59       91%28%84%29%; was see under MOUTHWASHES 1984-90   
% 215.36/215.59  |- rdf__type mesh__D012464sskos__Concept
% 215.36/215.59  |- skos__altLabel mesh__D039601 EIF-4A2
% 215.36/215.59  |- skos__hiddenLabel mesh__D039601 Eukaryotic Peptide Initiation Factor 4A
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D039601 2004
% 215.36/215.59  |- skos__altLabel mesh__D039601 Eukaryotic Initiation Factor EIF-4A
% 215.36/215.59  |- skos__altLabel mesh__D039601 EIF-4A
% 215.36/215.59  |- skos__broader mesh__D039601smesh__D020365
% 215.36/215.59  |- skos__hiddenLabel mesh__D039601 Initiation Factor-4A1, Eukaryotic
% 215.36/215.59  |- skos__altLabel mesh__D039601 EIF-4A3
% 215.36/215.59  |- mesh__recordOriginator mesh__D039601 jmp
% 215.36/215.59  |- skos__hiddenLabel mesh__D039601 Eukaryotic Initiation Factor 4A3
% 215.36/215.59  |- skos__hiddenLabel mesh__D039601 Eukaryotic Initiation Factor EIF 4A
% 215.36/215.59  |- skos__scopeNote mesh__D039601
% 215.36/215.59       A component of eukaryotic initiation factor 4F that as an RNA helicase involved in unwinding the secondary structure of the 5%27% UNTRANSLATED REGION of MRNA. The unwinding facilitates the binding of the 40S ribosomal subunit.%A%    
% 215.36/215.59  |- skos__hiddenLabel mesh__D039601 Peptide Initiation Factor EIF 4A
% 215.36/215.59  |- skos__prefLabel mesh__D039601 Eukaryotic Initiation Factor-4A
% 215.36/215.59  |- skos__hiddenLabel mesh__D039601 Factor-4A1, Eukaryotic Initiation
% 215.36/215.59  |- skos__hiddenLabel mesh__D039601 Initiation Factor-4A3, Eukaryotic
% 215.36/215.59  |- mesh__historyNote mesh__D039601
% 215.36/215.59       2003; use EUKARYOTIC INITIATION FACTOR-F4A %28%NM%29% 1980-2001%A%  
% 215.36/215.59  |- mesh__dateRevised mesh__D039601 2003-07-09
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D039601 2005
% 215.36/215.59  |- skos__hiddenLabel mesh__D039601 Eukaryotic Initiation Factor 4A2
% 215.36/215.59  |- skos__hiddenLabel mesh__D039601 Initiation Factor-4A2, Eukaryotic
% 215.36/215.59  |- mesh__dateEstablished mesh__D039601 2003-01-01
% 215.36/215.59  |- rdf__type mesh__D039601sskos__Concept
% 215.36/215.59  |- skos__altLabel mesh__D039601 Eukaryotic Peptide Initiation Factor-4A
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D039601 2006
% 215.36/215.59  |- skos__altLabel mesh__D039601 EIF4AIII
% 215.36/215.59  |- mesh__recordAuthorizer mesh__D039601 sjn
% 215.36/215.59  |- skos__historyNote mesh__D039601
% 215.36/215.59       Peptide Initiation Factors %28%1980-2002%29%
% 215.36/215.59  |- skos__altLabel mesh__D039601
% 215.36/215.59       Eukaryotic Translation-Initiation Factor 4AIII
% 215.36/215.59  |- skos__altLabel mesh__D039601 Peptide Initiation Factor EIF-4A
% 215.36/215.59  |- skos__hiddenLabel mesh__D039601 Eukaryotic Initiation Factor 4A1
% 215.36/215.59  |- skos__altLabel mesh__D039601 EIF-4A1
% 215.36/215.59  |- mesh__dateCreated mesh__D039601 2002-07-03
% 215.36/215.59  |- skos__hiddenLabel mesh__D039601 Eukaryotic Initiation Factor 4A
% 215.36/215.59  |- skos__broader mesh__D039601smesh__D039562
% 215.36/215.59  |- mesh__publicMeSHNote mesh__D039601
% 215.36/215.59       2003; EIF-4A %28%now EUKARYOTIC INITIATION FACTOR-4A%29% was indexed under PEPTIDE INITIATION FACTORS 1980-2002%A%  
% 215.36/215.59  |- mesh__recordMaintainer mesh__D039601 ssb
% 215.36/215.59  |- skos__hiddenLabel mesh__D039601
% 215.36/215.59       Eukaryotic Translation Initiation Factor 4AIII
% 215.36/215.59  |- skos__hiddenLabel mesh__D039601 Factor-4A3, Eukaryotic Initiation
% 215.36/215.59  |- skos__hiddenLabel mesh__D039601 Factor-4A2, Eukaryotic Initiation
% 215.36/215.59  |- skos__hiddenLabel mesh__D039601 Initiation Factor-4A, Eukaryotic
% 215.36/215.59  |- mesh__historyNote mesh__D006427
% 215.36/215.59       91%28%75%29%; was see under HEME 1975-90   
% 215.36/215.59  |- skos__broader mesh__D006427smesh__D006418
% 215.36/215.59  |- skos__hiddenLabel mesh__D006427 Chloride, Ferriprotoporphyrin IX
% 215.36/215.59  |- skos__altLabel mesh__D006427 Ferriprotoporphyrin IX Chloride
% 215.36/215.59  |- skos__altLabel mesh__D006427 Protohemin IX
% 215.36/215.59  |- skos__annotation mesh__D006427 a porphyrin   
% 215.36/215.59  |- mesh__recordOriginator mesh__D006427 NLM
% 215.36/215.59  |- skos__altLabel mesh__D006427 Ferriheme Chloride
% 215.36/215.59  |- mesh__recordMaintainer mesh__D006427 ssb
% 215.36/215.59  |- skos__scopeNote mesh__D006427
% 215.36/215.59       Chloro%28%7,12-diethenyl-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoato%28%4-%29%-N%28%21%29%,N%28%22%29%,N%28%23%29%,N%28%24%29%%29% ferrate%28%2-%29% dihydrogen.%A%    
% 215.36/215.59  |- skos__altLabel mesh__D006427 Chlorohemin
% 215.36/215.59  |- skos__hiddenLabel mesh__D006427 Chloride, Ferriheme
% 215.36/215.59  |- skos__hiddenLabel mesh__D006427 Hematin D-575, Alkaline
% 215.36/215.59  |- rdf__type mesh__D006427sskos__Concept
% 215.36/215.59  |- skos__hiddenLabel mesh__D006427 Alkaline Hematin D 575
% 215.36/215.59  |- mesh__publicMeSHNote mesh__D006427 91; was see under HEME 1975-90   
% 215.36/215.59  |- skos__prefLabel mesh__D006427 Hemin
% 215.36/215.59  |- mesh__recordAuthorizer mesh__D006427 sjn
% 215.36/215.59  |- mesh__dateCreated mesh__D006427 1999-01-01
% 215.36/215.59  |- mesh__dateRevised mesh__D006427 2005-06-30
% 215.36/215.59  |- mesh__dateEstablished mesh__D006427 1991-01-01
% 215.36/215.59  |- skos__altLabel mesh__D006427 Protohemin
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D006427 2006
% 215.36/215.59  |- mesh__onlineNote mesh__D006427 search HEME 1968-74   
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D016855 2006
% 215.36/215.59  |- skos__prefLabel mesh__D016855 Nairovirus
% 215.36/215.59  |- skos__broader mesh__D016855smesh__D002043
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D016855 2005
% 215.36/215.59  |- mesh__dateRevised mesh__D016855 2001-07-25
% 215.36/215.59  |- mesh__historyNote mesh__D016855 1992   
% 215.36/215.59  |- mesh__recordAuthorizer mesh__D016855 sjn
% 215.36/215.59  |- mesh__publicMeSHNote mesh__D016855
% 215.36/215.59       1992; for DUGBE VIRUS see NAIROBI SHEEP DISEASE VIRUSES 1994-2001%A%  
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D016855 2002
% 215.36/215.59  |- skos__historyNote mesh__D016855 Bunyaviridae %28%1980-1991%29%
% 215.36/215.59  |- mesh__dateEstablished mesh__D016855 1992-01-01
% 215.36/215.59  |- skos__annotation mesh__D016855
% 215.36/215.59       infection = NAIROBI SHEEP DISEASE or HEMORRHAGIC FEVER, CRIMEAN or if not so specified, coord IM with BUNYAVIRIDAE INFECTIONS %28%IM%29%%A%  
% 215.36/215.59  |- rdf__type mesh__D016855sskos__Concept
% 215.36/215.59  |- skos__hiddenLabel mesh__D016855 Nairoviruses
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D016855 2004
% 215.36/215.59  |- mesh__recordOriginator mesh__D016855 AGS
% 215.36/215.59  |- skos__scopeNote mesh__D016855
% 215.36/215.59       A genus of the family BUNYAVIRIDAE named after NAIROBI SHEEP DISEASE, an acute, hemorrhagic, tick-borne, gastroenteritis affecting sheep and goats. The type species is Dugbe virus. Some viruses in this genus are capable of causing severe and fatal disease in humans.%A%    
% 215.36/215.59  |- mesh__dateCreated mesh__D016855 1991-05-02
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D016855 2003
% 215.36/215.59  |- mesh__recordMaintainer mesh__D016855 ags
% 215.36/215.59  |- skos__altLabel mesh__D049231 Coglucosidase
% 215.36/215.59  |- mesh__recordOriginator mesh__D049231 jmp
% 215.36/215.59  |- mesh__activeMeSHYear mesh__D049231 2006
% 215.36/215.59  |- skos__altLabel mesh__D049231 SAP-1 Sphingolipid Activator
% 215.36/215.59  |- skos__hiddenLabel mesh__D049231 SAP A Protein
% 215.36/215.59  |- skos__hiddenLabel mesh__D049231 SAP D Protein
% 215.36/215.59  |- skos__altLabel mesh__D049231 Sphingolipid Activator Protein 2
% 215.36/215.59  |- mesh__dateEstablished mesh__D049231 2005-01-01
% 215.36/215.59  |- skos__altLabel mesh__D049231 Glucosylceramidase Activator
% 215.36/215.59  |- skos__hiddenLabel mesh__D049231 Co beta Glucosidase
% 215.36/215.59  |- skos__altLabel mesh__D049231 Testibumin
% 215.36/215.59  |- skos__altLabel mesh__D049231 Co-beta-Glucosidase
% 215.36/215.59  |- skos__historyNote mesh__D049231 Glycoproteins %28%1977-2004%29%
% 215.36/215.59  |- skos__hiddenLabel mesh__D049231 SAP C Protein
% 215.36/215.59  |- mesh__recordAuthorizer mesh__D049231 sjn
% 215.36/215.59  |- skos__altLabel mesh__D049231 SAP-C Protein
% 215.36/215.59  |- skos__altLabel mesh__D049231 Gaucher Activator Protein
% 215.36/215.60  |- skos__altLabel mesh__D049231 Sphingolipid Activator Protein-1
% 215.36/215.60  |- mesh__historyNote mesh__D049231 2005%28%1977%29%   
% 215.36/215.60  |- skos__altLabel mesh__D049231 Sphingolipid Activator Protein 1
% 215.36/215.60  |- skos__altLabel mesh__D049231 beta-Glucosidase Stimulating Protein
% 215.36/215.60  |- skos__hiddenLabel mesh__D049231 beta Glucosidase Activator Protein
% 215.36/215.60  |- skos__altLabel mesh__D049231 SAP-A Protein
% 215.36/215.60  |- skos__hiddenLabel mesh__D049231 SAP 1 Sphingolipid Activator
% 215.36/215.60  |- mesh__recordMaintainer mesh__D049231 SYSTEM
% 215.45/215.60  |- skos__altLabel mesh__D049231 SAP-D Protein
% 215.45/215.60  |- skos__broader mesh__D049231smesh__D049128
% 215.45/215.60  |- mesh__dateCreated mesh__D049231 2004-07-07
% 215.45/215.60  |- skos__hiddenLabel mesh__D049231 Sphingolipid Activator, SAP-1
% 215.45/215.60  |- mesh__publicMeSHNote mesh__D049231
% 215.45/215.60       2005; SAPOSIN A was indexed under GLYCOPROTEINS 1989-2004; SAPOSIN B was indexed under GLYCOPROTEINS 1993-2004 %26% PROTEINS 1981-1992; SAPOSIN D was indexed under GLYCOPROTEINS 1988-2004%A%  
% 215.45/215.60  |- skos__hiddenLabel mesh__D049231 beta Glucosidase Stimulating Protein
% 215.45/215.60  |- skos__prefLabel mesh__D049231 Saposins
% 215.45/215.60  |- rdf__type mesh__D049231sskos__Concept
% 215.45/215.60  |- skos__scopeNote mesh__D049231
% 215.45/215.60       A group of four homologous sphingolipid activator proteins that are formed from proteolytic cleavage of a common protein precursor molecule referred to as prosaposin.%A%    
% 215.45/215.60  |- mesh__dateRevised mesh__D049231 2005-06-30
% 215.45/215.60  |- skos__altLabel mesh__D049231 beta-Glucosidase Activator Protein
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D016057 1998
% 215.45/215.60  |- skos__altLabel mesh__D016057 Evoked Response, Auditory, Brain Stem
% 215.45/215.60  |- skos__annotation mesh__D016057 IM; DF: BAEP   
% 215.45/215.60  |- skos__hiddenLabel mesh__D016057 Response, Auditory Brainstem
% 215.45/215.60  |- skos__altLabel mesh__D016057 Brainstem Auditory Evoked Potentials
% 215.45/215.60  |- mesh__recordOriginator mesh__D016057 AGS
% 215.45/215.60  |- skos__hiddenLabel mesh__D016057 Brainstem Responses, Auditory
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D016057 2000
% 215.45/215.60  |- skos__hiddenLabel mesh__D016057 Brainstem Response, Auditory
% 215.45/215.60  |- skos__altLabel mesh__D016057 Acoustic Evoked Brain Stem Potentials
% 215.45/215.60  |- mesh__dateEstablished mesh__D016057 1991-01-01
% 215.45/215.60  |- skos__historyNote mesh__D016057
% 215.45/215.60       Evoked Potentials, Auditory %28%1979-1990%29%
% 215.45/215.60  |- mesh__dateCreated mesh__D016057 1990-03-23
% 215.45/215.60  |- skos__hiddenLabel mesh__D016057 Responses, Auditory Brainstem
% 215.45/215.60  |- skos__altLabel mesh__D016057 Brain Stem Auditory Evoked Potential
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D016057 2004
% 215.45/215.60  |- skos__altLabel mesh__D016057 Auditory Brain Stem Evoked Response
% 215.45/215.60  |- mesh__dateRevised mesh__D016057 1995-02-23
% 215.45/215.60  |- skos__scopeNote mesh__D016057
% 215.45/215.60       Electrical waves in the cerebral cortex generated by brain stem structures in response to auditory click stimuli. These are found to be abnormal in many patients with cerebellopontine angle lesions, multiple sclerosis, or other demyelinating diseases.%A%    
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D016057 1997
% 215.45/215.60  |- skos__altLabel mesh__D016057 Evoked Responses, Auditory, Brainstem
% 215.45/215.60  |- skos__historyNote mesh__D016057 Evoked Potentials %28%1970-1979%29%
% 215.45/215.60  |- mesh__recordAuthorizer mesh__D016057 PLS
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D016057 2003
% 215.45/215.60  |- skos__altLabel mesh__D016057 Brainstem Auditory Evoked Potential
% 215.45/215.60  |- skos__altLabel mesh__D016057 Acoustic Evoked Brainstem Potential
% 215.45/215.60  |- skos__altLabel mesh__D016057 Evoked Potentials, Auditory, Brainstem
% 215.45/215.60  |- skos__altLabel mesh__D016057 Auditory Brain Stem Evoked Responses
% 215.45/215.60  |- mesh__publicMeSHNote mesh__D016057 91   
% 215.45/215.60  |- skos__altLabel mesh__D016057 Auditory Brainstem Evoked Responses
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D016057 2002
% 215.45/215.60  |- skos__altLabel mesh__D016057 Brain Stem Auditory Evoked Potentials
% 215.45/215.60  |- rdf__type mesh__D016057sskos__Concept
% 215.45/215.60  |- mesh__recordMaintainer mesh__D016057 AGS
% 215.45/215.60  |- mesh__historyNote mesh__D016057 91   
% 215.45/215.60  |- skos__altLabel mesh__D016057 Auditory Brainstem Evoked Response
% 215.45/215.60  |- skos__altLabel mesh__D016057 Auditory Brain Stem Response
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D016057 1996
% 215.45/215.60  |- skos__altLabel mesh__D016057 Auditory Brain Stem Responses
% 215.45/215.60  |- skos__prefLabel mesh__D016057 Evoked Potentials, Auditory, Brain Stem
% 215.45/215.60  |- skos__broader mesh__D016057smesh__D005072
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D016057 2006
% 215.45/215.60  |- skos__hiddenLabel mesh__D016057 Auditory Brainstem Response
% 215.45/215.60  |- skos__altLabel mesh__D016057 Acoustic Evoked Brain Stem Potential
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D016057 1999
% 215.45/215.60  |- skos__altLabel mesh__D016057 Acoustic Evoked Brainstem Potentials
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D016057 2005
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D016057 2001
% 215.45/215.60  |- skos__related mesh__D016057smesh__D001300
% 215.45/215.60  |- skos__altLabel mesh__D016057 Evoked Response, Auditory, Brainstem
% 215.45/215.60  |- skos__altLabel mesh__D016057 Evoked Potential, Auditory, Brainstem
% 215.45/215.60  |- skos__altLabel mesh__D016057 Evoked Responses, Auditory, Brain Stem
% 215.45/215.60  |- rdf__type mesh__D002835sskos__Concept
% 215.45/215.60  |- mesh__historyNote mesh__D002835 1963   
% 215.45/215.60  |- skos__hiddenLabel mesh__D002835 Christian Ethic
% 215.45/215.60  |- mesh__recordOriginator mesh__D002835 NLM
% 215.45/215.60  |- mesh__dateCreated mesh__D002835 1999-01-01
% 215.45/215.60  |- skos__scopeNote mesh__D002835
% 215.45/215.60       The religion stemming from the life, teachings, and death of Jesus Christ: the religion that believes in God as the Father Almighty who works redemptively through the Holy Spirit for men%27%s salvation and that affirms Jesus Christ as Lord and Savior who proclaimed to man the gospel of salvation. %28%From Webster, 3d ed%29%%A%    
% 215.45/215.60  |- skos__broader mesh__D002835smesh__D012067
% 215.45/215.60  |- skos__prefLabel mesh__D002835 Christianity
% 215.45/215.60  |- mesh__dateRevised mesh__D002835 2002-07-03
% 215.45/215.60  |- mesh__recordMaintainer mesh__D002835 tjk
% 215.45/215.60  |- skos__hiddenLabel mesh__D002835 Ethics, Christian
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D002835 2006
% 215.45/215.60  |- skos__hiddenLabel mesh__D002835 Ethic, Christian
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D002835 2004
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D002835 2005
% 215.45/215.60  |- mesh__recordAuthorizer mesh__D002835 sjn
% 215.45/215.60  |- skos__annotation mesh__D002835 specify geog if pertinent   
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D002835 2003
% 215.45/215.60  |- mesh__dateCreated mesh__D002037 1999-01-01
% 215.45/215.60  |- skos__hiddenLabel mesh__D002037 Block, Bundle-Branch
% 215.45/215.60  |- skos__scopeNote mesh__D002037
% 215.45/215.60       A form of heart block in which one ventricle is excited before the other because of absence of conduction in one of the branches of the bundle of His.%A%    
% 215.45/215.60  |- mesh__recordMaintainer mesh__D002037 TAP
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D002037 2000
% 215.45/215.60  |- mesh__dateRevised mesh__D002037 1999-11-03
% 215.45/215.60  |- skos__hiddenLabel mesh__D002037 Fascicular Blocks
% 215.45/215.60  |- skos__hiddenLabel mesh__D002037 Blocks, Fascicular
% 215.45/215.60  |- rdf__type mesh__D002037sskos__Concept
% 215.45/215.60  |- skos__annotation mesh__D002037 disord of bundle of His   
% 215.45/215.60  |- skos__prefLabel mesh__D002037 Bundle-Branch Block
% 215.45/215.60  |- mesh__recordOriginator mesh__D002037 NLM
% 215.45/215.60  |- skos__hiddenLabel mesh__D002037 Blocks, Bundle-Branch
% 215.45/215.60  |- mesh__recordAuthorizer mesh__D002037 sjn
% 215.45/215.60  |- skos__broader mesh__D002037smesh__D006327
% 215.45/215.60  |- skos__hiddenLabel mesh__D002037 Block, Fascicular
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D002037 2004
% 215.45/215.60  |- skos__hiddenLabel mesh__D002037 Bundle Branch Block
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D002037 2002
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D002037 2006
% 215.45/215.60  |- skos__hiddenLabel mesh__D002037 Bundle-Branch Blocks
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D002037 2003
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D002037 2001
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D002037 2005
% 215.45/215.60  |- mesh__recordOriginator mesh__D007520 NLM
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D007520 2006
% 215.45/215.60  |- skos__prefLabel mesh__D007520 Isocarboxazid
% 215.45/215.60  |- mesh__dateCreated mesh__D007520 1999-01-01
% 215.45/215.60  |- skos__scopeNote mesh__D007520
% 215.45/215.60       An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. %28%From AMA, Drug Evaluations Annual, 1994, p311%29%%A%    
% 215.45/215.60  |- mesh__recordMaintainer mesh__D007520 ssb
% 215.45/215.60  |- rdf__type mesh__D007520sskos__Concept
% 215.45/215.60  |- mesh__dateRevised mesh__D007520 2005-06-30
% 215.45/215.60  |- skos__broader mesh__D007520smesh__D007555
% 215.45/215.60  |- mesh__recordAuthorizer mesh__D007520 sjn
% 215.45/215.60  |- skos__altLabel mesh__D012465 Salivary Duct Stones
% 215.45/215.60  |- skos__hiddenLabel mesh__D012465 Stone, Salivary Duct
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D012465 2003
% 215.45/215.60  |- mesh__recordMaintainer mesh__D012465 ags
% 215.45/215.60  |- mesh__dateCreated mesh__D012465 1999-01-01
% 215.45/215.60  |- skos__hiddenLabel mesh__D012465 Salivary Duct Calculus
% 215.45/215.60  |- skos__hiddenLabel mesh__D012465 Duct Calculus, Salivary
% 215.45/215.60  |- skos__altLabel mesh__D012465 Sialolithiasis, Ductal
% 215.45/215.60  |- skos__hiddenLabel mesh__D012465 Stones, Salivary Duct
% 215.45/215.60  |- skos__hiddenLabel mesh__D012465 Salivary Duct Stone
% 215.45/215.60  |- skos__hiddenLabel mesh__D012465 Duct Stones, Salivary
% 215.45/215.60  |- skos__hiddenLabel mesh__D012465 Sialolithiases, Ductal
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D012465 2004
% 215.45/215.60  |- mesh__recordOriginator mesh__D012465 NLM
% 215.45/215.60  |- mesh__publicMeSHNote mesh__D012465
% 215.45/215.60       66; SIALOLITHIASIS was see SALIVARY DUCT CALCULI 1966-88   
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D012465 2002
% 215.45/215.60  |- skos__hiddenLabel mesh__D012465 Duct Calculi, Salivary
% 215.45/215.60  |- skos__broader mesh__D012465smesh__D020792
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D012465 2005
% 215.45/215.60  |- skos__hiddenLabel mesh__D012465 Calculi, Salivary Duct
% 215.45/215.60  |- skos__broader mesh__D012465smesh__D012466
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D012465 2006
% 215.45/215.60  |- mesh__historyNote mesh__D012465
% 215.45/215.60       66; SIALOLITHIASIS was see SALIVARY DUCT CALCULI 1966-88   
% 215.45/215.60  |- skos__annotation mesh__D012465
% 215.45/215.60       chem composition of calculi: use /chem; /ultrastruct permitted; coord IM with specific precoord salivary gland dis term %28%IM%29%; do not confuse with SALIVARY GLAND CALCULI%A%  
% 215.45/215.60  |- mesh__onlineNote mesh__D012465
% 215.45/215.60       use SALIVARY DUCT CALCULI to search SIALOLITHIASIS 1966-88; to search for chem composition of salivary duct calculi, use SALIVARY DUCT CALCULI/anal 1987-90 %26% SALIVARY DUCT CALCULI/metab 1966-86%A%  
% 215.45/215.60  |- skos__scopeNote mesh__D012465
% 215.45/215.60       Presence of small calculi in the terminal salivary ducts %28%salivary sand%29%, or stones %28%larger calculi%29% found in the larger ducts.%A%    
% 215.45/215.60  |- skos__hiddenLabel mesh__D012465 Duct Stone, Salivary
% 215.45/215.60  |- mesh__recordAuthorizer mesh__D012465 sjn
% 215.45/215.60  |- skos__hiddenLabel mesh__D012465 Calculus, Salivary Duct
% 215.45/215.60  |- mesh__dateRevised mesh__D012465 2001-07-25
% 215.45/215.60  |- rdf__type mesh__D012465sskos__Concept
% 215.45/215.60  |- skos__prefLabel mesh__D012465 Salivary Duct Calculi
% 215.45/215.60  |- mesh__historyNote mesh__D039602 2003   
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D039602 2003
% 215.45/215.60  |- skos__altLabel mesh__D039602 Out-of-Hours Medical Care
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D039602 2006
% 215.45/215.60  |- mesh__dateCreated mesh__D039602 2002-07-02
% 215.45/215.60  |- skos__hiddenLabel mesh__D039602 Out of Hours Medical Care
% 215.45/215.60  |- skos__hiddenLabel mesh__D039602 Medical Care, Out-of-Hours
% 215.45/215.60  |- skos__related mesh__D039602smesh__D009551
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D039602 2005
% 215.45/215.60  |- skos__historyNote mesh__D039602
% 215.45/215.60       Emergency Medical Services %28%1991-2002%29%
% 215.45/215.60  |- skos__historyNote mesh__D039602 Telephone %28%1991-2002%29%
% 215.45/215.60  |- skos__broader mesh__D039602smesh__D003695
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D039602 2004
% 215.45/215.60  |- skos__scopeNote mesh__D039602
% 215.45/215.60       Medical care provided after the regular practice schedule of the physicians. Usually it is designed to deliver 24-hour-a-day and 365-day-a-year patient care coverage for emergencies, triage, pediatric care, or hospice care.%A%    
% 215.45/215.60  |- rdf__type mesh__D039602sskos__Concept
% 215.45/215.60  |- mesh__publicMeSHNote mesh__D039602 2003   
% 215.45/215.60  |- skos__prefLabel mesh__D039602 After-Hours Care
% 215.45/215.60  |- mesh__dateEstablished mesh__D039602 2003-01-01
% 215.45/215.60  |- skos__altLabel mesh__D039602 After Hours Care
% 215.45/215.60  |- mesh__dateCreated mesh__D006428 1974-12-12
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D006428 2003
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D006428 2006
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D006428 2005
% 215.45/215.60  |- skos__annotation mesh__D006428
% 215.45/215.60       do not use /util except by MeSH definition   
% 215.45/215.60  |- mesh__recordMaintainer mesh__D006428 PXP
% 215.45/215.60  |- mesh__dateRevised mesh__D006428 1997-06-20
% 215.45/215.60  |- mesh__publicMeSHNote mesh__D006428
% 215.45/215.60       91; was see under AMPUTATION 1975-90   
% 215.45/215.60  |- rdf__type mesh__D006428sskos__Concept
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D006428 1999
% 215.45/215.60  |- mesh__historyNote mesh__D006428
% 215.45/215.60       91%28%75%29%; was see under AMPUTATION 1975-90   
% 215.45/215.60  |- mesh__dateEstablished mesh__D006428 1991-01-01
% 215.45/215.60  |- skos__broader mesh__D006428smesh__D000671
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D006428 1998
% 215.45/215.60  |- skos__scopeNote mesh__D006428
% 215.45/215.60       Amputation of a lower limb through the sacroiliac joint.%A%    
% 215.45/215.60  |- skos__prefLabel mesh__D006428 Hemipelvectomy
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D006428 2002
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D006428 2001
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D006428 2004
% 215.45/215.60  |- mesh__recordAuthorizer mesh__D006428 SJN
% 215.45/215.60  |- skos__hiddenLabel mesh__D006428 Hemipelvectomies
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D006428 2000
% 215.45/215.60  |- mesh__recordOriginator mesh__D006428 NLM
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D017150 2003
% 215.45/215.60  |- mesh__historyNote mesh__D017150 93   
% 215.45/215.60  |- skos__prefLabel mesh__D017150 Public Sector
% 215.45/215.60  |- skos__scopeNote mesh__D017150
% 215.45/215.60       The area of a nation%27%s economy that is tax-supported and under government control.%A%    
% 215.45/215.60  |- skos__hiddenLabel mesh__D017150 Public Sectors
% 215.45/215.60  |- skos__hiddenLabel mesh__D017150 Public Domains
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D017150 2001
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D017150 2000A
% 215.45/215.60  |- mesh__recordAuthorizer mesh__D017150 ags
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D017150 2004
% 215.45/215.60  |- mesh__dateCreated mesh__D017150 1992-05-22
% 215.45/215.60  |- skos__hiddenLabel mesh__D017150 Enterprises, Public
% 215.45/215.60  |- skos__hiddenLabel mesh__D017150 Domains, Public
% 215.45/215.60  |- skos__hiddenLabel mesh__D017150 Domain, Public
% 215.45/215.60  |- skos__historyNote mesh__D017150 Government Agencies %28%1979-1992%29%
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D017150 2002
% 215.45/215.60  |- skos__hiddenLabel mesh__D017150 Enterprise, Public
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D017150 2005
% 215.45/215.60  |- skos__hiddenLabel mesh__D017150 Sectors, Public
% 215.45/215.60  |- skos__broader mesh__D017150smesh__D012942
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D017150 2006
% 215.45/215.60  |- mesh__dateEstablished mesh__D017150 1993-01-01
% 215.45/215.60  |- mesh__recordOriginator mesh__D017150 JLS
% 215.45/215.60  |- skos__broader mesh__D017150smesh__D010067
% 215.45/215.60  |- skos__annotation mesh__D017150
% 215.45/215.60       IM; specify nature of public endeavor %28%IM%29%; specify geog if pertinent%A%  
% 215.45/215.60  |- skos__hiddenLabel mesh__D017150 Sector, Public
% 215.45/215.60  |- mesh__publicMeSHNote mesh__D017150 93   
% 215.45/215.60  |- skos__hiddenLabel mesh__D017150 Public Enterprises
% 215.45/215.60  |- rdf__type mesh__D017150sskos__Concept
% 215.45/215.60  |- mesh__recordMaintainer mesh__D017150 ags
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D017150 2000
% 215.45/215.60  |- mesh__dateRevised mesh__D017150 1999-12-28
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D003130 2004
% 215.45/215.60  |- mesh__dateRevised mesh__D003130 2002-07-03
% 215.45/215.60  |- skos__hiddenLabel mesh__D003130 Combat Disorder
% 215.45/215.60  |- rdf__type mesh__D003130sskos__Concept
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D003130 2005
% 215.45/215.60  |- skos__altLabel mesh__D003130 War Neuroses
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D003130 2003
% 215.45/215.60  |- skos__altLabel mesh__D003130 Combat Neuroses
% 215.45/215.60  |- skos__related mesh__D003130smesh__D013313
% 215.45/215.60  |- mesh__onlineNote mesh__D003130
% 215.45/215.60       use COMBAT DISORDERS to search NEUROSES, WAR 1966-80   
% 215.45/215.60  |- skos__hiddenLabel mesh__D003130 Neurosis, Combat
% 215.45/215.60  |- skos__hiddenLabel mesh__D003130 Neurosis, War
% 215.45/215.60  |- skos__altLabel mesh__D003130 Neuroses, War
% 215.45/215.60  |- mesh__dateEstablished mesh__D003130 1963-01-01
% 215.45/215.60  |- skos__broader mesh__D003130smesh__D040921
% 215.45/215.60  |- skos__hiddenLabel mesh__D003130 Disorders, Combat
% 215.45/215.60  |- mesh__recordAuthorizer mesh__D003130 sjn
% 215.45/215.60  |- mesh__recordMaintainer mesh__D003130 JLS
% 215.45/215.60  |- mesh__dateCreated mesh__D003130 1999-01-01
% 215.45/215.60  |- mesh__recordOriginator mesh__D003130 NLM
% 215.45/215.60  |- mesh__publicMeSHNote mesh__D003130
% 215.45/215.60       91; was see under STRESS DISORDERS, POST-TRAUMATIC 1981-90; was NEUROSES, WAR 1963-80%A%  
% 215.45/215.60  |- skos__hiddenLabel mesh__D003130 Neuroses, Combat
% 215.45/215.60  |- skos__prefLabel mesh__D003130 Combat Disorders
% 215.45/215.60  |- mesh__historyNote mesh__D003130
% 215.45/215.60       91%28%81%29%; was see under STRESS DISORDERS, POST-TRAUMATIC 1981-90; was NEUROSES, WAR 1963-80%A%  
% 215.45/215.60  |- skos__altLabel mesh__D003130 Combat Neurosis
% 215.45/215.60  |- skos__annotation mesh__D003130
% 215.45/215.60       note category: do not confuse with war wounds %28% = WOUNDS AND INJURIES or specific inj %28%IM%29% + WAR %28%IM or NIM%29% %29%; STRESS DISORDERS, POST-TRAUMATIC is also available%A%  
% 215.45/215.60  |- skos__scopeNote mesh__D003130
% 215.45/215.60       Neurotic reactions to unusual, severe, or overwhelming military stress.%A%    
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D003130 2006
% 215.45/215.60  |- skos__hiddenLabel mesh__D003130 Disorder, Combat
% 215.45/215.60  |- skos__broader mesh__D016856smesh__D002043
% 215.45/215.60  |- skos__scopeNote mesh__D016856
% 215.45/215.60       A genus of the family BUNYAVIRIDAE comprising many viruses, most of which are transmitted by Phlebotomus flies and cause PHLEBOTOMUS FEVER. The type species is RIFT VALLEY FEVER VIRUS.%A%    
% 215.45/215.60  |- mesh__recordAuthorizer mesh__D016856 sjn
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D016856 2006
% 215.45/215.60  |- skos__prefLabel mesh__D016856 Phlebovirus
% 215.45/215.60  |- skos__historyNote mesh__D016856 Bunyaviridae %28%1983-1991%29%
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D016856 2002
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D016856 2005
% 215.45/215.60  |- mesh__dateRevised mesh__D016856 2001-07-25
% 215.45/215.60  |- mesh__historyNote mesh__D016856 92   
% 215.45/215.60  |- rdf__type mesh__D016856sskos__Concept
% 215.45/215.60  |- skos__annotation mesh__D016856
% 215.45/215.60       do not confuse X ref SANDFLY FEVER SICILIAN VIRUS with SANDFLY FEVER NAPLES VIRUS; infection: coord IM with PHLEBOTOMUS FEVER %28%IM%29% or if not so specified coord IM with BUNYAVIRIDAE INFECTIONS %28%IM%29%%A%  
% 215.45/215.60  |- mesh__dateEstablished mesh__D016856 1992-01-01
% 215.45/215.60  |- mesh__recordOriginator mesh__D016856 AGS
% 215.45/215.60  |- mesh__publicMeSHNote mesh__D016856 92   
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D016856 2004
% 215.45/215.60  |- skos__hiddenLabel mesh__D016856 Phleboviruses
% 215.45/215.60  |- mesh__dateCreated mesh__D016856 1991-05-02
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D016856 2003
% 215.45/215.60  |- mesh__recordMaintainer mesh__D016856 ags
% 215.45/215.60  |- mesh__recordMaintainer mesh__D016058 lkt
% 215.45/215.60  |- mesh__historyNote mesh__D016058 91   
% 215.45/215.60  |- skos__annotation mesh__D016058
% 215.45/215.60       do not use /util except by MeSH definition   
% 215.45/215.60  |- mesh__dateEstablished mesh__D016058 1991-01-01
% 215.45/215.60  |- mesh__dateCreated mesh__D016058 1990-03-23
% 215.45/215.60  |- skos__historyNote mesh__D016058 Self Administration %28%1979-1990%29%
% 215.45/215.60  |- skos__broader mesh__D016058smesh__D000698
% 215.45/215.60  |- skos__historyNote mesh__D016058 Analgesia %28%1975-1990%29%
% 215.45/215.60  |- skos__altLabel mesh__D016058 Patient-Controlled Analgesia
% 215.45/215.60  |- skos__hiddenLabel mesh__D016058 Analgesia, Patient Controlled
% 215.45/215.60  |- rdf__type mesh__D016058sskos__Concept
% 215.45/215.60  |- skos__scopeNote mesh__D016058
% 215.45/215.60       Relief of PAIN, without loss of CONSCIOUSNESS, through ANALGESIC AGENTS administered by the patients. It has been used successfully to control POSTOPERATIVE PAIN, during OBSTETRIC LABOR, after BURNS, and in TERMINAL CARE. The choice of agent, dose, and lockout interval greatly influence effectiveness. The potential for overdose can be minimized by combining small bolus doses with a mandatory interval between successive doses %28%lockout interval%29%.%A%    
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D016058 2005
% 215.45/215.60  |- mesh__recordAuthorizer mesh__D016058 sjn
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D016058 2006
% 215.45/215.60  |- skos__hiddenLabel mesh__D016058 Patient Controlled Analgesia
% 215.45/215.60  |- skos__prefLabel mesh__D016058 Analgesia, Patient-Controlled
% 215.45/215.60  |- mesh__publicMeSHNote mesh__D016058 91   
% 215.45/215.60  |- mesh__dateRevised mesh__D016058 2004-07-07
% 215.45/215.60  |- mesh__recordOriginator mesh__D016058 AGS
% 215.45/215.60  |- skos__prefLabel mesh__D002836 Hemophilia B
% 215.45/215.60  |- skos__hiddenLabel mesh__D002836 Deficiencies, Factor IX
% 215.45/215.60  |- skos__broader mesh__D002836smesh__D020147
% 215.45/215.60  |- skos__broader mesh__D002836smesh__D025861
% 215.45/215.60  |- mesh__publicMeSHNote mesh__D002836
% 215.45/215.60       99; see CHRISTMAS DISEASE 1966-98; for HEMOPHILIA B see CHRISTMAS DISEASE 1974-98%A%  
% 215.45/215.60  |- skos__broader mesh__D002836smesh__D006474
% 215.45/215.60  |- skos__scopeNote mesh__D002836
% 215.45/215.60       A deficiency of blood coagulation factor IX inherited as an X-linked disorder. %28%Also known as Christmas Disease, after the first patient studied in detail, not the holy day.%29% Historical and clinical features resemble those in classic hemophilia %28%HEMOPHILIA A%29%, but patients present with fewer symptoms. Severity of bleeding is usually similar in members of a single family. Many patients are asymptomatic until the hemostatic system is stressed by surgery or trauma. Treatment is similar to that for hemophilia A. %28%From Cecil Textbook of Medicine, 19th ed, p1008%29%%A%    
% 215.45/215.60  |- skos__altLabel mesh__D002836 Haemophilia B
% 215.45/215.60  |- mesh__recordMaintainer mesh__D002836 ssb
% 215.45/215.60  |- mesh__historyNote mesh__D002836 99%28%66%29%   
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D002836 2006
% 215.45/215.60  |- mesh__recordOriginator mesh__D002836 NLM
% 215.45/215.60  |- skos__hiddenLabel mesh__D002836 Bs, Hemophilia
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D002836 2004
% 215.45/215.60  |- mesh__dateRevised mesh__D002836 2002-07-02
% 215.45/215.60  |- skos__hiddenLabel mesh__D002836 Bs, Haemophilia
% 215.45/215.60  |- skos__hiddenLabel mesh__D002836 Hemophilia Bs
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D002836 2005
% 215.45/215.60  |- skos__altLabel mesh__D002836 Deficiency, Factor IX
% 215.45/215.60  |- skos__hiddenLabel mesh__D002836 Disease, Christmas
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D002836 2003
% 215.45/215.60  |- skos__altLabel mesh__D002836 Factor IX Deficiency
% 215.45/215.60  |- skos__hiddenLabel mesh__D002836 Haemophilia Bs
% 215.45/215.60  |- skos__altLabel mesh__D002836 Christmas Disease
% 215.45/215.60  |- skos__broader mesh__D002836smesh__D040181
% 215.45/215.60  |- skos__hiddenLabel mesh__D002836 Factor IX Deficiencies
% 215.45/215.60  |- rdf__type mesh__D002836sskos__Concept
% 215.45/215.60  |- skos__hiddenLabel mesh__D002836 B, Hemophilia
% 215.45/215.60  |- mesh__dateCreated mesh__D002836 1999-01-01
% 215.45/215.60  |- skos__related mesh__D002836smesh__D006467
% 215.45/215.60  |- mesh__recordAuthorizer mesh__D002836 sjn
% 215.45/215.60  |- skos__hiddenLabel mesh__D002836 B, Haemophilia
% 215.45/215.60  |- skos__prefLabel mesh__D002038 Bungarotoxins
% 215.45/215.60  |- rdf__type mesh__D002038sskos__Concept
% 215.45/215.60  |- skos__hiddenLabel mesh__D002038 alpha Bungarotoxin
% 215.45/215.60  |- mesh__dateEstablished mesh__D002038 1974-01-01
% 215.45/215.60  |- mesh__dateRevised mesh__D002038 2005-06-30
% 215.45/215.60  |- skos__scopeNote mesh__D002038
% 215.45/215.60       Neurotoxic proteins from the venom of the banded or Formosan krait %28%Bungarus multicinctus, an elapid snake%29%. alpha-Bungarotoxin blocks nicotinic acetylcholine receptors and has been used to isolate and study them; beta- and gamma-bungarotoxins act presynaptically causing acetylcholine release and depletion. Both alpha and beta forms have been characterized, the alpha being similar to the large, long or Type II neurotoxins from other elapid venoms.%A%    
% 215.45/215.60  |- skos__hiddenLabel mesh__D002038 beta Bungarotoxin
% 215.45/215.60  |- mesh__dateCreated mesh__D002038 1999-01-01
% 215.45/215.60  |- mesh__recordMaintainer mesh__D002038 ssb
% 215.45/215.60  |- mesh__publicMeSHNote mesh__D002038 74   
% 215.45/215.60  |- skos__broader mesh__D002038smesh__D004546
% 215.45/215.60  |- skos__hiddenLabel mesh__D002038 kappa Bungarotoxin
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D002038 2006
% 215.45/215.60  |- mesh__historyNote mesh__D002038 74%28%73%29%   
% 215.45/215.60  |- skos__annotation mesh__D002038
% 215.45/215.60       from the krait, a snake; /antag permitted but consider also ANTIVENINS; alpha-bungarotoxin %26% beta-bungarotoxin go here%A%  
% 215.45/215.60  |- mesh__recordOriginator mesh__D002038 NLM
% 215.45/215.60  |- mesh__recordAuthorizer mesh__D002038 sjn
% 215.45/215.60  |- skos__prefLabel mesh__D007521 Isocitrate Dehydrogenase
% 215.45/215.60  |- mesh__dateRevised mesh__D007521 2003-07-09
% 215.45/215.60  |- skos__altLabel mesh__D007521 Isocitrate Dehydrogenase %28%NAD+%29%
% 215.45/215.60  |- mesh__recordMaintainer mesh__D007521 ssb
% 215.45/215.60  |- skos__altLabel mesh__D007521 NAD Isocitrate Dehydrogenase
% 215.45/215.60  |- skos__scopeNote mesh__D007521
% 215.45/215.60       An enzyme of the oxidoreductase class that catalyzes the conversion of isocitrate and NAD+ to yield 2-ketoglutarate, carbon dioxide, and NADH. It occurs in cell mitochondria. The enzyme requires Mg2+, Mn2+; it is activated by ADP, citrate, and Ca2+, and inhibited by NADH, NADPH, and ATP. The reaction is the key rate-limiting step of the citric acid %28%tricarboxylic%29% cycle. %28%From Dorland, 27th ed%29% %28%The NADP+ enzyme is EC 1.1.1.42.%29% EC 1.1.1.41.%A%    
% 215.45/215.60  |- rdf__type mesh__D007521sskos__Concept
% 215.45/215.60  |- mesh__recordAuthorizer mesh__D007521 sjn
% 215.45/215.60  |- skos__hiddenLabel mesh__D007521 Isocitrate Dehydrogenase, NAD
% 215.45/215.60  |- skos__hiddenLabel mesh__D007521 Dehydrogenase, Isocitrate
% 215.45/215.60  |- skos__hiddenLabel mesh__D007521 Dehydrogenase, NAD Isocitrate
% 215.45/215.60  |- mesh__recordOriginator mesh__D007521 NLM
% 215.45/215.60  |- mesh__publicMeSHNote mesh__D007521 65   
% 215.45/215.60  |- mesh__historyNote mesh__D007521 65%28%63%29%   
% 215.45/215.60  |- skos__broader mesh__D007521smesh__D000429
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D007521 2006
% 215.45/215.60  |- mesh__dateCreated mesh__D007521 1999-01-01
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D007521 2005
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D007521 2004
% 215.45/215.60  |- skos__hiddenLabel mesh__D007521 Isocitrate Dehydrogenase I
% 215.45/215.60  |- mesh__dateEstablished mesh__D007521 1965-01-01
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D012466 1995
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D012466 2004
% 215.45/215.60  |- mesh__recordAuthorizer mesh__D012466 NLM
% 215.45/215.60  |- skos__hiddenLabel mesh__D012466 Diseases, Salivary Gland
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D012466 2005
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D012466 2000
% 215.45/215.60  |- mesh__dateEstablished mesh__D012466 1965-01-01
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D012466 1991
% 215.45/215.60  |- mesh__dateRevised mesh__D012466 1990-05-29
% 215.45/215.60  |- mesh__historyNote mesh__D012466 65   
% 215.45/215.60  |- skos__hiddenLabel mesh__D012466 Disease, Salivary Gland
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D012466 2001
% 215.45/215.60  |- mesh__recordMaintainer mesh__D012466 PLS
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D012466 2006
% 215.45/215.60  |- skos__annotation mesh__D012466
% 215.45/215.60       GEN: prefer specifics; inflamm dis = SIALADENITIS; tuberc sialadenitis or tuberc of salivary glands = SIALADENITIS %28%IM%29% + TUBERCULOSIS, ORAL %28%IM%29%%A%  
% 215.45/215.60  |- mesh__activeMeSHYear mesh__D012466 1996
% 215.45/215.60  |- skos__hiddenLabel mesh__D012466 Gland Diseases, Salivary
% 215.45/215.61  |- mesh__recordOriginator mesh__D012466 NLM
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D012466 2002
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D012466 1997
% 215.45/215.61  |- mesh__publicMeSHNote mesh__D012466 65   
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D012466 1992
% 215.45/215.61  |- skos__hiddenLabel mesh__D012466 Salivary Gland Disease
% 215.45/215.61  |- skos__hiddenLabel mesh__D012466 Gland Disease, Salivary
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D012466 1998
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D012466 1993
% 215.45/215.61  |- rdf__type mesh__D012466sskos__Concept
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D012466 1994
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D012466 2003
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D012466 1999
% 215.45/215.61  |- mesh__dateCreated mesh__D012466 1999-01-01
% 215.45/215.61  |- skos__broader mesh__D012466smesh__D009059
% 215.45/215.61  |- skos__prefLabel mesh__D012466 Salivary Gland Diseases
% 215.45/215.61  |- skos__prefLabel mesh__D039603 Eukaryotic Initiation Factor-4G
% 215.45/215.61  |- skos__altLabel mesh__D039603 Peptide Initiation Factor EIF-4G
% 215.45/215.61  |- skos__altLabel mesh__D039603 EIF-4G
% 215.45/215.61  |- mesh__dateEstablished mesh__D039603 2003-01-01
% 215.45/215.61  |- skos__hiddenLabel mesh__D039603 Peptide Initiation Factor EIF 4G
% 215.45/215.61  |- skos__altLabel mesh__D039603 EIF4G
% 215.45/215.61  |- skos__hiddenLabel mesh__D039603 Eukaryotic Peptide Initiation Factor 4G
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D039603 2004
% 215.45/215.61  |- skos__altLabel mesh__D039603 Eukaryotic Peptide Initiation Factor-4G
% 215.45/215.61  |- rdf__type mesh__D039603sskos__Concept
% 215.45/215.61  |- mesh__publicMeSHNote mesh__D039603
% 215.45/215.61       2003; EIF-4G %28%now EUKARYOTIC INITIATION FACTOR-4G%29% was indexed under PEPTIDE INITIATION FACTORS 1997-2002%A%  
% 215.45/215.61  |- skos__hiddenLabel mesh__D039603 EIF 4G
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D039603 2003
% 215.45/215.61  |- skos__altLabel mesh__D039603 Eukaryotic-Translation Initiation Factor 4G
% 215.45/215.61  |- mesh__historyNote mesh__D039603
% 215.45/215.61       2003; use EUKARYOTIC INITIATION FACTOR-4G %28%NM%29% 1997-2002   
% 215.45/215.61  |- skos__altLabel mesh__D039603
% 215.45/215.61       Eukaryotic Translation Initiation Factor 4 gamma
% 215.45/215.61  |- mesh__dateCreated mesh__D039603 2002-07-03
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D039603 2006
% 215.45/215.61  |- skos__historyNote mesh__D039603
% 215.45/215.61       Peptide Initiation Factors %28%1997-2002%29%
% 215.45/215.61  |- skos__broader mesh__D039603smesh__D039562
% 215.45/215.61  |- skos__scopeNote mesh__D039603
% 215.45/215.61       A component of eukaryotic initiation factor-4F that is involved in multiple protein interactions at the site of translation initiation. Thus it may serve a role in bringing together various initiation factors at the site of translation initiation.%A%    
% 215.45/215.61  |- skos__hiddenLabel mesh__D039603
% 215.45/215.61       Eukaryotic Translation Initiation Factor 4G
% 215.45/215.61  |- skos__hiddenLabel mesh__D039603 Eukaryotic Initiation Factor 4G
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D039603 2005
% 215.45/215.61  |- mesh__dateCreated mesh__D006429 1999-01-01
% 215.45/215.61  |- skos__hiddenLabel mesh__D006429 Post-Ictal Hemiplegias
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D006429 2001
% 215.45/215.61  |- skos__hiddenLabel mesh__D006429 Hemiplegias
% 215.45/215.61  |- skos__prefLabel mesh__D006429 Hemiplegia
% 215.45/215.61  |- skos__hiddenLabel mesh__D006429 Monoplegias
% 215.45/215.61  |- mesh__recordMaintainer mesh__D006429 KEV
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D006429 2000
% 215.45/215.61  |- skos__hiddenLabel mesh__D006429 Hemiplegia, Post Ictal
% 215.45/215.61  |- skos__hiddenLabel mesh__D006429 Flaccid Hemiplegias
% 215.45/215.61  |- skos__hiddenLabel mesh__D006429 Flaccid Hemiplegia
% 215.45/215.61  |- mesh__recordOriginator mesh__D006429 NLM
% 215.45/215.61  |- skos__broader mesh__D006429smesh__D010243
% 215.45/215.61  |- skos__hiddenLabel mesh__D006429 Crossed Hemiplegias
% 215.45/215.61  |- skos__hiddenLabel mesh__D006429 Infantile Hemiplegia
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D006429 2004
% 215.45/215.61  |- skos__hiddenLabel mesh__D006429 Hemiplegias, Post-Ictal
% 215.45/215.61  |- skos__hiddenLabel mesh__D006429 Hemiplegias, Spastic
% 215.45/215.61  |- skos__hiddenLabel mesh__D006429 Hemiplegias, Flaccid
% 215.45/215.61  |- skos__hiddenLabel mesh__D006429 Transient Hemiplegias
% 215.45/215.61  |- mesh__dateRevised mesh__D006429 1999-11-03
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D006429 2003
% 215.45/215.61  |- skos__scopeNote mesh__D006429
% 215.45/215.61       Severe or complete loss of motor function on one side of the body. This condition is usually caused by BRAIN DISEASES that are localized to the cerebral hemisphere opposite to the side of weakness. Less frequently, BRAIN STEM lesions; cervical SPINAL CORD DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; and other conditions may manifest as hemiplegia. The term hemiparesis %28%see PARESIS%29% refers to mild to moderate weakness involving one side of the body.%A%    
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D006429 2006
% 215.45/215.61  |- skos__hiddenLabel mesh__D006429 Hemiplegias, Crossed
% 215.45/215.61  |- skos__hiddenLabel mesh__D006429 Post-Ictal Hemiplegia
% 215.45/215.61  |- skos__hiddenLabel mesh__D006429 Crossed Hemiplegia
% 215.45/215.61  |- skos__hiddenLabel mesh__D006429 Hemiplegias, Transient
% 215.45/215.61  |- mesh__recordAuthorizer mesh__D006429 sjn
% 215.45/215.61  |- skos__hiddenLabel mesh__D006429 Transient Hemiplegia
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D006429 2005
% 215.45/215.61  |- skos__hiddenLabel mesh__D006429 Hemiplegias, Infantile
% 215.45/215.61  |- skos__hiddenLabel mesh__D006429 Infantile Hemiplegias
% 215.45/215.61  |- skos__hiddenLabel mesh__D006429 Spastic Hemiplegias
% 215.45/215.61  |- rdf__type mesh__D006429sskos__Concept
% 215.45/215.61  |- skos__hiddenLabel mesh__D006429 Spastic Hemiplegia
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D006429 2002
% 215.45/215.61  |- mesh__publicMeSHNote mesh__D017151 93   
% 215.45/215.61  |- mesh__recordAuthorizer mesh__D017151 sjn
% 215.45/215.61  |- skos__altLabel mesh__D017151 Catalytic Antibodies
% 215.45/215.61  |- skos__scopeNote mesh__D017151
% 215.45/215.61       Antibodies that can catalyze a wide variety of chemical reactions. They are characterized by high substrate specificity and share many mechanistic features with enzymes.%A%    
% 215.45/215.61  |- mesh__dateRevised mesh__D017151 2005-06-30
% 215.45/215.61  |- skos__hiddenLabel mesh__D017151 Catalytic Antibody
% 215.45/215.61  |- skos__historyNote mesh__D017151 Catalysis %28%1986-1992%29%
% 215.45/215.61  |- mesh__recordOriginator mesh__D017151 AGS
% 215.45/215.61  |- mesh__dateCreated mesh__D017151 1992-05-07
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D017151 2006
% 215.45/215.61  |- skos__historyNote mesh__D017151 Antibodies %28%1986-1992%29%
% 215.45/215.61  |- rdf__type mesh__D017151sskos__Concept
% 215.45/215.61  |- mesh__recordMaintainer mesh__D017151 ssb
% 215.45/215.61  |- skos__prefLabel mesh__D017151 Antibodies, Catalytic
% 215.45/215.61  |- skos__altLabel mesh__D017151 Antibody, Catalytic
% 215.45/215.61  |- mesh__historyNote mesh__D017151 93   
% 215.45/215.61  |- mesh__dateEstablished mesh__D017151 1993-01-01
% 215.45/215.61  |- skos__historyNote mesh__D017151 Antibodies, Monoclonal %28%1986-1992%29%
% 215.45/215.61  |- skos__annotation mesh__D017151
% 215.45/215.61       do not coord with ANTIBODY FORMATION for /biosyn   
% 215.45/215.61  |- skos__broader mesh__D017151smesh__D000906
% 215.45/215.61  |- skos__hiddenLabel mesh__D003131 Therapies, Combined Modality
% 215.45/215.61  |- skos__hiddenLabel mesh__D003131 Modality Therapy, Combined
% 215.45/215.61  |- mesh__recordAuthorizer mesh__D003131 sjn
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D003131 2004
% 215.45/215.61  |- mesh__historyNote mesh__D003131 84   
% 215.45/215.61  |- mesh__recordMaintainer mesh__D003131 sjn
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D003131 2002
% 215.45/215.61  |- skos__prefLabel mesh__D003131 Combined Modality Therapy
% 215.45/215.61  |- rdf__type mesh__D003131sskos__Concept
% 215.45/215.61  |- mesh__dateRevised mesh__D003131 2001-08-03
% 215.45/215.61  |- skos__hiddenLabel mesh__D003131 Multimodal Treatments
% 215.45/215.61  |- skos__hiddenLabel mesh__D003131 Modality Therapies, Combined
% 215.45/215.61  |- mesh__publicMeSHNote mesh__D003131 84   
% 215.45/215.61  |- skos__hiddenLabel mesh__D003131 Treatments, Multimodal
% 215.45/215.61  |- mesh__dateCreated mesh__D003131 1983-06-10
% 215.45/215.61  |- skos__annotation mesh__D003131
% 215.45/215.61       almost never IM; coordinate disease term with specific ther qualif %28%IM%29% + specific ther %28%IM or NIM%29%: TN 6; for combined ther of drugs DRUG COMBINATIONS or DRUG THERAPY, COMBINATION is available, for combined anticancer ther ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS is available; CHEMOTHERAPY, ADJUVANT is also available; Manual 24.4.2.2+%A%  
% 215.45/215.61  |- skos__hiddenLabel mesh__D003131 Treatment, Multimodal
% 215.45/215.61  |- skos__scopeNote mesh__D003131
% 215.45/215.61       The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.%A%    
% 215.45/215.61  |- mesh__dateEstablished mesh__D003131 1984-01-01
% 215.45/215.61  |- mesh__recordOriginator mesh__D003131 SH
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D003131 2005
% 215.45/215.61  |- skos__hiddenLabel mesh__D003131 Combined Modality Therapies
% 215.45/215.61  |- skos__altLabel mesh__D003131 Multimodal Treatment
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D003131 2003
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D003131 2006
% 215.45/215.61  |- skos__historyNote mesh__D003131
% 215.45/215.61       Drug Therapy, Combination %28%1974-1983%29%
% 215.45/215.61  |- skos__broader mesh__D003131smesh__D013812
% 215.45/215.61  |- skos__altLabel mesh__D003131 Therapy, Combined Modality
% 215.45/215.61  |- skos__related mesh__D003131smesh__D000971
% 215.45/215.61  |- mesh__dateCreated mesh__D016857 1991-05-02
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D016857 2000
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D016857 2005
% 215.45/215.61  |- mesh__historyNote mesh__D016857 92   
% 215.45/215.61  |- rdf__type mesh__D016857sskos__Concept
% 215.45/215.61  |- mesh__dateRevised mesh__D016857 1999-11-03
% 215.45/215.61  |- skos__annotation mesh__D016857 CARBON DIOXIDE/blood is also available   
% 215.45/215.61  |- mesh__recordAuthorizer mesh__D016857 sjn
% 215.45/215.61  |- skos__hiddenLabel mesh__D016857 Hypocapnias
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D016857 2002
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D016857 2004
% 215.45/215.61  |- skos__historyNote mesh__D016857 Carbon Dioxide/blood %28%1966-1991%29%
% 215.45/215.61  |- skos__related mesh__D016857smesh__D000472
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D016857 2003
% 215.45/215.61  |- skos__broader mesh__D016857smesh__D012818
% 215.45/215.61  |- mesh__dateEstablished mesh__D016857 1992-01-01
% 215.45/215.61  |- skos__prefLabel mesh__D016857 Hypocapnia
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D016857 2001
% 215.45/215.61  |- mesh__recordMaintainer mesh__D016857 KEV
% 215.45/215.61  |- mesh__publicMeSHNote mesh__D016857 92   
% 215.45/215.61  |- skos__scopeNote mesh__D016857
% 215.45/215.61       Clinical manifestation consisting of a deficiency of carbon dioxide in arterial blood.%A%    
% 215.45/215.61  |- mesh__recordOriginator mesh__D016857 TGC
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D016857 2006
% 215.45/215.61  |- mesh__dateEstablished mesh__D016059 1991-01-01
% 215.45/215.61  |- skos__scopeNote mesh__D016059
% 215.45/215.61       Range through which a joint can be extended and flexed. This is frequently assessed following surgery of the joint.%A%    
% 215.45/215.61  |- skos__altLabel mesh__D016059 Joint Range of Motion
% 215.45/215.61  |- mesh__recordAuthorizer mesh__D016059 sjn
% 215.45/215.61  |- rdf__type mesh__D016059sskos__Concept
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D016059 2005
% 215.45/215.61  |- skos__historyNote mesh__D016059 specific joints %28%1966-1990%29%
% 215.45/215.61  |- mesh__publicMeSHNote mesh__D016059 91   
% 215.45/215.61  |- skos__historyNote mesh__D016059 Movement %28%1966-1990%29%
% 215.45/215.61  |- skos__broader mesh__D016059smesh__D010808
% 215.45/215.61  |- mesh__recordOriginator mesh__D016059 AGS
% 215.45/215.61  |- mesh__dateRevised mesh__D016059 2003-07-09
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D016059 2006
% 215.45/215.61  |- skos__prefLabel mesh__D016059 Range of Motion, Articular
% 215.45/215.61  |- skos__broader mesh__D016059smesh__D043703
% 215.45/215.61  |- skos__altLabel mesh__D016059 Range of Motion
% 215.45/215.61  |- mesh__dateCreated mesh__D016059 1990-03-23
% 215.45/215.61  |- mesh__recordMaintainer mesh__D016059 nns
% 215.45/215.61  |- mesh__historyNote mesh__D016059 91   
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D016059 2004
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D002837 2004
% 215.45/215.61  |- skos__hiddenLabel mesh__D002837 Chromaffin Granule
% 215.45/215.61  |- mesh__dateCreated mesh__D002837 1977-04-27
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D002837 2005
% 215.45/215.61  |- skos__prefLabel mesh__D002837 Chromaffin Granules
% 215.45/215.61  |- skos__annotation mesh__D002837
% 215.45/215.61       A 11 qualif except /cytol; /genet permitted   
% 215.45/215.61  |- mesh__historyNote mesh__D002837
% 215.45/215.61       91%28%78%29%; was see under CHROMAFFIN SYSTEM 1978-90   
% 215.45/215.61  |- skos__hiddenLabel mesh__D002837 Granules, Chromaffin
% 215.45/215.61  |- skos__broader mesh__D002837smesh__D002838
% 215.45/215.61  |- skos__broader mesh__D002837smesh__D003594
% 215.45/215.61  |- skos__scopeNote mesh__D002837
% 215.45/215.61       Granules in the adrenal glands and various other organs, which are concerned with the synthesis, storage, metabolism, and secretion of epinephrine and norepinephrine.%A%    
% 215.45/215.61  |- mesh__dateRevised mesh__D002837 2003-07-09
% 215.45/215.61  |- mesh__recordAuthorizer mesh__D002837 sjn
% 215.45/215.61  |- rdf__type mesh__D002837sskos__Concept
% 215.45/215.61  |- mesh__recordMaintainer mesh__D002837 nns
% 215.45/215.61  |- skos__hiddenLabel mesh__D002837 Granule, Chromaffin
% 215.45/215.61  |- mesh__publicMeSHNote mesh__D002837
% 215.45/215.61       91; was see under CHROMAFFIN SYSTEM 1978-90   
% 215.45/215.61  |- skos__historyNote mesh__D002837 Chromaffin System %28%1966-1977%29%
% 215.45/215.61  |- mesh__recordOriginator mesh__D002837 VDK
% 215.45/215.61  |- skos__historyNote mesh__D002837 Cytoplasmic Granules %28%1966-1977%29%
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D002837 2006
% 215.45/215.61  |- mesh__dateEstablished mesh__D002837 1991-01-01
% 215.45/215.61  |- mesh__historyNote mesh__D007522
% 215.45/215.61       91%28%77%29%; was see under KETOACID-LYASES 1977-90   
% 215.45/215.61  |- rdf__type mesh__D007522sskos__Concept
% 215.45/215.61  |- skos__altLabel mesh__D007522 Isocitratase
% 215.45/215.61  |- mesh__publicMeSHNote mesh__D007522
% 215.45/215.61       91; was see under KETOACID-LYASES 1977-90   
% 215.45/215.61  |- mesh__dateCreated mesh__D007522 1976-04-16
% 215.45/215.61  |- skos__historyNote mesh__D007522 Isocitrates %28%1973-1976%29%
% 215.45/215.61  |- mesh__recordOriginator mesh__D007522 RLS
% 215.45/215.61  |- mesh__recordMaintainer mesh__D007522 ssb
% 215.45/215.61  |- skos__broader mesh__D007522smesh__D007652
% 215.45/215.61  |- skos__altLabel mesh__D007522 Isocitrase
% 215.45/215.61  |- skos__historyNote mesh__D007522 Ketoacid-Lyases %28%1973-1976%29%
% 215.45/215.61  |- skos__scopeNote mesh__D007522
% 215.45/215.61       A key enzyme in the glyoxylate cycle. It catalyzes the conversion of isocitrate to succinate and glyoxylate. EC 4.1.3.1.%A%    
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D007522 2006
% 215.45/215.61  |- mesh__recordAuthorizer mesh__D007522 sjn
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D007522 2005
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D007522 2004
% 215.45/215.61  |- skos__hiddenLabel mesh__D007522 Lyase, Isocitrate
% 215.45/215.61  |- skos__prefLabel mesh__D007522 Isocitrate Lyase
% 215.45/215.61  |- mesh__dateEstablished mesh__D007522 1991-01-01
% 215.45/215.61  |- mesh__dateRevised mesh__D007522 2003-07-09
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D012467 2000
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D012467 2004
% 215.45/215.61  |- skos__scopeNote mesh__D012467
% 215.45/215.61       A fistula between a salivary duct or gland and the cutaneous surface of the oral cavity.%A%    
% 215.45/215.61  |- skos__hiddenLabel mesh__D012467 Salivary Gland Fistulas
% 215.45/215.61  |- mesh__recordMaintainer mesh__D012467 KEV
% 215.45/215.61  |- skos__hiddenLabel mesh__D012467 Gland Fistulas, Salivary
% 215.45/215.61  |- skos__hiddenLabel mesh__D012467 Fistula, Salivary Gland
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D012467 2001
% 215.45/215.61  |- skos__annotation mesh__D012467
% 215.45/215.61       fistula policy: Manual 23.19+; coord IM with specific salivary gland or precoord salivary gland dis %28%IM%29%%A%  
% 215.45/215.61  |- mesh__recordOriginator mesh__D012467 NLM
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D012467 2005
% 215.45/215.61  |- skos__hiddenLabel mesh__D012467 Fistulas, Salivary Gland
% 215.45/215.61  |- skos__broader mesh__D012467smesh__D012466
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D012467 2002
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D012467 2006
% 215.45/215.61  |- rdf__type mesh__D012467sskos__Concept
% 215.45/215.61  |- skos__broader mesh__D012467smesh__D016155
% 215.45/215.61  |- mesh__dateCreated mesh__D012467 1999-01-01
% 215.45/215.61  |- skos__prefLabel mesh__D012467 Salivary Gland Fistula
% 215.45/215.61  |- skos__hiddenLabel mesh__D012467 Gland Fistula, Salivary
% 215.45/215.61  |- mesh__recordAuthorizer mesh__D012467 sjn
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D012467 2003
% 215.45/215.61  |- mesh__dateRevised mesh__D012467 1999-11-08
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D039604 2005
% 215.45/215.61  |- skos__scopeNote mesh__D039604
% 215.45/215.61       Communication services provided by a person or a machine to record and relay the message from the caller.%A%    
% 215.45/215.61  |- mesh__dateEstablished mesh__D039604 2003-01-01
% 215.45/215.61  |- skos__hiddenLabel mesh__D039604 Answering Service
% 215.45/215.61  |- skos__broader mesh__D039604smesh__D003142
% 215.45/215.61  |- rdf__type mesh__D039604sskos__Concept
% 215.45/215.61  |- skos__historyNote mesh__D039604 Telephone %28%1972-2002%29%
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D039604 2004
% 215.45/215.61  |- skos__broader mesh__D039604smesh__D013689
% 215.45/215.61  |- mesh__historyNote mesh__D039604 2003   
% 215.45/215.61  |- mesh__dateCreated mesh__D039604 2002-07-02
% 215.45/215.61  |- mesh__publicMeSHNote mesh__D039604 2003   
% 215.45/215.61  |- skos__prefLabel mesh__D039604 Answering Services
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D039604 2003
% 215.45/215.61  |- skos__broader mesh__D039604smesh__D039602
% 215.45/215.61  |- skos__historyNote mesh__D039604 Communication %28%1969-2002%29%
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D039604 2006
% 215.45/215.61  |- skos__altLabel mesh__D017950 Ganglion, Sensory
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D017950 1999
% 215.45/215.61  |- skos__broader mesh__D017950smesh__D017933
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D017950 1995
% 215.45/215.61  |- mesh__recordAuthorizer mesh__D017950 PLS
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D017950 2000
% 215.45/215.61  |- mesh__dateCreated mesh__D017950 1993-06-18
% 215.45/215.61  |- mesh__publicMeSHNote mesh__D017950 94   
% 215.45/215.61  |- mesh__dateEstablished mesh__D017950 1994-01-01
% 215.45/215.61  |- skos__scopeNote mesh__D017950
% 215.45/215.61       Clusters of neurons in the somatic peripheral nervous system which contain the cell bodies of sensory nerve axons. Sensory ganglia may also have intrinsic interneurons and non-neuronal supporting cells.%A%    
% 215.45/215.61  |- mesh__historyNote mesh__D017950 94   
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D017950 2001
% 215.45/215.61  |- skos__prefLabel mesh__D017950 Ganglia, Sensory
% 215.45/215.61  |- mesh__dateRevised mesh__D017950 1994-04-11
% 215.45/215.61  |- mesh__recordMaintainer mesh__D017950 TGC
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D017950 2003
% 215.45/215.61  |- mesh__recordOriginator mesh__D017950 RAZ
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D017950 2005
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D017950 1996
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D017950 2004
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D017950 2002
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D017950 1998
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D017950 2006
% 215.45/215.61  |- rdf__type mesh__D017950sskos__Concept
% 215.45/215.61  |- skos__altLabel mesh__D017950 Sensory Ganglia
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D017950 1997
% 215.45/215.61  |- skos__annotation mesh__D017950 ganglia of the peripheral nerv syst   
% 215.45/215.61  |- skos__hiddenLabel mesh__D017950 Sensory Ganglion
% 215.45/215.61  |- skos__broader mesh__D017950smesh__D005724
% 215.45/215.61  |- skos__broader mesh__D031621smesh__D029586
% 215.45/215.61  |- mesh__publicMeSHNote mesh__D031621 2003   
% 215.45/215.61  |- skos__scopeNote mesh__D031621
% 215.45/215.61       A plant genus of the family MORACEAE. Members have been used as an arrow poison.%A%    
% 215.45/215.61  |- mesh__dateEstablished mesh__D031621 2003-01-01
% 215.45/215.61  |- skos__prefLabel mesh__D031621 Antiaris
% 215.45/215.61  |- skos__annotation mesh__D031621
% 215.45/215.61       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.45/215.61  |- mesh__historyNote mesh__D031621 2003   
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D031621 2004
% 215.45/215.61  |- mesh__dateCreated mesh__D031621 2002-07-02
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D031621 2003
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D031621 2006
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D031621 2005
% 215.45/215.61  |- rdf__type mesh__D031621sskos__Concept
% 215.45/215.61  |- mesh__dateEstablished mesh__D017152 1993-01-01
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D017152 2006
% 215.45/215.61  |- skos__historyNote mesh__D017152 Autoantibodies %28%1983-1992%29%
% 215.45/215.61  |- mesh__dateCreated mesh__D017152 1992-05-07
% 215.45/215.61  |- skos__hiddenLabel mesh__D017152 Antibody, Antiphospholipid
% 215.45/215.61  |- skos__scopeNote mesh__D017152
% 215.45/215.61       Autoantibodies directed against phospholipids. These antibodies are characteristically found in patients with systemic lupus erythematosus %28%LUPUS ERYTHEMATOSUS, SYSTEMIC;%29%, ANTIPHOSPHOLIPID SYNDROME; related autoimmune diseases, some non-autoimmune diseases, and also in healthy individuals.%A%    
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D017152 2006A
% 215.45/215.61  |- mesh__dateRevised mesh__D017152 2005-07-19
% 215.45/215.61  |- rdf__type mesh__D017152sskos__Concept
% 215.45/215.61  |- skos__annotation mesh__D017152
% 215.45/215.61       do not coordinate with ANTIBODY FORMATION for /biosyn   
% 215.45/215.61  |- mesh__historyNote mesh__D017152 93   
% 215.45/215.61  |- mesh__publicMeSHNote mesh__D017152 93   
% 215.45/215.61  |- skos__related mesh__D017152smesh__D045163
% 215.45/215.61  |- skos__broader mesh__D017152smesh__D001323
% 215.45/215.61  |- mesh__recordAuthorizer mesh__D017152 ags
% 215.45/215.61  |- mesh__recordMaintainer mesh__D017152 ags
% 215.45/215.61  |- skos__altLabel mesh__D017152 Antiphospholipid Antibodies
% 215.45/215.61  |- skos__prefLabel mesh__D017152 Antibodies, Antiphospholipid
% 215.45/215.61  |- skos__related mesh__D017152smesh__D016736
% 215.45/215.61  |- mesh__recordOriginator mesh__D017152 AGS
% 215.45/215.61  |- skos__altLabel mesh__D017152 Antiphospholipid Antibody
% 215.45/215.61  |- mesh__recordOriginator mesh__D003930 NLM
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D003930 2006
% 215.45/215.61  |- skos__annotation mesh__D003930
% 215.45/215.61       coordinate IM with specific type of diabetes mellitus %28%IM%29% if pertinent%A%  
% 215.45/215.61  |- skos__prefLabel mesh__D003930 Diabetic Retinopathy
% 215.45/215.61  |- mesh__recordAuthorizer mesh__D003930 sjn
% 215.45/215.61  |- skos__broader mesh__D003930smesh__D012164
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D003930 2005
% 215.45/215.61  |- mesh__recordMaintainer mesh__D003930 lkt
% 215.45/215.61  |- skos__hiddenLabel mesh__D003930 Retinopathy, Diabetic
% 215.45/215.61  |- skos__broader mesh__D003930smesh__D003925
% 215.45/215.61  |- skos__scopeNote mesh__D003930
% 215.45/215.61       Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.%A%    
% 215.45/215.61  |- mesh__dateRevised mesh__D003930 2004-07-07
% 215.45/215.61  |- mesh__dateCreated mesh__D003930 1999-01-01
% 215.45/215.61  |- skos__hiddenLabel mesh__D003930 Diabetic Retinopathies
% 215.45/215.61  |- rdf__type mesh__D003930sskos__Concept
% 215.45/215.61  |- skos__hiddenLabel mesh__D003930 Retinopathies, Diabetic
% 215.45/215.61  |- rdf__type mesh__D003132sskos__Concept
% 215.45/215.61  |- mesh__dateRevised mesh__D003132 2002-07-02
% 215.45/215.61  |- skos__hiddenLabel mesh__D003132 Vendor
% 215.45/215.61  |- skos__related mesh__D003132smesh__D007221
% 215.45/215.61  |- mesh__dateCreated mesh__D003132 1999-01-01
% 215.45/215.61  |- skos__broader mesh__D003132smesh__D013676
% 215.45/215.61  |- skos__hiddenLabel mesh__D003132 Contraceptive Importations
% 215.45/215.61  |- skos__hiddenLabel mesh__D003132 Commerces
% 215.45/215.61  |- skos__hiddenLabel mesh__D003132 Sectors, Commercial
% 215.45/215.61  |- mesh__recordAuthorizer mesh__D003132 sjn
% 215.45/215.61  |- mesh__recordOriginator mesh__D003132 NLM
% 215.45/215.61  |- mesh__recordMaintainer mesh__D003132 jls
% 215.45/215.61  |- skos__hiddenLabel mesh__D003132 Price
% 215.45/215.61  |- skos__annotation mesh__D003132
% 215.45/215.61       includes business %26% trade; SPEC: SPEC qualif   
% 215.45/215.61  |- skos__hiddenLabel mesh__D003132 Commercial Sectors
% 215.45/215.61  |- skos__related mesh__D003132smesh__D040861
% 215.45/215.61  |- skos__hiddenLabel mesh__D003132 Importation, Contraceptive
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D003132 2005
% 215.45/215.61  |- skos__scopeNote mesh__D003132
% 215.45/215.61       The interchange of goods or commodities, especially on a large scale, between different countries or between populations within the same country. It includes trade %28%the buying, selling, or exchanging of commodities, whether wholesale or retail%29% and business %28%the purchase and sale of goods to make a profit%29%. %28%From Random House Unabridged Dictionary, 2d ed, p411, p2005 %26% p283%29%%A%    
% 215.45/215.61  |- skos__related mesh__D003132smesh__D004465
% 215.45/215.61  |- skos__prefLabel mesh__D003132 Commerce
% 215.45/215.61  |- skos__related mesh__D003132smesh__D016363
% 215.45/215.61  |- skos__hiddenLabel mesh__D003132 Importations, Contraceptive
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D003132 2003
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D003132 2006
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D003132 2004
% 215.45/215.61  |- skos__hiddenLabel mesh__D003132 Businesses
% 215.45/215.61  |- skos__hiddenLabel mesh__D003132 Sector, Commercial
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D016858 2006
% 215.45/215.61  |- mesh__dateCreated mesh__D016858 1991-05-02
% 215.45/215.61  |- mesh__historyNote mesh__D016858 92   
% 215.45/215.61  |- rdf__type mesh__D016858sskos__Concept
% 215.45/215.61  |- skos__historyNote mesh__D016858 Mycoplasma %28%1970-1991%29%
% 215.45/215.61  |- skos__scopeNote mesh__D016858
% 215.45/215.61       A species of the genus MYCOPLASMA, originally isolated infrequently from the lower genital tract of humans, and possessing uncertain pathogenicity. The incognitus strain of M. fermentans has been identified in necrotizing lesions of multiple organs from AIDS and non-AIDS patients dying of an acute influenza-like disease.%A%    
% 215.45/215.61  |- mesh__publicMeSHNote mesh__D016858 92   
% 215.45/215.61  |- skos__broader mesh__D016858smesh__D009174
% 215.45/215.61  |- mesh__dateRevised mesh__D016858 2005-06-30
% 215.45/215.61  |- skos__prefLabel mesh__D016858 Mycoplasma fermentans
% 215.45/215.61  |- mesh__recordAuthorizer mesh__D016858 sjn
% 215.45/215.61  |- skos__annotation mesh__D016858
% 215.45/215.61       infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29%   
% 215.45/215.61  |- mesh__recordMaintainer mesh__D016858 SYSTEM
% 215.45/215.61  |- mesh__recordOriginator mesh__D016858 AGS
% 215.45/215.61  |- mesh__dateEstablished mesh__D016858 1992-01-01
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D002838 2003
% 215.45/215.61  |- mesh__dateRevised mesh__D002838 1996-06-14
% 215.45/215.61  |- mesh__recordMaintainer mesh__D002838 PXP
% 215.45/215.61  |- rdf__type mesh__D002838sskos__Concept
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D002838 2001
% 215.45/215.61  |- skos__prefLabel mesh__D002838 Chromaffin System
% 215.45/215.61  |- skos__annotation mesh__D002838
% 215.45/215.61       /cytol: consider also specific CHROMAFFIN SYSTEM cell indentions%A%  
% 215.45/215.61  |- skos__hiddenLabel mesh__D002838 Systems, Chromaffin
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D002838 2000
% 215.45/215.61  |- mesh__dateCreated mesh__D002838 1999-01-01
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D002838 1999
% 215.45/215.61  |- skos__hiddenLabel mesh__D002838 System, Chromaffin
% 215.45/215.61  |- skos__hiddenLabel mesh__D002838 Chromaffin Systems
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D002838 1997
% 215.45/215.61  |- skos__hiddenLabel mesh__D002838 Systems, Argentaffin
% 215.45/215.61  |- skos__hiddenLabel mesh__D002838 System, Argentaffin
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D002838 1998
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D002838 2006
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D002838 2002
% 215.45/215.61  |- skos__altLabel mesh__D002838 Argentaffin System
% 215.45/215.61  |- skos__broader mesh__D002838smesh__D004703
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D002838 2004
% 215.45/215.61  |- skos__scopeNote mesh__D002838
% 215.45/215.61       The cells of the body which stain with chromium salts. They occur along the sympathetic nerves, in the adrenal gland, and in various other organs.%A%    
% 215.45/215.61  |- skos__hiddenLabel mesh__D002838 Argentaffin Systems
% 215.45/215.61  |- mesh__recordAuthorizer mesh__D002838 PLS
% 215.45/215.61  |- mesh__recordOriginator mesh__D002838 NLM
% 215.45/215.61  |- mesh__activeMeSHYear mesh__D002838 2005
% 215.45/215.62  |- skos__historyNote mesh__D007523 Tricarboxylic Acids %28%1966-1970%29%
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007523 1995
% 215.45/215.62  |- rdf__type mesh__D007523sskos__Concept
% 215.45/215.62  |- mesh__recordOriginator mesh__D007523 NLM
% 215.45/215.62  |- mesh__dateEstablished mesh__D007523 1973-01-01
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007523 1998
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007523 1993
% 215.45/215.62  |- mesh__dateCreated mesh__D007523 1999-01-01
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007523 2005
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007523 1996
% 215.45/215.62  |- mesh__publicMeSHNote mesh__D007523 73   
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007523 1999
% 215.45/215.62  |- mesh__recordMaintainer mesh__D007523 TAP
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007523 2000
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007523 2003
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007523 2006
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007523 1997
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007523 2001
% 215.45/215.62  |- mesh__recordAuthorizer mesh__D007523 PLS
% 215.45/215.62  |- mesh__dateRevised mesh__D007523 1992-05-19
% 215.45/215.62  |- skos__prefLabel mesh__D007523 Isocitrates
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007523 2004
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007523 2002
% 215.45/215.62  |- skos__broader mesh__D007523smesh__D002951
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007523 1994
% 215.45/215.62  |- mesh__historyNote mesh__D007523 73%28%71%29%   
% 215.45/215.62  |- mesh__dateRevised mesh__D045642 2005-06-30
% 215.45/215.62  |- skos__scopeNote mesh__D045642
% 215.45/215.62       The type species of gram-negative bacteria in the genus SPIROPLASMA, family SPIROPLASMATACEAE, causing citrus stubborn disease.%A%    
% 215.45/215.62  |- skos__prefLabel mesh__D045642 Spiroplasma citri
% 215.45/215.62  |- rdf__type mesh__D045642sskos__Concept
% 215.45/215.62  |- mesh__recordOriginator mesh__D045642 ags
% 215.45/215.62  |- mesh__historyNote mesh__D045642 2004   
% 215.45/215.62  |- skos__historyNote mesh__D045642 Spiroplasma %28%1975-2003%29%
% 215.45/215.62  |- skos__broader mesh__D045642smesh__D013149
% 215.45/215.62  |- mesh__publicMeSHNote mesh__D045642 2004   
% 215.45/215.62  |- mesh__dateCreated mesh__D045642 2003-07-09
% 215.45/215.62  |- mesh__recordAuthorizer mesh__D045642 sjn
% 215.45/215.62  |- mesh__recordMaintainer mesh__D045642 SYSTEM
% 215.45/215.62  |- mesh__dateEstablished mesh__D045642 2004-01-01
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D045642 2006
% 215.45/215.62  |- skos__annotation mesh__D012468
% 215.45/215.62       GEN: prefer specific precoord; coord IM with histol type of neopl %28%IM%29%%A%  
% 215.45/215.62  |- skos__hiddenLabel mesh__D012468 Salivary Gland Cancers
% 215.45/215.62  |- skos__hiddenLabel mesh__D012468 Cancer, Salivary Gland
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D012468 2006
% 215.45/215.62  |- mesh__recordMaintainer mesh__D012468 nns
% 215.45/215.62  |- skos__hiddenLabel mesh__D012468 Neoplasm, Salivary Gland
% 215.45/215.62  |- mesh__recordAuthorizer mesh__D012468 sjn
% 215.45/215.62  |- rdf__type mesh__D012468sskos__Concept
% 215.45/215.62  |- mesh__dateCreated mesh__D012468 1999-01-01
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D012468 2000
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D012468 2003
% 215.45/215.62  |- skos__altLabel mesh__D012468 Salivary Gland Cancer
% 215.45/215.62  |- skos__prefLabel mesh__D012468 Salivary Gland Neoplasms
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D012468 2001
% 215.45/215.62  |- mesh__dateRevised mesh__D012468 1999-11-03
% 215.45/215.62  |- mesh__recordOriginator mesh__D012468 NLM
% 215.45/215.62  |- skos__broader mesh__D012468smesh__D009062
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D012468 2004
% 215.45/215.62  |- skos__altLabel mesh__D012468 Cancer of the Salivary Gland
% 215.45/215.62  |- skos__hiddenLabel mesh__D012468 Gland Neoplasms, Salivary
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D012468 2002
% 215.45/215.62  |- skos__altLabel mesh__D012468 Neoplasms, Salivary Gland
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D012468 2005
% 215.45/215.62  |- skos__broader mesh__D012468smesh__D012466
% 215.45/215.62  |- skos__hiddenLabel mesh__D012468 Cancers, Salivary Gland
% 215.45/215.62  |- skos__hiddenLabel mesh__D012468 Salivary Gland Neoplasm
% 215.45/215.62  |- skos__scopeNote mesh__D012468
% 215.45/215.62       Tumors or cancer of the SALIVARY GLANDS.     
% 215.45/215.62  |- skos__hiddenLabel mesh__D012468 Gland Neoplasm, Salivary
% 215.45/215.62  |- skos__hiddenLabel mesh__D017951 Antigen Presentations
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017951 2002
% 215.45/215.62  |- skos__scopeNote mesh__D017951
% 215.45/215.62       The process by which antigen is presented to lymphocytes in a form they can recognize. This is performed by antigen presenting cells %28%APCs%29%. Some antigens require processing before they can be recognized. Antigen processing consists of ingestion and partial digestion of the antigen by the APC, followed by presentation of fragments on the cell surface. %28%From Rosen et al., Dictionary of Immunology, 1989%29%%A%    
% 215.45/215.62  |- skos__historyNote mesh__D017951 Macrophages/immunology %28%1981-1993%29%
% 215.45/215.62  |- mesh__recordOriginator mesh__D017951 AGS
% 215.45/215.62  |- skos__hiddenLabel mesh__D017951 Antigen Processings
% 215.45/215.62  |- skos__historyNote mesh__D017951 Antigens/immunology %28%1981-1987%29%
% 215.45/215.62  |- mesh__historyNote mesh__D017951 94   
% 215.45/215.62  |- skos__annotation mesh__D017951
% 215.45/215.62       process whereby an antigen is made recognizable to a lymphocyte%A%  
% 215.45/215.62  |- skos__historyNote mesh__D017951
% 215.45/215.62       Antigen-Presenting Cells/immunology %28%1985-1993%29%
% 215.45/215.62  |- mesh__recordMaintainer mesh__D017951 TAP
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017951 2003
% 215.45/215.62  |- mesh__recordAuthorizer mesh__D017951 PLS
% 215.45/215.62  |- skos__prefLabel mesh__D017951 Antigen Presentation
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017951 2005
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017951 2000
% 215.45/215.62  |- mesh__dateRevised mesh__D017951 1995-06-08
% 215.45/215.62  |- mesh__publicMeSHNote mesh__D017951 94   
% 215.45/215.62  |- mesh__dateEstablished mesh__D017951 1994-01-01
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017951 1996
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017951 2004
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017951 2001
% 215.45/215.62  |- skos__broader mesh__D017951smesh__D007111
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017951 1998
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017951 2006
% 215.45/215.62  |- skos__historyNote mesh__D017951 Antigens %28%1977-1984%29%
% 215.45/215.62  |- rdf__type mesh__D017951sskos__Concept
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017951 1997
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017951 1999
% 215.45/215.62  |- mesh__dateCreated mesh__D017951 1993-06-04
% 215.45/215.62  |- mesh__publicMeSHNote mesh__D031622 2003   
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D031622 2003
% 215.45/215.62  |- skos__annotation mesh__D031622
% 215.45/215.62       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D031622 2004
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D031622 2005
% 215.45/215.62  |- skos__prefLabel mesh__D031622 Artocarpus
% 215.45/215.62  |- mesh__dateEstablished mesh__D031622 2003-01-01
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D031622 2006
% 215.45/215.62  |- mesh__dateCreated mesh__D031622 2002-07-02
% 215.45/215.62  |- skos__scopeNote mesh__D031622
% 215.45/215.62       A plant genus of the family MORACEAE. Puag-haad extract, from A. lakoocha,  contains STILBENES and related 4-substituted RESORCINOLS.%A%    
% 215.45/215.62  |- skos__broader mesh__D031622smesh__D029586
% 215.45/215.62  |- mesh__historyNote mesh__D031622 2003   
% 215.45/215.62  |- rdf__type mesh__D031622sskos__Concept
% 215.45/215.62  |- mesh__dateRevised mesh__D017153 2005-07-19
% 215.45/215.62  |- mesh__recordOriginator mesh__D017153 AGS
% 215.45/215.62  |- skos__hiddenLabel mesh__D017153 Antibody, Anticardiolipin
% 215.45/215.62  |- rdf__type mesh__D017153sskos__Concept
% 215.45/215.62  |- skos__broader mesh__D017153smesh__D017152
% 215.45/215.62  |- mesh__historyNote mesh__D017153 93   
% 215.45/215.62  |- mesh__dateEstablished mesh__D017153 1993-01-01
% 215.45/215.62  |- mesh__recordAuthorizer mesh__D017153 ags
% 215.45/215.62  |- mesh__recordMaintainer mesh__D017153 ags
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017153 2006A
% 215.45/215.62  |- skos__annotation mesh__D017153
% 215.45/215.62       do not coordinate with ANTIBODY FORMATION for /biosyn   
% 215.45/215.62  |- mesh__publicMeSHNote mesh__D017153 93   
% 215.45/215.62  |- skos__historyNote mesh__D017153 Autoantibodies %28%1984-1992%29%
% 215.45/215.62  |- skos__scopeNote mesh__D017153
% 215.45/215.62       Antiphospholipid antibodies found in association with systemic lupus erythematosus %28%LUPUS ERYTHEMATOSUS, SYSTEMIC;%29%, ANTIPHOSPHOLIPID SYNDROME; and in a variety of other diseases as well as in healthy individuals. The antibodies are detected by solid-phase IMMUNOASSAY employing the purified phospholipid antigen CARDIOLIPIN.%A%    
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017153 2006
% 215.45/215.62  |- skos__prefLabel mesh__D017153 Antibodies, Anticardiolipin
% 215.45/215.62  |- mesh__dateCreated mesh__D017153 1992-05-07
% 215.45/215.62  |- skos__historyNote mesh__D017153 Antibodies %28%1984-1992%29%
% 215.45/215.62  |- skos__altLabel mesh__D017153 Anticardiolipin Antibodies
% 215.45/215.62  |- skos__altLabel mesh__D017153 Anticardiolipin Antibody
% 215.45/215.62  |- skos__altLabel mesh__D003931 Diketobutane
% 215.45/215.62  |- mesh__dateCreated mesh__D003931 1974-11-27
% 215.45/215.62  |- mesh__recordMaintainer mesh__D003931 CCR
% 215.45/215.62  |- mesh__recordAuthorizer mesh__D003931 sjn
% 215.45/215.62  |- skos__altLabel mesh__D003931 Biacetyl
% 215.45/215.62  |- skos__altLabel mesh__D003931 2,3-Butanedione
% 215.45/215.62  |- skos__hiddenLabel mesh__D003931 2,3 Butanedione
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D003931 2006
% 215.45/215.62  |- mesh__dateRevised mesh__D003931 2000-06-22
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D003931 2005
% 215.45/215.62  |- skos__prefLabel mesh__D003931 Diacetyl
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D003931 2002
% 215.45/215.62  |- skos__altLabel mesh__D003931 Dimethyldiketone
% 215.45/215.62  |- skos__broader mesh__D003931smesh__D002074
% 215.45/215.62  |- rdf__type mesh__D003931sskos__Concept
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D003931 2004
% 215.45/215.62  |- mesh__historyNote mesh__D003931
% 215.45/215.62       91%28%75%29%; was see under BUTANONES 1975-90   
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D003931 2001
% 215.45/215.62  |- skos__altLabel mesh__D003931 Dimethylglyoxal
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D003931 2003
% 215.45/215.62  |- skos__scopeNote mesh__D003931
% 215.45/215.62       Carrier of aroma of butter, vinegar, coffee, and other foods.%A%    
% 215.45/215.62  |- mesh__recordOriginator mesh__D003931 NLM
% 215.45/215.62  |- mesh__dateEstablished mesh__D003931 1991-01-01
% 215.45/215.62  |- mesh__publicMeSHNote mesh__D003931
% 215.45/215.62       91; was see under BUTANONES 1975-90   
% 215.45/215.62  |- skos__hiddenLabel mesh__D003133 Study, Professional Activity
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D003133 1996
% 215.45/215.62  |- mesh__dateEstablished mesh__D003133 1991-01-01
% 215.45/215.62  |- mesh__recordMaintainer mesh__D003133 TGC
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D003133 1999
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D003133 2005
% 215.45/215.62  |- skos__annotation mesh__D003133
% 215.45/215.62       add UNITED STATES %28%NIM%29%; DF: CPHA      CATALOG: use NAF entry%A%  
% 215.45/215.62  |- skos__hiddenLabel mesh__D003133 Medical Audit Programs
% 215.45/215.62  |- mesh__dateRevised mesh__D003133 1994-05-05
% 215.45/215.62  |- skos__prefLabel mesh__D003133
% 215.45/215.62       Commission on Professional and Hospital Activities
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D003133 1997
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D003133 2003
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D003133 2006
% 215.45/215.62  |- skos__broader mesh__D003133smesh__D008485
% 215.45/215.62  |- mesh__publicMeSHNote mesh__D003133
% 215.45/215.62       91; was see under MEDICAL AUDIT Aug 1977-90   
% 215.45/215.62  |- skos__hiddenLabel mesh__D003133 Professional Activity Studies
% 215.45/215.62  |- skos__hiddenLabel mesh__D003133 Audit Programs, Medical
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D003133 2000
% 215.45/215.62  |- mesh__dateCreated mesh__D003133 1977-05-05
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D003133 2004
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D003133 2001
% 215.45/215.62  |- skos__hiddenLabel mesh__D003133 Program, Medical Audit
% 215.45/215.62  |- skos__altLabel mesh__D003133
% 215.45/215.62       Commission on Professional, Hospital Activities
% 215.45/215.62  |- rdf__type mesh__D003133sskos__Concept
% 215.45/215.62  |- skos__scopeNote mesh__D003133
% 215.45/215.62       The non-profit, non-governmental organization which collects, processes, and distributes data on hospital use. Two programs of the Commission are the Professional Activity Study and the Medical Audit Program.%A%    
% 215.45/215.62  |- skos__hiddenLabel mesh__D003133 Programs, Medical Audit
% 215.45/215.62  |- mesh__historyNote mesh__D003133
% 215.45/215.62       91%28%Aug 77%29%; was see under MEDICAL AUDIT 1977-90   
% 215.45/215.62  |- mesh__recordOriginator mesh__D003133 EC
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D003133 1995
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D003133 2002
% 215.45/215.62  |- skos__hiddenLabel mesh__D003133 Audit Program, Medical
% 215.45/215.62  |- skos__hiddenLabel mesh__D003133 Studies, Professional Activity
% 215.45/215.62  |- mesh__recordAuthorizer mesh__D003133 PLS
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D003133 1998
% 215.45/215.62  |- rdf__type mesh__D016859sskos__Concept
% 215.45/215.62  |- mesh__historyNote mesh__D016859
% 215.45/215.62       92; 5-LIPOXYGENASE INHIBITORS was see LIPOXYGENASE INHIBITORS 1992-94%A%  
% 215.45/215.62  |- skos__historyNote mesh__D016859
% 215.45/215.62       Lipoxygenase/antagonists %26% inhibitors %28%1978-1991%29%
% 215.45/215.62  |- mesh__onlineNote mesh__D016859
% 215.45/215.62       use LIPOXYGENASE INHIBITORS to search 5-LIPOXYGENASE INHIBITORS 1992-94; use ARACHIDONATE 5-LIPOXYGENASE/ai 1995 forward%A%  
% 215.45/215.62  |- mesh__dateEstablished mesh__D016859 1992-01-01
% 215.45/215.62  |- mesh__dateCreated mesh__D016859 1991-05-02
% 215.45/215.62  |- mesh__recordMaintainer mesh__D016859 ags
% 215.45/215.62  |- mesh__publicMeSHNote mesh__D016859
% 215.45/215.62       92; 5-LIPOXYGENASE INHIBITORS was see LIPOXYGENASE INHIBITORS 1992-94%A%  
% 215.45/215.62  |- skos__prefLabel mesh__D016859 Lipoxygenase Inhibitors
% 215.45/215.62  |- skos__annotation mesh__D016859 DF: LIPOXYGENASE INHIB   
% 215.45/215.62  |- mesh__recordOriginator mesh__D016859 MXR
% 215.45/215.62  |- skos__scopeNote mesh__D016859
% 215.45/215.62       Compounds or agents that combine with lipoxygenase and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of the eicosanoid products hydroxyeicosatetraenoic acid and various leukotrienes.%A%    
% 215.45/215.62  |- skos__broader mesh__D016859smesh__D004791
% 215.45/215.62  |- mesh__dateRevised mesh__D016859 2005-06-30
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D016859 2006
% 215.45/215.62  |- mesh__recordAuthorizer mesh__D016859 sjn
% 215.45/215.62  |- skos__altLabel mesh__D016859 Inhibitors, Lipoxygenase
% 215.45/215.62  |- mesh__dateCreated mesh__D027581 2001-07-25
% 215.45/215.62  |- skos__prefLabel mesh__D027581 Cannabaceae
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D027581 2006
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D027581 2004
% 215.45/215.62  |- rdf__type mesh__D027581sskos__Concept
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D027581 2005
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D027581 2003
% 215.45/215.62  |- skos__historyNote mesh__D027581 Cannabis %28%1978-2001%29%
% 215.45/215.62  |- skos__broader mesh__D027581smesh__D019684
% 215.45/215.62  |- mesh__dateEstablished mesh__D027581 2002-01-01
% 215.45/215.62  |- mesh__historyNote mesh__D027581 2002; use Cannabis 1999-2001   
% 215.45/215.62  |- skos__annotation mesh__D027581
% 215.45/215.62       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.45/215.62  |- mesh__publicMeSHNote mesh__D027581 2002; see Cannabis 1999-2001   
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D027581 2002
% 215.45/215.62  |- skos__scopeNote mesh__D027581
% 215.45/215.62       A plant family of the order Urticales, subclass Hamamelidae, class Magnoliopsida.  It is most notable for the members, Cannabis and Hops.%A%    
% 215.45/215.62  |- mesh__recordAuthorizer mesh__D002839 sjn
% 215.45/215.62  |- skos__prefLabel mesh__D002839 Chromans
% 215.45/215.62  |- mesh__dateCreated mesh__D002839 1974-11-11
% 215.45/215.62  |- skos__annotation mesh__D002839 do not confuse with CHROMONES   
% 215.45/215.62  |- mesh__historyNote mesh__D002839
% 215.45/215.62       91%28%75%29%; was see under BENZOPYRANS 1975-90   
% 215.45/215.62  |- skos__broader mesh__D002839smesh__D001578
% 215.45/215.62  |- mesh__dateEstablished mesh__D002839 1991-01-01
% 215.45/215.62  |- rdf__type mesh__D002839sskos__Concept
% 215.45/215.62  |- mesh__recordOriginator mesh__D002839 NLM
% 215.45/215.62  |- mesh__dateRevised mesh__D002839 2005-06-30
% 215.45/215.62  |- skos__altLabel mesh__D002839 Dihydrobenzopyrans
% 215.45/215.62  |- skos__historyNote mesh__D002839 Benzopyrans %28%1968-1974%29%
% 215.45/215.62  |- mesh__publicMeSHNote mesh__D002839
% 215.45/215.62       91; was see under BENZOPYRANS 1975-90   
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D002839 2006
% 215.45/215.62  |- skos__scopeNote mesh__D002839
% 215.45/215.62       Benzopyrans saturated in the 2 and 3 positions.     
% 215.45/215.62  |- mesh__recordMaintainer mesh__D002839 ssb
% 215.45/215.62  |- rdf__type mesh__D013561sskos__Concept
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D013561 2005
% 215.45/215.62  |- skos__scopeNote mesh__D013561
% 215.45/215.62       A concept that stands for or suggests something else by reason of its relationship, association, convention, or resemblance. The symbolism may be mental or a visible sign or representation. %28%From Webster, 3d ed%29%%A%    
% 215.45/215.62  |- mesh__recordOriginator mesh__D013561 NLM
% 215.45/215.62  |- mesh__recordAuthorizer mesh__D013561 sjn
% 215.45/215.62  |- skos__broader mesh__D013561smesh__D010684
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D013561 2006
% 215.45/215.62  |- mesh__recordMaintainer mesh__D013561 jls
% 215.45/215.62  |- skos__broader mesh__D013561smesh__D006664
% 215.45/215.62  |- skos__prefLabel mesh__D013561 Symbolism
% 215.45/215.62  |- mesh__dateCreated mesh__D013561 1999-01-01
% 215.45/215.62  |- skos__annotation mesh__D013561
% 215.45/215.62       no qualif; symbolism in art, music, literature, etc. goes here; graphic symbols go in a variety of places where pertinent %28%EMBLEMS AND INSIGNIA; LANGUAGE; COMMUNICATION; WRITING; etc.%29%; coord IM with the object or concept symbolized %28%IM%29%%A%  
% 215.45/215.62  |- mesh__dateRevised mesh__D013561 2004-07-07
% 215.45/215.62  |- mesh__historyNote mesh__D013561
% 215.45/215.62       96; was SYMBOLISM %28%PSYCHOLOGY%29% 1979-95; was heading 1963-78%A%  
% 215.45/215.62  |- mesh__publicMeSHNote mesh__D013561
% 215.45/215.62       96; was SYMBOLISM %28%PSYCHOLOGY%29% 1979-95; was heading 1963-78%A%  
% 215.45/215.62  |- skos__hiddenLabel mesh__D013561 Symbolisms
% 215.45/215.62  |- skos__hiddenLabel mesh__D013561 Symbolisms %28%Psychology%29%
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007524 1998
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007524 1993
% 215.45/215.62  |- skos__broader mesh__D007524smesh__D011726
% 215.45/215.62  |- skos__broader mesh__D007524smesh__D000598
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007524 2005
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007524 1999
% 215.45/215.62  |- skos__scopeNote mesh__D007524
% 215.45/215.62       2-%28%4-Amino-4-carboxybutyl%29%-1-%28%5-amino-5-carboxypentyl%29%-3,5-bis%28%3-amino-3-carboxypropyl%29%pyridinium. A rare amino acid found in elastin, formed by condensation of four molecules of lysine into a pyridinium ring.%A%    
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007524 1996
% 215.45/215.62  |- skos__prefLabel mesh__D007524 Isodesmosine
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007524 2006
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007524 2003
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007524 1997
% 215.45/215.62  |- mesh__recordOriginator mesh__D007524 NLM
% 215.45/215.62  |- mesh__dateRevised mesh__D007524 1992-05-19
% 215.45/215.62  |- skos__historyNote mesh__D007524 Pyridinium Compounds %28%1970-1974%29%
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007524 2004
% 215.45/215.62  |- mesh__historyNote mesh__D007524
% 215.45/215.62       91%28%75%29%; was see under AMINO ACIDS 1975-90   
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007524 2000
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007524 1994
% 215.45/215.62  |- mesh__recordMaintainer mesh__D007524 TAP
% 215.45/215.62  |- mesh__publicMeSHNote mesh__D007524
% 215.45/215.62       91; was see under AMINO ACIDS 1975-90   
% 215.45/215.62  |- mesh__recordAuthorizer mesh__D007524 PLS
% 215.45/215.62  |- skos__historyNote mesh__D007524 Amino Acids %28%1972-1974%29%
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007524 2001
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007524 1995
% 215.45/215.62  |- mesh__dateCreated mesh__D007524 1974-11-19
% 215.45/215.62  |- rdf__type mesh__D007524sskos__Concept
% 215.45/215.62  |- mesh__dateEstablished mesh__D007524 1991-01-01
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D007524 2002
% 215.45/215.62  |- skos__related mesh__D045643smesh__D004260
% 215.45/215.62  |- mesh__publicMeSHNote mesh__D045643 2004; see DNA LIGASES 1978-2003   
% 215.45/215.62  |- rdf__type mesh__D045643sskos__Concept
% 215.45/215.62  |- skos__prefLabel mesh__D045643 DNA Repair Enzymes
% 215.45/215.62  |- skos__related mesh__D045643smesh__D004249
% 215.45/215.62  |- mesh__dateEstablished mesh__D045643 2004-01-01
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D045643 2006
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D045643 2004
% 215.45/215.62  |- skos__hiddenLabel mesh__D045643 Repair Enzymes, DNA
% 215.45/215.62  |- skos__scopeNote mesh__D045643
% 215.45/215.62       Enzymes that are involved in the reconstruction of a continuous two-stranded DNA molecule without mismatch from a molecule, which contained damaged regions.%A%    
% 215.45/215.62  |- skos__historyNote mesh__D045643 DNA Ligases %28%1978-2003%29%
% 215.45/215.62  |- mesh__dateCreated mesh__D045643 2003-07-09
% 215.45/215.62  |- skos__annotation mesh__D045643
% 215.45/215.62       GEN; prefer specifics; coord with specific enzyme not treed here%A%  
% 215.45/215.62  |- skos__broader mesh__D045643smesh__D004798
% 215.45/215.62  |- mesh__historyNote mesh__D045643 2004; use DNA LIGASES 1978-2003   
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D045643 2005
% 215.45/215.62  |- skos__hiddenLabel mesh__D045643 Enzymes, DNA Repair
% 215.45/215.62  |- rdf__type mesh__D012469sskos__Concept
% 215.45/215.62  |- skos__broader mesh__D012469smesh__D009055
% 215.45/215.62  |- mesh__dateCreated mesh__D012469 1999-01-01
% 215.45/215.62  |- mesh__recordMaintainer mesh__D012469 lkt
% 215.45/215.62  |- skos__hiddenLabel mesh__D012469 Salivary Gland
% 215.45/215.62  |- mesh__dateRevised mesh__D012469 2003-07-09
% 215.45/215.62  |- mesh__recordAuthorizer mesh__D012469 sjn
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D012469 2004
% 215.45/215.62  |- skos__hiddenLabel mesh__D012469 Glands, Salivary
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D012469 2005
% 215.45/215.62  |- skos__broader mesh__D012469smesh__D005088
% 215.45/215.62  |- skos__prefLabel mesh__D012469 Salivary Glands
% 215.45/215.62  |- skos__hiddenLabel mesh__D012469 Gland, Salivary
% 215.45/215.62  |- mesh__recordOriginator mesh__D012469 NLM
% 215.45/215.62  |- skos__scopeNote mesh__D012469
% 215.45/215.62       Glands that secrete SALIVA in the MOUTH. There are three pairs of salivary glands %28%PAROTID GLAND; SUBLINGUAL GLAND; SUBMANDIBULAR GLAND%29%.%A%    
% 215.45/215.62  |- mesh__considerAlso mesh__D012469 consider also terms at SIAL-   
% 215.45/215.62  |- skos__annotation mesh__D012469
% 215.45/215.62       GEN; /secret: see also SALIVATION; inflammation = SIALADENITIS; tuberc of salivary glands or tuberc sialadenitis = SIALADENITIS %28%IM%29% + TUBERCULOSIS, ORAL %28%IM%29%%A%  
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D012469 2006
% 215.45/215.62  |- skos__related mesh__D012469smesh__D012796
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017952 2005
% 215.45/215.62  |- mesh__recordMaintainer mesh__D017952 ags
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017952 2006
% 215.45/215.62  |- mesh__recordOriginator mesh__D017952 RAZ
% 215.45/215.62  |- skos__hiddenLabel mesh__D017952 Invertebrate Ganglions
% 215.45/215.62  |- rdf__type mesh__D017952sskos__Concept
% 215.45/215.62  |- skos__scopeNote mesh__D017952
% 215.45/215.62       Clusters of neuronal cell bodies in invertebrates. Invertebrate ganglia may also contain neuronal processes and non-neuronal supporting cells. Many invertebrate ganglia are favorable subjects for research because they have small numbers of functional neuronal types which can be identified from one animal to another.%A%    
% 215.45/215.62  |- skos__prefLabel mesh__D017952 Ganglia, Invertebrate
% 215.45/215.62  |- skos__broader mesh__D017952smesh__D005724
% 215.45/215.62  |- skos__altLabel mesh__D017952 Invertebrate Ganglia
% 215.45/215.62  |- mesh__dateRevised mesh__D017952 2004-07-07
% 215.45/215.62  |- mesh__dateCreated mesh__D017952 1993-06-18
% 215.45/215.62  |- mesh__recordAuthorizer mesh__D017952 sjn
% 215.45/215.62  |- mesh__dateEstablished mesh__D017952 1994-01-01
% 215.45/215.62  |- skos__broader mesh__D017952smesh__D000825
% 215.45/215.62  |- mesh__historyNote mesh__D017952 94   
% 215.45/215.62  |- skos__hiddenLabel mesh__D017952 Invertebrate Ganglion
% 215.45/215.62  |- skos__historyNote mesh__D017952 Ganglia %28%1966-1993%29%
% 215.45/215.62  |- skos__altLabel mesh__D017952 Ganglion, Invertebrate
% 215.45/215.62  |- mesh__publicMeSHNote mesh__D017952 94   
% 215.45/215.62  |- skos__hiddenLabel mesh__D017952 Ganglions, Invertebrate
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D031623 2003
% 215.45/215.62  |- mesh__historyNote mesh__D031623 2003   
% 215.45/215.62  |- skos__scopeNote mesh__D031623
% 215.45/215.62       A plant genus of the family MORACEAE. Members contain PYRROLIDINES.%A%    
% 215.45/215.62  |- skos__annotation mesh__D031623
% 215.45/215.62       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D031623 2004
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D031623 2005
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D031623 2006
% 215.45/215.62  |- skos__broader mesh__D031623smesh__D029586
% 215.45/215.62  |- skos__prefLabel mesh__D031623 Broussonetia
% 215.45/215.62  |- rdf__type mesh__D031623sskos__Concept
% 215.45/215.62  |- mesh__dateEstablished mesh__D031623 2003-01-01
% 215.45/215.62  |- mesh__dateCreated mesh__D031623 2002-07-02
% 215.45/215.62  |- mesh__publicMeSHNote mesh__D031623 2003   
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017154 1999
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017154 2006
% 215.45/215.62  |- skos__hiddenLabel mesh__D017154 Cells, Stromal
% 215.45/215.62  |- skos__scopeNote mesh__D017154
% 215.45/215.62       Connective tissue cells of an organ found in the loose connective tissue. These are most often associated with the uterine mucosa and the ovary as well as the hematopoietic system and elsewhere.%A%    
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017154 2001
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017154 2000
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017154 1998
% 215.45/215.62  |- skos__prefLabel mesh__D017154 Stromal Cells
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017154 2005
% 215.45/215.62  |- rdf__type mesh__D017154sskos__Concept
% 215.45/215.62  |- skos__hiddenLabel mesh__D017154 Cell, Stromal
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017154 1997
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017154 2004
% 215.45/215.62  |- mesh__dateEstablished mesh__D017154 1993-01-01
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017154 1996
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017154 2003
% 215.45/215.62  |- mesh__dateCreated mesh__D017154 1992-05-22
% 215.45/215.62  |- skos__annotation mesh__D017154
% 215.45/215.62       connective tissue cells; NIM; coord with organ /cytol %28%IM%29%%A%  
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017154 1995
% 215.45/215.62  |- skos__hiddenLabel mesh__D017154 Stromal Cell
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017154 1994
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017154 2002
% 215.45/215.62  |- mesh__historyNote mesh__D017154 93   
% 215.45/215.62  |- skos__broader mesh__D017154smesh__D003239
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D017154 1993
% 215.45/215.62  |- mesh__publicMeSHNote mesh__D017154 93   
% 215.45/215.62  |- skos__altLabel mesh__D003932 Diamorf
% 215.45/215.62  |- mesh__recordMaintainer mesh__D003932 ags
% 215.45/215.62  |- mesh__dateCreated mesh__D003932 1999-01-01
% 215.45/215.62  |- mesh__publicMeSHNote mesh__D003932
% 215.45/215.62       99; see DIACETYLMORPHINE 1978-98; for HEROIN see DIACETYLMORPHINE 1963-98%A%  
% 215.45/215.62  |- skos__altLabel mesh__D003932 Diacetylmorphine Hydrochloride
% 215.45/215.62  |- mesh__recordOriginator mesh__D003932 NLM
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D003932 2006
% 215.45/215.62  |- skos__altLabel mesh__D003932 APS Brand of Heroin Hydrochloride
% 215.45/215.62  |- skos__prefLabel mesh__D003932 Heroin
% 215.45/215.62  |- skos__altLabel mesh__D003932 Diacetylmorphine
% 215.45/215.62  |- skos__hiddenLabel mesh__D003932 Hydrochloride, Heroin
% 215.45/215.62  |- skos__hiddenLabel mesh__D003932 Hydrochloride, Diacetylmorphine
% 215.45/215.62  |- skos__hiddenLabel mesh__D003932 Min I Jet Morphine Sulphate
% 215.45/215.62  |- mesh__recordAuthorizer mesh__D003932 sjn
% 215.45/215.62  |- skos__scopeNote mesh__D003932
% 215.45/215.62       A narcotic analgesic that may be habit-forming. It is a controlled substance %28%opium derivative%29% listed in the U.S. Code of Federal Regulations, Title 21 Parts 329.1, 1308.11 %28%1987%29%. Sale is forbidden in the United States by Federal statute. %28%Merck Index, 11th ed%29%%A%    
% 215.45/215.62  |- rdf__type mesh__D003932sskos__Concept
% 215.45/215.62  |- skos__altLabel mesh__D003932 Diamorphine
% 215.45/215.62  |- mesh__dateRevised mesh__D003932 2005-06-30
% 215.45/215.62  |- skos__altLabel mesh__D003932
% 215.45/215.62       Evans Vaccines Brand of Heroin Hydrochloride
% 215.45/215.62  |- skos__broader mesh__D003932smesh__D009022
% 215.45/215.62  |- mesh__historyNote mesh__D003932 99%28%63%29%   
% 215.45/215.62  |- mesh__dateRevised mesh__D003134 2001-07-25
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D003134 2003
% 215.45/215.62  |- mesh__activeMeSHYear mesh__D003134 2006
% 215.45/215.63  |- skos__hiddenLabel mesh__D003134 Mentally Ill Commitments
% 215.45/215.63  |- skos__hiddenLabel mesh__D003134 Commitments, Involuntary
% 215.45/215.63  |- mesh__dateCreated mesh__D003134 1974-11-11
% 215.45/215.63  |- skos__hiddenLabel mesh__D003134 Commitments, Outpatient
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D003134 2004
% 215.45/215.63  |- skos__prefLabel mesh__D003134 Commitment of Mentally Ill
% 215.45/215.63  |- skos__hiddenLabel mesh__D003134 Commitment, Involuntary
% 215.45/215.63  |- skos__hiddenLabel mesh__D003134 Involuntary Commitments
% 215.45/215.63  |- mesh__publicMeSHNote mesh__D003134
% 215.45/215.63       83; was see under FORENSIC PSYCHIATRY 1975-82   
% 215.45/215.63  |- rdf__type mesh__D003134sskos__Concept
% 215.45/215.63  |- skos__hiddenLabel mesh__D003134 Outpatient Commitments
% 215.45/215.63  |- skos__hiddenLabel mesh__D003134 Commitment Duration
% 215.45/215.63  |- mesh__dateEstablished mesh__D003134 1983-01-01
% 215.45/215.63  |- mesh__historyNote mesh__D003134
% 215.45/215.63       83%28%75%29%; was see under FORENSIC PSYCHIATRY 1975-82   
% 215.45/215.63  |- skos__hiddenLabel mesh__D003134 Mentally Ill Commitment
% 215.45/215.63  |- skos__annotation mesh__D003134
% 215.45/215.63       do not coord with HOSPITALIZATION since this is inherent in the definition%A%  
% 215.45/215.63  |- skos__hiddenLabel mesh__D003134 Commitment Durations
% 215.45/215.63  |- skos__related mesh__D003134smesh__D028642
% 215.45/215.63  |- skos__related mesh__D003134smesh__D010344
% 215.45/215.63  |- mesh__recordMaintainer mesh__D003134 jrf
% 215.45/215.63  |- skos__hiddenLabel mesh__D003134 Commitment, Outpatient
% 215.45/215.63  |- mesh__recordAuthorizer mesh__D003134 sjn
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D003134 2005
% 215.45/215.63  |- mesh__recordOriginator mesh__D003134 NLM
% 215.45/215.63  |- skos__scopeNote mesh__D003134
% 215.45/215.63       Legal process required for the institutionalization of a patient with severe mental problems.%A%    
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D003134 2002
% 215.45/215.63  |- skos__broader mesh__D003134smesh__D005555
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D027582 2006
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D027582 2002
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D027582 2004
% 215.45/215.63  |- mesh__dateCreated mesh__D027582 2001-07-25
% 215.45/215.63  |- rdf__type mesh__D027582sskos__Concept
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D027582 2005
% 215.45/215.63  |- skos__scopeNote mesh__D027582
% 215.45/215.63       A plant genus in the CANNABACEAE family.  Best known for the buds of Humulus lupulus L. used in BEER.%A%    
% 215.45/215.63  |- skos__annotation mesh__D027582
% 215.45/215.63       BEER is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D027582 2003
% 215.45/215.63  |- skos__historyNote mesh__D027582 Beer %28%1974-2001%29%
% 215.45/215.63  |- skos__broader mesh__D027582smesh__D027581
% 215.45/215.63  |- skos__historyNote mesh__D027582 Plants, Medicinal %28%1974-2001%29%
% 215.45/215.63  |- mesh__dateEstablished mesh__D027582 2002-01-01
% 215.45/215.63  |- mesh__historyNote mesh__D027582 2002   
% 215.45/215.63  |- skos__altLabel mesh__D027582 Hops
% 215.45/215.63  |- skos__prefLabel mesh__D027582 Humulus
% 215.45/215.63  |- mesh__publicMeSHNote mesh__D027582 2002   
% 215.45/215.63  |- skos__altLabel mesh__D013562 Denervation, Sympathetic
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013562 2001
% 215.45/215.63  |- mesh__recordMaintainer mesh__D013562 NNS
% 215.45/215.63  |- skos__scopeNote mesh__D013562
% 215.45/215.63       The removal or interruption of some part of the sympathetic nervous system for therapeutic or research purposes.%A%    
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013562 2004
% 215.45/215.63  |- skos__broader mesh__D013562smesh__D017763
% 215.45/215.63  |- rdf__type mesh__D013562sskos__Concept
% 215.45/215.63  |- skos__hiddenLabel mesh__D013562 Sympathectomies
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013562 1999
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013562 2000
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013562 2003
% 215.45/215.63  |- skos__annotation mesh__D013562
% 215.45/215.63       do not use /util except by MeSH definition; coord with nerve /surg or plexus /surg %28%IM or NIM%29% but note that GANGLIONECTOMY is also available: see note there; lumbar sympathectomy: coord with LUMBOSACRAL PLEXUS/surg; coord IM with disease /surg %28%IM%29%%A%  
% 215.45/215.63  |- skos__prefLabel mesh__D013562 Sympathectomy
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013562 2006
% 215.45/215.63  |- mesh__recordOriginator mesh__D013562 NLM
% 215.45/215.63  |- skos__altLabel mesh__D013562 Sympathetic Denervation
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013562 2002
% 215.45/215.63  |- skos__hiddenLabel mesh__D013562 Sympathetic Denervations
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013562 2005
% 215.45/215.63  |- skos__hiddenLabel mesh__D013562 Denervations, Sympathetic
% 215.45/215.63  |- mesh__dateRevised mesh__D013562 1998-06-11
% 215.45/215.63  |- mesh__dateCreated mesh__D013562 1999-01-01
% 215.45/215.63  |- mesh__recordAuthorizer mesh__D013562 SJN
% 215.45/215.63  |- mesh__recordMaintainer mesh__D007525 lkt
% 215.45/215.63  |- skos__altLabel mesh__D007525 Electrofocusing
% 215.45/215.63  |- skos__broader mesh__D007525smesh__D004586
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D007525 2004
% 215.45/215.63  |- skos__annotation mesh__D007525 a type of electrophoresis; NIM   
% 215.45/215.63  |- skos__hiddenLabel mesh__D007525 Focusing, Isoelectric
% 215.45/215.63  |- skos__prefLabel mesh__D007525 Isoelectric Focusing
% 215.45/215.63  |- mesh__dateRevised mesh__D007525 2002-07-03
% 215.45/215.63  |- skos__historyNote mesh__D007525 Electrophoresis %28%1966-1969%29%
% 215.45/215.63  |- rdf__type mesh__D007525sskos__Concept
% 215.45/215.63  |- mesh__recordAuthorizer mesh__D007525 sjn
% 215.45/215.63  |- mesh__dateCreated mesh__D007525 1999-01-01
% 215.45/215.63  |- mesh__recordOriginator mesh__D007525 NLM
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D007525 2005
% 215.45/215.63  |- mesh__dateEstablished mesh__D007525 1974-01-01
% 215.45/215.63  |- mesh__historyNote mesh__D007525 74%28%70%29%   
% 215.45/215.63  |- skos__scopeNote mesh__D007525
% 215.45/215.63       Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site %28%or focus%29% at which the pH is equal to their isoelectric point.%A%    
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D007525 2006
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D007525 2003
% 215.45/215.63  |- mesh__publicMeSHNote mesh__D007525 74   
% 215.45/215.63  |- skos__historyNote mesh__D045644 Mycoplasma %28%1967-2003%29%
% 215.45/215.63  |- skos__prefLabel mesh__D045644 Mycoplasma agalactiae
% 215.45/215.63  |- mesh__dateRevised mesh__D045644 2005-06-30
% 215.45/215.63  |- skos__broader mesh__D045644smesh__D009174
% 215.45/215.63  |- mesh__dateEstablished mesh__D045644 2004-01-01
% 215.45/215.63  |- mesh__recordOriginator mesh__D045644 ags
% 215.45/215.63  |- mesh__publicMeSHNote mesh__D045644 2004   
% 215.45/215.63  |- mesh__dateCreated mesh__D045644 2003-07-09
% 215.45/215.63  |- skos__annotation mesh__D045644
% 215.45/215.63       infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29%   
% 215.45/215.63  |- mesh__historyNote mesh__D045644 2004   
% 215.45/215.63  |- skos__scopeNote mesh__D045644
% 215.45/215.63       A species of gram-negative bacteria causing contagious agalactia of SHEEP and GOATS.%A%    
% 215.45/215.63  |- rdf__type mesh__D045644sskos__Concept
% 215.45/215.63  |- mesh__recordMaintainer mesh__D045644 SYSTEM
% 215.45/215.63  |- mesh__recordAuthorizer mesh__D045644 sjn
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D045644 2006
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017953 2000
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017953 1998
% 215.45/215.63  |- skos__historyNote mesh__D017953 Cyanates %28%1966-1993%29%
% 215.45/215.63  |- skos__scopeNote mesh__D017953
% 215.45/215.63       Organic compounds that contain the -NCO radical.     
% 215.45/215.63  |- mesh__onlineNote mesh__D017953
% 215.45/215.63       use CYANATES to search ISOCYANATES 1993   
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017953 1997
% 215.45/215.63  |- rdf__type mesh__D017953sskos__Concept
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017953 2001
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017953 1994
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017953 1999
% 215.45/215.63  |- mesh__dateCreated mesh__D017953 1993-02-16
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017953 1995
% 215.45/215.63  |- skos__prefLabel mesh__D017953 Isocyanates
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017953 2002
% 215.45/215.63  |- skos__broader mesh__D017953smesh__D009930
% 215.45/215.63  |- mesh__publicMeSHNote mesh__D017953
% 215.45/215.63       94; ISOCYANATES was see CYANATES 1993   
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017953 2003
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017953 2005
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017953 2004
% 215.45/215.63  |- mesh__dateEstablished mesh__D017953 1994-01-01
% 215.45/215.63  |- mesh__historyNote mesh__D017953 94; ISOCYANATES was see CYANATES 1993   
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017953 1996
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017953 2006
% 215.45/215.63  |- mesh__dateCreated mesh__D031624 2002-07-03
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D031624 2006
% 215.45/215.63  |- skos__altLabel mesh__D031624 Osage Orange
% 215.45/215.63  |- skos__broader mesh__D031624smesh__D029586
% 215.45/215.63  |- skos__prefLabel mesh__D031624 Maclura
% 215.45/215.63  |- rdf__type mesh__D031624sskos__Concept
% 215.45/215.63  |- mesh__historyNote mesh__D031624 2003   
% 215.45/215.63  |- skos__scopeNote mesh__D031624
% 215.45/215.63       A plant genus of the family MORACEAE. Members contain maclurin, antifungal chalcones, and other compounds.%A%    
% 215.45/215.63  |- mesh__publicMeSHNote mesh__D031624 2003   
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D031624 2003
% 215.45/215.63  |- skos__annotation mesh__D031624
% 215.45/215.63       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D031624 2004
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D031624 2005
% 215.45/215.63  |- skos__altLabel mesh__D031624 Orange, Osage
% 215.45/215.63  |- mesh__dateEstablished mesh__D031624 2003-01-01
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017155 1998
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017155 2005
% 215.45/215.63  |- skos__hiddenLabel mesh__D017155 Wetabilities
% 215.45/215.63  |- rdf__type mesh__D017155sskos__Concept
% 215.45/215.63  |- skos__altLabel mesh__D017155 Hygroscopicity
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017155 2002
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017155 1997
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017155 2004
% 215.45/215.63  |- mesh__publicMeSHNote mesh__D017155 93   
% 215.45/215.63  |- skos__hiddenLabel mesh__D017155 Wettabilities
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017155 2001
% 215.45/215.63  |- skos__prefLabel mesh__D017155 Wettability
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017155 1996
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017155 2003
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017155 2000
% 215.45/215.63  |- skos__historyNote mesh__D017155 Surface Properties %28%1968-1992%29%
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017155 1995
% 215.45/215.63  |- skos__hiddenLabel mesh__D017155 Hygroscopicities
% 215.45/215.63  |- skos__altLabel mesh__D017155 Wetability
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017155 1994
% 215.45/215.63  |- mesh__historyNote mesh__D017155 93   
% 215.45/215.63  |- mesh__dateEstablished mesh__D017155 1993-01-01
% 215.45/215.63  |- skos__broader mesh__D017155smesh__D013499
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017155 1993
% 215.45/215.63  |- skos__scopeNote mesh__D017155
% 215.45/215.63       The quality or state of being wettable or the degree to which something can be wet. This is also the ability of any solid surface to be wetted when in contact with a liquid whose surface tension is reduced so that the liquid spreads over the surface of the solid.%A%    
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017155 1999
% 215.45/215.63  |- mesh__dateCreated mesh__D017155 1992-05-22
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017155 2006
% 215.45/215.63  |- skos__annotation mesh__D017155 almost never IM   
% 215.45/215.63  |- skos__hiddenLabel mesh__D003933 Diagnoses, Postmortem
% 215.45/215.63  |- skos__hiddenLabel mesh__D003933 Antemortem Diagnoses
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D003933 2006
% 215.45/215.63  |- mesh__dateRevised mesh__D003933 2005-06-30
% 215.45/215.63  |- skos__hiddenLabel mesh__D003933 Postmortem Diagnoses
% 215.45/215.63  |- mesh__runningHead mesh__D003933
% 215.45/215.63       E1 - PROCEDURES AND TECHNIQUES-DIAGNOSTIC   
% 215.45/215.63  |- skos__hiddenLabel mesh__D003933 Diagnosis, Postmortem
% 215.45/215.63  |- mesh__recordMaintainer mesh__D003933 lkt
% 215.45/215.63  |- rdf__type mesh__D003933sskos__Concept
% 215.45/215.63  |- mesh__recordOriginator mesh__D003933 NLM
% 215.45/215.63  |- skos__prefLabel mesh__D003933 Diagnosis
% 215.45/215.63  |- skos__hiddenLabel mesh__D003933 Diagnoses
% 215.45/215.63  |- skos__annotation mesh__D003933
% 215.45/215.63       general only; prefer /diag with disease term: Manual 19.7+, 19.8.22; in Chinese traditional medicine, diagnosis %26% therapy based on overall analysis of the patient%27%s state is bianzheng shizhi: see note under DIAGNOSIS, DIFFERENTIAL; DF: DIAG%A%  
% 215.45/215.63  |- skos__hiddenLabel mesh__D003933 Diagnosis, Antemortem
% 215.45/215.63  |- skos__scopeNote mesh__D003933
% 215.45/215.63       The determination of the nature of a disease or condition, or the distinguishing of one disease or condition from another. Assessment may be made through physical examination, laboratory tests, or the likes. Computerized programs may be used to enhance the decision-making process.%A%    
% 215.45/215.63  |- mesh__recordAuthorizer mesh__D003933 sjn
% 215.45/215.63  |- mesh__onlineNote mesh__D003933 pre-explosion = DIAGNOSIS %28%PX%29%   
% 215.45/215.63  |- skos__altLabel mesh__D003933 Examinations and Diagnoses
% 215.45/215.63  |- mesh__dateCreated mesh__D003933 1999-01-01
% 215.45/215.63  |- skos__hiddenLabel mesh__D003933 Diagnoses, Antemortem
% 215.45/215.63  |- skos__scopeNote mesh__D003135
% 215.45/215.63       The largest bile duct. It is formed by the junction of the CYSTIC DUCT and the COMMON HEPATIC DUCT.%A%    
% 215.45/215.63  |- skos__annotation mesh__D003135
% 215.45/215.63       inflammation = CHOLANGITIS + COMMON BILE DUCT DISEASES; calculi = COMMON BILE DUCT CALCULI see GALLSTONES but consider also CHOLEDOCHOLITHIASIS%A%  
% 215.45/215.63  |- skos__broader mesh__D003135smesh__D017734
% 215.45/215.63  |- mesh__considerAlso mesh__D003135 consider also terms at CHOLEDOCH-   
% 215.45/215.63  |- skos__hiddenLabel mesh__D003135 Duct, Common Bile
% 215.45/215.63  |- mesh__recordAuthorizer mesh__D003135 sjn
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D003135 2004
% 215.45/215.63  |- skos__prefLabel mesh__D003135 Common Bile Duct
% 215.45/215.63  |- skos__related mesh__D003135smesh__D002768
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D003135 2006
% 215.45/215.63  |- skos__altLabel mesh__D003135 Choledochus
% 215.45/215.63  |- mesh__recordOriginator mesh__D003135 NLM
% 215.45/215.63  |- mesh__dateRevised mesh__D003135 2003-07-09
% 215.45/215.63  |- mesh__dateCreated mesh__D003135 1999-01-01
% 215.45/215.63  |- mesh__recordMaintainer mesh__D003135 lkt
% 215.45/215.63  |- skos__hiddenLabel mesh__D003135 Common Bile Ducts
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D003135 2005
% 215.45/215.63  |- rdf__type mesh__D003135sskos__Concept
% 215.45/215.63  |- skos__hiddenLabel mesh__D003135 Bile Duct, Common
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013563 2003
% 215.45/215.63  |- skos__hiddenLabel mesh__D013563 Chemical Sympathectomies
% 215.45/215.63  |- mesh__dateEstablished mesh__D013563 1982-01-01
% 215.45/215.63  |- skos__annotation mesh__D013563
% 215.45/215.63       do not use /util except by MeSH definition; coord IM with specific chemical %28%no qualif%29% %28%NIM%29% + disease /ther %28%IM%29%; do not confuse with SYMPATHETIC NERVE BLOCK see AUTONOMIC NERVE BLOCK%A%  
% 215.45/215.63  |- skos__altLabel mesh__D013563 Chemosympathectomy
% 215.45/215.63  |- skos__historyNote mesh__D013563 Guanethidine %28%1966-1981%29%
% 215.45/215.63  |- skos__hiddenLabel mesh__D013563 Chemosympathectomies
% 215.45/215.63  |- skos__altLabel mesh__D013563 Sympathetic Denervation, Chemical
% 215.45/215.63  |- mesh__recordMaintainer mesh__D013563 PXP
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013563 1998
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013563 2002
% 215.45/215.63  |- mesh__recordOriginator mesh__D013563 SMH
% 215.45/215.63  |- mesh__dateCreated mesh__D013563 1981-02-27
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013563 2004
% 215.45/215.63  |- skos__hiddenLabel mesh__D013563 Sympathetic Denervations, Chemical
% 215.45/215.63  |- skos__historyNote mesh__D013563 Hydroxydopamines %28%1973-1981%29%
% 215.45/215.63  |- rdf__type mesh__D013563sskos__Concept
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013563 1999
% 215.45/215.63  |- mesh__historyNote mesh__D013563 82   
% 215.45/215.63  |- skos__hiddenLabel mesh__D013563 Chemical Sympathetic Denervations
% 215.45/215.63  |- skos__historyNote mesh__D013563 Sympathectomy %28%1966-1981%29%
% 215.45/215.63  |- mesh__publicMeSHNote mesh__D013563 82   
% 215.45/215.63  |- skos__prefLabel mesh__D013563 Sympathectomy, Chemical
% 215.45/215.63  |- skos__historyNote mesh__D013563 Dopamine %28%1966-1972%29%
% 215.45/215.63  |- mesh__recordAuthorizer mesh__D013563 SJN
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013563 2005
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013563 2000
% 215.45/215.63  |- skos__altLabel mesh__D013563 Chemical Sympathetic Denervation
% 215.45/215.63  |- skos__hiddenLabel mesh__D013563 Denervation, Chemical Sympathetic
% 215.45/215.63  |- skos__broader mesh__D013563smesh__D013562
% 215.45/215.63  |- mesh__dateRevised mesh__D013563 1997-06-20
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013563 2006
% 215.45/215.63  |- skos__historyNote mesh__D013563
% 215.45/215.63       specific sympathetic nervous system term %28%1966-1981%29%
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013563 2001
% 215.45/215.63  |- skos__altLabel mesh__D013563 Denervation, Sympathetic, Chemical
% 215.45/215.63  |- skos__historyNote mesh__D013563
% 215.45/215.63       Sympathetic Nervous System %28%1966-1981%29%
% 215.45/215.63  |- skos__hiddenLabel mesh__D013563 Sympathectomies, Chemical
% 215.45/215.63  |- skos__hiddenLabel mesh__D013563 Denervations, Chemical Sympathetic
% 215.45/215.63  |- skos__scopeNote mesh__D013563
% 215.45/215.63       Sympathectomy using chemicals %28%e.g., 6-hydroxydopamine or guanethidine%29% which selectively and reversibly destroy adrenergic nerve endings while leaving cholinergic nerve endings intact.%A%    
% 215.45/215.63  |- skos__altLabel mesh__D013563 Chemical Sympathectomy
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D007526 1994
% 215.45/215.63  |- mesh__dateRevised mesh__D007526 1990-04-13
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D007526 1991
% 215.45/215.63  |- skos__hiddenLabel mesh__D007526 Isoelectric Points
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D007526 1995
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D007526 2000
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D007526 1992
% 215.45/215.63  |- rdf__type mesh__D007526sskos__Concept
% 215.45/215.63  |- skos__scopeNote mesh__D007526
% 215.45/215.63       The pH in solutions of proteins and related compounds at which the dipolar ions are at a maximum.%A%    
% 215.45/215.63  |- skos__hiddenLabel mesh__D007526 Points, Isoelectric
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D007526 2001
% 215.45/215.63  |- mesh__recordAuthorizer mesh__D007526 PLS
% 215.45/215.63  |- mesh__recordMaintainer mesh__D007526 NLM
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D007526 1998
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D007526 1993
% 215.45/215.63  |- mesh__dateCreated mesh__D007526 1974-11-27
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D007526 2005
% 215.45/215.63  |- mesh__dateEstablished mesh__D007526 1991-01-01
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D007526 1999
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D007526 2002
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D007526 1996
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D007526 2006
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D007526 2003
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D007526 1997
% 215.45/215.63  |- skos__prefLabel mesh__D007526 Isoelectric Point
% 215.45/215.63  |- skos__annotation mesh__D007526 NIM; no qualif   
% 215.45/215.63  |- mesh__historyNote mesh__D007526
% 215.45/215.63       91%28%75%29%; was see under HYDROGEN-ION CONCENTRATION 1975-90   
% 215.45/215.63  |- skos__hiddenLabel mesh__D007526 Point, Isoelectric
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D007526 2004
% 215.45/215.63  |- mesh__recordOriginator mesh__D007526 NLM
% 215.45/215.63  |- mesh__publicMeSHNote mesh__D007526
% 215.45/215.63       91; was see under HYDROGEN-ION CONCENTRATION 1975-90   
% 215.45/215.63  |- skos__broader mesh__D007526smesh__D006863
% 215.45/215.63  |- mesh__historyNote mesh__D045645 2004   
% 215.45/215.63  |- rdf__type mesh__D045645sskos__Concept
% 215.45/215.63  |- skos__annotation mesh__D045645
% 215.45/215.63       infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29% + probably ARTHRITIS, INFECTIOUS %28%IM%29%%A%  
% 215.45/215.63  |- mesh__dateEstablished mesh__D045645 2004-01-01
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D045645 2006
% 215.45/215.63  |- mesh__recordMaintainer mesh__D045645 SYSTEM
% 215.45/215.63  |- skos__historyNote mesh__D045645 Mycoplasma %28%1967-2003%29%
% 215.45/215.63  |- mesh__recordAuthorizer mesh__D045645 sjn
% 215.45/215.63  |- skos__broader mesh__D045645smesh__D009174
% 215.45/215.63  |- mesh__dateCreated mesh__D045645 2003-07-09
% 215.45/215.63  |- skos__scopeNote mesh__D045645
% 215.45/215.63       A species of gram-negative bacteria causing purulent POLYARTHRITIS in RATS.%A%    
% 215.45/215.63  |- mesh__dateRevised mesh__D045645 2005-06-30
% 215.45/215.63  |- mesh__publicMeSHNote mesh__D045645 2004   
% 215.45/215.63  |- mesh__recordOriginator mesh__D045645 ags
% 215.45/215.63  |- skos__prefLabel mesh__D045645 Mycoplasma arthritidis
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017954 2000
% 215.45/215.63  |- skos__broader mesh__D017954smesh__D000349
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017954 2003
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017954 1997
% 215.45/215.63  |- mesh__dateEstablished mesh__D017954 1994-01-01
% 215.45/215.63  |- mesh__recordOriginator mesh__D017954 TGC
% 215.45/215.63  |- skos__altLabel mesh__D017954 Subsaharan Africa
% 215.45/215.63  |- skos__altLabel mesh__D017954 Sub-Saharan Africa
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017954 2006
% 215.45/215.63  |- skos__prefLabel mesh__D017954 Africa South of the Sahara
% 215.45/215.63  |- mesh__dateCreated mesh__D017954 1993-06-03
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017954 1996
% 215.45/215.63  |- rdf__type mesh__D017954sskos__Concept
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017954 2002
% 215.45/215.63  |- skos__altLabel mesh__D017954 Africa, Sub-Saharan
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017954 1999
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017954 2005
% 215.45/215.63  |- mesh__dateRevised mesh__D017954 1994-03-17
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017954 1995
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017954 1998
% 215.45/215.63  |- skos__annotation mesh__D017954
% 215.45/215.63       all of Africa except Algeria, Egypt, Libya, Morocco, Tunisia%A%  
% 215.45/215.63  |- mesh__historyNote mesh__D017954 94   
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017954 2001
% 215.45/215.63  |- mesh__recordMaintainer mesh__D017954 PLS
% 215.45/215.63  |- skos__scopeNote mesh__D017954
% 215.45/215.63       All of Africa except Northern Africa %28%AFRICA, NORTHERN%29%.%A%    
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017954 2004
% 215.45/215.63  |- mesh__recordAuthorizer mesh__D017954 PLS
% 215.45/215.63  |- skos__altLabel mesh__D031625 Mulberry
% 215.45/215.63  |- rdf__type mesh__D031625sskos__Concept
% 215.45/215.63  |- mesh__dateEstablished mesh__D031625 2003-01-01
% 215.45/215.63  |- skos__prefLabel mesh__D031625 Morus
% 215.45/215.63  |- mesh__dateCreated mesh__D031625 2002-07-03
% 215.45/215.63  |- skos__scopeNote mesh__D031625
% 215.45/215.63       A plant genus of the family MORACEAE that is widely planted for shade.%A%    
% 215.45/215.63  |- mesh__publicMeSHNote mesh__D031625 2003   
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D031625 2003
% 215.45/215.63  |- skos__annotation mesh__D031625
% 215.45/215.63       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D031625 2004
% 215.45/215.63  |- mesh__historyNote mesh__D031625 2003   
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D031625 2005
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D031625 2006
% 215.45/215.63  |- skos__broader mesh__D031625smesh__D029586
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017156 2003
% 215.45/215.63  |- skos__altLabel mesh__D017156 Rheography, Light Reflection
% 215.45/215.63  |- skos__prefLabel mesh__D017156 Photoplethysmography
% 215.45/215.63  |- skos__broader mesh__D017156smesh__D010991
% 215.45/215.63  |- skos__hiddenLabel mesh__D017156 Photoplethysmographies
% 215.45/215.63  |- skos__scopeNote mesh__D017156
% 215.45/215.63       Plethysmographic determination in which the intensity of light reflected from the skin surface and the red cells below is measured to determine the blood volume of the respective area. There are two types, transmission and reflectance.%A%    
% 215.45/215.63  |- mesh__recordAuthorizer mesh__D017156 SJN
% 215.45/215.63  |- skos__hiddenLabel mesh__D017156 Light Reflection Rheographies
% 215.45/215.63  |- skos__altLabel mesh__D017156 Photoreflexometry
% 215.45/215.63  |- mesh__dateCreated mesh__D017156 1992-05-22
% 215.45/215.63  |- skos__hiddenLabel mesh__D017156 Rheographies, Light Reflection
% 215.45/215.63  |- mesh__recordMaintainer mesh__D017156 PXP
% 215.45/215.63  |- skos__hiddenLabel mesh__D017156 Photoreflexometries
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017156 1999
% 215.45/215.63  |- mesh__historyNote mesh__D017156 93   
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017156 2006
% 215.45/215.63  |- skos__altLabel mesh__D017156 Light Reflection Rheography
% 215.45/215.63  |- mesh__dateRevised mesh__D017156 1997-06-20
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017156 2002
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017156 1998
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017156 2005
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017156 2001
% 215.45/215.63  |- mesh__publicMeSHNote mesh__D017156 93   
% 215.45/215.63  |- skos__annotation mesh__D017156
% 215.45/215.63       to determine local blood volume; NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: PHOTOPLETHYSMOGR%A%  
% 215.45/215.63  |- rdf__type mesh__D017156sskos__Concept
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017156 2004
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D017156 2000
% 215.45/215.63  |- mesh__dateEstablished mesh__D017156 1993-01-01
% 215.45/215.63  |- skos__historyNote mesh__D017156 Plethysmography %28%1966-1992%29%
% 215.45/215.63  |- mesh__recordOriginator mesh__D017156 JLS
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013564 1994
% 215.45/215.63  |- skos__hiddenLabel mesh__D013564 System, Sympathetic Nervous
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013564 2005
% 215.45/215.63  |- skos__hiddenLabel mesh__D013564 Nervous Systems, Sympathetic
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013564 2002
% 215.45/215.63  |- mesh__recordOriginator mesh__D013564 NLM
% 215.45/215.63  |- skos__related mesh__D013564smesh__D013566
% 215.45/215.63  |- mesh__recordMaintainer mesh__D013564 RAZ
% 215.45/215.63  |- mesh__dateCreated mesh__D013564 1999-01-01
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013564 1997
% 215.45/215.63  |- mesh__dateRevised mesh__D013564 1993-08-11
% 215.45/215.63  |- skos__hiddenLabel mesh__D013564 Nervous System, Sympathetic
% 215.45/215.63  |- skos__broader mesh__D013564smesh__D001341
% 215.45/215.63  |- skos__scopeNote mesh__D013564
% 215.45/215.63       The thoracolumbar division of the autonomic nervous system. Sympathetic preganglionic fibers originate in neurons of the intermediolateral column of the spinal cord and project to the paravertebral and prevertebral ganglia, which in turn project to target organs. The sympathetic nervous system mediates the body%27%s response to stressful situations, i.e., the fight or flight reactions. It often acts reciprocally to the parasympathetic system.%A%    
% 215.45/215.63  |- skos__annotation mesh__D013564
% 215.45/215.63       /drug eff: consider also SYMPATHOLYTICS %26% SYMPATHOMIMETICS; /surg: probably SYMPATHECTOMY%A%  
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013564 1996
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013564 2004
% 215.45/215.63  |- skos__related mesh__D013564smesh__D002838
% 215.45/215.63  |- mesh__recordAuthorizer mesh__D013564 PLS
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013564 2001
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013564 1999
% 215.45/215.63  |- rdf__type mesh__D013564sskos__Concept
% 215.45/215.63  |- skos__hiddenLabel mesh__D013564 Systems, Sympathetic Nervous
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013564 2003
% 215.45/215.63  |- skos__related mesh__D013564smesh__D013565
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013564 1995
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013564 2000
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013564 1998
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D013564 2006
% 215.45/215.63  |- skos__related mesh__D013564smesh__D013562
% 215.45/215.63  |- skos__hiddenLabel mesh__D013564 Sympathetic Nervous Systems
% 215.45/215.63  |- skos__prefLabel mesh__D013564 Sympathetic Nervous System
% 215.45/215.63  |- mesh__recordMaintainer mesh__D007527 ssb
% 215.45/215.63  |- skos__annotation mesh__D007527
% 215.45/215.63       IM general only; coord NIM with specific enzyme %28%IM%29%   
% 215.45/215.63  |- mesh__recordAuthorizer mesh__D007527 sjn
% 215.45/215.63  |- skos__altLabel mesh__D007527 Isozymes
% 215.45/215.63  |- mesh__activeMeSHYear mesh__D007527 2005
% 215.45/215.64  |- mesh__publicMeSHNote mesh__D007527 67   
% 215.45/215.64  |- skos__broader mesh__D007527smesh__D004798
% 215.45/215.64  |- rdf__type mesh__D007527sskos__Concept
% 215.45/215.64  |- mesh__recordOriginator mesh__D007527 NLM
% 215.45/215.64  |- mesh__dateCreated mesh__D007527 1999-01-01
% 215.45/215.64  |- skos__scopeNote mesh__D007527
% 215.45/215.64       One of various structurally related forms of an enzyme, each having the same mechanism but with differing chemical, physical, or immunological characteristics.%A%    
% 215.45/215.64  |- mesh__dateRevised mesh__D007527 2003-07-09
% 215.45/215.64  |- mesh__historyNote mesh__D007527 67%28%65%29%   
% 215.45/215.64  |- mesh__dateEstablished mesh__D007527 1967-01-01
% 215.45/215.64  |- skos__broader mesh__D007527smesh__D020033
% 215.45/215.64  |- skos__prefLabel mesh__D007527 Isoenzymes
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D007527 2004
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D007527 2006
% 215.45/215.64  |- mesh__recordMaintainer mesh__D045646 SYSTEM
% 215.45/215.64  |- skos__scopeNote mesh__D045646
% 215.45/215.64       A species of gram-negative bacteria pathogenic to CATTLE.%A%    
% 215.45/215.64  |- mesh__historyNote mesh__D045646 2004   
% 215.45/215.64  |- mesh__dateCreated mesh__D045646 2003-07-09
% 215.45/215.64  |- mesh__dateEstablished mesh__D045646 2004-01-01
% 215.45/215.64  |- skos__historyNote mesh__D045646 Mycoplasma %28%1966-2003%29%
% 215.45/215.64  |- mesh__publicMeSHNote mesh__D045646 2004   
% 215.45/215.64  |- mesh__recordAuthorizer mesh__D045646 sjn
% 215.45/215.64  |- skos__broader mesh__D045646smesh__D009174
% 215.45/215.64  |- rdf__type mesh__D045646sskos__Concept
% 215.45/215.64  |- mesh__dateRevised mesh__D045646 2005-06-30
% 215.45/215.64  |- skos__prefLabel mesh__D045646 Mycoplasma bovigenitalium
% 215.45/215.64  |- mesh__recordOriginator mesh__D045646 ags
% 215.45/215.64  |- skos__annotation mesh__D045646
% 215.45/215.64       infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29%   
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D045646 2006
% 215.45/215.64  |- skos__altLabel mesh__D017955 Leon Virus
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D017955 2006
% 215.45/215.64  |- mesh__historyNote mesh__D017955 2002 %28%1994%29%   
% 215.45/215.64  |- rdf__type mesh__D017955sskos__Concept
% 215.45/215.64  |- skos__hiddenLabel mesh__D017955 poliovirus 3, Human
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D017955 2005
% 215.45/215.64  |- skos__prefLabel mesh__D017955 Poliovirus
% 215.45/215.64  |- mesh__dateEstablished mesh__D017955 1994-01-01
% 215.45/215.64  |- skos__altLabel mesh__D017955 Poliovirus Type 3
% 215.45/215.64  |- skos__broader mesh__D017955smesh__D011053
% 215.45/215.64  |- mesh__recordAuthorizer mesh__D017955 sjn
% 215.45/215.64  |- skos__hiddenLabel mesh__D017955 poliovirus 1, Human
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D017955 2002
% 215.45/215.64  |- mesh__dateCreated mesh__D017955 1993-06-15
% 215.45/215.64  |- mesh__recordOriginator mesh__D017955 AGS
% 215.45/215.64  |- skos__altLabel mesh__D017955 Poliovirus Type 2
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D017955 2004
% 215.45/215.64  |- skos__annotation mesh__D017955 infection = POLIOMYELITIS   
% 215.45/215.64  |- skos__historyNote mesh__D017955 Polioviruses %28%1966-1993%29%
% 215.45/215.64  |- skos__scopeNote mesh__D017955
% 215.45/215.64       A species of ENTEROVIRUS which is the causal agent of POLIOMYELITIS in humans. Three serotypes %28%strains%29% exist. Transmission is by the fecal-oral route, pharyngeal secretions, or mechanical vector %28%flies%29%. Vaccines with both inactivated and live attenuated virus have proven effective in immunizing against the infection.%A%    
% 215.45/215.64  |- mesh__recordMaintainer mesh__D017955 ags
% 215.45/215.64  |- skos__hiddenLabel mesh__D017955 poliovirus 2, Human
% 215.45/215.64  |- mesh__dateRevised mesh__D017955 2001-07-25
% 215.45/215.64  |- mesh__publicMeSHNote mesh__D017955
% 215.45/215.64       2002; see POLIOVIRUSES, HUMAN 1-3 1994-2001; for BRUNHILDE VIRUS see POLIOVIRUS 1976-1993%A%  
% 215.45/215.64  |- skos__altLabel mesh__D017955 Poliovirus Type 1
% 215.45/215.64  |- skos__altLabel mesh__D017955 Lansing Virus
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D017955 2003
% 215.45/215.64  |- skos__altLabel mesh__D017955 Brunhilde Virus
% 215.45/215.64  |- skos__scopeNote mesh__D017157
% 215.45/215.64       A subclass of nematodes characterized by reduced or absent caudal papillae and an excretory system lacking lateral canals. Its organisms are usually infective to their final host.%A%    
% 215.45/215.64  |- mesh__dateRevised mesh__D017157 2003-07-09
% 215.45/215.64  |- mesh__dateEstablished mesh__D017157 1993-01-01
% 215.45/215.64  |- skos__annotation mesh__D017157
% 215.45/215.64       a subclass of nematodes; infection = ADENOPHOREA INFECTIONS%A%  
% 215.45/215.64  |- mesh__historyNote mesh__D017157 93   
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D017157 2006
% 215.45/215.64  |- mesh__dateCreated mesh__D017157 1992-05-07
% 215.45/215.64  |- skos__altLabel mesh__D017157 Aphasmidia
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D017157 2005
% 215.45/215.64  |- rdf__type mesh__D017157sskos__Concept
% 215.45/215.64  |- skos__prefLabel mesh__D017157 Adenophorea
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D017157 2004
% 215.45/215.64  |- skos__broader mesh__D017157smesh__D009348
% 215.45/215.64  |- mesh__publicMeSHNote mesh__D017157 93   
% 215.45/215.64  |- skos__altLabel mesh__D003935 Cardiovascular Diagnostic Technics
% 215.45/215.64  |- skos__altLabel mesh__D003935 Diagnostic Technics, Cardiovascular
% 215.45/215.64  |- mesh__recordOriginator mesh__D003935 NLM
% 215.45/215.64  |- skos__altLabel mesh__D003935 Cardiovascular Diagnostic Technique
% 215.45/215.64  |- skos__altLabel mesh__D003935 Technique, Cardiovascular Diagnostic
% 215.45/215.64  |- skos__historyNote mesh__D003935 specific technique %28%1966-1997%29%
% 215.45/215.64  |- skos__altLabel mesh__D003935 Technic, Cardiovascular Diagnostic
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003935 2005
% 215.45/215.64  |- skos__altLabel mesh__D003935 Technics, Cardiovascular Diagnostic
% 215.45/215.64  |- mesh__dateCreated mesh__D003935 1999-01-01
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003935 2002
% 215.45/215.64  |- skos__altLabel mesh__D003935 Cardiovascular Diagnostic Technic
% 215.45/215.64  |- skos__scopeNote mesh__D003935
% 215.45/215.64       Methods and procedures for the diagnosis of diseases or dysfunction of the cardiovascular system or its organs or demonstration of their physiological processes.%A%    
% 215.45/215.64  |- mesh__dateRevised mesh__D003935 1997-06-20
% 215.45/215.64  |- skos__altLabel mesh__D003935 Diagnostic Technique, Cardiovascular
% 215.45/215.64  |- mesh__dateEstablished mesh__D003935 1998-01-01
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003935 2006
% 215.45/215.64  |- skos__prefLabel mesh__D003935 Diagnostic Techniques, Cardiovascular
% 215.45/215.64  |- skos__annotation mesh__D003935
% 215.45/215.64       GEN or unspecified; prefer specifics; DF: DIAG TECHNIQUES CARDIOVASC%A%  
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003935 1998
% 215.45/215.64  |- skos__altLabel mesh__D003935 Diagnostic Technic, Cardiovascular
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003935 2003
% 215.45/215.64  |- skos__altLabel mesh__D003935 Cardiovascular Diagnostic Techniques
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003935 2000
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003935 1999
% 215.45/215.64  |- mesh__recordMaintainer mesh__D003935 TGC
% 215.45/215.64  |- skos__broader mesh__D003935smesh__D019937
% 215.45/215.64  |- rdf__type mesh__D003935sskos__Concept
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003935 2004
% 215.45/215.64  |- mesh__historyNote mesh__D003935 98; use explode 1975-97   
% 215.45/215.64  |- skos__altLabel mesh__D003935 Techniques, Cardiovascular Diagnostic
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003935 2001
% 215.45/215.64  |- mesh__publicMeSHNote mesh__D003935 98   
% 215.45/215.64  |- mesh__recordAuthorizer mesh__D003935 SJN
% 215.45/215.64  |- skos__scopeNote mesh__D003137
% 215.45/215.64       Diseases of the COMMON BILE DUCT including the AMPULLA OF VATER and the SPHINCTER OF ODDI.%A%    
% 215.45/215.64  |- rdf__type mesh__D003137sskos__Concept
% 215.45/215.64  |- skos__prefLabel mesh__D003137 Common Bile Duct Diseases
% 215.45/215.64  |- skos__broader mesh__D003137smesh__D001649
% 215.45/215.64  |- skos__historyNote mesh__D003137 Common Bile Duct %28%1966-1979%29%
% 215.45/215.64  |- mesh__dateEstablished mesh__D003137 1980-01-01
% 215.45/215.64  |- skos__historyNote mesh__D003137 Biliary Tract Diseases %28%1966-1979%29%
% 215.45/215.64  |- mesh__historyNote mesh__D003137 80   
% 215.45/215.64  |- mesh__publicMeSHNote mesh__D003137 80   
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003137 2004
% 215.45/215.64  |- skos__annotation mesh__D003137
% 215.45/215.64       inflamm dis = CHOLANGITIS %28%IM%29% + COMMON BILE DUCT DISEASES %28%IM%29%; calculi = COMMON BILE DUCT CALCULI see GALLSTONES but consider also CHOLEDOCHOLITHIASIS%A%  
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003137 2006
% 215.45/215.64  |- mesh__dateRevised mesh__D003137 2003-07-09
% 215.45/215.64  |- mesh__recordAuthorizer mesh__D003137 sjn
% 215.45/215.64  |- mesh__recordMaintainer mesh__D003137 lkt
% 215.45/215.64  |- mesh__dateCreated mesh__D003137 1979-05-29
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003137 2005
% 215.45/215.64  |- mesh__recordOriginator mesh__D003137 SMH
% 215.45/215.64  |- skos__broader mesh__D008620smesh__D002219
% 215.45/215.64  |- skos__scopeNote mesh__D008620
% 215.45/215.64       A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures %28%which may be exacerbated%29%. It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p603%29%%A%    
% 215.45/215.64  |- skos__hiddenLabel mesh__D008620 Meprobamate Reid-Rowell Brand
% 215.45/215.64  |- skos__hiddenLabel mesh__D008620 Meprobamate Alter Brand
% 215.45/215.64  |- skos__hiddenLabel mesh__D008620 Meprobamate Richard Brand
% 215.45/215.64  |- skos__hiddenLabel mesh__D008620 Reid Rowell Brand of Meprobamate
% 215.45/215.64  |- mesh__recordMaintainer mesh__D008620 CCR
% 215.45/215.64  |- skos__altLabel mesh__D008620 Wallace Brand 1 of Meprobamate
% 215.45/215.64  |- mesh__recordOriginator mesh__D008620 NLM
% 215.45/215.64  |- mesh__dateCreated mesh__D008620 1999-01-01
% 215.45/215.64  |- skos__hiddenLabel mesh__D008620 Meprobamate Wyeth Brand
% 215.45/215.64  |- skos__hiddenLabel mesh__D008620 Meprobamate Kade Brand
% 215.45/215.64  |- mesh__dateRevised mesh__D008620 2005-06-30
% 215.45/215.64  |- skos__altLabel mesh__D008620 Reid-Rowell Brand of Meprobamate
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D008620 2006
% 215.45/215.64  |- skos__altLabel mesh__D008620 Alter Brand of Meprobamate
% 215.45/215.64  |- skos__altLabel mesh__D008620 Wyeth Brand of Meprobamate
% 215.45/215.64  |- mesh__recordAuthorizer mesh__D008620 sjn
% 215.45/215.64  |- skos__altLabel mesh__D008620 Wallace Brand 2 of Meprobamate
% 215.45/215.64  |- skos__altLabel mesh__D008620 Sanofi Synthelabo Brand of Meprobamate
% 215.45/215.64  |- skos__altLabel mesh__D008620 Kade Brand of Meprobamate
% 215.45/215.64  |- rdf__type mesh__D008620sskos__Concept
% 215.45/215.64  |- skos__prefLabel mesh__D008620 Meprobamate
% 215.45/215.64  |- skos__altLabel mesh__D008620 Richard Brand of Meprobamate
% 215.45/215.64  |- mesh__dateRevised mesh__D013565 2005-06-30
% 215.45/215.64  |- mesh__dateCreated mesh__D013565 1999-01-01
% 215.45/215.64  |- skos__altLabel mesh__D013565 Sympatholytic Drugs
% 215.45/215.64  |- mesh__publicMeSHNote mesh__D013565
% 215.45/215.64       ADRENERGIC FALSE TRANSMITTERS was heading 1973-81   
% 215.45/215.64  |- skos__hiddenLabel mesh__D013565 Sympathetic Blocking Agents
% 215.45/215.64  |- skos__prefLabel mesh__D013565 Sympatholytics
% 215.45/215.64  |- skos__scopeNote mesh__D013565
% 215.45/215.64       Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals %28%see ADRENERGIC AGENTS%29%. Drugs that act in the central nervous system to reduce sympathetic activity %28%e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS%29% are included here.%A%    
% 215.45/215.64  |- skos__altLabel mesh__D013565 Sympatholytic Agents
% 215.45/215.64  |- mesh__recordAuthorizer mesh__D013565 sjn
% 215.45/215.64  |- mesh__recordOriginator mesh__D013565 NLM
% 215.45/215.64  |- skos__related mesh__D013565smesh__D018674
% 215.45/215.64  |- mesh__recordMaintainer mesh__D013565 ssb
% 215.45/215.64  |- rdf__type mesh__D013565sskos__Concept
% 215.45/215.64  |- mesh__onlineNote mesh__D013565
% 215.45/215.64       use SYMPATHOLYTICS to search ADRENERGIC FALSE TRANSMITTERS 1973-81%A%  
% 215.45/215.64  |- mesh__historyNote mesh__D013565
% 215.45/215.64       ADRENERGIC FALSE TRANSMITTERS was heading 1973-81   
% 215.45/215.64  |- skos__altLabel mesh__D013565 Sympathetic-Blocking Agents
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D013565 2006
% 215.45/215.64  |- skos__annotation mesh__D013565
% 215.45/215.64       GEN or unspecified; prefer specifics; consider also SYMPATHETIC NERVOUS SYSTEM /drug eff%A%  
% 215.45/215.64  |- skos__hiddenLabel mesh__D013565 Drugs, Sympatholytic
% 215.45/215.64  |- skos__related mesh__D013565smesh__D018663
% 215.45/215.64  |- skos__hiddenLabel mesh__D013565 Agents, Sympatholytic
% 215.45/215.64  |- skos__hiddenLabel mesh__D013565 Agents, Sympathetic-Blocking
% 215.45/215.64  |- skos__broader mesh__D013565smesh__D001337
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D007528 2003
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D007528 2006
% 215.45/215.64  |- mesh__historyNote mesh__D007528
% 215.45/215.64       91%28%75%29%; was see under AMINO ALCOHOLS 1975-90   
% 215.45/215.64  |- mesh__recordOriginator mesh__D007528 NLM
% 215.45/215.64  |- rdf__type mesh__D007528sskos__Concept
% 215.45/215.64  |- skos__historyNote mesh__D007528 Amino Alcohols %28%1969-1974%29%
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D007528 2002
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D007528 2005
% 215.45/215.64  |- skos__scopeNote mesh__D007528
% 215.45/215.64       Adrenergic beta-2 agonist used as bronchodilator for emphysema, bronchitis and asthma.%A%    
% 215.45/215.64  |- mesh__publicMeSHNote mesh__D007528
% 215.45/215.64       91; was see under AMINO ALCOHOLS 1975-90   
% 215.45/215.64  |- skos__altLabel mesh__D007528 Isoetarin
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D007528 2001
% 215.45/215.64  |- skos__prefLabel mesh__D007528 Isoetharine
% 215.45/215.64  |- mesh__dateCreated mesh__D007528 1974-11-19
% 215.45/215.64  |- skos__historyNote mesh__D007528 Propylamines %28%1972-1974%29%
% 215.45/215.64  |- skos__hiddenLabel mesh__D007528 Mesylate, Isoetharine
% 215.45/215.64  |- skos__historyNote mesh__D007528 Catechols %28%1969-1974%29%
% 215.45/215.64  |- skos__broader mesh__D007528smesh__D000605
% 215.45/215.64  |- mesh__recordMaintainer mesh__D007528 CCR
% 215.45/215.64  |- skos__altLabel mesh__D007528 Etyprenalinum
% 215.45/215.64  |- mesh__dateRevised mesh__D007528 2000-06-22
% 215.45/215.64  |- mesh__dateEstablished mesh__D007528 1991-01-01
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D007528 2004
% 215.45/215.64  |- mesh__recordAuthorizer mesh__D007528 sjn
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D018250 2005
% 215.45/215.64  |- rdf__type mesh__D018250sskos__Concept
% 215.45/215.64  |- mesh__recordAuthorizer mesh__D018250 PLS
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D018250 2000
% 215.45/215.64  |- mesh__recordMaintainer mesh__D018250 KEV
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D018250 1997
% 215.45/215.64  |- skos__prefLabel mesh__D018250 Acrospiroma, Eccrine
% 215.45/215.64  |- mesh__dateRevised mesh__D018250 1995-06-08
% 215.45/215.64  |- skos__historyNote mesh__D018250 Sweat Gland Neoplasms %28%1969-1984%29%
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D018250 2004
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D018250 1996
% 215.45/215.64  |- mesh__recordOriginator mesh__D018250 PLS
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D018250 2002
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D018250 2003
% 215.45/215.64  |- mesh__dateCreated mesh__D018250 1993-06-25
% 215.45/215.64  |- mesh__historyNote mesh__D018250 94   
% 215.45/215.64  |- skos__broader mesh__D018250smesh__D006607
% 215.45/215.64  |- skos__annotation mesh__D018250
% 215.45/215.64       /blood supply /chem /secret /ultrastruct permitted; coord IM with SWEAT GLAND NEOPLASMS %28%IM%29%%A%  
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D018250 1999
% 215.45/215.64  |- skos__historyNote mesh__D018250 Adenoma, Sweat Gland %28%1979-1993%29%
% 215.45/215.64  |- mesh__dateEstablished mesh__D018250 1994-01-01
% 215.45/215.64  |- skos__scopeNote mesh__D018250
% 215.45/215.64       A tumor derived from eccrine sweat duct epithelium which may be intra-epidermal %28%hidro-acanthoma simplex%29%, juxta-epidermal %28%eccrine poroma%29% or intradermal %28%dermal duct tumor%29%. They are comparatively uncommon. There is no indication that heredity or external agents cause these tumors. %28%Rook et al., Textbook of Dermatology, 4th ed, p2409%29%%A%    
% 215.45/215.64  |- skos__hiddenLabel mesh__D018250 Eccrine Acrospiromas
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D018250 2006
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D018250 1998
% 215.45/215.64  |- skos__hiddenLabel mesh__D018250 Eccrine Acrospiroma
% 215.45/215.64  |- skos__hiddenLabel mesh__D018250 Acrospiromas, Eccrine
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D018250 2001
% 215.45/215.64  |- mesh__publicMeSHNote mesh__D018250 94   
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D004230 2005
% 215.45/215.64  |- skos__prefLabel mesh__D004230 Dithizone
% 215.45/215.64  |- mesh__publicMeSHNote mesh__D004230
% 215.45/215.64       91; was see under AZO COMPOUNDS 1975-90; was see under INDICATORS AND REAGENTS 1963-74%A%  
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D004230 2001
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D004230 2003
% 215.45/215.64  |- skos__broader mesh__D004230smesh__D010659
% 215.45/215.64  |- skos__altLabel mesh__D004230 Diphenylthiocarbazone
% 215.45/215.64  |- skos__broader mesh__D004230smesh__D001391
% 215.45/215.64  |- mesh__recordOriginator mesh__D004230 NLM
% 215.45/215.64  |- rdf__type mesh__D004230sskos__Concept
% 215.45/215.64  |- mesh__onlineNote mesh__D004230 search INDICATORS AND REAGENTS 1966-74   
% 215.45/215.64  |- mesh__recordMaintainer mesh__D004230 CCR
% 215.45/215.64  |- skos__scopeNote mesh__D004230
% 215.45/215.64       Chelating agent used for heavy metal poisoning and assay.  It causes diabetes.%A%    
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D004230 2002
% 215.45/215.64  |- mesh__dateRevised mesh__D004230 2000-06-22
% 215.45/215.64  |- mesh__dateEstablished mesh__D004230 1991-01-01
% 215.45/215.64  |- skos__altLabel mesh__D004230 Dithizon
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D004230 2006
% 215.45/215.64  |- mesh__recordAuthorizer mesh__D004230 sjn
% 215.45/215.64  |- mesh__dateCreated mesh__D004230 1999-01-01
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D004230 2004
% 215.45/215.64  |- skos__annotation mesh__D004230 D25-26 qualif   
% 215.45/215.64  |- mesh__historyNote mesh__D004230
% 215.45/215.64       91%28%75%29%; was see under AZO COMPOUNDS 1975-90; was see under INDICATORS AND REAGENTS 1963-74%A%  
% 215.45/215.64  |- mesh__publicMeSHNote mesh__D045647
% 215.45/215.64       2004; DNA GLYCOSIDASES was indexed under N-GLYCOSIDE HYDROLASES 1982-2003, under GLYCOSIDE HYDROLASES %26% DNA 1978-1981%A%  
% 215.45/215.64  |- mesh__historyNote mesh__D045647
% 215.45/215.64       2004; use DNA GLYCOSIDASES %28%NM%29% 1980-2003   
% 215.45/215.64  |- skos__broader mesh__D045647smesh__D009699
% 215.45/215.64  |- skos__historyNote mesh__D045647 Glycoside Hydrolases %28%1978-1981%29%
% 215.45/215.64  |- skos__altLabel mesh__D045647 DNA N-glycosidase
% 215.45/215.64  |- mesh__recordOriginator mesh__D045647 jmp
% 215.45/215.64  |- skos__hiddenLabel mesh__D045647 Glycosylase, Methylpurine DNA
% 215.45/215.64  |- skos__scopeNote mesh__D045647
% 215.45/215.64       A family of DNA repair enzymes that recognize damaged nucleotide bases and remove them by hydrolyzing the N-glycosidic bond that attaches them to the sugar backbone of the DNA molecule. The process called BASE EXCISION REPAIR can be completed by a DNA-%28%APURINIC OR APYRIMIDINIC SITE%29% LYASE which excises the remaining RIBOSE sugar from the DNA.%A%    
% 215.45/215.64  |- rdf__type mesh__D045647sskos__Concept
% 215.45/215.64  |- mesh__dateEstablished mesh__D045647 2004-01-01
% 215.45/215.64  |- skos__altLabel mesh__D045647 DNA Glycosylase
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D045647 2006
% 215.45/215.64  |- skos__hiddenLabel mesh__D045647 DNA Glycosylase, Methylpurine
% 215.45/215.64  |- skos__hiddenLabel mesh__D045647 DNA N glycosidase
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D045647 2004
% 215.45/215.64  |- skos__hiddenLabel mesh__D045647 Glycosylase, DNA
% 215.45/215.64  |- skos__prefLabel mesh__D045647 DNA Glycosylases
% 215.45/215.64  |- skos__historyNote mesh__D045647 N-Glycosyl Hydrolases %28%1982-2003%29%
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D045647 2005
% 215.45/215.64  |- skos__historyNote mesh__D045647 DNA %28%1978-1981%29%
% 215.45/215.64  |- mesh__recordMaintainer mesh__D045647 jmp
% 215.45/215.64  |- skos__hiddenLabel mesh__D045647 Glycosylases, DNA
% 215.45/215.64  |- mesh__recordAuthorizer mesh__D045647 sjn
% 215.45/215.64  |- skos__broader mesh__D045647smesh__D045643
% 215.45/215.64  |- mesh__dateCreated mesh__D045647 2003-07-09
% 215.45/215.64  |- rdf__type mesh__D017956sskos__Concept
% 215.45/215.64  |- skos__hiddenLabel mesh__D017956 Photoreceptor, Invertebrate
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D017956 2000
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D017956 2006
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D017956 1999
% 215.45/215.64  |- mesh__recordMaintainer mesh__D017956 AGS
% 215.45/215.64  |- mesh__recordOriginator mesh__D017956 RAZ
% 215.45/215.64  |- mesh__dateCreated mesh__D017956 1993-06-18
% 215.45/215.64  |- mesh__dateEstablished mesh__D017956 1994-01-01
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D017956 2005
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D017956 1998
% 215.45/215.64  |- mesh__dateRevised mesh__D017956 1997-06-20
% 215.45/215.64  |- mesh__recordAuthorizer mesh__D017956 SJN
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D017956 2002
% 215.45/215.64  |- skos__annotation mesh__D017956
% 215.45/215.64       coord IM with specific invertebrate %28%IM%29%; DF: PHOTORECEPT INVERTEBRATE%A%  
% 215.45/215.64  |- skos__prefLabel mesh__D017956 Photoreceptors, Invertebrate
% 215.45/215.64  |- skos__historyNote mesh__D017956 Photoreceptors %28%1966-1993%29%
% 215.45/215.64  |- skos__scopeNote mesh__D017956
% 215.45/215.64       Cells in invertebrates which are specialized to detect and transduce light and darkness and relay that information centrally in the nervous system.%A%    
% 215.45/215.64  |- mesh__historyNote mesh__D017956 94   
% 215.45/215.64  |- mesh__publicMeSHNote mesh__D017956 94   
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D017956 2004
% 215.45/215.64  |- skos__broader mesh__D017956smesh__D000825
% 215.45/215.64  |- skos__broader mesh__D017956smesh__D010786
% 215.45/215.64  |- skos__altLabel mesh__D017956 Invertebrate Photoreceptors
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D017956 2001
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D017956 2003
% 215.45/215.64  |- skos__hiddenLabel mesh__D017956 Invertebrate Photoreceptor
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D017158 2005
% 215.45/215.64  |- mesh__dateRevised mesh__D017158 2003-07-09
% 215.45/215.64  |- mesh__recordMaintainer mesh__D017158 ags
% 215.45/215.64  |- mesh__dateCreated mesh__D017158 1992-05-08
% 215.45/215.64  |- mesh__historyNote mesh__D017158 93   
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D017158 2006
% 215.45/215.64  |- skos__scopeNote mesh__D017158
% 215.45/215.64       An order of nematodes of the subclass ADENOPHOREA. Its organisms commonly have a cylindrical esophagus. The superfamilies of this order are DIOCTOPHYMATOIDEA; MERMITHOIDEA; and TRICHUROIDEA.%A%    
% 215.45/215.64  |- mesh__publicMeSHNote mesh__D017158 93   
% 215.45/215.64  |- skos__prefLabel mesh__D017158 Enoplida
% 215.45/215.64  |- mesh__recordAuthorizer mesh__D017158 sjn
% 215.45/215.64  |- skos__broader mesh__D017158smesh__D017157
% 215.45/215.64  |- rdf__type mesh__D017158sskos__Concept
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D017158 2004
% 215.45/215.64  |- skos__annotation mesh__D017158
% 215.45/215.64       an order of nematodes; infection = ENOPLIDA INFECTIONS   
% 215.45/215.64  |- mesh__recordOriginator mesh__D017158 PXP
% 215.45/215.64  |- mesh__dateEstablished mesh__D017158 1993-01-01
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003936 1997
% 215.45/215.64  |- rdf__type mesh__D003936sskos__Concept
% 215.45/215.64  |- mesh__historyNote mesh__D003936
% 215.45/215.64       91%28%69%29%; was DIAGNOSIS, COMPUTER ASSISTED 1969-90 %28%Prov 1969-72%29%%A%  
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003936 2002
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003936 1998
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003936 1996
% 215.45/215.64  |- skos__prefLabel mesh__D003936 Diagnosis, Computer-Assisted
% 215.45/215.64  |- skos__broader mesh__D003936smesh__D003933
% 215.45/215.64  |- mesh__onlineNote mesh__D003936
% 215.45/215.64       use DIAGNOSIS, COMPUTER-ASSISTED to search DIAGNOSIS, COMPUTER ASSISTED l969-90 %28%as Prov 1969-72%29%%A%  
% 215.45/215.64  |- mesh__recordOriginator mesh__D003936 NLM
% 215.45/215.64  |- mesh__recordMaintainer mesh__D003936 TGC
% 215.45/215.64  |- skos__hiddenLabel mesh__D003936 Computer-Assisted Diagnoses
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003936 2001
% 215.45/215.64  |- skos__scopeNote mesh__D003936
% 215.45/215.64       Application of computer programs designed to assist the physician in solving a diagnostic problem.%A%    
% 215.45/215.64  |- skos__annotation mesh__D003936
% 215.45/215.64       GEN: prefer specifics; restrict to MeSH definition; IM; DF: DIAG COMPUTER ASSISTED%A%  
% 215.45/215.64  |- mesh__recordAuthorizer mesh__D003936 PLS
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003936 2006
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003936 2000
% 215.45/215.64  |- mesh__dateCreated mesh__D003936 1999-01-01
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003936 2004
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003936 1995
% 215.45/215.64  |- skos__broader mesh__D003936smesh__D003658
% 215.45/215.64  |- mesh__publicMeSHNote mesh__D003936
% 215.45/215.64       91; was DIAGNOSIS, COMPUTER ASSISTED 1973-90   
% 215.45/215.64  |- skos__historyNote mesh__D003936 Computers %28%1966-1968%29%
% 215.45/215.64  |- skos__hiddenLabel mesh__D003936 Diagnosis, Computer Assisted
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003936 1993
% 215.45/215.64  |- mesh__dateEstablished mesh__D003936 1973-01-01
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003936 2005
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003936 1999
% 215.45/215.64  |- skos__hiddenLabel mesh__D003936 Diagnoses, Computer-Assisted
% 215.45/215.64  |- skos__hiddenLabel mesh__D003936 Computer Assisted Diagnosis
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003936 2003
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003936 1994
% 215.45/215.64  |- mesh__dateRevised mesh__D003936 1992-05-14
% 215.45/215.64  |- skos__altLabel mesh__D003936 Computer-Assisted Diagnosis
% 215.45/215.64  |- mesh__dateEstablished mesh__D003138 1980-01-01
% 215.45/215.64  |- mesh__recordMaintainer mesh__D003138 lkt
% 215.45/215.64  |- mesh__dateCreated mesh__D003138 1979-05-29
% 215.45/215.64  |- mesh__historyNote mesh__D003138 80   
% 215.45/215.64  |- mesh__recordOriginator mesh__D003138 SMH
% 215.45/215.64  |- skos__broader mesh__D003138smesh__D001650
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003138 2004
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003138 2006
% 215.45/215.64  |- skos__historyNote mesh__D003138 Bile Duct Neoplasms %28%1966-1979%29%
% 215.45/215.64  |- mesh__dateRevised mesh__D003138 2003-07-09
% 215.45/215.64  |- skos__prefLabel mesh__D003138 Common Bile Duct Neoplasms
% 215.45/215.64  |- mesh__publicMeSHNote mesh__D003138 80   
% 215.45/215.64  |- skos__broader mesh__D003138smesh__D003137
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D003138 2005
% 215.45/215.64  |- rdf__type mesh__D003138sskos__Concept
% 215.45/215.64  |- skos__scopeNote mesh__D003138
% 215.45/215.64       Tumor or cancer of the COMMON BILE DUCT including the AMPULLA OF VATER and the SPHINCTER OF ODDI.%A%    
% 215.45/215.64  |- skos__historyNote mesh__D003138 Common Bile Duct %28%1966-1979%29%
% 215.45/215.64  |- skos__annotation mesh__D003138
% 215.45/215.64       coord IM with histol type of neopl %28%IM%29%   
% 215.45/215.64  |- mesh__recordAuthorizer mesh__D003138 sjn
% 215.45/215.64  |- mesh__publicMeSHNote mesh__D008621 91; was see under AZEPINES 1980-90   
% 215.45/215.64  |- skos__broader mesh__D008621smesh__D001381
% 215.45/215.64  |- skos__altLabel mesh__D008621 Shire Brand of Meptazinol Hydrochloride
% 215.45/215.64  |- skos__historyNote mesh__D008621 Phenols %28%1966-1976%29%
% 215.45/215.64  |- mesh__historyNote mesh__D008621
% 215.45/215.64       91%28%80%29%; was see under AZEPINES 1980-90   
% 215.45/215.64  |- skos__hiddenLabel mesh__D008621 WY22811
% 215.45/215.64  |- skos__historyNote mesh__D008621 Azepines %28%1966-1979%29%
% 215.45/215.64  |- mesh__dateEstablished mesh__D008621 1991-01-01
% 215.45/215.64  |- skos__prefLabel mesh__D008621 Meptazinol
% 215.45/215.64  |- mesh__recordMaintainer mesh__D008621 CCR
% 215.45/215.64  |- mesh__recordOriginator mesh__D008621 SH
% 215.45/215.64  |- mesh__activeMeSHYear mesh__D008621 2006
% 215.45/215.64  |- skos__hiddenLabel mesh__D008621 WY 22811
% 215.45/215.64  |- skos__altLabel mesh__D008621 Riemser Brand of Meptazinol Hydrochloride
% 215.45/215.64  |- skos__altLabel mesh__D008621
% 215.45/215.64       Cahill May Roberts Brand of Meptazinol Hydrochloride
% 215.45/215.64  |- mesh__dateRevised mesh__D008621 2005-06-30
% 215.45/215.64  |- mesh__dateCreated mesh__D008621 1979-05-30
% 215.45/215.64  |- rdf__type mesh__D008621sskos__Concept
% 215.45/215.64  |- mesh__recordAuthorizer mesh__D008621 sjn
% 215.45/215.65  |- skos__scopeNote mesh__D008621
% 215.45/215.65       A narcotic antagonist with analgesic properties. It is used for the control of moderate to severe pain.%A%    
% 215.45/215.65  |- skos__broader mesh__D013566smesh__D001337
% 215.45/215.65  |- skos__related mesh__D013566smesh__D002317
% 215.45/215.65  |- skos__hiddenLabel mesh__D013566 Drugs, Sympathomimetic
% 215.45/215.65  |- skos__annotation mesh__D013566
% 215.45/215.65       GEN or unspecified; prefer specifics; cardiotonics; consider also SYMPATHETIC NERVOUS SYSTEM /drug eff%A%  
% 215.45/215.65  |- skos__related mesh__D013566smesh__D008996
% 215.45/215.65  |- skos__related mesh__D013566smesh__D002316
% 215.45/215.65  |- mesh__dateRevised mesh__D013566 2005-06-30
% 215.45/215.65  |- skos__prefLabel mesh__D013566 Sympathomimetics
% 215.45/215.65  |- mesh__recordMaintainer mesh__D013566 ssb
% 215.45/215.65  |- rdf__type mesh__D013566sskos__Concept
% 215.45/215.65  |- skos__scopeNote mesh__D013566
% 215.45/215.65       Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.%A%    
% 215.45/215.65  |- skos__hiddenLabel mesh__D013566 Sympathomimetic Amines
% 215.45/215.65  |- skos__related mesh__D013566smesh__D011941
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D013566 2006
% 215.45/215.65  |- mesh__dateCreated mesh__D013566 1999-01-01
% 215.45/215.65  |- skos__related mesh__D013566smesh__D018759
% 215.45/215.65  |- skos__related mesh__D013566smesh__D000322
% 215.45/215.65  |- mesh__recordAuthorizer mesh__D013566 sjn
% 215.45/215.65  |- skos__altLabel mesh__D013566 Sympathomimetic Drugs
% 215.45/215.65  |- mesh__recordOriginator mesh__D013566 NLM
% 215.45/215.65  |- skos__altLabel mesh__D013566 Sympathomimetic Agents
% 215.45/215.65  |- skos__hiddenLabel mesh__D013566 Agents, Sympathomimetic
% 215.45/215.65  |- mesh__publicMeSHNote mesh__D007529 91; was see under FLAVONES 1975-90   
% 215.45/215.65  |- rdf__type mesh__D007529sskos__Concept
% 215.45/215.65  |- mesh__recordMaintainer mesh__D007529 ssb
% 215.45/215.65  |- mesh__dateRevised mesh__D007529 2005-06-30
% 215.45/215.65  |- mesh__recordAuthorizer mesh__D007529 sjn
% 215.45/215.65  |- mesh__dateCreated mesh__D007529 1974-11-11
% 215.45/215.65  |- skos__hiddenLabel mesh__D007529 3 Benzylchroman 4 Ones
% 215.45/215.65  |- mesh__historyNote mesh__D007529
% 215.45/215.65       91%28%75%29%; was see under FLAVONES 1975-90   
% 215.45/215.65  |- skos__hiddenLabel mesh__D007529 3 Benzylidene 4 Chromanones
% 215.45/215.65  |- skos__historyNote mesh__D007529 Flavones %28%1966-1974%29%
% 215.45/215.65  |- mesh__recordOriginator mesh__D007529 NLM
% 215.45/215.65  |- skos__altLabel mesh__D007529 3-Benzylchroman-4-Ones
% 215.45/215.65  |- skos__broader mesh__D007529smesh__D005419
% 215.45/215.65  |- skos__altLabel mesh__D007529 3-Benzylidene-4-Chromanones
% 215.45/215.65  |- mesh__dateEstablished mesh__D007529 1991-01-01
% 215.45/215.65  |- skos__scopeNote mesh__D007529
% 215.45/215.65       3-Phenylchromones. Isomeric form of FLAVONOIDS in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position.%A%    
% 215.45/215.65  |- skos__prefLabel mesh__D007529 Isoflavones
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D007529 2006
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018251 1996
% 215.45/215.65  |- rdf__type mesh__D018251sskos__Concept
% 215.45/215.65  |- skos__broader mesh__D018251smesh__D006607
% 215.45/215.65  |- mesh__recordAuthorizer mesh__D018251 PLS
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018251 2000
% 215.45/215.65  |- mesh__recordMaintainer mesh__D018251 KEV
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018251 2003
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018251 1997
% 215.45/215.65  |- mesh__dateRevised mesh__D018251 1995-06-08
% 215.45/215.65  |- skos__scopeNote mesh__D018251
% 215.45/215.65       A cystic form of sweat gland adenoma %28%ADENOMA, SWEAT GLAND%29%. It is produced by the cystic proliferation of apocrine secretory glands. It is not uncommon, occurring in adult life in no particular age group, with males and females equally affected. The commonest site is around the eye, particularly lateral to the outer canthus. It is cured by surgical removal. %28%Stedman, 25th ed; Rook et al., Textbook of Dermatology, 4th ed, p2410%29%%A%    
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018251 2001
% 215.45/215.65  |- mesh__publicMeSHNote mesh__D018251 94   
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018251 2004
% 215.45/215.65  |- mesh__recordOriginator mesh__D018251 PLS
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018251 1998
% 215.45/215.65  |- skos__prefLabel mesh__D018251 Hidrocystoma
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018251 2002
% 215.45/215.65  |- mesh__historyNote mesh__D018251 94   
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018251 2005
% 215.45/215.65  |- skos__annotation mesh__D018251
% 215.45/215.65       /blood supply /chem /secret /ultrastruct permitted; coord IM with SWEAT GLAND NEOPLASMS %28%IM%29%%A%  
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018251 1999
% 215.45/215.65  |- skos__historyNote mesh__D018251 Cystadenoma %28%1971-1993%29%
% 215.45/215.65  |- skos__hiddenLabel mesh__D018251 Hidrocystomas
% 215.45/215.65  |- skos__historyNote mesh__D018251 Sweat Gland Neoplasms %28%1971-1993%29%
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018251 2006
% 215.45/215.65  |- skos__historyNote mesh__D018251 Adenoma, Sweat Gland %28%1973-1989%29%
% 215.45/215.65  |- mesh__dateCreated mesh__D018251 1993-06-25
% 215.45/215.65  |- mesh__dateEstablished mesh__D018251 1994-01-01
% 215.45/215.65  |- skos__related mesh__D004231smesh__D004232
% 215.45/215.65  |- mesh__recordAuthorizer mesh__D004231 sjn
% 215.45/215.65  |- skos__annotation mesh__D004231 /drug eff: consider also DIURETICS   
% 215.45/215.65  |- skos__prefLabel mesh__D004231 Diuresis
% 215.45/215.65  |- skos__related mesh__D004231smesh__D009994
% 215.45/215.65  |- rdf__type mesh__D004231sskos__Concept
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D004231 2006
% 215.45/215.65  |- mesh__dateRevised mesh__D004231 2004-07-07
% 215.45/215.65  |- mesh__recordOriginator mesh__D004231 NLM
% 215.45/215.65  |- skos__hiddenLabel mesh__D004231 Diureses
% 215.45/215.65  |- skos__broader mesh__D004231smesh__D014553
% 215.45/215.65  |- mesh__dateCreated mesh__D004231 1999-01-01
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D004231 2005
% 215.45/215.65  |- mesh__recordMaintainer mesh__D004231 lkt
% 215.45/215.65  |- mesh__publicMeSHNote mesh__D017957 94   
% 215.45/215.65  |- mesh__historyNote mesh__D017957 94   
% 215.45/215.65  |- skos__broader mesh__D017957smesh__D030041
% 215.45/215.65  |- mesh__dateRevised mesh__D017957 2001-07-25
% 215.45/215.65  |- skos__scopeNote mesh__D017957
% 215.45/215.65       A strain of HEPATITIS A VIRUS which causes hepatitis in humans. The virus replicates in hepatocytes and is presumed to reach the intestine via the bile duct. Transmission occurs by the fecal-oral route.%A%    
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D017957 2004
% 215.45/215.65  |- skos__annotation mesh__D017957
% 215.45/215.65       infection = HEPATITIS A; HEPATITIS A VIRUS is also available%A%  
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D017957 2003
% 215.45/215.65  |- mesh__dateEstablished mesh__D017957 1994-01-01
% 215.45/215.65  |- skos__altLabel mesh__D017957 Human hepatitis A virus
% 215.45/215.65  |- skos__historyNote mesh__D017957 Hepatovirus %28%1966-1993%29%
% 215.45/215.65  |- mesh__recordMaintainer mesh__D017957 ags
% 215.45/215.65  |- rdf__type mesh__D017957sskos__Concept
% 215.45/215.65  |- mesh__recordAuthorizer mesh__D017957 sjn
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D017957 2006
% 215.45/215.65  |- skos__prefLabel mesh__D017957 Hepatitis A Virus, Human
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D017957 2002
% 215.45/215.65  |- mesh__dateCreated mesh__D017957 1993-06-04
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D017957 2005
% 215.45/215.65  |- mesh__recordOriginator mesh__D017957 AGS
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D017159 2006
% 215.45/215.65  |- mesh__historyNote mesh__D017159
% 215.45/215.65       93; DIOCTOPHYMA was see NEMATODA 1986-92; was heading 1963-85%A%  
% 215.45/215.65  |- skos__prefLabel mesh__D017159 Dioctophymatoidea
% 215.45/215.65  |- rdf__type mesh__D017159sskos__Concept
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D017159 2004
% 215.45/215.65  |- mesh__onlineNote mesh__D017159
% 215.45/215.65       use NEMATODA to search DIOCTOPHYMA 1966-92   
% 215.45/215.65  |- skos__historyNote mesh__D017159 Nematoda %28%1966-1992%29%
% 215.45/215.65  |- skos__annotation mesh__D017159
% 215.45/215.65       a superfamily of nematodes; infection: coord IM with ENOPLIDA INFECTIONS %28%IM%29%%A%  
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D017159 2005
% 215.45/215.65  |- mesh__publicMeSHNote mesh__D017159
% 215.45/215.65       93; DIOCTOPHYMA was see NEMATODA 1986-92; was heading 1963-85%A%  
% 215.45/215.65  |- mesh__dateRevised mesh__D017159 2003-07-09
% 215.45/215.65  |- mesh__dateCreated mesh__D017159 1992-05-20
% 215.45/215.65  |- mesh__dateEstablished mesh__D017159 1993-01-01
% 215.45/215.65  |- skos__scopeNote mesh__D017159
% 215.45/215.65       A superfamily of nematodes of the order ENOPLIDA. Characteristics include a well developed cylindrical esophagus.%A%    
% 215.45/215.65  |- skos__broader mesh__D017159smesh__D017158
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003937 1996
% 215.45/215.65  |- skos__prefLabel mesh__D003937 Diagnosis, Differential
% 215.45/215.65  |- skos__altLabel mesh__D003937 Differential Diagnoses
% 215.45/215.65  |- skos__scopeNote mesh__D003937
% 215.45/215.65       Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures.%A%    
% 215.45/215.65  |- mesh__recordMaintainer mesh__D003937 TGC
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003937 2002
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003937 2006
% 215.45/215.65  |- mesh__dateCreated mesh__D003937 1999-01-01
% 215.45/215.65  |- skos__altLabel mesh__D003937 Differential Diagnosis
% 215.45/215.65  |- skos__broader mesh__D003937smesh__D003933
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003937 2004
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003937 1995
% 215.45/215.65  |- mesh__recordOriginator mesh__D003937 NLM
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003937 2005
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003937 1999
% 215.45/215.65  |- rdf__type mesh__D003937sskos__Concept
% 215.45/215.65  |- mesh__dateRevised mesh__D003937 1994-05-23
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003937 2001
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003937 2003
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003937 1997
% 215.45/215.65  |- mesh__recordAuthorizer mesh__D003937 PLS
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003937 2000
% 215.45/215.65  |- skos__altLabel mesh__D003937 Diagnoses, Differential
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003937 1998
% 215.45/215.65  |- skos__annotation mesh__D003937
% 215.45/215.65       NIM; no qualif; correct NIM coord for %22%mimicking%22%, %22%simulating%22%; Manual 26.13+; in Chinese traditional med index bianzheng shizhi %28%%22%differentiation of symptoms %26% signs%22%%29% under DIAGNOSIS, DIFFERENTIAL %28%IM%29% + MEDICINE, CHINESE TRADITIONAL %28%IM%29%; DF: DIAG DIFFER%A%  
% 215.45/215.65  |- skos__hiddenLabel mesh__D003139 Acute Coryza
% 215.45/215.65  |- mesh__recordAuthorizer mesh__D003139 SJN
% 215.45/215.65  |- skos__broader mesh__D003139smesh__D012141
% 215.45/215.65  |- skos__scopeNote mesh__D003139
% 215.45/215.65       A catarrhal disorder of the upper respiratory tract, which may be viral, a mixed infection, or an allergic reaction. It is marked by acute coryza, slight rise in temperature, chilly sensations, and general indisposition. %28%Dorland, 27th ed%29%%A%    
% 215.45/215.65  |- skos__prefLabel mesh__D003139 Common Cold
% 215.45/215.65  |- mesh__recordMaintainer mesh__D003139 TGC
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003139 1999
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003139 1998
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003139 2002
% 215.45/215.65  |- mesh__dateCreated mesh__D003139 1999-01-01
% 215.45/215.65  |- skos__hiddenLabel mesh__D003139 Colds, Common
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003139 2004
% 215.45/215.65  |- skos__hiddenLabel mesh__D003139 Common Colds
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003139 2001
% 215.45/215.65  |- skos__altLabel mesh__D003139 Cold, Common
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003139 2003
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003139 2006
% 215.45/215.65  |- skos__annotation mesh__D003139 often caused by a picornavirus   
% 215.45/215.65  |- rdf__type mesh__D003139sskos__Concept
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003139 2000
% 215.45/215.65  |- mesh__dateRevised mesh__D003139 1997-06-20
% 215.45/215.65  |- skos__broader mesh__D003139smesh__D010850
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003139 2005
% 215.45/215.65  |- mesh__recordOriginator mesh__D003139 NLM
% 215.45/215.65  |- mesh__publicMeSHNote mesh__D008622
% 215.45/215.65       96; was MERBROMINE 1975-95 %28%see under FLUORESCEINS 1975-90%29%; MERCURESCEINE was see MERBROMINE 1975-95%A%  
% 215.45/215.65  |- skos__prefLabel mesh__D008622 Merbromin
% 215.45/215.65  |- mesh__dateEstablished mesh__D008622 1991-01-01
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D008622 2005
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D008622 2004
% 215.45/215.65  |- mesh__dateRevised mesh__D008622 2001-07-25
% 215.45/215.65  |- skos__altLabel mesh__D008622 Merbromine
% 215.45/215.65  |- mesh__onlineNote mesh__D008622
% 215.45/215.65       use MERBROMIN to search MERCURESCEINE 1975-95   
% 215.45/215.65  |- mesh__historyNote mesh__D008622
% 215.45/215.65       96; was MERBROMINE 1975-95 %28%see under FLUORESCEINS 1975-90%29%; MERCURESCEINE was see MERBROMINE 1975-95%A%  
% 215.45/215.65  |- mesh__recordAuthorizer mesh__D008622 sjn
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D008622 2003
% 215.45/215.65  |- rdf__type mesh__D008622sskos__Concept
% 215.45/215.65  |- mesh__dateCreated mesh__D008622 1974-11-19
% 215.45/215.65  |- skos__historyNote mesh__D008622 Fluoresceins %28%1969-1974%29%
% 215.45/215.65  |- skos__scopeNote mesh__D008622
% 215.45/215.65       A once-popular mercury containing topical antiseptic.     
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D008622 2002
% 215.45/215.65  |- mesh__recordOriginator mesh__D008622 NLM
% 215.45/215.65  |- mesh__recordMaintainer mesh__D008622 ssb
% 215.45/215.65  |- skos__broader mesh__D008622smesh__D009941
% 215.45/215.65  |- skos__historyNote mesh__D008622 Mercury %28%1972-1974%29%
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D008622 2006
% 215.45/215.65  |- mesh__recordAuthorizer mesh__D013567 NLM
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D013567 1990
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D013567 1992
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D013567 2001
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D013567 2003
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D013567 1998
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D013567 1991
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D013567 1993
% 215.45/215.65  |- rdf__type mesh__D013567sskos__Concept
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D013567 2002
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D013567 2004
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D013567 1999
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D013567 1994
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D013567 1989
% 215.45/215.65  |- mesh__dateCreated mesh__D013567 1999-01-01
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D013567 2005
% 215.45/215.65  |- mesh__recordOriginator mesh__D013567 NLM
% 215.45/215.65  |- skos__hiddenLabel mesh__D013567 Symphysiotomies
% 215.45/215.65  |- skos__broader mesh__D013567smesh__D013514
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D013567 1995
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D013567 1996
% 215.45/215.65  |- mesh__dateRevised mesh__D013567 1987-07-06
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D013567 2006
% 215.45/215.65  |- mesh__recordMaintainer mesh__D013567 BDS
% 215.45/215.65  |- skos__prefLabel mesh__D013567 Symphysiotomy
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D013567 2000
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D013567 1997
% 215.45/215.65  |- skos__annotation mesh__D013567
% 215.45/215.65       do not use /util except by MeSH definition   
% 215.45/215.65  |- mesh__historyNote mesh__D032721 2003; use FAMILY 2002   
% 215.45/215.65  |- skos__hiddenLabel mesh__D032721 Adult Son
% 215.45/215.65  |- skos__altLabel mesh__D032721 Adult Offspring
% 215.45/215.65  |- rdf__type mesh__D032721sskos__Concept
% 215.45/215.65  |- skos__historyNote mesh__D032721 Family %28%1974-2002%29%
% 215.45/215.65  |- skos__hiddenLabel mesh__D032721 Adult Daughter
% 215.45/215.65  |- mesh__publicMeSHNote mesh__D032721 2003; see FAMILY 2002   
% 215.45/215.65  |- skos__annotation mesh__D032721
% 215.45/215.65       HUMAN only; use only when the subject of discussion, not as a checktag%A%  
% 215.45/215.65  |- skos__altLabel mesh__D032721 Adult Daughters
% 215.45/215.65  |- skos__broader mesh__D032721smesh__D005190
% 215.45/215.65  |- skos__scopeNote mesh__D032721
% 215.45/215.65       Children who have reached maturity or the legal age of majority.%A%    
% 215.45/215.65  |- skos__altLabel mesh__D032721 Offspring, Adult
% 215.45/215.65  |- skos__prefLabel mesh__D032721 Adult Children
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D032721 2004
% 215.45/215.65  |- skos__broader mesh__D032721smesh__D009272
% 215.45/215.65  |- skos__altLabel mesh__D032721 Adult Sons
% 215.45/215.65  |- skos__hiddenLabel mesh__D032721 Daughters, Adult
% 215.45/215.65  |- skos__hiddenLabel mesh__D032721 Son, Adult
% 215.45/215.65  |- skos__altLabel mesh__D032721 Children, Adult
% 215.45/215.65  |- mesh__dateEstablished mesh__D032721 2003-01-01
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D032721 2003
% 215.45/215.65  |- mesh__dateCreated mesh__D032721 2002-07-02
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D032721 2006
% 215.45/215.65  |- skos__hiddenLabel mesh__D032721 Sons, Adult
% 215.45/215.65  |- skos__hiddenLabel mesh__D032721 Daughter, Adult
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D032721 2005
% 215.45/215.65  |- mesh__dateRevised mesh__D018252 1995-06-08
% 215.45/215.65  |- skos__historyNote mesh__D018252 Adenoma, Sweat Gland %28%1966-1993%29%
% 215.45/215.65  |- skos__scopeNote mesh__D018252
% 215.45/215.65       A benign tumor of the sweat glands which is usually multiple and results from malformation of sweat ducts. It is uncommon and more common in females than in males. It is most likely to appear at adolescence, and further lesions may develop during adult life. It does not appear to be hereditary. %28%Rook et al., Textbook of Dermatology, 4th ed, pp2407-8%29%%A%    
% 215.45/215.65  |- skos__historyNote mesh__D018252 Adenoma %28%1971-1993%29%
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018252 2004
% 215.45/215.65  |- mesh__dateCreated mesh__D018252 1993-06-25
% 215.45/215.65  |- mesh__dateEstablished mesh__D018252 1994-01-01
% 215.45/215.65  |- mesh__recordAuthorizer mesh__D018252 PLS
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018252 1998
% 215.45/215.65  |- mesh__recordOriginator mesh__D018252 PLS
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018252 2000
% 215.45/215.65  |- skos__broader mesh__D018252smesh__D006607
% 215.45/215.65  |- mesh__historyNote mesh__D018252 94   
% 215.45/215.65  |- skos__hiddenLabel mesh__D018252 Syringomas
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018252 2005
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018252 1999
% 215.45/215.65  |- skos__annotation mesh__D018252
% 215.45/215.65       /blood supply /chem /secret /ultrastruct permitted; coord IM with SWEAT GLAND NEOPLASMS %28%IM%29%%A%  
% 215.45/215.65  |- skos__prefLabel mesh__D018252 Syringoma
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018252 2001
% 215.45/215.65  |- mesh__publicMeSHNote mesh__D018252 94   
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018252 2006
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018252 2002
% 215.45/215.65  |- rdf__type mesh__D018252sskos__Concept
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018252 1996
% 215.45/215.65  |- skos__historyNote mesh__D018252 Sweat Gland Neoplasms %28%1968-1993%29%
% 215.45/215.65  |- mesh__recordMaintainer mesh__D018252 KEV
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018252 2003
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D018252 1997
% 215.45/215.65  |- mesh__recordMaintainer mesh__D004232 ssb
% 215.45/215.65  |- mesh__recordOriginator mesh__D004232 NLM
% 215.45/215.65  |- mesh__dateCreated mesh__D004232 1999-01-01
% 215.45/215.65  |- rdf__type mesh__D004232sskos__Concept
% 215.45/215.65  |- mesh__recordAuthorizer mesh__D004232 sjn
% 215.45/215.65  |- skos__broader mesh__D004232smesh__D045283
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D004232 2006
% 215.45/215.65  |- skos__scopeNote mesh__D004232
% 215.45/215.65       Agents that promote the excretion of urine through their effects on kidney function.%A%    
% 215.45/215.65  |- mesh__dateRevised mesh__D004232 2005-06-30
% 215.45/215.65  |- skos__related mesh__D004232smesh__D002257
% 215.45/215.65  |- skos__prefLabel mesh__D004232 Diuretics
% 215.45/215.65  |- mesh__publicMeSHNote mesh__D017958
% 215.45/215.65       97; was IMMUNODEFICIENCY VIRUSES, PRIMATE 1994-96   
% 215.45/215.65  |- skos__hiddenLabel mesh__D017958 Lentivirus, Primate
% 215.45/215.65  |- skos__prefLabel mesh__D017958 Lentiviruses, Primate
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D017958 2002
% 215.45/215.65  |- skos__hiddenLabel mesh__D017958 Immunodeficiency Virus, Primate
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D017958 2004
% 215.45/215.65  |- mesh__dateCreated mesh__D017958 1993-06-04
% 215.45/215.65  |- mesh__recordOriginator mesh__D017958 AGS
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D017958 1997
% 215.45/215.65  |- skos__altLabel mesh__D017958 Immunodeficiency Viruses, Primate
% 215.45/215.65  |- skos__hiddenLabel mesh__D017958 Primate Lentivirus
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D017958 2003
% 215.45/215.65  |- skos__altLabel mesh__D017958 Primate Immunodeficiency Viruses
% 215.45/215.65  |- rdf__type mesh__D017958sskos__Concept
% 215.45/215.65  |- skos__broader mesh__D017958smesh__D016086
% 215.45/215.65  |- skos__annotation mesh__D017958
% 215.45/215.65       a subgenus of the genus Lentivirus; infection: coord IM with LENTIVIRUS INFECTIONS %28%IM%29%%A%  
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D017958 2001
% 215.45/215.65  |- skos__scopeNote mesh__D017958
% 215.45/215.65       A subgenus of LENTIVIRUS comprising viruses that produce immunodeficiencies in primates, including humans.%A%    
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D017958 2006
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D017958 1999
% 215.45/215.65  |- mesh__recordAuthorizer mesh__D017958 PLS
% 215.45/215.65  |- skos__hiddenLabel mesh__D017958 Primate Lentiviruses
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D017958 2000
% 215.45/215.65  |- skos__hiddenLabel mesh__D017958 Viruses, Primate Immunodeficiency
% 215.45/215.65  |- skos__hiddenLabel mesh__D017958 Virus, Primate Immunodeficiency
% 215.45/215.65  |- mesh__dateRevised mesh__D017958 1996-06-10
% 215.45/215.65  |- mesh__historyNote mesh__D017958
% 215.45/215.65       97; was IMMUNODEFICIENCY VIRUSES, PRIMATE 1994-96   
% 215.45/215.65  |- mesh__dateEstablished mesh__D017958 1994-01-01
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D017958 2005
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D017958 1998
% 215.45/215.65  |- mesh__recordMaintainer mesh__D017958 AGS
% 215.45/215.65  |- skos__hiddenLabel mesh__D017958 Primate Immunodeficiency Virus
% 215.45/215.65  |- skos__broader mesh__D009985Q000451smesh__D009985
% 215.45/215.65  |- mesh__preferredCombination mesh__D009985Q000451smesh__D016530
% 215.45/215.65  |- rdf__type mesh__D009985Q000451smesh__CompoundConcept
% 215.45/215.65  |- skos__altLabel mesh__D003938 Techniques, Digestive System Diagnostic
% 215.45/215.65  |- mesh__dateRevised mesh__D003938 1997-06-20
% 215.45/215.65  |- mesh__recordOriginator mesh__D003938 NLM
% 215.45/215.65  |- mesh__dateEstablished mesh__D003938 1998-01-01
% 215.45/215.65  |- mesh__recordMaintainer mesh__D003938 TGC
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003938 2006
% 215.45/215.65  |- mesh__dateCreated mesh__D003938 1999-01-01
% 215.45/215.65  |- skos__altLabel mesh__D003938 Digestive System Diagnostic Technics
% 215.45/215.65  |- skos__scopeNote mesh__D003938
% 215.45/215.65       Methods and procedures for the diagnosis of diseases or dysfunction of the digestive system or its organs or demonstration of their physiological processes.%A%    
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003938 2004
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003938 2001
% 215.45/215.65  |- mesh__historyNote mesh__D003938 98; use explode 1975-97   
% 215.45/215.65  |- skos__altLabel mesh__D003938 Technics, Digestive System Diagnostic
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003938 2000
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003938 2005
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003938 1999
% 215.45/215.65  |- skos__altLabel mesh__D003938 Technic, Digestive System Diagnostic
% 215.45/215.65  |- rdf__type mesh__D003938sskos__Concept
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003938 2003
% 215.45/215.65  |- skos__altLabel mesh__D003938 Diagnostic Technics, Digestive System
% 215.45/215.65  |- skos__altLabel mesh__D003938 Digestive System Diagnostic Technique
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003938 1998
% 215.45/215.65  |- skos__altLabel mesh__D003938 Diagnostic Technique, Digestive System
% 215.45/215.65  |- mesh__recordAuthorizer mesh__D003938 SJN
% 215.45/215.65  |- skos__altLabel mesh__D003938 Technique, Digestive System Diagnostic
% 215.45/215.65  |- skos__altLabel mesh__D003938 Digestive System Diagnostic Technic
% 215.45/215.65  |- skos__annotation mesh__D003938
% 215.45/215.65       GEN or unspecified; prefer specifics; DF: DIAG TECHNIQUES DIGESTIVE SYSTEM%A%  
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D003938 2002
% 215.45/215.65  |- skos__altLabel mesh__D003938 Diagnostic Technic, Digestive System
% 215.45/215.65  |- skos__historyNote mesh__D003938 specific technique %28%1966-1997%29%
% 215.45/215.65  |- skos__prefLabel mesh__D003938 Diagnostic Techniques, Digestive System
% 215.45/215.65  |- skos__broader mesh__D003938smesh__D019937
% 215.45/215.65  |- skos__altLabel mesh__D003938 Digestive System Diagnostic Techniques
% 215.45/215.65  |- mesh__publicMeSHNote mesh__D003938 98   
% 215.45/215.65  |- mesh__publicMeSHNote mesh__D014660
% 215.45/215.65       84; was see under GASTROINTESTINAL HORMONES 1977-83   
% 215.45/215.65  |- skos__broader mesh__D014660smesh__D005768
% 215.45/215.65  |- skos__scopeNote mesh__D014660
% 215.45/215.65       A highly basic, 28 amino acid neuropeptide released from intestinal mucosa. It has a wide range of biological actions affecting the cardiovascular, gastrointestinal, and respiratory systems and is neuroprotective. It binds special receptors %28%RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE%29%.%A%    
% 215.45/215.65  |- skos__broader mesh__D014660smesh__D036361
% 215.45/215.65  |- skos__altLabel mesh__D014660 Vasoactive Intestinal Polypeptide
% 215.45/215.65  |- skos__hiddenLabel mesh__D014660 Polypeptide, Vasoactive Intestinal
% 215.45/215.65  |- mesh__historyNote mesh__D014660
% 215.45/215.65       84%28%77%29%; was see under GASTROINTESTINAL HORMONES 1977-83   
% 215.45/215.65  |- mesh__recordAuthorizer mesh__D014660 sjn
% 215.45/215.65  |- skos__altLabel mesh__D014660 VIP %28%Vasoactive Intestinal Peptide%29%
% 215.45/215.65  |- skos__hiddenLabel mesh__D014660 Intestinal Polypeptide, Vasoactive
% 215.45/215.65  |- rdf__type mesh__D014660sskos__Concept
% 215.45/215.65  |- mesh__dateCreated mesh__D014660 1976-04-13
% 215.45/215.65  |- skos__broader mesh__D014660smesh__D009479
% 215.45/215.65  |- mesh__recordOriginator mesh__D014660 RLS
% 215.45/215.65  |- mesh__dateRevised mesh__D014660 2005-06-30
% 215.45/215.65  |- skos__hiddenLabel mesh__D014660 Intestinal Peptide, Vasoactive
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D014660 2006
% 215.45/215.65  |- skos__prefLabel mesh__D014660 Vasoactive Intestinal Peptide
% 215.45/215.65  |- skos__hiddenLabel mesh__D014660 Peptide, Vasoactive Intestinal
% 215.45/215.65  |- skos__hiddenLabel mesh__D014660 Peptide, Vasointestinal
% 215.45/215.65  |- skos__historyNote mesh__D014660 Peptides %28%1974-1976%29%
% 215.45/215.65  |- mesh__recordMaintainer mesh__D014660 ssb
% 215.45/215.65  |- mesh__dateEstablished mesh__D014660 1984-01-01
% 215.45/215.65  |- skos__altLabel mesh__D014660 Vasointestinal Peptide
% 215.45/215.65  |- skos__historyNote mesh__D014660
% 215.45/215.65       Gastrointestinal Hormones %28%1974-1976%29%
% 215.45/215.65  |- skos__altLabel mesh__D008623 2-ME
% 215.45/215.65  |- mesh__publicMeSHNote mesh__D008623 66   
% 215.45/215.65  |- mesh__recordOriginator mesh__D008623 NLM
% 215.45/215.65  |- rdf__type mesh__D008623sskos__Concept
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D008623 2003
% 215.45/215.65  |- mesh__historyNote mesh__D008623 66%28%64%29%   
% 215.45/215.65  |- mesh__recordMaintainer mesh__D008623 ADP
% 215.45/215.65  |- skos__hiddenLabel mesh__D008623 2 Mercaptoethanol
% 215.45/215.65  |- skos__broader mesh__D008623smesh__D000431
% 215.45/215.65  |- mesh__dateEstablished mesh__D008623 1966-01-01
% 215.45/215.65  |- skos__prefLabel mesh__D008623 Mercaptoethanol
% 215.45/215.65  |- skos__broader mesh__D008623smesh__D013438
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D008623 2001
% 215.45/215.65  |- mesh__dateRevised mesh__D008623 1997-06-20
% 215.45/215.65  |- skos__altLabel mesh__D008623 2-Mercaptoethanol
% 215.45/215.65  |- mesh__dateCreated mesh__D008623 1999-01-01
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D008623 1999
% 215.45/215.65  |- mesh__recordAuthorizer mesh__D008623 SJN
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D008623 2000
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D008623 1998
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D008623 2006
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D008623 2005
% 215.45/215.65  |- mesh__activeMeSHYear mesh__D008623 2004
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D008623 2002
% 215.45/215.66  |- skos__altLabel mesh__D000640 3-Amino-1,2,4-triazole
% 215.45/215.66  |- mesh__dateRevised mesh__D000640 2005-06-30
% 215.45/215.66  |- rdf__type mesh__D000640sskos__Concept
% 215.45/215.66  |- skos__prefLabel mesh__D000640 Amitrole
% 215.45/215.66  |- skos__scopeNote mesh__D000640
% 215.45/215.66       A non-selective post-emergence, translocated herbicide. According to the Seventh Annual Report on Carcinogens %28%PB95-109781, 1994%29% this substance may reasonably be anticipated to be a carcinogen. %28%From Merck Index, 12th ed%29% It is an irreversible inhibitor of CATALASE, and thus impairs activity of peroxisomes.%A%    
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D000640 2006
% 215.45/215.66  |- skos__historyNote mesh__D000640 Herbicides %28%1966-1971%29%
% 215.45/215.66  |- skos__broader mesh__D000640smesh__D014230
% 215.45/215.66  |- mesh__publicMeSHNote mesh__D000640
% 215.45/215.66       91; was see under TRIAZOLES 1972-90   
% 215.45/215.66  |- mesh__dateEstablished mesh__D000640 1991-01-01
% 215.45/215.66  |- mesh__recordMaintainer mesh__D000640 ssb
% 215.45/215.66  |- mesh__dateCreated mesh__D000640 1999-01-01
% 215.45/215.66  |- skos__historyNote mesh__D000640 Triazoles %28%1966-1971%29%
% 215.45/215.66  |- skos__altLabel mesh__D000640 Aminotriazole
% 215.45/215.66  |- mesh__historyNote mesh__D000640
% 215.45/215.66       91%28%72%29%; was see under TRIAZOLES 1972-90   
% 215.45/215.66  |- mesh__recordAuthorizer mesh__D000640 sjn
% 215.45/215.66  |- mesh__recordOriginator mesh__D000640 NLM
% 215.45/215.66  |- rdf__type mesh__D013568sskos__Concept
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D013568 2004
% 215.45/215.66  |- mesh__dateRevised mesh__D013568 2001-07-25
% 215.45/215.66  |- mesh__dateCreated mesh__D013568 1999-01-01
% 215.45/215.66  |- skos__altLabel mesh__D013568 Symptoms and General Pathology
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D013568 2005
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D013568 2002
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D013568 2006
% 215.45/215.66  |- mesh__runningHead mesh__D013568
% 215.45/215.66       C23 - PATHOLOGICAL CONDITIONS, SIGNS AND SYMPTOMS   
% 215.45/215.66  |- mesh__publicMeSHNote mesh__D013568
% 215.45/215.66       2000; see SYMPTOMS AND GENERAL PATHOLOGY 1998-1999   
% 215.45/215.66  |- skos__annotation mesh__D013568
% 215.45/215.66       not used for indexing      CATALOG: do not use   
% 215.45/215.66  |- mesh__historyNote mesh__D013568
% 215.45/215.66       2000%28%1998%29%; use explode 1970-1997   
% 215.45/215.66  |- skos__prefLabel mesh__D013568
% 215.45/215.66       Pathological Conditions, Signs and Symptoms
% 215.45/215.66  |- mesh__recordAuthorizer mesh__D013568 sjn
% 215.45/215.66  |- mesh__recordOriginator mesh__D013568 NLM
% 215.45/215.66  |- mesh__dateEstablished mesh__D013568 1998-01-01
% 215.45/215.66  |- skos__scopeNote mesh__D013568
% 215.45/215.66       Abnormal anatomical or physiological conditions and objective or subjective manifestations of disease, not classified as disease or syndrome.%A%    
% 215.45/215.66  |- mesh__recordMaintainer mesh__D013568 ags
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D013568 2003
% 215.45/215.66  |- skos__related mesh__D032722smesh__D013727
% 215.45/215.66  |- mesh__dateCreated mesh__D032722 2002-07-02
% 215.45/215.66  |- mesh__historyNote mesh__D032722
% 215.45/215.66       2003; use ADVANCE DIRECTIVES 1999-2002   
% 215.45/215.66  |- mesh__publicMeSHNote mesh__D032722
% 215.45/215.66       2003; see ADVANCE DIRECTIVES 1999-2002   
% 215.45/215.66  |- skos__hiddenLabel mesh__D032722 Medical Planning, Advance
% 215.45/215.66  |- skos__scopeNote mesh__D032722
% 215.45/215.66       Discussions with patients and/or their representatives about the goals and desired direction of the patient%27%s care, particularly end-of-life care, in the event that the patient is or becomes incompetent to make decisions.%A%    
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D032722 2004
% 215.45/215.66  |- skos__altLabel mesh__D032722 Advance Health Care Planning
% 215.45/215.66  |- skos__prefLabel mesh__D032722 Advance Care Planning
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D032722 2006
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D032722 2003
% 215.45/215.66  |- skos__broader mesh__D032722smesh__D010347
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D032722 2005
% 215.45/215.66  |- skos__historyNote mesh__D032722 Advance Directives %28%1994-2002%29%
% 215.45/215.66  |- rdf__type mesh__D032722sskos__Concept
% 215.45/215.66  |- mesh__dateEstablished mesh__D032722 2003-01-01
% 215.45/215.66  |- skos__hiddenLabel mesh__D032722 Planning, Advance Medical
% 215.45/215.66  |- mesh__historyNote mesh__D018253 94   
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018253 2005
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018253 1999
% 215.45/215.66  |- skos__hiddenLabel mesh__D018253 Villous Adenomas
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018253 2002
% 215.45/215.66  |- skos__broader mesh__D018253smesh__D000236
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018253 2006
% 215.45/215.66  |- skos__prefLabel mesh__D018253 Adenoma, Villous
% 215.45/215.66  |- skos__historyNote mesh__D018253 Adenoma %28%1967-1993%29%
% 215.45/215.66  |- mesh__dateEstablished mesh__D018253 1994-01-01
% 215.45/215.66  |- rdf__type mesh__D018253sskos__Concept
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018253 1996
% 215.45/215.66  |- mesh__recordMaintainer mesh__D018253 KEV
% 215.45/215.66  |- skos__scopeNote mesh__D018253
% 215.45/215.66       An adenoma of the large intestine. It is usually a solitary, sessile, often large, tumor of colonic mucosa composed of mucinous epithelium covering delicate vascular projections. Hypersecretion and malignant changes occur frequently. %28%Stedman, 25th ed%29%%A%    
% 215.45/215.66  |- mesh__dateCreated mesh__D018253 1993-06-25
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018253 2003
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018253 1997
% 215.45/215.66  |- mesh__dateRevised mesh__D018253 1995-06-08
% 215.45/215.66  |- skos__hiddenLabel mesh__D018253 Adenomas, Villous
% 215.45/215.66  |- mesh__recordAuthorizer mesh__D018253 PLS
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018253 2000
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018253 2004
% 215.45/215.66  |- skos__hiddenLabel mesh__D018253 Villous Adenoma
% 215.45/215.66  |- skos__annotation mesh__D018253
% 215.45/215.66       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with probably COLONIC NEOPLASMS %28%IM%29%%A%  
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018253 1998
% 215.45/215.66  |- mesh__recordOriginator mesh__D018253 PLS
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018253 2001
% 215.45/215.66  |- mesh__publicMeSHNote mesh__D018253 94   
% 215.45/215.66  |- skos__hiddenLabel mesh__D010270 Egg Count, Parasite
% 215.45/215.66  |- skos__hiddenLabel mesh__D010270 Count, Parasite Egg
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D010270 2002
% 215.45/215.66  |- skos__hiddenLabel mesh__D010270 Counts, Parasite Egg
% 215.45/215.66  |- skos__broader mesh__D010270smesh__D003942
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D010270 1999
% 215.45/215.66  |- rdf__type mesh__D010270sskos__Concept
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D010270 2003
% 215.45/215.66  |- mesh__dateCreated mesh__D010270 1999-01-01
% 215.45/215.66  |- skos__hiddenLabel mesh__D010270 Parasite Egg Counts
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D010270 2005
% 215.45/215.66  |- skos__hiddenLabel mesh__D010270 Egg Counts, Parasite
% 215.45/215.66  |- skos__prefLabel mesh__D010270 Parasite Egg Count
% 215.45/215.66  |- mesh__recordOriginator mesh__D010270 NLM
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D010270 2004
% 215.45/215.66  |- mesh__historyNote mesh__D010270 74%28%71%29%   
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D010270 2006
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D010270 2000
% 215.45/215.66  |- mesh__recordAuthorizer mesh__D010270 SJN
% 215.45/215.66  |- mesh__publicMeSHNote mesh__D010270 74   
% 215.45/215.66  |- skos__annotation mesh__D010270
% 215.45/215.66       coord with specific parasite %28%IM%29% or parasitic dis %28%IM%29%   
% 215.45/215.66  |- mesh__dateEstablished mesh__D010270 1974-01-01
% 215.45/215.66  |- skos__historyNote mesh__D010270 Parasites %28%1966-1970%29%
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D010270 2001
% 215.45/215.66  |- skos__historyNote mesh__D010270 Ovum %28%1966-1970%29%
% 215.45/215.66  |- mesh__dateRevised mesh__D010270 1997-06-20
% 215.45/215.66  |- mesh__recordMaintainer mesh__D010270 PXP
% 215.45/215.66  |- skos__historyNote mesh__D010270 specific specimen
% 215.45/215.66  |- skos__historyNote mesh__D010270 specific parasite
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D010270 1998
% 215.45/215.66  |- mesh__dateEstablished mesh__D028681 2002-01-01
% 215.45/215.66  |- mesh__publicMeSHNote mesh__D028681
% 215.45/215.66       2002; see SOCIAL RESPONSIBILITY 1978-2001   
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D028681 2004
% 215.45/215.66  |- mesh__dateCreated mesh__D028681 2001-07-25
% 215.45/215.66  |- skos__hiddenLabel mesh__D028681 Moral Duty
% 215.45/215.66  |- mesh__historyNote mesh__D028681
% 215.45/215.66       2002; use SOCIAL RESPONSIBILITY 1978-2001   
% 215.45/215.66  |- skos__scopeNote mesh__D028681
% 215.45/215.66       Duties that are based in ETHICS, rather than in law.     
% 215.45/215.66  |- skos__prefLabel mesh__D028681 Moral Obligations
% 215.45/215.66  |- skos__hiddenLabel mesh__D028681 Duty, Moral
% 215.45/215.66  |- skos__hiddenLabel mesh__D028681 Obligation, Moral
% 215.45/215.66  |- skos__broader mesh__D028681smesh__D012941
% 215.45/215.66  |- skos__hiddenLabel mesh__D028681 Moral Obligation
% 215.45/215.66  |- skos__hiddenLabel mesh__D028681 Duties, Moral
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D028681 2005
% 215.45/215.66  |- skos__altLabel mesh__D028681 Moral Duties
% 215.45/215.66  |- rdf__type mesh__D028681sskos__Concept
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D028681 2006
% 215.45/215.66  |- skos__hiddenLabel mesh__D028681 Obligations, Moral
% 215.45/215.66  |- skos__historyNote mesh__D028681 Social Responsibility %28%1977-2001%29%
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D028681 2002
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D028681 2003
% 215.45/215.66  |- skos__prefLabel mesh__D003939 Diagnostic Techniques, Otological
% 215.45/215.66  |- mesh__recordOriginator mesh__D003939 NLM
% 215.45/215.66  |- skos__altLabel mesh__D003939 Diagnostic Technics, Otological
% 215.45/215.66  |- skos__hiddenLabel mesh__D003939 Technique, Otologic Diagnostic
% 215.45/215.66  |- mesh__dateRevised mesh__D003939 1997-06-20
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D003939 2006
% 215.45/215.66  |- skos__hiddenLabel mesh__D003939 Otologic Diagnostic Technics
% 215.45/215.66  |- skos__altLabel mesh__D003939 Techniques, Otological Diagnostic
% 215.45/215.66  |- skos__broader mesh__D003939smesh__D019937
% 215.45/215.66  |- skos__hiddenLabel mesh__D003939 Diagnostic Technic, Otologic
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D003939 1998
% 215.45/215.66  |- skos__hiddenLabel mesh__D003939 Techniques, Otologic Diagnostic
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D003939 2001
% 215.45/215.66  |- skos__altLabel mesh__D003939 Technics, Otological Diagnostic
% 215.45/215.66  |- skos__hiddenLabel mesh__D003939 Technic, Otologic Diagnostic
% 215.45/215.66  |- skos__hiddenLabel mesh__D003939 Technics, Otologic Diagnostic
% 215.45/215.66  |- skos__hiddenLabel mesh__D003939 Diagnostic Technique, Otologic
% 215.45/215.66  |- skos__historyNote mesh__D003939 specific technique %28%1966-1997%29%
% 215.45/215.66  |- mesh__dateCreated mesh__D003939 1999-01-01
% 215.45/215.66  |- mesh__recordMaintainer mesh__D003939 TGC
% 215.45/215.66  |- skos__annotation mesh__D003939
% 215.45/215.66       diag of ear dis or hearing disord; GEN or unspecified; prefer specifics; DF: DIAG TECHNIQUES OTOL%A%  
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D003939 1999
% 215.45/215.66  |- skos__scopeNote mesh__D003939
% 215.45/215.66       Methods and procedures for the diagnosis of diseases of the ear or of hearing disorders or demonstration of hearing acuity or loss.%A%    
% 215.45/215.66  |- skos__altLabel mesh__D003939 Diagnostic Technics, Otologic
% 215.45/215.66  |- skos__hiddenLabel mesh__D003939 Otologic Diagnostic Technic
% 215.45/215.66  |- mesh__recordAuthorizer mesh__D003939 SJN
% 215.45/215.66  |- skos__altLabel mesh__D003939 Otological Diagnostic Technique
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D003939 2002
% 215.45/215.66  |- skos__hiddenLabel mesh__D003939 Otologic Diagnostic Techniques
% 215.45/215.66  |- mesh__dateEstablished mesh__D003939 1998-01-01
% 215.45/215.66  |- skos__altLabel mesh__D003939 Otological Diagnostic Techniques
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D003939 2003
% 215.45/215.66  |- skos__altLabel mesh__D003939 Diagnostic Technique, Otological
% 215.45/215.66  |- skos__hiddenLabel mesh__D003939 Otologic Diagnostic Technique
% 215.45/215.66  |- skos__altLabel mesh__D003939 Diagnostic Technic, Otological
% 215.45/215.66  |- skos__altLabel mesh__D003939 Otological Diagnostic Technics
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D003939 2004
% 215.45/215.66  |- mesh__publicMeSHNote mesh__D003939 98   
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D003939 2005
% 215.45/215.66  |- skos__altLabel mesh__D003939 Technic, Otological Diagnostic
% 215.45/215.66  |- rdf__type mesh__D003939sskos__Concept
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D003939 2000
% 215.45/215.66  |- skos__altLabel mesh__D003939 Diagnostic Techniques, Otologic
% 215.45/215.66  |- skos__altLabel mesh__D003939 Technique, Otological Diagnostic
% 215.45/215.66  |- skos__altLabel mesh__D003939 Otological Diagnostic Technic
% 215.45/215.66  |- mesh__historyNote mesh__D003939 98; use explode 1975-97   
% 215.45/215.66  |- rdf__type mesh__D014661sskos__Concept
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D014661 2005
% 215.45/215.66  |- skos__broader mesh__D014661smesh__D006439
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D014661 2004
% 215.45/215.66  |- mesh__dateEstablished mesh__D014661 1978-01-01
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D014661 2006
% 215.45/215.66  |- mesh__recordOriginator mesh__D014661 VDK
% 215.45/215.66  |- mesh__dateCreated mesh__D014661 1977-04-27
% 215.45/215.66  |- skos__prefLabel mesh__D014661 Vasoconstriction
% 215.45/215.66  |- skos__related mesh__D014661smesh__D014662
% 215.45/215.66  |- mesh__publicMeSHNote mesh__D014661 78   
% 215.45/215.66  |- skos__hiddenLabel mesh__D014661 Vasoconstrictions
% 215.45/215.66  |- mesh__recordMaintainer mesh__D014661 nns
% 215.45/215.66  |- skos__scopeNote mesh__D014661
% 215.45/215.66       The physiological narrowing of BLOOD VESSELS by contraction of the VASCULAR SMOOTH MUSCLE.%A%    
% 215.45/215.66  |- mesh__dateRevised mesh__D014661 2003-07-09
% 215.45/215.66  |- skos__related mesh__D014661smesh__D014655
% 215.45/215.66  |- skos__historyNote mesh__D014661 Vascular Resistance %28%1966-1977%29%
% 215.45/215.66  |- skos__historyNote mesh__D014661 Vasomotor System %28%1966-1977%29%
% 215.45/215.66  |- skos__historyNote mesh__D014661
% 215.45/215.66       specific blood vessel/physiology %28%1966-1977%29%
% 215.45/215.66  |- mesh__recordAuthorizer mesh__D014661 sjn
% 215.45/215.66  |- skos__annotation mesh__D014661
% 215.45/215.66       coord IM with specific vessel or specific organ /blood supply; the physiol process; do not confuse with stenosis of specific blood vessels %28% = specific blood vessel %28%IM%29% + CONSTRICTION, PATHOLOGIC %28%NIM%29%%29%%A%  
% 215.45/215.66  |- mesh__historyNote mesh__D014661 78   
% 215.45/215.66  |- mesh__recordMaintainer mesh__D008624 PLS
% 215.45/215.66  |- mesh__dateCreated mesh__D008624 1999-01-01
% 215.45/215.66  |- rdf__type mesh__D008624sskos__Concept
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D008624 1995
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D008624 1993
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D008624 1998
% 215.45/215.66  |- mesh__dateRevised mesh__D008624 1992-06-29
% 215.45/215.66  |- skos__broader mesh__D008624smesh__D005021
% 215.45/215.66  |- mesh__recordAuthorizer mesh__D008624 PLS
% 215.45/215.66  |- mesh__recordOriginator mesh__D008624 NLM
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D008624 1999
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D008624 1996
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D008624 2005
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D008624 2000
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D008624 1997
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D008624 2006
% 215.45/215.66  |- skos__broader mesh__D008624smesh__D013438
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D008624 2003
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D008624 2001
% 215.45/215.66  |- skos__prefLabel mesh__D008624 Mercaptoethylamines
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D008624 2004
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D008624 2002
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D008624 1994
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D000641 2006
% 215.45/215.66  |- mesh__recordOriginator mesh__D000641 NLM
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D000641 1996
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D000641 2003
% 215.45/215.66  |- skos__annotation mesh__D000641
% 215.45/215.66       a colorless alkaline gas; formed in body during decomposition of organic matter%A%  
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D000641 2000
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D000641 1997
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D000641 2004
% 215.45/215.66  |- mesh__recordAuthorizer mesh__D000641 PLS
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D000641 1994
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D000641 2001
% 215.45/215.66  |- mesh__dateCreated mesh__D000641 1999-01-01
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D000641 1995
% 215.45/215.66  |- skos__prefLabel mesh__D000641 Ammonia
% 215.45/215.66  |- skos__broader mesh__D000641smesh__D005740
% 215.45/215.66  |- skos__broader mesh__D000641smesh__D017672
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D000641 1998
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D000641 2005
% 215.45/215.66  |- mesh__dateRevised mesh__D000641 1993-06-04
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D000641 2002
% 215.45/215.66  |- mesh__recordMaintainer mesh__D000641 TPW
% 215.45/215.66  |- skos__scopeNote mesh__D000641
% 215.45/215.66       Ammonia. A colorless alkaline gas. It is formed in the body during decomposition of organic materials during a large number of metabolically important reactions.%A%    
% 215.45/215.66  |- rdf__type mesh__D000641sskos__Concept
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D000641 1999
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D013569 2005
% 215.45/215.66  |- skos__annotation mesh__D013569
% 215.45/215.66       A 11 qualif except /cytol /transpl; /genet permitted; /physiol: consider also SYNAPTIC TRANSMISSION %28%see note there%29%%A%  
% 215.45/215.66  |- mesh__recordOriginator mesh__D013569 NLM
% 215.45/215.66  |- mesh__recordAuthorizer mesh__D013569 sjn
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D013569 2006
% 215.45/215.66  |- skos__related mesh__D013569smesh__D009435
% 215.45/215.66  |- skos__broader mesh__D013569smesh__D009420
% 215.45/215.66  |- skos__hiddenLabel mesh__D013569 Synapse
% 215.45/215.66  |- mesh__recordMaintainer mesh__D013569 TGC
% 215.45/215.66  |- skos__related mesh__D013569smesh__D017629
% 215.45/215.66  |- skos__scopeNote mesh__D013569
% 215.45/215.66       Specialized junctions at which a neuron communicates with a target cell. At classical synapses, a neuron%27%s presynaptic terminal releases a chemical transmitter stored in synaptic vesicles which diffuses across a narrow synaptic cleft and activates receptors on the postsynaptic membrane of the target cell. The target may be a dendrite, cell body, or axon of another neuron, or a specialized region of a muscle or secretory cell. Neurons may also communicate through direct electrical connections which are sometimes called electrical synapses; these are not included here but rather in GAP JUNCTIONS.%A%    
% 215.45/215.66  |- skos__broader mesh__D013569smesh__D007365
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D013569 2003
% 215.45/215.66  |- rdf__type mesh__D013569sskos__Concept
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D013569 2001
% 215.45/215.66  |- skos__prefLabel mesh__D013569 Synapses
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D013569 2004
% 215.45/215.66  |- mesh__dateRevised mesh__D013569 2000-06-22
% 215.45/215.66  |- mesh__dateCreated mesh__D013569 1999-01-01
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D013569 2002
% 215.45/215.66  |- skos__related mesh__D013569smesh__D013574
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018254 2006
% 215.45/215.66  |- skos__scopeNote mesh__D018254
% 215.45/215.66       A small, circumscribed, benign tumor of the genital tract, composed of small glandlike spaces lined by flattened or cuboidal mesothelium-like cells. %28%From Dorland, 27th ed%29%%A%    
% 215.45/215.66  |- skos__prefLabel mesh__D018254 Adenomatoid Tumor
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018254 2001
% 215.45/215.66  |- mesh__publicMeSHNote mesh__D018254 94   
% 215.45/215.66  |- rdf__type mesh__D018254sskos__Concept
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018254 1996
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018254 2002
% 215.45/215.66  |- mesh__recordMaintainer mesh__D018254 KEV
% 215.45/215.66  |- skos__broader mesh__D018254smesh__D000236
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018254 2003
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018254 1997
% 215.45/215.66  |- mesh__dateRevised mesh__D018254 1995-06-08
% 215.45/215.66  |- mesh__dateCreated mesh__D018254 1993-06-03
% 215.45/215.66  |- skos__hiddenLabel mesh__D018254 Tumors, Adenomatoid
% 215.45/215.66  |- skos__hiddenLabel mesh__D018254 Tumor, Adenomatoid
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018254 2004
% 215.45/215.66  |- mesh__dateEstablished mesh__D018254 1994-01-01
% 215.45/215.66  |- mesh__recordOriginator mesh__D018254 PLS
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018254 1998
% 215.45/215.66  |- skos__hiddenLabel mesh__D018254 Adenomatoid Tumors
% 215.45/215.66  |- skos__broader mesh__D018254smesh__D018301
% 215.45/215.66  |- mesh__historyNote mesh__D018254 94   
% 215.45/215.66  |- skos__annotation mesh__D018254
% 215.45/215.66       /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord genital/neopl term %28%IM%29%%A%  
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018254 2005
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018254 1999
% 215.45/215.66  |- mesh__recordAuthorizer mesh__D018254 PLS
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D018254 2000
% 215.45/215.66  |- skos__annotation mesh__D010271
% 215.45/215.66       GEN or unspecified only: prefer specifics; for parasiticides, consider ANTI-INFECTIVE AGENTS; ANTHELMINTICS; ANTIPROTOZOAL AGENTS %26% their specifics; in lower animals: Manual 22.20; relation to parasitic diseases: Manual 22.12-.20; parasites in food or parasitic contamination of food is indexed under FOOD PARASITOLOGY %28%IM%29% + specific parasite %28%IM%29% + specific food item %28%IM or NIM%29%%A%  
% 215.45/215.66  |- mesh__publicMeSHNote mesh__D010271 PARASITICIDES was heading 1963-66   
% 215.45/215.66  |- skos__related mesh__D010271smesh__D000981
% 215.45/215.66  |- skos__related mesh__D010271smesh__D000871
% 215.45/215.66  |- skos__prefLabel mesh__D010271 Parasites
% 215.45/215.66  |- mesh__dateRevised mesh__D010271 2005-07-08
% 215.45/215.66  |- rdf__type mesh__D010271sskos__Concept
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D010271 2004
% 215.45/215.66  |- mesh__recordMaintainer mesh__D010271 ags
% 215.45/215.66  |- skos__scopeNote mesh__D010271
% 215.45/215.66       Invertebrate organisms that live on or in another organism %28%the host%29%, and benefit at the expense of the other. Traditionally excluded from definition of parasites are pathogenic BACTERIA; FUNGI; VIRUSES; and PLANTS; though they may live parasitically.%A%    
% 215.45/215.66  |- skos__related mesh__D010271smesh__D000890
% 215.45/215.66  |- skos__related mesh__D010271smesh__D016266
% 215.45/215.66  |- skos__related mesh__D010271smesh__D006790
% 215.45/215.66  |- mesh__dateCreated mesh__D010271 1999-01-01
% 215.45/215.66  |- mesh__recordAuthorizer mesh__D010271 ags
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D010271 2006
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D010271 2006A
% 215.45/215.66  |- mesh__recordOriginator mesh__D010271 NLM
% 215.45/215.66  |- mesh__historyNote mesh__D010271 PARASITICIDES was heading 1963-66   
% 215.45/215.66  |- skos__broader mesh__D010271smesh__D007448
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D010271 2005
% 215.45/215.66  |- mesh__onlineNote mesh__D010271
% 215.45/215.66       search PARASITICIDES under ANTIPROTOZOAL AGENTS 1966   
% 215.45/215.66  |- skos__altLabel mesh__D004234 Osmotic Diuretics
% 215.45/215.66  |- mesh__recordAuthorizer mesh__D004234 sjn
% 215.45/215.66  |- skos__scopeNote mesh__D004234
% 215.45/215.66       Compounds that increase urine volume by increasing the amount of osmotically active solute in the urine. Osmotic diuretics also increase the osmolarity of plasma.%A%    
% 215.45/215.66  |- mesh__dateRevised mesh__D004234 2005-06-30
% 215.45/215.66  |- skos__prefLabel mesh__D004234 Diuretics, Osmotic
% 215.45/215.66  |- mesh__recordMaintainer mesh__D004234 ssb
% 215.45/215.66  |- mesh__recordOriginator mesh__D004234 NLM
% 215.45/215.66  |- skos__broader mesh__D004234smesh__D004232
% 215.45/215.66  |- mesh__publicMeSHNote mesh__D004234 74   
% 215.45/215.66  |- mesh__dateCreated mesh__D004234 1999-01-01
% 215.45/215.66  |- mesh__dateEstablished mesh__D004234 1974-01-01
% 215.45/215.66  |- rdf__type mesh__D004234sskos__Concept
% 215.45/215.66  |- mesh__historyNote mesh__D004234 74   
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D004234 2006
% 215.45/215.66  |- skos__hiddenLabel mesh__D014662 Agents, Vasopressor
% 215.45/215.66  |- skos__altLabel mesh__D014662 Vasoconstrictor Drugs
% 215.45/215.66  |- skos__scopeNote mesh__D014662
% 215.45/215.66       Drugs used to cause constriction of the blood vessels.     
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D014662 2006
% 215.45/215.66  |- mesh__historyNote mesh__D014662 67%28%65%29%   
% 215.45/215.66  |- mesh__dateCreated mesh__D014662 1999-01-01
% 215.45/215.66  |- skos__altLabel mesh__D014662 Vasoconstrictors
% 215.45/215.66  |- mesh__recordOriginator mesh__D014662 NLM
% 215.45/215.66  |- mesh__dateEstablished mesh__D014662 1967-01-01
% 215.45/215.66  |- mesh__dateRevised mesh__D014662 2005-06-30
% 215.45/215.66  |- skos__altLabel mesh__D014662 Vasoactive Agonists
% 215.45/215.66  |- mesh__publicMeSHNote mesh__D014662 67   
% 215.45/215.66  |- skos__hiddenLabel mesh__D014662 Drugs, Vasoconstrictor
% 215.45/215.66  |- skos__hiddenLabel mesh__D014662 Agents, Vasoconstrictor
% 215.45/215.66  |- skos__hiddenLabel mesh__D014662 Agonists, Vasoactive
% 215.45/215.66  |- skos__annotation mesh__D014662
% 215.45/215.66       consider also VASOMOTOR SYSTEM /drug eff   
% 215.45/215.66  |- mesh__recordMaintainer mesh__D014662 ssb
% 215.45/215.66  |- skos__prefLabel mesh__D014662 Vasoconstrictor Agents
% 215.45/215.66  |- skos__altLabel mesh__D014662 Vasopressor Agents
% 215.45/215.66  |- rdf__type mesh__D014662sskos__Concept
% 215.45/215.66  |- mesh__recordAuthorizer mesh__D014662 sjn
% 215.45/215.66  |- skos__broader mesh__D014662smesh__D002317
% 215.45/215.66  |- mesh__dateCreated mesh__D008625 1974-11-19
% 215.45/215.66  |- skos__altLabel mesh__D008625 Tiopronin
% 215.45/215.66  |- mesh__dateEstablished mesh__D008625 1989-01-01
% 215.45/215.66  |- mesh__recordAuthorizer mesh__D008625 sjn
% 215.45/215.66  |- skos__scopeNote mesh__D008625
% 215.45/215.66       Sulfhydryl acylated derivative of GLYCINE.     
% 215.45/215.66  |- skos__hiddenLabel mesh__D008625 Acid, 2-Thiol-propionamido-acetic
% 215.45/215.66  |- skos__hiddenLabel mesh__D008625 Acid, 2-Thiolpropionamidoacetic
% 215.45/215.66  |- skos__broader mesh__D008625smesh__D000603
% 215.45/215.66  |- skos__hiddenLabel mesh__D008625 alpha Mercaptopropionylglycine
% 215.45/215.66  |- mesh__recordMaintainer mesh__D008625 ssb
% 215.45/215.66  |- skos__prefLabel mesh__D008625 Thiopronine
% 215.45/215.66  |- skos__altLabel mesh__D008625 Mercaptopropionylglycine
% 215.45/215.66  |- skos__altLabel mesh__D008625 2-Thiol-propionamido-acetic Acid
% 215.45/215.66  |- skos__broader mesh__D008625smesh__D034442
% 215.45/215.66  |- skos__altLabel mesh__D008625 Tiopronine
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D008625 2006
% 215.45/215.66  |- skos__hiddenLabel mesh__D008625 2 Mercaptopropionylglycine
% 215.45/215.66  |- mesh__recordOriginator mesh__D008625 NLM
% 215.45/215.66  |- skos__hiddenLabel mesh__D008625 2 Thiol propionamido acetic Acid
% 215.45/215.66  |- mesh__dateRevised mesh__D008625 2005-06-30
% 215.45/215.66  |- mesh__publicMeSHNote mesh__D008625
% 215.45/215.66       2004; see MERCAPTOPROPIONYLGLYCINE 1989-2003 %26% see AMINO ACIDS, SULFUR 1975-1988%A%  
% 215.45/215.66  |- skos__historyNote mesh__D008625 Glycine %28%1974%29%
% 215.45/215.66  |- mesh__historyNote mesh__D008625 2004%28%1975%29%   
% 215.45/215.66  |- skos__altLabel mesh__D008625 alpha-Mercaptopropionylglycine
% 215.45/215.66  |- skos__historyNote mesh__D008625 Amino Acids, Sulfur %28%1974%29%
% 215.45/215.66  |- rdf__type mesh__D008625sskos__Concept
% 215.45/215.66  |- skos__altLabel mesh__D008625 2-Mercaptopropionylglycine
% 215.45/215.66  |- skos__altLabel mesh__D008625 2-Thiolpropionamidoacetic Acid
% 215.45/215.66  |- skos__hiddenLabel mesh__D008625 2 Thiolpropionamidoacetic Acid
% 215.45/215.66  |- mesh__publicMeSHNote mesh__D000642 73   
% 215.45/215.66  |- skos__broader mesh__D000642smesh__D019759
% 215.45/215.66  |- mesh__dateRevised mesh__D000642 2003-07-09
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D000642 2006
% 215.45/215.66  |- skos__prefLabel mesh__D000642 Ammonia-Lyases
% 215.45/215.66  |- mesh__historyNote mesh__D000642 73   
% 215.45/215.66  |- skos__hiddenLabel mesh__D000642 Ammonia Lyases
% 215.45/215.66  |- skos__historyNote mesh__D000642 Lyases %28%1966-1972%29%
% 215.45/215.66  |- mesh__dateCreated mesh__D000642 1999-01-01
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D000642 2004
% 215.45/215.66  |- mesh__dateEstablished mesh__D000642 1973-01-01
% 215.45/215.66  |- skos__scopeNote mesh__D000642
% 215.45/215.66       Enzymes that catalyze the formation of a carbon-carbon double bond by the elimination of AMMONIA.  EC 4.3.1.%A%    
% 215.45/215.66  |- mesh__recordMaintainer mesh__D000642 ssb
% 215.45/215.66  |- rdf__type mesh__D000642sskos__Concept
% 215.45/215.66  |- mesh__recordAuthorizer mesh__D000642 sjn
% 215.45/215.66  |- mesh__recordOriginator mesh__D000642 NLM
% 215.45/215.66  |- mesh__activeMeSHYear mesh__D000642 2005
% 215.45/215.66  |- skos__broader mesh__D014576Q000172smesh__D014576
% 215.45/215.66  |- mesh__preferredCombination mesh__D014576Q000172smesh__D017092
% 215.45/215.66  |- rdf__type mesh__D014576Q000172smesh__CompoundConcept
% 215.45/215.66  |- mesh__historyNote mesh__D018255 94   
% 215.45/215.66  |- mesh__publicMeSHNote mesh__D018255 94   
% 215.45/215.66  |- mesh__dateCreated mesh__D018255 1993-06-03
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D018255 2002
% 215.45/215.67  |- mesh__recordOriginator mesh__D018255 PLS
% 215.45/215.67  |- skos__altLabel mesh__D018255 Pulmonary Adenomatosis
% 215.45/215.67  |- mesh__recordMaintainer mesh__D018255 ags
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D018255 2006
% 215.45/215.67  |- skos__prefLabel mesh__D018255 Adenomatosis, Pulmonary
% 215.45/215.67  |- skos__scopeNote mesh__D018255
% 215.45/215.67       A neoplastic disease in which the alveoli and distal bronchi are filled with mucus and mucus-secreting columnar epithelial cells. It is characterized by abundant, extremely tenacious sputum, chills, fever, cough, dyspnea, and pleuritic pain. %28%Stedman, 25th ed%29%%A%    
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D018255 2001
% 215.45/215.67  |- mesh__dateEstablished mesh__D018255 1994-01-01
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D018255 2000
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D018255 2005
% 215.45/215.67  |- rdf__type mesh__D018255sskos__Concept
% 215.45/215.67  |- mesh__recordAuthorizer mesh__D018255 sjn
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D018255 2004
% 215.45/215.67  |- skos__hiddenLabel mesh__D018255 Pulmonary Adenomatoses
% 215.45/215.67  |- skos__hiddenLabel mesh__D018255 Adenomatoses, Pulmonary
% 215.45/215.67  |- mesh__dateRevised mesh__D018255 1999-11-03
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D018255 2003
% 215.45/215.67  |- skos__annotation mesh__D018255
% 215.45/215.67       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with LUNG NEOPLASMS %28%IM%29%; DF: ADENOMATOSIS PULM%A%  
% 215.45/215.67  |- skos__broader mesh__D018255smesh__D000236
% 215.45/215.67  |- mesh__historyNote mesh__D010272 PARASITICIDES was heading 1963-66   
% 215.45/215.67  |- skos__annotation mesh__D010272
% 215.45/215.67        GEN: prefer specifics; relation to parasites: Manual 22.12-.20; parasitic dis not in MeSH: Manual 22.17, 22.18; parasitic dis of heart = PARASITIC DISEASES or specific parasitic dis %28%IM%29% +  CARDIOMYOPATHIES %28%IM%29%, not HEART DISEASES; DF: PARASITIC DIS%A%  
% 215.45/215.67  |- mesh__dateRevised mesh__D010272 2004-07-13
% 215.45/215.67  |- rdf__type mesh__D010272sskos__Concept
% 215.45/215.67  |- mesh__runningHead mesh__D010272 C3 - DISEASES-PARASITIC   
% 215.45/215.67  |- mesh__dateCreated mesh__D010272 1999-01-01
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D010272 2006
% 215.45/215.67  |- mesh__recordAuthorizer mesh__D010272 sjn
% 215.45/215.67  |- skos__hiddenLabel mesh__D010272 Parasitic Disease
% 215.45/215.67  |- skos__hiddenLabel mesh__D010272 Disease, Parasitic
% 215.45/215.67  |- mesh__onlineNote mesh__D010272
% 215.45/215.67       search PARASITICIDES under ANTIPROTOZOAL AGENTS 1966   
% 215.45/215.67  |- skos__prefLabel mesh__D010272 Parasitic Diseases
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D010272 2005
% 215.45/215.67  |- mesh__recordMaintainer mesh__D010272 sjn
% 215.45/215.67  |- mesh__publicMeSHNote mesh__D010272 PARASITICIDES was heading 1963-66   
% 215.45/215.67  |- skos__hiddenLabel mesh__D010272 Diseases, Parasitic
% 215.45/215.67  |- skos__scopeNote mesh__D010272
% 215.45/215.67       Infections or infestations with parasitic organisms. They are often contracted through contact with an intermediate vector, but may occur as the result of direct exposure.%A%    
% 215.45/215.67  |- mesh__recordOriginator mesh__D010272 NLM
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D028683 2005
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D028683 2003
% 215.45/215.67  |- mesh__historyNote mesh__D028683
% 215.45/215.67       2002; for NAZISM use POLITICAL SYSTEMS 1990-2001   
% 215.45/215.67  |- mesh__dateEstablished mesh__D028683 2002-01-01
% 215.45/215.67  |- skos__altLabel mesh__D028683 Nazism
% 215.45/215.67  |- skos__scopeNote mesh__D028683
% 215.45/215.67       The doctrines and policies of the Nazis or the National Social German Workers party, which ruled Germany under Adolf Hitler from 1933-1945.  These doctrines and policies included racist nationalism, expansionism, and state control of the economy. %28%from Columbia Encyclopedia, 6th ed. and American Heritage College Dictionary, 3d ed.%29%%A%    
% 215.45/215.67  |- mesh__dateCreated mesh__D028683 2001-07-25
% 215.45/215.67  |- skos__annotation mesh__D028683 specify geog   
% 215.45/215.67  |- skos__broader mesh__D028683smesh__D011056
% 215.45/215.67  |- mesh__publicMeSHNote mesh__D028683
% 215.45/215.67       2002; for NAZISM see POLITICAL SYSTEMS 1990-2001   
% 215.45/215.67  |- skos__related mesh__D028683smesh__D017767
% 215.45/215.67  |- skos__historyNote mesh__D028683 Political Systems %28%1976-2001%29%
% 215.45/215.67  |- skos__hiddenLabel mesh__D028683 Socialism, National
% 215.45/215.67  |- skos__hiddenLabel mesh__D028683 Nazi
% 215.45/215.67  |- rdf__type mesh__D028683sskos__Concept
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D028683 2006
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D028683 2002
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D028683 2004
% 215.45/215.67  |- skos__prefLabel mesh__D028683 National Socialism
% 215.45/215.67  |- rdf__type mesh__D014663sskos__Concept
% 215.45/215.67  |- skos__historyNote mesh__D014663 Sympathomimetics %28%1966%29%
% 215.45/215.67  |- skos__hiddenLabel mesh__D014663 Nasal Vasoconstrictors
% 215.45/215.67  |- mesh__recordAuthorizer mesh__D014663 sjn
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D014663 2006
% 215.45/215.67  |- mesh__publicMeSHNote mesh__D014663
% 215.45/215.67       96; was VASOCONSTRICTOR AGENTS, NASAL 1967-95; NASAL DECONGESTANTS was see VASOCONSTRICTOR AGENTS, NASAL 1967-95%A%  
% 215.45/215.67  |- mesh__dateCreated mesh__D014663 1999-01-01
% 215.45/215.67  |- mesh__dateEstablished mesh__D014663 1967-01-01
% 215.45/215.67  |- skos__broader mesh__D014663smesh__D019141
% 215.45/215.67  |- mesh__recordMaintainer mesh__D014663 ssb
% 215.45/215.67  |- skos__prefLabel mesh__D014663 Nasal Decongestants
% 215.45/215.67  |- mesh__dateRevised mesh__D014663 2005-06-30
% 215.45/215.67  |- skos__hiddenLabel mesh__D014663 Nasal Vasoconstrictor Agents
% 215.45/215.67  |- mesh__recordOriginator mesh__D014663 NLM
% 215.45/215.67  |- skos__broader mesh__D014663smesh__D014662
% 215.45/215.67  |- skos__hiddenLabel mesh__D014663 Decongestants, Nasal
% 215.45/215.67  |- skos__hiddenLabel mesh__D014663 Agents, Nasal Vasoconstrictor
% 215.45/215.67  |- mesh__historyNote mesh__D014663
% 215.45/215.67       96; was VASOCONSTRICTOR AGENTS, NASAL 1967-95; NASAL DECONGESTANTS was see VASOCONSTRICTOR AGENTS, NASAL 1967-95%A%  
% 215.45/215.67  |- skos__scopeNote mesh__D014663
% 215.45/215.67       Drugs designed to treat inflammation of the nasal passages, generally the result of an infection %28%more often than not the common cold%29% or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. %28%From PharmAssist, The Family Guide to Health and Medicine, 1993%29%%A%    
% 215.45/215.67  |- mesh__recordOriginator mesh__D008626 NLM
% 215.45/215.67  |- skos__historyNote mesh__D008626
% 215.45/215.67       Organometallic Compounds %28%1968-1971%29%
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008626 2006
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008626 2003
% 215.45/215.67  |- mesh__recordAuthorizer mesh__D008626 SJN
% 215.45/215.67  |- skos__broader mesh__D008626smesh__D010663
% 215.45/215.67  |- skos__scopeNote mesh__D008626
% 215.45/215.67       Mercury-containing benzoic acid derivatives.     
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008626 2000
% 215.45/215.67  |- skos__historyNote mesh__D008626 Chloromercuribenzoates %28%1966-1971%29%
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008626 2004
% 215.45/215.67  |- skos__broader mesh__D008626smesh__D001565
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008626 2001
% 215.45/215.67  |- mesh__dateRevised mesh__D008626 1998-06-10
% 215.45/215.67  |- rdf__type mesh__D008626sskos__Concept
% 215.45/215.67  |- mesh__dateCreated mesh__D008626 1999-01-01
% 215.45/215.67  |- mesh__recordMaintainer mesh__D008626 ADP
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008626 2002
% 215.45/215.67  |- mesh__dateEstablished mesh__D008626 1972-01-01
% 215.45/215.67  |- skos__historyNote mesh__D008626 Mercury %28%1966-1971%29%
% 215.45/215.67  |- skos__historyNote mesh__D008626 Benzoates %28%1966-1971%29%
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008626 1999
% 215.45/215.67  |- skos__prefLabel mesh__D008626 Mercuribenzoates
% 215.45/215.67  |- mesh__historyNote mesh__D008626 72   
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008626 2005
% 215.45/215.67  |- mesh__publicMeSHNote mesh__D008626 72   
% 215.45/215.67  |- mesh__dateCreated mesh__D000643 1999-01-01
% 215.45/215.67  |- skos__broader mesh__D000643smesh__D002712
% 215.45/215.67  |- skos__hiddenLabel mesh__D000643 Chloride, Ammonium
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D000643 2004
% 215.45/215.67  |- mesh__recordMaintainer mesh__D000643 ssb
% 215.45/215.67  |- skos__scopeNote mesh__D000643
% 215.45/215.67       An acidifying agent that is used as an expectorant and a diuretic.%A%    
% 215.45/215.67  |- mesh__recordAuthorizer mesh__D000643 sjn
% 215.45/215.67  |- skos__prefLabel mesh__D000643 Ammonium Chloride
% 215.45/215.67  |- mesh__recordOriginator mesh__D000643 NLM
% 215.45/215.67  |- skos__annotation mesh__D000643 /analogs = AMMONIUM COMPOUNDS   
% 215.45/215.67  |- skos__broader mesh__D000643smesh__D000644
% 215.45/215.67  |- rdf__type mesh__D000643sskos__Concept
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D000643 2005
% 215.45/215.67  |- mesh__dateRevised mesh__D000643 2003-07-09
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D000643 2006
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D018256 1998
% 215.45/215.67  |- skos__broader mesh__D018256smesh__D000236
% 215.45/215.67  |- mesh__recordAuthorizer mesh__D018256 PLS
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D018256 2005
% 215.45/215.67  |- skos__scopeNote mesh__D018256
% 215.45/215.67       Benign neoplasms derived from glandular epithelium. %28%From Stedman, 25th ed%29%%A%    
% 215.45/215.67  |- skos__historyNote mesh__D018256 Adenoma %28%1968-1993%29%
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D018256 2002
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D018256 1997
% 215.45/215.67  |- mesh__publicMeSHNote mesh__D018256 94   
% 215.45/215.67  |- mesh__dateRevised mesh__D018256 1995-06-08
% 215.45/215.67  |- skos__prefLabel mesh__D018256 Adenomatous Polyps
% 215.45/215.67  |- rdf__type mesh__D018256sskos__Concept
% 215.45/215.67  |- mesh__dateCreated mesh__D018256 1993-06-25
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D018256 2004
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D018256 2001
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D018256 1996
% 215.45/215.67  |- skos__historyNote mesh__D018256 Adenocarcinoma %28%1966-1993%29%
% 215.45/215.67  |- skos__hiddenLabel mesh__D018256 Polyp, Adenomatous
% 215.45/215.67  |- skos__historyNote mesh__D018256 Intestinal Polyps %28%1967-1984%29%
% 215.45/215.67  |- mesh__dateEstablished mesh__D018256 1994-01-01
% 215.45/215.67  |- skos__hiddenLabel mesh__D018256 Polyps, Adenomatous
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D018256 2003
% 215.45/215.67  |- mesh__recordMaintainer mesh__D018256 KEV
% 215.45/215.67  |- skos__historyNote mesh__D018256 Polyps %28%1966-1993%29%
% 215.45/215.67  |- skos__annotation mesh__D018256
% 215.45/215.67       neoplastic; /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 215.45/215.67  |- skos__hiddenLabel mesh__D018256 Adenomatous Polyp
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D018256 2000
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D018256 1999
% 215.45/215.67  |- mesh__historyNote mesh__D018256 94   
% 215.45/215.67  |- mesh__recordOriginator mesh__D018256 PLS
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D018256 2006
% 215.45/215.67  |- mesh__recordMaintainer mesh__D010273 ags
% 215.45/215.67  |- mesh__dateCreated mesh__D010273 1999-01-01
% 215.45/215.67  |- skos__scopeNote mesh__D010273
% 215.45/215.67       Infections or infestations with parasitic organisms. The infestation may be experimental or veterinary.%A%    
% 215.45/215.67  |- skos__historyNote mesh__D010273
% 215.45/215.67       Parasitic Diseases/veterinary %28%1966-1997%29%
% 215.45/215.67  |- skos__broader mesh__D010273smesh__D000820
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D010273 2006
% 215.45/215.67  |- skos__hiddenLabel mesh__D010273 Parasitic Disease, Animal
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D010273 2005
% 215.45/215.67  |- mesh__recordOriginator mesh__D010273 NLM
% 215.45/215.67  |- skos__hiddenLabel mesh__D010273 Animal Parasitic Disease
% 215.45/215.67  |- skos__hiddenLabel mesh__D010273 Disease, Animal Parasitic
% 215.45/215.67  |- skos__annotation mesh__D010273
% 215.45/215.67       exper or vet; GEN or unspecified; prefer specific indentions or specific parasitic dis /vet; indexing policy: Manual 22.12-.20; don%27%t forget to check tag ANIMAL; DF: PARASITIC DIS ANIMALS%A%  
% 215.45/215.67  |- mesh__dateEstablished mesh__D010273 1998-01-01
% 215.45/215.67  |- skos__hiddenLabel mesh__D010273 Animal Parasitic Diseases
% 215.45/215.67  |- mesh__historyNote mesh__D010273 98; use explode 1975-97   
% 215.45/215.67  |- skos__hiddenLabel mesh__D010273 Diseases, Animal Parasitic
% 215.45/215.67  |- rdf__type mesh__D010273sskos__Concept
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D010273 2004
% 215.45/215.67  |- mesh__publicMeSHNote mesh__D010273 98   
% 215.45/215.67  |- skos__broader mesh__D010273smesh__D010272
% 215.45/215.67  |- mesh__dateRevised mesh__D010273 2003-07-30
% 215.45/215.67  |- skos__prefLabel mesh__D010273 Parasitic Diseases, Animal
% 215.45/215.67  |- mesh__recordAuthorizer mesh__D010273 sjn
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D014664 2006
% 215.45/215.67  |- mesh__recordMaintainer mesh__D014664 nns
% 215.45/215.67  |- mesh__dateRevised mesh__D014664 2003-07-09
% 215.45/215.67  |- skos__hiddenLabel mesh__D014664
% 215.45/215.67       Relaxation, Vascular Endothelium-Dependent
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D014664 2005
% 215.45/215.67  |- mesh__publicMeSHNote mesh__D014664 78   
% 215.45/215.67  |- skos__hiddenLabel mesh__D014664
% 215.45/215.67       Vascular Endothelium Dependent Relaxation
% 215.45/215.67  |- mesh__dateEstablished mesh__D014664 1978-01-01
% 215.45/215.67  |- mesh__historyNote mesh__D014664 78   
% 215.45/215.67  |- skos__historyNote mesh__D014664
% 215.45/215.67       tissue or organ/blood supply %28%1966-1977%29%
% 215.45/215.67  |- skos__hiddenLabel mesh__D014664
% 215.45/215.67       Endothelium-Dependent Relaxation, Vascular
% 215.45/215.67  |- mesh__recordAuthorizer mesh__D014664 sjn
% 215.45/215.67  |- skos__scopeNote mesh__D014664
% 215.45/215.67       The physiological widening of BLOOD VESSELS by relaxing the underlying VASCULAR SMOOTH MUSCLE.%A%    
% 215.45/215.67  |- skos__altLabel mesh__D014664 Vasodilatation
% 215.45/215.67  |- mesh__recordOriginator mesh__D014664 VDK
% 215.45/215.67  |- mesh__dateCreated mesh__D014664 1977-04-27
% 215.45/215.67  |- skos__altLabel mesh__D014664 Vasorelaxation
% 215.45/215.67  |- skos__related mesh__D014664smesh__D014665
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D014664 2004
% 215.45/215.67  |- rdf__type mesh__D014664sskos__Concept
% 215.45/215.67  |- skos__prefLabel mesh__D014664 Vasodilation
% 215.45/215.67  |- skos__annotation mesh__D014664
% 215.45/215.67       coord IM with specific vessel or specific organ /blood supply; the physiol process; pathol dilat = specific blood vessel %28%IM%29% + DILATATION, PATHOLOGIC %28%NIM%29% or ANEURYSM and its specifics%A%  
% 215.45/215.67  |- skos__broader mesh__D014664smesh__D006439
% 215.45/215.67  |- skos__historyNote mesh__D014664 Vasomotor System %28%1966-1977%29%
% 215.45/215.67  |- skos__broader mesh__D008627smesh__D002712
% 215.45/215.67  |- skos__broader mesh__D008627smesh__D017669
% 215.45/215.67  |- skos__annotation mesh__D008627 a local anti-infective   
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008627 2004
% 215.45/215.67  |- skos__altLabel mesh__D008627 Sublimate
% 215.45/215.67  |- skos__altLabel mesh__D008627 Mercury Bichloride
% 215.45/215.67  |- mesh__recordMaintainer mesh__D008627 JRT
% 215.45/215.67  |- skos__altLabel mesh__D008627 Mercury Dichloride
% 215.45/215.67  |- skos__hiddenLabel mesh__D008627 Perchloride, Mercuric
% 215.45/215.67  |- mesh__recordAuthorizer mesh__D008627 PLS
% 215.45/215.67  |- mesh__recordOriginator mesh__D008627 RLS
% 215.45/215.67  |- rdf__type mesh__D008627sskos__Concept
% 215.45/215.67  |- skos__hiddenLabel mesh__D008627 Sublimate, Corrosive
% 215.45/215.67  |- mesh__publicMeSHNote mesh__D008627 85   
% 215.45/215.67  |- skos__hiddenLabel mesh__D008627 Dichloride, Mercury
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008627 2000
% 215.45/215.67  |- mesh__dateRevised mesh__D008627 1995-06-16
% 215.45/215.67  |- skos__scopeNote mesh__D008627
% 215.45/215.67       Mercury chloride %28%HgCl2%29%. A highly toxic compound that volatizes slightly at ordinary temperature and appreciably at 100 degrees C. It is corrosive to mucous membranes and used as a topical antiseptic and disinfectant.%A%    
% 215.45/215.67  |- skos__altLabel mesh__D008627 HgCl2
% 215.45/215.67  |- mesh__dateEstablished mesh__D008627 1985-01-01
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008627 1998
% 215.45/215.67  |- mesh__dateCreated mesh__D008627 1984-05-30
% 215.45/215.67  |- skos__hiddenLabel mesh__D008627 Bichloride, Mercury
% 215.45/215.67  |- skos__historyNote mesh__D008627 Mercury %28%1966-1984%29%
% 215.45/215.67  |- mesh__historyNote mesh__D008627 85   
% 215.45/215.67  |- skos__altLabel mesh__D008627 Corrosive Sublimate
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008627 2001
% 215.45/215.67  |- skos__altLabel mesh__D008627 Mercury Perchloride
% 215.45/215.67  |- skos__prefLabel mesh__D008627 Mercuric Chloride
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008627 1999
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008627 1996
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008627 2005
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008627 2002
% 215.45/215.67  |- skos__hiddenLabel mesh__D008627 Chloride, Mercuric
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008627 1997
% 215.45/215.67  |- skos__altLabel mesh__D008627 Mercuric Perchloride
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008627 2006
% 215.45/215.67  |- skos__hiddenLabel mesh__D008627 Perchloride, Mercury
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008627 2003
% 215.45/215.67  |- skos__prefLabel mesh__D000644 Quaternary Ammonium Compounds
% 215.45/215.67  |- mesh__dateRevised mesh__D000644 2005-06-30
% 215.45/215.67  |- skos__broader mesh__D000644smesh__D009861
% 215.45/215.67  |- skos__broader mesh__D000644smesh__D017672
% 215.45/215.67  |- skos__related mesh__D000644smesh__D011726
% 215.45/215.67  |- rdf__type mesh__D000644sskos__Concept
% 215.45/215.67  |- mesh__recordMaintainer mesh__D000644 ssb
% 215.45/215.67  |- skos__hiddenLabel mesh__D000644 Ammonium Compounds, Quaternary
% 215.45/215.67  |- mesh__recordOriginator mesh__D000644 NLM
% 215.45/215.67  |- mesh__recordAuthorizer mesh__D000644 sjn
% 215.45/215.67  |- mesh__historyNote mesh__D000644 2006%28%1963%29%   
% 215.45/215.67  |- mesh__publicMeSHNote mesh__D000644
% 215.45/215.67       2006; see AMMONIUM COMPOUNDS 1963-2005   
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D000644 2006
% 215.45/215.67  |- skos__annotation mesh__D000644
% 215.45/215.67       general or unspecified; prefer specifics; DF: AMMONIUM CPDS%A%  
% 215.45/215.67  |- skos__broader mesh__D000644smesh__D000588
% 215.45/215.67  |- mesh__dateCreated mesh__D000644 1999-01-01
% 215.45/215.67  |- skos__scopeNote mesh__D000644
% 215.45/215.67       Derivatives of ammonium compounds, NH4+ Y-, in which all four of the hydrogens bonded to nitrogen have been replaced with hydrocarbyl groups. These are distinguished from IMINES which are RN=CR2.%A%    
% 215.45/215.67  |- skos__related mesh__D000644smesh__D011806
% 215.45/215.67  |- skos__hiddenLabel mesh__D018257 Helix Loop Helix Motifs
% 215.45/215.67  |- skos__annotation mesh__D018257
% 215.45/215.67       do not confuse with HELIX-TURN-HELIX MOTIFS   
% 215.45/215.67  |- skos__hiddenLabel mesh__D018257 Motifs, HLH
% 215.45/215.67  |- mesh__dateRevised mesh__D018257 2004-07-07
% 215.45/215.67  |- mesh__recordAuthorizer mesh__D018257 sjn
% 215.45/215.67  |- skos__hiddenLabel mesh__D018257 Helix-Loop-Helix Motif
% 215.45/215.67  |- skos__altLabel mesh__D018257 Motifs, Helix-Loop-Helix
% 215.45/215.67  |- skos__hiddenLabel mesh__D018257 Motifs, Helix Loop Helix
% 215.45/215.67  |- skos__hiddenLabel mesh__D018257 Motif, HLH
% 215.45/215.67  |- mesh__historyNote mesh__D018257 94   
% 215.45/215.67  |- skos__broader mesh__D018257smesh__D020816
% 215.45/215.67  |- skos__hiddenLabel mesh__D018257 HLH Motif
% 215.45/215.67  |- skos__scopeNote mesh__D018257
% 215.45/215.67       Recurring supersecondary structures characterized by 20 amino acids folding into two alpha helices connected by a non-helical %22%loop%22% segment. They are found in many sequence-specific DNA-BINDING PROTEINS and in CALCIUM-BINDING PROTEINS.%A%    
% 215.45/215.67  |- skos__hiddenLabel mesh__D018257 Motif, Helix-Loop-Helix
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D018257 2006
% 215.45/215.67  |- mesh__publicMeSHNote mesh__D018257 94   
% 215.45/215.67  |- mesh__dateCreated mesh__D018257 1993-06-03
% 215.45/215.67  |- skos__prefLabel mesh__D018257 Helix-Loop-Helix Motifs
% 215.45/215.67  |- mesh__dateEstablished mesh__D018257 1994-01-01
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D018257 2005
% 215.45/215.67  |- skos__altLabel mesh__D018257 HLH Motifs
% 215.45/215.67  |- rdf__type mesh__D018257sskos__Concept
% 215.45/215.67  |- mesh__recordMaintainer mesh__D018257 nns
% 215.45/215.67  |- skos__historyNote mesh__D018257 Amino Acid Sequence %28%1989-1993%29%
% 215.45/215.67  |- mesh__recordOriginator mesh__D018257 PXP
% 215.45/215.67  |- skos__historyNote mesh__D010274 Parasites %28%1966%29%
% 215.45/215.67  |- mesh__recordAuthorizer mesh__D010274 sjn
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D010274 2005
% 215.45/215.67  |- skos__hiddenLabel mesh__D010274 Parasitologies
% 215.45/215.67  |- mesh__recordMaintainer mesh__D010274 jls
% 215.45/215.67  |- mesh__publicMeSHNote mesh__D010274 67   
% 215.45/215.67  |- mesh__historyNote mesh__D010274 67   
% 215.45/215.67  |- skos__prefLabel mesh__D010274 Parasitology
% 215.45/215.67  |- mesh__dateRevised mesh__D010274 2001-07-25
% 215.45/215.67  |- rdf__type mesh__D010274sskos__Concept
% 215.45/215.67  |- skos__annotation mesh__D010274
% 215.45/215.67       SPEC only: SPEC qualif; prefer /parasitol with organs, higher animals %26% diseases: Manual 19.7+, 19.8.50; DF: PARASITOL%A%  
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D010274 2004
% 215.45/215.67  |- mesh__recordOriginator mesh__D010274 NLM
% 215.45/215.67  |- mesh__dateEstablished mesh__D010274 1967-01-01
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D010274 2002
% 215.45/215.67  |- skos__historyNote mesh__D010274 Parasitic Diseases %28%1966%29%
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D010274 2003
% 215.45/215.67  |- mesh__dateCreated mesh__D010274 1999-01-01
% 215.45/215.67  |- skos__broader mesh__D010274smesh__D001695
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D010274 2006
% 215.45/215.67  |- mesh__recordMaintainer mesh__D004237 ssb
% 215.45/215.67  |- skos__prefLabel mesh__D004237 Diuron
% 215.45/215.67  |- skos__altLabel mesh__D004237 DCMU
% 215.45/215.67  |- mesh__dateCreated mesh__D004237 1999-01-01
% 215.45/215.67  |- skos__scopeNote mesh__D004237 A pre-emergent herbicide.     
% 215.45/215.67  |- skos__altLabel mesh__D004237
% 215.45/215.67       3-%28%3,4-Dichlorophenyl%29%-1,1-dimethylurea
% 215.45/215.67  |- mesh__dateRevised mesh__D004237 2004-07-07
% 215.45/215.67  |- rdf__type mesh__D004237sskos__Concept
% 215.45/215.67  |- skos__broader mesh__D004237smesh__D010671
% 215.45/215.67  |- mesh__historyNote mesh__D004237 74%28%72%29%   
% 215.45/215.67  |- mesh__recordOriginator mesh__D004237 NLM
% 215.45/215.67  |- skos__historyNote mesh__D004237 Urea %28%1966-1971%29%
% 215.45/215.67  |- mesh__publicMeSHNote mesh__D004237 74   
% 215.45/215.67  |- skos__historyNote mesh__D004237 Herbicides %28%1966-1971%29%
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D004237 2006
% 215.45/215.67  |- mesh__dateEstablished mesh__D004237 1974-01-01
% 215.45/215.67  |- mesh__recordAuthorizer mesh__D004237 sjn
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D004237 2005
% 215.45/215.67  |- mesh__recordAuthorizer mesh__D009720 PLS
% 215.45/215.67  |- skos__scopeNote mesh__D009720
% 215.45/215.67       Registered nurses who hold Master%27%s degrees in nursing with an emphasis in clinical nursing and who function independently in coordinating plans for patient care.%A%    
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D009720 1999
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D009720 2003
% 215.45/215.67  |- skos__hiddenLabel mesh__D009720 Clinician, Nurse
% 215.45/215.67  |- rdf__type mesh__D009720sskos__Concept
% 215.45/215.67  |- mesh__recordOriginator mesh__D009720 EC
% 215.45/215.67  |- mesh__historyNote mesh__D009720
% 215.45/215.67       78; was NURSE CLINICIAN see NURSE PRACTITIONERS 1976-77, see NURSE PRACTITIONER 1973-75%A%  
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D009720 1996
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D009720 2004
% 215.45/215.67  |- mesh__recordMaintainer mesh__D009720 TGC
% 215.45/215.67  |- skos__broader mesh__D009720smesh__D009726
% 215.45/215.67  |- skos__altLabel mesh__D009720 Nurse Specialist, Clinical
% 215.45/215.67  |- mesh__dateEstablished mesh__D009720 1978-01-01
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D009720 2000
% 215.45/215.67  |- mesh__publicMeSHNote mesh__D009720
% 215.45/215.67       78; was NURSE CLINICIAN see NURSE PRACTITIONERS 1976-77, see NURSE PRACTITIONER 1973-75%A%  
% 215.45/215.67  |- skos__altLabel mesh__D009720 Specialists, Clinical Nurse
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D009720 2001
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D009720 1997
% 215.45/215.67  |- skos__historyNote mesh__D009720 Nurse Practitioners %28%1973-1977%29%
% 215.45/215.67  |- mesh__onlineNote mesh__D009720 search NURSE PRACTITIONERS 1973-77   
% 215.45/215.67  |- skos__prefLabel mesh__D009720 Nurse Clinicians
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D009720 1994
% 215.45/215.67  |- skos__altLabel mesh__D009720 Nurse Specialists, Clinical
% 215.45/215.67  |- skos__altLabel mesh__D009720 Clinical Nurse Specialists
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D009720 2005
% 215.45/215.67  |- skos__hiddenLabel mesh__D009720 Nurse Clinician
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D009720 1995
% 215.45/215.67  |- skos__hiddenLabel mesh__D009720 Clinicians, Nurse
% 215.45/215.67  |- skos__altLabel mesh__D009720 Clinical Nurse Specialist
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D009720 1998
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D009720 2006
% 215.45/215.67  |- mesh__dateRevised mesh__D009720 1993-06-02
% 215.45/215.67  |- mesh__dateCreated mesh__D009720 1977-05-11
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D009720 2002
% 215.45/215.67  |- skos__altLabel mesh__D009720 Specialist, Clinical Nurse
% 215.45/215.67  |- mesh__recordMaintainer mesh__D014665 ssb
% 215.45/215.67  |- skos__hiddenLabel mesh__D014665 Agents, Vasodilator
% 215.45/215.67  |- mesh__recordOriginator mesh__D014665 NLM
% 215.45/215.67  |- mesh__dateRevised mesh__D014665 2005-06-30
% 215.45/215.67  |- skos__hiddenLabel mesh__D014665 Antagonists, Vasoactive
% 215.45/215.67  |- rdf__type mesh__D014665sskos__Concept
% 215.45/215.67  |- skos__prefLabel mesh__D014665 Vasodilator Agents
% 215.45/215.67  |- skos__broader mesh__D014665smesh__D002317
% 215.45/215.67  |- skos__annotation mesh__D014665
% 215.45/215.67       consider also VASOMOTOR SYSTEM /drug eff   
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D014665 2006
% 215.45/215.67  |- skos__hiddenLabel mesh__D014665 Drugs, Vasodilator
% 215.45/215.67  |- skos__altLabel mesh__D014665 Vasodilator Drugs
% 215.45/215.67  |- mesh__dateCreated mesh__D014665 1999-01-01
% 215.45/215.67  |- mesh__recordAuthorizer mesh__D014665 sjn
% 215.45/215.67  |- skos__altLabel mesh__D014665 Vasodilators
% 215.45/215.67  |- skos__scopeNote mesh__D014665
% 215.45/215.67       Drugs used to cause dilation of the blood vessels.     
% 215.45/215.67  |- skos__broader mesh__D008628smesh__D028561
% 215.45/215.67  |- mesh__recordOriginator mesh__D008628 NLM
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008628 2006
% 215.45/215.67  |- rdf__type mesh__D008628sskos__Concept
% 215.45/215.67  |- skos__related mesh__D008628smesh__D008631
% 215.45/215.67  |- skos__annotation mesh__D008628 Hg-202   
% 215.45/215.67  |- mesh__dateCreated mesh__D008628 1999-01-01
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008628 2004
% 215.45/215.67  |- mesh__recordMaintainer mesh__D008628 jmp
% 215.45/215.67  |- mesh__dateRevised mesh__D008628 2001-07-25
% 215.45/215.67  |- skos__scopeNote mesh__D008628
% 215.45/215.67       A silver metallic element that exists as a liquid at room temperature. It has the atomic symbol Hg %28%from hydrargyrum, liquid silver%29%, atomic number 80, and atomic weight 200.59. Mercury is used in many industrial applications and its salts have been employed therapeutically as purgatives, antisyphilitics, disinfectants, and astringents. It can be absorbed through the skin and mucous membranes which leads to MERCURY POISONING. Because of its toxicity, the clinical use of mercury and mercurials is diminishing.%A%    
% 215.45/215.67  |- mesh__recordAuthorizer mesh__D008628 sjn
% 215.45/215.67  |- skos__broader mesh__D008628smesh__D019216
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008628 2002
% 215.45/215.67  |- skos__related mesh__D008628smesh__D008629
% 215.45/215.67  |- skos__prefLabel mesh__D008628 Mercury
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008628 2005
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D008628 2003
% 215.45/215.67  |- skos__related mesh__D008628smesh__D009941
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D000645 2003
% 215.45/215.67  |- skos__historyNote mesh__D000645 Ammonium Compounds %28%1966-1970%29%
% 215.45/215.67  |- mesh__dateCreated mesh__D000645 1999-01-01
% 215.45/215.67  |- skos__broader mesh__D000645smesh__D013431
% 215.45/215.67  |- mesh__recordMaintainer mesh__D000645 sjn
% 215.45/215.67  |- skos__hiddenLabel mesh__D000645 Sulfate, Ammonium
% 215.45/215.67  |- rdf__type mesh__D000645sskos__Concept
% 215.45/215.67  |- mesh__dateEstablished mesh__D000645 1974-01-01
% 215.45/215.67  |- skos__broader mesh__D000645smesh__D000644
% 215.45/215.67  |- mesh__historyNote mesh__D000645 74%28%71%29%   
% 215.45/215.67  |- skos__prefLabel mesh__D000645 Ammonium Sulfate
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D000645 2006
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D000645 2004
% 215.45/215.67  |- mesh__publicMeSHNote mesh__D000645 74   
% 215.45/215.67  |- mesh__dateRevised mesh__D000645 2002-07-03
% 215.45/215.67  |- mesh__recordOriginator mesh__D000645 NLM
% 215.45/215.67  |- mesh__recordAuthorizer mesh__D000645 sjn
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D000645 2005
% 215.45/215.67  |- skos__scopeNote mesh__D000645
% 215.45/215.67       Sulfuric acid diammonium salt. It is used in CHEMICAL FRACTIONATION of proteins.%A%    
% 215.45/215.67  |- mesh__activeMeSHYear mesh__D019350 2005
% 215.45/215.68  |- skos__broader mesh__D019350smesh__D012327
% 215.45/215.68  |- skos__altLabel mesh__D019350 Infections, Astroviridae
% 215.45/215.68  |- skos__annotation mesh__D019350 caused by Astrovirus   
% 215.45/215.68  |- skos__prefLabel mesh__D019350 Astroviridae Infections
% 215.45/215.68  |- mesh__recordMaintainer mesh__D019350 sjn
% 215.45/215.68  |- mesh__recordOriginator mesh__D019350 AGS
% 215.45/215.68  |- mesh__dateRevised mesh__D019350 2004-07-13
% 215.45/215.68  |- skos__hiddenLabel mesh__D019350 Astroviridae Infection
% 215.45/215.68  |- mesh__historyNote mesh__D019350 97   
% 215.45/215.68  |- mesh__dateEstablished mesh__D019350 1997-01-01
% 215.45/215.68  |- mesh__publicMeSHNote mesh__D019350 97   
% 215.45/215.68  |- skos__scopeNote mesh__D019350
% 215.45/215.68       Infections with ASTROVIRUS, causing gastroenteritis in human infants, calves, lambs, and piglets.%A%    
% 215.45/215.68  |- mesh__dateCreated mesh__D019350 1996-06-10
% 215.45/215.68  |- skos__hiddenLabel mesh__D019350 Infection, Astroviridae
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D019350 2006
% 215.45/215.68  |- rdf__type mesh__D019350sskos__Concept
% 215.45/215.68  |- mesh__recordAuthorizer mesh__D019350 sjn
% 215.45/215.68  |- rdf__type mesh__D033021sskos__Concept
% 215.45/215.68  |- skos__broader mesh__D033021smesh__D007887
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D033021 2003
% 215.45/215.68  |- mesh__publicMeSHNote mesh__D033021 2003   
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D033021 2006
% 215.45/215.68  |- mesh__dateCreated mesh__D033021 2002-07-03
% 215.45/215.68  |- skos__prefLabel mesh__D033021 Oxytropis
% 215.45/215.68  |- skos__annotation mesh__D033021
% 215.45/215.68       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D033021 2005
% 215.45/215.68  |- mesh__dateEstablished mesh__D033021 2003-01-01
% 215.45/215.68  |- skos__altLabel mesh__D033021 Locoweed, White
% 215.45/215.68  |- skos__scopeNote mesh__D033021
% 215.45/215.68       A plant genus of the family FABACEAE. Members contain SWAINSONINE.%A%    
% 215.45/215.68  |- mesh__historyNote mesh__D033021 2003   
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D033021 2004
% 215.45/215.68  |- mesh__recordAuthorizer mesh__D005330 sjn
% 215.45/215.68  |- mesh__recordMaintainer mesh__D005330 kle
% 215.45/215.68  |- mesh__dateEstablished mesh__D005330 1968-01-01
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D005330 2002
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D005330 2004
% 215.45/215.68  |- skos__hiddenLabel mesh__D005330 Syndromes, Twin Transfusion
% 215.45/215.68  |- mesh__recordOriginator mesh__D005330 NLM
% 215.45/215.68  |- skos__hiddenLabel mesh__D005330 Transfusions, Fetofetal
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D005330 2005
% 215.45/215.68  |- skos__hiddenLabel mesh__D005330 Fetofetal Transfusions
% 215.45/215.68  |- skos__historyNote mesh__D005330
% 215.45/215.68       Infant, Newborn, Diseases %28%1966-1967%29%
% 215.45/215.68  |- skos__hiddenLabel mesh__D005330 Cross Transfusion, Intrauterine
% 215.45/215.68  |- skos__hiddenLabel mesh__D005330 Cross-Transfusions, Intrauterine
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D005330 2006
% 215.45/215.68  |- skos__altLabel mesh__D005330 Twin Transfusion
% 215.45/215.68  |- skos__hiddenLabel mesh__D005330 Transfusion Syndromes, Twin
% 215.45/215.68  |- skos__hiddenLabel mesh__D005330 Syndrome, Twin Transfusion
% 215.45/215.68  |- mesh__publicMeSHNote mesh__D005330 68   
% 215.45/215.68  |- skos__hiddenLabel mesh__D005330 Intrauterine Cross-Transfusions
% 215.45/215.68  |- skos__hiddenLabel mesh__D005330 Twin Transfusions
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D005330 2000
% 215.45/215.68  |- skos__hiddenLabel mesh__D005330 Transfusion Syndrome, Twin
% 215.45/215.68  |- mesh__dateCreated mesh__D005330 1999-01-01
% 215.45/215.68  |- skos__altLabel mesh__D005330 Cross-Transfusion, Intrauterine
% 215.45/215.68  |- mesh__dateRevised mesh__D005330 1999-11-03
% 215.45/215.68  |- skos__hiddenLabel mesh__D005330 Transfusion, Twin
% 215.45/215.68  |- mesh__historyNote mesh__D005330 68   
% 215.45/215.68  |- skos__scopeNote mesh__D005330
% 215.45/215.68       Passage of blood from one fetus to another via an arteriovenous communication or other shunt, in a monozygotic twin pregnancy. It results in anemia in one twin and polycythemia in the other. %28%Lee et al., Wintrobe%27%s Clinical Hematology, 9th ed, p737-8%29%%A%    
% 215.45/215.68  |- skos__prefLabel mesh__D005330 Fetofetal Transfusion
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D005330 2001
% 215.45/215.68  |- skos__hiddenLabel mesh__D005330 Transfusion, Fetofetal
% 215.45/215.68  |- skos__altLabel mesh__D005330 Twin Transfusion Syndrome
% 215.45/215.68  |- skos__hiddenLabel mesh__D005330 Intrauterine Cross Transfusion
% 215.45/215.68  |- skos__altLabel mesh__D005330 Intrauterine Cross-Transfusion
% 215.45/215.68  |- skos__hiddenLabel mesh__D005330 Transfusions, Twin
% 215.45/215.68  |- skos__historyNote mesh__D005330 Anemia %28%1966-1967%29%
% 215.45/215.68  |- skos__annotation mesh__D005330
% 215.45/215.68       %22%passage of blood from one fetus to another via an arteriovenous communication or other shunt%22%; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; do not coord with DISEASES IN TWINS; TN 186: differentiate among various %22%transfusion%22% concepts%A%  
% 215.45/215.68  |- skos__broader mesh__D005330smesh__D000751
% 215.45/215.68  |- rdf__type mesh__D005330sskos__Concept
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D005330 2003
% 215.45/215.68  |- skos__hiddenLabel mesh__D005330 Twin Transfusion Syndromes
% 215.45/215.68  |- mesh__recordOriginator mesh__D018258 AGS
% 215.45/215.68  |- skos__altLabel mesh__D018258 Human Herpesvirus 2
% 215.45/215.68  |- mesh__dateCreated mesh__D018258 1993-06-04
% 215.45/215.68  |- skos__altLabel mesh__D018258 HHV-2
% 215.45/215.68  |- mesh__historyNote mesh__D018258 94   
% 215.45/215.68  |- skos__altLabel mesh__D018258 HSV-2
% 215.45/215.68  |- mesh__dateRevised mesh__D018258 2002-07-03
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D018258 2006
% 215.45/215.68  |- mesh__recordAuthorizer mesh__D018258 sjn
% 215.45/215.68  |- skos__scopeNote mesh__D018258
% 215.45/215.68       A species of SIMPLEXVIRUS associated with genital infections %28%HERPES GENITALIS%29%. It is transmitted by sexual intercourse and close personal contact.%A%    
% 215.45/215.68  |- skos__altLabel mesh__D018258 Herpes Simplex Virus 2
% 215.45/215.68  |- skos__altLabel mesh__D018258 Herpes Simplex Virus Type 2
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D018258 2005
% 215.45/215.68  |- skos__prefLabel mesh__D018258 Herpesvirus 2, Human
% 215.45/215.68  |- mesh__recordMaintainer mesh__D018258 ags
% 215.45/215.68  |- rdf__type mesh__D018258sskos__Concept
% 215.45/215.68  |- skos__annotation mesh__D018258
% 215.45/215.68       infection = HERPES GENITALIS usually; otherwise coord IM with HERPES SIMPLEX %28%IM%29% or its indentions %28%IM%29%; DF: HHV 2%A%  
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D018258 2004
% 215.45/215.68  |- skos__altLabel mesh__D018258 Herpesvirus 2 %28%alpha%29%, Human
% 215.45/215.68  |- mesh__publicMeSHNote mesh__D018258 94   
% 215.45/215.68  |- skos__broader mesh__D018258smesh__D018139
% 215.45/215.68  |- mesh__dateEstablished mesh__D018258 1994-01-01
% 215.45/215.68  |- skos__historyNote mesh__D018258 Simplexvirus %28%1966-1993%29%
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D018258 2003
% 215.45/215.68  |- mesh__recordOriginator mesh__D010275 NLM
% 215.45/215.68  |- skos__hiddenLabel mesh__D010275 Nervous Systems, Parasympathetic
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D010275 1996
% 215.45/215.68  |- skos__hiddenLabel mesh__D010275 Parasympathetic Nervous Systems
% 215.45/215.68  |- skos__hiddenLabel mesh__D010275 Nervous System, Parasympathetic
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D010275 1997
% 215.45/215.68  |- skos__broader mesh__D010275smesh__D001341
% 215.45/215.68  |- skos__related mesh__D010275smesh__D010277
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D010275 2000
% 215.45/215.68  |- skos__scopeNote mesh__D010275
% 215.45/215.68       The craniosacral division of the autonomic nervous system. The cell bodies of the parasympathetic preganglionic fibers are in brain stem nuclei and in the sacral spinal cord. They synapse in cranial autonomic ganglia or in terminal ganglia near target organs. The parasympathetic nervous system generally acts to conserve resources and restore homeostasis, often with effects reciprocal to the sympathetic nervous system.%A%    
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D010275 2003
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D010275 1998
% 215.45/215.68  |- mesh__dateCreated mesh__D010275 1999-01-01
% 215.45/215.68  |- skos__related mesh__D010275smesh__D010276
% 215.45/215.68  |- skos__annotation mesh__D010275
% 215.45/215.68       /drug eff: consider also PARASYMPATHOMIMETICS %26% PARASYMPATHOLYTICS%A%  
% 215.45/215.68  |- mesh__dateRevised mesh__D010275 1993-06-30
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D010275 2001
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D010275 1994
% 215.45/215.68  |- rdf__type mesh__D010275sskos__Concept
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D010275 1999
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D010275 2004
% 215.45/215.68  |- skos__hiddenLabel mesh__D010275 Systems, Parasympathetic Nervous
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D010275 2002
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D010275 1995
% 215.45/215.68  |- skos__prefLabel mesh__D010275 Parasympathetic Nervous System
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D010275 2005
% 215.45/215.68  |- mesh__recordMaintainer mesh__D010275 RAZ
% 215.45/215.68  |- skos__related mesh__D010275smesh__D017764
% 215.45/215.68  |- skos__hiddenLabel mesh__D010275 System, Parasympathetic Nervous
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D010275 2006
% 215.45/215.68  |- mesh__recordAuthorizer mesh__D010275 PLS
% 215.45/215.68  |- rdf__type mesh__D004238sskos__Concept
% 215.45/215.68  |- skos__hiddenLabel mesh__D004238 Diverticulitides
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D004238 2001
% 215.45/215.68  |- mesh__recordMaintainer mesh__D004238 adp
% 215.45/215.68  |- mesh__recordAuthorizer mesh__D004238 sjn
% 215.45/215.68  |- skos__scopeNote mesh__D004238
% 215.45/215.68       Inflammation of a DIVERTICULUM or diverticula.     
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D004238 2004
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D004238 2000
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D004238 2006
% 215.45/215.68  |- skos__annotation mesh__D004238
% 215.45/215.68       coord IM with precoord organ/dis terms %28%IM%29% or specific diverticulum %28%IM%29%%A%  
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D004238 2003
% 215.45/215.68  |- skos__broader mesh__D004238smesh__D010335
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D004238 2005
% 215.45/215.68  |- mesh__dateRevised mesh__D004238 1999-11-08
% 215.45/215.68  |- mesh__dateCreated mesh__D004238 1999-01-01
% 215.45/215.68  |- skos__prefLabel mesh__D004238 Diverticulitis
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D004238 2002
% 215.45/215.68  |- mesh__recordOriginator mesh__D004238 NLM
% 215.45/215.68  |- mesh__recordAuthorizer mesh__D009721 PLS
% 215.45/215.68  |- mesh__dateCreated mesh__D009721 1974-11-11
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D009721 2006
% 215.45/215.68  |- mesh__dateEstablished mesh__D009721 1977-01-01
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D009721 1994
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D009721 2001
% 215.45/215.68  |- mesh__recordOriginator mesh__D009721 NLM
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D009721 2005
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D009721 2004
% 215.45/215.68  |- mesh__publicMeSHNote mesh__D009721
% 215.45/215.68       77; was NURSE MIDWIFE see under NURSES 1975-76   
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D009721 1999
% 215.45/215.68  |- mesh__dateRevised mesh__D009721 1993-06-03
% 215.45/215.68  |- skos__scopeNote mesh__D009721
% 215.45/215.68       Professional nurses who have received postgraduate training in midwifery.%A%    
% 215.45/215.68  |- mesh__recordMaintainer mesh__D009721 PLS
% 215.45/215.68  |- skos__annotation mesh__D009721 check also tag PREGNANCY   
% 215.45/215.68  |- mesh__onlineNote mesh__D009721
% 215.45/215.68       use NURSE MIDWIVES to search NURSE MIDWIFE 1975-76   
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D009721 2000
% 215.45/215.68  |- rdf__type mesh__D009721sskos__Concept
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D009721 2003
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D009721 1998
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D009721 1997
% 215.45/215.68  |- mesh__historyNote mesh__D009721
% 215.45/215.68       77; was NURSE MIDWIFE see under NURSES 1975-76   
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D009721 1996
% 215.45/215.68  |- skos__altLabel mesh__D009721 Nurse-Midwife
% 215.45/215.68  |- skos__broader mesh__D009721smesh__D009726
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D009721 2002
% 215.45/215.68  |- skos__altLabel mesh__D009721 Nurse-Midwives
% 215.45/215.68  |- skos__hiddenLabel mesh__D009721 Nurse Midwife
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D009721 1995
% 215.45/215.68  |- skos__prefLabel mesh__D009721 Nurse Midwives
% 215.45/215.68  |- mesh__recordMaintainer mesh__D014666 TGC
% 215.45/215.68  |- skos__scopeNote mesh__D014666
% 215.45/215.68       The neural systems which act on vascular smooth muscle to control blood vessel diameter. The major neural control is through the sympathetic nervous system.%A%    
% 215.45/215.68  |- skos__related mesh__D014666smesh__D014665
% 215.45/215.68  |- mesh__dateRevised mesh__D014666 1997-06-20
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D014666 2004
% 215.45/215.68  |- skos__hiddenLabel mesh__D014666 Vasomotor Systems
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D014666 2002
% 215.45/215.68  |- rdf__type mesh__D014666sskos__Concept
% 215.45/215.68  |- skos__related mesh__D014666smesh__D017704
% 215.45/215.68  |- skos__related mesh__D014666smesh__D009131
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D014666 2003
% 215.45/215.68  |- mesh__recordOriginator mesh__D014666 NLM
% 215.45/215.68  |- skos__broader mesh__D014666smesh__D013564
% 215.45/215.68  |- skos__hiddenLabel mesh__D014666 System, Vasomotor
% 215.45/215.68  |- mesh__recordAuthorizer mesh__D014666 SJN
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D014666 1999
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D014666 2006
% 215.45/215.68  |- skos__prefLabel mesh__D014666 Vasomotor System
% 215.45/215.68  |- skos__hiddenLabel mesh__D014666 Systems, Vasomotor
% 215.45/215.68  |- mesh__dateCreated mesh__D014666 1999-01-01
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D014666 2001
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D014666 1998
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D014666 2005
% 215.45/215.68  |- skos__related mesh__D014666smesh__D014661
% 215.45/215.68  |- skos__related mesh__D014666smesh__D014664
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D014666 2000
% 215.45/215.68  |- skos__annotation mesh__D014666
% 215.45/215.68       /drug eff: consider also VASOCONSTRICTOR AGENTS %26% VASODILATOR AGENTS%A%  
% 215.45/215.68  |- skos__related mesh__D014666smesh__D014662
% 215.45/215.68  |- skos__broader mesh__D008629smesh__D007554
% 215.45/215.68  |- mesh__dateCreated mesh__D008629 1999-01-01
% 215.45/215.68  |- skos__prefLabel mesh__D008629 Mercury Isotopes
% 215.45/215.68  |- mesh__recordMaintainer mesh__D008629 nns
% 215.45/215.68  |- mesh__publicMeSHNote mesh__D008629 68   
% 215.45/215.68  |- skos__scopeNote mesh__D008629
% 215.45/215.68       Stable mercury atoms that have the same atomic number as the element mercury, but differ in atomic weight. Hg-196, 198-201, and 204 are stable mercury isotopes.%A%    
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D008629 2004
% 215.45/215.68  |- mesh__dateRevised mesh__D008629 2000-06-22
% 215.45/215.68  |- skos__historyNote mesh__D008629 Chlormerodrin %28%1966%29%
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D008629 2003
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D008629 2006
% 215.45/215.68  |- skos__historyNote mesh__D008629 Mercury %28%1966%29%
% 215.45/215.68  |- skos__hiddenLabel mesh__D008629 Isotopes, Mercury
% 215.45/215.68  |- rdf__type mesh__D008629sskos__Concept
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D008629 2002
% 215.45/215.68  |- mesh__recordOriginator mesh__D008629 NLM
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D008629 2005
% 215.45/215.68  |- skos__annotation mesh__D008629 Hg-196,198-201,204; NIM   
% 215.45/215.68  |- skos__historyNote mesh__D008629 Diuretics, Mercurial %28%1966%29%
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D008629 2001
% 215.45/215.68  |- mesh__dateEstablished mesh__D008629 1968-01-01
% 215.45/215.68  |- mesh__historyNote mesh__D008629 68%28%67%29%   
% 215.45/215.68  |- mesh__recordAuthorizer mesh__D008629 sjn
% 215.45/215.68  |- skos__hiddenLabel mesh__D000646 Sand Bath
% 215.45/215.68  |- mesh__recordAuthorizer mesh__D000646 sjn
% 215.45/215.68  |- skos__prefLabel mesh__D000646 Ammotherapy
% 215.45/215.68  |- mesh__dateEstablished mesh__D000646 1991-01-01
% 215.45/215.68  |- mesh__recordOriginator mesh__D000646 NLM
% 215.45/215.68  |- mesh__historyNote mesh__D000646
% 215.45/215.68       91%28%86%29%63; was see under HYPERTHERMIA, INDUCED 1986-90; was heading 1963-85%A%  
% 215.45/215.68  |- skos__annotation mesh__D000646
% 215.45/215.68       do not use /util except by MeSH definition   
% 215.45/215.68  |- skos__broader mesh__D000646smesh__D006979
% 215.45/215.68  |- rdf__type mesh__D000646sskos__Concept
% 215.45/215.68  |- mesh__publicMeSHNote mesh__D000646
% 215.45/215.68       91,63-85; was see under HYPERTHERMIA, INDUCED 1986-90; was heading 1963-85%A%  
% 215.45/215.68  |- mesh__dateRevised mesh__D000646 2005-06-30
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D000646 2006
% 215.45/215.68  |- skos__hiddenLabel mesh__D000646 Sandbath
% 215.45/215.68  |- skos__altLabel mesh__D000646 Sand Baths
% 215.45/215.68  |- skos__scopeNote mesh__D000646 Treatment by application of hot sand.     
% 215.45/215.68  |- skos__broader mesh__D000646smesh__D001452
% 215.45/215.68  |- mesh__recordMaintainer mesh__D000646 lkt
% 215.45/215.68  |- skos__altLabel mesh__D000646 Sandbaths
% 215.45/215.68  |- skos__hiddenLabel mesh__D000646 Bath, Sand
% 215.45/215.68  |- mesh__dateCreated mesh__D000646 1999-01-01
% 215.45/215.68  |- mesh__dateCreated mesh__D019351 1996-06-10
% 215.45/215.68  |- skos__annotation mesh__D019351
% 215.45/215.68       GEN or unspecified; prefer specifics; do not confuse with RUBELLA VIRUS infections %28% = RUBELLA%29%%A%  
% 215.45/215.68  |- mesh__recordAuthorizer mesh__D019351 sjn
% 215.45/215.68  |- mesh__historyNote mesh__D019351 97   
% 215.45/215.68  |- skos__hiddenLabel mesh__D019351 Rubulavirus Infection
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D019351 2004
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D019351 2002
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D019351 2003
% 215.45/215.68  |- mesh__recordMaintainer mesh__D019351 sjn
% 215.45/215.68  |- mesh__recordOriginator mesh__D019351 AGS
% 215.45/215.68  |- skos__scopeNote mesh__D019351
% 215.45/215.68       Infections with viruses of the genus RUBULAVIRUS, family PARAMYXOVIRIDAE.%A%    
% 215.45/215.68  |- skos__broader mesh__D019351smesh__D018184
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D019351 2006
% 215.45/215.68  |- mesh__dateEstablished mesh__D019351 1997-01-01
% 215.45/215.68  |- mesh__publicMeSHNote mesh__D019351 97   
% 215.45/215.68  |- skos__prefLabel mesh__D019351 Rubulavirus Infections
% 215.45/215.68  |- rdf__type mesh__D019351sskos__Concept
% 215.45/215.68  |- skos__altLabel mesh__D019351 Infections, Rubulavirus
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D019351 2005
% 215.45/215.68  |- mesh__dateRevised mesh__D019351 2001-08-03
% 215.45/215.68  |- skos__hiddenLabel mesh__D019351 Infection, Rubulavirus
% 215.45/215.68  |- mesh__dateEstablished mesh__D033022 2003-01-01
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D033022 2006
% 215.45/215.68  |- skos__prefLabel mesh__D033022 Vicia sativa
% 215.45/215.68  |- mesh__historyNote mesh__D033022 2003   
% 215.45/215.68  |- skos__annotation mesh__D033022
% 215.45/215.68       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D033022 2005
% 215.45/215.68  |- skos__altLabel mesh__D033022 Vetch, Common
% 215.45/215.68  |- mesh__dateCreated mesh__D033022 2002-07-03
% 215.45/215.68  |- skos__scopeNote mesh__D033022
% 215.45/215.68       A plant species of the genus VICIA, family FABACEAE. The seed is used for food and contains THIOCYANATES such as prunasin, cyanoalanine, cyanogen, and vicine.%A%    
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D033022 2004
% 215.45/215.68  |- skos__broader mesh__D033022smesh__D031306
% 215.45/215.68  |- rdf__type mesh__D033022sskos__Concept
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D033022 2003
% 215.45/215.68  |- mesh__publicMeSHNote mesh__D033022 2003   
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D005331 2005
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D005331 2004
% 215.45/215.68  |- mesh__publicMeSHNote mesh__D005331 68   
% 215.45/215.68  |- mesh__historyNote mesh__D005331 68%28%66%29%   
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D005331 2001
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D005331 2003
% 215.45/215.68  |- skos__prefLabel mesh__D005331 Fetomaternal Transfusion
% 215.45/215.68  |- skos__broader mesh__D005331smesh__D000751
% 215.45/215.68  |- skos__hiddenLabel mesh__D005331 Transfusions, Fetomaternal
% 215.45/215.68  |- skos__hiddenLabel mesh__D005331 Fetomaternal Hemorrhage
% 215.45/215.68  |- mesh__recordAuthorizer mesh__D005331 sjn
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D005331 2000
% 215.45/215.68  |- skos__altLabel mesh__D005331 Hemorrhage, Fetomaternal
% 215.45/215.68  |- skos__hiddenLabel mesh__D005331 Fetomaternal Hemorrhages
% 215.45/215.68  |- skos__hiddenLabel mesh__D005331 Hemorrhages, Fetomaternal
% 215.45/215.68  |- mesh__dateEstablished mesh__D005331 1968-01-01
% 215.45/215.68  |- mesh__dateRevised mesh__D005331 1999-11-03
% 215.45/215.68  |- mesh__recordMaintainer mesh__D005331 kle
% 215.45/215.68  |- skos__scopeNote mesh__D005331
% 215.45/215.68       Transplacental passage of fetal blood into the circulation of the maternal organism. %28%Dorland, 27th ed%29%%A%    
% 215.45/215.68  |- rdf__type mesh__D005331sskos__Concept
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D005331 2002
% 215.45/215.68  |- mesh__recordOriginator mesh__D005331 NLM
% 215.45/215.68  |- mesh__dateCreated mesh__D005331 1999-01-01
% 215.45/215.68  |- skos__hiddenLabel mesh__D005331 Fetomaternal Transfusions
% 215.45/215.68  |- skos__annotation mesh__D005331
% 215.45/215.68       transplacental passage of blood from fetus to mother%27%s circ; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; TN 186: differentiate among various %22%transfusion%22% concepts; transfer of immunity from mother to fetus = IMMUNITY, MATERNALLY-ACQUIRED%A%  
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D005331 2006
% 215.45/215.68  |- skos__hiddenLabel mesh__D005331 Transfusion, Fetomaternal
% 215.45/215.68  |- mesh__dateCreated mesh__D046748 2004-07-07
% 215.45/215.68  |- skos__hiddenLabel mesh__D046748 Spinal Epidural Hemorrhage
% 215.45/215.68  |- skos__altLabel mesh__D046748 Hemorrhage, Spinal Epidural
% 215.45/215.68  |- skos__hiddenLabel mesh__D046748 Epidural Hematoma, Spinal
% 215.45/215.68  |- skos__hiddenLabel mesh__D046748 Spinal Epidural Hematomas
% 215.45/215.68  |- mesh__recordMaintainer mesh__D046748 ags
% 215.45/215.68  |- rdf__type mesh__D046748sskos__Concept
% 215.45/215.68  |- mesh__dateEstablished mesh__D046748 2005-01-01
% 215.45/215.68  |- mesh__recordOriginator mesh__D046748 ags
% 215.45/215.68  |- skos__hiddenLabel mesh__D046748 Epidural Hemorrhage, Spinal
% 215.45/215.68  |- skos__broader mesh__D046748smesh__D006406
% 215.45/215.68  |- skos__scopeNote mesh__D046748
% 215.45/215.68       A rare epidural hematoma in the spinal epidural space, usually due to a vascular malformation %28%CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS%29% or TRAUMA. Spontaneous spinal epidural hematoma is a neurologic emergency due to a rapidly evolving compressive MYELOPATHY.%A%    
% 215.45/215.68  |- skos__hiddenLabel mesh__D046748 Epidural Hemorrhages, Spinal
% 215.45/215.68  |- skos__hiddenLabel mesh__D046748 Spinal Epidural Hemorrhages
% 215.45/215.68  |- skos__hiddenLabel mesh__D046748 Hemorrhages, Spinal Epidural
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D046748 2006
% 215.45/215.68  |- skos__hiddenLabel mesh__D046748 Hematomas, Spinal Epidural
% 215.45/215.68  |- skos__altLabel mesh__D046748 Spinal Epidural Hematoma
% 215.45/215.68  |- skos__prefLabel mesh__D046748 Hematoma, Epidural, Spinal
% 215.45/215.68  |- mesh__recordAuthorizer mesh__D046748 sjn
% 215.45/215.68  |- skos__hiddenLabel mesh__D046748 Epidural Hematomas, Spinal
% 215.45/215.68  |- skos__hiddenLabel mesh__D046748 Hematoma, Spinal Epidural
% 215.45/215.68  |- mesh__publicMeSHNote mesh__D046748 2005   
% 215.45/215.68  |- mesh__historyNote mesh__D046748 2005   
% 215.45/215.68  |- skos__historyNote mesh__D046748
% 215.45/215.68       Hematoma, Epidural, Cranial %28%1966-2004%29%
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D046748 2005
% 215.45/215.68  |- mesh__recordOriginator mesh__D018259 AGS
% 215.45/215.68  |- skos__altLabel mesh__D018259 HHV-1
% 215.45/215.68  |- mesh__dateCreated mesh__D018259 1993-06-04
% 215.45/215.68  |- mesh__dateEstablished mesh__D018259 1994-01-01
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D018259 2005
% 215.45/215.68  |- skos__altLabel mesh__D018259 Human herpesvirus 1
% 215.45/215.68  |- mesh__historyNote mesh__D018259 94   
% 215.45/215.68  |- mesh__publicMeSHNote mesh__D018259 94   
% 215.45/215.68  |- skos__altLabel mesh__D018259 Herpes Simplex Virus 1
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D018259 2006
% 215.45/215.68  |- mesh__recordMaintainer mesh__D018259 ags
% 215.45/215.68  |- skos__annotation mesh__D018259
% 215.45/215.68       infection: coord IM with HERPES SIMPLEX %28%IM%29% or its indentions %28%IM%29%; DF: HHV 1%A%  
% 215.45/215.68  |- skos__historyNote mesh__D018259 Simplexvirus %28%1966-1993%29%
% 215.45/215.68  |- skos__broader mesh__D018259smesh__D018139
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D018259 2003
% 215.45/215.68  |- skos__prefLabel mesh__D018259 Herpesvirus 1, Human
% 215.45/215.68  |- skos__altLabel mesh__D018259 Herpesvirus 1 %28%alpha%29%, Human
% 215.45/215.68  |- rdf__type mesh__D018259sskos__Concept
% 215.45/215.68  |- mesh__dateRevised mesh__D018259 2002-07-03
% 215.45/215.68  |- mesh__recordAuthorizer mesh__D018259 sjn
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D018259 2004
% 215.45/215.68  |- skos__altLabel mesh__D018259 HSV-1
% 215.45/215.68  |- skos__scopeNote mesh__D018259
% 215.45/215.68       The type species of SIMPLEXVIRUS causing most forms of non-genital herpes simplex in humans. Primary infection occurs mainly in infants and young children and then the virus becomes latent in the dorsal root ganglion. It then is periodically reactivated throughout life causing mostly benign conditions.%A%    
% 215.45/215.68  |- skos__altLabel mesh__D018259 Herpes Simplex Virus Type 1
% 215.45/215.68  |- mesh__dateRevised mesh__D010276 2005-06-30
% 215.45/215.68  |- mesh__onlineNote mesh__D010276
% 215.45/215.68       use PARASYMPATHOLYTICS to search ANTISPASMODICS %26% SPASMOLYTICS 1970-76; use MUSCLES 1966-69%A%  
% 215.45/215.68  |- mesh__publicMeSHNote mesh__D010276
% 215.45/215.68       ANTISPASMODICS %26% SPASMOLYTICS were see MUSCLE RELAXANTS 1963-69%A%  
% 215.45/215.68  |- mesh__historyNote mesh__D010276
% 215.45/215.68       ANTISPASMODICS %26% SPASMOLYTICS were see MUSCLE RELAXANTS 1963-69%A%  
% 215.45/215.68  |- skos__altLabel mesh__D010276 Antispasmodic Agents
% 215.45/215.68  |- skos__altLabel mesh__D010276 Parasympathetic-Blocking Agents
% 215.45/215.68  |- mesh__recordOriginator mesh__D010276 NLM
% 215.45/215.68  |- mesh__dateCreated mesh__D010276 1999-01-01
% 215.45/215.68  |- skos__annotation mesh__D010276
% 215.45/215.68       GEN or unspecified; prefer specifics; consider also PARASYMPATHETIC NERVOUS SYSTEM /drug eff%A%  
% 215.45/215.68  |- skos__related mesh__D010276smesh__D018727
% 215.45/215.68  |- skos__hiddenLabel mesh__D010276 Agents, Antispasmodic
% 215.45/215.68  |- skos__hiddenLabel mesh__D010276 Agents, Parasympatholytic
% 215.45/215.68  |- skos__altLabel mesh__D010276 Spasmolytics
% 215.45/215.68  |- skos__altLabel mesh__D010276 Parasympatholytic Drugs
% 215.45/215.68  |- skos__prefLabel mesh__D010276 Parasympatholytics
% 215.45/215.68  |- rdf__type mesh__D010276sskos__Concept
% 215.45/215.68  |- skos__scopeNote mesh__D010276
% 215.45/215.68       Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.%A%    
% 215.45/215.68  |- skos__hiddenLabel mesh__D010276 Agents, Parasympathetic-Blocking
% 215.45/215.68  |- mesh__recordMaintainer mesh__D010276 ssb
% 215.45/215.68  |- skos__hiddenLabel mesh__D010276 Parasympathetic Blocking Agents
% 215.45/215.68  |- skos__hiddenLabel mesh__D010276 Drugs, Antispasmodic
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D010276 2006
% 215.45/215.68  |- mesh__recordAuthorizer mesh__D010276 sjn
% 215.45/215.68  |- skos__altLabel mesh__D010276 Antispasmodic Drugs
% 215.45/215.68  |- skos__broader mesh__D010276smesh__D001337
% 215.45/215.68  |- skos__related mesh__D010276smesh__D000978
% 215.45/215.68  |- skos__altLabel mesh__D010276 Parasympatholytic Agents
% 215.45/215.68  |- skos__hiddenLabel mesh__D010276 Drugs, Parasympatholytic
% 215.45/215.68  |- skos__related mesh__D010276smesh__D000897
% 215.45/215.68  |- skos__altLabel mesh__D004239 Colonic Diverticulitis
% 215.45/215.68  |- mesh__recordAuthorizer mesh__D004239 sjn
% 215.45/215.68  |- mesh__dateRevised mesh__D004239 2003-07-09
% 215.45/215.68  |- mesh__recordMaintainer mesh__D004239 lkt
% 215.45/215.68  |- skos__prefLabel mesh__D004239 Diverticulitis, Colonic
% 215.45/215.68  |- skos__annotation mesh__D004239
% 215.45/215.68       do not confuse with DIVERTICULOSIS, COLONIC   
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D004239 2004
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D004239 2006
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D004239 2005
% 215.45/215.68  |- skos__scopeNote mesh__D004239
% 215.45/215.68       Inflammation of the COLONIC DIVERTICULA, generally with abscess formation and subsequent perforation.%A%    
% 215.45/215.68  |- mesh__dateCreated mesh__D004239 1999-01-01
% 215.45/215.68  |- mesh__recordOriginator mesh__D004239 NLM
% 215.45/215.68  |- skos__broader mesh__D004239smesh__D043963
% 215.45/215.68  |- rdf__type mesh__D004239sskos__Concept
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D009722 2005
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D009722 2004
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D009722 1999
% 215.45/215.68  |- mesh__recordAuthorizer mesh__D009722 PLS
% 215.45/215.68  |- rdf__type mesh__D009722sskos__Concept
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D009722 2003
% 215.45/215.68  |- mesh__activeMeSHYear mesh__D009722 1998
% 215.45/215.68  |- skos__hiddenLabel mesh__D009722 Practitioners, Nurse
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D009722 1997
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D009722 2001
% 215.45/215.69  |- mesh__onlineNote mesh__D009722
% 215.45/215.69       use NURSE PRACTITIONERS to search NURSE PRACTITIONER 1973-75%A%  
% 215.45/215.69  |- skos__prefLabel mesh__D009722 Nurse Practitioners
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D009722 1996
% 215.45/215.69  |- skos__broader mesh__D009722smesh__D009726
% 215.45/215.69  |- skos__scopeNote mesh__D009722
% 215.45/215.69       Nurses who are specially trained to assume an expanded role in providing medical care under the supervision of a physician.%A%    
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D009722 2000
% 215.45/215.69  |- mesh__dateRevised mesh__D009722 1992-05-15
% 215.45/215.69  |- mesh__recordOriginator mesh__D009722 SMH
% 215.45/215.69  |- mesh__dateCreated mesh__D009722 1975-07-23
% 215.45/215.69  |- mesh__dateEstablished mesh__D009722 1976-01-01
% 215.45/215.69  |- skos__hiddenLabel mesh__D009722 Practitioner, Nurse
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D009722 1995
% 215.45/215.69  |- mesh__historyNote mesh__D009722 76; was NURSE PRACTITIONER 1973-75   
% 215.45/215.69  |- mesh__publicMeSHNote mesh__D009722 76; was NURSE PRACTITIONER 1973-75   
% 215.45/215.69  |- skos__hiddenLabel mesh__D009722 Nurse Practitioner
% 215.45/215.69  |- mesh__recordMaintainer mesh__D009722 TAP
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D009722 2006
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D009722 1994
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D009722 2002
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D009722 1993
% 215.45/215.69  |- rdf__type mesh__D014667sskos__Concept
% 215.45/215.69  |- mesh__recordMaintainer mesh__D014667 ssb
% 215.45/215.69  |- skos__prefLabel mesh__D014667 Vasopressins
% 215.45/215.69  |- skos__altLabel mesh__D014667 beta-Hypophamine
% 215.45/215.69  |- mesh__recordOriginator mesh__D014667 NLM
% 215.45/215.69  |- skos__related mesh__D014667smesh__D017483
% 215.45/215.69  |- skos__broader mesh__D014667smesh__D036361
% 215.45/215.69  |- mesh__dateRevised mesh__D014667 2005-06-30
% 215.45/215.69  |- mesh__dateCreated mesh__D014667 1999-01-01
% 215.45/215.69  |- skos__broader mesh__D014667smesh__D009479
% 215.45/215.69  |- skos__altLabel mesh__D014667 Antidiuretic Hormones
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D014667 2006
% 215.45/215.69  |- skos__hiddenLabel mesh__D014667 Hormones, Antidiuretic
% 215.45/215.69  |- skos__hiddenLabel mesh__D014667 beta Hypophamine
% 215.45/215.69  |- skos__broader mesh__D014667smesh__D009842
% 215.45/215.69  |- skos__scopeNote mesh__D014667
% 215.45/215.69       Octapeptide antidiuretic hormones released by the NEUROHYPOPHYSIS of all vertebrates %28%chemical composition varies with species%29%. They control water metabolism and balance by regulating LUNG; GILLS; KIDNEY; etc., and water loss, and also contract smooth muscle. They may also be NEUROTRANSMITTERS. Also included are synthetic vasopressin derivatives. Vasopressins are used pharmacologically as renal agents, vasoconstrictor agents, and hemostatics.%A%    
% 215.45/215.69  |- mesh__onlineNote mesh__D014667
% 215.45/215.69       use VASOPRESSINS to search VASOPRESSIN 1966-78   
% 215.45/215.69  |- skos__altLabel mesh__D014667 Vasopressin
% 215.45/215.69  |- skos__related mesh__D014667smesh__D007177
% 215.45/215.69  |- mesh__publicMeSHNote mesh__D014667 79; was VASOPRESSIN 1963-78   
% 215.45/215.69  |- mesh__historyNote mesh__D014667 79; was VASOPRESSIN 1963-78   
% 215.45/215.69  |- skos__broader mesh__D014667smesh__D010909
% 215.45/215.69  |- mesh__recordAuthorizer mesh__D014667 sjn
% 215.45/215.69  |- skos__annotation mesh__D014667
% 215.45/215.69       general or unspecified; prefer specifics; /secret: consider also INAPPROPRIATE ADH SYNDROME%A%  
% 215.45/215.69  |- skos__broader mesh__D003238Q000166smesh__D003238
% 215.45/215.69  |- mesh__preferredCombination mesh__D003238Q000166smesh__D003239
% 215.45/215.69  |- rdf__type mesh__D003238Q000166smesh__CompoundConcept
% 215.45/215.69  |- skos__hiddenLabel mesh__D000647 States, Amnestic
% 215.45/215.69  |- skos__hiddenLabel mesh__D000647 Amnestic States
% 215.45/215.69  |- skos__hiddenLabel mesh__D000647 Amnesias
% 215.45/215.69  |- skos__hiddenLabel mesh__D000647 Tactile Amnesia
% 215.45/215.69  |- mesh__dateRevised mesh__D000647 2003-07-25
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D000647 2006
% 215.45/215.69  |- skos__hiddenLabel mesh__D000647 Hysterical Amnesias
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D000647 2004
% 215.45/215.69  |- skos__hiddenLabel mesh__D000647 Hysterical Amnesia
% 215.45/215.69  |- skos__hiddenLabel mesh__D000647 Tactile Amnesias
% 215.45/215.69  |- skos__hiddenLabel mesh__D000647 State, Amnestic
% 215.45/215.69  |- skos__hiddenLabel mesh__D000647 Amnesias, Tactile
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D000647 2005
% 215.45/215.69  |- skos__hiddenLabel mesh__D000647 Temporary Amnesias
% 215.45/215.69  |- skos__hiddenLabel mesh__D000647 Amnesias, Dissociative
% 215.45/215.69  |- skos__altLabel mesh__D000647 Amnesia-Memory Loss
% 215.45/215.69  |- skos__hiddenLabel mesh__D000647 Temporary Amnesia
% 215.45/215.69  |- mesh__recordAuthorizer mesh__D000647 sjn
% 215.45/215.69  |- skos__hiddenLabel mesh__D000647 Dissociative Amnesia
% 215.45/215.69  |- skos__scopeNote mesh__D000647
% 215.45/215.69       Pathologic partial or complete loss of the ability to recall past experiences %28%AMNESIA, RETROGRADE%29% or to form new memories %28%AMNESIA, ANTEROGRADE%29%. This condition may be of organic or psychologic origin. Organic forms of amnesia are usually associated with dysfunction of the DIENCEPHALON or HIPPOCAMPUS. %28%From Adams et al., Principles of Neurology, 6th ed, pp426-7%29%%A%    
% 215.45/215.69  |- skos__broader mesh__D000647smesh__D019965
% 215.45/215.69  |- mesh__recordOriginator mesh__D000647 NLM
% 215.45/215.69  |- mesh__dateCreated mesh__D000647 1999-01-01
% 215.45/215.69  |- skos__broader mesh__D000647smesh__D008569
% 215.45/215.69  |- skos__hiddenLabel mesh__D000647 Global Amnesias
% 215.45/215.69  |- skos__hiddenLabel mesh__D000647 Amnesia Memory Loss
% 215.45/215.69  |- skos__hiddenLabel mesh__D000647 Amnesias, Hysterical
% 215.45/215.69  |- mesh__recordMaintainer mesh__D000647 sjn
% 215.45/215.69  |- skos__hiddenLabel mesh__D000647 Amnesias, Global
% 215.45/215.69  |- skos__prefLabel mesh__D000647 Amnesia
% 215.45/215.69  |- rdf__type mesh__D000647sskos__Concept
% 215.45/215.69  |- skos__hiddenLabel mesh__D000647 Dissociative Amnesias
% 215.45/215.69  |- skos__hiddenLabel mesh__D000647 Amnesia-Memory Losses
% 215.45/215.69  |- skos__hiddenLabel mesh__D000647 Amnesias, Temporary
% 215.45/215.69  |- skos__hiddenLabel mesh__D000647 Global Amnesia
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D019352 2003
% 215.45/215.69  |- skos__broader mesh__D019352smesh__D003710
% 215.45/215.69  |- mesh__historyNote mesh__D019352 97; CENSUS was see DEMOGRAPHY 1990-96   
% 215.45/215.69  |- skos__scopeNote mesh__D019352
% 215.45/215.69       Enumerations of populations usually recording identities of all persons in every place of residence with age or date of birth, sex, occupation, national origin, language, marital status, income, relation to head of household, information on the dwelling place, education, literacy, health-related data %28%e.g., permanent disability%29%, etc. The census or %22%numbering of the people%22% is mentioned several times in the Old Testament. Among the Romans, censuses were intimately connected with the enumeration of troops before and after battle and probably a military necessity. %28%From Last, A Dictionary of Epidemiology, 3d ed; Garrison, An Introduction to the History of Medicine, 4th ed, p66, p119%29%%A%    
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D019352 2004
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D019352 2001
% 215.45/215.69  |- mesh__dateEstablished mesh__D019352 1997-01-01
% 215.45/215.69  |- skos__hiddenLabel mesh__D019352 Census Method
% 215.45/215.69  |- mesh__dateCreated mesh__D019352 1996-06-10
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D019352 2002
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D019352 1997
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D019352 2005
% 215.45/215.69  |- skos__historyNote mesh__D019352 Demography %28%1966-1996%29%
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D019352 2006
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D019352 1998
% 215.45/215.69  |- mesh__publicMeSHNote mesh__D019352
% 215.45/215.69       97; CENSUS was see DEMOGRAPHY 1990-96   
% 215.45/215.69  |- skos__annotation mesh__D019352
% 215.45/215.69       for modern %26% hist censuses; IM; specify geog   
% 215.45/215.69  |- skos__prefLabel mesh__D019352 Censuses
% 215.45/215.69  |- rdf__type mesh__D019352sskos__Concept
% 215.45/215.69  |- skos__hiddenLabel mesh__D019352 Methods, Census
% 215.45/215.69  |- mesh__onlineNote mesh__D019352
% 215.45/215.69       use DEMOGRAPHY to search CENSUS 1990-96   
% 215.45/215.69  |- skos__altLabel mesh__D019352 Census
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D019352 1999
% 215.45/215.69  |- skos__hiddenLabel mesh__D019352 Method, Census
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D019352 2000
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D033023 2006
% 215.45/215.69  |- mesh__dateEstablished mesh__D033023 2003-01-01
% 215.45/215.69  |- skos__historyNote mesh__D033023 specific foot joints %28%1976-2002%29%
% 215.45/215.69  |- mesh__recordOriginator mesh__D033023 ags
% 215.45/215.69  |- skos__annotation mesh__D033023 prefer specifics   
% 215.45/215.69  |- skos__altLabel mesh__D033023 Articulationes pedis
% 215.45/215.69  |- mesh__dateCreated mesh__D033023 2002-07-02
% 215.45/215.69  |- skos__hiddenLabel mesh__D033023 Joint, Intermetatarsal
% 215.45/215.69  |- skos__historyNote mesh__D033023 Tarsal Joints %28%1973-2002%29%
% 215.45/215.69  |- mesh__recordAuthorizer mesh__D033023 sjn
% 215.45/215.69  |- mesh__publicMeSHNote mesh__D033023
% 215.45/215.69       2003; for INTERMETATARSAL JOINT see TARSAL JOINTS 1965-2005; for FOOT JOINT see TARSAL JOINTS 1975-2002%A%  
% 215.45/215.69  |- mesh__historyNote mesh__D033023
% 215.45/215.69       2003; for INTERMETATARSAL JOINT use TARSAL JOINTS 1965-2005; for FOOT JOINT use TARSAL JOINTS 1975-2002%A%  
% 215.45/215.69  |- skos__hiddenLabel mesh__D033023 Foot Joint
% 215.45/215.69  |- mesh__dateRevised mesh__D033023 2005-06-30
% 215.45/215.69  |- skos__scopeNote mesh__D033023
% 215.45/215.69       The articulations extending from the ANKLE distally to the TOES. These include the ANKLE JOINT; TARSAL JOINTS; METATARSOPHALANGEAL JOINT; and TOE JOINT.%A%    
% 215.45/215.69  |- skos__hiddenLabel mesh__D033023 Joints, Foot
% 215.45/215.69  |- rdf__type mesh__D033023sskos__Concept
% 215.45/215.69  |- skos__prefLabel mesh__D033023 Foot Joints
% 215.45/215.69  |- skos__hiddenLabel mesh__D033023 Joints, Intermetatarsal
% 215.45/215.69  |- mesh__recordMaintainer mesh__D033023 ags
% 215.45/215.69  |- skos__hiddenLabel mesh__D033023 Intermetatarsal Joints
% 215.45/215.69  |- skos__broader mesh__D033023smesh__D007596
% 215.45/215.69  |- skos__hiddenLabel mesh__D033023 Joint, Foot
% 215.45/215.69  |- rdf__type mesh__D005332sskos__Concept
% 215.45/215.69  |- skos__historyNote mesh__D005332 Prenatal Diagnosis %28%1973-1976%29%
% 215.45/215.69  |- skos__broader mesh__D005332smesh__D013513
% 215.45/215.69  |- skos__altLabel mesh__D005332 Amnioscopic Surgery
% 215.45/215.69  |- skos__hiddenLabel mesh__D005332 Amnioscopic Surgeries
% 215.45/215.69  |- skos__scopeNote mesh__D005332
% 215.45/215.69       Endoscopic examination, therapy or surgery of the fetus and amniotic cavity through abdominal or uterine entry.%A%    
% 215.45/215.69  |- skos__hiddenLabel mesh__D005332 Embryoscopic Surgical Procedure
% 215.45/215.69  |- skos__related mesh__D005332smesh__D000650
% 215.45/215.69  |- skos__hiddenLabel mesh__D005332 Fetoscopic Surgical Procedure
% 215.45/215.69  |- skos__broader mesh__D005332smesh__D046128
% 215.45/215.69  |- skos__hiddenLabel mesh__D005332 Fetoscopic Surgeries
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D005332 2005
% 215.45/215.69  |- skos__altLabel mesh__D005332 Surgery, Amnioscopic
% 215.45/215.69  |- skos__altLabel mesh__D005332 Surgery, Fetoscopic
% 215.45/215.69  |- mesh__historyNote mesh__D005332 1991%28%1971%29%   
% 215.45/215.69  |- skos__hiddenLabel mesh__D005332 Surgical Procedure, Embryoscopic
% 215.45/215.69  |- skos__hiddenLabel mesh__D005332 Surgical Procedure, Fetoscopic
% 215.45/215.69  |- skos__altLabel mesh__D005332 Surgical Procedures, Embryoscopic
% 215.45/215.69  |- skos__altLabel mesh__D005332 Surgical Procedures, Fetoscopic
% 215.45/215.69  |- skos__hiddenLabel mesh__D005332 Amnioscopies
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D005332 2006
% 215.45/215.69  |- skos__broader mesh__D005332smesh__D011296
% 215.45/215.69  |- skos__hiddenLabel mesh__D005332 Procedures, Embryoscopic Surgical
% 215.45/215.69  |- mesh__dateEstablished mesh__D005332 1991-01-01
% 215.45/215.69  |- skos__hiddenLabel mesh__D005332 Embryoscopies
% 215.45/215.69  |- skos__broader mesh__D005332smesh__D004724
% 215.45/215.69  |- skos__hiddenLabel mesh__D005332 Surgeries, Amnioscopic
% 215.45/215.69  |- skos__historyNote mesh__D005332 Endoscopy %28%1966-1976%29%
% 215.45/215.69  |- skos__altLabel mesh__D005332 Embryoscopic Surgery
% 215.45/215.69  |- skos__hiddenLabel mesh__D005332 Procedures, Amnioscopic Surgical
% 215.45/215.69  |- mesh__recordOriginator mesh__D005332 SMH
% 215.45/215.69  |- skos__hiddenLabel mesh__D005332 Procedure, Fetoscopic Surgical
% 215.45/215.69  |- skos__hiddenLabel mesh__D005332 Amnioscopic Surgical Procedure
% 215.45/215.69  |- mesh__dateRevised mesh__D005332 2004-07-07
% 215.45/215.69  |- skos__hiddenLabel mesh__D005332 Surgeries, Fetoscopic
% 215.45/215.69  |- skos__hiddenLabel mesh__D005332 Procedure, Embryoscopic Surgical
% 215.45/215.69  |- skos__hiddenLabel mesh__D005332 Surgeries, Embryoscopic
% 215.45/215.69  |- mesh__publicMeSHNote mesh__D005332
% 215.45/215.69       1991; see PRENATAL DIAGNOSIS 1977-1990; for AMNIOSCOPY see AMNIOSCOPY 1971-1999%A%  
% 215.45/215.69  |- mesh__dateCreated mesh__D005332 1976-04-13
% 215.45/215.69  |- mesh__recordMaintainer mesh__D005332 lkt
% 215.45/215.69  |- skos__altLabel mesh__D005332 Surgical Procedures, Amnioscopic
% 215.45/215.69  |- skos__hiddenLabel mesh__D005332 Embryoscopic Surgeries
% 215.45/215.69  |- skos__hiddenLabel mesh__D005332 Fetoscopies
% 215.45/215.69  |- skos__related mesh__D005332smesh__D000653
% 215.45/215.69  |- mesh__recordAuthorizer mesh__D005332 sjn
% 215.45/215.69  |- skos__hiddenLabel mesh__D005332 Surgical Procedure, Amnioscopic
% 215.45/215.69  |- skos__prefLabel mesh__D005332 Fetoscopy
% 215.45/215.69  |- skos__hiddenLabel mesh__D005332 Procedures, Fetoscopic Surgical
% 215.45/215.69  |- skos__hiddenLabel mesh__D005332 Procedure, Amnioscopic Surgical
% 215.45/215.69  |- skos__altLabel mesh__D005332 Surgery, Embryoscopic
% 215.45/215.69  |- skos__altLabel mesh__D005332 Fetoscopic Surgery
% 215.45/215.69  |- mesh__recordAuthorizer mesh__D046749 sjn
% 215.45/215.69  |- skos__scopeNote mesh__D046749
% 215.45/215.69       The family Sturnidae, in the order PASSERIFORMES. The starling family also includes mynahs and oxpeckers.%A%    
% 215.45/215.69  |- mesh__historyNote mesh__D046749 2005   
% 215.45/215.69  |- mesh__recordMaintainer mesh__D046749 ags
% 215.45/215.69  |- rdf__type mesh__D046749sskos__Concept
% 215.45/215.69  |- skos__altLabel mesh__D046749 Oxpeckers
% 215.45/215.69  |- skos__historyNote mesh__D046749 Birds %28%1964-1998%29%
% 215.45/215.69  |- skos__hiddenLabel mesh__D046749 Oxpecker
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D046749 2006
% 215.45/215.69  |- skos__hiddenLabel mesh__D046749 Mynah
% 215.45/215.69  |- skos__altLabel mesh__D046749 Sturnidae
% 215.45/215.69  |- skos__broader mesh__D046749smesh__D020308
% 215.45/215.69  |- skos__prefLabel mesh__D046749 Starlings
% 215.45/215.69  |- mesh__recordOriginator mesh__D046749 ags
% 215.45/215.69  |- mesh__dateEstablished mesh__D046749 2005-01-01
% 215.45/215.69  |- skos__hiddenLabel mesh__D046749 Starling
% 215.45/215.69  |- mesh__publicMeSHNote mesh__D046749 2005   
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D046749 2005
% 215.45/215.69  |- mesh__dateCreated mesh__D046749 2004-07-07
% 215.45/215.69  |- skos__historyNote mesh__D046749 Songbirds %28%1999-2004%29%
% 215.45/215.69  |- skos__altLabel mesh__D029780 Cypress, Yellow
% 215.45/215.69  |- skos__prefLabel mesh__D029780 Chamaecyparis
% 215.45/215.69  |- skos__altLabel mesh__D029780 Cypress, Lawson%27%s False
% 215.45/215.69  |- mesh__dateCreated mesh__D029780 2001-07-25
% 215.45/215.69  |- mesh__dateRevised mesh__D029780 2002-07-02
% 215.45/215.69  |- mesh__historyNote mesh__D029780 2002   
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D029780 2005
% 215.45/215.69  |- skos__broader mesh__D029780smesh__D029779
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D029780 2006
% 215.45/215.69  |- skos__annotation mesh__D029780
% 215.45/215.69       note X refs containing cedar and cypress: check text to distinguish from other cedar and cypress terms in MeSH; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.45/215.69  |- mesh__publicMeSHNote mesh__D029780 2002   
% 215.45/215.69  |- skos__scopeNote mesh__D029780
% 215.45/215.69       A plant genus of the family CUPRESSACEAE which should not be confused with other cedar and cypress trees of THUJA or CUPRESSUS genera.%A%    
% 215.45/215.69  |- rdf__type mesh__D029780sskos__Concept
% 215.45/215.69  |- skos__altLabel mesh__D029780 Cedar, Yellow
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D029780 2003
% 215.45/215.69  |- skos__altLabel mesh__D029780 Lawson%27%s False Cypress
% 215.45/215.69  |- skos__altLabel mesh__D029780 Hinoki Cypress
% 215.45/215.69  |- skos__altLabel mesh__D029780 Atlantic White Cedar
% 215.45/215.69  |- mesh__dateEstablished mesh__D029780 2002-01-01
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D029780 2004
% 215.45/215.69  |- skos__altLabel mesh__D029780 Cedar, Atlantic White
% 215.45/215.69  |- rdf__type mesh__D010277sskos__Concept
% 215.45/215.69  |- skos__related mesh__D010277smesh__D002800
% 215.45/215.69  |- mesh__recordMaintainer mesh__D010277 ssb
% 215.45/215.69  |- skos__annotation mesh__D010277
% 215.45/215.69       GEN or unspecified; prefer specifics; consider also PARASYMPATHETIC NERVOUS SYSTEM /drug eff%A%  
% 215.45/215.69  |- mesh__recordAuthorizer mesh__D010277 sjn
% 215.45/215.69  |- skos__prefLabel mesh__D010277 Parasympathomimetics
% 215.45/215.69  |- skos__related mesh__D010277smesh__D018721
% 215.45/215.69  |- skos__broader mesh__D010277smesh__D001337
% 215.45/215.69  |- skos__altLabel mesh__D010277 Parasympathomimetic Drugs
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D010277 2006
% 215.45/215.69  |- mesh__dateRevised mesh__D010277 2005-06-30
% 215.45/215.69  |- skos__altLabel mesh__D010277 Parasympathomimetic Agents
% 215.45/215.69  |- skos__scopeNote mesh__D010277
% 215.45/215.69       Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine %28%CHOLINESTERASE INHIBITORS%29%. Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons %28%GANGLIONIC STIMULANTS%29% are not included here.%A%    
% 215.45/215.69  |- mesh__recordOriginator mesh__D010277 NLM
% 215.45/215.69  |- skos__hiddenLabel mesh__D010277 Agents, Parasympathomimetic
% 215.45/215.69  |- mesh__dateCreated mesh__D010277 1999-01-01
% 215.45/215.69  |- skos__hiddenLabel mesh__D010277 Drugs, Parasympathomimetic
% 215.45/215.69  |- skos__altLabel mesh__D015760 Janssen Brand of Alfentanil Hydrochloride
% 215.45/215.69  |- skos__altLabel mesh__D015760 Alfentanyl
% 215.45/215.69  |- mesh__recordMaintainer mesh__D015760 mdb
% 215.45/215.69  |- skos__altLabel mesh__D015760 ICI Brand of Alfentanil Hydrochloride
% 215.45/215.69  |- skos__scopeNote mesh__D015760
% 215.45/215.69       A short-acting opioid anesthetic and analgesic derivative of FENTANYL. It produces an early peak analgesic effect and fast recovery of consciousness. Alfentanil is effective as an anesthetic during surgery, for supplementation of analgesia during surgical procedures, and as an analgesic for critically ill patients.%A%    
% 215.45/215.69  |- mesh__recordOriginator mesh__D015760 RLS
% 215.45/215.69  |- skos__altLabel mesh__D015760 Alfenta
% 215.45/215.69  |- mesh__dateCreated mesh__D015760 1989-05-15
% 215.45/215.69  |- mesh__historyNote mesh__D015760 90   
% 215.45/215.69  |- rdf__type mesh__D015760sskos__Concept
% 215.45/215.69  |- skos__hiddenLabel mesh__D015760 R39209
% 215.45/215.69  |- skos__hiddenLabel mesh__D015760 R 39209
% 215.45/215.69  |- skos__historyNote mesh__D015760
% 215.45/215.69       Fentanyl/analogs %26% derivatives %28%1966-1989%29%
% 215.45/215.69  |- skos__broader mesh__D015760smesh__D005283
% 215.45/215.69  |- mesh__dateRevised mesh__D015760 2004-07-07
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D015760 2005
% 215.45/215.69  |- mesh__dateEstablished mesh__D015760 1990-01-01
% 215.45/215.69  |- mesh__publicMeSHNote mesh__D015760 90   
% 215.45/215.69  |- skos__altLabel mesh__D015760 Esteve Brand of Alfentanil Hydrochloride
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D015760 2006
% 215.45/215.69  |- mesh__recordAuthorizer mesh__D015760 sjn
% 215.45/215.69  |- skos__prefLabel mesh__D015760 Alfentanil
% 215.45/215.69  |- skos__altLabel mesh__D015760 Limifen
% 215.45/215.69  |- skos__broader mesh__D009723smesh__D011369
% 215.45/215.69  |- mesh__dateRevised mesh__D009723 2002-10-31
% 215.45/215.69  |- mesh__dateCreated mesh__D009723 1999-01-01
% 215.45/215.69  |- skos__scopeNote mesh__D009723
% 215.45/215.69       Interaction between the patient and nurse.     
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D009723 2002
% 215.45/215.69  |- mesh__recordMaintainer mesh__D009723 jls
% 215.45/215.69  |- skos__hiddenLabel mesh__D009723 Patient Relationship, Nurse
% 215.45/215.69  |- skos__prefLabel mesh__D009723 Nurse-Patient Relations
% 215.45/215.69  |- skos__hiddenLabel mesh__D009723 Nurse-Patient Relation
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D009723 2006
% 215.45/215.69  |- skos__hiddenLabel mesh__D009723 Relationships, Nurse Patient
% 215.45/215.69  |- skos__hiddenLabel mesh__D009723 Relationship, Nurse Patient
% 215.45/215.69  |- skos__altLabel mesh__D009723 Nurse Patient Relations
% 215.45/215.69  |- skos__hiddenLabel mesh__D009723 Patient Relationships, Nurse
% 215.45/215.69  |- skos__hiddenLabel mesh__D009723 Patient Relations, Nurse
% 215.45/215.69  |- skos__hiddenLabel mesh__D009723 Nurse Patient Relationships
% 215.45/215.69  |- skos__altLabel mesh__D009723 Nurse Patient Relationship
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D009723 2005
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D009723 2003A
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D009723 2004
% 215.45/215.69  |- mesh__recordAuthorizer mesh__D009723 jls
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D009723 2001
% 215.45/215.69  |- mesh__recordOriginator mesh__D009723 NLM
% 215.45/215.69  |- skos__hiddenLabel mesh__D009723 Relations, Nurse-Patient
% 215.45/215.69  |- rdf__type mesh__D009723sskos__Concept
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D009723 2003
% 215.45/215.69  |- skos__annotation mesh__D009723 no qualif; DF: NURSE PATIENT RELAT   
% 215.45/215.69  |- skos__hiddenLabel mesh__D009723 Relations, Nurse Patient
% 215.45/215.69  |- mesh__dateEstablished mesh__D001740 1991-01-01
% 215.45/215.69  |- mesh__dateCreated mesh__D001740 1974-12-12
% 215.45/215.69  |- mesh__publicMeSHNote mesh__D001740 91; was see under SPIDERS 1975-90   
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D001740 2006
% 215.45/215.69  |- skos__prefLabel mesh__D001740 Black Widow Spider
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D001740 2005
% 215.45/215.69  |- skos__scopeNote mesh__D001740
% 215.45/215.69       A venomous New World spider with an hourglass-shaped red mark on the abdomen.%A%    
% 215.45/215.69  |- skos__altLabel mesh__D001740 Latrodectus mactans
% 215.45/215.69  |- rdf__type mesh__D001740sskos__Concept
% 215.45/215.69  |- mesh__dateRevised mesh__D001740 2003-07-09
% 215.45/215.69  |- skos__broader mesh__D001740smesh__D013112
% 215.45/215.69  |- mesh__recordOriginator mesh__D001740 NLM
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D001740 2004
% 215.45/215.69  |- mesh__recordMaintainer mesh__D001740 ags
% 215.45/215.69  |- mesh__recordAuthorizer mesh__D001740 sjn
% 215.45/215.69  |- mesh__historyNote mesh__D001740
% 215.45/215.69       91%28%75%29%; was see under SPIDERS 1975-90   
% 215.45/215.69  |- skos__annotation mesh__D001740
% 215.45/215.69       /microbiol /parasitol /virol permitted; bite: coord IM with ARACHNIDISM %28%IM%29%%A%  
% 215.45/215.69  |- mesh__publicMeSHNote mesh__D014668 73   
% 215.45/215.69  |- rdf__type mesh__D014668sskos__Concept
% 215.45/215.69  |- mesh__dateCreated mesh__D014668 1999-01-01
% 215.45/215.69  |- skos__altLabel mesh__D014668 Vasopressin, Non-Mammalian
% 215.45/215.69  |- mesh__recordMaintainer mesh__D014668 ssb
% 215.45/215.69  |- skos__altLabel mesh__D014668 Argiprestocine
% 215.45/215.69  |- skos__hiddenLabel mesh__D014668 Vasopressin, Non Mammalian
% 215.45/215.69  |- mesh__recordAuthorizer mesh__D014668 sjn
% 215.45/215.69  |- skos__prefLabel mesh__D014668 Vasotocin
% 215.45/215.69  |- skos__altLabel mesh__D014668 Arginine Oxytocin
% 215.45/215.69  |- skos__hiddenLabel mesh__D014668 Isoleucyl Vasopressin
% 215.45/215.69  |- skos__altLabel mesh__D014668 Arginine Vasotocin
% 215.45/215.69  |- skos__scopeNote mesh__D014668
% 215.45/215.69       Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly, cyclic 1-6 disulfide. The non-mammalian hormone that controls water and salt metabolism. It is the phylogenetic precursor of both ANTIDIURETIC HORMONES and OXYTOCIN and a possible neuroendocrine mediator in mammals. Vasotocin has oxytocic and vasopressor actions.%A%    
% 215.45/215.69  |- skos__altLabel mesh__D014668 Argiprestocin
% 215.45/215.69  |- skos__hiddenLabel mesh__D014668 Vasotocin, Arginine
% 215.45/215.69  |- skos__hiddenLabel mesh__D014668 Vasopressin, 3-Isoleucyl
% 215.45/215.69  |- skos__altLabel mesh__D014668 3-Isoleucyl Vasopressin
% 215.45/215.69  |- skos__altLabel mesh__D014668 %28%8-Arginine%29%Oxytocin
% 215.45/215.69  |- skos__hiddenLabel mesh__D014668 Non-Mammalian Vasopressin
% 215.45/215.69  |- mesh__recordOriginator mesh__D014668 NLM
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D014668 2006
% 215.45/215.69  |- skos__broader mesh__D014668smesh__D010909
% 215.45/215.69  |- skos__altLabel mesh__D014668 Vasopressin, Isoleucyl
% 215.45/215.69  |- skos__broader mesh__D014668smesh__D014667
% 215.45/215.69  |- mesh__dateRevised mesh__D014668 2005-06-30
% 215.45/215.69  |- mesh__dateEstablished mesh__D014668 1973-01-01
% 215.45/215.69  |- mesh__historyNote mesh__D014668 73%28%63%29%   
% 215.45/215.69  |- skos__hiddenLabel mesh__D014668 Oxytocin, Arginine
% 215.45/215.69  |- skos__hiddenLabel mesh__D014668 3 Isoleucyl Vasopressin
% 215.45/215.69  |- mesh__historyNote mesh__D019353 97   
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D019353 2004
% 215.45/215.69  |- skos__historyNote mesh__D019353
% 215.45/215.69       specific disease/epidemiology %28%1966-1996%29%
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D019353 2000
% 215.45/215.69  |- mesh__recordMaintainer mesh__D019353 jls
% 215.45/215.69  |- mesh__dateRevised mesh__D019353 2004-07-22
% 215.45/215.69  |- mesh__publicMeSHNote mesh__D019353 97   
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D019353 2005
% 215.45/215.69  |- skos__broader mesh__D019353smesh__D011634
% 215.45/215.69  |- skos__annotation mesh__D019353
% 215.45/215.69       note category; do not confuse with epidemic dis %28% = EPIDEMICS see DISEASE OUTBREAKS%29%; IM; coord IM with specific dis /epidemiol %28%IM%29% %26% specify geog; DF: ENDEMIC DIS%A%  
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D019353 2006
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D019353 2001
% 215.45/215.69  |- mesh__recordOriginator mesh__D019353 TGC
% 215.45/215.69  |- mesh__dateEstablished mesh__D019353 1997-01-01
% 215.45/215.69  |- mesh__recordAuthorizer mesh__D019353 jls
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D019353 2005A
% 215.45/215.69  |- rdf__type mesh__D019353sskos__Concept
% 215.45/215.69  |- mesh__dateCreated mesh__D019353 1996-06-10
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D019353 2002
% 215.45/215.69  |- skos__prefLabel mesh__D019353 Endemic Diseases
% 215.45/215.69  |- skos__hiddenLabel mesh__D019353 Disease, Endemic
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D019353 2003
% 215.45/215.69  |- skos__hiddenLabel mesh__D019353 Endemic Disease
% 215.45/215.69  |- skos__hiddenLabel mesh__D019353 Diseases, Endemic
% 215.45/215.69  |- skos__scopeNote mesh__D019353
% 215.45/215.69       The constant presence of diseases or infectious agents within a given geographic area or population group. It may also refer to the usual prevalence of a given disease with such area or group. It includes holoendemic and hyperendemic diseases. A holoendemic disease is one for which a high prevalent level of infection begins early in life and affects most of the child population, leading to a state of equilibrium such that the adult population shows evidence of the disease much less commonly than do children %28%malaria in many communities is a holoendemic disease%29%. A hyperendemic disease is one that is constantly present at a high incidence and/or prevalence rate and affects all groups equally. %28%Last, A Dictionary of Epidemiology, 3d ed, p53, 78, 80%29%%A%    
% 215.45/215.69  |- mesh__dateCreated mesh__D000648 1975-07-21
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D000648 2002
% 215.45/215.69  |- skos__broader mesh__D000648smesh__D000647
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D000648 2004
% 215.45/215.69  |- skos__hiddenLabel mesh__D000648 Amnesias, Pre-Ictal
% 215.45/215.69  |- skos__hiddenLabel mesh__D000648 Amnesia, Pre Ictal
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D000648 2005
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D000648 2000A
% 215.45/215.69  |- mesh__recordOriginator mesh__D000648 EC
% 215.45/215.69  |- mesh__activeMeSHYear mesh__D000648 2003
% 215.45/215.69  |- skos__hiddenLabel mesh__D000648 Retrograde Amnesias
% 215.45/215.69  |- skos__prefLabel mesh__D000648 Amnesia, Retrograde
% 215.45/215.69  |- mesh__recordMaintainer mesh__D000648 ags
% 215.45/215.69  |- mesh__recordAuthorizer mesh__D000648 ags
% 215.45/215.69  |- skos__hiddenLabel mesh__D000648 Memory Loss, Pre-Ictal
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D000648 2001
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D000648 2000
% 215.45/215.70  |- mesh__publicMeSHNote mesh__D000648
% 215.45/215.70       1991; was see under AMNESIA 1976-1990   
% 215.45/215.70  |- rdf__type mesh__D000648sskos__Concept
% 215.45/215.70  |- skos__hiddenLabel mesh__D000648 Memory Losses, Retrograde
% 215.45/215.70  |- skos__hiddenLabel mesh__D000648 Memory Losses, Pre-Ictal
% 215.45/215.70  |- mesh__dateRevised mesh__D000648 1999-11-23
% 215.45/215.70  |- mesh__dateEstablished mesh__D000648 1991-01-01
% 215.45/215.70  |- skos__hiddenLabel mesh__D000648 Pre-Ictal Amnesia
% 215.45/215.70  |- skos__hiddenLabel mesh__D000648 Retrograde Memory Loss
% 215.45/215.70  |- mesh__historyNote mesh__D000648
% 215.45/215.70       1991%28%1976%29%; was see under AMNESIA 1976-1990   
% 215.45/215.70  |- skos__hiddenLabel mesh__D000648 Pre-Ictal Amnesias
% 215.45/215.70  |- skos__hiddenLabel mesh__D000648 Amnesias, Retrograde
% 215.45/215.70  |- skos__historyNote mesh__D000648 Amnesia %28%1966-1975%29%
% 215.45/215.70  |- skos__hiddenLabel mesh__D000648 Pre Ictal Memory Loss
% 215.45/215.70  |- skos__scopeNote mesh__D000648
% 215.45/215.70       Loss of the ability to recall information that had been previously encoded in memory prior to a specified or approximate point in time. This process may be organic or psychogenic in origin. Organic forms may be associated with CRANIOCEREBRAL TRAUMA; CEREBROVASCULAR ACCIDENTS; SEIZURES; DEMENTIA; and a wide variety of other conditions that impair cerebral function. %28%From Adams et al., Principles of Neurology, 6th ed, pp426-9%29%%A%    
% 215.45/215.70  |- skos__hiddenLabel mesh__D000648 Retrograde Memory Losses
% 215.45/215.70  |- skos__altLabel mesh__D000648 Retrograde Amnesia
% 215.45/215.70  |- skos__hiddenLabel mesh__D000648 Pre-Ictal Memory Losses
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D000648 2006
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D011370 1996
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D011370 1998
% 215.45/215.70  |- mesh__dateEstablished mesh__D011370 1991-01-01
% 215.45/215.70  |- mesh__dateRevised mesh__D011370 1995-06-08
% 215.45/215.70  |- skos__scopeNote mesh__D011370
% 215.45/215.70       3,6-Diaminoacridine. Topical antiseptic used mainly in wound dressings.%A%    
% 215.45/215.70  |- rdf__type mesh__D011370sskos__Concept
% 215.45/215.70  |- skos__prefLabel mesh__D011370 Proflavine
% 215.45/215.70  |- skos__broader mesh__D011370smesh__D000609
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D011370 1997
% 215.45/215.70  |- mesh__dateCreated mesh__D011370 1974-11-19
% 215.45/215.70  |- skos__hiddenLabel mesh__D011370 Hemisulfate, Proflavine
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D011370 2000
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D011370 1999
% 215.45/215.70  |- mesh__publicMeSHNote mesh__D011370
% 215.45/215.70       91; was see under ACRIDINES 1975-90   
% 215.45/215.70  |- mesh__historyNote mesh__D011370
% 215.45/215.70       91%28%75%29%; was see under ACRIDINES 1975-90   
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D011370 2003
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D011370 2001
% 215.45/215.70  |- skos__annotation mesh__D011370 an anti-infective   
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D011370 2005
% 215.45/215.70  |- skos__historyNote mesh__D011370 Acridines %28%1969-1974%29%
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D011370 2004
% 215.45/215.70  |- skos__historyNote mesh__D011370 Diamines %28%1974%29%
% 215.45/215.70  |- skos__altLabel mesh__D011370 Proflavin
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D011370 2006
% 215.45/215.70  |- mesh__recordOriginator mesh__D011370 NLM
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D011370 2002
% 215.45/215.70  |- mesh__recordAuthorizer mesh__D011370 PLS
% 215.45/215.70  |- mesh__recordMaintainer mesh__D011370 JRT
% 215.45/215.70  |- skos__hiddenLabel mesh__D005333 Fetal Tissues
% 215.45/215.70  |- skos__altLabel mesh__D005333 Fetuses
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D005333 2005A
% 215.45/215.70  |- skos__related mesh__D005333smesh__D005332
% 215.45/215.70  |- mesh__historyNote mesh__D005333
% 215.45/215.70       PRENATAL INFLUENCES was heading 1963-72   
% 215.45/215.70  |- mesh__publicMeSHNote mesh__D005333
% 215.45/215.70       PRENATAL INFLUENCES was heading 1963-72   
% 215.45/215.70  |- skos__related mesh__D005333smesh__D005865
% 215.45/215.70  |- skos__related mesh__D005333smesh__D008431
% 215.45/215.70  |- skos__hiddenLabel mesh__D005333 Tissues, Fetal
% 215.45/215.70  |- skos__prefLabel mesh__D005333 Fetus
% 215.45/215.70  |- rdf__type mesh__D005333sskos__Concept
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D005333 2005
% 215.45/215.70  |- skos__related mesh__D005333smesh__D033042
% 215.45/215.70  |- skos__hiddenLabel mesh__D005333 Tissue, Fetal
% 215.45/215.70  |- mesh__dateRevised mesh__D005333 2004-10-20
% 215.45/215.70  |- mesh__recordMaintainer mesh__D005333 sjn
% 215.45/215.70  |- skos__annotation mesh__D005333
% 215.45/215.70       mammalian only; human: 3d month to term; fetus in fetu: index under FETUS /abnorm; FETUS and PREGNANCY: Manual 18.4.3, 21.55; definition %26% use: 21.53; specialty for fetus %26% newborn inf = PERINATOLOGY; retained fetus: index under ABORTION, MISSED; for mummified fetus, consider also ABORTION, MISSED; lithopedion: coord FETUS %28%IM%29% + CALCINOSIS %28%IM%29%; intrauterine surg goes under FETUS /surg; fetal organs %26% tissues in tissue %26% cell cultures: coord FETUS + organ or tissue without qualif %28%not with /embryol%29% + culture term, all probably NIM%A%  
% 215.45/215.70  |- mesh__dateCreated mesh__D005333 1978-06-19
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D005333 2006
% 215.45/215.70  |- mesh__recordOriginator mesh__D005333 SMH
% 215.45/215.70  |- skos__broader mesh__D005333smesh__D004628
% 215.45/215.70  |- mesh__onlineNote mesh__D005333
% 215.45/215.70       search PRENATAL INFLUENCES under PREGNANCY 1966-72   
% 215.45/215.70  |- skos__scopeNote mesh__D005333
% 215.45/215.70       The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO.%A%    
% 215.45/215.70  |- mesh__recordAuthorizer mesh__D005333 sjn
% 215.45/215.70  |- skos__broader mesh__D029781smesh__D029779
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D029781 2006
% 215.45/215.70  |- mesh__publicMeSHNote mesh__D029781 2002   
% 215.45/215.70  |- rdf__type mesh__D029781sskos__Concept
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D029781 2003
% 215.45/215.70  |- skos__scopeNote mesh__D029781
% 215.45/215.70       A plant genus of the family CUPRESSACEAE.  Cypress ordinarily refers to this but also forms part of the name of plants in other genera.%A%    
% 215.45/215.70  |- mesh__dateRevised mesh__D029781 2002-07-03
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D029781 2004
% 215.45/215.70  |- skos__annotation mesh__D029781
% 215.45/215.70       X ref CYPRESS: check text; restrict to genus CUPRESSUS; do not use for other genera referred to as cyprus in the literature; check MeSH for other cypress terms; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.45/215.70  |- mesh__dateCreated mesh__D029781 2001-07-25
% 215.45/215.70  |- mesh__dateEstablished mesh__D029781 2002-01-01
% 215.45/215.70  |- mesh__historyNote mesh__D029781 2002   
% 215.45/215.70  |- skos__prefLabel mesh__D029781 Cupressus
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D029781 2005
% 215.45/215.70  |- mesh__recordAuthorizer mesh__D010278 sjn
% 215.45/215.70  |- skos__broader mesh__D010278smesh__D009946
% 215.45/215.70  |- skos__altLabel mesh__D010278 Ethyl Parathion
% 215.45/215.70  |- skos__scopeNote mesh__D010278
% 215.45/215.70       A highly toxic cholinesterase inhibitor that is used as an acaricide and as an insecticide.%A%    
% 215.45/215.70  |- skos__altLabel mesh__D010278 Phosphostigmine
% 215.45/215.70  |- mesh__recordOriginator mesh__D010278 NLM
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D010278 2006
% 215.45/215.70  |- mesh__dateRevised mesh__D010278 2005-06-30
% 215.45/215.70  |- skos__prefLabel mesh__D010278 Parathion
% 215.45/215.70  |- skos__hiddenLabel mesh__D010278 Parathion, Ethyl
% 215.45/215.70  |- mesh__dateCreated mesh__D010278 1999-01-01
% 215.45/215.70  |- skos__annotation mesh__D010278 TN 111 for eff on insects   
% 215.45/215.70  |- rdf__type mesh__D010278sskos__Concept
% 215.45/215.70  |- skos__altLabel mesh__D010278 Thiophos
% 215.45/215.70  |- mesh__recordMaintainer mesh__D010278 ssb
% 215.45/215.70  |- mesh__recordAuthorizer mesh__D015761 sjn
% 215.45/215.70  |- skos__hiddenLabel mesh__D015761 Fampridine SR
% 215.45/215.70  |- mesh__recordMaintainer mesh__D015761 ssb
% 215.45/215.70  |- skos__hiddenLabel mesh__D015761 4 Aminopyridine Sustained Release
% 215.45/215.70  |- rdf__type mesh__D015761sskos__Concept
% 215.45/215.70  |- skos__hiddenLabel mesh__D015761 4 Aminopyridine
% 215.45/215.70  |- skos__hiddenLabel mesh__D015761 VMI103
% 215.45/215.70  |- skos__altLabel mesh__D015761 Pymadine
% 215.45/215.70  |- mesh__dateRevised mesh__D015761 2004-07-07
% 215.45/215.70  |- mesh__dateCreated mesh__D015761 1989-05-25
% 215.45/215.70  |- mesh__recordOriginator mesh__D015761 RLS
% 215.45/215.70  |- mesh__dateEstablished mesh__D015761 1990-01-01
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D015761 2005
% 215.45/215.70  |- skos__historyNote mesh__D015761 Pyridines %28%1966-1978%29%
% 215.45/215.70  |- mesh__historyNote mesh__D015761 90   
% 215.45/215.70  |- mesh__publicMeSHNote mesh__D015761 90   
% 215.45/215.70  |- skos__historyNote mesh__D015761 Aminopyridines %28%1979-1989%29%
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D015761 2006
% 215.45/215.70  |- skos__hiddenLabel mesh__D015761 VMI 103
% 215.45/215.70  |- skos__altLabel mesh__D015761 Fampridine-SR
% 215.45/215.70  |- skos__scopeNote mesh__D015761
% 215.45/215.70       One of the POTASSIUM CHANNEL BLOCKERS, with secondary effect on calcium currents, which is  used mainly as a research tool and to characterize channel subtypes.%A%    
% 215.45/215.70  |- skos__prefLabel mesh__D015761 4-Aminopyridine
% 215.45/215.70  |- skos__broader mesh__D015761smesh__D000631
% 215.45/215.70  |- skos__hiddenLabel mesh__D015761 Sustained Release, 4-Aminopyridine
% 215.45/215.70  |- mesh__recordOriginator mesh__D009724 NLM
% 215.45/215.70  |- mesh__dateCreated mesh__D009724 1999-01-01
% 215.45/215.70  |- mesh__dateEstablished mesh__D009724 1973-01-01
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D009724 1995
% 215.45/215.70  |- skos__hiddenLabel mesh__D009724 Nursery
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D009724 2000
% 215.45/215.70  |- skos__prefLabel mesh__D009724 Nurseries
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D009724 2006
% 215.45/215.70  |- mesh__dateRevised mesh__D009724 1994-04-16
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D009724 2005
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D009724 2004
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D009724 1999
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D009724 2002
% 215.45/215.70  |- mesh__recordMaintainer mesh__D009724 TGC
% 215.45/215.70  |- rdf__type mesh__D009724sskos__Concept
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D009724 2003
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D009724 1998
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D009724 1997
% 215.45/215.70  |- skos__scopeNote mesh__D009724
% 215.45/215.70       Facilities which provide care for infants.     
% 215.45/215.70  |- mesh__publicMeSHNote mesh__D009724 73   
% 215.45/215.70  |- skos__annotation mesh__D009724
% 215.45/215.70       in hosp = NURSERIES, HOSPITAL; check also tag INFANT   
% 215.45/215.70  |- mesh__recordAuthorizer mesh__D009724 PLS
% 215.45/215.70  |- mesh__historyNote mesh__D009724 73   
% 215.45/215.70  |- skos__related mesh__D009724smesh__D002656
% 215.45/215.70  |- skos__broader mesh__D009724smesh__D006268
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D009724 1996
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D009724 2001
% 215.45/215.70  |- skos__broader mesh__D001741smesh__D044383
% 215.45/215.70  |- mesh__recordMaintainer mesh__D001741 jls
% 215.45/215.70  |- mesh__dateRevised mesh__D001741 2003-07-14
% 215.45/215.70  |- mesh__recordAuthorizer mesh__D001741 sjn
% 215.45/215.70  |- skos__hiddenLabel mesh__D001741 Americans, African
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D001741 2006
% 215.45/215.70  |- mesh__historyNote mesh__D001741 76; was NEGROES 1963-75   
% 215.45/215.70  |- skos__scopeNote mesh__D001741
% 215.45/215.70       Persons living in the United States having origins in any of the black groups of Africa.%A%    
% 215.45/215.70  |- rdf__type mesh__D001741sskos__Concept
% 215.45/215.70  |- mesh__recordOriginator mesh__D001741 EC
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D001741 2004
% 215.45/215.70  |- skos__prefLabel mesh__D001741 African Americans
% 215.45/215.70  |- skos__broader mesh__D001741smesh__D005006
% 215.45/215.70  |- mesh__dateCreated mesh__D001741 1975-07-25
% 215.45/215.70  |- mesh__dateEstablished mesh__D001741 1976-01-01
% 215.45/215.70  |- mesh__publicMeSHNote mesh__D001741
% 215.45/215.70       2004%28%1963%29%; see BLACKS 1976-2003; see NEGROES 1963-75   
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D001741 2005
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D014669 2004
% 215.45/215.70  |- mesh__dateEstablished mesh__D014669 1988-01-01
% 215.45/215.70  |- skos__hiddenLabel mesh__D014669 Vasostomies
% 215.45/215.70  |- skos__scopeNote mesh__D014669
% 215.45/215.70       Surgical anastomosis or fistulization of the spermatic ducts to restore fertility in a previously vasectomized male.%A%    
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D014669 2001
% 215.45/215.70  |- skos__altLabel mesh__D014669 Vasectomy Reversal
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D014669 2005
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D014669 1999
% 215.45/215.70  |- mesh__dateRevised mesh__D014669 1997-06-20
% 215.45/215.70  |- skos__prefLabel mesh__D014669 Vasovasostomy
% 215.45/215.70  |- mesh__recordMaintainer mesh__D014669 PXP
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D014669 2002
% 215.45/215.70  |- skos__broader mesh__D014669smesh__D000714
% 215.45/215.70  |- skos__hiddenLabel mesh__D014669 Vasovasostomies
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D014669 2006
% 215.45/215.70  |- mesh__recordAuthorizer mesh__D014669 SJN
% 215.45/215.70  |- mesh__recordOriginator mesh__D014669 SCD
% 215.45/215.70  |- skos__broader mesh__D014669smesh__D013243
% 215.45/215.70  |- skos__annotation mesh__D014669
% 215.45/215.70       to reverse sterilization; do not use /util except by MeSH definition%A%  
% 215.45/215.70  |- skos__hiddenLabel mesh__D014669 Reversals, Vasectomy
% 215.45/215.70  |- skos__broader mesh__D014669smesh__D013521
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D014669 2003
% 215.45/215.70  |- mesh__historyNote mesh__D014669 88   
% 215.45/215.70  |- mesh__dateCreated mesh__D014669 1987-03-23
% 215.45/215.70  |- mesh__publicMeSHNote mesh__D014669 88   
% 215.45/215.70  |- rdf__type mesh__D014669sskos__Concept
% 215.45/215.70  |- skos__hiddenLabel mesh__D014669 Reversal, Vasectomy
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D014669 2000
% 215.45/215.70  |- skos__historyNote mesh__D014669 Vas Deferens/surgery %28%1966-1987%29%
% 215.45/215.70  |- skos__hiddenLabel mesh__D014669 Vasectomy Reversals
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D014669 1998
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D019354 2002
% 215.45/215.70  |- mesh__publicMeSHNote mesh__D019354
% 215.45/215.70       97; LACTIC ACID was indexed under LACTATES 1981-96   
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D019354 2006
% 215.45/215.70  |- rdf__type mesh__D019354sskos__Concept
% 215.45/215.70  |- mesh__recordAuthorizer mesh__D019354 sjn
% 215.45/215.70  |- mesh__recordMaintainer mesh__D019354 CCR
% 215.45/215.70  |- skos__historyNote mesh__D019354 Lactates %28%1981-1996%29%
% 215.45/215.70  |- skos__prefLabel mesh__D019354 Sodium Lactate
% 215.45/215.70  |- mesh__recordOriginator mesh__D019354 ADP
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D019354 2003
% 215.45/215.70  |- skos__scopeNote mesh__D019354
% 215.45/215.70       The sodium salt of racemic or inactive lactic acid. It is a hygroscopic agent used intravenously as a systemic and urinary alkalizer.%A%    
% 215.45/215.70  |- mesh__onlineNote mesh__D019354
% 215.45/215.70       use LACTIC ACID %28%NM%29% to search SODIUM LACTATE 1981-96   
% 215.45/215.70  |- mesh__historyNote mesh__D019354
% 215.45/215.70       97; SODIUM LACTATE was SY to LACTIC ACID %28%NM%29% 1981-96   
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D019354 2004
% 215.45/215.70  |- mesh__dateEstablished mesh__D019354 1997-01-01
% 215.45/215.70  |- skos__hiddenLabel mesh__D019354 Lactate, Sodium
% 215.45/215.70  |- mesh__dateRevised mesh__D019354 2000-06-22
% 215.45/215.70  |- skos__broader mesh__D019354smesh__D007773
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D019354 2001
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D019354 2005
% 215.45/215.70  |- mesh__dateCreated mesh__D019354 1996-06-10
% 215.45/215.70  |- skos__scopeNote mesh__D000649
% 215.45/215.70       Percutaneous transabdominal puncture of the uterus during pregnancy to obtain amniotic fluid. It is commonly used for fetal karyotype determination in order to diagnose abnormal fetal conditions.%A%    
% 215.45/215.70  |- mesh__dateEstablished mesh__D000649 1973-01-01
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D000649 2002
% 215.45/215.70  |- skos__hiddenLabel mesh__D000649 Amniocenteses
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D000649 2004
% 215.45/215.70  |- mesh__recordOriginator mesh__D000649 NLM
% 215.45/215.70  |- mesh__recordMaintainer mesh__D000649 PXP
% 215.45/215.70  |- mesh__historyNote mesh__D000649 73%28%71%29%   
% 215.45/215.70  |- mesh__publicMeSHNote mesh__D000649 73   
% 215.45/215.70  |- skos__broader mesh__D000649smesh__D011296
% 215.45/215.70  |- skos__historyNote mesh__D000649 Amnion %28%1966-1970%29%
% 215.45/215.70  |- mesh__dateRevised mesh__D000649 1997-06-20
% 215.45/215.70  |- skos__prefLabel mesh__D000649 Amniocentesis
% 215.45/215.70  |- skos__broader mesh__D000649smesh__D019152
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D000649 2000
% 215.45/215.70  |- skos__annotation mesh__D000649
% 215.45/215.70       do not use /util except by MeSH definition   
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D000649 1998
% 215.45/215.70  |- mesh__recordAuthorizer mesh__D000649 SJN
% 215.45/215.70  |- rdf__type mesh__D000649sskos__Concept
% 215.45/215.70  |- skos__related mesh__D000649smesh__D015193
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D000649 1999
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D000649 2005
% 215.45/215.70  |- skos__historyNote mesh__D000649 Punctures %28%1966-1970%29%
% 215.45/215.70  |- skos__broader mesh__D000649smesh__D003581
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D000649 2001
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D000649 2003
% 215.45/215.70  |- mesh__dateCreated mesh__D000649 1999-01-01
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D000649 2006
% 215.45/215.70  |- skos__hiddenLabel mesh__D011371 Hutchinson Gilford Syndrome
% 215.45/215.70  |- skos__hiddenLabel mesh__D011371 Syndrome, Hutchinson-Gilford
% 215.45/215.70  |- skos__scopeNote mesh__D011371
% 215.45/215.70       An abnormal congenital condition, associated with defects in the LAMIN TYPE A gene, which is characterized by premature aging in children, where all the changes of cell senescence occur. It is manifested by premature greying; hair loss; hearing loss %28%DEAFNESS%29%; cataracts %28%CATARACT%29%; ARTHRITIS; OSTEOPOROSIS; DIABETES MELLITUS; atrophy of subcutaneous fat; skeletal hypoplasia; elevated urinary HYALURONIC ACID; and accelerated ATHEROSCLEROSIS. Many affected individuals develop malignant tumors, especially SARCOMA.%A%    
% 215.45/215.70  |- mesh__recordAuthorizer mesh__D011371 sjn
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D011371 2005
% 215.45/215.70  |- skos__altLabel mesh__D011371 Hutchinson-Gilford Syndrome
% 215.45/215.70  |- mesh__recordMaintainer mesh__D011371 ssb
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D011371 2004
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D011371 2006
% 215.45/215.70  |- skos__related mesh__D011371smesh__D003057
% 215.45/215.70  |- skos__broader mesh__D011371smesh__D008661
% 215.45/215.70  |- mesh__dateCreated mesh__D011371 1999-01-01
% 215.45/215.70  |- skos__prefLabel mesh__D011371 Progeria
% 215.45/215.70  |- rdf__type mesh__D011371sskos__Concept
% 215.45/215.70  |- mesh__recordOriginator mesh__D011371 NLM
% 215.45/215.70  |- skos__related mesh__D011371smesh__D014898
% 215.45/215.70  |- mesh__dateRevised mesh__D011371 2003-07-09
% 215.45/215.70  |- skos__related mesh__D005334smesh__D000894
% 215.45/215.70  |- skos__hiddenLabel mesh__D005334 Fevers
% 215.45/215.70  |- skos__altLabel mesh__D005334 Hyperthermia
% 215.45/215.70  |- skos__annotation mesh__D005334
% 215.45/215.70       /ther = treatment of FEVER: differentiate from FEVER THERAPY see HYPERTHERMIA, INDUCED %28% = high body temp induced to treat dis%29%; /chem ind: consider also HYPERTHERMIA, INDUCED or PYROGENS%A%  
% 215.45/215.70  |- mesh__recordAuthorizer mesh__D005334 sjn
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D005334 2002
% 215.45/215.70  |- rdf__type mesh__D005334sskos__Concept
% 215.45/215.70  |- skos__hiddenLabel mesh__D005334 Pyrexias
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D005334 2005
% 215.45/215.70  |- skos__prefLabel mesh__D005334 Fever
% 215.45/215.70  |- skos__related mesh__D005334smesh__D011749
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D005334 2003
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D005334 2006
% 215.45/215.70  |- mesh__recordOriginator mesh__D005334 NLM
% 215.45/215.70  |- skos__related mesh__D005334smesh__D008305
% 215.45/215.70  |- skos__altLabel mesh__D005334 Pyrexia
% 215.45/215.70  |- mesh__dateRevised mesh__D005334 1999-11-03
% 215.45/215.70  |- mesh__recordMaintainer mesh__D005334 KEV
% 215.45/215.70  |- skos__broader mesh__D005334smesh__D001832
% 215.45/215.70  |- skos__related mesh__D005334smesh__D000893
% 215.45/215.70  |- skos__related mesh__D005334smesh__D006360
% 215.45/215.70  |- skos__hiddenLabel mesh__D005334 Hyperthermias
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D005334 2004
% 215.45/215.70  |- skos__scopeNote mesh__D005334
% 215.45/215.70       An abnormal elevation of body temperature, usually as a result of a pathologic process.%A%    
% 215.45/215.70  |- skos__related mesh__D005334smesh__D006979
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D005334 2000
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D005334 2001
% 215.45/215.70  |- mesh__dateCreated mesh__D005334 1999-01-01
% 215.45/215.70  |- mesh__publicMeSHNote mesh__D029782 2002   
% 215.45/215.70  |- rdf__type mesh__D029782sskos__Concept
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D029782 2003
% 215.45/215.70  |- skos__scopeNote mesh__D029782
% 215.45/215.70       A plant genus of the family CUPRESSACEAE. The common name of %27%Cedar%27% makes this easily confused with other trees using that name including cedrus, JUNIPERUS; and CHAMAECYPARIS.%A%    
% 215.45/215.70  |- skos__annotation mesh__D029782
% 215.45/215.70       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D029782 2004
% 215.45/215.70  |- mesh__dateEstablished mesh__D029782 2002-01-01
% 215.45/215.70  |- mesh__dateRevised mesh__D029782 2002-07-03
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D029782 2005
% 215.45/215.70  |- skos__prefLabel mesh__D029782 Libocedrus
% 215.45/215.70  |- mesh__dateCreated mesh__D029782 2001-07-25
% 215.45/215.70  |- skos__broader mesh__D029782smesh__D029779
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D029782 2006
% 215.45/215.70  |- mesh__historyNote mesh__D029782 2002   
% 215.45/215.70  |- skos__broader mesh__D010279smesh__D004700
% 215.45/215.70  |- skos__hiddenLabel mesh__D010279 Diseases, Parathyroid
% 215.45/215.70  |- skos__hiddenLabel mesh__D010279 Disorders, Parathyroid
% 215.45/215.70  |- skos__altLabel mesh__D010279 Parathyroid Disorders
% 215.45/215.70  |- skos__hiddenLabel mesh__D010279 Parathyroid Disease
% 215.45/215.70  |- skos__hiddenLabel mesh__D010279 Disease, Parathyroid
% 215.45/215.70  |- mesh__recordAuthorizer mesh__D010279 sjn
% 215.45/215.70  |- mesh__recordMaintainer mesh__D010279 lkt
% 215.45/215.70  |- skos__hiddenLabel mesh__D010279 Disorder, Parathyroid
% 215.45/215.70  |- skos__annotation mesh__D010279
% 215.45/215.70       general or unspecified; prefer specifics   
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D010279 2006
% 215.45/215.70  |- skos__prefLabel mesh__D010279 Parathyroid Diseases
% 215.45/215.70  |- mesh__historyNote mesh__D010279 66   
% 215.45/215.70  |- mesh__dateEstablished mesh__D010279 1966-01-01
% 215.45/215.70  |- mesh__dateCreated mesh__D010279 1999-01-01
% 215.45/215.70  |- mesh__publicMeSHNote mesh__D010279 66   
% 215.45/215.70  |- mesh__recordOriginator mesh__D010279 NLM
% 215.45/215.70  |- rdf__type mesh__D010279sskos__Concept
% 215.45/215.70  |- mesh__dateRevised mesh__D010279 2005-06-30
% 215.45/215.70  |- skos__hiddenLabel mesh__D010279 Parathyroid Disorder
% 215.45/215.70  |- skos__scopeNote mesh__D010279
% 215.45/215.70       Pathological processes of the PARATHYROID GLANDS. They usually manifest as hypersecretion or hyposecretion of PARATHYROID HORMONE that regulates the balance of CALCIUM; PHOSPHORUS; and MAGNESIUM in the body.%A%    
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D015762 2005
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D015762 1996
% 215.45/215.70  |- skos__historyNote mesh__D015762 Adenosine %28%1966-1989%29%
% 215.45/215.70  |- mesh__dateCreated mesh__D015762 1989-05-16
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D015762 2004
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D015762 1998
% 215.45/215.70  |- mesh__dateEstablished mesh__D015762 1990-01-01
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D015762 2006
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D015762 1997
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D015762 1994
% 215.45/215.70  |- mesh__publicMeSHNote mesh__D015762 90   
% 215.45/215.70  |- skos__broader mesh__D015762smesh__D000241
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D015762 1999
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D015762 2002
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D015762 1995
% 215.45/215.70  |- skos__prefLabel mesh__D015762 2-Chloroadenosine
% 215.45/215.70  |- mesh__recordAuthorizer mesh__D015762 PLS
% 215.45/215.70  |- mesh__recordOriginator mesh__D015762 RLS
% 215.45/215.70  |- mesh__historyNote mesh__D015762 90   
% 215.45/215.70  |- skos__hiddenLabel mesh__D015762 2 Chloroadenosine
% 215.45/215.70  |- mesh__dateRevised mesh__D015762 1993-06-03
% 215.45/215.70  |- rdf__type mesh__D015762sskos__Concept
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D015762 2000
% 215.45/215.70  |- mesh__recordMaintainer mesh__D015762 TAP
% 215.45/215.70  |- skos__scopeNote mesh__D015762
% 215.45/215.70       2-Chloroadenosine. A metabolically stable analog of adenosine which acts as an adenosine receptor agonist. The compound has a potent effect on the peripheral and central nervous system.%A%    
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D015762 2003
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D015762 2001
% 215.45/215.70  |- skos__annotation mesh__D015762 an adenosine recept agonist   
% 215.45/215.70  |- mesh__dateRevised mesh__D009725 1996-06-10
% 215.45/215.70  |- mesh__onlineNote mesh__D009725
% 215.45/215.70       use NURSERIES, HOSPITAL to search HOSPITAL NURSERIES 1972-77%A%  
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D009725 2005
% 215.45/215.70  |- mesh__recordMaintainer mesh__D009725 KEV
% 215.45/215.70  |- skos__altLabel mesh__D009725 Hospital Nursery
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D009725 2000
% 215.45/215.70  |- mesh__historyNote mesh__D009725 78; was HOSPITAL NURSERIES 1972-77   
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D009725 2006
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D009725 2003
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D009725 1998
% 215.45/215.70  |- skos__broader mesh__D009725smesh__D009724
% 215.45/215.70  |- mesh__activeMeSHYear mesh__D009725 2001
% 215.45/215.70  |- mesh__publicMeSHNote mesh__D009725 78; was HOSPITAL NURSERIES 1972-77   
% 215.45/215.70  |- mesh__dateEstablished mesh__D009725 1972-01-01
% 215.45/215.71  |- skos__scopeNote mesh__D009725
% 215.45/215.71       Hospital facilities which provide care for newborn infants.%A%    
% 215.45/215.71  |- mesh__recordOriginator mesh__D009725 NLM
% 215.45/215.71  |- skos__altLabel mesh__D009725 Hospital Nurseries
% 215.45/215.71  |- mesh__activeMeSHYear mesh__D009725 2004
% 215.45/215.71  |- mesh__activeMeSHYear mesh__D009725 1999
% 215.45/215.71  |- skos__historyNote mesh__D009725
% 215.45/215.71       Infant, Newborn, Diseases %28%1966-1971%29%
% 215.45/215.71  |- mesh__activeMeSHYear mesh__D009725 2002
% 215.45/215.71  |- skos__broader mesh__D009725smesh__D006757
% 215.45/215.71  |- rdf__type mesh__D009725sskos__Concept
% 215.45/215.71  |- mesh__dateCreated mesh__D009725 1999-01-01
% 215.45/215.71  |- mesh__activeMeSHYear mesh__D009725 1997
% 215.45/215.71  |- skos__historyNote mesh__D009725 Cross Infection %28%1966-1971%29%
% 215.45/215.71  |- skos__prefLabel mesh__D009725 Nurseries, Hospital
% 215.45/215.71  |- skos__altLabel mesh__D009725 Nursery, Hospital
% 215.45/215.71  |- skos__annotation mesh__D009725 check also tag INFANT, NEWBORN   
% 215.45/215.71  |- mesh__recordAuthorizer mesh__D009725 PLS
% 215.45/215.71  |- skos__hiddenLabel mesh__D001742 Fever, Blackwater
% 215.45/215.71  |- mesh__activeMeSHYear mesh__D001742 2005
% 215.45/215.71  |- skos__hiddenLabel mesh__D001742 Black Water Fevers
% 215.45/215.71  |- mesh__activeMeSHYear mesh__D001742 2001
% 215.45/215.71  |- skos__hiddenLabel mesh__D001742 Fevers, Black Water
% 215.45/215.71  |- skos__scopeNote mesh__D001742
% 215.45/215.71       A complication of MALARIA, FALCIPARUM characterized by the passage of dark red to black urine.%A%    
% 215.45/215.71  |- mesh__activeMeSHYear mesh__D001742 2006
% 215.45/215.71  |- mesh__dateRevised mesh__D001742 2000-06-22
% 215.45/215.71  |- rdf__type mesh__D001742sskos__Concept
% 215.45/215.71  |- skos__broader mesh__D001742smesh__D016778
% 215.45/215.71  |- mesh__dateEstablished mesh__D001742 1991-01-01
% 215.45/215.71  |- mesh__activeMeSHYear mesh__D001742 2003
% 215.45/215.71  |- skos__hiddenLabel mesh__D001742 Malarias, Hemolytic
% 215.45/215.71  |- skos__hiddenLabel mesh__D001742 Fevers, Blackwater
% 215.45/215.71  |- skos__hiddenLabel mesh__D001742 Hemolytic Malarias
% 215.45/215.71  |- mesh__publicMeSHNote mesh__D001742 1991; see MALARIA 1975-1990   
% 215.45/215.71  |- skos__hiddenLabel mesh__D001742 Fever, Black Water
% 215.45/215.71  |- mesh__activeMeSHYear mesh__D001742 2002
% 215.45/215.71  |- mesh__recordMaintainer mesh__D001742 PXP
% 215.45/215.71  |- mesh__activeMeSHYear mesh__D001742 2004
% 215.45/215.71  |- mesh__historyNote mesh__D001742 1991%28%1975%29%   
% 215.45/215.71  |- skos__hiddenLabel mesh__D001742 Hemolytic Malaria
% 215.45/215.71  |- skos__hiddenLabel mesh__D001742 Blackwater Fevers
% 215.45/215.71  |- skos__altLabel mesh__D001742 Black Water Fever
% 215.45/215.71  |- mesh__dateCreated mesh__D001742 1999-01-01
% 215.45/215.71  |- mesh__recordOriginator mesh__D001742 NLM
% 215.45/215.71  |- skos__prefLabel mesh__D001742 Blackwater Fever
% 215.45/215.71  |- skos__altLabel mesh__D001742 Malaria, Hemolytic
% 215.45/215.71  |- mesh__recordAuthorizer mesh__D001742 sjn
% 215.45/215.71  |- mesh__recordMaintainer mesh__D019355 ssb
% 215.45/215.71  |- mesh__dateRevised mesh__D019355 2005-06-30
% 215.45/215.71  |- skos__scopeNote mesh__D019355
% 215.45/215.71       A colorless crystalline or white powdery organic, tricarboxylic acid occurring in plants, especially citrus fruits, and used as a flavoring agent, as an antioxidant in foods, and as a sequestrating agent. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 215.45/215.71  |- skos__prefLabel mesh__D019355 Calcium Citrate
% 215.45/215.71  |- mesh__publicMeSHNote mesh__D019355
% 215.45/215.71       97; CALCIUM CITRATE was indexed under CITRATES 1979-96   
% 215.45/215.71  |- mesh__onlineNote mesh__D019355
% 215.45/215.71       use CITRIC ACID %28%NM%29% to search CALCIUM CITRATE 1980-96   
% 215.45/215.71  |- mesh__dateCreated mesh__D019355 1996-06-10
% 215.45/215.71  |- skos__historyNote mesh__D019355 Citrates %28%1979-1996%29%
% 215.45/215.71  |- skos__hiddenLabel mesh__D019355 Citrate, Calcium
% 215.45/215.71  |- skos__broader mesh__D019355smesh__D017610
% 215.45/215.71  |- skos__broader mesh__D019355smesh__D002951
% 215.45/215.71  |- mesh__recordAuthorizer mesh__D019355 sjn
% 215.45/215.71  |- mesh__historyNote mesh__D019355
% 215.45/215.71       97; CALCIUM CITRATE was SY to CITRIC ACID %28%NM%29% 1979-96   
% 215.45/215.71  |- mesh__recordOriginator mesh__D019355 ADP
% 215.45/215.71  |- skos__broader mesh__D019355smesh__D005421
% 215.45/215.71  |- skos__hiddenLabel mesh__D019355 Calcium Citrates
% 215.56/215.71  |- skos__hiddenLabel mesh__D019355 Citrates, Calcium
% 215.56/215.71  |- mesh__dateEstablished mesh__D019355 1997-01-01
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D019355 2006
% 215.56/215.71  |- rdf__type mesh__D019355sskos__Concept
% 215.56/215.71  |- skos__altLabel mesh__D011372 Progestagens
% 215.56/215.71  |- mesh__publicMeSHNote mesh__D011372
% 215.56/215.71       2004; see PROGESTATIONAL HORMONES 1963-2003   
% 215.56/215.71  |- mesh__dateCreated mesh__D011372 1999-01-01
% 215.56/215.71  |- skos__scopeNote mesh__D011372
% 215.56/215.71       Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY.%A%    
% 215.56/215.71  |- skos__altLabel mesh__D011372 Progestational Hormones
% 215.56/215.71  |- skos__altLabel mesh__D011372 Progestational Agents
% 215.56/215.71  |- rdf__type mesh__D011372sskos__Concept
% 215.56/215.71  |- skos__altLabel mesh__D011372 Progestagenic Agents
% 215.56/215.71  |- mesh__recordOriginator mesh__D011372 NLM
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D011372 2004
% 215.56/215.71  |- skos__altLabel mesh__D011372 Gestagenic Agents
% 215.56/215.71  |- skos__broader mesh__D011372smesh__D006728
% 215.56/215.71  |- skos__altLabel mesh__D011372 Progestogens
% 215.56/215.71  |- mesh__recordAuthorizer mesh__D011372 sjn
% 215.56/215.71  |- skos__altLabel mesh__D011372 Gestagens
% 215.56/215.71  |- skos__prefLabel mesh__D011372 Progestins
% 215.56/215.71  |- skos__altLabel mesh__D011372 Progestational Compounds
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D011372 2006
% 215.56/215.71  |- mesh__dateEstablished mesh__D011372 1963-01-01
% 215.56/215.71  |- mesh__historyNote mesh__D011372 2004 %28%1963%29%   
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D011372 2005
% 215.56/215.71  |- mesh__recordMaintainer mesh__D011372 lkt
% 215.56/215.71  |- mesh__dateRevised mesh__D011372 2003-07-09
% 215.56/215.71  |- skos__historyNote mesh__D005335 Fever %28%1966-1970%29%
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005335 2006
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005335 2003
% 215.56/215.71  |- mesh__recordMaintainer mesh__D005335 KEV
% 215.56/215.71  |- mesh__dateEstablished mesh__D005335 1974-01-01
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005335 2000
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005335 2004
% 215.56/215.71  |- skos__broader mesh__D005335smesh__D005334
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005335 2001
% 215.56/215.71  |- skos__scopeNote mesh__D005335
% 215.56/215.71       Fever in which the etiology cannot be ascertained.     
% 215.56/215.71  |- skos__annotation mesh__D005335
% 215.56/215.71       referred to as FUO; for ultimate determ of cause or origin coord FEVER OF UNKNOWN ORIGIN /etiol %28%IM%29% %28%not /diag%29% + disease /compl %28%IM%29% %28%not /diag%29%%A%  
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005335 2002
% 215.56/215.71  |- mesh__recordAuthorizer mesh__D005335 sjn
% 215.56/215.71  |- mesh__dateCreated mesh__D005335 1999-01-01
% 215.56/215.71  |- skos__prefLabel mesh__D005335 Fever of Unknown Origin
% 215.56/215.71  |- skos__hiddenLabel mesh__D005335 Unknown Origin Fevers
% 215.56/215.71  |- mesh__dateRevised mesh__D005335 1999-11-03
% 215.56/215.71  |- mesh__publicMeSHNote mesh__D005335 74   
% 215.56/215.71  |- rdf__type mesh__D005335sskos__Concept
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005335 2005
% 215.56/215.71  |- skos__hiddenLabel mesh__D005335 Unknown Origin Fever
% 215.56/215.71  |- mesh__historyNote mesh__D005335 74%28%71%29%   
% 215.56/215.71  |- mesh__recordOriginator mesh__D005335 NLM
% 215.56/215.71  |- skos__scopeNote mesh__D029783
% 215.56/215.71       A plant genus of the family CUPRESSACEAE.     
% 215.56/215.71  |- mesh__dateRevised mesh__D029783 2003-07-25
% 215.56/215.71  |- skos__prefLabel mesh__D029783 Thuja
% 215.56/215.71  |- mesh__recordMaintainer mesh__D029783 nns
% 215.56/215.71  |- skos__altLabel mesh__D029783 Cedar, Western Red
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D029783 2006
% 215.56/215.71  |- mesh__publicMeSHNote mesh__D029783 2002   
% 215.56/215.71  |- rdf__type mesh__D029783sskos__Concept
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D029783 2004
% 215.56/215.71  |- skos__altLabel mesh__D029783 Arbor Vitae
% 215.56/215.71  |- mesh__historyNote mesh__D029783 2002   
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D029783 2005
% 215.56/215.71  |- mesh__recordAuthorizer mesh__D029783 sjn
% 215.56/215.71  |- skos__annotation mesh__D029783
% 215.56/215.71       X ref CEDAR, WESTERN RED: do not confuse with other cedar terms in MeSH; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.56/215.71  |- mesh__recordOriginator mesh__D029783 ssb
% 215.56/215.71  |- skos__broader mesh__D029783smesh__D029779
% 215.56/215.71  |- mesh__dateCreated mesh__D029783 2001-07-25
% 215.56/215.71  |- mesh__dateEstablished mesh__D029783 2002-01-01
% 215.56/215.71  |- skos__altLabel mesh__D029783 Biota orientalis
% 215.56/215.71  |- mesh__dateEstablished mesh__D015763 1990-01-01
% 215.56/215.71  |- skos__prefLabel mesh__D015763 2-Amino-5-phosphonovalerate
% 215.56/215.71  |- mesh__publicMeSHNote mesh__D015763 90   
% 215.56/215.71  |- skos__altLabel mesh__D015763 5-Phosphononorvaline
% 215.56/215.71  |- skos__altLabel mesh__D015763 2-Amino-5-phosphonovaleric Acid
% 215.56/215.71  |- skos__scopeNote mesh__D015763
% 215.56/215.71       The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors %28%RECEPTORS, N-METHYL-D-ASPARTATE%29%. The L form is inactive at NMDA receptors but may affect the AP4 %28%2-amino-4-phosphonobutyrate; APB%29% excitatory amino acid receptors.%A%    
% 215.56/215.71  |- skos__historyNote mesh__D015763 Valine %28%1966-1974%29%
% 215.56/215.71  |- skos__historyNote mesh__D015763 Anticonvulsants %28%1966-1989%29%
% 215.56/215.71  |- skos__annotation mesh__D015763 DF: AP5   
% 215.56/215.71  |- skos__broader mesh__D015763smesh__D019606
% 215.56/215.71  |- mesh__dateRevised mesh__D015763 2001-07-25
% 215.56/215.71  |- skos__altLabel mesh__D015763 2-Amino-5-phosphonopentanoic Acid
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D015763 2002
% 215.56/215.71  |- rdf__type mesh__D015763sskos__Concept
% 215.56/215.71  |- mesh__recordAuthorizer mesh__D015763 sjn
% 215.56/215.71  |- skos__hiddenLabel mesh__D015763 2 Amino 5 phosphonopentanoic Acid
% 215.56/215.71  |- skos__altLabel mesh__D015763 2-Amino-5-phosphonopentanoate
% 215.56/215.71  |- skos__hiddenLabel mesh__D015763 5 Phosphononorvaline
% 215.56/215.71  |- mesh__recordMaintainer mesh__D015763 ssb
% 215.56/215.71  |- skos__broader mesh__D015763smesh__D014633
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D015763 2003
% 215.56/215.71  |- skos__hiddenLabel mesh__D015763 2 Amino 5 phosphonopentanoate
% 215.56/215.71  |- mesh__dateCreated mesh__D015763 1989-05-25
% 215.56/215.71  |- mesh__recordOriginator mesh__D015763 RLS
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D015763 2005
% 215.56/215.71  |- skos__hiddenLabel mesh__D015763 2 Amino 5 phosphonovalerate
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D015763 2004
% 215.56/215.71  |- mesh__historyNote mesh__D015763 90   
% 215.56/215.71  |- skos__hiddenLabel mesh__D015763 2 Amino 5 phosphonovaleric Acid
% 215.56/215.71  |- skos__historyNote mesh__D015763
% 215.56/215.71       Valine/analogs %26% derivatives %28%1975-1989%29%
% 215.56/215.71  |- skos__altLabel mesh__D015763 2-APV
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D015763 2006
% 215.56/215.71  |- mesh__recordAuthorizer mesh__D009726 sjn
% 215.56/215.71  |- skos__scopeNote mesh__D009726
% 215.56/215.71       Professionals qualified by education at an accredited school of nursing and licensed by state law to practice nursing. They provide services to patients requiring assistance in recovering or maintaining their physical or mental health.%A%    
% 215.56/215.71  |- mesh__historyNote mesh__D009726 67%28%65%29%   
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D009726 2006
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D009726 2003
% 215.56/215.71  |- mesh__publicMeSHNote mesh__D009726 67   
% 215.56/215.71  |- skos__hiddenLabel mesh__D009726 Nurse
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D009726 2004
% 215.56/215.71  |- skos__altLabel mesh__D009726 Nursing Personnel
% 215.56/215.71  |- rdf__type mesh__D009726sskos__Concept
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D009726 2000
% 215.56/215.71  |- mesh__dateEstablished mesh__D009726 1967-01-01
% 215.56/215.71  |- mesh__dateRevised mesh__D009726 1999-11-03
% 215.56/215.71  |- mesh__dateCreated mesh__D009726 1999-01-01
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D009726 2001
% 215.56/215.71  |- mesh__recordOriginator mesh__D009726 NLM
% 215.56/215.71  |- skos__prefLabel mesh__D009726 Nurses
% 215.56/215.71  |- skos__broader mesh__D009726smesh__D006282
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D009726 2002
% 215.56/215.71  |- mesh__recordMaintainer mesh__D009726 kle
% 215.56/215.71  |- skos__annotation mesh__D009726
% 215.56/215.71       relation to nurs specialties: Manual 34.11.3   
% 215.56/215.71  |- skos__altLabel mesh__D009726 Personnel, Nursing
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D009726 2005
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D001743 2006
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D001743 2000
% 215.56/215.71  |- mesh__dateRevised mesh__D001743 1991-06-20
% 215.56/215.71  |- skos__related mesh__D001743smesh__D003559
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D001743 1997
% 215.56/215.71  |- rdf__type mesh__D001743sskos__Concept
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D001743 2003
% 215.56/215.71  |- skos__related mesh__D001743smesh__D000283
% 215.56/215.71  |- skos__related mesh__D001743smesh__D014546
% 215.56/215.71  |- skos__related mesh__D001743smesh__D003558
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D001743 2001
% 215.56/215.71  |- skos__broader mesh__D001743smesh__D014551
% 215.56/215.71  |- mesh__considerAlso mesh__D001743
% 215.56/215.71       consider also terms at CYST- and VESIC-   
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D001743 2004
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D001743 1994
% 215.56/215.71  |- skos__prefLabel mesh__D001743 Bladder
% 215.56/215.71  |- mesh__recordAuthorizer mesh__D001743 PLS
% 215.56/215.71  |- mesh__dateCreated mesh__D001743 1999-01-01
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D001743 1998
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D001743 1995
% 215.56/215.71  |- skos__hiddenLabel mesh__D001743 Bladders
% 215.56/215.71  |- mesh__recordMaintainer mesh__D001743 TGC
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D001743 1992
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D001743 2002
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D001743 1999
% 215.56/215.71  |- skos__annotation mesh__D001743 inflammation = CYSTITIS   
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D001743 2005
% 215.56/215.71  |- skos__related mesh__D001743smesh__D015653
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D001743 1996
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D001743 1993
% 215.56/215.71  |- mesh__recordOriginator mesh__D001743 NLM
% 215.56/215.71  |- skos__broader mesh__D002118Q000737smesh__D002118
% 215.56/215.71  |- rdf__type mesh__D002118Q000737smesh__CompoundConcept
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D019356 2006
% 215.56/215.71  |- mesh__historyNote mesh__D019356 97   
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D019356 2005
% 215.56/215.71  |- rdf__type mesh__D019356sskos__Concept
% 215.56/215.71  |- mesh__recordOriginator mesh__D019356 TGC
% 215.56/215.71  |- skos__hiddenLabel mesh__D019356 Grave Robberies
% 215.56/215.71  |- mesh__recordMaintainer mesh__D019356 jls
% 215.56/215.71  |- mesh__publicMeSHNote mesh__D019356 97   
% 215.56/215.71  |- skos__prefLabel mesh__D019356 Grave Robbing
% 215.56/215.71  |- skos__scopeNote mesh__D019356
% 215.56/215.71       The stealing of corpses after burial, especially for medical dissection. In the late 18th and early 19th centuries, in the absence of laws governing the acquisition of dissecting material for the study of anatomy, the needs of anatomy classes were met by surreptitious methods: body-snatching and grave robbing. The infamous practice of %22%burking%22%, murder to procure bodies for dissection, was given the name of a rascal named W. Burke, hanged in Edinburgh in 1829. %28%Random House Unabridged Dictionary, 2d ed; from Garrison, An Introduction to the History of Medicine, 4th ed, p447; from Castiglioni, A History of Medicine, 2d ed, p676%29%%A%    
% 215.56/215.71  |- skos__hiddenLabel mesh__D019356 Robbery, Grave
% 215.56/215.71  |- skos__hiddenLabel mesh__D019356 Robbing, Grave
% 215.56/215.71  |- skos__altLabel mesh__D019356 Grave Robbery
% 215.56/215.71  |- mesh__dateEstablished mesh__D019356 1997-01-01
% 215.56/215.71  |- skos__hiddenLabel mesh__D019356 Robberies, Grave
% 215.56/215.71  |- mesh__dateRevised mesh__D019356 2004-07-07
% 215.56/215.71  |- skos__annotation mesh__D019356
% 215.56/215.71       stealing of corpses, espec for med dissection; usually in hist contexts; check hist tags%A%  
% 215.56/215.71  |- mesh__dateCreated mesh__D019356 1996-06-10
% 215.56/215.71  |- skos__broader mesh__D019356smesh__D006666
% 215.56/215.71  |- mesh__recordAuthorizer mesh__D019356 sjn
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005336 1991
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005336 1994
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005336 2004
% 215.56/215.71  |- skos__annotation mesh__D005336 SPEC: SPEC qualif   
% 215.56/215.71  |- mesh__recordOriginator mesh__D005336 NLM
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005336 1992
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005336 1995
% 215.56/215.71  |- mesh__dateEstablished mesh__D005336 1973-01-01
% 215.56/215.71  |- skos__historyNote mesh__D005336 Optics %28%1966-1969%29%
% 215.56/215.71  |- mesh__dateCreated mesh__D005336 1999-01-01
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005336 1993
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005336 1998
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005336 2000
% 215.56/215.71  |- mesh__dateRevised mesh__D005336 1989-06-14
% 215.56/215.71  |- skos__hiddenLabel mesh__D005336 Fiber Optic
% 215.56/215.71  |- skos__broader mesh__D005336smesh__D009906
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005336 1999
% 215.56/215.71  |- mesh__recordMaintainer mesh__D005336 TGC
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005336 2001
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005336 1996
% 215.56/215.71  |- skos__hiddenLabel mesh__D005336 Optics, Fiber
% 215.56/215.71  |- mesh__recordAuthorizer mesh__D005336 PLS
% 215.56/215.71  |- mesh__historyNote mesh__D005336 73%28%70%29%   
% 215.56/215.71  |- rdf__type mesh__D005336sskos__Concept
% 215.56/215.71  |- skos__hiddenLabel mesh__D005336 Optic, Fiber
% 215.56/215.71  |- skos__prefLabel mesh__D005336 Fiber Optics
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005336 2005
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005336 2002
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005336 1997
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005336 1990
% 215.56/215.71  |- mesh__publicMeSHNote mesh__D005336 73   
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005336 2006
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D005336 2003
% 215.56/215.71  |- mesh__publicMeSHNote mesh__D029784 2002   
% 215.56/215.71  |- mesh__dateCreated mesh__D029784 2001-07-25
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D029784 2005
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D029784 2004
% 215.56/215.71  |- rdf__type mesh__D029784sskos__Concept
% 215.56/215.71  |- skos__scopeNote mesh__D029784
% 215.56/215.71       A plant genus of the family Cycadaceae, order Cycadales, class Cycadopsida,  division CYCADOPHYTA of palm-like trees.  It is a source of CYCASIN, the beta-D-glucoside of methylazoxymethanol.%A%    
% 215.56/215.71  |- mesh__dateRevised mesh__D029784 2002-07-03
% 215.56/215.71  |- skos__prefLabel mesh__D029784 Cycas
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D029784 2003
% 215.56/215.71  |- skos__altLabel mesh__D029784 Palm, Cycad
% 215.56/215.71  |- mesh__historyNote mesh__D029784 2002   
% 215.56/215.71  |- skos__altLabel mesh__D029784 Palm, False Sago
% 215.56/215.71  |- mesh__dateEstablished mesh__D029784 2002-01-01
% 215.56/215.71  |- skos__broader mesh__D029784smesh__D032462
% 215.56/215.71  |- skos__annotation mesh__D029784
% 215.56/215.71       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D029784 2006
% 215.56/215.71  |- skos__broader mesh__D000293Q000523smesh__D000293
% 215.56/215.71  |- mesh__preferredCombination mesh__D000293Q000523smesh__D000297
% 215.56/215.71  |- rdf__type mesh__D000293Q000523smesh__CompoundConcept
% 215.56/215.71  |- mesh__dateEstablished mesh__D015764 1990-01-01
% 215.56/215.71  |- mesh__dateRevised mesh__D015764 2004-07-07
% 215.56/215.71  |- skos__hiddenLabel mesh__D015764 CERM 1978
% 215.56/215.71  |- mesh__dateCreated mesh__D015764 1989-05-25
% 215.56/215.71  |- skos__hiddenLabel mesh__D015764 Bepridil, alpha Isomer
% 215.56/215.71  |- skos__hiddenLabel mesh__D015764 Monohydrochloride, Bepridil
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D015764 2006
% 215.56/215.71  |- skos__historyNote mesh__D015764
% 215.56/215.71       Antihypertensive Agents %28%1966-1989%29%
% 215.56/215.71  |- skos__historyNote mesh__D015764
% 215.56/215.71       Calcium Channel Blockers %28%1982-1989%29%
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D015764 2005
% 215.56/215.71  |- skos__altLabel mesh__D015764 1978-CERM
% 215.56/215.71  |- skos__altLabel mesh__D015764 Riom Brand of Bepridil Hydrochloride
% 215.56/215.71  |- skos__historyNote mesh__D015764 Pyrrolidines %28%1966-1989%29%
% 215.56/215.71  |- skos__altLabel mesh__D015764 Wallace Brand of Bepridil Hydrochloride
% 215.56/215.71  |- skos__hiddenLabel mesh__D015764 Bepridil Monohydrochloride, alpha Isomer
% 215.56/215.71  |- skos__historyNote mesh__D015764 Anti-Arrhythmia Agents %28%1976-1989%29%
% 215.56/215.71  |- mesh__recordOriginator mesh__D015764 RLS
% 215.56/215.71  |- skos__hiddenLabel mesh__D015764 Monohydrochloride, alpha-Isomer Bepridil
% 215.56/215.71  |- skos__hiddenLabel mesh__D015764 1978 CERM
% 215.56/215.71  |- skos__scopeNote mesh__D015764
% 215.56/215.71       A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.%A%    
% 215.56/215.71  |- mesh__historyNote mesh__D015764 90   
% 215.56/215.71  |- skos__hiddenLabel mesh__D015764 CERM1978
% 215.56/215.71  |- rdf__type mesh__D015764sskos__Concept
% 215.56/215.71  |- skos__altLabel mesh__D015764 Unicordium
% 215.56/215.71  |- skos__altLabel mesh__D015764 Nourypharma Brand of Bepridil Hydrochloride
% 215.56/215.71  |- skos__broader mesh__D015764smesh__D011759
% 215.56/215.71  |- skos__hiddenLabel mesh__D015764 1978CERM
% 215.56/215.71  |- mesh__publicMeSHNote mesh__D015764 90   
% 215.56/215.71  |- skos__altLabel mesh__D015764 Bedapin
% 215.56/215.71  |- mesh__recordMaintainer mesh__D015764 mdb
% 215.56/215.71  |- skos__prefLabel mesh__D015764 Bepridil
% 215.56/215.71  |- mesh__recordAuthorizer mesh__D015764 sjn
% 215.56/215.71  |- skos__hiddenLabel mesh__D009727 Male Nurses
% 215.56/215.71  |- mesh__recordOriginator mesh__D009727 NLM
% 215.56/215.71  |- mesh__dateCreated mesh__D009727 1999-01-01
% 215.56/215.71  |- mesh__dateEstablished mesh__D009727 1967-01-01
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D009727 1997
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D009727 2002
% 215.56/215.71  |- skos__historyNote mesh__D009727 Nursing %28%1966%29%
% 215.56/215.71  |- skos__broader mesh__D009727smesh__D008571
% 215.56/215.71  |- skos__prefLabel mesh__D009727 Nurses, Male
% 215.56/215.71  |- skos__hiddenLabel mesh__D009727 Male Nurse
% 215.56/215.71  |- mesh__recordAuthorizer mesh__D009727 PLS
% 215.56/215.71  |- mesh__recordMaintainer mesh__D009727 TAP
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D009727 2005
% 215.56/215.71  |- skos__scopeNote mesh__D009727 Nurses of the male sex.     
% 215.56/215.71  |- mesh__historyNote mesh__D009727 67   
% 215.56/215.71  |- skos__annotation mesh__D009727
% 215.56/215.71       relation to nurs specialties: Manual 34.11.3; use of check tags: Manual 34.6%A%  
% 215.56/215.71  |- skos__hiddenLabel mesh__D009727 Nurse, Male
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D009727 2006
% 215.56/215.71  |- mesh__dateRevised mesh__D009727 1996-06-10
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D009727 2003
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D009727 1998
% 215.56/215.71  |- mesh__publicMeSHNote mesh__D009727 67   
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D009727 2000
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D009727 2004
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D009727 1999
% 215.56/215.71  |- skos__broader mesh__D009727smesh__D009726
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D009727 2001
% 215.56/215.71  |- rdf__type mesh__D009727sskos__Concept
% 215.56/215.71  |- skos__hiddenLabel mesh__D001744 Vesical Calculus
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D001744 2004
% 215.56/215.71  |- skos__broader mesh__D001744smesh__D001745
% 215.56/215.71  |- skos__hiddenLabel mesh__D001744 Stone, Bladder
% 215.56/215.71  |- skos__broader mesh__D001744smesh__D014545
% 215.56/215.71  |- skos__hiddenLabel mesh__D001744 Calculi, Bladder
% 215.56/215.71  |- skos__altLabel mesh__D001744 Cystoliths
% 215.56/215.71  |- mesh__dateCreated mesh__D001744 1999-01-01
% 215.56/215.71  |- mesh__activeMeSHYear mesh__D001744 2002
% 215.56/215.71  |- mesh__dateRevised mesh__D001744 2005-07-30
% 215.56/215.71  |- skos__hiddenLabel mesh__D001744 Bladder Calculus
% 215.56/215.71  |- mesh__recordMaintainer mesh__D001744 jls
% 215.56/215.71  |- skos__hiddenLabel mesh__D001744 Stones, Bladder
% 215.57/215.71  |- mesh__recordOriginator mesh__D001744 NLM
% 215.57/215.71  |- skos__hiddenLabel mesh__D001744 Cystolith
% 215.57/215.71  |- mesh__activeMeSHYear mesh__D001744 2005
% 215.57/215.71  |- mesh__activeMeSHYear mesh__D001744 2000
% 215.57/215.71  |- skos__prefLabel mesh__D001744 Bladder Calculi
% 215.57/215.71  |- skos__altLabel mesh__D001744 Bladder Stones
% 215.57/215.71  |- skos__altLabel mesh__D001744 Vesical Calculi
% 215.57/215.71  |- mesh__activeMeSHYear mesh__D001744 2006A
% 215.57/215.71  |- skos__hiddenLabel mesh__D001744 Bladder Stone
% 215.57/215.71  |- mesh__onlineNote mesh__D001744
% 215.57/215.71       to search for chem composition of bladder calculi, use BLADDER CALCULI/anal 1987-90 %26% BLADDER CALCULI/metab 1966-86%A%  
% 215.57/215.71  |- mesh__activeMeSHYear mesh__D001744 2006
% 215.57/215.71  |- skos__hiddenLabel mesh__D001744 Calculus, Bladder
% 215.57/215.71  |- mesh__activeMeSHYear mesh__D001744 2001
% 215.57/215.71  |- rdf__type mesh__D001744sskos__Concept
% 215.57/215.71  |- mesh__recordAuthorizer mesh__D001744 jls
% 215.57/215.71  |- mesh__activeMeSHYear mesh__D001744 2003
% 215.57/215.72  |- skos__hiddenLabel mesh__D001744 Calculi, Vesical
% 215.57/215.72  |- skos__annotation mesh__D001744
% 215.57/215.72       chem composition of calculi: use /chem; /ultrastruct permitted%A%  
% 215.57/215.72  |- skos__hiddenLabel mesh__D001744 Calculus, Vesical
% 215.57/215.72  |- skos__scopeNote mesh__D001744
% 215.57/215.72       Calculi of the urinary bladder; also known as vesical calculi or bladder stones, and cystoliths.%A%    
% 215.57/215.72  |- mesh__dateCreated mesh__D020100 1998-06-10
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D020100 2004
% 215.57/215.72  |- skos__historyNote mesh__D020100
% 215.57/215.72       Biocompatible Materials %28%1975-1998%29%
% 215.57/215.72  |- mesh__dateEstablished mesh__D020100 1999-01-01
% 215.57/215.72  |- skos__scopeNote mesh__D020100
% 215.57/215.72       Water swollen, rigid, 3-dimensional network of cross-linked, hydrophilic macromolecules, 20-95%25% water. They are used in paints, printing inks, foodstuffs, pharmaceuticals, and cosmetics. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 215.57/215.72  |- skos__prefLabel mesh__D020100 Hydrogels
% 215.57/215.72  |- skos__annotation mesh__D020100 HYDROGEL is also available   
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D020100 2005
% 215.57/215.72  |- rdf__type mesh__D020100sskos__Concept
% 215.57/215.72  |- mesh__dateRevised mesh__D020100 2003-07-09
% 215.57/215.72  |- skos__broader mesh__D020100smesh__D005782
% 215.57/215.72  |- mesh__historyNote mesh__D020100 99   
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D020100 2006
% 215.57/215.72  |- mesh__publicMeSHNote mesh__D020100 99   
% 215.57/215.72  |- skos__scopeNote mesh__D047048
% 215.57/215.72       Major egg yolk proteins from egg-laying animals such as non-mammalian VERTEBRATES; ARTHROPODS; and others. They are high-density lipoglycoproteins derived from circulating precursors, VITELLOGENINS. Vitellins serve as nutrients for the growing non-mammalian embryos %28%EMBRYO, NONMAMMALIAN%29%.%A%    
% 215.57/215.72  |- skos__historyNote mesh__D047048 Egg Proteins %28%1972-2004%29%
% 215.57/215.72  |- skos__historyNote mesh__D047048 Vitellogenin %28%1978-2004%29%
% 215.57/215.72  |- mesh__dateRevised mesh__D047048 2005-06-30
% 215.57/215.72  |- mesh__dateEstablished mesh__D047048 2005-01-01
% 215.57/215.72  |- mesh__recordMaintainer mesh__D047048 SYSTEM
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D047048 2006
% 215.57/215.72  |- mesh__publicMeSHNote mesh__D047048 2005; see EGG PROTEINS 1989-2004   
% 215.57/215.72  |- mesh__historyNote mesh__D047048 2005; use EGG PROTEINS 1989-2004   
% 215.57/215.72  |- mesh__dateCreated mesh__D047048 2004-07-07
% 215.57/215.72  |- mesh__recordAuthorizer mesh__D047048 sjn
% 215.57/215.72  |- skos__broader mesh__D047048smesh__D004527
% 215.57/215.72  |- skos__prefLabel mesh__D047048 Vitellins
% 215.57/215.72  |- rdf__type mesh__D047048sskos__Concept
% 215.57/215.72  |- skos__altLabel mesh__D047048 Vitellin
% 215.57/215.72  |- mesh__recordOriginator mesh__D047048 lkt
% 215.57/215.72  |- mesh__recordAuthorizer mesh__D019357 sjn
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D019357 2005
% 215.57/215.72  |- rdf__type mesh__D019357sskos__Concept
% 215.57/215.72  |- mesh__onlineNote mesh__D019357
% 215.57/215.72       use CITRIC ACID %28%NM%29% to search POTASSIUM CITRATE 1980-96   
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D019357 2002
% 215.57/215.72  |- skos__broader mesh__D019357smesh__D002951
% 215.57/215.72  |- skos__hiddenLabel mesh__D019357 Anhydrous, Potassium Citrate
% 215.57/215.72  |- mesh__dateRevised mesh__D019357 2000-06-21
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D019357 2004
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D019357 2001
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D019357 2003
% 215.57/215.72  |- skos__hiddenLabel mesh__D019357 Citrate, Potassium
% 215.57/215.72  |- mesh__publicMeSHNote mesh__D019357
% 215.57/215.72       97; POTASSIUM CITRATE was indexed under CITRATES 1979-96   
% 215.57/215.72  |- skos__historyNote mesh__D019357 Citrates %28%1979-1996%29%
% 215.57/215.72  |- skos__scopeNote mesh__D019357
% 215.57/215.72       A powder that dissolves in water, which is administered orally, and is used as a diuretic, expectorant, systemic alkalizer, and electrolyte replenisher.%A%    
% 215.57/215.72  |- mesh__recordOriginator mesh__D019357 ADP
% 215.57/215.72  |- mesh__historyNote mesh__D019357
% 215.57/215.72       97; POTASSIUM CITRATE was SY to CITRIC ACID %28%NM%29% 1979-96   
% 215.57/215.72  |- mesh__recordMaintainer mesh__D019357 CCR
% 215.57/215.72  |- mesh__dateEstablished mesh__D019357 1997-01-01
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D019357 2006
% 215.57/215.72  |- skos__prefLabel mesh__D019357 Potassium Citrate
% 215.57/215.72  |- mesh__dateCreated mesh__D019357 1996-06-10
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D011374 2006
% 215.57/215.72  |- skos__broader mesh__D011374smesh__D003339
% 215.57/215.72  |- skos__scopeNote mesh__D011374
% 215.57/215.72       The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS.%A%    
% 215.57/215.72  |- skos__prefLabel mesh__D011374 Progesterone
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D011374 2005
% 215.57/215.72  |- mesh__dateRevised mesh__D011374 2005-07-13
% 215.57/215.72  |- skos__broader mesh__D011374smesh__D011282
% 215.57/215.72  |- mesh__dateCreated mesh__D011374 1999-01-01
% 215.57/215.72  |- rdf__type mesh__D011374sskos__Concept
% 215.57/215.72  |- skos__altLabel mesh__D011374 Pregnenedione
% 215.57/215.72  |- mesh__recordAuthorizer mesh__D011374 ags
% 215.57/215.72  |- mesh__recordMaintainer mesh__D011374 ags
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D011374 2004
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D011374 2006A
% 215.57/215.72  |- skos__related mesh__D011374smesh__D011980
% 215.57/215.72  |- mesh__recordOriginator mesh__D011374 NLM
% 215.57/215.72  |- skos__broader mesh__D011374smesh__D045167
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D011374 2005A
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D005337 2004
% 215.57/215.72  |- mesh__recordMaintainer mesh__D005337 adp
% 215.57/215.72  |- mesh__recordAuthorizer mesh__D005337 sjn
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D005337 2006
% 215.57/215.72  |- mesh__dateCreated mesh__D005337 1999-01-01
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D005337 2003
% 215.57/215.72  |- skos__prefLabel mesh__D005337 Fibrin
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D005337 2005
% 215.57/215.72  |- skos__broader mesh__D005337smesh__D001798
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D005337 2002
% 215.57/215.72  |- skos__hiddenLabel mesh__D005337 I, Antithrombin
% 215.57/215.72  |- mesh__dateRevised mesh__D005337 2000-06-21
% 215.57/215.72  |- mesh__recordOriginator mesh__D005337 NLM
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D005337 2001
% 215.57/215.72  |- skos__scopeNote mesh__D005337
% 215.57/215.72       A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot.%A%    
% 215.57/215.72  |- rdf__type mesh__D005337sskos__Concept
% 215.57/215.72  |- skos__scopeNote mesh__D029785
% 215.57/215.72       The sedge plant family of the order Cyperales, subclass Commelinidae, class Liliopsida %28%monocotyledons%29%%A%    
% 215.57/215.72  |- skos__broader mesh__D029785smesh__D019684
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D029785 2002
% 215.57/215.72  |- mesh__dateCreated mesh__D029785 2001-07-25
% 215.57/215.72  |- mesh__dateEstablished mesh__D029785 2002-01-01
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D029785 2006
% 215.57/215.72  |- mesh__publicMeSHNote mesh__D029785 2002   
% 215.57/215.72  |- skos__prefLabel mesh__D029785 Cyperaceae
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D029785 2005
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D029785 2004
% 215.57/215.72  |- rdf__type mesh__D029785sskos__Concept
% 215.57/215.72  |- skos__annotation mesh__D029785
% 215.57/215.72       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D029785 2003
% 215.57/215.72  |- mesh__historyNote mesh__D029785 2002   
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D015765 2006
% 215.57/215.72  |- skos__hiddenLabel mesh__D015765 Monomesylate, Almitrine
% 215.57/215.72  |- skos__altLabel mesh__D015765 Servier Brand of Almitrine Dimesilate
% 215.57/215.72  |- mesh__recordAuthorizer mesh__D015765 sjn
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D015765 2005
% 215.57/215.72  |- skos__broader mesh__D015765smesh__D014227
% 215.57/215.72  |- skos__altLabel mesh__D015765
% 215.57/215.72       Euth%C3%%A9%rapie Brand of Almitrine Dimesilate
% 215.57/215.72  |- skos__historyNote mesh__D015765 Analeptics %28%1966-1989%29%
% 215.57/215.72  |- skos__altLabel mesh__D015765 Almitrine Bis%28%methanesulfonate%29%
% 215.57/215.72  |- skos__altLabel mesh__D015765 Almitrine Bismesylate
% 215.57/215.72  |- rdf__type mesh__D015765sskos__Concept
% 215.57/215.72  |- skos__scopeNote mesh__D015765
% 215.57/215.72       A respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug increases arterial oxygen tension while decreasing arterial carbon dioxide tension in patients with chronic obstructive pulmonary disease. It may also prove useful in the treatment of nocturnal oxygen desaturation without impairing the quality of sleep.%A%    
% 215.57/215.72  |- skos__historyNote mesh__D015765 Piperazines %28%1966-1989%29%
% 215.57/215.72  |- mesh__publicMeSHNote mesh__D015765 90   
% 215.57/215.72  |- mesh__recordMaintainer mesh__D015765 mdb
% 215.57/215.72  |- mesh__recordOriginator mesh__D015765 RLS
% 215.57/215.72  |- mesh__dateEstablished mesh__D015765 1990-01-01
% 215.57/215.72  |- mesh__dateCreated mesh__D015765 1989-05-15
% 215.57/215.72  |- mesh__dateRevised mesh__D015765 2004-07-07
% 215.57/215.72  |- mesh__historyNote mesh__D015765 90   
% 215.57/215.72  |- skos__prefLabel mesh__D015765 Almitrine
% 215.57/215.72  |- skos__broader mesh__D015765smesh__D010879
% 215.57/215.72  |- mesh__recordAuthorizer mesh__D009728 SJN
% 215.57/215.72  |- skos__hiddenLabel mesh__D009728 Nursing Auxiliary
% 215.57/215.72  |- skos__scopeNote mesh__D009728
% 215.57/215.72       Allied health personnel who assist the professional nurse in routine duties.%A%    
% 215.57/215.72  |- mesh__recordMaintainer mesh__D009728 TGC
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D009728 2002
% 215.57/215.72  |- skos__altLabel mesh__D009728 Nursing Auxiliaries
% 215.57/215.72  |- skos__hiddenLabel mesh__D009728 Auxiliaries, Nursing
% 215.57/215.72  |- mesh__dateRevised mesh__D009728 1997-06-20
% 215.57/215.72  |- skos__hiddenLabel mesh__D009728 Aide, Nurses%27%
% 215.57/215.72  |- skos__hiddenLabel mesh__D009728 Nurses%27% Aide
% 215.57/215.72  |- skos__hiddenLabel mesh__D009728 Aides, Nurses%27%
% 215.57/215.72  |- skos__hiddenLabel mesh__D009728 Nurses Aides
% 215.57/215.72  |- skos__broader mesh__D009728smesh__D000488
% 215.57/215.72  |- skos__hiddenLabel mesh__D009728 Nurse%27%s Aides
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D009728 2005
% 215.57/215.72  |- skos__prefLabel mesh__D009728 Nurses%27% Aides
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D009728 1998
% 215.57/215.72  |- skos__hiddenLabel mesh__D009728 Auxiliary, Nursing
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D009728 2000
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D009728 2003
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D009728 2006
% 215.57/215.72  |- mesh__recordOriginator mesh__D009728 NLM
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D009728 1999
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D009728 2001
% 215.57/215.72  |- rdf__type mesh__D009728sskos__Concept
% 215.57/215.72  |- mesh__dateCreated mesh__D009728 1999-01-01
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D009728 2004
% 215.57/215.72  |- skos__hiddenLabel mesh__D009728 Nurse Aides
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D001745 1995
% 215.57/215.72  |- mesh__recordAuthorizer mesh__D001745 PLS
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D001745 1992
% 215.57/215.72  |- skos__hiddenLabel mesh__D001745 Bladder Disease
% 215.57/215.72  |- skos__hiddenLabel mesh__D001745 Diseases, Bladder
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D001745 1999
% 215.57/215.72  |- skos__hiddenLabel mesh__D001745 Cystoceles
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D001745 2005
% 215.57/215.72  |- skos__prefLabel mesh__D001745 Bladder Diseases
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D001745 1996
% 215.57/215.72  |- skos__hiddenLabel mesh__D001745 Disease, Bladder
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D001745 1993
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D001745 2002
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D001745 2006
% 215.57/215.72  |- rdf__type mesh__D001745sskos__Concept
% 215.57/215.72  |- mesh__dateRevised mesh__D001745 1991-11-02
% 215.57/215.72  |- mesh__recordOriginator mesh__D001745 NLM
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D001745 1997
% 215.57/215.72  |- skos__annotation mesh__D001745
% 215.57/215.72       GEN: prefer specifics; inflamm dis = CYSTITIS   
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D001745 2003
% 215.57/215.72  |- skos__broader mesh__D001745smesh__D014570
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D001745 2000
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D001745 2004
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D001745 1994
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D001745 2001
% 215.57/215.72  |- mesh__recordMaintainer mesh__D001745 PLS
% 215.57/215.72  |- mesh__dateCreated mesh__D001745 1999-01-01
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D001745 1998
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D034121 2006
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D034121 2005A
% 215.57/215.72  |- skos__scopeNote mesh__D034121
% 215.57/215.72       Health care services related to human REPRODUCTION and diseases of the reproductive system. Services are provided to both sexes and usually by physicians in the medical or the surgical specialities such as REPRODUCTIVE MEDICINE; ANDROLOGY; GYNECOLOGY; OBSTETRICS; and PERINATOLOGY.%A%    
% 215.57/215.72  |- skos__related mesh__D034121smesh__D012099
% 215.57/215.72  |- mesh__recordMaintainer mesh__D034121 jls
% 215.57/215.72  |- skos__hiddenLabel mesh__D034121 Health Services, Reproductive
% 215.57/215.72  |- skos__hiddenLabel mesh__D034121 Health Service, Reproductive
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D034121 2005
% 215.57/215.72  |- mesh__recordAuthorizer mesh__D034121 jls
% 215.57/215.72  |- skos__broader mesh__D034121smesh__D006296
% 215.57/215.72  |- skos__historyNote mesh__D034121 Family Planning %28%1983-2002%29%
% 215.57/215.72  |- skos__hiddenLabel mesh__D034121 Service, Reproductive Health
% 215.57/215.72  |- skos__hiddenLabel mesh__D034121 Services, Reproductive Health
% 215.57/215.72  |- mesh__recordOriginator mesh__D034121 lkt
% 215.57/215.72  |- mesh__publicMeSHNote mesh__D034121 2003   
% 215.57/215.72  |- skos__hiddenLabel mesh__D034121 Reproductive Health Service
% 215.57/215.72  |- rdf__type mesh__D034121sskos__Concept
% 215.57/215.72  |- mesh__historyNote mesh__D034121 2003   
% 215.57/215.72  |- mesh__dateCreated mesh__D034121 2002-07-03
% 215.57/215.72  |- mesh__dateEstablished mesh__D034121 2003-01-01
% 215.57/215.72  |- skos__prefLabel mesh__D034121 Reproductive Health Services
% 215.57/215.72  |- mesh__dateRevised mesh__D034121 2004-08-02
% 215.57/215.72  |- mesh__recordOriginator mesh__D006430 NLM
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D006430 2004
% 215.57/215.72  |- mesh__dateRevised mesh__D006430 2003-07-09
% 215.57/215.72  |- skos__annotation mesh__D006430
% 215.57/215.72       do not use /drug eff for insecticides: TN 111   
% 215.57/215.72  |- skos__broader mesh__D006430smesh__D007313
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D006430 2005
% 215.57/215.72  |- mesh__dateCreated mesh__D006430 1999-01-01
% 215.57/215.72  |- mesh__recordMaintainer mesh__D006430 ags
% 215.57/215.72  |- mesh__recordAuthorizer mesh__D006430 sjn
% 215.57/215.72  |- skos__prefLabel mesh__D006430 Hemiptera
% 215.57/215.72  |- rdf__type mesh__D006430sskos__Concept
% 215.57/215.72  |- mesh__historyNote mesh__D006430 75   
% 215.57/215.72  |- skos__scopeNote mesh__D006430
% 215.57/215.72       A large order of insects characterized by having the mouth parts adapted to piercing or sucking. It is comprised of four suborders: HETEROPTERA, Auchenorrhyncha, Sternorrhyncha, and Coleorrhyncha.%A%    
% 215.57/215.72  |- mesh__dateEstablished mesh__D006430 1975-01-01
% 215.57/215.72  |- skos__historyNote mesh__D006430 Insects %28%1966-1974%29%
% 215.57/215.72  |- mesh__publicMeSHNote mesh__D006430 75   
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D006430 2006
% 215.57/215.72  |- mesh__dateEstablished mesh__D020101 1999-01-01
% 215.57/215.72  |- skos__broader mesh__D020101smesh__D013084
% 215.57/215.72  |- mesh__recordOriginator mesh__D020101 NDW
% 215.57/215.72  |- skos__scopeNote mesh__D020101
% 215.57/215.72       Changes that occur to liberate the enzymes of the ACROSOME of a sperm %28%SPERMATOZOA%29%. Acrosome reaction allows the sperm to penetrate the ZONA PELLUCIDA and enter the OVUM during FERTILIZATION.%A%    
% 215.57/215.72  |- mesh__recordAuthorizer mesh__D020101 sjn
% 215.57/215.72  |- skos__prefLabel mesh__D020101 Acrosome Reaction
% 215.57/215.72  |- skos__hiddenLabel mesh__D020101 Reactions, Acrosome
% 215.57/215.72  |- mesh__dateRevised mesh__D020101 2004-07-07
% 215.57/215.72  |- rdf__type mesh__D020101sskos__Concept
% 215.57/215.72  |- skos__historyNote mesh__D020101 Acrosome/physiology %28%1975-1998%29%
% 215.57/215.72  |- skos__related mesh__D020101smesh__D000177
% 215.57/215.72  |- skos__hiddenLabel mesh__D020101 Reaction, Acrosome
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D020101 2005
% 215.57/215.72  |- mesh__recordMaintainer mesh__D020101 lkt
% 215.57/215.72  |- skos__hiddenLabel mesh__D020101 Acrosome Reactions
% 215.57/215.72  |- mesh__historyNote mesh__D020101 99   
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D020101 2006
% 215.57/215.72  |- mesh__dateCreated mesh__D020101 1998-06-10
% 215.57/215.72  |- skos__historyNote mesh__D020101 Spermatozoa %28%1966-1974%29%
% 215.57/215.72  |- mesh__publicMeSHNote mesh__D020101 99   
% 215.57/215.72  |- mesh__dateEstablished mesh__D019358 1997-01-01
% 215.57/215.72  |- skos__hiddenLabel mesh__D019358 Fat Substitute
% 215.57/215.72  |- mesh__historyNote mesh__D019358
% 215.57/215.72       97; was FAT SUBSTITUTES %28%NM%29% 1990-96   
% 215.57/215.72  |- mesh__publicMeSHNote mesh__D019358
% 215.57/215.72       97; FAT SUBSTITUTES was indexed under DIETARY PROTEINS 1994-96 %26% PROTEINS 1990-93%A%  
% 215.57/215.72  |- skos__hiddenLabel mesh__D019358 Fat, Artificial
% 215.57/215.72  |- mesh__dateRevised mesh__D019358 2003-07-09
% 215.57/215.72  |- skos__scopeNote mesh__D019358
% 215.57/215.72       Compounds used in food or in food preparation to replace dietary fats. They may be carbohydrate-, protein-, or fat-based. Fat substitutes are usually lower in calories but provide the same texture as fats.%A%    
% 215.57/215.72  |- skos__hiddenLabel mesh__D019358 Fats, Artificial
% 215.57/215.72  |- mesh__dateCreated mesh__D019358 1996-06-10
% 215.57/215.72  |- mesh__recordAuthorizer mesh__D019358 sjn
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D019358 2006
% 215.57/215.72  |- skos__altLabel mesh__D019358 Artificial Fats
% 215.57/215.72  |- mesh__onlineNote mesh__D019358
% 215.57/215.72       use FAT SUBSTITUTES %28%NM%29% to search FAT SUBSTITUTES 1990-96%A%  
% 215.57/215.72  |- skos__historyNote mesh__D019358 Dietary Proteins %28%1994-1996%29%
% 215.57/215.72  |- rdf__type mesh__D019358sskos__Concept
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D019358 2005
% 215.57/215.72  |- skos__hiddenLabel mesh__D019358 Artificial Fat
% 215.57/215.72  |- skos__hiddenLabel mesh__D019358 Substitutes, Fat
% 215.57/215.72  |- skos__prefLabel mesh__D019358 Fat Substitutes
% 215.57/215.72  |- skos__annotation mesh__D019358
% 215.57/215.72       IM; coord with specific substitute %28%IM%29% if pertinent; D25-26 qualif%A%  
% 215.57/215.72  |- skos__historyNote mesh__D019358 Proteins %28%1990-1993%29%
% 215.57/215.72  |- skos__hiddenLabel mesh__D019358 Substitute, Fat
% 215.57/215.72  |- mesh__recordMaintainer mesh__D019358 ssb
% 215.57/215.72  |- mesh__recordOriginator mesh__D019358 TPW
% 215.57/215.72  |- skos__broader mesh__D019358smesh__D005503
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D019358 2004
% 215.57/215.72  |- skos__altLabel mesh__D011375
% 215.57/215.72       3 beta-Hydroxy-delta-5-Steroid Dehydrogenase
% 215.57/215.72  |- mesh__dateCreated mesh__D011375 1974-11-19
% 215.57/215.72  |- skos__prefLabel mesh__D011375 Progesterone Reductase
% 215.57/215.72  |- mesh__recordMaintainer mesh__D011375 ssb
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D011375 2005
% 215.57/215.72  |- mesh__publicMeSHNote mesh__D011375
% 215.57/215.72       91; was see under 3-HYDROXYSTEROID DEHYDROGENASES 1975-90%A%  
% 215.57/215.72  |- skos__hiddenLabel mesh__D011375 Reductase, Progesterone
% 215.57/215.72  |- skos__altLabel mesh__D011375
% 215.57/215.72       Steroid delta%28%5%29%-3 beta-ol Dehydrogenase
% 215.57/215.72  |- mesh__recordOriginator mesh__D011375 NLM
% 215.57/215.72  |- skos__hiddenLabel mesh__D011375
% 215.57/215.72       Dehydrogenase, 5-Ene-3 beta-hydroxysteroid
% 215.57/215.72  |- skos__historyNote mesh__D011375
% 215.57/215.72       Hydroxysteroid Dehydrogenases %28%1972-1974%29%
% 215.57/215.72  |- mesh__dateRevised mesh__D011375 2003-07-09
% 215.57/215.72  |- rdf__type mesh__D011375sskos__Concept
% 215.57/215.72  |- mesh__historyNote mesh__D011375
% 215.57/215.72       91%28%75%29%; was see under 3-HYDROXYSTEROID DEHYDROGENASES 1975-90%A%  
% 215.57/215.72  |- mesh__recordAuthorizer mesh__D011375 sjn
% 215.57/215.72  |- skos__broader mesh__D011375smesh__D015096
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D011375 2004
% 215.57/215.72  |- mesh__dateEstablished mesh__D011375 1991-01-01
% 215.57/215.72  |- skos__altLabel mesh__D011375 5-Ene-3 beta-hydroxysteroid Dehydrogenase
% 215.57/215.72  |- skos__hiddenLabel mesh__D011375
% 215.57/215.72       5 Ene 3 beta hydroxysteroid Dehydrogenase
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D011375 2006
% 215.57/215.72  |- skos__hiddenLabel mesh__D011375
% 215.57/215.72       Dehydrogenase, 3 beta-Hydroxy-delta-5-Steroid
% 215.57/215.72  |- skos__hiddenLabel mesh__D011375
% 215.57/215.72       3 beta Hydroxy delta 5 Steroid Dehydrogenase
% 215.57/215.72  |- skos__scopeNote mesh__D011375
% 215.57/215.72       An enzyme that catalyzes the reduction of a 3 beta-hydroxy-delta%28%5%29%-steroid to 3-oxo-delta%28%4%29%-steroid in the presence of NAD. It converts pregnenolone to progesterone and dehydroepiandrosterone to androstenedione. EC 1.1.1.145.%A%    
% 215.57/215.72  |- skos__annotation mesh__D005338 in texts as FDP; DF: FFDP   
% 215.57/215.72  |- skos__altLabel mesh__D005338 Fibrin Fibrinogen Split Products
% 215.57/215.72  |- skos__hiddenLabel mesh__D005338 Degradation Products, Fibrin
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D005338 2005
% 215.57/215.72  |- mesh__dateCreated mesh__D005338 1975-07-25
% 215.57/215.72  |- skos__scopeNote mesh__D005338
% 215.57/215.72       Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis.%A%    
% 215.57/215.72  |- mesh__recordAuthorizer mesh__D005338 sjn
% 215.57/215.72  |- skos__broader mesh__D005338smesh__D005340
% 215.57/215.72  |- skos__broader mesh__D005338smesh__D005337
% 215.57/215.72  |- mesh__dateEstablished mesh__D005338 1976-01-01
% 215.57/215.72  |- mesh__recordMaintainer mesh__D005338 ssb
% 215.57/215.72  |- mesh__dateRevised mesh__D005338 2003-07-22
% 215.57/215.72  |- skos__altLabel mesh__D005338 Antithrombin VI
% 215.57/215.72  |- skos__historyNote mesh__D005338 Fibrinogen/metabolism %28%1970-1975%29%
% 215.57/215.72  |- mesh__publicMeSHNote mesh__D005338 76   
% 215.57/215.72  |- rdf__type mesh__D005338sskos__Concept
% 215.57/215.72  |- mesh__historyNote mesh__D005338 76   
% 215.57/215.72  |- skos__altLabel mesh__D005338 Fibrin Degradation Products
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D005338 2004
% 215.57/215.72  |- skos__historyNote mesh__D005338 Fibrin/metabolism %28%1970-1975%29%
% 215.57/215.72  |- skos__prefLabel mesh__D005338 Fibrin Fibrinogen Degradation Products
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D005338 2006
% 215.57/215.72  |- mesh__recordOriginator mesh__D005338 RLS
% 215.57/215.72  |- mesh__recordOriginator mesh__D016060 AGS
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D016060 2001
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D016060 1997
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D016060 2005
% 215.57/215.72  |- skos__altLabel mesh__D016060 Sorption Detoxication
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D016060 2000
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D016060 1996
% 215.57/215.72  |- skos__hiddenLabel mesh__D016060 Sorption Detoxifications
% 215.57/215.72  |- skos__annotation mesh__D016060
% 215.57/215.72       do not use /util except by MeSH definition; DF: SORPTION DETOX%A%  
% 215.57/215.72  |- skos__broader mesh__D016060smesh__D013812
% 215.57/215.72  |- mesh__recordMaintainer mesh__D016060 TGC
% 215.57/215.72  |- skos__historyNote mesh__D016060 Adsorption %28%1977-1982%29%
% 215.57/215.72  |- mesh__publicMeSHNote mesh__D016060 91   
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D016060 1999
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D016060 2004
% 215.57/215.72  |- skos__hiddenLabel mesh__D016060 Detoxifications, Sorption
% 215.57/215.72  |- rdf__type mesh__D016060sskos__Concept
% 215.57/215.72  |- skos__hiddenLabel mesh__D016060 Sorption Detoxications
% 215.57/215.72  |- skos__hiddenLabel mesh__D016060 Detoxification, Sorption
% 215.57/215.72  |- mesh__dateRevised mesh__D016060 1993-06-03
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D016060 2002
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D016060 1995
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D016060 1998
% 215.57/215.72  |- mesh__recordAuthorizer mesh__D016060 PLS
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D016060 2003
% 215.57/215.72  |- mesh__historyNote mesh__D016060 91   
% 215.57/215.72  |- skos__hiddenLabel mesh__D016060 Detoxications, Sorption
% 215.57/215.72  |- mesh__dateCreated mesh__D016060 1990-02-12
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D016060 1994
% 215.57/215.72  |- mesh__dateEstablished mesh__D016060 1991-01-01
% 215.57/215.72  |- skos__prefLabel mesh__D016060 Sorption Detoxification
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D016060 2006
% 215.57/215.72  |- skos__scopeNote mesh__D016060
% 215.57/215.72       Elimination of toxic or biologically active substances from body fluids by interaction with a sorbent medium. The types of media include absorbents, adsorbents, ion-exchange materials, and complexing agents. Detoxification can be extracorporeal %28%hemodialysis, hemofiltration, hemoperfusion, plasmapheresis%29%, or occur inside the body %28%enterosorption, peritoneal dialysis%29%.%A%    
% 215.57/215.72  |- skos__historyNote mesh__D016060 Hemoperfusion %28%1983-1990%29%
% 215.57/215.72  |- skos__altLabel mesh__D016060 Detoxication, Sorption
% 215.57/215.72  |- mesh__historyNote mesh__D002040
% 215.57/215.72       91%28%72%29%; was BUNOLOL 1972-90 %28%Prov 1972%29%   
% 215.57/215.72  |- mesh__dateRevised mesh__D002040 2005-06-30
% 215.57/215.72  |- skos__scopeNote mesh__D002040
% 215.57/215.72       A nonselective beta-adrenoceptor antagonist used in the treatment of glaucoma.%A%    
% 215.57/215.72  |- skos__historyNote mesh__D002040 Sympatholytics %28%1966-1971%29%
% 215.57/215.72  |- skos__hiddenLabel mesh__D002040 PMSLevobunolol
% 215.57/215.72  |- skos__altLabel mesh__D002040 Apotex Brand of Levobunolol Hydrochloride
% 215.57/215.72  |- skos__broader mesh__D002040smesh__D050198
% 215.57/215.72  |- skos__altLabel mesh__D002040 Allergan Brand of Levobunolol Hydrochloride
% 215.57/215.72  |- skos__altLabel mesh__D002040 Akorn Brand of Levobunolol Hydrochloride
% 215.57/215.72  |- mesh__publicMeSHNote mesh__D002040 91; was BUNOLOL 1973-90   
% 215.57/215.72  |- skos__hiddenLabel mesh__D002040
% 215.57/215.72       Pharm Allergan Brand of Levobunolol Hydrochloride
% 215.57/215.72  |- rdf__type mesh__D002040sskos__Concept
% 215.57/215.72  |- skos__historyNote mesh__D002040 Amino Alcohols %28%1966-1971%29%
% 215.57/215.72  |- skos__hiddenLabel mesh__D002040 PMS Levobunolol
% 215.57/215.72  |- mesh__recordMaintainer mesh__D002040 ssb
% 215.57/215.72  |- mesh__dateEstablished mesh__D002040 1973-01-01
% 215.57/215.72  |- mesh__recordOriginator mesh__D002040 NLM
% 215.57/215.72  |- skos__hiddenLabel mesh__D002040 NovoLevobunolol
% 215.57/215.72  |- skos__prefLabel mesh__D002040 Levobunolol
% 215.57/215.72  |- skos__hiddenLabel mesh__D002040 Novo Levobunolol
% 215.57/215.72  |- skos__hiddenLabel mesh__D002040 ApoLevobunolol
% 215.57/215.72  |- mesh__recordAuthorizer mesh__D002040 sjn
% 215.57/215.72  |- skos__altLabel mesh__D002040
% 215.57/215.72       Novopharm Brand of Levobunolol Hydrochloride
% 215.57/215.72  |- skos__hiddenLabel mesh__D002040 Apo Levobunolol
% 215.57/215.72  |- skos__hiddenLabel mesh__D002040 ratio Levobunolol
% 215.57/215.72  |- skos__broader mesh__D002040smesh__D013764
% 215.57/215.72  |- skos__hiddenLabel mesh__D002040 W 6412A
% 215.57/215.72  |- skos__altLabel mesh__D002040
% 215.57/215.72       Ratiopharm Brand of Levobunolol Hydrochloride
% 215.57/215.72  |- skos__hiddenLabel mesh__D002040 W6412A
% 215.57/215.72  |- mesh__onlineNote mesh__D002040
% 215.57/215.72       use LEVOBUNOLOL to search BUNOLOL 1972-90 %28%as Prov 1972%29%   
% 215.57/215.72  |- skos__broader mesh__D002040smesh__D011412
% 215.57/215.72  |- skos__altLabel mesh__D002040
% 215.57/215.72       Ciba Vision Brand of Levobunolol Hydrochloride
% 215.57/215.72  |- skos__hiddenLabel mesh__D002040 W7000A
% 215.57/215.72  |- mesh__dateCreated mesh__D002040 1999-01-01
% 215.57/215.72  |- mesh__activeMeSHYear mesh__D002040 2006
% 215.57/215.73  |- skos__altLabel mesh__D002040
% 215.57/215.73       Pharm-Allergan Brand of Levobunolol Hydrochloride
% 215.57/215.73  |- skos__hiddenLabel mesh__D002040 W 7000A
% 215.57/215.73  |- skos__altLabel mesh__D002040
% 215.57/215.73       Pharmascience Brand of Levobunolol Hydrochloride
% 215.57/215.73  |- skos__prefLabel mesh__D029786 Cyperus
% 215.57/215.73  |- mesh__historyNote mesh__D029786 2002   
% 215.57/215.73  |- skos__broader mesh__D029786smesh__D029785
% 215.57/215.73  |- skos__scopeNote mesh__D029786
% 215.57/215.73       A plant genus of the family CYPERACEAE. SESQUITERPENES are found in some of the species.%A%    
% 215.57/215.73  |- mesh__dateEstablished mesh__D029786 2002-01-01
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D029786 2006
% 215.57/215.73  |- skos__altLabel mesh__D029786 Yellow Nutgrass
% 215.57/215.73  |- mesh__publicMeSHNote mesh__D029786 2002   
% 215.57/215.73  |- skos__annotation mesh__D029786
% 215.57/215.73       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D029786 2005
% 215.57/215.73  |- rdf__type mesh__D029786sskos__Concept
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D029786 2004
% 215.57/215.73  |- skos__altLabel mesh__D029786 Chufa
% 215.57/215.73  |- mesh__dateCreated mesh__D029786 2001-07-25
% 215.57/215.73  |- skos__altLabel mesh__D029786 Flatsedge
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D029786 2003
% 215.57/215.73  |- skos__altLabel mesh__D029786 Sedge, Nut
% 215.57/215.73  |- mesh__dateRevised mesh__D029786 2002-07-03
% 215.57/215.73  |- skos__altLabel mesh__D029786 Sedge, Flat
% 215.57/215.73  |- skos__altLabel mesh__D029786 Nut Sedge
% 215.57/215.73  |- mesh__dateRevised mesh__D015766 2004-07-07
% 215.57/215.73  |- skos__altLabel mesh__D015766
% 215.57/215.73       Smith Kline %26% French Brand of Albendazole
% 215.57/215.73  |- skos__altLabel mesh__D015766 Bilutac
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D015766 2005
% 215.57/215.73  |- skos__broader mesh__D015766smesh__D001562
% 215.57/215.73  |- skos__historyNote mesh__D015766 Anthelmintics %28%1966-1989%29%
% 215.57/215.73  |- mesh__publicMeSHNote mesh__D015766 90   
% 215.57/215.73  |- skos__altLabel mesh__D015766 Zentel
% 215.57/215.73  |- skos__broader mesh__D015766smesh__D002219
% 215.57/215.73  |- skos__altLabel mesh__D015766 Mediamix V Disthelm
% 215.57/215.73  |- skos__altLabel mesh__D015766 Fustery Brand of Albendazole
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D015766 2006
% 215.57/215.73  |- skos__historyNote mesh__D015766 Benzimidazoles %28%1966-1989%29%
% 215.57/215.73  |- skos__hiddenLabel mesh__D015766 SKF 62979
% 215.57/215.73  |- skos__hiddenLabel mesh__D015766 Albendazole Liferpal Brand
% 215.57/215.73  |- skos__hiddenLabel mesh__D015766 Monohydrochloride, Albendazole
% 215.57/215.73  |- mesh__recordAuthorizer mesh__D015766 sjn
% 215.57/215.73  |- skos__altLabel mesh__D015766 SmithKline Beecham Brand of Albendazole
% 215.57/215.73  |- skos__altLabel mesh__D015766 Valdecasas Brand of Albendazole
% 215.57/215.73  |- skos__altLabel mesh__D015766 Pfizer Brand of Albendazole
% 215.57/215.73  |- skos__hiddenLabel mesh__D015766 SK%26%F62979
% 215.57/215.73  |- mesh__recordOriginator mesh__D015766 RLS
% 215.57/215.73  |- skos__altLabel mesh__D015766 Armstrong Brand of Albendazole
% 215.57/215.73  |- skos__altLabel mesh__D015766 Liferpal Brand of Albendazole
% 215.57/215.73  |- skos__altLabel mesh__D015766 Albenza
% 215.57/215.73  |- skos__hiddenLabel mesh__D015766 SKF62979
% 215.57/215.73  |- rdf__type mesh__D015766sskos__Concept
% 215.57/215.73  |- skos__hiddenLabel mesh__D015766 Albendazole Hormona Brand
% 215.57/215.73  |- skos__hiddenLabel mesh__D015766 Albendazole Fustery Brand
% 215.57/215.73  |- skos__hiddenLabel mesh__D015766 Albendazole Pfizer Brand
% 215.57/215.73  |- skos__hiddenLabel mesh__D015766 Albendazole Armstrong Brand
% 215.57/215.73  |- skos__altLabel mesh__D015766 Hormona Brand of Albendazole
% 215.57/215.73  |- mesh__historyNote mesh__D015766 90   
% 215.57/215.73  |- mesh__dateCreated mesh__D015766 1989-05-15
% 215.57/215.73  |- skos__hiddenLabel mesh__D015766 V Disthelm, Mediamix
% 215.57/215.73  |- skos__hiddenLabel mesh__D015766 Albendazole Valdecasas Brand
% 215.57/215.73  |- mesh__dateEstablished mesh__D015766 1990-01-01
% 215.57/215.73  |- skos__hiddenLabel mesh__D015766 SK%26%F 62979
% 215.57/215.73  |- skos__altLabel mesh__D015766 Sanicoopa Brand of Albendazole
% 215.57/215.73  |- skos__altLabel mesh__D015766 No%C3%%A9% -Socopharm Brand of Albendazole
% 215.57/215.73  |- mesh__recordMaintainer mesh__D015766 ssb
% 215.57/215.73  |- skos__hiddenLabel mesh__D015766 Albendazole Diba Brand
% 215.57/215.73  |- skos__hiddenLabel mesh__D015766 Albendazole Sanicoopa Brand
% 215.57/215.73  |- skos__altLabel mesh__D015766 Diba Brand of Albendazole
% 215.57/215.73  |- skos__prefLabel mesh__D015766 Albendazole
% 215.57/215.73  |- skos__scopeNote mesh__D015766
% 215.57/215.73       A benzimidazole broad-spectrum anthelmintic structurally related to MEBENDAZOLE that is effective against many diseases. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p38%29%%A%    
% 215.57/215.73  |- skos__altLabel mesh__D015766 SKF-62979
% 215.57/215.73  |- skos__hiddenLabel mesh__D015766
% 215.57/215.73       No%C3%%A9%  Socopharm Brand of Albendazole
% 215.57/215.73  |- skos__hiddenLabel mesh__D015766 Disthelm, Mediamix V
% 215.57/215.73  |- mesh__recordOriginator mesh__D009729 NLM
% 215.57/215.73  |- skos__scopeNote mesh__D009729
% 215.57/215.73       The field of nursing care concerned with the promotion, maintenance, and restoration of health.%A%    
% 215.57/215.73  |- skos__broader mesh__D009729smesh__D006281
% 215.57/215.73  |- mesh__recordMaintainer mesh__D009729 jls
% 215.57/215.73  |- skos__related mesh__D009729smesh__D004471
% 215.57/215.73  |- skos__related mesh__D009729smesh__D004506
% 215.57/215.73  |- mesh__dateRevised mesh__D009729 2003-07-09
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D009729 2005
% 215.57/215.73  |- mesh__recordAuthorizer mesh__D009729 sjn
% 215.57/215.73  |- skos__annotation mesh__D009729
% 215.57/215.73       the nursing profession only: NURSING CARE is for patients; /legislation %26% jurisprudence = LEGISLATION, NURSING or NURSING %28%IM%29% + JURISPRUDENCE %28%IM%29%; available is /nurs: Manual 19.7+, 19.8.48; DF: NURS%A%  
% 215.57/215.73  |- skos__prefLabel mesh__D009729 Nursing
% 215.57/215.73  |- skos__related mesh__D009729smesh__D007884
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D009729 2006
% 215.57/215.73  |- skos__hiddenLabel mesh__D009729 Nursings
% 215.57/215.73  |- rdf__type mesh__D009729sskos__Concept
% 215.57/215.73  |- mesh__dateCreated mesh__D009729 1999-01-01
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D009729 2004
% 215.57/215.73  |- skos__related mesh__D009729smesh__D006676
% 215.57/215.73  |- skos__broader mesh__D009729smesh__D011364
% 215.57/215.73  |- skos__scopeNote mesh__D001746
% 215.57/215.73       A birth defect in which the urinary BLADDER is malformed and exposed, inside out, and protruded through the ABDOMINAL WALL. It is caused by closure defects involving the top front surface of the bladder, as well as the lower abdominal wall; SKIN; MUSCLES; and the pubic bone.%A%    
% 215.57/215.73  |- mesh__historyNote mesh__D001746 65%28%63%29%   
% 215.57/215.73  |- mesh__recordAuthorizer mesh__D001746 sjn
% 215.57/215.73  |- mesh__dateCreated mesh__D001746 1999-01-01
% 215.57/215.73  |- mesh__publicMeSHNote mesh__D001746 65   
% 215.57/215.73  |- skos__broader mesh__D001746smesh__D001745
% 215.57/215.73  |- mesh__dateRevised mesh__D001746 2005-06-30
% 215.57/215.73  |- skos__hiddenLabel mesh__D001746 Bladder Exstrophies
% 215.57/215.73  |- skos__altLabel mesh__D001746 Bladder Extrophy
% 215.57/215.73  |- skos__prefLabel mesh__D001746 Bladder Exstrophy
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D001746 2006
% 215.57/215.73  |- mesh__dateEstablished mesh__D001746 1965-01-01
% 215.57/215.73  |- rdf__type mesh__D001746sskos__Concept
% 215.57/215.73  |- skos__hiddenLabel mesh__D001746 Extrophy, Bladder
% 215.57/215.73  |- skos__broader mesh__D001746smesh__D014564
% 215.57/215.73  |- skos__hiddenLabel mesh__D001746 Bladder Extrophies
% 215.57/215.73  |- mesh__recordMaintainer mesh__D001746 lkt
% 215.57/215.73  |- skos__hiddenLabel mesh__D001746 Extrophies, Bladder
% 215.57/215.73  |- skos__hiddenLabel mesh__D001746 Exstrophy, Bladder
% 215.57/215.73  |- mesh__recordOriginator mesh__D001746 NLM
% 215.57/215.73  |- skos__hiddenLabel mesh__D001746 Exstrophies, Bladder
% 215.57/215.73  |- skos__broader mesh__D013177Q000293smesh__D013177
% 215.57/215.73  |- mesh__preferredCombination mesh__D013177Q000293smesh__D001265
% 215.57/215.73  |- rdf__type mesh__D013177Q000293smesh__CompoundConcept
% 215.57/215.73  |- skos__historyNote mesh__D020900 Plants, Medicinal %28%1967-1999%29%
% 215.57/215.73  |- mesh__dateRevised mesh__D020900 2002-07-03
% 215.57/215.73  |- mesh__historyNote mesh__D020900 2000   
% 215.57/215.73  |- mesh__recordAuthorizer mesh__D020900 sjn
% 215.57/215.73  |- skos__historyNote mesh__D020900 Plant Extracts %28%1976-1999%29%
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D020900 2003
% 215.57/215.73  |- mesh__recordMaintainer mesh__D020900 ssb
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D020900 2004
% 215.57/215.73  |- skos__annotation mesh__D020900
% 215.57/215.73       a plant genus not sea urchin superorder; X ref CONEFLOWER, PURPLE: CONEFLOWER, PRAIRIE see RATIBIDA and CONEFLOWER, ORANGE see RUDBECKIA are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.57/215.73  |- mesh__publicMeSHNote mesh__D020900 2000   
% 215.57/215.73  |- skos__altLabel mesh__D020900 Rudbeckia purpurea
% 215.57/215.73  |- mesh__dateEstablished mesh__D020900 2000-01-01
% 215.57/215.73  |- mesh__dateCreated mesh__D020900 1999-11-03
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D020900 2005
% 215.57/215.73  |- skos__altLabel mesh__D020900 Coneflower, Purple
% 215.57/215.73  |- rdf__type mesh__D020900sskos__Concept
% 215.57/215.73  |- skos__scopeNote mesh__D020900
% 215.57/215.73       A genus of perennial herbs used topically and internally. It contains echinacoside, GLYCOSIDES; INULIN; isobutyl amides, resin, and SESQUITERPENES.%A%    
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D020900 2006
% 215.57/215.73  |- skos__prefLabel mesh__D020900 Echinacea
% 215.57/215.73  |- mesh__recordOriginator mesh__D020900 ags
% 215.57/215.73  |- skos__broader mesh__D020900smesh__D019659
% 215.57/215.73  |- skos__broader mesh__D006431smesh__D006470
% 215.57/215.73  |- skos__altLabel mesh__D006431 Biliary Tract Hemorrhage
% 215.57/215.73  |- skos__prefLabel mesh__D006431 Hemobilia
% 215.57/215.73  |- mesh__dateCreated mesh__D006431 1979-05-29
% 215.57/215.73  |- mesh__dateEstablished mesh__D006431 1980-01-01
% 215.57/215.73  |- mesh__historyNote mesh__D006431 80   
% 215.57/215.73  |- mesh__recordOriginator mesh__D006431 SMH
% 215.57/215.73  |- mesh__publicMeSHNote mesh__D006431 80   
% 215.57/215.73  |- rdf__type mesh__D006431sskos__Concept
% 215.57/215.73  |- skos__hiddenLabel mesh__D006431 Biliary Tract Hemorrhages
% 215.57/215.73  |- mesh__recordMaintainer mesh__D006431 lkt
% 215.57/215.73  |- skos__historyNote mesh__D006431 Biliary Tract Diseases %28%1966-1979%29%
% 215.57/215.73  |- skos__historyNote mesh__D006431
% 215.57/215.73       Hemorrhage, Gastrointestinal %28%1966-1979%29%
% 215.57/215.73  |- skos__scopeNote mesh__D006431
% 215.57/215.73       Hemorrhage in or through the BILIARY TRACT due to trauma, inflammation, CHOLELITHIASIS, vascular disease, or neoplasms.%A%    
% 215.57/215.73  |- mesh__recordAuthorizer mesh__D006431 sjn
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D006431 2006
% 215.57/215.73  |- skos__hiddenLabel mesh__D006431 Hemobilias
% 215.57/215.73  |- skos__historyNote mesh__D006431 Liver/injuries %28%1966-1979%29%
% 215.57/215.73  |- mesh__dateRevised mesh__D006431 2003-07-09
% 215.57/215.73  |- skos__altLabel mesh__D006431 Hemorrhage, Biliary Tract
% 215.57/215.73  |- skos__historyNote mesh__D006431 Hemorrhage %28%1966-1979%29%
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D006431 2005
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D006431 2004
% 215.57/215.73  |- skos__historyNote mesh__D006431 Hepatic Artery %28%1966-1979%29%
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D020102 2006
% 215.57/215.73  |- mesh__dateCreated mesh__D020102 1998-06-10
% 215.57/215.73  |- mesh__recordOriginator mesh__D020102 NDW
% 215.57/215.73  |- skos__historyNote mesh__D020102 Mycobacterium %28%1966-1998%29%
% 215.57/215.73  |- skos__broader mesh__D020102smesh__D009170
% 215.57/215.73  |- skos__prefLabel mesh__D020102 Mycobacterium smegmatis
% 215.57/215.73  |- mesh__publicMeSHNote mesh__D020102 99   
% 215.57/215.73  |- skos__annotation mesh__D020102
% 215.57/215.73       infection: coord IM with MYCOBACTERIUM INFECTIONS, ATYPICAL %28%IM%29%; DF: MYCOBACT SMEGMATIS%A%  
% 215.57/215.73  |- mesh__historyNote mesh__D020102 99   
% 215.57/215.73  |- skos__scopeNote mesh__D020102
% 215.57/215.73       A rapid-growing, nonphotochromogenic species of MYCOBACTERIUM originally isolated from human smegma and found also in soil and water. %28%From Dorland, 28th ed%29%%A%    
% 215.57/215.73  |- mesh__recordAuthorizer mesh__D020102 sjn
% 215.57/215.73  |- mesh__dateEstablished mesh__D020102 1999-01-01
% 215.57/215.73  |- rdf__type mesh__D020102sskos__Concept
% 215.57/215.73  |- mesh__dateRevised mesh__D020102 2005-06-30
% 215.57/215.73  |- mesh__recordMaintainer mesh__D020102 SYSTEM
% 215.57/215.73  |- skos__hiddenLabel mesh__D047848 Russo Japanese War, 1904 1905
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D047848 2006
% 215.57/215.73  |- mesh__recordAuthorizer mesh__D047848 sjn
% 215.57/215.73  |- mesh__dateCreated mesh__D047848 2004-07-07
% 215.57/215.73  |- skos__scopeNote mesh__D047848
% 215.57/215.73       Conflict from 1904 through 1905 between Russia and Japan regarding Manchuria and Korea.%A%    
% 215.57/215.73  |- mesh__historyNote mesh__D047848 2005   
% 215.57/215.73  |- mesh__recordOriginator mesh__D047848 jls
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D047848 2005
% 215.57/215.73  |- mesh__recordMaintainer mesh__D047848 jls
% 215.57/215.73  |- skos__broader mesh__D047848smesh__D049673
% 215.57/215.73  |- mesh__publicMeSHNote mesh__D047848 2005   
% 215.57/215.73  |- skos__altLabel mesh__D047848 Russo-Japanese War, 1904-1905
% 215.57/215.73  |- skos__prefLabel mesh__D047848 Russian-Japanese War
% 215.57/215.73  |- skos__hiddenLabel mesh__D047848 Russian Japanese War
% 215.57/215.73  |- mesh__dateEstablished mesh__D047848 2005-01-01
% 215.57/215.73  |- rdf__type mesh__D047848sskos__Concept
% 215.57/215.73  |- mesh__recordOriginator mesh__D019359 TGC
% 215.57/215.73  |- mesh__recordAuthorizer mesh__D019359 SJN
% 215.57/215.73  |- skos__broader mesh__D019359smesh__D006809
% 215.57/215.73  |- mesh__publicMeSHNote mesh__D019359 97   
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D019359 2000
% 215.57/215.73  |- skos__broader mesh__D019359smesh__D012586
% 215.57/215.73  |- mesh__dateEstablished mesh__D019359 1997-01-01
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D019359 2006
% 215.57/215.73  |- skos__prefLabel mesh__D019359 Knowledge
% 215.57/215.73  |- rdf__type mesh__D019359sskos__Concept
% 215.57/215.73  |- mesh__historyNote mesh__D019359 97   
% 215.57/215.73  |- mesh__dateRevised mesh__D019359 1998-06-10
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D019359 2005
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D019359 1999
% 215.57/215.73  |- mesh__dateCreated mesh__D019359 1996-06-10
% 215.57/215.73  |- skos__scopeNote mesh__D019359
% 215.57/215.73       The body of truths or facts accumulated in the course of time, the cumulated sum of information, its volume and nature, in any civilization, period, or country.%A%    
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D019359 2004
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D019359 2002
% 215.57/215.73  |- mesh__recordMaintainer mesh__D019359 JLS
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D019359 2003
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D019359 2001
% 215.57/215.73  |- skos__annotation mesh__D019359
% 215.57/215.73       restrict to knowledge as an abstract or philosophical concept, as %22%transmission of knowledge%22%; do not use as coord for knowledge of specific subjects as %22%fuller use of our knowledge about children%22%; will figure largely in hist articles %26% hist contexts; %22%medical knowledge%22% is probably MEDICINE %26% not here%A%  
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D011376 1996
% 215.57/215.73  |- skos__historyNote mesh__D011376 Alpha Globulins %28%1974-1976%29%
% 215.57/215.73  |- mesh__dateEstablished mesh__D011376 1991-01-01
% 215.57/215.73  |- skos__hiddenLabel mesh__D011376 Progesterone Binding Globulin
% 215.57/215.73  |- mesh__recordMaintainer mesh__D011376 PLS
% 215.57/215.73  |- mesh__publicMeSHNote mesh__D011376
% 215.57/215.73       91; was see under ALPHA GLOBULINS 1977-90   
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D011376 1997
% 215.57/215.73  |- skos__scopeNote mesh__D011376
% 215.57/215.73       A glycoprotein migrating as alpha 1-globulin, molecular weight 70,000 to 120,000. The protein, which is present in increased amounts in the plasma during pregnancy, binds mainly progesterone, with other steroids including testosterone competing weakly.%A%    
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D011376 2000
% 215.57/215.73  |- skos__altLabel mesh__D011376 Transprogestin
% 215.57/215.73  |- skos__broader mesh__D011376smesh__D000510
% 215.57/215.73  |- rdf__type mesh__D011376sskos__Concept
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D011376 1998
% 215.57/215.73  |- mesh__historyNote mesh__D011376
% 215.57/215.73       91%28%77%29%; was see under ALPHA GLOBULINS 1977-90   
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D011376 2003
% 215.57/215.73  |- skos__hiddenLabel mesh__D011376 Progesterone Binding Protein
% 215.57/215.73  |- skos__historyNote mesh__D011376 Serum Globulins %28%1974-1976%29%
% 215.57/215.73  |- mesh__recordOriginator mesh__D011376 RLS
% 215.57/215.73  |- skos__historyNote mesh__D011376 Progesterone %28%1974-1976%29%
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D011376 2001
% 215.57/215.73  |- skos__annotation mesh__D011376
% 215.57/215.73       an alpha-globulin; /biosyn /physiol permitted   
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D011376 1999
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D011376 2004
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D011376 2002
% 215.57/215.73  |- skos__prefLabel mesh__D011376 Progesterone-Binding Globulin
% 215.57/215.73  |- skos__altLabel mesh__D011376 Progesterone-Binding Protein
% 215.57/215.73  |- skos__hiddenLabel mesh__D011376 Protein, Progesterone-Binding
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D011376 2005
% 215.57/215.73  |- skos__hiddenLabel mesh__D011376 Globulin, Progesterone-Binding
% 215.57/215.73  |- mesh__recordAuthorizer mesh__D011376 PLS
% 215.57/215.73  |- mesh__dateCreated mesh__D011376 1976-04-16
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D011376 2006
% 215.57/215.73  |- mesh__dateRevised mesh__D011376 1995-03-20
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D005339 2000
% 215.57/215.73  |- mesh__onlineNote mesh__D005339
% 215.57/215.73       use FIBRIN FOAM to search FIBRIN FILM AND FOAM 1966-72 %28%as Prov%29%%A%  
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D005339 2003
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D005339 2006
% 215.57/215.73  |- skos__historyNote mesh__D005339 Hemostatics %28%1966-1972%29%
% 215.57/215.73  |- skos__prefLabel mesh__D005339 Fibrin Foam
% 215.57/215.73  |- mesh__publicMeSHNote mesh__D005339
% 215.57/215.73       73; was FIBRIN FILM AND FOAM see under HEMOSTATICS 1963-72%A%  
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D005339 2005
% 215.57/215.73  |- skos__annotation mesh__D005339 a hemostatic   
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D005339 1997
% 215.57/215.73  |- skos__broader mesh__D005339smesh__D005337
% 215.57/215.73  |- mesh__historyNote mesh__D005339
% 215.57/215.73       73; was FIBRIN FILM AND FOAM 1963-72 %28%Prov%29% see under HEMOSTATICS%A%  
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D005339 1996
% 215.57/215.73  |- mesh__recordMaintainer mesh__D005339 JRT
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D005339 1999
% 215.57/215.73  |- mesh__recordOriginator mesh__D005339 NLM
% 215.57/215.73  |- rdf__type mesh__D005339sskos__Concept
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D005339 2002
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D005339 1998
% 215.57/215.73  |- mesh__recordAuthorizer mesh__D005339 PLS
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D005339 2001
% 215.57/215.73  |- mesh__dateRevised mesh__D005339 1995-05-18
% 215.57/215.73  |- skos__hiddenLabel mesh__D005339 Foam, Fibrin
% 215.57/215.73  |- mesh__dateCreated mesh__D005339 1999-01-01
% 215.57/215.73  |- mesh__dateEstablished mesh__D005339 1973-01-01
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D005339 2004
% 215.57/215.73  |- skos__scopeNote mesh__D005339
% 215.57/215.73       A dry artificial sterile sponge of fibrin prepared by clotting with thrombin a foam or solution of fibrinogen. It is used in conjunction with thrombin as a hemostatic in surgery at sites where bleeding cannot be controlled by more common methods. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p648%29%%A%    
% 215.57/215.73  |- skos__broader mesh__D016061smesh__D016060
% 215.57/215.73  |- skos__historyNote mesh__D016061 Intestinal Absorption %28%1983-1990%29%
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D016061 1997
% 215.57/215.73  |- skos__hiddenLabel mesh__D016061 Enterosorptions
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D016061 1993
% 215.57/215.73  |- mesh__dateCreated mesh__D016061 1990-02-12
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D016061 2000
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D016061 1998
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D016061 2003
% 215.57/215.73  |- mesh__dateEstablished mesh__D016061 1991-01-01
% 215.57/215.73  |- skos__prefLabel mesh__D016061 Enterosorption
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D016061 1991
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D016061 1994
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D016061 2001
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D016061 1999
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D016061 2004
% 215.57/215.73  |- skos__scopeNote mesh__D016061
% 215.57/215.73       Adsorption of substances from the gastrointestinal tract onto an orally administered sorbent medium like activated charcoal. This technique is used to eliminate toxic and some biologically active substances and serves to modify the lipid and amino acid spectrum of the intestinal contents.%A%    
% 215.57/215.73  |- rdf__type mesh__D016061sskos__Concept
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D016061 1995
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D016061 2002
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D016061 2005
% 215.57/215.73  |- mesh__historyNote mesh__D016061 91   
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D016061 1996
% 215.57/215.73  |- mesh__publicMeSHNote mesh__D016061 91   
% 215.57/215.73  |- skos__annotation mesh__D016061
% 215.57/215.73       a type of sorption detoxification: do not use Dorland: read MeSH definition; do not use /util except by MeSH definition%A%  
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D016061 2006
% 215.57/215.73  |- skos__historyNote mesh__D016061 Adsorption %28%1983-1990%29%
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D016061 1992
% 215.57/215.73  |- skos__scopeNote mesh__D029787
% 215.57/215.73       A plant genus of the family Droseraceae, order Nepenthales, subclass Dilleniidae, class Magnoliopsida, that contains naphthoquinone glucosides. The name sundew is rarely used for PYROLA.%A%    
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D029787 2005
% 215.57/215.73  |- skos__prefLabel mesh__D029787 Drosera
% 215.57/215.73  |- mesh__dateRevised mesh__D029787 2002-07-03
% 215.57/215.73  |- skos__broader mesh__D029787smesh__D031257
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D029787 2003
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D029787 2006
% 215.57/215.73  |- mesh__publicMeSHNote mesh__D029787 2002   
% 215.57/215.73  |- skos__annotation mesh__D029787
% 215.57/215.73       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.57/215.73  |- rdf__type mesh__D029787sskos__Concept
% 215.57/215.73  |- mesh__historyNote mesh__D029787 2002   
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D029787 2004
% 215.57/215.73  |- mesh__dateCreated mesh__D029787 2001-07-25
% 215.57/215.73  |- mesh__dateEstablished mesh__D029787 2002-01-01
% 215.57/215.73  |- rdf__type mesh__D015767sskos__Concept
% 215.57/215.73  |- skos__prefLabel mesh__D015767 Mefloquine
% 215.57/215.73  |- skos__hiddenLabel mesh__D015767 WR177,602
% 215.57/215.73  |- mesh__recordOriginator mesh__D015767 RLS
% 215.57/215.73  |- skos__hiddenLabel mesh__D015767 WR 142,490
% 215.57/215.73  |- skos__broader mesh__D015767smesh__D011804
% 215.57/215.73  |- mesh__recordMaintainer mesh__D015767 CCR
% 215.57/215.73  |- skos__hiddenLabel mesh__D015767 Ro 21 5998 001
% 215.57/215.73  |- mesh__publicMeSHNote mesh__D015767 90   
% 215.57/215.73  |- mesh__dateCreated mesh__D015767 1989-05-25
% 215.57/215.73  |- skos__hiddenLabel mesh__D015767
% 215.57/215.73       Hoffmann La Roche Brand of Mefloquine Hydrochloride
% 215.57/215.73  |- mesh__recordAuthorizer mesh__D015767 sjn
% 215.57/215.73  |- mesh__dateEstablished mesh__D015767 1990-01-01
% 215.57/215.73  |- skos__altLabel mesh__D015767 Mephloquine
% 215.57/215.73  |- skos__hiddenLabel mesh__D015767 WR142,490
% 215.57/215.73  |- skos__scopeNote mesh__D015767
% 215.57/215.73       A phospholipid-interacting antimalarial drug %28%ANTIMALARIALS%29%.  It is very effective against PLASMODIUM FALCIPARUM with very few side effects.%A%    
% 215.57/215.73  |- skos__altLabel mesh__D015767 Roche Brand of Mefloquine Hydrochloride
% 215.57/215.73  |- skos__hiddenLabel mesh__D015767 WR 177,602
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D015767 2006
% 215.57/215.73  |- skos__historyNote mesh__D015767 Antimalarials %28%1966-1989%29%
% 215.57/215.73  |- skos__historyNote mesh__D015767 Quinolines %28%1966-1989%29%
% 215.57/215.73  |- mesh__dateRevised mesh__D015767 2005-06-30
% 215.57/215.73  |- skos__hiddenLabel mesh__D015767 Ro215998001
% 215.57/215.73  |- skos__altLabel mesh__D015767
% 215.57/215.73       Hoffmann-La Roche Brand of Mefloquine Hydrochloride
% 215.57/215.73  |- mesh__historyNote mesh__D015767 90   
% 215.57/215.73  |- mesh__dateCreated mesh__D034921 2002-07-03
% 215.57/215.73  |- skos__altLabel mesh__D034921 Type B Lamins
% 215.57/215.73  |- mesh__dateRevised mesh__D034921 2005-06-30
% 215.57/215.73  |- skos__historyNote mesh__D034921 Nuclear Proteins %28%1991-2002%29%
% 215.57/215.73  |- skos__broader mesh__D034921smesh__D034882
% 215.57/215.73  |- mesh__recordMaintainer mesh__D034921 SYSTEM
% 215.57/215.73  |- skos__hiddenLabel mesh__D034921 Lamins, Type B
% 215.57/215.73  |- mesh__recordAuthorizer mesh__D034921 sjn
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D034921 2006
% 215.57/215.73  |- rdf__type mesh__D034921sskos__Concept
% 215.57/215.73  |- skos__scopeNote mesh__D034921
% 215.57/215.73       A subclass of ubiquitously-expressed lamins having an acidic isoelectric point. They are found to remain bound to nuclear membranes during mitosis.%A%    
% 215.57/215.73  |- mesh__publicMeSHNote mesh__D034921
% 215.57/215.73       2003; LAMIN B was indexed under NUCLEAR PROTEINS 1991-2002%A%  
% 215.57/215.73  |- skos__altLabel mesh__D034921 Lamin B
% 215.57/215.73  |- skos__annotation mesh__D034921 see SCR for specific lamins   
% 215.57/215.73  |- mesh__dateEstablished mesh__D034921 2003-01-01
% 215.57/215.73  |- skos__prefLabel mesh__D034921 Lamin Type B
% 215.57/215.73  |- mesh__recordOriginator mesh__D034921 jmp
% 215.57/215.73  |- mesh__historyNote mesh__D034921
% 215.57/215.73       2003; for LAMIN B use LAMINS %28%NM%29% 1991-2002   
% 215.57/215.73  |- mesh__dateRevised mesh__D001747 1999-11-08
% 215.57/215.73  |- mesh__dateCreated mesh__D001747 1999-01-01
% 215.57/215.73  |- mesh__recordOriginator mesh__D001747 NLM
% 215.57/215.73  |- skos__annotation mesh__D001747
% 215.57/215.73       fistula policy: Manual 23.19+; VESICOVAGINAL FISTULA is available%A%  
% 215.57/215.73  |- skos__hiddenLabel mesh__D001747 Fistula, Bladder
% 215.57/215.73  |- skos__hiddenLabel mesh__D001747 Bladder Fistulas
% 215.57/215.73  |- mesh__recordAuthorizer mesh__D001747 sjn
% 215.57/215.73  |- skos__scopeNote mesh__D001747
% 215.57/215.73       An abnormal passage in the bladder or between the bladder and any surrounding organ.%A%    
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D001747 2002
% 215.57/215.73  |- skos__hiddenLabel mesh__D001747 Fistulas, Bladder
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D001747 2006
% 215.57/215.73  |- skos__broader mesh__D001747smesh__D001745
% 215.57/215.73  |- skos__altLabel mesh__D001747 Vesical Fistula
% 215.57/215.73  |- rdf__type mesh__D001747sskos__Concept
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D001747 2004
% 215.57/215.73  |- skos__prefLabel mesh__D001747 Bladder Fistula
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D001747 2005
% 215.57/215.73  |- skos__hiddenLabel mesh__D001747 Vesical Fistulas
% 215.57/215.73  |- skos__hiddenLabel mesh__D001747 Fistulas, Vesical
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D001747 2001
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D001747 2003
% 215.57/215.73  |- skos__hiddenLabel mesh__D001747 Fistula, Vesical
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D001747 2000
% 215.57/215.73  |- mesh__recordMaintainer mesh__D001747 KEV
% 215.57/215.73  |- skos__broader mesh__D001747smesh__D014548
% 215.57/215.73  |- skos__altLabel mesh__D020901 Kawa
% 215.57/215.73  |- mesh__recordOriginator mesh__D020901 ags
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D020901 2003
% 215.57/215.73  |- skos__prefLabel mesh__D020901 Kava
% 215.57/215.73  |- mesh__dateRevised mesh__D020901 2002-07-03
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D020901 2004
% 215.57/215.73  |- mesh__dateEstablished mesh__D020901 2000-01-01
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D020901 2005
% 215.57/215.73  |- skos__scopeNote mesh__D020901
% 215.57/215.73       Dried rhizome and roots of Piper methysticum, a shrub native to Oceania and known for its anti-anxiety and sedative properties. Heavy usage results in some adverse effects. It contains ALKALOIDS; LACTONES; kawain, methysticin, mucilage, STARCH, and yangonin. Kava is also the name of the pungent beverage prepared from the plant%27%s roots.%A%    
% 215.57/215.73  |- mesh__recordAuthorizer mesh__D020901 sjn
% 215.57/215.73  |- skos__broader mesh__D020901smesh__D031701
% 215.57/215.73  |- mesh__publicMeSHNote mesh__D020901
% 215.57/215.73       2000; KAVA was indexed under PLANT EXTRACTS 1981-1999   
% 215.57/215.73  |- mesh__activeMeSHYear mesh__D020901 2006
% 215.57/215.74  |- mesh__recordMaintainer mesh__D020901 ssb
% 215.57/215.74  |- rdf__type mesh__D020901sskos__Concept
% 215.57/215.74  |- skos__altLabel mesh__D020901 Kava Kava
% 215.57/215.74  |- mesh__dateCreated mesh__D020901 1999-11-03
% 215.57/215.74  |- skos__altLabel mesh__D020901 Kawa Kawa
% 215.57/215.74  |- skos__historyNote mesh__D020901 Plants, Medicinal %28%1967-1999%29%
% 215.57/215.74  |- skos__altLabel mesh__D020901 Piper methysticum
% 215.57/215.74  |- mesh__historyNote mesh__D020901 2000   
% 215.57/215.74  |- skos__historyNote mesh__D020901 Plant Extracts %28%1967-1999%29%
% 215.57/215.74  |- skos__prefLabel mesh__D006432 Hemochromatosis
% 215.57/215.74  |- mesh__recordAuthorizer mesh__D006432 sjn
% 215.57/215.74  |- mesh__dateRevised mesh__D006432 2001-07-25
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D006432 2002
% 215.57/215.74  |- skos__annotation mesh__D006432 accumulation of hemosiderin in tissue   
% 215.57/215.74  |- skos__hiddenLabel mesh__D006432 Bronze Diabetes
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D006432 2006
% 215.57/215.74  |- skos__scopeNote mesh__D006432
% 215.57/215.74       A disorder due to the deposition of hemosiderin in the parenchymal cells, causing tissue damage and dysfunction of the liver, pancreas, heart, and pituitary. Full development of the disease in women is restricted by menstruation, pregnancy, and lower dietary intake of iron. Acquired hemochromatosis may be the result of blood transfusions, excessive dietary iron, or secondary to other disease. Idiopathic or genetic hemochromatosis is an autosomal recessive disorder of metabolism associated with a gene tightly linked to the A locus of the HLA complex on chromosome 6. %28%From Dorland, 27th ed%29%%A%    
% 215.57/215.74  |- skos__altLabel mesh__D006432 Diabetes, Bronze
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D006432 2005
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D006432 2004
% 215.57/215.74  |- skos__hiddenLabel mesh__D006432 Hemochromatoses
% 215.57/215.74  |- skos__broader mesh__D006432smesh__D019190
% 215.57/215.74  |- mesh__recordOriginator mesh__D006432 NLM
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D006432 2003
% 215.57/215.74  |- mesh__dateCreated mesh__D006432 1999-01-01
% 215.57/215.74  |- mesh__recordMaintainer mesh__D006432 nns
% 215.57/215.74  |- skos__broader mesh__D006432smesh__D008664
% 215.57/215.74  |- rdf__type mesh__D006432sskos__Concept
% 215.57/215.74  |- mesh__dateCreated mesh__D020103 1998-06-11
% 215.57/215.74  |- skos__historyNote mesh__D020103 Mucorales %28%1983-1998%29%
% 215.57/215.74  |- mesh__publicMeSHNote mesh__D020103 99   
% 215.57/215.74  |- rdf__type mesh__D020103sskos__Concept
% 215.57/215.74  |- mesh__recordOriginator mesh__D020103 AGS
% 215.57/215.74  |- skos__annotation mesh__D020103
% 215.57/215.74       infection: coord IM with MUCORMYCOSIS %28%IM%29%   
% 215.57/215.74  |- skos__broader mesh__D020103smesh__D009090
% 215.57/215.74  |- skos__prefLabel mesh__D020103 Rhizomucor
% 215.57/215.74  |- mesh__recordMaintainer mesh__D020103 SYSTEM
% 215.57/215.74  |- mesh__historyNote mesh__D020103 99   
% 215.57/215.74  |- skos__scopeNote mesh__D020103
% 215.57/215.74       A genus of zygomycetous fungi of the family Mucoraceae, order MUCORALES.%A%    
% 215.57/215.74  |- mesh__recordAuthorizer mesh__D020103 sjn
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D020103 2006
% 215.57/215.74  |- mesh__dateEstablished mesh__D020103 1999-01-01
% 215.57/215.74  |- mesh__dateRevised mesh__D020103 2005-06-30
% 215.57/215.74  |- mesh__publicMeSHNote mesh__D047849 2005   
% 215.57/215.74  |- skos__hiddenLabel mesh__D047849 War, Crimean
% 215.57/215.74  |- skos__prefLabel mesh__D047849 Crimean War
% 215.57/215.74  |- rdf__type mesh__D047849sskos__Concept
% 215.57/215.74  |- skos__altLabel mesh__D047849 Crimean War, 1853-1856
% 215.57/215.74  |- mesh__recordAuthorizer mesh__D047849 sjn
% 215.57/215.74  |- mesh__recordMaintainer mesh__D047849 jls
% 215.57/215.74  |- mesh__historyNote mesh__D047849 2005   
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D047849 2006
% 215.57/215.74  |- skos__scopeNote mesh__D047849
% 215.57/215.74       Conflict between Russia and its ally the Ottoman Empire and England, France, and Sardinia. The immediate dispute was between Russia and France over control of Palestinian holy places.%A%    
% 215.57/215.74  |- mesh__dateCreated mesh__D047849 2004-07-07
% 215.57/215.74  |- skos__broader mesh__D047849smesh__D049672
% 215.57/215.74  |- mesh__recordOriginator mesh__D047849 jls
% 215.57/215.74  |- skos__hiddenLabel mesh__D047849 Crimean War, 1853 1856
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D047849 2005
% 215.57/215.74  |- mesh__dateEstablished mesh__D047849 2005-01-01
% 215.57/215.74  |- skos__scopeNote mesh__D011377
% 215.57/215.74       A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers.%A%    
% 215.57/215.74  |- rdf__type mesh__D011377sskos__Concept
% 215.57/215.74  |- skos__altLabel mesh__D011377 Xilamide
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D011377 2003
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D011377 2004
% 215.57/215.74  |- mesh__recordMaintainer mesh__D011377 nns
% 215.57/215.74  |- skos__altLabel mesh__D011377 Xylamide
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D011377 2005
% 215.57/215.74  |- skos__broader mesh__D011377smesh__D005973
% 215.57/215.74  |- mesh__publicMeSHNote mesh__D011377
% 215.57/215.74       91; was see under GLUTAMINE 1975-90   
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D011377 2006
% 215.57/215.74  |- skos__prefLabel mesh__D011377 Proglumide
% 215.57/215.74  |- skos__historyNote mesh__D011377 Glutamine %28%1972-1974%29%
% 215.57/215.74  |- mesh__dateCreated mesh__D011377 1974-11-11
% 215.57/215.74  |- mesh__recordOriginator mesh__D011377 NLM
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D011377 2002
% 215.57/215.74  |- skos__historyNote mesh__D011377 Benzamides %28%1974%29%
% 215.57/215.74  |- mesh__historyNote mesh__D011377
% 215.57/215.74       91%28%75%29%; was see under GLUTAMINE 1975-90   
% 215.57/215.74  |- mesh__dateEstablished mesh__D011377 1991-01-01
% 215.57/215.74  |- mesh__dateRevised mesh__D011377 2001-07-25
% 215.57/215.74  |- mesh__recordAuthorizer mesh__D011377 sjn
% 215.57/215.74  |- mesh__recordOriginator mesh__D016860 AGS
% 215.57/215.74  |- mesh__onlineNote mesh__D016860
% 215.57/215.74       use CD4 IMMUNOADHESINS %28%NM%29% to search CD4 IMMUNOADHESIN %28%NM%29% 1989-91%A%  
% 215.57/215.74  |- skos__historyNote mesh__D016860
% 215.57/215.74       Antigens, Differentiation, T-Lymphocyte %28%1989%29%
% 215.57/215.74  |- skos__broader mesh__D016860smesh__D011993
% 215.57/215.74  |- mesh__dateRevised mesh__D016860 2005-06-30
% 215.57/215.74  |- skos__hiddenLabel mesh__D016860 CD4 IgG
% 215.57/215.74  |- rdf__type mesh__D016860sskos__Concept
% 215.57/215.74  |- skos__prefLabel mesh__D016860 CD4 Immunoadhesins
% 215.57/215.74  |- mesh__publicMeSHNote mesh__D016860
% 215.57/215.74       92; CD4 IMMUNOADHESIN %28%NM%29% was indexed under IGG %26% ANTIGENS, CD %26% ANTIBODIES, ANTI-IDIOTYPIC 1990-91 and under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1989.%A%  
% 215.57/215.74  |- skos__altLabel mesh__D016860 Immunoadhesins, CD4
% 215.57/215.74  |- mesh__recordMaintainer mesh__D016860 ssb
% 215.57/215.74  |- mesh__dateCreated mesh__D016860 1991-07-12
% 215.57/215.74  |- skos__historyNote mesh__D016860 Antigens, CD %28%1990-1991%29%
% 215.57/215.74  |- mesh__historyNote mesh__D016860
% 215.57/215.74       92; was CD4 IMMUNOADHESIN %28%NM%29% 1989-91   
% 215.57/215.74  |- mesh__recordAuthorizer mesh__D016860 sjn
% 215.57/215.74  |- skos__broader mesh__D016860smesh__D007141
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D016860 2006
% 215.57/215.74  |- mesh__dateEstablished mesh__D016860 1992-01-01
% 215.57/215.74  |- skos__scopeNote mesh__D016860
% 215.57/215.74       Chimeric molecules resulting from the fusion of recombinant soluble CD4 to the Fc portion of immunoglobulins. These have potential use in the therapy of AIDS since they possess both the gp120-binding and HIV-blocking properties of rCD4 as well as the long plasma half-life and Fc receptor-binding functions of immunoglobulin.%A%    
% 215.57/215.74  |- skos__historyNote mesh__D016860 IgG %28%1989-1991%29%
% 215.57/215.74  |- skos__broader mesh__D016860smesh__D015815
% 215.57/215.74  |- skos__historyNote mesh__D016062 Surface Properties %28%1966-1990%29%
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D016062 1998
% 215.57/215.74  |- mesh__publicMeSHNote mesh__D016062 91   
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D016062 2003
% 215.57/215.74  |- skos__prefLabel mesh__D016062 Porosity
% 215.57/215.74  |- mesh__dateEstablished mesh__D016062 1991-01-01
% 215.57/215.74  |- skos__scopeNote mesh__D016062
% 215.57/215.74       Condition of having pores or open spaces. This often refers to bones, bone implants, or bone cements, but can refer to the porous state of any solid substance.%A%    
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D016062 1994
% 215.57/215.74  |- mesh__recordOriginator mesh__D016062 AGS
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D016062 1999
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D016062 2004
% 215.57/215.74  |- rdf__type mesh__D016062sskos__Concept
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D016062 1995
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D016062 2000
% 215.57/215.74  |- skos__annotation mesh__D016062 almost never IM   
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D016062 2005
% 215.57/215.74  |- mesh__historyNote mesh__D016062 91   
% 215.57/215.74  |- skos__broader mesh__D016062smesh__D010825
% 215.57/215.74  |- mesh__dateRevised mesh__D016062 1992-05-18
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D016062 1996
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D016062 2001
% 215.57/215.74  |- skos__historyNote mesh__D016062 Chemistry, Physical %28%1966-1990%29%
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D016062 2006
% 215.57/215.74  |- mesh__recordMaintainer mesh__D016062 TAP
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D016062 1997
% 215.57/215.74  |- mesh__activeMeSHYear mesh__D016062 2002
% 215.57/215.74  |- mesh__recordAuthorizer mesh__D016062 PLS
% 215.66/215.81  |- skos__hiddenLabel mesh__D016062 Porosities
% 215.66/215.81  |- mesh__dateCreated mesh__D016062 1990-03-23
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D016062 1993
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D002840 2004
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D002840 2000
% 215.66/215.81  |- skos__broader mesh__D002840smesh__D000838
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D002840 1996
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D002840 1995
% 215.66/215.81  |- skos__broader mesh__D002840smesh__D017608
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D002840 2003
% 215.66/215.81  |- skos__prefLabel mesh__D002840 Chromates
% 215.66/215.81  |- skos__scopeNote mesh__D002840
% 215.66/215.81       Salts of chromic acid containing the CrO%28%2-%29%4 radical.     
% 215.66/215.81  |- mesh__recordMaintainer mesh__D002840 TPW
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D002840 1994
% 215.66/215.81  |- rdf__type mesh__D002840sskos__Concept
% 215.66/215.81  |- mesh__dateRevised mesh__D002840 1993-06-04
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D002840 1999
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D002840 2006
% 215.66/215.81  |- mesh__recordAuthorizer mesh__D002840 PLS
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D002840 2002
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D002840 1998
% 215.66/215.81  |- mesh__dateCreated mesh__D002840 1999-01-01
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D002840 2005
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D002840 2001
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D002840 1997
% 215.66/215.81  |- mesh__recordOriginator mesh__D002840 NLM
% 215.66/215.81  |- mesh__recordAuthorizer mesh__D002042 sjn
% 215.66/215.81  |- mesh__recordMaintainer mesh__D002042 ags
% 215.66/215.81  |- rdf__type mesh__D002042sskos__Concept
% 215.66/215.81  |- skos__broader mesh__D002042smesh__D016851
% 215.66/215.81  |- mesh__publicMeSHNote mesh__D002042
% 215.66/215.81       2002; see BUNYAMWERA VIRUS GROUP 1991-2001, see BUNYAVIRIDAE 1981-1990, see ARBOVIRUSES 1975-80%A%  
% 215.66/215.81  |- skos__altLabel mesh__D002042 Calovo virus
% 215.66/215.81  |- mesh__dateRevised mesh__D002042 2004-07-08
% 215.66/215.81  |- skos__altLabel mesh__D002042 Chittoor virus
% 215.66/215.81  |- skos__annotation mesh__D002042
% 215.66/215.81       infection: coord IM with BUNYAVIRIDAE INFECTIONS %28%IM%29%   
% 215.66/215.81  |- mesh__historyNote mesh__D002042 2002 %28%1975%29%   
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D002042 2005
% 215.66/215.81  |- mesh__dateCreated mesh__D002042 1974-12-12
% 215.66/215.81  |- skos__scopeNote mesh__D002042
% 215.66/215.81       A species in the ORTHOBUNYAVIRUS genus of the family BUNYAVIRIDAE. A large number of serotypes or strains exist in many parts of the world. They are transmitted by mosquitoes and infect humans in some areas.%A%    
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D002042 2006
% 215.66/215.81  |- skos__prefLabel mesh__D002042 Bunyamwera virus
% 215.66/215.81  |- mesh__dateEstablished mesh__D002042 1991-01-01
% 215.66/215.81  |- mesh__recordOriginator mesh__D002042 NLM
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D029788 2006
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D029788 2003
% 215.66/215.81  |- mesh__publicMeSHNote mesh__D029788 2002   
% 215.66/215.81  |- skos__broader mesh__D029788smesh__D031262
% 215.66/215.81  |- skos__annotation mesh__D029788
% 215.66/215.81       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D029788 2004
% 215.66/215.81  |- rdf__type mesh__D029788sskos__Concept
% 215.66/215.81  |- mesh__dateRevised mesh__D029788 2002-07-03
% 215.66/215.81  |- skos__prefLabel mesh__D029788 Diospyros
% 215.66/215.81  |- skos__altLabel mesh__D029788 Persimmon
% 215.66/215.81  |- mesh__dateEstablished mesh__D029788 2002-01-01
% 215.66/215.81  |- mesh__historyNote mesh__D029788 2002   
% 215.66/215.81  |- skos__altLabel mesh__D029788 Sapote, Black
% 215.66/215.81  |- mesh__dateCreated mesh__D029788 2001-07-25
% 215.66/215.81  |- skos__scopeNote mesh__D029788
% 215.66/215.81       A plant genus of the family EBENACEAE, order Ebenales, subclass Dilleniidae, class Magnoliopsida best known for the edible fruit and the antibacterial activity and compounds of the wood.%A%    
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D029788 2005
% 215.66/215.81  |- mesh__recordAuthorizer mesh__D040161 sjn
% 215.66/215.81  |- rdf__type mesh__D040161sskos__Concept
% 215.66/215.81  |- skos__historyNote mesh__D040161 Actinomycetales %28%1980-2002%29%
% 215.66/215.81  |- skos__broader mesh__D040161smesh__D000192
% 215.66/215.81  |- mesh__recordMaintainer mesh__D040161 SYSTEM
% 215.66/215.81  |- skos__scopeNote mesh__D040161
% 215.66/215.81       Genus of BACTERIA in the family Frankiaceae. They are nitrogen-fixing root-nodule symbionts of many species of woody dicotyledonous plants.%A%    
% 215.66/215.81  |- mesh__dateCreated mesh__D040161 2002-07-03
% 215.66/215.81  |- mesh__recordOriginator mesh__D040161 ags
% 215.66/215.81  |- skos__prefLabel mesh__D040161 Frankia
% 215.66/215.81  |- mesh__publicMeSHNote mesh__D040161 2003   
% 215.66/215.81  |- mesh__dateRevised mesh__D040161 2005-06-30
% 215.66/215.81  |- mesh__historyNote mesh__D040161 2003   
% 215.66/215.81  |- mesh__dateEstablished mesh__D040161 2003-01-01
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D040161 2006
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D001748 1998
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D001748 2006
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D001748 1996
% 215.66/215.81  |- rdf__type mesh__D001748sskos__Concept
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D001748 2004
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D001748 2001
% 215.66/215.81  |- mesh__recordMaintainer mesh__D001748 PLS
% 215.66/215.81  |- skos__broader mesh__D001748smesh__D014524
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D001748 1991
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D001748 2000
% 215.66/215.81  |- skos__hiddenLabel mesh__D001748 Neck Obstructions, Bladder
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D001748 2005
% 215.66/215.81  |- skos__hiddenLabel mesh__D001748 Neck Obstruction, Bladder
% 215.66/215.81  |- skos__prefLabel mesh__D001748 Bladder Neck Obstruction
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D001748 2003
% 215.66/215.81  |- mesh__recordOriginator mesh__D001748 NLM
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D001748 1995
% 215.66/215.81  |- mesh__dateCreated mesh__D001748 1999-01-01
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D001748 2002
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D001748 1993
% 215.66/215.81  |- mesh__dateRevised mesh__D001748 1990-05-29
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D001748 1999
% 215.66/215.81  |- skos__hiddenLabel mesh__D001748 Obstruction, Bladder Neck
% 215.66/215.81  |- skos__hiddenLabel mesh__D001748 Bladder Neck Obstructions
% 215.66/215.81  |- skos__hiddenLabel mesh__D001748 Obstructions, Bladder Neck
% 215.66/215.81  |- skos__broader mesh__D001748smesh__D001745
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D001748 1994
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D001748 1997
% 215.66/215.81  |- mesh__recordAuthorizer mesh__D001748 NLM
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D001748 1992
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D012470 2005
% 215.66/215.81  |- skos__hiddenLabel mesh__D012470 Gland, Minor Salivary
% 215.66/215.81  |- mesh__recordAuthorizer mesh__D012470 sjn
% 215.66/215.81  |- mesh__recordMaintainer mesh__D012470 lkt
% 215.66/215.81  |- skos__scopeNote mesh__D012470
% 215.66/215.81       Accessory salivary glands located in the lip, cheek, tongue, floor of mouth, palate and intramaxillary.%A%    
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D012470 2004
% 215.66/215.81  |- skos__prefLabel mesh__D012470 Salivary Glands, Minor
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D012470 2006
% 215.66/215.81  |- mesh__dateCreated mesh__D012470 1978-05-19
% 215.66/215.81  |- skos__hiddenLabel mesh__D012470 Minor Salivary Glands
% 215.66/215.81  |- skos__annotation mesh__D012470
% 215.66/215.81       diseases: coord NIM with SALIVARY GLAND DISEASES %28%IM%29%   
% 215.66/215.81  |- skos__historyNote mesh__D012470 Salivary Glands %28%1966-1978%29%
% 215.66/215.81  |- mesh__publicMeSHNote mesh__D012470
% 215.66/215.81       91; was see under SALIVARY GLANDS 1979-90   
% 215.66/215.81  |- rdf__type mesh__D012470sskos__Concept
% 215.66/215.81  |- skos__broader mesh__D012470smesh__D012469
% 215.66/215.81  |- skos__hiddenLabel mesh__D012470 Minor Salivary Gland
% 215.66/215.81  |- skos__hiddenLabel mesh__D012470 Salivary Gland, Minor
% 215.66/215.81  |- mesh__historyNote mesh__D012470
% 215.66/215.81       91%28%79%29%; was see under SALIVARY GLANDS 1979-90   
% 215.66/215.81  |- skos__hiddenLabel mesh__D012470 Glands, Minor Salivary
% 215.66/215.81  |- mesh__dateEstablished mesh__D012470 1991-01-01
% 215.66/215.81  |- mesh__recordOriginator mesh__D012470 RC
% 215.66/215.81  |- mesh__dateRevised mesh__D012470 2003-07-09
% 215.66/215.81  |- skos__altLabel mesh__D020902 St. Johns Wort
% 215.66/215.81  |- skos__altLabel mesh__D020902 St. John%27%s Wort
% 215.66/215.81  |- skos__altLabel mesh__D020902 Saint Johns Wort
% 215.66/215.81  |- mesh__historyNote mesh__D020902
% 215.66/215.81       2000; for Hypericum %26% St. Johns Wort use THEALES 1999   
% 215.66/215.81  |- skos__altLabel mesh__D020902 Saint Johnswort
% 215.66/215.81  |- skos__altLabel mesh__D020902 Saint John%27%s Wort
% 215.66/215.81  |- mesh__recordOriginator mesh__D020902 ags
% 215.66/215.81  |- mesh__dateRevised mesh__D020902 2005-06-30
% 215.66/215.81  |- skos__altLabel mesh__D020902 St. Johnswort
% 215.66/215.81  |- mesh__dateEstablished mesh__D020902 2000-01-01
% 215.66/215.81  |- skos__annotation mesh__D020902
% 215.66/215.81       coordinate with specific PLANT COMPONENTS term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.66/215.81  |- skos__scopeNote mesh__D020902
% 215.66/215.81       Genus of perennial plants in the family CLUSIACEAE %28%sometimes classified as Hypericaceae%29%. Herbal and homeopathic preparations are used for depression, neuralgias, and a variety of other conditions. Hypericum contains flavonoids; GLYCOSIDES; mucilage, TANNINS; volatile oils %28%OILS, ESSENTIAL%29%, hypericin and hyperforin.%A%    
% 215.66/215.81  |- mesh__recordMaintainer mesh__D020902 ssb
% 215.66/215.81  |- mesh__publicMeSHNote mesh__D020902
% 215.66/215.81       2000; for Hypericum %26% St. Johns Wort see THEALES 1999;   
% 215.66/215.81  |- skos__broader mesh__D020902smesh__D028084
% 215.66/215.81  |- skos__historyNote mesh__D020902 Plant Extracts %28%1965-1998%29%
% 215.66/215.81  |- mesh__dateCreated mesh__D020902 1999-11-08
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D020902 2006
% 215.66/215.81  |- mesh__recordAuthorizer mesh__D020902 sjn
% 215.66/215.81  |- skos__prefLabel mesh__D020902 Hypericum
% 215.66/215.81  |- rdf__type mesh__D020902sskos__Concept
% 215.66/215.81  |- skos__historyNote mesh__D020902 Theales %28%1999%29%
% 215.66/215.81  |- skos__historyNote mesh__D020902 Plants, Medicinal %28%1969-1998%29%
% 215.66/215.81  |- skos__broader mesh__D006433smesh__D006420
% 215.66/215.81  |- skos__annotation mesh__D006433 a pigment %26% blood protein   
% 215.66/215.81  |- skos__broader mesh__D006433smesh__D001798
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D006433 2006
% 215.66/215.81  |- skos__hiddenLabel mesh__D006433 alpha Haemocyanin
% 215.66/215.81  |- mesh__recordAuthorizer mesh__D006433 sjn
% 215.66/215.81  |- mesh__dateRevised mesh__D006433 2005-06-30
% 215.66/215.81  |- mesh__publicMeSHNote mesh__D006433 68   
% 215.66/215.81  |- skos__broader mesh__D006433smesh__D008667
% 215.66/215.81  |- mesh__dateCreated mesh__D006433 1999-01-01
% 215.66/215.81  |- mesh__historyNote mesh__D006433 68%28%64%29%   
% 215.66/215.81  |- rdf__type mesh__D006433sskos__Concept
% 215.66/215.81  |- skos__prefLabel mesh__D006433 Hemocyanin
% 215.66/215.81  |- mesh__recordMaintainer mesh__D006433 ssb
% 215.66/215.81  |- mesh__dateEstablished mesh__D006433 1968-01-01
% 215.66/215.81  |- mesh__recordOriginator mesh__D006433 NLM
% 215.66/215.81  |- skos__broader mesh__D006433smesh__D010860
% 215.66/215.81  |- mesh__dateEstablished mesh__D020104 1999-01-01
% 215.66/215.81  |- mesh__historyNote mesh__D020104
% 215.66/215.81       2004%28%1999%29%; for NEUROPHILIN use VASCULAR ENDOTHELIAL GROWTH FACTOR %28%NM%29% 1997-2003%A%  
% 215.66/215.81  |- rdf__type mesh__D020104sskos__Concept
% 215.66/215.81  |- mesh__dateRevised mesh__D020104 2003-07-09
% 215.66/215.81  |- skos__scopeNote mesh__D020104
% 215.66/215.81       Members of a family of highly conserved proteins which are all cis-trans peptidyl-prolyl isomerases %28%PEPTIDYLPROLYL ISOMERASE%29%. They bind the immunosuppressant drugs CYCLOSPORINE; TACROLIMUS and SIROLIMUS. They possess rotomase activity, which is inhibited by the immunosuppressant drugs that bind to them.%A%    
% 215.66/215.81  |- skos__altLabel mesh__D020104 Neurophilin
% 215.66/215.81  |- mesh__recordAuthorizer mesh__D020104 sjn
% 215.66/215.81  |- mesh__recordOriginator mesh__D020104 ADP
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D020104 2006
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D020104 2004
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D020104 2005
% 215.66/215.81  |- mesh__publicMeSHNote mesh__D020104
% 215.66/215.81       2004; NEUROPHILIN was indexed under LYMPHOKINES 1974-2003; ENDOTHELIAL GROWTH FACTORS 1991-2003 %26% INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 2002%A%  
% 215.66/215.81  |- skos__broader mesh__D020104smesh__D011955
% 215.66/215.81  |- mesh__recordMaintainer mesh__D020104 jmp
% 215.66/215.81  |- skos__broader mesh__D020104smesh__D019696
% 215.66/215.81  |- mesh__dateCreated mesh__D020104 1998-06-10
% 215.66/215.81  |- skos__annotation mesh__D020104
% 215.66/215.81       don%27%t confuse X ref NEUROPHILINS with NEUROPILINS   
% 215.66/215.81  |- skos__broader mesh__D020104smesh__D011971
% 215.66/215.81  |- skos__historyNote mesh__D020104
% 215.66/215.81       Immunosuppressive Agents %28%1990-1998%29%
% 215.66/215.81  |- skos__prefLabel mesh__D020104 Immunophilins
% 215.66/215.81  |- rdf__type mesh__D011378sskos__Concept
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D011378 2003
% 215.66/215.81  |- skos__broader mesh__D011378smesh__D008336
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D011378 2000
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D011378 2004
% 215.66/215.81  |- mesh__dateCreated mesh__D011378 1999-01-01
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D011378 2001
% 215.66/215.81  |- mesh__dateRevised mesh__D011378 1999-11-03
% 215.66/215.81  |- skos__broader mesh__D011378smesh__D007569
% 215.66/215.81  |- mesh__recordOriginator mesh__D011378 NLM
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D011378 2005
% 215.66/215.81  |- skos__hiddenLabel mesh__D011378 Prognathisms
% 215.66/215.81  |- skos__scopeNote mesh__D011378
% 215.66/215.81       A condition marked by abnormal protrusion of the mandible. %28%Dorland, 27th ed%29%%A%    
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D011378 2002
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D011378 2006
% 215.66/215.81  |- mesh__recordAuthorizer mesh__D011378 sjn
% 215.66/215.81  |- mesh__recordMaintainer mesh__D011378 kle
% 215.66/215.81  |- skos__annotation mesh__D011378
% 215.66/215.81       abnormal protrusion of mandible; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; consider also MALOCCLUSION, ANGLE CLASS III%A%  
% 215.66/215.81  |- skos__prefLabel mesh__D011378 Prognathism
% 215.66/215.81  |- skos__broader mesh__D005145Q000293smesh__D005145
% 215.66/215.81  |- mesh__preferredCombination mesh__D005145Q000293smesh__D005151
% 215.66/215.81  |- rdf__type mesh__D005145Q000293smesh__CompoundConcept
% 215.66/215.81  |- mesh__recordAuthorizer mesh__D016861 sjn
% 215.66/215.81  |- skos__altLabel mesh__D016861 Inhibitors, Cyclo-Oxygenase
% 215.66/215.81  |- skos__historyNote mesh__D016861
% 215.66/215.81       Prostaglandin-Endoperoxide Synthase/antagonists %26% inhibitors %28%1981-1991%29%
% 215.66/215.81  |- skos__altLabel mesh__D016861
% 215.66/215.81       Prostaglandin Endoperoxide Synthase Inhibitors
% 215.66/215.81  |- skos__altLabel mesh__D016861 Prostaglandin Synthase Inhibitors
% 215.66/215.81  |- rdf__type mesh__D016861sskos__Concept
% 215.66/215.81  |- mesh__onlineNote mesh__D016861
% 215.66/215.81       use ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL to search PROSTAGLANDIN SYNTHESIS ANTAGONISTS 1987-94%A%  
% 215.66/215.81  |- skos__broader mesh__D016861smesh__D000894
% 215.66/215.81  |- skos__broader mesh__D016861smesh__D004791
% 215.66/215.81  |- skos__prefLabel mesh__D016861 Cyclooxygenase Inhibitors
% 215.66/215.81  |- skos__altLabel mesh__D016861 Cyclo-Oxygenase Inhibitors
% 215.66/215.81  |- mesh__dateRevised mesh__D016861 2005-07-01
% 215.66/215.81  |- mesh__recordMaintainer mesh__D016861 sjn
% 215.66/215.81  |- skos__altLabel mesh__D016861 Inhibitors, Cyclooxygenase
% 215.66/215.81  |- skos__altLabel mesh__D016861
% 215.66/215.81       Inhibitors, Prostaglandin-Endoperoxide Synthase
% 215.66/215.81  |- mesh__dateCreated mesh__D016861 1991-07-18
% 215.66/215.81  |- skos__hiddenLabel mesh__D016861 Inhibitors, Cyclo Oxygenase
% 215.66/215.81  |- skos__annotation mesh__D016861 DF: CYCLOOXYGENASE INHIB   
% 215.66/215.81  |- skos__altLabel mesh__D016861 Inhibitors, Prostaglandin Synthase
% 215.66/215.81  |- mesh__recordOriginator mesh__D016861 MXR
% 215.66/215.81  |- mesh__publicMeSHNote mesh__D016861
% 215.66/215.81       92; PROSTAGLANDIN SYNTHESIS ANTAGONISTS was see ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL 1987-94%A%  
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D016861 2006
% 215.66/215.81  |- skos__scopeNote mesh__D016861
% 215.66/215.81       Compounds or agents that combine with cyclooxygenase %28%PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES%29% and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes.%A%    
% 215.66/215.81  |- skos__hiddenLabel mesh__D016861 Cyclo Oxygenase Inhibitors
% 215.66/215.81  |- mesh__historyNote mesh__D016861
% 215.66/215.81       92; PROSTAGLANDIN SYNTHESIS ANTAGONISTS was see ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL 1987-94%A%  
% 215.66/215.81  |- skos__altLabel mesh__D016861 Prostaglandin Synthesis Antagonists
% 215.66/215.81  |- skos__hiddenLabel mesh__D016861
% 215.66/215.81       Inhibitors, Prostaglandin Endoperoxide Synthase
% 215.66/215.81  |- mesh__dateEstablished mesh__D016861 1992-01-01
% 215.66/215.81  |- skos__hiddenLabel mesh__D016861 Antagonists, Prostaglandin Synthesis
% 215.66/215.81  |- skos__altLabel mesh__D016063 Surgical Hemorrhage
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D016063 2001
% 215.66/215.81  |- mesh__historyNote mesh__D016063 91   
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D016063 2005
% 215.66/215.81  |- mesh__recordAuthorizer mesh__D016063 sjn
% 215.66/215.81  |- skos__prefLabel mesh__D016063 Blood Loss, Surgical
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D016063 2002
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D016063 2006
% 215.66/215.81  |- skos__scopeNote mesh__D016063
% 215.66/215.81       Loss of blood during a surgical procedure.     
% 215.66/215.81  |- skos__related mesh__D016063smesh__D006488
% 215.66/215.81  |- skos__altLabel mesh__D016063 Hemorrhage, Surgical
% 215.66/215.81  |- mesh__dateCreated mesh__D016063 1990-03-23
% 215.66/215.81  |- mesh__recordMaintainer mesh__D016063 KEV
% 215.66/215.81  |- mesh__publicMeSHNote mesh__D016063 91   
% 215.66/215.81  |- skos__hiddenLabel mesh__D016063 Surgical Blood Losses
% 215.66/215.81  |- skos__broader mesh__D016063smesh__D007431
% 215.66/215.81  |- skos__annotation mesh__D016063
% 215.66/215.81       /prev: consider also HEMOSTASIS, SURGICAL; for vol of blood lost, coord IM with BLOOD VOLUME %28%NIM%29%; DF: BLOOD LOSS SURG%A%  
% 215.66/215.81  |- mesh__recordOriginator mesh__D016063 AGS
% 215.66/215.81  |- skos__hiddenLabel mesh__D016063 Surgical Hemorrhages
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D016063 2003
% 215.66/215.81  |- skos__altLabel mesh__D016063 Surgical Blood Loss
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D016063 2000
% 215.66/215.81  |- mesh__dateRevised mesh__D016063 1999-11-08
% 215.66/215.81  |- skos__broader mesh__D016063smesh__D006470
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D016063 2004
% 215.66/215.81  |- mesh__dateEstablished mesh__D016063 1991-01-01
% 215.66/215.81  |- skos__historyNote mesh__D016063 Hemorrhage %28%1966-1990%29%
% 215.66/215.81  |- rdf__type mesh__D016063sskos__Concept
% 215.66/215.81  |- mesh__historyNote mesh__D002841 1976   
% 215.66/215.81  |- mesh__recordOriginator mesh__D002841 JW
% 215.66/215.81  |- skos__historyNote mesh__D002841 Bacteria %28%1966-1974%29%
% 215.66/215.81  |- rdf__type mesh__D002841sskos__Concept
% 215.66/215.81  |- skos__scopeNote mesh__D002841
% 215.66/215.81       A family of phototrophic purple sulfur bacteria that deposit globules of elemental sulfur inside their cells. They are found in diverse aquatic environments.%A%    
% 215.66/215.81  |- mesh__dateEstablished mesh__D002841 1976-01-01
% 215.66/215.81  |- mesh__recordMaintainer mesh__D002841 SYSTEM
% 215.66/215.81  |- skos__altLabel mesh__D002841 Purple Sulfur Bacteria
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D002841 2006
% 215.66/215.81  |- skos__altLabel mesh__D002841 Bacteria, Purple Sulfur
% 215.66/215.81  |- mesh__publicMeSHNote mesh__D002841 1976; see THIORHODACEAE 1975   
% 215.66/215.81  |- skos__broader mesh__D002841smesh__D020563
% 215.66/215.81  |- mesh__dateCreated mesh__D002841 1975-07-25
% 215.66/215.81  |- mesh__recordAuthorizer mesh__D002841 sjn
% 215.66/215.81  |- skos__prefLabel mesh__D002841 Chromatiaceae
% 215.66/215.81  |- mesh__dateRevised mesh__D002841 2005-06-30
% 215.66/215.81  |- mesh__dateCreated mesh__D002043 1980-05-21
% 215.66/215.81  |- skos__scopeNote mesh__D002043
% 215.66/215.81       A family of viruses, mainly arboviruses, consisting of a single strand of RNA. Virions are enveloped particles 90-120 nm diameter. The complete family contains over 300 members arranged in five genera:  ORTHOBUNYAVIRUS; HANTAVIRUS; NAIROVIRUS; PHLEBOVIRUS; and TOSPOVIRUS.%A%    
% 215.66/215.81  |- mesh__dateRevised mesh__D002043 2004-07-07
% 215.66/215.81  |- mesh__activeMeSHYear mesh__D002043 2005
% 215.66/215.81  |- mesh__recordAuthorizer mesh__D002043 sjn
% 215.66/215.82  |- skos__annotation mesh__D002043
% 215.66/215.82       from BUNYAmwera, an African place name; infection = BUNYAVIRIDAE INFECTIONS%A%  
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D002043 2006
% 215.66/215.82  |- skos__historyNote mesh__D002043
% 215.66/215.82       Bunyamwera Group Viruses %28%1975-1980%29%
% 215.66/215.82  |- mesh__publicMeSHNote mesh__D002043 81   
% 215.66/215.82  |- mesh__dateEstablished mesh__D002043 1981-01-01
% 215.66/215.82  |- skos__prefLabel mesh__D002043 Bunyaviridae
% 215.66/215.82  |- mesh__recordOriginator mesh__D002043 RC
% 215.66/215.82  |- skos__historyNote mesh__D002043 Arboviruses %28%1966-1980%29%
% 215.66/215.82  |- skos__broader mesh__D002043smesh__D012328
% 215.66/215.82  |- mesh__recordMaintainer mesh__D002043 ags
% 215.66/215.82  |- rdf__type mesh__D002043sskos__Concept
% 215.66/215.82  |- mesh__historyNote mesh__D002043 81   
% 215.66/215.82  |- skos__broader mesh__D029789smesh__D035682
% 215.66/215.82  |- mesh__historyNote mesh__D029789 2002   
% 215.66/215.82  |- skos__prefLabel mesh__D029789 Ephedra
% 215.66/215.82  |- mesh__dateCreated mesh__D029789 2001-07-25
% 215.66/215.82  |- mesh__dateEstablished mesh__D029789 2002-01-01
% 215.66/215.82  |- skos__scopeNote mesh__D029789
% 215.66/215.82       A plant genus of the family Ephedraceae, order Ephedrales, class Gnetopsida, division Gnetophyta.%A%    
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D029789 2005
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D029789 2006
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D029789 2003
% 215.66/215.82  |- mesh__dateRevised mesh__D029789 2002-07-03
% 215.66/215.82  |- mesh__publicMeSHNote mesh__D029789 2002   
% 215.66/215.82  |- skos__annotation mesh__D029789
% 215.66/215.82       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D029789 2004
% 215.66/215.82  |- rdf__type mesh__D029789sskos__Concept
% 215.66/215.82  |- skos__hiddenLabel mesh__D015769 Respiratory Tract Granuloma
% 215.66/215.82  |- mesh__recordAuthorizer mesh__D015769 sjn
% 215.66/215.82  |- mesh__dateEstablished mesh__D015769 1998-01-01
% 215.66/215.82  |- mesh__dateRevised mesh__D015769 1999-11-03
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D015769 2002
% 215.66/215.82  |- skos__prefLabel mesh__D015769 Granuloma, Respiratory Tract
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D015769 2004
% 215.66/215.82  |- mesh__recordMaintainer mesh__D015769 KEV
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D015769 2005
% 215.66/215.82  |- skos__historyNote mesh__D015769
% 215.66/215.82       Respiratory Tract Diseases %28%1969-1997%29%
% 215.66/215.82  |- mesh__historyNote mesh__D015769 98; use explode 1990-97   
% 215.66/215.82  |- skos__hiddenLabel mesh__D015769 Respiratory Tract Granulomas
% 215.66/215.82  |- skos__historyNote mesh__D015769 Granuloma %28%1969-1997%29%
% 215.66/215.82  |- skos__scopeNote mesh__D015769
% 215.66/215.82       Granulomatous disorders affecting one or more sites in the respiratory tract.%A%    
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D015769 2006
% 215.66/215.82  |- skos__hiddenLabel mesh__D015769 Granulomas, Respiratory Tract
% 215.66/215.82  |- skos__broader mesh__D015769smesh__D006099
% 215.66/215.82  |- mesh__dateCreated mesh__D015769 1989-04-07
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D015769 2000
% 215.66/215.82  |- mesh__publicMeSHNote mesh__D015769 98   
% 215.66/215.82  |- mesh__recordOriginator mesh__D015769 PXP
% 215.66/215.82  |- rdf__type mesh__D015769sskos__Concept
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D015769 2001
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D015769 2003
% 215.66/215.82  |- skos__broader mesh__D001749smesh__D001745
% 215.66/215.82  |- mesh__dateRevised mesh__D001749 2005-06-30
% 215.66/215.82  |- skos__hiddenLabel mesh__D001749 Cancer, Bladder
% 215.66/215.82  |- skos__altLabel mesh__D001749 Neoplasms, Bladder
% 215.66/215.82  |- skos__hiddenLabel mesh__D001749 Cancers, Bladder
% 215.66/215.82  |- skos__hiddenLabel mesh__D001749 Neoplasm, Bladder
% 215.66/215.82  |- mesh__recordMaintainer mesh__D001749 lkt
% 215.66/215.82  |- skos__hiddenLabel mesh__D001749 Bladder Tumor
% 215.66/215.82  |- mesh__dateCreated mesh__D001749 1999-01-01
% 215.66/215.82  |- skos__hiddenLabel mesh__D001749 Tumor, Bladder
% 215.66/215.82  |- skos__altLabel mesh__D001749 Cancer of the Bladder
% 215.66/215.82  |- skos__scopeNote mesh__D001749
% 215.66/215.82       Tumors or cancer of the urinary BLADDER.     
% 215.66/215.82  |- mesh__recordOriginator mesh__D001749 NLM
% 215.66/215.82  |- skos__broader mesh__D001749smesh__D014571
% 215.66/215.82  |- skos__prefLabel mesh__D001749 Bladder Neoplasms
% 215.66/215.82  |- skos__hiddenLabel mesh__D001749 Tumors, Bladder
% 215.66/215.82  |- skos__altLabel mesh__D001749 Cancer of Bladder
% 215.66/215.82  |- skos__annotation mesh__D001749
% 215.66/215.82       coordinate IM with histological type of neoplasm %28%IM%29%   
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D001749 2006
% 215.66/215.82  |- mesh__recordAuthorizer mesh__D001749 sjn
% 215.66/215.82  |- skos__hiddenLabel mesh__D001749 Bladder Cancers
% 215.66/215.82  |- rdf__type mesh__D001749sskos__Concept
% 215.66/215.82  |- skos__hiddenLabel mesh__D001749 Bladder Neoplasm
% 215.66/215.82  |- skos__altLabel mesh__D001749 Bladder Tumors
% 215.66/215.82  |- skos__prefLabel mesh__D012471 Salivary Proteins
% 215.66/215.82  |- rdf__type mesh__D012471sskos__Concept
% 215.66/215.82  |- skos__historyNote mesh__D012471 Salivary Glands %28%1966-1976%29%
% 215.66/215.82  |- skos__altLabel mesh__D012471 Salivary Gland Proteins
% 215.66/215.82  |- mesh__recordAuthorizer mesh__D012471 sjn
% 215.66/215.82  |- skos__historyNote mesh__D012471 Saliva %28%1966-1976%29%
% 215.66/215.82  |- skos__hiddenLabel mesh__D012471 Proteins, Salivary
% 215.66/215.82  |- skos__broader mesh__D012471smesh__D011506
% 215.66/215.82  |- mesh__dateRevised mesh__D012471 2005-06-30
% 215.66/215.82  |- mesh__recordMaintainer mesh__D012471 SYSTEM
% 215.66/215.82  |- mesh__dateEstablished mesh__D012471 1977-01-01
% 215.66/215.82  |- skos__hiddenLabel mesh__D012471 Proteins, Salivary Gland
% 215.66/215.82  |- mesh__dateCreated mesh__D012471 1976-04-16
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D012471 2006
% 215.66/215.82  |- mesh__publicMeSHNote mesh__D012471 77   
% 215.66/215.82  |- skos__annotation mesh__D012471
% 215.66/215.82       do not confuse with SIALOPROTEINS, a type of glycoprotein%A%  
% 215.66/215.82  |- skos__historyNote mesh__D012471 Proteins %28%1966-1976%29%
% 215.66/215.82  |- mesh__historyNote mesh__D012471 77   
% 215.66/215.82  |- mesh__recordOriginator mesh__D012471 RLS
% 215.66/215.82  |- skos__scopeNote mesh__D012471
% 215.66/215.82       Proteins found in SALIVA and the SALIVARY GLANDS. Some show enzymatic activity, but their composition varies in different individuals.%A%    
% 215.66/215.82  |- skos__prefLabel mesh__D020903 Tanacetum parthenium
% 215.66/215.82  |- skos__annotation mesh__D020903
% 215.66/215.82       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.66/215.82  |- skos__historyNote mesh__D020903 Sesquiterpenes %28%1977-1999%29%
% 215.66/215.82  |- mesh__recordAuthorizer mesh__D020903 sjn
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D020903 2004
% 215.66/215.82  |- mesh__dateCreated mesh__D020903 1999-11-03
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D020903 2003
% 215.66/215.82  |- skos__altLabel mesh__D020903 Feverfew
% 215.66/215.82  |- mesh__dateEstablished mesh__D020903 2000-01-01
% 215.66/215.82  |- skos__historyNote mesh__D020903 Plants, Medicinal %28%1980-1999%29%
% 215.66/215.82  |- skos__scopeNote mesh__D020903
% 215.66/215.82       An aromatic perennial plant species that has been used to treat migraines, arthritis, and as a febrifuge. It contains TANNINS, volatile oils %28%OILS, ESSENTIAL%29%, and sesquiterpene lactones, especially parthenolide.%A%    
% 215.66/215.82  |- mesh__recordOriginator mesh__D020903 ags
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D020903 2006
% 215.66/215.82  |- rdf__type mesh__D020903sskos__Concept
% 215.66/215.82  |- mesh__publicMeSHNote mesh__D020903
% 215.66/215.82       2003; see FEVERFEW 2000-2002, see SESQUITERPENES 1986-1999%A%  
% 215.66/215.82  |- skos__broader mesh__D020903smesh__D031203
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D020903 2005
% 215.66/215.82  |- mesh__dateRevised mesh__D020903 2002-07-03
% 215.66/215.82  |- mesh__recordMaintainer mesh__D020903 ssb
% 215.66/215.82  |- skos__altLabel mesh__D020903 Chrysanthemum parthenium
% 215.66/215.82  |- mesh__historyNote mesh__D020903 2003%28%2000%29%   
% 215.66/215.82  |- skos__broader mesh__D006434smesh__D001773
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D006434 2006
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D006434 2004
% 215.66/215.82  |- skos__annotation mesh__D006434
% 215.66/215.82       invertebrates only; A 11 qualif; check tag ANIMALS   
% 215.66/215.82  |- skos__hiddenLabel mesh__D006434 Hemocyte
% 215.66/215.82  |- mesh__historyNote mesh__D006434
% 215.66/215.82       91%28%77%29%; was see under BLOOD CELLS 1977-90   
% 215.66/215.82  |- mesh__dateEstablished mesh__D006434 1991-01-01
% 215.66/215.82  |- skos__historyNote mesh__D006434 Blood Cells %28%1966-1976%29%
% 215.66/215.82  |- mesh__dateRevised mesh__D006434 2003-07-30
% 215.66/215.82  |- skos__scopeNote mesh__D006434
% 215.66/215.82       Any blood or formed element especially in invertebrates.%A%    
% 215.66/215.82  |- mesh__recordMaintainer mesh__D006434 ags
% 215.66/215.82  |- mesh__recordAuthorizer mesh__D006434 sjn
% 215.66/215.82  |- mesh__publicMeSHNote mesh__D006434
% 215.66/215.82       91; was see under BLOOD CELLS 1977-90   
% 215.66/215.82  |- skos__historyNote mesh__D006434 Hemolymph %28%1966-1976%29%
% 215.66/215.82  |- rdf__type mesh__D006434sskos__Concept
% 215.66/215.82  |- mesh__recordOriginator mesh__D006434 VDK
% 215.66/215.82  |- skos__prefLabel mesh__D006434 Hemocytes
% 215.66/215.82  |- mesh__dateCreated mesh__D006434 1976-05-19
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D006434 2005
% 215.66/215.82  |- mesh__dateCreated mesh__D020105 1998-06-10
% 215.66/215.82  |- skos__altLabel mesh__D020105
% 215.66/215.82       Sanofi Synthelabo Brand of Milrinone Lactate
% 215.66/215.82  |- skos__prefLabel mesh__D020105 Milrinone
% 215.66/215.82  |- skos__hiddenLabel mesh__D020105 Win 47203
% 215.66/215.82  |- skos__altLabel mesh__D020105 Sanofi Winthrop Brand of Milrinone Lactate
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D020105 2006
% 215.66/215.82  |- mesh__dateEstablished mesh__D020105 1999-01-01
% 215.66/215.82  |- skos__scopeNote mesh__D020105
% 215.66/215.82       A positive inotropic cardiotonic agent with vasodilator properties. It inhibits cAMP phosphodiesterase activity in myocardium and vascular smooth muscle. Milrinone is a derivative of amrinone and has 20-30 times the ionotropic potency of amrinone.%A%    
% 215.66/215.82  |- skos__altLabel mesh__D020105 Sanofi Synthelabo Brand of Milrinone
% 215.66/215.82  |- mesh__publicMeSHNote mesh__D020105
% 215.66/215.82       99; MILRINONE was indexed under PYRIDONES 1983-98   
% 215.66/215.82  |- mesh__recordAuthorizer mesh__D020105 sjn
% 215.66/215.82  |- skos__altLabel mesh__D020105 Sanofi Brand of Milrinone Lactate
% 215.66/215.82  |- mesh__dateRevised mesh__D020105 2005-06-30
% 215.66/215.82  |- skos__hiddenLabel mesh__D020105 Win47203
% 215.66/215.82  |- mesh__historyNote mesh__D020105 99; use MILRINONE %28%NM%29% 1983-98   
% 215.66/215.82  |- skos__broader mesh__D020105smesh__D000676
% 215.66/215.82  |- skos__altLabel mesh__D020105 Corotrop
% 215.66/215.82  |- skos__hiddenLabel mesh__D020105 Lactate, Milrinone
% 215.66/215.82  |- mesh__recordOriginator mesh__D020105 ADP
% 215.66/215.82  |- mesh__recordMaintainer mesh__D020105 CCR
% 215.66/215.82  |- rdf__type mesh__D020105sskos__Concept
% 215.66/215.82  |- skos__historyNote mesh__D020105 Pyridones %28%1983-1998%29%
% 215.66/215.82  |- mesh__dateCreated mesh__D011379 1999-01-01
% 215.66/215.82  |- skos__scopeNote mesh__D011379
% 215.66/215.82       A prediction of the probable outcome of a disease based on a individual%27%s condition and the usual course of the disease as seen in similar situations.%A%    
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D011379 2005
% 215.66/215.82  |- mesh__recordAuthorizer mesh__D011379 sjn
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D011379 2006
% 215.66/215.82  |- skos__prefLabel mesh__D011379 Prognosis
% 215.66/215.82  |- skos__broader mesh__D011379smesh__D003933
% 215.66/215.82  |- mesh__recordMaintainer mesh__D011379 lkt
% 215.66/215.82  |- skos__hiddenLabel mesh__D011379 Prognoses
% 215.66/215.82  |- rdf__type mesh__D011379sskos__Concept
% 215.66/215.82  |- mesh__dateRevised mesh__D011379 2003-07-09
% 215.66/215.82  |- mesh__recordOriginator mesh__D011379 NLM
% 215.66/215.82  |- skos__annotation mesh__D011379
% 215.66/215.82       almost never IM; IM only when GEN; NIM with progn of specific dis /diag %28%IM%29%; Manual 19.8.22; despite category, do not restrict to diagnosis: progn after ther or surg is PROGNOSIS %28%NIM%29%%A%  
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D011379 2004
% 215.66/215.82  |- skos__annotation mesh__D016862
% 215.66/215.82       not a neoplasm; coord IM with specif part of brain or precoord brain/dis %28%IM%29%%A%  
% 215.66/215.82  |- rdf__type mesh__D016862sskos__Concept
% 215.66/215.82  |- skos__altLabel mesh__D016862 Intracranial Tuberculoma
% 215.66/215.82  |- mesh__dateEstablished mesh__D016862 1992-01-01
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016862 2003
% 215.66/215.82  |- mesh__recordAuthorizer mesh__D016862 sjn
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016862 2005
% 215.66/215.82  |- skos__hiddenLabel mesh__D016862 Intracranial Tuberculomas
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016862 2000
% 215.66/215.82  |- skos__historyNote mesh__D016862 Brain Diseases %28%1968-1991%29%
% 215.66/215.82  |- skos__hiddenLabel mesh__D016862 Tuberculomas, Intracranial
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016862 2004
% 215.66/215.82  |- mesh__recordOriginator mesh__D016862 PXP
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016862 2001
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016862 2006
% 215.66/215.82  |- mesh__publicMeSHNote mesh__D016862 92   
% 215.66/215.82  |- skos__broader mesh__D016862smesh__D014375
% 215.66/215.82  |- skos__historyNote mesh__D016862 Tuberculoma %28%1968-1991%29%
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016862 2000A
% 215.66/215.82  |- mesh__recordMaintainer mesh__D016862 sjn
% 215.66/215.82  |- skos__prefLabel mesh__D016862 Tuberculoma, Intracranial
% 215.66/215.82  |- mesh__historyNote mesh__D016862 92   
% 215.66/215.82  |- skos__broader mesh__D016862smesh__D020306
% 215.66/215.82  |- mesh__dateRevised mesh__D016862 2000-06-29
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016862 2002
% 215.66/215.82  |- mesh__dateCreated mesh__D016862 1991-05-30
% 215.66/215.82  |- skos__scopeNote mesh__D016862
% 215.66/215.82       A well-circumscribed mass composed of tuberculous granulation tissue that may occur in the cerebral hemispheres, cerebellum, brain stem, or perimeningeal spaces. Multiple lesions are quite common. Management of intracranial manifestations vary with lesion site. Intracranial tuberculomas may be associated with SEIZURES, focal neurologic deficits, and INTRACRANIAL HYPERTENSION. Spinal cord tuberculomas may be associated with localized or radicular pain, weakness, sensory loss, and incontinence. Tuberculomas may arise as OPPORTUNISTIC INFECTIONS, but also occur in immunocompetent individuals.%A%    
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016064 2006
% 215.66/215.82  |- skos__scopeNote mesh__D016064
% 215.66/215.82       Delivery of an infant through the vagina in a female who has had a prior cesarean section.%A%    
% 215.66/215.82  |- skos__annotation mesh__D016064 DF: VBAC   
% 215.66/215.82  |- mesh__recordAuthorizer mesh__D016064 sjn
% 215.66/215.82  |- mesh__recordMaintainer mesh__D016064 PXP
% 215.66/215.82  |- skos__historyNote mesh__D016064 Labor %28%1980-1987%29%
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016064 2003
% 215.66/215.82  |- skos__prefLabel mesh__D016064 Vaginal Birth after Cesarean
% 215.66/215.82  |- mesh__dateCreated mesh__D016064 1990-03-23
% 215.66/215.82  |- skos__broader mesh__D016064smesh__D036861
% 215.66/215.82  |- mesh__publicMeSHNote mesh__D016064 91   
% 215.66/215.82  |- mesh__dateRevised mesh__D016064 2002-07-03
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016064 2004
% 215.66/215.82  |- mesh__dateEstablished mesh__D016064 1991-01-01
% 215.66/215.82  |- skos__altLabel mesh__D016064 Vaginal Births after Cesarean
% 215.66/215.82  |- rdf__type mesh__D016064sskos__Concept
% 215.66/215.82  |- skos__historyNote mesh__D016064 Cesarean Section %28%1980-1990%29%
% 215.66/215.82  |- skos__historyNote mesh__D016064 Delivery %28%1980-1990%29%
% 215.66/215.82  |- mesh__recordOriginator mesh__D016064 AGS
% 215.66/215.82  |- mesh__historyNote mesh__D016064 91   
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016064 2005
% 215.66/215.82  |- skos__altLabel mesh__D016064 Vaginal Birth after Cesareans
% 215.66/215.82  |- mesh__recordOriginator mesh__D002842 NLM
% 215.66/215.82  |- skos__annotation mesh__D002842
% 215.66/215.82       A 11 qualif except /cytol; /genet permitted   
% 215.66/215.82  |- rdf__type mesh__D002842sskos__Concept
% 215.66/215.82  |- skos__prefLabel mesh__D002842 Chromatids
% 215.66/215.82  |- mesh__dateRevised mesh__D002842 2003-07-09
% 215.66/215.82  |- skos__scopeNote mesh__D002842
% 215.66/215.82       Either of the two longitudinally adjacent threads formed when a eukaryotic chromosome replicates prior to mitosis. The chromatids are held together at the centromere. Sister chromatids are derived from the same chromosome. %28%Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed%29%%A%    
% 215.66/215.82  |- skos__broader mesh__D002842smesh__D022004
% 215.66/215.82  |- mesh__dateEstablished mesh__D002842 1968-01-01
% 215.66/215.82  |- mesh__dateCreated mesh__D002842 1999-01-01
% 215.66/215.82  |- skos__hiddenLabel mesh__D002842 Chromatid
% 215.66/215.82  |- mesh__recordMaintainer mesh__D002842 nns
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D002842 2006
% 215.66/215.82  |- mesh__recordAuthorizer mesh__D002842 sjn
% 215.66/215.82  |- skos__related mesh__D002842smesh__D012854
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D002842 2005
% 215.66/215.82  |- mesh__historyNote mesh__D002842 68   
% 215.66/215.82  |- mesh__publicMeSHNote mesh__D002842 68   
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D002842 2004
% 215.66/215.82  |- skos__historyNote mesh__D002842 Chromosomes %28%1966-1967%29%
% 215.66/215.82  |- skos__scopeNote mesh__D002044
% 215.66/215.82       Virus diseases caused by the BUNYAVIRIDAE.     
% 215.66/215.82  |- skos__altLabel mesh__D002044 Infections, Bunyaviridae
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D002044 2000
% 215.66/215.82  |- mesh__publicMeSHNote mesh__D002044
% 215.66/215.82       92; was BUNYAVIRUS INFECTIONS 1981-91   
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D002044 2004
% 215.66/215.82  |- mesh__historyNote mesh__D002044 92; was BUNYAVIRUS INFECTIONS 1981-91   
% 215.66/215.82  |- skos__historyNote mesh__D002044 Arbovirus Infections %28%1966-1980%29%
% 215.66/215.82  |- mesh__recordMaintainer mesh__D002044 TGC
% 215.66/215.82  |- mesh__recordOriginator mesh__D002044 RC
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D002044 1999
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D002044 2001
% 215.66/215.82  |- skos__altLabel mesh__D002044 Bunyavirus Infections
% 215.66/215.82  |- mesh__dateCreated mesh__D002044 1980-05-13
% 215.66/215.82  |- mesh__recordAuthorizer mesh__D002044 PLS
% 215.66/215.82  |- mesh__onlineNote mesh__D002044
% 215.66/215.82       use BUNYAVIRIDAE INFECTIONS to search BUNYAVIRUS INFECTIONS 1981-91%A%  
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D002044 1997
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D002044 2002
% 215.66/215.82  |- rdf__type mesh__D002044sskos__Concept
% 215.66/215.82  |- skos__hiddenLabel mesh__D002044 Bunyavirus Infection
% 215.66/215.82  |- skos__annotation mesh__D002044 GEN or unspecified; prefer specifics   
% 215.66/215.82  |- skos__broader mesh__D002044smesh__D012327
% 215.66/215.82  |- mesh__dateRevised mesh__D002044 1996-06-10
% 215.66/215.82  |- mesh__dateEstablished mesh__D002044 1981-01-01
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D002044 2005
% 215.66/215.82  |- skos__hiddenLabel mesh__D002044 Bunyaviridae Infection
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D002044 2006
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D002044 2003
% 215.66/215.82  |- skos__prefLabel mesh__D002044 Bunyaviridae Infections
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D002044 1998
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D040961 2004
% 215.66/215.82  |- mesh__publicMeSHNote mesh__D040961 2003; see GENE FREQUENCY 1975-2002   
% 215.66/215.82  |- skos__broader mesh__D040961smesh__D005787
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D040961 2005
% 215.66/215.82  |- mesh__historyNote mesh__D040961 2003; use GENE FREQUENCY 1975-2002   
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D040961 2006
% 215.66/215.82  |- skos__prefLabel mesh__D040961 Genetic Drift
% 215.66/215.82  |- skos__scopeNote mesh__D040961
% 215.66/215.82       The fluctuation of the ALLELE FREQUENCY from one generation to the next.%A%    
% 215.66/215.82  |- mesh__dateEstablished mesh__D040961 2003-01-01
% 215.66/215.82  |- mesh__dateCreated mesh__D040961 2002-07-03
% 215.66/215.82  |- skos__altLabel mesh__D040961 Drift, Genetic
% 215.66/215.82  |- rdf__type mesh__D040961sskos__Concept
% 215.66/215.82  |- skos__historyNote mesh__D040961 Gene Frequency %28%1968-2002%29%
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D040961 2003
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D012472 1998
% 215.66/215.82  |- skos__annotation mesh__D012472
% 215.66/215.82       TN 169: relation to SALIVA %26% SALIVARY GLANDS   
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D012472 2002
% 215.66/215.82  |- mesh__recordOriginator mesh__D012472 NLM
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D012472 1999
% 215.66/215.82  |- skos__broader mesh__D012472smesh__D004068
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D012472 2003
% 215.66/215.82  |- mesh__recordMaintainer mesh__D012472 TGC
% 215.66/215.82  |- mesh__recordAuthorizer mesh__D012472 SJN
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D012472 2005
% 215.66/215.82  |- skos__prefLabel mesh__D012472 Salivation
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D012472 2004
% 215.66/215.82  |- mesh__dateCreated mesh__D012472 1999-01-01
% 215.66/215.82  |- skos__scopeNote mesh__D012472
% 215.66/215.82       The secretion of saliva which serves to moisten and soften food and keep the mouth moist. %28%From Dorland, 28th ed%29%%A%    
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D012472 2006
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D012472 2000
% 215.66/215.82  |- skos__related mesh__D012472smesh__D012798
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D012472 2001
% 215.66/215.82  |- skos__related mesh__D012472smesh__D014987
% 215.66/215.82  |- mesh__dateRevised mesh__D012472 1997-06-20
% 215.66/215.82  |- rdf__type mesh__D012472sskos__Concept
% 215.66/215.82  |- skos__broader mesh__D020904smesh__D009414
% 215.66/215.82  |- mesh__dateRevised mesh__D020904 2005-06-30
% 215.66/215.82  |- skos__altLabel mesh__D020904 GMF
% 215.66/215.82  |- skos__hiddenLabel mesh__D020904 Factor-beta, Glia Maturation
% 215.66/215.82  |- mesh__dateEstablished mesh__D020904 2000-01-01
% 215.66/215.82  |- skos__prefLabel mesh__D020904 Glia Maturation Factor
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D020904 2006
% 215.66/215.82  |- mesh__recordMaintainer mesh__D020904 ssb
% 215.66/215.82  |- rdf__type mesh__D020904sskos__Concept
% 215.66/215.82  |- mesh__dateCreated mesh__D020904 1999-11-03
% 215.66/215.82  |- mesh__recordOriginator mesh__D020904 jmp
% 215.66/215.82  |- skos__hiddenLabel mesh__D020904 Maturation Factor-beta, Glia
% 215.66/215.82  |- skos__hiddenLabel mesh__D020904 Maturation Factor, Glial
% 215.66/215.82  |- skos__historyNote mesh__D020904 Nerve Tissue Proteins %28%1977-1999%29%
% 215.66/215.82  |- mesh__recordAuthorizer mesh__D020904 sjn
% 215.66/215.82  |- mesh__historyNote mesh__D020904
% 215.66/215.82       2000; use GLIAL MATURATION FACTOR %28%NM%29% 1977-1999   
% 215.66/215.82  |- skos__altLabel mesh__D020904 Glia Maturation Factor-beta
% 215.66/215.82  |- skos__scopeNote mesh__D020904
% 215.66/215.82       A factor identified in the brain that influences the growth and differentiation of NEURONS and NEUROGLIA. Glia maturation factor beta is the 17-kDa polypeptide product of the GMFB gene and is the principal component of GLIA MATURATION FACTOR.%A%    
% 215.66/215.82  |- mesh__publicMeSHNote mesh__D020904
% 215.66/215.82       2000; GLIAL MATURATION FACTOR %28%now GLIA MATURATION FACTOR%29% was indexed under NERVE TISSUE PROTEINS 1977-1999%A%  
% 215.66/215.82  |- skos__altLabel mesh__D020904 GMFbeta
% 215.66/215.82  |- skos__altLabel mesh__D020904 GMF-beta
% 215.66/215.82  |- skos__altLabel mesh__D020904 Glial Maturation Factor
% 215.66/215.82  |- skos__annotation mesh__D020904
% 215.66/215.82       do not confuse with GLIAL GROWTH FACTOR; see NEUREGULIN-1%A%  
% 215.66/215.82  |- skos__hiddenLabel mesh__D020904 GMF beta
% 215.66/215.82  |- skos__hiddenLabel mesh__D020904 Maturation Factor, Glia
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D006435 2004
% 215.66/215.82  |- mesh__dateEstablished mesh__D006435 1967-01-01
% 215.66/215.82  |- skos__hiddenLabel mesh__D006435 Extracorporeal Dialyses
% 215.66/215.82  |- skos__hiddenLabel mesh__D006435 Dialyses, Extracorporeal
% 215.66/215.82  |- mesh__publicMeSHNote mesh__D006435 2001; see HEMODIALYSIS 1967-2000   
% 215.66/215.82  |- mesh__recordMaintainer mesh__D006435 ags
% 215.66/215.82  |- mesh__recordOriginator mesh__D006435 NLM
% 215.66/215.82  |- rdf__type mesh__D006435sskos__Concept
% 215.66/215.82  |- skos__hiddenLabel mesh__D006435 Renal Dialyses
% 215.66/215.82  |- skos__prefLabel mesh__D006435 Renal Dialysis
% 215.66/215.82  |- skos__broader mesh__D006435smesh__D017582
% 215.66/215.82  |- mesh__dateRevised mesh__D006435 2002-07-03
% 215.66/215.82  |- skos__altLabel mesh__D006435 Dialysis, Renal
% 215.66/215.82  |- skos__related mesh__D006435smesh__D007688
% 215.66/215.82  |- skos__annotation mesh__D006435
% 215.66/215.82       /instrum permitted but consider also KIDNEY, ARTIFICIAL   
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D006435 2005
% 215.66/215.82  |- skos__historyNote mesh__D006435 Kidney, Artificial %28%1966%29%
% 215.66/215.82  |- mesh__recordAuthorizer mesh__D006435 sjn
% 215.66/215.82  |- mesh__historyNote mesh__D006435 2001%28%1967%29%   
% 215.66/215.82  |- skos__broader mesh__D006435smesh__D016060
% 215.66/215.82  |- skos__historyNote mesh__D006435 Dialysis %28%1966%29%
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D006435 2006
% 215.66/215.82  |- skos__altLabel mesh__D006435 Extracorporeal Dialysis
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D006435 2003
% 215.66/215.82  |- skos__hiddenLabel mesh__D006435 Hemodialyses
% 215.66/215.82  |- mesh__dateCreated mesh__D006435 1999-01-01
% 215.66/215.82  |- skos__hiddenLabel mesh__D006435 Dialyses, Renal
% 215.66/215.82  |- skos__scopeNote mesh__D006435
% 215.66/215.82       Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION.%A%    
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D020106 2005
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D020106 2001
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D020106 2003
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D020106 2006
% 215.66/215.82  |- mesh__publicMeSHNote mesh__D020106
% 215.66/215.82       99; ACRYLAMIDE was indexed under ACRYLAMIDES 1982-98   
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D020106 2002
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D020106 2004
% 215.66/215.82  |- skos__scopeNote mesh__D020106
% 215.66/215.82       A colorless, odorless, highly water soluble vinyl monomer formed from the hydration of acrylonitrile. It is primarily used in research laboratories for electrophoresis, chromatography, and electron microscopy and in the sewage and wastewater treatment industries.%A%    
% 215.66/215.82  |- skos__historyNote mesh__D020106 Acrylamides %28%1982-1998%29%
% 215.66/215.82  |- mesh__dateCreated mesh__D020106 1998-06-10
% 215.66/215.82  |- skos__prefLabel mesh__D020106 Acrylamide
% 215.66/215.82  |- mesh__historyNote mesh__D020106 99; use ACRYLAMIDE %28%NM%29% 1982-98   
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D020106 1999
% 215.66/215.82  |- skos__broader mesh__D020106smesh__D000178
% 215.66/215.82  |- skos__annotation mesh__D020106 ACRYLAMIDES is also available   
% 215.66/215.82  |- mesh__dateEstablished mesh__D020106 1999-01-01
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D020106 2000
% 215.66/215.82  |- rdf__type mesh__D020106sskos__Concept
% 215.66/215.82  |- skos__annotation mesh__D016863
% 215.66/215.82       gram-pos bact infect; GEN: avoid; prefer specifics; DF: BACILLACEAE INFECT%A%  
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016863 2006
% 215.66/215.82  |- skos__broader mesh__D016863smesh__D016908
% 215.66/215.82  |- mesh__recordMaintainer mesh__D016863 PLS
% 215.66/215.82  |- mesh__recordOriginator mesh__D016863 PXP
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016863 2002
% 215.66/215.82  |- skos__scopeNote mesh__D016863
% 215.66/215.82       Infections with bacteria of the family BACILLACEAE.     
% 215.66/215.82  |- mesh__historyNote mesh__D016863 92   
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016863 1996
% 215.66/215.82  |- mesh__dateEstablished mesh__D016863 1992-01-01
% 215.66/215.82  |- skos__hiddenLabel mesh__D016863 Infection, Bacillaceae
% 215.66/215.82  |- skos__prefLabel mesh__D016863 Bacillaceae Infections
% 215.66/215.82  |- mesh__recordAuthorizer mesh__D016863 PLS
% 215.66/215.82  |- mesh__dateRevised mesh__D016863 1993-06-02
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016863 1998
% 215.66/215.82  |- skos__hiddenLabel mesh__D016863 Bacillaceae Infection
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016863 1997
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016863 1994
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016863 1999
% 215.66/215.82  |- rdf__type mesh__D016863sskos__Concept
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016863 2000
% 215.66/215.82  |- mesh__dateCreated mesh__D016863 1991-05-30
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016863 1995
% 215.66/215.82  |- skos__altLabel mesh__D016863 Infections, Bacillaceae
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016863 2003
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016863 2001
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016863 2005
% 215.66/215.82  |- mesh__publicMeSHNote mesh__D016863 92   
% 215.66/215.82  |- mesh__activeMeSHYear mesh__D016863 2004
% 215.66/215.82  |- rdf__type mesh__D016065sskos__Concept
% 215.66/215.83  |- mesh__publicMeSHNote mesh__D016065 91   
% 215.66/215.83  |- skos__prefLabel mesh__D016065 Myoelectric Complex, Migrating
% 215.66/215.83  |- mesh__dateEstablished mesh__D016065 1991-01-01
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016065 1998
% 215.66/215.83  |- skos__hiddenLabel mesh__D016065 Migrating Motor Complexes
% 215.66/215.83  |- skos__broader mesh__D016065smesh__D005769
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016065 2002
% 215.66/215.83  |- skos__hiddenLabel mesh__D016065 Motor Complex, Migrating
% 215.66/215.83  |- skos__broader mesh__D016065smesh__D000200
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016065 2006
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016065 2001
% 215.66/215.83  |- skos__altLabel mesh__D016065 Migrating Motor Complex
% 215.66/215.83  |- skos__hiddenLabel mesh__D016065 Complex, Migrating Myoelectric
% 215.66/215.83  |- skos__altLabel mesh__D016065 Complexes, Migrating Myoelectric
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016065 2000
% 215.66/215.83  |- mesh__dateRevised mesh__D016065 1997-06-20
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016065 2005
% 215.66/215.83  |- skos__scopeNote mesh__D016065
% 215.66/215.83       Bursts of depolarization that move from the stomach to the ileocecal valve at regular frequency during the interdigestive period. The complex and its accompanying motor activity periodically cleanse the bowel of interdigestive secretion and debris in preparation for the next meal.%A%    
% 215.66/215.83  |- mesh__recordOriginator mesh__D016065 AGS
% 215.66/215.83  |- mesh__historyNote mesh__D016065 91   
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016065 2004
% 215.66/215.83  |- skos__hiddenLabel mesh__D016065 Myoelectric Complexes, Migrating
% 215.66/215.83  |- skos__altLabel mesh__D016065 Complexes, Migrating Motor
% 215.66/215.83  |- mesh__recordAuthorizer mesh__D016065 SJN
% 215.66/215.83  |- skos__historyNote mesh__D016065
% 215.66/215.83       Gastrointestinal Motility %28%1977-1990%29%
% 215.66/215.83  |- mesh__dateCreated mesh__D016065 1990-03-23
% 215.66/215.83  |- mesh__recordMaintainer mesh__D016065 TPW
% 215.66/215.83  |- skos__hiddenLabel mesh__D016065 Migrating Myoelectric Complex
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016065 2003
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016065 1999
% 215.66/215.83  |- skos__hiddenLabel mesh__D016065 Motor Complexes, Migrating
% 215.66/215.83  |- skos__hiddenLabel mesh__D016065 Migrating Myoelectric Complexes
% 215.66/215.83  |- skos__hiddenLabel mesh__D016065 Complex, Migrating Motor
% 215.66/215.83  |- mesh__dateCreated mesh__D002843 1999-01-01
% 215.66/215.83  |- mesh__dateRevised mesh__D002843 2005-07-13
% 215.66/215.83  |- rdf__type mesh__D002843sskos__Concept
% 215.66/215.83  |- mesh__dateEstablished mesh__D002843 1972-01-01
% 215.66/215.83  |- mesh__recordAuthorizer mesh__D002843 ags
% 215.66/215.83  |- mesh__recordMaintainer mesh__D002843 ags
% 215.66/215.83  |- mesh__historyNote mesh__D002843 72   
% 215.66/215.83  |- skos__scopeNote mesh__D002843
% 215.66/215.83       The material of CHROMOSOMES. It is a complex of DNA; HISTONES; and nonhistone proteins %28%CHROMOSOMAL PROTEINS, NON-HISTONE%29% found within the nucleus of a cell.%A%    
% 215.66/215.83  |- skos__broader mesh__D002843smesh__D022004
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D002843 2006A
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D002843 2005
% 215.66/215.83  |- mesh__recordOriginator mesh__D002843 NLM
% 215.66/215.83  |- skos__broader mesh__D002843smesh__D009698
% 215.66/215.83  |- skos__prefLabel mesh__D002843 Chromatin
% 215.66/215.83  |- skos__hiddenLabel mesh__D002843 Chromatins
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D002843 2006
% 215.66/215.83  |- skos__historyNote mesh__D002843 Sex Chromatin %28%1966-1971%29%
% 215.66/215.83  |- mesh__publicMeSHNote mesh__D002843 72   
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D002843 2004
% 215.66/215.83  |- skos__historyNote mesh__D002843 Chromosomes %28%1966-1971%29%
% 215.66/215.83  |- skos__altLabel mesh__D002045
% 215.66/215.83       Jenapharm Brand of Bupivacaine Hydrochloride
% 215.66/215.83  |- skos__broader mesh__D002045smesh__D000813
% 215.66/215.83  |- skos__altLabel mesh__D002045 Astra Brand of Bupivacaine Hydrochloride
% 215.66/215.83  |- skos__altLabel mesh__D002045 Abbott Brand of Bupivacaine Hydrochloride
% 215.66/215.83  |- skos__hiddenLabel mesh__D002045 Braun, Bupivacaina
% 215.66/215.83  |- skos__hiddenLabel mesh__D002045 Anhydrous, Bupivacaine
% 215.66/215.83  |- skos__hiddenLabel mesh__D002045 Janapharm, Bupivacain
% 215.66/215.83  |- skos__altLabel mesh__D002045 Carbostesin
% 215.66/215.83  |- skos__altLabel mesh__D002045 Marcaine
% 215.66/215.83  |- skos__altLabel mesh__D002045 Aventis Brand of Bupivacaine Hydrochloride
% 215.66/215.83  |- skos__altLabel mesh__D002045 Marcain
% 215.66/215.83  |- rdf__type mesh__D002045sskos__Concept
% 215.66/215.83  |- skos__altLabel mesh__D002045 Pisa Brand of Bupivacaine Hydrochloride
% 215.66/215.83  |- skos__prefLabel mesh__D002045 Bupivacaine
% 215.66/215.83  |- mesh__recordMaintainer mesh__D002045 CCR
% 215.66/215.83  |- skos__hiddenLabel mesh__D002045 Bupivacain RPR
% 215.66/215.83  |- skos__altLabel mesh__D002045
% 215.66/215.83       1-Butyl-N-%28%2,6-dimethylphenyl%29%-2-piperidinecarboxamide
% 215.66/215.83  |- mesh__dateCreated mesh__D002045 1999-01-01
% 215.66/215.83  |- mesh__dateRevised mesh__D002045 2005-06-30
% 215.66/215.83  |- skos__historyNote mesh__D002045 Anesthetics, Local %28%1966-1970%29%
% 215.66/215.83  |- skos__altLabel mesh__D002045
% 215.66/215.83       AstraZeneca Brand of Bupivacaine Hydrochloride
% 215.66/215.83  |- skos__altLabel mesh__D002045 Bupivacaine Monohydrochloride, Monohydrate
% 215.66/215.83  |- mesh__publicMeSHNote mesh__D002045 73   
% 215.66/215.83  |- mesh__recordOriginator mesh__D002045 NLM
% 215.66/215.83  |- mesh__dateEstablished mesh__D002045 1973-01-01
% 215.66/215.83  |- skos__scopeNote mesh__D002045 A widely used local anesthetic agent.     
% 215.66/215.83  |- skos__altLabel mesh__D002045 Inibsa Brand of Bupivacaine Hydrochloride
% 215.66/215.83  |- skos__altLabel mesh__D002045 Braun Brand of Bupivacaine Hydrochloride
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D002045 2006
% 215.66/215.83  |- mesh__recordAuthorizer mesh__D002045 sjn
% 215.66/215.83  |- skos__hiddenLabel mesh__D002045 Carbonate, Bupivacaine
% 215.66/215.83  |- mesh__historyNote mesh__D002045 73%28%71%29%   
% 215.66/215.83  |- skos__hiddenLabel mesh__D002045 Hydrochloride, Bupivacaine
% 215.66/215.83  |- skos__broader mesh__D002045smesh__D010875
% 215.66/215.83  |- skos__altLabel mesh__D002045
% 215.66/215.83       Strathmann Brand of Bupivacaine Hydrochloride
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D012473 2005
% 215.66/215.83  |- mesh__dateRevised mesh__D012473 1992-05-20
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D012473 1997
% 215.66/215.83  |- rdf__type mesh__D012473sskos__Concept
% 215.66/215.83  |- mesh__historyNote mesh__D012473
% 215.66/215.83       91%28%75%29%; was see under PROTAMINES 1975-90   
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D012473 1993
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D012473 1996
% 215.66/215.83  |- mesh__recordMaintainer mesh__D012473 TAP
% 215.66/215.83  |- mesh__recordAuthorizer mesh__D012473 PLS
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D012473 2001
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D012473 1999
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D012473 2004
% 215.66/215.83  |- mesh__onlineNote mesh__D012473 search PROTAMINES 1966-74   
% 215.66/215.83  |- skos__prefLabel mesh__D012473 Salmine
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D012473 1995
% 215.66/215.83  |- mesh__recordOriginator mesh__D012473 NLM
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D012473 1998
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D012473 2000
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D012473 2003
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D012473 1994
% 215.66/215.83  |- mesh__publicMeSHNote mesh__D012473
% 215.66/215.83       91; was see under PROTAMINES 1975-90   
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D012473 2006
% 215.66/215.83  |- mesh__dateEstablished mesh__D012473 1991-01-01
% 215.66/215.83  |- mesh__dateCreated mesh__D012473 1999-01-01
% 215.66/215.83  |- skos__broader mesh__D012473smesh__D011479
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D012473 2002
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D006436 1999
% 215.66/215.83  |- mesh__dateEstablished mesh__D006436 1991-01-01
% 215.66/215.83  |- skos__broader mesh__D006436smesh__D006757
% 215.66/215.83  |- rdf__type mesh__D006436sskos__Concept
% 215.66/215.83  |- mesh__recordOriginator mesh__D006436 EC
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D006436 1997
% 215.66/215.83  |- mesh__recordAuthorizer mesh__D006436 PLS
% 215.66/215.83  |- skos__altLabel mesh__D006436 Hospital Hemodialysis Units
% 215.66/215.83  |- skos__altLabel mesh__D006436 Renal Dialysis Units, Hospital
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D006436 2005
% 215.66/215.83  |- mesh__dateCreated mesh__D006436 1981-02-26
% 215.66/215.83  |- skos__hiddenLabel mesh__D006436 Units, Hospital Hemodialysis
% 215.66/215.83  |- skos__hiddenLabel mesh__D006436 Hospital Hemodialysis Unit
% 215.66/215.83  |- skos__hiddenLabel mesh__D006436 Hemodialysis Unit, Hospital
% 215.66/215.83  |- skos__annotation mesh__D006436
% 215.66/215.83       restrict to hosps: non-hosp = HEMODIALYSIS + AMBULATORY CARE FACILITIES but HEMODIALYSIS, HOME is also available%A%  
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D006436 2006
% 215.66/215.83  |- mesh__recordMaintainer mesh__D006436 TGC
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D006436 2003
% 215.66/215.83  |- mesh__historyNote mesh__D006436
% 215.66/215.83       91%28%82%29%; was see under HOSPITAL UNITS 1982-90   
% 215.66/215.83  |- skos__scopeNote mesh__D006436
% 215.66/215.83       Hospital units in which care is provided the hemodialysis patient. This includes hemodialysis centers in hospitals.%A%    
% 215.66/215.83  |- skos__historyNote mesh__D006436 Hospital Units %28%1974-1981%29%
% 215.66/215.83  |- skos__historyNote mesh__D006436 Hemodialysis %28%1974-1981%29%
% 215.66/215.83  |- mesh__dateRevised mesh__D006436 1996-06-10
% 215.66/215.83  |- mesh__publicMeSHNote mesh__D006436
% 215.66/215.83       91; was see under HOSPITAL UNITS 1982-90   
% 215.66/215.83  |- skos__hiddenLabel mesh__D006436 Unit, Hospital Hemodialysis
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D006436 2000
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D006436 2004
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D006436 2001
% 215.66/215.83  |- skos__prefLabel mesh__D006436 Hemodialysis Units, Hospital
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D006436 1998
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D006436 2002
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D020107 2006
% 215.66/215.83  |- mesh__dateEstablished mesh__D020107 1999-01-01
% 215.66/215.83  |- mesh__dateRevised mesh__D020107 2005-06-30
% 215.66/215.83  |- skos__annotation mesh__D020107
% 215.66/215.83       TROPONIN C %26% TROPONIN I are also available   
% 215.66/215.83  |- skos__broader mesh__D020107smesh__D014336
% 215.66/215.83  |- mesh__dateCreated mesh__D020107 1998-06-11
% 215.66/215.83  |- mesh__recordOriginator mesh__D020107 ADP
% 215.66/215.83  |- skos__hiddenLabel mesh__D020107 T1, Troponin
% 215.66/215.83  |- mesh__publicMeSHNote mesh__D020107
% 215.66/215.83       99; TROPONIN T was indexed under TROPONIN 1981-98   
% 215.66/215.83  |- skos__hiddenLabel mesh__D020107 T, Troponin
% 215.66/215.83  |- skos__scopeNote mesh__D020107
% 215.66/215.83       One of the three polypeptide chains that make up the TROPONIN complex. It is a cardiac-specific protein that binds to TROPOMYOSIN. It is released from damaged or injured heart muscle cells %28%MYOCYTES, CARDIAC%29%. Defects in the gene encoding troponin T result in FAMILIAL HYPERTROPHIC CARDIOMYOPATHY.%A%    
% 215.66/215.83  |- skos__historyNote mesh__D020107 Troponin %28%1981-1998%29%
% 215.66/215.83  |- rdf__type mesh__D020107sskos__Concept
% 215.66/215.83  |- skos__altLabel mesh__D020107 Troponin-T
% 215.66/215.83  |- skos__prefLabel mesh__D020107 Troponin T
% 215.66/215.83  |- skos__related mesh__D020107smesh__D024741
% 215.66/215.83  |- mesh__historyNote mesh__D020107 99; use TROPONIN T %28%NM%29% 1981-98   
% 215.66/215.83  |- skos__hiddenLabel mesh__D020107 T2, Troponin
% 215.66/215.83  |- mesh__recordMaintainer mesh__D020107 DRC
% 215.66/215.83  |- mesh__recordAuthorizer mesh__D020107 sjn
% 215.66/215.83  |- mesh__publicMeSHNote mesh__D016864 92   
% 215.66/215.83  |- mesh__historyNote mesh__D016864 92   
% 215.66/215.83  |- skos__scopeNote mesh__D016864
% 215.66/215.83       Rare autosomal dominant syndrome characterized by mesenchymal and epithelial neoplasms at multiple sites.  MUTATION of the p53 tumor suppressor gene, a component of the DNA DAMAGE response pathway, apparently predisposes family members who inherit it to develop certain cancers. The spectrum of cancers in the syndrome was shown to include, in addition to BREAST CANCER and soft tissue sarcomas %28%SARCOMA%29%; BRAIN TUMORS; OSTEOSARCOMA; LEUKEMIA; and ADRENOCORTICAL CARCINOMA.%A%    
% 215.66/215.83  |- skos__related mesh__D016864smesh__D016158
% 215.66/215.83  |- mesh__dateCreated mesh__D016864 1991-06-21
% 215.66/215.83  |- mesh__dateRevised mesh__D016864 2005-06-30
% 215.66/215.83  |- skos__broader mesh__D016864smesh__D049914
% 215.66/215.83  |- skos__broader mesh__D016864smesh__D009386
% 215.66/215.83  |- rdf__type mesh__D016864sskos__Concept
% 215.66/215.83  |- skos__historyNote mesh__D016864 Neoplasms %28%1982-1986%29%
% 215.66/215.83  |- mesh__dateEstablished mesh__D016864 1992-01-01
% 215.66/215.83  |- skos__prefLabel mesh__D016864 Li-Fraumeni Syndrome
% 215.66/215.83  |- mesh__recordAuthorizer mesh__D016864 sjn
% 215.66/215.83  |- skos__historyNote mesh__D016864 Syndrome %28%1982-1986%29%
% 215.66/215.83  |- mesh__recordMaintainer mesh__D016864 nns
% 215.66/215.83  |- mesh__recordOriginator mesh__D016864 AGS
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016864 2006
% 215.66/215.83  |- skos__hiddenLabel mesh__D016864 Li Fraumeni Syndrome
% 215.66/215.83  |- skos__historyNote mesh__D016864
% 215.66/215.83       Neoplastic Syndromes, Hereditary %28%1987-1991%29%
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016066 1997
% 215.66/215.83  |- skos__hiddenLabel mesh__D016066 Pleural Effusions, Malignant
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016066 2006
% 215.66/215.83  |- mesh__publicMeSHNote mesh__D016066 91   
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016066 1996
% 215.66/215.83  |- skos__historyNote mesh__D016066 Pleural Effusion %28%1966-1990%29%
% 215.66/215.83  |- skos__hiddenLabel mesh__D016066 Malignant Pleural Effusion
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016066 2005
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016066 2002
% 215.66/215.83  |- skos__hiddenLabel mesh__D016066 Effusions, Malignant Pleural
% 215.66/215.83  |- mesh__historyNote mesh__D016066 91   
% 215.66/215.83  |- mesh__recordMaintainer mesh__D016066 KEV
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016066 2004
% 215.66/215.83  |- skos__annotation mesh__D016066
% 215.66/215.83       note category; presence of fluid in the pleural space as a compl of cancer%A%  
% 215.66/215.83  |- skos__broader mesh__D016066smesh__D010996
% 215.66/215.83  |- skos__scopeNote mesh__D016066
% 215.66/215.83       Presence of fluid in the pleural cavity as a complication of malignant disease. Malignant pleural effusions often contain actual malignant cells.%A%    
% 215.66/215.83  |- skos__prefLabel mesh__D016066 Pleural Effusion, Malignant
% 215.66/215.83  |- skos__broader mesh__D016066smesh__D010997
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016066 2001
% 215.66/215.83  |- mesh__recordAuthorizer mesh__D016066 PLS
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016066 2003
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016066 1999
% 215.66/215.83  |- skos__historyNote mesh__D016066 specific neoplasm %28%1966-1990%29%
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016066 2000
% 215.66/215.83  |- skos__hiddenLabel mesh__D016066 Effusion, Malignant Pleural
% 215.66/215.83  |- rdf__type mesh__D016066sskos__Concept
% 215.66/215.83  |- mesh__dateCreated mesh__D016066 1990-02-12
% 215.66/215.83  |- mesh__recordOriginator mesh__D016066 AGS
% 215.66/215.83  |- skos__hiddenLabel mesh__D016066 Malignant Pleural Effusions
% 215.66/215.83  |- mesh__dateRevised mesh__D016066 1995-06-08
% 215.66/215.83  |- mesh__dateEstablished mesh__D016066 1991-01-01
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016066 1998
% 215.66/215.83  |- skos__broader mesh__D002844smesh__D016965
% 215.66/215.83  |- mesh__recordAuthorizer mesh__D002844 sjn
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D002844 2006
% 215.66/215.83  |- skos__broader mesh__D002844smesh__D002841
% 215.66/215.83  |- mesh__recordOriginator mesh__D002844 NLM
% 215.66/215.83  |- mesh__dateRevised mesh__D002844 2005-06-30
% 215.66/215.83  |- mesh__recordMaintainer mesh__D002844 SYSTEM
% 215.66/215.83  |- skos__scopeNote mesh__D002844
% 215.66/215.83       A genus of gram-negative, ovoid to rod-shaped bacteria that is phototrophic. All species use ammonia as a nitrogen source. Some strains are found only in sulfide-containing freshwater habitats exposed to light while others may occur in marine, estuarine, and freshwater environments.%A%    
% 215.66/215.83  |- skos__annotation mesh__D002844 in water   
% 215.66/215.83  |- mesh__dateCreated mesh__D002844 1999-01-01
% 215.66/215.83  |- rdf__type mesh__D002844sskos__Concept
% 215.66/215.83  |- skos__prefLabel mesh__D002844 Chromatium
% 215.66/215.83  |- skos__historyNote mesh__D002046 Propanolamines %28%1974-1978%29%
% 215.66/215.83  |- skos__hiddenLabel mesh__D002046 KL255
% 215.66/215.83  |- skos__broader mesh__D002046smesh__D050198
% 215.66/215.83  |- mesh__recordAuthorizer mesh__D002046 sjn
% 215.66/215.83  |- skos__broader mesh__D002046smesh__D011412
% 215.66/215.83  |- skos__historyNote mesh__D002046 Amino Alcohols %28%1966-1974%29%
% 215.66/215.83  |- skos__prefLabel mesh__D002046 Bupranolol
% 215.66/215.83  |- mesh__recordMaintainer mesh__D002046 ssb
% 215.66/215.83  |- mesh__historyNote mesh__D002046
% 215.66/215.83       91%28%79%29%; was see under PROPANOLAMINES 1979-90   
% 215.66/215.83  |- mesh__publicMeSHNote mesh__D002046
% 215.66/215.83       91; was see under PROPANOLAMINES 1979-90   
% 215.66/215.83  |- mesh__dateEstablished mesh__D002046 1991-01-01
% 215.66/215.83  |- mesh__dateCreated mesh__D002046 1978-02-01
% 215.66/215.83  |- rdf__type mesh__D002046sskos__Concept
% 215.66/215.83  |- skos__altLabel mesh__D002046 Desma Brand of Bupranolol Hydrochloride
% 215.66/215.83  |- mesh__recordOriginator mesh__D002046 SH
% 215.66/215.83  |- skos__scopeNote mesh__D002046
% 215.66/215.83       An adrenergic-beta-2 antagonist that has been used for cardiac arrhythmia, angina pectoris, hypertension, glaucoma, and as an antithrombotic.%A%    
% 215.66/215.83  |- mesh__dateRevised mesh__D002046 2005-06-30
% 215.66/215.83  |- skos__hiddenLabel mesh__D002046 KL 255
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D002046 2006
% 215.66/215.83  |- mesh__historyNote mesh__D048148 2005%28%1993%29%   
% 215.66/215.83  |- skos__altLabel mesh__D048148 Casein Kinase 1 delta
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D048148 2006A
% 215.66/215.83  |- mesh__recordMaintainer mesh__D048148 ags
% 215.66/215.83  |- mesh__recordAuthorizer mesh__D048148 ags
% 215.66/215.83  |- skos__historyNote mesh__D048148 Protein Kinases %28%1993-2004%29%
% 215.66/215.83  |- mesh__dateEstablished mesh__D048148 2005-01-01
% 215.66/215.83  |- skos__altLabel mesh__D048148 Protein Kinase CK1delta
% 215.66/215.83  |- skos__broader mesh__D048148smesh__D047389
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D048148 2006
% 215.66/215.83  |- rdf__type mesh__D048148sskos__Concept
% 215.66/215.83  |- mesh__publicMeSHNote mesh__D048148
% 215.66/215.83       2005; CASEIN KINASE IALPHA was indxed under PROTEIN KINASES 1993-2004%A%  
% 215.66/215.83  |- mesh__recordOriginator mesh__D048148 jmp
% 215.66/215.83  |- mesh__dateCreated mesh__D048148 2004-07-07
% 215.66/215.83  |- skos__altLabel mesh__D048148 Casein Kinase I delta
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D048148 2005
% 215.66/215.83  |- skos__prefLabel mesh__D048148 Casein Kinase Idelta
% 215.66/215.83  |- skos__scopeNote mesh__D048148
% 215.66/215.83       A casein kinase I isoenzyme that plays a regulatory role in a variety of cellular functions including vesicular transport, CHROMOSOME SEGREGATION; CYTOKINESIS, developmental processes, and the CIRCADIAN RHYTHM.%A%    
% 215.66/215.83  |- mesh__dateRevised mesh__D048148 2005-07-12
% 215.66/215.83  |- mesh__recordMaintainer mesh__D012474 ags
% 215.66/215.83  |- mesh__historyNote mesh__D012474 72   
% 215.66/215.83  |- mesh__dateEstablished mesh__D012474 1972-01-01
% 215.66/215.83  |- skos__altLabel mesh__D012474 Oncorhynchus gorbuscha
% 215.66/215.83  |- mesh__publicMeSHNote mesh__D012474 72   
% 215.66/215.83  |- mesh__dateRevised mesh__D012474 2003-07-09
% 215.66/215.83  |- skos__hiddenLabel mesh__D012474 Pink Salmon
% 215.66/215.83  |- mesh__recordAuthorizer mesh__D012474 sjn
% 215.66/215.83  |- skos__annotation mesh__D012474
% 215.66/215.83       genera Oncorhynchus and Salmo may be either salmon or trout; check text; canned salmon = SALMON %28%IM%29% + FOOD PRESERVATION %28%IM%29%%A%  
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D012474 2004
% 215.66/215.83  |- skos__hiddenLabel mesh__D012474 Sockeye Salmon
% 215.66/215.83  |- skos__hiddenLabel mesh__D012474 Chinook Salmon
% 215.66/215.83  |- skos__altLabel mesh__D012474 Oncorhynchus nerka
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D012474 2006
% 215.66/215.83  |- skos__broader mesh__D012474smesh__D012487
% 215.66/215.83  |- mesh__dateCreated mesh__D012474 1999-01-01
% 215.66/215.83  |- skos__altLabel mesh__D012474 Salmon, Chinook
% 215.66/215.83  |- skos__historyNote mesh__D012474 Salmonidae %28%1968-1971%29%
% 215.66/215.83  |- skos__scopeNote mesh__D012474
% 215.66/215.83       Fish of the genera ONCORHYNCHUS and Salmo in the family SALMONIDAE. They are anadromous game fish, frequenting the coastal waters of both the North Atlantic and Pacific. They are known for their gameness as a sport fish and for the quality of their flesh as a table fish. %28%Webster, 3d ed%29%.%A%    
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D012474 2005
% 215.66/215.83  |- mesh__recordOriginator mesh__D012474 NLM
% 215.66/215.83  |- rdf__type mesh__D012474sskos__Concept
% 215.66/215.83  |- skos__prefLabel mesh__D012474 Salmon
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D020906 2006
% 215.66/215.83  |- mesh__recordAuthorizer mesh__D020906 sjn
% 215.66/215.83  |- rdf__type mesh__D020906sskos__Concept
% 215.66/215.83  |- mesh__publicMeSHNote mesh__D020906 2000   
% 215.66/215.83  |- mesh__historyNote mesh__D020906 2000   
% 215.66/215.83  |- mesh__dateCreated mesh__D020906 1999-11-03
% 215.66/215.83  |- skos__hiddenLabel mesh__D020906 Abrasion, Dental Air
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D020906 2003
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D020906 2002
% 215.66/215.83  |- skos__historyNote mesh__D020906
% 215.66/215.83       Dental Cavity Preparation %28%1996-1999%29%
% 215.66/215.83  |- mesh__dateEstablished mesh__D020906 2000-01-01
% 215.66/215.83  |- skos__scopeNote mesh__D020906
% 215.66/215.83       A technique using a pneumatic, high-pressure stream of aluminum oxide to remove DENTAL ENAMEL; DENTIN; and restorative materials from teeth. In contrast to using DENTAL HIGH-SPEED EQUIPMENT, this method usually requires no dental anesthesia %28%ANESTHESIA, DENTAL%29% and reduces risks of tooth chipping and microfracturing. It is used primarily for routine DENTAL CAVITY PREPARATION.%A%    
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D020906 2004
% 215.66/215.83  |- skos__prefLabel mesh__D020906 Air Abrasion, Dental
% 215.66/215.83  |- mesh__recordOriginator mesh__D020906 ndw
% 215.66/215.83  |- skos__broader mesh__D020906smesh__D003813
% 215.66/215.83  |- skos__hiddenLabel mesh__D020906 Dental Air Abrasions
% 215.66/215.83  |- mesh__dateRevised mesh__D020906 2001-07-25
% 215.66/215.83  |- skos__hiddenLabel mesh__D020906 Abrasions, Dental Air
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D020906 2005
% 215.66/215.83  |- skos__hiddenLabel mesh__D020906 Air Abrasions, Dental
% 215.66/215.83  |- skos__altLabel mesh__D020906 Dental Air Abrasion
% 215.66/215.83  |- mesh__recordMaintainer mesh__D020906 mdb
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D006437 2001
% 215.66/215.83  |- mesh__publicMeSHNote mesh__D006437 73   
% 215.66/215.83  |- mesh__dateRevised mesh__D006437 2000-06-22
% 215.66/215.83  |- skos__altLabel mesh__D006437 Renal Dialysis, Home
% 215.66/215.83  |- mesh__recordOriginator mesh__D006437 NLM
% 215.66/215.83  |- skos__historyNote mesh__D006437 Hemodialysis %28%1966-1972%29%
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D006437 2005
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D006437 2002
% 215.66/215.83  |- skos__historyNote mesh__D006437 Home Care Services %28%1966-1972%29%
% 215.66/215.83  |- skos__hiddenLabel mesh__D006437 Dialyses, Home Renal
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D006437 2006
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D006437 2003
% 215.66/215.83  |- mesh__dateCreated mesh__D006437 1999-01-01
% 215.66/215.83  |- skos__hiddenLabel mesh__D006437 Home Hemodialyses
% 215.66/215.83  |- mesh__recordAuthorizer mesh__D006437 sjn
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D006437 2004
% 215.66/215.83  |- skos__historyNote mesh__D006437 Peritoneal Dialysis %28%1966-1972%29%
% 215.66/215.83  |- skos__hiddenLabel mesh__D006437 Dialysis, Home Renal
% 215.66/215.83  |- skos__scopeNote mesh__D006437
% 215.66/215.83       Long-term maintenance hemodialysis in the home.     
% 215.66/215.83  |- skos__historyNote mesh__D006437 Home Nursing %28%1966-1972%29%
% 215.66/215.83  |- skos__broader mesh__D006437smesh__D006699
% 215.66/215.83  |- mesh__dateEstablished mesh__D006437 1973-01-01
% 215.66/215.83  |- mesh__recordMaintainer mesh__D006437 RAZ
% 215.66/215.83  |- skos__hiddenLabel mesh__D006437 Renal Dialyses, Home
% 215.66/215.83  |- mesh__historyNote mesh__D006437 73   
% 215.66/215.83  |- skos__prefLabel mesh__D006437 Hemodialysis, Home
% 215.66/215.83  |- skos__hiddenLabel mesh__D006437 Home Renal Dialyses
% 215.66/215.83  |- skos__altLabel mesh__D006437 Home Hemodialysis
% 215.66/215.83  |- skos__historyNote mesh__D006437 Kidney, Artificial %28%1966-1972%29%
% 215.66/215.83  |- skos__hiddenLabel mesh__D006437 Hemodialyses, Home
% 215.66/215.83  |- rdf__type mesh__D006437sskos__Concept
% 215.66/215.83  |- skos__annotation mesh__D006437
% 215.66/215.83       /instrum permitted if not KIDNEY, ARTIFICIAL   
% 215.66/215.83  |- skos__hiddenLabel mesh__D006437 Home Renal Dialysis
% 215.66/215.83  |- skos__broader mesh__D006437smesh__D006435
% 215.66/215.83  |- mesh__dateCreated mesh__D020108 1998-06-10
% 215.66/215.83  |- skos__altLabel mesh__D020108 Aventis Brand of Nicorandil
% 215.66/215.83  |- skos__hiddenLabel mesh__D020108 Nicorandil Merck Brand
% 215.66/215.83  |- skos__historyNote mesh__D020108
% 215.66/215.83       Niacinamide/analogs %26% derivatives %28%1978-1998%29%
% 215.66/215.83  |- skos__hiddenLabel mesh__D020108 Nicorandil Aventis Brand
% 215.66/215.83  |- skos__scopeNote mesh__D020108
% 215.66/215.83       A derivative of the NIACINAMIDE that is structurally combined with an organic nitrate. It is a potassium-channel opener that causes vasodilatation of arterioles and large coronary arteries. Its nitrate-like properties produce venous vasodilation through stimulation of guanylate cyclase.%A%    
% 215.66/215.83  |- mesh__dateEstablished mesh__D020108 1999-01-01
% 215.66/215.83  |- rdf__type mesh__D020108sskos__Concept
% 215.66/215.83  |- skos__altLabel mesh__D020108 Merck Brand of Nicorandil
% 215.66/215.83  |- mesh__recordAuthorizer mesh__D020108 sjn
% 215.66/215.83  |- skos__hiddenLabel mesh__D020108 Nitrate, 2-Nicotinamidoethyl
% 215.66/215.83  |- mesh__historyNote mesh__D020108 99; use NICORANDIL %28%NM%29% 1978-98   
% 215.66/215.83  |- skos__altLabel mesh__D020108
% 215.66/215.83       Rh%C3%%B4%ne-Poulenc Rorer Brand of Nicorandil
% 215.66/215.83  |- mesh__dateRevised mesh__D020108 2005-06-30
% 215.66/215.83  |- skos__hiddenLabel mesh__D020108 SG 75
% 215.66/215.83  |- skos__hiddenLabel mesh__D020108 2 Nicotinamidoethyl Nitrate
% 215.66/215.83  |- skos__altLabel mesh__D020108 Aventis Pharma Brand of Nicorandil
% 215.66/215.83  |- skos__hiddenLabel mesh__D020108 2 Nicotinamidethyl Nitrate
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D020108 2006
% 215.66/215.83  |- mesh__recordMaintainer mesh__D020108 ssb
% 215.66/215.83  |- mesh__recordOriginator mesh__D020108 ADP
% 215.66/215.83  |- skos__altLabel mesh__D020108 2-Nicotinamidethyl Nitrate
% 215.66/215.83  |- skos__broader mesh__D020108smesh__D009566
% 215.66/215.83  |- skos__hiddenLabel mesh__D020108 SG75
% 215.66/215.83  |- skos__hiddenLabel mesh__D020108
% 215.66/215.83       Rh%C3%%B4%ne Poulenc Rorer Brand of Nicorandil
% 215.66/215.83  |- skos__altLabel mesh__D020108
% 215.66/215.83       Merck Lipha Sant%C3%%A9% Brand of Nicorandil
% 215.66/215.83  |- skos__broader mesh__D020108smesh__D009536
% 215.66/215.83  |- skos__altLabel mesh__D020108 2-Nicotinamidoethyl Nitrate
% 215.66/215.83  |- skos__historyNote mesh__D020108 Nitrates %28%1978-1982%29%
% 215.66/215.83  |- mesh__publicMeSHNote mesh__D020108
% 215.66/215.83       99; NICORANDIL was indexed under NIACINAMIDE 1983-98 %26% NITRATES 1978-82%A%  
% 215.66/215.83  |- skos__prefLabel mesh__D020108 Nicorandil
% 215.66/215.83  |- skos__hiddenLabel mesh__D020108 Nitrate, 2-Nicotinamidethyl
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016865 2003
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016865 1994
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016865 2006
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016865 2002
% 215.66/215.83  |- skos__hiddenLabel mesh__D016865 Reassortant Virus
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016865 2005
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016865 1997
% 215.66/215.83  |- mesh__historyNote mesh__D016865 92   
% 215.66/215.83  |- mesh__recordMaintainer mesh__D016865 TGC
% 215.66/215.83  |- mesh__publicMeSHNote mesh__D016865 92   
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016865 1993
% 215.66/215.83  |- skos__historyNote mesh__D016865
% 215.66/215.83       specific virus/genetics %28%1981-1991%29%
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016865 1996
% 215.66/215.83  |- mesh__dateEstablished mesh__D016865 1992-01-01
% 215.66/215.83  |- skos__annotation mesh__D016865
% 215.66/215.83       %22%viruses containing 2 or more pieces of nucleic acid from different parents%22%: see MeSH definition; coord IM with specific parent viruses %28%IM%29%%A%  
% 215.66/215.83  |- skos__prefLabel mesh__D016865 Reassortant Viruses
% 215.66/215.83  |- mesh__recordOriginator mesh__D016865 AGS
% 215.66/215.83  |- rdf__type mesh__D016865sskos__Concept
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016865 1999
% 215.66/215.83  |- mesh__recordAuthorizer mesh__D016865 PLS
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016865 2001
% 215.66/215.83  |- skos__hiddenLabel mesh__D016865 Virus, Reassortant
% 215.66/215.83  |- mesh__dateRevised mesh__D016865 1992-05-18
% 215.66/215.83  |- skos__hiddenLabel mesh__D016865 Viruses, Reassortant
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016865 2004
% 215.66/215.83  |- mesh__activeMeSHYear mesh__D016865 1995
% 215.66/215.84  |- mesh__dateCreated mesh__D016865 1991-05-02
% 215.66/215.84  |- skos__scopeNote mesh__D016865
% 215.66/215.84       Viruses containing two or more pieces of nucleic acid %28%segmented genome%29% from different parents. Such viruses are produced in cells coinfected with different strains of a given virus.%A%    
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016865 1998
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016865 2000
% 215.66/215.84  |- skos__historyNote mesh__D016865 Recombination, Genetic %28%1981-1991%29%
% 215.66/215.84  |- skos__broader mesh__D016865smesh__D014780
% 215.66/215.84  |- skos__hiddenLabel mesh__D016067 Nerve Transfers
% 215.66/215.84  |- skos__hiddenLabel mesh__D016067 Neurotizations
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016067 2004
% 215.66/215.84  |- mesh__recordOriginator mesh__D016067 AGS
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016067 2000
% 215.66/215.84  |- mesh__dateRevised mesh__D016067 1997-06-20
% 215.66/215.84  |- skos__broader mesh__D016067smesh__D019635
% 215.66/215.84  |- skos__annotation mesh__D016067
% 215.66/215.84       do not use /util except by MeSH definition; coord IM with specific nerve /surg %28%IM or NIM%29%%A%  
% 215.66/215.84  |- skos__prefLabel mesh__D016067 Nerve Transfer
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016067 1999
% 215.66/215.84  |- skos__hiddenLabel mesh__D016067 Crossover, Nerve
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016067 2003
% 215.66/215.84  |- skos__historyNote mesh__D016067
% 215.66/215.84       specific nerve/transplantation %28%1972-1990%29%
% 215.66/215.84  |- mesh__recordAuthorizer mesh__D016067 SJN
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016067 1998
% 215.66/215.84  |- mesh__dateCreated mesh__D016067 1990-06-06
% 215.66/215.84  |- rdf__type mesh__D016067sskos__Concept
% 215.66/215.84  |- mesh__recordMaintainer mesh__D016067 PXP
% 215.66/215.84  |- mesh__publicMeSHNote mesh__D016067 91   
% 215.66/215.84  |- skos__hiddenLabel mesh__D016067 Transfer, Nerve
% 215.66/215.84  |- skos__related mesh__D016067smesh__D009416
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016067 2006
% 215.66/215.84  |- skos__scopeNote mesh__D016067
% 215.66/215.84       Surgical reinnervation of a denervated peripheral target using a healthy donor nerve and/or its proximal stump. The direct connection is usually made to a healthy postlesional distal portion of a non-functioning nerve or implanted directly into denervated muscle or insensitive skin. Nerve sprouts will grow from the transferred nerve into the denervated elements and establish contact between them and the neurons that formerly controlled another area.%A%    
% 215.66/215.84  |- mesh__dateEstablished mesh__D016067 1991-01-01
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016067 2002
% 215.66/215.84  |- skos__historyNote mesh__D016067 specific nerve/surgery %28%1970-1990%29%
% 215.66/215.84  |- skos__hiddenLabel mesh__D016067 Nerve Crossovers
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016067 2005
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016067 2001
% 215.66/215.84  |- skos__hiddenLabel mesh__D016067 Crossovers, Nerve
% 215.66/215.84  |- skos__hiddenLabel mesh__D016067 Transfers, Nerve
% 215.66/215.84  |- skos__altLabel mesh__D016067 Neurotization
% 215.66/215.84  |- mesh__historyNote mesh__D016067 91   
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D002845 2006
% 215.66/215.84  |- skos__prefLabel mesh__D002845 Chromatography
% 215.66/215.84  |- mesh__recordMaintainer mesh__D002845 lkt
% 215.66/215.84  |- skos__hiddenLabel mesh__D002845 Chromatographies
% 215.66/215.84  |- skos__broader mesh__D002845smesh__D002623
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D002845 2003
% 215.66/215.84  |- skos__annotation mesh__D002845
% 215.66/215.84       GEN: prefer specifics; NIM; on Sephadex G = GEL FILTRATION see CHROMATOGRAPHY, GEL; on DEAE Sephadex = CHROMATOGRAPHY, ION EXCHANGE; DF: CHROMATOGR%A%  
% 215.66/215.84  |- mesh__dateRevised mesh__D002845 2002-07-03
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D002845 2004
% 215.66/215.84  |- skos__scopeNote mesh__D002845
% 215.66/215.84       Techniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases.  A mobile phase %28%fluid or gas%29% passes through a column containing a stationary phase of porous solid or liquid coated on a solid support.  Usage is both analytical for small amounts and preparative for bulk amounts.%A%    
% 215.66/215.84  |- mesh__dateCreated mesh__D002845 1999-01-01
% 215.66/215.84  |- rdf__type mesh__D002845sskos__Concept
% 215.66/215.84  |- mesh__recordAuthorizer mesh__D002845 sjn
% 215.66/215.84  |- mesh__publicMeSHNote mesh__D002845 66   
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D002845 2005
% 215.66/215.84  |- mesh__historyNote mesh__D002845 66   
% 215.66/215.84  |- mesh__recordOriginator mesh__D002845 NLM
% 215.66/215.84  |- skos__historyNote mesh__D002047 Dihydromorphinone %28%1966-1968%29%
% 215.66/215.84  |- skos__prefLabel mesh__D002047 Buprenorphine
% 215.66/215.84  |- mesh__dateRevised mesh__D002047 2005-06-30
% 215.66/215.84  |- skos__hiddenLabel mesh__D002047 6029 M
% 215.66/215.84  |- mesh__recordMaintainer mesh__D002047 lkw
% 215.66/215.84  |- skos__altLabel mesh__D002047 Buprex
% 215.66/215.84  |- mesh__dateCreated mesh__D002047 1978-03-17
% 215.66/215.84  |- skos__altLabel mesh__D002047 Temgesic
% 215.66/215.84  |- skos__hiddenLabel mesh__D002047 RX 6029 M
% 215.66/215.84  |- skos__altLabel mesh__D002047
% 215.66/215.84       Reckitt %26% Colman Brand 2 of Buprenorphine Hydrochloride
% 215.66/215.84  |- mesh__historyNote mesh__D002047
% 215.66/215.84       87%28%79%29%; was see under MORPHINANS 1979-86   
% 215.66/215.84  |- rdf__type mesh__D002047sskos__Concept
% 215.66/215.84  |- skos__altLabel mesh__D002047 Essex Brand of Buprenorphine Hydrochloride
% 215.66/215.84  |- mesh__dateEstablished mesh__D002047 1987-01-01
% 215.66/215.84  |- skos__hiddenLabel mesh__D002047 Buprenorphine Gr%C3%%BC%nenthal Brand
% 215.66/215.84  |- mesh__recordAuthorizer mesh__D002047 sjn
% 215.66/215.84  |- skos__altLabel mesh__D002047
% 215.66/215.84       Reckitt Benckiser Brand of Buprenorphine Hydrochloride
% 215.66/215.84  |- skos__altLabel mesh__D002047
% 215.66/215.84       Schering-Plough Brand of Buprenorphine Hydrochloride
% 215.66/215.84  |- skos__scopeNote mesh__D002047
% 215.66/215.84       A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use.%A%    
% 215.66/215.84  |- skos__historyNote mesh__D002047 Morphine %28%1966-1968%29%
% 215.66/215.84  |- skos__hiddenLabel mesh__D002047 RX6029M
% 215.66/215.84  |- mesh__recordOriginator mesh__D002047 SH
% 215.66/215.84  |- mesh__publicMeSHNote mesh__D002047
% 215.66/215.84       87; was see under MORPHINANS 1979-86   
% 215.66/215.84  |- skos__historyNote mesh__D002047 Morphinans %28%1969-1978%29%
% 215.66/215.84  |- skos__altLabel mesh__D002047 Key Brand of Buprenorphine Hydrochloride
% 215.66/215.84  |- skos__hiddenLabel mesh__D002047 Hydrochloride, Buprenorphine
% 215.66/215.84  |- skos__altLabel mesh__D002047
% 215.66/215.84       Gr%C3%%BC%nenthal Brand of Buprenorphine Hydrochloride
% 215.66/215.84  |- skos__altLabel mesh__D002047 RX-6029-M
% 215.66/215.84  |- skos__altLabel mesh__D002047
% 215.66/215.84       Reckitt Brand of Buprenorphine Hydrochloride
% 215.66/215.84  |- skos__altLabel mesh__D002047 Gr%C3%%BC%nenthal Brand of Buprenorphine
% 215.66/215.84  |- skos__hiddenLabel mesh__D002047
% 215.66/215.84       Schering Plough Brand of Buprenorphine Hydrochloride
% 215.66/215.84  |- skos__broader mesh__D002047smesh__D009019
% 215.66/215.84  |- skos__hiddenLabel mesh__D002047 6029M
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D002047 2006
% 215.66/215.84  |- skos__altLabel mesh__D002047 Temg%C3%%A9%sic
% 215.66/215.84  |- skos__altLabel mesh__D002047
% 215.66/215.84       Reckitt %26% Colman Brand 1 of Buprenorphine Hydrochloride
% 215.66/215.84  |- skos__scopeNote mesh__D007530
% 215.66/215.84       A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.%A%    
% 215.66/215.84  |- mesh__recordOriginator mesh__D007530 NLM
% 215.66/215.84  |- mesh__publicMeSHNote mesh__D007530
% 215.66/215.84       87; was see under METHYL ETHERS 1975-86   
% 215.66/215.84  |- skos__prefLabel mesh__D007530 Isoflurane
% 215.66/215.84  |- skos__historyNote mesh__D007530 Ethers %28%1971-1974%29%
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D007530 2001
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D007530 2005
% 215.66/215.84  |- mesh__dateEstablished mesh__D007530 1987-01-01
% 215.66/215.84  |- mesh__historyNote mesh__D007530
% 215.66/215.84       87%28%75%29%; was see under METHYL ETHERS 1975-86   
% 215.66/215.84  |- skos__historyNote mesh__D007530 Hydrocarbons, Fluorinated %28%1974%29%
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D007530 2006
% 215.66/215.84  |- skos__broader mesh__D007530smesh__D008738
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D007530 2002
% 215.66/215.84  |- mesh__dateCreated mesh__D007530 1974-11-11
% 215.66/215.84  |- mesh__recordAuthorizer mesh__D007530 sjn
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D007530 2003
% 215.66/215.84  |- mesh__recordMaintainer mesh__D007530 CCR
% 215.66/215.84  |- mesh__dateRevised mesh__D007530 2000-06-22
% 215.66/215.84  |- rdf__type mesh__D007530sskos__Concept
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D007530 2004
% 215.66/215.84  |- mesh__recordMaintainer mesh__D048149 jmp
% 215.66/215.84  |- skos__prefLabel mesh__D048149 Casein Kinase Iepsilon
% 215.66/215.84  |- mesh__recordOriginator mesh__D048149 jmp
% 215.66/215.84  |- skos__broader mesh__D048149smesh__D047389
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D048149 2006
% 215.66/215.84  |- mesh__recordAuthorizer mesh__D048149 sjn
% 215.66/215.84  |- rdf__type mesh__D048149sskos__Concept
% 215.66/215.84  |- mesh__publicMeSHNote mesh__D048149
% 215.66/215.84       2005; CASEIN KINASE IEPSILON was indexed under PROTEIN KINASES 1993-2004%A%  
% 215.66/215.84  |- mesh__dateCreated mesh__D048149 2004-07-07
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D048149 2005
% 215.66/215.84  |- skos__historyNote mesh__D048149 Protein Kinases %28%1998-2004%29%
% 215.66/215.84  |- mesh__dateEstablished mesh__D048149 2005-01-01
% 215.66/215.84  |- mesh__historyNote mesh__D048149 2005%28%1998%29%   
% 215.66/215.84  |- skos__scopeNote mesh__D048149
% 215.66/215.84       A casein kinase I isoenzyme with specificity for proteins involved the regulation of the CIRCADIAN RHYTHM.%A%    
% 215.66/215.84  |- skos__altLabel mesh__D048149 Casein Kinase 1 epsilon
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D012475 2006
% 215.66/215.84  |- mesh__recordOriginator mesh__D012475 NLM
% 215.66/215.84  |- mesh__dateCreated mesh__D012475 1999-01-01
% 215.66/215.84  |- skos__annotation mesh__D012475
% 215.66/215.84       GEN or unspecified; prefer specifics; infection = SALMONELLA INFECTIONS or its specifics: see notes on species terms for various infections%A%  
% 215.66/215.84  |- skos__prefLabel mesh__D012475 Salmonella
% 215.66/215.84  |- mesh__recordMaintainer mesh__D012475 SYSTEM
% 215.66/215.84  |- skos__broader mesh__D012475smesh__D004755
% 215.66/215.84  |- rdf__type mesh__D012475sskos__Concept
% 215.66/215.84  |- mesh__recordAuthorizer mesh__D012475 sjn
% 215.66/215.84  |- mesh__dateRevised mesh__D012475 2005-06-30
% 215.66/215.84  |- skos__scopeNote mesh__D012475
% 215.66/215.84       A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that utilizes citrate as a sole carbon source. It is pathogenic for humans, causing enteric fevers, gastroenteritis, and bacteremia. Food poisoning is the most common clinical manifestation. Organisms within this genus are separated on the basis of antigenic characteristics, sugar fermentation patterns, and bacteriophage susceptibility.%A%    
% 215.66/215.84  |- skos__hiddenLabel mesh__D020907
% 215.66/215.84       Q Type Voltage Dependent Calcium Channels
% 215.66/215.84  |- skos__hiddenLabel mesh__D020907 Q Type VDCC
% 215.66/215.84  |- skos__hiddenLabel mesh__D020907 Q Type Calcium Channel
% 215.66/215.84  |- skos__hiddenLabel mesh__D020907 Calcium Channel, Q-Type
% 215.66/215.84  |- mesh__recordMaintainer mesh__D020907 SYSTEM
% 215.66/215.84  |- skos__scopeNote mesh__D020907
% 215.66/215.84       CALCIUM CHANNELS located in the neurons of the brain.     
% 215.66/215.84  |- mesh__dateCreated mesh__D020907 1999-11-04
% 215.66/215.84  |- mesh__dateEstablished mesh__D020907 2000-01-01
% 215.66/215.84  |- skos__hiddenLabel mesh__D020907 Calcium Channels, Q Type
% 215.66/215.84  |- mesh__recordOriginator mesh__D020907 adp
% 215.66/215.84  |- skos__hiddenLabel mesh__D020907 Channel, Q-Type Calcium
% 215.66/215.84  |- mesh__recordAuthorizer mesh__D020907 sjn
% 215.66/215.84  |- skos__historyNote mesh__D020907 Calcium Channels %28%1994-1999%29%
% 215.66/215.84  |- mesh__publicMeSHNote mesh__D020907
% 215.66/215.84       2000; Q-TYPE VDCC was indexed under CALCIUM CHANNELS 1999%A%  
% 215.66/215.84  |- mesh__historyNote mesh__D020907
% 215.66/215.84       2000; for Q-TYPE VDCC use VOLTAGE-DEPENDENT CALCIUM CHANNELS %28%P-Q TYPE%29% %28%NM%29% 1999%A%  
% 215.66/215.84  |- skos__hiddenLabel mesh__D020907 VDCC, Q-Type
% 215.66/215.84  |- skos__hiddenLabel mesh__D020907 Q Type Calcium Channels
% 215.66/215.84  |- skos__altLabel mesh__D020907 Q-Type VDCC
% 215.66/215.84  |- skos__annotation mesh__D020907 DF: VDCC Q   
% 215.66/215.84  |- skos__altLabel mesh__D020907 Q-Type Calcium Channel
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D020907 2006
% 215.66/215.84  |- skos__altLabel mesh__D020907 Q-Type Voltage-Dependent Calcium Channels
% 215.66/215.84  |- mesh__dateRevised mesh__D020907 2005-06-30
% 215.66/215.84  |- rdf__type mesh__D020907sskos__Concept
% 215.66/215.84  |- skos__altLabel mesh__D020907 Q-Type Calcium Channels
% 215.66/215.84  |- skos__prefLabel mesh__D020907 Calcium Channels, Q-Type
% 215.66/215.84  |- skos__broader mesh__D020907smesh__D020864
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D020109 2002
% 215.66/215.84  |- mesh__recordMaintainer mesh__D020109 TWD
% 215.66/215.84  |- rdf__type mesh__D020109sskos__Concept
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D020109 2005
% 215.66/215.84  |- mesh__historyNote mesh__D020109 99; use DEVAZEPIDE %28%NM%29% 1986-98   
% 215.66/215.84  |- skos__hiddenLabel mesh__D020109 L 364,718
% 215.66/215.84  |- mesh__publicMeSHNote mesh__D020109
% 215.66/215.84       99; DEVAZEPIDE was indexed under BENZODIAZEPINONES 1986-98%A%  
% 215.66/215.84  |- mesh__dateRevised mesh__D020109 2000-06-22
% 215.66/215.84  |- mesh__dateCreated mesh__D020109 1998-06-10
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D020109 2003
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D020109 2006
% 215.66/215.84  |- skos__broader mesh__D020109smesh__D001570
% 215.66/215.84  |- mesh__dateEstablished mesh__D020109 1999-01-01
% 215.66/215.84  |- skos__scopeNote mesh__D020109
% 215.66/215.84       A derivative of benzodiazepine that acts on the cholecystokinin A %28%CCKA%29% receptor to antagonize CCK-8%27%s %28%SINCALIDE%29% physiological and behavioral effects, such as pancreatic stimulation and inhibition of feeding.%A%    
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D020109 2004
% 215.66/215.84  |- mesh__recordAuthorizer mesh__D020109 sjn
% 215.66/215.84  |- skos__hiddenLabel mesh__D020109 MK329
% 215.66/215.84  |- skos__hiddenLabel mesh__D020109 L364,718
% 215.66/215.84  |- skos__historyNote mesh__D020109 Benzodiazepinones %28%1986-1998%29%
% 215.66/215.84  |- mesh__recordOriginator mesh__D020109 ADP
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D020109 2001
% 215.66/215.84  |- skos__prefLabel mesh__D020109 Devazepide
% 215.66/215.84  |- skos__hiddenLabel mesh__D020109 MK 329
% 215.66/215.84  |- mesh__dateRevised mesh__D006438 2003-07-22
% 215.66/215.84  |- rdf__type mesh__D006438sskos__Concept
% 215.66/215.84  |- mesh__dateEstablished mesh__D006438 1979-01-01
% 215.66/215.84  |- mesh__publicMeSHNote mesh__D006438 79   
% 215.66/215.84  |- skos__historyNote mesh__D006438 Plasma Substitutes %28%1966-1978%29%
% 215.66/215.84  |- skos__broader mesh__D006438smesh__D013812
% 215.66/215.84  |- mesh__historyNote mesh__D006438 79   
% 215.66/215.84  |- mesh__recordOriginator mesh__D006438 SMH
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D006438 2004
% 215.66/215.84  |- skos__prefLabel mesh__D006438 Hemodilution
% 215.66/215.84  |- skos__hiddenLabel mesh__D006438 Hemodilutions
% 215.66/215.84  |- skos__historyNote mesh__D006438 Cardiopulmonary Bypass %28%1972-1978%29%
% 215.66/215.84  |- mesh__dateCreated mesh__D006438 1978-01-26
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D006438 2006
% 215.66/215.84  |- mesh__recordMaintainer mesh__D006438 nns
% 215.66/215.84  |- skos__scopeNote mesh__D006438
% 215.66/215.84       Reduction of blood viscosity usually by the addition of cell free solutions. Used clinically %28%1%29% in states of impaired microcirculation, %28%2%29% for replacement of intraoperative blood loss without homologous blood transfusion, and %28%3%29% in cardiopulmonary bypass and hypothermia.%A%    
% 215.66/215.84  |- skos__historyNote mesh__D006438 Blood Viscosity %28%1966-1978%29%
% 215.66/215.84  |- skos__historyNote mesh__D006438 Blood Volume %28%1966-1978%29%
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D006438 2005
% 215.66/215.84  |- skos__historyNote mesh__D006438
% 215.66/215.84       Extracorporeal Circulation %28%1967-1978%29%
% 215.66/215.84  |- mesh__recordAuthorizer mesh__D006438 sjn
% 215.66/215.84  |- skos__annotation mesh__D006438
% 215.66/215.84       do not use /util except by MeSH definition   
% 215.66/215.84  |- mesh__dateCreated mesh__D017160 1992-05-22
% 215.66/215.84  |- skos__prefLabel mesh__D017160 Trichinella spiralis
% 215.66/215.84  |- skos__historyNote mesh__D017160 Trichinella %28%1966-1992%29%
% 215.66/215.84  |- skos__scopeNote mesh__D017160
% 215.66/215.84       A parasite of carnivorous mammals that causes TRICHINOSIS. It is especially common in rats and in swine fed uncooked garbage. Human infection is initiated by the consumption of raw or insufficiently cooked pork or other meat containing the encysted larvae.%A%    
% 215.66/215.84  |- mesh__dateEstablished mesh__D017160 1993-01-01
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D017160 2006
% 215.66/215.84  |- skos__annotation mesh__D017160
% 215.66/215.84       a species of nematode common in rats %26% swine; infection: coord IM with TRICHINOSIS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D017160 2005
% 215.66/215.84  |- mesh__recordOriginator mesh__D017160 PXP
% 215.66/215.84  |- skos__altLabel mesh__D017160 Trichina spiralis
% 215.66/215.84  |- mesh__recordMaintainer mesh__D017160 sjn
% 215.66/215.84  |- rdf__type mesh__D017160sskos__Concept
% 215.66/215.84  |- mesh__publicMeSHNote mesh__D017160 93   
% 215.66/215.84  |- mesh__historyNote mesh__D017160 93   
% 215.66/215.84  |- skos__broader mesh__D017160smesh__D014234
% 215.66/215.84  |- mesh__recordAuthorizer mesh__D017160 sjn
% 215.66/215.84  |- mesh__dateRevised mesh__D017160 2004-07-13
% 215.66/215.84  |- skos__hiddenLabel mesh__D003140 Control, Parasite
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D003140 2006
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D003140 2002
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D003140 2004
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D003140 2005
% 215.66/215.84  |- rdf__type mesh__D003140sskos__Concept
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D003140 2003
% 215.66/215.84  |- skos__broader mesh__D003140smesh__D015980
% 215.66/215.84  |- mesh__recordAuthorizer mesh__D003140 sjn
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D003140 2001
% 215.66/215.84  |- skos__related mesh__D003140smesh__D004199
% 215.66/215.84  |- skos__hiddenLabel mesh__D003140 Control, Communicable Disease
% 215.66/215.84  |- mesh__recordMaintainer mesh__D003140 kle
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D003140 2000
% 215.66/215.84  |- mesh__recordOriginator mesh__D003140 NLM
% 215.66/215.84  |- skos__related mesh__D003140smesh__D004197
% 215.66/215.84  |- skos__prefLabel mesh__D003140 Communicable Disease Control
% 215.66/215.84  |- mesh__dateCreated mesh__D003140 1999-01-01
% 215.66/215.84  |- skos__annotation mesh__D003140
% 215.66/215.84       GEN only: prefer Cat C term with /prev; INFECTION CONTROL is available: see note there%A%  
% 215.66/215.84  |- skos__related mesh__D003140smesh__D017053
% 215.66/215.84  |- mesh__dateRevised mesh__D003140 1999-11-03
% 215.66/215.84  |- skos__scopeNote mesh__D003140
% 215.66/215.84       Programs of surveillance designed to prevent the transmission of disease by any means from person to person or from animal to man.%A%    
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016866 2000
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016866 2005
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016866 1997
% 215.66/215.84  |- mesh__historyNote mesh__D016866 92   
% 215.66/215.84  |- skos__broader mesh__D016866smesh__D016905
% 215.66/215.84  |- skos__hiddenLabel mesh__D016866 Infection, Bacteroidaceae
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016866 1996
% 215.66/215.84  |- mesh__recordMaintainer mesh__D016866 PLS
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016866 2002
% 215.66/215.84  |- skos__altLabel mesh__D016866 Infections, Bacteroidaceae
% 215.66/215.84  |- rdf__type mesh__D016866sskos__Concept
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016866 1999
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016866 2004
% 215.66/215.84  |- skos__prefLabel mesh__D016866 Bacteroidaceae Infections
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016866 1995
% 215.66/215.84  |- skos__annotation mesh__D016866
% 215.66/215.84       gram-neg bact infect; GEN: avoid; prefer specifics; DF: BACTEROIDACEAE INFECT%A%  
% 215.66/215.84  |- skos__scopeNote mesh__D016866
% 215.66/215.84       Infections with bacteria of the family BACTEROIDACEAE.     
% 215.66/215.84  |- mesh__dateRevised mesh__D016866 1993-06-02
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016866 1998
% 215.66/215.84  |- mesh__dateCreated mesh__D016866 1991-05-30
% 215.66/215.84  |- mesh__publicMeSHNote mesh__D016866 92   
% 215.66/215.84  |- mesh__dateEstablished mesh__D016866 1992-01-01
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016866 2003
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016866 1994
% 215.66/215.84  |- mesh__recordAuthorizer mesh__D016866 PLS
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016866 2001
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D016866 2006
% 215.66/215.84  |- skos__hiddenLabel mesh__D016866 Bacteroidaceae Infection
% 215.66/215.84  |- mesh__recordOriginator mesh__D016866 PXP
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D002846 2004
% 215.66/215.84  |- skos__altLabel mesh__D002846 Affinity Chromatography
% 215.66/215.84  |- skos__hiddenLabel mesh__D002846 Chromatographies, Affinity
% 215.66/215.84  |- mesh__dateEstablished mesh__D002846 1974-01-01
% 215.66/215.84  |- mesh__recordOriginator mesh__D002846 NLM
% 215.66/215.84  |- mesh__historyNote mesh__D002846 74%28%72%29%   
% 215.66/215.84  |- mesh__dateCreated mesh__D002846 1999-01-01
% 215.66/215.84  |- mesh__recordMaintainer mesh__D002846 lkt
% 215.66/215.84  |- rdf__type mesh__D002846sskos__Concept
% 215.66/215.84  |- skos__prefLabel mesh__D002846 Chromatography, Affinity
% 215.66/215.84  |- skos__historyNote mesh__D002846 appropriate substances used for binding
% 215.66/215.84  |- skos__historyNote mesh__D002846 Chromatography %28%1966-1971%29%
% 215.66/215.84  |- skos__annotation mesh__D002846
% 215.66/215.84       an anal chem technique; NIM; DF: CHROMATOGR AFFINITY   
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D002846 2005
% 215.66/215.84  |- mesh__dateRevised mesh__D002846 2002-07-02
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D002846 2006
% 215.66/215.84  |- skos__scopeNote mesh__D002846
% 215.66/215.84       A chromatographic technique that utilizes the ability of biological molecules to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 215.66/215.84  |- mesh__recordAuthorizer mesh__D002846 sjn
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D002846 2003
% 215.66/215.84  |- skos__broader mesh__D002846smesh__D002853
% 215.66/215.84  |- skos__hiddenLabel mesh__D002846 Affinity Chromatographies
% 215.66/215.84  |- mesh__publicMeSHNote mesh__D002846 74   
% 215.66/215.84  |- mesh__recordAuthorizer mesh__D002048 PLS
% 215.66/215.84  |- mesh__historyNote mesh__D002048
% 215.66/215.84       91%28%75%29%; was see under MORTUARY PRACTICE 1975-90   
% 215.66/215.84  |- mesh__dateEstablished mesh__D002048 1991-01-01
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D002048 2001
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D002048 2004
% 215.66/215.84  |- mesh__recordMaintainer mesh__D002048 TGC
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D002048 2000
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D002048 2006
% 215.66/215.84  |- skos__prefLabel mesh__D002048 Burial
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D002048 2003
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D002048 1997
% 215.66/215.84  |- skos__scopeNote mesh__D002048
% 215.66/215.84       The act or ceremony of putting a corpse into the ground or a vault, or into the sea. The custom of burial is primeval and omnipresent in all cultures and civilizations, generally accompanied by ceremonial rites.%A%    
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D002048 2005
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D002048 1999
% 215.66/215.84  |- mesh__onlineNote mesh__D002048 search MORTUARY PRACTICE 1966-74   
% 215.66/215.84  |- mesh__publicMeSHNote mesh__D002048
% 215.66/215.84       91; was see under MORTUARY PRACTICE 1975-90   
% 215.66/215.84  |- mesh__recordOriginator mesh__D002048 NLM
% 215.66/215.84  |- mesh__dateCreated mesh__D002048 1999-01-01
% 215.66/215.84  |- skos__broader mesh__D002048smesh__D009027
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D002048 1996
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D002048 1998
% 215.66/215.84  |- skos__annotation mesh__D002048
% 215.66/215.84       in primitive or advanced cultures, historical or modern   
% 215.66/215.84  |- mesh__dateRevised mesh__D002048 1995-03-13
% 215.66/215.84  |- rdf__type mesh__D002048sskos__Concept
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D002048 2002
% 215.66/215.84  |- skos__hiddenLabel mesh__D002048 Burials
% 215.66/215.84  |- mesh__dateRevised mesh__D007531 2005-06-30
% 215.66/215.84  |- mesh__dateCreated mesh__D007531 1999-01-01
% 215.66/215.84  |- mesh__recordMaintainer mesh__D007531 exl
% 215.66/215.84  |- skos__altLabel mesh__D007531 DFP
% 215.66/215.84  |- mesh__recordAuthorizer mesh__D007531 sjn
% 215.66/215.84  |- rdf__type mesh__D007531sskos__Concept
% 215.66/215.84  |- skos__hiddenLabel mesh__D007531 Di isopropylphosphorofluoridate
% 215.66/215.84  |- skos__broader mesh__D007531smesh__D009943
% 215.66/215.84  |- skos__altLabel mesh__D007531 Diisopropylphosphofluoridate
% 215.66/215.84  |- skos__altLabel mesh__D007531 Merck Brand of Isoflurophate
% 215.66/215.84  |- mesh__recordOriginator mesh__D007531 NLM
% 215.66/215.84  |- skos__altLabel mesh__D007531 Fluorostigmine
% 215.66/215.84  |- skos__altLabel mesh__D007531 Fluostigmine
% 215.66/215.84  |- skos__altLabel mesh__D007531 Di-isopropylphosphorofluoridate
% 215.66/215.84  |- skos__scopeNote mesh__D007531
% 215.66/215.84       An irreversible cholinesterase inhibitor with actions similar to those of echothiophate. It is a powerful miotic used mainly in the treatment of glaucoma. Its vapor is highly toxic and it is recommended that only solutions in arachis oil be used therapeutically. %28%From Martindale, The Extra Pharmacopoeia, 29th ed, p1330%29%%A%    
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D007531 2006
% 215.66/215.84  |- skos__altLabel mesh__D007531
% 215.66/215.84       Bis%28%1-methylethyl%29% Phosphorofluoridate
% 215.66/215.84  |- skos__prefLabel mesh__D007531 Isoflurophate
% 215.66/215.84  |- skos__altLabel mesh__D007531 Diisopropylfluorophosphate
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 14 3 3 Protein
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 14 3 3 Proteins
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 14 3 3 zeta Protein
% 215.66/215.84  |- skos__historyNote mesh__D048948 Nerve Tissue Proteins %28%1981-1994%29%
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 14 3 3 eta Protein
% 215.66/215.84  |- skos__altLabel mesh__D048948 14-3-3epsilon Protein
% 215.66/215.84  |- skos__scopeNote mesh__D048948
% 215.66/215.84       A large family of signal-transducing adaptor proteins present in wide variety of eukaryotes. They are PHOSPHOSERINE and PHOSPHOTHREONINE binding proteins involved in important cellular processes including SIGNAL TRANSDUCTION; CELL-CYCLE control; APOPTOSIS; and cellular stress responses. 14-3-3 proteins function by interacting with other signal-transducing proteins and effecting changes in their enzymatic activity and subcellular localization.  The name 14-3-3 derives from numerical designations used in the original fractionation patterns of the proteins.%A%    
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 14-3-3 Protein, Brain
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 14 3 3tau Protein
% 215.66/215.84  |- mesh__historyNote mesh__D048948 2005%28%1981%29%   
% 215.66/215.84  |- skos__altLabel mesh__D048948 14-3-3 tau Protein
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 eta Protein, 14-3-3
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 14 3 3 Protein, beta Isoform
% 215.66/215.84  |- rdf__type mesh__D048948sskos__Concept
% 215.66/215.84  |- mesh__publicMeSHNote mesh__D048948
% 215.66/215.84       2005; 14-3-3 PROTEINS was indexed under TYROSINE 3-MONOOXYGENASE 2000-2004, under PROTEINS 1995-1999, %26% under NERVE TISSUE PROTEINS 1981-1994%A%  
% 215.66/215.84  |- mesh__dateEstablished mesh__D048948 2005-01-01
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D048948 2006
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 14 3 3 gamma Protein
% 215.66/215.84  |- skos__altLabel mesh__D048948 14-3-3 beta Protein
% 215.66/215.84  |- mesh__recordMaintainer mesh__D048948 DRC
% 215.66/215.84  |- skos__altLabel mesh__D048948 Protein 14-3-3
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 Protein, 14-3-3tau
% 215.66/215.84  |- skos__altLabel mesh__D048948 14-3-3 epsilon Protein
% 215.66/215.84  |- skos__altLabel mesh__D048948 14-3-3beta Protein
% 215.66/215.84  |- skos__historyNote mesh__D048948
% 215.66/215.84       Tyrosine 3-Monooxygenase %28%2000-2004%29%
% 215.66/215.84  |- mesh__recordAuthorizer mesh__D048948 sjn
% 215.66/215.84  |- mesh__dateRevised mesh__D048948 2005-06-30
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 14 3 3epsilon Protein
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 14 3 3beta Protein
% 215.66/215.84  |- skos__broader mesh__D048948smesh__D048868
% 215.66/215.84  |- skos__altLabel mesh__D048948 14-3-3zeta Protein
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 14 3 3 Protein, eta Isoform
% 215.66/215.84  |- skos__historyNote mesh__D048948 Proteins %28%1995-1999%29%
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 Brain 14 3 3 Protein
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 14 3 3 beta Protein
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 14 3 3gamma Protein
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 14 3 3 tau Protein
% 215.66/215.84  |- skos__altLabel mesh__D048948 Brain 14-3-3 Protein
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 14 3 3 Protein, tau Isoform
% 215.66/215.84  |- skos__altLabel mesh__D048948 14-3-3 zeta Protein
% 215.66/215.84  |- skos__prefLabel mesh__D048948 14-3-3 Proteins
% 215.66/215.84  |- skos__altLabel mesh__D048948 14-3-3 eta Protein
% 215.66/215.84  |- skos__altLabel mesh__D048948 14-3-3gamma Protein
% 215.66/215.84  |- skos__altLabel mesh__D048948 14-3-3 gamma Protein
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 14 3 3eta Protein
% 215.66/215.84  |- mesh__recordOriginator mesh__D048948 jmp
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 14 3 3 Protein, zeta Isoform
% 215.66/215.84  |- skos__altLabel mesh__D048948 14-3-3 Protein
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 14 3 3zeta Protein
% 215.66/215.84  |- mesh__dateCreated mesh__D048948 2004-07-07
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 14 3 3 epsilon Protein
% 215.66/215.84  |- skos__altLabel mesh__D048948 14-3-3eta Protein
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 14 3 3 Protein, epsilon Isoform
% 215.66/215.84  |- skos__altLabel mesh__D048948 14-3-3tau Protein
% 215.66/215.84  |- skos__hiddenLabel mesh__D048948 14 3 3 Protein, gamma Isoform
% 215.66/215.84  |- skos__historyNote mesh__D012476 Enterobacteriaceae %28%1966-1977%29%
% 215.66/215.84  |- mesh__activeMeSHYear mesh__D012476 2006
% 215.66/215.84  |- mesh__dateCreated mesh__D012476 1977-03-01
% 215.66/215.85  |- mesh__recordMaintainer mesh__D012476 SYSTEM
% 215.66/215.85  |- skos__annotation mesh__D012476
% 215.66/215.85       infection: coord IM with SALMONELLA INFECTIONS %28%IM%29%   
% 215.66/215.85  |- mesh__dateEstablished mesh__D012476 1991-01-01
% 215.66/215.85  |- skos__altLabel mesh__D012476 Salmonella choleraesuis subsp. arizonae
% 215.66/215.85  |- skos__altLabel mesh__D012476 Salmonella enterica serovar arizonae
% 215.66/215.85  |- rdf__type mesh__D012476sskos__Concept
% 215.66/215.85  |- skos__historyNote mesh__D012476 Salmonella %28%1966-1977%29%
% 215.66/215.85  |- skos__prefLabel mesh__D012476 Salmonella arizonae
% 215.66/215.85  |- skos__altLabel mesh__D012476 Arizona Bacteria
% 215.66/215.85  |- mesh__publicMeSHNote mesh__D012476
% 215.66/215.85       91; was see under SALMONELLA 1978-90   
% 215.66/215.85  |- mesh__historyNote mesh__D012476
% 215.66/215.85       91%28%78%29%; was see under SALMONELLA 1978-90   
% 215.66/215.85  |- skos__scopeNote mesh__D012476
% 215.66/215.85       Gram-negative rods widely distributed in LIZARDS and SNAKES, and implicated in enteric, bone %28%BONE DISEASES%29%, and joint infections %28%JOINT DISEASES%29% in humans.%A%    
% 215.66/215.85  |- mesh__recordAuthorizer mesh__D012476 sjn
% 215.66/215.85  |- mesh__recordOriginator mesh__D012476 AEP
% 215.66/215.85  |- mesh__dateRevised mesh__D012476 2005-06-30
% 215.66/215.85  |- skos__broader mesh__D012476smesh__D012475
% 215.66/215.85  |- skos__hiddenLabel mesh__D020908 Channel, R-Type Calcium
% 215.66/215.85  |- skos__hiddenLabel mesh__D020908
% 215.66/215.85       R Type Voltage Dependent Calcium Channels
% 215.66/215.85  |- skos__scopeNote mesh__D020908
% 215.66/215.85       CALCIUM CHANNELS located in the neurons of the brain. They are inhibited by the marine snail toxin, omega conotoxin MVIIC.%A%    
% 215.66/215.85  |- skos__hiddenLabel mesh__D020908 R Type Calcium Channels
% 215.66/215.85  |- skos__prefLabel mesh__D020908 Calcium Channels, R-Type
% 215.66/215.85  |- mesh__dateRevised mesh__D020908 2005-06-30
% 215.66/215.85  |- skos__altLabel mesh__D020908 R-Type Calcium Channels
% 215.66/215.85  |- skos__hiddenLabel mesh__D020908 R Type VDCC
% 215.66/215.85  |- skos__hiddenLabel mesh__D020908 Calcium Channels, R Type
% 215.66/215.85  |- skos__broader mesh__D020908smesh__D020864
% 215.66/215.85  |- skos__altLabel mesh__D020908 R-Type VDCC
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D020908 2006
% 215.66/215.85  |- skos__historyNote mesh__D020908 Calcium Channels %28%1992-1999%29%
% 215.66/215.85  |- rdf__type mesh__D020908sskos__Concept
% 215.66/215.85  |- mesh__historyNote mesh__D020908 2000   
% 215.66/215.85  |- mesh__recordOriginator mesh__D020908 adp
% 215.66/215.85  |- mesh__recordAuthorizer mesh__D020908 sjn
% 215.66/215.85  |- mesh__publicMeSHNote mesh__D020908 2000   
% 215.66/215.85  |- skos__altLabel mesh__D020908 R-Type Calcium Channel
% 215.66/215.85  |- skos__hiddenLabel mesh__D020908 Calcium Channel, R-Type
% 215.66/215.85  |- mesh__recordMaintainer mesh__D020908 SYSTEM
% 215.66/215.85  |- skos__altLabel mesh__D020908 R-Type Voltage-Dependent Calcium Channels
% 215.66/215.85  |- skos__hiddenLabel mesh__D020908 VDCC, R-Type
% 215.66/215.85  |- mesh__dateEstablished mesh__D020908 2000-01-01
% 215.66/215.85  |- skos__annotation mesh__D020908 DF: VDCC R   
% 215.66/215.85  |- skos__hiddenLabel mesh__D020908 R Type Calcium Channel
% 215.66/215.85  |- mesh__dateCreated mesh__D020908 1999-11-08
% 215.66/215.85  |- skos__prefLabel mesh__D006439 Hemodynamic Processes
% 215.66/215.85  |- rdf__type mesh__D006439sskos__Concept
% 215.66/215.85  |- mesh__dateCreated mesh__D006439 1999-01-01
% 215.66/215.85  |- mesh__dateRevised mesh__D006439 2003-07-09
% 215.66/215.85  |- mesh__recordOriginator mesh__D006439 NLM
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D006439 2004
% 215.66/215.85  |- skos__hiddenLabel mesh__D006439 Processes, Hemodynamic
% 215.66/215.85  |- mesh__recordMaintainer mesh__D006439 nns
% 215.66/215.85  |- skos__annotation mesh__D006439
% 215.66/215.85       GEN; prefer specifics; hemodynamics and hemodynamic phenomena unspecified go here; use /physiol or /physiopathol, not /blood with coordinating terms: Manual 19.8.10, 23.28, 28.18.1%A%  
% 215.66/215.85  |- skos__altLabel mesh__D006439 Hemodynamic Process
% 215.66/215.85  |- mesh__dateEstablished mesh__D006439 1966-01-01
% 215.66/215.85  |- skos__broader mesh__D006439smesh__D045125
% 215.66/215.85  |- mesh__recordAuthorizer mesh__D006439 sjn
% 215.66/215.85  |- skos__scopeNote mesh__D006439
% 215.66/215.85       Biological actions and events that support the functions involved in systemic or regional BLOOD CIRCULATION.%A%    
% 215.66/215.85  |- mesh__historyNote mesh__D006439 2004%28%1964%29%   
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D006439 2006
% 215.66/215.85  |- skos__hiddenLabel mesh__D006439 Process, Hemodynamic
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D006439 2005
% 215.66/215.85  |- mesh__publicMeSHNote mesh__D006439 2004; see HEMODYNAMICS 1966-2003   
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D017161 2006
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D017161 2005
% 215.66/215.85  |- mesh__dateCreated mesh__D017161 1992-05-22
% 215.66/215.85  |- skos__scopeNote mesh__D017161
% 215.66/215.85       A subclass of nematodes characterized by numerous caudal papillae and an excretory system possessing lateral canals.%A%    
% 215.66/215.85  |- skos__altLabel mesh__D017161 Phasmidia
% 215.66/215.85  |- rdf__type mesh__D017161sskos__Concept
% 215.66/215.85  |- mesh__historyNote mesh__D017161 93   
% 215.66/215.85  |- mesh__dateEstablished mesh__D017161 1993-01-01
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D017161 2004
% 215.66/215.85  |- mesh__dateRevised mesh__D017161 2003-07-09
% 215.66/215.85  |- skos__prefLabel mesh__D017161 Secernentea
% 215.66/215.85  |- skos__annotation mesh__D017161
% 215.66/215.85       a subclass of nematodes; infection = SECERNENTEA INFECTIONS%A%  
% 215.66/215.85  |- mesh__publicMeSHNote mesh__D017161 93   
% 215.66/215.85  |- skos__broader mesh__D017161smesh__D009348
% 215.66/215.85  |- skos__hiddenLabel mesh__D003141 Disease, Infectious
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003141 2000
% 215.66/215.85  |- mesh__recordOriginator mesh__D003141 NLM
% 215.66/215.85  |- skos__annotation mesh__D003141
% 215.66/215.85       /prev = COMMUNICABLE DISEASE CONTROL for GEN only; do not confuse X ref INFECTIOUS DISEASES with INFECTION: see note there%A%  
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003141 1995
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003141 1993
% 215.66/215.85  |- skos__hiddenLabel mesh__D003141 Diseases, Communicable
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003141 1994
% 215.66/215.85  |- mesh__dateCreated mesh__D003141 1999-01-01
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003141 1992
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003141 1999
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003141 2002
% 215.66/215.85  |- mesh__recordAuthorizer mesh__D003141 PLS
% 215.66/215.85  |- mesh__recordMaintainer mesh__D003141 PLS
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003141 1997
% 215.66/215.85  |- skos__prefLabel mesh__D003141 Communicable Diseases
% 215.66/215.85  |- mesh__dateRevised mesh__D003141 1991-11-04
% 215.66/215.85  |- skos__hiddenLabel mesh__D003141 Diseases, Infectious
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003141 1998
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003141 2006
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003141 1996
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003141 2004
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003141 2005
% 215.66/215.85  |- skos__altLabel mesh__D003141 Infectious Diseases
% 215.66/215.85  |- rdf__type mesh__D003141sskos__Concept
% 215.66/215.85  |- skos__hiddenLabel mesh__D003141 Infectious Disease
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003141 1991
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003141 2001
% 215.66/215.85  |- skos__hiddenLabel mesh__D003141 Disease, Communicable
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003141 2003
% 215.66/215.85  |- skos__related mesh__D003141smesh__D004197
% 215.66/215.85  |- skos__broader mesh__D003141smesh__D007239
% 215.66/215.85  |- skos__hiddenLabel mesh__D003141 Communicable Disease
% 215.66/215.85  |- skos__historyNote mesh__D016867
% 215.66/215.85       Immunologic Deficiency Syndromes %28%1977-1991%29%
% 215.66/215.85  |- skos__historyNote mesh__D016867 Immunosuppression %28%1976-1991%29%
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D016867 2006
% 215.66/215.85  |- skos__hiddenLabel mesh__D016867 Immunosuppressed Hosts
% 215.66/215.85  |- skos__hiddenLabel mesh__D016867 Immunocompromised Patients
% 215.66/215.85  |- skos__prefLabel mesh__D016867 Immunocompromised Host
% 215.66/215.85  |- skos__hiddenLabel mesh__D016867 Host, Immunocompromised
% 215.66/215.85  |- skos__altLabel mesh__D016867 Immunocompromised Patient
% 215.66/215.85  |- skos__hiddenLabel mesh__D016867 Hosts, Immunosuppressed
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D016867 2005
% 215.66/215.85  |- mesh__recordAuthorizer mesh__D016867 sjn
% 215.66/215.85  |- skos__hiddenLabel mesh__D016867 Host, Immunosuppressed
% 215.66/215.85  |- skos__hiddenLabel mesh__D016867 Immunocompromised Hosts
% 215.66/215.85  |- mesh__historyNote mesh__D016867 92   
% 215.66/215.85  |- rdf__type mesh__D016867sskos__Concept
% 215.66/215.85  |- skos__hiddenLabel mesh__D016867 Patients, Immunocompromised
% 215.66/215.85  |- mesh__recordMaintainer mesh__D016867 sjn
% 215.66/215.85  |- skos__scopeNote mesh__D016867
% 215.66/215.85       A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation.%A%    
% 215.66/215.85  |- skos__altLabel mesh__D016867 Immunosuppressed Host
% 215.66/215.85  |- skos__historyNote mesh__D016867 Immune Tolerance %28%1980-1991%29%
% 215.66/215.85  |- skos__annotation mesh__D016867
% 215.66/215.85       note category: a physiol state in man or animal; coord IM with disease or physiol state complicating the immunocompromised state %28%IM with /immunol%29% or with the immunosuppressive agent %28%IM with pertinent subh%29%%A%  
% 215.66/215.85  |- skos__hiddenLabel mesh__D016867 Hosts, Immunocompromised
% 215.66/215.85  |- mesh__dateRevised mesh__D016867 2004-07-13
% 215.66/215.85  |- mesh__publicMeSHNote mesh__D016867 92   
% 215.66/215.85  |- skos__broader mesh__D016867smesh__D007109
% 215.66/215.85  |- mesh__recordOriginator mesh__D016867 TGC
% 215.66/215.85  |- mesh__dateEstablished mesh__D016867 1992-01-01
% 215.66/215.85  |- skos__hiddenLabel mesh__D016867 Patient, Immunocompromised
% 215.66/215.85  |- mesh__dateCreated mesh__D016867 1991-05-02
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D002847 2004
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D002847 2005
% 215.66/215.85  |- mesh__recordAuthorizer mesh__D002847 sjn
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D002847 2003
% 215.66/215.85  |- skos__hiddenLabel mesh__D002847 Chromatographies, Agarose
% 215.66/215.85  |- rdf__type mesh__D002847sskos__Concept
% 215.66/215.85  |- mesh__publicMeSHNote mesh__D002847
% 215.66/215.85       91; was see under CHROMATOGRAPHY, GEL 1975-90   
% 215.66/215.85  |- skos__altLabel mesh__D002847 Sepharose Chromatography
% 215.66/215.85  |- mesh__recordOriginator mesh__D002847 NLM
% 215.66/215.85  |- skos__altLabel mesh__D002847 Chromatography, Sepharose
% 215.66/215.85  |- skos__prefLabel mesh__D002847 Chromatography, Agarose
% 215.66/215.85  |- mesh__dateRevised mesh__D002847 2002-07-02
% 215.66/215.85  |- skos__annotation mesh__D002847
% 215.66/215.85       a type of gel chromatogr; NIM; DF: CHROMATOGR AGAROSE   
% 215.66/215.85  |- skos__hiddenLabel mesh__D002847 Agarose Chromatographies
% 215.66/215.85  |- skos__hiddenLabel mesh__D002847 Chromatographies, Sepharose
% 215.66/215.85  |- mesh__dateCreated mesh__D002847 1974-11-11
% 215.66/215.85  |- mesh__historyNote mesh__D002847
% 215.66/215.85       91%28%75%29%; was see under CHROMATOGRAPHY, GEL 1975-90   
% 215.66/215.85  |- mesh__dateEstablished mesh__D002847 1991-01-01
% 215.66/215.85  |- mesh__recordMaintainer mesh__D002847 lkt
% 215.66/215.85  |- skos__broader mesh__D002847smesh__D002850
% 215.66/215.85  |- skos__altLabel mesh__D002847 Agarose Chromatography
% 215.66/215.85  |- skos__scopeNote mesh__D002847
% 215.66/215.85       A method of gel filtration chromatography using agarose, the non-ionic component of agar, for the separation of compounds with molecular weights up to several million.%A%    
% 215.66/215.85  |- skos__hiddenLabel mesh__D002847 Sepharose Chromatographies
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D002847 2006
% 215.66/215.85  |- mesh__recordMaintainer mesh__D002049 CCR
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D002049 2004
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D002049 2002
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D002049 2006
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D002049 2003
% 215.66/215.85  |- mesh__dateCreated mesh__D002049 1974-11-11
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D002049 2001
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D002049 2005
% 215.66/215.85  |- mesh__dateRevised mesh__D002049 2000-06-22
% 215.66/215.85  |- skos__prefLabel mesh__D002049 Burimamide
% 215.66/215.85  |- skos__historyNote mesh__D002049 Thiourea %28%1972-1974%29%
% 215.66/215.85  |- mesh__publicMeSHNote mesh__D002049 91; was see under THIOUREA 1975-90   
% 215.66/215.85  |- rdf__type mesh__D002049sskos__Concept
% 215.66/215.85  |- skos__broader mesh__D002049smesh__D013890
% 215.66/215.85  |- skos__historyNote mesh__D002049 Imidazoles %28%1972-1974%29%
% 215.66/215.85  |- skos__scopeNote mesh__D002049
% 215.66/215.85       An antagonist of histamine that appears to block both H2 and H3 histamine receptors. It has been used in the treatment of ulcers.%A%    
% 215.66/215.85  |- mesh__historyNote mesh__D002049
% 215.66/215.85       91%28%75%29%; was see under THIOUREA 1975-90   
% 215.66/215.85  |- mesh__recordOriginator mesh__D002049 NLM
% 215.66/215.85  |- mesh__dateEstablished mesh__D002049 1991-01-01
% 215.66/215.85  |- mesh__recordAuthorizer mesh__D002049 sjn
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D007532 2003
% 215.66/215.85  |- mesh__recordMaintainer mesh__D007532 jmp
% 215.66/215.85  |- rdf__type mesh__D007532sskos__Concept
% 215.66/215.85  |- skos__broader mesh__D007532smesh__D000601
% 215.66/215.85  |- skos__altLabel mesh__D007532 L-Isoleucine
% 215.66/215.85  |- mesh__dateRevised mesh__D007532 2001-07-25
% 215.66/215.85  |- skos__hiddenLabel mesh__D007532 Isoleucine, L Isomer
% 215.66/215.85  |- mesh__recordAuthorizer mesh__D007532 sjn
% 215.66/215.85  |- skos__annotation mesh__D007532 /biosyn /defic /physiol permitted   
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D007532 2006
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D007532 2002
% 215.66/215.85  |- skos__altLabel mesh__D007532 Isoleucine, L-Isomer
% 215.66/215.85  |- skos__scopeNote mesh__D007532
% 215.66/215.85       An essential branched-chain aliphatic amino acid found in many proteins. It is an isomer of LEUCINE. It is important in hemoglobin synthesis and regulation of blood sugar and energy levels.%A%    
% 215.66/215.85  |- skos__hiddenLabel mesh__D007532 L-Isomer Isoleucine
% 215.66/215.85  |- mesh__recordOriginator mesh__D007532 NLM
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D007532 2005
% 215.66/215.85  |- skos__broader mesh__D007532smesh__D000597
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D007532 2004
% 215.66/215.85  |- mesh__dateCreated mesh__D007532 1999-01-01
% 215.66/215.85  |- skos__prefLabel mesh__D007532 Isoleucine
% 215.66/215.85  |- skos__hiddenLabel mesh__D048949 Pain, Labor
% 215.66/215.85  |- skos__scopeNote mesh__D048949
% 215.66/215.85       Pain associated with OBSTETRIC LABOR in CHILDBIRTH. It is caused primarily by UTERINE CONTRACTION as well as pressure on the CERVIX; BLADDER; and the GASTROINTESTINAL TRACT. Labor pain mostly occurs in the ABDOMEN; the GROIN; and the BACK.%A%    
% 215.66/215.85  |- mesh__recordAuthorizer mesh__D048949 sjn
% 215.66/215.85  |- skos__broader mesh__D048949smesh__D010146
% 215.66/215.85  |- skos__historyNote mesh__D048949 Pain %28%1965-2004%29%
% 215.66/215.85  |- mesh__dateEstablished mesh__D048949 2005-01-01
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D048949 2006
% 215.66/215.85  |- mesh__historyNote mesh__D048949 2005   
% 215.66/215.85  |- skos__altLabel mesh__D048949 Obstetric Pain
% 215.66/215.85  |- rdf__type mesh__D048949sskos__Concept
% 215.66/215.85  |- mesh__dateCreated mesh__D048949 2004-07-07
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D048949 2005
% 215.66/215.85  |- mesh__recordOriginator mesh__D048949 lkt
% 215.66/215.85  |- skos__historyNote mesh__D048949 Labor, Obstetric %28%1965-2004%29%
% 215.66/215.85  |- skos__hiddenLabel mesh__D048949 Pain, Obstetric
% 215.66/215.85  |- mesh__recordMaintainer mesh__D048949 lkt
% 215.66/215.85  |- skos__prefLabel mesh__D048949 Labor Pain
% 215.66/215.85  |- mesh__publicMeSHNote mesh__D048949 2005   
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D012477 2006
% 215.66/215.85  |- mesh__dateEstablished mesh__D012477 1974-01-01
% 215.66/215.85  |- mesh__recordAuthorizer mesh__D012477 sjn
% 215.66/215.85  |- skos__altLabel mesh__D012477 Salmonella enterica serovar enteritidis
% 215.66/215.85  |- rdf__type mesh__D012477sskos__Concept
% 215.66/215.85  |- mesh__dateRevised mesh__D012477 2005-06-30
% 215.66/215.85  |- skos__scopeNote mesh__D012477
% 215.66/215.85       A serotype of Salmonella enterica which is an etiologic agent of gastroenteritis in man and other animals.%A%    
% 215.66/215.85  |- mesh__recordMaintainer mesh__D012477 SYSTEM
% 215.66/215.85  |- skos__annotation mesh__D012477
% 215.66/215.85       infection: coord IM with SALMONELLA INFECTIONS %28%IM%29%   
% 215.66/215.85  |- mesh__dateCreated mesh__D012477 1999-01-01
% 215.66/215.85  |- mesh__recordOriginator mesh__D012477 NLM
% 215.66/215.85  |- skos__broader mesh__D012477smesh__D019779
% 215.66/215.85  |- skos__prefLabel mesh__D012477 Salmonella enteritidis
% 215.66/215.85  |- mesh__historyNote mesh__D012477 74%28%72%29%   
% 215.66/215.85  |- skos__historyNote mesh__D012477 Salmonella %28%1966-1971%29%
% 215.66/215.85  |- mesh__publicMeSHNote mesh__D012477 74   
% 215.66/215.85  |- skos__altLabel mesh__D020909 Bayer Brand of Acarbose
% 215.66/215.85  |- skos__historyNote mesh__D020909 Trisaccharides %28%1980-1999%29%
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D020909 2006
% 215.66/215.85  |- mesh__historyNote mesh__D020909
% 215.66/215.85       2000; use ACARBOSE %28%NM%29% 1979-1999   
% 215.66/215.85  |- skos__altLabel mesh__D020909 Prandase
% 215.66/215.85  |- skos__altLabel mesh__D020909 Lasa Brand of Acarbose
% 215.66/215.85  |- mesh__dateRevised mesh__D020909 2005-06-30
% 215.66/215.85  |- skos__prefLabel mesh__D020909 Acarbose
% 215.66/215.85  |- rdf__type mesh__D020909sskos__Concept
% 215.66/215.85  |- skos__broader mesh__D020909smesh__D014312
% 215.66/215.85  |- skos__altLabel mesh__D020909 Glucor
% 215.66/215.85  |- mesh__dateCreated mesh__D020909 1999-11-03
% 215.66/215.85  |- mesh__publicMeSHNote mesh__D020909
% 215.66/215.85       2000; ACARBOSE was indexed under TRISACCHARIDES 1980-1999, CYCLOHEXANOLS 1979-1981, %26% POLYSACCHARIDES 1978-1979%A%  
% 215.66/215.85  |- skos__historyNote mesh__D020909 Cyclohexanols %28%1979-1981%29%
% 215.66/215.85  |- skos__altLabel mesh__D020909 Glucobay
% 215.66/215.85  |- skos__historyNote mesh__D020909
% 215.66/215.85       Polysaccharides, Bacterial %28%1978-1979%29%
% 215.66/215.85  |- mesh__recordMaintainer mesh__D020909 exl
% 215.66/215.85  |- mesh__recordAuthorizer mesh__D020909 sjn
% 215.66/215.85  |- mesh__dateEstablished mesh__D020909 2000-01-01
% 215.66/215.85  |- mesh__recordOriginator mesh__D020909 adp
% 215.66/215.85  |- skos__scopeNote mesh__D020909
% 215.66/215.85       An inhibitor of alpha glucosidase that retards the digestion and absorption of carbohydrates in the small intestine and hence reduces the increase in blood-glucose concentrations after a carbohydrate load. It is given orally to non-insulin dependent diabetes mellitus patients where diet modification or oral hypoglycemic agents do not control their condition. %28%From Martindale The Extra Pharmacopoeia, 31st ed%29%%A%    
% 215.66/215.85  |- skos__hiddenLabel mesh__D017960 Bovine Lentivirus
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D017960 2002
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D017960 1994
% 215.66/215.85  |- mesh__dateCreated mesh__D017960 1993-06-30
% 215.66/215.85  |- mesh__historyNote mesh__D017960 94   
% 215.66/215.85  |- mesh__publicMeSHNote mesh__D017960 94   
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D017960 2001
% 215.66/215.85  |- skos__broader mesh__D017960smesh__D016086
% 215.66/215.85  |- skos__hiddenLabel mesh__D017960 Lentivirus, Bovine
% 215.66/215.85  |- mesh__dateEstablished mesh__D017960 1994-01-01
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D017960 2004
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D017960 2000
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D017960 2006
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D017960 2003
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D017960 2005
% 215.66/215.85  |- rdf__type mesh__D017960sskos__Concept
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D017960 1997
% 215.66/215.85  |- skos__prefLabel mesh__D017960 Lentiviruses, Bovine
% 215.66/215.85  |- skos__annotation mesh__D017960
% 215.66/215.85       a subgenus of the genus Lentivirus; infection: coord IM with LENTIVIRUS INFECTIONS %28%IM%29%%A%  
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D017960 1999
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D017960 1996
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D017960 1995
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D017960 1998
% 215.66/215.85  |- skos__scopeNote mesh__D017960
% 215.66/215.85       A subgenus of LENTIVIRUS comprising viruses that produce multi-organ disease with long incubation periods in cattle.%A%    
% 215.66/215.85  |- skos__altLabel mesh__D017960 Bovine Lentiviruses
% 215.66/215.85  |- mesh__dateEstablished mesh__D017162 1993-01-01
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D017162 2006
% 215.66/215.85  |- mesh__dateCreated mesh__D017162 1992-05-07
% 215.66/215.85  |- skos__annotation mesh__D017162
% 215.66/215.85       an order of nematodes; do not confuse with the genus ASCARIDIA; infection = ASCARIDIDA INFECTIONS%A%  
% 215.66/215.85  |- mesh__publicMeSHNote mesh__D017162 93   
% 215.66/215.85  |- rdf__type mesh__D017162sskos__Concept
% 215.66/215.85  |- mesh__historyNote mesh__D017162 93   
% 215.66/215.85  |- skos__broader mesh__D017162smesh__D017161
% 215.66/215.85  |- skos__prefLabel mesh__D017162 Ascaridida
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D017162 2004
% 215.66/215.85  |- mesh__dateRevised mesh__D017162 2003-07-09
% 215.66/215.85  |- skos__scopeNote mesh__D017162
% 215.66/215.85       An order of nematodes of the subclass SECERNENTEA. Its organisms possess two or three pairs of dorsolateral caudal papillae.%A%    
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D017162 2005
% 215.66/215.85  |- skos__altLabel mesh__D003940 Technics, Endocrine Diagnostic
% 215.66/215.85  |- skos__altLabel mesh__D003940 Techniques, Endocrine Diagnostic
% 215.66/215.85  |- skos__prefLabel mesh__D003940 Diagnostic Techniques, Endocrine
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003940 2006
% 215.66/215.85  |- mesh__recordAuthorizer mesh__D003940 SJN
% 215.66/215.85  |- mesh__recordMaintainer mesh__D003940 TGC
% 215.66/215.85  |- skos__altLabel mesh__D003940 Technic, Endocrine Diagnostic
% 215.66/215.85  |- skos__altLabel mesh__D003940 Diagnostic Technics, Endocrine
% 215.66/215.85  |- mesh__historyNote mesh__D003940 98; use explode 1975-97   
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003940 2005
% 215.66/215.85  |- skos__broader mesh__D003940smesh__D019937
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003940 2002
% 215.66/215.85  |- skos__altLabel mesh__D003940 Diagnostic Technic, Endocrine
% 215.66/215.85  |- skos__annotation mesh__D003940
% 215.66/215.85       GEN or unspecified; prefer specifics; DF: DIAG TECHNIQUES ENDOCRINE%A%  
% 215.66/215.85  |- skos__historyNote mesh__D003940 specific technique %28%1966-1997%29%
% 215.66/215.85  |- skos__altLabel mesh__D003940 Technique, Endocrine Diagnostic
% 215.66/215.85  |- skos__altLabel mesh__D003940 Endocrine Diagnostic Technique
% 215.66/215.85  |- skos__altLabel mesh__D003940 Diagnostic Technique, Endocrine
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003940 2004
% 215.66/215.85  |- mesh__dateRevised mesh__D003940 1997-06-20
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003940 2001
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003940 1999
% 215.66/215.85  |- skos__altLabel mesh__D003940 Endocrine Diagnostic Techniques
% 215.66/215.85  |- mesh__dateCreated mesh__D003940 1999-01-01
% 215.66/215.85  |- skos__altLabel mesh__D003940 Endocrine Diagnostic Technic
% 215.66/215.85  |- skos__scopeNote mesh__D003940
% 215.66/215.85       Methods and procedures for the diagnosis of diseases or dysfunction of the endocrine glands or demonstration of their physiological processes.%A%    
% 215.66/215.85  |- rdf__type mesh__D003940sskos__Concept
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003940 2003
% 215.66/215.85  |- mesh__dateEstablished mesh__D003940 1998-01-01
% 215.66/215.85  |- mesh__recordOriginator mesh__D003940 NLM
% 215.66/215.85  |- skos__altLabel mesh__D003940 Endocrine Diagnostic Technics
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003940 2000
% 215.66/215.85  |- mesh__publicMeSHNote mesh__D003940 98   
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003940 1998
% 215.66/215.85  |- skos__scopeNote mesh__D050596
% 215.66/215.85       The GENETIC RECOMBINATION of the parts of two or more GENES, including an ONCOGENE as at least one of the fusion partners. Such gene fusions are often detected in neoplastic cells and are transcribed into ONCOGENE FUSION PROTEINS.%A%    
% 215.66/215.85  |- mesh__dateEstablished mesh__D050596 2006-01-01
% 215.66/215.85  |- skos__hiddenLabel mesh__D050596 Oncogene Fusions
% 215.66/215.85  |- skos__prefLabel mesh__D050596 Oncogene Fusion
% 215.66/215.85  |- mesh__recordMaintainer mesh__D050596 nns
% 215.66/215.85  |- mesh__dateCreated mesh__D050596 2005-06-30
% 215.66/215.85  |- skos__related mesh__D050596smesh__D015514
% 215.66/215.85  |- mesh__historyNote mesh__D050596 2006   
% 215.66/215.85  |- skos__broader mesh__D050596smesh__D050939
% 215.66/215.85  |- mesh__recordOriginator mesh__D050596 nns
% 215.66/215.85  |- mesh__recordAuthorizer mesh__D050596 sjn
% 215.66/215.85  |- mesh__publicMeSHNote mesh__D050596 2006   
% 215.66/215.85  |- rdf__type mesh__D050596sskos__Concept
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D050596 2006
% 215.66/215.85  |- skos__broader mesh__D003142smesh__D001519
% 215.66/215.85  |- skos__hiddenLabel mesh__D003142 Communication Program
% 215.66/215.85  |- mesh__recordAuthorizer mesh__D003142 sjn
% 215.66/215.85  |- mesh__dateCreated mesh__D003142 1999-01-01
% 215.66/215.85  |- skos__prefLabel mesh__D003142 Communication
% 215.66/215.85  |- mesh__recordOriginator mesh__D003142 NLM
% 215.66/215.85  |- mesh__recordMaintainer mesh__D003142 jrf
% 215.66/215.85  |- skos__broader mesh__D003142smesh__D007254
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003142 2006
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003142 2005
% 215.66/215.85  |- mesh__dateRevised mesh__D003142 2002-07-03
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003142 2004
% 215.66/215.85  |- skos__hiddenLabel mesh__D003142 Programs, Communication
% 215.66/215.85  |- skos__annotation mesh__D003142
% 215.66/215.85       includes personal %26% technological communication; ANIMAL COMMUNICATION is also available%A%  
% 215.66/215.85  |- skos__scopeNote mesh__D003142
% 215.66/215.85       The exchange or transmission of ideas, attitudes, or beliefs between individuals or groups.%A%    
% 215.66/215.85  |- rdf__type mesh__D003142sskos__Concept
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D003142 2003
% 215.66/215.85  |- skos__hiddenLabel mesh__D003142 Communication, Personal
% 215.66/215.85  |- skos__hiddenLabel mesh__D003142 Program, Communication
% 215.66/215.85  |- skos__hiddenLabel mesh__D003142 Personnel, Communications
% 215.66/215.85  |- skos__broader mesh__D016333Q000037smesh__D016333
% 215.66/215.85  |- mesh__preferredCombination mesh__D016333Q000037smesh__D017320
% 215.66/215.85  |- rdf__type mesh__D016333Q000037smesh__CompoundConcept
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D016868 1999
% 215.66/215.85  |- mesh__dateEstablished mesh__D016868 1992-01-01
% 215.66/215.85  |- mesh__dateRevised mesh__D016868 1993-06-03
% 215.66/215.85  |- mesh__recordMaintainer mesh__D016868 TAP
% 215.66/215.85  |- mesh__recordAuthorizer mesh__D016868 PLS
% 215.66/215.85  |- skos__historyNote mesh__D016868
% 215.66/215.85       Enterobacteriaceae Infections %28%1970-1991%29%
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D016868 2001
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D016868 1998
% 215.66/215.85  |- mesh__publicMeSHNote mesh__D016868 92   
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D016868 2004
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D016868 2000
% 215.66/215.85  |- mesh__dateCreated mesh__D016868 1991-05-30
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D016868 1995
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D016868 2003
% 215.66/215.85  |- skos__hiddenLabel mesh__D016868 Infection, Serratia
% 215.66/215.85  |- skos__historyNote mesh__D016868 Serratia %28%1978-1991%29%
% 215.66/215.85  |- skos__hiddenLabel mesh__D016868 Serratia Infection
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D016868 1994
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D016868 1997
% 215.66/215.85  |- skos__prefLabel mesh__D016868 Serratia Infections
% 215.66/215.85  |- mesh__recordOriginator mesh__D016868 PXP
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D016868 2006
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D016868 1996
% 215.66/215.85  |- skos__scopeNote mesh__D016868
% 215.66/215.85       Infections with bacteria of the genus SERRATIA.     
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D016868 2002
% 215.66/215.85  |- mesh__activeMeSHYear mesh__D016868 2005
% 215.66/215.85  |- mesh__historyNote mesh__D016868 92   
% 215.66/215.85  |- skos__altLabel mesh__D016868 Infections, Serratia
% 215.66/215.85  |- skos__historyNote mesh__D016868 Serratia marcescens %28%1972-1991%29%
% 215.66/215.85  |- rdf__type mesh__D016868sskos__Concept
% 215.66/215.85  |- skos__annotation mesh__D016868 gram-neg bact infect   
% 215.66/215.85  |- skos__broader mesh__D016868smesh__D004756
% 215.66/215.85  |- skos__scopeNote mesh__D041261
% 215.66/215.85       A species of halophilic bacteria in the genus VIBRIO, which lives in warm SEAWATER. It can cause infections in those who eat raw contaminated seafood or have open wounds exposed to seawater.%A%    
% 215.66/215.85  |- mesh__recordOriginator mesh__D041261 ags
% 215.66/215.85  |- mesh__dateCreated mesh__D041261 2002-07-03
% 215.66/215.85  |- skos__annotation mesh__D041261
% 215.66/215.85       infection: coord IM with VIBRIO INFECTIONS %28%IM%29%   
% 215.66/215.85  |- mesh__historyNote mesh__D041261 2003   
% 215.66/215.85  |- mesh__recordMaintainer mesh__D041261 SYSTEM
% 215.66/215.86  |- skos__broader mesh__D041261smesh__D014733
% 215.66/215.86  |- skos__prefLabel mesh__D041261 Vibrio vulnificus
% 215.66/215.86  |- skos__historyNote mesh__D041261 Vibrio %28%1981-2002%29%
% 215.66/215.86  |- mesh__recordAuthorizer mesh__D041261 sjn
% 215.66/215.86  |- mesh__publicMeSHNote mesh__D041261 2003   
% 215.66/215.86  |- mesh__dateRevised mesh__D041261 2005-06-30
% 215.66/215.86  |- mesh__dateEstablished mesh__D041261 2003-01-01
% 215.66/215.86  |- rdf__type mesh__D041261sskos__Concept
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D041261 2006
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D002848 2005
% 215.66/215.86  |- skos__prefLabel mesh__D002848 Chromatography, DEAE-Cellulose
% 215.66/215.86  |- mesh__recordMaintainer mesh__D002848 lkt
% 215.66/215.86  |- mesh__dateRevised mesh__D002848 2002-07-03
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D002848 2003
% 215.66/215.86  |- skos__broader mesh__D002848smesh__D002852
% 215.66/215.86  |- mesh__publicMeSHNote mesh__D002848 70   
% 215.66/215.86  |- rdf__type mesh__D002848sskos__Concept
% 215.66/215.86  |- skos__altLabel mesh__D002848 DEAE-Cellulose Chromatography
% 215.66/215.86  |- mesh__dateCreated mesh__D002848 1999-01-01
% 215.66/215.86  |- mesh__recordAuthorizer mesh__D002848 sjn
% 215.66/215.86  |- skos__annotation mesh__D002848
% 215.66/215.86       a type of ion exchange chromatogr: do not confuse with chromatogr on DEAE Sephadex %28% = CHROMATOGRAPHY, ION EXCHANGE%29%; NIM; DF: CHROMATOGR DEAE CELLULOSE%A%  
% 215.66/215.86  |- mesh__dateEstablished mesh__D002848 1970-01-01
% 215.66/215.86  |- skos__hiddenLabel mesh__D002848 Chromatography, DEAE Cellulose
% 215.66/215.86  |- skos__hiddenLabel mesh__D002848 DEAE Cellulose Chromatography
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D002848 2006
% 215.66/215.86  |- mesh__recordOriginator mesh__D002848 NLM
% 215.66/215.86  |- skos__scopeNote mesh__D002848
% 215.66/215.86       A type of ion exchange chromatography using diethylaminoethyl cellulose %28%DEAE-CELLULOSE%29% as a positively charged resin. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D002848 2004
% 215.66/215.86  |- skos__historyNote mesh__D002848 Chromatography %28%1966-1969%29%
% 215.66/215.86  |- mesh__historyNote mesh__D002848 70   
% 215.66/215.86  |- skos__scopeNote mesh__D013570
% 215.66/215.86       Cell membranes associated with synapses. Both presynaptic and postsynaptic membranes are included along with their integral or tightly associated specializations for the release or reception of transmitters.%A%    
% 215.66/215.86  |- skos__historyNote mesh__D013570 Synapses %28%1966-1969%29%
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D013570 2001
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D013570 2003
% 215.66/215.86  |- mesh__publicMeSHNote mesh__D013570 73   
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D013570 2005
% 215.66/215.86  |- rdf__type mesh__D013570sskos__Concept
% 215.66/215.86  |- skos__hiddenLabel mesh__D013570 Membranes, Synaptic
% 215.66/215.86  |- skos__hiddenLabel mesh__D013570 Synaptic Membrane
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D013570 2004
% 215.66/215.86  |- mesh__dateRevised mesh__D013570 2000-06-22
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D013570 2002
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D013570 2006
% 215.66/215.86  |- skos__broader mesh__D013570smesh__D002462
% 215.66/215.86  |- skos__hiddenLabel mesh__D013570 Membrane, Synaptic
% 215.66/215.86  |- mesh__dateEstablished mesh__D013570 1973-01-01
% 215.66/215.86  |- mesh__dateCreated mesh__D013570 1999-01-01
% 215.66/215.86  |- skos__broader mesh__D013570smesh__D013569
% 215.66/215.86  |- skos__related mesh__D013570smesh__D013574
% 215.66/215.86  |- mesh__recordMaintainer mesh__D013570 TGC
% 215.66/215.86  |- mesh__recordAuthorizer mesh__D013570 sjn
% 215.66/215.86  |- skos__historyNote mesh__D013570 Cell Membrane %28%1966-1969%29%
% 215.66/215.86  |- skos__annotation mesh__D013570
% 215.66/215.86       A 11 qualif except /cytol; /genet permitted   
% 215.66/215.86  |- skos__prefLabel mesh__D013570 Synaptic Membranes
% 215.66/215.86  |- mesh__recordOriginator mesh__D013570 NLM
% 215.66/215.86  |- mesh__historyNote mesh__D013570 73%28%70%29%   
% 215.66/215.86  |- skos__hiddenLabel mesh__D007533 Isoleucine tRNA Ligase
% 215.66/215.86  |- skos__altLabel mesh__D007533 Isoleucyl-tRNA Synthetase
% 215.66/215.86  |- skos__hiddenLabel mesh__D007533 Synthetase, Isoleucyl-tRNA
% 215.66/215.86  |- mesh__recordOriginator mesh__D007533 NLM
% 215.66/215.86  |- skos__scopeNote mesh__D007533
% 215.66/215.86       An enzyme that activates isoleucine with its specific transfer RNA. EC 6.1.1.5.%A%    
% 215.66/215.86  |- skos__historyNote mesh__D007533
% 215.66/215.86       Amino Acyl T RNA Synthetases %28%1972-1974%29%
% 215.66/215.86  |- skos__historyNote mesh__D007533 Isoleucine %28%1972-1974%29%
% 215.66/215.86  |- mesh__publicMeSHNote mesh__D007533
% 215.66/215.86       98%28%75%29%; see ISOLEUCYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A%  
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D007533 2006
% 215.66/215.86  |- skos__broader mesh__D007533smesh__D000604
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D007533 2005
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D007533 2004
% 215.66/215.86  |- mesh__recordMaintainer mesh__D007533 ssb
% 215.66/215.86  |- mesh__dateEstablished mesh__D007533 1991-01-01
% 215.66/215.86  |- skos__hiddenLabel mesh__D007533 Ligase, Isoleucine-tRNA
% 215.66/215.86  |- mesh__dateRevised mesh__D007533 2003-07-09
% 215.66/215.86  |- rdf__type mesh__D007533sskos__Concept
% 215.66/215.86  |- skos__hiddenLabel mesh__D007533 Ligase, Ile-tRNA
% 215.66/215.86  |- mesh__dateCreated mesh__D007533 1974-11-19
% 215.66/215.86  |- mesh__historyNote mesh__D007533 98%28%75%29%   
% 215.66/215.86  |- skos__prefLabel mesh__D007533 Isoleucine-tRNA Ligase
% 215.66/215.86  |- mesh__recordAuthorizer mesh__D007533 sjn
% 215.66/215.86  |- skos__hiddenLabel mesh__D007533 Isoleucyl tRNA Synthetase
% 215.66/215.86  |- skos__hiddenLabel mesh__D007533 Ile tRNA Ligase
% 215.66/215.86  |- skos__altLabel mesh__D007533 Isoleucyl T RNA Synthetase
% 215.66/215.86  |- skos__altLabel mesh__D007533 Ile-tRNA Ligase
% 215.66/215.86  |- skos__hiddenLabel mesh__D012478 Salmonella Food Poisonings
% 215.66/215.86  |- skos__broader mesh__D012478smesh__D005517
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D012478 1997
% 215.66/215.86  |- skos__prefLabel mesh__D012478 Salmonella Food Poisoning
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D012478 2006
% 215.66/215.86  |- rdf__type mesh__D012478sskos__Concept
% 215.66/215.86  |- skos__broader mesh__D012478smesh__D012480
% 215.66/215.86  |- skos__hiddenLabel mesh__D012478 Poisonings, Salmonella Food
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D012478 2000
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D012478 1998
% 215.66/215.86  |- mesh__dateRevised mesh__D012478 1992-05-18
% 215.66/215.86  |- mesh__recordMaintainer mesh__D012478 TAP
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D012478 1993
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D012478 2001
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D012478 2003
% 215.66/215.86  |- mesh__dateCreated mesh__D012478 1999-01-01
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D012478 1999
% 215.66/215.86  |- mesh__recordOriginator mesh__D012478 NLM
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D012478 1994
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D012478 2002
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D012478 2004
% 215.66/215.86  |- skos__hiddenLabel mesh__D012478 Food Poisonings, Salmonella
% 215.66/215.86  |- skos__altLabel mesh__D012478 Food Poisoning, Salmonella
% 215.66/215.86  |- skos__scopeNote mesh__D012478
% 215.66/215.86       Poisoning caused by ingestion of food harboring species of SALMONELLA. Conditions of raising, shipping, slaughtering, and marketing of domestic animals contribute to the spread of this bacterium in the food supply.%A%    
% 215.66/215.86  |- skos__hiddenLabel mesh__D012478 Poisoning, Salmonella Food
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D012478 1995
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D012478 1996
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D012478 2005
% 215.66/215.86  |- mesh__recordAuthorizer mesh__D012478 PLS
% 215.66/215.86  |- mesh__dateCreated mesh__D017961 1993-06-04
% 215.66/215.86  |- skos__scopeNote mesh__D017961
% 215.66/215.86       A subgenus of LENTIVIRUS comprising viruses that produce multi-organ disease with long incubation periods in horses.%A%    
% 215.66/215.86  |- skos__hiddenLabel mesh__D017961 Lentivirus, Equine
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D017961 2004
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D017961 2002
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D017961 2006
% 215.66/215.86  |- skos__altLabel mesh__D017961 Equine Lentiviruses
% 215.66/215.86  |- mesh__publicMeSHNote mesh__D017961 94   
% 215.66/215.86  |- skos__prefLabel mesh__D017961 Lentiviruses, Equine
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D017961 2003
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D017961 2001
% 215.66/215.86  |- skos__broader mesh__D017961smesh__D016086
% 215.66/215.86  |- rdf__type mesh__D017961sskos__Concept
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D017961 2005
% 215.66/215.86  |- skos__hiddenLabel mesh__D017961 Equine Lentivirus
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D017961 1997
% 215.66/215.86  |- skos__annotation mesh__D017961
% 215.66/215.86       a subgenus of the genus Lentivirus; infection: coord IM with LENTIVIRUS INFECTIONS %28%IM%29%%A%  
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D017961 1999
% 215.66/215.86  |- mesh__dateEstablished mesh__D017961 1994-01-01
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D017961 1996
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D017961 2000
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D017961 1995
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D017961 1998
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D017961 1994
% 215.66/215.86  |- mesh__historyNote mesh__D017961 94   
% 215.66/215.86  |- skos__scopeNote mesh__D017163
% 215.66/215.86       A genus of nematodes of the superfamily ASCARIDOIDEA. Its organisms are found in the stomachs of marine animals and birds. Human infection occurs by ingestion of raw fish that contain larvae.%A%    
% 215.66/215.86  |- rdf__type mesh__D017163sskos__Concept
% 215.66/215.86  |- mesh__recordMaintainer mesh__D017163 sjn
% 215.66/215.86  |- mesh__dateEstablished mesh__D017163 1993-01-01
% 215.66/215.86  |- skos__historyNote mesh__D017163 Nematoda %28%1966-1992%29%
% 215.66/215.86  |- mesh__publicMeSHNote mesh__D017163 93; was see NEMATODA 1989-92   
% 215.66/215.86  |- mesh__recordAuthorizer mesh__D017163 sjn
% 215.66/215.86  |- mesh__onlineNote mesh__D017163
% 215.66/215.86       use NEMATODA to search ANISAKIS 1989-92   
% 215.66/215.86  |- mesh__recordOriginator mesh__D017163 PXP
% 215.66/215.86  |- skos__annotation mesh__D017163
% 215.66/215.86       a genus of nematodes found in marine animals %26% birds; infection = ANISAKIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 215.66/215.86  |- skos__prefLabel mesh__D017163 Anisakis
% 215.66/215.86  |- skos__broader mesh__D017163smesh__D001199
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D017163 2005
% 215.66/215.86  |- mesh__dateRevised mesh__D017163 2004-07-13
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D017163 2006
% 215.66/215.86  |- skos__historyNote mesh__D017163 Ascaridoidea %28%1975-1988%29%
% 215.66/215.86  |- mesh__dateCreated mesh__D017163 1992-05-07
% 215.66/215.86  |- mesh__historyNote mesh__D017163 93; was see NEMATODA 1989-92   
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D003941 1999
% 215.66/215.86  |- skos__altLabel mesh__D003941 Technique, Ophthalmological Diagnostic
% 215.66/215.86  |- skos__altLabel mesh__D003941 Diagnostic Technique, Ophthalmological
% 215.66/215.86  |- skos__hiddenLabel mesh__D003941 Diagnostic Technique, Ophthalmologic
% 215.66/215.86  |- skos__hiddenLabel mesh__D003941 Technic, Ophthalmologic Diagnostic
% 215.66/215.86  |- skos__altLabel mesh__D003941 Techniques, Ophthalmological Diagnostic
% 215.66/215.86  |- skos__altLabel mesh__D003941 Diagnostic Techniques, Ophthalmologic
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D003941 2005
% 215.66/215.86  |- skos__altLabel mesh__D003941 Ophthalmological Diagnostic Technics
% 215.66/215.86  |- skos__hiddenLabel mesh__D003941 Ophthalmologic Diagnostic Technics
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D003941 2000
% 215.66/215.86  |- mesh__publicMeSHNote mesh__D003941 98   
% 215.66/215.86  |- skos__altLabel mesh__D003941 Diagnostic Technics, Ophthalmological
% 215.66/215.86  |- skos__hiddenLabel mesh__D003941 Techniques, Ophthalmologic Diagnostic
% 215.66/215.86  |- skos__hiddenLabel mesh__D003941 Technique, Ophthalmologic Diagnostic
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D003941 2006
% 215.66/215.86  |- mesh__recordAuthorizer mesh__D003941 SJN
% 215.66/215.86  |- skos__altLabel mesh__D003941 Technics, Ophthalmological Diagnostic
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D003941 2001
% 215.66/215.86  |- skos__altLabel mesh__D003941 Diagnostic Technics, Ophthalmologic
% 215.66/215.86  |- mesh__recordOriginator mesh__D003941 NLM
% 215.66/215.86  |- skos__altLabel mesh__D003941 Ophthalmological Diagnostic Techniques
% 215.66/215.86  |- mesh__dateCreated mesh__D003941 1999-01-01
% 215.66/215.86  |- skos__hiddenLabel mesh__D003941 Ophthalmologic Diagnostic Technique
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D003941 2002
% 215.66/215.86  |- skos__hiddenLabel mesh__D003941 Ophthalmologic Diagnostic Techniques
% 215.66/215.86  |- skos__hiddenLabel mesh__D003941 Technics, Ophthalmologic Diagnostic
% 215.66/215.86  |- skos__altLabel mesh__D003941 Technic, Ophthalmological Diagnostic
% 215.66/215.86  |- skos__altLabel mesh__D003941 Diagnostic Technic, Ophthalmological
% 215.66/215.86  |- skos__scopeNote mesh__D003941
% 215.66/215.86       Methods and procedures for the diagnosis of diseases of the eye or of vision disorders.%A%    
% 215.66/215.86  |- skos__hiddenLabel mesh__D003941 Diagnostic Technic, Ophthalmologic
% 215.66/215.86  |- skos__prefLabel mesh__D003941 Diagnostic Techniques, Ophthalmological
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D003941 2003
% 215.66/215.86  |- mesh__recordMaintainer mesh__D003941 TGC
% 215.66/215.86  |- mesh__historyNote mesh__D003941 98; use explode 1975-97   
% 215.66/215.86  |- skos__altLabel mesh__D003941 Ophthalmological Diagnostic Technic
% 215.66/215.86  |- mesh__dateEstablished mesh__D003941 1998-01-01
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D003941 1998
% 215.66/215.86  |- skos__altLabel mesh__D003941 Ophthalmological Diagnostic Technique
% 215.66/215.86  |- skos__hiddenLabel mesh__D003941 Ophthalmologic Diagnostic Technic
% 215.66/215.86  |- skos__historyNote mesh__D003941 specific technique %28%1966-1997%29%
% 215.66/215.86  |- skos__annotation mesh__D003941
% 215.66/215.86       diag of eye dis or vision disord; GEN or unspecified; prefer specifics; DF: DIAG TECHNIQUES OPHTHALMOL%A%  
% 215.66/215.86  |- rdf__type mesh__D003941sskos__Concept
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D003941 2004
% 215.66/215.86  |- mesh__dateRevised mesh__D003941 1997-06-20
% 215.66/215.86  |- skos__broader mesh__D003941smesh__D019937
% 215.66/215.86  |- skos__related mesh__D003143smesh__D049250
% 215.66/215.86  |- mesh__dateCreated mesh__D003143 1979-04-11
% 215.66/215.86  |- skos__altLabel mesh__D003143 Communication Aids for Handicapped
% 215.66/215.86  |- skos__hiddenLabel mesh__D003143 Text Telecommunications
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D003143 2005
% 215.66/215.86  |- mesh__publicMeSHNote mesh__D003143
% 215.66/215.86       93; was COMMUNICATION AIDS FOR HANDICAPPED 1980-92 %28%see under SELF-HELP DEVICES 1980-90%29%%A%  
% 215.66/215.86  |- skos__hiddenLabel mesh__D003143 Telecommunications, Text
% 215.66/215.86  |- skos__prefLabel mesh__D003143 Communication Aids for Disabled
% 215.66/215.86  |- skos__hiddenLabel mesh__D003143 Text Telephones
% 215.66/215.86  |- mesh__historyNote mesh__D003143
% 215.66/215.86       93; was COMMUNICATION AIDS FOR HANDICAPPED 1980-92 %28%see under SELF-HELP DEVICES 1980-90%29%%A%  
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D003143 2006
% 215.66/215.86  |- skos__hiddenLabel mesh__D003143 Communication Board
% 215.66/215.86  |- skos__broader mesh__D003143smesh__D012656
% 215.66/215.86  |- skos__hiddenLabel mesh__D003143 Synthesizers, Speech
% 215.66/215.86  |- skos__altLabel mesh__D003143 Text Telephone
% 215.66/215.86  |- skos__hiddenLabel mesh__D003143 Text Telecommunication Device
% 215.66/215.86  |- mesh__recordOriginator mesh__D003143 RC
% 215.66/215.86  |- mesh__recordAuthorizer mesh__D003143 sjn
% 215.66/215.86  |- mesh__recordMaintainer mesh__D003143 ags
% 215.66/215.86  |- skos__hiddenLabel mesh__D003143 Synthesizer, Speech
% 215.66/215.86  |- mesh__dateRevised mesh__D003143 2004-07-07
% 215.66/215.86  |- skos__historyNote mesh__D003143 Communication %28%1966-1979%29%
% 215.66/215.86  |- skos__historyNote mesh__D003143
% 215.66/215.86       Nonverbal Communication %28%1970-1979%29%
% 215.66/215.86  |- mesh__onlineNote mesh__D003143
% 215.66/215.86       use COMMUNICATION AIDS FOR DISABLED to search COMMUNICATION AIDS FOR HANDICAPPED 1980-92%A%  
% 215.66/215.86  |- skos__hiddenLabel mesh__D003143 Telecommunication, Text
% 215.66/215.86  |- skos__hiddenLabel mesh__D003143 Telecommunication Device, Text
% 215.66/215.86  |- skos__hiddenLabel mesh__D003143 Speech Synthesizer
% 215.66/215.86  |- skos__altLabel mesh__D003143 TTY Telephone
% 215.66/215.86  |- rdf__type mesh__D003143sskos__Concept
% 215.66/215.86  |- skos__hiddenLabel mesh__D003143 TTY Telephones
% 215.66/215.86  |- skos__scopeNote mesh__D003143
% 215.66/215.86       Equipment that provides mentally or physically disabled persons with a means of communication. The aids include display boards, typewriters, cathode ray tubes, computers, and speech synthesizers. The output of such aids includes written words, artificial speech, language signs, Morse code, and pictures.%A%    
% 215.66/215.86  |- skos__hiddenLabel mesh__D003143 Telecommunication Devices, Text
% 215.66/215.86  |- mesh__dateEstablished mesh__D003143 1991-01-01
% 215.66/215.86  |- skos__altLabel mesh__D003143 TDD
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D016869 2002
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D016869 1998
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D016869 2004
% 215.66/215.86  |- skos__scopeNote mesh__D016869
% 215.66/215.86       Infections with bacteria of the genus UREAPLASMA.     
% 215.66/215.86  |- mesh__dateCreated mesh__D016869 1991-05-30
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D016869 1995
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D016869 2003
% 215.66/215.86  |- skos__altLabel mesh__D016869 Infections, Ureaplasma
% 215.66/215.86  |- mesh__dateEstablished mesh__D016869 1992-01-01
% 215.66/215.86  |- mesh__recordMaintainer mesh__D016869 TAP
% 215.66/215.86  |- skos__historyNote mesh__D016869 Mycoplasma Infections %28%1977-1979%29%
% 215.66/215.86  |- mesh__dateRevised mesh__D016869 1993-06-03
% 215.66/215.86  |- mesh__recordAuthorizer mesh__D016869 PLS
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D016869 1994
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D016869 2001
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D016869 1997
% 215.66/215.86  |- mesh__recordOriginator mesh__D016869 PXP
% 215.66/215.86  |- mesh__publicMeSHNote mesh__D016869 92   
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D016869 2006
% 215.66/215.86  |- skos__hiddenLabel mesh__D016869 Ureaplasma Infection
% 215.66/215.86  |- skos__prefLabel mesh__D016869 Ureaplasma Infections
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D016869 2000
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D016869 1996
% 215.66/215.86  |- skos__historyNote mesh__D016869 Ureaplasma %28%1977-1991%29%
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D016869 2005
% 215.66/215.86  |- skos__hiddenLabel mesh__D016869 Infection, Ureaplasma
% 215.66/215.86  |- skos__annotation mesh__D016869
% 215.66/215.86       gram-neg bact infect; DF: UREAPLASMA INFECT   
% 215.66/215.86  |- mesh__historyNote mesh__D016869 92   
% 215.66/215.86  |- rdf__type mesh__D016869sskos__Concept
% 215.66/215.86  |- skos__historyNote mesh__D016869
% 215.66/215.86       Mycoplasmatales Infections %28%1980-1991%29%
% 215.66/215.86  |- skos__broader mesh__D016869smesh__D009180
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D016869 1999
% 215.66/215.86  |- mesh__historyNote mesh__D002849 66   
% 215.66/215.86  |- mesh__dateCreated mesh__D002849 1999-01-01
% 215.66/215.86  |- skos__scopeNote mesh__D002849
% 215.66/215.86       Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix.%A%    
% 215.66/215.86  |- skos__prefLabel mesh__D002849 Chromatography, Gas
% 215.66/215.86  |- mesh__publicMeSHNote mesh__D002849 66   
% 215.66/215.86  |- skos__hiddenLabel mesh__D002849 Gas-Liquid Chromatographies
% 215.66/215.86  |- mesh__recordOriginator mesh__D002849 NLM
% 215.66/215.86  |- skos__hiddenLabel mesh__D002849 Gas Chromatographies
% 215.66/215.86  |- mesh__recordMaintainer mesh__D002849 lkt
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D002849 2006
% 215.66/215.86  |- skos__annotation mesh__D002849
% 215.66/215.86       an anal chem technique; NIM; DF: CHROMATOGR GAS   
% 215.66/215.86  |- mesh__dateRevised mesh__D002849 2002-07-03
% 215.66/215.86  |- mesh__dateEstablished mesh__D002849 1966-01-01
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D002849 2004
% 215.66/215.86  |- skos__hiddenLabel mesh__D002849 Chromatography, Gas Liquid
% 215.66/215.86  |- skos__hiddenLabel mesh__D002849 Gas-Liquid Chromatography
% 215.66/215.86  |- skos__altLabel mesh__D002849 Gas Chromatography
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D002849 2005
% 215.66/215.86  |- skos__hiddenLabel mesh__D002849 Chromatographies, Gas
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D002849 2003
% 215.66/215.86  |- skos__broader mesh__D002849smesh__D002845
% 215.66/215.86  |- skos__hiddenLabel mesh__D002849 Chromatographies, Gas-Liquid
% 215.66/215.86  |- mesh__recordAuthorizer mesh__D002849 sjn
% 215.66/215.86  |- rdf__type mesh__D002849sskos__Concept
% 215.66/215.86  |- skos__broader mesh__D007534smesh__D004187
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D007534 2006
% 215.66/215.86  |- mesh__dateCreated mesh__D007534 1977-12-15
% 215.66/215.86  |- mesh__dateRevised mesh__D007534 2004-07-07
% 215.66/215.86  |- mesh__recordAuthorizer mesh__D007534 sjn
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D007534 2005
% 215.66/215.86  |- mesh__historyNote mesh__D007534
% 215.66/215.86       91%28%79%29%; was see under DISACCHARIDES 1979-90   
% 215.66/215.86  |- mesh__dateEstablished mesh__D007534 1991-01-01
% 215.66/215.86  |- mesh__publicMeSHNote mesh__D007534
% 215.66/215.86       91; was see under DISACCHARIDES 1979-90   
% 215.66/215.86  |- rdf__type mesh__D007534sskos__Concept
% 215.66/215.86  |- skos__prefLabel mesh__D007534 Isomaltose
% 215.66/215.86  |- mesh__recordMaintainer mesh__D007534 jmp
% 215.66/215.86  |- mesh__recordOriginator mesh__D007534 RLS
% 215.66/215.86  |- skos__broader mesh__D007534smesh__D005936
% 215.66/215.86  |- skos__historyNote mesh__D007534 Disaccharides %28%1966-1978%29%
% 215.66/215.86  |- skos__scopeNote mesh__D007534
% 215.66/215.86       A disaccharide consisting of two glucose units in an alpha %28%1-6%29% glycosidic linkage.%A%    
% 215.66/215.86  |- rdf__type mesh__D012479sskos__Concept
% 215.66/215.86  |- skos__prefLabel mesh__D012479 Salmonella paratyphi C
% 215.66/215.86  |- skos__annotation mesh__D012479
% 215.66/215.86       infection: coord IM with PARATYPHOID FEVER %28%IM%29%   
% 215.66/215.86  |- mesh__recordMaintainer mesh__D012479 ags
% 215.66/215.86  |- skos__historyNote mesh__D012479 Salmonella paratyphi A %28%1966-1974%29%
% 215.66/215.86  |- mesh__dateEstablished mesh__D012479 1991-01-01
% 215.66/215.86  |- mesh__recordAuthorizer mesh__D012479 sjn
% 215.66/215.86  |- skos__altLabel mesh__D012479 Salmonella enterica serovar Paratyphi C
% 215.66/215.86  |- mesh__historyNote mesh__D012479 2003, 1975   
% 215.66/215.86  |- skos__altLabel mesh__D012479 Salmonella hirschfeldii
% 215.66/215.86  |- mesh__dateRevised mesh__D012479 2005-06-30
% 215.66/215.86  |- skos__historyNote mesh__D012479 Salmonella %28%1974%29%
% 215.66/215.86  |- mesh__publicMeSHNote mesh__D012479
% 215.66/215.86       2003, 1975; see SALMONELLA HIRSCHFELDII 1991-2002, see SALMONELLA 1976-1990, see SALMONELLA PARATYPHI 1966-1974%A%  
% 215.66/215.86  |- skos__scopeNote mesh__D012479
% 215.66/215.86       A serotype of SALMONELLA ENTERICA which is an agent of PARATYPHOID FEVER in Asia, Africa, and southern Europe.%A%    
% 215.66/215.86  |- mesh__recordOriginator mesh__D012479 JW
% 215.66/215.86  |- skos__broader mesh__D012479smesh__D019779
% 215.66/215.86  |- mesh__dateCreated mesh__D012479 1975-07-23
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D012479 2006
% 215.66/215.86  |- skos__prefLabel mesh__D017962 alpha-Linolenic Acid
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D017962 2005
% 215.66/215.86  |- skos__hiddenLabel mesh__D017962 alpha Linolenic Acid
% 215.66/215.86  |- mesh__dateCreated mesh__D017962 1993-06-04
% 215.66/215.86  |- skos__hiddenLabel mesh__D017962 alpha Linolenic Acid, Ammonium Salt
% 215.66/215.86  |- skos__broader mesh__D017962smesh__D015525
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D017962 2004
% 215.66/215.86  |- mesh__recordMaintainer mesh__D017962 ssb
% 215.66/215.86  |- mesh__recordOriginator mesh__D017962 TPW
% 215.66/215.86  |- skos__hiddenLabel mesh__D017962 alpha Linolenic Acid, Zinc Salt
% 215.66/215.86  |- skos__hiddenLabel mesh__D017962 alpha Linolenic Acid, Potassium Salt
% 215.66/215.86  |- skos__hiddenLabel mesh__D017962 alpha Linolenic Acid, Magnesium Salt
% 215.66/215.86  |- skos__historyNote mesh__D017962 Linolenic Acids %28%1980-1993%29%
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D017962 2006
% 215.66/215.86  |- skos__broader mesh__D017962smesh__D008042
% 215.66/215.86  |- skos__scopeNote mesh__D017962
% 215.66/215.86       A fatty acid that is found in plants and involved in the formation of prostaglandins.%A%    
% 215.66/215.86  |- rdf__type mesh__D017962sskos__Concept
% 215.66/215.86  |- mesh__dateRevised mesh__D017962 2003-07-09
% 215.66/215.86  |- skos__hiddenLabel mesh__D017962 alpha Linolenic Acid, Lithium Salt
% 215.66/215.86  |- mesh__recordAuthorizer mesh__D017962 sjn
% 215.66/215.86  |- mesh__dateEstablished mesh__D017962 1994-01-01
% 215.66/215.86  |- skos__hiddenLabel mesh__D017962 alpha Linolenic Acid, Sodium Salt
% 215.66/215.86  |- skos__hiddenLabel mesh__D017962 alpha Linolenic Acid, Calcium Salt
% 215.66/215.86  |- mesh__publicMeSHNote mesh__D017962
% 215.66/215.86       94; ALPHA-LINOLENIC ACID was indexed under LINOLENIC ACIDS 1980-93%A%  
% 215.66/215.86  |- skos__annotation mesh__D017962
% 215.66/215.86       GAMMA-LINOLENIC ACID is an omega-6 fatty acid; DF: note short X ref%A%  
% 215.66/215.86  |- mesh__historyNote mesh__D017962
% 215.66/215.86       94; was ALPHA-LINOLENIC ACID %28%NM%29% 1980-93   
% 215.66/215.86  |- mesh__onlineNote mesh__D017962
% 215.66/215.86       use ALPHA-LINOLENIC ACID %28%NM%29% to search ALPHA-LINOLENIC ACID 1980-93%A%  
% 215.66/215.86  |- mesh__dateRevised mesh__D017164 2004-07-13
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D017164 2005
% 215.66/215.86  |- skos__annotation mesh__D017164
% 215.66/215.86       a species of nematode, the largest found in the human intestine; infection: coord IM with ASCARIASIS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 215.66/215.86  |- mesh__recordOriginator mesh__D017164 PXP
% 215.66/215.86  |- skos__prefLabel mesh__D017164 Ascaris lumbricoides
% 215.66/215.86  |- mesh__recordMaintainer mesh__D017164 sjn
% 215.66/215.86  |- mesh__dateEstablished mesh__D017164 1993-01-01
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D017164 2006
% 215.66/215.86  |- mesh__dateCreated mesh__D017164 1992-05-07
% 215.66/215.86  |- skos__scopeNote mesh__D017164
% 215.66/215.86       A species of parasitic nematode that is the largest found in the human intestine. Its distribution is worldwide, but it is more prevalent in areas of poor sanitation. Human infection with A. lumbricoides is acquired by swallowing fully embryonated eggs from contaminated soil.%A%    
% 215.66/215.86  |- rdf__type mesh__D017164sskos__Concept
% 215.66/215.86  |- mesh__historyNote mesh__D017164 93   
% 215.66/215.86  |- mesh__publicMeSHNote mesh__D017164 93   
% 215.66/215.86  |- mesh__recordAuthorizer mesh__D017164 sjn
% 215.66/215.86  |- skos__historyNote mesh__D017164 Ascaris %28%1966-1992%29%
% 215.66/215.86  |- skos__broader mesh__D017164smesh__D001200
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D003942 2001
% 215.66/215.86  |- skos__hiddenLabel mesh__D003942 Laboratory Procedure
% 215.66/215.86  |- mesh__recordMaintainer mesh__D003942 PXP
% 215.66/215.86  |- skos__broader mesh__D003942smesh__D003933
% 215.66/215.86  |- skos__altLabel mesh__D003942 Laboratory Technics and Procedures
% 215.66/215.86  |- mesh__recordOriginator mesh__D003942 NLM
% 215.66/215.86  |- skos__hiddenLabel mesh__D003942 Diagnoses, Laboratory
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D003942 2005
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D003942 2000
% 215.66/215.86  |- mesh__dateCreated mesh__D003942 1999-01-01
% 215.66/215.86  |- mesh__publicMeSHNote mesh__D003942
% 215.66/215.86       98; see DIAGNOSIS, LABORATORY 1963-97   
% 215.66/215.86  |- skos__hiddenLabel mesh__D003942 Procedure, Laboratory
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D003942 1999
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D003942 2004
% 215.66/215.86  |- rdf__type mesh__D003942sskos__Concept
% 215.66/215.86  |- skos__scopeNote mesh__D003942
% 215.66/215.86       Methods, procedures, and tests performed in the laboratory with an intended application to the diagnosis of disease or understanding of physiological functioning. The techniques include examination of microbiological, cytological, chemical, and biochemical specimens, normal and pathological.%A%    
% 215.66/215.86  |- skos__altLabel mesh__D003942 Techniques and Procedures, Laboratory
% 215.66/215.86  |- skos__altLabel mesh__D003942 Diagnosis, Laboratory
% 215.66/215.86  |- skos__altLabel mesh__D003942 Technics and Procedures, Laboratory
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D003942 1998
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D003942 2003
% 215.66/215.86  |- mesh__recordAuthorizer mesh__D003942 SJN
% 215.66/215.86  |- skos__annotation mesh__D003942 GEN: prefer specifics; Manual 26.7   
% 215.66/215.86  |- skos__prefLabel mesh__D003942 Laboratory Techniques and Procedures
% 215.66/215.86  |- skos__related mesh__D003942smesh__D019411
% 215.66/215.86  |- mesh__historyNote mesh__D003942 98%28%63%29%   
% 215.66/215.86  |- skos__altLabel mesh__D003942 Diagnoses and Laboratory Examinations
% 215.66/215.86  |- skos__hiddenLabel mesh__D003942 Laboratory Diagnoses
% 215.66/215.86  |- skos__hiddenLabel mesh__D003942 Procedures, Laboratory
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D003942 2002
% 215.66/215.86  |- mesh__dateRevised mesh__D003942 1997-06-20
% 215.66/215.86  |- mesh__onlineNote mesh__D003942
% 215.66/215.86       pre-explosion = LABORATORY TECHNIQUES A%23%D PROCEDURES %28%PX%29%%A%  
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D003942 2006
% 215.66/215.86  |- mesh__recordMaintainer mesh__D050598 DRC
% 215.66/215.86  |- mesh__recordOriginator mesh__D050598 DRC
% 215.66/215.86  |- mesh__recordAuthorizer mesh__D050598 sjn
% 215.66/215.86  |- mesh__activeMeSHYear mesh__D050598 2006
% 215.66/215.86  |- rdf__type mesh__D050598sskos__Concept
% 215.66/215.86  |- skos__altLabel mesh__D050598
% 215.66/215.86       Brain-Specific Na-Dependent Inorganic Phosphate Cotransporter
% 215.66/215.87  |- skos__historyNote mesh__D050598 Membrane Transport Proteins %28%2005%29%
% 215.66/215.87  |- skos__hiddenLabel mesh__D050598
% 215.66/215.87       Brain Specific Na Dependent Inorganic Phosphate Cotransporter
% 215.66/215.87  |- skos__altLabel mesh__D050598 VGLUT1 Protein
% 215.66/215.87  |- skos__prefLabel mesh__D050598 Vesicular Glutamate Transport Protein 1
% 215.66/215.87  |- skos__altLabel mesh__D050598 Vesicular Glutamate Transporter 1
% 215.66/215.87  |- mesh__dateEstablished mesh__D050598 2006-01-01
% 215.66/215.87  |- mesh__publicMeSHNote mesh__D050598
% 215.66/215.87       2006; VESICULAR GLUTAMATE TRANSPORTER 1 was indexed under MEMBRANE TRANSPORT PROTEINS 2005, under VESICULAR TRANSPORT PROTEINS 2004-2005, %26% under CARRIER PROTEINS 2001-2004%A%  
% 215.66/215.87  |- skos__historyNote mesh__D050598
% 215.66/215.87       Vesicular Transport Proteins %28%2004%29%
% 215.66/215.87  |- skos__broader mesh__D050598smesh__D050496
% 215.66/215.87  |- skos__historyNote mesh__D050598 Carrier Proteins %28%2001-2004%29%
% 215.66/215.87  |- skos__annotation mesh__D050598 see SCR for organism-specific terms   
% 215.66/215.87  |- mesh__historyNote mesh__D050598 2006%28%2001%29%   
% 215.66/215.87  |- skos__scopeNote mesh__D050598
% 215.66/215.87       A vesicular glutamate transporter protein that is predominately expressed in TELENCEPHALON of the BRAIN.%A%    
% 215.66/215.87  |- skos__altLabel mesh__D050598 BNPI Protein
% 215.66/215.87  |- mesh__dateCreated mesh__D050598 2005-06-30
% 215.66/215.87  |- skos__hiddenLabel mesh__D003144 Communication Barrier
% 215.66/215.87  |- mesh__historyNote mesh__D003144
% 215.66/215.87       91%28%79%29%; was see under COMMUNICATION 1979-90   
% 215.66/215.87  |- mesh__dateCreated mesh__D003144 1978-05-04
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003144 2003
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003144 2006
% 215.66/215.87  |- skos__prefLabel mesh__D003144 Communication Barriers
% 215.66/215.87  |- skos__hiddenLabel mesh__D003144 Barrier, Communication
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003144 2004
% 215.66/215.87  |- mesh__publicMeSHNote mesh__D003144
% 215.66/215.87       91; was see under COMMUNICATION 1979-90   
% 215.66/215.87  |- rdf__type mesh__D003144sskos__Concept
% 215.66/215.87  |- mesh__dateRevised mesh__D003144 2002-07-02
% 215.66/215.87  |- skos__hiddenLabel mesh__D003144 Barriers, Communication
% 215.66/215.87  |- skos__annotation mesh__D003144
% 215.66/215.87       language, cultural, sociol, etc., communication barriers; no qualif; coord IM with specific %22%barrier%22% if pertinent %28%IM%29% but if language is the barrier, note that MULTILINGUALISM is also available%A%  
% 215.66/215.87  |- skos__broader mesh__D003144smesh__D003142
% 215.66/215.87  |- mesh__recordMaintainer mesh__D003144 TGC
% 215.66/215.87  |- mesh__dateEstablished mesh__D003144 1991-01-01
% 215.66/215.87  |- mesh__recordAuthorizer mesh__D003144 sjn
% 215.66/215.87  |- skos__historyNote mesh__D003144 Communication %28%1966-1978%29%
% 215.66/215.87  |- skos__scopeNote mesh__D003144
% 215.66/215.87       Those factors, such as language or sociocultural relationships, which interfere in the meaningful interpretation and transmission of ideas between individuals or groups.%A%    
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003144 2005
% 215.66/215.87  |- mesh__recordOriginator mesh__D003144 EC
% 215.66/215.87  |- skos__broader mesh__D009141Q000254smesh__D009141
% 215.66/215.87  |- mesh__preferredCombination mesh__D009141Q000254smesh__D041641
% 215.66/215.87  |- rdf__type mesh__D009141Q000254smesh__CompoundConcept
% 215.66/215.87  |- skos__broader mesh__D013572smesh__D022161
% 215.66/215.87  |- mesh__dateCreated mesh__D013572 1999-01-01
% 215.66/215.87  |- skos__scopeNote mesh__D013572
% 215.66/215.87       Membrane-bound compartments which contain transmitter molecules. Synaptic vesicles are concentrated at presynaptic terminals. They actively sequester transmitter molecules from the cytoplasm. In at least some synapses, transmitter release occurs by fusion of these vesicles with the presynaptic membrane, followed by exocytosis of their contents.%A%    
% 215.66/215.87  |- skos__hiddenLabel mesh__D013572 Vesicle, Synaptic
% 215.66/215.87  |- mesh__publicMeSHNote mesh__D013572 72   
% 215.66/215.87  |- skos__hiddenLabel mesh__D013572 Synaptic Vesicle
% 215.66/215.87  |- skos__historyNote mesh__D013572 Cytoplasmic Granules %28%1966-1969%29%
% 215.66/215.87  |- skos__broader mesh__D013572smesh__D013569
% 215.66/215.87  |- skos__hiddenLabel mesh__D013572 Vesicles, Synaptic
% 215.66/215.87  |- mesh__recordAuthorizer mesh__D013572 sjn
% 215.66/215.87  |- skos__historyNote mesh__D013572 Synapses %28%1966-1969%29%
% 215.66/215.87  |- mesh__recordOriginator mesh__D013572 NLM
% 215.66/215.87  |- skos__annotation mesh__D013572
% 215.66/215.87       A 11 qualif except /cytol; /genet permitted   
% 215.66/215.87  |- mesh__recordMaintainer mesh__D013572 nns
% 215.66/215.87  |- mesh__dateEstablished mesh__D013572 1972-01-01
% 215.66/215.87  |- skos__prefLabel mesh__D013572 Synaptic Vesicles
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D013572 2005
% 215.66/215.87  |- rdf__type mesh__D013572sskos__Concept
% 215.66/215.87  |- mesh__dateRevised mesh__D013572 2003-07-09
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D013572 2004
% 215.66/215.87  |- mesh__historyNote mesh__D013572 72%28%70%29%   
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D013572 2006
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D007535 2006
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D007535 2004
% 215.66/215.87  |- skos__broader mesh__D007535smesh__D004798
% 215.66/215.87  |- mesh__dateRevised mesh__D007535 2003-07-09
% 215.66/215.87  |- mesh__recordAuthorizer mesh__D007535 sjn
% 215.66/215.87  |- skos__scopeNote mesh__D007535
% 215.66/215.87       A class of enzymes that catalyze geometric or structural changes within a molecule to form a single product. The reactions do not involve a net change in the concentrations of compounds other than the substrate and the product.%28%from Dorland, 28th ed%29% EC 5.%A%    
% 215.66/215.87  |- rdf__type mesh__D007535sskos__Concept
% 215.66/215.87  |- mesh__recordMaintainer mesh__D007535 ssb
% 215.66/215.87  |- mesh__recordOriginator mesh__D007535 NLM
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D007535 2005
% 215.66/215.87  |- mesh__dateCreated mesh__D007535 1999-01-01
% 215.66/215.87  |- skos__prefLabel mesh__D007535 Isomerases
% 215.66/215.87  |- skos__annotation mesh__D007535
% 215.66/215.87       GEN only; see Tree D8 under ISOMERASES %26% choose the most specific%A%  
% 215.66/215.87  |- skos__prefLabel mesh__D017963 Azithromycin
% 215.66/215.87  |- mesh__onlineNote mesh__D017963
% 215.66/215.87       use AZITHROMYCIN %28%NM%29% to search AZITHROMYCIN 1987-93   
% 215.66/215.87  |- mesh__dateEstablished mesh__D017963 1994-01-01
% 215.66/215.87  |- skos__altLabel mesh__D017963 Azythromycin
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D017963 2006
% 215.66/215.87  |- skos__altLabel mesh__D017963 Zitromax
% 215.66/215.87  |- skos__altLabel mesh__D017963 Azitrocin
% 215.66/215.87  |- mesh__historyNote mesh__D017963
% 215.66/215.87       94; was AZITHROMYCIN %28%NM%29% 1987-93   
% 215.66/215.87  |- rdf__type mesh__D017963sskos__Concept
% 215.66/215.87  |- skos__altLabel mesh__D017963 Lesvi Brand of Azithromycin Dihydrate
% 215.66/215.87  |- mesh__dateCreated mesh__D017963 1993-06-04
% 215.66/215.87  |- skos__hiddenLabel mesh__D017963 Monohydrate, Azithromycin
% 215.66/215.87  |- mesh__recordMaintainer mesh__D017963 ssb
% 215.66/215.87  |- mesh__recordOriginator mesh__D017963 TPW
% 215.66/215.87  |- mesh__publicMeSHNote mesh__D017963
% 215.66/215.87       94; AZITHROMYCIN was indexed under ERYTHROMYCIN/*analogs %26% derivatives 1987-93%A%  
% 215.66/215.87  |- mesh__dateRevised mesh__D017963 2004-07-07
% 215.66/215.87  |- skos__historyNote mesh__D017963
% 215.66/215.87       Erythromycin/analogs %26% derivatives %28%1987-1993%29%
% 215.66/215.87  |- skos__hiddenLabel mesh__D017963 Dihydrate, Azithromycin
% 215.66/215.87  |- skos__broader mesh__D017963smesh__D004917
% 215.66/215.87  |- skos__altLabel mesh__D017963 Bayer Brand of Azithromycin Dihydrate
% 215.66/215.87  |- skos__altLabel mesh__D017963 Pharmacia Brand of Azithromycin Dihydrate
% 215.66/215.87  |- skos__altLabel mesh__D017963 Pfizer Brand of Azithromycin Dihydrate
% 215.66/215.87  |- skos__altLabel mesh__D017963 Pfizer Brand of Azithromycin
% 215.66/215.87  |- skos__altLabel mesh__D017963 Funk Brand of Azithromycin Dihydrate
% 215.66/215.87  |- mesh__recordAuthorizer mesh__D017963 sjn
% 215.66/215.87  |- skos__altLabel mesh__D017963 Ultreon
% 215.66/215.87  |- skos__altLabel mesh__D017963 Mack Brand of Azithromycin Dihydrate
% 215.66/215.87  |- skos__scopeNote mesh__D017963
% 215.66/215.87       A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis.%A%    
% 215.66/215.87  |- skos__hiddenLabel mesh__D017963 CP 62993
% 215.66/215.87  |- skos__altLabel mesh__D017963 Azadose
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D017963 2005
% 215.66/215.87  |- skos__altLabel mesh__D017963 Vita Brand of Azithromycin Dihydrate
% 215.66/215.87  |- skos__hiddenLabel mesh__D017963 CP62993
% 215.66/215.87  |- skos__hiddenLabel mesh__D017963 Azithromycin Pfizer Brand
% 215.66/215.87  |- mesh__publicMeSHNote mesh__D017165 93   
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D017165 2005
% 215.66/215.87  |- skos__historyNote mesh__D017165 Ascaris %28%1966-1992%29%
% 215.66/215.87  |- mesh__recordAuthorizer mesh__D017165 sjn
% 215.66/215.87  |- mesh__recordOriginator mesh__D017165 PXP
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D017165 2006
% 215.66/215.87  |- mesh__dateRevised mesh__D017165 2004-07-13
% 215.66/215.87  |- mesh__dateCreated mesh__D017165 1992-05-07
% 215.66/215.87  |- rdf__type mesh__D017165sskos__Concept
% 215.66/215.87  |- mesh__recordMaintainer mesh__D017165 sjn
% 215.66/215.87  |- mesh__historyNote mesh__D017165 93   
% 215.66/215.87  |- mesh__dateEstablished mesh__D017165 1993-01-01
% 215.66/215.87  |- skos__broader mesh__D017165smesh__D001200
% 215.66/215.87  |- skos__annotation mesh__D017165
% 215.66/215.87       a species of nematode usually found in pigs, transmissible to humans; infection: coord IM with ASCARIASIS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 215.66/215.87  |- skos__prefLabel mesh__D017165 Ascaris suum
% 215.66/215.87  |- skos__scopeNote mesh__D017165
% 215.66/215.87       A species of parasitic nematode usually found in domestic pigs and a few other animals. Human infection can also occur, presumably as result of handling pig manure, and can lead to intestinal obstruction.%A%    
% 215.66/215.87  |- skos__broader mesh__D003943smesh__D019937
% 215.66/215.87  |- skos__hiddenLabel mesh__D003943 Techniques, Neurologic Diagnostic
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003943 2005
% 215.66/215.87  |- skos__altLabel mesh__D003943 Technic, Neurological Diagnostic
% 215.66/215.87  |- skos__hiddenLabel mesh__D003943 Neurologic Diagnostic Technics
% 215.66/215.87  |- skos__altLabel mesh__D003943 Diagnostic Technique, Neurological
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003943 2000
% 215.66/215.87  |- mesh__recordMaintainer mesh__D003943 MSR
% 215.66/215.87  |- skos__altLabel mesh__D003943 Diagnostic Technic, Neurological
% 215.66/215.87  |- skos__hiddenLabel mesh__D003943 Diagnostic Technique, Neurologic
% 215.66/215.87  |- mesh__publicMeSHNote mesh__D003943 98   
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003943 2006
% 215.66/215.87  |- skos__hiddenLabel mesh__D003943 Diagnostic Technic, Neurologic
% 215.66/215.87  |- skos__altLabel mesh__D003943 Neurological Diagnostic Techniques
% 215.66/215.87  |- skos__altLabel mesh__D003943 Neurological Diagnostic Technique
% 215.66/215.87  |- skos__hiddenLabel mesh__D003943 Technique, Neurologic Diagnostic
% 215.66/215.87  |- skos__altLabel mesh__D003943 Techniques, Neurological Diagnostic
% 215.66/215.87  |- mesh__recordAuthorizer mesh__D003943 SJN
% 215.66/215.87  |- mesh__dateRevised mesh__D003943 1998-06-10
% 215.66/215.87  |- mesh__dateCreated mesh__D003943 1999-01-01
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003943 2001
% 215.66/215.87  |- skos__scopeNote mesh__D003943
% 215.66/215.87       Methods and procedures for the diagnosis of diseases of the nervous system, central and peripheral, or demonstration of neurologic function or dysfunction.%A%    
% 215.66/215.87  |- mesh__recordOriginator mesh__D003943 NLM
% 215.66/215.87  |- skos__altLabel mesh__D003943 Diagnostic Techniques, Neurologic
% 215.66/215.87  |- skos__altLabel mesh__D003943 Technique, Neurological Diagnostic
% 215.66/215.87  |- skos__hiddenLabel mesh__D003943 Neurologic Diagnostic Technic
% 215.66/215.87  |- skos__altLabel mesh__D003943 Diagnostic Technics, Neurologic
% 215.66/215.87  |- skos__altLabel mesh__D003943 Technics, Neurological Diagnostic
% 215.66/215.87  |- skos__altLabel mesh__D003943 Neurological Diagnostic Technics
% 215.66/215.87  |- skos__hiddenLabel mesh__D003943 Technic, Neurologic Diagnostic
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003943 2002
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003943 2003
% 215.66/215.87  |- mesh__historyNote mesh__D003943 98; use explode 1975-97   
% 215.66/215.87  |- skos__altLabel mesh__D003943 Neurological Diagnostic Technic
% 215.66/215.87  |- mesh__dateEstablished mesh__D003943 1998-01-01
% 215.66/215.87  |- skos__prefLabel mesh__D003943 Diagnostic Techniques, Neurological
% 215.66/215.87  |- skos__annotation mesh__D003943
% 215.66/215.87       GEN or unspecified; prefer specifics; NEUROLOGIC EXAMINATION is also available; DF: DIAG TECHNIQUES NEUROL%A%  
% 215.66/215.87  |- skos__altLabel mesh__D003943 Diagnostic Technics, Neurological
% 215.66/215.87  |- skos__hiddenLabel mesh__D003943 Neurologic Diagnostic Technique
% 215.66/215.87  |- rdf__type mesh__D003943sskos__Concept
% 215.66/215.87  |- skos__hiddenLabel mesh__D003943 Technics, Neurologic Diagnostic
% 215.66/215.87  |- skos__historyNote mesh__D003943 specific technique %28%1966-1997%29%
% 215.66/215.87  |- skos__hiddenLabel mesh__D003943 Neurologic Diagnostic Techniques
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003943 2004
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003943 1999
% 215.66/215.87  |- skos__hiddenLabel mesh__D050599
% 215.66/215.87       Differentiation Associated Na Dependent Inorganic Phosphate Cotransporter
% 215.66/215.87  |- mesh__dateEstablished mesh__D050599 2006-01-01
% 215.66/215.87  |- skos__broader mesh__D050599smesh__D050496
% 215.66/215.87  |- mesh__publicMeSHNote mesh__D050599
% 215.66/215.87       2006; VESICULAR GLUTAMATE TRANSPORTER 2 was indexed under MEMBRANE TRANSPORT PROTEINS 2005, under VESICULAR TRANSPORT PROTEINS 2004-2005, under CARRIER PROTEINS 2001-2004%A%  
% 215.66/215.87  |- skos__annotation mesh__D050599 see SCR for organism-specific terms   
% 215.66/215.87  |- mesh__recordMaintainer mesh__D050599 DRC
% 215.66/215.87  |- mesh__dateCreated mesh__D050599 2005-06-30
% 215.66/215.87  |- skos__historyNote mesh__D050599 Membrane Transport Proteins %28%2005%29%
% 215.66/215.87  |- skos__prefLabel mesh__D050599 Vesicular Glutamate Transport Protein 2
% 215.66/215.87  |- skos__altLabel mesh__D050599 DNPI Protein
% 215.66/215.87  |- rdf__type mesh__D050599sskos__Concept
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D050599 2006
% 215.66/215.87  |- mesh__recordOriginator mesh__D050599 DRC
% 215.66/215.87  |- skos__historyNote mesh__D050599
% 215.66/215.87       Vesicular Transport Proteins %28%2004%29%
% 215.66/215.87  |- mesh__recordAuthorizer mesh__D050599 sjn
% 215.66/215.87  |- skos__scopeNote mesh__D050599
% 215.66/215.87       A vesicular glutamate transporter protein that is predominately expressed in the DIENCEPHALON and lower brainstem regions of the CENTRAL NERVOUS SYSTEM.%A%    
% 215.66/215.87  |- mesh__historyNote mesh__D050599 2006%28%2001%29%   
% 215.66/215.87  |- skos__altLabel mesh__D050599 Vesicular Glutamate Transporter 2
% 215.66/215.87  |- skos__altLabel mesh__D050599
% 215.66/215.87       Differentiation-Associated Na-Dependent Inorganic Phosphate Cotransporter
% 215.66/215.87  |- skos__altLabel mesh__D050599 VGLUT2 Protein
% 215.66/215.87  |- skos__historyNote mesh__D050599 Carrier Proteins %28%2001-2004%29%
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003145 1994
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003145 2001
% 215.66/215.87  |- mesh__dateCreated mesh__D003145 1978-12-14
% 215.66/215.87  |- rdf__type mesh__D003145sskos__Concept
% 215.66/215.87  |- mesh__recordMaintainer mesh__D003145 ags
% 215.66/215.87  |- skos__hiddenLabel mesh__D003145 Method, Total Communication
% 215.66/215.87  |- skos__hiddenLabel mesh__D003145 Total Communication Method
% 215.66/215.87  |- skos__broader mesh__D003145smesh__D012048
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003145 1992
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003145 1995
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003145 2002
% 215.66/215.87  |- skos__historyNote mesh__D003145 Communication %28%1966-1979%29%
% 215.66/215.87  |- skos__prefLabel mesh__D003145 Communication Methods, Total
% 215.66/215.87  |- mesh__historyNote mesh__D003145
% 215.66/215.87       91%28%80%29%; was see under REHABILITATION 1980-90   
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003145 1998
% 215.66/215.87  |- skos__historyNote mesh__D003145
% 215.66/215.87       Deafness %28%1966%29% /rehabilitation %28%1967-1979%29%
% 215.66/215.87  |- skos__hiddenLabel mesh__D003145 Communication Method, Total
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003145 1993
% 215.66/215.87  |- skos__hiddenLabel mesh__D003145 Methods, Total Communication
% 215.66/215.87  |- mesh__dateRevised mesh__D003145 1999-12-13
% 215.66/215.87  |- skos__scopeNote mesh__D003145
% 215.66/215.87       Utilization of all available receptive and expressive modes for the purpose of achieving communication with the hearing impaired, such as gestures, postures, facial expression, types of voice, formal speech and non-speech systems, and simultaneous communication.%A%    
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003145 1996
% 215.66/215.87  |- mesh__dateEstablished mesh__D003145 1991-01-01
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003145 2000A
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003145 1999
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003145 2005
% 215.66/215.87  |- mesh__recordAuthorizer mesh__D003145 ags
% 215.66/215.87  |- skos__altLabel mesh__D003145 Total Communication Methods
% 215.66/215.87  |- mesh__publicMeSHNote mesh__D003145
% 215.66/215.87       91; was see under REHABILITATION 1980-90   
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003145 1997
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003145 2003
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003145 2006
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003145 2000
% 215.66/215.87  |- mesh__recordOriginator mesh__D003145 RC
% 215.66/215.87  |- skos__annotation mesh__D003145
% 215.66/215.87       no qualif; restrict to commun with hearing-impaired; coord with specific hearing disord /rehabil%A%  
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003145 2004
% 215.66/215.87  |- skos__broader mesh__D013573smesh__D022004
% 215.66/215.87  |- mesh__dateCreated mesh__D013573 1985-05-23
% 215.66/215.87  |- skos__hiddenLabel mesh__D013573 Complex, Synaptinemal
% 215.66/215.87  |- mesh__dateRevised mesh__D013573 2005-06-30
% 215.66/215.87  |- skos__hiddenLabel mesh__D013573 Complex, Synaptonemal
% 215.66/215.87  |- skos__historyNote mesh__D013573 Cell Division %28%1966-1967%29%
% 215.66/215.87  |- mesh__dateEstablished mesh__D013573 1991-01-01
% 215.66/215.87  |- rdf__type mesh__D013573sskos__Concept
% 215.66/215.87  |- skos__altLabel mesh__D013573 Synaptinemal Complex
% 215.66/215.87  |- mesh__recordAuthorizer mesh__D013573 sjn
% 215.66/215.87  |- mesh__publicMeSHNote mesh__D013573 91; was see under MEIOSIS 1986-90   
% 215.66/215.87  |- mesh__recordOriginator mesh__D013573 AEP
% 215.66/215.87  |- skos__scopeNote mesh__D013573
% 215.66/215.87       The three-part structure of ribbon-like proteinaceous material that serves to align and join the paired homologous CHROMOSOMES. It is formed during the ZYGOTENE STAGE of the first meiotic division. It is a prerequisite for CROSSING OVER.%A%    
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D013573 2006
% 215.66/215.87  |- mesh__recordMaintainer mesh__D013573 nns
% 215.66/215.87  |- skos__broader mesh__D013573smesh__D023902
% 215.66/215.87  |- skos__prefLabel mesh__D013573 Synaptonemal Complex
% 215.66/215.87  |- mesh__historyNote mesh__D013573
% 215.66/215.87       91%28%86%29%; was see under MEIOSIS 1986-90   
% 215.66/215.87  |- skos__historyNote mesh__D013573 Meiosis %28%1968-1985%29%
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D007536 2004
% 215.66/215.87  |- mesh__publicMeSHNote mesh__D007536 74   
% 215.66/215.87  |- mesh__dateEstablished mesh__D007536 1974-01-01
% 215.66/215.87  |- skos__annotation mesh__D007536 NIM; no qualif   
% 215.66/215.87  |- mesh__recordMaintainer mesh__D007536 TPW
% 215.66/215.87  |- skos__broader mesh__D007536smesh__D002625
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D007536 2000
% 215.66/215.87  |- skos__prefLabel mesh__D007536 Isomerism
% 215.66/215.87  |- rdf__type mesh__D007536sskos__Concept
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D007536 2001
% 215.66/215.87  |- mesh__historyNote mesh__D007536 74%28%71%29%   
% 215.66/215.87  |- skos__hiddenLabel mesh__D007536 Isomerisms
% 215.66/215.87  |- mesh__recordAuthorizer mesh__D007536 PLS
% 215.66/215.87  |- skos__scopeNote mesh__D007536
% 215.66/215.87       The phenomenon whereby certain chemical compounds have structures that are different although the compounds possess the same elemental composition. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%    
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D007536 2002
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D007536 1998
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D007536 2005
% 215.66/215.87  |- mesh__dateCreated mesh__D007536 1999-01-01
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D007536 1999
% 215.66/215.87  |- skos__historyNote mesh__D007536 Chemistry, Organic %28%1966-1970%29%
% 215.66/215.87  |- mesh__dateRevised mesh__D007536 1996-06-10
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D007536 2006
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D007536 2003
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D007536 1997
% 215.66/215.87  |- mesh__recordOriginator mesh__D007536 NLM
% 215.66/215.87  |- skos__hiddenLabel mesh__D017964 R51211
% 215.66/215.87  |- mesh__recordAuthorizer mesh__D017964 sjn
% 215.66/215.87  |- mesh__dateEstablished mesh__D017964 1994-01-01
% 215.66/215.87  |- skos__scopeNote mesh__D017964
% 215.66/215.87       One of the triazole ANTIFUNGAL AGENTS that inhibits cytochrome P-450-dependent enzymes resulting in impairment of ERGOSTEROL synthesis.  It has been used against histoplasmosis, blastomycosis, cryptococcal meningitis %26% aspergillosis.%A%    
% 215.66/215.87  |- skos__historyNote mesh__D017964
% 215.66/215.87       Ketoconazole/analogs %26% derivatives %28%1984-1993%29%
% 215.66/215.87  |- mesh__onlineNote mesh__D017964
% 215.66/215.87       use ITRACONAZOLE %28%NM%29% to search ITRACONAZOLE 1984-93   
% 215.66/215.87  |- skos__broader mesh__D017964smesh__D010879
% 215.66/215.87  |- mesh__historyNote mesh__D017964
% 215.66/215.87       94; was ITRACONAZOLE %28%NM%29% 1984-93   
% 215.66/215.87  |- mesh__publicMeSHNote mesh__D017964
% 215.66/215.87       94; ITRACONAZOLE was indexed under KETOCONAZOLE/*analogs %26% derivatives 1984-93%A%  
% 215.66/215.87  |- skos__hiddenLabel mesh__D017964 R 51211
% 215.66/215.87  |- skos__broader mesh__D017964smesh__D014230
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D017964 2006
% 215.66/215.87  |- mesh__recordOriginator mesh__D017964 TPW
% 215.66/215.87  |- mesh__dateCreated mesh__D017964 1993-06-04
% 215.66/215.87  |- skos__prefLabel mesh__D017964 Itraconazole
% 215.66/215.87  |- mesh__recordMaintainer mesh__D017964 ssb
% 215.66/215.87  |- rdf__type mesh__D017964sskos__Concept
% 215.66/215.87  |- mesh__dateRevised mesh__D017964 2005-06-30
% 215.66/215.87  |- mesh__dateEstablished mesh__D017166 1993-01-01
% 215.66/215.87  |- mesh__dateCreated mesh__D017166 1992-05-22
% 215.66/215.87  |- skos__annotation mesh__D017166
% 215.66/215.87       a species of nematode found in the dog intestine; infection: coord IM with TOXOCARIASIS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 215.66/215.87  |- skos__prefLabel mesh__D017166 Toxocara canis
% 215.66/215.87  |- mesh__historyNote mesh__D017166 93   
% 215.66/215.87  |- mesh__dateRevised mesh__D017166 2003-07-09
% 215.66/215.87  |- mesh__publicMeSHNote mesh__D017166 93   
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D017166 2006
% 215.66/215.87  |- skos__broader mesh__D017166smesh__D014119
% 215.66/215.87  |- skos__historyNote mesh__D017166 Toxocara %28%1966-1992%29%
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D017166 2005
% 215.66/215.87  |- rdf__type mesh__D017166sskos__Concept
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D017166 2004
% 215.66/215.87  |- skos__scopeNote mesh__D017166
% 215.66/215.87       A species of parasitic nematode found in the intestine of dogs. Lesions in the brain, liver, eye, kidney, and lung are caused by migrating larvae. In humans, these larvae do not follow normal patterns and may produce visceral larva migrans %28%LARVA MIGRANS, VISCERAL%29%.%A%    
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Techniques, Obstetrical and Gynecological Diagnostic
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Obstetric and Gynecologic Diagnostic Technics
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Diagnostic Technics, Obstetrical and Gynecological
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Obstetric and Gynecologic Diagnostic Technique
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003944 2006
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Technique, Obstetric and Gynecologic Diagnostic
% 215.66/215.87  |- mesh__publicMeSHNote mesh__D003944 98   
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Technic, Obstetric and Gynecologic Diagnostic
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Obstetric and Gynecologic Diagnostic Techniques
% 215.66/215.87  |- skos__annotation mesh__D003944
% 215.66/215.87       avoid: too inclusive; prefer specifics; check the tag FEMALE %26% check the tags FEMALE %26% PREGNANCY when applicable; DF: DIAG TECHNIQUES OB GYN%A%  
% 215.66/215.87  |- mesh__dateRevised mesh__D003944 1997-06-20
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003944 2001
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Diagnostic Techniques, Obstetric and Gynecologic
% 215.66/215.87  |- mesh__recordOriginator mesh__D003944 NLM
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003944 2005
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Technique, Obstetrical and Gynecological Diagnostic
% 215.66/215.87  |- skos__scopeNote mesh__D003944
% 215.66/215.87       Methods and procedures for the diagnosis of conditions related to pregnancy, labor, and the puerperium and of diseases of the female genitalia. It includes also demonstration of genital and pregnancy physiology.%A%    
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Technic, Obstetrical and Gynecological Diagnostic
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Obstetrical and Gynecological Diagnostic Technique
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Obstetric and Gynecologic Diagnostic Technic
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Diagnostic Technique, Obstetric and Gynecologic
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Obstetrical and Gynecological Diagnostic Technics
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003944 2000
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Techniques, Obstetric and Gynecologic Diagnostic
% 215.66/215.87  |- mesh__dateCreated mesh__D003944 1999-01-01
% 215.66/215.87  |- skos__prefLabel mesh__D003944
% 215.66/215.87       Diagnostic Techniques, Obstetrical and Gynecological
% 215.66/215.87  |- rdf__type mesh__D003944sskos__Concept
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Diagnostic Technics, Obstetric and Gynecologic
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Obstetrical and Gynecological Diagnostic Techniques
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003944 2004
% 215.66/215.87  |- mesh__recordAuthorizer mesh__D003944 SJN
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Diagnostic Technic, Obstetrical and Gynecological
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Obstetrical and Gynecological Diagnostic Technic
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003944 1999
% 215.66/215.87  |- mesh__recordMaintainer mesh__D003944 TGC
% 215.66/215.87  |- mesh__historyNote mesh__D003944 98; use explode 1975-97   
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003944 2003
% 215.66/215.87  |- mesh__dateEstablished mesh__D003944 1998-01-01
% 215.66/215.87  |- mesh__onlineNote mesh__D003944
% 215.66/215.87       emphasis here is on technique; consider also GENITAL DISEASES, FEMALE /DI or /DI with specific gynecol dis %26% PREGNANCY COMPLICATIONS /DI %26% /DI with specific pregn compl%A%  
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Diagnostic Technique, Obstetrical and Gynecological
% 215.66/215.87  |- skos__broader mesh__D003944smesh__D019937
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003944 1998
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003944 2002
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Technics, Obstetric and Gynecologic Diagnostic
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Diagnostic Technic, Obstetric and Gynecologic
% 215.66/215.87  |- skos__historyNote mesh__D003944 specific technique %28%1966-1997%29%
% 215.66/215.87  |- skos__altLabel mesh__D003944
% 215.66/215.87       Technics, Obstetrical and Gynecological Diagnostic
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003146 2000
% 215.66/215.87  |- mesh__publicMeSHNote mesh__D003146 98   
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003146 1998
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003146 2001
% 215.66/215.87  |- skos__prefLabel mesh__D003146 Communications Media
% 215.66/215.87  |- skos__historyNote mesh__D003146 Mass Media %28%1978-1997%29%
% 215.66/215.87  |- skos__scopeNote mesh__D003146
% 215.66/215.87       The means of interchanging or transmitting and receiving information. Historically the media were written: books, journals, newspapers, and other publications; in the modern age the media include, in addition, radio, television, computers, and information networks.%A%    
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003146 1999
% 215.66/215.87  |- mesh__dateEstablished mesh__D003146 1998-01-01
% 215.66/215.87  |- skos__annotation mesh__D003146 GEN or unspecified; prefer specifics   
% 215.66/215.87  |- mesh__recordMaintainer mesh__D003146 TGC
% 215.66/215.87  |- mesh__historyNote mesh__D003146 98; use explode 1975-97   
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003146 2005
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003146 2002
% 215.66/215.87  |- mesh__recordOriginator mesh__D003146 NLM
% 215.66/215.87  |- skos__broader mesh__D003146smesh__D007254
% 215.66/215.87  |- skos__historyNote mesh__D003146 specific medium %28%1966-1997%29%
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003146 2006
% 215.66/215.87  |- mesh__dateRevised mesh__D003146 1997-06-20
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003146 2003
% 215.66/215.87  |- skos__historyNote mesh__D003146 Communication %28%1966-1997%29%
% 215.66/215.87  |- skos__hiddenLabel mesh__D003146 Media, Communications
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D003146 2004
% 215.66/215.87  |- mesh__recordAuthorizer mesh__D003146 SJN
% 215.66/215.87  |- rdf__type mesh__D003146sskos__Concept
% 215.66/215.87  |- mesh__dateCreated mesh__D003146 1999-01-01
% 215.66/215.87  |- mesh__dateCreated mesh__D049248 2004-07-07
% 215.66/215.87  |- rdf__type mesh__D049248sskos__Concept
% 215.66/215.87  |- skos__broader mesh__D049248smesh__D014950
% 215.66/215.87  |- skos__scopeNote mesh__D049248
% 215.66/215.87       Traumatic or experimentally induced separation of the head from the body in an animal or human.%A%    
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D049248 2005
% 215.66/215.87  |- mesh__publicMeSHNote mesh__D049248 2005   
% 215.66/215.87  |- mesh__recordAuthorizer mesh__D049248 sjn
% 215.66/215.87  |- mesh__recordMaintainer mesh__D049248 ags
% 215.66/215.87  |- mesh__dateEstablished mesh__D049248 2005-01-01
% 215.66/215.87  |- skos__prefLabel mesh__D049248 Decapitation
% 215.66/215.87  |- mesh__recordOriginator mesh__D049248 ags
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D049248 2006
% 215.66/215.87  |- mesh__historyNote mesh__D049248 2005   
% 215.66/215.87  |- skos__hiddenLabel mesh__D049248 Decapitations
% 215.66/215.87  |- skos__broader mesh__D013574smesh__D013347
% 215.66/215.87  |- mesh__dateRevised mesh__D013574 2000-06-22
% 215.66/215.87  |- mesh__recordAuthorizer mesh__D013574 sjn
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D013574 2002
% 215.66/215.87  |- mesh__recordOriginator mesh__D013574 NLM
% 215.66/215.87  |- mesh__activeMeSHYear mesh__D013574 2005
% 215.66/215.87  |- skos__hiddenLabel mesh__D013574 Synaptosome
% 215.66/215.87  |- mesh__dateCreated mesh__D013574 1999-01-01
% 215.66/215.87  |- skos__prefLabel mesh__D013574 Synaptosomes
% 215.66/215.88  |- skos__scopeNote mesh__D013574
% 215.66/215.88       Pinched-off nerve endings and their contents of vesicles and cytoplasm together with the attached subsynaptic area of the membrane of the post-synaptic cell. They are largely artificial structures produced by fractionation after selective centrifugation of nervous tissue homogenates.%A%    
% 215.66/215.88  |- skos__historyNote mesh__D013574 Nerve Endings %28%1966-1971%29%
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D013574 2001
% 215.66/215.88  |- mesh__recordMaintainer mesh__D013574 TAP
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D013574 2004
% 215.66/215.88  |- skos__annotation mesh__D013574 A 11 qualif except /cytol   
% 215.66/215.88  |- rdf__type mesh__D013574sskos__Concept
% 215.66/215.88  |- mesh__historyNote mesh__D013574 74%28%72%29%   
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D013574 2003
% 215.66/215.88  |- skos__historyNote mesh__D013574 Synaptic Vesicles %28%1970-1971%29%
% 215.66/215.88  |- mesh__dateEstablished mesh__D013574 1974-01-01
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D013574 2006
% 215.66/215.88  |- mesh__publicMeSHNote mesh__D013574 74   
% 215.66/215.88  |- mesh__historyNote mesh__D007537
% 215.66/215.88       91%28%84%29%; was see under MUSCLE CONTRACTION 1984-90; was EXERCISE, ISOMETRIC see under EXERTION 1977-83%A%  
% 215.66/215.88  |- mesh__recordAuthorizer mesh__D007537 sjn
% 215.66/215.88  |- skos__historyNote mesh__D007537 Exertion %28%1966-1976%29%
% 215.66/215.88  |- skos__hiddenLabel mesh__D007537 Contractions, Isometric
% 215.66/215.88  |- skos__prefLabel mesh__D007537 Isometric Contraction
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D007537 2005
% 215.66/215.88  |- mesh__recordOriginator mesh__D007537 MM
% 215.66/215.88  |- skos__hiddenLabel mesh__D007537 Isometric Contractions
% 215.66/215.88  |- mesh__dateEstablished mesh__D007537 1991-01-01
% 215.66/215.88  |- skos__broader mesh__D007537smesh__D009119
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D007537 2006
% 215.66/215.88  |- skos__scopeNote mesh__D007537
% 215.66/215.88       Muscular contractions characterized by increase in tension without change in length.%A%    
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D007537 2004
% 215.66/215.88  |- mesh__recordMaintainer mesh__D007537 nns
% 215.66/215.88  |- mesh__publicMeSHNote mesh__D007537
% 215.66/215.88       91; was see under MUSCLE CONTRACTION 1984-90; was EXERCISE, ISOMETRIC see under EXERTION 1977-83%A%  
% 215.66/215.88  |- mesh__onlineNote mesh__D007537
% 215.66/215.88       use ISOMETRIC CONTRACTION to search EXERCISE, ISOMETRIC 1977-83%A%  
% 215.66/215.88  |- skos__hiddenLabel mesh__D007537 Contraction, Isometric
% 215.66/215.88  |- mesh__dateRevised mesh__D007537 2003-07-09
% 215.66/215.88  |- skos__annotation mesh__D007537
% 215.66/215.88       do not confuse with ISOTONIC CONTRACTION   
% 215.66/215.88  |- rdf__type mesh__D007537sskos__Concept
% 215.66/215.88  |- mesh__dateCreated mesh__D007537 1976-04-27
% 215.66/215.88  |- mesh__recordMaintainer mesh__D017965 ssb
% 215.66/215.88  |- skos__hiddenLabel mesh__D017965 gamma Linolenic Acid
% 215.66/215.88  |- mesh__historyNote mesh__D017965
% 215.66/215.88       94; was GAMMA-LINOLENIC ACID %28%NM%29% 1980-93   
% 215.66/215.88  |- skos__scopeNote mesh__D017965
% 215.66/215.88       An omega-6 fatty acid produced in the body as the delta 6-desaturase metabolite of linoleic acid. It is converted to dihomo-gamma-linolenic acid, a biosynthetic precursor of monoenoic prostaglandins such as PGE1. %28%From Merck Index, 11th ed%29%%A%    
% 215.66/215.88  |- skos__hiddenLabel mesh__D017965 gamma Linolenic Acid, Ammonium Salt
% 215.66/215.88  |- skos__hiddenLabel mesh__D017965 gamma Linolenic Acid, Indium Salt
% 215.66/215.88  |- skos__broader mesh__D017965smesh__D043371
% 215.66/215.88  |- skos__hiddenLabel mesh__D017965 gamma Linolenic Acid, Sodium Salt
% 215.66/215.88  |- skos__prefLabel mesh__D017965 gamma-Linolenic Acid
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D017965 2005
% 215.66/215.88  |- mesh__publicMeSHNote mesh__D017965
% 215.66/215.88       94; GAMMA-LINOLENIC ACID was indexed under LINOLENIC ACIDS 1980-93%A%  
% 215.66/215.88  |- mesh__recordAuthorizer mesh__D017965 sjn
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D017965 2004
% 215.66/215.88  |- mesh__dateEstablished mesh__D017965 1994-01-01
% 215.66/215.88  |- skos__hiddenLabel mesh__D017965 gamma Linolenic Acid, Zinc Salt
% 215.66/215.88  |- skos__historyNote mesh__D017965 Linolenic Acids %28%1980-1993%29%
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D017965 2006
% 215.66/215.88  |- rdf__type mesh__D017965sskos__Concept
% 215.66/215.88  |- mesh__dateRevised mesh__D017965 2003-07-09
% 215.66/215.88  |- skos__hiddenLabel mesh__D017965 gamma Linolenic Acid, Cerium Salt
% 215.66/215.88  |- skos__hiddenLabel mesh__D017965 gamma Linolenic Acid, Lithium Salt
% 215.66/215.88  |- mesh__onlineNote mesh__D017965
% 215.66/215.88       use GAMMA-LINOLENIC ACID %28%NM%29% to search GAMMA-LINOLENIC ACID 1980-93%A%  
% 215.66/215.88  |- mesh__recordOriginator mesh__D017965 TPW
% 215.66/215.88  |- skos__annotation mesh__D017965
% 215.66/215.88       ALPHA-LINOLENIC ACID is an omega-3 fatty acid   
% 215.66/215.88  |- mesh__dateCreated mesh__D017965 1993-06-04
% 215.66/215.88  |- skos__broader mesh__D017965smesh__D008042
% 215.66/215.88  |- skos__hiddenLabel mesh__D017965 gamma Linolenic Acid, Potassium Salt
% 215.66/215.88  |- mesh__dateRevised mesh__D017167 2003-07-09
% 215.66/215.88  |- mesh__dateEstablished mesh__D017167 1993-01-01
% 215.66/215.88  |- mesh__historyNote mesh__D017167 93   
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D017167 2006
% 215.66/215.88  |- mesh__dateCreated mesh__D017167 1992-05-22
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D017167 2005
% 215.66/215.88  |- skos__scopeNote mesh__D017167
% 215.66/215.88       An order of nematodes of the subclass SECERNENTEA. Its organisms are characterized by a single, ventral excretory gland and a relatively stout, short body.%A%    
% 215.66/215.88  |- skos__broader mesh__D017167smesh__D017161
% 215.66/215.88  |- rdf__type mesh__D017167sskos__Concept
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D017167 2004
% 215.66/215.88  |- mesh__publicMeSHNote mesh__D017167 93   
% 215.66/215.88  |- skos__prefLabel mesh__D017167 Oxyurida
% 215.66/215.88  |- skos__annotation mesh__D017167
% 215.66/215.88       an order of nematodes; infection = OXYURIDA INFECTIONS   
% 215.66/215.88  |- skos__hiddenLabel mesh__D003945 Oral Diagnoses
% 215.66/215.88  |- skos__hiddenLabel mesh__D003945 Examinations, Oral
% 215.66/215.88  |- skos__hiddenLabel mesh__D003945 Oral Examinations
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D003945 2002
% 215.66/215.88  |- mesh__dateEstablished mesh__D003945 1965-01-01
% 215.66/215.88  |- skos__related mesh__D003945smesh__D011861
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D003945 2005
% 215.66/215.88  |- mesh__dateRevised mesh__D003945 1997-06-20
% 215.66/215.88  |- skos__broader mesh__D003945smesh__D003813
% 215.66/215.88  |- mesh__recordMaintainer mesh__D003945 PXP
% 215.66/215.88  |- mesh__dateCreated mesh__D003945 1999-01-01
% 215.66/215.88  |- skos__prefLabel mesh__D003945 Diagnosis, Oral
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D003945 2006
% 215.66/215.88  |- skos__altLabel mesh__D003945 Oral Examination
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D003945 2000
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D003945 1998
% 215.66/215.88  |- skos__altLabel mesh__D003945 Oral Diagnosis
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D003945 2003
% 215.66/215.88  |- mesh__publicMeSHNote mesh__D003945 65   
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D003945 2001
% 215.66/215.88  |- skos__annotation mesh__D003945
% 215.66/215.88       GEN or unspecified; avoid as NIM coord: prefer /diag with specific mouth or tooth dis; includes both clinical %26% radiogr exam of mouth but for radiogr of teeth use RADIOGRAPHY, DENTAL; DF: DIAG ORAL%A%  
% 215.66/215.88  |- skos__hiddenLabel mesh__D003945 Diagnoses, Oral
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D003945 1999
% 215.66/215.88  |- mesh__recordOriginator mesh__D003945 NLM
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D003945 2004
% 215.66/215.88  |- rdf__type mesh__D003945sskos__Concept
% 215.66/215.88  |- mesh__recordAuthorizer mesh__D003945 SJN
% 215.66/215.88  |- skos__scopeNote mesh__D003945
% 215.66/215.88       Examination of the mouth and teeth toward the identification and diagnosis of intraoral disease or manifestation of non-oral conditions.%A%    
% 215.66/215.88  |- mesh__historyNote mesh__D003945 65   
% 215.66/215.88  |- mesh__historyNote mesh__D003147 1998%28%1985%29%   
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D003147 2004
% 215.66/215.88  |- mesh__recordOriginator mesh__D003147 RC
% 215.66/215.88  |- skos__hiddenLabel mesh__D003147 Neurogenic Communication Disorder
% 215.66/215.88  |- mesh__recordMaintainer mesh__D003147 mdb
% 215.66/215.88  |- skos__hiddenLabel mesh__D003147 Communication Disorder
% 215.66/215.88  |- mesh__dateEstablished mesh__D003147 1985-01-01
% 215.66/215.88  |- skos__hiddenLabel mesh__D003147 Disability, Communication
% 215.66/215.88  |- skos__hiddenLabel mesh__D003147 Dysfunction, Communicative
% 215.66/215.88  |- skos__historyNote mesh__D003147 Hearing Disorders %28%1966-1984%29%
% 215.66/215.88  |- skos__hiddenLabel mesh__D003147 Childhood Communication Disorder
% 215.66/215.88  |- skos__altLabel mesh__D003147 Developmental Communication Disorders
% 215.66/215.88  |- skos__broader mesh__D003147smesh__D019952
% 215.66/215.88  |- skos__hiddenLabel mesh__D003147 Communication Disability
% 215.66/215.88  |- skos__hiddenLabel mesh__D003147 Communicative Disorder
% 215.66/215.88  |- skos__hiddenLabel mesh__D003147 Dysfunctions, Communicative
% 215.66/215.88  |- skos__hiddenLabel mesh__D003147 Disabilities, Communication
% 215.66/215.88  |- mesh__recordAuthorizer mesh__D003147 sjn
% 215.66/215.88  |- skos__scopeNote mesh__D003147
% 215.66/215.88       Disorders of verbal and nonverbal communication caused by receptive or expressive LANGUAGE DISORDERS, cognitive dysfunction %28%e.g., MENTAL RETARDATION%29%, psychiatric conditions, and HEARING DISORDERS.%A%    
% 215.66/215.88  |- mesh__dateRevised mesh__D003147 2001-07-25
% 215.66/215.88  |- skos__hiddenLabel mesh__D003147 Developmental Communication Disorder
% 215.66/215.88  |- rdf__type mesh__D003147sskos__Concept
% 215.66/215.88  |- skos__hiddenLabel mesh__D003147 Communicative Dysfunctions
% 215.66/215.88  |- skos__annotation mesh__D003147
% 215.66/215.88       GEN or unspecified: prefer specifics HEARING DISORDERS; LANGUAGE DISORDERS or SPEECH DISORDERS%A%  
% 215.66/215.88  |- skos__altLabel mesh__D003147 Communication Disorders, Childhood
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D003147 2005
% 215.66/215.88  |- skos__hiddenLabel mesh__D003147 Communication Disorder, Neurogenic
% 215.66/215.88  |- skos__hiddenLabel mesh__D003147 Communication Disorders, Acquired
% 215.66/215.88  |- skos__altLabel mesh__D003147 Communicative Disorders
% 215.66/215.88  |- skos__hiddenLabel mesh__D003147 Acquired Communication Disorder
% 215.66/215.88  |- skos__prefLabel mesh__D003147 Communication Disorders
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D003147 2006
% 215.66/215.88  |- skos__hiddenLabel mesh__D003147 Communication Disorder, Childhood
% 215.66/215.88  |- skos__historyNote mesh__D003147 Language Disorders %28%1967-1984%29%
% 215.66/215.88  |- mesh__dateCreated mesh__D003147 1984-04-11
% 215.66/215.88  |- skos__broader mesh__D003147smesh__D019954
% 215.66/215.88  |- skos__hiddenLabel mesh__D003147 Communication Disorder, Acquired
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D003147 2003
% 215.66/215.88  |- skos__altLabel mesh__D003147 Communication Disorders, Neurogenic
% 215.66/215.88  |- mesh__publicMeSHNote mesh__D003147
% 215.66/215.88       1998; see COMMUNICATIVE DISORDERS 1985-97   
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D003147 2002
% 215.66/215.88  |- skos__historyNote mesh__D003147 Speech Disorders %28%1966-1984%29%
% 215.66/215.88  |- skos__hiddenLabel mesh__D003147 Communication Disorder, Developmental
% 215.66/215.88  |- skos__hiddenLabel mesh__D008630 Poisonings, Mercury
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D008630 2006
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D008630 2000
% 215.66/215.88  |- mesh__recordOriginator mesh__D008630 NLM
% 215.66/215.88  |- skos__hiddenLabel mesh__D008630 Mercury Poisonings
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D008630 2003
% 215.66/215.88  |- skos__altLabel mesh__D008630 Poisoning, Mercury
% 215.66/215.88  |- skos__annotation mesh__D008630
% 215.66/215.88       GEN only: consider also /pois with specific mercury terms; occup mercury pois: coord IM with OCCUPATIONAL DISEASES %28%IM%29% but not also ENVIRONMENTAL EXPOSURE %28%see note there%29%%A%  
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D008630 2001
% 215.66/215.88  |- rdf__type mesh__D008630sskos__Concept
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D008630 2004
% 215.66/215.88  |- skos__broader mesh__D008630smesh__D011041
% 215.66/215.88  |- skos__prefLabel mesh__D008630 Mercury Poisoning
% 215.66/215.88  |- mesh__recordAuthorizer mesh__D008630 sjn
% 215.66/215.88  |- mesh__dateCreated mesh__D008630 1999-01-01
% 215.66/215.88  |- mesh__dateRevised mesh__D008630 1999-11-05
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D008630 2002
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D008630 2005
% 215.66/215.88  |- mesh__recordMaintainer mesh__D008630 KEV
% 215.66/215.88  |- mesh__recordMaintainer mesh__D022301 ssb
% 215.66/215.88  |- skos__broader mesh__D022301smesh__D022283
% 215.66/215.88  |- mesh__dateCreated mesh__D022301 2000-06-22
% 215.66/215.88  |- mesh__publicMeSHNote mesh__D022301 2001   
% 215.66/215.88  |- mesh__recordOriginator mesh__D022301 ags
% 215.66/215.88  |- skos__altLabel mesh__D022301 HSV Vaccines
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D022301 2006
% 215.66/215.88  |- rdf__type mesh__D022301sskos__Concept
% 215.66/215.88  |- skos__altLabel mesh__D022301 Simplexvirus Vaccines
% 215.66/215.88  |- mesh__historyNote mesh__D022301 2001   
% 215.66/215.88  |- skos__prefLabel mesh__D022301 Herpes Simplex Virus Vaccines
% 215.66/215.88  |- mesh__dateRevised mesh__D022301 2005-06-30
% 215.66/215.88  |- mesh__recordAuthorizer mesh__D022301 sjn
% 215.66/215.88  |- mesh__dateEstablished mesh__D022301 2001-01-01
% 215.66/215.88  |- skos__historyNote mesh__D022301 Viral Vaccines %28%1973-2000%29%
% 215.66/215.88  |- skos__annotation mesh__D022301
% 215.66/215.88       coord IM with specific simplexvirus /immunol %28%IM%29%   
% 215.66/215.88  |- skos__hiddenLabel mesh__D022301 Vaccines, HSV
% 215.66/215.88  |- skos__scopeNote mesh__D022301
% 215.66/215.88       Vaccines or candidate vaccines used to prevent infection with viruses from the genus SIMPLEXVIRUS. This includes vaccines for HSV-1 and HSV-2.%A%    
% 215.66/215.88  |- skos__hiddenLabel mesh__D022301 Vaccines, Simplexvirus
% 215.66/215.88  |- mesh__publicMeSHNote mesh__D049249 2005   
% 215.66/215.88  |- mesh__dateEstablished mesh__D049249 2005-01-01
% 215.66/215.88  |- mesh__recordOriginator mesh__D049249 ags
% 215.66/215.88  |- skos__hiddenLabel mesh__D049249 Exhumations
% 215.66/215.88  |- mesh__historyNote mesh__D049249 2005   
% 215.66/215.88  |- mesh__recordMaintainer mesh__D049249 ags
% 215.66/215.88  |- skos__related mesh__D049249smesh__D011180
% 215.66/215.88  |- skos__prefLabel mesh__D049249 Exhumation
% 215.66/215.88  |- skos__broader mesh__D049249smesh__D005554
% 215.66/215.88  |- skos__scopeNote mesh__D049249
% 215.66/215.88       Removal of a dead body from the earth after burial.     
% 215.66/215.88  |- mesh__recordAuthorizer mesh__D049249 sjn
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D049249 2006
% 215.66/215.88  |- skos__related mesh__D049249smesh__D018732
% 215.66/215.88  |- rdf__type mesh__D049249sskos__Concept
% 215.66/215.88  |- mesh__dateCreated mesh__D049249 2004-07-07
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D049249 2005
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Stokes-Adams Syncope
% 215.66/215.88  |- skos__prefLabel mesh__D013575 Syncope
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Syncopes, Situational
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Convulsive Syncope
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Episode, Syncopal
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Drop Attacks
% 215.66/215.88  |- mesh__recordAuthorizer mesh__D013575 ags
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Syncopes, Cardiogenic
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Syncopes, Stokes-Adams
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Convulsive Syncopes
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Syncopes, Tussive
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Deglutitional Syncope
% 215.66/215.88  |- mesh__recordOriginator mesh__D013575 NLM
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D013575 2005
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Syncopal Episodes
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Presyncopes
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D013575 2000
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Carotid Sinus Syncopes
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Situational Syncopes
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Stokes-Adams Syncopes
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Vertigos, Syncopal
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Hyperventilation Syncope
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Effort Syncopes
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Syncopes, Hyperventilation
% 215.66/215.88  |- skos__altLabel mesh__D013575 Fainting
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Hyperventilation Syncopes
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Vertigo, Syncopal
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Syncopes, Postural
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D013575 2006
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Cardiogenic Syncopes
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Syncopes, Effort
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Situational Syncope
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Syncope, Stokes Adams
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Tussive Syncopes
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D013575 2001
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D013575 2000A
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Syncopes, Micturition
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Syncopes
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Attack, Drop
% 215.66/215.88  |- skos__scopeNote mesh__D013575
% 215.66/215.88       A transient loss of consciousness and postural tone caused by diminished blood flow to the brain %28%i.e., BRAIN ISCHEMIA%29%. Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. %28%From Adams et al., Principles of Neurology, 6th ed, pp367-9%29%%A%    
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Syncopes, Deglutitional
% 215.66/215.88  |- rdf__type mesh__D013575sskos__Concept
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Cardiogenic Syncope
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D013575 2003
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Micturition Syncope
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Postural Syncopes
% 215.66/215.88  |- skos__broader mesh__D013575smesh__D014474
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D013575 2002
% 215.66/215.88  |- mesh__recordMaintainer mesh__D013575 ags
% 215.66/215.88  |- mesh__dateRevised mesh__D013575 1999-11-26
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Carotid Sinus Syncope
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Effort Syncope
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D013575 2004
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Syncopes, Carotid Sinus
% 215.66/215.88  |- skos__related mesh__D013575smesh__D014474
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Postural Syncope
% 215.66/215.88  |- mesh__dateCreated mesh__D013575 1999-01-01
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Tussive Syncope
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Deglutitional Syncopes
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Syncopes, Convulsive
% 215.66/215.88  |- skos__hiddenLabel mesh__D013575 Micturition Syncopes
% 215.66/215.88  |- skos__broader mesh__D007538smesh__D006834
% 215.66/215.88  |- skos__broader mesh__D007538smesh__D007539
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D007538 2005
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D007538 2002
% 215.66/215.88  |- mesh__dateCreated mesh__D007538 1999-01-01
% 215.66/215.88  |- skos__altLabel mesh__D007538 Isonicotinic Acid Hydrazide
% 215.66/215.88  |- skos__altLabel mesh__D007538 Ftivazide
% 215.66/215.88  |- mesh__historyNote mesh__D007538
% 215.66/215.88       /adv eff-pois-tox was ISONIAZID TOXICOLOGY 1963-65   
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D007538 2006
% 215.66/215.88  |- mesh__recordAuthorizer mesh__D007538 sjn
% 215.66/215.88  |- mesh__dateRevised mesh__D007538 2000-06-22
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D007538 2003
% 215.66/215.88  |- skos__hiddenLabel mesh__D007538 Hydrazide, Isonicotinic Acid
% 215.66/215.88  |- mesh__recordMaintainer mesh__D007538 CCR
% 215.66/215.88  |- mesh__publicMeSHNote mesh__D007538
% 215.66/215.88       /adverse effects /poisoning /toxicity were ISONIAZID TOXICOLOGY 1963-65%A%  
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D007538 2004
% 215.66/215.88  |- skos__prefLabel mesh__D007538 Isoniazid
% 215.66/215.88  |- mesh__recordOriginator mesh__D007538 NLM
% 215.66/215.88  |- rdf__type mesh__D007538sskos__Concept
% 215.66/215.88  |- skos__scopeNote mesh__D007538
% 215.66/215.88       Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.%A%    
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D007538 2001
% 215.66/215.88  |- skos__altLabel mesh__D018260 Serum Actin Inhibitory Protein
% 215.66/215.88  |- rdf__type mesh__D018260sskos__Concept
% 215.66/215.88  |- skos__altLabel mesh__D018260 Gelsolin Protein
% 215.66/215.88  |- mesh__dateRevised mesh__D018260 2005-06-30
% 215.66/215.88  |- mesh__dateCreated mesh__D018260 1993-06-03
% 215.66/215.88  |- skos__scopeNote mesh__D018260
% 215.66/215.88       A 90-kDa protein produced by macrophages that severs ACTIN filaments and forms a cap on the newly exposed filament end. Gelsolin is activated by CALCIUM ions and participates in the assembly and disassembly of actin, thereby increasing the motility of some CELLS.%A%    
% 215.66/215.88  |- mesh__recordOriginator mesh__D018260 PXP
% 215.66/215.88  |- mesh__recordMaintainer mesh__D018260 DRC
% 215.66/215.88  |- mesh__publicMeSHNote mesh__D018260
% 215.66/215.88       1994; GELSOLIN was indexed under CALCIUM-BINDING PROTEINS and MICROFILAMENT PROTEINS 1980-1993; SERUM ACTIN IHIBITORY PROTEIN was indexed under MICROFILAMENT PROTEINS 1988-2005, %26% under MUSCLE PROTEINS %26% PROTEINS 1986-1987%A%  
% 215.66/215.88  |- skos__prefLabel mesh__D018260 Gelsolin
% 215.66/215.88  |- skos__broader mesh__D018260smesh__D052139
% 215.66/215.88  |- mesh__recordAuthorizer mesh__D018260 sjn
% 215.66/215.88  |- mesh__dateEstablished mesh__D018260 1994-01-01
% 215.66/215.88  |- mesh__historyNote mesh__D018260 1994%28%1980%29%   
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D018260 2006
% 215.66/215.88  |- skos__broader mesh__D018260smesh__D008840
% 215.66/215.88  |- skos__scopeNote mesh__D004240
% 215.66/215.88       A pathological condition manifested as a pouch or sac opening from a tubular or saccular organ.%A%    
% 215.66/215.88  |- mesh__dateCreated mesh__D004240 1999-01-01
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D004240 2005
% 215.66/215.88  |- skos__annotation mesh__D004240
% 215.66/215.88       coord IM with precoord organ/dis term %28%IM%29% but note specifics are available%A%  
% 215.66/215.88  |- mesh__recordOriginator mesh__D004240 NLM
% 215.66/215.88  |- skos__altLabel mesh__D004240 Diverticula
% 215.66/215.88  |- rdf__type mesh__D004240sskos__Concept
% 215.66/215.88  |- mesh__historyNote mesh__D004240 92; was DIVERTICULOSIS 1963-91   
% 215.66/215.88  |- mesh__recordMaintainer mesh__D004240 jls
% 215.66/215.88  |- mesh__onlineNote mesh__D004240
% 215.66/215.88       use DIVERTICULUM to search DIVERTICULOSIS 1966-91   
% 215.66/215.88  |- skos__prefLabel mesh__D004240 Diverticulum
% 215.66/215.88  |- mesh__publicMeSHNote mesh__D004240 92; was DIVERTICULOSIS 1963-91   
% 215.66/215.88  |- mesh__recordAuthorizer mesh__D004240 sjn
% 215.66/215.88  |- mesh__dateRevised mesh__D004240 2004-07-19
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D004240 2006
% 215.66/215.88  |- skos__broader mesh__D004240smesh__D020763
% 215.66/215.88  |- skos__scopeNote mesh__D017966
% 215.66/215.88       Projection neurons in the cerebral cortex and the hippocampus. Pyramidal cells have a pyramid-shaped soma with the apex and an apical dendrite pointed toward the pial surface and other dendrites and an axon emerging from the base. The axons may have local collaterals but also project outside their cortical region.%A%    
% 215.66/215.88  |- skos__hiddenLabel mesh__D017966 Cell, Pyramidal
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D017966 2001
% 215.66/215.88  |- mesh__historyNote mesh__D017966 94   
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D017966 2004
% 215.66/215.88  |- mesh__dateRevised mesh__D017966 1999-11-03
% 215.66/215.88  |- skos__hiddenLabel mesh__D017966 Cells, Pyramidal
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D017966 2000
% 215.66/215.88  |- mesh__recordMaintainer mesh__D017966 ags
% 215.66/215.88  |- skos__prefLabel mesh__D017966 Pyramidal Cells
% 215.66/215.88  |- mesh__recordOriginator mesh__D017966 RAZ
% 215.66/215.88  |- skos__broader mesh__D017966smesh__D006624
% 215.66/215.88  |- skos__hiddenLabel mesh__D017966 Pyramidal Cell
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D017966 2003
% 215.66/215.88  |- mesh__dateEstablished mesh__D017966 1994-01-01
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D017966 2006
% 215.66/215.88  |- skos__broader mesh__D017966smesh__D002540
% 215.66/215.88  |- mesh__recordAuthorizer mesh__D017966 sjn
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D017966 2002
% 215.66/215.88  |- rdf__type mesh__D017966sskos__Concept
% 215.66/215.88  |- mesh__dateCreated mesh__D017966 1993-06-18
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D017966 2005
% 215.66/215.88  |- mesh__publicMeSHNote mesh__D017966 94   
% 215.66/215.88  |- skos__broader mesh__D017966smesh__D009474
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D017168 2005
% 215.66/215.88  |- mesh__publicMeSHNote mesh__D017168 93   
% 215.66/215.88  |- skos__scopeNote mesh__D017168
% 215.66/215.88       An order of nematodes of the subclass SECERNENTEA. Its organisms are characterized by an annulated or smooth cuticle and the absence of caudal glands.%A%    
% 215.66/215.88  |- skos__prefLabel mesh__D017168 Rhabditida
% 215.66/215.88  |- rdf__type mesh__D017168sskos__Concept
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D017168 2004
% 215.66/215.88  |- mesh__dateEstablished mesh__D017168 1993-01-01
% 215.66/215.88  |- skos__annotation mesh__D017168
% 215.66/215.88       an order of nematodes; do not confuse with the superfamily RHABDITOIDEA; infection = RHABDITIDA INFECTIONS%A%  
% 215.66/215.88  |- mesh__dateRevised mesh__D017168 2003-07-09
% 215.66/215.88  |- mesh__dateCreated mesh__D017168 1992-05-22
% 215.66/215.88  |- skos__broader mesh__D017168smesh__D017161
% 215.66/215.88  |- mesh__historyNote mesh__D017168 93   
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D017168 2006
% 215.66/215.88  |- mesh__dateRevised mesh__D003148 1999-11-03
% 215.66/215.88  |- skos__altLabel mesh__D003148 Marxism
% 215.66/215.88  |- skos__prefLabel mesh__D003148 Communism
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D003148 2002
% 215.66/215.88  |- mesh__recordMaintainer mesh__D003148 kle
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D003148 2004
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D003148 2001
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D003148 2006
% 215.66/215.88  |- mesh__dateCreated mesh__D003148 1999-01-01
% 215.66/215.88  |- skos__broader mesh__D003148smesh__D011056
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D003148 2003
% 215.66/215.88  |- skos__annotation mesh__D003148 specify geog if pertinent   
% 215.66/215.88  |- skos__scopeNote mesh__D003148
% 215.66/215.88       A totalitarian system of government in which a single authoritarian party controls state-owned means of production with the professed aim of establishing a classless society.%A%    
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D003148 2000
% 215.66/215.88  |- mesh__activeMeSHYear mesh__D003148 2005
% 215.66/215.88  |- mesh__recordAuthorizer mesh__D003148 sjn
% 215.66/215.88  |- rdf__type mesh__D003148sskos__Concept
% 215.74/215.88  |- mesh__recordOriginator mesh__D003148 NLM
% 215.74/215.88  |- mesh__activeMeSHYear mesh__D008631 1997
% 215.74/215.88  |- mesh__activeMeSHYear mesh__D008631 1994
% 215.74/215.88  |- skos__prefLabel mesh__D008631 Mercury Radioisotopes
% 215.74/215.88  |- skos__scopeNote mesh__D008631
% 215.74/215.88       Unstable isotopes of mercury that decay or disintegrate emitting radiation. Hg atoms with atomic weights 185-195, 197, 203, 205, and 206 are radioactive mercury isotopes.%A%    
% 215.74/215.88  |- skos__broader mesh__D008631smesh__D011868
% 215.74/215.88  |- mesh__recordAuthorizer mesh__D008631 PLS
% 215.74/215.88  |- rdf__type mesh__D008631sskos__Concept
% 215.74/215.88  |- mesh__activeMeSHYear mesh__D008631 2004
% 215.74/215.88  |- mesh__activeMeSHYear mesh__D008631 1995
% 215.74/215.88  |- skos__hiddenLabel mesh__D008631 Radioisotopes, Mercury
% 215.74/215.88  |- mesh__activeMeSHYear mesh__D008631 2000
% 215.74/215.88  |- mesh__historyNote mesh__D008631 75   
% 215.74/215.88  |- mesh__activeMeSHYear mesh__D008631 1998
% 215.74/215.88  |- mesh__publicMeSHNote mesh__D008631 75   
% 215.74/215.88  |- mesh__recordOriginator mesh__D008631 NLM
% 215.74/215.88  |- skos__broader mesh__D008631smesh__D008629
% 215.74/215.88  |- mesh__activeMeSHYear mesh__D008631 2001
% 215.74/215.88  |- mesh__dateEstablished mesh__D008631 1975-09-01
% 215.74/215.88  |- skos__historyNote mesh__D008631 Radioisotopes %28%1968-1974%29%
% 215.74/215.88  |- mesh__activeMeSHYear mesh__D008631 2005
% 215.74/215.88  |- mesh__activeMeSHYear mesh__D008631 1999
% 215.74/215.88  |- mesh__onlineNote mesh__D008631
% 215.74/215.88       search MERCURY ISOTOPES 1967-74 %28%as Prov 1967%29%   
% 215.74/215.88  |- skos__annotation mesh__D008631
% 215.74/215.88       Hg-185-195, 197, 203, 205, 206; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D008631 2006
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D008631 1996
% 215.74/215.89  |- mesh__dateCreated mesh__D008631 1974-11-11
% 215.74/215.89  |- mesh__dateRevised mesh__D008631 1993-06-02
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D008631 2002
% 215.74/215.89  |- skos__historyNote mesh__D008631 Mercury Isotopes %28%1968-1974%29%
% 215.74/215.89  |- mesh__recordMaintainer mesh__D008631 TPW
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D008631 2003
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D013576 2004
% 215.74/215.89  |- skos__annotation mesh__D013576
% 215.74/215.89       do not confuse with POLYDACTYLY; coord IM with FINGERS /abnorm %28%IM%29% or TOES /abnorm %28%IM%29%; ACROCEPHALOSYNDACTYLIA is also available%A%  
% 215.74/215.89  |- mesh__publicMeSHNote mesh__D013576 94; was SYNDACTYLIA 1967-93   
% 215.74/215.89  |- rdf__type mesh__D013576sskos__Concept
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D013576 2003
% 215.74/215.89  |- mesh__onlineNote mesh__D013576
% 215.74/215.89       use SYNDACTYLY to search SYNDACTYLIA 1967-93   
% 215.74/215.89  |- skos__hiddenLabel mesh__D013576 Syndactylias
% 215.74/215.89  |- skos__historyNote mesh__D013576 Fingers/abnormalities %28%1966%29%
% 215.74/215.89  |- mesh__recordMaintainer mesh__D013576 lkt
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D013576 2006
% 215.74/215.89  |- skos__broader mesh__D013576smesh__D013580
% 215.74/215.89  |- skos__prefLabel mesh__D013576 Syndactyly
% 215.74/215.89  |- skos__related mesh__D013576smesh__D017689
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D013576 2005
% 215.74/215.89  |- skos__scopeNote mesh__D013576
% 215.74/215.89       A congenital anomaly of the hand or foot, marked by the webbing between adjacent fingers or toes. Syndactylies are classified as complete or incomplete by the degree of joining. Syndactylies can also be simple or complex. Simple syndactyly indicates joining of only skin or soft tissue; complex syndactyly marks joining of bony elements.%A%    
% 215.74/215.89  |- mesh__recordAuthorizer mesh__D013576 sjn
% 215.74/215.89  |- mesh__recordOriginator mesh__D013576 NLM
% 215.74/215.89  |- mesh__dateCreated mesh__D013576 1999-01-01
% 215.74/215.89  |- mesh__dateRevised mesh__D013576 2002-07-03
% 215.74/215.89  |- mesh__historyNote mesh__D013576 94; was SYNDACTYLIA 1967-93   
% 215.74/215.89  |- skos__hiddenLabel mesh__D013576 Syndactylies
% 215.74/215.89  |- mesh__dateEstablished mesh__D013576 1967-01-01
% 215.74/215.89  |- skos__altLabel mesh__D013576 Syndactylia
% 215.74/215.89  |- skos__broader mesh__D013576smesh__D017880
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D007539 2002
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D007539 1999
% 215.74/215.89  |- mesh__recordMaintainer mesh__D007539 KEV
% 215.74/215.89  |- mesh__onlineNote mesh__D007539
% 215.74/215.89       use ISONICOTINIC ACIDS to search ISONICOTINIC ACID 1966-74%A%  
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D007539 2005
% 215.74/215.89  |- skos__prefLabel mesh__D007539 Isonicotinic Acids
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D007539 1997
% 215.74/215.89  |- skos__hiddenLabel mesh__D007539 Acids, Isonicotinic
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D007539 2003
% 215.74/215.89  |- mesh__publicMeSHNote mesh__D007539 75; was ISONICOTINIC ACID 1963-74   
% 215.74/215.89  |- mesh__dateRevised mesh__D007539 1995-05-18
% 215.74/215.89  |- skos__hiddenLabel mesh__D007539 Acid, Isonicotinic
% 215.74/215.89  |- mesh__recordOriginator mesh__D007539 NLM
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D007539 2006
% 215.74/215.89  |- skos__broader mesh__D007539smesh__D011725
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D007539 2004
% 215.74/215.89  |- rdf__type mesh__D007539sskos__Concept
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D007539 2000
% 215.74/215.89  |- skos__scopeNote mesh__D007539
% 215.74/215.89       Heterocyclic acids that are derivatives of 4-pyridinecarboxylic acid %28%isonicotinic acid%29%.%A%    
% 215.74/215.89  |- mesh__historyNote mesh__D007539 75; was ISONICOTINIC ACID 1963-74   
% 215.74/215.89  |- skos__broader mesh__D007539smesh__D000147
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D007539 2001
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D007539 1998
% 215.74/215.89  |- mesh__recordAuthorizer mesh__D007539 PLS
% 215.74/215.89  |- mesh__dateCreated mesh__D007539 1999-01-01
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D007539 1996
% 215.74/215.89  |- skos__annotation mesh__D007539 hydrazide = ISONIAZID   
% 215.74/215.89  |- mesh__dateCreated mesh__D018261 1993-06-25
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018261 1997
% 215.74/215.89  |- mesh__recordOriginator mesh__D018261 PLS
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018261 2004
% 215.74/215.89  |- mesh__dateEstablished mesh__D018261 1994-01-01
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018261 1996
% 215.74/215.89  |- skos__broader mesh__D018261smesh__D008654
% 215.74/215.89  |- skos__historyNote mesh__D018261 Mesothelioma %28%1979-1993%29%
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018261 2001
% 215.74/215.89  |- mesh__publicMeSHNote mesh__D018261 94   
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018261 2003
% 215.74/215.89  |- skos__prefLabel mesh__D018261 Mesothelioma, Cystic
% 215.74/215.89  |- mesh__historyNote mesh__D018261 94   
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018261 2000
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018261 1999
% 215.74/215.89  |- skos__scopeNote mesh__D018261
% 215.74/215.89       A peritoneal mesothelioma affecting mainly young females and producing cysts of variable size and number lined by a single layer of benign mesothelial cells. The disease follows a benign course and is compatible with a normal life expectancy, requiring occasionally partial excision or decompression for relief of pain or other symptoms. Malignant potential is exceptional. %28%From Holland et al., Cancer Medicine, 3d ed, p1345%29%%A%    
% 215.74/215.89  |- skos__annotation mesh__D018261
% 215.74/215.89       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with PERITONEAL NEOPLASMS %28%IM%29%%A%  
% 215.74/215.89  |- mesh__recordAuthorizer mesh__D018261 PLS
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018261 2006
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018261 1998
% 215.74/215.89  |- rdf__type mesh__D018261sskos__Concept
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018261 2005
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018261 2002
% 215.74/215.89  |- skos__hiddenLabel mesh__D018261 Cystic Mesothelioma
% 215.74/215.89  |- skos__hiddenLabel mesh__D018261 Mesotheliomas, Cystic
% 215.74/215.89  |- skos__hiddenLabel mesh__D018261 Cystic Mesotheliomas
% 215.74/215.89  |- mesh__recordMaintainer mesh__D018261 KEV
% 215.74/215.89  |- mesh__dateRevised mesh__D018261 1995-06-08
% 215.74/215.89  |- skos__altLabel mesh__D004241 Colonic Diverticula
% 215.74/215.89  |- skos__hiddenLabel mesh__D004241 Diverticulum, Colonic
% 215.74/215.89  |- mesh__dateRevised mesh__D004241 2003-07-09
% 215.74/215.89  |- mesh__recordMaintainer mesh__D004241 lkt
% 215.74/215.89  |- skos__scopeNote mesh__D004241
% 215.74/215.89       A pouch or sac opening from the COLON.     
% 215.74/215.89  |- mesh__publicMeSHNote mesh__D004241
% 215.74/215.89       2001; see DIVERTICULOSIS, COLONIC 1963-2000   
% 215.74/215.89  |- rdf__type mesh__D004241sskos__Concept
% 215.74/215.89  |- skos__altLabel mesh__D004241 Colonic Diverticulum
% 215.74/215.89  |- skos__hiddenLabel mesh__D004241 Colon Diverticulum
% 215.74/215.89  |- skos__hiddenLabel mesh__D004241 Diverticula, Colonic
% 215.74/215.89  |- skos__altLabel mesh__D004241 Diverticula, Colon
% 215.74/215.89  |- mesh__recordOriginator mesh__D004241 NLM
% 215.74/215.89  |- mesh__historyNote mesh__D004241 2001%28%1963%29%   
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D004241 2006
% 215.74/215.89  |- skos__altLabel mesh__D004241 Colon Diverticula
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D004241 2004
% 215.74/215.89  |- skos__prefLabel mesh__D004241 Diverticulum, Colon
% 215.74/215.89  |- mesh__dateCreated mesh__D004241 1999-01-01
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D004241 2005
% 215.74/215.89  |- mesh__recordAuthorizer mesh__D004241 sjn
% 215.74/215.89  |- skos__broader mesh__D004241smesh__D004240
% 215.74/215.89  |- skos__scopeNote mesh__D017967
% 215.74/215.89       Inorganic compounds that contain zinc as an integral part of the molecule.%A%    
% 215.74/215.89  |- skos__historyNote mesh__D017967 Zinc %28%1966-1993%29%
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017967 2005
% 215.74/215.89  |- skos__broader mesh__D017967smesh__D007287
% 215.74/215.89  |- skos__hiddenLabel mesh__D017967 Compounds, Zinc
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017967 1998
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017967 2001
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017967 1995
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017967 2000
% 215.74/215.89  |- mesh__historyNote mesh__D017967 94   
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017967 2004
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017967 1994
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017967 1997
% 215.74/215.89  |- skos__prefLabel mesh__D017967 Zinc Compounds
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017967 2003
% 215.74/215.89  |- mesh__dateEstablished mesh__D017967 1994-01-01
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017967 1996
% 215.74/215.89  |- rdf__type mesh__D017967sskos__Concept
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017967 2002
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017967 2006
% 215.74/215.89  |- skos__annotation mesh__D017967
% 215.74/215.89       inorganic; GEN or unspecified; prefer specifics; DF: ZINC CPDS%A%  
% 215.74/215.89  |- mesh__dateCreated mesh__D017967 1993-06-21
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017967 1999
% 215.74/215.89  |- mesh__publicMeSHNote mesh__D017967 94   
% 215.74/215.89  |- skos__altLabel mesh__D017169 Post-Traumatic Neoplasms
% 215.74/215.89  |- skos__scopeNote mesh__D017169
% 215.74/215.89       Tumors, cancer or other neoplasms caused by or resulting from trauma or other non-radiation injuries.%A%    
% 215.74/215.89  |- skos__hiddenLabel mesh__D017169 Post-Traumatic Neoplasm
% 215.74/215.89  |- rdf__type mesh__D017169sskos__Concept
% 215.74/215.89  |- skos__hiddenLabel mesh__D017169 Neoplasms, Post Traumatic
% 215.74/215.89  |- skos__hiddenLabel mesh__D017169 Post Traumatic Neoplasms
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017169 2004
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017169 2002
% 215.74/215.89  |- skos__hiddenLabel mesh__D017169 Malignancy, Post-Traumatic
% 215.74/215.89  |- skos__annotation mesh__D017169
% 215.74/215.89       IM; coord with specific histol type %28%IM%29% + organ/neopl term %28%IM%29%; Manual 24.4.3.3; neopl after radiation inj = NEOPLASMS, RADIATION-INDUCED; DF: NEOPL POST TRAUMATIC%A%  
% 215.74/215.89  |- mesh__recordOriginator mesh__D017169 JLS
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017169 2003
% 215.74/215.89  |- mesh__dateRevised mesh__D017169 1999-11-03
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017169 2001
% 215.74/215.89  |- mesh__publicMeSHNote mesh__D017169 93   
% 215.74/215.89  |- skos__hiddenLabel mesh__D017169 Post-Traumatic Cancers
% 215.74/215.89  |- mesh__recordAuthorizer mesh__D017169 sjn
% 215.74/215.89  |- skos__hiddenLabel mesh__D017169 Malignancies, Post Traumatic
% 215.74/215.89  |- skos__hiddenLabel mesh__D017169 Cancer, Post-Traumatic
% 215.74/215.89  |- skos__broader mesh__D017169smesh__D009369
% 215.74/215.89  |- skos__hiddenLabel mesh__D017169 Post-Traumatic Malignancies
% 215.74/215.89  |- mesh__recordMaintainer mesh__D017169 nns
% 215.74/215.89  |- skos__hiddenLabel mesh__D017169 Neoplasm, Post-Traumatic
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017169 2000
% 215.74/215.89  |- mesh__dateEstablished mesh__D017169 1993-01-01
% 215.74/215.89  |- skos__hiddenLabel mesh__D017169 Post-Traumatic Malignancy
% 215.74/215.89  |- skos__hiddenLabel mesh__D017169 Post Traumatic Cancer
% 215.74/215.89  |- mesh__historyNote mesh__D017169 93   
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017169 2006
% 215.74/215.89  |- skos__altLabel mesh__D017169 Post-Traumatic Cancer
% 215.74/215.89  |- skos__prefLabel mesh__D017169 Neoplasms, Post-Traumatic
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017169 2005
% 215.74/215.89  |- skos__hiddenLabel mesh__D017169 Cancers, Post-Traumatic
% 215.74/215.89  |- mesh__dateCreated mesh__D017169 1992-05-22
% 215.74/215.89  |- mesh__recordMaintainer mesh__D003947 PXP
% 215.74/215.89  |- skos__altLabel mesh__D003947 Diagnostic Technic, Radioisotope
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003947 1998
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003947 2003
% 215.74/215.89  |- mesh__historyNote mesh__D003947
% 215.74/215.89       98%28%88%29%; was DIAGNOSIS, RADIOISOTOPE %28%NON MESH%29% 1974-87   
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003947 2000
% 215.74/215.89  |- skos__broader mesh__D003947smesh__D019937
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003947 1999
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003947 2004
% 215.74/215.89  |- rdf__type mesh__D003947sskos__Concept
% 215.74/215.89  |- skos__annotation mesh__D003947
% 215.74/215.89       GEN only: prefer /radionuclide with dis; DF: DIAG TECHNIQUES RADIOISOTOPE%A%  
% 215.74/215.89  |- skos__altLabel mesh__D003947 Techniques, Radioisotope Diagnostic
% 215.74/215.89  |- skos__altLabel mesh__D003947 Diagnostic Technics, Radioisotope
% 215.74/215.89  |- mesh__dateEstablished mesh__D003947 1988-01-01
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003947 2001
% 215.74/215.89  |- mesh__recordAuthorizer mesh__D003947 SJN
% 215.74/215.89  |- mesh__recordOriginator mesh__D003947 NLM
% 215.74/215.89  |- skos__prefLabel mesh__D003947 Diagnostic Techniques, Radioisotope
% 215.74/215.89  |- skos__altLabel mesh__D003947 Technic, Radioisotope Diagnostic
% 215.74/215.89  |- mesh__publicMeSHNote mesh__D003947
% 215.74/215.89       98; see DIAGNOSIS, RADIOISOTOPE 1988-97   
% 215.74/215.89  |- skos__altLabel mesh__D003947 Technique, Radioisotope Diagnostic
% 215.74/215.89  |- skos__altLabel mesh__D003947 Radioisotope Diagnostic Technics
% 215.74/215.89  |- skos__altLabel mesh__D003947 Diagnostic Technique, Radioisotope
% 215.74/215.89  |- skos__altLabel mesh__D003947 Radioisotope Diagnostic Techniques
% 215.74/215.89  |- skos__altLabel mesh__D003947 Radioisotope Diagnostic Technique
% 215.74/215.89  |- skos__altLabel mesh__D003947 Radioisotope Diagnostic Technic
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003947 2005
% 215.74/215.89  |- skos__scopeNote mesh__D003947
% 215.74/215.89       Any diagnostic evaluation using radioactive %28%unstable%29% isotopes. This diagnosis includes many nuclear medicine procedures as well as radioimmunoassay tests.%A%    
% 215.74/215.89  |- mesh__dateCreated mesh__D003947 1999-01-01
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003947 2002
% 215.74/215.89  |- skos__altLabel mesh__D003947 Technics, Radioisotope Diagnostic
% 215.74/215.89  |- mesh__dateRevised mesh__D003947 1997-06-20
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003947 2006
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003149 1999
% 215.74/215.89  |- skos__annotation mesh__D003149 SPEC: SPEC qualif; DF: COMMUNITY DENT   
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003149 2004
% 215.74/215.89  |- mesh__recordMaintainer mesh__D003149 PLS
% 215.74/215.89  |- mesh__recordAuthorizer mesh__D003149 PLS
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003149 2006
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003149 2000
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003149 1996
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003149 1995
% 215.74/215.89  |- mesh__publicMeSHNote mesh__D003149
% 215.74/215.89       91; was see under PUBLIC HEALTH DENTISTRY 1975-90   
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003149 1998
% 215.74/215.89  |- mesh__dateCreated mesh__D003149 1999-01-01
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003149 2003
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003149 1994
% 215.74/215.89  |- skos__prefLabel mesh__D003149 Community Dentistry
% 215.74/215.89  |- mesh__recordOriginator mesh__D003149 NLM
% 215.74/215.89  |- mesh__dateEstablished mesh__D003149 1991-01-01
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003149 2005
% 215.74/215.89  |- rdf__type mesh__D003149sskos__Concept
% 215.74/215.89  |- skos__broader mesh__D003149smesh__D011636
% 215.74/215.89  |- mesh__onlineNote mesh__D003149 search PUBLIC HEALTH DENTISTRY 1971-74   
% 215.74/215.89  |- skos__altLabel mesh__D003149 Dentistry, Community
% 215.74/215.89  |- mesh__historyNote mesh__D003149
% 215.74/215.89       91%28%75%29%; was see under PUBLIC HEALTH DENTISTRY 1975-90   
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003149 2002
% 215.74/215.89  |- mesh__dateRevised mesh__D003149 1993-05-26
% 215.74/215.89  |- skos__scopeNote mesh__D003149
% 215.74/215.89       The practice of dentistry concerned with preventive as well as diagnostic and treatment programs in a circumscribed population.%A%    
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003149 2001
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D003149 1997
% 215.74/215.89  |- skos__altLabel mesh__D008632 Mermithid
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D008632 2006
% 215.74/215.89  |- skos__prefLabel mesh__D008632 Mermithoidea
% 215.74/215.89  |- mesh__recordAuthorizer mesh__D008632 sjn
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D008632 2005
% 215.74/215.89  |- skos__scopeNote mesh__D008632
% 215.74/215.89       A superfamily of nematodes of the order ENOPLIDA. Characteristics include a reduced alimentary tract and the presence of a trophosome. Its organisms can be present in the human intestine through ingestion of unwashed or contaminated raw vegetables.%A%    
% 215.74/215.89  |- rdf__type mesh__D008632sskos__Concept
% 215.74/215.89  |- mesh__recordMaintainer mesh__D008632 sjn
% 215.74/215.89  |- mesh__recordOriginator mesh__D008632 NLM
% 215.74/215.89  |- mesh__dateCreated mesh__D008632 1999-01-01
% 215.74/215.89  |- skos__annotation mesh__D008632
% 215.74/215.89       a superfamily of nematodes; infection %28%probably accidental through food contam%29%: coord IM with ENOPLIDA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 215.74/215.89  |- mesh__dateRevised mesh__D008632 2004-07-13
% 215.74/215.89  |- skos__broader mesh__D008632smesh__D017158
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D013577 2003
% 215.74/215.89  |- skos__hiddenLabel mesh__D013577 Syndromes
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D013577 2006
% 215.74/215.89  |- skos__broader mesh__D013577smesh__D004194
% 215.74/215.89  |- mesh__dateEstablished mesh__D013577 1991-01-01
% 215.74/215.89  |- skos__prefLabel mesh__D013577 Syndrome
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D013577 2001
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D013577 2005
% 215.74/215.89  |- mesh__dateRevised mesh__D013577 2000-06-22
% 215.74/215.89  |- mesh__historyNote mesh__D013577
% 215.74/215.89       91%28%72%29%; was see under DISEASE 1972-90   
% 215.74/215.89  |- skos__annotation mesh__D013577
% 215.74/215.89       NIM; no qualif; policy: Manual 23.20.2.1, 23.26+   
% 215.74/215.89  |- mesh__dateCreated mesh__D013577 1999-01-01
% 215.74/215.89  |- mesh__publicMeSHNote mesh__D013577 91; was see under DISEASE 1972-90   
% 215.74/215.89  |- skos__scopeNote mesh__D013577
% 215.74/215.89       A symptom complex of unknown etiology, that is characteristic of a particular abnormality.%A%    
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D013577 2004
% 215.74/215.89  |- mesh__recordAuthorizer mesh__D013577 sjn
% 215.74/215.89  |- mesh__recordMaintainer mesh__D013577 ags
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D013577 2002
% 215.74/215.89  |- mesh__recordOriginator mesh__D013577 NLM
% 215.74/215.89  |- rdf__type mesh__D013577sskos__Concept
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018262 2002
% 215.74/215.89  |- skos__hiddenLabel mesh__D018262 Cell Adenocarcinoma, Clear
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018262 2003
% 215.74/215.89  |- skos__hiddenLabel mesh__D018262 Adenocarcinomas, Clear Cell
% 215.74/215.89  |- mesh__historyNote mesh__D018262 94   
% 215.74/215.89  |- mesh__dateCreated mesh__D018262 1993-06-25
% 215.74/215.89  |- skos__scopeNote mesh__D018262
% 215.74/215.89       An adenocarcinoma characterized by the presence of varying combinations of clear and hobnail-shaped tumor cells. There are three predominant patterns described as tubulocystic, solid, and papillary. These tumors, usually located in the female reproductive organs, have been seen more frequently in young women since 1970 as a result of the association with intrauterine exposure to diethylstilbestrol. %28%From Holland et al., Cancer Medicine, 3d ed%29%%A%    
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018262 1999
% 215.74/215.89  |- mesh__dateEstablished mesh__D018262 1994-01-01
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018262 2006
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018262 1998
% 215.74/215.89  |- rdf__type mesh__D018262sskos__Concept
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018262 2001
% 215.74/215.89  |- mesh__publicMeSHNote mesh__D018262 94   
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018262 2005
% 215.74/215.89  |- skos__prefLabel mesh__D018262 Adenocarcinoma, Clear Cell
% 215.74/215.89  |- skos__hiddenLabel mesh__D018262 Clear Cell Adenocarcinomas
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018262 2000
% 215.74/215.89  |- skos__broader mesh__D018262smesh__D000230
% 215.74/215.89  |- skos__hiddenLabel mesh__D018262 Clear Cell Adenocarcinoma
% 215.74/215.89  |- mesh__recordAuthorizer mesh__D018262 PLS
% 215.74/215.89  |- mesh__recordMaintainer mesh__D018262 KEV
% 215.74/215.89  |- mesh__dateRevised mesh__D018262 1995-06-08
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018262 1997
% 215.74/215.89  |- mesh__recordOriginator mesh__D018262 PLS
% 215.74/215.89  |- skos__hiddenLabel mesh__D018262 Cell Adenocarcinomas, Clear
% 215.74/215.89  |- skos__historyNote mesh__D018262 Adenocarcinoma %28%1966-1993%29%
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018262 2004
% 215.74/215.89  |- skos__annotation mesh__D018262
% 215.74/215.89       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D018262 1996
% 215.74/215.89  |- mesh__recordMaintainer mesh__D051696 DRC
% 215.74/215.89  |- mesh__dateCreated mesh__D051696 2005-06-30
% 215.74/215.89  |- skos__altLabel mesh__D051696 ATF Transcription Factors
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D051696 2006
% 215.74/215.89  |- mesh__recordAuthorizer mesh__D051696 sjn
% 215.74/215.89  |- mesh__recordOriginator mesh__D051696 DRC
% 215.74/215.89  |- skos__scopeNote mesh__D051696
% 215.74/215.89       Activating transcription factors were originally identified as DNA-BINDING PROTEINS that interact with EARLY PROMOTERS from ADENOVIRUSES. They are a family of basic leucine zipper transcription factors that bind to the consensus site TGACGTCA of the cyclic AMP response element, and are closely related to CYCLIC AMP-RESPONSIVE DNA-BINDING PROTEIN.%A%    
% 215.74/215.89  |- skos__hiddenLabel mesh__D051696 Transcription Factors, ATF
% 215.74/215.89  |- skos__broader mesh__D051696smesh__D050976
% 215.74/215.89  |- skos__hiddenLabel mesh__D051696 Factors, ATF Transcription
% 215.74/215.89  |- skos__annotation mesh__D051696 general; prefer specifics   
% 215.74/215.89  |- mesh__publicMeSHNote mesh__D051696 2006   
% 215.74/215.89  |- mesh__dateEstablished mesh__D051696 2006-01-01
% 215.74/215.89  |- mesh__historyNote mesh__D051696 2006   
% 215.74/215.89  |- skos__prefLabel mesh__D051696 Activating Transcription Factors
% 215.74/215.89  |- rdf__type mesh__D051696sskos__Concept
% 215.74/215.89  |- skos__annotation mesh__D004242
% 215.74/215.89       human %26% animal; /adv eff permitted for hazards of diving as a Cat G3 concept, /inj permitted for diving as a sport in Cat I: coord IM with specific inj %28%IM%29%; /physiol permitted; includes scuba %26% bell diving%A%  
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D004242 2002
% 215.74/215.89  |- mesh__recordOriginator mesh__D004242 NLM
% 215.74/215.89  |- mesh__recordMaintainer mesh__D004242 TGC
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D004242 1999
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D004242 2006
% 215.74/215.89  |- skos__hiddenLabel mesh__D004242 Divings
% 215.74/215.89  |- skos__broader mesh__D004242smesh__D004780
% 215.74/215.89  |- skos__related mesh__D004242smesh__D007222
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D004242 1998
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D004242 2005
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D004242 2004
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D004242 2001
% 215.74/215.89  |- mesh__dateCreated mesh__D004242 1999-01-01
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D004242 2003
% 215.74/215.89  |- mesh__dateRevised mesh__D004242 1997-06-20
% 215.74/215.89  |- skos__scopeNote mesh__D004242
% 215.74/215.89       An activity in which the organism plunges into water. It includes scuba and bell diving. Diving as natural behavior of animals goes here, as well as diving in decompression experiments with humans or animals.%A%    
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D004242 2000
% 215.74/215.89  |- mesh__recordAuthorizer mesh__D004242 SJN
% 215.74/215.89  |- mesh__historyNote mesh__D004242
% 215.74/215.89       was in Cat G only 1975-80; was in Cat E only 1968-74; was in Cat E %26% J 1963-67%A%  
% 215.74/215.89  |- skos__prefLabel mesh__D004242 Diving
% 215.74/215.89  |- skos__broader mesh__D004242smesh__D013550
% 215.74/215.89  |- rdf__type mesh__D004242sskos__Concept
% 215.74/215.89  |- skos__related mesh__D004242smesh__D003665
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017968 2002
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017968 1995
% 215.74/215.89  |- mesh__dateCreated mesh__D017968 1993-06-21
% 215.74/215.89  |- mesh__historyNote mesh__D017968 94   
% 215.74/215.89  |- skos__hiddenLabel mesh__D017968 Compounds, Vanadium
% 215.74/215.89  |- mesh__publicMeSHNote mesh__D017968 94   
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017968 2004
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017968 1994
% 215.74/215.89  |- skos__broader mesh__D017968smesh__D007287
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017968 1997
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017968 2001
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017968 2003
% 215.74/215.89  |- skos__prefLabel mesh__D017968 Vanadium Compounds
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017968 1996
% 215.74/215.89  |- skos__historyNote mesh__D017968 Vanadium %28%1966-1993%29%
% 215.74/215.89  |- rdf__type mesh__D017968sskos__Concept
% 215.74/215.89  |- skos__annotation mesh__D017968
% 215.74/215.89       inorganic; GEN or unspecified; prefer specifics; DF: VANADIUM CPDS%A%  
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017968 2000
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017968 2006
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017968 1999
% 215.74/215.89  |- skos__scopeNote mesh__D017968
% 215.74/215.89       Inorganic compounds that contain vanadium as an integral part of the molecule.%A%    
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017968 2005
% 215.74/215.89  |- mesh__dateEstablished mesh__D017968 1994-01-01
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D017968 1998
% 215.74/215.89  |- mesh__publicMeSHNote mesh__D042361 2004; see BREAST 1975-2003   
% 215.74/215.89  |- skos__hiddenLabel mesh__D042361 Glands, Human Mammary
% 215.74/215.89  |- skos__hiddenLabel mesh__D042361 Mammary Gland, Human
% 215.74/215.89  |- skos__hiddenLabel mesh__D042361 Gland, Mammary
% 215.74/215.89  |- skos__hiddenLabel mesh__D042361 Epithelium, Human Mammary
% 215.74/215.89  |- skos__hiddenLabel mesh__D042361 Human Mammary Epithelium
% 215.74/215.89  |- skos__hiddenLabel mesh__D042361 Human Mammary Duct
% 215.74/215.89  |- mesh__dateCreated mesh__D042361 2003-07-09
% 215.74/215.89  |- skos__hiddenLabel mesh__D042361 Human Mammary Ducts
% 215.74/215.89  |- skos__prefLabel mesh__D042361 Mammary Glands, Human
% 215.74/215.89  |- skos__altLabel mesh__D042361 Mammary Epithelium, Human
% 215.74/215.89  |- skos__broader mesh__D042361smesh__D001940
% 215.74/215.89  |- skos__hiddenLabel mesh__D042361 Human Mammary Alveolus
% 215.74/215.89  |- skos__hiddenLabel mesh__D042361 Mammary Duct, Human
% 215.74/215.89  |- skos__hiddenLabel mesh__D042361 Mammary Lobule, Human
% 215.74/215.89  |- mesh__dateRevised mesh__D042361 2004-07-13
% 215.74/215.89  |- skos__hiddenLabel mesh__D042361 Alveoli, Human Mammary
% 215.74/215.89  |- mesh__recordOriginator mesh__D042361 lkt
% 215.74/215.89  |- skos__hiddenLabel mesh__D042361 Human Mammary Lobule
% 215.74/215.89  |- skos__broader mesh__D042361smesh__D005088
% 215.74/215.89  |- mesh__dateEstablished mesh__D042361 2004-01-01
% 215.74/215.89  |- skos__altLabel mesh__D042361 Human Mammary Gland
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D042361 2006
% 215.74/215.89  |- skos__hiddenLabel mesh__D042361 Human Mammary Alveoli
% 215.74/215.89  |- skos__altLabel mesh__D042361 Mammary Gland
% 215.74/215.89  |- skos__historyNote mesh__D042361 Breast %28%1965-2003%29%
% 215.74/215.89  |- rdf__type mesh__D042361sskos__Concept
% 215.74/215.89  |- skos__hiddenLabel mesh__D042361 Human Mammary Epithelia
% 215.74/215.89  |- skos__hiddenLabel mesh__D042361 Human Mammary Lobules
% 215.74/215.89  |- skos__hiddenLabel mesh__D042361 Duct, Human Mammary
% 215.74/215.89  |- skos__scopeNote mesh__D042361
% 215.74/215.89       Glandular tissue in the BREAST of human that is under the influence of hormones such as ESTROGENS; PROGESTINS; and PROLACTIN. In WOMEN, after PARTURITION, the mammary glands secrete milk %28%MILK, HUMAN%29% for the nourishment of the young.%A%    
% 215.74/215.89  |- mesh__activeMeSHYear mesh__D042361 2005
% 215.74/215.89  |- mesh__historyNote mesh__D042361 2004; use BREAST 1975-2003   
% 215.74/215.89  |- skos__annotation mesh__D042361 for animals use MAMMARY GLANDS, ANIMAL   
% 215.74/215.89  |- skos__altLabel mesh__D042361 Human Mammary Glands
% 215.74/215.89  |- skos__hiddenLabel mesh__D042361 Mammary Alveolus, Human
% 215.74/215.90  |- skos__hiddenLabel mesh__D042361 Glands, Mammary
% 215.74/215.90  |- skos__hiddenLabel mesh__D042361 Ducts, Human Mammary
% 215.74/215.90  |- skos__hiddenLabel mesh__D042361 Alveolus, Human Mammary
% 215.74/215.90  |- mesh__recordMaintainer mesh__D042361 sjn
% 215.74/215.90  |- mesh__recordAuthorizer mesh__D042361 sjn
% 215.74/215.90  |- skos__hiddenLabel mesh__D042361 Epithelia, Human Mammary
% 215.74/215.90  |- skos__hiddenLabel mesh__D042361 Gland, Human Mammary
% 215.74/215.90  |- skos__altLabel mesh__D042361 Mammary Glands
% 215.74/215.90  |- skos__altLabel mesh__D003948 Technique, Respiratory System Diagnostic
% 215.74/215.90  |- skos__altLabel mesh__D003948 Diagnostic Technics, Respiratory System
% 215.74/215.90  |- skos__prefLabel mesh__D003948 Diagnostic Techniques, Respiratory System
% 215.74/215.90  |- mesh__recordMaintainer mesh__D003948 TGC
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D003948 2001
% 215.74/215.90  |- mesh__historyNote mesh__D003948 98; use explode 1975-97   
% 215.74/215.90  |- mesh__dateEstablished mesh__D003948 1998-01-01
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D003948 2006
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D003948 2000
% 215.74/215.90  |- mesh__dateCreated mesh__D003948 1999-01-01
% 215.74/215.90  |- skos__scopeNote mesh__D003948
% 215.74/215.90       Methods and procedures for the diagnosis of diseases of the respiratory tract or its organs. It includes RESPIRATORY FUNCTION TESTS.%A%    
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D003948 2004
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D003948 2005
% 215.74/215.90  |- skos__altLabel mesh__D003948 Diagnostic Technique, Respiratory System
% 215.74/215.90  |- skos__annotation mesh__D003948
% 215.74/215.90       GEN or unspecified; prefer specifics; DF: DIAG TECHNIQUES RESPIRATORY SYSTEM%A%  
% 215.74/215.90  |- skos__altLabel mesh__D003948 Technic, Respiratory System Diagnostic
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D003948 2003
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D003948 1999
% 215.74/215.90  |- rdf__type mesh__D003948sskos__Concept
% 215.74/215.90  |- mesh__recordAuthorizer mesh__D003948 SJN
% 215.74/215.90  |- skos__altLabel mesh__D003948 Technics, Respiratory System Diagnostic
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D003948 2002
% 215.74/215.90  |- skos__altLabel mesh__D003948 Respiratory System Diagnostic Technic
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D003948 1998
% 215.74/215.90  |- skos__altLabel mesh__D003948 Respiratory System Diagnostic Technique
% 215.74/215.90  |- skos__altLabel mesh__D003948 Respiratory System Diagnostic Technics
% 215.74/215.90  |- skos__altLabel mesh__D003948 Respiratory System Diagnostic Techniques
% 215.74/215.90  |- skos__historyNote mesh__D003948 specific technique %28%1966-1997%29%
% 215.74/215.90  |- skos__broader mesh__D003948smesh__D019937
% 215.74/215.90  |- mesh__recordOriginator mesh__D003948 NLM
% 215.74/215.90  |- mesh__publicMeSHNote mesh__D003948 98   
% 215.74/215.90  |- mesh__dateRevised mesh__D003948 1997-06-20
% 215.74/215.90  |- skos__altLabel mesh__D003948 Techniques, Respiratory System Diagnostic
% 215.74/215.90  |- skos__altLabel mesh__D003948 Diagnostic Technic, Respiratory System
% 215.74/215.90  |- skos__scopeNote mesh__D014670
% 215.74/215.90       A dilation of the duodenal papilla that is the opening of the juncture of the COMMON BILE DUCT and the MAIN PANCREATIC DUCT, also known as the hepatopancreatic ampulla.%A%    
% 215.74/215.90  |- skos__related mesh__D014670smesh__D002760
% 215.74/215.90  |- skos__hiddenLabel mesh__D014670 Major Duodenal Papilla
% 215.74/215.90  |- skos__broader mesh__D014670smesh__D004386
% 215.74/215.90  |- skos__related mesh__D014670smesh__D016717
% 215.74/215.90  |- skos__annotation mesh__D014670
% 215.74/215.90       diseases: coord IM with COMMON BILE DUCT DISEASES %28%IM%29%; inflammation: coord IM with CHOLANGITIS %28%IM%29%; neopl: coord IM with COMMON BILE DUCT NEOPLASMS %28%IM%29%; note X ref DUODENAL PAPILLA, MAJOR: do not confuse with DUODENAL PAPILLA, MINOR see PANCREATIC DUCTS; %22%duodenal papilla%22% unspecified is probably DUODENAL PAPILLA, MAJOR%A%  
% 215.74/215.90  |- rdf__type mesh__D014670sskos__Concept
% 215.74/215.90  |- mesh__recordAuthorizer mesh__D014670 sjn
% 215.74/215.90  |- skos__hiddenLabel mesh__D014670 Vater Ampulla
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014670 2004
% 215.74/215.90  |- mesh__recordMaintainer mesh__D014670 lkt
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014670 2006
% 215.74/215.90  |- mesh__historyNote mesh__D014670 2004 %28%1963%29%   
% 215.74/215.90  |- mesh__recordOriginator mesh__D014670 NLM
% 215.74/215.90  |- skos__hiddenLabel mesh__D014670 Ampullas, Hepatopancreatic
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014670 2005
% 215.74/215.90  |- skos__hiddenLabel mesh__D014670 Ampulla, Hepatopancreatic
% 215.74/215.90  |- skos__hiddenLabel mesh__D014670 Hepatopancreatic Ampullas
% 215.74/215.90  |- skos__related mesh__D014670smesh__D013105
% 215.74/215.90  |- skos__hiddenLabel mesh__D014670 Ampulla, Vater%27%s
% 215.74/215.90  |- skos__altLabel mesh__D014670 Hepatopancreatic Ampulla
% 215.74/215.90  |- mesh__dateRevised mesh__D014670 2003-07-09
% 215.74/215.90  |- mesh__dateCreated mesh__D014670 1999-01-01
% 215.74/215.90  |- skos__broader mesh__D014670smesh__D003135
% 215.74/215.90  |- skos__altLabel mesh__D014670 Vater%27%s Ampulla
% 215.74/215.90  |- mesh__publicMeSHNote mesh__D014670
% 215.74/215.90       2004; see VATER%27%S AMPULLA 1963-2003   
% 215.74/215.90  |- skos__prefLabel mesh__D014670 Ampulla of Vater
% 215.74/215.90  |- skos__hiddenLabel mesh__D014670 Vaters Ampulla
% 215.74/215.90  |- mesh__dateRevised mesh__D000650 2005-06-30
% 215.74/215.90  |- mesh__recordMaintainer mesh__D000650 lkt
% 215.74/215.90  |- skos__broader mesh__D000650smesh__D005321
% 215.74/215.90  |- skos__annotation mesh__D000650
% 215.74/215.90       not restricted to mammals; intra-amniotic injections = AMNION + INJECTIONS; amniotomy = AMNION /surg + probably LABOR, INDUCED%A%  
% 215.74/215.90  |- skos__scopeNote mesh__D000650
% 215.74/215.90       The innermost membranous sac that surrounds and protects the developing EMBRYO which is bathed in the AMNIOTIC FLUID. Amnion cells are secretory EPITHELIAL CELLS and contribute to the amniotic fluid.%A%    
% 215.74/215.90  |- skos__hiddenLabel mesh__D000650 Amniotic Membranes
% 215.74/215.90  |- skos__altLabel mesh__D000650 Amniotic Membrane
% 215.74/215.90  |- skos__prefLabel mesh__D000650 Amnion
% 215.74/215.90  |- mesh__recordAuthorizer mesh__D000650 sjn
% 215.74/215.90  |- mesh__recordOriginator mesh__D000650 NLM
% 215.74/215.90  |- mesh__dateCreated mesh__D000650 1999-01-01
% 215.74/215.90  |- skos__hiddenLabel mesh__D000650 Membranes, Amniotic
% 215.74/215.90  |- skos__hiddenLabel mesh__D000650 Membrane, Amniotic
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D000650 2006
% 215.74/215.90  |- skos__related mesh__D000650smesh__D005332
% 215.74/215.90  |- rdf__type mesh__D000650sskos__Concept
% 215.74/215.90  |- skos__hiddenLabel mesh__D000650 Amnions
% 215.74/215.90  |- skos__broader mesh__D035423Q000530smesh__D035423
% 215.74/215.90  |- mesh__preferredCombination mesh__D035423Q000530smesh__D013902
% 215.74/215.90  |- rdf__type mesh__D035423Q000530smesh__CompoundConcept
% 215.74/215.90  |- skos__broader mesh__D005492Q000172smesh__D005492
% 215.74/215.90  |- mesh__preferredCombination mesh__D005492Q000172smesh__D005494
% 215.74/215.90  |- rdf__type mesh__D005492Q000172smesh__CompoundConcept
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D013578 2003
% 215.74/215.90  |- mesh__recordMaintainer mesh__D013578 CCR
% 215.74/215.90  |- skos__scopeNote mesh__D013578
% 215.74/215.90       Sympathetic alpha-adrenergic agonist with actions like PHENYLEPHRINE. It is used as a vasoconstrictor in circulatory failure, asthma, nasal congestion, and glaucoma.%A%    
% 215.74/215.90  |- mesh__publicMeSHNote mesh__D013578 80; was OXEDRINE 1963-79   
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D013578 2001
% 215.74/215.90  |- skos__prefLabel mesh__D013578 Synephrine
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D013578 2006
% 215.74/215.90  |- skos__broader mesh__D013578smesh__D004983
% 215.74/215.90  |- mesh__dateRevised mesh__D013578 2000-06-22
% 215.74/215.90  |- mesh__dateCreated mesh__D013578 1999-01-01
% 215.74/215.90  |- skos__broader mesh__D013578smesh__D014439
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D013578 2005
% 215.74/215.90  |- mesh__historyNote mesh__D013578 80; was OXEDRINE 1963-79   
% 215.74/215.90  |- mesh__recordAuthorizer mesh__D013578 sjn
% 215.74/215.90  |- mesh__onlineNote mesh__D013578
% 215.74/215.90       use SYNEPHRINE to search OXEDRINE 1966-79   
% 215.74/215.90  |- mesh__recordOriginator mesh__D013578 NLM
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D013578 2002
% 215.74/215.90  |- rdf__type mesh__D013578sskos__Concept
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D013578 2004
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D018263 2002
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D018263 1998
% 215.74/215.90  |- skos__hiddenLabel mesh__D018263 Follicular Adenocarcinoma
% 215.74/215.90  |- skos__historyNote mesh__D018263 Adenocarcinoma %28%1969-1993%29%
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D018263 2005
% 215.74/215.90  |- mesh__historyNote mesh__D018263 94   
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D018263 1999
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D018263 2006
% 215.74/215.90  |- skos__scopeNote mesh__D018263
% 215.74/215.90       An adenocarcinoma of the thyroid gland, in which the cells are arranged in the form of follicles. %28%From Dorland, 27th ed%29%%A%    
% 215.74/215.90  |- rdf__type mesh__D018263sskos__Concept
% 215.74/215.90  |- skos__hiddenLabel mesh__D018263 Adenocarcinomas, Follicular
% 215.74/215.90  |- skos__historyNote mesh__D018263 Thyroid Neoplasms %28%1969-1993%29%
% 215.74/215.90  |- mesh__dateEstablished mesh__D018263 1994-01-01
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D018263 2000
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D018263 1996
% 215.74/215.90  |- mesh__dateCreated mesh__D018263 1993-06-25
% 215.74/215.90  |- skos__broader mesh__D018263smesh__D000230
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D018263 2003
% 215.74/215.90  |- mesh__recordAuthorizer mesh__D018263 PLS
% 215.74/215.90  |- mesh__recordMaintainer mesh__D018263 KEV
% 215.74/215.90  |- mesh__dateRevised mesh__D018263 1995-06-08
% 215.74/215.90  |- skos__hiddenLabel mesh__D018263 Follicular Adenocarcinomas
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D018263 1997
% 215.74/215.90  |- skos__prefLabel mesh__D018263 Adenocarcinoma, Follicular
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D018263 2004
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D018263 2001
% 215.74/215.90  |- mesh__recordOriginator mesh__D018263 PLS
% 215.74/215.90  |- mesh__publicMeSHNote mesh__D018263 94   
% 215.74/215.90  |- skos__annotation mesh__D018263
% 215.74/215.90       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with THYROID NEOPLASMS %28%IM%29%%A%  
% 215.74/215.90  |- skos__hiddenLabel mesh__D010280 Glands, Parathyroid
% 215.74/215.90  |- skos__prefLabel mesh__D010280 Parathyroid Glands
% 215.74/215.90  |- skos__annotation mesh__D010280 /surg: consider also PARATHYROIDECTOMY   
% 215.74/215.90  |- mesh__dateRevised mesh__D010280 2005-06-30
% 215.74/215.90  |- skos__broader mesh__D010280smesh__D004702
% 215.74/215.90  |- skos__hiddenLabel mesh__D010280 Gland, Parathyroid
% 215.74/215.90  |- rdf__type mesh__D010280sskos__Concept
% 215.74/215.90  |- mesh__recordOriginator mesh__D010280 NLM
% 215.74/215.90  |- mesh__dateCreated mesh__D010280 1999-01-01
% 215.74/215.90  |- skos__scopeNote mesh__D010280
% 215.74/215.90       Two pairs of small oval-shaped glands located in the front and the base of the NECK and adjacent to the two lobes of THYROID GLAND. They secrete PARATHYROID HORMONE that regulates the balance of CALCIUM; PHOSPHORUS; and MAGNESIUM in the body.%A%    
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D010280 2006
% 215.74/215.90  |- skos__related mesh__D010280smesh__D016105
% 215.74/215.90  |- skos__hiddenLabel mesh__D010280 Parathyroid Gland
% 215.74/215.90  |- mesh__recordAuthorizer mesh__D010280 sjn
% 215.74/215.90  |- mesh__recordMaintainer mesh__D010280 lkt
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D051697 2006
% 215.74/215.90  |- skos__altLabel mesh__D051697 ATF1 Transcription Factor
% 215.74/215.90  |- mesh__recordMaintainer mesh__D051697 DRC
% 215.74/215.90  |- mesh__recordOriginator mesh__D051697 DRC
% 215.74/215.90  |- mesh__dateCreated mesh__D051697 2005-06-30
% 215.74/215.90  |- mesh__publicMeSHNote mesh__D051697
% 215.74/215.90       2006; ACTIVATING TRANSCRIPTION FACTOR 1 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1993-2005%A%  
% 215.74/215.90  |- skos__scopeNote mesh__D051697
% 215.74/215.90       An activating transcription factor that regulates expression of a variety of genes including C-JUN GENES and TRANSFORMING GROWTH FACTOR BETA2.%A%    
% 215.74/215.90  |- mesh__historyNote mesh__D051697 2006%28%1993%29%   
% 215.74/215.90  |- mesh__recordAuthorizer mesh__D051697 sjn
% 215.74/215.90  |- skos__broader mesh__D051697smesh__D051696
% 215.74/215.90  |- rdf__type mesh__D051697sskos__Concept
% 215.74/215.90  |- skos__prefLabel mesh__D051697 Activating Transcription Factor 1
% 215.74/215.90  |- skos__hiddenLabel mesh__D051697 Transcription Factor, ATF1
% 215.74/215.90  |- skos__altLabel mesh__D051697 Activating Transcription Factor-1
% 215.74/215.90  |- mesh__dateEstablished mesh__D051697 2006-01-01
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D004243 2006
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D004243 1998
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D004243 1997
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D004243 2005
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D004243 2004
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D004243 2002
% 215.74/215.90  |- mesh__recordOriginator mesh__D004243 NLM
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D004243 1996
% 215.74/215.90  |- mesh__dateCreated mesh__D004243 1999-01-01
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D004243 2003
% 215.74/215.90  |- skos__prefLabel mesh__D004243 Divorce
% 215.74/215.90  |- mesh__recordMaintainer mesh__D004243 PLS
% 215.74/215.90  |- skos__broader mesh__D004243smesh__D017533
% 215.74/215.90  |- skos__scopeNote mesh__D004243
% 215.74/215.90       Legal dissolution of an officially recognized marriage relationship.%A%    
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D004243 1995
% 215.74/215.90  |- skos__hiddenLabel mesh__D004243 Divorces
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D004243 2001
% 215.74/215.90  |- rdf__type mesh__D004243sskos__Concept
% 215.74/215.90  |- skos__hiddenLabel mesh__D004243 Separations
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D004243 1994
% 215.74/215.90  |- mesh__recordAuthorizer mesh__D004243 NLM
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D004243 2000
% 215.74/215.90  |- skos__broader mesh__D004243smesh__D012940
% 215.74/215.90  |- mesh__dateRevised mesh__D004243 1993-06-05
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D004243 1999
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D017969 2003
% 215.74/215.90  |- mesh__dateEstablished mesh__D017969 1994-01-01
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D017969 1996
% 215.74/215.90  |- rdf__type mesh__D017969sskos__Concept
% 215.74/215.90  |- skos__annotation mesh__D017969
% 215.74/215.90       a subgenus of the genus Lentivirus; infection: coord IM with LENTIVIRUS INFECTIONS %28%IM%29%%A%  
% 215.74/215.90  |- skos__prefLabel mesh__D017969 Lentiviruses, Feline
% 215.74/215.90  |- skos__scopeNote mesh__D017969
% 215.74/215.90       A subgenus of LENTIVIRUS comprising viruses that produce multi-organ disease with long incubation periods in cats.%A%    
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D017969 2006
% 215.74/215.90  |- skos__hiddenLabel mesh__D017969 Feline Lentivirus
% 215.74/215.90  |- skos__hiddenLabel mesh__D017969 Lentivirus, Feline
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D017969 1999
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D017969 2002
% 215.74/215.90  |- mesh__dateCreated mesh__D017969 1993-06-04
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D017969 2005
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D017969 1998
% 215.74/215.90  |- mesh__publicMeSHNote mesh__D017969 94   
% 215.74/215.90  |- skos__altLabel mesh__D017969 Feline Lentiviruses
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D017969 1995
% 215.74/215.90  |- mesh__historyNote mesh__D017969 94   
% 215.74/215.90  |- skos__broader mesh__D017969smesh__D016086
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D017969 2001
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D017969 2004
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D017969 1994
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D017969 1997
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D017969 2000
% 215.74/215.90  |- skos__broader mesh__D003949smesh__D019937
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D003949 2004
% 215.74/215.90  |- skos__annotation mesh__D003949
% 215.74/215.90       GEN: prefer specifics; DF: DIAG TECHNIQUES SURG   
% 215.74/215.90  |- mesh__dateEstablished mesh__D003949 1966-01-01
% 215.74/215.90  |- mesh__recordOriginator mesh__D003949 NLM
% 215.74/215.90  |- skos__altLabel mesh__D003949 Diagnostic Technics, Surgical
% 215.74/215.90  |- mesh__dateRevised mesh__D003949 1997-06-20
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D003949 2005
% 215.74/215.90  |- mesh__recordMaintainer mesh__D003949 PXP
% 215.74/215.90  |- skos__altLabel mesh__D003949 Diagnostic Technique, Surgical
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D003949 2003
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D003949 2001
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D003949 1999
% 215.74/215.90  |- rdf__type mesh__D003949sskos__Concept
% 215.74/215.90  |- skos__altLabel mesh__D003949 Surgical Diagnostic Technics
% 215.74/215.90  |- skos__altLabel mesh__D003949 Technique, Surgical Diagnostic
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D003949 2000
% 215.74/215.90  |- skos__altLabel mesh__D003949 Technics, Surgical Diagnostic
% 215.74/215.90  |- skos__altLabel mesh__D003949 Surgical Diagnostic Techniques
% 215.74/215.90  |- mesh__historyNote mesh__D003949 98%28%66%29%   
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D003949 1998
% 215.74/215.90  |- skos__altLabel mesh__D003949 Surgical Diagnostic Technique
% 215.74/215.90  |- skos__altLabel mesh__D003949 Surgical Diagnostic Technic
% 215.74/215.90  |- skos__altLabel mesh__D003949 Techniques, Surgical Diagnostic
% 215.74/215.90  |- mesh__publicMeSHNote mesh__D003949
% 215.74/215.90       98; see DIAGNOSIS, SURGICAL 1966-97   
% 215.74/215.90  |- skos__altLabel mesh__D003949 Diagnostic Technic, Surgical
% 215.74/215.90  |- skos__scopeNote mesh__D003949
% 215.74/215.90       Methods and procedures for the diagnosis of disease or dysfunction by examination of the pathological site or operative field during surgical intervention.%A%    
% 215.74/215.90  |- mesh__recordAuthorizer mesh__D003949 SJN
% 215.74/215.90  |- skos__prefLabel mesh__D003949 Diagnostic Techniques, Surgical
% 215.74/215.90  |- skos__altLabel mesh__D003949 Technic, Surgical Diagnostic
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D003949 2002
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D003949 2006
% 215.74/215.90  |- mesh__dateCreated mesh__D003949 1999-01-01
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014671 2003
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014671 1996
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014671 2005
% 215.74/215.90  |- rdf__type mesh__D014671sskos__Concept
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014671 1998
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014671 2004
% 215.74/215.90  |- mesh__dateRevised mesh__D014671 1995-05-25
% 215.74/215.90  |- skos__prefLabel mesh__D014671 Vatican City
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014671 1997
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014671 2002
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014671 2006
% 215.74/215.90  |- mesh__dateCreated mesh__D014671 1999-01-01
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014671 1999
% 215.74/215.90  |- mesh__recordMaintainer mesh__D014671 PLS
% 215.74/215.90  |- skos__broader mesh__D014671smesh__D005060
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014671 2000
% 215.74/215.90  |- mesh__recordOriginator mesh__D014671 NLM
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014671 2001
% 215.74/215.90  |- mesh__recordAuthorizer mesh__D014671 PLS
% 215.74/215.90  |- mesh__recordMaintainer mesh__D008634 CCR
% 215.74/215.90  |- mesh__onlineNote mesh__D008634
% 215.74/215.90       use DIURETICS, MERCURIAL to search MERSALYL 1966-74   
% 215.74/215.90  |- mesh__dateCreated mesh__D008634 1999-01-01
% 215.74/215.90  |- mesh__historyNote mesh__D008634
% 215.74/215.90       91%28%75%29%; was see under DIURETICS, MERCURIAL 1975-90   
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D008634 2002
% 215.74/215.90  |- skos__broader mesh__D008634smesh__D000479
% 215.74/215.90  |- mesh__publicMeSHNote mesh__D008634
% 215.74/215.90       91; was see under DIURETICS, MERCURIAL 1975-90   
% 215.74/215.90  |- mesh__recordOriginator mesh__D008634 NLM
% 215.74/215.90  |- skos__scopeNote mesh__D008634
% 215.74/215.90       A toxic thiol mercury salt formerly used as a diuretic. It inhibits various biochemical functions, especially in mitochondria, and is used to study those functions.%A%    
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D008634 2006
% 215.74/215.90  |- skos__altLabel mesh__D008634 Mercuramide
% 215.74/215.90  |- mesh__dateEstablished mesh__D008634 1991-01-01
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D008634 2005
% 215.74/215.90  |- skos__prefLabel mesh__D008634 Mersalyl
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D008634 2004
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D008634 2001
% 215.74/215.90  |- mesh__dateRevised mesh__D008634 2000-06-21
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D008634 2003
% 215.74/215.90  |- mesh__recordAuthorizer mesh__D008634 sjn
% 215.74/215.90  |- skos__hiddenLabel mesh__D008634 Acid, Mersalyl
% 215.74/215.90  |- rdf__type mesh__D008634sskos__Concept
% 215.74/215.90  |- skos__related mesh__D010281smesh__D044162
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D010281 2005
% 215.74/215.90  |- skos__annotation mesh__D010281
% 215.74/215.90       /defic: consider also HYPOPARATHYROIDISM; see SCR for organism-specific terms%A%  
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D010281 2004
% 215.74/215.90  |- skos__altLabel mesh__D010281 Parathormone
% 215.74/215.90  |- skos__altLabel mesh__D010281 PTH %28%1-84%29%
% 215.74/215.90  |- skos__altLabel mesh__D010281 Parathyroid Hormone %28%1-84%29%
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D010281 2006
% 215.74/215.90  |- skos__scopeNote mesh__D010281
% 215.74/215.90       A polypeptide hormone %28%84 amino acid residues%29% secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates.%A%    
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D010281 2005A
% 215.74/215.90  |- mesh__recordAuthorizer mesh__D010281 jls
% 215.74/215.90  |- mesh__dateRevised mesh__D010281 2004-07-30
% 215.74/215.90  |- mesh__historyNote mesh__D010281 2004%28%1963-1981%29%;   
% 215.74/215.90  |- skos__related mesh__D010281smesh__D007011
% 215.74/215.90  |- mesh__recordOriginator mesh__D010281 NLM
% 215.74/215.90  |- skos__prefLabel mesh__D010281 Parathyroid Hormone
% 215.74/215.90  |- skos__hiddenLabel mesh__D010281 Hormone, Parathyroid
% 215.74/215.90  |- mesh__publicMeSHNote mesh__D010281
% 215.74/215.90       2004; see PARATHYROID HORMONES 1982-2003, see PARATHYROID HORMONE 1963-1981%A%  
% 215.74/215.90  |- mesh__recordMaintainer mesh__D010281 jls
% 215.74/215.90  |- skos__altLabel mesh__D010281 Parathyrin
% 215.74/215.90  |- rdf__type mesh__D010281sskos__Concept
% 215.74/215.90  |- mesh__dateCreated mesh__D010281 1999-01-01
% 215.74/215.90  |- skos__broader mesh__D010281smesh__D036361
% 215.74/215.90  |- skos__altLabel mesh__D051698 ATF2 Transcription Factor
% 215.74/215.90  |- mesh__dateEstablished mesh__D051698 2006-01-01
% 215.74/215.90  |- skos__hiddenLabel mesh__D051698 CRE Binding Protein 1
% 215.74/215.90  |- skos__scopeNote mesh__D051698
% 215.74/215.90       An activating transcription factor that regulates expression of a variety of GENES including C-JUN GENES; CYCLIN A; CYCLIN D1; and ACTIVATING TRANSCRIPTION FACTOR 3.%A%    
% 215.74/215.90  |- skos__altLabel mesh__D051698 CRE-Binding Protein 1
% 215.74/215.90  |- skos__prefLabel mesh__D051698 Activating Transcription Factor 2
% 215.74/215.90  |- rdf__type mesh__D051698sskos__Concept
% 215.74/215.90  |- mesh__publicMeSHNote mesh__D051698
% 215.74/215.90       2006; ACTIVATING TRANSCRIPTION FACTOR 2 was indexed under DNA-BINDING PROTEIN, CYCLIC-AMP RESPONSIVE %26% TRANSCRIPTION FACTORS 1993-2005%A%  
% 215.74/215.90  |- mesh__recordMaintainer mesh__D051698 DRC
% 215.74/215.90  |- mesh__dateCreated mesh__D051698 2005-06-30
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D051698 2006
% 215.74/215.90  |- skos__hiddenLabel mesh__D051698 Transcription Factor, ATF2
% 215.74/215.90  |- mesh__historyNote mesh__D051698 2006%28%1993%29%   
% 215.74/215.90  |- mesh__recordOriginator mesh__D051698 DRC
% 215.74/215.90  |- mesh__recordAuthorizer mesh__D051698 sjn
% 215.74/215.90  |- skos__broader mesh__D051698smesh__D051696
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D004244 2006
% 215.74/215.90  |- skos__prefLabel mesh__D004244 Dizziness
% 215.74/215.90  |- skos__altLabel mesh__D004244 Light-Headedness
% 215.74/215.90  |- mesh__dateCreated mesh__D004244 1978-05-17
% 215.74/215.90  |- skos__historyNote mesh__D004244 Vertigo %28%1966-1978%29%
% 215.74/215.90  |- mesh__publicMeSHNote mesh__D004244 1979   
% 215.74/215.90  |- mesh__dateRevised mesh__D004244 2004-07-07
% 215.74/215.90  |- mesh__recordMaintainer mesh__D004244 nns
% 215.74/215.90  |- mesh__historyNote mesh__D004244 1979   
% 215.74/215.90  |- skos__hiddenLabel mesh__D004244 Light Headedness
% 215.74/215.90  |- skos__scopeNote mesh__D004244
% 215.74/215.90       An imprecise term which may refer to a sense of spatial disorientation, motion of the environment, or lightheadedness.%A%    
% 215.74/215.90  |- skos__broader mesh__D004244smesh__D012678
% 215.74/215.90  |- rdf__type mesh__D004244sskos__Concept
% 215.74/215.90  |- skos__altLabel mesh__D004244 Dizzyness
% 215.74/215.90  |- skos__annotation mesh__D004244
% 215.74/215.90       differentiate from VERTIGO, illusion of revolution in space, but use word of text%A%  
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D004244 2005
% 215.74/215.90  |- mesh__dateEstablished mesh__D004244 1979-01-01
% 215.74/215.90  |- mesh__recordOriginator mesh__D004244 RC
% 215.74/215.90  |- skos__related mesh__D004244smesh__D014717
% 215.74/215.90  |- mesh__recordAuthorizer mesh__D004244 sjn
% 215.74/215.90  |- mesh__recordOriginator mesh__D014672 NLM
% 215.74/215.90  |- skos__prefLabel mesh__D014672 Vectorcardiography
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014672 2004
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014672 2001
% 215.74/215.90  |- skos__hiddenLabel mesh__D014672 Vectorcardiographies
% 215.74/215.90  |- mesh__recordMaintainer mesh__D014672 PXP
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014672 2006
% 215.74/215.90  |- mesh__dateCreated mesh__D014672 1999-01-01
% 215.74/215.90  |- skos__broader mesh__D014672smesh__D004562
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014672 1999
% 215.74/215.90  |- mesh__dateRevised mesh__D014672 1997-06-20
% 215.74/215.90  |- skos__altLabel mesh__D014672 Vector Electrocardiography
% 215.74/215.90  |- skos__altLabel mesh__D014672 Vectercardiography
% 215.74/215.90  |- skos__hiddenLabel mesh__D014672 Polarcardiographies
% 215.74/215.90  |- skos__altLabel mesh__D014672 Electrocardiography, Vector
% 215.74/215.90  |- mesh__publicMeSHNote mesh__D014672
% 215.74/215.90       POLARCARDIOGRAPHY was heading 1975-96 %28%see under VECTORCARDIOGRAPHY 1975-90%29%; was see under VECTORCARDIOGRAPHY 1965-74 %28%Prov 1965-73%29%%A%  
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014672 2002
% 215.74/215.90  |- mesh__recordAuthorizer mesh__D014672 SJN
% 215.74/215.90  |- skos__hiddenLabel mesh__D014672 Electrocardiographies, Vector
% 215.74/215.90  |- skos__hiddenLabel mesh__D014672 Vector Electrocardiographies
% 215.74/215.90  |- skos__scopeNote mesh__D014672
% 215.74/215.90       Recording of the moment-to-moment electromotive forces of the heart on a plane of the body surface delineated as a vector function of time.%A%    
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014672 2003
% 215.74/215.90  |- skos__annotation mesh__D014672
% 215.74/215.90       /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: VECTORCARDIOGR or VECTOR ECG%A%  
% 215.74/215.90  |- skos__hiddenLabel mesh__D014672 Vectercardiographies
% 215.74/215.90  |- rdf__type mesh__D014672sskos__Concept
% 215.74/215.90  |- mesh__historyNote mesh__D014672
% 215.74/215.90       POLARCARDIOGRAPHY was heading 1975-96 %28%see under VECTORCARDIOGRAPHY 1975-90%29%; was see under VECTORCARDIOGRAPHY 1965-74 %28%Prov 1965-73%29%%A%  
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014672 2005
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014672 2000
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D014672 1998
% 215.74/215.90  |- skos__broader mesh__D008635smesh__D000470
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D008635 2006
% 215.74/215.90  |- mesh__recordMaintainer mesh__D008635 CCR
% 215.74/215.90  |- skos__prefLabel mesh__D008635 Mescaline
% 215.74/215.90  |- mesh__historyNote mesh__D008635
% 215.74/215.90       PEYOTE was see under MESCALINE 1963-78   
% 215.74/215.90  |- skos__scopeNote mesh__D008635
% 215.74/215.90       Hallucinogenic alkaloid isolated from the flowering heads %28%peyote%29% of Lophophora %28%formerly Anhalonium%29% williamsii, a Mexican cactus used in Indian religious rites and as an experimental psychotomimetic. Among its cellular effects are agonist actions at some types of serotonin receptors. It has no accepted therapeutic uses although it is legal for religious use by members of the Native American Church.%A%    
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D008635 2004
% 215.74/215.90  |- skos__altLabel mesh__D008635 Trimethoxyphenethylamine
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D008635 2005
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D008635 2002
% 215.74/215.90  |- mesh__recordOriginator mesh__D008635 NLM
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D008635 2003
% 215.74/215.90  |- rdf__type mesh__D008635sskos__Concept
% 215.74/215.90  |- skos__altLabel mesh__D008635 3,4,5-Trimethoxyphenethylamine
% 215.74/215.90  |- mesh__dateRevised mesh__D008635 2000-06-22
% 215.74/215.90  |- skos__broader mesh__D008635smesh__D010627
% 215.74/215.90  |- mesh__onlineNote mesh__D008635 use MESCALINE to search PEYOTE 1966-78   
% 215.74/215.90  |- mesh__activeMeSHYear mesh__D008635 2001
% 215.74/215.90  |- skos__annotation mesh__D008635
% 215.74/215.90       a peyote alkaloid from Mexican cactus called mescal   
% 215.74/215.90  |- mesh__recordAuthorizer mesh__D008635 sjn
% 215.74/215.91  |- mesh__dateCreated mesh__D008635 1999-01-01
% 215.74/215.91  |- skos__hiddenLabel mesh__D000652 Intrauterine Amputation
% 215.74/215.91  |- mesh__recordOriginator mesh__D000652 AEP
% 215.74/215.91  |- skos__hiddenLabel mesh__D000652 Grooves, Annular
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D000652 2004
% 215.74/215.91  |- skos__historyNote mesh__D000652 Amnion %28%1966-1982%29%
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D000652 2002
% 215.74/215.91  |- skos__scopeNote mesh__D000652
% 215.74/215.91       A disorder present in the newborn infant in which constriction rings or bands, causing soft tissue depressions, encircle digits, extremities, or limbs and sometimes the neck, thorax, or abdomen. They may be associated with intrauterine amputations.%A%    
% 215.74/215.91  |- skos__hiddenLabel mesh__D000652 Band, Amniotic
% 215.74/215.91  |- mesh__recordAuthorizer mesh__D000652 sjn
% 215.74/215.91  |- mesh__publicMeSHNote mesh__D000652 83   
% 215.74/215.91  |- skos__historyNote mesh__D000652
% 215.74/215.91       specific anatomic heading/abnormalities %28%1966-1982%29%
% 215.74/215.91  |- skos__hiddenLabel mesh__D000652 Ring Constriction, Intrauterine
% 215.74/215.91  |- skos__hiddenLabel mesh__D000652 Intrauterine Ring Constriction
% 215.74/215.91  |- skos__hiddenLabel mesh__D000652 Groove, Annular
% 215.74/215.91  |- skos__hiddenLabel mesh__D000652 Constriction, Intrauterine Ring
% 215.74/215.91  |- mesh__dateCreated mesh__D000652 1982-04-19
% 215.74/215.91  |- skos__hiddenLabel mesh__D000652 Bands, Amniotic
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D000652 2005
% 215.74/215.91  |- skos__hiddenLabel mesh__D000652 Syndrome, Amniotic Band
% 215.74/215.91  |- skos__hiddenLabel mesh__D000652 Intrauterine Amputations
% 215.74/215.91  |- skos__hiddenLabel mesh__D000652 Constrictions, Intrauterine Ring
% 215.74/215.91  |- skos__hiddenLabel mesh__D000652 Syndrome, Streeter
% 215.74/215.91  |- skos__annotation mesh__D000652
% 215.74/215.91       constriction bands in newborn inf; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D000652 2000
% 215.74/215.91  |- rdf__type mesh__D000652sskos__Concept
% 215.74/215.91  |- skos__hiddenLabel mesh__D000652 Intrauterine Ring Constrictions
% 215.74/215.91  |- skos__hiddenLabel mesh__D000652 Annular Groove
% 215.74/215.91  |- skos__hiddenLabel mesh__D000652 Amniotic Band
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D000652 2006
% 215.74/215.91  |- skos__prefLabel mesh__D000652 Amniotic Band Syndrome
% 215.74/215.91  |- mesh__recordMaintainer mesh__D000652 kle
% 215.74/215.91  |- skos__hiddenLabel mesh__D000652 Amputations, Intrauterine
% 215.74/215.91  |- mesh__dateEstablished mesh__D000652 1983-01-01
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D000652 2001
% 215.74/215.91  |- skos__altLabel mesh__D000652 Streeter Syndrome
% 215.74/215.91  |- mesh__historyNote mesh__D000652 83   
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D000652 2003
% 215.74/215.91  |- skos__broader mesh__D000652smesh__D007232
% 215.74/215.91  |- mesh__dateRevised mesh__D000652 1999-11-03
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018265 1996
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018265 2003
% 215.74/215.91  |- mesh__recordMaintainer mesh__D018265 KEV
% 215.74/215.91  |- mesh__dateRevised mesh__D018265 1995-06-08
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018265 2000
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018265 1997
% 215.74/215.91  |- skos__scopeNote mesh__D018265
% 215.74/215.91       A thyroid neoplasm of mixed papillary and follicular arrangement. Its biological behavior and prognosis is the same as that of a papillary adenocarcinoma of the thyroid. %28%From DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1271%29%%A%    
% 215.74/215.91  |- mesh__dateCreated mesh__D018265 1993-06-25
% 215.74/215.91  |- mesh__recordOriginator mesh__D018265 PLS
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018265 2004
% 215.74/215.91  |- mesh__recordAuthorizer mesh__D018265 PLS
% 215.74/215.91  |- skos__historyNote mesh__D018265 Carcinoma, Papillary %28%1970-1993%29%
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018265 2001
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018265 1998
% 215.74/215.91  |- mesh__publicMeSHNote mesh__D018265 94   
% 215.74/215.91  |- skos__annotation mesh__D018265
% 215.74/215.91       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with THYROID NEOPLASMS %28%IM%29%%A%  
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018265 2005
% 215.74/215.91  |- mesh__historyNote mesh__D018265 94   
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018265 2002
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018265 1999
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018265 2006
% 215.74/215.91  |- skos__broader mesh__D018265smesh__D000231
% 215.74/215.91  |- rdf__type mesh__D018265sskos__Concept
% 215.74/215.91  |- skos__prefLabel mesh__D018265 Carcinoma, Papillary, Follicular
% 215.74/215.91  |- skos__broader mesh__D018265smesh__D018263
% 215.74/215.91  |- skos__historyNote mesh__D018265 Adenocarcinoma %28%1970-1993%29%
% 215.74/215.91  |- mesh__dateEstablished mesh__D018265 1994-01-01
% 215.74/215.91  |- skos__hiddenLabel mesh__D010282 Carcinomas, Parathyroid
% 215.74/215.91  |- skos__hiddenLabel mesh__D010282 Parathyroid Neoplasm
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D010282 2006
% 215.74/215.91  |- skos__hiddenLabel mesh__D010282 Adenoma, Parathyroid
% 215.74/215.91  |- skos__altLabel mesh__D010282 Parathyroid Cancer
% 215.74/215.91  |- skos__hiddenLabel mesh__D010282 Cancer, Parathyroid
% 215.74/215.91  |- skos__hiddenLabel mesh__D010282 Parathyroid Cancers
% 215.74/215.91  |- skos__altLabel mesh__D010282 Cancer of the Parathyroid
% 215.74/215.91  |- mesh__recordMaintainer mesh__D010282 lkt
% 215.74/215.91  |- skos__hiddenLabel mesh__D010282 Cancers, Parathyroid
% 215.74/215.91  |- skos__altLabel mesh__D010282 Cancer of Parathyroid
% 215.74/215.91  |- mesh__recordAuthorizer mesh__D010282 sjn
% 215.74/215.91  |- skos__broader mesh__D010282smesh__D006258
% 215.74/215.91  |- skos__hiddenLabel mesh__D010282 Parathyroid Carcinomas
% 215.74/215.91  |- rdf__type mesh__D010282sskos__Concept
% 215.74/215.91  |- skos__broader mesh__D010282smesh__D004701
% 215.74/215.91  |- mesh__dateCreated mesh__D010282 1999-01-01
% 215.74/215.91  |- skos__prefLabel mesh__D010282 Parathyroid Neoplasms
% 215.74/215.91  |- mesh__dateRevised mesh__D010282 2005-06-30
% 215.74/215.91  |- skos__altLabel mesh__D010282 Neoplasms, Parathyroid
% 215.74/215.91  |- skos__annotation mesh__D010282
% 215.74/215.91       coordinate IM with histological type of neoplasm %28%IM%29%; parathyroid adenoma: coordinate IM with ADENOMA in spite of entry term PARATHYROID ADENOMA%A%  
% 215.74/215.91  |- skos__hiddenLabel mesh__D010282 Neoplasm, Parathyroid
% 215.74/215.91  |- skos__hiddenLabel mesh__D010282 Carcinoma, Parathyroid
% 215.74/215.91  |- skos__scopeNote mesh__D010282
% 215.74/215.91       Tumors or cancer of the PARATHYROID GLANDS.     
% 215.74/215.91  |- mesh__recordOriginator mesh__D010282 NLM
% 215.74/215.91  |- skos__hiddenLabel mesh__D010282 Adenomas, Parathyroid
% 215.74/215.91  |- skos__hiddenLabel mesh__D010282 Parathyroid Adenomas
% 215.74/215.91  |- skos__broader mesh__D010282smesh__D010279
% 215.74/215.91  |- skos__broader mesh__D051699smesh__D050976
% 215.74/215.91  |- rdf__type mesh__D051699sskos__Concept
% 215.74/215.91  |- mesh__historyNote mesh__D051699 2006%28%1993%29%   
% 215.74/215.91  |- mesh__recordAuthorizer mesh__D051699 sjn
% 215.74/215.91  |- skos__scopeNote mesh__D051699
% 215.74/215.91       A basic leucine zipper transcription factor that is highly homologous to ACTIVATING TRANSCRIPTION FACTOR 2. It binds the consensus site TGACGTCA of the cyclic AMP response element in partnership with either PROTO-ONCOGENE PROTEINS C-JUN or activating transcription factor 2.%A%    
% 215.74/215.91  |- mesh__publicMeSHNote mesh__D051699
% 215.74/215.91       2006; CYCLIC AMP RESPONSE ELEMENT BINDING PROTEIN A was indexed under DNA-BINDING PROTEIN, CYCLIC-AMP RESPONSIVE %26% TRANSCRIPTION FACTORS 1993-2005%A%  
% 215.74/215.91  |- mesh__dateEstablished mesh__D051699 2006-01-01
% 215.74/215.91  |- skos__hiddenLabel mesh__D051699 CRE BPa Transcription Factor
% 215.74/215.91  |- skos__altLabel mesh__D051699
% 215.74/215.91       Cyclic AMP Response Element Binding Protein A
% 215.74/215.91  |- skos__altLabel mesh__D051699 CRE-BPa Transcription Factor
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D051699 2006
% 215.74/215.91  |- skos__altLabel mesh__D051699
% 215.74/215.91       Cyclic AMP Response Element Binding Protein 5
% 215.74/215.91  |- mesh__recordOriginator mesh__D051699 DRC
% 215.74/215.91  |- skos__prefLabel mesh__D051699
% 215.74/215.91       Cyclic AMP Response Element-Binding Protein A
% 215.74/215.91  |- mesh__recordMaintainer mesh__D051699 DRC
% 215.74/215.91  |- mesh__dateCreated mesh__D051699 2005-06-30
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D004245 2004
% 215.74/215.91  |- skos__altLabel mesh__D004245 DMF Indexes
% 215.74/215.91  |- mesh__dateEstablished mesh__D004245 1966-01-01
% 215.74/215.91  |- mesh__dateRevised mesh__D004245 1992-05-14
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D004245 2000
% 215.74/215.91  |- mesh__recordMaintainer mesh__D004245 PLS
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D004245 1994
% 215.74/215.91  |- skos__hiddenLabel mesh__D004245 Indexes, DMF
% 215.74/215.91  |- skos__hiddenLabel mesh__D004245 Indexe, DMF
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D004245 2001
% 215.74/215.91  |- mesh__recordAuthorizer mesh__D004245 PLS
% 215.74/215.91  |- skos__annotation mesh__D004245 no qualif   
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D004245 1995
% 215.74/215.91  |- mesh__historyNote mesh__D004245 66   
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D004245 2002
% 215.74/215.91  |- skos__scopeNote mesh__D004245
% 215.74/215.91       %22%Decayed, missing and filled teeth,%22% a routinely used statistical concept in dentistry.%A%    
% 215.74/215.91  |- rdf__type mesh__D004245sskos__Concept
% 215.74/215.91  |- skos__hiddenLabel mesh__D004245 DMF Indices
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D004245 1998
% 215.74/215.91  |- skos__hiddenLabel mesh__D004245 Indices, DMF
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D004245 1993
% 215.74/215.91  |- skos__hiddenLabel mesh__D004245 DMF Indexe
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D004245 2005
% 215.74/215.91  |- skos__prefLabel mesh__D004245 DMF Index
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D004245 1996
% 215.74/215.91  |- mesh__dateCreated mesh__D004245 1999-01-01
% 215.74/215.91  |- skos__hiddenLabel mesh__D004245 Index, DMF
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D004245 1999
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D004245 2003
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D004245 2006
% 215.74/215.91  |- mesh__publicMeSHNote mesh__D004245 66   
% 215.74/215.91  |- mesh__recordOriginator mesh__D004245 NLM
% 215.74/215.91  |- skos__broader mesh__D004245smesh__D003753
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D004245 1997
% 215.74/215.91  |- skos__hiddenLabel mesh__D014673 Bromide, Vecuronium
% 215.74/215.91  |- mesh__recordMaintainer mesh__D014673 TWD
% 215.74/215.91  |- skos__historyNote mesh__D014673 Androstanes %28%1968-1971%29%
% 215.74/215.91  |- skos__historyNote mesh__D014673
% 215.74/215.91       Pancuronium/analogs %26% derivatives %28%1972-1986%29%
% 215.74/215.91  |- mesh__historyNote mesh__D014673
% 215.74/215.91       95; was VECURONIUM 1987-94; VECURONIUM BROMIDE was see VECURONIUM 1987-94%A%  
% 215.74/215.91  |- skos__hiddenLabel mesh__D014673 Hydrochloride, Vecuronium
% 215.74/215.91  |- skos__hiddenLabel mesh__D014673 NC45
% 215.74/215.91  |- mesh__recordAuthorizer mesh__D014673 sjn
% 215.74/215.91  |- mesh__onlineNote mesh__D014673
% 215.74/215.91       use VECURONIUM BROMIDE to search VECURONIUM 1987-94   
% 215.74/215.91  |- mesh__recordOriginator mesh__D014673 RLS
% 215.74/215.91  |- skos__prefLabel mesh__D014673 Vecuronium Bromide
% 215.74/215.91  |- mesh__dateCreated mesh__D014673 1986-06-02
% 215.74/215.91  |- skos__scopeNote mesh__D014673
% 215.74/215.91       Monoquaternary homolog of PANCURONIUM. A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. Its lack of significant cardiovascular effects and lack of dependence on good kidney function for elimination as well as its short duration of action and easy reversibility provide advantages over, or alternatives to, other established neuromuscular blocking agents.%A%    
% 215.74/215.91  |- skos__hiddenLabel mesh__D014673 Phosphate, Vecuronium
% 215.74/215.91  |- mesh__dateEstablished mesh__D014673 1987-01-01
% 215.74/215.91  |- skos__hiddenLabel mesh__D014673 Citrate, Vecuronium
% 215.74/215.91  |- skos__altLabel mesh__D014673 ORG-NC 45
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D014673 2003
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D014673 2001
% 215.74/215.91  |- skos__hiddenLabel mesh__D014673 ORG NC 45
% 215.74/215.91  |- skos__hiddenLabel mesh__D014673 Hydrobromide, Vecuronium
% 215.74/215.91  |- rdf__type mesh__D014673sskos__Concept
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D014673 2005
% 215.74/215.91  |- mesh__publicMeSHNote mesh__D014673
% 215.74/215.91       95; was VECURONIUM 1987-94; VECURONIUM BROMIDE was see VECURONIUM 1987-94%A%  
% 215.74/215.91  |- skos__hiddenLabel mesh__D014673 ORGNC45
% 215.74/215.91  |- skos__altLabel mesh__D014673 Vecuronium Hydrobromide
% 215.74/215.91  |- skos__altLabel mesh__D014673 ORG-NC-45
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D014673 2004
% 215.74/215.91  |- mesh__dateRevised mesh__D014673 2000-06-22
% 215.74/215.91  |- skos__broader mesh__D014673smesh__D000732
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D014673 2006
% 215.74/215.91  |- skos__hiddenLabel mesh__D014673 NC 45
% 215.74/215.91  |- skos__hiddenLabel mesh__D014673 Maleate, Vecuronium
% 215.74/215.91  |- skos__hiddenLabel mesh__D014673 ORG NC45
% 215.74/215.91  |- skos__hiddenLabel mesh__D014673 ORGNC 45
% 215.74/215.91  |- skos__altLabel mesh__D014673 ORG-NC45
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D014673 2002
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008636 2005
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008636 2000
% 215.74/215.91  |- skos__hiddenLabel mesh__D008636 Cerebral Peduncles
% 215.74/215.91  |- mesh__recordMaintainer mesh__D008636 TAP
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008636 1997
% 215.74/215.91  |- skos__hiddenLabel mesh__D008636 Midbrains
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008636 2006
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008636 2003
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008636 2001
% 215.74/215.91  |- skos__prefLabel mesh__D008636 Mesencephalon
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008636 2004
% 215.74/215.91  |- skos__hiddenLabel mesh__D008636 Peduncle, Cerebral
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008636 2002
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008636 1994
% 215.74/215.91  |- mesh__dateCreated mesh__D008636 1999-01-01
% 215.74/215.91  |- skos__altLabel mesh__D008636 Midbrain
% 215.74/215.91  |- rdf__type mesh__D008636sskos__Concept
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008636 1995
% 215.74/215.91  |- mesh__dateRevised mesh__D008636 1992-05-15
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008636 1998
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008636 1993
% 215.74/215.91  |- skos__broader mesh__D008636smesh__D001933
% 215.74/215.91  |- skos__hiddenLabel mesh__D008636 Peduncles, Cerebral
% 215.74/215.91  |- mesh__recordAuthorizer mesh__D008636 PLS
% 215.74/215.91  |- skos__hiddenLabel mesh__D008636 Mesencephalons
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008636 1999
% 215.74/215.91  |- mesh__recordOriginator mesh__D008636 NLM
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008636 1996
% 215.74/215.91  |- mesh__dateCreated mesh__D000653 1999-01-01
% 215.74/215.91  |- skos__related mesh__D000653smesh__D006831
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D000653 2002
% 215.74/215.91  |- skos__hiddenLabel mesh__D000653 Amniotic Fluids
% 215.74/215.91  |- mesh__recordOriginator mesh__D000653 NLM
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D000653 2004
% 215.74/215.91  |- mesh__recordAuthorizer mesh__D000653 sjn
% 215.74/215.91  |- skos__hiddenLabel mesh__D000653 Fluid Indices, Amniotic
% 215.74/215.91  |- skos__annotation mesh__D000653
% 215.74/215.91       intra-amniotic injections do not go here: use AMNION + INJECTIONS; excess fluid and hydramnios = POLYHYDRAMNIOS; fluid deficiency = OLIGOHYDRAMNIOS%A%  
% 215.74/215.91  |- skos__hiddenLabel mesh__D000653 Fluid Index, Amniotic
% 215.74/215.91  |- skos__related mesh__D000653smesh__D005332
% 215.74/215.91  |- skos__related mesh__D000653smesh__D004619
% 215.74/215.91  |- mesh__recordMaintainer mesh__D000653 nns
% 215.74/215.91  |- skos__prefLabel mesh__D000653 Amniotic Fluid
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D000653 2000
% 215.74/215.91  |- skos__hiddenLabel mesh__D000653 Fluid, Amniotic
% 215.74/215.91  |- skos__related mesh__D000653smesh__D016104
% 215.74/215.91  |- skos__hiddenLabel mesh__D000653 Indices, Amniotic Fluid
% 215.74/215.91  |- skos__hiddenLabel mesh__D000653 Fluids, Amniotic
% 215.74/215.91  |- mesh__dateRevised mesh__D000653 1999-11-05
% 215.74/215.91  |- rdf__type mesh__D000653sskos__Concept
% 215.74/215.91  |- skos__broader mesh__D000653smesh__D004622
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D000653 2005
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D000653 2001
% 215.74/215.91  |- skos__hiddenLabel mesh__D000653 Amniotic Fluid Indices
% 215.74/215.91  |- skos__hiddenLabel mesh__D000653 Index, Amniotic Fluid
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D000653 2006
% 215.74/215.91  |- skos__scopeNote mesh__D000653
% 215.74/215.91       Amniotic cavity fluid which is produced by the AMNION and fetal lungs and kidneys.%A%    
% 215.74/215.91  |- skos__broader mesh__D000653smesh__D005441
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D000653 2003
% 215.74/215.91  |- mesh__recordOriginator mesh__D018266 PLS
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018266 2004
% 215.74/215.91  |- mesh__dateEstablished mesh__D018266 1994-01-01
% 215.74/215.91  |- skos__broader mesh__D018266smesh__D018294
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018266 1998
% 215.74/215.91  |- skos__annotation mesh__D018266
% 215.74/215.91       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with SEBACEOUS GLAND NEOPLASMS %28%IM%29%%A%  
% 215.74/215.91  |- skos__historyNote mesh__D018266
% 215.74/215.91       Sebaceous Gland Neoplasms %28%1969-1993%29%
% 215.74/215.91  |- skos__hiddenLabel mesh__D018266 Sebaceous Adenocarcinoma
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018266 2005
% 215.74/215.91  |- mesh__historyNote mesh__D018266 94   
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018266 2000
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018266 1999
% 215.74/215.91  |- mesh__dateCreated mesh__D018266 1993-06-25
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018266 2006
% 215.74/215.91  |- mesh__recordAuthorizer mesh__D018266 PLS
% 215.74/215.91  |- skos__historyNote mesh__D018266 Adenocarcinoma %28%1969-1993%29%
% 215.74/215.91  |- rdf__type mesh__D018266sskos__Concept
% 215.74/215.91  |- skos__hiddenLabel mesh__D018266 Adenocarcinomas, Sebaceous
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018266 2001
% 215.74/215.91  |- mesh__publicMeSHNote mesh__D018266 94   
% 215.74/215.91  |- skos__scopeNote mesh__D018266
% 215.74/215.91       A malignant tumor composed of cells showing differentiation toward sebaceous epithelium. The tumor is solitary, firm, somewhat raised, more or less translucent, and covered with normal or slightly verrucose epidermis. It may be yellow or orange. The face and scalp are the commonest sites. The growth can be slow or rapid but metastasis is uncommon. Surgery cures most of the cases. %28%From Rook et al., Textbook of Dermatology, 4th ed, pp2403-4%29%%A%    
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018266 2002
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018266 1996
% 215.74/215.91  |- skos__prefLabel mesh__D018266 Adenocarcinoma, Sebaceous
% 215.74/215.91  |- skos__broader mesh__D018266smesh__D000230
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018266 2003
% 215.74/215.91  |- mesh__recordMaintainer mesh__D018266 KEV
% 215.74/215.91  |- mesh__dateRevised mesh__D018266 1995-06-08
% 215.74/215.91  |- skos__hiddenLabel mesh__D018266 Sebaceous Adenocarcinomas
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018266 1997
% 215.74/215.91  |- skos__broader mesh__D010283smesh__D000820
% 215.74/215.91  |- skos__annotation mesh__D010283
% 215.74/215.91       caused by Mycobacterium paratuberculosis; usually animal; check tag ANIMAL%A%  
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D010283 2000
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D010283 1995
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D010283 1998
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D010283 2003
% 215.74/215.91  |- mesh__dateCreated mesh__D010283 1999-01-01
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D010283 1994
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D010283 2006
% 215.74/215.91  |- mesh__recordOriginator mesh__D010283 NLM
% 215.74/215.91  |- skos__scopeNote mesh__D010283
% 215.74/215.91       An infectious disease caused by MYCOBACTERIUM PARATUBERCULOSIS. Characteristics include chronic debilitation and weight loss.%A%    
% 215.74/215.91  |- skos__hiddenLabel mesh__D010283 Disease, Johne%27%s
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D010283 2002
% 215.74/215.91  |- skos__altLabel mesh__D010283 Johne Disease
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D010283 2005
% 215.74/215.91  |- mesh__recordMaintainer mesh__D010283 TAP
% 215.74/215.91  |- skos__broader mesh__D010283smesh__D009164
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D010283 1997
% 215.74/215.91  |- skos__prefLabel mesh__D010283 Paratuberculosis
% 215.74/215.91  |- mesh__recordAuthorizer mesh__D010283 PLS
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D010283 1996
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D010283 2001
% 215.74/215.91  |- skos__hiddenLabel mesh__D010283 Disease, Johne
% 215.74/215.91  |- skos__hiddenLabel mesh__D010283 Paratuberculoses
% 215.74/215.91  |- skos__hiddenLabel mesh__D010283 Johnes Disease
% 215.74/215.91  |- skos__altLabel mesh__D010283 Johne%27%s Disease
% 215.74/215.91  |- mesh__dateRevised mesh__D010283 1993-06-02
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D010283 1999
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D010283 2004
% 215.74/215.91  |- rdf__type mesh__D010283sskos__Concept
% 215.74/215.91  |- skos__altLabel mesh__D004246 Dimethylphenylpiperazinium
% 215.74/215.91  |- mesh__dateEstablished mesh__D004246 1991-01-01
% 215.74/215.91  |- rdf__type mesh__D004246sskos__Concept
% 215.74/215.91  |- skos__scopeNote mesh__D004246
% 215.74/215.91       A selective nicotinic cholinergic agonist used as a research tool. DMPP activates nicotinic receptors in autonomic ganglia but has little effect at the neuromuscular junction.%A%    
% 215.74/215.91  |- skos__historyNote mesh__D004246 Piperazines %28%1966-1971%29%
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D004246 2005
% 215.74/215.91  |- mesh__recordOriginator mesh__D004246 NLM
% 215.74/215.91  |- mesh__dateCreated mesh__D004246 1999-01-01
% 215.74/215.91  |- skos__hiddenLabel mesh__D004246 1,1 Dimethyl 4 phenylpiperazine Iodide
% 215.74/215.91  |- skos__historyNote mesh__D004246 Ganglionic Stimulants %28%1971%29%
% 215.74/215.91  |- skos__altLabel mesh__D004246 DMPP
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D004246 2006
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D004246 2003
% 215.74/215.91  |- skos__hiddenLabel mesh__D004246 Iodide, 1,1-Dimethyl-4-phenylpiperazine
% 215.74/215.91  |- skos__broader mesh__D004246smesh__D010879
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D004246 2004
% 215.74/215.91  |- skos__hiddenLabel mesh__D004246 Iodide, Dimethylphenylpiperazinium
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D004246 2001
% 215.74/215.91  |- mesh__historyNote mesh__D004246 2001%28%1972%29%;   
% 215.74/215.91  |- mesh__recordAuthorizer mesh__D004246 ags
% 215.74/215.91  |- skos__prefLabel mesh__D004246 Dimethylphenylpiperazinium Iodide
% 215.74/215.91  |- mesh__publicMeSHNote mesh__D004246
% 215.74/215.91       2001; see DMPP 1991-2000 %26% PIPERAZINES 1972-1990   
% 215.74/215.91  |- mesh__recordMaintainer mesh__D004246 ags
% 215.74/215.91  |- mesh__dateRevised mesh__D004246 2000-07-06
% 215.74/215.91  |- skos__altLabel mesh__D004246 1,1-Dimethyl-4-phenylpiperazine Iodide
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D004246 2002
% 215.74/215.91  |- skos__hiddenLabel mesh__D014674 Proteins, Vegetable
% 215.74/215.91  |- skos__annotation mesh__D014674
% 215.74/215.91       restrict to proteins from vegetables: for fruit proteins index under FRUITS + DIETARY PROTEINS + PLANT PROTEINS; for proteins in non-dietary plants index under PLANT PROTEINS; coord IM with specific vegetable %28%IM%29%%A%  
% 215.74/215.91  |- mesh__onlineNote mesh__D014674 search PLANT PROTEINS 1966-74   
% 215.74/215.91  |- skos__scopeNote mesh__D014674
% 215.74/215.91       Proteins which are present in or isolated from vegetables or vegetable products used as food. The concept is distinguished from PLANT PROTEINS which refers to non-dietary proteins from plants.%A%    
% 215.74/215.91  |- skos__historyNote mesh__D014674 Plant Proteins %28%1966-1974%29%
% 215.74/215.91  |- rdf__type mesh__D014674sskos__Concept
% 215.74/215.91  |- skos__broader mesh__D014674smesh__D010940
% 215.74/215.91  |- mesh__recordAuthorizer mesh__D014674 sjn
% 215.74/215.91  |- mesh__historyNote mesh__D014674
% 215.74/215.91       75; was see under PLANT PROTEINS 1963-74   
% 215.74/215.91  |- mesh__recordMaintainer mesh__D014674 SYSTEM
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D014674 2006
% 215.74/215.91  |- mesh__dateCreated mesh__D014674 1999-01-01
% 215.74/215.91  |- mesh__publicMeSHNote mesh__D014674
% 215.74/215.91       75; was see under PLANT PROTEINS 1963-74   
% 215.74/215.91  |- mesh__recordOriginator mesh__D014674 NLM
% 215.74/215.91  |- skos__prefLabel mesh__D014674 Vegetable Proteins
% 215.74/215.91  |- mesh__dateRevised mesh__D014674 2005-06-30
% 215.74/215.91  |- skos__broader mesh__D014674smesh__D004044
% 215.74/215.91  |- mesh__dateEstablished mesh__D014674 1975-01-01
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008637 2006
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008637 2003
% 215.74/215.91  |- mesh__recordAuthorizer mesh__D008637 PLS
% 215.74/215.91  |- mesh__dateRevised mesh__D008637 1995-06-08
% 215.74/215.91  |- mesh__recordOriginator mesh__D008637 NLM
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008637 2004
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008637 2000
% 215.74/215.91  |- skos__prefLabel mesh__D008637 Mesenchymoma
% 215.74/215.91  |- mesh__dateCreated mesh__D008637 1999-01-01
% 215.74/215.91  |- rdf__type mesh__D008637sskos__Concept
% 215.74/215.91  |- skos__hiddenLabel mesh__D008637 Mesenchymomas
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008637 2001
% 215.74/215.91  |- skos__scopeNote mesh__D008637
% 215.74/215.91       A mixed mesenchymal tumor composed of two or more mesodermal cellular elements not commonly associated, not counting fibrous tissue as one of the elements. Mesenchymomas are widely distributed in the body and about 75%25% are malignant. %28%Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1866%29%%A%    
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008637 1998
% 215.74/215.91  |- skos__annotation mesh__D008637
% 215.74/215.91       benign or malignant; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008637 2002
% 215.74/215.91  |- mesh__recordMaintainer mesh__D008637 KEV
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008637 1999
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008637 1996
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008637 2005
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D008637 1997
% 215.74/215.91  |- skos__broader mesh__D008637smesh__D018193
% 215.74/215.91  |- skos__altLabel mesh__D000654 Bramble Brand of Amobarbital Sodium
% 215.74/215.91  |- mesh__recordMaintainer mesh__D000654 lkw
% 215.74/215.91  |- skos__altLabel mesh__D000654 Fawns %26% McAllan Brand of Amorbarbital
% 215.74/215.91  |- skos__altLabel mesh__D000654 Flynn Brand of Amobarbital Sodium
% 215.74/215.91  |- skos__altLabel mesh__D000654 Flynn Brand of Amobarbital
% 215.74/215.91  |- skos__altLabel mesh__D000654 Lilly Brand of Amobarbital Sodium
% 215.74/215.91  |- skos__altLabel mesh__D000654 Protea Brand of Amobarbital Sodium
% 215.74/215.91  |- skos__hiddenLabel mesh__D000654 Sodium, Amobarbital
% 215.74/215.91  |- skos__altLabel mesh__D000654 Amylobarbitone
% 215.74/215.91  |- skos__altLabel mesh__D000654 Transital
% 215.74/215.91  |- skos__hiddenLabel mesh__D000654 Amobarbital, Sodium
% 215.74/215.91  |- skos__altLabel mesh__D000654 Novopharm Brand of Amobarbital Sodium
% 215.74/215.91  |- skos__altLabel mesh__D000654 Lilly Brand of Amobarbital
% 215.74/215.91  |- skos__prefLabel mesh__D000654 Amobarbital
% 215.74/215.91  |- skos__altLabel mesh__D000654 Sodium Amytal
% 215.74/215.91  |- skos__broader mesh__D000654smesh__D001463
% 215.74/215.91  |- rdf__type mesh__D000654sskos__Concept
% 215.74/215.91  |- mesh__recordOriginator mesh__D000654 NLM
% 215.74/215.91  |- skos__scopeNote mesh__D000654
% 215.74/215.91       A barbiturate with hypnotic and sedative properties %28%but not antianxiety%29%. Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p565%29%%A%    
% 215.74/215.91  |- mesh__recordAuthorizer mesh__D000654 sjn
% 215.74/215.91  |- skos__altLabel mesh__D000654 Sodium Amobarbital
% 215.74/215.91  |- skos__hiddenLabel mesh__D000654 NeurAmyl
% 215.74/215.91  |- skos__altLabel mesh__D000654 Adams Brand of Amobarbital Sodium
% 215.74/215.91  |- skos__altLabel mesh__D000654 ICN Brand of Amorbarbital
% 215.74/215.91  |- skos__altLabel mesh__D000654 Pentymal
% 215.74/215.91  |- skos__altLabel mesh__D000654 Miquel Brand of Amorbarbital
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D000654 2006
% 215.74/215.91  |- skos__altLabel mesh__D000654 Hosbon Brand of Amorbarbital
% 215.74/215.91  |- skos__altLabel mesh__D000654 Houd%C3%%A9% Brand of Amobarbital Sodium
% 215.74/215.91  |- skos__hiddenLabel mesh__D000654 Amorbarbital Miquel Brand
% 215.74/215.91  |- mesh__dateCreated mesh__D000654 1999-01-01
% 215.74/215.91  |- mesh__dateRevised mesh__D000654 2005-06-30
% 215.74/215.91  |- skos__altLabel mesh__D000654 Adams Brand of Amorbarbital
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018267 1997
% 215.74/215.91  |- mesh__activeMeSHYear mesh__D018267 2004
% 215.74/215.91  |- skos__broader mesh__D018267smesh__D000230
% 215.74/215.91  |- skos__hiddenLabel mesh__D018267 Cell Carcinomas, Acinar
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D018267 1996
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D018267 2003
% 215.74/215.92  |- mesh__recordMaintainer mesh__D018267 KEV
% 215.74/215.92  |- skos__hiddenLabel mesh__D018267 Cell Carcinoma, Acinar
% 215.74/215.92  |- skos__historyNote mesh__D018267 Carcinoma %28%1966-1993%29%
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D018267 2002
% 215.74/215.92  |- mesh__publicMeSHNote mesh__D018267 94   
% 215.74/215.92  |- mesh__recordOriginator mesh__D018267 PLS
% 215.74/215.92  |- mesh__recordAuthorizer mesh__D018267 PLS
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D018267 1999
% 215.74/215.92  |- mesh__historyNote mesh__D018267 94   
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D018267 2006
% 215.74/215.92  |- skos__hiddenLabel mesh__D018267 Acinar Cell Carcinomas
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D018267 2001
% 215.74/215.92  |- skos__scopeNote mesh__D018267
% 215.74/215.92       A malignant tumor arising from secreting cells of a racemose gland, particularly the salivary glands. Racemose %28%Latin racemosus, full of clusters%29% refers, as does acinar %28%Latin acinus, grape%29%, to small saclike dilatations in various glands. Acinar cell carcinomas are usually well differentiated and account for about 13%25% of the cancers arising in the parotid gland. Lymph node metastasis occurs in about 16%25% of cases. Local recurrences and distant metastases many years after treatment are common. This tumor appears in all age groups and is most common in women. %28%Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1240; from DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p575%29%%A%    
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D018267 1998
% 215.74/215.92  |- skos__hiddenLabel mesh__D018267 Acinar Cell Carcinoma
% 215.74/215.92  |- skos__annotation mesh__D018267
% 215.74/215.92       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 215.74/215.92  |- skos__prefLabel mesh__D018267 Carcinoma, Acinar Cell
% 215.74/215.92  |- mesh__dateCreated mesh__D018267 1993-06-25
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D018267 2005
% 215.74/215.92  |- skos__hiddenLabel mesh__D018267 Carcinomas, Acinar Cell
% 215.74/215.92  |- mesh__dateEstablished mesh__D018267 1994-01-01
% 215.74/215.92  |- rdf__type mesh__D018267sskos__Concept
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D018267 2000
% 215.74/215.92  |- mesh__dateRevised mesh__D018267 1995-06-08
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D010284 2006
% 215.74/215.92  |- mesh__recordAuthorizer mesh__D010284 sjn
% 215.74/215.92  |- mesh__onlineNote mesh__D010284
% 215.74/215.92       use PARATYPHOID FEVER to search PARATYPHOID FEVERS 1966-91%A%  
% 215.74/215.92  |- skos__hiddenLabel mesh__D010284 Fevers, Paratyphoid
% 215.74/215.92  |- skos__broader mesh__D010284smesh__D012480
% 215.74/215.92  |- mesh__publicMeSHNote mesh__D010284 92; was PARATYPHOID FEVERS 1963-91   
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D010284 2005
% 215.74/215.92  |- skos__prefLabel mesh__D010284 Paratyphoid Fever
% 215.74/215.92  |- mesh__recordOriginator mesh__D010284 NLM
% 215.74/215.92  |- mesh__historyNote mesh__D010284 92; was PARATYPHOID FEVERS 1963-91   
% 215.74/215.92  |- skos__annotation mesh__D010284
% 215.74/215.92       specify Salmonella paratyphi species if possible %28%IM%29%   
% 215.74/215.92  |- skos__scopeNote mesh__D010284
% 215.74/215.92       A prolonged febrile illness commonly caused by several Paratyphi serotypes of SALMONELLA ENTERICA. It is similar to TYPHOID FEVER but less severe.%A%    
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D010284 2004
% 215.74/215.92  |- rdf__type mesh__D010284sskos__Concept
% 215.74/215.92  |- mesh__recordMaintainer mesh__D010284 ags
% 215.74/215.92  |- mesh__dateRevised mesh__D010284 2002-07-03
% 215.74/215.92  |- skos__hiddenLabel mesh__D010284 Fever, Paratyphoid
% 215.74/215.92  |- skos__hiddenLabel mesh__D010284 Paratyphoid Fevers
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D010284 2003
% 215.74/215.92  |- mesh__dateCreated mesh__D010284 1999-01-01
% 215.74/215.92  |- mesh__recordAuthorizer mesh__D037421 sjn
% 215.74/215.92  |- mesh__dateCreated mesh__D037421 2002-07-02
% 215.74/215.92  |- mesh__dateRevised mesh__D037421 2003-07-09
% 215.74/215.92  |- mesh__dateEstablished mesh__D037421 2003-01-01
% 215.74/215.92  |- rdf__type mesh__D037421sskos__Concept
% 215.74/215.92  |- mesh__recordMaintainer mesh__D037421 ags
% 215.74/215.92  |- skos__scopeNote mesh__D037421
% 215.74/215.92       A class in the phylum CNIDARIA, comprised mostly of corals and anemones. All members occur only as polyps; the medusa stage is completely absent.%A%    
% 215.74/215.92  |- skos__prefLabel mesh__D037421 Anthozoa
% 215.74/215.92  |- skos__broader mesh__D037421smesh__D003063
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D037421 2005
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D037421 2004
% 215.74/215.92  |- mesh__recordOriginator mesh__D037421 ags
% 215.74/215.92  |- mesh__publicMeSHNote mesh__D037421
% 215.74/215.92       2003; for CORALS see CNIDARIA 1998-2002   
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D037421 2006
% 215.74/215.92  |- mesh__historyNote mesh__D037421
% 215.74/215.92       2003; for CORALS use CNIDARIA 1998-2002   
% 215.74/215.92  |- skos__historyNote mesh__D037421 Cnidaria %28%1970-2002%29%
% 215.74/215.92  |- skos__related mesh__D004247smesh__D009691
% 215.74/215.92  |- skos__hiddenLabel mesh__D004247 B-Form DNA
% 215.74/215.92  |- mesh__dateCreated mesh__D004247 1999-01-01
% 215.74/215.92  |- skos__related mesh__D004247smesh__D009693
% 215.74/215.92  |- skos__related mesh__D004247smesh__D017931
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D004247 2006
% 215.74/215.92  |- skos__related mesh__D004247smesh__D012091
% 215.74/215.92  |- mesh__recordMaintainer mesh__D004247 exl
% 215.74/215.92  |- skos__hiddenLabel mesh__D004247 Double-Stranded DNA
% 215.74/215.92  |- mesh__recordOriginator mesh__D004247 NLM
% 215.74/215.92  |- skos__scopeNote mesh__D004247
% 215.74/215.92       A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines %28%adenine and guanine%29% and pyrimidines %28%thymine and cytosine%29%, forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines %28%adenine to thymine and guanine to cytosine%29%.%A%    
% 215.74/215.92  |- skos__annotation mesh__D004247
% 215.74/215.92       GEN: prefer specifics; /biosyn permitted but consider also DNA REPLICATION; structural DNA models = DNA %28%IM%29% + MOLECULAR MODELS %28%IM%29%%A%  
% 215.74/215.92  |- mesh__recordAuthorizer mesh__D004247 sjn
% 215.74/215.92  |- skos__broader mesh__D004247smesh__D009696
% 215.74/215.92  |- mesh__dateRevised mesh__D004247 2005-06-30
% 215.74/215.92  |- skos__altLabel mesh__D004247 Deoxyribonucleic Acid
% 215.74/215.92  |- skos__hiddenLabel mesh__D004247 DNA, Double Stranded
% 215.74/215.92  |- skos__related mesh__D004247smesh__D005815
% 215.74/215.92  |- skos__altLabel mesh__D004247 B-DNA
% 215.74/215.92  |- skos__prefLabel mesh__D004247 DNA
% 215.74/215.92  |- rdf__type mesh__D004247sskos__Concept
% 215.74/215.92  |- skos__hiddenLabel mesh__D004247 DNA, B Form
% 215.74/215.92  |- skos__altLabel mesh__D004247 ds-DNA
% 215.74/215.92  |- mesh__dateEstablished mesh__D009730 1987-01-01
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009730 1998
% 215.74/215.92  |- skos__hiddenLabel mesh__D009730 Nursing Assessments
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009730 2003
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009730 2000
% 215.74/215.92  |- mesh__historyNote mesh__D009730
% 215.74/215.92       87%28%80%29%; was see under NURSING PROCESS 1980-86, was NURSING DIAGNOSIS see under NURSING CARE 1975-79%A%  
% 215.74/215.92  |- skos__broader mesh__D009730smesh__D009736
% 215.74/215.92  |- rdf__type mesh__D009730sskos__Concept
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009730 1999
% 215.74/215.92  |- skos__scopeNote mesh__D009730
% 215.74/215.92       Evaluation of the nature and extent of nursing problems presented by a patient for the purpose of patient care planning.%A%    
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009730 2004
% 215.74/215.92  |- mesh__recordMaintainer mesh__D009730 TGC
% 215.74/215.92  |- skos__prefLabel mesh__D009730 Nursing Assessment
% 215.74/215.92  |- mesh__dateRevised mesh__D009730 1994-05-05
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009730 1996
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009730 2001
% 215.74/215.92  |- skos__hiddenLabel mesh__D009730 Protocol, Nursing
% 215.74/215.92  |- skos__hiddenLabel mesh__D009730 Nursing Protocol
% 215.74/215.92  |- skos__hiddenLabel mesh__D009730 Assessments, Nursing
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009730 1997
% 215.74/215.92  |- skos__annotation mesh__D009730
% 215.74/215.92       to evaluate nature %26% extent of nurs problems of patient to plan patient care; do not confuse with NURSING AUDIT %28%to evaluate quality of nurs care%29%; DF: NURS ASSESS%A%  
% 215.74/215.92  |- mesh__recordOriginator mesh__D009730 NLM
% 215.74/215.92  |- skos__altLabel mesh__D009730 Nursing Protocols
% 215.74/215.92  |- skos__altLabel mesh__D009730 Assessment, Nursing
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009730 2005
% 215.74/215.92  |- mesh__recordAuthorizer mesh__D009730 PLS
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009730 2002
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009730 1995
% 215.74/215.92  |- mesh__dateCreated mesh__D009730 1974-11-11
% 215.74/215.92  |- mesh__publicMeSHNote mesh__D009730
% 215.74/215.92       87; was see under NURSING PROCESS 1980-86, was NURSING DIAGNOSIS see under NURSING CARE 1975-79%A%  
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009730 2006
% 215.74/215.92  |- skos__historyNote mesh__D023401
% 215.74/215.92       Animal Testing Alternatives %28%1985-2000%29%
% 215.74/215.92  |- skos__hiddenLabel mesh__D023401 Alternative, Animal Use
% 215.74/215.92  |- skos__hiddenLabel mesh__D023401 Use Alternatives, Animal
% 215.74/215.92  |- mesh__dateRevised mesh__D023401 2002-07-02
% 215.74/215.92  |- skos__hiddenLabel mesh__D023401 Use Alternative, Animal
% 215.74/215.92  |- skos__hiddenLabel mesh__D023401 Alternatives, Animal Use
% 215.74/215.92  |- skos__hiddenLabel mesh__D023401 Animal Use Alternative
% 215.74/215.92  |- mesh__dateCreated mesh__D023401 2000-06-21
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D023401 2005
% 215.74/215.92  |- mesh__historyNote mesh__D023401 2001   
% 215.74/215.92  |- skos__broader mesh__D023401smesh__D032761
% 215.74/215.92  |- skos__scopeNote mesh__D023401
% 215.74/215.92       Alternatives to the use of animals in research, testing, and education. The alternatives may include reduction in the number of animals used, replacement of animals with a non-animal model or with animals of a species lower phylogenetically, or refinement of methods to minimize pain and distress of animals used.%A%    
% 215.74/215.92  |- mesh__recordOriginator mesh__D023401 jls
% 215.74/215.92  |- skos__related mesh__D023401smesh__D000827
% 215.74/215.92  |- mesh__publicMeSHNote mesh__D023401 2001   
% 215.74/215.92  |- mesh__recordAuthorizer mesh__D023401 sjn
% 215.74/215.92  |- rdf__type mesh__D023401sskos__Concept
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D023401 2006
% 215.74/215.92  |- skos__prefLabel mesh__D023401 Animal Use Alternatives
% 215.74/215.92  |- mesh__dateEstablished mesh__D023401 2001-01-01
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D023401 2003
% 215.74/215.92  |- mesh__recordMaintainer mesh__D023401 tjk
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D023401 2004
% 215.74/215.92  |- skos__related mesh__D023401smesh__D032761
% 215.74/215.92  |- mesh__dateRevised mesh__D014675 2004-07-07
% 215.74/215.92  |- mesh__recordOriginator mesh__D014675 NLM
% 215.74/215.92  |- skos__annotation mesh__D014675
% 215.74/215.92       as plant %26% food; vegetables as plant tissue: Manual 31.10; vegetables as food: Manual 22.30, 31.9; selected qualif from Cat B6 %26% Cat J2%A%  
% 215.74/215.92  |- skos__prefLabel mesh__D014675 Vegetables
% 215.74/215.92  |- skos__hiddenLabel mesh__D014675 Vegetable
% 215.74/215.92  |- rdf__type mesh__D014675sskos__Concept
% 215.74/215.92  |- skos__broader mesh__D014675smesh__D010945
% 215.74/215.92  |- mesh__recordAuthorizer mesh__D014675 sjn
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D014675 2006
% 215.74/215.92  |- skos__broader mesh__D014675smesh__D005502
% 215.74/215.92  |- mesh__dateCreated mesh__D014675 1999-01-01
% 215.74/215.92  |- mesh__recordMaintainer mesh__D014675 ssb
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D014675 2005
% 215.74/215.92  |- rdf__type mesh__D008638sskos__Concept
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D008638 1995
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D008638 2002
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D008638 1998
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D008638 1993
% 215.74/215.92  |- skos__annotation mesh__D008638
% 215.74/215.92       GEN or unspecified; prefer MESENTERIC ARTERY, INFERIOR or MESENTERIC ARTERY, SUPERIOR; occlusion or obstruction: coord NIM with MESENTERIC VASCULAR OCCLUSION %28%IM%29%; embolism or thrombosis: index under MESENTERIC VASCULAR OCCLUSION %28%IM%29% + EMBOLISM or THROMBOSIS %28%IM%29% + MESENTERIC ARTERIES %28%NIM%29%; duodenal compression by superior mesenteric artery = SUPERIOR MESENTERIC ARTERY SYNDROME%A%  
% 215.74/215.92  |- mesh__dateRevised mesh__D008638 1992-05-15
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D008638 1999
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D008638 1996
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D008638 2005
% 215.74/215.92  |- skos__hiddenLabel mesh__D008638 Arteries, Mesenteric
% 215.74/215.92  |- mesh__recordAuthorizer mesh__D008638 PLS
% 215.74/215.92  |- mesh__recordOriginator mesh__D008638 NLM
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D008638 1997
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D008638 2006
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D008638 2003
% 215.74/215.92  |- skos__scopeNote mesh__D008638
% 215.74/215.92       Arteries which arise from the abdominal aorta and distribute to most of the intestines.%A%    
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D008638 2000
% 215.74/215.92  |- mesh__recordMaintainer mesh__D008638 TAP
% 215.74/215.92  |- skos__hiddenLabel mesh__D008638 Artery, Mesenteric
% 215.74/215.92  |- skos__broader mesh__D008638smesh__D001158
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D008638 2004
% 215.74/215.92  |- skos__hiddenLabel mesh__D008638 Mesenteric Artery
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D008638 1994
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D008638 2001
% 215.74/215.92  |- skos__prefLabel mesh__D008638 Mesenteric Arteries
% 215.74/215.92  |- mesh__dateCreated mesh__D008638 1999-01-01
% 215.74/215.92  |- mesh__historyNote mesh__D000655
% 215.74/215.92       AMODIACHIN was see AMODIAQUINE 1978-95   
% 215.74/215.92  |- skos__scopeNote mesh__D000655
% 215.74/215.92       A 4-aminoquinoquinoline compound with anti-inflammatory properties.%A%    
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D000655 2005
% 215.74/215.92  |- skos__altLabel mesh__D000655 Roussel Brand of Amodiaquine Hydrochloride
% 215.74/215.92  |- skos__broader mesh__D000655smesh__D000634
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D000655 2006
% 215.74/215.92  |- mesh__dateRevised mesh__D000655 2003-07-09
% 215.74/215.92  |- mesh__publicMeSHNote mesh__D000655
% 215.74/215.92       AMODIACHIN was see AMODIAQUINE 1978-95   
% 215.74/215.92  |- mesh__dateCreated mesh__D000655 1999-01-01
% 215.74/215.92  |- skos__altLabel mesh__D000655 Amodiaquin
% 215.74/215.92  |- mesh__recordMaintainer mesh__D000655 ssb
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D000655 2004
% 215.74/215.92  |- skos__altLabel mesh__D000655 Amodiachin
% 215.74/215.92  |- skos__prefLabel mesh__D000655 Amodiaquine
% 215.74/215.92  |- mesh__recordOriginator mesh__D000655 NLM
% 215.74/215.92  |- skos__altLabel mesh__D000655 Camoquin
% 215.74/215.92  |- mesh__recordAuthorizer mesh__D000655 sjn
% 215.74/215.92  |- rdf__type mesh__D000655sskos__Concept
% 215.74/215.92  |- mesh__recordMaintainer mesh__D005340 ssb
% 215.74/215.92  |- skos__broader mesh__D005340smesh__D001779
% 215.74/215.92  |- skos__broader mesh__D005340smesh__D011498
% 215.74/215.92  |- mesh__dateRevised mesh__D005340 2005-06-30
% 215.74/215.92  |- mesh__recordOriginator mesh__D005340 NLM
% 215.74/215.92  |- skos__related mesh__D005340smesh__D003029
% 215.74/215.92  |- skos__hiddenLabel mesh__D005340 Factor I, Coagulation
% 215.74/215.92  |- skos__hiddenLabel mesh__D005340 gamma Fibrinogen
% 215.74/215.92  |- skos__altLabel mesh__D005340 Coagulation Factor I
% 215.74/215.92  |- skos__broader mesh__D005340smesh__D000209
% 215.74/215.92  |- skos__related mesh__D005340smesh__D006490
% 215.74/215.92  |- mesh__dateCreated mesh__D005340 1999-01-01
% 215.74/215.92  |- skos__altLabel mesh__D005340 Factor I
% 215.74/215.92  |- skos__altLabel mesh__D005340 Blood Coagulation Factor I
% 215.74/215.92  |- skos__annotation mesh__D005340
% 215.74/215.92       a blood coag factor: do not confuse X ref FACTOR I with COMPLEMENT FACTOR I%A%  
% 215.74/215.92  |- rdf__type mesh__D005340sskos__Concept
% 215.74/215.92  |- skos__scopeNote mesh__D005340
% 215.74/215.92       Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains %28%alpha, beta, gamma%29% held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products.%A%    
% 215.74/215.92  |- skos__hiddenLabel mesh__D005340 I, Coagulation Factor
% 215.74/215.92  |- mesh__recordAuthorizer mesh__D005340 sjn
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D005340 2006
% 215.74/215.92  |- skos__prefLabel mesh__D005340 Fibrinogen
% 215.74/215.92  |- skos__prefLabel mesh__D018268 Adrenocortical Carcinoma
% 215.74/215.92  |- mesh__dateCreated mesh__D018268 1993-06-25
% 215.74/215.92  |- mesh__dateEstablished mesh__D018268 1994-01-01
% 215.74/215.92  |- skos__hiddenLabel mesh__D018268 Adrenal Cortical Carcinoma
% 215.74/215.92  |- skos__hiddenLabel mesh__D018268 Carcinomas, Adrenal Cortical
% 215.74/215.92  |- skos__broader mesh__D018268smesh__D000306
% 215.74/215.92  |- mesh__publicMeSHNote mesh__D018268
% 215.74/215.92       2005; see CARCINOMA, ADRENAL CORTICAL 1994-2004   
% 215.74/215.92  |- skos__historyNote mesh__D018268 Carcinoma %28%1966-1993%29%
% 215.74/215.92  |- skos__historyNote mesh__D018268
% 215.74/215.92       Adrenal Gland Neoplasms %28%1966-1974%29%
% 215.74/215.92  |- skos__altLabel mesh__D018268 Carcinoma, Adrenal Cortical
% 215.74/215.92  |- mesh__recordAuthorizer mesh__D018268 sjn
% 215.74/215.92  |- mesh__recordMaintainer mesh__D018268 lkt
% 215.74/215.92  |- mesh__recordOriginator mesh__D018268 PLS
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D018268 2006
% 215.74/215.92  |- skos__hiddenLabel mesh__D018268 Carcinomas, Adrenocortical
% 215.74/215.92  |- skos__hiddenLabel mesh__D018268 Adrenal Cortical Carcinomas
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D018268 2005
% 215.74/215.92  |- rdf__type mesh__D018268sskos__Concept
% 215.74/215.92  |- mesh__historyNote mesh__D018268 2005 %28%1994%29%   
% 215.74/215.92  |- skos__historyNote mesh__D018268
% 215.74/215.92       Adrenal Cortex Neoplasms %28%1970-1993%29%
% 215.74/215.92  |- skos__scopeNote mesh__D018268
% 215.74/215.92       A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic %28%ANAPLASIA%29% masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism %28%CUSHING SYNDROME%29%; HYPERALDOSTERONISM; and/or VIRILISM.%A%    
% 215.74/215.92  |- mesh__dateRevised mesh__D018268 2004-07-07
% 215.74/215.92  |- skos__broader mesh__D018268smesh__D000230
% 215.74/215.92  |- skos__hiddenLabel mesh__D018268 Adrenocortical Carcinomas
% 215.74/215.92  |- skos__annotation mesh__D018268
% 215.74/215.92       coordinate IM with ADRENAL CORTEX NEOPLASMS %28%IM%29%   
% 215.74/215.92  |- skos__altLabel mesh__D018268 Carcinoma, Adrenocortical
% 215.74/215.92  |- skos__hiddenLabel mesh__D010285 Pseudocowpox viruses
% 215.74/215.92  |- skos__scopeNote mesh__D010285
% 215.74/215.92       A species of PARAPOXVIRUS causing a pox-like disease on udders of cows that may spread to milkers.%A%    
% 215.74/215.92  |- mesh__publicMeSHNote mesh__D010285
% 215.74/215.92       94; was PARAVACCINIA VIRUS 1975-93 %28%see under POXVIRIDAE 1981-90, see under POXVIRUSES 1975-80%29%; PSEUDO-COWPOX VIRUS was see PARAVACCINIA VIRUS 1975-93%A%  
% 215.74/215.92  |- skos__altLabel mesh__D010285 Milker%27%s nodes virus
% 215.74/215.92  |- skos__hiddenLabel mesh__D010285 Milkers%27% Nodes Viruses
% 215.74/215.92  |- skos__altLabel mesh__D010285 Milkers%27% Nodes Virus
% 215.74/215.92  |- skos__broader mesh__D010285smesh__D018157
% 215.74/215.92  |- rdf__type mesh__D010285sskos__Concept
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D010285 2004
% 215.74/215.92  |- mesh__historyNote mesh__D010285
% 215.74/215.92       94; was PARAVACCINIA VIRUS 1975-93 %28%see under POXVIRIDAE 1981-90, see under POXVIRUSES 1975-80%29%; PSEUDO-COWPOX VIRUS was see PARAVACCINIA VIRUS 1975-93%A%  
% 215.74/215.92  |- skos__altLabel mesh__D010285 Pseudo-Cowpox Virus
% 215.74/215.92  |- skos__altLabel mesh__D010285 Paravaccinia virus
% 215.74/215.92  |- mesh__dateCreated mesh__D010285 1974-12-12
% 215.74/215.92  |- mesh__recordAuthorizer mesh__D010285 sjn
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D010285 2003
% 215.74/215.92  |- skos__hiddenLabel mesh__D010285 Milker nodes virus
% 215.74/215.92  |- mesh__recordMaintainer mesh__D010285 ags
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D010285 2006
% 215.74/215.92  |- skos__prefLabel mesh__D010285 Pseudocowpox virus
% 215.74/215.92  |- skos__hiddenLabel mesh__D010285 Milkers Nodes Virus
% 215.74/215.92  |- skos__hiddenLabel mesh__D010285 Paravaccinia viruses
% 215.74/215.92  |- skos__hiddenLabel mesh__D010285 Pseudo Cowpox Virus
% 215.74/215.92  |- mesh__dateRevised mesh__D010285 2001-07-25
% 215.74/215.92  |- skos__hiddenLabel mesh__D010285 Milker%27%s nodes viruses
% 215.74/215.92  |- mesh__onlineNote mesh__D010285
% 215.74/215.92       use PSEUDOCOWPOX VIRUS to search PARAVACCINIA VIRUS %26% PSEUDO-COWPOX VIRUS 1975-93%A%  
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D010285 2005
% 215.74/215.92  |- skos__annotation mesh__D010285
% 215.74/215.92       infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29%   
% 215.74/215.92  |- mesh__dateEstablished mesh__D010285 1991-01-01
% 215.74/215.92  |- skos__hiddenLabel mesh__D010285 Pseudo-Cowpox Viruses
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D010285 2002
% 215.74/215.92  |- mesh__recordOriginator mesh__D010285 NLM
% 215.74/215.92  |- skos__historyNote mesh__D004248 Cytosine Nucleotides %28%1973-1974%29%
% 215.74/215.92  |- mesh__dateCreated mesh__D004248 1974-11-19
% 215.74/215.92  |- mesh__dateRevised mesh__D004248 2003-07-09
% 215.74/215.92  |- mesh__recordAuthorizer mesh__D004248 sjn
% 215.74/215.92  |- skos__annotation mesh__D004248
% 215.74/215.92       do not confuse with SITE-SPECIFIC DNA METHYLTRANSFERASE %28%CYTOSINE-SPECIFIC%29%%A%  
% 215.74/215.92  |- rdf__type mesh__D004248sskos__Concept
% 215.74/215.92  |- skos__broader mesh__D004248smesh__D015254
% 215.74/215.92  |- mesh__recordMaintainer mesh__D004248 ssb
% 215.74/215.92  |- skos__prefLabel mesh__D004248 DNA %28%Cytosine-5-%29%-Methyltransferase
% 215.74/215.92  |- skos__scopeNote mesh__D004248
% 215.74/215.92       An enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine to the 5-position of cytosine or to the 6-position in adenine in mammalian DNA. EC 2.1.1.37.%A%    
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D004248 2004
% 215.74/215.92  |- skos__hiddenLabel mesh__D004248 Cytosine-5-Methylase, DNA
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D004248 2006
% 215.74/215.92  |- mesh__publicMeSHNote mesh__D004248
% 215.74/215.92       86; was see under METHYLTRANSFERASES 1975-85   
% 215.74/215.92  |- mesh__dateEstablished mesh__D004248 1986-01-01
% 215.74/215.92  |- skos__historyNote mesh__D004248 DNA %28%1973-1974%29%
% 215.74/215.92  |- skos__hiddenLabel mesh__D004248 DNA Cytosine 5 Methylase
% 215.74/215.92  |- skos__altLabel mesh__D004248 DNA Cytosine-5-Methylase
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D004248 2005
% 215.74/215.92  |- skos__historyNote mesh__D004248 Methyltransferases %28%1973-1974%29%
% 215.74/215.92  |- mesh__historyNote mesh__D004248
% 215.74/215.92       86%28%75%29%; was see under METHYLTRANSFERASES 1975-85   
% 215.74/215.92  |- mesh__recordOriginator mesh__D004248 NLM
% 215.74/215.92  |- skos__altLabel mesh__D004248 DNA %28%Cytosine 5%29% Methyltransferase
% 215.74/215.92  |- skos__hiddenLabel mesh__D009731 Nursing Audits
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009731 1996
% 215.74/215.92  |- mesh__recordOriginator mesh__D009731 NLM
% 215.74/215.92  |- skos__annotation mesh__D009731
% 215.74/215.92       to evaluate quality of nurs care; do not confuse with NURSING ASSESSMENT %28%to evaluate nurs problems of patient to plan care%29%; DF: NURS AUDIT%A%  
% 215.74/215.92  |- skos__altLabel mesh__D009731 Audit, Nursing
% 215.74/215.92  |- mesh__recordMaintainer mesh__D009731 TGC
% 215.74/215.92  |- mesh__dateCreated mesh__D009731 1999-01-01
% 215.74/215.92  |- mesh__publicMeSHNote mesh__D009731 68   
% 215.74/215.92  |- skos__broader mesh__D009731smesh__D011785
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009731 2002
% 215.74/215.92  |- skos__prefLabel mesh__D009731 Nursing Audit
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009731 1997
% 215.74/215.92  |- mesh__recordAuthorizer mesh__D009731 PLS
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009731 2005
% 215.74/215.92  |- skos__scopeNote mesh__D009731
% 215.74/215.92       A detailed review and evaluation of selected clinical records by qualified professional personnel for evaluating quality of nursing care.%A%    
% 215.74/215.92  |- mesh__historyNote mesh__D009731 68   
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009731 1995
% 215.74/215.92  |- mesh__dateEstablished mesh__D009731 1968-01-01
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009731 2006
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009731 1998
% 215.74/215.92  |- skos__historyNote mesh__D009731
% 215.74/215.92       Nursing Service, Hospital %28%1966-1967%29%
% 215.74/215.92  |- skos__broader mesh__D009731smesh__D011787
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009731 2000
% 215.74/215.92  |- skos__hiddenLabel mesh__D009731 Audits, Nursing
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009731 2003
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009731 2001
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009731 1999
% 215.74/215.92  |- rdf__type mesh__D009731sskos__Concept
% 215.74/215.92  |- mesh__dateRevised mesh__D009731 1994-05-05
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D009731 2004
% 215.74/215.92  |- rdf__type mesh__D047850sskos__Concept
% 215.74/215.92  |- mesh__historyNote mesh__D047850 2005   
% 215.74/215.92  |- mesh__recordMaintainer mesh__D047850 jls
% 215.74/215.92  |- skos__hiddenLabel mesh__D047850 Revolution, 1789-1799 France
% 215.74/215.92  |- skos__altLabel mesh__D047850 France Revolution, 1789-1799
% 215.74/215.92  |- mesh__recordAuthorizer mesh__D047850 sjn
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D047850 2005
% 215.74/215.92  |- mesh__dateEstablished mesh__D047850 2005-01-01
% 215.74/215.92  |- mesh__dateCreated mesh__D047850 2004-07-07
% 215.74/215.92  |- skos__broader mesh__D047850smesh__D049671
% 215.74/215.92  |- mesh__recordOriginator mesh__D047850 jls
% 215.74/215.92  |- skos__hiddenLabel mesh__D047850 Revolution, French
% 215.74/215.92  |- mesh__publicMeSHNote mesh__D047850 2005   
% 215.74/215.92  |- skos__prefLabel mesh__D047850 French Revolution
% 215.74/215.92  |- skos__scopeNote mesh__D047850
% 215.74/215.92       Conflict during which traditional monarchy was ended and modern government functions were instituted.%A%    
% 215.74/215.92  |- skos__hiddenLabel mesh__D047850 France Revolution, 1789 1799
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D047850 2006
% 215.74/215.92  |- skos__scopeNote mesh__D014676
% 215.74/215.92       Dietary practice of completely avoiding meat products in their DIET, consuming vegetables, grains, and nuts. Some who are called lacto-ovo also include milk and egg products.%A%    
% 215.74/215.92  |- skos__altLabel mesh__D014676 Vegetarianism
% 215.74/215.92  |- skos__hiddenLabel mesh__D014676 Diets, Vegan
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D014676 2004
% 215.74/215.92  |- mesh__recordOriginator mesh__D014676 NLM
% 215.74/215.92  |- skos__altLabel mesh__D014676 Vegan Diet
% 215.74/215.92  |- mesh__historyNote mesh__D014676 2003%28%1963%29%   
% 215.74/215.92  |- rdf__type mesh__D014676sskos__Concept
% 215.74/215.92  |- skos__hiddenLabel mesh__D014676 Diets, Vegetarian
% 215.74/215.92  |- mesh__recordMaintainer mesh__D014676 kle
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D014676 2003
% 215.74/215.92  |- skos__hiddenLabel mesh__D014676 Vegan Diets
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D014676 2006
% 215.74/215.92  |- skos__prefLabel mesh__D014676 Diet, Vegetarian
% 215.74/215.92  |- skos__broader mesh__D014676smesh__D004032
% 215.74/215.92  |- skos__altLabel mesh__D014676 Vegetarian Diet
% 215.74/215.92  |- mesh__dateRevised mesh__D014676 2002-07-03
% 215.74/215.92  |- mesh__dateCreated mesh__D014676 1999-01-01
% 215.74/215.92  |- skos__hiddenLabel mesh__D014676 Vegetarian Diets
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D014676 2005
% 215.74/215.92  |- skos__annotation mesh__D014676
% 215.74/215.92       IM; coord with specific edible %28%IM%29% if pertinent   
% 215.74/215.92  |- mesh__recordAuthorizer mesh__D014676 sjn
% 215.74/215.92  |- mesh__publicMeSHNote mesh__D014676 2003; see VEGETARIANISM 1963-2003   
% 215.74/215.92  |- skos__hiddenLabel mesh__D008639 Cysts, Mesenteric
% 215.74/215.92  |- skos__prefLabel mesh__D008639 Mesenteric Cyst
% 215.74/215.92  |- skos__hiddenLabel mesh__D008639 Mesenteric Cysts
% 215.74/215.92  |- mesh__dateRevised mesh__D008639 2004-07-07
% 215.74/215.92  |- skos__broader mesh__D008639smesh__D010534
% 215.74/215.92  |- skos__broader mesh__D008639smesh__D003560
% 215.74/215.92  |- mesh__recordOriginator mesh__D008639 NLM
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D008639 2005
% 215.74/215.92  |- mesh__recordMaintainer mesh__D008639 lkt
% 215.74/215.92  |- skos__hiddenLabel mesh__D008639 Cyst, Mesenteric
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D008639 2006
% 215.74/215.92  |- mesh__recordAuthorizer mesh__D008639 sjn
% 215.74/215.92  |- mesh__dateCreated mesh__D008639 1999-01-01
% 215.74/215.92  |- rdf__type mesh__D008639sskos__Concept
% 215.74/215.92  |- skos__scopeNote mesh__D008639
% 215.74/215.92       A rare intra-abdominal tumor in the MESENTERY. Mesenteric cysts are usually benign and can be very large fluid-filled %28%2000 mL%29% lesions.%A%    
% 215.74/215.92  |- mesh__recordAuthorizer mesh__D000656 sjn
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D000656 2006
% 215.74/215.92  |- mesh__dateRevised mesh__D000656 2003-07-09
% 215.74/215.92  |- skos__broader mesh__D000656smesh__D016846
% 215.74/215.92  |- skos__prefLabel mesh__D000656 Amoeba
% 215.74/215.92  |- mesh__dateCreated mesh__D000656 1999-01-01
% 215.74/215.92  |- skos__altLabel mesh__D000656 Ameba
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D000656 2004
% 215.74/215.92  |- mesh__recordMaintainer mesh__D000656 ags
% 215.74/215.92  |- skos__scopeNote mesh__D000656
% 215.74/215.92       A genus of ameboid protozoa. Characteristics include a vesicular nucleus and the formation of several lodopodia, one of which is dominant at a given time. Reproduction occurs asexually by binary fission.%A%    
% 215.74/215.92  |- skos__related mesh__D000656smesh__D000563
% 215.74/215.92  |- skos__annotation mesh__D000656
% 215.74/215.92       the genus name: X ref AMEBA sometimes used loosely for the common nouns ameba %26% amoeba; /drug eff: consider also AMEBICIDES; infection = AMEBIASIS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 215.74/215.92  |- rdf__type mesh__D000656sskos__Concept
% 215.74/215.92  |- mesh__activeMeSHYear mesh__D000656 2005
% 215.74/215.92  |- mesh__recordOriginator mesh__D000656 NLM
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D005341 2006
% 215.74/215.93  |- mesh__recordAuthorizer mesh__D005341 sjn
% 215.74/215.93  |- skos__altLabel mesh__D005341 Fibrinolysin
% 215.74/215.93  |- skos__broader mesh__D005341smesh__D012697
% 215.74/215.93  |- mesh__recordMaintainer mesh__D005341 CCR
% 215.74/215.93  |- skos__hiddenLabel mesh__D005341 Glu Plasmin
% 215.74/215.93  |- skos__altLabel mesh__D005341 Glu-Plasmin
% 215.74/215.93  |- skos__altLabel mesh__D005341 Aventis Pharma Brand of Plasmin
% 215.74/215.93  |- mesh__onlineNote mesh__D005341
% 215.74/215.93       use PLASMIN to search FIBRINOLYSIN 1966-92   
% 215.74/215.93  |- skos__prefLabel mesh__D005341 Plasmin
% 215.74/215.93  |- mesh__dateRevised mesh__D005341 2005-06-30
% 215.74/215.93  |- mesh__historyNote mesh__D005341
% 215.74/215.93       93; was FIBRINOLYSIN 1963-92; PLASMIN was see FIBRINOLYSIN 1963-92%A%  
% 215.74/215.93  |- skos__altLabel mesh__D005341 Protease F
% 215.74/215.93  |- skos__scopeNote mesh__D005341
% 215.74/215.93       A product of the lysis of plasminogen %28%profibrinolysin%29% by PLASMINOGEN activators. It is composed of two polypeptide chains, light %28%B%29% and heavy %28%A%29%, with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins.%A%    
% 215.74/215.93  |- mesh__recordOriginator mesh__D005341 NLM
% 215.74/215.93  |- rdf__type mesh__D005341sskos__Concept
% 215.74/215.93  |- mesh__dateCreated mesh__D005341 1999-01-01
% 215.74/215.93  |- mesh__publicMeSHNote mesh__D005341
% 215.74/215.93       93; was FIBRINOLYSIN 1963-92; PLASMIN was see FIBRINOLYSIN 1963-92%A%  
% 215.74/215.93  |- skos__historyNote mesh__D018269 Endometriosis %28%1966-1993%29%
% 215.74/215.93  |- mesh__historyNote mesh__D018269 94   
% 215.74/215.93  |- skos__broader mesh__D018269smesh__D016889
% 215.74/215.93  |- skos__scopeNote mesh__D018269
% 215.74/215.93       An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.%A%    
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D018269 2006
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D018269 2006A
% 215.74/215.93  |- skos__prefLabel mesh__D018269 Carcinoma, Endometrioid
% 215.74/215.93  |- mesh__publicMeSHNote mesh__D018269 94   
% 215.74/215.93  |- mesh__recordMaintainer mesh__D018269 ags
% 215.74/215.93  |- skos__broader mesh__D018269smesh__D010051
% 215.74/215.93  |- mesh__recordAuthorizer mesh__D018269 ags
% 215.74/215.93  |- mesh__dateEstablished mesh__D018269 1994-01-01
% 215.74/215.93  |- rdf__type mesh__D018269sskos__Concept
% 215.74/215.93  |- mesh__dateCreated mesh__D018269 1993-06-25
% 215.74/215.93  |- skos__annotation mesh__D018269
% 215.74/215.93       coordinate IM with OVARIAN NEOPLASMS %28%IM%29% or ENDOMETRIAL NEOPLASMS %28%IM%29%%A%  
% 215.74/215.93  |- skos__historyNote mesh__D018269 Adenocarcinoma %28%1966-1993%29%
% 215.74/215.93  |- skos__broader mesh__D018269smesh__D000230
% 215.74/215.93  |- skos__hiddenLabel mesh__D018269 Endometrioid Adenocarcinomas
% 215.74/215.93  |- skos__historyNote mesh__D018269 Ovarian Neoplasms %28%1966-1993%29%
% 215.74/215.93  |- skos__hiddenLabel mesh__D018269 Endometrioid Carcinomas
% 215.74/215.93  |- skos__hiddenLabel mesh__D018269 Adenocarcinomas, Endometrioid
% 215.74/215.93  |- skos__hiddenLabel mesh__D018269 Carcinomas, Endometrioid
% 215.74/215.93  |- mesh__dateRevised mesh__D018269 2005-07-22
% 215.74/215.93  |- skos__hiddenLabel mesh__D018269 Endometrioid Carcinoma
% 215.74/215.93  |- skos__altLabel mesh__D018269 Endometrioid Adenocarcinoma
% 215.74/215.93  |- mesh__recordOriginator mesh__D018269 PLS
% 215.74/215.93  |- mesh__onlineNote mesh__D010286
% 215.74/215.93       use PARAVENTRICULAR HYPOTHALAMIC NUCLEUS to search PARAVENTRICULAR NUCLEUS 1975-82%A%  
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D010286 1999
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D010286 2004
% 215.74/215.93  |- rdf__type mesh__D010286sskos__Concept
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D010286 2002
% 215.74/215.93  |- mesh__recordOriginator mesh__D010286 NLM
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D010286 1995
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D010286 1998
% 215.74/215.93  |- mesh__dateEstablished mesh__D010286 1983-01-01
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D010286 2003
% 215.74/215.93  |- skos__altLabel mesh__D010286 Paraventricular Nucleus
% 215.74/215.93  |- skos__broader mesh__D010286smesh__D007032
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D010286 2006
% 215.74/215.93  |- mesh__recordMaintainer mesh__D010286 TGC
% 215.74/215.93  |- mesh__recordAuthorizer mesh__D010286 PLS
% 215.74/215.93  |- mesh__dateRevised mesh__D010286 1994-05-12
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D010286 2001
% 215.74/215.93  |- skos__hiddenLabel mesh__D010286 Paraventricular Nucleus, Hypothalamic
% 215.74/215.93  |- skos__hiddenLabel mesh__D010286 Nucleus, Paraventricular
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D010286 2005
% 215.74/215.93  |- skos__hiddenLabel mesh__D010286 Hypothalamic Nucleus, Paraventricular
% 215.74/215.93  |- skos__hiddenLabel mesh__D010286 Nucleus, Paraventricular Hypothalamic
% 215.74/215.93  |- skos__annotation mesh__D010286 in the anterior hypothalamus   
% 215.74/215.93  |- mesh__historyNote mesh__D010286
% 215.74/215.93       83; was PARAVENTRICULAR NUCLEUS see under HYPOTHALAMUS 1975-82%A%  
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D010286 1997
% 215.74/215.93  |- skos__hiddenLabel mesh__D010286 Nucleus, Hypothalamic Paraventricular
% 215.74/215.93  |- skos__prefLabel mesh__D010286 Paraventricular Hypothalamic Nucleus
% 215.74/215.93  |- mesh__dateCreated mesh__D010286 1974-11-11
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D010286 2000
% 215.74/215.93  |- skos__scopeNote mesh__D010286
% 215.74/215.93       Nucleus in the anterior part of the hypothalamus.     
% 215.74/215.93  |- skos__altLabel mesh__D010286 Hypothalamic Paraventricular Nucleus
% 215.74/215.93  |- mesh__publicMeSHNote mesh__D010286
% 215.74/215.93       83; was PARAVENTRICULAR NUCLEUS see under HYPOTHALAMUS 1975-82%A%  
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D010286 1996
% 215.74/215.93  |- skos__related mesh__D004249smesh__D011740
% 215.74/215.93  |- mesh__historyNote mesh__D004249 87   
% 215.74/215.93  |- skos__related mesh__D004249smesh__D009154
% 215.74/215.93  |- mesh__recordMaintainer mesh__D004249 nns
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D004249 2004
% 215.74/215.93  |- skos__prefLabel mesh__D004249 DNA Damage
% 215.74/215.93  |- skos__annotation mesh__D004249
% 215.74/215.93       do not use /drug eff %26% /rad eff for DNA damage induced by drugs or radiation; do not confuse with DNA FRAGMENTATION: see note there%A%  
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D004249 2006
% 215.74/215.93  |- mesh__dateEstablished mesh__D004249 1987-01-01
% 215.74/215.93  |- skos__altLabel mesh__D004249 Injury, DNA
% 215.74/215.93  |- mesh__recordAuthorizer mesh__D004249 sjn
% 215.74/215.93  |- skos__hiddenLabel mesh__D004249 Stresses, Genotoxic
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D004249 2005
% 215.74/215.93  |- mesh__dateRevised mesh__D004249 2003-07-25
% 215.74/215.93  |- skos__scopeNote mesh__D004249
% 215.74/215.93       Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand %28%PYRIMIDINE DIMERS%29% or interstrand crosslinking. Damage can often be repaired %28%DNA REPAIR%29%. If the damage is extensive, it can induce APOPTOSIS.%A%    
% 215.74/215.93  |- skos__hiddenLabel mesh__D004249 Injuries, DNA
% 215.74/215.93  |- skos__hiddenLabel mesh__D004249 Genotoxic Stresses
% 215.74/215.93  |- skos__historyNote mesh__D004249 DNA Replication %28%1968-1986%29%
% 215.74/215.93  |- skos__hiddenLabel mesh__D004249 Damages, DNA
% 215.74/215.93  |- skos__hiddenLabel mesh__D004249 Damage, DNA
% 215.74/215.93  |- skos__hiddenLabel mesh__D004249 DNA Damages
% 215.74/215.93  |- skos__altLabel mesh__D004249 DNA Injury
% 215.74/215.93  |- mesh__dateCreated mesh__D004249 1986-06-19
% 215.74/215.93  |- skos__historyNote mesh__D004249 DNA %28%1966-1986%29%
% 215.74/215.93  |- mesh__publicMeSHNote mesh__D004249 87   
% 215.74/215.93  |- mesh__recordOriginator mesh__D004249 SCD
% 215.74/215.93  |- skos__broader mesh__D004249smesh__D039361
% 215.74/215.93  |- skos__broader mesh__D004249smesh__D007280
% 215.74/215.93  |- skos__altLabel mesh__D004249 Stress, Genotoxic
% 215.74/215.93  |- skos__historyNote mesh__D004249 DNA Repair %28%1971-1986%29%
% 215.74/215.93  |- skos__hiddenLabel mesh__D004249 DNA Injuries
% 215.74/215.93  |- rdf__type mesh__D004249sskos__Concept
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D009732 2005
% 215.74/215.93  |- skos__broader mesh__D009732smesh__D006296
% 215.74/215.93  |- mesh__historyNote mesh__D009732 66   
% 215.74/215.93  |- mesh__recordOriginator mesh__D009732 NLM
% 215.74/215.93  |- skos__prefLabel mesh__D009732 Nursing Care
% 215.74/215.93  |- skos__broader mesh__D009732smesh__D005791
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D009732 2006
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D009732 2002
% 215.74/215.93  |- skos__annotation mesh__D009732
% 215.74/215.93       GEN %26% for patients only: NURSING is for the nursing profession; /legislation %26% jurisprudence = LEGISLATION, NURSING or NURSING %28%IM%29% + JURISPRUDENCE %28%IM%29%; prefer /nursing: Manual 19.7+, 19.8.48; DF: NURS CARE%A%  
% 215.74/215.93  |- mesh__recordMaintainer mesh__D009732 kle
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D009732 2003
% 215.74/215.93  |- mesh__publicMeSHNote mesh__D009732 66   
% 215.74/215.93  |- skos__altLabel mesh__D009732 Nursing Care Management
% 215.74/215.93  |- skos__altLabel mesh__D009732 Care, Nursing
% 215.74/215.93  |- mesh__recordAuthorizer mesh__D009732 sjn
% 215.74/215.93  |- rdf__type mesh__D009732sskos__Concept
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D009732 2004
% 215.74/215.93  |- skos__scopeNote mesh__D009732
% 215.74/215.93       Care given to patients by nursing service personnel.     
% 215.74/215.93  |- mesh__dateEstablished mesh__D009732 1966-01-01
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D009732 2000
% 215.74/215.93  |- mesh__dateRevised mesh__D009732 1999-11-03
% 215.74/215.93  |- mesh__dateCreated mesh__D009732 1999-01-01
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D009732 2001
% 215.74/215.93  |- skos__hiddenLabel mesh__D047851 9 11 2001 Attack
% 215.74/215.93  |- mesh__dateCreated mesh__D047851 2004-07-07
% 215.74/215.93  |- mesh__recordOriginator mesh__D047851 jls
% 215.74/215.93  |- skos__hiddenLabel mesh__D047851 Attack, 9-11-2001
% 215.74/215.93  |- skos__prefLabel mesh__D047851 September 11 Terrorist Attacks
% 215.74/215.93  |- mesh__historyNote mesh__D047851 2005   
% 215.74/215.93  |- skos__hiddenLabel mesh__D047851 Attacks, 9-11-2001
% 215.74/215.93  |- skos__altLabel mesh__D047851 World Trade Center Attack, 2001
% 215.74/215.93  |- mesh__recordAuthorizer mesh__D047851 sjn
% 215.74/215.93  |- mesh__publicMeSHNote mesh__D047851 2005   
% 215.74/215.93  |- skos__scopeNote mesh__D047851
% 215.74/215.93       Terrorism on September 11, 2001 against targets in New York, the Pentagon in Virginia, and an aborted attack that ended in Pennsylvania.%A%    
% 215.74/215.93  |- mesh__recordMaintainer mesh__D047851 ags
% 215.74/215.93  |- skos__hiddenLabel mesh__D047851 9-11-2001 Attacks
% 215.74/215.93  |- mesh__dateEstablished mesh__D047851 2005-01-01
% 215.74/215.93  |- mesh__dateRevised mesh__D047851 2005-06-30
% 215.74/215.93  |- skos__altLabel mesh__D047851 September 11 Terrorist Attacks, 2001
% 215.74/215.93  |- skos__altLabel mesh__D047851 9-11-2001 Attack
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D047851 2006
% 215.74/215.93  |- skos__broader mesh__D047851smesh__D049674
% 215.74/215.93  |- rdf__type mesh__D047851sskos__Concept
% 215.74/215.93  |- skos__broader mesh__D047851smesh__D023481
% 215.74/215.93  |- skos__broader mesh__D014677smesh__D010592
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D014677 2006
% 215.74/215.93  |- skos__prefLabel mesh__D014677 Vehicles
% 215.74/215.93  |- skos__annotation mesh__D014677
% 215.74/215.93       pharmacy %26% pharmacol, not transportation %28% = MOTOR VEHICLES%29%; NIM; when IM, D25-26 qualif%A%  
% 215.74/215.93  |- mesh__dateCreated mesh__D014677 1999-01-01
% 215.74/215.93  |- mesh__dateRevised mesh__D014677 2003-07-09
% 215.74/215.93  |- mesh__recordAuthorizer mesh__D014677 sjn
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D014677 2005
% 215.74/215.93  |- skos__broader mesh__D014677smesh__D016503
% 215.74/215.93  |- mesh__recordMaintainer mesh__D014677 ssb
% 215.74/215.93  |- mesh__recordOriginator mesh__D014677 NLM
% 215.74/215.93  |- skos__scopeNote mesh__D014677
% 215.74/215.93       A carrier or inert medium used as a solvent %28%or diluent%29% in which the medicinally active agent is formulated and or administered. %28%Dictionary of Pharmacy, 1986%29%%A%    
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D014677 2004
% 215.74/215.93  |- rdf__type mesh__D014677sskos__Concept
% 215.74/215.93  |- skos__hiddenLabel mesh__D014677 Vehicle
% 215.74/215.93  |- mesh__dateRevised mesh__D000657 2004-07-07
% 215.74/215.93  |- skos__altLabel mesh__D000657
% 215.74/215.93       2-Chloro-11-%28%1-piperazinyl%29%dibenz%28%b,f%29%%28%1,4%29%oxazepine
% 215.74/215.93  |- skos__historyNote mesh__D000657 Piperazines %28%1971-1974%29%
% 215.74/215.93  |- mesh__publicMeSHNote mesh__D000657
% 215.74/215.93       91; was see under DIBENZOXAZEPINES 1975-90   
% 215.74/215.93  |- skos__altLabel mesh__D000657 Wyeth Brand of Amoxapine
% 215.74/215.93  |- skos__altLabel mesh__D000657 D%C3%%A9%fanyl
% 215.74/215.93  |- skos__historyNote mesh__D000657 Dibenzoxazepines %28%1971-1974%29%
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D000657 2006
% 215.74/215.93  |- skos__hiddenLabel mesh__D000657 Amoxapine Cyanamid Brand
% 215.74/215.93  |- skos__altLabel mesh__D000657 Lederle Brand of Amoxapine
% 215.74/215.93  |- skos__prefLabel mesh__D000657 Amoxapine
% 215.74/215.93  |- mesh__historyNote mesh__D000657
% 215.74/215.93       91%28%75%29%; was see under DIBENZOXAZEPINES 1975-90   
% 215.74/215.93  |- skos__altLabel mesh__D000657 Cyanamid Brand of Amoxapine
% 215.74/215.93  |- mesh__recordAuthorizer mesh__D000657 sjn
% 215.74/215.93  |- skos__altLabel mesh__D000657 Desmethylloxapine
% 215.74/215.93  |- mesh__recordOriginator mesh__D000657 NLM
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D000657 2005
% 215.74/215.93  |- skos__hiddenLabel mesh__D000657 CL 67,772
% 215.74/215.93  |- skos__broader mesh__D000657smesh__D008152
% 215.74/215.93  |- mesh__dateCreated mesh__D000657 1974-11-27
% 215.74/215.93  |- skos__hiddenLabel mesh__D000657 CL67,772
% 215.74/215.93  |- skos__hiddenLabel mesh__D000657 Amoxapine Wyeth Brand
% 215.74/215.93  |- skos__hiddenLabel mesh__D000657 Amoxapine Lederle Brand
% 215.74/215.93  |- mesh__recordMaintainer mesh__D000657 mdb
% 215.74/215.93  |- skos__altLabel mesh__D000657 Asendis
% 215.74/215.93  |- mesh__dateEstablished mesh__D000657 1991-01-01
% 215.74/215.93  |- skos__scopeNote mesh__D000657
% 215.74/215.93       The N-demethylated derivative of the antipsychotic agent LOXAPINE that works by blocking the reuptake of norepinephrine, serotonin, or both. It also blocks dopamine receptors.%A%    
% 215.74/215.93  |- rdf__type mesh__D000657sskos__Concept
% 215.74/215.93  |- skos__hiddenLabel mesh__D019362 Pentoxyresorufin O Dealkylase
% 215.74/215.93  |- skos__historyNote mesh__D019362 Oxidoreductases %28%1985-1996%29%
% 215.74/215.93  |- mesh__dateEstablished mesh__D019362 1997-01-01
% 215.74/215.93  |- skos__altLabel mesh__D019362 Pentoxyresorufin O-Dealkylase
% 215.74/215.93  |- skos__scopeNote mesh__D019362
% 215.74/215.93       A major cytochrome P-450 enzyme which is inducible by PHENOBARBITAL in both the LIVER and SMALL INTESTINE. It is active in the metabolism of compounds like pentoxyresorufin, TESTOSTERONE, and ANDROSTENEDIONE. This enzyme, encoded by CYP2B1 gene, also mediates the activation of CYCLOPHOSPHAMIDE and IFOSFAMIDE to MUTAGENS.%A%    
% 215.74/215.93  |- mesh__onlineNote mesh__D019362
% 215.74/215.93       use CYTOCHROME P-450 CYP2B1 %28%NM%29% to search PENTOXYRESORUFIN O-DEALKYLASE 1985-96%A%  
% 215.74/215.93  |- skos__altLabel mesh__D019362 CYP 2B1
% 215.74/215.93  |- skos__altLabel mesh__D019362 BROD
% 215.74/215.93  |- skos__altLabel mesh__D019362 7-Benzyloxyresorufin O-Dealkylase
% 215.74/215.93  |- mesh__historyNote mesh__D019362
% 215.74/215.93       97; was PENTOXYRESORUFIN O-DEALKYLASE %28%NM%29% 1985-96   
% 215.74/215.93  |- skos__prefLabel mesh__D019362 Cytochrome P-450 CYP2B1
% 215.74/215.93  |- mesh__dateCreated mesh__D019362 1996-06-13
% 215.74/215.93  |- mesh__dateRevised mesh__D019362 2004-07-07
% 215.74/215.93  |- mesh__publicMeSHNote mesh__D019362
% 215.74/215.93       97; PENTOXYRESORUFIN O-DEALKYLASE was indexed under CYTOCHROME P-450 %26% OXIDOREDUCTASES 1985-96%A%  
% 215.74/215.93  |- skos__altLabel mesh__D019362 PROD
% 215.74/215.93  |- skos__altLabel mesh__D019362 CYP2B1
% 215.74/215.93  |- skos__hiddenLabel mesh__D019362 O-Dealkylase, Pentoxyresorufin
% 215.74/215.93  |- skos__hiddenLabel mesh__D019362 Cytochrome P 450 CYP2B1
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D019362 2006
% 215.74/215.93  |- mesh__recordAuthorizer mesh__D019362 sjn
% 215.74/215.93  |- skos__altLabel mesh__D019362 Cytochrome P450 2B1
% 215.74/215.93  |- rdf__type mesh__D019362sskos__Concept
% 215.74/215.93  |- skos__historyNote mesh__D019362 Cytochrome P-450 %28%1985-1996%29%
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D019362 2005
% 215.74/215.93  |- skos__hiddenLabel mesh__D019362 7 Benzyloxyresorufin O Dealkylase
% 215.74/215.93  |- skos__altLabel mesh__D019362 7-Pentylresorufin O-Depentylase
% 215.74/215.93  |- mesh__recordMaintainer mesh__D019362 ssb
% 215.74/215.93  |- mesh__recordOriginator mesh__D019362 ADP
% 215.74/215.93  |- skos__hiddenLabel mesh__D019362 Benzyloxyresorufin O Dealkylase
% 215.74/215.93  |- skos__broader mesh__D019362smesh__D001189
% 215.74/215.93  |- skos__altLabel mesh__D019362 Benzyloxyresorufin O-Dealkylase
% 215.74/215.93  |- skos__annotation mesh__D019362
% 215.74/215.93       do not confuse with other cytochrome P-450 CYP%27%s   
% 215.74/215.93  |- skos__hiddenLabel mesh__D019362 7 Pentylresorufin O Depentylase
% 215.74/215.93  |- skos__broader mesh__D005342smesh__D001777
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D005342 2004
% 215.74/215.93  |- mesh__recordMaintainer mesh__D005342 nns
% 215.74/215.93  |- skos__scopeNote mesh__D005342
% 215.74/215.93       The natural enzymatic dissolution of FIBRIN.     
% 215.74/215.93  |- mesh__dateRevised mesh__D005342 2003-07-09
% 215.74/215.93  |- mesh__recordAuthorizer mesh__D005342 sjn
% 215.74/215.93  |- skos__prefLabel mesh__D005342 Fibrinolysis
% 215.74/215.93  |- skos__hiddenLabel mesh__D005342 Fibrinolyses
% 215.74/215.93  |- mesh__dateCreated mesh__D005342 1999-01-01
% 215.74/215.93  |- rdf__type mesh__D005342sskos__Concept
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D005342 2006
% 215.74/215.93  |- mesh__recordOriginator mesh__D005342 NLM
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D005342 2005
% 215.74/215.93  |- mesh__dateRevised mesh__D029790 2002-07-03
% 215.74/215.93  |- mesh__dateEstablished mesh__D029790 2002-01-01
% 215.74/215.93  |- mesh__historyNote mesh__D029790 2002   
% 215.74/215.93  |- skos__annotation mesh__D029790
% 215.74/215.93       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.74/215.93  |- rdf__type mesh__D029790sskos__Concept
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D029790 2006
% 215.74/215.93  |- skos__prefLabel mesh__D029790 Ephedra sinica
% 215.74/215.93  |- skos__altLabel mesh__D029790 Ma huang
% 215.74/215.93  |- mesh__publicMeSHNote mesh__D029790 2002   
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D029790 2005
% 215.74/215.93  |- skos__scopeNote mesh__D029790
% 215.74/215.93       A plant species of the family Ephedraceae, order Ephedrales, class Gnetopsida, division Gnetophyta. It is a source of EPHEDRINE and other alkaloids.%A%    
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D029790 2004
% 215.74/215.93  |- mesh__dateCreated mesh__D029790 2001-07-25
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D029790 2003
% 215.74/215.93  |- skos__broader mesh__D029790smesh__D029789
% 215.74/215.93  |- skos__altLabel mesh__D029790 Chinese Ephedra
% 215.74/215.93  |- skos__broader mesh__D007962Q000637smesh__D007962
% 215.74/215.93  |- mesh__preferredCombination mesh__D007962Q000637smesh__D017708
% 215.74/215.93  |- rdf__type mesh__D007962Q000637smesh__CompoundConcept
% 215.74/215.93  |- skos__hiddenLabel mesh__D010287 Relationship, Parent Child
% 215.74/215.93  |- mesh__recordAuthorizer mesh__D010287 sjn
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D010287 2004
% 215.74/215.93  |- rdf__type mesh__D010287sskos__Concept
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D010287 2005
% 215.74/215.93  |- skos__hiddenLabel mesh__D010287 Parent-Child Relationships
% 215.74/215.93  |- skos__hiddenLabel mesh__D010287 Parent Child Relationships
% 215.74/215.93  |- skos__hiddenLabel mesh__D010287 Child Relationships, Parent
% 215.74/215.93  |- skos__hiddenLabel mesh__D010287 Parent Child Relations
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D010287 2006
% 215.74/215.93  |- skos__hiddenLabel mesh__D010287 Relation, Parent-Child
% 215.74/215.93  |- mesh__recordMaintainer mesh__D010287 hjn
% 215.74/215.93  |- skos__scopeNote mesh__D010287
% 215.74/215.93       The interactions between parent and child.     
% 215.74/215.93  |- mesh__recordOriginator mesh__D010287 NLM
% 215.74/215.93  |- skos__broader mesh__D010287smesh__D005195
% 215.74/215.93  |- skos__altLabel mesh__D010287 Parent-Child Relationship
% 215.74/215.93  |- skos__altLabel mesh__D010287 Parent Child Relationship
% 215.74/215.93  |- skos__annotation mesh__D010287 human only; DF: PARENT CHILD RELAT   
% 215.74/215.93  |- skos__hiddenLabel mesh__D010287 Relations, Parent-Child
% 215.74/215.93  |- skos__hiddenLabel mesh__D010287 Relationship, Parent-Child
% 215.74/215.93  |- mesh__dateRevised mesh__D010287 2002-07-03
% 215.74/215.93  |- skos__prefLabel mesh__D010287 Parent-Child Relations
% 215.74/215.93  |- skos__hiddenLabel mesh__D010287 Child Relationship, Parent
% 215.74/215.93  |- skos__hiddenLabel mesh__D010287 Relationships, Parent-Child
% 215.74/215.93  |- skos__hiddenLabel mesh__D010287 Relationships, Parent Child
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D010287 2003
% 215.74/215.93  |- mesh__dateCreated mesh__D010287 1999-01-01
% 215.74/215.93  |- skos__hiddenLabel mesh__D010287 Parent-Child Relation
% 215.74/215.93  |- mesh__dateEstablished mesh__D009733 1991-01-01
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D009733 1998
% 215.74/215.93  |- skos__hiddenLabel mesh__D009733 Diagnoses, Nursing
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D009733 1997
% 215.74/215.93  |- skos__scopeNote mesh__D009733
% 215.74/215.93       Conclusions derived from the nursing assessment that establish a health status profile for the patient and from which nursing interventions may be ordered.%A%    
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D009733 2002
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D009733 1996
% 215.74/215.93  |- mesh__publicMeSHNote mesh__D009733
% 215.74/215.93       91; was see under NURSING ASSESSMENT 1987-90; was see NURSING ASSESSMENT 1980-86; was see under NURSING CARE 1975-79%A%  
% 215.74/215.93  |- skos__annotation mesh__D009733
% 215.74/215.93       based on nurs assessment: see MeSH definition; DF: NURS DIAG%A%  
% 215.74/215.93  |- skos__hiddenLabel mesh__D009733 Nursing Diagnoses
% 215.74/215.93  |- skos__prefLabel mesh__D009733 Nursing Diagnosis
% 215.74/215.93  |- mesh__historyNote mesh__D009733
% 215.74/215.93       91%28%87%29%%28%75-79%29%; was see under NURSING ASSESSMENT 1987-90; was see NURSING ASSESSMENT 1980-86; was see under NURSING CARE 1975-79%A%  
% 215.74/215.93  |- mesh__recordAuthorizer mesh__D009733 PLS
% 215.74/215.93  |- skos__historyNote mesh__D009733 Nursing Assessment %28%1980-1986%29%
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D009733 1995
% 215.74/215.93  |- mesh__dateCreated mesh__D009733 1986-05-30
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D009733 2006
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D009733 2001
% 215.74/215.93  |- mesh__recordOriginator mesh__D009733 EC
% 215.74/215.93  |- skos__broader mesh__D009733smesh__D009730
% 215.74/215.93  |- mesh__onlineNote mesh__D009733 search NURSING ASSESSMENT 1975-86   
% 215.74/215.93  |- mesh__recordMaintainer mesh__D009733 TGC
% 215.74/215.93  |- skos__altLabel mesh__D009733 Diagnosis, Nursing
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D009733 2005
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D009733 2004
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D009733 1999
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D009733 2000
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D009733 2003
% 215.74/215.93  |- rdf__type mesh__D009733sskos__Concept
% 215.74/215.93  |- mesh__dateRevised mesh__D009733 1994-05-05
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D001750 2002
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Neurogenic Bladders
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Neuropathic Bladders
% 215.74/215.93  |- mesh__dateCreated mesh__D001750 1999-01-01
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D001750 2004
% 215.74/215.93  |- skos__altLabel mesh__D001750 Neurogenic Urinary Bladder Disorder
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Bladder Disorders, Neurogenic
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Bladders, Atonic Neurogenic
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Bladders, Spastic Neurogenic
% 215.74/215.93  |- mesh__dateRevised mesh__D001750 1999-11-23
% 215.74/215.93  |- skos__scopeNote mesh__D001750
% 215.74/215.93       Dysfunction of the urinary bladder due to disease of the central or peripheral nervous system pathways involved in the control of micturition. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES.%A%    
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Neurogenic Bladders, Uninhibited
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Bladders, Neuropathic
% 215.74/215.93  |- rdf__type mesh__D001750sskos__Concept
% 215.74/215.93  |- mesh__recordOriginator mesh__D001750 NLM
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Neurogenic Bladders, Atonic
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Bladder, Uninhibited Neurogenic
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D001750 2005
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Spastic Neurogenic Bladders
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Bladders, Neurogenic
% 215.74/215.93  |- skos__broader mesh__D001750smesh__D009461
% 215.74/215.93  |- mesh__recordMaintainer mesh__D001750 ags
% 215.74/215.93  |- skos__altLabel mesh__D001750
% 215.74/215.93       Neurogenic Dysfunction of the Urinary Bladder
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Atonic Neurogenic Bladder
% 215.74/215.93  |- skos__prefLabel mesh__D001750 Bladder, Neurogenic
% 215.74/215.93  |- skos__altLabel mesh__D001750 Neurogenic Bladder Disorder
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Uninhibited Neurogenic Bladders
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Bladder, Neuropathic
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D001750 2000A
% 215.74/215.93  |- skos__altLabel mesh__D001750 Bladder Disorder, Neurogenic
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D001750 2006
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Spastic Neurogenic Bladder
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Bladders, Uninhibited Neurogenic
% 215.74/215.93  |- skos__broader mesh__D001750smesh__D001745
% 215.74/215.93  |- mesh__recordAuthorizer mesh__D001750 ags
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Neurogenic Bladder Disorders
% 215.74/215.93  |- skos__altLabel mesh__D001750 Neuropathic Bladder
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Bladder, Spastic Neurogenic
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D001750 2000
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Neurogeneses, Bladder
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Atonic Neurogenic Bladders
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Uninhibited Neurogenic Bladder
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Bladder, Atonic Neurogenic
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Neurogenesis, Bladder
% 215.74/215.93  |- skos__altLabel mesh__D001750 Urinary Bladder Neurogenic Dysfunction
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D001750 2001
% 215.74/215.93  |- skos__altLabel mesh__D001750 Neurogenic Bladder
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D001750 2003
% 215.74/215.93  |- skos__hiddenLabel mesh__D001750 Neurogenic Bladders, Spastic
% 215.74/215.93  |- skos__altLabel mesh__D001750 Urinary Bladder Disorder, Neurogenic
% 215.74/215.93  |- skos__hiddenLabel mesh__D047852 Nuclear Accident, Chernobyl
% 215.74/215.93  |- skos__historyNote mesh__D047852 Nuclear Reactors %28%1986-2004%29%
% 215.74/215.93  |- skos__hiddenLabel mesh__D047852 Accident, Chernobyl Nuclear
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D047852 2005C
% 215.74/215.93  |- skos__hiddenLabel mesh__D047852 Chernobyl Nuclear Accidents
% 215.74/215.93  |- skos__altLabel mesh__D047852
% 215.74/215.93       Chernobyl Nuclear Accident, Chornobyl, Ukraine, 1986
% 215.74/215.93  |- skos__altLabel mesh__D047852 Chornobyl Nuclear Disaster
% 215.74/215.93  |- skos__altLabel mesh__D047852 Chornobyl Nuclear Accident
% 215.74/215.93  |- skos__hiddenLabel mesh__D047852 Nuclear Accident, Chornobyl
% 215.74/215.93  |- mesh__dateCreated mesh__D047852 2004-07-07
% 215.74/215.93  |- skos__hiddenLabel mesh__D047852 Disasters, Chornobyl Nuclear
% 215.74/215.93  |- skos__hiddenLabel mesh__D047852 Accident, Chornobyl Nuclear
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D047852 2005D
% 215.74/215.93  |- skos__scopeNote mesh__D047852
% 215.74/215.93       April 25th -26th, 1986 nuclear power accident that occurred at Chernobyl in the former USSR %28%Ukraine%29% located 80 miles north of Kiev.%A%    
% 215.74/215.93  |- skos__related mesh__D047852smesh__D009688
% 215.74/215.93  |- mesh__recordMaintainer mesh__D047852 jls
% 215.74/215.93  |- skos__prefLabel mesh__D047852 Chernobyl Nuclear Accident
% 215.74/215.93  |- skos__hiddenLabel mesh__D047852 Nuclear Disasters, Chornobyl
% 215.74/215.93  |- skos__hiddenLabel mesh__D047852 Chornobyl Nuclear Accidents
% 215.74/215.93  |- skos__hiddenLabel mesh__D047852 Nuclear Accidents, Chornobyl
% 215.74/215.93  |- skos__hiddenLabel mesh__D047852 Nuclear Accidents, Chernobyl
% 215.74/215.93  |- rdf__type mesh__D047852sskos__Concept
% 215.74/215.93  |- skos__hiddenLabel mesh__D047852 Accidents, Chornobyl Nuclear
% 215.74/215.93  |- skos__hiddenLabel mesh__D047852 Disaster, Chornobyl Nuclear
% 215.74/215.93  |- skos__related mesh__D047852smesh__D004190
% 215.74/215.93  |- skos__hiddenLabel mesh__D047852 Nuclear Disaster, Chornobyl
% 215.74/215.93  |- mesh__recordAuthorizer mesh__D047852 jls
% 215.74/215.93  |- skos__broader mesh__D047852smesh__D049673
% 215.74/215.93  |- skos__historyNote mesh__D047852 Accidents %28%1986-2004%29%
% 215.74/215.93  |- skos__hiddenLabel mesh__D047852 Chornobyl Nuclear Disasters
% 215.74/215.93  |- mesh__historyNote mesh__D047852 2005   
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D047852 2005
% 215.74/215.93  |- mesh__activeMeSHYear mesh__D047852 2005A
% 215.74/215.93  |- mesh__recordOriginator mesh__D047852 jls
% 215.74/215.94  |- mesh__dateEstablished mesh__D047852 2005-01-01
% 215.74/215.94  |- mesh__publicMeSHNote mesh__D047852 2005   
% 215.74/215.94  |- mesh__dateRevised mesh__D047852 2004-11-19
% 215.74/215.94  |- skos__hiddenLabel mesh__D047852 Accidents, Chernobyl Nuclear
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D047852 2005B
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D047852 2006
% 215.74/215.94  |- skos__prefLabel mesh__D014678 Veillonella
% 215.74/215.94  |- skos__annotation mesh__D014678
% 215.74/215.94       in mouth, intestines %26% resp tract of man %26% other animals   
% 215.74/215.94  |- skos__scopeNote mesh__D014678
% 215.74/215.94       A genus of gram-negative, anaerobic cocci parasitic in the mouth and in the intestinal and respiratory tracts of man and other animals.%A%    
% 215.74/215.94  |- mesh__dateCreated mesh__D014678 1999-01-01
% 215.74/215.94  |- mesh__recordAuthorizer mesh__D014678 sjn
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D014678 2006
% 215.74/215.94  |- skos__broader mesh__D014678smesh__D045854
% 215.74/215.94  |- mesh__recordOriginator mesh__D014678 NLM
% 215.74/215.94  |- mesh__recordMaintainer mesh__D014678 SYSTEM
% 215.74/215.94  |- mesh__dateRevised mesh__D014678 2005-06-30
% 215.74/215.94  |- rdf__type mesh__D014678sskos__Concept
% 215.74/215.94  |- mesh__dateRevised mesh__D019363 2004-07-13
% 215.74/215.94  |- mesh__recordMaintainer mesh__D019363 sjn
% 215.74/215.94  |- skos__altLabel mesh__D019363 CYP 1A1
% 215.74/215.94  |- skos__scopeNote mesh__D019363
% 215.74/215.94       A liver microsomal cytochrome P-450 monooxygenase capable of biotransforming xenobiotics such as polycyclic hydrocarbons and halogenated aromatic hydrocarbons into carcinogenic or mutagenic compounds. They have been found in mammals and fish. This enzyme, encoded by CYP1A1 gene, can be measured by using ethoxyresorufin as a substrate for the ethoxyresorufin O-deethylase activity.%A%    
% 215.74/215.94  |- skos__altLabel mesh__D019363 Ethoxyresorufin O-Deethylase
% 215.74/215.94  |- skos__altLabel mesh__D019363 CYP1A1
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D019363 2006
% 215.74/215.94  |- skos__altLabel mesh__D019363 CYP1A1 Protein
% 215.74/215.94  |- mesh__dateEstablished mesh__D019363 1997-01-01
% 215.74/215.94  |- rdf__type mesh__D019363sskos__Concept
% 215.74/215.94  |- skos__altLabel mesh__D019363 Cytochrome P450 IA1
% 215.74/215.94  |- mesh__historyNote mesh__D019363
% 215.74/215.94       97; was ETHOXYRESORUFIN O-DEETHYLASE %28%NM%29% 1979-96   
% 215.74/215.94  |- skos__prefLabel mesh__D019363 Cytochrome P-450 CYP1A1
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D019363 2005
% 215.74/215.94  |- skos__altLabel mesh__D019363 EROD
% 215.74/215.94  |- skos__altLabel mesh__D019363 Ethylresorufin O-Deethylase
% 215.74/215.94  |- mesh__publicMeSHNote mesh__D019363
% 215.74/215.94       97; ETHOXYRESORUFIN O-DEETHYLASE was indexed under CYTOCHROME P-450 1982-96, OXIDOREDUCTASES 1980-96, %26% OXAZINES 1979-81%A%  
% 215.74/215.94  |- mesh__onlineNote mesh__D019363
% 215.74/215.94       use CYTOCHROME P-450 CYP1A1 %28%NM%29% to search ETHOXYRESORUFIN O-DEETHYLASE 1980-96%A%  
% 215.74/215.94  |- mesh__recordAuthorizer mesh__D019363 sjn
% 215.74/215.94  |- skos__broader mesh__D019363smesh__D001189
% 215.74/215.94  |- skos__altLabel mesh__D019363 Ethoxyresorufin Dealkylase
% 215.74/215.94  |- skos__historyNote mesh__D019363 Cytochrome P-450 %28%1982-1996%29%
% 215.74/215.94  |- skos__annotation mesh__D019363
% 215.74/215.94       do not confuse with other cytochrome P-450 CYP%27%s   
% 215.74/215.94  |- mesh__dateCreated mesh__D019363 1996-06-24
% 215.74/215.94  |- skos__historyNote mesh__D019363 Oxidoreductases %28%1980-1996%29%
% 215.74/215.94  |- skos__hiddenLabel mesh__D019363 Cytochrome P 450 CYP1A1
% 215.74/215.94  |- skos__historyNote mesh__D019363 Oxazines %28%1979-1981%29%
% 215.74/215.94  |- skos__altLabel mesh__D019363 7-Ethoxyresorufin O-Deethylase
% 215.74/215.94  |- mesh__recordOriginator mesh__D019363 ADP
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D000658 2006
% 215.74/215.94  |- skos__hiddenLabel mesh__D000658 BRL2333
% 215.74/215.94  |- skos__broader mesh__D000658smesh__D000667
% 215.74/215.94  |- skos__scopeNote mesh__D000658
% 215.74/215.94       A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration.%A%    
% 215.74/215.94  |- skos__historyNote mesh__D000658 Ampicillin %28%1975-1974%29%
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D000658 2005
% 215.74/215.94  |- skos__hiddenLabel mesh__D000658 parenteral, Clamoxyl
% 215.74/215.94  |- skos__prefLabel mesh__D000658 Amoxicillin
% 215.74/215.94  |- skos__altLabel mesh__D000658
% 215.74/215.94       SmithKline Beecham Brand of Amoxicillin Sodium Salt
% 215.74/215.94  |- skos__altLabel mesh__D000658 Clariana Brand of Amoxicillin
% 215.74/215.94  |- mesh__publicMeSHNote mesh__D000658
% 215.74/215.94       80; was see under AMPICILLIN 1975-79   
% 215.74/215.94  |- mesh__dateEstablished mesh__D000658 1980-01-01
% 215.74/215.94  |- mesh__recordAuthorizer mesh__D000658 sjn
% 215.74/215.94  |- mesh__historyNote mesh__D000658
% 215.74/215.94       80%28%75%29%; was see under AMPICILLIN 1975-79   
% 215.74/215.94  |- mesh__recordOriginator mesh__D000658 NLM
% 215.74/215.94  |- skos__hiddenLabel mesh__D000658 G.A., Clamoxyl
% 215.74/215.94  |- skos__altLabel mesh__D000658 Clamoxyl parenteral
% 215.74/215.94  |- skos__altLabel mesh__D000658 Pfizer Brand of Amoxicillin Sodium Salt
% 215.74/215.94  |- skos__altLabel mesh__D000658 Clamoxyl G.A.
% 215.74/215.94  |- skos__altLabel mesh__D000658 Amoxicilline
% 215.74/215.94  |- skos__altLabel mesh__D000658 Hydroxyampicillin
% 215.74/215.94  |- skos__altLabel mesh__D000658 Penamox
% 215.74/215.94  |- rdf__type mesh__D000658sskos__Concept
% 215.74/215.94  |- skos__hiddenLabel mesh__D000658 BRL 2333
% 215.74/215.94  |- skos__historyNote mesh__D000658 Penicillins %28%1972-1974%29%
% 215.74/215.94  |- mesh__dateRevised mesh__D000658 2004-07-07
% 215.74/215.94  |- mesh__dateCreated mesh__D000658 1974-11-11
% 215.74/215.94  |- skos__hiddenLabel mesh__D000658 trihydrate, Amoxicillin
% 215.74/215.94  |- skos__hiddenLabel mesh__D000658 Amoxicillin Clariana Brand
% 215.74/215.94  |- skos__altLabel mesh__D000658 Amoxycillin
% 215.74/215.94  |- mesh__recordMaintainer mesh__D000658 ssb
% 215.74/215.94  |- skos__hiddenLabel mesh__D011380 Self-Instruction Program
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D011380 2000
% 215.74/215.94  |- mesh__publicMeSHNote mesh__D011380 66   
% 215.74/215.94  |- mesh__historyNote mesh__D011380 66   
% 215.74/215.94  |- skos__scopeNote mesh__D011380
% 215.74/215.94       Instruction in which learners progress at their own rate using workbooks, textbooks, or electromechanical devices that provide information in discrete steps, test learning at each step, and provide immediate feedback about achievement. %28%ERIC, Thesaurus of ERIC Descriptors, 1996%29%.%A%    
% 215.74/215.94  |- skos__hiddenLabel mesh__D011380 Programmed Instructions
% 215.74/215.94  |- rdf__type mesh__D011380sskos__Concept
% 215.74/215.94  |- skos__hiddenLabel mesh__D011380 Programmed Textbooks
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D011380 2001
% 215.74/215.94  |- mesh__dateRevised mesh__D011380 1999-11-03
% 215.74/215.94  |- skos__prefLabel mesh__D011380 Programmed Instruction
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D011380 2003
% 215.74/215.94  |- mesh__recordMaintainer mesh__D011380 jls
% 215.74/215.94  |- skos__hiddenLabel mesh__D011380 Programs, Self-Instruction
% 215.74/215.94  |- mesh__recordOriginator mesh__D011380 NLM
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D011380 2004
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D011380 2005
% 215.74/215.94  |- skos__hiddenLabel mesh__D011380 Programmed Textbook
% 215.74/215.94  |- skos__hiddenLabel mesh__D011380 Instructions, Programmed
% 215.74/215.94  |- skos__hiddenLabel mesh__D011380 Learning, Programmed
% 215.74/215.94  |- skos__broader mesh__D011380smesh__D013663
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D011380 2002
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D011380 2006
% 215.74/215.94  |- skos__hiddenLabel mesh__D011380 Self Instruction Programs
% 215.74/215.94  |- skos__hiddenLabel mesh__D011380 Instruction, Programmed
% 215.74/215.94  |- mesh__recordAuthorizer mesh__D011380 sjn
% 215.74/215.94  |- skos__annotation mesh__D011380 IM   
% 215.74/215.94  |- mesh__dateEstablished mesh__D011380 1966-01-01
% 215.74/215.94  |- mesh__dateCreated mesh__D011380 1999-01-01
% 215.74/215.94  |- skos__hiddenLabel mesh__D011380 Textbook, Programmed
% 215.74/215.94  |- skos__hiddenLabel mesh__D011380 Program, Self-Instruction
% 215.74/215.94  |- mesh__dateEstablished mesh__D005343 1966-01-01
% 215.74/215.94  |- skos__hiddenLabel mesh__D005343 Agents, Fibrinolytic
% 215.74/215.94  |- mesh__publicMeSHNote mesh__D005343 66   
% 215.74/215.94  |- mesh__dateRevised mesh__D005343 2005-06-30
% 215.74/215.94  |- mesh__dateCreated mesh__D005343 1999-01-01
% 215.74/215.94  |- rdf__type mesh__D005343sskos__Concept
% 215.74/215.94  |- skos__hiddenLabel mesh__D005343 Agents, Thrombolytic
% 215.74/215.94  |- mesh__recordOriginator mesh__D005343 NLM
% 215.74/215.94  |- skos__hiddenLabel mesh__D005343 Drugs, Fibrinolytic
% 215.74/215.94  |- skos__hiddenLabel mesh__D005343 Drugs, Antithrombic
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D005343 2006
% 215.74/215.94  |- skos__prefLabel mesh__D005343 Fibrinolytic Agents
% 215.74/215.94  |- skos__altLabel mesh__D005343 Antithrombotic Agents
% 215.74/215.94  |- skos__hiddenLabel mesh__D005343 Drugs, Thrombolytic
% 215.74/215.94  |- skos__hiddenLabel mesh__D005343 Agents, Antithrombotic
% 215.74/215.94  |- skos__scopeNote mesh__D005343
% 215.74/215.94       Fibrinolysin or agents that convert plasminogen to fibrinolysin %28%PLASMIN%29%.%A%    
% 215.74/215.94  |- skos__altLabel mesh__D005343 Thrombolytic Agents
% 215.74/215.94  |- skos__altLabel mesh__D005343 Thrombolytic Drugs
% 215.74/215.94  |- skos__altLabel mesh__D005343 Antithrombic Drugs
% 215.74/215.94  |- skos__broader mesh__D005343smesh__D002317
% 215.74/215.94  |- mesh__recordMaintainer mesh__D005343 ssb
% 215.74/215.94  |- mesh__historyNote mesh__D005343 66   
% 215.74/215.94  |- skos__altLabel mesh__D005343 Fibrinolytic Drugs
% 215.74/215.94  |- mesh__recordAuthorizer mesh__D005343 sjn
% 215.74/215.94  |- skos__broader mesh__D005343smesh__D006401
% 215.74/215.94  |- skos__broader mesh__D005343smesh__D050299
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D029791 2005
% 215.74/215.94  |- skos__scopeNote mesh__D029791
% 215.74/215.94       The heath plant family of the order Ericales, subclass Dilleniidae, class Magnoliopsida that are generally shrubs or small trees. Leaves are alternate, simple, and leathery; flowers are symmetrical with a 4- or 5-parted corolla of partly fused petals.%A%    
% 215.74/215.94  |- skos__prefLabel mesh__D029791 Ericaceae
% 215.74/215.94  |- rdf__type mesh__D029791sskos__Concept
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D029791 2006
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D029791 2003
% 215.74/215.94  |- mesh__publicMeSHNote mesh__D029791 2002   
% 215.74/215.94  |- mesh__dateRevised mesh__D029791 2002-07-03
% 215.74/215.94  |- mesh__historyNote mesh__D029791 2002   
% 215.74/215.94  |- mesh__dateEstablished mesh__D029791 2002-01-01
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D029791 2004
% 215.74/215.94  |- mesh__recordMaintainer mesh__D029791 ssb
% 215.74/215.94  |- mesh__dateCreated mesh__D029791 2001-07-25
% 215.74/215.94  |- mesh__recordOriginator mesh__D029791 ssb
% 215.74/215.94  |- mesh__recordAuthorizer mesh__D029791 sjn
% 215.74/215.94  |- skos__broader mesh__D029791smesh__D019684
% 215.74/215.94  |- skos__annotation mesh__D029791
% 215.74/215.94       GEN or unspecified; prefer specifics; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.74/215.94  |- mesh__onlineNote mesh__D010288
% 215.74/215.94       use PARENTERAL NUTRITION to search PARENTERAL FEEDING 1966-91%A%  
% 215.74/215.94  |- skos__prefLabel mesh__D010288 Parenteral Nutrition
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D010288 2005
% 215.74/215.94  |- skos__altLabel mesh__D010288 Nutrition, Parenteral
% 215.74/215.94  |- skos__hiddenLabel mesh__D010288 Feedings, Intravenous
% 215.74/215.94  |- skos__hiddenLabel mesh__D010288 Feeding, Parenteral
% 215.74/215.94  |- skos__hiddenLabel mesh__D010288 Feedings, Parenteral
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D010288 2006
% 215.74/215.94  |- mesh__recordAuthorizer mesh__D010288 sjn
% 215.74/215.94  |- mesh__recordMaintainer mesh__D010288 lkt
% 215.74/215.94  |- skos__broader mesh__D010288smesh__D005248
% 215.74/215.94  |- skos__annotation mesh__D010288
% 215.74/215.94       for nourishment: differentiate from FLUID THERAPY %28%to replace fluids%29% or ENTERAL NUTRITION %28%see note there%29% or INFUSIONS, PARENTERAL %28%merely a method of admin drugs %26% chemicals%29%; do not use /util except by MeSH definition; coord IM with dis /ther %28%IM%29%, not dis /diet ther%A%  
% 215.74/215.94  |- mesh__publicMeSHNote mesh__D010288 92; was PARENTERAL FEEDING 1966-91   
% 215.74/215.94  |- skos__hiddenLabel mesh__D010288 Intravenous Feedings
% 215.74/215.94  |- skos__broader mesh__D010288smesh__D018529
% 215.74/215.94  |- mesh__recordOriginator mesh__D010288 NLM
% 215.74/215.94  |- mesh__dateCreated mesh__D010288 1999-01-01
% 215.74/215.94  |- mesh__historyNote mesh__D010288 92; was PARENTERAL FEEDING 1966-91   
% 215.74/215.94  |- mesh__dateRevised mesh__D010288 2003-07-09
% 215.74/215.94  |- rdf__type mesh__D010288sskos__Concept
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D010288 2004
% 215.74/215.94  |- skos__hiddenLabel mesh__D010288 Parenteral Feedings
% 215.74/215.94  |- skos__scopeNote mesh__D010288
% 215.74/215.94       The administering of nutrients for assimilation and utilization by a patient who cannot maintain adequate nutrition by enteral feeding alone. Nutrients are administered by a route other than the alimentary canal %28%e.g., intravenously, subcutaneously%29%.%A%    
% 215.74/215.94  |- skos__hiddenLabel mesh__D010288 Feeding, Intravenous
% 215.74/215.94  |- skos__related mesh__D010288smesh__D005217
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D009734 1996
% 215.74/215.94  |- mesh__historyNote mesh__D009734 88   
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D009734 2000
% 215.74/215.94  |- mesh__dateEstablished mesh__D009734 1988-01-01
% 215.74/215.94  |- skos__historyNote mesh__D009734 Faculty, Nursing %28%1966-1987%29%
% 215.74/215.94  |- skos__altLabel mesh__D009734 Faculty Practice, Nursing
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D009734 1995
% 215.74/215.94  |- mesh__publicMeSHNote mesh__D009734 88   
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D009734 2006
% 215.74/215.94  |- skos__scopeNote mesh__D009734
% 215.74/215.94       Clinical practice by members of the nursing faculty in order to maintain a balance in their nursing activities--clinical, education, and research.%A%    
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D009734 2002
% 215.74/215.94  |- skos__annotation mesh__D009734
% 215.74/215.94       clin practice by nurs faculty to maintain balanced professional activities; DF: NURS FACULTY PRACTICE%A%  
% 215.74/215.94  |- skos__hiddenLabel mesh__D009734 Faculty Practices, Nursing
% 215.74/215.94  |- mesh__recordMaintainer mesh__D009734 TGC
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D009734 2005
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D009734 2004
% 215.74/215.94  |- mesh__dateCreated mesh__D009734 1987-03-04
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D009734 1999
% 215.74/215.94  |- skos__hiddenLabel mesh__D009734 Practices, Nursing Faculty
% 215.74/215.94  |- mesh__recordAuthorizer mesh__D009734 PLS
% 215.74/215.94  |- skos__broader mesh__D009734smesh__D011364
% 215.74/215.94  |- skos__hiddenLabel mesh__D009734 Nursing Faculty Practices
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D009734 2003
% 215.74/215.94  |- rdf__type mesh__D009734sskos__Concept
% 215.74/215.94  |- mesh__dateRevised mesh__D009734 1994-05-05
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D009734 2001
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D009734 1998
% 215.74/215.94  |- skos__prefLabel mesh__D009734 Nursing Faculty Practice
% 215.74/215.94  |- mesh__recordOriginator mesh__D009734 EC
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D009734 1997
% 215.74/215.94  |- skos__altLabel mesh__D009734 Practice, Nursing Faculty
% 215.74/215.94  |- skos__hiddenLabel mesh__D001751 Implantations, Blade
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D001751 2005
% 215.74/215.94  |- mesh__recordOriginator mesh__D001751 SMH
% 215.74/215.94  |- skos__annotation mesh__D001751
% 215.74/215.94       an endosseous dent implant; do not use /util except by MeSH definition%A%  
% 215.74/215.94  |- mesh__historyNote mesh__D001751
% 215.74/215.94       91%28%79%29%; was see under DENTAL IMPLANTATION, ENDOSSEOUS 1979-90; ENDOSSEOUS BLADE IMPLANTS was see under DENTAL IMPLANTATION 1974%A%  
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D001751 2001
% 215.74/215.94  |- rdf__type mesh__D001751sskos__Concept
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D001751 2004
% 215.74/215.94  |- mesh__onlineNote mesh__D001751 search DENTAL IMPLANTATION 1974   
% 215.74/215.94  |- mesh__recordMaintainer mesh__D001751 ags
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D001751 2000
% 215.74/215.94  |- skos__historyNote mesh__D001751 Dental Implantation %28%1966-1976%29%
% 215.74/215.94  |- skos__scopeNote mesh__D001751
% 215.74/215.94       Insertion of an endosseous implant with a narrow wedge-shaped infrastructure extending through the oral mucosa into the mouth and bearing openings or vents through which tissue grows to obtain retention.%A%    
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D001751 2003
% 215.74/215.94  |- skos__broader mesh__D001751smesh__D003758
% 215.74/215.94  |- skos__prefLabel mesh__D001751 Blade Implantation
% 215.74/215.94  |- skos__hiddenLabel mesh__D001751 Blade Implantations
% 215.74/215.94  |- mesh__publicMeSHNote mesh__D001751
% 215.74/215.94       91; was see under DENTAL IMPLANTATION, ENDOSSEOUS 1979-80; ENDOSSEOUS BLADE IMPLANTS was see under DENTAL IMPLANTATION 1974%A%  
% 215.74/215.94  |- skos__historyNote mesh__D001751
% 215.74/215.94       Dental Implantation, Endosseous %28%1977-1978%29%
% 215.74/215.94  |- skos__hiddenLabel mesh__D001751 Implantation, Blade
% 215.74/215.94  |- mesh__dateEstablished mesh__D001751 1991-01-01
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D001751 2006
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D001751 2002
% 215.74/215.94  |- mesh__dateCreated mesh__D001751 1978-01-23
% 215.74/215.94  |- mesh__dateRevised mesh__D001751 1999-11-03
% 215.74/215.94  |- mesh__recordAuthorizer mesh__D001751 sjn
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D019364 2005
% 215.74/215.94  |- mesh__recordAuthorizer mesh__D019364 sjn
% 215.74/215.94  |- mesh__dateRevised mesh__D019364 1999-11-03
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D019364 2006
% 215.74/215.94  |- rdf__type mesh__D019364sskos__Concept
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D019364 2000
% 215.74/215.94  |- skos__broader mesh__D019364smesh__D010686
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D019364 2003
% 215.74/215.94  |- mesh__publicMeSHNote mesh__D019364 97   
% 215.74/215.94  |- skos__prefLabel mesh__D019364 Humoralism
% 215.74/215.94  |- mesh__historyNote mesh__D019364 97   
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D019364 2004
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D019364 2001
% 215.74/215.94  |- mesh__recordOriginator mesh__D019364 TGC
% 215.74/215.94  |- mesh__dateEstablished mesh__D019364 1997-01-01
% 215.74/215.94  |- mesh__recordMaintainer mesh__D019364 KEV
% 215.74/215.94  |- skos__scopeNote mesh__D019364
% 215.74/215.94       An ancient Greek medical theory that health and illness result from a balance or imbalance of body fluids or %22%humors%22%. The humors are blood, phlegm, yellow bile, and black bile.%A%    
% 215.74/215.94  |- mesh__dateCreated mesh__D019364 1996-06-10
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D019364 2002
% 215.74/215.94  |- skos__hiddenLabel mesh__D000659 Deaminase, AMP
% 215.74/215.94  |- skos__broader mesh__D000659smesh__D009709
% 215.74/215.94  |- mesh__publicMeSHNote mesh__D000659
% 215.74/215.94       91; was see under NUCLEOTIDE DEAMINASES 1975-90   
% 215.74/215.94  |- skos__altLabel mesh__D000659 AMP Aminohydrolase
% 215.74/215.94  |- skos__scopeNote mesh__D000659
% 215.74/215.94       An enzyme that catalyzes the deamination of AMP to IMP. EC 3.5.4.6.%A%    
% 215.74/215.94  |- skos__altLabel mesh__D000659 Myoadenylate Deaminase
% 215.74/215.94  |- rdf__type mesh__D000659sskos__Concept
% 215.74/215.94  |- mesh__historyNote mesh__D000659
% 215.74/215.94       91%28%75%29%; was see under NUCLEOTIDE DEAMINASES 1975-90   
% 215.74/215.94  |- mesh__recordMaintainer mesh__D000659 ssb
% 215.74/215.94  |- skos__historyNote mesh__D000659 Aminohydrolases %28%1974%29%
% 215.74/215.94  |- skos__historyNote mesh__D000659 Adenosine Monophosphate %28%1974%29%
% 215.74/215.94  |- skos__hiddenLabel mesh__D000659 Deaminase, 5%27%-AMP
% 215.74/215.94  |- skos__hiddenLabel mesh__D000659 Deaminase, Myoadenylate
% 215.74/215.94  |- skos__prefLabel mesh__D000659 AMP Deaminase
% 215.74/215.94  |- skos__hiddenLabel mesh__D000659 Aminase, AMP
% 215.74/215.94  |- mesh__dateEstablished mesh__D000659 1991-01-01
% 215.74/215.94  |- skos__altLabel mesh__D000659 AMP Aminase
% 215.74/215.94  |- mesh__dateRevised mesh__D000659 2003-07-09
% 215.74/215.94  |- skos__hiddenLabel mesh__D000659 5%27% AMP Deaminase
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D000659 2006
% 215.74/215.94  |- mesh__dateCreated mesh__D000659 1974-11-19
% 215.74/215.94  |- skos__altLabel mesh__D000659 5%27%-AMP Deaminase
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D000659 2004
% 215.74/215.94  |- skos__hiddenLabel mesh__D000659 Aminohydrolase, AMP
% 215.74/215.94  |- skos__altLabel mesh__D000659 Adenylate Deaminase
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D000659 2005
% 215.74/215.94  |- skos__hiddenLabel mesh__D000659 Deaminase, Adenylate
% 215.74/215.94  |- mesh__recordOriginator mesh__D000659 NLM
% 215.74/215.94  |- mesh__recordAuthorizer mesh__D000659 sjn
% 215.74/215.94  |- skos__annotation mesh__D011381 IM; no qualif   
% 215.74/215.94  |- rdf__type mesh__D011381sskos__Concept
% 215.74/215.94  |- mesh__historyNote mesh__D011381 87   
% 215.74/215.94  |- mesh__recordAuthorizer mesh__D011381 sjn
% 215.74/215.94  |- mesh__dateCreated mesh__D011381 1986-06-18
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D011381 2005
% 215.74/215.94  |- skos__scopeNote mesh__D011381
% 215.74/215.94       Specific languages used to prepare computer programs.     
% 215.74/215.94  |- skos__broader mesh__D011381smesh__D012984
% 215.74/215.94  |- mesh__dateEstablished mesh__D011381 1987-01-01
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D011381 2006
% 215.74/215.94  |- mesh__dateRevised mesh__D011381 2004-07-07
% 215.74/215.94  |- skos__hiddenLabel mesh__D011381 Programming Language
% 215.74/215.94  |- mesh__recordMaintainer mesh__D011381 jls
% 215.74/215.94  |- mesh__recordOriginator mesh__D011381 EC
% 215.74/215.94  |- mesh__publicMeSHNote mesh__D011381 87   
% 215.74/215.94  |- skos__prefLabel mesh__D011381 Programming Languages
% 215.74/215.94  |- skos__hiddenLabel mesh__D011381 Language, Programming
% 215.74/215.94  |- skos__hiddenLabel mesh__D011381 Languages, Programming
% 215.74/215.94  |- rdf__type mesh__D005344sskos__Concept
% 215.74/215.94  |- mesh__recordAuthorizer mesh__D005344 sjn
% 215.74/215.94  |- skos__broader mesh__D005344smesh__D005340
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D005344 2006
% 215.74/215.94  |- skos__historyNote mesh__D005344 Peptides %28%1968-1975%29%
% 215.74/215.94  |- skos__broader mesh__D005344smesh__D010455
% 215.74/215.94  |- skos__broader mesh__D005344smesh__D005337
% 215.74/215.94  |- mesh__dateRevised mesh__D005344 2005-06-30
% 215.74/215.94  |- skos__historyNote mesh__D005344 Fibrinogen %28%1968-1975%29%
% 215.74/215.94  |- skos__hiddenLabel mesh__D005344 A, Fibrinopeptide
% 215.74/215.94  |- skos__broader mesh__D005344smesh__D001779
% 215.74/215.94  |- mesh__dateEstablished mesh__D005344 1991-01-01
% 215.74/215.94  |- mesh__publicMeSHNote mesh__D005344
% 215.74/215.94       98; see FIBRINOPEPTIDES A 1991-97; see FIBRINOGEN 1976-90%A%  
% 215.74/215.94  |- skos__hiddenLabel mesh__D005344 A, Fibrinopeptides
% 215.74/215.94  |- mesh__recordOriginator mesh__D005344 RLS
% 215.74/215.94  |- skos__prefLabel mesh__D005344 Fibrinopeptide A
% 215.74/215.94  |- mesh__dateCreated mesh__D005344 1975-07-25
% 215.74/215.94  |- skos__scopeNote mesh__D005344
% 215.74/215.94       Two small peptide chains removed from the N-terminal segment of the alpha chains of fibrinogen by the action of thrombin during the blood coagulation process. Each peptide chain contains 18 amino acid residues. In vivo, fibrinopeptide A is used as a marker to determine the rate of conversion of fibrinogen to fibrin by thrombin.%A%    
% 215.74/215.94  |- skos__broader mesh__D005344smesh__D015415
% 215.74/215.94  |- mesh__recordMaintainer mesh__D005344 ssb
% 215.74/215.94  |- skos__altLabel mesh__D005344 Fibrinopeptides A
% 215.74/215.94  |- mesh__historyNote mesh__D005344 98%28%76%29%   
% 215.74/215.94  |- rdf__type mesh__D029792sskos__Concept
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D029792 2006
% 215.74/215.94  |- skos__broader mesh__D029792smesh__D029791
% 215.74/215.94  |- skos__scopeNote mesh__D029792
% 215.74/215.94       A plant genus of the family ERICACEAE.     
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D029792 2003
% 215.74/215.94  |- mesh__publicMeSHNote mesh__D029792 2002   
% 215.74/215.94  |- skos__annotation mesh__D029792
% 215.74/215.94       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.74/215.94  |- mesh__dateEstablished mesh__D029792 2002-01-01
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D029792 2004
% 215.74/215.94  |- skos__altLabel mesh__D029792 Bearberry
% 215.74/215.94  |- skos__prefLabel mesh__D029792 Arctostaphylos
% 215.74/215.94  |- mesh__historyNote mesh__D029792 2002   
% 215.74/215.94  |- mesh__dateCreated mesh__D029792 2001-07-25
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D029792 2005
% 215.74/215.94  |- skos__altLabel mesh__D029792 Uva-ursi
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D029792 2002
% 215.74/215.94  |- mesh__dateEstablished mesh__D010289 1986-01-01
% 215.74/215.94  |- skos__altLabel mesh__D010289 Hyperalimentation, Parenteral
% 215.74/215.94  |- mesh__recordAuthorizer mesh__D010289 sjn
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D010289 2005
% 215.74/215.94  |- skos__altLabel mesh__D010289 Nutrition, Total Parenteral
% 215.74/215.94  |- skos__related mesh__D010289smesh__D011492
% 215.74/215.94  |- mesh__onlineNote mesh__D010289
% 215.74/215.94       use PARENTERAL NUTRITION, TOTAL to search PARENTERAL HYPERALIMENTATION 1975-91%A%  
% 215.74/215.94  |- mesh__recordMaintainer mesh__D010289 lkt
% 215.74/215.94  |- skos__annotation mesh__D010289
% 215.74/215.94       do not use /util except by MeSH definition; coord IM with dis /ther %28%IM%29%, not dis /diet ther; DF: TPN%A%  
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D010289 2006
% 215.74/215.94  |- skos__scopeNote mesh__D010289
% 215.74/215.94       The delivery of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously, or by some other non-alimentary route. The basic components of TPN solutions are protein hydrolysates or free amino acid mixtures, monosaccharides, and electrolytes. Components are selected for their ability to reverse catabolism, promote anabolism, and build structural proteins.%A%    
% 215.74/215.94  |- mesh__publicMeSHNote mesh__D010289
% 215.74/215.94       92; was PARENTERAL HYPERALIMENTATION 1975-91 %28%see under PARENTERAL FEEDING 1975-85%29%%A%  
% 215.74/215.94  |- skos__prefLabel mesh__D010289 Parenteral Nutrition, Total
% 215.74/215.94  |- skos__hiddenLabel mesh__D010289 Hyperalimentation, Intravenous
% 215.74/215.94  |- mesh__recordOriginator mesh__D010289 NLM
% 215.74/215.94  |- skos__altLabel mesh__D010289 Total Parenteral Nutrition
% 215.74/215.94  |- rdf__type mesh__D010289sskos__Concept
% 215.74/215.94  |- mesh__historyNote mesh__D010289
% 215.74/215.94       92; was PARENTERAL HYPERALIMENTATION 1975-91 %28%see under PARENTERAL FEEDING 1975-85%29%%A%  
% 215.74/215.94  |- skos__broader mesh__D010289smesh__D010288
% 215.74/215.94  |- mesh__dateCreated mesh__D010289 1974-12-12
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D010289 2004
% 215.74/215.94  |- mesh__dateRevised mesh__D010289 2003-07-09
% 215.74/215.94  |- skos__altLabel mesh__D010289 Parenteral Hyperalimentation
% 215.74/215.94  |- mesh__publicMeSHNote mesh__D015772
% 215.74/215.94       2005; see BW-775C 1996-2004; see BW 755C 1990; see BW-755C 1990-1995%A%  
% 215.74/215.94  |- mesh__dateCreated mesh__D015772 1989-05-25
% 215.74/215.94  |- mesh__dateEstablished mesh__D015772 1990-01-01
% 215.74/215.94  |- skos__historyNote mesh__D015772
% 215.74/215.94       Anti-Inflammatory Agents %28%1966-1986%29%
% 215.74/215.94  |- skos__altLabel mesh__D015772 BW755C
% 215.74/215.94  |- skos__historyNote mesh__D015772
% 215.74/215.94       Anti-Inflammatory Agents, Non-Steroidal %28%1987-1989%29%
% 215.74/215.94  |- skos__broader mesh__D015772smesh__D011720
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D015772 2006
% 215.74/215.94  |- mesh__recordAuthorizer mesh__D015772 sjn
% 215.74/215.94  |- skos__scopeNote mesh__D015772
% 215.74/215.94       A dual inhibitor of both cyclooxygenase and lipoxygenase pathways. It exerts an anti-inflammatory effect by inhibiting the formation of prostaglandins and leukotrienes. The drug also enhances pulmonary hypoxic vasoconstriction and has a protective effect after myocardial ischemia.%A%    
% 215.74/215.94  |- mesh__recordMaintainer mesh__D015772 ssb
% 215.74/215.94  |- skos__historyNote mesh__D015772 Pyrazoles %28%1966-1989%29%
% 215.74/215.94  |- mesh__dateRevised mesh__D015772 2005-06-30
% 215.74/215.94  |- mesh__historyNote mesh__D015772 2005%28%1991%29%   
% 215.74/215.94  |- mesh__recordOriginator mesh__D015772 RLS
% 215.74/215.94  |- skos__prefLabel mesh__D015772
% 215.74/215.94       4,5-Dihydro-1-%28%3-%28%trifluoromethyl%29%phenyl%29%-1H-pyrazol-3-amine
% 215.74/215.94  |- rdf__type mesh__D015772sskos__Concept
% 215.74/215.94  |- skos__hiddenLabel mesh__D015772 BW 755C
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D009735 2004
% 215.74/215.94  |- skos__hiddenLabel mesh__D009735 Home, Nursing
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D009735 2005
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D009735 2001
% 215.74/215.94  |- mesh__recordOriginator mesh__D009735 NLM
% 215.74/215.94  |- rdf__type mesh__D009735sskos__Concept
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D009735 2003
% 215.74/215.94  |- skos__hiddenLabel mesh__D009735 Nursing Home
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D009735 2000
% 215.74/215.94  |- skos__broader mesh__D009735smesh__D012112
% 215.74/215.94  |- mesh__recordMaintainer mesh__D009735 kle
% 215.74/215.94  |- skos__altLabel mesh__D009735 Homes, Nursing
% 215.74/215.94  |- mesh__recordAuthorizer mesh__D009735 sjn
% 215.74/215.94  |- mesh__dateCreated mesh__D009735 1999-01-01
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D009735 2002
% 215.74/215.94  |- skos__annotation mesh__D009735
% 215.74/215.94       nursing homes for the aged: coord IM with HOMES FOR THE AGED %28%IM%29%; DF: NURS HOMES%A%  
% 215.74/215.94  |- mesh__dateRevised mesh__D009735 1999-11-03
% 215.74/215.94  |- skos__scopeNote mesh__D009735
% 215.74/215.94       Facilities which provide nursing supervision and limited medical care to persons who do not require hospitalization.%A%    
% 215.74/215.94  |- mesh__activeMeSHYear mesh__D009735 2006
% 215.74/215.95  |- skos__prefLabel mesh__D009735 Nursing Homes
% 215.74/215.95  |- skos__hiddenLabel mesh__D001752 Phases, Blast
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D001752 2004
% 215.74/215.95  |- skos__broader mesh__D001752smesh__D002471
% 215.74/215.95  |- mesh__dateEstablished mesh__D001752 1987-01-01
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D001752 2002
% 215.74/215.95  |- skos__hiddenLabel mesh__D001752 Crisis, Blast
% 215.74/215.95  |- mesh__recordAuthorizer mesh__D001752 sjn
% 215.74/215.95  |- mesh__recordOriginator mesh__D001752 VDK
% 215.74/215.95  |- mesh__publicMeSHNote mesh__D001752 87   
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D001752 2003
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D001752 2001
% 215.74/215.95  |- skos__altLabel mesh__D001752 Blast Phase
% 215.74/215.95  |- skos__broader mesh__D001752smesh__D015464
% 215.74/215.95  |- mesh__dateRevised mesh__D001752 2000-06-22
% 215.74/215.95  |- skos__scopeNote mesh__D001752
% 215.74/215.95       Rapid increase in the proportion of blast cells in the blood and bone marrow.%A%    
% 215.74/215.95  |- skos__hiddenLabel mesh__D001752 Phase, Blast
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D001752 2006
% 215.74/215.95  |- mesh__dateCreated mesh__D001752 1986-03-26
% 215.74/215.95  |- skos__hiddenLabel mesh__D001752 Crises, Blast
% 215.74/215.95  |- skos__hiddenLabel mesh__D001752 Blast Phases
% 215.74/215.95  |- skos__hiddenLabel mesh__D001752 Blast Crises
% 215.74/215.95  |- mesh__recordMaintainer mesh__D001752 TPW
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D001752 2005
% 215.74/215.95  |- mesh__historyNote mesh__D001752 87   
% 215.74/215.95  |- skos__prefLabel mesh__D001752 Blast Crisis
% 215.74/215.95  |- skos__annotation mesh__D001752
% 215.74/215.95       note category; IM; coord with specific neopl term /pathol %28%IM%29%; do not confuse with BLAST TRANSFORMATION see LYMPHOCYTE TRANSFORMATION%A%  
% 215.74/215.95  |- rdf__type mesh__D001752sskos__Concept
% 215.74/215.95  |- mesh__dateEstablished mesh__D019365 1997-01-01
% 215.74/215.95  |- rdf__type mesh__D019365sskos__Concept
% 215.74/215.95  |- skos__broader mesh__D019365smesh__D013561
% 215.74/215.95  |- mesh__dateCreated mesh__D019365 1996-06-10
% 215.74/215.95  |- skos__annotation mesh__D019365
% 215.74/215.95       IM; coord with object of comparison %28%IM%29%   
% 215.74/215.95  |- skos__scopeNote mesh__D019365
% 215.74/215.95       The application of a concept to that which it is not literally the same but which suggests a resemblance and comparison. Medical metaphors were widespread in ancient literature; the description of a sick body was often used by ancient writers to define a critical condition of the State, in which one corrupt part can ruin the entire system. %28%From Med Secoli Arte Sci, 1990;2%28%3%29%:abstract 331%29%%A%    
% 215.74/215.95  |- skos__hiddenLabel mesh__D019365 Metaphors
% 215.74/215.95  |- mesh__recordAuthorizer mesh__D019365 sjn
% 215.74/215.95  |- mesh__dateRevised mesh__D019365 2004-07-07
% 215.74/215.95  |- mesh__historyNote mesh__D019365 97   
% 215.74/215.95  |- mesh__recordMaintainer mesh__D019365 jls
% 215.74/215.95  |- mesh__publicMeSHNote mesh__D019365 97   
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D019365 2005
% 215.74/215.95  |- skos__prefLabel mesh__D019365 Metaphor
% 215.74/215.95  |- mesh__recordOriginator mesh__D019365 TGC
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D019365 2006
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011382 1995
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011382 2004
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011382 2006
% 215.74/215.95  |- mesh__dateRevised mesh__D011382 1990-02-16
% 215.74/215.95  |- skos__broader mesh__D011382smesh__D009874
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011382 1991
% 215.74/215.95  |- mesh__recordOriginator mesh__D011382 NLM
% 215.74/215.95  |- mesh__historyNote mesh__D011382
% 215.74/215.95       91%28%75%29%; was see under OPERATIONS RESEARCH 1969-90; was see under OPERATIONS RESEARCH %26% PROGRAMMED INSTRUCTION 1966-68%A%  
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011382 2002
% 215.74/215.95  |- mesh__recordAuthorizer mesh__D011382 PLS
% 215.74/215.95  |- skos__scopeNote mesh__D011382
% 215.74/215.95       A technique of operations research for solving certain kinds of problems involving many variables where a best value or set of best values is to be found. It is most likely to be feasible when the quantity to be optimized, sometimes called the objective function, can be stated as a mathematical expression in terms of the various activities within the system, and when this expression is simply proportional to the measure of the activities, i.e., is linear, and when all the restrictions are also linear. It is different from computer programming, although problems using linear programming techniques may be programmed on a computer.%A%    
% 215.74/215.95  |- mesh__dateCreated mesh__D011382 1999-01-01
% 215.74/215.95  |- mesh__onlineNote mesh__D011382
% 215.74/215.95       search OPERATIONS RESEARCH 1969-74 %26% OPERATIONS RESEARCH %26% PROGRAMMED INSTRUCTION 1966-68%A%  
% 215.74/215.95  |- mesh__publicMeSHNote mesh__D011382
% 215.74/215.95       91; was see under OPERATIONS RESEARCH 1969-90; was see under OPERATIONS RESEARCH %26% PROGRAMMED INSTRUCTION 1966-68%A%  
% 215.74/215.95  |- mesh__recordMaintainer mesh__D011382 PLS
% 215.74/215.95  |- skos__annotation mesh__D011382 IM   
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011382 1996
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011382 1998
% 215.74/215.95  |- mesh__dateEstablished mesh__D011382 1991-01-01
% 215.74/215.95  |- rdf__type mesh__D011382sskos__Concept
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011382 1992
% 215.74/215.95  |- skos__prefLabel mesh__D011382 Programming, Linear
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011382 2000
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011382 1997
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011382 1994
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011382 2003
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011382 2001
% 215.74/215.95  |- skos__hiddenLabel mesh__D011382 Linear Programming
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011382 1999
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011382 2005
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011382 1993
% 215.74/215.95  |- skos__hiddenLabel mesh__D005345 B, Fibrinopeptides
% 215.74/215.95  |- mesh__dateEstablished mesh__D005345 1991-01-01
% 215.74/215.95  |- rdf__type mesh__D005345sskos__Concept
% 215.74/215.95  |- skos__prefLabel mesh__D005345 Fibrinopeptide B
% 215.74/215.95  |- skos__historyNote mesh__D005345 Fibrinogen %28%1968-1975%29%
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D005345 2006
% 215.74/215.95  |- skos__scopeNote mesh__D005345
% 215.74/215.95       Two small peptide chains removed from the N-terminal segment of the beta chains of fibrinogen by the action of thrombin. Each peptide chain contains 20 amino acid residues. The removal of fibrinopeptides B is not required for coagulation.%A%    
% 215.74/215.95  |- skos__broader mesh__D005345smesh__D010455
% 215.74/215.95  |- mesh__recordOriginator mesh__D005345 RLS
% 215.74/215.95  |- skos__broader mesh__D005345smesh__D005340
% 215.74/215.95  |- mesh__dateCreated mesh__D005345 1975-07-25
% 215.74/215.95  |- skos__broader mesh__D005345smesh__D005337
% 215.74/215.95  |- mesh__recordAuthorizer mesh__D005345 sjn
% 215.74/215.95  |- mesh__publicMeSHNote mesh__D005345
% 215.74/215.95       98; see FIBRINOPEPTIDES B 1991-97; see FIBRINOGEN 1976-90%A%  
% 215.74/215.95  |- skos__broader mesh__D005345smesh__D001779
% 215.74/215.95  |- skos__altLabel mesh__D005345 Fibrinopeptides B
% 215.74/215.95  |- skos__hiddenLabel mesh__D005345 B, Fibrinopeptide
% 215.74/215.95  |- mesh__dateRevised mesh__D005345 2005-06-30
% 215.74/215.95  |- skos__historyNote mesh__D005345 Peptides %28%1968-1975%29%
% 215.74/215.95  |- mesh__recordMaintainer mesh__D005345 ssb
% 215.74/215.95  |- mesh__historyNote mesh__D005345 98%28%76%29%   
% 215.74/215.95  |- skos__prefLabel mesh__D029793 Rhododendron
% 215.74/215.95  |- mesh__historyNote mesh__D029793 2002   
% 215.74/215.95  |- mesh__dateEstablished mesh__D029793 2002-01-01
% 215.74/215.95  |- mesh__dateCreated mesh__D029793 2001-07-25
% 215.74/215.95  |- skos__broader mesh__D029793smesh__D029791
% 215.74/215.95  |- skos__scopeNote mesh__D029793
% 215.74/215.95       A plant genus of the family ERICACEAE.     
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D029793 2002
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D029793 2005
% 215.74/215.95  |- rdf__type mesh__D029793sskos__Concept
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D029793 2006
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D029793 2003
% 215.74/215.95  |- mesh__publicMeSHNote mesh__D029793 2002   
% 215.74/215.95  |- skos__annotation mesh__D029793
% 215.74/215.95       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D029793 2004
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D015773 2006
% 215.74/215.95  |- mesh__dateCreated mesh__D015773 1989-07-19
% 215.74/215.95  |- skos__altLabel mesh__D015773 Merck Frosst Brand of Enalaprilat Anhydrous
% 215.74/215.95  |- skos__hiddenLabel mesh__D015773 MK422
% 215.74/215.95  |- skos__altLabel mesh__D015773 Biovail Brand of Enalaprilat Anhydrous
% 215.74/215.95  |- skos__altLabel mesh__D015773
% 215.74/215.95       Boehringer Ingelheim Brand of Enalaprilat Anhydrous
% 215.74/215.95  |- skos__altLabel mesh__D015773 MSD Brand of Enalaprilat
% 215.74/215.95  |- skos__hiddenLabel mesh__D015773 MK 422
% 215.74/215.95  |- skos__prefLabel mesh__D015773 Enalaprilat
% 215.74/215.95  |- mesh__recordAuthorizer mesh__D015773 sjn
% 215.74/215.95  |- skos__scopeNote mesh__D015773
% 215.74/215.95       The active metabolite of ENALAPRIL and a potent intravenously administered angiotensin-converting enzyme inhibitor. It is an effective agent for the treatment of essential hypertension and has beneficial hemodynamic effects in heart failure. The drug produces renal vasodilation with an increase in sodium excretion.%A%    
% 215.74/215.95  |- skos__hiddenLabel mesh__D015773 Anhydrous Enalaprilat Citrate
% 215.74/215.95  |- skos__hiddenLabel mesh__D015773 Anhydrous, Enalaprilat
% 215.74/215.95  |- mesh__recordMaintainer mesh__D015773 exl
% 215.74/215.95  |- rdf__type mesh__D015773sskos__Concept
% 215.74/215.95  |- skos__broader mesh__D015773smesh__D004656
% 215.74/215.95  |- skos__altLabel mesh__D015773 Enalaprilic Acid
% 215.74/215.95  |- mesh__dateRevised mesh__D015773 2005-06-30
% 215.74/215.95  |- skos__altLabel mesh__D015773 Teva Brand of Enalaprilat
% 215.74/215.95  |- skos__historyNote mesh__D015773 Dipeptides %28%1966-1985%29%
% 215.74/215.95  |- mesh__recordOriginator mesh__D015773 RLS
% 215.74/215.95  |- mesh__dateEstablished mesh__D015773 1990-01-01
% 215.74/215.95  |- mesh__historyNote mesh__D015773 90   
% 215.74/215.95  |- mesh__publicMeSHNote mesh__D015773 90   
% 215.74/215.95  |- skos__historyNote mesh__D015773 Enalapril %28%1986-1989%29%
% 215.74/215.95  |- mesh__dateCreated mesh__D009736 1979-04-11
% 215.74/215.95  |- skos__prefLabel mesh__D009736 Nursing Process
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009736 1999
% 215.74/215.95  |- skos__annotation mesh__D009736
% 215.74/215.95       %22%total of nursing care activities%22%; do not confuse with NURSING %28%the profession%29%, NURSING CARE %28%the patient%29%, NURSING SERVICES; DF: NURS PROCESS%A%  
% 215.74/215.95  |- mesh__recordMaintainer mesh__D009736 TGC
% 215.74/215.95  |- skos__historyNote mesh__D009736 Nursing Care %28%1966-1979%29%
% 215.74/215.95  |- skos__broader mesh__D009736smesh__D003191
% 215.74/215.95  |- rdf__type mesh__D009736sskos__Concept
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009736 2003
% 215.74/215.95  |- skos__hiddenLabel mesh__D009736 Nursing Processes
% 215.74/215.95  |- mesh__dateRevised mesh__D009736 1994-05-05
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009736 1997
% 215.74/215.95  |- mesh__historyNote mesh__D009736 80   
% 215.74/215.95  |- mesh__recordOriginator mesh__D009736 EC
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009736 1998
% 215.74/215.95  |- mesh__recordAuthorizer mesh__D009736 PLS
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009736 2001
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009736 1996
% 215.74/215.95  |- mesh__dateEstablished mesh__D009736 1980-01-01
% 215.74/215.95  |- skos__hiddenLabel mesh__D009736 Processes, Nursing
% 215.74/215.95  |- mesh__publicMeSHNote mesh__D009736 80   
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009736 2000
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009736 1995
% 215.74/215.95  |- skos__scopeNote mesh__D009736
% 215.74/215.95       The sum total of nursing activities which includes assessment %28%identifying needs%29%, intervention %28%ministering to needs%29%, and evaluation %28%validating the effectiveness of the help given%29%.%A%    
% 215.74/215.95  |- skos__historyNote mesh__D009736 Patient Care Planning %28%1968-1979%29%
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009736 2006
% 215.74/215.95  |- skos__altLabel mesh__D009736 Process, Nursing
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009736 2004
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009736 2005
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009736 2002
% 215.74/215.95  |- mesh__recordAuthorizer mesh__D001753 sjn
% 215.74/215.95  |- skos__hiddenLabel mesh__D001753 Injury, Blast
% 215.74/215.95  |- skos__annotation mesh__D001753
% 215.74/215.95       various body inj from waves of high-pressure velocity; /compl permitted but do not confuse with /pathol%A%  
% 215.74/215.95  |- mesh__recordMaintainer mesh__D001753 jls
% 215.74/215.95  |- mesh__dateEstablished mesh__D001753 1973-01-01
% 215.74/215.95  |- mesh__historyNote mesh__D001753 73; was BLAST INJURY 1963-72   
% 215.74/215.95  |- skos__hiddenLabel mesh__D001753 Blast Injury
% 215.74/215.95  |- mesh__onlineNote mesh__D001753
% 215.74/215.95       use BLAST INJURIES to search BLAST INJURY 1966-72   
% 215.74/215.95  |- mesh__publicMeSHNote mesh__D001753 73; was BLAST INJURY 1963-72   
% 215.74/215.95  |- skos__broader mesh__D001753smesh__D001469
% 215.74/215.95  |- mesh__dateCreated mesh__D001753 1999-01-01
% 215.74/215.95  |- skos__altLabel mesh__D001753 Injuries, Blast
% 215.74/215.95  |- skos__prefLabel mesh__D001753 Blast Injuries
% 215.74/215.95  |- skos__scopeNote mesh__D001753
% 215.74/215.95       Injuries resulting when a person is struck by particles impelled with violent force from an explosion. Blast causes pulmonary concussion and hemorrhage, laceration of other thoracic and abdominal viscera, ruptured ear drums, and minor effects in the central nervous system. %28%From Dorland, 27th ed%29%%A%    
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D001753 2006
% 215.74/215.95  |- mesh__recordOriginator mesh__D001753 NLM
% 215.74/215.95  |- rdf__type mesh__D001753sskos__Concept
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D001753 2005
% 215.74/215.95  |- mesh__dateRevised mesh__D001753 2004-07-19
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D019366 2000
% 215.74/215.95  |- mesh__historyNote mesh__D019366 97   
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D019366 2004
% 215.74/215.95  |- mesh__publicMeSHNote mesh__D019366 97   
% 215.74/215.95  |- mesh__dateEstablished mesh__D019366 1997-01-01
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D019366 2001
% 215.74/215.95  |- skos__broader mesh__D019366smesh__D002962
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D019366 1997
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D019366 2005
% 215.74/215.95  |- mesh__dateCreated mesh__D019366 1996-06-10
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D019366 2002
% 215.74/215.95  |- skos__annotation mesh__D019366
% 215.74/215.95       note category; refers usually to Europe %26% the Americas; IM; specify Category Z continent or country if relevant%A%  
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D019366 2006
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D019366 1998
% 215.74/215.95  |- rdf__type mesh__D019366sskos__Concept
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D019366 1999
% 215.74/215.95  |- skos__scopeNote mesh__D019366
% 215.74/215.95       A historical and cultural entity dispersed across the wide geographical area of Europe, as opposed to the East, Asia, and Africa. The term was used by scholars through the late medieval period. Thereafter, with the impact of colonialism and the transmission of cultures, Western World was sometimes expanded to include the Americas. %28%Dr. James H. Cassedy, NLM History of Medicine Division%29%%A%    
% 215.74/215.95  |- skos__prefLabel mesh__D019366 Western World
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D019366 2003
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011383 2001
% 215.74/215.95  |- skos__broader mesh__D011383smesh__D003191
% 215.74/215.95  |- mesh__dateCreated mesh__D011383 1999-01-01
% 215.74/215.95  |- skos__hiddenLabel mesh__D011383 Patient Care, Progressive
% 215.74/215.95  |- skos__hiddenLabel mesh__D011383 Progressive Patient Cares
% 215.74/215.95  |- mesh__publicMeSHNote mesh__D011383 66   
% 215.74/215.95  |- skos__scopeNote mesh__D011383
% 215.74/215.95       Organization of medical and nursing care according to the degree of illness and care requirements in the hospital. The elements are intensive care, intermediate care, self-care, long-term care, and organized home care.%A%    
% 215.74/215.95  |- mesh__recordOriginator mesh__D011383 NLM
% 215.74/215.95  |- skos__prefLabel mesh__D011383 Progressive Patient Care
% 215.74/215.95  |- rdf__type mesh__D011383sskos__Concept
% 215.74/215.95  |- skos__hiddenLabel mesh__D011383 Care, Progressive Patient
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011383 2002
% 215.74/215.95  |- skos__hiddenLabel mesh__D011383 Patient Cares, Progressive
% 215.74/215.95  |- mesh__dateEstablished mesh__D011383 1966-01-01
% 215.74/215.95  |- skos__hiddenLabel mesh__D011383 Cares, Progressive Patient
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011383 2003
% 215.74/215.95  |- mesh__recordAuthorizer mesh__D011383 sjn
% 215.74/215.95  |- skos__annotation mesh__D011383 IM   
% 215.74/215.95  |- mesh__recordMaintainer mesh__D011383 kle
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011383 2005
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011383 2004
% 215.74/215.95  |- mesh__dateRevised mesh__D011383 1999-11-03
% 215.74/215.95  |- mesh__historyNote mesh__D011383 66%28%64%29%   
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011383 2006
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011383 2000
% 215.74/215.95  |- mesh__historyNote mesh__D005346 2001%28%1984%29%   
% 215.74/215.95  |- mesh__recordMaintainer mesh__D005346 ssb
% 215.74/215.95  |- skos__altLabel mesh__D005346 DNA Synthesis Factor
% 215.74/215.95  |- mesh__dateCreated mesh__D005346 1983-05-31
% 215.74/215.95  |- mesh__dateEstablished mesh__D005346 1984-01-01
% 215.74/215.95  |- skos__related mesh__D005346smesh__D017468
% 215.74/215.95  |- skos__hiddenLabel mesh__D005346 Growth Factors, Fibroblast
% 215.74/215.95  |- skos__broader mesh__D005346smesh__D036341
% 215.74/215.95  |- skos__historyNote mesh__D005346 Mitogens %28%1974-1983%29%
% 215.74/215.95  |- skos__scopeNote mesh__D005346
% 215.74/215.95       A family of small polypeptide growth factors that share several common features including a strong affinity for HEPARIN, and a central barrel-shaped core region of 140 amino acids that is highly homologous between family members. Although originally studied as proteins that stimulate the growth of fibroblasts this distinction is no longer a requirement for membership in the fibroblast growth factor family.%A%    
% 215.74/215.95  |- skos__broader mesh__D005346smesh__D006133
% 215.74/215.95  |- skos__hiddenLabel mesh__D005346 Growth Factor, Fibroblast
% 215.74/215.95  |- skos__altLabel mesh__D005346 Fibroblast Growth Factor
% 215.74/215.95  |- skos__historyNote mesh__D005346 Nerve Tissue Proteins %28%1974-1983%29%
% 215.74/215.95  |- mesh__recordOriginator mesh__D005346 RLS
% 215.74/215.95  |- skos__historyNote mesh__D005346 Fibroblasts %28%1974-1983%29%
% 215.74/215.95  |- mesh__recordAuthorizer mesh__D005346 sjn
% 215.74/215.95  |- skos__historyNote mesh__D005346 Pituitary Hormones %28%1974-1983%29%
% 215.74/215.95  |- skos__altLabel mesh__D005346 Fibroblast Growth Regulatory Factor
% 215.74/215.95  |- skos__historyNote mesh__D005346 Growth Substances %28%1974-1983%29%
% 215.74/215.95  |- rdf__type mesh__D005346sskos__Concept
% 215.74/215.95  |- mesh__publicMeSHNote mesh__D005346
% 215.74/215.95       2001; see FIBROBLAST GROWTH FACTOR 1984-2001   
% 215.74/215.95  |- skos__prefLabel mesh__D005346 Fibroblast Growth Factors
% 215.74/215.95  |- skos__historyNote mesh__D005346 Peptides %28%1974-1983%29%
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D005346 2006
% 215.74/215.95  |- mesh__dateRevised mesh__D005346 2005-06-30
% 215.74/215.95  |- skos__annotation mesh__D029794
% 215.74/215.95       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D029794 2005
% 215.74/215.95  |- mesh__historyNote mesh__D029794 2002   
% 215.74/215.95  |- rdf__type mesh__D029794sskos__Concept
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D029794 2006
% 215.74/215.95  |- mesh__dateCreated mesh__D029794 2001-07-25
% 215.74/215.95  |- skos__broader mesh__D029794smesh__D029791
% 215.74/215.95  |- skos__altLabel mesh__D029794 Wild Rosemary
% 215.74/215.95  |- skos__altLabel mesh__D029794 Labrador Tea
% 215.74/215.95  |- skos__scopeNote mesh__D029794
% 215.74/215.95       A plant genus of the family ERICACEAE.     
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D029794 2002
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D029794 2003
% 215.74/215.95  |- mesh__publicMeSHNote mesh__D029794 2002   
% 215.74/215.95  |- skos__prefLabel mesh__D029794 Ledum
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D029794 2004
% 215.74/215.95  |- mesh__dateEstablished mesh__D029794 2002-01-01
% 215.74/215.95  |- skos__prefLabel mesh__D015774 Ganciclovir
% 215.74/215.95  |- mesh__historyNote mesh__D015774 90   
% 215.74/215.95  |- skos__altLabel mesh__D015774 Gancyclovir
% 215.74/215.95  |- mesh__dateCreated mesh__D015774 1989-09-01
% 215.74/215.95  |- rdf__type mesh__D015774sskos__Concept
% 215.74/215.95  |- skos__scopeNote mesh__D015774
% 215.74/215.95       An ACYCLOVIR analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections.%A%    
% 215.74/215.95  |- mesh__recordOriginator mesh__D015774 AGS
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D015774 2003
% 215.74/215.95  |- skos__historyNote mesh__D015774
% 215.74/215.95       Acyclovir/analogs %26% derivatives %28%1982-1989%29%
% 215.74/215.95  |- skos__annotation mesh__D015774
% 215.74/215.95       do not confuse DHPG, a common abbrev for ganciclovir with DHPG for both 3,4-dihydroxyphenylglycol %26% 3,4-dihydroxyphenylethylene glycol%A%  
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D015774 2005
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D015774 2004
% 215.74/215.95  |- mesh__dateRevised mesh__D015774 2001-07-25
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D015774 2006
% 215.74/215.95  |- mesh__dateEstablished mesh__D015774 1990-01-01
% 215.74/215.95  |- mesh__publicMeSHNote mesh__D015774 90   
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D015774 2002
% 215.74/215.95  |- skos__broader mesh__D015774smesh__D000212
% 215.74/215.95  |- mesh__recordAuthorizer mesh__D015774 sjn
% 215.74/215.95  |- skos__historyNote mesh__D015774
% 215.74/215.95       Guanine/analogs %26% derivatives %28%1982-1983%29%
% 215.74/215.95  |- mesh__recordMaintainer mesh__D015774 ssb
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009737 2002
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009737 1999
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009737 1996
% 215.74/215.95  |- rdf__type mesh__D009737sskos__Concept
% 215.74/215.95  |- skos__scopeNote mesh__D009737
% 215.74/215.95       Data recorded by nurses concerning the nursing care given to the patient, including judgment of the patient%27%s progress.%A%    
% 215.74/215.95  |- mesh__recordMaintainer mesh__D009737 PLS
% 215.74/215.95  |- mesh__dateCreated mesh__D009737 1999-01-01
% 215.74/215.95  |- skos__historyNote mesh__D009737 Medical Records %28%1966%29%
% 215.74/215.95  |- skos__annotation mesh__D009737
% 215.74/215.95       FORMS AND RECORDS CONTROL, also available, is probably NIM when coord; DF: NURS RECORDS%A%  
% 215.74/215.95  |- mesh__dateEstablished mesh__D009737 1967-01-01
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009737 1997
% 215.74/215.95  |- mesh__recordAuthorizer mesh__D009737 PLS
% 215.74/215.95  |- mesh__historyNote mesh__D009737 67   
% 215.74/215.95  |- skos__prefLabel mesh__D009737 Nursing Records
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009737 1994
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009737 2005
% 215.74/215.95  |- skos__hiddenLabel mesh__D009737 Nursing Record
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009737 2000
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009737 1995
% 215.74/215.95  |- mesh__dateRevised mesh__D009737 1992-05-15
% 215.74/215.95  |- skos__hiddenLabel mesh__D009737 Record, Nursing
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009737 2006
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009737 2003
% 215.74/215.95  |- skos__broader mesh__D009737smesh__D011996
% 215.74/215.95  |- skos__related mesh__D009737smesh__D005568
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009737 2001
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009737 1993
% 215.74/215.95  |- mesh__publicMeSHNote mesh__D009737 67   
% 215.74/215.95  |- mesh__recordOriginator mesh__D009737 NLM
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009737 1998
% 215.74/215.95  |- skos__altLabel mesh__D009737 Records, Nursing
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D009737 2004
% 215.74/215.95  |- skos__broader mesh__D001754smesh__D008411
% 215.74/215.95  |- skos__prefLabel mesh__D001754 Blastocladiella
% 215.74/215.95  |- mesh__dateCreated mesh__D001754 1999-01-01
% 215.74/215.95  |- mesh__recordOriginator mesh__D001754 NLM
% 215.74/215.95  |- skos__scopeNote mesh__D001754
% 215.74/215.95       A genus of aquatic fungi of the family Blastocladiaceae, order Blastocladiales, used in the study of zoospore formation.%A%    
% 215.74/215.95  |- mesh__recordAuthorizer mesh__D001754 sjn
% 215.74/215.95  |- mesh__publicMeSHNote mesh__D001754
% 215.74/215.95       91; see MASTIGOMYCOTINA 1986-90, see PHYCOMYCETES 1963-85%A%  
% 215.74/215.95  |- mesh__historyNote mesh__D001754
% 215.74/215.95       91; use CHYTRIDIOMYCOTA 1986-90, use FUNGI 1963-85   
% 215.74/215.95  |- mesh__recordMaintainer mesh__D001754 SYSTEM
% 215.74/215.95  |- mesh__dateRevised mesh__D001754 2005-06-30
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D001754 2006
% 215.74/215.95  |- mesh__dateEstablished mesh__D001754 1991-01-01
% 215.74/215.95  |- rdf__type mesh__D001754sskos__Concept
% 215.74/215.95  |- skos__scopeNote mesh__D020110
% 215.74/215.95       A potassium-channel opener that produces direct peripheral vasodilatation of the arterioles. It reduces blood pressure and peripheral resistance and produces fluid retention. %28%Martindale The Extra Pharmacopoeia, 31st ed%29%%A%    
% 215.74/215.95  |- skos__hiddenLabel mesh__D020110 Anhydrous, Pinacidil
% 215.74/215.95  |- mesh__dateRevised mesh__D020110 2000-06-21
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D020110 2004
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D020110 2001
% 215.74/215.95  |- mesh__recordAuthorizer mesh__D020110 sjn
% 215.74/215.95  |- mesh__publicMeSHNote mesh__D020110
% 215.74/215.95       99; PINACIDIL was indexed under GUANIDINES 1983-98 %26% PYRIDINES 1980-82%A%  
% 215.74/215.95  |- mesh__dateEstablished mesh__D020110 1999-01-01
% 215.74/215.95  |- skos__historyNote mesh__D020110 Guanidines %28%1983-1998%29%
% 215.74/215.95  |- mesh__recordOriginator mesh__D020110 ADP
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D020110 2005
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D020110 2002
% 215.74/215.95  |- skos__broader mesh__D020110smesh__D006146
% 215.74/215.95  |- rdf__type mesh__D020110sskos__Concept
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D020110 2006
% 215.74/215.95  |- mesh__recordMaintainer mesh__D020110 CCR
% 215.74/215.95  |- mesh__historyNote mesh__D020110 99; use PINACIDIL %28%NM%29% 1980-98   
% 215.74/215.95  |- mesh__dateCreated mesh__D020110 1998-06-10
% 215.74/215.95  |- skos__prefLabel mesh__D020110 Pinacidil
% 215.74/215.95  |- skos__historyNote mesh__D020110 Pyridines %28%1980-1982%29%
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D020110 2003
% 215.74/215.95  |- skos__broader mesh__D019367smesh__D008514
% 215.74/215.95  |- skos__scopeNote mesh__D019367
% 215.74/215.95       A modified Greco-Arabic medical system flourishing today as unani medicine. It was the product of Arab physicians and scholars captivated by Greek philosophy, science, and medicine. It is practiced today in India and Pakistan, largely as a type of herbal medicine. %28%From Magner, A History of Medicine, 1992, p136%29%%A%    
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D019367 2005
% 215.74/215.95  |- mesh__recordMaintainer mesh__D019367 jls
% 215.74/215.95  |- skos__broader mesh__D019367smesh__D008519
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D019367 2006
% 215.74/215.95  |- mesh__dateEstablished mesh__D019367 1997-01-01
% 215.74/215.95  |- mesh__publicMeSHNote mesh__D019367 97   
% 215.74/215.95  |- rdf__type mesh__D019367sskos__Concept
% 215.74/215.95  |- skos__prefLabel mesh__D019367 Medicine, Unani
% 215.74/215.95  |- mesh__recordOriginator mesh__D019367 TGC
% 215.74/215.95  |- mesh__dateCreated mesh__D019367 1996-06-10
% 215.74/215.95  |- skos__annotation mesh__D019367
% 215.74/215.95       a type of Arabic %26% herbal med common in India %26% Pakistan; specify geog only if relevant; do not capitalize unani in titles %26% translations; DF: MED UNANI%A%  
% 215.74/215.95  |- skos__altLabel mesh__D019367 Unani Medicine
% 215.74/215.95  |- mesh__dateRevised mesh__D019367 2004-07-07
% 215.74/215.95  |- mesh__recordAuthorizer mesh__D019367 sjn
% 215.74/215.95  |- mesh__historyNote mesh__D019367 97   
% 215.74/215.95  |- mesh__dateRevised mesh__D011384 2005-06-30
% 215.74/215.95  |- skos__historyNote mesh__D011384 Insulin %28%1966-1971%29%
% 215.74/215.95  |- mesh__recordAuthorizer mesh__D011384 sjn
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D011384 2006
% 215.74/215.95  |- skos__annotation mesh__D011384
% 215.74/215.95       an insulin precursor; /biosyn /physiol permitted   
% 215.74/215.95  |- mesh__recordMaintainer mesh__D011384 SYSTEM
% 215.74/215.95  |- mesh__dateEstablished mesh__D011384 1972-01-01
% 215.74/215.95  |- mesh__historyNote mesh__D011384 72   
% 215.74/215.95  |- skos__prefLabel mesh__D011384 Proinsulin
% 215.74/215.95  |- mesh__publicMeSHNote mesh__D011384 72   
% 215.74/215.95  |- skos__broader mesh__D011384smesh__D011498
% 215.74/215.95  |- mesh__dateCreated mesh__D011384 1999-01-01
% 215.74/215.95  |- skos__broader mesh__D011384smesh__D007328
% 215.74/215.95  |- rdf__type mesh__D011384sskos__Concept
% 215.74/215.95  |- skos__scopeNote mesh__D011384
% 215.74/215.95       A precursor of insulin, with a molecular weight of 8,000 to 10,000. It has minimum hormonal activity and is converted to insulin by removal of the connecting C peptide, leaving the two %28%A and B%29%-chain, active insulin molecule. %28%Dorland, 28th ed%29%%A%    
% 215.74/215.95  |- mesh__recordOriginator mesh__D011384 NLM
% 215.74/215.95  |- skos__broader mesh__D005347smesh__D003239
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D005347 2002
% 215.74/215.95  |- mesh__recordAuthorizer mesh__D005347 sjn
% 215.74/215.95  |- mesh__dateCreated mesh__D005347 1999-01-01
% 215.74/215.95  |- skos__hiddenLabel mesh__D005347 Fibroblast
% 215.74/215.95  |- mesh__dateEstablished mesh__D005347 1965-01-01
% 215.74/215.95  |- skos__prefLabel mesh__D005347 Fibroblasts
% 215.74/215.95  |- mesh__dateRevised mesh__D005347 1999-11-03
% 215.74/215.95  |- mesh__activeMeSHYear mesh__D005347 2005
% 215.74/215.95  |- rdf__type mesh__D005347sskos__Concept
% 215.74/215.96  |- mesh__historyNote mesh__D005347 65%28%64%29%   
% 215.74/215.96  |- mesh__recordOriginator mesh__D005347 NLM
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D005347 2006
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D005347 2003
% 215.74/215.96  |- skos__broader mesh__D005347smesh__D013234
% 215.74/215.96  |- mesh__recordMaintainer mesh__D005347 KEV
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D005347 2000
% 215.74/215.96  |- mesh__publicMeSHNote mesh__D005347 65   
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D005347 2004
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D005347 2001
% 215.74/215.96  |- skos__scopeNote mesh__D005347
% 215.74/215.96       Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules.%A%    
% 215.74/215.96  |- skos__altLabel mesh__D024501 Myosin IIB
% 215.74/215.96  |- skos__altLabel mesh__D024501 Myosin B
% 215.74/215.96  |- skos__prefLabel mesh__D024501 Nonmuscle Myosin Type IIB
% 215.74/215.96  |- mesh__historyNote mesh__D024501
% 215.74/215.96       2002; for MYOSIN B use MYOSINS 1982-2001   
% 215.74/215.96  |- mesh__dateRevised mesh__D024501 2005-06-30
% 215.74/215.96  |- rdf__type mesh__D024501sskos__Concept
% 215.74/215.96  |- skos__hiddenLabel mesh__D024501 Non Muscle Myosin Type IIB
% 215.74/215.96  |- mesh__recordAuthorizer mesh__D024501 sjn
% 215.74/215.96  |- skos__broader mesh__D024501smesh__D024462
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D024501 2006
% 215.74/215.96  |- skos__historyNote mesh__D024501 Myosin %28%1982-2001%29%
% 215.74/215.96  |- mesh__publicMeSHNote mesh__D024501 2002   
% 215.74/215.96  |- mesh__recordMaintainer mesh__D024501 DRC
% 215.74/215.96  |- mesh__dateCreated mesh__D024501 2001-07-25
% 215.74/215.96  |- skos__hiddenLabel mesh__D024501 Myosin Type IIB, Non Muscle
% 215.74/215.96  |- skos__altLabel mesh__D024501 Non-Muscle Myosin Type IIB
% 215.74/215.96  |- mesh__recordOriginator mesh__D024501 jmp
% 215.74/215.96  |- skos__altLabel mesh__D024501 Myosin Type IIB, Non-Muscle
% 215.74/215.96  |- skos__scopeNote mesh__D024501
% 215.74/215.96       A nonmuscle isoform of myosin type II found predominantly in neuronal tissue.%A%    
% 215.74/215.96  |- mesh__dateEstablished mesh__D024501 2002-01-01
% 215.74/215.96  |- skos__prefLabel mesh__D029795 Calluna
% 215.74/215.96  |- skos__broader mesh__D029795smesh__D029791
% 215.74/215.96  |- skos__annotation mesh__D029795
% 215.74/215.96       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D029795 2002
% 215.74/215.96  |- skos__scopeNote mesh__D029795
% 215.74/215.96       A plant genus of the family ERICACEAE.     
% 215.74/215.96  |- mesh__dateEstablished mesh__D029795 2002-01-01
% 215.74/215.96  |- mesh__dateCreated mesh__D029795 2001-07-25
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D029795 2006
% 215.74/215.96  |- skos__altLabel mesh__D029795 Scotch Heather
% 215.74/215.96  |- mesh__historyNote mesh__D029795 2002   
% 215.74/215.96  |- rdf__type mesh__D029795sskos__Concept
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D029795 2005
% 215.74/215.96  |- mesh__publicMeSHNote mesh__D029795 2002   
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D029795 2004
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D029795 2003
% 215.74/215.96  |- skos__prefLabel mesh__D015775 Fractures, Stress
% 215.74/215.96  |- mesh__recordAuthorizer mesh__D015775 sjn
% 215.74/215.96  |- rdf__type mesh__D015775sskos__Concept
% 215.74/215.96  |- skos__hiddenLabel mesh__D015775 Stress Fracture
% 215.74/215.96  |- mesh__recordMaintainer mesh__D015775 ssb
% 215.74/215.96  |- skos__hiddenLabel mesh__D015775 Fracture, March
% 215.74/215.96  |- skos__scopeNote mesh__D015775
% 215.74/215.96       Fractures due to the strain caused by repetitive exercise. They are thought to arise from a combination of muscle fatigue and bone failure, and occur in situations where bone remodeling predominates over repair. The classical stress fracture is the march fracture of military personnel, in which the metatarsal undergoes repeated stress during marching. The most common sites of stress fractures are the metatarsus, fibula, tibia, and femoral neck.%A%    
% 215.74/215.96  |- skos__annotation mesh__D015775
% 215.74/215.96       fract caused by repetitive strain; X ref FATIGUE FRACTURES refers to bone fractures: do not use for metal fatigue as in fatigue fract of amalgams, nails, screw plates, etc %28%index under STRESS, MECHANICAL%29%; coord IM with specific organ /inj or organ/fract term %28%IM%29%%A%  
% 215.74/215.96  |- skos__altLabel mesh__D015775 Fatigue Fractures
% 215.74/215.96  |- mesh__dateRevised mesh__D015775 2005-06-30
% 215.74/215.96  |- mesh__historyNote mesh__D015775 90   
% 215.74/215.96  |- skos__historyNote mesh__D015775 Fractures %28%1966-1989%29%
% 215.74/215.96  |- skos__hiddenLabel mesh__D015775 Fracture, Stress
% 215.74/215.96  |- skos__hiddenLabel mesh__D015775 Fatigue Fracture
% 215.74/215.96  |- skos__hiddenLabel mesh__D015775 March Fractures
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D015775 2006
% 215.74/215.96  |- skos__historyNote mesh__D015775
% 215.74/215.96       Repetition Strain Injury %28%1987-1989%29%
% 215.74/215.96  |- mesh__dateEstablished mesh__D015775 1990-01-01
% 215.74/215.96  |- mesh__publicMeSHNote mesh__D015775 90   
% 215.74/215.96  |- mesh__recordOriginator mesh__D015775 AGS
% 215.74/215.96  |- skos__altLabel mesh__D015775 Fractures, Fatigue
% 215.74/215.96  |- skos__hiddenLabel mesh__D015775 Fracture, Fatigue
% 215.74/215.96  |- skos__altLabel mesh__D015775 Fractures, March
% 215.74/215.96  |- skos__hiddenLabel mesh__D015775 March Fracture
% 215.74/215.96  |- skos__altLabel mesh__D015775 Stress Fractures
% 215.74/215.96  |- skos__broader mesh__D015775smesh__D050723
% 215.74/215.96  |- mesh__dateCreated mesh__D015775 1989-05-15
% 215.74/215.96  |- skos__historyNote mesh__D015775 Stress, Mechanical %28%1971-1989%29%
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D009738 1997
% 215.74/215.96  |- mesh__historyNote mesh__D009738
% 215.74/215.96       78; was HOSPITAL NURSING SERVICE 1963-77   
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D009738 2001
% 215.74/215.96  |- mesh__recordOriginator mesh__D009738 NLM
% 215.74/215.96  |- mesh__onlineNote mesh__D009738
% 215.74/215.96       use NURSING SERVICE, HOSPITAL to search HOSPITAL NURSING SERVICE 1966-77%A%  
% 215.74/215.96  |- skos__altLabel mesh__D009738 Service, Hospital Nursing
% 215.74/215.96  |- skos__prefLabel mesh__D009738 Nursing Service, Hospital
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D009738 2002
% 215.74/215.96  |- skos__hiddenLabel mesh__D009738 Services, Hospital Nursing
% 215.74/215.96  |- skos__broader mesh__D009738smesh__D006748
% 215.74/215.96  |- skos__hiddenLabel mesh__D009738 Nursing Services, Hospital
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D009738 2005
% 215.74/215.96  |- mesh__recordMaintainer mesh__D009738 KEV
% 215.74/215.96  |- mesh__recordAuthorizer mesh__D009738 PLS
% 215.74/215.96  |- skos__altLabel mesh__D009738 Hospital Nursing Service
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D009738 2006
% 215.74/215.96  |- mesh__dateRevised mesh__D009738 1995-05-22
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D009738 2003
% 215.74/215.96  |- skos__broader mesh__D009738smesh__D009739
% 215.74/215.96  |- skos__annotation mesh__D009738
% 215.74/215.96       hosp only: non-hosp nurs serv = NURSING SERVICES; DF: NURS SERV HOSP%A%  
% 215.74/215.96  |- skos__hiddenLabel mesh__D009738 Hospital Nursing Services
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D009738 1998
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D009738 2004
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D009738 1999
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D009738 1996
% 215.74/215.96  |- skos__scopeNote mesh__D009738
% 215.74/215.96       The hospital department which is responsible for the organization and administration of nursing activities.%A%    
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D009738 2000
% 215.74/215.96  |- rdf__type mesh__D009738sskos__Concept
% 215.74/215.96  |- mesh__dateCreated mesh__D009738 1999-01-01
% 215.74/215.96  |- mesh__publicMeSHNote mesh__D009738
% 215.74/215.96       78; was HOSPITAL NURSING SERVICE 1963-77   
% 215.74/215.96  |- skos__annotation mesh__D001755
% 215.74/215.96       Mammalian only; non-mammalian, use BLASTULA; /transpl: coord BLASTOCYST %28%NIM with no qualif%29% + EMBRYO TRANSFER %28%IM%29%; do not confuse with BLASTOCYTES see BLASTOMERES%A%  
% 215.74/215.96  |- mesh__dateCreated mesh__D001755 1999-01-01
% 215.74/215.96  |- skos__scopeNote mesh__D001755
% 215.74/215.96       Early preimplantation mammalian EMBRYO in the post-MORULA stage. Its structure consists of a TROPHOBLASTS-enclosed fluid-filled cavity with an inner cell mass. After EMBRYO IMPLANTATION, the inner cell mass of the blastocyst becomes the embryonic disc of the developing embryo.%A%    
% 215.74/215.96  |- skos__altLabel mesh__D001755 Embryo, Preimplantation
% 215.74/215.96  |- mesh__dateRevised mesh__D001755 2004-07-07
% 215.74/215.96  |- mesh__publicMeSHNote mesh__D001755 74   
% 215.74/215.96  |- mesh__recordMaintainer mesh__D001755 lkt
% 215.74/215.96  |- skos__prefLabel mesh__D001755 Blastocyst
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D001755 2005
% 215.74/215.96  |- skos__broader mesh__D001755smesh__D004622
% 215.74/215.96  |- mesh__dateEstablished mesh__D001755 1974-01-01
% 215.74/215.96  |- mesh__recordOriginator mesh__D001755 NLM
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D001755 2006
% 215.74/215.96  |- skos__hiddenLabel mesh__D001755 Preimplantation Embryos
% 215.74/215.96  |- mesh__recordAuthorizer mesh__D001755 sjn
% 215.74/215.96  |- rdf__type mesh__D001755sskos__Concept
% 215.74/215.96  |- skos__hiddenLabel mesh__D001755 Blastocysts
% 215.74/215.96  |- mesh__historyNote mesh__D001755 74   
% 215.74/215.96  |- skos__hiddenLabel mesh__D001755 Embryos, Preimplantation
% 215.74/215.96  |- skos__hiddenLabel mesh__D001755 Preimplantation Embryo
% 215.74/215.96  |- skos__broader mesh__D007668Q000637smesh__D007668
% 215.74/215.96  |- mesh__preferredCombination mesh__D007668Q000637smesh__D016030
% 215.74/215.96  |- rdf__type mesh__D007668Q000637smesh__CompoundConcept
% 215.74/215.96  |- skos__broader mesh__D006440smesh__D017582
% 215.74/215.96  |- skos__broader mesh__D006440smesh__D016060
% 215.74/215.96  |- skos__hiddenLabel mesh__D006440 Continuous Arteriovenous Hemofiltration
% 215.74/215.96  |- skos__altLabel mesh__D006440 CAVH
% 215.74/215.96  |- mesh__recordOriginator mesh__D006440 SCD
% 215.74/215.96  |- skos__hiddenLabel mesh__D006440 Hemofiltration, Venovenous
% 215.74/215.96  |- skos__hiddenLabel mesh__D006440 Hemofiltration, Arteriovenous
% 215.74/215.96  |- skos__hiddenLabel mesh__D006440 Arteriovenous Hemofiltration, Continuous
% 215.74/215.96  |- skos__historyNote mesh__D006440 Blood %28%1966-1987%29%
% 215.74/215.96  |- skos__hiddenLabel mesh__D006440
% 215.74/215.96       Arteriovenous Hemofiltrations, Continuous
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D006440 2005
% 215.74/215.96  |- mesh__recordAuthorizer mesh__D006440 sjn
% 215.74/215.96  |- mesh__publicMeSHNote mesh__D006440 88   
% 215.74/215.96  |- skos__broader mesh__D006440smesh__D005112
% 215.74/215.96  |- skos__hiddenLabel mesh__D006440 Hemofiltrations, Arteriovenous
% 215.74/215.96  |- mesh__dateEstablished mesh__D006440 1988-01-01
% 215.74/215.96  |- skos__hiddenLabel mesh__D006440 Hemofiltrations
% 215.74/215.96  |- skos__annotation mesh__D006440
% 215.74/215.96       a type of ultrafiltration; do not use /util except by MeSH definition; DF: note short X ref%A%  
% 215.74/215.96  |- mesh__dateRevised mesh__D006440 2002-07-02
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D006440 2006
% 215.74/215.96  |- skos__hiddenLabel mesh__D006440
% 215.74/215.96       Hemofiltrations, Continuous Arteriovenous
% 215.74/215.96  |- skos__prefLabel mesh__D006440 Hemofiltration
% 215.74/215.96  |- skos__historyNote mesh__D006440 Ultrafiltration %28%1973-1987%29%
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D006440 2003
% 215.74/215.96  |- skos__hiddenLabel mesh__D006440 Hemofiltrations, Venovenous
% 215.74/215.96  |- skos__scopeNote mesh__D006440
% 215.74/215.96       Extracorporeal ultrafiltration technique without hemodialysis for treatment of fluid overload and electrolyte disturbances affecting renal, cardiac, or pulmonary function.%A%    
% 215.74/215.96  |- skos__broader mesh__D006440smesh__D014462
% 215.74/215.96  |- mesh__dateCreated mesh__D006440 1987-05-08
% 215.74/215.96  |- skos__historyNote mesh__D006440 Filtration %28%1966-1987%29%
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D006440 2004
% 215.74/215.96  |- skos__hiddenLabel mesh__D006440 Continuous Arteriovenous Hemofiltrations
% 215.74/215.96  |- skos__hiddenLabel mesh__D006440 Venovenous Hemofiltrations
% 215.74/215.96  |- skos__hiddenLabel mesh__D006440 Arteriovenous Hemofiltrations
% 215.74/215.96  |- mesh__historyNote mesh__D006440 88   
% 215.74/215.96  |- mesh__recordMaintainer mesh__D006440 lkt
% 215.74/215.96  |- skos__historyNote mesh__D006440
% 215.74/215.96       Extracorporeal Circulation %28%1966-1987%29%
% 215.74/215.96  |- rdf__type mesh__D006440sskos__Concept
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D020111 2002
% 215.74/215.96  |- mesh__publicMeSHNote mesh__D020111
% 215.74/215.96       99; AROCLOR 1254 was indexed under AROCLORS 1980-98   
% 215.74/215.96  |- skos__prefLabel mesh__D020111 Aroclor 1254
% 215.74/215.96  |- skos__broader mesh__D020111smesh__D001140
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D020111 2005
% 215.74/215.96  |- skos__hiddenLabel mesh__D020111 1254, Aroclor
% 215.74/215.96  |- mesh__dateCreated mesh__D020111 1998-06-10
% 215.74/215.96  |- rdf__type mesh__D020111sskos__Concept
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D020111 2006
% 215.74/215.96  |- skos__hiddenLabel mesh__D020111 Aroclor1254
% 215.74/215.96  |- skos__scopeNote mesh__D020111
% 215.74/215.96       A mixture of polychlorinated biphenyls that induces hepatic microsomal UDP-glucuronyl transferase activity towards thyroxine.%A%    
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D020111 2000
% 215.74/215.96  |- mesh__dateEstablished mesh__D020111 1999-01-01
% 215.74/215.96  |- skos__historyNote mesh__D020111 Aroclors %28%1980-1998%29%
% 215.74/215.96  |- mesh__dateRevised mesh__D020111 1999-11-03
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D020111 2003
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D020111 2001
% 215.74/215.96  |- mesh__recordAuthorizer mesh__D020111 sjn
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D020111 2004
% 215.74/215.96  |- mesh__recordOriginator mesh__D020111 ADP
% 215.74/215.96  |- mesh__recordMaintainer mesh__D020111 adp
% 215.74/215.96  |- skos__altLabel mesh__D020111 Aroclor-1254
% 215.74/215.96  |- skos__annotation mesh__D020111 AROCLORS is also available   
% 215.74/215.96  |- mesh__historyNote mesh__D020111
% 215.74/215.96       99; use AROCLOR 1254 %28%NM%29% 1980-98   
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D019368 2004
% 215.74/215.96  |- skos__broader mesh__D019368smesh__D010811
% 215.74/215.96  |- skos__annotation mesh__D019368
% 215.74/215.96       restrict to Nature as an abstract or philosophical concept, as %22%von Humboldt%27%s Views of Nature%22% or %22%the laws of nature%22%; not for %22%the nature of science%22% or %22%the nature of psychoanalytic theory%22%; no qualif%A%  
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D019368 2003
% 215.74/215.96  |- mesh__dateEstablished mesh__D019368 1997-01-01
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D019368 1997
% 215.74/215.96  |- mesh__dateCreated mesh__D019368 1996-06-10
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D019368 2002
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D019368 2006
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D019368 2001
% 215.74/215.96  |- mesh__historyNote mesh__D019368 97   
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D019368 2005
% 215.74/215.96  |- rdf__type mesh__D019368sskos__Concept
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D019368 1999
% 215.74/215.96  |- skos__prefLabel mesh__D019368 Nature
% 215.74/215.96  |- mesh__publicMeSHNote mesh__D019368 97   
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D019368 2000
% 215.74/215.96  |- skos__scopeNote mesh__D019368
% 215.74/215.96       The system of all phenomena in space and time; the totality of physical reality. It is both a scientific and philosophic concept appearing in all historic eras. %28%Webster 2d; Dr. James H. Cassedy, NLM History of Medicine Division%29%%A%    
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D019368 1998
% 215.74/215.96  |- mesh__recordOriginator mesh__D011385 NLM
% 215.74/215.96  |- mesh__recordMaintainer mesh__D011385 JLS
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D011385 2000
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D011385 2005
% 215.74/215.96  |- mesh__dateCreated mesh__D011385 1999-01-01
% 215.74/215.96  |- mesh__publicMeSHNote mesh__D011385 69   
% 215.74/215.96  |- skos__annotation mesh__D011385 no qualif   
% 215.74/215.96  |- skos__broader mesh__D011385smesh__D003674
% 215.74/215.96  |- mesh__recordAuthorizer mesh__D011385 SJN
% 215.74/215.96  |- mesh__historyNote mesh__D011385 69   
% 215.74/215.96  |- skos__prefLabel mesh__D011385 Projection
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D011385 2002
% 215.74/215.96  |- rdf__type mesh__D011385sskos__Concept
% 215.74/215.96  |- skos__historyNote mesh__D011385 Defense Mechanisms %28%1966-1968%29%
% 215.74/215.96  |- mesh__dateRevised mesh__D011385 1997-06-20
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D011385 2004
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D011385 1999
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D011385 2003
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D011385 1998
% 215.74/215.96  |- skos__scopeNote mesh__D011385
% 215.74/215.96       A defense mechanism, operating unconsciously, whereby that which is emotionally unacceptable in the self is rejected and attributed %28%projected%29% to others.%A%    
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D011385 2001
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D011385 2006
% 215.74/215.96  |- mesh__dateEstablished mesh__D011385 1969-01-01
% 215.74/215.96  |- skos__broader mesh__D038522smesh__D047108
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D038522 2006
% 215.74/215.96  |- skos__scopeNote mesh__D038522
% 215.74/215.96       The division of a ZYGOTE into two parts, each of which is capable of further development.%A%    
% 215.74/215.96  |- rdf__type mesh__D038522sskos__Concept
% 215.74/215.96  |- skos__prefLabel mesh__D038522 Twinning, Monozygotic
% 215.74/215.96  |- skos__hiddenLabel mesh__D038522 Monozygotic Twinning
% 215.74/215.96  |- mesh__dateCreated mesh__D038522 2002-07-03
% 215.74/215.96  |- mesh__recordAuthorizer mesh__D038522 sjn
% 215.74/215.96  |- mesh__historyNote mesh__D038522
% 215.74/215.96       2005 %28%2003%29%; use TWINS 1978-2002   
% 215.74/215.96  |- mesh__dateRevised mesh__D038522 2005-06-30
% 215.74/215.96  |- skos__annotation mesh__D038522 TWINS, MONOZYGOTIC is also available   
% 215.74/215.96  |- mesh__dateEstablished mesh__D038522 2003-01-01
% 215.74/215.96  |- mesh__publicMeSHNote mesh__D038522
% 215.74/215.96       2005; see TWINNING 2003-2004; see TWINS 1978-2002   
% 215.74/215.96  |- mesh__recordMaintainer mesh__D038522 lkt
% 215.74/215.96  |- mesh__recordOriginator mesh__D038522 tjk
% 215.74/215.96  |- skos__historyNote mesh__D038522 Twins %28%1966-2002%29%
% 215.74/215.96  |- skos__hiddenLabel mesh__D005348 Breast Fibrocystic Disease
% 215.74/215.96  |- skos__annotation mesh__D005348
% 215.74/215.96       commonly chronic so do not coordinate with CHRONIC DISEASE; breast cyst fluid: coordinate IM with EXUDATES AND TRANSUDATES with pertinent qualifiers %28%NIM%29%; BREAST CYST is also available%A%  
% 215.74/215.96  |- mesh__dateEstablished mesh__D005348 1984-01-01
% 215.74/215.96  |- skos__hiddenLabel mesh__D005348 Adenoses, Microglandular
% 215.74/215.96  |- skos__historyNote mesh__D005348 Breast Diseases %28%1966-1979%29%
% 215.74/215.96  |- skos__broader mesh__D005348smesh__D001941
% 215.74/215.96  |- rdf__type mesh__D005348sskos__Concept
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D005348 2005
% 215.74/215.96  |- skos__altLabel mesh__D005348 Mammary Dysplasia
% 215.74/215.96  |- mesh__recordMaintainer mesh__D005348 lkt
% 215.74/215.96  |- mesh__dateRevised mesh__D005348 2004-07-07
% 215.74/215.96  |- skos__hiddenLabel mesh__D005348 Breast Adenosis
% 215.74/215.96  |- skos__hiddenLabel mesh__D005348 Breast Disease, Fibrocystic
% 215.74/215.96  |- skos__altLabel mesh__D005348 Cystic Disease of Breast
% 215.74/215.96  |- mesh__recordAuthorizer mesh__D005348 sjn
% 215.74/215.96  |- mesh__dateCreated mesh__D005348 1978-12-20
% 215.74/215.96  |- skos__altLabel mesh__D005348 Fibrocystic Changes of Breast
% 215.74/215.96  |- skos__hiddenLabel mesh__D005348 Adenosis, Microglandular
% 215.74/215.96  |- skos__hiddenLabel mesh__D005348 Breast Disease, Cystic
% 215.74/215.96  |- skos__prefLabel mesh__D005348 Fibrocystic Breast Disease
% 215.74/215.96  |- skos__altLabel mesh__D005348 Fibrocystic Mastopathy
% 215.74/215.96  |- skos__hiddenLabel mesh__D005348 Dysplasia, Breast
% 215.74/215.96  |- skos__hiddenLabel mesh__D005348 Microglandular Adenoses
% 215.74/215.96  |- skos__hiddenLabel mesh__D005348 Disease, Fibrocystic Breast
% 215.74/215.96  |- skos__hiddenLabel mesh__D005348 Breast Fibrocystic Change
% 215.74/215.96  |- mesh__recordOriginator mesh__D005348 VDK
% 215.74/215.96  |- skos__hiddenLabel mesh__D005348 Breast Cystic Disease
% 215.74/215.96  |- skos__hiddenLabel mesh__D005348 Breast Cystic Diseases
% 215.74/215.96  |- skos__altLabel mesh__D005348 Adenosis of Breast
% 215.74/215.96  |- skos__hiddenLabel mesh__D005348 Mastopathy, Fibrocystic
% 215.74/215.96  |- skos__scopeNote mesh__D005348
% 215.74/215.96       A common and benign breast disease characterized by varying degree of fibrocystic changes in the breast tissue. There are three major patterns of morphological changes, including FIBROSIS, formation of CYSTS, and proliferation of glandular tissue %28%adenosis%29%. The fibrocystic breast has a dense irregular lumpy bumpy consistency.%A%    
% 215.74/215.96  |- skos__hiddenLabel mesh__D005348 Dysplasia, Mammary
% 215.74/215.96  |- mesh__historyNote mesh__D005348 2005 %28%1980%29%   
% 215.74/215.96  |- skos__hiddenLabel mesh__D005348 Cystic Mastitis, Chronic
% 215.74/215.96  |- skos__altLabel mesh__D005348 Breast Dysplasia
% 215.74/215.96  |- skos__related mesh__D005348smesh__D047688
% 215.74/215.96  |- skos__hiddenLabel mesh__D005348 Disease, Cystic Breast
% 215.74/215.96  |- skos__altLabel mesh__D005348 Fibrocystic Disease of Breast
% 215.74/215.96  |- skos__hiddenLabel mesh__D005348 Breast Fibrocystic Changes
% 215.74/215.96  |- mesh__publicMeSHNote mesh__D005348
% 215.74/215.96       2005; see FIBROCYSTIC DISEASE OF BREAST 1984-2004, see BREAST DISEASES 1980-1983%A%  
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D005348 2006
% 215.74/215.96  |- skos__annotation mesh__D024502
% 215.74/215.96       deficiency: coordinate ALPHA-TOCOPHEROL /defic %28%IM%29% with VITAMIN E DEFICIENCY %28%IM%29%%A%  
% 215.74/215.96  |- mesh__publicMeSHNote mesh__D024502 2002; see VITAMIN E 1966-2001   
% 215.74/215.96  |- mesh__recordOriginator mesh__D024502 lkt
% 215.74/215.96  |- rdf__type mesh__D024502sskos__Concept
% 215.74/215.96  |- mesh__dateEstablished mesh__D024502 2002-01-01
% 215.74/215.96  |- skos__scopeNote mesh__D024502
% 215.74/215.96       A natural tocopherol and one of the most potent antioxidant tocopherols.  It exhibits antioxidant activity by virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus. It has four methyl groups on the 6-chromanol nucleus. The natural d form of alpha-tocopherol is more active than its synthetic dl-alpha-tocopherol racemic mixture.%A%    
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D024502 2006
% 215.74/215.96  |- skos__hiddenLabel mesh__D024502 alpha Tocopherol
% 215.74/215.96  |- skos__prefLabel mesh__D024502 alpha-Tocopherol
% 215.74/215.96  |- skos__broader mesh__D024502smesh__D024505
% 215.74/215.96  |- mesh__dateRevised mesh__D024502 2005-06-30
% 215.74/215.96  |- mesh__dateCreated mesh__D024502 2001-07-25
% 215.74/215.96  |- mesh__historyNote mesh__D024502 2002; use VITAMIN E 1966-2001   
% 215.74/215.96  |- skos__historyNote mesh__D024502 Vitamin E %28%1965-2001%29%
% 215.74/215.96  |- mesh__recordAuthorizer mesh__D024502 sjn
% 215.74/215.96  |- skos__altLabel mesh__D024502
% 215.74/215.96       3,4-Dihydro-2,5,7,8-tetramethyl-2-%28%4,8,12-trimethyltridecyl%29%-2H-1-benzopyran-6-ol
% 215.74/215.96  |- mesh__recordMaintainer mesh__D024502 ssb
% 215.74/215.96  |- skos__prefLabel mesh__D002050 Burkina Faso
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D002050 2005
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D002050 2000
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D002050 1999
% 215.74/215.96  |- skos__scopeNote mesh__D002050
% 215.74/215.96       A republic in western Africa, south and east of MALI and west of NIGER. Its capital is Ouagadougou. It was formerly called Upper Volta until 1984. A French protectorate was established over the region 1895-97. It was part of Upper Senegal-Niger colony until 1919 when it became a separate colony. Burkina Faso remained under French jurisdiction with varied status until it became totally independent in 1960. Its name is native, meaning land of worthy men, from burkina %28%worthy%29% + faso %28%land, literally father village from fa %28%father%29% + so %28%village%29%%29%. %28%From Webster%27%s New Geographical Dictionary, 1988, p191, 1273 %26% Room, Brewer%27%s Dictionary of Names, 1992, p85%29%%A%    
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D002050 2003
% 215.74/215.96  |- mesh__recordOriginator mesh__D002050 NLM
% 215.74/215.96  |- skos__broader mesh__D002050smesh__D000354
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D002050 1998
% 215.74/215.96  |- rdf__type mesh__D002050sskos__Concept
% 215.74/215.96  |- skos__annotation mesh__D002050
% 215.74/215.96       a republic in western Africa; X ref UPPER VOLTA was its former name%A%  
% 215.74/215.96  |- mesh__historyNote mesh__D002050 86; was UPPER VOLTA 1963-85   
% 215.74/215.96  |- skos__altLabel mesh__D002050 Burkina Fasso
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D002050 2002
% 215.74/215.96  |- mesh__recordAuthorizer mesh__D002050 SJN
% 215.74/215.96  |- skos__altLabel mesh__D002050 Upper Volta
% 215.74/215.96  |- mesh__onlineNote mesh__D002050
% 215.74/215.96       use BURKINA FASO to search UPPER VOLTA 1966-85   
% 215.74/215.96  |- mesh__dateCreated mesh__D002050 1999-01-01
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D002050 2006
% 215.74/215.96  |- mesh__recordMaintainer mesh__D002050 TGC
% 215.74/215.96  |- mesh__dateRevised mesh__D002050 1997-06-20
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D002050 2004
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D002050 2001
% 215.74/215.96  |- mesh__dateEstablished mesh__D029796 2002-01-01
% 215.74/215.96  |- skos__broader mesh__D029796smesh__D029791
% 215.74/215.96  |- skos__annotation mesh__D029796
% 215.74/215.96       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D029796 2006
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D029796 2002
% 215.74/215.96  |- skos__prefLabel mesh__D029796 Vaccinium
% 215.74/215.96  |- rdf__type mesh__D029796sskos__Concept
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D029796 2005
% 215.74/215.96  |- mesh__publicMeSHNote mesh__D029796 2002   
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D029796 2004
% 215.74/215.96  |- skos__scopeNote mesh__D029796
% 215.74/215.96       A plant genus of the family ERICACEAE known for species with edible fruits.%A%    
% 215.74/215.96  |- mesh__dateCreated mesh__D029796 2001-07-25
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D029796 2003
% 215.74/215.96  |- mesh__historyNote mesh__D029796 2002   
% 215.74/215.96  |- skos__altLabel mesh__D015776 Unna-Thost Syndrome
% 215.74/215.96  |- mesh__historyNote mesh__D015776 90   
% 215.74/215.96  |- skos__hiddenLabel mesh__D015776 Syndrome, Thost-Unna
% 215.74/215.96  |- skos__hiddenLabel mesh__D015776 Thost Unna Syndrome
% 215.74/215.96  |- rdf__type mesh__D015776sskos__Concept
% 215.74/215.96  |- skos__hiddenLabel mesh__D015776 Unna Thost Syndrome
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D015776 2004
% 215.74/215.96  |- mesh__recordOriginator mesh__D015776 AGS
% 215.74/215.96  |- mesh__dateCreated mesh__D015776 1989-10-19
% 215.74/215.96  |- mesh__publicMeSHNote mesh__D015776 90   
% 215.74/215.96  |- skos__prefLabel mesh__D015776 Keratoderma, Palmoplantar, Diffuse
% 215.74/215.96  |- mesh__recordAuthorizer mesh__D015776 sjn
% 215.74/215.96  |- skos__altLabel mesh__D015776 Thost-Unna Syndrome
% 215.74/215.96  |- mesh__dateEstablished mesh__D015776 1990-01-01
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D015776 2003
% 215.74/215.96  |- skos__historyNote mesh__D015776
% 215.74/215.96       Keratoderma, Palmoplantar %28%1974-1989%29%
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D015776 2006
% 215.74/215.96  |- mesh__recordMaintainer mesh__D015776 nns
% 215.74/215.96  |- skos__hiddenLabel mesh__D015776 Syndrome, Unna-Thost
% 215.74/215.96  |- skos__altLabel mesh__D015776 Tylosis
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D015776 2002
% 215.74/215.96  |- skos__broader mesh__D015776smesh__D007645
% 215.74/215.96  |- mesh__dateRevised mesh__D015776 2001-07-25
% 215.74/215.96  |- skos__historyNote mesh__D015776 Keratosis %28%1966-1973%29%
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D015776 2005
% 215.74/215.96  |- skos__annotation mesh__D015776
% 215.74/215.96       do not confuse with KERATODERMA, PALMOPLANTAR   
% 215.74/215.96  |- skos__scopeNote mesh__D015776
% 215.74/215.96       An autosomal dominant disorder characterized by a widely distributed, well-demarcated hyperkeratosis of the palms and soles. There is more than one genotypically distinct form, each of which is clinically similar but histologically distinguishable. Diffuse palmoplantar keratoderma is distinct from palmoplantar keratoderma %28%KERATODERMA, PALMOPLANTAR%29%, as the former exhibits autosomal dominant inheritance and hyperhidrosis is frequently present.%A%    
% 215.74/215.96  |- mesh__dateRevised mesh__D009739 1999-11-03
% 215.74/215.96  |- skos__hiddenLabel mesh__D009739 Service, Nursing
% 215.74/215.96  |- mesh__publicMeSHNote mesh__D009739 78   
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D009739 2002
% 215.74/215.96  |- mesh__dateCreated mesh__D009739 1977-05-19
% 215.74/215.96  |- mesh__recordMaintainer mesh__D009739 kle
% 215.74/215.96  |- mesh__dateEstablished mesh__D009739 1978-01-01
% 215.74/215.96  |- skos__broader mesh__D009739smesh__D006296
% 215.74/215.96  |- mesh__historyNote mesh__D009739 78   
% 215.74/215.96  |- mesh__recordAuthorizer mesh__D009739 sjn
% 215.74/215.96  |- skos__annotation mesh__D009739
% 215.74/215.96       GEN or unspecified as hosp nurs services %28% = NURSING SERVICES, HOSPITAL%29%; IM; DF: NURS SERV%A%  
% 215.74/215.96  |- skos__altLabel mesh__D009739 Services, Nursing
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D009739 2005
% 215.74/215.96  |- skos__scopeNote mesh__D009739
% 215.74/215.96       A general concept referring to the organization and administration of nursing activities.%A%    
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D009739 2003
% 215.74/215.96  |- mesh__recordOriginator mesh__D009739 EC
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D009739 2006
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D009739 2000
% 215.74/215.96  |- skos__prefLabel mesh__D009739 Nursing Services
% 215.74/215.96  |- rdf__type mesh__D009739sskos__Concept
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D009739 2004
% 215.74/215.96  |- skos__hiddenLabel mesh__D009739 Nursing Service
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D009739 2001
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D001756 1996
% 215.74/215.96  |- mesh__publicMeSHNote mesh__D001756
% 215.74/215.96       80; was see under BLASTOCYST 1975-79, was see under GERM LAYERS 1968-74%A%  
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D001756 1993
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D001756 2006
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D001756 2001
% 215.74/215.96  |- mesh__recordMaintainer mesh__D001756 PLS
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D001756 1997
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D001756 1991
% 215.74/215.96  |- rdf__type mesh__D001756sskos__Concept
% 215.74/215.96  |- mesh__activeMeSHYear mesh__D001756 2003
% 215.74/215.96  |- skos__annotation mesh__D001756 A 11 qualif   
% 215.74/215.96  |- skos__broader mesh__D001756smesh__D001755
% 215.74/215.96  |- skos__historyNote mesh__D001756 Germ Layers %28%1966-1974%29%
% 215.74/215.97  |- skos__prefLabel mesh__D001756 Blastoderm
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D001756 2004
% 215.74/215.97  |- mesh__dateRevised mesh__D001756 1990-05-26
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D001756 1994
% 215.74/215.97  |- skos__historyNote mesh__D001756 Blastocyst %28%1975-1979%29%
% 215.74/215.97  |- mesh__recordAuthorizer mesh__D001756 NLM
% 215.74/215.97  |- mesh__onlineNote mesh__D001756 search GERM LAYERS 1968-74   
% 215.74/215.97  |- mesh__dateCreated mesh__D001756 1999-01-01
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D001756 2002
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D001756 1998
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D001756 1995
% 215.74/215.97  |- mesh__dateEstablished mesh__D001756 1980-01-01
% 215.74/215.97  |- skos__scopeNote mesh__D001756
% 215.74/215.97       A single layer of cells produced by cleavage of the fertilized ovum and forming the outer cells of the blastula.%A%    
% 215.74/215.97  |- mesh__historyNote mesh__D001756
% 215.74/215.97       80%28%75%29%; was see under BLASTOCYST 1975-79, was see under GERM LAYERS 1968-74%A%  
% 215.74/215.97  |- mesh__recordOriginator mesh__D001756 NLM
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D001756 1992
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D001756 1999
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D001756 2005
% 215.74/215.97  |- skos__hiddenLabel mesh__D001756 Blastoderms
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D001756 2000
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020910 2000
% 215.74/215.97  |- mesh__recordAuthorizer mesh__D020910 sjn
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020910 2000B
% 215.74/215.97  |- mesh__dateRevised mesh__D020910 2000-01-21
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020910 2000C
% 215.74/215.97  |- mesh__historyNote mesh__D020910
% 215.74/215.97       2000; use KETOROLAC %28%NM%29% 1983-1999   
% 215.74/215.97  |- skos__annotation mesh__D020910 KETOROLAC TROMETHAMINE is available   
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020910 2001
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020910 2003
% 215.74/215.97  |- skos__broader mesh__D020910smesh__D007213
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020910 2002
% 215.74/215.97  |- mesh__recordOriginator mesh__D020910 adp
% 215.74/215.97  |- mesh__dateEstablished mesh__D020910 2000-01-01
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020910 2004
% 215.74/215.97  |- skos__historyNote mesh__D020910
% 215.74/215.97       Tolmetin/analogs %26% derivatives %28%1983-1999%29%
% 215.74/215.97  |- skos__scopeNote mesh__D020910
% 215.74/215.97       A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is an NSAID and is used principally for its analgesic activity. %28%From Martindale The Extra Pharmacopoeia, 31st ed%29%%A%    
% 215.74/215.97  |- mesh__publicMeSHNote mesh__D020910
% 215.74/215.97       2000; KETOROLAC was indexed under TOLMETIN/analogs %26% derivatives 1983-1999%A%  
% 215.74/215.97  |- mesh__dateCreated mesh__D020910 1999-11-03
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020910 2005
% 215.74/215.97  |- mesh__recordMaintainer mesh__D020910 ags
% 215.74/215.97  |- rdf__type mesh__D020910sskos__Concept
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020910 2006
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020910 2000A
% 215.74/215.97  |- skos__prefLabel mesh__D020910 Ketorolac
% 215.74/215.97  |- mesh__recordOriginator mesh__D006441 RLS
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D006441 2005
% 215.74/215.97  |- mesh__publicMeSHNote mesh__D006441
% 215.74/215.97       79; was see under HEMOGLOBINS 1977-78   
% 215.74/215.97  |- mesh__dateRevised mesh__D006441 2004-07-13
% 215.74/215.97  |- mesh__recordMaintainer mesh__D006441 sjn
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D006441 2006
% 215.74/215.97  |- skos__annotation mesh__D006441
% 215.74/215.97       normal adult hemoglobin; /urine: coord IM with HEMOGLOBINURIA %28%IM%29%; DF: HBA%A%  
% 215.74/215.97  |- mesh__dateCreated mesh__D006441 1976-04-27
% 215.74/215.97  |- mesh__historyNote mesh__D006441
% 215.74/215.97       79%28%77%29%; was see under HEMOGLOBINS 1977-78   
% 215.74/215.97  |- mesh__dateEstablished mesh__D006441 1979-01-01
% 215.74/215.97  |- mesh__recordAuthorizer mesh__D006441 sjn
% 215.74/215.97  |- skos__broader mesh__D006441smesh__D006454
% 215.74/215.97  |- skos__scopeNote mesh__D006441
% 215.74/215.97       Normal adult human hemoglobin. The globin moiety consists of two alpha and two beta chains.%A%    
% 215.74/215.97  |- skos__prefLabel mesh__D006441 Hemoglobin A
% 215.74/215.97  |- rdf__type mesh__D006441sskos__Concept
% 215.74/215.97  |- skos__hiddenLabel mesh__D006441 A, Hemoglobin
% 215.74/215.97  |- skos__historyNote mesh__D006441 Hemoglobins %28%1966-1976%29%
% 215.74/215.97  |- skos__scopeNote mesh__D020112
% 215.74/215.97       A fluorescent probe with low toxicity which is a potent substrate for P-glycoprotein and the bacterial multidrug efflux transporter. It is used to assess mitochondrial bioenergetics in living cells and to measure the efflux activity of P-glycoprotein in both normal and malignant cells. %28%Leukemia 1997;11%28%7%29%:1124-30%29%%A%    
% 215.74/215.97  |- skos__broader mesh__D020112smesh__D012235
% 215.74/215.97  |- rdf__type mesh__D020112sskos__Concept
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020112 2005
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020112 2000
% 215.74/215.97  |- mesh__dateEstablished mesh__D020112 1999-01-01
% 215.74/215.97  |- skos__prefLabel mesh__D020112 Rhodamine 123
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020112 2006
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020112 2001
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020112 2003
% 215.74/215.97  |- mesh__publicMeSHNote mesh__D020112
% 215.74/215.97       99; RHODAMINE 123 was indexed under RHODAMINES 1982-98   
% 215.74/215.97  |- skos__related mesh__D020112smesh__D020168
% 215.74/215.97  |- skos__historyNote mesh__D020112 Rhodamines %28%1982-1998%29%
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020112 2004
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020112 1999
% 215.74/215.97  |- mesh__historyNote mesh__D020112
% 215.74/215.97       99; use RHODAMINE 123 %28%NM%29% 1982-98   
% 215.74/215.97  |- mesh__dateCreated mesh__D020112 1998-07-20
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020112 2002
% 215.74/215.97  |- skos__hiddenLabel mesh__D020112 123, Rhodamine
% 215.74/215.97  |- mesh__publicMeSHNote mesh__D019369 97   
% 215.74/215.97  |- skos__scopeNote mesh__D019369
% 215.74/215.97       The state that distinguishes organisms from inorganic matter, manifested by growth, metabolism, reproduction, and adaptation. It includes the course of existence, the sum of experiences, the mode of existing, or the fact of being. Over the centuries inquiries into the nature of life have crossed the boundaries from philosophy to biology, forensic medicine, anthropology, etc., in creative as well as scientific literature. %28%Random House Unabridged Dictionary, 2d ed; Dr. James H. Cassedy, NLM History of Medicine Division%29%%A%    
% 215.74/215.97  |- skos__historyNote mesh__D019369 Philosophy, Medical %28%1966-1996%29%
% 215.74/215.97  |- skos__historyNote mesh__D019369 Philosophy %28%1966-1996%29%
% 215.74/215.97  |- mesh__dateRevised mesh__D019369 2002-07-03
% 215.74/215.97  |- skos__prefLabel mesh__D019369 Life
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D019369 2006
% 215.74/215.97  |- mesh__dateEstablished mesh__D019369 1997-01-01
% 215.74/215.97  |- mesh__recordMaintainer mesh__D019369 tjk
% 215.74/215.97  |- mesh__dateCreated mesh__D019369 1996-06-10
% 215.74/215.97  |- mesh__recordAuthorizer mesh__D019369 sjn
% 215.74/215.97  |- mesh__historyNote mesh__D019369 97   
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D019369 2005
% 215.74/215.97  |- rdf__type mesh__D019369sskos__Concept
% 215.74/215.97  |- skos__broader mesh__D019369smesh__D010684
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D019369 2004
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D019369 2003
% 215.74/215.97  |- mesh__recordOriginator mesh__D019369 TGC
% 215.74/215.97  |- skos__hiddenLabel mesh__D011386 Technics, Projective
% 215.74/215.97  |- rdf__type mesh__D011386sskos__Concept
% 215.74/215.97  |- skos__hiddenLabel mesh__D011386 Projective Technique
% 215.74/215.97  |- skos__hiddenLabel mesh__D011386 Frustration Study, Picture
% 215.74/215.97  |- mesh__recordAuthorizer mesh__D011386 ags
% 215.74/215.97  |- skos__prefLabel mesh__D011386 Projective Techniques
% 215.74/215.97  |- mesh__publicMeSHNote mesh__D011386
% 215.74/215.97       1991; see PROJECTIVE TECHNICS 1963-1990; for ROSENZWEIG PICTURE-FRUSTRATION STUDY see ROSENZWEIG PICTURE-FRUSTRATION STUDY 1991-1999; see PROJECTIVE TECHNICS 1975-1980; for PICTURE FRUSTRATION STUDY see ROSENZWEIG PICTURE-FRUSTRATION STUDY 1979-1991; see PROJECTIVE TECHNIQUES 1975-1999; for SZONDI TEST see SZONDI TEST 1991-1999; see PROJECTIVE TECHNIQUES 1975-1900%A%  
% 215.74/215.97  |- skos__hiddenLabel mesh__D011386 Test, Szondi
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011386 2004
% 215.74/215.97  |- mesh__recordMaintainer mesh__D011386 ags
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011386 2001
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011386 2000A
% 215.74/215.97  |- skos__hiddenLabel mesh__D011386 Technic, Projective
% 215.74/215.97  |- skos__hiddenLabel mesh__D011386 Study, Rosenzweig Picture-Frustration
% 215.74/215.97  |- skos__altLabel mesh__D011386 Projective Technics
% 215.74/215.97  |- mesh__recordOriginator mesh__D011386 NLM
% 215.74/215.97  |- mesh__historyNote mesh__D011386 1991%28%1963%29%   
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011386 2003
% 215.74/215.97  |- mesh__dateRevised mesh__D011386 1999-11-26
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011386 2000
% 215.74/215.97  |- skos__scopeNote mesh__D011386
% 215.74/215.97       Techniques whereby personality attributes are revealed through the subject%27%s responses to relatively unstructured, ambiguous, or vague stimuli. These responses represent projections of the subject%27%s own fears and needs.%A%    
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011386 2006
% 215.74/215.97  |- skos__hiddenLabel mesh__D011386 Study, Picture Frustration
% 215.74/215.97  |- skos__altLabel mesh__D011386 Rosenzweig Picture Frustration Study
% 215.74/215.97  |- skos__hiddenLabel mesh__D011386 Projective Technic
% 215.74/215.97  |- skos__hiddenLabel mesh__D011386 Techniques, Projective
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011386 2005
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011386 2002
% 215.74/215.97  |- skos__broader mesh__D011386smesh__D010556
% 215.74/215.97  |- mesh__dateCreated mesh__D011386 1999-01-01
% 215.74/215.97  |- skos__hiddenLabel mesh__D011386 Technique, Projective
% 215.74/215.97  |- skos__broader mesh__D005349smesh__D047011
% 215.74/215.97  |- mesh__dateRevised mesh__D005349 2005-06-30
% 215.74/215.97  |- mesh__recordOriginator mesh__D005349 NLM
% 215.74/215.97  |- skos__hiddenLabel mesh__D005349 Fibroins, Dragline Silk
% 215.74/215.97  |- mesh__historyNote mesh__D005349 2005 %28%1966%29%   
% 215.74/215.97  |- rdf__type mesh__D005349sskos__Concept
% 215.74/215.97  |- skos__altLabel mesh__D005349 Spidroins
% 215.74/215.97  |- skos__hiddenLabel mesh__D005349 Spider Fibroins
% 215.74/215.97  |- skos__altLabel mesh__D005349 Fibroin
% 215.74/215.97  |- skos__scopeNote mesh__D005349
% 215.74/215.97       Fibrous proteins secreted by INSECTS and SPIDERS. Generally, the term refers to silkworm fibroin secreted by the silk gland cells of SILKWORMS, Bombyx mori. Spider fibroins are called spidroins or dragline silk fibroins%A%    
% 215.74/215.97  |- mesh__dateCreated mesh__D005349 1999-01-01
% 215.74/215.97  |- mesh__recordMaintainer mesh__D005349 SYSTEM
% 215.74/215.97  |- mesh__recordAuthorizer mesh__D005349 sjn
% 215.74/215.97  |- skos__altLabel mesh__D005349 Dragline Silk Fibroins
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D005349 2006
% 215.74/215.97  |- mesh__publicMeSHNote mesh__D005349 2005; see FIBROIN 1966-2004   
% 215.74/215.97  |- skos__prefLabel mesh__D005349 Fibroins
% 215.74/215.97  |- rdf__type mesh__D024503sskos__Concept
% 215.74/215.97  |- mesh__recordMaintainer mesh__D024503 ssb
% 215.74/215.97  |- mesh__dateEstablished mesh__D024503 2002-01-01
% 215.74/215.97  |- mesh__publicMeSHNote mesh__D024503 2002; see VITAMIN E 1966-2001   
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D024503 2006
% 215.74/215.97  |- skos__historyNote mesh__D024503 Vitamin E %28%1971-2001%29%
% 215.74/215.97  |- skos__hiddenLabel mesh__D024503 beta Tocopherol
% 215.74/215.97  |- skos__prefLabel mesh__D024503 beta-Tocopherol
% 215.74/215.97  |- mesh__historyNote mesh__D024503 2002; use VITAMIN E 1966-2001   
% 215.74/215.97  |- skos__altLabel mesh__D024503
% 215.74/215.97       3,4-Dihydro-2,5,8-trimethyl-2-%28%4,8,12- trimethyltridecyl%29%-2H-1-benzopyran-6-ol
% 215.74/215.97  |- skos__annotation mesh__D024503
% 215.74/215.97       deficiency: coordinate BETA-TOCOPHEROL /defic %28%IM%29% with VITAMIN E DEFICIENCY %28%IM%29%%A%  
% 215.74/215.97  |- skos__broader mesh__D024503smesh__D024505
% 215.74/215.97  |- mesh__dateRevised mesh__D024503 2005-06-30
% 215.74/215.97  |- mesh__dateCreated mesh__D024503 2001-07-25
% 215.74/215.97  |- skos__scopeNote mesh__D024503
% 215.74/215.97       A natural tocopherol with less antioxidant activity than alpha-tocopherol.  It exhibits antioxidant activity by virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus. As in GAMMA-TOCOPHEROL, it also has three methyl groups on the 6-chromanol nucleus but at different sites.%A%    
% 215.74/215.97  |- mesh__recordAuthorizer mesh__D024503 sjn
% 215.74/215.97  |- mesh__recordOriginator mesh__D024503 lkt
% 215.74/215.97  |- skos__altLabel mesh__D002051 Burkitt%27%s Lymphoma
% 215.74/215.97  |- skos__broader mesh__D002051smesh__D016402
% 215.74/215.97  |- mesh__dateRevised mesh__D002051 2005-06-30
% 215.74/215.97  |- rdf__type mesh__D002051sskos__Concept
% 215.74/215.97  |- mesh__recordMaintainer mesh__D002051 ags
% 215.74/215.97  |- mesh__dateEstablished mesh__D002051 1968-01-01
% 215.74/215.97  |- skos__altLabel mesh__D002051 Lymphoma, Burkitt
% 215.74/215.97  |- mesh__recordOriginator mesh__D002051 NLM
% 215.74/215.97  |- skos__broader mesh__D002051smesh__D020031
% 215.74/215.97  |- mesh__recordAuthorizer mesh__D002051 sjn
% 215.74/215.97  |- skos__broader mesh__D002051smesh__D016393
% 215.74/215.97  |- mesh__historyNote mesh__D002051 98%28%68%29%   
% 215.74/215.97  |- skos__hiddenLabel mesh__D002051 Lymphoma, Burkitt%27%s
% 215.74/215.97  |- skos__altLabel mesh__D002051 Burkitt Tumor
% 215.74/215.97  |- skos__altLabel mesh__D002051 Burkitt%27%s Tumor
% 215.74/215.97  |- skos__prefLabel mesh__D002051 Burkitt Lymphoma
% 215.74/215.97  |- mesh__dateCreated mesh__D002051 1999-01-01
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D002051 2006
% 215.74/215.97  |- skos__hiddenLabel mesh__D002051 Tumor, Burkitt%27%s
% 215.74/215.97  |- skos__hiddenLabel mesh__D002051 Burkitts Lymphoma
% 215.74/215.97  |- skos__hiddenLabel mesh__D002051 Tumor, Burkitt
% 215.74/215.97  |- skos__scopeNote mesh__D002051
% 215.74/215.97       A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus %28%HERPESVIRUS 4, HUMAN%29% has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.%A%    
% 215.74/215.97  |- skos__hiddenLabel mesh__D002051 Burkitts Tumor
% 215.74/215.97  |- mesh__publicMeSHNote mesh__D002051
% 215.74/215.97       98; see BURKITT%27%S LYMPHOMA 1968-97; for BURKITT TUMOR see BURKITT%27%S TUMOR 1968-97; for LYMPHOMA, BURKITT see LYMPHOMA, BURKITT%27%S 1968-97%A%  
% 215.74/215.97  |- mesh__dateEstablished mesh__D029797 2002-01-01
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D029797 2006
% 215.74/215.97  |- skos__prefLabel mesh__D029797 Huckleberry Plant
% 215.74/215.97  |- skos__annotation mesh__D029797
% 215.74/215.97       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.74/215.97  |- mesh__dateCreated mesh__D029797 2001-07-25
% 215.74/215.97  |- rdf__type mesh__D029797sskos__Concept
% 215.74/215.97  |- skos__scopeNote mesh__D029797
% 215.74/215.97       Several plant species of the genus VACCINIUM known for the edible huckleberry fruit.%A%    
% 215.74/215.97  |- mesh__publicMeSHNote mesh__D029797 2002   
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D029797 2005
% 215.74/215.97  |- skos__altLabel mesh__D029797 Huckleberries
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D029797 2004
% 215.74/215.97  |- mesh__historyNote mesh__D029797 2002   
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D029797 2003
% 215.74/215.97  |- skos__broader mesh__D029797smesh__D029796
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D029797 2002
% 215.74/215.97  |- rdf__type mesh__D015777sskos__Concept
% 215.74/215.97  |- skos__annotation mesh__D015777 GEN or unspecified; prefer specifics   
% 215.74/215.97  |- skos__prefLabel mesh__D015777 Eicosanoids
% 215.74/215.97  |- skos__broader mesh__D015777smesh__D012898
% 215.74/215.97  |- skos__historyNote mesh__D015777 Leukotrienes %28%1989%29%
% 215.74/215.97  |- mesh__publicMeSHNote mesh__D015777 90   
% 215.74/215.97  |- skos__historyNote mesh__D015777 Prostaglandins %28%1966-1989%29%
% 215.74/215.97  |- skos__related mesh__D015777smesh__D018055
% 215.74/215.97  |- mesh__recordOriginator mesh__D015777 RLS
% 215.74/215.97  |- mesh__dateCreated mesh__D015777 1989-05-15
% 215.74/215.97  |- mesh__dateEstablished mesh__D015777 1990-01-01
% 215.74/215.97  |- mesh__recordMaintainer mesh__D015777 ssb
% 215.74/215.97  |- mesh__historyNote mesh__D015777 90   
% 215.74/215.97  |- skos__altLabel mesh__D015777 Icosanoids
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D015777 2006
% 215.74/215.97  |- skos__scopeNote mesh__D015777
% 215.74/215.97       A class of compounds named after and generally derived from C20 fatty acids %28%EICOSANOIC ACIDS%29% that includes PROSTAGLANDINS; LEUKOTRIENES; THROMBOXANES, and HYDROXYEICOSATETRAENOIC ACIDS. They have hormone-like effects mediated by specialized receptors %28%RECEPTORS, EICOSANOID%29%.%A%    
% 215.74/215.97  |- skos__historyNote mesh__D015777
% 215.74/215.97       Fatty Acids, Unsaturated %28%1973-1989%29%
% 215.74/215.97  |- skos__historyNote mesh__D015777 Arachidonic Acids %28%1967-1989%29%
% 215.74/215.97  |- skos__historyNote mesh__D015777 Thromboxanes %28%1978-1989%29%
% 215.74/215.97  |- mesh__recordAuthorizer mesh__D015777 sjn
% 215.74/215.97  |- skos__broader mesh__D015777smesh__D005231
% 215.74/215.97  |- mesh__dateRevised mesh__D015777 2005-06-30
% 215.74/215.97  |- skos__historyNote mesh__D001757 Zygote %28%1975-1979%29%
% 215.74/215.97  |- rdf__type mesh__D001757sskos__Concept
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D001757 2003
% 215.74/215.97  |- skos__altLabel mesh__D001757 Blastocytes
% 215.74/215.97  |- mesh__recordAuthorizer mesh__D001757 sjn
% 215.74/215.97  |- mesh__publicMeSHNote mesh__D001757 80   
% 215.74/215.97  |- skos__hiddenLabel mesh__D001757 Blastomere
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D001757 2004
% 215.74/215.97  |- mesh__dateRevised mesh__D001757 2002-07-02
% 215.74/215.97  |- skos__hiddenLabel mesh__D001757 Blastocyte
% 215.74/215.97  |- skos__historyNote mesh__D001757 Cell Division %28%1966-1979%29%
% 215.74/215.97  |- mesh__dateEstablished mesh__D001757 1980-01-01
% 215.74/215.97  |- skos__annotation mesh__D001757
% 215.74/215.97       do not confuse X ref BLASTOCYTES with BLASTOCYST   
% 215.74/215.97  |- skos__scopeNote mesh__D001757
% 215.74/215.97       The undifferentiated cells produced by early cleavages of the fertilized egg %28%ZYGOTE%29% inside the intact ZONA PELLUCIDA. Blastomeres are formed during the MORULA and the BLASTULA stages of the preimplantation EMBRYO.%A%    
% 215.74/215.97  |- skos__prefLabel mesh__D001757 Blastomeres
% 215.74/215.97  |- mesh__historyNote mesh__D001757 80   
% 215.74/215.97  |- skos__broader mesh__D001757smesh__D004622
% 215.74/215.97  |- mesh__recordMaintainer mesh__D001757 lkt
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D001757 2005
% 215.74/215.97  |- mesh__dateCreated mesh__D001757 1979-04-17
% 215.74/215.97  |- skos__historyNote mesh__D001757 Blastocyst %28%1974-1979%29%
% 215.74/215.97  |- mesh__recordOriginator mesh__D001757 AEP
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D001757 2006
% 215.74/215.97  |- skos__broader mesh__D001757smesh__D002477
% 215.74/215.97  |- mesh__publicMeSHNote mesh__D020911
% 215.74/215.97       2000; KETOROLAC TROMETHAMINE was indexed under TOLMETIN/analogs %26% derivatives %26% TROMETHAMINE 1986-1999%A%  
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020911 2003
% 215.74/215.97  |- mesh__recordMaintainer mesh__D020911 sjn
% 215.74/215.97  |- skos__broader mesh__D020911smesh__D007213
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020911 2000
% 215.74/215.97  |- skos__historyNote mesh__D020911 Tromethamine %28%1986-1999%29%
% 215.74/215.97  |- mesh__dateEstablished mesh__D020911 2000-01-01
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020911 2004
% 215.74/215.97  |- mesh__recordAuthorizer mesh__D020911 sjn
% 215.74/215.97  |- skos__hiddenLabel mesh__D020911 Tromethamine, Ketorolac
% 215.74/215.97  |- mesh__dateRevised mesh__D020911 2000-01-21
% 215.74/215.97  |- skos__prefLabel mesh__D020911 Ketorolac Tromethamine
% 215.74/215.97  |- skos__scopeNote mesh__D020911
% 215.74/215.97       A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity.%A%    
% 215.74/215.97  |- mesh__historyNote mesh__D020911
% 215.74/215.97       2000; use KETOROLAC TROMETHAMINE %28%NM%29% 1986-1999   
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020911 2001
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020911 2005
% 215.74/215.97  |- skos__annotation mesh__D020911 KETOROLAC is also available   
% 215.74/215.97  |- mesh__recordOriginator mesh__D020911 adp
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020911 2002
% 215.74/215.97  |- rdf__type mesh__D020911sskos__Concept
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020911 2006
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020911 2000A
% 215.74/215.97  |- mesh__dateCreated mesh__D020911 1999-11-03
% 215.74/215.97  |- skos__historyNote mesh__D020911
% 215.74/215.97       Tolmetin/analogs %26% derivatives %28%1986-1999%29%
% 215.74/215.97  |- rdf__type mesh__D006442sskos__Concept
% 215.74/215.97  |- skos__hiddenLabel mesh__D006442 Glycosylated A1b Hemoglobin
% 215.74/215.97  |- mesh__recordMaintainer mesh__D006442 sjn
% 215.74/215.97  |- skos__altLabel mesh__D006442 Glycosylated Hemoglobin A
% 215.74/215.97  |- skos__hiddenLabel mesh__D006442 A1b Hemoglobin, Glycosylated
% 215.74/215.97  |- skos__altLabel mesh__D006442 Hb A1a-1
% 215.74/215.97  |- skos__broader mesh__D006442smesh__D006027
% 215.74/215.97  |- skos__annotation mesh__D006442
% 215.74/215.97       urine: coord IM with HEMOGLOBINURIA %28%IM%29%; DF: note short X refs%A%  
% 215.74/215.97  |- skos__broader mesh__D006442smesh__D006441
% 215.74/215.97  |- skos__hiddenLabel mesh__D006442 Glycosylated Hemoglobin
% 215.74/215.97  |- skos__hiddenLabel mesh__D006442 Hemoglobins, Glycated
% 215.74/215.97  |- skos__altLabel mesh__D006442 Glycated Hemoglobins
% 215.74/215.97  |- skos__historyNote mesh__D006442 Hemoglobin A %28%1977-1981%29%
% 215.74/215.97  |- skos__prefLabel mesh__D006442 Hemoglobin A, Glycosylated
% 215.74/215.97  |- skos__historyNote mesh__D006442 Hemoglobins %28%1966-1976%29%
% 215.74/215.97  |- skos__scopeNote mesh__D006442
% 215.74/215.97       Minor hemoglobin components of human erythrocytes designated A1a, A1b, and A1c. Hemoglobin A1c is most important since its sugar moiety is glucose covalently bound to the terminal amino acid of the beta chain. Since normal glycohemoglobin concentrations exclude marked blood glucose fluctuations over the preceding three to four weeks, the concentration of glycosylated hemoglobin A is a more reliable index of the blood sugar average over a long period of time.%A%    
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D006442 2006
% 215.74/215.97  |- skos__altLabel mesh__D006442 Hemoglobin A%28%1%29%
% 215.74/215.97  |- mesh__publicMeSHNote mesh__D006442 82   
% 215.74/215.97  |- skos__hiddenLabel mesh__D006442 A1a-1 Hemoglobin, Glycosylated
% 215.74/215.97  |- mesh__dateRevised mesh__D006442 2004-07-13
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D006442 2005
% 215.74/215.97  |- skos__altLabel mesh__D006442 Glycohemoglobin A
% 215.74/215.97  |- mesh__historyNote mesh__D006442 82   
% 215.74/215.97  |- skos__altLabel mesh__D006442 Hb A1c
% 215.74/215.97  |- skos__altLabel mesh__D006442 Hb A1a+b
% 215.74/215.97  |- skos__hiddenLabel mesh__D006442 Glycosylated A1a-1 Hemoglobin
% 215.74/215.97  |- mesh__recordOriginator mesh__D006442 RLS
% 215.74/215.97  |- mesh__dateCreated mesh__D006442 1981-05-12
% 215.74/215.97  |- skos__altLabel mesh__D006442 HbA1
% 215.74/215.97  |- skos__hiddenLabel mesh__D006442 Hemoglobin, Glycosylated A1a 1
% 215.74/215.97  |- mesh__dateEstablished mesh__D006442 1982-01-01
% 215.74/215.97  |- skos__altLabel mesh__D006442 Hb A1b
% 215.74/215.97  |- mesh__recordAuthorizer mesh__D006442 sjn
% 215.74/215.97  |- skos__altLabel mesh__D006442 Hb A1
% 215.74/215.97  |- skos__altLabel mesh__D020113 Manesco Brand of Phenolphthalein
% 215.74/215.97  |- skos__altLabel mesh__D020113 Schering-Plough Brand of Phenolphthalein
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D020113 2006
% 215.74/215.97  |- skos__altLabel mesh__D020113 Thompson Brand of Phenolphthalein
% 215.74/215.97  |- mesh__recordMaintainer mesh__D020113 lkw
% 215.74/215.97  |- skos__historyNote mesh__D020113 Phenolphthaleins %28%1983-1998%29%
% 215.74/215.97  |- mesh__dateCreated mesh__D020113 1998-06-10
% 215.74/215.97  |- skos__prefLabel mesh__D020113 Phenolphthalein
% 215.74/215.97  |- mesh__publicMeSHNote mesh__D020113
% 215.74/215.97       99; PHENOLPHTHALEIN was indexed under PHENOLPHTHALEINS 1983-98%A%  
% 215.74/215.97  |- skos__scopeNote mesh__D020113
% 215.74/215.97       An acid-base indicator which is colorless in acid solution, but turns pink to red as the solution becomes alkaline. It is used medicinally as a cathartic.%A%    
% 215.74/215.97  |- skos__broader mesh__D020113smesh__D010635
% 215.74/215.97  |- mesh__historyNote mesh__D020113
% 215.74/215.97       99; use PHENOLPHTHALEIN %28%NM%29% 1983-98   
% 215.74/215.97  |- mesh__dateEstablished mesh__D020113 1999-01-01
% 215.74/215.97  |- skos__altLabel mesh__D020113 Laxettes
% 215.74/215.97  |- mesh__recordAuthorizer mesh__D020113 sjn
% 215.74/215.97  |- skos__annotation mesh__D020113 PHENOLPHTHALEINS is also available   
% 215.74/215.97  |- skos__altLabel mesh__D020113 Mentholatum Brand of Phenolphthalein
% 215.74/215.97  |- skos__altLabel mesh__D020113 Key Brand of Phenolphthalein
% 215.74/215.97  |- mesh__dateRevised mesh__D020113 2005-06-30
% 215.74/215.97  |- skos__altLabel mesh__D020113 Novartis Brand of Phenolphthalein
% 215.74/215.97  |- mesh__recordOriginator mesh__D020113 ADP
% 215.74/215.97  |- rdf__type mesh__D020113sskos__Concept
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011387 2004
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011387 2002
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011387 1999
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011387 1992
% 215.74/215.97  |- mesh__recordOriginator mesh__D011387 AEP
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011387 2003
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011387 1995
% 215.74/215.97  |- mesh__recordMaintainer mesh__D011387 TGC
% 215.74/215.97  |- mesh__dateEstablished mesh__D011387 1991-01-01
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011387 1998
% 215.74/215.97  |- mesh__recordAuthorizer mesh__D011387 PLS
% 215.74/215.97  |- skos__prefLabel mesh__D011387 Prokaryotic Cells
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011387 2006
% 215.74/215.97  |- mesh__historyNote mesh__D011387
% 215.74/215.97       91%28%78%29%; was see under CELLS 1978-90   
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011387 1994
% 215.74/215.97  |- skos__hiddenLabel mesh__D011387 Prokaryotic Cell
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011387 2001
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011387 2005
% 215.74/215.97  |- skos__broader mesh__D011387smesh__D002477
% 215.74/215.97  |- skos__scopeNote mesh__D011387
% 215.74/215.97       Cells, such as those of bacteria and the blue green algae, which lack a nuclear membrane so that the nuclear material is either scattered in the cytoplasm or collected in a nucleoid region.%A%    
% 215.74/215.97  |- mesh__publicMeSHNote mesh__D011387 91; was see under CELLS 1978-90   
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011387 2000
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011387 1997
% 215.74/215.97  |- mesh__dateCreated mesh__D011387 1977-03-01
% 215.74/215.97  |- rdf__type mesh__D011387sskos__Concept
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011387 1993
% 215.74/215.97  |- skos__historyNote mesh__D011387
% 215.74/215.97       appropriate cell, organism, subcellular fraction, or process
% 215.74/215.97  |- skos__annotation mesh__D011387
% 215.74/215.97       GEN: prefer BACTERIA or specific bact; A 11 qualif with discretion%A%  
% 215.74/215.97  |- skos__hiddenLabel mesh__D011387 Cell, Prokaryotic
% 215.74/215.97  |- skos__hiddenLabel mesh__D011387 Cells, Prokaryotic
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D011387 1996
% 215.74/215.97  |- mesh__dateRevised mesh__D011387 1991-05-30
% 215.74/215.97  |- mesh__dateCreated mesh__D038524 2002-07-03
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D038524 2006
% 215.74/215.97  |- skos__prefLabel mesh__D038524 Diffusion Magnetic Resonance Imaging
% 215.74/215.97  |- mesh__recordAuthorizer mesh__D038524 sjn
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D038524 2005
% 215.74/215.97  |- mesh__recordMaintainer mesh__D038524 ags
% 215.74/215.97  |- skos__altLabel mesh__D038524 Diffusion Weighted MRI
% 215.74/215.97  |- skos__historyNote mesh__D038524
% 215.74/215.97       Magnetic Resonance Spectroscopy %28%1984-1988%29%
% 215.74/215.97  |- rdf__type mesh__D038524sskos__Concept
% 215.74/215.97  |- mesh__dateRevised mesh__D038524 2004-07-07
% 215.74/215.97  |- skos__broader mesh__D038524smesh__D008279
% 215.74/215.97  |- mesh__recordOriginator mesh__D038524 lkt
% 215.74/215.97  |- skos__hiddenLabel mesh__D038524 MRI, Diffusion Weighted
% 215.74/215.97  |- skos__altLabel mesh__D038524 Magnetic Resonance Imaging, Diffusion
% 215.74/215.97  |- skos__historyNote mesh__D038524
% 215.74/215.97       Magnetic Resonance Imaging %28%1989-2002%29%
% 215.74/215.97  |- mesh__publicMeSHNote mesh__D038524 2003   
% 215.74/215.97  |- mesh__dateEstablished mesh__D038524 2003-01-01
% 215.74/215.97  |- mesh__historyNote mesh__D038524 2003   
% 215.74/215.97  |- skos__scopeNote mesh__D038524
% 215.74/215.97       A diagnostic technique that incorporates the measurement of molecular diffusion %28%such as water or metabolites%29% for tissue assessment by MRI. The degree of molecular movement can be measured by changes of apparent diffusion coefficient %28%ADC%29% with time, as reflected by tissue microstructure. Diffusion MRI has been used to study BRAIN ISCHEMIA and tumor response to treatment.%A%    
% 215.74/215.97  |- skos__hiddenLabel mesh__D038524 Diffusion MRIs
% 215.74/215.97  |- skos__altLabel mesh__D038524 Diffusion MRI
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D016870 1997
% 215.74/215.97  |- skos__broader mesh__D016870smesh__D016905
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D016870 1999
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D016870 1996
% 215.74/215.97  |- rdf__type mesh__D016870sskos__Concept
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D016870 1995
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D016870 1998
% 215.74/215.97  |- skos__annotation mesh__D016870
% 215.74/215.97       gram-neg bact infect; GEN: avoid; prefer specifics; DF: NEISSERIACEAE INFECT%A%  
% 215.74/215.97  |- skos__prefLabel mesh__D016870 Neisseriaceae Infections
% 215.74/215.97  |- skos__hiddenLabel mesh__D016870 Infection, Neisseriaceae
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D016870 1994
% 215.74/215.97  |- mesh__dateCreated mesh__D016870 1991-05-30
% 215.74/215.97  |- skos__scopeNote mesh__D016870
% 215.74/215.97       Infections with bacteria of the family NEISSERIACEAE.     
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D016870 2002
% 215.74/215.97  |- mesh__recordAuthorizer mesh__D016870 PLS
% 215.74/215.97  |- mesh__dateRevised mesh__D016870 1993-06-03
% 215.74/215.97  |- mesh__dateEstablished mesh__D016870 1992-01-01
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D016870 2004
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D016870 2001
% 215.74/215.97  |- mesh__activeMeSHYear mesh__D016870 2006
% 215.74/215.98  |- skos__hiddenLabel mesh__D016870 Neisseriaceae Infection
% 215.74/215.98  |- mesh__historyNote mesh__D016870 92   
% 215.74/215.98  |- mesh__recordOriginator mesh__D016870 PXP
% 215.74/215.98  |- mesh__activeMeSHYear mesh__D016870 2003
% 215.74/215.98  |- mesh__recordMaintainer mesh__D016870 TAP
% 215.74/215.98  |- mesh__activeMeSHYear mesh__D016870 2005
% 215.74/215.98  |- mesh__activeMeSHYear mesh__D016870 2000
% 215.74/215.98  |- mesh__publicMeSHNote mesh__D016870 92   
% 215.74/215.98  |- skos__altLabel mesh__D016870 Infections, Neisseriaceae
% 215.74/215.98  |- skos__altLabel mesh__D030541 Genetic Information Databases
% 215.74/215.98  |- skos__altLabel mesh__D030541 Genetic Data Bases
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Data Bases, Genetic
% 215.74/215.98  |- skos__scopeNote mesh__D030541
% 215.74/215.98       DATABASES devoted to knowledge about specific genes and gene products.%A%    
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Genetic Data Bank
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Genetic Sequence Database
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Information Database, Genetic
% 215.74/215.98  |- mesh__recordOriginator mesh__D030541 nns
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Genetic Database
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Databank, Genetic
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Genetic Databank
% 215.74/215.98  |- skos__altLabel mesh__D030541 Genetic Databanks
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Sequence Databases, Genetic
% 215.74/215.98  |- skos__prefLabel mesh__D030541 Databases, Genetic
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Databases, Genetic Information
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Genetic Data Base
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Bank, Genetic Data
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Databanks, Genetic
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Database, Genetic
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Data Bank, Genetic
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Data Banks, Genetic
% 215.74/215.98  |- skos__altLabel mesh__D030541 Genetic Data Banks
% 215.74/215.98  |- skos__altLabel mesh__D030541 Genetic Databases
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Database, Genetic Sequence
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Information Databases, Genetic
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Data Base, Genetic
% 215.74/215.98  |- mesh__dateRevised mesh__D030541 2004-07-07
% 215.74/215.98  |- mesh__activeMeSHYear mesh__D030541 2005
% 215.74/215.98  |- mesh__dateCreated mesh__D030541 2001-07-25
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Genetic Information Database
% 215.74/215.98  |- mesh__historyNote mesh__D030541 2002   
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Database, Genetic Information
% 215.74/215.98  |- skos__annotation mesh__D030541
% 215.74/215.98       DATABASES, NUCLEIC ACID and DATABASES, PROTEIN are also available%A%  
% 215.74/215.98  |- skos__related mesh__D030541smesh__D005820
% 215.74/215.98  |- mesh__activeMeSHYear mesh__D030541 2006
% 215.74/215.98  |- skos__broader mesh__D030541smesh__D016208
% 215.74/215.98  |- mesh__dateEstablished mesh__D030541 2002-01-01
% 215.74/215.98  |- mesh__recordMaintainer mesh__D030541 jls
% 215.74/215.98  |- rdf__type mesh__D030541sskos__Concept
% 215.74/215.98  |- mesh__recordAuthorizer mesh__D030541 sjn
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Sequence Database, Genetic
% 215.74/215.98  |- skos__altLabel mesh__D030541 OMIM
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Banks, Genetic Data
% 215.74/215.98  |- skos__hiddenLabel mesh__D030541 Databases, Genetic Sequence
% 215.74/215.98  |- mesh__publicMeSHNote mesh__D030541 2002   
% 215.74/215.98  |- skos__prefLabel mesh__D002850 Chromatography, Gel
% 215.74/215.98  |- skos__altLabel mesh__D002850 Gel Chromatography
% 215.74/215.98  |- skos__altLabel mesh__D002850 Exclusion Chromatography
% 215.74/215.98  |- mesh__activeMeSHYear mesh__D002850 2004
% 215.74/215.98  |- skos__altLabel mesh__D002850 Gel Permeation Chromatography
% 215.74/215.98  |- mesh__dateEstablished mesh__D002850 1976-01-01
% 215.74/215.98  |- skos__hiddenLabel mesh__D002850 Filtration Chromatography, Gel
% 215.74/215.98  |- skos__hiddenLabel mesh__D002850 Sieve Chromatography, Molecular
% 215.74/215.98  |- mesh__historyNote mesh__D002850
% 215.74/215.98       76; was GEL FILTRATION 1966-75; CHROMATOGRAPHY, GEL was see under GEL FILTRATION 1966-75; CHROMATOGRAPHY, EXCLUSION was see under CHROMATOGRAPHY, GEL 1976, was see under GEL FILTRATION 1973-75%A%  
% 215.74/215.98  |- mesh__activeMeSHYear mesh__D002850 2003
% 215.74/215.98  |- skos__annotation mesh__D002850 DF: CHROMATOGR GEL   
% 215.74/215.98  |- mesh__onlineNote mesh__D002850
% 215.74/215.98       use CHROMATOGRAPHY, GEL to search GEL FILTRATION 1966-75 %26% CHROMATOGRAPHY, EXCLUSION 1973-75%A%  
% 215.84/215.98  |- rdf__type mesh__D002850sskos__Concept
% 215.84/215.98  |- mesh__publicMeSHNote mesh__D002850
% 215.84/215.98       76; was GEL FILTRATION 1966-75; CHROMATOGRAPHY, GEL was see under GEL FILTRATION 1966-75; CHROMATOGRAPHY, EXCLUSION was see under CHROMATOGRAPHY, GEL 1976, was see under GEL FILTRATION 1973-75%A%  
% 215.84/215.98  |- mesh__recordAuthorizer mesh__D002850 sjn
% 215.84/215.98  |- mesh__recordOriginator mesh__D002850 JW
% 215.84/215.98  |- mesh__recordMaintainer mesh__D002850 ssb
% 215.84/215.98  |- skos__hiddenLabel mesh__D002850 Exclusion Chromatography, Size
% 215.84/215.98  |- skos__altLabel mesh__D002850 Chromatography, Exclusion
% 215.84/215.98  |- skos__hiddenLabel mesh__D002850 Size Exclusion Chromatography
% 215.84/215.98  |- skos__altLabel mesh__D002850 Molecular Sieve Chromatography
% 215.84/215.98  |- skos__hiddenLabel mesh__D002850 Filtration, Gel
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D002850 2006
% 215.84/215.98  |- skos__broader mesh__D002850smesh__D002853
% 215.84/215.98  |- skos__altLabel mesh__D002850 Gel Filtration Chromatography
% 215.84/215.98  |- skos__altLabel mesh__D002850 Chromatography, Molecular Sieve
% 215.84/215.98  |- skos__scopeNote mesh__D002850
% 215.84/215.98       Chromatography on non-ionic gels without regard to the mechanism of solute discrimination.%A%    
% 215.84/215.98  |- skos__altLabel mesh__D002850 Gel Filtration
% 215.84/215.98  |- mesh__dateCreated mesh__D002850 1975-07-25
% 215.84/215.98  |- skos__altLabel mesh__D002850 Chromatography, Gel Permeation
% 215.84/215.98  |- skos__hiddenLabel mesh__D002850 Chromatography, Gel Filtration
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D002850 2005
% 215.84/215.98  |- mesh__dateRevised mesh__D002850 2002-07-03
% 215.84/215.98  |- mesh__historyNote mesh__D024504 2002; use VITAMIN E 1966-2001   
% 215.84/215.98  |- skos__historyNote mesh__D024504 Vitamin E %28%1969-2001%29%
% 215.84/215.98  |- skos__broader mesh__D024504smesh__D024505
% 215.84/215.98  |- mesh__dateRevised mesh__D024504 2005-06-30
% 215.84/215.98  |- mesh__dateCreated mesh__D024504 2001-07-25
% 215.84/215.98  |- skos__prefLabel mesh__D024504 gamma-Tocopherol
% 215.84/215.98  |- mesh__recordAuthorizer mesh__D024504 sjn
% 215.84/215.98  |- skos__altLabel mesh__D024504
% 215.84/215.98       3,4-Dihydro-2,7,8-trimethyl-2-%28%4,8,12- trimethyltridecyl%29%-2H-1-benzopyran-6-ol.
% 215.84/215.98  |- mesh__publicMeSHNote mesh__D024504 2002; see VITAMIN E 1966-2001   
% 215.84/215.98  |- mesh__recordMaintainer mesh__D024504 ssb
% 215.84/215.98  |- mesh__recordOriginator mesh__D024504 lkt
% 215.84/215.98  |- skos__annotation mesh__D024504
% 215.84/215.98       deficiency: coordinate GAMMA-TOCOPHEROL /defic %28%IM%29% with VITAMIN E DEFICIENCY %28%IM%29%%A%  
% 215.84/215.98  |- rdf__type mesh__D024504sskos__Concept
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D024504 2006
% 215.84/215.98  |- skos__scopeNote mesh__D024504
% 215.84/215.98       A natural tocopherol with less antioxidant activity than ALPHA-TOCOPHEROL.  It exhibits antioxidant activity by virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus. As in BETA-TOCOPHEROL, it also has three methyl groups on the 6-chromanol nucleus but at different sites.%A%    
% 215.84/215.98  |- mesh__dateEstablished mesh__D024504 2002-01-01
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D002052 2002
% 215.84/215.98  |- skos__altLabel mesh__D002052 Myanma
% 215.84/215.98  |- skos__annotation mesh__D002052
% 215.84/215.98       capital Rangoon became Yangon when Burma became Myanmar in 1989.%A%  
% 215.84/215.98  |- mesh__dateCreated mesh__D002052 1999-01-01
% 215.84/215.98  |- skos__scopeNote mesh__D002052
% 215.84/215.98       A republic of southeast Asia, northwest of Thailand, long familiar as Burma. Its capital is Yangon, formerly Rangoon. Inhabited by people of Mongolian stock and probably of Tibetan origin, by the 3d century A.D. it was settled by Hindus. The modern Burmese state was founded in the 18th century but was in conflict with the British during the 19th century. Made a crown colony of Great Britain in 1937, it was granted independence in 1947. In 1989 it became Myanmar. The name comes from myanma, meaning the strong, as applied to the Burmese people themselves. %28%From Webster%27%s New Geographical Dictionary, 1988, p192 %26% Room, Brewer%27%s Dictionary of Names, 1992, p367%29%%A%    
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D002052 2006
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D002052 2004
% 215.84/215.98  |- mesh__historyNote mesh__D002052 93; was BURMA 1968-92   
% 215.84/215.98  |- mesh__recordMaintainer mesh__D002052 TGC
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D002052 2005
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D002052 1999
% 215.84/215.98  |- mesh__dateRevised mesh__D002052 1995-06-08
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D002052 2003
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D002052 2001
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D002052 1997
% 215.84/215.98  |- skos__prefLabel mesh__D002052 Myanmar
% 215.84/215.98  |- skos__altLabel mesh__D002052 Burma
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D002052 2000
% 215.84/215.98  |- mesh__onlineNote mesh__D002052 use MYANMAR to search BURMA 1968-92   
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D002052 1998
% 215.84/215.98  |- rdf__type mesh__D002052sskos__Concept
% 215.84/215.98  |- mesh__recordOriginator mesh__D002052 NLM
% 215.84/215.98  |- skos__broader mesh__D002052smesh__D001210
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D002052 1996
% 215.84/215.98  |- mesh__recordAuthorizer mesh__D002052 PLS
% 215.84/215.98  |- mesh__publicMeSHNote mesh__D029798 2002   
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D029798 2005
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D029798 2004
% 215.84/215.98  |- skos__altLabel mesh__D029798 Blueberries
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D029798 2002
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D029798 2003
% 215.84/215.98  |- mesh__dateCreated mesh__D029798 2001-07-25
% 215.84/215.98  |- skos__broader mesh__D029798smesh__D029796
% 215.84/215.98  |- mesh__historyNote mesh__D029798 2002   
% 215.84/215.98  |- skos__scopeNote mesh__D029798
% 215.84/215.98       Several plant species of the genus VACCINIUM known for the edible blueberry fruit.%A%    
% 215.84/215.98  |- mesh__dateEstablished mesh__D029798 2002-01-01
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D029798 2006
% 215.84/215.98  |- skos__prefLabel mesh__D029798 Blueberry Plant
% 215.84/215.98  |- skos__annotation mesh__D029798
% 215.84/215.98       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.84/215.98  |- rdf__type mesh__D029798sskos__Concept
% 215.84/215.98  |- mesh__dateRevised mesh__D015778 2005-06-30
% 215.84/215.98  |- skos__scopeNote mesh__D015778
% 215.84/215.98       Allelic alloantigens often responsible for weak graft rejection in cases when %28%major%29% histocompatibility has been established by standard tests. In the mouse they are coded by more than 500 genes at up to 30 minor histocompatibility loci. The most well-known minor histocompatibility antigen in mammals is the H-Y antigen.%A%    
% 215.84/215.98  |- skos__prefLabel mesh__D015778 Minor Histocompatibility Antigens
% 215.84/215.98  |- skos__altLabel mesh__D015778 Minor Histocompatibility Peptides
% 215.84/215.98  |- skos__historyNote mesh__D015778
% 215.84/215.98       Histocompatibility Antigens %28%1972-1989%29%
% 215.84/215.98  |- mesh__dateEstablished mesh__D015778 1990-01-01
% 215.84/215.98  |- mesh__historyNote mesh__D015778 90   
% 215.84/215.98  |- mesh__dateCreated mesh__D015778 1989-05-15
% 215.84/215.98  |- skos__hiddenLabel mesh__D015778 Histocompatibility Peptides, Minor
% 215.84/215.98  |- mesh__recordMaintainer mesh__D015778 ssb
% 215.84/215.98  |- skos__broader mesh__D015778smesh__D006649
% 215.84/215.98  |- mesh__recordOriginator mesh__D015778 AGS
% 215.84/215.98  |- mesh__recordAuthorizer mesh__D015778 sjn
% 215.84/215.98  |- skos__altLabel mesh__D015778 Histocompatibility Antigens, Minor
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D015778 2006
% 215.84/215.98  |- rdf__type mesh__D015778sskos__Concept
% 215.84/215.98  |- mesh__publicMeSHNote mesh__D015778 90   
% 215.84/215.98  |- skos__broader mesh__D001758smesh__D003904
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D001758 2006
% 215.84/215.98  |- skos__scopeNote mesh__D001758
% 215.84/215.98       A genus of onygenacetous mitosporic fungi whose perfect state is Ajellomyces %28%see ONYGENALES%29%. The species Blastomyces dermatitidis %28%perfect state Ajellomyces dermatitidis%29% causes blastomycosis.%A%    
% 215.84/215.98  |- rdf__type mesh__D001758sskos__Concept
% 215.84/215.98  |- mesh__recordOriginator mesh__D001758 NLM
% 215.84/215.98  |- mesh__recordMaintainer mesh__D001758 SYSTEM
% 215.84/215.98  |- mesh__recordAuthorizer mesh__D001758 sjn
% 215.84/215.98  |- skos__prefLabel mesh__D001758 Blastomyces
% 215.84/215.98  |- mesh__dateCreated mesh__D001758 1999-01-01
% 215.84/215.98  |- mesh__dateRevised mesh__D001758 2005-06-30
% 215.84/215.98  |- skos__related mesh__D001758smesh__D020036
% 215.84/215.98  |- skos__annotation mesh__D001758
% 215.84/215.98       infection = BLASTOMYCOSIS; BLASTOMYCES BRASILIENSIS see PARACOCCIDIOIDES is available%A%  
% 215.84/215.98  |- mesh__dateRevised mesh__D012480 1996-06-10
% 215.84/215.98  |- skos__broader mesh__D012480smesh__D004756
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D012480 2001
% 215.84/215.98  |- skos__prefLabel mesh__D012480 Salmonella Infections
% 215.84/215.98  |- mesh__dateCreated mesh__D012480 1999-01-01
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D012480 2005
% 215.84/215.98  |- rdf__type mesh__D012480sskos__Concept
% 215.84/215.98  |- skos__scopeNote mesh__D012480
% 215.84/215.98       Infections with bacteria of the genus SALMONELLA.     
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D012480 2000
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D012480 1997
% 215.84/215.98  |- skos__hiddenLabel mesh__D012480 Salmonella Infection
% 215.84/215.98  |- mesh__recordOriginator mesh__D012480 NLM
% 215.84/215.98  |- skos__hiddenLabel mesh__D012480 Salmonelloses
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D012480 1999
% 215.84/215.98  |- skos__hiddenLabel mesh__D012480 Infection, Salmonella
% 215.84/215.98  |- mesh__recordMaintainer mesh__D012480 TGC
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D012480 2004
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D012480 1998
% 215.84/215.98  |- skos__altLabel mesh__D012480 Salmonellosis
% 215.84/215.98  |- skos__annotation mesh__D012480
% 215.84/215.98       gram-neg bact infect; GEN or unspecified; see notes on specific species terms; SALMONELLA INFECTIONS, ANIMAL %26% SALMONELLA FOOD POISONING are available%A%  
% 215.84/215.98  |- skos__altLabel mesh__D012480 Infections, Salmonella
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D012480 2002
% 215.84/215.98  |- mesh__recordAuthorizer mesh__D012480 PLS
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D012480 2006
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D012480 2003
% 215.84/215.98  |- skos__broader mesh__D005502Q000331smesh__D005502
% 215.84/215.98  |- mesh__preferredCombination mesh__D005502Q000331smesh__D007881
% 215.84/215.98  |- rdf__type mesh__D005502Q000331smesh__CompoundConcept
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide BC Brand
% 215.84/215.98  |- skos__altLabel mesh__D020912 ct-Arzneimittel Brand of Moclobemide
% 215.84/215.98  |- mesh__recordOriginator mesh__D020912 adp
% 215.84/215.98  |- skos__altLabel mesh__D020912 BC Brand of Moclobemide
% 215.84/215.98  |- skos__altLabel mesh__D020912 Nu-Pharm Brand of Moclobemide
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide Pharmascience Brand
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Nu Moclobemide
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide Bull Brand
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Apo Moclobemide
% 215.84/215.98  |- skos__altLabel mesh__D020912 Hoffmann-La Roche Brand of Moclobemide
% 215.84/215.98  |- mesh__historyNote mesh__D020912
% 215.84/215.98       2000; use MOCLOBEMIDE %28%NM%29% 1982-1999   
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Stada, Moclobemid
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide betapharm Brand
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide, Healthsense
% 215.84/215.98  |- skos__altLabel mesh__D020912 Temmler Brand of Moclobemide
% 215.84/215.98  |- mesh__recordMaintainer mesh__D020912 CCR
% 215.84/215.98  |- skos__altLabel mesh__D020912 Moclamine
% 215.84/215.98  |- mesh__publicMeSHNote mesh__D020912
% 215.84/215.98       2000; MOCLOBEMIDE was indexed under BENZAMIDES 1982-1999   
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide 1A Brand
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide Nu-Pharm Brand
% 215.84/215.98  |- mesh__dateRevised mesh__D020912 2005-06-30
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 ct Arzneimittel Brand of Moclobemide
% 215.84/215.98  |- skos__altLabel mesh__D020912 Chem mart Brand of Moclobemide
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide Temmler Brand
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 AZU, Moclobemid
% 215.84/215.98  |- skos__altLabel mesh__D020912 Aurorex
% 215.84/215.98  |- skos__altLabel mesh__D020912 Azupharma Brand of Moclobemide
% 215.84/215.98  |- rdf__type mesh__D020912sskos__Concept
% 215.84/215.98  |- skos__altLabel mesh__D020912 Manerix
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide Alphapharm Brand
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide Kendrick Brand
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide, GenRX
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide Faulding Brand
% 215.84/215.98  |- skos__altLabel mesh__D020912 Apotex Brand of Moclobemide
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide Healthsense Brand
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide Azupharma Brand
% 215.84/215.98  |- skos__altLabel mesh__D020912 Stadapharm Brand of Moclobemide
% 215.84/215.98  |- skos__altLabel mesh__D020912 1A Brand of Moclobemide
% 215.84/215.98  |- mesh__dateCreated mesh__D020912 1999-11-04
% 215.84/215.98  |- skos__altLabel mesh__D020912 betapharm Brand of Moclobemide
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemid 1A Pharma
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 von ct, Moclobemid
% 215.84/215.98  |- skos__altLabel mesh__D020912 Faulding Brand of Moclobemide
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide Novopharm Brand
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemid Puren
% 215.84/215.98  |- skos__altLabel mesh__D020912 Alphapharm Brand of Moclobemide
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide ct-Arzneimittel Brand
% 215.84/215.98  |- skos__scopeNote mesh__D020912
% 215.84/215.98       A reversible inhibitor of monoamine oxidase type A; %28%RIMA%29%; %28%see MONOAMINE OXIDASE INHIBITORS%29% that has antidepressive properties.%A%    
% 215.84/215.98  |- skos__altLabel mesh__D020912 Alpharma Brand of Moclobemide
% 215.84/215.98  |- skos__altLabel mesh__D020912 Kendrick Brand of Moclobemide
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide Roche Brand
% 215.84/215.98  |- skos__altLabel mesh__D020912 Ro-11-1163
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Hoffmann La Roche Brand of Moclobemide
% 215.84/215.98  |- skos__altLabel mesh__D020912 Pharmascience Brand of Moclobemide
% 215.84/215.98  |- skos__altLabel mesh__D020912 Roche Brand of Moclobemide
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide Stadapharm Brand
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Ro 11 1163
% 215.84/215.98  |- skos__altLabel mesh__D020912 Novopharm Brand of Moclobemide
% 215.84/215.98  |- skos__altLabel mesh__D020912 Merck dura Brand of Moclobemide
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide, Chem mart
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide Alpharma Brand
% 215.84/215.98  |- skos__prefLabel mesh__D020912 Moclobemide
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemid1A Pharma
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide ratiopharm Brand
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide Apotex Brand
% 215.84/215.98  |- skos__altLabel mesh__D020912 Moclobamide
% 215.84/215.98  |- skos__broader mesh__D020912smesh__D001549
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 NovoMoclobemide
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Novo Moclobemide
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemid ratiopharm
% 215.84/215.98  |- mesh__recordAuthorizer mesh__D020912 sjn
% 215.84/215.98  |- skos__altLabel mesh__D020912 Healthsense Brand of Moclobemide
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide Hexal Brand
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide esparma Brand
% 215.84/215.98  |- skos__altLabel mesh__D020912 ratiopharm Brand of Moclobemide
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D020912 2006
% 215.84/215.98  |- skos__altLabel mesh__D020912 esparma Brand of Moclobemide
% 215.84/215.98  |- mesh__dateEstablished mesh__D020912 2000-01-01
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Moclobemide, DBL
% 215.84/215.98  |- skos__altLabel mesh__D020912 Terry White Chemists Brand of Moclobemide
% 215.84/215.98  |- skos__altLabel mesh__D020912 Hexal Brand of Moclobemide
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 NuMoclobemide
% 215.84/215.98  |- skos__altLabel mesh__D020912 Bull Brand of Moclobemide
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 Nu Pharm Brand of Moclobemide
% 215.84/215.98  |- skos__historyNote mesh__D020912 Benzamides %28%1982-1999%29%
% 215.84/215.98  |- skos__hiddenLabel mesh__D020912 PMS Moclobemide
% 215.84/215.98  |- mesh__dateEstablished mesh__D006443 1991-01-01
% 215.84/215.98  |- mesh__recordAuthorizer mesh__D006443 sjn
% 215.84/215.98  |- skos__historyNote mesh__D006443 Hemoglobins %28%1966-1976%29%
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D006443 2006
% 215.84/215.98  |- mesh__recordMaintainer mesh__D006443 sjn
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D006443 2005
% 215.84/215.98  |- mesh__publicMeSHNote mesh__D006443
% 215.84/215.98       91; was see under HEMOGLOBIN A 1979-90   
% 215.84/215.98  |- mesh__historyNote mesh__D006443
% 215.84/215.98       91%28%79%29%; was see under HEMOGLOBIN A 1979-90   
% 215.84/215.98  |- skos__annotation mesh__D006443
% 215.84/215.98       /urine: coord NIM with HEMOGLOBINURIA %28%IM%29%; DF: HBA2   
% 215.84/215.98  |- skos__broader mesh__D006443smesh__D006441
% 215.84/215.98  |- mesh__dateCreated mesh__D006443 1978-05-18
% 215.84/215.98  |- skos__hiddenLabel mesh__D006443 A2, Hemoglobin
% 215.84/215.98  |- skos__historyNote mesh__D006443 Hemoglobin A %28%1977-1978%29%
% 215.84/215.98  |- mesh__dateRevised mesh__D006443 2004-07-13
% 215.84/215.98  |- skos__scopeNote mesh__D006443
% 215.84/215.98       An adult hemoglobin component normally present in hemolysates from human erythrocytes in concentrations of about 3%25%. The hemoglobin is composed of two alpha chains and two delta chains. The percentage of HbA2 varies in some hematologic disorders, but is about double in beta-thalassemia.%A%    
% 215.84/215.98  |- skos__prefLabel mesh__D006443 Hemoglobin A2
% 215.84/215.98  |- rdf__type mesh__D006443sskos__Concept
% 215.84/215.98  |- mesh__recordOriginator mesh__D006443 RLS
% 215.84/215.98  |- skos__historyNote mesh__D020114 Rickettsia %28%1976-1998%29%
% 215.84/215.98  |- mesh__publicMeSHNote mesh__D020114 99   
% 215.84/215.98  |- mesh__historyNote mesh__D020114 99   
% 215.84/215.98  |- skos__annotation mesh__D020114 infection = BOUTONNEUSE FEVER   
% 215.84/215.98  |- mesh__recordAuthorizer mesh__D020114 sjn
% 215.84/215.98  |- mesh__dateEstablished mesh__D020114 1999-01-01
% 215.84/215.98  |- rdf__type mesh__D020114sskos__Concept
% 215.84/215.98  |- mesh__dateRevised mesh__D020114 2005-06-30
% 215.84/215.98  |- mesh__recordMaintainer mesh__D020114 SYSTEM
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D020114 2006
% 215.84/215.98  |- mesh__dateCreated mesh__D020114 1998-06-11
% 215.84/215.98  |- skos__broader mesh__D020114smesh__D012281
% 215.84/215.98  |- skos__prefLabel mesh__D020114 Rickettsia conorii
% 215.84/215.98  |- mesh__recordOriginator mesh__D020114 NDW
% 215.84/215.98  |- skos__scopeNote mesh__D020114
% 215.84/215.98       A species of gram-negative, aerobic bacteria that is the etiologic agent of BOUTONNEUSE FEVER. It resembles RICKETTSIA RICKETTSII but is antigenically distinct and less virulent for animals and man. %28%From Bergey%27%s Manual of Systematic Bacteriology, vol 1%29%%A%    
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D011388 2004
% 215.84/215.98  |- skos__broader mesh__D011388smesh__D006065
% 215.84/215.98  |- skos__hiddenLabel mesh__D011388 Pituitary Lactogenic Hormone
% 215.84/215.98  |- skos__hiddenLabel mesh__D011388 Hormone, Pituitary Lactogenic
% 215.84/215.98  |- skos__broader mesh__D011388smesh__D010908
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D011388 2005
% 215.84/215.98  |- skos__scopeNote mesh__D011388
% 215.84/215.98       A lactogenic hormone secreted by the adenohypophysis %28%PITUITARY GLAND, ANTERIOR%29%. It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate.%A%    
% 215.84/215.98  |- mesh__recordAuthorizer mesh__D011388 sjn
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D011388 2006
% 215.84/215.98  |- mesh__dateCreated mesh__D011388 1999-01-01
% 215.84/215.98  |- mesh__recordMaintainer mesh__D011388 lkt
% 215.84/215.98  |- skos__hiddenLabel mesh__D011388 Pituitary Mammotropic Hormone
% 215.84/215.98  |- skos__prefLabel mesh__D011388 Prolactin
% 215.84/215.98  |- skos__hiddenLabel mesh__D011388 Hormone, Pituitary Mammotropic
% 215.84/215.98  |- mesh__dateRevised mesh__D011388 2002-07-03
% 215.84/215.98  |- skos__altLabel mesh__D011388 Mammotropin
% 215.84/215.98  |- skos__altLabel mesh__D011388 Lactogenic Hormone, Pituitary
% 215.84/215.98  |- rdf__type mesh__D011388sskos__Concept
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D011388 2003
% 215.84/215.98  |- skos__related mesh__D011388smesh__D006966
% 215.84/215.98  |- skos__annotation mesh__D011388
% 215.84/215.98       /blood: consider also HYPERPROLACTINEMIA   
% 215.84/215.98  |- skos__related mesh__D011388smesh__D011981
% 215.84/215.98  |- skos__altLabel mesh__D011388 PRL %28%Prolactin%29%
% 215.84/215.98  |- skos__altLabel mesh__D011388 Mammotropic Hormone, Pituitary
% 215.84/215.98  |- mesh__recordOriginator mesh__D011388 NLM
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D016871 1994
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D016871 2001
% 215.84/215.98  |- mesh__dateRevised mesh__D016871 1993-06-02
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D016871 2004
% 215.84/215.98  |- mesh__dateCreated mesh__D016871 1991-05-30
% 215.84/215.98  |- mesh__recordMaintainer mesh__D016871 TAP
% 215.84/215.98  |- skos__prefLabel mesh__D016871 Pasteurellaceae Infections
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D016871 2000
% 215.84/215.98  |- mesh__publicMeSHNote mesh__D016871 92   
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D016871 2006
% 215.84/215.98  |- mesh__historyNote mesh__D016871 92   
% 215.84/215.98  |- skos__broader mesh__D016871smesh__D016905
% 215.84/215.98  |- skos__scopeNote mesh__D016871
% 215.84/215.98       Infections with bacteria of the family PASTEURELLACEAE.%A%    
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D016871 2003
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D016871 2005
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D016871 1997
% 215.84/215.98  |- skos__altLabel mesh__D016871 Infections, Pasteurellaceae
% 215.84/215.98  |- mesh__recordOriginator mesh__D016871 PXP
% 215.84/215.98  |- skos__hiddenLabel mesh__D016871 Pasteurellaceae Infection
% 215.84/215.98  |- skos__annotation mesh__D016871
% 215.84/215.98       gram-neg bact infect; GEN: avoid, prefer specifics; DF: PASTEURELLACEAE INFECT%A%  
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D016871 1999
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D016871 1996
% 215.84/215.98  |- rdf__type mesh__D016871sskos__Concept
% 215.84/215.98  |- mesh__dateEstablished mesh__D016871 1992-01-01
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D016871 1995
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D016871 1998
% 215.84/215.98  |- skos__hiddenLabel mesh__D016871 Infection, Pasteurellaceae
% 215.84/215.98  |- mesh__activeMeSHYear mesh__D016871 2002
% 215.84/215.99  |- mesh__recordAuthorizer mesh__D016871 PLS
% 215.84/215.99  |- skos__altLabel mesh__D002851 HPLC
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D002851 2003
% 215.84/215.99  |- mesh__dateRevised mesh__D002851 2002-07-03
% 215.84/215.99  |- rdf__type mesh__D002851sskos__Concept
% 215.84/215.99  |- mesh__onlineNote mesh__D002851
% 215.84/215.99       use CHROMATOGRAPHY, HIGH PRESSURE LIQUID to search CHROMATOGRAPHY, HIGH SPEED LIQUID 1976-80%A%  
% 215.84/215.99  |- skos__altLabel mesh__D002851 Chromatography, Liquid, High Pressure
% 215.84/215.99  |- skos__altLabel mesh__D002851 Chromatography, High Performance Liquid
% 215.84/215.99  |- skos__altLabel mesh__D002851 Chromatography, High Speed Liquid
% 215.84/215.99  |- mesh__dateEstablished mesh__D002851 1976-01-01
% 215.84/215.99  |- skos__prefLabel mesh__D002851 Chromatography, High Pressure Liquid
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D002851 2006
% 215.84/215.99  |- mesh__historyNote mesh__D002851
% 215.84/215.99       81; was CHROMATOGRAPHY, HIGH SPEED LIQUID 1976-80   
% 215.84/215.99  |- skos__scopeNote mesh__D002851
% 215.84/215.99       Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed.%A%    
% 215.84/215.99  |- mesh__publicMeSHNote mesh__D002851
% 215.84/215.99       81; was CHROMATOGRAPHY, HIGH SPEED LIQUID 1976-80   
% 215.84/215.99  |- mesh__dateCreated mesh__D002851 1975-07-25
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D002851 2005
% 215.84/215.99  |- mesh__recordOriginator mesh__D002851 JW
% 215.84/215.99  |- mesh__recordAuthorizer mesh__D002851 sjn
% 215.84/215.99  |- skos__annotation mesh__D002851
% 215.84/215.99       an anal chem technique; NIM; DF: note short X ref   
% 215.84/215.99  |- skos__historyNote mesh__D002851 Chromatography %28%1966-1975%29%
% 215.84/215.99  |- skos__broader mesh__D002851smesh__D002853
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D002851 2004
% 215.84/215.99  |- mesh__recordMaintainer mesh__D002851 lkt
% 215.84/215.99  |- skos__annotation mesh__D024505
% 215.84/215.99       deficiency: coordinate TOCOPHEROLS /defic %28%IM%29% with VITAMIN E DEFICIENCY %28%IM%29%%A%  
% 215.84/215.99  |- skos__altLabel mesh__D024505 Tocopherol
% 215.84/215.99  |- skos__historyNote mesh__D024505 Vitamin E %28%1963-2001%29%
% 215.84/215.99  |- mesh__dateRevised mesh__D024505 2005-06-30
% 215.84/215.99  |- mesh__recordOriginator mesh__D024505 lkt
% 215.84/215.99  |- rdf__type mesh__D024505sskos__Concept
% 215.84/215.99  |- mesh__dateCreated mesh__D024505 2001-07-25
% 215.84/215.99  |- mesh__recordAuthorizer mesh__D024505 sjn
% 215.84/215.99  |- skos__prefLabel mesh__D024505 Tocopherols
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D024505 2006
% 215.84/215.99  |- mesh__publicMeSHNote mesh__D024505 2002; see VITAMIN E 1966-2001   
% 215.84/215.99  |- mesh__recordMaintainer mesh__D024505 ssb
% 215.84/215.99  |- mesh__dateEstablished mesh__D024505 2002-01-01
% 215.84/215.99  |- skos__broader mesh__D024505smesh__D014810
% 215.84/215.99  |- mesh__historyNote mesh__D024505 2002; use VITAMIN E 1966-2001   
% 215.84/215.99  |- skos__scopeNote mesh__D024505
% 215.84/215.99       A collective name for a group of closely related lipids that contain substitutions on the 2H-1-benzopyran-6-ol nucleus and a long hydrocarbon chain of isoprenoid units. They are antioxidants by virtue of the phenolic hydrogen. Tocopherols react with the most reactive form of oxygen and protect unsaturated fatty acids from oxidation.%A%    
% 215.84/215.99  |- skos__prefLabel mesh__D002053 Burn Units
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D002053 2006
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D002053 1994
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D002053 1993
% 215.84/215.99  |- mesh__recordAuthorizer mesh__D002053 PLS
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D002053 2005
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D002053 2004
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D002053 1999
% 215.84/215.99  |- mesh__dateRevised mesh__D002053 1992-03-25
% 215.84/215.99  |- mesh__recordMaintainer mesh__D002053 TGC
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D002053 2002
% 215.84/215.99  |- skos__historyNote mesh__D002053 Intensive Care Units %28%1966-1981%29%
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D002053 2003
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D002053 1998
% 215.84/215.99  |- skos__hiddenLabel mesh__D002053 Center, Burn
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D002053 1997
% 215.84/215.99  |- skos__hiddenLabel mesh__D002053 Centers, Burn
% 215.84/215.99  |- skos__broader mesh__D002053smesh__D007362
% 215.84/215.99  |- mesh__dateCreated mesh__D002053 1981-02-26
% 215.84/215.99  |- rdf__type mesh__D002053sskos__Concept
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D002053 1996
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D002053 2001
% 215.84/215.99  |- mesh__publicMeSHNote mesh__D002053
% 215.84/215.99       91; was see under INTENSIVE CARE UNITS 1982-90   
% 215.84/215.99  |- skos__hiddenLabel mesh__D002053 Units, Burn
% 215.84/215.99  |- mesh__dateEstablished mesh__D002053 1991-01-01
% 215.84/215.99  |- mesh__historyNote mesh__D002053
% 215.84/215.99       91%28%82%29%; was see under INTENSIVE CARE UNITS 1982-90   
% 215.84/215.99  |- skos__scopeNote mesh__D002053
% 215.84/215.99       Specialized hospital facilities which provide intensive care for burn patients.%A%    
% 215.84/215.99  |- skos__hiddenLabel mesh__D002053 Burn Center
% 215.84/215.99  |- skos__hiddenLabel mesh__D002053 Burn Unit
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D002053 1995
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D002053 2000
% 215.84/215.99  |- mesh__recordOriginator mesh__D002053 EC
% 215.84/215.99  |- skos__hiddenLabel mesh__D002053 Unit, Burn
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D029799 2002
% 215.84/215.99  |- skos__broader mesh__D029799smesh__D029796
% 215.84/215.99  |- mesh__dateEstablished mesh__D029799 2002-01-01
% 215.84/215.99  |- mesh__dateCreated mesh__D029799 2001-07-25
% 215.84/215.99  |- skos__scopeNote mesh__D029799
% 215.84/215.99       A plant species of the family VACCINIUM known for the sour fruit which is sometimes used for urinary tract infections.%A%    
% 215.84/215.99  |- skos__annotation mesh__D029799
% 215.84/215.99       distinguish from Highbush Cranberry = VIBURNUM; specify Plant Components; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.84/215.99  |- skos__altLabel mesh__D029799 Cranberries
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D029799 2005
% 215.84/215.99  |- skos__prefLabel mesh__D029799 Vaccinium macrocarpon
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D029799 2006
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D029799 2003
% 215.84/215.99  |- mesh__historyNote mesh__D029799 2002   
% 215.84/215.99  |- rdf__type mesh__D029799sskos__Concept
% 215.84/215.99  |- mesh__publicMeSHNote mesh__D029799 2002   
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D029799 2004
% 215.84/215.99  |- rdf__type mesh__D001759sskos__Concept
% 215.84/215.99  |- skos__prefLabel mesh__D001759 Blastomycosis
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D001759 2005
% 215.84/215.99  |- skos__scopeNote mesh__D001759
% 215.84/215.99       A fungal infection that may appear in two forms: 1, a primary lesion characterized by the formation of a small cutaneous nodule and small nodules along the lymphatics that may heal within several months; and 2, chronic granulomatous lesions characterized by thick crusts, warty growths, and unusual vascularity and infection in the middle or upper lobes of the lung.%A%    
% 215.84/215.99  |- skos__broader mesh__D001759smesh__D009181
% 215.84/215.99  |- mesh__dateCreated mesh__D001759 1999-01-01
% 215.84/215.99  |- mesh__recordOriginator mesh__D001759 NLM
% 215.84/215.99  |- skos__broader mesh__D001759smesh__D003881
% 215.84/215.99  |- skos__annotation mesh__D001759
% 215.84/215.99       fungus dis; do not confuse X ref BLASTOMYCOSIS, NORTH AMERICAN with BLASTOMYCOSIS, SOUTH AMERICAN see PARACOCCIDIOIDOMYCOSIS%A%  
% 215.84/215.99  |- mesh__recordAuthorizer mesh__D001759 sjn
% 215.84/215.99  |- mesh__dateRevised mesh__D001759 2004-07-07
% 215.84/215.99  |- mesh__recordMaintainer mesh__D001759 wdj
% 215.84/215.99  |- skos__hiddenLabel mesh__D001759 North American Blastomycosis
% 215.84/215.99  |- skos__hiddenLabel mesh__D001759 Blastomycoses
% 215.84/215.99  |- mesh__activeMeSHYear mesh__D001759 2006
% 215.84/215.99  |- skos__broader mesh__D012481smesh__D000820
% 215.84/215.99  |- skos__broader mesh__D012481smesh__D012480
% 215.84/215.99  |- skos__hiddenLabel mesh__D012481 Infection, Animal Salmonella
% 215.84/215.99  |- skos__prefLabel mesh__D012481 Salmonella Infections, Animal
% 215.84/215.99  |- mesh__dateRevised mesh__D012481 2003-07-30
% 215.84/215.99  |- rdf__type mesh__D012481sskos__Concept
% 215.84/215.99  |- skos__hiddenLabel mesh__D012481 Infections, Animal Salmonella
% 215.84/215.99  |- mesh__recordMaintainer mesh__D012481 ags
% 215.84/215.99  |- skos__scopeNote mesh__D012481
% 215.84/215.99       Infections in animals with bacteria of the genus SALMONELLA.%A%    
% 215.84/215.99  |- mesh__recordAuthorizer mesh__D012481 sjn
% 215.84/215.99  |- skos__annotation mesh__D012481
% 215.84/215.99       exper or vet; don%27%t forget to check tag ANIMALS   
% 215.84/215.99  |- skos__hiddenLabel mesh__D012481 Animal Salmonella Infection
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D012481 2005
% 215.85/215.99  |- skos__hiddenLabel mesh__D012481 Animal Salmonella Infections
% 215.85/215.99  |- skos__hiddenLabel mesh__D012481 Salmonella Infection, Animal
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D012481 2004
% 215.85/215.99  |- mesh__dateCreated mesh__D012481 1999-01-01
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D012481 2006
% 215.85/215.99  |- mesh__recordOriginator mesh__D012481 NLM
% 215.85/215.99  |- mesh__dateCreated mesh__D020913 1999-11-05
% 215.85/215.99  |- skos__scopeNote mesh__D020913
% 215.85/215.99       An angiotensin-converting enzyme inhibitor. It is used in patients with hypertension and heart failure.%A%    
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D020913 2006
% 215.85/215.99  |- skos__historyNote mesh__D020913 Indoles %28%1985-1999%29%
% 215.85/215.99  |- skos__hiddenLabel mesh__D020913 Erbumine, Perindopril
% 215.85/215.99  |- mesh__recordOriginator mesh__D020913 adp
% 215.85/215.99  |- rdf__type mesh__D020913sskos__Concept
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D020913 2002
% 215.85/215.99  |- mesh__dateRevised mesh__D020913 2000-06-22
% 215.85/215.99  |- skos__hiddenLabel mesh__D020913 S 94903
% 215.85/215.99  |- skos__broader mesh__D020913smesh__D007211
% 215.85/215.99  |- skos__altLabel mesh__D020913 S 9490-3
% 215.85/215.99  |- mesh__recordMaintainer mesh__D020913 TWD
% 215.85/215.99  |- skos__hiddenLabel mesh__D020913 S 9490
% 215.85/215.99  |- mesh__publicMeSHNote mesh__D020913
% 215.85/215.99       2000; PERINDOPRIL was indexed under INDOLES 1985-1999   
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D020913 2003
% 215.85/215.99  |- skos__hiddenLabel mesh__D020913 S9490
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D020913 2004
% 215.85/215.99  |- skos__prefLabel mesh__D020913 Perindopril
% 215.85/215.99  |- skos__hiddenLabel mesh__D020913 S 9490 3
% 215.85/215.99  |- mesh__dateEstablished mesh__D020913 2000-01-01
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D020913 2005
% 215.85/215.99  |- mesh__historyNote mesh__D020913
% 215.85/215.99       2000; use PERINDOPRIL %28%NM%29% 1985-1999   
% 215.85/215.99  |- skos__altLabel mesh__D020913 Pirindopril
% 215.85/215.99  |- mesh__recordAuthorizer mesh__D020913 sjn
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D020913 2001
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D006444 2005
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D006444 2004
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D006444 2001
% 215.85/215.99  |- skos__annotation mesh__D006444
% 215.85/215.99       /urine: coord IM with HEMOGLOBINURIA %28%IM%29%; DF: HBC   
% 215.85/215.99  |- skos__broader mesh__D006444smesh__D006455
% 215.85/215.99  |- mesh__recordMaintainer mesh__D006444 adp
% 215.85/215.99  |- mesh__recordOriginator mesh__D006444 NLM
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D006444 2003
% 215.85/215.99  |- mesh__dateCreated mesh__D006444 1999-01-01
% 215.85/215.99  |- rdf__type mesh__D006444sskos__Concept
% 215.85/215.99  |- mesh__recordAuthorizer mesh__D006444 sjn
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D006444 2002
% 215.85/215.99  |- skos__scopeNote mesh__D006444
% 215.85/215.99       A commonly occurring abnormal hemoglobin in which lysine replaces a glutamic acid residue at the sixth position of the beta chains. It results in reduced plasticity of erythrocytes.%A%    
% 215.85/215.99  |- mesh__dateRevised mesh__D006444 2000-06-21
% 215.85/215.99  |- skos__hiddenLabel mesh__D006444 C, Hemoglobin
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D006444 2006
% 215.85/215.99  |- skos__prefLabel mesh__D006444 Hemoglobin C
% 215.85/215.99  |- mesh__dateRevised mesh__D020115 2003-07-09
% 215.85/215.99  |- skos__altLabel mesh__D020115 Progastricsin
% 215.85/215.99  |- skos__scopeNote mesh__D020115
% 215.85/215.99       This is one of the 2 related pepsinogen systems in humans. It is found in prostate and seminal fluid whereas PEPSINOGEN A is not.%A%    
% 215.85/215.99  |- mesh__historyNote mesh__D020115 99; use PEPSINOGENS 1987-98   
% 215.85/215.99  |- skos__prefLabel mesh__D020115 Pepsinogen C
% 215.85/215.99  |- skos__altLabel mesh__D020115 Pepsinogen II
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D020115 2006
% 215.85/215.99  |- mesh__dateEstablished mesh__D020115 1999-01-01
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D020115 2004
% 215.85/215.99  |- skos__historyNote mesh__D020115 Pepsinogens %28%1972-1998%29%
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D020115 2005
% 215.85/215.99  |- skos__broader mesh__D020115smesh__D010435
% 215.85/215.99  |- mesh__publicMeSHNote mesh__D020115 99   
% 215.85/215.99  |- mesh__dateCreated mesh__D020115 1998-06-10
% 215.85/215.99  |- rdf__type mesh__D020115sskos__Concept
% 215.85/215.99  |- mesh__dateEstablished mesh__D044563 2004-01-01
% 215.85/215.99  |- skos__broader mesh__D044563smesh__D012316
% 215.85/215.99  |- mesh__historyNote mesh__D044563 2004; use RNA, CATALYTIC 1991-2003   
% 215.85/215.99  |- skos__broader mesh__D044563smesh__D016337
% 215.85/215.99  |- skos__altLabel mesh__D044563 Self-Splicing Ribosomal RNA
% 215.85/215.99  |- mesh__dateCreated mesh__D044563 2003-07-09
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D044563 2005
% 215.85/215.99  |- mesh__publicMeSHNote mesh__D044563 2004; see RNA, CATALYTIC 1991-2003   
% 215.85/215.99  |- skos__prefLabel mesh__D044563 RNA, Ribosomal, Self-Splicing
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D044563 2006
% 215.85/215.99  |- skos__broader mesh__D044563smesh__D012335
% 215.85/215.99  |- skos__hiddenLabel mesh__D044563 Self Splicing Ribosomal RNA
% 215.85/215.99  |- skos__historyNote mesh__D044563 RNA, Catalytic %28%1991-2003%29%
% 215.85/215.99  |- rdf__type mesh__D044563sskos__Concept
% 215.85/215.99  |- skos__hiddenLabel mesh__D044563 RNA, Self-Splicing Ribosomal
% 215.85/215.99  |- skos__scopeNote mesh__D044563
% 215.85/215.99       Components of ribosomal RNA that undergo auto-catalyzed molecular rearrangements of their RNA sequence.%A%    
% 215.85/215.99  |- skos__hiddenLabel mesh__D044563 Ribosomal RNA, Self-Splicing
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D044563 2004
% 215.85/215.99  |- mesh__publicMeSHNote mesh__D011389 75   
% 215.85/215.99  |- skos__prefLabel mesh__D011389 Prolactin Release-Inhibiting Hormone
% 215.85/215.99  |- mesh__recordAuthorizer mesh__D011389 sjn
% 215.85/215.99  |- skos__historyNote mesh__D011389 Prolactin %28%1968-1974%29%
% 215.85/215.99  |- skos__scopeNote mesh__D011389
% 215.85/215.99       A polypeptide hormone produced in the HYPOTHALAMUS that inhibits the release of PROLACTIN.%A%    
% 215.85/215.99  |- skos__historyNote mesh__D011389
% 215.85/215.99       Pituitary Hormone Releasing Hormones %28%1968-1974%29%
% 215.85/215.99  |- skos__annotation mesh__D011389 DF: PRIH   
% 215.85/215.99  |- mesh__dateRevised mesh__D011389 2005-06-30
% 215.85/215.99  |- skos__hiddenLabel mesh__D011389 Hormone, Prolactin Release-Inhibiting
% 215.85/215.99  |- mesh__dateCreated mesh__D011389 1974-11-11
% 215.85/215.99  |- mesh__recordMaintainer mesh__D011389 ssb
% 215.85/215.99  |- skos__broader mesh__D011389smesh__D009479
% 215.85/215.99  |- skos__hiddenLabel mesh__D011389 Release-Inhibiting Hormone, Prolactin
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D011389 2006
% 215.85/215.99  |- skos__altLabel mesh__D011389 Prolactin Release Inhibiting Hormone
% 215.85/215.99  |- mesh__historyNote mesh__D011389 75   
% 215.85/215.99  |- rdf__type mesh__D011389sskos__Concept
% 215.85/215.99  |- skos__broader mesh__D011389smesh__D010905
% 215.85/215.99  |- mesh__recordOriginator mesh__D011389 NLM
% 215.85/215.99  |- mesh__dateEstablished mesh__D011389 1975-09-01
% 215.85/215.99  |- skos__hiddenLabel mesh__D002852 Chromatographies, Ion-Exchange
% 215.85/215.99  |- skos__hiddenLabel mesh__D002852 Ion Exchange Chromatography
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D002852 2006
% 215.85/215.99  |- mesh__recordAuthorizer mesh__D002852 sjn
% 215.85/215.99  |- mesh__dateCreated mesh__D002852 1999-01-01
% 215.85/215.99  |- mesh__recordMaintainer mesh__D002852 lkt
% 215.85/215.99  |- skos__hiddenLabel mesh__D002852 Ion Exchange Chromatographies
% 215.85/215.99  |- skos__hiddenLabel mesh__D002852 Chromatographies, Ion Exchange
% 215.85/215.99  |- skos__altLabel mesh__D002852 Ion-Exchange Chromatography
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D002852 2005
% 215.85/215.99  |- skos__broader mesh__D002852smesh__D002853
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D002852 2004
% 215.85/215.99  |- mesh__dateRevised mesh__D002852 2002-07-03
% 215.85/215.99  |- mesh__recordOriginator mesh__D002852 NLM
% 215.85/215.99  |- skos__prefLabel mesh__D002852 Chromatography, Ion Exchange
% 215.85/215.99  |- mesh__dateEstablished mesh__D002852 1966-01-01
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D002852 2003
% 215.85/215.99  |- rdf__type mesh__D002852sskos__Concept
% 215.85/215.99  |- skos__scopeNote mesh__D002852
% 215.85/215.99       Separation technique in which the stationary phase consists of ion exchange resins. The resins contain loosely held small ions that easily exchange places with other small ions of like charge present in solutions washed over the resins.%A%    
% 215.85/215.99  |- skos__altLabel mesh__D002852 Chromatography, Ion-Exchange
% 215.85/215.99  |- skos__hiddenLabel mesh__D002852 Ion-Exchange Chromatographies
% 215.85/215.99  |- skos__annotation mesh__D002852
% 215.85/215.99       an anal chem technique; NIM; DF: CHROMATOGR ION EXCHANGE   
% 215.85/215.99  |- mesh__publicMeSHNote mesh__D002852 66   
% 215.85/215.99  |- mesh__historyNote mesh__D002852 66   
% 215.85/215.99  |- skos__prefLabel mesh__D024506 5%27% Flanking Region
% 215.85/215.99  |- mesh__dateEstablished mesh__D024506 2002-01-01
% 215.85/215.99  |- mesh__recordMaintainer mesh__D024506 nns
% 215.85/215.99  |- skos__related mesh__D024506smesh__D020121
% 215.85/215.99  |- skos__hiddenLabel mesh__D024506 Flanking Sequence, 5%27%
% 215.85/215.99  |- mesh__recordOriginator mesh__D024506 nns
% 215.85/215.99  |- skos__broader mesh__D024506smesh__D040461
% 215.85/215.99  |- skos__broader mesh__D024506smesh__D021901
% 215.85/215.99  |- skos__hiddenLabel mesh__D024506 Flanking Sequences, 5%27%
% 215.85/215.99  |- skos__hiddenLabel mesh__D024506 Regions, 5%27% Flanking
% 215.85/215.99  |- mesh__dateCreated mesh__D024506 2001-07-25
% 215.85/215.99  |- skos__scopeNote mesh__D024506
% 215.85/215.99       The region of DNA which borders the 5%27% end of a transcription unit and where a variety of regulatory sequences are located.%A%    
% 215.85/215.99  |- rdf__type mesh__D024506sskos__Concept
% 215.85/215.99  |- skos__hiddenLabel mesh__D024506 5%27% Flanking Sequences
% 215.85/215.99  |- skos__hiddenLabel mesh__D024506 5%27% Flanking Regions
% 215.85/215.99  |- skos__hiddenLabel mesh__D024506 Sequences, 5%27% Flanking
% 215.85/215.99  |- mesh__dateRevised mesh__D024506 2005-06-30
% 215.85/215.99  |- skos__hiddenLabel mesh__D024506 Region, 5%27% Flanking
% 215.85/215.99  |- skos__altLabel mesh__D024506 5%27% Flanking Sequence
% 215.85/215.99  |- skos__annotation mesh__D024506
% 215.85/215.99       do not confuse with 5%27% UNTRANSLATED REGIONS   
% 215.85/215.99  |- mesh__historyNote mesh__D024506 2002   
% 215.85/215.99  |- skos__hiddenLabel mesh__D024506 Flanking Regions, 5%27%
% 215.85/215.99  |- skos__altLabel mesh__D024506 Flanking Region, 5%27%
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D024506 2006
% 215.85/215.99  |- mesh__recordAuthorizer mesh__D024506 sjn
% 215.85/215.99  |- mesh__publicMeSHNote mesh__D024506 2002   
% 215.85/215.99  |- skos__hiddenLabel mesh__D024506 Sequence, 5%27% Flanking
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D002054 2003
% 215.85/215.99  |- skos__annotation mesh__D002054
% 215.85/215.99       %22%painful oral symptoms assoc with a burning sensation%22%   
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D002054 2006
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D002054 1998
% 215.85/215.99  |- skos__historyNote mesh__D002054 Mouth Diseases %28%1966-1967%29%
% 215.85/215.99  |- mesh__recordMaintainer mesh__D002054 TGC
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D002054 2001
% 215.85/215.99  |- mesh__recordAuthorizer mesh__D002054 PLS
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D002054 2004
% 215.85/215.99  |- mesh__dateEstablished mesh__D002054 1991-01-01
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D002054 1996
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D002054 1999
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D002054 2002
% 215.85/215.99  |- mesh__publicMeSHNote mesh__D002054
% 215.85/215.99       91; was see under MOUTH DISEASES 1968-90   
% 215.85/215.99  |- mesh__recordOriginator mesh__D002054 NLM
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D002054 1997
% 215.85/215.99  |- mesh__historyNote mesh__D002054
% 215.85/215.99       91%28%68%29%; was see under MOUTH DISEASES 1968-90   
% 215.85/215.99  |- skos__hiddenLabel mesh__D002054 Mouth Syndrome, Burning
% 215.85/215.99  |- skos__prefLabel mesh__D002054 Burning Mouth Syndrome
% 215.85/215.99  |- skos__hiddenLabel mesh__D002054 Syndrome, Burning Mouth
% 215.85/215.99  |- mesh__dateRevised mesh__D002054 1994-05-24
% 215.85/215.99  |- skos__hiddenLabel mesh__D002054 Mouth Syndromes, Burning
% 215.85/215.99  |- rdf__type mesh__D002054sskos__Concept
% 215.85/215.99  |- skos__hiddenLabel mesh__D002054 Burning Mouth Syndromes
% 215.85/215.99  |- skos__broader mesh__D002054smesh__D009059
% 215.85/215.99  |- mesh__dateCreated mesh__D002054 1999-01-01
% 215.85/215.99  |- skos__scopeNote mesh__D002054
% 215.85/215.99       A group of painful oral symptoms associated with a burning or similar sensation. There is usually a significant organic component with a degree of functional overlay; it is not limited to the psychophysiologic group of disorders.%A%    
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D002054 2005
% 215.85/215.99  |- skos__hiddenLabel mesh__D002054 Syndromes, Burning Mouth
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D002054 1995
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D002054 2000
% 215.85/215.99  |- rdf__type mesh__D012482sskos__Concept
% 215.85/215.99  |- mesh__historyNote mesh__D012482
% 215.85/215.99       1976; for SALMONELLA PARATYPHI use SALMONELLA PARATYPHI 1963-1975%A%  
% 215.85/215.99  |- mesh__recordOriginator mesh__D012482 NLM
% 215.85/215.99  |- mesh__recordMaintainer mesh__D012482 SYSTEM
% 215.85/215.99  |- mesh__publicMeSHNote mesh__D012482
% 215.85/215.99       1976; for SALMONELLA PARATYPHI see SALMONELLA PARATYPHI 1963-1975%A%  
% 215.85/215.99  |- skos__broader mesh__D012482smesh__D019779
% 215.85/215.99  |- mesh__recordAuthorizer mesh__D012482 sjn
% 215.85/215.99  |- mesh__dateCreated mesh__D012482 1999-01-01
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D012482 2006
% 215.85/215.99  |- skos__altLabel mesh__D012482 Salmonella paratyphi
% 215.85/215.99  |- mesh__dateRevised mesh__D012482 2005-06-30
% 215.85/215.99  |- skos__prefLabel mesh__D012482 Salmonella paratyphi A
% 215.85/215.99  |- skos__annotation mesh__D012482
% 215.85/215.99       infection: coord IM with PARATYPHOID FEVER %28%IM%29%   
% 215.85/215.99  |- skos__scopeNote mesh__D012482
% 215.85/215.99       A serotype of SALMONELLA ENTERICA that causes mild PARATYPHOID FEVER in humans.%A%    
% 215.85/215.99  |- skos__altLabel mesh__D012482 Salmonella enterica serovar Paratyphi A
% 215.85/215.99  |- skos__hiddenLabel mesh__D020914 Myopathy, Congenital Non-Progressive
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D020914 2004
% 215.85/215.99  |- skos__hiddenLabel mesh__D020914 Aggregate Myopathy, Tubular
% 215.85/215.99  |- mesh__recordMaintainer mesh__D020914 ags
% 215.85/215.99  |- skos__hiddenLabel mesh__D020914 Structural Myopathy, Congenital
% 215.85/215.99  |- skos__historyNote mesh__D020914 Neuromuscular Diseases %28%1976-1999%29%
% 215.85/215.99  |- skos__hiddenLabel mesh__D020914 Myopathies, Centronuclear
% 215.85/215.99  |- skos__hiddenLabel mesh__D020914 Congenital Structural Myopathy
% 215.85/215.99  |- mesh__historyNote mesh__D020914 2000   
% 215.85/215.99  |- skos__altLabel mesh__D020914 Congenital Structural Myopathies
% 215.85/215.99  |- skos__hiddenLabel mesh__D020914 Myotubular Myopathies
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D020914 2005
% 215.85/215.99  |- skos__hiddenLabel mesh__D020914 Tubular Aggregate Myopathies
% 215.85/215.99  |- skos__hiddenLabel mesh__D020914 Myopathy, Tubular Aggregate
% 215.85/215.99  |- skos__hiddenLabel mesh__D020914 Myopathies, Congenital Non-Progressive
% 215.85/215.99  |- skos__historyNote mesh__D020914 Muscular Atrophy %28%1976-1999%29%
% 215.85/215.99  |- skos__hiddenLabel mesh__D020914 Myopathies, Tubular Aggregate
% 215.85/215.99  |- skos__altLabel mesh__D020914 Structural Myopathies, Congenital
% 215.85/215.99  |- skos__altLabel mesh__D020914 Congenital Non-Progressive Myopathies
% 215.85/215.99  |- skos__altLabel mesh__D020914 Non-Progressive Myopathies, Congenital
% 215.85/215.99  |- mesh__dateEstablished mesh__D020914 2000-01-01
% 215.85/215.99  |- skos__broader mesh__D020914smesh__D009135
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D020914 2006
% 215.85/215.99  |- skos__hiddenLabel mesh__D020914 Myotubular Myopathy
% 215.85/215.99  |- skos__hiddenLabel mesh__D020914 Aggregate Myopathies, Tubular
% 215.85/215.99  |- mesh__dateCreated mesh__D020914 1999-11-09
% 215.85/215.99  |- skos__hiddenLabel mesh__D020914 Myopathy, Congenital Structural
% 215.85/215.99  |- skos__hiddenLabel mesh__D020914 Non Progressive Myopathies, Congenital
% 215.85/215.99  |- skos__hiddenLabel mesh__D020914 Centronuclear Myopathies
% 215.85/215.99  |- mesh__recordAuthorizer mesh__D020914 sjn
% 215.85/215.99  |- mesh__dateRevised mesh__D020914 2001-07-25
% 215.85/215.99  |- skos__hiddenLabel mesh__D020914 Myopathies, Myotubular
% 215.85/215.99  |- skos__hiddenLabel mesh__D020914 Myopathy, Centronuclear
% 215.85/215.99  |- skos__altLabel mesh__D020914 Myopathy, Myotubular
% 215.85/215.99  |- skos__hiddenLabel mesh__D020914 Myopathies, Congenital Structural
% 215.85/215.99  |- rdf__type mesh__D020914sskos__Concept
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D020914 2003
% 215.85/215.99  |- skos__hiddenLabel mesh__D020914 Congenital Non-Progressive Myopathy
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D020914 2002
% 215.85/215.99  |- skos__prefLabel mesh__D020914 Myopathies, Structural, Congenital
% 215.85/215.99  |- skos__hiddenLabel mesh__D020914 Non-Progressive Myopathy, Congenital
% 215.85/215.99  |- mesh__publicMeSHNote mesh__D020914 2000   
% 215.85/215.99  |- skos__hiddenLabel mesh__D020914 Congenital Non Progressive Myopathies
% 215.85/215.99  |- skos__scopeNote mesh__D020914
% 215.85/215.99       A heterogeneous group of diseases characterized by the early onset of hypotonia, developmental delay of motor skills, non-progressive weakness. Each of these disorders is associated with a specific histologic muscle fiber abnormality.%A%    
% 215.85/215.99  |- mesh__recordOriginator mesh__D020914 KEV
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D006445 2003
% 215.85/215.99  |- mesh__historyNote mesh__D006445 72%28%66%29%   
% 215.85/215.99  |- skos__hiddenLabel mesh__D006445 Diseases, Hemoglobin C
% 215.85/215.99  |- mesh__dateCreated mesh__D006445 1999-01-01
% 215.85/215.99  |- skos__annotation mesh__D006445
% 215.85/215.99       a congen hemolytic anemia; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; do not confuse with HEMOGLOBIN SC DISEASE%A%  
% 215.85/215.99  |- mesh__publicMeSHNote mesh__D006445 72   
% 215.85/215.99  |- skos__broader mesh__D006445smesh__D000745
% 215.85/215.99  |- rdf__type mesh__D006445sskos__Concept
% 215.85/215.99  |- mesh__dateEstablished mesh__D006445 1972-01-01
% 215.85/215.99  |- mesh__recordOriginator mesh__D006445 NLM
% 215.85/215.99  |- skos__hiddenLabel mesh__D006445 C Diseases, Hemoglobin
% 215.85/215.99  |- skos__hiddenLabel mesh__D006445 C Disease, Hemoglobin
% 215.85/215.99  |- skos__scopeNote mesh__D006445
% 215.85/215.99       A disease characterized by compensated hemolysis with a normal hemoglobin level or a mild to moderate anemia. There may be intermittent abdominal discomfort, splenomegaly, and slight jaundice.%A%    
% 215.85/215.99  |- mesh__recordMaintainer mesh__D006445 nns
% 215.85/215.99  |- mesh__activeMeSHYear mesh__D006445 2006
% 215.85/215.99  |- skos__prefLabel mesh__D006445 Hemoglobin C Disease
% 215.85/215.99  |- skos__hiddenLabel mesh__D006445 Disease, Hemoglobin C
% 215.85/215.99  |- skos__broader mesh__D006445smesh__D006453
% 215.85/216.00  |- mesh__recordAuthorizer mesh__D006445 sjn
% 215.85/216.00  |- skos__hiddenLabel mesh__D006445 Hemoglobin C Diseases
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D006445 2005
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D006445 2004
% 215.85/216.00  |- mesh__dateRevised mesh__D006445 2001-07-25
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D006445 2002
% 215.85/216.00  |- skos__broader mesh__D020116smesh__D010435
% 215.85/216.00  |- skos__scopeNote mesh__D020116
% 215.85/216.00       This is one of 2 related pepsinogen systems in humans and is also known as pepsinogen. %28%The other is PEPSINOGEN C.%29% This includes isozymogens Pg1-Pg5 %28%pepsinogens 1-5, group I or products of PGA1-PGA5 genes%29%. This is the main pepsinogen found in urine.%A%    
% 215.85/216.00  |- mesh__publicMeSHNote mesh__D020116
% 215.85/216.00       99; for PEPSINOGEN see PEPSINOGEN 1972-98; UROPEPSINOGEN was indexed under PEPSINOGEN 1978-98%A%  
% 215.85/216.00  |- skos__altLabel mesh__D020116 Pepsinogen
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D020116 2005
% 215.85/216.00  |- skos__prefLabel mesh__D020116 Pepsinogen A
% 215.85/216.00  |- mesh__historyNote mesh__D020116
% 215.85/216.00       99; for PEPSINOGEN use PEPSINOGENS 1972-98; for UROPEPSINOGEN use PEPSINOGEN A %28%NM%29% 1978-98%A%  
% 215.85/216.00  |- mesh__dateCreated mesh__D020116 1998-06-10
% 215.85/216.00  |- mesh__dateEstablished mesh__D020116 1999-01-01
% 215.85/216.00  |- rdf__type mesh__D020116sskos__Concept
% 215.85/216.00  |- skos__altLabel mesh__D020116 Uropepsinogen
% 215.85/216.00  |- mesh__dateRevised mesh__D020116 2003-07-09
% 215.85/216.00  |- skos__altLabel mesh__D020116 Pepsinogen I
% 215.85/216.00  |- skos__historyNote mesh__D020116 Pepsinogens %28%1980-1998%29%
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D020116 2006
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D020116 2004
% 215.85/216.00  |- skos__historyNote mesh__D016873
% 215.85/216.00       Rickettsiaceae Infections %28%1975-1991%29%
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D016873 2006A
% 215.85/216.00  |- skos__hiddenLabel mesh__D016873 Ehrlichioses
% 215.85/216.00  |- mesh__recordMaintainer mesh__D016873 ags
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D016873 2006
% 215.85/216.00  |- mesh__historyNote mesh__D016873 92   
% 215.85/216.00  |- mesh__dateEstablished mesh__D016873 1992-01-01
% 215.85/216.00  |- skos__broader mesh__D016873smesh__D000711
% 215.85/216.00  |- mesh__recordAuthorizer mesh__D016873 ags
% 215.85/216.00  |- skos__scopeNote mesh__D016873
% 215.85/216.00       A tick-borne disease characterized by FEVER; HEADACHE; myalgias; ANOREXIA; and occasionally RASH. It is caused by several bacterial species and can produce disease in DOGS; CATTLE; SHEEP; GOATS; HORSES; and humans. The primary species causing human disease are EHRLICHIA CHAFFEENSIS; ANAPLASMA PHAGOCYTOPHILUM; and Ehrlichia ewingii.%A%    
% 215.85/216.00  |- mesh__dateCreated mesh__D016873 1991-05-30
% 215.85/216.00  |- rdf__type mesh__D016873sskos__Concept
% 215.85/216.00  |- skos__broader mesh__D016873smesh__D017282
% 215.85/216.00  |- mesh__recordOriginator mesh__D016873 PXP
% 215.85/216.00  |- skos__historyNote mesh__D016873 Ehrlichia %28%1975-1991%29%
% 215.85/216.00  |- mesh__dateRevised mesh__D016873 2005-07-13
% 215.85/216.00  |- skos__prefLabel mesh__D016873 Ehrlichiosis
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D016873 2005
% 215.85/216.00  |- mesh__publicMeSHNote mesh__D016873 92   
% 215.85/216.00  |- mesh__recordOriginator mesh__D002853 JW
% 215.85/216.00  |- mesh__historyNote mesh__D002853 76   
% 215.85/216.00  |- skos__prefLabel mesh__D002853 Chromatography, Liquid
% 215.85/216.00  |- skos__historyNote mesh__D002853 Chromatography %28%1966-1975%29%
% 215.85/216.00  |- mesh__recordMaintainer mesh__D002853 lkt
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002853 2006
% 215.85/216.00  |- skos__scopeNote mesh__D002853
% 215.85/216.00       Chromatographic techniques in which the mobile phase is a liquid.%A%    
% 215.85/216.00  |- mesh__dateCreated mesh__D002853 1975-07-25
% 215.85/216.00  |- skos__altLabel mesh__D002853 Liquid Chromatography
% 215.85/216.00  |- mesh__dateEstablished mesh__D002853 1976-01-01
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002853 2005
% 215.85/216.00  |- skos__broader mesh__D002853smesh__D002845
% 215.85/216.00  |- mesh__publicMeSHNote mesh__D002853 76   
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002853 2004
% 215.85/216.00  |- rdf__type mesh__D002853sskos__Concept
% 215.85/216.00  |- mesh__dateRevised mesh__D002853 2002-07-03
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002853 2003
% 215.85/216.00  |- skos__annotation mesh__D002853
% 215.85/216.00       an anal chem technique; NIM; DF: CHROMATOGR LIQUID   
% 215.85/216.00  |- mesh__recordAuthorizer mesh__D002853 sjn
% 215.85/216.00  |- skos__altLabel mesh__D024507 Non-muscle Myosin Type IIA
% 215.85/216.00  |- mesh__historyNote mesh__D024507 2002   
% 215.85/216.00  |- skos__hiddenLabel mesh__D024507 Myosin Type IIA, Non Muscle
% 215.85/216.00  |- skos__altLabel mesh__D024507 Myosin IIA
% 215.85/216.00  |- mesh__recordAuthorizer mesh__D024507 sjn
% 215.85/216.00  |- skos__altLabel mesh__D024507 Myosin A
% 215.85/216.00  |- skos__scopeNote mesh__D024507
% 215.85/216.00       A nonmuscle isoform of myosin type II found predominantly in platelets, lymphocytes, neutrophils and brush border enterocytes.%A%    
% 215.85/216.00  |- skos__prefLabel mesh__D024507 Nonmuscle Myosin Type IIA
% 215.85/216.00  |- rdf__type mesh__D024507sskos__Concept
% 215.85/216.00  |- skos__hiddenLabel mesh__D024507 Non muscle Myosin Type IIA
% 215.85/216.00  |- mesh__recordOriginator mesh__D024507 jmp
% 215.85/216.00  |- skos__broader mesh__D024507smesh__D024462
% 215.85/216.00  |- mesh__dateCreated mesh__D024507 2001-07-25
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D024507 2006
% 215.85/216.00  |- mesh__publicMeSHNote mesh__D024507 2002   
% 215.85/216.00  |- skos__altLabel mesh__D024507 Myosin Type IIA, Non-Muscle
% 215.85/216.00  |- mesh__recordMaintainer mesh__D024507 DRC
% 215.85/216.00  |- skos__historyNote mesh__D024507 Myosin %28%1997-2001%29%
% 215.85/216.00  |- mesh__dateEstablished mesh__D024507 2002-01-01
% 215.85/216.00  |- mesh__dateRevised mesh__D024507 2005-06-30
% 215.85/216.00  |- mesh__dateRevised mesh__D002055 1997-06-20
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002055 2004
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002055 1999
% 215.85/216.00  |- skos__hiddenLabel mesh__D002055 Professional Burnout
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002055 2000
% 215.85/216.00  |- mesh__recordMaintainer mesh__D002055 JLS
% 215.85/216.00  |- skos__scopeNote mesh__D002055
% 215.85/216.00       An excessive stress reaction to one%27%s occupational or professional environment. It is manifested by feelings of emotional and physical exhaustion coupled with a sense of frustration and failure.%A%    
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002055 2001
% 215.85/216.00  |- mesh__historyNote mesh__D002055
% 215.85/216.00       90%28%83%29%; was see under STRESS, PSYCHOLOGICAL 1983-89   
% 215.85/216.00  |- mesh__recordOriginator mesh__D002055 EC
% 215.85/216.00  |- skos__prefLabel mesh__D002055 Burnout, Professional
% 215.85/216.00  |- rdf__type mesh__D002055sskos__Concept
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002055 2002
% 215.85/216.00  |- mesh__dateCreated mesh__D002055 1982-04-27
% 215.85/216.00  |- skos__historyNote mesh__D002055 Stress, Psychological %28%1969-1982%29%
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002055 2005
% 215.85/216.00  |- skos__broader mesh__D002055smesh__D013315
% 215.85/216.00  |- mesh__dateEstablished mesh__D002055 1990-01-01
% 215.85/216.00  |- skos__annotation mesh__D002055
% 215.85/216.00       use Cat F3 qualif %26% even those with discretion   
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002055 2006
% 215.85/216.00  |- mesh__recordAuthorizer mesh__D002055 SJN
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002055 2003
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002055 1998
% 215.85/216.00  |- mesh__publicMeSHNote mesh__D002055
% 215.85/216.00       90; was see under STRESS, PSYCHOLOGICAL 1983-89   
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D012483 1993
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D012483 2003
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D012483 2001
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D012483 1995
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D012483 2005
% 215.85/216.00  |- mesh__dateRevised mesh__D012483 1992-05-22
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D012483 2004
% 215.85/216.00  |- mesh__dateCreated mesh__D012483 1999-01-01
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D012483 2006
% 215.85/216.00  |- mesh__recordMaintainer mesh__D012483 AGS
% 215.85/216.00  |- skos__annotation mesh__D012483
% 215.85/216.00       coord IM with specific Salmonella %28%NIM%29%   
% 215.85/216.00  |- skos__prefLabel mesh__D012483 Salmonella Phages
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D012483 2002
% 215.85/216.00  |- mesh__recordOriginator mesh__D012483 NLM
% 215.85/216.00  |- skos__hiddenLabel mesh__D012483 Salmonella Bacteriophage
% 215.85/216.00  |- mesh__recordAuthorizer mesh__D012483 PLS
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D012483 1996
% 215.85/216.00  |- rdf__type mesh__D012483sskos__Concept
% 215.85/216.00  |- skos__broader mesh__D012483smesh__D001435
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D012483 1998
% 215.85/216.00  |- skos__hiddenLabel mesh__D012483 Salmonella Phage
% 215.85/216.00  |- skos__scopeNote mesh__D012483
% 215.85/216.00       Viruses whose host is Salmonella. A frequently encountered Salmonella phage is BACTERIOPHAGE P22.%A%    
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D012483 1997
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D012483 1994
% 215.85/216.00  |- skos__altLabel mesh__D012483 Salmonella Bacteriophages
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D012483 2000
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D012483 1999
% 215.85/216.00  |- skos__hiddenLabel mesh__D012483 Bacteriophage, Salmonella
% 215.85/216.00  |- skos__hiddenLabel mesh__D012483 Bacteriophages, Salmonella
% 215.85/216.00  |- skos__hiddenLabel mesh__D020915 Syndrome, Wernicke-Korsakoff
% 215.85/216.00  |- mesh__historyNote mesh__D020915
% 215.85/216.00       2000; use ALCOHOL AMNESTIC DISORDER 1963-1999; for KORSAKOFF PSYCHOSIS use ALCOHOL AMNESTIC DISORDER 1980-1999%A%  
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D020915 2006
% 215.85/216.00  |- skos__hiddenLabel mesh__D020915 Psychosis, Korsakoff
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D020915 2002
% 215.85/216.00  |- rdf__type mesh__D020915sskos__Concept
% 215.85/216.00  |- skos__hiddenLabel mesh__D020915 Psychoses, Korsakoff
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D020915 2005
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D020915 2001
% 215.85/216.00  |- skos__hiddenLabel mesh__D020915 Syndrome, Korsakoff
% 215.85/216.00  |- skos__broader mesh__D020915smesh__D000425
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D020915 2004
% 215.85/216.00  |- mesh__dateCreated mesh__D020915 1999-11-03
% 215.85/216.00  |- skos__hiddenLabel mesh__D020915 Wernicke Korsakoff Syndrome
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D020915 2000
% 215.85/216.00  |- skos__broader mesh__D020915smesh__D008569
% 215.85/216.00  |- skos__prefLabel mesh__D020915 Korsakoff Syndrome
% 215.85/216.00  |- skos__altLabel mesh__D020915 Wernicke-Korsakoff Syndrome
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D020915 2003
% 215.85/216.00  |- skos__hiddenLabel mesh__D020915 Wernicke-Korsakoff Syndromes
% 215.85/216.00  |- skos__hiddenLabel mesh__D020915 Korsakoff Psychoses
% 215.85/216.00  |- mesh__dateEstablished mesh__D020915 2000-01-01
% 215.85/216.00  |- mesh__publicMeSHNote mesh__D020915
% 215.85/216.00       2000; see ALCOHOL AMNESTIC DISORDER 1963-1999; for KORSAKOFF PSYCHOSIS see ALCOHOL AMNESTIC DISORDER 1980-1999%A%  
% 215.85/216.00  |- skos__hiddenLabel mesh__D020915 Syndromes, Wernicke-Korsakoff
% 215.85/216.00  |- skos__altLabel mesh__D020915 Korsakoff Psychosis
% 215.85/216.00  |- skos__scopeNote mesh__D020915
% 215.85/216.00       An acquired cognitive disorder characterized by inattentiveness and the inability to form short term memories. This disorder is frequently associated with chronic ALCOHOLISM; but it may also result from dietary deficiencies; CRANIOCEREBRAL TRAUMA; NEOPLASMS; CEREBROVASCULAR DISORDERS; ENCEPHALITIS; EPILEPSY; and other conditions. %28%Adams et al., Principles of Neurology, 6th ed, p1139%29%%A%    
% 215.85/216.00  |- mesh__dateEstablished mesh__D006446 1991-01-01
% 215.85/216.00  |- mesh__recordAuthorizer mesh__D006446 sjn
% 215.85/216.00  |- rdf__type mesh__D006446sskos__Concept
% 215.85/216.00  |- skos__historyNote mesh__D006446 Hemoglobins, Abnormal %28%1966-1976%29%
% 215.85/216.00  |- skos__annotation mesh__D006446
% 215.85/216.00       /urine: coord IM with HEMOGLOBINURIA %28%IM%29%; DF: HBE   
% 215.85/216.00  |- mesh__recordMaintainer mesh__D006446 adp
% 215.85/216.00  |- mesh__dateRevised mesh__D006446 2000-06-21
% 215.85/216.00  |- skos__scopeNote mesh__D006446
% 215.85/216.00       An abnormal hemoglobin that results from the substitution of lysine for glutamic acid at position 26 of the beta chain. It is most frequently observed in southeast Asian populations.%A%    
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D006446 2005
% 215.85/216.00  |- skos__prefLabel mesh__D006446 Hemoglobin E
% 215.85/216.00  |- skos__broader mesh__D006446smesh__D006455
% 215.85/216.00  |- skos__hiddenLabel mesh__D006446 E, Hemoglobin
% 215.85/216.00  |- mesh__historyNote mesh__D006446
% 215.85/216.00       91%28%77%29%; was see under HEMOGLOBINS, ABNORMAL 1977-90   
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D006446 2006
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D006446 2003
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D006446 2001
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D006446 2004
% 215.85/216.00  |- mesh__dateCreated mesh__D006446 1976-04-27
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D006446 2002
% 215.85/216.00  |- mesh__publicMeSHNote mesh__D006446
% 215.85/216.00       91; was see under HEMOGLOBINS, ABNORMAL 1977-90   
% 215.85/216.00  |- mesh__recordOriginator mesh__D006446 RLS
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D020117 2003
% 215.85/216.00  |- skos__hiddenLabel mesh__D020117 R51619
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D020117 2001
% 215.85/216.00  |- mesh__recordOriginator mesh__D020117 ADP
% 215.85/216.00  |- mesh__recordMaintainer mesh__D020117 CCR
% 215.85/216.00  |- mesh__publicMeSHNote mesh__D020117
% 215.85/216.00       99; CISAPRIDE was indexed under PIPERIDINES 1984-98   
% 215.85/216.00  |- skos__broader mesh__D020117smesh__D010880
% 215.85/216.00  |- skos__scopeNote mesh__D020117
% 215.85/216.00       A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. %28%Martindale The Extra Pharmacopoeia, 31st ed%29%%A%    
% 215.85/216.00  |- rdf__type mesh__D020117sskos__Concept
% 215.85/216.00  |- mesh__historyNote mesh__D020117 99; use CISAPRIDE %28%NM%29% 1984-98   
% 215.85/216.00  |- skos__hiddenLabel mesh__D020117 R 51619
% 215.85/216.00  |- mesh__dateCreated mesh__D020117 1998-06-10
% 215.85/216.00  |- skos__prefLabel mesh__D020117 Cisapride
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D020117 2006
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D020117 2002
% 215.85/216.00  |- mesh__dateEstablished mesh__D020117 1999-01-01
% 215.85/216.00  |- skos__broader mesh__D020117smesh__D001549
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D020117 2004
% 215.85/216.00  |- mesh__recordAuthorizer mesh__D020117 sjn
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D020117 2005
% 215.85/216.00  |- skos__historyNote mesh__D020117 Piperidines %28%1984-1998%29%
% 215.85/216.00  |- mesh__dateRevised mesh__D020117 2000-06-22
% 215.85/216.00  |- skos__related mesh__D016874smesh__D016900
% 215.85/216.00  |- skos__hiddenLabel mesh__D016874 Tangles, Neurofibrillary
% 215.85/216.00  |- mesh__historyNote mesh__D016874 92   
% 215.85/216.00  |- skos__prefLabel mesh__D016874 Neurofibrillary Tangles
% 215.85/216.00  |- skos__broader mesh__D016874smesh__D009454
% 215.85/216.00  |- mesh__publicMeSHNote mesh__D016874 92   
% 215.85/216.00  |- mesh__recordMaintainer mesh__D016874 nns
% 215.85/216.00  |- skos__scopeNote mesh__D016874
% 215.85/216.00       Abnormal structures located in various parts of the brain and composed of dense arrays of paired helical filaments %28%neurofilaments and microtubules%29%. These double helical stacks of transverse subunits are twisted into left-handed ribbon-like filaments that likely incorporate the following proteins: %28%1%29% the intermediate filaments: medium- and high-molecular-weight neurofilaments; %28%2%29% the microtubule-associated proteins map-2 and tau; %28%3%29% actin; and %28%4%29% UBIQUITINS. As one of the hallmarks of ALZHEIMER DISEASE, the neurofibrillary tangles eventually occupy the whole of the cytoplasm in certain classes of cell in the neocortex, hippocampus, brain stem, and diencephalon. The number of these tangles, as seen in post mortem histology, correlates with the degree of dementia during life. Some studies suggest that tangle antigens leak into the systemic circulation both in the course of normal aging and in cases of Alzheimer disease.%A%    
% 215.85/216.00  |- rdf__type mesh__D016874sskos__Concept
% 215.85/216.00  |- mesh__dateEstablished mesh__D016874 1992-01-01
% 215.85/216.00  |- mesh__dateRevised mesh__D016874 2003-07-09
% 215.85/216.00  |- mesh__recordAuthorizer mesh__D016874 sjn
% 215.85/216.00  |- mesh__dateCreated mesh__D016874 1991-05-02
% 215.85/216.00  |- skos__annotation mesh__D016874
% 215.85/216.00       %22%one of the hallmarks of Alzheimer disease%22%; A 11 qualif except /cytol; /genet permitted%A%  
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D016874 2005
% 215.85/216.00  |- skos__hiddenLabel mesh__D016874 Neurofibrillary Tangle
% 215.85/216.00  |- skos__hiddenLabel mesh__D016874 Tangle, Neurofibrillary
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D016874 2004
% 215.85/216.00  |- skos__related mesh__D016874smesh__D024801
% 215.85/216.00  |- skos__historyNote mesh__D016874 Neurofibrils %28%1968-1991%29%
% 215.85/216.00  |- mesh__recordOriginator mesh__D016874 MXR
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D016874 2006
% 215.85/216.00  |- mesh__publicMeSHNote mesh__D049250 2005   
% 215.85/216.00  |- mesh__recordAuthorizer mesh__D049250 sjn
% 215.85/216.00  |- mesh__recordMaintainer mesh__D049250 ags
% 215.85/216.00  |- skos__related mesh__D049250smesh__D003143
% 215.85/216.00  |- skos__altLabel mesh__D049250 Voice Recognition Software
% 215.85/216.00  |- mesh__dateEstablished mesh__D049250 2005-01-01
% 215.85/216.00  |- skos__hiddenLabel mesh__D049250 Recognition Software, Voice
% 215.85/216.00  |- skos__related mesh__D049250smesh__D014584
% 215.85/216.00  |- skos__scopeNote mesh__D049250
% 215.85/216.00       Software capable of recognizing dictation and transcribing the spoken words into written text.%A%    
% 215.85/216.00  |- mesh__recordOriginator mesh__D049250 ags
% 215.85/216.00  |- mesh__dateCreated mesh__D049250 2004-07-07
% 215.85/216.00  |- skos__broader mesh__D049250smesh__D012984
% 215.85/216.00  |- skos__hiddenLabel mesh__D049250 Software, Voice Recognition
% 215.85/216.00  |- skos__hiddenLabel mesh__D049250 Software, Speech Recognition
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D049250 2005
% 215.85/216.00  |- rdf__type mesh__D049250sskos__Concept
% 215.85/216.00  |- skos__hiddenLabel mesh__D049250 Recognition Software, Speech
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D049250 2006
% 215.85/216.00  |- skos__prefLabel mesh__D049250 Speech Recognition Software
% 215.85/216.00  |- mesh__historyNote mesh__D049250 2005   
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002854 2006
% 215.85/216.00  |- skos__hiddenLabel mesh__D002854 Chromatographies, Paper
% 215.85/216.00  |- mesh__recordAuthorizer mesh__D002854 sjn
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002854 2005
% 215.85/216.00  |- mesh__historyNote mesh__D002854 66   
% 215.85/216.00  |- skos__scopeNote mesh__D002854
% 215.85/216.00       An analytical technique for resolution of a chemical mixture into its component compounds. Compounds are separated on an adsorbent paper %28%stationary phase%29% by their varied degree of solubility/mobility in the eluting solvent %28%mobile phase%29%.%A%    
% 215.85/216.00  |- mesh__recordMaintainer mesh__D002854 lkt
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002854 2004
% 215.85/216.00  |- rdf__type mesh__D002854sskos__Concept
% 215.85/216.00  |- skos__broader mesh__D002854smesh__D002853
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002854 2003
% 215.85/216.00  |- mesh__recordOriginator mesh__D002854 NLM
% 215.85/216.00  |- mesh__dateEstablished mesh__D002854 1966-01-01
% 215.85/216.00  |- skos__altLabel mesh__D002854 Paper Chromatography
% 215.85/216.00  |- skos__prefLabel mesh__D002854 Chromatography, Paper
% 215.85/216.00  |- mesh__dateCreated mesh__D002854 1999-01-01
% 215.85/216.00  |- skos__annotation mesh__D002854 DF: CHROMATOGR PAPER   
% 215.85/216.00  |- mesh__publicMeSHNote mesh__D002854 66   
% 215.85/216.00  |- mesh__dateRevised mesh__D002854 2002-07-03
% 215.85/216.00  |- skos__hiddenLabel mesh__D002854 Paper Chromatographies
% 215.85/216.00  |- mesh__recordOriginator mesh__D024508 lkt
% 215.85/216.00  |- skos__annotation mesh__D024508
% 215.85/216.00       deficiency: coordinate TOCOTRIENOLS /defic %28%IM%29% with VITAMIN E DEFICIENCY %28%IM%29%%A%  
% 215.85/216.00  |- rdf__type mesh__D024508sskos__Concept
% 215.85/216.00  |- mesh__dateCreated mesh__D024508 2001-07-25
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D024508 2006
% 215.85/216.00  |- skos__altLabel mesh__D024508 Tocotrienol
% 215.85/216.00  |- mesh__recordMaintainer mesh__D024508 ssb
% 215.85/216.00  |- mesh__publicMeSHNote mesh__D024508 2002; see VITAMIN E 1966-2001   
% 215.85/216.00  |- mesh__historyNote mesh__D024508 2002; use VITAMIN E 1966-2001   
% 215.85/216.00  |- skos__historyNote mesh__D024508 Vitamin E %28%1969-2001%29%
% 215.85/216.00  |- mesh__dateRevised mesh__D024508 2005-06-30
% 215.85/216.00  |- mesh__recordAuthorizer mesh__D024508 sjn
% 215.85/216.00  |- skos__scopeNote mesh__D024508
% 215.85/216.00       Natural analogs of TOCOPHEROLS exhibiting antioxidant activity.  These tocol derivatives and isomers contain a benzopyran ring and an unsaturated isoprenoid side chain.%A%    
% 215.85/216.00  |- skos__prefLabel mesh__D024508 Tocotrienols
% 215.85/216.00  |- skos__broader mesh__D024508smesh__D014810
% 215.85/216.00  |- mesh__dateEstablished mesh__D024508 2002-01-01
% 215.85/216.00  |- mesh__recordOriginator mesh__D002056 NLM
% 215.85/216.00  |- rdf__type mesh__D002056sskos__Concept
% 215.85/216.00  |- mesh__dateCreated mesh__D002056 1999-01-01
% 215.85/216.00  |- mesh__dateRevised mesh__D002056 1996-06-10
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002056 2005
% 215.85/216.00  |- skos__prefLabel mesh__D002056 Burns
% 215.85/216.00  |- skos__scopeNote mesh__D002056
% 215.85/216.00       Injuries to tissues caused by contact with heat, steam, chemicals %28%BURNS, CHEMICAL%29%, electricity %28%BURNS, ELECTRIC%29%, or the like.%A%    
% 215.85/216.00  |- mesh__recordMaintainer mesh__D002056 PXP
% 215.85/216.00  |- skos__broader mesh__D002056smesh__D014947
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002056 2003
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002056 2006
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002056 1998
% 215.85/216.00  |- skos__hiddenLabel mesh__D002056 Burn
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002056 2000
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002056 2004
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002056 1999
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002056 2001
% 215.85/216.00  |- mesh__recordAuthorizer mesh__D002056 PLS
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002056 1997
% 215.85/216.00  |- skos__annotation mesh__D002056
% 215.85/216.00       GEN; %22%thermal injury%22%; EYE BURNS %26% SUNBURN are also available; burn shock: coord IM with SHOCK, TRAUMATIC %28%IM%29%%A%  
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D002056 2002
% 215.85/216.00  |- skos__historyNote mesh__D012484 Salmonella paratyphi A %28%1966-1974%29%
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D012484 2006
% 215.85/216.00  |- skos__prefLabel mesh__D012484 Salmonella paratyphi B
% 215.85/216.00  |- mesh__dateCreated mesh__D012484 1975-07-21
% 215.85/216.00  |- mesh__recordAuthorizer mesh__D012484 sjn
% 215.85/216.00  |- mesh__recordOriginator mesh__D012484 JW
% 215.85/216.00  |- mesh__dateRevised mesh__D012484 2005-06-30
% 215.85/216.00  |- rdf__type mesh__D012484sskos__Concept
% 215.85/216.00  |- skos__annotation mesh__D012484
% 215.85/216.00       infection: coord IM with PARATYPHOID FEVER %28%IM%29%   
% 215.85/216.00  |- mesh__publicMeSHNote mesh__D012484
% 215.85/216.00       2003, 1975; see SALMONELLA SCHOTTMUELLERI 1991-2002, see  SALMONELLA 1976-1990, see SALMONELLA PARATYPHI 1966-1974%A%  
% 215.85/216.00  |- skos__altLabel mesh__D012484 Salmonella schottmuelleri
% 215.85/216.00  |- mesh__historyNote mesh__D012484 2003, 1975   
% 215.85/216.00  |- skos__altLabel mesh__D012484 Salmonella enterica serovar Paratyphi B
% 215.85/216.00  |- skos__scopeNote mesh__D012484
% 215.85/216.00       A serotype of SALMONELLA ENTERICA which is an agent of PARATYPHOID FEVER in humans.%A%    
% 215.85/216.00  |- mesh__recordMaintainer mesh__D012484 SYSTEM
% 215.85/216.00  |- mesh__dateEstablished mesh__D012484 1991-01-01
% 215.85/216.00  |- skos__broader mesh__D012484smesh__D019779
% 215.85/216.00  |- skos__historyNote mesh__D012484 Salmonella %28%1974%29%
% 215.85/216.00  |- skos__hiddenLabel mesh__D020916 alpha Conotoxin
% 215.85/216.00  |- skos__hiddenLabel mesh__D020916 alpha Conotoxins
% 215.85/216.00  |- mesh__historyNote mesh__D020916 2000   
% 215.85/216.00  |- skos__annotation mesh__D020916
% 215.85/216.00       OMEGA-CONOTOXINS and OMEGA-CONOTOXIN GVIA are available   
% 215.85/216.00  |- mesh__recordOriginator mesh__D020916 adp
% 215.85/216.00  |- mesh__publicMeSHNote mesh__D020916 2000   
% 215.85/216.00  |- skos__historyNote mesh__D020916 Mollusk Venoms %28%1986-1999%29%
% 215.85/216.00  |- skos__altLabel mesh__D020916 mu-Conotoxin
% 215.85/216.00  |- skos__altLabel mesh__D020916 Conotoxin
% 215.85/216.00  |- mesh__dateRevised mesh__D020916 2005-06-30
% 215.85/216.00  |- mesh__dateEstablished mesh__D020916 2000-01-01
% 215.85/216.00  |- skos__hiddenLabel mesh__D020916 mu Conotoxin
% 215.85/216.00  |- mesh__recordMaintainer mesh__D020916 ssb
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D020916 2006
% 215.85/216.00  |- skos__hiddenLabel mesh__D020916 mu Conotoxins
% 215.85/216.00  |- skos__altLabel mesh__D020916 alpha-Conotoxin
% 215.85/216.00  |- mesh__dateCreated mesh__D020916 1999-11-03
% 215.85/216.00  |- rdf__type mesh__D020916sskos__Concept
% 215.85/216.00  |- skos__prefLabel mesh__D020916 Conotoxins
% 215.85/216.00  |- skos__broader mesh__D020916smesh__D008978
% 215.85/216.00  |- mesh__recordAuthorizer mesh__D020916 sjn
% 215.85/216.00  |- skos__scopeNote mesh__D020916
% 215.85/216.00       Peptide neurotoxins from the marine fish-hunting snails of the genus CONUS. They contain 13 to 29 amino acids which are strongly basic and are highly cross-linked by disulfide bonds. There are three types of conotoxins, omega-, alpha-, and mu-. OMEGA-CONOTOXINS inhibit voltage-activated entry of calcium into the presynaptic membrane and therefore the release of ACETYLCHOLINE. Alpha-conotoxins inhibit the postsynaptic acetylcholine receptor. Mu-conotoxins prevent the generation of muscle action potentials. %28%From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed%29%%A%    
% 215.85/216.00  |- skos__altLabel mesh__D039621 EIF3
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621
% 215.85/216.00       Eukaryotic Initiation Factor 3, gamma Subunit
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621 EIF3 alpha
% 215.85/216.00  |- skos__altLabel mesh__D039621
% 215.85/216.00       Eukaryotic Peptide Initiation Factor-3, Subunit 2
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621 Int 6 Protein
% 215.85/216.00  |- skos__altLabel mesh__D039621
% 215.85/216.00       Eukaryotic Initiation Factor-3, beta Subunit
% 215.85/216.00  |- skos__altLabel mesh__D039621 Eukaryotic Peptide Initiation Factor-3
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621
% 215.85/216.00       Eukaryotic Peptide Initiation Factor 3, Subunit 3
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621
% 215.85/216.00       Eukaryotic Initiation Factor 3, Subunit 4
% 215.85/216.00  |- skos__altLabel mesh__D039621 EIF3 p110
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621 EIF3 gamma
% 215.85/216.00  |- skos__broader mesh__D039621smesh__D039642
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621 Int 6 Gene Product
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621 Eukaryotic Peptide Initiation Factor 3
% 215.85/216.00  |- skos__prefLabel mesh__D039621 Eukaryotic Initiation Factor-3
% 215.85/216.00  |- mesh__recordAuthorizer mesh__D039621 sjn
% 215.85/216.00  |- skos__altLabel mesh__D039621 Eukaryotic Initiation Factor-3 p110
% 215.85/216.00  |- skos__altLabel mesh__D039621 EIF-3
% 215.85/216.00  |- skos__altLabel mesh__D039621 EIF3-zeta
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621 Gene Product, Int-6
% 215.85/216.00  |- mesh__recordMaintainer mesh__D039621 jmp
% 215.85/216.00  |- skos__altLabel mesh__D039621
% 215.85/216.00       Eukaryotic Peptide Initiation Factor-3, Subunit 1
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621 Eukaryotic Initiation Factor 3
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621 Initiation Factor-3, Eukaryotic
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621
% 215.85/216.00       Eukaryotic Initiation Factor 3, delta Subunit
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621 EIF3 epsilon
% 215.85/216.00  |- skos__altLabel mesh__D039621 p42 EIF3 Protein
% 215.85/216.00  |- skos__altLabel mesh__D039621
% 215.85/216.00       Eukaryotic Peptide Initiation Factor 3, Subunit 5
% 215.85/216.00  |- skos__altLabel mesh__D039621 EIF3-beta
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621
% 215.85/216.00       Eukaryotic Initiation Factor 3, Subunit 8
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621
% 215.85/216.00       Eukaryotic Initiation Factor 3, Subunit 5
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D039621 2006
% 215.85/216.00  |- mesh__dateCreated mesh__D039621 2002-07-03
% 215.85/216.00  |- skos__scopeNote mesh__D039621
% 215.85/216.00       A multisubunit eukaryotic initiation factor that contains at least 8 distinct polypeptides.  It plays a role in recycling of ribosomal subunits to the site of transcription initiation by promoting the dissociation of non-translating ribosomal subunits. It also is involved in promoting the binding of a ternary complex of EUKARYOTIC INITIATION FACTOR-2; GTP; and INITIATOR TRNA to the 40S ribosomal subunit.%A%    
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621
% 215.85/216.00       Eukaryotic Translation Initiation Factor 3, Subunit 8
% 215.85/216.00  |- skos__altLabel mesh__D039621 EIF3S3 Protein
% 215.85/216.00  |- skos__altLabel mesh__D039621 EIF3-gamma
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621
% 215.85/216.00       Eukaryotic Initiation Factor 3, beta Subunit
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621
% 215.85/216.00       Eukaryotic Initiation Factor 3, Subunit 1
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621
% 215.85/216.00       Eukaryotic Initiation Factor 3, Subunit 2
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D039621 2005
% 215.85/216.00  |- rdf__type mesh__D039621sskos__Concept
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621
% 215.85/216.00       Eukaryotic Peptide Initiation Factor 3, Subunit 1
% 215.85/216.00  |- skos__altLabel mesh__D039621
% 215.85/216.00       Eukaryotic Translation Initiation Factor-3, Subunit 8
% 215.85/216.00  |- skos__altLabel mesh__D039621 EIF3-alpha
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621 EIF3 Protein, p42
% 215.85/216.00  |- mesh__activeMeSHYear mesh__D039621 2004
% 215.85/216.00  |- skos__altLabel mesh__D039621
% 215.85/216.00       Eukaryotic Peptide Initiation Factor-3, Subunit 4
% 215.85/216.00  |- mesh__publicMeSHNote mesh__D039621
% 215.85/216.00       2003; EIF-3 %28%now EUKARYOTIC INITIATION FACTOR-3%29% was indexed under PEPTIDE INITIATION FACTORS 1990-2002; EUKARYOTIC INITIATION FACTOR 3 P110 %28%now EUKARYOTIC INITIATION FACTOR-3%29% was indexed under PEPTIDE INITIATION FACTORS 2000-2002; EUKARYOTIC INITIATION FACTOR 3, SUBUNIT 4 %28%now EUKARYOTIC INITIATION FACTOR-3%29% was indexed under PEPTIDE INITIATION FACTORS 1999-2002; INT-6 PROTEIN %28%now EUKARYOTIC INITIATION FACTOR-3%29% was indexed under PEPTIDE INITIATION FACTORS 1995-2002%A%  
% 215.85/216.00  |- skos__altLabel mesh__D039621 EIF3-epsilon
% 215.85/216.00  |- skos__altLabel mesh__D039621 INT6 Protein
% 215.85/216.00  |- skos__altLabel mesh__D039621
% 215.85/216.00       Eukaryotic Initiation Factor-3, delta Subunit
% 215.85/216.00  |- mesh__historyNote mesh__D039621
% 215.85/216.00       2003; use EUKARYOTIC INITIATION FACTOR-3 %28%NM%29% 1990-2002   
% 215.85/216.00  |- skos__altLabel mesh__D039621
% 215.85/216.00       Eukaryotic Peptide Initiation Factor-3, alpha Subunit
% 215.85/216.00  |- skos__altLabel mesh__D039621 EIF3S3 Gene Product
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621
% 215.85/216.00       Eukaryotic Initiation Factor 3, Subunit 6
% 215.85/216.00  |- skos__hiddenLabel mesh__D039621 Peptide Initiation Factor EIF 3
% 215.85/216.00  |- mesh__recordOriginator mesh__D039621 jmp
% 215.85/216.00  |- mesh__dateEstablished mesh__D039621 2003-01-01
% 215.85/216.01  |- skos__hiddenLabel mesh__D039621
% 215.85/216.01       Eukaryotic Peptide Initiation Factor 3, Subunit 2
% 215.85/216.01  |- skos__hiddenLabel mesh__D039621
% 215.85/216.01       Eukaryotic Initiation Factor 3, Subunit 3
% 215.85/216.01  |- skos__hiddenLabel mesh__D039621
% 215.85/216.01       Eukaryotic Initiation Factor 3, zeta Subunit
% 215.85/216.01  |- skos__altLabel mesh__D039621 EIF3S4 Protein
% 215.85/216.01  |- skos__altLabel mesh__D039621
% 215.85/216.01       Eukaryotic Initiation Factor-3, gamma Subunit
% 215.85/216.01  |- skos__altLabel mesh__D039621 EIF3-p48
% 215.85/216.01  |- skos__altLabel mesh__D039621 Int-6 Protein
% 215.85/216.01  |- skos__historyNote mesh__D039621
% 215.85/216.01       Peptide Initiation Factors %28%1990-2002%29%
% 215.85/216.01  |- mesh__activeMeSHYear mesh__D039621 2003
% 215.85/216.01  |- skos__altLabel mesh__D039621
% 215.85/216.01       Eukaryotic Peptide Initiation Factor-3, Subunit 3
% 215.85/216.01  |- skos__altLabel mesh__D039621 EIF3 p42 Protein
% 215.85/216.01  |- skos__altLabel mesh__D039621 Peptide Initiation Factor EIF-3
% 215.85/216.01  |- skos__hiddenLabel mesh__D039621
% 215.85/216.01       Eukaryotic Peptide Initiation Factor 3, alpha Subunit
% 215.85/216.01  |- skos__hiddenLabel mesh__D039621 Eukaryotic Initiation Factor 3 p110
% 215.85/216.01  |- skos__altLabel mesh__D039621
% 215.85/216.01       Eukaryotic Initiation Factor-3, zeta Subunit
% 215.85/216.01  |- skos__altLabel mesh__D039621 Int-6 Gene Product
% 215.85/216.01  |- skos__hiddenLabel mesh__D039621
% 215.85/216.01       Eukaryotic Initiation Factor 3, Subunit 7
% 215.85/216.01  |- skos__hiddenLabel mesh__D039621
% 215.85/216.01       Eukaryotic Peptide Initiation Factor 3, Subunit 4
% 215.85/216.01  |- mesh__activeMeSHYear mesh__D006447 2002
% 215.85/216.01  |- rdf__type mesh__D006447sskos__Concept
% 215.85/216.01  |- skos__scopeNote mesh__D006447
% 215.85/216.01       An abnormal hemoglobin composed of four beta chains. It is caused by the reduced synthesis of the alpha chain. This abnormality results in ALPHA-THALASSEMIA.%A%    
% 215.85/216.01  |- skos__prefLabel mesh__D006447 Hemoglobin H
% 215.85/216.01  |- mesh__recordMaintainer mesh__D006447 adp
% 215.85/216.01  |- mesh__activeMeSHYear mesh__D006447 2005
% 215.85/216.01  |- mesh__publicMeSHNote mesh__D006447
% 215.85/216.01       91; was see under HEMOGLOBINS, ABNORMAL 1973-90   
% 215.85/216.01  |- skos__broader mesh__D006447smesh__D006455
% 215.85/216.01  |- mesh__recordAuthorizer mesh__D006447 sjn
% 215.85/216.01  |- mesh__activeMeSHYear mesh__D006447 2006
% 215.85/216.01  |- mesh__activeMeSHYear mesh__D006447 2003
% 215.85/216.01  |- mesh__dateCreated mesh__D006447 1999-01-01
% 215.85/216.01  |- mesh__activeMeSHYear mesh__D006447 2004
% 215.85/216.01  |- skos__annotation mesh__D006447
% 215.85/216.01       /urine: coord IM with HEMOGLOBINURIA %28%IM%29%; DF: HBH   
% 215.85/216.01  |- skos__hiddenLabel mesh__D006447 H, Hemoglobin
% 215.85/216.01  |- skos__related mesh__D006447smesh__D017085
% 215.85/216.01  |- mesh__dateEstablished mesh__D006447 1991-01-01
% 215.85/216.01  |- mesh__activeMeSHYear mesh__D006447 2001
% 215.85/216.01  |- mesh__historyNote mesh__D006447
% 215.85/216.01       91%28%73%29%; was see under HEMOGLOBINS, ABNORMAL 1973-90   
% 215.85/216.01  |- mesh__recordOriginator mesh__D006447 NLM
% 215.85/216.01  |- mesh__dateRevised mesh__D006447 2000-06-22
% 215.85/216.01  |- mesh__recordAuthorizer mesh__D020118 sjn
% 215.85/216.01  |- mesh__dateEstablished mesh__D020118 1999-01-01
% 215.85/216.01  |- rdf__type mesh__D020118sskos__Concept
% 215.85/216.01  |- mesh__dateRevised mesh__D020118 2005-06-30
% 215.85/216.01  |- skos__historyNote mesh__D020118 Alcaligenes %28%1995-1998%29%
% 215.85/216.01  |- mesh__historyNote mesh__D020118 2006 %28%1999%29%   
% 215.85/216.01  |- skos__broader mesh__D020118smesh__D049921
% 215.85/216.01  |- mesh__publicMeSHNote mesh__D020118
% 215.85/216.01       2006; see RALSTONIA EUTROPHA 1999-2005   
% 215.85/216.01  |- skos__scopeNote mesh__D020118
% 215.85/216.01       A gram-negative, facultatively chemoautotrophic bacterium, formerly called Ralstonia eutropha, found in water and soil.%A%    
% 215.85/216.01  |- skos__altLabel mesh__D020118 Alcaligenes eutropha
% 215.85/216.01  |- mesh__recordOriginator mesh__D020118 NDW
% 215.85/216.01  |- mesh__activeMeSHYear mesh__D020118 2006
% 215.85/216.01  |- skos__altLabel mesh__D020118 Ralstonia eutropha
% 215.85/216.01  |- skos__prefLabel mesh__D020118 Wautersia eutropha
% 215.85/216.01  |- mesh__recordMaintainer mesh__D020118 ags
% 215.85/216.01  |- mesh__dateCreated mesh__D020118 1998-06-11
% 215.85/216.01  |- mesh__activeMeSHYear mesh__D025601 2005
% 215.85/216.01  |- mesh__dateCreated mesh__D025601 2001-07-25
% 215.85/216.01  |- skos__prefLabel mesh__D025601 Adenomatous Polyposis Coli Protein
% 215.85/216.01  |- skos__broader mesh__D025601smesh__D003598
% 215.85/216.01  |- skos__scopeNote mesh__D025601
% 215.85/216.01       A negative regulator of beta-catenin signaling which is mutant in ADENOMATOUS POLYPOSIS COLI and GARDNER SYNDROME.%A%    
% 215.85/216.01  |- skos__historyNote mesh__D025601 Neoplasm Proteins %28%1993-1994%29%
% 215.85/216.01  |- skos__related mesh__D025601smesh__D017491
% 215.85/216.01  |- mesh__recordMaintainer mesh__D025601 jmp
% 215.85/216.01  |- mesh__publicMeSHNote mesh__D025601 2002   
% 215.85/216.01  |- mesh__dateEstablished mesh__D025601 2002-01-01
% 215.85/216.01  |- skos__historyNote mesh__D025601 Cytoskeletal Proteins %28%1994-2001%29%
% 215.86/216.01  |- rdf__type mesh__D025601sskos__Concept
% 215.86/216.01  |- mesh__recordAuthorizer mesh__D025601 sjn
% 215.86/216.01  |- mesh__recordOriginator mesh__D025601 nns
% 215.86/216.01  |- mesh__dateRevised mesh__D025601 2004-07-07
% 215.86/216.01  |- mesh__historyNote mesh__D025601
% 215.86/216.01       2002; use ADENOMATOUS POLYPOSIS COLI PROTEIN %28%NM%29% 1993-2001%A%  
% 215.86/216.01  |- skos__related mesh__D025601smesh__D005736
% 215.86/216.01  |- skos__broader mesh__D025601smesh__D025521
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D025601 2006
% 215.86/216.01  |- skos__related mesh__D025601smesh__D011125
% 215.86/216.01  |- rdf__type mesh__D016875sskos__Concept
% 215.86/216.01  |- skos__hiddenLabel mesh__D016875 Proteins, tau
% 215.86/216.01  |- mesh__recordAuthorizer mesh__D016875 sjn
% 215.86/216.01  |- skos__historyNote mesh__D016875 Microtubules %28%1976-1985%29%
% 215.86/216.01  |- skos__related mesh__D016875smesh__D024801
% 215.86/216.01  |- skos__hiddenLabel mesh__D016875 Protein, tau
% 215.86/216.01  |- mesh__publicMeSHNote mesh__D016875
% 215.86/216.01       1992; TAU %28%NM%29% was indexed under MICROTUBULE-ASSOCIATED PROTEINS 1985-91 %26% under PROTEINS 1977-84%A%  
% 215.86/216.01  |- skos__prefLabel mesh__D016875 tau Proteins
% 215.86/216.01  |- mesh__onlineNote mesh__D016875
% 215.86/216.01       use TAU PROTEINS %28%NM%29% to search TAU %28%NM%29% 1980-90   
% 215.86/216.01  |- skos__historyNote mesh__D016875
% 215.86/216.01       Microtubule-Associated Proteins %28%1986-1991%29%
% 215.86/216.01  |- mesh__historyNote mesh__D016875 1992; use TAU %28%NM%29% 1977-91   
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D016875 2006
% 215.86/216.01  |- skos__scopeNote mesh__D016875
% 215.86/216.01       Microtubule-associated proteins that are mainly expressed in neurons. Tau proteins constitute several isoforms and play an important role in the assembly of tubulin monomers into microtubules and in maintaining the cytoskeleton and axonal transport. Aggregation of specific sets of tau proteins in filamentous inclusions is the common feature of intraneuronal and glial fibrillar lesions %28%NEUROFIBRILLARY TANGLES; NEUROPIL THREADS%29% in numerous neurodegenerative disorders %28%ALZHEIMER DISEASE; TAUOPATHIES%29%.%A%    
% 215.86/216.01  |- mesh__dateEstablished mesh__D016875 1992-01-01
% 215.86/216.01  |- mesh__recordOriginator mesh__D016875 MXR
% 215.86/216.01  |- mesh__dateCreated mesh__D016875 1991-07-12
% 215.86/216.01  |- mesh__dateRevised mesh__D016875 2005-06-30
% 215.86/216.01  |- mesh__recordMaintainer mesh__D016875 SYSTEM
% 215.86/216.01  |- skos__broader mesh__D016875smesh__D008869
% 215.86/216.01  |- skos__altLabel mesh__D016875 tau Protein
% 215.86/216.01  |- skos__prefLabel mesh__D002855 Chromatography, Thin Layer
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D002855 2006
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D002855 2003
% 215.86/216.01  |- skos__hiddenLabel mesh__D002855 Chromatographies, Thin Layer
% 215.86/216.01  |- skos__altLabel mesh__D002855 Chromatography, Thin-Layer
% 215.86/216.01  |- mesh__dateRevised mesh__D002855 2002-07-03
% 215.86/216.01  |- skos__hiddenLabel mesh__D002855 Thin-Layer Chromatography
% 215.86/216.01  |- skos__hiddenLabel mesh__D002855 Thin-Layer Chromatographies
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D002855 2004
% 215.86/216.01  |- mesh__dateCreated mesh__D002855 1999-01-01
% 215.86/216.01  |- rdf__type mesh__D002855sskos__Concept
% 215.86/216.01  |- skos__hiddenLabel mesh__D002855 Thin Layer Chromatographies
% 215.86/216.01  |- mesh__recordAuthorizer mesh__D002855 sjn
% 215.86/216.01  |- skos__scopeNote mesh__D002855
% 215.86/216.01       Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 215.86/216.01  |- mesh__historyNote mesh__D002855 66   
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D002855 2005
% 215.86/216.01  |- mesh__publicMeSHNote mesh__D002855 66   
% 215.86/216.01  |- mesh__dateEstablished mesh__D002855 1966-01-01
% 215.86/216.01  |- skos__broader mesh__D002855smesh__D002853
% 215.86/216.01  |- skos__altLabel mesh__D002855 Thin Layer Chromatography
% 215.86/216.01  |- skos__hiddenLabel mesh__D002855 Chromatographies, Thin-Layer
% 215.86/216.01  |- mesh__recordMaintainer mesh__D002855 lkt
% 215.86/216.01  |- skos__annotation mesh__D002855
% 215.86/216.01       a type of liquid chromatogr; NIM; DF: CHROMATOGR THIN LAYER%A%  
% 215.86/216.01  |- mesh__recordOriginator mesh__D002855 NLM
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D024509 2006
% 215.86/216.01  |- mesh__publicMeSHNote mesh__D024509 2002   
% 215.86/216.01  |- skos__scopeNote mesh__D024509
% 215.86/216.01       The region of DNA which borders the 3%27% end of a transcription unit and where a variety of regulatory sequences are located.%A%    
% 215.86/216.01  |- skos__broader mesh__D024509smesh__D021901
% 215.86/216.01  |- skos__prefLabel mesh__D024509 3%27% Flanking Region
% 215.86/216.01  |- mesh__dateCreated mesh__D024509 2001-08-03
% 215.86/216.01  |- skos__hiddenLabel mesh__D024509 Flanking Sequence, 3%27%
% 215.86/216.01  |- skos__hiddenLabel mesh__D024509 3%27% Flanking Regions
% 215.86/216.01  |- skos__hiddenLabel mesh__D024509 Sequence, 3%27% Flanking
% 215.86/216.01  |- skos__altLabel mesh__D024509 Flanking Region, 3%27%
% 215.86/216.01  |- skos__hiddenLabel mesh__D024509 Sequences, 3%27% Flanking
% 215.86/216.01  |- skos__hiddenLabel mesh__D024509 3%27% Flanking Sequences
% 215.86/216.01  |- skos__hiddenLabel mesh__D024509 Region, 3%27% Flanking
% 215.86/216.01  |- skos__hiddenLabel mesh__D024509 Flanking Regions, 3%27%
% 215.86/216.01  |- skos__hiddenLabel mesh__D024509 Flanking Sequences, 3%27%
% 215.86/216.01  |- mesh__recordOriginator mesh__D024509 nns
% 215.86/216.01  |- skos__broader mesh__D024509smesh__D040461
% 215.86/216.01  |- skos__related mesh__D024509smesh__D020413
% 215.86/216.01  |- mesh__historyNote mesh__D024509 2002   
% 215.86/216.01  |- skos__annotation mesh__D024509
% 215.86/216.01       do not confuse with 3%27% UNTRANSLATED REGIONS   
% 215.86/216.01  |- mesh__dateEstablished mesh__D024509 2002-01-01
% 215.86/216.01  |- skos__altLabel mesh__D024509 3%27% Flanking Sequence
% 215.86/216.01  |- mesh__dateRevised mesh__D024509 2005-06-30
% 215.86/216.01  |- mesh__recordMaintainer mesh__D024509 nns
% 215.86/216.01  |- mesh__recordAuthorizer mesh__D024509 sjn
% 215.86/216.01  |- skos__hiddenLabel mesh__D024509 Regions, 3%27% Flanking
% 215.86/216.01  |- rdf__type mesh__D024509sskos__Concept
% 215.86/216.01  |- skos__annotation mesh__D002057
% 215.86/216.01       chem eye burns = BURNS, CHEMICAL %28%IM%29% + EYE BURNS /chem ind %28%IM%29%%A%  
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D002057 2005
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D002057 2002
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D002057 1995
% 215.86/216.01  |- skos__altLabel mesh__D002057 Chemical Burns
% 215.86/216.01  |- skos__prefLabel mesh__D002057 Burns, Chemical
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D002057 2006
% 215.86/216.01  |- mesh__recordOriginator mesh__D002057 NLM
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D002057 2003
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D002057 1998
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D002057 1993
% 215.86/216.01  |- skos__hiddenLabel mesh__D002057 Chemical Burn
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D002057 2004
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D002057 1999
% 215.86/216.01  |- mesh__recordMaintainer mesh__D002057 TGC
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D002057 1996
% 215.86/216.01  |- mesh__dateRevised mesh__D002057 1992-03-25
% 215.86/216.01  |- skos__broader mesh__D002057smesh__D002056
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D002057 1997
% 215.86/216.01  |- skos__hiddenLabel mesh__D002057 Burn, Chemical
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D002057 2000
% 215.86/216.01  |- rdf__type mesh__D002057sskos__Concept
% 215.86/216.01  |- mesh__dateCreated mesh__D002057 1999-01-01
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D002057 2001
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D002057 1994
% 215.86/216.01  |- mesh__recordAuthorizer mesh__D002057 PLS
% 215.86/216.01  |- mesh__recordOriginator mesh__D007540 NLM
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D007540 2004
% 215.86/216.01  |- rdf__type mesh__D007540sskos__Concept
% 215.86/216.01  |- skos__broader mesh__D007540smesh__D000147
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D007540 1994
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D007540 2001
% 215.86/216.01  |- mesh__recordAuthorizer mesh__D007540 PLS
% 215.86/216.01  |- mesh__publicMeSHNote mesh__D007540 68   
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D007540 1995
% 215.86/216.01  |- mesh__recordMaintainer mesh__D007540 TAP
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D007540 1998
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D007540 2005
% 215.86/216.01  |- skos__broader mesh__D007540smesh__D010880
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D007540 2002
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D007540 1993
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D007540 1999
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D007540 2006
% 215.86/216.01  |- mesh__dateCreated mesh__D007540 1999-01-01
% 215.86/216.01  |- mesh__historyNote mesh__D007540 68   
% 215.86/216.01  |- skos__hiddenLabel mesh__D007540 Acids, Isonipecotic
% 215.86/216.01  |- skos__prefLabel mesh__D007540 Isonipecotic Acids
% 215.86/216.01  |- mesh__dateRevised mesh__D007540 1992-05-19
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D007540 1996
% 215.86/216.01  |- mesh__dateEstablished mesh__D007540 1968-01-01
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D007540 2003
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D007540 2000
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D007540 1997
% 215.86/216.01  |- skos__annotation mesh__D012485 infection = TYPHOID FEVER   
% 215.86/216.01  |- skos__prefLabel mesh__D012485 Salmonella typhi
% 215.86/216.01  |- skos__altLabel mesh__D012485 Salmonella typhosa
% 215.86/216.01  |- mesh__dateCreated mesh__D012485 1975-07-23
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D012485 2006
% 215.86/216.01  |- mesh__recordMaintainer mesh__D012485 SYSTEM
% 215.86/216.01  |- mesh__publicMeSHNote mesh__D012485 76; was SALMONELLA TYPHOSA 1963-75   
% 215.86/216.01  |- mesh__dateEstablished mesh__D012485 1976-01-01
% 215.86/216.01  |- mesh__recordAuthorizer mesh__D012485 sjn
% 215.86/216.01  |- skos__broader mesh__D012485smesh__D019779
% 215.86/216.01  |- skos__altLabel mesh__D012485 Salmonella enterica serovar Typhi
% 215.86/216.01  |- rdf__type mesh__D012485sskos__Concept
% 215.86/216.01  |- mesh__dateRevised mesh__D012485 2005-06-30
% 215.86/216.01  |- mesh__onlineNote mesh__D012485
% 215.86/216.01       use SALMONELLA TYPHI to search SALMONELLA TYPHOSA 1966-75%A%  
% 215.86/216.01  |- mesh__historyNote mesh__D012485 76; was SALMONELLA TYPHOSA 1963-75   
% 215.86/216.01  |- skos__scopeNote mesh__D012485
% 215.86/216.01       A serotype of SALMONELLA ENTERICA which is the etiologic agent of TYPHOID FEVER.%A%    
% 215.86/216.01  |- mesh__recordOriginator mesh__D012485 JW
% 215.86/216.01  |- skos__hiddenLabel mesh__D020917 c-trk, gp140
% 215.86/216.01  |- mesh__dateRevised mesh__D020917 2005-06-30
% 215.86/216.01  |- skos__prefLabel mesh__D020917 Receptor, trkA
% 215.86/216.01  |- mesh__recordOriginator mesh__D020917 jmp
% 215.86/216.01  |- skos__broader mesh__D020917smesh__D020794
% 215.86/216.01  |- skos__broader mesh__D020917smesh__D017475
% 215.86/216.01  |- skos__altLabel mesh__D020917 p140-trkA
% 215.86/216.01  |- skos__hiddenLabel mesh__D020917 c trk Protein
% 215.86/216.01  |- skos__altLabel mesh__D020917
% 215.86/216.01       Receptor, Neurotrophic Tyrosine Kinase Type 1
% 215.86/216.01  |- skos__historyNote mesh__D020917
% 215.86/216.01       Receptor Protein-Tyrosine Kinases %28%1994-1999%29%
% 215.86/216.01  |- mesh__dateEstablished mesh__D020917 2000-01-01
% 215.86/216.01  |- skos__hiddenLabel mesh__D020917 trk, Proto-Oncogene Protein
% 215.86/216.01  |- skos__altLabel mesh__D020917
% 215.86/216.01       Neurotrophic Tyrosine Kinase Receptor Type 1
% 215.86/216.01  |- skos__altLabel mesh__D020917 trk1 Transforming Tryrosine Kinase
% 215.86/216.01  |- skos__hiddenLabel mesh__D020917 Receptor, NTRK1
% 215.86/216.01  |- skos__hiddenLabel mesh__D020917 c-trk, Proto-Oncogene Products
% 215.86/216.01  |- skos__hiddenLabel mesh__D020917 Proto Oncogene Products c trk
% 215.86/216.01  |- mesh__dateCreated mesh__D020917 1999-11-04
% 215.86/216.01  |- skos__altLabel mesh__D020917 trkA Receptor
% 215.86/216.01  |- skos__altLabel mesh__D020917 gp140 c-trk
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D020917 2006
% 215.86/216.01  |- skos__scopeNote mesh__D020917
% 215.86/216.01       A protein-tyrosine kinase receptor that is specific for NERVE GROWTH FACTOR; NEUROTROPHIN 3; neurotrophin 4, neurotrophin 5. It plays a crucial role in pain sensation and thermoregulation in humans. Gene mutations that cause loss of receptor function are associated with congenital insensitivity to pain with anhidrosis, while gene rearrangements that activate the protein-tyrosine kinase function are associated with tumorigenesis.%A%    
% 215.86/216.01  |- skos__hiddenLabel mesh__D020917 p140 trkA
% 215.86/216.01  |- skos__historyNote mesh__D020917
% 215.86/216.01       Proto-Oncogene Proteins %28%1990-1999%29%
% 215.86/216.01  |- mesh__recordMaintainer mesh__D020917 jmp
% 215.86/216.01  |- mesh__publicMeSHNote mesh__D020917
% 215.86/216.01       2000; PROTO-ONCOGENE PROTEIN TRK %28%now RECEPTOR, TYPE 1 NEUROTROPHIC TYROSINE KINASE%29% was indexed under PROTO-ONCOGENE PROTEINS 1990-1999, RECEPTOR PROTEIN-TYROSINE KINASE 1994-1999 %26% RECEPTORS, NERVE GROWTH FACTOR 1994-1999%A%  
% 215.86/216.01  |- skos__annotation mesh__D020917 DF: RECEPT TRKA   
% 215.86/216.01  |- skos__altLabel mesh__D020917 Proto-Oncogene Protein trk
% 215.86/216.01  |- skos__altLabel mesh__D020917 c-trk Protein
% 215.86/216.01  |- skos__hiddenLabel mesh__D020917 trk Proto Oncogene Protein
% 215.86/216.01  |- mesh__recordAuthorizer mesh__D020917 sjn
% 215.86/216.01  |- skos__hiddenLabel mesh__D020917 gp140 c trk
% 215.86/216.01  |- skos__historyNote mesh__D020917
% 215.86/216.01       Receptors, Nerve Growth Factor %28%1994-1999%29%
% 215.86/216.01  |- skos__altLabel mesh__D020917 trk Proto-Oncogene Protein
% 215.86/216.01  |- skos__hiddenLabel mesh__D020917 Proto-Oncogene Protein, trk
% 215.86/216.01  |- rdf__type mesh__D020917sskos__Concept
% 215.86/216.01  |- skos__altLabel mesh__D020917 Proto-Oncogene Products c-trk
% 215.86/216.01  |- skos__hiddenLabel mesh__D020917 Proto Oncogene Protein trk
% 215.86/216.01  |- mesh__historyNote mesh__D020917
% 215.86/216.01       2000; use RECEPTOR, TYPE 1 NEUROTROPHIC TYROSINE KINASE%28%NM%29% 1990-1999%A%  
% 215.86/216.01  |- skos__altLabel mesh__D020917 gp140%28%c-TRK%29%
% 215.86/216.01  |- skos__altLabel mesh__D020917 NTRK1 Receptor
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D006448 2006
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D006448 2003
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D006448 2000
% 215.86/216.01  |- skos__scopeNote mesh__D006448
% 215.86/216.01       A group of abnormal hemoglobins with similar electrophoretic characteristics. They have faster electrophoretic mobility and different amino acid substitutions in either the alpha or beta chains than normal adult hemoglobin. Some of the variants produce hematologic abnormalities, others result in no clinical disorders.%A%    
% 215.86/216.01  |- mesh__historyNote mesh__D006448
% 215.86/216.01       91%28%77%29%; was see under HEMOGLOBINS, ABNORMAL 1977-90   
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D006448 2004
% 215.86/216.01  |- mesh__dateCreated mesh__D006448 1976-04-27
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D006448 2001
% 215.86/216.01  |- mesh__dateRevised mesh__D006448 1995-03-17
% 215.86/216.01  |- mesh__publicMeSHNote mesh__D006448
% 215.86/216.01       91; was see under HEMOGLOBINS, ABNORMAL 1977-90   
% 215.86/216.01  |- mesh__recordOriginator mesh__D006448 RLS
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D006448 2002
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D006448 1998
% 215.86/216.01  |- skos__hiddenLabel mesh__D006448 J, Hemoglobin
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D006448 1999
% 215.86/216.01  |- mesh__dateEstablished mesh__D006448 1991-01-01
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D006448 1996
% 215.86/216.01  |- rdf__type mesh__D006448sskos__Concept
% 215.86/216.01  |- mesh__recordMaintainer mesh__D006448 PLS
% 215.86/216.01  |- mesh__recordAuthorizer mesh__D006448 PLS
% 215.86/216.01  |- skos__annotation mesh__D006448
% 215.86/216.01       an abnorm hemoglobin; /urine: coord IM with HEMOGLOBINURIA %28%IM%29%; DF: HBJ%A%  
% 215.86/216.01  |- skos__prefLabel mesh__D006448 Hemoglobin J
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D006448 1997
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D006448 2005
% 215.86/216.01  |- skos__historyNote mesh__D006448 Hemoglobins, Abnormal %28%1966-1976%29%
% 215.86/216.01  |- skos__broader mesh__D006448smesh__D006455
% 215.86/216.01  |- mesh__dateRevised mesh__D017170 2003-07-09
% 215.86/216.01  |- skos__annotation mesh__D017170
% 215.86/216.01       a species of nematode; infection: coord IM with STRONGYLOIDIASIS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 215.86/216.01  |- skos__historyNote mesh__D017170 Strongyloides %28%1968-1992%29%
% 215.86/216.01  |- skos__scopeNote mesh__D017170
% 215.86/216.01       A species of parasitic nematode found in rats.     
% 215.86/216.01  |- skos__prefLabel mesh__D017170 Strongyloides ratti
% 215.86/216.01  |- mesh__dateEstablished mesh__D017170 1993-01-01
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D017170 2006
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D017170 2005
% 215.86/216.01  |- mesh__publicMeSHNote mesh__D017170 93   
% 215.86/216.01  |- skos__broader mesh__D017170smesh__D013321
% 215.86/216.01  |- rdf__type mesh__D017170sskos__Concept
% 215.86/216.01  |- mesh__historyNote mesh__D017170 93   
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D017170 2004
% 215.86/216.01  |- mesh__dateCreated mesh__D017170 1992-05-22
% 215.86/216.01  |- mesh__dateRevised mesh__D025602 2005-06-30
% 215.86/216.01  |- skos__broader mesh__D025602smesh__D025604
% 215.86/216.01  |- skos__scopeNote mesh__D025602
% 215.86/216.01       Light driven chloride ion pumps that are ubiquitously found in halophilic archaea %28%HALOBACTERIALES%29%.%A%    
% 215.86/216.01  |- mesh__publicMeSHNote mesh__D025602 2002   
% 215.86/216.01  |- mesh__dateEstablished mesh__D025602 2002-01-01
% 215.86/216.01  |- skos__hiddenLabel mesh__D025602 9 cis Halorhodopsin
% 215.86/216.01  |- mesh__recordOriginator mesh__D025602 jmp
% 215.86/216.01  |- rdf__type mesh__D025602sskos__Concept
% 215.86/216.01  |- skos__broader mesh__D025602smesh__D027321
% 215.86/216.01  |- skos__altLabel mesh__D025602 Halorhodopsin Chromoprotein
% 215.86/216.01  |- mesh__dateCreated mesh__D025602 2001-08-03
% 215.86/216.01  |- skos__historyNote mesh__D025602 Bacteriorhodopsins %28%1981-2001%29%
% 215.86/216.01  |- mesh__recordMaintainer mesh__D025602 SYSTEM
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D025602 2006
% 215.86/216.01  |- mesh__historyNote mesh__D025602 2002   
% 215.86/216.01  |- skos__broader mesh__D025602smesh__D019843
% 215.86/216.01  |- mesh__recordAuthorizer mesh__D025602 sjn
% 215.86/216.01  |- skos__prefLabel mesh__D025602 Halorhodopsins
% 215.86/216.01  |- skos__altLabel mesh__D025602 Halorhodopsin
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D003150 2004
% 215.86/216.01  |- skos__hiddenLabel mesh__D003150 Worker, Village Health
% 215.86/216.01  |- skos__hiddenLabel mesh__D003150 Aide, Community Health
% 215.86/216.01  |- mesh__recordOriginator mesh__D003150 NLM
% 215.86/216.01  |- skos__hiddenLabel mesh__D003150 Health Workers, Village
% 215.86/216.01  |- skos__hiddenLabel mesh__D003150 Workers, Community
% 215.86/216.01  |- rdf__type mesh__D003150sskos__Concept
% 215.86/216.01  |- skos__hiddenLabel mesh__D003150 Doctors, Barefoot
% 215.86/216.01  |- skos__scopeNote mesh__D003150
% 215.86/216.01       Persons trained to assist professional health personnel in communicating with residents in the community concerning needs and availability of health services.%A%    
% 215.86/216.01  |- skos__historyNote mesh__D003150
% 215.86/216.01       Community Mental Health Services %28%1967-1970%29%
% 215.86/216.01  |- mesh__recordAuthorizer mesh__D003150 sjn
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D003150 2002
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D003150 2003
% 215.86/216.01  |- skos__hiddenLabel mesh__D003150 Barefoot Doctor
% 215.86/216.01  |- skos__hiddenLabel mesh__D003150 Doctor, Barefoot
% 215.86/216.01  |- skos__hiddenLabel mesh__D003150 Workers, Village Health
% 215.86/216.01  |- mesh__dateRevised mesh__D003150 1999-11-03
% 215.86/216.01  |- skos__hiddenLabel mesh__D003150 Community Worker
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D003150 2006
% 215.86/216.01  |- skos__prefLabel mesh__D003150 Community Health Aides
% 215.86/216.01  |- skos__hiddenLabel mesh__D003150 Health Aides, Community
% 215.86/216.01  |- mesh__publicMeSHNote mesh__D003150 71   
% 215.86/216.01  |- skos__hiddenLabel mesh__D003150 Personnel, Family Planning
% 215.86/216.01  |- mesh__recordMaintainer mesh__D003150 kle
% 215.86/216.01  |- mesh__dateEstablished mesh__D003150 1971-01-01
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D003150 2001
% 215.86/216.01  |- skos__annotation mesh__D003150 IM   
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D003150 2005
% 215.86/216.01  |- skos__hiddenLabel mesh__D003150 Planning Personnel, Family
% 215.86/216.01  |- skos__historyNote mesh__D003150
% 215.86/216.01       Community Health Services %28%1966-1970%29%
% 215.86/216.01  |- skos__hiddenLabel mesh__D003150 Health Aide, Community
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D003150 2000
% 215.86/216.01  |- mesh__historyNote mesh__D003150 71   
% 215.86/216.01  |- skos__hiddenLabel mesh__D003150 Community Health Aide
% 215.86/216.01  |- skos__broader mesh__D003150smesh__D000488
% 215.86/216.01  |- skos__hiddenLabel mesh__D003150 Health Worker, Village
% 215.86/216.01  |- mesh__dateCreated mesh__D003150 1999-01-01
% 215.86/216.01  |- skos__hiddenLabel mesh__D003150 Village Health Workers
% 215.86/216.01  |- skos__hiddenLabel mesh__D003150 Aides, Community Health
% 215.86/216.01  |- skos__hiddenLabel mesh__D003150 Worker, Community
% 215.86/216.01  |- skos__broader mesh__D016876smesh__D003722
% 215.86/216.01  |- skos__hiddenLabel mesh__D016876 Alloys, Porcelain-Metal
% 215.86/216.01  |- mesh__activeMeSHYear mesh__D016876 2001
% 215.86/216.01  |- skos__historyNote mesh__D016876 Dental Alloys %28%1971-1991%29%
% 215.86/216.01  |- mesh__publicMeSHNote mesh__D016876 92   
% 215.86/216.01  |- skos__altLabel mesh__D016876 Metallo-Ceramic Alloy
% 215.86/216.01  |- skos__altLabel mesh__D016876 Porcelain-Metal Alloys
% 215.87/216.01  |- mesh__dateEstablished mesh__D016876 1992-01-01
% 215.87/216.01  |- skos__prefLabel mesh__D016876 Metal Ceramic Alloys
% 215.87/216.01  |- skos__hiddenLabel mesh__D016876 Metallo Ceramic Alloy
% 215.87/216.01  |- skos__scopeNote mesh__D016876
% 215.87/216.01       The fusion of ceramics %28%porcelain%29% to an alloy of two or more metals for use in restorative and prosthodontic dentistry. Examples of metal alloys employed include cobalt-chromium, gold-palladium, gold-platinum-palladium, and nickel-based alloys.%A%    
% 215.87/216.01  |- mesh__activeMeSHYear mesh__D016876 2006
% 215.87/216.01  |- skos__hiddenLabel mesh__D016876 Alloy, Metallo-Ceramic
% 215.87/216.01  |- mesh__activeMeSHYear mesh__D016876 2000
% 215.87/216.01  |- skos__hiddenLabel mesh__D016876 Metallo Ceramic Alloys
% 215.87/216.01  |- mesh__historyNote mesh__D016876 92   
% 215.87/216.01  |- mesh__dateCreated mesh__D016876 1991-05-02
% 215.87/216.01  |- skos__broader mesh__D016876smesh__D000497
% 215.87/216.01  |- skos__annotation mesh__D016876
% 215.87/216.01       a dental alloy; D25-26 qualif; specify metals %28%IM or NIM%29% if particularly discussed%A%  
% 215.87/216.01  |- skos__altLabel mesh__D016876 Metal Ceramic Alloy
% 215.87/216.01  |- mesh__activeMeSHYear mesh__D016876 2005
% 215.87/216.01  |- skos__hiddenLabel mesh__D016876 Alloy, Metalloceramic
% 215.87/216.01  |- mesh__activeMeSHYear mesh__D016876 2004
% 215.87/216.01  |- skos__hiddenLabel mesh__D016876 Restorations, Metal Ceramic
% 215.87/216.01  |- rdf__type mesh__D016876sskos__Concept
% 215.87/216.01  |- skos__hiddenLabel mesh__D016876 Alloys, Metal Ceramic
% 215.87/216.01  |- skos__hiddenLabel mesh__D016876 Alloy, Metal Ceramic
% 215.87/216.01  |- skos__altLabel mesh__D016876 Metalloceramic Alloys
% 215.87/216.01  |- mesh__activeMeSHYear mesh__D016876 2002
% 215.87/216.01  |- mesh__recordMaintainer mesh__D016876 ADP
% 215.87/216.01  |- mesh__dateRevised mesh__D016876 1996-06-10
% 215.87/216.01  |- skos__hiddenLabel mesh__D016876 Alloys, Metalloceramic
% 215.87/216.01  |- mesh__activeMeSHYear mesh__D016876 1999
% 215.87/216.01  |- mesh__activeMeSHYear mesh__D016876 2003
% 215.87/216.01  |- skos__altLabel mesh__D016876 Metallo-Ceramic Alloys
% 215.87/216.01  |- skos__hiddenLabel mesh__D016876 Porcelain Metal Alloys
% 215.87/216.02  |- skos__altLabel mesh__D016876 Metalloceramic Alloy
% 215.87/216.02  |- skos__hiddenLabel mesh__D016876 Alloys, Metallo-Ceramic
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D016876 1998
% 215.87/216.02  |- mesh__recordOriginator mesh__D016876 MXR
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D016876 1997
% 215.87/216.02  |- mesh__recordAuthorizer mesh__D016876 PLS
% 215.87/216.02  |- mesh__recordMaintainer mesh__D002856 mdb
% 215.87/216.02  |- skos__scopeNote mesh__D002856
% 215.87/216.02       The large pigment cells of fish, amphibia, reptiles and many invertebrates which actively disperse and aggregate their pigment granules. These cells include MELANOPHORES, erythrophores, xanthophores, leucophores and iridiophores. %28%In algae, chromatophores refer to CHLOROPLASTS. In phototrophic bacteria chromatophores refer to membranous organelles %28%BACTERIAL CHROMATOPHORES%29%.%29%%A%    
% 215.87/216.02  |- skos__broader mesh__D002856smesh__D004847
% 215.87/216.02  |- skos__prefLabel mesh__D002856 Chromatophores
% 215.87/216.02  |- mesh__recordOriginator mesh__D002856 NLM
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002856 2004
% 215.87/216.02  |- mesh__dateCreated mesh__D002856 1999-01-01
% 215.87/216.02  |- rdf__type mesh__D002856sskos__Concept
% 215.87/216.02  |- skos__related mesh__D002856smesh__D010858
% 215.87/216.02  |- mesh__dateRevised mesh__D002856 2003-07-09
% 215.87/216.02  |- skos__annotation mesh__D002856
% 215.87/216.02       do not confuse with chromophores %28%chemical groups imparting color to a cpd%29%; BACTERIAL CHROMATOPHORES is available%A%  
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002856 2005
% 215.87/216.02  |- mesh__recordAuthorizer mesh__D002856 sjn
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002856 2006
% 215.87/216.02  |- skos__hiddenLabel mesh__D002856 Chromatophore
% 215.87/216.02  |- skos__hiddenLabel mesh__D002058 Burn, Electric
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002058 1999
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002058 2006
% 215.87/216.02  |- mesh__recordOriginator mesh__D002058 NLM
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002058 1993
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002058 2003
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002058 1996
% 215.87/216.02  |- mesh__dateRevised mesh__D002058 1990-11-10
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002058 1995
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002058 1998
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002058 2005
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002058 1992
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002058 1994
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002058 2002
% 215.87/216.02  |- rdf__type mesh__D002058sskos__Concept
% 215.87/216.02  |- mesh__dateCreated mesh__D002058 1999-01-01
% 215.87/216.02  |- skos__broader mesh__D002058smesh__D004556
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002058 2001
% 215.87/216.02  |- skos__broader mesh__D002058smesh__D002056
% 215.87/216.02  |- skos__altLabel mesh__D002058 Electric Burns
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002058 2000
% 215.87/216.02  |- mesh__recordAuthorizer mesh__D002058 PLS
% 215.87/216.02  |- skos__prefLabel mesh__D002058 Burns, Electric
% 215.87/216.02  |- mesh__recordMaintainer mesh__D002058 PXP
% 215.87/216.02  |- skos__scopeNote mesh__D002058
% 215.87/216.02       Burns produced by contact with electric current or from a sudden discharge of electricity.%A%    
% 215.87/216.02  |- skos__hiddenLabel mesh__D002058 Electric Burn
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002058 1997
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002058 2004
% 215.87/216.02  |- skos__prefLabel mesh__D007541 Isopentenyladenosine
% 215.87/216.02  |- mesh__recordAuthorizer mesh__D007541 sjn
% 215.87/216.02  |- mesh__dateEstablished mesh__D007541 1991-01-01
% 215.87/216.02  |- mesh__recordMaintainer mesh__D007541 ssb
% 215.87/216.02  |- skos__historyNote mesh__D007541 Alkenes %28%1972-1974%29%
% 215.87/216.02  |- mesh__publicMeSHNote mesh__D007541
% 215.87/216.02       91; was see under ADENOSINE 1975-90   
% 215.87/216.02  |- mesh__historyNote mesh__D007541
% 215.87/216.02       91%28%75%29%; was see under ADENOSINE 1975-90   
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D007541 2006
% 215.87/216.02  |- mesh__recordOriginator mesh__D007541 NLM
% 215.87/216.02  |- skos__scopeNote mesh__D007541
% 215.87/216.02       N%28%6%29%-%5B%delta%28%3%29%-isopentenyl%5D%adenosine. Isopentenyl derivative of adenosine which is a member of the cytokinin family of plant growth regulators.%A%    
% 215.87/216.02  |- skos__broader mesh__D007541smesh__D000241
% 215.87/216.02  |- skos__historyNote mesh__D007541 Adenosine %28%1972-1974%29%
% 215.87/216.02  |- skos__broader mesh__D007541smesh__D003583
% 215.87/216.02  |- rdf__type mesh__D007541sskos__Concept
% 215.87/216.02  |- mesh__dateCreated mesh__D007541 1974-11-19
% 215.87/216.02  |- skos__altLabel mesh__D007541
% 215.87/216.02       N%28%6%29%-%28%delta%28%2%29%-Isopentenyl%29%Adenosine
% 215.87/216.02  |- mesh__dateRevised mesh__D007541 2005-06-30
% 215.87/216.02  |- mesh__recordMaintainer mesh__D012486 SYSTEM
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D012486 2006
% 215.87/216.02  |- mesh__dateCreated mesh__D012486 1999-01-01
% 215.87/216.02  |- skos__annotation mesh__D012486
% 215.87/216.02       infection: coordinate IM with SALMONELLA INFECTIONS %28%IM%29% or SALMONELLA FOOD POISONING %28%IM%29% if pertinent%A%  
% 215.87/216.02  |- skos__scopeNote mesh__D012486
% 215.87/216.02       A serotype of Salmonella enterica that is a frequent agent of Salmonella gastroenteritis in humans. It also causes PARATYPHOID FEVER.%A%    
% 215.87/216.02  |- skos__prefLabel mesh__D012486 Salmonella typhimurium
% 215.87/216.02  |- mesh__recordOriginator mesh__D012486 NLM
% 215.87/216.02  |- skos__broader mesh__D012486smesh__D019779
% 215.87/216.02  |- rdf__type mesh__D012486sskos__Concept
% 215.87/216.02  |- mesh__recordAuthorizer mesh__D012486 sjn
% 215.87/216.02  |- mesh__dateRevised mesh__D012486 2005-06-30
% 215.87/216.02  |- skos__historyNote mesh__D020918
% 215.87/216.02       Reflex Sympathetic Dystrophy %28%1995-1999%29%
% 215.87/216.02  |- skos__broader mesh__D020918smesh__D001342
% 215.87/216.02  |- skos__scopeNote mesh__D020918
% 215.87/216.02       Conditions characterized by pain involving an extremity or other body region, HYPERESTHESIA, and localized autonomic dysfunction following injury to soft tissue or nerve. The pain is usually associated with ERYTHEMA; SKIN TEMPERATURE changes, abnormal sudomotor activity %28%i.e., changes in sweating due to altered sympathetic innervation%29% or edema. The degree of pain and other manifestations is out of proportion to that expected from the inciting event. Two subtypes of this condition have been described: type I; %28%REFLEX SYMPATHETIC DYSTROPHY%29% and type II; %28%CAUSALGIA%29%. %28%From Pain 1995 Oct;63%28%1%29%:127-33%29%%A%    
% 215.87/216.02  |- mesh__recordOriginator mesh__D020918 KEV
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D020918 2005
% 215.87/216.02  |- skos__altLabel mesh__D020918 Pain Syndromes, Regional Complex
% 215.87/216.02  |- mesh__recordMaintainer mesh__D020918 mdb
% 215.87/216.02  |- skos__broader mesh__D020918smesh__D010523
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D020918 2006
% 215.87/216.02  |- mesh__recordAuthorizer mesh__D020918 sjn
% 215.87/216.02  |- rdf__type mesh__D020918sskos__Concept
% 215.87/216.02  |- mesh__dateCreated mesh__D020918 1999-11-03
% 215.87/216.02  |- skos__altLabel mesh__D020918
% 215.87/216.02       CRPS %28%Complex Regional Pain Syndromes%29%
% 215.87/216.02  |- mesh__publicMeSHNote mesh__D020918 2000   
% 215.87/216.02  |- mesh__historyNote mesh__D020918 2000   
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D020918 2003
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D020918 2002
% 215.87/216.02  |- mesh__dateEstablished mesh__D020918 2000-01-01
% 215.87/216.02  |- skos__prefLabel mesh__D020918 Complex Regional Pain Syndromes
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D020918 2004
% 215.87/216.02  |- mesh__dateRevised mesh__D020918 2001-07-25
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D006449 2004
% 215.87/216.02  |- mesh__dateCreated mesh__D006449 1976-04-27
% 215.87/216.02  |- mesh__dateRevised mesh__D006449 1995-03-17
% 215.87/216.02  |- skos__historyNote mesh__D006449 Hemoglobins, Abnormal %28%1966-1976%29%
% 215.87/216.02  |- skos__hiddenLabel mesh__D006449 M, Hemoglobin
% 215.87/216.02  |- mesh__publicMeSHNote mesh__D006449
% 215.87/216.02       91; was see under HEMOGLOBINS, ABNORMAL 1977-90   
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D006449 1998
% 215.87/216.02  |- skos__annotation mesh__D006449
% 215.87/216.02       an abnorm hemoglobin; /urine: coord IM with HEMOGLOBINURIA %28%IM%29%; DF: HBM%A%  
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D006449 2000
% 215.87/216.02  |- skos__prefLabel mesh__D006449 Hemoglobin M
% 215.87/216.02  |- mesh__historyNote mesh__D006449
% 215.87/216.02       91%28%77%29%; was see under HEMOGLOBINS, ABNORMAL 1977-90   
% 215.87/216.02  |- skos__scopeNote mesh__D006449
% 215.87/216.02       A group of abnormal hemoglobins in which amino acid substitutions take place in either the alpha or beta chains but near the heme iron. This results in facilitated oxidation of the hemoglobin to yield excess methemoglobin which leads to cyanosis.%A%    
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D006449 1999
% 215.87/216.02  |- mesh__dateEstablished mesh__D006449 1991-01-01
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D006449 1996
% 215.87/216.02  |- rdf__type mesh__D006449sskos__Concept
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D006449 2001
% 215.87/216.02  |- mesh__recordOriginator mesh__D006449 RLS
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D006449 1997
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D006449 2005
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D006449 2002
% 215.87/216.02  |- skos__broader mesh__D006449smesh__D006455
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D006449 2006
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D006449 2003
% 215.87/216.02  |- mesh__recordMaintainer mesh__D006449 TGC
% 215.87/216.02  |- mesh__recordAuthorizer mesh__D006449 PLS
% 215.87/216.02  |- mesh__dateCreated mesh__D017171 1992-05-22
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D017171 2006
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D017171 2005
% 215.87/216.02  |- skos__historyNote mesh__D017171 Strongyloides %28%1966-1992%29%
% 215.87/216.02  |- skos__broader mesh__D017171smesh__D013321
% 215.87/216.02  |- rdf__type mesh__D017171sskos__Concept
% 215.87/216.02  |- mesh__dateEstablished mesh__D017171 1993-01-01
% 215.87/216.02  |- mesh__historyNote mesh__D017171 93   
% 215.87/216.02  |- skos__prefLabel mesh__D017171 Strongyloides stercoralis
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D017171 2004
% 215.87/216.02  |- mesh__publicMeSHNote mesh__D017171 93   
% 215.87/216.02  |- skos__scopeNote mesh__D017171
% 215.87/216.02       A species of parasitic nematode widely distributed in tropical and subtropical countries. The females and their larvae inhabit the mucosa of the intestinal tract, where they cause ulceration and diarrhea.%A%    
% 215.87/216.02  |- mesh__dateRevised mesh__D017171 2003-07-09
% 215.87/216.02  |- skos__annotation mesh__D017171
% 215.87/216.02       a species of nematode; infection: coord IM with STRONGYLOIDIASIS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 215.87/216.02  |- skos__scopeNote mesh__D025603
% 215.87/216.02       Photosensory rhodopsins found in microorganisms such as HALOBACTERIA. They convert light signals into biochemical information that regulates certain cellular functions such as flagellar motor activity.%A%    
% 215.87/216.02  |- mesh__recordMaintainer mesh__D025603 SYSTEM
% 215.87/216.02  |- mesh__historyNote mesh__D025603 2002   
% 215.87/216.02  |- skos__broader mesh__D025603smesh__D025604
% 215.87/216.02  |- mesh__recordAuthorizer mesh__D025603 sjn
% 215.87/216.02  |- mesh__publicMeSHNote mesh__D025603 2002   
% 215.87/216.02  |- mesh__dateCreated mesh__D025603 2001-07-25
% 215.87/216.02  |- rdf__type mesh__D025603sskos__Concept
% 215.87/216.02  |- mesh__dateRevised mesh__D025603 2005-06-30
% 215.87/216.02  |- skos__annotation mesh__D025603 do not confuse with RHODOPSIN   
% 215.87/216.02  |- skos__hiddenLabel mesh__D025603 Rhodopsins, Sensory
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D025603 2006
% 215.87/216.02  |- skos__historyNote mesh__D025603 Bacteriorhodopsin %28%1988-2001%29%
% 215.87/216.02  |- mesh__dateEstablished mesh__D025603 2002-01-01
% 215.87/216.02  |- mesh__recordOriginator mesh__D025603 jmp
% 215.87/216.02  |- skos__prefLabel mesh__D025603 Sensory Rhodopsins
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D003151 2003
% 215.87/216.02  |- mesh__publicMeSHNote mesh__D003151
% 215.87/216.02       79; was NEIGHBORHOOD HEALTH CENTERS see under COMMUNITY HEALTH SERVICES 1968-78%A%  
% 215.87/216.02  |- skos__hiddenLabel mesh__D003151 Centers, Neighborhood Health
% 215.87/216.02  |- skos__broader mesh__D003151smesh__D000554
% 215.87/216.02  |- mesh__dateRevised mesh__D003151 1999-11-03
% 215.87/216.02  |- skos__hiddenLabel mesh__D003151 Community Health Center
% 215.87/216.02  |- skos__altLabel mesh__D003151 Satellite Centers
% 215.87/216.02  |- mesh__onlineNote mesh__D003151
% 215.87/216.02       use COMMUNITY HEALTH CENTERS to search NEIGHBORHOOD HEALTH CENTERS 1975-78; use COMMUNITY HEALTH SERVICES 1968-74%A%  
% 215.87/216.02  |- mesh__historyNote mesh__D003151
% 215.87/216.02       79; was NEIGHBORHOOD HEALTH CENTERS see under COMMUNITY HEALTH SERVICES 1968-78%A%  
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D003151 2002
% 215.87/216.02  |- skos__hiddenLabel mesh__D003151 Centers, Community Health
% 215.87/216.02  |- mesh__dateCreated mesh__D003151 1999-01-01
% 215.87/216.02  |- skos__hiddenLabel mesh__D003151 Center, Community Health
% 215.87/216.02  |- skos__hiddenLabel mesh__D003151 Neighborhood Health Center
% 215.87/216.02  |- skos__hiddenLabel mesh__D003151 Health Center, Community
% 215.87/216.02  |- mesh__dateEstablished mesh__D003151 1979-01-01
% 215.87/216.02  |- skos__hiddenLabel mesh__D003151 Health Centers, Neighborhood
% 215.87/216.02  |- skos__hiddenLabel mesh__D003151 Health Centers, Community
% 215.87/216.02  |- skos__hiddenLabel mesh__D003151 Center, Neighborhood Health
% 215.87/216.02  |- skos__hiddenLabel mesh__D003151 Center, Satellite
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D003151 2006
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D003151 2004
% 215.87/216.02  |- mesh__recordAuthorizer mesh__D003151 sjn
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D003151 2001
% 215.87/216.02  |- skos__historyNote mesh__D003151
% 215.87/216.02       Community Health Services %28%1966-1974%29%
% 215.87/216.02  |- skos__hiddenLabel mesh__D003151 Health Center, Neighborhood
% 215.87/216.02  |- skos__scopeNote mesh__D003151
% 215.87/216.02       Facilities which administer the delivery of health care services to people living in a community or neighborhood.%A%    
% 215.87/216.02  |- mesh__recordOriginator mesh__D003151 NLM
% 215.87/216.02  |- skos__hiddenLabel mesh__D003151 Satellite Center
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D003151 2000
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D003151 2005
% 215.87/216.02  |- skos__hiddenLabel mesh__D003151 Centers, Satellite
% 215.87/216.02  |- mesh__recordMaintainer mesh__D003151 kle
% 215.87/216.02  |- rdf__type mesh__D003151sskos__Concept
% 215.87/216.02  |- skos__annotation mesh__D003151 IM   
% 215.87/216.02  |- skos__prefLabel mesh__D003151 Community Health Centers
% 215.87/216.02  |- rdf__type mesh__D016877sskos__Concept
% 215.87/216.02  |- skos__prefLabel mesh__D016877 Oxidants
% 215.87/216.02  |- skos__broader mesh__D016877smesh__D009676
% 215.87/216.02  |- mesh__publicMeSHNote mesh__D016877 92   
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D016877 2004
% 215.87/216.02  |- skos__hiddenLabel mesh__D016877 Agents, Oxidizing
% 215.87/216.02  |- mesh__dateCreated mesh__D016877 1991-05-02
% 215.87/216.02  |- mesh__recordOriginator mesh__D016877 MXR
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D016877 2006
% 215.87/216.02  |- skos__annotation mesh__D016877 /biosyn /physiol permitted   
% 215.87/216.02  |- skos__broader mesh__D016877smesh__D020313
% 215.87/216.02  |- mesh__recordAuthorizer mesh__D016877 sjn
% 215.87/216.02  |- mesh__historyNote mesh__D016877 92   
% 215.87/216.02  |- mesh__recordMaintainer mesh__D016877 ssb
% 215.87/216.02  |- skos__related mesh__D016877smesh__D000975
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D016877 2005
% 215.87/216.02  |- skos__historyNote mesh__D016877 Oxidation-Reduction %28%1966-1991%29%
% 215.87/216.02  |- skos__altLabel mesh__D016877 Oxidizing Agents
% 215.87/216.02  |- skos__scopeNote mesh__D016877
% 215.87/216.02       Oxidizing agents or electron-accepting molecules in chemical reactions in which electrons are transferred from one molecule to another %28%OXIDATION-REDUCTION%29%. In vivo, it appears that phagocyte-generated oxidants function as tumor promoters or cocarcinogens rather than as complete carcinogens perhaps because of the high levels of endogenous antioxidant defenses. It is also thought that oxidative damage in joints may trigger the autoimmune response that characterizes the persistence of the rheumatoid disease process.%A%    
% 215.87/216.02  |- mesh__dateEstablished mesh__D016877 1992-01-01
% 215.87/216.02  |- mesh__dateRevised mesh__D016877 2003-07-09
% 215.87/216.02  |- rdf__type mesh__D016079sskos__Concept
% 215.87/216.02  |- mesh__publicMeSHNote mesh__D016079 91   
% 215.87/216.02  |- skos__hiddenLabel mesh__D016079 Abandonment, Patient
% 215.87/216.02  |- mesh__dateCreated mesh__D016079 1990-06-07
% 215.87/216.02  |- mesh__dateRevised mesh__D016079 2002-10-31
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D016079 2006
% 215.87/216.02  |- mesh__dateEstablished mesh__D016079 1991-01-01
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D016079 2002
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D016079 2005
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D016079 2003A
% 215.87/216.02  |- skos__annotation mesh__D016079
% 215.87/216.02       refusal of a health professional to treat a patient: do not confuse with PATIENT REFUSAL OF TREATMENT see TREATMENT REFUSAL%A%  
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D016079 2001
% 215.87/216.02  |- skos__broader mesh__D016079smesh__D011320
% 215.87/216.02  |- mesh__recordMaintainer mesh__D016079 jls
% 215.87/216.02  |- skos__prefLabel mesh__D016079 Refusal to Treat
% 215.87/216.02  |- mesh__historyNote mesh__D016079 91   
% 215.87/216.02  |- skos__scopeNote mesh__D016079
% 215.87/216.02       Refusal of the health professional to initiate or continue treatment of a patient or group of patients. The refusal can be based on any reason. The concept is differentiated from PATIENT REFUSAL OF TREATMENT see TREATMENT REFUSAL which originates with the patient and not the health professional.%A%    
% 215.87/216.02  |- skos__historyNote mesh__D016079
% 215.87/216.02       Continuity of Patient Care %28%1975-1990%29%
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D016079 2004
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D016079 2000
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D016079 1999
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D016079 2003
% 215.87/216.02  |- skos__historyNote mesh__D016079
% 215.87/216.02       Physician-Patient Relations %28%1966-1990%29%
% 215.87/216.02  |- skos__historyNote mesh__D016079
% 215.87/216.02       Attitude of Health Personnel %28%1968-1990%29%
% 215.87/216.02  |- mesh__recordOriginator mesh__D016079 TGC
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D016079 1998
% 215.87/216.02  |- mesh__recordAuthorizer mesh__D016079 jls
% 215.87/216.02  |- skos__broader mesh__D016079smesh__D001291
% 215.87/216.02  |- skos__related mesh__D002857smesh__D002859
% 215.87/216.02  |- skos__scopeNote mesh__D002857
% 215.87/216.02       A trace element that plays a role in glucose metabolism. It has the atomic symbol Cr, atomic number 24, and atomic weight 52. According to the Fourth Annual Report on Carcinogens %28%NTP85-002,1985%29%, chromium and some of its compounds have been listed as known carcinogens.%A%    
% 215.87/216.02  |- mesh__recordAuthorizer mesh__D002857 sjn
% 215.87/216.02  |- skos__annotation mesh__D002857 Cr-52   
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002857 2006
% 215.87/216.02  |- mesh__recordOriginator mesh__D002857 NLM
% 215.87/216.02  |- skos__broader mesh__D002857smesh__D028561
% 215.87/216.02  |- skos__broader mesh__D002857smesh__D019216
% 215.87/216.02  |- mesh__dateRevised mesh__D002857 2005-06-30
% 215.87/216.02  |- mesh__dateCreated mesh__D002857 1999-01-01
% 215.87/216.02  |- mesh__recordMaintainer mesh__D002857 ssb
% 215.87/216.02  |- skos__related mesh__D002857smesh__D002860
% 215.87/216.02  |- rdf__type mesh__D002857sskos__Concept
% 215.87/216.02  |- skos__prefLabel mesh__D002857 Chromium
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002059 1996
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002059 2003
% 215.87/216.02  |- skos__altLabel mesh__D002059 Inhalation Burns
% 215.87/216.02  |- mesh__recordAuthorizer mesh__D002059 PLS
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002059 2000
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002059 1998
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002059 2005
% 215.87/216.02  |- skos__hiddenLabel mesh__D002059 Inhalation Burn
% 215.87/216.02  |- skos__hiddenLabel mesh__D002059 Burn, Inhalation
% 215.87/216.02  |- mesh__recordOriginator mesh__D002059 NLM
% 215.87/216.02  |- rdf__type mesh__D002059sskos__Concept
% 215.87/216.02  |- skos__scopeNote mesh__D002059
% 215.87/216.02       Burns of the respiratory tract caused by heat or inhaled chemicals.%A%    
% 215.87/216.02  |- mesh__dateCreated mesh__D002059 1999-01-01
% 215.87/216.02  |- skos__broader mesh__D002059smesh__D002056
% 215.87/216.02  |- skos__prefLabel mesh__D002059 Burns, Inhalation
% 215.87/216.02  |- mesh__recordMaintainer mesh__D002059 TGC
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002059 2002
% 215.87/216.02  |- mesh__dateRevised mesh__D002059 1995-02-23
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002059 1997
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002059 2004
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002059 2001
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002059 1999
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D002059 2006
% 215.87/216.02  |- skos__annotation mesh__D002059
% 215.87/216.02       resp tract burns from heat or chemicals; SMOKE INHALATION INJURY is also available%A%  
% 215.87/216.02  |- mesh__dateEstablished mesh__D007542 1991-01-01
% 215.87/216.02  |- skos__prefLabel mesh__D007542 Inosine Pranobex
% 215.87/216.02  |- skos__altLabel mesh__D007542 Metisoprinol
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D007542 2006
% 215.87/216.02  |- skos__historyNote mesh__D007542
% 215.87/216.02       Acetanilides %28%1974%29% /analogs %26% derivatives %28%1975%29%
% 215.87/216.02  |- skos__hiddenLabel mesh__D007542 Pranobex, Inosine
% 215.87/216.02  |- skos__scopeNote mesh__D007542
% 215.87/216.02       An alkylamino-alcohol complex of inosine used in the treatment of a variety of viral infections. Unlike other antiviral agents, it acts by modifying or stimulating cell-mediated immune processes rather than acting on the virus directly.%A%    
% 215.87/216.02  |- skos__historyNote mesh__D007542 Dimethylamines %28%1974-1975%29%
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D007542 2002
% 215.87/216.02  |- skos__historyNote mesh__D007542
% 215.87/216.02       Inosine %28%1974%29% /analogs %26% derivatives %28%1975%29%
% 215.87/216.02  |- skos__altLabel mesh__D007542 Methysoprinol
% 215.87/216.02  |- mesh__recordOriginator mesh__D007542 SH
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D007542 2003
% 215.87/216.02  |- mesh__recordAuthorizer mesh__D007542 sjn
% 215.87/216.02  |- skos__altLabel mesh__D007542 Methisoprinol
% 215.87/216.02  |- mesh__dateRevised mesh__D007542 2001-07-25
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D007542 2004
% 215.87/216.02  |- mesh__historyNote mesh__D007542
% 215.87/216.02       96; was ISOPRINOSINE 1976-95 %28%see under INOSINE 1976-90%29%   
% 215.87/216.02  |- mesh__dateCreated mesh__D007542 1975-07-23
% 215.87/216.02  |- skos__hiddenLabel mesh__D007542 NPT10381
% 215.87/216.02  |- rdf__type mesh__D007542sskos__Concept
% 215.87/216.02  |- skos__broader mesh__D007542smesh__D007288
% 215.87/216.02  |- mesh__recordMaintainer mesh__D007542 jmp
% 215.87/216.02  |- skos__altLabel mesh__D007542 Isoprinosine
% 215.87/216.02  |- mesh__publicMeSHNote mesh__D007542
% 215.87/216.02       96; was ISOPRINOSINE 1976-95 %28%see under INOSINE 1976-90%29%   
% 215.87/216.02  |- skos__broader mesh__D007542smesh__D000083
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D007542 2005
% 215.87/216.02  |- skos__hiddenLabel mesh__D007542 NPT 10381
% 215.87/216.02  |- skos__altLabel mesh__D007542 Inosiplex
% 215.87/216.02  |- rdf__type mesh__D012487sskos__Concept
% 215.87/216.02  |- mesh__recordAuthorizer mesh__D012487 ags
% 215.87/216.02  |- mesh__dateRevised mesh__D012487 2005-07-29
% 215.87/216.02  |- mesh__historyNote mesh__D012487 1968   
% 215.87/216.02  |- skos__hiddenLabel mesh__D012487 Salmonid
% 215.87/216.02  |- skos__scopeNote mesh__D012487
% 215.87/216.02       A family of anadromous fish comprising SALMON; TROUT; whitefish; and graylings. They are the most important food and game fishes. Their habitat is the northern Atlantic and Pacific, both marine and inland, and the Great Lakes. %28%Nelson: Fishes of the World, 1976, p97%29%%A%    
% 215.87/216.02  |- mesh__dateEstablished mesh__D012487 1968-01-01
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D012487 2006A
% 215.87/216.02  |- skos__annotation mesh__D012487
% 215.87/216.02       GEN or unspecified; prefer SALMON %26% TROUT but check text for genera Oncorhynchus %26% Salmo: some are salmon, some are trout%A%  
% 215.87/216.02  |- mesh__recordMaintainer mesh__D012487 ags
% 215.87/216.02  |- mesh__publicMeSHNote mesh__D012487 1968   
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D012487 2004
% 215.87/216.02  |- skos__hiddenLabel mesh__D012487 Grayling
% 215.87/216.02  |- skos__altLabel mesh__D012487 Salmonids
% 215.87/216.02  |- skos__broader mesh__D012487smesh__D017858
% 215.87/216.02  |- skos__altLabel mesh__D012487 Thymallus
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D012487 2006
% 215.87/216.02  |- mesh__recordOriginator mesh__D012487 NLM
% 215.87/216.02  |- mesh__dateCreated mesh__D012487 1999-01-01
% 215.87/216.02  |- skos__prefLabel mesh__D012487 Salmonidae
% 215.87/216.02  |- skos__historyNote mesh__D012487 Fishes %28%1966-1967%29%
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D012487 2005
% 215.87/216.02  |- skos__hiddenLabel mesh__D020919 Sleep State Misperceptions
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D020919 2005
% 215.87/216.02  |- skos__hiddenLabel mesh__D020919 Posttraumatic Hypersomnias
% 215.87/216.02  |- skos__hiddenLabel mesh__D020919 Posttraumatic Hypersomnia
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D020919 2006
% 215.87/216.02  |- rdf__type mesh__D020919sskos__Concept
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D020919 2000
% 215.87/216.02  |- skos__scopeNote mesh__D020919
% 215.87/216.02       Dyssomnias %28%i.e., insomnias or hypersomnias%29% associated with dysfunction of internal sleep mechanisms or secondary to a sleep-related medical disorder %28%e.g., sleep apnea, post-traumatic sleep disorders, etc.%29%. %28%From Thorpy, Sleep Disorders Medicine, 1994, p187%29%%A%    
% 215.87/216.02  |- mesh__historyNote mesh__D020919 2000   
% 215.87/216.02  |- skos__hiddenLabel mesh__D020919 Post-Traumatic Hypersomnia
% 215.87/216.02  |- skos__hiddenLabel mesh__D020919 Hypersomnias, Post-Traumatic
% 215.87/216.02  |- skos__hiddenLabel mesh__D020919 Hypersomnias, Posttraumatic
% 215.87/216.02  |- skos__hiddenLabel mesh__D020919 Intrinsic Sleep Disorder
% 215.87/216.02  |- skos__prefLabel mesh__D020919 Sleep Disorders, Intrinsic
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D020919 2003
% 215.87/216.02  |- mesh__dateEstablished mesh__D020919 2000-01-01
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D020919 2001
% 215.87/216.02  |- skos__hiddenLabel mesh__D020919 Sleep Disorder, Intrinsic
% 215.87/216.02  |- skos__altLabel mesh__D020919 Hypersomnia, Posttraumatic
% 215.87/216.02  |- skos__broader mesh__D020919smesh__D020920
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D020919 2004
% 215.87/216.02  |- skos__altLabel mesh__D020919 Intrinsic Sleep Disorders
% 215.87/216.02  |- skos__hiddenLabel mesh__D020919 Post-Traumatic Hypersomnias
% 215.87/216.02  |- mesh__publicMeSHNote mesh__D020919 2000   
% 215.87/216.02  |- skos__hiddenLabel mesh__D020919 Hypersomnia, Post Traumatic
% 215.87/216.02  |- mesh__dateCreated mesh__D020919 1999-11-09
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D020919 2002
% 215.87/216.02  |- mesh__dateCreated mesh__D017970 1993-06-21
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D017970 1995
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D017970 1998
% 215.87/216.02  |- mesh__publicMeSHNote mesh__D017970 94   
% 215.87/216.02  |- skos__prefLabel mesh__D017970 Thorium Compounds
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D017970 2001
% 215.87/216.02  |- skos__scopeNote mesh__D017970
% 215.87/216.02       Inorganic compounds that contain thorium as an integral part of the molecule.%A%    
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D017970 1994
% 215.87/216.02  |- mesh__historyNote mesh__D017970 94   
% 215.87/216.02  |- skos__hiddenLabel mesh__D017970 Compounds, Thorium
% 215.87/216.02  |- skos__historyNote mesh__D017970 Thorium %28%1966-1993%29%
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D017970 2000
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D017970 2004
% 215.87/216.02  |- mesh__dateEstablished mesh__D017970 1994-01-01
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D017970 2006
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D017970 2003
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D017970 2005
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D017970 1997
% 215.87/216.02  |- rdf__type mesh__D017970sskos__Concept
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D017970 1999
% 215.87/216.02  |- skos__broader mesh__D017970smesh__D007287
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D017970 2002
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D017970 1996
% 215.87/216.02  |- skos__annotation mesh__D017970
% 215.87/216.02       inorganic; GEN or unspecified; prefer specifics; DF: THORIUM CPDS%A%  
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D031641 2003
% 215.87/216.02  |- skos__altLabel mesh__D031641 Sweet Gale
% 215.87/216.02  |- skos__broader mesh__D031641smesh__D029590
% 215.87/216.02  |- skos__scopeNote mesh__D031641
% 215.87/216.02       A plant genus of the family MYRICACEAE. Members contain myricanol. The common name of bayberry is similar to the name barberry which is used for BERBERIS and MAHONIA.%A%    
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D031641 2006
% 215.87/216.02  |- skos__altLabel mesh__D031641 Bayberry
% 215.87/216.02  |- mesh__activeMeSHYear mesh__D031641 2004
% 215.87/216.02  |- mesh__dateEstablished mesh__D031641 2003-01-01
% 215.87/216.02  |- rdf__type mesh__D031641sskos__Concept
% 215.87/216.02  |- skos__annotation mesh__D031641
% 215.87/216.02       X ref BOG MYRTLE: MYRTLE see MYRTUS is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.87/216.02  |- mesh__publicMeSHNote mesh__D031641 2003   
% 215.87/216.02  |- mesh__historyNote mesh__D031641 2003   
% 215.87/216.03  |- mesh__dateCreated mesh__D031641 2002-07-02
% 215.87/216.03  |- skos__altLabel mesh__D031641 Bog Myrtle
% 215.87/216.03  |- skos__altLabel mesh__D031641 Myrtle, Bog
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D031641 2005
% 215.87/216.03  |- skos__prefLabel mesh__D031641 Myrica
% 215.87/216.03  |- rdf__type mesh__D017172sskos__Concept
% 215.87/216.03  |- skos__annotation mesh__D017172
% 215.87/216.03       a superfamily of nematodes; do not confuse with the order RHABDITIDA; infection: coord IM with RHABDITIDA INFECTIONS %28%IM%29%%A%  
% 215.87/216.03  |- skos__broader mesh__D017172smesh__D017168
% 215.87/216.03  |- mesh__publicMeSHNote mesh__D017172
% 215.87/216.03       93,63-85; was see NEMATODA 1986-92; RHABDITIS %26% TURBATRIX were see NEMATODA 1986-92%A%  
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D017172 2004
% 215.87/216.03  |- skos__historyNote mesh__D017172 Nematoda %28%1966-1992%29%
% 215.87/216.03  |- mesh__onlineNote mesh__D017172
% 215.87/216.03       use NEMATODA to search RHABDITOIDEA 1966-92 %26% RHABDITIS %26% TURBATRIX 1986-92%A%  
% 215.87/216.03  |- skos__prefLabel mesh__D017172 Rhabditoidea
% 215.87/216.03  |- skos__scopeNote mesh__D017172
% 215.87/216.03       A superfamily of nematodes of the order RHABDITIDA. Characteristics include an open tube stoma and an excretory system with lateral canals.%A%    
% 215.87/216.03  |- mesh__dateRevised mesh__D017172 2003-07-09
% 215.87/216.03  |- mesh__dateCreated mesh__D017172 1992-05-22
% 215.87/216.03  |- mesh__dateEstablished mesh__D017172 1993-01-01
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D017172 2006
% 215.87/216.03  |- mesh__historyNote mesh__D017172
% 215.87/216.03       93,63-85; was see NEMATODA 1986-92; RHABDITIS %26% TURBATRIX were see NEMATODA 1986-92%A%  
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D017172 2005
% 215.87/216.03  |- skos__annotation mesh__D003950
% 215.87/216.03       GEN or unspecified; prefer specifics; DF: DIAG TECHNIQUES UROL%A%  
% 215.87/216.03  |- mesh__recordOriginator mesh__D003950 NLM
% 215.87/216.03  |- skos__historyNote mesh__D003950 specific technique %28%1966-1997%29%
% 215.87/216.03  |- mesh__dateCreated mesh__D003950 1999-01-01
% 215.87/216.03  |- skos__hiddenLabel mesh__D003950 Technic, Urologic Diagnostic
% 215.87/216.03  |- mesh__dateRevised mesh__D003950 1997-06-20
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003950 2001
% 215.87/216.03  |- skos__hiddenLabel mesh__D003950 Urologic Diagnostic Technics
% 215.87/216.03  |- skos__altLabel mesh__D003950 Techniques, Urological Diagnostic
% 215.87/216.03  |- skos__hiddenLabel mesh__D003950 Technics, Urologic Diagnostic
% 215.87/216.03  |- skos__hiddenLabel mesh__D003950 Techniques, Urologic Diagnostic
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003950 1998
% 215.87/216.03  |- skos__altLabel mesh__D003950 Technic, Urological Diagnostic
% 215.87/216.03  |- skos__altLabel mesh__D003950 Urological Diagnostic Technique
% 215.87/216.03  |- mesh__historyNote mesh__D003950 98; use explode 1975-97   
% 215.87/216.03  |- skos__altLabel mesh__D003950 Technique, Urological Diagnostic
% 215.87/216.03  |- mesh__dateEstablished mesh__D003950 1998-01-01
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003950 2006
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003950 2000
% 215.87/216.03  |- skos__altLabel mesh__D003950 Diagnostic Technique, Urological
% 215.87/216.03  |- skos__hiddenLabel mesh__D003950 Diagnostic Technique, Urologic
% 215.87/216.03  |- skos__altLabel mesh__D003950 Urological Diagnostic Techniques
% 215.87/216.03  |- skos__broader mesh__D003950smesh__D019937
% 215.87/216.03  |- mesh__publicMeSHNote mesh__D003950 98   
% 215.87/216.03  |- mesh__recordAuthorizer mesh__D003950 SJN
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003950 2005
% 215.87/216.03  |- skos__altLabel mesh__D003950 Technics, Urological Diagnostic
% 215.87/216.03  |- skos__altLabel mesh__D003950 Diagnostic Technics, Urological
% 215.87/216.03  |- mesh__recordMaintainer mesh__D003950 TGC
% 215.87/216.03  |- rdf__type mesh__D003950sskos__Concept
% 215.87/216.03  |- skos__hiddenLabel mesh__D003950 Urologic Diagnostic Technique
% 215.87/216.03  |- skos__scopeNote mesh__D003950
% 215.87/216.03       Methods and procedures for the diagnosis of diseases or dysfunction of the urinary tract or its organs or demonstration of its physiological processes.%A%    
% 215.87/216.03  |- skos__altLabel mesh__D003950 Urological Diagnostic Technic
% 215.87/216.03  |- skos__altLabel mesh__D003950 Urological Diagnostic Technics
% 215.87/216.03  |- skos__hiddenLabel mesh__D003950 Technique, Urologic Diagnostic
% 215.87/216.03  |- skos__altLabel mesh__D003950 Diagnostic Technic, Urological
% 215.87/216.03  |- skos__hiddenLabel mesh__D003950 Urologic Diagnostic Techniques
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003950 2004
% 215.87/216.03  |- skos__altLabel mesh__D003950 Diagnostic Techniques, Urologic
% 215.87/216.03  |- skos__altLabel mesh__D003950 Diagnostic Technics, Urologic
% 215.87/216.03  |- skos__hiddenLabel mesh__D003950 Diagnostic Technic, Urologic
% 215.87/216.03  |- skos__hiddenLabel mesh__D003950 Urologic Diagnostic Technic
% 215.87/216.03  |- skos__prefLabel mesh__D003950 Diagnostic Techniques, Urological
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003950 2002
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003950 2003
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003950 1999
% 215.87/216.03  |- skos__hiddenLabel mesh__D025604 Rhodopsins, Bacterial
% 215.87/216.03  |- skos__hiddenLabel mesh__D025604 Rhodopsins, Archaeal
% 215.87/216.03  |- mesh__publicMeSHNote mesh__D025604 2002   
% 215.87/216.03  |- rdf__type mesh__D025604sskos__Concept
% 215.87/216.03  |- mesh__historyNote mesh__D025604 2002   
% 215.87/216.03  |- skos__annotation mesh__D025604
% 215.87/216.03       Do not confuse X ref BACTERIAL RHODOPSINS with BACTERIORHODOPSINS%A%  
% 215.87/216.03  |- skos__scopeNote mesh__D025604
% 215.87/216.03       Rhodopsin molecules found in microorganisms such as ARCHAEA and PROTEOBACTERIA.%A%    
% 215.87/216.03  |- skos__prefLabel mesh__D025604 Rhodopsins, Microbial
% 215.87/216.03  |- mesh__recordAuthorizer mesh__D025604 sjn
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D025604 2006
% 215.87/216.03  |- mesh__dateCreated mesh__D025604 2001-07-25
% 215.87/216.03  |- mesh__dateEstablished mesh__D025604 2002-01-01
% 215.87/216.03  |- mesh__dateRevised mesh__D025604 2005-06-30
% 215.87/216.03  |- skos__hiddenLabel mesh__D025604 Microbial Rhodopsins
% 215.87/216.03  |- mesh__recordMaintainer mesh__D025604 SYSTEM
% 215.87/216.03  |- skos__broader mesh__D025604smesh__D020283
% 215.87/216.03  |- mesh__recordOriginator mesh__D025604 jmp
% 215.87/216.03  |- skos__scopeNote mesh__D003152
% 215.87/216.03       General and comprehensive nursing practice directed to individuals, families, or groups as it relates to and contributes to the health of a population. This is not an official program of a Public Health Department.%A%    
% 215.87/216.03  |- skos__hiddenLabel mesh__D003152 Nursings, Community Health
% 215.87/216.03  |- skos__hiddenLabel mesh__D003152 Health Nursing, Community
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003152 2000
% 215.87/216.03  |- mesh__recordOriginator mesh__D003152 NLM
% 215.87/216.03  |- mesh__dateCreated mesh__D003152 1974-11-11
% 215.87/216.03  |- mesh__historyNote mesh__D003152
% 215.87/216.03       77%28%75%29%; was see under COMMUNITY HEALTH SERVICES 1975-76   
% 215.87/216.03  |- mesh__publicMeSHNote mesh__D003152
% 215.87/216.03       77; was see under COMMUNITY HEALTH SERVICES 1975-76   
% 215.87/216.03  |- mesh__recordMaintainer mesh__D003152 kle
% 215.87/216.03  |- skos__altLabel mesh__D003152 Nursing, Community Health
% 215.87/216.03  |- skos__prefLabel mesh__D003152 Community Health Nursing
% 215.87/216.03  |- skos__hiddenLabel mesh__D003152 Community Health Nursings
% 215.87/216.03  |- skos__hiddenLabel mesh__D003152 Health Visitor
% 215.87/216.03  |- mesh__dateRevised mesh__D003152 1999-11-03
% 215.87/216.03  |- skos__hiddenLabel mesh__D003152 Visitor, Health
% 215.87/216.03  |- skos__broader mesh__D003152smesh__D003153
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003152 2006
% 215.87/216.03  |- skos__broader mesh__D003152smesh__D013041
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003152 2002
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003152 2004
% 215.87/216.03  |- skos__hiddenLabel mesh__D003152 Health Nursings, Community
% 215.87/216.03  |- skos__hiddenLabel mesh__D003152 Nurses, Visiting
% 215.87/216.03  |- skos__hiddenLabel mesh__D003152 Nurse, Visiting
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003152 2005
% 215.87/216.03  |- rdf__type mesh__D003152sskos__Concept
% 215.87/216.03  |- skos__hiddenLabel mesh__D003152 Visitors, Health
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003152 2003
% 215.87/216.03  |- skos__annotation mesh__D003152
% 215.87/216.03       SPEC qualif; do not confuse with PUBLIC HEALTH NURSING %28%a government function%29%%A%  
% 215.87/216.03  |- skos__hiddenLabel mesh__D003152 Visiting Nurse
% 215.87/216.03  |- mesh__dateEstablished mesh__D003152 1977-01-01
% 215.87/216.03  |- mesh__recordAuthorizer mesh__D003152 sjn
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003152 2001
% 215.87/216.03  |- skos__broader mesh__D016878smesh__D011115
% 215.87/216.03  |- skos__broader mesh__D016878smesh__D000015
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D016878 2001
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D016878 2000A
% 215.87/216.03  |- skos__hiddenLabel mesh__D016878 Syndrome, Crow-Fukase
% 215.87/216.03  |- mesh__recordAuthorizer mesh__D016878 ags
% 215.87/216.03  |- skos__altLabel mesh__D016878 Crow-Fukase Syndrome
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D016878 2000
% 215.87/216.03  |- mesh__dateCreated mesh__D016878 1991-05-02
% 215.87/216.03  |- skos__broader mesh__D016878smesh__D010265
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D016878 2004
% 215.87/216.03  |- mesh__recordOriginator mesh__D016878 MXR
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D016878 2003
% 215.87/216.03  |- skos__hiddenLabel mesh__D016878 Syndrome, Takatsuki%27%s
% 215.87/216.03  |- mesh__publicMeSHNote mesh__D016878 1992   
% 215.87/216.03  |- skos__hiddenLabel mesh__D016878 Syndrome, POEMS
% 215.87/216.03  |- mesh__recordMaintainer mesh__D016878 ags
% 215.87/216.03  |- skos__hiddenLabel mesh__D016878 Crow Fukase Syndrome
% 215.87/216.03  |- skos__scopeNote mesh__D016878
% 215.87/216.03       A multisystemic disorder characterized by a sensorimotor polyneuropathy %28%POLYNEUROPATHIES%29%, organomegaly, endocrinopathy, monoclonal gammopathy, and pigmentary skin changes. Other clinical features which may be present include EDEMA; CACHEXIA; microangiopathic glomerulopathy; pulmonary hypertension %28%HYPERTENSION, PULMONARY%29%; cutaneous necrosis; THROMBOCYTOSIS; and POLYCYTHEMIA. This disorder is frequently associated with osteosclerotic myeloma. %28%From Adams et al., Principles of Neurology, 6th ed, p1335; Rev Med Interne 1997;18%28%7%29%:553-62%29%%A%    
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D016878 2002
% 215.87/216.03  |- skos__hiddenLabel mesh__D016878 Takatsuki Syndrome
% 215.87/216.03  |- mesh__dateRevised mesh__D016878 1999-12-08
% 215.87/216.03  |- skos__prefLabel mesh__D016878 POEMS Syndrome
% 215.87/216.03  |- skos__altLabel mesh__D016878 Takatsuki%27%s Syndrome
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D016878 2006
% 215.87/216.03  |- rdf__type mesh__D016878sskos__Concept
% 215.87/216.03  |- mesh__historyNote mesh__D016878 1992   
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D016878 2005
% 215.87/216.03  |- skos__annotation mesh__D016878
% 215.87/216.03       for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal gammopathy, Skin changes; DF: POEMS%A%  
% 215.87/216.03  |- mesh__dateEstablished mesh__D016878 1992-01-01
% 215.87/216.03  |- skos__broader mesh__D002858smesh__D000497
% 215.87/216.03  |- mesh__recordOriginator mesh__D002858 NLM
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D002858 1997
% 215.87/216.03  |- skos__altLabel mesh__D002858 Nickel-Chromium Alloys
% 215.87/216.03  |- rdf__type mesh__D002858sskos__Concept
% 215.87/216.03  |- skos__hiddenLabel mesh__D002858 Chromium Nickel Alloys
% 215.87/216.03  |- mesh__recordMaintainer mesh__D002858 TPW
% 215.87/216.03  |- skos__hiddenLabel mesh__D002858 Alloys, Chromium
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D002858 2005
% 215.87/216.03  |- skos__hiddenLabel mesh__D002858 Chromium Cobalt Alloys
% 215.87/216.03  |- mesh__dateCreated mesh__D002858 1999-01-01
% 215.87/216.03  |- skos__hiddenLabel mesh__D002858 Alloys, Nickel-Chromium
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D002858 2000
% 215.87/216.03  |- skos__hiddenLabel mesh__D002858 Nickel Chromium Alloys
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D002858 1996
% 215.87/216.03  |- mesh__publicMeSHNote mesh__D002858
% 215.87/216.03       82; was CHROMIUM-COBALT ALLOYS 1965-81   
% 215.87/216.03  |- mesh__recordAuthorizer mesh__D002858 PLS
% 215.87/216.03  |- mesh__dateEstablished mesh__D002858 1965-01-01
% 215.87/216.03  |- skos__hiddenLabel mesh__D002858 Alloys, Cobalt-Chromium
% 215.87/216.03  |- skos__hiddenLabel mesh__D002858 Alloys, Chromium-Cobalt
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D002858 1999
% 215.87/216.03  |- skos__scopeNote mesh__D002858
% 215.87/216.03       Specific alloys not less than 85%25% chromium and nickel or cobalt, with traces of either nickel or cobalt, molybdenum, and other substances. They are used in partial dentures, orthopedic implants, etc.%A%    
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D002858 2004
% 215.87/216.03  |- mesh__onlineNote mesh__D002858
% 215.87/216.03       use CHROMIUM ALLOYS to search CHROMIUM-COBALT ALLOYS 1966-81 thru 1966%A%  
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D002858 2002
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D002858 1995
% 215.87/216.03  |- skos__related mesh__D002858smesh__D003764
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D002858 1998
% 215.87/216.03  |- skos__altLabel mesh__D002858 Chromium-Cobalt Alloys
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D002858 2003
% 215.87/216.03  |- skos__hiddenLabel mesh__D002858 Cobalt Chromium Alloys
% 215.87/216.03  |- skos__broader mesh__D002858smesh__D017608
% 215.87/216.03  |- mesh__dateRevised mesh__D002858 1993-06-04
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D002858 1994
% 215.87/216.03  |- skos__annotation mesh__D002858
% 215.87/216.03       used in dent technol %26% orthopedics; D25-26 qualif   
% 215.87/216.03  |- skos__broader mesh__D002858smesh__D003722
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D002858 2006
% 215.87/216.03  |- mesh__historyNote mesh__D002858
% 215.87/216.03       82; was CHROMIUM-COBALT ALLOYS 1965-81   
% 215.87/216.03  |- skos__hiddenLabel mesh__D002858 Alloys, Chromium-Nickel
% 215.87/216.03  |- skos__prefLabel mesh__D002858 Chromium Alloys
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D002858 2001
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D013580 2000
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D013580 2006
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D013580 2003
% 215.87/216.03  |- skos__hiddenLabel mesh__D013580 Synostoses
% 215.87/216.03  |- mesh__recordAuthorizer mesh__D013580 sjn
% 215.87/216.03  |- rdf__type mesh__D013580sskos__Concept
% 215.87/216.03  |- mesh__dateCreated mesh__D013580 1999-01-01
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D013580 2005
% 215.87/216.03  |- skos__broader mesh__D013580smesh__D004413
% 215.87/216.03  |- skos__annotation mesh__D013580
% 215.87/216.03       abnorm union between bones or parts of bones; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 215.87/216.03  |- skos__scopeNote mesh__D013580
% 215.87/216.03       A union between adjacent bones or parts of a single bone formed by osseous material, such as ossified connecting cartilage or fibrous tissue. %28%Dorland, 27th ed%29%%A%    
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D013580 2002
% 215.87/216.03  |- mesh__dateRevised mesh__D013580 1999-11-03
% 215.87/216.03  |- mesh__recordOriginator mesh__D013580 NLM
% 215.87/216.03  |- skos__prefLabel mesh__D013580 Synostosis
% 215.87/216.03  |- skos__broader mesh__D013580smesh__D009139
% 215.87/216.03  |- mesh__recordMaintainer mesh__D013580 kle
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D013580 2001
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D013580 2004
% 215.87/216.03  |- skos__altLabel mesh__D045662 Etching, Dental
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D045662 2004
% 215.87/216.03  |- mesh__publicMeSHNote mesh__D045662
% 215.87/216.03       2004; see ACID ETCHING, DENTAL 1977-2003   
% 215.87/216.03  |- skos__broader mesh__D045662smesh__D001840
% 215.87/216.03  |- skos__prefLabel mesh__D045662 Dental Etching
% 215.87/216.03  |- skos__annotation mesh__D045662 coord with agent or method   
% 215.87/216.03  |- mesh__dateCreated mesh__D045662 2003-07-09
% 215.87/216.03  |- skos__scopeNote mesh__D045662
% 215.87/216.03       Preparation of TOOTH surfaces, and of materials bonded to teeth or DENTAL IMPLANTS, with agents and methods which roughen the surface to facilitate adhesion. Agents include phosphoric or other acids %28%ACID ETCHING, DENTAL%29% and methods include LASERS.%A%    
% 215.87/216.03  |- skos__historyNote mesh__D045662 Acid Etching, Dental %28%1977-2003%29%
% 215.87/216.03  |- mesh__historyNote mesh__D045662
% 215.87/216.03       2004; use ACID ETCHING, DENTAL 1977-2003   
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D045662 2006
% 215.87/216.03  |- mesh__dateEstablished mesh__D045662 2004-01-01
% 215.87/216.03  |- rdf__type mesh__D045662sskos__Concept
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D045662 2005
% 215.87/216.03  |- skos__prefLabel mesh__D012488 Salpingitis
% 215.87/216.03  |- skos__broader mesh__D012488smesh__D000292
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D012488 2004
% 215.87/216.03  |- skos__broader mesh__D012488smesh__D005184
% 215.87/216.03  |- mesh__recordAuthorizer mesh__D012488 sjn
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D012488 2003
% 215.87/216.03  |- skos__hiddenLabel mesh__D012488 Salpingitides
% 215.87/216.03  |- mesh__dateRevised mesh__D012488 2002-07-03
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D012488 2006
% 215.87/216.03  |- mesh__dateCreated mesh__D012488 1999-01-01
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D012488 2005
% 215.87/216.03  |- skos__scopeNote mesh__D012488
% 215.87/216.03       Inflammation of the uterine salpinx, the trumpet-shaped FALLOPIAN TUBES, usually caused by ascending infections of organisms from the lower reproductive tract. Salpingitis can lead to tubal scarring, hydrosalpinx, tubal occlusion, INFERTILITY, and ectopic pregnancy %28%PREGNANCY, ECTOPIC%29%%A%    
% 215.87/216.03  |- rdf__type mesh__D012488sskos__Concept
% 215.87/216.03  |- mesh__recordOriginator mesh__D012488 NLM
% 215.87/216.03  |- mesh__recordMaintainer mesh__D012488 TGC
% 215.87/216.03  |- skos__hiddenLabel mesh__D017971 Compounds, Tin
% 215.87/216.03  |- skos__broader mesh__D017971smesh__D007287
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D017971 2002
% 215.87/216.03  |- skos__annotation mesh__D017971
% 215.87/216.03       inorganic; GEN or unspecified; prefer specifics; DF: TIN CPDS%A%  
% 215.87/216.03  |- mesh__dateCreated mesh__D017971 1993-06-21
% 215.87/216.03  |- mesh__publicMeSHNote mesh__D017971 94   
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D017971 2004
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D017971 2001
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D017971 2006
% 215.87/216.03  |- skos__scopeNote mesh__D017971
% 215.87/216.03       Inorganic compounds that contain tin as an integral part of the molecule.%A%    
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D017971 2003
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D017971 2005
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D017971 2000
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D017971 1997
% 215.87/216.03  |- skos__historyNote mesh__D017971 Tin %28%1966-1993%29%
% 215.87/216.03  |- rdf__type mesh__D017971sskos__Concept
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D017971 1999
% 215.87/216.03  |- mesh__dateEstablished mesh__D017971 1994-01-01
% 215.87/216.03  |- skos__prefLabel mesh__D017971 Tin Compounds
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D017971 1996
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D017971 1995
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D017971 1998
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D017971 1994
% 215.87/216.03  |- mesh__historyNote mesh__D017971 94   
% 215.87/216.03  |- skos__prefLabel mesh__D031642 Myoporaceae
% 215.87/216.03  |- mesh__dateCreated mesh__D031642 2002-07-03
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D031642 2004
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D031642 2003
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D031642 2006
% 215.87/216.03  |- skos__scopeNote mesh__D031642
% 215.87/216.03       A plant family of the order Scrophulariales, subclass Asteridae, class Magnoliopsida.%A%    
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D031642 2005
% 215.87/216.03  |- mesh__historyNote mesh__D031642 2003   
% 215.87/216.03  |- rdf__type mesh__D031642sskos__Concept
% 215.87/216.03  |- mesh__dateEstablished mesh__D031642 2003-01-01
% 215.87/216.03  |- skos__annotation mesh__D031642
% 215.87/216.03       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.87/216.03  |- skos__broader mesh__D031642smesh__D019684
% 215.87/216.03  |- mesh__publicMeSHNote mesh__D031642 2003   
% 215.87/216.03  |- mesh__dateEstablished mesh__D017173 1993-01-01
% 215.87/216.03  |- mesh__historyNote mesh__D017173 93   
% 215.87/216.03  |- skos__annotation mesh__D017173 DF: C ELEGANS   
% 215.87/216.03  |- skos__prefLabel mesh__D017173 Caenorhabditis elegans
% 215.87/216.03  |- mesh__recordMaintainer mesh__D017173 ags
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D017173 2004
% 215.87/216.03  |- skos__historyNote mesh__D017173 Nematoda %28%1968-1978%29%
% 215.87/216.03  |- mesh__dateRevised mesh__D017173 2003-07-09
% 215.87/216.03  |- mesh__publicMeSHNote mesh__D017173 93   
% 215.87/216.03  |- skos__scopeNote mesh__D017173
% 215.87/216.03       A species of nematode that is widely used in biological, biochemical, and genetic studies.%A%    
% 215.87/216.03  |- mesh__recordAuthorizer mesh__D017173 sjn
% 215.87/216.03  |- mesh__dateCreated mesh__D017173 1992-05-07
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D017173 2006
% 215.87/216.03  |- skos__related mesh__D017173smesh__D029742
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D017173 2005
% 215.87/216.03  |- skos__broader mesh__D017173smesh__D002107
% 215.87/216.03  |- mesh__recordOriginator mesh__D017173 PXP
% 215.87/216.03  |- rdf__type mesh__D017173sskos__Concept
% 215.87/216.03  |- skos__historyNote mesh__D017173 Caenorhabditis %28%1979-1992%29%
% 215.87/216.03  |- skos__prefLabel mesh__D003951 Diagnostic Errors
% 215.87/216.03  |- skos__historyNote mesh__D003951 Diagnosis %28%1966-1969%29%
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003951 2005
% 215.87/216.03  |- skos__broader mesh__D003951smesh__D003933
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003951 2000
% 215.87/216.03  |- mesh__recordOriginator mesh__D003951 NLM
% 215.87/216.03  |- mesh__dateEstablished mesh__D003951 1973-01-01
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003951 2004
% 215.87/216.03  |- mesh__publicMeSHNote mesh__D003951 73   
% 215.87/216.03  |- mesh__recordMaintainer mesh__D003951 JLS
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003951 1999
% 215.87/216.03  |- skos__hiddenLabel mesh__D003951 Error, Diagnostic
% 215.87/216.03  |- skos__broader mesh__D003951smesh__D019300
% 215.87/216.03  |- mesh__dateCreated mesh__D003951 1999-01-01
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003951 2003
% 215.87/216.03  |- skos__scopeNote mesh__D003951
% 215.87/216.03       Incorrect diagnoses after clinical examination or technical diagnostic procedures.%A%    
% 215.87/216.03  |- rdf__type mesh__D003951sskos__Concept
% 215.87/216.03  |- mesh__recordAuthorizer mesh__D003951 SJN
% 215.87/216.03  |- mesh__historyNote mesh__D003951 73%28%70%29%   
% 215.87/216.03  |- skos__annotation mesh__D003951
% 215.87/216.03       IM; coord with specific dis /diag %28%IM%29% %26% specific diag procedure; do not confuse with differ diag; DF: DIAG ERR%A%  
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003951 2002
% 215.87/216.03  |- mesh__dateRevised mesh__D003951 1998-06-10
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003951 2006
% 215.87/216.03  |- skos__altLabel mesh__D003951 Errors, Diagnostic
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003951 2001
% 215.87/216.03  |- skos__hiddenLabel mesh__D003951 Diagnostic Error
% 215.87/216.03  |- mesh__dateRevised mesh__D003153 2001-07-25
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003153 2006
% 215.87/216.03  |- skos__prefLabel mesh__D003153 Community Health Services
% 215.87/216.03  |- mesh__dateEstablished mesh__D003153 1967-01-01
% 215.87/216.03  |- skos__broader mesh__D003153smesh__D006296
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003153 2005
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003153 2004
% 215.87/216.03  |- skos__altLabel mesh__D003153 Health Services, Community
% 215.87/216.03  |- skos__hiddenLabel mesh__D003153 Health Service, Community
% 215.87/216.03  |- mesh__historyNote mesh__D003153 67%28%65%29%   
% 215.87/216.03  |- rdf__type mesh__D003153sskos__Concept
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003153 2003
% 215.87/216.03  |- mesh__recordAuthorizer mesh__D003153 sjn
% 215.87/216.03  |- skos__hiddenLabel mesh__D003153 Health Care, Community
% 215.87/216.03  |- skos__hiddenLabel mesh__D003153 Community Healthcares
% 215.87/216.03  |- skos__altLabel mesh__D003153 Community Healthcare
% 215.87/216.03  |- mesh__recordOriginator mesh__D003153 NLM
% 215.87/216.03  |- skos__hiddenLabel mesh__D003153 Care, Community Health
% 215.87/216.03  |- skos__hiddenLabel mesh__D003153 Healthcare, Community
% 215.87/216.03  |- skos__annotation mesh__D003153 IM; DF: COMMUNITY HEALTH SERV   
% 215.87/216.03  |- skos__hiddenLabel mesh__D003153 Community Health Service
% 215.87/216.03  |- mesh__recordMaintainer mesh__D003153 jls
% 215.87/216.03  |- skos__hiddenLabel mesh__D003153 Healthcares, Community
% 215.87/216.03  |- skos__scopeNote mesh__D003153
% 215.87/216.03       Diagnostic, therapeutic and preventive health services provided for individuals in the community.%A%    
% 215.87/216.03  |- skos__hiddenLabel mesh__D003153 Service, Community Health
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D003153 2002
% 215.87/216.03  |- mesh__dateCreated mesh__D003153 1999-01-01
% 215.87/216.03  |- skos__altLabel mesh__D003153 Services, Community Health
% 215.87/216.03  |- mesh__publicMeSHNote mesh__D003153 67   
% 215.87/216.03  |- mesh__recordAuthorizer mesh__D016879 PLS
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D016879 2004
% 215.87/216.03  |- mesh__recordOriginator mesh__D016879 MXR
% 215.87/216.03  |- mesh__dateEstablished mesh__D016879 1992-01-01
% 215.87/216.03  |- skos__broader mesh__D016879smesh__D013812
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D016879 1997
% 215.87/216.03  |- skos__prefLabel mesh__D016879 Salvage Therapy
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D016879 2001
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D016879 2003
% 215.87/216.03  |- skos__broader mesh__D016879smesh__D003131
% 215.87/216.03  |- skos__hiddenLabel mesh__D016879 Salvage Therapies
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D016879 1996
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D016879 2000
% 215.87/216.03  |- mesh__dateCreated mesh__D016879 1991-05-02
% 215.87/216.03  |- mesh__dateRevised mesh__D016879 1995-06-08
% 215.87/216.03  |- mesh__publicMeSHNote mesh__D016879 92   
% 215.87/216.03  |- skos__annotation mesh__D016879
% 215.87/216.03       after failure of other types of ther; usually in cancer ther; do not use /util except by MeSH definition; Manual 24.4.2.2.2%A%  
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D016879 2006
% 215.87/216.03  |- mesh__historyNote mesh__D016879 92   
% 215.87/216.03  |- skos__altLabel mesh__D016879 Therapy, Salvage
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D016879 1999
% 215.87/216.03  |- rdf__type mesh__D016879sskos__Concept
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D016879 2005
% 215.87/216.03  |- skos__hiddenLabel mesh__D016879 Therapies, Salvage
% 215.87/216.03  |- mesh__recordMaintainer mesh__D016879 TGC
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D016879 1998
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D016879 2002
% 215.87/216.03  |- skos__scopeNote mesh__D016879
% 215.87/216.03       A therapeutic approach, involving chemotherapy, radiation therapy, or surgery, after initial regimens have failed to lead to improvement in a patient%27%s condition. Salvage therapy is most often used for neoplastic diseases.%A%    
% 215.87/216.03  |- mesh__dateRevised mesh__D002859 2000-06-22
% 215.87/216.03  |- mesh__recordOriginator mesh__D002859 NLM
% 215.87/216.03  |- mesh__recordMaintainer mesh__D002859 nns
% 215.87/216.03  |- skos__scopeNote mesh__D002859
% 215.87/216.03       Stable chromium atoms that have the same atomic number as the element chromium, but differ in atomic weight. Cr-50, 53, and 54 are stable chromium isotopes.%A%    
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D002859 2001
% 215.87/216.03  |- skos__prefLabel mesh__D002859 Chromium Isotopes
% 215.87/216.03  |- skos__hiddenLabel mesh__D002859 Isotopes, Chromium
% 215.87/216.03  |- skos__broader mesh__D002859smesh__D007554
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D002859 2006
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D002859 2004
% 215.87/216.03  |- skos__annotation mesh__D002859 Cr-50, 53, 54; NIM   
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D002859 2005
% 215.87/216.03  |- mesh__recordAuthorizer mesh__D002859 sjn
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D002859 2003
% 215.87/216.03  |- rdf__type mesh__D002859sskos__Concept
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D002859 2002
% 215.87/216.03  |- mesh__dateCreated mesh__D002859 1999-01-01
% 215.87/216.03  |- mesh__recordOriginator mesh__D013581 NLM
% 215.87/216.03  |- mesh__dateRevised mesh__D013581 2003-07-09
% 215.87/216.03  |- mesh__activeMeSHYear mesh__D013581 2005
% 215.87/216.03  |- mesh__dateCreated mesh__D013581 1999-01-01
% 215.87/216.03  |- rdf__type mesh__D013581sskos__Concept
% 215.87/216.03  |- skos__scopeNote mesh__D013581
% 215.87/216.03       Non-neoplastic tumor-like lesions at joints, developed from the SYNOVIAL MEMBRANE of a joint through the JOINT CAPSULE into the periarticular tissues. They are filled with SYNOVIAL FLUID with a smooth and translucent appearance. A synovial cyst can develop from any joint, but most commonly at the back of the knee, where it is known as POPLITEAL CYST.%A%    
% 215.87/216.03  |- skos__prefLabel mesh__D013581 Synovial Cyst
% 215.87/216.03  |- mesh__recordAuthorizer mesh__D013581 sjn
% 215.87/216.03  |- skos__annotation mesh__D013581
% 215.87/216.03       non-neoplastic; also available GANGLION CYSTS   
% 215.87/216.04  |- skos__broader mesh__D013581smesh__D003560
% 215.87/216.04  |- mesh__recordMaintainer mesh__D013581 lkt
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D013581 2004
% 215.87/216.04  |- skos__hiddenLabel mesh__D013581 Cyst, Synovial
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D013581 2006
% 215.87/216.04  |- skos__hiddenLabel mesh__D013581 Cysts, Synovial
% 215.87/216.04  |- skos__altLabel mesh__D013581 Synovial Cysts
% 215.87/216.04  |- skos__scopeNote mesh__D007544
% 215.87/216.04       A non-metabolizable galactose analog that induces expression of the LAC OPERON.%A%    
% 215.87/216.04  |- mesh__dateCreated mesh__D007544 1974-11-19
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D007544 2006
% 215.87/216.04  |- skos__prefLabel mesh__D007544 Isopropyl Thiogalactoside
% 215.87/216.04  |- skos__hiddenLabel mesh__D007544
% 215.87/216.04       1-Thio-beta-D-galactopyranoside, Isopropyl
% 215.87/216.04  |- skos__altLabel mesh__D007544 Isopropyl 1-Thio-beta-D-galactopyranoside
% 215.87/216.04  |- mesh__historyNote mesh__D007544
% 215.87/216.04       91%28%75%29%; was see under THIOGLYCOSIDES 1975-90   
% 215.87/216.04  |- mesh__dateEstablished mesh__D007544 1991-01-01
% 215.87/216.04  |- mesh__recordOriginator mesh__D007544 NLM
% 215.87/216.04  |- skos__historyNote mesh__D007544 Thioglycosides %28%1974%29%
% 215.87/216.04  |- mesh__publicMeSHNote mesh__D007544
% 215.87/216.04       91; was see under THIOGLYCOSIDES 1975-90   
% 215.87/216.04  |- skos__historyNote mesh__D007544 Galactose %28%1974%29%
% 215.87/216.04  |- rdf__type mesh__D007544sskos__Concept
% 215.87/216.04  |- mesh__recordMaintainer mesh__D007544 ssb
% 215.87/216.04  |- mesh__dateRevised mesh__D007544 2005-06-30
% 215.87/216.04  |- skos__altLabel mesh__D007544 IPTG
% 215.87/216.04  |- skos__broader mesh__D007544smesh__D013862
% 215.87/216.04  |- skos__hiddenLabel mesh__D007544
% 215.87/216.04       Isopropyl 1 Thio beta D galactopyranoside
% 215.87/216.04  |- skos__hiddenLabel mesh__D007544 Thiogalactoside, Isopropyl
% 215.87/216.04  |- mesh__recordAuthorizer mesh__D007544 sjn
% 215.87/216.04  |- mesh__dateEstablished mesh__D045663 2004-01-01
% 215.87/216.04  |- skos__broader mesh__D045663smesh__D049329
% 215.87/216.04  |- skos__broader mesh__D045663smesh__D008863
% 215.87/216.04  |- mesh__historyNote mesh__D045663 2004   
% 215.87/216.04  |- mesh__dateCreated mesh__D045663 2003-07-09
% 215.87/216.04  |- skos__hiddenLabel mesh__D045663 Dot, Quantum
% 215.87/216.04  |- mesh__publicMeSHNote mesh__D045663 2004   
% 215.87/216.04  |- mesh__dateRevised mesh__D045663 2004-07-07
% 215.87/216.04  |- skos__related mesh__D045663smesh__D012666
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D045663 2006
% 215.87/216.04  |- skos__prefLabel mesh__D045663 Quantum Dots
% 215.87/216.04  |- rdf__type mesh__D045663sskos__Concept
% 215.87/216.04  |- skos__hiddenLabel mesh__D045663 Dots, Quantum
% 215.87/216.04  |- mesh__recordOriginator mesh__D045663 ssb
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D045663 2005
% 215.87/216.04  |- mesh__recordMaintainer mesh__D045663 ssb
% 215.87/216.04  |- skos__hiddenLabel mesh__D045663 Quantum Dot
% 215.87/216.04  |- mesh__recordAuthorizer mesh__D045663 sjn
% 215.87/216.04  |- skos__scopeNote mesh__D045663
% 215.87/216.04       Nanometer sized fragments %28%the dots%29% of semiconductor crystalline material which emits PHOTONS. The wavelength is based on the quantum confinement size of the dot. They are brighter and more persistent than organic chemical INDICATORS. They can be embedded in MICROBEADS for high throughput ANALYTICAL CHEMISTRY.%A%    
% 215.87/216.04  |- skos__annotation mesh__D045663
% 215.87/216.04       do not confuse with microscopic fluorescent bar codes which are micrometer sized%A%  
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D012489 1999
% 215.87/216.04  |- mesh__dateRevised mesh__D012489 1997-06-20
% 215.87/216.04  |- mesh__dateCreated mesh__D012489 1987-03-20
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D012489 2002
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D012489 1998
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D012489 2004
% 215.87/216.04  |- mesh__historyNote mesh__D012489 88   
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D012489 2003
% 215.87/216.04  |- mesh__recordOriginator mesh__D012489 SCD
% 215.87/216.04  |- mesh__dateEstablished mesh__D012489 1988-01-01
% 215.87/216.04  |- skos__hiddenLabel mesh__D012489 Salpingostomies
% 215.87/216.04  |- mesh__recordAuthorizer mesh__D012489 SJN
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D012489 2001
% 215.87/216.04  |- skos__broader mesh__D012489smesh__D000714
% 215.87/216.04  |- mesh__publicMeSHNote mesh__D012489 88   
% 215.87/216.04  |- skos__historyNote mesh__D012489
% 215.87/216.04       Fallopian Tube Diseases/surgery %28%1966-1987%29%
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D012489 2006
% 215.87/216.04  |- skos__scopeNote mesh__D012489
% 215.87/216.04       Formation of an artificial opening in a fallopian tube.%A%    
% 215.87/216.04  |- rdf__type mesh__D012489sskos__Concept
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D012489 2000
% 215.87/216.04  |- mesh__recordMaintainer mesh__D012489 PXP
% 215.87/216.04  |- skos__prefLabel mesh__D012489 Salpingostomy
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D012489 2005
% 215.87/216.04  |- skos__historyNote mesh__D012489
% 215.87/216.04       Fallopian Tubes/surgery %28%1966-1987%29%
% 215.87/216.04  |- skos__annotation mesh__D012489
% 215.87/216.04       do not use /util except by MeSH definition   
% 215.87/216.04  |- skos__broader mesh__D012489smesh__D013509
% 215.87/216.04  |- skos__prefLabel mesh__D017972 Lentiviruses, Ovine-Caprine
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017972 2006
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017972 2003
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017972 2005
% 215.87/216.04  |- rdf__type mesh__D017972sskos__Concept
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017972 1997
% 215.87/216.04  |- skos__hiddenLabel mesh__D017972 Ovine Caprine Lentiviruses
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017972 1999
% 215.87/216.04  |- skos__annotation mesh__D017972
% 215.87/216.04       a subgenus of the genus Lentivirus; infection: coord IM with LENTIVIRUS INFECTIONS %28%IM%29%%A%  
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017972 1996
% 215.87/216.04  |- skos__scopeNote mesh__D017972
% 215.87/216.04       A subgenus of LENTIVIRUS comprising viruses that produce multi-organ disease with long incubation periods in sheep and goats.%A%    
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017972 1995
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017972 1998
% 215.87/216.04  |- mesh__dateCreated mesh__D017972 1993-06-04
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017972 2002
% 215.87/216.04  |- skos__hiddenLabel mesh__D017972 Lentivirus, Ovine-Caprine
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017972 1994
% 215.87/216.04  |- mesh__historyNote mesh__D017972 94   
% 215.87/216.04  |- skos__hiddenLabel mesh__D017972 Lentiviruses, Ovine Caprine
% 215.87/216.04  |- mesh__publicMeSHNote mesh__D017972 94   
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017972 2001
% 215.87/216.04  |- skos__broader mesh__D017972smesh__D016086
% 215.87/216.04  |- skos__hiddenLabel mesh__D017972 Ovine-Caprine Lentivirus
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017972 2004
% 215.87/216.04  |- skos__altLabel mesh__D017972 Ovine-Caprine Lentiviruses
% 215.87/216.04  |- mesh__dateEstablished mesh__D017972 1994-01-01
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017972 2000
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D031643 2004
% 215.87/216.04  |- skos__scopeNote mesh__D031643
% 215.87/216.04       A plant genus of the family MYOPORACEAE. Members contain dehydrongaione, deisopropylngaione, dehydromyodesmone and other furanoid sesquiterpene essential oils. It is the source of Ngaio oil and ngaione.%A%    
% 215.87/216.04  |- skos__prefLabel mesh__D031643 Myoporum
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D031643 2003
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D031643 2006
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D031643 2005
% 215.87/216.04  |- skos__broader mesh__D031643smesh__D031642
% 215.87/216.04  |- rdf__type mesh__D031643sskos__Concept
% 215.87/216.04  |- mesh__publicMeSHNote mesh__D031643 2003   
% 215.87/216.04  |- skos__altLabel mesh__D031643 Boobialla
% 215.87/216.04  |- mesh__historyNote mesh__D031643 2003   
% 215.87/216.04  |- skos__annotation mesh__D031643
% 215.87/216.04       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.87/216.04  |- mesh__dateCreated mesh__D031643 2002-07-02
% 215.87/216.04  |- mesh__dateEstablished mesh__D031643 2003-01-01
% 215.87/216.04  |- mesh__historyNote mesh__D017174 93   
% 215.87/216.04  |- skos__broader mesh__D017174smesh__D017161
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017174 2004
% 215.87/216.04  |- mesh__dateCreated mesh__D017174 1992-05-22
% 215.87/216.04  |- skos__annotation mesh__D017174
% 215.87/216.04       an order of nematodes; do not confuse with the suborder SPIRURINA or the superfamily SPIRUROIDEA; infection = SPIRURIDA INFECTIONS%A%  
% 215.87/216.04  |- skos__prefLabel mesh__D017174 Spirurida
% 215.87/216.04  |- mesh__dateRevised mesh__D017174 2003-07-09
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017174 2005
% 215.87/216.04  |- mesh__dateEstablished mesh__D017174 1993-01-01
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017174 2006
% 215.87/216.04  |- skos__scopeNote mesh__D017174
% 215.87/216.04       An order of nematodes of the subclass SECERNENTEA. Characteristics include ventral or caudoventral papillae and an esophagus divided into anterior muscular and posterior glandular parts.%A%    
% 215.87/216.04  |- mesh__publicMeSHNote mesh__D017174 93   
% 215.87/216.04  |- rdf__type mesh__D017174sskos__Concept
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003952 2000
% 215.87/216.04  |- skos__historyNote mesh__D003952 Radionuclide Imaging %28%1977-1987%29%
% 215.87/216.04  |- skos__historyNote mesh__D003952 Radiology %28%1971-1987%29%
% 215.87/216.04  |- rdf__type mesh__D003952sskos__Concept
% 215.87/216.04  |- skos__historyNote mesh__D003952 Radiography %28%1975-1987%29%
% 215.87/216.04  |- skos__altLabel mesh__D003952 Imaging Techniques
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003952 2001
% 215.87/216.04  |- skos__related mesh__D003952smesh__D019047
% 215.87/216.04  |- skos__hiddenLabel mesh__D003952 Imaging Technic
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003952 2003
% 215.87/216.04  |- skos__hiddenLabel mesh__D003952 Imaging Technique
% 215.87/216.04  |- skos__hiddenLabel mesh__D003952 Technic, Imaging
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003952 1998
% 215.87/216.04  |- skos__hiddenLabel mesh__D003952 Techniques, Imaging
% 215.87/216.04  |- mesh__publicMeSHNote mesh__D003952 88   
% 215.87/216.04  |- skos__historyNote mesh__D003952 Ultrasonics %28%1971-1987%29%
% 215.87/216.04  |- skos__historyNote mesh__D003952 Photography %28%1966-1971%29%
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003952 2002
% 215.87/216.04  |- skos__hiddenLabel mesh__D003952 Technique, Imaging
% 215.87/216.04  |- skos__scopeNote mesh__D003952
% 215.87/216.04       Any visual display of structural or functional patterns of organs or tissues for diagnostic evaluation. It includes measuring physiologic and metabolic responses to physical and chemical stimuli, as well as ultramicroscopy.%A%    
% 215.87/216.04  |- mesh__dateRevised mesh__D003952 1997-06-20
% 215.87/216.04  |- mesh__historyNote mesh__D003952 88   
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003952 2004
% 215.87/216.04  |- skos__broader mesh__D003952smesh__D019937
% 215.87/216.04  |- skos__related mesh__D003952smesh__D007091
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003952 1999
% 215.87/216.04  |- skos__historyNote mesh__D003952
% 215.87/216.04       specific radiographic technique %28%1966-1987%29%
% 215.87/216.04  |- mesh__recordMaintainer mesh__D003952 PXP
% 215.87/216.04  |- skos__annotation mesh__D003952
% 215.87/216.04       GEN only: prefer specific techniques; use for diag or non-diag study of organs%A%  
% 215.87/216.04  |- skos__prefLabel mesh__D003952 Diagnostic Imaging
% 215.87/216.04  |- skos__hiddenLabel mesh__D003952 Technics, Imaging
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003952 2005
% 215.87/216.04  |- mesh__dateEstablished mesh__D003952 1988-01-01
% 215.87/216.04  |- skos__altLabel mesh__D003952 Imaging, Diagnostic
% 215.87/216.04  |- skos__historyNote mesh__D003952 Ultrasonic Diagnosis %28%1985-1987%29%
% 215.87/216.04  |- skos__historyNote mesh__D003952 Thermography %28%1966-1987%29%
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003952 2006
% 215.87/216.04  |- mesh__recordAuthorizer mesh__D003952 SJN
% 215.87/216.04  |- skos__historyNote mesh__D003952
% 215.87/216.04       Nuclear Magnetic Resonance %28%1975-1987%29%
% 215.87/216.04  |- skos__historyNote mesh__D003952
% 215.87/216.04       Tomography, X-Ray Computed %28%1977-1987%29%
% 215.87/216.04  |- mesh__dateCreated mesh__D003952 1987-03-16
% 215.87/216.04  |- skos__historyNote mesh__D003952 Technology, Radiologic %28%1966-1987%29%
% 215.87/216.04  |- mesh__recordOriginator mesh__D003952 SCD
% 215.87/216.04  |- skos__altLabel mesh__D003952 Imaging, Medical
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003154 2005
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003154 2004
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003154 2002
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003154 2003
% 215.87/216.04  |- rdf__type mesh__D003154sskos__Concept
% 215.87/216.04  |- skos__annotation mesh__D003154
% 215.87/216.04       SPEC only: SPEC qualif; DF: COMMUNITY MED   
% 215.87/216.04  |- skos__altLabel mesh__D003154 Medicine, Community
% 215.87/216.04  |- mesh__dateEstablished mesh__D003154 1977-01-01
% 215.87/216.04  |- mesh__historyNote mesh__D003154
% 215.87/216.04       77%28%75%29%; was see under COMPREHENSIVE HEALTH CARE 1970-76   
% 215.87/216.04  |- mesh__onlineNote mesh__D003154
% 215.87/216.04       search COMPREHENSIVE HEALTH CARE 1970-74   
% 215.87/216.04  |- skos__prefLabel mesh__D003154 Community Medicine
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003154 2001
% 215.87/216.04  |- skos__scopeNote mesh__D003154
% 215.87/216.04       A branch of medicine concerned with the total health of the individual within the home environment and in the community, and with the application of comprehensive care to the prevention and treatment of illness in the entire community.%A%    
% 215.87/216.04  |- skos__broader mesh__D003154smesh__D008511
% 215.87/216.04  |- mesh__recordAuthorizer mesh__D003154 sjn
% 215.87/216.04  |- mesh__dateCreated mesh__D003154 1999-01-01
% 215.87/216.04  |- mesh__dateRevised mesh__D003154 1999-11-03
% 215.87/216.04  |- mesh__recordOriginator mesh__D003154 NLM
% 215.87/216.04  |- mesh__recordMaintainer mesh__D003154 kle
% 215.87/216.04  |- mesh__publicMeSHNote mesh__D003154
% 215.87/216.04       77; was see under COMPREHENSIVE HEALTH CARE 1970-76   
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003154 2000
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003154 2006
% 215.87/216.04  |- skos__prefLabel mesh__D013582 Synovial Fluid
% 215.87/216.04  |- skos__hiddenLabel mesh__D013582 Synovial Fluids
% 215.87/216.04  |- rdf__type mesh__D013582sskos__Concept
% 215.87/216.04  |- mesh__recordMaintainer mesh__D013582 nns
% 215.87/216.04  |- skos__altLabel mesh__D013582 Synovia
% 215.87/216.04  |- mesh__recordOriginator mesh__D013582 NLM
% 215.87/216.04  |- skos__hiddenLabel mesh__D013582 Fluids, Synovial
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D013582 2005
% 215.87/216.04  |- skos__broader mesh__D013582smesh__D045604
% 215.87/216.04  |- skos__broader mesh__D013582smesh__D013583
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D013582 2004
% 215.87/216.04  |- mesh__dateCreated mesh__D013582 1999-01-01
% 215.87/216.04  |- mesh__recordAuthorizer mesh__D013582 sjn
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D013582 2006
% 215.87/216.04  |- skos__scopeNote mesh__D013582
% 215.87/216.04       The clear, viscous fluid secreted by the SYNOVIAL MEMBRANE. It contains mucin, albumin, fat, and mineral salts and serves to lubricate joints.%A%    
% 215.87/216.04  |- skos__hiddenLabel mesh__D013582 Fluid, Synovial
% 215.87/216.04  |- mesh__dateRevised mesh__D013582 2003-07-09
% 215.87/216.04  |- skos__hiddenLabel mesh__D007545 Hydrochloride, Isoproterenol
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D007545 2003
% 215.87/216.04  |- mesh__dateRevised mesh__D007545 2000-06-22
% 215.87/216.04  |- rdf__type mesh__D007545sskos__Concept
% 215.87/216.04  |- skos__altLabel mesh__D007545 Isopropyl Noradrenaline
% 215.87/216.04  |- skos__altLabel mesh__D007545 Isopropylnorepinephrine
% 215.87/216.04  |- mesh__recordAuthorizer mesh__D007545 sjn
% 215.87/216.04  |- skos__prefLabel mesh__D007545 Isoproterenol
% 215.87/216.04  |- skos__broader mesh__D007545smesh__D002395
% 215.87/216.04  |- mesh__recordMaintainer mesh__D007545 CCR
% 215.87/216.04  |- skos__hiddenLabel mesh__D007545 Sulfate, Isoproterenol
% 215.87/216.04  |- skos__altLabel mesh__D007545 Isopropylarterenol
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D007545 2002
% 215.87/216.04  |- mesh__recordOriginator mesh__D007545 NLM
% 215.87/216.04  |- skos__hiddenLabel mesh__D007545 Noradrenaline, Isopropyl
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D007545 2006
% 215.87/216.04  |- skos__broader mesh__D007545smesh__D004983
% 215.87/216.04  |- skos__scopeNote mesh__D007545
% 215.87/216.04       Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.%A%    
% 215.87/216.04  |- skos__altLabel mesh__D007545 Isadrin
% 215.87/216.04  |- skos__altLabel mesh__D007545 Isoprenaline
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D007545 2005
% 215.87/216.04  |- skos__altLabel mesh__D007545 Isopropylnoradrenaline
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D007545 2004
% 215.87/216.04  |- skos__altLabel mesh__D007545
% 215.87/216.04       4-%28%1-Hydroxy-2-%28%%28%1-methylethyl%29%amino%29%ethyl%29%-1,2-benzenediol
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D007545 2001
% 215.87/216.04  |- mesh__dateCreated mesh__D007545 1999-01-01
% 215.87/216.04  |- skos__hiddenLabel mesh__D045664 Convertase, PC3 Prohormone
% 215.87/216.04  |- skos__altLabel mesh__D045664 PC1 Prohormone Convertase
% 215.87/216.04  |- skos__broader mesh__D045664smesh__D012697
% 215.87/216.04  |- mesh__dateCreated mesh__D045664 2003-07-09
% 215.87/216.04  |- skos__altLabel mesh__D045664 PC3 Endoprotease
% 215.87/216.04  |- mesh__recordAuthorizer mesh__D045664 sjn
% 215.87/216.04  |- skos__hiddenLabel mesh__D045664 Endoprotease, PC3
% 215.87/216.04  |- skos__hiddenLabel mesh__D045664 Convertase, PC1 Prohormone
% 215.87/216.04  |- skos__hiddenLabel mesh__D045664 Convertase PC1, Neuroendocrine
% 215.87/216.04  |- skos__broader mesh__D045664smesh__D043484
% 215.87/216.04  |- skos__hiddenLabel mesh__D045664 Prohormone Convertase, PC3
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D045664 2005
% 215.87/216.04  |- mesh__publicMeSHNote mesh__D045664
% 215.87/216.04       2004; PC1 PROHORMONE CONVERTASE, NEUROENDOCRINE CONVERTASE PC1, PC3 ENDOPROTEASE %26% PROHORMONE CONVERTASE 1 were indexed under ASPARTIC ENDOPEPTIDASES 1991-2003; PC1 ENDOPROTEASE %26% PC3 PROHORMONE CONVERTASE were indexed under ASPARTIC ENDOPEPTIDASES 1993-2003; PROPROTEIN CONVERTASE SPC3 was indexed under ASPARTIC ENDOPEPTIDASES 2001-2003; PROINSULIN CONVERTASE 1 was indexed under ASPARTIC ENDOPEPTIDASES 2002-2003;%A%  
% 215.87/216.04  |- skos__altLabel mesh__D045664 PC1 Endoprotease
% 215.87/216.04  |- skos__scopeNote mesh__D045664
% 215.87/216.04       A CALCIUM-dependent endopeptidase that has specificity for cleavage at ARGININE that is near paired basic residues. It cleaves a variety of prohormones including PRO-OPIOMELANOCORTIN; PRORENIN; proenkephalins; prodynorphin; prosomatostatin; and PROINSULIN.%A%    
% 215.87/216.04  |- mesh__historyNote mesh__D045664
% 215.87/216.04       2004; for PC1 PROHORMONE CONVERTASE, NEUROENDOCRINE CONVERTASE PC1, PC3 ENDOPROTEASE, PROHORMONE CONVERTASE 1 use PROPROTEIN CONVERTASE %28%NM%29% 1991-2003; for PC1 ENDOPROTEASE %26% PC3 PROHORMONE CONVERTASE use PROPROTEIN CONVERTASE %28%NM%29% 1993-2003; for PROPROTEIN CONVERTASE SPC3 use PROPROTEIN CONVERTASE %28%NM%29% 2001-2003; for PROINSULIN CONVERTASE 1 use PROPROTEIN CONVERTASE %28%NM%29% 2002-2003%A%  
% 215.87/216.04  |- skos__altLabel mesh__D045664 Neuroendocrine Convertase PC1
% 215.87/216.04  |- mesh__recordMaintainer mesh__D045664 jmp
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D045664 2006
% 215.87/216.04  |- skos__altLabel mesh__D045664 Prohormone Convertase 1
% 215.87/216.04  |- skos__hiddenLabel mesh__D045664 Convertase SPC3, Proprotein
% 215.87/216.04  |- mesh__recordOriginator mesh__D045664 jmp
% 215.87/216.04  |- mesh__dateEstablished mesh__D045664 2004-01-01
% 215.87/216.04  |- skos__historyNote mesh__D045664
% 215.87/216.04       Aspartic Endopeptidases %28%1991-2003%29%
% 215.87/216.04  |- rdf__type mesh__D045664sskos__Concept
% 215.87/216.04  |- skos__altLabel mesh__D045664 Proprotein Convertase SPC3
% 215.87/216.04  |- skos__prefLabel mesh__D045664 Proprotein Convertase 1
% 215.87/216.04  |- skos__altLabel mesh__D045664 Prohormone Convertase 3
% 215.87/216.04  |- skos__hiddenLabel mesh__D045664 Endoprotease, PC1
% 215.87/216.04  |- skos__hiddenLabel mesh__D045664 Convertase 1, Proprotein
% 215.87/216.04  |- skos__altLabel mesh__D045664 Proinsulin Convertase 1
% 215.87/216.04  |- skos__altLabel mesh__D045664 Prohormone Convertase, PC1
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D045664 2004
% 215.87/216.04  |- skos__altLabel mesh__D045664 PC3 Prohormone Convertase
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017973 1997
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017973 1999
% 215.87/216.04  |- mesh__dateEstablished mesh__D017973 1994-01-01
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017973 1996
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017973 2000
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017973 1995
% 215.87/216.04  |- skos__prefLabel mesh__D017973 Tungsten Compounds
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017973 1998
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017973 1994
% 215.87/216.04  |- mesh__historyNote mesh__D017973 94   
% 215.87/216.04  |- skos__annotation mesh__D017973
% 215.87/216.04       inorganic; GEN or unspecified; prefer specifics; DF: TUNGSTEN CPDS%A%  
% 215.87/216.04  |- skos__broader mesh__D017973smesh__D007287
% 215.87/216.04  |- skos__historyNote mesh__D017973 Tungsten %28%1966-1993%29%
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017973 2004
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017973 2002
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017973 2006
% 215.87/216.04  |- mesh__dateCreated mesh__D017973 1993-06-21
% 215.87/216.04  |- mesh__publicMeSHNote mesh__D017973 94   
% 215.87/216.04  |- skos__hiddenLabel mesh__D017973 Compounds, Tungsten
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017973 2003
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017973 2001
% 215.87/216.04  |- skos__scopeNote mesh__D017973
% 215.87/216.04       Inorganic compounds that contain tungsten as an integral part of the molecule.%A%    
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017973 2005
% 215.87/216.04  |- rdf__type mesh__D017973sskos__Concept
% 215.87/216.04  |- rdf__type mesh__D031644sskos__Concept
% 215.87/216.04  |- skos__scopeNote mesh__D031644
% 215.87/216.04       A plant genus of the family MYRSINACEAE. Members contain ardisiacrispins %28%oleanane triterpenoid saponins%29%, ardicrenin, and cyclamiretin.%A%    
% 215.87/216.04  |- mesh__dateEstablished mesh__D031644 2003-01-01
% 215.87/216.04  |- mesh__historyNote mesh__D031644 2003   
% 215.87/216.04  |- mesh__publicMeSHNote mesh__D031644 2003   
% 215.87/216.04  |- mesh__dateCreated mesh__D031644 2002-07-02
% 215.87/216.04  |- skos__annotation mesh__D031644
% 215.87/216.04       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D031644 2004
% 215.87/216.04  |- skos__prefLabel mesh__D031644 Ardisia
% 215.87/216.04  |- skos__broader mesh__D031644smesh__D029591
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D031644 2006
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D031644 2003
% 215.87/216.04  |- skos__altLabel mesh__D031644 Marlberry
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D031644 2005
% 215.87/216.04  |- skos__scopeNote mesh__D017175
% 215.87/216.04       A suborder of nematodes characterized by larvae lacking cephalic hooks and a tail that is generally long and pointed.%A%    
% 215.87/216.04  |- mesh__dateRevised mesh__D017175 2003-07-09
% 215.87/216.04  |- skos__prefLabel mesh__D017175 Camallanina
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017175 2005
% 215.87/216.04  |- skos__broader mesh__D017175smesh__D017174
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017175 2006
% 215.87/216.04  |- mesh__dateCreated mesh__D017175 1992-05-07
% 215.87/216.04  |- skos__annotation mesh__D017175
% 215.87/216.04       a suborder of nematodes; infection: coord IM with SPIRURIDA INFECTIONS %28%IM%29%%A%  
% 215.87/216.04  |- rdf__type mesh__D017175sskos__Concept
% 215.87/216.04  |- mesh__dateEstablished mesh__D017175 1993-01-01
% 215.87/216.04  |- mesh__historyNote mesh__D017175 93   
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D017175 2004
% 215.87/216.04  |- mesh__publicMeSHNote mesh__D017175 93   
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003953 2005
% 215.87/216.04  |- mesh__dateRevised mesh__D003953 1997-06-20
% 215.87/216.04  |- skos__hiddenLabel mesh__D003953 Group, Diagnostic Related
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003953 2001
% 215.87/216.04  |- mesh__recordOriginator mesh__D003953 EC
% 215.87/216.04  |- skos__hiddenLabel mesh__D003953 Diagnosis-Related Group
% 215.87/216.04  |- mesh__recordMaintainer mesh__D003953 PXP
% 215.87/216.04  |- mesh__dateEstablished mesh__D003953 1986-01-01
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003953 1999
% 215.87/216.04  |- skos__altLabel mesh__D003953 Case Mixes
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003953 2004
% 215.87/216.04  |- skos__altLabel mesh__D003953 DRGs
% 215.87/216.04  |- rdf__type mesh__D003953sskos__Concept
% 215.87/216.04  |- skos__altLabel mesh__D003953 DRG
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003953 2000
% 215.87/216.04  |- skos__annotation mesh__D003953 DF: note short X ref   
% 215.87/216.04  |- skos__hiddenLabel mesh__D003953 Diagnostic-Related Groups
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003953 1998
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003953 2003
% 215.87/216.04  |- skos__altLabel mesh__D003953 Group, Diagnostic-Related
% 215.87/216.04  |- skos__historyNote mesh__D003953
% 215.87/216.04       Costs and Cost Analysis %28%1966-1985%29%
% 215.87/216.04  |- skos__hiddenLabel mesh__D003953 Groups, Diagnostic Related
% 215.87/216.04  |- skos__prefLabel mesh__D003953 Diagnosis-Related Groups
% 215.87/216.04  |- mesh__historyNote mesh__D003953
% 215.87/216.04       92; was DIAGNOSTIC RELATED GROUPS 1986-91; was CASE MIX see under COSTS AND COST ANALYSIS 1982-85; DIAGNOSTIC RELATED GROUPS was see CASE MIX 1982-85%A%  
% 215.87/216.04  |- skos__hiddenLabel mesh__D003953 Groups, Diagnosis-Related
% 215.87/216.04  |- skos__hiddenLabel mesh__D003953 Group, Diagnosis-Related
% 215.87/216.04  |- skos__hiddenLabel mesh__D003953 Diagnostic Related Group
% 215.87/216.04  |- skos__broader mesh__D003953smesh__D011445
% 215.87/216.04  |- skos__scopeNote mesh__D003953
% 215.87/216.04       A system for classifying patient care by relating common characteristics such as diagnosis, treatment, and age to an expected consumption of hospital resources and length of stay. Its purpose is to provide a framework for specifying case mix and to reduce hospital costs and reimbursements and it forms the cornerstone of the prospective payment system.%A%    
% 215.87/216.04  |- mesh__recordAuthorizer mesh__D003953 SJN
% 215.87/216.04  |- mesh__dateCreated mesh__D003953 1985-05-20
% 215.87/216.04  |- skos__hiddenLabel mesh__D003953 Diagnosis Related Groups
% 215.87/216.04  |- mesh__onlineNote mesh__D003953
% 215.87/216.04       use DIAGNOSIS-RELATED GROUPS to search DIAGNOSTIC RELATED GROUPS 1986-91 %26% CASE MIX 1982-85%A%  
% 215.87/216.04  |- skos__altLabel mesh__D003953 Diagnostic-Related Group
% 215.87/216.04  |- skos__altLabel mesh__D003953 Groups, Diagnostic-Related
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003953 2006
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003953 2002
% 215.87/216.04  |- mesh__publicMeSHNote mesh__D003953
% 215.87/216.04       92; was DIAGNOSTIC RELATED GROUPS 1986-91; was CASE MIX see under COSTS AND COST ANALYSIS 1982-85; DIAGNOSTIC RELATED GROUPS was see CASE MIX 1982-85%A%  
% 215.87/216.04  |- mesh__recordAuthorizer mesh__D003155 sjn
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003155 2004
% 215.87/216.04  |- mesh__recordMaintainer mesh__D003155 kle
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003155 2002
% 215.87/216.04  |- skos__scopeNote mesh__D003155
% 215.87/216.04       Facilities which administer the delivery of psychologic and psychiatric services to people living in a neighborhood or community.%A%    
% 215.87/216.04  |- skos__historyNote mesh__D003155
% 215.87/216.04       Community Mental Health Services %28%1967-1978%29%
% 215.87/216.04  |- mesh__recordOriginator mesh__D003155 EC
% 215.87/216.04  |- rdf__type mesh__D003155sskos__Concept
% 215.87/216.04  |- skos__broader mesh__D003155smesh__D000554
% 215.87/216.04  |- mesh__dateRevised mesh__D003155 1999-11-03
% 215.87/216.04  |- mesh__historyNote mesh__D003155
% 215.87/216.04       79; was see COMMUNITY MENTAL HEALTH SERVICES 1978   
% 215.87/216.04  |- mesh__onlineNote mesh__D003155
% 215.87/216.04       search COMMUNITY MENTAL HEALTH SERVICES 1978   
% 215.87/216.04  |- mesh__publicMeSHNote mesh__D003155
% 215.87/216.04       79; was see COMMUNITY MENTAL HEALTH SERVICES 1978   
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003155 2005
% 215.87/216.04  |- mesh__dateEstablished mesh__D003155 1979-01-01
% 215.87/216.04  |- mesh__dateCreated mesh__D003155 1978-05-17
% 215.87/216.04  |- skos__prefLabel mesh__D003155 Community Mental Health Centers
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003155 2000
% 215.87/216.04  |- skos__annotation mesh__D003155 DF: note short X ref   
% 215.87/216.04  |- skos__altLabel mesh__D003155 CMHC
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003155 2003
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003155 2006
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D003155 2001
% 215.87/216.04  |- skos__altLabel mesh__D013583 Synovium
% 215.87/216.04  |- rdf__type mesh__D013583sskos__Concept
% 215.87/216.04  |- skos__scopeNote mesh__D013583
% 215.87/216.04       The inner membrane of a joint capsule surrounding a freely movable joint. It is loosely attached to the external fibrous capsule and secretes SYNOVIAL FLUID.%A%    
% 215.87/216.04  |- skos__hiddenLabel mesh__D013583 Membrane, Synovial
% 215.87/216.04  |- mesh__recordAuthorizer mesh__D013583 sjn
% 215.87/216.04  |- skos__hiddenLabel mesh__D013583 Membranes, Synovial
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D013583 2002
% 215.87/216.04  |- skos__prefLabel mesh__D013583 Synovial Membrane
% 215.87/216.04  |- skos__hiddenLabel mesh__D013583 Synovial Membranes
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D013583 2003
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D013583 2005
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D013583 2000
% 215.87/216.04  |- mesh__recordMaintainer mesh__D013583 KEV
% 215.87/216.04  |- skos__annotation mesh__D013583 inflammation = SYNOVITIS   
% 215.87/216.04  |- mesh__recordOriginator mesh__D013583 NLM
% 215.87/216.04  |- skos__broader mesh__D013583smesh__D017746
% 215.87/216.04  |- mesh__activeMeSHYear mesh__D013583 2004
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013583 2001
% 215.87/216.05  |- mesh__dateRevised mesh__D013583 1999-11-03
% 215.87/216.05  |- mesh__dateCreated mesh__D013583 1999-01-01
% 215.87/216.05  |- skos__altLabel mesh__D013583 Membrana Synovialis Capsulae Articularis
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013583 2006
% 215.87/216.05  |- skos__broader mesh__D051794Q000172smesh__D051794
% 215.87/216.05  |- mesh__preferredCombination mesh__D051794Q000172smesh__D006623
% 215.87/216.05  |- rdf__type mesh__D051794Q000172smesh__CompoundConcept
% 215.87/216.05  |- rdf__type mesh__D007546sskos__Concept
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D007546 2001
% 215.87/216.05  |- mesh__publicMeSHNote mesh__D007546
% 215.87/216.05       69; TYLOCREBRINE was heading 1973-84   
% 215.87/216.05  |- skos__historyNote mesh__D007546 Quinolines %28%1966-1968%29%
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D007546 2000
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D007546 1999
% 215.87/216.05  |- mesh__recordMaintainer mesh__D007546 KEV
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D007546 2006
% 215.87/216.05  |- mesh__dateEstablished mesh__D007546 1969-01-01
% 215.87/216.05  |- mesh__onlineNote mesh__D007546
% 215.87/216.05       use ISOQUINOLINES to search TYLOCREBRINE 1972-84 %28%as Prov 1972%29%%A%  
% 215.87/216.05  |- mesh__historyNote mesh__D007546
% 215.87/216.05       69; TYLOCREBRINE was heading 1972-84 %28%Prov 1972%29%   
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D007546 1997
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D007546 1998
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D007546 2005
% 215.87/216.05  |- mesh__recordAuthorizer mesh__D007546 PLS
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D007546 2004
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D007546 2002
% 215.87/216.05  |- mesh__dateRevised mesh__D007546 1995-05-18
% 215.87/216.05  |- mesh__dateCreated mesh__D007546 1999-01-01
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D007546 1996
% 215.87/216.05  |- mesh__recordOriginator mesh__D007546 NLM
% 215.87/216.05  |- skos__prefLabel mesh__D007546 Isoquinolines
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D007546 2003
% 215.87/216.05  |- skos__broader mesh__D007546smesh__D006574
% 215.87/216.05  |- skos__scopeNote mesh__D007546
% 215.87/216.05       A group of compounds with the heterocyclic ring structure of benzo%28%c%29%pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. %28%From Stedman, 25th ed%29%%A%    
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017974 1994
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017974 1999
% 215.87/216.05  |- skos__prefLabel mesh__D017974 Uranium Compounds
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017974 2000
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017974 1995
% 215.87/216.05  |- mesh__dateCreated mesh__D017974 1993-06-21
% 215.87/216.05  |- mesh__publicMeSHNote mesh__D017974 94   
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017974 2001
% 215.87/216.05  |- mesh__dateEstablished mesh__D017974 1994-01-01
% 215.87/216.05  |- skos__historyNote mesh__D017974 Uranium %28%1966-1993%29%
% 215.87/216.05  |- mesh__historyNote mesh__D017974 94   
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017974 2003
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017974 2005
% 215.87/216.05  |- skos__scopeNote mesh__D017974
% 215.87/216.05       Inorganic compounds that contain uranium as an integral part of the molecule.%A%    
% 215.87/216.05  |- skos__broader mesh__D017974smesh__D007287
% 215.87/216.05  |- skos__annotation mesh__D017974
% 215.87/216.05       inorganic; GEN or unspecified; prefer specifics; DF: URANIUM CPDS%A%  
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017974 2004
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017974 2002
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017974 2006
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017974 1996
% 215.87/216.05  |- skos__hiddenLabel mesh__D017974 Compounds, Uranium
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017974 1998
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017974 1997
% 215.87/216.05  |- rdf__type mesh__D017974sskos__Concept
% 215.87/216.05  |- mesh__publicMeSHNote mesh__D031645 2003   
% 215.87/216.05  |- skos__annotation mesh__D031645
% 215.87/216.05       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.87/216.05  |- skos__scopeNote mesh__D031645
% 215.87/216.05       A plant genus of the family MYRSINACEAE. Members contain embelin.%A%    
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D031645 2004
% 215.87/216.05  |- mesh__dateEstablished mesh__D031645 2003-01-01
% 215.87/216.05  |- skos__prefLabel mesh__D031645 Embelia
% 215.87/216.05  |- mesh__historyNote mesh__D031645 2003   
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D031645 2006
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D031645 2003
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D031645 2005
% 215.87/216.05  |- skos__broader mesh__D031645smesh__D029591
% 215.87/216.05  |- rdf__type mesh__D031645sskos__Concept
% 215.87/216.05  |- mesh__dateCreated mesh__D031645 2002-07-03
% 215.87/216.05  |- skos__prefLabel mesh__D017176 Dracunculoidea
% 215.87/216.05  |- skos__annotation mesh__D017176
% 215.87/216.05       a superfamily of nematodes; infection: coord IM with SPIRURIDA INFECTIONS %28%IM%29%%A%  
% 215.87/216.05  |- rdf__type mesh__D017176sskos__Concept
% 215.87/216.05  |- skos__scopeNote mesh__D017176
% 215.87/216.05       A superfamily of nematodes of the suborder CAMALLANINA. Its organisms possess a poorly developed buccal cavity and a rudimentary esophagus and intestine.%A%    
% 215.87/216.05  |- mesh__publicMeSHNote mesh__D017176 93   
% 215.87/216.05  |- skos__broader mesh__D017176smesh__D017175
% 215.87/216.05  |- mesh__historyNote mesh__D017176 93   
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017176 2004
% 215.87/216.05  |- mesh__dateRevised mesh__D017176 2003-07-09
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017176 2005
% 215.87/216.05  |- mesh__dateCreated mesh__D017176 1992-05-20
% 215.87/216.05  |- mesh__dateEstablished mesh__D017176 1993-01-01
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017176 2006
% 215.87/216.05  |- skos__prefLabel mesh__D003954 Diagnostic Services
% 215.87/216.05  |- skos__historyNote mesh__D003954 Diagnosis %28%1966-1967%29%
% 215.87/216.05  |- mesh__recordMaintainer mesh__D003954 KEV
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003954 1997
% 215.87/216.05  |- skos__broader mesh__D003954smesh__D011314
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003954 1996
% 215.87/216.05  |- skos__hiddenLabel mesh__D003954 Diagnostic Service
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003954 2002
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003954 2006
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003954 2001
% 215.87/216.05  |- skos__historyNote mesh__D003954 Physical Examination %28%1966-1967%29%
% 215.87/216.05  |- mesh__recordAuthorizer mesh__D003954 PLS
% 215.87/216.05  |- mesh__publicMeSHNote mesh__D003954 68   
% 215.87/216.05  |- skos__scopeNote mesh__D003954
% 215.87/216.05       Organized services for the purpose of providing diagnosis to promote and maintain health.%A%    
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003954 2005
% 215.87/216.05  |- mesh__recordOriginator mesh__D003954 NLM
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003954 2000
% 215.87/216.05  |- skos__hiddenLabel mesh__D003954 Service, Diagnostic
% 215.87/216.05  |- skos__altLabel mesh__D003954 Services, Diagnostic
% 215.87/216.05  |- mesh__dateCreated mesh__D003954 1999-01-01
% 215.87/216.05  |- skos__annotation mesh__D003954 DF: DIAG SERV   
% 215.87/216.05  |- mesh__dateRevised mesh__D003954 1995-05-22
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003954 1999
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003954 2004
% 215.87/216.05  |- rdf__type mesh__D003954sskos__Concept
% 215.87/216.05  |- mesh__historyNote mesh__D003954 68   
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003954 1998
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003954 2003
% 215.87/216.05  |- mesh__dateEstablished mesh__D003954 1968-01-01
% 215.87/216.05  |- rdf__type mesh__D003156sskos__Concept
% 215.87/216.05  |- skos__prefLabel mesh__D003156 Community Mental Health Services
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003156 2001
% 215.87/216.05  |- mesh__dateCreated mesh__D003156 1999-01-01
% 215.87/216.05  |- skos__altLabel mesh__D003156 Mental Health Services, Community
% 215.87/216.05  |- mesh__recordAuthorizer mesh__D003156 sjn
% 215.87/216.05  |- skos__broader mesh__D003156smesh__D008605
% 215.87/216.05  |- mesh__historyNote mesh__D003156 67   
% 215.87/216.05  |- mesh__recordOriginator mesh__D003156 NLM
% 215.87/216.05  |- mesh__recordMaintainer mesh__D003156 kle
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003156 2002
% 215.87/216.05  |- skos__altLabel mesh__D003156 Services, Mental Health Community
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003156 2005
% 215.87/216.05  |- mesh__dateRevised mesh__D003156 1999-11-03
% 215.87/216.05  |- skos__altLabel mesh__D003156 Services, Community Mental Health
% 215.87/216.05  |- skos__altLabel mesh__D003156 Health Services, Community Mental
% 215.87/216.05  |- mesh__publicMeSHNote mesh__D003156 67   
% 215.87/216.05  |- skos__broader mesh__D003156smesh__D003153
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003156 2003
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003156 2006
% 215.87/216.05  |- skos__scopeNote mesh__D003156
% 215.87/216.05       Diagnostic, therapeutic and preventive mental health services provided for individuals in the community.%A%    
% 215.87/216.05  |- mesh__dateEstablished mesh__D003156 1967-01-01
% 215.87/216.05  |- skos__historyNote mesh__D003156 Mental Health Services %28%1966%29%
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003156 2004
% 215.87/216.05  |- skos__annotation mesh__D003156
% 215.87/216.05       Public Laws 88-164 %26% 89-105; DF: COMMUNITY MENTAL HEALTH SERV%A%  
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003156 2000
% 215.87/216.05  |- mesh__publicMeSHNote mesh__D013584 94; was SYNOVIOMA 1963-93   
% 215.87/216.05  |- skos__broader mesh__D013584smesh__D012509
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013584 2003
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013584 2001
% 215.87/216.05  |- mesh__historyNote mesh__D013584 94; was SYNOVIOMA 1963-93   
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013584 2005
% 215.87/216.05  |- skos__scopeNote mesh__D013584
% 215.87/216.05       A malignant neoplasm arising from tenosynovial tissue of the joints and in synovial cells of tendons and bursae. The legs are the most common site, but the tumor can occur in the abdominal wall and other trunk muscles. There are two recognized types: the monophasic %28%characterized by sheaths of monotonous spindle cells%29% and the biphasic %28%characterized by slit-like spaces or clefts within the tumor, lined by cuboidal or tall columnar epithelial cells%29%. These sarcomas occur most commonly in the second and fourth decades of life. %28%From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1363%29%%A%    
% 215.87/216.05  |- mesh__recordMaintainer mesh__D013584 KEV
% 215.87/216.05  |- skos__broader mesh__D013584smesh__D009372
% 215.87/216.05  |- mesh__onlineNote mesh__D013584
% 215.87/216.05       use SARCOMA, SYNOVIAL to search SYNOVIOMA 1966-93   
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013584 1996
% 215.87/216.05  |- skos__hiddenLabel mesh__D013584 Sarcomas, Synovial
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013584 2004
% 215.87/216.05  |- mesh__dateCreated mesh__D013584 1999-01-01
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013584 1998
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013584 2006
% 215.87/216.05  |- mesh__dateRevised mesh__D013584 1995-06-08
% 215.87/216.05  |- skos__annotation mesh__D013584
% 215.87/216.05       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013584 1997
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013584 2002
% 215.87/216.05  |- skos__hiddenLabel mesh__D013584 Synovial Sarcomas
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013584 1999
% 215.87/216.05  |- skos__hiddenLabel mesh__D013584 Synovial Sarcoma
% 215.87/216.05  |- skos__hiddenLabel mesh__D013584 Synoviomas
% 215.87/216.05  |- rdf__type mesh__D013584sskos__Concept
% 215.87/216.05  |- skos__altLabel mesh__D013584 Synovioma
% 215.87/216.05  |- skos__prefLabel mesh__D013584 Sarcoma, Synovial
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013584 2000
% 215.87/216.05  |- mesh__recordAuthorizer mesh__D013584 PLS
% 215.87/216.05  |- mesh__recordOriginator mesh__D013584 NLM
% 215.87/216.05  |- mesh__historyNote mesh__D007547
% 215.87/216.05       91%28%75%29%; was see under SORBITOL 1975-90   
% 215.87/216.05  |- mesh__dateRevised mesh__D007547 2004-07-07
% 215.87/216.05  |- skos__prefLabel mesh__D007547 Isosorbide
% 215.87/216.05  |- mesh__dateEstablished mesh__D007547 1991-01-01
% 215.87/216.05  |- mesh__publicMeSHNote mesh__D007547 91; was see under SORBITOL 1975-90   
% 215.87/216.05  |- mesh__recordMaintainer mesh__D007547 ssb
% 215.87/216.05  |- skos__annotation mesh__D007547 a diuretic   
% 215.87/216.05  |- mesh__recordOriginator mesh__D007547 NLM
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D007547 2005
% 215.87/216.05  |- mesh__dateCreated mesh__D007547 1974-11-11
% 215.87/216.05  |- skos__historyNote mesh__D007547 Sorbitol %28%1974%29%
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D007547 2006
% 215.87/216.05  |- mesh__recordAuthorizer mesh__D007547 sjn
% 215.87/216.05  |- skos__scopeNote mesh__D007547
% 215.87/216.05       1,4:3,6-Dianhydro D-glucitol. Chemically inert osmotic diuretic used mainly to treat hydrocephalus; also used in glaucoma.%A%    
% 215.87/216.05  |- skos__historyNote mesh__D007547 Ethers, Cyclic %28%1974%29%
% 215.87/216.05  |- skos__broader mesh__D007547smesh__D013012
% 215.87/216.05  |- rdf__type mesh__D007547sskos__Concept
% 215.87/216.05  |- skos__prefLabel mesh__D017975 Ruthenium Compounds
% 215.87/216.05  |- skos__scopeNote mesh__D017975
% 215.87/216.05       Inorganic compounds that contain ruthenium as an integral part of the molecule.%A%    
% 215.87/216.05  |- mesh__historyNote mesh__D017975 94   
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017975 2003
% 215.87/216.05  |- skos__annotation mesh__D017975
% 215.87/216.05       inorganic; GEN or unspecified; prefer specifics; DF: RUTHENIUM CPDS%A%  
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017975 2000
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017975 2005
% 215.87/216.05  |- mesh__dateCreated mesh__D017975 1993-06-21
% 215.87/216.05  |- mesh__publicMeSHNote mesh__D017975 94   
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017975 2004
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017975 2001
% 215.87/216.05  |- mesh__dateEstablished mesh__D017975 1994-01-01
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017975 2006
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017975 1996
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017975 1998
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017975 1997
% 215.87/216.05  |- rdf__type mesh__D017975sskos__Concept
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017975 1994
% 215.87/216.05  |- skos__hiddenLabel mesh__D017975 Compounds, Ruthenium
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017975 1999
% 215.87/216.05  |- skos__broader mesh__D017975smesh__D007287
% 215.87/216.05  |- skos__historyNote mesh__D017975 Ruthenium %28%1966-1993%29%
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017975 2002
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017975 1995
% 215.87/216.05  |- skos__altLabel mesh__D031646 Guava, Pineapple
% 215.87/216.05  |- mesh__publicMeSHNote mesh__D031646 2003   
% 215.87/216.05  |- skos__prefLabel mesh__D031646 Feijoa
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D031646 2003
% 215.87/216.05  |- mesh__dateCreated mesh__D031646 2002-07-03
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D031646 2004
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D031646 2005
% 215.87/216.05  |- skos__altLabel mesh__D031646 Pineapple Guava
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D031646 2006
% 215.87/216.05  |- mesh__dateEstablished mesh__D031646 2003-01-01
% 215.87/216.05  |- skos__annotation mesh__D031646
% 215.87/216.05       GUAVA see PSIDIUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.87/216.05  |- skos__broader mesh__D031646smesh__D027822
% 215.87/216.05  |- skos__altLabel mesh__D031646 Guavasteen
% 215.87/216.05  |- skos__scopeNote mesh__D031646
% 215.87/216.05       A plant genus of the family MYRTACEAE that is cultivated for the edible fruit, which is different from the ordinary guava %28%PSIDIUM%29%.%A%    
% 215.87/216.05  |- mesh__historyNote mesh__D031646 2003   
% 215.87/216.05  |- rdf__type mesh__D031646sskos__Concept
% 215.87/216.05  |- rdf__type mesh__D050800sskos__Concept
% 215.87/216.05  |- skos__prefLabel mesh__D050800 STAT6 Transcription Factor
% 215.87/216.05  |- mesh__publicMeSHNote mesh__D050800
% 215.87/216.05       2006; STAT6 PROTEIN was indexed under TRANS-ACTIVATORS 1995-2005%A%  
% 215.87/216.05  |- skos__broader mesh__D050800smesh__D050791
% 215.87/216.05  |- skos__scopeNote mesh__D050800
% 215.87/216.05       A signal transducer and activator of transcription that mediates cellular responses to INTERLEUKIN-4. Stat6 has been shown to partner with NF-KAPPA B and CCAAT-ENHANCER-BINDING PROTEINS to regulate GENETIC TRANSCRIPTION of interleukin-4 responsive GENES.%A%    
% 215.87/216.05  |- skos__hiddenLabel mesh__D050800 Transcription Factor, STAT6
% 215.87/216.05  |- mesh__dateEstablished mesh__D050800 2006-01-01
% 215.87/216.05  |- mesh__recordAuthorizer mesh__D050800 sjn
% 215.87/216.05  |- mesh__historyNote mesh__D050800 2006%28%1995%29%   
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D050800 2006
% 215.87/216.05  |- mesh__dateCreated mesh__D050800 2005-06-30
% 215.87/216.05  |- skos__altLabel mesh__D050800
% 215.87/216.05       Signal Transducer and Activator of Transcription 6
% 215.87/216.05  |- mesh__recordOriginator mesh__D050800 DRC
% 215.87/216.05  |- mesh__recordMaintainer mesh__D050800 DRC
% 215.87/216.05  |- skos__altLabel mesh__D050800 STAT6 Protein
% 215.87/216.05  |- rdf__type mesh__D017177sskos__Concept
% 215.87/216.05  |- mesh__dateEstablished mesh__D017177 1993-01-01
% 215.87/216.05  |- mesh__historyNote mesh__D017177 93   
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017177 2004
% 215.87/216.05  |- mesh__dateRevised mesh__D017177 2003-07-09
% 215.87/216.05  |- skos__prefLabel mesh__D017177 Spirurina
% 215.87/216.05  |- mesh__publicMeSHNote mesh__D017177 93   
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017177 2005
% 215.87/216.05  |- skos__broader mesh__D017177smesh__D017174
% 215.87/216.05  |- skos__annotation mesh__D017177
% 215.87/216.05       a suborder of nematodes; do not confuse with the order SPIRURIDA or the superfamily SPIRUROIDEA; infection: coord IM with SPIRURIDA INFECTIONS %28%IM%29%%A%  
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D017177 2006
% 215.87/216.05  |- skos__scopeNote mesh__D017177
% 215.87/216.05       A suborder of nematodes characterized by larvae possessing cephalic hooks and multinucleated esophageal glands.%A%    
% 215.87/216.05  |- mesh__dateCreated mesh__D017177 1992-05-22
% 215.87/216.05  |- skos__hiddenLabel mesh__D003955 Routine Admission Tests
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003955 2006
% 215.87/216.05  |- skos__hiddenLabel mesh__D003955 Examinations, Preadmission Physical
% 215.87/216.05  |- skos__annotation mesh__D003955
% 215.87/216.05       do not confuse with PHYSICAL EXAMINATION or MASS SCREENING%A%  
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003955 2001
% 215.87/216.05  |- skos__hiddenLabel mesh__D003955 Test, Diagnostic
% 215.87/216.05  |- mesh__dateCreated mesh__D003955 1981-05-15
% 215.87/216.05  |- rdf__type mesh__D003955sskos__Concept
% 215.87/216.05  |- skos__altLabel mesh__D003955 Diagnostic Test, Routine
% 215.87/216.05  |- skos__hiddenLabel mesh__D003955 Routine Admission Test
% 215.87/216.05  |- skos__altLabel mesh__D003955 Routine Diagnostic Test
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003955 2002
% 215.87/216.05  |- mesh__dateRevised mesh__D003955 1997-06-20
% 215.87/216.05  |- skos__hiddenLabel mesh__D003955 Physical Examinations, Preadmission
% 215.87/216.05  |- skos__hiddenLabel mesh__D003955 Admission Test, Hospital
% 215.87/216.05  |- mesh__dateEstablished mesh__D003955 1982-01-01
% 215.87/216.05  |- skos__altLabel mesh__D003955 Admission Tests, Hospital
% 215.87/216.05  |- skos__hiddenLabel mesh__D003955 Preadmission Physical Examinations
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003955 2003
% 215.87/216.05  |- skos__broader mesh__D003955smesh__D019937
% 215.87/216.05  |- skos__hiddenLabel mesh__D003955 Test, Routine Admission
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003955 1998
% 215.87/216.05  |- mesh__historyNote mesh__D003955
% 215.87/216.05       82; PHYSICAL EXAMINATION, PREADMISSION was see under PHYSICAL EXAMINATION Aug 77-81%A%  
% 215.87/216.05  |- mesh__recordMaintainer mesh__D003955 PXP
% 215.87/216.05  |- skos__hiddenLabel mesh__D003955 Hospital Admission Test
% 215.87/216.05  |- skos__altLabel mesh__D003955 Routine Diagnostic Tests
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003955 2004
% 215.87/216.05  |- skos__hiddenLabel mesh__D003955 Tests, Routine Admission
% 215.87/216.05  |- skos__altLabel mesh__D003955 Test, Routine Diagnostic
% 215.87/216.05  |- skos__altLabel mesh__D003955 Tests, Diagnostic
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003955 1999
% 215.87/216.05  |- mesh__recordOriginator mesh__D003955 SMH
% 215.87/216.05  |- skos__altLabel mesh__D003955 Examination, Preadmission Physical
% 215.87/216.05  |- mesh__recordAuthorizer mesh__D003955 SJN
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003955 2005
% 215.87/216.05  |- skos__altLabel mesh__D003955 Tests, Routine Diagnostic
% 215.87/216.05  |- skos__hiddenLabel mesh__D003955 Admission Test, Routine
% 215.87/216.05  |- skos__scopeNote mesh__D003955
% 215.87/216.05       Diagnostic procedures, such as laboratory tests and x-rays, routinely performed on all individuals or specified categories of individuals in a specified situation, e.g., patients being admitted to the hospital. These include routine tests administered to neonates.%A%    
% 215.87/216.05  |- skos__prefLabel mesh__D003955 Diagnostic Tests, Routine
% 215.87/216.05  |- skos__hiddenLabel mesh__D003955 Test, Hospital Admission
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003955 2000
% 215.87/216.05  |- skos__hiddenLabel mesh__D003955 Diagnostic Test
% 215.87/216.05  |- mesh__publicMeSHNote mesh__D003955
% 215.87/216.05       82; PHYSICAL EXAMINATION, PREADMISSION was see under PHYSICAL EXAMINATION Aug 77-81%A%  
% 215.87/216.05  |- skos__altLabel mesh__D003955 Tests, Hospital Admission
% 215.87/216.05  |- skos__altLabel mesh__D003955 Preadmission Physical Examination
% 215.87/216.05  |- mesh__onlineNote mesh__D003955
% 215.87/216.05       use DIAGNOSTIC TESTS, ROUTINE to search PHYSICAL EXAMINATION, PREADMISSION Aug 77-81%A%  
% 215.87/216.05  |- skos__altLabel mesh__D003157 Service, Community Pharmaceutic
% 215.87/216.05  |- mesh__recordMaintainer mesh__D003157 kle
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003157 2005
% 215.87/216.05  |- mesh__onlineNote mesh__D003157
% 215.87/216.05       search COMMUNITY PHARMACIES under PHARMACIES 1968-78   
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003157 2000
% 215.87/216.05  |- mesh__publicMeSHNote mesh__D003157
% 215.87/216.05       68; COMMUNITY PHARMACIES was see under PHARMACIES 1968-78%A%  
% 215.87/216.05  |- skos__altLabel mesh__D003157 Services, Community Pharmacy
% 215.87/216.05  |- skos__altLabel mesh__D003157 Services, Community Pharmaceutic
% 215.87/216.05  |- skos__scopeNote mesh__D003157
% 215.87/216.05       Total pharmaceutical services provided to the public through community pharmacies.%A%    
% 215.87/216.05  |- skos__altLabel mesh__D003157 Services, Community Pharmaceutical
% 215.87/216.05  |- skos__altLabel mesh__D003157 Pharmaceutic Services, Community
% 215.87/216.05  |- skos__hiddenLabel mesh__D003157 Community Pharmaceutical Service
% 215.87/216.05  |- skos__altLabel mesh__D003157 Pharmaceutical Services, Community
% 215.87/216.05  |- skos__altLabel mesh__D003157 Community Pharmaceutical Services
% 215.87/216.05  |- skos__hiddenLabel mesh__D003157 Community Pharmacy Service
% 215.87/216.05  |- skos__historyNote mesh__D003157 Pharmacy %28%1966-1967%29%
% 215.87/216.05  |- mesh__dateEstablished mesh__D003157 1968-01-01
% 215.87/216.05  |- skos__annotation mesh__D003157 DF: COMMUNITY PHARM SERV   
% 215.87/216.05  |- mesh__dateCreated mesh__D003157 1999-01-01
% 215.87/216.05  |- rdf__type mesh__D003157sskos__Concept
% 215.87/216.05  |- mesh__recordOriginator mesh__D003157 NLM
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003157 2004
% 215.87/216.05  |- skos__altLabel mesh__D003157 Pharmaceutical Service, Community
% 215.87/216.05  |- skos__historyNote mesh__D003157 Pharmacies %28%1966-1967%29%
% 215.87/216.05  |- skos__prefLabel mesh__D003157 Community Pharmacy Services
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003157 2002
% 215.87/216.05  |- mesh__recordAuthorizer mesh__D003157 sjn
% 215.87/216.05  |- skos__altLabel mesh__D003157 Service, Community Pharmaceutical
% 215.87/216.05  |- skos__broader mesh__D003157smesh__D010593
% 215.87/216.05  |- skos__broader mesh__D003157smesh__D003153
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003157 2003
% 215.87/216.05  |- skos__hiddenLabel mesh__D003157 Community Pharmaceutic Service
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003157 2006
% 215.87/216.05  |- mesh__dateRevised mesh__D003157 1999-11-03
% 215.87/216.05  |- skos__altLabel mesh__D003157 Pharmacy Services, Community
% 215.87/216.05  |- skos__hiddenLabel mesh__D003157 Pharmacy Service, Community
% 215.87/216.05  |- mesh__historyNote mesh__D003157
% 215.87/216.05       68; COMMUNITY PHARMACIES was see under PHARMACIES 1968-78%A%  
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D003157 2001
% 215.87/216.05  |- skos__altLabel mesh__D003157 Community Pharmaceutic Services
% 215.87/216.05  |- skos__hiddenLabel mesh__D003157 Pharmaceutic Service, Community
% 215.87/216.05  |- skos__altLabel mesh__D003157 Service, Community Pharmacy
% 215.87/216.05  |- rdf__type mesh__D008640sskos__Concept
% 215.87/216.05  |- skos__hiddenLabel mesh__D008640 Lymphadenitis, Mesenteric
% 215.87/216.05  |- mesh__recordAuthorizer mesh__D008640 sjn
% 215.87/216.05  |- mesh__dateRevised mesh__D008640 2004-07-07
% 215.87/216.05  |- skos__hiddenLabel mesh__D008640 Mesenteric Lymphadenitides
% 215.87/216.05  |- skos__prefLabel mesh__D008640 Mesenteric Lymphadenitis
% 215.87/216.05  |- skos__broader mesh__D008640smesh__D010532
% 215.87/216.05  |- mesh__recordMaintainer mesh__D008640 lkt
% 215.87/216.05  |- mesh__dateCreated mesh__D008640 1999-01-01
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D008640 2005
% 215.87/216.05  |- skos__annotation mesh__D008640
% 215.87/216.05       coordinate IM with specific infection %28%IM%29% if pertinent   
% 215.87/216.05  |- skos__hiddenLabel mesh__D008640 Lymphadenitides, Mesenteric
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D008640 2006
% 215.87/216.05  |- mesh__recordOriginator mesh__D008640 NLM
% 215.87/216.05  |- skos__scopeNote mesh__D008640
% 215.87/216.05       INFLAMMATION of LYMPH NODES in the MESENTERY.     
% 215.87/216.05  |- skos__broader mesh__D008640smesh__D008199
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013585 1996
% 215.87/216.05  |- mesh__dateCreated mesh__D013585 1999-01-01
% 215.87/216.05  |- mesh__recordMaintainer mesh__D013585 TGC
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013585 2006
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013585 2000
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013585 1998
% 215.87/216.05  |- mesh__recordAuthorizer mesh__D013585 PLS
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013585 1997
% 215.87/216.05  |- mesh__recordOriginator mesh__D013585 NLM
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013585 2001
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013585 1994
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013585 1999
% 215.87/216.05  |- rdf__type mesh__D013585sskos__Concept
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013585 1995
% 215.87/216.05  |- mesh__dateRevised mesh__D013585 1993-06-03
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013585 2002
% 215.87/216.05  |- skos__hiddenLabel mesh__D013585 Synovitides
% 215.87/216.05  |- skos__prefLabel mesh__D013585 Synovitis
% 215.87/216.05  |- skos__broader mesh__D013585smesh__D007592
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013585 2003
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013585 2005
% 215.87/216.05  |- skos__annotation mesh__D013585
% 215.87/216.05       inflamm of synovial membrane: do not confuse with TENOSYNOVITIS, inflamm of tendon sheath%A%  
% 215.87/216.05  |- skos__scopeNote mesh__D013585
% 215.87/216.05       Inflammation of a synovial membrane. It is usually painful, particularly on motion, and is characterized by a fluctuating swelling due to effusion within a synovial sac. %28%Dorland, 27th ed%29%%A%    
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D013585 2004
% 215.87/216.05  |- skos__hiddenLabel mesh__D007548 IsoBid
% 215.87/216.05  |- mesh__historyNote mesh__D007548 74%28%66%29%   
% 215.87/216.05  |- skos__prefLabel mesh__D007548 Isosorbide Dinitrate
% 215.87/216.05  |- mesh__recordAuthorizer mesh__D007548 sjn
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D007548 2005
% 215.87/216.05  |- mesh__dateCreated mesh__D007548 1999-01-01
% 215.87/216.05  |- skos__hiddenLabel mesh__D007548 Dinitrate, Isosorbide
% 215.87/216.05  |- skos__hiddenLabel mesh__D007548 Isoket Retard 120
% 215.87/216.05  |- mesh__activeMeSHYear mesh__D007548 2006
% 215.87/216.05  |- mesh__recordMaintainer mesh__D007548 ssb
% 215.87/216.05  |- mesh__recordOriginator mesh__D007548 NLM
% 215.87/216.05  |- mesh__publicMeSHNote mesh__D007548 74   
% 215.87/216.05  |- mesh__dateEstablished mesh__D007548 1974-01-01
% 215.87/216.05  |- skos__hiddenLabel mesh__D007548 Iso Bid
% 215.87/216.05  |- rdf__type mesh__D007548sskos__Concept
% 215.87/216.05  |- skos__broader mesh__D007548smesh__D007547
% 215.87/216.05  |- skos__hiddenLabel mesh__D007548 Isoket Retard120
% 215.87/216.05  |- skos__scopeNote mesh__D007548
% 215.87/216.05       A vasodilator used in the treatment of ANGINA PECTORIS. Its actions are similar to NITROGLYCERIN but with a slower onset of action.%A%    
% 215.87/216.06  |- mesh__dateRevised mesh__D007548 2004-07-07
% 215.87/216.06  |- skos__hiddenLabel mesh__D018270 Carcinomas, Mammary Ductal
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D018270 2005
% 215.87/216.06  |- mesh__recordOriginator mesh__D018270 PLS
% 215.87/216.06  |- mesh__dateRevised mesh__D018270 2004-07-13
% 215.87/216.06  |- skos__prefLabel mesh__D018270 Carcinoma, Ductal, Breast
% 215.87/216.06  |- mesh__publicMeSHNote mesh__D018270
% 215.87/216.06       2004; see CARCINOMA, INFILTRATING DUCT 1994-2003   
% 215.87/216.06  |- skos__altLabel mesh__D018270 Mammary Ductal Carcinoma
% 215.87/216.06  |- mesh__dateCreated mesh__D018270 1993-06-28
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D018270 2006
% 215.87/216.06  |- mesh__historyNote mesh__D018270 2004 %28%1994%29%   
% 215.87/216.06  |- mesh__recordMaintainer mesh__D018270 sjn
% 215.87/216.06  |- rdf__type mesh__D018270sskos__Concept
% 215.87/216.06  |- skos__altLabel mesh__D018270 Carcinoma, Infiltrating Duct
% 215.87/216.06  |- skos__broader mesh__D018270smesh__D044584
% 215.87/216.06  |- skos__altLabel mesh__D018270 Carcinoma, Invasive Ductal, Breast
% 215.87/216.06  |- skos__scopeNote mesh__D018270
% 215.87/216.06       An invasive %28%infiltrating%29% CARCINOMA of the mammary ductal system %28%MAMMARY GLANDS%29% in the human BREAST.%A%    
% 215.87/216.06  |- mesh__recordAuthorizer mesh__D018270 sjn
% 215.87/216.06  |- skos__annotation mesh__D018270
% 215.87/216.06       coord IM with BREAST NEOPLASMS %28%IM%29%   
% 215.87/216.06  |- skos__broader mesh__D018270smesh__D001943
% 215.87/216.06  |- skos__hiddenLabel mesh__D018270 Carcinomas, Infiltrating Duct
% 215.87/216.06  |- skos__hiddenLabel mesh__D018270 Mammary Ductal Carcinomas
% 215.87/216.06  |- skos__altLabel mesh__D018270 Invasive Ductal Carcinoma, Breast
% 215.87/216.06  |- mesh__dateEstablished mesh__D018270 1994-01-01
% 215.87/216.06  |- mesh__dateEstablished mesh__D004250 1980-01-01
% 215.87/216.06  |- skos__historyNote mesh__D004250 DNA, Superhelical %28%1978-1979%29%
% 215.87/216.06  |- skos__historyNote mesh__D004250 DNA Replication %28%1968-1979%29%
% 215.87/216.06  |- skos__annotation mesh__D004250 GEN or unspecified; prefer specifics   
% 215.87/216.06  |- skos__historyNote mesh__D004250
% 215.87/216.06       DNA Untwisting Proteins %28%1978-1979%29%
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D004250 2005
% 215.87/216.06  |- skos__altLabel mesh__D004250 DNA Type 2 Topoisomerase
% 215.87/216.06  |- skos__prefLabel mesh__D004250 DNA Topoisomerases, Type II
% 215.87/216.06  |- skos__historyNote mesh__D004250 DNA %28%1966-1977%29%
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D004250 2006
% 215.87/216.06  |- skos__broader mesh__D004250smesh__D026942
% 215.87/216.06  |- skos__altLabel mesh__D004250 DNA Topoisomerase %28%ATP-Hydrolysing%29%
% 215.87/216.06  |- skos__altLabel mesh__D004250 Type II DNA Topoisomerase
% 215.87/216.06  |- mesh__historyNote mesh__D004250
% 215.87/216.06       2002; use DNA TOPOISOMERASE %28%ATP-HYDROLYSING%29% 1994-2001, use DNA GYRASE 1980-1993%A%  
% 215.87/216.06  |- mesh__recordAuthorizer mesh__D004250 sjn
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D004250 2004
% 215.87/216.06  |- mesh__recordOriginator mesh__D004250 RLS
% 215.87/216.06  |- skos__altLabel mesh__D004250 DNA Topoisomerase II
% 215.87/216.06  |- mesh__publicMeSHNote mesh__D004250
% 215.87/216.06       2002; see DNA TOPOISOMERASE %28%ATP-HYDROLYSING%29% 1994-2001, see  DNA GYRASE 1980-1993%A%  
% 215.87/216.06  |- mesh__dateCreated mesh__D004250 1979-05-23
% 215.87/216.06  |- skos__altLabel mesh__D004250 Topoisomerase II
% 215.87/216.06  |- skos__scopeNote mesh__D004250
% 215.87/216.06       DNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex.%A%    
% 215.87/216.06  |- mesh__recordMaintainer mesh__D004250 ssb
% 215.87/216.06  |- mesh__dateRevised mesh__D004250 2003-07-09
% 215.87/216.06  |- rdf__type mesh__D004250sskos__Concept
% 215.87/216.06  |- skos__annotation mesh__D017976
% 215.87/216.06       GEN only; prefer specifics; do not confuse with PHOSPHOROUS ACIDS or with PHOSPHORIC ACIDS%A%  
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017976 2005
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017976 2004
% 215.87/216.06  |- skos__hiddenLabel mesh__D017976 Acids, Phosphonous
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017976 2006
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017976 1996
% 215.87/216.06  |- skos__scopeNote mesh__D017976
% 215.87/216.06       Inorganic acids that contain phosphorus as an integral part of the molecule.%A%    
% 215.87/216.06  |- mesh__dateCreated mesh__D017976 1993-06-28
% 215.87/216.06  |- mesh__historyNote mesh__D017976
% 215.87/216.06       94; PHOSPHINOUS ACIDS %26% PHOSPHONOUS ACIDS were headings 1968-93%A%  
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017976 1998
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017976 2002
% 215.87/216.06  |- rdf__type mesh__D017976sskos__Concept
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017976 1997
% 215.87/216.06  |- skos__broader mesh__D017976smesh__D000148
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017976 1994
% 215.87/216.06  |- skos__hiddenLabel mesh__D017976 Acids, Phosphinous
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017976 1999
% 215.87/216.06  |- mesh__onlineNote mesh__D017976
% 215.87/216.06       use PHOSPHORUS ACIDS to search PHOSPHINOUS ACIDS %26% PHOSPHONOUS ACIDS 1968-93%A%  
% 215.87/216.06  |- skos__historyNote mesh__D017976 Phosphorus %28%1966-1993%29%
% 215.87/216.06  |- skos__hiddenLabel mesh__D017976 Acids, Phosphorus
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017976 1995
% 215.87/216.06  |- mesh__publicMeSHNote mesh__D017976
% 215.87/216.06       94; PHOSPHINOUS ACIDS %26% PHOSPHONOUS ACIDS were headings 1968-93%A%  
% 215.87/216.06  |- skos__broader mesh__D017976smesh__D017553
% 215.87/216.06  |- mesh__dateEstablished mesh__D017976 1994-01-01
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017976 2000
% 215.87/216.06  |- skos__prefLabel mesh__D017976 Phosphorus Acids
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017976 2003
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017976 2001
% 215.87/216.06  |- mesh__historyNote mesh__D031647 2003   
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D031647 2005
% 215.87/216.06  |- mesh__recordAuthorizer mesh__D031647 sjn
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D031647 2006
% 215.87/216.06  |- mesh__recordMaintainer mesh__D031647 sjn
% 215.87/216.06  |- skos__broader mesh__D031647smesh__D027822
% 215.87/216.06  |- mesh__dateRevised mesh__D031647 2004-07-13
% 215.87/216.06  |- skos__annotation mesh__D031647
% 215.87/216.06       X ref GUAVA: PINEAPPLE GUAVA see FEIJOA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.87/216.06  |- mesh__recordOriginator mesh__D031647 ssb
% 215.87/216.06  |- mesh__dateCreated mesh__D031647 2002-07-03
% 215.87/216.06  |- skos__prefLabel mesh__D031647 Psidium
% 215.87/216.06  |- rdf__type mesh__D031647sskos__Concept
% 215.87/216.06  |- skos__scopeNote mesh__D031647
% 215.87/216.06       A plant genus of the family MYRTACEAE that bears an edible fruit and contains guavin B and quercetin glycosides.%A%    
% 215.87/216.06  |- mesh__dateEstablished mesh__D031647 2003-01-01
% 215.87/216.06  |- skos__altLabel mesh__D031647 Guava
% 215.87/216.06  |- mesh__publicMeSHNote mesh__D031647 2003   
% 215.87/216.06  |- skos__altLabel mesh__D050801 Ternary Complex Transcription Factors
% 215.87/216.06  |- mesh__recordAuthorizer mesh__D050801 ags
% 215.87/216.06  |- skos__broader mesh__D050801smesh__D050783
% 215.87/216.06  |- mesh__publicMeSHNote mesh__D050801 2006   
% 215.87/216.06  |- mesh__recordMaintainer mesh__D050801 ags
% 215.87/216.06  |- skos__hiddenLabel mesh__D050801 Complex Proteins, Ternary
% 215.87/216.06  |- mesh__dateRevised mesh__D050801 2005-07-19
% 215.87/216.06  |- mesh__historyNote mesh__D050801 2006   
% 215.87/216.06  |- skos__scopeNote mesh__D050801
% 215.87/216.06       A subclass of c-ets proto-oncogene proteins that were first described by their property of binding to DNA when associated with other regulatory proteins such as SERUM RESPONSE FACTOR. They contain an amino-terminal ets domain that binds to DNA along with centrally located SERUM RESPONSE FACTOR interacting domain, and carboxy-terminal map kinase activation domains. They play an important role in transcriptional regulation by INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS.%A%    
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D050801 2006
% 215.87/216.06  |- skos__prefLabel mesh__D050801 Ternary Complex Factors
% 215.87/216.06  |- mesh__dateEstablished mesh__D050801 2006-01-01
% 215.87/216.06  |- mesh__recordOriginator mesh__D050801 jmp
% 215.87/216.06  |- skos__altLabel mesh__D050801 Ternary Complex Proteins
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D050801 2006A
% 215.87/216.06  |- skos__hiddenLabel mesh__D050801 Complex Factors, Ternary
% 215.87/216.06  |- rdf__type mesh__D050801sskos__Concept
% 215.87/216.06  |- mesh__dateCreated mesh__D050801 2005-06-30
% 215.87/216.06  |- mesh__publicMeSHNote mesh__D017178 93   
% 215.87/216.06  |- mesh__historyNote mesh__D017178 93   
% 215.87/216.06  |- mesh__dateCreated mesh__D017178 1992-05-07
% 215.87/216.06  |- mesh__recordAuthorizer mesh__D017178 sjn
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017178 2005
% 215.87/216.06  |- skos__broader mesh__D017178smesh__D002009
% 215.87/216.06  |- skos__historyNote mesh__D017178 Filarioidea %28%1966-1974%29%
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017178 2004
% 215.87/216.06  |- rdf__type mesh__D017178sskos__Concept
% 215.87/216.06  |- mesh__dateEstablished mesh__D017178 1993-01-01
% 215.87/216.06  |- skos__annotation mesh__D017178
% 215.87/216.06       infection: coord IM with FILARIASIS %28%IM%29% or if with possible lymphatic involvement, ELEPHANTIASIS, FILARIAL %28%IM%29%; coord with specific helminth term %28%ANTIGENS, HELMINTH, etc%29% if pertinent; /drug eff: consider FILARICIDES%A%  
% 215.87/216.06  |- skos__scopeNote mesh__D017178
% 215.87/216.06       A species of parasitic nematode causing Malayan filariasis and having a distribution centering roughly on the Malay peninsula. The life cycle of B. malayi is similar to that of WUCHERERIA BANCROFTI, except that in most areas the principal mosquito vectors belong to the genus Mansonia.%A%    
% 215.87/216.06  |- skos__historyNote mesh__D017178 Brugia %28%1975-1992%29%
% 215.87/216.06  |- skos__prefLabel mesh__D017178 Brugia malayi
% 215.87/216.06  |- mesh__dateRevised mesh__D017178 2003-07-09
% 215.87/216.06  |- mesh__recordOriginator mesh__D017178 PXP
% 215.87/216.06  |- mesh__recordMaintainer mesh__D017178 ags
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017178 2006
% 215.87/216.06  |- mesh__recordMaintainer mesh__D003956 lkt
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D003956 2005
% 215.87/216.06  |- mesh__dateCreated mesh__D003956 1999-01-01
% 215.87/216.06  |- mesh__recordOriginator mesh__D003956 NLM
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D003956 2006
% 215.87/216.06  |- skos__annotation mesh__D003956
% 215.87/216.06       anal %26% phys chem process; NIM; in ther of kidney dis %22%dialysis%22% is likely to be RENAL DIALYSIS or PERITONEAL DIALYSIS; nothing to do with %22%dialysis retinae%22% %28% = RETINAL DIALYSES see RETINAL PERFORATIONS%29%%A%  
% 215.87/216.06  |- mesh__dateRevised mesh__D003956 2002-07-03
% 215.87/216.06  |- skos__scopeNote mesh__D003956
% 215.87/216.06       A process of selective diffusion through a membrane. It is usually used to separate low-molecular-weight solutes which diffuse through the membrane from the colloidal and high-molecular-weight solutes which do not. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D003956 2003
% 215.87/216.06  |- skos__broader mesh__D003956smesh__D002627
% 215.87/216.06  |- skos__prefLabel mesh__D003956 Dialysis
% 215.87/216.06  |- mesh__recordAuthorizer mesh__D003956 sjn
% 215.87/216.06  |- skos__broader mesh__D003956smesh__D002623
% 215.87/216.06  |- skos__hiddenLabel mesh__D003956 Dialyses
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D003956 2004
% 215.87/216.06  |- rdf__type mesh__D003956sskos__Concept
% 215.87/216.06  |- mesh__dateEstablished mesh__D003158 1973-01-01
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D003158 2006
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D003158 2003
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D003158 1997
% 215.87/216.06  |- mesh__recordMaintainer mesh__D003158 TAP
% 215.87/216.06  |- mesh__publicMeSHNote mesh__D003158
% 215.87/216.06       80; was PSYCHIATRY, COMMUNITY 1973-79   
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D003158 2004
% 215.87/216.06  |- mesh__historyNote mesh__D003158
% 215.87/216.06       80; was PSYCHIATRY, COMMUNITY 1971-79 %28%Prov 1971-72%29%   
% 215.87/216.06  |- rdf__type mesh__D003158sskos__Concept
% 215.87/216.06  |- mesh__dateCreated mesh__D003158 1999-01-01
% 215.87/216.06  |- mesh__dateRevised mesh__D003158 1995-05-18
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D003158 2000
% 215.87/216.06  |- mesh__onlineNote mesh__D003158
% 215.87/216.06       use COMMUNITY PSYCHIATRY to search PSYCHIATRY, COMMUNITY 1971-79 %28%as Prov 1971-72%29%%A%  
% 215.87/216.06  |- skos__annotation mesh__D003158 SPEC: SPEC qualif   
% 215.87/216.06  |- skos__broader mesh__D003158smesh__D011570
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D003158 2001
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D003158 1998
% 215.87/216.06  |- skos__historyNote mesh__D003158 Psychiatry %28%1966-1970%29%
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D003158 2005
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D003158 2002
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D003158 1999
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D003158 1996
% 215.87/216.06  |- skos__altLabel mesh__D003158 Psychiatry, Community
% 215.87/216.06  |- skos__prefLabel mesh__D003158 Community Psychiatry
% 215.87/216.06  |- skos__scopeNote mesh__D003158
% 215.87/216.06       Branch of psychiatry concerned with the provision and delivery of a coordinated program of mental health care to a specified population. The foci included in this concept are: all social, psychological and physical factors related to etiology, prevention, and maintaining positive mental health in the community.%A%    
% 215.87/216.06  |- mesh__recordOriginator mesh__D003158 NLM
% 215.87/216.06  |- skos__hiddenLabel mesh__D003158 Psychiatry, Social
% 215.87/216.06  |- mesh__recordAuthorizer mesh__D003158 PLS
% 215.87/216.06  |- skos__scopeNote mesh__D008641
% 215.87/216.06       Obstruction of the flow in the SPLANCHNIC CIRCULATION by ATHEROSCLEROSIS; EMBOLISM; THROMBOSIS; STENOSIS; TRAUMA; and compression or intrinsic pressure from adjacent tumors. Rare causes are drugs, intestinal parasites, and vascular immunoinflammatory diseases such as PERIARTERITIS NODOSA and THROMBOANGIITIS OBLITERANS. %28%From Juergens et al., Peripheral Vascular Diseases, 5th ed, pp295-6%29%%A%    
% 215.87/216.06  |- skos__hiddenLabel mesh__D008641 Vascular Occlusion, Mesenteric
% 215.87/216.06  |- skos__hiddenLabel mesh__D008641 Occlusions, Mesenteric Vascular
% 215.87/216.06  |- skos__prefLabel mesh__D008641 Mesenteric Vascular Occlusion
% 215.87/216.06  |- mesh__dateCreated mesh__D008641 1999-01-01
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D008641 2005
% 215.87/216.06  |- mesh__recordAuthorizer mesh__D008641 sjn
% 215.87/216.06  |- skos__hiddenLabel mesh__D008641 Mesenteric Vascular Occlusions
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D008641 2006
% 215.87/216.06  |- skos__broader mesh__D008641smesh__D010532
% 215.87/216.06  |- skos__broader mesh__D008641smesh__D001157
% 215.87/216.06  |- mesh__recordMaintainer mesh__D008641 lkt
% 215.87/216.06  |- skos__hiddenLabel mesh__D008641 Occlusion, Mesenteric Vascular
% 215.87/216.06  |- mesh__dateRevised mesh__D008641 2003-07-09
% 215.87/216.06  |- rdf__type mesh__D008641sskos__Concept
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D008641 2004
% 215.87/216.06  |- skos__hiddenLabel mesh__D008641 Vascular Occlusions, Mesenteric
% 215.87/216.06  |- skos__annotation mesh__D008641
% 215.87/216.06       coord IM with MESENTERIC ARTERIES %28%NIM%29% or MESENTERIC VEINS %28%NIM%29%; embolism or thrombosis: see notes under MESENTERIC ARTERIES %26% MESENTERIC VEINS; coord IM with target organ losing its blood supply %28%COLON /blood supply, JEJUNUM /blood supply%29% %28%IM or NIM%29% only if particularly discussed; do not confuse with SUPERIOR MESENTERIC ARTERY SYNDROME %28%duodenal compression BY the superior mesenteric artery, not OF%29%%A%  
% 215.87/216.06  |- skos__broader mesh__D008641smesh__D007410
% 215.87/216.06  |- mesh__recordOriginator mesh__D008641 NLM
% 215.87/216.06  |- skos__prefLabel mesh__D013586 Synovitis, Pigmented Villonodular
% 215.87/216.06  |- mesh__recordOriginator mesh__D013586 RC
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D013586 2000
% 215.87/216.06  |- mesh__recordAuthorizer mesh__D013586 PLS
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D013586 1997
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D013586 2003
% 215.87/216.06  |- skos__hiddenLabel mesh__D013586 Villonodular Synovitides, Pigmented
% 215.87/216.06  |- skos__scopeNote mesh__D013586
% 215.87/216.06       Outgrowths of synovial membrane composed of villi and fibrous nodules characterized histologically by hemosiderin- and lipid-containing macrophages and multinucleated giant cells. It usually occurs in the knee.%A%    
% 215.87/216.06  |- mesh__historyNote mesh__D013586
% 215.87/216.06       91%28%78%29%; was see under SYNOVITIS 1978-90   
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D013586 2006
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D013586 1993
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D013586 1996
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D013586 2002
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D013586 1999
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D013586 2005
% 215.87/216.06  |- skos__annotation mesh__D013586 usually in the knee   
% 215.87/216.06  |- rdf__type mesh__D013586sskos__Concept
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D013586 1995
% 215.87/216.06  |- mesh__dateRevised mesh__D013586 1992-05-22
% 215.87/216.06  |- skos__historyNote mesh__D013586 Synovitis %28%1966-1977%29%
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D013586 1998
% 215.87/216.06  |- mesh__dateEstablished mesh__D013586 1991-01-01
% 215.87/216.06  |- skos__broader mesh__D013586smesh__D013585
% 215.87/216.06  |- skos__hiddenLabel mesh__D013586 Synovitides, Pigmented Villonodular
% 215.87/216.06  |- skos__hiddenLabel mesh__D013586 Pigmented Villonodular Synovitis
% 215.87/216.06  |- mesh__recordMaintainer mesh__D013586 TGC
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D013586 1994
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D013586 2001
% 215.87/216.06  |- skos__hiddenLabel mesh__D013586 Villonodular Synovitis, Pigmented
% 215.87/216.06  |- mesh__publicMeSHNote mesh__D013586
% 215.87/216.06       91; was see under SYNOVITIS 1978-90   
% 215.87/216.06  |- skos__hiddenLabel mesh__D013586 Pigmented Villonodular Synovitides
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D013586 2004
% 215.87/216.06  |- mesh__dateCreated mesh__D013586 1977-03-01
% 215.87/216.06  |- mesh__recordMaintainer mesh__D007549 ags
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D007549 2004
% 215.87/216.06  |- skos__broader mesh__D007549smesh__D021743
% 215.87/216.06  |- mesh__dateRevised mesh__D007549 2003-07-09
% 215.87/216.06  |- rdf__type mesh__D007549sskos__Concept
% 215.87/216.06  |- mesh__recordAuthorizer mesh__D007549 sjn
% 215.87/216.06  |- skos__scopeNote mesh__D007549
% 215.87/216.06       A genus of protozoan parasites found in the intestines of birds, amphibians, reptiles, and mammals, including man. The oocysts produce two sporocysts, each with four sporozoites. Many species are parasitic in wild and domestic animals.%A%    
% 215.87/216.06  |- skos__annotation mesh__D007549
% 215.87/216.06       infection = ISOSPORIASIS; coord with specific protozoan terms %28%ANTIGENS, PROTOZOAN, etc%29% if pertinent%A%  
% 215.87/216.06  |- skos__prefLabel mesh__D007549 Isospora
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D007549 2005
% 215.87/216.06  |- mesh__dateCreated mesh__D007549 1999-01-01
% 215.87/216.06  |- mesh__recordOriginator mesh__D007549 NLM
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D007549 2006
% 215.87/216.06  |- mesh__recordOriginator mesh__D018271 PXP
% 215.87/216.06  |- mesh__recordMaintainer mesh__D018271 SYSTEM
% 215.87/216.06  |- skos__hiddenLabel mesh__D018271 Recognition Particle, Signal
% 215.87/216.06  |- mesh__onlineNote mesh__D018271
% 215.87/216.06       use SIGNAL RECOGNITION PARTICLE %28%NM%29% to search SIGNAL RECOGNITION PARTICLE 1985-93%A%  
% 215.87/216.06  |- mesh__recordAuthorizer mesh__D018271 sjn
% 215.87/216.06  |- skos__broader mesh__D018271smesh__D020736
% 215.87/216.06  |- mesh__dateEstablished mesh__D018271 1994-01-01
% 215.87/216.06  |- skos__altLabel mesh__D018271 SRP %28%Signal Recognition Particle%29%
% 215.87/216.06  |- skos__scopeNote mesh__D018271
% 215.87/216.06       A cytosolic ribonucleoprotein complex that acts to induce elongation arrest of nascent presecretory and membrane proteins until the ribosome becomes associated with the rough endoplasmic reticulum. It consists of a 7S RNA and at least six polypeptide subunits %28%relative molecular masses 9, 14, 19, 54, 68, and 72K%29%.%A%    
% 215.87/216.06  |- mesh__dateRevised mesh__D018271 2005-06-30
% 215.87/216.06  |- mesh__dateCreated mesh__D018271 1993-06-03
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D018271 2006
% 215.87/216.06  |- mesh__publicMeSHNote mesh__D018271
% 215.87/216.06       94; SIGNAL RECOGNITION PARTICLE was indexed under RIBONUCLEOPROTEINS 1985-93%A%  
% 215.87/216.06  |- skos__historyNote mesh__D018271 Ribonucleoproteins %28%1985-1993%29%
% 215.87/216.06  |- rdf__type mesh__D018271sskos__Concept
% 215.87/216.06  |- skos__annotation mesh__D018271 DF: note short X ref   
% 215.87/216.06  |- skos__prefLabel mesh__D018271 Signal Recognition Particle
% 215.87/216.06  |- skos__related mesh__D018271smesh__D021382
% 215.87/216.06  |- skos__hiddenLabel mesh__D018271 Particle, Signal Recognition
% 215.87/216.06  |- mesh__historyNote mesh__D018271
% 215.87/216.06       94; was SIGNAL RECOGNITION PARTICLE %28%NM%29% 1985-93   
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 Element, Tn
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 IS Element
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 DNA Transposable Element
% 215.87/216.06  |- skos__related mesh__D004251smesh__D018626
% 215.87/216.06  |- skos__broader mesh__D004251smesh__D004247
% 215.87/216.06  |- skos__historyNote mesh__D004251 Recombination, Genetic %28%1968-1979%29%
% 215.87/216.06  |- skos__annotation mesh__D004251
% 215.87/216.06       do not use for retrotransposable elements %28%RETROELEMENTS%29%%A%  
% 215.87/216.06  |- rdf__type mesh__D004251sskos__Concept
% 215.87/216.06  |- skos__altLabel mesh__D004251 Transposable Elements
% 215.87/216.06  |- skos__related mesh__D004251smesh__D010957
% 215.87/216.06  |- mesh__recordMaintainer mesh__D004251 nns
% 215.87/216.06  |- skos__related mesh__D004251smesh__D016254
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 Transposon, DNA
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D004251 2006
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 Element, Transposable
% 215.87/216.06  |- skos__historyNote mesh__D004251 Plasmids %28%1975-1979%29%
% 215.87/216.06  |- skos__altLabel mesh__D004251 Sequence Elements, Insertion
% 215.87/216.06  |- skos__altLabel mesh__D004251 IS Elements
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 DNA Transposon
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 Elements, Transposable
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 Element, DNA Insertion
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 Insertion Sequence Element
% 215.87/216.06  |- skos__historyNote mesh__D004251 Mutation %28%1966-1979%29%
% 215.87/216.06  |- mesh__dateCreated mesh__D004251 1978-12-21
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 Tn Element
% 215.87/216.06  |- skos__historyNote mesh__D004251 Base Sequence %28%1971-1979%29%
% 215.87/216.06  |- mesh__recordAuthorizer mesh__D004251 sjn
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 Transposable Element, DNA
% 215.87/216.06  |- mesh__recordOriginator mesh__D004251 AEP
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 Elements, DNA Transposable
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 Elements, Tn
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 Elements, DNA Insertion
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 Element, Insertion Sequence
% 215.87/216.06  |- skos__broader mesh__D004251smesh__D020071
% 215.87/216.06  |- skos__related mesh__D004251smesh__D004274
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 Transposons, DNA
% 215.87/216.06  |- skos__altLabel mesh__D004251 Elements, Insertion Sequence
% 215.87/216.06  |- mesh__publicMeSHNote mesh__D004251
% 215.87/216.06       99; see DNA INSERTION ELEMENTS 1980-98; for INSERTION SEQUENCE ELEMENTS see INSERTION SEQUENCE ELEMENTS 1980%A%  
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 DNA Insertion Element
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 Element, IS
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 Element, DNA Transposable
% 215.87/216.06  |- skos__scopeNote mesh__D004251
% 215.87/216.06       Discrete segments of DNA which can excise and reintegrate to another site in the genome. Most are inactive, i.e., have not been found to exist outside the integrated state. DNA transposable elements include bacterial IS %28%insertion sequence%29% elements, Tn elements, the maize controlling elements Ac and Ds, Drosophila P, gypsy, and pogo elements, the human Tigger elements and the Tc and mariner elements which are found throughout the animal kingdom.%A%    
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 Sequence Element, Insertion
% 215.87/216.06  |- mesh__dateEstablished mesh__D004251 1980-01-01
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 Insertion Elements, DNA
% 215.87/216.06  |- mesh__historyNote mesh__D004251 99%28%80%29%   
% 215.87/216.06  |- mesh__dateRevised mesh__D004251 2005-06-30
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 Transposable Elements, DNA
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 Elements, IS
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 Insertion Element, DNA
% 215.87/216.06  |- skos__prefLabel mesh__D004251 DNA Transposable Elements
% 215.87/216.06  |- skos__hiddenLabel mesh__D004251 Transposable Element
% 215.87/216.06  |- mesh__recordMaintainer mesh__D017977 ags
% 215.87/216.06  |- rdf__type mesh__D017977sskos__Concept
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017977 2006A
% 215.87/216.06  |- skos__altLabel mesh__D017977 Human T Cell Leukemia Lymphoma Viruses
% 215.87/216.06  |- skos__broader mesh__D017977smesh__D012190
% 215.87/216.06  |- skos__annotation mesh__D017977
% 215.87/216.06       infection = DELTARETROVIRUS INFECTIONS + TUMOR VIRUS INFECTIONS if pertinent%A%  
% 215.87/216.06  |- skos__altLabel mesh__D017977 Leukemia Viruses, Human T Cell
% 215.87/216.06  |- skos__altLabel mesh__D017977 Human T-Cell Leukemia-Lymphoma Viruses
% 215.87/216.06  |- mesh__dateCreated mesh__D017977 1993-06-04
% 215.87/216.06  |- skos__scopeNote mesh__D017977
% 215.87/216.06       A genus in the family RETROVIRIDAE consisting of exogenous horizontally-transmitted viruses found in a few groups of mammals. Infections caused by these viruses include human B- or adult T-cell leukemia/lymphoma %28%LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED%29%, and bovine leukemia %28%ENZOOTIC BOVINE LEUKOSIS%29%. The type species is LEUKEMIA VIRUS, BOVINE.%A%    
% 215.87/216.06  |- mesh__publicMeSHNote mesh__D017977
% 215.87/216.06       2002; see HTLV-BLV VIRUSES 1994-2001; for HTLV VIRUSES see HTLV VIRUSES 1989-1993, see HUMAN T-CELL LEUKEMIA VIRUS 1984-1988; for HUMAN T-CELL LEUKEMIA-LYMPHOMA VIRUSES %26% LEUKEMIA VIRUSES, HUMAN T-CELL see HUMAN T-CELL LEUKEMIA VIRUS 1985-1988, see HTLV VIRUSES 1989-1993; for HUMAN T-CELL LEUKEMIA VIRUSES %26% T-CELL LEUKEMIA VIRUSES, HUMAN see HTLV VIRUSES 1989-1993%A%  
% 215.87/216.06  |- skos__altLabel mesh__D017977 Leukemia Viruses, Human T-Cell
% 215.87/216.06  |- skos__altLabel mesh__D017977 BLV-HTLV Viruses
% 215.87/216.06  |- mesh__recordAuthorizer mesh__D017977 ags
% 215.87/216.06  |- mesh__historyNote mesh__D017977
% 215.87/216.06       2002 %28%1994%29%; for HTLV VIRUSES use HTLV VIRUSES 1989-1993, use HUMAN T-CELL LEUKEMIA VIRUS 1984-1988; for HUMAN T-CELL LEUKEMIA-LYMPHOMA VIRUSES %26% LEUKEMIA VIRUSES, HUMAN T-CELL use HUMAN T-CELL LEUKEMIA VIRUS 1985-1988, use HTLV VIRUSES 1989-1993; for HUMAN T-CELL LEUKEMIA VIRUSES %26% T-CELL LEUKEMIA VIRUSES, HUMAN use HTLV VIRUSES 1989-1993%A%  
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017977 2006B
% 215.87/216.06  |- skos__altLabel mesh__D017977 Human T Cell Leukemia Viruses
% 215.87/216.06  |- skos__altLabel mesh__D017977 HTLV-BLV Viruses
% 215.87/216.06  |- mesh__dateRevised mesh__D017977 2005-07-18
% 215.87/216.06  |- mesh__recordOriginator mesh__D017977 AGS
% 215.87/216.06  |- skos__hiddenLabel mesh__D017977 BLV HTLV Viruses
% 215.87/216.06  |- skos__altLabel mesh__D017977 HTLV Viruses
% 215.87/216.06  |- skos__prefLabel mesh__D017977 Deltaretrovirus
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017977 2005
% 215.87/216.06  |- skos__altLabel mesh__D017977 Human T-Cell Leukemia Viruses
% 215.87/216.06  |- skos__hiddenLabel mesh__D017977 HTLV BLV Viruses
% 215.87/216.06  |- skos__altLabel mesh__D017977 T Cell Leukemia Viruses, Human
% 215.87/216.06  |- mesh__dateEstablished mesh__D017977 1994-01-01
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017977 2006
% 215.87/216.06  |- mesh__dateCreated mesh__D031648 2002-07-03
% 215.87/216.06  |- skos__scopeNote mesh__D031648
% 215.87/216.06       A plant genus of the family MYRTACEAE. The common name of tea tree more often refers to MELALEUCA or LEPTOSPERMUM.%A%    
% 215.87/216.06  |- skos__broader mesh__D031648smesh__D027822
% 215.87/216.06  |- skos__prefLabel mesh__D031648 Kunzea
% 215.87/216.06  |- rdf__type mesh__D031648sskos__Concept
% 215.87/216.06  |- mesh__historyNote mesh__D031648 2003   
% 215.87/216.06  |- mesh__publicMeSHNote mesh__D031648 2003   
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D031648 2003
% 215.87/216.06  |- skos__annotation mesh__D031648
% 215.87/216.06       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D031648 2005
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D031648 2004
% 215.87/216.06  |- mesh__dateEstablished mesh__D031648 2003-01-01
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D031648 2006
% 215.87/216.06  |- skos__altLabel mesh__D031648 Kanuka
% 215.87/216.06  |- mesh__publicMeSHNote mesh__D050802
% 215.87/216.06       2006; VALINE DEHYDROGENASE %28%NADP+%29% was indexed under AMINO ACID OXIDOREDUCTASES 1989-2004%A%  
% 215.87/216.06  |- mesh__recordOriginator mesh__D050802 AKE
% 215.87/216.06  |- skos__broader mesh__D050802smesh__D000594
% 215.87/216.06  |- mesh__dateEstablished mesh__D050802 2006-01-01
% 215.87/216.06  |- mesh__recordAuthorizer mesh__D050802 sjn
% 215.87/216.06  |- mesh__dateCreated mesh__D050802 2005-06-30
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D050802 2006
% 215.87/216.06  |- skos__scopeNote mesh__D050802
% 215.87/216.06       An amino acid oxidoreductase that catalyzes the oxidative hydroxylation of L-VALINE to 3-methyl-2-oxobutanoate and AMMONIA in the presence of NADP.%A%    
% 215.87/216.06  |- mesh__historyNote mesh__D050802 2006%28%1989%29%   
% 215.87/216.06  |- skos__hiddenLabel mesh__D050802 NADP-Dependent Valine Dehydrogenase
% 215.87/216.06  |- skos__hiddenLabel mesh__D050802 Dehydrogenase, NADP-Dependent Valine
% 215.87/216.06  |- mesh__recordMaintainer mesh__D050802 AKE
% 215.87/216.06  |- rdf__type mesh__D050802sskos__Concept
% 215.87/216.06  |- skos__altLabel mesh__D050802 Valine Dehydrogenase, NADP-Dependent
% 215.87/216.06  |- skos__prefLabel mesh__D050802 Valine Dehydrogenase %28%NADP+%29%
% 215.87/216.06  |- skos__hiddenLabel mesh__D050802 Valine Dehydrogenase, NADP Dependent
% 215.87/216.06  |- skos__historyNote mesh__D017179 Filarioidea %28%1966-1974%29%
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017179 2004
% 215.87/216.06  |- mesh__publicMeSHNote mesh__D017179 93   
% 215.87/216.06  |- rdf__type mesh__D017179sskos__Concept
% 215.87/216.06  |- mesh__recordAuthorizer mesh__D017179 sjn
% 215.87/216.06  |- skos__prefLabel mesh__D017179 Brugia pahangi
% 215.87/216.06  |- skos__broader mesh__D017179smesh__D002009
% 215.87/216.06  |- skos__annotation mesh__D017179
% 215.87/216.06       infection: coord IM with FILARIASIS %28%IM%29%; coord with specific helminth term %28%ANTIGENS, HELMINTH, etc%29% if pertinent; /drug eff: consider FILARICIDES%A%  
% 215.87/216.06  |- mesh__dateEstablished mesh__D017179 1993-01-01
% 215.87/216.06  |- mesh__dateRevised mesh__D017179 2003-07-09
% 215.87/216.06  |- mesh__recordOriginator mesh__D017179 PXP
% 215.87/216.06  |- mesh__recordMaintainer mesh__D017179 ags
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017179 2006
% 215.87/216.06  |- skos__historyNote mesh__D017179 Brugia %28%1975-1992%29%
% 215.87/216.06  |- mesh__historyNote mesh__D017179 93   
% 215.87/216.06  |- mesh__dateCreated mesh__D017179 1992-05-07
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D017179 2005
% 215.87/216.06  |- skos__scopeNote mesh__D017179
% 215.87/216.06       A species of parasitic nematode found in man and other mammals. It has been reported from Malaya and East Pakistan and may produce symptoms of tropical eosinophilia.%A%    
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D003957 2006
% 215.87/216.06  |- mesh__historyNote mesh__D003957
% 215.87/216.06       91%28%79%29%; was see under ACETANILIDES 1979-90; was DIAMPHENETHIDE see under ACETANILIDE 1975-78%A%  
% 215.87/216.06  |- mesh__onlineNote mesh__D003957
% 215.87/216.06       use DIAMFENETIDE to search DIAMPHENETHIDE 1975-78   
% 215.87/216.06  |- mesh__dateEstablished mesh__D003957 1991-01-01
% 215.87/216.06  |- skos__historyNote mesh__D003957 Ethyl Ethers %28%1974%29%
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D003957 2003
% 215.87/216.06  |- mesh__publicMeSHNote mesh__D003957
% 215.87/216.06       91; was see under ACETANILIDES 1979-90; was DIAMPHENETHIDE see under ACETANILIDE 1975-78%A%  
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D003957 2001
% 215.87/216.06  |- mesh__activeMeSHYear mesh__D003957 2004
% 215.87/216.06  |- rdf__type mesh__D003957sskos__Concept
% 215.87/216.06  |- mesh__recordOriginator mesh__D003957 NLM
% 215.87/216.06  |- skos__altLabel mesh__D003957 Acemidophen
% 215.87/216.07  |- mesh__dateCreated mesh__D003957 1974-11-27
% 215.87/216.07  |- skos__altLabel mesh__D003957
% 215.87/216.07       Di-%28%2-%28%4-acetamidophenoxy%29%ethyl%29% Ether
% 215.87/216.07  |- skos__historyNote mesh__D003957 Phenyl Ethers %28%1974%29%
% 215.87/216.07  |- mesh__recordAuthorizer mesh__D003957 sjn
% 215.87/216.07  |- skos__historyNote mesh__D003957 Acetanilides %28%1974%29%
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D003957 2002
% 215.87/216.07  |- skos__altLabel mesh__D003957 Diamphenethide
% 215.87/216.07  |- skos__prefLabel mesh__D003957 Diamfenetide
% 215.87/216.07  |- mesh__dateRevised mesh__D003957 2000-06-21
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D003957 2005
% 215.87/216.07  |- mesh__recordMaintainer mesh__D003957 CCR
% 215.87/216.07  |- skos__scopeNote mesh__D003957
% 215.87/216.07       Anthelmintic. It has been shown to be useful in fasciola infections in sheep.%A%    
% 215.87/216.07  |- skos__broader mesh__D003957smesh__D000083
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D003159 2003A
% 215.87/216.07  |- mesh__historyNote mesh__D003159 78   
% 215.87/216.07  |- skos__annotation mesh__D003159
% 215.87/216.07       specify institution %28%IM%29% + geog if pertinent; DF: COMMUNITY INSTITUTIONAL RELAT%A%  
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D003159 2000
% 215.87/216.07  |- skos__hiddenLabel mesh__D003159 Relation, Community-Institutional
% 215.87/216.07  |- mesh__recordAuthorizer mesh__D003159 sjn
% 215.87/216.07  |- skos__broader mesh__D003159smesh__D011641
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D003159 2004
% 215.87/216.07  |- skos__hiddenLabel mesh__D003159 Outreach, Community
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D003159 2006
% 215.87/216.07  |- mesh__recordOriginator mesh__D003159 EC
% 215.87/216.07  |- skos__prefLabel mesh__D003159 Community-Institutional Relations
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D003159 2003
% 215.87/216.07  |- skos__hiddenLabel mesh__D003159 Community Institutional Relations
% 215.87/216.07  |- skos__hiddenLabel mesh__D003159 Relation, Community
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D003159 2005
% 215.87/216.07  |- skos__hiddenLabel mesh__D003159 Relations, Community-Institutional
% 215.87/216.07  |- mesh__publicMeSHNote mesh__D003159 78   
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D003159 2002
% 215.87/216.07  |- skos__hiddenLabel mesh__D003159 Relations, Community
% 215.87/216.07  |- skos__hiddenLabel mesh__D003159 Community Relation
% 215.87/216.07  |- rdf__type mesh__D003159sskos__Concept
% 215.87/216.07  |- mesh__dateEstablished mesh__D003159 1978-01-01
% 215.87/216.07  |- mesh__recordMaintainer mesh__D003159 sjn
% 215.87/216.07  |- mesh__dateRevised mesh__D003159 2002-10-23
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D003159 2001
% 215.87/216.07  |- skos__hiddenLabel mesh__D003159 Community-Institutional Relation
% 215.87/216.07  |- mesh__dateCreated mesh__D003159 1977-05-05
% 215.87/216.07  |- skos__scopeNote mesh__D003159
% 215.87/216.07       The interactions between members of a community and representatives of the institutions within that community.%A%    
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D008642 2006
% 215.87/216.07  |- skos__hiddenLabel mesh__D008642 Vein, Mesenteric
% 215.87/216.07  |- mesh__dateRevised mesh__D008642 2003-07-09
% 215.87/216.07  |- skos__hiddenLabel mesh__D008642 Mesenteric Vein
% 215.87/216.07  |- mesh__recordOriginator mesh__D008642 NLM
% 215.87/216.07  |- skos__hiddenLabel mesh__D008642 Veins, Mesenteric
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D008642 2004
% 215.87/216.07  |- skos__broader mesh__D008642smesh__D011168
% 215.87/216.07  |- rdf__type mesh__D008642sskos__Concept
% 215.87/216.07  |- skos__scopeNote mesh__D008642
% 215.87/216.07       Veins which return blood from the intestines; the inferior mesenteric vein empties into the splenic vein, the superior mesenteric vein joins the splenic vein to form the portal vein.%A%    
% 215.87/216.07  |- mesh__recordAuthorizer mesh__D008642 sjn
% 215.87/216.07  |- mesh__recordMaintainer mesh__D008642 lkt
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D008642 2005
% 215.87/216.07  |- skos__annotation mesh__D008642
% 215.87/216.07       occlusion or obstruction: coord NIM with MESENTERIC VASCULAR OCCLUSION %28%IM%29%; venous thrombosis: index under MESENTERIC VASCULAR OCCLUSION %28%IM%29% + VENOUS THROMBOSIS %28%IM%29% + MESENTERIC VEINS %28%NIM%29%%A%  
% 215.87/216.07  |- skos__prefLabel mesh__D008642 Mesenteric Veins
% 215.87/216.07  |- mesh__dateCreated mesh__D008642 1999-01-01
% 215.87/216.07  |- skos__annotation mesh__D013587
% 215.87/216.07       /diag: consider also SYPHILIS SERODIAGNOSIS; note terms for specific types of syphilis%A%  
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D013587 2006
% 215.87/216.07  |- mesh__dateCreated mesh__D013587 1999-01-01
% 215.87/216.07  |- mesh__recordMaintainer mesh__D013587 ags
% 215.87/216.07  |- mesh__recordAuthorizer mesh__D013587 sjn
% 215.87/216.07  |- skos__hiddenLabel mesh__D013587 Pox, Great
% 215.87/216.07  |- rdf__type mesh__D013587sskos__Concept
% 215.87/216.07  |- skos__broader mesh__D013587smesh__D014211
% 215.87/216.07  |- skos__prefLabel mesh__D013587 Syphilis
% 215.87/216.07  |- skos__broader mesh__D013587smesh__D015231
% 215.87/216.07  |- mesh__dateRevised mesh__D013587 2005-06-30
% 215.87/216.07  |- mesh__recordOriginator mesh__D013587 NLM
% 215.87/216.07  |- skos__scopeNote mesh__D013587
% 215.87/216.07       A contagious venereal disease caused by the spirochete TREPONEMA PALLIDUM.%A%    
% 215.87/216.07  |- skos__altLabel mesh__D013587 Great Pox
% 215.87/216.07  |- mesh__recordAuthorizer mesh__D032741 ags
% 215.87/216.07  |- skos__prefLabel mesh__D032741 Monascus
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D032741 2006
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D032741 2006A
% 215.87/216.07  |- mesh__recordMaintainer mesh__D032741 ags
% 215.87/216.07  |- skos__scopeNote mesh__D032741
% 215.87/216.07       A genus in the family Monascaceae, order EUROTIALES. One species, Monascus purpureus, has multiple uses in traditional Chinese medicine %28%MEDICINE, CHINESE TRADITIONAL%29%.%A%    
% 215.87/216.07  |- mesh__dateCreated mesh__D032741 2002-07-03
% 215.87/216.07  |- skos__historyNote mesh__D032741 Ascomycota %28%1975-2002%29%
% 215.87/216.07  |- mesh__dateEstablished mesh__D032741 2003-01-01
% 215.87/216.07  |- mesh__publicMeSHNote mesh__D032741 2003   
% 215.87/216.07  |- rdf__type mesh__D032741sskos__Concept
% 215.87/216.07  |- mesh__recordOriginator mesh__D032741 ags
% 215.87/216.07  |- mesh__historyNote mesh__D032741 2003   
% 215.87/216.07  |- skos__broader mesh__D032741smesh__D032641
% 215.87/216.07  |- mesh__dateRevised mesh__D032741 2005-07-19
% 215.87/216.07  |- skos__prefLabel mesh__D018272 Porins
% 215.87/216.07  |- mesh__recordMaintainer mesh__D018272 DRC
% 215.87/216.07  |- skos__historyNote mesh__D018272
% 215.87/216.07       Bacterial Outer Membrane Proteins %28%1985-1993%29%
% 215.87/216.07  |- mesh__onlineNote mesh__D018272
% 215.87/216.07       use PORINS %28%NM%29% to search PORINS %26% PHOE PROTEIN 1977-93   
% 215.87/216.07  |- mesh__recordAuthorizer mesh__D018272 sjn
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D018272 2006
% 215.87/216.07  |- mesh__dateEstablished mesh__D018272 1994-01-01
% 215.87/216.07  |- skos__hiddenLabel mesh__D018272 Proteins, Pore
% 215.87/216.07  |- rdf__type mesh__D018272sskos__Concept
% 215.87/216.07  |- mesh__publicMeSHNote mesh__D018272
% 215.87/216.07       94; PORINS %26% PHOE PROTEIN were indexed under BACTERIAL OUTER MEMBRANE PROTEINS 1985-93 %26% MEMBRANE PROTEINS 1977-93%A%  
% 215.87/216.07  |- skos__broader mesh__D018272smesh__D007473
% 215.87/216.07  |- mesh__historyNote mesh__D018272
% 215.87/216.07       94; was PORINS %28%NM%29% 1977-93; PHOE PROTEIN was SY to PORINS %28%NM%29% 1977-93%A%  
% 215.87/216.07  |- mesh__dateRevised mesh__D018272 2005-06-30
% 215.87/216.07  |- mesh__dateCreated mesh__D018272 1993-06-03
% 215.87/216.07  |- skos__scopeNote mesh__D018272
% 215.87/216.07       Porins are protein molecules that were originally found in the outer membrane of GRAM-NEGATIVE BACTERIA and that form multi-meric channels for the passive DIFFUSION of WATER; IONS; or other small molecules.  Porins are present in bacterial CELL WALLS, as well as in plant, fungal, mammalian and other vertebrate CELL MEMBRANES and MITOCHONDRIAL MEMBRANES.%A%    
% 215.87/216.07  |- mesh__recordOriginator mesh__D018272 PXP
% 215.87/216.07  |- skos__historyNote mesh__D018272 Membrane Proteins %28%1977-1984%29%
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D004252 2002
% 215.87/216.07  |- rdf__type mesh__D004252sskos__Concept
% 215.87/216.07  |- skos__prefLabel mesh__D004252 DNA Mutational Analysis
% 215.87/216.07  |- mesh__recordMaintainer mesh__D004252 TGC
% 215.87/216.07  |- mesh__dateEstablished mesh__D004252 1991-01-01
% 215.87/216.07  |- mesh__recordOriginator mesh__D004252 SCD
% 215.87/216.07  |- skos__historyNote mesh__D004252 Mutation %28%1966-1987%29%
% 215.87/216.07  |- skos__hiddenLabel mesh__D004252 DNA Mutational Analyses
% 215.87/216.07  |- mesh__dateRevised mesh__D004252 1995-05-31
% 215.87/216.07  |- mesh__historyNote mesh__D004252
% 215.87/216.07       91%28%88%29%; was see under BASE SEQUENCE 1988-90   
% 215.87/216.07  |- skos__altLabel mesh__D004252 Analysis, DNA Mutational
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D004252 1999
% 215.87/216.07  |- skos__hiddenLabel mesh__D004252 Mutational Analyses, DNA
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D004252 2006
% 215.87/216.07  |- skos__broader mesh__D004252smesh__D017422
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D004252 1997
% 215.87/216.07  |- skos__scopeNote mesh__D004252
% 215.87/216.07       Biochemical identification of mutational changes in a nucleotide sequence.%A%    
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D004252 2004
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D004252 2001
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D004252 1998
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D004252 2000
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D004252 2005
% 215.87/216.07  |- skos__altLabel mesh__D004252 Mutational Analysis, DNA
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D004252 1996
% 215.87/216.07  |- mesh__dateCreated mesh__D004252 1987-05-09
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D004252 2003
% 215.87/216.07  |- skos__annotation mesh__D004252
% 215.87/216.07       IM GEN only; coord NIM with specific DNA %26%/or specific protein %28%IM%29%; DF: DNA MUTATIONAL ANAL%A%  
% 215.87/216.07  |- mesh__recordAuthorizer mesh__D004252 PLS
% 215.87/216.07  |- skos__related mesh__D004252smesh__D018807
% 215.87/216.07  |- skos__hiddenLabel mesh__D004252 Analyses, DNA Mutational
% 215.87/216.07  |- mesh__publicMeSHNote mesh__D004252
% 215.87/216.07       91; was see under BASE SEQUENCE 1988-90   
% 215.87/216.07  |- skos__historyNote mesh__D004252 Base Sequence %28%1978-1987%29%
% 215.87/216.07  |- skos__broader mesh__D008531Q000151smesh__D008531
% 215.87/216.07  |- mesh__preferredCombination mesh__D008531Q000151smesh__D006627
% 215.87/216.07  |- rdf__type mesh__D008531Q000151smesh__CompoundConcept
% 215.87/216.07  |- mesh__dateEstablished mesh__D031649 2003-01-01
% 215.87/216.07  |- rdf__type mesh__D031649sskos__Concept
% 215.87/216.07  |- mesh__publicMeSHNote mesh__D031649 2003   
% 215.87/216.07  |- mesh__dateCreated mesh__D031649 2002-07-03
% 215.87/216.07  |- skos__prefLabel mesh__D031649 Leptospermum
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D031649 2003
% 215.87/216.07  |- skos__annotation mesh__D031649
% 215.87/216.07       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D031649 2005
% 215.87/216.07  |- mesh__historyNote mesh__D031649 2003   
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D031649 2004
% 215.87/216.07  |- skos__altLabel mesh__D031649 Manuka, New Zealand
% 215.87/216.07  |- skos__altLabel mesh__D031649 New Zealand Manuka
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D031649 2006
% 215.87/216.07  |- skos__broader mesh__D031649smesh__D027822
% 215.87/216.07  |- skos__scopeNote mesh__D031649
% 215.87/216.07       A plant genus of the family MYRTACEAE. The common name of tea tree is also used for MELALEUCA and KUNZEA.%A%    
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D017978 1998
% 215.87/216.07  |- rdf__type mesh__D017978sskos__Concept
% 215.87/216.07  |- mesh__dateCreated mesh__D017978 1993-06-21
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D017978 2001
% 215.87/216.07  |- skos__altLabel mesh__D017978 Growth Factor Receptors
% 215.87/216.07  |- mesh__publicMeSHNote mesh__D017978 94   
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D017978 2006
% 215.87/216.07  |- skos__altLabel mesh__D017978 Trophic Factor Receptor
% 215.87/216.07  |- skos__altLabel mesh__D017978 Receptors, Growth Factors
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D017978 1999
% 215.87/216.07  |- skos__prefLabel mesh__D017978 Receptors, Growth Factor
% 215.87/216.07  |- skos__altLabel mesh__D017978 Receptors, Trophic Factor
% 215.87/216.07  |- mesh__dateRevised mesh__D017978 1997-06-20
% 215.87/216.07  |- mesh__recordAuthorizer mesh__D017978 SJN
% 215.87/216.07  |- mesh__recordOriginator mesh__D017978 RAZ
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D017978 2002
% 215.87/216.07  |- skos__broader mesh__D017978smesh__D018000
% 215.87/216.07  |- mesh__historyNote mesh__D017978 94   
% 215.87/216.07  |- mesh__recordMaintainer mesh__D017978 NDW
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D017978 2003
% 215.87/216.07  |- skos__historyNote mesh__D017978
% 215.87/216.07       Receptors, Cell Surface %28%1980-1993%29%
% 215.87/216.07  |- skos__scopeNote mesh__D017978
% 215.87/216.07       Cell surface receptors that bind growth or trophic factors with high affinity, triggering intracellular responses which influence the growth, differentiation, or survival of cells.%A%    
% 215.87/216.07  |- skos__hiddenLabel mesh__D017978 Factor Receptor, Trophic
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D017978 2000
% 215.87/216.07  |- skos__hiddenLabel mesh__D017978 Receptor, Trophic Factor
% 215.87/216.07  |- skos__annotation mesh__D017978
% 215.87/216.07       GEN; prefer specifics; DF: RECEPT GROWTH FACTOR   
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D017978 2005
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D017978 2004
% 215.87/216.07  |- skos__hiddenLabel mesh__D017978 Growth Factors Receptors
% 215.87/216.07  |- mesh__dateEstablished mesh__D017978 1994-01-01
% 215.87/216.07  |- skos__broader mesh__D020245Q000031smesh__D020245
% 215.87/216.07  |- mesh__preferredCombination mesh__D020245Q000031smesh__D002729
% 215.87/216.07  |- rdf__type mesh__D020245Q000031smesh__CompoundConcept
% 215.87/216.07  |- skos__hiddenLabel mesh__D050803 Dehydrogenase, Leucine
% 215.87/216.07  |- skos__hiddenLabel mesh__D050803 Dehydrogenase, L-Leucine
% 215.87/216.07  |- skos__historyNote mesh__D050803 Leucine %28%1970-1979%29%
% 215.87/216.07  |- mesh__publicMeSHNote mesh__D050803
% 215.87/216.07       2006; LEUCINE DEHYDROGENASE was indexed under AMINO ACID OXIDOREDUCTASES 1970-2005 %26% LEUCINE 1970-1982%A%  
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D050803 2006
% 215.87/216.07  |- mesh__recordOriginator mesh__D050803 AKE
% 215.87/216.07  |- mesh__dateEstablished mesh__D050803 2006-01-01
% 215.87/216.07  |- mesh__recordAuthorizer mesh__D050803 sjn
% 215.87/216.07  |- mesh__dateCreated mesh__D050803 2005-06-30
% 215.87/216.07  |- skos__prefLabel mesh__D050803 Leucine Dehydrogenase
% 215.87/216.07  |- mesh__recordMaintainer mesh__D050803 AKE
% 215.87/216.07  |- rdf__type mesh__D050803sskos__Concept
% 215.87/216.07  |- skos__historyNote mesh__D050803
% 215.87/216.07       Amino Acid Oxidoreductases %28%1970-2005%29%
% 215.87/216.07  |- mesh__historyNote mesh__D050803 2006%28%1970%29%   
% 215.87/216.07  |- skos__altLabel mesh__D050803
% 215.87/216.07       Leucine %28%Branched-Chain Amino Acid%29% Dehydrogenase
% 215.87/216.07  |- skos__scopeNote mesh__D050803
% 215.87/216.07       An octameric enzyme belonging to the superfamily of amino acid dehydrogenases. Leucine dehydrogenase catalyzes the reversible oxidative deamination of L-LEUCINE, to 4-methyl-2-oxopentanoate %28%2-ketoisocaproate%29% and AMMONIA, with the corresponding reduction of the cofactor NAD+.%A%    
% 215.87/216.07  |- skos__altLabel mesh__D050803 L-Leucine Dehydrogenase
% 215.87/216.07  |- skos__broader mesh__D050803smesh__D000594
% 215.87/216.07  |- skos__hiddenLabel mesh__D050803 L Leucine Dehydrogenase
% 215.87/216.07  |- rdf__type mesh__D003958sskos__Concept
% 215.87/216.07  |- skos__annotation mesh__D003958
% 215.87/216.07       do not confuse with Diamide, a brand name of CHLORPROPAMIDE; D25-26 qualif%A%  
% 215.87/216.07  |- mesh__recordMaintainer mesh__D003958 CCR
% 215.87/216.07  |- mesh__recordAuthorizer mesh__D003958 sjn
% 215.87/216.07  |- skos__altLabel mesh__D003958
% 215.87/216.07       Diazodicarboxylic Acid Bis%28%N,N-dimethyl%29%amide
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D003958 2002
% 215.87/216.07  |- skos__altLabel mesh__D003958 Tetramethylazoformamide
% 215.87/216.07  |- skos__hiddenLabel mesh__D003958 Bisdimethylamide, Diazodicarboxylic Acid
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D003958 2005
% 215.87/216.07  |- skos__broader mesh__D003958smesh__D001391
% 215.87/216.07  |- mesh__recordOriginator mesh__D003958 RLS
% 215.87/216.07  |- skos__altLabel mesh__D003958 Diazodicarboxylic Acid Bisdimethylamide
% 215.87/216.07  |- skos__scopeNote mesh__D003958
% 215.87/216.07       A sulfhydryl reagent which oxidizes sulfhydryl groups to the disulfide form. It is a radiation-sensitizing agent of anoxic bacterial and mammalian cells.%A%    
% 215.87/216.07  |- mesh__dateRevised mesh__D003958 2000-06-21
% 215.87/216.07  |- skos__hiddenLabel mesh__D003958 Acid Bisdimethylamide, Diazodicarboxylic
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D003958 2006
% 215.87/216.07  |- mesh__historyNote mesh__D003958
% 215.87/216.07       91%28%77%29%; was see under AZO COMPOUNDS 1977-90   
% 215.87/216.07  |- skos__altLabel mesh__D003958
% 215.87/216.07       Dizene Dicarboxylic Acid Bis%28%N,N-dimethylamide%29%
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D003958 2001
% 215.87/216.07  |- skos__historyNote mesh__D003958 Formamides %28%1966-1976%29%
% 215.87/216.07  |- skos__altLabel mesh__D003958
% 215.87/216.07       Dizenedicarboxylic Acid Bis%28%N,N-dimethylamide%29%
% 215.87/216.07  |- mesh__publicMeSHNote mesh__D003958
% 215.87/216.07       91; was see under AZO COMPOUNDS 1977-90   
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D003958 2003
% 215.87/216.07  |- mesh__dateCreated mesh__D003958 1976-05-19
% 215.87/216.07  |- skos__prefLabel mesh__D003958 Diamide
% 215.87/216.07  |- mesh__dateEstablished mesh__D003958 1991-01-01
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D003958 2004
% 215.87/216.07  |- skos__historyNote mesh__D003958 Azo Compounds %28%1966-1976%29%
% 215.87/216.07  |- skos__hiddenLabel mesh__D014680 Engorgements, Venous
% 215.87/216.07  |- skos__hiddenLabel mesh__D014680 Venous Engorgements
% 215.87/216.07  |- skos__hiddenLabel mesh__D014680 Engorgement, Venous
% 215.87/216.07  |- rdf__type mesh__D014680sskos__Concept
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D014680 2002
% 215.87/216.07  |- mesh__dateRevised mesh__D014680 1995-05-23
% 215.87/216.07  |- skos__related mesh__D014680smesh__D010690
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D014680 2004
% 215.87/216.07  |- skos__hiddenLabel mesh__D014680 Vein
% 215.87/216.07  |- mesh__recordOriginator mesh__D014680 NLM
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D014680 1997
% 215.87/216.07  |- skos__annotation mesh__D014680
% 215.87/216.07       IM GEN only; NIM as coord to indicate specific vein, as %27%pancreatic%27% vein = PANCREAS /blood supply %28%IM%29% + VEINS %28%NIM%29%; venous blood: probably not indexed as being the usual sampling method but if significant coord BLOOD %28%NIM%29% + VEINS or specific vein %28%NIM%29%; venous pressure = VENOUS PRESSURE or CENTRAL VENOUS PRESSURE; inflammation = PHLEBITIS%A%  
% 215.87/216.07  |- skos__prefLabel mesh__D014680 Veins
% 215.87/216.07  |- mesh__recordMaintainer mesh__D014680 KEV
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D014680 2001
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D014680 2006
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D014680 2003
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D014680 1999
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D014680 1996
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D014680 2000
% 215.87/216.07  |- mesh__recordAuthorizer mesh__D014680 PLS
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D014680 2005
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D014680 1998
% 215.87/216.07  |- skos__broader mesh__D014680smesh__D001808
% 215.87/216.07  |- mesh__dateCreated mesh__D014680 1999-01-01
% 215.87/216.07  |- mesh__considerAlso mesh__D014680 consider also terms at PHLEB-   
% 215.87/216.07  |- skos__scopeNote mesh__D014680
% 215.87/216.07       The vessels carrying blood toward the heart.     
% 215.87/216.07  |- mesh__recordAuthorizer mesh__D008643 sjn
% 215.87/216.07  |- mesh__recordMaintainer mesh__D008643 nns
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D008643 2003
% 215.87/216.07  |- skos__annotation mesh__D008643
% 215.87/216.07       avoid /blood supply: prefer MESENTERIC ARTERIES or MESENTERIC VEINS but for mesenteric circulation use SPLANCHNIC CIRCULATION; diseases: coord IM with PERITONEAL DISEASES %28%IM%29%; neopl: coord IM with PERITONEAL NEOPLASMS %28%IM%29%%A%  
% 215.87/216.07  |- skos__prefLabel mesh__D008643 Mesentery
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D008643 2004
% 215.87/216.07  |- rdf__type mesh__D008643sskos__Concept
% 215.87/216.07  |- skos__broader mesh__D008643smesh__D010537
% 215.87/216.07  |- mesh__recordOriginator mesh__D008643 NLM
% 215.87/216.07  |- skos__scopeNote mesh__D008643
% 215.87/216.07       A layer of the peritoneum which attaches the abdominal viscera to the ABDOMINAL WALL and conveys their blood vessels and nerves.%A%    
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D008643 2005
% 215.87/216.07  |- skos__hiddenLabel mesh__D008643 Mesenteries
% 215.87/216.07  |- mesh__dateRevised mesh__D008643 2002-07-03
% 215.87/216.07  |- mesh__dateCreated mesh__D008643 1999-01-01
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D008643 2006
% 215.87/216.07  |- skos__annotation mesh__D013588
% 215.87/216.07       do not use /util except by MeSH definition; DF: SYPHILIS SERODIAG%A%  
% 215.87/216.07  |- rdf__type mesh__D013588sskos__Concept
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D013588 2002
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D013588 1998
% 215.87/216.07  |- mesh__publicMeSHNote mesh__D013588
% 215.87/216.07       WASSERMANN REACTION was heading 1963-96; KAHN TEST was heading 1963-91%A%  
% 215.87/216.07  |- mesh__onlineNote mesh__D013588
% 215.87/216.07       use SYPHILIS SERODIAGNOSIS to search WASSERMANN REACTION 1966-96 %26% KAHN TEST 1966-91%A%  
% 215.87/216.07  |- mesh__recordOriginator mesh__D013588 NLM
% 215.87/216.07  |- skos__altLabel mesh__D013588 Serodiagnosis, Syphilis
% 215.87/216.07  |- mesh__historyNote mesh__D013588
% 215.87/216.07       WASSERMANN REACTION was heading 1963-96; KAHN TEST was heading 1963-91%A%  
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D013588 2004
% 215.87/216.07  |- mesh__recordAuthorizer mesh__D013588 SJN
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D013588 2001
% 215.87/216.07  |- skos__scopeNote mesh__D013588 Serologic tests for syphilis.     
% 215.87/216.07  |- skos__hiddenLabel mesh__D013588 Reaction, Wassermann
% 215.87/216.07  |- skos__prefLabel mesh__D013588 Syphilis Serodiagnosis
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D013588 2003
% 215.87/216.07  |- skos__broader mesh__D013588smesh__D012698
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D013588 2000
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D013588 2006
% 215.87/216.07  |- skos__hiddenLabel mesh__D013588 Serodiagnoses, Syphilis
% 215.87/216.07  |- mesh__recordMaintainer mesh__D013588 PXP
% 215.87/216.07  |- mesh__dateCreated mesh__D013588 1999-01-01
% 215.87/216.07  |- skos__hiddenLabel mesh__D013588 Test, Kahn
% 215.87/216.07  |- skos__hiddenLabel mesh__D013588 Syphilis Serodiagnoses
% 215.87/216.07  |- mesh__dateRevised mesh__D013588 1997-06-20
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D013588 1999
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D013588 2005
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D018273 2006
% 215.87/216.07  |- skos__hiddenLabel mesh__D018273 Carcinomas, Islet Cell
% 215.87/216.07  |- skos__hiddenLabel mesh__D018273 Islet Cell Carcinoma
% 215.87/216.07  |- skos__broader mesh__D018273smesh__D010190
% 215.87/216.07  |- rdf__type mesh__D018273sskos__Concept
% 215.87/216.07  |- skos__scopeNote mesh__D018273
% 215.87/216.07       A primary malignant neoplasm of the pancreatic ISLET CELLS. Usually it involves the non-INSULIN-producing cell types, the PANCREATIC ALPHA CELLS and the pancreatic delta cells %28%SOMATOSTATIN-SECRETING CELLS%29% in GLUCAGONOMA and SOMATOSTATINOMA, respectively.%A%    
% 215.87/216.07  |- skos__historyNote mesh__D018273 Adenoma, Islet Cell %28%1966-1993%29%
% 215.87/216.07  |- skos__broader mesh__D018273smesh__D000230
% 215.87/216.07  |- skos__altLabel mesh__D018273 Islet Cell Tumor, Malignant
% 215.87/216.07  |- mesh__dateCreated mesh__D018273 1993-06-25
% 215.87/216.07  |- mesh__recordOriginator mesh__D018273 PLS
% 215.87/216.07  |- skos__prefLabel mesh__D018273 Carcinoma, Islet Cell
% 215.87/216.07  |- mesh__dateEstablished mesh__D018273 1994-01-01
% 215.87/216.07  |- mesh__publicMeSHNote mesh__D018273 94   
% 215.87/216.07  |- mesh__recordAuthorizer mesh__D018273 sjn
% 215.87/216.07  |- skos__annotation mesh__D018273
% 215.87/216.07       coord IM with PANCREATIC NEOPLASMS %28%IM%29%   
% 215.87/216.07  |- mesh__historyNote mesh__D018273 94   
% 215.87/216.07  |- mesh__recordMaintainer mesh__D018273 sjn
% 215.87/216.07  |- skos__hiddenLabel mesh__D018273 Islet Cell Carcinomas
% 215.87/216.07  |- mesh__dateRevised mesh__D018273 2005-07-01
% 215.87/216.07  |- skos__hiddenLabel mesh__D010290 Parental Ages
% 215.87/216.07  |- skos__hiddenLabel mesh__D010290 Step-Parent
% 215.87/216.07  |- skos__historyNote mesh__D010290 Family %28%1966%29%
% 215.87/216.07  |- skos__scopeNote mesh__D010290
% 215.87/216.07       Persons functioning as natural, adoptive, or substitute parents. The heading includes the concept of parenthood as well as preparation for becoming a parent.%A%    
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D010290 2004
% 215.87/216.07  |- mesh__dateRevised mesh__D010290 2002-07-02
% 215.87/216.07  |- mesh__dateCreated mesh__D010290 1999-01-01
% 215.87/216.07  |- skos__hiddenLabel mesh__D010290 Stepparents
% 215.87/216.07  |- mesh__recordOriginator mesh__D010290 NLM
% 215.87/216.07  |- mesh__publicMeSHNote mesh__D010290 69   
% 215.87/216.07  |- skos__annotation mesh__D010290
% 215.87/216.07       HUMAN only;  /psychol: consider also PARENT-CHILD RELATIONS; %22%unwed parent%22%: coord IM with ILLEGITIMACY %28%IM%29%%A%  
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D010290 2006
% 215.87/216.07  |- mesh__dateEstablished mesh__D010290 1969-01-01
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D010290 2003
% 215.87/216.07  |- skos__broader mesh__D010290smesh__D009679
% 215.87/216.07  |- skos__related mesh__D010290smesh__D035622
% 215.87/216.07  |- skos__altLabel mesh__D010290 Stepparent
% 215.87/216.07  |- skos__hiddenLabel mesh__D010290 Step Parents
% 215.87/216.07  |- skos__related mesh__D010290smesh__D033282
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D010290 2005
% 215.87/216.07  |- skos__hiddenLabel mesh__D010290 Parent
% 215.87/216.07  |- mesh__recordAuthorizer mesh__D010290 sjn
% 215.87/216.07  |- skos__hiddenLabel mesh__D010290 Status, Parenthood
% 215.87/216.07  |- skos__hiddenLabel mesh__D010290 Age, Parental
% 215.87/216.07  |- mesh__recordMaintainer mesh__D010290 hjn
% 215.87/216.07  |- mesh__historyNote mesh__D010290 69%28%67%29%   
% 215.87/216.07  |- skos__broader mesh__D010290smesh__D009272
% 215.87/216.07  |- skos__related mesh__D010290smesh__D015406
% 215.87/216.07  |- rdf__type mesh__D010290sskos__Concept
% 215.87/216.07  |- skos__hiddenLabel mesh__D010290 Ages, Parental
% 215.87/216.07  |- skos__related mesh__D010290smesh__D016241
% 215.87/216.07  |- skos__prefLabel mesh__D010290 Parents
% 215.87/216.07  |- skos__prefLabel mesh__D004253 DNA Nucleotidylexotransferase
% 215.87/216.07  |- skos__broader mesh__D004253smesh__D004254
% 215.87/216.07  |- skos__hiddenLabel mesh__D004253 Deoxynucleotidyl Transferase, Terminal
% 215.87/216.07  |- skos__historyNote mesh__D004253
% 215.87/216.07       DNA Nucleotidyltransferases %28%1968-1978%29%
% 215.87/216.07  |- skos__hiddenLabel mesh__D004253 Antigen, Tdt
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D004253 2006
% 215.87/216.07  |- mesh__historyNote mesh__D004253
% 215.87/216.07       89%28%79%29%; was see under DNA NUCLEOTIDYLTRANSFERASES 1979-88%A%  
% 215.87/216.07  |- skos__altLabel mesh__D004253 Desoxynucleotidyl Transferase
% 215.87/216.07  |- skos__hiddenLabel mesh__D004253 Transferase, Desoxynucleotidyl
% 215.87/216.07  |- skos__altLabel mesh__D004253 Desoxynucleotidyltransferase
% 215.87/216.07  |- skos__hiddenLabel mesh__D004253
% 215.87/216.07       Deoxyribonucleotidyltransferase, Terminal
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D004253 2005
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D004253 2004
% 215.87/216.07  |- skos__hiddenLabel mesh__D004253 Enzyme, Terminal Addition
% 215.87/216.07  |- skos__altLabel mesh__D004253 Terminal Deoxyribonucleotidyltransferase
% 215.87/216.07  |- skos__altLabel mesh__D004253 Terminal Addition Enzyme
% 215.87/216.07  |- skos__hiddenLabel mesh__D004253 Transferase, Terminal Deoxynucleotidyl
% 215.87/216.07  |- mesh__recordMaintainer mesh__D004253 ssb
% 215.87/216.07  |- skos__altLabel mesh__D004253 Deoxynucleotidyltransferase
% 215.87/216.07  |- mesh__recordAuthorizer mesh__D004253 sjn
% 215.87/216.07  |- mesh__dateRevised mesh__D004253 2003-07-09
% 215.87/216.07  |- skos__hiddenLabel mesh__D004253
% 215.87/216.07       Deoxyribonucleotidyl Transferase, Terminal
% 215.87/216.07  |- skos__altLabel mesh__D004253 Terminal Deoxyribonucleotidyl Transferase
% 215.87/216.07  |- mesh__dateCreated mesh__D004253 1978-05-16
% 215.87/216.07  |- skos__altLabel mesh__D004253 Deoxynucleotidyl Transferase
% 215.87/216.07  |- skos__altLabel mesh__D004253 Terminal Deoxynucleotidyl Transferase
% 215.87/216.07  |- skos__hiddenLabel mesh__D004253
% 215.87/216.07       Transferase, Terminal Deoxyribonucleotidyl
% 215.87/216.07  |- mesh__publicMeSHNote mesh__D004253
% 215.87/216.07       89; was see under DNA NUCLEOTIDYLTRANSFERASES 1979-88   
% 215.87/216.07  |- mesh__dateEstablished mesh__D004253 1989-01-01
% 215.87/216.07  |- skos__historyNote mesh__D004253 Transferases %28%1966-1967%29%
% 215.87/216.07  |- skos__hiddenLabel mesh__D004253 Transferase, Deoxynucleotidyl
% 215.87/216.07  |- rdf__type mesh__D004253sskos__Concept
% 215.87/216.07  |- skos__hiddenLabel mesh__D004253 Nucleotidylexotransferase, DNA
% 215.87/216.07  |- mesh__recordOriginator mesh__D004253 RLS
% 215.87/216.07  |- skos__scopeNote mesh__D004253
% 215.87/216.07       A non-template-directed DNA polymerase normally found in vertebrate thymus and bone marrow. It catalyzes the elongation of oligo- or polydeoxynucleotide chains and is widely used as a tool in the differential diagnosis of acute leukemias in man. EC 2.7.7.31.%A%    
% 215.87/216.07  |- skos__hiddenLabel mesh__D004253 Addition Enzyme, Terminal
% 215.87/216.07  |- skos__broader mesh__D017979smesh__D017612
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D017979 2003
% 215.87/216.07  |- mesh__recordAuthorizer mesh__D017979 sjn
% 215.87/216.07  |- mesh__dateEstablished mesh__D017979 1994-01-01
% 215.87/216.07  |- rdf__type mesh__D017979sskos__Concept
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D017979 2002
% 215.87/216.07  |- mesh__dateCreated mesh__D017979 1993-06-04
% 215.87/216.07  |- mesh__activeMeSHYear mesh__D017979 2006
% 215.87/216.08  |- skos__prefLabel mesh__D017979 Gold Colloid
% 215.87/216.08  |- mesh__dateRevised mesh__D017979 2000-06-22
% 215.87/216.08  |- mesh__publicMeSHNote mesh__D017979 94   
% 215.87/216.08  |- mesh__recordMaintainer mesh__D017979 adp
% 215.87/216.08  |- skos__hiddenLabel mesh__D017979 Colloid, Gold
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D017979 2005
% 215.87/216.08  |- skos__historyNote mesh__D017979 Gold %28%1986-1993%29%
% 215.87/216.08  |- skos__altLabel mesh__D017979 Colloidal Gold
% 215.87/216.08  |- skos__scopeNote mesh__D017979
% 215.87/216.08       A suspension of metallic gold particles.     
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D017979 2001
% 215.87/216.08  |- skos__hiddenLabel mesh__D017979 Gold, Colloidal
% 215.87/216.08  |- mesh__historyNote mesh__D017979 94   
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D017979 2004
% 215.87/216.08  |- mesh__recordOriginator mesh__D017979 TPW
% 215.87/216.08  |- mesh__historyNote mesh__D050804 2006%28%1975%29%   
% 215.87/216.08  |- mesh__recordMaintainer mesh__D050804 AKE
% 215.87/216.08  |- skos__hiddenLabel mesh__D050804 Oxidase, Aspartic
% 215.87/216.08  |- rdf__type mesh__D050804sskos__Concept
% 215.87/216.08  |- skos__hiddenLabel mesh__D050804 Oxidase, D-Aspartate
% 215.87/216.08  |- skos__altLabel mesh__D050804 Aspartic Oxidase
% 215.87/216.08  |- mesh__publicMeSHNote mesh__D050804
% 215.87/216.08       2006; D-ASPARTATE OXIDASE was indexed under AMINO ACID OXIDOREDUCTASES 1975-2005 %26% under ASPARTIC ACID 1975-1981%A%  
% 215.87/216.08  |- skos__historyNote mesh__D050804
% 215.87/216.08       Amino Acid Oxidoreductases %28%1975-2005%29%
% 215.87/216.08  |- mesh__recordOriginator mesh__D050804 AKE
% 215.87/216.08  |- skos__broader mesh__D050804smesh__D000594
% 215.87/216.08  |- mesh__dateEstablished mesh__D050804 2006-01-01
% 215.87/216.08  |- skos__historyNote mesh__D050804 Aspartic Acid %28%1975-1979%29%
% 215.87/216.08  |- mesh__recordAuthorizer mesh__D050804 sjn
% 215.87/216.08  |- skos__scopeNote mesh__D050804
% 215.87/216.08       An FAD-dependent peroxisomal flavoenzyme, this catalyzes the oxidative deamination of D-ASPARTATE to OXALOACETATE and AMMONIA using oxygen as electron acceptor.%A%    
% 215.87/216.08  |- skos__prefLabel mesh__D050804 D-Aspartate Oxidase
% 215.87/216.08  |- skos__altLabel mesh__D050804 D-aspartic Oxidase
% 215.87/216.08  |- skos__hiddenLabel mesh__D050804 D Aspartate Oxidase
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D050804 2006
% 215.87/216.08  |- skos__hiddenLabel mesh__D050804 Oxidase, D-aspartic
% 215.87/216.08  |- mesh__dateCreated mesh__D050804 2005-06-30
% 215.87/216.08  |- skos__hiddenLabel mesh__D050804 D aspartic Oxidase
% 215.87/216.08  |- mesh__recordOriginator mesh__D003959 NLM
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D003959 1997
% 215.87/216.08  |- mesh__dateEstablished mesh__D003959 1974-01-01
% 215.87/216.08  |- skos__prefLabel mesh__D003959 Diamines
% 215.87/216.08  |- skos__scopeNote mesh__D003959
% 215.87/216.08       Organic chemicals which have two amino groups in an aliphatic chain.%A%    
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D003959 2005
% 215.87/216.08  |- mesh__dateCreated mesh__D003959 1999-01-01
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D003959 2002
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D003959 2006
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D003959 1994
% 215.87/216.08  |- mesh__dateRevised mesh__D003959 1992-05-13
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D003959 2003
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D003959 1998
% 215.87/216.08  |- mesh__recordAuthorizer mesh__D003959 PLS
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D003959 1995
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D003959 2000
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D003959 1999
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D003959 2004
% 215.87/216.08  |- mesh__historyNote mesh__D003959 74   
% 215.87/216.08  |- skos__broader mesh__D003959smesh__D011073
% 215.87/216.08  |- rdf__type mesh__D003959sskos__Concept
% 215.87/216.08  |- mesh__recordMaintainer mesh__D003959 TAP
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D003959 1996
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D003959 2001
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D003959 1993
% 215.87/216.08  |- mesh__publicMeSHNote mesh__D003959 74   
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014681 2000
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014681 2006
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014681 1999
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014681 2003
% 215.87/216.08  |- mesh__historyNote mesh__D014681 78   
% 215.87/216.08  |- mesh__recordAuthorizer mesh__D014681 PLS
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014681 1996
% 215.87/216.08  |- mesh__recordMaintainer mesh__D014681 PXP
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014681 2005
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014681 1995
% 215.87/216.08  |- skos__broader mesh__D014681smesh__D009056
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014681 1998
% 215.87/216.08  |- skos__historyNote mesh__D014681 Cleft Palate %28%1966-1977%29%
% 215.87/216.08  |- mesh__dateCreated mesh__D014681 1977-05-13
% 215.87/216.08  |- skos__hiddenLabel mesh__D014681 Incompetences, Palatopharyngeal
% 215.87/216.08  |- mesh__dateEstablished mesh__D014681 1978-01-01
% 215.87/216.08  |- skos__hiddenLabel mesh__D014681 Velopharyngeal Insufficiencies
% 215.87/216.08  |- skos__hiddenLabel mesh__D014681 Incompetence, Palatopharyngeal
% 215.87/216.08  |- skos__scopeNote mesh__D014681
% 215.87/216.08       Failure of the soft palate to reach the posterior pharyngeal wall. It may be caused by cleft palate surgery, palatal or pharyngeal abnormalities or injury, or neuromuscular dysfunction of the velopharyngeal sphincter. It causes hypernasality of speech.%A%    
% 215.87/216.08  |- skos__related mesh__D014681smesh__D013064
% 215.87/216.08  |- skos__historyNote mesh__D014681 Pharynx %28%1966-1977%29%
% 215.87/216.08  |- mesh__publicMeSHNote mesh__D014681 78   
% 215.87/216.08  |- skos__hiddenLabel mesh__D014681 Insufficiencies, Velopharyngeal
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014681 2002
% 215.87/216.08  |- skos__prefLabel mesh__D014681 Velopharyngeal Insufficiency
% 215.87/216.08  |- skos__hiddenLabel mesh__D014681 Insufficiency, Velopharyngeal
% 215.87/216.08  |- skos__hiddenLabel mesh__D014681 Palatopharyngeal Incompetences
% 215.87/216.08  |- mesh__recordOriginator mesh__D014681 AEP
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014681 2001
% 215.87/216.08  |- skos__broader mesh__D014681smesh__D010608
% 215.87/216.08  |- skos__annotation mesh__D014681
% 215.87/216.08       failure of soft palate to reach posterior wall of pharynx%A%  
% 215.87/216.08  |- rdf__type mesh__D014681sskos__Concept
% 215.87/216.08  |- mesh__dateRevised mesh__D014681 1994-05-12
% 215.87/216.08  |- skos__altLabel mesh__D014681 Palatopharyngeal Incompetence
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014681 2004
% 215.87/216.08  |- skos__historyNote mesh__D014681 Palate %28%1966-1977%29%
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014681 1997
% 215.87/216.08  |- mesh__recordAuthorizer mesh__D008644 PLS
% 215.87/216.08  |- skos__hiddenLabel mesh__D008644 Teeth Mesial Movement
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D008644 2006
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D008644 1993
% 215.87/216.08  |- mesh__dateCreated mesh__D008644 1999-01-01
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D008644 1994
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D008644 2001
% 215.87/216.08  |- skos__broader mesh__D008644smesh__D014085
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D008644 2005
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D008644 2004
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D008644 1992
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D008644 1999
% 215.87/216.08  |- mesh__onlineNote mesh__D008644 search TOOTH MIGRATION 1966-74   
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D008644 2000
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D008644 2003
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D008644 1998
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D008644 1997
% 215.87/216.08  |- rdf__type mesh__D008644sskos__Concept
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D008644 1991
% 215.87/216.08  |- skos__hiddenLabel mesh__D008644 Teeth Mesial Movements
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D008644 1996
% 215.87/216.08  |- mesh__dateEstablished mesh__D008644 1991-01-01
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D008644 2002
% 215.87/216.08  |- skos__annotation mesh__D008644 use Cat C qualif   
% 215.87/216.08  |- mesh__recordMaintainer mesh__D008644 NLM
% 215.87/216.08  |- mesh__historyNote mesh__D008644
% 215.87/216.08       91%28%75%29%; was see under TOOTH MIGRATION 1975-90   
% 215.87/216.08  |- skos__prefLabel mesh__D008644 Mesial Movement of Teeth
% 215.87/216.08  |- mesh__publicMeSHNote mesh__D008644
% 215.87/216.08       91; was see under TOOTH MIGRATION 1975-90   
% 215.87/216.08  |- mesh__recordOriginator mesh__D008644 NLM
% 215.87/216.08  |- mesh__dateRevised mesh__D008644 1990-04-13
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D008644 1995
% 215.87/216.08  |- skos__altLabel mesh__D000661 Amphetamine Sulfate %28%2:1%29%
% 215.87/216.08  |- skos__altLabel mesh__D000661 Amfetamine
% 215.87/216.08  |- skos__altLabel mesh__D000661 levo-Amphetamine
% 215.87/216.08  |- skos__altLabel mesh__D000661 Phenamine
% 215.87/216.08  |- skos__prefLabel mesh__D000661 Amphetamine
% 215.87/216.08  |- skos__scopeNote mesh__D000661
% 215.87/216.08       A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.%A%    
% 215.87/216.08  |- skos__hiddenLabel mesh__D000661 l Amphetamine
% 215.87/216.08  |- skos__altLabel mesh__D000661 Levoamphetamine
% 215.87/216.08  |- mesh__recordMaintainer mesh__D000661 mdb
% 215.87/216.08  |- skos__altLabel mesh__D000661 Phenopromin
% 215.87/216.08  |- skos__annotation mesh__D000661
% 215.87/216.08       a specific chem: do not confuse with AMPHETAMINES; d-amphetamine = DEXTROAMPHETAMINE; N-methylamphetamine = METHAMPHETAMINE%A%  
% 215.87/216.08  |- skos__hiddenLabel mesh__D000661 Sulfate, Amphetamine
% 215.87/216.08  |- mesh__dateCreated mesh__D000661 1999-01-01
% 215.87/216.08  |- skos__hiddenLabel mesh__D000661 levo Amphetamine
% 215.87/216.08  |- skos__altLabel mesh__D000661 Miquel Brand of Amfetamine Sulfate
% 215.87/216.08  |- skos__broader mesh__D000661smesh__D000662
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D000661 2006
% 215.87/216.08  |- mesh__recordAuthorizer mesh__D000661 sjn
% 215.87/216.08  |- rdf__type mesh__D000661sskos__Concept
% 215.87/216.08  |- skos__altLabel mesh__D000661 Desoxynorephedrin
% 215.87/216.08  |- mesh__recordOriginator mesh__D000661 NLM
% 215.87/216.08  |- mesh__dateRevised mesh__D000661 2004-07-07
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D000661 2005
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D013589 2002
% 215.87/216.08  |- mesh__recordOriginator mesh__D013589 NLM
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D013589 1998
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D013589 2005
% 215.87/216.08  |- skos__hiddenLabel mesh__D013589 Syphilitic Aortitis
% 215.87/216.08  |- mesh__historyNote mesh__D013589
% 215.87/216.08       AORTITIS, SYPHILITIC was see under SYPHILIS, CARDIOVASCULAR 1963-83 %28%Prov 1963-74%29%%A%  
% 215.87/216.08  |- mesh__dateRevised mesh__D013589 1991-06-12
% 215.87/216.08  |- skos__hiddenLabel mesh__D013589 Cardiovascular Syphilis
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D013589 1995
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D013589 1994
% 215.87/216.08  |- skos__prefLabel mesh__D013589 Syphilis, Cardiovascular
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D013589 2001
% 215.87/216.08  |- skos__hiddenLabel mesh__D013589 Aortitides, Syphilitic
% 215.87/216.08  |- skos__annotation mesh__D013589
% 215.87/216.08       coord IM with specific cardiovasc organ or dis %28%IM%29% but note X ref below%A%  
% 215.87/216.08  |- mesh__onlineNote mesh__D013589
% 215.87/216.08       use SYPHILIS, CARDIOVASCULAR to search AORTITIS, SYPHILITIC 1966-83 %28%as Prov 1966-74%29%%A%  
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D013589 1997
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D013589 2004
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D013589 2000
% 215.87/216.08  |- mesh__recordAuthorizer mesh__D013589 PLS
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D013589 1996
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D013589 2003
% 215.87/216.08  |- mesh__dateCreated mesh__D013589 1999-01-01
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D013589 1993
% 215.87/216.08  |- skos__broader mesh__D013589smesh__D002318
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D013589 1999
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D013589 2006
% 215.87/216.08  |- rdf__type mesh__D013589sskos__Concept
% 215.87/216.08  |- skos__hiddenLabel mesh__D013589 Syphilitic Aortitides
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D013589 1992
% 215.87/216.08  |- mesh__recordMaintainer mesh__D013589 PXP
% 215.87/216.08  |- skos__broader mesh__D013589smesh__D013587
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D018274 2004
% 215.87/216.08  |- mesh__dateCreated mesh__D018274 1993-06-03
% 215.87/216.08  |- skos__prefLabel mesh__D018274 Electroporation
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D018274 2002
% 215.87/216.08  |- skos__broader mesh__D018274smesh__D003584
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D018274 2003
% 215.87/216.08  |- skos__annotation mesh__D018274 a cytol technique   
% 215.87/216.08  |- mesh__dateRevised mesh__D018274 2000-06-22
% 215.87/216.08  |- mesh__historyNote mesh__D018274 94   
% 215.87/216.08  |- skos__scopeNote mesh__D018274
% 215.87/216.08       A technique in which electric pulses of intensity in kilovolts per centimeter and of microsecond-to-millisecond duration cause a temporary loss of the semipermeability of cell membranes, thus leading to ion leakage, escape of metabolites, and increased uptake by cells of drugs, molecular probes, and DNA. Some applications of electroporation include introduction of plasmids or foreign DNA into living cells for transfection, fusion of cells to prepare hybridomas, and insertion of proteins into cell membranes.%A%    
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D018274 2006
% 215.87/216.08  |- skos__hiddenLabel mesh__D018274 Electroporations
% 215.87/216.08  |- mesh__dateEstablished mesh__D018274 1994-01-01
% 215.87/216.08  |- rdf__type mesh__D018274sskos__Concept
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D018274 2001
% 215.87/216.08  |- mesh__publicMeSHNote mesh__D018274 94   
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D018274 2005
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Pareses, Muscle
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Paresis, Upper Extremity
% 215.87/216.08  |- skos__altLabel mesh__D010291 Crural Paresis
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Extremity Pareses, Lower
% 215.87/216.08  |- mesh__dateCreated mesh__D010291 1999-01-01
% 215.87/216.08  |- skos__altLabel mesh__D010291 Muscle Paresis
% 215.87/216.08  |- skos__scopeNote mesh__D010291
% 215.87/216.08       A general term referring to a mild to moderate degree of muscular weakness, occasionally used as a synonym for PARALYSIS %28%severe or complete loss of motor function%29%. In the older literature, paresis often referred specifically to paretic neurosyphilis %28%see NEUROSYPHILIS%29%. %22%General paresis%22% and %22%general paralysis%22% may still carry that connotation. Bilateral lower extremity paresis is referred to as PARAPARESIS.%A%    
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D010291 2006
% 215.87/216.08  |- skos__broader mesh__D010291smesh__D009461
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Paresis, Crural
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Pareses, Crural
% 215.87/216.08  |- mesh__recordAuthorizer mesh__D010291 sjn
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Crural Pareses
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Paresis, Brachial
% 215.87/216.08  |- mesh__historyNote mesh__D010291
% 215.87/216.08       1963; for HEMIPARESIS use HEMIPLEGIA 1974-1999   
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D010291 2005
% 215.87/216.08  |- skos__annotation mesh__D010291
% 215.87/216.08       remember that %22%paresis%22% is sometimes just %22%paralysis%22% in foreign lit; spastic paraparesis = PARAPARESIS, SPASTIC or PARAPARESIS, TROPICAL SPASTIC if caused by HUMAN T-LYMPHOTROPIC VIRUS 1%A%  
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Monopareses
% 215.87/216.08  |- rdf__type mesh__D010291sskos__Concept
% 215.87/216.08  |- mesh__recordMaintainer mesh__D010291 sjn
% 215.87/216.08  |- mesh__dateRevised mesh__D010291 2004-07-13
% 215.87/216.08  |- skos__prefLabel mesh__D010291 Paresis
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Pareses, Muscular
% 215.87/216.08  |- mesh__recordOriginator mesh__D010291 NLM
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Muscle Pareses
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Pareses
% 215.87/216.08  |- skos__altLabel mesh__D010291 Brachial Paresis
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Extremity Paresis, Upper
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Paresis, Muscle
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Extremity Pareses, Upper
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Pareses, Upper Extremity
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Pareses, Brachial
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Pareses, Lower Extremity
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Brachial Pareses
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Extremity Paresis, Lower
% 215.87/216.08  |- skos__altLabel mesh__D010291 Muscular Paresis
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Paresis, Muscular
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Upper Extremity Pareses
% 215.87/216.08  |- mesh__publicMeSHNote mesh__D010291
% 215.87/216.08       1963; for HEMIPARESIS see HEMIPLEGIA 1974-1999   
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Paresis, Lower Extremity
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Lower Extremity Pareses
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Muscular Pareses
% 215.87/216.08  |- skos__hiddenLabel mesh__D010291 Hemipareses
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D026706 2004
% 215.87/216.08  |- mesh__recordMaintainer mesh__D026706 jls
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D026706 2002
% 215.87/216.08  |- skos__related mesh__D026706smesh__D026684
% 215.87/216.08  |- skos__annotation mesh__D026706
% 215.87/216.08       do not confuse with FATHERS or PATERNITY   
% 215.87/216.08  |- mesh__recordAuthorizer mesh__D026706 jls
% 215.87/216.08  |- mesh__dateCreated mesh__D026706 2001-07-25
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D026706 2005
% 215.87/216.08  |- skos__related mesh__D026706smesh__D026686
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D026706 2003A
% 215.87/216.08  |- mesh__historyNote mesh__D026706 2002   
% 215.87/216.08  |- skos__prefLabel mesh__D026706 Paternalism
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D026706 2006
% 215.87/216.08  |- mesh__publicMeSHNote mesh__D026706 2002   
% 215.87/216.08  |- rdf__type mesh__D026706sskos__Concept
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D026706 2003
% 215.87/216.08  |- mesh__dateRevised mesh__D026706 2002-10-31
% 215.87/216.08  |- mesh__recordOriginator mesh__D026706 hjn
% 215.87/216.08  |- skos__broader mesh__D026706smesh__D011593
% 215.87/216.08  |- skos__scopeNote mesh__D026706
% 215.87/216.08       Interference with the FREEDOM or PERSONAL AUTONOMY of another person, with justifications referring to the promotion of the person%27%s good or the prevention of harm to the person. %28%from Cambridge Dictionary of Philosophy, 1995%29%; more generally, not allowing a person to make decisions on his or her own behalf.%A%    
% 215.87/216.08  |- mesh__dateEstablished mesh__D026706 2002-01-01
% 215.87/216.08  |- mesh__dateCreated mesh__D004254 1999-01-01
% 215.87/216.08  |- mesh__dateRevised mesh__D004254 2003-07-09
% 215.87/216.08  |- mesh__onlineNote mesh__D004254
% 215.87/216.08       use DNA NUCLEOTIDYLTRANSFERASES to search DNA NUCLEOTIDYLTRANSFERASE 1968-72%A%  
% 215.87/216.08  |- mesh__publicMeSHNote mesh__D004254
% 215.87/216.08       73; was DNA NUCLEOTIDYLTRANSFERASE 1968-72   
% 215.87/216.08  |- skos__scopeNote mesh__D004254
% 215.87/216.08       Enzymes that catalyze the incorporation of deoxyribonucleotides into a chain of DNA.  EC 2.7.7.-.%A%    
% 215.87/216.08  |- skos__historyNote mesh__D004254
% 215.87/216.08       Nucleotidyltransferases %28%1966-1967%29%
% 215.87/216.08  |- rdf__type mesh__D004254sskos__Concept
% 215.87/216.08  |- mesh__dateEstablished mesh__D004254 1968-01-01
% 215.87/216.08  |- mesh__historyNote mesh__D004254
% 215.87/216.08       73; was DNA NUCLEOTIDYLTRANSFERASE 1968-72   
% 215.87/216.08  |- mesh__recordOriginator mesh__D004254 NLM
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D004254 2006
% 215.87/216.08  |- mesh__recordMaintainer mesh__D004254 ssb
% 215.87/216.08  |- mesh__recordAuthorizer mesh__D004254 sjn
% 215.87/216.08  |- skos__broader mesh__D004254smesh__D009713
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D004254 2005
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D004254 2004
% 215.87/216.08  |- skos__prefLabel mesh__D004254 DNA Nucleotidyltransferases
% 215.87/216.08  |- skos__hiddenLabel mesh__D004254 Nucleotidyltransferases, DNA
% 215.87/216.08  |- mesh__recordAuthorizer mesh__D050805 sjn
% 215.87/216.08  |- skos__scopeNote mesh__D050805
% 215.87/216.08       A congenital or acquired condition in which the SPLEEN is not in its normal anatomical position but moves about in the ABDOMEN. This is due to laxity or absence of suspensory ligaments which normally provide peritoneal attachments to keep the SPLEEN in a fixed position. Clinical symptoms include ABDOMINAL PAIN, splenic TORSION and ISCHEMIA.%A%    
% 215.87/216.08  |- skos__prefLabel mesh__D050805 Wandering Spleen
% 215.87/216.08  |- mesh__dateCreated mesh__D050805 2005-06-30
% 215.87/216.08  |- mesh__recordOriginator mesh__D050805 lkt
% 215.87/216.08  |- skos__hiddenLabel mesh__D050805 Spleens, Wandering
% 215.87/216.08  |- mesh__publicMeSHNote mesh__D050805 2006   
% 215.87/216.08  |- skos__broader mesh__D050805smesh__D013158
% 215.87/216.08  |- mesh__historyNote mesh__D050805 2006   
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D050805 2006
% 215.87/216.08  |- mesh__dateEstablished mesh__D050805 2006-01-01
% 215.87/216.08  |- skos__historyNote mesh__D050805 Splenic Diseases %28%1967-2005%29%
% 215.87/216.08  |- mesh__recordMaintainer mesh__D050805 lkt
% 215.87/216.08  |- skos__hiddenLabel mesh__D050805 Wandering Spleens
% 215.87/216.08  |- skos__hiddenLabel mesh__D050805 Spleen, Wandering
% 215.87/216.08  |- rdf__type mesh__D050805sskos__Concept
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014682 1995
% 215.87/216.08  |- skos__broader mesh__D014682smesh__D014684
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014682 1998
% 215.87/216.08  |- skos__hiddenLabel mesh__D014682 Cavas, Inferior Vena
% 215.87/216.08  |- skos__hiddenLabel mesh__D014682 Cava, Inferior Vena
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014682 1994
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014682 2000
% 215.87/216.08  |- mesh__dateCreated mesh__D014682 1999-01-01
% 215.87/216.08  |- skos__hiddenLabel mesh__D014682 Inferior Vena Cavas
% 215.87/216.08  |- mesh__recordAuthorizer mesh__D014682 PLS
% 215.87/216.08  |- skos__hiddenLabel mesh__D014682 Vena Cavas, Inferior
% 215.87/216.08  |- mesh__dateRevised mesh__D014682 1992-05-18
% 215.87/216.08  |- skos__prefLabel mesh__D014682 Vena Cava, Inferior
% 215.87/216.08  |- skos__hiddenLabel mesh__D014682 Inferior Vena Cava
% 215.87/216.08  |- rdf__type mesh__D014682sskos__Concept
% 215.87/216.08  |- skos__scopeNote mesh__D014682
% 215.87/216.08       The venous trunk which receives blood from the lower extremities and from the pelvic and abdominal organs.%A%    
% 215.87/216.08  |- mesh__recordMaintainer mesh__D014682 TAP
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014682 2004
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014682 2002
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014682 1997
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014682 2006
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014682 1999
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014682 2003
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014682 2001
% 215.87/216.08  |- mesh__recordOriginator mesh__D014682 NLM
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014682 1996
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014682 1993
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D014682 2005
% 215.87/216.08  |- skos__annotation mesh__D008645
% 215.87/216.08       infection: coord IM with CESTODE INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D008645 2005
% 215.87/216.08  |- mesh__recordOriginator mesh__D008645 EC
% 215.87/216.08  |- skos__prefLabel mesh__D008645 Mesocestoides
% 215.87/216.08  |- mesh__recordMaintainer mesh__D008645 sjn
% 215.87/216.08  |- rdf__type mesh__D008645sskos__Concept
% 215.87/216.08  |- mesh__dateEstablished mesh__D008645 1991-01-01
% 215.87/216.08  |- mesh__dateCreated mesh__D008645 1985-03-15
% 215.87/216.08  |- skos__historyNote mesh__D008645 Cestoda %28%1966-1985%29%
% 215.87/216.08  |- mesh__onlineNote mesh__D008645
% 215.87/216.08       use MESOCESTOIDES to search MESOCESTROIDES 1986   
% 215.87/216.08  |- skos__broader mesh__D008645smesh__D002589
% 215.87/216.08  |- mesh__recordAuthorizer mesh__D008645 sjn
% 215.87/216.08  |- skos__scopeNote mesh__D008645
% 215.87/216.08       A genus of tapeworm, containing several species, found as adults in birds and mammals. The larvae or cysticercoid stage develop in invertebrates. Human infection has been reported and is probably acquired from eating inadequately cooked meat of animals infected with the second larval stage known as the tetrahythridium.%A%    
% 215.87/216.08  |- mesh__historyNote mesh__D008645
% 215.87/216.08       91%28%87%29%; was see under CESTODA 1987-90; was MESOCESTROIDES see under CESTODA 1986%A%  
% 215.87/216.08  |- mesh__dateRevised mesh__D008645 2004-07-13
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D008645 2006
% 215.87/216.08  |- mesh__publicMeSHNote mesh__D008645
% 215.87/216.08       91; was see under CESTODA 1987-90; was MESOCESTROIDES see under CESTODA 1986%A%  
% 215.87/216.08  |- skos__broader mesh__D000662smesh__D010627
% 215.87/216.08  |- mesh__recordMaintainer mesh__D000662 jls
% 215.87/216.08  |- mesh__publicMeSHNote mesh__D000662 76   
% 215.87/216.08  |- skos__related mesh__D000662smesh__D001067
% 215.87/216.08  |- mesh__recordAuthorizer mesh__D000662 sjn
% 215.87/216.08  |- skos__annotation mesh__D000662
% 215.87/216.08       GEN or unspecified; prefer specifics; do not confuse with AMPHETAMINE, a specific chem; N-methylamphetamine = METHAMPHETAMINE%A%  
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D000662 2006
% 215.87/216.08  |- mesh__dateRevised mesh__D000662 2004-07-19
% 215.87/216.08  |- rdf__type mesh__D000662sskos__Concept
% 215.87/216.08  |- mesh__dateEstablished mesh__D000662 1976-01-01
% 215.87/216.08  |- skos__prefLabel mesh__D000662 Amphetamines
% 215.87/216.08  |- mesh__historyNote mesh__D000662 76; was NON MESH before 1976   
% 215.87/216.08  |- mesh__recordOriginator mesh__D000662 SH
% 215.87/216.08  |- mesh__dateCreated mesh__D000662 1975-07-25
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D000662 2005
% 215.87/216.08  |- skos__scopeNote mesh__D000662
% 215.87/216.08       Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.%A%    
% 215.87/216.08  |- skos__historyNote mesh__D000662 Amphetamine %28%1966-1975%29%
% 215.87/216.08  |- skos__related mesh__D000662smesh__D000697
% 215.87/216.08  |- mesh__dateEstablished mesh__D018275 1994-01-01
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D018275 2000
% 215.87/216.08  |- skos__hiddenLabel mesh__D018275 Lobular Carcinomas
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D018275 1996
% 215.87/216.08  |- mesh__dateCreated mesh__D018275 1993-06-25
% 215.87/216.08  |- skos__broader mesh__D018275smesh__D018299
% 215.87/216.08  |- skos__annotation mesh__D018275
% 215.87/216.08       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with BREAST NEOPLASMS %28%IM%29%%A%  
% 215.87/216.08  |- skos__broader mesh__D018275smesh__D000230
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D018275 2003
% 215.87/216.08  |- mesh__recordAuthorizer mesh__D018275 PLS
% 215.87/216.08  |- mesh__recordMaintainer mesh__D018275 KEV
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D018275 1997
% 215.87/216.08  |- mesh__dateRevised mesh__D018275 1995-06-08
% 215.87/216.08  |- skos__hiddenLabel mesh__D018275 Carcinomas, Lobular
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D018275 2004
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D018275 2001
% 215.87/216.08  |- mesh__publicMeSHNote mesh__D018275 94   
% 215.87/216.08  |- mesh__recordOriginator mesh__D018275 PLS
% 215.87/216.08  |- skos__scopeNote mesh__D018275
% 215.87/216.08       A infiltrating %28%invasive%29% breast cancer, relatively uncommon, accounting for only 5%25%-10%25% of breast tumors in most series. It is often an area of ill-defined thickening in the breast, in contrast to the dominant lump characteristic of ductal carcinoma. It is typically composed of small cells in a linear arrangement with a tendency to grow around ducts and lobules. There is likelihood of axillary nodal involvement with metastasis to meningeal and serosal surfaces. %28%DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1205%29%%A%    
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D018275 2002
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D018275 1998
% 215.87/216.08  |- skos__hiddenLabel mesh__D018275 Lobular Carcinoma
% 215.87/216.08  |- mesh__activeMeSHYear mesh__D018275 2005
% 215.87/216.08  |- skos__historyNote mesh__D018275 Breast Neoplasms %28%1966-1993%29%
% 215.87/216.08  |- mesh__historyNote mesh__D018275 94   
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D018275 1999
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D018275 2006
% 215.87/216.09  |- skos__historyNote mesh__D018275 Carcinoma %28%1966-1993%29%
% 215.87/216.09  |- rdf__type mesh__D018275sskos__Concept
% 215.87/216.09  |- skos__prefLabel mesh__D018275 Carcinoma, Lobular
% 215.87/216.09  |- skos__hiddenLabel mesh__D010292 Painful Paresthesia
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D010292 2004
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D010292 2001
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D010292 2006
% 215.87/216.09  |- mesh__recordMaintainer mesh__D010292 KEV
% 215.87/216.09  |- skos__hiddenLabel mesh__D010292 Painful Paresthesias
% 215.87/216.09  |- skos__scopeNote mesh__D010292
% 215.87/216.09       Subjective cutaneous sensations %28%e.g., cold, warmth, tingling, pressure, etc.%29% that are experienced spontaneously in the absence of stimulation.%A%    
% 215.87/216.09  |- mesh__recordAuthorizer mesh__D010292 sjn
% 215.87/216.09  |- skos__annotation mesh__D010292
% 215.87/216.09       burning, tingling, prickling sensations go here   
% 215.87/216.09  |- skos__hiddenLabel mesh__D010292 Dysesthesias
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D010292 2002
% 215.87/216.09  |- skos__hiddenLabel mesh__D010292 Paresthesias, Distal
% 215.87/216.09  |- skos__hiddenLabel mesh__D010292 Distal Paresthesias
% 215.87/216.09  |- skos__hiddenLabel mesh__D010292 Formications
% 215.87/216.09  |- rdf__type mesh__D010292sskos__Concept
% 215.87/216.09  |- mesh__dateCreated mesh__D010292 1999-01-01
% 215.87/216.09  |- skos__hiddenLabel mesh__D010292 Paresthesias, Painful
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D010292 2003
% 215.87/216.09  |- mesh__dateRevised mesh__D010292 1999-11-03
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D010292 2005
% 215.87/216.09  |- skos__hiddenLabel mesh__D010292 Distal Paresthesia
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D010292 2000
% 215.87/216.09  |- mesh__recordOriginator mesh__D010292 NLM
% 215.87/216.09  |- skos__broader mesh__D010292smesh__D020886
% 215.87/216.09  |- skos__prefLabel mesh__D010292 Paresthesia
% 215.87/216.09  |- skos__hiddenLabel mesh__D010292 Paresthesias
% 215.87/216.09  |- skos__scopeNote mesh__D051100
% 215.87/216.09       The founding member of the glial cell line-derived neurotrophic factor family. It was originally characterized as a NERVE GROWTH FACTOR promoting the survival of MIDBRAIN dopaminergic NEURONS, and it has been studied as a potential treatment for PARKINSON DISEASE.%A%    
% 215.87/216.09  |- mesh__dateEstablished mesh__D051100 2006-01-01
% 215.87/216.09  |- mesh__recordAuthorizer mesh__D051100 sjn
% 215.87/216.09  |- skos__hiddenLabel mesh__D051100 Growth Factor, GDNF
% 215.87/216.09  |- skos__altLabel mesh__D051100 GDNF
% 215.87/216.09  |- skos__altLabel mesh__D051100 GDNF Growth Factor
% 215.87/216.09  |- skos__annotation mesh__D051100
% 215.87/216.09       GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTORS is also available%A%  
% 215.87/216.09  |- mesh__historyNote mesh__D051100 2006%28%1993%29%   
% 215.87/216.09  |- skos__altLabel mesh__D051100 Glial Cell-Line Derived Neurotrophic Factor
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D051100 2006
% 215.87/216.09  |- mesh__publicMeSHNote mesh__D051100
% 215.87/216.09       2006; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR was indexed under NERVE GROWTH FACTORS 2003-2005, %26% under NERVE TISSUE PROTEINS 1993-2002%A%  
% 215.87/216.09  |- mesh__recordMaintainer mesh__D051100 DRC
% 215.87/216.09  |- rdf__type mesh__D051100sskos__Concept
% 215.87/216.09  |- skos__hiddenLabel mesh__D051100
% 215.87/216.09       Glial Cell Line Derived Neurotrophic Factor
% 215.87/216.09  |- skos__prefLabel mesh__D051100
% 215.87/216.09       Glial Cell Line-Derived Neurotrophic Factor
% 215.87/216.09  |- mesh__dateCreated mesh__D051100 2005-06-30
% 215.87/216.09  |- mesh__recordOriginator mesh__D051100 DRC
% 215.87/216.09  |- skos__broader mesh__D051100smesh__D051098
% 215.87/216.09  |- mesh__recordMaintainer mesh__D004255 ssb
% 215.87/216.09  |- mesh__recordAuthorizer mesh__D004255 sjn
% 215.87/216.09  |- skos__altLabel mesh__D004255 Deoxyribodipyrimidine Photolyase
% 215.87/216.09  |- mesh__historyNote mesh__D004255
% 215.87/216.09       97; was DNA PHOTOLYASE 1975-96 %28%see under LYASES 1975-90%29%; DEOXYRIBODIPYRIMIDINE PHOTOLYASE was see DNA PHOTOLYASE 1975-96%A%  
% 215.87/216.09  |- skos__hiddenLabel mesh__D004255 Enzyme, Photoreactivating
% 215.87/216.09  |- skos__hiddenLabel mesh__D004255 Photoreactivating Enzyme, DNA
% 215.87/216.09  |- mesh__publicMeSHNote mesh__D004255
% 215.87/216.09       97; was DNA PHOTOLYASE 1975-96 %28%see under LYASES 1975-90%29%; DEOXYRIBODIPYRIMIDINE PHOTOLYASE was see DNA PHOTOLYASE 1975-96%A%  
% 215.87/216.09  |- skos__hiddenLabel mesh__D004255 Photolyase, Deoxyribodipyrimidine
% 215.87/216.09  |- rdf__type mesh__D004255sskos__Concept
% 215.87/216.09  |- mesh__dateCreated mesh__D004255 1974-11-19
% 215.87/216.09  |- skos__historyNote mesh__D004255 Lyases %28%1972-1974%29%
% 215.87/216.09  |- skos__historyNote mesh__D004255 DNA %28%1972-1974%29%
% 215.87/216.09  |- skos__hiddenLabel mesh__D004255 Enzyme, DNA Photoreactivating
% 215.87/216.09  |- skos__hiddenLabel mesh__D004255 Photolyase, DNA
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D004255 2006
% 215.87/216.09  |- skos__broader mesh__D004255smesh__D019755
% 215.87/216.09  |- skos__scopeNote mesh__D004255
% 215.87/216.09       An enzyme that catalyzes the reactivation by light of UV-irradiated DNA. It breaks two carbon-carbon bonds in pyrimidine dimers in DNA. EC 4.1.99.3.%A%    
% 215.87/216.09  |- mesh__dateEstablished mesh__D004255 1991-01-01
% 215.87/216.09  |- skos__altLabel mesh__D004255 Photoreactivating Enzyme
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D004255 2005
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D004255 2004
% 215.87/216.09  |- mesh__recordOriginator mesh__D004255 NLM
% 215.87/216.09  |- skos__broader mesh__D004255smesh__D045643
% 215.87/216.09  |- skos__altLabel mesh__D004255 DNA Photoreactivating Enzyme
% 215.87/216.09  |- mesh__dateRevised mesh__D004255 2003-07-09
% 215.87/216.09  |- skos__historyNote mesh__D004255 Photochemistry %28%1972-1974%29%
% 215.87/216.09  |- skos__hiddenLabel mesh__D004255 Photo-Lyase, Deoxyribodipyrimidine
% 215.87/216.09  |- skos__hiddenLabel mesh__D004255 Deoxyribodipyrimidine Photo Lyase
% 215.87/216.09  |- skos__altLabel mesh__D004255 DNA Photolyase
% 215.87/216.09  |- skos__prefLabel mesh__D004255 Deoxyribodipyrimidine Photo-Lyase
% 215.87/216.09  |- mesh__historyNote mesh__D050806 2006   
% 215.87/216.09  |- skos__hiddenLabel mesh__D050806 Arthroplasty, Finger Replacement
% 215.87/216.09  |- mesh__dateCreated mesh__D050806 2005-06-30
% 215.87/216.09  |- mesh__publicMeSHNote mesh__D050806 2006   
% 215.87/216.09  |- skos__broader mesh__D050806smesh__D019643
% 215.87/216.09  |- skos__prefLabel mesh__D050806 Arthroplasty, Replacement, Finger
% 215.87/216.09  |- skos__hiddenLabel mesh__D050806 Finger Replacement Arthroplasties
% 215.87/216.09  |- skos__historyNote mesh__D050806 Fingers %28%1967-2005%29%
% 215.87/216.09  |- rdf__type mesh__D050806sskos__Concept
% 215.87/216.09  |- skos__historyNote mesh__D050806 Replantation %28%1967-2005%29%
% 215.87/216.09  |- skos__hiddenLabel mesh__D050806 Replacement Arthroplasties, Finger
% 215.87/216.09  |- skos__scopeNote mesh__D050806
% 215.87/216.09       Partial or total replacement of one or more FINGERS, or a FINGER JOINT.%A%    
% 215.87/216.09  |- skos__altLabel mesh__D050806 Finger Replacement Arthroplasty
% 215.87/216.09  |- mesh__dateEstablished mesh__D050806 2006-01-01
% 215.87/216.09  |- mesh__recordAuthorizer mesh__D050806 sjn
% 215.87/216.09  |- mesh__recordMaintainer mesh__D050806 lkt
% 215.87/216.09  |- skos__hiddenLabel mesh__D050806 Arthroplasties, Finger Replacement
% 215.87/216.09  |- mesh__recordOriginator mesh__D050806 lkt
% 215.87/216.09  |- skos__hiddenLabel mesh__D050806 Replacement Arthroplasty, Finger
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D050806 2006
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014683 1995
% 215.87/216.09  |- skos__related mesh__D014683smesh__D013479
% 215.87/216.09  |- mesh__recordMaintainer mesh__D014683 TAP
% 215.87/216.09  |- skos__scopeNote mesh__D014683
% 215.87/216.09       The venous trunk which returns blood from the head, neck, upper extremities and chest.%A%    
% 215.87/216.09  |- skos__hiddenLabel mesh__D014683 Cavas, Superior Vena
% 215.87/216.09  |- skos__hiddenLabel mesh__D014683 Vena Cavas, Superior
% 215.87/216.09  |- mesh__dateRevised mesh__D014683 1992-05-18
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014683 2000
% 215.87/216.09  |- mesh__recordOriginator mesh__D014683 NLM
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014683 2001
% 215.87/216.09  |- mesh__recordAuthorizer mesh__D014683 PLS
% 215.87/216.09  |- skos__hiddenLabel mesh__D014683 Superior Vena Cava
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014683 2003
% 215.87/216.09  |- skos__hiddenLabel mesh__D014683 Superior Vena Cavas
% 215.87/216.09  |- skos__hiddenLabel mesh__D014683 Cava, Superior Vena
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014683 1996
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014683 2005
% 215.87/216.09  |- skos__broader mesh__D014683smesh__D014684
% 215.87/216.09  |- rdf__type mesh__D014683sskos__Concept
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014683 1998
% 215.87/216.09  |- skos__prefLabel mesh__D014683 Vena Cava, Superior
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014683 2004
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014683 2002
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014683 1997
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014683 1994
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014683 2006
% 215.87/216.09  |- mesh__dateCreated mesh__D014683 1999-01-01
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014683 1999
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014683 1993
% 215.87/216.09  |- mesh__recordAuthorizer mesh__D008646 sjn
% 215.87/216.09  |- mesh__recordMaintainer mesh__D008646 ags
% 215.87/216.09  |- mesh__historyNote mesh__D008646
% 215.87/216.09       MESOSIGMOID was see under MESOCOLON 1963-78   
% 215.87/216.09  |- mesh__onlineNote mesh__D008646
% 215.87/216.09       use MESOCOLON to search MESOSIGMOID 1966-78   
% 215.87/216.09  |- skos__annotation mesh__D008646
% 215.87/216.09       diseases: coord IM with PERITONEAL DISEASES %28%IM%29%; neopl: coord IM with PERITONEAL NEOPLASMS %28%IM%29%%A%  
% 215.87/216.09  |- skos__prefLabel mesh__D008646 Mesocolon
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D008646 2006
% 215.87/216.09  |- mesh__dateCreated mesh__D008646 1999-01-01
% 215.87/216.09  |- mesh__recordOriginator mesh__D008646 NLM
% 215.87/216.09  |- skos__broader mesh__D008646smesh__D008643
% 215.87/216.09  |- skos__hiddenLabel mesh__D008646 Mesosigmoids
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D008646 2004
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D008646 2005
% 215.87/216.09  |- mesh__dateRevised mesh__D008646 2002-07-03
% 215.87/216.09  |- skos__hiddenLabel mesh__D008646 Mesocolons
% 215.87/216.09  |- skos__scopeNote mesh__D008646
% 215.87/216.09       The fold of peritoneum by which the COLON is attached to the posterior ABDOMINAL WALL.%A%    
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D008646 2003
% 215.87/216.09  |- rdf__type mesh__D008646sskos__Concept
% 215.87/216.09  |- mesh__dateCreated mesh__D000663 1999-01-01
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D000663 2006
% 215.87/216.09  |- rdf__type mesh__D000663sskos__Concept
% 215.87/216.09  |- skos__annotation mesh__D000663
% 215.87/216.09       GEN or unspecified; prefer specific available orders, families %26% genera; NIM when exper animal%A%  
% 215.87/216.09  |- mesh__dateRevised mesh__D000663 2003-07-09
% 215.87/216.09  |- skos__broader mesh__D000663smesh__D014714
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D000663 2005
% 215.87/216.09  |- mesh__recordAuthorizer mesh__D000663 sjn
% 215.87/216.09  |- mesh__recordOriginator mesh__D000663 NLM
% 215.87/216.09  |- skos__scopeNote mesh__D000663
% 215.87/216.09       VERTEBRATES such as frogs, toads, newts and salamanders that live in a semiaquatic environment.%A%    
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D000663 2004
% 215.87/216.09  |- skos__prefLabel mesh__D000663 Amphibia
% 215.87/216.09  |- mesh__recordMaintainer mesh__D000663 ags
% 215.87/216.09  |- skos__related mesh__D000663smesh__D029845
% 215.87/216.09  |- skos__altLabel mesh__D000663 Amphibians
% 215.87/216.09  |- skos__related mesh__D018276smesh__D018813
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D018276 1997
% 215.87/216.09  |- mesh__dateRevised mesh__D018276 1995-06-08
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D018276 2004
% 215.87/216.09  |- mesh__recordOriginator mesh__D018276 PLS
% 215.87/216.09  |- mesh__dateEstablished mesh__D018276 1994-01-01
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D018276 2000
% 215.87/216.09  |- skos__broader mesh__D018276smesh__D018299
% 215.87/216.09  |- mesh__dateCreated mesh__D018276 1993-06-25
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D018276 1998
% 215.87/216.09  |- mesh__recordAuthorizer mesh__D018276 PLS
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D018276 2005
% 215.87/216.09  |- mesh__historyNote mesh__D018276 94   
% 215.87/216.09  |- skos__related mesh__D018276smesh__D018814
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D018276 1999
% 215.87/216.09  |- skos__broader mesh__D018276smesh__D018278
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D018276 2001
% 215.87/216.09  |- mesh__publicMeSHNote mesh__D018276 94   
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D018276 2006
% 215.87/216.09  |- skos__hiddenLabel mesh__D018276 Carcinomas, Medullary
% 215.87/216.09  |- skos__prefLabel mesh__D018276 Carcinoma, Medullary
% 215.87/216.09  |- skos__historyNote mesh__D018276 Carcinoma %28%1966-1993%29%
% 215.87/216.09  |- skos__annotation mesh__D018276
% 215.87/216.09       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 215.87/216.09  |- skos__hiddenLabel mesh__D018276 Medullary Carcinoma
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D018276 2002
% 215.87/216.09  |- rdf__type mesh__D018276sskos__Concept
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D018276 1996
% 215.87/216.09  |- skos__scopeNote mesh__D018276
% 215.87/216.09       A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%25%-7%25% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%25%-10%25% of all thyroid malignancies. %28%From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1141; Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D018276 2003
% 215.87/216.09  |- mesh__recordMaintainer mesh__D018276 KEV
% 215.87/216.09  |- skos__hiddenLabel mesh__D018276 Medullary Carcinomas
% 215.87/216.09  |- skos__prefLabel mesh__D010293 Pargyline
% 215.87/216.09  |- rdf__type mesh__D010293sskos__Concept
% 215.87/216.09  |- mesh__dateCreated mesh__D010293 1999-01-01
% 215.87/216.09  |- mesh__recordOriginator mesh__D010293 NLM
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D010293 2003
% 215.87/216.09  |- mesh__recordMaintainer mesh__D010293 ssb
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D010293 2005
% 215.87/216.09  |- mesh__publicMeSHNote mesh__D010293 65   
% 215.87/216.09  |- skos__broader mesh__D010293smesh__D001596
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D010293 2004
% 215.87/216.09  |- mesh__dateEstablished mesh__D010293 1965-01-01
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D010293 2006
% 215.87/216.09  |- mesh__historyNote mesh__D010293 65%28%63%29%   
% 215.87/216.09  |- mesh__dateRevised mesh__D010293 2001-07-25
% 215.87/216.09  |- mesh__recordAuthorizer mesh__D010293 sjn
% 215.87/216.09  |- skos__scopeNote mesh__D010293
% 215.87/216.09       A monoamine oxidase inhibitor with antihypertensive properties.%A%    
% 215.87/216.09  |- skos__hiddenLabel mesh__D010293 Hydrochloride, Pargyline
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D010293 2002
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D051101 2006
% 215.87/216.09  |- skos__scopeNote mesh__D051101
% 215.87/216.09       A glial cell line-derived neurotrophic factor ligand that is specific for the GFRA2 RECEPTOR.  Neurturin is essential for the development of specific postganglionic parasympathetic NEURONS.%A%    
% 215.87/216.09  |- mesh__historyNote mesh__D051101 2006%28%1997%29%   
% 215.87/216.09  |- skos__prefLabel mesh__D051101 Neurturin
% 215.87/216.09  |- skos__altLabel mesh__D051101 Nrtn Protein
% 215.87/216.09  |- mesh__dateCreated mesh__D051101 2005-06-30
% 215.87/216.09  |- mesh__dateEstablished mesh__D051101 2006-01-01
% 215.87/216.09  |- rdf__type mesh__D051101sskos__Concept
% 215.87/216.09  |- mesh__recordOriginator mesh__D051101 DRC
% 215.87/216.09  |- mesh__recordAuthorizer mesh__D051101 sjn
% 215.87/216.09  |- mesh__publicMeSHNote mesh__D051101
% 215.87/216.09       2006; NEURTURIN was indexed under NERVE GROWTH FACTORS 1997-2005%A%  
% 215.87/216.09  |- skos__broader mesh__D051101smesh__D051098
% 215.87/216.09  |- mesh__recordMaintainer mesh__D051101 DRC
% 215.87/216.09  |- mesh__recordMaintainer mesh__D004256 ssb
% 215.87/216.09  |- skos__hiddenLabel mesh__D004256 DNA Dependent DNA Polymerase I
% 215.87/216.09  |- skos__altLabel mesh__D004256 DNA-Dependent DNA Polymerase I
% 215.87/216.09  |- rdf__type mesh__D004256sskos__Concept
% 215.87/216.09  |- skos__scopeNote mesh__D004256
% 215.87/216.09       A DNA-dependent DNA polymerase characterized in prokaryotes and may be present in higher organisms. It has both 3%27%-5%27% and 5%27%-3%27% exonuclease activity, but cannot use native double-stranded DNA as template-primer. It is not inhibited by sulfhydryl reagents and is active in both DNA synthesis and repair. EC 2.7.7.7.%A%    
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D004256 2005
% 215.87/216.09  |- mesh__recordAuthorizer mesh__D004256 sjn
% 215.87/216.09  |- mesh__historyNote mesh__D004256
% 215.87/216.09       84%28%77%29%; for DNA POLYMERASE ALPHA use DNA POLYMERASE II 1982-97%A%  
% 215.87/216.09  |- skos__hiddenLabel mesh__D004256 Polymerase I, DNA
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D004256 2006
% 215.87/216.09  |- skos__hiddenLabel mesh__D004256 Polymerase alpha, DNA
% 215.87/216.09  |- skos__altLabel mesh__D004256 Pol I
% 215.87/216.09  |- skos__altLabel mesh__D004256 Klenow Fragment
% 215.87/216.09  |- mesh__dateCreated mesh__D004256 1976-04-21
% 215.87/216.09  |- skos__altLabel mesh__D004256 DNA Polymerase alpha
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D004256 2004
% 215.87/216.09  |- mesh__dateEstablished mesh__D004256 1984-01-01
% 215.87/216.09  |- mesh__publicMeSHNote mesh__D004256
% 215.87/216.09       84; see DNA POLYMERASES 1977-83; for DNA POLYMERASE ALPHA see DNA POLYMERASE II 1982-97%A%  
% 215.87/216.09  |- skos__historyNote mesh__D004256
% 215.87/216.09       DNA Nucleotidyltransferases %28%1968-1976%29%
% 215.87/216.09  |- mesh__dateRevised mesh__D004256 2003-07-09
% 215.87/216.09  |- skos__prefLabel mesh__D004256 DNA Polymerase I
% 215.87/216.09  |- mesh__recordOriginator mesh__D004256 RLS
% 215.87/216.09  |- skos__broader mesh__D004256smesh__D004259
% 215.87/216.09  |- skos__hiddenLabel mesh__D050807 Elk-1, ets-Domain Protein
% 215.87/216.09  |- mesh__recordOriginator mesh__D050807 jmp
% 215.87/216.09  |- skos__altLabel mesh__D050807 Elk-1 Transcription Factor
% 215.87/216.09  |- rdf__type mesh__D050807sskos__Concept
% 215.87/216.09  |- skos__prefLabel mesh__D050807 ets-Domain Protein Elk-1
% 215.87/216.09  |- mesh__historyNote mesh__D050807 2006%28%1989%29%   
% 215.87/216.09  |- skos__hiddenLabel mesh__D050807 Transcription Factor, Elk1
% 215.87/216.09  |- skos__hiddenLabel mesh__D050807 Elk 1 Transcription Factor
% 215.87/216.09  |- mesh__dateCreated mesh__D050807 2005-06-30
% 215.87/216.09  |- skos__hiddenLabel mesh__D050807 Elk 1 ets Domain Protein
% 215.87/216.09  |- skos__hiddenLabel mesh__D050807 Ets Like Protein 1
% 215.87/216.09  |- skos__hiddenLabel mesh__D050807 ets-Domain Protein, Elk1
% 215.87/216.09  |- skos__hiddenLabel mesh__D050807 ets-Domain Protein, Elk-1
% 215.87/216.09  |- skos__hiddenLabel mesh__D050807 Factor Elk1, Transcription
% 215.87/216.09  |- skos__hiddenLabel mesh__D050807 Elk1 ets Domain Protein
% 215.87/216.09  |- mesh__dateEstablished mesh__D050807 2006-01-01
% 215.87/216.09  |- skos__hiddenLabel mesh__D050807 ets Domain Protein Elk 1
% 215.87/216.09  |- skos__historyNote mesh__D050807 DNA-Binding Proteins %28%1989-2005%29%
% 215.87/216.09  |- skos__altLabel mesh__D050807 Elk1 Transcription Factor
% 215.87/216.09  |- skos__annotation mesh__D050807 see SCR for organism-specific terms   
% 215.87/216.09  |- skos__historyNote mesh__D050807
% 215.87/216.09       Proto-Oncogene Proteins %28%1989-2005%29%
% 215.87/216.09  |- mesh__recordMaintainer mesh__D050807 jmp
% 215.87/216.09  |- skos__altLabel mesh__D050807 Ets-Like Protein 1
% 215.87/216.09  |- skos__altLabel mesh__D050807 Transcription Factor Elk1
% 215.87/216.09  |- skos__altLabel mesh__D050807 Elk-1 ets-Domain Protein
% 215.87/216.09  |- skos__historyNote mesh__D050807 Transcription Factors %28%1989-2005%29%
% 215.87/216.09  |- mesh__recordAuthorizer mesh__D050807 sjn
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D050807 2006
% 215.87/216.09  |- skos__scopeNote mesh__D050807
% 215.87/216.09       A member of the ternary complex family of ets-related transcription factors that is regulated by MITOGEN-ACTIVATED PROTEIN KINASES including JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; and P38 MITOGEN-ACTIVATED PROTEIN KINASES.%A%    
% 215.87/216.09  |- skos__hiddenLabel mesh__D050807 Elk1, Transcription Factor
% 215.87/216.09  |- skos__hiddenLabel mesh__D050807 Transcription Factor, Elk-1
% 215.87/216.09  |- mesh__publicMeSHNote mesh__D050807
% 215.87/216.09       2006; ETS-DOMAIN PROTEIN ELK-1 was indexed under PROTO-ONCOGENE PROTEINS, TRANSCRIPTION FACTORS, DNA-BINDING PROTEINS 1995-2005, under RETROVIRIDAE PROTEINS 1989, %26% under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-1994%A%  
% 215.87/216.09  |- skos__broader mesh__D050807smesh__D050801
% 215.87/216.09  |- skos__altLabel mesh__D050807 Elk1 ets-Domain Protein
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014684 2002
% 215.87/216.09  |- skos__broader mesh__D014684smesh__D014680
% 215.87/216.09  |- mesh__recordMaintainer mesh__D014684 TAP
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014684 2003
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014684 1996
% 215.87/216.09  |- skos__scopeNote mesh__D014684
% 215.87/216.09       The inferior and superior venae cavae.     
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014684 2005
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014684 2000
% 215.87/216.09  |- rdf__type mesh__D014684sskos__Concept
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014684 1998
% 215.87/216.09  |- skos__annotation mesh__D014684
% 215.87/216.09       try to specify VENA CAVA, INFERIOR or VENA CAVA, SUPERIOR%A%  
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014684 2004
% 215.87/216.09  |- mesh__recordOriginator mesh__D014684 NLM
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014684 2001
% 215.87/216.09  |- mesh__recordAuthorizer mesh__D014684 PLS
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014684 1997
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014684 1994
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014684 2006
% 215.87/216.09  |- mesh__dateCreated mesh__D014684 1999-01-01
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014684 1999
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014684 1993
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D014684 1995
% 215.87/216.09  |- skos__hiddenLabel mesh__D014684 Cavae, Venae
% 215.87/216.09  |- skos__prefLabel mesh__D014684 Venae Cavae
% 215.87/216.09  |- mesh__dateRevised mesh__D014684 1992-05-18
% 215.87/216.09  |- skos__annotation mesh__D008647
% 215.87/216.09       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget to apply check tag%A%  
% 215.87/216.09  |- mesh__dateEstablished mesh__D008647 1991-01-01
% 215.87/216.09  |- mesh__recordMaintainer mesh__D008647 ags
% 215.87/216.09  |- skos__prefLabel mesh__D008647 Mesocricetus
% 215.87/216.09  |- skos__altLabel mesh__D008647 Mesocricetus auratus
% 215.87/216.09  |- mesh__recordAuthorizer mesh__D008647 sjn
% 215.87/216.09  |- skos__altLabel mesh__D008647 Hamsters, Golden
% 215.87/216.09  |- skos__broader mesh__D008647smesh__D006224
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D008647 2006
% 215.87/216.09  |- mesh__dateCreated mesh__D008647 1999-01-01
% 215.87/216.09  |- mesh__onlineNote mesh__D008647 search HAMSTERS 1966-74   
% 215.87/216.09  |- mesh__historyNote mesh__D008647
% 215.87/216.09       91%28%75%29%; was see under HAMSTERS 1975-90   
% 215.87/216.09  |- skos__hiddenLabel mesh__D008647 Golden Syrian Hamsters
% 215.87/216.09  |- skos__hiddenLabel mesh__D008647 Syrian Hamsters, Golden
% 215.87/216.09  |- skos__scopeNote mesh__D008647
% 215.87/216.09       A genus of the family Muridae having three species. The present domesticated strains were developed from individuals brought from Syria. They are widely used in biomedical research.%A%    
% 215.87/216.09  |- rdf__type mesh__D008647sskos__Concept
% 215.87/216.09  |- mesh__recordOriginator mesh__D008647 NLM
% 215.87/216.09  |- mesh__publicMeSHNote mesh__D008647 91; was see under HAMSTERS 1975-90   
% 215.87/216.09  |- skos__altLabel mesh__D008647 Hamsters, Syrian
% 215.87/216.09  |- mesh__dateRevised mesh__D008647 2005-07-01
% 215.87/216.09  |- skos__hiddenLabel mesh__D008647 Syrian Hamsters
% 215.87/216.09  |- skos__broader mesh__D000664smesh__D014688
% 215.87/216.09  |- skos__hiddenLabel mesh__D000664 Venom, Amphibian
% 215.87/216.09  |- rdf__type mesh__D000664sskos__Concept
% 215.87/216.09  |- skos__hiddenLabel mesh__D000664 Venom, Toad
% 215.87/216.09  |- skos__altLabel mesh__D000664 Toad Venoms
% 215.87/216.09  |- mesh__publicMeSHNote mesh__D000664 78   
% 215.87/216.09  |- mesh__recordAuthorizer mesh__D000664 sjn
% 215.87/216.09  |- mesh__recordOriginator mesh__D000664 SH
% 215.87/216.09  |- mesh__dateEstablished mesh__D000664 1978-01-01
% 215.87/216.09  |- mesh__dateCreated mesh__D000664 1977-04-22
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D000664 2006
% 215.87/216.09  |- mesh__recordMaintainer mesh__D000664 ssb
% 215.87/216.09  |- skos__historyNote mesh__D000664 Amphibia %28%1966-1977%29%
% 215.87/216.09  |- skos__scopeNote mesh__D000664
% 215.87/216.09       Venoms produced by frogs, toads, salamanders, etc. The venom glands are usually on the skin of the back and contain cardiotoxic glycosides, cholinolytics, and a number of other bioactive materials, many of which have been characterized. The venoms have been used as arrow poisons and include bufogenin, bufotoxin, bufagin, bufotalin, histrionicotoxins, and pumiliotoxin.%A%    
% 215.87/216.09  |- skos__altLabel mesh__D000664 Frog Venom
% 215.87/216.09  |- skos__historyNote mesh__D000664 Venoms %28%1966-1977%29%
% 215.87/216.09  |- skos__hiddenLabel mesh__D000664 Venoms, Frog
% 215.87/216.09  |- mesh__historyNote mesh__D000664 78   
% 215.87/216.09  |- skos__hiddenLabel mesh__D000664 Venom, Frog
% 215.87/216.09  |- mesh__dateRevised mesh__D000664 2005-06-30
% 215.87/216.09  |- skos__annotation mesh__D000664
% 215.87/216.09       /antag permitted but consider also ANTIVENINS; /enzymol permitted; coord IM with specific amphibian %28%IM or NIM%29%%A%  
% 215.87/216.09  |- skos__hiddenLabel mesh__D000664 Venoms, Toad
% 215.87/216.09  |- skos__altLabel mesh__D000664 Amphibian Venom
% 215.87/216.09  |- skos__hiddenLabel mesh__D000664 Venoms, Amphibian
% 215.87/216.09  |- skos__prefLabel mesh__D000664 Amphibian Venoms
% 215.87/216.09  |- mesh__dateEstablished mesh__D027801 2002-01-01
% 215.87/216.09  |- skos__annotation mesh__D027801
% 215.87/216.09       GALANTHAMINE is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.87/216.09  |- mesh__historyNote mesh__D027801 2002   
% 215.87/216.09  |- skos__scopeNote mesh__D027801
% 215.87/216.09       A plant genus in the family LILIACEAE %28%sometimes classified as Amaryllidaceae%29%.  Galanthus nivalis L. is the source of GALANTHAMINE.%A%    
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D027801 2006
% 215.87/216.09  |- rdf__type mesh__D027801sskos__Concept
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D027801 2005
% 215.87/216.09  |- skos__historyNote mesh__D027801 Plants, Medicinal %28%1965-2001%29%
% 215.87/216.09  |- skos__altLabel mesh__D027801 Snowdrops
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D027801 2004
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D027801 2003
% 215.87/216.09  |- skos__broader mesh__D027801smesh__D019668
% 215.87/216.09  |- skos__prefLabel mesh__D027801 Galanthus
% 215.87/216.09  |- mesh__dateCreated mesh__D027801 2001-07-25
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D027801 2002
% 215.87/216.09  |- mesh__publicMeSHNote mesh__D027801 2002   
% 215.87/216.09  |- mesh__recordMaintainer mesh__D027003 ssb
% 215.87/216.09  |- mesh__recordOriginator mesh__D027003 ssb
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D027003 2006
% 215.87/216.09  |- skos__prefLabel mesh__D027003 Urticaceae
% 215.87/216.09  |- rdf__type mesh__D027003sskos__Concept
% 215.87/216.09  |- skos__broader mesh__D027003smesh__D019684
% 215.87/216.09  |- skos__annotation mesh__D027003
% 215.87/216.09       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D027003 2005
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D027003 2004
% 215.87/216.09  |- mesh__dateEstablished mesh__D027003 2002-01-01
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D027003 2003
% 215.87/216.09  |- mesh__dateRevised mesh__D027003 2002-07-03
% 215.87/216.09  |- mesh__recordAuthorizer mesh__D027003 sjn
% 215.87/216.09  |- mesh__publicMeSHNote mesh__D027003 2002   
% 215.87/216.09  |- skos__scopeNote mesh__D027003
% 215.87/216.09       The nettles plant family of the order Urticales, subclass Hamamelidae, class Magnoliopsida. Many have stinging hairs on stems and leaves. Flowers are small and greenish in leaf axils. The fruit is dry and one-seeded.%A%    
% 215.87/216.09  |- mesh__historyNote mesh__D027003 2002   
% 215.87/216.09  |- mesh__dateCreated mesh__D027003 2001-07-25
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D018277 2005
% 215.87/216.09  |- skos__annotation mesh__D018277
% 215.87/216.09       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with organ/neopl term %28%IM%29%%A%  
% 215.87/216.09  |- mesh__historyNote mesh__D018277 94   
% 215.87/216.09  |- skos__scopeNote mesh__D018277
% 215.87/216.09       A tumor of both low- and high-grade malignancy. The low-grade grow slowly, appear in any age group, and are readily cured by excision. The high-grade behave aggressively, widely infiltrate the salivary gland and produce lymph node and distant metastases. Mucoepidermoid carcinomas account for about 21%25% of the malignant tumors of the parotid gland and 10%25% of the sublingual gland. They are the most common malignant tumor of the parotid. %28%From DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p575; Holland et al., Cancer Medicine, 3d ed, p1240%29%%A%    
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D018277 2002
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D018277 1999
% 215.87/216.09  |- skos__hiddenLabel mesh__D018277 Carcinomas, Mucoepidermoid
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D018277 2006
% 215.87/216.09  |- skos__hiddenLabel mesh__D018277 Mucoepidermoid Carcinoma
% 215.87/216.09  |- rdf__type mesh__D018277sskos__Concept
% 215.87/216.09  |- skos__hiddenLabel mesh__D018277 Mucoepidermoid Carcinomas
% 215.87/216.09  |- mesh__dateEstablished mesh__D018277 1994-01-01
% 215.87/216.09  |- mesh__activeMeSHYear mesh__D018277 1996
% 215.87/216.10  |- skos__broader mesh__D018277smesh__D000230
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D018277 2003
% 215.87/216.10  |- mesh__recordMaintainer mesh__D018277 KEV
% 215.87/216.10  |- skos__prefLabel mesh__D018277 Carcinoma, Mucoepidermoid
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D018277 2000
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D018277 1997
% 215.87/216.10  |- mesh__dateRevised mesh__D018277 1995-06-08
% 215.87/216.10  |- mesh__dateCreated mesh__D018277 1993-06-25
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D018277 2004
% 215.87/216.10  |- mesh__recordOriginator mesh__D018277 PLS
% 215.87/216.10  |- mesh__recordAuthorizer mesh__D018277 PLS
% 215.87/216.10  |- skos__broader mesh__D018277smesh__D018297
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D018277 2001
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D018277 1998
% 215.87/216.10  |- mesh__publicMeSHNote mesh__D018277 94   
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D010294 1993
% 215.87/216.10  |- rdf__type mesh__D010294sskos__Concept
% 215.87/216.10  |- skos__hiddenLabel mesh__D010294 Bone, Parietal
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D010294 2002
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D010294 1995
% 215.87/216.10  |- mesh__dateCreated mesh__D010294 1999-01-01
% 215.87/216.10  |- mesh__dateRevised mesh__D010294 1979-01-11
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D010294 1990
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D010294 2003
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D010294 2005
% 215.87/216.10  |- skos__prefLabel mesh__D010294 Parietal Bone
% 215.87/216.10  |- skos__annotation mesh__D010294
% 215.87/216.10       fractures: coord PARIETAL BONE /inj %28%IM%29% + SKULL FRACTURES %28%IM%29%; neopl: coord IM with SKULL NEOPLASMS %28%IM%29%%A%  
% 215.87/216.10  |- skos__broader mesh__D010294smesh__D012886
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D010294 2004
% 215.87/216.10  |- skos__hiddenLabel mesh__D010294 Bones, Parietal
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D010294 2006
% 215.87/216.10  |- mesh__recordOriginator mesh__D010294 NLM
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D010294 2000
% 215.87/216.10  |- mesh__recordAuthorizer mesh__D010294 MED
% 215.87/216.10  |- skos__hiddenLabel mesh__D010294 Parietal Bones
% 215.87/216.10  |- mesh__recordMaintainer mesh__D010294 GJB
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D010294 2001
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D010294 1996
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D010294 1991
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D010294 1998
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D010294 1989
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D010294 1992
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D010294 1997
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D010294 1994
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D010294 1999
% 215.87/216.10  |- mesh__dateCreated mesh__D051900 2005-06-30
% 215.87/216.10  |- mesh__dateRevised mesh__D051900 2005-08-02
% 215.87/216.10  |- skos__altLabel mesh__D051900 Madh3 Protein
% 215.87/216.10  |- mesh__dateEstablished mesh__D051900 2006-01-01
% 215.87/216.10  |- skos__broader mesh__D051900smesh__D051896
% 215.87/216.10  |- mesh__historyNote mesh__D051900 2006%28%1996%29%   
% 215.87/216.10  |- mesh__recordAuthorizer mesh__D051900 ags
% 215.87/216.10  |- mesh__recordMaintainer mesh__D051900 ags
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D051900 2006
% 215.87/216.10  |- skos__prefLabel mesh__D051900 Smad3 Protein
% 215.87/216.10  |- mesh__recordOriginator mesh__D051900 DRC
% 215.87/216.10  |- rdf__type mesh__D051900sskos__Concept
% 215.87/216.10  |- mesh__publicMeSHNote mesh__D051900
% 215.87/216.10       2006; SMAD3 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1996-2005%A%  
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D051900 2006A
% 215.87/216.10  |- skos__scopeNote mesh__D051900
% 215.87/216.10       A receptor-regulated smad protein that undergoes PHOSPHORYLATION by ACTIVIN RECEPTORS, TYPE I. Activated Smad3 can bind directly to DNA, and it regulates TRANSFORMING GROWTH FACTOR BETA and ACTIVIN signaling.%A%    
% 215.87/216.10  |- skos__hiddenLabel mesh__D051102 Serine Palmitoyl CoA Transferase 2
% 215.87/216.10  |- mesh__recordAuthorizer mesh__D051102 ags
% 215.87/216.10  |- skos__altLabel mesh__D051102 Serine Palmitoyltransferase 2
% 215.87/216.10  |- rdf__type mesh__D051102sskos__Concept
% 215.87/216.10  |- skos__hiddenLabel mesh__D051102 Palmitoyltransferase 2, Serine
% 215.87/216.10  |- skos__historyNote mesh__D051102 Acyltransferases %28%1984-2005%29%
% 215.87/216.10  |- skos__altLabel mesh__D051102 Serine Palmitoyltransferase
% 215.87/216.10  |- skos__altLabel mesh__D051102 Serine Palmitoyltransferase 1
% 215.87/216.10  |- skos__altLabel mesh__D051102
% 215.87/216.10       Palmitoyl-CoA-L-Serine C-Palmitoyltransferase %28%Decarboxylating%29%
% 215.87/216.10  |- skos__altLabel mesh__D051102 Serine-Palmitoyl-CoA Transferase 2
% 215.87/216.10  |- skos__hiddenLabel mesh__D051102 Serine C Palmitoyltransferase
% 215.87/216.10  |- skos__prefLabel mesh__D051102 Serine C-Palmitoyltransferase
% 215.87/216.10  |- skos__broader mesh__D051102smesh__D000217
% 215.87/216.10  |- mesh__dateCreated mesh__D051102 2005-06-30
% 215.87/216.10  |- mesh__dateEstablished mesh__D051102 2006-01-01
% 215.87/216.10  |- skos__altLabel mesh__D051102
% 215.87/216.10       Serine Palmitoyltransferase, Long Chain Base Subunit 2
% 215.87/216.10  |- mesh__publicMeSHNote mesh__D051102
% 215.87/216.10       2006; SERINE C-PALMITOYLTRANSFERASE was indexed under ACYLTRANSFERASES 1984-2005%A%  
% 215.87/216.10  |- skos__hiddenLabel mesh__D051102 Palmitoyltransferase 1, Serine
% 215.87/216.10  |- skos__altLabel mesh__D051102
% 215.87/216.10       Palmitoyl-Coenzyme A-L-Serine C-Palmitoyltransferase %28%Decarboxylating%29%
% 215.87/216.10  |- skos__hiddenLabel mesh__D051102 Palmitoyltransferase, Serine
% 215.87/216.10  |- skos__scopeNote mesh__D051102
% 215.87/216.10       A key enzyme in SPHINGOLIPIDS biosynthesis, this enzyme catalyzes the pyridoxal-5%27%-phosphate-dependent condensation of L-SERINE and PALMITOYL COENZYME A to 3-dehydro-D-sphinganine. The enzyme consists of two different subunits.%A%    
% 215.87/216.10  |- skos__hiddenLabel mesh__D051102 C-Palmitoyltransferase, Serine
% 215.87/216.10  |- skos__altLabel mesh__D051102
% 215.87/216.10       Serine Palmitoyltransferase, Long Chain Base Subunit 1
% 215.87/216.10  |- mesh__historyNote mesh__D051102 2006%28%1984%29%   
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D051102 2006A
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D051102 2006
% 215.87/216.10  |- mesh__dateRevised mesh__D051102 2005-08-01
% 215.87/216.10  |- mesh__recordOriginator mesh__D051102 AKE
% 215.87/216.10  |- mesh__recordMaintainer mesh__D051102 ags
% 215.87/216.10  |- skos__hiddenLabel mesh__D051102 Transferase 2, Serine-Palmitoyl-CoA
% 215.87/216.10  |- skos__historyNote mesh__D004257
% 215.87/216.10       DNA Nucleotidyltransferases %28%1968-1976%29%
% 215.87/216.10  |- rdf__type mesh__D004257sskos__Concept
% 215.87/216.10  |- skos__altLabel mesh__D004257 Pol II
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D004257 2005
% 215.87/216.10  |- mesh__recordOriginator mesh__D004257 RLS
% 215.87/216.10  |- mesh__recordMaintainer mesh__D004257 ssb
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D004257 2006
% 215.87/216.10  |- skos__hiddenLabel mesh__D004257 Polymerase II, DNA
% 215.87/216.10  |- skos__prefLabel mesh__D004257 DNA Polymerase II
% 215.87/216.10  |- mesh__dateCreated mesh__D004257 1976-04-21
% 215.87/216.10  |- mesh__historyNote mesh__D004257
% 215.87/216.10       84%28%77%29%; for DNA POLYMERASE EPSILON use DNA POLYMERASE II %28%NM%29% 1994-97%A%  
% 215.87/216.10  |- skos__hiddenLabel mesh__D004257 DNA Dependent DNA Polymerase II
% 215.87/216.10  |- skos__altLabel mesh__D004257 DNA Polymerase epsilon
% 215.87/216.10  |- skos__altLabel mesh__D004257 DNA-Dependent DNA Polymerase II
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D004257 2004
% 215.87/216.10  |- mesh__publicMeSHNote mesh__D004257
% 215.87/216.10       84; see DNA POLYMERASES 1977-83; DNA POLYMERASE EPSILON was indexed under DNA POLYMERASES 1994-97%A%  
% 215.87/216.10  |- mesh__recordAuthorizer mesh__D004257 sjn
% 215.87/216.10  |- skos__hiddenLabel mesh__D004257 Polymerase epsilon, DNA
% 215.87/216.10  |- mesh__dateRevised mesh__D004257 2003-07-09
% 215.87/216.10  |- skos__broader mesh__D004257smesh__D004259
% 215.87/216.10  |- skos__scopeNote mesh__D004257
% 215.87/216.10       A DNA-dependent DNA polymerase characterized in E. coli and other lower organisms. It may be present in higher organisms and has an intrinsic molecular activity only 5%25% of that of DNA Polymerase I. This polymerase has 3%27%-5%27% exonuclease activity, is effective only on duplex DNA with gaps or single-strand ends of less than 100 nucleotides as template, and is inhibited by sulfhydryl reagents. EC 2.7.7.7.%A%    
% 215.87/216.10  |- mesh__dateEstablished mesh__D004257 1984-01-01
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D009740 2004
% 215.87/216.10  |- mesh__recordAuthorizer mesh__D009740 PLS
% 215.87/216.10  |- mesh__publicMeSHNote mesh__D009740 73   
% 215.87/216.10  |- mesh__dateRevised mesh__D009740 1994-05-05
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D009740 2002
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D009740 1998
% 215.87/216.10  |- skos__altLabel mesh__D009740 Staff, Nursing
% 215.87/216.10  |- mesh__recordMaintainer mesh__D009740 TGC
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D009740 2003
% 215.87/216.10  |- skos__broader mesh__D009740smesh__D006282
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D009740 1997
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D009740 2001
% 215.87/216.10  |- skos__altLabel mesh__D009740 Nursing Staffs
% 215.87/216.10  |- skos__altLabel mesh__D009740 Staffs, Nursing
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D009740 2000
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D009740 1996
% 215.87/216.10  |- mesh__dateEstablished mesh__D009740 1973-01-01
% 215.87/216.10  |- mesh__historyNote mesh__D009740 73   
% 215.87/216.10  |- mesh__recordOriginator mesh__D009740 NLM
% 215.87/216.10  |- mesh__dateCreated mesh__D009740 1999-01-01
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D009740 1995
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D009740 2006
% 215.87/216.10  |- skos__scopeNote mesh__D009740
% 215.87/216.10       Personnel who provide nursing service to patients in an organized facility, institution, or agency.%A%    
% 215.87/216.10  |- skos__annotation mesh__D009740
% 215.87/216.10       other than in hosp; in hosp = NURSING STAFF, HOSPITAL; coord IM with nurs or med milieu %28%IM%29%; DF: NURS STAFF%A%  
% 215.87/216.10  |- skos__prefLabel mesh__D009740 Nursing Staff
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D009740 2005
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D009740 1999
% 215.87/216.10  |- rdf__type mesh__D009740sskos__Concept
% 215.87/216.10  |- mesh__recordAuthorizer mesh__D050808 sjn
% 215.87/216.10  |- skos__hiddenLabel mesh__D050808 Serum Response Factor Protein 1a
% 215.87/216.10  |- mesh__publicMeSHNote mesh__D050808
% 215.87/216.10       2006; ETS-DOMAIN PROTEIN ELK was indexed under DNA-BINDING PROTEINS 1995-2005 %26% FUNGAL PROTEINS 1992-1994%A%  
% 215.87/216.10  |- skos__hiddenLabel mesh__D050808 ets Domain Protein Elk 4
% 215.87/216.10  |- skos__altLabel mesh__D050808 Sap-1a Ets-Domain Protein
% 215.87/216.10  |- skos__hiddenLabel mesh__D050808 Serum Response Factor Protein 1b
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D050808 2006
% 215.87/216.10  |- skos__altLabel mesh__D050808 Serum Response Factor Accessory Protein 1
% 215.87/216.10  |- mesh__recordMaintainer mesh__D050808 jmp
% 215.87/216.10  |- skos__hiddenLabel mesh__D050808 Elk-4, ets-Domain Protein
% 215.87/216.10  |- skos__hiddenLabel mesh__D050808 Sap1a Ets Domain Protein
% 215.87/216.10  |- skos__hiddenLabel mesh__D050808 Elk 4 ets Domain Protein
% 215.87/216.10  |- skos__hiddenLabel mesh__D050808 Sap 1b Ets Domain Protein
% 215.87/216.10  |- skos__prefLabel mesh__D050808 ets-Domain Protein Elk-4
% 215.87/216.10  |- mesh__recordOriginator mesh__D050808 jmp
% 215.87/216.10  |- skos__hiddenLabel mesh__D050808 Ets-Domain Protein, Sap-1a
% 215.87/216.10  |- skos__altLabel mesh__D050808 Sap1b Ets-Domain Protein
% 215.87/216.10  |- skos__altLabel mesh__D050808 SRF Accessory Protein 1
% 215.87/216.10  |- skos__hiddenLabel mesh__D050808 Sap1b Ets Domain Protein
% 215.87/216.10  |- skos__hiddenLabel mesh__D050808 Ets-Domain Protein, Sap1a
% 215.87/216.10  |- mesh__dateEstablished mesh__D050808 2006-01-01
% 215.87/216.10  |- skos__broader mesh__D050808smesh__D050801
% 215.87/216.10  |- skos__hiddenLabel mesh__D050808 Ets-Domain Protein, Sap-1b
% 215.87/216.10  |- mesh__dateCreated mesh__D050808 2005-06-30
% 215.87/216.10  |- skos__scopeNote mesh__D050808
% 215.87/216.10       A member of the ternary complex family of ets-related transcription factors that is regulated by MITOGEN-ACTIVATED PROTEIN KINASES such as EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; and P38 MITOGEN-ACTIVATED PROTEIN KINASES.%A%    
% 215.87/216.10  |- skos__annotation mesh__D050808 see SCR for organism-specific terms   
% 215.87/216.10  |- skos__historyNote mesh__D050808 Fungal Proteins %28%1992-1994%29%
% 215.87/216.10  |- rdf__type mesh__D050808sskos__Concept
% 215.87/216.10  |- skos__altLabel mesh__D050808 Sap1a Ets-Domain Protein
% 215.87/216.10  |- skos__hiddenLabel mesh__D050808 ets-Domain Protein, Elk-4
% 215.87/216.10  |- skos__hiddenLabel mesh__D050808 Ets-Domain Protein, Sap1b
% 215.87/216.10  |- skos__altLabel mesh__D050808 Elk-4 ets-Domain Protein
% 215.87/216.10  |- skos__historyNote mesh__D050808 DNA-Binding Proteins %28%1995-2005%29%
% 215.87/216.10  |- skos__hiddenLabel mesh__D050808 Sap 1a Ets Domain Protein
% 215.87/216.10  |- mesh__historyNote mesh__D050808 2006%28%1992%29%   
% 215.87/216.10  |- skos__altLabel mesh__D050808 Sap-1b Ets-Domain Protein
% 215.87/216.10  |- rdf__type mesh__D014685sskos__Concept
% 215.87/216.10  |- skos__hiddenLabel mesh__D014685 Tumor, Veterinary Venereal
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D014685 2005
% 215.87/216.10  |- skos__historyNote mesh__D014685 Neoplasms %28%1966-1978%29%
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D014685 2004
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D014685 2006
% 215.87/216.10  |- skos__altLabel mesh__D014685 Transmissible Venereal Tumors
% 215.87/216.10  |- skos__hiddenLabel mesh__D014685 Venereal Tumor, Transmissible
% 215.87/216.10  |- mesh__historyNote mesh__D014685 79   
% 215.87/216.10  |- skos__hiddenLabel mesh__D014685 Tumor, Transmissible Venereal
% 215.87/216.10  |- mesh__recordOriginator mesh__D014685 VDK
% 215.87/216.10  |- skos__altLabel mesh__D014685 Veterinary Venereal Tumors
% 215.87/216.10  |- skos__altLabel mesh__D014685 Venereal Tumors, Transmissible
% 215.87/216.10  |- skos__hiddenLabel mesh__D014685 Transmissible Venereal Tumor
% 215.87/216.10  |- skos__annotation mesh__D014685
% 215.87/216.10       do not coord with GENITALIA or specific genital term unless especially discussed; coord IM with precoord animal/dis term %28%IM%29% + animal %28%NIM%29%; /blood supply /chem /second /secret /ultrastruct permitted; don%27%t forget check tag ANIMALS%A%  
% 215.87/216.10  |- skos__historyNote mesh__D014685 Dog Diseases %28%1966-1978%29%
% 215.87/216.10  |- skos__prefLabel mesh__D014685 Venereal Tumors, Veterinary
% 215.87/216.10  |- skos__broader mesh__D014685smesh__D014565
% 215.87/216.10  |- skos__scopeNote mesh__D014685
% 215.87/216.10       Tumors most commonly seen on or near the genitalia. They are venereal, most likely transmitted through transplantation of cells by contact. Metastases have been reported. Spontaneous regression may occur.%A%    
% 215.87/216.10  |- skos__hiddenLabel mesh__D014685 Veterinary Venereal Tumor
% 215.87/216.10  |- mesh__publicMeSHNote mesh__D014685 79   
% 215.87/216.10  |- mesh__dateRevised mesh__D014685 2003-07-30
% 215.87/216.10  |- skos__altLabel mesh__D014685 Tumors, Transmissible Venereal
% 215.87/216.10  |- mesh__recordAuthorizer mesh__D014685 sjn
% 215.87/216.10  |- skos__broader mesh__D014685smesh__D000820
% 215.87/216.10  |- mesh__dateEstablished mesh__D014685 1979-01-01
% 215.87/216.10  |- mesh__dateCreated mesh__D014685 1978-05-19
% 215.87/216.10  |- skos__hiddenLabel mesh__D014685 Venereal Tumor, Veterinary
% 215.87/216.10  |- skos__altLabel mesh__D014685 Tumors, Veterinary Venereal
% 215.87/216.10  |- mesh__recordMaintainer mesh__D014685 sjn
% 215.87/216.10  |- skos__historyNote mesh__D014685 Venereal Diseases %28%1966-1978%29%
% 215.87/216.10  |- skos__altLabel mesh__D008648 Mesenchyme
% 215.87/216.10  |- skos__annotation mesh__D008648 A 11 qualif   
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D008648 2005
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D008648 1995
% 215.87/216.10  |- skos__hiddenLabel mesh__D008648 Mesenchymas
% 215.87/216.10  |- mesh__recordOriginator mesh__D008648 NLM
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D008648 2000
% 215.87/216.10  |- skos__prefLabel mesh__D008648 Mesoderm
% 215.87/216.10  |- skos__broader mesh__D008648smesh__D005855
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D008648 2006
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D008648 1993
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D008648 2003
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D008648 1998
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D008648 2001
% 215.87/216.10  |- mesh__recordMaintainer mesh__D008648 TGC
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D008648 2004
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D008648 1999
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D008648 1996
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D008648 2002
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D008648 1997
% 215.87/216.10  |- rdf__type mesh__D008648sskos__Concept
% 215.87/216.10  |- skos__scopeNote mesh__D008648 The middle germ layer of the embryo.     
% 215.87/216.10  |- mesh__recordAuthorizer mesh__D008648 PLS
% 215.87/216.10  |- mesh__dateRevised mesh__D008648 1992-05-22
% 215.87/216.10  |- mesh__dateCreated mesh__D008648 1999-01-01
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D008648 1994
% 215.87/216.10  |- skos__annotation mesh__D000665 buffers; D25-26 qualif   
% 215.87/216.10  |- rdf__type mesh__D000665sskos__Concept
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D000665 2005
% 215.87/216.10  |- skos__broader mesh__D000665smesh__D002021
% 215.87/216.10  |- mesh__dateCreated mesh__D000665 1979-02-27
% 215.87/216.10  |- mesh__historyNote mesh__D000665
% 215.87/216.10       91%28%80%29%; was see under BUFFERS 1980-90   
% 215.87/216.10  |- skos__hiddenLabel mesh__D000665 Ampholytes, Carrier
% 215.87/216.10  |- mesh__publicMeSHNote mesh__D000665 91; was see under BUFFERS 1980-90   
% 215.87/216.10  |- mesh__recordOriginator mesh__D000665 SH
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D000665 2006
% 215.87/216.10  |- mesh__dateRevised mesh__D000665 2003-07-09
% 215.87/216.10  |- skos__historyNote mesh__D000665 Isoelectric Focusing %28%1970-1979%29%
% 215.87/216.10  |- skos__hiddenLabel mesh__D000665 Focusing Agents, Isoelectric
% 215.87/216.10  |- skos__historyNote mesh__D000665 Buffers %28%1966-1979%29%
% 215.87/216.10  |- mesh__recordMaintainer mesh__D000665 ssb
% 215.87/216.10  |- mesh__dateEstablished mesh__D000665 1991-01-01
% 215.87/216.10  |- skos__altLabel mesh__D000665 Carrier Ampholytes
% 215.87/216.10  |- skos__altLabel mesh__D000665 Ampholines
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D000665 2004
% 215.87/216.10  |- mesh__recordAuthorizer mesh__D000665 sjn
% 215.87/216.10  |- skos__prefLabel mesh__D000665 Ampholyte Mixtures
% 215.87/216.10  |- skos__hiddenLabel mesh__D000665 Agents, Isoelectric Focusing
% 215.87/216.10  |- skos__altLabel mesh__D000665 Isoelectric Focusing Agents
% 215.87/216.10  |- skos__scopeNote mesh__D000665
% 215.87/216.10       Such mixtures of amphoteric electrolytes or buffers that provide a continuous range of pH in an electric field; used for separating proteins by their isoelectric points, i.e., by isoelectric focusing.%A%    
% 215.87/216.10  |- skos__hiddenLabel mesh__D000665 Mixtures, Ampholyte
% 215.87/216.10  |- mesh__recordMaintainer mesh__D019370 hjn
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D019370 2003
% 215.87/216.10  |- skos__annotation mesh__D019370
% 215.87/216.10       observation only as a scientific method, as %22%Langerhans, a genius at observation%22%, %22%the father of clinical observation%22%; not for %22%electron microscopy observations on pleistocene tissues%22% or %22%hist observations on dental care%22% or %22%observations on difficult children%22% or %22%diagnostic observations on hypertension%22%%A%  
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D019370 2005
% 215.87/216.10  |- mesh__dateCreated mesh__D019370 1996-06-10
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D019370 2004
% 215.87/216.10  |- mesh__publicMeSHNote mesh__D019370 97   
% 215.87/216.10  |- skos__prefLabel mesh__D019370 Observation
% 215.87/216.10  |- rdf__type mesh__D019370sskos__Concept
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D019370 2006
% 215.87/216.10  |- skos__broader mesh__D019370smesh__D036262
% 215.87/216.10  |- mesh__dateRevised mesh__D019370 2002-07-03
% 215.87/216.10  |- mesh__recordAuthorizer mesh__D019370 sjn
% 215.87/216.10  |- mesh__dateEstablished mesh__D019370 1997-01-01
% 215.87/216.10  |- skos__scopeNote mesh__D019370
% 215.87/216.10       The act of regarding attentively and studying facts and occurrences, gathering data through analyzing, measuring, and drawing conclusions, with the purpose of applying the observed information to theoretical assumptions. Observation as a scientific method in the acquisition of knowledge began in classical antiquity; in modern science and medicine its greatest application is facilitated by modern technology. Observation is one of the components of the research process.%A%    
% 215.87/216.10  |- mesh__historyNote mesh__D019370 97   
% 215.87/216.10  |- mesh__recordOriginator mesh__D019370 TGC
% 215.87/216.10  |- mesh__dateCreated mesh__D033041 2002-07-03
% 215.87/216.10  |- skos__broader mesh__D033041smesh__D035843
% 215.87/216.10  |- mesh__historyNote mesh__D033041 2003; use RESEARCH 1996-2002   
% 215.87/216.10  |- mesh__dateRevised mesh__D033041 2004-07-13
% 215.87/216.10  |- skos__broader mesh__D033041smesh__D008919
% 215.87/216.10  |- mesh__recordMaintainer mesh__D033041 sjn
% 215.87/216.10  |- skos__historyNote mesh__D033041 Research %28%1985-2002%29%
% 215.87/216.10  |- mesh__dateEstablished mesh__D033041 2003-01-01
% 215.87/216.10  |- skos__hiddenLabel mesh__D033041 Experimentations, Embryo
% 215.87/216.10  |- skos__related mesh__D033041smesh__D033042
% 215.87/216.10  |- skos__related mesh__D033041smesh__D006805
% 215.87/216.10  |- skos__hiddenLabel mesh__D033041 Embryo Experimentations
% 215.87/216.10  |- skos__hiddenLabel mesh__D033041 Embryo Research, Human
% 215.87/216.10  |- mesh__recordOriginator mesh__D033041 jrf
% 215.87/216.10  |- skos__altLabel mesh__D033041 Human Embryo Research
% 215.87/216.10  |- mesh__publicMeSHNote mesh__D033041 2003; see RESEARCH 1996-2002   
% 215.87/216.10  |- skos__altLabel mesh__D033041 Embryo Experimentation
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D033041 2005
% 215.87/216.10  |- skos__annotation mesh__D033041
% 215.87/216.10       mammalian only; IM for ethical, legal, moral, social, or religious aspects of research on embryos; do not routinely add for research involving embryos; X ref  Embryo Cell Research: coord with specific type of cell%A%  
% 215.87/216.10  |- skos__historyNote mesh__D033041 Embryo %28%1985-2002%29%
% 215.87/216.10  |- rdf__type mesh__D033041sskos__Concept
% 215.87/216.10  |- mesh__recordAuthorizer mesh__D033041 sjn
% 215.87/216.10  |- skos__prefLabel mesh__D033041 Embryo Research
% 215.87/216.10  |- skos__hiddenLabel mesh__D033041 Research, Embryo
% 215.87/216.10  |- skos__scopeNote mesh__D033041
% 215.87/216.10       Experimentation on, or using the organs or tissues from, a human or other mammalian conceptus during the prenatal stage of development that is characterized by rapid morphological changes and the differentiation of basic structures. In humans, this includes the period from the time of fertilization to the end of the eighth week after fertilization.%A%    
% 215.87/216.10  |- skos__hiddenLabel mesh__D033041 Research, Human Embryo
% 215.87/216.10  |- skos__hiddenLabel mesh__D033041 Research, Embryo Cell
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D033041 2006
% 215.87/216.10  |- skos__hiddenLabel mesh__D033041 Experimentation, Embryo
% 215.87/216.10  |- skos__hiddenLabel mesh__D033041 Cell Research, Embryo
% 215.87/216.10  |- skos__related mesh__D033041smesh__D032984
% 215.87/216.10  |- skos__related mesh__D033041smesh__D004622
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D027802 2006
% 215.87/216.10  |- mesh__dateCreated mesh__D027802 2001-07-25
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D027802 2002
% 215.87/216.10  |- rdf__type mesh__D027802sskos__Concept
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D027802 2005
% 215.87/216.10  |- mesh__historyNote mesh__D027802 2002   
% 215.87/216.10  |- skos__scopeNote mesh__D027802
% 215.87/216.10       Hypoxis is a plant genus in the family LILIACEAE %28%sometimes classified as Hypoxidaceae%29%.%A%    
% 215.87/216.10  |- skos__prefLabel mesh__D027802 Hypoxis
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D027802 2004
% 215.87/216.10  |- skos__annotation mesh__D027802
% 215.87/216.10       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.87/216.10  |- skos__historyNote mesh__D027802 Plants, Medicinal %28%1978-2001%29%
% 215.87/216.10  |- mesh__activeMeSHYear mesh__D027802 2003
% 215.96/216.10  |- skos__broader mesh__D027802smesh__D019668
% 215.96/216.10  |- mesh__publicMeSHNote mesh__D027802 2002   
% 215.96/216.10  |- mesh__dateEstablished mesh__D027802 2002-01-01
% 215.96/216.10  |- mesh__activeMeSHYear mesh__D005350 2003
% 215.96/216.10  |- skos__scopeNote mesh__D005350
% 215.96/216.10       A benign tumor of fibrous or fully developed connective tissue.%A%    
% 215.96/216.10  |- skos__hiddenLabel mesh__D005350 Fibromas
% 215.96/216.10  |- mesh__activeMeSHYear mesh__D005350 2004
% 215.96/216.10  |- mesh__recordOriginator mesh__D005350 NLM
% 215.96/216.10  |- mesh__dateCreated mesh__D005350 1999-01-01
% 215.96/216.10  |- skos__broader mesh__D005350smesh__D018218
% 215.96/216.10  |- mesh__recordMaintainer mesh__D005350 mdb
% 215.96/216.10  |- skos__altLabel mesh__D005350 Fibromyxoma
% 215.96/216.10  |- skos__prefLabel mesh__D005350 Fibroma
% 215.96/216.10  |- skos__hiddenLabel mesh__D005350 Myxofibromas
% 215.96/216.10  |- rdf__type mesh__D005350sskos__Concept
% 215.96/216.10  |- skos__annotation mesh__D005350
% 215.96/216.10       not for uterine fibroma %28% = LEIOMYOMA + UTERINE NEOPLASMS%29%; note X ref FIBROMATOSIS but FIBROMATOSIS, ABDOMINAL; FIBROMATOSIS, AGGRESSIVE %26% FIBROMATOSIS, GINGIVAL are available; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 215.96/216.10  |- skos__hiddenLabel mesh__D005350 Fibromatoses
% 215.96/216.10  |- mesh__recordAuthorizer mesh__D005350 sjn
% 215.96/216.10  |- mesh__dateRevised mesh__D005350 2001-07-25
% 215.96/216.10  |- mesh__activeMeSHYear mesh__D005350 2005
% 215.96/216.10  |- mesh__activeMeSHYear mesh__D005350 2002
% 215.96/216.10  |- skos__hiddenLabel mesh__D005350 Fibromyxomas
% 215.96/216.10  |- mesh__activeMeSHYear mesh__D005350 2006
% 215.96/216.10  |- skos__related mesh__D005350smesh__D014402
% 215.96/216.10  |- mesh__activeMeSHYear mesh__D018278 2001
% 215.96/216.10  |- mesh__recordAuthorizer mesh__D018278 PLS
% 215.96/216.10  |- skos__scopeNote mesh__D018278
% 215.96/216.10       A group of carcinomas which share a characteristic morphology, often being composed of clusters and trabecular sheets of round %22%blue cells%22%, granular chromatin, and an attenuated rim of poorly demarcated cytoplasm. Neuroendocrine tumors include carcinoids, small %28%%22%oat%22%%29% cell carcinomas, medullary carcinoma of the thyroid, Merkel cell tumor, cutaneous neuroendocrine carcinoma, pancreatic islet cell tumors, and pheochromocytoma. Neurosecretory granules are found within the tumor cells. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 215.96/216.10  |- skos__hiddenLabel mesh__D018278 Carcinomas, Neuroendocrine
% 215.96/216.10  |- mesh__publicMeSHNote mesh__D018278 94   
% 215.96/216.10  |- rdf__type mesh__D018278sskos__Concept
% 215.96/216.10  |- mesh__activeMeSHYear mesh__D018278 2002
% 215.96/216.10  |- mesh__activeMeSHYear mesh__D018278 1996
% 215.96/216.10  |- mesh__recordMaintainer mesh__D018278 KEV
% 215.96/216.10  |- skos__broader mesh__D018278smesh__D000230
% 215.96/216.10  |- mesh__activeMeSHYear mesh__D018278 2003
% 215.96/216.10  |- skos__hiddenLabel mesh__D018278 Neuroendocrine Carcinomas
% 215.96/216.10  |- skos__broader mesh__D018278smesh__D018358
% 215.96/216.10  |- skos__annotation mesh__D018278
% 215.96/216.10       blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 215.96/216.10  |- mesh__activeMeSHYear mesh__D018278 1997
% 215.96/216.10  |- mesh__dateRevised mesh__D018278 1995-06-08
% 215.96/216.10  |- mesh__activeMeSHYear mesh__D018278 2004
% 215.96/216.10  |- mesh__recordOriginator mesh__D018278 PLS
% 215.96/216.10  |- mesh__activeMeSHYear mesh__D018278 1998
% 215.96/216.10  |- skos__hiddenLabel mesh__D018278 Neuroendocrine Carcinoma
% 215.96/216.10  |- mesh__dateEstablished mesh__D018278 1994-01-01
% 215.96/216.10  |- mesh__activeMeSHYear mesh__D018278 2005
% 215.96/216.10  |- mesh__activeMeSHYear mesh__D018278 1999
% 215.96/216.10  |- mesh__historyNote mesh__D018278 94   
% 215.96/216.10  |- mesh__activeMeSHYear mesh__D018278 2006
% 215.96/216.10  |- mesh__dateCreated mesh__D018278 1993-06-25
% 215.96/216.10  |- mesh__activeMeSHYear mesh__D018278 2000
% 215.96/216.10  |- skos__prefLabel mesh__D018278 Carcinoma, Neuroendocrine
% 215.96/216.10  |- skos__hiddenLabel mesh__D010295 Oxyntic Cell
% 215.96/216.10  |- skos__scopeNote mesh__D010295
% 215.96/216.10       Rounded or pyramidal cells of the GASTRIC GLANDS. They secrete HYDROCHLORIC ACID and produce gastric intrinsic factor, a glycoprotein that binds VITAMIN B12.%A%    
% 215.96/216.10  |- skos__hiddenLabel mesh__D010295 Gastric Parietal Cell
% 215.96/216.10  |- mesh__dateCreated mesh__D010295 1983-05-31
% 215.96/216.10  |- skos__broader mesh__D010295smesh__D004847
% 215.96/216.10  |- mesh__recordMaintainer mesh__D010295 lkt
% 215.96/216.10  |- rdf__type mesh__D010295sskos__Concept
% 215.96/216.10  |- skos__related mesh__D010295smesh__D005744
% 215.96/216.10  |- skos__hiddenLabel mesh__D010295 Cell, Oxyntic
% 215.96/216.10  |- mesh__recordAuthorizer mesh__D010295 sjn
% 215.96/216.10  |- skos__altLabel mesh__D010295 Oxyntic Cells
% 215.96/216.10  |- skos__historyNote mesh__D010295 Stomach %28%1966-1983%29%
% 215.96/216.10  |- skos__broader mesh__D010295smesh__D005753
% 215.96/216.10  |- skos__historyNote mesh__D010295 Gastric Acid %28%1981-1983%29%
% 215.96/216.10  |- skos__prefLabel mesh__D010295 Parietal Cells, Gastric
% 215.96/216.10  |- mesh__dateEstablished mesh__D010295 1984-01-01
% 215.96/216.11  |- mesh__historyNote mesh__D010295 84   
% 215.96/216.11  |- mesh__publicMeSHNote mesh__D010295 84   
% 215.96/216.11  |- skos__historyNote mesh__D010295 Gastric Mucosa %28%1966-1983%29%
% 215.96/216.11  |- skos__hiddenLabel mesh__D010295 Cells, Gastric Parietal
% 215.96/216.11  |- skos__historyNote mesh__D010295 Gastric Juice %28%1966-1983%29%
% 215.96/216.11  |- skos__hiddenLabel mesh__D010295 Cell, Gastric Parietal
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D010295 2006
% 215.96/216.11  |- skos__altLabel mesh__D010295 Gastric Parietal Cells
% 215.96/216.11  |- mesh__recordOriginator mesh__D010295 AEP
% 215.96/216.11  |- mesh__dateRevised mesh__D010295 2005-06-30
% 215.96/216.11  |- skos__hiddenLabel mesh__D010295 Cells, Oxyntic
% 215.96/216.11  |- skos__related mesh__D010295smesh__D007437
% 215.96/216.11  |- skos__hiddenLabel mesh__D010295 Parietal Cell, Gastric
% 215.96/216.11  |- mesh__publicMeSHNote mesh__D051901
% 215.96/216.11       2006; SMAD4 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1997-2005, %26% under PROTEINS 1996%A%  
% 215.96/216.11  |- skos__hiddenLabel mesh__D051901 Smad, Common
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D051901 2006
% 215.96/216.11  |- mesh__recordOriginator mesh__D051901 DRC
% 215.96/216.11  |- skos__broader mesh__D051901smesh__D051785
% 215.96/216.11  |- mesh__recordMaintainer mesh__D051901 ags
% 215.96/216.11  |- mesh__dateEstablished mesh__D051901 2006-01-01
% 215.96/216.11  |- rdf__type mesh__D051901sskos__Concept
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D051901 2006A
% 215.96/216.11  |- mesh__dateCreated mesh__D051901 2005-06-30
% 215.96/216.11  |- skos__altLabel mesh__D051901 Common Smad
% 215.96/216.11  |- skos__scopeNote mesh__D051901
% 215.96/216.11       A signal transducing adaptor protein and tumor suppressor protein. It forms a complex with activated RECEPTOR-REGULATED SMAD PROTEINS. The complex then translocates to the CELL NUCLEUS and regulates GENETIC TRANSCRIPTION of target GENES.%A%    
% 215.96/216.11  |- mesh__dateRevised mesh__D051901 2005-07-21
% 215.96/216.11  |- skos__broader mesh__D051901smesh__D025521
% 215.96/216.11  |- mesh__historyNote mesh__D051901 2006%28%1996%29%   
% 215.96/216.11  |- skos__altLabel mesh__D051901 MADH4 Protein
% 215.96/216.11  |- skos__prefLabel mesh__D051901 Smad4 Protein
% 215.96/216.11  |- mesh__recordAuthorizer mesh__D051901 ags
% 215.96/216.11  |- skos__hiddenLabel mesh__D051103
% 215.96/216.11       3-Phosphate Acyltransferase, 1-Palmitylglycerol
% 215.96/216.11  |- skos__hiddenLabel mesh__D051103
% 215.96/216.11       Coenzyme A-Monacylglycerophosphateacyltransferase, Acyl
% 215.96/216.11  |- skos__hiddenLabel mesh__D051103
% 215.96/216.11       Acyl Coenzyme A Monacylglycerophosphateacyltransferase
% 215.96/216.11  |- skos__hiddenLabel mesh__D051103 1 AGP Acyltransferase
% 215.96/216.11  |- skos__altLabel mesh__D051103 1-Acylglycerophosphate Acyltransferase
% 215.96/216.11  |- mesh__dateEstablished mesh__D051103 2006-01-01
% 215.96/216.11  |- mesh__recordAuthorizer mesh__D051103 sjn
% 215.96/216.11  |- skos__hiddenLabel mesh__D051103
% 215.96/216.11       1 Palmitylglycerol 3 Phosphate Acyltransferase
% 215.96/216.11  |- skos__hiddenLabel mesh__D051103
% 215.96/216.11       Acyl CoA Monoacylglycerophosphateacyltransferase
% 215.96/216.11  |- skos__prefLabel mesh__D051103
% 215.96/216.11       1-Acylglycerol-3-Phosphate O-Acyltransferase
% 215.96/216.11  |- skos__hiddenLabel mesh__D051103
% 215.96/216.11       CoA-1-Acyl-Syn-Glycerol-3-Phosphate O-Acyltransferase, Acyl
% 215.96/216.11  |- mesh__historyNote mesh__D051103
% 215.96/216.11       2006%28%1980%29%; use ACYLTRANSFERASES 1973-1979, use COENZYME A %26% PHOSPHOLIPIDS 1973-1978%A%  
% 215.96/216.11  |- skos__hiddenLabel mesh__D051103
% 215.96/216.11       CoA-Monoacylglycerophosphateacyltransferase, Acyl
% 215.96/216.11  |- skos__altLabel mesh__D051103
% 215.96/216.11       Acyl CoA-Monoacylglycerophosphateacyltransferase
% 215.96/216.11  |- skos__scopeNote mesh__D051103
% 215.96/216.11       An enzyme that catalyzes the acyl group transfer of ACYL COA to 1-acyl-sn-glycerol 3-phosphate to generate 1,2-diacyl-sn-glycerol 3-phosphate. This enzyme has alpha, beta, gamma, delta and epsilon subunits.%A%    
% 215.96/216.11  |- skos__altLabel mesh__D051103 1-AGP-Acyltransferase
% 215.96/216.11  |- skos__hiddenLabel mesh__D051103
% 215.96/216.11       1 Acylglycerol 3 Phosphate O Acyltransferase
% 215.96/216.11  |- skos__hiddenLabel mesh__D051103 Acyltransferase, 1-Acylglycerophosphate
% 215.96/216.11  |- skos__hiddenLabel mesh__D051103
% 215.96/216.11       O-Acyltransferase, Acyl CoA-1-Acyl-Syn-Glycerol-3-Phosphate
% 215.96/216.11  |- skos__altLabel mesh__D051103
% 215.96/216.11       Acyl CoA-1-Acyl-Syn-Glycerol-3-Phosphate O-Acyltransferase
% 215.96/216.11  |- skos__hiddenLabel mesh__D051103 1 Acylglycerophosphate Acyltransferase
% 215.96/216.11  |- mesh__recordOriginator mesh__D051103 AKE
% 215.96/216.11  |- skos__hiddenLabel mesh__D051103
% 215.96/216.11       Acyl CoA 1 Acyl Syn Glycerol 3 Phosphate O Acyltransferase
% 215.96/216.11  |- mesh__recordMaintainer mesh__D051103 AKE
% 215.96/216.11  |- skos__hiddenLabel mesh__D051103
% 215.96/216.11       O-Acyltransferase, 1-Acylglycerol-3-Phosphate
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D051103 2006
% 215.96/216.11  |- skos__hiddenLabel mesh__D051103
% 215.96/216.11       1 Acylglycerol Phosphate Acyltransferase 2
% 215.96/216.11  |- mesh__dateCreated mesh__D051103 2005-06-30
% 215.96/216.11  |- skos__broader mesh__D051103smesh__D000217
% 215.96/216.11  |- skos__hiddenLabel mesh__D051103
% 215.96/216.11       Acyltransferase, 1-Palmitylglycerol 3-Phosphate
% 215.96/216.11  |- skos__altLabel mesh__D051103
% 215.96/216.11       Acyl Coenzyme A-Monacylglycerophosphateacyltransferase
% 215.96/216.11  |- mesh__publicMeSHNote mesh__D051103
% 215.96/216.11       2006; 1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE was indexed under ACYLTRANSFERASES 1973-2005, %26% under COENZYME A %26% PHOSPHOLIPIDS 1973-1978%A%  
% 215.96/216.11  |- skos__hiddenLabel mesh__D051103
% 215.96/216.11       A-Monacylglycerophosphateacyltransferase, Acyl Coenzyme
% 215.96/216.11  |- rdf__type mesh__D051103sskos__Concept
% 215.96/216.11  |- mesh__recordAuthorizer mesh__D004258 sjn
% 215.96/216.11  |- skos__hiddenLabel mesh__D004258 Polymerase delta, DNA
% 215.96/216.11  |- skos__altLabel mesh__D004258 Pol III
% 215.96/216.11  |- skos__altLabel mesh__D004258 DNA Polymerase delta
% 215.96/216.11  |- mesh__publicMeSHNote mesh__D004258
% 215.96/216.11       91; see DNA POLYMERASES 1977-90, DNA POLYMERASE DELTA was indexed under DNA POLYMERASES 1980-97%A%  
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D004258 2004
% 215.96/216.11  |- skos__hiddenLabel mesh__D004258 DNA Dependent DNA Polymerase III
% 215.96/216.11  |- skos__prefLabel mesh__D004258 DNA Polymerase III
% 215.96/216.11  |- mesh__dateRevised mesh__D004258 2003-07-09
% 215.96/216.11  |- skos__broader mesh__D004258smesh__D004259
% 215.96/216.11  |- mesh__recordOriginator mesh__D004258 RLS
% 215.96/216.11  |- skos__historyNote mesh__D004258
% 215.96/216.11       DNA Nucleotidyltransferases %28%1968-1976%29%
% 215.96/216.11  |- skos__hiddenLabel mesh__D004258 Polymerase III, DNA
% 215.96/216.11  |- mesh__historyNote mesh__D004258
% 215.96/216.11       91%28%77%29%; for DNA POLYMERASE DELTA use DNA POLYMERASE III %28%NM%29% 1980-97%A%  
% 215.96/216.11  |- mesh__dateEstablished mesh__D004258 1991-01-01
% 215.96/216.11  |- mesh__recordMaintainer mesh__D004258 ssb
% 215.96/216.11  |- rdf__type mesh__D004258sskos__Concept
% 215.96/216.11  |- skos__scopeNote mesh__D004258
% 215.96/216.11       A DNA-dependent DNA polymerase characterized in E. coli and other lower organisms but may be present in higher organisms. Use also for a more complex form of DNA polymerase III designated as DNA polymerase III* or pol III* which is 15 times more active biologically than DNA polymerase I in the synthesis of DNA. This polymerase has both 3%27%-5%27% and 5%27%-3%27% exonuclease activities, is inhibited by sulfhydryl reagents, and has the same template-primer dependence as pol II. EC 2.7.7.7.%A%    
% 215.96/216.11  |- skos__altLabel mesh__D004258 DNA-Dependent DNA Polymerase III
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D004258 2005
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D004258 2006
% 215.96/216.11  |- mesh__dateCreated mesh__D004258 1976-04-21
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D009741 2004
% 215.96/216.11  |- skos__scopeNote mesh__D009741
% 215.96/216.11       Personnel who provide nursing service to patients in a hospital.%A%    
% 215.96/216.11  |- skos__broader mesh__D009741smesh__D009740
% 215.96/216.11  |- mesh__recordAuthorizer mesh__D009741 PLS
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D009741 1996
% 215.96/216.11  |- skos__broader mesh__D009741smesh__D010564
% 215.96/216.11  |- skos__altLabel mesh__D009741 Staffs, Hospital Nursing
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D009741 2002
% 215.96/216.11  |- mesh__historyNote mesh__D009741
% 215.96/216.11       78; was HOSPITAL NURSING STAFF 1968-77   
% 215.96/216.11  |- mesh__dateCreated mesh__D009741 1999-01-01
% 215.96/216.11  |- mesh__publicMeSHNote mesh__D009741
% 215.96/216.11       78; was HOSPITAL NURSING STAFF 1968-77   
% 215.96/216.11  |- skos__altLabel mesh__D009741 Staff, Hospital Nursing
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D009741 1997
% 215.96/216.11  |- skos__annotation mesh__D009741
% 215.96/216.11       hosp only: non-hosp nurs staff = NURSING STAFF; DF: NURS STAFF HOSP%A%  
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D009741 1994
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D009741 2000
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D009741 2005
% 215.96/216.11  |- skos__historyNote mesh__D009741
% 215.96/216.11       Nursing Service, Hospital %28%1966-1967%29%
% 215.96/216.11  |- skos__altLabel mesh__D009741 Nursing Staffs, Hospital
% 215.96/216.11  |- skos__altLabel mesh__D009741 Hospital Nursing Staff
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D009741 1995
% 215.96/216.11  |- mesh__recordMaintainer mesh__D009741 TAP
% 215.96/216.11  |- mesh__dateRevised mesh__D009741 1992-05-15
% 215.96/216.11  |- mesh__dateEstablished mesh__D009741 1968-01-01
% 215.96/216.11  |- skos__prefLabel mesh__D009741 Nursing Staff, Hospital
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D009741 2006
% 215.96/216.11  |- mesh__onlineNote mesh__D009741
% 215.96/216.11       use NURSING STAFF, HOSPITAL to search HOSPITAL NURSING STAFF 1968-77%A%  
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D009741 2001
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D009741 1998
% 215.96/216.11  |- skos__altLabel mesh__D009741 Hospital Nursing Staffs
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D009741 2003
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D009741 1999
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D009741 1993
% 215.96/216.11  |- mesh__recordOriginator mesh__D009741 NLM
% 215.96/216.11  |- rdf__type mesh__D009741sskos__Concept
% 215.96/216.11  |- skos__prefLabel mesh__D050809 POU Domain Factors
% 215.96/216.11  |- mesh__publicMeSHNote mesh__D050809
% 215.96/216.11       2006; TRANSCRIPTION FACTOR POU was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1992-2004%A%  
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D050809 2006
% 215.96/216.11  |- mesh__historyNote mesh__D050809 2006%28%1992%29%   
% 215.96/216.11  |- mesh__recordAuthorizer mesh__D050809 sjn
% 215.96/216.11  |- skos__scopeNote mesh__D050809
% 215.96/216.11       A family of transcription factors characterized by the presence of a bipartite DNA-binding domain known as the POU domain. The POU domain contains two subdomains, a POU-specific domain and a POU-homeodomain. The POU domain was originally identified as a region of approximately 150 amino acids shared between the Pit-1, Oct-1, Oct-2, and Unc-86 transcription factors.%A%    
% 215.96/216.11  |- skos__altLabel mesh__D050809 Pit-Oct-Unc Proteins
% 215.96/216.11  |- skos__broader mesh__D050809smesh__D014157
% 215.96/216.11  |- skos__hiddenLabel mesh__D050809 Pit Oct Unc Proteins
% 215.96/216.11  |- rdf__type mesh__D050809sskos__Concept
% 215.96/216.11  |- skos__broader mesh__D050809smesh__D004268
% 215.96/216.11  |- mesh__recordMaintainer mesh__D050809 DRC
% 215.96/216.11  |- skos__altLabel mesh__D050809 Transcription Factor POU
% 215.96/216.11  |- mesh__recordOriginator mesh__D050809 DRC
% 215.96/216.11  |- mesh__dateEstablished mesh__D050809 2006-01-01
% 215.96/216.11  |- skos__altLabel mesh__D050809 POU Proteins
% 215.96/216.11  |- mesh__dateCreated mesh__D050809 2005-06-30
% 215.96/216.11  |- skos__hiddenLabel mesh__D050809 POU, Transcription Factor
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D014686 1999
% 215.96/216.11  |- skos__annotation mesh__D014686 SPEC: SPEC qualif; DF: VENEREOL   
% 215.96/216.11  |- skos__related mesh__D014686smesh__D012749
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D014686 2001
% 215.96/216.11  |- mesh__dateCreated mesh__D014686 1982-04-30
% 215.96/216.11  |- mesh__recordMaintainer mesh__D014686 PXP
% 215.96/216.11  |- mesh__historyNote mesh__D014686 83   
% 215.96/216.11  |- mesh__dateEstablished mesh__D014686 1983-01-01
% 215.96/216.11  |- mesh__publicMeSHNote mesh__D014686 83   
% 215.96/216.11  |- mesh__dateRevised mesh__D014686 1997-06-20
% 215.96/216.11  |- skos__broader mesh__D014686smesh__D013040
% 215.96/216.11  |- skos__scopeNote mesh__D014686
% 215.96/216.11       A branch of medicine which deals with sexually transmitted disease.%A%    
% 215.96/216.11  |- mesh__recordOriginator mesh__D014686 EC
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D014686 2002
% 215.96/216.11  |- mesh__recordAuthorizer mesh__D014686 SJN
% 215.96/216.11  |- skos__historyNote mesh__D014686 Venereal Diseases %28%1966-1982%29%
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D014686 2003
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D014686 2005
% 215.96/216.11  |- rdf__type mesh__D014686sskos__Concept
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D014686 1998
% 215.96/216.11  |- skos__prefLabel mesh__D014686 Venereology
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D014686 2004
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D014686 2006
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D014686 2000
% 215.96/216.11  |- skos__scopeNote mesh__D008649
% 215.96/216.11       A rare tumor of the female genital tract, most often the ovary, formerly considered to be derived from mesonephric rests. Two varieties are recognized: %28%1%29% clear cell carcinoma, so called because of its histologic resemblance to renal cell carcinoma, and now considered to be of muellerian duct derivation and %28%2%29% an embryonal tumor %28%called also ENDODERMAL SINUS TUMOR and yolk sac tumor%29%, occurring chiefly in children. The latter variety may also arise in the testis. %28%Dorland, 27th ed%29%%A%    
% 215.96/216.11  |- mesh__recordAuthorizer mesh__D008649 PLS
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D008649 2006
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D008649 2003
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D008649 1998
% 215.96/216.11  |- skos__annotation mesh__D008649
% 215.96/216.11       benign or malignant; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 215.96/216.11  |- skos__prefLabel mesh__D008649 Mesonephroma
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D008649 2004
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D008649 1999
% 215.96/216.11  |- mesh__dateRevised mesh__D008649 1995-06-08
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D008649 1996
% 215.96/216.11  |- mesh__recordOriginator mesh__D008649 NLM
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D008649 2000
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D008649 1997
% 215.96/216.11  |- skos__hiddenLabel mesh__D008649 Mesonephromas
% 215.96/216.11  |- rdf__type mesh__D008649sskos__Concept
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D008649 2001
% 215.96/216.11  |- skos__broader mesh__D008649smesh__D009373
% 215.96/216.11  |- mesh__dateCreated mesh__D008649 1999-01-01
% 215.96/216.11  |- mesh__recordMaintainer mesh__D008649 KEV
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D008649 2002
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D008649 2005
% 215.96/216.11  |- mesh__historyNote mesh__D000666
% 215.96/216.11       98; for AMPHOCIL use AMPHOTERICIN B %28%NM%29% 1992-97   
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D000666 2006
% 215.96/216.11  |- mesh__dateCreated mesh__D000666 1999-01-01
% 215.96/216.11  |- skos__scopeNote mesh__D000666
% 215.96/216.11       Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela.%A%    
% 215.96/216.11  |- skos__broader mesh__D000666smesh__D018942
% 215.96/216.11  |- mesh__publicMeSHNote mesh__D000666
% 215.96/216.11       98; AMPHOCIL %28%now AMPHOTERICIN B%29% was indexed under AMPHOTERICIN B/*analogs %26% derivatives %26% CHOLESTEROL ESTERS 1992-97%A%  
% 215.96/216.11  |- mesh__recordMaintainer mesh__D000666 ssb
% 215.96/216.11  |- mesh__dateRevised mesh__D000666 2004-07-07
% 215.96/216.11  |- rdf__type mesh__D000666sskos__Concept
% 215.96/216.11  |- mesh__recordOriginator mesh__D000666 NLM
% 215.96/216.11  |- mesh__recordAuthorizer mesh__D000666 sjn
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D000666 2005
% 215.96/216.11  |- skos__prefLabel mesh__D000666 Amphotericin B
% 215.96/216.11  |- skos__annotation mesh__D019371
% 215.96/216.11       an aspect of med geog: do not use for anatomical topogr %28% = organ /anat%29%; coord IM with specific dis /epidemiol %28%IM%29% or med or physiol aspect %28%IM%29% + specific geog locale; no qualif unless as SPEC; DF: TOPOGR MED%A%  
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D019371 2005
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D019371 1998
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D019371 2004
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D019371 1997
% 215.96/216.11  |- mesh__dateEstablished mesh__D019371 1997-01-01
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D019371 2000
% 215.96/216.11  |- mesh__dateCreated mesh__D019371 1996-06-13
% 215.96/216.11  |- rdf__type mesh__D019371sskos__Concept
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D019371 2006
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D019371 1999
% 215.96/216.11  |- skos__prefLabel mesh__D019371 Topography, Medical
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D019371 2001
% 215.96/216.11  |- mesh__publicMeSHNote mesh__D019371 97   
% 215.96/216.11  |- mesh__historyNote mesh__D019371 97   
% 215.96/216.11  |- skos__broader mesh__D019371smesh__D005843
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D019371 2002
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D019371 2003
% 215.96/216.11  |- skos__scopeNote mesh__D019371
% 215.96/216.11       The systematic surveying, mapping, charting, and description of specific geographical sites, with reference to the physical features that were presumed to influence health and disease. Often associated with Hippocrates, the process became a significant part of public health investigation and epidemiological methodology, particularly between the 17th and 19th centuries. Medical topography should be differentiated from EPIDEMIOLOGY in that the former emphasizes geography whereas the latter emphasizes disease outbreaks. %28%Dr. James H. Cassedy, NLM History of Medicine Division%29%%A%    
% 215.96/216.11  |- skos__altLabel mesh__D019371 Medical Topography
% 215.96/216.11  |- skos__hiddenLabel mesh__D033042 Research, Fetal
% 215.96/216.11  |- skos__related mesh__D033042smesh__D005333
% 215.96/216.11  |- skos__scopeNote mesh__D033042
% 215.96/216.11       Experimentation on, or using the organs or tissues from, a human or other mammalian conceptus in the postembryonic period, after the major structures have been outlined. In humans, this corresponds to the period from the third month after fertilization until birth.%A%    
% 215.96/216.11  |- skos__related mesh__D033042smesh__D032984
% 215.96/216.11  |- skos__broader mesh__D033042smesh__D035843
% 215.96/216.11  |- mesh__dateCreated mesh__D033042 2002-07-03
% 215.96/216.11  |- skos__related mesh__D033042smesh__D033041
% 215.96/216.11  |- skos__hiddenLabel mesh__D033042 Cell Research, Fetal
% 215.96/216.11  |- skos__broader mesh__D033042smesh__D008919
% 215.96/216.11  |- mesh__dateRevised mesh__D033042 2004-07-13
% 215.96/216.11  |- skos__annotation mesh__D033042
% 215.96/216.11       mammalian only; IM for ethical, legal, moral, social, or religious aspects of research on fetuses; do not routinely add for research involving fetuses; X ref  Fetal Cell Research: coord with specific type of cell%A%  
% 215.96/216.11  |- mesh__recordMaintainer mesh__D033042 sjn
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D033042 2005
% 215.96/216.11  |- rdf__type mesh__D033042sskos__Concept
% 215.96/216.11  |- skos__related mesh__D033042smesh__D016332
% 215.96/216.11  |- mesh__dateEstablished mesh__D033042 2003-01-01
% 215.96/216.11  |- skos__related mesh__D033042smesh__D006805
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D033042 2006
% 215.96/216.11  |- mesh__recordOriginator mesh__D033042 jrf
% 215.96/216.11  |- skos__prefLabel mesh__D033042 Fetal Research
% 215.96/216.11  |- skos__hiddenLabel mesh__D033042 Research, Fetal Cell
% 215.96/216.11  |- mesh__historyNote mesh__D033042
% 215.96/216.11       2003; use RESEARCH 1996-2002; for FETAL TISSUE RESEARCH use RESEARCH 1995-2002%A%  
% 215.96/216.11  |- skos__hiddenLabel mesh__D033042 Experimentation, Fetal
% 215.96/216.11  |- mesh__publicMeSHNote mesh__D033042
% 215.96/216.11       2003; see RESEARCH 1996-2002; for FETAL TISSUE RESEARCH see RESEARCH 1995-2002%A%  
% 215.96/216.11  |- skos__altLabel mesh__D033042 Fetal Experimentation
% 215.96/216.11  |- skos__hiddenLabel mesh__D033042 Research, Fetal Tissue
% 215.96/216.11  |- mesh__recordAuthorizer mesh__D033042 sjn
% 215.96/216.11  |- skos__prefLabel mesh__D005351 Fibromatosis, Gingival
% 215.96/216.11  |- mesh__recordAuthorizer mesh__D005351 sjn
% 215.96/216.11  |- rdf__type mesh__D005351sskos__Concept
% 215.96/216.11  |- skos__hiddenLabel mesh__D005351 Fibromatoses, Gingival
% 215.96/216.11  |- mesh__historyNote mesh__D005351 97; was FIBROMATOSIS GINGIVAE 1965-96   
% 215.96/216.11  |- mesh__recordMaintainer mesh__D005351 kle
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D005351 2002
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D005351 2005
% 215.96/216.11  |- skos__broader mesh__D005351smesh__D019214
% 215.96/216.11  |- mesh__dateEstablished mesh__D005351 1965-01-01
% 215.96/216.11  |- skos__scopeNote mesh__D005351
% 215.96/216.11       Generalized or localized diffuse fibrous overgrowth of the gingival tissue, usually transmitted as an autosomal dominant trait, but some cases are idiopathic and others produced by drugs. The enlarged gingiva is pink, firm, and has a leather-like consistency with a minutely pebbled surface and in severe cases the teeth are almost completely covered and the enlargement projects into the oral vestibule. %28%Dorland, 28th ed%29%%A%    
% 215.96/216.11  |- mesh__dateRevised mesh__D005351 1999-11-03
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D005351 2006
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D005351 2000
% 215.96/216.11  |- skos__broader mesh__D005351smesh__D009056
% 215.96/216.11  |- skos__altLabel mesh__D005351 Fibromatosis Gingivae
% 215.96/216.11  |- mesh__publicMeSHNote mesh__D005351
% 215.96/216.11       97; was FIBROMATOSIS GINGIVAE 1965-96   
% 215.96/216.11  |- mesh__recordOriginator mesh__D005351 NLM
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D005351 2003
% 215.96/216.11  |- skos__annotation mesh__D005351
% 215.96/216.11       non-neoplastic; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D005351 2001
% 215.96/216.11  |- skos__hiddenLabel mesh__D005351 Gingival Fibromatoses
% 215.96/216.11  |- skos__altLabel mesh__D005351 Gingival Fibromatosis
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D005351 2004
% 215.96/216.11  |- mesh__dateCreated mesh__D005351 1999-01-01
% 215.96/216.11  |- skos__altLabel mesh__D046768 Pancreatic Nesidioblastosis
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D046768 2005
% 215.96/216.11  |- skos__historyNote mesh__D046768 Hyperinsulinism %28%1971-2004%29%
% 215.96/216.11  |- skos__altLabel mesh__D046768 Nesidioblastosis of Pancreas
% 215.96/216.11  |- skos__altLabel mesh__D046768
% 215.96/216.11       Hyperinsulinism, Familial, with Pancreatic Nesidioblastosis
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D046768 2006
% 215.96/216.11  |- skos__broader mesh__D046768smesh__D002239
% 215.96/216.11  |- mesh__publicMeSHNote mesh__D046768
% 215.96/216.11       2005; see PANCREATIC DISEASES 1983-2004   
% 215.96/216.11  |- skos__prefLabel mesh__D046768 Nesidioblastosis
% 215.96/216.11  |- skos__hiddenLabel mesh__D046768 Nesidioblastosis, Pancreatic
% 215.96/216.11  |- skos__broader mesh__D046768smesh__D010182
% 215.96/216.11  |- skos__scopeNote mesh__D046768
% 215.96/216.11       An inherited autosomal recessive syndrome characterized by the disorganized formation of new islets in the PANCREAS and PERSISTENT HYPERINSULINEMIA HYPOGLYCEMIA OF INFANCY. It is due to focal hyperplasia of pancreatic ISLET CELLS budding off from the ductal structures and forming new islets of Langerhans. Mutations in the islet cells involve the potassium channel gene KCNJ11 or the ATP-binding cassette transporter gene ABCC8, both on CHROMOSOME 11.%A%    
% 215.96/216.11  |- mesh__historyNote mesh__D046768
% 215.96/216.11       2005; use PANCREATIC DISEASES 1983-2004   
% 215.96/216.11  |- mesh__dateCreated mesh__D046768 2004-07-07
% 215.96/216.11  |- skos__historyNote mesh__D046768 Hyperplasia %28%1968-2004%29%
% 215.96/216.11  |- mesh__recordMaintainer mesh__D046768 lkt
% 215.96/216.11  |- mesh__recordAuthorizer mesh__D046768 sjn
% 215.96/216.11  |- mesh__dateEstablished mesh__D046768 2005-01-01
% 215.96/216.11  |- skos__historyNote mesh__D046768 Islets of Langerhans %28%1968-2004%29%
% 215.96/216.11  |- mesh__recordOriginator mesh__D046768 lkt
% 215.96/216.11  |- rdf__type mesh__D046768sskos__Concept
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D018279 2002
% 215.96/216.11  |- skos__prefLabel mesh__D018279 Carcinoma, Signet Ring Cell
% 215.96/216.11  |- mesh__publicMeSHNote mesh__D018279 94   
% 215.96/216.11  |- mesh__recordOriginator mesh__D018279 PLS
% 215.96/216.11  |- skos__altLabel mesh__D018279 Signet Ring Cell Carcinoma
% 215.96/216.11  |- mesh__historyNote mesh__D018279 94   
% 215.96/216.11  |- mesh__dateCreated mesh__D018279 1993-06-28
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D018279 2006
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D018279 2001
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D018279 2005
% 215.96/216.11  |- mesh__dateEstablished mesh__D018279 1994-01-01
% 215.96/216.11  |- rdf__type mesh__D018279sskos__Concept
% 215.96/216.11  |- skos__scopeNote mesh__D018279
% 215.96/216.11       A poorly differentiated adenocarcinoma in which the nucleus is pressed to one side by a cytoplasmic droplet of mucus. It usually arises in the gastrointestinal system.%A%    
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D018279 2000
% 215.96/216.11  |- skos__annotation mesh__D018279
% 215.96/216.11       coord IM with precoord organ/neopl term %28%IM%29%   
% 215.96/216.11  |- mesh__dateRevised mesh__D018279 1999-11-03
% 215.96/216.11  |- mesh__recordAuthorizer mesh__D018279 sjn
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D018279 2004
% 215.96/216.11  |- skos__broader mesh__D018279smesh__D000230
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D018279 2003
% 215.96/216.11  |- mesh__recordMaintainer mesh__D018279 KEV
% 215.96/216.11  |- skos__broader mesh__D018279smesh__D018297
% 215.96/216.11  |- skos__historyNote mesh__D018279
% 215.96/216.11       Adenocarcinoma, Mucinous %28%1966-1993%29%
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D010296 2002
% 215.96/216.11  |- rdf__type mesh__D010296sskos__Concept
% 215.96/216.11  |- mesh__recordOriginator mesh__D010296 NLM
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D010296 2004
% 215.96/216.11  |- skos__scopeNote mesh__D010296
% 215.96/216.11       Upper central part of the cerebral hemisphere.     
% 215.96/216.11  |- mesh__recordMaintainer mesh__D010296 TPW
% 215.96/216.11  |- mesh__dateCreated mesh__D010296 1999-01-01
% 215.96/216.11  |- skos__hiddenLabel mesh__D010296 Lobes, Parietal
% 215.96/216.11  |- skos__annotation mesh__D010296
% 215.96/216.11       dis: coord IM with BRAIN DISEASES %28%IM%29%; neopl: coord IM with BRAIN NEOPLASMS %28%IM%29%%A%  
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D010296 2003
% 215.96/216.11  |- skos__prefLabel mesh__D010296 Parietal Lobe
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D010296 2001
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D010296 2006
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D010296 2000
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D010296 2005
% 215.96/216.11  |- skos__hiddenLabel mesh__D010296 Lobe, Parietal
% 215.96/216.11  |- skos__hiddenLabel mesh__D010296 Parietal Lobes
% 215.96/216.11  |- skos__broader mesh__D010296smesh__D002540
% 215.96/216.11  |- mesh__dateRevised mesh__D010296 1998-06-10
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D010296 1999
% 215.96/216.11  |- mesh__recordAuthorizer mesh__D010296 SJN
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D051902 2006
% 215.96/216.11  |- mesh__recordOriginator mesh__D051902 DRC
% 215.96/216.11  |- mesh__recordMaintainer mesh__D051902 ags
% 215.96/216.11  |- rdf__type mesh__D051902sskos__Concept
% 215.96/216.11  |- skos__scopeNote mesh__D051902
% 215.96/216.11       A receptor-regulated smad protein that undergoes PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS. It regulates BONE MORPHOGENETIC PROTEIN signaling and is essential for PHYSIOLOGICAL ANGIOGENESIS.%A%    
% 215.96/216.11  |- skos__altLabel mesh__D051902 Madh5 Protein
% 215.96/216.11  |- mesh__dateRevised mesh__D051902 2005-07-08
% 215.96/216.11  |- mesh__dateEstablished mesh__D051902 2006-01-01
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D051902 2006A
% 215.96/216.11  |- skos__altLabel mesh__D051902 Dwarfin-C
% 215.96/216.11  |- mesh__dateCreated mesh__D051902 2005-06-30
% 215.96/216.11  |- skos__prefLabel mesh__D051902 Smad5 Protein
% 215.96/216.11  |- mesh__recordAuthorizer mesh__D051902 ags
% 215.96/216.11  |- skos__broader mesh__D051902smesh__D051896
% 215.96/216.11  |- mesh__publicMeSHNote mesh__D051902
% 215.96/216.11       2006; SMAD5 PROTEIN was indexed under DNA-BINDING PROTEINS %26% PHOSPHOPROTEINS %26% TRANS-ACTIVATORS 1996-2005%A%  
% 215.96/216.11  |- mesh__historyNote mesh__D051902 2006%28%1996%29%   
% 215.96/216.11  |- skos__hiddenLabel mesh__D051902 Dwarfin C
% 215.96/216.11  |- mesh__historyNote mesh__D004259
% 215.96/216.11       98%28%68%29%; for DNA POLYMERASE use DNA NUCLEOTIDYLTRANSFERASES 1968-76%A%  
% 215.96/216.11  |- mesh__dateRevised mesh__D004259 2003-07-09
% 215.96/216.11  |- skos__prefLabel mesh__D004259 DNA-Directed DNA Polymerase
% 215.96/216.11  |- skos__hiddenLabel mesh__D004259 DNA Directed DNA Polymerase
% 215.96/216.11  |- skos__altLabel mesh__D004259 DNA-Dependent DNA Polymerases
% 215.96/216.11  |- skos__hiddenLabel mesh__D004259 Polymerase, DNA-Directed DNA
% 215.96/216.11  |- skos__hiddenLabel mesh__D004259 DNA Polymerases, DNA-Dependent
% 215.96/216.11  |- mesh__recordAuthorizer mesh__D004259 sjn
% 215.96/216.11  |- skos__hiddenLabel mesh__D004259 DNA Polymerase, DNA-Directed
% 215.96/216.11  |- rdf__type mesh__D004259sskos__Concept
% 215.96/216.11  |- skos__scopeNote mesh__D004259
% 215.96/216.11       DNA-dependent DNA polymerases found in bacteria, animal and plant cells. During the replication process, these enzymes catalyze the addition of deoxyribonucleotide residues to the end of a DNA strand in the presence of DNA as template-primer. They also possess exonuclease activity and therefore function in DNA repair. EC 2.7.7.7.%A%    
% 215.96/216.11  |- skos__hiddenLabel mesh__D004259 Polymerase N3, DNA
% 215.96/216.11  |- mesh__recordOriginator mesh__D004259 RLS
% 215.96/216.11  |- mesh__dateEstablished mesh__D004259 1977-01-01
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D004259 2005
% 215.96/216.11  |- skos__historyNote mesh__D004259
% 215.96/216.11       DNA Nucleotidyltransferases %28%1968-1976%29%
% 215.96/216.11  |- skos__broader mesh__D004259smesh__D004254
% 215.96/216.11  |- skos__annotation mesh__D004259 GEN; prefer specifics   
% 215.96/216.11  |- skos__hiddenLabel mesh__D004259 Polymerases, DNA-Dependent DNA
% 215.96/216.11  |- skos__hiddenLabel mesh__D004259 Polymerases, DNA
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D004259 2006
% 215.96/216.11  |- skos__altLabel mesh__D004259 DNA Polymerases
% 215.96/216.11  |- mesh__recordMaintainer mesh__D004259 ssb
% 215.96/216.11  |- skos__hiddenLabel mesh__D004259 DNA Dependent DNA Polymerases
% 215.96/216.11  |- mesh__publicMeSHNote mesh__D004259
% 215.96/216.11       98; see DNA POLYMERASES 1977-97, for DNA POLYMERASE see DNA NUCLEOTIDYLTRANSFERASES 1973-76, see DNA NUCLEOTIDYLTRANSFERASE 1968-72%A%  
% 215.96/216.11  |- mesh__dateCreated mesh__D004259 1976-04-19
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D004259 2004
% 215.96/216.11  |- skos__historyNote mesh__D009742 Models, Theoretical %28%1968-1985%29%
% 215.96/216.11  |- skos__hiddenLabel mesh__D009742 Nursing Theories
% 215.96/216.11  |- skos__related mesh__D009742smesh__D016294
% 215.96/216.11  |- mesh__activeMeSHYear mesh__D009742 1997
% 215.96/216.11  |- mesh__dateEstablished mesh__D009742 1986-01-01
% 215.96/216.11  |- skos__historyNote mesh__D009742 Philosophy, Nursing %28%1969-1985%29%
% 215.96/216.12  |- skos__hiddenLabel mesh__D009742 Theories, Nursing
% 215.96/216.12  |- mesh__historyNote mesh__D009742 86   
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009742 2005
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009742 2002
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009742 1995
% 215.96/216.12  |- mesh__recordAuthorizer mesh__D009742 PLS
% 215.96/216.12  |- mesh__publicMeSHNote mesh__D009742 86   
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009742 2006
% 215.96/216.12  |- skos__prefLabel mesh__D009742 Nursing Theory
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009742 1998
% 215.96/216.12  |- skos__scopeNote mesh__D009742
% 215.96/216.12       Concepts, definitions, and propositions applied to the study of various phenomena which pertain to nursing and nursing research.%A%    
% 215.96/216.12  |- skos__altLabel mesh__D009742 Theory, Nursing
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009742 2003
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009742 1999
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009742 2000
% 215.96/216.12  |- mesh__dateCreated mesh__D009742 1985-03-11
% 215.96/216.12  |- mesh__recordMaintainer mesh__D009742 TGC
% 215.96/216.12  |- skos__annotation mesh__D009742 no qualif; DF: NURS THEORY   
% 215.96/216.12  |- mesh__recordOriginator mesh__D009742 EC
% 215.96/216.12  |- mesh__dateRevised mesh__D009742 1994-05-05
% 215.96/216.12  |- rdf__type mesh__D009742sskos__Concept
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009742 2004
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009742 2001
% 215.96/216.12  |- skos__broader mesh__D009742smesh__D009729
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009742 1996
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D014687 2000
% 215.96/216.12  |- rdf__type mesh__D014687sskos__Concept
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D014687 2003
% 215.96/216.12  |- mesh__recordAuthorizer mesh__D014687 PLS
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D014687 1996
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D014687 2006
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D014687 1999
% 215.96/216.12  |- skos__prefLabel mesh__D014687 Venezuela
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D014687 2002
% 215.96/216.12  |- mesh__dateRevised mesh__D014687 1995-05-23
% 215.96/216.12  |- mesh__dateCreated mesh__D014687 1999-01-01
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D014687 2005
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D014687 1998
% 215.96/216.12  |- mesh__recordOriginator mesh__D014687 NLM
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D014687 2001
% 215.96/216.12  |- skos__broader mesh__D014687smesh__D013020
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D014687 2004
% 215.96/216.12  |- mesh__recordMaintainer mesh__D014687 KEV
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D014687 1997
% 215.96/216.12  |- mesh__recordMaintainer mesh__D000667 ssb
% 215.96/216.12  |- skos__scopeNote mesh__D000667
% 215.96/216.12       Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.%A%    
% 215.96/216.12  |- skos__altLabel mesh__D000667 Aminobenzylpenicillin
% 215.96/216.12  |- mesh__recordOriginator mesh__D000667 NLM
% 215.96/216.12  |- mesh__recordAuthorizer mesh__D000667 sjn
% 215.96/216.12  |- skos__hiddenLabel mesh__D000667 KSR1
% 215.96/216.12  |- mesh__dateRevised mesh__D000667 2004-07-07
% 215.96/216.12  |- mesh__dateEstablished mesh__D000667 1965-01-01
% 215.96/216.12  |- rdf__type mesh__D000667sskos__Concept
% 215.96/216.12  |- skos__hiddenLabel mesh__D000667 Aminobenzyl Penicillin
% 215.96/216.12  |- mesh__historyNote mesh__D000667 65%28%64%29%   
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D000667 2005
% 215.96/216.12  |- skos__hiddenLabel mesh__D000667 Sodium, Ampicillin
% 215.96/216.12  |- skos__broader mesh__D000667smesh__D010400
% 215.96/216.12  |- skos__altLabel mesh__D000667 Penicillin, Aminobenzyl
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D000667 2006
% 215.96/216.12  |- skos__hiddenLabel mesh__D000667 Trihydrate, Ampicillin
% 215.96/216.12  |- skos__hiddenLabel mesh__D000667 KS R1
% 215.96/216.12  |- mesh__publicMeSHNote mesh__D000667 65   
% 215.96/216.12  |- skos__prefLabel mesh__D000667 Ampicillin
% 215.96/216.12  |- mesh__dateCreated mesh__D000667 1999-01-01
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D019372 2001
% 215.96/216.12  |- mesh__historyNote mesh__D019372 97   
% 215.96/216.12  |- skos__prefLabel mesh__D019372 Orphanages
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D019372 2004
% 215.96/216.12  |- mesh__dateCreated mesh__D019372 1996-06-10
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D019372 2000
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D019372 2003
% 215.96/216.12  |- skos__hiddenLabel mesh__D019372 Orphanage
% 215.96/216.12  |- mesh__recordAuthorizer mesh__D019372 sjn
% 215.96/216.12  |- mesh__dateRevised mesh__D019372 1999-11-03
% 215.96/216.12  |- mesh__recordMaintainer mesh__D019372 kle
% 215.96/216.12  |- skos__scopeNote mesh__D019372
% 215.96/216.12       Institutions for the housing and care of orphans, foundlings, and abandoned children. They have existed as such since the medieval period but the heading is applicable to such usage also in modern parlance.%A%    
% 215.96/216.12  |- rdf__type mesh__D019372sskos__Concept
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D019372 2006
% 215.96/216.12  |- skos__annotation mesh__D019372 hist or modern usage   
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D019372 2002
% 215.96/216.12  |- skos__broader mesh__D019372smesh__D012112
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D019372 2005
% 215.96/216.12  |- mesh__recordOriginator mesh__D019372 TGC
% 215.96/216.12  |- mesh__dateEstablished mesh__D019372 1997-01-01
% 215.96/216.12  |- mesh__publicMeSHNote mesh__D019372 97   
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D005352 2001
% 215.96/216.12  |- skos__prefLabel mesh__D005352 Fibromuscular Dysplasia
% 215.96/216.12  |- mesh__recordMaintainer mesh__D005352 NLM
% 215.96/216.12  |- skos__historyNote mesh__D005352
% 215.96/216.12       Renal Artery Obstruction %28%1966-1977%29%
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D005352 1997
% 215.96/216.12  |- mesh__recordOriginator mesh__D005352 VDK
% 215.96/216.12  |- skos__broader mesh__D005352smesh__D001157
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D005352 2005
% 215.96/216.12  |- mesh__publicMeSHNote mesh__D005352
% 215.96/216.12       91; was see under ARTERIAL OCCLUSIVE DISEASES 1978-90   
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D005352 1994
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D005352 2006
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D005352 2002
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D005352 1995
% 215.96/216.12  |- skos__scopeNote mesh__D005352
% 215.96/216.12       An idiopathic, segmental, nonatheromatous disease of the musculature of arterial walls, leading to stenosis of small and medium-sized arteries. Most commonly affected are the renal arteries; involvement of the axillary, iliac, basilar, carotid, hepatic and intracranial arteries have been reported.%A%    
% 215.96/216.12  |- skos__historyNote mesh__D005352 Vascular Diseases %28%1966-1977%29%
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D005352 1991
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D005352 2003
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D005352 1992
% 215.96/216.12  |- skos__hiddenLabel mesh__D005352 Dysplasia, Fibromuscular
% 215.96/216.12  |- skos__hiddenLabel mesh__D005352 Dysplasias, Fibromuscular
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D005352 1998
% 215.96/216.12  |- skos__hiddenLabel mesh__D005352 Fibromuscular Dysplasias
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D005352 2004
% 215.96/216.12  |- mesh__dateCreated mesh__D005352 1977-04-27
% 215.96/216.12  |- skos__historyNote mesh__D005352
% 215.96/216.12       Carotid Artery Diseases %28%1966-1977%29%
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D005352 1993
% 215.96/216.12  |- skos__annotation mesh__D005352
% 215.96/216.12       affects musculature of arterial walls: do not confuse with various musc dis in Cat C5; coord IM with specific artery or pre-coord arterial dis %28%IM%29%%A%  
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D005352 2000
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D005352 1999
% 215.96/216.12  |- mesh__recordAuthorizer mesh__D005352 PLS
% 215.96/216.12  |- mesh__dateRevised mesh__D005352 1990-04-13
% 215.96/216.12  |- mesh__historyNote mesh__D005352
% 215.96/216.12       91%28%78%29%; was see under ARTERIAL OCCLUSIVE DISEASES 1978-90%A%  
% 215.96/216.12  |- rdf__type mesh__D005352sskos__Concept
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D005352 1996
% 215.96/216.12  |- skos__historyNote mesh__D005352
% 215.96/216.12       Arterial Occlusive Diseases %28%1973-1977%29%
% 215.96/216.12  |- mesh__dateEstablished mesh__D005352 1991-01-01
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D010297 2003
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D010297 2000
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D010297 2006
% 215.96/216.12  |- mesh__dateRevised mesh__D010297 1974-12-04
% 215.96/216.12  |- skos__prefLabel mesh__D010297 Paris
% 215.96/216.12  |- mesh__recordMaintainer mesh__D010297 GHR
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D010297 1997
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D010297 2005
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D010297 1993
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D010297 2002
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D010297 1996
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D010297 1990
% 215.96/216.12  |- mesh__recordOriginator mesh__D010297 NLM
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D010297 1999
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D010297 1992
% 215.96/216.12  |- skos__broader mesh__D010297smesh__D005602
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D010297 1995
% 215.96/216.12  |- rdf__type mesh__D010297sskos__Concept
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D010297 1998
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D010297 1989
% 215.96/216.12  |- mesh__recordAuthorizer mesh__D010297 NLM
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D010297 2004
% 215.96/216.12  |- mesh__dateCreated mesh__D010297 1999-01-01
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D010297 2001
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D010297 1994
% 215.96/216.12  |- skos__broader mesh__D010297smesh__D002947
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D010297 1991
% 215.96/216.12  |- skos__altLabel mesh__D051903 Interleukin Enhancer Binding Factor 2
% 215.96/216.12  |- mesh__dateEstablished mesh__D051903 2006-01-01
% 215.96/216.12  |- rdf__type mesh__D051903sskos__Concept
% 215.96/216.12  |- skos__broader mesh__D051903smesh__D050779
% 215.96/216.12  |- skos__prefLabel mesh__D051903 Nuclear Factor 45 Protein
% 215.96/216.12  |- skos__altLabel mesh__D051903 ILF2 Protein
% 215.96/216.12  |- mesh__recordOriginator mesh__D051903 jmp
% 215.96/216.12  |- mesh__historyNote mesh__D051903 2006%28%1993%29%   
% 215.96/216.12  |- skos__scopeNote mesh__D051903
% 215.96/216.12       A protein subunit that takes part in forming nuclear factor 90 protein complexes.%A%    
% 215.96/216.12  |- mesh__recordAuthorizer mesh__D051903 sjn
% 215.96/216.12  |- skos__altLabel mesh__D051903 NF45 Protein
% 215.96/216.12  |- mesh__recordMaintainer mesh__D051903 jmp
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D051903 2006
% 215.96/216.12  |- mesh__dateCreated mesh__D051903 2005-06-30
% 215.96/216.12  |- mesh__publicMeSHNote mesh__D051903
% 215.96/216.12       2006; NUCLEAR FACTOR 45 PROTEIN was indexed under TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; %26% DNA-BINDING PROTEINS 1993-2005%A%  
% 215.96/216.12  |- mesh__historyNote mesh__D015780 90   
% 215.96/216.12  |- mesh__recordOriginator mesh__D015780 RLS
% 215.96/216.12  |- rdf__type mesh__D015780sskos__Concept
% 215.96/216.12  |- skos__historyNote mesh__D015780 Antibiotics, Lactam %28%1983-1989%29%
% 215.96/216.12  |- skos__scopeNote mesh__D015780
% 215.96/216.12       A group of beta-lactam antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom. THIENAMYCINS are a subgroup of carbapenems which have a sulfur atom as the first constituent of the side chain.%A%    
% 215.96/216.12  |- mesh__dateEstablished mesh__D015780 1990-01-01
% 215.96/216.12  |- mesh__publicMeSHNote mesh__D015780 90   
% 215.96/216.12  |- mesh__recordAuthorizer mesh__D015780 sjn
% 215.96/216.12  |- skos__historyNote mesh__D015780 Antibiotics %28%1966-1982%29%
% 215.96/216.12  |- skos__hiddenLabel mesh__D015780 Carbapenem Antibiotics
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D015780 2006
% 215.96/216.12  |- mesh__dateRevised mesh__D015780 2004-07-07
% 215.96/216.12  |- mesh__dateCreated mesh__D015780 1989-05-25
% 215.96/216.12  |- skos__broader mesh__D015780smesh__D047090
% 215.96/216.12  |- skos__altLabel mesh__D015780 Antibiotics, Carbapenem
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D015780 2005
% 215.96/216.12  |- skos__prefLabel mesh__D015780 Carbapenems
% 215.96/216.12  |- mesh__recordMaintainer mesh__D015780 ssb
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009743 2006
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009743 1998
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009743 2000
% 215.96/216.12  |- skos__hiddenLabel mesh__D009743 Practical Nursings
% 215.96/216.12  |- skos__altLabel mesh__D009743 Practical Nursing
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009743 2003
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009743 2001
% 215.96/216.12  |- skos__scopeNote mesh__D009743
% 215.96/216.12       The practice of nursing by licensed, non-registered persons qualified to provide routine care to the sick.%A%    
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009743 1999
% 215.96/216.12  |- mesh__dateRevised mesh__D009743 1994-05-05
% 215.96/216.12  |- rdf__type mesh__D009743sskos__Concept
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009743 2004
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009743 1996
% 215.96/216.12  |- skos__annotation mesh__D009743 SPEC: SPEC qualif; DF: NURS PRACTICAL   
% 215.96/216.12  |- skos__hiddenLabel mesh__D009743 Nursings, Practical
% 215.96/216.12  |- mesh__recordOriginator mesh__D009743 NLM
% 215.96/216.12  |- mesh__recordMaintainer mesh__D009743 TGC
% 215.96/216.12  |- skos__prefLabel mesh__D009743 Nursing, Practical
% 215.96/216.12  |- mesh__dateCreated mesh__D009743 1999-01-01
% 215.96/216.12  |- skos__broader mesh__D009743smesh__D009732
% 215.96/216.12  |- skos__broader mesh__D009743smesh__D006281
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009743 2002
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009743 1997
% 215.96/216.12  |- mesh__recordAuthorizer mesh__D009743 PLS
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009743 2005
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009743 1995
% 215.96/216.12  |- skos__hiddenLabel mesh__D001760 Tests, Aspirin Tolerance
% 215.96/216.12  |- rdf__type mesh__D001760sskos__Concept
% 215.96/216.12  |- skos__hiddenLabel mesh__D001760 Method, Duke
% 215.96/216.12  |- skos__prefLabel mesh__D001760 Bleeding Time
% 215.96/216.12  |- skos__historyNote mesh__D001760 Blood Coagulation %28%1966-1979%29%
% 215.96/216.12  |- skos__hiddenLabel mesh__D001760 Bleeding Times
% 215.96/216.12  |- skos__hiddenLabel mesh__D001760 Time, Template Bleeding
% 215.96/216.12  |- skos__hiddenLabel mesh__D001760 Method, Ivy
% 215.96/216.12  |- skos__historyNote mesh__D001760
% 215.96/216.12       Blood Platelet Disorders %28%1966-1979%29%
% 215.96/216.12  |- skos__altLabel mesh__D001760 Bleeding Time, Template
% 215.96/216.12  |- skos__annotation mesh__D001760 usually NIM   
% 215.96/216.12  |- mesh__dateCreated mesh__D001760 1979-03-07
% 215.96/216.12  |- skos__broader mesh__D001760smesh__D045122
% 215.96/216.12  |- skos__related mesh__D001760smesh__D015539
% 215.96/216.12  |- mesh__recordMaintainer mesh__D001760 nns
% 215.96/216.12  |- mesh__publicMeSHNote mesh__D001760
% 215.96/216.12       91; was see under PLATELET FUNCTION TESTS 1980-90   
% 215.96/216.12  |- skos__scopeNote mesh__D001760
% 215.96/216.12       Duration of blood flow after skin puncture. This test is used as a measure of capillary and platelet function.%A%    
% 215.96/216.12  |- skos__hiddenLabel mesh__D001760 Time, Bleeding
% 215.96/216.12  |- skos__hiddenLabel mesh__D001760 Test, Aspirin Tolerance
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D001760 2004
% 215.96/216.12  |- mesh__dateEstablished mesh__D001760 1991-01-01
% 215.96/216.12  |- skos__hiddenLabel mesh__D001760 Times, Bleeding
% 215.96/216.12  |- mesh__recordAuthorizer mesh__D001760 sjn
% 215.96/216.12  |- skos__hiddenLabel mesh__D001760 Tolerance Tests, Aspirin
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D001760 2005
% 215.96/216.12  |- mesh__historyNote mesh__D001760
% 215.96/216.12       91%28%80%29%; was see under PLATELET FUNCTION TESTS 1980-90   
% 215.96/216.12  |- skos__historyNote mesh__D001760 Thrombocytosis %28%1966-1979%29%
% 215.96/216.12  |- mesh__recordOriginator mesh__D001760 SMH
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D001760 2006
% 215.96/216.12  |- skos__hiddenLabel mesh__D001760 Template Bleeding Times
% 215.96/216.12  |- skos__historyNote mesh__D001760 Thrombocytopenia %28%1966-1979%29%
% 215.96/216.12  |- skos__hiddenLabel mesh__D001760 Bleeding Times, Template
% 215.96/216.12  |- skos__hiddenLabel mesh__D001760 Aspirin Tolerance Tests
% 215.96/216.12  |- mesh__dateRevised mesh__D001760 2003-07-09
% 215.96/216.12  |- skos__hiddenLabel mesh__D001760 Times, Template Bleeding
% 215.96/216.12  |- skos__hiddenLabel mesh__D001760 Tolerance Test, Aspirin
% 215.96/216.12  |- skos__historyNote mesh__D001760 Blood Platelets %28%1966-1979%29%
% 215.96/216.12  |- skos__historyNote mesh__D001760
% 215.96/216.12       Blood Coagulation Tests %28%1966-1979%29%
% 215.96/216.12  |- skos__broader mesh__D001760smesh__D010979
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D014688 2006
% 215.96/216.12  |- mesh__dateCreated mesh__D014688 1999-01-01
% 215.96/216.12  |- skos__broader mesh__D014688smesh__D045424
% 215.96/216.12  |- mesh__recordAuthorizer mesh__D014688 sjn
% 215.96/216.12  |- skos__broader mesh__D014688smesh__D014118
% 215.96/216.12  |- skos__annotation mesh__D014688
% 215.96/216.12       general or unspecified only: prefer specifics; coordinate with the animal producing the venom but many specific precoordinated venom terms are available %28%AMPHIBIAN VENOMS; ARTHROPOD VENOMS; SNAKE VENOMS %26% its indentions, etc.%29%%A%  
% 215.96/216.12  |- skos__scopeNote mesh__D014688
% 215.96/216.12       Poisonous animal secretions forming fluid mixtures of many different enzymes, toxins, and other substances. These substances are produced in specialized glands and secreted through specialized delivery systems %28%nematocysts, spines, fangs, etc.%29% for disabling prey or predator.%A%    
% 215.96/216.12  |- mesh__recordMaintainer mesh__D014688 ssb
% 215.96/216.12  |- skos__altLabel mesh__D014688 Venom
% 215.96/216.12  |- mesh__recordOriginator mesh__D014688 NLM
% 215.96/216.12  |- skos__broader mesh__D014688smesh__D012634
% 215.96/216.12  |- mesh__dateRevised mesh__D014688 2005-06-30
% 215.96/216.12  |- rdf__type mesh__D014688sskos__Concept
% 215.96/216.12  |- skos__related mesh__D014688smesh__D000997
% 215.96/216.12  |- skos__prefLabel mesh__D014688 Venoms
% 215.96/216.12  |- skos__hiddenLabel mesh__D000668 Resistance, Ampicillin
% 215.96/216.12  |- mesh__dateCreated mesh__D000668 1987-05-09
% 215.96/216.12  |- skos__prefLabel mesh__D000668 Ampicillin Resistance
% 215.96/216.12  |- mesh__publicMeSHNote mesh__D000668 88   
% 215.96/216.12  |- skos__broader mesh__D000668smesh__D010403
% 215.96/216.12  |- mesh__recordOriginator mesh__D000668 SCD
% 215.96/216.12  |- rdf__type mesh__D000668sskos__Concept
% 215.96/216.12  |- mesh__dateEstablished mesh__D000668 1988-01-01
% 215.96/216.12  |- mesh__historyNote mesh__D000668 88   
% 215.96/216.12  |- mesh__recordMaintainer mesh__D000668 ssb
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D000668 2005
% 215.96/216.12  |- skos__historyNote mesh__D000668
% 215.96/216.12       Drug Resistance, Microbial %28%1966-1987%29%
% 215.96/216.12  |- skos__hiddenLabel mesh__D000668 Resistances, Ampicillin
% 215.96/216.12  |- mesh__recordAuthorizer mesh__D000668 sjn
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D000668 2006
% 215.96/216.12  |- skos__scopeNote mesh__D000668
% 215.96/216.12       Nonsusceptibility of a microbe to the action of ampicillin, a penicillin derivative that interferes with cell wall synthesis.%A%    
% 215.96/216.12  |- mesh__dateRevised mesh__D000668 2003-07-09
% 215.96/216.12  |- skos__hiddenLabel mesh__D000668 Ampicillin Resistances
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D000668 2004
% 215.96/216.12  |- skos__historyNote mesh__D000668 Ampicillin %28%1966-1987%29%
% 215.96/216.12  |- skos__hiddenLabel mesh__D011390 Prolactin Releasing Hormone
% 215.96/216.12  |- skos__annotation mesh__D011390 DF: PRH   
% 215.96/216.12  |- mesh__recordMaintainer mesh__D011390 ssb
% 215.96/216.12  |- skos__broader mesh__D011390smesh__D009479
% 215.96/216.12  |- skos__broader mesh__D011390smesh__D010906
% 215.96/216.12  |- skos__prefLabel mesh__D011390 Prolactin-Releasing Hormone
% 215.96/216.12  |- skos__historyNote mesh__D011390
% 215.96/216.12       Pituitary Hormone Releasing Hormones %28%1968-1974%29%
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D011390 2006
% 215.96/216.12  |- mesh__recordOriginator mesh__D011390 NLM
% 215.96/216.12  |- mesh__dateEstablished mesh__D011390 1975-09-01
% 215.96/216.12  |- mesh__historyNote mesh__D011390
% 215.96/216.12       92; was PROLACTIN RELEASING HORMONE 1975-91; was see under PITUITARY HORMONE RELEASING HORMONES 1974; was PROLACTIN RELEASING FACTOR see under PITUITARY HORMONE RELEASING FACTORS 1968-73%A%  
% 215.96/216.12  |- mesh__publicMeSHNote mesh__D011390
% 215.96/216.12       92; was PROLACTIN RELEASING HORMONE 1975-91; was see under PITUITARY HORMONE RELEASING HORMONES 1974; was PROLACTIN RELEASING FACTOR see under PITUITARY HORMONE RELEASING FACTORS 1968-73%A%  
% 215.96/216.12  |- mesh__onlineNote mesh__D011390
% 215.96/216.12       use PROLACTIN-RELEASING HORMONE to search PROLACTIN RELEASING HORMONE 1975-91%A%  
% 215.96/216.12  |- mesh__recordAuthorizer mesh__D011390 sjn
% 215.96/216.12  |- mesh__dateRevised mesh__D011390 2005-06-30
% 215.96/216.12  |- skos__hiddenLabel mesh__D011390 Hormone, Prolactin-Releasing
% 215.96/216.12  |- rdf__type mesh__D011390sskos__Concept
% 215.96/216.12  |- skos__scopeNote mesh__D011390
% 215.96/216.12       A polypeptide hormone that originates in the hypothalamus and stimulates the secretion of prolactin in the pituitary gland.%A%    
% 215.96/216.12  |- mesh__dateCreated mesh__D011390 1999-01-01
% 215.96/216.12  |- skos__broader mesh__D027805smesh__D007887
% 215.96/216.12  |- skos__scopeNote mesh__D027805
% 215.96/216.12       A plant genus in the family FABACEAE which is the source of edible beans and  the lectin PHYTOHEMAGGLUTININS.%A%    
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D027805 2006A
% 215.96/216.12  |- skos__annotation mesh__D027805
% 215.96/216.12       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.96/216.12  |- mesh__recordMaintainer mesh__D027805 ags
% 215.96/216.12  |- mesh__publicMeSHNote mesh__D027805 2002; see LEGUMES 1978-2001   
% 215.96/216.12  |- mesh__recordOriginator mesh__D027805 ssb
% 215.96/216.12  |- skos__historyNote mesh__D027805 Fabaceae %28%1978-2001%29%
% 215.96/216.12  |- mesh__historyNote mesh__D027805 2002; use FABACEAE 1978-2001   
% 215.96/216.12  |- mesh__recordAuthorizer mesh__D027805 ags
% 215.96/216.12  |- skos__prefLabel mesh__D027805 Phaseolus
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D027805 2005
% 215.96/216.12  |- skos__altLabel mesh__D027805 Kidney Bean
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D027805 2006
% 215.96/216.12  |- rdf__type mesh__D027805sskos__Concept
% 215.96/216.12  |- skos__altLabel mesh__D027805 Tepary Bean
% 215.96/216.12  |- mesh__dateCreated mesh__D027805 2001-07-25
% 215.96/216.12  |- mesh__dateEstablished mesh__D027805 2002-01-01
% 215.96/216.12  |- mesh__dateRevised mesh__D027805 2005-07-27
% 215.96/216.12  |- skos__historyNote mesh__D005353 Cryoglobulins %28%1966-1979%29%
% 215.96/216.12  |- skos__hiddenLabel mesh__D005353 alpha 2 Surface Binding Glycoprotein
% 215.96/216.12  |- skos__altLabel mesh__D005353 LETS Proteins
% 215.96/216.12  |- skos__hiddenLabel mesh__D005353 Proteins, LETS
% 215.96/216.12  |- skos__related mesh__D005353smesh__D017469
% 215.96/216.12  |- skos__hiddenLabel mesh__D005353 Globulins, Cold-Insoluble
% 215.96/216.12  |- skos__historyNote mesh__D005353 Membrane Proteins %28%1977-1979%29%
% 215.96/216.12  |- skos__broader mesh__D005353smesh__D012712
% 215.96/216.12  |- rdf__type mesh__D005353sskos__Concept
% 215.96/216.12  |- skos__broader mesh__D005353smesh__D008562
% 215.96/216.12  |- skos__hiddenLabel mesh__D005353 Cold Insoluble Globulins
% 215.96/216.12  |- mesh__dateRevised mesh__D005353 2005-06-30
% 215.96/216.12  |- skos__broader mesh__D005353smesh__D016326
% 215.96/216.12  |- skos__hiddenLabel mesh__D005353 Glycoprotein, Opsonic
% 215.96/216.12  |- skos__altLabel mesh__D005353 alpha 2-Surface Binding Glycoprotein
% 215.96/216.12  |- skos__altLabel mesh__D005353 Opsonic alpha%28%2%29%SB Glycoprotein
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D005353 2006
% 215.96/216.12  |- skos__altLabel mesh__D005353 Fibronectin
% 215.96/216.12  |- skos__prefLabel mesh__D005353 Fibronectins
% 215.96/216.12  |- skos__scopeNote mesh__D005353
% 215.96/216.12       Glycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins.%A%    
% 215.96/216.12  |- mesh__dateCreated mesh__D005353 1979-02-21
% 215.96/216.12  |- skos__annotation mesh__D005353
% 215.96/216.12       extracellular matrix proteins; /biosyn /physiol permitted%A%  
% 215.96/216.12  |- mesh__recordAuthorizer mesh__D005353 sjn
% 215.96/216.12  |- skos__altLabel mesh__D005353 Cold-Insoluble Globulins
% 215.96/216.12  |- mesh__historyNote mesh__D005353 80   
% 215.96/216.12  |- mesh__recordOriginator mesh__D005353 RLS
% 215.96/216.12  |- mesh__publicMeSHNote mesh__D005353 80   
% 215.96/216.12  |- mesh__recordMaintainer mesh__D005353 SYSTEM
% 215.96/216.12  |- skos__historyNote mesh__D005353 Glycoproteins %28%1966-1979%29%
% 215.96/216.12  |- mesh__dateEstablished mesh__D005353 1980-01-01
% 215.96/216.12  |- skos__altLabel mesh__D005353 Opsonic Glycoprotein
% 215.96/216.12  |- skos__scopeNote mesh__D010298
% 215.96/216.12       The number of offspring a female has borne. It is contrasted with GRAVIDITY, which refers to the number of pregnancies, regardless of outcome.%A%    
% 215.96/216.12  |- mesh__recordAuthorizer mesh__D010298 sjn
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D010298 2005
% 215.96/216.12  |- skos__annotation mesh__D010298
% 215.96/216.12       human %26% animal; relation to PREGNANCY: Manual 28.16.4   
% 215.96/216.12  |- skos__related mesh__D010298smesh__D020073
% 215.96/216.12  |- skos__prefLabel mesh__D010298 Parity
% 215.96/216.12  |- skos__broader mesh__D010298smesh__D011247
% 215.96/216.12  |- rdf__type mesh__D010298sskos__Concept
% 215.96/216.12  |- skos__hiddenLabel mesh__D010298 Ratio, Parity Progression
% 215.96/216.12  |- mesh__dateEstablished mesh__D010298 1970-01-01
% 215.96/216.12  |- mesh__dateCreated mesh__D010298 1999-01-01
% 215.96/216.12  |- mesh__historyNote mesh__D010298 70%28%65%29%   
% 215.96/216.12  |- mesh__recordOriginator mesh__D010298 NLM
% 215.96/216.12  |- mesh__publicMeSHNote mesh__D010298 70   
% 215.96/216.12  |- skos__hiddenLabel mesh__D010298 Parity Progression Ratios
% 215.96/216.12  |- skos__broader mesh__D010298smesh__D017584
% 215.96/216.12  |- mesh__recordMaintainer mesh__D010298 lkt
% 215.96/216.12  |- skos__hiddenLabel mesh__D010298 Ratios, Parity Progression
% 215.96/216.12  |- mesh__dateRevised mesh__D010298 2004-07-07
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D010298 2006
% 215.96/216.12  |- mesh__recordAuthorizer mesh__D051904 sjn
% 215.96/216.12  |- skos__altLabel mesh__D051904 Smad9 Protein
% 215.96/216.12  |- mesh__dateCreated mesh__D051904 2005-06-30
% 215.96/216.12  |- skos__scopeNote mesh__D051904
% 215.96/216.12       A receptor-regulated smad protein that undergoes PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS and regulates BONE MORPHOGENETIC PROTEIN signaling.%A%    
% 215.96/216.12  |- mesh__dateEstablished mesh__D051904 2006-01-01
% 215.96/216.12  |- skos__prefLabel mesh__D051904 Smad8 Protein
% 215.96/216.12  |- mesh__historyNote mesh__D051904 2006   
% 215.96/216.12  |- skos__broader mesh__D051904smesh__D051896
% 215.96/216.12  |- mesh__recordOriginator mesh__D051904 DRC
% 215.96/216.12  |- mesh__recordMaintainer mesh__D051904 DRC
% 215.96/216.12  |- mesh__publicMeSHNote mesh__D051904 2006   
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D051904 2006
% 215.96/216.12  |- skos__altLabel mesh__D051904 Madh9 Protein
% 215.96/216.12  |- rdf__type mesh__D051904sskos__Concept
% 215.96/216.12  |- skos__annotation mesh__D009744
% 215.96/216.12       IM; coord with specific nurs specialty %28%IM%29%; DF: NURS PRIVATE DUTY%A%  
% 215.96/216.12  |- skos__altLabel mesh__D009744 Private Duty Nursing
% 215.96/216.12  |- skos__altLabel mesh__D009744 Nursing, Private Practice
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009744 2003
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009744 1999
% 215.96/216.12  |- rdf__type mesh__D009744sskos__Concept
% 215.96/216.12  |- mesh__dateRevised mesh__D009744 1994-05-05
% 215.96/216.12  |- mesh__dateEstablished mesh__D009744 1967-01-01
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009744 2004
% 215.96/216.12  |- skos__altLabel mesh__D009744 Private Practice Nursing
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009744 1996
% 215.96/216.12  |- mesh__activeMeSHYear mesh__D009744 2000
% 215.96/216.13  |- mesh__recordMaintainer mesh__D009744 TGC
% 215.96/216.13  |- mesh__historyNote mesh__D009744 67   
% 215.96/216.13  |- mesh__dateCreated mesh__D009744 1999-01-01
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D009744 2001
% 215.96/216.13  |- skos__broader mesh__D009744smesh__D009729
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D009744 1997
% 215.96/216.13  |- skos__historyNote mesh__D009744 Nursing %28%1966%29%
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D009744 2005
% 215.96/216.13  |- skos__scopeNote mesh__D009744
% 215.96/216.13       The practice of nursing by a registered or licensed nurse to care for a specific patient in a health facility or in the home.%A%    
% 215.96/216.13  |- skos__prefLabel mesh__D009744 Nursing, Private Duty
% 215.96/216.13  |- mesh__recordOriginator mesh__D009744 NLM
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D009744 1995
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D009744 2006
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D009744 1998
% 215.96/216.13  |- mesh__publicMeSHNote mesh__D009744 67   
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D009744 2002
% 215.96/216.13  |- mesh__recordAuthorizer mesh__D009744 PLS
% 215.96/216.13  |- skos__hiddenLabel mesh__D001761 Sulfate, Bleomycin
% 215.96/216.13  |- mesh__dateCreated mesh__D001761 1999-01-01
% 215.96/216.13  |- mesh__recordMaintainer mesh__D001761 DRC
% 215.96/216.13  |- skos__scopeNote mesh__D001761
% 215.96/216.13       A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors.%A%    
% 215.96/216.13  |- skos__altLabel mesh__D001761 Bleomycin A%28%2%29%
% 215.96/216.13  |- mesh__historyNote mesh__D001761
% 215.96/216.13       96; was BLEOMYCINS 1981-95, was BLEOMYCIN 1972-80 %28%Prov 1972-73%29%%A%  
% 215.96/216.13  |- skos__altLabel mesh__D001761 Blanoxan
% 215.96/216.13  |- skos__altLabel mesh__D001761 Almirall Brand of Bleomycin Sulfate
% 215.96/216.13  |- skos__altLabel mesh__D001761 Bellon Brand of Bleomycin Sulfate
% 215.96/216.13  |- skos__annotation mesh__D001761
% 215.96/216.13       a glycopeptide antineoplastic antibiotic   
% 215.96/216.13  |- skos__broader mesh__D001761smesh__D006020
% 215.96/216.13  |- rdf__type mesh__D001761sskos__Concept
% 215.96/216.13  |- mesh__publicMeSHNote mesh__D001761
% 215.96/216.13       96; was BLEOMYCINS 1981-95, was BLEOMYCIN 1974-80   
% 215.96/216.13  |- skos__altLabel mesh__D001761 Mack Brand of Bleomycin Sulfate
% 215.96/216.13  |- skos__altLabel mesh__D001761 Bleomycins
% 215.96/216.13  |- skos__hiddenLabel mesh__D001761 BLEOcell
% 215.96/216.13  |- skos__altLabel mesh__D001761 Bull Brand of Bleomycin Sulfate
% 215.96/216.13  |- skos__altLabel mesh__D001761 cell pharm Brand of Bleomycin Sulfate
% 215.96/216.13  |- skos__hiddenLabel mesh__D001761
% 215.96/216.13       Bristol Myers Squibb Brand of Bleomycin Sulfate
% 215.96/216.13  |- mesh__recordOriginator mesh__D001761 NLM
% 215.96/216.13  |- skos__hiddenLabel mesh__D001761 Mack, Bleomycinum
% 215.96/216.13  |- skos__hiddenLabel mesh__D001761 Bellon, Bl%C3%%A9%omycine
% 215.96/216.13  |- skos__hiddenLabel mesh__D001761 BLEO cell
% 215.96/216.13  |- mesh__recordAuthorizer mesh__D001761 sjn
% 215.96/216.13  |- skos__altLabel mesh__D001761
% 215.96/216.13       Bristol-Myers Squibb Brand of Bleomycin Sulfate
% 215.96/216.13  |- skos__altLabel mesh__D001761 Bleomycin B%28%2%29%
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D001761 2006
% 215.96/216.13  |- skos__altLabel mesh__D001761 Lemery Brand of Bleomycin Sulfate
% 215.96/216.13  |- mesh__dateRevised mesh__D001761 2005-06-30
% 215.96/216.13  |- mesh__dateEstablished mesh__D001761 1974-01-01
% 215.96/216.13  |- skos__historyNote mesh__D001761
% 215.96/216.13       Antibiotics, Antineoplastic %28%1967-1970%29%
% 215.96/216.13  |- skos__prefLabel mesh__D001761 Bleomycin
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D014689 1999
% 215.96/216.13  |- mesh__publicMeSHNote mesh__D014689 73   
% 215.96/216.13  |- mesh__dateCreated mesh__D014689 1999-01-01
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D014689 2000
% 215.96/216.13  |- mesh__historyNote mesh__D014689 73   
% 215.96/216.13  |- mesh__dateRevised mesh__D014689 1994-05-27
% 215.96/216.13  |- skos__broader mesh__D014689smesh__D014652
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D014689 2006
% 215.96/216.13  |- mesh__recordAuthorizer mesh__D014689 PLS
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D014689 1998
% 215.96/216.13  |- skos__scopeNote mesh__D014689
% 215.96/216.13       Inadequacy of the venous valves and impairment of venous return %28%venous stasis%29% usually from the legs, often with edema and sometimes with stasis ulcers at the ankle.%A%    
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D014689 2005
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D014689 1995
% 215.96/216.13  |- skos__hiddenLabel mesh__D014689 Venous Insufficiencies
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D014689 2002
% 215.96/216.13  |- mesh__recordOriginator mesh__D014689 NLM
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D014689 1997
% 215.96/216.13  |- skos__hiddenLabel mesh__D014689 Insufficiency, Venous
% 215.96/216.13  |- skos__prefLabel mesh__D014689 Venous Insufficiency
% 215.96/216.13  |- mesh__recordMaintainer mesh__D014689 TGC
% 215.96/216.13  |- rdf__type mesh__D014689sskos__Concept
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D014689 2004
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D014689 1996
% 215.96/216.13  |- skos__historyNote mesh__D014689 Vascular Diseases %28%1966-1972%29%
% 215.96/216.13  |- skos__annotation mesh__D014689
% 215.96/216.13       GEN or unspecified but usually of the legs; coord IM with specific vein %28%IM%29% or organ /blood supply %28%IM%29% if pertinent%A%  
% 215.96/216.13  |- skos__hiddenLabel mesh__D014689 Insufficiencies, Venous
% 215.96/216.13  |- mesh__dateEstablished mesh__D014689 1973-01-01
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D014689 2001
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D014689 2003
% 215.96/216.13  |- skos__prefLabel mesh__D019374 Colony-Stimulating Factors, Recombinant
% 215.96/216.13  |- mesh__recordMaintainer mesh__D019374 ssb
% 215.96/216.13  |- skos__altLabel mesh__D019374 CSF Recombinant
% 215.96/216.13  |- mesh__recordOriginator mesh__D019374 ADP
% 215.96/216.13  |- skos__hiddenLabel mesh__D019374 Recombinant Colony Stimulating Factors
% 215.96/216.13  |- skos__scopeNote mesh__D019374
% 215.96/216.13       COLONY-STIMULATING FACTORS prepared by recombinant DNA technology.%A%    
% 215.96/216.13  |- mesh__dateEstablished mesh__D019374 1997-01-01
% 215.96/216.13  |- mesh__historyNote mesh__D019374 97   
% 215.96/216.13  |- skos__historyNote mesh__D019374 Recombinant Proteins %28%1985-1996%29%
% 215.96/216.13  |- mesh__publicMeSHNote mesh__D019374 97   
% 215.96/216.13  |- skos__hiddenLabel mesh__D019374 Recombinant, CSF
% 215.96/216.13  |- skos__broader mesh__D019374smesh__D011994
% 215.96/216.13  |- skos__historyNote mesh__D019374
% 215.96/216.13       Colony-Stimulating Factors %28%1985-1996%29%
% 215.96/216.13  |- skos__annotation mesh__D019374
% 215.96/216.13       colony-stimulating factors %22%prepared by recombinant DNA technol%22%; /drug eff permitted; DF: note short X ref%A%  
% 215.96/216.13  |- mesh__dateCreated mesh__D019374 1996-06-10
% 215.96/216.13  |- skos__altLabel mesh__D019374 Recombinant Colony-Stimulating Factors
% 215.96/216.13  |- skos__hiddenLabel mesh__D019374 Factors, Recombinant Colony-Stimulating
% 215.96/216.13  |- skos__broader mesh__D019374smesh__D003115
% 215.96/216.13  |- rdf__type mesh__D019374sskos__Concept
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D019374 2006
% 215.96/216.13  |- mesh__dateRevised mesh__D019374 2005-06-30
% 215.96/216.13  |- mesh__recordAuthorizer mesh__D019374 sjn
% 215.96/216.13  |- skos__hiddenLabel mesh__D019374 Colony Stimulating Factors, Recombinant
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D000669 2003
% 215.96/216.13  |- mesh__dateCreated mesh__D000669 1999-01-01
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D000669 2002
% 215.96/216.13  |- mesh__publicMeSHNote mesh__D000669 73   
% 215.96/216.13  |- skos__scopeNote mesh__D000669
% 215.96/216.13       Electronic devices that increase the strength of an input signal, or apparatus for increasing the magnification of a microscope. %28%From Dorland, 28th ed%29%%A%    
% 215.96/216.13  |- skos__broader mesh__D000669smesh__D004581
% 215.96/216.13  |- skos__prefLabel mesh__D000669 Amplifiers
% 215.96/216.13  |- skos__annotation mesh__D000669 NIM   
% 215.96/216.13  |- mesh__recordMaintainer mesh__D000669 PXP
% 215.96/216.13  |- rdf__type mesh__D000669sskos__Concept
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D000669 1999
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D000669 2001
% 215.96/216.13  |- mesh__dateRevised mesh__D000669 1997-06-20
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D000669 2006
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D000669 2000
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D000669 1998
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D000669 2004
% 215.96/216.13  |- mesh__recordAuthorizer mesh__D000669 SJN
% 215.96/216.13  |- mesh__dateEstablished mesh__D000669 1973-01-01
% 215.96/216.13  |- mesh__recordOriginator mesh__D000669 NLM
% 215.96/216.13  |- skos__broader mesh__D000669smesh__D004864
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D000669 2005
% 215.96/216.13  |- skos__hiddenLabel mesh__D000669 Amplifier
% 215.96/216.13  |- mesh__historyNote mesh__D000669 73%28%66%29%   
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D011391 2004
% 215.96/216.13  |- mesh__historyNote mesh__D011391 77   
% 215.96/216.13  |- mesh__recordOriginator mesh__D011391 MM
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D011391 2002
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D011391 2006
% 215.96/216.13  |- mesh__dateRevised mesh__D011391 1999-11-03
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D011391 2003
% 215.96/216.13  |- mesh__publicMeSHNote mesh__D011391 77   
% 215.96/216.13  |- skos__annotation mesh__D011391
% 215.96/216.13       GEN or unspecified but almost never IM; coord with organ/dis precoord %28%IM%29%%A%  
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D011391 2001
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D011391 2005
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D011391 2000
% 215.96/216.13  |- mesh__dateCreated mesh__D011391 1976-05-19
% 215.96/216.13  |- mesh__recordMaintainer mesh__D011391 KEV
% 215.96/216.13  |- skos__scopeNote mesh__D011391
% 215.96/216.13       The protrusion of an organ or part of an organ into a natural or artificial orifice.%A%    
% 215.96/216.13  |- skos__hiddenLabel mesh__D011391 Prolapses
% 215.96/216.13  |- rdf__type mesh__D011391sskos__Concept
% 215.96/216.13  |- skos__broader mesh__D011391smesh__D020763
% 215.96/216.13  |- skos__prefLabel mesh__D011391 Prolapse
% 215.96/216.13  |- mesh__dateEstablished mesh__D011391 1977-01-01
% 215.96/216.13  |- mesh__recordAuthorizer mesh__D011391 sjn
% 215.96/216.13  |- skos__historyNote mesh__D027806 Fabaceae %28%1978-2001%29%
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D027806 2005
% 215.96/216.13  |- mesh__publicMeSHNote mesh__D027806
% 215.96/216.13       2005; see LENTILS 2001-2004; see FABACEAE 1978-2001   
% 215.96/216.13  |- skos__prefLabel mesh__D027806 Lens Plant
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D027806 2006
% 215.96/216.13  |- mesh__recordAuthorizer mesh__D027806 sjn
% 215.96/216.13  |- rdf__type mesh__D027806sskos__Concept
% 215.96/216.13  |- mesh__dateEstablished mesh__D027806 2002-01-01
% 215.96/216.13  |- skos__annotation mesh__D027806
% 215.96/216.13       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.96/216.13  |- mesh__dateRevised mesh__D027806 2004-07-07
% 215.96/216.13  |- mesh__historyNote mesh__D027806
% 215.96/216.13       2005%28%2002%29%; use FABACEAE 1978-2001   
% 215.96/216.13  |- skos__broader mesh__D027806smesh__D007887
% 215.96/216.13  |- skos__scopeNote mesh__D027806
% 215.96/216.13       A plant genus of the FABACEAE family known for the seeds used as food.%A%    
% 215.96/216.13  |- mesh__recordMaintainer mesh__D027806 ssb
% 215.96/216.13  |- mesh__recordOriginator mesh__D027806 ssb
% 215.96/216.13  |- mesh__dateCreated mesh__D027806 2001-07-25
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D005354 2000
% 215.96/216.13  |- rdf__type mesh__D005354sskos__Concept
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D005354 1996
% 215.96/216.13  |- mesh__recordAuthorizer mesh__D005354 PLS
% 215.96/216.13  |- mesh__dateRevised mesh__D005354 1995-06-08
% 215.96/216.13  |- mesh__recordMaintainer mesh__D005354 KEV
% 215.96/216.13  |- skos__broader mesh__D005354smesh__D018218
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D005354 2006
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D005354 2002
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D005354 2005
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D005354 2004
% 215.96/216.13  |- mesh__recordOriginator mesh__D005354 NLM
% 215.96/216.13  |- skos__hiddenLabel mesh__D005354 Fibrosarcomas
% 215.96/216.13  |- skos__broader mesh__D005354smesh__D012509
% 215.96/216.13  |- skos__prefLabel mesh__D005354 Fibrosarcoma
% 215.96/216.13  |- skos__annotation mesh__D005354
% 215.96/216.13       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D005354 2003
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D005354 1999
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D005354 2001
% 215.96/216.13  |- skos__scopeNote mesh__D005354
% 215.96/216.13       A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. %28%Stedman, 25th ed%29%%A%    
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D005354 1998
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D005354 1997
% 215.96/216.13  |- mesh__dateCreated mesh__D005354 1999-01-01
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D010299 1997
% 215.96/216.13  |- mesh__dateCreated mesh__D010299 1977-05-11
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D010299 1993
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D010299 1998
% 215.96/216.13  |- mesh__recordOriginator mesh__D010299 EC
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D010299 2000
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D010299 1994
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D010299 1999
% 215.96/216.13  |- skos__broader mesh__D010299smesh__D005160
% 215.96/216.13  |- mesh__dateEstablished mesh__D010299 1991-01-01
% 215.96/216.13  |- skos__hiddenLabel mesh__D010299 Parking Facility
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D010299 2003
% 215.96/216.13  |- rdf__type mesh__D010299sskos__Concept
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D010299 2001
% 215.96/216.13  |- mesh__dateRevised mesh__D010299 1992-05-15
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D010299 1995
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D010299 2004
% 215.96/216.13  |- mesh__recordMaintainer mesh__D010299 TGC
% 215.96/216.13  |- skos__prefLabel mesh__D010299 Parking Facilities
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D010299 2002
% 215.96/216.13  |- mesh__publicMeSHNote mesh__D010299
% 215.96/216.13       91; was see under FACILITY DESIGN AND CONSTRUCTION Aug 1977-90%A%  
% 215.96/216.13  |- skos__hiddenLabel mesh__D010299 Facilities, Parking
% 215.96/216.13  |- mesh__historyNote mesh__D010299
% 215.96/216.13       91%28%Aug 77%29%; was see under FACILITY DESIGN AND CONSTRUCTION 1977-90%A%  
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D010299 2005
% 215.96/216.13  |- skos__scopeNote mesh__D010299
% 215.96/216.13       Indoor or outdoor areas designated for the parking of vehicles.%A%    
% 215.96/216.13  |- mesh__recordAuthorizer mesh__D010299 PLS
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D010299 1996
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D010299 2006
% 215.96/216.13  |- skos__hiddenLabel mesh__D010299 Facility, Parking
% 215.96/216.13  |- mesh__historyNote mesh__D051905 2006%28%1997%29%   
% 215.96/216.13  |- mesh__recordOriginator mesh__D051905 DRC
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D051905 2006
% 215.96/216.13  |- mesh__recordAuthorizer mesh__D051905 sjn
% 215.96/216.13  |- skos__broader mesh__D051905smesh__D051785
% 215.96/216.13  |- skos__prefLabel mesh__D051905 Smad6 Protein
% 215.96/216.13  |- mesh__dateEstablished mesh__D051905 2006-01-01
% 215.96/216.13  |- rdf__type mesh__D051905sskos__Concept
% 215.96/216.13  |- mesh__dateCreated mesh__D051905 2005-06-30
% 215.96/216.13  |- skos__broader mesh__D051905smesh__D051897
% 215.96/216.13  |- mesh__recordMaintainer mesh__D051905 DRC
% 215.96/216.13  |- mesh__publicMeSHNote mesh__D051905
% 215.96/216.13       2006; SMAD6 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1997-2005%A%  
% 215.96/216.13  |- skos__scopeNote mesh__D051905
% 215.96/216.13       An inhibitory Smad protein that negatively regulates the SIGNAL TRANSDUCTION PATHWAYS from BONE MORPHOGENETIC PROTEIN RECEPTORS. Smad6 inhibits PHOSPHORYLATION of SMAD2 PROTEIN and SMAD3 PROTEIN.%A%    
% 215.96/216.13  |- mesh__dateEstablished mesh__D015782 1990-01-01
% 215.96/216.13  |- skos__historyNote mesh__D015782 Lymphokines %28%1986-1989%29%
% 215.96/216.13  |- mesh__publicMeSHNote mesh__D015782 90   
% 215.96/216.13  |- mesh__recordOriginator mesh__D015782 AGS
% 215.96/216.13  |- skos__historyNote mesh__D015782 Growth Substances %28%1986-1989%29%
% 215.96/216.13  |- skos__scopeNote mesh__D015782
% 215.96/216.13       Neuronal growth factor and lymphokine product of lectin-stimulated T-cells which induces immunoglobulin secretion. Its amino acid sequence is partially homologous to the HIV envelope glycoprotein gp120, which may explain, in part, the pathogenesis of AIDS DEMENTIA COMPLEX. Closely related to PHOSPHOHEXOSE ISOMERASE; AUTOCRINE MOTILITY FACTOR and maturation factor.%A%    
% 215.96/216.13  |- mesh__recordAuthorizer mesh__D015782 sjn
% 215.96/216.13  |- skos__broader mesh__D015782smesh__D008222
% 215.96/216.13  |- mesh__historyNote mesh__D015782 90   
% 215.96/216.13  |- mesh__dateRevised mesh__D015782 2005-06-30
% 215.96/216.13  |- skos__prefLabel mesh__D015782 Neuroleukin
% 215.96/216.13  |- mesh__recordMaintainer mesh__D015782 ssb
% 215.96/216.13  |- rdf__type mesh__D015782sskos__Concept
% 215.96/216.13  |- skos__broader mesh__D015782smesh__D019747
% 215.96/216.13  |- mesh__dateCreated mesh__D015782 1989-05-15
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D015782 2006
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D009745 1995
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D009745 2006
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D009745 2001
% 215.96/216.13  |- mesh__recordMaintainer mesh__D009745 TGC
% 215.96/216.13  |- mesh__historyNote mesh__D009745 66   
% 215.96/216.13  |- mesh__recordOriginator mesh__D009745 NLM
% 215.96/216.13  |- skos__annotation mesh__D009745
% 215.96/216.13       IM; in British jnls nursing %22%sisters%22% go here but %22%matron%22% goes under NURSE ADMINISTRATORS; DF: NURS SUPERVISORY%A%  
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D009745 2005
% 215.96/216.13  |- skos__hiddenLabel mesh__D009745 Nurse, Head
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D009745 2004
% 215.96/216.13  |- skos__scopeNote mesh__D009745
% 215.96/216.13       Administration of nursing services for one or more clinical units.%A%    
% 215.96/216.13  |- skos__prefLabel mesh__D009745 Nursing, Supervisory
% 215.96/216.13  |- mesh__dateEstablished mesh__D009745 1966-01-01
% 215.96/216.13  |- mesh__publicMeSHNote mesh__D009745 66   
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D009745 1999
% 215.96/216.13  |- skos__hiddenLabel mesh__D009745 Head Nurse
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D009745 2000
% 215.96/216.13  |- skos__hiddenLabel mesh__D009745 Charge Nurse
% 215.96/216.13  |- skos__hiddenLabel mesh__D009745 Nurse, Charge
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D009745 2003
% 215.96/216.13  |- skos__altLabel mesh__D009745 Head Nurses
% 215.96/216.13  |- mesh__dateRevised mesh__D009745 1994-05-05
% 215.96/216.13  |- rdf__type mesh__D009745sskos__Concept
% 215.96/216.13  |- skos__broader mesh__D009745smesh__D009729
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D009745 1998
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D009745 1997
% 215.96/216.13  |- skos__hiddenLabel mesh__D009745 Nurses, Charge
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D009745 2002
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D009745 1996
% 215.96/216.13  |- skos__altLabel mesh__D009745 Supervisory Nursing
% 215.96/216.13  |- mesh__dateCreated mesh__D009745 1999-01-01
% 215.96/216.13  |- mesh__recordAuthorizer mesh__D009745 PLS
% 215.96/216.13  |- mesh__historyNote mesh__D001762
% 215.96/216.13       91%28%65%29%; was see under EYELID DISEASES 1965-90   
% 215.96/216.13  |- skos__broader mesh__D001762smesh__D005141
% 215.96/216.13  |- rdf__type mesh__D001762sskos__Concept
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D001762 2004
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D001762 1997
% 215.96/216.13  |- skos__hiddenLabel mesh__D001762 Blepharitides
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D001762 2001
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D001762 2003
% 215.96/216.13  |- skos__prefLabel mesh__D001762 Blepharitis
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D001762 1996
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D001762 1995
% 215.96/216.13  |- mesh__recordMaintainer mesh__D001762 TGC
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D001762 2000
% 215.96/216.13  |- mesh__dateEstablished mesh__D001762 1991-01-01
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D001762 1994
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D001762 2006
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D001762 1999
% 215.96/216.13  |- mesh__dateRevised mesh__D001762 1993-05-25
% 215.96/216.13  |- skos__scopeNote mesh__D001762 Inflammation of the eyelids.     
% 215.96/216.13  |- mesh__recordAuthorizer mesh__D001762 PLS
% 215.96/216.13  |- mesh__publicMeSHNote mesh__D001762
% 215.96/216.13       91; was see under EYELID DISEASES 1965-90   
% 215.96/216.13  |- skos__annotation mesh__D001762 inflamm of eyelid   
% 215.96/216.13  |- mesh__dateCreated mesh__D001762 1999-01-01
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D001762 2005
% 215.96/216.13  |- mesh__recordOriginator mesh__D001762 NLM
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D001762 1998
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D001762 2002
% 215.96/216.13  |- mesh__publicMeSHNote mesh__D028101 2002; see Papaver 1998-2001   
% 215.96/216.13  |- skos__broader mesh__D028101smesh__D019684
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D028101 2006
% 215.96/216.13  |- mesh__dateEstablished mesh__D028101 2002-01-01
% 215.96/216.13  |- rdf__type mesh__D028101sskos__Concept
% 215.96/216.13  |- skos__prefLabel mesh__D028101 Papaveraceae
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D028101 2005
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D028101 2004
% 215.96/216.13  |- skos__historyNote mesh__D028101 Papaver %28%1998-2001%29%
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D028101 2003
% 215.96/216.13  |- mesh__dateCreated mesh__D028101 2001-07-25
% 215.96/216.13  |- mesh__historyNote mesh__D028101 2002; use Papaver 1998-2001   
% 215.96/216.13  |- mesh__dateRevised mesh__D028101 2002-07-03
% 215.96/216.13  |- skos__scopeNote mesh__D028101
% 215.96/216.13       The poppy plant family of the order Papaverales, subclass Magnoliidae, class Magnoliopsida. These have bisexual, regular, cup-shaped flowers with one superior pistil and many stamens; 2 or 3 conspicuous, separate sepals and a number of separate petals. The fruit is a capsule. Leaves are usually deeply cut or divided into leaflets.%A%    
% 215.96/216.13  |- skos__annotation mesh__D028101
% 215.96/216.13       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.96/216.13  |- skos__hiddenLabel mesh__D019375 Recombinant G CSF
% 215.96/216.13  |- mesh__dateRevised mesh__D019375 2005-06-30
% 215.96/216.13  |- mesh__recordAuthorizer mesh__D019375 sjn
% 215.96/216.13  |- mesh__historyNote mesh__D019375 97   
% 215.96/216.13  |- skos__altLabel mesh__D019375 Recombinant G-CSF
% 215.96/216.13  |- skos__historyNote mesh__D019375
% 215.96/216.13       Granulocyte Colony-Stimulating Factor %28%1991-1996%29%
% 215.96/216.13  |- mesh__recordMaintainer mesh__D019375 ssb
% 215.96/216.13  |- mesh__recordOriginator mesh__D019375 ADP
% 215.96/216.13  |- skos__broader mesh__D019375smesh__D019374
% 215.96/216.13  |- skos__historyNote mesh__D019375 Recombinant Proteins %28%1986-1996%29%
% 215.96/216.13  |- mesh__dateEstablished mesh__D019375 1997-01-01
% 215.96/216.13  |- skos__altLabel mesh__D019375
% 215.96/216.13       Recombinant Granulocyte Colony Stimulating Factor
% 215.96/216.13  |- skos__altLabel mesh__D019375 G-CSF, Recombinant
% 215.96/216.13  |- skos__prefLabel mesh__D019375
% 215.96/216.13       Granulocyte Colony Stimulating Factor, Recombinant
% 215.96/216.13  |- rdf__type mesh__D019375sskos__Concept
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D019375 2006
% 215.96/216.13  |- mesh__publicMeSHNote mesh__D019375 97   
% 215.96/216.13  |- skos__broader mesh__D019375smesh__D016179
% 215.96/216.13  |- mesh__dateCreated mesh__D019375 1996-06-10
% 215.96/216.13  |- skos__hiddenLabel mesh__D019375 G CSF, Recombinant
% 215.96/216.13  |- skos__historyNote mesh__D019375
% 215.96/216.13       Colony-Stimulating Factors %28%1986-1990%29%
% 215.96/216.13  |- skos__annotation mesh__D019375 DF: GCSF RECOMBINANT   
% 215.96/216.13  |- skos__scopeNote mesh__D019375
% 215.96/216.13       Granulocyte colony stimulating factors prepared by recombinant DNA technology.%A%    
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D011392 2004
% 215.96/216.13  |- mesh__recordOriginator mesh__D011392 NLM
% 215.96/216.13  |- mesh__recordMaintainer mesh__D011392 adp
% 215.96/216.13  |- skos__annotation mesh__D011392 /biosyn /defic /physiol permitted   
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D011392 2002
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D011392 2006
% 215.96/216.13  |- skos__scopeNote mesh__D011392
% 215.96/216.13       A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons.%A%    
% 215.96/216.13  |- mesh__recordAuthorizer mesh__D011392 sjn
% 215.96/216.13  |- skos__hiddenLabel mesh__D011392 L Proline
% 215.96/216.13  |- skos__altLabel mesh__D011392 L-Proline
% 215.96/216.13  |- mesh__dateCreated mesh__D011392 1999-01-01
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D011392 2000
% 215.96/216.13  |- skos__prefLabel mesh__D011392 Proline
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D011392 2001
% 215.96/216.13  |- mesh__dateRevised mesh__D011392 1999-11-03
% 215.96/216.13  |- rdf__type mesh__D011392sskos__Concept
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D011392 2003
% 215.96/216.13  |- skos__broader mesh__D011392smesh__D007098
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D011392 2005
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D027807 2003
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D027807 2004
% 215.96/216.13  |- mesh__historyNote mesh__D027807 2002; use FABACEAE 1986-2001   
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D027807 2002
% 215.96/216.13  |- mesh__dateCreated mesh__D027807 2001-07-25
% 215.96/216.13  |- mesh__dateEstablished mesh__D027807 2002-01-01
% 215.96/216.13  |- skos__broader mesh__D027807smesh__D007887
% 215.96/216.13  |- skos__annotation mesh__D027807
% 215.96/216.13       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 215.96/216.13  |- skos__prefLabel mesh__D027807 Lathyrus
% 215.96/216.13  |- skos__historyNote mesh__D027807 Fabaceae %28%1978-2001%29%
% 215.96/216.13  |- mesh__publicMeSHNote mesh__D027807 2002; see FABACEAE 1986-2001   
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D027807 2005
% 215.96/216.13  |- skos__scopeNote mesh__D027807
% 215.96/216.13       A plant genus in the family FABACEAE known for LATHYRISM poisoning.%A%    
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D027807 2006
% 215.96/216.13  |- rdf__type mesh__D027807sskos__Concept
% 215.96/216.13  |- mesh__recordAuthorizer mesh__D052200 sjn
% 215.96/216.13  |- mesh__historyNote mesh__D052200 2006   
% 215.96/216.13  |- mesh__dateEstablished mesh__D052200 2006-01-01
% 215.96/216.13  |- skos__scopeNote mesh__D052200
% 215.96/216.13       A species of gram-positive, rod-shaped LACTIC ACID bacteria found naturally in the human intestinal flora and BREAST MILK.%A%    
% 215.96/216.13  |- skos__prefLabel mesh__D052200 Lactobacillus reuteri
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D052200 2006
% 215.96/216.13  |- rdf__type mesh__D052200sskos__Concept
% 215.96/216.13  |- skos__broader mesh__D052200smesh__D007778
% 215.96/216.13  |- skos__historyNote mesh__D052200 Lactobacillus %28%1982-2005%29%
% 215.96/216.13  |- mesh__dateCreated mesh__D052200 2005-06-30
% 215.96/216.13  |- mesh__recordOriginator mesh__D052200 ags
% 215.96/216.13  |- mesh__recordMaintainer mesh__D052200 ags
% 215.96/216.13  |- mesh__publicMeSHNote mesh__D052200 2006   
% 215.96/216.13  |- mesh__publicMeSHNote mesh__D005355 87   
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D005355 2005
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D005355 2004
% 215.96/216.13  |- skos__prefLabel mesh__D005355 Fibrosis
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D005355 2001
% 215.96/216.13  |- mesh__dateCreated mesh__D005355 1986-03-25
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D005355 2003
% 215.96/216.13  |- mesh__historyNote mesh__D005355 87   
% 215.96/216.13  |- mesh__recordAuthorizer mesh__D005355 sjn
% 215.96/216.13  |- mesh__activeMeSHYear mesh__D005355 2000
% 215.96/216.13  |- skos__historyNote mesh__D005355
% 215.96/216.13       specific organ/pathology %28%1966-1986%29%
% 215.96/216.13  |- skos__hiddenLabel mesh__D005355 Fibroses
% 215.96/216.13  |- skos__scopeNote mesh__D005355
% 215.96/216.13       Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.%A%    
% 215.96/216.13  |- skos__broader mesh__D005355smesh__D010335
% 215.96/216.13  |- mesh__dateRevised mesh__D005355 1999-11-03
% 215.96/216.13  |- rdf__type mesh__D005355sskos__Concept
% 215.96/216.13  |- mesh__dateEstablished mesh__D005355 1987-01-01
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D005355 2002
% 215.96/216.14  |- mesh__recordOriginator mesh__D005355 SH
% 215.96/216.14  |- mesh__recordMaintainer mesh__D005355 KEV
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D005355 2006
% 215.96/216.14  |- skos__annotation mesh__D005355
% 215.96/216.14       NIM only as pathol process with no qualif: coord with Cat A term /pathol %28%IM%29%; several specific fibrosis terms are also available%A%  
% 215.96/216.14  |- skos__altLabel mesh__D051906 Madh7 Protein
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D051906 2006
% 215.96/216.14  |- rdf__type mesh__D051906sskos__Concept
% 215.96/216.14  |- skos__scopeNote mesh__D051906
% 215.96/216.14       An inhibitory smad protein that associates with TRANSFORMING GROWTH FACTOR BETA RECEPTORS and BONE MORPHOGENETIC PROTEIN RECEPTORS. It negatively regulates SIGNAL TRANSDUCTION PATHWAYS by inhibiting PHOSPHORYLATION of RECEPTOR-REGULATED SMAD PROTEINS.%A%    
% 215.96/216.14  |- mesh__recordAuthorizer mesh__D051906 sjn
% 215.96/216.14  |- skos__prefLabel mesh__D051906 Smad7 Protein
% 215.96/216.14  |- mesh__dateEstablished mesh__D051906 2006-01-01
% 215.96/216.14  |- mesh__dateCreated mesh__D051906 2005-06-30
% 215.96/216.14  |- mesh__historyNote mesh__D051906 2006%28%1997%29%   
% 215.96/216.14  |- skos__broader mesh__D051906smesh__D051897
% 215.96/216.14  |- mesh__publicMeSHNote mesh__D051906
% 215.96/216.14       2006; SMAD7 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1997-2005%A%  
% 215.96/216.14  |- mesh__recordOriginator mesh__D051906 DRC
% 215.96/216.14  |- mesh__recordMaintainer mesh__D051906 DRC
% 215.96/216.14  |- skos__broader mesh__D015783smesh__D007499
% 215.96/216.14  |- mesh__recordMaintainer mesh__D015783 nns
% 215.96/216.14  |- skos__broader mesh__D015783smesh__D015785
% 215.96/216.14  |- mesh__recordAuthorizer mesh__D015783 sjn
% 215.96/216.14  |- rdf__type mesh__D015783sskos__Concept
% 215.96/216.14  |- skos__broader mesh__D015783smesh__D005124
% 215.96/216.14  |- mesh__dateRevised mesh__D015783 2001-07-25
% 215.96/216.14  |- skos__prefLabel mesh__D015783 Aniridia
% 215.96/216.14  |- mesh__historyNote mesh__D015783 90   
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D015783 2004
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D015783 2002
% 215.96/216.14  |- skos__historyNote mesh__D015783 Chromosome Deletion %28%1975-1989%29%
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D015783 2006
% 215.96/216.14  |- mesh__dateEstablished mesh__D015783 1990-01-01
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D015783 2003
% 215.96/216.14  |- skos__historyNote mesh__D015783 Iris/abnormalities %28%1966-1989%29%
% 215.96/216.14  |- mesh__recordOriginator mesh__D015783 EGC
% 215.96/216.14  |- mesh__publicMeSHNote mesh__D015783 90   
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D015783 2005
% 215.96/216.14  |- skos__scopeNote mesh__D015783
% 215.96/216.14       A congenital abnormality in which there is only a rudimentary iris. This is due to the failure of the optic cup to grow. Aniridia also occurs in a hereditary form, usually autosomal dominant.%A%    
% 215.96/216.14  |- mesh__dateCreated mesh__D015783 1989-05-25
% 215.96/216.14  |- skos__annotation mesh__D015783
% 215.96/216.14       rudimentary iris; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D009746 2004
% 215.96/216.14  |- skos__prefLabel mesh__D009746 Nursing, Team
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D009746 2005
% 215.96/216.14  |- mesh__dateRevised mesh__D009746 1999-11-03
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D009746 2003
% 215.96/216.14  |- mesh__historyNote mesh__D009746 67%28%65%29%   
% 215.96/216.14  |- rdf__type mesh__D009746sskos__Concept
% 215.96/216.14  |- mesh__dateEstablished mesh__D009746 1967-01-01
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D009746 2001
% 215.96/216.14  |- mesh__recordOriginator mesh__D009746 NLM
% 215.96/216.14  |- skos__broader mesh__D009746smesh__D010348
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D009746 2000
% 215.96/216.14  |- mesh__dateCreated mesh__D009746 1999-01-01
% 215.96/216.14  |- mesh__recordMaintainer mesh__D009746 kle
% 215.96/216.14  |- skos__annotation mesh__D009746
% 215.96/216.14       IM; consider also PATIENT CARE TEAM; DF: NURS TEAM   
% 215.96/216.14  |- mesh__recordAuthorizer mesh__D009746 sjn
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D009746 2006
% 215.96/216.14  |- skos__scopeNote mesh__D009746
% 215.96/216.14       Coordination of nursing services by various nursing care personnel under the leadership of a professional nurse. The team may consist of a professional nurse, nurses%27% aides, and the practical nurse.%A%    
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D009746 2002
% 215.96/216.14  |- skos__altLabel mesh__D009746 Team Nursing
% 215.96/216.14  |- mesh__publicMeSHNote mesh__D009746 67   
% 215.96/216.14  |- skos__hiddenLabel mesh__D001763 Eyelid Ptoses
% 215.96/216.14  |- mesh__recordMaintainer mesh__D001763 TGC
% 215.96/216.14  |- skos__altLabel mesh__D001763 Ptosis, Eyelid
% 215.96/216.14  |- skos__broader mesh__D001763smesh__D005141
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001763 2006
% 215.96/216.14  |- mesh__recordOriginator mesh__D001763 NLM
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001763 1999
% 215.96/216.14  |- mesh__dateEstablished mesh__D001763 1967-01-01
% 215.96/216.14  |- skos__related mesh__D001763smesh__D019882
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001763 2002
% 215.96/216.14  |- mesh__dateCreated mesh__D001763 1999-01-01
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001763 2005
% 215.96/216.14  |- mesh__historyNote mesh__D001763 67%28%65%29%   
% 215.96/216.14  |- skos__annotation mesh__D001763 drooping eyelid   
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001763 1998
% 215.96/216.14  |- skos__hiddenLabel mesh__D001763 Ptoses, Eyelid
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001763 2001
% 215.96/216.14  |- mesh__recordAuthorizer mesh__D001763 SJN
% 215.96/216.14  |- rdf__type mesh__D001763sskos__Concept
% 215.96/216.14  |- skos__prefLabel mesh__D001763 Blepharoptosis
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001763 2004
% 215.96/216.14  |- mesh__publicMeSHNote mesh__D001763 67   
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001763 2000
% 215.96/216.14  |- skos__hiddenLabel mesh__D001763 Eyelid Ptosis
% 215.96/216.14  |- skos__scopeNote mesh__D001763
% 215.96/216.14       Drooping of the upper lid due to deficient development or paralysis of the levator palpebrae muscle.%A%    
% 215.96/216.14  |- mesh__dateRevised mesh__D001763 1997-06-20
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001763 2003
% 215.96/216.14  |- skos__hiddenLabel mesh__D001763 Blepharoptoses
% 215.96/216.14  |- skos__hiddenLabel mesh__D019376
% 215.96/216.14       Recombinant Methionyl Human Granulocyte Colony Stimulating Factor
% 215.96/216.14  |- skos__hiddenLabel mesh__D019376 G CSF Recombinant, Human Methionyl
% 215.96/216.14  |- mesh__dateEstablished mesh__D019376 1997-01-01
% 215.96/216.14  |- skos__altLabel mesh__D019376 r-metHuG-CSF
% 215.96/216.14  |- mesh__dateCreated mesh__D019376 1996-06-10
% 215.96/216.14  |- mesh__recordMaintainer mesh__D019376 ssb
% 215.96/216.14  |- skos__scopeNote mesh__D019376
% 215.96/216.14       A hematopoietic growth factor which promotes proliferation and maturation of neutrophil granulocytes. Clinically it is effective in decreasing the incidence of febrile neutropenia in patients with non-myeloid malignancies receiving myelosuppressive therapy or in reducing the duration of neutropenia and neutropenia-related clinical sequelae in patients with non-myeloid malignancies undergoing myeloblastive chemotherapy followed by BMT. It has also been used in AIDS patients with CMV retinitis being treated with GANCICLOVIR. %28%Gelman CR, Rumack BH %26% Hess AJ %28%eds%29%: DRUGDEX%28%R%29% System. MICROMEDEX, Inc., Englewood, Colorado %28%Edition expires 11/30/95%29%%29%%A%    
% 215.96/216.14  |- mesh__publicMeSHNote mesh__D019376
% 215.96/216.14       97; FILGRASTIM was indexed under GRANULOCYTE COLONY-STIMULATING FACTOR 1994-96, RECOMBINANT PROTEINS 1992-96, %26% COLONY-STIMULATING FACTORS 1992-93%A%  
% 215.96/216.14  |- skos__altLabel mesh__D019376
% 215.96/216.14       Recombinant-Methionyl Human Granulocyte Colony-Stimulating Factor
% 215.96/216.14  |- skos__altLabel mesh__D019376 G-CSF Recombinant, Human Methionyl
% 215.96/216.14  |- mesh__dateRevised mesh__D019376 2005-06-30
% 215.96/216.14  |- mesh__recordAuthorizer mesh__D019376 sjn
% 215.96/216.14  |- skos__prefLabel mesh__D019376 Filgrastim
% 215.96/216.14  |- rdf__type mesh__D019376sskos__Concept
% 215.96/216.14  |- skos__historyNote mesh__D019376
% 215.96/216.14       Colony-Stimulating Factors %28%1992-1993%29%
% 215.96/216.14  |- mesh__recordOriginator mesh__D019376 TPW
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D019376 2006
% 215.96/216.14  |- mesh__onlineNote mesh__D019376
% 215.96/216.14       use FILGRASTIM %28%NM%29% to search FILGRASTIM 1992-96   
% 215.96/216.14  |- skos__broader mesh__D019376smesh__D019375
% 215.96/216.14  |- skos__historyNote mesh__D019376 Recombinant Proteins %28%1992-1996%29%
% 215.96/216.14  |- mesh__historyNote mesh__D019376 97; was FILGRASTIM %28%NM%29% 1992-96   
% 215.96/216.14  |- skos__annotation mesh__D019376 /drug eff permitted   
% 215.96/216.14  |- skos__historyNote mesh__D019376
% 215.96/216.14       Granulocyte Colony-Stimulating Factor %28%1994-1996%29%
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D011393 2006
% 215.96/216.14  |- skos__hiddenLabel mesh__D011393 Hydroxylase, Peptidyl Prolyl
% 215.96/216.14  |- skos__hiddenLabel mesh__D011393 4-Dioxygenase, Proline,2-Oxoglutarate
% 215.96/216.14  |- mesh__onlineNote mesh__D011393
% 215.96/216.14       use PROCOLLAGEN-PROLINE DIOXYGENASE to search PROLINE HYDROXYLASE 1972-93 %28%as Prov 1972-73%29% %26% PROLINE,2-OXOGLUTARATE DIOXYGENASE 1977-93%A%  
% 215.96/216.14  |- mesh__dateRevised mesh__D011393 2004-07-07
% 215.96/216.14  |- mesh__dateEstablished mesh__D011393 1974-01-01
% 215.96/216.14  |- skos__hiddenLabel mesh__D011393 Prolyl Hydroxylase, Peptidyl
% 215.96/216.14  |- skos__hiddenLabel mesh__D011393 4-Hydroxylase, Prolyl
% 215.96/216.14  |- mesh__historyNote mesh__D011393
% 215.96/216.14       94; was PROLINE HYDROXYLASE 1972-93 %28%Prov 1972-73%29%; PROLINE,2-OXOGLUTARATE 4-DIOXYGENASE was PROLINE,2-OXOGLUTARATE DIOXYGENASE see PROLINE HYDROXYLASE 1977-93%A%  
% 215.96/216.14  |- mesh__dateCreated mesh__D011393 1999-01-01
% 215.96/216.14  |- skos__hiddenLabel mesh__D011393 Hydroxylase, Proline
% 215.96/216.14  |- skos__altLabel mesh__D011393 Protocollagen Prolyl Hydroxylase
% 215.96/216.14  |- skos__altLabel mesh__D011393 Prolyl 4-Hydroxylase
% 215.96/216.14  |- mesh__recordOriginator mesh__D011393 NLM
% 215.96/216.14  |- skos__hiddenLabel mesh__D011393 Prolyl 4-Hydroxylase, Procollagen
% 215.96/216.14  |- skos__historyNote mesh__D011393 Hydroxylases %28%1966-1971%29%
% 215.96/216.14  |- skos__broader mesh__D011393smesh__D006899
% 215.96/216.14  |- skos__hiddenLabel mesh__D011393 Hydroxylase, Prolyl
% 215.96/216.14  |- skos__altLabel mesh__D011393 Proline Hydroxylase
% 215.96/216.14  |- skos__hiddenLabel mesh__D011393 Procollagen Proline Dioxygenase
% 215.96/216.14  |- skos__scopeNote mesh__D011393
% 215.96/216.14       A mixed-function oxygenase that catalyzes the hydroxylation of a prolyl-glycyl-containing-peptide, usually in protocollagen, to a hydroxyprolylglycyl-containing-peptide. The enzyme utilizes molecular oxygen with a concomitant oxidative decarboxylation of 2-oxoglutarate to succinate. EC 1.14.11.2.%A%    
% 215.96/216.14  |- skos__hiddenLabel mesh__D011393 Prolyl 4 Hydroxylase
% 215.96/216.14  |- skos__altLabel mesh__D011393 Procollagen Prolyl 4-Hydroxylase
% 215.96/216.14  |- mesh__recordAuthorizer mesh__D011393 sjn
% 215.96/216.14  |- rdf__type mesh__D011393sskos__Concept
% 215.96/216.14  |- skos__altLabel mesh__D011393 Prolyl Hydroxylase
% 215.96/216.14  |- mesh__recordMaintainer mesh__D011393 ssb
% 215.96/216.14  |- skos__hiddenLabel mesh__D011393 Dioxygenase, Procollagen-Proline
% 215.96/216.14  |- skos__hiddenLabel mesh__D011393 Procollagen Prolyl 4 Hydroxylase
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D011393 2005
% 215.96/216.14  |- skos__hiddenLabel mesh__D011393 Prolyl Hydroxylase, Protocollagen
% 215.96/216.14  |- skos__hiddenLabel mesh__D011393 4-Hydroxylase, Procollagen Prolyl
% 215.96/216.14  |- mesh__publicMeSHNote mesh__D011393
% 215.96/216.14       94; was PROLINE HYDROXYLASE 1974-93; PROLINE,2-OXOGLUTARATE 4-DIOXYGENASE was PROLINE,2-OXOGLUTARATE DIOXYGENASE see PROLINE HYDROXYLASE 1977-93%A%  
% 215.96/216.14  |- skos__altLabel mesh__D011393 Proline,2-Oxoglutarate 4-Dioxygenase
% 215.96/216.14  |- skos__altLabel mesh__D011393 Peptidyl Prolyl Hydroxylase
% 215.96/216.14  |- skos__prefLabel mesh__D011393 Procollagen-Proline Dioxygenase
% 215.96/216.14  |- skos__related mesh__D011393smesh__D019704
% 215.96/216.14  |- skos__hiddenLabel mesh__D011393 Proline,2 Oxoglutarate 4 Dioxygenase
% 215.96/216.14  |- skos__hiddenLabel mesh__D011393 Hydroxylase, Protocollagen Prolyl
% 215.96/216.14  |- skos__historyNote mesh__D052201 Lactobacillus %28%1963-2005%29%
% 215.96/216.14  |- mesh__recordOriginator mesh__D052201 ags
% 215.96/216.14  |- mesh__dateCreated mesh__D052201 2005-06-30
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D052201 2006
% 215.96/216.14  |- mesh__recordAuthorizer mesh__D052201 sjn
% 215.96/216.14  |- mesh__historyNote mesh__D052201 2006   
% 215.96/216.14  |- skos__scopeNote mesh__D052201
% 215.96/216.14       A species of gram-positive, rod-shaped bacteria used in PROBIOTICS.%A%    
% 215.96/216.14  |- rdf__type mesh__D052201sskos__Concept
% 215.96/216.14  |- mesh__dateEstablished mesh__D052201 2006-01-01
% 215.96/216.14  |- skos__broader mesh__D052201smesh__D007778
% 215.96/216.14  |- mesh__recordMaintainer mesh__D052201 ags
% 215.96/216.14  |- mesh__publicMeSHNote mesh__D052201 2006   
% 215.96/216.14  |- skos__prefLabel mesh__D052201 Lactobacillus rhamnosus
% 215.96/216.14  |- skos__scopeNote mesh__D005356
% 215.96/216.14       A common nonarticular rheumatic syndrome characterized by myalgia and multiple points of focal muscle tenderness to palpation %28%trigger points%29%. Muscle pain is typically aggravated by inactivity or exposure to cold. This condition is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, HEADACHES, and occasionally DEPRESSION. There is significant overlap between fibromyalgia and the chronic fatigue syndrome %28%FATIGUE SYNDROME, CHRONIC%29%. Fibromyalgia may arise as a primary or secondary disease process. It is most frequent in females aged 20 to 50 years. %28%From Adams et al., Principles of Neurology, 6th ed, p1494-95%29%%A%    
% 215.96/216.14  |- rdf__type mesh__D005356sskos__Concept
% 215.96/216.14  |- mesh__dateRevised mesh__D005356 1999-11-03
% 215.96/216.14  |- skos__broader mesh__D005356smesh__D012216
% 215.96/216.14  |- mesh__recordOriginator mesh__D005356 NLM
% 215.96/216.14  |- skos__altLabel mesh__D005356 Diffuse Myofascial Pain Syndrome
% 215.96/216.14  |- skos__hiddenLabel mesh__D005356 Fibromyositis Fibromyalgia Syndrome
% 215.96/216.14  |- skos__altLabel mesh__D005356 Fibromyositis-Fibromyalgia Syndrome
% 215.96/216.14  |- skos__altLabel mesh__D005356 Fibromyalgia-Fibromyositis Syndrome
% 215.96/216.14  |- skos__hiddenLabel mesh__D005356 Fibromyalgia-Fibromyositis Syndromes
% 215.96/216.14  |- skos__hiddenLabel mesh__D005356 Syndromes, Fibromyalgia-Fibromyositis
% 215.96/216.14  |- skos__altLabel mesh__D005356 Rheumatism, Muscular
% 215.96/216.14  |- mesh__recordAuthorizer mesh__D005356 sjn
% 215.96/216.14  |- skos__hiddenLabel mesh__D005356 Primary Fibromyalgias
% 215.96/216.14  |- skos__hiddenLabel mesh__D005356 Fibromyalgias, Primary
% 215.96/216.14  |- skos__hiddenLabel mesh__D005356 Syndrome, Fibromyalgia-Fibromyositis
% 215.96/216.14  |- skos__hiddenLabel mesh__D005356 Muscular Rheumatism
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D005356 2002
% 215.96/216.14  |- mesh__dateCreated mesh__D005356 1999-01-01
% 215.96/216.14  |- mesh__recordMaintainer mesh__D005356 KEV
% 215.96/216.14  |- skos__hiddenLabel mesh__D005356 Fibromyalgia Fibromyositis Syndrome
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D005356 2003
% 215.96/216.14  |- skos__hiddenLabel mesh__D005356 Fibromyalgias, Secondary
% 215.96/216.14  |- skos__prefLabel mesh__D005356 Fibromyalgia
% 215.96/216.14  |- skos__related mesh__D005356smesh__D015673
% 215.96/216.14  |- skos__altLabel mesh__D005356 Myofascial Pain Syndrome, Diffuse
% 215.96/216.14  |- skos__hiddenLabel mesh__D005356 Fibromyalgias
% 215.96/216.14  |- skos__altLabel mesh__D005356 Fibrositis
% 215.96/216.14  |- mesh__publicMeSHNote mesh__D005356 89; was FIBROSITIS 1963-88   
% 215.96/216.14  |- skos__broader mesh__D005356smesh__D009135
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D005356 2004
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D005356 2005
% 215.96/216.14  |- skos__hiddenLabel mesh__D005356 Primary Fibromyalgia
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D005356 2000
% 215.96/216.14  |- skos__hiddenLabel mesh__D005356 Fibromyositis-Fibromyalgia Syndromes
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D005356 2006
% 215.96/216.14  |- mesh__onlineNote mesh__D005356
% 215.96/216.14       use FIBROMYALGIA to search FIBROSITIS 1966-88   
% 215.96/216.14  |- skos__hiddenLabel mesh__D005356 Syndromes, Fibromyositis-Fibromyalgia
% 215.96/216.14  |- skos__hiddenLabel mesh__D005356 Syndrome, Fibromyositis-Fibromyalgia
% 215.96/216.14  |- skos__hiddenLabel mesh__D005356 Fibrositides
% 215.96/216.14  |- skos__hiddenLabel mesh__D005356 Secondary Fibromyalgias
% 215.96/216.14  |- mesh__historyNote mesh__D005356 89; was FIBROSITIS 1963-88   
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D005356 2001
% 215.96/216.14  |- skos__hiddenLabel mesh__D005356 Secondary Fibromyalgia
% 215.96/216.14  |- mesh__dateEstablished mesh__D024510 2002-01-01
% 215.96/216.14  |- mesh__historyNote mesh__D024510 2002   
% 215.96/216.14  |- skos__hiddenLabel mesh__D024510 Development, Muscle
% 215.96/216.14  |- skos__scopeNote mesh__D024510
% 215.96/216.14       Developmental events leading to the formation of adult muscular system, which includes differentiation of the various types of muscle cell precursors, migration of myoblasts, activation of myogenesis and development of muscle anchorage.%A%    
% 215.96/216.14  |- mesh__recordOriginator mesh__D024510 nns
% 215.96/216.14  |- mesh__recordAuthorizer mesh__D024510 sjn
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D024510 2006
% 215.96/216.14  |- mesh__recordMaintainer mesh__D024510 lkt
% 215.96/216.14  |- mesh__publicMeSHNote mesh__D024510 2002   
% 215.96/216.14  |- mesh__dateCreated mesh__D024510 2001-07-25
% 215.96/216.14  |- rdf__type mesh__D024510sskos__Concept
% 215.96/216.14  |- skos__altLabel mesh__D024510 Muscular Development
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D024510 2005
% 215.96/216.14  |- skos__annotation mesh__D024510
% 215.96/216.14       coord with specific muscle term if pertinent   
% 215.96/216.14  |- skos__broader mesh__D024510smesh__D041641
% 215.96/216.14  |- skos__hiddenLabel mesh__D024510 Development, Muscular
% 215.96/216.14  |- mesh__dateRevised mesh__D024510 2004-07-07
% 215.96/216.14  |- skos__prefLabel mesh__D024510 Muscle Development
% 215.96/216.14  |- skos__altLabel mesh__D051907 LAMP Proteins
% 215.96/216.14  |- mesh__recordAuthorizer mesh__D051907 sjn
% 215.96/216.14  |- skos__hiddenLabel mesh__D051907 Membrane Proteins, Lysosomal
% 215.96/216.14  |- mesh__recordMaintainer mesh__D051907 DRC
% 215.96/216.14  |- skos__hiddenLabel mesh__D051907
% 215.96/216.14       Membrane Glycoproteins, Lysosome-Associated
% 215.96/216.14  |- mesh__dateEstablished mesh__D051907 2006-01-01
% 215.96/216.14  |- mesh__publicMeSHNote mesh__D051907
% 215.96/216.14       2006; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS was indexed under ANTIGENS, CD 2003-2005, %26% under MEMBRANE GLYCOPROTEINS 1986-2002%A%  
% 215.96/216.14  |- skos__altLabel mesh__D051907 DC-LAMP Protein
% 215.96/216.14  |- skos__hiddenLabel mesh__D051907 Lysosome Associated Membrane Proteins
% 215.96/216.14  |- skos__hiddenLabel mesh__D051907 Membrane Glycoproteins, Lysosomal
% 215.96/216.14  |- mesh__historyNote mesh__D051907 2006%28%1986%29%   
% 215.96/216.14  |- skos__altLabel mesh__D051907 Lipophosphoglycan Proteins %28%Lysosome%29%
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D051907 2006
% 215.96/216.14  |- skos__prefLabel mesh__D051907 Lysosome-Associated Membrane Glycoproteins
% 215.96/216.14  |- skos__hiddenLabel mesh__D051907 DC LAMP Protein
% 215.96/216.14  |- skos__altLabel mesh__D051907 Lysosome-Associated Membrane Proteins
% 215.96/216.14  |- skos__scopeNote mesh__D051907
% 215.96/216.14       Ubiquitously expressed integral membrane glycoproteins found in the LYSOSOME.%A%    
% 215.96/216.14  |- skos__hiddenLabel mesh__D051907 Lysosomal Associated Membrane Protein 3
% 215.96/216.14  |- skos__altLabel mesh__D051907 LIMP Proteins
% 215.96/216.14  |- mesh__dateCreated mesh__D051907 2005-06-30
% 215.96/216.14  |- rdf__type mesh__D051907sskos__Concept
% 215.96/216.14  |- skos__altLabel mesh__D051907 Lysosomal Membrane Proteins
% 215.96/216.14  |- skos__broader mesh__D051907smesh__D008562
% 215.96/216.14  |- skos__altLabel mesh__D051907 LGP Proteins %28%Lysosome%29%
% 215.96/216.14  |- mesh__recordOriginator mesh__D051907 DRC
% 215.96/216.14  |- skos__hiddenLabel mesh__D051907 Lysosomal Associated Membrane Proteins
% 215.96/216.14  |- skos__hiddenLabel mesh__D051907
% 215.96/216.14       Lysosome Associated Membrane Glycoproteins
% 215.96/216.14  |- skos__altLabel mesh__D015784 Kerlon
% 215.96/216.14  |- skos__altLabel mesh__D015784 Boots Brand of Betaxolol Hydrochloride
% 215.96/216.14  |- skos__altLabel mesh__D015784 Betoptima
% 215.96/216.14  |- mesh__dateRevised mesh__D015784 2005-06-30
% 215.96/216.14  |- skos__altLabel mesh__D015784 Betaxolol Alcon
% 215.96/216.14  |- mesh__recordOriginator mesh__D015784 RLS
% 215.96/216.14  |- skos__scopeNote mesh__D015784
% 215.96/216.14       A cardioselective beta-1-adrenergic antagonist with no partial agonist activity.%A%    
% 215.96/216.14  |- skos__historyNote mesh__D015784 Propanolamines %28%1974-1989%29%
% 215.96/216.14  |- mesh__historyNote mesh__D015784 90   
% 215.96/216.14  |- skos__altLabel mesh__D015784
% 215.96/216.14       Synth%C3%%A9%labo Brand of Betaxolol Hydrochloride
% 215.96/216.14  |- skos__altLabel mesh__D015784 Alcon Brand of Betaxolol Hydrochloride
% 215.96/216.14  |- skos__hiddenLabel mesh__D015784 Hydrochloride, Betaxolol
% 215.96/216.14  |- skos__hiddenLabel mesh__D015784 SL75212
% 215.96/216.14  |- rdf__type mesh__D015784sskos__Concept
% 215.96/216.14  |- skos__altLabel mesh__D015784 Searle Brand of Betaxolol Hydrochloride
% 215.96/216.14  |- skos__altLabel mesh__D015784 Lorex Brand of Betaxolol Hydrochloride
% 215.96/216.14  |- mesh__dateCreated mesh__D015784 1989-05-26
% 215.96/216.14  |- skos__prefLabel mesh__D015784 Betaxolol
% 215.96/216.14  |- skos__altLabel mesh__D015784 Allphar Brand of Betaxolol Hydrochloride
% 215.96/216.14  |- skos__hiddenLabel mesh__D015784 ALO 1401 02
% 215.96/216.14  |- skos__hiddenLabel mesh__D015784 Alcon, Betaxolol
% 215.96/216.14  |- skos__historyNote mesh__D015784
% 215.96/216.14       Antihypertensive Agents %28%1966-1989%29%
% 215.96/216.14  |- skos__altLabel mesh__D015784 Oxodal
% 215.96/216.14  |- skos__broader mesh__D015784smesh__D011412
% 215.96/216.14  |- mesh__dateEstablished mesh__D015784 1990-01-01
% 215.96/216.14  |- mesh__publicMeSHNote mesh__D015784 90   
% 215.96/216.14  |- skos__historyNote mesh__D015784
% 215.96/216.14       Adrenergic beta-Antagonists %28%1969-1989%29%
% 215.96/216.14  |- skos__hiddenLabel mesh__D015784 ALO140102
% 215.96/216.14  |- skos__altLabel mesh__D015784 Synthelabo Brand of Betaxolol Hydrochloride
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D015784 2006
% 215.96/216.14  |- mesh__recordAuthorizer mesh__D015784 sjn
% 215.96/216.14  |- skos__altLabel mesh__D015784 Schwarz Brand of Betaxolol Hydrochloride
% 215.96/216.14  |- mesh__recordMaintainer mesh__D015784 ssb
% 215.96/216.14  |- skos__broader mesh__D015784smesh__D050198
% 215.96/216.14  |- skos__hiddenLabel mesh__D015784 SL 75212
% 215.96/216.14  |- skos__annotation mesh__D009747
% 215.96/216.14       GEN; prefer specifics; differentiate from FOOD and DIET; clinical nutrition as a specialty goes here%A%  
% 215.96/216.14  |- skos__related mesh__D009747smesh__D004032
% 215.96/216.14  |- skos__altLabel mesh__D009747 Nutrition Indexes
% 215.96/216.14  |- skos__hiddenLabel mesh__D009747 Nutrition Indices
% 215.96/216.14  |- skos__prefLabel mesh__D009747 Nutrition
% 215.96/216.14  |- skos__related mesh__D009747smesh__D005502
% 215.96/216.14  |- mesh__recordAuthorizer mesh__D009747 sjn
% 215.96/216.14  |- mesh__dateCreated mesh__D009747 1999-01-01
% 215.96/216.14  |- skos__hiddenLabel mesh__D009747 Indexes, Nutrition
% 215.96/216.14  |- skos__broader mesh__D009747smesh__D006281
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D009747 2006
% 215.96/216.14  |- skos__broader mesh__D009747smesh__D001670
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D009747 2004
% 215.96/216.14  |- mesh__recordMaintainer mesh__D009747 ssb
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D009747 2005
% 215.96/216.14  |- mesh__dateRevised mesh__D009747 2002-07-03
% 215.96/216.14  |- skos__hiddenLabel mesh__D009747 Indices, Nutrition
% 215.96/216.14  |- mesh__recordOriginator mesh__D009747 NLM
% 215.96/216.14  |- skos__scopeNote mesh__D009747
% 215.96/216.14       The science of food, the nutrients and other substances contained therein, their action, interaction, and balance in relation to health and disease.%A%    
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D009747 2003
% 215.96/216.14  |- rdf__type mesh__D009747sskos__Concept
% 215.96/216.14  |- skos__hiddenLabel mesh__D009747 Index, Nutrition
% 215.96/216.14  |- mesh__recordAuthorizer mesh__D001764 PLS
% 215.96/216.14  |- mesh__dateRevised mesh__D001764 1993-05-25
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001764 1995
% 215.96/216.14  |- skos__hiddenLabel mesh__D001764 Blepharospasms
% 215.96/216.14  |- mesh__recordOriginator mesh__D001764 NLM
% 215.96/216.14  |- mesh__dateEstablished mesh__D001764 1991-01-01
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001764 1999
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001764 1994
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001764 2002
% 215.96/216.14  |- mesh__recordMaintainer mesh__D001764 TGC
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001764 1998
% 215.96/216.14  |- skos__broader mesh__D001764smesh__D005141
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001764 2006
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001764 2001
% 215.96/216.14  |- mesh__publicMeSHNote mesh__D001764
% 215.96/216.14       91; was see under EYELID DISEASES 1975-90   
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001764 1997
% 215.96/216.14  |- rdf__type mesh__D001764sskos__Concept
% 215.96/216.14  |- skos__scopeNote mesh__D001764
% 215.96/216.14       Excessive winking; tonic or clonic spasm of the orbicularis oculi muscle.%A%    
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001764 2005
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001764 2000
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001764 1996
% 215.96/216.14  |- skos__annotation mesh__D001764 spasm of eyelid musc   
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001764 2004
% 215.96/216.14  |- mesh__historyNote mesh__D001764
% 215.96/216.14       91%28%75%29%; was see under EYELID DISEASES 1975-90   
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D001764 2003
% 215.96/216.14  |- mesh__dateCreated mesh__D001764 1974-11-11
% 215.96/216.14  |- skos__prefLabel mesh__D001764 Blepharospasm
% 215.96/216.14  |- mesh__recordMaintainer mesh__D028901 ags
% 215.96/216.14  |- skos__related mesh__D028901smesh__D019913
% 215.96/216.14  |- skos__altLabel mesh__D028901 Nuclear Localization Signal-Binding Protein
% 215.96/216.14  |- skos__altLabel mesh__D028901 NLS Receptor
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D028901 2006
% 215.96/216.14  |- skos__hiddenLabel mesh__D028901 receptor, NLS
% 215.96/216.14  |- mesh__dateEstablished mesh__D028901 2002-01-01
% 215.96/216.14  |- skos__altLabel mesh__D028901 Nuclear Localization Sequence Receptor
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D028901 2006A
% 215.96/216.14  |- skos__historyNote mesh__D028901 Nuclear Proteins %28%1994-2001%29%
% 215.96/216.14  |- skos__prefLabel mesh__D028901 alpha Karyopherins
% 215.96/216.14  |- skos__hiddenLabel mesh__D028901 Karyopherins, alpha
% 215.96/216.14  |- mesh__dateCreated mesh__D028901 2001-07-25
% 215.96/216.14  |- skos__altLabel mesh__D028901 Karyopherin alpha
% 215.96/216.14  |- mesh__publicMeSHNote mesh__D028901
% 215.96/216.14       2002; KARYOPHERIN ALPHA %28%now ALPHA KARYOPHERINS%29% was indexed under NUCLEAR PROTEINS 1994-2001; IMPORTIN-ALPHA was indexed under NUCLEAR PROTEINS 1995-2001; NLS-BINDING PROTEIN, NLSBP %26% NUCLEAR LOCALIZATION SIGNAL-BINDING PROTEIN were indexed under NUCLEAR PROTEINS %26% PHOSPHOPROTEINS 1992-2001%A%  
% 215.96/216.14  |- skos__altLabel mesh__D028901 NLS-Binding Protein
% 215.96/216.14  |- mesh__recordOriginator mesh__D028901 jmp
% 215.96/216.14  |- mesh__recordAuthorizer mesh__D028901 ags
% 215.96/216.14  |- skos__broader mesh__D028901smesh__D028884
% 215.96/216.14  |- skos__scopeNote mesh__D028901
% 215.96/216.14       Nucleocytoplasmic transport molecules that bind to the NUCLEAR LOCALIZATION SIGNALS of cytoplasmic molecules destined to be imported into the CELL NUCLEUS. Once attached to their cargo they bind to BETA KARYOPHERINS and are transported through the NUCLEAR PORE COMPLEX. Inside the CELL NUCLEUS alpha karyopherins dissociate from beta karypherins and their cargo. They then form a complex with CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN and RAN GTP-BINDING PROTEIN which is exported to the CYTOPLASM.%A%    
% 215.96/216.14  |- skos__altLabel mesh__D028901 NLSBP
% 215.96/216.14  |- mesh__dateRevised mesh__D028901 2005-07-12
% 215.96/216.14  |- skos__altLabel mesh__D028901 Importin-alpha
% 215.96/216.14  |- mesh__historyNote mesh__D028901
% 215.96/216.14       2002; use ALPHA KARYOPHERINS %28%NM%29% 1994-2001; for IMPORTIN-ALPHA use KARYOPHERINS 1995-2001; for NLS-BINDING PROTEIN, NLSBP %26% NUCLEAR LOCALIZATION SIGNAL-BINDING PROTEIN use NOPP140 %28%NM%29% 1992-2001%A%  
% 215.96/216.14  |- rdf__type mesh__D028901sskos__Concept
% 215.96/216.14  |- mesh__publicMeSHNote mesh__D020120
% 215.96/216.14       99; IODOCYANOPINDOLOL was indexed under PINDOLOL/analogs %26% derivatives 1981-98%A%  
% 215.96/216.14  |- mesh__dateEstablished mesh__D020120 1999-01-01
% 215.96/216.14  |- mesh__historyNote mesh__D020120
% 215.96/216.14       99; use IODOCYANOPINDOLOL %28%NM%29% 1981-98   
% 215.96/216.14  |- mesh__dateRevised mesh__D020120 2005-06-30
% 215.96/216.14  |- mesh__recordAuthorizer mesh__D020120 sjn
% 215.96/216.14  |- skos__altLabel mesh__D020120 I-Cyanopindolol
% 215.96/216.14  |- skos__altLabel mesh__D020120 ICYP
% 215.96/216.14  |- skos__hiddenLabel mesh__D020120 I Cyanopindolol
% 215.96/216.14  |- skos__prefLabel mesh__D020120 Iodocyanopindolol
% 215.96/216.14  |- mesh__recordOriginator mesh__D020120 ADP
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D020120 2006
% 215.96/216.14  |- rdf__type mesh__D020120sskos__Concept
% 215.96/216.14  |- mesh__recordMaintainer mesh__D020120 ssb
% 215.96/216.14  |- skos__historyNote mesh__D020120
% 215.96/216.14       Pindolol/analogs %26% derivatives %28%1981-1998%29%
% 215.96/216.14  |- mesh__dateCreated mesh__D020120 1998-06-10
% 215.96/216.14  |- skos__scopeNote mesh__D020120
% 215.96/216.14       A highly selective and specific beta antagonist that is used to characterize beta-adrenoceptors.%A%    
% 215.96/216.14  |- skos__broader mesh__D020120smesh__D010869
% 215.96/216.14  |- rdf__type mesh__D047068sskos__Concept
% 215.96/216.14  |- skos__hiddenLabel mesh__D047068 Serotonin N Acetyltransferase
% 215.96/216.14  |- mesh__dateEstablished mesh__D047068 2005-01-01
% 215.96/216.14  |- skos__hiddenLabel mesh__D047068 N-Acetyltransferase, Serotonin
% 215.96/216.14  |- skos__altLabel mesh__D047068 Serotonin Acetylase
% 215.96/216.14  |- mesh__recordAuthorizer mesh__D047068 sjn
% 215.96/216.14  |- skos__hiddenLabel mesh__D047068 Acetyltransferase, Serotonin
% 215.96/216.14  |- skos__altLabel mesh__D047068 Serotonin N-Acetyltransferase
% 215.96/216.14  |- skos__scopeNote mesh__D047068
% 215.96/216.14       An acetyltransferase with specificity towards the amine group of aromatic alkylamines %28%arylalkylamines%29% such as SEROTONIN. This enzyme is also referred to as serotonin acetylase despite the fact that serotonin acetylation can also occur through the action of broad specificity acetyltransferases such as ARYLAMINE N-ACETYLTRANSFERASE.%A%    
% 215.96/216.14  |- mesh__dateCreated mesh__D047068 2004-07-07
% 215.96/216.14  |- mesh__publicMeSHNote mesh__D047068
% 215.96/216.14       2005; ARYLALKYLAMINE-N-ACETYLTRANSFERASE was indexed under ARYLAMINE N-ACETYLTRANSFERASE 1986-2004; for SEROTONIN ACETYLTRANSFERASE see ARYLAMINE N-ACETYLTRANSFERASE 1980-2004, for SEROTONIN N-ACETYLTRANSFERASE see ARYLAMINE N-ACETYLTRANSFERASE 1982-2004%A%  
% 215.96/216.14  |- skos__prefLabel mesh__D047068 Arylalkylamine N-Acetyltransferase
% 215.96/216.14  |- skos__altLabel mesh__D047068 Serotonin Acetyltransferase
% 215.96/216.14  |- mesh__recordMaintainer mesh__D047068 jmp
% 215.96/216.14  |- skos__hiddenLabel mesh__D047068 Arylalkylamine N Acetyltransferase
% 215.96/216.14  |- skos__hiddenLabel mesh__D047068 N-Acetyltransferase, Arylalkylamine
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D047068 2005
% 215.96/216.14  |- skos__broader mesh__D047068smesh__D000217
% 215.96/216.14  |- mesh__recordOriginator mesh__D047068 jmp
% 215.96/216.14  |- mesh__historyNote mesh__D047068 2005%28%1986%29%   
% 215.96/216.14  |- mesh__activeMeSHYear mesh__D047068 2006
% 215.96/216.15  |- skos__annotation mesh__D047068
% 215.96/216.15       do not confuse with ARYLAMINE N-ACETYLTRANSFERASE   
% 215.96/216.15  |- skos__historyNote mesh__D047068
% 215.96/216.15       Arylamine N-Acetyltransferase %28%1986-2004%29%
% 215.96/216.15  |- skos__historyNote mesh__D019377
% 215.96/216.15       Hydroxyeicosatetraenoic Acids %28%1985-1996%29%
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D019377 2004
% 215.96/216.15  |- skos__broader mesh__D019377smesh__D006893
% 215.96/216.15  |- skos__altLabel mesh__D019377 12-HETE
% 215.96/216.15  |- skos__annotation mesh__D019377 DF: note short X ref   
% 215.96/216.15  |- mesh__dateRevised mesh__D019377 2003-07-09
% 215.96/216.15  |- skos__historyNote mesh__D019377 Hydroxy Acids %28%1976-1978%29%
% 215.96/216.15  |- skos__historyNote mesh__D019377 Arachidonic Acids %28%1975-1984%29%
% 215.96/216.15  |- skos__hiddenLabel mesh__D019377 Acid, 12-S-Hydroxyeicosatetraenoic
% 215.96/216.15  |- mesh__dateEstablished mesh__D019377 1997-01-01
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D019377 2005
% 215.96/216.15  |- skos__scopeNote mesh__D019377
% 215.96/216.15       A lipoxygenase metabolite of ARACHIDONIC ACID. It is a highly selective ligand used to label mu-opioid receptors in both membranes and tissue sections. The 12-S-HETE analog has been reported to augment tumor cell metastatic potential through activation of protein kinase C. %28%J Pharmacol Exp Ther 1995; 274%28%3%29%:1545-51; J Natl Cancer Inst 1994; 86%28%15%29%:1145-51%29%%A%    
% 215.96/216.15  |- skos__altLabel mesh__D019377 12-S-Hydroxyeicosatetraenoic Acid
% 215.96/216.15  |- mesh__historyNote mesh__D019377
% 215.96/216.15       97; was 12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID %28%NM%29% 1975-96%A%  
% 215.96/216.15  |- skos__historyNote mesh__D019377 Fatty Alcohols %28%1975-1976%29%
% 215.96/216.15  |- rdf__type mesh__D019377sskos__Concept
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D019377 2006
% 215.96/216.15  |- mesh__dateCreated mesh__D019377 1996-06-10
% 215.96/216.15  |- skos__prefLabel mesh__D019377 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid
% 215.96/216.15  |- mesh__onlineNote mesh__D019377
% 215.96/216.15       use 12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID %28%NM%29% to search 12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID 1980-96%A%  
% 215.96/216.15  |- mesh__publicMeSHNote mesh__D019377
% 215.96/216.15       97; 12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID was indexed under HYDROXYEICOSATETRAENOIC ACIDS 1985-96, ARACHIDONIC ACIDS 1975-84, HYDROXY ACIDS 1976-80, %26% FATTY ALCOHOLS 1975-76%A%  
% 215.96/216.15  |- skos__hiddenLabel mesh__D019377 12 S Hydroxyeicosatetraenoic Acid
% 215.96/216.15  |- skos__broader mesh__D011394smesh__D000587
% 215.96/216.15  |- skos__historyNote mesh__D011394 Amine Oxidoreductases %28%1975-1979%29%
% 215.96/216.15  |- mesh__dateEstablished mesh__D011394 1991-01-01
% 215.96/216.15  |- rdf__type mesh__D011394sskos__Concept
% 215.96/216.15  |- skos__scopeNote mesh__D011394
% 215.96/216.15       The first enzyme of the proline degradative pathway. It catalyzes the oxidation of proline to pyrroline-5-carboxylic acid in the presence of oxygen and water. The action is not reversible. The specific activity of proline oxidase increases with age. EC 1.5.3.-.%A%    
% 215.96/216.15  |- mesh__publicMeSHNote mesh__D011394
% 215.96/216.15       91; was see under AMINE OXIDOREDUCTASES 1980-90   
% 215.96/216.15  |- mesh__recordOriginator mesh__D011394 RLS
% 215.96/216.15  |- skos__broader mesh__D011394smesh__D000594
% 215.96/216.15  |- skos__prefLabel mesh__D011394 Proline Oxidase
% 215.96/216.15  |- skos__altLabel mesh__D011394 Proline Dehydrogenase
% 215.96/216.15  |- mesh__dateCreated mesh__D011394 1979-05-23
% 215.96/216.15  |- skos__hiddenLabel mesh__D011394 Oxidase, Proline
% 215.96/216.15  |- mesh__historyNote mesh__D011394
% 215.96/216.15       91%28%80%29%; was see under AMINE OXIDOREDUCTASES 1980-90   
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D011394 2006
% 215.96/216.15  |- skos__hiddenLabel mesh__D011394 Dehydrogenase, Proline
% 215.96/216.15  |- skos__historyNote mesh__D011394
% 215.96/216.15       Amino Acid Oxidoreductases %28%1966-1979%29%
% 215.96/216.15  |- skos__historyNote mesh__D011394 Oxidoreductases %28%1966-1979%29%
% 215.96/216.15  |- skos__historyNote mesh__D011394 Oxygenases %28%1966-1979%29%
% 215.96/216.15  |- mesh__recordMaintainer mesh__D011394 jmp
% 215.96/216.15  |- mesh__recordAuthorizer mesh__D011394 sjn
% 215.96/216.15  |- mesh__dateRevised mesh__D011394 2005-06-30
% 215.96/216.15  |- skos__broader mesh__D052202smesh__D014623
% 215.96/216.15  |- rdf__type mesh__D052202sskos__Concept
% 215.96/216.15  |- skos__prefLabel mesh__D052202 Hydrocolpos
% 215.96/216.15  |- mesh__publicMeSHNote mesh__D052202 2006   
% 215.96/216.15  |- mesh__recordOriginator mesh__D052202 lkt
% 215.96/216.15  |- mesh__dateCreated mesh__D052202 2005-06-30
% 215.96/216.15  |- mesh__recordMaintainer mesh__D052202 lkt
% 215.96/216.15  |- mesh__dateEstablished mesh__D052202 2006-01-01
% 215.96/216.15  |- skos__historyNote mesh__D052202 Vagina/abnormalities %28%1966-2005%29%
% 215.96/216.15  |- mesh__recordAuthorizer mesh__D052202 sjn
% 215.96/216.15  |- skos__scopeNote mesh__D052202
% 215.96/216.15       A fluid-filled VAGINA that is obstructed.     
% 215.96/216.15  |- mesh__historyNote mesh__D052202 2006   
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D052202 2006
% 215.96/216.15  |- skos__annotation mesh__D005357
% 215.96/216.15       GEN or unspecified; prefer specifics; periapical fibrous dysplasia = CEMENTOMA; craniofacial fibrous dysplasia = FIBROUS DYSPLASIA, POLYOSTOTIC %28%IM%29% + SKULL %28%IM%29% + FACIAL BONES %28%IM%29%%A%  
% 215.96/216.15  |- mesh__recordMaintainer mesh__D005357 TGC
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D005357 1999
% 215.96/216.15  |- mesh__dateRevised mesh__D005357 1996-06-10
% 215.96/216.15  |- mesh__dateEstablished mesh__D005357 1967-01-01
% 215.96/216.15  |- mesh__historyNote mesh__D005357
% 215.96/216.15       67; was FIBROUS DYSPLASIA 1963-66 %28%Prov%29%; ALBRIGHT%27%S DISEASE %26% JAFFE-LICHTENSTEIN DISEASE were see under OSTEITIS FIBROSA 1963-66%A%  
% 215.96/216.15  |- skos__prefLabel mesh__D005357 Fibrous Dysplasia of Bone
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D005357 1997
% 215.96/216.15  |- skos__hiddenLabel mesh__D005357 Bone Fibrous Dysplasia
% 215.96/216.15  |- rdf__type mesh__D005357sskos__Concept
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D005357 2005
% 215.96/216.15  |- mesh__recordOriginator mesh__D005357 NLM
% 215.96/216.15  |- mesh__publicMeSHNote mesh__D005357
% 215.96/216.15       67; ALBRIGHT%27%S DISEASE %26% JAFFE-LICHTENSTEIN DISEASE were see under OSTEITIS FIBROSA 1963-66%A%  
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D005357 2000
% 215.96/216.15  |- skos__broader mesh__D005357smesh__D010009
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D005357 2006
% 215.96/216.15  |- mesh__recordAuthorizer mesh__D005357 PLS
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D005357 2003
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D005357 2001
% 215.96/216.15  |- skos__altLabel mesh__D005357 Osteitis Fibrosa Disseminata
% 215.96/216.15  |- mesh__onlineNote mesh__D005357
% 215.96/216.15       use FIBROUS DYSPLASIA OF BONE to search FIBROUS DYSPLASIA 1966 %28%as Prov%29%; search ALBRIGHT%27%S DISEASE %26% JAFFE-LICHTENSTEIN DISEASE under OSTEITIS FIBROSA CYSTICA 1966%A%  
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D005357 2004
% 215.96/216.15  |- skos__scopeNote mesh__D005357
% 215.96/216.15       A disease of bone marked by thinning of the cortex and replacement of bone marrow by gritty fibrous tissue containing bony spicules, producing pain, disability, and gradually increasing deformity. Only one bone may be involved %28%FIBROUS DYSPLASIA, MONOSTOTIC%29% or several %28%FIBROUS DYSPLASIA, POLYOSTOTIC%29%. %28%From Dorland, 28th ed%29%%A%    
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D005357 2002
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D005357 1998
% 215.96/216.15  |- skos__hiddenLabel mesh__D005357 Bone Fibrous Dysplasias
% 215.96/216.15  |- mesh__dateCreated mesh__D005357 1999-01-01
% 215.96/216.15  |- skos__hiddenLabel mesh__D015785 Diseases, Hereditary Eye
% 215.96/216.15  |- mesh__recordOriginator mesh__D015785 EGC
% 215.96/216.15  |- rdf__type mesh__D015785sskos__Concept
% 215.96/216.15  |- skos__prefLabel mesh__D015785 Eye Diseases, Hereditary
% 215.96/216.15  |- skos__hiddenLabel mesh__D015785 Hereditary Eye Disease
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D015785 2003
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D015785 2005
% 215.96/216.15  |- skos__broader mesh__D015785smesh__D030342
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D015785 2004
% 215.96/216.15  |- mesh__dateEstablished mesh__D015785 1990-01-01
% 215.96/216.15  |- mesh__historyNote mesh__D015785 90   
% 215.96/216.15  |- skos__hiddenLabel mesh__D015785 Disease, Hereditary Eye
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D015785 2006
% 215.96/216.15  |- mesh__publicMeSHNote mesh__D015785 90   
% 215.96/216.15  |- mesh__recordMaintainer mesh__D015785 nns
% 215.96/216.15  |- mesh__dateCreated mesh__D015785 1989-09-06
% 215.96/216.15  |- mesh__dateRevised mesh__D015785 2001-07-25
% 215.96/216.15  |- skos__historyNote mesh__D015785 Eye Diseases/genetics %28%1966-1989%29%
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D015785 2002
% 215.96/216.15  |- skos__hiddenLabel mesh__D015785 Eye Disease, Hereditary
% 215.96/216.15  |- skos__scopeNote mesh__D015785
% 215.96/216.15       Transmission of gene defects or chromosomal aberrations/abnormalities which are expressed in extreme variation in the structure or function of the eye. These may be evident at birth, but may be manifested later with progression of the disorder.%A%    
% 215.96/216.15  |- mesh__recordAuthorizer mesh__D015785 sjn
% 215.96/216.15  |- skos__broader mesh__D015785smesh__D005128
% 215.96/216.15  |- skos__altLabel mesh__D015785 Hereditary Eye Diseases
% 215.96/216.15  |- skos__annotation mesh__D009748
% 215.96/216.15       differentiate from DEFICIENCY DISEASES %28%results from deficient intake%29% %26% METABOLIC DISEASES%A%  
% 215.96/216.15  |- mesh__dateCreated mesh__D009748 1999-01-01
% 215.96/216.15  |- mesh__historyNote mesh__D009748
% 215.96/216.15       MALNUTRITION was see under DEFICIENCY DISEASES 1963-66   
% 215.96/216.15  |- mesh__dateRevised mesh__D009748 2003-07-09
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D009748 2006
% 215.96/216.15  |- mesh__recordAuthorizer mesh__D009748 sjn
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D009748 2004
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D009748 2005
% 215.96/216.15  |- mesh__onlineNote mesh__D009748
% 215.96/216.15       use DEFICIENCY DISEASES to search MALNUTRITION 1966   
% 215.96/216.15  |- skos__broader mesh__D009748smesh__D009750
% 215.96/216.15  |- mesh__recordMaintainer mesh__D009748 lkt
% 215.96/216.15  |- mesh__publicMeSHNote mesh__D009748
% 215.96/216.15       MALNUTRITION was see under DEFICIENCY DISEASES 1963-66   
% 215.96/216.15  |- rdf__type mesh__D009748sskos__Concept
% 215.96/216.15  |- skos__altLabel mesh__D009748 Nutritional Disorders
% 215.96/216.15  |- skos__hiddenLabel mesh__D009748 Nutritional Disorder
% 215.96/216.15  |- skos__prefLabel mesh__D009748 Nutrition Disorders
% 215.96/216.15  |- skos__related mesh__D009748smesh__D005247
% 215.96/216.15  |- skos__hiddenLabel mesh__D009748 Nutrition Disorder
% 215.96/216.15  |- skos__scopeNote mesh__D009748
% 215.96/216.15       Disorders caused by nutritional imbalance, either overnutrition or undernutrition.%A%    
% 215.96/216.15  |- mesh__recordOriginator mesh__D009748 NLM
% 215.96/216.15  |- mesh__recordMaintainer mesh__D001765 lkt
% 215.96/216.15  |- skos__hiddenLabel mesh__D001765 Syndrome, Blind Loop
% 215.96/216.15  |- mesh__dateCreated mesh__D001765 1999-01-01
% 215.96/216.15  |- skos__broader mesh__D001765smesh__D008286
% 215.96/216.15  |- skos__altLabel mesh__D001765 Bacterial Overgrowth Syndrome
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D001765 2006
% 215.96/216.15  |- mesh__recordOriginator mesh__D001765 NLM
% 215.96/216.15  |- rdf__type mesh__D001765sskos__Concept
% 215.96/216.15  |- mesh__publicMeSHNote mesh__D001765 73   
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D001765 2005
% 215.96/216.15  |- skos__hiddenLabel mesh__D001765 Syndrome, Bacterial Overgrowth
% 215.96/216.15  |- mesh__recordAuthorizer mesh__D001765 sjn
% 215.96/216.15  |- mesh__historyNote mesh__D001765 73%28%69%29%   
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D001765 2004
% 215.96/216.15  |- skos__prefLabel mesh__D001765 Blind Loop Syndrome
% 215.96/216.15  |- mesh__dateRevised mesh__D001765 2003-07-09
% 215.96/216.15  |- skos__hiddenLabel mesh__D001765 Stagnant Loop Syndromes
% 215.96/216.15  |- skos__altLabel mesh__D001765 Stagnant Loop Syndrome
% 215.96/216.15  |- skos__hiddenLabel mesh__D001765 Loop Syndromes, Stagnant
% 215.96/216.15  |- skos__hiddenLabel mesh__D001765 Loop Syndrome, Stagnant
% 215.96/216.15  |- skos__scopeNote mesh__D001765
% 215.96/216.15       A malabsorption syndrome that is associated with a blind loop in the upper SMALL INTESTINE that is characterized by the lack of peristaltic movement, stasis of INTESTINAL CONTENTS, and the overgrowth of BACTERIA. Such bacterial overgrowth interferes with BILE SALTS action, FATTY ACIDS processing, MICROVILLI integrity, and the ABSORPTION of nutrients such as VITAMIN B12 and FOLIC ACID.%A%    
% 215.96/216.15  |- mesh__dateEstablished mesh__D001765 1973-01-01
% 215.96/216.15  |- skos__hiddenLabel mesh__D001765 Syndromes, Stagnant Loop
% 215.96/216.15  |- skos__hiddenLabel mesh__D001765 Syndrome, Stagnant Loop
% 215.96/216.15  |- skos__historyNote mesh__D001765
% 215.96/216.15       Malabsorption Syndromes %28%1966-1968%29%
% 215.96/216.15  |- mesh__publicMeSHNote mesh__D034141 2003   
% 215.96/216.15  |- skos__scopeNote mesh__D034141
% 215.96/216.15       A condition in which albumin level in blood %28%SERUM ALBUMIN%29% is below the normal range. Hypoalbuminemia may be due to decreased hepatic albumin synthesis, increased albumin catabolism, altered albumin distribution, or albumin loss through the urine %28%ALBUMINURIA%29%.%A%    
% 215.96/216.15  |- mesh__dateEstablished mesh__D034141 2003-01-01
% 215.96/216.15  |- rdf__type mesh__D034141sskos__Concept
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D034141 2003
% 215.96/216.15  |- skos__historyNote mesh__D034141 Serum Albumin %28%1965-2002%29%
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D034141 2005
% 215.96/216.15  |- skos__broader mesh__D034141smesh__D007019
% 215.96/216.15  |- mesh__dateCreated mesh__D034141 2002-07-03
% 215.96/216.15  |- mesh__historyNote mesh__D034141 2003   
% 215.96/216.15  |- skos__prefLabel mesh__D034141 Hypoalbuminemia
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D034141 2004
% 215.96/216.15  |- skos__historyNote mesh__D034141 Hypoproteinemia %28%1965-2002%29%
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D034141 2006
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D006450 2002
% 215.96/216.15  |- skos__hiddenLabel mesh__D006450 SC Disease, Hemoglobin
% 215.96/216.15  |- skos__hiddenLabel mesh__D006450 Diseases, Hemoglobin SC
% 215.96/216.15  |- skos__hiddenLabel mesh__D006450 SC Diseases
% 215.96/216.15  |- rdf__type mesh__D006450sskos__Concept
% 215.96/216.15  |- mesh__recordAuthorizer mesh__D006450 sjn
% 215.96/216.15  |- skos__annotation mesh__D006450
% 215.96/216.15       a sickle cell anemia; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; do not confuse with HEMOGLOBIN C DISEASE%A%  
% 215.96/216.15  |- mesh__recordOriginator mesh__D006450 VDK
% 215.96/216.15  |- skos__prefLabel mesh__D006450 Hemoglobin SC Disease
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D006450 2005
% 215.96/216.15  |- skos__historyNote mesh__D006450 Hemoglobin C Disease %28%1966-1983%29%
% 215.96/216.15  |- skos__scopeNote mesh__D006450
% 215.96/216.15       One of the sickle cell disorders characterized by the presence of both hemoglobin S and hemoglobin C. It is similar to, but less severe than sickle cell anemia.%A%    
% 215.96/216.15  |- skos__altLabel mesh__D006450 Sickle Cell Hemoglobin C Disease
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D006450 2006
% 215.96/216.15  |- mesh__historyNote mesh__D006450
% 215.96/216.15       91%28%84%29%; was see under ANEMIA, SICKLE CELL 1984-90   
% 215.96/216.15  |- skos__historyNote mesh__D006450 Anemia, Sickle Cell %28%1966-1983%29%
% 215.96/216.15  |- mesh__dateCreated mesh__D006450 1983-05-03
% 215.96/216.15  |- skos__hiddenLabel mesh__D006450 Disease, Hemoglobin SC
% 215.96/216.15  |- skos__hiddenLabel mesh__D006450 SC Diseases, Hemoglobin
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D006450 2003
% 215.96/216.15  |- skos__altLabel mesh__D006450 SC Disease
% 215.96/216.15  |- skos__hiddenLabel mesh__D006450 Diseases, SC
% 215.96/216.15  |- mesh__recordMaintainer mesh__D006450 nns
% 215.96/216.15  |- skos__hiddenLabel mesh__D006450 Disease, SC
% 215.96/216.15  |- mesh__dateRevised mesh__D006450 2001-07-25
% 215.96/216.15  |- skos__broader mesh__D006450smesh__D000755
% 215.96/216.15  |- mesh__dateEstablished mesh__D006450 1991-01-01
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D006450 2004
% 215.96/216.15  |- skos__hiddenLabel mesh__D006450 Hemoglobin SC Diseases
% 215.96/216.15  |- mesh__publicMeSHNote mesh__D006450
% 215.96/216.15       91; was see under ANEMIA, SICKLE CELL 1984-90   
% 215.96/216.15  |- skos__hiddenLabel mesh__D020121 Region, 5%27% Untranslated
% 215.96/216.15  |- skos__hiddenLabel mesh__D020121 5%27%UTRs
% 215.96/216.15  |- mesh__recordOriginator mesh__D020121 NNS
% 215.96/216.15  |- skos__altLabel mesh__D020121 5%27% UTR
% 215.96/216.15  |- skos__altLabel mesh__D020121 5%27%UTR
% 215.96/216.15  |- skos__hiddenLabel mesh__D020121 Sequence, mRNA Leader
% 215.96/216.15  |- skos__altLabel mesh__D020121 Leader Sequences, mRNA
% 215.96/216.15  |- skos__hiddenLabel mesh__D020121 mRNA Leader Sequence
% 215.96/216.15  |- skos__hiddenLabel mesh__D020121 5%27% Untranslated Region
% 215.96/216.15  |- mesh__recordMaintainer mesh__D020121 nns
% 215.96/216.15  |- skos__hiddenLabel mesh__D020121 Sequence, Leader mRNA
% 215.96/216.15  |- skos__hiddenLabel mesh__D020121 Sequences, mRNA Leader
% 215.96/216.15  |- rdf__type mesh__D020121sskos__Concept
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D020121 2006
% 215.96/216.15  |- skos__scopeNote mesh__D020121
% 215.96/216.15       The sequence at the 5%27% end of the messenger RNA that does not code for product. This sequence contains the ribosome binding site and other transcription and translation regulating sequences.%A%    
% 215.96/216.15  |- skos__hiddenLabel mesh__D020121 Sequences, Leader mRNA
% 215.96/216.15  |- mesh__dateRevised mesh__D020121 2005-06-30
% 215.96/216.15  |- mesh__recordAuthorizer mesh__D020121 sjn
% 215.96/216.15  |- skos__hiddenLabel mesh__D020121 Untranslated Regions, 5%27%
% 215.96/216.15  |- mesh__publicMeSHNote mesh__D020121 99   
% 215.96/216.15  |- mesh__dateEstablished mesh__D020121 1999-01-01
% 215.96/216.15  |- skos__annotation mesh__D020121
% 215.96/216.15       do not confuse with RNA, SPLICED LEADER; do not confuse with 5%27% FLANKING REGION%A%  
% 215.96/216.15  |- skos__broader mesh__D020121smesh__D020506
% 215.96/216.15  |- skos__prefLabel mesh__D020121 5%27% Untranslated Regions
% 215.96/216.15  |- skos__hiddenLabel mesh__D020121 UTRs, 5%27%
% 215.96/216.15  |- skos__hiddenLabel mesh__D020121 Leader mRNA Sequence
% 215.96/216.15  |- skos__related mesh__D020121smesh__D024506
% 215.96/216.15  |- skos__hiddenLabel mesh__D020121 mRNA Sequence, Leader
% 215.96/216.15  |- mesh__historyNote mesh__D020121 99   
% 215.96/216.15  |- skos__hiddenLabel mesh__D020121 Untranslated Region, 5%27%
% 215.96/216.15  |- skos__hiddenLabel mesh__D020121 UTR, 5%27%
% 215.96/216.15  |- skos__hiddenLabel mesh__D020121 Regions, 5%27% Untranslated
% 215.96/216.15  |- mesh__dateCreated mesh__D020121 1998-06-11
% 215.96/216.15  |- skos__hiddenLabel mesh__D020121 5%27% UTRs
% 215.96/216.15  |- skos__altLabel mesh__D020121 mRNA Leader Sequences
% 215.96/216.15  |- skos__altLabel mesh__D020121 Leader mRNA Sequences
% 215.96/216.15  |- skos__hiddenLabel mesh__D020121 Leader Sequence, mRNA
% 215.96/216.15  |- skos__historyNote mesh__D020121 RNA, Messenger %28%1975-1998%29%
% 215.96/216.15  |- skos__hiddenLabel mesh__D020121 mRNA Sequences, Leader
% 215.96/216.15  |- skos__historyNote mesh__D047069 Pyrazoles %28%1965-2004%29%
% 215.96/216.15  |- mesh__historyNote mesh__D047069 2005   
% 215.96/216.15  |- mesh__recordMaintainer mesh__D047069 ags
% 215.96/216.15  |- mesh__dateCreated mesh__D047069 2004-07-07
% 215.96/216.15  |- mesh__dateRevised mesh__D047069 2005-07-21
% 215.96/216.15  |- mesh__publicMeSHNote mesh__D047069 2005   
% 215.96/216.15  |- skos__scopeNote mesh__D047069
% 215.96/216.15       Compounds with a five-membered heterocyclic ring with two nitrogens and a keto OXYGEN. Some are inhibitors of TNF-ALPHA production.%A%    
% 215.96/216.15  |- skos__hiddenLabel mesh__D047069 Pyrazolin 5 Ones
% 215.96/216.15  |- mesh__dateEstablished mesh__D047069 2005-01-01
% 215.96/216.15  |- mesh__recordOriginator mesh__D047069 ssb
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D047069 2006
% 215.96/216.15  |- skos__prefLabel mesh__D047069 Pyrazolones
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D047069 2006A
% 215.96/216.15  |- mesh__recordAuthorizer mesh__D047069 ags
% 215.96/216.15  |- rdf__type mesh__D047069sskos__Concept
% 215.96/216.15  |- skos__broader mesh__D047069smesh__D011720
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D019378 2006
% 215.96/216.15  |- skos__altLabel mesh__D019378 GM-CSF, Recombinant
% 215.96/216.15  |- mesh__recordOriginator mesh__D019378 TPW
% 215.96/216.15  |- rdf__type mesh__D019378sskos__Concept
% 215.96/216.15  |- skos__historyNote mesh__D019378 Recombinant Proteins %28%1985-1996%29%
% 215.96/216.15  |- skos__altLabel mesh__D019378
% 215.96/216.15       Recombinant Granulocyte-Macrophage Colony-Stimulating Factors
% 215.96/216.15  |- skos__annotation mesh__D019378
% 215.96/216.15       %22%prepared by recombinant DNA technol%22%; /drug eff permitted; in titles %26% translations spell with hyphens: %22%granulocyte-macrophage colony-stimulating%22%; DF: GMCSF RECOMBINANT%A%  
% 215.96/216.15  |- mesh__dateRevised mesh__D019378 2005-06-30
% 215.96/216.15  |- mesh__recordAuthorizer mesh__D019378 sjn
% 215.96/216.15  |- skos__historyNote mesh__D019378
% 215.96/216.15       Granulocyte-Macrophage Colony-Stimulating Factor %28%1991-1996%29%
% 215.96/216.15  |- skos__hiddenLabel mesh__D019378 GM CSF, Recombinant
% 215.96/216.15  |- skos__broader mesh__D019378smesh__D019374
% 215.96/216.15  |- skos__historyNote mesh__D019378
% 215.96/216.15       Colony-Stimulating Factors %28%1985-1990%29%
% 215.96/216.15  |- skos__hiddenLabel mesh__D019378
% 215.96/216.15       Recombinant Granulocyte Macrophage Colony Stimulating Factors
% 215.96/216.15  |- mesh__dateEstablished mesh__D019378 1997-01-01
% 215.96/216.15  |- skos__scopeNote mesh__D019378
% 215.96/216.15       Granulocyte-macrophage colony-stimulating factors prepared by recombinant DNA technology.%A%    
% 215.96/216.15  |- mesh__historyNote mesh__D019378 97   
% 215.96/216.15  |- skos__altLabel mesh__D019378 Recombinant GM-CSF
% 215.96/216.15  |- mesh__publicMeSHNote mesh__D019378 97   
% 215.96/216.15  |- mesh__dateCreated mesh__D019378 1996-06-10
% 215.96/216.15  |- skos__prefLabel mesh__D019378
% 215.96/216.15       Granulocyte Macrophage Colony-Stimulating Factors, Recombinant
% 215.96/216.15  |- mesh__recordMaintainer mesh__D019378 ssb
% 215.96/216.15  |- skos__broader mesh__D019378smesh__D016178
% 215.96/216.15  |- skos__prefLabel mesh__D011395 Promazine
% 215.96/216.15  |- skos__broader mesh__D011395smesh__D010640
% 215.96/216.15  |- mesh__recordAuthorizer mesh__D011395 sjn
% 215.96/216.15  |- mesh__dateRevised mesh__D011395 2005-06-30
% 215.96/216.15  |- mesh__recordMaintainer mesh__D011395 ssb
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D011395 2006
% 215.96/216.15  |- skos__hiddenLabel mesh__D011395 Hydrochloride, Promazine
% 215.96/216.15  |- mesh__dateCreated mesh__D011395 1999-01-01
% 215.96/216.15  |- mesh__recordOriginator mesh__D011395 NLM
% 215.96/216.15  |- skos__scopeNote mesh__D011395
% 215.96/216.15       A phenothiazine with actions similar to CHLORPROMAZINE but with less antipsychotic activity. It is primarily used in short-term treatment of disturbed behavior and as an antiemetic.%A%    
% 215.96/216.15  |- rdf__type mesh__D011395sskos__Concept
% 215.96/216.15  |- skos__prefLabel mesh__D052203 Ferrosoferric Oxide
% 215.96/216.15  |- skos__hiddenLabel mesh__D052203 Oxide, Ferriferrous
% 215.96/216.15  |- skos__altLabel mesh__D052203 Ferriferrous Oxide
% 215.96/216.15  |- mesh__recordMaintainer mesh__D052203 ags
% 215.96/216.15  |- skos__broader mesh__D052203smesh__D008903
% 215.96/216.15  |- mesh__historyNote mesh__D052203 2006 %28%1981%29%   
% 215.96/216.15  |- mesh__publicMeSHNote mesh__D052203
% 215.96/216.15       2006; FERROSOFERRIC OXIDE was indexed under OXIDES 1991-2005 and IRON 1981-2005%A%  
% 215.96/216.15  |- skos__hiddenLabel mesh__D052203 Oxide, Ferrosoferric
% 215.96/216.15  |- mesh__dateCreated mesh__D052203 2005-06-30
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D052203 2006
% 215.96/216.15  |- mesh__recordOriginator mesh__D052203 ags
% 215.96/216.15  |- mesh__dateEstablished mesh__D052203 2006-01-01
% 215.96/216.15  |- rdf__type mesh__D052203sskos__Concept
% 215.96/216.15  |- skos__scopeNote mesh__D052203
% 215.96/216.15       Iron oxide %28%Fe3O4%29%. It is a black ore of IRON that forms opaque crystals and exerts strong magnetism. The NANOPARTICLES; and MICROSPHERES of its mineral form, magnetite, have many biomedical applications.%A%    
% 215.96/216.15  |- mesh__recordAuthorizer mesh__D052203 sjn
% 215.96/216.15  |- mesh__dateEstablished mesh__D005358 1991-01-01
% 215.96/216.15  |- skos__hiddenLabel mesh__D005358 Dysplasia, Monostotic Fibrous
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D005358 1997
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D005358 2002
% 215.96/216.15  |- skos__annotation mesh__D005358
% 215.96/216.15       Jaffe-Lichtenstein usually goes here but check text for possible %22%polyostotic%22%%A%  
% 215.96/216.15  |- rdf__type mesh__D005358sskos__Concept
% 215.96/216.15  |- skos__prefLabel mesh__D005358 Fibrous Dysplasia, Monostotic
% 215.96/216.15  |- skos__broader mesh__D005358smesh__D005357
% 215.96/216.15  |- mesh__dateRevised mesh__D005358 1996-06-10
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D005358 2005
% 215.96/216.15  |- mesh__onlineNote mesh__D005358
% 215.96/216.15       use FIBROUS DYSPLASIA OF BONE to search FIBROUS DYSPLASIA, MONOSTOTIC 1967-74; search ALBRIGHT%27%S DISEASE %26% JAFFE-LICHTENSTEIN DISEASE under OSTEITIS FIBROSA CYSTICA 1966%A%  
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D005358 2006
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D005358 2003
% 215.96/216.15  |- skos__hiddenLabel mesh__D005358 Monostotic Fibrous Dysplasia
% 215.96/216.15  |- mesh__historyNote mesh__D005358
% 215.96/216.15       91%28%75%29%; was see under FIBROUS DYSPLASIA OF BONE 1967-90; ALBRIGHT%27%S DISEASE %26% JAFFE-LICHTENSTEIN DISEASE were see under OSTEITIS FIBROSA 1963-66%A%  
% 215.96/216.15  |- mesh__publicMeSHNote mesh__D005358
% 215.96/216.15       91; was see under FIBROUS DYSPLASIA OF BONE 1967-90; ALBRIGHT%27%S DISEASE %26% JAFFE-LICHTENSTEIN DISEASE were see under OSTEITIS FIBROSA 1963-66%A%  
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D005358 2004
% 215.96/216.15  |- skos__hiddenLabel mesh__D005358 Monostotic Fibrous Dysplasias
% 215.96/216.15  |- mesh__recordOriginator mesh__D005358 NLM
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D005358 1998
% 215.96/216.15  |- skos__hiddenLabel mesh__D005358 Dysplasias, Monostotic Fibrous
% 215.96/216.15  |- mesh__dateCreated mesh__D005358 1999-01-01
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D005358 2000
% 215.96/216.15  |- skos__hiddenLabel mesh__D005358 Fibrous Dysplasias, Monostotic
% 215.96/216.15  |- mesh__recordMaintainer mesh__D005358 TGC
% 215.96/216.15  |- mesh__recordAuthorizer mesh__D005358 PLS
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D005358 1999
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D005358 2001
% 215.96/216.15  |- skos__scopeNote mesh__D005358
% 215.96/216.15       FIBROUS DYSPLASIA OF BONE involving only one bone.     
% 215.96/216.15  |- mesh__dateEstablished mesh__D016080 1991-01-01
% 215.96/216.15  |- mesh__recordOriginator mesh__D016080 AGS
% 215.96/216.15  |- skos__hiddenLabel mesh__D016080 Cyst, Perineural
% 215.96/216.15  |- skos__hiddenLabel mesh__D016080 Cyst, Intracranial Arachnoid
% 215.96/216.15  |- skos__altLabel mesh__D016080 Tarlov Cysts
% 215.96/216.15  |- skos__hiddenLabel mesh__D016080 Leptomeningeal Cyst
% 215.96/216.15  |- mesh__historyNote mesh__D016080 1991   
% 215.96/216.15  |- skos__hiddenLabel mesh__D016080 Cyst, Leptomeningeal
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D016080 2001
% 215.96/216.15  |- mesh__publicMeSHNote mesh__D016080 1991   
% 215.96/216.15  |- skos__hiddenLabel mesh__D016080 Cysts, Tarlov
% 215.96/216.15  |- skos__hiddenLabel mesh__D016080 Arachnoid Cyst
% 215.96/216.15  |- skos__historyNote mesh__D016080 Cysts %28%1966-1990%29%
% 215.96/216.15  |- skos__hiddenLabel mesh__D016080 Perineural Cyst
% 215.96/216.15  |- skos__annotation mesh__D016080 non-neoplastic   
% 215.96/216.15  |- skos__scopeNote mesh__D016080
% 215.96/216.15       Intracranial or spinal cavities containing a cerebrospinal-like fluid, the wall of which is composed of arachnoidal cells. They are most often developmental or related to trauma. Intracranial arachnoid cysts usually occur adjacent to arachnoidal cistern and may present with HYDROCEPHALUS; HEADACHE; SEIZURES; and focal neurologic signs. Spinal arachnoid cysts may be extradural, intradural, or perineural and tend to present with signs and symptoms indicative of a RADICULOPATHY. %28%From Joynt, Clinical Neurology, 1994, Ch44, pp105-115%29%%A%    
% 215.96/216.15  |- mesh__recordAuthorizer mesh__D016080 sjn
% 215.96/216.15  |- skos__altLabel mesh__D016080 Leptomeningeal Cysts
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D016080 2000
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D016080 2006
% 215.96/216.15  |- mesh__dateCreated mesh__D016080 1990-03-23
% 215.96/216.15  |- skos__broader mesh__D016080smesh__D003560
% 215.96/216.15  |- skos__historyNote mesh__D016080 Arachnoid %28%1966-1990%29%
% 215.96/216.15  |- skos__hiddenLabel mesh__D016080 Arachnoid Cyst, Intracranial
% 215.96/216.15  |- skos__hiddenLabel mesh__D016080 Arachnoid Diverticulas
% 215.96/216.15  |- skos__hiddenLabel mesh__D016080 Arachnoid Cysts, Intracranial
% 215.96/216.15  |- mesh__dateRevised mesh__D016080 1999-11-03
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D016080 2005
% 215.96/216.15  |- skos__hiddenLabel mesh__D016080 Cysts, Perineural
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D016080 2004
% 215.96/216.15  |- skos__hiddenLabel mesh__D016080 Cysts, Arachnoid
% 215.96/216.15  |- skos__hiddenLabel mesh__D016080 Cysts, Intracranial Arachnoid
% 215.96/216.15  |- rdf__type mesh__D016080sskos__Concept
% 215.96/216.15  |- skos__prefLabel mesh__D016080 Arachnoid Cysts
% 215.96/216.15  |- skos__hiddenLabel mesh__D016080 Cyst, Arachnoid
% 215.96/216.15  |- mesh__recordMaintainer mesh__D016080 KEV
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D016080 2002
% 215.96/216.15  |- skos__broader mesh__D016080smesh__D020863
% 215.96/216.15  |- skos__hiddenLabel mesh__D016080 Intracranial Arachnoid Cyst
% 215.96/216.15  |- skos__altLabel mesh__D016080 Arachnoid Diverticula
% 215.96/216.15  |- skos__hiddenLabel mesh__D016080 Diverticula, Arachnoid
% 215.96/216.15  |- skos__hiddenLabel mesh__D016080 Diverticulas, Arachnoid
% 215.96/216.15  |- skos__hiddenLabel mesh__D016080 Cysts, Leptomeningeal
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D016080 2003
% 215.96/216.15  |- mesh__dateCreated mesh__D002060 1999-01-01
% 215.96/216.15  |- mesh__recordAuthorizer mesh__D002060 sjn
% 215.96/216.15  |- skos__hiddenLabel mesh__D002060 Fabricius Bursa
% 215.96/216.15  |- skos__broader mesh__D002060smesh__D008221
% 215.96/216.15  |- mesh__publicMeSHNote mesh__D002060 66   
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D002060 2004
% 215.96/216.15  |- rdf__type mesh__D002060sskos__Concept
% 215.96/216.15  |- mesh__historyNote mesh__D002060 66%28%65%29%   
% 215.96/216.15  |- mesh__recordMaintainer mesh__D002060 jmp
% 215.96/216.15  |- mesh__recordOriginator mesh__D002060 NLM
% 215.96/216.15  |- skos__prefLabel mesh__D002060 Bursa of Fabricius
% 215.96/216.15  |- mesh__dateEstablished mesh__D002060 1966-01-01
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D002060 2005
% 215.96/216.15  |- skos__broader mesh__D002060smesh__D000825
% 215.96/216.15  |- skos__scopeNote mesh__D002060
% 215.96/216.15       An epithelial outgrowth of the cloaca in birds similar to the thymus in mammals. It atrophies within 6 months after birth and remains as a fibrous remnant in adult birds. It is composed of lymphoid tissue and prior to involution, is the site of B-lymphocyte maturation.%A%    
% 215.96/216.15  |- mesh__dateRevised mesh__D002060 2003-07-09
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D002060 2006
% 215.96/216.15  |- mesh__historyNote mesh__D015786
% 215.96/216.15       2004%28%1990%29%; for APOCYTOCHROME B5 use CYTOCHROMES B %28%NM%29% 1980-2003%A%  
% 215.96/216.15  |- mesh__dateCreated mesh__D015786 1989-07-14
% 215.96/216.15  |- skos__annotation mesh__D015786
% 215.96/216.15       spell in titles %26% translations with lowercase b: cytochrome b5%A%  
% 215.96/216.15  |- mesh__activeMeSHYear mesh__D015786 2006
% 215.96/216.15  |- mesh__dateEstablished mesh__D015786 1990-01-01
% 215.96/216.15  |- skos__hiddenLabel mesh__D015786 Cytochrome b 5
% 215.96/216.15  |- skos__broader mesh__D015786smesh__D003573
% 215.96/216.16  |- skos__scopeNote mesh__D015786
% 215.96/216.16       Cytochromes of the b group that are found bound to cytoplasmic side of ENDOPLASMIC RETICULUM. They serve as electron carrier proteins for a variety of membrane-bound OXYGENASES. They are reduced by the enzyme CYTOCHROME-B%28%5%29% REDUCTASE.%A%    
% 215.96/216.16  |- mesh__recordAuthorizer mesh__D015786 sjn
% 215.96/216.16  |- skos__historyNote mesh__D015786 Cytochromes %28%1966-1982%29%
% 215.96/216.16  |- skos__historyNote mesh__D015786 Cytochrome b %28%1983-1989%29%
% 215.96/216.16  |- mesh__recordOriginator mesh__D015786 RLS
% 215.96/216.16  |- skos__prefLabel mesh__D015786 Cytochromes b5
% 215.96/216.16  |- rdf__type mesh__D015786sskos__Concept
% 215.96/216.16  |- skos__altLabel mesh__D015786 Ferricytochrome b5
% 215.96/216.16  |- skos__altLabel mesh__D015786 Cytochrome b-5
% 215.96/216.16  |- mesh__recordMaintainer mesh__D015786 jls
% 215.96/216.16  |- mesh__publicMeSHNote mesh__D015786
% 215.96/216.16       2004; see CYTOCHROME B5 1990-2003; APOCYTOCHROME B5 was indexed under CYTOCROME B %26% APOPROTEINS 1983-2003, under CYTOCHROMES 1979-1982%A%  
% 215.96/216.16  |- skos__altLabel mesh__D015786 Cytochrome b5
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D015786 2005
% 215.96/216.16  |- mesh__dateRevised mesh__D015786 2004-07-19
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D009749 2005
% 215.96/216.16  |- mesh__recordMaintainer mesh__D009749 sjn
% 215.96/216.16  |- skos__hiddenLabel mesh__D009749 Nutrition Survey
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D009749 2006
% 215.96/216.16  |- skos__hiddenLabel mesh__D009749 Survey, Nutrition
% 215.96/216.16  |- mesh__recordOriginator mesh__D009749 NLM
% 215.96/216.16  |- skos__hiddenLabel mesh__D009749 Surveys, Nutrition
% 215.96/216.16  |- skos__broader mesh__D009749smesh__D006306
% 215.96/216.16  |- skos__prefLabel mesh__D009749 Nutrition Surveys
% 215.96/216.16  |- skos__annotation mesh__D009749
% 215.96/216.16       no qualif; TN 97: caution against word %22%survey%22%; do not confuse with NUTRITION ASSESSMENT: survey refers to a population in a given geog area, assessment refers to an individual%A%  
% 215.96/216.16  |- mesh__dateCreated mesh__D009749 1999-01-01
% 215.96/216.16  |- rdf__type mesh__D009749sskos__Concept
% 215.96/216.16  |- mesh__recordAuthorizer mesh__D009749 sjn
% 215.96/216.16  |- skos__scopeNote mesh__D009749
% 215.96/216.16       A systematic collection of factual data pertaining to the nutritional status of a human population within a given geographic area. Data from these surveys are used in preparing NUTRITION ASSESSMENTs.%A%    
% 215.96/216.16  |- skos__altLabel mesh__D009749 NHANES
% 215.96/216.16  |- mesh__dateRevised mesh__D009749 2004-07-13
% 215.96/216.16  |- skos__broader mesh__D009749smesh__D015596
% 215.96/216.16  |- mesh__recordMaintainer mesh__D001766 KEV
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D001766 2005
% 215.96/216.16  |- skos__prefLabel mesh__D001766 Blindness
% 215.96/216.16  |- skos__hiddenLabel mesh__D001766 Acquired Blindness
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D001766 2001
% 215.96/216.16  |- skos__hiddenLabel mesh__D001766 Hysterical Blindness
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D001766 2006
% 215.96/216.16  |- mesh__dateRevised mesh__D001766 1999-11-03
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D001766 2003
% 215.96/216.16  |- rdf__type mesh__D001766sskos__Concept
% 215.96/216.16  |- skos__related mesh__D001766smesh__D012682
% 215.96/216.16  |- skos__hiddenLabel mesh__D001766 Monocular Blindness
% 215.96/216.16  |- skos__related mesh__D001766smesh__D015354
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D001766 2002
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D001766 2004
% 215.96/216.16  |- skos__annotation mesh__D001766
% 215.96/216.16       for Braille coord IM with SENSORY AIDS %28%IM%29% + READING %28%IM%29%%A%  
% 215.96/216.16  |- skos__hiddenLabel mesh__D001766 Legal Blindness
% 215.96/216.16  |- skos__broader mesh__D001766smesh__D014786
% 215.96/216.16  |- mesh__recordOriginator mesh__D001766 NLM
% 215.96/216.16  |- mesh__dateCreated mesh__D001766 1999-01-01
% 215.96/216.16  |- skos__hiddenLabel mesh__D001766 Complete Blindness
% 215.96/216.16  |- skos__scopeNote mesh__D001766
% 215.96/216.16       The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.%A%    
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D001766 2000
% 215.96/216.16  |- skos__hiddenLabel mesh__D001766 Amauroses
% 215.96/216.16  |- mesh__recordAuthorizer mesh__D001766 sjn
% 215.96/216.16  |- skos__hiddenLabel mesh__D001766 Transient Blindness
% 215.96/216.16  |- skos__altLabel mesh__D020920 Sleep Disorder, Limit-Setting
% 215.96/216.16  |- mesh__recordMaintainer mesh__D020920 sjn
% 215.96/216.16  |- skos__hiddenLabel mesh__D020920 Adjustment Sleep Disorders
% 215.96/216.16  |- skos__hiddenLabel mesh__D020920 Sleep Disorders, Limit-Setting
% 215.96/216.16  |- skos__hiddenLabel mesh__D020920 Eating-Drinking Syndromes, Nocturnal
% 215.96/216.16  |- skos__broader mesh__D020920smesh__D012893
% 215.96/216.16  |- skos__scopeNote mesh__D020920
% 215.96/216.16       A broad category of sleep disorders characterized by either hypersomnolence or insomnia. The three major subcategories include intrinsic %28%i.e., arising from within the body%29% %28%SLEEP DISORDERS, INTRINSIC%29%, extrinsic %28%secondary to environmental conditions or various pathologic conditions%29%, and disturbances of circadian rhythm. %28%From Thorpy, Sleep Disorders Medicine, 1994, p187%29%%A%    
% 215.96/216.16  |- skos__hiddenLabel mesh__D020920 Sleep Disorders, Adjustment
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D020920 2004
% 215.96/216.16  |- skos__hiddenLabel mesh__D020920 Nocturnal Eating-Drinking Syndromes
% 215.96/216.16  |- skos__hiddenLabel mesh__D020920 Nocturnal Eating Drinking Syndrome
% 215.96/216.16  |- skos__hiddenLabel mesh__D020920 Sleep Disorders, Environmental
% 215.96/216.16  |- skos__hiddenLabel mesh__D020920 Sleep Disorder, Extrinsic
% 215.96/216.16  |- mesh__dateRevised mesh__D020920 2003-07-22
% 215.96/216.16  |- skos__hiddenLabel mesh__D020920 Sleep Hygiene, Inadequate
% 215.96/216.16  |- skos__altLabel mesh__D020920 Sleep Disorder, Environmental
% 215.96/216.16  |- skos__hiddenLabel mesh__D020920 Eating-Drinking Syndrome, Nocturnal
% 215.96/216.16  |- mesh__historyNote mesh__D020920 2000   
% 215.96/216.16  |- mesh__recordOriginator mesh__D020920 KEV
% 215.96/216.16  |- skos__hiddenLabel mesh__D020920 Syndromes, Nocturnal Eating-Drinking
% 215.96/216.16  |- mesh__dateCreated mesh__D020920 1999-11-03
% 215.96/216.16  |- skos__historyNote mesh__D020920 Circadian Rhythm %28%1966-1999%29%
% 215.96/216.16  |- skos__hiddenLabel mesh__D020920 Limit Setting Sleep Disorder
% 215.96/216.16  |- skos__hiddenLabel mesh__D020920 Dyssomnia
% 215.96/216.16  |- skos__hiddenLabel mesh__D020920 Syndrome, Nocturnal Eating-Drinking
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D020920 2006
% 215.96/216.16  |- rdf__type mesh__D020920sskos__Concept
% 215.96/216.16  |- mesh__publicMeSHNote mesh__D020920 2000   
% 215.96/216.16  |- skos__prefLabel mesh__D020920 Dyssomnias
% 215.96/216.16  |- mesh__dateEstablished mesh__D020920 2000-01-01
% 215.96/216.16  |- skos__hiddenLabel mesh__D020920 Extrinsic Sleep Disorders
% 215.96/216.16  |- skos__hiddenLabel mesh__D020920 Extrinsic Sleep Disorder
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D020920 2005
% 215.96/216.16  |- skos__hiddenLabel mesh__D020920 Sleep Disorder, Limit Setting
% 215.96/216.16  |- skos__hiddenLabel mesh__D020920 Limit-Setting Sleep Disorders
% 215.96/216.16  |- skos__hiddenLabel mesh__D020920 Environmental Sleep Disorders
% 215.96/216.16  |- mesh__recordAuthorizer mesh__D020920 sjn
% 215.96/216.16  |- skos__altLabel mesh__D020920 Sleep Disorder, Adjustment
% 215.96/216.16  |- mesh__recordOriginator mesh__D006451 NLM
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D006451 1996
% 215.96/216.16  |- skos__hiddenLabel mesh__D006451 S, Hemoglobin
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D006451 2005
% 215.96/216.16  |- mesh__recordAuthorizer mesh__D006451 PLS
% 215.96/216.16  |- skos__altLabel mesh__D006451 Deoxygenated Sickle Hemoglobin
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D006451 2002
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D006451 1997
% 215.96/216.16  |- mesh__dateEstablished mesh__D006451 1977-01-01
% 215.96/216.16  |- skos__hiddenLabel mesh__D006451 Hemoglobin, Deoxygenated Sickle
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D006451 2006
% 215.96/216.16  |- skos__broader mesh__D006451smesh__D006455
% 215.96/216.16  |- skos__annotation mesh__D006451
% 215.96/216.16       /urine: coord IM with HEMOGLOBINURIA %28%IM%29%; hemoglobin S disease = ANEMIA, SICKLE CELL; DF: HBS%A%  
% 215.96/216.16  |- mesh__onlineNote mesh__D006451
% 215.96/216.16       use HEMOGLOBIN, SICKLE to search HEMOGLOBIN S 1973-74 %28%as Prov%29%%A%  
% 215.96/216.16  |- skos__hiddenLabel mesh__D006451 Sickle Hemoglobin
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D006451 1994
% 215.96/216.16  |- mesh__dateRevised mesh__D006451 1992-05-19
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D006451 2003
% 215.96/216.16  |- skos__hiddenLabel mesh__D006451 Sickle Hemoglobin, Deoxygenated
% 215.96/216.16  |- mesh__dateCreated mesh__D006451 1999-01-01
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D006451 2000
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D006451 1995
% 215.96/216.16  |- mesh__historyNote mesh__D006451
% 215.96/216.16       77%28%75%29%; was HEMOGLOBIN S 1973-74 %28%Prov%29%   
% 215.96/216.16  |- skos__scopeNote mesh__D006451
% 215.96/216.16       An abnormal hemoglobin resulting from the substitution of valine for glutamic acid at position 6 of the beta chain of the globin moiety. The heterozygous state results in sickle cell trait, the homozygous in sickle cell anemia.%A%    
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D006451 2004
% 215.96/216.16  |- skos__historyNote mesh__D006451 Hemoglobins, Abnormal %28%1966-1972%29%
% 215.96/216.16  |- mesh__recordMaintainer mesh__D006451 TAP
% 215.96/216.16  |- skos__hiddenLabel mesh__D006451 SS, Hemoglobin
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D006451 1998
% 215.96/216.16  |- skos__prefLabel mesh__D006451 Hemoglobin, Sickle
% 215.96/216.16  |- skos__hiddenLabel mesh__D006451 S, Deoxyhemoglobin
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D006451 2001
% 215.96/216.16  |- rdf__type mesh__D006451sskos__Concept
% 215.96/216.16  |- skos__altLabel mesh__D006451 Hemoglobin S
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D006451 1993
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D006451 1999
% 215.96/216.16  |- mesh__publicMeSHNote mesh__D006451 77   
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D020122 2006
% 215.96/216.16  |- rdf__type mesh__D020122sskos__Concept
% 215.96/216.16  |- skos__hiddenLabel mesh__D020122 t Butyl Hydroperoxide
% 215.96/216.16  |- mesh__publicMeSHNote mesh__D020122
% 215.96/216.16       99; TERT-BUTYLHYDROPEROXIDE was indexed under PEROXIDES 1976-98%A%  
% 215.96/216.16  |- skos__historyNote mesh__D020122 Peroxides %28%1976-1998%29%
% 215.96/216.16  |- skos__scopeNote mesh__D020122
% 215.96/216.16       A direct-acting oxidative stress-inducing agent used to examine the effects of oxidant stress on Ca%28%2+%29%-dependent signal transduction in vascular endothelial cells. It is also used as a catalyst in polymerization reactions and to introduce peroxy groups into organic molecules.%A%    
% 215.96/216.16  |- mesh__historyNote mesh__D020122
% 215.96/216.16       99; use TERT-BUTYLHYDROPEROXIDE %28%NM%29% 1980-98   
% 215.96/216.16  |- skos__altLabel mesh__D020122 t-Butyl Hydroperoxide
% 215.96/216.16  |- mesh__dateCreated mesh__D020122 1998-06-11
% 215.96/216.16  |- skos__hiddenLabel mesh__D020122 tert Butyl Hydroperoxide
% 215.96/216.16  |- mesh__dateRevised mesh__D020122 2005-06-30
% 215.96/216.16  |- skos__hiddenLabel mesh__D020122 t Butylhydroperoxide
% 215.96/216.16  |- mesh__recordAuthorizer mesh__D020122 sjn
% 215.96/216.16  |- mesh__recordMaintainer mesh__D020122 ssb
% 215.96/216.16  |- skos__hiddenLabel mesh__D020122 Hydroperoxide, t-Butyl
% 215.96/216.16  |- skos__altLabel mesh__D020122 tert-Butyl Hydroperoxide
% 215.96/216.16  |- mesh__dateEstablished mesh__D020122 1999-01-01
% 215.96/216.16  |- skos__prefLabel mesh__D020122 tert-Butylhydroperoxide
% 215.96/216.16  |- skos__hiddenLabel mesh__D020122 tert Butylhydroperoxide
% 215.96/216.16  |- skos__altLabel mesh__D020122 t-Butylhydroperoxide
% 215.96/216.16  |- skos__hiddenLabel mesh__D020122 tertiary Butylhydroperoxide
% 215.96/216.16  |- skos__hiddenLabel mesh__D020122 Hydroperoxide, tert-Butyl
% 215.96/216.16  |- skos__altLabel mesh__D020122 tertiary-Butylhydroperoxide
% 215.96/216.16  |- mesh__recordOriginator mesh__D020122 ADP
% 215.96/216.16  |- skos__broader mesh__D020122smesh__D010545
% 215.96/216.16  |- mesh__historyNote mesh__D047868 2005   
% 215.96/216.16  |- mesh__recordOriginator mesh__D047868 nns
% 215.96/216.16  |- skos__scopeNote mesh__D047868
% 215.96/216.16       A benign neoplasm of alveolar pneumocytes or ontogenetically primitive counterparts thereof. Morphological patterns that have been described include: solid, hemorrhagic, papillary, and sclerotic. Most lesions display a combination of two or three morphological patterns. Despite the implication by its name %28%HEMANGIOMA%29% of a vascular neoplasm, pulmonary sclerosing hemangioma is considered by most authorities to be an epithelial tumor. %28%Histopathology 2003;43%28%3%29%:239-43; Arch Pathol Lab Med. 2001;125%28%10%29%: 1335-9%29%%A%    
% 215.96/216.16  |- mesh__publicMeSHNote mesh__D047868 2005   
% 215.96/216.16  |- skos__historyNote mesh__D047868 Dermatofibroma %28%1972-2004%29%
% 215.96/216.16  |- skos__hiddenLabel mesh__D047868 Sclerosing Hemangiomas, Lung
% 215.96/216.16  |- skos__broader mesh__D047868smesh__D008175
% 215.96/216.16  |- skos__hiddenLabel mesh__D047868 Pulmonary Sclerosing Hemangiomas
% 215.96/216.16  |- skos__hiddenLabel mesh__D047868 Lung Sclerosing Hemangiomas
% 215.96/216.16  |- skos__prefLabel mesh__D047868 Pulmonary Sclerosing Hemangioma
% 215.96/216.16  |- skos__altLabel mesh__D047868 Hemangioma, Sclerosing, Pulmonary
% 215.96/216.16  |- rdf__type mesh__D047868sskos__Concept
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D047868 2005
% 215.96/216.16  |- skos__altLabel mesh__D047868 Lung Sclerosing Hemangioma
% 215.96/216.16  |- skos__hiddenLabel mesh__D047868 Hemangiomas, Lung Sclerosing
% 215.96/216.16  |- skos__hiddenLabel mesh__D047868 Hemangioma, Pulmonary Sclerosing
% 215.96/216.16  |- skos__hiddenLabel mesh__D047868 Hemangioma, Lung Sclerosing
% 215.96/216.16  |- skos__hiddenLabel mesh__D047868 Sclerosing Hemangioma, Pulmonary
% 215.96/216.16  |- skos__hiddenLabel mesh__D047868 Hemangiomas, Pulmonary Sclerosing
% 215.96/216.16  |- skos__related mesh__D047868smesh__D006391
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D047868 2006
% 215.96/216.16  |- mesh__dateCreated mesh__D047868 2004-07-07
% 215.96/216.16  |- skos__hiddenLabel mesh__D047868 Sclerosing Hemangioma, Lung
% 215.96/216.16  |- mesh__recordMaintainer mesh__D047868 nns
% 215.96/216.16  |- skos__altLabel mesh__D047868 Sclerosing Hemangioma of the Lung
% 215.96/216.16  |- mesh__dateEstablished mesh__D047868 2005-01-01
% 215.96/216.16  |- skos__hiddenLabel mesh__D047868 Sclerosing Hemangiomas, Pulmonary
% 215.96/216.16  |- mesh__recordAuthorizer mesh__D047868 sjn
% 215.96/216.16  |- mesh__dateCreated mesh__D019379 1996-06-10
% 215.96/216.16  |- skos__broader mesh__D019379smesh__D010281
% 215.96/216.16  |- mesh__historyNote mesh__D019379
% 215.96/216.16       97; was PARATHYROID HORMONE PEPTIDE %28%1-34%29% %28%NM%29% 1978-96   
% 215.96/216.16  |- skos__hiddenLabel mesh__D019379 Acetate, Teriparatide
% 215.96/216.16  |- mesh__recordMaintainer mesh__D019379 ssb
% 215.96/216.16  |- skos__altLabel mesh__D019379 Parathyroid Hormone Peptide %28%1-34%29%
% 215.96/216.16  |- skos__altLabel mesh__D019379 hPTH %28%1-34%29%
% 215.96/216.16  |- mesh__recordOriginator mesh__D019379 TPW
% 215.96/216.16  |- mesh__dateRevised mesh__D019379 2005-06-30
% 215.96/216.16  |- mesh__recordAuthorizer mesh__D019379 sjn
% 215.96/216.16  |- skos__historyNote mesh__D019379 Parathyroid Hormones %28%1978-1996%29%
% 215.96/216.16  |- mesh__publicMeSHNote mesh__D019379
% 215.96/216.16       97; PARATHYROID HORMONE PEPTIDE %28%1-34%29% was indexed under PARATHYROID HORMONES %26% PEPTIDE FRAGMENTS 1978-96%A%  
% 215.96/216.16  |- mesh__onlineNote mesh__D019379
% 215.96/216.16       use TERIPARATIDE %28%NM%29% to search PARATHYROID HORMONE PEPTIDE %28%1-34%29% 1978-96%A%  
% 215.96/216.16  |- mesh__dateEstablished mesh__D019379 1997-01-01
% 215.96/216.16  |- skos__altLabel mesh__D019379 Human Parathyroid Hormone %28%1-34%29%
% 215.96/216.16  |- skos__historyNote mesh__D019379 Peptide Fragments %28%1978-1996%29%
% 215.96/216.16  |- skos__prefLabel mesh__D019379 Teriparatide
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D019379 2006
% 215.96/216.16  |- rdf__type mesh__D019379sskos__Concept
% 215.96/216.16  |- skos__scopeNote mesh__D019379
% 215.96/216.16       A synthetic polypeptide that consists of the 1-34 amino-acid fragment of human PARATHYROID HORMONE, the biologically active N-terminal region. The acetate form is given by intravenous infusion in the differential diagnosis of HYPOPARATHYROIDISM and PSEUDOHYPOPARATHYROIDISM. %28%Reynolds JEF%28%Ed%29%: Martindale: The Extra Pharmacopoeia %28%electronic version%29%. Micromedex, Inc, Englewood, CO, 1995%29%%A%    
% 215.96/216.16  |- skos__altLabel mesh__D011396 Dimethylmeperidine
% 215.96/216.16  |- skos__prefLabel mesh__D011396 Promedol
% 215.96/216.16  |- rdf__type mesh__D011396sskos__Concept
% 215.96/216.16  |- mesh__dateCreated mesh__D011396 1977-04-22
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D011396 2001
% 215.96/216.16  |- skos__scopeNote mesh__D011396
% 215.96/216.16       A narcotic analgesic similar to MEPERIDINE; it exists in four stereoisomers, two of which, the beta %28%isopromedol%29% and the gamma %28%trimeperidine%29% are active.%A%    
% 215.96/216.16  |- mesh__historyNote mesh__D011396
% 215.96/216.16       91%28%78%29%; was see under MEPERIDINE 1978-90   
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D011396 2004
% 215.96/216.16  |- mesh__dateEstablished mesh__D011396 1991-01-01
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D011396 2003
% 215.96/216.16  |- mesh__recordAuthorizer mesh__D011396 sjn
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D011396 2006
% 215.96/216.16  |- skos__historyNote mesh__D011396 Propionates %28%1966-1977%29%
% 215.96/216.16  |- skos__broader mesh__D011396smesh__D008614
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D011396 2002
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D011396 2005
% 215.96/216.16  |- mesh__recordOriginator mesh__D011396 SH
% 215.96/216.16  |- skos__historyNote mesh__D011396 Piperidines %28%1966-1974%29%
% 215.96/216.16  |- mesh__recordMaintainer mesh__D011396 TWD
% 215.96/216.16  |- mesh__publicMeSHNote mesh__D011396
% 215.96/216.16       91; was see under MEPERIDINE 1978-90   
% 215.96/216.16  |- mesh__dateRevised mesh__D011396 2000-06-22
% 215.96/216.16  |- skos__historyNote mesh__D011396 Meperidine %28%1975-1977%29%
% 215.96/216.16  |- mesh__publicMeSHNote mesh__D005359
% 215.96/216.16       91; was see under FIBROUS DYSPLASIA OF BONE 1967-90; ALBRIGHT%27%S DISEASE %26% JAFFE-LICHTENSTEIN DISEASE were see under OSTEITIS FIBROSA 1963-66%A%  
% 215.96/216.16  |- skos__hiddenLabel mesh__D005359 Dysplasia, Polyostotic Fibrous
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D005359 2006
% 215.96/216.16  |- mesh__recordOriginator mesh__D005359 NLM
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D005359 2003
% 215.96/216.16  |- skos__scopeNote mesh__D005359
% 215.96/216.16       FIBROUS DYSPLASIA OF BONE affecting several or many bones. When associated with melanotic pigmentation of the skin and endocrine disorders, it is known as Albright%27%s syndrome. %28%From Dorland, 28th ed%29%%A%    
% 215.96/216.16  |- skos__hiddenLabel mesh__D005359 Fibrous Dysplasias, Polyostotic
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D005359 2000
% 215.96/216.16  |- skos__prefLabel mesh__D005359 Fibrous Dysplasia, Polyostotic
% 215.96/216.16  |- mesh__historyNote mesh__D005359
% 215.96/216.16       91%28%75%29%; was see under FIBROUS DYSPLASIA OF BONE 1967-90; ALBRIGHT%27%S DISEASE %26% JAFFE-LICHTENSTEIN DISEASE were see under OSTEITIS FIBROSA 1963-66%A%  
% 215.96/216.16  |- mesh__onlineNote mesh__D005359
% 215.96/216.16       use FIBROUS DYSPLASIA OF BONE to search FIBROUS DYSPLASIA, POLYOSTOTIC 1967-74; search ALBRIGHT%27%S DISEASE %26% JAFFE-LICHTENSTEIN DISEASE under OSTEITIS FIBROSA CYSTICA 1966%A%  
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D005359 2004
% 215.96/216.16  |- mesh__recordAuthorizer mesh__D005359 PLS
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D005359 1998
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D005359 2001
% 215.96/216.16  |- mesh__dateCreated mesh__D005359 1999-01-01
% 215.96/216.16  |- skos__hiddenLabel mesh__D005359 Albright Syndrome
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D005359 1999
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D005359 2002
% 215.96/216.16  |- skos__hiddenLabel mesh__D005359 McCune Albright Syndrome
% 215.96/216.16  |- skos__annotation mesh__D005359
% 215.96/216.16       sometimes Jaffe-Lichtenstein %28%usually monostotic%29% goes here: check text; craniofacial fibrous dysplasia: coord IM with FACIAL BONES %28%IM%29% + SKULL %28%IM%29%%A%  
% 215.96/216.16  |- skos__hiddenLabel mesh__D005359 Albrights Syndrome
% 215.96/216.16  |- mesh__recordMaintainer mesh__D005359 TGC
% 215.96/216.16  |- skos__altLabel mesh__D005359 McCune-Albright Syndrome
% 215.96/216.16  |- skos__hiddenLabel mesh__D005359 Polyostotic Fibrous Dysplasia
% 215.96/216.16  |- mesh__dateRevised mesh__D005359 1996-06-10
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D005359 1997
% 215.96/216.16  |- skos__hiddenLabel mesh__D005359 Dysplasias, Polyostotic Fibrous
% 215.96/216.16  |- rdf__type mesh__D005359sskos__Concept
% 215.96/216.16  |- skos__broader mesh__D005359smesh__D005357
% 215.96/216.16  |- mesh__dateEstablished mesh__D005359 1991-01-01
% 215.96/216.16  |- skos__hiddenLabel mesh__D005359 Syndrome, Albright%27%s
% 215.96/216.16  |- skos__hiddenLabel mesh__D005359 Syndrome, McCune-Albright
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D005359 2005
% 215.96/216.16  |- skos__hiddenLabel mesh__D005359 Polyostotic Fibrous Dysplasias
% 215.96/216.16  |- skos__hiddenLabel mesh__D016081 Cycles, Lunar
% 215.96/216.16  |- skos__hiddenLabel mesh__D016081 Lunar Cycles
% 215.96/216.16  |- skos__hiddenLabel mesh__D016081 Cycles, Moon
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D016081 2006
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D016081 1998
% 215.96/216.16  |- mesh__publicMeSHNote mesh__D016081 91   
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D016081 1995
% 215.96/216.16  |- skos__historyNote mesh__D016081 Astronomy %28%1966-1990%29%
% 215.96/216.16  |- skos__altLabel mesh__D016081 Moon Phases
% 215.96/216.16  |- skos__altLabel mesh__D016081 Moon Cycle
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D016081 2003
% 215.96/216.16  |- skos__hiddenLabel mesh__D016081 Moon Phase
% 215.96/216.16  |- skos__hiddenLabel mesh__D016081 Lunar Phase
% 215.96/216.16  |- skos__prefLabel mesh__D016081 Moon
% 215.96/216.16  |- skos__hiddenLabel mesh__D016081 Moon Cycles
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D016081 1999
% 215.96/216.16  |- skos__hiddenLabel mesh__D016081 Cycle, Lunar
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D016081 2002
% 215.96/216.16  |- mesh__dateEstablished mesh__D016081 1991-01-01
% 215.96/216.16  |- rdf__type mesh__D016081sskos__Concept
% 215.96/216.16  |- mesh__dateCreated mesh__D016081 1990-06-06
% 215.96/216.16  |- mesh__dateRevised mesh__D016081 1994-02-28
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D016081 2004
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D016081 1996
% 215.96/216.16  |- skos__scopeNote mesh__D016081
% 215.96/216.16       The natural satellite of the planet Earth. It includes the lunar cycles or phases, the lunar month, lunar landscapes, geography, and soil.%A%    
% 215.96/216.16  |- skos__hiddenLabel mesh__D016081 Phase, Moon
% 215.96/216.16  |- skos__hiddenLabel mesh__D016081 Phases, Moon
% 215.96/216.16  |- mesh__recordOriginator mesh__D016081 TGC
% 215.96/216.16  |- skos__hiddenLabel mesh__D016081 Phases, Lunar
% 215.96/216.16  |- skos__hiddenLabel mesh__D016081 Cycle, Moon
% 215.96/216.16  |- skos__broader mesh__D016081smesh__D018534
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D016081 1997
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D016081 2000
% 215.96/216.16  |- mesh__recordAuthorizer mesh__D016081 PLS
% 215.96/216.16  |- mesh__historyNote mesh__D016081 91   
% 215.96/216.16  |- mesh__recordMaintainer mesh__D016081 JLS
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D016081 2005
% 215.96/216.16  |- skos__annotation mesh__D016081
% 215.96/216.16       no qualif; includes lunar cycles, landscape, geography, soil; moon illusion: coord IM with OPTICAL ILLUSIONS %28%IM%29%%A%  
% 215.96/216.16  |- skos__historyNote mesh__D016081 Periodicity %28%1966-1990%29%
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D016081 2001
% 215.96/216.16  |- skos__hiddenLabel mesh__D016081 Moons
% 215.96/216.16  |- skos__historyNote mesh__D016081 Space Flight %28%1966-1990%29%
% 215.96/216.16  |- skos__historyNote mesh__D016081
% 215.96/216.16       Extraterrestrial Environment %28%1966-1990%29%
% 215.96/216.16  |- skos__hiddenLabel mesh__D016081 Phase, Lunar
% 215.96/216.16  |- skos__historyNote mesh__D016081 Meteorological Factors %28%1977-1990%29%
% 215.96/216.16  |- mesh__publicMeSHNote mesh__D002061 65   
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D002061 1990
% 215.96/216.16  |- skos__hiddenLabel mesh__D002061 Synovial Bursas
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D002061 1997
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D002061 2004
% 215.96/216.16  |- rdf__type mesh__D002061sskos__Concept
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D002061 2000
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D002061 1994
% 215.96/216.16  |- mesh__dateEstablished mesh__D002061 1965-01-01
% 215.96/216.16  |- skos__broader mesh__D002061smesh__D007596
% 215.96/216.16  |- mesh__historyNote mesh__D002061 65   
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D002061 1995
% 215.96/216.16  |- skos__prefLabel mesh__D002061 Bursa, Synovial
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D002061 2001
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D002061 1991
% 215.96/216.16  |- skos__hiddenLabel mesh__D002061 Synovial Bursa
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D002061 1989
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D002061 1992
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D002061 1998
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D002061 2005
% 215.96/216.16  |- skos__annotation mesh__D002061 inflammation = BURSITIS   
% 215.96/216.16  |- skos__hiddenLabel mesh__D002061 Bursas, Synovial
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D002061 1993
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D002061 2006
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D002061 1999
% 215.96/216.16  |- mesh__recordMaintainer mesh__D002061 HMM
% 215.96/216.16  |- mesh__dateRevised mesh__D002061 1978-10-25
% 215.96/216.16  |- mesh__recordOriginator mesh__D002061 NLM
% 215.96/216.16  |- mesh__dateCreated mesh__D002061 1999-01-01
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D002061 2002
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D002061 1996
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D002061 2003
% 215.96/216.16  |- mesh__recordAuthorizer mesh__D002061 NLM
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D015787 1998
% 215.96/216.16  |- skos__annotation mesh__D015787
% 215.96/216.16       from a tick bite; %22%stage-1 manifestation of LYME DISEASE%22%%A%  
% 215.96/216.16  |- mesh__dateEstablished mesh__D015787 1990-01-01
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D015787 1997
% 215.96/216.16  |- skos__historyNote mesh__D015787 Erythema %28%1966-1987%29%
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D015787 2001
% 215.96/216.16  |- mesh__publicMeSHNote mesh__D015787 90   
% 215.96/216.16  |- skos__broader mesh__D015787smesh__D004890
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D015787 1999
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D015787 1995
% 215.96/216.16  |- mesh__recordMaintainer mesh__D015787 PXP
% 215.96/216.16  |- skos__scopeNote mesh__D015787
% 215.96/216.16       A deep type of gyrate erythema that follows a bite by an ixodid tick; it is a stage-1 manifestation of LYME DISEASE. The site of the bite is characterized by a red papule that expands peripherally as a nonscaling, palpable band that clears centrally. This condition is often associated with systemic symptoms such as chills, fever, headache, malaise, nausea, vomiting, fatigue, backache, and stiff neck.%A%    
% 215.96/216.16  |- skos__broader mesh__D015787smesh__D017192
% 215.96/216.16  |- mesh__dateCreated mesh__D015787 1989-05-15
% 215.96/216.16  |- skos__prefLabel mesh__D015787 Erythema Chronicum Migrans
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D015787 2002
% 215.96/216.16  |- rdf__type mesh__D015787sskos__Concept
% 215.96/216.16  |- skos__historyNote mesh__D015787 Borrelia %28%1986-1989%29%
% 215.96/216.16  |- skos__historyNote mesh__D015787 Lyme Disease %28%1984-1989%29%
% 215.96/216.16  |- mesh__recordAuthorizer mesh__D015787 PLS
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D015787 2003
% 215.96/216.16  |- skos__historyNote mesh__D015787 Ticks %28%1983-1989%29%
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D015787 2005
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D015787 2004
% 215.96/216.16  |- mesh__historyNote mesh__D015787 90   
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D015787 1996
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D015787 2006
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D015787 2000
% 215.96/216.16  |- mesh__recordOriginator mesh__D015787 PXP
% 215.96/216.16  |- mesh__dateRevised mesh__D015787 1994-02-08
% 215.96/216.16  |- skos__broader mesh__D015787smesh__D008193
% 215.96/216.16  |- skos__hiddenLabel mesh__D034941 Extremities, Upper
% 215.96/216.16  |- skos__historyNote mesh__D034941 Arm %28%1963-2002%29%
% 215.96/216.16  |- skos__hiddenLabel mesh__D034941 Upper Extremities
% 215.96/216.16  |- skos__annotation mesh__D034941
% 215.96/216.16       prefer specifics; Manual 21.58: table of human, primate %26% non-primate extremities%A%  
% 215.96/216.16  |- mesh__dateCreated mesh__D034941 2002-07-03
% 215.96/216.16  |- skos__altLabel mesh__D034941 Upper Limb
% 215.96/216.16  |- skos__prefLabel mesh__D034941 Upper Extremity
% 215.96/216.16  |- mesh__dateEstablished mesh__D034941 2003-01-01
% 215.96/216.16  |- skos__hiddenLabel mesh__D034941 Upper Limbs
% 215.96/216.16  |- skos__altLabel mesh__D034941 Membrum superius
% 215.96/216.16  |- skos__altLabel mesh__D034941 Extremity, Upper
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D034941 2005
% 215.96/216.16  |- mesh__publicMeSHNote mesh__D034941 2003; see ARM 1987-2002   
% 215.96/216.16  |- skos__related mesh__D034941smesh__D001133
% 215.96/216.16  |- skos__broader mesh__D034941smesh__D005121
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D034941 2003
% 215.96/216.16  |- mesh__historyNote mesh__D034941 2003; use ARM 1987-2002   
% 215.96/216.16  |- skos__scopeNote mesh__D034941
% 215.96/216.16       The region of the upper limb in animals, extending from the deltoid region to the HAND, and including the ARM; AXILLA; and SHOULDER.%A%    
% 215.96/216.16  |- skos__hiddenLabel mesh__D034941 Limb, Upper
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D034941 2006
% 215.96/216.16  |- rdf__type mesh__D034941sskos__Concept
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D034941 2004
% 215.96/216.16  |- skos__hiddenLabel mesh__D034941 Limbs, Upper
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D001767 2006
% 215.96/216.16  |- mesh__recordAuthorizer mesh__D001767 sjn
% 215.96/216.16  |- skos__altLabel mesh__D001767 Reflex, Blink
% 215.96/216.16  |- rdf__type mesh__D001767sskos__Concept
% 215.96/216.16  |- skos__broader mesh__D001767smesh__D012018
% 215.96/216.16  |- mesh__activeMeSHYear mesh__D001767 2004
% 215.96/216.16  |- mesh__dateEstablished mesh__D001767 1981-01-01
% 215.96/216.16  |- skos__annotation mesh__D001767
% 215.96/216.16       voluntary %26% involuntary blinking; winking goes here   
% 215.96/216.16  |- mesh__dateRevised mesh__D001767 2003-07-09
% 215.96/216.17  |- skos__hiddenLabel mesh__D001767 Blink Reflex
% 215.96/216.17  |- skos__altLabel mesh__D001767 Reflex, Corneal
% 215.96/216.17  |- skos__scopeNote mesh__D001767
% 215.96/216.17       Brief closing of the eyelids by involuntary normal periodic closing, as a protective measure, or by voluntary action.%A%    
% 215.96/216.17  |- skos__altLabel mesh__D001767 Orbicularis Oculi Reflexes
% 215.96/216.17  |- skos__historyNote mesh__D001767 Reflex %28%1966-1980%29%
% 215.96/216.17  |- skos__hiddenLabel mesh__D001767 Reflexes, Orbicularis Oculi
% 215.96/216.17  |- skos__altLabel mesh__D001767 Orbicularis Oculi Reflex
% 215.96/216.17  |- skos__hiddenLabel mesh__D001767 Reflexes, Blink
% 215.96/216.17  |- mesh__recordOriginator mesh__D001767 RC
% 215.96/216.17  |- skos__prefLabel mesh__D001767 Blinking
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D001767 2005
% 215.96/216.17  |- mesh__recordMaintainer mesh__D001767 nns
% 215.96/216.17  |- skos__historyNote mesh__D001767 Eyelids %28%1966-1980%29%
% 215.96/216.17  |- mesh__dateCreated mesh__D001767 1980-04-04
% 215.96/216.17  |- mesh__publicMeSHNote mesh__D001767 81   
% 215.96/216.17  |- skos__broader mesh__D001767smesh__D043723
% 215.96/216.17  |- mesh__historyNote mesh__D001767 81   
% 215.96/216.17  |- mesh__historyNote mesh__D020921 2000   
% 215.96/216.17  |- skos__prefLabel mesh__D020921 Sleep Arousal Disorders
% 215.96/216.17  |- skos__hiddenLabel mesh__D020921 Arousal Disorder, Sleep
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D020921 2003
% 215.96/216.17  |- skos__broader mesh__D020921smesh__D020447
% 215.96/216.17  |- skos__hiddenLabel mesh__D020921 Sleep Arousal Disorder
% 215.96/216.17  |- skos__hiddenLabel mesh__D020921 Confusional Arousal
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D020921 2001
% 215.96/216.17  |- skos__hiddenLabel mesh__D020921 Arousal, Confusional
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D020921 2006
% 215.96/216.17  |- mesh__dateCreated mesh__D020921 1999-11-05
% 215.96/216.17  |- rdf__type mesh__D020921sskos__Concept
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D020921 2000
% 215.96/216.17  |- mesh__dateEstablished mesh__D020921 2000-01-01
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D020921 2005
% 215.96/216.17  |- skos__historyNote mesh__D020921 Arousal %28%1968-1999%29%
% 215.96/216.17  |- skos__historyNote mesh__D020921 Sleep Disorders %28%1968-1999%29%
% 215.96/216.17  |- skos__hiddenLabel mesh__D020921 Arousals, Confusional
% 215.96/216.17  |- skos__altLabel mesh__D020921 Arousal Disorders, Sleep
% 215.96/216.17  |- skos__scopeNote mesh__D020921
% 215.96/216.17       Sleep disorders characterized by impaired arousal from the deeper stages of sleep %28%generally stage III or IV sleep%29%.%A%    
% 215.96/216.17  |- mesh__publicMeSHNote mesh__D020921 2000   
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D020921 2002
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D020921 2004
% 215.96/216.17  |- skos__hiddenLabel mesh__D006452 Hemoglobinometries
% 215.96/216.17  |- skos__scopeNote mesh__D006452
% 215.96/216.17       Measurement of hemoglobin concentration in blood.     
% 215.96/216.17  |- mesh__dateRevised mesh__D006452 1998-06-11
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D006452 2003
% 215.96/216.17  |- mesh__dateCreated mesh__D006452 1999-01-01
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D006452 2001
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D006452 2004
% 215.96/216.17  |- skos__prefLabel mesh__D006452 Hemoglobinometry
% 215.96/216.17  |- skos__broader mesh__D006452smesh__D006403
% 215.96/216.17  |- mesh__recordOriginator mesh__D006452 NLM
% 215.96/216.17  |- mesh__recordAuthorizer mesh__D006452 SJN
% 215.96/216.17  |- rdf__type mesh__D006452sskos__Concept
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D006452 1999
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D006452 2002
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D006452 2005
% 215.96/216.17  |- mesh__recordMaintainer mesh__D006452 MSR
% 215.96/216.17  |- skos__annotation mesh__D006452
% 215.96/216.17       NIM; do not equate with HEMOGLOBINS /anal; note ERYTHROCYTE HEMOGLOBIN, MEAN CELL see ERYTHROCYTE INDICES is available%A%  
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D006452 2006
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D006452 2000
% 215.96/216.17  |- skos__altLabel mesh__D020123 Rapamycin
% 215.96/216.17  |- mesh__recordMaintainer mesh__D020123 CCR
% 215.96/216.17  |- rdf__type mesh__D020123sskos__Concept
% 215.96/216.17  |- skos__hiddenLabel mesh__D020123 AY 22 989
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D020123 2006
% 215.96/216.17  |- skos__broader mesh__D020123smesh__D018942
% 215.96/216.17  |- mesh__historyNote mesh__D020123 99; use SIROLIMUS %28%NM%29% 1980-97   
% 215.96/216.17  |- mesh__recordAuthorizer mesh__D020123 sjn
% 215.96/216.17  |- skos__historyNote mesh__D020123 Polyenes %28%1976-1998%29%
% 215.96/216.17  |- mesh__dateEstablished mesh__D020123 1999-01-01
% 215.96/216.17  |- skos__hiddenLabel mesh__D020123 AY 22989
% 215.96/216.17  |- skos__altLabel mesh__D020123 Wyeth Brand of Sirolimus
% 215.96/216.17  |- skos__prefLabel mesh__D020123 Sirolimus
% 215.96/216.17  |- mesh__dateRevised mesh__D020123 2005-06-30
% 215.96/216.17  |- mesh__dateCreated mesh__D020123 1998-06-11
% 215.96/216.17  |- skos__scopeNote mesh__D020123
% 215.96/216.17       A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to IMMUNOPHILINS. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties.%A%    
% 215.96/216.17  |- mesh__recordOriginator mesh__D020123 ADP
% 215.96/216.17  |- mesh__publicMeSHNote mesh__D020123
% 215.96/216.17       99; RAPAMYCIN %28%now SIROLIMUS%29% was indexed under POLYENES 1976-98%A%  
% 215.96/216.17  |- skos__altLabel mesh__D047869 Korean War, 1950-1953
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D047869 2005
% 215.96/216.17  |- mesh__dateEstablished mesh__D047869 2005-01-01
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D047869 2006
% 215.96/216.17  |- mesh__dateCreated mesh__D047869 2004-07-07
% 215.96/216.17  |- mesh__recordOriginator mesh__D047869 jls
% 215.96/216.17  |- mesh__recordAuthorizer mesh__D047869 sjn
% 215.96/216.17  |- mesh__historyNote mesh__D047869 2005   
% 215.96/216.17  |- skos__hiddenLabel mesh__D047869 Conflict, Korean
% 215.96/216.17  |- skos__altLabel mesh__D047869 Korean Conflict
% 215.96/216.17  |- skos__hiddenLabel mesh__D047869 War, Korean
% 215.96/216.17  |- skos__broader mesh__D047869smesh__D049673
% 215.96/216.17  |- skos__scopeNote mesh__D047869
% 215.96/216.17       An armed conflict between Communist and non-Communist forces in Korea from June 25, 1950, to July 27, 1953.  The parties included United Nations forces from 15 member nations under United States command against military from North Korea and the Peoples Republic of China.%A%    
% 215.96/216.17  |- mesh__recordMaintainer mesh__D047869 jls
% 215.96/216.17  |- mesh__publicMeSHNote mesh__D047869 2005   
% 215.96/216.17  |- skos__hiddenLabel mesh__D047869 Korean War, 1950 1953
% 215.96/216.17  |- skos__hiddenLabel mesh__D047869 1950-1953 Korean War
% 215.96/216.17  |- rdf__type mesh__D047869sskos__Concept
% 215.96/216.17  |- skos__prefLabel mesh__D047869 Korean War
% 215.96/216.17  |- skos__hiddenLabel mesh__D011397 RU 5020
% 215.96/216.17  |- mesh__dateEstablished mesh__D011397 1991-01-01
% 215.96/216.17  |- mesh__publicMeSHNote mesh__D011397
% 215.96/216.17       91; was see under NORPREGNADIENES 1986-90; was R 5020 see under NORPREGNADIENES 1979-85%A%  
% 215.96/216.17  |- skos__altLabel mesh__D011397 Aventis Brand of Promegestone
% 215.96/216.17  |- mesh__onlineNote mesh__D011397
% 215.96/216.17       use PROMEGESTONE to search R 5020 1979-85   
% 215.96/216.17  |- skos__historyNote mesh__D011397 Pregnanes %28%1968-1974%29%
% 215.96/216.17  |- mesh__historyNote mesh__D011397
% 215.96/216.17       91%28%86%29%; was see under NORPREGNADIENES 1986-90; was R 5020 see under NORPREGNADIENES 1979-85%A%  
% 215.96/216.17  |- skos__historyNote mesh__D011397 Norpregnadienes %28%1975-1978%29%
% 215.96/216.17  |- mesh__recordMaintainer mesh__D011397 lkw
% 215.96/216.17  |- skos__scopeNote mesh__D011397
% 215.96/216.17       A synthetic progestin which is useful for the study of progestin distribution and progestin tissue receptors, as it is not bound by transcortin and binds to progesterone receptors with a higher association constant than progesterone.%A%    
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D011397 2006
% 215.96/216.17  |- skos__altLabel mesh__D011397 RU-5020
% 215.96/216.17  |- skos__historyNote mesh__D011397
% 215.96/216.17       Progestational Hormones, Synthetic %28%1975-1978%29%
% 215.96/216.17  |- mesh__recordOriginator mesh__D011397 RLS
% 215.96/216.17  |- skos__hiddenLabel mesh__D011397 R 5020
% 215.96/216.17  |- skos__altLabel mesh__D011397
% 215.96/216.17       17,21-Dimethyl-19-nor-4,9-pregnadiene-3,20-dione
% 215.96/216.17  |- mesh__dateCreated mesh__D011397 1978-03-15
% 215.96/216.17  |- skos__historyNote mesh__D011397
% 215.96/216.17       Progestational Hormones %28%1966-1974%29%
% 215.96/216.17  |- skos__altLabel mesh__D011397 RU5020
% 215.96/216.17  |- skos__altLabel mesh__D011397 Promestone
% 215.96/216.17  |- mesh__recordAuthorizer mesh__D011397 sjn
% 215.96/216.17  |- skos__prefLabel mesh__D011397 Promegestone
% 215.96/216.17  |- mesh__dateRevised mesh__D011397 2005-06-30
% 215.96/216.17  |- skos__altLabel mesh__D011397 R5020
% 215.96/216.17  |- skos__annotation mesh__D011397 D25-26   
% 215.96/216.17  |- skos__broader mesh__D011397smesh__D009649
% 215.96/216.17  |- rdf__type mesh__D011397sskos__Concept
% 215.96/216.17  |- mesh__dateEstablished mesh__D016880 1992-01-01
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D016880 2005
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D016880 2002
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D016880 2003
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D016880 2006
% 215.96/216.17  |- mesh__recordMaintainer mesh__D016880 mdb
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D016880 2004
% 215.96/216.17  |- mesh__dateRevised mesh__D016880 2001-07-25
% 215.96/216.17  |- mesh__historyNote mesh__D016880 92   
% 215.96/216.17  |- mesh__recordAuthorizer mesh__D016880 sjn
% 215.96/216.17  |- mesh__publicMeSHNote mesh__D016880 92   
% 215.96/216.17  |- skos__scopeNote mesh__D016880
% 215.96/216.17       A physical property showing different values in relation to the direction in or along which the measurement is made. The physical property may be with regard to thermal or electric conductivity or light refraction. In crystallography, it describes crystals whose index of refraction varies with the direction of the incident light. It is also called acolotropy and colotropy. The opposite of anisotropy is isotropy wherein the same values characterize the object when measured along axes in all directions.%A%    
% 215.96/216.17  |- skos__broader mesh__D016880smesh__D002627
% 215.96/216.17  |- rdf__type mesh__D016880sskos__Concept
% 215.96/216.17  |- mesh__recordOriginator mesh__D016880 TGC
% 215.96/216.17  |- skos__broader mesh__D016880smesh__D009906
% 215.96/216.17  |- mesh__dateCreated mesh__D016880 1991-05-02
% 215.96/216.17  |- skos__hiddenLabel mesh__D016880 Anisotropies
% 215.96/216.17  |- skos__annotation mesh__D016880
% 215.96/216.17       NIM; no qualif; coord with specific determinative technique %28%IM or NIM%29% like NMR; MRI; CRYSTALLOGRAPHY; etc.%A%  
% 215.96/216.17  |- skos__prefLabel mesh__D016880 Anisotropy
% 215.96/216.17  |- skos__historyNote mesh__D016082
% 215.96/216.17       Extraterrestrial Environment %28%1966-1990%29%
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D016082 2003
% 215.96/216.17  |- mesh__recordMaintainer mesh__D016082 TGC
% 215.96/216.17  |- mesh__historyNote mesh__D016082 91   
% 215.96/216.17  |- skos__broader mesh__D016082smesh__D001256
% 215.96/216.17  |- skos__scopeNote mesh__D016082
% 215.96/216.17       The group of celestial bodies, including the EARTH, orbiting around and gravitationally bound by the sun. It includes nine planets, 34 natural satellites, more than 1,000 observed comets, and thousands of lesser bodies known as MINOR PLANETS %28%asteroids%29% and METEOROIDS. %28%From Academic American Encyclopedia, 1983%29%%A%    
% 215.96/216.17  |- skos__annotation mesh__D016082
% 215.96/216.17       no qualif; METEOROIDS is available: see MeSH definition there%A%  
% 215.96/216.17  |- skos__historyNote mesh__D016082 Astronomy %28%1966-1990%29%
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D016082 2001
% 215.96/216.17  |- mesh__recordAuthorizer mesh__D016082 SJN
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D016082 1999
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D016082 2006
% 215.96/216.17  |- mesh__recordOriginator mesh__D016082 TGC
% 215.96/216.17  |- mesh__dateRevised mesh__D016082 1997-06-20
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D016082 2000
% 215.96/216.17  |- mesh__publicMeSHNote mesh__D016082 91   
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D016082 1998
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D016082 2005
% 215.96/216.17  |- skos__hiddenLabel mesh__D016082 Natural Satellites
% 215.96/216.17  |- mesh__dateCreated mesh__D016082 1990-02-12
% 215.96/216.17  |- rdf__type mesh__D016082sskos__Concept
% 215.96/216.17  |- skos__hiddenLabel mesh__D016082 Natural Satellite
% 215.96/216.17  |- skos__hiddenLabel mesh__D016082 System, Solar
% 215.96/216.17  |- skos__hiddenLabel mesh__D016082 Satellite, Natural
% 215.96/216.17  |- skos__prefLabel mesh__D016082 Solar System
% 215.96/216.17  |- mesh__dateEstablished mesh__D016082 1991-01-01
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D016082 2002
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D016082 2004
% 215.96/216.17  |- mesh__dateRevised mesh__D002860 1993-06-01
% 215.96/216.17  |- mesh__onlineNote mesh__D002860 search CHROMIUM ISOTOPES 1966-73   
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002860 2002
% 215.96/216.17  |- skos__prefLabel mesh__D002860 Chromium Radioisotopes
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002860 2006
% 215.96/216.17  |- mesh__dateEstablished mesh__D002860 1974-01-01
% 215.96/216.17  |- skos__broader mesh__D002860smesh__D002859
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002860 1996
% 215.96/216.17  |- skos__broader mesh__D002860smesh__D011868
% 215.96/216.17  |- mesh__publicMeSHNote mesh__D002860 74   
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002860 1997
% 215.96/216.17  |- skos__annotation mesh__D002860
% 215.96/216.17       Cr-46-49,51,55,56; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 215.96/216.17  |- mesh__dateCreated mesh__D002860 1999-01-01
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002860 1998
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002860 2003
% 215.96/216.17  |- mesh__recordAuthorizer mesh__D002860 PLS
% 215.96/216.17  |- mesh__historyNote mesh__D002860 74   
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002860 2000
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002860 1994
% 215.96/216.17  |- mesh__recordMaintainer mesh__D002860 TPW
% 215.96/216.17  |- skos__scopeNote mesh__D002860
% 215.96/216.17       Unstable isotopes of chromium that decay or disintegrate emitting radiation. Cr atoms with atomic weights of 46-49, 51, 55, and 56 are radioactive chromium isotopes.%A%    
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002860 1999
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002860 2004
% 215.96/216.17  |- rdf__type mesh__D002860sskos__Concept
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002860 2001
% 215.96/216.17  |- mesh__recordOriginator mesh__D002860 NLM
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002860 1995
% 215.96/216.17  |- skos__hiddenLabel mesh__D002860 Radioisotopes, Chromium
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002860 2005
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002062 2006
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002062 2004
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002062 2001
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002062 1997
% 215.96/216.17  |- skos__altLabel mesh__D002062 Capsulitis, Adhesive
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002062 2000
% 215.96/216.17  |- mesh__recordOriginator mesh__D002062 NLM
% 215.96/216.17  |- mesh__dateCreated mesh__D002062 1999-01-01
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002062 1998
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002062 2005
% 215.96/216.17  |- skos__hiddenLabel mesh__D002062 Adhesive Capsulitides
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002062 1996
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002062 2003
% 215.96/216.17  |- rdf__type mesh__D002062sskos__Concept
% 215.96/216.17  |- skos__hiddenLabel mesh__D002062 Capsulitides, Adhesive
% 215.96/216.17  |- mesh__recordMaintainer mesh__D002062 JLS
% 215.96/216.17  |- mesh__dateRevised mesh__D002062 1994-04-19
% 215.96/216.17  |- skos__prefLabel mesh__D002062 Bursitis
% 215.96/216.17  |- skos__broader mesh__D002062smesh__D007592
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002062 2002
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002062 1995
% 215.96/216.17  |- mesh__recordAuthorizer mesh__D002062 PLS
% 215.96/216.17  |- skos__hiddenLabel mesh__D002062 Bursitides
% 215.96/216.17  |- skos__annotation mesh__D002062 a joint dis   
% 215.96/216.17  |- skos__scopeNote mesh__D002062
% 215.96/216.17       Inflammation of a bursa, occasionally accompanied by a calcific deposit in the underlying supraspinatus tendon. The most common site is the subdeltoid bursa. %28%Dorland, 27th ed%29%%A%    
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D002062 1999
% 215.96/216.17  |- skos__broader mesh__D015788smesh__D015234
% 215.96/216.17  |- mesh__dateEstablished mesh__D015788 1990-01-01
% 215.96/216.17  |- mesh__dateCreated mesh__D015788 1989-05-15
% 215.96/216.17  |- skos__hiddenLabel mesh__D015788 HLA A1 Antigen
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D015788 2006
% 215.96/216.17  |- mesh__dateRevised mesh__D015788 2005-06-30
% 215.96/216.17  |- skos__altLabel mesh__D015788 HLA-A1
% 215.96/216.17  |- skos__scopeNote mesh__D015788
% 215.96/216.17       Human histocompatibility %28%HLA%29% surface antigen encoded by the A locus on chromosome 6. Individuals bearing this allele are more susceptible to Hodgkin%27%s disease. HLA-A1 is in linkage disequilibrium with HLA-B8 and HLA-DR3.%A%    
% 215.96/216.17  |- skos__historyNote mesh__D015788 HLA Antigens %28%1977-1988%29%
% 215.96/216.17  |- skos__hiddenLabel mesh__D015788 Antigen, HLA-A1
% 215.96/216.17  |- skos__historyNote mesh__D015788 HLA-A Antigens %28%1989%29%
% 215.96/216.17  |- mesh__recordMaintainer mesh__D015788 ssb
% 215.96/216.17  |- mesh__historyNote mesh__D015788 90   
% 215.96/216.17  |- skos__annotation mesh__D015788
% 215.96/216.17       assoc with susceptibility to Hodgkin%27%s dis; DF: HLA A1   
% 215.96/216.17  |- rdf__type mesh__D015788sskos__Concept
% 215.96/216.17  |- skos__prefLabel mesh__D015788 HLA-A1 Antigen
% 215.96/216.17  |- mesh__recordOriginator mesh__D015788 AGS
% 215.96/216.17  |- mesh__publicMeSHNote mesh__D015788 90   
% 215.96/216.17  |- mesh__recordAuthorizer mesh__D015788 sjn
% 215.96/216.17  |- skos__related mesh__D040181smesh__D025064
% 215.96/216.17  |- skos__related mesh__D040181smesh__D041321
% 215.96/216.17  |- skos__altLabel mesh__D040181 Genetic Diseases, X-Chromosome Linked
% 215.96/216.17  |- mesh__recordOriginator mesh__D040181 jmp
% 215.96/216.17  |- skos__prefLabel mesh__D040181 Genetic Diseases, X-Linked
% 215.96/216.17  |- skos__broader mesh__D040181smesh__D030342
% 215.96/216.17  |- skos__historyNote mesh__D040181
% 215.96/216.17       specific disease/Genetics %28%1984-2002%29%
% 215.96/216.17  |- skos__historyNote mesh__D040181
% 215.96/216.17       Linkage %28%Genetics%29% %28%1984-2002%29%
% 215.96/216.17  |- skos__hiddenLabel mesh__D040181 Genetic Diseases, X Linked
% 215.96/216.17  |- skos__related mesh__D040181smesh__D050172
% 215.96/216.17  |- mesh__dateCreated mesh__D040181 2002-07-03
% 215.96/216.17  |- skos__hiddenLabel mesh__D040181 X-Linked Genetic Disease
% 215.96/216.17  |- skos__altLabel mesh__D040181 X-Linked Genetic Diseases
% 215.96/216.17  |- mesh__historyNote mesh__D040181 2003   
% 215.96/216.17  |- skos__scopeNote mesh__D040181
% 215.96/216.17       Genetic diseases that are linked to gene mutations on the X CHROMOSOME in humans %28%X CHROMOSOME, HUMAN%29% or the X CHROMOSOME in other species. Included here are animal models of human X-linked diseases.%A%    
% 215.96/216.17  |- skos__hiddenLabel mesh__D040181 Genetic Diseases, X Chromosome Linked
% 215.96/216.17  |- mesh__dateRevised mesh__D040181 2005-06-30
% 215.96/216.17  |- skos__hiddenLabel mesh__D040181 Diseases, X-Linked Genetic
% 215.96/216.17  |- skos__hiddenLabel mesh__D040181 Disease, X-Linked Genetic
% 215.96/216.17  |- mesh__publicMeSHNote mesh__D040181 2003   
% 215.96/216.17  |- skos__hiddenLabel mesh__D040181 Genetic Disease, X-Linked
% 215.96/216.17  |- skos__hiddenLabel mesh__D040181 X Linked Genetic Diseases
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D040181 2006
% 215.96/216.17  |- rdf__type mesh__D040181sskos__Concept
% 215.96/216.17  |- mesh__recordAuthorizer mesh__D040181 sjn
% 215.96/216.17  |- mesh__recordMaintainer mesh__D040181 nns
% 215.96/216.17  |- skos__historyNote mesh__D040181
% 215.96/216.17       Genetic Diseases, Inborn %28%1966-2002%29%
% 215.96/216.17  |- mesh__dateEstablished mesh__D040181 2003-01-01
% 215.96/216.17  |- skos__related mesh__D040181smesh__D012729
% 215.96/216.17  |- skos__broader mesh__D001768smesh__D012872
% 215.96/216.17  |- skos__prefLabel mesh__D001768 Blister
% 215.96/216.17  |- skos__broader mesh__D001768smesh__D020763
% 215.96/216.17  |- skos__scopeNote mesh__D001768
% 215.96/216.17       Visible accumulations of fluid within or beneath the epidermis.%A%    
% 215.96/216.17  |- mesh__dateCreated mesh__D001768 1999-01-01
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D001768 2002
% 215.96/216.17  |- skos__altLabel mesh__D001768 Bullae
% 215.96/216.17  |- mesh__recordOriginator mesh__D001768 NLM
% 215.96/216.17  |- skos__hiddenLabel mesh__D001768 Lesions, Bullous
% 215.96/216.17  |- skos__hiddenLabel mesh__D001768 Lesion, Bullous
% 215.96/216.17  |- skos__hiddenLabel mesh__D001768 Bullous Lesions
% 215.96/216.17  |- skos__altLabel mesh__D001768 Bleb
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D001768 2005
% 215.96/216.17  |- mesh__recordAuthorizer mesh__D001768 sjn
% 215.96/216.17  |- skos__hiddenLabel mesh__D001768 Vesications
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D001768 2006
% 215.96/216.17  |- skos__altLabel mesh__D001768 Bulla
% 215.96/216.17  |- skos__altLabel mesh__D001768 Vesication
% 215.96/216.17  |- skos__annotation mesh__D001768
% 215.96/216.17       FEVER BLISTER see HERPES LABIALIS is also available   
% 215.96/216.17  |- mesh__recordMaintainer mesh__D001768 jmp
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D001768 2001
% 215.96/216.17  |- rdf__type mesh__D001768sskos__Concept
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D001768 2003
% 215.96/216.17  |- skos__hiddenLabel mesh__D001768 Blisters
% 215.96/216.17  |- skos__hiddenLabel mesh__D001768 Blebs
% 215.96/216.17  |- mesh__dateRevised mesh__D001768 2000-06-22
% 215.96/216.17  |- skos__altLabel mesh__D001768 Bullous Lesion
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D001768 2004
% 215.96/216.17  |- mesh__dateEstablished mesh__D012490 1991-01-01
% 215.96/216.17  |- skos__historyNote mesh__D012490 Quinolines %28%1966-1968%29%
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D012490 2006
% 215.96/216.17  |- skos__historyNote mesh__D012490 Alkaloids %28%1966-1978%29%
% 215.96/216.17  |- skos__prefLabel mesh__D012490 Salsoline Alkaloids
% 215.96/216.17  |- skos__broader mesh__D012490smesh__D044005
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D012490 2005
% 215.96/216.17  |- rdf__type mesh__D012490sskos__Concept
% 215.96/216.17  |- mesh__publicMeSHNote mesh__D012490
% 215.96/216.17       91; was see under ISOQUINOLINES 1979-90   
% 215.96/216.17  |- skos__historyNote mesh__D012490 Isoquinolines %28%1969-1978%29%
% 215.96/216.17  |- skos__hiddenLabel mesh__D012490 Alkaloids, Salsoline
% 215.96/216.17  |- mesh__recordOriginator mesh__D012490 SH
% 215.96/216.17  |- skos__broader mesh__D012490smesh__D000470
% 215.96/216.17  |- mesh__dateCreated mesh__D012490 1978-02-08
% 215.96/216.17  |- mesh__dateRevised mesh__D012490 2004-07-07
% 215.96/216.17  |- mesh__recordAuthorizer mesh__D012490 sjn
% 215.96/216.17  |- mesh__historyNote mesh__D012490
% 215.96/216.17       91%28%79%29%; was see under ISOQUINOLINES 1979-90   
% 215.96/216.17  |- skos__scopeNote mesh__D012490
% 215.96/216.17       Tetrahydroisoquinolinol alkaloids in both dextro and levo forms, originally found in SALSOLA plants.%A%    
% 215.96/216.17  |- mesh__recordMaintainer mesh__D012490 ssb
% 215.96/216.17  |- skos__hiddenLabel mesh__D020922 Talking, Sleep
% 215.96/216.17  |- skos__hiddenLabel mesh__D020922 Starts, Sleep
% 215.96/216.17  |- skos__hiddenLabel mesh__D020922 Transitional Disorder, Sleep-Wake
% 215.96/216.17  |- mesh__recordOriginator mesh__D020922 KEV
% 215.96/216.17  |- skos__hiddenLabel mesh__D020922 Transition Disorder, Sleep-Wake
% 215.96/216.17  |- skos__hiddenLabel mesh__D020922 Nocturna, Jactatio Capitis
% 215.96/216.17  |- skos__scopeNote mesh__D020922
% 215.96/216.17       Parasomnias characterized by behavioral abnormalities that occur during the transition between wakefulness and sleep %28%or between sleep and wakefulness%29%.%A%    
% 215.96/216.17  |- skos__hiddenLabel mesh__D020922 Cramps, Nocturnal Leg
% 215.96/216.17  |- skos__altLabel mesh__D020922 Transitional Disorders, Sleep-Wake
% 215.96/216.17  |- mesh__dateCreated mesh__D020922 1999-11-03
% 215.96/216.17  |- skos__hiddenLabel mesh__D020922 Sleep Wake Transitional Disorders
% 215.96/216.17  |- skos__prefLabel mesh__D020922 Sleep-Wake Transition Disorders
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D020922 2005
% 215.96/216.17  |- skos__hiddenLabel mesh__D020922 Transition Disorders, Sleep Wake
% 215.96/216.17  |- skos__altLabel mesh__D020922 Rhythmic Movement Disorders, Nocturnal
% 215.96/216.17  |- skos__hiddenLabel mesh__D020922 Sleep-Wake Transition Disorder
% 215.96/216.17  |- skos__hiddenLabel mesh__D020922 Leg Cramps, Nocturnal
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D020922 2006
% 215.96/216.17  |- mesh__recordMaintainer mesh__D020922 sjn
% 215.96/216.17  |- rdf__type mesh__D020922sskos__Concept
% 215.96/216.17  |- skos__hiddenLabel mesh__D020922 Starts, Somnolescent
% 215.96/216.17  |- skos__hiddenLabel mesh__D020922 Sleep-Wake Transitional Disorder
% 215.96/216.17  |- skos__hiddenLabel mesh__D020922 Leg Cramp, Nocturnal
% 215.96/216.17  |- skos__altLabel mesh__D020922 Sleep-Wake Transitional Disorders
% 215.96/216.17  |- skos__hiddenLabel mesh__D020922 Transitional Disorders, Sleep Wake
% 215.96/216.17  |- mesh__recordAuthorizer mesh__D020922 sjn
% 215.96/216.17  |- skos__hiddenLabel mesh__D020922 Sleep Wake Transition Disorders
% 215.96/216.17  |- skos__hiddenLabel mesh__D020922 Nocturnal Leg Cramp
% 215.96/216.17  |- skos__altLabel mesh__D020922 Jactatio Capitis Nocturna
% 215.96/216.17  |- skos__hiddenLabel mesh__D020922 Cramp, Nocturnal Leg
% 215.96/216.17  |- mesh__historyNote mesh__D020922 2000   
% 215.96/216.17  |- skos__broader mesh__D020922smesh__D020447
% 215.96/216.17  |- skos__altLabel mesh__D020922 Transition Disorders, Sleep-Wake
% 215.96/216.17  |- mesh__dateRevised mesh__D020922 2003-07-22
% 215.96/216.17  |- mesh__publicMeSHNote mesh__D020922 2000   
% 215.96/216.17  |- skos__historyNote mesh__D020922
% 215.96/216.17       Sleep Initiation and Maintenance Disorders %28%1986-1999%29%
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D020922 2004
% 215.96/216.17  |- mesh__dateEstablished mesh__D020922 2000-01-01
% 215.96/216.17  |- mesh__publicMeSHNote mesh__D006453 68   
% 215.96/216.17  |- mesh__recordAuthorizer mesh__D006453 sjn
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D006453 2004
% 215.96/216.17  |- mesh__recordMaintainer mesh__D006453 nns
% 215.96/216.17  |- skos__broader mesh__D006453smesh__D006402
% 215.96/216.17  |- rdf__type mesh__D006453sskos__Concept
% 215.96/216.17  |- skos__annotation mesh__D006453
% 215.96/216.17       do not confuse with HEMOGLOBINS, ABNORMAL %28%D12%29%: use term in the text; coord IM with specific abnormal hemoglobin %28%IM%29% but HEMOGLOBIN C DISEASE; THALASSEMIA %28%hemoglobin H disease%29% %26% ANEMIA, SICKLE CELL %28%hemoglobin S disease%29% are available%A%  
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D006453 2005
% 215.96/216.17  |- mesh__dateRevised mesh__D006453 2001-07-25
% 215.96/216.17  |- skos__broader mesh__D006453smesh__D030342
% 215.96/216.17  |- mesh__recordOriginator mesh__D006453 NLM
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D006453 2006
% 215.96/216.17  |- mesh__historyNote mesh__D006453 68   
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D006453 2002
% 215.96/216.17  |- skos__related mesh__D006453smesh__D006455
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D006453 2003
% 215.96/216.17  |- skos__prefLabel mesh__D006453 Hemoglobinopathies
% 215.96/216.17  |- skos__hiddenLabel mesh__D006453 Hemoglobinopathy
% 215.96/216.17  |- mesh__dateEstablished mesh__D006453 1968-01-01
% 215.96/216.17  |- mesh__dateCreated mesh__D006453 1999-01-01
% 215.96/216.17  |- skos__scopeNote mesh__D006453
% 215.96/216.17       A group of inherited disorders characterized by structural alterations within the hemoglobin molecule.%A%    
% 215.96/216.17  |- mesh__dateRevised mesh__D020124 2005-06-30
% 215.96/216.17  |- mesh__publicMeSHNote mesh__D020124 99   
% 215.96/216.17  |- skos__broader mesh__D020124smesh__D016965
% 215.96/216.17  |- skos__scopeNote mesh__D020124
% 215.96/216.17       A rod-shaped bacterium surrounded by a sheath-like structure which protrudes balloon-like beyond the ends of the cell. It is thermophilic, with growth occurring at temperatures as high as 90 degrees C. It is isolated from geothermally heated marine sediments or hot springs. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 215.96/216.17  |- mesh__recordOriginator mesh__D020124 NDW
% 215.96/216.17  |- mesh__dateCreated mesh__D020124 1998-06-11
% 215.96/216.17  |- mesh__historyNote mesh__D020124 99   
% 215.96/216.17  |- mesh__recordMaintainer mesh__D020124 SYSTEM
% 215.96/216.17  |- rdf__type mesh__D020124sskos__Concept
% 215.96/216.17  |- skos__historyNote mesh__D020124
% 215.96/216.17       Gram-Negative Anaerobic Bacteria %28%1988-1998%29%
% 215.96/216.17  |- skos__prefLabel mesh__D020124 Thermotoga maritima
% 215.96/216.17  |- mesh__dateEstablished mesh__D020124 1999-01-01
% 215.96/216.17  |- mesh__recordAuthorizer mesh__D020124 sjn
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D020124 2006
% 215.96/216.17  |- mesh__activeMeSHYear mesh__D011398 2006
% 215.96/216.17  |- skos__hiddenLabel mesh__D011398 Hydrochloride, Promethazine
% 215.96/216.17  |- mesh__dateRevised mesh__D011398 2005-06-30
% 215.96/216.17  |- mesh__recordAuthorizer mesh__D011398 sjn
% 215.96/216.17  |- skos__prefLabel mesh__D011398 Promethazine
% 215.96/216.17  |- skos__broader mesh__D011398smesh__D011437
% 215.96/216.17  |- mesh__dateCreated mesh__D011398 1999-01-01
% 215.96/216.17  |- rdf__type mesh__D011398sskos__Concept
% 215.96/216.17  |- mesh__recordMaintainer mesh__D011398 ssb
% 215.96/216.17  |- skos__scopeNote mesh__D011398
% 215.96/216.17       A phenothiazine derivative with histamine H1-blocking, antimuscarinic, and sedative properties. It is used as an antiallergic, in pruritus, for motion sickness and sedation, and also in animals.%A%    
% 215.96/216.18  |- mesh__recordOriginator mesh__D011398 NLM
% 215.96/216.18  |- skos__broader mesh__D011398smesh__D010640
% 215.96/216.18  |- skos__altLabel mesh__D011398 Phenargan
% 215.96/216.18  |- skos__altLabel mesh__D011398 Proazamine
% 215.96/216.18  |- mesh__dateCreated mesh__D016881 1991-05-02
% 215.96/216.18  |- mesh__publicMeSHNote mesh__D016881 1992   
% 215.96/216.18  |- skos__broader mesh__D016881smesh__D009181
% 215.96/216.18  |- mesh__recordMaintainer mesh__D016881 ags
% 215.96/216.18  |- skos__hiddenLabel mesh__D016881 Microsporidioses
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D016881 2006
% 215.96/216.18  |- skos__scopeNote mesh__D016881
% 215.96/216.18       Infections with FUNGI of the phylum MICROSPORIDIA.     
% 215.96/216.18  |- mesh__recordOriginator mesh__D016881 PXP
% 215.96/216.18  |- skos__altLabel mesh__D016881 Infections, Microspora
% 215.96/216.18  |- skos__hiddenLabel mesh__D016881 Microspora Infection
% 215.96/216.18  |- mesh__dateRevised mesh__D016881 2005-06-30
% 215.96/216.18  |- skos__annotation mesh__D016881
% 215.96/216.18       do not confuse with Microsporum infections, one of the DERMATOMYCOSES %28%see note at MICROSPORUM%29%%A%  
% 215.96/216.18  |- mesh__recordAuthorizer mesh__D016881 sjn
% 215.96/216.18  |- skos__prefLabel mesh__D016881 Microsporidiosis
% 215.96/216.18  |- skos__altLabel mesh__D016881 Microspora Infections
% 215.96/216.18  |- mesh__historyNote mesh__D016881 1992   
% 215.96/216.18  |- rdf__type mesh__D016881sskos__Concept
% 215.96/216.18  |- skos__hiddenLabel mesh__D016881 Infection, Microspora
% 215.96/216.18  |- mesh__dateEstablished mesh__D016881 1992-01-01
% 215.96/216.18  |- skos__historyNote mesh__D016083 Astronomy %28%1966-1990%29%
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D016083 1998
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D016083 2005
% 215.96/216.18  |- rdf__type mesh__D016083sskos__Concept
% 215.96/216.18  |- skos__related mesh__D016083smesh__D005118
% 215.96/216.18  |- skos__historyNote mesh__D016083
% 215.96/216.18       Extraterrestrial Environment %28%1966-1990%29%
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D016083 2002
% 215.96/216.18  |- skos__broader mesh__D016083smesh__D016082
% 215.96/216.18  |- skos__related mesh__D016083smesh__D018543
% 215.96/216.18  |- skos__scopeNote mesh__D016083
% 215.96/216.18       Heavenly bodies with their own motion among the stars, revolving, in the case of the solar system, around the sun, along the plane of the ecliptic. They are grouped into inner planets and outer planets, based on distance from the sun and common characteristics.%A%    
% 215.96/216.18  |- mesh__dateEstablished mesh__D016083 1991-01-01
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D016083 2004
% 215.96/216.18  |- skos__annotation mesh__D016083
% 215.96/216.18       no qualif; does not include comets or meteors: METEOROIDS is available; natural satellites: index under SOLAR SYSTEM%A%  
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D016083 2001
% 215.96/216.18  |- mesh__recordAuthorizer mesh__D016083 SJN
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D016083 2003
% 215.96/216.18  |- mesh__recordOriginator mesh__D016083 TGC
% 215.96/216.18  |- mesh__historyNote mesh__D016083 91   
% 215.96/216.18  |- mesh__dateRevised mesh__D016083 1997-06-20
% 215.96/216.18  |- skos__hiddenLabel mesh__D016083 Planet
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D016083 2000
% 215.96/216.18  |- mesh__recordMaintainer mesh__D016083 TGC
% 215.96/216.18  |- mesh__publicMeSHNote mesh__D016083 91   
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D016083 1999
% 215.96/216.18  |- mesh__dateCreated mesh__D016083 1990-02-12
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D016083 2006
% 215.96/216.18  |- skos__prefLabel mesh__D016083 Planets
% 215.96/216.18  |- skos__broader mesh__D002861smesh__D006092
% 215.96/216.18  |- mesh__recordOriginator mesh__D002861 NLM
% 215.96/216.18  |- mesh__recordMaintainer mesh__D002861 SYSTEM
% 215.96/216.18  |- skos__annotation mesh__D002861 in soil %26% water   
% 215.96/216.18  |- mesh__dateCreated mesh__D002861 1999-01-01
% 215.96/216.18  |- skos__scopeNote mesh__D002861
% 215.96/216.18       A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria occurring in soil and water. Its organisms are generally nonpathogenic, but some species do cause infections of mammals, including humans.%A%    
% 215.96/216.18  |- skos__broader mesh__D002861smesh__D009346
% 215.96/216.18  |- mesh__recordAuthorizer mesh__D002861 sjn
% 215.96/216.18  |- rdf__type mesh__D002861sskos__Concept
% 215.96/216.18  |- skos__prefLabel mesh__D002861 Chromobacterium
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002861 2006
% 215.96/216.18  |- mesh__dateRevised mesh__D002861 2005-06-30
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002063 1998
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002063 2005
% 215.96/216.18  |- mesh__dateRevised mesh__D002063 1997-06-20
% 215.96/216.18  |- skos__scopeNote mesh__D002063
% 215.96/216.18       A republic in eastern Africa bounded on the north by RWANDA and on the south by TANZANIA. It was formerly called Urundi. Its capital is Bujumbura. With Ruanda it was part of the Belgian trust territory of Ruanda-Urundi from 1919 to 1962 when it was divided into two independent countries, Burundi and Rwanda. The name comes from the name of the people, the Barundi: Ba- is the prefix for the people, Bu- is the prefix for the country. %28%From Webster%27%s New Geographical Dictionary, 1988, p194, 1034; Room, Brewer%27%s Dictionary of Names, 1992, p86%29%%A%    
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002063 2003
% 215.96/216.18  |- skos__broader mesh__D002063smesh__D000351
% 215.96/216.18  |- rdf__type mesh__D002063sskos__Concept
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002063 2001
% 215.96/216.18  |- mesh__recordOriginator mesh__D002063 NLM
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002063 2000
% 215.96/216.18  |- mesh__recordAuthorizer mesh__D002063 SJN
% 215.96/216.18  |- skos__prefLabel mesh__D002063 Burundi
% 215.96/216.18  |- mesh__recordMaintainer mesh__D002063 TGC
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002063 1999
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002063 2006
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002063 2002
% 215.96/216.18  |- skos__altLabel mesh__D002063 Urundi
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002063 2004
% 215.96/216.18  |- skos__annotation mesh__D002063
% 215.96/216.18       a republic in eastern Africa; X ref URUNDI was its former name%A%  
% 215.96/216.18  |- mesh__dateCreated mesh__D002063 1999-01-01
% 215.96/216.18  |- skos__annotation mesh__D015789
% 215.96/216.18       assoc with recognition of INFLUENZA A VIRUS; DF: HLA A2   
% 215.96/216.18  |- mesh__dateCreated mesh__D015789 1989-09-06
% 215.96/216.18  |- mesh__dateRevised mesh__D015789 2005-06-30
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D015789 2006
% 215.96/216.18  |- mesh__historyNote mesh__D015789 90   
% 215.96/216.18  |- mesh__recordMaintainer mesh__D015789 ssb
% 215.96/216.18  |- skos__altLabel mesh__D015789 HLA-A2
% 215.96/216.18  |- skos__historyNote mesh__D015789 HLA-A Antigens %28%1989%29%
% 215.96/216.18  |- skos__scopeNote mesh__D015789
% 215.96/216.18       Human histocompatibility %28%HLA%29% surface antigen encoded by the A locus on chromosome 6. The HLA-A2 antigen is associated with recognition of the INFLUENZA A VIRUS.%A%    
% 215.96/216.18  |- skos__hiddenLabel mesh__D015789 Antigen, HLA-A2
% 215.96/216.18  |- skos__historyNote mesh__D015789 HLA Antigens %28%1976-1988%29%
% 215.96/216.18  |- rdf__type mesh__D015789sskos__Concept
% 215.96/216.18  |- mesh__publicMeSHNote mesh__D015789 90   
% 215.96/216.18  |- skos__prefLabel mesh__D015789 HLA-A2 Antigen
% 215.96/216.18  |- mesh__recordAuthorizer mesh__D015789 sjn
% 215.96/216.18  |- mesh__recordOriginator mesh__D015789 AGS
% 215.96/216.18  |- skos__broader mesh__D015789smesh__D015234
% 215.96/216.18  |- skos__hiddenLabel mesh__D015789 HLA A2 Antigen
% 215.96/216.18  |- mesh__dateEstablished mesh__D015789 1990-01-01
% 215.96/216.18  |- skos__related mesh__D001769smesh__D006410
% 215.96/216.18  |- skos__scopeNote mesh__D001769
% 215.96/216.18       The body fluid that circulates in the vascular system %28%BLOOD VESSELS%29%. Whole blood includes PLASMA and BLOOD CELLS.%A%    
% 215.96/216.18  |- skos__broader mesh__D001769smesh__D001826
% 215.96/216.18  |- mesh__considerAlso mesh__D001769 consider also terms at HEM-   
% 215.96/216.18  |- skos__related mesh__D001769smesh__D009780
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D001769 2006
% 215.96/216.18  |- mesh__recordOriginator mesh__D001769 NLM
% 215.96/216.18  |- rdf__type mesh__D001769sskos__Concept
% 215.96/216.18  |- skos__annotation mesh__D001769
% 215.96/216.18       GEN only as a substance: prefer /blood with higher animals, substances %26% diseases: Manual 19.7+, 19.8.10; not for hemodynamics: Manual 23.28, 23.29; reinfusion = BLOOD TRANSFUSION, AUTOLOGOUS; venous blood: probably not indexed as being the usual sampling method but if significant coord BLOOD %28%NIM%29% + VEINS or specific vein %28%NIM%29%; arterial blood: index only if significant %26% coord BLOOD %28%NIM%29% + ARTERIES or specific artery %28%NIM%29%; %22%blood picture%22% = probably BLOOD CELLS or BLOOD CELL COUNT; hemospermia: index under SEMEN %28%IM%29% + BLOOD %28%IM%29%; %22%blood clot%22%: physiol clot or clotting = BLOOD COAGULATION, pathol clot or clotting = THROMBOSIS or EMBOLISM%A%  
% 215.96/216.18  |- mesh__recordAuthorizer mesh__D001769 sjn
% 215.96/216.18  |- skos__prefLabel mesh__D001769 Blood
% 215.96/216.18  |- mesh__dateCreated mesh__D001769 1999-01-01
% 215.96/216.18  |- mesh__recordMaintainer mesh__D001769 tpw
% 215.96/216.18  |- skos__broader mesh__D001769smesh__D006424
% 215.96/216.18  |- mesh__dateRevised mesh__D001769 2005-06-30
% 215.96/216.18  |- mesh__dateRevised mesh__D012491 1995-06-08
% 215.96/216.18  |- skos__hiddenLabel mesh__D012491 Gland, Rectal
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D012491 1997
% 215.96/216.18  |- mesh__publicMeSHNote mesh__D012491 70   
% 215.96/216.18  |- skos__hiddenLabel mesh__D012491 Salt Glands
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D012491 2002
% 215.96/216.18  |- mesh__recordAuthorizer mesh__D012491 PLS
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D012491 1999
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D012491 1996
% 215.96/216.18  |- skos__broader mesh__D012491smesh__D000825
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D012491 2001
% 215.96/216.18  |- skos__hiddenLabel mesh__D012491 Glands, Rectal
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D012491 2004
% 215.96/216.18  |- mesh__dateEstablished mesh__D012491 1970-01-01
% 215.96/216.18  |- skos__hiddenLabel mesh__D012491 Rectal Glands
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D012491 2000
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D012491 1998
% 215.96/216.18  |- skos__hiddenLabel mesh__D012491 Gland, Salt
% 215.96/216.18  |- skos__altLabel mesh__D012491 Rectal Gland
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D012491 2006
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D012491 2003
% 215.96/216.18  |- mesh__recordMaintainer mesh__D012491 TAP
% 215.96/216.18  |- mesh__recordOriginator mesh__D012491 NLM
% 215.96/216.18  |- skos__annotation mesh__D012491
% 215.96/216.18       in marine animals %26% birds only; X ref RECTAL GLAND is found in sharks, rays %26% skates %26% is used often in marine electrolyte studies%A%  
% 215.96/216.18  |- mesh__historyNote mesh__D012491 70%28%64%29%   
% 215.96/216.18  |- skos__prefLabel mesh__D012491 Salt Gland
% 215.96/216.18  |- mesh__dateCreated mesh__D012491 1999-01-01
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D012491 2005
% 215.96/216.18  |- skos__hiddenLabel mesh__D012491 Glands, Salt
% 215.96/216.18  |- rdf__type mesh__D012491sskos__Concept
% 215.96/216.18  |- skos__scopeNote mesh__D012491
% 215.96/216.18       A compound tubular gland, located around the eyes and nasal passages in marine animals and birds, the physiology of which figures in water-electrolyte balance. The Pekin duck serves as a common research animal in salt gland studies. A rectal gland or rectal salt gland in the dogfish shark is attached at the junction of the intestine and cloaca and aids the kidneys in removing excess salts from the blood. %28%Storer, Usinger, Stebbins %26% Nybakken: General Zoology, 6th ed, p658%29%%A%    
% 215.96/216.18  |- skos__hiddenLabel mesh__D020923 Erection, Sleep-Related Painful
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D020923 2002
% 215.96/216.18  |- skos__hiddenLabel mesh__D020923 REM Sleep Parasomnia
% 215.96/216.18  |- skos__historyNote mesh__D020923 Sleep, REM %28%1986-1999%29%
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D020923 2006
% 215.96/216.18  |- mesh__publicMeSHNote mesh__D020923 2000   
% 215.96/216.18  |- skos__altLabel mesh__D020923 Rapid Eye Movement Sleep Parasomnias
% 215.96/216.18  |- skos__hiddenLabel mesh__D020923 Sleep Related Painful Erections
% 215.96/216.18  |- skos__hiddenLabel mesh__D020923 Parasomnia, REM Sleep
% 215.96/216.18  |- rdf__type mesh__D020923sskos__Concept
% 215.96/216.18  |- skos__hiddenLabel mesh__D020923 Erections, Sleep-Related Painful
% 215.96/216.18  |- mesh__dateCreated mesh__D020923 1999-11-03
% 215.96/216.18  |- skos__hiddenLabel mesh__D020923 Sinus Arrest, REM Sleep Related
% 215.96/216.18  |- skos__altLabel mesh__D020923 Sinus Arrest, REM Sleep-Related
% 215.96/216.18  |- skos__scopeNote mesh__D020923
% 215.96/216.18       Abnormal behavioral or physiologic events that are associated with REM sleep, including REM SLEEP BEHAVIOR DISORDER.%A%    
% 215.96/216.18  |- skos__hiddenLabel mesh__D020923 REM Sleep Related Sinus Arrest
% 215.96/216.18  |- skos__altLabel mesh__D020923 Sleep, REM, Parasomnias
% 215.96/216.18  |- mesh__historyNote mesh__D020923 2000   
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D020923 2003
% 215.96/216.18  |- skos__hiddenLabel mesh__D020923 Sleep-Related Painful Erection
% 215.96/216.18  |- mesh__dateEstablished mesh__D020923 2000-01-01
% 215.96/216.18  |- skos__annotation mesh__D020923
% 215.96/216.18       do not confuse with REM SLEEP BEHAVIOR DISORDER   
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D020923 2000
% 215.96/216.18  |- skos__historyNote mesh__D020923 Sleep Disorders %28%1986-1999%29%
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D020923 2004
% 215.96/216.18  |- skos__hiddenLabel mesh__D020923 Painful Erection, Sleep-Related
% 215.96/216.18  |- skos__altLabel mesh__D020923 Parasomnias, REM Sleep
% 215.96/216.18  |- skos__hiddenLabel mesh__D020923 Painful Erections, Sleep Related
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D020923 2001
% 215.96/216.18  |- skos__altLabel mesh__D020923 Painful Erections, Sleep-Related
% 215.96/216.18  |- skos__broader mesh__D020923smesh__D020447
% 215.96/216.18  |- skos__prefLabel mesh__D020923 REM Sleep Parasomnias
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D020923 2005
% 215.96/216.18  |- mesh__recordMaintainer mesh__D006454 adp
% 215.96/216.18  |- mesh__recordOriginator mesh__D006454 NLM
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D006454 2005
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D006454 2004
% 215.96/216.18  |- mesh__onlineNote mesh__D006454
% 215.96/216.18       use HEMOGLOBINS to search HEMOGLOBIN 1966-74   
% 215.96/216.18  |- skos__altLabel mesh__D006454 Hemoglobin
% 215.96/216.18  |- mesh__publicMeSHNote mesh__D006454 75; was HEMOGLOBIN 1963-74   
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D006454 2003
% 215.96/216.18  |- skos__prefLabel mesh__D006454 Hemoglobins
% 215.96/216.18  |- skos__broader mesh__D006454smesh__D001798
% 215.96/216.18  |- mesh__dateCreated mesh__D006454 1999-01-01
% 215.96/216.18  |- skos__annotation mesh__D006454
% 215.96/216.18       GEN or unspecified; prefer specifics; /anal: permitted %26% do not equate with HEMOGLOBINOMETRY; %22%mean cell erythrocyte hemoglobin%22% = ERYTHROCYTE INDICES; Bohr effect is indexed OXYHEMOGLOBINS /metab %28%IM%29% + PH %28%NIM%29%%A%  
% 215.96/216.18  |- mesh__recordAuthorizer mesh__D006454 sjn
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D006454 2002
% 215.96/216.18  |- rdf__type mesh__D006454sskos__Concept
% 215.96/216.18  |- skos__hiddenLabel mesh__D006454 Hemoglobin, Ferrous
% 215.96/216.18  |- skos__broader mesh__D006454smesh__D006420
% 215.96/216.18  |- mesh__historyNote mesh__D006454 75; was HEMOGLOBIN 1963-74   
% 215.96/216.18  |- mesh__dateRevised mesh__D006454 2000-06-22
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D006454 2006
% 215.96/216.18  |- skos__scopeNote mesh__D006454
% 215.96/216.18       The oxygen-carrying pigments of erythrocytes. They are found in all vertebrates and some invertebrates. The structure of the globin moiety differs between species.%A%    
% 215.96/216.18  |- skos__related mesh__D006454smesh__D007502
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D006454 2001
% 215.96/216.18  |- skos__hiddenLabel mesh__D020125 Missense Mutation
% 215.96/216.18  |- skos__related mesh__D020125smesh__D019943
% 215.96/216.18  |- skos__broader mesh__D020125smesh__D009154
% 215.96/216.18  |- mesh__dateEstablished mesh__D020125 1999-01-01
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D020125 2004
% 215.96/216.18  |- mesh__dateRevised mesh__D020125 2002-07-03
% 215.96/216.18  |- skos__prefLabel mesh__D020125 Mutation, Missense
% 215.96/216.18  |- skos__hiddenLabel mesh__D020125 Mutations, Missense
% 215.96/216.18  |- skos__hiddenLabel mesh__D020125 Missense Mutations
% 215.96/216.18  |- skos__related mesh__D020125smesh__D017354
% 215.96/216.18  |- rdf__type mesh__D020125sskos__Concept
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D020125 2005
% 215.96/216.18  |- skos__historyNote mesh__D020125 Amino Acid Sequence %28%1966-1998%29%
% 215.96/216.18  |- mesh__historyNote mesh__D020125 99   
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D020125 2006
% 215.96/216.18  |- mesh__dateCreated mesh__D020125 1998-06-10
% 215.96/216.18  |- skos__scopeNote mesh__D020125
% 215.96/216.18       A mutation in which a codon is mutated to one directing the incorporation of a different amino acid. This substitution may result in an inactive or unstable product. %28%From A Dictionary of Genetics, King %26% Stansfield, 5th ed%29%%A%    
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D020125 2003
% 215.96/216.18  |- mesh__publicMeSHNote mesh__D020125 99   
% 215.96/216.18  |- skos__broader mesh__D011399smesh__D028581
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D011399 2005
% 215.96/216.18  |- mesh__recordOriginator mesh__D011399 NLM
% 215.96/216.18  |- mesh__dateCreated mesh__D011399 1999-01-01
% 215.96/216.18  |- mesh__recordMaintainer mesh__D011399 jmp
% 215.96/216.18  |- skos__broader mesh__D011399smesh__D004603
% 215.96/216.18  |- mesh__recordAuthorizer mesh__D011399 sjn
% 215.96/216.18  |- rdf__type mesh__D011399sskos__Concept
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D011399 2004
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D011399 2002
% 215.96/216.18  |- mesh__dateRevised mesh__D011399 2001-07-25
% 215.96/216.18  |- skos__prefLabel mesh__D011399 Promethium
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D011399 2003
% 215.96/216.18  |- skos__scopeNote mesh__D011399
% 215.96/216.18       Promethium. A radioactive element of the rare earth family of metals. It has the atomic symbol Pm, atomic number 61, and atomic weight 147. It has been used in the construction of atomic batteries, in the preparation of self-luminous compounds, and as a beta-particle source for thickness gauges.%A%    
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D011399 2006
% 215.96/216.18  |- skos__annotation mesh__D011399
% 215.96/216.18       naturally radioactive; a rare earth metal; IM   
% 215.96/216.18  |- skos__hiddenLabel mesh__D016882 Complexes, Immuno-Stimulating
% 215.96/216.18  |- skos__annotation mesh__D016882
% 215.96/216.18       coord IM with specific type of vaccine %28%IM or NIM%29%; DF: ISCOM%A%  
% 215.96/216.18  |- skos__related mesh__D016882smesh__D012503
% 215.96/216.18  |- mesh__dateEstablished mesh__D016882 1992-01-01
% 215.96/216.18  |- mesh__recordOriginator mesh__D016882 AGS
% 215.96/216.18  |- skos__hiddenLabel mesh__D016882 Immuno Stimulating Complexes
% 215.96/216.18  |- skos__altLabel mesh__D016882 Immuno-Stimulating Complexes
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D016882 2006
% 215.96/216.18  |- mesh__historyNote mesh__D016882 92   
% 215.96/216.18  |- mesh__publicMeSHNote mesh__D016882 92   
% 215.96/216.18  |- skos__scopeNote mesh__D016882
% 215.96/216.18       A formulation for presenting an antigen to induce specific immunologic responses. It consists of an assembly of antigens in multimeric form. The assembly is attached to a matrix with a built-in adjuvant, saponin. ISCOMs induce strong serum antibody responses, and are used as highly immunogenic forms of subunit vaccines.%A%    
% 215.96/216.18  |- skos__hiddenLabel mesh__D016882 Complexes, Immunostimulating
% 215.96/216.18  |- skos__prefLabel mesh__D016882 ISCOMs
% 215.96/216.18  |- skos__historyNote mesh__D016882 Adjuvants, Immunologic %28%1985-1991%29%
% 215.96/216.18  |- mesh__dateCreated mesh__D016882 1991-08-17
% 215.96/216.18  |- skos__historyNote mesh__D016882 Viral Vaccines %28%1985-1991%29%
% 215.96/216.18  |- rdf__type mesh__D016882sskos__Concept
% 215.96/216.18  |- skos__broader mesh__D016882smesh__D022223
% 215.96/216.18  |- skos__altLabel mesh__D016882 ISCOM
% 215.96/216.18  |- mesh__dateRevised mesh__D016882 2005-06-30
% 215.96/216.18  |- mesh__recordMaintainer mesh__D016882 ssb
% 215.96/216.18  |- skos__altLabel mesh__D016882 Immunostimulating Complexes
% 215.96/216.18  |- mesh__recordAuthorizer mesh__D016882 sjn
% 215.96/216.18  |- mesh__recordMaintainer mesh__D016084 nns
% 215.96/216.18  |- skos__prefLabel mesh__D016084 Bronchoconstriction
% 215.96/216.18  |- skos__hiddenLabel mesh__D016084 Constrictions, Bronchial
% 215.96/216.18  |- mesh__publicMeSHNote mesh__D016084 91   
% 215.96/216.18  |- skos__annotation mesh__D016084
% 215.96/216.18       IM; physiol process or chem induced state: do not confuse with pathol bronchial constriction %28% = BRONCHIAL DISEASES %28%IM%29% + CONSTRICTION, PATHOLOGIC %28%NIM%29% or more likely ASTHMA%29%; /drug eff: consider also BRONCHOCONSTRICTOR AGENTS which induce bronchoconstriction or BRONCHODILATOR AGENTS which counteract it%A%  
% 215.96/216.18  |- mesh__dateCreated mesh__D016084 1990-02-12
% 215.96/216.18  |- skos__hiddenLabel mesh__D016084 Bronchial Constrictions
% 215.96/216.18  |- skos__hiddenLabel mesh__D016084 Constriction, Bronchial
% 215.96/216.18  |- skos__hiddenLabel mesh__D016084 Bronchoconstrictions
% 215.96/216.18  |- skos__historyNote mesh__D016084 Bronchi/physiology %28%1966-1990%29%
% 215.96/216.18  |- mesh__dateEstablished mesh__D016084 1991-01-01
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D016084 2004
% 215.96/216.18  |- skos__broader mesh__D016084smesh__D015656
% 215.96/216.18  |- mesh__historyNote mesh__D016084 91   
% 215.96/216.18  |- skos__related mesh__D016084smesh__D001985
% 215.96/216.18  |- mesh__recordAuthorizer mesh__D016084 sjn
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D016084 2006
% 215.96/216.18  |- skos__scopeNote mesh__D016084
% 215.96/216.18       Narrowing of the caliber of the BRONCHI, physiologically or as a result of pharmacological intervention.%A%    
% 215.96/216.18  |- mesh__dateRevised mesh__D016084 2003-07-09
% 215.96/216.18  |- skos__altLabel mesh__D016084 Bronchial Constriction
% 215.96/216.18  |- skos__related mesh__D016084smesh__D016085
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D016084 2005
% 215.96/216.18  |- mesh__recordOriginator mesh__D016084 TGC
% 215.96/216.18  |- rdf__type mesh__D016084sskos__Concept
% 215.96/216.18  |- skos__broader mesh__D002862smesh__D003881
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002862 1998
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002862 2002
% 215.96/216.18  |- skos__annotation mesh__D002862
% 215.96/216.18       fungus dis of skin; coord IM with causative agent %28%IM%29%   
% 215.96/216.18  |- skos__scopeNote mesh__D002862
% 215.96/216.18       Scaly papule or warty growth, caused by five fungi, that spreads as a result of satellite lesions affecting the foot or leg. The extremity may become swollen and, at its distal portion, covered with various nodular, tumorous, verrucous lesions that resemble cauliflower. In rare instances, the disease may begin on the hand or wrist and involve the entire upper extremity. %28%Arnold, Odom, and James, Andrew%27%s Diseases of the Skin, 8th ed, p362%29%%A%    
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002862 2006
% 215.96/216.18  |- skos__hiddenLabel mesh__D002862 Chromoblastomycoses
% 215.96/216.18  |- mesh__dateCreated mesh__D002862 1999-01-01
% 215.96/216.18  |- skos__altLabel mesh__D002862 Dermatitis Verrucosa
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002862 1997
% 215.96/216.18  |- mesh__dateRevised mesh__D002862 1993-06-02
% 215.96/216.18  |- mesh__recordMaintainer mesh__D002862 TAP
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002862 2001
% 215.96/216.18  |- skos__altLabel mesh__D002862 Chromomycosis
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002862 2005
% 215.96/216.18  |- skos__hiddenLabel mesh__D002862 Chromomycoses
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002862 2000
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002862 1995
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002862 1996
% 215.96/216.18  |- mesh__recordOriginator mesh__D002862 NLM
% 215.96/216.18  |- skos__prefLabel mesh__D002862 Chromoblastomycosis
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002862 2004
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002862 1994
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002862 2003
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002862 1999
% 215.96/216.18  |- mesh__recordAuthorizer mesh__D002862 PLS
% 215.96/216.18  |- rdf__type mesh__D002862sskos__Concept
% 215.96/216.18  |- mesh__recordMaintainer mesh__D002064 jmp
% 215.96/216.18  |- mesh__dateEstablished mesh__D002064 1984-01-01
% 215.96/216.18  |- skos__hiddenLabel mesh__D002064 HOE766
% 215.96/216.18  |- skos__scopeNote mesh__D002064
% 215.96/216.18       A potent and durable analog of naturally occurring gonadotropin-releasing hormone %28%GONADORELIN%29%.%A%    
% 215.96/216.18  |- skos__altLabel mesh__D002064 Intervet Brand of Buserelin Acetate
% 215.96/216.18  |- skos__altLabel mesh__D002064 Bigonist
% 215.96/216.18  |- skos__altLabel mesh__D002064 Hoechst Brand of Buserelin Acetate
% 215.96/216.18  |- skos__altLabel mesh__D002064 Aventis Brand of Buserelin
% 215.96/216.18  |- skos__altLabel mesh__D002064 Suprecur
% 215.96/216.18  |- mesh__dateCreated mesh__D002064 1983-04-04
% 215.96/216.18  |- skos__altLabel mesh__D002064 Aventis Brand of Buserelin Acetate
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002064 2006
% 215.96/216.18  |- skos__broader mesh__D002064smesh__D007987
% 215.96/216.18  |- mesh__onlineNote mesh__D002064
% 215.96/216.18       use BUSERELIN to search BUSERELIN ACETATE 1984-91   
% 215.96/216.18  |- mesh__recordAuthorizer mesh__D002064 sjn
% 215.96/216.18  |- mesh__publicMeSHNote mesh__D002064
% 215.96/216.18       92; was BUSERELIN ACETATE 1984-91; BUSERELIN was see BUSERELIN ACETATE 1984-91%A%  
% 215.96/216.18  |- skos__historyNote mesh__D002064
% 215.96/216.18       LH %28%Luteinizing Hormone%29% %28%1966-1973%29%
% 215.96/216.18  |- mesh__dateRevised mesh__D002064 2004-07-07
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D002064 2005
% 215.96/216.18  |- skos__hiddenLabel mesh__D002064 Buserelin Aventis Brand
% 215.96/216.18  |- skos__altLabel mesh__D002064 Suprefact
% 215.96/216.18  |- skos__hiddenLabel mesh__D002064 Acetate, Buserelin
% 215.96/216.18  |- mesh__historyNote mesh__D002064
% 215.96/216.18       92; was BUSERELIN ACETATE 1984-91; BUSERELIN was see BUSERELIN ACETATE 1984-91%A%  
% 215.96/216.18  |- skos__altLabel mesh__D002064 Profact
% 215.96/216.18  |- skos__altLabel mesh__D002064 Tiloryth
% 215.96/216.18  |- skos__historyNote mesh__D002064
% 215.96/216.18       LH-FSH Releasing Hormone/analogs %26% derivatives %28%1974-1983%29%
% 215.96/216.18  |- skos__historyNote mesh__D002064 FSH %28%1966-1973%29%
% 215.96/216.18  |- rdf__type mesh__D002064sskos__Concept
% 215.96/216.18  |- skos__historyNote mesh__D002064
% 215.96/216.18       Pituitary Hormone Releasing Hormones %28%1968-1973%29%
% 215.96/216.18  |- mesh__recordOriginator mesh__D002064 RLS
% 215.96/216.18  |- skos__hiddenLabel mesh__D002064 HOE 766
% 215.96/216.18  |- skos__prefLabel mesh__D002064 Buserelin
% 215.96/216.18  |- mesh__historyNote mesh__D029201 2002   
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D029201 2002
% 215.96/216.18  |- mesh__publicMeSHNote mesh__D029201 2002   
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D029201 2003
% 215.96/216.18  |- mesh__dateCreated mesh__D029201 2001-07-25
% 215.96/216.18  |- skos__broader mesh__D029201smesh__D019684
% 215.96/216.18  |- skos__annotation mesh__D029201
% 215.96/216.18       GEN or unspecified; prefer specifics; specify Plant Components; for /Chem coord with D tree compound and/or Preparation; for therap. coordinate with PLANT PREPARATION or children and Diseases and PHYTOTHERAPY%A%  
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D029201 2004
% 215.96/216.18  |- rdf__type mesh__D029201sskos__Concept
% 215.96/216.18  |- skos__prefLabel mesh__D029201 Hamamelidaceae
% 215.96/216.18  |- mesh__dateEstablished mesh__D029201 2002-01-01
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D029201 2005
% 215.96/216.18  |- skos__scopeNote mesh__D029201
% 215.96/216.18       A plant family of the order Hamamelidales, subclass Hamamelidae, class Magnoliopsida.%A%    
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D029201 2006
% 215.96/216.18  |- mesh__publicMeSHNote mesh__D040981 2003   
% 215.96/216.18  |- mesh__dateCreated mesh__D040981 2002-07-02
% 215.96/216.18  |- skos__prefLabel mesh__D040981 Acinetobacter baumannii
% 215.96/216.18  |- mesh__dateRevised mesh__D040981 2005-06-30
% 215.96/216.18  |- mesh__activeMeSHYear mesh__D040981 2006
% 215.96/216.18  |- rdf__type mesh__D040981sskos__Concept
% 215.96/216.18  |- skos__annotation mesh__D040981
% 215.96/216.18       infection: coord IM with ACINETOBACTER INFECTIONS %28%IM%29%   
% 215.96/216.18  |- mesh__recordOriginator mesh__D040981 ags
% 215.96/216.18  |- mesh__recordAuthorizer mesh__D040981 sjn
% 215.96/216.18  |- skos__broader mesh__D040981smesh__D000150
% 215.96/216.18  |- mesh__dateEstablished mesh__D040981 2003-01-01
% 216.04/216.18  |- mesh__historyNote mesh__D040981 2003   
% 216.04/216.18  |- skos__scopeNote mesh__D040981
% 216.04/216.18       A species of gram-negative, aerobic bacteria, commonly found in the clinical laboratory, and frequently resistant to common antibiotics.%A%    
% 216.04/216.18  |- skos__historyNote mesh__D040981 Acinetobacter %28%1988-2002%29%
% 216.04/216.18  |- mesh__recordMaintainer mesh__D040981 SYSTEM
% 216.04/216.18  |- mesh__recordOriginator mesh__D012492 NLM
% 216.04/216.18  |- mesh__activeMeSHYear mesh__D012492 1999
% 216.04/216.18  |- skos__broader mesh__D012492smesh__D007287
% 216.04/216.18  |- skos__prefLabel mesh__D012492 Salts
% 216.04/216.18  |- mesh__dateRevised mesh__D012492 1997-06-20
% 216.04/216.18  |- mesh__recordMaintainer mesh__D012492 TGC
% 216.04/216.18  |- mesh__activeMeSHYear mesh__D012492 1998
% 216.04/216.18  |- mesh__activeMeSHYear mesh__D012492 2004
% 216.04/216.18  |- skos__scopeNote mesh__D012492
% 216.04/216.18       Substances produced from the reaction between acids and bases; compounds consisting of a metal %28%positive%29% and nonmetal %28%negative%29% radical. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 216.04/216.18  |- mesh__activeMeSHYear mesh__D012492 2002
% 216.04/216.18  |- mesh__activeMeSHYear mesh__D012492 2006
% 216.04/216.18  |- mesh__activeMeSHYear mesh__D012492 2003
% 216.04/216.18  |- mesh__activeMeSHYear mesh__D012492 2001
% 216.04/216.18  |- mesh__activeMeSHYear mesh__D012492 2005
% 216.04/216.18  |- mesh__recordAuthorizer mesh__D012492 SJN
% 216.04/216.18  |- mesh__dateCreated mesh__D012492 1999-01-01
% 216.04/216.18  |- mesh__activeMeSHYear mesh__D012492 2000
% 216.04/216.18  |- rdf__type mesh__D012492sskos__Concept
% 216.04/216.18  |- skos__annotation mesh__D012492
% 216.04/216.18       note plural: not for %22%salt%22% referring to common salt %28%SODIUM CHLORIDE%29% or TABLE SALT see SODIUM CHLORIDE, DIETARY; GEN; NIM; Manual 25.5.5.2%A%  
% 216.04/216.18  |- mesh__activeMeSHYear mesh__D020924 2000
% 216.04/216.18  |- skos__related mesh__D020924smesh__D014555
% 216.04/216.18  |- mesh__historyNote mesh__D020924 2000   
% 216.04/216.18  |- mesh__activeMeSHYear mesh__D020924 2003
% 216.04/216.18  |- mesh__activeMeSHYear mesh__D020924 2001
% 216.04/216.19  |- skos__prefLabel mesh__D020924 Urological Manifestations
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D020924 2004
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D020924 2002
% 216.04/216.19  |- mesh__dateEstablished mesh__D020924 2000-01-01
% 216.04/216.19  |- skos__hiddenLabel mesh__D020924 Urological Manifestation
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D020924 2005
% 216.04/216.19  |- mesh__publicMeSHNote mesh__D020924 2000   
% 216.04/216.19  |- mesh__dateCreated mesh__D020924 1999-11-03
% 216.04/216.19  |- skos__broader mesh__D020924smesh__D012816
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D020924 2006
% 216.04/216.19  |- skos__hiddenLabel mesh__D020924 Manifestations, Urological
% 216.04/216.19  |- skos__annotation mesh__D020924 not used in indexing   
% 216.04/216.19  |- rdf__type mesh__D020924sskos__Concept
% 216.04/216.19  |- skos__hiddenLabel mesh__D020924 Manifestation, Urological
% 216.04/216.19  |- skos__scopeNote mesh__D020924
% 216.04/216.19       Clinical disturbances of the urinary system.     
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D006455 2003
% 216.04/216.19  |- skos__scopeNote mesh__D006455
% 216.04/216.19       Hemoglobins characterized by structural alterations within the molecule. The alteration can be either absence, addition or substitution of one or more amino acids in the globin part of the molecule at selected positions in the polypeptide chains.%A%    
% 216.04/216.19  |- mesh__dateCreated mesh__D006455 1999-01-01
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D006455 2001
% 216.04/216.19  |- mesh__recordOriginator mesh__D006455 NLM
% 216.04/216.19  |- skos__annotation mesh__D006455
% 216.04/216.19       /urine: coord IM with HEMOGLOBINURIA %28%IM%29%; do not confuse with HEMOGLOBINOPATHIES: use term in the text%A%  
% 216.04/216.19  |- mesh__dateRevised mesh__D006455 1999-11-03
% 216.04/216.19  |- rdf__type mesh__D006455sskos__Concept
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D006455 2000
% 216.04/216.19  |- skos__altLabel mesh__D006455 Abnormal Hemoglobins
% 216.04/216.19  |- mesh__recordAuthorizer mesh__D006455 sjn
% 216.04/216.19  |- skos__broader mesh__D006455smesh__D006454
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D006455 2006
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D006455 2002
% 216.04/216.19  |- skos__prefLabel mesh__D006455 Hemoglobins, Abnormal
% 216.04/216.19  |- mesh__recordMaintainer mesh__D006455 adp
% 216.04/216.19  |- skos__related mesh__D006455smesh__D006453
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D006455 2005
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D006455 2004
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D020126 2006
% 216.04/216.19  |- skos__hiddenLabel mesh__D020126 NSC89671
% 216.04/216.19  |- skos__altLabel mesh__D020126 Synergisidin
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D020126 2005
% 216.04/216.19  |- mesh__recordMaintainer mesh__D020126 ssb
% 216.04/216.19  |- mesh__dateCreated mesh__D020126 1998-06-10
% 216.04/216.19  |- skos__hiddenLabel mesh__D020126 NSC 89671
% 216.04/216.19  |- mesh__historyNote mesh__D020126
% 216.04/216.19       99; use BREFELDIN A %28%NM%29% 1980-98   
% 216.04/216.19  |- skos__historyNote mesh__D020126 Cyclopentanes %28%1974-1998%29%
% 216.04/216.19  |- skos__prefLabel mesh__D020126 Brefeldin A
% 216.04/216.19  |- skos__altLabel mesh__D020126 Ascotoxin
% 216.04/216.19  |- mesh__recordAuthorizer mesh__D020126 sjn
% 216.04/216.19  |- mesh__dateEstablished mesh__D020126 1999-01-01
% 216.04/216.19  |- skos__altLabel mesh__D020126 Decumbin
% 216.04/216.19  |- rdf__type mesh__D020126sskos__Concept
% 216.04/216.19  |- mesh__publicMeSHNote mesh__D020126
% 216.04/216.19       99; BREFELDIN A was indexed under CYCLOPENTANES 1974-98   
% 216.04/216.19  |- mesh__recordOriginator mesh__D020126 ADP
% 216.04/216.19  |- mesh__dateRevised mesh__D020126 2004-07-07
% 216.04/216.19  |- skos__altLabel mesh__D020126 Cyanein
% 216.04/216.19  |- skos__broader mesh__D020126smesh__D018942
% 216.04/216.19  |- skos__scopeNote mesh__D020126
% 216.04/216.19       A fungal metabolite which is a macrocyclic lactone exhibiting a wide range of antibiotic activity.%A%    
% 216.04/216.19  |- skos__altLabel mesh__D016883 Ketoacidosis, Diabetic
% 216.04/216.19  |- mesh__recordMaintainer mesh__D016883 ags
% 216.04/216.19  |- skos__prefLabel mesh__D016883 Diabetic Ketoacidosis
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D016883 2005
% 216.04/216.19  |- skos__hiddenLabel mesh__D016883 Diabetic Ketoacidoses
% 216.04/216.19  |- mesh__publicMeSHNote mesh__D016883
% 216.04/216.19       92; KETOSIS, DIABETIC was heading 1975-91 %28%see under ACIDOSIS, DIABETIC 1975-90%29%; ACIDOSIS, DIABETIC was heading 1966-91%A%  
% 216.04/216.19  |- skos__altLabel mesh__D016883 Acidosis, Diabetic
% 216.04/216.19  |- skos__broader mesh__D016883smesh__D003920
% 216.04/216.19  |- skos__hiddenLabel mesh__D016883 Acidoses, Diabetic
% 216.04/216.19  |- skos__scopeNote mesh__D016883
% 216.04/216.19       A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by excessive LIPOLYSIS, oxidation of FATTY ACIDS, production of KETONE BODIES, a sweet smell to the breath %28%KETOSIS;%29% DEHYDRATION; and depressed consciousness leading to COMA.%A%    
% 216.04/216.19  |- skos__hiddenLabel mesh__D016883 Diabetic Ketoses
% 216.04/216.19  |- mesh__onlineNote mesh__D016883
% 216.04/216.19       use DIABETIC KETOACIDOSIS to search KETOSIS, DIABETIC 1975-91 %26% ACIDOSIS, DIABETIC 1966-91%A%  
% 216.04/216.19  |- skos__hiddenLabel mesh__D016883 Ketoses, Diabetic
% 216.04/216.19  |- rdf__type mesh__D016883sskos__Concept
% 216.04/216.19  |- skos__hiddenLabel mesh__D016883 Diabetic Acidoses
% 216.04/216.19  |- mesh__dateEstablished mesh__D016883 1992-01-01
% 216.04/216.19  |- mesh__dateRevised mesh__D016883 2005-07-18
% 216.04/216.19  |- skos__broader mesh__D016883smesh__D048909
% 216.04/216.19  |- mesh__recordAuthorizer mesh__D016883 ags
% 216.04/216.19  |- skos__altLabel mesh__D016883 Ketosis, Diabetic
% 216.04/216.19  |- mesh__recordOriginator mesh__D016883 AGS
% 216.04/216.19  |- skos__hiddenLabel mesh__D016883 Ketoacidoses, Diabetic
% 216.04/216.19  |- skos__altLabel mesh__D016883 Diabetic Acidosis
% 216.04/216.19  |- mesh__historyNote mesh__D016883
% 216.04/216.19       92; KETOSIS, DIABETIC was heading 1975-91 %28%see under ACIDOSIS, DIABETIC 1975-90%29%; ACIDOSIS, DIABETIC was heading 1966-91%A%  
% 216.04/216.19  |- mesh__dateCreated mesh__D016883 1991-05-30
% 216.04/216.19  |- skos__broader mesh__D016883smesh__D000138
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D016883 2006
% 216.04/216.19  |- skos__altLabel mesh__D016883 Diabetic Ketosis
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D016883 2006A
% 216.04/216.19  |- skos__broader mesh__D016085smesh__D019141
% 216.04/216.19  |- skos__scopeNote mesh__D016085
% 216.04/216.19       Agents causing the narrowing of the lumen of a bronchus or bronchiole.%A%    
% 216.04/216.19  |- mesh__recordOriginator mesh__D016085 TGC
% 216.04/216.19  |- skos__prefLabel mesh__D016085 Bronchoconstrictor Agents
% 216.04/216.19  |- skos__hiddenLabel mesh__D016085 Agents, Bronchoconstrictor
% 216.04/216.19  |- mesh__recordMaintainer mesh__D016085 ssb
% 216.04/216.19  |- mesh__publicMeSHNote mesh__D016085 91   
% 216.04/216.19  |- skos__broader mesh__D016085smesh__D001337
% 216.04/216.19  |- skos__hiddenLabel mesh__D016085 Bronchial Constricting Agents
% 216.04/216.19  |- skos__altLabel mesh__D016085 Bronchoconstrictors
% 216.04/216.19  |- mesh__historyNote mesh__D016085 91   
% 216.04/216.19  |- mesh__dateCreated mesh__D016085 1990-06-06
% 216.04/216.19  |- skos__annotation mesh__D016085 consider also BRONCHI /drug eff   
% 216.04/216.19  |- skos__hiddenLabel mesh__D016085 Agents, Bronchial-Constricting
% 216.04/216.19  |- mesh__dateRevised mesh__D016085 2005-06-30
% 216.04/216.19  |- mesh__dateEstablished mesh__D016085 1991-01-01
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D016085 2006
% 216.04/216.19  |- skos__historyNote mesh__D016085 Bronchi/drug effects %28%1966-1990%29%
% 216.04/216.19  |- skos__altLabel mesh__D016085 Bronchial-Constricting Agents
% 216.04/216.19  |- rdf__type mesh__D016085sskos__Concept
% 216.04/216.19  |- mesh__recordAuthorizer mesh__D016085 sjn
% 216.04/216.19  |- skos__broader mesh__D002863smesh__D007202
% 216.04/216.19  |- skos__hiddenLabel mesh__D002863 Compounds, Chromogenic
% 216.04/216.19  |- skos__scopeNote mesh__D002863
% 216.04/216.19       Colorless, endogenous or exogenous pigment precursors that may be transformed by biological mechanisms into colored compounds; used in biochemical assays and in diagnosis as indicators, especially in the form of enzyme substrates. Synonym: chromogens %28%not to be confused with pigment-synthesizing bacteria also called chromogens%29%.%A%    
% 216.04/216.19  |- mesh__recordOriginator mesh__D002863 SH
% 216.04/216.19  |- mesh__recordAuthorizer mesh__D002863 sjn
% 216.04/216.19  |- skos__prefLabel mesh__D002863 Chromogenic Compounds
% 216.04/216.19  |- mesh__dateCreated mesh__D002863 1980-04-02
% 216.04/216.19  |- mesh__recordMaintainer mesh__D002863 ssb
% 216.04/216.19  |- mesh__publicMeSHNote mesh__D002863 81   
% 216.04/216.19  |- skos__annotation mesh__D002863
% 216.04/216.19       %22%colorless ... precursors that may be transformed ... into colored cpds; used in biochem assays %26% ... as indicators%22%; D25-26 qualif; DF: CHROMOGENIC CPDS%A%  
% 216.04/216.19  |- mesh__dateRevised mesh__D002863 2005-06-30
% 216.04/216.19  |- mesh__historyNote mesh__D002863 81   
% 216.04/216.19  |- skos__hiddenLabel mesh__D002863 Substrates, Chromogenic
% 216.04/216.19  |- skos__broader mesh__D002863smesh__D004396
% 216.04/216.19  |- rdf__type mesh__D002863sskos__Concept
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D002863 2006
% 216.04/216.19  |- mesh__dateEstablished mesh__D002863 1981-01-01
% 216.04/216.19  |- skos__hiddenLabel mesh__D002065 Nu Buspirone
% 216.04/216.19  |- skos__altLabel mesh__D002065
% 216.04/216.19       N-%28%4-%28%4-%28%2-pyrimidinyl%29%-1-piperazinyl%29%butyl%29%-1-cyclopentanediacetamide
% 216.04/216.19  |- skos__altLabel mesh__D002065 Ratiopharm Brand of Buspirone Hydrochloride
% 216.04/216.19  |- skos__altLabel mesh__D002065 Armstrong Brand of Buspirone Hydrochloride
% 216.04/216.19  |- skos__hiddenLabel mesh__D002065
% 216.04/216.19       Bristol Myers Brand of Buspirone Hydrochloride
% 216.04/216.19  |- skos__historyNote mesh__D002065 Spiro Compounds %28%1973-1982%29%
% 216.04/216.19  |- rdf__type mesh__D002065sskos__Concept
% 216.04/216.19  |- skos__broader mesh__D002065smesh__D013141
% 216.04/216.19  |- skos__broader mesh__D002065smesh__D011743
% 216.04/216.19  |- skos__altLabel mesh__D002065 Novopharm Brand of Buspirone Hydrochloride
% 216.04/216.19  |- skos__hiddenLabel mesh__D002065
% 216.04/216.19       Nu Pharm Brand of Buspirone Hydrochloride
% 216.04/216.19  |- skos__altLabel mesh__D002065
% 216.04/216.19       Bristol-Myers Brand of Buspirone Hydrochloride
% 216.04/216.19  |- skos__altLabel mesh__D002065 Hormosan Brand of Buspirone Hydrochloride
% 216.04/216.19  |- mesh__recordOriginator mesh__D002065 RLS
% 216.04/216.19  |- skos__altLabel mesh__D002065 Eisai Brand of Buspirone Hydrochloride
% 216.04/216.19  |- skos__hiddenLabel mesh__D002065 ratio Buspirone
% 216.04/216.19  |- skos__altLabel mesh__D002065 Nu-Pharm Brand of Buspirone Hydrochloride
% 216.04/216.19  |- skos__altLabel mesh__D002065 Bespar
% 216.04/216.19  |- mesh__publicMeSHNote mesh__D002065 88   
% 216.04/216.19  |- skos__altLabel mesh__D002065 Genpharm Brand of Buspirone
% 216.04/216.19  |- mesh__recordMaintainer mesh__D002065 CCR
% 216.04/216.19  |- mesh__historyNote mesh__D002065 88   
% 216.04/216.19  |- skos__hiddenLabel mesh__D002065 MJ 9022 1
% 216.04/216.19  |- mesh__dateRevised mesh__D002065 2005-06-30
% 216.04/216.19  |- skos__hiddenLabel mesh__D002065 MJ90221
% 216.04/216.19  |- mesh__dateCreated mesh__D002065 1987-05-04
% 216.04/216.19  |- skos__altLabel mesh__D002065
% 216.04/216.19       Bristol-Myers Squibb Brand of Buspirone Hydrochloride
% 216.04/216.19  |- skos__hiddenLabel mesh__D002065
% 216.04/216.19       Bristol Myers Squibb Brand of Buspirone Hydrochloride
% 216.04/216.19  |- skos__historyNote mesh__D002065 Pyrimidines %28%1972-1987%29%
% 216.04/216.19  |- skos__scopeNote mesh__D002065
% 216.04/216.19       An anxiolytic agent and a serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the benzodiazepines, but it has an efficacy comparable to DIAZEPAM.%A%    
% 216.04/216.19  |- skos__hiddenLabel mesh__D002065 Lin Buspirone
% 216.04/216.19  |- skos__prefLabel mesh__D002065 Buspirone
% 216.04/216.19  |- skos__hiddenLabel mesh__D002065 Novo Buspirone
% 216.04/216.19  |- skos__altLabel mesh__D002065 Hexal Brand of Buspirone Hydrochloride
% 216.04/216.19  |- skos__hiddenLabel mesh__D002065 Hydrochloride, Buspirone
% 216.04/216.19  |- mesh__recordAuthorizer mesh__D002065 sjn
% 216.04/216.19  |- skos__altLabel mesh__D002065
% 216.04/216.19       Pharmascience Brand of Buspirone Hydrochloride
% 216.04/216.19  |- skos__altLabel mesh__D002065
% 216.04/216.19       Linson Pharma Brand of Buspirone Hydrochloride
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D002065 2006
% 216.04/216.19  |- skos__altLabel mesh__D002065 UPSA Brand of Buspirone Hydrochloride
% 216.04/216.19  |- skos__hiddenLabel mesh__D002065 Gen Buspirone
% 216.04/216.19  |- skos__hiddenLabel mesh__D002065 Apo Buspirone
% 216.04/216.19  |- mesh__dateEstablished mesh__D002065 1988-01-01
% 216.04/216.19  |- skos__altLabel mesh__D002065 Apotex Brand of Buspirone Hydrochloride
% 216.04/216.19  |- skos__hiddenLabel mesh__D002065 PMS Buspirone
% 216.04/216.19  |- skos__prefLabel mesh__D012493 Samarium
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D012493 2003
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D012493 2005
% 216.04/216.19  |- skos__annotation mesh__D012493
% 216.04/216.19       a rare earth metal; Sm-152; Sm-144, 150, 154 = SAMARIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Sm-142, 143, 145-149, 151, 153, 155-157 = SAMARIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D012493 2004
% 216.04/216.19  |- mesh__dateCreated mesh__D012493 1999-01-01
% 216.04/216.19  |- mesh__recordMaintainer mesh__D012493 jmp
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D012493 2002
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D012493 2006
% 216.04/216.19  |- mesh__recordOriginator mesh__D012493 NLM
% 216.04/216.19  |- mesh__dateRevised mesh__D012493 2001-07-25
% 216.04/216.19  |- skos__scopeNote mesh__D012493
% 216.04/216.19       Samarium. An element of the rare earth family of metals. It has the atomic symbol Sm, atomic number 62, and atomic weight 150.36. The oxide is used in the control rods of some nuclear reactors.%A%    
% 216.04/216.19  |- rdf__type mesh__D012493sskos__Concept
% 216.04/216.19  |- mesh__recordAuthorizer mesh__D012493 sjn
% 216.04/216.19  |- skos__broader mesh__D012493smesh__D028581
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Ischemic-Hypoxic Encephalopathies
% 216.04/216.19  |- skos__altLabel mesh__D020925 Ischemia-Hypoxia, Brain
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Cerebral Ischemia-Anoxias
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Hypoxic Ischemic Encephalopathy
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Anoxia-Ischemias, Cerebral
% 216.04/216.19  |- skos__altLabel mesh__D020925 Cerebral Ischemia-Hypoxia
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Brain Hypoxia-Ischemias
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Ischemia Anoxia, Brain
% 216.04/216.19  |- skos__historyNote mesh__D020925
% 216.04/216.19       Cerebrovascular Disorders %28%1971-1999%29%
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Ischemia-Anoxias, Cerebral
% 216.04/216.19  |- mesh__recordMaintainer mesh__D020925 sjn
% 216.04/216.19  |- skos__altLabel mesh__D020925 Brain Hypoxia-Ischemia
% 216.04/216.19  |- skos__altLabel mesh__D020925 Cerebral Anoxia-Ischemia
% 216.04/216.19  |- skos__altLabel mesh__D020925 Encephalopathy, Hypoxic-Ischemic
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Anoxia Ischemia, Cerebral
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Encephalopathy, Anoxic Ischemic
% 216.04/216.19  |- skos__altLabel mesh__D020925 Ischemia-Anoxia, Brain
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Hypoxic Ischemic Brain Injury
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Ischemia Anoxia, Cerebral
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Encephalopathies, Ischemic-Hypoxic
% 216.04/216.19  |- mesh__dateEstablished mesh__D020925 2000-01-01
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Hypoxia-Ischemias, Brain
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Ischemic Hypoxic Encephalopathy
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Brain Ischemia Anoxia
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Cerebral Ischemia Anoxia
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Anoxic-Ischemic Brain Injuries
% 216.04/216.19  |- skos__altLabel mesh__D020925 Ischemia-Anoxia, Cerebral
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Hypoxia Ischemia, Cerebral
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Encephalopathies, Anoxic-Ischemic
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Brain Anoxia-Ischemias
% 216.04/216.19  |- skos__altLabel mesh__D020925 Hypoxia-Ischemia, Cerebral
% 216.04/216.19  |- skos__scopeNote mesh__D020925
% 216.04/216.19       A disorder characterized by a reduction in oxygen supply %28%HYPOXIA%29% combined with reduced blood flow %28%ISCHEMIA%29% to the brain. This condition may result from a localized obstruction of a cerebral artery or from systemic hypoperfusion. Prolonged hypoxia-ischemia is associated with ISCHEMIC ATTACK, TRANSIENT; BRAIN INFARCTION; BRAIN EDEMA; COMA; and other conditions.%A%    
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Ischemia-Anoxias, Brain
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Brain Ischemia-Anoxias
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Hypoxia-Ischemias, Cerebral
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Cerebral Ischemia Hypoxia
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Brain Ischemia Hypoxia
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Brain Anoxia Ischemia
% 216.04/216.19  |- skos__altLabel mesh__D020925 Ischemia-Hypoxia, Cerebral
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Ischemia Hypoxia, Cerebral
% 216.04/216.19  |- mesh__dateRevised mesh__D020925 2003-07-25
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Cerebral Anoxia Ischemia
% 216.04/216.19  |- skos__altLabel mesh__D020925 Ischemic-Hypoxic Encephalopathy
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Brain Injuries, Hypoxic-Ischemic
% 216.04/216.19  |- mesh__historyNote mesh__D020925 2000   
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D020925 2006
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Cerebral Anoxia-Ischemias
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Anoxic Ischemic Brain Injury
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Cerebral Hypoxia Ischemia
% 216.04/216.19  |- mesh__recordAuthorizer mesh__D020925 sjn
% 216.04/216.19  |- rdf__type mesh__D020925sskos__Concept
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Hypoxic-Ischemic Encephalopathies
% 216.04/216.19  |- skos__prefLabel mesh__D020925 Hypoxia-Ischemia, Brain
% 216.04/216.19  |- skos__broader mesh__D020925smesh__D002561
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Hypoxia Ischemia, Brain
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Brain Injury, Anoxic Ischemic
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Ischemia Hypoxia, Brain
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Injury, Hypoxic-Ischemic Brain
% 216.04/216.19  |- skos__altLabel mesh__D020925 Brain Ischemia-Anoxia
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Hypoxic-Ischemic Brain Injuries
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Encephalopathy, Hypoxic Ischemic
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Anoxic-Ischemic Encephalopathies
% 216.04/216.19  |- skos__related mesh__D020925smesh__D000860
% 216.04/216.19  |- skos__altLabel mesh__D020925 Hypoxic-Ischemic Brain Injury
% 216.04/216.19  |- skos__altLabel mesh__D020925 Brain Anoxia-Ischemia
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D020925 2005
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Brain Ischemia-Hypoxias
% 216.04/216.19  |- mesh__dateCreated mesh__D020925 1999-11-05
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Injuries, Anoxic-Ischemic Brain
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Brain Injury, Hypoxic-Ischemic
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Encephalopathies, Hypoxic-Ischemic
% 216.04/216.19  |- skos__altLabel mesh__D020925 Brain Injury, Anoxic-Ischemic
% 216.04/216.19  |- skos__historyNote mesh__D020925 Anoxia %28%1971-1999%29%
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Brain Injuries, Anoxic-Ischemic
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Injuries, Hypoxic-Ischemic Brain
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Brain Hypoxia Ischemia
% 216.04/216.19  |- skos__altLabel mesh__D020925 Brain Ischemia-Hypoxia
% 216.04/216.19  |- skos__altLabel mesh__D020925 Encephalopathy, Anoxic-Ischemic
% 216.04/216.19  |- mesh__recordOriginator mesh__D020925 KEV
% 216.04/216.19  |- skos__altLabel mesh__D020925 Anoxic-Ischemic Brain Injury
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Cerebral Hypoxia-Ischemias
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Anoxic Ischemic Encephalopathy
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Ischemia-Hypoxias, Brain
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Injury, Anoxic-Ischemic Brain
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Anoxia-Ischemias, Brain
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Ischemia-Hypoxias, Cerebral
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D020925 2004
% 216.04/216.19  |- mesh__publicMeSHNote mesh__D020925 2000   
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Anoxia Ischemia, Brain
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Cerebral Ischemia-Hypoxias
% 216.04/216.19  |- skos__hiddenLabel mesh__D020925 Encephalopathy, Ischemic-Hypoxic
% 216.04/216.19  |- skos__altLabel mesh__D020925 Cerebral Ischemia-Anoxia
% 216.04/216.19  |- rdf__type mesh__D006456sskos__Concept
% 216.04/216.19  |- skos__scopeNote mesh__D006456
% 216.04/216.19       The presence of free hemoglobin in the urine.     
% 216.04/216.19  |- skos__broader mesh__D006456smesh__D000743
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D006456 1998
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D006456 1997
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D006456 2002
% 216.04/216.19  |- skos__broader mesh__D006456smesh__D014570
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D006456 2006
% 216.04/216.19  |- mesh__recordMaintainer mesh__D006456 TGC
% 216.04/216.19  |- mesh__recordAuthorizer mesh__D006456 PLS
% 216.04/216.19  |- mesh__dateRevised mesh__D006456 1996-06-10
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D006456 2005
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D006456 2004
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D006456 2001
% 216.04/216.19  |- mesh__recordOriginator mesh__D006456 NLM
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D006456 2003
% 216.04/216.19  |- mesh__dateCreated mesh__D006456 1999-01-01
% 216.04/216.19  |- skos__hiddenLabel mesh__D006456 Hemoglobinurias
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D006456 2000
% 216.04/216.19  |- skos__prefLabel mesh__D006456 Hemoglobinuria
% 216.04/216.19  |- skos__annotation mesh__D006456
% 216.04/216.19       HEMOGLOBINURIA, PAROXYSMAL is also available: see note there%A%  
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D006456 1999
% 216.04/216.19  |- skos__related mesh__D020127smesh__D012046
% 216.04/216.19  |- skos__related mesh__D020127smesh__D003289
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D020127 2001
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D020127 2003
% 216.04/216.19  |- skos__hiddenLabel mesh__D020127 Function Recovery
% 216.04/216.19  |- mesh__recordOriginator mesh__D020127 NDW
% 216.04/216.19  |- mesh__dateRevised mesh__D020127 1999-11-03
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D020127 2000
% 216.04/216.19  |- mesh__publicMeSHNote mesh__D020127 99   
% 216.04/216.19  |- skos__broader mesh__D020127smesh__D001686
% 216.04/216.19  |- rdf__type mesh__D020127sskos__Concept
% 216.04/216.19  |- skos__scopeNote mesh__D020127
% 216.04/216.19       A partial or complete return to the normal or proper physiologic activity of an organ or part following disease or trauma.%A%    
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D020127 2002
% 216.04/216.19  |- mesh__historyNote mesh__D020127 99   
% 216.04/216.19  |- mesh__recordMaintainer mesh__D020127 jls
% 216.04/216.19  |- mesh__recordAuthorizer mesh__D020127 sjn
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D020127 2006
% 216.04/216.19  |- skos__prefLabel mesh__D020127 Recovery of Function
% 216.04/216.19  |- skos__hiddenLabel mesh__D020127 Function Recoveries
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D020127 2004
% 216.04/216.19  |- mesh__dateEstablished mesh__D020127 1999-01-01
% 216.04/216.19  |- skos__related mesh__D020127smesh__D012075
% 216.04/216.19  |- mesh__dateCreated mesh__D020127 1998-06-11
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D020127 2005
% 216.04/216.19  |- mesh__dateCreated mesh__D016884 1991-05-02
% 216.04/216.19  |- skos__hiddenLabel mesh__D016884
% 216.04/216.19       Polyendocrinopathy-Candidiasis-Ectodermal-Dystrophy, Autoimmune
% 216.04/216.19  |- skos__hiddenLabel mesh__D016884 Polyendocrinopathy, Autoimmune
% 216.04/216.19  |- skos__altLabel mesh__D016884 Autoimmune Polyglandular Syndrome Type II
% 216.04/216.19  |- mesh__publicMeSHNote mesh__D016884 92   
% 216.04/216.19  |- skos__altLabel mesh__D016884 Schmidt%27%s Syndrome
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D016884 2006A
% 216.04/216.19  |- rdf__type mesh__D016884sskos__Concept
% 216.04/216.19  |- skos__altLabel mesh__D016884 Autoimmune Syndrome Type II, Polyglandular
% 216.04/216.19  |- skos__broader mesh__D016884smesh__D004700
% 216.04/216.19  |- skos__hiddenLabel mesh__D016884 Autoimmune Polyendocrinopathies
% 216.04/216.19  |- mesh__recordAuthorizer mesh__D016884 ags
% 216.04/216.19  |- skos__altLabel mesh__D016884 Autoimmune Polyglandular Syndrome Type I
% 216.04/216.19  |- skos__altLabel mesh__D016884
% 216.04/216.19       Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal-Dystrophy
% 216.04/216.19  |- skos__annotation mesh__D016884
% 216.04/216.19       do not coordinate with specific endocrine disease term or CANDIDIASIS unless particularly discussed%A%  
% 216.04/216.19  |- skos__hiddenLabel mesh__D016884 Schmidt Syndrome
% 216.04/216.19  |- skos__scopeNote mesh__D016884
% 216.04/216.19       Autoimmune diseases affecting multiple endocrine organs. Type I is characterized by childhood onset and chronic mucocutaneous candidiasis %28%CANDIDIASIS, CHRONIC MUCOCUTANEOUS%29%, while type II exhibits any combination of adrenal insufficiency %28%ADDISON%27%S DISEASE%29%, lymphocytic thyroiditis %28%THYROIDITIS, AUTOIMMUNE;%29%, HYPOPARATHYROIDISM; and gonadal failure. In both types organ-specific ANTIBODIES against a variety of ENDOCRINE GLANDS have been detected. The type II syndrome differs from type I in that it is associated with HLA-A1 and B8 haplotypes, onset is usually in adulthood, and candidiasis is not present.%A%    
% 216.04/216.19  |- skos__hiddenLabel mesh__D016884
% 216.04/216.19       Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy
% 216.04/216.19  |- skos__altLabel mesh__D016884 Autoimmune Syndrome Type I, Polyglandular
% 216.04/216.19  |- mesh__dateEstablished mesh__D016884 1992-01-01
% 216.04/216.19  |- skos__hiddenLabel mesh__D016884 Autoimmune Polyendocrinopathy
% 216.04/216.19  |- mesh__dateRevised mesh__D016884 2005-08-02
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D016884 2006
% 216.04/216.19  |- mesh__historyNote mesh__D016884 92   
% 216.04/216.19  |- mesh__recordOriginator mesh__D016884 AGS
% 216.04/216.19  |- skos__hiddenLabel mesh__D016884 Syndrome, Schmidt%27%s
% 216.04/216.19  |- skos__hiddenLabel mesh__D016884
% 216.04/216.19       Polyendocrinopathy-Candidiasis-Ectodermal-Dystrophies, Autoimmune
% 216.04/216.19  |- mesh__recordMaintainer mesh__D016884 ags
% 216.04/216.19  |- skos__hiddenLabel mesh__D016884 Schmidts Syndrome
% 216.04/216.19  |- skos__historyNote mesh__D016884 Endocrine Diseases %28%1978-1991%29%
% 216.04/216.19  |- skos__broader mesh__D016884smesh__D001327
% 216.04/216.19  |- skos__prefLabel mesh__D016884 Polyendocrinopathies, Autoimmune
% 216.04/216.19  |- skos__historyNote mesh__D016884 Autoimmune Diseases %28%1968-1991%29%
% 216.04/216.19  |- skos__hiddenLabel mesh__D016884
% 216.04/216.19       Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal-Dystrophies
% 216.04/216.19  |- skos__broader mesh__D016086smesh__D012190
% 216.04/216.19  |- skos__annotation mesh__D016086
% 216.04/216.19       a genus of the family Retroviridae; Latin lenti-, slow, refers to its long incubation period; infection = LENTIVIRUS INFECTIONS%A%  
% 216.04/216.19  |- skos__historyNote mesh__D016086 Visna Virus %28%1979-1990%29%
% 216.04/216.19  |- skos__prefLabel mesh__D016086 Lentivirus
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D016086 1997
% 216.04/216.19  |- mesh__recordOriginator mesh__D016086 AGS
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D016086 2004
% 216.04/216.19  |- mesh__publicMeSHNote mesh__D016086 94; was LENTIVIRINAE 1991-93   
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D016086 2000
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D016086 1998
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D016086 2005
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D016086 2001
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D016086 1999
% 216.04/216.19  |- mesh__dateEstablished mesh__D016086 1991-01-01
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D016086 2006
% 216.04/216.19  |- skos__scopeNote mesh__D016086
% 216.04/216.19       A genus of the family RETROVIRIDAE consisting of non-oncogenic retroviruses that produce multi-organ diseases characterized by long incubation periods and persistent infection. Lentiviruses are unique in that they contain open reading frames %28%ORFs%29% between the pol and env genes and in the 3%27% env region. Five serogroups are recognized, reflecting the mammalian hosts with which they are associated. HIV-1 is the type species.%A%    
% 216.04/216.19  |- mesh__onlineNote mesh__D016086
% 216.04/216.19       use LENTIVIRUS to search LENTIVIRINAE 1991-93   
% 216.04/216.19  |- mesh__historyNote mesh__D016086 94; was LENTIVIRINAE 1991-93   
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D016086 2002
% 216.04/216.19  |- skos__hiddenLabel mesh__D016086 Lentiviruses
% 216.04/216.19  |- rdf__type mesh__D016086sskos__Concept
% 216.04/216.19  |- mesh__dateCreated mesh__D016086 1990-06-06
% 216.04/216.19  |- mesh__recordMaintainer mesh__D016086 AGS
% 216.04/216.19  |- mesh__dateRevised mesh__D016086 1996-06-10
% 216.04/216.19  |- mesh__activeMeSHYear mesh__D016086 2003
% 216.04/216.19  |- mesh__recordAuthorizer mesh__D016086 PLS
% 216.04/216.20  |- mesh__recordMaintainer mesh__D002864 SYSTEM
% 216.04/216.20  |- mesh__recordAuthorizer mesh__D002864 sjn
% 216.04/216.20  |- skos__historyNote mesh__D002864 Chromaffin System %28%1966-1972%29%
% 216.04/216.20  |- mesh__historyNote mesh__D002864
% 216.04/216.20       91%28%73%29%; was see under NERVE TISSUE PROTEINS 1973-90   
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D002864 2006
% 216.04/216.20  |- skos__broader mesh__D002864smesh__D009419
% 216.04/216.20  |- skos__broader mesh__D002864smesh__D008074
% 216.04/216.20  |- mesh__recordOriginator mesh__D002864 NLM
% 216.04/216.20  |- rdf__type mesh__D002864sskos__Concept
% 216.04/216.20  |- mesh__dateRevised mesh__D002864 2005-06-30
% 216.04/216.20  |- skos__historyNote mesh__D002864 Nerve Tissue Proteins %28%1966-1972%29%
% 216.04/216.20  |- mesh__publicMeSHNote mesh__D002864
% 216.04/216.20       91; was see under NERVE TISSUE PROTEINS 1973-90   
% 216.04/216.20  |- skos__prefLabel mesh__D002864 Chromogranins
% 216.04/216.20  |- skos__annotation mesh__D002864 nerve tissue proteins   
% 216.04/216.20  |- mesh__dateEstablished mesh__D002864 1991-01-01
% 216.04/216.20  |- mesh__dateCreated mesh__D002864 1999-01-01
% 216.04/216.20  |- mesh__recordAuthorizer mesh__D002066 sjn
% 216.04/216.20  |- skos__altLabel mesh__D002066 Glaxo Wellcome Brand of Busulfan
% 216.04/216.20  |- mesh__dateCreated mesh__D002066 1999-01-01
% 216.04/216.20  |- mesh__recordMaintainer mesh__D002066 ssb
% 216.04/216.20  |- skos__hiddenLabel mesh__D002066 Busulfan Orphan Brand
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D002066 2006
% 216.04/216.20  |- skos__altLabel mesh__D002066 Wellcome Brand of Busulfan
% 216.04/216.20  |- mesh__dateRevised mesh__D002066 2005-06-30
% 216.04/216.20  |- mesh__recordOriginator mesh__D002066 NLM
% 216.04/216.20  |- skos__hiddenLabel mesh__D002066 Busulfan GlaxoSmithKline Brand
% 216.04/216.20  |- rdf__type mesh__D002066sskos__Concept
% 216.04/216.20  |- skos__prefLabel mesh__D002066 Busulfan
% 216.04/216.20  |- skos__broader mesh__D002066smesh__D002072
% 216.04/216.20  |- skos__altLabel mesh__D002066 GlaxoSmithKline Brand of Busulfan
% 216.04/216.20  |- skos__altLabel mesh__D002066 Myl%C3%%A9%ran
% 216.04/216.20  |- skos__scopeNote mesh__D002066
% 216.04/216.20       An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia %28%MYELOID LEUKEMIA, CHRONIC%29%, but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%, busulfan is listed as a known carcinogen.%A%    
% 216.04/216.20  |- skos__altLabel mesh__D002066 Busulphan
% 216.04/216.20  |- skos__hiddenLabel mesh__D002066 Wellcome, Busulfan
% 216.04/216.20  |- skos__hiddenLabel mesh__D002066 Busulfan Wellcome Brand
% 216.04/216.20  |- skos__altLabel mesh__D002066 Orphan Brand of Busulfan
% 216.04/216.20  |- skos__broader mesh__D002066smesh__D008698
% 216.04/216.20  |- skos__annotation mesh__D048168
% 216.04/216.20       infection: coordinate IM with ESCHERICHIA COLI INFECTIONS %28%IM%29%%A%  
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D048168 2006
% 216.04/216.20  |- skos__historyNote mesh__D048168 Escherichia coli %28%1965-2004%29%
% 216.04/216.20  |- rdf__type mesh__D048168sskos__Concept
% 216.04/216.20  |- mesh__historyNote mesh__D048168 2005   
% 216.04/216.20  |- skos__prefLabel mesh__D048168 Escherichia coli K12
% 216.04/216.20  |- skos__broader mesh__D048168smesh__D004926
% 216.04/216.20  |- mesh__dateRevised mesh__D048168 2005-06-30
% 216.04/216.20  |- mesh__recordMaintainer mesh__D048168 SYSTEM
% 216.04/216.20  |- mesh__dateEstablished mesh__D048168 2005-01-01
% 216.04/216.20  |- mesh__publicMeSHNote mesh__D048168 2005   
% 216.04/216.20  |- mesh__recordAuthorizer mesh__D048168 sjn
% 216.04/216.20  |- skos__scopeNote mesh__D048168
% 216.04/216.20       A species of gram-negative, rod-shaped bacteria belonging to the K serogroup of ESCHERICHIA COLI. It lives as a harmless inhabitant of the human LARGE INTESTINE and is widely used in medical and GENETIC RESEARCH.%A%    
% 216.04/216.20  |- mesh__dateCreated mesh__D048168 2004-07-07
% 216.04/216.20  |- skos__altLabel mesh__D048168 E coli K12
% 216.04/216.20  |- mesh__recordOriginator mesh__D048168 ags
% 216.04/216.20  |- skos__scopeNote mesh__D012494
% 216.04/216.20       Studies in which a number of subjects are selected from all subjects in a defined population. Conclusions based on sample results may be attributed only to the population sampled.%A%    
% 216.04/216.20  |- skos__hiddenLabel mesh__D012494 Sampling Study
% 216.04/216.20  |- mesh__recordAuthorizer mesh__D012494 sjn
% 216.04/216.20  |- skos__hiddenLabel mesh__D012494 Studies, Sampling
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D012494 2004
% 216.04/216.20  |- mesh__dateCreated mesh__D012494 1999-01-01
% 216.04/216.20  |- skos__prefLabel mesh__D012494 Sampling Studies
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D012494 2006
% 216.04/216.20  |- skos__annotation mesh__D012494
% 216.04/216.20       NIM with specific study IM; no qualif; epidemiological %26% statist only: not for blood samples, soil samples, water samples, air samples, etc.%A%  
% 216.04/216.20  |- skos__hiddenLabel mesh__D012494 Probability Samples
% 216.04/216.20  |- rdf__type mesh__D012494sskos__Concept
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D012494 2002
% 216.04/216.20  |- mesh__recordOriginator mesh__D012494 NLM
% 216.04/216.20  |- mesh__recordMaintainer mesh__D012494 ags
% 216.04/216.20  |- skos__hiddenLabel mesh__D012494 Samples, Probability
% 216.04/216.20  |- mesh__dateEstablished mesh__D012494 1967-01-01
% 216.04/216.20  |- mesh__historyNote mesh__D012494 67%28%65%29%   
% 216.04/216.20  |- skos__hiddenLabel mesh__D012494 Study, Sampling
% 216.04/216.20  |- skos__broader mesh__D012494smesh__D016020
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D012494 2003
% 216.04/216.20  |- mesh__dateRevised mesh__D012494 2001-07-25
% 216.04/216.20  |- mesh__publicMeSHNote mesh__D012494 67   
% 216.04/216.20  |- skos__hiddenLabel mesh__D012494 Sample, Probability
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D012494 2005
% 216.04/216.20  |- skos__hiddenLabel mesh__D020926 MPV785
% 216.04/216.20  |- skos__scopeNote mesh__D020926
% 216.04/216.20       An agonist of RECEPTORS, ADRENERGIC ALPHA-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of DEXMEDETOMIDINE.%A%    
% 216.04/216.20  |- skos__broader mesh__D020926smesh__D007093
% 216.04/216.20  |- mesh__recordOriginator mesh__D020926 adp
% 216.04/216.20  |- mesh__dateRevised mesh__D020926 2005-06-30
% 216.04/216.20  |- mesh__dateEstablished mesh__D020926 2000-01-01
% 216.04/216.20  |- mesh__recordMaintainer mesh__D020926 ssb
% 216.04/216.20  |- mesh__historyNote mesh__D020926
% 216.04/216.20       2000; use MEDETOMIDINE %28%NM%29% 1986-1999   
% 216.04/216.20  |- skos__hiddenLabel mesh__D020926 Hydrochloride, Medetomidine
% 216.04/216.20  |- skos__historyNote mesh__D020926 Imidazoles %28%1986-1999%29%
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D020926 2006
% 216.04/216.20  |- mesh__recordAuthorizer mesh__D020926 sjn
% 216.04/216.20  |- mesh__publicMeSHNote mesh__D020926
% 216.04/216.20       2000; MEDETOMIDINE was indexed under IMIDAZOLES 1986-1999%A%  
% 216.04/216.20  |- skos__hiddenLabel mesh__D020926 MPV 785
% 216.04/216.20  |- mesh__dateCreated mesh__D020926 1999-11-03
% 216.04/216.20  |- rdf__type mesh__D020926sskos__Concept
% 216.04/216.20  |- skos__prefLabel mesh__D020926 Medetomidine
% 216.04/216.20  |- skos__altLabel mesh__D020926 Levomedetomidine
% 216.04/216.20  |- mesh__historyNote mesh__D006457
% 216.04/216.20       78; was MARCHIAFAVA-MICHELI SYNDROME 1963-77   
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006457 2006
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006457 1996
% 216.04/216.20  |- skos__hiddenLabel mesh__D006457 Cold Paroxysmal Hemoglobinuria
% 216.04/216.20  |- mesh__publicMeSHNote mesh__D006457
% 216.04/216.20       78; was MARCHIAFAVA-MICHELI SYNDROME 1963-77   
% 216.04/216.20  |- mesh__recordMaintainer mesh__D006457 PLS
% 216.04/216.20  |- skos__hiddenLabel mesh__D006457 Hemoglobinuria, Cold Paroxysmal
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006457 2004
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006457 2005
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006457 2002
% 216.04/216.20  |- skos__broader mesh__D006457smesh__D009190
% 216.04/216.20  |- skos__hiddenLabel mesh__D006457 Nocturnal Paroxysmal Hemoglobinuria
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006457 1995
% 216.04/216.20  |- skos__altLabel mesh__D006457 Paroxysmal Hemoglobinuria, Nocturnal
% 216.04/216.20  |- skos__hiddenLabel mesh__D006457 Hemoglobinuria, Nocturnal Paroxysmal
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006457 2003
% 216.04/216.20  |- mesh__dateCreated mesh__D006457 1999-01-01
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006457 1993
% 216.04/216.20  |- skos__scopeNote mesh__D006457
% 216.04/216.20       Disorder characterized by intravascular hemolysis and hemoglobinuria. Some cases occur on exposure to cold and are due to the presence of an autohemolysin in the serum. Other cases are more marked during or immediately after sleep and are considered to be due to an acquired intracorpuscular defect.%A%    
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006457 1994
% 216.04/216.20  |- skos__hiddenLabel mesh__D006457 Syndrome, Marchiafava-Micheli
% 216.04/216.20  |- mesh__recordAuthorizer mesh__D006457 PLS
% 216.04/216.20  |- skos__prefLabel mesh__D006457 Hemoglobinuria, Paroxysmal
% 216.04/216.20  |- skos__hiddenLabel mesh__D006457 Paroxysmal Hemoglobinuria
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006457 1999
% 216.04/216.20  |- skos__annotation mesh__D006457
% 216.04/216.20       also called %22%paroxysmal nocturnal hemoglobinuria%22% so ignore %22%nocturnal%22%%A%  
% 216.04/216.20  |- mesh__dateRevised mesh__D006457 1994-09-23
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006457 1992
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006457 2001
% 216.04/216.20  |- rdf__type mesh__D006457sskos__Concept
% 216.04/216.20  |- skos__broader mesh__D006457smesh__D006456
% 216.04/216.20  |- mesh__recordOriginator mesh__D006457 NLM
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006457 1997
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006457 1998
% 216.04/216.20  |- skos__hiddenLabel mesh__D006457 Marchiafava Micheli Syndrome
% 216.04/216.20  |- mesh__onlineNote mesh__D006457
% 216.04/216.20       use HEMOGLOBINURIA, PAROXYSMAL to search MARCHIAFAVA-MICHELI SYNDROME 1966-77%A%  
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006457 2000
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D020128 2002
% 216.04/216.20  |- mesh__dateEstablished mesh__D020128 1999-01-01
% 216.04/216.20  |- skos__related mesh__D020128smesh__D008826
% 216.04/216.20  |- skos__annotation mesh__D020128
% 216.04/216.20       do not confuse with LETHAL DOSE 50, determined in animals%A%  
% 216.04/216.20  |- mesh__historyNote mesh__D020128 99   
% 216.04/216.20  |- rdf__type mesh__D020128sskos__Concept
% 216.04/216.20  |- skos__prefLabel mesh__D020128 Inhibitory Concentration 50
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D020128 2006
% 216.04/216.20  |- skos__hiddenLabel mesh__D020128 Concentration 50, Inhibitory
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D020128 2001
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D020128 2004
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D020128 2000
% 216.04/216.20  |- skos__broader mesh__D020128smesh__D002620
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D020128 2005
% 216.04/216.20  |- skos__scopeNote mesh__D020128
% 216.04/216.20       The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50%25% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture.%A%    
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D020128 2003
% 216.04/216.20  |- skos__altLabel mesh__D020128 IC50
% 216.04/216.20  |- skos__hiddenLabel mesh__D020128 50, Inhibitory Concentration
% 216.04/216.20  |- skos__historyNote mesh__D020128
% 216.04/216.20       Cell Survival/drug effects %28%1971-1998%29%
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D020128 1999
% 216.04/216.20  |- mesh__dateCreated mesh__D020128 1998-06-10
% 216.04/216.20  |- skos__broader mesh__D020128smesh__D018675
% 216.04/216.20  |- mesh__publicMeSHNote mesh__D020128 99   
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D016885 2000
% 216.04/216.20  |- skos__altLabel mesh__D016885 Department of Agriculture %28%U.S.%29%
% 216.04/216.20  |- mesh__recordOriginator mesh__D016885 TGC
% 216.04/216.20  |- rdf__type mesh__D016885sskos__Concept
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D016885 2001
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D016885 2003
% 216.04/216.20  |- skos__prefLabel mesh__D016885 United States Department of Agriculture
% 216.04/216.20  |- skos__historyNote mesh__D016885 Government Agencies %28%1966-1991%29%
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D016885 2005
% 216.04/216.20  |- mesh__publicMeSHNote mesh__D016885 92   
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D016885 2004
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D016885 2002
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D016885 2006
% 216.04/216.20  |- skos__annotation mesh__D016885
% 216.04/216.20       add UNITED STATES %28%NIM%29%; research support by this agency is checked as OTHER US GOVT SUPPORT; DF: USDA      CATALOG: use NAF entry%A%  
% 216.04/216.20  |- mesh__dateRevised mesh__D016885 1997-06-20
% 216.04/216.20  |- mesh__recordAuthorizer mesh__D016885 SJN
% 216.04/216.20  |- mesh__historyNote mesh__D016885 92   
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D016885 1998
% 216.04/216.20  |- mesh__dateEstablished mesh__D016885 1992-01-01
% 216.04/216.20  |- skos__scopeNote mesh__D016885
% 216.04/216.20       A department of the United States Government concerned with improving and maintaining farm income and developing and expanding markets for agricultural products. It also helps landowners in protecting the soil, water, forest, and other natural resources. It carries out rural development and conservation programs. Through inspection and grading services it safeguards and insures standards of quality in food supply and production.%A%    
% 216.04/216.20  |- mesh__recordMaintainer mesh__D016885 PXP
% 216.04/216.20  |- skos__broader mesh__D016885smesh__D006077
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D016885 1999
% 216.04/216.20  |- mesh__dateCreated mesh__D016885 1991-05-30
% 216.04/216.20  |- skos__altLabel mesh__D016087 BIV
% 216.04/216.20  |- skos__historyNote mesh__D016087 Retroviridae %28%1987-1990%29%
% 216.04/216.20  |- skos__hiddenLabel mesh__D016087 Immunodeficiency-Like Viruses, Bovine
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D016087 2002
% 216.04/216.20  |- mesh__onlineNote mesh__D016087
% 216.04/216.20       use IMMUNODEFICIENCY VIRUS, BOVINE to search BOVINE IMMUNODEFICIENCY-LIKE VIRUS 1991-93%A%  
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D016087 2006
% 216.04/216.20  |- mesh__historyNote mesh__D016087
% 216.04/216.20       94; was BOVINE IMMUNODEFICIENCY-LIKE VIRUS 1991-93   
% 216.04/216.20  |- skos__hiddenLabel mesh__D016087 Immunodeficiency Viruses, Bovine
% 216.04/216.20  |- skos__hiddenLabel mesh__D016087 Bovine Immunodeficiency-Like Viruses
% 216.04/216.20  |- mesh__dateEstablished mesh__D016087 1991-01-01
% 216.04/216.20  |- rdf__type mesh__D016087sskos__Concept
% 216.04/216.20  |- skos__broader mesh__D016087smesh__D017960
% 216.04/216.20  |- skos__hiddenLabel mesh__D016087 Bovine Immunodeficiency Like Virus
% 216.04/216.20  |- mesh__dateRevised mesh__D016087 2001-07-25
% 216.04/216.20  |- mesh__recordOriginator mesh__D016087 AGS
% 216.04/216.20  |- skos__hiddenLabel mesh__D016087 Bovine Immunodeficiency Viruses
% 216.04/216.20  |- skos__altLabel mesh__D016087 Bovine immunodeficiency virus
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D016087 2003
% 216.04/216.20  |- mesh__recordAuthorizer mesh__D016087 sjn
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D016087 2004
% 216.04/216.20  |- skos__altLabel mesh__D016087 Bovine Immunodeficiency-Like Virus
% 216.04/216.20  |- skos__prefLabel mesh__D016087 Immunodeficiency Virus, Bovine
% 216.04/216.20  |- skos__annotation mesh__D016087
% 216.04/216.20       infection: coord IM with LENTIVIRUS INFECTIONS %28%IM%29%; DF: BIV%A%  
% 216.04/216.20  |- skos__hiddenLabel mesh__D016087 Immunodeficiency-Like Virus, Bovine
% 216.04/216.20  |- mesh__publicMeSHNote mesh__D016087
% 216.04/216.20       94; was BOVINE IMMUNODEFICIENCY-LIKE VIRUS 1991-93   
% 216.04/216.20  |- skos__scopeNote mesh__D016087
% 216.04/216.20       The type species of LENTIVIRUS, subgenus bovine lentiviruses %28%LENTIVIRUSES, BOVINE%29%, found in cattle and causing lymphadenopathy, LYMPHOCYTOSIS, central nervous system lesions, progressive weakness, and emaciation. It has immunological cross-reactivity with other lentiviruses including HIV.%A%    
% 216.04/216.20  |- mesh__recordMaintainer mesh__D016087 ags
% 216.04/216.20  |- mesh__dateCreated mesh__D016087 1990-03-23
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D016087 2005
% 216.04/216.20  |- rdf__type mesh__D002865sskos__Concept
% 216.04/216.20  |- mesh__publicMeSHNote mesh__D002865 73   
% 216.04/216.20  |- mesh__historyNote mesh__D002865 73%28%72%29%   
% 216.04/216.20  |- mesh__dateRevised mesh__D002865 2004-07-07
% 216.04/216.20  |- skos__scopeNote mesh__D002865
% 216.04/216.20       A complex of several closely related glycosidic antibiotics from Streptomyces griseus. The major component, CHROMOMYCIN A3, is used as a fluorescent stain of DNA where it attaches and inhibits RNA synthesis. It is also used as an antineoplastic agent, especially for solid tumors.%A%    
% 216.04/216.20  |- mesh__dateEstablished mesh__D002865 1973-01-01
% 216.04/216.20  |- skos__prefLabel mesh__D002865 Chromomycins
% 216.04/216.20  |- mesh__recordAuthorizer mesh__D002865 sjn
% 216.04/216.20  |- mesh__dateCreated mesh__D002865 1999-01-01
% 216.04/216.20  |- skos__broader mesh__D002865smesh__D006027
% 216.04/216.20  |- mesh__recordMaintainer mesh__D002865 ssb
% 216.04/216.20  |- skos__historyNote mesh__D002865
% 216.04/216.20       Antibiotics, Antineoplastic %28%1967-1971%29%
% 216.04/216.20  |- skos__annotation mesh__D002865 antineoplastic antibiotics   
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D002865 2006
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D002865 2005
% 216.04/216.20  |- mesh__recordOriginator mesh__D002865 NLM
% 216.04/216.20  |- mesh__dateCreated mesh__D007550 1975-07-18
% 216.04/216.20  |- skos__altLabel mesh__D007550 Isothiouronium
% 216.04/216.20  |- mesh__historyNote mesh__D007550
% 216.04/216.20       91%28%76%29%; was see under THIOUREA 1976-90   
% 216.04/216.20  |- skos__broader mesh__D007550smesh__D013890
% 216.04/216.20  |- skos__hiddenLabel mesh__D007550 AHR 1911
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D007550 2006
% 216.04/216.20  |- mesh__recordAuthorizer mesh__D007550 sjn
% 216.04/216.20  |- mesh__dateRevised mesh__D007550 2004-07-07
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D007550 2005
% 216.04/216.20  |- skos__historyNote mesh__D007550
% 216.04/216.20       Thiourea %28%1973-1974%29% /analogs %26% derivatives %28%1975%29%
% 216.04/216.20  |- mesh__dateEstablished mesh__D007550 1991-01-01
% 216.04/216.20  |- mesh__recordOriginator mesh__D007550 SH
% 216.04/216.20  |- skos__scopeNote mesh__D007550
% 216.04/216.20       An undecenyl THIOUREA which may have topical anti-inflammatory activity.%A%    
% 216.04/216.20  |- skos__historyNote mesh__D007550 Undecylenic Acids %28%1973-1975%29%
% 216.04/216.20  |- skos__hiddenLabel mesh__D007550 AHR1911
% 216.04/216.20  |- rdf__type mesh__D007550sskos__Concept
% 216.04/216.20  |- mesh__publicMeSHNote mesh__D007550 91; was see under THIOUREA 1976-90   
% 216.04/216.20  |- skos__prefLabel mesh__D007550 Isothiuronium
% 216.04/216.20  |- mesh__recordMaintainer mesh__D007550 jmp
% 216.04/216.20  |- mesh__recordAuthorizer mesh__D048169 sjn
% 216.04/216.20  |- mesh__publicMeSHNote mesh__D048169 2005   
% 216.04/216.20  |- mesh__recordOriginator mesh__D048169 ags
% 216.04/216.20  |- mesh__dateCreated mesh__D048169 2004-07-07
% 216.04/216.20  |- skos__historyNote mesh__D048169 Anopheles %28%1965-2004%29%
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D048169 2005
% 216.04/216.20  |- skos__prefLabel mesh__D048169 Anopheles gambiae
% 216.04/216.20  |- mesh__historyNote mesh__D048169 2005   
% 216.04/216.20  |- mesh__dateEstablished mesh__D048169 2005-01-01
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D048169 2006
% 216.04/216.20  |- rdf__type mesh__D048169sskos__Concept
% 216.04/216.20  |- skos__scopeNote mesh__D048169
% 216.04/216.20       A species of mosquito in the genus Anopheles and the principle vector of MALARIA in Africa.%A%    
% 216.04/216.20  |- mesh__recordMaintainer mesh__D048169 ags
% 216.04/216.20  |- skos__broader mesh__D048169smesh__D000852
% 216.04/216.20  |- mesh__dateEstablished mesh__D012495 1988-01-01
% 216.04/216.20  |- rdf__type mesh__D012495sskos__Concept
% 216.04/216.20  |- mesh__recordMaintainer mesh__D012495 PXP
% 216.04/216.20  |- mesh__recordAuthorizer mesh__D012495 SJN
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D012495 1998
% 216.04/216.20  |- skos__prefLabel mesh__D012495 San Francisco
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D012495 2000
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D012495 1999
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D012495 2003
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D012495 2001
% 216.04/216.20  |- mesh__recordOriginator mesh__D012495 EC
% 216.04/216.20  |- skos__broader mesh__D012495smesh__D002140
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D012495 2005
% 216.04/216.20  |- mesh__dateCreated mesh__D012495 1987-02-27
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D012495 2004
% 216.04/216.20  |- mesh__dateRevised mesh__D012495 1997-06-20
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D012495 2006
% 216.04/216.20  |- skos__broader mesh__D012495smesh__D002947
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D012495 2002
% 216.04/216.20  |- mesh__historyNote mesh__D012495 88   
% 216.04/216.20  |- mesh__recordAuthorizer mesh__D020927 sjn
% 216.04/216.20  |- skos__scopeNote mesh__D020927
% 216.04/216.20       A selective inhibitor of RECEPTORS, ADRENERGIC ALPHA-2 that has analgesic and sedative properties. MEDETOMIDINE is the other racemic form.%A%    
% 216.04/216.20  |- mesh__dateCreated mesh__D020927 1999-11-09
% 216.04/216.20  |- mesh__dateEstablished mesh__D020927 2000-01-01
% 216.04/216.20  |- mesh__recordOriginator mesh__D020927 adp
% 216.04/216.20  |- mesh__publicMeSHNote mesh__D020927
% 216.04/216.20       2000; MEDETOMIDINE %28%now DEXMEDETOMIDINE%29% was indexed under  IMIDAZOLES 1990-1999%A%  
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D020927 2006
% 216.04/216.20  |- skos__hiddenLabel mesh__D020927 Hydrochloride, Dexmedetomidine
% 216.04/216.20  |- skos__hiddenLabel mesh__D020927 MPV1440
% 216.04/216.20  |- mesh__dateRevised mesh__D020927 2005-06-30
% 216.04/216.20  |- rdf__type mesh__D020927sskos__Concept
% 216.04/216.20  |- mesh__historyNote mesh__D020927
% 216.04/216.20       2000; use DEXMEDETOMIDINE %28%NM%29% 1990-1999   
% 216.04/216.20  |- skos__hiddenLabel mesh__D020927 MPV 1440
% 216.04/216.20  |- mesh__recordMaintainer mesh__D020927 ssb
% 216.04/216.20  |- skos__prefLabel mesh__D020927 Dexmedetomidine
% 216.04/216.20  |- skos__historyNote mesh__D020927 Imidazoles %28%1990-1999%29%
% 216.04/216.20  |- skos__broader mesh__D020927smesh__D007093
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006458 2000
% 216.04/216.20  |- skos__broader mesh__D006458smesh__D000825
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006458 2006
% 216.04/216.20  |- skos__scopeNote mesh__D006458
% 216.04/216.20       The blood/lymphlike nutrient fluid of some invertebrates.%A%    
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006458 2003
% 216.04/216.20  |- mesh__dateCreated mesh__D006458 1999-01-01
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006458 2001
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006458 2004
% 216.04/216.20  |- mesh__recordOriginator mesh__D006458 NLM
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006458 2002
% 216.04/216.20  |- mesh__dateRevised mesh__D006458 1999-11-03
% 216.04/216.20  |- mesh__recordAuthorizer mesh__D006458 sjn
% 216.04/216.20  |- skos__annotation mesh__D006458
% 216.04/216.20       coord substance in hemolymph with substance /blood   
% 216.04/216.20  |- mesh__recordMaintainer mesh__D006458 KEV
% 216.04/216.20  |- rdf__type mesh__D006458sskos__Concept
% 216.04/216.20  |- skos__hiddenLabel mesh__D006458 Hemolymphs
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D006458 2005
% 216.04/216.20  |- skos__prefLabel mesh__D006458 Hemolymph
% 216.04/216.20  |- skos__annotation mesh__D017180
% 216.04/216.20       originates below the bundle of His: do not confuse with TACHYCARDIA, SUPRAVENTRICULAR which originates above the bundle of His%A%  
% 216.04/216.20  |- mesh__recordOriginator mesh__D017180 TGC
% 216.04/216.20  |- mesh__recordMaintainer mesh__D017180 NDW
% 216.04/216.20  |- rdf__type mesh__D017180sskos__Concept
% 216.04/216.20  |- skos__historyNote mesh__D017180 Tachycardia %28%1966-1992%29%
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D017180 2000
% 216.04/216.20  |- skos__broader mesh__D017180smesh__D013610
% 216.04/216.20  |- mesh__historyNote mesh__D017180 93   
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D017180 2001
% 216.04/216.20  |- mesh__recordAuthorizer mesh__D017180 sjn
% 216.04/216.20  |- skos__hiddenLabel mesh__D017180 Tachycardias, Ventricular
% 216.04/216.20  |- mesh__publicMeSHNote mesh__D017180 93   
% 216.04/216.20  |- mesh__dateRevised mesh__D017180 1999-11-03
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D017180 2003
% 216.04/216.20  |- skos__hiddenLabel mesh__D017180 Ventricular Tachycardias
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D017180 2005
% 216.04/216.20  |- mesh__dateCreated mesh__D017180 1992-05-22
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D017180 2004
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D017180 2002
% 216.04/216.20  |- mesh__dateEstablished mesh__D017180 1993-01-01
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D017180 2006
% 216.04/216.20  |- skos__hiddenLabel mesh__D017180 Ventricular Tachycardia
% 216.04/216.20  |- skos__prefLabel mesh__D017180 Tachycardia, Ventricular
% 216.04/216.20  |- skos__scopeNote mesh__D017180
% 216.04/216.20       An abnormally rapid ventricular rhythm with wide QRS complexes, usually in excess of 150 per minute. It is generated within the ventricle, below the BUNDLE OF HIS, and is most commonly associated with atrioventricular dissociation.%A%    
% 216.04/216.20  |- skos__altLabel mesh__D003160 Comparative Studies
% 216.04/216.20  |- mesh__dateCreated mesh__D003160 1999-01-01
% 216.04/216.20  |- skos__altLabel mesh__D003160 Comparative Study %5B%Publication Type%5D%
% 216.04/216.20  |- mesh__recordMaintainer mesh__D003160 jls
% 216.04/216.20  |- mesh__recordAuthorizer mesh__D003160 sjn
% 216.04/216.20  |- skos__altLabel mesh__D003160 Comparative Study %5B%Pub Type%5D%
% 216.04/216.20  |- skos__prefLabel mesh__D003160 Comparative Study
% 216.04/216.20  |- mesh__recordOriginator mesh__D003160 NLM
% 216.04/216.20  |- skos__broader mesh__D003160smesh__D052182
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D003160 2006
% 216.04/216.20  |- skos__annotation mesh__D003160
% 216.04/216.20       do not use for comparison of subject %26% normal controls; differentiate from the specialties  ANATOMY, COMPARATIVE; HISTOLOGY, COMPARATIVE; etc%A%  
% 216.04/216.20  |- mesh__historyNote mesh__D003160
% 216.04/216.20       1966; restricted to comparison of drugs or technics only 1966-1973%A%  
% 216.04/216.20  |- mesh__dateRevised mesh__D003160 2005-06-30
% 216.04/216.20  |- skos__altLabel mesh__D003160 Comparative Study %5B%PT%5D%
% 216.04/216.20  |- rdf__type mesh__D003160sskos__Concept
% 216.04/216.20  |- skos__broader mesh__D016088smesh__D017972
% 216.04/216.20  |- skos__altLabel mesh__D016088 Virus, Caprine Arthritis-Encephalitis
% 216.04/216.20  |- skos__hiddenLabel mesh__D016088 Arthritis Encephalitis Virus, Caprine
% 216.04/216.20  |- mesh__dateEstablished mesh__D016088 1991-01-01
% 216.04/216.20  |- rdf__type mesh__D016088sskos__Concept
% 216.04/216.20  |- skos__hiddenLabel mesh__D016088 Caprine arthritis encephalitis virus
% 216.04/216.20  |- mesh__dateCreated mesh__D016088 1990-06-07
% 216.04/216.20  |- mesh__historyNote mesh__D016088
% 216.04/216.20       94; was CAPRINE ARTHRITIS-ENCEPHALITIS VIRUS 1991-93   
% 216.04/216.20  |- skos__scopeNote mesh__D016088
% 216.04/216.20       A species of LENTIVIRUS, subgenus ovine-caprine lentiviruses %28%LENTIVIRUSES, OVINE-CAPRINE%29%, closely related to VISNA-MAEDI VIRUS and causing acute encephalomyelitis; chronic arthritis; PNEUMONIA; MASTITIS; and GLOMERULONEPHRITIS in goats. It is transmitted mainly in the colostrum and milk.%A%    
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D016088 2002
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D016088 2003
% 216.04/216.20  |- mesh__dateRevised mesh__D016088 2005-07-27
% 216.04/216.20  |- skos__altLabel mesh__D016088 Caprine arthritis-encephalitis virus
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D016088 2004
% 216.04/216.20  |- skos__hiddenLabel mesh__D016088 Arthritis Encephalitis Viruses, Caprine
% 216.04/216.20  |- skos__altLabel mesh__D016088 CAEV
% 216.04/216.20  |- mesh__onlineNote mesh__D016088
% 216.04/216.20       use ARTHRITIS-ENCEPHALITIS VIRUS, CAPRINE to search CAPRINE ARTHRITIS-ENCEPHALITIS VIRUS 1991-93%A%  
% 216.04/216.20  |- skos__historyNote mesh__D016088 Retroviridae %28%1983-1990%29%
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D016088 2006A
% 216.04/216.20  |- mesh__recordOriginator mesh__D016088 AGS
% 216.04/216.20  |- mesh__recordMaintainer mesh__D016088 ags
% 216.04/216.20  |- mesh__recordAuthorizer mesh__D016088 ags
% 216.04/216.20  |- skos__altLabel mesh__D016088 Arthritis-Encephalitis Viruses, Caprine
% 216.04/216.20  |- skos__historyNote mesh__D016088 Visna Virus %28%1983-1990%29%
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D016088 2005
% 216.04/216.20  |- skos__altLabel mesh__D016088 Viruses, Caprine Arthritis-Encephalitis
% 216.04/216.20  |- skos__hiddenLabel mesh__D016088 Caprine Arthritis Encephalitis Viruses
% 216.04/216.20  |- skos__annotation mesh__D016088
% 216.04/216.20       infection: coord IM with LENTIVIRUS INFECTIONS %28%IM%29%; DF: CAEV%A%  
% 216.04/216.20  |- skos__altLabel mesh__D016088 Caprine Arthritis-Encephalitis Viruses
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D016088 2006
% 216.04/216.20  |- mesh__publicMeSHNote mesh__D016088
% 216.04/216.20       94; was CAPRINE ARTHRITIS-ENCEPHALITIS VIRUS 1991-93   
% 216.04/216.20  |- skos__prefLabel mesh__D016088 Arthritis-Encephalitis Virus, Caprine
% 216.04/216.20  |- rdf__type mesh__D002866sskos__Concept
% 216.04/216.20  |- skos__altLabel mesh__D002866 Carbocromen
% 216.04/216.20  |- skos__altLabel mesh__D002866 Carbochromene
% 216.04/216.20  |- mesh__dateCreated mesh__D002866 1974-11-19
% 216.04/216.20  |- skos__hiddenLabel mesh__D002866 Hydrochloride, Chromonar
% 216.04/216.20  |- mesh__recordOriginator mesh__D002866 NLM
% 216.04/216.20  |- skos__historyNote mesh__D002866 Glycolates %28%1970-1974%29%
% 216.04/216.20  |- mesh__dateRevised mesh__D002866 2005-06-30
% 216.04/216.20  |- skos__historyNote mesh__D002866 Coumarins %28%1970-1974%29%
% 216.04/216.20  |- mesh__dateEstablished mesh__D002866 1991-01-01
% 216.04/216.20  |- skos__historyNote mesh__D002866 Diethylamines %28%1974%29%
% 216.04/216.20  |- skos__altLabel mesh__D002866 Carbocromene
% 216.04/216.20  |- mesh__activeMeSHYear mesh__D002866 2006
% 216.04/216.20  |- skos__prefLabel mesh__D002866 Chromonar
% 216.04/216.20  |- mesh__historyNote mesh__D002866
% 216.04/216.20       91%28%75%29%; was see under COUMARINS 1975-90   
% 216.04/216.21  |- mesh__recordAuthorizer mesh__D002866 sjn
% 216.04/216.21  |- mesh__recordMaintainer mesh__D002866 ssb
% 216.04/216.21  |- skos__scopeNote mesh__D002866 A coronary vasodilator agent.     
% 216.04/216.21  |- skos__altLabel mesh__D002866 Carbochromen
% 216.04/216.21  |- mesh__publicMeSHNote mesh__D002866
% 216.04/216.21       91; was see under COUMARINS 1975-90   
% 216.04/216.21  |- skos__broader mesh__D002866smesh__D003374
% 216.04/216.21  |- skos__scopeNote mesh__D007551
% 216.04/216.21       Muscle contraction with negligible change in the force of contraction but shortening of the distance between the origin and insertion.%A%    
% 216.04/216.21  |- mesh__dateEstablished mesh__D007551 1991-01-01
% 216.04/216.21  |- mesh__dateRevised mesh__D007551 2003-07-09
% 216.04/216.21  |- mesh__historyNote mesh__D007551
% 216.04/216.21       91%28%84%29%; was see under MUSCLE CONTRACTION 1984-90   
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D007551 2005
% 216.04/216.21  |- mesh__recordOriginator mesh__D007551 RC
% 216.04/216.21  |- skos__historyNote mesh__D007551 Muscle Contraction %28%1966-1983%29%
% 216.04/216.21  |- mesh__publicMeSHNote mesh__D007551
% 216.04/216.21       91; was see under MUSCLE CONTRACTION 1984-90   
% 216.04/216.21  |- skos__annotation mesh__D007551
% 216.04/216.21       do not confuse with ISOMETRIC CONTRACTION   
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D007551 2006
% 216.04/216.21  |- skos__hiddenLabel mesh__D007551 Contraction, Isotonic
% 216.04/216.21  |- skos__hiddenLabel mesh__D007551 Isotonic Contractions
% 216.04/216.21  |- skos__broader mesh__D007551smesh__D009119
% 216.04/216.21  |- mesh__recordMaintainer mesh__D007551 nns
% 216.04/216.21  |- skos__historyNote mesh__D007551 Muscles %28%1966-1983%29%
% 216.04/216.21  |- mesh__dateCreated mesh__D007551 1983-06-15
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D007551 2004
% 216.04/216.21  |- skos__hiddenLabel mesh__D007551 Contractions, Isotonic
% 216.04/216.21  |- rdf__type mesh__D007551sskos__Concept
% 216.04/216.21  |- skos__prefLabel mesh__D007551 Isotonic Contraction
% 216.04/216.21  |- mesh__recordAuthorizer mesh__D007551 sjn
% 216.04/216.21  |- skos__scopeNote mesh__D048968
% 216.04/216.21       Symptoms of NAUSEA and VOMITING in pregnant women that usually occur in the morning during the first 2 to 3 months of PREGNANCY. Severe persistent vomiting during pregnancy is called HYPEREMESIS GRAVIDARUM.%A%    
% 216.04/216.21  |- mesh__historyNote mesh__D048968 2005   
% 216.04/216.21  |- skos__historyNote mesh__D048968 Nausea %28%1968-2004%29%
% 216.04/216.21  |- skos__historyNote mesh__D048968 Vomiting %28%1968-2004%29%
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D048968 2006
% 216.04/216.21  |- mesh__dateCreated mesh__D048968 2004-07-07
% 216.04/216.21  |- skos__broader mesh__D048968smesh__D014839
% 216.04/216.21  |- mesh__recordMaintainer mesh__D048968 lkt
% 216.04/216.21  |- rdf__type mesh__D048968sskos__Concept
% 216.04/216.21  |- skos__prefLabel mesh__D048968 Morning Sickness
% 216.04/216.21  |- mesh__dateEstablished mesh__D048968 2005-01-01
% 216.04/216.21  |- mesh__recordOriginator mesh__D048968 lkt
% 216.04/216.21  |- skos__annotation mesh__D048968 check tags FEMALE %26% PREGNANCY   
% 216.04/216.21  |- mesh__publicMeSHNote mesh__D048968 2005   
% 216.04/216.21  |- skos__hiddenLabel mesh__D048968 Sickness, Morning
% 216.04/216.21  |- skos__broader mesh__D048968smesh__D011248
% 216.04/216.21  |- mesh__dateRevised mesh__D048968 2005-06-30
% 216.04/216.21  |- mesh__recordAuthorizer mesh__D048968 sjn
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D012496 1998
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D012496 2002
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D012496 1997
% 216.04/216.21  |- mesh__recordOriginator mesh__D012496 NLM
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D012496 1999
% 216.04/216.21  |- mesh__recordAuthorizer mesh__D012496 PLS
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D012496 2003
% 216.04/216.21  |- skos__prefLabel mesh__D012496 San Marino
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D012496 2005
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D012496 2004
% 216.04/216.21  |- mesh__dateCreated mesh__D012496 1999-01-01
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D012496 2006
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D012496 2000
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D012496 2001
% 216.04/216.21  |- mesh__recordMaintainer mesh__D012496 KEV
% 216.04/216.21  |- skos__broader mesh__D012496smesh__D005060
% 216.04/216.21  |- mesh__dateRevised mesh__D012496 1995-05-23
% 216.04/216.21  |- rdf__type mesh__D012496sskos__Concept
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D012496 1996
% 216.04/216.21  |- skos__scopeNote mesh__D020928
% 216.04/216.21       A superfamily of PROTEIN-SERINE-THREONINE KINASES that are activated by diverse stimuli via protein kinase cascades. They are the final components of the cascades, activated by phosphorylation by MITOGEN-ACTIVATED PROTEIN KINASE KINASES which in turn are activated by mitogen-activated protein kinase kinase kinases %28%MAP KINASE KINASE KINASES%29%.%A%    
% 216.04/216.21  |- skos__annotation mesh__D020928 DF: ERKS   
% 216.04/216.21  |- skos__hiddenLabel mesh__D020928 Protein Kinases, Mitogen-Activated
% 216.04/216.21  |- mesh__dateEstablished mesh__D020928 2000-01-01
% 216.04/216.21  |- skos__historyNote mesh__D020928
% 216.04/216.21       Ca%28%2+%29%-Calmodulin Dependent Protein Kinase %28%1994-1999%29%
% 216.04/216.21  |- skos__hiddenLabel mesh__D020928 Kinases, Mitogen-Activated Protein
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D020928 2006
% 216.04/216.21  |- skos__hiddenLabel mesh__D020928 Mitogen Activated Protein Kinases
% 216.04/216.21  |- mesh__dateCreated mesh__D020928 1999-11-03
% 216.04/216.21  |- rdf__type mesh__D020928sskos__Concept
% 216.04/216.21  |- skos__historyNote mesh__D020928 Protein Kinases %28%1989-1999%29%
% 216.04/216.21  |- mesh__recordOriginator mesh__D020928 nns
% 216.04/216.21  |- skos__historyNote mesh__D020928
% 216.04/216.21       Protein-Serine-Threonine Kinases %28%1993-1999%29%
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D020928 2005
% 216.04/216.21  |- mesh__recordAuthorizer mesh__D020928 sjn
% 216.04/216.21  |- mesh__publicMeSHNote mesh__D020928
% 216.04/216.21       2000; for EXTRACELLULAR SIGNAL-REGULATED KINASES see CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1994-1999%A%  
% 216.04/216.21  |- mesh__dateRevised mesh__D020928 2004-07-07
% 216.04/216.21  |- skos__prefLabel mesh__D020928 Mitogen-Activated Protein Kinases
% 216.04/216.21  |- mesh__historyNote mesh__D020928
% 216.04/216.21       2000; for EXTRACELLULAR SIGNAL-REGULATED KINASES use  CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1994-1999%A%  
% 216.04/216.21  |- skos__broader mesh__D020928smesh__D038461
% 216.04/216.21  |- mesh__recordMaintainer mesh__D020928 jmp
% 216.04/216.21  |- skos__historyNote mesh__D020928
% 216.04/216.21       Protein-Tyrosine Kinase %28%1989-1999%29%
% 216.04/216.21  |- skos__related mesh__D020928smesh__D020935
% 216.04/216.21  |- skos__broader mesh__D020928smesh__D047908
% 216.04/216.21  |- skos__broader mesh__D020928smesh__D017346
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D031650 2006
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D031650 2003
% 216.04/216.21  |- mesh__dateCreated mesh__D031650 2002-07-03
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D031650 2004
% 216.04/216.21  |- mesh__dateEstablished mesh__D031650 2003-01-01
% 216.04/216.21  |- skos__prefLabel mesh__D031650 Melaleuca
% 216.04/216.21  |- skos__altLabel mesh__D031650 Niaouli
% 216.04/216.21  |- mesh__historyNote mesh__D031650 2003   
% 216.04/216.21  |- mesh__publicMeSHNote mesh__D031650 2003   
% 216.04/216.21  |- rdf__type mesh__D031650sskos__Concept
% 216.04/216.21  |- skos__annotation mesh__D031650
% 216.04/216.21       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.04/216.21  |- skos__broader mesh__D031650smesh__D027822
% 216.04/216.21  |- skos__altLabel mesh__D031650 Cajuput
% 216.04/216.21  |- skos__scopeNote mesh__D031650
% 216.04/216.21       A plant genus of the family MYRTACEAE. M. alternifolia foliage is a source of TEA TREE OIL. The common name of tea tree also refers to LEPTOSPERMUM or KUNZEA. M. vindifolia is a source of niaouli oil. M. cajuputi and M. leucadendra are sources of cajuput oil.%A%    
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D031650 2005
% 216.04/216.21  |- skos__historyNote mesh__D006459 Hemolysins %28%1966-1977%29%
% 216.04/216.21  |- skos__hiddenLabel mesh__D006459 Factors, Hemolysin
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D006459 2004
% 216.04/216.21  |- skos__broader mesh__D006459smesh__D010957
% 216.04/216.21  |- skos__historyNote mesh__D006459 Plasmids %28%1966-1977%29%
% 216.04/216.21  |- mesh__dateRevised mesh__D006459 2003-07-09
% 216.04/216.21  |- skos__prefLabel mesh__D006459 Hemolysin Factors
% 216.04/216.21  |- mesh__dateEstablished mesh__D006459 1991-01-01
% 216.04/216.21  |- mesh__dateCreated mesh__D006459 1977-05-09
% 216.04/216.21  |- skos__scopeNote mesh__D006459
% 216.04/216.21       Plasmids controlling the synthesis of hemolysin by bacteria.%A%    
% 216.04/216.21  |- mesh__recordMaintainer mesh__D006459 nns
% 216.04/216.21  |- skos__hiddenLabel mesh__D006459 Factors, Hly
% 216.04/216.21  |- rdf__type mesh__D006459sskos__Concept
% 216.04/216.21  |- mesh__publicMeSHNote mesh__D006459 91; was see under PLASMIDS 1978-90   
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D006459 2005
% 216.04/216.21  |- mesh__recordAuthorizer mesh__D006459 sjn
% 216.04/216.21  |- mesh__historyNote mesh__D006459
% 216.04/216.21       91%28%78%29%; was see under PLASMIDS 1978-90   
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D006459 2006
% 216.04/216.21  |- skos__altLabel mesh__D006459 Hly Factors
% 216.04/216.21  |- mesh__recordOriginator mesh__D006459 AEP
% 216.04/216.21  |- rdf__type mesh__D017181sskos__Concept
% 216.04/216.21  |- mesh__dateEstablished mesh__D017181 1993-01-01
% 216.04/216.21  |- mesh__historyNote mesh__D017181 93   
% 216.04/216.21  |- skos__broader mesh__D017181smesh__D009854
% 216.04/216.21  |- mesh__recordMaintainer mesh__D017181 ags
% 216.04/216.21  |- skos__annotation mesh__D017181
% 216.04/216.21       infection: coord IM with ONCHOCERCIASIS %28%IM%29%; coord with specific helminth term %28%ANTIGENS, HELMINTH, etc%29% if pertinent; /drug eff: consider FILARICIDES%A%  
% 216.04/216.21  |- skos__historyNote mesh__D017181 Onchocerca %28%1966-1992%29%
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D017181 2005
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D017181 2004
% 216.04/216.21  |- mesh__dateRevised mesh__D017181 2003-07-09
% 216.04/216.21  |- skos__scopeNote mesh__D017181
% 216.04/216.21       A species of parasitic nematodes widely distributed throughout central Africa and also found in northern South America, southern Mexico, and Guatemala. Its intermediate host and vector is the blackfly or buffalo gnat.%A%    
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D017181 2006
% 216.04/216.21  |- mesh__publicMeSHNote mesh__D017181 93   
% 216.04/216.21  |- mesh__recordAuthorizer mesh__D017181 sjn
% 216.04/216.21  |- mesh__recordOriginator mesh__D017181 PXP
% 216.04/216.21  |- mesh__dateCreated mesh__D017181 1992-05-22
% 216.04/216.21  |- skos__prefLabel mesh__D017181 Onchocerca volvulus
% 216.04/216.21  |- mesh__onlineNote mesh__D003161
% 216.04/216.21       use COMPARTMENT SYNDROMES to search VOLKMANN%27%S CONTRACTURE 1966-80%A%  
% 216.04/216.21  |- skos__hiddenLabel mesh__D003161 Contracture, Volkmann
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D003161 2006
% 216.04/216.21  |- skos__prefLabel mesh__D003161 Compartment Syndromes
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D003161 2000
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D003161 1996
% 216.04/216.21  |- mesh__dateEstablished mesh__D003161 1981-01-01
% 216.04/216.21  |- mesh__recordMaintainer mesh__D003161 TGC
% 216.04/216.21  |- skos__historyNote mesh__D003161 Muscular Diseases %28%1966-1980%29%
% 216.04/216.21  |- skos__annotation mesh__D003161
% 216.04/216.21       increased pressure within a space causing various disord of circ %26% funct%A%  
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D003161 2003
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D003161 1997
% 216.04/216.21  |- skos__historyNote mesh__D003161 Ischemia %28%1966-1980%29%
% 216.04/216.21  |- skos__hiddenLabel mesh__D003161 Syndrome, Compartment
% 216.04/216.21  |- mesh__recordOriginator mesh__D003161 RC
% 216.04/216.21  |- skos__historyNote mesh__D003161
% 216.04/216.21       Anterior Compartment Syndrome %28%1972-1980%29%
% 216.04/216.21  |- skos__hiddenLabel mesh__D003161 Compartment Syndrome
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D003161 2001
% 216.04/216.21  |- rdf__type mesh__D003161sskos__Concept
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D003161 2004
% 216.04/216.21  |- mesh__dateCreated mesh__D003161 1980-05-14
% 216.04/216.21  |- skos__scopeNote mesh__D003161
% 216.04/216.21       Conditions in which increased pressure within a limited space compromises the circulation and function of tissue within that space. Compartmentation involves mainly the leg but also involved are the forearm, arm, thigh, shoulder, and buttock. Some of the causes of increased pressure are trauma, tight dressings, hemorrhage, and exercise. Sequelae include nerve compression, paralysis, and contracture.%A%    
% 216.04/216.21  |- mesh__recordAuthorizer mesh__D003161 PLS
% 216.04/216.21  |- mesh__dateRevised mesh__D003161 1994-05-24
% 216.04/216.21  |- skos__hiddenLabel mesh__D003161 Syndromes, Compartment
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D003161 1995
% 216.04/216.21  |- skos__broader mesh__D003161smesh__D009135
% 216.04/216.21  |- mesh__publicMeSHNote mesh__D003161
% 216.04/216.21       81; VOLKMANN CONTRACTURE was heading VOLKMANN%27%S CONTRACTURE 1963-80%A%  
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D003161 2002
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D003161 1998
% 216.04/216.21  |- skos__related mesh__D003161smesh__D009408
% 216.04/216.21  |- mesh__historyNote mesh__D003161
% 216.04/216.21       81; VOLKMANN CONTRACTURE was heading VOLKMANN%27%S CONTRACTURE 1963-80%A%  
% 216.04/216.21  |- skos__broader mesh__D003161smesh__D007511
% 216.04/216.21  |- skos__historyNote mesh__D003161 Muscles %28%1966-1980%29%
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D003161 2005
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D003161 1999
% 216.04/216.21  |- skos__hiddenLabel mesh__D016887 Resuscitations, Mouth-to-Mouth
% 216.04/216.21  |- skos__related mesh__D016887smesh__D006323
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D016887 2006
% 216.04/216.21  |- skos__scopeNote mesh__D016887
% 216.04/216.21       The artificial substitution of heart and lung action as indicated for HEART ARREST resulting from electric shock, DROWNING, respiratory arrest, or other causes. The two major components of cardiopulmonary resuscitation are artificial ventilation %28%RESPIRATION, ARTIFICIAL%29% and closed-chest CARDIAC MASSAGE.%A%    
% 216.04/216.21  |- skos__altLabel mesh__D016887 Cardio-Pulmonary Resuscitation
% 216.04/216.21  |- skos__historyNote mesh__D016887 Resuscitation %28%1971-1991%29%
% 216.04/216.21  |- mesh__recordOriginator mesh__D016887 MXR
% 216.04/216.21  |- mesh__dateEstablished mesh__D016887 1992-01-01
% 216.04/216.21  |- skos__broader mesh__D016887smesh__D012151
% 216.04/216.21  |- mesh__dateRevised mesh__D016887 2005-06-30
% 216.04/216.21  |- mesh__onlineNote mesh__D016887
% 216.04/216.21       use RESUSCITATION to search CARDIOPULMONARY RESUSCITATION 1978-91 %26% MOUTH-TO-MOUTH RESUSCITATION 1990-91%A%  
% 216.04/216.21  |- skos__hiddenLabel mesh__D016887 Resuscitation, Cardiopulmonary
% 216.04/216.21  |- rdf__type mesh__D016887sskos__Concept
% 216.04/216.21  |- skos__hiddenLabel mesh__D016887 Resuscitation, Cardio-Pulmonary
% 216.04/216.21  |- mesh__recordAuthorizer mesh__D016887 sjn
% 216.04/216.21  |- skos__altLabel mesh__D016887 CPR
% 216.04/216.21  |- mesh__dateCreated mesh__D016887 1991-05-30
% 216.04/216.21  |- skos__hiddenLabel mesh__D016887 Cardio Pulmonary Resuscitation
% 216.04/216.21  |- skos__hiddenLabel mesh__D016887 Mouth-to-Mouth Resuscitations
% 216.04/216.21  |- skos__prefLabel mesh__D016887 Cardiopulmonary Resuscitation
% 216.04/216.21  |- skos__hiddenLabel mesh__D016887 Mouth to Mouth Resuscitation
% 216.04/216.21  |- skos__hiddenLabel mesh__D016887 Resuscitation, Mouth-to-Mouth
% 216.04/216.21  |- skos__altLabel mesh__D016887 Life Support, Basic Cardiac
% 216.04/216.21  |- mesh__recordMaintainer mesh__D016887 nns
% 216.04/216.21  |- mesh__historyNote mesh__D016887
% 216.04/216.21       92; was see RESUSCITATION 1978-91; MOUTH-TO-MOUTH RESUSCITATION was see RESUSCITATION 1990-91%A%  
% 216.04/216.21  |- mesh__publicMeSHNote mesh__D016887
% 216.04/216.21       92; was see RESUSCITATION 1978-91; MOUTH-TO-MOUTH RESUSCITATION was see RESUSCITATION 1990-91%A%  
% 216.04/216.21  |- skos__hiddenLabel mesh__D016089 T-Lymphotropic Virus, Feline
% 216.04/216.21  |- skos__hiddenLabel mesh__D016089 T-Lymphotropic Lentivirus, Feline
% 216.04/216.21  |- skos__altLabel mesh__D016089 Lentivirus, Puma
% 216.04/216.21  |- skos__annotation mesh__D016089
% 216.04/216.21       infection: coord IM with LENTIVIRUS INFECTIONS %28%IM%29% or FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME %28%IM%29% if so specified by author; DF: FIV%A%  
% 216.04/216.21  |- skos__broader mesh__D016089smesh__D017969
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D016089 2006
% 216.04/216.21  |- skos__scopeNote mesh__D016089
% 216.04/216.21       A species of LENTIVIRUS, subgenus feline lentiviruses %28%LENTIVIRUSES, FELINE%29% isolated from cats with a chronic wasting syndrome, presumed to be immune deficiency. There are 3 strains: Petaluma %28%FIP-P%29%, Oma %28%FIP-O%29% and Puma lentivirus %28%PLV%29%. There is no antigenic relationship between FIV and HIV, nor does FIV grow in human T-cells.%A%    
% 216.04/216.21  |- mesh__recordMaintainer mesh__D016089 sjn
% 216.04/216.21  |- mesh__dateCreated mesh__D016089 1990-03-23
% 216.04/216.21  |- mesh__recordAuthorizer mesh__D016089 sjn
% 216.04/216.21  |- skos__hiddenLabel mesh__D016089 Feline Immunodeficiency Viruses
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D016089 2005
% 216.04/216.21  |- mesh__historyNote mesh__D016089
% 216.04/216.21       94; was FELINE IMMUNODEFICIENCY VIRUS 1991-93   
% 216.04/216.21  |- skos__historyNote mesh__D016089 Retroviridae %28%1987-1990%29%
% 216.04/216.21  |- skos__altLabel mesh__D016089 FTLV
% 216.04/216.21  |- skos__altLabel mesh__D016089 Feline T-Lymphotropic Virus
% 216.04/216.21  |- mesh__recordOriginator mesh__D016089 AGS
% 216.04/216.21  |- rdf__type mesh__D016089sskos__Concept
% 216.04/216.21  |- skos__hiddenLabel mesh__D016089 Feline T Lymphotropic Lentivirus
% 216.04/216.21  |- skos__prefLabel mesh__D016089 Immunodeficiency Virus, Feline
% 216.04/216.21  |- skos__altLabel mesh__D016089 Feline Immunodeficiency Virus
% 216.04/216.21  |- mesh__publicMeSHNote mesh__D016089
% 216.04/216.21       94; was FELINE IMMUNODEFICIENCY VIRUS 1991-93   
% 216.04/216.21  |- mesh__dateEstablished mesh__D016089 1991-01-01
% 216.04/216.21  |- skos__altLabel mesh__D016089 Feline T-Lymphotropic Lentivirus
% 216.04/216.21  |- mesh__onlineNote mesh__D016089
% 216.04/216.21       use IMMUNODEFICIENCY VIRUS, FELINE to search FELINE IMMUNODEFICIENCY VIRUS 1991-93%A%  
% 216.04/216.21  |- skos__hiddenLabel mesh__D016089 Lentivirus, Feline T-Lymphotropic
% 216.04/216.21  |- skos__altLabel mesh__D016089 FIV
% 216.04/216.21  |- skos__hiddenLabel mesh__D016089 Feline T Lymphotropic Virus
% 216.04/216.21  |- mesh__dateRevised mesh__D016089 2004-07-13
% 216.04/216.21  |- rdf__type mesh__D002867sskos__Concept
% 216.04/216.21  |- mesh__recordAuthorizer mesh__D002867 sjn
% 216.04/216.21  |- skos__broader mesh__D002867smesh__D001578
% 216.04/216.21  |- skos__prefLabel mesh__D002867 Chromones
% 216.04/216.21  |- mesh__recordOriginator mesh__D002867 NLM
% 216.04/216.21  |- skos__hiddenLabel mesh__D002867 1,4 Benzopyrones
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D002867 2006
% 216.04/216.21  |- mesh__dateRevised mesh__D002867 2005-06-30
% 216.04/216.21  |- skos__annotation mesh__D002867 do not confuse with CHROMANS   
% 216.04/216.21  |- skos__altLabel mesh__D002867 1,4-Benzopyrones
% 216.04/216.21  |- mesh__recordMaintainer mesh__D002867 ssb
% 216.04/216.21  |- mesh__dateCreated mesh__D002867 1999-01-01
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D002069 2001
% 216.04/216.21  |- skos__scopeNote mesh__D002069
% 216.04/216.21       A benzocycloheptapyridoisoquinolinol that has been used as an antipsychotic, especially in schizophrenia.%A%    
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D002069 2005
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D002069 2002
% 216.04/216.21  |- mesh__dateCreated mesh__D002069 1977-04-22
% 216.04/216.21  |- skos__prefLabel mesh__D002069 Butaclamol
% 216.04/216.21  |- mesh__historyNote mesh__D002069
% 216.04/216.21       91%28%78%29%; was see under DIBENZOCYCLOHEPTENES 1978-90   
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D002069 2006
% 216.04/216.21  |- skos__hiddenLabel mesh__D002069 Hydrochloride, Butaclamol
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D002069 2003
% 216.04/216.21  |- mesh__dateRevised mesh__D002069 2000-06-21
% 216.04/216.21  |- skos__hiddenLabel mesh__D002069 AY 23,028
% 216.04/216.21  |- skos__historyNote mesh__D002069 Dibenzocycloheptenes %28%1968-1977%29%
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D002069 2004
% 216.04/216.21  |- mesh__publicMeSHNote mesh__D002069
% 216.04/216.21       91; was see under DIBENZOCYCLOHEPTENES 1978-90   
% 216.04/216.21  |- mesh__recordMaintainer mesh__D002069 TWD
% 216.04/216.21  |- mesh__recordAuthorizer mesh__D002069 sjn
% 216.04/216.21  |- rdf__type mesh__D002069sskos__Concept
% 216.04/216.21  |- skos__broader mesh__D002069smesh__D003986
% 216.04/216.21  |- mesh__recordOriginator mesh__D002069 SH
% 216.04/216.21  |- mesh__dateEstablished mesh__D002069 1991-01-01
% 216.04/216.21  |- skos__hiddenLabel mesh__D002069 AY23,028
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D007552 2005
% 216.04/216.21  |- skos__annotation mesh__D007552
% 216.04/216.21       GEN; NIM; no qualif when NIM coord; qualif is usually attached to specific drug in solution; when IM, only D25-26 qualif; DF: ISOTONIC SOL%A%  
% 216.04/216.21  |- skos__scopeNote mesh__D007552
% 216.04/216.21       Solutions having the same osmotic pressure as blood serum, or another solution with which they are compared. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed %26% Dorland, 28th ed%29%%A%    
% 216.04/216.21  |- skos__prefLabel mesh__D007552 Isotonic Solutions
% 216.04/216.21  |- mesh__recordAuthorizer mesh__D007552 sjn
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D007552 2006
% 216.04/216.21  |- mesh__dateCreated mesh__D007552 1999-01-01
% 216.04/216.21  |- mesh__recordMaintainer mesh__D007552 ssb
% 216.04/216.21  |- skos__broader mesh__D007552smesh__D012996
% 216.04/216.21  |- mesh__recordOriginator mesh__D007552 NLM
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D007552 2004
% 216.04/216.21  |- rdf__type mesh__D007552sskos__Concept
% 216.04/216.21  |- skos__hiddenLabel mesh__D007552 Solutions, Isotonic
% 216.04/216.21  |- mesh__dateRevised mesh__D007552 2003-07-09
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D012497 2005
% 216.04/216.21  |- mesh__recordAuthorizer mesh__D012497 sjn
% 216.04/216.21  |- skos__related mesh__D012497smesh__D001619
% 216.04/216.21  |- skos__broader mesh__D012497smesh__D020143
% 216.04/216.21  |- skos__historyNote mesh__D012497 Sphingolipidosis %28%1974-1978%29%
% 216.04/216.21  |- rdf__type mesh__D012497sskos__Concept
% 216.04/216.21  |- skos__prefLabel mesh__D012497 Sandhoff Disease
% 216.04/216.21  |- skos__broader mesh__D012497smesh__D005733
% 216.04/216.21  |- skos__altLabel mesh__D012497 G%28%M2%29% Gangliosidosis, Type II
% 216.04/216.21  |- mesh__dateEstablished mesh__D012497 1979-01-01
% 216.04/216.21  |- mesh__dateRevised mesh__D012497 2004-07-07
% 216.04/216.21  |- skos__altLabel mesh__D012497 Deficiency Disease, Hexosaminidase A and B
% 216.04/216.21  |- skos__altLabel mesh__D012497 Sandhoff Disease, Juvenile
% 216.04/216.21  |- mesh__publicMeSHNote mesh__D012497 1979   
% 216.04/216.21  |- skos__altLabel mesh__D012497 Sandhoff Disease, Infantile
% 216.04/216.21  |- skos__altLabel mesh__D012497 Gangliosidosis G%28%M2%29%, Type II
% 216.04/216.21  |- skos__altLabel mesh__D012497 Gangliosidosis GM2, Type II
% 216.04/216.21  |- mesh__dateCreated mesh__D012497 1978-05-22
% 216.04/216.21  |- skos__historyNote mesh__D012497 Gangliosidosis %28%1976-1978%29%
% 216.04/216.21  |- skos__altLabel mesh__D012497 Sandhoff Disease, Adult
% 216.04/216.21  |- skos__altLabel mesh__D012497 GM2 Gangliosidosis, Type II
% 216.04/216.21  |- skos__altLabel mesh__D012497 Sandhoff%27%s Disease
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D012497 2006
% 216.04/216.21  |- mesh__recordMaintainer mesh__D012497 jmp
% 216.04/216.21  |- skos__historyNote mesh__D012497
% 216.04/216.21       G%28%M2%29% Ganglioside %28%1975-1978%29%
% 216.04/216.21  |- skos__historyNote mesh__D012497 Lipoidosis %28%1966-1978%29%
% 216.04/216.21  |- skos__scopeNote mesh__D012497
% 216.04/216.21       An autosomal inherited disease caused by deficiency of the enzymes hexosaminidase A %26% B %28%see BETA-N-ACETYLHEXOSAMINIDASE%29% which leads to an accumulation of GM2 ganglioside and sphingolipid globoside in neurons and other organs. Clinical manifestations resemble TAY-SACHS DISEASE, but the disease is not limited to Askenazi Jews and may feature hepatosplenomegaly. The infantile form presents in the first 4 months of life with psychomotor delay, hypotonia followed by spasticity, and cherry red spots in the macula. Rare juvenile and adult forms have been reported. %28%From Menkes, Textbook of Child Neurology, 5th ed, p92%29%%A%    
% 216.04/216.21  |- skos__hiddenLabel mesh__D012497 Sandhoffs Disease
% 216.04/216.21  |- mesh__historyNote mesh__D012497 1979   
% 216.04/216.21  |- mesh__recordOriginator mesh__D012497 RC
% 216.04/216.21  |- skos__historyNote mesh__D012497 Hexosaminidases %28%1971-1978%29%
% 216.04/216.21  |- skos__altLabel mesh__D012497 Hexosaminidase A and B Deficiency Disease
% 216.04/216.21  |- skos__historyNote mesh__D012497 Gangliosides %28%1966-1978%29%
% 216.04/216.21  |- skos__altLabel mesh__D020929 MAPKKs
% 216.04/216.21  |- skos__hiddenLabel mesh__D020929 MAP ERK Kinase
% 216.04/216.21  |- rdf__type mesh__D020929sskos__Concept
% 216.04/216.21  |- mesh__recordOriginator mesh__D020929 nns
% 216.04/216.21  |- skos__altLabel mesh__D020929 MEKs
% 216.04/216.21  |- skos__hiddenLabel mesh__D020929 Mitogen Activated Protein Kinase Kinases
% 216.04/216.21  |- mesh__publicMeSHNote mesh__D020929
% 216.04/216.21       2000; MAP KINASE KINASE and MAPKK %28%now MITOGEN-ACTIVATED KINASE KINASES%29% were indexed under PROTEIN KINASES 1992-1999; MAP-ERK KINASE %28%now MITOGEN-ACTIVATED KINASE KINASES%29% was indexed under PROTEIN-TYROSINE KINASE 1992-1999%A%  
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D020929 2005
% 216.04/216.21  |- skos__altLabel mesh__D020929 MAP Kinase Kinases
% 216.04/216.21  |- skos__scopeNote mesh__D020929
% 216.04/216.21       A serine-threonine protein kinase family whose members are components in protein kinase cascades activated by diverse stimuli. These MAPK kinases phosphorylate MITOGEN-ACTIVATED PROTEIN KINASES and are themselves phosphorylated by MAP KINASE KINASE KINASES. JNK kinases %28%also known as SAPK kinases%29% are a subfamily.%A%    
% 216.04/216.21  |- skos__hiddenLabel mesh__D020929 Kinases, MAPK
% 216.04/216.21  |- mesh__dateRevised mesh__D020929 2004-07-07
% 216.04/216.21  |- skos__altLabel mesh__D020929 MAP-ERK Kinase
% 216.04/216.21  |- skos__prefLabel mesh__D020929 Mitogen-Activated Protein Kinase Kinases
% 216.04/216.21  |- skos__broader mesh__D020929smesh__D011505
% 216.04/216.21  |- skos__related mesh__D020929smesh__D020935
% 216.04/216.21  |- skos__historyNote mesh__D020929
% 216.04/216.21       Protein-Tyrosine Kinase %28%1989-1999%29%
% 216.04/216.21  |- mesh__dateCreated mesh__D020929 1999-11-03
% 216.04/216.21  |- skos__historyNote mesh__D020929 Protein Kinases %28%1989-1999%29%
% 216.04/216.21  |- skos__hiddenLabel mesh__D020929 Kinase, MAP-ERK
% 216.04/216.21  |- mesh__historyNote mesh__D020929
% 216.04/216.21       2000; for MAP-ERK KINASE use MEK1 PROTEIN %28%NM%29% 1992-1999   
% 216.04/216.21  |- mesh__recordMaintainer mesh__D020929 jmp
% 216.04/216.21  |- skos__historyNote mesh__D020929
% 216.04/216.21       Protein-Serine-Threonine Kinases %28%1993-1999%29%
% 216.04/216.21  |- skos__hiddenLabel mesh__D020929 Kinase Kinase, Map
% 216.04/216.21  |- mesh__recordAuthorizer mesh__D020929 sjn
% 216.04/216.21  |- skos__altLabel mesh__D020929 MAPK Kinases
% 216.04/216.21  |- skos__broader mesh__D020929smesh__D047908
% 216.04/216.21  |- skos__broader mesh__D020929smesh__D017346
% 216.04/216.21  |- skos__altLabel mesh__D020929 MAPKK
% 216.04/216.21  |- skos__hiddenLabel mesh__D020929 MAPK ERK Kinases
% 216.04/216.21  |- skos__hiddenLabel mesh__D020929 Kinases, MAP Kinase
% 216.04/216.21  |- skos__altLabel mesh__D020929 Map Kinase Kinase
% 216.04/216.21  |- skos__hiddenLabel mesh__D020929 Kinases, MAPK-ERK
% 216.04/216.21  |- mesh__dateEstablished mesh__D020929 2000-01-01
% 216.04/216.21  |- skos__hiddenLabel mesh__D020929 Kinase, Map Kinase
% 216.04/216.21  |- skos__hiddenLabel mesh__D020929 Kinase Kinases, MAP
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D020929 2006
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D031651 2005
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D031651 2003
% 216.04/216.21  |- mesh__dateCreated mesh__D031651 2002-07-03
% 216.04/216.21  |- mesh__recordMaintainer mesh__D031651 ags
% 216.04/216.21  |- mesh__recordOriginator mesh__D031651 ssb
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D031651 2006
% 216.04/216.21  |- mesh__dateRevised mesh__D031651 2005-07-27
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D031651 2004
% 216.04/216.21  |- mesh__dateEstablished mesh__D031651 2003-01-01
% 216.04/216.21  |- skos__scopeNote mesh__D031651
% 216.04/216.21       A plant genus of the family MYRTACEAE. Members contain PHYTOHEMAGGLUTININS.%A%    
% 216.04/216.21  |- skos__altLabel mesh__D031651 Myrtle
% 216.04/216.21  |- rdf__type mesh__D031651sskos__Concept
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D031651 2006A
% 216.04/216.21  |- mesh__historyNote mesh__D031651 2003   
% 216.04/216.21  |- skos__prefLabel mesh__D031651 Myrtus
% 216.04/216.21  |- mesh__publicMeSHNote mesh__D031651 2003   
% 216.04/216.21  |- skos__broader mesh__D031651smesh__D027822
% 216.04/216.21  |- mesh__recordAuthorizer mesh__D031651 ags
% 216.04/216.21  |- skos__annotation mesh__D031651
% 216.04/216.21       X ref MYRTLE: BOG MYRTLE see MYRICA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.04/216.21  |- mesh__recordOriginator mesh__D017182 PXP
% 216.04/216.21  |- skos__annotation mesh__D017182
% 216.04/216.21       infection = SETARIASIS; coord with specific helminth term %28%ANTIGENS, HELMINTH, etc%29% if pertinent;%A%  
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D017182 2005
% 216.04/216.21  |- mesh__recordAuthorizer mesh__D017182 sjn
% 216.04/216.21  |- mesh__historyNote mesh__D017182 2003%28%1993%29%   
% 216.04/216.21  |- rdf__type mesh__D017182sskos__Concept
% 216.04/216.21  |- mesh__recordMaintainer mesh__D017182 ags
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D017182 2004
% 216.04/216.21  |- mesh__dateCreated mesh__D017182 1992-05-22
% 216.04/216.21  |- mesh__publicMeSHNote mesh__D017182 2003; see SETARIA 1993-2003   
% 216.04/216.21  |- mesh__dateRevised mesh__D017182 2003-07-09
% 216.04/216.21  |- skos__historyNote mesh__D017182 Filarioidea %28%1966-1992%29%
% 216.04/216.21  |- skos__scopeNote mesh__D017182
% 216.04/216.21       A genus of parasitic nematodes found in the peritoneal cavity of wild or domestic cattle or equines.%A%    
% 216.04/216.21  |- skos__prefLabel mesh__D017182 Setaria Nematode
% 216.04/216.21  |- skos__broader mesh__D017182smesh__D005370
% 216.04/216.21  |- mesh__dateEstablished mesh__D017182 1993-01-01
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D017182 2006
% 216.04/216.21  |- skos__historyNote mesh__D003960 Pimelic Acids %28%1972-1974%29%
% 216.04/216.21  |- mesh__dateEstablished mesh__D003960 1991-01-01
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D003960 2003
% 216.04/216.21  |- mesh__publicMeSHNote mesh__D003960
% 216.04/216.21       91; was see under AMINO ACIDS, DIAMINO 1980-90; was see under PIMELIC ACIDS 1975-79%A%  
% 216.04/216.21  |- rdf__type mesh__D003960sskos__Concept
% 216.04/216.21  |- skos__broader mesh__D003960smesh__D000599
% 216.04/216.21  |- skos__prefLabel mesh__D003960 Diaminopimelic Acid
% 216.04/216.21  |- mesh__activeMeSHYear mesh__D003960 2004
% 216.04/216.21  |- skos__broader mesh__D003960smesh__D010867
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D003960 2005
% 216.04/216.22  |- mesh__recordMaintainer mesh__D003960 CCR
% 216.04/216.22  |- skos__historyNote mesh__D003960 Amino Acids, Diamino %28%1974%29%
% 216.04/216.22  |- skos__hiddenLabel mesh__D003960 Acid, Diaminopimelic
% 216.04/216.22  |- mesh__historyNote mesh__D003960
% 216.04/216.22       91%28%75%29%; was see under AMINO ACIDS, DIAMINO 1980-90; was see under PIMELIC ACIDS 1975-79%A%  
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D003960 2001
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D003960 2006
% 216.04/216.22  |- mesh__recordOriginator mesh__D003960 NLM
% 216.04/216.22  |- mesh__dateCreated mesh__D003960 1974-11-19
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D003960 2002
% 216.04/216.22  |- mesh__recordAuthorizer mesh__D003960 sjn
% 216.04/216.22  |- mesh__dateRevised mesh__D003960 2000-06-21
% 216.04/216.22  |- skos__hiddenLabel mesh__D003162 Competency-Based Educations
% 216.04/216.22  |- mesh__recordMaintainer mesh__D003162 TGC
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D003162 2002
% 216.04/216.22  |- skos__scopeNote mesh__D003162
% 216.04/216.22       Educational programs designed to ensure that students attain prespecified levels of competence in a given field or training activity. Emphasis is on achievement or specified objectives.%A%    
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D003162 2003
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D003162 1997
% 216.04/216.22  |- mesh__historyNote mesh__D003162
% 216.04/216.22       91%28%79%29%; was see under CURRICULUM 1979-90   
% 216.04/216.22  |- skos__broader mesh__D003162smesh__D003479
% 216.04/216.22  |- skos__prefLabel mesh__D003162 Competency-Based Education
% 216.04/216.22  |- rdf__type mesh__D003162sskos__Concept
% 216.04/216.22  |- mesh__dateRevised mesh__D003162 1992-05-07
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D003162 2004
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D003162 1994
% 216.04/216.22  |- skos__hiddenLabel mesh__D003162 Education, Competency Based
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D003162 2000
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D003162 1995
% 216.04/216.22  |- skos__altLabel mesh__D003162 Education, Competency-Based
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D003162 2001
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D003162 1998
% 216.04/216.22  |- mesh__dateEstablished mesh__D003162 1991-01-01
% 216.04/216.22  |- skos__hiddenLabel mesh__D003162 Competency Based Education
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D003162 2005
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D003162 1999
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D003162 1993
% 216.04/216.22  |- mesh__recordAuthorizer mesh__D003162 PLS
% 216.04/216.22  |- mesh__publicMeSHNote mesh__D003162
% 216.04/216.22       91; was see under CURRICULUM 1979-90   
% 216.04/216.22  |- mesh__dateCreated mesh__D003162 1978-05-08
% 216.04/216.22  |- skos__hiddenLabel mesh__D003162 Educations, Competency-Based
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D003162 2006
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D003162 1996
% 216.04/216.22  |- mesh__recordOriginator mesh__D003162 EC
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D016888 2001
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D016888 1998
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D016888 1997
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D016888 1992
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D016888 1994
% 216.04/216.22  |- skos__prefLabel mesh__D016888 Angiodysplasia
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D016888 1999
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D016888 1993
% 216.04/216.22  |- rdf__type mesh__D016888sskos__Concept
% 216.04/216.22  |- skos__scopeNote mesh__D016888
% 216.04/216.22       Degenerative, acquired lesions consisting of distorted, dilated, thin-walled vessels lined by vascular endothelium. This pathological state is seen especially in the gastrointestinal tract and is frequently a cause of upper and lower gastrointestinal hemorrhage in the elderly.%A%    
% 216.04/216.22  |- mesh__publicMeSHNote mesh__D016888 92   
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D016888 1995
% 216.04/216.22  |- mesh__dateCreated mesh__D016888 1991-05-30
% 216.04/216.22  |- skos__historyNote mesh__D016888
% 216.04/216.22       Arteriovenous Malformations %28%1976-1991%29%
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D016888 2002
% 216.04/216.22  |- mesh__dateEstablished mesh__D016888 1992-01-01
% 216.04/216.22  |- skos__broader mesh__D016888smesh__D014652
% 216.04/216.22  |- skos__hiddenLabel mesh__D016888 Angiodysplasias
% 216.04/216.22  |- skos__annotation mesh__D016888
% 216.04/216.22       acquired only: congen = ARTERIOVENOUS MALFORMATIONS; seen often in gastrointestinal tract%A%  
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D016888 2003
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D016888 2005
% 216.04/216.22  |- skos__historyNote mesh__D016888
% 216.04/216.22       Gastrointestinal Hemorrhage %28%1976-1991%29%
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D016888 2004
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D016888 2006
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D016888 2000
% 216.04/216.22  |- skos__historyNote mesh__D016888 Angiomatosis %28%1966-1976%29%
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D016888 1996
% 216.04/216.22  |- mesh__historyNote mesh__D016888 92   
% 216.04/216.22  |- mesh__historyNote mesh__D041281 2003   
% 216.04/216.22  |- mesh__recordAuthorizer mesh__D041281 sjn
% 216.04/216.22  |- skos__annotation mesh__D041281
% 216.04/216.22       do not confuse with the seroGROUP australis, sometimes termed Leptospira australis %28%index LEPTOSPIRA INTERROGANS%29%; infection: coord IM with probably LEPTOSPIROSIS %28%IM%29%%A%  
% 216.04/216.22  |- mesh__publicMeSHNote mesh__D041281 2003   
% 216.04/216.22  |- skos__scopeNote mesh__D041281
% 216.04/216.22       A serovar of the bacterial species LEPTOSPIRA INTERROGANS, characteristically associated with a severe zoonotic disease in humans.%A%    
% 216.04/216.22  |- skos__broader mesh__D041281smesh__D007921
% 216.04/216.22  |- mesh__recordMaintainer mesh__D041281 SYSTEM
% 216.04/216.22  |- mesh__dateRevised mesh__D041281 2005-06-30
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D041281 2006
% 216.04/216.22  |- skos__prefLabel mesh__D041281 Leptospira interrogans serovar australis
% 216.04/216.22  |- rdf__type mesh__D041281sskos__Concept
% 216.04/216.22  |- mesh__dateEstablished mesh__D041281 2003-01-01
% 216.04/216.22  |- mesh__recordOriginator mesh__D041281 ags
% 216.04/216.22  |- mesh__dateCreated mesh__D041281 2002-07-03
% 216.04/216.22  |- skos__historyNote mesh__D041281 Leptospira interrogans %28%1980-2002%29%
% 216.04/216.22  |- skos__hiddenLabel mesh__D002868 Non Histone Chromosomal Proteins
% 216.04/216.22  |- skos__altLabel mesh__D002868 Chromosomal Proteins, Nonhistone
% 216.04/216.22  |- skos__altLabel mesh__D002868 Non-Histone Chromosomal Proteins
% 216.04/216.22  |- skos__scopeNote mesh__D002868
% 216.04/216.22       Nucleoproteins, which in contrast to HISTONES, are acid insoluble. They are involved in chromosomal functions; e.g. they bind selectively to DNA, stimulate transcription resulting in tissue-specific RNA synthesis and undergo specific changes in response to various hormones or phytomitogens.%A%    
% 216.04/216.22  |- skos__historyNote mesh__D002868 Chromosomes %28%1966-1976%29%
% 216.04/216.22  |- mesh__recordAuthorizer mesh__D002868 sjn
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D002868 2006
% 216.04/216.22  |- mesh__historyNote mesh__D002868 77   
% 216.04/216.22  |- skos__hiddenLabel mesh__D002868 Non Histone Chromosomal Phosphoproteins
% 216.04/216.22  |- skos__hiddenLabel mesh__D002868 Proteins, Non-Histone Chromosomal
% 216.04/216.22  |- mesh__dateCreated mesh__D002868 1976-04-16
% 216.04/216.22  |- mesh__publicMeSHNote mesh__D002868 77   
% 216.04/216.22  |- mesh__dateEstablished mesh__D002868 1977-01-01
% 216.04/216.22  |- skos__prefLabel mesh__D002868 Chromosomal Proteins, Non-Histone
% 216.04/216.22  |- skos__historyNote mesh__D002868 Nucleoproteins %28%1966-1976%29%
% 216.04/216.22  |- rdf__type mesh__D002868sskos__Concept
% 216.04/216.22  |- skos__hiddenLabel mesh__D002868 Nonhistone Chromosomal Proteins
% 216.04/216.22  |- skos__altLabel mesh__D002868 Chromosomal Proteins, Non Histone
% 216.04/216.22  |- mesh__dateRevised mesh__D002868 2005-06-30
% 216.04/216.22  |- skos__broader mesh__D002868smesh__D009687
% 216.04/216.22  |- mesh__recordMaintainer mesh__D002868 SYSTEM
% 216.04/216.22  |- mesh__recordOriginator mesh__D002868 RLS
% 216.04/216.22  |- skos__broader mesh__D002868smesh__D009698
% 216.04/216.22  |- skos__hiddenLabel mesh__D002868 Chromosomal Phosphoproteins, Non-Histone
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D013590 2004
% 216.04/216.22  |- mesh__recordAuthorizer mesh__D013590 sjn
% 216.04/216.22  |- mesh__onlineNote mesh__D013590
% 216.04/216.22       use SYPHILIS, CONGENITAL to search HUTCHINSON%27%S TEETH 1966-91%A%  
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D013590 2006
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D013590 2003
% 216.04/216.22  |- mesh__dateCreated mesh__D013590 1999-01-01
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D013590 2005
% 216.04/216.22  |- rdf__type mesh__D013590sskos__Concept
% 216.04/216.22  |- skos__broader mesh__D013590smesh__D013587
% 216.04/216.22  |- skos__prefLabel mesh__D013590 Syphilis, Congenital
% 216.04/216.22  |- skos__broader mesh__D013590smesh__D007232
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D013590 2002
% 216.04/216.22  |- skos__scopeNote mesh__D013590
% 216.04/216.22       Syphilis acquired in utero and manifested by any of several characteristic tooth %28%Hutchinson%27%s teeth%29% or bone malformations and by active mucocutaneous syphilis at birth or shortly thereafter. Ocular and neurologic changes may also occur.%A%    
% 216.04/216.22  |- mesh__publicMeSHNote mesh__D013590
% 216.04/216.22       HUTCHINSON%27%S TEETH was heading 1965-91   
% 216.04/216.22  |- mesh__recordOriginator mesh__D013590 NLM
% 216.04/216.22  |- mesh__recordMaintainer mesh__D013590 kle
% 216.04/216.22  |- skos__annotation mesh__D013590
% 216.04/216.22       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 216.04/216.22  |- skos__hiddenLabel mesh__D013590 Hutchinsons Teeth
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D013590 2001
% 216.04/216.22  |- mesh__dateRevised mesh__D013590 1999-11-03
% 216.04/216.22  |- skos__hiddenLabel mesh__D013590 Hutchinson Teeth
% 216.04/216.22  |- skos__hiddenLabel mesh__D013590 Teeth, Hutchinson%27%s
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D013590 2000
% 216.04/216.22  |- skos__altLabel mesh__D013590 Congenital Syphilis
% 216.04/216.22  |- mesh__historyNote mesh__D013590
% 216.04/216.22       HUTCHINSON%27%S TEETH was heading 1965-91   
% 216.04/216.22  |- skos__broader mesh__D019946Q000031smesh__D019946
% 216.04/216.22  |- mesh__preferredCombination mesh__D019946Q000031smesh__D011409
% 216.04/216.22  |- rdf__type mesh__D019946Q000031smesh__CompoundConcept
% 216.04/216.22  |- skos__scopeNote mesh__D007553
% 216.04/216.22       Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labeled substances unless the methods of labeling are substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms.%A%    
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D007553 2005A
% 216.04/216.22  |- mesh__dateRevised mesh__D007553 2004-07-28
% 216.04/216.22  |- skos__historyNote mesh__D007553 specific isotope %28%1966-1971%29%
% 216.04/216.22  |- skos__hiddenLabel mesh__D007553 Affinity Tagging, Isotope-Coded
% 216.04/216.22  |- mesh__recordMaintainer mesh__D007553 jls
% 216.04/216.22  |- skos__hiddenLabel mesh__D007553 Tagging, Isotope-Coded Affinity
% 216.04/216.22  |- skos__hiddenLabel mesh__D007553 Labeling, Stable Isotope
% 216.04/216.22  |- skos__altLabel mesh__D007553 Isotopically-Coded Affinity Tagging
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D007553 2004
% 216.04/216.22  |- skos__hiddenLabel mesh__D007553 Stable Isotope Labeling
% 216.04/216.22  |- skos__annotation mesh__D007553
% 216.04/216.22       restrict to techniques of labeling with isotopes %28%stable or radioactive%29%: do not use for radioisotope tracer studies of %22%labeled%22% cells, microorganisms or chemicals %28% = chemical with no qualify %28%NIM%29% or /diag use %28%NIM%29%: Manual 19.8.23%29%, as Cr51-labeled erythrocytes = ERYTHROCYTES + CHROMIUM RADIOISOTOPES /diag use but not ISOTOPE LABELING%A%  
% 216.04/216.22  |- rdf__type mesh__D007553sskos__Concept
% 216.04/216.22  |- mesh__dateEstablished mesh__D007553 1973-01-01
% 216.04/216.22  |- skos__hiddenLabel mesh__D007553 Tagging, Isotopically-Coded Affinity
% 216.04/216.22  |- skos__hiddenLabel mesh__D007553 Labeling, Isotope
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D007553 2005B
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D007553 2005
% 216.04/216.22  |- skos__broader mesh__D007553smesh__D008919
% 216.04/216.22  |- mesh__historyNote mesh__D007553 73%28%71%29%   
% 216.04/216.22  |- mesh__recordAuthorizer mesh__D007553 jls
% 216.04/216.22  |- skos__hiddenLabel mesh__D007553 Isotope Coded Affinity Tagging
% 216.04/216.22  |- mesh__publicMeSHNote mesh__D007553 73   
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D007553 2006
% 216.04/216.22  |- mesh__dateCreated mesh__D007553 1999-01-01
% 216.04/216.22  |- skos__prefLabel mesh__D007553 Isotope Labeling
% 216.04/216.22  |- mesh__recordOriginator mesh__D007553 NLM
% 216.04/216.22  |- skos__hiddenLabel mesh__D007553 Affinity Tagging, Isotopically-Coded
% 216.04/216.22  |- skos__annotation mesh__D012498 SPEC; SPEC qualif   
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D012498 2002
% 216.04/216.22  |- mesh__dateRevised mesh__D012498 1997-06-20
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D012498 2004
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D012498 1999
% 216.04/216.22  |- skos__prefLabel mesh__D012498 Sanitary Engineering
% 216.04/216.22  |- skos__broader mesh__D012498smesh__D004782
% 216.04/216.22  |- skos__broader mesh__D012498smesh__D004738
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D012498 2003
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D012498 1998
% 216.04/216.22  |- skos__broader mesh__D012498smesh__D012499
% 216.04/216.22  |- skos__hiddenLabel mesh__D012498 Engineering, Sanitary
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D012498 2001
% 216.04/216.22  |- mesh__recordAuthorizer mesh__D012498 SJN
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D012498 2006
% 216.04/216.22  |- mesh__dateCreated mesh__D012498 1999-01-01
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D012498 2000
% 216.04/216.22  |- mesh__recordOriginator mesh__D012498 NLM
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D012498 2005
% 216.04/216.22  |- skos__scopeNote mesh__D012498
% 216.04/216.22       A branch of engineering concerned with the design, construction, and maintenance of environmental facilities conducive to public health, such as water supply and waste disposal.%A%    
% 216.04/216.22  |- rdf__type mesh__D012498sskos__Concept
% 216.04/216.22  |- mesh__recordMaintainer mesh__D012498 TPW
% 216.04/216.22  |- skos__hiddenLabel mesh__D017981 Receptor, Neuromodulator
% 216.04/216.22  |- skos__altLabel mesh__D017981 Neurotransmitter Receptor
% 216.04/216.22  |- skos__hiddenLabel mesh__D017981 Receptors, Neuromediator
% 216.04/216.22  |- mesh__onlineNote mesh__D017981
% 216.04/216.22       use RECEPTORS, NEUROTRANSMITTER to search NEUROTRANSMITTER RECEPTORS %26% SYNAPTIC RECEPTORS 1991-93; NEUROHUMOR RECEPTORS, NEUROMEDIATOR RECEPTORS, NEUROMODULATOR RECEPTORS, NEUROREGULATOR RECEPTORS %26% RECEPTORS, NEUROHUMOR 1987-93, %26% RECEPTORS, SYNAPTIC 1970-93 %28%as Prov 1970-72%29%%A%  
% 216.04/216.22  |- skos__hiddenLabel mesh__D017981 Neuroregulators Receptors
% 216.04/216.22  |- skos__hiddenLabel mesh__D017981 Receptor, Neuroregulator
% 216.04/216.22  |- skos__hiddenLabel mesh__D017981 Neurotransmitters Receptors
% 216.04/216.22  |- mesh__dateRevised mesh__D017981 1997-06-20
% 216.04/216.22  |- skos__altLabel mesh__D017981 Neuromodulator Receptors
% 216.04/216.22  |- skos__altLabel mesh__D017981 Receptors, Synaptic
% 216.04/216.22  |- skos__hiddenLabel mesh__D017981 Receptors, Neuromodulator
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D017981 1999
% 216.04/216.22  |- skos__annotation mesh__D017981
% 216.04/216.22       GEN; prefer specifics; DF: RECEPT NEUROTRANSM   
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D017981 2004
% 216.04/216.22  |- skos__altLabel mesh__D017981 Receptors, Neurohumor
% 216.04/216.22  |- skos__altLabel mesh__D017981 Receptors, Neuromediators
% 216.04/216.22  |- skos__prefLabel mesh__D017981 Receptors, Neurotransmitter
% 216.04/216.22  |- mesh__recordOriginator mesh__D017981 RAZ
% 216.04/216.22  |- skos__hiddenLabel mesh__D017981 Neuromediators Receptors
% 216.04/216.22  |- mesh__dateCreated mesh__D017981 1993-06-15
% 216.04/216.22  |- skos__altLabel mesh__D017981 Receptors, Neuroregulators
% 216.04/216.22  |- mesh__activeMeSHYear mesh__D017981 1998
% 216.04/216.29  |- skos__scopeNote mesh__D017981
% 216.04/216.29       Cell surface receptors that bind signalling molecules released by neurons and convert these signals into intracellular changes influencing the behavior of cells. Neurotransmitter is used here in its most general sense, including not only messengers that act to regulate ion channels, but also those which act on second messenger systems and those which may act at a distance from their release sites. Included are receptors for neuromodulators, neuroregulators, neuromediators, and neurohumors, whether or not located at synapses.%A%    
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D017981 2002
% 216.04/216.29  |- mesh__dateEstablished mesh__D017981 1994-01-01
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D017981 2003
% 216.04/216.29  |- skos__altLabel mesh__D017981 Neuromediator Receptors
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D017981 2006
% 216.04/216.29  |- mesh__recordMaintainer mesh__D017981 NDW
% 216.04/216.29  |- skos__altLabel mesh__D017981 Receptors, Neuromodulators
% 216.04/216.29  |- mesh__recordAuthorizer mesh__D017981 SJN
% 216.04/216.29  |- skos__broader mesh__D017981smesh__D011956
% 216.04/216.29  |- skos__altLabel mesh__D017981 Neurohumor Receptors
% 216.04/216.29  |- skos__hiddenLabel mesh__D017981 Receptor, Neuromediator
% 216.04/216.29  |- mesh__publicMeSHNote mesh__D017981
% 216.04/216.29       94; was see RECEPTORS, SYNAPTIC 1984-93; RECEPTORS, NEUROHUMOR was heading 1987-93; RECEPTORS, SYNAPTIC was heading 1973-93 %28%was SYNAPTIC RECEPTORS 1973-90%29%; NEUROTRANSMITTER RECEPTORS %26% SYNAPTIC RECEPTORS were see RECEPTORS, SYNAPTIC 1991-93; NEUROHUMOR RECEPTORS, NEUROMEDIATOR RECEPTORS, NEUROMODULATOR RECEPTORS, %26% NEUROREGULATOR RECEPTORS were see RECEPTORS, NEUROHUMOR 1987-93%A%  
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D017981 2001
% 216.04/216.29  |- rdf__type mesh__D017981sskos__Concept
% 216.04/216.29  |- skos__altLabel mesh__D017981 Neuroregulator Receptors
% 216.04/216.29  |- skos__hiddenLabel mesh__D017981 Receptors, Neuroregulator
% 216.04/216.29  |- skos__altLabel mesh__D017981 Neuroregulator Receptor
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D017981 2005
% 216.04/216.29  |- skos__altLabel mesh__D017981 Receptors, Neurotransmitters
% 216.04/216.29  |- mesh__historyNote mesh__D017981
% 216.04/216.29       94; was see RECEPTORS, SYNAPTIC 1984-93; RECEPTORS, NEUROHUMOR was heading 1987-93; RECEPTORS, SYNAPTIC was heading 1970-93 %28%was SYNAPTIC RECEPTORS 1970-90 %28%Prov 1970-72%29%; NEUROTRANSMITTER RECEPTORS %26% SYNAPTIC RECEPTORS were see RECEPTORS, SYNAPTIC 1991-93; NEUROHUMOR RECEPTORS, NEUROMEDIATOR RECEPTORS, NEUROMODULATOR RECEPTORS, %26% NEUROREGULATOR RECEPTORS were see RECEPTORS, NEUROHUMOR 1987-93%A%  
% 216.04/216.29  |- skos__hiddenLabel mesh__D017981 Neurotransmitter Receptors
% 216.04/216.29  |- skos__altLabel mesh__D017981 Neuromediator Receptor
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D017981 2000
% 216.04/216.29  |- skos__hiddenLabel mesh__D017981 Neuromodulators Receptors
% 216.04/216.29  |- skos__hiddenLabel mesh__D017981 Receptor, Neurotransmitter
% 216.04/216.29  |- mesh__historyNote mesh__D031652 2003   
% 216.04/216.29  |- rdf__type mesh__D031652sskos__Concept
% 216.04/216.29  |- mesh__publicMeSHNote mesh__D031652 2003   
% 216.04/216.29  |- mesh__dateCreated mesh__D031652 2002-07-03
% 216.04/216.29  |- mesh__dateEstablished mesh__D031652 2003-01-01
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D031652 2005
% 216.04/216.29  |- skos__scopeNote mesh__D031652
% 216.04/216.29       A plant family of the order Nymphaeales, subclass Magnoliidae, class Magnoliopsida.  They are aquatic plants.%A%    
% 216.04/216.29  |- skos__broader mesh__D031652smesh__D019684
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D031652 2003
% 216.04/216.29  |- skos__annotation mesh__D031652
% 216.04/216.29       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D031652 2006
% 216.04/216.29  |- skos__prefLabel mesh__D031652 Nelumbonaceae
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D031652 2004
% 216.04/216.29  |- skos__broader mesh__D017183smesh__D017161
% 216.04/216.29  |- rdf__type mesh__D017183sskos__Concept
% 216.04/216.29  |- mesh__dateEstablished mesh__D017183 1993-01-01
% 216.04/216.29  |- mesh__historyNote mesh__D017183 93   
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D017183 2004
% 216.04/216.29  |- mesh__publicMeSHNote mesh__D017183 93   
% 216.04/216.29  |- mesh__dateRevised mesh__D017183 2003-07-09
% 216.04/216.29  |- skos__prefLabel mesh__D017183 Strongylida
% 216.04/216.29  |- skos__annotation mesh__D017183
% 216.04/216.29       an order of nematodes: do not confuse with STRONGYLOIDEA, a superfamily; infection = STRONGYLIDA INFECTIONS%A%  
% 216.04/216.29  |- mesh__dateCreated mesh__D017183 1992-05-22
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D017183 2006
% 216.04/216.29  |- skos__scopeNote mesh__D017183
% 216.04/216.29       An order of nematodes of the subclass SECERNENTEA. Characteristics include an H-shaped excretory system with two subventral glands.%A%    
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D017183 2005
% 216.04/216.29  |- mesh__dateEstablished mesh__D003961 1991-01-01
% 216.04/216.29  |- skos__hiddenLabel mesh__D003961 NSC132313
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D003961 2005
% 216.04/216.29  |- mesh__publicMeSHNote mesh__D003961
% 216.04/216.29       91; was see under SUGAR ALCOHOLS 1979-90   
% 216.04/216.29  |- mesh__historyNote mesh__D003961
% 216.04/216.29       91%28%79%29%; was see under SUGAR ALCOHOLS 1979-90   
% 216.04/216.29  |- mesh__recordAuthorizer mesh__D003961 sjn
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D003961 2006
% 216.04/216.29  |- skos__altLabel mesh__D003961 Diepoxygalactitol
% 216.04/216.29  |- skos__scopeNote mesh__D003961
% 216.04/216.29       One of the cytotoxic dihalohexitols that may have alkylating antineoplastic activity. It causes bone marrow toxicity. The active form is thought to be the diepoxide.%A%    
% 216.04/216.29  |- mesh__recordOriginator mesh__D003961 SH
% 216.04/216.29  |- skos__altLabel mesh__D003961 Dianhydrodulcitol
% 216.04/216.29  |- skos__broader mesh__D003961smesh__D004376
% 216.04/216.29  |- skos__historyNote mesh__D003961 Ethers, Cyclic %28%1966-1978%29%
% 216.04/216.29  |- skos__altLabel mesh__D003961 Diepoxydulcitol
% 216.04/216.29  |- skos__altLabel mesh__D003961 1,2,5,6-Dianhydrogalactitol
% 216.04/216.29  |- mesh__recordMaintainer mesh__D003961 ssb
% 216.04/216.29  |- skos__prefLabel mesh__D003961 Dianhydrogalactitol
% 216.04/216.29  |- skos__historyNote mesh__D003961 Alcohols %28%1966-1971%29%
% 216.04/216.29  |- mesh__dateRevised mesh__D003961 2004-07-07
% 216.04/216.29  |- mesh__dateCreated mesh__D003961 1978-02-07
% 216.04/216.29  |- skos__hiddenLabel mesh__D003961 NSC 132313
% 216.04/216.29  |- skos__historyNote mesh__D003961 Dulcitol %28%1972-1978%29%
% 216.04/216.29  |- rdf__type mesh__D003961sskos__Concept
% 216.04/216.29  |- mesh__publicMeSHNote mesh__D003163 68   
% 216.04/216.29  |- skos__historyNote mesh__D003163 Behavior %28%1966-1967%29%
% 216.04/216.29  |- skos__hiddenLabel mesh__D003163 Competitive Behaviors
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D003163 2006
% 216.04/216.29  |- skos__hiddenLabel mesh__D003163 Behaviors, Competitive
% 216.04/216.29  |- mesh__recordAuthorizer mesh__D003163 sjn
% 216.04/216.29  |- skos__broader mesh__D003163smesh__D012919
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D003163 2004
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D003163 2005
% 216.04/216.29  |- mesh__recordOriginator mesh__D003163 NLM
% 216.04/216.29  |- mesh__dateEstablished mesh__D003163 1968-01-01
% 216.04/216.29  |- rdf__type mesh__D003163sskos__Concept
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D003163 2003
% 216.04/216.29  |- mesh__recordMaintainer mesh__D003163 JLS
% 216.04/216.29  |- mesh__historyNote mesh__D003163 68   
% 216.04/216.29  |- skos__historyNote mesh__D003163 Motivation %28%1966-1967%29%
% 216.04/216.29  |- mesh__dateRevised mesh__D003163 2002-07-02
% 216.04/216.29  |- skos__historyNote mesh__D003163 Behavior, Animal %28%1966-1967%29%
% 216.04/216.29  |- skos__hiddenLabel mesh__D003163 Behavior, Competitive
% 216.04/216.29  |- skos__prefLabel mesh__D003163 Competitive Behavior
% 216.04/216.29  |- skos__scopeNote mesh__D003163
% 216.04/216.29       The direct struggle between individuals for environmental necessities or for a common goal.%A%    
% 216.04/216.29  |- skos__annotation mesh__D003163 human %26% animal   
% 216.04/216.29  |- mesh__dateCreated mesh__D003163 1999-01-01
% 216.04/216.29  |- skos__hiddenLabel mesh__D016889 Cancers, Endometrial
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D016889 2006
% 216.04/216.29  |- skos__annotation mesh__D016889
% 216.04/216.29       coord IM with histol type of neopl %28%IM%29%   
% 216.04/216.29  |- mesh__historyNote mesh__D016889 92   
% 216.04/216.29  |- skos__hiddenLabel mesh__D016889 Endometrium Carcinoma
% 216.04/216.29  |- skos__hiddenLabel mesh__D016889 Endometrial Cancers
% 216.04/216.29  |- rdf__type mesh__D016889sskos__Concept
% 216.04/216.29  |- mesh__dateCreated mesh__D016889 1991-05-30
% 216.04/216.29  |- skos__broader mesh__D016889smesh__D014594
% 216.04/216.29  |- skos__scopeNote mesh__D016889
% 216.04/216.29       Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.%A%    
% 216.04/216.29  |- skos__hiddenLabel mesh__D016889 Neoplasm, Endometrial
% 216.04/216.29  |- skos__hiddenLabel mesh__D016889 Endometrium Carcinomas
% 216.04/216.29  |- skos__hiddenLabel mesh__D016889 Cancer, Endometrial
% 216.04/216.29  |- skos__altLabel mesh__D016889 Endometrium Cancer
% 216.04/216.29  |- skos__altLabel mesh__D016889 Carcinoma of Endometrium
% 216.04/216.29  |- mesh__publicMeSHNote mesh__D016889 92   
% 216.04/216.29  |- skos__hiddenLabel mesh__D016889 Cancers, Endometrium
% 216.04/216.29  |- skos__prefLabel mesh__D016889 Endometrial Neoplasms
% 216.04/216.29  |- mesh__dateEstablished mesh__D016889 1992-01-01
% 216.04/216.29  |- skos__hiddenLabel mesh__D016889 Endometrial Carcinomas
% 216.04/216.29  |- skos__hiddenLabel mesh__D016889 Endometrium Cancers
% 216.04/216.29  |- mesh__recordAuthorizer mesh__D016889 sjn
% 216.04/216.29  |- skos__hiddenLabel mesh__D016889 Carcinoma, Endometrial
% 216.04/216.29  |- mesh__dateRevised mesh__D016889 2005-06-30
% 216.04/216.29  |- skos__altLabel mesh__D016889 Neoplasms, Endometrial
% 216.04/216.29  |- skos__altLabel mesh__D016889 Endometrial Cancer
% 216.04/216.29  |- skos__historyNote mesh__D016889 Uterine Neoplasms %28%1966-1991%29%
% 216.04/216.29  |- skos__hiddenLabel mesh__D016889 Cancer, Endometrium
% 216.04/216.29  |- mesh__recordOriginator mesh__D016889 TGC
% 216.04/216.29  |- skos__altLabel mesh__D016889 Cancer of Endometrium
% 216.04/216.29  |- mesh__recordMaintainer mesh__D016889 lkt
% 216.04/216.29  |- skos__altLabel mesh__D016889 Cancer of the Endometrium
% 216.04/216.29  |- skos__hiddenLabel mesh__D016889 Endometrial Neoplasm
% 216.04/216.29  |- skos__hiddenLabel mesh__D016889 Carcinomas, Endometrial
% 216.04/216.29  |- skos__hiddenLabel mesh__D002869 Karyotypes, Abnormal
% 216.04/216.29  |- mesh__dateRevised mesh__D002869 2002-07-02
% 216.04/216.29  |- skos__hiddenLabel mesh__D002869 Aberrations, Cytogenetic
% 216.04/216.29  |- skos__hiddenLabel mesh__D002869 Abnormal Karyotypes
% 216.04/216.29  |- skos__altLabel mesh__D002869 Cytogenetic Abnormalities
% 216.04/216.29  |- skos__altLabel mesh__D002869 Chromosome Abnormalities
% 216.04/216.29  |- skos__hiddenLabel mesh__D002869 Aberration, Chromosome
% 216.04/216.29  |- skos__hiddenLabel mesh__D002869 Cytogenetic Abnormality
% 216.04/216.29  |- skos__hiddenLabel mesh__D002869 Aberrations, Chromosomal
% 216.04/216.29  |- skos__altLabel mesh__D002869 Abnormalities, Chromosome
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D002869 2004
% 216.04/216.29  |- skos__altLabel mesh__D002869 Cytogenetic Aberrations
% 216.04/216.29  |- skos__hiddenLabel mesh__D002869 Cytogenetic Aberration
% 216.04/216.29  |- mesh__dateEstablished mesh__D002869 1968-01-01
% 216.04/216.29  |- skos__hiddenLabel mesh__D002869 Chromosome Aberration
% 216.04/216.29  |- skos__hiddenLabel mesh__D002869 Chromosomal Aberration
% 216.04/216.29  |- skos__hiddenLabel mesh__D002869 Aberration, Chromosomal
% 216.04/216.29  |- mesh__recordOriginator mesh__D002869 NLM
% 216.04/216.29  |- skos__broader mesh__D002869smesh__D010335
% 216.04/216.29  |- skos__altLabel mesh__D002869 Chromosomal Aberrations
% 216.04/216.29  |- mesh__recordAuthorizer mesh__D002869 sjn
% 216.04/216.29  |- skos__scopeNote mesh__D002869
% 216.04/216.29       Abnormal number or structure of chromosomes. Many chromosome aberrations, but not all, are the cause of CHROMOSOME DISORDERS.%A%    
% 216.04/216.29  |- skos__altLabel mesh__D002869 Abnormalities, Autosome
% 216.04/216.29  |- skos__hiddenLabel mesh__D002869 Chromosome Abnormality
% 216.04/216.29  |- skos__historyNote mesh__D002869
% 216.04/216.29       Chromosome Abnormalities %28%1966-1967%29%
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D002869 2003
% 216.04/216.29  |- rdf__type mesh__D002869sskos__Concept
% 216.04/216.29  |- skos__hiddenLabel mesh__D002869 Chromosomal Abnormalities
% 216.04/216.29  |- skos__annotation mesh__D002869
% 216.04/216.29       coord IM with specific numbered chromosome or sex chromosome %28%IM%29% but not with CHROMOSOMES, HUMAN%A%  
% 216.04/216.29  |- skos__hiddenLabel mesh__D002869 Abnormality, Chromosomal
% 216.04/216.29  |- skos__hiddenLabel mesh__D002869 Abnormalities, Cytogenetic
% 216.04/216.29  |- mesh__publicMeSHNote mesh__D002869
% 216.04/216.29       1968; for CHROMOSOME ABNORMALITIES see CHROMOSOME ABNORMALITIES 1963-2001; for AUTOSOME ABNORMALITIES see CHROMOSOME ABNORMALITIES 1963-2001%A%  
% 216.04/216.29  |- skos__hiddenLabel mesh__D002869 Abnormality, Chromosome
% 216.04/216.29  |- mesh__recordMaintainer mesh__D002869 nns
% 216.04/216.29  |- mesh__historyNote mesh__D002869
% 216.04/216.29       1968; for CHROMOSOME ABNORMALITIES use CHROMOSOME ABERRATIONS 1963-2001 or CHROMOSOME DISORDERS 1963-2001; for AUTOSOME ABNORMALITIES use CHROMOSOME ABERRATIONS 1963-2001 or CHROMOSOME DISORDERS 1963-2001%A%  
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D002869 2006
% 216.04/216.29  |- skos__hiddenLabel mesh__D002869 Abnormality, Autosome
% 216.04/216.29  |- skos__hiddenLabel mesh__D002869 Abnormality, Cytogenetic
% 216.04/216.29  |- skos__hiddenLabel mesh__D002869 Aberration, Cytogenetic
% 216.04/216.29  |- skos__hiddenLabel mesh__D002869 Chromosomal Abnormality
% 216.04/216.29  |- skos__hiddenLabel mesh__D002869 Aberrations, Chromosome
% 216.04/216.29  |- skos__hiddenLabel mesh__D002869 Autosome Abnormality
% 216.04/216.29  |- skos__altLabel mesh__D002869 Abnormalities, Chromosomal
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D002869 2005
% 216.04/216.29  |- mesh__dateCreated mesh__D002869 1999-01-01
% 216.04/216.29  |- skos__prefLabel mesh__D002869 Chromosome Aberrations
% 216.04/216.29  |- skos__altLabel mesh__D002869 Karyotype, Abnormal
% 216.04/216.29  |- skos__broader mesh__D002869smesh__D009154
% 216.04/216.29  |- skos__related mesh__D002869smesh__D020732
% 216.04/216.29  |- skos__related mesh__D002869smesh__D025063
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D013591 2001
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D013591 2006
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D013591 1997
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D013591 2003
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D013591 2000
% 216.04/216.29  |- mesh__recordAuthorizer mesh__D013591 PLS
% 216.04/216.29  |- skos__broader mesh__D013591smesh__D017192
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D013591 2005
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D013591 1999
% 216.04/216.29  |- mesh__dateCreated mesh__D013591 1999-01-01
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D013591 1996
% 216.04/216.29  |- rdf__type mesh__D013591sskos__Concept
% 216.04/216.29  |- mesh__recordMaintainer mesh__D013591 PXP
% 216.04/216.29  |- skos__broader mesh__D013591smesh__D013587
% 216.04/216.29  |- mesh__dateRevised mesh__D013591 1994-02-08
% 216.04/216.29  |- skos__prefLabel mesh__D013591 Syphilis, Cutaneous
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D013591 1995
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D013591 1998
% 216.04/216.29  |- skos__altLabel mesh__D013591 Skin Syphilis
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D013591 2002
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D013591 2004
% 216.04/216.29  |- skos__hiddenLabel mesh__D013591 Cutaneous Syphilis
% 216.04/216.29  |- mesh__recordOriginator mesh__D013591 NLM
% 216.04/216.29  |- skos__scopeNote mesh__D013591
% 216.04/216.29       Cutaneous lesions arising from infection with Treponema pallidum. In the primary stage, 18-21 days following infection, one or more chancres appear. If untreated, the subsequent stages of the disease appear as syphilids. These eruptions are superficial, nondestructive, exanthematic, transient, macular roseolas that may later be maculopapular or papular polymorphous or scaly, pustular, pigmented eruptions.%28%Arnold, Odom, and James, Andrew%27%s Diseases of the Skin, 8th ed, p409%29%%A%    
% 216.04/216.29  |- skos__hiddenLabel mesh__D013591 Syphilis, Skin
% 216.04/216.29  |- skos__hiddenLabel mesh__D013591 Syphilid
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D007554 2004
% 216.04/216.29  |- skos__related mesh__D007554smesh__D011868
% 216.04/216.29  |- mesh__publicMeSHNote mesh__D007554
% 216.04/216.29       74; was see under RADIOISOTOPES 1963-73   
% 216.04/216.29  |- rdf__type mesh__D007554sskos__Concept
% 216.04/216.29  |- mesh__recordOriginator mesh__D007554 NLM
% 216.04/216.29  |- mesh__recordMaintainer mesh__D007554 nns
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D007554 2001
% 216.04/216.29  |- skos__scopeNote mesh__D007554
% 216.04/216.29       Atomic species differing in mass number but having the same atomic number. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 216.04/216.29  |- skos__annotation mesh__D007554
% 216.04/216.29       for stable isotopes only; GEN: avoid as IM; NIM as coord; Manual 25.20+; m for metastable = RADIOISOTOPES or specific pre-coord radioisotope%A%  
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D007554 2005
% 216.04/216.29  |- mesh__onlineNote mesh__D007554 search RADIOISOTOPES 1966-73   
% 216.04/216.29  |- skos__prefLabel mesh__D007554 Isotopes
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D007554 2006
% 216.04/216.29  |- mesh__historyNote mesh__D007554
% 216.04/216.29       74; was see under RADIOISOTOPES 1963-73   
% 216.04/216.29  |- skos__broader mesh__D007554smesh__D007287
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D007554 2002
% 216.04/216.29  |- mesh__dateCreated mesh__D007554 1999-01-01
% 216.04/216.29  |- mesh__dateEstablished mesh__D007554 1974-01-01
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D007554 2003
% 216.04/216.29  |- mesh__recordAuthorizer mesh__D007554 sjn
% 216.04/216.29  |- mesh__dateRevised mesh__D007554 2000-06-22
% 216.04/216.29  |- mesh__recordMaintainer mesh__D012499 kle
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D012499 2003
% 216.04/216.29  |- mesh__onlineNote mesh__D012499
% 216.04/216.29       search SANITARY SURVEYS under HEALTH SURVEYS 1966   
% 216.04/216.29  |- skos__broader mesh__D012499smesh__D011634
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D012499 2000
% 216.04/216.29  |- mesh__recordOriginator mesh__D012499 NLM
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D012499 2006
% 216.04/216.29  |- skos__annotation mesh__D012499 SPEC: SPEC qualif   
% 216.04/216.29  |- mesh__dateCreated mesh__D012499 1999-01-01
% 216.04/216.29  |- skos__scopeNote mesh__D012499
% 216.04/216.29       The development and establishment of environmental conditions favorable to the health of the public.%A%    
% 216.04/216.29  |- mesh__publicMeSHNote mesh__D012499
% 216.04/216.29       SANITARY SURVEYS was heading 1963-66   
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D012499 2005
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D012499 2002
% 216.04/216.29  |- rdf__type mesh__D012499sskos__Concept
% 216.04/216.29  |- mesh__historyNote mesh__D012499 SANITARY SURVEYS was heading 1963-66   
% 216.04/216.29  |- mesh__recordAuthorizer mesh__D012499 sjn
% 216.04/216.29  |- skos__broader mesh__D012499smesh__D003140
% 216.04/216.29  |- mesh__dateRevised mesh__D012499 1999-11-03
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D012499 2004
% 216.04/216.29  |- skos__broader mesh__D012499smesh__D004782
% 216.04/216.29  |- skos__prefLabel mesh__D012499 Sanitation
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D012499 2001
% 216.04/216.29  |- mesh__dateRevised mesh__D017982 2005-06-30
% 216.04/216.29  |- mesh__dateEstablished mesh__D017982 1994-01-01
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D017982 2006
% 216.04/216.29  |- skos__broader mesh__D017982smesh__D017981
% 216.04/216.29  |- skos__scopeNote mesh__D017982
% 216.04/216.29       Cell surface proteins that bind biogenic amines with high affinity and regulate intracellular signals which influence the behavior of cells. Biogenic amine is a chemically imprecise term which, by convention, includes the catecholamines epinephrine, norepinephrine, and dopamine, the indoleamine serotonin, the imidazolamine histamine, and compounds closely related to each of these.%A%    
% 216.04/216.29  |- rdf__type mesh__D017982sskos__Concept
% 216.04/216.29  |- skos__altLabel mesh__D017982 Biogenic Amines Receptors
% 216.04/216.29  |- skos__altLabel mesh__D017982 Biogenic Amine Receptors
% 216.04/216.29  |- skos__broader mesh__D017982smesh__D011956
% 216.04/216.29  |- skos__altLabel mesh__D017982 Biogenic Amine Receptor
% 216.04/216.29  |- mesh__recordMaintainer mesh__D017982 jmp
% 216.04/216.29  |- skos__prefLabel mesh__D017982 Receptors, Biogenic Amine
% 216.04/216.29  |- mesh__dateCreated mesh__D017982 1993-06-30
% 216.04/216.29  |- mesh__recordAuthorizer mesh__D017982 sjn
% 216.04/216.29  |- mesh__publicMeSHNote mesh__D017982 94   
% 216.04/216.29  |- skos__altLabel mesh__D017982 Receptors, Biogenic Amines
% 216.04/216.29  |- mesh__historyNote mesh__D017982 94   
% 216.04/216.29  |- skos__annotation mesh__D017982
% 216.04/216.29       GEN; prefer specifics; DF: RECEPT BIOGENIC AMINE   
% 216.04/216.29  |- mesh__recordOriginator mesh__D017982 RAZ
% 216.04/216.29  |- skos__hiddenLabel mesh__D017982 Receptor, Biogenic Amine
% 216.04/216.29  |- rdf__type mesh__D031653sskos__Concept
% 216.04/216.29  |- skos__prefLabel mesh__D031653 Nelumbo
% 216.04/216.29  |- mesh__publicMeSHNote mesh__D031653 2003   
% 216.04/216.29  |- skos__annotation mesh__D031653
% 216.04/216.29       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.04/216.29  |- mesh__historyNote mesh__D031653 2003   
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D031653 2005
% 216.04/216.29  |- skos__scopeNote mesh__D031653
% 216.04/216.29       A plant genus of the family NELUMBONACEAE. The common name of lotus is also for LOTUS and NYMPHAEA.%A%    
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D031653 2003
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D031653 2006
% 216.04/216.29  |- skos__broader mesh__D031653smesh__D031652
% 216.04/216.29  |- mesh__activeMeSHYear mesh__D031653 2004
% 216.04/216.29  |- mesh__dateCreated mesh__D031653 2002-07-03
% 216.04/216.29  |- mesh__dateEstablished mesh__D031653 2003-01-01
% 216.04/216.29  |- skos__annotation mesh__D017184
% 216.04/216.29       a genus of nematode found in mice; infection: coord IM with STRONGYLIDA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 216.04/216.29  |- mesh__dateCreated mesh__D017184 1992-05-22
% 216.15/216.29  |- skos__broader mesh__D017184smesh__D006369
% 216.15/216.29  |- skos__historyNote mesh__D017184 Heligmosomatoidea %28%1986-1992%29%
% 216.15/216.29  |- mesh__dateEstablished mesh__D017184 1993-01-01
% 216.15/216.29  |- mesh__activeMeSHYear mesh__D017184 2006
% 216.15/216.29  |- skos__historyNote mesh__D017184 Nematoda %28%1966-1985%29%
% 216.15/216.29  |- skos__scopeNote mesh__D017184
% 216.15/216.29       A genus of nematodes found mainly in mice. Its organisms are used in biomedical research.%A%    
% 216.15/216.29  |- skos__prefLabel mesh__D017184 Nematospiroides
% 216.15/216.29  |- mesh__activeMeSHYear mesh__D017184 2005
% 216.15/216.29  |- rdf__type mesh__D017184sskos__Concept
% 216.15/216.29  |- mesh__publicMeSHNote mesh__D017184 93   
% 216.15/216.29  |- mesh__historyNote mesh__D017184 93   
% 216.15/216.29  |- mesh__activeMeSHYear mesh__D017184 2004
% 216.15/216.29  |- mesh__dateRevised mesh__D017184 2003-07-09
% 216.15/216.29  |- skos__historyNote mesh__D003962 Anisoles %28%1974%29%
% 216.15/216.29  |- skos__hiddenLabel mesh__D003962 Sulfate, Dianisidine
% 216.15/216.29  |- mesh__recordOriginator mesh__D003962 MEG
% 216.15/216.29  |- mesh__activeMeSHYear mesh__D003962 2006
% 216.15/216.29  |- mesh__dateCreated mesh__D003962 1974-11-19
% 216.15/216.29  |- mesh__activeMeSHYear mesh__D003962 2001
% 216.15/216.29  |- skos__scopeNote mesh__D003962
% 216.15/216.29       Highly toxic compound which can cause skin irritation and sensitization. It is used in manufacture of azo dyes.%A%    
% 216.15/216.29  |- mesh__publicMeSHNote mesh__D003962
% 216.15/216.29       91; was see under BENZIDINES 1977-90; was see under AMINOBIPHENYL COMPOUNDS 1975-76; 3,3%27%-DIMETHOXYBENZIDINE was indexed under DIANISIDINE 1982-96%A%  
% 216.15/216.29  |- mesh__dateRevised mesh__D003962 2000-06-22
% 216.15/216.30  |- skos__hiddenLabel mesh__D003962 O Dianisidine
% 216.15/216.30  |- skos__historyNote mesh__D003962 Biphenyl Compounds %28%1969-1974%29%
% 216.15/216.30  |- skos__historyNote mesh__D003962 Aniline Compounds %28%1969-1974%29%
% 216.15/216.30  |- skos__hiddenLabel mesh__D003962 Dihydrochloride, Dianisidine
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003962 2002
% 216.15/216.30  |- skos__broader mesh__D003962smesh__D001713
% 216.15/216.30  |- mesh__recordAuthorizer mesh__D003962 sjn
% 216.15/216.30  |- skos__hiddenLabel mesh__D003962 3,3%27% Dimethoxybenzidine
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003962 2003
% 216.15/216.30  |- rdf__type mesh__D003962sskos__Concept
% 216.15/216.30  |- skos__prefLabel mesh__D003962 Dianisidine
% 216.15/216.30  |- skos__altLabel mesh__D003962 3,3%27%-Dimethoxybenzidine
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003962 2004
% 216.15/216.30  |- mesh__dateEstablished mesh__D003962 1991-01-01
% 216.15/216.30  |- skos__hiddenLabel mesh__D003962 Hydrochloride, Dianisidine
% 216.15/216.30  |- skos__altLabel mesh__D003962 O-Dianisidine
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003962 2005
% 216.15/216.30  |- mesh__recordMaintainer mesh__D003962 CCR
% 216.15/216.30  |- mesh__historyNote mesh__D003962
% 216.15/216.30       91%28%75%29%; was see under BENZIDINES 1977-90; was see under AMINOBIPHENYL COMPOUNDS 1975-76; 3,3%27%-DIMETHOXYBENZIDINE was %28%NM%29% 1982-96%A%  
% 216.15/216.30  |- skos__broader mesh__D009020Q000031smesh__D009020
% 216.15/216.30  |- mesh__preferredCombination mesh__D009020Q000031smesh__D009022
% 216.15/216.30  |- rdf__type mesh__D009020Q000031smesh__CompoundConcept
% 216.15/216.30  |- skos__altLabel mesh__D003164 Contract Bidding
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003164 2005
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003164 2004
% 216.15/216.30  |- mesh__recordOriginator mesh__D003164 EC
% 216.15/216.30  |- skos__historyNote mesh__D003164 Financial Management %28%1978-1985%29%
% 216.15/216.30  |- skos__hiddenLabel mesh__D003164 Competitive Biddings
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003164 2003
% 216.15/216.30  |- mesh__publicMeSHNote mesh__D003164
% 216.15/216.30       91; was see under FINANCIAL MANAGEMENT 1986-90   
% 216.15/216.30  |- rdf__type mesh__D003164sskos__Concept
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003164 2001
% 216.15/216.30  |- skos__hiddenLabel mesh__D003164 Request for Proposals
% 216.15/216.30  |- skos__hiddenLabel mesh__D003164 Proposal, Request for
% 216.15/216.30  |- skos__hiddenLabel mesh__D003164 Bidding, Contract
% 216.15/216.30  |- mesh__historyNote mesh__D003164
% 216.15/216.30       91%28%86%29%; was see under FINANCIAL MANAGEMENT 1986-90   
% 216.15/216.30  |- skos__hiddenLabel mesh__D003164 Contract Biddings
% 216.15/216.30  |- mesh__recordAuthorizer mesh__D003164 SJN
% 216.15/216.30  |- skos__hiddenLabel mesh__D003164 Biddings, Competitive
% 216.15/216.30  |- mesh__dateCreated mesh__D003164 1985-04-24
% 216.15/216.30  |- skos__prefLabel mesh__D003164 Competitive Bidding
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003164 2000
% 216.15/216.30  |- mesh__recordMaintainer mesh__D003164 JLS
% 216.15/216.30  |- skos__historyNote mesh__D003164 Contract Services %28%1978-1985%29%
% 216.15/216.30  |- mesh__dateRevised mesh__D003164 1998-06-10
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003164 1999
% 216.15/216.30  |- skos__hiddenLabel mesh__D003164 Bidding, Competitive
% 216.15/216.30  |- skos__hiddenLabel mesh__D003164 Biddings, Contract
% 216.15/216.30  |- skos__hiddenLabel mesh__D003164 Proposals, Request for
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003164 2006
% 216.15/216.30  |- mesh__dateEstablished mesh__D003164 1991-01-01
% 216.15/216.30  |- skos__scopeNote mesh__D003164
% 216.15/216.30       Pricing statements presented by more than one party for the purpose of securing a contract.%A%    
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003164 2002
% 216.15/216.30  |- skos__broader mesh__D003164smesh__D003284
% 216.15/216.30  |- skos__broader mesh__D013592smesh__D013587
% 216.15/216.30  |- mesh__recordMaintainer mesh__D013592 mdb
% 216.15/216.30  |- skos__prefLabel mesh__D013592 Syphilis, Latent
% 216.15/216.30  |- mesh__recordOriginator mesh__D013592 NLM
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013592 2004
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013592 2006
% 216.15/216.30  |- skos__hiddenLabel mesh__D013592 Latent Syphilis
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013592 2003
% 216.15/216.30  |- mesh__recordAuthorizer mesh__D013592 sjn
% 216.15/216.30  |- mesh__dateRevised mesh__D013592 2002-07-03
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013592 2005
% 216.15/216.30  |- mesh__dateCreated mesh__D013592 1999-01-01
% 216.15/216.30  |- rdf__type mesh__D013592sskos__Concept
% 216.15/216.30  |- mesh__dateCreated mesh__D007555 1999-01-01
% 216.15/216.30  |- mesh__dateRevised mesh__D007555 2005-06-30
% 216.15/216.30  |- skos__scopeNote mesh__D007555
% 216.15/216.30       Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions.%A%    
% 216.15/216.30  |- mesh__recordAuthorizer mesh__D007555 sjn
% 216.15/216.30  |- rdf__type mesh__D007555sskos__Concept
% 216.15/216.30  |- skos__prefLabel mesh__D007555 Isoxazoles
% 216.15/216.30  |- mesh__publicMeSHNote mesh__D007555 91; was see under OXAZOLES 1975-90   
% 216.15/216.30  |- mesh__recordOriginator mesh__D007555 NLM
% 216.15/216.30  |- mesh__historyNote mesh__D007555
% 216.15/216.30       91%28%75%29%; was see under OXAZOLES 1975-90   
% 216.15/216.30  |- mesh__onlineNote mesh__D007555 search OXAZOLES 1966-74   
% 216.15/216.30  |- skos__broader mesh__D007555smesh__D001393
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D007555 2006
% 216.15/216.30  |- mesh__recordMaintainer mesh__D007555 ssb
% 216.15/216.30  |- mesh__dateEstablished mesh__D007555 1991-01-01
% 216.15/216.30  |- skos__annotation mesh__D017983
% 216.15/216.30       GEN; prefer specifics; DF: RECEPT CATECHOLAMINE   
% 216.15/216.30  |- mesh__recordMaintainer mesh__D017983 jmp
% 216.15/216.30  |- mesh__onlineNote mesh__D017983
% 216.15/216.30       use RECEPTORS, CATECHOLAMINE %28%NM%29% to search CATECHOLAMINE RECEPTOR 1982-93%A%  
% 216.15/216.30  |- skos__altLabel mesh__D017983 Catecholamine Receptor
% 216.15/216.30  |- mesh__dateRevised mesh__D017983 2005-06-30
% 216.15/216.30  |- mesh__dateEstablished mesh__D017983 1994-01-01
% 216.15/216.30  |- skos__broader mesh__D017983smesh__D017982
% 216.15/216.30  |- skos__altLabel mesh__D017983 Receptors, Catecholamines
% 216.15/216.30  |- skos__altLabel mesh__D017983 Catecholamine Receptors
% 216.15/216.30  |- skos__scopeNote mesh__D017983
% 216.15/216.30       Cell surface proteins that bind catecholamines with high affinity and trigger intracellular changes which influence the behavior of cells. The catecholamine messengers epinephrine, norepinephrine, and dopamine are synthesized from tyrosine by a common biosynthetic pathway.%A%    
% 216.15/216.30  |- mesh__recordAuthorizer mesh__D017983 sjn
% 216.15/216.30  |- mesh__publicMeSHNote mesh__D017983
% 216.15/216.30       94; CATECHOLAMINE RECEPTOR was indexed under RECEPTORS, ADRENERGIC 1982-93%A%  
% 216.15/216.30  |- skos__hiddenLabel mesh__D017983 Catecholamines Receptors
% 216.15/216.30  |- skos__historyNote mesh__D017983 Receptors, Adrenergic %28%1982-1993%29%
% 216.15/216.30  |- skos__broader mesh__D017983smesh__D043562
% 216.15/216.30  |- skos__prefLabel mesh__D017983 Receptors, Catecholamine
% 216.15/216.30  |- skos__hiddenLabel mesh__D017983 Receptor, Catecholamine
% 216.15/216.30  |- mesh__dateCreated mesh__D017983 1993-06-21
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D017983 2006
% 216.15/216.30  |- mesh__historyNote mesh__D017983
% 216.15/216.30       94; was CATECHOLAMINE RECEPTOR %28%NM%29% 1982-93   
% 216.15/216.30  |- rdf__type mesh__D017983sskos__Concept
% 216.15/216.30  |- mesh__recordOriginator mesh__D017983 RAZ
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D031654 2005
% 216.15/216.30  |- skos__prefLabel mesh__D031654 Nuphar
% 216.15/216.30  |- skos__altLabel mesh__D031654 Lily, Yellow Pond
% 216.15/216.30  |- mesh__historyNote mesh__D031654 2003   
% 216.15/216.30  |- rdf__type mesh__D031654sskos__Concept
% 216.15/216.30  |- mesh__dateEstablished mesh__D031654 2003-01-01
% 216.15/216.30  |- mesh__publicMeSHNote mesh__D031654 2003   
% 216.15/216.30  |- skos__altLabel mesh__D031654 Pond Lily, Yellow
% 216.15/216.30  |- skos__annotation mesh__D031654
% 216.15/216.30       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D031654 2004
% 216.15/216.30  |- mesh__dateCreated mesh__D031654 2002-07-03
% 216.15/216.30  |- skos__broader mesh__D031654smesh__D030702
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D031654 2003
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D031654 2006
% 216.15/216.30  |- skos__scopeNote mesh__D031654
% 216.15/216.30       A plant genus of the family NYMPHAEACEAE. Members contain sesquiterpene thioalkaloids.%A%    
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D017185 2006
% 216.15/216.30  |- mesh__dateCreated mesh__D017185 1992-05-07
% 216.15/216.30  |- mesh__dateRevised mesh__D017185 2004-07-13
% 216.15/216.30  |- skos__prefLabel mesh__D017185 Angiostrongylus cantonensis
% 216.15/216.30  |- skos__scopeNote mesh__D017185
% 216.15/216.30       A species of parasitic nematodes distributed throughout the Pacific islands that infests the lungs of domestic rats. Human infection, caused by consumption of raw slugs and land snails, results in eosinophilic meningitis.%A%    
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D017185 2005
% 216.15/216.30  |- mesh__recordOriginator mesh__D017185 PXP
% 216.15/216.30  |- rdf__type mesh__D017185sskos__Concept
% 216.15/216.30  |- mesh__dateEstablished mesh__D017185 1993-01-01
% 216.15/216.30  |- mesh__historyNote mesh__D017185 93   
% 216.15/216.30  |- skos__historyNote mesh__D017185 Metastrongyloidea %28%1966-1990%29%
% 216.15/216.30  |- mesh__publicMeSHNote mesh__D017185 93   
% 216.15/216.30  |- skos__annotation mesh__D017185
% 216.15/216.30       a species of nematode in rat %26% man; infection: coord IM with STRONGYLIDA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 216.15/216.30  |- mesh__recordMaintainer mesh__D017185 sjn
% 216.15/216.30  |- mesh__recordAuthorizer mesh__D017185 sjn
% 216.15/216.30  |- skos__broader mesh__D017185smesh__D000801
% 216.15/216.30  |- skos__historyNote mesh__D017185 Angiostrongylus %28%1981-1992%29%
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003963 2003
% 216.15/216.30  |- mesh__dateCreated mesh__D003963 1999-01-01
% 216.15/216.30  |- skos__annotation mesh__D003963 an irritant dermatitis   
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003963 1998
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003963 2002
% 216.15/216.30  |- skos__altLabel mesh__D003963 Diaper Rashes
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003963 2006
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003963 1997
% 216.15/216.30  |- skos__hiddenLabel mesh__D003963 Rash, Diaper
% 216.15/216.30  |- mesh__recordMaintainer mesh__D003963 TAP
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003963 2001
% 216.15/216.30  |- skos__hiddenLabel mesh__D003963 Rashes, Diaper
% 216.15/216.30  |- skos__prefLabel mesh__D003963 Diaper Rash
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003963 2005
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003963 1996
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003963 1995
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003963 2000
% 216.15/216.30  |- skos__broader mesh__D003963smesh__D017453
% 216.15/216.30  |- skos__scopeNote mesh__D003963
% 216.15/216.30       A type of irritant dermatitis localized to the area in contact with a diaper and occurring most often as a reaction to prolonged contact with urine, feces, or retained soap or detergent.%A%    
% 216.15/216.30  |- mesh__recordAuthorizer mesh__D003963 PLS
% 216.15/216.30  |- mesh__recordOriginator mesh__D003963 NLM
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003963 2004
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003963 1994
% 216.15/216.30  |- rdf__type mesh__D003963sskos__Concept
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003963 1999
% 216.15/216.30  |- mesh__dateRevised mesh__D003963 1993-06-02
% 216.15/216.30  |- mesh__dateCreated mesh__D050010 2005-06-30
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D050010 2006B
% 216.15/216.30  |- skos__broader mesh__D050010smesh__D030342
% 216.15/216.30  |- mesh__publicMeSHNote mesh__D050010 2006   
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D050010 2006A
% 216.15/216.30  |- mesh__recordAuthorizer mesh__D050010 ags
% 216.15/216.30  |- mesh__dateEstablished mesh__D050010 2006-01-01
% 216.15/216.30  |- skos__scopeNote mesh__D050010
% 216.15/216.30       An inherited autosomal dominant trait characterized by abnormally elevated levels of total serum THYROXINE; %28%T4%29% in euthyroid patients with abnormal SERUM ALBUMIN that binds T4 with enhanced affinity. The serum levels of free T4, free T3, and TSH are normal. It is one of several T4 abnormalities produced by non-thyroid disorder. This condition is due to mutations of the ALB gene on CHROMOSOME 4.%A%    
% 216.15/216.30  |- mesh__recordOriginator mesh__D050010 lkt
% 216.15/216.30  |- mesh__recordMaintainer mesh__D050010 ags
% 216.15/216.30  |- skos__altLabel mesh__D050010 Familial Dysalbuminemic Hyperthyroxinemia
% 216.15/216.30  |- rdf__type mesh__D050010sskos__Concept
% 216.15/216.30  |- mesh__dateRevised mesh__D050010 2005-08-02
% 216.15/216.30  |- skos__prefLabel mesh__D050010 Hyperthyroxinemia, Familial Dysalbuminemic
% 216.15/216.30  |- skos__hiddenLabel mesh__D050010
% 216.15/216.30       Dysalbuminemic Hyperthyroxinemia, Familial
% 216.15/216.30  |- skos__historyNote mesh__D050010 Serum Albumin %28%1982-2005%29%
% 216.15/216.30  |- skos__historyNote mesh__D050010 Thyroxine %28%1982-2005%29%
% 216.15/216.30  |- skos__broader mesh__D050010smesh__D006981
% 216.15/216.30  |- mesh__historyNote mesh__D050010 2006   
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D050010 2006
% 216.15/216.30  |- mesh__recordOriginator mesh__D003165 NLM
% 216.15/216.30  |- skos__hiddenLabel mesh__D003165 Complement, Hemolytic
% 216.15/216.30  |- skos__hiddenLabel mesh__D003165 Proteins, Complement
% 216.15/216.30  |- skos__altLabel mesh__D003165 Complement Proteins
% 216.15/216.30  |- skos__related mesh__D003165smesh__D011951
% 216.15/216.30  |- skos__altLabel mesh__D003165 Complement
% 216.15/216.30  |- mesh__dateCreated mesh__D003165 1999-01-01
% 216.15/216.30  |- skos__hiddenLabel mesh__D003165 Protein, Complement
% 216.15/216.30  |- skos__annotation mesh__D003165
% 216.15/216.30       general or unspecified; prefer specifics   
% 216.15/216.30  |- mesh__dateRevised mesh__D003165 2005-06-30
% 216.15/216.30  |- skos__prefLabel mesh__D003165 Complement System Proteins
% 216.15/216.30  |- mesh__publicMeSHNote mesh__D003165 2006; see COMPLEMENT 1963-2005   
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003165 2006
% 216.15/216.30  |- skos__altLabel mesh__D003165 Complement Protein
% 216.15/216.30  |- skos__scopeNote mesh__D003165
% 216.15/216.30       Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation %28%CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY%29%.%A%    
% 216.15/216.30  |- skos__broader mesh__D003165smesh__D007162
% 216.15/216.30  |- mesh__historyNote mesh__D003165 2006 %28%1963%29%   
% 216.15/216.30  |- skos__hiddenLabel mesh__D003165 Proteins, Complement System
% 216.15/216.30  |- mesh__recordAuthorizer mesh__D003165 sjn
% 216.15/216.30  |- mesh__recordMaintainer mesh__D003165 lkt
% 216.15/216.30  |- skos__related mesh__D003165smesh__D003167
% 216.15/216.30  |- rdf__type mesh__D003165sskos__Concept
% 216.15/216.30  |- mesh__dateRevised mesh__D013593 1995-05-23
% 216.15/216.30  |- skos__prefLabel mesh__D013593 Syria
% 216.15/216.30  |- skos__broader mesh__D013593smesh__D008877
% 216.15/216.30  |- mesh__recordMaintainer mesh__D013593 KEV
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013593 2004
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013593 2002
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013593 2006
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013593 2003
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013593 2001
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013593 1997
% 216.15/216.30  |- mesh__recordOriginator mesh__D013593 NLM
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013593 2005
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013593 1999
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013593 1996
% 216.15/216.30  |- mesh__dateCreated mesh__D013593 1999-01-01
% 216.15/216.30  |- rdf__type mesh__D013593sskos__Concept
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013593 1998
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013593 2000
% 216.15/216.30  |- mesh__recordAuthorizer mesh__D013593 PLS
% 216.15/216.30  |- skos__broader mesh__D007556smesh__D011412
% 216.15/216.30  |- mesh__recordMaintainer mesh__D007556 ssb
% 216.15/216.30  |- rdf__type mesh__D007556sskos__Concept
% 216.15/216.30  |- skos__prefLabel mesh__D007556 Isoxsuprine
% 216.15/216.30  |- skos__broader mesh__D007556smesh__D010627
% 216.15/216.30  |- mesh__dateRevised mesh__D007556 2005-06-30
% 216.15/216.30  |- mesh__recordAuthorizer mesh__D007556 sjn
% 216.15/216.30  |- mesh__dateEstablished mesh__D007556 1973-01-01
% 216.15/216.30  |- skos__scopeNote mesh__D007556
% 216.15/216.30       A beta-adrenergic agonist that causes direct relaxation of uterine and vascular smooth muscle. Its vasodilating actions are greater on the arteries supplying skeletal muscle than on those supplying skin. It is used in the treatment of peripheral vascular disease and in premature labor.%A%    
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D007556 2006
% 216.15/216.30  |- skos__hiddenLabel mesh__D007556 Hydrochloride, Isoxsuprine
% 216.15/216.30  |- mesh__recordOriginator mesh__D007556 NLM
% 216.15/216.30  |- skos__historyNote mesh__D007556 Sympathomimetics %28%1966-1971%29%
% 216.15/216.30  |- skos__historyNote mesh__D007556 Amino Alcohols %28%1966-1971%29%
% 216.15/216.30  |- mesh__publicMeSHNote mesh__D007556 73   
% 216.15/216.30  |- mesh__dateCreated mesh__D007556 1999-01-01
% 216.15/216.30  |- mesh__historyNote mesh__D007556 73%28%72%29%   
% 216.15/216.30  |- skos__hiddenLabel mesh__D017984 PK10169
% 216.15/216.30  |- mesh__dateCreated mesh__D017984 1993-06-04
% 216.15/216.30  |- mesh__historyNote mesh__D017984
% 216.15/216.30       94; was heading 1992-93; was see HEPARIN, LOW-MOLECULAR-WEIGHT 1990-91%A%  
% 216.15/216.30  |- mesh__onlineNote mesh__D017984
% 216.15/216.30       use HEPARIN, LOW-MOLECULAR-WEIGHT to search ENOXAPARIN 1990-93%A%  
% 216.15/216.30  |- skos__hiddenLabel mesh__D017984 EMT967
% 216.15/216.30  |- mesh__recordMaintainer mesh__D017984 exl
% 216.15/216.30  |- skos__altLabel mesh__D017984 PK-10169
% 216.15/216.30  |- skos__hiddenLabel mesh__D017984 PK 10,169
% 216.15/216.30  |- mesh__recordOriginator mesh__D017984 TPW
% 216.15/216.30  |- mesh__dateEstablished mesh__D017984 1994-01-01
% 216.15/216.30  |- skos__hiddenLabel mesh__D017984 PK 10169
% 216.15/216.30  |- skos__hiddenLabel mesh__D017984 EMT 966
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D017984 2006
% 216.15/216.30  |- skos__prefLabel mesh__D017984 Enoxaparin
% 216.15/216.30  |- skos__altLabel mesh__D017984 Enoxaparine
% 216.15/216.30  |- rdf__type mesh__D017984sskos__Concept
% 216.15/216.30  |- skos__broader mesh__D017984smesh__D006495
% 216.15/216.30  |- mesh__dateRevised mesh__D017984 2005-06-30
% 216.15/216.30  |- skos__hiddenLabel mesh__D017984 EMT 967
% 216.15/216.30  |- mesh__publicMeSHNote mesh__D017984
% 216.15/216.30       92; was heading 1992-93; was see HEPARIN, LOW MOLECULAR WEIGHT 1990-91%A%  
% 216.15/216.30  |- skos__scopeNote mesh__D017984
% 216.15/216.30       Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. %28%From Merck Index, 11th ed%29%%A%    
% 216.15/216.30  |- skos__hiddenLabel mesh__D017984 PK10,169
% 216.15/216.30  |- skos__hiddenLabel mesh__D017984 EMT966
% 216.15/216.30  |- mesh__recordAuthorizer mesh__D017984 sjn
% 216.15/216.30  |- skos__scopeNote mesh__D031655
% 216.15/216.30       A plant genus of the family NYSSACEAE %28%or Cornaceae by some%29%.%A%    
% 216.15/216.30  |- rdf__type mesh__D031655sskos__Concept
% 216.15/216.30  |- mesh__publicMeSHNote mesh__D031655 2003   
% 216.15/216.30  |- skos__altLabel mesh__D031655 Tupelo
% 216.15/216.30  |- mesh__historyNote mesh__D031655 2003   
% 216.15/216.30  |- skos__annotation mesh__D031655
% 216.15/216.30       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D031655 2004
% 216.15/216.30  |- mesh__dateEstablished mesh__D031655 2003-01-01
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D031655 2006
% 216.15/216.30  |- skos__prefLabel mesh__D031655 Nyssa
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D031655 2003
% 216.15/216.30  |- skos__broader mesh__D031655smesh__D030701
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D031655 2005
% 216.15/216.30  |- mesh__dateCreated mesh__D031655 2002-07-03
% 216.15/216.30  |- mesh__dateEstablished mesh__D017186 1993-01-01
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D017186 2006
% 216.15/216.30  |- skos__hiddenLabel mesh__D017186 Titrations
% 216.15/216.30  |- mesh__recordOriginator mesh__D017186 TGC
% 216.15/216.30  |- mesh__publicMeSHNote mesh__D017186 93   
% 216.15/216.30  |- mesh__recordAuthorizer mesh__D017186 sjn
% 216.15/216.30  |- skos__historyNote mesh__D017186 specific technique %28%1966-1992%29%
% 216.15/216.30  |- rdf__type mesh__D017186sskos__Concept
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D017186 2003
% 216.15/216.30  |- mesh__historyNote mesh__D017186 93   
% 216.15/216.30  |- skos__broader mesh__D017186smesh__D002623
% 216.15/216.30  |- skos__scopeNote mesh__D017186
% 216.15/216.30       Chemical analysis by titration, the determination of a given component in solution by addition of a liquid reagent of known strength until a given endpoint %28%e.g., a change in color%29% is reached.%A%    
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D017186 2004
% 216.15/216.30  |- mesh__dateCreated mesh__D017186 1992-05-22
% 216.15/216.30  |- mesh__recordMaintainer mesh__D017186 lkt
% 216.15/216.30  |- skos__prefLabel mesh__D017186 Titrimetry
% 216.15/216.30  |- mesh__dateRevised mesh__D017186 2002-07-03
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D017186 2005
% 216.15/216.30  |- skos__annotation mesh__D017186
% 216.15/216.30       an anal chem technique; GEN %26% unspecified: prefer specifics; NIM%A%  
% 216.15/216.30  |- skos__scopeNote mesh__D003964
% 216.15/216.30       The musculofibrous partition that separates the THORACIC CAVITY from the ABDOMINAL CAVITY. Contraction of the diaphragm increases the volume of the thoracic cavity aiding INHALATION.%A%    
% 216.15/216.30  |- skos__annotation mesh__D003964
% 216.15/216.30       IM when organ of respiration; NIM in studies on muscle tissue; /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 216.15/216.30  |- skos__hiddenLabel mesh__D003964 Diaphragms, Respiratory
% 216.15/216.30  |- skos__hiddenLabel mesh__D003964 Diaphragms
% 216.15/216.30  |- mesh__recordMaintainer mesh__D003964 lkt
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003964 2006
% 216.15/216.30  |- skos__hiddenLabel mesh__D003964 Diaphragm, Respiratory
% 216.15/216.30  |- skos__altLabel mesh__D003964 Respiratory Diaphragm
% 216.15/216.30  |- mesh__recordOriginator mesh__D003964 NLM
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003964 2005
% 216.15/216.30  |- mesh__recordAuthorizer mesh__D003964 sjn
% 216.15/216.30  |- rdf__type mesh__D003964sskos__Concept
% 216.15/216.30  |- skos__hiddenLabel mesh__D003964 Respiratory Diaphragms
% 216.15/216.30  |- skos__prefLabel mesh__D003964 Diaphragm
% 216.15/216.30  |- skos__broader mesh__D003964smesh__D012132
% 216.15/216.30  |- mesh__dateCreated mesh__D003964 1999-01-01
% 216.15/216.30  |- mesh__dateRevised mesh__D003964 2004-07-07
% 216.15/216.30  |- mesh__recordOriginator mesh__D003166 RLS
% 216.15/216.30  |- mesh__recordMaintainer mesh__D003166 lkt
% 216.15/216.30  |- mesh__recordAuthorizer mesh__D003166 sjn
% 216.15/216.30  |- skos__hiddenLabel mesh__D003166 Activating Enzymes, Complement
% 216.15/216.30  |- skos__broader mesh__D003166smesh__D003165
% 216.15/216.30  |- skos__historyNote mesh__D003166 Esterases %28%1966-1977%29%
% 216.15/216.30  |- skos__historyNote mesh__D003166 Serum Globulins %28%1970-1977%29%
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D003166 2006
% 216.15/216.30  |- mesh__publicMeSHNote mesh__D003166 78   
% 216.15/216.30  |- skos__historyNote mesh__D003166 Complement %28%1968-1977%29%
% 216.15/216.30  |- skos__prefLabel mesh__D003166 Complement Activating Enzymes
% 216.15/216.30  |- skos__scopeNote mesh__D003166
% 216.15/216.30       Enzymes that activate one or more COMPLEMENT PROTEINS in the complement system leading to the formation of the COMPLEMENT MEMBRANE ATTACK COMPLEX, an important response in host defense. They are enzymes in the various COMPLEMENT ACTIVATION pathways.%A%    
% 216.15/216.30  |- skos__historyNote mesh__D003166 specific complement %28%1975-1977%29%
% 216.15/216.30  |- mesh__historyNote mesh__D003166 78   
% 216.15/216.30  |- skos__hiddenLabel mesh__D003166 Enzymes, Complement Activating
% 216.15/216.30  |- mesh__dateRevised mesh__D003166 2005-06-30
% 216.15/216.30  |- mesh__dateEstablished mesh__D003166 1978-01-01
% 216.15/216.30  |- skos__broader mesh__D003166smesh__D006867
% 216.15/216.30  |- rdf__type mesh__D003166sskos__Concept
% 216.15/216.30  |- skos__historyNote mesh__D003166 Hydrolases %28%1966-1977%29%
% 216.15/216.30  |- mesh__dateCreated mesh__D003166 1977-04-15
% 216.15/216.30  |- skos__altLabel mesh__D049268 PET Scan
% 216.15/216.30  |- mesh__dateEstablished mesh__D049268 2005-01-01
% 216.15/216.30  |- mesh__recordOriginator mesh__D049268 ssb
% 216.15/216.30  |- mesh__historyNote mesh__D049268
% 216.15/216.30       2005; use TOMOGRAPHY, EMISSION-COMPUTED 1979-2004   
% 216.15/216.30  |- skos__historyNote mesh__D049268
% 216.15/216.30       Tomography, Emission-Computed %28%1969-2004%29%
% 216.15/216.30  |- skos__hiddenLabel mesh__D049268 Positron Emission Tomography
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D049268 2005
% 216.15/216.30  |- mesh__publicMeSHNote mesh__D049268
% 216.15/216.30       2005; see TOMOGRAPHY, EMISSION-COMPUTED 1979-2004   
% 216.15/216.30  |- mesh__recordAuthorizer mesh__D049268 sjn
% 216.15/216.30  |- skos__prefLabel mesh__D049268 Positron-Emission Tomography
% 216.15/216.30  |- rdf__type mesh__D049268sskos__Concept
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D049268 2006
% 216.15/216.30  |- skos__hiddenLabel mesh__D049268 Scan, PET
% 216.15/216.30  |- skos__broader mesh__D049268smesh__D014055
% 216.15/216.30  |- mesh__recordMaintainer mesh__D049268 ssb
% 216.15/216.30  |- skos__altLabel mesh__D049268 Tomography, Positron-Emission
% 216.15/216.30  |- skos__scopeNote mesh__D049268
% 216.15/216.30       An imaging technique using compounds labelled with short-lived positron-emitting radionuclides %28%such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18%29% to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and BRAIN. SPECT is closely related to PET, but uses isotopes with longer half-lives and resolution is lower.%A%    
% 216.15/216.30  |- skos__hiddenLabel mesh__D049268 PET Scans
% 216.15/216.30  |- skos__hiddenLabel mesh__D049268 Tomography, Positron Emission
% 216.15/216.30  |- skos__hiddenLabel mesh__D049268 Scans, PET
% 216.15/216.30  |- mesh__dateCreated mesh__D049268 2004-07-07
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013594 2003
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013594 2005
% 216.15/216.30  |- mesh__recordMaintainer mesh__D013594 KEV
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013594 1996
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013594 2004
% 216.15/216.30  |- mesh__dateCreated mesh__D013594 1999-01-01
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013594 2002
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013594 1998
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013594 2006
% 216.15/216.30  |- mesh__dateRevised mesh__D013594 1995-05-23
% 216.15/216.30  |- skos__scopeNote mesh__D013594
% 216.15/216.30       Instruments used for injecting or withdrawing fluids. %28%Stedman, 25th ed%29%%A%    
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013594 1997
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013594 1999
% 216.15/216.30  |- skos__hiddenLabel mesh__D013594 Karman Syringe
% 216.15/216.30  |- skos__hiddenLabel mesh__D013594 Syringe
% 216.15/216.30  |- rdf__type mesh__D013594sskos__Concept
% 216.15/216.30  |- skos__prefLabel mesh__D013594 Syringes
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013594 2000
% 216.15/216.30  |- mesh__recordAuthorizer mesh__D013594 PLS
% 216.15/216.30  |- mesh__recordOriginator mesh__D013594 NLM
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D013594 2001
% 216.15/216.30  |- skos__broader mesh__D013594smesh__D004864
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D007557 2002
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D007557 1994
% 216.15/216.30  |- mesh__recordOriginator mesh__D007557 NLM
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D007557 1999
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D007557 2006
% 216.15/216.30  |- mesh__activeMeSHYear mesh__D007557 2004
% 216.15/216.31  |- mesh__activeMeSHYear mesh__D007557 1997
% 216.15/216.31  |- mesh__activeMeSHYear mesh__D007557 1998
% 216.15/216.31  |- mesh__dateRevised mesh__D007557 1992-05-20
% 216.15/216.31  |- mesh__activeMeSHYear mesh__D007557 2005
% 216.15/216.31  |- mesh__dateCreated mesh__D007557 1999-01-01
% 216.15/216.31  |- mesh__activeMeSHYear mesh__D007557 2001
% 216.15/216.31  |- mesh__activeMeSHYear mesh__D007557 1996
% 216.15/216.31  |- mesh__activeMeSHYear mesh__D007557 2003
% 216.15/216.31  |- mesh__activeMeSHYear mesh__D007557 2000
% 216.15/216.31  |- rdf__type mesh__D007557sskos__Concept
% 216.15/216.31  |- mesh__recordMaintainer mesh__D007557 PLS
% 216.15/216.31  |- mesh__activeMeSHYear mesh__D007557 1995
% 216.15/216.31  |- skos__prefLabel mesh__D007557 Israel
% 216.15/216.31  |- skos__broader mesh__D007557smesh__D008877
% 216.15/216.31  |- mesh__recordAuthorizer mesh__D007557 PLS
% 216.15/216.31  |- mesh__activeMeSHYear mesh__D007557 1993
% 216.15/216.31  |- mesh__publicMeSHNote mesh__D017985
% 216.15/216.31       2006%28%1994%29%; see TEDELPARIN 1994-2005, see HEPARIN, LOW-MOLECULAR-WEIGHT 1992-1993%A%  
% 216.15/216.31  |- skos__hiddenLabel mesh__D017985 Kabi2165
% 216.15/216.31  |- mesh__dateCreated mesh__D017985 1993-06-03
% 216.15/216.31  |- mesh__recordAuthorizer mesh__D017985 sjn
% 216.15/216.31  |- mesh__recordMaintainer mesh__D017985 ssb
% 216.15/216.31  |- skos__prefLabel mesh__D017985 Dalteparin
% 216.15/216.31  |- skos__historyNote mesh__D017985
% 216.15/216.31       Heparin, Low-Molecular-Weight %28%1988-1993%29%
% 216.15/216.31  |- mesh__activeMeSHYear mesh__D017985 2006
% 216.15/216.31  |- rdf__type mesh__D017985sskos__Concept
% 216.15/216.31  |- skos__altLabel mesh__D017985 Fragmine
% 216.15/216.31  |- skos__hiddenLabel mesh__D017985 FR860
% 216.15/216.31  |- skos__altLabel mesh__D017985 Tedelparin
% 216.15/216.31  |- mesh__dateEstablished mesh__D017985 1994-01-01
% 216.15/216.31  |- mesh__recordOriginator mesh__D017985 TPW
% 216.16/216.31  |- mesh__dateRevised mesh__D017985 2005-06-30
% 216.16/216.31  |- skos__broader mesh__D017985smesh__D006495
% 216.16/216.31  |- skos__hiddenLabel mesh__D017985 Kabi 2165
% 216.16/216.31  |- skos__hiddenLabel mesh__D017985 FR 860
% 216.16/216.31  |- skos__hiddenLabel mesh__D017985 Sodium, Dalteparin
% 216.16/216.31  |- skos__scopeNote mesh__D017985
% 216.16/216.31       A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. %28%From Merck Index, 11th ed%29%%A%    
% 216.16/216.31  |- mesh__historyNote mesh__D017985
% 216.16/216.31       2006%28%1994%29%; use HEPARIN, LOW-MOLECULAR-WEIGHT 1992-1993   
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D031656 2004
% 216.16/216.31  |- skos__scopeNote mesh__D031656
% 216.16/216.31       A small plant family of the order Santalales, subclass Rosidae, class Magnoliopsida.%A%    
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D031656 2006
% 216.16/216.31  |- mesh__dateCreated mesh__D031656 2002-07-03
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D031656 2003
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D031656 2005
% 216.16/216.31  |- skos__prefLabel mesh__D031656 Olacaceae
% 216.16/216.31  |- rdf__type mesh__D031656sskos__Concept
% 216.16/216.31  |- mesh__dateEstablished mesh__D031656 2003-01-01
% 216.16/216.31  |- skos__annotation mesh__D031656
% 216.16/216.31       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.16/216.31  |- skos__broader mesh__D031656smesh__D019684
% 216.16/216.31  |- skos__altLabel mesh__D031656 Muira Puama
% 216.16/216.31  |- mesh__historyNote mesh__D031656 2003   
% 216.16/216.31  |- mesh__publicMeSHNote mesh__D031656 2003   
% 216.16/216.31  |- mesh__recordOriginator mesh__D050810 DRC
% 216.16/216.31  |- rdf__type mesh__D050810sskos__Concept
% 216.16/216.31  |- skos__altLabel mesh__D050810 Oct Proteins
% 216.16/216.31  |- mesh__historyNote mesh__D050810 2006   
% 216.16/216.31  |- skos__hiddenLabel mesh__D050810 Transcription Factors, Octamer
% 216.16/216.31  |- mesh__dateEstablished mesh__D050810 2006-01-01
% 216.16/216.31  |- mesh__publicMeSHNote mesh__D050810 2006   
% 216.16/216.31  |- mesh__recordAuthorizer mesh__D050810 sjn
% 216.16/216.31  |- skos__scopeNote mesh__D050810
% 216.16/216.31       A family of POU domain factors that bind the octamer motif ATTTGCAT in PROMOTER and ENHANCER regions to regulate GENE EXPRESSION.%A%    
% 216.16/216.31  |- mesh__dateCreated mesh__D050810 2005-06-30
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D050810 2006
% 216.16/216.31  |- skos__broader mesh__D050810smesh__D050809
% 216.16/216.31  |- skos__annotation mesh__D050810 general; prefer specifics   
% 216.16/216.31  |- skos__prefLabel mesh__D050810 Octamer Transcription Factors
% 216.16/216.31  |- mesh__recordMaintainer mesh__D050810 DRC
% 216.16/216.31  |- skos__annotation mesh__D017187
% 216.16/216.31       an order of nematodes in plants; transmit plant viruses   
% 216.16/216.31  |- skos__prefLabel mesh__D017187 Tylenchida
% 216.16/216.31  |- rdf__type mesh__D017187sskos__Concept
% 216.16/216.31  |- mesh__dateEstablished mesh__D017187 1993-01-01
% 216.16/216.31  |- mesh__onlineNote mesh__D017187
% 216.16/216.31       use TYLENCHOIDEA to search TYLENCHIDA 1986-92   
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D017187 2004
% 216.16/216.31  |- mesh__dateRevised mesh__D017187 2003-07-09
% 216.16/216.31  |- skos__scopeNote mesh__D017187
% 216.16/216.31       An order of nematodes consisting of many species which are plant parasites. Female worms lay eggs that hatch either in soil or in the host plant.%A%    
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D017187 2005
% 216.16/216.31  |- mesh__historyNote mesh__D017187 93; was see TYLENCHOIDEA 1986-92   
% 216.16/216.31  |- skos__broader mesh__D017187smesh__D017161
% 216.16/216.31  |- mesh__dateCreated mesh__D017187 1992-05-22
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D017187 2006
% 216.16/216.31  |- mesh__publicMeSHNote mesh__D017187 93; was see TYLENCHOIDEA 1986-92   
% 216.16/216.31  |- skos__hiddenLabel mesh__D003965 Eventration, Diaphragmatic
% 216.16/216.31  |- skos__altLabel mesh__D003965 Eventration of Diaphragm
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D003965 2006
% 216.16/216.31  |- skos__prefLabel mesh__D003965 Diaphragmatic Eventration
% 216.16/216.31  |- skos__broader mesh__D003965smesh__D004065
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D003965 2005
% 216.16/216.31  |- rdf__type mesh__D003965sskos__Concept
% 216.16/216.31  |- skos__hiddenLabel mesh__D003965 Diaphragm Eventration
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D003965 2004
% 216.16/216.31  |- mesh__recordMaintainer mesh__D003965 lkt
% 216.16/216.31  |- mesh__dateCreated mesh__D003965 1999-01-01
% 216.16/216.31  |- mesh__recordOriginator mesh__D003965 NLM
% 216.16/216.31  |- mesh__dateRevised mesh__D003965 2003-07-09
% 216.16/216.31  |- skos__scopeNote mesh__D003965
% 216.16/216.31       A congenital abnormality characterized by the elevation of the DIAPHRAGM dome. It is the result of a thinned diaphragmatic muscle and injured PHRENIC NERVE, allowing the intra-abdominal viscera to push the diaphragm upward against the LUNG.%A%    
% 216.16/216.31  |- mesh__recordAuthorizer mesh__D003965 sjn
% 216.16/216.31  |- mesh__dateCreated mesh__D036341 2002-07-03
% 216.16/216.31  |- skos__related mesh__D036341smesh__D019899
% 216.16/216.31  |- mesh__dateRevised mesh__D036341 2005-07-18
% 216.16/216.31  |- mesh__recordOriginator mesh__D036341 jmp
% 216.16/216.31  |- skos__related mesh__D036341smesh__D017978
% 216.16/216.31  |- skos__prefLabel mesh__D036341
% 216.16/216.31       Intercellular Signaling Peptides and Proteins
% 216.16/216.31  |- skos__broader mesh__D036341smesh__D010455
% 216.16/216.31  |- mesh__recordAuthorizer mesh__D036341 ags
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D036341 2006A
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D036341 2006
% 216.16/216.31  |- mesh__publicMeSHNote mesh__D036341 2003   
% 216.16/216.31  |- skos__related mesh__D036341smesh__D036361
% 216.16/216.31  |- mesh__dateEstablished mesh__D036341 2003-01-01
% 216.16/216.31  |- skos__broader mesh__D036341smesh__D006133
% 216.16/216.31  |- skos__hiddenLabel mesh__D036341 Peptide Factors, Paracrine
% 216.16/216.31  |- skos__broader mesh__D036341smesh__D011506
% 216.16/216.31  |- skos__annotation mesh__D036341
% 216.16/216.31       coordinate with PARACRINE COMMUNICATION %28%NIM%29% if hormone action is localized; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS is also available%A%  
% 216.16/216.31  |- mesh__historyNote mesh__D036341 2003   
% 216.16/216.31  |- mesh__recordMaintainer mesh__D036341 ags
% 216.16/216.31  |- rdf__type mesh__D036341sskos__Concept
% 216.16/216.31  |- skos__scopeNote mesh__D036341
% 216.16/216.31       Regulatory proteins and peptides that are signaling molecules involved in the process of PARACRINE COMMUNICATION. They are generally considered factors that are expressed by one cell and are responded to by receptors on another nearby cell. They are distinguished from HORMONES in that their actions are local rather than distal.%A%    
% 216.16/216.31  |- mesh__dateRevised mesh__D003167 2005-06-30
% 216.16/216.31  |- mesh__historyNote mesh__D003167 79   
% 216.16/216.31  |- mesh__dateEstablished mesh__D003167 1979-01-01
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D003167 2006
% 216.16/216.31  |- skos__hiddenLabel mesh__D003167 Complement Activations
% 216.16/216.31  |- mesh__publicMeSHNote mesh__D003167 79   
% 216.16/216.31  |- mesh__recordAuthorizer mesh__D003167 sjn
% 216.16/216.31  |- skos__historyNote mesh__D003167
% 216.16/216.31       Complement Fixation Tests %28%1966-1978%29%
% 216.16/216.31  |- skos__broader mesh__D003167smesh__D007109
% 216.16/216.31  |- skos__historyNote mesh__D003167 Complement %28%1966-1978%29%
% 216.16/216.31  |- skos__scopeNote mesh__D003167
% 216.16/216.31       The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES.%A%    
% 216.16/216.31  |- mesh__recordMaintainer mesh__D003167 lkt
% 216.16/216.31  |- mesh__dateCreated mesh__D003167 1977-12-02
% 216.16/216.31  |- skos__related mesh__D003167smesh__D003168
% 216.16/216.31  |- mesh__recordOriginator mesh__D003167 AEP
% 216.16/216.31  |- rdf__type mesh__D003167sskos__Concept
% 216.16/216.31  |- skos__prefLabel mesh__D003167 Complement Activation
% 216.16/216.31  |- skos__hiddenLabel mesh__D003167 Activations, Complement
% 216.16/216.31  |- skos__hiddenLabel mesh__D003167 Activation, Complement
% 216.16/216.31  |- mesh__recordMaintainer mesh__D008650 TGC
% 216.16/216.31  |- mesh__dateCreated mesh__D008650 1974-11-19
% 216.16/216.31  |- skos__scopeNote mesh__D008650
% 216.16/216.31       The excretory organ of the embryo, collective Wolffian tubules, which forms the urogenital fold from which the reproductive organs develop. The mesonephros is the permanent kidney in fish and amphibians, but atrophies in reptiles, birds, and mammals.%A%    
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D008650 1996
% 216.16/216.31  |- mesh__publicMeSHNote mesh__D008650 75   
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D008650 1995
% 216.16/216.31  |- mesh__historyNote mesh__D008650 75   
% 216.16/216.31  |- mesh__dateRevised mesh__D008650 1991-01-07
% 216.16/216.31  |- skos__prefLabel mesh__D008650 Mesonephros
% 216.16/216.31  |- skos__historyNote mesh__D008650 Kidney %28%1966-1974%29%
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D008650 2006
% 216.16/216.31  |- mesh__recordAuthorizer mesh__D008650 PLS
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D008650 2002
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D008650 1994
% 216.16/216.31  |- skos__broader mesh__D008650smesh__D004622
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D008650 1993
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D008650 1999
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D008650 2005
% 216.16/216.31  |- mesh__recordOriginator mesh__D008650 NLM
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D008650 2001
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D008650 2004
% 216.16/216.31  |- rdf__type mesh__D008650sskos__Concept
% 216.16/216.31  |- skos__hiddenLabel mesh__D008650 Body, Wolffian
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D008650 2000
% 216.16/216.31  |- mesh__dateEstablished mesh__D008650 1975-09-01
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D008650 1992
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D008650 1998
% 216.16/216.31  |- skos__altLabel mesh__D008650 Wolffian Body
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D008650 1997
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D008650 2003
% 216.16/216.31  |- skos__broader mesh__D022321smesh__D014765
% 216.16/216.31  |- skos__hiddenLabel mesh__D022321 Vaccines, Japanese Encephalitis
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D022321 2006
% 216.16/216.31  |- skos__hiddenLabel mesh__D022321 Encephalitis Vaccines, Japanese
% 216.16/216.31  |- mesh__dateRevised mesh__D022321 2005-06-30
% 216.16/216.31  |- skos__prefLabel mesh__D022321 Japanese Encephalitis Vaccines
% 216.16/216.31  |- mesh__recordMaintainer mesh__D022321 ssb
% 216.16/216.31  |- mesh__publicMeSHNote mesh__D022321 2001   
% 216.16/216.31  |- rdf__type mesh__D022321sskos__Concept
% 216.16/216.31  |- mesh__dateCreated mesh__D022321 2000-06-22
% 216.16/216.31  |- mesh__recordOriginator mesh__D022321 ags
% 216.16/216.31  |- mesh__historyNote mesh__D022321 2001   
% 216.16/216.31  |- skos__annotation mesh__D022321
% 216.16/216.31       vaccines to prevent infections caused by ENCEPHALITIS VIRUS, JAPANESE only, not ENCEPHALITIS VIRUSES, JAPANESE.%A%  
% 216.16/216.31  |- mesh__recordAuthorizer mesh__D022321 sjn
% 216.16/216.31  |- skos__historyNote mesh__D022321 Viral Vaccines %28%1966-2000%29%
% 216.16/216.31  |- mesh__dateEstablished mesh__D022321 2001-01-01
% 216.16/216.31  |- skos__scopeNote mesh__D022321
% 216.16/216.31       Vaccines or candidate vaccines used to prevent infection with Japanese B encephalitis virus %28%ENCEPHALITIS VIRUS, JAPANESE%29%.%A%    
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D049269 2005
% 216.16/216.31  |- rdf__type mesh__D049269sskos__Concept
% 216.16/216.31  |- skos__historyNote mesh__D049269 Telecommunications %28%1983-2004%29%
% 216.16/216.31  |- skos__hiddenLabel mesh__D049269 Videoconferencings
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D049269 2006
% 216.16/216.31  |- mesh__recordMaintainer mesh__D049269 ags
% 216.16/216.31  |- mesh__dateEstablished mesh__D049269 2005-01-01
% 216.16/216.31  |- mesh__publicMeSHNote mesh__D049269 2005   
% 216.16/216.31  |- mesh__dateRevised mesh__D049269 2005-07-12
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D049269 2006A
% 216.16/216.31  |- mesh__historyNote mesh__D049269 2005   
% 216.16/216.31  |- skos__hiddenLabel mesh__D049269 Videoconferences
% 216.16/216.31  |- skos__scopeNote mesh__D049269
% 216.16/216.31       Communications via an interactive conference between two or more participants at different sites, using computer networks %28%COMPUTER COMMUNICATION NETWORKS%29% or other telecommunication links to transmit audio, video, and data.%A%    
% 216.16/216.31  |- mesh__dateCreated mesh__D049269 2004-07-07
% 216.16/216.31  |- skos__broader mesh__D049269smesh__D013685
% 216.16/216.31  |- mesh__recordAuthorizer mesh__D049269 ags
% 216.16/216.31  |- skos__prefLabel mesh__D049269 Videoconferencing
% 216.16/216.31  |- mesh__recordOriginator mesh__D049269 ags
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D013595 2000
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D013595 2000A
% 216.16/216.31  |- skos__hiddenLabel mesh__D013595 Morvans Disease
% 216.16/216.31  |- skos__hiddenLabel mesh__D013595 Morvan%27%s Diseases
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D013595 2004
% 216.16/216.31  |- mesh__recordOriginator mesh__D013595 NLM
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D013595 2001
% 216.16/216.31  |- mesh__dateCreated mesh__D013595 1999-01-01
% 216.16/216.31  |- skos__hiddenLabel mesh__D013595 Morvan Diseases
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D013595 2006
% 216.16/216.31  |- skos__broader mesh__D013595smesh__D013118
% 216.16/216.31  |- mesh__recordMaintainer mesh__D013595 ags
% 216.16/216.31  |- skos__hiddenLabel mesh__D013595 Myelosyringoses
% 216.16/216.31  |- skos__prefLabel mesh__D013595 Syringomyelia
% 216.16/216.31  |- skos__altLabel mesh__D013595 Myelosyringosis
% 216.16/216.31  |- rdf__type mesh__D013595sskos__Concept
% 216.16/216.31  |- skos__altLabel mesh__D013595 Syringomyelus
% 216.16/216.31  |- mesh__recordAuthorizer mesh__D013595 ags
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D013595 2002
% 216.16/216.31  |- skos__hiddenLabel mesh__D013595 Syringomyelias
% 216.16/216.31  |- skos__altLabel mesh__D013595 Morvan%27%s Disease
% 216.16/216.31  |- skos__scopeNote mesh__D013595
% 216.16/216.31       Longitudinal cavities in the spinal cord, most often in the cervical region, which may extend for multiple spinal levels. The cavities are lined by dense, gliogenous tissue and may be associated with SPINAL CORD NEOPLASMS; spinal cord traumatic injuries; and vascular malformations. Syringomyelia is marked clinically by pain and PARESTHESIA, muscular atrophy of the hands, and analgesia with thermoanesthesia of the hands and arms, but with the tactile sense preserved %28%sensory dissociation%29%. Lower extremity spasticity and incontinence may also develop. %28%From Adams et al., Principles of Neurology, 6th ed, p1269%29%%A%    
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D013595 2003
% 216.16/216.31  |- mesh__dateRevised mesh__D013595 1999-12-07
% 216.16/216.31  |- skos__hiddenLabel mesh__D013595 Hydrosyringomyelias
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D013595 2005
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D007558 1992
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D007558 2005
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D007558 1997
% 216.16/216.31  |- mesh__recordAuthorizer mesh__D007558 PLS
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D007558 2004
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D007558 1998
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D007558 2002
% 216.16/216.31  |- mesh__dateCreated mesh__D007558 1999-01-01
% 216.16/216.31  |- skos__broader mesh__D007558smesh__D005060
% 216.16/216.31  |- mesh__dateRevised mesh__D007558 1991-11-25
% 216.16/216.31  |- mesh__recordOriginator mesh__D007558 NLM
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D007558 1996
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D007558 2003
% 216.16/216.31  |- rdf__type mesh__D007558sskos__Concept
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D007558 1995
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D007558 2001
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D007558 1993
% 216.16/216.31  |- skos__annotation mesh__D007558
% 216.16/216.31       ROME %26% VATICAN CITY are also available   
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D007558 1994
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D007558 2000
% 216.16/216.31  |- skos__prefLabel mesh__D007558 Italy
% 216.16/216.31  |- mesh__recordMaintainer mesh__D007558 PLS
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D007558 1999
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D007558 2006
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D018280 1996
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D018280 2000
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D018280 1998
% 216.16/216.31  |- skos__prefLabel mesh__D018280 Carcinoma, Skin Appendage
% 216.16/216.31  |- skos__broader mesh__D018280smesh__D018294
% 216.16/216.31  |- skos__scopeNote mesh__D018280
% 216.16/216.31       A malignant tumor of the skin appendages, which include the hair, nails, sebaceous glands, sweat glands, and the mammary glands. %28%From Dorland, 27th ed%29%%A%    
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D018280 1997
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D018280 2003
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D018280 2001
% 216.16/216.31  |- mesh__recordOriginator mesh__D018280 PLS
% 216.16/216.31  |- skos__hiddenLabel mesh__D018280 Carcinomas, Skin Appendage
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D018280 1999
% 216.16/216.31  |- mesh__dateEstablished mesh__D018280 1994-01-01
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D018280 2005
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D018280 2004
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D018280 2006
% 216.16/216.31  |- mesh__dateRevised mesh__D018280 2005-08-02
% 216.16/216.31  |- mesh__historyNote mesh__D018280 94   
% 216.16/216.31  |- mesh__recordAuthorizer mesh__D018280 ags
% 216.16/216.31  |- rdf__type mesh__D018280sskos__Concept
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D018280 2006A
% 216.16/216.31  |- skos__annotation mesh__D018280
% 216.16/216.31       coordinate IM with SKIN NEOPLASMS %28%IM%29% or specific pre-coordinated skin appendage/ neoplasm term %28%IM%29%%A%  
% 216.16/216.31  |- skos__hiddenLabel mesh__D018280 Skin Appendage Carcinoma
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D018280 2002
% 216.16/216.31  |- skos__hiddenLabel mesh__D018280 Appendage Carcinomas, Skin
% 216.16/216.31  |- mesh__dateCreated mesh__D018280 1993-06-03
% 216.16/216.31  |- mesh__publicMeSHNote mesh__D018280 94   
% 216.16/216.31  |- skos__broader mesh__D018280smesh__D000230
% 216.16/216.31  |- skos__hiddenLabel mesh__D018280 Appendage Carcinoma, Skin
% 216.16/216.31  |- skos__hiddenLabel mesh__D018280 Skin Appendage Carcinomas
% 216.16/216.31  |- mesh__recordMaintainer mesh__D018280 ags
% 216.16/216.31  |- skos__hiddenLabel mesh__D026712 Life Sanctities
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D026712 2003
% 216.16/216.31  |- mesh__dateEstablished mesh__D026712 2002-01-01
% 216.16/216.31  |- skos__hiddenLabel mesh__D026712 Economic Life Valuations
% 216.16/216.31  |- skos__altLabel mesh__D026712 Sanctity of Life
% 216.16/216.31  |- skos__altLabel mesh__D026712 Life Economic Value
% 216.16/216.31  |- mesh__recordOriginator mesh__D026712 tjk
% 216.16/216.31  |- mesh__recordMaintainer mesh__D026712 ags
% 216.16/216.31  |- mesh__dateRevised mesh__D026712 2002-07-03
% 216.16/216.31  |- skos__altLabel mesh__D026712 Economic Life Valuation
% 216.16/216.31  |- skos__altLabel mesh__D026712 Economic Value, Life
% 216.16/216.31  |- skos__related mesh__D026712smesh__D012945
% 216.16/216.31  |- skos__hiddenLabel mesh__D026712 Life, Respect for
% 216.16/216.31  |- mesh__historyNote mesh__D026712 2002   
% 216.16/216.31  |- skos__hiddenLabel mesh__D026712 Valuations, Economic Life
% 216.16/216.31  |- skos__hiddenLabel mesh__D026712 Life Sanctity
% 216.16/216.31  |- mesh__dateCreated mesh__D026712 2001-07-25
% 216.16/216.31  |- skos__broader mesh__D026712smesh__D019369
% 216.16/216.31  |- skos__altLabel mesh__D026712 Valuation, Economic Life
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D026712 2006
% 216.16/216.31  |- mesh__publicMeSHNote mesh__D026712
% 216.16/216.31       2002; for ECONOMIC VALUE OF LIFE %26% LIFE VALUATION, ECONOMIC see ECONOMIC VALUE OF LIFE 1991-2001; see ECONOMICS 1983-1990%A%  
% 216.16/216.31  |- skos__related mesh__D026712smesh__D011788
% 216.16/216.31  |- skos__historyNote mesh__D026712 Quality of Life %28%1976-2001%29%
% 216.16/216.31  |- skos__altLabel mesh__D026712 Economic Values, Life
% 216.16/216.31  |- skos__hiddenLabel mesh__D026712 Life Valuations, Economic
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D026712 2005
% 216.16/216.31  |- rdf__type mesh__D026712sskos__Concept
% 216.16/216.31  |- skos__annotation mesh__D026712
% 216.16/216.31       X ref ECONOMIC VALUE OF LIFE: coord with /econ + specific economics tern%A%  
% 216.16/216.31  |- skos__hiddenLabel mesh__D026712 Life, Right to
% 216.16/216.31  |- skos__prefLabel mesh__D026712 Value of Life
% 216.16/216.31  |- skos__scopeNote mesh__D026712
% 216.16/216.31       The intrinsic moral worth ascribed to a living being. %28%Bioethics Thesaurus%29%%A%    
% 216.16/216.31  |- skos__altLabel mesh__D026712 Respect for Life
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D026712 2004
% 216.16/216.31  |- mesh__recordAuthorizer mesh__D026712 sjn
% 216.16/216.31  |- skos__altLabel mesh__D026712 Life Economic Values
% 216.16/216.31  |- rdf__type mesh__D004260sskos__Concept
% 216.16/216.31  |- mesh__dateRevised mesh__D004260 2003-07-09
% 216.16/216.31  |- skos__related mesh__D004260smesh__D011740
% 216.16/216.31  |- mesh__dateEstablished mesh__D004260 1974-01-01
% 216.16/216.31  |- skos__broader mesh__D004260smesh__D039361
% 216.16/216.31  |- mesh__recordOriginator mesh__D004260 NLM
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D004260 2005
% 216.16/216.31  |- skos__hiddenLabel mesh__D004260 Excision Repairs
% 216.16/216.31  |- skos__hiddenLabel mesh__D004260 Excision Repair, Nucleotide
% 216.16/216.31  |- skos__hiddenLabel mesh__D004260 Nucleotide Excision Repairs
% 216.16/216.31  |- skos__hiddenLabel mesh__D004260 Base Excision Repairs
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D004260 2006
% 216.16/216.31  |- skos__historyNote mesh__D004260 DNA/biosynthesis %28%1966-1970%29%
% 216.16/216.31  |- mesh__dateCreated mesh__D004260 1999-01-01
% 216.16/216.31  |- mesh__recordAuthorizer mesh__D004260 sjn
% 216.16/216.31  |- skos__hiddenLabel mesh__D004260 Repair, Excision
% 216.16/216.31  |- skos__historyNote mesh__D004260 DNA %28%1966-1970%29%
% 216.16/216.31  |- mesh__historyNote mesh__D004260 74%28%71%29%   
% 216.16/216.31  |- skos__scopeNote mesh__D004260
% 216.16/216.31       The reconstruction of a continuous two-stranded DNA molecule without mismatch from a molecule which contained damaged regions. The major repair mechanisms are excision repair, in which defective regions in one strand are excised and resynthesized using the complementary base pairing information in the intact strand; photoreactivation repair, in which the lethal and mutagenic effects of ultraviolet light are eliminated; and post-replication repair, in which the primary lesions are not repaired, but the gaps in one daughter duplex are filled in by incorporation of portions of the other %28%undamaged%29% daughter duplex. Excision repair and post-replication repair are sometimes referred to as %22%dark repair%22% because they do not require light.%A%    
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D004260 2004
% 216.16/216.31  |- skos__hiddenLabel mesh__D004260 Repair, Base Excision
% 216.16/216.31  |- mesh__recordMaintainer mesh__D004260 jmp
% 216.16/216.31  |- skos__hiddenLabel mesh__D004260 Repairs, Base Excision
% 216.16/216.31  |- skos__annotation mesh__D004260 coord IM with specific DNA %28%IM%29%   
% 216.16/216.31  |- skos__hiddenLabel mesh__D004260 Excision Repair, Base
% 216.16/216.31  |- mesh__publicMeSHNote mesh__D004260 74   
% 216.16/216.31  |- skos__prefLabel mesh__D004260 DNA Repair
% 216.16/216.31  |- skos__broader mesh__D014841Q000172smesh__D014841
% 216.16/216.31  |- mesh__preferredCombination mesh__D014841Q000172smesh__D014842
% 216.16/216.31  |- rdf__type mesh__D014841Q000172smesh__CompoundConcept
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D017986 2005
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D017986 2004
% 216.16/216.31  |- skos__scopeNote mesh__D017986
% 216.16/216.31       A group of viruses in the genus GAMMARETROVIRUS comprising a few isolates from birds, with no known corresponding endogenous relatives.%A%    
% 216.16/216.31  |- skos__annotation mesh__D017986
% 216.16/216.31       coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%%A%  
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D017986 2006
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D017986 2002
% 216.16/216.31  |- mesh__dateCreated mesh__D017986 1993-06-04
% 216.16/216.31  |- mesh__dateRevised mesh__D017986 2001-07-25
% 216.16/216.31  |- skos__hiddenLabel mesh__D017986 virus, Chick syncytial
% 216.16/216.31  |- skos__broader mesh__D017986smesh__D017988
% 216.16/216.31  |- rdf__type mesh__D017986sskos__Concept
% 216.16/216.31  |- skos__hiddenLabel mesh__D017986 Viruses, Avian Reticuloendotheliosis
% 216.16/216.31  |- skos__hiddenLabel mesh__D017986 syncytial viruses, Chick
% 216.16/216.31  |- skos__hiddenLabel mesh__D017986 viruses, Chick syncytial
% 216.16/216.31  |- skos__hiddenLabel mesh__D017986 Reticuloendotheliosis Virus, Avian
% 216.16/216.31  |- mesh__recordOriginator mesh__D017986 AGS
% 216.16/216.31  |- mesh__recordAuthorizer mesh__D017986 sjn
% 216.16/216.31  |- skos__hiddenLabel mesh__D017986 syncytial virus, Chick
% 216.16/216.31  |- skos__hiddenLabel mesh__D017986 Chick syncytial viruses
% 216.16/216.31  |- skos__altLabel mesh__D017986 Avian Reticuloendotheliosis Viruses
% 216.16/216.31  |- skos__altLabel mesh__D017986 Avian Reticuloendotheliosis Virus Group
% 216.16/216.31  |- skos__hiddenLabel mesh__D017986 Avian Reticuloendotheliosis Virus
% 216.16/216.31  |- mesh__dateEstablished mesh__D017986 1994-01-01
% 216.16/216.31  |- mesh__publicMeSHNote mesh__D017986
% 216.16/216.31       2002; see RETICULOENDOTHELIOSIS VIRUSES 1994-2001   
% 216.16/216.31  |- skos__hiddenLabel mesh__D017986 Virus, Avian Reticuloendotheliosis
% 216.16/216.31  |- skos__prefLabel mesh__D017986 Reticuloendotheliosis Viruses, Avian
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D017986 2003
% 216.16/216.31  |- mesh__recordMaintainer mesh__D017986 ags
% 216.16/216.31  |- mesh__historyNote mesh__D017986 2002 %28%1994%29%   
% 216.16/216.31  |- mesh__historyNote mesh__D031657 2003   
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D031657 2006
% 216.16/216.31  |- mesh__activeMeSHYear mesh__D031657 2003
% 216.16/216.31  |- skos__scopeNote mesh__D031657
% 216.16/216.31       A plant genus of the family OLEACEAE. Members contain suspensaside.%A%    
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D031657 2005
% 216.16/216.32  |- skos__altLabel mesh__D031657 Lian qiao
% 216.16/216.32  |- skos__altLabel mesh__D031657 Goldenbells
% 216.16/216.32  |- rdf__type mesh__D031657sskos__Concept
% 216.16/216.32  |- mesh__dateCreated mesh__D031657 2002-07-03
% 216.16/216.32  |- skos__broader mesh__D031657smesh__D029592
% 216.16/216.32  |- mesh__publicMeSHNote mesh__D031657 2003   
% 216.16/216.32  |- skos__prefLabel mesh__D031657 Forsythia
% 216.16/216.32  |- skos__annotation mesh__D031657
% 216.16/216.32       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D031657 2004
% 216.16/216.32  |- mesh__dateEstablished mesh__D031657 2003-01-01
% 216.16/216.32  |- mesh__historyNote mesh__D050811 2006%28%1986%29%   
% 216.16/216.32  |- mesh__recordAuthorizer mesh__D050811 ags
% 216.16/216.32  |- skos__hiddenLabel mesh__D050811 Transcription Factor, Oct-1
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D050811 2006B
% 216.16/216.32  |- skos__altLabel mesh__D050811 Oct-1 Transcription Factor
% 216.16/216.32  |- mesh__recordMaintainer mesh__D050811 ags
% 216.16/216.32  |- skos__hiddenLabel mesh__D050811 Transcription Factor-1, Octamer
% 216.16/216.32  |- skos__hiddenLabel mesh__D050811 Oct-1, Transcription Factor
% 216.16/216.32  |- skos__hiddenLabel mesh__D050811 Transcription Factor Oct 1
% 216.16/216.32  |- skos__hiddenLabel mesh__D050811 Oct 1 Transcription Factor
% 216.16/216.32  |- skos__altLabel mesh__D050811 Nuclear Factor III
% 216.16/216.32  |- skos__prefLabel mesh__D050811 Octamer Transcription Factor-1
% 216.16/216.32  |- skos__hiddenLabel mesh__D050811 Transcription Factor, NFIII
% 216.16/216.32  |- skos__hiddenLabel mesh__D050811 Transcription Factor OTF 1
% 216.16/216.32  |- skos__altLabel mesh__D050811 Octamer Transcription Factor OTF-1
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D050811 2006
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D050811 2006A
% 216.16/216.32  |- mesh__dateEstablished mesh__D050811 2006-01-01
% 216.16/216.32  |- skos__altLabel mesh__D050811 Transcription Factor OTF-1
% 216.16/216.32  |- skos__altLabel mesh__D050811 OTF-1 Transcription Factor
% 216.16/216.32  |- skos__altLabel mesh__D050811 NFIII Transcription Factor
% 216.16/216.32  |- skos__broader mesh__D050811smesh__D050810
% 216.16/216.32  |- mesh__publicMeSHNote mesh__D050811
% 216.16/216.32       2006; TRANSCRIPTION FACTOR OCT-1 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005, NUCLEAR PROTEINS 1986-1989, %26% NUCLEOPROTEINS 1986-1987%A%  
% 216.16/216.32  |- skos__hiddenLabel mesh__D050811 OTF 1 Transcription Factor
% 216.16/216.32  |- skos__altLabel mesh__D050811 Octamer Transcription Factor 1
% 216.16/216.32  |- mesh__recordOriginator mesh__D050811 DRC
% 216.16/216.32  |- skos__altLabel mesh__D050811 Transcription Factor Oct-1
% 216.16/216.32  |- mesh__dateCreated mesh__D050811 2005-06-30
% 216.16/216.32  |- skos__hiddenLabel mesh__D050811 OTF-1, Transcription Factor
% 216.16/216.32  |- skos__scopeNote mesh__D050811
% 216.16/216.32       A ubiquitously expressed octamer transcription factor that regulates GENETIC TRANSCRIPTION of SMALL NUCLEAR RNA; IMMUNOGLOBULIN GENES; and HISTONE H2B genes.%A%    
% 216.16/216.32  |- rdf__type mesh__D050811sskos__Concept
% 216.16/216.32  |- skos__hiddenLabel mesh__D050811 Octamer Transcription Factor OTF 1
% 216.16/216.32  |- mesh__dateRevised mesh__D050811 2005-08-03
% 216.16/216.32  |- skos__hiddenLabel mesh__D050811 Transcription Factor, OTF-1
% 216.16/216.32  |- skos__prefLabel mesh__D017188 Adenophorea Infections
% 216.16/216.32  |- mesh__dateRevised mesh__D017188 1993-06-04
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017188 2004
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017188 1997
% 216.16/216.32  |- skos__hiddenLabel mesh__D017188 Infection, Aphasmidia
% 216.16/216.32  |- skos__altLabel mesh__D017188 Infections, Adenophorea
% 216.16/216.32  |- skos__hiddenLabel mesh__D017188 Infection, Adenophorea
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017188 2001
% 216.16/216.32  |- skos__hiddenLabel mesh__D017188 Adenophorea Infection
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017188 2005
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017188 1998
% 216.16/216.32  |- mesh__recordOriginator mesh__D017188 PXP
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017188 2002
% 216.16/216.32  |- skos__annotation mesh__D017188 nematode infect   
% 216.16/216.32  |- skos__altLabel mesh__D017188 Infections, Aphasmidia
% 216.16/216.32  |- mesh__dateEstablished mesh__D017188 1993-01-01
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017188 2006
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017188 1994
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017188 1999
% 216.16/216.32  |- mesh__dateCreated mesh__D017188 1992-05-07
% 216.16/216.32  |- skos__scopeNote mesh__D017188
% 216.16/216.32       Infections with nematodes of the subclass ADENOPHOREA.     
% 216.16/216.32  |- mesh__recordMaintainer mesh__D017188 JLS
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017188 1995
% 216.16/216.32  |- skos__broader mesh__D017188smesh__D009349
% 216.16/216.32  |- skos__hiddenLabel mesh__D017188 Aphasmidia Infection
% 216.16/216.32  |- rdf__type mesh__D017188sskos__Concept
% 216.16/216.32  |- mesh__publicMeSHNote mesh__D017188 93   
% 216.16/216.32  |- skos__altLabel mesh__D017188 Aphasmidia Infections
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017188 2003
% 216.16/216.32  |- mesh__historyNote mesh__D017188 93   
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017188 1996
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017188 2000
% 216.16/216.32  |- mesh__recordAuthorizer mesh__D017188 PLS
% 216.16/216.32  |- skos__hiddenLabel mesh__D003966 Disease, Engelmann%27%s
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003966 2005
% 216.16/216.32  |- mesh__recordMaintainer mesh__D003966 PLS
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003966 2000
% 216.16/216.32  |- skos__hiddenLabel mesh__D003966 Dysplasia, Progressive Diaphyseal
% 216.16/216.32  |- rdf__type mesh__D003966sskos__Concept
% 216.16/216.32  |- skos__hiddenLabel mesh__D003966 Disease, Engelmann
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003966 1995
% 216.16/216.32  |- mesh__recordOriginator mesh__D003966 NLM
% 216.16/216.32  |- skos__hiddenLabel mesh__D003966 Diaphyseal Dysplasias, Progressive
% 216.16/216.32  |- mesh__recordAuthorizer mesh__D003966 PLS
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003966 2004
% 216.16/216.32  |- skos__altLabel mesh__D003966 Engelmann%27%s Disease
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003966 1999
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003966 1994
% 216.16/216.32  |- mesh__dateRevised mesh__D003966 1991-06-18
% 216.16/216.32  |- skos__hiddenLabel mesh__D003966 Syndrome, Camurati-Engelmann
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003966 2003
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003966 1993
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003966 1998
% 216.16/216.32  |- skos__hiddenLabel mesh__D003966 Dysplasias, Progressive Diaphyseal
% 216.16/216.32  |- skos__scopeNote mesh__D003966
% 216.16/216.32       Progressive thickening of diaphyseal cortex of long bones.%A%    
% 216.16/216.32  |- mesh__historyNote mesh__D003966
% 216.16/216.32       91%28%75%29%; was see under OSTEOCHONDRODYSPLASIAS 1985-90; was see under BONE DISEASES, DEVELOPMENTAL 1975-84%A%  
% 216.16/216.32  |- skos__broader mesh__D003966smesh__D010009
% 216.16/216.32  |- skos__altLabel mesh__D003966 Engelmann Disease
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003966 1992
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003966 1997
% 216.16/216.32  |- mesh__dateEstablished mesh__D003966 1991-01-01
% 216.16/216.32  |- mesh__dateCreated mesh__D003966 1974-11-11
% 216.16/216.32  |- skos__hiddenLabel mesh__D003966 Camurati Engelmann Syndrome
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003966 2002
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003966 1996
% 216.16/216.32  |- skos__altLabel mesh__D003966 Camurati-Engelmann Syndrome
% 216.16/216.32  |- mesh__publicMeSHNote mesh__D003966
% 216.16/216.32       91; was see under OSTEOCHONDRODYSPLASIAS 1985-90; was see under BONE DISEASES, DEVELOPMENTAL 1975-84%A%  
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003966 2006
% 216.16/216.32  |- skos__prefLabel mesh__D003966 Diaphyseal Dysplasia, Progressive
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003966 2001
% 216.16/216.32  |- skos__altLabel mesh__D036342 Eph Receptor Ligands
% 216.16/216.32  |- skos__prefLabel mesh__D036342 Ephrins
% 216.16/216.32  |- skos__hiddenLabel mesh__D036342 Ligands, Eph Receptor
% 216.16/216.32  |- skos__broader mesh__D036342smesh__D036341
% 216.16/216.32  |- mesh__recordAuthorizer mesh__D036342 sjn
% 216.16/216.32  |- mesh__historyNote mesh__D036342 2003   
% 216.16/216.32  |- mesh__recordMaintainer mesh__D036342 ssb
% 216.16/216.32  |- mesh__dateCreated mesh__D036342 2002-07-03
% 216.16/216.32  |- skos__hiddenLabel mesh__D036342 Receptor Ligands, Eph
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D036342 2006
% 216.16/216.32  |- mesh__publicMeSHNote mesh__D036342 2003   
% 216.16/216.32  |- mesh__recordOriginator mesh__D036342 jmp
% 216.16/216.32  |- mesh__dateRevised mesh__D036342 2005-06-30
% 216.16/216.32  |- skos__broader mesh__D036342smesh__D008565
% 216.16/216.32  |- skos__scopeNote mesh__D036342
% 216.16/216.32       Signaling proteins that are ligands for the EPH FAMILY RECEPTORS. They are membrane-bound proteins that are attached to the CELL MEMBRANE either through a GLYCOINOSITOL PHOSPHOLIPID MEMBRANE ANCHOR or through a transmembrane domain. Many of the ephrins are considered important intercellular signaling molecules that control morphogenic changes during embryogenesis.%A%    
% 216.16/216.32  |- mesh__dateEstablished mesh__D036342 2003-01-01
% 216.16/216.32  |- rdf__type mesh__D036342sskos__Concept
% 216.16/216.32  |- mesh__dateRevised mesh__D003168 1997-06-20
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003168 2006
% 216.16/216.32  |- skos__altLabel mesh__D003168 Complement Absorption Test, Conglutinating
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003168 2003
% 216.16/216.32  |- skos__hiddenLabel mesh__D003168 Fixation Test, Complement
% 216.16/216.32  |- skos__hiddenLabel mesh__D003168 Conglutination Reactions
% 216.16/216.32  |- skos__hiddenLabel mesh__D003168 Tests, Complement Fixation
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003168 2004
% 216.16/216.32  |- mesh__recordAuthorizer mesh__D003168 SJN
% 216.16/216.32  |- skos__prefLabel mesh__D003168 Complement Fixation Tests
% 216.16/216.32  |- skos__hiddenLabel mesh__D003168 Test, Complement Fixation
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003168 2000
% 216.16/216.32  |- mesh__publicMeSHNote mesh__D003168
% 216.16/216.32       CONGLUTINATION REACTION was heading 1975-96 %28%see under COMPLEMENT FIXATION TESTS 1975-90%29%; COMPLEMENT ABSORPTION TEST, CONGLUTINATING was see CONGLUTINATION REACTION 1992-96%A%  
% 216.16/216.32  |- skos__hiddenLabel mesh__D003168 Reactions, Conglutination
% 216.16/216.32  |- rdf__type mesh__D003168sskos__Concept
% 216.16/216.32  |- mesh__dateCreated mesh__D003168 1999-01-01
% 216.16/216.32  |- mesh__recordMaintainer mesh__D003168 PXP
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003168 2001
% 216.16/216.32  |- mesh__historyNote mesh__D003168
% 216.16/216.32       CONGLUTINATION REACTION was heading 1975-96 %28%see under COMPLEMENT FIXATION TESTS 1975-90%29%; COMPLEMENT ABSORPTION TEST, CONGLUTINATING was see CONGLUTINATION REACTION 1992-96%A%  
% 216.16/216.32  |- skos__altLabel mesh__D003168 Conglutination Reaction
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003168 2002
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003168 1998
% 216.16/216.32  |- skos__scopeNote mesh__D003168
% 216.16/216.32       Serologic tests based on inactivation of complement by the antigen-antibody complex %28%stage 1%29%. Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody %28%hemolysin%29% requiring complement for its completion %28%stage 2%29%. Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1.%A%    
% 216.16/216.32  |- mesh__recordOriginator mesh__D003168 NLM
% 216.16/216.32  |- skos__hiddenLabel mesh__D003168 Reaction, Conglutination
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003168 2005
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003168 1999
% 216.16/216.32  |- skos__broader mesh__D003168smesh__D012698
% 216.16/216.32  |- skos__hiddenLabel mesh__D003168 Fixation Tests, Complement
% 216.16/216.32  |- skos__hiddenLabel mesh__D003168 Complement Fixation Test
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D008651 2000
% 216.16/216.32  |- skos__hiddenLabel mesh__D008651 mu-Meson
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D008651 1995
% 216.16/216.32  |- skos__hiddenLabel mesh__D008651 pi Mesons
% 216.16/216.32  |- skos__historyNote mesh__D008651 Elementary Particles %28%1975-1984%29%
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D008651 2006
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D008651 1994
% 216.16/216.32  |- skos__hiddenLabel mesh__D008651 mu Mesons
% 216.16/216.32  |- skos__prefLabel mesh__D008651 Mesons
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D008651 1999
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D008651 2005
% 216.16/216.32  |- rdf__type mesh__D008651sskos__Concept
% 216.16/216.32  |- skos__hiddenLabel mesh__D008651 pi-Meson
% 216.16/216.32  |- skos__hiddenLabel mesh__D008651 Muon
% 216.16/216.32  |- mesh__dateRevised mesh__D008651 1993-06-02
% 216.16/216.32  |- mesh__dateCreated mesh__D008651 1984-02-24
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D008651 2004
% 216.16/216.32  |- skos__altLabel mesh__D008651 Muons
% 216.16/216.32  |- mesh__recordOriginator mesh__D008651 SH
% 216.16/216.32  |- skos__hiddenLabel mesh__D008651 Pion
% 216.16/216.32  |- skos__scopeNote mesh__D008651
% 216.16/216.32       Short-lived elementary particles found in cosmic radiation or produced from nuclear disintegration. Their mass is between that of protons and electrons and they can be negative, positive, or neutral. pi-Mesons %28%pions%29% are heavier than mu-mesons %28%muons%29% and are proposed for cancer radiotherapy because their capture and disintegration by matter produces powerful, but short-lived, secondary radiation.%A%    
% 216.16/216.32  |- skos__historyNote mesh__D008651 Nuclear Physics %28%1966-1974%29%
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D008651 1998
% 216.16/216.32  |- mesh__recordAuthorizer mesh__D008651 PLS
% 216.16/216.32  |- mesh__publicMeSHNote mesh__D008651
% 216.16/216.32       91; was see under ELEMENTARY PARTICLES 1985-90, was see ELEMENTARY PARTICLES 1975-84; MUONS was see ELEMENTARY PARTICLES 1975-84%A%  
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D008651 2002
% 216.16/216.32  |- skos__hiddenLabel mesh__D008651 Meson
% 216.16/216.32  |- skos__broader mesh__D008651smesh__D004601
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D008651 1997
% 216.16/216.32  |- mesh__onlineNote mesh__D008651
% 216.16/216.32       use ELEMENTARY PARTICLES to search MESONS %26% MUONS 1975-84%A%  
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D008651 2003
% 216.16/216.32  |- mesh__recordMaintainer mesh__D008651 TGC
% 216.16/216.32  |- mesh__dateEstablished mesh__D008651 1991-01-01
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D008651 2001
% 216.16/216.32  |- skos__altLabel mesh__D008651 Pions
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D008651 1996
% 216.16/216.32  |- mesh__historyNote mesh__D008651
% 216.16/216.32       91%28%85%29%; was see under ELEMENTARY PARTICLES 1985-90, was see ELEMENTARY PARTICLES 1975-84; MUONS was see ELEMENTARY PARTICLES 1975-84%A%  
% 216.16/216.32  |- skos__annotation mesh__D008651 elementary particles; IM   
% 216.16/216.32  |- skos__hiddenLabel mesh__D007559 MK933
% 216.16/216.32  |- skos__historyNote mesh__D007559 Antiprotozoal Agents %28%1966-1986%29%
% 216.16/216.32  |- skos__altLabel mesh__D007559 Merck Brand of Ivermectin
% 216.16/216.32  |- mesh__dateRevised mesh__D007559 2005-06-30
% 216.16/216.32  |- mesh__recordOriginator mesh__D007559 RLS
% 216.16/216.32  |- skos__historyNote mesh__D007559 Insecticides %28%1966-1986%29%
% 216.16/216.32  |- skos__historyNote mesh__D007559 Anthelmintics %28%1966-1986%29%
% 216.16/216.32  |- skos__hiddenLabel mesh__D007559 Ivermectin Merck Brand
% 216.16/216.32  |- mesh__recordAuthorizer mesh__D007559 sjn
% 216.16/216.32  |- rdf__type mesh__D007559sskos__Concept
% 216.16/216.32  |- skos__scopeNote mesh__D007559
% 216.16/216.32       A mixture of mostly avermectin H2B1a  %28%RN 71827-03-7%29% with some avermectin H2B1b %28%RN 70209-81-3%29%, which are macrolides from STREPTOMYCES avermitilis. It binds glutamate-gated chloride channel to cause increased permeability and hyperpolarization of nerve and muscle cells. It also interacts with other CHLORIDE CHANNELS. It is a broad spectrum antiparasitic that is active against microfilariae of ONCHOCERCA VOLVULUS but not the adult form.%A%    
% 216.16/216.32  |- mesh__publicMeSHNote mesh__D007559
% 216.16/216.32       1987; for MECTIZAN see IVERMECTIN 1987-1999   
% 216.16/216.32  |- skos__historyNote mesh__D007559 Lactones %28%1966-1986%29%
% 216.16/216.32  |- skos__broader mesh__D007559smesh__D018942
% 216.16/216.32  |- skos__historyNote mesh__D007559 Filaricides %28%1973-1986%29%
% 216.16/216.32  |- mesh__dateEstablished mesh__D007559 1987-01-01
% 216.16/216.32  |- mesh__recordMaintainer mesh__D007559 ssb
% 216.16/216.32  |- skos__hiddenLabel mesh__D007559 MK 933
% 216.16/216.32  |- mesh__historyNote mesh__D007559
% 216.16/216.32       1987; for MECTIZAN use IVERMECTIN %28%NM%29% 1987-1999   
% 216.16/216.32  |- skos__historyNote mesh__D007559 Antinematodal Agents %28%1974-1986%29%
% 216.16/216.32  |- mesh__dateCreated mesh__D007559 1986-06-16
% 216.16/216.32  |- skos__prefLabel mesh__D007559 Ivermectin
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D007559 2006
% 216.16/216.32  |- mesh__publicMeSHNote mesh__D018281 94   
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D018281 2006
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D018281 1999
% 216.16/216.32  |- skos__historyNote mesh__D018281 Adenoma, Bile Duct %28%1967-1993%29%
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D018281 2002
% 216.16/216.32  |- skos__annotation mesh__D018281
% 216.16/216.32       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with BILE DUCT NEOPLASMS %28%IM%29% + BILE DUCTS, INTRAHEPATIC %28%IM%29%%A%  
% 216.16/216.32  |- rdf__type mesh__D018281sskos__Concept
% 216.16/216.32  |- mesh__dateEstablished mesh__D018281 1994-01-01
% 216.16/216.32  |- skos__broader mesh__D018281smesh__D000230
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D018281 2000
% 216.16/216.32  |- skos__prefLabel mesh__D018281 Cholangiocarcinoma
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D018281 2003
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D018281 1996
% 216.16/216.32  |- mesh__recordAuthorizer mesh__D018281 PLS
% 216.16/216.32  |- skos__hiddenLabel mesh__D018281 Cholangiocarcinomas
% 216.16/216.32  |- skos__scopeNote mesh__D018281
% 216.16/216.32       A malignant tumor arising from the intrahepatic bile duct epithelium. It is composed of ducts lined by cuboidal or columnar cells that do not contain bile, with abundant stroma. %28%From Holland et al., Cancer Medicine, 3d ed, p1455; Stedman, 25th ed%29%%A%    
% 216.16/216.32  |- skos__historyNote mesh__D018281 Bile Duct Neoplasms %28%1966-1993%29%
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D018281 2001
% 216.16/216.32  |- mesh__recordMaintainer mesh__D018281 KEV
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D018281 2005
% 216.16/216.32  |- mesh__dateRevised mesh__D018281 1995-06-08
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D018281 1998
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D018281 2004
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D018281 1997
% 216.16/216.32  |- mesh__recordOriginator mesh__D018281 PLS
% 216.16/216.32  |- skos__historyNote mesh__D018281 Liver Neoplasms %28%1966-1993%29%
% 216.16/216.32  |- mesh__historyNote mesh__D018281 94   
% 216.16/216.32  |- mesh__dateCreated mesh__D018281 1993-06-28
% 216.16/216.32  |- skos__prefLabel mesh__D004261 DNA Replication
% 216.16/216.32  |- skos__hiddenLabel mesh__D004261 DNA Replications
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D004261 2005
% 216.16/216.32  |- mesh__dateRevised mesh__D004261 2002-07-02
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D004261 2006
% 216.16/216.32  |- skos__annotation mesh__D004261
% 216.16/216.32       coord IM with specific DNA %28%IM%29%; coord IM with VIRUS REPLICATION %28%IM%29% for DNA replic in viruses; consider also DNA /biosyn%A%  
% 216.16/216.32  |- mesh__recordMaintainer mesh__D004261 nns
% 216.16/216.32  |- skos__related mesh__D004261smesh__D014779
% 216.16/216.32  |- mesh__dateCreated mesh__D004261 1999-01-01
% 216.16/216.32  |- skos__historyNote mesh__D004261 DNA/biosynthesis %28%1966-1967%29%
% 216.16/216.32  |- skos__related mesh__D004261smesh__D004265
% 216.16/216.32  |- mesh__historyNote mesh__D004261 68   
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D004261 2003
% 216.16/216.32  |- skos__broader mesh__D004261smesh__D039361
% 216.16/216.32  |- mesh__publicMeSHNote mesh__D004261 68   
% 216.16/216.32  |- mesh__recordOriginator mesh__D004261 NLM
% 216.16/216.32  |- skos__altLabel mesh__D004261 Replication, Autonomous
% 216.16/216.32  |- skos__related mesh__D004261smesh__D004264
% 216.16/216.32  |- skos__hiddenLabel mesh__D004261 Replications, DNA
% 216.16/216.32  |- skos__hiddenLabel mesh__D004261 Replication, DNA
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D004261 2004
% 216.16/216.32  |- skos__scopeNote mesh__D004261
% 216.16/216.32       The process by which a DNA molecule is duplicated.     
% 216.16/216.32  |- mesh__dateEstablished mesh__D004261 1968-01-01
% 216.16/216.32  |- mesh__recordAuthorizer mesh__D004261 sjn
% 216.16/216.32  |- skos__hiddenLabel mesh__D004261 Replications, Autonomous
% 216.16/216.32  |- skos__related mesh__D004261smesh__D016196
% 216.16/216.32  |- rdf__type mesh__D004261sskos__Concept
% 216.16/216.32  |- skos__hiddenLabel mesh__D004261 Autonomous Replications
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D031658 2006
% 216.16/216.32  |- mesh__dateEstablished mesh__D031658 2003-01-01
% 216.16/216.32  |- skos__annotation mesh__D031658
% 216.16/216.32       OLIVE, RUSSIAN see ELAEAGNUS is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.16/216.32  |- mesh__historyNote mesh__D031658 2003   
% 216.16/216.32  |- rdf__type mesh__D031658sskos__Concept
% 216.16/216.32  |- mesh__publicMeSHNote mesh__D031658 2003   
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D031658 2003
% 216.16/216.32  |- skos__broader mesh__D031658smesh__D029592
% 216.16/216.32  |- skos__altLabel mesh__D031658 Olive Tree
% 216.16/216.32  |- skos__scopeNote mesh__D031658
% 216.16/216.32       A plant genus of the family OLEACEAE. The olive fruit is the source of olive oil.%A%    
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D031658 2004
% 216.16/216.32  |- skos__prefLabel mesh__D031658 Olea
% 216.16/216.32  |- mesh__dateCreated mesh__D031658 2002-07-03
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D031658 2005
% 216.16/216.32  |- mesh__recordMaintainer mesh__D050812 ags
% 216.16/216.32  |- skos__related mesh__D050812smesh__D007839
% 216.16/216.32  |- mesh__recordAuthorizer mesh__D050812 sjn
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D050812 2006
% 216.16/216.32  |- mesh__dateCreated mesh__D050812 2005-06-30
% 216.16/216.32  |- skos__hiddenLabel mesh__D050812 Procedures, Split-Brain
% 216.16/216.32  |- skos__historyNote mesh__D050812 Corpus Callosum %28%1966-2005%29%
% 216.16/216.32  |- skos__hiddenLabel mesh__D050812 Split Brain Procedure
% 216.16/216.32  |- skos__scopeNote mesh__D050812
% 216.16/216.32       Complete severing of the CORPUS CALLOSUM. In humans it is usually performed to treat medically intractable, multifocal EPILEPSY. EXPERIMENTAL ANIMAL MODELS of split brain preparations are used in research.%A%    
% 216.16/216.32  |- mesh__recordOriginator mesh__D050812 ags
% 216.16/216.32  |- rdf__type mesh__D050812sskos__Concept
% 216.16/216.32  |- skos__hiddenLabel mesh__D050812 Split Brain
% 216.16/216.32  |- skos__hiddenLabel mesh__D050812 Split-Brain Procedures
% 216.16/216.32  |- mesh__historyNote mesh__D050812 2006   
% 216.16/216.32  |- mesh__dateEstablished mesh__D050812 2006-01-01
% 216.16/216.32  |- mesh__publicMeSHNote mesh__D050812 2006   
% 216.16/216.32  |- skos__prefLabel mesh__D050812 Split-Brain Procedure
% 216.16/216.32  |- skos__altLabel mesh__D050812 Split-Brain
% 216.16/216.32  |- skos__broader mesh__D050812smesh__D019635
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017189 2005
% 216.16/216.32  |- mesh__historyNote mesh__D017189
% 216.16/216.32       93; DIOCTOPHYMA RENALE INFECTIONS was heading 1968-92   
% 216.16/216.32  |- mesh__onlineNote mesh__D017189
% 216.16/216.32       use ENOPLIDA INFECTIONS to search DIOCTOPHYMA RENALE INFECTIONS 1968-92%A%  
% 216.16/216.32  |- skos__altLabel mesh__D017189 Infections, Dioctophyma renale
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017189 1998
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017189 2006
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017189 2000
% 216.16/216.32  |- mesh__dateRevised mesh__D017189 1993-06-04
% 216.16/216.32  |- mesh__dateCreated mesh__D017189 1992-05-08
% 216.16/216.32  |- skos__annotation mesh__D017189 nematode infect   
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017189 1994
% 216.16/216.32  |- mesh__recordAuthorizer mesh__D017189 PLS
% 216.16/216.32  |- mesh__recordOriginator mesh__D017189 PXP
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017189 1999
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017189 2001
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017189 1995
% 216.16/216.32  |- skos__hiddenLabel mesh__D017189 Dioctophyma renale Infection
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017189 2002
% 216.16/216.32  |- skos__prefLabel mesh__D017189 Enoplida Infections
% 216.16/216.32  |- skos__hiddenLabel mesh__D017189 Infection, Enoplida
% 216.16/216.32  |- mesh__dateEstablished mesh__D017189 1993-01-01
% 216.16/216.32  |- skos__hiddenLabel mesh__D017189 Enoplida Infection
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017189 2003
% 216.16/216.32  |- rdf__type mesh__D017189sskos__Concept
% 216.16/216.32  |- skos__scopeNote mesh__D017189
% 216.16/216.32       Infections with nematodes of the order ENOPLIDA.     
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017189 1996
% 216.16/216.32  |- skos__altLabel mesh__D017189 Infections, Enoplida
% 216.16/216.32  |- skos__broader mesh__D017189smesh__D017188
% 216.16/216.32  |- skos__hiddenLabel mesh__D017189 Infection, Dioctophyma renale
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017189 2004
% 216.16/216.32  |- mesh__recordMaintainer mesh__D017189 JLS
% 216.16/216.32  |- mesh__publicMeSHNote mesh__D017189
% 216.16/216.32       93; DIOCTOPHYMA RENALE INFECTIONS was heading 1968-92   
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D017189 1997
% 216.16/216.32  |- skos__broader mesh__D003967smesh__D012817
% 216.16/216.32  |- rdf__type mesh__D003967sskos__Concept
% 216.16/216.32  |- skos__related mesh__D003967smesh__D000930
% 216.16/216.32  |- mesh__recordMaintainer mesh__D003967 lkt
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003967 2004
% 216.16/216.32  |- skos__related mesh__D003967smesh__D015532
% 216.16/216.32  |- mesh__dateCreated mesh__D003967 1999-01-01
% 216.16/216.32  |- skos__hiddenLabel mesh__D003967 Diarrheas
% 216.16/216.32  |- mesh__dateRevised mesh__D003967 2003-07-09
% 216.16/216.32  |- skos__annotation mesh__D003967
% 216.16/216.32       in infants = DIARRHEA, INFANTILE + appropriate check tags%A%  
% 216.16/216.32  |- mesh__recordOriginator mesh__D003967 NLM
% 216.16/216.32  |- mesh__recordAuthorizer mesh__D003967 sjn
% 216.16/216.32  |- skos__scopeNote mesh__D003967
% 216.16/216.32       An increased liquidity or decreased consistency of  FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.%A%    
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003967 2006
% 216.16/216.32  |- skos__prefLabel mesh__D003967 Diarrhea
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D003967 2005
% 216.16/216.32  |- skos__broader mesh__D011506Q000134smesh__D011506
% 216.16/216.32  |- mesh__preferredCombination mesh__D011506Q000134smesh__D002556
% 216.16/216.32  |- rdf__type mesh__D011506Q000134smesh__CompoundConcept
% 216.16/216.32  |- mesh__dateEstablished mesh__D036343 2003-01-01
% 216.16/216.32  |- mesh__activeMeSHYear mesh__D036343 2006
% 216.16/216.32  |- mesh__publicMeSHNote mesh__D036343 2003   
% 216.16/216.32  |- mesh__recordAuthorizer mesh__D036343 sjn
% 216.16/216.32  |- mesh__historyNote mesh__D036343 2003   
% 216.16/216.32  |- skos__broader mesh__D036343smesh__D007529
% 216.16/216.32  |- skos__scopeNote mesh__D036343
% 216.16/216.32       A group of compounds which can be described as benzo-pyrano-furano-benzenes which can be formed from ISOFLAVONES by internal coupling of the B ring to the 4-ketone position. Members include medicarpin, phaseolin, and pisatin which are found in FABACEAE.%A%    
% 216.16/216.32  |- skos__prefLabel mesh__D036343 Pterocarpans
% 216.16/216.32  |- mesh__recordMaintainer mesh__D036343 ssb
% 216.16/216.32  |- mesh__dateCreated mesh__D036343 2002-07-03
% 216.16/216.32  |- mesh__recordOriginator mesh__D036343 ssb
% 216.16/216.32  |- rdf__type mesh__D036343sskos__Concept
% 216.16/216.32  |- skos__broader mesh__D036343smesh__D006576
% 216.16/216.32  |- mesh__dateRevised mesh__D036343 2005-06-30
% 216.18/216.32  |- skos__broader mesh__D036343smesh__D001572
% 216.18/216.32  |- skos__altLabel mesh__D003169 Complement Inactivating Proteins
% 216.18/216.32  |- skos__altLabel mesh__D003169 Serum Complement Inactivators
% 216.18/216.32  |- mesh__recordAuthorizer mesh__D003169 sjn
% 216.18/216.32  |- mesh__recordOriginator mesh__D003169 RLS
% 216.18/216.32  |- skos__historyNote mesh__D003169 specific complement/AI %28%1975-1977%29%
% 216.18/216.32  |- rdf__type mesh__D003169sskos__Concept
% 216.18/216.32  |- skos__hiddenLabel mesh__D003169 Inactivators, Serum Complement
% 216.18/216.32  |- skos__scopeNote mesh__D003169
% 216.18/216.32       Serum proteins that negatively regulate the cascade process of COMPLEMENT ACTIVATION. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host. The complement system is tightly regulated by inactivators that accelerate the decay of intermediates and certain cell surface receptors.%A%    
% 216.18/216.32  |- skos__altLabel mesh__D003169 Complement Cytolysis Inhibiting Proteins
% 216.18/216.32  |- skos__annotation mesh__D003169
% 216.18/216.32       do not confuse with COMPLEMENT INACTIVATING AGENTS; DF: COMPLEMENT INACT%A%  
% 216.18/216.32  |- skos__hiddenLabel mesh__D003169 Complement Inactivators, Serum
% 216.18/216.33  |- skos__prefLabel mesh__D003169 Complement Inactivator Proteins
% 216.18/216.33  |- mesh__publicMeSHNote mesh__D003169
% 216.18/216.33       2006; see COMPLEMENT INACTIVATORS 1978-2005   
% 216.18/216.33  |- skos__broader mesh__D003169smesh__D003165
% 216.18/216.33  |- skos__hiddenLabel mesh__D003169 Inactivator Proteins, Complement
% 216.18/216.33  |- mesh__dateRevised mesh__D003169 2005-06-30
% 216.18/216.33  |- skos__hiddenLabel mesh__D003169 Proteins, Complement Inactivating
% 216.18/216.33  |- mesh__historyNote mesh__D003169 2006 %28%1978%29%   
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D003169 2006
% 216.18/216.33  |- mesh__dateEstablished mesh__D003169 1978-01-01
% 216.18/216.33  |- skos__hiddenLabel mesh__D003169 Proteins, Complement Inactivator
% 216.18/216.33  |- skos__historyNote mesh__D003169 Complement %28%1968-1977%29%
% 216.18/216.33  |- skos__hiddenLabel mesh__D003169 Inactivating Proteins, Complement
% 216.18/216.33  |- mesh__dateCreated mesh__D003169 1977-04-15
% 216.18/216.33  |- mesh__recordMaintainer mesh__D003169 ssb
% 216.18/216.33  |- mesh__publicMeSHNote mesh__D008652
% 216.18/216.33       91; was see under PORPHYRINS 1975-90   
% 216.18/216.33  |- skos__scopeNote mesh__D008652
% 216.18/216.33       Porphyrins with four methyl, two ethyl, and two propionic acid side chains attached to the pyrrole rings.%A%    
% 216.18/216.33  |- mesh__dateRevised mesh__D008652 2005-06-30
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D008652 2006
% 216.18/216.33  |- skos__broader mesh__D008652smesh__D011166
% 216.18/216.33  |- mesh__recordOriginator mesh__D008652 NLM
% 216.18/216.33  |- mesh__dateEstablished mesh__D008652 1991-01-01
% 216.18/216.33  |- mesh__historyNote mesh__D008652
% 216.18/216.33       91%28%75%29%; was see under PORPHYRINS 1975-90   
% 216.18/216.33  |- skos__historyNote mesh__D008652 Porphyrins %28%1968-1974%29%
% 216.18/216.33  |- mesh__dateCreated mesh__D008652 1974-11-19
% 216.18/216.33  |- rdf__type mesh__D008652sskos__Concept
% 216.18/216.33  |- mesh__recordAuthorizer mesh__D008652 sjn
% 216.18/216.33  |- skos__prefLabel mesh__D008652 Mesoporphyrins
% 216.18/216.33  |- mesh__recordMaintainer mesh__D008652 ssb
% 216.18/216.33  |- mesh__dateEstablished mesh__D013597 1966-01-01
% 216.18/216.33  |- mesh__historyNote mesh__D013597
% 216.18/216.33       66%28%65%29%; was see under HUMAN ENGINEERING 1963-65   
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D013597 2002
% 216.18/216.33  |- skos__related mesh__D013597smesh__D013647
% 216.18/216.33  |- mesh__dateRevised mesh__D013597 1995-05-23
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D013597 2003
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D013597 2005
% 216.18/216.33  |- skos__prefLabel mesh__D013597 Systems Analysis
% 216.18/216.33  |- mesh__recordMaintainer mesh__D013597 KEV
% 216.18/216.33  |- skos__hiddenLabel mesh__D013597 Systems Analyses
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D013597 2004
% 216.18/216.33  |- mesh__dateCreated mesh__D013597 1999-01-01
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D013597 1996
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D013597 2006
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D013597 2000
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D013597 1998
% 216.18/216.33  |- mesh__recordAuthorizer mesh__D013597 PLS
% 216.18/216.33  |- skos__broader mesh__D013597smesh__D007254
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D013597 1997
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D013597 2001
% 216.18/216.33  |- skos__annotation mesh__D013597 no qualif   
% 216.18/216.33  |- skos__altLabel mesh__D013597 Analysis, Systems
% 216.18/216.33  |- mesh__publicMeSHNote mesh__D013597
% 216.18/216.33       66; was see under HUMAN ENGINEERING 1963-65   
% 216.18/216.33  |- mesh__recordOriginator mesh__D013597 NLM
% 216.18/216.33  |- skos__scopeNote mesh__D013597
% 216.18/216.33       The analysis of an activity, procedure, method, technique, or business to determine what must be accomplished and how the necessary operations may best be accomplished.%A%    
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D013597 1999
% 216.18/216.33  |- skos__hiddenLabel mesh__D013597 Analyses, Systems
% 216.18/216.33  |- rdf__type mesh__D013597sskos__Concept
% 216.18/216.33  |- skos__prefLabel mesh__D018282 Cystadenocarcinoma, Mucinous
% 216.18/216.33  |- rdf__type mesh__D018282sskos__Concept
% 216.18/216.33  |- skos__historyNote mesh__D018282 Cystadenocarcinoma %28%1966-1993%29%
% 216.18/216.33  |- skos__annotation mesh__D018282
% 216.18/216.33       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 216.18/216.33  |- skos__hiddenLabel mesh__D018282 Mucinous Cystadenocarcinoma
% 216.18/216.33  |- mesh__publicMeSHNote mesh__D018282 94   
% 216.18/216.33  |- skos__scopeNote mesh__D018282
% 216.18/216.33       A malignant cystic or semisolid tumor most often occurring in the ovary. Rarely, one is solid. This tumor may develop from a mucinous cystadenoma, or it may be malignant at the onset. The cysts are lined with tall columnar epithelial cells; in others, the epithelium consists of many layers of cells that have lost normal structure entirely. In the more undifferentiated tumors, one may see sheets and nests of tumor cells that have very little resemblance to the parent structure. %28%Hughes, Obstetric-Gynecologic Terminology, 1972, p184%29%%A%    
% 216.18/216.33  |- skos__broader mesh__D018282smesh__D003536
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018282 2002
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018282 2003
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018282 1996
% 216.18/216.33  |- mesh__dateEstablished mesh__D018282 1994-01-01
% 216.18/216.33  |- mesh__recordMaintainer mesh__D018282 KEV
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018282 2005
% 216.18/216.33  |- mesh__dateRevised mesh__D018282 1995-06-08
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018282 1998
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018282 2004
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018282 1997
% 216.18/216.33  |- skos__historyNote mesh__D018282 Cystadenoma %28%1969-1979%29%
% 216.18/216.33  |- mesh__recordOriginator mesh__D018282 PLS
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018282 2000
% 216.18/216.33  |- mesh__historyNote mesh__D018282 94   
% 216.18/216.33  |- skos__hiddenLabel mesh__D018282 Mucinous Cystadenocarcinomas
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018282 2006
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018282 1999
% 216.18/216.33  |- mesh__recordAuthorizer mesh__D018282 PLS
% 216.18/216.33  |- skos__hiddenLabel mesh__D018282 Cystadenocarcinomas, Mucinous
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018282 2001
% 216.18/216.33  |- mesh__dateCreated mesh__D018282 1993-06-25
% 216.18/216.33  |- skos__broader mesh__D004262smesh__D004706
% 216.18/216.33  |- mesh__recordAuthorizer mesh__D004262 sjn
% 216.18/216.33  |- mesh__publicMeSHNote mesh__D004262
% 216.18/216.33       79; was DNA RESTRICTION ENZYME 1978, was DNA RESTRICTION ENZYME see under ENDONUCLEASES 1975-77%A%  
% 216.18/216.33  |- skos__prefLabel mesh__D004262 DNA Restriction Enzymes
% 216.18/216.33  |- skos__historyNote mesh__D004262 Endonucleases %28%1974%29%
% 216.18/216.33  |- mesh__dateCreated mesh__D004262 1974-11-19
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D004262 2004
% 216.18/216.33  |- skos__broader mesh__D004262smesh__D015280
% 216.18/216.33  |- mesh__dateEstablished mesh__D004262 1978-01-01
% 216.18/216.33  |- skos__related mesh__D004262smesh__D012150
% 216.18/216.33  |- skos__hiddenLabel mesh__D004262 Restriction Enzymes, DNA
% 216.18/216.33  |- skos__scopeNote mesh__D004262
% 216.18/216.33       Enzymes that are part of the restriction-modification systems. They catalyze the endonucleolytic cleavage of DNA sequences which lack the species-specific methylation pattern in the host cell%27%s DNA. Cleavage yields random or specific double-stranded fragments with terminal 5%27%-phosphates. The function of restriction enzymes is to destroy any foreign DNA that invades the host cell. Most have been studied in bacterial systems, but a few have been found in eukaryotic organisms. They are also used as tools for the systematic dissection and mapping of chromosomes, in the determination of base sequences of DNAs, and have made it possible to splice and recombine genes from one organism into the genome of another. EC 3.21.1.%A%    
% 216.18/216.33  |- mesh__recordMaintainer mesh__D004262 ssb
% 216.18/216.33  |- skos__hiddenLabel mesh__D004262 Endonuclease, Restriction
% 216.18/216.33  |- mesh__historyNote mesh__D004262
% 216.18/216.33       79; was DNA RESTRICTION ENZYME 1978, was DNA RESTRICTION ENZYME see under ENDONUCLEASES 1975-77%A%  
% 216.18/216.33  |- skos__altLabel mesh__D004262 Restriction Endonucleases
% 216.18/216.33  |- skos__annotation mesh__D004262
% 216.18/216.33       DNA restriction enzyme used as a DNA marker: coord probably NIM with GENETIC MARKER %28%IM%29%%A%  
% 216.18/216.33  |- rdf__type mesh__D004262sskos__Concept
% 216.18/216.33  |- mesh__dateRevised mesh__D004262 2003-07-09
% 216.18/216.33  |- skos__related mesh__D004262smesh__D015183
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D004262 2005
% 216.18/216.33  |- skos__altLabel mesh__D004262 DNA Restriction Enzyme
% 216.18/216.33  |- skos__historyNote mesh__D004262 Deoxyribonucleases %28%1974%29%
% 216.18/216.33  |- mesh__recordOriginator mesh__D004262 NLM
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D004262 2006
% 216.18/216.33  |- skos__altLabel mesh__D004262 Restriction Endonuclease
% 216.18/216.33  |- mesh__onlineNote mesh__D004262
% 216.18/216.33       use DNA RESTRICTION ENZYMES to search DNA RESTRICTION ENZYME l975-89%A%  
% 216.18/216.33  |- skos__hiddenLabel mesh__D004262 Endonucleases, Restriction
% 216.18/216.33  |- skos__hiddenLabel mesh__D004262 Restriction Enzyme, DNA
% 216.18/216.33  |- skos__hiddenLabel mesh__D004262 Enzymes, DNA Restriction
% 216.18/216.33  |- mesh__recordOriginator mesh__D017988 AGS
% 216.18/216.33  |- mesh__recordAuthorizer mesh__D017988 sjn
% 216.18/216.33  |- skos__hiddenLabel mesh__D017988 Murine Tumor Viruses
% 216.18/216.33  |- mesh__dateRevised mesh__D017988 2002-07-03
% 216.18/216.33  |- mesh__dateEstablished mesh__D017988 1994-01-01
% 216.18/216.33  |- skos__altLabel mesh__D017988 Mammalian Type C Retroviruses
% 216.18/216.33  |- skos__hiddenLabel mesh__D017988 retrovirus, Viper
% 216.18/216.33  |- mesh__historyNote mesh__D017988 2002 %28%1994%29%   
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D017988 2003
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D017988 2005
% 216.18/216.33  |- skos__annotation mesh__D017988
% 216.18/216.33       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%%A%  
% 216.18/216.33  |- mesh__recordMaintainer mesh__D017988 ags
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D017988 2004
% 216.18/216.33  |- skos__hiddenLabel mesh__D017988 Viper retroviruses
% 216.18/216.33  |- skos__broader mesh__D017988smesh__D012190
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D017988 2006
% 216.18/216.33  |- skos__scopeNote mesh__D017988
% 216.18/216.33       A genus of RETROVIRIDAE comprising endogenous sequences in mammals, related RETICULOENDOTHELIOSIS VIRUSES, AVIAN, and a reptilian virus. Many species contain oncogenes and cause leukemias and sarcomas.%A%    
% 216.18/216.33  |- rdf__type mesh__D017988sskos__Concept
% 216.18/216.33  |- mesh__publicMeSHNote mesh__D017988
% 216.18/216.33       2002; see RETROVIRUSES TYPE C, MAMMALIAN 1994-2001; for TUMOR VIRUSES, MURINE see TUMOR VIRUSES, MURINE 1996-2002%A%  
% 216.18/216.33  |- mesh__dateCreated mesh__D017988 1993-06-04
% 216.18/216.33  |- skos__altLabel mesh__D017988 Retroviruses Type C, Mammalian
% 216.18/216.33  |- skos__hiddenLabel mesh__D017988 Gammaretroviruses
% 216.18/216.33  |- skos__altLabel mesh__D017988 Type C Retroviruses, Mammalian
% 216.18/216.33  |- skos__prefLabel mesh__D017988 Gammaretrovirus
% 216.18/216.33  |- skos__broader mesh__D031659smesh__D029592
% 216.18/216.33  |- mesh__recordOriginator mesh__D031659 ssb
% 216.18/216.33  |- skos__scopeNote mesh__D031659
% 216.18/216.33       A plant genus of the family OLEACEAE. Oleuropein, a phenolic secoiridoid glycoside, is found in the leaves.%A%    
% 216.18/216.33  |- mesh__dateCreated mesh__D031659 2002-07-03
% 216.18/216.33  |- mesh__dateEstablished mesh__D031659 2003-01-01
% 216.18/216.33  |- mesh__recordMaintainer mesh__D031659 ssb
% 216.18/216.33  |- rdf__type mesh__D031659sskos__Concept
% 216.18/216.33  |- mesh__publicMeSHNote mesh__D031659 2003   
% 216.18/216.33  |- skos__altLabel mesh__D031659 Ligustri lucidi
% 216.18/216.33  |- mesh__dateRevised mesh__D031659 2003-07-09
% 216.18/216.33  |- mesh__historyNote mesh__D031659 2003   
% 216.18/216.33  |- skos__altLabel mesh__D031659 Privet
% 216.18/216.33  |- skos__annotation mesh__D031659
% 216.18/216.33       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D031659 2005
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D031659 2004
% 216.18/216.33  |- mesh__recordAuthorizer mesh__D031659 sjn
% 216.18/216.33  |- skos__prefLabel mesh__D031659 Ligustrum
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D031659 2006
% 216.18/216.33  |- skos__hiddenLabel mesh__D042381 Granulocyte Precursor Cell
% 216.18/216.33  |- mesh__publicMeSHNote mesh__D042381
% 216.18/216.33       2004; for PROMYELOCYTES see GRANULOCYTES 1985-2003   
% 216.18/216.33  |- skos__hiddenLabel mesh__D042381 Precursor Cells, Granulocyte
% 216.18/216.33  |- skos__historyNote mesh__D042381
% 216.18/216.33       Granulocytes or specifics %28%1975-2003%29%
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D042381 2006
% 216.18/216.33  |- skos__related mesh__D042381smesh__D007950
% 216.18/216.33  |- skos__hiddenLabel mesh__D042381 Cell, Granulocyte Precursor
% 216.18/216.33  |- skos__related mesh__D042381smesh__D015473
% 216.18/216.33  |- mesh__historyNote mesh__D042381
% 216.18/216.33       2004; for PROMYELOCYTES use GRANULOCYTES 1985-2003   
% 216.18/216.33  |- skos__hiddenLabel mesh__D042381 Precursor Cells, Granulocytic
% 216.18/216.33  |- skos__hiddenLabel mesh__D042381 Myelocyte
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D042381 2005
% 216.18/216.33  |- skos__scopeNote mesh__D042381
% 216.18/216.33       The cells in the granulocytic series that give rise to mature granulocytes %28%NEUTROPHILS; EOSINOPHILS; and BASOPHILS.%29%  These precursor cells include myeloblasts, promyelocytes, myelocytes and metamyelocytes.%A%    
% 216.18/216.33  |- skos__altLabel mesh__D042381 Progranulocytes
% 216.18/216.33  |- skos__broader mesh__D042381smesh__D006098
% 216.18/216.33  |- skos__hiddenLabel mesh__D042381 Cells, Granulocyte Precursor
% 216.18/216.33  |- skos__hiddenLabel mesh__D042381 Granulocytic Precursor Cell
% 216.18/216.33  |- skos__hiddenLabel mesh__D042381 Metamyelocyte
% 216.18/216.33  |- skos__hiddenLabel mesh__D042381 Progranulocyte
% 216.18/216.33  |- skos__hiddenLabel mesh__D042381 Cell, Granulocytic Precursor
% 216.18/216.33  |- rdf__type mesh__D042381sskos__Concept
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D042381 2004
% 216.18/216.33  |- skos__broader mesh__D042381smesh__D023461
% 216.18/216.33  |- skos__hiddenLabel mesh__D042381 Precursor Cell, Granulocytic
% 216.18/216.33  |- skos__hiddenLabel mesh__D042381 Precursor Cell, Granulocyte
% 216.18/216.33  |- mesh__dateEstablished mesh__D042381 2004-01-01
% 216.18/216.33  |- skos__hiddenLabel mesh__D042381 Cells, Granulocytic Precursor
% 216.18/216.33  |- skos__hiddenLabel mesh__D042381 Promyelocyte
% 216.18/216.33  |- skos__hiddenLabel mesh__D042381 Premyelocyte
% 216.18/216.33  |- skos__altLabel mesh__D042381 Premyelocytes
% 216.18/216.33  |- skos__altLabel mesh__D042381 Granulocytic Precursor Cells
% 216.18/216.33  |- mesh__dateCreated mesh__D042381 2003-07-09
% 216.18/216.33  |- skos__altLabel mesh__D042381 Myeloblast
% 216.18/216.33  |- skos__prefLabel mesh__D042381 Granulocyte Precursor Cells
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D050813 2006
% 216.18/216.33  |- mesh__dateEstablished mesh__D050813 2006-01-01
% 216.18/216.33  |- skos__scopeNote mesh__D050813
% 216.18/216.33       An octamer transcription factor expressed primarily in B-LYMPHOCYTES and the developing CENTRAL NERVOUS SYSTEM that regulates GENETIC TRANSCRIPTION of IMMUNOGLOBULIN GENES.%A%    
% 216.18/216.33  |- skos__hiddenLabel mesh__D050813 Oct-2, Transcription Factor
% 216.18/216.33  |- skos__hiddenLabel mesh__D050813 Transcription Factor, Oct-2
% 216.18/216.33  |- mesh__recordOriginator mesh__D050813 DRC
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D050813 2006A
% 216.18/216.33  |- skos__hiddenLabel mesh__D050813 Transcription Factor Oct 2
% 216.18/216.33  |- skos__altLabel mesh__D050813 Transcription Factor Oct-2
% 216.18/216.33  |- rdf__type mesh__D050813sskos__Concept
% 216.18/216.33  |- skos__broader mesh__D050813smesh__D050810
% 216.18/216.33  |- skos__hiddenLabel mesh__D050813 Octamer Transcription Factor 2
% 216.18/216.33  |- skos__hiddenLabel mesh__D050813 Transcription Factor-2, Octamer
% 216.18/216.33  |- mesh__dateCreated mesh__D050813 2005-06-30
% 216.18/216.33  |- mesh__recordAuthorizer mesh__D050813 ags
% 216.18/216.33  |- mesh__dateRevised mesh__D050813 2005-08-03
% 216.18/216.33  |- skos__prefLabel mesh__D050813 Octamer Transcription Factor-2
% 216.18/216.33  |- mesh__publicMeSHNote mesh__D050813 2006   
% 216.18/216.33  |- skos__hiddenLabel mesh__D050813 Oct 2 Transcription Factor
% 216.18/216.33  |- mesh__recordMaintainer mesh__D050813 ags
% 216.18/216.33  |- skos__altLabel mesh__D050813 Oct-2 Transcription Factor
% 216.18/216.33  |- mesh__historyNote mesh__D050813 2006   
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D003968 2004
% 216.18/216.33  |- skos__broader mesh__D003968smesh__D003967
% 216.18/216.33  |- skos__scopeNote mesh__D003968
% 216.18/216.33       DIARRHEA occurring in infants from newborn to 24-months old.%A%    
% 216.18/216.33  |- skos__hiddenLabel mesh__D003968 Infantile Diarrheas
% 216.18/216.33  |- mesh__dateRevised mesh__D003968 2003-07-09
% 216.18/216.33  |- skos__prefLabel mesh__D003968 Diarrhea, Infantile
% 216.18/216.33  |- skos__altLabel mesh__D003968 Infantile Diarrhea
% 216.18/216.33  |- skos__hiddenLabel mesh__D003968 Diarrheas, Infantile
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D003968 2005
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D003968 2006
% 216.18/216.33  |- mesh__recordMaintainer mesh__D003968 lkt
% 216.18/216.33  |- skos__annotation mesh__D003968
% 216.18/216.33       human only; don%27%t forget infant check tags as pertinent   
% 216.18/216.33  |- mesh__dateCreated mesh__D003968 1999-01-01
% 216.18/216.33  |- mesh__recordOriginator mesh__D003968 NLM
% 216.18/216.33  |- mesh__recordAuthorizer mesh__D003968 sjn
% 216.18/216.33  |- rdf__type mesh__D003968sskos__Concept
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D014690 2004
% 216.18/216.33  |- skos__altLabel mesh__D014690 Blood Pressure, Venous
% 216.18/216.33  |- mesh__publicMeSHNote mesh__D014690 70   
% 216.18/216.33  |- mesh__dateRevised mesh__D014690 2003-07-09
% 216.18/216.33  |- mesh__recordMaintainer mesh__D014690 nns
% 216.18/216.33  |- skos__annotation mesh__D014690
% 216.18/216.33       IM GEN only; NIM for pressure within a specific vessel; CENTRAL VENOUS PRESSURE %26% PORTAL PRESSURE are also available; venous hypertension: index under VENOUS PRESSURE %28%IM%29% %26% do not coord with HYPERTENSION%A%  
% 216.18/216.33  |- skos__hiddenLabel mesh__D014690 Pressure, Venous
% 216.18/216.33  |- mesh__recordOriginator mesh__D014690 NLM
% 216.18/216.33  |- skos__prefLabel mesh__D014690 Venous Pressure
% 216.18/216.33  |- skos__hiddenLabel mesh__D014690 Venous Pressures
% 216.18/216.33  |- skos__hiddenLabel mesh__D014690 Venous Blood Pressure
% 216.18/216.33  |- skos__hiddenLabel mesh__D014690 Pressures, Venous Blood
% 216.18/216.33  |- skos__hiddenLabel mesh__D014690 Pressure, Venous Blood
% 216.18/216.33  |- skos__hiddenLabel mesh__D014690 Blood Pressures, Venous
% 216.18/216.33  |- mesh__dateEstablished mesh__D014690 1970-01-01
% 216.18/216.33  |- skos__historyNote mesh__D014690 Veins %28%1966-1969%29%
% 216.18/216.33  |- mesh__dateCreated mesh__D014690 1999-01-01
% 216.18/216.33  |- skos__scopeNote mesh__D014690
% 216.18/216.33       The blood pressure in the VEINS. It is usually measured to assess the filling PRESSURE to the HEART VENTRICLE.%A%    
% 216.18/216.33  |- skos__hiddenLabel mesh__D014690 Venous Blood Pressures
% 216.18/216.33  |- rdf__type mesh__D014690sskos__Concept
% 216.18/216.33  |- skos__hiddenLabel mesh__D014690 Pressures, Venous
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D014690 2005
% 216.18/216.33  |- skos__historyNote mesh__D014690 Blood Pressure %28%1966-1969%29%
% 216.18/216.33  |- skos__broader mesh__D014690smesh__D001794
% 216.18/216.33  |- mesh__historyNote mesh__D014690 70   
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D014690 2006
% 216.18/216.33  |- mesh__recordAuthorizer mesh__D014690 sjn
% 216.18/216.33  |- skos__historyNote mesh__D008653 Phenothiazines %28%1966-1971%29%
% 216.18/216.33  |- mesh__dateEstablished mesh__D008653 1973-01-01
% 216.18/216.33  |- mesh__publicMeSHNote mesh__D008653 73   
% 216.18/216.33  |- skos__scopeNote mesh__D008653
% 216.18/216.33       A phenothiazine antipsychotic with effects similar to CHLORPROMAZINE.%A%    
% 216.18/216.33  |- mesh__recordMaintainer mesh__D008653 ssb
% 216.18/216.33  |- skos__prefLabel mesh__D008653 Mesoridazine
% 216.18/216.33  |- rdf__type mesh__D008653sskos__Concept
% 216.18/216.33  |- mesh__dateRevised mesh__D008653 2005-06-30
% 216.18/216.33  |- mesh__recordOriginator mesh__D008653 NLM
% 216.18/216.33  |- skos__historyNote mesh__D008653 Tranquilizing Agents %28%1966-1971%29%
% 216.18/216.33  |- skos__broader mesh__D008653smesh__D010640
% 216.18/216.33  |- mesh__dateCreated mesh__D008653 1999-01-01
% 216.18/216.33  |- mesh__historyNote mesh__D008653 73%28%72%29%   
% 216.18/216.33  |- mesh__recordAuthorizer mesh__D008653 sjn
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D008653 2006
% 216.18/216.33  |- skos__prefLabel mesh__D000670 Amprolium
% 216.18/216.33  |- skos__broader mesh__D000670smesh__D010847
% 216.18/216.33  |- skos__hiddenLabel mesh__D000670 No%C3%%A9% Socopharm Hydrochloride
% 216.18/216.33  |- skos__hiddenLabel mesh__D000670 Hydrochloride, No%C3%%A9%-Socopharm
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D000670 2005
% 216.18/216.33  |- mesh__dateEstablished mesh__D000670 1991-01-01
% 216.18/216.33  |- skos__historyNote mesh__D000670 Picolines %28%1966-1971%29%
% 216.18/216.33  |- mesh__dateRevised mesh__D000670 2004-07-07
% 216.18/216.33  |- skos__altLabel mesh__D000670 No%C3%%A9%-Socopharm Hydrochloride
% 216.18/216.33  |- rdf__type mesh__D000670sskos__Concept
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D000670 2006
% 216.18/216.33  |- skos__scopeNote mesh__D000670
% 216.18/216.33       Veterinary coccidiostat that interferes with thiamine metabolism. It may cause thiamine deficiency.%A%    
% 216.18/216.33  |- mesh__historyNote mesh__D000670
% 216.18/216.33       91%28%81%29%; was see under PICOLINES 1981-90; was AMPROL see under PICOLINES 1979-80 %26% see under PICOLINE/analogs %26% derivatives 1975-78%A%  
% 216.18/216.33  |- mesh__onlineNote mesh__D000670 use AMPROLIUM to search AMPROL 1975-81   
% 216.18/216.33  |- mesh__recordAuthorizer mesh__D000670 sjn
% 216.18/216.33  |- mesh__recordMaintainer mesh__D000670 mdb
% 216.18/216.33  |- mesh__recordOriginator mesh__D000670 NLM
% 216.18/216.33  |- mesh__publicMeSHNote mesh__D000670
% 216.18/216.33       91; was see under PICOLINES 1981-90; was AMPROL see under PICOLINES 1979-80 %26% see under PICOLINE/analogs %26% derivatives 1975-78%A%  
% 216.18/216.33  |- skos__historyNote mesh__D000670 Antiprotozoal Agents %28%1966-1971%29%
% 216.18/216.33  |- mesh__dateCreated mesh__D000670 1999-01-01
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D013598 2005
% 216.18/216.33  |- skos__hiddenLabel mesh__D013598 Systems Theory, General
% 216.18/216.33  |- skos__hiddenLabel mesh__D013598 Theories, Queuing
% 216.18/216.33  |- rdf__type mesh__D013598sskos__Concept
% 216.18/216.33  |- skos__scopeNote mesh__D013598
% 216.18/216.33       Principles, models, and laws that apply to complex interrelationships and interdependencies of sets of linked components which form a functioning whole, a system. Any system may be composed of components which are systems in their own right %28%sub-systems%29%, such as several organs within an individual organism.%A%    
% 216.18/216.33  |- skos__related mesh__D013598smesh__D049490
% 216.18/216.33  |- skos__hiddenLabel mesh__D013598 Theories, Systems
% 216.18/216.33  |- skos__hiddenLabel mesh__D013598 General Systems Theories
% 216.18/216.33  |- mesh__historyNote mesh__D013598 80; was see SYSTEMS ANALYSIS 1976-79   
% 216.18/216.33  |- skos__related mesh__D013598smesh__D008962
% 216.18/216.33  |- skos__hiddenLabel mesh__D013598 Theory, General Systems
% 216.18/216.33  |- mesh__onlineNote mesh__D013598 search SYSTEMS ANALYSIS 1976-79   
% 216.18/216.33  |- skos__prefLabel mesh__D013598 Systems Theory
% 216.18/216.33  |- mesh__dateEstablished mesh__D013598 1980-01-01
% 216.18/216.33  |- mesh__recordAuthorizer mesh__D013598 sjn
% 216.18/216.33  |- skos__hiddenLabel mesh__D013598 Systems Theories, General
% 216.18/216.33  |- mesh__recordMaintainer mesh__D013598 nns
% 216.18/216.33  |- skos__hiddenLabel mesh__D013598 Theories, General Systems
% 216.18/216.33  |- skos__historyNote mesh__D013598 Systems Analysis %28%1966-1979%29%
% 216.18/216.33  |- mesh__recordOriginator mesh__D013598 EC
% 216.18/216.33  |- skos__hiddenLabel mesh__D013598 Theory, Systems
% 216.18/216.33  |- skos__hiddenLabel mesh__D013598 Theory, Queuing
% 216.18/216.33  |- skos__hiddenLabel mesh__D013598 Queuing Theories
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D013598 2006
% 216.18/216.33  |- mesh__publicMeSHNote mesh__D013598
% 216.18/216.33       80; was see SYSTEMS ANALYSIS 1976-79   
% 216.18/216.33  |- skos__hiddenLabel mesh__D013598 Systems Theories
% 216.18/216.33  |- skos__broader mesh__D013598smesh__D012586
% 216.18/216.33  |- mesh__dateCreated mesh__D013598 1979-05-31
% 216.18/216.33  |- skos__related mesh__D013598smesh__D013597
% 216.18/216.33  |- mesh__dateRevised mesh__D013598 2004-07-07
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018283 2006
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018283 1999
% 216.18/216.33  |- skos__prefLabel mesh__D018283 Cystadenocarcinoma, Papillary
% 216.18/216.33  |- skos__annotation mesh__D018283
% 216.18/216.33       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 216.18/216.33  |- skos__hiddenLabel mesh__D018283 Cystadenocarcinomas, Papillary
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018283 2002
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018283 2005
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018283 1998
% 216.18/216.33  |- rdf__type mesh__D018283sskos__Concept
% 216.18/216.33  |- skos__hiddenLabel mesh__D018283 Papillary Cystadenocarcinomas
% 216.18/216.33  |- skos__historyNote mesh__D018283 Cystadenocarcinoma %28%1980-1993%29%
% 216.18/216.33  |- mesh__recordMaintainer mesh__D018283 KEV
% 216.18/216.33  |- skos__historyNote mesh__D018283 Cystadenoma %28%1966-1979%29%
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018283 2001
% 216.18/216.33  |- mesh__publicMeSHNote mesh__D018283 94   
% 216.18/216.33  |- mesh__dateRevised mesh__D018283 1995-06-08
% 216.18/216.33  |- skos__broader mesh__D018283smesh__D003536
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018283 2004
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018283 1997
% 216.18/216.33  |- mesh__recordOriginator mesh__D018283 PLS
% 216.18/216.33  |- mesh__dateEstablished mesh__D018283 1994-01-01
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018283 2000
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018283 2003
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D018283 1996
% 216.18/216.33  |- skos__hiddenLabel mesh__D018283 Papillary Cystadenocarcinoma
% 216.18/216.33  |- mesh__recordAuthorizer mesh__D018283 PLS
% 216.18/216.33  |- skos__scopeNote mesh__D018283
% 216.18/216.33       An adenocarcinoma in which the tumor elements are arranged as finger-like processes or as a solid spherical nodule projecting from an epithelial surface.%A%    
% 216.18/216.33  |- mesh__historyNote mesh__D018283 94   
% 216.18/216.33  |- mesh__dateCreated mesh__D018283 1993-06-03
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D004263 2000
% 216.18/216.33  |- mesh__dateRevised mesh__D004263 1993-06-18
% 216.18/216.33  |- mesh__dateEstablished mesh__D004263 1978-01-01
% 216.18/216.33  |- skos__historyNote mesh__D004263 DNA Viruses %28%1966-1977%29%
% 216.18/216.33  |- skos__historyNote mesh__D004263 Oncogenic Viruses %28%1966-1977%29%
% 216.18/216.33  |- mesh__recordMaintainer mesh__D004263 PLS
% 216.18/216.33  |- skos__scopeNote mesh__D004263
% 216.18/216.33       DNA viruses producing malignant tumors. Of the six major groupings of DNA viruses four contain members which are actually or potentially oncogenic: the Adenoviridae, the Herpesviridae, the Papovaviridae, and the Poxviridae.%A%    
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D004263 1994
% 216.18/216.33  |- skos__hiddenLabel mesh__D004263 Viruses, DNA Tumor
% 216.18/216.33  |- skos__hiddenLabel mesh__D004263 DNA Tumor Virus
% 216.18/216.33  |- mesh__recordAuthorizer mesh__D004263 PLS
% 216.18/216.33  |- skos__hiddenLabel mesh__D004263 Tumor Virus, DNA
% 216.18/216.33  |- rdf__type mesh__D004263sskos__Concept
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D004263 2001
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D004263 1995
% 216.18/216.33  |- mesh__historyNote mesh__D004263 78   
% 216.18/216.33  |- skos__hiddenLabel mesh__D004263 Virus, DNA Tumor
% 216.18/216.33  |- skos__broader mesh__D004263smesh__D004267
% 216.18/216.33  |- skos__broader mesh__D004263smesh__D009858
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D004263 2005
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D004263 1998
% 216.18/216.33  |- skos__annotation mesh__D004263
% 216.18/216.33       GEN only: prefer specifics; infection: coord IM with TUMOR VIRUS INFECTIONS %28%IM%29%%A%  
% 216.18/216.33  |- skos__hiddenLabel mesh__D004263 Tumor Viruses, DNA
% 216.18/216.33  |- mesh__dateCreated mesh__D004263 1977-05-13
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D004263 2006
% 216.18/216.33  |- mesh__activeMeSHYear mesh__D004263 1999
% 216.18/216.34  |- mesh__recordOriginator mesh__D004263 AEP
% 216.18/216.34  |- skos__prefLabel mesh__D004263 DNA Tumor Viruses
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D004263 2002
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D004263 2003
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D004263 1996
% 216.18/216.34  |- mesh__publicMeSHNote mesh__D004263 78   
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D004263 2004
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D004263 1997
% 216.18/216.34  |- mesh__recordAuthorizer mesh__D017989 sjn
% 216.18/216.34  |- mesh__recordOriginator mesh__D017989 AGS
% 216.18/216.34  |- skos__annotation mesh__D017989
% 216.18/216.34       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% + LEUKEMIA %28%IM%29% if pertinent; DF: GALV%A%  
% 216.18/216.34  |- skos__altLabel mesh__D017989 GALV
% 216.18/216.34  |- skos__prefLabel mesh__D017989 Leukemia Virus, Gibbon Ape
% 216.18/216.34  |- mesh__dateEstablished mesh__D017989 1994-01-01
% 216.18/216.34  |- mesh__publicMeSHNote mesh__D017989 94   
% 216.18/216.34  |- mesh__historyNote mesh__D017989 94   
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D017989 2003
% 216.18/216.34  |- skos__altLabel mesh__D017989 Gibbon ape leukemia virus
% 216.18/216.34  |- skos__broader mesh__D017989smesh__D015301
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D017989 2005
% 216.18/216.34  |- mesh__recordMaintainer mesh__D017989 ags
% 216.18/216.34  |- rdf__type mesh__D017989sskos__Concept
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D017989 2004
% 216.18/216.34  |- mesh__dateCreated mesh__D017989 1993-06-04
% 216.18/216.34  |- skos__broader mesh__D017989smesh__D017988
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D017989 2002
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D017989 2006
% 216.18/216.34  |- skos__scopeNote mesh__D017989
% 216.18/216.34       A species of GAMMARETROVIRUS causing leukemia in the gibbon ape. Natural transmission is by contact.%A%    
% 216.18/216.34  |- mesh__dateRevised mesh__D017989 2001-07-25
% 216.18/216.34  |- skos__hiddenLabel mesh__D050814 Transcription Factor Oct 3
% 216.18/216.34  |- skos__altLabel mesh__D050814 POU5F1 Transcription Factor
% 216.18/216.34  |- skos__prefLabel mesh__D050814 Octamer Transcription Factor-3
% 216.18/216.34  |- skos__scopeNote mesh__D050814
% 216.18/216.34       An octamer transcription factor that is expressed primarily in totipotent embryonic STEM CELLS and GERM CELLS and is down-regulated during CELL DIFFERENTIATION.%A%    
% 216.18/216.34  |- skos__broader mesh__D050814smesh__D050810
% 216.18/216.34  |- skos__altLabel mesh__D050814 Oct-3 Transcription Factor
% 216.18/216.34  |- skos__hiddenLabel mesh__D050814 Oct 3 Transcription Factor
% 216.18/216.34  |- skos__altLabel mesh__D050814 Oct-4 Transcription Factor
% 216.18/216.34  |- rdf__type mesh__D050814sskos__Concept
% 216.18/216.34  |- skos__hiddenLabel mesh__D050814 Oct-3, Transcription Factor
% 216.18/216.34  |- skos__hiddenLabel mesh__D050814 Transcription Factor, Oct-3
% 216.18/216.34  |- skos__hiddenLabel mesh__D050814 Transcription Factor-3, Octamer
% 216.18/216.34  |- skos__hiddenLabel mesh__D050814 Transcription Factor, POU5F1
% 216.18/216.34  |- skos__hiddenLabel mesh__D050814 Oct-4, Transcription Factor
% 216.18/216.34  |- skos__altLabel mesh__D050814 Transcription Factor Oct-3
% 216.18/216.34  |- mesh__publicMeSHNote mesh__D050814
% 216.18/216.34       2006; TRANSCRIPTION FACTOR OCT-3 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005%A%  
% 216.18/216.34  |- mesh__dateEstablished mesh__D050814 2006-01-01
% 216.18/216.34  |- skos__hiddenLabel mesh__D050814 Octamer Transcription Factor 3
% 216.18/216.34  |- skos__hiddenLabel mesh__D050814 Transcription Factor, Oct-4
% 216.18/216.34  |- mesh__recordAuthorizer mesh__D050814 sjn
% 216.18/216.34  |- mesh__historyNote mesh__D050814 2006%28%1990%29%   
% 216.18/216.34  |- skos__hiddenLabel mesh__D050814 Transcription Factor Oct 4
% 216.18/216.34  |- skos__altLabel mesh__D050814 POU Domain, Class 5, Transcription Factor 1
% 216.18/216.34  |- skos__hiddenLabel mesh__D050814 Oct 4 Transcription Factor
% 216.18/216.34  |- mesh__recordMaintainer mesh__D050814 DRC
% 216.18/216.34  |- skos__altLabel mesh__D050814 Transcription Factor Oct-4
% 216.18/216.34  |- mesh__dateCreated mesh__D050814 2005-06-30
% 216.18/216.34  |- mesh__recordOriginator mesh__D050814 DRC
% 216.18/216.34  |- skos__hiddenLabel mesh__D050814 Octamer Binding Protein 4
% 216.18/216.34  |- skos__altLabel mesh__D050814 Octamer-Binding Protein 4
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D050814 2006
% 216.18/216.34  |- skos__hiddenLabel mesh__D003969 Diarrhea Syndrome, Watery
% 216.18/216.34  |- mesh__historyNote mesh__D003969
% 216.18/216.34       94; was DIARRHEOGENIC TUMOR 1982-93 %28%see under ISLET CELL TUMOR 1982-90%29%; VIPOMA was see DIARRHEOGENIC TUMOR 1982-93%A%  
% 216.18/216.34  |- skos__altLabel mesh__D003969 Vipoma Syndrome
% 216.18/216.34  |- skos__altLabel mesh__D003969 Verner-Morrison Syndrome
% 216.18/216.34  |- skos__historyNote mesh__D003969 Diarrhea %28%1966-1981%29%
% 216.18/216.34  |- skos__historyNote mesh__D003969 Islet Cell Tumor %28%1966-1981%29%
% 216.18/216.34  |- skos__hiddenLabel mesh__D003969 Syndrome, Vipoma
% 216.18/216.34  |- skos__historyNote mesh__D003969 Pancreatic Neoplasms %28%1966-1981%29%
% 216.18/216.34  |- skos__hiddenLabel mesh__D003969 Tumors, VIP-Secreting %28%VIPoma%29%
% 216.18/216.34  |- skos__hiddenLabel mesh__D003969 VIP Secreting Tumor %28%VIPoma%29%
% 216.18/216.34  |- skos__hiddenLabel mesh__D003969 Tumor, Diarrheogenic
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D003969 2006
% 216.18/216.34  |- mesh__dateEstablished mesh__D003969 1991-01-01
% 216.18/216.34  |- skos__altLabel mesh__D003969 Watery Diarrhea Syndrome
% 216.18/216.34  |- skos__hiddenLabel mesh__D003969 Tumors, Diarrheogenic
% 216.18/216.34  |- mesh__recordMaintainer mesh__D003969 lkt
% 216.18/216.34  |- skos__hiddenLabel mesh__D003969 VIP-Secreting Tumors %28%VIPoma%29%
% 216.18/216.34  |- skos__historyNote mesh__D003969
% 216.18/216.34       Gastrointestinal Hormones %28%1966-1981%29%
% 216.18/216.34  |- skos__hiddenLabel mesh__D003969 Syndrome, Watery Diarrhea
% 216.18/216.34  |- skos__altLabel mesh__D003969 WDHA
% 216.18/216.34  |- skos__altLabel mesh__D003969 Diarrheogenic Tumor
% 216.18/216.34  |- skos__altLabel mesh__D003969 VIP-Secreting Tumor %28%VIPoma%29%
% 216.18/216.34  |- skos__hiddenLabel mesh__D003969 Vipomas
% 216.18/216.34  |- rdf__type mesh__D003969sskos__Concept
% 216.18/216.34  |- mesh__publicMeSHNote mesh__D003969
% 216.18/216.34       94; was DIARRHEOGENIC TUMOR 1982-93 %28%see under ISLET CELL TUMOR 1982-90%29%; VIPOMA was see DIARRHEOGENIC TUMOR 1982-93%A%  
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D003969 2005
% 216.18/216.34  |- skos__altLabel mesh__D003969 Watery Diarrhea with Hypokalemic Alkalosis
% 216.18/216.34  |- skos__broader mesh__D003969smesh__D018273
% 216.18/216.34  |- mesh__recordOriginator mesh__D003969 VDK
% 216.18/216.34  |- skos__hiddenLabel mesh__D003969 Tumor, VIP-Secreting %28%VIPoma%29%
% 216.18/216.34  |- mesh__onlineNote mesh__D003969
% 216.18/216.34       use VIPOMA to search DIARRHEOGENIC TUMOR 1982-93   
% 216.18/216.34  |- skos__annotation mesh__D003969
% 216.18/216.34       coord IM with PANCREATIC NEOPLASMS %28%IM%29%   
% 216.18/216.34  |- skos__hiddenLabel mesh__D003969 Verner Morrison Syndrome
% 216.18/216.34  |- mesh__dateRevised mesh__D003969 2004-07-07
% 216.18/216.34  |- skos__historyNote mesh__D003969
% 216.18/216.34       Vasoactive Intestinal Peptide %28%1977-1981%29%
% 216.18/216.34  |- mesh__dateCreated mesh__D003969 1981-05-19
% 216.18/216.34  |- skos__prefLabel mesh__D003969 Vipoma
% 216.18/216.34  |- mesh__recordAuthorizer mesh__D003969 sjn
% 216.18/216.34  |- skos__scopeNote mesh__D003969
% 216.18/216.34       A tumor that secretes VASOACTIVE INTESTINAL PEPTIDE, a neuropeptide that causes VASODILATION; relaxation of smooth muscles; watery DIARRHEA; HYPOKALEMIA; and HYPOCHLORHYDRIA. Vipomas, derived from the pancreatic ISLET CELLS, generally are malignant and can secrete other hormones. In most cases, Vipomas are located in the PANCREAS but can be found in extrapancreatic sites.%A%    
% 216.18/216.34  |- skos__hiddenLabel mesh__D003969 Diarrheogenic Tumors
% 216.18/216.34  |- skos__altLabel mesh__D003969 WDHH
% 216.18/216.34  |- skos__altLabel mesh__D003969 Diarrheogenic Islet Cell Tumor
% 216.18/216.34  |- skos__hiddenLabel mesh__D003969 Cholera, Pancreatic
% 216.18/216.34  |- skos__broader mesh__D003969smesh__D018278
% 216.18/216.34  |- skos__hiddenLabel mesh__D003969 Syndrome, Verner-Morrison
% 216.18/216.34  |- mesh__recordMaintainer mesh__D014691 NNS
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D014691 2006
% 216.18/216.34  |- skos__hiddenLabel mesh__D014691 Ventilations
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D014691 2003
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D014691 1999
% 216.18/216.34  |- mesh__dateRevised mesh__D014691 1998-06-11
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D014691 2005
% 216.18/216.34  |- mesh__recordAuthorizer mesh__D014691 SJN
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D014691 2002
% 216.18/216.34  |- skos__broader mesh__D014691smesh__D004780
% 216.18/216.34  |- mesh__dateCreated mesh__D014691 1999-01-01
% 216.18/216.34  |- mesh__recordOriginator mesh__D014691 NLM
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D014691 2001
% 216.18/216.34  |- rdf__type mesh__D014691sskos__Concept
% 216.18/216.34  |- skos__annotation mesh__D014691
% 216.18/216.34       environment, not lungs %28% = PULMONARY VENTILATION%29%   
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D014691 2000
% 216.18/216.34  |- skos__related mesh__D014691smesh__D020378
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D014691 2004
% 216.18/216.34  |- skos__scopeNote mesh__D014691
% 216.18/216.34       Supplying a building or house, their rooms and corridors, with fresh air. The controlling of the environment thus may be in public or domestic sites and in medical or non-medical locales. %28%From Dorland, 28th ed%29%%A%    
% 216.18/216.34  |- skos__prefLabel mesh__D014691 Ventilation
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D008654 2004
% 216.18/216.34  |- mesh__dateRevised mesh__D008654 1995-06-08
% 216.18/216.34  |- rdf__type mesh__D008654sskos__Concept
% 216.18/216.34  |- skos__broader mesh__D008654smesh__D018301
% 216.18/216.34  |- skos__prefLabel mesh__D008654 Mesothelioma
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D008654 1997
% 216.18/216.34  |- skos__broader mesh__D008654smesh__D000236
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D008654 2002
% 216.18/216.34  |- mesh__recordAuthorizer mesh__D008654 PLS
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D008654 2005
% 216.18/216.34  |- mesh__dateCreated mesh__D008654 1999-01-01
% 216.18/216.34  |- skos__annotation mesh__D008654
% 216.18/216.34       benign or malignant; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 216.18/216.34  |- mesh__recordMaintainer mesh__D008654 KEV
% 216.18/216.34  |- skos__scopeNote mesh__D008654
% 216.18/216.34       A tumor derived from mesothelial tissue %28%peritoneum, pleura, pericardium%29%. It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. %28%Dorland, 27th ed%29%%A%    
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D008654 1998
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D008654 2006
% 216.18/216.34  |- skos__hiddenLabel mesh__D008654 Mesotheliomas
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D008654 2000
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D008654 1999
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D008654 2003
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D008654 2001
% 216.18/216.34  |- mesh__recordOriginator mesh__D008654 NLM
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D008654 1996
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D000671 2005
% 216.18/216.34  |- skos__annotation mesh__D000671
% 216.18/216.34       a surg procedure: do not confuse with AMPUTATION, TRAUMATIC; do not use /util except by MeSH definition%A%  
% 216.18/216.34  |- rdf__type mesh__D000671sskos__Concept
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D000671 1998
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D000671 2006
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D000671 2000
% 216.18/216.34  |- skos__prefLabel mesh__D000671 Amputation
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D000671 1999
% 216.18/216.34  |- skos__broader mesh__D000671smesh__D019637
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D000671 2001
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D000671 2002
% 216.18/216.34  |- mesh__recordMaintainer mesh__D000671 PXP
% 216.18/216.34  |- mesh__dateCreated mesh__D000671 1999-01-01
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D000671 2003
% 216.18/216.34  |- mesh__dateRevised mesh__D000671 1997-06-20
% 216.18/216.34  |- mesh__recordAuthorizer mesh__D000671 SJN
% 216.18/216.34  |- skos__hiddenLabel mesh__D000671 Amputations
% 216.18/216.34  |- skos__scopeNote mesh__D000671
% 216.18/216.34       The removal of a limb or other appendage or outgrowth of the body. %28%Dorland, 28th ed%29%%A%    
% 216.18/216.34  |- mesh__recordOriginator mesh__D000671 NLM
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D000671 2004
% 216.18/216.34  |- skos__historyNote mesh__D013599 Heart Ventricle %28%1966-1978%29%
% 216.18/216.34  |- mesh__dateEstablished mesh__D013599 1991-01-01
% 216.18/216.34  |- skos__prefLabel mesh__D013599 Systole
% 216.18/216.34  |- mesh__recordOriginator mesh__D013599 VDK
% 216.18/216.34  |- skos__hiddenLabel mesh__D013599 Interval, Systolic Time
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D013599 2004
% 216.18/216.34  |- skos__hiddenLabel mesh__D013599 Systolic Time Intervals
% 216.18/216.34  |- mesh__historyNote mesh__D013599
% 216.18/216.34       91%28%79%29%; was see under MYOCARDIAL CONTRACTION 1979-90   
% 216.18/216.34  |- mesh__dateRevised mesh__D013599 2003-07-09
% 216.18/216.34  |- skos__hiddenLabel mesh__D013599 Time Interval, Systolic
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D013599 2006
% 216.18/216.34  |- skos__hiddenLabel mesh__D013599 Systoles
% 216.18/216.34  |- skos__hiddenLabel mesh__D013599 Intervals, Systolic Time
% 216.18/216.34  |- mesh__recordAuthorizer mesh__D013599 sjn
% 216.18/216.34  |- skos__broader mesh__D013599smesh__D009200
% 216.18/216.34  |- skos__scopeNote mesh__D013599
% 216.18/216.34       Period of contraction of the HEART, especially of the HEART VENTRICLES.%A%    
% 216.18/216.34  |- skos__annotation mesh__D013599
% 216.18/216.34       SYSTOLIC PRESSURE see BLOOD PRESSURE %26% do not add SYSTOLE %28%NIM%29% unless particularly discussed%A%  
% 216.18/216.34  |- mesh__recordMaintainer mesh__D013599 nns
% 216.18/216.34  |- skos__historyNote mesh__D013599 Myocardial Contraction %28%1975-1978%29%
% 216.18/216.34  |- skos__hiddenLabel mesh__D013599 Time Intervals, Systolic
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D013599 2005
% 216.18/216.34  |- mesh__dateCreated mesh__D013599 1977-12-06
% 216.18/216.34  |- skos__historyNote mesh__D013599 Heart %28%1966-1978%29%
% 216.18/216.34  |- mesh__publicMeSHNote mesh__D013599
% 216.18/216.34       91; was see under MYOCARDIAL CONTRACTION 1979-90   
% 216.18/216.34  |- rdf__type mesh__D013599sskos__Concept
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018284 2005
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018284 1998
% 216.18/216.34  |- rdf__type mesh__D018284sskos__Concept
% 216.18/216.34  |- mesh__recordAuthorizer mesh__D018284 PLS
% 216.18/216.34  |- skos__scopeNote mesh__D018284
% 216.18/216.34       A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated papillary serous cystadenocarcinoma cells. Psammoma bodies may be present. The tumor generally adheres to surrounding structures and produces ascites. %28%From Hughes, Obstetric-Gynecologic Terminology, 1972, p185%29%%A%    
% 216.18/216.34  |- skos__historyNote mesh__D018284 Cystadenocarcinoma %28%1975-1993%29%
% 216.18/216.34  |- skos__hiddenLabel mesh__D018284 Serous Cystadenocarcinomas
% 216.18/216.34  |- skos__hiddenLabel mesh__D018284 Serous Cystadenocarcinoma
% 216.18/216.34  |- skos__annotation mesh__D018284
% 216.18/216.34       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 216.18/216.34  |- skos__hiddenLabel mesh__D018284 Cystadenocarcinomas, Serous
% 216.18/216.34  |- mesh__recordMaintainer mesh__D018284 KEV
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018284 2002
% 216.18/216.34  |- mesh__dateRevised mesh__D018284 1995-06-08
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018284 2004
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018284 1997
% 216.18/216.34  |- mesh__recordOriginator mesh__D018284 PLS
% 216.18/216.34  |- mesh__dateCreated mesh__D018284 1993-06-25
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018284 2003
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018284 1996
% 216.18/216.34  |- skos__prefLabel mesh__D018284 Cystadenocarcinoma, Serous
% 216.18/216.34  |- skos__historyNote mesh__D018284 Cystadenoma %28%1966-1979%29%
% 216.18/216.34  |- mesh__historyNote mesh__D018284 94   
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018284 2001
% 216.18/216.34  |- mesh__publicMeSHNote mesh__D018284 94   
% 216.18/216.34  |- skos__broader mesh__D018284smesh__D003536
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018284 2006
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018284 1999
% 216.18/216.34  |- mesh__dateEstablished mesh__D018284 1994-01-01
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018284 2000
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D004264 2004
% 216.18/216.34  |- skos__altLabel mesh__D004264 DNA Relaxing Enzyme
% 216.18/216.34  |- skos__altLabel mesh__D004264 DNA Relaxing Enzymes
% 216.18/216.34  |- skos__broader mesh__D004264smesh__D026942
% 216.18/216.34  |- mesh__publicMeSHNote mesh__D004264
% 216.18/216.34       2002; see DNA TOPOISOMERASE 1994-2001, see DNA UNTWISTING PROTEINS 1978-1993; for DNA NICKING-CLOSING PROTEIN see DNA NICKING-CLOSING PROTEINS 1978-1993; for DNA RELAXING ENZYME see DNA RELAXING ENZYMES 1978-1993; for DNA UNTWISTING ENZYME see DNA UNTWISTING ENZYMES 1978-1993; for OMEGA PROTEIN see OMEGA PROTEINS 1978-1993%A%  
% 216.18/216.34  |- skos__historyNote mesh__D004264 Deoxyribonucleases %28%1966-1977%29%
% 216.18/216.34  |- skos__altLabel mesh__D004264 DNA Untwisting Enzyme
% 216.18/216.34  |- skos__altLabel mesh__D004264 Topoisomerase I
% 216.18/216.34  |- skos__altLabel mesh__D004264 DNA Untwisting Enzymes
% 216.18/216.34  |- mesh__dateRevised mesh__D004264 2003-07-09
% 216.18/216.34  |- mesh__recordOriginator mesh__D004264 RLS
% 216.18/216.34  |- skos__altLabel mesh__D004264 DNA Untwisting Proteins
% 216.18/216.34  |- skos__altLabel mesh__D004264 DNA Topoisomerase
% 216.18/216.34  |- skos__scopeNote mesh__D004264
% 216.18/216.34       DNA TOPOISOMERASES that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. DNA Topoisomerases, Type I enzymes reduce the topological stress in the DNA structure by relaxing the superhelical turns and knotted rings in the DNA helix.%A%    
% 216.18/216.34  |- skos__prefLabel mesh__D004264 DNA Topoisomerases, Type I
% 216.18/216.34  |- skos__historyNote mesh__D004264 Proteins %28%1966-1977%29%
% 216.18/216.34  |- skos__historyNote mesh__D004264 specific protein %28%1966-1977%29%
% 216.18/216.34  |- skos__altLabel mesh__D004264 DNA Nicking-Closing Protein
% 216.18/216.34  |- skos__altLabel mesh__D004264 DNA Relaxing Protein
% 216.18/216.34  |- mesh__dateEstablished mesh__D004264 1978-01-01
% 216.18/216.34  |- rdf__type mesh__D004264sskos__Concept
% 216.18/216.34  |- skos__annotation mesh__D004264
% 216.18/216.34       GEN or unspecified; prefer specifics; do not confuse X ref DNA UNTWISTING PROTEIN with DNA UNWINDING PROTEINS see DNA HELICASES%A%  
% 216.18/216.34  |- mesh__historyNote mesh__D004264
% 216.18/216.34       2002; use DNA TOPOISOMERASE 1994-2001, use DNA UNTWISTING PROTEINS 1978-1993; for DNA NICKING-CLOSING PROTEIN use DNA NICKING-CLOSING PROTEINS 1978-1993; for DNA RELAXING ENZYME use DNA RELAXING ENZYMES 1978-1993; for DNA UNTWISTING ENZYME use DNA UNTWISTING ENZYMES 1978-1993; for OMEGA PROTEIN use OMEGA PROTEINS 1978-1993%A%  
% 216.18/216.34  |- mesh__recordMaintainer mesh__D004264 ssb
% 216.18/216.34  |- mesh__recordAuthorizer mesh__D004264 sjn
% 216.18/216.34  |- mesh__dateCreated mesh__D004264 1977-04-15
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D004264 2006
% 216.18/216.34  |- skos__altLabel mesh__D004264 DNA Untwisting Protein
% 216.18/216.34  |- skos__historyNote mesh__D004264 DNA, Circular %28%1973-1977%29%
% 216.18/216.34  |- skos__altLabel mesh__D004264 DNA Nicking-Closing Proteins
% 216.18/216.34  |- skos__altLabel mesh__D004264 DNA Topoisomerase I
% 216.18/216.34  |- skos__historyNote mesh__D004264
% 216.18/216.34       Polynucleotide Synthetases %28%1973-1977%29%
% 216.18/216.34  |- skos__altLabel mesh__D004264 DNA Type 1 Topoisomerase
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D004264 2005
% 216.18/216.34  |- skos__altLabel mesh__D004264 Type I DNA Topoisomerase
% 216.18/216.34  |- skos__hiddenLabel mesh__D050815 Compression Fracture
% 216.18/216.34  |- mesh__dateCreated mesh__D050815 2005-06-30
% 216.18/216.34  |- skos__scopeNote mesh__D050815
% 216.18/216.34       Crumbling or smashing of cancellous BONE by forces acting parallel to the long axis of bone. It is applied particularly to vertebral body fractures %28%SPINAL FRACTURES%29%. %28%Blauvelt and Nelson, A Manual of Orthopedic Terminology, 1994, p4%29%%A%    
% 216.18/216.34  |- rdf__type mesh__D050815sskos__Concept
% 216.18/216.34  |- skos__prefLabel mesh__D050815 Fractures, Compression
% 216.18/216.34  |- skos__historyNote mesh__D050815 Fractures, Bone %28%1967-2005%29%
% 216.18/216.34  |- mesh__recordOriginator mesh__D050815 ags
% 216.18/216.34  |- skos__altLabel mesh__D050815 Compression Fractures
% 216.18/216.34  |- skos__hiddenLabel mesh__D050815 Fracture, Compression
% 216.18/216.34  |- mesh__publicMeSHNote mesh__D050815 2006   
% 216.18/216.34  |- mesh__recordMaintainer mesh__D050815 ags
% 216.18/216.34  |- skos__broader mesh__D050815smesh__D050723
% 216.18/216.34  |- mesh__historyNote mesh__D050815 2006   
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D050815 2006
% 216.18/216.34  |- mesh__dateEstablished mesh__D050815 2006-01-01
% 216.18/216.34  |- skos__historyNote mesh__D050815 Spinal Fractures %28%1988-2005%29%
% 216.18/216.34  |- mesh__recordAuthorizer mesh__D050815 sjn
% 216.18/216.34  |- skos__hiddenLabel mesh__D014692 Ventilation Perfusion Ratio
% 216.18/216.34  |- skos__hiddenLabel mesh__D014692 Ratio, Ventilation-Perfusion
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D014692 2005
% 216.18/216.34  |- mesh__historyNote mesh__D014692 70%28%68%29%   
% 216.18/216.34  |- mesh__dateRevised mesh__D014692 2003-07-09
% 216.18/216.34  |- skos__annotation mesh__D014692 a resp funct test   
% 216.18/216.34  |- skos__broader mesh__D014692smesh__D044702
% 216.18/216.34  |- mesh__dateCreated mesh__D014692 1999-01-01
% 216.18/216.34  |- skos__hiddenLabel mesh__D014692 Ventilation-Perfusion Ratios
% 216.18/216.34  |- skos__historyNote mesh__D014692
% 216.18/216.34       Respiratory Function Tests %28%1966-1967%29%
% 216.18/216.34  |- mesh__recordAuthorizer mesh__D014692 sjn
% 216.18/216.34  |- rdf__type mesh__D014692sskos__Concept
% 216.18/216.34  |- mesh__publicMeSHNote mesh__D014692 70   
% 216.18/216.34  |- skos__broader mesh__D014692smesh__D011659
% 216.18/216.34  |- skos__prefLabel mesh__D014692 Ventilation-Perfusion Ratio
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D014692 2004
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D014692 2006
% 216.18/216.34  |- mesh__recordMaintainer mesh__D014692 nns
% 216.18/216.34  |- mesh__dateEstablished mesh__D014692 1970-01-01
% 216.18/216.34  |- mesh__recordOriginator mesh__D014692 NLM
% 216.18/216.34  |- skos__scopeNote mesh__D014692
% 216.18/216.34       The ratio of alveolar ventilation to simultaneous alveolar capillary blood flow in any part of the lung. %28%Stedman, 25th ed%29%%A%    
% 216.18/216.34  |- skos__hiddenLabel mesh__D014692 Ratios, Ventilation-Perfusion
% 216.18/216.34  |- mesh__dateRevised mesh__D008655 2005-06-30
% 216.18/216.34  |- mesh__recordOriginator mesh__D008655 NLM
% 216.18/216.34  |- skos__altLabel mesh__D008655 Jenapharm Brand of Mesterolone
% 216.18/216.34  |- skos__hiddenLabel mesh__D008655 Mesterolone Schering Brand
% 216.18/216.34  |- skos__scopeNote mesh__D008655
% 216.18/216.34       17 beta-Hydroxy-1 alpha-methyl-5 alpha-androstan-3-one. A synthetic steroid with anabolic and androgenic activities.%A%    
% 216.18/216.34  |- mesh__dateCreated mesh__D008655 1974-11-11
% 216.18/216.34  |- skos__altLabel mesh__D008655 Schering Brand of Mesterolone
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D008655 2006
% 216.18/216.34  |- mesh__recordMaintainer mesh__D008655 CCR
% 216.18/216.34  |- skos__broader mesh__D008655smesh__D013196
% 216.18/216.34  |- mesh__recordAuthorizer mesh__D008655 sjn
% 216.18/216.34  |- mesh__publicMeSHNote mesh__D008655
% 216.18/216.34       91; was see under STANOLONE 1975-90   
% 216.18/216.34  |- skos__historyNote mesh__D008655 Methane %28%1973-1974%29%
% 216.18/216.34  |- skos__prefLabel mesh__D008655 Mesterolone
% 216.18/216.34  |- skos__hiddenLabel mesh__D008655 Mesterolone Jenapharm Brand
% 216.18/216.34  |- mesh__historyNote mesh__D008655
% 216.18/216.34       91%28%75%29%; was see under STANOLONE 1975-90   
% 216.18/216.34  |- mesh__dateEstablished mesh__D008655 1991-01-01
% 216.18/216.34  |- skos__historyNote mesh__D008655 Stanolone %28%1972-1974%29%
% 216.18/216.34  |- skos__annotation mesh__D008655 an anabolic steroid   
% 216.18/216.34  |- rdf__type mesh__D008655sskos__Concept
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D000672 2003
% 216.18/216.34  |- mesh__recordAuthorizer mesh__D000672 sjn
% 216.18/216.34  |- skos__related mesh__D000672smesh__D010591
% 216.18/216.34  |- skos__scopeNote mesh__D000672
% 216.18/216.34       The part of a limb or tail following amputation that is proximal to the amputated section.%A%    
% 216.18/216.34  |- mesh__recordOriginator mesh__D000672 NLM
% 216.18/216.34  |- skos__broader mesh__D000672smesh__D005121
% 216.18/216.34  |- skos__annotation mesh__D000672
% 216.18/216.34       restrict to extremities: do not use for gastric stump %28% = GASTRIC STUMP%29%, appendiceal stump, ureteral stump, cervical stump %26% the like %28%indexed probably under relevant -ECTOMY or other surg term%29%%A%  
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D000672 2002
% 216.18/216.34  |- mesh__recordMaintainer mesh__D000672 KEV
% 216.18/216.34  |- rdf__type mesh__D000672sskos__Concept
% 216.18/216.34  |- skos__hiddenLabel mesh__D000672 Stump, Amputation
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D000672 2006
% 216.18/216.34  |- mesh__dateCreated mesh__D000672 1999-01-01
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D000672 2001
% 216.18/216.34  |- skos__hiddenLabel mesh__D000672 Stumps, Amputation
% 216.18/216.34  |- skos__prefLabel mesh__D000672 Amputation Stumps
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D000672 2005
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D000672 2000
% 216.18/216.34  |- mesh__dateRevised mesh__D000672 1999-11-03
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D000672 2004
% 216.18/216.34  |- skos__hiddenLabel mesh__D000672 Amputation Stump
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018285 2004
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018285 1997
% 216.18/216.34  |- mesh__recordOriginator mesh__D018285 PLS
% 216.18/216.34  |- mesh__dateEstablished mesh__D018285 1994-01-01
% 216.18/216.34  |- skos__historyNote mesh__D018285 Adenoma, Bile Duct %28%1981-1993%29%
% 216.18/216.34  |- skos__hiddenLabel mesh__D018285 Klatskins Tumor
% 216.18/216.34  |- skos__historyNote mesh__D018285 Adenocarcinoma %28%1986-1993%29%
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018285 2003
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018285 2001
% 216.18/216.34  |- mesh__publicMeSHNote mesh__D018285 94   
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018285 1996
% 216.18/216.34  |- skos__hiddenLabel mesh__D018285 Klatskin Tumor
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018285 2000
% 216.18/216.34  |- mesh__dateCreated mesh__D018285 1993-06-28
% 216.18/216.34  |- mesh__historyNote mesh__D018285 94   
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018285 2006
% 216.18/216.34  |- mesh__recordAuthorizer mesh__D018285 PLS
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018285 1999
% 216.18/216.34  |- skos__annotation mesh__D018285
% 216.18/216.34       blood supply /chem /second /secret /ultrastruct permitted; coord IM with HEPATIC DUCT, COMMON %28%IM%29% + BILE DUCT NEOPLASMS %28%IM%29%%A%  
% 216.18/216.34  |- skos__hiddenLabel mesh__D018285 Tumor, Klatskin%27%s
% 216.18/216.34  |- skos__historyNote mesh__D018285 Bile Duct Neoplasms %28%1981-1993%29%
% 216.18/216.34  |- rdf__type mesh__D018285sskos__Concept
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018285 2005
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018285 1998
% 216.18/216.34  |- skos__prefLabel mesh__D018285 Klatskin%27%s Tumor
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D018285 2002
% 216.18/216.34  |- skos__broader mesh__D018285smesh__D000230
% 216.18/216.34  |- skos__scopeNote mesh__D018285
% 216.18/216.34       Adenocarcinoma of the common hepatic duct bifurcation. These tumors are generally small, sharply localized, and seldom metastasizing. G. Klatskin%27%s original review of 13 cases was published in 1965. Once thought to be relatively uncommon, tumors of the bifurcation of the bile duct now appear to comprise more than one-half of all bile duct cancers. %28%From Holland et al., Cancer Medicine, 3d ed, p1457%29%%A%    
% 216.18/216.34  |- mesh__recordMaintainer mesh__D018285 KEV
% 216.18/216.34  |- mesh__dateRevised mesh__D018285 1995-06-08
% 216.18/216.34  |- mesh__dateRevised mesh__D004265 2003-07-09
% 216.18/216.34  |- skos__prefLabel mesh__D004265 DNA Helicases
% 216.18/216.34  |- skos__hiddenLabel mesh__D004265 Helicases, DNA
% 216.18/216.34  |- skos__historyNote mesh__D004265 specific protein %28%1966-1977%29%
% 216.18/216.34  |- skos__historyNote mesh__D004265 Deoxyribonucleases %28%1966-1977%29%
% 216.18/216.34  |- skos__broader mesh__D004265smesh__D007535
% 216.18/216.34  |- mesh__publicMeSHNote mesh__D004265
% 216.18/216.34       94; was DNA UNWINDING PROTEINS 1978-93   
% 216.18/216.34  |- mesh__dateEstablished mesh__D004265 1978-01-01
% 216.18/216.34  |- rdf__type mesh__D004265sskos__Concept
% 216.18/216.34  |- mesh__recordOriginator mesh__D004265 RLS
% 216.18/216.34  |- skos__hiddenLabel mesh__D004265 Proteins, DNA Unwinding
% 216.18/216.34  |- mesh__dateCreated mesh__D004265 1977-04-15
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D004265 2006
% 216.18/216.34  |- skos__historyNote mesh__D004265 Proteins %28%1966-1977%29%
% 216.18/216.34  |- skos__scopeNote mesh__D004265
% 216.18/216.34       Proteins that promote unwinding of duplex DNA during replication by binding cooperatively to single-stranded regions of DNA or to short regions of duplex DNA that are undergoing transient opening. EC 5.99.-.%A%    
% 216.18/216.34  |- skos__hiddenLabel mesh__D004265 Unwinding Proteins, DNA
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D004265 2005
% 216.18/216.34  |- skos__historyNote mesh__D004265 Endonucleases %28%1973-1977%29%
% 216.18/216.34  |- mesh__activeMeSHYear mesh__D004265 2004
% 216.18/216.34  |- skos__altLabel mesh__D004265 DNA Unwinding Proteins
% 216.18/216.34  |- mesh__recordMaintainer mesh__D004265 ssb
% 216.18/216.34  |- skos__annotation mesh__D004265
% 216.18/216.34       promotes unwinding of DNA helix; do not confuse X ref DNA UNWINDING PROTEINS with DNA UNTWISTING PROTEIN see DNA TOPOISOMERASE%A%  
% 216.18/216.34  |- mesh__onlineNote mesh__D004265
% 216.18/216.34       use DNA HELICASES to search DNA UNWINDING PROTEINS 1978-93%A%  
% 216.18/216.34  |- mesh__historyNote mesh__D004265
% 216.18/216.34       94; was DNA UNWINDING PROTEINS 1978-93   
% 216.18/216.34  |- mesh__recordAuthorizer mesh__D004265 sjn
% 216.18/216.34  |- skos__altLabel mesh__D050816 SCIP Protein
% 216.18/216.34  |- mesh__dateEstablished mesh__D050816 2006-01-01
% 216.18/216.34  |- skos__hiddenLabel mesh__D050816 Octamer Transcription Factor 6
% 216.18/216.34  |- skos__hiddenLabel mesh__D050816 Factor-6, Octamer Transcription
% 216.18/216.34  |- skos__prefLabel mesh__D050816 Octamer Transcription Factor-6
% 216.18/216.34  |- skos__altLabel mesh__D050816 Transcription Factor Oct-6
% 216.18/216.34  |- mesh__recordMaintainer mesh__D050816 DRC
% 216.18/216.34  |- mesh__recordOriginator mesh__D050816 DRC
% 216.18/216.35  |- skos__scopeNote mesh__D050816
% 216.18/216.35       An octamer transcription factor that plays an important role in the MYELIN SHEATH development by SCHWANN CELLS.%A%    
% 216.18/216.35  |- skos__altLabel mesh__D050816 Octamer-Binding Protein Oct-6
% 216.18/216.35  |- mesh__recordAuthorizer mesh__D050816 sjn
% 216.18/216.35  |- mesh__historyNote mesh__D050816 2006%28%1990%29%   
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D050816 2006
% 216.18/216.35  |- skos__hiddenLabel mesh__D050816 Oct 6 Transcription Factor
% 216.18/216.35  |- mesh__dateCreated mesh__D050816 2005-06-30
% 216.18/216.35  |- skos__hiddenLabel mesh__D050816 Oct-6, Transcription Factor
% 216.18/216.35  |- skos__hiddenLabel mesh__D050816 Transcription Factor Tst 1
% 216.18/216.35  |- skos__altLabel mesh__D050816 Oct-6 Transcription Factor
% 216.18/216.35  |- skos__hiddenLabel mesh__D050816 Oct-6, Octamer-Binding Protein
% 216.18/216.35  |- rdf__type mesh__D050816sskos__Concept
% 216.18/216.35  |- skos__hiddenLabel mesh__D050816 Transcription Factor-6, Octamer
% 216.18/216.35  |- skos__broader mesh__D050816smesh__D050810
% 216.18/216.35  |- skos__hiddenLabel mesh__D050816 Octamer Binding Protein Oct 6
% 216.18/216.35  |- skos__altLabel mesh__D050816 Transcription Factor Tst-1
% 216.18/216.35  |- skos__hiddenLabel mesh__D050816 Tst-1, Transcription Factor
% 216.18/216.35  |- skos__hiddenLabel mesh__D050816 Transcription Factor, Oct-6
% 216.18/216.35  |- skos__hiddenLabel mesh__D050816 POU Transcription Factor Oct 6
% 216.18/216.35  |- skos__altLabel mesh__D050816 POU Transcription Factor Oct-6
% 216.18/216.35  |- skos__hiddenLabel mesh__D050816 Transcription Factor Oct 6
% 216.18/216.35  |- mesh__publicMeSHNote mesh__D050816
% 216.18/216.35       2006; TRANSCRIPTION FACTOR OCT-6 was indexed under TRANSCRIPTION FACTORS 1990-2005%A%  
% 216.18/216.35  |- skos__hiddenLabel mesh__D050816 Factor, Oct-6 Transcription
% 216.18/216.35  |- mesh__dateCreated mesh__D014693 1999-01-01
% 216.18/216.35  |- skos__hiddenLabel mesh__D014693 Ventricular Fibrillations
% 216.18/216.35  |- rdf__type mesh__D014693sskos__Concept
% 216.18/216.35  |- mesh__recordMaintainer mesh__D014693 sjn
% 216.18/216.35  |- mesh__dateRevised mesh__D014693 2003-07-25
% 216.18/216.35  |- skos__broader mesh__D014693smesh__D001145
% 216.18/216.35  |- mesh__recordOriginator mesh__D014693 NLM
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D014693 2004
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D014693 2006
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D014693 2005
% 216.18/216.35  |- skos__hiddenLabel mesh__D014693 Fibrillation, Ventricular
% 216.18/216.35  |- skos__prefLabel mesh__D014693 Ventricular Fibrillation
% 216.18/216.35  |- skos__annotation mesh__D014693
% 216.18/216.35       does not include ventric flutter %28% = ARRHYTHMIA %28%IM%29% + HEART VENTRICLES %28%NIM%29%%29%%A%  
% 216.18/216.35  |- skos__hiddenLabel mesh__D014693 Fibrillations, Ventricular
% 216.18/216.35  |- mesh__recordAuthorizer mesh__D014693 sjn
% 216.18/216.35  |- rdf__type mesh__D008656sskos__Concept
% 216.18/216.35  |- mesh__recordMaintainer mesh__D008656 lkt
% 216.18/216.35  |- mesh__publicMeSHNote mesh__D008656 65   
% 216.18/216.35  |- skos__scopeNote mesh__D008656
% 216.18/216.35       The 3-methyl ether of ETHINYL ESTRADIOL. It must be demethylated to be biologically active. It is used as the estrogen component of many combination ORAL CONTRACEPTIVES.%A%    
% 216.18/216.35  |- skos__prefLabel mesh__D008656 Mestranol
% 216.18/216.35  |- skos__altLabel mesh__D008656 Ethinyl Estradiol 3-Methyl Ether
% 216.18/216.35  |- mesh__recordOriginator mesh__D008656 NLM
% 216.18/216.35  |- mesh__dateRevised mesh__D008656 2003-07-09
% 216.18/216.35  |- mesh__dateEstablished mesh__D008656 1965-01-01
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D008656 2006
% 216.18/216.35  |- mesh__dateCreated mesh__D008656 1999-01-01
% 216.18/216.35  |- mesh__historyNote mesh__D008656 65%28%64%29%   
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D008656 2005
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D008656 2004
% 216.18/216.35  |- skos__hiddenLabel mesh__D008656 Ethinyl Estradiol 3 Methyl Ether
% 216.18/216.35  |- skos__broader mesh__D008656smesh__D004997
% 216.18/216.35  |- mesh__recordAuthorizer mesh__D008656 sjn
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000673 1996
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000673 1995
% 216.18/216.35  |- mesh__dateRevised mesh__D000673 1991-06-20
% 216.18/216.35  |- mesh__historyNote mesh__D000673 72   
% 216.18/216.35  |- skos__scopeNote mesh__D000673
% 216.18/216.35       Loss of a limb or other bodily appendage by accidental injury.%A%    
% 216.18/216.35  |- skos__historyNote mesh__D000673 Amputation %28%1966-1971%29%
% 216.18/216.35  |- skos__related mesh__D000673smesh__D012092
% 216.18/216.35  |- skos__hiddenLabel mesh__D000673 Amputations, Traumatic
% 216.18/216.35  |- mesh__publicMeSHNote mesh__D000673 72   
% 216.18/216.35  |- rdf__type mesh__D000673sskos__Concept
% 216.18/216.35  |- mesh__recordAuthorizer mesh__D000673 PLS
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000673 2006
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000673 1994
% 216.18/216.35  |- skos__prefLabel mesh__D000673 Amputation, Traumatic
% 216.18/216.35  |- skos__annotation mesh__D000673
% 216.18/216.35       by accident or inj: do not confuse with AMPUTATION, a surg procedure; /surg: consider also REPLANTATION%A%  
% 216.18/216.35  |- mesh__dateCreated mesh__D000673 1999-01-01
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000673 1999
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000673 1993
% 216.18/216.35  |- mesh__dateEstablished mesh__D000673 1972-01-01
% 216.18/216.35  |- mesh__recordOriginator mesh__D000673 NLM
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000673 2005
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000673 2002
% 216.18/216.35  |- skos__hiddenLabel mesh__D000673 Traumatic Amputations
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000673 1998
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000673 1992
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000673 2004
% 216.18/216.35  |- skos__hiddenLabel mesh__D000673 Traumatic Amputation
% 216.18/216.35  |- skos__broader mesh__D000673smesh__D014947
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000673 2001
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000673 1997
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000673 2003
% 216.18/216.35  |- mesh__recordMaintainer mesh__D000673 TGC
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000673 2000
% 216.18/216.35  |- skos__hiddenLabel mesh__D018286 Cell Carcinomas, Giant
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018286 2003
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018286 1996
% 216.18/216.35  |- skos__hiddenLabel mesh__D018286 Giant Cell Carcinomas
% 216.18/216.35  |- mesh__dateCreated mesh__D018286 1993-06-25
% 216.18/216.35  |- mesh__historyNote mesh__D018286 94   
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018286 2006
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018286 1999
% 216.18/216.35  |- mesh__dateEstablished mesh__D018286 1994-01-01
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018286 2001
% 216.18/216.35  |- mesh__publicMeSHNote mesh__D018286 94   
% 216.18/216.35  |- rdf__type mesh__D018286sskos__Concept
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018286 2005
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018286 1998
% 216.18/216.35  |- skos__prefLabel mesh__D018286 Carcinoma, Giant Cell
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018286 2000
% 216.18/216.35  |- skos__historyNote mesh__D018286 Carcinoma %28%1966-1993%29%
% 216.18/216.35  |- skos__hiddenLabel mesh__D018286 Carcinomas, Giant Cell
% 216.18/216.35  |- mesh__recordAuthorizer mesh__D018286 PLS
% 216.18/216.35  |- skos__hiddenLabel mesh__D018286 Giant Cell Carcinoma
% 216.18/216.35  |- mesh__recordMaintainer mesh__D018286 KEV
% 216.18/216.35  |- mesh__dateRevised mesh__D018286 1995-06-08
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018286 2004
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018286 1997
% 216.18/216.35  |- skos__broader mesh__D018286smesh__D002277
% 216.18/216.35  |- mesh__recordOriginator mesh__D018286 PLS
% 216.18/216.35  |- skos__historyNote mesh__D018286 Giant Cell Tumors %28%1966-1989%29%
% 216.18/216.35  |- skos__hiddenLabel mesh__D018286 Cell Carcinoma, Giant
% 216.18/216.35  |- skos__scopeNote mesh__D018286
% 216.18/216.35       An epithelial neoplasm characterized by unusually large anaplastic cells. It is highly malignant with fulminant clinical course, bizarre histologic appearance and poor prognosis. It is most common in the lung and thyroid. %28%From Stedman, 25th ed %26% Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018286 2002
% 216.18/216.35  |- skos__annotation mesh__D018286
% 216.18/216.35       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 216.18/216.35  |- rdf__type mesh__D004266sskos__Concept
% 216.18/216.35  |- mesh__recordOriginator mesh__D004266 NLM
% 216.18/216.35  |- skos__hiddenLabel mesh__D004266 Virus Infection, DNA
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D004266 2002
% 216.18/216.35  |- mesh__dateEstablished mesh__D004266 1998-01-01
% 216.18/216.35  |- skos__altLabel mesh__D004266 Infections, DNA Virus
% 216.18/216.35  |- skos__historyNote mesh__D004266 DNA Viruses %28%1966-1997%29%
% 216.18/216.35  |- mesh__recordMaintainer mesh__D004266 TGC
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D004266 2006
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D004266 1999
% 216.18/216.35  |- skos__hiddenLabel mesh__D004266 Virus Infections, DNA
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D004266 2005
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D004266 1998
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D004266 2004
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D004266 2001
% 216.18/216.35  |- mesh__historyNote mesh__D004266 98; use explode 1975-97   
% 216.18/216.35  |- skos__prefLabel mesh__D004266 DNA Virus Infections
% 216.18/216.35  |- mesh__dateCreated mesh__D004266 1999-01-01
% 216.18/216.35  |- skos__broader mesh__D004266smesh__D014777
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D004266 2003
% 216.18/216.35  |- skos__historyNote mesh__D004266 Virus Diseases %28%1966-1997%29%
% 216.18/216.35  |- skos__annotation mesh__D004266
% 216.18/216.35       GEN or unspecified; prefer specifics; DF: DNA VIRUS INFECT%A%  
% 216.18/216.35  |- mesh__publicMeSHNote mesh__D004266 98   
% 216.18/216.35  |- mesh__dateRevised mesh__D004266 1997-06-20
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D004266 2000
% 216.18/216.35  |- skos__hiddenLabel mesh__D004266 DNA Virus Infection
% 216.18/216.35  |- mesh__recordAuthorizer mesh__D004266 SJN
% 216.18/216.35  |- skos__hiddenLabel mesh__D004266 Infection, DNA Virus
% 216.18/216.35  |- skos__altLabel mesh__D050817 Transcription Factor GHF-1
% 216.18/216.35  |- mesh__recordOriginator mesh__D050817 DRC
% 216.18/216.35  |- skos__hiddenLabel mesh__D050817 Pit-2, Transcription Factor
% 216.18/216.35  |- skos__hiddenLabel mesh__D050817 Pit 1 Transcription Factor
% 216.18/216.35  |- skos__hiddenLabel mesh__D050817 GHF-1, Transcription Factor
% 216.18/216.35  |- skos__altLabel mesh__D050817 Pit1 Growth Hormone Factor
% 216.18/216.35  |- skos__altLabel mesh__D050817 GHF-1 Transcription Factor
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D050817 2006
% 216.18/216.35  |- skos__broader mesh__D050817smesh__D050809
% 216.18/216.35  |- mesh__dateEstablished mesh__D050817 2006-01-01
% 216.18/216.35  |- skos__hiddenLabel mesh__D050817 GHF 1 Transcription Factor
% 216.18/216.35  |- skos__altLabel mesh__D050817
% 216.18/216.35       Pituitary-Specific Transcription Factor Pit-1
% 216.18/216.35  |- skos__scopeNote mesh__D050817
% 216.18/216.35       A POU domain factor that regulates expression of GROWTH HORMONE; PROLACTIN; and THYROTROPIN-BETA in the ANTERIOR PITUITARY GLAND.%A%    
% 216.18/216.35  |- skos__hiddenLabel mesh__D050817 Transcription Factor GHF 1
% 216.18/216.35  |- mesh__historyNote mesh__D050817 2006%28%1989%29%   
% 216.18/216.35  |- mesh__recordMaintainer mesh__D050817 DRC
% 216.18/216.35  |- skos__hiddenLabel mesh__D050817
% 216.18/216.35       Pituitary Specific Transcription Factor Pit 1
% 216.18/216.35  |- skos__hiddenLabel mesh__D050817 Transcription Factor, GHF-1
% 216.18/216.35  |- mesh__recordAuthorizer mesh__D050817 sjn
% 216.18/216.35  |- rdf__type mesh__D050817sskos__Concept
% 216.18/216.35  |- skos__hiddenLabel mesh__D050817 Pit-1, Transcription Factor
% 216.18/216.35  |- skos__hiddenLabel mesh__D050817 Transcription Factor Pit 2
% 216.18/216.35  |- mesh__dateCreated mesh__D050817 2005-06-30
% 216.18/216.35  |- skos__altLabel mesh__D050817 Pit-2 Protein
% 216.18/216.35  |- skos__prefLabel mesh__D050817 Transcription Factor Pit-1
% 216.18/216.35  |- skos__hiddenLabel mesh__D050817 Pit 2 Protein
% 216.18/216.35  |- mesh__publicMeSHNote mesh__D050817
% 216.18/216.35       2006; TRANSCRIPTION FACTOR PIT-1 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1989-2005%A%  
% 216.18/216.35  |- skos__hiddenLabel mesh__D050817 Transcription Factor Pit 1
% 216.18/216.35  |- skos__altLabel mesh__D050817 Pit-1 Transcription Factor
% 216.18/216.35  |- skos__altLabel mesh__D050817 GHF1 Protein
% 216.18/216.35  |- skos__hiddenLabel mesh__D050817 Transcription Factor, Pit-1
% 216.18/216.35  |- skos__hiddenLabel mesh__D014694 Inflow Obstruction, Ventricular
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D014694 2006
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D014694 2002
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D014694 1997
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D014694 2003
% 216.18/216.35  |- skos__altLabel mesh__D014694 Right Ventricular Outflow Obstruction
% 216.18/216.35  |- rdf__type mesh__D014694sskos__Concept
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D014694 2004
% 216.18/216.35  |- mesh__dateRevised mesh__D014694 1991-06-19
% 216.18/216.35  |- skos__altLabel mesh__D014694 Outflow Obstruction, Right Ventricular
% 216.18/216.35  |- skos__altLabel mesh__D014694 Ventricular Inflow Obstruction
% 216.18/216.35  |- skos__scopeNote mesh__D014694
% 216.18/216.35       Occlusion of the ventricular outflow or inflow tract on either side of the heart. It may result from a congenital defect or predisposing heart disease, or as a complication of surgery or tumors of the heart or its vessels.%A%    
% 216.18/216.35  |- mesh__dateCreated mesh__D014694 1987-04-02
% 216.18/216.35  |- mesh__publicMeSHNote mesh__D014694 88   
% 216.18/216.35  |- mesh__historyNote mesh__D014694 88   
% 216.18/216.35  |- mesh__recordOriginator mesh__D014694 SCD
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D014694 1994
% 216.18/216.35  |- skos__hiddenLabel mesh__D014694 Obstruction, Ventricular Inflow
% 216.18/216.35  |- skos__hiddenLabel mesh__D014694 Outflow Obstruction, Ventricular
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D014694 1998
% 216.18/216.35  |- skos__broader mesh__D014694smesh__D006331
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D014694 1995
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D014694 2000
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D014694 1992
% 216.18/216.35  |- skos__hiddenLabel mesh__D014694 Ventricular Outflow Obstructions
% 216.18/216.35  |- mesh__recordMaintainer mesh__D014694 TGC
% 216.18/216.35  |- skos__hiddenLabel mesh__D014694 Inflow Obstructions, Ventricular
% 216.18/216.35  |- skos__historyNote mesh__D014694 Heart Ventricle %28%1966-1987%29%
% 216.18/216.35  |- skos__hiddenLabel mesh__D014694 Outflow Obstructions, Ventricular
% 216.18/216.35  |- mesh__dateEstablished mesh__D014694 1988-01-01
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D014694 1999
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D014694 2005
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D014694 2001
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D014694 1996
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D014694 1993
% 216.18/216.35  |- skos__altLabel mesh__D014694 Outflow Obstruction, Left Ventricular
% 216.18/216.35  |- skos__altLabel mesh__D014694 Left Ventricular Outflow Obstruction
% 216.18/216.35  |- skos__hiddenLabel mesh__D014694 Obstructions, Ventricular Inflow
% 216.18/216.35  |- skos__hiddenLabel mesh__D014694 Obstructions, Ventricular Outflow
% 216.18/216.35  |- skos__hiddenLabel mesh__D014694 Obstruction, Ventricular Outflow
% 216.18/216.35  |- skos__prefLabel mesh__D014694 Ventricular Outflow Obstruction
% 216.18/216.35  |- mesh__recordAuthorizer mesh__D014694 PLS
% 216.18/216.35  |- skos__hiddenLabel mesh__D014694 Ventricular Inflow Obstructions
% 216.18/216.35  |- mesh__historyNote mesh__D047070
% 216.18/216.35       2005; use BANDAGES, HYDROCOLLOID %28%NM%29% 1988-2004   
% 216.18/216.35  |- skos__broader mesh__D047070smesh__D001458
% 216.18/216.35  |- skos__hiddenLabel mesh__D047070 Dressings, Hydrocolloid
% 216.18/216.35  |- skos__scopeNote mesh__D047070
% 216.18/216.35       Dressings comprised of a self-adhesive matrix to which hydrophilic absorbent particles are embedded. The particles consist of CELLULOSE derivatives; calcium ALGINATES; PECTINS; or GELS. The utility is based on providing a moist environment for WOUND HEALING.%A%    
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D047070 2005
% 216.18/216.35  |- skos__altLabel mesh__D047070 Hydrocolloid Dressing
% 216.18/216.35  |- mesh__dateCreated mesh__D047070 2004-07-07
% 216.18/216.35  |- skos__hiddenLabel mesh__D047070 Bandage, Hydrogel
% 216.18/216.35  |- mesh__recordOriginator mesh__D047070 ssb
% 216.18/216.35  |- mesh__publicMeSHNote mesh__D047070
% 216.18/216.35       2005; HYDROCOLLOID DRESSING was indexed under COLLOIDS 1988-2004%A%  
% 216.18/216.35  |- skos__hiddenLabel mesh__D047070 Hydrocolloid Bandages
% 216.18/216.35  |- skos__hiddenLabel mesh__D047070 Hydrocolloid Dressings
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D047070 2006
% 216.18/216.35  |- skos__hiddenLabel mesh__D047070 Hydrogel Bandages
% 216.18/216.35  |- rdf__type mesh__D047070sskos__Concept
% 216.18/216.35  |- mesh__recordMaintainer mesh__D047070 ssb
% 216.18/216.35  |- mesh__dateEstablished mesh__D047070 2005-01-01
% 216.18/216.35  |- mesh__recordAuthorizer mesh__D047070 sjn
% 216.18/216.35  |- skos__hiddenLabel mesh__D047070 Hydrogel Bandage
% 216.18/216.35  |- skos__hiddenLabel mesh__D047070 Dressing, Hydrocolloid
% 216.18/216.35  |- skos__hiddenLabel mesh__D047070 Bandage, Hydrocolloid
% 216.18/216.35  |- skos__prefLabel mesh__D047070 Bandages, Hydrocolloid
% 216.18/216.35  |- skos__hiddenLabel mesh__D047070 Hydrocolloid Bandage
% 216.18/216.35  |- skos__hiddenLabel mesh__D008657 Rates, Metabolic Clearance
% 216.18/216.35  |- mesh__publicMeSHNote mesh__D008657 68   
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D008657 2000
% 216.18/216.35  |- skos__hiddenLabel mesh__D008657 Rate, Metabolic Clearance
% 216.18/216.35  |- skos__hiddenLabel mesh__D008657 Clearance Rate, Metabolic
% 216.18/216.35  |- skos__hiddenLabel mesh__D008657 Metabolic Clearance Rates
% 216.18/216.35  |- skos__broader mesh__D008657smesh__D001711
% 216.18/216.35  |- mesh__recordMaintainer mesh__D008657 PXP
% 216.18/216.35  |- mesh__historyNote mesh__D008657 68   
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D008657 2006
% 216.18/216.35  |- mesh__dateCreated mesh__D008657 1999-01-01
% 216.18/216.35  |- skos__scopeNote mesh__D008657
% 216.18/216.35       Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site.%A%    
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D008657 2002
% 216.18/216.35  |- skos__broader mesh__D008657smesh__D003942
% 216.18/216.35  |- mesh__recordAuthorizer mesh__D008657 SJN
% 216.18/216.35  |- skos__prefLabel mesh__D008657 Metabolic Clearance Rate
% 216.18/216.35  |- skos__hiddenLabel mesh__D008657 Clearance Rates, Metabolic
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D008657 2004
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D008657 1999
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D008657 2005
% 216.18/216.35  |- mesh__dateRevised mesh__D008657 1997-06-20
% 216.18/216.35  |- mesh__dateEstablished mesh__D008657 1968-01-01
% 216.18/216.35  |- skos__historyNote mesh__D008657
% 216.18/216.35       specific heading/metabolism %28%1966-1967%29%
% 216.18/216.35  |- skos__annotation mesh__D008657
% 216.18/216.35       NIM with specific drug /pharmacokin %28%IM%29%; not for metab rate: read restricted MeSH definition%A%  
% 216.18/216.35  |- mesh__recordOriginator mesh__D008657 NLM
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D008657 2003
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D008657 1998
% 216.18/216.35  |- rdf__type mesh__D008657sskos__Concept
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D008657 2001
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000674 1999
% 216.18/216.35  |- skos__hiddenLabel mesh__D000674 Amputee
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000674 1993
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000674 2005
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000674 2001
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000674 1998
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000674 2004
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000674 2000
% 216.18/216.35  |- skos__prefLabel mesh__D000674 Amputees
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000674 1997
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000674 2003
% 216.18/216.35  |- mesh__recordAuthorizer mesh__D000674 PLS
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000674 1996
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000674 1995
% 216.18/216.35  |- mesh__recordMaintainer mesh__D000674 TGC
% 216.18/216.35  |- rdf__type mesh__D000674sskos__Concept
% 216.18/216.35  |- skos__broader mesh__D000674smesh__D006233
% 216.18/216.35  |- mesh__recordOriginator mesh__D000674 NLM
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000674 2006
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000674 1994
% 216.18/216.35  |- mesh__dateRevised mesh__D000674 1992-05-07
% 216.18/216.35  |- skos__annotation mesh__D000674
% 216.18/216.35       do not coord ARM %28%NIM%29% or LEG %28%NIM%29% unless specifically relevant%A%  
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D000674 2002
% 216.18/216.35  |- mesh__dateCreated mesh__D000674 1999-01-01
% 216.18/216.35  |- skos__annotation mesh__D018287
% 216.18/216.35       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term but probably LUNG NEOPLASMS %28%IM%29%%A%  
% 216.18/216.35  |- skos__hiddenLabel mesh__D018287 Large Cell Carcinomas
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018287 2005
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018287 1998
% 216.18/216.35  |- mesh__historyNote mesh__D018287 94   
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018287 2006
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018287 1999
% 216.18/216.35  |- skos__scopeNote mesh__D018287
% 216.18/216.35       A tumor of undifferentiated %28%anaplastic%29% cells of large size. It is usually bronchogenic. %28%From Dorland, 27th ed%29%%A%    
% 216.18/216.35  |- rdf__type mesh__D018287sskos__Concept
% 216.18/216.35  |- skos__historyNote mesh__D018287
% 216.18/216.35       Carcinoma, Non-Small-Cell Lung %28%1987-1993%29%
% 216.18/216.35  |- skos__broader mesh__D018287smesh__D002277
% 216.18/216.35  |- skos__hiddenLabel mesh__D018287 Carcinomas, Large Cell
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018287 2000
% 216.18/216.35  |- mesh__dateEstablished mesh__D018287 1994-01-01
% 216.18/216.35  |- mesh__dateCreated mesh__D018287 1993-06-25
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018287 2003
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018287 1996
% 216.18/216.35  |- mesh__recordAuthorizer mesh__D018287 PLS
% 216.18/216.35  |- skos__hiddenLabel mesh__D018287 Large Cell Carcinoma
% 216.18/216.35  |- mesh__recordMaintainer mesh__D018287 KEV
% 216.18/216.35  |- skos__historyNote mesh__D018287 Carcinoma, Oat Cell %28%1980-1993%29%
% 216.18/216.35  |- skos__hiddenLabel mesh__D018287 Cell Carcinomas, Large
% 216.18/216.35  |- mesh__dateRevised mesh__D018287 1995-06-08
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018287 2004
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018287 2001
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018287 1997
% 216.18/216.35  |- mesh__publicMeSHNote mesh__D018287 94   
% 216.18/216.35  |- skos__prefLabel mesh__D018287 Carcinoma, Large Cell
% 216.18/216.35  |- mesh__recordOriginator mesh__D018287 PLS
% 216.18/216.35  |- skos__hiddenLabel mesh__D018287 Cell Carcinoma, Large
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D018287 2002
% 216.18/216.35  |- mesh__historyNote mesh__D037441 2003   
% 216.18/216.35  |- rdf__type mesh__D037441sskos__Concept
% 216.18/216.35  |- skos__broader mesh__D037441smesh__D037401
% 216.18/216.35  |- mesh__dateCreated mesh__D037441 2002-07-02
% 216.18/216.35  |- skos__altLabel mesh__D037441 Sea Nettle, Atlantic
% 216.18/216.35  |- mesh__dateEstablished mesh__D037441 2003-01-01
% 216.18/216.35  |- mesh__publicMeSHNote mesh__D037441 2003   
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D037441 2004
% 216.18/216.35  |- skos__altLabel mesh__D037441 Chrysaora quinquecirrha
% 216.18/216.35  |- skos__prefLabel mesh__D037441 Sea Nettle, East Coast
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D037441 2006
% 216.18/216.35  |- skos__scopeNote mesh__D037441
% 216.18/216.35       Species of jellyfish, in the family Pelagiidae, order Semaeostomeae, class SCYPHOZOA. Their painful sting is caused by a venom toxic to humans.%A%    
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D037441 2005
% 216.18/216.35  |- skos__historyNote mesh__D037441 Cnidaria %28%1968-2002%29%
% 216.18/216.35  |- mesh__dateRevised mesh__D037441 2003-07-09
% 216.18/216.35  |- mesh__recordMaintainer mesh__D004267 TGC
% 216.18/216.35  |- mesh__recordAuthorizer mesh__D004267 SJN
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D004267 2006
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D004267 1999
% 216.18/216.35  |- mesh__publicMeSHNote mesh__D004267 66   
% 216.18/216.35  |- skos__broader mesh__D004267smesh__D014780
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D004267 2005
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D004267 1998
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D004267 2004
% 216.18/216.35  |- mesh__recordOriginator mesh__D004267 NLM
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D004267 2002
% 216.18/216.35  |- skos__prefLabel mesh__D004267 DNA Viruses
% 216.18/216.35  |- skos__hiddenLabel mesh__D004267 Viruses, DNA
% 216.18/216.35  |- mesh__dateCreated mesh__D004267 1999-01-01
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D004267 2003
% 216.18/216.35  |- skos__hiddenLabel mesh__D004267 DNA Virus
% 216.18/216.35  |- skos__scopeNote mesh__D004267 Viruses whose nucleic acid is DNA.     
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D004267 2001
% 216.18/216.35  |- skos__broader mesh__D004267smesh__D014712
% 216.18/216.35  |- mesh__dateEstablished mesh__D004267 1966-01-01
% 216.18/216.35  |- rdf__type mesh__D004267sskos__Concept
% 216.18/216.35  |- mesh__historyNote mesh__D004267 66   
% 216.18/216.35  |- mesh__dateRevised mesh__D004267 1997-06-20
% 216.18/216.35  |- skos__annotation mesh__D004267
% 216.18/216.35       avoid: too general; prefer specifics; infection = DNA VIRUS INFECTIONS%A%  
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D004267 2000
% 216.18/216.35  |- skos__related mesh__D004267smesh__D004279
% 216.18/216.35  |- skos__hiddenLabel mesh__D004267 Virus, DNA
% 216.18/216.35  |- mesh__dateRevised mesh__D009750 1999-11-05
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D009750 2002
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D009750 2004
% 216.18/216.35  |- skos__annotation mesh__D009750
% 216.18/216.35       not used for indexing; CATALOG: do not use   
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D009750 2001
% 216.18/216.35  |- skos__scopeNote mesh__D009750
% 216.18/216.35       A collective term for nutritional disorders %28%result of poor assimilation or utilization of food%29% and metabolic disorders %28%result of poor metabolism or inherited enzyme abnormality%29%.%A%    
% 216.18/216.35  |- mesh__publicMeSHNote mesh__D009750 98   
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D009750 2003
% 216.18/216.35  |- mesh__historyNote mesh__D009750 98; use explode 1971-97   
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D009750 2000
% 216.18/216.35  |- mesh__dateEstablished mesh__D009750 1998-01-01
% 216.18/216.35  |- skos__prefLabel mesh__D009750 Nutritional and Metabolic Diseases
% 216.18/216.35  |- mesh__runningHead mesh__D009750
% 216.18/216.35       C18 - DISEASES-NUTRITIONAL AND METABOLIC   
% 216.18/216.35  |- mesh__recordOriginator mesh__D009750 NLM
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D009750 2006
% 216.18/216.35  |- mesh__dateCreated mesh__D009750 1999-01-01
% 216.18/216.35  |- mesh__recordAuthorizer mesh__D009750 sjn
% 216.18/216.35  |- rdf__type mesh__D009750sskos__Concept
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D009750 2005
% 216.18/216.35  |- mesh__recordMaintainer mesh__D009750 KEV
% 216.18/216.35  |- skos__hiddenLabel mesh__D023421 Experimental Animal Model
% 216.18/216.35  |- mesh__recordMaintainer mesh__D023421 ags
% 216.18/216.35  |- mesh__publicMeSHNote mesh__D023421 2001   
% 216.18/216.35  |- mesh__dateRevised mesh__D023421 2003-07-09
% 216.18/216.35  |- mesh__dateCreated mesh__D023421 2000-06-21
% 216.18/216.35  |- skos__hiddenLabel mesh__D023421 Animal Models
% 216.18/216.35  |- mesh__activeMeSHYear mesh__D023421 2005
% 216.18/216.35  |- skos__hiddenLabel mesh__D023421 Model, Laboratory Animal
% 216.18/216.36  |- skos__hiddenLabel mesh__D023421 Animal Model
% 216.18/216.36  |- rdf__type mesh__D023421sskos__Concept
% 216.18/216.36  |- mesh__recordOriginator mesh__D023421 jls
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D023421 2004
% 216.18/216.36  |- mesh__dateEstablished mesh__D023421 2001-01-01
% 216.18/216.36  |- skos__broader mesh__D023421smesh__D008919
% 216.18/216.36  |- skos__hiddenLabel mesh__D023421 Laboratory Animal Model
% 216.18/216.36  |- skos__hiddenLabel mesh__D023421 Animal Model, Laboratory
% 216.18/216.36  |- skos__scopeNote mesh__D023421
% 216.18/216.36       Non-human animals, selected because of specific characteristics, for use in experimental research, teaching, or testing.%A%    
% 216.18/216.36  |- mesh__recordAuthorizer mesh__D023421 sjn
% 216.18/216.36  |- mesh__historyNote mesh__D023421 2001   
% 216.18/216.36  |- skos__hiddenLabel mesh__D023421 Animal Models, Experimental
% 216.18/216.36  |- skos__hiddenLabel mesh__D023421 Model, Animal
% 216.18/216.36  |- skos__hiddenLabel mesh__D023421 Models, Experimental Animal
% 216.18/216.36  |- skos__hiddenLabel mesh__D023421 Animal Models, Laboratory
% 216.18/216.36  |- skos__related mesh__D023421smesh__D032761
% 216.18/216.36  |- skos__prefLabel mesh__D023421 Models, Animal
% 216.18/216.36  |- skos__hiddenLabel mesh__D023421 Animal Model, Experimental
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D023421 2006
% 216.18/216.36  |- skos__hiddenLabel mesh__D023421 Models, Laboratory Animal
% 216.18/216.36  |- skos__hiddenLabel mesh__D023421 Model, Experimental Animal
% 216.18/216.36  |- skos__altLabel mesh__D050818 Brn-3 Transcription Factor
% 216.18/216.36  |- mesh__historyNote mesh__D050818 2006%28%1992%29%   
% 216.18/216.36  |- skos__hiddenLabel mesh__D050818 Brn-3, Transcription Factor
% 216.18/216.36  |- skos__hiddenLabel mesh__D050818 Brn 3 Transcription Factor
% 216.18/216.36  |- mesh__recordMaintainer mesh__D050818 DRC
% 216.18/216.36  |- mesh__dateCreated mesh__D050818 2005-06-30
% 216.18/216.36  |- skos__broader mesh__D050818smesh__D050809
% 216.18/216.36  |- skos__scopeNote mesh__D050818
% 216.18/216.36       A family of mammalian POU domain factors that are expressed predominately in NEURONS.%A%    
% 216.18/216.36  |- skos__hiddenLabel mesh__D050818 Transcription Factor, Brn-3
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D050818 2006
% 216.18/216.36  |- skos__annotation mesh__D050818 general; prefer specifics   
% 216.18/216.36  |- mesh__dateEstablished mesh__D050818 2006-01-01
% 216.18/216.36  |- skos__prefLabel mesh__D050818 Transcription Factor Brn-3
% 216.18/216.36  |- rdf__type mesh__D050818sskos__Concept
% 216.18/216.36  |- mesh__publicMeSHNote mesh__D050818
% 216.18/216.36       2006; TRANSCRIPTION FACTOR BRN-3 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1992-2004%A%  
% 216.18/216.36  |- skos__hiddenLabel mesh__D050818 Transcription Factor Brn 3
% 216.18/216.36  |- mesh__recordAuthorizer mesh__D050818 sjn
% 216.18/216.36  |- mesh__recordOriginator mesh__D050818 DRC
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D014695 2003
% 216.18/216.36  |- rdf__type mesh__D014695sskos__Concept
% 216.18/216.36  |- mesh__recordOriginator mesh__D014695 SMH
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D014695 2005
% 216.18/216.36  |- mesh__dateRevised mesh__D014695 1997-06-20
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D014695 2004
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D014695 1998
% 216.18/216.36  |- skos__hiddenLabel mesh__D014695 Cerebral Ventriculographies
% 216.18/216.36  |- mesh__recordAuthorizer mesh__D014695 SJN
% 216.18/216.36  |- skos__prefLabel mesh__D014695 Cerebral Ventriculography
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D014695 2002
% 216.18/216.36  |- mesh__dateCreated mesh__D014695 1976-04-13
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D014695 2006
% 216.18/216.36  |- mesh__historyNote mesh__D014695
% 216.18/216.36       90; was VENTRICULOGRAPHY, CEREBRAL 1977-89; was VENTRICULOGRAPHY 1963-76%A%  
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D014695 1999
% 216.18/216.36  |- mesh__onlineNote mesh__D014695
% 216.18/216.36       use CEREBRAL VENTRICULOGRAPHY to search VENTRICULOGRAPHY, CEREBRAL 1977-89 %26% VENTRICULOGRAPHY 1966-76%A%  
% 216.18/216.36  |- skos__scopeNote mesh__D014695
% 216.18/216.36       Radiography of the ventricular system of the brain after injection of air or other contrast medium directly into the cerebral ventricles. It is used also for x-ray computed tomography of the cerebral ventricles.%A%    
% 216.18/216.36  |- mesh__dateEstablished mesh__D014695 1977-01-01
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D014695 2000
% 216.18/216.36  |- mesh__recordMaintainer mesh__D014695 PXP
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D014695 2001
% 216.18/216.36  |- skos__broader mesh__D014695smesh__D009485
% 216.18/216.36  |- skos__altLabel mesh__D014695 Ventriculography, Cerebral
% 216.18/216.36  |- mesh__publicMeSHNote mesh__D014695
% 216.18/216.36       90; was VENTRICULOGRAPHY, CEREBRAL 1977-89; was  VENTRICULOGRAPHY 1963-76%A%  
% 216.18/216.36  |- skos__hiddenLabel mesh__D014695 Ventriculographies, Cerebral
% 216.18/216.36  |- skos__annotation mesh__D014695
% 216.18/216.36       /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: CEREBRAL VENTRICULOGR%A%  
% 216.18/216.36  |- mesh__recordOriginator mesh__D047071 ssb
% 216.18/216.36  |- skos__prefLabel mesh__D047071 beta-Glucans
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D047071 2006
% 216.18/216.36  |- skos__hiddenLabel mesh__D047071 beta Glucans
% 216.18/216.36  |- rdf__type mesh__D047071sskos__Concept
% 216.18/216.36  |- mesh__historyNote mesh__D047071 2005   
% 216.18/216.36  |- mesh__publicMeSHNote mesh__D047071 2005   
% 216.18/216.36  |- skos__historyNote mesh__D047071 Glucans %28%1978-2004%29%
% 216.18/216.36  |- skos__broader mesh__D047071smesh__D005936
% 216.18/216.36  |- skos__scopeNote mesh__D047071
% 216.18/216.36       Glucose polymers consisting of a backbone of beta%28%1-%3E%3%29%-linked beta-D-glucopyranosyl units with beta%28%1-%3E%6%29% linked side chains of various lengths. They are a major component of the CELL WALL of organisms and of soluble DIETARY FIBER.%A%    
% 216.18/216.36  |- mesh__recordMaintainer mesh__D047071 ssb
% 216.18/216.36  |- mesh__dateEstablished mesh__D047071 2005-01-01
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D047071 2005
% 216.18/216.36  |- mesh__recordAuthorizer mesh__D047071 sjn
% 216.18/216.36  |- mesh__dateCreated mesh__D047071 2004-07-07
% 216.18/216.36  |- skos__hiddenLabel mesh__D008658 Metabolic Drug Detoxication
% 216.18/216.36  |- skos__altLabel mesh__D008658 Metabolic Detoxification, Drug
% 216.18/216.36  |- mesh__recordOriginator mesh__D008658 NLM
% 216.18/216.36  |- skos__hiddenLabel mesh__D008658 Metabolic Detoxifications, Drug
% 216.18/216.36  |- skos__hiddenLabel mesh__D008658 Metabolic Drug Detoxications
% 216.18/216.36  |- skos__altLabel mesh__D008658 Drug Detoxication, Metabolic
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D008658 2005
% 216.18/216.36  |- skos__hiddenLabel mesh__D008658 Metabolic Detoxications, Drug
% 216.18/216.36  |- mesh__publicMeSHNote mesh__D008658
% 216.18/216.36       80; was see under BIOTRANSFORMATION 1970-79   
% 216.18/216.36  |- skos__altLabel mesh__D008658 Detoxification, Drug, Metabolic
% 216.18/216.36  |- mesh__recordMaintainer mesh__D008658 ssb
% 216.18/216.36  |- skos__hiddenLabel mesh__D008658 Detoxification, Drug Metabolic
% 216.18/216.36  |- skos__hiddenLabel mesh__D008658 Detoxication, Drug Metabolic
% 216.18/216.36  |- skos__hiddenLabel mesh__D008658 Detoxifications, Drug Metabolic
% 216.18/216.36  |- skos__hiddenLabel mesh__D008658 Drug Detoxications, Metabolic
% 216.18/216.36  |- skos__hiddenLabel mesh__D008658 Drug Metabolic Detoxications
% 216.18/216.36  |- rdf__type mesh__D008658sskos__Concept
% 216.18/216.36  |- skos__hiddenLabel mesh__D008658 Drug Metabolic Detoxification
% 216.18/216.36  |- mesh__recordAuthorizer mesh__D008658 sjn
% 216.18/216.36  |- skos__hiddenLabel mesh__D008658 Detoxications, Drug Metabolic
% 216.18/216.36  |- skos__hiddenLabel mesh__D008658 Detoxications, Metabolic Drug
% 216.18/216.36  |- mesh__onlineNote mesh__D008658 search BIOTRANSFORMATION 1970-74   
% 216.18/216.36  |- skos__broader mesh__D008658smesh__D001711
% 216.18/216.36  |- skos__annotation mesh__D008658
% 216.18/216.36       NIM with specific drug /pharmacokin %28%IM%29%; for reduction of pharmacol activ of both toxic and non-toxic agents; DF: METAB DETOX DRUG%A%  
% 216.18/216.36  |- skos__hiddenLabel mesh__D008658 Drug Metabolic Detoxifications
% 216.18/216.36  |- skos__prefLabel mesh__D008658 Metabolic Detoxication, Drug
% 216.18/216.36  |- skos__hiddenLabel mesh__D008658 Drug Metabolic Detoxication
% 216.18/216.36  |- mesh__dateEstablished mesh__D008658 1980-01-01
% 216.18/216.36  |- skos__scopeNote mesh__D008658
% 216.18/216.36       Reduction of pharmacologic activity or toxicity of a drug or other foreign substance by a living system, usually by enzymatic action. It includes those metabolic transformations that make the substance more soluble for faster renal excretion.%A%    
% 216.18/216.36  |- mesh__dateRevised mesh__D008658 2004-07-07
% 216.18/216.36  |- skos__altLabel mesh__D008658 Detoxication, Drug, Metabolic
% 216.18/216.36  |- mesh__historyNote mesh__D008658
% 216.18/216.36       80%28%75%29%; was see under BIOTRANSFORMATION 1970-79   
% 216.18/216.36  |- skos__hiddenLabel mesh__D008658 Detoxication, Metabolic Drug
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D008658 2006
% 216.18/216.36  |- mesh__dateCreated mesh__D008658 1999-01-01
% 216.18/216.36  |- mesh__dateRevised mesh__D000675 2005-06-30
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D000675 2006
% 216.18/216.36  |- skos__broader mesh__D000675smesh__D000632
% 216.18/216.36  |- mesh__recordOriginator mesh__D000675 SH
% 216.18/216.36  |- skos__annotation mesh__D000675
% 216.18/216.36       an analgesic %26% non-steroidal anti-inflamm agent   
% 216.18/216.36  |- skos__hiddenLabel mesh__D000675
% 216.18/216.36       4 Amino 1,5 Dimethyl 2 Phenyl 3H Pyrazolone
% 216.18/216.36  |- skos__scopeNote mesh__D000675
% 216.18/216.36       A metabolite of AMINOPYRINE with analgesic and anti-inflammatory properties. It is used as a reagent for biochemical reactions producing peroxides or phenols. Ampyrone stimulates LIVER MICROSOMES and is also used to measure extracellular water.%A%    
% 216.18/216.36  |- mesh__dateCreated mesh__D000675 1979-04-30
% 216.18/216.36  |- skos__hiddenLabel mesh__D000675 4 Aminoantipyrine
% 216.18/216.36  |- skos__prefLabel mesh__D000675 Ampyrone
% 216.18/216.36  |- skos__altLabel mesh__D000675 4-Aminoantipyrine
% 216.18/216.36  |- skos__altLabel mesh__D000675 4-Amino-1,5-Dimethyl-2-Phenyl-3H-Pyrazolone
% 216.18/216.36  |- skos__historyNote mesh__D000675
% 216.18/216.36       Antipyrine %28%1966-1974%29% /analogs %26% derivatives %28%1975-1979%29%
% 216.18/216.36  |- mesh__publicMeSHNote mesh__D000675
% 216.18/216.36       91; was see under ANTIPYRINE 1980-90   
% 216.18/216.36  |- mesh__recordAuthorizer mesh__D000675 sjn
% 216.18/216.36  |- skos__hiddenLabel mesh__D000675 4 Aminophenazone
% 216.18/216.36  |- rdf__type mesh__D000675sskos__Concept
% 216.18/216.36  |- mesh__recordMaintainer mesh__D000675 ssb
% 216.18/216.36  |- skos__altLabel mesh__D000675 4-Aminophenazone
% 216.18/216.36  |- mesh__dateEstablished mesh__D000675 1991-01-01
% 216.18/216.36  |- skos__altLabel mesh__D000675 Aminoantipyrine
% 216.18/216.36  |- mesh__historyNote mesh__D000675
% 216.18/216.36       91%28%80%29%; was see under ANTIPYRINE 1980-90   
% 216.18/216.36  |- skos__altLabel mesh__D019380 AIDS Drugs
% 216.18/216.36  |- mesh__dateCreated mesh__D019380 1996-06-10
% 216.18/216.36  |- skos__hiddenLabel mesh__D019380 Drugs, Anti-AIDS
% 216.18/216.36  |- skos__altLabel mesh__D019380 Anti-AIDS Agents
% 216.18/216.36  |- mesh__recordMaintainer mesh__D019380 ssb
% 216.18/216.36  |- skos__annotation mesh__D019380
% 216.18/216.36       consider also AIDS /drug ther; may be used for articles on simian acquired immunodefic syndrome %26% simian immunodefic virus%A%  
% 216.18/216.36  |- mesh__publicMeSHNote mesh__D019380 97   
% 216.18/216.36  |- skos__scopeNote mesh__D019380
% 216.18/216.36       Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.%A%    
% 216.18/216.36  |- skos__hiddenLabel mesh__D019380 Drugs, AIDS
% 216.18/216.36  |- skos__broader mesh__D019380smesh__D044966
% 216.18/216.36  |- skos__hiddenLabel mesh__D019380 Anti HIV Agents
% 216.18/216.36  |- skos__hiddenLabel mesh__D019380 Anti AIDS Drugs
% 216.18/216.36  |- skos__altLabel mesh__D019380 Anti-AIDS Drugs
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D019380 2005
% 216.18/216.36  |- skos__hiddenLabel mesh__D019380 Agents, Anti-AIDS
% 216.18/216.36  |- rdf__type mesh__D019380sskos__Concept
% 216.18/216.36  |- skos__hiddenLabel mesh__D019380 Agents, Anti-HIV
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D019380 2004
% 216.18/216.36  |- mesh__dateRevised mesh__D019380 2003-07-09
% 216.18/216.36  |- skos__hiddenLabel mesh__D019380 Anti AIDS Agents
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D019380 2006
% 216.18/216.36  |- mesh__recordAuthorizer mesh__D019380 sjn
% 216.18/216.36  |- skos__hiddenLabel mesh__D019380 Anti HIV Drugs
% 216.18/216.36  |- skos__altLabel mesh__D019380 Anti-HIV Drugs
% 216.18/216.36  |- skos__historyNote mesh__D019380 Antiviral Agents %28%1985-1996%29%
% 216.18/216.36  |- skos__hiddenLabel mesh__D019380 Drugs, Anti-HIV
% 216.18/216.36  |- mesh__dateEstablished mesh__D019380 1997-01-01
% 216.18/216.36  |- skos__prefLabel mesh__D019380 Anti-HIV Agents
% 216.18/216.36  |- mesh__recordOriginator mesh__D019380 TPW
% 216.18/216.36  |- mesh__historyNote mesh__D019380 97   
% 216.18/216.36  |- mesh__dateRevised mesh__D005360 2005-06-30
% 216.18/216.36  |- skos__scopeNote mesh__D005360
% 216.18/216.36       The bone of the lower leg lateral to and smaller than the tibia. In proportion to its length, it is the most slender of the long bones.%A%    
% 216.18/216.36  |- mesh__recordOriginator mesh__D005360 NLM
% 216.18/216.36  |- mesh__recordMaintainer mesh__D005360 ags
% 216.18/216.36  |- rdf__type mesh__D005360sskos__Concept
% 216.18/216.36  |- mesh__dateCreated mesh__D005360 1999-01-01
% 216.18/216.36  |- skos__hiddenLabel mesh__D005360 Fibulas
% 216.18/216.36  |- skos__broader mesh__D005360smesh__D007867
% 216.18/216.36  |- skos__prefLabel mesh__D005360 Fibula
% 216.18/216.36  |- mesh__recordAuthorizer mesh__D005360 sjn
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D005360 2006
% 216.18/216.36  |- mesh__recordAuthorizer mesh__D018288 sjn
% 216.18/216.36  |- skos__hiddenLabel mesh__D018288 Oat Cell Carcinomas
% 216.18/216.36  |- skos__hiddenLabel mesh__D018288 Carcinomas, Reserve Cell
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D018288 2006
% 216.18/216.36  |- skos__broader mesh__D018288smesh__D008175
% 216.18/216.36  |- skos__hiddenLabel mesh__D018288 Carcinomas, Oat Cell
% 216.18/216.36  |- skos__hiddenLabel mesh__D018288 Reserve Cell Carcinoma
% 216.18/216.36  |- skos__hiddenLabel mesh__D018288 Round Cell Carcinomas
% 216.18/216.36  |- mesh__historyNote mesh__D018288
% 216.18/216.36       94; was see CARCINOMA, OAT CELL 1982-93; CARCINOMA, OAT CELL was heading 1972-93 %28%Prov 1972-73%29%; SMALL CELL LUNG CANCER was see CARCINOMA, OAT CELL 1991-93; CARCINOMA, RESERVE CELL was see CARCINOMA, OAT CELL 1976-93; RESERVE CELL CARCINOMA was see CARCINOMA, OAT CELL 1974-93%A%  
% 216.18/216.36  |- rdf__type mesh__D018288sskos__Concept
% 216.18/216.36  |- skos__hiddenLabel mesh__D018288 Carcinomas, Small Cell
% 216.18/216.36  |- skos__prefLabel mesh__D018288 Carcinoma, Small Cell
% 216.18/216.36  |- skos__altLabel mesh__D018288 Carcinoma, Round Cell
% 216.18/216.36  |- skos__hiddenLabel mesh__D018288 Round Cell Carcinoma
% 216.18/216.36  |- skos__hiddenLabel mesh__D018288 Oat Cell Carcinoma
% 216.18/216.36  |- mesh__dateRevised mesh__D018288 2005-06-30
% 216.18/216.36  |- skos__altLabel mesh__D018288 Carcinoma, Reserve Cell
% 216.18/216.36  |- mesh__recordMaintainer mesh__D018288 jls
% 216.18/216.36  |- skos__altLabel mesh__D018288 Carcinoma, Small Cell Lung
% 216.18/216.36  |- skos__hiddenLabel mesh__D018288 Carcinomas, Round Cell
% 216.18/216.36  |- skos__hiddenLabel mesh__D018288 Small Cell Carcinoma
% 216.18/216.36  |- mesh__onlineNote mesh__D018288
% 216.18/216.36       use CARCINOMA, SMALL CELL to search CARCINOMA, OAT CELL 1972-93 %28%as Prov 1972-73%29%, SMALL CELL LUNG CANCER 1991-93, CARCINOMA, RESERVE CELL 1976-93, %26% RESERVE CELL CARCINOMA 1974-93%A%  
% 216.18/216.36  |- mesh__dateCreated mesh__D018288 1993-07-02
% 216.18/216.36  |- mesh__recordOriginator mesh__D018288 PLS
% 216.18/216.36  |- skos__altLabel mesh__D018288 Small Cell Lung Cancer
% 216.18/216.36  |- mesh__dateEstablished mesh__D018288 1994-01-01
% 216.18/216.36  |- skos__hiddenLabel mesh__D018288 Small Cell Carcinomas
% 216.18/216.36  |- skos__annotation mesh__D018288
% 216.18/216.36       coordinate %28%IM%29%  with probably LUNG NEOPLASMS %28%IM%29%, otherwise coordinate IM with other precoordinated organ/neoplasm term %28%IM%29% if appropriate; do not confuse with CARCINOMA, NON-SMALL-CELL LUNG;  DF: SCLC%A%  
% 216.18/216.36  |- skos__scopeNote mesh__D018288
% 216.18/216.36       An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. There are admixtures of small cell lung carcinoma with other types of lung cancer. Small cell carcinomas are distinguished by their distinctive biological features, response to chemotherapy and radiotherapy, and by their nearly universal tendency to develop overt or subclinical metastases, which frequently eliminates surgery in most patients. %28%From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7%29%%A%    
% 216.18/216.36  |- skos__broader mesh__D018288smesh__D018278
% 216.18/216.36  |- skos__related mesh__D018288smesh__D002289
% 216.18/216.36  |- mesh__publicMeSHNote mesh__D018288
% 216.18/216.36       94; was see CARCINOMA, OAT CELL 1982-93; CARCINOMA, OAT CELL was heading 1974-93; SMALL CELL LUNG CANCER was see CARCINOMA, OAT CELL 1991-93; CARCINOMA, RESERVE CELL was see CARCINOMA, OAT CELL 1976-93; RESERVE CELL CARCINOMA was see CARCINOMA, OAT CELL 1974-93%A%  
% 216.18/216.36  |- skos__hiddenLabel mesh__D018288 Reserve Cell Carcinomas
% 216.18/216.36  |- mesh__dateRevised mesh__D004268 2005-06-30
% 216.18/216.36  |- skos__hiddenLabel mesh__D004268 DNA Single Stranded Binding Protein
% 216.18/216.36  |- skos__altLabel mesh__D004268 DNA Binding Protein
% 216.18/216.36  |- mesh__dateCreated mesh__D004268 1983-03-17
% 216.18/216.36  |- skos__related mesh__D004268smesh__D004261
% 216.18/216.36  |- skos__hiddenLabel mesh__D004268 Single Stranded DNA Binding Protein
% 216.18/216.36  |- skos__historyNote mesh__D004268 DNA Unwinding Proteins %28%1981-1983%29%
% 216.18/216.36  |- skos__altLabel mesh__D004268 Single-Stranded DNA-Binding Protein
% 216.18/216.36  |- skos__broader mesh__D004268smesh__D011506
% 216.18/216.36  |- skos__altLabel mesh__D004268 DNA Single-Stranded Binding Protein
% 216.18/216.36  |- mesh__recordMaintainer mesh__D004268 SYSTEM
% 216.18/216.36  |- skos__hiddenLabel mesh__D004268 Binding Protein, DNA
% 216.18/216.36  |- mesh__dateEstablished mesh__D004268 1984-01-01
% 216.18/216.36  |- skos__hiddenLabel mesh__D004268 Single Stranded DNA Binding Proteins
% 216.18/216.36  |- skos__related mesh__D004268smesh__D016350
% 216.18/216.36  |- mesh__onlineNote mesh__D004268
% 216.18/216.36       use DNA UNWINDING PROTEINS to search DNA HELIX DESTABILIZING PROTEINS 1980-83%A%  
% 216.18/216.36  |- skos__hiddenLabel mesh__D004268 DNA-Binding Protein, Single-Stranded
% 216.18/216.36  |- mesh__recordOriginator mesh__D004268 RLS
% 216.18/216.36  |- skos__scopeNote mesh__D004268
% 216.18/216.36       Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases.%A%    
% 216.18/216.36  |- skos__altLabel mesh__D004268 SS DNA BP
% 216.18/216.36  |- skos__related mesh__D004268smesh__D018257
% 216.18/216.36  |- skos__hiddenLabel mesh__D004268 DNA Binding Proteins
% 216.18/216.36  |- skos__prefLabel mesh__D004268 DNA-Binding Proteins
% 216.18/216.36  |- skos__related mesh__D004268smesh__D019077
% 216.18/216.36  |- skos__related mesh__D004268smesh__D016335
% 216.18/216.36  |- rdf__type mesh__D004268sskos__Concept
% 216.18/216.36  |- skos__historyNote mesh__D004268 Carrier Proteins %28%1978-1981%29%
% 216.18/216.36  |- mesh__historyNote mesh__D004268
% 216.18/216.36       84; DNA HELIX DESTABILIZING PROTEINS was see DNA UNWINDING PROTEINS 1980-83%A%  
% 216.18/216.36  |- mesh__publicMeSHNote mesh__D004268
% 216.18/216.36       84; DNA HELIX DESTABILIZING PROTEINS was see DNA UNWINDING PROTEINS 1980-83%A%  
% 216.18/216.36  |- mesh__recordAuthorizer mesh__D004268 sjn
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D004268 2006
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D009751 1997
% 216.18/216.36  |- mesh__publicMeSHNote mesh__D009751
% 216.18/216.36       84; was see under NUTRITION 1975-83   
% 216.18/216.36  |- skos__historyNote mesh__D009751 specific nutrient
% 216.18/216.36  |- skos__hiddenLabel mesh__D009751 Requirements, Nutritional
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D009751 1996
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D009751 2006
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D009751 1995
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D009751 1991
% 216.18/216.36  |- mesh__dateCreated mesh__D009751 1999-01-01
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D009751 2002
% 216.18/216.36  |- mesh__historyNote mesh__D009751
% 216.18/216.36       84%28%68%29%; was see under NUTRITION 1975-83, was Prov 1968-74%A%  
% 216.18/216.36  |- skos__prefLabel mesh__D009751 Nutritional Requirements
% 216.18/216.36  |- mesh__recordAuthorizer mesh__D009751 PLS
% 216.18/216.36  |- rdf__type mesh__D009751sskos__Concept
% 216.18/216.36  |- mesh__dateEstablished mesh__D009751 1984-01-01
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D009751 2005
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D009751 1994
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D009751 1990
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D009751 2001
% 216.18/216.36  |- skos__annotation mesh__D009751
% 216.18/216.36       no qualif; NIM when specific nutrient is IM; not for nutritional requirements of bacteria, etc. %28% = microorganism /growth or /metab or /physiol%29%%A%  
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D009751 1993
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D009751 2004
% 216.18/216.36  |- mesh__dateRevised mesh__D009751 1989-06-14
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D009751 1999
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D009751 2000
% 216.18/216.36  |- mesh__recordMaintainer mesh__D009751 TGC
% 216.18/216.36  |- skos__hiddenLabel mesh__D009751 Requirement, Nutritional
% 216.18/216.36  |- skos__hiddenLabel mesh__D009751 Nutritional Requirement
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D009751 1992
% 216.18/216.36  |- skos__broader mesh__D009751smesh__D009747
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D009751 2003
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D009751 1998
% 216.18/216.36  |- mesh__recordOriginator mesh__D009751 NLM
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D023422 2004
% 216.18/216.36  |- mesh__recordAuthorizer mesh__D023422 sjn
% 216.18/216.36  |- mesh__dateCreated mesh__D023422 2000-06-22
% 216.18/216.36  |- skos__broader mesh__D023422smesh__D023382
% 216.18/216.36  |- skos__hiddenLabel mesh__D023422 Tests, Skin Irritancy
% 216.18/216.36  |- mesh__dateEstablished mesh__D023422 2001-01-01
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D023422 2003
% 216.18/216.36  |- mesh__historyNote mesh__D023422 2001   
% 216.18/216.36  |- mesh__publicMeSHNote mesh__D023422 2001   
% 216.18/216.36  |- skos__hiddenLabel mesh__D023422 Skin Irritancy Test
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D023422 2006
% 216.18/216.36  |- mesh__recordMaintainer mesh__D023422 jls
% 216.18/216.36  |- skos__prefLabel mesh__D023422 Skin Irritancy Tests
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D023422 2002
% 216.18/216.36  |- skos__hiddenLabel mesh__D023422 Irritancy Test, Skin
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D023422 2005
% 216.18/216.36  |- skos__scopeNote mesh__D023422
% 216.18/216.36       Tests or bioassays that measure the skin sensitization potential of various chemicals.%A%    
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D023422 2001
% 216.18/216.36  |- rdf__type mesh__D023422sskos__Concept
% 216.18/216.36  |- mesh__recordOriginator mesh__D023422 jls
% 216.18/216.36  |- skos__hiddenLabel mesh__D023422 Irritancy Tests, Skin
% 216.18/216.36  |- skos__hiddenLabel mesh__D023422 Test, Skin Irritancy
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D050819 2006
% 216.18/216.36  |- skos__prefLabel mesh__D050819 Transcription Factor Brn-3A
% 216.18/216.36  |- skos__hiddenLabel mesh__D050819 Transcription Factor Brn 3A
% 216.18/216.36  |- mesh__historyNote mesh__D050819 2006%28%1992%29%   
% 216.18/216.36  |- skos__hiddenLabel mesh__D050819 Brn-3A, Transcription Factor
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D050819 2006B
% 216.18/216.36  |- mesh__recordMaintainer mesh__D050819 ags
% 216.18/216.36  |- mesh__dateRevised mesh__D050819 2005-08-03
% 216.18/216.36  |- mesh__dateCreated mesh__D050819 2005-06-30
% 216.18/216.36  |- skos__hiddenLabel mesh__D050819 Transcription Factor, Brn-3A
% 216.18/216.36  |- skos__broader mesh__D050819smesh__D050818
% 216.18/216.36  |- skos__hiddenLabel mesh__D050819 Transcription Factor, Pou4f1
% 216.18/216.36  |- rdf__type mesh__D050819sskos__Concept
% 216.18/216.36  |- skos__altLabel mesh__D050819 Pou4f1 Transcription Factor
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D050819 2006A
% 216.18/216.36  |- mesh__publicMeSHNote mesh__D050819
% 216.18/216.36       2006; TRANSCRIPTION FACTOR BRM-3A was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1992-2005%A%  
% 216.18/216.36  |- mesh__recordAuthorizer mesh__D050819 ags
% 216.18/216.36  |- mesh__recordOriginator mesh__D050819 DRC
% 216.18/216.36  |- skos__altLabel mesh__D050819 POU Domain, Class 4, Transcription Factor 1
% 216.18/216.36  |- mesh__dateEstablished mesh__D050819 2006-01-01
% 216.18/216.36  |- skos__scopeNote mesh__D050819
% 216.18/216.36       A POU domain factor that activates GENETIC TRANSCRIPTION of GENES encoding NEUROFILAMENT PROTEINS; alpha internexin; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; and BCL-2 PROTO-ONCOGENE PROTEINS.%A%    
% 216.18/216.36  |- skos__hiddenLabel mesh__D050819 Brn 3A Transcription Factor
% 216.18/216.36  |- skos__altLabel mesh__D050819 Brn-3A Transcription Factor
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D014696 1998
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D014696 2001
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D014696 2006
% 216.18/216.36  |- mesh__dateEstablished mesh__D014696 1991-01-01
% 216.18/216.36  |- skos__hiddenLabel mesh__D014696 Ventriculocisternostomies
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D014696 1999
% 216.18/216.36  |- mesh__publicMeSHNote mesh__D014696
% 216.18/216.36       91; was see under CEREBROSPINAL FLUID SHUNTS 1988-90   
% 216.18/216.36  |- skos__scopeNote mesh__D014696
% 216.18/216.36       Surgical creation of an opening in a cerebral ventricle.%A%    
% 216.18/216.36  |- mesh__dateRevised mesh__D014696 1997-06-20
% 216.18/216.36  |- skos__broader mesh__D014696smesh__D002557
% 216.18/216.36  |- skos__historyNote mesh__D014696
% 216.18/216.36       Cerebrospinal Fluid Shunts %28%1972-1987%29%
% 216.18/216.36  |- skos__historyNote mesh__D014696
% 216.18/216.36       Cerebral Ventricles/surgery %28%1966-1987%29%
% 216.18/216.36  |- mesh__dateCreated mesh__D014696 1987-03-18
% 216.18/216.36  |- mesh__recordAuthorizer mesh__D014696 SJN
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D014696 2002
% 216.18/216.36  |- mesh__recordOriginator mesh__D014696 SCD
% 216.18/216.36  |- skos__prefLabel mesh__D014696 Ventriculostomy
% 216.18/216.36  |- skos__annotation mesh__D014696
% 216.18/216.36       refers to cerebral ventricles only, not heart nor stomach; do not use /util except by MeSH definition%A%  
% 216.18/216.36  |- skos__hiddenLabel mesh__D014696 Ventriculostomies
% 216.18/216.36  |- mesh__historyNote mesh__D014696
% 216.18/216.36       91%28%88%29%; was see under CEREBROSPINAL FLUID SHUNTS 1988-90   
% 216.18/216.36  |- rdf__type mesh__D014696sskos__Concept
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D014696 2003
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D014696 2000
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D014696 2005
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D014696 2004
% 216.18/216.36  |- mesh__recordMaintainer mesh__D014696 PXP
% 216.18/216.36  |- mesh__dateEstablished mesh__D047072 2005-01-01
% 216.18/216.36  |- skos__broader mesh__D047072smesh__D004791
% 216.18/216.36  |- mesh__recordMaintainer mesh__D047072 ssb
% 216.18/216.36  |- mesh__recordAuthorizer mesh__D047072 sjn
% 216.18/216.36  |- mesh__publicMeSHNote mesh__D047072 2005   
% 216.18/216.36  |- skos__prefLabel mesh__D047072 Aromatase Inhibitors
% 216.18/216.36  |- mesh__dateCreated mesh__D047072 2004-07-07
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D047072 2005
% 216.18/216.36  |- skos__historyNote mesh__D047072
% 216.18/216.36       Aromatase/antagonists %26% inhibitors %28%1975-2004%29%
% 216.18/216.36  |- skos__scopeNote mesh__D047072
% 216.18/216.36       Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones.%A%    
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D047072 2006
% 216.18/216.36  |- skos__hiddenLabel mesh__D047072 Inhibitors, Aromatase
% 216.18/216.36  |- mesh__recordOriginator mesh__D047072 ssb
% 216.18/216.36  |- mesh__historyNote mesh__D047072 2005   
% 216.18/216.36  |- rdf__type mesh__D047072sskos__Concept
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D008659 2005
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D008659 2002
% 216.18/216.36  |- mesh__recordAuthorizer mesh__D008659 SJN
% 216.18/216.36  |- skos__hiddenLabel mesh__D008659 Metabolic Disease
% 216.18/216.36  |- skos__prefLabel mesh__D008659 Metabolic Diseases
% 216.18/216.36  |- mesh__recordMaintainer mesh__D008659 TGC
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D008659 2003
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D008659 1998
% 216.18/216.36  |- mesh__dateRevised mesh__D008659 1997-06-20
% 216.18/216.36  |- rdf__type mesh__D008659sskos__Concept
% 216.18/216.36  |- mesh__recordOriginator mesh__D008659 NLM
% 216.18/216.36  |- skos__hiddenLabel mesh__D008659 Disease, Metabolic
% 216.18/216.36  |- skos__scopeNote mesh__D008659
% 216.18/216.36       Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality %28%METABOLISM, INBORN ERRORS%29% or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. %28%Stedman, 26th ed%29%%A%    
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D008659 2001
% 216.18/216.36  |- skos__altLabel mesh__D008659 Diseases, Metabolic
% 216.18/216.36  |- mesh__onlineNote mesh__D008659
% 216.18/216.36       pre-explosion = METABOLIC DISEASES %28%PX%29%   
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D008659 2000
% 216.18/216.36  |- skos__hiddenLabel mesh__D008659 Thesaurismoses
% 216.18/216.36  |- skos__altLabel mesh__D008659 Thesaurismosis
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D008659 2006
% 216.18/216.36  |- mesh__dateCreated mesh__D008659 1999-01-01
% 216.18/216.36  |- skos__broader mesh__D008659smesh__D009750
% 216.18/216.36  |- skos__annotation mesh__D008659
% 216.18/216.36       GEN: prefer specifics; TN 194: differentiate from DEFICIENCY DISEASES; DF: METAB DIS%A%  
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D008659 2004
% 216.18/216.36  |- mesh__activeMeSHYear mesh__D008659 1999
% 216.18/216.36  |- skos__broader mesh__D000676smesh__D000631
% 216.18/216.36  |- mesh__recordOriginator mesh__D000676 RLS
% 216.18/216.36  |- skos__altLabel mesh__D000676 LAW Brand of Amrinone
% 216.18/216.36  |- skos__altLabel mesh__D000676 Sanofi Winthrop Brand of Amrinone
% 216.18/216.36  |- mesh__dateCreated mesh__D000676 1986-06-16
% 216.18/216.36  |- mesh__publicMeSHNote mesh__D000676 87   
% 216.18/216.36  |- skos__historyNote mesh__D000676 Pyridines %28%1966-1978%29%
% 216.18/216.36  |- skos__altLabel mesh__D000676
% 216.18/216.36       5-Amino-%28%3,4%27%-bipyridine%29%-6%28%1H%29%-one
% 216.18/216.36  |- skos__scopeNote mesh__D000676
% 216.18/216.36       A positive inotropic cardiotonic %28%CARDIOTONIC AGENTS%29% with vasodilator properties, phosphodiesterase inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.%A%    
% 216.18/216.36  |- rdf__type mesh__D000676sskos__Concept
% 216.18/216.36  |- skos__altLabel mesh__D000676 Sanofi Brand of Amrinone Lactate
% 216.18/216.37  |- skos__hiddenLabel mesh__D000676 Win 40680
% 216.18/216.37  |- mesh__recordMaintainer mesh__D000676 mdb
% 216.18/216.37  |- skos__historyNote mesh__D000676 Aminopyridines %28%1979-1986%29%
% 216.18/216.37  |- mesh__dateRevised mesh__D000676 2004-07-07
% 216.18/216.37  |- mesh__recordAuthorizer mesh__D000676 sjn
% 216.18/216.37  |- mesh__dateEstablished mesh__D000676 1987-01-01
% 216.18/216.37  |- skos__hiddenLabel mesh__D000676 Amrinone LAW Brand
% 216.18/216.37  |- skos__altLabel mesh__D000676 Amrinon
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D000676 2006
% 216.18/216.37  |- mesh__historyNote mesh__D000676 87   
% 216.18/216.37  |- skos__prefLabel mesh__D000676 Amrinone
% 216.18/216.37  |- skos__hiddenLabel mesh__D000676 Win40680
% 216.18/216.37  |- skos__altLabel mesh__D000676 Sanofi Winthrop Brand of Amrinone Lactate
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D000676 2005
% 216.18/216.37  |- mesh__dateEstablished mesh__D005361 1991-01-01
% 216.18/216.37  |- mesh__historyNote mesh__D005361 2000%28%1990%29%   
% 216.18/216.37  |- mesh__dateCreated mesh__D005361 1974-11-19
% 216.18/216.37  |- mesh__recordMaintainer mesh__D005361 ssb
% 216.18/216.37  |- rdf__type mesh__D005361sskos__Concept
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D005361 2005
% 216.18/216.37  |- skos__prefLabel mesh__D005361 Ficain
% 216.18/216.37  |- skos__historyNote mesh__D005361
% 216.18/216.37       Peptide Peptidohydrolases %28%1971-1974%29%
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D005361 2006
% 216.18/216.37  |- skos__altLabel mesh__D005361 Ficin
% 216.18/216.37  |- mesh__dateRevised mesh__D005361 2003-07-09
% 216.18/216.37  |- mesh__recordOriginator mesh__D005361 NLM
% 216.18/216.37  |- skos__broader mesh__D005361smesh__D003546
% 216.18/216.37  |- mesh__publicMeSHNote mesh__D005361
% 216.18/216.37       2000; see FICIN 1990-1999; see CYSTEINE PROTEINASES 1975-1990%A%  
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D005361 2004
% 216.18/216.37  |- mesh__recordAuthorizer mesh__D005361 sjn
% 216.18/216.37  |- skos__scopeNote mesh__D005361
% 216.18/216.37       A sulfhydryl proteinase with cysteine at the active site from ficus latex. Preferential cleavage is at tyrosine and phenylalanine residues. EC 3.4.22.3.%A%    
% 216.18/216.37  |- skos__scopeNote mesh__D018289
% 216.18/216.37       A variant of well-differentiated epidermoid carcinoma that is most common in the oral cavity, but also occurs in the larynx, nasal cavity, esophagus, penis, anorectal region, vulva, vagina, uterine cervix, and skin, especially on the sole of the foot. Most intraoral cases occur in elderly male abusers of smokeless tobacco. The treatment is surgical resection. Radiotherapy is not indicated, as up to 30%25% treated with radiation become highly aggressive within six months. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D018289 2003
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D018289 1996
% 216.18/216.37  |- mesh__recordMaintainer mesh__D018289 KEV
% 216.18/216.37  |- skos__hiddenLabel mesh__D018289 Verrucous Carcinomas
% 216.18/216.37  |- mesh__dateCreated mesh__D018289 1993-06-25
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D018289 2000
% 216.18/216.37  |- mesh__dateRevised mesh__D018289 1995-06-08
% 216.18/216.37  |- skos__hiddenLabel mesh__D018289 Verrucous Carcinoma
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D018289 2004
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D018289 1997
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D018289 2001
% 216.18/216.37  |- mesh__recordOriginator mesh__D018289 PLS
% 216.18/216.37  |- mesh__recordAuthorizer mesh__D018289 PLS
% 216.18/216.37  |- skos__broader mesh__D018289smesh__D018307
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D018289 2005
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D018289 1998
% 216.18/216.37  |- mesh__publicMeSHNote mesh__D018289 94   
% 216.18/216.37  |- skos__hiddenLabel mesh__D018289 Carcinomas, Verrucous
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D018289 2002
% 216.18/216.37  |- skos__annotation mesh__D018289
% 216.18/216.37       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D018289 2006
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D018289 1999
% 216.18/216.37  |- mesh__historyNote mesh__D018289 94   
% 216.18/216.37  |- skos__prefLabel mesh__D018289 Carcinoma, Verrucous
% 216.18/216.37  |- skos__broader mesh__D018289smesh__D002277
% 216.18/216.37  |- rdf__type mesh__D018289sskos__Concept
% 216.18/216.37  |- mesh__dateEstablished mesh__D018289 1994-01-01
% 216.18/216.37  |- skos__historyNote mesh__D018289 Carcinoma, Papillary %28%1969-1993%29%
% 216.18/216.37  |- skos__prefLabel mesh__D004269 DNA, Bacterial
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D004269 2000
% 216.18/216.37  |- skos__broader mesh__D004269smesh__D004247
% 216.18/216.37  |- mesh__recordAuthorizer mesh__D004269 PLS
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D004269 2001
% 216.18/216.37  |- skos__scopeNote mesh__D004269
% 216.18/216.37       Deoxyribonucleic acid that makes up the genetic material of bacteria.%A%    
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D004269 2002
% 216.18/216.37  |- skos__altLabel mesh__D004269 Bacterial DNA
% 216.18/216.37  |- rdf__type mesh__D004269sskos__Concept
% 216.18/216.37  |- skos__annotation mesh__D004269
% 216.18/216.37       IM; coord with specific bacterium %28%IM%29%; /drug eff /ultrastruct permitted; DF: DNA BACT%A%  
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D004269 2005
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D004269 1998
% 216.18/216.37  |- mesh__dateRevised mesh__D004269 1995-06-08
% 216.18/216.37  |- mesh__dateCreated mesh__D004269 1999-01-01
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D004269 2006
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D004269 1999
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D004269 2003
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D004269 1996
% 216.18/216.37  |- mesh__recordOriginator mesh__D004269 NLM
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D004269 2004
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D004269 1997
% 216.18/216.37  |- mesh__recordMaintainer mesh__D004269 KEV
% 216.18/216.37  |- mesh__recordMaintainer mesh__D009752 PLS
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009752 1996
% 216.18/216.37  |- mesh__dateRevised mesh__D009752 1992-05-15
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009752 2006
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009752 1995
% 216.18/216.37  |- skos__prefLabel mesh__D009752 Nutritional Status
% 216.18/216.37  |- rdf__type mesh__D009752sskos__Concept
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009752 2005
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009752 1994
% 216.18/216.37  |- mesh__dateEstablished mesh__D009752 1987-01-01
% 216.18/216.37  |- skos__annotation mesh__D009752 restrict to humans %26% Cat B2   
% 216.18/216.37  |- mesh__dateCreated mesh__D009752 1986-04-18
% 216.18/216.37  |- skos__broader mesh__D009752smesh__D006304
% 216.18/216.37  |- mesh__publicMeSHNote mesh__D009752 87   
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009752 1993
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009752 2004
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009752 1999
% 216.18/216.37  |- skos__scopeNote mesh__D009752
% 216.18/216.37       State of the body in relation to the consumption and utilization of nutrients.%A%    
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009752 2002
% 216.18/216.37  |- skos__hiddenLabel mesh__D009752 Status, Nutritional
% 216.18/216.37  |- skos__broader mesh__D009752smesh__D009747
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009752 2003
% 216.18/216.37  |- mesh__recordAuthorizer mesh__D009752 PLS
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009752 1998
% 216.18/216.37  |- mesh__recordOriginator mesh__D009752 VDK
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009752 2001
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009752 1997
% 216.18/216.37  |- mesh__historyNote mesh__D009752 87   
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009752 2000
% 216.18/216.37  |- skos__historyNote mesh__D014697 Hypothalamus, Middle %28%1975-1982%29%
% 216.18/216.37  |- skos__historyNote mesh__D014697 Hypothalamus %28%1966-1982%29%
% 216.18/216.37  |- mesh__historyNote mesh__D014697 83   
% 216.18/216.37  |- mesh__dateRevised mesh__D014697 1992-05-18
% 216.18/216.37  |- skos__scopeNote mesh__D014697
% 216.18/216.37       A nucleus of the middle hypothalamus, the largest cell group of the tuberal region with small-to-medium size cells.%A%    
% 216.18/216.37  |- mesh__recordMaintainer mesh__D014697 TAP
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014697 2000
% 216.18/216.37  |- mesh__recordOriginator mesh__D014697 RC
% 216.18/216.37  |- skos__broader mesh__D014697smesh__D007033
% 216.18/216.37  |- rdf__type mesh__D014697sskos__Concept
% 216.18/216.37  |- skos__hiddenLabel mesh__D014697 Nucleus, Ventromedial Hypothalamic
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014697 2003
% 216.18/216.37  |- skos__prefLabel mesh__D014697 Ventromedial Hypothalamic Nucleus
% 216.18/216.37  |- mesh__dateCreated mesh__D014697 1982-04-28
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014697 2001
% 216.18/216.37  |- mesh__dateEstablished mesh__D014697 1983-01-01
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014697 2005
% 216.18/216.37  |- mesh__recordAuthorizer mesh__D014697 PLS
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014697 1996
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014697 2004
% 216.18/216.37  |- mesh__publicMeSHNote mesh__D014697 83   
% 216.18/216.37  |- skos__altLabel mesh__D014697 Hypothalamic Nucleus, Ventromedial
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014697 1998
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014697 2006
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014697 1997
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014697 1994
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014697 1999
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014697 2002
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014697 1993
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014697 1995
% 216.18/216.37  |- skos__hiddenLabel mesh__D000677 NSC141549
% 216.18/216.37  |- skos__altLabel mesh__D000677 G%C3%%B6%decke Brand of Amsacrine
% 216.18/216.37  |- skos__hiddenLabel mesh__D000677 meta AMSA
% 216.18/216.37  |- skos__hiddenLabel mesh__D000677 AMSA P D
% 216.18/216.37  |- skos__hiddenLabel mesh__D000677 Cains Acridine
% 216.18/216.37  |- mesh__recordOriginator mesh__D000677 RLS
% 216.18/216.37  |- skos__hiddenLabel mesh__D000677 NSC 156303
% 216.18/216.37  |- mesh__historyNote mesh__D000677 87   
% 216.18/216.37  |- mesh__dateCreated mesh__D000677 1986-06-03
% 216.18/216.37  |- skos__hiddenLabel mesh__D000677 NSC 141549
% 216.18/216.37  |- skos__hiddenLabel mesh__D000677 NSC249992
% 216.18/216.37  |- skos__hiddenLabel mesh__D000677 AMSA PD
% 216.18/216.37  |- mesh__dateRevised mesh__D000677 2004-07-07
% 216.18/216.37  |- skos__hiddenLabel mesh__D000677 NSC156303
% 216.18/216.37  |- skos__historyNote mesh__D000677 Aminoacridines %28%1980-1986%29%
% 216.18/216.37  |- skos__hiddenLabel mesh__D000677 SN 11841
% 216.18/216.37  |- skos__altLabel mesh__D000677 Amsacrina
% 216.18/216.37  |- skos__altLabel mesh__D000677 SN11841
% 216.18/216.37  |- skos__altLabel mesh__D000677 AMSA P-D
% 216.18/216.37  |- mesh__recordAuthorizer mesh__D000677 sjn
% 216.18/216.37  |- skos__hiddenLabel mesh__D000677 Amsacrine G%C3%%B6%decke Brand
% 216.18/216.37  |- mesh__recordMaintainer mesh__D000677 mdb
% 216.18/216.37  |- mesh__publicMeSHNote mesh__D000677 87   
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D000677 2006
% 216.18/216.37  |- mesh__dateEstablished mesh__D000677 1987-01-01
% 216.18/216.37  |- skos__altLabel mesh__D000677 Parke Davis Brand of Amsacrine Lactate
% 216.18/216.37  |- skos__broader mesh__D000677smesh__D000609
% 216.18/216.37  |- skos__historyNote mesh__D000677 Acridines %28%1966-1979%29%
% 216.18/216.37  |- skos__altLabel mesh__D000677 Cain%27%s Acridine
% 216.18/216.37  |- rdf__type mesh__D000677sskos__Concept
% 216.18/216.37  |- skos__altLabel mesh__D000677 Parke Davis Brand of Amsacrine
% 216.18/216.37  |- skos__scopeNote mesh__D000677
% 216.18/216.37       Aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects.%A%    
% 216.18/216.37  |- skos__altLabel mesh__D000677 m-AMSA
% 216.18/216.37  |- skos__altLabel mesh__D000677 meta-AMSA
% 216.18/216.37  |- skos__hiddenLabel mesh__D000677 Cain Acridine
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D000677 2005
% 216.18/216.37  |- skos__altLabel mesh__D000677 AMSA
% 216.18/216.37  |- skos__prefLabel mesh__D000677 Amsacrine
% 216.18/216.37  |- skos__hiddenLabel mesh__D000677 Acridine, Cain%27%s
% 216.18/216.37  |- skos__hiddenLabel mesh__D000677 NSC 249992
% 216.18/216.37  |- skos__hiddenLabel mesh__D019382
% 216.18/216.37       Hoffmann La Roche Brand of Human Growth Hormone
% 216.18/216.37  |- skos__altLabel mesh__D019382 Irisfarma Brand of Human Growth Hormone
% 216.18/216.37  |- skos__hiddenLabel mesh__D019382 CryoTropin
% 216.18/216.37  |- mesh__dateCreated mesh__D019382 1996-06-10
% 216.18/216.37  |- skos__altLabel mesh__D019382 Eli Lilly Brand of Human Growth Hormone
% 216.18/216.37  |- skos__altLabel mesh__D019382 Umatrope
% 216.18/216.37  |- skos__altLabel mesh__D019382 Pharmacia Brand of Human Growth Hormone
% 216.18/216.37  |- skos__scopeNote mesh__D019382
% 216.18/216.37       A 191-amino acid polypeptide hormone secreted by the human adenohypophysis %28%PITUITARY GLAND, ANTERIOR%29%, also known as GH or somatotropin. Synthetic growth hormone, termed somatropin, has replaced the natural form in therapeutic usage such as treatment of dwarfism in children with growth hormone deficiency.%A%    
% 216.18/216.37  |- skos__prefLabel mesh__D019382 Human Growth Hormone
% 216.18/216.37  |- skos__altLabel mesh__D019382 r-hGH-M
% 216.18/216.37  |- mesh__dateRevised mesh__D019382 2005-06-30
% 216.18/216.37  |- skos__hiddenLabel mesh__D019382 Cryo Tropin
% 216.18/216.37  |- mesh__publicMeSHNote mesh__D019382
% 216.18/216.37       2003; see SOMATROPIN 1997-2002; SEROSTIM was indexed under SOMATOTROPINS, RECOMBINANT 1996-2002; NORDITROPIN was indexed under SOMATOTROPIN %26% RECOMBINANT PROTEINS 1992-1996%A%  
% 216.18/216.37  |- skos__altLabel mesh__D019382 Somatropin
% 216.18/216.37  |- mesh__historyNote mesh__D019382
% 216.18/216.37       2003 %28%1997%29%; for SEROSTIM use SOMATOTROPINS, RECOMBINANT %28%NM%29% 1996-2002; use NORDITROPIN %28%NM%29% 1992-1996%A%  
% 216.18/216.37  |- skos__altLabel mesh__D019382 Serono Brand of Human Growth Hormone
% 216.18/216.37  |- skos__altLabel mesh__D019382
% 216.18/216.37       Hoffmann La-Roche Brand of Human Growth Hormone
% 216.18/216.37  |- skos__altLabel mesh__D019382 Somatropin %28%Human%29%
% 216.18/216.37  |- skos__altLabel mesh__D019382 Pisa Brand of Human Growth Hormone
% 216.18/216.37  |- skos__hiddenLabel mesh__D019382 Growth Hormone, Human
% 216.18/216.37  |- skos__altLabel mesh__D019382 Lilly Brand of Human Growth Hormone
% 216.18/216.37  |- rdf__type mesh__D019382sskos__Concept
% 216.18/216.37  |- skos__altLabel mesh__D019382 Cryopharma Brand of Human Growth Hormone
% 216.18/216.37  |- skos__altLabel mesh__D019382 hGH %28%Human Growth Hormone%29%
% 216.18/216.37  |- skos__historyNote mesh__D019382 Somatotropin %28%1976-1996%29%
% 216.18/216.37  |- skos__altLabel mesh__D019382 Genotonorm
% 216.18/216.37  |- skos__altLabel mesh__D019382 Norditropine
% 216.18/216.37  |- skos__altLabel mesh__D019382 Novo Nordisk Brand of Human Growth Hormone
% 216.18/216.37  |- skos__altLabel mesh__D019382 Somatotropin %28%Human%29%
% 216.18/216.37  |- skos__altLabel mesh__D019382 Ferring Brand of Human Growth Hormone
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D019382 2006
% 216.18/216.37  |- skos__altLabel mesh__D019382
% 216.18/216.37       Pharmacia Spain Brand of Human Growth Hormone
% 216.18/216.37  |- skos__altLabel mesh__D019382 Serostim
% 216.18/216.37  |- skos__broader mesh__D019382smesh__D013006
% 216.18/216.37  |- skos__altLabel mesh__D019382 r-hGH%28%m%29%
% 216.18/216.37  |- mesh__recordOriginator mesh__D019382 TPW
% 216.18/216.37  |- mesh__recordAuthorizer mesh__D019382 sjn
% 216.18/216.37  |- skos__altLabel mesh__D019382 Allphar Brand of Human Growth Hormone
% 216.18/216.37  |- skos__historyNote mesh__D019382 Recombinant Proteins %28%1986-1996%29%
% 216.18/216.37  |- skos__altLabel mesh__D019382
% 216.18/216.37       Sanofi Synthelabo Brand of Human Growth Hormone
% 216.18/216.37  |- skos__altLabel mesh__D019382 Norditropin Simplexx
% 216.18/216.37  |- mesh__recordMaintainer mesh__D019382 CCR
% 216.18/216.37  |- skos__annotation mesh__D019382
% 216.18/216.37       note species specificity; do not confuse with GROWTH HORMONE, unspecified; despite X ref, coord with RECOMBINANT PROTEINS for recombinant human growth hormone%A%  
% 216.18/216.37  |- mesh__dateEstablished mesh__D019382 1997-01-01
% 216.18/216.37  |- rdf__type mesh__D005362sskos__Concept
% 216.18/216.37  |- mesh__recordAuthorizer mesh__D005362 sjn
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D005362 2005
% 216.18/216.37  |- skos__historyNote mesh__D005362 Propanediols %28%1974%29%
% 216.18/216.37  |- mesh__dateCreated mesh__D005362 1974-11-19
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D005362 2006
% 216.18/216.37  |- mesh__historyNote mesh__D005362
% 216.18/216.37       90%28%75%29%; was see under POLYSACCHARIDES 1975-89   
% 216.18/216.37  |- mesh__recordMaintainer mesh__D005362 ssb
% 216.18/216.37  |- skos__historyNote mesh__D005362 Polysaccharides %28%1971-1974%29%
% 216.18/216.37  |- mesh__dateEstablished mesh__D005362 1990-01-01
% 216.18/216.37  |- mesh__publicMeSHNote mesh__D005362
% 216.18/216.37       90; was see under POLYSACCHARIDES 1975-89   
% 216.18/216.37  |- skos__prefLabel mesh__D005362 Ficoll
% 216.18/216.37  |- skos__scopeNote mesh__D005362
% 216.18/216.37       A sucrose polymer of high molecular weight.     
% 216.18/216.37  |- mesh__recordOriginator mesh__D005362 NLM
% 216.18/216.37  |- mesh__dateRevised mesh__D005362 2004-07-07
% 216.18/216.37  |- skos__broader mesh__D005362smesh__D011134
% 216.18/216.37  |- skos__historyNote mesh__D005362 Sucrose %28%1971-1974%29%
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D015790 2006
% 216.18/216.37  |- mesh__dateRevised mesh__D015790 2004-07-07
% 216.18/216.37  |- mesh__recordOriginator mesh__D015790 RLS
% 216.18/216.37  |- mesh__dateEstablished mesh__D015790 1990-01-01
% 216.18/216.37  |- skos__altLabel mesh__D015790 Sodium Cefonicid
% 216.18/216.37  |- skos__scopeNote mesh__D015790
% 216.18/216.37       A second-generation cephalosporin administered intravenously or intramuscularly. Its bactericidal action results from inhibition of cell wall synthesis. It is used for urinary tract infections, lower respiratory tract infections, and soft tissue and bone infections.%A%    
% 216.18/216.37  |- skos__prefLabel mesh__D015790 Cefonicid
% 216.18/216.37  |- mesh__recordMaintainer mesh__D015790 ssb
% 216.18/216.37  |- skos__historyNote mesh__D015790
% 216.18/216.37       Cefamandole/analogs %26% derivatives %28%1978-1989%29%
% 216.18/216.37  |- skos__hiddenLabel mesh__D015790 SKF 75073 2
% 216.18/216.37  |- mesh__recordAuthorizer mesh__D015790 sjn
% 216.18/216.37  |- skos__hiddenLabel mesh__D015790 SKF750732
% 216.18/216.37  |- mesh__historyNote mesh__D015790 90   
% 216.18/216.37  |- mesh__dateCreated mesh__D015790 1989-05-25
% 216.18/216.37  |- rdf__type mesh__D015790sskos__Concept
% 216.18/216.37  |- skos__hiddenLabel mesh__D015790 SK%26%F75073
% 216.18/216.37  |- skos__historyNote mesh__D015790 Cephalosporins %28%1966-1977%29%
% 216.18/216.37  |- skos__hiddenLabel mesh__D015790 Cefonicid, Sodium
% 216.18/216.37  |- skos__broader mesh__D015790smesh__D002511
% 216.18/216.37  |- skos__hiddenLabel mesh__D015790 SK%26%F 75073
% 216.18/216.37  |- skos__altLabel mesh__D015790 Cefonicid Monosodium Salt
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D015790 2005
% 216.18/216.37  |- mesh__publicMeSHNote mesh__D015790 90   
% 216.18/216.37  |- mesh__recordOriginator mesh__D009753 VDK
% 216.18/216.37  |- mesh__historyNote mesh__D009753 79   
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009753 2004
% 216.18/216.37  |- skos__altLabel mesh__D009753 Availability, Nutritional Biologic
% 216.18/216.37  |- skos__altLabel mesh__D009753 Availability, Biological Nutritional
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009753 1996
% 216.18/216.37  |- skos__altLabel mesh__D009753 Biologic Availability, Nutritional
% 216.18/216.37  |- skos__historyNote mesh__D009753 Nutrition %28%1966-1978%29%
% 216.18/216.37  |- skos__hiddenLabel mesh__D009753 Nutritional Biologic Availability
% 216.18/216.37  |- mesh__dateEstablished mesh__D009753 1979-01-01
% 216.18/216.37  |- skos__hiddenLabel mesh__D009753 Values, Nutritive
% 216.18/216.37  |- skos__hiddenLabel mesh__D009753 Nutritive Values
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009753 2003
% 216.18/216.37  |- skos__scopeNote mesh__D009753
% 216.18/216.37       An indication of the contribution of a food to the nutrient content of the diet. This value depends on the quantity of a food which is digested and absorbed and the amounts of the essential nutrients %28%protein, fat, carbohydrate, minerals, vitamins%29% which it contains. This value can be affected by soil and growing conditions, handling and storage, and processing.%A%    
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009753 2002
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009753 1999
% 216.18/216.37  |- mesh__recordAuthorizer mesh__D009753 PLS
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009753 2006
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009753 1995
% 216.18/216.37  |- skos__hiddenLabel mesh__D009753 Availability, Nutritional Biological
% 216.18/216.37  |- skos__prefLabel mesh__D009753 Nutritive Value
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009753 1998
% 216.18/216.37  |- skos__altLabel mesh__D009753 Nutritional Availability, Biologic
% 216.18/216.37  |- mesh__dateCreated mesh__D009753 1978-05-19
% 216.18/216.37  |- skos__altLabel mesh__D009753 Biologic Nutritional Availability
% 216.18/216.37  |- mesh__publicMeSHNote mesh__D009753 79   
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009753 2005
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009753 1994
% 216.18/216.37  |- skos__hiddenLabel mesh__D009753 Value, Nutritive
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009753 2001
% 216.18/216.37  |- skos__altLabel mesh__D009753 Nutritional Availability, Biological
% 216.18/216.37  |- mesh__recordMaintainer mesh__D009753 JLS
% 216.18/216.37  |- skos__hiddenLabel mesh__D009753 Availability, Nutritional
% 216.18/216.37  |- skos__hiddenLabel mesh__D009753 Availability, Biologic Nutritional
% 216.18/216.37  |- skos__broader mesh__D009753smesh__D009747
% 216.18/216.37  |- skos__hiddenLabel mesh__D009753 Biological Nutritional Availability
% 216.18/216.37  |- rdf__type mesh__D009753sskos__Concept
% 216.18/216.37  |- skos__altLabel mesh__D009753 Nutritional Availability
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009753 2000
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D009753 1997
% 216.18/216.37  |- skos__altLabel mesh__D009753 Nutritional Biological Availability
% 216.18/216.37  |- mesh__dateRevised mesh__D009753 1993-06-04
% 216.18/216.37  |- skos__altLabel mesh__D009753 Biological Availability, Nutritional
% 216.18/216.37  |- skos__annotation mesh__D009753
% 216.18/216.37       NIM; coord with specific food %28%IM%29%; no qualif   
% 216.18/216.37  |- skos__annotation mesh__D001770
% 216.18/216.37       restrict to bactericidal: not for fungicidal probably fungus %28%IM%29% + BLOOD PHYSIOLOGY %28%IM%29%; the natural bactericidal property of the blood: do not confuse with SERUM BACTERICIDAL TEST %28%after antibiotic ther%29%%A%  
% 216.18/216.37  |- skos__broader mesh__D001770smesh__D045123
% 216.18/216.37  |- skos__hiddenLabel mesh__D001770 Blood Bactericidal Activities
% 216.18/216.37  |- skos__related mesh__D001770smesh__D015610
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D001770 2006A
% 216.18/216.37  |- mesh__recordOriginator mesh__D001770 NLM
% 216.18/216.37  |- rdf__type mesh__D001770sskos__Concept
% 216.18/216.37  |- skos__broader mesh__D001770smesh__D045122
% 216.18/216.37  |- mesh__dateCreated mesh__D001770 1999-01-01
% 216.18/216.37  |- skos__scopeNote mesh__D001770
% 216.18/216.37       The natural bactericidal property of BLOOD due to normally occurring antibacterial substances such as beta lysin, leukin, etc. This activity needs to be distinguished from the bactericidal activity contained in a patient%27%s serum as a result of antimicrobial therapy, which is measured by a SERUM BACTERICIDAL TEST.%A%    
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D001770 2004
% 216.18/216.37  |- skos__hiddenLabel mesh__D001770 Bactericidal Activity, Blood
% 216.18/216.37  |- skos__hiddenLabel mesh__D001770 Activity, Blood Bactericidal
% 216.18/216.37  |- skos__hiddenLabel mesh__D001770 Bactericidal Activities, Blood
% 216.18/216.37  |- skos__related mesh__D001770smesh__D023181
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D001770 2005
% 216.18/216.37  |- mesh__recordMaintainer mesh__D001770 ags
% 216.18/216.37  |- mesh__historyNote mesh__D001770 70%28%65%29%   
% 216.18/216.37  |- mesh__dateEstablished mesh__D001770 1970-01-01
% 216.18/216.37  |- mesh__publicMeSHNote mesh__D001770 70   
% 216.18/216.37  |- mesh__dateRevised mesh__D001770 2005-08-03
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D001770 2006
% 216.18/216.37  |- mesh__recordAuthorizer mesh__D001770 ags
% 216.18/216.37  |- skos__hiddenLabel mesh__D001770 Activities, Blood Bactericidal
% 216.18/216.37  |- skos__broader mesh__D001770smesh__D007113
% 216.18/216.37  |- skos__prefLabel mesh__D001770 Blood Bactericidal Activity
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014698 2002
% 216.18/216.37  |- mesh__dateRevised mesh__D014698 1995-06-16
% 216.18/216.37  |- skos__scopeNote mesh__D014698
% 216.18/216.37       Toxic substances isolated from various strains of Streptomyces. They are 20-membered macrolides that inhibit oxidative phosphorylation and mitochondrial ATPases. Venturicidins A and B are glycosides. Used mainly as tools in the study of mitochondrial function.%A%    
% 216.18/216.37  |- skos__annotation mesh__D014698
% 216.18/216.37       uncoupling agents %26% antifungal antibiotics; from Streptomyces%A%  
% 216.18/216.37  |- skos__broader mesh__D014698smesh__D007783
% 216.18/216.37  |- rdf__type mesh__D014698sskos__Concept
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014698 2003
% 216.18/216.37  |- mesh__recordOriginator mesh__D014698 SH
% 216.18/216.37  |- mesh__historyNote mesh__D014698
% 216.18/216.37       91%28%77%29%; was see under LACTONES 1977-90   
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014698 2005
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014698 1996
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014698 2004
% 216.18/216.37  |- mesh__publicMeSHNote mesh__D014698 91; was see under LACTONES 1977-90   
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014698 1998
% 216.18/216.37  |- skos__historyNote mesh__D014698 Glycosides %28%1973-1974%29%
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014698 2006
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014698 2000
% 216.18/216.37  |- skos__prefLabel mesh__D014698 Venturicidins
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014698 1997
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014698 1999
% 216.18/216.37  |- mesh__recordMaintainer mesh__D014698 JRT
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D014698 2001
% 216.18/216.37  |- mesh__dateEstablished mesh__D014698 1991-01-01
% 216.18/216.37  |- mesh__recordAuthorizer mesh__D014698 PLS
% 216.18/216.37  |- skos__historyNote mesh__D014698
% 216.18/216.37       Antibiotics, Antifungal %28%1973-1976%29%
% 216.18/216.37  |- skos__historyNote mesh__D014698 Lactones %28%1973-1976%29%
% 216.18/216.37  |- skos__historyNote mesh__D014698 Rhamnose %28%1973-1974%29%
% 216.18/216.37  |- mesh__dateCreated mesh__D014698 1976-04-16
% 216.18/216.37  |- skos__altLabel mesh__D000678 Neoamygdalin
% 216.18/216.37  |- mesh__recordMaintainer mesh__D000678 ssb
% 216.18/216.37  |- mesh__dateRevised mesh__D000678 2004-07-07
% 216.18/216.37  |- skos__altLabel mesh__D000678 Amygdaloside
% 216.18/216.37  |- skos__broader mesh__D000678smesh__D005960
% 216.18/216.37  |- rdf__type mesh__D000678sskos__Concept
% 216.18/216.37  |- skos__annotation mesh__D000678 /biosyn permitted if by plant   
% 216.18/216.37  |- mesh__dateEstablished mesh__D000678 1979-01-01
% 216.18/216.37  |- skos__hiddenLabel mesh__D000678 Mandelonitrile beta Gentiobioside
% 216.18/216.37  |- mesh__recordAuthorizer mesh__D000678 sjn
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D000678 2005
% 216.18/216.37  |- skos__broader mesh__D000678smesh__D009570
% 216.18/216.37  |- skos__prefLabel mesh__D000678 Amygdalin
% 216.18/216.37  |- skos__altLabel mesh__D000678 Mandelonitrile-beta-Gentiobioside
% 216.18/216.37  |- skos__historyNote mesh__D000678 Nitriles %28%1968-1975%29%
% 216.18/216.37  |- skos__historyNote mesh__D000678 Glycosides %28%1966-1975%29%
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D000678 2006
% 216.18/216.37  |- mesh__publicMeSHNote mesh__D000678
% 216.18/216.37       79; was see under NITRILES 1976-78; LAETRILE was see AMYGDALIN 1979-95, see under NITRILES 1975-78;%A%  
% 216.18/216.37  |- mesh__historyNote mesh__D000678
% 216.18/216.37       79%28%76%29%; was see under NITRILES 1976-78; LAETRILE was see AMYGDALIN 1979-95, see under NITRILES 1975-78%A%  
% 216.18/216.37  |- mesh__onlineNote mesh__D000678
% 216.18/216.37       use AMYGDALIN to search LAETRILE 1975-78   
% 216.18/216.37  |- mesh__recordOriginator mesh__D000678 RLS
% 216.18/216.37  |- skos__historyNote mesh__D000678 Cyanides %28%1966-1967%29%
% 216.18/216.37  |- skos__historyNote mesh__D000678 Mandelic Acids %28%1966-1975%29%
% 216.18/216.37  |- skos__scopeNote mesh__D000678
% 216.18/216.37       A cyanogenic glycoside found in the seeds of Rosaceae.     
% 216.18/216.37  |- mesh__dateCreated mesh__D000678 1975-07-23
% 216.18/216.37  |- mesh__activeMeSHYear mesh__D005363 2006
% 216.18/216.37  |- skos__altLabel mesh__D005363 Psoralene
% 216.18/216.37  |- skos__annotation mesh__D005363
% 216.18/216.37       do not confuse X ref PSORALEN, this specific drug, with PSORALENS;%A%  
% 216.18/216.37  |- mesh__dateRevised mesh__D005363 2005-06-30
% 216.18/216.37  |- mesh__recordOriginator mesh__D005363 NLM
% 216.18/216.37  |- skos__historyNote mesh__D005363 Furans %28%1966-1974%29%
% 216.18/216.37  |- skos__prefLabel mesh__D005363 Ficusin
% 216.18/216.37  |- skos__scopeNote mesh__D005363
% 216.18/216.37       A naturally occurring furocoumarin, found in PSORALEA. After photoactivation with UV radiation, it binds DNA via single and double-stranded cross-linking.%A%    
% 216.18/216.37  |- skos__broader mesh__D005363smesh__D011564
% 216.18/216.37  |- mesh__dateCreated mesh__D005363 1974-11-19
% 216.18/216.37  |- mesh__publicMeSHNote mesh__D005363
% 216.18/216.37       91; was see under PSORALENS 1979-90; was see under COUMARINS 1975-78%A%  
% 216.18/216.37  |- mesh__recordAuthorizer mesh__D005363 sjn
% 216.18/216.38  |- skos__altLabel mesh__D005363 Psoralen
% 216.18/216.38  |- rdf__type mesh__D005363sskos__Concept
% 216.18/216.38  |- mesh__dateEstablished mesh__D005363 1991-01-01
% 216.18/216.38  |- mesh__historyNote mesh__D005363
% 216.18/216.38       91%28%75%29%; was see under PSORALENS 1979-90; was see under COUMARINS 1975-78%A%  
% 216.18/216.38  |- mesh__recordMaintainer mesh__D005363 ssb
% 216.18/216.38  |- skos__historyNote mesh__D005363 Coumarins %28%1966-1974%29%
% 216.18/216.38  |- skos__hiddenLabel mesh__D015791 Antigen, HLA-A3
% 216.18/216.38  |- skos__hiddenLabel mesh__D015791 HLA A3 Antigen
% 216.18/216.38  |- skos__historyNote mesh__D015791 HLA-A Antigens %28%1989%29%
% 216.18/216.38  |- skos__historyNote mesh__D015791 HLA Antigens %28%1976-1988%29%
% 216.18/216.38  |- mesh__recordOriginator mesh__D015791 AGS
% 216.18/216.38  |- rdf__type mesh__D015791sskos__Concept
% 216.18/216.38  |- skos__altLabel mesh__D015791 HLA-A3
% 216.18/216.38  |- skos__annotation mesh__D015791 assoc with hemochromatosis; DF: HLA A3   
% 216.18/216.38  |- mesh__recordMaintainer mesh__D015791 ssb
% 216.18/216.38  |- mesh__recordAuthorizer mesh__D015791 sjn
% 216.18/216.38  |- mesh__historyNote mesh__D015791 90   
% 216.18/216.38  |- mesh__publicMeSHNote mesh__D015791 90   
% 216.18/216.38  |- skos__broader mesh__D015791smesh__D015234
% 216.18/216.38  |- mesh__dateCreated mesh__D015791 1989-05-15
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D015791 2006
% 216.18/216.38  |- mesh__dateEstablished mesh__D015791 1990-01-01
% 216.18/216.38  |- skos__scopeNote mesh__D015791
% 216.18/216.38       Human histocompatibility %28%HLA%29% surface antigen encoded by the A locus on chromosome 6. The allele occurs with increased frequency in individuals with idiopathic hemochromatosis. HLA-A3 is in linkage disequilibrium with HLA-B7 and HLA-DR2.%A%    
% 216.18/216.38  |- skos__prefLabel mesh__D015791 HLA-A3 Antigen
% 216.18/216.38  |- mesh__dateRevised mesh__D015791 2005-06-30
% 216.18/216.38  |- skos__altLabel mesh__D051116 Acetyl-LDL Receptors
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D051116 2006
% 216.18/216.38  |- mesh__recordMaintainer mesh__D051116 DRC
% 216.18/216.38  |- skos__altLabel mesh__D051116 Receptor, Acetyl-LDL
% 216.18/216.38  |- skos__altLabel mesh__D051116 Macrophage Scavenger Receptors
% 216.18/216.38  |- skos__altLabel mesh__D051116 Macrophage Scavenger Receptor
% 216.18/216.38  |- skos__broader mesh__D051116smesh__D011971
% 216.18/216.38  |- skos__hiddenLabel mesh__D051116 Receptor, Scavenger
% 216.18/216.38  |- skos__altLabel mesh__D051116 Scavenger Receptors
% 216.18/216.38  |- mesh__recordOriginator mesh__D051116 DRC
% 216.18/216.38  |- skos__altLabel mesh__D051116 Acetylated LDL Receptor
% 216.18/216.38  |- skos__broader mesh__D051116smesh__D011973
% 216.18/216.38  |- skos__scopeNote mesh__D051116
% 216.18/216.38       A large group of structurally diverse cell surface receptors that mediate endocytic uptake of modified LIPOPROTEINS. Scavenger receptors are expressed by MYELOID CELLS and some ENDOTHELIAL CELLS, and were originally characterized based on their ability to bind acetylated LOW-DENSITY LIPOPROTEINS. They can also bind a variety of other polyanionic ligand. Certain scavenger receptors can internalize micro-organisms as well as apoptotic cells.%A%    
% 216.18/216.38  |- rdf__type mesh__D051116sskos__Concept
% 216.18/216.38  |- skos__annotation mesh__D051116 general; prefer specifics   
% 216.18/216.38  |- skos__hiddenLabel mesh__D051116 Receptor, Acetyl LDL
% 216.18/216.38  |- skos__altLabel mesh__D051116 Receptor, Macrophage Scavenger
% 216.18/216.38  |- mesh__dateCreated mesh__D051116 2005-06-30
% 216.18/216.38  |- skos__altLabel mesh__D051116 Acetyl-LDL Receptor
% 216.18/216.38  |- skos__hiddenLabel mesh__D051116 LDL Receptor, Acetylated
% 216.18/216.38  |- skos__hiddenLabel mesh__D051116 Acetyl LDL Receptor
% 216.18/216.38  |- skos__altLabel mesh__D051116 Scavenger Receptor
% 216.18/216.38  |- mesh__dateEstablished mesh__D051116 2006-01-01
% 216.18/216.38  |- mesh__recordAuthorizer mesh__D051116 sjn
% 216.18/216.38  |- skos__hiddenLabel mesh__D051116 Acetyl LDL Receptors
% 216.18/216.38  |- skos__hiddenLabel mesh__D051116 Receptors, Acetyl-LDL
% 216.18/216.38  |- mesh__publicMeSHNote mesh__D051116
% 216.18/216.38       2006; RECEPTORS, SCAVENGER was indexed under RECEPTORS, IMMUNOLOGIC 1985-2005, %26% under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-1984%A%  
% 216.18/216.38  |- mesh__historyNote mesh__D051116 2006%28%1981%29%   
% 216.18/216.38  |- skos__hiddenLabel mesh__D051116 Receptor, Acetylated LDL
% 216.18/216.38  |- skos__prefLabel mesh__D051116 Receptors, Scavenger
% 216.18/216.38  |- mesh__recordAuthorizer mesh__D009754 sjn
% 216.18/216.38  |- skos__broader mesh__D009754smesh__D005502
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D009754 2003
% 216.18/216.38  |- skos__scopeNote mesh__D009754
% 216.18/216.38       Botanically, a type of single-seeded fruit in which the pericarp enclosing the seed is a hard woody shell. In common usage the term is used loosely for any hard, oil-rich kernel. Of those commonly eaten, only hazel, filbert, and chestnut are strictly nuts. Walnuts, pecans, almonds, and coconuts are really drupes. Brazil nuts, pistachios, macadamias, and cashews are really seeds with a hard shell derived from the testa rather than the pericarp.%A%    
% 216.18/216.38  |- rdf__type mesh__D009754sskos__Concept
% 216.18/216.38  |- skos__prefLabel mesh__D009754 Nuts
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D009754 2004
% 216.18/216.38  |- skos__hiddenLabel mesh__D009754 Nut
% 216.18/216.38  |- mesh__dateCreated mesh__D009754 1999-01-01
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D009754 2005
% 216.18/216.38  |- mesh__dateRevised mesh__D009754 2002-07-03
% 216.18/216.38  |- skos__broader mesh__D009754smesh__D005638
% 216.18/216.38  |- mesh__recordOriginator mesh__D009754 NLM
% 216.18/216.38  |- mesh__recordMaintainer mesh__D009754 tpw
% 216.18/216.38  |- skos__annotation mesh__D009754
% 216.18/216.38       as seed %26% food; /adv eff; consider also NUT HYPERSENSITIVITY; PEANUTS see ARACHIS HYPOGAEA is also available%A%  
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D009754 2006
% 216.18/216.38  |- mesh__recordMaintainer mesh__D001771 sjn
% 216.18/216.38  |- skos__scopeNote mesh__D001771
% 216.18/216.38       Centers for collecting, characterizing and storing human blood.%A%    
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D001771 2005
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D001771 2006
% 216.18/216.38  |- skos__hiddenLabel mesh__D001771 Banks, Blood
% 216.18/216.38  |- mesh__dateRevised mesh__D001771 2004-07-13
% 216.18/216.38  |- mesh__recordOriginator mesh__D001771 NLM
% 216.18/216.38  |- skos__broader mesh__D001771smesh__D018070
% 216.18/216.38  |- skos__hiddenLabel mesh__D001771 Blood Bank
% 216.18/216.38  |- mesh__recordAuthorizer mesh__D001771 sjn
% 216.18/216.38  |- skos__prefLabel mesh__D001771 Blood Banks
% 216.18/216.38  |- rdf__type mesh__D001771sskos__Concept
% 216.18/216.38  |- mesh__dateCreated mesh__D001771 1999-01-01
% 216.18/216.38  |- skos__hiddenLabel mesh__D001771 Bank, Blood
% 216.18/216.38  |- skos__hiddenLabel mesh__D014699 Venule
% 216.18/216.38  |- mesh__recordAuthorizer mesh__D014699 SJN
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D014699 1998
% 216.18/216.38  |- mesh__dateEstablished mesh__D014699 1991-01-01
% 216.18/216.38  |- mesh__recordMaintainer mesh__D014699 TGC
% 216.18/216.38  |- skos__scopeNote mesh__D014699
% 216.18/216.38       The minute vessels that collect blood from the capillary plexuses and join together to form veins.%A%    
% 216.18/216.38  |- skos__broader mesh__D014699smesh__D014680
% 216.18/216.38  |- skos__prefLabel mesh__D014699 Venules
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D014699 2001
% 216.18/216.38  |- skos__broader mesh__D014699smesh__D008833
% 216.18/216.38  |- mesh__dateCreated mesh__D014699 1977-03-01
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D014699 2004
% 216.18/216.38  |- rdf__type mesh__D014699sskos__Concept
% 216.18/216.38  |- skos__historyNote mesh__D014699 Veins %28%1966-1977%29%
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D014699 2000
% 216.18/216.38  |- mesh__onlineNote mesh__D014699 search VEINS 1966-74   
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D014699 2003
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D014699 2006
% 216.18/216.38  |- mesh__historyNote mesh__D014699
% 216.18/216.38       91%28%78%29%; was see under VEINS 1975-90; was see under VEINS 1964-74%A%  
% 216.18/216.38  |- mesh__publicMeSHNote mesh__D014699
% 216.18/216.38       91; was see under VEINS 1975-90; was see under VEINS 1964-74%A%  
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D014699 2002
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D014699 1999
% 216.18/216.38  |- mesh__dateRevised mesh__D014699 1997-06-20
% 216.18/216.38  |- mesh__recordOriginator mesh__D014699 VDK
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D014699 2005
% 216.18/216.38  |- skos__annotation mesh__D014699
% 216.18/216.38       restrict to blood vessels: not for %22%lymphatic venules%22% or %22%postcapillary venules%22%: see note on LYMPHATIC SYSTEM; IM GEN only; NIM as coord with specific organ /blood supply %28%IM%29%%A%  
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D000679 2000
% 216.18/216.38  |- mesh__publicMeSHNote mesh__D000679
% 216.18/216.38       2000%28%1966%29%; see AMYGDALOID BODY 1966-1996; for AMYGDALA see AMYGDALOID BODY 1979-1999%A%  
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D000679 2005
% 216.18/216.38  |- mesh__historyNote mesh__D000679 2000%28%1966%29%   
% 216.18/216.38  |- skos__altLabel mesh__D000679 Amygdaloid Body
% 216.18/216.38  |- skos__scopeNote mesh__D000679
% 216.18/216.38       Almond-shaped group of basal nuclei anterior to the inferior horn of the lateral ventricle of the brain, within the temporal lobe. The amygdala is part of the limbic system.%A%    
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D000679 2006
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D000679 2001
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D000679 2003
% 216.18/216.38  |- mesh__dateRevised mesh__D000679 1999-11-03
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D000679 2004
% 216.18/216.38  |- skos__broader mesh__D000679smesh__D008032
% 216.18/216.38  |- mesh__recordMaintainer mesh__D000679 ags
% 216.18/216.38  |- mesh__dateCreated mesh__D000679 1999-01-01
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D000679 2002
% 216.18/216.38  |- skos__prefLabel mesh__D000679 Amygdala
% 216.18/216.38  |- skos__hiddenLabel mesh__D000679 Amygdaloid Bodies
% 216.18/216.38  |- mesh__recordAuthorizer mesh__D000679 sjn
% 216.18/216.38  |- rdf__type mesh__D000679sskos__Concept
% 216.18/216.38  |- skos__broader mesh__D000679smesh__D001479
% 216.18/216.38  |- mesh__recordOriginator mesh__D000679 NLM
% 216.18/216.38  |- mesh__recordMaintainer mesh__D019384 ssb
% 216.18/216.38  |- skos__hiddenLabel mesh__D019384 Synthesis Inhibitors, RNA
% 216.18/216.38  |- skos__annotation mesh__D019384
% 216.18/216.38       despite X refs, coord IM with DNA /biosyn %28%IM%29% or RNA /biosyn %28%IM%29% or specific nucleic acid /biosyn %28%IM%29%; DF: NUCLEIC ACID SYN INHIB%A%  
% 216.18/216.38  |- skos__broader mesh__D019384smesh__D004791
% 216.18/216.38  |- skos__historyNote mesh__D019384 DNA %28%1974-1996%29%
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D019384 2005
% 216.18/216.38  |- mesh__dateEstablished mesh__D019384 1997-01-01
% 216.18/216.38  |- skos__altLabel mesh__D019384 Inhibitors, Nucleic Acid Synthesis
% 216.18/216.38  |- mesh__publicMeSHNote mesh__D019384 97   
% 216.18/216.38  |- mesh__historyNote mesh__D019384 97   
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D019384 2004
% 216.18/216.38  |- mesh__dateRevised mesh__D019384 2003-07-09
% 216.18/216.38  |- mesh__dateCreated mesh__D019384 1996-06-10
% 216.18/216.38  |- skos__hiddenLabel mesh__D019384 Synthesis Inhibitors, DNA
% 216.18/216.38  |- mesh__recordAuthorizer mesh__D019384 sjn
% 216.18/216.38  |- skos__scopeNote mesh__D019384
% 216.18/216.38       Compounds that inhibit cell production of DNA or RNA.     
% 216.18/216.38  |- skos__historyNote mesh__D019384 RNA %28%1966-1996%29%
% 216.18/216.38  |- skos__historyNote mesh__D019384 Nucleic Acids %28%1971-1996%29%
% 216.18/216.38  |- mesh__recordOriginator mesh__D019384 TPW
% 216.18/216.38  |- rdf__type mesh__D019384sskos__Concept
% 216.18/216.38  |- skos__altLabel mesh__D019384 Inhibitors, RNA Synthesis
% 216.18/216.38  |- skos__altLabel mesh__D019384 Inhibitors, DNA Synthesis
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D019384 2006
% 216.18/216.38  |- skos__prefLabel mesh__D019384 Nucleic Acid Synthesis Inhibitors
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005364 1992
% 216.18/216.38  |- skos__historyNote mesh__D005364 Visual Perception %28%1966-1971%29%
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005364 2004
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005364 1999
% 216.18/216.38  |- skos__broader mesh__D005364smesh__D010465
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005364 2000
% 216.18/216.38  |- skos__prefLabel mesh__D005364 Field Dependence-Independence
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005364 1993
% 216.18/216.38  |- mesh__dateCreated mesh__D005364 1999-01-01
% 216.18/216.38  |- skos__hiddenLabel mesh__D005364 Field Dependence-Independences
% 216.18/216.38  |- mesh__recordAuthorizer mesh__D005364 PLS
% 216.18/216.38  |- skos__hiddenLabel mesh__D005364 Dependence-Independence, Field
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005364 2001
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005364 1996
% 216.18/216.38  |- mesh__recordOriginator mesh__D005364 NLM
% 216.18/216.38  |- mesh__publicMeSHNote mesh__D005364 72   
% 216.18/216.38  |- mesh__historyNote mesh__D005364 72   
% 216.18/216.38  |- skos__hiddenLabel mesh__D005364 Field Dependence Independence
% 216.18/216.38  |- rdf__type mesh__D005364sskos__Concept
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005364 2005
% 216.18/216.38  |- skos__historyNote mesh__D005364 Perception %28%1966-1971%29%
% 216.18/216.38  |- mesh__recordMaintainer mesh__D005364 TGC
% 216.18/216.38  |- skos__annotation mesh__D005364 no qualif   
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005364 1997
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005364 1994
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005364 2006
% 216.18/216.38  |- skos__broader mesh__D005364smesh__D014796
% 216.18/216.38  |- mesh__dateEstablished mesh__D005364 1972-01-01
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005364 2002
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005364 1995
% 216.18/216.38  |- mesh__dateRevised mesh__D005364 1991-06-11
% 216.18/216.38  |- skos__scopeNote mesh__D005364
% 216.18/216.38       The ability to respond to segments of the perceptual experience rather than to the whole.%A%    
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005364 2003
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005364 1998
% 216.18/216.38  |- skos__hiddenLabel mesh__D005364 Dependence-Independences, Field
% 216.18/216.38  |- mesh__recordOriginator mesh__D015792 EGC
% 216.18/216.38  |- skos__historyNote mesh__D015792 Retinal Degeneration %28%1970-1989%29%
% 216.18/216.38  |- mesh__recordMaintainer mesh__D015792 nns
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D015792 2006
% 216.18/216.38  |- mesh__recordAuthorizer mesh__D015792 sjn
% 216.18/216.38  |- skos__scopeNote mesh__D015792
% 216.18/216.38       Congenital, often bilateral, retinal abnormality characterized by the arrangement of outer nuclear retinal cells in a palisading or radiating pattern surrounding a central ocular space. This disorder is sometimes hereditary.%A%    
% 216.18/216.38  |- skos__annotation mesh__D015792
% 216.18/216.38       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D015792 2003
% 216.18/216.38  |- mesh__dateRevised mesh__D015792 2001-07-25
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D015792 2005
% 216.18/216.38  |- mesh__dateCreated mesh__D015792 1989-05-25
% 216.18/216.38  |- skos__hiddenLabel mesh__D015792 Retinal Dysplasias
% 216.18/216.38  |- skos__hiddenLabel mesh__D015792 Dysplasia, Retinal
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D015792 2002
% 216.18/216.38  |- skos__broader mesh__D015792smesh__D015785
% 216.18/216.38  |- mesh__historyNote mesh__D015792 90   
% 216.18/216.38  |- skos__historyNote mesh__D015792 Retina/abnormalities %28%1966-1989%29%
% 216.18/216.38  |- skos__broader mesh__D015792smesh__D012164
% 216.18/216.38  |- skos__broader mesh__D015792smesh__D005124
% 216.18/216.38  |- rdf__type mesh__D015792sskos__Concept
% 216.18/216.38  |- skos__prefLabel mesh__D015792 Retinal Dysplasia
% 216.18/216.38  |- skos__hiddenLabel mesh__D015792 Dysplasias, Retinal
% 216.18/216.38  |- mesh__dateEstablished mesh__D015792 1990-01-01
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D015792 2004
% 216.18/216.38  |- mesh__publicMeSHNote mesh__D015792 90   
% 216.18/216.38  |- rdf__type mesh__D051117sskos__Concept
% 216.18/216.38  |- skos__altLabel mesh__D051117 SR-A Proteins
% 216.18/216.38  |- skos__prefLabel mesh__D051117 Scavenger Receptors, Class A
% 216.18/216.38  |- skos__altLabel mesh__D051117
% 216.18/216.38       Macrophage Type-II Class-A Scavenger Receptor
% 216.18/216.38  |- mesh__publicMeSHNote mesh__D051117
% 216.18/216.38       2006; SCAVENGER RECEPTORS, CLASS A was indexed under RECEPTORS, IMMUNOLOGIC 2005; SCAVENGER RECEPTORS, CLASS A, TYPE I-II was indexed under RECEPTORS, IMMUNOLOGIC 2005, %26% under ANTIGENS, CD36 2001-2005; MACROPHAGE TYPE-II CLASS-A SCAVENGER RECEPTOR %26% MACROPHAGE TYPE-I CLASS-A SCAVENGER RECEPTOR were indexed under RECEPTORS, IMMUNOLOGIC 1994-2005 %26% under RECEPTORS, ENDOGENOUS SUBSTANCES 1993%A%  
% 216.18/216.38  |- mesh__recordAuthorizer mesh__D051117 sjn
% 216.18/216.38  |- mesh__historyNote mesh__D051117 2006%28%2005%29%   
% 216.18/216.38  |- skos__altLabel mesh__D051117 Scavenger Receptor Class A Type I-II
% 216.18/216.38  |- mesh__recordMaintainer mesh__D051117 DRC
% 216.18/216.38  |- skos__altLabel mesh__D051117 SR-AII Protein
% 216.18/216.38  |- skos__altLabel mesh__D051117 SR-AI Protein
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D051117 2006
% 216.18/216.38  |- skos__broader mesh__D051117smesh__D051116
% 216.18/216.38  |- skos__altLabel mesh__D051117
% 216.18/216.38       Macrophage Type-I Class-A Scavenger Receptor
% 216.18/216.38  |- mesh__recordOriginator mesh__D051117 DRC
% 216.18/216.38  |- skos__scopeNote mesh__D051117
% 216.18/216.38       A family of scavenger receptors that mediate the influx of LIPIDS into MACROPHAGES and are involved in FOAM CELL formation.%A%    
% 216.18/216.38  |- mesh__dateEstablished mesh__D051117 2006-01-01
% 216.18/216.38  |- skos__altLabel mesh__D051117 SR-AI-II Receptors
% 216.18/216.38  |- mesh__dateCreated mesh__D051117 2005-06-30
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D009755 1996
% 216.18/216.38  |- skos__prefLabel mesh__D009755 Night Blindness
% 216.18/216.38  |- skos__altLabel mesh__D009755 Nyctalopia
% 216.18/216.38  |- mesh__dateRevised mesh__D009755 1993-06-02
% 216.18/216.38  |- mesh__onlineNote mesh__D009755
% 216.18/216.38       use NIGHT BLINDNESS to search NYCTALOPIA 1966-89   
% 216.18/216.38  |- mesh__recordOriginator mesh__D009755 NLM
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D009755 2002
% 216.18/216.38  |- skos__hiddenLabel mesh__D009755 Blindness, Night
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D009755 2005
% 216.18/216.38  |- mesh__dateCreated mesh__D009755 1999-01-01
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D009755 1997
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D009755 1994
% 216.18/216.38  |- skos__broader mesh__D009755smesh__D014786
% 216.18/216.38  |- mesh__recordAuthorizer mesh__D009755 PLS
% 216.18/216.38  |- skos__scopeNote mesh__D009755
% 216.18/216.38       Failure or imperfection of vision at night or in dim light, with good vision only on bright days. %28%Dorland, 27th ed%29%%A%    
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D009755 2006
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D009755 1995
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D009755 2000
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D009755 1998
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D009755 2003
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D009755 2001
% 216.18/216.38  |- mesh__historyNote mesh__D009755
% 216.18/216.38       90; was NIGHT BLINDNESS see NYCTALOPIA 1963-89   
% 216.18/216.38  |- rdf__type mesh__D009755sskos__Concept
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D009755 1999
% 216.18/216.38  |- mesh__publicMeSHNote mesh__D009755
% 216.18/216.38       90; was NIGHT BLINDNESS see NYCTALOPIA 1963-89   
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D009755 2004
% 216.18/216.38  |- mesh__recordMaintainer mesh__D009755 TGC
% 216.18/216.38  |- skos__broader mesh__D001772smesh__D002452
% 216.18/216.38  |- skos__hiddenLabel mesh__D001772 Count, Blood Cell
% 216.18/216.38  |- skos__hiddenLabel mesh__D001772 Count, Complete Blood
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D001772 2006
% 216.18/216.38  |- skos__annotation mesh__D001772
% 216.18/216.38       GEN; prefer specifics;  %22%blood picture%22% probably goes here or under specifics; usually NIM; coord with disease /blood, not /physiopathol%A%  
% 216.18/216.38  |- mesh__dateRevised mesh__D001772 2003-07-09
% 216.18/216.38  |- skos__hiddenLabel mesh__D001772 Number, Blood Cell
% 216.18/216.38  |- skos__altLabel mesh__D001772 Blood Cell Number
% 216.18/216.38  |- skos__hiddenLabel mesh__D001772 Numbers, Blood Cell
% 216.18/216.38  |- skos__hiddenLabel mesh__D001772 Blood Counts, Complete
% 216.18/216.38  |- skos__hiddenLabel mesh__D001772 Counts, Complete Blood
% 216.18/216.38  |- skos__broader mesh__D001772smesh__D045122
% 216.18/216.38  |- rdf__type mesh__D001772sskos__Concept
% 216.18/216.38  |- skos__scopeNote mesh__D001772
% 216.18/216.38       The number of LEUKOCYTES and ERYTHROCYTES per unit volume in a sample of venous BLOOD. A complete blood count %28%CBC%29% also includes measurement of the HEMOGLOBIN; HEMATOCRIT; and ERYTHROCYTE INDICES.%A%    
% 216.18/216.38  |- skos__prefLabel mesh__D001772 Blood Cell Count
% 216.18/216.38  |- mesh__dateCreated mesh__D001772 1999-01-01
% 216.18/216.38  |- skos__hiddenLabel mesh__D001772 Blood Cell Numbers
% 216.18/216.38  |- mesh__recordMaintainer mesh__D001772 nns
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D001772 2004
% 216.18/216.38  |- skos__broader mesh__D001772smesh__D006403
% 216.18/216.38  |- mesh__recordOriginator mesh__D001772 NLM
% 216.18/216.38  |- skos__hiddenLabel mesh__D001772 Counts, Blood Cell
% 216.18/216.38  |- mesh__recordAuthorizer mesh__D001772 sjn
% 216.18/216.38  |- skos__hiddenLabel mesh__D001772 Complete Blood Counts
% 216.18/216.38  |- skos__hiddenLabel mesh__D001772 Blood Cell Counts
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D001772 2005
% 216.18/216.38  |- skos__hiddenLabel mesh__D001772 Complete Blood Count
% 216.18/216.38  |- skos__broader mesh__D001921Q000032smesh__D001921
% 216.18/216.38  |- mesh__preferredCombination mesh__D001921Q000032smesh__D001923
% 216.18/216.38  |- rdf__type mesh__D001921Q000032smesh__CompoundConcept
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005365 2001
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005365 2005
% 216.18/216.38  |- skos__altLabel mesh__D005365 Formiminoglutamic Acid Test
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005365 2004
% 216.18/216.38  |- skos__hiddenLabel mesh__D005365 Test, Formiminoglutamic Acid
% 216.18/216.38  |- mesh__recordAuthorizer mesh__D005365 sjn
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005365 2000
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005365 2003
% 216.18/216.38  |- skos__broader mesh__D005365smesh__D006403
% 216.18/216.38  |- skos__hiddenLabel mesh__D005365 Acid Test, Formiminoglutamic
% 216.18/216.38  |- skos__prefLabel mesh__D005365 FIGLU Test
% 216.18/216.38  |- mesh__dateEstablished mesh__D005365 1966-01-01
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005365 2002
% 216.18/216.38  |- skos__scopeNote mesh__D005365
% 216.18/216.38       A urine test for formiminoglutamic acid, an intermediate metabolite in L-histidine catabolism in the conversion of L-histidine to L-glutamic acid. It may be an indicator of vitamin B12 or folic acid deficiency or liver disease.%A%    
% 216.18/216.38  |- mesh__dateCreated mesh__D005365 1999-01-01
% 216.18/216.38  |- mesh__dateRevised mesh__D005365 1999-11-03
% 216.18/216.38  |- skos__hiddenLabel mesh__D005365 Test, FIGLU
% 216.18/216.38  |- skos__hiddenLabel mesh__D005365 FIGLU Tests
% 216.18/216.38  |- rdf__type mesh__D005365sskos__Concept
% 216.18/216.38  |- skos__hiddenLabel mesh__D005365 Acid Tests, Formiminoglutamic
% 216.18/216.38  |- mesh__historyNote mesh__D005365 66%28%64%29%   
% 216.18/216.38  |- mesh__recordOriginator mesh__D005365 NLM
% 216.18/216.38  |- mesh__publicMeSHNote mesh__D005365 66   
% 216.18/216.38  |- mesh__recordMaintainer mesh__D005365 KEV
% 216.18/216.38  |- skos__hiddenLabel mesh__D005365 Tests, FIGLU
% 216.18/216.38  |- skos__hiddenLabel mesh__D005365 Tests, Formiminoglutamic Acid
% 216.18/216.38  |- skos__hiddenLabel mesh__D005365 Formiminoglutamic Acid Tests
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D005365 2006
% 216.18/216.38  |- mesh__dateEstablished mesh__D043484 2004-01-01
% 216.18/216.38  |- skos__altLabel mesh__D043484 Pro-Opiocortin Converting Protease
% 216.18/216.38  |- skos__hiddenLabel mesh__D043484 Convertases, Proprotein
% 216.18/216.38  |- skos__historyNote mesh__D043484
% 216.18/216.38       Aspartic Endopeptidases %28%1994-2003%29%
% 216.18/216.38  |- mesh__recordMaintainer mesh__D043484 AKE
% 216.18/216.38  |- skos__altLabel mesh__D043484 Proprotein Convertase
% 216.18/216.38  |- skos__hiddenLabel mesh__D043484 Convertases, Prohormone
% 216.18/216.38  |- mesh__historyNote mesh__D043484
% 216.18/216.38       2004; use PROPROTEIN CONVERTASES %28%NM%29% 2002-2003; for PRO-OPIOMELANOCORTIN CONVERTING ENZYME use PROPROTEIN CONVERTASES %28%NM%29% 1982-2003%A%  
% 216.18/216.38  |- skos__hiddenLabel mesh__D043484 Subtilisin Like Proprotein Convertases
% 216.18/216.38  |- skos__altLabel mesh__D043484 Prohormone Convertase
% 216.18/216.38  |- mesh__recordAuthorizer mesh__D043484 sjn
% 216.18/216.38  |- skos__prefLabel mesh__D043484 Proprotein Convertases
% 216.18/216.38  |- skos__hiddenLabel mesh__D043484 Convertase, Proopiomelanocortin
% 216.18/216.38  |- skos__hiddenLabel mesh__D043484 Pro Opiocortin Converting Enzyme
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D043484 2004
% 216.18/216.38  |- skos__altLabel mesh__D043484 Pro-Opiocortin Converting Enzyme
% 216.18/216.38  |- skos__hiddenLabel mesh__D043484 POMC Converting Enzyme
% 216.18/216.38  |- skos__hiddenLabel mesh__D043484 Pro Opiomelanocortin Converting Enzyme
% 216.18/216.38  |- skos__hiddenLabel mesh__D043484 Convertase, POMC
% 216.18/216.38  |- skos__historyNote mesh__D043484 Subtilisins %28%2002-2003%29%
% 216.18/216.38  |- skos__altLabel mesh__D043484 POMC-Converting Enzyme
% 216.18/216.38  |- skos__hiddenLabel mesh__D043484 Proprotein Convertases, Subtilisin-Like
% 216.18/216.38  |- rdf__type mesh__D043484sskos__Concept
% 216.18/216.38  |- skos__hiddenLabel mesh__D043484 Pro Opiocortin Converting Protease
% 216.18/216.38  |- skos__hiddenLabel mesh__D043484 Convertase, Proprotein
% 216.18/216.38  |- mesh__dateCreated mesh__D043484 2003-07-22
% 216.18/216.38  |- skos__altLabel mesh__D043484 POMC Enzyme
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D043484 2005
% 216.18/216.38  |- skos__hiddenLabel mesh__D043484 Converting Protease, Pro-Opiocortin
% 216.18/216.38  |- skos__hiddenLabel mesh__D043484 Convertases, Subtilisin-Like Proprotein
% 216.18/216.38  |- mesh__publicMeSHNote mesh__D043484
% 216.18/216.38       2004; PROPROTEIN COVERTASES was indexed under SUBSTILISINS 2002-2003; PRO-OPIOMELANOCORTIN CONVERTING ENZYME was indexed under ASPARTIC ENDOPEPTIDASES 1994-2003, under PEPTIDE PEPTIDOHYDROLASES 1982-1993%A%  
% 216.18/216.38  |- mesh__recordOriginator mesh__D043484 AKE
% 216.18/216.38  |- skos__altLabel mesh__D043484 POMC Convertase
% 216.18/216.38  |- skos__altLabel mesh__D043484 Proopiomelanocortin Convertase
% 216.18/216.38  |- skos__hiddenLabel mesh__D043484 Converting Enzyme, Pro-Opiomelanocortin
% 216.18/216.38  |- skos__hiddenLabel mesh__D043484 Convertase, Prohormone
% 216.18/216.38  |- skos__historyNote mesh__D043484
% 216.18/216.38       Peptide Peptidohydrolases %28%1982-1993%29%
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D043484 2006
% 216.18/216.38  |- skos__hiddenLabel mesh__D043484 Converting Enzyme, Pro-Opiocortin
% 216.18/216.38  |- skos__scopeNote mesh__D043484
% 216.18/216.38       Proteolytic enzymes that are involved in the conversion of protein precursors such as peptide prohormones into PEPTIDE HORMONES. Some are ENDOPEPTIDASES, some are EXOPEPTIDASES.%A%    
% 216.18/216.38  |- skos__broader mesh__D043484smesh__D010447
% 216.18/216.38  |- skos__scopeNote mesh__D051916
% 216.18/216.38       A ubiquitously expressed complement receptor that binds COMPLEMENT C3B and COMPLEMENT C4B and serves as a cofactor for their inactivation. CD46 also interacts with a wide variety of pathogens and mediates immune response.%A%    
% 216.18/216.38  |- skos__altLabel mesh__D051916 CD46 Antigen
% 216.18/216.38  |- mesh__recordMaintainer mesh__D051916 DRC
% 216.18/216.38  |- skos__broader mesh__D051916smesh__D015703
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D051916 2006
% 216.18/216.38  |- rdf__type mesh__D051916sskos__Concept
% 216.18/216.38  |- mesh__recordAuthorizer mesh__D051916 sjn
% 216.18/216.38  |- skos__altLabel mesh__D051916 Trophoblast-Leukocyte Common Antigen
% 216.18/216.38  |- skos__hiddenLabel mesh__D051916 Trophoblast Leukocyte Common Antigen
% 216.18/216.38  |- skos__broader mesh__D051916smesh__D003169
% 216.18/216.38  |- skos__altLabel mesh__D051916 Membrane Cofactor Protein
% 216.18/216.38  |- mesh__dateCreated mesh__D051916 2005-06-30
% 216.18/216.38  |- mesh__publicMeSHNote mesh__D051916
% 216.18/216.38       2006; ANTIGENS, CD46 was indexed under MEMBRANE GLYCOPROTEINS 1988-2005, %26% under ANTIGENS, CD 1992-2005, %26% under ANTIGENS, DIFFERENTIATION 1990-1991, %26% under MEMBRANE PROTEINS 1987%A%  
% 216.18/216.38  |- mesh__dateEstablished mesh__D051916 2006-01-01
% 216.18/216.38  |- skos__altLabel mesh__D051916 CD46 Antigens
% 216.18/216.38  |- skos__prefLabel mesh__D051916 Antigens, CD46
% 216.18/216.38  |- skos__broader mesh__D051916smesh__D011951
% 216.18/216.38  |- skos__hiddenLabel mesh__D051916 Common Antigen, Trophoblast-Leukocyte
% 216.18/216.38  |- mesh__historyNote mesh__D051916 2006%28%1987%29%   
% 216.18/216.38  |- skos__hiddenLabel mesh__D051916 Antigen, CD46
% 216.18/216.38  |- mesh__recordOriginator mesh__D051916 DRC
% 216.18/216.38  |- mesh__recordOriginator mesh__D015793 AGS
% 216.18/216.38  |- mesh__recordAuthorizer mesh__D015793 sjn
% 216.18/216.38  |- skos__historyNote mesh__D015793 HLA-B Antigens %28%1989%29%
% 216.18/216.38  |- skos__annotation mesh__D015793
% 216.18/216.38       assoc with narcolepsy %26% hemochromatosis; DF: HLA B7   
% 216.18/216.38  |- skos__broader mesh__D015793smesh__D015235
% 216.18/216.38  |- rdf__type mesh__D015793sskos__Concept
% 216.18/216.38  |- skos__hiddenLabel mesh__D015793 Antigen, HLA-B7
% 216.18/216.38  |- mesh__dateRevised mesh__D015793 2005-06-30
% 216.18/216.38  |- skos__prefLabel mesh__D015793 HLA-B7 Antigen
% 216.18/216.38  |- skos__scopeNote mesh__D015793
% 216.18/216.38       Human histocompatibility %28%HLA%29% surface antigen encoded by the B locus on chromosome 6. There is a weak association between the presence of the HLA-B7 antigen and the diseases of narcolepsy and idiopathic hemochromatosis. HLA-B7 is in linkage disequilibrium with HLA-A3 and HLA-DR2.%A%    
% 216.18/216.38  |- mesh__historyNote mesh__D015793 90   
% 216.18/216.38  |- skos__historyNote mesh__D015793 HLA Antigens %28%1972-1988%29%
% 216.18/216.38  |- mesh__dateEstablished mesh__D015793 1990-01-01
% 216.18/216.38  |- mesh__recordMaintainer mesh__D015793 ssb
% 216.18/216.38  |- mesh__dateCreated mesh__D015793 1989-05-15
% 216.18/216.38  |- skos__altLabel mesh__D015793 HLA-B7
% 216.18/216.38  |- mesh__publicMeSHNote mesh__D015793 90   
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D015793 2006
% 216.18/216.38  |- skos__hiddenLabel mesh__D015793 HLA B7 Antigen
% 216.18/216.38  |- mesh__dateCreated mesh__D009756 1999-01-01
% 216.18/216.38  |- mesh__dateEstablished mesh__D009756 1973-01-01
% 216.18/216.38  |- skos__historyNote mesh__D009756 Amino Alcohols %28%1966-1971%29%
% 216.18/216.38  |- skos__historyNote mesh__D009756 Sympathomimetics %28%1966-1971%29%
% 216.18/216.38  |- mesh__activeMeSHYear mesh__D009756 2006
% 216.18/216.39  |- skos__scopeNote mesh__D009756
% 216.18/216.39       A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.%A%    
% 216.18/216.39  |- mesh__recordOriginator mesh__D009756 NLM
% 216.18/216.39  |- mesh__historyNote mesh__D009756 73%28%72%29%   
% 216.18/216.39  |- skos__altLabel mesh__D009756 Buphenin
% 216.18/216.39  |- mesh__recordMaintainer mesh__D009756 ssb
% 216.18/216.39  |- skos__broader mesh__D009756smesh__D010627
% 216.18/216.39  |- skos__prefLabel mesh__D009756 Nylidrin
% 216.18/216.39  |- skos__broader mesh__D009756smesh__D010665
% 216.18/216.39  |- skos__altLabel mesh__D009756 Bufenine
% 216.18/216.39  |- rdf__type mesh__D009756sskos__Concept
% 216.18/216.39  |- mesh__recordAuthorizer mesh__D009756 sjn
% 216.18/216.39  |- mesh__publicMeSHNote mesh__D009756 73   
% 216.18/216.39  |- skos__hiddenLabel mesh__D009756 Hydrochloride, Nylidrin
% 216.18/216.39  |- mesh__dateRevised mesh__D009756 2005-06-30
% 216.18/216.39  |- skos__altLabel mesh__D009756 Fardi Brand of Buphenine Hydrochloride
% 216.18/216.39  |- skos__broader mesh__D009756smesh__D011412
% 216.18/216.39  |- skos__altLabel mesh__D009756 Aventis Brand of Buphenine Hydrochloride
% 216.18/216.39  |- skos__altLabel mesh__D009756 Buphenine
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001773 1996
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001773 1995
% 216.18/216.39  |- mesh__recordAuthorizer mesh__D001773 PLS
% 216.18/216.39  |- mesh__recordMaintainer mesh__D001773 TGC
% 216.18/216.39  |- skos__hiddenLabel mesh__D001773 Cells, Blood
% 216.18/216.39  |- skos__hiddenLabel mesh__D001773 Blood Cell
% 216.18/216.39  |- mesh__recordOriginator mesh__D001773 NLM
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001773 2002
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001773 1994
% 216.18/216.39  |- skos__broader mesh__D001773smesh__D001769
% 216.18/216.39  |- skos__hiddenLabel mesh__D001773 Cell, Blood
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001773 2006
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001773 1999
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001773 2001
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001773 1993
% 216.18/216.39  |- mesh__dateCreated mesh__D001773 1999-01-01
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001773 2005
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001773 1998
% 216.18/216.39  |- mesh__dateRevised mesh__D001773 1991-08-23
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001773 2000
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001773 1992
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001773 2004
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001773 1997
% 216.18/216.39  |- rdf__type mesh__D001773sskos__Concept
% 216.18/216.39  |- skos__prefLabel mesh__D001773 Blood Cells
% 216.18/216.39  |- skos__annotation mesh__D001773
% 216.18/216.39       GEN; %22%blood picture%22% probably goes here or under BLOOD CELL COUNT; A 11 qualif%A%  
% 216.18/216.39  |- skos__broader mesh__D001773smesh__D002477
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001773 2003
% 216.18/216.39  |- mesh__publicMeSHNote mesh__D019386
% 216.18/216.39       97; ALENDRONATE was indexed under DIPHOSPHONATES 1987-96   
% 216.18/216.39  |- mesh__historyNote mesh__D019386
% 216.18/216.39       97; was ALENDRONATE %28%NM%29% 1987-96   
% 216.18/216.39  |- skos__broader mesh__D019386smesh__D004164
% 216.18/216.39  |- skos__altLabel mesh__D019386 Alendronate Monosodium Salt, Trihydrate
% 216.18/216.39  |- skos__altLabel mesh__D019386 Aminohydroxybutane Bisphosphonate
% 216.18/216.39  |- mesh__dateCreated mesh__D019386 1996-06-10
% 216.18/216.39  |- skos__prefLabel mesh__D019386 Alendronate
% 216.18/216.39  |- mesh__onlineNote mesh__D019386
% 216.18/216.39       use ALENDRONATE %28%NM%29% to search ALENDRONATE 1987-96   
% 216.18/216.39  |- skos__hiddenLabel mesh__D019386 Sodium, Alendronate
% 216.18/216.39  |- skos__altLabel mesh__D019386
% 216.18/216.39       4-Amino-1-Hydroxybutylidene 1,1-Biphosphonate
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D019386 2006
% 216.18/216.39  |- mesh__recordOriginator mesh__D019386 TPW
% 216.18/216.39  |- rdf__type mesh__D019386sskos__Concept
% 216.18/216.39  |- mesh__recordAuthorizer mesh__D019386 sjn
% 216.18/216.39  |- mesh__dateRevised mesh__D019386 2005-06-30
% 216.18/216.39  |- skos__hiddenLabel mesh__D019386 MK 217
% 216.18/216.39  |- skos__hiddenLabel mesh__D019386 Bisphosphonate, Aminohydroxybutane
% 216.18/216.39  |- skos__historyNote mesh__D019386 Diphosphonates %28%1987-1996%29%
% 216.18/216.39  |- skos__scopeNote mesh__D019386
% 216.18/216.39       A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.%A%    
% 216.18/216.39  |- mesh__recordMaintainer mesh__D019386 ssb
% 216.18/216.39  |- skos__hiddenLabel mesh__D019386
% 216.18/216.39       4 Amino 1 Hydroxybutylidene 1,1 Biphosphonate
% 216.18/216.39  |- skos__hiddenLabel mesh__D019386 MK217
% 216.18/216.39  |- mesh__dateEstablished mesh__D019386 1997-01-01
% 216.18/216.39  |- mesh__recordOriginator mesh__D005366 NLM
% 216.18/216.39  |- skos__prefLabel mesh__D005366 Figural Aftereffect
% 216.18/216.39  |- skos__hiddenLabel mesh__D005366 Figural Aftereffects
% 216.18/216.39  |- mesh__recordMaintainer mesh__D005366 nns
% 216.18/216.39  |- skos__broader mesh__D005366smesh__D043722
% 216.18/216.39  |- mesh__recordAuthorizer mesh__D005366 sjn
% 216.18/216.39  |- mesh__dateCreated mesh__D005366 1999-01-01
% 216.18/216.39  |- skos__hiddenLabel mesh__D005366 Aftereffects, Figural
% 216.18/216.39  |- mesh__dateRevised mesh__D005366 2003-07-09
% 216.18/216.39  |- rdf__type mesh__D005366sskos__Concept
% 216.18/216.39  |- skos__broader mesh__D005366smesh__D014796
% 216.18/216.39  |- skos__scopeNote mesh__D005366
% 216.18/216.39       A perceptual phenomenon used by Gestalt psychologists to demonstrate that events in one part of the perceptual field may affect perception in another part.%A%    
% 216.18/216.39  |- skos__altLabel mesh__D005366 Aftereffect, Figural
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D005366 2006
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D005366 2005
% 216.18/216.39  |- skos__annotation mesh__D005366
% 216.18/216.39       usually involves displacement of afterimage of geometric pattern in shape %26% space: differentiate from AFTERIMAGE; while both are in the field of perception, AFTERIMAGE is likely to be in ophthalmol jrnls, FIGURAL AFTEREFFECT, in psychol jrnls%A%  
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D005366 2004
% 216.18/216.39  |- mesh__dateCreated mesh__D043485 2003-07-09
% 216.18/216.39  |- mesh__publicMeSHNote mesh__D043485
% 216.18/216.39       2004; see PARAGANGLIA, NONCHROMAFFIN 1994-2003   
% 216.18/216.39  |- skos__historyNote mesh__D043485
% 216.18/216.39       Paraganglioma, Extra-Adrenal %28%1965-2003%29%
% 216.18/216.39  |- skos__prefLabel mesh__D043485 Glomus Tympanicum
% 216.18/216.39  |- skos__hiddenLabel mesh__D043485 Tympanicum, Glomus
% 216.18/216.39  |- skos__scopeNote mesh__D043485
% 216.18/216.39       A highly vascular ovoid body of chemoreceptive tissue lying adjacent to the TYMPANIC CAVITY. It is derived from NEURAL CREST tissue and is considered part of the diffuse neuroendocrine system.  It is the site of a rare neoplasm called a GLOMUS TYMPANICUM TUMOR.%A%    
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D043485 2006
% 216.18/216.39  |- skos__historyNote mesh__D043485
% 216.18/216.39       Paraganglia, Nonchromaffin %28%1989-2003%29%
% 216.18/216.39  |- mesh__dateEstablished mesh__D043485 2004-01-01
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D043485 2005
% 216.18/216.39  |- mesh__historyNote mesh__D043485
% 216.18/216.39       2004; use PARAGANGLIA, NONCHROMAFFIN 1994-2003   
% 216.18/216.39  |- skos__broader mesh__D043485smesh__D010234
% 216.18/216.39  |- rdf__type mesh__D043485sskos__Concept
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D043485 2004
% 216.18/216.39  |- skos__broader mesh__D043485smesh__D004432
% 216.18/216.39  |- mesh__recordOriginator mesh__D010500 EC
% 216.18/216.39  |- rdf__type mesh__D010500sskos__Concept
% 216.18/216.39  |- skos__prefLabel mesh__D010500 Perinatology
% 216.18/216.39  |- skos__related mesh__D010500smesh__D016389
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010500 2002
% 216.18/216.39  |- skos__related mesh__D010500smesh__D007232
% 216.18/216.39  |- skos__broader mesh__D010500smesh__D010372
% 216.18/216.39  |- mesh__dateEstablished mesh__D010500 1977-01-01
% 216.18/216.39  |- skos__historyNote mesh__D010500 Pediatrics %28%1966-1976%29%
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010500 1998
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010500 2005
% 216.18/216.39  |- mesh__dateRevised mesh__D010500 1997-06-20
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010500 1999
% 216.18/216.39  |- skos__historyNote mesh__D010500 Obstetrics %28%1966-1976%29%
% 216.18/216.39  |- skos__annotation mesh__D010500
% 216.18/216.39       = fetus + newborn inf: differentiate from NEONATOLOGY, the newborn inf only; SPEC: SPEC qualif; DF: PERINATOL%A%  
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010500 2003
% 216.18/216.39  |- mesh__recordAuthorizer mesh__D010500 SJN
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010500 2006
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010500 2000
% 216.18/216.39  |- mesh__historyNote mesh__D010500 77   
% 216.18/216.39  |- skos__scopeNote mesh__D010500
% 216.18/216.39       The branch of medicine dealing with the fetus and infant during the perinatal period. The perinatal period begins with the twenty-eighth week of gestation and ends twenty-eight days after birth. %28%From Dorland, 27th ed%29%%A%    
% 216.18/216.39  |- skos__related mesh__D010500smesh__D011248
% 216.18/216.39  |- mesh__publicMeSHNote mesh__D010500 77   
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010500 2004
% 216.18/216.39  |- skos__related mesh__D010500smesh__D005315
% 216.18/216.39  |- skos__related mesh__D010500smesh__D018743
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010500 2001
% 216.18/216.39  |- mesh__recordMaintainer mesh__D010500 PXP
% 216.18/216.39  |- mesh__dateCreated mesh__D010500 1976-04-13
% 216.18/216.39  |- rdf__type mesh__D051917sskos__Concept
% 216.18/216.39  |- skos__altLabel mesh__D051917 Leukocyte Sialoglycoprotein
% 216.18/216.39  |- mesh__dateCreated mesh__D051917 2005-06-30
% 216.18/216.39  |- skos__broader mesh__D051917smesh__D012795
% 216.18/216.39  |- skos__prefLabel mesh__D051917 Antigens, CD43
% 216.18/216.39  |- skos__broader mesh__D051917smesh__D052116
% 216.18/216.39  |- skos__scopeNote mesh__D051917
% 216.18/216.39       A sialic acid-rich protein and an integral cell membrane mucin. It plays an important role in activation of T-LYMPHOCYTES.%A%    
% 216.18/216.39  |- skos__hiddenLabel mesh__D051917 Sialoglycoprotein, Leukocyte
% 216.18/216.39  |- mesh__recordMaintainer mesh__D051917 DRC
% 216.18/216.39  |- mesh__historyNote mesh__D051917 2006%28%1984%29%   
% 216.18/216.39  |- skos__broader mesh__D051917smesh__D015703
% 216.18/216.39  |- skos__altLabel mesh__D051917 CD43 Antigens
% 216.18/216.39  |- mesh__recordOriginator mesh__D051917 DRC
% 216.18/216.39  |- skos__altLabel mesh__D051917 CD43 Antigen
% 216.18/216.39  |- skos__altLabel mesh__D051917 Leukosialin
% 216.18/216.39  |- skos__hiddenLabel mesh__D051917 Antigen, CD43
% 216.18/216.39  |- mesh__publicMeSHNote mesh__D051917
% 216.18/216.39       2006; ANTIGENS, CD43 was indexed under SIALOGLYCOPROTEINS %26% ANTIGENS, CD 1984-2005%A%  
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D051917 2006
% 216.18/216.39  |- mesh__recordAuthorizer mesh__D051917 sjn
% 216.18/216.39  |- skos__altLabel mesh__D051917 Sialophorin
% 216.18/216.39  |- mesh__dateEstablished mesh__D051917 2006-01-01
% 216.18/216.39  |- skos__related mesh__D015794smesh__D009755
% 216.18/216.39  |- skos__prefLabel mesh__D015794 Choroideremia
% 216.18/216.39  |- rdf__type mesh__D015794sskos__Concept
% 216.18/216.39  |- skos__historyNote mesh__D015794
% 216.18/216.39       Uveal Diseases/genetics %28%1977-1989%29%
% 216.18/216.39  |- skos__historyNote mesh__D015794 Choroid %28%1966-1989%29%
% 216.18/216.39  |- skos__annotation mesh__D015794
% 216.18/216.39       of the eye, not of the choroid plexus: progressive degen in male, nonprogressive in female%A%  
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D015794 2004
% 216.18/216.39  |- skos__broader mesh__D015794smesh__D040181
% 216.18/216.39  |- mesh__recordMaintainer mesh__D015794 nns
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D015794 2006
% 216.18/216.39  |- skos__historyNote mesh__D015794 Eye Diseases %28%1966-1974%29%
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D015794 2003
% 216.18/216.39  |- mesh__dateEstablished mesh__D015794 1990-01-01
% 216.18/216.39  |- mesh__recordOriginator mesh__D015794 EGC
% 216.18/216.39  |- skos__scopeNote mesh__D015794
% 216.18/216.39       An X chromosome-linked abnormality characterized by atrophy of the choroid and degeneration of the retinal pigment epithelium causing night blindness.%A%    
% 216.18/216.39  |- mesh__publicMeSHNote mesh__D015794 90   
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D015794 2005
% 216.18/216.39  |- mesh__recordAuthorizer mesh__D015794 sjn
% 216.18/216.39  |- mesh__dateCreated mesh__D015794 1989-05-25
% 216.18/216.39  |- mesh__dateRevised mesh__D015794 2002-07-03
% 216.18/216.39  |- skos__broader mesh__D015794smesh__D015785
% 216.18/216.39  |- mesh__historyNote mesh__D015794 90   
% 216.18/216.39  |- skos__broader mesh__D015794smesh__D015862
% 216.18/216.39  |- skos__hiddenLabel mesh__D015794 Choroideremias
% 216.18/216.39  |- mesh__recordAuthorizer mesh__D048170 sjn
% 216.18/216.39  |- mesh__recordMaintainer mesh__D048170 SYSTEM
% 216.18/216.39  |- skos__historyNote mesh__D048170 Streptomyces %28%1975-2004%29%
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D048170 2006
% 216.18/216.39  |- skos__broader mesh__D048170smesh__D013302
% 216.18/216.39  |- rdf__type mesh__D048170sskos__Concept
% 216.18/216.39  |- mesh__recordOriginator mesh__D048170 ags
% 216.18/216.39  |- mesh__dateCreated mesh__D048170 2004-07-07
% 216.18/216.39  |- skos__prefLabel mesh__D048170 Streptomyces lividans
% 216.18/216.39  |- mesh__historyNote mesh__D048170 2005   
% 216.18/216.39  |- mesh__publicMeSHNote mesh__D048170 2005   
% 216.18/216.39  |- mesh__dateEstablished mesh__D048170 2005-01-01
% 216.18/216.39  |- skos__scopeNote mesh__D048170
% 216.18/216.39       An actinomycete used for production of commercial ANTIBIOTICS and as a host for gene cloning.%A%    
% 216.18/216.39  |- mesh__dateRevised mesh__D048170 2005-06-30
% 216.18/216.39  |- mesh__recordMaintainer mesh__D009757 jmp
% 216.18/216.39  |- mesh__recordAuthorizer mesh__D009757 sjn
% 216.18/216.39  |- skos__altLabel mesh__D009757 Nylon
% 216.18/216.39  |- skos__altLabel mesh__D009757 Polyamides
% 216.18/216.39  |- skos__prefLabel mesh__D009757 Nylons
% 216.18/216.39  |- skos__hiddenLabel mesh__D009757 Ethilons
% 216.18/216.39  |- skos__hiddenLabel mesh__D009757 Dermalons
% 216.18/216.39  |- mesh__dateRevised mesh__D009757 2004-07-07
% 216.18/216.39  |- mesh__dateCreated mesh__D009757 1999-01-01
% 216.18/216.39  |- skos__broader mesh__D009757smesh__D010969
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D009757 2006
% 216.18/216.39  |- skos__scopeNote mesh__D009757
% 216.18/216.39       Polymers where the main polymer chain comprises recurring amide groups. These compounds are generally formed from combinations of diamines, diacids, and amino acids and yield fibers, sheeting, or extruded forms used in textiles, gels, filters, sutures, contact lenses, and other biomaterials.%A%    
% 216.18/216.39  |- skos__broader mesh__D009757smesh__D013784
% 216.18/216.39  |- skos__broader mesh__D009757smesh__D008420
% 216.18/216.39  |- skos__altLabel mesh__D009757 Polyamide
% 216.18/216.39  |- mesh__historyNote mesh__D009757 80; was NYLON in Cat D %26% J 1963-79   
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D009757 2005
% 216.18/216.39  |- mesh__recordOriginator mesh__D009757 NLM
% 216.18/216.39  |- mesh__publicMeSHNote mesh__D009757 80; was NYLON 1963-79   
% 216.18/216.39  |- rdf__type mesh__D009757sskos__Concept
% 216.18/216.39  |- mesh__onlineNote mesh__D009757 use NYLONS to search NYLON 1966-79   
% 216.18/216.39  |- skos__annotation mesh__D009757 D25-26 qualif   
% 216.18/216.39  |- mesh__dateRevised mesh__D001774 1997-06-20
% 216.18/216.39  |- skos__hiddenLabel mesh__D001774 Chemical Analyses, Blood
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001774 2006
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001774 1999
% 216.18/216.39  |- skos__hiddenLabel mesh__D001774 Analyses, Blood Chemical
% 216.18/216.39  |- mesh__recordMaintainer mesh__D001774 PXP
% 216.18/216.39  |- mesh__dateCreated mesh__D001774 1999-01-01
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001774 2005
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001774 1998
% 216.18/216.39  |- mesh__recordOriginator mesh__D001774 NLM
% 216.18/216.39  |- skos__altLabel mesh__D001774 Chemical Analysis, Blood
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001774 2002
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001774 2004
% 216.18/216.39  |- skos__hiddenLabel mesh__D001774 Blood Chemical Analyses
% 216.18/216.39  |- rdf__type mesh__D001774sskos__Concept
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001774 2001
% 216.18/216.39  |- skos__broader mesh__D001774smesh__D019963
% 216.18/216.39  |- skos__prefLabel mesh__D001774 Blood Chemical Analysis
% 216.18/216.39  |- skos__altLabel mesh__D001774 Analysis, Blood Chemical
% 216.18/216.39  |- mesh__recordAuthorizer mesh__D001774 SJN
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001774 2003
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001774 2000
% 216.18/216.39  |- skos__annotation mesh__D001774
% 216.18/216.39       GEN only: prefer specific substance with /blood; emphasis is on technique: not for %22%blood chemistry%22%; when general %26% IM, qualif permitted; when not to use: Manual 25.14.3 %26% TN 25%A%  
% 216.18/216.39  |- mesh__recordAuthorizer mesh__D020130 sjn
% 216.18/216.39  |- mesh__historyNote mesh__D020130 1999%28%1966%29%   
% 216.18/216.39  |- mesh__dateCreated mesh__D020130 1998-06-18
% 216.18/216.39  |- mesh__dateEstablished mesh__D020130 1999-01-01
% 216.18/216.39  |- mesh__recordOriginator mesh__D020130 NNS
% 216.18/216.39  |- skos__broader mesh__D020130smesh__D015388
% 216.18/216.39  |- skos__prefLabel mesh__D020130 Bacterial Chromatophores
% 216.18/216.39  |- skos__scopeNote mesh__D020130
% 216.18/216.39       Organelles of phototrophic bacteria which contain photosynthetic pigments and which are formed from an invagination of the cytoplasmic membrane.%A%    
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D020130 2006
% 216.18/216.39  |- mesh__dateRevised mesh__D020130 2003-07-09
% 216.18/216.39  |- rdf__type mesh__D020130sskos__Concept
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D020130 2005
% 216.18/216.39  |- mesh__recordMaintainer mesh__D020130 ags
% 216.18/216.39  |- mesh__publicMeSHNote mesh__D020130
% 216.18/216.39       1999; see PHOTOTROPHIC BACTERIA or specifics %26% CHROMATOPHORES 1966-1998%A%  
% 216.18/216.39  |- skos__hiddenLabel mesh__D020130 Bacterial Chromatophore
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D020130 2004
% 216.18/216.39  |- skos__altLabel mesh__D020130 Chromatophores, Bacterial
% 216.18/216.39  |- skos__hiddenLabel mesh__D020130 Chromatophore, Bacterial
% 216.18/216.39  |- skos__prefLabel mesh__D038541 Neisseria meningitidis, Serogroup B
% 216.18/216.39  |- skos__altLabel mesh__D038541 Meningococci, Serogroup B
% 216.18/216.39  |- mesh__dateRevised mesh__D038541 2005-06-30
% 216.18/216.39  |- skos__altLabel mesh__D038541 Meningococcus, Serogroup B
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D038541 2006
% 216.18/216.39  |- mesh__recordMaintainer mesh__D038541 SYSTEM
% 216.18/216.39  |- skos__scopeNote mesh__D038541
% 216.18/216.39       Strains of Neisseria meningitidis which are the most common ones causing infections or disease in infants. Serogroup B strains are isolated most frequently in sporadic cases, and are less common in outbreaks and epidemics.%A%    
% 216.18/216.39  |- rdf__type mesh__D038541sskos__Concept
% 216.18/216.39  |- mesh__dateEstablished mesh__D038541 2003-01-01
% 216.18/216.39  |- mesh__historyNote mesh__D038541 2003   
% 216.18/216.39  |- skos__annotation mesh__D038541
% 216.18/216.39       infection: coord IM with MENINGITIS, MENINGOCOCCAL %28%IM%29% or, if not meningitis, MENINGOCOCCAL INFECTIONS %28%IM%29%%A%  
% 216.18/216.39  |- skos__historyNote mesh__D038541 Neisseria meningitidis %28%1972-2002%29%
% 216.18/216.39  |- mesh__publicMeSHNote mesh__D038541 2003   
% 216.18/216.39  |- mesh__dateCreated mesh__D038541 2002-07-03
% 216.18/216.39  |- mesh__recordOriginator mesh__D038541 ags
% 216.18/216.39  |- mesh__recordAuthorizer mesh__D038541 sjn
% 216.18/216.39  |- skos__broader mesh__D038541smesh__D009345
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D005367 1998
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D005367 1997
% 216.18/216.39  |- rdf__type mesh__D005367sskos__Concept
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D005367 1996
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D005367 2002
% 216.18/216.39  |- mesh__dateRevised mesh__D005367 1995-06-08
% 216.18/216.39  |- mesh__recordOriginator mesh__D005367 NLM
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D005367 2006
% 216.18/216.39  |- skos__scopeNote mesh__D005367
% 216.18/216.39       A republic consisting of an island group in Melanesia, in the southwest Pacific Ocean. Its capital is Suva. It was discovered by Abel Tasman in 1643 and was visited by Captain Cook in 1774. It was used by escaped convicts from Australia as early as 1804. It was annexed by Great Britain in 1874 but achieved independence in 1970. The name Fiji is of uncertain origin. In its present form it may represent that of Viti, the main island in the group. %28%From Webster%27%s New Geographical Dictionary, 1988, p396 %26% Room, Brewer%27%s Dictionary of Names, 1992, p186%29%%A%    
% 216.18/216.39  |- skos__annotation mesh__D005367 an island group in Melanesia   
% 216.18/216.39  |- skos__broader mesh__D005367smesh__D008542
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D005367 2005
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D005367 2004
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D005367 2001
% 216.18/216.39  |- mesh__dateCreated mesh__D005367 1974-11-11
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D005367 2003
% 216.18/216.39  |- skos__prefLabel mesh__D005367 Fiji
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D005367 1999
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D005367 2000
% 216.18/216.39  |- mesh__dateEstablished mesh__D005367 1975-01-01
% 216.18/216.39  |- mesh__recordMaintainer mesh__D005367 TGC
% 216.18/216.39  |- mesh__historyNote mesh__D005367 75   
% 216.18/216.39  |- mesh__recordAuthorizer mesh__D005367 PLS
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D024521 2006
% 216.18/216.39  |- skos__related mesh__D024521smesh__D019581
% 216.18/216.39  |- skos__broader mesh__D024521smesh__D000825
% 216.18/216.39  |- mesh__publicMeSHNote mesh__D024521 2002   
% 216.18/216.39  |- rdf__type mesh__D024521sskos__Concept
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D024521 2005
% 216.18/216.39  |- mesh__historyNote mesh__D024521 2002   
% 216.18/216.39  |- skos__historyNote mesh__D024521 Brain %28%1970-2001%29%
% 216.18/216.39  |- skos__scopeNote mesh__D024521
% 216.18/216.39       Prominent lobed neuropils found in ANNELIDA and all ARTHROPODS except crustaceans. They are thought to be involved in olfactory learning and memory.%A%    
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D024521 2004
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D024521 2003
% 216.18/216.39  |- mesh__dateEstablished mesh__D024521 2002-01-01
% 216.18/216.39  |- mesh__dateCreated mesh__D024521 2001-07-25
% 216.18/216.39  |- skos__hiddenLabel mesh__D024521 Mushroom Body
% 216.18/216.39  |- skos__prefLabel mesh__D024521 Mushroom Bodies
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D024521 2002
% 216.18/216.39  |- mesh__recordMaintainer mesh__D010501 TAP
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010501 2005
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010501 2000
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010501 1999
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010501 2003
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010501 1997
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010501 2006
% 216.18/216.39  |- mesh__recordOriginator mesh__D010501 NLM
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010501 2001
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010501 2004
% 216.18/216.39  |- mesh__dateCreated mesh__D010501 1999-01-01
% 216.18/216.39  |- skos__prefLabel mesh__D010501 Perinephritis
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010501 2002
% 216.18/216.39  |- mesh__recordAuthorizer mesh__D010501 PLS
% 216.18/216.39  |- rdf__type mesh__D010501sskos__Concept
% 216.18/216.39  |- skos__broader mesh__D010501smesh__D007674
% 216.18/216.39  |- skos__hiddenLabel mesh__D010501 Perinephritides
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010501 1994
% 216.18/216.39  |- skos__scopeNote mesh__D010501
% 216.18/216.39       Inflammation of the perinephrium. It is marked by fever, local pain, and tenderness on pressure. %28%Dorland, 27th ed%29%%A%    
% 216.18/216.39  |- mesh__dateRevised mesh__D010501 1993-06-02
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010501 1998
% 216.18/216.39  |- skos__annotation mesh__D010501
% 216.18/216.39       inflamm of perinephrium %26% other tissue around the kidney   
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010501 1995
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D010501 1996
% 216.18/216.39  |- mesh__dateEstablished mesh__D051918 2006-01-01
% 216.18/216.39  |- skos__hiddenLabel mesh__D051918 B Lymphocyte Cell Adhesion Molecule
% 216.18/216.39  |- skos__hiddenLabel mesh__D051918 Siglec 2
% 216.18/216.39  |- mesh__recordAuthorizer mesh__D051918 sjn
% 216.18/216.39  |- mesh__publicMeSHNote mesh__D051918
% 216.18/216.39       2006; ANTIGENS, CD22 was indexed under ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE, under ANTIGENS, CD, under CELL ADHESION MOLECULES %26% under LECTINS 1988-2005%A%  
% 216.18/216.39  |- skos__altLabel mesh__D051918 CD22 Glycoprotein
% 216.18/216.39  |- mesh__dateCreated mesh__D051918 2005-06-30
% 216.18/216.39  |- mesh__recordMaintainer mesh__D051918 DRC
% 216.18/216.39  |- mesh__historyNote mesh__D051918 2006%28%1988%29%   
% 216.18/216.39  |- skos__altLabel mesh__D051918 Siglec-2
% 216.18/216.39  |- skos__broader mesh__D051918smesh__D015815
% 216.18/216.39  |- skos__broader mesh__D051918smesh__D037102
% 216.18/216.39  |- skos__scopeNote mesh__D051918
% 216.18/216.39       A lectin and cell adhesion molecule found in B-LYMPHOCYTES. It interacts with SIALIC ACIDS and mediates signaling from B-CELL ANTIGEN RECEPTORS.%A%    
% 216.18/216.39  |- skos__hiddenLabel mesh__D051918 Glycoprotein, CD22
% 216.18/216.39  |- mesh__recordOriginator mesh__D051918 DRC
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D051918 2006
% 216.18/216.39  |- skos__prefLabel mesh__D051918 Antigens, CD22
% 216.18/216.39  |- skos__broader mesh__D051918smesh__D015703
% 216.18/216.39  |- skos__hiddenLabel mesh__D051918 Antigen, CD22
% 216.18/216.39  |- rdf__type mesh__D051918sskos__Concept
% 216.18/216.39  |- skos__altLabel mesh__D051918 B-Lymphocyte Cell Adhesion Molecule
% 216.18/216.39  |- skos__altLabel mesh__D051918 CD22 Antigen
% 216.18/216.39  |- skos__altLabel mesh__D051918 CD22 Antigens
% 216.18/216.39  |- mesh__historyNote mesh__D015795 90   
% 216.18/216.39  |- skos__hiddenLabel mesh__D015795 Antigen, HLA-B8
% 216.18/216.39  |- skos__altLabel mesh__D015795 HLA-B8
% 216.18/216.39  |- mesh__dateRevised mesh__D015795 2005-06-30
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D015795 2006
% 216.18/216.39  |- skos__hiddenLabel mesh__D015795 HLA B8 Antigen
% 216.18/216.39  |- mesh__recordMaintainer mesh__D015795 ssb
% 216.18/216.39  |- mesh__dateEstablished mesh__D015795 1990-01-01
% 216.18/216.39  |- skos__scopeNote mesh__D015795
% 216.18/216.39       Human histocompatibility %28%HLA%29% surface antigen encoded by the B locus on chromosome 6. It is in linkage disequilibrium with HLA-A1 and HLA-DR3. This explains the fact that though HLA-B8 was originally associated with several diseases, including celiac disease, dermatitis herpetiformis, and myasthenia gravis, their association with HLA-DR3 is now considered more significant.%A%    
% 216.18/216.39  |- mesh__publicMeSHNote mesh__D015795 90   
% 216.18/216.39  |- skos__prefLabel mesh__D015795 HLA-B8 Antigen
% 216.18/216.39  |- skos__historyNote mesh__D015795 HLA Antigens %28%1975-1988%29%
% 216.18/216.39  |- mesh__dateCreated mesh__D015795 1989-05-25
% 216.18/216.39  |- skos__historyNote mesh__D015795 HLA-B Antigens %28%1989%29%
% 216.18/216.39  |- mesh__recordOriginator mesh__D015795 AGS
% 216.18/216.39  |- mesh__recordAuthorizer mesh__D015795 sjn
% 216.18/216.39  |- skos__annotation mesh__D015795 read MeSH definition; DF: HLA B8   
% 216.18/216.39  |- rdf__type mesh__D015795sskos__Concept
% 216.18/216.39  |- skos__broader mesh__D015795smesh__D015235
% 216.18/216.39  |- mesh__recordOriginator mesh__D009758 NLM
% 216.18/216.39  |- skos__broader mesh__D009758smesh__D008018
% 216.18/216.39  |- mesh__dateRevised mesh__D009758 2004-07-07
% 216.18/216.39  |- skos__prefLabel mesh__D009758 Nymph
% 216.18/216.39  |- mesh__dateCreated mesh__D009758 1999-01-01
% 216.18/216.39  |- skos__historyNote mesh__D009758 specific arachnid %28%1973-1991%29%
% 216.18/216.39  |- mesh__recordAuthorizer mesh__D009758 sjn
% 216.18/216.39  |- mesh__publicMeSHNote mesh__D009758 91; was see under INSECTS 1973-90   
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D009758 2006
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D009758 2005
% 216.18/216.39  |- skos__scopeNote mesh__D009758
% 216.18/216.39       The immature stage in the life cycle of those orders of insects characterized by gradual metamorphosis, in which the young resemble the imago in general form of body, including compound eyes and external wings; also the 8-legged stage of mites and ticks that follows the first moult.%A%    
% 216.18/216.39  |- rdf__type mesh__D009758sskos__Concept
% 216.18/216.39  |- skos__historyNote mesh__D009758 specific insect %28%1973-1991%29%
% 216.18/216.39  |- mesh__recordMaintainer mesh__D009758 lkt
% 216.18/216.39  |- mesh__dateEstablished mesh__D009758 1991-01-01
% 216.18/216.39  |- skos__annotation mesh__D009758
% 216.18/216.39       NIM; for metamorphosing arthropods only; do not use /embryol with ref to nymph%A%  
% 216.18/216.39  |- mesh__historyNote mesh__D009758
% 216.18/216.39       91%28%73%29%; was see under INSECTS 1973-90   
% 216.18/216.39  |- skos__related mesh__D001775smesh__D010991
% 216.18/216.39  |- skos__related mesh__D001775smesh__D011673
% 216.18/216.39  |- skos__annotation mesh__D001775
% 216.18/216.39       general or unspecified, systemic; note specific indentions in tree;  Manual 21.4.2-21.6; with diseases, coord IM with disease /physiopathol, not /blood %28%IM%29%; circulatory failure or circulatory collapse = SHOCK; DF: BLOOD CIRC%A%  
% 216.18/216.39  |- mesh__dateCreated mesh__D001775 1999-01-01
% 216.18/216.39  |- skos__related mesh__D001775smesh__D002319
% 216.18/216.39  |- mesh__recordOriginator mesh__D001775 NLM
% 216.18/216.39  |- skos__scopeNote mesh__D001775
% 216.18/216.39       The movement of the BLOOD as it is pumped through the CARDIOVASCULAR SYSTEM.%A%    
% 216.18/216.39  |- skos__prefLabel mesh__D001775 Blood Circulation
% 216.18/216.39  |- mesh__activeMeSHYear mesh__D001775 2006
% 216.18/216.39  |- skos__related mesh__D001775smesh__D007511
% 216.18/216.40  |- mesh__recordAuthorizer mesh__D001775 sjn
% 216.18/216.40  |- skos__related mesh__D001775smesh__D006439
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D001775 2005
% 216.18/216.40  |- rdf__type mesh__D001775sskos__Concept
% 216.18/216.40  |- mesh__recordMaintainer mesh__D001775 sjn
% 216.18/216.40  |- skos__altLabel mesh__D001775 Circulation, Blood
% 216.18/216.40  |- skos__related mesh__D001775smesh__D006940
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D001775 2004
% 216.18/216.40  |- skos__broader mesh__D001775smesh__D045125
% 216.18/216.40  |- mesh__dateRevised mesh__D001775 2003-07-09
% 216.18/216.40  |- skos__prefLabel mesh__D006460 Hemolysins
% 216.18/216.40  |- skos__broader mesh__D006460smesh__D003603
% 216.18/216.40  |- mesh__recordAuthorizer mesh__D006460 sjn
% 216.18/216.40  |- mesh__dateRevised mesh__D006460 2005-06-30
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D006460 2006
% 216.18/216.40  |- skos__scopeNote mesh__D006460
% 216.18/216.40       Substances, usually of biological origin, that destroy blood cells; they may be antibodies or other immunologic factors, toxins, enzymes, etc.; hemotoxins are toxic to blood in general, including the clotting mechanism; hematotoxins may refer to the hematopoietic system.%A%    
% 216.18/216.40  |- mesh__recordMaintainer mesh__D006460 ssb
% 216.18/216.40  |- skos__altLabel mesh__D006460 Hematoxins
% 216.18/216.40  |- rdf__type mesh__D006460sskos__Concept
% 216.18/216.40  |- skos__broader mesh__D006460smesh__D000906
% 216.18/216.40  |- mesh__recordOriginator mesh__D006460 NLM
% 216.18/216.40  |- skos__altLabel mesh__D006460 Hemalysins
% 216.18/216.40  |- mesh__dateCreated mesh__D006460 1999-01-01
% 216.18/216.40  |- mesh__historyNote mesh__D020131 99   
% 216.18/216.40  |- mesh__dateCreated mesh__D020131 1998-06-10
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D020131 2006
% 216.18/216.40  |- rdf__type mesh__D020131sskos__Concept
% 216.18/216.40  |- skos__related mesh__D020131smesh__D005810
% 216.18/216.40  |- skos__hiddenLabel mesh__D020131 Duplicate Gene
% 216.18/216.40  |- skos__broader mesh__D020131smesh__D005796
% 216.18/216.40  |- skos__scopeNote mesh__D020131
% 216.18/216.40       Two identical genes showing the same phenotypic action but localized in different regions of a chromosome or on different chromosomes. %28%From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A%    
% 216.18/216.40  |- skos__annotation mesh__D020131
% 216.18/216.40       coord with specific gene or gene product; do not confuse with GENE DUPLICATION%A%  
% 216.18/216.40  |- mesh__dateEstablished mesh__D020131 1999-01-01
% 216.18/216.40  |- mesh__recordMaintainer mesh__D020131 nns
% 216.18/216.40  |- mesh__dateRevised mesh__D020131 2005-06-30
% 216.18/216.40  |- mesh__recordAuthorizer mesh__D020131 sjn
% 216.18/216.40  |- mesh__publicMeSHNote mesh__D020131 99   
% 216.18/216.40  |- skos__hiddenLabel mesh__D020131 Gene, Duplicate
% 216.18/216.40  |- mesh__recordOriginator mesh__D020131 NDW
% 216.18/216.40  |- skos__altLabel mesh__D020131 Duplicate Genes
% 216.18/216.40  |- skos__prefLabel mesh__D020131 Genes, Duplicate
% 216.18/216.40  |- mesh__recordAuthorizer mesh__D019388 sjn
% 216.18/216.40  |- skos__altLabel mesh__D019388 Cytochrome P450 1A2
% 216.18/216.40  |- skos__altLabel mesh__D019388 Cytochrome P-450 LM4
% 216.18/216.40  |- skos__annotation mesh__D019388
% 216.18/216.40       do not confuse with other cytochrome P-450 CYP%27%s   
% 216.18/216.40  |- mesh__recordMaintainer mesh__D019388 sjn
% 216.18/216.40  |- rdf__type mesh__D019388sskos__Concept
% 216.18/216.40  |- skos__hiddenLabel mesh__D019388 CYP1A2, Cytochrome P-450
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D019388 2006
% 216.18/216.40  |- skos__altLabel mesh__D019388 CYP1A2
% 216.18/216.40  |- skos__altLabel mesh__D019388 CYP 1A2
% 216.18/216.40  |- mesh__recordOriginator mesh__D019388 ADP
% 216.18/216.40  |- skos__hiddenLabel mesh__D019388 Demethylase, Caffeine
% 216.18/216.40  |- skos__scopeNote mesh__D019388
% 216.18/216.40       A cytochrome P-450 monooxygenase that can be induced by polycyclic aromatic xenobiotics in the liver of human and several animal species. This enzyme is of significant clinical interest due to the large number of drug interactions associated with its induction and its metabolism of THEOPHYLLINE. Caffeine is considered to be a model substrate for this enzyme. CYP1A2 activity can also be increased by environmental factors such as cigarette smoking, charbroiled meat, cruciferous vegetables, and a number of drugs including phenytoin, phenobarbital, and omeprazole.%A%    
% 216.18/216.40  |- mesh__historyNote mesh__D019388
% 216.18/216.40       97; was PHENACETIN O-DEALKYLASE %28%NM%29% 1976-96   
% 216.18/216.40  |- skos__hiddenLabel mesh__D019388 Phenacetin O Dealkylase
% 216.18/216.40  |- skos__prefLabel mesh__D019388 Cytochrome P-450 CYP1A2
% 216.18/216.40  |- skos__hiddenLabel mesh__D019388 O-Dealkylase, Phenacetin
% 216.18/216.40  |- mesh__dateCreated mesh__D019388 1996-06-24
% 216.18/216.40  |- mesh__dateRevised mesh__D019388 2004-07-13
% 216.18/216.40  |- skos__altLabel mesh__D019388 Cytochrome P-450 LM%28%4%29%
% 216.18/216.40  |- skos__broader mesh__D019388smesh__D001189
% 216.18/216.40  |- skos__altLabel mesh__D019388 Caffeine Demethylase
% 216.18/216.40  |- mesh__dateEstablished mesh__D019388 1997-01-01
% 216.18/216.40  |- mesh__publicMeSHNote mesh__D019388
% 216.18/216.40       97; PHENACETIN O-DEALKYLASE was indexed under OXIDOREDUCTASES 1980-96, CYTOCHROME P-450 1976-96, %26% PHENACETIN 1976-80%A%  
% 216.18/216.40  |- skos__altLabel mesh__D019388 Phenacetin O-Dealkylase
% 216.18/216.40  |- skos__altLabel mesh__D019388 Cytochrome P-450d
% 216.18/216.40  |- mesh__onlineNote mesh__D019388
% 216.18/216.40       use CYTOCHROME P-450 CYP1A2 %28%NM%29% to search PHENACETIN O-DEALKYLASE 1980-96%A%  
% 216.18/216.40  |- skos__historyNote mesh__D019388 Phenacetin %28%1976-1980%29%
% 216.18/216.40  |- skos__hiddenLabel mesh__D019388 Cytochrome P 450 CYP1A2
% 216.18/216.40  |- skos__hiddenLabel mesh__D019388 Cytochrome P 450d
% 216.18/216.40  |- skos__historyNote mesh__D019388 Oxidoreductases %28%1980-1996%29%
% 216.18/216.40  |- skos__historyNote mesh__D019388 Cytochrome P-450 %28%1976-1996%29%
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D019388 2005
% 216.18/216.40  |- skos__prefLabel mesh__D038542 Neisseria meningitidis, Serogroup C
% 216.18/216.40  |- skos__scopeNote mesh__D038542
% 216.18/216.40       Strains of Neisseria meningitidis responsible for most sporadic cases in teenagers and almost all outbreaks of disease in this age group. These strains are less common in infants.%A%    
% 216.18/216.40  |- mesh__historyNote mesh__D038542 2003   
% 216.18/216.40  |- skos__annotation mesh__D038542
% 216.18/216.40       infection: coord IM with MENINGITIS, MENINGOCOCCAL %28%IM%29% or, if not meningitis, MENINGOCOCCAL INFECTIONS %28%IM%29%%A%  
% 216.18/216.40  |- skos__broader mesh__D038542smesh__D009345
% 216.18/216.40  |- skos__altLabel mesh__D038542 Meningococcus, Serogroup C
% 216.18/216.40  |- rdf__type mesh__D038542sskos__Concept
% 216.18/216.40  |- skos__altLabel mesh__D038542 Meningococci, Serogroup C
% 216.18/216.40  |- mesh__recordOriginator mesh__D038542 ags
% 216.18/216.40  |- mesh__recordMaintainer mesh__D038542 SYSTEM
% 216.18/216.40  |- mesh__dateCreated mesh__D038542 2002-07-03
% 216.18/216.40  |- mesh__recordAuthorizer mesh__D038542 sjn
% 216.18/216.40  |- skos__historyNote mesh__D038542 Neisseria meningitidis %28%1974-2002%29%
% 216.18/216.40  |- mesh__publicMeSHNote mesh__D038542 2003   
% 216.18/216.40  |- mesh__dateRevised mesh__D038542 2005-06-30
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D038542 2006
% 216.18/216.40  |- mesh__dateEstablished mesh__D038542 2003-01-01
% 216.18/216.40  |- skos__hiddenLabel mesh__D005368 Elaeophoriases
% 216.18/216.40  |- skos__scopeNote mesh__D005368
% 216.18/216.40       Infections with nematodes of the superfamily FILARIOIDEA. The presence of living worms in the body is mainly asymptomatic but the death of adult worms leads to granulomatous inflammation and permanent fibrosis. Organisms of the genus Elaeophora infect wild elk and domestic sheep causing ischemic necrosis of the brain, blindness, and dermatosis of the face.%A%    
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D005368 2000
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D005368 2005A
% 216.18/216.40  |- mesh__historyNote mesh__D005368
% 216.18/216.40       ELAEOPHORIASIS was heading 1975-92 %28%see under FILARIASIS 1975-90%29%%A%  
% 216.18/216.40  |- mesh__publicMeSHNote mesh__D005368
% 216.18/216.40       ELAEOPHORIASIS was heading 1975-92 %28%see under FILARIASIS 1975-90%29%%A%  
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D005368 2006
% 216.18/216.40  |- skos__annotation mesh__D005368
% 216.18/216.40       GEN: prefer specifics; drug ther: consider FILARICIDES   
% 216.18/216.40  |- mesh__onlineNote mesh__D005368
% 216.18/216.40       use FILARIASIS to search ELAEOPHORIASIS 1975-92   
% 216.18/216.40  |- skos__altLabel mesh__D005368 Infections, Filarioidea
% 216.18/216.40  |- skos__altLabel mesh__D005368 Filarioidea Infections
% 216.18/216.40  |- skos__hiddenLabel mesh__D005368 Filarioidea Infection
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D005368 2004
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D005368 2005
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D005368 2002
% 216.18/216.40  |- mesh__recordAuthorizer mesh__D005368 jls
% 216.18/216.40  |- skos__prefLabel mesh__D005368 Filariasis
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D005368 2003
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D005368 1999
% 216.18/216.40  |- mesh__recordOriginator mesh__D005368 NLM
% 216.18/216.40  |- skos__broader mesh__D005368smesh__D017205
% 216.18/216.40  |- skos__hiddenLabel mesh__D005368 Filariases
% 216.18/216.40  |- mesh__dateCreated mesh__D005368 1999-01-01
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D005368 2001
% 216.18/216.40  |- rdf__type mesh__D005368sskos__Concept
% 216.18/216.40  |- skos__hiddenLabel mesh__D005368 Infection, Filarioidea
% 216.18/216.40  |- mesh__dateRevised mesh__D005368 2004-07-27
% 216.18/216.40  |- mesh__recordMaintainer mesh__D005368 jls
% 216.18/216.40  |- rdf__type mesh__D024522sskos__Concept
% 216.18/216.40  |- skos__hiddenLabel mesh__D024522 Gene, BRCA2
% 216.18/216.40  |- skos__historyNote mesh__D024522
% 216.18/216.40       Genes, Tumor Suppressor %28%1995-2001%29%
% 216.18/216.40  |- skos__altLabel mesh__D024522 BRCA2 Gene
% 216.18/216.40  |- skos__scopeNote mesh__D024522
% 216.18/216.40       A tumor suppressor gene %28%GENES, TUMOR SUPPRESSOR%29% located on human chromosome 13 at locus 13q12.3. Mutations in this gene predispose humans to breast and ovarian cancer. It encodes a large, nuclear protein that is an essential component of DNA repair pathways, suppressing the formation of gross chromosomal rearrangements. %28%from Genes Dev 2000;14%28%11%29%:1400-6%29%%A%    
% 216.18/216.40  |- skos__hiddenLabel mesh__D024522 BRCA2 Genes
% 216.18/216.40  |- mesh__recordMaintainer mesh__D024522 ags
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D024522 2006A
% 216.18/216.40  |- mesh__dateEstablished mesh__D024522 2002-01-01
% 216.18/216.40  |- mesh__dateRevised mesh__D024522 2005-07-14
% 216.18/216.40  |- mesh__historyNote mesh__D024522 2002   
% 216.18/216.40  |- skos__broader mesh__D024522smesh__D016147
% 216.18/216.40  |- skos__annotation mesh__D024522 BRCA stands for %22%BReast CAncer%22%   
% 216.18/216.40  |- mesh__recordOriginator mesh__D024522 nns
% 216.18/216.40  |- skos__related mesh__D024522smesh__D024682
% 216.18/216.40  |- mesh__recordAuthorizer mesh__D024522 ags
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D024522 2006
% 216.18/216.40  |- skos__prefLabel mesh__D024522 Genes, BRCA2
% 216.18/216.40  |- mesh__publicMeSHNote mesh__D024522 2002   
% 216.18/216.40  |- mesh__dateCreated mesh__D024522 2001-07-25
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D002070 1999
% 216.18/216.40  |- mesh__onlineNote mesh__D002070
% 216.18/216.40       use BUTADIENES to search BUTADIENE 1966-77   
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D002070 2006
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D002070 2001
% 216.18/216.40  |- mesh__dateCreated mesh__D002070 1999-01-01
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D002070 1996
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D002070 2003
% 216.18/216.40  |- mesh__recordAuthorizer mesh__D002070 PLS
% 216.18/216.40  |- skos__scopeNote mesh__D002070
% 216.18/216.40       Four carbon unsaturated hydrocarbons containing two double bonds.%A%    
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D002070 1997
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D002070 2004
% 216.18/216.40  |- rdf__type mesh__D002070sskos__Concept
% 216.18/216.40  |- mesh__dateRevised mesh__D002070 1995-05-18
% 216.18/216.40  |- mesh__recordOriginator mesh__D002070 NLM
% 216.18/216.40  |- mesh__publicMeSHNote mesh__D002070 78; was BUTADIENE 1963-77   
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D002070 2002
% 216.18/216.40  |- skos__broader mesh__D002070smesh__D000466
% 216.18/216.40  |- mesh__recordMaintainer mesh__D002070 TAP
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D002070 1998
% 216.18/216.40  |- mesh__historyNote mesh__D002070 78; was BUTADIENE 1963-77   
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D002070 2005
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D002070 2000
% 216.18/216.40  |- skos__prefLabel mesh__D002070 Butadienes
% 216.18/216.40  |- skos__hiddenLabel mesh__D010502 Perineums
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D010502 2006
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D010502 2004
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D010502 1990
% 216.18/216.40  |- mesh__dateCreated mesh__D010502 1999-01-01
% 216.18/216.40  |- skos__prefLabel mesh__D010502 Perineum
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D010502 2000
% 216.18/216.40  |- skos__broader mesh__D010502smesh__D001829
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D010502 1991
% 216.18/216.40  |- rdf__type mesh__D010502sskos__Concept
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D010502 1989
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D010502 2001
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D010502 1994
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D010502 1992
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D010502 2002
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D010502 1998
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D010502 1995
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D010502 1993
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D010502 1996
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D010502 1999
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D010502 2005
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D010502 1997
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D010502 2003
% 216.18/216.40  |- skos__historyNote mesh__D015796 HLA Antigens %28%1975-1988%29%
% 216.18/216.40  |- skos__prefLabel mesh__D015796 HLA-B27 Antigen
% 216.18/216.40  |- mesh__dateEstablished mesh__D015796 1990-01-01
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D015796 2006
% 216.18/216.40  |- mesh__publicMeSHNote mesh__D015796 90   
% 216.18/216.40  |- mesh__recordAuthorizer mesh__D015796 sjn
% 216.18/216.40  |- skos__historyNote mesh__D015796 HLA-B Antigens %28%1989%29%
% 216.18/216.40  |- mesh__recordMaintainer mesh__D015796 ssb
% 216.18/216.40  |- skos__hiddenLabel mesh__D015796 HLA B27 Antigen
% 216.18/216.40  |- skos__annotation mesh__D015796
% 216.18/216.40       assoc with acute anterior uveitis, ankylosing spondylitis %26% Reiter%27%s dis; DF: HLA B27%A%  
% 216.18/216.40  |- skos__hiddenLabel mesh__D015796 Antigen, HLA-B27
% 216.18/216.40  |- skos__scopeNote mesh__D015796
% 216.18/216.40       Human histocompatibility %28%HLA%29% surface antigen encoded by the B locus on chromosome 6. It is strongly associated with acute anterior uveitis, ankylosing spondylitis, and REITER DISEASE.%A%    
% 216.18/216.40  |- mesh__dateRevised mesh__D015796 2005-06-30
% 216.18/216.40  |- mesh__historyNote mesh__D015796 90   
% 216.18/216.40  |- mesh__dateCreated mesh__D015796 1989-05-15
% 216.18/216.40  |- mesh__recordOriginator mesh__D015796 AGS
% 216.18/216.40  |- rdf__type mesh__D015796sskos__Concept
% 216.18/216.40  |- skos__broader mesh__D015796smesh__D015235
% 216.18/216.40  |- skos__altLabel mesh__D015796 HLA-B27
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Nystagmus, Multidirectional
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Positional Nystagmus, Non-Fatigable
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Nystagmus, Rebound
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Ocular Nystagmus, Spontaneous
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D009759 2006
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Nystagmus, Fatigable Positional
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D009759 2001
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Nystagmus, Temporary
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Nystagmus, Rotational
% 216.18/216.40  |- mesh__recordOriginator mesh__D009759 NLM
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Nystagmus, Symptomatic
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Nystagmus, Horizontal
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Nystagmus, Rotary
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Nystagmus, Unidirectional
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Nystagmus, See-Saw
% 216.18/216.40  |- mesh__dateRevised mesh__D009759 2000-06-22
% 216.18/216.40  |- mesh__recordMaintainer mesh__D009759 ags
% 216.18/216.40  |- skos__broader mesh__D009759smesh__D015835
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Nystagmus, Retraction
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Nystagmus, Pendular
% 216.18/216.40  |- mesh__dateCreated mesh__D009759 1999-01-01
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Nystagmus, Spontaneous Ocular
% 216.18/216.40  |- skos__related mesh__D009759smesh__D004584
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Positional Nystagmus, Fatigable
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Nystagmus, Vertical
% 216.18/216.40  |- rdf__type mesh__D009759sskos__Concept
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Pathologic Nystagmus
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D009759 2002
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Nystagmus, Dissociated
% 216.18/216.40  |- skos__related mesh__D009759smesh__D009760
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Nystagmus, Periodic Alternating
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Alternating Nystagmus, Periodic
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Nystagmus, Jerk
% 216.18/216.40  |- skos__annotation mesh__D009759
% 216.18/216.40       do not confuse with NYSTAGMUS, PHYSIOLOGIC; NYSTAGMUS, CONGENITAL is also available%A%  
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D009759 2003
% 216.18/216.40  |- skos__prefLabel mesh__D009759 Nystagmus, Pathologic
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Nystagmus, Conjugate
% 216.18/216.40  |- skos__scopeNote mesh__D009759
% 216.18/216.40       Involuntary movements of the eye that are divided into two types, jerk and pendular. Jerk nystagmus has a slow phase in one direction followed by a corrective fast phase in the opposite direction, and is usually caused by central or peripheral vestibular dysfunction. Pendular nystagmus features oscillations that are of equal velocity in both directions and this condition is often associated with visual loss early in life. %28%Adams et al., Principles of Neurology, 6th ed, p272%29%%A%    
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Non Fatigable Positional Nystagmus
% 216.18/216.40  |- mesh__recordAuthorizer mesh__D009759 sjn
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Nystagmus, Permanent
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 See Saw Nystagmus
% 216.18/216.40  |- mesh__historyNote mesh__D009759 2000   
% 216.18/216.40  |- mesh__publicMeSHNote mesh__D009759
% 216.18/216.40       2000; see NYSTAGMUS 1966-1999; for NYSTAGMUS see NYSTAGMUS, PATHOLOGIC 2000%A%  
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Nystagmus, Non-Fatigable Positional
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D009759 2004
% 216.18/216.40  |- skos__hiddenLabel mesh__D009759 Nystagmus, Convergence
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D009759 2005
% 216.18/216.40  |- mesh__recordAuthorizer mesh__D001776 SJN
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D001776 2005
% 216.18/216.40  |- rdf__type mesh__D001776sskos__Concept
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D001776 2000
% 216.18/216.40  |- skos__annotation mesh__D001776
% 216.18/216.40       NIM; /drug eff /rad eff permitted; coord with disease /physiopathol, not /blood; DF: BLOOD CIRC TIME%A%  
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D001776 2004
% 216.18/216.40  |- mesh__dateRevised mesh__D001776 1997-06-20
% 216.18/216.40  |- skos__hiddenLabel mesh__D001776 Blood Circulation Times
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D001776 2003
% 216.18/216.40  |- skos__broader mesh__D001776smesh__D003935
% 216.18/216.40  |- skos__altLabel mesh__D001776 Circulation Time, Blood
% 216.18/216.40  |- skos__scopeNote mesh__D001776
% 216.18/216.40       Determination of the shortest time interval between the injection of a substance in the vein and its arrival at some distant site in sufficient concentration to produce a recognizable end result. It represents approximately the inverse of the average velocity of blood flow between two points.%A%    
% 216.18/216.40  |- mesh__recordOriginator mesh__D001776 NLM
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D001776 1999
% 216.18/216.40  |- skos__hiddenLabel mesh__D001776 Circulation Times, Blood
% 216.18/216.40  |- mesh__dateCreated mesh__D001776 1999-01-01
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D001776 2002
% 216.18/216.40  |- skos__hiddenLabel mesh__D001776 Times, Blood Circulation
% 216.18/216.40  |- mesh__recordMaintainer mesh__D001776 PXP
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D001776 1998
% 216.18/216.40  |- skos__altLabel mesh__D001776 Time, Blood Circulation
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D001776 2006
% 216.18/216.40  |- skos__prefLabel mesh__D001776 Blood Circulation Time
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D001776 2001
% 216.18/216.40  |- mesh__historyNote mesh__D020930
% 216.18/216.40       2000; use MAP KINASE KINASE KINASE %28%1992-1999%29%   
% 216.18/216.40  |- mesh__dateRevised mesh__D020930 2004-07-07
% 216.18/216.40  |- skos__altLabel mesh__D020930 MAP3 Kinases
% 216.18/216.40  |- skos__altLabel mesh__D020930 Kinases, MAP Kinase Kinase
% 216.18/216.40  |- mesh__recordOriginator mesh__D020930 nns
% 216.18/216.40  |- mesh__recordMaintainer mesh__D020930 jmp
% 216.18/216.40  |- skos__hiddenLabel mesh__D020930 Kinases, MAPK-ERK Kinase
% 216.18/216.40  |- skos__altLabel mesh__D020930 MEK Kinases
% 216.18/216.40  |- skos__hiddenLabel mesh__D020930 Kinases, MEK
% 216.18/216.40  |- skos__historyNote mesh__D020930
% 216.18/216.40       Protein-Serine-Threonine Kinases %28%1993-1999%29%
% 216.18/216.40  |- skos__related mesh__D020930smesh__D020935
% 216.18/216.40  |- skos__historyNote mesh__D020930 Protein Kinases %28%1989-1999%29%
% 216.18/216.40  |- skos__hiddenLabel mesh__D020930 Kinase Kinases, MAPK-ERK
% 216.18/216.40  |- skos__hiddenLabel mesh__D020930 MAPK ERK Kinase Kinases
% 216.18/216.40  |- skos__prefLabel mesh__D020930 MAP Kinase Kinase Kinases
% 216.18/216.40  |- skos__broader mesh__D020930smesh__D047908
% 216.18/216.40  |- skos__hiddenLabel mesh__D020930 Kinases, MAP3
% 216.18/216.40  |- skos__broader mesh__D020930smesh__D017346
% 216.18/216.40  |- skos__hiddenLabel mesh__D020930
% 216.18/216.40       Mitogen Activated Protein Kinase Kinase Kinases
% 216.18/216.40  |- mesh__publicMeSHNote mesh__D020930
% 216.18/216.40       2000; MAP KINASE KINASE KINASE %28%now MAP KINASE KINASE KINASES%29% was indexed under PROTEIN-SERINE-THREONINE KINASES %28%1992-1999%29%%A%  
% 216.18/216.40  |- skos__altLabel mesh__D020930
% 216.18/216.40       Mitogen-Activated Protein Kinase Kinase Kinases
% 216.18/216.40  |- mesh__dateCreated mesh__D020930 1999-11-03
% 216.18/216.40  |- skos__historyNote mesh__D020930
% 216.18/216.40       Protein-Tyrosine Kinase %28%1989-1999%29%
% 216.18/216.40  |- skos__altLabel mesh__D020930 MAPKKKs
% 216.18/216.40  |- rdf__type mesh__D020930sskos__Concept
% 216.18/216.40  |- skos__scopeNote mesh__D020930
% 216.18/216.40       Mitogen-activated protein kinase kinase kinases %28%MAPKKKs%29% are serine-threonine protein kinases that initiate protein kinase signaling cascades. They phosphorylate MITOGEN-ACTIVATED PROTEIN KINASE KINASES; %28%MAPKKs%29% which in turn phosphorylate MITOGEN-ACTIVATED PROTEIN KINASES; %28%MAPKs%29%.%A%    
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D020930 2006
% 216.18/216.40  |- skos__altLabel mesh__D020930 MEKKs
% 216.18/216.40  |- mesh__dateEstablished mesh__D020930 2000-01-01
% 216.18/216.40  |- skos__altLabel mesh__D020930 MAP Kinase Kinase Kinase
% 216.18/216.40  |- mesh__recordAuthorizer mesh__D020930 sjn
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D020930 2005
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D006461 2006
% 216.18/216.40  |- mesh__recordOriginator mesh__D006461 NLM
% 216.18/216.40  |- skos__annotation mesh__D006461
% 216.18/216.40       hemolysis in gel = HEMOLYTIC PLAQUE TECHNIQUE   
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D006461 2005
% 216.18/216.40  |- mesh__recordAuthorizer mesh__D006461 sjn
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D006461 2004
% 216.18/216.40  |- mesh__dateRevised mesh__D006461 2000-06-22
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D006461 2002
% 216.18/216.40  |- rdf__type mesh__D006461sskos__Concept
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D006461 2003
% 216.18/216.40  |- mesh__recordMaintainer mesh__D006461 adp
% 216.18/216.40  |- skos__prefLabel mesh__D006461 Hemolysis
% 216.18/216.40  |- skos__broader mesh__D006461smesh__D000937
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D006461 2001
% 216.18/216.40  |- skos__scopeNote mesh__D006461
% 216.18/216.40       The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.%A%    
% 216.18/216.40  |- mesh__dateCreated mesh__D006461 1999-01-01
% 216.18/216.40  |- skos__related mesh__D006461smesh__D009996
% 216.18/216.40  |- skos__related mesh__D006461smesh__D000743
% 216.18/216.40  |- skos__broader mesh__D006461smesh__D010335
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D020132 2005
% 216.18/216.40  |- skos__broader mesh__D020132smesh__D020022
% 216.18/216.40  |- mesh__dateCreated mesh__D020132 1998-06-10
% 216.18/216.40  |- mesh__historyNote mesh__D020132 99   
% 216.18/216.40  |- skos__prefLabel mesh__D020132 Anticipation, Genetic
% 216.18/216.40  |- skos__hiddenLabel mesh__D020132 Genetic Anticipations
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D020132 2004
% 216.18/216.40  |- skos__scopeNote mesh__D020132
% 216.18/216.40       The apparent tendency of certain diseases to appear at earlier AGE OF ONSET and with increasing severity in successive generations. %28%Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A%    
% 216.18/216.40  |- mesh__recordMaintainer mesh__D020132 KEV
% 216.18/216.40  |- mesh__publicMeSHNote mesh__D020132 99   
% 216.18/216.40  |- skos__related mesh__D020132smesh__D019683
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D020132 2003
% 216.18/216.40  |- mesh__dateEstablished mesh__D020132 1999-01-01
% 216.18/216.40  |- mesh__recordAuthorizer mesh__D020132 sjn
% 216.18/216.40  |- mesh__recordOriginator mesh__D020132 NDW
% 216.18/216.40  |- skos__related mesh__D020132smesh__D020022
% 216.18/216.40  |- skos__altLabel mesh__D020132 Genetic Anticipation
% 216.18/216.40  |- skos__broader mesh__D020132smesh__D040582
% 216.18/216.40  |- skos__related mesh__D020132smesh__D019680
% 216.18/216.40  |- mesh__dateRevised mesh__D020132 2002-07-02
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D020132 2006
% 216.18/216.40  |- rdf__type mesh__D020132sskos__Concept
% 216.18/216.40  |- skos__hiddenLabel mesh__D020132 Anticipations, Genetic
% 216.18/216.40  |- skos__broader mesh__D006321Q000098smesh__D006321
% 216.18/216.40  |- mesh__preferredCombination mesh__D006321Q000098smesh__D003331
% 216.18/216.40  |- rdf__type mesh__D006321Q000098smesh__CompoundConcept
% 216.18/216.40  |- rdf__type mesh__D019389sskos__Concept
% 216.18/216.40  |- skos__altLabel mesh__D019389 Debrisoquine Hydroxylase
% 216.18/216.40  |- skos__altLabel mesh__D019389 Sparteine Monooxygenase
% 216.18/216.40  |- skos__hiddenLabel mesh__D019389 P450 2D6, Cytochrome
% 216.18/216.40  |- mesh__recordMaintainer mesh__D019389 ags
% 216.18/216.40  |- skos__hiddenLabel mesh__D019389 Imipramine 2 Hydroxylase
% 216.18/216.40  |- skos__hiddenLabel mesh__D019389 2-Hydroxylase, Imipramine
% 216.18/216.40  |- skos__altLabel mesh__D019389 Debrisoquine 4-Monooxygenase
% 216.18/216.40  |- skos__broader mesh__D019389smesh__D001189
% 216.18/216.40  |- skos__hiddenLabel mesh__D019389 4-Hydroxylase, Debrisoquine
% 216.18/216.40  |- skos__hiddenLabel mesh__D019389 P-450 CYP2D6, Cytochrome
% 216.18/216.40  |- skos__historyNote mesh__D019389 Hydroxylases %28%1979-1996%29%
% 216.18/216.40  |- mesh__historyNote mesh__D019389
% 216.18/216.40       97; was DEBRISOQUINE 4-HYDROXYLASE %28%NM%29% 1982-96   
% 216.18/216.40  |- mesh__recordOriginator mesh__D019389 ADP
% 216.18/216.40  |- skos__hiddenLabel mesh__D019389 Debrisoquine 4 Hydroxylase
% 216.18/216.40  |- skos__altLabel mesh__D019389 CYP 2D6
% 216.18/216.40  |- skos__hiddenLabel mesh__D019389 Hydroxylase, Debrisoquine
% 216.18/216.40  |- skos__hiddenLabel mesh__D019389 CYP2D6, Cytochrome P-450
% 216.18/216.40  |- mesh__dateCreated mesh__D019389 1996-06-13
% 216.18/216.40  |- skos__prefLabel mesh__D019389 Cytochrome P-450 CYP2D6
% 216.18/216.40  |- skos__hiddenLabel mesh__D019389 Monooxygenase, Sparteine
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D019389 2005
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D019389 2006A
% 216.18/216.40  |- skos__scopeNote mesh__D019389
% 216.18/216.40       A cytochrome P450 enzyme that catalyzes the hydroxylation of many drugs and environmental chemicals, such as DEBRISOQUINE; ADRENERGIC RECEPTOR ANTAGONISTS; and TRICYCLIC ANTIDEPRESSANTS. This enzyme is deficient in up to 10 percent of the Caucasian population.%A%    
% 216.18/216.40  |- mesh__dateEstablished mesh__D019389 1997-01-01
% 216.18/216.40  |- skos__hiddenLabel mesh__D019389 Cytochrome P 450 CYP2D6
% 216.18/216.40  |- mesh__recordAuthorizer mesh__D019389 ags
% 216.18/216.40  |- mesh__publicMeSHNote mesh__D019389
% 216.18/216.40       97; DEBRISOQUINE 4-HYDROXYLASE was indexed under CYTOCHROME P-450 %26% HYDROXYLASES 1982-96%A%  
% 216.18/216.40  |- mesh__onlineNote mesh__D019389
% 216.18/216.40       use CYTOCHROME P-450 CYP2D6 %28%NM%29% to search DEBRISOQUINE 4-HYDROXYLASE 1982-96%A%  
% 216.18/216.40  |- skos__hiddenLabel mesh__D019389 Debrisoquine 4 Monooxygenase
% 216.18/216.40  |- skos__altLabel mesh__D019389 Imipramine 2-Hydroxylase
% 216.18/216.40  |- skos__annotation mesh__D019389
% 216.18/216.40       do not confuse with other cytochrome P-450 CYP%27%s   
% 216.18/216.40  |- skos__altLabel mesh__D019389 Debrisoquine 4-Hydroxylase
% 216.18/216.40  |- mesh__activeMeSHYear mesh__D019389 2006
% 216.18/216.40  |- skos__altLabel mesh__D019389 Cytochrome P450 2D6
% 216.18/216.40  |- skos__altLabel mesh__D019389 CYP2D6
% 216.18/216.40  |- mesh__dateRevised mesh__D019389 2005-07-13
% 216.18/216.40  |- skos__hiddenLabel mesh__D019389 4-Monooxygenase, Debrisoquine
% 216.18/216.40  |- skos__historyNote mesh__D019389 Cytochrome P-450 %28%1975-1996%29%
% 216.18/216.40  |- mesh__recordOriginator mesh__D005369 NLM
% 216.18/216.40  |- mesh__publicMeSHNote mesh__D005369
% 216.18/216.40       91; was see under ANTHELMINTICS 1973-90   
% 216.18/216.41  |- skos__annotation mesh__D005369
% 216.18/216.41       consider also FILARIOIDEA /drug eff %26% FILARIASIS /drug ther or pertinent specifics%A%  
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D005369 2006
% 216.18/216.41  |- mesh__historyNote mesh__D005369
% 216.18/216.41       91%28%73%29%; was see under ANTHELMINTICS 1973-90   
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D005369 2004
% 216.18/216.41  |- mesh__recordAuthorizer mesh__D005369 sjn
% 216.18/216.41  |- mesh__dateCreated mesh__D005369 1999-01-01
% 216.18/216.41  |- skos__broader mesh__D005369smesh__D000969
% 216.18/216.41  |- mesh__dateEstablished mesh__D005369 1991-01-01
% 216.18/216.41  |- skos__scopeNote mesh__D005369
% 216.18/216.41       Pharmacological agents destructive to nematodes in the superfamily Filarioidea.%A%    
% 216.18/216.41  |- mesh__recordMaintainer mesh__D005369 ssb
% 216.18/216.41  |- mesh__dateRevised mesh__D005369 2003-07-09
% 216.18/216.41  |- rdf__type mesh__D005369sskos__Concept
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D005369 2005
% 216.18/216.41  |- skos__prefLabel mesh__D005369 Filaricides
% 216.18/216.41  |- mesh__recordAuthorizer mesh__D010503 sjn
% 216.18/216.41  |- skos__historyNote mesh__D010503 Staining %28%1966-1976%29%
% 216.18/216.41  |- skos__historyNote mesh__D010503 Periodic Acids %28%1966-1976%29%
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D010503 2004
% 216.18/216.41  |- skos__hiddenLabel mesh__D010503 Periodic Acid-Schiff Reactions
% 216.18/216.41  |- mesh__recordOriginator mesh__D010503 SMH
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D010503 2006
% 216.18/216.41  |- mesh__dateCreated mesh__D010503 1976-04-27
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D010503 2003
% 216.18/216.41  |- skos__historyNote mesh__D010503 Histocytochemistry %28%1966-1976%29%
% 216.18/216.41  |- skos__hiddenLabel mesh__D010503 Periodic Acid Schiff Reaction
% 216.18/216.41  |- skos__hiddenLabel mesh__D010503 PAS Reactions
% 216.18/216.41  |- mesh__dateRevised mesh__D010503 2001-07-25
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D010503 2002
% 216.18/216.41  |- mesh__dateEstablished mesh__D010503 1991-01-01
% 216.18/216.41  |- skos__broader mesh__D010503smesh__D006651
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D010503 2005
% 216.18/216.41  |- mesh__historyNote mesh__D010503
% 216.18/216.41       91%28%77%29%; was see under HISTOCYTOCHEMISTRY 1979-90; was see under STAINS AND STAINING 1977-78%A%  
% 216.18/216.41  |- mesh__recordMaintainer mesh__D010503 nns
% 216.18/216.41  |- skos__hiddenLabel mesh__D010503 Reactions, Periodic Acid-Schiff
% 216.18/216.41  |- skos__prefLabel mesh__D010503 Periodic Acid-Schiff Reaction
% 216.18/216.41  |- skos__scopeNote mesh__D010503
% 216.18/216.41       A histochemical technique for staining carbohydrates. It is based on PERIODIC ACID oxidation of a substance containing adjacent hydroxyl groups. The resulting aldehydes react with Schiff reagent to form a colored product.%A%    
% 216.18/216.41  |- mesh__publicMeSHNote mesh__D010503
% 216.18/216.41       91; was see under HISTOCYTOCHEMISTRY 1979-90; was see under STAINS AND STAINING 1977-78%A%  
% 216.18/216.41  |- skos__hiddenLabel mesh__D010503 Reactions, PAS
% 216.18/216.41  |- skos__hiddenLabel mesh__D010503 Reaction, Periodic Acid-Schiff
% 216.18/216.41  |- skos__hiddenLabel mesh__D010503 Reaction, PAS
% 216.18/216.41  |- rdf__type mesh__D010503sskos__Concept
% 216.18/216.41  |- skos__broader mesh__D010503smesh__D013194
% 216.18/216.41  |- skos__altLabel mesh__D010503 PAS Reaction
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D015797 2006
% 216.18/216.41  |- mesh__publicMeSHNote mesh__D015797 90   
% 216.18/216.41  |- mesh__recordOriginator mesh__D015797 AGS
% 216.18/216.41  |- skos__altLabel mesh__D015797 HLA-Bw35
% 216.18/216.41  |- skos__hiddenLabel mesh__D015797 Antigen, HLA-B35
% 216.18/216.41  |- skos__annotation mesh__D015797
% 216.18/216.41       weakly assoc with several dis; DF: HLA B35   
% 216.18/216.41  |- mesh__recordAuthorizer mesh__D015797 sjn
% 216.18/216.41  |- skos__historyNote mesh__D015797 HLA-B Antigens %28%1989%29%
% 216.18/216.41  |- mesh__recordMaintainer mesh__D015797 ssb
% 216.18/216.41  |- skos__altLabel mesh__D015797 HLA-B35
% 216.18/216.41  |- mesh__dateCreated mesh__D015797 1989-05-15
% 216.18/216.41  |- skos__broader mesh__D015797smesh__D015235
% 216.18/216.41  |- skos__scopeNote mesh__D015797
% 216.18/216.41       Human histocompatibility %28%HLA%29% surface antigen encoded by the B locus on chromosome 6. It is weakly associated with a number of diseases.%A%    
% 216.18/216.41  |- rdf__type mesh__D015797sskos__Concept
% 216.18/216.41  |- skos__historyNote mesh__D015797 HLA Antigens %28%1976-1988%29%
% 216.18/216.41  |- skos__prefLabel mesh__D015797 HLA-B35 Antigen
% 216.18/216.41  |- mesh__dateRevised mesh__D015797 2005-06-30
% 216.18/216.41  |- skos__hiddenLabel mesh__D015797 HLA B35 Antigen
% 216.18/216.41  |- mesh__historyNote mesh__D015797 90   
% 216.18/216.41  |- mesh__dateEstablished mesh__D015797 1990-01-01
% 216.18/216.41  |- skos__prefLabel mesh__D001777 Blood Coagulation
% 216.18/216.41  |- skos__related mesh__D001777smesh__D011517
% 216.18/216.41  |- skos__related mesh__D001777smesh__D000925
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D001777 2004
% 216.18/216.41  |- mesh__dateRevised mesh__D001777 2003-07-09
% 216.18/216.41  |- skos__related mesh__D001777smesh__D013918
% 216.18/216.41  |- skos__related mesh__D001777smesh__D014914
% 216.18/216.41  |- skos__altLabel mesh__D001777 Coagulation, Blood
% 216.18/216.41  |- skos__related mesh__D001777smesh__D010314
% 216.18/216.41  |- skos__scopeNote mesh__D001777
% 216.18/216.41       The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot.%A%    
% 216.18/216.41  |- mesh__dateCreated mesh__D001777 1999-01-01
% 216.18/216.41  |- skos__altLabel mesh__D001777 Blood Clotting
% 216.18/216.41  |- skos__related mesh__D001777smesh__D003029
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D001777 2006
% 216.18/216.41  |- skos__annotation mesh__D001777
% 216.18/216.41       coord BLOOD COAGULATION in diseases with disease /blood, not /physiopathol; %22%blood clot%22% if physiol goes here, if pathol, goes under THROMBOSIS or EMBOLISM; DF: BLOOD COAG%A%  
% 216.18/216.41  |- skos__related mesh__D001777smesh__D001780
% 216.18/216.41  |- mesh__recordOriginator mesh__D001777 NLM
% 216.18/216.41  |- skos__broader mesh__D001777smesh__D006487
% 216.18/216.41  |- rdf__type mesh__D001777sskos__Concept
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D001777 2005
% 216.18/216.41  |- mesh__recordMaintainer mesh__D001777 nns
% 216.18/216.41  |- skos__related mesh__D001777smesh__D006490
% 216.18/216.41  |- skos__hiddenLabel mesh__D001777 Clotting, Blood
% 216.18/216.41  |- mesh__recordAuthorizer mesh__D001777 sjn
% 216.18/216.41  |- skos__hiddenLabel mesh__D001777 Blood Clottings
% 216.18/216.41  |- mesh__recordAuthorizer mesh__D020931 sjn
% 216.18/216.41  |- skos__altLabel mesh__D020931 ran Proteins
% 216.18/216.41  |- skos__altLabel mesh__D020931 TC4 Protein
% 216.18/216.41  |- skos__hiddenLabel mesh__D020931 Nuclear Protein, ras-Related
% 216.18/216.41  |- skos__altLabel mesh__D020931 ras-Related Nuclear Protein
% 216.18/216.41  |- skos__broader mesh__D020931smesh__D029543
% 216.18/216.41  |- skos__altLabel mesh__D020931 ran Protein
% 216.18/216.41  |- skos__hiddenLabel mesh__D020931 ran GTP Binding Protein
% 216.18/216.41  |- skos__scopeNote mesh__D020931
% 216.18/216.41       A monomeric GTP-binding protein involved in nucleocytoplasmic transport of proteins into the nucleus and RNA into the cytoplasm. This enzyme was formerly listed as EC 3.6.1.47.%A%    
% 216.18/216.41  |- rdf__type mesh__D020931sskos__Concept
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D020931 2006
% 216.18/216.41  |- mesh__dateEstablished mesh__D020931 2000-01-01
% 216.18/216.41  |- skos__hiddenLabel mesh__D020931 ras Related Nuclear Protein
% 216.18/216.41  |- skos__historyNote mesh__D020931 Nuclear Proteins %28%1991-1999%29%
% 216.18/216.41  |- mesh__historyNote mesh__D020931
% 216.18/216.41       2000; use RAN GTP-BINDING PROTEIN %28%NM%29% 1991-1999   
% 216.18/216.41  |- mesh__dateRevised mesh__D020931 2005-06-30
% 216.18/216.41  |- mesh__recordOriginator mesh__D020931 jmp
% 216.18/216.41  |- skos__prefLabel mesh__D020931 ran GTP-Binding Protein
% 216.18/216.41  |- skos__broader mesh__D020931smesh__D020559
% 216.18/216.41  |- mesh__dateCreated mesh__D020931 1999-11-03
% 216.18/216.41  |- skos__hiddenLabel mesh__D020931 GTP-Binding Protein, ran
% 216.18/216.41  |- mesh__publicMeSHNote mesh__D020931
% 216.18/216.41       2000; RAN PROTEIN %28%now RAN GTP-BINDING PROTEIN%29% was indexed under NUCLEAR PROTEINS 1991-1999%A%  
% 216.18/216.41  |- mesh__recordMaintainer mesh__D020931 jmp
% 216.18/216.41  |- skos__broader mesh__D020931smesh__D009687
% 216.18/216.41  |- skos__hiddenLabel mesh__D006462 Plaque Techniques, Hemolytic
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D006462 2005
% 216.18/216.41  |- rdf__type mesh__D006462sskos__Concept
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D006462 2001
% 216.18/216.41  |- skos__hiddenLabel mesh__D006462 Technique, Jerne%27%s Plaque
% 216.18/216.41  |- skos__historyNote mesh__D006462 Antibody Formation %28%1966-1968%29%
% 216.18/216.41  |- skos__hiddenLabel mesh__D006462 Jerne Plaque Technique
% 216.18/216.41  |- mesh__publicMeSHNote mesh__D006462
% 216.18/216.41       91; was HEMOLYTIC PLAQUE TECHNIC 1973-90   
% 216.18/216.41  |- skos__hiddenLabel mesh__D006462 Technique, Hemolytic Plaque
% 216.18/216.41  |- skos__hiddenLabel mesh__D006462 Plaque Technic, Jerne%27%s
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D006462 2000
% 216.18/216.41  |- skos__hiddenLabel mesh__D006462 Plaque Technic, Hemolytic
% 216.18/216.41  |- mesh__recordOriginator mesh__D006462 NLM
% 216.18/216.41  |- skos__broader mesh__D006462smesh__D007158
% 216.18/216.41  |- skos__hiddenLabel mesh__D006462 Jernes Plaque Technique
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D006462 2004
% 216.18/216.41  |- mesh__dateRevised mesh__D006462 1999-11-03
% 216.18/216.41  |- skos__hiddenLabel mesh__D006462 Technic, Jerne%27%s Plaque
% 216.18/216.41  |- mesh__recordAuthorizer mesh__D006462 sjn
% 216.18/216.41  |- skos__altLabel mesh__D006462 Hemolytic Plaque Technic
% 216.18/216.41  |- skos__hiddenLabel mesh__D006462 Plaque Technics, Hemolytic
% 216.18/216.41  |- skos__hiddenLabel mesh__D006462 Hemolytic Plaque Technics
% 216.18/216.41  |- mesh__dateEstablished mesh__D006462 1973-01-01
% 216.18/216.41  |- mesh__dateCreated mesh__D006462 1999-01-01
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D006462 2003
% 216.18/216.41  |- skos__hiddenLabel mesh__D006462 Techniques, Hemolytic Plaque
% 216.18/216.41  |- skos__altLabel mesh__D006462 Jerne%27%s Plaque Technic
% 216.18/216.41  |- skos__hiddenLabel mesh__D006462 Jernes Plaque Technic
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D006462 2002
% 216.18/216.41  |- skos__broader mesh__D006462smesh__D007159
% 216.18/216.41  |- skos__altLabel mesh__D006462 Jerne%27%s Plaque Technique
% 216.18/216.41  |- skos__hiddenLabel mesh__D006462 Plaque Technique, Jerne%27%s
% 216.18/216.41  |- skos__hiddenLabel mesh__D006462 Plaque Technique, Hemolytic
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D006462 2006
% 216.18/216.41  |- skos__hiddenLabel mesh__D006462 Technics, Hemolytic Plaque
% 216.18/216.41  |- mesh__recordMaintainer mesh__D006462 kle
% 216.18/216.41  |- mesh__historyNote mesh__D006462
% 216.18/216.41       91%28%69%29%; was HEMOLYTIC PLAQUE TECHNIC 1969-90 %28%Prov 1969-72%29%%A%  
% 216.18/216.41  |- skos__annotation mesh__D006462
% 216.18/216.41       for detecting antibody-producing cells; hemolysis in gel goes here%A%  
% 216.18/216.41  |- skos__hiddenLabel mesh__D006462 Technic, Hemolytic Plaque
% 216.18/216.41  |- skos__prefLabel mesh__D006462 Hemolytic Plaque Technique
% 216.18/216.41  |- skos__hiddenLabel mesh__D006462 Hemolytic Plaque Techniques
% 216.18/216.41  |- skos__hiddenLabel mesh__D006462 Jerne Plaque Technic
% 216.18/216.41  |- mesh__onlineNote mesh__D006462
% 216.18/216.41       use HEMOLYTIC PLAQUE TECHNIQUE to search HEMOLYTIC PLAQUE TECHNIC 1969-90%A%  
% 216.18/216.41  |- mesh__recordAuthorizer mesh__D020133 sjn
% 216.18/216.41  |- skos__altLabel mesh__D020133 RT-PCR
% 216.18/216.41  |- mesh__recordOriginator mesh__D020133 NDW
% 216.18/216.41  |- mesh__publicMeSHNote mesh__D020133 99   
% 216.18/216.41  |- skos__broader mesh__D020133smesh__D016133
% 216.18/216.41  |- skos__scopeNote mesh__D020133
% 216.18/216.41       A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols.%A%    
% 216.18/216.41  |- mesh__dateEstablished mesh__D020133 1999-01-01
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D020133 2003
% 216.18/216.41  |- skos__altLabel mesh__D020133 RTPCR
% 216.18/216.41  |- mesh__historyNote mesh__D020133 99   
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D020133 2004
% 216.18/216.41  |- mesh__dateCreated mesh__D020133 1998-06-11
% 216.18/216.41  |- mesh__recordMaintainer mesh__D020133 lkt
% 216.18/216.41  |- mesh__dateRevised mesh__D020133 2002-07-03
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D020133 2005
% 216.18/216.41  |- skos__historyNote mesh__D020133
% 216.18/216.41       RNA-Directed DNA Polymerase %28%1991-1998%29%
% 216.18/216.41  |- skos__historyNote mesh__D020133
% 216.18/216.41       Polymerase Chain Reaction %28%1991-1998%29%
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D020133 2006
% 216.18/216.41  |- skos__prefLabel mesh__D020133
% 216.18/216.41       Reverse Transcriptase Polymerase Chain Reaction
% 216.18/216.41  |- rdf__type mesh__D020133sskos__Concept
% 216.18/216.41  |- skos__altLabel mesh__D020133
% 216.18/216.41       Polymerase Chain Reaction, Reverse Transcriptase
% 216.18/216.41  |- skos__related mesh__D020133smesh__D012194
% 216.18/216.41  |- skos__broader mesh__D000906Q000096smesh__D000906
% 216.18/216.41  |- mesh__preferredCombination mesh__D000906Q000096smesh__D000917
% 216.18/216.41  |- rdf__type mesh__D000906Q000096smesh__CompoundConcept
% 216.18/216.41  |- skos__scopeNote mesh__D016890
% 216.18/216.41       Infection with FUNGI of the genus ENCEPHALITOZOON. Lesions commonly occur in the BRAIN and KIDNEY tubules. Other sites of infection in MAMMALS are the LIVER; ADRENAL GLANDS; OPTIC NERVES; RETINA; and MYOCARDIUM.%A%    
% 216.18/216.41  |- mesh__dateRevised mesh__D016890 2005-06-30
% 216.18/216.41  |- mesh__dateEstablished mesh__D016890 1992-01-01
% 216.18/216.41  |- mesh__recordOriginator mesh__D016890 PXP
% 216.18/216.41  |- mesh__recordAuthorizer mesh__D016890 sjn
% 216.18/216.41  |- skos__historyNote mesh__D016890
% 216.18/216.41       Encephalitozoon cuniculi %28%1982-1991%29%
% 216.18/216.41  |- skos__historyNote mesh__D016890 Protozoa %28%1978-1981%29%
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D016890 2006
% 216.18/216.41  |- mesh__publicMeSHNote mesh__D016890 92   
% 216.18/216.41  |- mesh__historyNote mesh__D016890 92   
% 216.18/216.41  |- skos__historyNote mesh__D016890 Sporozoea %28%1972-1981%29%
% 216.18/216.41  |- skos__prefLabel mesh__D016890 Encephalitozoonosis
% 216.18/216.41  |- mesh__dateCreated mesh__D016890 1991-05-02
% 216.18/216.41  |- rdf__type mesh__D016890sskos__Concept
% 216.18/216.41  |- skos__historyNote mesh__D016890 Protozoan Infections %28%1972-1991%29%
% 216.18/216.41  |- mesh__recordMaintainer mesh__D016890 ags
% 216.18/216.41  |- skos__broader mesh__D016890smesh__D016881
% 216.18/216.41  |- skos__hiddenLabel mesh__D016890 Encephalitozoonoses
% 216.18/216.41  |- skos__altLabel mesh__D030561 Databases, RNA
% 216.18/216.41  |- skos__altLabel mesh__D030561 DDBJ
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 RNA Database
% 216.18/216.41  |- mesh__dateCreated mesh__D030561 2001-07-25
% 216.18/216.41  |- skos__altLabel mesh__D030561 DNA Data Banks
% 216.18/216.41  |- skos__altLabel mesh__D030561 EMBL Nucleotide Sequence Database
% 216.18/216.41  |- mesh__dateRevised mesh__D030561 2005-07-29
% 216.18/216.41  |- skos__altLabel mesh__D030561 Nucleic Acid Databases
% 216.18/216.41  |- mesh__recordMaintainer mesh__D030561 ags
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 Databank, DNA
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 DNA Databank
% 216.18/216.41  |- skos__altLabel mesh__D030561 Databases, RNA Sequence
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 Sequence Databases, DNA
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 DNA Sequence Database
% 216.18/216.41  |- mesh__publicMeSHNote mesh__D030561
% 216.18/216.41       2002; for DNA DATABANKS see DATABASES, FACTUAL 1994-2001   
% 216.18/216.41  |- skos__altLabel mesh__D030561 Databases, DNA Sequence
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 Sequence Database, RNA
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D030561 2006
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 Database, DNA Sequence
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 Databanks, DNA
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 Database, RNA Sequence
% 216.18/216.41  |- skos__prefLabel mesh__D030561 Databases, Nucleic Acid
% 216.18/216.41  |- skos__related mesh__D030561smesh__D005820
% 216.18/216.41  |- skos__related mesh__D030561smesh__D015723
% 216.18/216.41  |- skos__altLabel mesh__D030561 DNA Databanks
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D030561 2006A
% 216.18/216.41  |- skos__altLabel mesh__D030561 Databases, Nucleic Acid Sequence
% 216.18/216.41  |- rdf__type mesh__D030561sskos__Concept
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D030561 2005
% 216.18/216.41  |- mesh__dateEstablished mesh__D030561 2002-01-01
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 DNA Database
% 216.18/216.41  |- mesh__recordAuthorizer mesh__D030561 ags
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 Data Banks, DNA
% 216.18/216.41  |- mesh__historyNote mesh__D030561
% 216.18/216.41       2002; for DNA DATABANKS use DATABASES, FACTUAL 1994-2001   
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 DNA Data Bank
% 216.18/216.41  |- skos__related mesh__D030561smesh__D016172
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 Banks, DNA Data
% 216.18/216.41  |- mesh__recordOriginator mesh__D030561 nns
% 216.18/216.41  |- skos__scopeNote mesh__D030561
% 216.18/216.41       DATABASES containing information about NUCLEIC ACIDS such as BASE SEQUENCE; SNPS; NUCLEIC ACID CONFORMATION; and other properties. Information about the DNA fragments kept in a GENE LIBRARY or GENOMIC LIBRARY is often maintained in DNA databases.%A%    
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 Sequence Database, DNA
% 216.18/216.41  |- skos__altLabel mesh__D030561 Databases, DNA
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 Nucleic Acid Database
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 RNA Sequence Database
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 Database, Nucleic Acid
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 Data Bank, DNA
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 Database, DNA
% 216.18/216.41  |- skos__broader mesh__D030561smesh__D030541
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 Sequence Databases, RNA
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 Bank, DNA Data
% 216.18/216.41  |- skos__hiddenLabel mesh__D030561 Database, RNA
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Syncytial Viruses, Bovine
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Spumaviruses, Hamster
% 216.18/216.41  |- skos__scopeNote mesh__D016092
% 216.18/216.41       Genus of non-oncogenic retroviruses which establish persistent infections in many animal species but are considered non-pathogenic. Its organisms have been isolated from primates %28%including humans%29%, cattle, cats, hamsters, and sea lions. Spumaviruses have a foamy or lace-like appearance and are often accompanied by syncytium formation. Chimpanzee foamy virus is the type species.%A%    
% 216.18/216.41  |- mesh__recordAuthorizer mesh__D016092 sjn
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Foamy Virus, Simian
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D016092 2006
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Sea Lion Spumaviruses
% 216.18/216.41  |- rdf__type mesh__D016092sskos__Concept
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Syncytium-Forming Virus, Feline
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Human Foamy Viruses
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Spumaviruses, Sea Lion
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Bovine Syncytial Viruses
% 216.18/216.41  |- skos__altLabel mesh__D016092 Spumaviruses
% 216.18/216.41  |- mesh__historyNote mesh__D016092
% 216.18/216.41       94; was SPUMAVIRINAE 1991-93; FOAMY VIRUS was see under RETROVIRIDAE 1981-90, was see under LEUKOVIRUSES 1978-80, %26% was see under LEUKEMOGENIC VIRUSES 1975-77.%A%  
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Spumaviruses, Human
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D016092 2005
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Syncytial Virus, Bovine
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Foamy Viruses, Simian
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D016092 2004
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Foamy Virus, Human
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Foamy Viruses
% 216.18/216.41  |- mesh__recordMaintainer mesh__D016092 ags
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Feline Syncytium Forming Virus
% 216.18/216.41  |- skos__broader mesh__D016092smesh__D012190
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Hamster Spumaviruses
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D016092 2002
% 216.18/216.41  |- skos__altLabel mesh__D016092 Feline Syncytium-Forming Virus
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D016092 2003
% 216.18/216.41  |- skos__altLabel mesh__D016092 Bovine Syncytial Virus
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Feline Syncytium-Forming Viruses
% 216.18/216.41  |- skos__altLabel mesh__D016092 Foamy Virus
% 216.18/216.41  |- skos__prefLabel mesh__D016092 Spumavirus
% 216.18/216.41  |- mesh__dateEstablished mesh__D016092 1991-01-01
% 216.18/216.41  |- mesh__recordOriginator mesh__D016092 AGS
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Simian Foamy Virus
% 216.18/216.41  |- skos__altLabel mesh__D016092 Human Spumavirus
% 216.18/216.41  |- mesh__onlineNote mesh__D016092
% 216.18/216.41       use SPUMAVIRUS to search SPUMAVIRINAE 1991-93   
% 216.18/216.41  |- skos__annotation mesh__D016092
% 216.18/216.41       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29%   
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Spumavirus, Human
% 216.18/216.41  |- mesh__dateRevised mesh__D016092 2001-07-25
% 216.18/216.41  |- mesh__publicMeSHNote mesh__D016092
% 216.18/216.41       94; was SPUMAVIRINAE 1991-93; FOAMY VIRUS was see under RETROVIRIDAE 1981-90, was see under LEUKOVIRUSES 1978-80, %26% was see under LEUKEMOGENIC VIRUSES 1975-77.%A%  
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Human Spumaviruses
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Foamy Viruses, Human
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Syncytium-Forming Viruses, Feline
% 216.18/216.41  |- mesh__dateCreated mesh__D016092 1990-03-23
% 216.18/216.41  |- skos__historyNote mesh__D016092 Foamy Virus %28%1975-1990%29%
% 216.18/216.41  |- skos__historyNote mesh__D016092 Retroviridae %28%1977-1990%29%
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Spumavirus, Sea Lion
% 216.18/216.41  |- skos__hiddenLabel mesh__D016092 Spumavirus, Hamster
% 216.18/216.41  |- skos__altLabel mesh__D016092 Human Foamy Virus
% 216.18/216.41  |- mesh__recordMaintainer mesh__D002072 ADP
% 216.18/216.41  |- skos__historyNote mesh__D002072 Glycols %28%1969-1974%29%
% 216.18/216.41  |- mesh__recordOriginator mesh__D002072 NLM
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D002072 2002
% 216.18/216.41  |- mesh__dateRevised mesh__D002072 1997-06-20
% 216.18/216.41  |- skos__prefLabel mesh__D002072 Butylene Glycols
% 216.18/216.41  |- skos__altLabel mesh__D002072 Dihydroxybutanes
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D002072 1998
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D002072 2005
% 216.18/216.41  |- mesh__dateCreated mesh__D002072 1974-11-11
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D002072 1999
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D002072 2006
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D002072 2000
% 216.18/216.41  |- skos__hiddenLabel mesh__D002072 Glycols, Butylene
% 216.18/216.41  |- mesh__historyNote mesh__D002072 98%28%75%29%   
% 216.18/216.41  |- skos__altLabel mesh__D002072 Butanediols
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D002072 2003
% 216.18/216.41  |- mesh__recordAuthorizer mesh__D002072 SJN
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D002072 2001
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D002072 2004
% 216.18/216.41  |- mesh__publicMeSHNote mesh__D002072 98; see BUTANEDIOLS 1975-97   
% 216.18/216.41  |- skos__scopeNote mesh__D002072
% 216.18/216.41       4-carbon straight chain aliphatic hydrocarbons substituted with two hydroxyl groups. The hydroxyl groups cannot be on the same carbon atom.%A%    
% 216.18/216.41  |- mesh__dateEstablished mesh__D002072 1975-09-01
% 216.18/216.41  |- rdf__type mesh__D002072sskos__Concept
% 216.18/216.41  |- skos__broader mesh__D002072smesh__D006018
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D010504 2006
% 216.18/216.41  |- skos__hiddenLabel mesh__D010504 Acid, Periodic
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D010504 2003
% 216.18/216.41  |- mesh__recordOriginator mesh__D010504 NLM
% 216.18/216.41  |- mesh__publicMeSHNote mesh__D010504
% 216.18/216.41       94; was PERIODIC ACIDS 1963-93; PERIODIC ACID was indexed under PERIODIC ACIDS 1987-93%A%  
% 216.18/216.41  |- mesh__recordAuthorizer mesh__D010504 sjn
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D010504 2005
% 216.18/216.41  |- mesh__historyNote mesh__D010504
% 216.18/216.41       94; was PERIODIC ACIDS 1963-93; PERIODIC ACID was NM 1987-93%A%  
% 216.18/216.41  |- rdf__type mesh__D010504sskos__Concept
% 216.18/216.41  |- skos__broader mesh__D010504smesh__D000148
% 216.18/216.41  |- skos__prefLabel mesh__D010504 Periodic Acid
% 216.18/216.41  |- skos__broader mesh__D010504smesh__D017613
% 216.18/216.41  |- mesh__dateRevised mesh__D010504 2001-07-25
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D010504 2002
% 216.18/216.41  |- skos__altLabel mesh__D010504 Paraperiodic Acid
% 216.18/216.41  |- skos__scopeNote mesh__D010504 A strong oxidizing agent.     
% 216.18/216.41  |- mesh__recordMaintainer mesh__D010504 CCR
% 216.18/216.41  |- skos__hiddenLabel mesh__D010504 Acid, Paraperiodic
% 216.18/216.41  |- mesh__onlineNote mesh__D010504
% 216.18/216.41       use PERIODIC ACID to search PERIODIC ACIDS 1966-93   
% 216.18/216.41  |- skos__hiddenLabel mesh__D010504 Acids, Periodic
% 216.18/216.41  |- mesh__dateCreated mesh__D010504 1999-01-01
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D010504 2004
% 216.18/216.41  |- skos__altLabel mesh__D015798 HLA-DR1
% 216.18/216.41  |- mesh__historyNote mesh__D015798 90   
% 216.18/216.41  |- mesh__dateCreated mesh__D015798 1989-05-15
% 216.18/216.41  |- mesh__dateRevised mesh__D015798 2005-06-30
% 216.18/216.41  |- skos__hiddenLabel mesh__D015798 HLA DR1 Antigen
% 216.18/216.41  |- skos__broader mesh__D015798smesh__D006684
% 216.18/216.41  |- rdf__type mesh__D015798sskos__Concept
% 216.18/216.41  |- mesh__recordOriginator mesh__D015798 AGS
% 216.18/216.41  |- skos__historyNote mesh__D015798 HLA-DR Antigens %28%1986-1989%29%
% 216.18/216.41  |- skos__historyNote mesh__D015798
% 216.18/216.41       Histocompatibility Antigens Class II %28%1981-1986%29%
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D015798 2006
% 216.18/216.41  |- skos__scopeNote mesh__D015798
% 216.18/216.41       Human immune-response, D-related antigen encoded by the D locus on chromosome 6 and found on lymphoid cells.%A%    
% 216.18/216.41  |- mesh__dateEstablished mesh__D015798 1990-01-01
% 216.18/216.41  |- skos__hiddenLabel mesh__D015798 Antigen, HLA-DR1
% 216.18/216.41  |- mesh__publicMeSHNote mesh__D015798 90   
% 216.18/216.41  |- mesh__recordAuthorizer mesh__D015798 sjn
% 216.18/216.41  |- skos__annotation mesh__D015798 read MeSH definition; DF: HLA DR1   
% 216.18/216.41  |- mesh__recordMaintainer mesh__D015798 ssb
% 216.18/216.41  |- skos__prefLabel mesh__D015798 HLA-DR1 Antigen
% 216.18/216.41  |- skos__altLabel mesh__D001778 Disorders, Blood Coagulation
% 216.18/216.41  |- skos__hiddenLabel mesh__D001778 Coagulation Disorder, Blood
% 216.18/216.41  |- skos__scopeNote mesh__D001778
% 216.18/216.41       Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.%A%    
% 216.18/216.41  |- skos__altLabel mesh__D001778 Coagulation Disorders, Blood
% 216.18/216.41  |- mesh__dateCreated mesh__D001778 1999-01-01
% 216.18/216.41  |- mesh__recordOriginator mesh__D001778 NLM
% 216.18/216.41  |- skos__prefLabel mesh__D001778 Blood Coagulation Disorders
% 216.18/216.41  |- mesh__recordMaintainer mesh__D001778 jls
% 216.18/216.41  |- mesh__recordAuthorizer mesh__D001778 sjn
% 216.18/216.41  |- skos__hiddenLabel mesh__D001778 Disorder, Blood Coagulation
% 216.18/216.41  |- mesh__activeMeSHYear mesh__D001778 2005
% 216.18/216.41  |- mesh__dateRevised mesh__D001778 2004-07-19
% 216.27/216.41  |- skos__annotation mesh__D001778
% 216.27/216.41       GEN: prefer specifics; consider also COAGULATION PROTEIN DISORDERS and indentions; see also THROMBOSIS; EMBOLISM and specifics in C14; /genet: consider also BLOOD COAGULATION DISORDERS, INHERITED; DF: BLOOD COAG DIS%A%  
% 216.27/216.41  |- mesh__activeMeSHYear mesh__D001778 2006
% 216.27/216.41  |- skos__broader mesh__D001778smesh__D006402
% 216.27/216.41  |- rdf__type mesh__D001778sskos__Concept
% 216.27/216.41  |- skos__hiddenLabel mesh__D001778 Blood Coagulation Disorder
% 216.27/216.41  |- rdf__type mesh__D020932sskos__Concept
% 216.27/216.41  |- mesh__dateRevised mesh__D020932 2005-06-30
% 216.27/216.41  |- mesh__recordOriginator mesh__D020932 jmp
% 216.27/216.41  |- mesh__historyNote mesh__D020932
% 216.27/216.41       2000; use NERVE GROWTH FACTORS 1966-1999   
% 216.27/216.41  |- mesh__activeMeSHYear mesh__D020932 2006
% 216.27/216.41  |- mesh__publicMeSHNote mesh__D020932
% 216.27/216.41       2000; see NERVE GROWTH FACTORS 1980-1999, see NERVE GROWTH FACTOR 1966-1979%A%  
% 216.27/216.41  |- skos__broader mesh__D020932smesh__D009414
% 216.27/216.41  |- skos__hiddenLabel mesh__D020932 Factor, beta-Nerve Growth
% 216.27/216.41  |- mesh__dateEstablished mesh__D020932 2000-01-01
% 216.27/216.41  |- skos__annotation mesh__D020932 NERVE GROWTH FACTORS is also available   
% 216.27/216.41  |- mesh__recordAuthorizer mesh__D020932 sjn
% 216.27/216.41  |- skos__altLabel mesh__D020932 beta-Nerve Growth Factor
% 216.27/216.41  |- skos__hiddenLabel mesh__D020932 beta Nerve Growth Factor
% 216.27/216.42  |- skos__hiddenLabel mesh__D020932 NGF 1beta
% 216.27/216.42  |- skos__historyNote mesh__D020932 Nerve Growth Factors %28%1980-1999%29%
% 216.27/216.42  |- skos__prefLabel mesh__D020932 Nerve Growth Factor
% 216.27/216.42  |- skos__historyNote mesh__D020932 Nerve Growth Factor %28%1966-1979%29%
% 216.27/216.42  |- skos__scopeNote mesh__D020932
% 216.27/216.42       NERVE GROWTH FACTOR is the first of a series of neurotrophic factors that were found to influence the growth and differentiation of sympathetic and sensory neurons. It is comprised of alpha, beta, and gamma subunits. The beta subunit is responsible for its growth stimulating activity.%A%    
% 216.27/216.42  |- skos__altLabel mesh__D020932 NGF
% 216.27/216.42  |- mesh__dateCreated mesh__D020932 1999-11-05
% 216.27/216.42  |- skos__altLabel mesh__D020932 Nerve Growth Factor 1
% 216.27/216.42  |- skos__altLabel mesh__D020932 NGF-1beta
% 216.27/216.42  |- mesh__recordMaintainer mesh__D020932 ssb
% 216.27/216.42  |- skos__altLabel mesh__D020134 Catalytic Site
% 216.27/216.42  |- mesh__dateEstablished mesh__D020134 1999-01-01
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D020134 2006
% 216.27/216.42  |- skos__prefLabel mesh__D020134 Catalytic Domain
% 216.27/216.42  |- skos__historyNote mesh__D020134 Amino Acid Sequence %28%1975-1998%29%
% 216.27/216.42  |- skos__hiddenLabel mesh__D020134 Regions, Catalytic
% 216.27/216.42  |- skos__hiddenLabel mesh__D020134 Cores, Catalytic
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D020134 2003
% 216.27/216.42  |- skos__scopeNote mesh__D020134
% 216.27/216.42       The region of an enzyme that interacts with its substrate to cause the enzymatic reaction.%A%    
% 216.27/216.42  |- mesh__publicMeSHNote mesh__D020134 99   
% 216.27/216.42  |- skos__hiddenLabel mesh__D020134 Catalytic Domains
% 216.27/216.42  |- skos__hiddenLabel mesh__D020134 Catalytic Sites
% 216.27/216.42  |- skos__hiddenLabel mesh__D020134 Subunit, Catalytic
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D020134 2004
% 216.27/216.42  |- skos__broader mesh__D020134smesh__D000595
% 216.27/216.42  |- mesh__historyNote mesh__D020134 99   
% 216.27/216.42  |- skos__hiddenLabel mesh__D020134 Catalytic Regions
% 216.27/216.42  |- skos__hiddenLabel mesh__D020134 Domains, Catalytic
% 216.27/216.42  |- skos__hiddenLabel mesh__D020134 Site, Catalytic
% 216.27/216.42  |- mesh__dateCreated mesh__D020134 1998-06-10
% 216.27/216.42  |- skos__hiddenLabel mesh__D020134 Core, Catalytic
% 216.27/216.42  |- skos__altLabel mesh__D020134 Catalytic Region
% 216.27/216.42  |- skos__hiddenLabel mesh__D020134 Subunits, Catalytic
% 216.27/216.42  |- skos__altLabel mesh__D020134 Catalytic Core
% 216.27/216.42  |- skos__hiddenLabel mesh__D020134 Sites, Catalytic
% 216.27/216.42  |- skos__hiddenLabel mesh__D020134 Catalytic Subunits
% 216.27/216.42  |- rdf__type mesh__D020134sskos__Concept
% 216.27/216.42  |- mesh__dateRevised mesh__D020134 2002-07-03
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D020134 2005
% 216.27/216.42  |- skos__hiddenLabel mesh__D020134 Region, Catalytic
% 216.27/216.42  |- skos__hiddenLabel mesh__D020134 Domain, Catalytic
% 216.27/216.42  |- skos__hiddenLabel mesh__D020134 Catalytic Cores
% 216.27/216.42  |- skos__altLabel mesh__D020134 Catalytic Subunit
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D006463 2000
% 216.27/216.42  |- skos__historyNote mesh__D006463 Anemia, Hemolytic %28%1966-1971%29%
% 216.27/216.42  |- skos__prefLabel mesh__D006463 Hemolytic-Uremic Syndrome
% 216.27/216.42  |- skos__hiddenLabel mesh__D006463 Syndrome, Hemolytic-Uremic
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D006463 2004
% 216.27/216.42  |- mesh__dateCreated mesh__D006463 1999-01-01
% 216.27/216.42  |- skos__hiddenLabel mesh__D006463 Hemolytic Uremic Syndrome
% 216.27/216.42  |- mesh__recordMaintainer mesh__D006463 NNS
% 216.27/216.42  |- mesh__historyNote mesh__D006463 74%28%72%29%   
% 216.27/216.42  |- skos__scopeNote mesh__D006463
% 216.27/216.42       Syndrome of hemolytic anemia, thrombocytopenia, and acute renal failure, with pathological finding of thrombotic microangiopathy in kidney and renal cortical necrosis.%A%    
% 216.27/216.42  |- rdf__type mesh__D006463sskos__Concept
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D006463 2001
% 216.27/216.42  |- skos__altLabel mesh__D006463 Gasser Syndrome
% 216.27/216.42  |- skos__historyNote mesh__D006463 Uremia %28%1966-1971%29%
% 216.27/216.42  |- skos__hiddenLabel mesh__D006463 Gassers Syndrome
% 216.27/216.42  |- skos__hiddenLabel mesh__D006463 Hemolytic-Uremic Syndromes
% 216.27/216.42  |- mesh__recordAuthorizer mesh__D006463 SJN
% 216.27/216.42  |- skos__altLabel mesh__D006463 Gasser%27%s Syndrome
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D006463 1999
% 216.27/216.42  |- skos__broader mesh__D006463smesh__D000743
% 216.27/216.42  |- skos__hiddenLabel mesh__D006463 Syndrome, Gasser
% 216.27/216.42  |- mesh__recordOriginator mesh__D006463 NLM
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D006463 2005
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D006463 2002
% 216.27/216.42  |- skos__hiddenLabel mesh__D006463 Syndrome, Gasser%27%s
% 216.27/216.42  |- mesh__dateEstablished mesh__D006463 1974-01-01
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D006463 2006
% 216.27/216.42  |- skos__broader mesh__D006463smesh__D013921
% 216.27/216.42  |- mesh__publicMeSHNote mesh__D006463 74   
% 216.27/216.42  |- mesh__dateRevised mesh__D006463 1998-06-10
% 216.27/216.42  |- skos__hiddenLabel mesh__D006463 Syndromes, Gasser
% 216.27/216.42  |- skos__broader mesh__D006463smesh__D014511
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D006463 2003
% 216.27/216.42  |- skos__broader mesh__D000110Q000037smesh__D000110
% 216.27/216.42  |- mesh__preferredCombination mesh__D000110Q000037smesh__D002800
% 216.27/216.42  |- rdf__type mesh__D000110Q000037smesh__CompoundConcept
% 216.27/216.42  |- mesh__dateCreated mesh__D044582 2003-07-09
% 216.27/216.42  |- skos__scopeNote mesh__D044582
% 216.27/216.42       Instruments for the visual examination of interior structures related to NEUROSURGICAL PROCEDURES. There are two broad categories of neuroendoscopes, the rigid scope and the flexible scope, for various types of procedures.%A%    
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D044582 2006
% 216.27/216.42  |- mesh__dateEstablished mesh__D044582 2004-01-01
% 216.27/216.42  |- skos__historyNote mesh__D044582 Endoscopes %28%1990-2003%29%
% 216.27/216.42  |- rdf__type mesh__D044582sskos__Concept
% 216.27/216.42  |- skos__prefLabel mesh__D044582 Neuroendoscopes
% 216.27/216.42  |- skos__broader mesh__D044582smesh__D019723
% 216.27/216.42  |- mesh__historyNote mesh__D044582 2004   
% 216.27/216.42  |- skos__related mesh__D044582smesh__D044583
% 216.27/216.42  |- mesh__publicMeSHNote mesh__D044582 2004   
% 216.27/216.42  |- skos__altLabel mesh__D044582 Neuroendoscope
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D044582 2004
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D044582 2005
% 216.27/216.42  |- skos__altLabel mesh__D016891 Autosomal Dominant Polycystic Kidney
% 216.27/216.42  |- skos__altLabel mesh__D016891 Adult Polycystic Kidney Disease Type 1
% 216.27/216.42  |- skos__altLabel mesh__D016891 ADPKD
% 216.27/216.42  |- skos__historyNote mesh__D016891 Kidney, Polycystic %28%1974-1991%29%
% 216.27/216.42  |- mesh__publicMeSHNote mesh__D016891
% 216.27/216.42       1992; see KIDNEY, POLYCYSTIC, AUTOSOMAL DOMINANT 1992-2000%A%  
% 216.27/216.42  |- rdf__type mesh__D016891sskos__Concept
% 216.27/216.42  |- mesh__dateEstablished mesh__D016891 1992-01-01
% 216.27/216.42  |- skos__altLabel mesh__D016891
% 216.27/216.42       Polycystic Kidney Disease, Autosomal Dominant
% 216.27/216.42  |- mesh__dateRevised mesh__D016891 2005-06-30
% 216.27/216.42  |- skos__altLabel mesh__D016891 Adult Polycystic Kidney Disease Type 2
% 216.27/216.42  |- mesh__recordOriginator mesh__D016891 AGS
% 216.27/216.42  |- skos__scopeNote mesh__D016891
% 216.27/216.42       Kidney disorders with autosomal dominant inheritance and characterized by multiple CYSTS in both KIDNEYS with progressive deterioration of renal function.%A%    
% 216.27/216.42  |- mesh__recordAuthorizer mesh__D016891 sjn
% 216.27/216.42  |- mesh__recordMaintainer mesh__D016891 lkt
% 216.27/216.42  |- skos__broader mesh__D016891smesh__D007690
% 216.27/216.42  |- skos__altLabel mesh__D016891 Adult Polycystic Kidney Disease
% 216.27/216.42  |- skos__prefLabel mesh__D016891 Polycystic Kidney, Autosomal Dominant
% 216.27/216.42  |- mesh__dateCreated mesh__D016891 1991-05-30
% 216.27/216.42  |- mesh__historyNote mesh__D016891 1992   
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D016891 2006
% 216.27/216.42  |- skos__altLabel mesh__D016891 Kidney, Polycystic, Autosomal Dominant
% 216.27/216.42  |- skos__hiddenLabel mesh__D030562 Database, Protein
% 216.27/216.42  |- skos__altLabel mesh__D030562 Databases, Amino Acid Sequence
% 216.27/216.42  |- skos__altLabel mesh__D030562 Amino Acid Sequence Databases
% 216.27/216.42  |- mesh__dateRevised mesh__D030562 2004-07-07
% 216.27/216.42  |- mesh__publicMeSHNote mesh__D030562 2002   
% 216.27/216.42  |- mesh__dateCreated mesh__D030562 2001-07-25
% 216.27/216.42  |- mesh__dateEstablished mesh__D030562 2002-01-01
% 216.27/216.42  |- skos__prefLabel mesh__D030562 Databases, Protein
% 216.27/216.42  |- skos__hiddenLabel mesh__D030562 Sequence Databases, Protein
% 216.27/216.42  |- mesh__recordOriginator mesh__D030562 nns
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D030562 2005
% 216.27/216.42  |- skos__historyNote mesh__D030562 Information Systems %28%1987-1990%29%
% 216.27/216.42  |- skos__hiddenLabel mesh__D030562 Structure Database, Protein
% 216.27/216.42  |- skos__hiddenLabel mesh__D030562 Sequence Database, Protein
% 216.27/216.42  |- skos__historyNote mesh__D030562 Databases, Factual %28%1991-2001%29%
% 216.27/216.42  |- skos__hiddenLabel mesh__D030562 Structure Databases, Protein
% 216.27/216.42  |- skos__altLabel mesh__D030562 Protein Databases
% 216.27/216.42  |- skos__hiddenLabel mesh__D030562 Databases, Protein Structure
% 216.27/216.42  |- skos__broader mesh__D030562smesh__D030541
% 216.27/216.42  |- skos__hiddenLabel mesh__D030562 SWISS PROT
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D030562 2006
% 216.27/216.42  |- skos__hiddenLabel mesh__D030562 Protein Sequence Database
% 216.27/216.42  |- skos__scopeNote mesh__D030562
% 216.27/216.42       DATABASES containing information about PROTEINS such as AMINO ACID SEQUENCE; PROTEIN CONFORMATION; and other properties.%A%    
% 216.27/216.42  |- skos__hiddenLabel mesh__D030562 Databases, Protein Sequence
% 216.27/216.42  |- mesh__recordMaintainer mesh__D030562 jls
% 216.27/216.42  |- skos__hiddenLabel mesh__D030562 Protein Structure Database
% 216.27/216.42  |- skos__hiddenLabel mesh__D030562 Database, Protein Structure
% 216.27/216.42  |- mesh__historyNote mesh__D030562 2002   
% 216.27/216.42  |- skos__hiddenLabel mesh__D030562 Protein Database
% 216.27/216.42  |- mesh__recordAuthorizer mesh__D030562 sjn
% 216.27/216.42  |- skos__altLabel mesh__D030562 SwissProt
% 216.27/216.42  |- rdf__type mesh__D030562sskos__Concept
% 216.27/216.42  |- skos__hiddenLabel mesh__D030562 Database, Protein Sequence
% 216.27/216.42  |- skos__scopeNote mesh__D052216
% 216.27/216.42       A peptide processed from proglucagon in the GI TRACT that acts at glucagon-like peptide-1 receptor and is degraded by DIPEPTIDYL-PEPTIDASE IV. It stimulates INSULIN secretion.%A%    
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D052216 2006
% 216.27/216.42  |- mesh__recordMaintainer mesh__D052216 ssb
% 216.27/216.42  |- rdf__type mesh__D052216sskos__Concept
% 216.27/216.42  |- skos__altLabel mesh__D052216 Proglucagon %28%78-107%29%
% 216.27/216.42  |- skos__altLabel mesh__D052216 GLP-1
% 216.27/216.42  |- skos__altLabel mesh__D052216 Glucagon-Like Peptide-1
% 216.27/216.42  |- skos__broader mesh__D052216smesh__D004763
% 216.27/216.42  |- mesh__dateCreated mesh__D052216 2005-06-30
% 216.27/216.42  |- mesh__publicMeSHNote mesh__D052216 2006   
% 216.27/216.42  |- skos__prefLabel mesh__D052216 Glucagon-Like Peptide 1
% 216.27/216.42  |- skos__hiddenLabel mesh__D052216 Glucagon Like Peptide 1
% 216.27/216.42  |- mesh__recordAuthorizer mesh__D052216 sjn
% 216.27/216.42  |- skos__hiddenLabel mesh__D052216 GLP 1
% 216.27/216.42  |- mesh__historyNote mesh__D052216 2006   
% 216.27/216.42  |- mesh__recordOriginator mesh__D052216 ssb
% 216.27/216.42  |- mesh__dateEstablished mesh__D052216 2006-01-01
% 216.27/216.42  |- skos__hiddenLabel mesh__D016093 retrovirus 2, Simian
% 216.27/216.42  |- skos__historyNote mesh__D016093 Oncogenic Viruses %28%1972-1976%29%
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D016093 2006
% 216.27/216.42  |- skos__hiddenLabel mesh__D016093 Mason Pfizer monkey virus
% 216.27/216.42  |- skos__altLabel mesh__D016093 SRV-3
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D016093 2002
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D016093 2005
% 216.27/216.42  |- rdf__type mesh__D016093sskos__Concept
% 216.27/216.42  |- mesh__recordAuthorizer mesh__D016093 sjn
% 216.27/216.42  |- skos__broader mesh__D016093smesh__D030121
% 216.27/216.42  |- skos__hiddenLabel mesh__D016093 retrovirus 1, Simian
% 216.27/216.42  |- mesh__historyNote mesh__D016093 91; was see SIV 1989-90   
% 216.27/216.42  |- skos__prefLabel mesh__D016093 Mason-Pfizer monkey virus
% 216.27/216.42  |- mesh__publicMeSHNote mesh__D016093 91; was see SIV 1989-90   
% 216.27/216.42  |- mesh__dateEstablished mesh__D016093 1991-01-01
% 216.27/216.42  |- mesh__dateRevised mesh__D016093 2001-07-25
% 216.27/216.42  |- skos__altLabel mesh__D016093 SRV-2
% 216.27/216.42  |- mesh__recordOriginator mesh__D016093 AGS
% 216.27/216.42  |- skos__annotation mesh__D016093
% 216.27/216.42       infection: coord IM with SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME %28%IM%29% or if not so specified RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%; DF: MPMV%A%  
% 216.27/216.42  |- skos__scopeNote mesh__D016093
% 216.27/216.42       A species of BETARETROVIRUS isolated from mammary carcinoma in rhesus monkeys. It appears to have evolved from a recombination between a murine B oncovirus and a primate C oncovirus related to the baboon endogenous virus. Several serologically distinct strains exist. MPMV induces simian AIDS %28%SAIDS%29%.%A%    
% 216.27/216.42  |- skos__hiddenLabel mesh__D016093 monkey virus, Mason-Pfizer
% 216.27/216.42  |- mesh__recordMaintainer mesh__D016093 ags
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D016093 2004
% 216.27/216.42  |- skos__altLabel mesh__D016093 SRV-1
% 216.27/216.42  |- mesh__onlineNote mesh__D016093
% 216.27/216.42       use SIV to search MASON-PFIZER MONKEY VIRUS 1989-90   
% 216.27/216.42  |- skos__broader mesh__D016093smesh__D015301
% 216.27/216.42  |- skos__historyNote mesh__D016093 Retroviridae %28%1977-1990%29%
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D016093 2003
% 216.27/216.42  |- skos__historyNote mesh__D016093
% 216.27/216.42       Vertebrate Viruses, Unclassified %28%1966-1971%29%
% 216.27/216.42  |- mesh__dateCreated mesh__D016093 1990-03-23
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D002871 2001
% 216.27/216.42  |- mesh__dateCreated mesh__D002871 1978-03-13
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D002871 2006
% 216.27/216.42  |- skos__scopeNote mesh__D002871
% 216.27/216.42       Staining of bands, or chromosome segments, allowing the precise identification of individual chromosomes or parts of chromosomes. Applications include the determination of chromosome rearrangements in malformation syndromes and cancer, the chemistry of chromosome segments, chromosome changes during evolution, and, in conjunction with cell hybridization studies, chromosome mapping.%A%    
% 216.27/216.42  |- skos__historyNote mesh__D002871 Chromosome Aberrations %28%1968-1978%29%
% 216.27/216.42  |- mesh__historyNote mesh__D002871 79   
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D002871 2002
% 216.27/216.42  |- skos__historyNote mesh__D002871 Staining %28%1966-1978%29%
% 216.27/216.42  |- skos__hiddenLabel mesh__D002871 Chromosome Bandings
% 216.27/216.42  |- mesh__publicMeSHNote mesh__D002871 79   
% 216.27/216.42  |- skos__historyNote mesh__D002871 Chromosomes %28%1966-1978%29%
% 216.27/216.42  |- skos__broader mesh__D002871smesh__D013194
% 216.27/216.42  |- mesh__recordAuthorizer mesh__D002871 sjn
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D002871 2003
% 216.27/216.42  |- skos__broader mesh__D002871smesh__D020732
% 216.27/216.42  |- skos__hiddenLabel mesh__D002871 Bandings, Chromosome
% 216.27/216.42  |- skos__altLabel mesh__D002871 Banding, Chromosome
% 216.27/216.42  |- skos__prefLabel mesh__D002871 Chromosome Banding
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D002871 2004
% 216.27/216.42  |- skos__historyNote mesh__D002871 specific dye %28%1966-1978%29%
% 216.27/216.42  |- mesh__recordOriginator mesh__D002871 SMH
% 216.27/216.42  |- mesh__dateEstablished mesh__D002871 1979-01-01
% 216.27/216.42  |- rdf__type mesh__D002871sskos__Concept
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D002871 2005
% 216.27/216.42  |- mesh__recordMaintainer mesh__D002871 KEV
% 216.27/216.42  |- mesh__dateRevised mesh__D002871 2000-06-22
% 216.27/216.42  |- skos__historyNote mesh__D002871 specific chromosome %28%1966-1978%29%
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D002073 2005
% 216.27/216.42  |- skos__historyNote mesh__D002073 Alkanes %28%1966-1972%29%
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D002073 1998
% 216.27/216.42  |- mesh__dateEstablished mesh__D002073 1973-01-01
% 216.27/216.42  |- mesh__publicMeSHNote mesh__D002073 73   
% 216.27/216.42  |- mesh__recordAuthorizer mesh__D002073 PLS
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D002073 1993
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D002073 1999
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D002073 2006
% 216.27/216.42  |- skos__annotation mesh__D002073
% 216.27/216.42       does not include butenes %28% = ALKENES%29%; CYCLOBUTANES is also available%A%  
% 216.27/216.42  |- mesh__recordOriginator mesh__D002073 NLM
% 216.27/216.42  |- mesh__dateCreated mesh__D002073 1999-01-01
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D002073 2002
% 216.27/216.42  |- mesh__historyNote mesh__D002073 73   
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D002073 1996
% 216.27/216.42  |- skos__prefLabel mesh__D002073 Butanes
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D002073 2003
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D002073 1997
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D002073 2004
% 216.27/216.42  |- mesh__recordMaintainer mesh__D002073 TGC
% 216.27/216.42  |- rdf__type mesh__D002073sskos__Concept
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D002073 2000
% 216.27/216.42  |- mesh__dateRevised mesh__D002073 1992-05-08
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D002073 1994
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D002073 1995
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D002073 2001
% 216.27/216.42  |- skos__broader mesh__D002073smesh__D000473
% 216.27/216.42  |- mesh__historyNote mesh__D010505 2000 %28%1966%29%   
% 216.27/216.42  |- rdf__type mesh__D010505sskos__Concept
% 216.27/216.42  |- skos__altLabel mesh__D010505 Periodic Fever Syndromes, Hereditary
% 216.27/216.42  |- skos__scopeNote mesh__D010505
% 216.27/216.42       An autosomal recessive inherited disease characterized by episodic FEVER; severe ABDOMINAL PAIN; PLEURISY; ARTHRITIS; and a characteristic ankle RASH. Disease flare-ups tend to last 3 days, and individuals are asymptomatic between attacks. ORCHITIS; benign recurrent MENINGITIS; HEADACHE; and AMYLOID nephropathy may also occur. %28%From Medicine %28%Baltimore%29% 1998 Jul;77%28%4%29%:268-97%29%%A%    
% 216.27/216.42  |- skos__annotation mesh__D010505
% 216.27/216.42       a specific disease entity: do not use X ref PERIODIC DISEASE for periodically occurring dis %28% = PERIODICITY %28%IM%29% + disease %28%IM%29%%29%%A%  
% 216.27/216.42  |- skos__altLabel mesh__D010505 Periodic Disease
% 216.27/216.42  |- mesh__publicMeSHNote mesh__D010505
% 216.27/216.42       2000; see PERIODIC DISEASE 1966-1999; for FAMILIAL MEDITERRANEAN FEVER see PERIODIC DISEASE 1966-1999%A%  
% 216.27/216.42  |- mesh__dateCreated mesh__D010505 1999-01-01
% 216.27/216.42  |- skos__hiddenLabel mesh__D010505 Fever, Familial Mediterranean
% 216.27/216.42  |- mesh__recordOriginator mesh__D010505 NLM
% 216.27/216.42  |- mesh__recordAuthorizer mesh__D010505 sjn
% 216.27/216.42  |- skos__altLabel mesh__D010505 Mediterranean Fever, Familial
% 216.27/216.42  |- skos__altLabel mesh__D010505 Wolff Periodic Disease
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D010505 2006
% 216.27/216.42  |- skos__prefLabel mesh__D010505 Familial Mediterranean Fever
% 216.27/216.42  |- skos__broader mesh__D010505smesh__D001327
% 216.27/216.42  |- skos__altLabel mesh__D010505 Periodic Disease, Wolff%27%s
% 216.27/216.42  |- mesh__dateRevised mesh__D010505 2004-07-07
% 216.27/216.42  |- skos__broader mesh__D010505smesh__D030342
% 216.27/216.42  |- skos__altLabel mesh__D010505 Wolff%27%s Periodic Disease
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D010505 2005
% 216.27/216.42  |- mesh__recordMaintainer mesh__D010505 nns
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D015799 2002
% 216.27/216.42  |- mesh__recordAuthorizer mesh__D015799 sjn
% 216.27/216.42  |- rdf__type mesh__D015799sskos__Concept
% 216.27/216.42  |- skos__historyNote mesh__D015799 Atrophy %28%1970-1989%29%
% 216.27/216.42  |- mesh__dateCreated mesh__D015799 1989-05-26
% 216.27/216.42  |- skos__hiddenLabel mesh__D015799 Atrophy, Gyrate
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D015799 2003
% 216.27/216.42  |- mesh__recordOriginator mesh__D015799 EGC
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D015799 2005
% 216.27/216.42  |- skos__historyNote mesh__D015799 Choroid %28%1970-1989%29%
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D015799 2004
% 216.27/216.42  |- mesh__historyNote mesh__D015799 90   
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D015799 2006
% 216.27/216.42  |- skos__annotation mesh__D015799
% 216.27/216.42       a hered eye dis; /congen permitted: read MeSH definition   
% 216.27/216.42  |- mesh__recordMaintainer mesh__D015799 nns
% 216.27/216.42  |- skos__broader mesh__D015799smesh__D015785
% 216.27/216.42  |- skos__broader mesh__D015799smesh__D015862
% 216.27/216.42  |- mesh__dateEstablished mesh__D015799 1990-01-01
% 216.27/216.42  |- skos__prefLabel mesh__D015799 Gyrate Atrophy
% 216.27/216.42  |- mesh__publicMeSHNote mesh__D015799 90   
% 216.27/216.42  |- skos__scopeNote mesh__D015799
% 216.27/216.42       Progressive, autosomal recessive, diffuse atrophy of the choroid, pigment epithelium, and sensory retina that begins in childhood.%A%    
% 216.27/216.42  |- mesh__dateRevised mesh__D015799 2001-07-25
% 216.27/216.42  |- skos__hiddenLabel mesh__D015799 Gyrate Atrophies
% 216.27/216.42  |- skos__hiddenLabel mesh__D015799 Atrophies, Gyrate
% 216.27/216.42  |- skos__historyNote mesh__D015799 Retinal Degeneration %28%1970-1989%29%
% 216.27/216.42  |- skos__prefLabel mesh__D001779 Blood Coagulation Factors
% 216.27/216.42  |- skos__altLabel mesh__D001779 Factor, Coagulation
% 216.27/216.42  |- skos__altLabel mesh__D001779 Coagulation Factors
% 216.27/216.42  |- mesh__recordMaintainer mesh__D001779 ssb
% 216.27/216.42  |- skos__altLabel mesh__D001779 Factors, Coagulation
% 216.27/216.42  |- skos__related mesh__D001779smesh__D003029
% 216.27/216.42  |- mesh__recordOriginator mesh__D001779 NLM
% 216.27/216.42  |- skos__altLabel mesh__D001779 Blood Coagulation Factor
% 216.27/216.42  |- skos__broader mesh__D001779smesh__D001798
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D001779 2006
% 216.27/216.42  |- skos__altLabel mesh__D001779 Coagulation Factor
% 216.27/216.42  |- skos__hiddenLabel mesh__D001779 Factor, Blood Coagulation
% 216.27/216.42  |- skos__altLabel mesh__D001779 Coagulation Factors, Blood
% 216.27/216.42  |- mesh__recordAuthorizer mesh__D001779 sjn
% 216.27/216.42  |- skos__altLabel mesh__D001779 Coagulation Factor, Blood
% 216.27/216.42  |- rdf__type mesh__D001779sskos__Concept
% 216.27/216.42  |- skos__broader mesh__D001779smesh__D001685
% 216.27/216.42  |- mesh__dateRevised mesh__D001779 2005-06-30
% 216.27/216.42  |- skos__annotation mesh__D001779
% 216.27/216.42       GEN or unspecified; prefer specifics; DF: BLOOD COAG FACTORS%A%  
% 216.27/216.42  |- skos__scopeNote mesh__D001779
% 216.27/216.42       Endogenous substances, usually proteins, that are involved in the blood coagulation process.%A%    
% 216.27/216.42  |- mesh__dateCreated mesh__D001779 1999-01-01
% 216.27/216.42  |- skos__hiddenLabel mesh__D001779 Factors, Blood Coagulation
% 216.27/216.42  |- skos__historyNote mesh__D020933 Nerve Growth Factors %28%1990-1999%29%
% 216.27/216.42  |- mesh__historyNote mesh__D020933
% 216.27/216.42       2000; use NEUROTROPHIN 3 %28%NM%29% 1990-1999; for NERVE GROWTH FACTOR 2 use NERVE GROWTH FACTORS 1992-1999%A%  
% 216.27/216.42  |- mesh__dateEstablished mesh__D020933 2000-01-01
% 216.27/216.42  |- mesh__recordMaintainer mesh__D020933 ssb
% 216.27/216.42  |- mesh__dateCreated mesh__D020933 1999-11-03
% 216.27/216.42  |- mesh__dateRevised mesh__D020933 2005-06-30
% 216.27/216.42  |- mesh__recordOriginator mesh__D020933 jmp
% 216.27/216.42  |- skos__scopeNote mesh__D020933
% 216.27/216.42       A neurotrophic factor involved in regulating the survival of visceral and proprioceptive sensory neurons. It is closely homologous to nerve growth factor beta and BRAIN-DERIVED NEUROTROPHIC FACTOR.%A%    
% 216.27/216.42  |- skos__prefLabel mesh__D020933 Neurotrophin 3
% 216.27/216.42  |- mesh__publicMeSHNote mesh__D020933
% 216.27/216.42       2000; NEUROTROPHIN 3 was indexed under NERVE GROWTH FACTORS 1990-1999; for NERVE GROWTH FACTOR 2 see NERVE GROWTH FACTORS 1992-1999%A%  
% 216.27/216.42  |- skos__altLabel mesh__D020933 NGF-2
% 216.27/216.42  |- mesh__recordAuthorizer mesh__D020933 sjn
% 216.27/216.42  |- skos__hiddenLabel mesh__D020933 NGF 2
% 216.27/216.42  |- rdf__type mesh__D020933sskos__Concept
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D020933 2006
% 216.27/216.42  |- skos__broader mesh__D020933smesh__D009414
% 216.27/216.42  |- skos__historyNote mesh__D006464 Hemodialysis %28%1967-1977%29%
% 216.27/216.42  |- skos__hiddenLabel mesh__D006464 Hemoperfusions
% 216.27/216.42  |- skos__broader mesh__D006464smesh__D005112
% 216.27/216.42  |- skos__altLabel mesh__D006464 Hemosorption
% 216.27/216.42  |- skos__historyNote mesh__D006464 Perfusion %28%1966-1977%29%
% 216.27/216.42  |- skos__scopeNote mesh__D006464
% 216.27/216.42       Removal of toxins or metabolites from the circulation by the passing of blood, within a suitable extracorporeal circuit, over semipermeable microcapsules containing adsorbents %28%e.g., activated charcoal%29% or enzymes, other enzyme preparations %28%e.g., gel-entrapped microsomes, membrane-free enzymes bound to artificial carriers%29%, or other adsorbents %28%e.g., various resins, albumin-conjugated agarose%29%.%A%    
% 216.27/216.42  |- mesh__recordAuthorizer mesh__D006464 sjn
% 216.27/216.42  |- mesh__dateRevised mesh__D006464 2005-06-30
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D006464 2006
% 216.27/216.42  |- skos__prefLabel mesh__D006464 Hemoperfusion
% 216.27/216.42  |- skos__historyNote mesh__D006464 Kidney, Artificial %28%1966-1977%29%
% 216.27/216.42  |- mesh__historyNote mesh__D006464 78   
% 216.27/216.42  |- mesh__recordMaintainer mesh__D006464 nns
% 216.27/216.42  |- mesh__dateCreated mesh__D006464 1977-04-22
% 216.27/216.42  |- skos__annotation mesh__D006464
% 216.27/216.42       do not confuse with RENAL DIALYSIS or PERFUSION; HEMOFILTRATION is available%A%  
% 216.27/216.42  |- mesh__dateEstablished mesh__D006464 1978-01-01
% 216.27/216.42  |- skos__broader mesh__D006464smesh__D016060
% 216.27/216.42  |- mesh__recordOriginator mesh__D006464 SMH
% 216.27/216.42  |- skos__hiddenLabel mesh__D006464 Hemosorptions
% 216.27/216.42  |- rdf__type mesh__D006464sskos__Concept
% 216.27/216.42  |- skos__hiddenLabel mesh__D020135 Nucleic Acids, Peptide
% 216.27/216.42  |- mesh__publicMeSHNote mesh__D020135 99   
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D020135 2001
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D020135 2004
% 216.27/216.42  |- mesh__dateEstablished mesh__D020135 1999-01-01
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D020135 1999
% 216.27/216.42  |- skos__historyNote mesh__D020135 Peptides %28%1993-1998%29%
% 216.27/216.42  |- skos__scopeNote mesh__D020135
% 216.27/216.42       DNA analogs containing neutral amide backbone linkages composed of aminoethyl glycine units instead of the usual phosphodiester linkage of deoxyribose groups. Peptide nucleic acids have high biological stability and higher affinity for complementary DNA or RNA sequences than analogous DNA oligomers.%A%    
% 216.27/216.42  |- skos__hiddenLabel mesh__D020135 Acids, Peptide Nucleic
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D020135 2002
% 216.27/216.42  |- skos__broader mesh__D020135smesh__D009696
% 216.27/216.42  |- rdf__type mesh__D020135sskos__Concept
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D020135 2005
% 216.27/216.42  |- mesh__historyNote mesh__D020135 99   
% 216.27/216.42  |- skos__historyNote mesh__D020135 Nucleic Acids %28%1981-1998%29%
% 216.27/216.42  |- mesh__dateCreated mesh__D020135 1998-06-10
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D020135 2006
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D020135 2000
% 216.27/216.42  |- skos__prefLabel mesh__D020135 Peptide Nucleic Acids
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D020135 2003
% 216.27/216.42  |- mesh__dateCreated mesh__D044583 2003-07-09
% 216.27/216.42  |- skos__hiddenLabel mesh__D044583 Neuroendoscopies
% 216.27/216.42  |- skos__historyNote mesh__D044583 Endoscopy %28%1995-2003%29%
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D044583 2006
% 216.27/216.42  |- mesh__publicMeSHNote mesh__D044583 2004   
% 216.27/216.42  |- skos__scopeNote mesh__D044583
% 216.27/216.42       PROCEDURES that use NEUROENDOSCOPES for disease diagnosis and treatment. Neuroendoscopy, generally an integration of the neuroendoscope with a computer-assisted NEURONAVIGATION system, provides guidance in NEUROSURGICAL PROCEDURES.%A%    
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D044583 2005
% 216.27/216.42  |- rdf__type mesh__D044583sskos__Concept
% 216.27/216.42  |- skos__related mesh__D044583smesh__D044582
% 216.27/216.42  |- mesh__activeMeSHYear mesh__D044583 2004
% 216.27/216.42  |- mesh__historyNote mesh__D044583 2004   
% 216.27/216.43  |- mesh__dateEstablished mesh__D044583 2004-01-01
% 216.27/216.43  |- skos__prefLabel mesh__D044583 Neuroendoscopy
% 216.27/216.43  |- skos__broader mesh__D044583smesh__D004724
% 216.27/216.43  |- mesh__dateRevised mesh__D052217 2005-07-21
% 216.27/216.43  |- skos__broader mesh__D052217smesh__D010750
% 216.27/216.43  |- mesh__historyNote mesh__D052217 2006   
% 216.27/216.43  |- mesh__recordAuthorizer mesh__D052217 ags
% 216.27/216.43  |- skos__altLabel mesh__D052217
% 216.27/216.43       Fanconi Anemia Group A Complementing Protein
% 216.27/216.43  |- mesh__dateEstablished mesh__D052217 2006-01-01
% 216.27/216.43  |- rdf__type mesh__D052217sskos__Concept
% 216.27/216.43  |- skos__scopeNote mesh__D052217
% 216.27/216.43       A Fanconi anemia complementation group protein that is the most commonly mutated protein in FANCONI ANEMIA. It undergoes PHOSPHORYLATION by PROTEIN KINASE B and forms a complex with FANCC PROTEIN in the CELL NUCLEUS.%A%    
% 216.27/216.43  |- skos__broader mesh__D052217smesh__D051856
% 216.27/216.43  |- skos__altLabel mesh__D052217 Fanconi Anemia Group A Protein
% 216.27/216.43  |- mesh__recordMaintainer mesh__D052217 ags
% 216.27/216.43  |- mesh__publicMeSHNote mesh__D052217 2006   
% 216.27/216.43  |- mesh__recordOriginator mesh__D052217 DRC
% 216.27/216.43  |- skos__altLabel mesh__D052217 FANCA Protein
% 216.27/216.43  |- skos__broader mesh__D052217smesh__D009687
% 216.27/216.43  |- mesh__dateCreated mesh__D052217 2005-06-30
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D052217 2006A
% 216.27/216.43  |- skos__prefLabel mesh__D052217
% 216.27/216.43       Fanconi Anemia Complementation Group A Protein
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D052217 2006
% 216.27/216.43  |- skos__scopeNote mesh__D002872
% 216.27/216.43       Actual loss of a portion of the chromosome.     
% 216.27/216.43  |- skos__hiddenLabel mesh__D002872 Partial Monosomies
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002872 2003
% 216.27/216.43  |- mesh__dateCreated mesh__D002872 1974-11-11
% 216.27/216.43  |- skos__historyNote mesh__D002872 Chromosome Aberrations %28%1968-1974%29%
% 216.27/216.43  |- skos__hiddenLabel mesh__D002872 Monosomies, Partial
% 216.27/216.43  |- skos__broader mesh__D002872smesh__D017384
% 216.27/216.43  |- skos__historyNote mesh__D002872
% 216.27/216.43       Chromosome Abnormalities %28%1966-1967%29%
% 216.27/216.43  |- skos__altLabel mesh__D002872 Partial Monosomy
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002872 2004
% 216.27/216.43  |- mesh__dateRevised mesh__D002872 2002-07-03
% 216.27/216.43  |- skos__broader mesh__D002872smesh__D019656
% 216.27/216.43  |- skos__prefLabel mesh__D002872 Chromosome Deletion
% 216.27/216.43  |- mesh__recordOriginator mesh__D002872 NLM
% 216.27/216.43  |- skos__hiddenLabel mesh__D002872 Chromosome Deletions
% 216.27/216.43  |- mesh__dateEstablished mesh__D002872 1978-01-01
% 216.27/216.43  |- rdf__type mesh__D002872sskos__Concept
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002872 2005
% 216.27/216.43  |- mesh__publicMeSHNote mesh__D002872
% 216.27/216.43       78; was see under CHROMOSOME ABERRATIONS 1975-77   
% 216.27/216.43  |- mesh__historyNote mesh__D002872
% 216.27/216.43       78%28%75%29%; was see under CHROMOSOME ABERRATIONS 1975-77   
% 216.27/216.43  |- skos__annotation mesh__D002872
% 216.27/216.43       for coord see note on CHROMOSOME ABERRATIONS   
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002872 2006
% 216.27/216.43  |- skos__hiddenLabel mesh__D002872 Deletions, Chromosome
% 216.27/216.43  |- skos__hiddenLabel mesh__D002872 Deletion, Chromosome
% 216.27/216.43  |- skos__altLabel mesh__D002872 Monosomy, Partial
% 216.27/216.43  |- mesh__recordMaintainer mesh__D002872 nns
% 216.27/216.43  |- mesh__recordAuthorizer mesh__D002872 sjn
% 216.27/216.43  |- skos__related mesh__D002872smesh__D017353
% 216.27/216.43  |- skos__broader mesh__D002872smesh__D002869
% 216.27/216.43  |- mesh__historyNote mesh__D002074 68   
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002074 2002
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002074 1995
% 216.27/216.43  |- mesh__recordAuthorizer mesh__D002074 PLS
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002074 1993
% 216.27/216.43  |- skos__prefLabel mesh__D002074 Butanones
% 216.27/216.43  |- skos__historyNote mesh__D002074 Ketones %28%1966-1967%29%
% 216.27/216.43  |- mesh__dateRevised mesh__D002074 1992-05-08
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002074 1994
% 216.27/216.43  |- mesh__recordMaintainer mesh__D002074 TGC
% 216.27/216.43  |- skos__broader mesh__D002074smesh__D007659
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002074 1999
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002074 2006
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002074 2004
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002074 1997
% 216.27/216.43  |- mesh__publicMeSHNote mesh__D002074 68   
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002074 2001
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002074 2005
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002074 2000
% 216.27/216.43  |- mesh__dateCreated mesh__D002074 1999-01-01
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002074 1998
% 216.27/216.43  |- mesh__recordOriginator mesh__D002074 NLM
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002074 1996
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002074 2003
% 216.27/216.43  |- rdf__type mesh__D002074sskos__Concept
% 216.27/216.43  |- mesh__dateEstablished mesh__D002074 1968-01-01
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010506 2002
% 216.27/216.43  |- skos__scopeNote mesh__D010506
% 216.27/216.43       A publication issued at stated, more or less regular, intervals.%A%    
% 216.27/216.43  |- skos__prefLabel mesh__D010506 Periodicals
% 216.27/216.43  |- skos__hiddenLabel mesh__D010506 Periodical
% 216.27/216.43  |- mesh__dateCreated mesh__D010506 1999-01-01
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010506 2004
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010506 2001
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010506 2006
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010506 2003
% 216.27/216.43  |- skos__hiddenLabel mesh__D010506 Magazine
% 216.27/216.43  |- skos__hiddenLabel mesh__D010506 Newsletter
% 216.27/216.43  |- skos__broader mesh__D010506smesh__D012693
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010506 2005
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010506 2000
% 216.27/216.43  |- skos__hiddenLabel mesh__D010506 Journal
% 216.27/216.43  |- mesh__recordOriginator mesh__D010506 NLM
% 216.27/216.43  |- skos__annotation mesh__D010506
% 216.27/216.43       IM; med periodicals, med journals, med newsletters: do not coord with MEDICINE; writing for periodicals goes here but see note on WRITING; note X ref NEWSLETTERS: for articles from newsletters, Publication Type NEWSPAPER ARTICLE is available%A%  
% 216.27/216.43  |- skos__altLabel mesh__D010506 Journals
% 216.27/216.43  |- mesh__recordAuthorizer mesh__D010506 sjn
% 216.27/216.43  |- mesh__recordMaintainer mesh__D010506 kle
% 216.27/216.43  |- rdf__type mesh__D010506sskos__Concept
% 216.27/216.43  |- mesh__dateRevised mesh__D010506 1999-11-03
% 216.27/216.43  |- skos__hiddenLabel mesh__D020934 Factor, Ciliary Neurotrophic
% 216.27/216.43  |- skos__broader mesh__D020934smesh__D009414
% 216.27/216.43  |- mesh__recordAuthorizer mesh__D020934 sjn
% 216.27/216.43  |- skos__related mesh__D020934smesh__D020801
% 216.27/216.43  |- skos__altLabel mesh__D020934 Ciliary Neuronotrophic Factor
% 216.27/216.43  |- mesh__recordMaintainer mesh__D020934 ssb
% 216.27/216.43  |- skos__altLabel mesh__D020934 CNTF
% 216.27/216.43  |- mesh__historyNote mesh__D020934
% 216.27/216.43       2000; use CILIARY NEUROTROPHIC FACTOR %28%NM%29% 1980-1999   
% 216.27/216.43  |- skos__hiddenLabel mesh__D020934 Neuronotrophic Factor, Ciliary
% 216.27/216.43  |- mesh__dateEstablished mesh__D020934 2000-01-01
% 216.27/216.43  |- mesh__recordOriginator mesh__D020934 jmp
% 216.27/216.43  |- mesh__publicMeSHNote mesh__D020934
% 216.27/216.43       2000; CILIARY NEUROTROPHIC FACTOR was indexed under NERVE TISSUE PROTEINS 1980-1999%A%  
% 216.27/216.43  |- mesh__dateRevised mesh__D020934 2005-06-30
% 216.27/216.43  |- skos__hiddenLabel mesh__D020934 Neurotrophic Factor, Ciliary
% 216.27/216.43  |- mesh__dateCreated mesh__D020934 1999-11-08
% 216.27/216.43  |- skos__scopeNote mesh__D020934
% 216.27/216.43       A neurotrophic factor that promotes the survival of various neuronal cell types and may play an important role in the injury response in the nervous system.%A%    
% 216.27/216.43  |- skos__hiddenLabel mesh__D020934 Factor, Ciliary Neuronotrophic
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D020934 2006
% 216.27/216.43  |- skos__prefLabel mesh__D020934 Ciliary Neurotrophic Factor
% 216.27/216.43  |- rdf__type mesh__D020934sskos__Concept
% 216.27/216.43  |- skos__historyNote mesh__D020934 Nerve Tissue Proteins %28%1980-1999%29%
% 216.27/216.43  |- skos__broader mesh__D006465smesh__D010532
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D006465 2006
% 216.27/216.43  |- skos__hiddenLabel mesh__D006465 Hemoperitoneums
% 216.27/216.43  |- mesh__recordOriginator mesh__D006465 NLM
% 216.27/216.43  |- mesh__recordMaintainer mesh__D006465 lkt
% 216.27/216.43  |- mesh__dateRevised mesh__D006465 2004-07-07
% 216.27/216.43  |- skos__prefLabel mesh__D006465 Hemoperitoneum
% 216.27/216.43  |- mesh__recordAuthorizer mesh__D006465 sjn
% 216.27/216.43  |- mesh__dateCreated mesh__D006465 1999-01-01
% 216.27/216.43  |- rdf__type mesh__D006465sskos__Concept
% 216.27/216.43  |- skos__broader mesh__D006465smesh__D006470
% 216.27/216.43  |- skos__scopeNote mesh__D006465
% 216.27/216.43       Accumulations of blood in the PERITONEAL CAVITY due to internal HEMORRHAGE.%A%    
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D006465 2005
% 216.27/216.43  |- skos__broader mesh__D020136smesh__D011092
% 216.27/216.43  |- skos__historyNote mesh__D020136 Polyethylene Glycols %28%1981-1998%29%
% 216.27/216.43  |- mesh__dateCreated mesh__D020136 1998-06-10
% 216.27/216.43  |- skos__broader mesh__D020136smesh__D020100
% 216.27/216.43  |- rdf__type mesh__D020136sskos__Concept
% 216.27/216.43  |- mesh__dateRevised mesh__D020136 2004-07-07
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D020136 2005
% 216.27/216.43  |- skos__prefLabel mesh__D020136 Hydrogel
% 216.27/216.43  |- mesh__dateEstablished mesh__D020136 1999-01-01
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D020136 2006
% 216.27/216.43  |- mesh__recordAuthorizer mesh__D020136 sjn
% 216.27/216.43  |- mesh__recordOriginator mesh__D020136 ADP
% 216.27/216.43  |- skos__annotation mesh__D020136
% 216.27/216.43       a specific compound; do not confuse with HYDROGELS   
% 216.27/216.43  |- mesh__recordMaintainer mesh__D020136 jmp
% 216.27/216.43  |- skos__scopeNote mesh__D020136
% 216.27/216.43       A network of cross-linked hydrophilic macromolecules used in biomedical applications.%A%    
% 216.27/216.43  |- mesh__publicMeSHNote mesh__D020136
% 216.27/216.43       99; HYDROGEL was indexed under POLYETHYLENE GLYCOLS 1981-98%A%  
% 216.27/216.43  |- mesh__historyNote mesh__D020136 99; use HYDROGEL %28%NM%29% 1981-97   
% 216.27/216.43  |- skos__broader mesh__D011486Q000172smesh__D011486
% 216.27/216.43  |- mesh__preferredCombination mesh__D011486Q000172smesh__D020151
% 216.27/216.43  |- rdf__type mesh__D011486Q000172smesh__CompoundConcept
% 216.27/216.43  |- skos__altLabel mesh__D044584 Ductal Carcinoma
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D044584 2006
% 216.27/216.43  |- skos__broader mesh__D044584smesh__D018299
% 216.27/216.43  |- mesh__dateEstablished mesh__D044584 2004-01-01
% 216.27/216.43  |- mesh__publicMeSHNote mesh__D044584
% 216.27/216.43       2004, 1963-1993; see CARCINOMA, INFILTRATING DUCT 1994-2003%A%  
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D044584 2005
% 216.27/216.43  |- rdf__type mesh__D044584sskos__Concept
% 216.27/216.43  |- skos__annotation mesh__D044584
% 216.27/216.43       coord IM with precoord organ/neopl term %28%IM%29%; CARCINOMA, DUCTAL, BREAST and CARCINOMA, PANCREATIC DUCTAL are also available%A%  
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D044584 2004
% 216.27/216.43  |- skos__scopeNote mesh__D044584
% 216.27/216.43       Malignant neoplasms involving the ductal systems of any of a number of organs, such as the MAMMARY GLANDS, the PANCREAS, the PROSTATE, or the LACRIMAL GLAND.%A%    
% 216.27/216.43  |- skos__hiddenLabel mesh__D044584 Carcinomas, Ductal
% 216.27/216.43  |- mesh__dateCreated mesh__D044584 2003-07-09
% 216.27/216.43  |- mesh__historyNote mesh__D044584
% 216.27/216.43       2004, 1963-1993; use CARCINOMA, INFILTRATING DUCT 1994-2003%A%  
% 216.27/216.43  |- skos__prefLabel mesh__D044584 Carcinoma, Ductal
% 216.27/216.43  |- skos__hiddenLabel mesh__D044584 Ductal Carcinomas
% 216.27/216.43  |- skos__broader mesh__D044584smesh__D000230
% 216.27/216.43  |- skos__broader mesh__D016893smesh__D002340
% 216.27/216.43  |- skos__hiddenLabel mesh__D016893 Narrowing, Carotid Artery
% 216.27/216.43  |- skos__hiddenLabel mesh__D016893 Stenoses, Carotid
% 216.27/216.43  |- skos__hiddenLabel mesh__D016893 Narrowings, Carotid Artery
% 216.27/216.43  |- mesh__dateEstablished mesh__D016893 1992-01-01
% 216.27/216.43  |- skos__hiddenLabel mesh__D016893 Artery Narrowing, Carotid
% 216.27/216.43  |- mesh__dateCreated mesh__D016893 1991-05-30
% 216.27/216.43  |- skos__hiddenLabel mesh__D016893 Carotid Artery Stenoses
% 216.27/216.43  |- mesh__recordAuthorizer mesh__D016893 sjn
% 216.27/216.43  |- skos__altLabel mesh__D016893 Stenosis, External Carotid Artery
% 216.27/216.43  |- skos__hiddenLabel mesh__D016893 Plaques, Carotid Artery
% 216.27/216.43  |- skos__hiddenLabel mesh__D016893 Carotid Artery Plaques
% 216.27/216.43  |- skos__altLabel mesh__D016893 Carotid Artery Stenosis
% 216.27/216.43  |- skos__altLabel mesh__D016893 Carotid Artery Ulcerating Plaque
% 216.27/216.43  |- skos__annotation mesh__D016893
% 216.27/216.43       coord IM with specific carotid artery %28%IM%29%   
% 216.27/216.43  |- mesh__recordMaintainer mesh__D016893 nns
% 216.27/216.43  |- skos__altLabel mesh__D016893 Carotid Artery Narrowing
% 216.27/216.43  |- rdf__type mesh__D016893sskos__Concept
% 216.27/216.43  |- skos__altLabel mesh__D016893 Ulcerating Plaque, Carotid Artery
% 216.27/216.43  |- skos__hiddenLabel mesh__D016893 Carotid Ulcers
% 216.27/216.43  |- skos__broader mesh__D016893smesh__D001157
% 216.27/216.43  |- skos__hiddenLabel mesh__D016893 Artery Plaque, Carotid
% 216.27/216.43  |- skos__hiddenLabel mesh__D016893 Artery Stenosis, Carotid
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D016893 2005
% 216.27/216.43  |- skos__altLabel mesh__D016893 Plaque, Ulcerating, Carotid Artery
% 216.27/216.43  |- skos__hiddenLabel mesh__D016893 Ulcers, Carotid
% 216.27/216.43  |- skos__hiddenLabel mesh__D016893 Stenoses, Carotid Artery
% 216.27/216.43  |- skos__hiddenLabel mesh__D016893 Artery Plaques, Carotid
% 216.27/216.43  |- skos__historyNote mesh__D016893
% 216.27/216.43       Carotid Artery Diseases %28%1966-1991%29%
% 216.27/216.43  |- skos__prefLabel mesh__D016893 Carotid Stenosis
% 216.27/216.43  |- skos__altLabel mesh__D016893 Stenosis, Common Carotid Artery
% 216.27/216.43  |- skos__hiddenLabel mesh__D016893 Artery Stenoses, Carotid
% 216.27/216.43  |- skos__scopeNote mesh__D016893
% 216.27/216.43       Narrowing or stricture of the internal, common, or external carotid artery, most often as a result of atherosclerotic plaque formation. Ulcerations may form in atherosclerotic plaques and induce thrombus formation. Platelet or cholesterol emboli may arise from stenotic carotid lesions and induce a transient ischemic attack %28%ISCHEMIC ATTACK, TRANSIENT%29% or CEREBROVASCULAR ACCIDENT. Emboli which travel to the eye may manifest as AMAUROSIS FUGAX %28%temporary blindness%29%. %28%From Adams et al., Principles of Neurology, 6th ed, pp822-3%29%%A%    
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D016893 2006
% 216.27/216.43  |- skos__hiddenLabel mesh__D016893 Artery Narrowings, Carotid
% 216.27/216.43  |- skos__hiddenLabel mesh__D016893 Stenosis, Carotid
% 216.27/216.43  |- mesh__publicMeSHNote mesh__D016893 1992   
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D016893 2003
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D016893 2002
% 216.27/216.43  |- skos__hiddenLabel mesh__D016893 Ulcer, Carotid
% 216.27/216.43  |- skos__related mesh__D016893smesh__D016894
% 216.27/216.43  |- mesh__dateRevised mesh__D016893 2001-07-25
% 216.27/216.43  |- mesh__recordOriginator mesh__D016893 MXR
% 216.27/216.43  |- skos__hiddenLabel mesh__D016893 Carotid Stenoses
% 216.27/216.43  |- skos__hiddenLabel mesh__D016893 Stenosis, Carotid Artery
% 216.27/216.43  |- skos__hiddenLabel mesh__D016893 Plaque, Carotid Artery
% 216.27/216.43  |- mesh__historyNote mesh__D016893 1992   
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D016893 2004
% 216.27/216.43  |- skos__hiddenLabel mesh__D016893 Carotid Artery Narrowings
% 216.27/216.43  |- mesh__recordOriginator mesh__D052218 DRC
% 216.27/216.43  |- mesh__dateCreated mesh__D052218 2005-06-30
% 216.27/216.43  |- skos__broader mesh__D052218smesh__D051856
% 216.27/216.43  |- skos__altLabel mesh__D052218
% 216.27/216.43       Fanconi Anemia Group C Complementing Protein
% 216.27/216.43  |- skos__scopeNote mesh__D052218
% 216.27/216.43       A Fanconi anemia complementation group protein that regulates the activities of CYTOCHROME P450 REDUCTASE and GLUTATHIONE S-TRANSFERASE. It is found predominately in the CYTOPLASM, but moves to the CELL NUCLEUS in response to FANCE PROTEIN.%A%    
% 216.27/216.43  |- mesh__recordMaintainer mesh__D052218 ags
% 216.27/216.43  |- mesh__historyNote mesh__D052218 2006%28%1993%29%   
% 216.27/216.43  |- mesh__dateRevised mesh__D052218 2005-07-21
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D052218 2006A
% 216.27/216.43  |- mesh__dateEstablished mesh__D052218 2006-01-01
% 216.27/216.43  |- skos__altLabel mesh__D052218 Fanconi Anemia Group C Protein
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D052218 2006
% 216.27/216.43  |- skos__prefLabel mesh__D052218
% 216.27/216.43       Fanconi Anemia Complementation Group C Protein
% 216.27/216.43  |- mesh__recordAuthorizer mesh__D052218 ags
% 216.27/216.43  |- mesh__publicMeSHNote mesh__D052218
% 216.27/216.43       2006; FANCONI ANEMIA COMPLEMENTATION GROUP C PROTEIN was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% CELL CYCLE PROTEINS 1993-2005%A%  
% 216.27/216.43  |- skos__altLabel mesh__D052218 FANCC Protein
% 216.27/216.43  |- rdf__type mesh__D052218sskos__Concept
% 216.27/216.43  |- mesh__historyNote mesh__D002873 82   
% 216.27/216.43  |- skos__broader mesh__D002873smesh__D043171
% 216.27/216.43  |- skos__hiddenLabel mesh__D002873 Fragility, Chromosome
% 216.27/216.43  |- skos__scopeNote mesh__D002873
% 216.27/216.43       Susceptibility of chromosomes to breakage leading to translocation; CHROMOSOME INVERSION; SEQUENCE DELETION; or other CHROMOSOME BREAKAGE related aberrations.%A%    
% 216.27/216.43  |- mesh__dateEstablished mesh__D002873 1982-01-01
% 216.27/216.43  |- mesh__publicMeSHNote mesh__D002873 82   
% 216.27/216.43  |- mesh__recordMaintainer mesh__D002873 ags
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002873 2004
% 216.27/216.43  |- skos__related mesh__D002873smesh__D043283
% 216.27/216.43  |- skos__altLabel mesh__D002873 Chromosomal Fragility
% 216.27/216.43  |- mesh__dateRevised mesh__D002873 2005-08-02
% 216.27/216.43  |- mesh__recordOriginator mesh__D002873 AEP
% 216.27/216.43  |- rdf__type mesh__D002873sskos__Concept
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002873 2005
% 216.27/216.43  |- skos__historyNote mesh__D002873 Chromosome Aberrations %28%1968-1981%29%
% 216.27/216.43  |- mesh__dateCreated mesh__D002873 1981-02-23
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002873 2006
% 216.27/216.43  |- skos__related mesh__D002873smesh__D019680
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002873 2006A
% 216.27/216.43  |- skos__hiddenLabel mesh__D002873 Fragility, Chromosomal
% 216.27/216.43  |- skos__prefLabel mesh__D002873 Chromosome Fragility
% 216.27/216.43  |- skos__historyNote mesh__D002873 Chromosomes %28%1966-1967%29%
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D002873 2006B
% 216.27/216.43  |- skos__related mesh__D002873smesh__D005600
% 216.27/216.43  |- skos__related mesh__D002873smesh__D019457
% 216.27/216.43  |- mesh__recordAuthorizer mesh__D002873 ags
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010507 1998
% 216.27/216.43  |- skos__hiddenLabel mesh__D010507 Biorhythm
% 216.27/216.43  |- skos__altLabel mesh__D010507 Rhythmicity
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010507 2003
% 216.27/216.43  |- mesh__recordOriginator mesh__D010507 NLM
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010507 1997
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010507 2002
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010507 2005
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010507 1999
% 216.27/216.43  |- skos__related mesh__D010507smesh__D002940
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010507 1992
% 216.27/216.43  |- skos__hiddenLabel mesh__D010507 Cyclicities
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010507 2004
% 216.27/216.43  |- skos__annotation mesh__D010507
% 216.27/216.43       IM + coord with specific dis for periodically occurring dis %28%IM%29%; no qualif; do not confuse with PERIODIC DISEASE, a specific clin entity: see Dorland%A%  
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010507 1994
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010507 1991
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010507 2006
% 216.27/216.43  |- mesh__dateRevised mesh__D010507 1989-08-31
% 216.27/216.43  |- skos__altLabel mesh__D010507 Bioperiodicity
% 216.27/216.43  |- mesh__recordMaintainer mesh__D010507 PLS
% 216.27/216.43  |- skos__broader mesh__D010507smesh__D013995
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010507 1993
% 216.27/216.43  |- skos__scopeNote mesh__D010507
% 216.27/216.43       The tendency of a phenomenon to recur at regular intervals; in biological systems, the recurrence of certain activities %28%including hormonal, cellular, neural%29% may be annual, seasonal, monthly, daily, or more frequently %28%ultradian%29%.%A%    
% 216.27/216.43  |- skos__related mesh__D010507smesh__D001683
% 216.27/216.43  |- skos__hiddenLabel mesh__D010507 Bioperiodicities
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010507 1995
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010507 2000
% 216.27/216.43  |- mesh__recordAuthorizer mesh__D010507 PLS
% 216.27/216.43  |- skos__hiddenLabel mesh__D010507 Periodicities
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010507 2001
% 216.27/216.43  |- skos__prefLabel mesh__D010507 Periodicity
% 216.27/216.43  |- skos__hiddenLabel mesh__D010507 Rhythmicities
% 216.27/216.43  |- skos__broader mesh__D010507smesh__D002909
% 216.27/216.43  |- rdf__type mesh__D010507sskos__Concept
% 216.27/216.43  |- skos__altLabel mesh__D010507 Cyclicity
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010507 1996
% 216.27/216.43  |- mesh__dateCreated mesh__D010507 1999-01-01
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D010507 1990
% 216.27/216.43  |- mesh__historyNote mesh__D020935 2000   
% 216.27/216.43  |- skos__related mesh__D020935smesh__D020930
% 216.27/216.43  |- skos__hiddenLabel mesh__D020935 Kinase Cascades, MAP
% 216.27/216.43  |- skos__hiddenLabel mesh__D020935 Kinase Module, MAP
% 216.27/216.43  |- skos__altLabel mesh__D020935 MAP Kinase Modules
% 216.27/216.43  |- mesh__recordMaintainer mesh__D020935 jmp
% 216.27/216.43  |- skos__hiddenLabel mesh__D020935 Cascades, MAP Kinase
% 216.27/216.43  |- skos__hiddenLabel mesh__D020935 Cascade, MAP Kinase
% 216.27/216.43  |- skos__historyNote mesh__D020935
% 216.27/216.43       Protein-Serine-Threonine Kinases %28%1993-1999%29%
% 216.27/216.43  |- skos__hiddenLabel mesh__D020935 Kinase Cascade, MAP
% 216.27/216.43  |- mesh__recordAuthorizer mesh__D020935 sjn
% 216.27/216.43  |- mesh__dateEstablished mesh__D020935 2000-01-01
% 216.27/216.43  |- skos__hiddenLabel mesh__D020935 MAP Kinase Cascades
% 216.27/216.43  |- skos__prefLabel mesh__D020935 MAP Kinase Signaling System
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D020935 2005
% 216.27/216.43  |- skos__related mesh__D020935smesh__D020929
% 216.27/216.43  |- skos__hiddenLabel mesh__D020935 Modules, MAP Kinase
% 216.27/216.43  |- skos__scopeNote mesh__D020935
% 216.27/216.43       An intracellular signaling system involving the MAP kinase cascades %28%three-membered protein kinase cascades%29%. Various upstream activators, which act in response to extracellular stimuli, trigger the cascades by activating the first member of a cascade, MAP KINASE KINASE KINASES; %28%MAPKKKs%29%. Activated MAPKKKs phosphorylate MITOGEN-ACTIVATED PROTEIN KINASE KINASES which in turn phosphorylate the MITOGEN-ACTIVATED PROTEIN KINASES; %28%MAPKs%29%. The MAPKs then act on various downstream targets to affect gene expression. In mammals, there are several distinct MAP kinase pathways including the ERK %28%extracellular signal-regulated kinase%29% pathway, the SAPK/JNK %28%stress-activated protein kinase/c-jun kinase%29% pathway, and the p38 kinase pathway. There is some sharing of components among the pathways depending on which stimulus originates activation of the cascade.%A%    
% 216.27/216.43  |- skos__broader mesh__D020935smesh__D015398
% 216.27/216.43  |- skos__altLabel mesh__D020935 MAP Kinase Signaling Cascades
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D020935 2006
% 216.27/216.43  |- rdf__type mesh__D020935sskos__Concept
% 216.27/216.43  |- skos__historyNote mesh__D020935
% 216.27/216.43       Protein-Tyrosine Kinase %28%1989-1999%29%
% 216.27/216.43  |- skos__related mesh__D020935smesh__D020928
% 216.27/216.43  |- skos__historyNote mesh__D020935 Protein Kinases %28%1989-1999%29%
% 216.27/216.43  |- mesh__dateCreated mesh__D020935 1999-11-05
% 216.27/216.43  |- mesh__dateRevised mesh__D020935 2004-07-07
% 216.27/216.43  |- mesh__recordOriginator mesh__D020935 nns
% 216.27/216.43  |- skos__historyNote mesh__D020935
% 216.27/216.43       Ca%28%2+%29%-Calmodulin Dependent Protein Kinase %28%1994-1999%29%
% 216.27/216.43  |- skos__hiddenLabel mesh__D020935 Kinase Modules, MAP
% 216.27/216.43  |- mesh__publicMeSHNote mesh__D020935 2000   
% 216.27/216.43  |- skos__hiddenLabel mesh__D020935 MAP Kinase Module
% 216.27/216.43  |- skos__hiddenLabel mesh__D020935 Module, MAP Kinase
% 216.27/216.43  |- mesh__dateRevised mesh__D006466 1995-03-17
% 216.27/216.43  |- skos__broader mesh__D006466smesh__D000209
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D006466 2002
% 216.27/216.43  |- skos__broader mesh__D006466smesh__D006023
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D006466 1999
% 216.27/216.43  |- mesh__recordMaintainer mesh__D006466 PLS
% 216.27/216.43  |- mesh__historyNote mesh__D006466 74%28%71%29%   
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D006466 1998
% 216.27/216.43  |- mesh__dateEstablished mesh__D006466 1974-01-01
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D006466 1997
% 216.27/216.43  |- skos__broader mesh__D006466smesh__D001609
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D006466 2006
% 216.27/216.43  |- skos__historyNote mesh__D006466 Beta Globulins %28%1966-1970%29%
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D006466 2001
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D006466 1996
% 216.27/216.43  |- mesh__recordAuthorizer mesh__D006466 PLS
% 216.27/216.43  |- skos__historyNote mesh__D006466 Heme %28%1966-1970%29%
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D006466 2005
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D006466 2004
% 216.27/216.43  |- mesh__recordOriginator mesh__D006466 NLM
% 216.27/216.43  |- skos__annotation mesh__D006466 a beta-globulin   
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D006466 2000
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D006466 2003
% 216.27/216.43  |- skos__prefLabel mesh__D006466 Hemopexin
% 216.27/216.43  |- rdf__type mesh__D006466sskos__Concept
% 216.27/216.43  |- mesh__publicMeSHNote mesh__D006466 74   
% 216.27/216.43  |- mesh__dateCreated mesh__D006466 1999-01-01
% 216.27/216.43  |- skos__prefLabel mesh__D020137 Base Pair Mismatch
% 216.27/216.43  |- rdf__type mesh__D020137sskos__Concept
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D020137 2005
% 216.27/216.43  |- mesh__historyNote mesh__D020137 99   
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D020137 2006
% 216.27/216.43  |- mesh__dateCreated mesh__D020137 1998-06-10
% 216.27/216.43  |- mesh__publicMeSHNote mesh__D020137 99   
% 216.27/216.43  |- mesh__recordOriginator mesh__D020137 NDW
% 216.27/216.43  |- skos__broader mesh__D020137smesh__D009154
% 216.27/216.43  |- mesh__dateEstablished mesh__D020137 1999-01-01
% 216.27/216.43  |- skos__related mesh__D020137smesh__D020180
% 216.27/216.43  |- mesh__recordAuthorizer mesh__D020137 sjn
% 216.27/216.43  |- skos__hiddenLabel mesh__D020137 Mismatches, Base Pair
% 216.27/216.43  |- skos__related mesh__D020137smesh__D020029
% 216.27/216.43  |- skos__hiddenLabel mesh__D020137 Mismatch, Base Pair
% 216.27/216.43  |- skos__scopeNote mesh__D020137
% 216.27/216.43       The presence of an uncomplimentary base in double-stranded DNA caused by spontaneous deamination of cytosine or adenine, mismatching during homologous recombination, or errors in DNA replication. Multiple, sequential base pair mismatches lead to formation of heteroduplex DNA; %28%NUCLEIC ACID HETERODUPLEXES%29%.%A%    
% 216.27/216.43  |- mesh__recordMaintainer mesh__D020137 jls
% 216.27/216.43  |- skos__related mesh__D020137smesh__D009692
% 216.27/216.43  |- skos__altLabel mesh__D020137 Base Pair Mismatches
% 216.27/216.43  |- mesh__dateRevised mesh__D020137 2004-07-19
% 216.27/216.43  |- skos__broader mesh__D013831Q000172smesh__D013831
% 216.27/216.43  |- mesh__preferredCombination mesh__D013831Q000172smesh__D013832
% 216.27/216.43  |- rdf__type mesh__D013831Q000172smesh__CompoundConcept
% 216.27/216.43  |- skos__scopeNote mesh__D011600
% 216.27/216.43       The study of the effects of drugs on mental and behavioral activity.%A%    
% 216.27/216.43  |- skos__broader mesh__D011600smesh__D010600
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D011600 2006
% 216.27/216.43  |- mesh__recordOriginator mesh__D011600 NLM
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D011600 2002
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D011600 2004
% 216.27/216.43  |- mesh__recordMaintainer mesh__D011600 jls
% 216.27/216.43  |- rdf__type mesh__D011600sskos__Concept
% 216.27/216.43  |- mesh__recordAuthorizer mesh__D011600 sjn
% 216.27/216.43  |- skos__broader mesh__D011600smesh__D001525
% 216.27/216.43  |- skos__related mesh__D011600smesh__D011619
% 216.27/216.43  |- mesh__dateCreated mesh__D011600 1999-01-01
% 216.27/216.43  |- skos__annotation mesh__D011600
% 216.27/216.43       SPEC: IM, SPEC qualif; NIM coord, no qualif; Manual 27.13: relation to PSYCHOTROPIC DRUGS; DF: PSYCHOPHARMACOL%A%  
% 216.27/216.43  |- skos__prefLabel mesh__D011600 Psychopharmacology
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D011600 2005
% 216.27/216.43  |- mesh__dateRevised mesh__D011600 2001-07-25
% 216.27/216.43  |- mesh__activeMeSHYear mesh__D011600 2003
% 216.27/216.44  |- skos__broader mesh__D011600smesh__D013000
% 216.27/216.44  |- skos__hiddenLabel mesh__D016894 Carotid Endarterectomies
% 216.27/216.44  |- skos__annotation mesh__D016894
% 216.27/216.44       specify CAROTID ARTERY, EXTERNAL or CAROTID ARTERY, INTERNAL %28%IM or NIM%29% if pertinent%A%  
% 216.27/216.44  |- skos__historyNote mesh__D016894 Endarterectomy %28%1966-1991%29%
% 216.27/216.44  |- mesh__dateRevised mesh__D016894 1999-11-03
% 216.27/216.44  |- rdf__type mesh__D016894sskos__Concept
% 216.27/216.44  |- skos__prefLabel mesh__D016894 Endarterectomy, Carotid
% 216.27/216.44  |- mesh__recordAuthorizer mesh__D016894 sjn
% 216.27/216.44  |- skos__related mesh__D016894smesh__D016893
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D016894 2002
% 216.27/216.44  |- mesh__dateCreated mesh__D016894 1991-05-30
% 216.27/216.44  |- mesh__historyNote mesh__D016894 1992   
% 216.27/216.44  |- skos__scopeNote mesh__D016894
% 216.27/216.44       The excision of the thickened, atheromatous tunica intima of a carotid artery.%A%    
% 216.27/216.44  |- mesh__dateEstablished mesh__D016894 1992-01-01
% 216.27/216.44  |- mesh__publicMeSHNote mesh__D016894 1992   
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D016894 2004
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D016894 2001
% 216.27/216.44  |- mesh__recordOriginator mesh__D016894 MXR
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D016894 2006
% 216.27/216.44  |- skos__broader mesh__D016894smesh__D004691
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D016894 2003
% 216.27/216.44  |- skos__hiddenLabel mesh__D016894 Endarterectomies, Carotid
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D016894 2005
% 216.27/216.44  |- mesh__recordMaintainer mesh__D016894 KEV
% 216.27/216.44  |- skos__altLabel mesh__D016894 Carotid Endarterectomy
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D016894 2000
% 216.27/216.44  |- skos__broader mesh__D001842Q000254smesh__D001842
% 216.27/216.44  |- mesh__preferredCombination mesh__D001842Q000254smesh__D001846
% 216.27/216.44  |- rdf__type mesh__D001842Q000254smesh__CompoundConcept
% 216.27/216.44  |- skos__broader mesh__D052219smesh__D009687
% 216.27/216.44  |- skos__scopeNote mesh__D052219
% 216.27/216.44       A Fanconi anemia complementation group protein. It is an essential component of a nuclear core complex that protects the GENOME against CHROMOSOMAL INSTABILITY. It interacts directly with FANCG PROTEIN and helps stabilize a complex with FANCA PROTEIN and FANCC PROTEIN.%A%    
% 216.27/216.44  |- skos__prefLabel mesh__D052219
% 216.27/216.44       Fanconi Anemia Complementation Group F Protein
% 216.27/216.44  |- mesh__dateCreated mesh__D052219 2005-06-30
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D052219 2006
% 216.27/216.44  |- mesh__dateEstablished mesh__D052219 2006-01-01
% 216.27/216.44  |- rdf__type mesh__D052219sskos__Concept
% 216.27/216.44  |- mesh__recordAuthorizer mesh__D052219 sjn
% 216.27/216.44  |- mesh__historyNote mesh__D052219 2006%28%2000%29%   
% 216.27/216.44  |- skos__altLabel mesh__D052219 FANCF Protein
% 216.27/216.44  |- mesh__recordMaintainer mesh__D052219 DRC
% 216.27/216.44  |- skos__altLabel mesh__D052219 Fanconi Anemia Group F Protein
% 216.27/216.44  |- mesh__recordOriginator mesh__D052219 DRC
% 216.27/216.44  |- skos__broader mesh__D052219smesh__D051856
% 216.27/216.44  |- mesh__publicMeSHNote mesh__D052219
% 216.27/216.44       2006; FANCONI ANEMIA COMPLEMENTATION GROUP F PROTEIN was indexed under RNA-BINDING PROTEINS 2000-2005%A%  
% 216.27/216.44  |- skos__altLabel mesh__D052219
% 216.27/216.44       Fanconi Anemia Group F Complementing Protein
% 216.27/216.44  |- skos__related mesh__D002874smesh__D012150
% 216.27/216.44  |- skos__hiddenLabel mesh__D002874 Gene Mappings
% 216.27/216.44  |- skos__hiddenLabel mesh__D002874 Mappings, Genome
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D002874 2004
% 216.27/216.44  |- skos__related mesh__D002874smesh__D020732
% 216.27/216.44  |- skos__hiddenLabel mesh__D002874 Mappings, Gene
% 216.27/216.44  |- skos__altLabel mesh__D002874 Gene Mapping
% 216.27/216.44  |- skos__altLabel mesh__D002874 Linkage Mapping
% 216.27/216.44  |- skos__hiddenLabel mesh__D002874 Mapping, Gene
% 216.27/216.44  |- skos__scopeNote mesh__D002874
% 216.27/216.44       Any method used for determining the location of and relative distances between genes on a chromosome.%A%    
% 216.27/216.44  |- skos__hiddenLabel mesh__D002874 Chromosome Mappings
% 216.27/216.44  |- skos__hiddenLabel mesh__D002874 Mapping, Genome
% 216.27/216.44  |- mesh__dateRevised mesh__D002874 2001-07-25
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D002874 2003
% 216.27/216.44  |- skos__hiddenLabel mesh__D002874 Mappings, Chromosome
% 216.27/216.44  |- mesh__publicMeSHNote mesh__D002874
% 216.27/216.44       1967; for GENOME MAPPING see HUMAN GENOME PROJECT 1990-2001%A%  
% 216.27/216.44  |- skos__hiddenLabel mesh__D002874 Linkage Mappings
% 216.27/216.44  |- skos__hiddenLabel mesh__D002874 Mapping, Chromosome
% 216.27/216.44  |- rdf__type mesh__D002874sskos__Concept
% 216.27/216.44  |- mesh__recordAuthorizer mesh__D002874 sjn
% 216.27/216.44  |- skos__broader mesh__D002874smesh__D005821
% 216.27/216.44  |- skos__hiddenLabel mesh__D002874 Mappings, Linkage
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D002874 2002
% 216.27/216.44  |- mesh__historyNote mesh__D002874
% 216.27/216.44       1967%28%1965%29%; for GENOME MAPPING use HUMAN GENOME PROJECT 1990-2001%A%  
% 216.27/216.44  |- skos__prefLabel mesh__D002874 Chromosome Mapping
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D002874 2006
% 216.27/216.44  |- skos__hiddenLabel mesh__D002874 Genome Mappings
% 216.27/216.44  |- mesh__dateCreated mesh__D002874 1999-01-01
% 216.27/216.44  |- mesh__recordMaintainer mesh__D002874 nns
% 216.27/216.44  |- mesh__dateEstablished mesh__D002874 1967-01-01
% 216.27/216.44  |- skos__hiddenLabel mesh__D002874 Mapping, Linkage
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D002874 2005
% 216.27/216.44  |- mesh__recordOriginator mesh__D002874 NLM
% 216.27/216.44  |- mesh__dateRevised mesh__D002076 2004-07-07
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D002076 2005
% 216.27/216.44  |- mesh__publicMeSHNote mesh__D002076
% 216.27/216.44       96; was BUTIROSINS 1975-95 %28%see under ANTIBIOTICS, AMINOGLYCOSIDE 1975-90%29%%A%  
% 216.27/216.44  |- skos__altLabel mesh__D002076 Butirosin Sulphate
% 216.27/216.44  |- skos__historyNote mesh__D002076 Aminoglycosides %28%1974%29%
% 216.27/216.44  |- mesh__dateCreated mesh__D002076 1974-11-19
% 216.27/216.44  |- skos__hiddenLabel mesh__D002076 Anhydrous Butirosin Sulfate
% 216.27/216.44  |- skos__scopeNote mesh__D002076
% 216.27/216.44       A water-soluble aminoglycosidic antibiotic complex isolated from fermentation filtrates of Bacillus circulans. Two components %28%A and B%29% have been separated from the complex. Both are active against many gram-positive and some gram-negative bacteria.%A%    
% 216.27/216.44  |- mesh__recordOriginator mesh__D002076 NLM
% 216.27/216.44  |- rdf__type mesh__D002076sskos__Concept
% 216.27/216.44  |- mesh__recordMaintainer mesh__D002076 ssb
% 216.27/216.44  |- mesh__historyNote mesh__D002076
% 216.27/216.44       96; was BUTIROSINS 1975-95 %28%see under ANTIBIOTICS, AMINOGLYCOSIDE 1975-90%29%%A%  
% 216.27/216.44  |- skos__broader mesh__D002076smesh__D000617
% 216.27/216.44  |- skos__hiddenLabel mesh__D002076 Sulfate, Anhydrous Butirosin
% 216.27/216.44  |- skos__hiddenLabel mesh__D002076 Sulphate, Butirosin
% 216.27/216.44  |- skos__altLabel mesh__D002076 Butirosins
% 216.27/216.44  |- mesh__dateEstablished mesh__D002076 1991-01-01
% 216.27/216.44  |- skos__historyNote mesh__D002076 Antibiotics %28%1973-1974%29%
% 216.27/216.44  |- skos__prefLabel mesh__D002076 Butirosin Sulfate
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D002076 2006
% 216.27/216.44  |- mesh__recordAuthorizer mesh__D002076 sjn
% 216.27/216.44  |- skos__hiddenLabel mesh__D002076 Sulfate, Butirosin
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D010508 2005
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D010508 1999
% 216.27/216.44  |- mesh__dateEstablished mesh__D010508 1991-01-01
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D010508 2004
% 216.27/216.44  |- mesh__dateRevised mesh__D010508 1994-05-27
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D010508 2006
% 216.27/216.44  |- mesh__recordOriginator mesh__D010508 NLM
% 216.27/216.44  |- skos__prefLabel mesh__D010508 Periodontal Abscess
% 216.27/216.44  |- skos__broader mesh__D010508smesh__D000038
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D010508 1995
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D010508 2002
% 216.27/216.44  |- mesh__publicMeSHNote mesh__D010508
% 216.27/216.44       91; was see under PERIODONTITIS 1980-90; was ABSCESS, PERIODONTAL see under PERIODONTITIS 1965-79%A%  
% 216.27/216.44  |- mesh__historyNote mesh__D010508
% 216.27/216.44       91%28%80%29%; was see under PERIODONTITIS 1980-90; was ABSCESS, PERIODONTAL see under PERIODONTITIS 1965-79%A%  
% 216.27/216.44  |- skos__altLabel mesh__D010508 Abscess, Periodontal
% 216.27/216.44  |- skos__hiddenLabel mesh__D010508 Periodontal Abscesses
% 216.27/216.44  |- skos__broader mesh__D010508smesh__D010518
% 216.27/216.44  |- mesh__recordMaintainer mesh__D010508 PLS
% 216.27/216.44  |- rdf__type mesh__D010508sskos__Concept
% 216.27/216.44  |- mesh__dateCreated mesh__D010508 1999-01-01
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D010508 1996
% 216.27/216.44  |- skos__hiddenLabel mesh__D010508 Abscesses, Periodontal
% 216.27/216.44  |- skos__scopeNote mesh__D010508
% 216.27/216.44       Localized circumscribed purulent area of inflammation in the periodontal tissue. It is a derivative of marginal periodontitis and commonly associated with suprabony and infrabony pockets and interradicular involvements, in contrast to periapical abscess which is attributable to pulp necrosis.%A%    
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D010508 1998
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D010508 2000
% 216.27/216.44  |- skos__annotation mesh__D010508
% 216.27/216.44       do not confuse with PERIAPICAL ABSCESS: see X refs there; for coord read note on ABSCESS%A%  
% 216.27/216.44  |- mesh__recordAuthorizer mesh__D010508 PLS
% 216.27/216.44  |- mesh__onlineNote mesh__D010508
% 216.27/216.44       use PERIODONTAL ABSCESS to search ABSCESS, PERIODONTAL 1975-80; use PERIODONTITIS 1966-74%A%  
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D010508 2003
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D010508 2001
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D010508 1997
% 216.27/216.44  |- skos__altLabel mesh__D020936 Benign Non-Familial Neonatal Convulsions
% 216.27/216.44  |- skos__broader mesh__D020936smesh__D007232
% 216.27/216.44  |- skos__hiddenLabel mesh__D020936 Benign Neonatal Epilepsy
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D020936 2000
% 216.27/216.44  |- mesh__dateCreated mesh__D020936 1999-11-03
% 216.27/216.44  |- skos__altLabel mesh__D020936 Familial Benign Neonatal Convulsions
% 216.27/216.44  |- skos__altLabel mesh__D020936 Epilespy, Benign Neonatal, Non-Familial
% 216.27/216.44  |- skos__hiddenLabel mesh__D020936 Benign Non Familial Neonatal Convulsions
% 216.27/216.44  |- mesh__publicMeSHNote mesh__D020936 2000   
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D020936 2006
% 216.27/216.44  |- skos__hiddenLabel mesh__D020936 Convulsion, Benign Neonatal
% 216.27/216.44  |- rdf__type mesh__D020936sskos__Concept
% 216.27/216.44  |- skos__hiddenLabel mesh__D020936 Neonatal Epilepsies, Benign
% 216.27/216.44  |- skos__altLabel mesh__D020936 Benign Neonatal Nonfamilial Epilepsy
% 216.27/216.44  |- skos__altLabel mesh__D020936 Convulsions, Benign Neonatal, Non-Familial
% 216.27/216.44  |- skos__hiddenLabel mesh__D020936 Benign Neonatal Convulsion
% 216.27/216.44  |- skos__altLabel mesh__D020936 Non-Familial Benign Neonatal Convulsions
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D020936 2005
% 216.27/216.44  |- skos__altLabel mesh__D020936 Familial Benign Neonatal Epilepsy
% 216.27/216.44  |- skos__prefLabel mesh__D020936 Epilepsy, Benign Neonatal
% 216.27/216.44  |- skos__altLabel mesh__D020936 Epilepsy, Benign Neonatal, Familial
% 216.27/216.44  |- skos__hiddenLabel mesh__D020936 Epilepsies, Benign Neonatal
% 216.27/216.44  |- skos__hiddenLabel mesh__D020936 Benign Neonatal Epilepsies
% 216.27/216.44  |- skos__hiddenLabel mesh__D020936 Neonatal Epilepsy, Benign
% 216.27/216.44  |- skos__hiddenLabel mesh__D020936 Convulsions, Benign Neonatal
% 216.27/216.44  |- skos__hiddenLabel mesh__D020936 Benign Neonatal Non Familial Convulsions
% 216.27/216.44  |- skos__scopeNote mesh__D020936
% 216.27/216.44       A condition marked by recurrent seizures that occur during the first 4-6 weeks of life despite an otherwise benign neonatal course. Autosomal dominant familial and sporadic forms have been identified. Seizures generally consist of brief episodes of tonic posturing and other movements, apnea, eye deviations, and blood pressure fluctuations. These tend to remit after the 6th week of life. The risk of developing epilepsy at an older age is moderately increased in the familial form of this disorder. %28%Neurologia 1996 Feb;11%28%2%29%:51-5%29%%A%    
% 216.27/216.44  |- skos__altLabel mesh__D020936 Benign Familial Neonatal Convulsions
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D020936 2004
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D020936 2002
% 216.27/216.44  |- skos__altLabel mesh__D020936 Non-Familial Benign Neonatal Epilepsy
% 216.27/216.44  |- skos__historyNote mesh__D020936 Epilepsy %28%1968-1999%29%
% 216.27/216.44  |- skos__broader mesh__D020936smesh__D004827
% 216.27/216.44  |- skos__hiddenLabel mesh__D020936 Benign Neonatal Convulsions
% 216.27/216.44  |- skos__altLabel mesh__D020936 Convulsions, Benign Neonatal, Familial
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D020936 2003
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D020936 2001
% 216.27/216.44  |- skos__hiddenLabel mesh__D020936 Non Familial Benign Neonatal Epilepsy
% 216.27/216.44  |- mesh__historyNote mesh__D020936 2000   
% 216.27/216.44  |- skos__hiddenLabel mesh__D020936 Non Familial Benign Neonatal Convulsions
% 216.27/216.44  |- skos__hiddenLabel mesh__D020936 Neonatal Convulsion, Benign
% 216.27/216.44  |- mesh__dateEstablished mesh__D020936 2000-01-01
% 216.27/216.44  |- skos__altLabel mesh__D020936 Epilepsy, Benign Neonatal, Nonfamilial
% 216.27/216.44  |- skos__altLabel mesh__D020936 Neonatal Convulsions, Benign
% 216.27/216.44  |- skos__altLabel mesh__D020936 Benign Neonatal Non-Familial Convulsions
% 216.27/216.44  |- skos__altLabel mesh__D039641 Integrin beta Subunits
% 216.27/216.44  |- skos__altLabel mesh__D039641 beta Integrins
% 216.27/216.44  |- mesh__publicMeSHNote mesh__D039641 2003   
% 216.27/216.44  |- mesh__dateCreated mesh__D039641 2002-07-02
% 216.27/216.44  |- mesh__dateRevised mesh__D039641 2003-07-09
% 216.27/216.44  |- rdf__type mesh__D039641sskos__Concept
% 216.27/216.44  |- skos__scopeNote mesh__D039641
% 216.27/216.44       Integrin beta chains combine with integrin alpha chains to form heterodimeric cell surface receptors.  Integrins have traditionally been classified into functional groups based on the identity of one of three beta chains present in the heterodimer. The beta chain is necessary and sufficient for integrin-dependent signaling. Its short cytoplasmic tail contains sequences critical for inside-out signaling.%A%    
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D039641 2004
% 216.27/216.44  |- mesh__dateEstablished mesh__D039641 2003-01-01
% 216.27/216.44  |- mesh__historyNote mesh__D039641 2003   
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D039641 2006
% 216.27/216.44  |- skos__hiddenLabel mesh__D039641 beta Chains, Integrin
% 216.27/216.44  |- skos__hiddenLabel mesh__D039641 Integrins, beta
% 216.27/216.44  |- skos__broader mesh__D039641smesh__D016023
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D039641 2005
% 216.27/216.44  |- skos__historyNote mesh__D039641 Integrins %28%1990-2002%29%
% 216.27/216.44  |- skos__prefLabel mesh__D039641 Integrin beta Chains
% 216.27/216.44  |- skos__hiddenLabel mesh__D006467 Deficiencies, Factor VIII
% 216.27/216.44  |- skos__hiddenLabel mesh__D006467 Hemophilia As
% 216.27/216.44  |- mesh__recordAuthorizer mesh__D006467 sjn
% 216.27/216.44  |- skos__broader mesh__D006467smesh__D006474
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D006467 2006
% 216.27/216.44  |- skos__altLabel mesh__D006467 Deficiency, Factor VIII
% 216.27/216.44  |- mesh__publicMeSHNote mesh__D006467
% 216.27/216.44       99; see HEMOPHILIA 1966-98; for HEMOPHILIA A see HEMOPHILIA 1993-98%A%  
% 216.27/216.44  |- skos__hiddenLabel mesh__D006467 As, Hemophilia
% 216.27/216.44  |- skos__altLabel mesh__D006467 Factor VIII Deficiency
% 216.27/216.44  |- mesh__historyNote mesh__D006467 99%28%66%29%   
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D006467 2005
% 216.27/216.44  |- skos__prefLabel mesh__D006467 Hemophilia A
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D006467 2004
% 216.27/216.44  |- skos__related mesh__D006467smesh__D002836
% 216.27/216.44  |- skos__hiddenLabel mesh__D006467 A, Hemophilia
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D006467 2003
% 216.27/216.44  |- skos__scopeNote mesh__D006467
% 216.27/216.44       The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage.%A%    
% 216.27/216.44  |- mesh__recordMaintainer mesh__D006467 ssb
% 216.27/216.44  |- skos__related mesh__D006467smesh__D006395
% 216.27/216.44  |- rdf__type mesh__D006467sskos__Concept
% 216.27/216.44  |- mesh__dateCreated mesh__D006467 1999-01-01
% 216.27/216.44  |- mesh__recordOriginator mesh__D006467 NLM
% 216.27/216.44  |- skos__altLabel mesh__D006467 Hemophilia
% 216.27/216.44  |- mesh__dateRevised mesh__D006467 2002-07-02
% 216.27/216.44  |- skos__broader mesh__D006467smesh__D025861
% 216.27/216.44  |- skos__broader mesh__D006467smesh__D020147
% 216.27/216.44  |- skos__altLabel mesh__D006467 Haemophilia
% 216.27/216.44  |- skos__hiddenLabel mesh__D006467 Factor VIII Deficiencies
% 216.27/216.44  |- skos__related mesh__D020138smesh__D006712
% 216.27/216.44  |- mesh__recordAuthorizer mesh__D020138 sjn
% 216.27/216.44  |- mesh__publicMeSHNote mesh__D020138 99   
% 216.27/216.44  |- skos__historyNote mesh__D020138 Homocysteine/blood %28%1991-1998%29%
% 216.27/216.44  |- skos__scopeNote mesh__D020138
% 216.27/216.44       An inborn error of methionone metabolism which produces an excess of homocysteine in the blood. It is often caused by a deficiency of CYSTATHIONINE BETA-SYNTHASE and is a risk factor for coronary vascular disease.%A%    
% 216.27/216.44  |- skos__related mesh__D020138smesh__D003541
% 216.27/216.44  |- mesh__dateEstablished mesh__D020138 1999-01-01
% 216.27/216.44  |- rdf__type mesh__D020138sskos__Concept
% 216.27/216.44  |- mesh__dateRevised mesh__D020138 2001-07-25
% 216.27/216.44  |- skos__hiddenLabel mesh__D020138 Hyperhomocysteinemias
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D020138 2006
% 216.27/216.44  |- mesh__recordMaintainer mesh__D020138 nns
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D020138 2004
% 216.27/216.44  |- skos__prefLabel mesh__D020138 Hyperhomocysteinemia
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D020138 2005
% 216.27/216.44  |- mesh__dateCreated mesh__D020138 1998-06-10
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D020138 2003
% 216.27/216.44  |- mesh__recordOriginator mesh__D020138 NDW
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D020138 2002
% 216.27/216.44  |- skos__broader mesh__D020138smesh__D000592
% 216.27/216.44  |- mesh__historyNote mesh__D020138 99   
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D011601 1993
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D011601 1999
% 216.27/216.44  |- mesh__publicMeSHNote mesh__D011601 70   
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D011601 2001
% 216.27/216.44  |- skos__scopeNote mesh__D011601
% 216.27/216.44       The science dealing with the correlation of the physical characteristics of a stimulus, e.g., frequency or intensity, with the response to the stimulus, in order to assess the psychologic factors involved in the relationship.%A%    
% 216.27/216.44  |- rdf__type mesh__D011601sskos__Concept
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D011601 1997
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D011601 1990
% 216.27/216.44  |- mesh__dateRevised mesh__D011601 1978-12-05
% 216.27/216.44  |- mesh__recordAuthorizer mesh__D011601 NLM
% 216.27/216.44  |- mesh__recordOriginator mesh__D011601 NLM
% 216.27/216.44  |- skos__historyNote mesh__D011601 Perception %28%1966-1969%29%
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D011601 2002
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D011601 1991
% 216.27/216.44  |- mesh__dateCreated mesh__D011601 1999-01-01
% 216.27/216.44  |- skos__related mesh__D011601smesh__D004056
% 216.27/216.44  |- skos__broader mesh__D011601smesh__D010825
% 216.27/216.44  |- skos__hiddenLabel mesh__D011601 Psychophysic
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D011601 2005
% 216.27/216.44  |- skos__broader mesh__D011601smesh__D001525
% 216.27/216.44  |- mesh__dateEstablished mesh__D011601 1970-01-01
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D011601 2003
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D011601 1994
% 216.27/216.44  |- mesh__recordMaintainer mesh__D011601 HMM
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D011601 1989
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D011601 1992
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D011601 2006
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D011601 2000
% 216.27/216.44  |- mesh__historyNote mesh__D011601 70   
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D011601 1998
% 216.27/216.44  |- skos__prefLabel mesh__D011601 Psychophysics
% 216.27/216.44  |- skos__annotation mesh__D011601
% 216.27/216.44       SPEC: IM, SPEC qualif; NIM coord, no qualif; PSYCHOACOUSTICS is also available%A%  
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D011601 2004
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D011601 1995
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D011601 1996
% 216.27/216.44  |- skos__hiddenLabel mesh__D016895 Low Serum Media
% 216.27/216.44  |- skos__historyNote mesh__D016895 Culture Media %28%1966-1991%29%
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D016895 2004
% 216.27/216.44  |- skos__broader mesh__D016895smesh__D003470
% 216.27/216.44  |- mesh__dateCreated mesh__D016895 1991-05-30
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D016895 2006
% 216.27/216.44  |- mesh__historyNote mesh__D016895 92   
% 216.27/216.44  |- mesh__publicMeSHNote mesh__D016895 92   
% 216.27/216.44  |- skos__altLabel mesh__D016895 Protein-Free Media
% 216.27/216.44  |- skos__hiddenLabel mesh__D016895 Serum-Free Culture Media
% 216.27/216.44  |- mesh__recordOriginator mesh__D016895 MXR
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D016895 2005
% 216.27/216.44  |- skos__hiddenLabel mesh__D016895 Protein Free Media
% 216.27/216.44  |- mesh__recordMaintainer mesh__D016895 ssb
% 216.27/216.44  |- skos__hiddenLabel mesh__D016895 Serum Free Media
% 216.27/216.44  |- skos__hiddenLabel mesh__D016895 Media, Serum-Free
% 216.27/216.44  |- skos__hiddenLabel mesh__D016895 Media, Serum-Free Culture
% 216.27/216.44  |- skos__altLabel mesh__D016895 Serum-Free Media
% 216.27/216.44  |- mesh__dateEstablished mesh__D016895 1992-01-01
% 216.27/216.44  |- rdf__type mesh__D016895sskos__Concept
% 216.27/216.44  |- skos__hiddenLabel mesh__D016895 Media, Protein-Free
% 216.27/216.44  |- mesh__recordAuthorizer mesh__D016895 sjn
% 216.27/216.44  |- skos__prefLabel mesh__D016895 Culture Media, Serum-Free
% 216.27/216.44  |- skos__hiddenLabel mesh__D016895 Media, Low-Serum
% 216.27/216.44  |- skos__hiddenLabel mesh__D016895 Culture Media, Serum Free
% 216.27/216.44  |- skos__scopeNote mesh__D016895
% 216.27/216.44       CULTURE MEDIA free of serum proteins but including the minimal essential substances required for cell growth. This type of medium avoids the presence of extraneous substances that may affect cell proliferation or unwanted activation of cells.%A%    
% 216.27/216.44  |- skos__annotation mesh__D016895
% 216.27/216.44       %22%culture media free of serum proteins%22%; NIM; D25-26 qualif with caution%A%  
% 216.27/216.44  |- mesh__dateRevised mesh__D016895 2003-07-09
% 216.27/216.44  |- mesh__historyNote mesh__D016097 91   
% 216.27/216.44  |- skos__altLabel mesh__D016097 Simian AIDS
% 216.27/216.44  |- skos__altLabel mesh__D016097 Simian Acquired Immune Deficiency Syndrome
% 216.27/216.44  |- skos__altLabel mesh__D016097 AIDS, Simian
% 216.27/216.44  |- skos__historyNote mesh__D016097 Monkey Diseases %28%1983-1990%29%
% 216.27/216.44  |- mesh__dateEstablished mesh__D016097 1991-01-01
% 216.27/216.44  |- mesh__recordMaintainer mesh__D016097 sjn
% 216.27/216.44  |- mesh__dateRevised mesh__D016097 2005-07-01
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D016097 2006
% 216.27/216.44  |- skos__hiddenLabel mesh__D016097
% 216.27/216.44       Simian Acquired Immuno Deficiency Syndrome
% 216.27/216.44  |- mesh__recordOriginator mesh__D016097 AGS
% 216.27/216.44  |- skos__hiddenLabel mesh__D016097 Simian AIDSs
% 216.27/216.44  |- skos__prefLabel mesh__D016097 Simian Acquired Immunodeficiency Syndrome
% 216.27/216.44  |- skos__broader mesh__D016097smesh__D016180
% 216.27/216.44  |- rdf__type mesh__D016097sskos__Concept
% 216.27/216.44  |- mesh__recordAuthorizer mesh__D016097 sjn
% 216.27/216.44  |- skos__altLabel mesh__D016097 SAIDS
% 216.27/216.44  |- skos__scopeNote mesh__D016097
% 216.27/216.44       Acquired defect of cellular immunity that occurs naturally in macaques infected with SRV serotypes, experimentally in monkeys inoculated with SRV or MASON-PFIZER MONKEY VIRUS; %28%MPMV%29%, or in monkeys infected with SIMIAN IMMUNODEFICIENCY VIRUS.%A%    
% 216.27/216.44  |- skos__broader mesh__D016097smesh__D012897
% 216.27/216.44  |- skos__hiddenLabel mesh__D016097 AIDSs, Simian
% 216.27/216.44  |- skos__historyNote mesh__D016097 Retrovirus Infections %28%1986-1990%29%
% 216.27/216.44  |- mesh__dateCreated mesh__D016097 1990-03-23
% 216.27/216.44  |- skos__annotation mesh__D016097
% 216.27/216.44       coord IM with RETROVIRUSES, SIMIAN or a specific %28%IM%29% or MASON-PFIZER MONKEY VIRUS %28%IM%29% or SIMIAN IMMUNODEFICIENCY VIRUS %28%IM%29% if pertinent; DF: note short X ref%A%  
% 216.27/216.44  |- mesh__publicMeSHNote mesh__D016097 91   
% 216.27/216.44  |- skos__altLabel mesh__D016097 Simian Acquired Immuno-Deficiency Syndrome
% 216.27/216.44  |- skos__broader mesh__D016097smesh__D008992
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D002875 2005
% 216.27/216.44  |- skos__prefLabel mesh__D002875 Chromosomes
% 216.27/216.44  |- skos__annotation mesh__D002875 GEN or unspecified; prefer specifics   
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D002875 2004
% 216.27/216.44  |- skos__broader mesh__D002875smesh__D042581
% 216.27/216.44  |- skos__hiddenLabel mesh__D002875 Chromosome
% 216.27/216.44  |- skos__broader mesh__D002875smesh__D040342
% 216.27/216.44  |- rdf__type mesh__D002875sskos__Concept
% 216.27/216.44  |- mesh__recordAuthorizer mesh__D002875 sjn
% 216.27/216.44  |- skos__related mesh__D002875smesh__D007621
% 216.27/216.44  |- mesh__dateCreated mesh__D002875 1999-01-01
% 216.27/216.44  |- skos__scopeNote mesh__D002875
% 216.27/216.44       In a prokaryotic cell or in the nucleus of a eukaryotic cell, a structure consisting of or containing DNA which carries the genetic information essential to the cell. %28%From Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed%29%%A%    
% 216.27/216.44  |- mesh__dateRevised mesh__D002875 2003-07-09
% 216.27/216.44  |- mesh__recordMaintainer mesh__D002875 nns
% 216.27/216.44  |- mesh__recordOriginator mesh__D002875 NLM
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D002875 2006
% 216.27/216.44  |- skos__broader mesh__D002875smesh__D022082
% 216.27/216.44  |- skos__altLabel mesh__D002077 Intervet Brand of Butorphanol Tartrate
% 216.27/216.44  |- mesh__recordOriginator mesh__D002077 SH
% 216.27/216.44  |- mesh__recordAuthorizer mesh__D002077 sjn
% 216.27/216.44  |- rdf__type mesh__D002077sskos__Concept
% 216.27/216.44  |- skos__altLabel mesh__D002077 Cephalon Brand of Butorphanol Tartrate
% 216.27/216.44  |- skos__broader mesh__D002077smesh__D009019
% 216.27/216.44  |- mesh__dateCreated mesh__D002077 1978-05-01
% 216.27/216.44  |- mesh__dateRevised mesh__D002077 2005-06-30
% 216.27/216.44  |- skos__altLabel mesh__D002077
% 216.27/216.44       Bristol-Myers Squibb Brand of Butorphanol Tartrate
% 216.27/216.44  |- mesh__publicMeSHNote mesh__D002077
% 216.27/216.44       91; was see under MORPHINANS 1979-90   
% 216.27/216.44  |- skos__historyNote mesh__D002077 Morphinans %28%1969-1978%29%
% 216.27/216.44  |- mesh__dateEstablished mesh__D002077 1991-01-01
% 216.27/216.44  |- skos__prefLabel mesh__D002077 Butorphanol
% 216.27/216.44  |- skos__altLabel mesh__D002077 Fort Dodge Brand of Butorphanol Tartrate
% 216.27/216.44  |- skos__altLabel mesh__D002077
% 216.27/216.44       17-%28%Cyclobutylmethyl%29%morphinan-3,14-diol
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D002077 2006
% 216.27/216.44  |- skos__altLabel mesh__D002077 Geneva Brand of Butorphanol Tartrate
% 216.27/216.44  |- skos__scopeNote mesh__D002077
% 216.27/216.44       A synthetic morphinan analgesic with narcotic antagonist action. It is used in the management of severe pain.%A%    
% 216.27/216.44  |- skos__hiddenLabel mesh__D002077 BC 2627
% 216.27/216.44  |- mesh__historyNote mesh__D002077
% 216.27/216.44       91%28%79%29%; was see under MORPHINANS 1979-90   
% 216.27/216.44  |- skos__altLabel mesh__D002077 Apotex Brand of Butorphanol Tartrate
% 216.27/216.44  |- skos__hiddenLabel mesh__D002077 BC2627
% 216.27/216.44  |- mesh__recordMaintainer mesh__D002077 lkw
% 216.27/216.44  |- skos__altLabel mesh__D002077 Stadol NS
% 216.27/216.44  |- mesh__recordAuthorizer mesh__D010509 PLS
% 216.27/216.44  |- skos__hiddenLabel mesh__D010509 Cysts, Dentoalveolar
% 216.27/216.44  |- skos__hiddenLabel mesh__D010509 Dentoalveolar Cysts
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D010509 1998
% 216.27/216.44  |- skos__hiddenLabel mesh__D010509 Cyst, Lateral
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D010509 2000
% 216.27/216.44  |- skos__altLabel mesh__D010509 Root Cyst, Dental
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D010509 1997
% 216.27/216.44  |- skos__altLabel mesh__D010509 Cysts, Dental Root
% 216.27/216.44  |- skos__broader mesh__D010509smesh__D010510
% 216.27/216.44  |- skos__annotation mesh__D010509
% 216.27/216.44       non-neoplastic; /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/dis term %28%IM%29%%A%  
% 216.27/216.44  |- skos__hiddenLabel mesh__D010509 Cysts, Periodontal
% 216.27/216.44  |- skos__broader mesh__D010509smesh__D009807
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D010509 2006
% 216.27/216.44  |- mesh__dateRevised mesh__D010509 1990-05-29
% 216.27/216.44  |- skos__scopeNote mesh__D010509
% 216.27/216.44       An epithelium-lined sac containing fluid; usually found at the apex of a pulp-involved tooth. The lateral type occurs less frequently along the side of the root.%A%    
% 216.27/216.44  |- skos__hiddenLabel mesh__D010509 Cyst, Periodontal
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D010509 1996
% 216.27/216.44  |- skos__hiddenLabel mesh__D010509 Cysts, Lateral
% 216.27/216.44  |- skos__altLabel mesh__D010509 Dental Root Cyst
% 216.27/216.44  |- mesh__activeMeSHYear mesh__D010509 2005
% 216.27/216.44  |- rdf__type mesh__D010509sskos__Concept
% 216.27/216.44  |- skos__altLabel mesh__D010509 Dental Root Cysts
% 216.27/216.44  |- skos__altLabel mesh__D010509 Cyst, Dental Root
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D010509 2004
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D010509 2002
% 216.27/216.45  |- skos__altLabel mesh__D010509 Root Cysts, Dental
% 216.27/216.45  |- skos__hiddenLabel mesh__D010509 Cyst, Dentoalveolar
% 216.27/216.45  |- mesh__dateCreated mesh__D010509 1999-01-01
% 216.27/216.45  |- skos__hiddenLabel mesh__D010509 Lateral Cysts
% 216.27/216.45  |- mesh__dateEstablished mesh__D010509 1965-01-01
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D010509 1993
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D010509 1991
% 216.27/216.45  |- skos__hiddenLabel mesh__D010509 Periodontal Cysts
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D010509 2003
% 216.27/216.45  |- mesh__recordMaintainer mesh__D010509 TAP
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D010509 1995
% 216.27/216.45  |- mesh__publicMeSHNote mesh__D010509 65   
% 216.27/216.45  |- skos__altLabel mesh__D010509 Lateral Cyst
% 216.27/216.45  |- mesh__historyNote mesh__D010509 65   
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D010509 1992
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D010509 1999
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D010509 2001
% 216.27/216.45  |- mesh__recordOriginator mesh__D010509 NLM
% 216.27/216.45  |- skos__altLabel mesh__D010509 Dentoalveolar Cyst
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D010509 1994
% 216.27/216.45  |- skos__prefLabel mesh__D010509 Periodontal Cyst
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D007560 2003
% 216.27/216.45  |- skos__prefLabel mesh__D007560 Cote d%27%Ivoire
% 216.27/216.45  |- skos__scopeNote mesh__D007560
% 216.27/216.45       A republic in western Africa, south of MALI and BURKINA FASO. Its capital is Abidjan. It was formerly called Ivory Coast. From 1842 the French had a treaty with the native rulers. By 1889 a French protectorate was established and in 1893 it was made a colony. Cote d%27%Ivoire achieved self-government in 1958 and became an independent republic in 1960. It is named for the ivory first traded by the Portuguese there in the 16th century. %28%From Webster%27%s New Geographical Dictionary, 1988, p295, 560 %26% Room, Brewer%27%s Dictionary of Names, 1992, p264%29%%A%    
% 216.27/216.45  |- mesh__onlineNote mesh__D007560
% 216.27/216.45       use COTE D%27%IVOIRE to search IVORY COAST 1971-93   
% 216.27/216.45  |- mesh__recordAuthorizer mesh__D007560 sjn
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D007560 2006
% 216.27/216.45  |- mesh__historyNote mesh__D007560 94; was IVORY COAST 1971-93   
% 216.27/216.45  |- mesh__recordMaintainer mesh__D007560 jls
% 216.27/216.45  |- skos__annotation mesh__D007560
% 216.27/216.45       a republic in western Africa; X ref IVORY COAST was its former name; in translations use the French name C%C3%%B4%te d%27%Ivoire with circumflex%A%  
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D007560 2005
% 216.27/216.45  |- skos__broader mesh__D007560smesh__D000354
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D007560 2002
% 216.27/216.45  |- mesh__dateRevised mesh__D007560 2001-08-13
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D007560 2004
% 216.27/216.45  |- mesh__recordOriginator mesh__D007560 NLM
% 216.27/216.45  |- skos__altLabel mesh__D007560 Ivory Coast
% 216.27/216.45  |- mesh__dateCreated mesh__D007560 1999-01-01
% 216.27/216.45  |- rdf__type mesh__D007560sskos__Concept
% 216.27/216.45  |- mesh__publicMeSHNote mesh__D039642 2003   
% 216.27/216.45  |- skos__hiddenLabel mesh__D039642 Initiation Factors, Chloroplast
% 216.27/216.45  |- mesh__recordMaintainer mesh__D039642 SYSTEM
% 216.27/216.45  |- rdf__type mesh__D039642sskos__Concept
% 216.27/216.45  |- skos__broader mesh__D039642smesh__D010448
% 216.27/216.45  |- skos__scopeNote mesh__D039642
% 216.27/216.45        Peptide initiation factors from eukaryotic organisms. Over twelve factors are involved in  PEPTIDE CHAIN INITIATION, TRANSLATIONAL in eukaryotic cells. Many of these factors play a role in controlling the rate of MRNA TRANSLATION.%A%    
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D039642 2006
% 216.27/216.45  |- skos__annotation mesh__D039642 GEN or unspecified; prefer specifics   
% 216.27/216.45  |- skos__hiddenLabel mesh__D039642 Initiation Factors, Eukaryotic
% 216.27/216.45  |- skos__hiddenLabel mesh__D039642 Initiation Factors, Mitochodrial
% 216.27/216.45  |- skos__altLabel mesh__D039642 Mitochondrial Peptide Initiation Factors
% 216.27/216.45  |- skos__historyNote mesh__D039642
% 216.27/216.45       Peptide Initiation Factors %28%1973-2002%29%
% 216.27/216.45  |- mesh__recordOriginator mesh__D039642 jmp
% 216.27/216.45  |- skos__altLabel mesh__D039642 Translation Initiation Factors, Eukaryotic
% 216.27/216.45  |- skos__altLabel mesh__D039642 Chloroplast Peptide Initiation Factors
% 216.27/216.45  |- skos__altLabel mesh__D039642 Peptide Initiation Factors, Eukaryotic
% 216.27/216.45  |- skos__prefLabel mesh__D039642 Eukaryotic Initiation Factors
% 216.27/216.45  |- mesh__dateEstablished mesh__D039642 2003-01-01
% 216.27/216.45  |- mesh__recordAuthorizer mesh__D039642 sjn
% 216.27/216.45  |- mesh__historyNote mesh__D039642 2003   
% 216.27/216.45  |- mesh__dateRevised mesh__D039642 2005-06-30
% 216.27/216.45  |- skos__altLabel mesh__D039642 Eukaryotic Peptide Initiation Factors
% 216.27/216.45  |- mesh__dateCreated mesh__D039642 2002-07-03
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Seizure, Focal Sensory
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Seizure, Olfactory Partial
% 216.27/216.45  |- skos__prefLabel mesh__D020937 Epilepsy, Partial, Sensory
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Seizure, Gustatory Partial
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Seizure, Partial Sensory
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D020937 2000
% 216.27/216.45  |- skos__altLabel mesh__D020937 Sensory Seizure Disorder
% 216.27/216.45  |- mesh__dateCreated mesh__D020937 1999-11-03
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D020937 2006
% 216.27/216.45  |- skos__historyNote mesh__D020937 Epilepsies, Partial %28%1977-1999%29%
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Visual Partial Seizures
% 216.27/216.45  |- rdf__type mesh__D020937sskos__Concept
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Focal Sensory Seizures
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Gustatory Partial Seizures
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Vertiginous Partial Seizures
% 216.27/216.45  |- skos__altLabel mesh__D020937 Seizure Disorder, Sensory
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Partial Seizures, Visual
% 216.27/216.45  |- mesh__publicMeSHNote mesh__D020937 2000   
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Partial Seizures, Vertiginous
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Epilepsy, Sensory Partial
% 216.27/216.45  |- skos__altLabel mesh__D020937 Sensory Partial Seizure Disorder
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D020937 2005
% 216.27/216.45  |- skos__altLabel mesh__D020937 Partial Epilepsy, Sensory
% 216.27/216.45  |- skos__altLabel mesh__D020937 Sensory Focal Seizure Disorder
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Sensory Seizure, Focal
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Partial Seizure, Vertiginous
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Seizures, Partial Sensory
% 216.27/216.45  |- skos__altLabel mesh__D020937 Seizure Disorder, Partial, Sensory
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Partial Seizure, Olfactory
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Olfactory Partial Seizures
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Seizure Disorders, Sensory
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Sensory Seizures, Focal
% 216.27/216.45  |- skos__altLabel mesh__D020937 Focal Seizure Disorder, Sensory
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Sensory Seizure, Partial
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D020937 2004
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Partial Seizure, Gustatory
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Seizure, Vertiginous Partial
% 216.27/216.45  |- skos__altLabel mesh__D020937
% 216.27/216.45       Simple Partial Seizures, Special Sensory Symptoms
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Seizures, Vertiginous Partial
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Partial Sensory Seizures
% 216.27/216.45  |- skos__altLabel mesh__D020937 Seizure Disorder, Sensory, Focal
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D020937 2002
% 216.27/216.45  |- skos__altLabel mesh__D020937 Partial Sensory Seizure
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Sensory Seizures, Partial
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Partial Seizures, Olfactory
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D020937 2003
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Seizure, Visual Partial
% 216.27/216.45  |- skos__historyNote mesh__D020937 Epilepsy %28%1966-1976%29%
% 216.27/216.45  |- mesh__historyNote mesh__D020937 2000   
% 216.27/216.45  |- skos__scopeNote mesh__D020937
% 216.27/216.45       A disorder characterized by recurrent focal onset seizures which have sensory %28%i.e., olfactory, visual, tactile, gustatory, or auditory%29% manifestations. Partial seizures that feature alterations of consciousness are referred to as complex partial seizures %28%EPILEPSY, COMPLEX PARTIAL%29%.%A%    
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Epilepsy, Sensory
% 216.27/216.45  |- mesh__dateEstablished mesh__D020937 2000-01-01
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Sensory Partial Epilepsy
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Partial Seizures, Gustatory
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Partial Seizure, Visual
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D020937 2001
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Seizures, Olfactory Partial
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Seizures, Focal Sensory
% 216.27/216.45  |- skos__broader mesh__D020937smesh__D004828
% 216.27/216.45  |- skos__hiddenLabel mesh__D020937 Sensory Seizure Disorders
% 216.27/216.45  |- rdf__type mesh__D020139sskos__Concept
% 216.27/216.45  |- skos__hiddenLabel mesh__D020139 Gastroschises
% 216.27/216.45  |- mesh__dateRevised mesh__D020139 2004-07-07
% 216.27/216.45  |- skos__prefLabel mesh__D020139 Gastroschisis
% 216.27/216.45  |- mesh__historyNote mesh__D020139 99   
% 216.27/216.45  |- mesh__recordAuthorizer mesh__D020139 sjn
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D020139 2006
% 216.27/216.45  |- skos__scopeNote mesh__D020139
% 216.27/216.45       A congenital defect with major fissure in the ABDOMINAL WALL lateral to, but not at, the UMBILICUS. This results in the extrusion of VISCERA. Unlike OMPHALOCELE, herniated structures in gastroschisis are not covered by a sac or PERITONEUM.%A%    
% 216.27/216.45  |- skos__broader mesh__D020139smesh__D046449
% 216.27/216.45  |- mesh__dateEstablished mesh__D020139 1999-01-01
% 216.27/216.45  |- skos__broader mesh__D020139smesh__D009139
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D020139 2005
% 216.27/216.45  |- skos__historyNote mesh__D020139
% 216.27/216.45       Abdominal Muscles/abnormalities %28%1966-1998%29%
% 216.27/216.45  |- mesh__recordOriginator mesh__D020139 NDW
% 216.27/216.45  |- skos__annotation mesh__D020139 do not confuse with HERNIA, UMBILICAL   
% 216.27/216.45  |- mesh__publicMeSHNote mesh__D020139 99   
% 216.27/216.45  |- mesh__dateCreated mesh__D020139 1998-06-10
% 216.27/216.45  |- mesh__recordMaintainer mesh__D020139 lkt
% 216.27/216.45  |- skos__broader mesh__D006468smesh__D006491
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D006468 2001
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D006468 2003
% 216.27/216.45  |- mesh__recordOriginator mesh__D006468 NLM
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D006468 2000
% 216.27/216.45  |- mesh__dateCreated mesh__D006468 1999-01-01
% 216.27/216.45  |- rdf__type mesh__D006468sskos__Concept
% 216.27/216.45  |- mesh__recordMaintainer mesh__D006468 sjn
% 216.27/216.45  |- mesh__recordAuthorizer mesh__D006468 sjn
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D006468 2002
% 216.27/216.45  |- mesh__dateRevised mesh__D006468 2002-10-23
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D006468 2003A
% 216.27/216.45  |- skos__scopeNote mesh__D006468
% 216.27/216.45       Collection of air and blood in the pleural cavity.     
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D006468 2006
% 216.27/216.45  |- skos__broader mesh__D006468smesh__D010995
% 216.27/216.45  |- skos__prefLabel mesh__D006468 Hemopneumothorax
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D006468 2004
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D006468 2005
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D017190 1994
% 216.27/216.45  |- rdf__type mesh__D017190sskos__Concept
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D017190 2000
% 216.27/216.45  |- skos__hiddenLabel mesh__D017190 Infection, Secernentea
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D017190 1995
% 216.27/216.45  |- mesh__dateRevised mesh__D017190 1993-06-03
% 216.27/216.45  |- mesh__recordAuthorizer mesh__D017190 PLS
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D017190 2001
% 216.27/216.45  |- skos__altLabel mesh__D017190 Phasmidia Infections
% 216.27/216.45  |- mesh__recordMaintainer mesh__D017190 TGC
% 216.27/216.45  |- skos__altLabel mesh__D017190 Infections, Phasmidia
% 216.27/216.45  |- skos__hiddenLabel mesh__D017190 Infection, Phasmidia
% 216.27/216.45  |- skos__hiddenLabel mesh__D017190 Secernentea Infection
% 216.27/216.45  |- skos__scopeNote mesh__D017190
% 216.27/216.45       Infections with nematodes of the subclass SECERNENTEA.     
% 216.27/216.45  |- mesh__publicMeSHNote mesh__D017190 93   
% 216.27/216.45  |- skos__altLabel mesh__D017190 Infections, Secernentea
% 216.27/216.45  |- mesh__historyNote mesh__D017190 93   
% 216.27/216.45  |- skos__broader mesh__D017190smesh__D009349
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D017190 1996
% 216.27/216.45  |- mesh__dateCreated mesh__D017190 1992-05-22
% 216.27/216.45  |- skos__annotation mesh__D017190 nematode infect   
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D017190 2003
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D017190 2002
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D017190 1998
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D017190 2005
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D017190 1997
% 216.27/216.45  |- skos__hiddenLabel mesh__D017190 Phasmidia Infection
% 216.27/216.45  |- mesh__recordOriginator mesh__D017190 PXP
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D017190 2004
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D017190 1999
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D017190 2006
% 216.27/216.45  |- mesh__dateEstablished mesh__D017190 1993-01-01
% 216.27/216.45  |- skos__prefLabel mesh__D017190 Secernentea Infections
% 216.27/216.45  |- mesh__publicMeSHNote mesh__D025622 2002   
% 216.27/216.45  |- skos__historyNote mesh__D025622 Bacteriophages %28%1974-2001%29%
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D025622 2002
% 216.27/216.45  |- rdf__type mesh__D025622sskos__Concept
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D025622 2006
% 216.27/216.45  |- mesh__dateCreated mesh__D025622 2001-07-25
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D025622 2005
% 216.27/216.45  |- skos__broader mesh__D025622smesh__D003090
% 216.27/216.45  |- mesh__historyNote mesh__D025622 2002   
% 216.27/216.45  |- skos__hiddenLabel mesh__D025622 PRD1, Bacteriophage
% 216.27/216.45  |- skos__broader mesh__D025622smesh__D017916
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D025622 2004
% 216.27/216.45  |- skos__altLabel mesh__D025622 Phage PRD1
% 216.27/216.45  |- skos__scopeNote mesh__D025622
% 216.27/216.45       Bacteriophage and type species in the genus Tectivirus, family TECTIVIRIDAE. They are specific for Gram-negative bacteria.%A%    
% 216.27/216.45  |- skos__prefLabel mesh__D025622 Bacteriophage PRD1
% 216.27/216.45  |- mesh__dateEstablished mesh__D025622 2002-01-01
% 216.27/216.45  |- skos__hiddenLabel mesh__D025622 PRD1, Phage
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D025622 2003
% 216.27/216.45  |- skos__altLabel mesh__D025622 Enterobacteria phage PRD1
% 216.27/216.45  |- mesh__publicMeSHNote mesh__D003170
% 216.27/216.45       91; was see under COMPLEMENT ACTIVATION 1979-90   
% 216.27/216.45  |- mesh__recordAuthorizer mesh__D003170 sjn
% 216.27/216.45  |- mesh__historyNote mesh__D003170
% 216.27/216.45       91%28%79%29%; was see under COMPLEMENT ACTIVATION 1979-90   
% 216.27/216.45  |- skos__altLabel mesh__D003170 Alternative Complement Pathway
% 216.27/216.45  |- mesh__recordOriginator mesh__D003170 AEP
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D003170 2006
% 216.27/216.45  |- mesh__recordMaintainer mesh__D003170 lkt
% 216.27/216.45  |- mesh__dateEstablished mesh__D003170 1991-01-01
% 216.27/216.45  |- rdf__type mesh__D003170sskos__Concept
% 216.27/216.45  |- skos__broader mesh__D003170smesh__D003167
% 216.27/216.45  |- skos__prefLabel mesh__D003170 Complement Pathway, Alternative
% 216.27/216.45  |- mesh__dateRevised mesh__D003170 2005-06-30
% 216.27/216.45  |- skos__historyNote mesh__D003170 Complement %28%1966-1978%29%
% 216.27/216.45  |- skos__altLabel mesh__D003170 Complement Activation Pathway, Alternative
% 216.27/216.45  |- skos__altLabel mesh__D003170 Alternative Complement Activation Pathway
% 216.27/216.45  |- mesh__dateCreated mesh__D003170 1977-12-02
% 216.27/216.45  |- skos__scopeNote mesh__D003170
% 216.27/216.45       Complement activation initiated by the interaction of microbial ANTIGENS with COMPLEMENT C3B. When COMPLEMENT FACTOR B binds to the membrane-bound C3b, COMPLEMENT FACTOR D cleaves it to form alternative C3 CONVERTASE %28%C3BBB%29% which, stabilized by COMPLEMENT FACTOR P, is able to cleave multiple COMPLEMENT C3 to form alternative C5 CONVERTASE %28%C3BBB3B%29% leading to cleavage of COMPLEMENT C5 and the assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX.%A%    
% 216.27/216.45  |- skos__historyNote mesh__D003170
% 216.27/216.45       Complement Fixation Tests %28%1966-1978%29%
% 216.27/216.45  |- skos__altLabel mesh__D003170 Properdin Pathway
% 216.27/216.45  |- skos__hiddenLabel mesh__D011602 Psychophysiologic Disorder
% 216.27/216.45  |- mesh__publicMeSHNote mesh__D011602 68   
% 216.27/216.45  |- skos__altLabel mesh__D011602 Psychosomatic Disorders
% 216.27/216.45  |- skos__hiddenLabel mesh__D011602 Psychosomatic Disorder
% 216.27/216.45  |- mesh__dateRevised mesh__D011602 2003-07-09
% 216.27/216.45  |- skos__scopeNote mesh__D011602
% 216.27/216.45       A group of disorders characterized by physical symptoms that are affected by emotional factors and involve a single organ system, usually under AUTONOMIC NERVOUS SYSTEM control. %28%American Psychiatric Glossary, 1988%29%%A%    
% 216.27/216.45  |- mesh__historyNote mesh__D011602 68   
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D011602 2005
% 216.27/216.45  |- skos__broader mesh__D011602smesh__D009461
% 216.27/216.45  |- skos__annotation mesh__D011602
% 216.27/216.45       differentiate from PSYCHOSOMATIC MEDICINE which is the field; coord IM with specific dis /psychol %28%IM%29%;  Manual 27.12; DF: PSYCHOPHYSIOL DIS%A%  
% 216.27/216.45  |- skos__historyNote mesh__D011602 Psychosomatic Medicine %28%1966-1967%29%
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D011602 2006
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D011602 2004
% 216.27/216.45  |- mesh__recordOriginator mesh__D011602 NLM
% 216.27/216.45  |- rdf__type mesh__D011602sskos__Concept
% 216.27/216.45  |- skos__hiddenLabel mesh__D011602 Psychophysiological Disorder
% 216.27/216.45  |- mesh__dateEstablished mesh__D011602 1968-01-01
% 216.27/216.45  |- skos__altLabel mesh__D011602 Psychophysiological Disorders
% 216.27/216.45  |- mesh__recordMaintainer mesh__D011602 lkt
% 216.27/216.45  |- skos__prefLabel mesh__D011602 Psychophysiologic Disorders
% 216.27/216.45  |- mesh__recordAuthorizer mesh__D011602 sjn
% 216.27/216.45  |- mesh__dateCreated mesh__D011602 1999-01-01
% 216.27/216.45  |- skos__broader mesh__D016896smesh__D017063
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D016896 2004
% 216.27/216.45  |- mesh__dateEstablished mesh__D016896 1992-01-01
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D016896 2002
% 216.27/216.45  |- skos__hiddenLabel mesh__D016896 Outcome, Rehabilitation
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D016896 2006
% 216.27/216.45  |- mesh__dateRevised mesh__D016896 1998-06-11
% 216.27/216.45  |- skos__hiddenLabel mesh__D016896 Outcome, Treatment
% 216.27/216.45  |- mesh__historyNote mesh__D016896 92   
% 216.27/216.45  |- mesh__recordAuthorizer mesh__D016896 SJN
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D016896 2003
% 216.27/216.45  |- mesh__dateCreated mesh__D016896 1991-06-20
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D016896 2001
% 216.27/216.45  |- skos__hiddenLabel mesh__D016896 Efficacy, Treatment
% 216.27/216.45  |- skos__hiddenLabel mesh__D016896 Effectiveness, Treatment
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D016896 2005
% 216.27/216.45  |- mesh__recordOriginator mesh__D016896 MXR
% 216.27/216.45  |- skos__prefLabel mesh__D016896 Treatment Outcome
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D016896 2000
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D016896 1999
% 216.27/216.45  |- skos__annotation mesh__D016896
% 216.27/216.45       IM: GEN only; coord NIM with dis /ther %28%IM%29%, as %22%analysis of treatment outcome in Alzheimer dis at onset%22%%A%  
% 216.27/216.45  |- mesh__publicMeSHNote mesh__D016896 92   
% 216.27/216.45  |- rdf__type mesh__D016896sskos__Concept
% 216.27/216.45  |- skos__scopeNote mesh__D016896
% 216.27/216.45       Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, practicability, etc., of these interventions in individual cases or series.%A%    
% 216.27/216.45  |- skos__broader mesh__D016896smesh__D011379
% 216.27/216.45  |- skos__altLabel mesh__D016896 Treatment Efficacy
% 216.27/216.45  |- mesh__recordMaintainer mesh__D016896 JLS
% 216.27/216.45  |- skos__broader mesh__D016098smesh__D020271
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D016098 2006
% 216.27/216.45  |- skos__altLabel mesh__D016098 Gerstmann-Straussler Syndrome
% 216.27/216.45  |- skos__scopeNote mesh__D016098
% 216.27/216.45       An autosomal dominant familial prion disease with a wide spectrum of clinical presentations including ATAXIA, spastic paraparesis, extrapyramidal signs, and DEMENTIA. Clinical onset is in the third to sixth decade of life and the mean duration of illness prior to death is five years. Several kindreds with variable clinical and pathologic features have been described. Pathologic features include cerebral prion protein amyloidosis, and spongiform or neurofibrillary degeneration. %28%From Brain Pathol 1998 Jul;8%28%3%29%:499-513; Brain Pathol 1995 Jan;5%28%1%29%:61-75%29%%A%    
% 216.27/216.45  |- mesh__historyNote mesh__D016098
% 216.27/216.45       2000%28%1991%29%; use SLOW VIRUS DISEASES 1988-1990; GERSTMANN-STRAUSSLER-SCHEINKER DISEASE was GERSTMANN-STRAUSSLER-SCHEINDER DISEASE see GERSTMANN-STRAUSSLER SYNDROME 1991%A%  
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D016098 2002
% 216.27/216.45  |- rdf__type mesh__D016098sskos__Concept
% 216.27/216.45  |- mesh__dateCreated mesh__D016098 1990-06-06
% 216.27/216.45  |- skos__hiddenLabel mesh__D016098 Gerstmann Straussler Syndrome
% 216.27/216.45  |- skos__historyNote mesh__D016098 Slow Virus Diseases %28%1988-1990%29%
% 216.27/216.45  |- mesh__publicMeSHNote mesh__D016098
% 216.27/216.45       2000; see GERSTMANN-STRAUSSLER SYNDROME 1991-1999; see SLOW VIRUS DISEASES 1988-1990; GERSTMANN-STRAUSSLER-SCHEINKER DISEASE was GERSTMANN-STRAUSSLER-SCHEINDER DISEASE see GERSTMANN-STRAUSSLER SYNDROME 1991%A%  
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D016098 2003
% 216.27/216.45  |- skos__altLabel mesh__D016098
% 216.27/216.45       Inherited Spongiform Encephalopathy, Gerstmann-Straussler
% 216.27/216.45  |- skos__annotation mesh__D016098
% 216.27/216.45       a prion dis: do not confuse with GERSTMANN SYNDROME, a type of agnosia%A%  
% 216.27/216.45  |- mesh__dateRevised mesh__D016098 2001-07-25
% 216.27/216.45  |- mesh__recordOriginator mesh__D016098 AGS
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D016098 2004
% 216.27/216.45  |- mesh__recordAuthorizer mesh__D016098 sjn
% 216.27/216.45  |- skos__prefLabel mesh__D016098 Gerstmann-Straussler-Scheinker Disease
% 216.27/216.45  |- skos__hiddenLabel mesh__D016098
% 216.27/216.45       Inherited Spongiform Encephalopathy, Gerstmann Straussler
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D016098 2005
% 216.27/216.45  |- skos__altLabel mesh__D016098
% 216.27/216.45       Gerstmann-Straussler Inherited Spongiform Encephalopathy
% 216.27/216.45  |- skos__broader mesh__D016098smesh__D017096
% 216.27/216.45  |- mesh__recordMaintainer mesh__D016098 nns
% 216.27/216.45  |- skos__hiddenLabel mesh__D016098 Gerstmann Straussler Scheinker Disease
% 216.27/216.45  |- skos__hiddenLabel mesh__D016098
% 216.27/216.45       Gerstmann Straussler Inherited Spongiform Encephalopathy
% 216.27/216.45  |- mesh__dateEstablished mesh__D016098 1991-01-01
% 216.27/216.45  |- mesh__publicMeSHNote mesh__D002876 68   
% 216.27/216.45  |- skos__annotation mesh__D002876
% 216.27/216.45       A 11 qualif except /cytol; /genet permitted; coord IM with specific bact /genet %28%IM%29%; DF: CHROMOSOMES BACT%A%  
% 216.27/216.45  |- skos__altLabel mesh__D002876 Chromosome, Bacterial
% 216.27/216.45  |- skos__scopeNote mesh__D002876
% 216.27/216.45       Structures within the nucleus of bacterial cells consisting of or containing DNA, which carry genetic information essential to the cell.%A%    
% 216.27/216.45  |- mesh__recordMaintainer mesh__D002876 TGC
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D002876 2003
% 216.27/216.45  |- rdf__type mesh__D002876sskos__Concept
% 216.27/216.45  |- mesh__dateEstablished mesh__D002876 1968-01-01
% 216.27/216.45  |- skos__altLabel mesh__D002876 Bacterial Chromosome
% 216.27/216.45  |- mesh__dateCreated mesh__D002876 1999-01-01
% 216.27/216.45  |- skos__broader mesh__D002876smesh__D002875
% 216.27/216.45  |- mesh__recordAuthorizer mesh__D002876 sjn
% 216.27/216.45  |- mesh__historyNote mesh__D002876 68   
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D002876 2006
% 216.27/216.45  |- skos__prefLabel mesh__D002876 Chromosomes, Bacterial
% 216.27/216.45  |- skos__altLabel mesh__D002876 Bacterial Chromosomes
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D002876 2005
% 216.27/216.45  |- skos__historyNote mesh__D002876 Chromosomes %28%1966-1967%29%
% 216.27/216.45  |- mesh__dateRevised mesh__D002876 2002-07-02
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D002876 2004
% 216.27/216.45  |- mesh__recordOriginator mesh__D002876 NLM
% 216.27/216.45  |- rdf__type mesh__D002078sskos__Concept
% 216.27/216.45  |- skos__hiddenLabel mesh__D002078 Hydrochloride, Butoxamine
% 216.27/216.45  |- mesh__publicMeSHNote mesh__D002078
% 216.27/216.45       91; was see under PROPANOLAMINES 1973-90   
% 216.27/216.45  |- skos__broader mesh__D002078smesh__D010627
% 216.27/216.45  |- skos__historyNote mesh__D002078 Antilipemic Agents %28%1966-1972%29%
% 216.27/216.45  |- mesh__recordAuthorizer mesh__D002078 sjn
% 216.27/216.45  |- mesh__dateCreated mesh__D002078 1999-01-01
% 216.27/216.45  |- mesh__historyNote mesh__D002078
% 216.27/216.45       91%28%73%29%; was see under PROPANOLAMINES 1973-90   
% 216.27/216.45  |- mesh__recordMaintainer mesh__D002078 ssb
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D002078 2006
% 216.27/216.45  |- skos__altLabel mesh__D002078 Butaxamine
% 216.27/216.45  |- skos__historyNote mesh__D002078 Amino Alcohols %28%1966-1972%29%
% 216.27/216.45  |- mesh__dateRevised mesh__D002078 2005-06-30
% 216.27/216.45  |- skos__scopeNote mesh__D002078
% 216.27/216.45       A beta-2 selective adrenergic antagonist. It is used primarily in animal and tissue experiments to characterize beta-2 receptor involvement and identify beta-2 receptors.%A%    
% 216.27/216.45  |- mesh__recordOriginator mesh__D002078 NLM
% 216.27/216.45  |- skos__historyNote mesh__D002078
% 216.27/216.45       Adrenergic Beta Receptor Blockaders %28%1969-1972%29%
% 216.27/216.45  |- skos__prefLabel mesh__D002078 Butoxamine
% 216.27/216.45  |- mesh__dateEstablished mesh__D002078 1991-01-01
% 216.27/216.45  |- skos__hiddenLabel mesh__D020938 Epilepsy, Hemimotor
% 216.27/216.45  |- skos__altLabel mesh__D020938 Seizure Disorder, Motor
% 216.27/216.45  |- skos__hiddenLabel mesh__D020938 Epilepsy, Focal Motor
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D020938 2003
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D020938 2002
% 216.27/216.45  |- mesh__historyNote mesh__D020938 2000   
% 216.27/216.45  |- skos__hiddenLabel mesh__D020938 Hemimotor Epilepsies
% 216.27/216.45  |- skos__hiddenLabel mesh__D020938 Seizure, Versive
% 216.27/216.45  |- skos__hiddenLabel mesh__D020938 Focal Clonic Seizure
% 216.27/216.45  |- skos__hiddenLabel mesh__D020938 Versive Seizure
% 216.27/216.45  |- skos__hiddenLabel mesh__D020938 Epilepsy, Motor Partial
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D020938 2004
% 216.27/216.45  |- mesh__dateEstablished mesh__D020938 2000-01-01
% 216.27/216.45  |- skos__altLabel mesh__D020938 Partial Seizure Disorder, Motor
% 216.27/216.45  |- skos__broader mesh__D020938smesh__D004828
% 216.27/216.45  |- skos__hiddenLabel mesh__D020938 Seizures, Versive
% 216.27/216.45  |- skos__hiddenLabel mesh__D020938 Hemimotor Seizure Disorders
% 216.27/216.45  |- mesh__dateCreated mesh__D020938 1999-11-03
% 216.27/216.45  |- skos__altLabel mesh__D020938 Focal Motor Epilepsy
% 216.27/216.45  |- skos__altLabel mesh__D020938 Motor Seizure Disorder
% 216.27/216.45  |- skos__altLabel mesh__D020938 Hemimotor Epilepsy
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D020938 2005
% 216.27/216.45  |- skos__hiddenLabel mesh__D020938 Seizure, Focal Clonic
% 216.27/216.45  |- skos__hiddenLabel mesh__D020938 Motor Seizure Disorders
% 216.27/216.45  |- skos__hiddenLabel mesh__D020938 Focal Tonic Seizure
% 216.27/216.45  |- skos__hiddenLabel mesh__D020938 Tonic Seizure, Focal
% 216.27/216.45  |- skos__altLabel mesh__D020938 Partial Epilepsy, Motor
% 216.27/216.45  |- skos__altLabel mesh__D020938 Motor Partial Seizure Disorder
% 216.27/216.45  |- skos__hiddenLabel mesh__D020938 Seizure Disorders, Hemimotor
% 216.27/216.45  |- skos__historyNote mesh__D020938 Epilepsies, Partial %28%1977-1999%29%
% 216.27/216.45  |- skos__scopeNote mesh__D020938
% 216.27/216.45       A disorder characterized by recurrent localized paroxysmal discharges of cerebral neurons that give rise to seizures that have motor manifestations. The majority of partial motor seizures originate in the FRONTAL LOBE %28%see also EPILEPSY, FRONTAL LOBE%29%. Motor seizures may manifest as tonic or clonic movements involving the face, one limb or one side of the body. A variety of more complex patterns of movement, including abnormal posturing of extremities, may also occur.%A%    
% 216.27/216.45  |- skos__hiddenLabel mesh__D020938 Clonic Seizures, Focal
% 216.27/216.45  |- skos__hiddenLabel mesh__D020938 Tonic Seizures, Focal
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D020938 2000
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D020938 2006
% 216.27/216.45  |- rdf__type mesh__D020938sskos__Concept
% 216.27/216.45  |- skos__altLabel mesh__D020938 Seizure Disorder, Partial, Motor
% 216.27/216.45  |- skos__altLabel mesh__D020938 Seizure Disorder, Hemimotor
% 216.27/216.45  |- skos__hiddenLabel mesh__D020938 Motor Epilepsy, Focal
% 216.27/216.45  |- mesh__publicMeSHNote mesh__D020938 2000   
% 216.27/216.45  |- skos__prefLabel mesh__D020938 Epilepsy, Partial, Motor
% 216.27/216.45  |- skos__hiddenLabel mesh__D020938 Seizure Disorders, Motor
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D020938 2001
% 216.27/216.45  |- mesh__dateCreated mesh__D031660 2002-07-03
% 216.27/216.45  |- skos__broader mesh__D031660smesh__D029592
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D031660 2003
% 216.27/216.45  |- mesh__publicMeSHNote mesh__D031660 2003   
% 216.27/216.45  |- mesh__dateEstablished mesh__D031660 2003-01-01
% 216.27/216.45  |- rdf__type mesh__D031660sskos__Concept
% 216.27/216.45  |- skos__annotation mesh__D031660
% 216.27/216.45       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.27/216.45  |- mesh__historyNote mesh__D031660 2003   
% 216.27/216.45  |- skos__prefLabel mesh__D031660 Jasminum
% 216.27/216.45  |- mesh__activeMeSHYear mesh__D031660 2006
% 216.27/216.45  |- skos__altLabel mesh__D031660 Jasmine
% 216.27/216.45  |- skos__scopeNote mesh__D031660
% 216.27/216.45       A plant genus of the family OLEACEAE. Members contain secoiridoid glucosides and this is the source of oil of jasmine.%A%    
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D031660 2004
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D031660 2005
% 216.27/216.46  |- mesh__dateRevised mesh__D006469 1999-11-24
% 216.27/216.46  |- skos__broader mesh__D006469smesh__D008171
% 216.27/216.46  |- mesh__dateCreated mesh__D006469 1999-01-01
% 216.27/216.46  |- rdf__type mesh__D006469sskos__Concept
% 216.27/216.46  |- skos__broader mesh__D006469smesh__D012818
% 216.27/216.46  |- mesh__recordMaintainer mesh__D006469 ags
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D006469 2001
% 216.27/216.46  |- skos__scopeNote mesh__D006469
% 216.27/216.46       Bronchial hemorrhage manifested with spitting of blood.%A%    
% 216.27/216.46  |- mesh__recordAuthorizer mesh__D006469 ags
% 216.27/216.46  |- mesh__recordOriginator mesh__D006469 NLM
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D006469 2000
% 216.27/216.46  |- skos__hiddenLabel mesh__D006469 Hemoptyses
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D006469 2006
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D006469 2000A
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D006469 2004
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D006469 2005
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D006469 2002
% 216.27/216.46  |- skos__prefLabel mesh__D006469 Hemoptysis
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D006469 2003
% 216.27/216.46  |- skos__broader mesh__D006469smesh__D006470
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017191 1995
% 216.27/216.46  |- skos__hiddenLabel mesh__D017191 Infection, Ascaridida
% 216.27/216.46  |- skos__annotation mesh__D017191
% 216.27/216.46       nematoda infect caused by ASCARIDIDA; do not confuse with ASCARIDIASIS %28%caused by ASCARIDIA%29%%A%  
% 216.27/216.46  |- skos__broader mesh__D017191smesh__D017190
% 216.27/216.46  |- mesh__dateEstablished mesh__D017191 1993-01-01
% 216.27/216.46  |- skos__prefLabel mesh__D017191 Ascaridida Infections
% 216.27/216.46  |- mesh__dateRevised mesh__D017191 1993-06-04
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017191 2000
% 216.27/216.46  |- mesh__historyNote mesh__D017191 93   
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017191 1996
% 216.27/216.46  |- mesh__recordMaintainer mesh__D017191 JLS
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017191 2003
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017191 2001
% 216.27/216.46  |- mesh__recordAuthorizer mesh__D017191 PLS
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017191 1998
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017191 2005
% 216.27/216.46  |- skos__scopeNote mesh__D017191
% 216.27/216.46       Infections with nematodes of the order ASCARIDIDA.     
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017191 1997
% 216.27/216.46  |- mesh__recordOriginator mesh__D017191 PXP
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017191 2004
% 216.27/216.46  |- mesh__publicMeSHNote mesh__D017191 93   
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017191 1999
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017191 2006
% 216.27/216.46  |- skos__hiddenLabel mesh__D017191 Ascaridida Infection
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017191 1994
% 216.27/216.46  |- rdf__type mesh__D017191sskos__Concept
% 216.27/216.46  |- mesh__dateCreated mesh__D017191 1992-05-07
% 216.27/216.46  |- skos__altLabel mesh__D017191 Infections, Ascaridida
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017191 2002
% 216.27/216.46  |- skos__broader mesh__D015221Q000037smesh__D015221
% 216.27/216.46  |- mesh__preferredCombination mesh__D015221Q000037smesh__D026902
% 216.27/216.46  |- rdf__type mesh__D015221Q000037smesh__CompoundConcept
% 216.27/216.46  |- mesh__dateCreated mesh__D003171 1977-12-02
% 216.27/216.46  |- skos__altLabel mesh__D003171 Classical Complement Pathway
% 216.27/216.46  |- mesh__historyNote mesh__D003171
% 216.27/216.46       91%28%79%29%; was see under COMPLEMENT ACTIVATION 1979-90   
% 216.27/216.46  |- skos__altLabel mesh__D003171 Classical Complement Activation Pathway
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D003171 2006
% 216.27/216.46  |- skos__historyNote mesh__D003171
% 216.27/216.46       Complement Fixation Tests %28%1966-1978%29%
% 216.27/216.46  |- rdf__type mesh__D003171sskos__Concept
% 216.27/216.46  |- skos__scopeNote mesh__D003171
% 216.27/216.46       Complement activation initiated by the binding of COMPLEMENT C1 to ANTIGEN-ANTIBODY COMPLEXES at the COMPLEMENT C1Q subunit. This leads to the sequential activation of COMPLEMENT C1R and COMPLEMENT C1S subunits. Activated C1s cleaves COMPLEMENT C4 and COMPLEMENT C2 forming the membrane-bound classical C3 CONVERTASE %28%C4B2A%29% and the subsequent C5 CONVERTASE %28%C4B2A3B%29% leading to cleavage of COMPLEMENT C5 and the assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX.%A%    
% 216.27/216.46  |- skos__prefLabel mesh__D003171 Complement Pathway, Classical
% 216.27/216.46  |- mesh__recordAuthorizer mesh__D003171 sjn
% 216.27/216.46  |- skos__broader mesh__D003171smesh__D003167
% 216.27/216.46  |- mesh__recordOriginator mesh__D003171 AEP
% 216.27/216.46  |- skos__historyNote mesh__D003171 Complement %28%1966-1978%29%
% 216.27/216.46  |- mesh__publicMeSHNote mesh__D003171
% 216.27/216.46       91; was see under COMPLEMENT ACTIVATION 1979-90   
% 216.27/216.46  |- skos__altLabel mesh__D003171 Complement Activation Pathway, Classical
% 216.27/216.46  |- mesh__dateEstablished mesh__D003171 1991-01-01
% 216.27/216.46  |- mesh__recordMaintainer mesh__D003171 lkt
% 216.27/216.46  |- mesh__dateRevised mesh__D003171 2005-06-30
% 216.27/216.46  |- skos__hiddenLabel mesh__D011603 Psychologies, Physiologic
% 216.27/216.46  |- skos__broader mesh__D011603smesh__D011579
% 216.27/216.46  |- skos__hiddenLabel mesh__D011603
% 216.27/216.46       Mind Body Relationship %28%Physiology%29%
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D011603 2005
% 216.27/216.46  |- skos__broader mesh__D011603smesh__D010827
% 216.27/216.46  |- mesh__recordAuthorizer mesh__D011603 sjn
% 216.27/216.46  |- skos__hiddenLabel mesh__D011603
% 216.27/216.46       Mind-Body Relationships %28%Physiology%29%
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D011603 2006
% 216.27/216.46  |- mesh__onlineNote mesh__D011603
% 216.27/216.46       use PSYCHOPHYSIOLOGY to search MIND-BODY RELATIONS 1996   
% 216.27/216.46  |- skos__broader mesh__D011603smesh__D001525
% 216.27/216.46  |- skos__hiddenLabel mesh__D011603 Mind Body Relations %28%Physiology%29%
% 216.27/216.46  |- skos__hiddenLabel mesh__D011603 Mind-Body Relation %28%Physiology%29%
% 216.27/216.46  |- mesh__publicMeSHNote mesh__D011603
% 216.27/216.46       MIND-BODY RELATIONS %28%PHYSIOLOGY%29% was MIND-BODY RELATIONS see PSYCHOPHYSIOLOGY 1996%A%  
% 216.27/216.46  |- mesh__dateRevised mesh__D011603 2004-07-13
% 216.27/216.46  |- skos__hiddenLabel mesh__D011603 Relations, Mind-Body %28%Physiology%29%
% 216.27/216.46  |- skos__annotation mesh__D011603
% 216.27/216.46       SPEC: SPEC qualif; NIM as coord but use /physiol with F1 %26% F2 terms %26% /psychol with C %26% F3 terms; no qualif when NIM coord; do not confuse X ref MIND-BODY RELATIONS %28%PHYSIOLOGY%29% with MIND-BODY RELATIONS %28%METAPHYSICS%29%: see MeSH definition %26% note there; Manual 27.12; DF: PSYCHOPHYSIOL%A%  
% 216.27/216.46  |- rdf__type mesh__D011603sskos__Concept
% 216.27/216.46  |- skos__related mesh__D011603smesh__D011611
% 216.27/216.46  |- mesh__recordMaintainer mesh__D011603 sjn
% 216.27/216.46  |- skos__scopeNote mesh__D011603
% 216.27/216.46       The study of the physiological basis of human and animal behavior.%A%    
% 216.27/216.46  |- skos__hiddenLabel mesh__D011603 Relation, Mind-Body %28%Physiology%29%
% 216.27/216.46  |- skos__altLabel mesh__D011603 Mind-Body Relationship %28%Physiology%29%
% 216.27/216.46  |- skos__hiddenLabel mesh__D011603
% 216.27/216.46       Relationship, Mind-Body %28%Physiology%29%
% 216.27/216.46  |- mesh__dateCreated mesh__D011603 1999-01-01
% 216.27/216.46  |- skos__broader mesh__D011603smesh__D026441
% 216.27/216.46  |- skos__altLabel mesh__D011603 Psychology, Physiologic
% 216.27/216.46  |- skos__altLabel mesh__D011603 Psychology, Physiological
% 216.27/216.46  |- skos__altLabel mesh__D011603 Physiologic Psychology
% 216.27/216.46  |- skos__prefLabel mesh__D011603 Psychophysiology
% 216.27/216.46  |- mesh__recordOriginator mesh__D011603 NLM
% 216.27/216.46  |- skos__altLabel mesh__D011603 Physiological Psychology
% 216.27/216.46  |- mesh__historyNote mesh__D011603
% 216.27/216.46       MIND-BODY RELATIONS %28%PHYSIOLOGY%29% was MIND-BODY RELATIONS see PSYCHOPHYSIOLOGY 1996%A%  
% 216.27/216.46  |- skos__hiddenLabel mesh__D011603
% 216.27/216.46       Relationships, Mind-Body %28%Physiology%29%
% 216.27/216.46  |- skos__hiddenLabel mesh__D011603 Physiologic Psychologies
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D016897 2004
% 216.27/216.46  |- mesh__publicMeSHNote mesh__D016897 92   
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D016897 2002
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D016897 2006
% 216.27/216.46  |- skos__hiddenLabel mesh__D016897 Bursts, Respiratory
% 216.27/216.46  |- mesh__recordOriginator mesh__D016897 MXR
% 216.27/216.46  |- mesh__historyNote mesh__D016897 92   
% 216.27/216.46  |- mesh__dateRevised mesh__D016897 1997-06-20
% 216.27/216.46  |- mesh__recordAuthorizer mesh__D016897 SJN
% 216.27/216.46  |- mesh__dateEstablished mesh__D016897 1992-01-01
% 216.27/216.46  |- skos__hiddenLabel mesh__D016897 Oxidative Bursts
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D016897 1998
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D016897 2000
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D016897 1999
% 216.27/216.46  |- skos__altLabel mesh__D016897 Oxidative Burst
% 216.27/216.46  |- mesh__dateCreated mesh__D016897 1991-05-30
% 216.27/216.46  |- skos__broader mesh__D016897smesh__D019069
% 216.27/216.46  |- rdf__type mesh__D016897sskos__Concept
% 216.27/216.46  |- skos__related mesh__D016897smesh__D006105
% 216.27/216.46  |- skos__hiddenLabel mesh__D016897 Bursts, Oxidative
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D016897 2001
% 216.27/216.46  |- skos__scopeNote mesh__D016897
% 216.27/216.46       A large increase in oxygen uptake by neutrophils and most types of tissue macrophages through activation of an NADPH-cytochrome b-dependent oxidase that reduces oxygen to a superoxide. Individuals with an inherited defect in which the oxidase that reduces oxygen to superoxide is decreased or absent %28%GRANULOMATOUS DISEASE, CHRONIC%29% often die as a result of recurrent bacterial infections.%A%    
% 216.27/216.46  |- skos__annotation mesh__D016897
% 216.27/216.46       %22%large increase in oxygen uptake by neutrophils %26% most types of tissue macrophages%22%%A%  
% 216.27/216.46  |- mesh__recordMaintainer mesh__D016897 ADP
% 216.27/216.46  |- skos__historyNote mesh__D016897 Oxygen Consumption %28%1976-1991%29%
% 216.27/216.46  |- skos__prefLabel mesh__D016897 Respiratory Burst
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D016897 2003
% 216.27/216.46  |- skos__hiddenLabel mesh__D016897 Respiratory Bursts
% 216.27/216.46  |- skos__hiddenLabel mesh__D016897 Burst, Oxidative
% 216.27/216.46  |- skos__broader mesh__D016897smesh__D010101
% 216.27/216.46  |- skos__hiddenLabel mesh__D016897 Burst, Respiratory
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D016897 2005
% 216.27/216.46  |- skos__broader mesh__D016099smesh__D016145
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D016099 2003
% 216.27/216.46  |- skos__altLabel mesh__D016099
% 216.27/216.46       Procedure, Endoscopic Gastrointestinal, Surgical
% 216.27/216.46  |- mesh__recordAuthorizer mesh__D016099 sjn
% 216.27/216.46  |- skos__hiddenLabel mesh__D016099 Endoscopies, Gastrointestinal
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D016099 2000
% 216.27/216.46  |- skos__prefLabel mesh__D016099 Endoscopy, Gastrointestinal
% 216.27/216.46  |- mesh__recordMaintainer mesh__D016099 nns
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D016099 2004
% 216.27/216.46  |- skos__hiddenLabel mesh__D016099 Endoscopic Gastrointestinal Surgeries
% 216.27/216.46  |- skos__altLabel mesh__D016099
% 216.27/216.46       Gastrointestinal Endoscopic Surgical Procedures
% 216.27/216.46  |- skos__altLabel mesh__D016099 Endoscopic Gastrointestinal Surgery
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D016099 2001
% 216.27/216.46  |- skos__altLabel mesh__D016099
% 216.27/216.46       Endoscopic Gastrointestinal Surgical Procedures
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D016099 2005
% 216.27/216.46  |- skos__annotation mesh__D016099 GEN only: prefer specifics   
% 216.27/216.46  |- skos__historyNote mesh__D016099 Endoscopy %28%1966-1990%29%
% 216.27/216.46  |- mesh__historyNote mesh__D016099 91   
% 216.27/216.46  |- skos__hiddenLabel mesh__D016099 Gastrointestinal Surgery, Endoscopic
% 216.27/216.46  |- skos__altLabel mesh__D016099
% 216.27/216.46       Surgical Procedure, Endoscopic Gastrointestinal
% 216.27/216.46  |- skos__altLabel mesh__D016099
% 216.27/216.46       Procedure, Gastrointestinal Endoscopic Surgical
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D016099 2002
% 216.27/216.46  |- mesh__publicMeSHNote mesh__D016099 91   
% 216.27/216.46  |- skos__altLabel mesh__D016099
% 216.27/216.46       Procedures, Endoscopic Gastrointestinal, Surgical
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D016099 2006
% 216.27/216.46  |- skos__hiddenLabel mesh__D016099 Gastrointestinal Surgeries, Endoscopic
% 216.27/216.46  |- mesh__dateCreated mesh__D016099 1990-06-06
% 216.27/216.46  |- skos__hiddenLabel mesh__D016099 Surgery, Endoscopic Gastrointestinal
% 216.27/216.46  |- mesh__dateRevised mesh__D016099 1999-11-03
% 216.27/216.46  |- mesh__dateEstablished mesh__D016099 1991-01-01
% 216.27/216.46  |- rdf__type mesh__D016099sskos__Concept
% 216.27/216.46  |- skos__historyNote mesh__D016099 Gastroscopy %28%1966-1990%29%
% 216.27/216.46  |- skos__scopeNote mesh__D016099
% 216.27/216.46       Endoscopic examination, therapy or surgery of the gastrointestinal tract.%A%    
% 216.27/216.46  |- skos__hiddenLabel mesh__D016099 Surgeries, Endoscopic Gastrointestinal
% 216.27/216.46  |- mesh__recordOriginator mesh__D016099 AGS
% 216.27/216.46  |- skos__altLabel mesh__D016099
% 216.27/216.46       Procedures, Gastrointestinal Endoscopic Surgical
% 216.27/216.46  |- skos__hiddenLabel mesh__D016099 Gastrointestinal Endoscopy
% 216.27/216.46  |- skos__hiddenLabel mesh__D016099 Gastrointestinal Endoscopies
% 216.27/216.46  |- skos__broader mesh__D002877smesh__D033481
% 216.27/216.46  |- skos__historyNote mesh__D002877 Chromosomes %28%1966-1977%29%
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D002877 2006
% 216.27/216.46  |- mesh__recordMaintainer mesh__D002877 ags
% 216.27/216.46  |- mesh__dateEstablished mesh__D002877 1978-01-01
% 216.27/216.46  |- mesh__dateRevised mesh__D002877 2005-07-12
% 216.27/216.46  |- skos__prefLabel mesh__D002877 Chromosomes, Human
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D002877 2005
% 216.27/216.46  |- skos__hiddenLabel mesh__D002877 Chromosome, Human
% 216.27/216.46  |- skos__hiddenLabel mesh__D002877 Human Chromosomes
% 216.27/216.46  |- mesh__recordAuthorizer mesh__D002877 ags
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D002877 2006A
% 216.27/216.46  |- skos__annotation mesh__D002877
% 216.27/216.46       GEN only: prefer specifics; do not coord with pre-coord chromosome terms, such as CHROMOSOME ABERRATIONS; CHROMOSOMAL PROTEINS, NON-HISTONE; etc.: check tag  HUMANS will serve for these%A%  
% 216.27/216.46  |- rdf__type mesh__D002877sskos__Concept
% 216.27/216.46  |- skos__scopeNote mesh__D002877
% 216.27/216.46       Very long DNA molecules and associated proteins, HISTONES, and non-histone chromosomal proteins %28%CHROMOSOMAL PROTEINS, NON-HISTONE%29%. Normally 46 chromosomes, including two sex chromosomes are found in the nucleus of human cells. They carry the hereditary information of the individual.%A%    
% 216.27/216.46  |- mesh__publicMeSHNote mesh__D002877 78   
% 216.27/216.46  |- mesh__dateCreated mesh__D002877 1977-04-27
% 216.27/216.46  |- skos__hiddenLabel mesh__D002877 Human Chromosome
% 216.27/216.46  |- mesh__historyNote mesh__D002877 78   
% 216.27/216.46  |- mesh__recordOriginator mesh__D002877 VDK
% 216.27/216.46  |- skos__scopeNote mesh__D002079
% 216.27/216.46       The fatty portion of milk, separated as a soft yellowish solid when milk or cream is churned. It is processed for cooking and table use. %28%Random House Unabridged Dictionary, 2d ed%29%%A%    
% 216.27/216.46  |- skos__hiddenLabel mesh__D002079 Butters
% 216.27/216.46  |- mesh__dateRevised mesh__D002079 2003-07-09
% 216.27/216.46  |- mesh__recordOriginator mesh__D002079 NLM
% 216.27/216.46  |- skos__broader mesh__D002079smesh__D004041
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D002079 2005
% 216.27/216.46  |- mesh__dateCreated mesh__D002079 1999-01-01
% 216.27/216.46  |- skos__prefLabel mesh__D002079 Butter
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D002079 2006
% 216.27/216.46  |- skos__annotation mesh__D002079
% 216.27/216.46       a dairy product %26% dietary fat; MARGARINE is also available%A%  
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D002079 2004
% 216.27/216.46  |- mesh__recordAuthorizer mesh__D002079 sjn
% 216.27/216.46  |- skos__broader mesh__D002079smesh__D003611
% 216.27/216.46  |- mesh__recordMaintainer mesh__D002079 ssb
% 216.27/216.46  |- rdf__type mesh__D002079sskos__Concept
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D007562 2000
% 216.27/216.46  |- skos__altLabel mesh__D007562 Jakob-Creutzfeldt Syndrome
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D007562 2006
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 Encephalopathies, Subacute Spongiform
% 216.27/216.46  |- mesh__publicMeSHNote mesh__D007562
% 216.27/216.46       91; was JAKOB-CREUTZFELDT SYNDROME 1981-90; was CREUTZFELDT-JAKOB DISEASE 1973-80%A%  
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 Spongiform Encephalopathies, Subacute
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 CJD %28%Creutzfeldt Jakob Disease%29%
% 216.27/216.46  |- skos__historyNote mesh__D007562
% 216.27/216.46       Central Nervous System Diseases %28%1966-1968%29%
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 New Variant Creutzfeldt Jakob Disease
% 216.27/216.46  |- mesh__onlineNote mesh__D007562
% 216.27/216.46       use CREUTZFELDT-JAKOB SYNDROME to search JAKOB-CREUTZFELDT SYNDROME 1981-90 %26% CREUTZFELDT-JAKOB DISEASE 1969-80 %28%as Prov 1969-72%29%%A%  
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 Creutzfeldt Jakob Disease
% 216.27/216.46  |- mesh__dateCreated mesh__D007562 1999-01-01
% 216.27/216.46  |- skos__altLabel mesh__D007562 CJD
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D007562 2001
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 Familial Creutzfeldt Jakob Disease
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 Syndrome, Creutzfeldt-Jakob
% 216.27/216.46  |- mesh__recordOriginator mesh__D007562 NLM
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 Encephalopathy, Subacute Spongiform
% 216.27/216.46  |- rdf__type mesh__D007562sskos__Concept
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 Variants, CJD %28%V-CJD%29%
% 216.27/216.46  |- skos__broader mesh__D007562smesh__D003704
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D007562 2002
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D007562 2003
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 Jakob Creutzfeldt Disease
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 CJD Variants %28%V-CJD%29%
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 Creutzfeldt Jakob Syndrome
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 Creutzfeldt-Jakob Diseases, Familial
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 Jakob Creutzfeldt Syndrome
% 216.27/216.46  |- mesh__recordMaintainer mesh__D007562 ags
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 Creutzfeldt Jakob Disease, New Variant
% 216.27/216.46  |- skos__altLabel mesh__D007562 CJD Variant %28%V-CJD%29%
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 Subacute Spongiform Encephalopathies
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 CJDs %28%Creutzfeldt-Jakob Disease%29%
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 Familial Creutzfeldt-Jakob Diseases
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D007562 2000A
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D007562 2004
% 216.27/216.46  |- mesh__recordAuthorizer mesh__D007562 ags
% 216.27/216.46  |- skos__altLabel mesh__D007562 Creutzfeldt-Jakob Disease
% 216.27/216.46  |- skos__altLabel mesh__D007562 CJD %28%Creutzfeldt-Jakob Disease%29%
% 216.27/216.46  |- skos__altLabel mesh__D007562
% 216.27/216.46       V-CJD %28%Variant-Creutzfeldt-Jakob Disease%29%
% 216.27/216.46  |- mesh__dateRevised mesh__D007562 1999-11-23
% 216.27/216.46  |- mesh__dateEstablished mesh__D007562 1973-01-01
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 Disease, Familial Creutzfeldt-Jakob
% 216.27/216.46  |- skos__altLabel mesh__D007562 Creutzfeldt-Jakob Disease, New Variant
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 Disease, Jakob-Creutzfeldt
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 Variant, CJD %28%V-CJD%29%
% 216.27/216.46  |- skos__prefLabel mesh__D007562 Creutzfeldt-Jakob Syndrome
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 Subacute Spongiform Encephalopathy
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 Syndrome, Jakob-Creutzfeldt
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 Creutzfeldt Jakob Disease, Familial
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D007562 2005
% 216.27/216.46  |- skos__altLabel mesh__D007562 Jakob-Creutzfeldt Disease
% 216.27/216.46  |- skos__broader mesh__D007562smesh__D017096
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 CJD Variant %28%V CJD%29%
% 216.27/216.46  |- mesh__historyNote mesh__D007562
% 216.27/216.46       91; was JAKOB-CREUTZFELDT SYNDROME 1981-90; was CREUTZFELDT-JAKOB DISEASE 1969-80 %28%Prov 1969-72%29%%A%  
% 216.27/216.46  |- skos__hiddenLabel mesh__D007562 Disease, Creutzfeldt-Jakob
% 216.27/216.46  |- skos__scopeNote mesh__D007562
% 216.27/216.46       A rare transmissible encephalopathy most prevalent between the ages of 50 and 70 years. Affected individuals may present with sleep disturbances, personality changes, ATAXIA; APHASIA, visual loss, weakness, muscle atrophy, MYOCLONUS, progressive dementia, and death within one year of disease onset. A familial form exhibiting autosomal dominant inheritance and a new variant CJD %28%potentially associated with ENCEPHALOPATHY, BOVINE SPONGIFORM%29% have been described. Pathological features include prominent cerebellar and cerebral cortical spongiform degeneration and the presence of PRIONS. %28%From N Engl J Med, 1998 Dec 31;339%28%27%29%%29%%A%    
% 216.27/216.46  |- skos__altLabel mesh__D007562 Familial Creutzfeldt-Jakob Disease
% 216.27/216.46  |- skos__altLabel mesh__D007562 Spongiform Encephalopathy, Subacute
% 216.27/216.46  |- skos__prefLabel mesh__D020939 Ginger
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D020939 2006
% 216.27/216.46  |- skos__altLabel mesh__D020939 Zingiber officinale
% 216.27/216.46  |- rdf__type mesh__D020939sskos__Concept
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D020939 2002
% 216.27/216.46  |- skos__scopeNote mesh__D020939
% 216.27/216.46       Deciduous plant rich in volatile oil %28%OILS, VOLATILE%29%. It is used as a flavoring agent and has many other uses both internally and topically.%A%    
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D020939 2005
% 216.27/216.46  |- mesh__recordOriginator mesh__D020939 ags
% 216.27/216.46  |- mesh__publicMeSHNote mesh__D020939
% 216.27/216.46       2000; see ZINGIBERALES 1998-1999, see SPICES 1993-1997   
% 216.27/216.46  |- mesh__recordMaintainer mesh__D020939 ssb
% 216.27/216.46  |- mesh__historyNote mesh__D020939
% 216.27/216.46       2000; use ZINGIBERALES 1998-1999, use SPICES 1993-1997   
% 216.27/216.46  |- mesh__dateRevised mesh__D020939 2001-07-25
% 216.27/216.46  |- skos__historyNote mesh__D020939 Spices %28%1993-1997%29%
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D020939 2004
% 216.27/216.46  |- mesh__recordAuthorizer mesh__D020939 sjn
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D020939 2003
% 216.27/216.46  |- mesh__dateCreated mesh__D020939 1999-11-03
% 216.27/216.46  |- skos__historyNote mesh__D020939 Zingiberales %28%1998-1999%29%
% 216.27/216.46  |- mesh__dateEstablished mesh__D020939 2000-01-01
% 216.27/216.46  |- skos__broader mesh__D020939smesh__D030521
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017990 2005
% 216.27/216.46  |- skos__scopeNote mesh__D017990
% 216.27/216.46       A genus of PARVOVIRIDAE, subfamily DENSOVIRINAE, comprising helper-independent viruses containing only two species. Junonia coenia densovirus is the type species.%A%    
% 216.27/216.46  |- skos__prefLabel mesh__D017990 Densovirus
% 216.27/216.46  |- mesh__dateCreated mesh__D017990 1993-06-04
% 216.27/216.46  |- skos__hiddenLabel mesh__D017990 Parvovirus, Insect
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017990 2003
% 216.27/216.46  |- mesh__historyNote mesh__D017990 94; was see PARVOVIRIDAE 1992-93   
% 216.27/216.46  |- rdf__type mesh__D017990sskos__Concept
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017990 2006
% 216.27/216.46  |- mesh__dateEstablished mesh__D017990 1994-01-01
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017990 2004
% 216.27/216.46  |- mesh__recordMaintainer mesh__D017990 ags
% 216.27/216.46  |- skos__hiddenLabel mesh__D017990 Insect Parvovirus
% 216.27/216.46  |- skos__hiddenLabel mesh__D017990 Densoviruses
% 216.27/216.46  |- mesh__onlineNote mesh__D017990
% 216.27/216.46       use PARVOVIRIDAE to search DENSOVIRUS 1992-93   
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017990 2002
% 216.27/216.46  |- skos__historyNote mesh__D017990 Parvoviridae %28%1987-1993%29%
% 216.27/216.46  |- skos__broader mesh__D017990smesh__D019223
% 216.27/216.46  |- mesh__recordAuthorizer mesh__D017990 sjn
% 216.27/216.46  |- mesh__recordOriginator mesh__D017990 AGS
% 216.27/216.46  |- mesh__dateRevised mesh__D017990 2001-07-25
% 216.27/216.46  |- skos__annotation mesh__D017990
% 216.27/216.46       coord IM with specific insect /virol %28%IM%29%   
% 216.27/216.46  |- mesh__publicMeSHNote mesh__D017990 94; was see PARVOVIRIDAE 1992-93   
% 216.27/216.46  |- skos__altLabel mesh__D017990 Parvoviruses, Insect
% 216.27/216.46  |- skos__altLabel mesh__D017990 Insect Parvoviruses
% 216.27/216.46  |- skos__prefLabel mesh__D031661 Fraxinus
% 216.27/216.46  |- skos__broader mesh__D031661smesh__D029592
% 216.27/216.46  |- mesh__publicMeSHNote mesh__D031661 2003   
% 216.27/216.46  |- skos__altLabel mesh__D031661 Ash, Common
% 216.27/216.46  |- rdf__type mesh__D031661sskos__Concept
% 216.27/216.46  |- skos__annotation mesh__D031661
% 216.27/216.46       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D031661 2005
% 216.27/216.46  |- mesh__dateEstablished mesh__D031661 2003-01-01
% 216.27/216.46  |- skos__altLabel mesh__D031661 Ash Tree
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D031661 2006
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D031661 2003
% 216.27/216.46  |- skos__scopeNote mesh__D031661
% 216.27/216.46       A plant genus of the family OLEACEAE. Members contain secoiridoid glucosides.%A%    
% 216.27/216.46  |- mesh__historyNote mesh__D031661 2003   
% 216.27/216.46  |- mesh__dateCreated mesh__D031661 2002-07-02
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D031661 2004
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017192 2001
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017192 1996
% 216.27/216.46  |- skos__hiddenLabel mesh__D017192 Bacterial Skin Disease
% 216.27/216.46  |- mesh__dateCreated mesh__D017192 1992-05-22
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017192 2005
% 216.27/216.46  |- skos__hiddenLabel mesh__D017192 Diseases, Bacterial Skin
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017192 2004
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017192 1998
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017192 1997
% 216.27/216.46  |- mesh__dateEstablished mesh__D017192 1993-01-01
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017192 2006
% 216.27/216.46  |- mesh__recordMaintainer mesh__D017192 PXP
% 216.27/216.46  |- skos__broader mesh__D017192smesh__D012874
% 216.27/216.46  |- skos__hiddenLabel mesh__D017192 Disease, Bacterial Skin
% 216.27/216.46  |- skos__broader mesh__D017192smesh__D001424
% 216.27/216.46  |- skos__hiddenLabel mesh__D017192 Skin Disease, Bacterial
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017192 1999
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017192 2002
% 216.27/216.46  |- skos__scopeNote mesh__D017192 Skin diseases caused by bacteria.     
% 216.27/216.46  |- mesh__dateRevised mesh__D017192 1994-02-08
% 216.27/216.46  |- rdf__type mesh__D017192sskos__Concept
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017192 1995
% 216.27/216.46  |- skos__annotation mesh__D017192
% 216.27/216.46       GEN or unspecified; coord IM with precoord bact infect %28%IM%29%%A%  
% 216.27/216.46  |- mesh__recordOriginator mesh__D017192 MXR
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017192 2000
% 216.27/216.46  |- mesh__historyNote mesh__D017192 93   
% 216.27/216.46  |- skos__altLabel mesh__D017192 Bacterial Skin Diseases
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D017192 2003
% 216.27/216.46  |- mesh__publicMeSHNote mesh__D017192 93   
% 216.27/216.46  |- skos__prefLabel mesh__D017192 Skin Diseases, Bacterial
% 216.27/216.46  |- mesh__recordAuthorizer mesh__D017192 PLS
% 216.27/216.46  |- rdf__type mesh__D003970sskos__Concept
% 216.27/216.46  |- skos__related mesh__D003970smesh__D007742
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D003970 2004
% 216.27/216.46  |- mesh__recordMaintainer mesh__D003970 lkt
% 216.27/216.46  |- skos__hiddenLabel mesh__D003970 Diastemas
% 216.27/216.46  |- mesh__historyNote mesh__D003970 72%28%67%29%   
% 216.27/216.46  |- mesh__publicMeSHNote mesh__D003970 72   
% 216.27/216.46  |- skos__broader mesh__D003970smesh__D003817
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D003970 2006
% 216.27/216.46  |- skos__scopeNote mesh__D003970
% 216.27/216.46       An abnormal opening or fissure between two adjacent teeth.%A%    
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D003970 2005
% 216.27/216.46  |- skos__broader mesh__D003970smesh__D008310
% 216.27/216.46  |- mesh__dateEstablished mesh__D003970 1972-01-01
% 216.27/216.46  |- skos__historyNote mesh__D003970 Dentition %28%1966%29%
% 216.27/216.46  |- mesh__recordOriginator mesh__D003970 NLM
% 216.27/216.46  |- mesh__dateRevised mesh__D003970 2003-07-09
% 216.27/216.46  |- mesh__recordAuthorizer mesh__D003970 sjn
% 216.27/216.46  |- skos__prefLabel mesh__D003970 Diastema
% 216.27/216.46  |- mesh__dateCreated mesh__D003970 1999-01-01
% 216.27/216.46  |- mesh__activeMeSHYear mesh__D003172 2006
% 216.27/216.46  |- mesh__recordOriginator mesh__D003172 NLM
% 216.27/216.46  |- skos__historyNote mesh__D003172 Calcium %28%1966-1974%29%
% 216.27/216.46  |- skos__broader mesh__D003172smesh__D003165
% 216.27/216.46  |- mesh__historyNote mesh__D003172 2006 %28%1975%29%   
% 216.27/216.46  |- mesh__recordMaintainer mesh__D003172 lkt
% 216.27/216.46  |- skos__altLabel mesh__D003172 Complement 1
% 216.27/216.46  |- mesh__dateRevised mesh__D003172 2005-06-30
% 216.27/216.46  |- rdf__type mesh__D003172sskos__Concept
% 216.27/216.46  |- skos__hiddenLabel mesh__D003172 C1, Complement
% 216.27/216.46  |- skos__scopeNote mesh__D003172
% 216.27/216.46       The first complement component to act in the activation of CLASSICAL COMPLEMENT PATHWAY. It is a calcium-dependent trimolecular complex made up of three subcomponents: COMPLEMENT C1Q; COMPLEMENT C1R; and COMPLEMENT C1S at 1:2:2 ratios.  When the intact C1 binds to at least two antibodies %28%involving C1q%29%, C1r and C1s are sequentially activated, leading to subsequent steps in the cascade of COMPLEMENT ACTIVATION.%A%    
% 216.27/216.46  |- mesh__dateCreated mesh__D003172 1974-11-11
% 216.27/216.46  |- skos__annotation mesh__D003172
% 216.27/216.46       /antag permitted but consider also COMPLEMENT C1 INACTIVATOR PROTEINS%A%  
% 216.27/216.46  |- skos__altLabel mesh__D003172 Complement Component 1
% 216.27/216.46  |- skos__historyNote mesh__D003172 Complement %28%1968-1974%29%
% 216.27/216.46  |- mesh__recordAuthorizer mesh__D003172 sjn
% 216.27/216.46  |- skos__hiddenLabel mesh__D003172 Component 1, Complement
% 216.27/216.46  |- skos__hiddenLabel mesh__D003172 Complement, C1
% 216.27/216.46  |- skos__altLabel mesh__D003172 C1 Complement
% 216.27/216.46  |- mesh__dateEstablished mesh__D003172 1978-01-01
% 216.27/216.46  |- mesh__publicMeSHNote mesh__D003172
% 216.27/216.46       2006; see COMPLEMENT 1 1978-2005, see COMPLEMENT 1975-1977%A%  
% 216.27/216.46  |- skos__prefLabel mesh__D003172 Complement C1
% 216.27/216.47  |- skos__scopeNote mesh__D011604
% 216.27/216.47       A group of mental disorders associated with organic brain damage and caused by poisoning from alcohol.%A%    
% 216.27/216.47  |- mesh__recordOriginator mesh__D011604 NLM
% 216.27/216.47  |- skos__hiddenLabel mesh__D011604 Alcoholic Psychoses
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D011604 2004
% 216.27/216.47  |- mesh__recordMaintainer mesh__D011604 KEV
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D011604 2006
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D011604 2003
% 216.27/216.47  |- mesh__recordAuthorizer mesh__D011604 sjn
% 216.27/216.47  |- mesh__dateRevised mesh__D011604 1999-11-08
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D011604 2002
% 216.27/216.47  |- mesh__dateCreated mesh__D011604 1999-01-01
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D011604 2005
% 216.27/216.47  |- skos__broader mesh__D011604smesh__D019973
% 216.27/216.47  |- skos__broader mesh__D011604smesh__D011605
% 216.27/216.47  |- rdf__type mesh__D011604sskos__Concept
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D011604 2001
% 216.27/216.47  |- skos__prefLabel mesh__D011604 Psychoses, Alcoholic
% 216.27/216.47  |- skos__broader mesh__D011604smesh__D020751
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D011604 2000
% 216.27/216.47  |- mesh__recordMaintainer mesh__D016898 ssb
% 216.27/216.47  |- skos__historyNote mesh__D016898 Interferon Type I %28%1983-1991%29%
% 216.27/216.47  |- skos__altLabel mesh__D016898 Interferon Alfa
% 216.27/216.47  |- skos__hiddenLabel mesh__D016898 Interferon alpha
% 216.27/216.47  |- skos__hiddenLabel mesh__D016898 Lymphoblast Interferon
% 216.27/216.47  |- mesh__historyNote mesh__D016898
% 216.27/216.47       92; was INTERFERON, ALPHA see INTERFERON TYPE I 1983-91; INTERFERON, LYMPHOBLAST %26% INTERFERON, LEUKOCYTE were see INTERFERON TYPE I 1983-91; INTERFERON ALFA-N1 was see INTERFERON TYPE I 1989-91%A%  
% 216.27/216.47  |- mesh__publicMeSHNote mesh__D016898
% 216.27/216.47       92; was INTERFERON, ALPHA see INTERFERON TYPE I 1983-91; INTERFERON, LYMPHOBLAST %26% INTERFERON, LEUKOCYTE were see INTERFERON TYPE I 1983-91; INTERFERON ALFA-N1 was see INTERFERON TYPE I 1989-91%A%  
% 216.27/216.47  |- skos__altLabel mesh__D016898 Interferon, Leukocyte
% 216.27/216.47  |- skos__hiddenLabel mesh__D016898 Lymphoblastoid Interferon
% 216.27/216.47  |- skos__altLabel mesh__D016898 Interferon, alpha
% 216.27/216.47  |- mesh__dateCreated mesh__D016898 1991-05-30
% 216.27/216.47  |- skos__hiddenLabel mesh__D016898 alpha Interferon
% 216.27/216.47  |- rdf__type mesh__D016898sskos__Concept
% 216.27/216.47  |- mesh__dateEstablished mesh__D016898 1992-01-01
% 216.27/216.47  |- mesh__dateRevised mesh__D016898 2005-06-30
% 216.27/216.47  |- skos__hiddenLabel mesh__D016898 Leukocyte Interferon
% 216.27/216.47  |- skos__altLabel mesh__D016898 Interferon, Lymphoblastoid
% 216.27/216.47  |- skos__altLabel mesh__D016898 Interferon, Lymphoblast
% 216.27/216.47  |- mesh__recordOriginator mesh__D016898 PLS
% 216.27/216.47  |- mesh__recordAuthorizer mesh__D016898 sjn
% 216.27/216.47  |- skos__hiddenLabel mesh__D016898 Interferon Alfa n1
% 216.27/216.47  |- skos__hiddenLabel mesh__D016898 Interferon Alfa n3
% 216.27/216.47  |- skos__broader mesh__D016898smesh__D007370
% 216.27/216.47  |- skos__altLabel mesh__D016898 Interferon Alfa-n3
% 216.27/216.47  |- skos__prefLabel mesh__D016898 Interferon-alpha
% 216.27/216.47  |- skos__altLabel mesh__D016898 alpha-Interferon
% 216.27/216.47  |- skos__scopeNote mesh__D016898
% 216.27/216.47       One of the type I interferons %28%INTERFERON TYPE I%29% produced by peripheral blood leukocytes or lymphoblastoid cells when exposed to live or inactivated virus, double-stranded RNA, or bacterial products. It is the major interferon produced by virus-induced leukocyte cultures and, in addition to its pronounced antiviral activity, it causes activation of NK cells.%A%    
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D016898 2006
% 216.27/216.47  |- mesh__onlineNote mesh__D016898
% 216.27/216.47       use INTERFERON TYPE I to search INTERFERON-ALPHA, INTERFERON, LYMPHOBLAST %26% INTERFERON, LEUKOCYTE 1983-91 %26% INTERFERON ALFA-N1 1989-91%A%  
% 216.27/216.47  |- mesh__dateCreated mesh__D002878 1986-06-19
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D002878 2006
% 216.27/216.47  |- skos__broader mesh__D002878smesh__D002900
% 216.27/216.47  |- mesh__recordAuthorizer mesh__D002878 sjn
% 216.27/216.47  |- skos__scopeNote mesh__D002878
% 216.27/216.47       A specific pair of human chromosomes in group A %28%CHROMOSOMES, HUMAN, 1-3%29% of the human chromosome classification.%A%    
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D002878 2005
% 216.27/216.47  |- mesh__recordMaintainer mesh__D002878 sjn
% 216.27/216.47  |- mesh__recordOriginator mesh__D002878 SCD
% 216.27/216.47  |- mesh__publicMeSHNote mesh__D002878 87   
% 216.27/216.47  |- rdf__type mesh__D002878sskos__Concept
% 216.27/216.47  |- skos__prefLabel mesh__D002878 Chromosomes, Human, Pair 1
% 216.27/216.47  |- skos__historyNote mesh__D002878
% 216.27/216.47       Chromosomes, Human, 1-3 %28%1968-1986%29%
% 216.27/216.47  |- mesh__historyNote mesh__D002878 87   
% 216.27/216.47  |- mesh__dateEstablished mesh__D002878 1987-01-01
% 216.27/216.47  |- mesh__dateRevised mesh__D002878 2004-07-13
% 216.27/216.47  |- skos__altLabel mesh__D002878 Chromosome 1
% 216.27/216.47  |- mesh__recordAuthorizer mesh__D007563 PLS
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007563 1996
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007563 2003
% 216.27/216.47  |- skos__broader mesh__D007563smesh__D014900
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007563 1997
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007563 2004
% 216.27/216.47  |- skos__scopeNote mesh__D007563
% 216.27/216.47       An island in the Greater Antilles in the West Indies. Its capital is Kingston. It was discovered in 1494 by Columbus and was a Spanish colony 1509-1655 until captured by the English. Its flourishing slave trade was abolished in the 19th century. It was a British colony 1655-1958 and a territory of the West Indies Federation 1958-62. It achieved full independence in 1962. The name is from the Arawak Xaymaca, rich in springs or land of springs. %28%From Webster%27%s New Geographical Dictionary, 1988, p564 %26% Room, Brewer%27%s Dictionary of Names, 1992, p267%29%%A%    
% 216.27/216.47  |- skos__prefLabel mesh__D007563 Jamaica
% 216.27/216.47  |- rdf__type mesh__D007563sskos__Concept
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007563 2002
% 216.27/216.47  |- mesh__dateRevised mesh__D007563 1995-02-21
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007563 2000
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007563 1998
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007563 2005
% 216.27/216.47  |- mesh__recordOriginator mesh__D007563 NLM
% 216.27/216.47  |- skos__annotation mesh__D007563
% 216.27/216.47       an island in the Greater Antilles in the West Indies   
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007563 1999
% 216.27/216.47  |- mesh__dateCreated mesh__D007563 1999-01-01
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007563 2006
% 216.27/216.47  |- mesh__recordMaintainer mesh__D007563 TGC
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007563 2001
% 216.27/216.47  |- skos__historyNote mesh__D045682 Mycoplasma %28%1971-2003%29%
% 216.27/216.47  |- mesh__dateCreated mesh__D045682 2003-07-09
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D045682 2006
% 216.27/216.47  |- skos__scopeNote mesh__D045682
% 216.27/216.47       A species of gram-negative bacteria causing MASTITIS; ARTHRITIS; and RESPIRATORY TRACT DISEASES in CATTLE.%A%    
% 216.27/216.47  |- mesh__recordAuthorizer mesh__D045682 sjn
% 216.27/216.47  |- mesh__dateEstablished mesh__D045682 2004-01-01
% 216.27/216.47  |- rdf__type mesh__D045682sskos__Concept
% 216.27/216.47  |- skos__annotation mesh__D045682
% 216.27/216.47       infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29%   
% 216.27/216.47  |- mesh__publicMeSHNote mesh__D045682 2004   
% 216.27/216.47  |- mesh__historyNote mesh__D045682 2004   
% 216.27/216.47  |- skos__broader mesh__D045682smesh__D009174
% 216.27/216.47  |- mesh__recordMaintainer mesh__D045682 SYSTEM
% 216.27/216.47  |- skos__prefLabel mesh__D045682 Mycoplasma bovis
% 216.27/216.47  |- mesh__dateRevised mesh__D045682 2005-06-30
% 216.27/216.47  |- mesh__recordOriginator mesh__D045682 ags
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D031662 2004
% 216.27/216.47  |- skos__broader mesh__D031662smesh__D029592
% 216.27/216.47  |- skos__scopeNote mesh__D031662
% 216.27/216.47       A plant genus of the family OLEACEAE. Oleuropein has been identified in the stem bark.%A%    
% 216.27/216.47  |- rdf__type mesh__D031662sskos__Concept
% 216.27/216.47  |- mesh__publicMeSHNote mesh__D031662 2003   
% 216.27/216.47  |- skos__annotation mesh__D031662
% 216.27/216.47       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.27/216.47  |- mesh__dateCreated mesh__D031662 2002-07-03
% 216.27/216.47  |- mesh__dateEstablished mesh__D031662 2003-01-01
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D031662 2005
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D031662 2003
% 216.27/216.47  |- skos__prefLabel mesh__D031662 Syringa
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D031662 2006
% 216.27/216.47  |- mesh__historyNote mesh__D031662 2003   
% 216.27/216.47  |- skos__annotation mesh__D017193
% 216.27/216.47       GEN or unspecified; coord IM with precoord viral infect %28%IM%29%%A%  
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017193 2000
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017193 1998
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017193 1997
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017193 2006
% 216.27/216.47  |- mesh__publicMeSHNote mesh__D017193 93   
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017193 1994
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017193 1993
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017193 2001
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017193 1999
% 216.27/216.47  |- mesh__dateCreated mesh__D017193 1992-05-22
% 216.27/216.47  |- skos__hiddenLabel mesh__D017193 Viral Skin Disease
% 216.27/216.47  |- rdf__type mesh__D017193sskos__Concept
% 216.27/216.47  |- skos__hiddenLabel mesh__D017193 Diseases, Viral Skin
% 216.27/216.47  |- skos__prefLabel mesh__D017193 Skin Diseases, Viral
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017193 1995
% 216.27/216.47  |- skos__hiddenLabel mesh__D017193 Skin Disease, Viral
% 216.27/216.47  |- mesh__dateEstablished mesh__D017193 1993-01-01
% 216.27/216.47  |- skos__hiddenLabel mesh__D017193 Disease, Viral Skin
% 216.27/216.47  |- skos__broader mesh__D017193smesh__D012874
% 216.27/216.47  |- skos__altLabel mesh__D017193 Viral Skin Diseases
% 216.27/216.47  |- mesh__historyNote mesh__D017193 93   
% 216.27/216.47  |- skos__scopeNote mesh__D017193 Skin diseases caused by viruses.     
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017193 2002
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017193 2003
% 216.27/216.47  |- skos__broader mesh__D017193smesh__D014777
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017193 1996
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017193 2005
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017193 2004
% 216.27/216.47  |- skos__broader mesh__D003971smesh__D009200
% 216.27/216.47  |- mesh__recordOriginator mesh__D003971 VDK
% 216.27/216.47  |- skos__prefLabel mesh__D003971 Diastole
% 216.27/216.47  |- rdf__type mesh__D003971sskos__Concept
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D003971 2004
% 216.27/216.47  |- mesh__dateCreated mesh__D003971 1977-12-06
% 216.27/216.47  |- mesh__recordAuthorizer mesh__D003971 sjn
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D003971 2005
% 216.27/216.47  |- mesh__publicMeSHNote mesh__D003971
% 216.27/216.47       91; was see under MYOCARDIAL CONTRACTION 1979-90   
% 216.27/216.47  |- skos__historyNote mesh__D003971 Heart Ventricle %28%1966-1978%29%
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D003971 2006
% 216.27/216.47  |- skos__hiddenLabel mesh__D003971 Diastoles
% 216.27/216.47  |- mesh__recordMaintainer mesh__D003971 nns
% 216.27/216.47  |- skos__annotation mesh__D003971
% 216.27/216.47       DIASTOLIC PRESSURE see BLOOD PRESSURE %26% do not add DIASTOLE %28%NIM%29% unless particularly discussed%A%  
% 216.27/216.47  |- mesh__dateRevised mesh__D003971 2003-07-09
% 216.27/216.47  |- skos__historyNote mesh__D003971 Heart %28%1966-1978%29%
% 216.27/216.47  |- skos__broader mesh__D003971smesh__D009126
% 216.27/216.47  |- skos__scopeNote mesh__D003971
% 216.27/216.47       Post-systolic relaxation of the HEART, especially the HEART VENTRICLES.%A%    
% 216.27/216.47  |- mesh__dateEstablished mesh__D003971 1991-01-01
% 216.27/216.47  |- mesh__historyNote mesh__D003971
% 216.27/216.47       91%28%79%29%; was see under MYOCARDIAL CONTRACTION 1979-90   
% 216.27/216.47  |- skos__hiddenLabel mesh__D003173 Esterase, Complement 1
% 216.27/216.47  |- skos__hiddenLabel mesh__D003173 Complement, C1s
% 216.27/216.47  |- skos__broader mesh__D003173smesh__D003172
% 216.27/216.47  |- mesh__recordAuthorizer mesh__D003173 sjn
% 216.27/216.47  |- mesh__dateEstablished mesh__D003173 1990-01-01
% 216.27/216.47  |- skos__historyNote mesh__D003173 Esterases %28%1966-1977%29%
% 216.27/216.47  |- skos__hiddenLabel mesh__D003173 C1s, Complement
% 216.27/216.47  |- mesh__recordMaintainer mesh__D003173 lkt
% 216.27/216.47  |- skos__hiddenLabel mesh__D003173 Esterase, C 1
% 216.27/216.47  |- skos__scopeNote mesh__D003173
% 216.27/216.47       A 77-kDa subcomponent of complement C1, encoded by gene C1S, is a SERINE PROTEASE existing as a proenzyme %28%homodimer%29% in the intact complement C1 complex. Upon the binding of COMPLEMENT C1Q to antibodies, the activated COMPLEMENT C1R cleaves C1s into two chains, A %28%heavy%29% and B %28%light, the serine protease%29%, linked by disulfide bonds yielding the active C1s. The activated C1s, in turn, cleaves COMPLEMENT C2 and COMPLEMENT C4 to form C4b2a %28%CLASSICAL C3 CONVERTASE%29%.%A%    
% 216.27/216.47  |- skos__broader mesh__D003173smesh__D003166
% 216.27/216.47  |- skos__hiddenLabel mesh__D003173 Component 1s, Complement
% 216.27/216.47  |- skos__altLabel mesh__D003173 Complement Component 1s
% 216.27/216.47  |- skos__prefLabel mesh__D003173 Complement C1s
% 216.27/216.47  |- skos__altLabel mesh__D003173 Complement 1 Esterase
% 216.27/216.47  |- mesh__dateRevised mesh__D003173 2005-06-30
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D003173 2006
% 216.27/216.47  |- skos__historyNote mesh__D003173 Complement 1 %28%1975-1977%29%
% 216.27/216.47  |- skos__hiddenLabel mesh__D003173 Esterase, C1
% 216.27/216.47  |- skos__altLabel mesh__D003173 C1s Complement
% 216.27/216.47  |- skos__altLabel mesh__D003173 C1 Esterase
% 216.27/216.47  |- mesh__historyNote mesh__D003173 2006 %28%1978%29%   
% 216.27/216.47  |- skos__altLabel mesh__D003173 Complement 1s
% 216.27/216.47  |- rdf__type mesh__D003173sskos__Concept
% 216.27/216.47  |- skos__altLabel mesh__D003173 C 1 Esterase
% 216.27/216.47  |- mesh__recordOriginator mesh__D003173 RLS
% 216.27/216.47  |- mesh__publicMeSHNote mesh__D003173
% 216.27/216.47       2006; see COMPLEMENT 1S 1990-2005; for COMPLEMENT 1 ESTERASE see COMPLEMENT ACTIVATING ENZYMES 1978-1989%A%  
% 216.27/216.47  |- mesh__dateCreated mesh__D003173 1977-05-16
% 216.27/216.47  |- mesh__dateRevised mesh__D011605 1999-11-03
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D011605 2001
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D011605 2004
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D011605 2000
% 216.27/216.47  |- mesh__historyNote mesh__D011605 81; was PSYCHOSES, TOXIC 1963-80   
% 216.27/216.47  |- skos__hiddenLabel mesh__D011605 Drug Psychoses
% 216.27/216.47  |- skos__hiddenLabel mesh__D011605 Psychoses, Substance Induced
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D011605 2006
% 216.27/216.47  |- skos__annotation mesh__D011605 PSYCHOSES, ALCOHOLIC is available   
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D011605 2003
% 216.27/216.47  |- skos__altLabel mesh__D011605 Toxic Psychoses
% 216.27/216.47  |- skos__altLabel mesh__D011605 Psychoses, Toxic
% 216.27/216.47  |- mesh__recordOriginator mesh__D011605 NLM
% 216.27/216.47  |- mesh__dateCreated mesh__D011605 1999-01-01
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D011605 2005
% 216.27/216.47  |- skos__broader mesh__D011605smesh__D011041
% 216.27/216.47  |- skos__scopeNote mesh__D011605
% 216.27/216.47       Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance.%A%    
% 216.27/216.47  |- skos__hiddenLabel mesh__D011605 Substance Induced Psychoses
% 216.27/216.47  |- skos__broader mesh__D011605smesh__D019966
% 216.27/216.47  |- rdf__type mesh__D011605sskos__Concept
% 216.27/216.47  |- mesh__recordAuthorizer mesh__D011605 sjn
% 216.27/216.47  |- mesh__publicMeSHNote mesh__D011605 81; was PSYCHOSES, TOXIC 1963-80   
% 216.27/216.47  |- skos__broader mesh__D011605smesh__D011618
% 216.27/216.47  |- mesh__onlineNote mesh__D011605
% 216.27/216.47       use PSYCHOSES, SUBSTANCE-INDUCED to search PSYCHOSES, TOXIC 1966-80%A%  
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D011605 2002
% 216.27/216.47  |- mesh__recordMaintainer mesh__D011605 adp
% 216.27/216.47  |- skos__altLabel mesh__D011605 Substance-Induced Psychoses
% 216.27/216.47  |- skos__prefLabel mesh__D011605 Psychoses, Substance-Induced
% 216.27/216.47  |- rdf__type mesh__D016899sskos__Concept
% 216.27/216.47  |- mesh__recordAuthorizer mesh__D016899 sjn
% 216.27/216.47  |- skos__altLabel mesh__D016899 Interferon-beta1
% 216.27/216.47  |- mesh__dateCreated mesh__D016899 1991-05-30
% 216.27/216.47  |- mesh__recordOriginator mesh__D016899 PLS
% 216.27/216.47  |- skos__hiddenLabel mesh__D016899 beta Interferon
% 216.27/216.47  |- mesh__publicMeSHNote mesh__D016899
% 216.27/216.47       92; was INTERFERON, BETA see INTERFERON TYPE I 1983-91; INTERFERON, FIBROBLAST was see INTERFERON TYPE I 1983-91%A%  
% 216.27/216.47  |- mesh__historyNote mesh__D016899
% 216.27/216.47       92; was INTERFERON, BETA see INTERFERON TYPE I 1983-91; INTERFERON, FIBROBLAST was see INTERFERON TYPE I 1983-91%A%  
% 216.27/216.47  |- skos__altLabel mesh__D016899 Interferon, beta
% 216.27/216.47  |- skos__hiddenLabel mesh__D016899 Fibroblast Interferon
% 216.27/216.47  |- mesh__recordMaintainer mesh__D016899 ssb
% 216.27/216.47  |- skos__altLabel mesh__D016899 Interferon, beta-1
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D016899 2006
% 216.27/216.47  |- skos__historyNote mesh__D016899 Interferon Type I %28%1984-1991%29%
% 216.27/216.47  |- skos__altLabel mesh__D016899 Interferon, Fibroblast
% 216.27/216.47  |- skos__altLabel mesh__D016899 beta-Interferon
% 216.27/216.47  |- skos__hiddenLabel mesh__D016899 Interferon, beta 1
% 216.27/216.47  |- mesh__dateEstablished mesh__D016899 1992-01-01
% 216.27/216.47  |- skos__prefLabel mesh__D016899 Interferon-beta
% 216.27/216.47  |- mesh__onlineNote mesh__D016899
% 216.27/216.47       use INTERFERON TYPE I to search INTERFERON, BETA %26% INTERFERON, FIBROBLAST 1983-91%A%  
% 216.27/216.47  |- skos__hiddenLabel mesh__D016899 Interferon beta1
% 216.27/216.47  |- skos__scopeNote mesh__D016899
% 216.27/216.47       One of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA. It is a cytokine with antiviral, antiproliferative, and immunomodulating activity.%A%    
% 216.27/216.47  |- mesh__dateRevised mesh__D016899 2005-06-30
% 216.27/216.47  |- skos__hiddenLabel mesh__D016899 beta 1 Interferon
% 216.27/216.47  |- skos__hiddenLabel mesh__D016899 Interferon beta
% 216.27/216.47  |- skos__broader mesh__D016899smesh__D007370
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D002879 2006
% 216.27/216.47  |- skos__historyNote mesh__D002879
% 216.27/216.47       Chromosomes, Human, 6-12 %28%1968-1986%29%
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D002879 2006A
% 216.27/216.47  |- skos__altLabel mesh__D002879 Chromosome 10
% 216.27/216.47  |- mesh__historyNote mesh__D002879 87   
% 216.27/216.47  |- mesh__dateRevised mesh__D002879 2005-07-11
% 216.27/216.47  |- mesh__recordOriginator mesh__D002879 SCD
% 216.27/216.47  |- mesh__dateEstablished mesh__D002879 1987-01-01
% 216.27/216.47  |- mesh__publicMeSHNote mesh__D002879 87   
% 216.27/216.47  |- skos__scopeNote mesh__D002879
% 216.27/216.47       A specific pair of GROUP C CHROMOSOMES of the human chromosome classification.%A%    
% 216.27/216.47  |- rdf__type mesh__D002879sskos__Concept
% 216.27/216.47  |- skos__prefLabel mesh__D002879 Chromosomes, Human, Pair 10
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D002879 2005
% 216.27/216.47  |- mesh__recordAuthorizer mesh__D002879 ags
% 216.27/216.47  |- skos__broader mesh__D002879smesh__D002906
% 216.27/216.47  |- mesh__recordMaintainer mesh__D002879 ags
% 216.27/216.47  |- mesh__dateCreated mesh__D002879 1986-06-19
% 216.27/216.47  |- mesh__recordOriginator mesh__D007564 NLM
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007564 1997
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007564 2004
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007564 2001
% 216.27/216.47  |- rdf__type mesh__D007564sskos__Concept
% 216.27/216.47  |- mesh__recordAuthorizer mesh__D007564 PLS
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007564 1995
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007564 1998
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007564 2005
% 216.27/216.47  |- skos__prefLabel mesh__D007564 Japan
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007564 2002
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007564 1999
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007564 2006
% 216.27/216.47  |- mesh__recordMaintainer mesh__D007564 TGC
% 216.27/216.47  |- mesh__dateCreated mesh__D007564 1999-01-01
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007564 1996
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007564 2003
% 216.27/216.47  |- skos__annotation mesh__D007564
% 216.27/216.47       TOKYO is also available; Japanese are of MONGOLOID RACE; Ainus, an indigenous people of Japan, are of CAUCASOID RACE, not MONGOLOID RACE%A%  
% 216.27/216.47  |- skos__broader mesh__D007564smesh__D005202
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D007564 2000
% 216.27/216.47  |- mesh__dateRevised mesh__D007564 1994-06-03
% 216.27/216.47  |- skos__altLabel mesh__D045683 Furin Protein
% 216.27/216.47  |- mesh__dateCreated mesh__D045683 2003-07-09
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D045683 2006
% 216.27/216.47  |- mesh__publicMeSHNote mesh__D045683
% 216.27/216.47       2004; FURIN was indexed under SUBTILISINS 1993-2003   
% 216.27/216.47  |- skos__broader mesh__D045683smesh__D012697
% 216.27/216.47  |- rdf__type mesh__D045683sskos__Concept
% 216.27/216.47  |- skos__altLabel mesh__D045683 Paired Basic Amino Acid Cleaving Enzyme
% 216.27/216.47  |- skos__historyNote mesh__D045683 Subtilisins %28%1993-2003%29%
% 216.27/216.47  |- skos__hiddenLabel mesh__D045683 Processing Enzyme, Dibasic
% 216.27/216.47  |- mesh__dateEstablished mesh__D045683 2004-01-01
% 216.27/216.47  |- skos__altLabel mesh__D045683 SPC1 Proteinase
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D045683 2004
% 216.27/216.47  |- skos__prefLabel mesh__D045683 Furin
% 216.27/216.47  |- mesh__historyNote mesh__D045683 2004; use FURIN %28%NM%29% 1993-2003   
% 216.27/216.47  |- skos__historyNote mesh__D045683 Serine Endopeptidases %28%1989-1992%29%
% 216.27/216.47  |- skos__broader mesh__D045683smesh__D043484
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D045683 2005
% 216.27/216.47  |- skos__scopeNote mesh__D045683
% 216.27/216.47       A proprotein convertase with specificity for the proproteins of PROALBUMIN; COMPLEMENT 3C; and VON WILLEBRAND FACTOR. It has specificity for cleavage near paired ARGININE residues that are separated by two amino acids.%A%    
% 216.27/216.47  |- skos__altLabel mesh__D045683 Dibasic Processing Enzyme
% 216.27/216.47  |- skos__broader mesh__D020136Q000031smesh__D020136
% 216.27/216.47  |- mesh__preferredCombination mesh__D020136Q000031smesh__D020100
% 216.27/216.47  |- rdf__type mesh__D020136Q000031smesh__CompoundConcept
% 216.27/216.47  |- skos__historyNote mesh__D017992 Parvoviridae %28%1974-1993%29%
% 216.27/216.47  |- skos__hiddenLabel mesh__D017992 Parvoviruses, Raccoon
% 216.27/216.47  |- skos__annotation mesh__D017992
% 216.27/216.47       GEN or unspecified; prefer specifics; infection: coord IM with PARVOVIRIDAE INFECTIONS %28%IM%29%%A%  
% 216.27/216.47  |- skos__scopeNote mesh__D017992
% 216.27/216.47       A genus of the family PARVOVIRIDAE, subfamily PARVOVIRINAE, infecting a variety of vertebrates including humans. Parvoviruses are responsible for a number of important diseases but also can be non-pathogenic in certain hosts. The type species is MICE MINUTE VIRUS.%A%    
% 216.27/216.47  |- skos__altLabel mesh__D017992 Infectious Enteritis Virus of Mink
% 216.27/216.47  |- mesh__dateRevised mesh__D017992 2001-07-25
% 216.27/216.47  |- mesh__recordOriginator mesh__D017992 AGS
% 216.27/216.47  |- skos__altLabel mesh__D017992 Rat virus
% 216.27/216.47  |- mesh__recordAuthorizer mesh__D017992 sjn
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017992 2005
% 216.27/216.47  |- skos__hiddenLabel mesh__D017992 enteritis viruses, Mink
% 216.27/216.47  |- skos__hiddenLabel mesh__D017992 Parvoviruses
% 216.27/216.47  |- skos__hiddenLabel mesh__D017992 enteritis virus, Mink
% 216.27/216.47  |- skos__altLabel mesh__D017992 Raccoon parvovirus
% 216.27/216.47  |- skos__prefLabel mesh__D017992 Parvovirus
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017992 2003
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017992 2006
% 216.27/216.47  |- skos__altLabel mesh__D017992 Latent Rat Virus
% 216.27/216.47  |- mesh__dateEstablished mesh__D017992 1994-01-01
% 216.27/216.47  |- rdf__type mesh__D017992sskos__Concept
% 216.27/216.47  |- skos__hiddenLabel mesh__D017992 Rat Virus, Latent
% 216.27/216.47  |- skos__hiddenLabel mesh__D017992 Raccoon Parvoviruses
% 216.27/216.47  |- mesh__dateCreated mesh__D017992 1993-06-04
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017992 2004
% 216.27/216.47  |- skos__hiddenLabel mesh__D017992 Mink enteritis viruses
% 216.27/216.47  |- skos__hiddenLabel mesh__D017992 Rat viruses
% 216.27/216.47  |- mesh__historyNote mesh__D017992
% 216.27/216.47       1994; use PARVOVIRIDAE 1992-1993; for LATENT RAT VIRUS use LATENT RAT VIRUS 1975-1993; for PARVOVIRUS, RACCOON use PARVIRUSES, FELINE 1994-2001; for MINK ENTERITIS VIRUS use PARVOVIRUS, FELINE 1994-2001; for INFECTIOUS ENTERITIS VIRUS OF MINK use PARVOVIRUS, FELINE 1976-2001%A%  
% 216.27/216.47  |- skos__historyNote mesh__D017992 DNA Viruses %28%1966-1973%29%
% 216.27/216.47  |- skos__hiddenLabel mesh__D017992 Latent Rat Viruses
% 216.27/216.47  |- mesh__recordMaintainer mesh__D017992 ags
% 216.27/216.47  |- mesh__publicMeSHNote mesh__D017992
% 216.27/216.47       1994; see PARVOVIRIDAE 1992-1993; for LATENT RAT VIRUS see LATENT RAT VIRUS 1991-2001, see PARVOVIRIDAE 1981-1990, see PARVOVIRUSES 1975-1980;  for PARVOVIRUS, RACCOON see PARVIRUSES, FELINE 1994-2001; for MINK ENTERITIS VIRUS see PARVOVIRUS, FELINE 1994-2001; for INFECTIOUS ENTERITIS VIRUS OF MINK see PARVOVIRUS, FELINE 1994-2001, see FELINE INFECTIOUS ENTERITIS VIRUS 1991-1993, see PARVOVIRIDAE 1981-1990, see PARVOVIRUSES 1975-1980%A%  
% 216.27/216.47  |- skos__hiddenLabel mesh__D017992 Rat Viruses, Latent
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017992 2002
% 216.27/216.47  |- skos__broader mesh__D017992smesh__D019219
% 216.27/216.47  |- rdf__type mesh__D031663sskos__Concept
% 216.27/216.47  |- mesh__historyNote mesh__D031663 2003   
% 216.27/216.47  |- mesh__publicMeSHNote mesh__D031663 2003   
% 216.27/216.47  |- skos__annotation mesh__D031663
% 216.27/216.47       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.27/216.47  |- skos__prefLabel mesh__D031663 Clarkia
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D031663 2005
% 216.27/216.47  |- skos__scopeNote mesh__D031663
% 216.27/216.47       A plant genus, of the family ONAGRACEAE, which is the subject of genetic studies. The floral aroma is attributed to benzenoid esters and benzylacetate.%A%    
% 216.27/216.47  |- skos__broader mesh__D031663smesh__D029594
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D031663 2003
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D031663 2006
% 216.27/216.47  |- mesh__dateCreated mesh__D031663 2002-07-03
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D031663 2004
% 216.27/216.47  |- mesh__dateEstablished mesh__D031663 2003-01-01
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017194 2000
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017194 1997
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017194 2003
% 216.27/216.47  |- skos__hiddenLabel mesh__D017194 Oxyurida Infection
% 216.27/216.47  |- skos__scopeNote mesh__D017194
% 216.27/216.47       Infections with nematodes of the order OXYURIDA.     
% 216.27/216.47  |- mesh__recordAuthorizer mesh__D017194 PLS
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017194 1996
% 216.27/216.47  |- mesh__dateEstablished mesh__D017194 1993-01-01
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017194 2006
% 216.27/216.47  |- skos__broader mesh__D017194smesh__D017190
% 216.27/216.47  |- skos__annotation mesh__D017194 nematode infect   
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017194 2002
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017194 1999
% 216.27/216.47  |- mesh__recordOriginator mesh__D017194 PXP
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017194 2005
% 216.27/216.47  |- mesh__publicMeSHNote mesh__D017194 93   
% 216.27/216.47  |- mesh__recordMaintainer mesh__D017194 TGC
% 216.27/216.47  |- rdf__type mesh__D017194sskos__Concept
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017194 1995
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017194 1998
% 216.27/216.47  |- mesh__dateRevised mesh__D017194 1993-06-02
% 216.27/216.47  |- skos__prefLabel mesh__D017194 Oxyurida Infections
% 216.27/216.47  |- skos__hiddenLabel mesh__D017194 Infection, Oxyurida
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017194 1994
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017194 2001
% 216.27/216.47  |- mesh__historyNote mesh__D017194 93   
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D017194 2004
% 216.27/216.47  |- mesh__dateCreated mesh__D017194 1992-05-22
% 216.27/216.47  |- skos__altLabel mesh__D017194 Infections, Oxyurida
% 216.27/216.47  |- skos__broader mesh__D003972smesh__D006979
% 216.27/216.47  |- mesh__activeMeSHYear mesh__D003972 2006
% 216.27/216.47  |- skos__hiddenLabel mesh__D003972 Diathermies
% 216.27/216.47  |- mesh__dateCreated mesh__D003972 1999-01-01
% 216.27/216.47  |- mesh__recordOriginator mesh__D003972 NLM
% 216.27/216.47  |- mesh__recordAuthorizer mesh__D003972 sjn
% 216.27/216.47  |- skos__prefLabel mesh__D003972 Diathermy
% 216.27/216.47  |- mesh__dateRevised mesh__D003972 2005-06-30
% 216.27/216.47  |- skos__scopeNote mesh__D003972
% 216.27/216.47       The induction of local hyperthermia by either short radio waves or high-frequency sound waves.%A%    
% 216.27/216.47  |- skos__annotation mesh__D003972
% 216.27/216.47       do not use /util except by MeSH definition   
% 216.27/216.47  |- rdf__type mesh__D003972sskos__Concept
% 216.27/216.47  |- mesh__recordMaintainer mesh__D003972 lkt
% 216.27/216.47  |- mesh__recordOriginator mesh__D003174 RLS
% 216.27/216.47  |- skos__altLabel mesh__D003174 Complement C1 Inhibitor Proteins
% 216.27/216.47  |- skos__altLabel mesh__D003174 Complement 1 Esterase Inhibitors
% 216.27/216.47  |- skos__broader mesh__D003174smesh__D003169
% 216.27/216.48  |- mesh__recordAuthorizer mesh__D003174 sjn
% 216.27/216.48  |- skos__historyNote mesh__D003174 Enzyme Inhibitors %28%1975-1977%29%
% 216.27/216.48  |- skos__altLabel mesh__D003174 Complement Component 1 Inactivator Proteins
% 216.27/216.48  |- mesh__dateEstablished mesh__D003174 1978-01-01
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D003174 2006
% 216.27/216.48  |- skos__hiddenLabel mesh__D003174 Esterase Inhibitor, C1
% 216.27/216.48  |- skos__historyNote mesh__D003174 Complement 1 %28%1975-1977%29%
% 216.27/216.48  |- skos__historyNote mesh__D003174 Glycoproteins %28%1966-1977%29%
% 216.27/216.48  |- rdf__type mesh__D003174sskos__Concept
% 216.27/216.48  |- skos__altLabel mesh__D003174 Complement C1 Inactivating Proteins
% 216.27/216.48  |- skos__altLabel mesh__D003174 C1 Esterase Inhibitor
% 216.27/216.48  |- skos__prefLabel mesh__D003174 Complement C1 Inactivator Proteins
% 216.27/216.48  |- skos__historyNote mesh__D003174
% 216.27/216.48       Enzymes %28%1966-1967%29% /antagonists %26% inhibitors %28%1968-1974%29%
% 216.27/216.48  |- skos__hiddenLabel mesh__D003174 Inhibitor, C1 Esterase
% 216.27/216.48  |- mesh__dateCreated mesh__D003174 1977-04-15
% 216.27/216.48  |- skos__annotation mesh__D003174
% 216.27/216.48       do not confuse with COMPLEMENT C1 INHIBITOR PROTEIN; DF: C 1 INACT%A%  
% 216.27/216.48  |- mesh__dateRevised mesh__D003174 2005-06-30
% 216.27/216.48  |- skos__altLabel mesh__D003174 Complement C1 Inhibiting Proteins
% 216.27/216.48  |- mesh__publicMeSHNote mesh__D003174
% 216.27/216.48       2006; see COMPLEMENT 1 INACTIVATORS 1978-2005   
% 216.27/216.48  |- mesh__recordMaintainer mesh__D003174 ssb
% 216.27/216.48  |- mesh__historyNote mesh__D003174 2006 %28%1978%29%   
% 216.27/216.48  |- skos__scopeNote mesh__D003174
% 216.27/216.48       Serum proteins that inhibit, antagonize, or inactivate COMPLEMENT C1 or its subunits.%A%    
% 216.27/216.48  |- skos__broader mesh__D003174smesh__D015843
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D011606 2005
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D011606 1997
% 216.27/216.48  |- mesh__dateCreated mesh__D011606 1999-01-01
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D011606 1999
% 216.27/216.48  |- skos__scopeNote mesh__D011606
% 216.27/216.48       The stages of development of the psychological aspects of sexuality from birth to adulthood; i.e., oral, anal, genital, and latent periods.%A%    
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D011606 2002
% 216.27/216.48  |- skos__hiddenLabel mesh__D011606 Stage, Phallic
% 216.27/216.48  |- skos__historyNote mesh__D011606 Sex Behavior %28%1966-1967%29%
% 216.27/216.48  |- skos__hiddenLabel mesh__D011606 Stages, Phallic
% 216.27/216.48  |- skos__hiddenLabel mesh__D011606 Anal Stages
% 216.27/216.48  |- skos__hiddenLabel mesh__D011606 Developments, Psychosexual
% 216.27/216.48  |- rdf__type mesh__D011606sskos__Concept
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D011606 1998
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D011606 2001
% 216.27/216.48  |- skos__broader mesh__D011606smesh__D011574
% 216.27/216.48  |- skos__hiddenLabel mesh__D011606 Stage, Anal
% 216.27/216.48  |- mesh__dateEstablished mesh__D011606 1968-01-01
% 216.27/216.48  |- mesh__publicMeSHNote mesh__D011606
% 216.27/216.48       68; ANAL STAGE was heading 1975-96 %28%see under PSYCHOSEXUAL DEVELOPMENT 1975-90%29%; was see under PSYCHOSEXUAL DEVELOPMENT 1968-74; PHALLIC STAGE was heading 1975-96 %28%see under PSYCHOSEXUAL DEVELOPMENT 1975-90%29%%A%  
% 216.27/216.48  |- mesh__recordAuthorizer mesh__D011606 PLS
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D011606 2000
% 216.27/216.48  |- skos__prefLabel mesh__D011606 Psychosexual Development
% 216.27/216.48  |- mesh__dateRevised mesh__D011606 1996-06-10
% 216.27/216.48  |- skos__historyNote mesh__D011606 Child Psychology %28%1966-1967%29%
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D011606 2004
% 216.27/216.48  |- skos__hiddenLabel mesh__D011606 Stages, Anal
% 216.27/216.48  |- mesh__recordMaintainer mesh__D011606 PXP
% 216.27/216.48  |- skos__broader mesh__D011606smesh__D010553
% 216.27/216.48  |- skos__hiddenLabel mesh__D011606 Psychosexual Developments
% 216.27/216.48  |- skos__hiddenLabel mesh__D011606 Development, Psychosexual
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D011606 2006
% 216.27/216.48  |- mesh__recordOriginator mesh__D011606 NLM
% 216.27/216.48  |- skos__hiddenLabel mesh__D011606 Phallic Stages
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D011606 2003
% 216.27/216.48  |- mesh__historyNote mesh__D011606
% 216.27/216.48       68; ANAL STAGE was heading 1975-96 %28%see under PSYCHOSEXUAL DEVELOPMENT 1975-90%29%; was see under PSYCHOSEXUAL DEVELOPMENT 1968-74; PHALLIC STAGE was heading 1975-96 %28%see under PSYCHOSEXUAL DEVELOPMENT 1975-90%29%%A%  
% 216.27/216.48  |- mesh__dateRevised mesh__D007565 2005-06-30
% 216.27/216.48  |- skos__prefLabel mesh__D007565 Jaundice
% 216.27/216.48  |- mesh__recordAuthorizer mesh__D007565 sjn
% 216.27/216.48  |- skos__altLabel mesh__D007565 Icterus
% 216.27/216.48  |- skos__broader mesh__D007565smesh__D012877
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D007565 2006
% 216.27/216.48  |- mesh__dateCreated mesh__D007565 1999-01-01
% 216.27/216.48  |- mesh__recordOriginator mesh__D007565 NLM
% 216.27/216.48  |- skos__annotation mesh__D007565
% 216.27/216.48       general or unspecified; prefer specifics   
% 216.27/216.48  |- skos__scopeNote mesh__D007565
% 216.27/216.48       A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction.%A%    
% 216.27/216.48  |- skos__broader mesh__D007565smesh__D006932
% 216.27/216.48  |- mesh__recordMaintainer mesh__D007565 lkt
% 216.27/216.48  |- rdf__type mesh__D007565sskos__Concept
% 216.27/216.48  |- mesh__dateCreated mesh__D045684 2003-07-09
% 216.27/216.48  |- mesh__publicMeSHNote mesh__D045684 2004   
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D045684 2006
% 216.27/216.48  |- mesh__historyNote mesh__D045684 2004   
% 216.27/216.48  |- mesh__dateEstablished mesh__D045684 2004-01-01
% 216.27/216.48  |- mesh__dateRevised mesh__D045684 2005-06-30
% 216.27/216.48  |- rdf__type mesh__D045684sskos__Concept
% 216.27/216.48  |- skos__scopeNote mesh__D045684
% 216.27/216.48       A species of gram-negative bacteria causing CONJUNCTIVITIS and KERATOCONJUNCTIVITIS in SHEEP and GOATS.%A%    
% 216.27/216.48  |- skos__prefLabel mesh__D045684 Mycoplasma conjunctivae
% 216.27/216.48  |- mesh__recordOriginator mesh__D045684 ags
% 216.27/216.48  |- mesh__recordMaintainer mesh__D045684 SYSTEM
% 216.27/216.48  |- skos__annotation mesh__D045684
% 216.27/216.48       infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29% + probably CONJUNCTIVITIS, BACTERIAL %28%IM%29% or KERATOCONJUNCTIVITIS, INFECTIOUS %28%IM%29%%A%  
% 216.27/216.48  |- skos__broader mesh__D045684smesh__D009174
% 216.27/216.48  |- skos__historyNote mesh__D045684 Mycoplasma %28%1972-2003%29%
% 216.27/216.48  |- mesh__recordAuthorizer mesh__D045684 sjn
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017993 2005
% 216.27/216.48  |- mesh__publicMeSHNote mesh__D017993 94   
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017993 2002
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017993 2003
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017993 2006
% 216.27/216.48  |- skos__hiddenLabel mesh__D017993 Canine Parvoviruses
% 216.27/216.48  |- skos__historyNote mesh__D017993 Parvoviridae %28%1979-1993%29%
% 216.27/216.48  |- skos__annotation mesh__D017993
% 216.27/216.48       infection: coord IM with PARVOVIRIDAE INFECTIONS %28%IM%29%   
% 216.27/216.48  |- mesh__dateRevised mesh__D017993 2001-07-25
% 216.27/216.48  |- mesh__recordOriginator mesh__D017993 AGS
% 216.27/216.48  |- rdf__type mesh__D017993sskos__Concept
% 216.27/216.48  |- skos__broader mesh__D017993smesh__D017992
% 216.27/216.48  |- mesh__recordAuthorizer mesh__D017993 sjn
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017993 2004
% 216.27/216.48  |- skos__scopeNote mesh__D017993
% 216.27/216.48       A species of the genus PARVOVIRUS and a host range variant of feline parvovirus %28%PARVOVIRUS, FELINE%29%. It causes a highly infectious fulminating enteritis in dogs producing high mortality. It is distinct from minute virus of canines, another parvovirus which is sometimes also called canine parvovirus.%A%    
% 216.27/216.48  |- skos__hiddenLabel mesh__D017993 Parvoviruses, Canine
% 216.27/216.48  |- mesh__recordMaintainer mesh__D017993 ags
% 216.27/216.48  |- skos__prefLabel mesh__D017993 Parvovirus, Canine
% 216.27/216.48  |- mesh__dateEstablished mesh__D017993 1994-01-01
% 216.27/216.48  |- skos__altLabel mesh__D017993 Canine parvovirus
% 216.27/216.48  |- mesh__dateCreated mesh__D017993 1993-06-04
% 216.27/216.48  |- mesh__historyNote mesh__D017993 94   
% 216.27/216.48  |- skos__prefLabel mesh__D031664 Oenothera
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D031664 2005
% 216.27/216.48  |- mesh__dateEstablished mesh__D031664 2003-01-01
% 216.27/216.48  |- mesh__dateCreated mesh__D031664 2002-07-03
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D031664 2003
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D031664 2006
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D031664 2004
% 216.27/216.48  |- mesh__historyNote mesh__D031664 2003   
% 216.27/216.48  |- rdf__type mesh__D031664sskos__Concept
% 216.27/216.48  |- skos__scopeNote mesh__D031664
% 216.27/216.48       A plant genus of the family ONAGRACEAE. Members contain oenotheins.%A%    
% 216.27/216.48  |- skos__broader mesh__D031664smesh__D029594
% 216.27/216.48  |- mesh__publicMeSHNote mesh__D031664 2003   
% 216.27/216.48  |- skos__annotation mesh__D031664
% 216.27/216.48       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017195 1993
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017195 1996
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017195 2001
% 216.27/216.48  |- skos__broader mesh__D017195smesh__D002664
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017195 2006
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017195 2000
% 216.27/216.48  |- skos__annotation mesh__D017195 age 13-18; check the tag ADOLESCENCE   
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017195 1999
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017195 2005
% 216.27/216.48  |- skos__hiddenLabel mesh__D017195 Nutritions, Adolescent
% 216.27/216.48  |- skos__hiddenLabel mesh__D017195 Nutrition, Adolescent
% 216.27/216.48  |- rdf__type mesh__D017195sskos__Concept
% 216.27/216.48  |- skos__prefLabel mesh__D017195 Adolescent Nutrition
% 216.27/216.48  |- mesh__dateCreated mesh__D017195 1992-05-11
% 216.27/216.48  |- skos__hiddenLabel mesh__D017195 Adolescent Nutritions
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017195 1995
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017195 1998
% 216.27/216.48  |- skos__historyNote mesh__D017195 Nutrition %28%1970-1992%29%
% 216.27/216.48  |- skos__historyNote mesh__D017195 Adolescence %28%1970-1992%29%
% 216.27/216.48  |- mesh__dateEstablished mesh__D017195 1993-01-01
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017195 1994
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017195 2002
% 216.27/216.48  |- mesh__historyNote mesh__D017195 93   
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017195 2004
% 216.27/216.48  |- mesh__publicMeSHNote mesh__D017195 93   
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017195 1997
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017195 2003
% 216.27/216.48  |- skos__scopeNote mesh__D017195
% 216.27/216.48       Nutrition of children aged 13-18 years.     
% 216.27/216.48  |- skos__altLabel mesh__D003973 Amidotrizoate
% 216.27/216.48  |- skos__hiddenLabel mesh__D003973 Diatrizoate, Sodium
% 216.27/216.48  |- skos__broader mesh__D003973smesh__D014283
% 216.27/216.48  |- skos__hiddenLabel mesh__D003973 Sodium Magnesium Diatrizoate
% 216.27/216.48  |- mesh__recordMaintainer mesh__D003973 CCR
% 216.27/216.48  |- mesh__dateRevised mesh__D003973 2000-06-21
% 216.27/216.48  |- skos__prefLabel mesh__D003973 Diatrizoate
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D003973 2003
% 216.27/216.48  |- rdf__type mesh__D003973sskos__Concept
% 216.27/216.48  |- skos__altLabel mesh__D003973 Urogranoic Acid
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D003973 2004
% 216.27/216.48  |- skos__hiddenLabel mesh__D003973 50, Hypaque
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D003973 2001
% 216.27/216.48  |- skos__hiddenLabel mesh__D003973 Sodium, Diatrizoate
% 216.27/216.48  |- skos__scopeNote mesh__D003973
% 216.27/216.48       A commonly used x-ray contrast medium.  As DIATRIZOATE MEGLUMINE and as Diatrizoate sodium, it is used for gastrointestinal studies, angiography, and urography.%A%    
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D003973 2005
% 216.27/216.48  |- skos__annotation mesh__D003973 D25-26 qualif   
% 216.27/216.48  |- mesh__recordOriginator mesh__D003973 NLM
% 216.27/216.48  |- skos__hiddenLabel mesh__D003973 Diatrizoate, Sodium-Magnesium
% 216.27/216.48  |- skos__altLabel mesh__D003973 Diatrizoate Sodium
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D003973 2002
% 216.27/216.48  |- mesh__recordAuthorizer mesh__D003973 sjn
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D003973 2006
% 216.27/216.48  |- mesh__dateCreated mesh__D003973 1999-01-01
% 216.27/216.48  |- skos__hiddenLabel mesh__D003973 Acid, Urogranoic
% 216.27/216.48  |- skos__altLabel mesh__D003973 Amidotrezoate
% 216.27/216.48  |- skos__hiddenLabel mesh__D003175 C2, Complement
% 216.27/216.48  |- mesh__recordOriginator mesh__D003175 NLM
% 216.27/216.48  |- skos__historyNote mesh__D003175 Magnesium %28%1966-1974%29%
% 216.27/216.48  |- skos__hiddenLabel mesh__D003175 Component 2, Complement
% 216.27/216.48  |- mesh__recordMaintainer mesh__D003175 lkt
% 216.27/216.48  |- skos__historyNote mesh__D003175 Complement %28%1968-1974%29%
% 216.27/216.48  |- mesh__dateCreated mesh__D003175 1974-11-11
% 216.27/216.48  |- mesh__dateRevised mesh__D003175 2005-06-30
% 216.27/216.48  |- skos__altLabel mesh__D003175 Complement 2
% 216.27/216.48  |- skos__altLabel mesh__D003175 Complement Component 2
% 216.27/216.48  |- mesh__historyNote mesh__D003175 2006 %28%1975%29%   
% 216.27/216.48  |- mesh__publicMeSHNote mesh__D003175
% 216.27/216.48       2006; see COMPLEMENT 2 1978-2005, see COMPLEMENT 1975-1977%A%  
% 216.27/216.48  |- skos__prefLabel mesh__D003175 Complement C2
% 216.27/216.48  |- skos__hiddenLabel mesh__D003175 Complement, C2
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D003175 2006
% 216.27/216.48  |- skos__broader mesh__D003175smesh__D003165
% 216.27/216.48  |- mesh__recordAuthorizer mesh__D003175 sjn
% 216.27/216.48  |- skos__historyNote mesh__D003175 Protein Binding %28%1966-1974%29%
% 216.27/216.48  |- mesh__dateEstablished mesh__D003175 1978-01-01
% 216.27/216.48  |- rdf__type mesh__D003175sskos__Concept
% 216.27/216.48  |- skos__scopeNote mesh__D003175
% 216.27/216.48       A component of the CLASSICAL COMPLEMENT PATHWAY. C2 is cleaved by activated COMPLEMENT C1S into COMPLEMENT C2B and COMPLEMENT C2A. C2a, the COOH-terminal fragment containing a SERINE PROTEASE, combines with COMPLEMENT C4B to form C4b2a %28%CLASSICAL PATHWAY C3 CONVERTASE%29% and subsequent C4b2a3b %28%CLASSICAL PATHWAY C5 CONVERTASE%29%.%A%    
% 216.27/216.48  |- skos__altLabel mesh__D003175 C2 Complement
% 216.27/216.48  |- skos__hiddenLabel mesh__D007566 Chronic Idiopathic Jaundices
% 216.27/216.48  |- skos__scopeNote mesh__D007566
% 216.27/216.48       A benign, autosomally recessive inherited hyperbilirubinemia characterized by the presence of a dark pigment in the centrilobular region of the liver cells. There is a functional defect in biliary excretion of bilirubin, cholephilic dyes, and porphyrins. Affected persons may be asymptomatic or have vague constitutional or gastrointestinal symptoms. The liver may be slightly enlarged, and oral and intravenous cholangiography fails to visualize the biliary tract.%A%    
% 216.27/216.48  |- skos__broader mesh__D007566smesh__D007567
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D007566 2006
% 216.27/216.48  |- skos__hiddenLabel mesh__D007566 Idiopathic Jaundice, Chronic
% 216.27/216.48  |- mesh__dateCreated mesh__D007566 1999-01-01
% 216.27/216.48  |- skos__hiddenLabel mesh__D007566 Jaundices, Chronic Idiopathic
% 216.27/216.48  |- mesh__dateRevised mesh__D007566 2005-06-30
% 216.27/216.48  |- mesh__recordAuthorizer mesh__D007566 sjn
% 216.27/216.48  |- skos__broader mesh__D007566smesh__D008661
% 216.27/216.48  |- skos__altLabel mesh__D007566 Dubin-Johnson Syndrome
% 216.27/216.48  |- skos__prefLabel mesh__D007566 Jaundice, Chronic Idiopathic
% 216.27/216.48  |- skos__hiddenLabel mesh__D007566 Idiopathic Jaundices, Chronic
% 216.27/216.48  |- skos__hiddenLabel mesh__D007566 Chronic Idiopathic Jaundice
% 216.27/216.48  |- rdf__type mesh__D007566sskos__Concept
% 216.27/216.48  |- mesh__recordOriginator mesh__D007566 NLM
% 216.27/216.48  |- skos__hiddenLabel mesh__D007566 Syndrome, Dubin-Johnson
% 216.27/216.48  |- skos__hiddenLabel mesh__D007566 Dubin Johnson Syndrome
% 216.27/216.48  |- mesh__recordMaintainer mesh__D007566 lkt
% 216.27/216.48  |- mesh__publicMeSHNote mesh__D045685 2004   
% 216.27/216.48  |- skos__annotation mesh__D045685
% 216.27/216.48       infection: coord IM with PNEUMONIA, MYCOPLASMA /vet %28%IM%29% + CATTLE DISEASES %28%IM%29% or MYCOPLASMA INFECTIONS /vet %28%IM%29% + CATTLE DISEASES %28%IM%29% + RESPIRATORY TRACT INFECTIONS/vet %28%IM%29%%A%  
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D045685 2006
% 216.27/216.48  |- skos__scopeNote mesh__D045685
% 216.27/216.48       A species of gram-negative bacteria causing PNEUMONIA, MYCOPLASMA in calves. Mycoplasma dispar also possibly plays a synergistic role with other BACTERIA and VIRUSES to cause other RESPIRATORY TRACT DISEASES in calves.%A%    
% 216.27/216.48  |- mesh__recordAuthorizer mesh__D045685 sjn
% 216.27/216.48  |- rdf__type mesh__D045685sskos__Concept
% 216.27/216.48  |- skos__historyNote mesh__D045685 Mycoplasma %28%1970-2003%29%
% 216.27/216.48  |- mesh__recordMaintainer mesh__D045685 SYSTEM
% 216.27/216.48  |- mesh__historyNote mesh__D045685 2004   
% 216.27/216.48  |- mesh__dateEstablished mesh__D045685 2004-01-01
% 216.27/216.48  |- mesh__dateRevised mesh__D045685 2005-06-30
% 216.27/216.48  |- mesh__recordOriginator mesh__D045685 ags
% 216.27/216.48  |- mesh__dateCreated mesh__D045685 2003-07-09
% 216.27/216.48  |- skos__prefLabel mesh__D045685 Mycoplasma dispar
% 216.27/216.48  |- skos__broader mesh__D045685smesh__D009174
% 216.27/216.48  |- skos__prefLabel mesh__D012700 Serositis
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D012700 2004
% 216.27/216.48  |- rdf__type mesh__D012700sskos__Concept
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D012700 2005
% 216.27/216.48  |- mesh__recordOriginator mesh__D012700 NLM
% 216.27/216.48  |- mesh__dateRevised mesh__D012700 1999-11-03
% 216.27/216.48  |- mesh__recordAuthorizer mesh__D012700 sjn
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D012700 2003
% 216.27/216.48  |- skos__scopeNote mesh__D012700 Inflammation of a serous membrane.     
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D012700 2001
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D012700 2000
% 216.27/216.48  |- mesh__dateCreated mesh__D012700 1999-01-01
% 216.27/216.48  |- skos__hiddenLabel mesh__D012700 Serositides
% 216.27/216.48  |- mesh__recordMaintainer mesh__D012700 KEV
% 216.27/216.48  |- skos__broader mesh__D012700smesh__D007249
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D012700 2006
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D012700 2002
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017994 1996
% 216.27/216.48  |- mesh__publicMeSHNote mesh__D017994 94   
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017994 2001
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017994 1998
% 216.27/216.48  |- mesh__recordOriginator mesh__D017994 AGS
% 216.27/216.48  |- mesh__recordMaintainer mesh__D017994 TGC
% 216.27/216.48  |- mesh__historyNote mesh__D017994 94   
% 216.27/216.48  |- skos__prefLabel mesh__D017994 Iridovirus
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017994 2000
% 216.27/216.48  |- skos__broader mesh__D017994smesh__D007497
% 216.27/216.48  |- mesh__recordAuthorizer mesh__D017994 PLS
% 216.27/216.48  |- skos__annotation mesh__D017994
% 216.27/216.48       a genus of iridescent %28%irido-%29% insect viruses of the family Iridoviridae; coord IM with specific insect /virol %28%IM%29%%A%  
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017994 2004
% 216.27/216.48  |- skos__historyNote mesh__D017994 DNA Viruses %28%1975-1977%29%
% 216.27/216.48  |- mesh__dateEstablished mesh__D017994 1994-01-01
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017994 2006
% 216.27/216.48  |- skos__historyNote mesh__D017994 Iridoviridae %28%1979-1993%29%
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017994 2003
% 216.27/216.48  |- rdf__type mesh__D017994sskos__Concept
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017994 2005
% 216.27/216.48  |- skos__hiddenLabel mesh__D017994 Iridoviruses
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017994 1997
% 216.27/216.48  |- skos__scopeNote mesh__D017994
% 216.27/216.48       A genus of IRIDOVIRIDAE comprising small iridescent insect viruses. The infected larvae and purified virus pellets exhibit a blue to purple iridescence.%A%    
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017994 2002
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017994 1999
% 216.27/216.48  |- skos__broader mesh__D017994smesh__D007304
% 216.27/216.48  |- mesh__dateRevised mesh__D017994 1995-03-13
% 216.27/216.48  |- mesh__dateCreated mesh__D017994 1993-06-04
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D031665 2003
% 216.27/216.48  |- skos__broader mesh__D031665smesh__D031664
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D031665 2006
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D031665 2004
% 216.27/216.48  |- mesh__dateCreated mesh__D031665 2002-07-03
% 216.27/216.48  |- mesh__dateEstablished mesh__D031665 2003-01-01
% 216.27/216.48  |- skos__prefLabel mesh__D031665 Oenothera biennis
% 216.27/216.48  |- skos__altLabel mesh__D031665 Primrose, Evening
% 216.27/216.48  |- rdf__type mesh__D031665sskos__Concept
% 216.27/216.48  |- skos__annotation mesh__D031665
% 216.27/216.48       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.27/216.48  |- mesh__publicMeSHNote mesh__D031665 2003   
% 216.27/216.48  |- skos__scopeNote mesh__D031665
% 216.27/216.48       A plant species, of the genus OENOTHERA, family ONAGRACEAE, that is the source of evening primrose oil.%A%    
% 216.27/216.48  |- mesh__historyNote mesh__D031665 2003   
% 216.27/216.48  |- skos__altLabel mesh__D031665 Evening Primrose
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D031665 2005
% 216.27/216.48  |- rdf__type mesh__D017196sskos__Concept
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017196 1995
% 216.27/216.48  |- skos__annotation mesh__D017196 nematode infect   
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017196 2002
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017196 1998
% 216.27/216.48  |- mesh__recordOriginator mesh__D017196 PXP
% 216.27/216.48  |- mesh__publicMeSHNote mesh__D017196 93   
% 216.27/216.48  |- mesh__recordMaintainer mesh__D017196 TGC
% 216.27/216.48  |- skos__altLabel mesh__D017196 Infections, Rhabditida
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017196 1994
% 216.27/216.48  |- skos__scopeNote mesh__D017196
% 216.27/216.48       Infections with nematodes of the order RHABDITIDA.     
% 216.27/216.48  |- mesh__dateRevised mesh__D017196 1993-06-02
% 216.27/216.48  |- mesh__historyNote mesh__D017196 93   
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017196 2004
% 216.27/216.48  |- skos__prefLabel mesh__D017196 Rhabditida Infections
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017196 1997
% 216.27/216.48  |- skos__hiddenLabel mesh__D017196 Rhabditida Infection
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017196 2001
% 216.27/216.48  |- mesh__dateCreated mesh__D017196 1992-05-22
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017196 2003
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017196 2000
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017196 1996
% 216.27/216.48  |- mesh__dateEstablished mesh__D017196 1993-01-01
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017196 2006
% 216.27/216.48  |- mesh__recordAuthorizer mesh__D017196 PLS
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017196 1999
% 216.27/216.48  |- skos__hiddenLabel mesh__D017196 Infection, Rhabditida
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D017196 2005
% 216.27/216.48  |- skos__broader mesh__D017196smesh__D017190
% 216.27/216.48  |- skos__broader mesh__D003974smesh__D008536
% 216.27/216.48  |- mesh__recordOriginator mesh__D003974 NLM
% 216.27/216.48  |- mesh__historyNote mesh__D003974
% 216.27/216.48       87%28%82%29%; was see under DIATRIZOATE 1982-86; was MEGLUMINE DIATRIZOATE see under DIATRIZOATE 1975-81%A%  
% 216.27/216.48  |- skos__historyNote mesh__D003974 Sorbitol %28%1972-1974%29%
% 216.27/216.48  |- skos__hiddenLabel mesh__D003974 Reno M Dip
% 216.27/216.48  |- skos__hiddenLabel mesh__D003974 Reno MDip
% 216.27/216.48  |- skos__hiddenLabel mesh__D003974 Meglumine, Diatrizoate
% 216.27/216.48  |- skos__scopeNote mesh__D003974
% 216.27/216.48       A versatile x-ray contrast medium for diagnostic radiology. It can be administered by most routes.%A%    
% 216.27/216.48  |- mesh__dateCreated mesh__D003974 1974-11-11
% 216.27/216.48  |- skos__hiddenLabel mesh__D003974 Methylglucamine, Diatrizoate
% 216.27/216.48  |- skos__altLabel mesh__D003974 Methylglucamine Diatrizoate
% 216.27/216.48  |- skos__hiddenLabel mesh__D003974 Renografin M76
% 216.27/216.48  |- skos__hiddenLabel mesh__D003974 Diatrizoate, Methylglucamine
% 216.27/216.48  |- skos__annotation mesh__D003974 D25-26 qualif   
% 216.27/216.48  |- mesh__recordMaintainer mesh__D003974 ssb
% 216.27/216.48  |- skos__hiddenLabel mesh__D003974 Acid, Amidotrizoic
% 216.27/216.48  |- skos__altLabel mesh__D003974 Meglumine Diatrizoate
% 216.27/216.48  |- skos__altLabel mesh__D003974 Gastrografin
% 216.27/216.48  |- skos__historyNote mesh__D003974 Amino Sugars %28%1972-1974%29%
% 216.27/216.48  |- skos__hiddenLabel mesh__D003974 Renografin M 76
% 216.27/216.48  |- skos__altLabel mesh__D003974 Meglumine Amidotrizoate
% 216.27/216.48  |- skos__broader mesh__D003974smesh__D014283
% 216.27/216.48  |- skos__altLabel mesh__D003974 Urografin
% 216.27/216.48  |- skos__prefLabel mesh__D003974 Diatrizoate Meglumine
% 216.27/216.48  |- skos__altLabel mesh__D003974 Diatrizoate Methylglucamine
% 216.27/216.48  |- rdf__type mesh__D003974sskos__Concept
% 216.27/216.48  |- mesh__dateRevised mesh__D003974 2004-07-07
% 216.27/216.48  |- skos__altLabel mesh__D003974 Renograffin
% 216.27/216.48  |- skos__hiddenLabel mesh__D003974 Diatrizoate, Meglumine
% 216.27/216.48  |- skos__historyNote mesh__D003974 Diatrizoate %28%1971-1974%29%
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D003974 2006
% 216.27/216.48  |- skos__altLabel mesh__D003974 Gastrographin
% 216.27/216.48  |- skos__hiddenLabel mesh__D003974 Amidotrizoate, Meglumine
% 216.27/216.48  |- skos__hiddenLabel mesh__D003974 Acid, Amidotricoic
% 216.27/216.48  |- mesh__dateEstablished mesh__D003974 1987-01-01
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D003974 2005
% 216.27/216.48  |- mesh__recordAuthorizer mesh__D003974 sjn
% 216.27/216.48  |- skos__hiddenLabel mesh__D003974 Methylglucamine, Diatrizoic Acid
% 216.27/216.48  |- mesh__onlineNote mesh__D003974
% 216.27/216.48       use DIATRIZOATE MEGLUMINE to search MEGLUMINE DIATRIZOATE 1975-81%A%  
% 216.27/216.48  |- mesh__publicMeSHNote mesh__D003974
% 216.27/216.48       87; was see under DIATRIZOATE 1982-86; was MEGLUMINE DIATRIZOATE see under DIATRIZOATE 1975-81%A%  
% 216.27/216.48  |- mesh__dateRevised mesh__D003176 2005-07-11
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D003176 2006A
% 216.27/216.48  |- mesh__dateCreated mesh__D003176 1974-11-11
% 216.27/216.48  |- skos__historyNote mesh__D003176 Phagocytosis %28%1966-1974%29%
% 216.27/216.48  |- skos__hiddenLabel mesh__D003176 Precursor Complement 3
% 216.27/216.48  |- skos__altLabel mesh__D003176 C3 Precursor
% 216.27/216.48  |- skos__historyNote mesh__D003176
% 216.27/216.48       Immune Adherence Reaction %28%1971-1974%29%
% 216.27/216.48  |- mesh__publicMeSHNote mesh__D003176
% 216.27/216.48       2006; see COMPLEMENT 3 1978-2005, see COMPLEMENT 1975-1977; COMPLEMENT C3 PRECURSOR was indexed under COMPLEMENT 3 1982-2005%A%  
% 216.27/216.48  |- skos__altLabel mesh__D003176 Complement 3
% 216.27/216.48  |- mesh__recordOriginator mesh__D003176 NLM
% 216.27/216.48  |- skos__altLabel mesh__D003176 Complement Component 3
% 216.27/216.48  |- skos__broader mesh__D003176smesh__D003165
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D003176 2006
% 216.27/216.48  |- skos__scopeNote mesh__D003176
% 216.27/216.48       A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase.%A%    
% 216.27/216.48  |- skos__hiddenLabel mesh__D003176 C3, Complement
% 216.27/216.48  |- skos__hiddenLabel mesh__D003176 Complement, C3
% 216.27/216.48  |- skos__hiddenLabel mesh__D003176 Precursor, Complement C3
% 216.27/216.48  |- skos__hiddenLabel mesh__D003176 Component 3, Complement
% 216.27/216.48  |- skos__altLabel mesh__D003176 C3 Complement
% 216.27/216.48  |- mesh__historyNote mesh__D003176 2006 %28%1975%29%   
% 216.27/216.48  |- mesh__recordMaintainer mesh__D003176 ags
% 216.27/216.48  |- mesh__recordAuthorizer mesh__D003176 ags
% 216.27/216.48  |- mesh__activeMeSHYear mesh__D003176 2006B
% 216.27/216.48  |- rdf__type mesh__D003176sskos__Concept
% 216.27/216.48  |- skos__historyNote mesh__D003176 Neutrophils %28%1966-1974%29%
% 216.27/216.48  |- skos__altLabel mesh__D003176 Precursor-Complement 3
% 216.27/216.48  |- mesh__dateEstablished mesh__D003176 1978-01-01
% 216.27/216.48  |- skos__hiddenLabel mesh__D003176 Precursor, C3
% 216.27/216.48  |- skos__prefLabel mesh__D003176 Complement C3
% 216.27/216.48  |- skos__historyNote mesh__D003176 Chemotaxis %28%1966-1974%29%
% 216.27/216.48  |- skos__hiddenLabel mesh__D003176 Pro Complement 3
% 216.27/216.48  |- skos__altLabel mesh__D003176 Pro-C3
% 216.27/216.48  |- skos__hiddenLabel mesh__D003176 Pro C3
% 216.27/216.48  |- skos__historyNote mesh__D003176 Anaphylaxis %28%1966-1974%29%
% 216.27/216.48  |- skos__broader mesh__D003176smesh__D000209
% 216.27/216.48  |- skos__hiddenLabel mesh__D003176 C3 Precursor, Complement
% 216.27/216.48  |- skos__historyNote mesh__D003176 Complement %28%1968-1974%29%
% 216.27/216.48  |- skos__altLabel mesh__D003176 Pro-Complement 3
% 216.27/216.48  |- skos__broader mesh__D007567smesh__D051556
% 216.27/216.48  |- mesh__recordOriginator mesh__D007567 NLM
% 216.27/216.49  |- skos__altLabel mesh__D007567 Neonatal Jaundice
% 216.27/216.49  |- skos__annotation mesh__D007567 check the tag INFANT, NEWBORN   
% 216.27/216.49  |- skos__scopeNote mesh__D007567
% 216.27/216.49       Yellow discoloration of the SKIN; MUCOUS MEMBRANE; and SCLERA in the NEWBORN. It is a sign of NEONATAL HYPERBILIRUBINEMIA. Most cases are transient self-limiting %28%PHYSIOLOGICAL NEONATAL JAUNDICE%29% occurring in the first week of life, but some can be a sign of pathological disorders, particularly LIVER DISEASES.%A%    
% 216.27/216.49  |- skos__altLabel mesh__D007567 Severe Jaundice in Neonate
% 216.27/216.49  |- mesh__activeMeSHYear mesh__D007567 2006
% 216.27/216.49  |- skos__related mesh__D007567smesh__D051556
% 216.27/216.49  |- skos__hiddenLabel mesh__D007567 Neonatal Jaundice, Physiological
% 216.27/216.49  |- mesh__recordMaintainer mesh__D007567 lkt
% 216.27/216.49  |- skos__altLabel mesh__D007567 Icterus Gravis Neonatorum
% 216.27/216.49  |- mesh__dateCreated mesh__D007567 1999-01-01
% 216.27/216.49  |- mesh__dateRevised mesh__D007567 2005-06-30
% 216.27/216.49  |- skos__related mesh__D007567smesh__D004899
% 216.27/216.49  |- mesh__recordAuthorizer mesh__D007567 sjn
% 216.27/216.49  |- skos__prefLabel mesh__D007567 Jaundice, Neonatal
% 216.27/216.49  |- mesh__publicMeSHNote mesh__D007567
% 216.27/216.49       1966; for ICTERUS GRAVIS NEONATORUM see ERYTHROBLASTOSIS FETAL 1975-2005%A%  
% 216.27/216.49  |- mesh__historyNote mesh__D007567
% 216.27/216.49       1966; for ICTERUS GRAVIS NEONATORUM use ERYTHROBLASTOSIS FETAL 1975-2005%A%  
% 216.27/216.49  |- rdf__type mesh__D007567sskos__Concept
% 216.27/216.49  |- skos__hiddenLabel mesh__D007567 Jaundice, Physiological Neonatal
% 216.27/216.49  |- mesh__historyNote mesh__D026721 2002   
% 216.27/216.49  |- mesh__recordMaintainer mesh__D026721 nns
% 216.34/216.49  |- mesh__dateEstablished mesh__D026721 2002-01-01
% 216.34/216.49  |- skos__broader mesh__D026721smesh__D012323
% 216.34/216.49  |- mesh__dateRevised mesh__D026721 2004-07-07
% 216.34/216.49  |- rdf__type mesh__D026721sskos__Concept
% 216.34/216.49  |- skos__prefLabel mesh__D026721 RNA 3%27% End Processing
% 216.34/216.49  |- mesh__recordOriginator mesh__D026721 nns
% 216.34/216.49  |- mesh__publicMeSHNote mesh__D026721 2002   
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D026721 2005
% 216.34/216.49  |- skos__altLabel mesh__D026721 3%27% End Processing, RNA
% 216.34/216.49  |- skos__scopeNote mesh__D026721
% 216.34/216.49       The steps that generate the 3%27% ends of mature RNA molecules. For most mRNAs %28%RNA, MESSENGER%29%, 3%27% end processing referred to as POLYADENYLATION includes the addition of POLY A.%A%    
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D026721 2006
% 216.34/216.49  |- mesh__recordAuthorizer mesh__D026721 sjn
% 216.34/216.49  |- mesh__dateCreated mesh__D026721 2001-07-25
% 216.34/216.49  |- skos__historyNote mesh__D026721
% 216.34/216.49       RNA Processing, Post-Transcriptional %28%1984-2001%29%
% 216.34/216.49  |- skos__historyNote mesh__D045686 Mycoplasma %28%1965-2003%29%
% 216.34/216.49  |- skos__annotation mesh__D045686
% 216.34/216.49       infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29%   
% 216.34/216.49  |- mesh__dateRevised mesh__D045686 2005-06-30
% 216.34/216.49  |- mesh__recordOriginator mesh__D045686 ags
% 216.34/216.49  |- skos__broader mesh__D045686smesh__D009174
% 216.34/216.49  |- mesh__recordMaintainer mesh__D045686 SYSTEM
% 216.34/216.49  |- skos__prefLabel mesh__D045686 Mycoplasma gallisepticum
% 216.34/216.49  |- mesh__dateCreated mesh__D045686 2003-07-09
% 216.34/216.49  |- skos__scopeNote mesh__D045686
% 216.34/216.49       A species of gram-negative bacteria causing chronic respiratory disease in POULTRY.%A%    
% 216.34/216.49  |- mesh__recordAuthorizer mesh__D045686 sjn
% 216.34/216.49  |- mesh__publicMeSHNote mesh__D045686 2004   
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D045686 2006
% 216.34/216.49  |- mesh__dateEstablished mesh__D045686 2004-01-01
% 216.34/216.49  |- rdf__type mesh__D045686sskos__Concept
% 216.34/216.49  |- mesh__historyNote mesh__D045686 2004   
% 216.34/216.49  |- rdf__type mesh__D012701sskos__Concept
% 216.34/216.49  |- mesh__onlineNote mesh__D012701
% 216.34/216.49       use SEROTONIN to search HYDROXYTRYPTAMINE 1975-92   
% 216.34/216.49  |- skos__altLabel mesh__D012701 Hippophaine
% 216.34/216.49  |- skos__annotation mesh__D012701
% 216.34/216.49       /antag = SEROTONIN ANTAGONISTS but consider also SEROTONIN UPTAKE INHIBITORS%A%  
% 216.34/216.49  |- skos__scopeNote mesh__D012701
% 216.34/216.49       A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families %28%RECEPTORS, SEROTONIN%29% explain the broad physiological actions and distribution of this biochemical mediator.%A%    
% 216.34/216.49  |- skos__prefLabel mesh__D012701 Serotonin
% 216.34/216.49  |- mesh__publicMeSHNote mesh__D012701
% 216.34/216.49       HYDROXYTRYPTAMINE was see SEROTONIN 1975-92   
% 216.34/216.49  |- mesh__historyNote mesh__D012701
% 216.34/216.49       HYDROXYTRYPTAMINE was see SEROTONIN 1975-92   
% 216.34/216.49  |- mesh__dateCreated mesh__D012701 1999-01-01
% 216.34/216.49  |- skos__altLabel mesh__D012701 5-Hydroxytryptamine
% 216.34/216.49  |- skos__altLabel mesh__D012701 5-HT
% 216.34/216.49  |- skos__broader mesh__D012701smesh__D012898
% 216.34/216.49  |- mesh__recordOriginator mesh__D012701 NLM
% 216.34/216.49  |- skos__altLabel mesh__D012701 3-%28%2-Aminoethyl%29%-1H-indol-5-ol
% 216.34/216.49  |- skos__hiddenLabel mesh__D012701 5 Hydroxytryptamine
% 216.34/216.49  |- mesh__recordAuthorizer mesh__D012701 sjn
% 216.34/216.49  |- skos__related mesh__D012701smesh__D018490
% 216.34/216.49  |- skos__altLabel mesh__D012701 Enteramine
% 216.34/216.49  |- mesh__dateRevised mesh__D012701 2005-06-30
% 216.34/216.49  |- skos__related mesh__D012701smesh__D011985
% 216.34/216.49  |- mesh__recordMaintainer mesh__D012701 ssb
% 216.34/216.49  |- skos__broader mesh__D012701smesh__D014363
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D012701 2006
% 216.34/216.49  |- mesh__historyNote mesh__D017995 94   
% 216.34/216.49  |- mesh__recordMaintainer mesh__D017995 ags
% 216.34/216.49  |- mesh__recordAuthorizer mesh__D017995 sjn
% 216.34/216.49  |- mesh__dateCreated mesh__D017995 1993-06-30
% 216.34/216.49  |- skos__hiddenLabel mesh__D017995 Ranaviruses
% 216.34/216.49  |- mesh__publicMeSHNote mesh__D017995 94   
% 216.34/216.49  |- skos__historyNote mesh__D017995 DNA Viruses %28%1966-1977%29%
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D017995 2004
% 216.34/216.49  |- mesh__recordOriginator mesh__D017995 AGS
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D017995 2006
% 216.34/216.49  |- skos__prefLabel mesh__D017995 Ranavirus
% 216.34/216.49  |- rdf__type mesh__D017995sskos__Concept
% 216.34/216.49  |- skos__scopeNote mesh__D017995
% 216.34/216.49       A genus of IRIDOVIRIDAE which infects amphibians. It is non-pathogenic for its natural host, Rana pipiens, but is lethal for tadpoles and Fowler toads. Frog virus 3 is the type species.%A%    
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D017995 2005
% 216.34/216.49  |- mesh__dateRevised mesh__D017995 2003-07-09
% 216.34/216.49  |- skos__broader mesh__D017995smesh__D007497
% 216.34/216.49  |- skos__hiddenLabel mesh__D017995 Frog Virus
% 216.34/216.49  |- skos__historyNote mesh__D017995 Iridoviridae %28%1977-1993%29%
% 216.34/216.49  |- skos__annotation mesh__D017995
% 216.34/216.49       infection: coord IM with DNA VIRUS INFECTIONS %28%IM%29%   
% 216.34/216.49  |- mesh__dateEstablished mesh__D017995 1994-01-01
% 216.34/216.49  |- skos__altLabel mesh__D017995 Frog Viruses
% 216.34/216.49  |- mesh__publicMeSHNote mesh__D031666 2003   
% 216.34/216.49  |- skos__annotation mesh__D031666
% 216.34/216.49       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.34/216.49  |- mesh__dateCreated mesh__D031666 2002-07-03
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D031666 2004
% 216.34/216.49  |- skos__scopeNote mesh__D031666
% 216.34/216.49       A plant genus of the family ONAGRACEAE. The common name of fireweed is also used with other plants.%A%    
% 216.34/216.49  |- skos__prefLabel mesh__D031666 Epilobium
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D031666 2006
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D031666 2003
% 216.34/216.49  |- skos__broader mesh__D031666smesh__D029594
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D031666 2005
% 216.34/216.49  |- mesh__historyNote mesh__D031666 2003   
% 216.34/216.49  |- rdf__type mesh__D031666sskos__Concept
% 216.34/216.49  |- mesh__dateEstablished mesh__D031666 2003-01-01
% 216.34/216.49  |- skos__altLabel mesh__D050820 Pou4f2 Transcription Factor
% 216.34/216.49  |- skos__hiddenLabel mesh__D050820 Transcription Factor, Pou4f2
% 216.34/216.49  |- mesh__dateEstablished mesh__D050820 2006-01-01
% 216.34/216.49  |- mesh__historyNote mesh__D050820 2006%28%1992%29%   
% 216.34/216.49  |- skos__hiddenLabel mesh__D050820 Brn 3B Transcription Factor
% 216.34/216.49  |- mesh__publicMeSHNote mesh__D050820
% 216.34/216.49       2006; TRANSCRIPTION FACTOR BRN-3B was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS %28%1992-2005%29%%A%  
% 216.34/216.49  |- mesh__recordMaintainer mesh__D050820 ags
% 216.34/216.49  |- mesh__dateRevised mesh__D050820 2005-08-03
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D050820 2006
% 216.34/216.49  |- mesh__recordOriginator mesh__D050820 DRC
% 216.34/216.49  |- mesh__dateCreated mesh__D050820 2005-06-30
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D050820 2006A
% 216.34/216.49  |- skos__altLabel mesh__D050820 Pou4f2 Protein
% 216.34/216.49  |- rdf__type mesh__D050820sskos__Concept
% 216.34/216.49  |- skos__altLabel mesh__D050820 Brn-3B Transcription Factor
% 216.34/216.49  |- skos__hiddenLabel mesh__D050820 Brn-3B, Transcription Factor
% 216.34/216.49  |- skos__prefLabel mesh__D050820 Transcription Factor Brn-3B
% 216.34/216.49  |- skos__altLabel mesh__D050820 POU Domain, Class 4, Transcription Factor 2
% 216.34/216.49  |- mesh__recordAuthorizer mesh__D050820 ags
% 216.34/216.49  |- skos__hiddenLabel mesh__D050820 Transcription Factor Brn 3B
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D050820 2006B
% 216.34/216.49  |- skos__hiddenLabel mesh__D050820 Transcription Factor, Brn-3B
% 216.34/216.49  |- skos__scopeNote mesh__D050820
% 216.34/216.49       A POU domain factor that represses GENETIC TRANSCRIPTION of GENES encoding NEUROFILAMENT PROTEINS, alpha internexin, and SYNAPTOSOMAL-ASSOCIATED PROTEIN 25.%A%    
% 216.34/216.49  |- skos__broader mesh__D050820smesh__D050818
% 216.34/216.49  |- mesh__dateRevised mesh__D003975 2003-07-09
% 216.34/216.49  |- rdf__type mesh__D003975sskos__Concept
% 216.34/216.49  |- skos__scopeNote mesh__D003975
% 216.34/216.49       A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. It is used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p589%29%%A%    
% 216.34/216.49  |- mesh__recordMaintainer mesh__D003975 ssb
% 216.34/216.49  |- mesh__publicMeSHNote mesh__D003975 65   
% 216.34/216.49  |- skos__altLabel mesh__D003975
% 216.34/216.49       7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D003975 2004
% 216.34/216.49  |- mesh__dateEstablished mesh__D003975 1965-01-01
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D003975 2005
% 216.34/216.49  |- mesh__dateCreated mesh__D003975 1999-01-01
% 216.34/216.49  |- mesh__recordOriginator mesh__D003975 NLM
% 216.34/216.49  |- skos__related mesh__D003975smesh__D011963
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D003975 2006
% 216.34/216.49  |- skos__broader mesh__D003975smesh__D001570
% 216.34/216.49  |- skos__prefLabel mesh__D003975 Diazepam
% 216.34/216.49  |- mesh__recordAuthorizer mesh__D003975 sjn
% 216.34/216.49  |- mesh__historyNote mesh__D003975 65%28%63%29%   
% 216.34/216.49  |- skos__historyNote mesh__D011609 Galactose %28%1972-1974%29%
% 216.34/216.49  |- skos__hiddenLabel mesh__D011609 Galactoside, Sphingosine
% 216.34/216.49  |- mesh__publicMeSHNote mesh__D011609
% 216.34/216.49       91; was see under SPHINGOSINE 1975-90   
% 216.34/216.49  |- skos__historyNote mesh__D011609 Sphingosine %28%1972-1974%29%
% 216.34/216.49  |- mesh__recordMaintainer mesh__D011609 ssb
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D011609 2005
% 216.34/216.49  |- mesh__dateEstablished mesh__D011609 1991-01-01
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D011609 2006
% 216.34/216.49  |- skos__broader mesh__D011609smesh__D013110
% 216.34/216.49  |- skos__broader mesh__D011609smesh__D006028
% 216.34/216.49  |- mesh__dateCreated mesh__D011609 1974-11-19
% 216.34/216.49  |- mesh__recordOriginator mesh__D011609 NLM
% 216.34/216.49  |- skos__prefLabel mesh__D011609 Psychosine
% 216.34/216.49  |- mesh__historyNote mesh__D011609
% 216.34/216.49       91%28%75%29%; was see under SPHINGOSINE 1975-90   
% 216.34/216.49  |- skos__altLabel mesh__D011609 Galactosylsphingosine
% 216.34/216.49  |- skos__historyNote mesh__D011609 Glycosides %28%1974%29%
% 216.34/216.49  |- rdf__type mesh__D011609sskos__Concept
% 216.34/216.49  |- skos__scopeNote mesh__D011609
% 216.34/216.49       An intermediate in the biosynthesis of cerebrosides. It is formed by reaction of sphingosine with UDP-galactose and then itself reacts with fatty acid-Coenzyme A to form the cerebroside.%A%    
% 216.34/216.49  |- skos__altLabel mesh__D011609 Sphingosine Galactoside
% 216.34/216.49  |- mesh__dateRevised mesh__D011609 2004-07-07
% 216.34/216.49  |- mesh__recordAuthorizer mesh__D011609 sjn
% 216.34/216.49  |- mesh__dateRevised mesh__D008660 2005-07-08
% 216.34/216.49  |- mesh__recordMaintainer mesh__D008660 ags
% 216.34/216.49  |- skos__altLabel mesh__D008660 Process, Metabolic
% 216.34/216.49  |- skos__altLabel mesh__D008660 Metabolic Processes
% 216.34/216.49  |- mesh__publicMeSHNote mesh__D008660
% 216.34/216.49       TISSUE METABOLISM was heading 1963-65   
% 216.34/216.49  |- mesh__historyNote mesh__D008660
% 216.34/216.49       METABOLIC PROCESSES was NON MESH 1992-97; TISSUE METABOLISM was heading 1963-65%A%  
% 216.34/216.49  |- skos__broader mesh__D008660smesh__D001670
% 216.34/216.49  |- skos__scopeNote mesh__D008660
% 216.34/216.49       The sum of chemical changes that occur within the tissues of an organism consisting of anabolism %28%biosysthesis%29% and catabolism; the buildup and breakdown of molecules for utilization by the body.%A%    
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D008660 2006
% 216.34/216.49  |- skos__annotation mesh__D008660
% 216.34/216.49       GEN only as the metabolic process irrespective of substance; prefer /metab with organs, organisms, diseases, substances: Manual 19.7+, 19.8.44, 19.10+; DF: METAB%A%  
% 216.34/216.49  |- mesh__recordOriginator mesh__D008660 NLM
% 216.34/216.49  |- skos__altLabel mesh__D008660 Metabolic Process
% 216.34/216.49  |- mesh__dateCreated mesh__D008660 1999-01-01
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D008660 2006A
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D008660 2005
% 216.34/216.49  |- skos__altLabel mesh__D008660 Processes, Metabolic
% 216.34/216.49  |- skos__prefLabel mesh__D008660 Metabolism
% 216.34/216.49  |- mesh__recordAuthorizer mesh__D008660 ags
% 216.34/216.49  |- rdf__type mesh__D008660sskos__Concept
% 216.34/216.49  |- mesh__recordMaintainer mesh__D007568 KEV
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D007568 2006
% 216.34/216.49  |- skos__broader mesh__D007568smesh__D013284
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D007568 2002
% 216.34/216.49  |- skos__related mesh__D007568smesh__D013704
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D007568 2004
% 216.34/216.49  |- mesh__recordOriginator mesh__D007568 NLM
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D007568 2005
% 216.34/216.49  |- mesh__dateCreated mesh__D007568 1999-01-01
% 216.34/216.49  |- skos__scopeNote mesh__D007568
% 216.34/216.49       Bony structure of the mouth that holds the teeth. It consists of the MANDIBLE and the MAXILLA.%A%    
% 216.34/216.49  |- skos__broader mesh__D007568smesh__D005147
% 216.34/216.49  |- mesh__dateRevised mesh__D007568 1999-11-03
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D007568 2003
% 216.34/216.49  |- skos__hiddenLabel mesh__D007568 Jaws
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D007568 2001
% 216.34/216.49  |- rdf__type mesh__D007568sskos__Concept
% 216.34/216.49  |- mesh__historyNote mesh__D007568 65; was JAWS 1963-64   
% 216.34/216.49  |- mesh__publicMeSHNote mesh__D007568 65; was JAWS 1963-64   
% 216.34/216.49  |- skos__annotation mesh__D007568
% 216.34/216.49       /injuries: TN 115; upper jaw = MAXILLA; lower jaw = MANDIBLE; French %22%maxillaires%22% usually means jaws not necessarily maxilla%A%  
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D007568 2000
% 216.34/216.49  |- skos__related mesh__D007568smesh__D003724
% 216.34/216.49  |- mesh__considerAlso mesh__D007568
% 216.34/216.49       consider also terms at MANDIB- and MAXILL-   
% 216.34/216.49  |- mesh__recordAuthorizer mesh__D007568 sjn
% 216.34/216.49  |- mesh__dateEstablished mesh__D007568 1965-01-01
% 216.34/216.49  |- skos__prefLabel mesh__D007568 Jaw
% 216.34/216.49  |- skos__hiddenLabel mesh__D018290 Cervical Intraepithelial Neoplasm
% 216.34/216.49  |- skos__historyNote mesh__D018290 Carcinoma in Situ %28%1973-1993%29%
% 216.34/216.49  |- skos__historyNote mesh__D018290 Cervix Dysplasia %28%1977-1993%29%
% 216.34/216.49  |- skos__altLabel mesh__D018290 Cervical Intraepithelial Neoplasms
% 216.34/216.49  |- skos__hiddenLabel mesh__D018290 Intraepithelial Neoplasms, Cervical
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D018290 2006
% 216.34/216.49  |- skos__altLabel mesh__D018290 Neoplasia, Cervical Intraepithelial
% 216.34/216.49  |- mesh__historyNote mesh__D018290 94   
% 216.34/216.49  |- mesh__dateCreated mesh__D018290 1993-06-25
% 216.34/216.49  |- skos__broader mesh__D018290smesh__D002278
% 216.34/216.49  |- rdf__type mesh__D018290sskos__Concept
% 216.34/216.49  |- skos__annotation mesh__D018290
% 216.34/216.49       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with UTERINE CERVICAL NEOPLASMS %28%IM%29%; DF: CIN%A%  
% 216.34/216.49  |- skos__hiddenLabel mesh__D018290 Neoplasms, Cervical Intraepithelial
% 216.34/216.49  |- skos__historyNote mesh__D018290 Cervix Neoplasms %28%1966-1993%29%
% 216.34/216.49  |- mesh__dateEstablished mesh__D018290 1994-01-01
% 216.34/216.49  |- mesh__recordAuthorizer mesh__D018290 sjn
% 216.34/216.49  |- skos__scopeNote mesh__D018290
% 216.34/216.49       A malignancy arising in uterine cervical epithelium and confined thereto, representing a continuum of histological changes ranging from well-differentiated CIN 1 %28%formerly, mild dysplasia%29% to severe dysplasia/carcinoma in situ, CIN 3. The lesion arises at the squamocolumnar cell junction at the transformation zone of the endocervical canal, with a variable tendency to develop invasive epidermoid carcinoma, a tendency that is enhanced by concomitant human papillomaviral infection. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 216.34/216.49  |- mesh__dateRevised mesh__D018290 2005-07-01
% 216.34/216.49  |- skos__related mesh__D018290smesh__D002578
% 216.34/216.49  |- skos__hiddenLabel mesh__D018290 Intraepithelial Neoplasm, Cervical
% 216.34/216.49  |- mesh__publicMeSHNote mesh__D018290 94   
% 216.34/216.49  |- skos__related mesh__D018290smesh__D002583
% 216.34/216.49  |- skos__hiddenLabel mesh__D018290 Neoplasm, Cervical Intraepithelial
% 216.34/216.49  |- mesh__recordMaintainer mesh__D018290 sjn
% 216.34/216.49  |- skos__altLabel mesh__D018290 Intraepithelial Neoplasia, Cervical
% 216.34/216.49  |- skos__historyNote mesh__D018290
% 216.34/216.49       Carcinoma, Squamous Cell %28%1966-1993%29%
% 216.34/216.49  |- skos__prefLabel mesh__D018290 Cervical Intraepithelial Neoplasia
% 216.34/216.49  |- mesh__recordOriginator mesh__D018290 PLS
% 216.34/216.49  |- skos__altLabel mesh__D004270 Circular DNA
% 216.34/216.49  |- mesh__historyNote mesh__D004270 74%28%73%29%   
% 216.34/216.49  |- mesh__recordMaintainer mesh__D004270 nns
% 216.34/216.49  |- mesh__recordOriginator mesh__D004270 NLM
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D004270 2006
% 216.34/216.49  |- skos__annotation mesh__D004270 IM; /drug eff /ultrastruct permitted   
% 216.34/216.49  |- mesh__dateEstablished mesh__D004270 1974-01-01
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D004270 2005
% 216.34/216.49  |- mesh__recordAuthorizer mesh__D004270 sjn
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D004270 2004
% 216.34/216.49  |- mesh__dateCreated mesh__D004270 1999-01-01
% 216.34/216.49  |- skos__broader mesh__D004270smesh__D004247
% 216.34/216.49  |- mesh__dateRevised mesh__D004270 2003-07-09
% 216.34/216.49  |- rdf__type mesh__D004270sskos__Concept
% 216.34/216.49  |- mesh__publicMeSHNote mesh__D004270 74   
% 216.34/216.49  |- skos__prefLabel mesh__D004270 DNA, Circular
% 216.34/216.49  |- skos__scopeNote mesh__D004270
% 216.34/216.49       Any of the covalently closed DNA molecules found in bacteria, many viruses, mitochondria, plastids, and plasmids. Small, polydisperse circular DNA%27%s have also been observed in a number of eukaryotic organisms and are suggested to have homology with chromosomal DNA and the capacity to be inserted into, and excised from, chromosomal DNA. It is a fragment of DNA formed by a process of looping out and deletion, containing a constant region of the mu heavy chain and the 3%27%-part of the mu switch region. Circular DNA is a normal product of rearrangement among gene segments encoding the variable regions of immunoglobulin light and heavy chains, as well as the T-cell receptor. %28%Riger et al., Glossary of Genetics, 5th ed %26% Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 216.34/216.49  |- skos__historyNote mesh__D004270 DNA %28%1966-1972%29%
% 216.34/216.49  |- mesh__recordMaintainer mesh__D012702 ssb
% 216.34/216.49  |- skos__scopeNote mesh__D012702
% 216.34/216.49       Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonin agonists.%A%    
% 216.34/216.49  |- skos__hiddenLabel mesh__D012702 Antagonists, 5 HT
% 216.34/216.49  |- skos__hiddenLabel mesh__D012702 Agents, Antiserotonergic
% 216.34/216.49  |- mesh__publicMeSHNote mesh__D012702 78,64-67   
% 216.34/216.49  |- skos__altLabel mesh__D012702 5-Hydroxytryptamine Antagonists
% 216.34/216.49  |- skos__hiddenLabel mesh__D012702 5 HT Antagonists
% 216.34/216.49  |- skos__altLabel mesh__D012702 Antagonists, 5-HT
% 216.34/216.49  |- skos__annotation mesh__D012702
% 216.34/216.49       GEN or unspecified; prefer specifics; differentiate from SEROTONIN UPTAKE INHIBITORS: read MeSH definition; do not confuse with SEROTONIN AGONISTS; DF: SEROTONIN ANTAG%A%  
% 216.34/216.49  |- skos__altLabel mesh__D012702 5-HT Antagonists
% 216.34/216.49  |- skos__broader mesh__D012702smesh__D018490
% 216.34/216.49  |- skos__hiddenLabel mesh__D012702 Antagonists, 5 Hydroxytryptamine
% 216.34/216.49  |- skos__historyNote mesh__D012702
% 216.34/216.49       Serotonin/antagonists %26% inhibitors %28%1968-1977%29%
% 216.34/216.49  |- skos__hiddenLabel mesh__D012702 5 Hydroxytryptamine Antagonists
% 216.34/216.49  |- skos__altLabel mesh__D012702 Antiserotonergic Agents
% 216.34/216.49  |- skos__historyNote mesh__D012702 Serotonin %28%1966-1967%29%
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D012702 2006
% 216.34/216.49  |- mesh__dateEstablished mesh__D012702 1978-01-01
% 216.34/216.49  |- mesh__recordOriginator mesh__D012702 SH
% 216.34/216.49  |- mesh__recordAuthorizer mesh__D012702 sjn
% 216.34/216.49  |- skos__related mesh__D012702smesh__D017367
% 216.34/216.49  |- mesh__dateCreated mesh__D012702 1977-04-22
% 216.34/216.49  |- skos__altLabel mesh__D012702 Antagonists, 5-Hydroxytryptamine
% 216.34/216.49  |- rdf__type mesh__D012702sskos__Concept
% 216.34/216.49  |- mesh__dateRevised mesh__D012702 2005-06-30
% 216.34/216.49  |- mesh__historyNote mesh__D012702 78,64-67   
% 216.34/216.49  |- skos__hiddenLabel mesh__D012702 Blockaders, Serotonin
% 216.34/216.49  |- mesh__onlineNote mesh__D012702
% 216.34/216.49       search SEROTONIN /antagonists %26% inhibitors 1968-77 %26% SEROTONIN 1966-67%A%  
% 216.34/216.49  |- skos__altLabel mesh__D012702 Antagonists, Serotonin
% 216.34/216.49  |- skos__altLabel mesh__D012702 Serotonin Blockaders
% 216.34/216.49  |- skos__prefLabel mesh__D012702 Serotonin Antagonists
% 216.34/216.49  |- skos__broader mesh__D017996smesh__D011212
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D017996 2003
% 216.34/216.49  |- rdf__type mesh__D017996sskos__Concept
% 216.34/216.49  |- skos__scopeNote mesh__D017996
% 216.34/216.49       A subfamily of POXVIRIDAE comprising poxviruses infecting insects including members of COLEOPTERA; DIPTERA; LEPIDOPTERA; and ORTHOPTERA.%A%    
% 216.34/216.49  |- skos__annotation mesh__D017996
% 216.34/216.49       coord IM with specific insect /virol %28%IM%29%   
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D017996 2005
% 216.34/216.49  |- skos__historyNote mesh__D017996 Poxviridae %28%1966-1993%29%
% 216.34/216.49  |- skos__prefLabel mesh__D017996 Entomopoxvirinae
% 216.34/216.49  |- skos__broader mesh__D017996smesh__D007304
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D017996 2002
% 216.34/216.49  |- mesh__dateCreated mesh__D017996 1993-06-04
% 216.34/216.49  |- skos__altLabel mesh__D017996 Entomopoxviruses
% 216.34/216.49  |- skos__hiddenLabel mesh__D017996 Entomopoxvirus
% 216.34/216.49  |- mesh__publicMeSHNote mesh__D017996 94   
% 216.34/216.49  |- mesh__historyNote mesh__D017996 94   
% 216.34/216.49  |- mesh__dateRevised mesh__D017996 2005-07-12
% 216.34/216.49  |- mesh__recordOriginator mesh__D017996 AGS
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D017996 2006A
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D017996 2004
% 216.34/216.49  |- mesh__recordAuthorizer mesh__D017996 ags
% 216.34/216.49  |- mesh__recordMaintainer mesh__D017996 ags
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D017996 2006
% 216.34/216.49  |- mesh__dateEstablished mesh__D017996 1994-01-01
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D031667 2006
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D031667 2003
% 216.34/216.49  |- skos__prefLabel mesh__D031667 Dendrobium
% 216.34/216.49  |- mesh__dateCreated mesh__D031667 2002-07-03
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D031667 2005
% 216.34/216.49  |- rdf__type mesh__D031667sskos__Concept
% 216.34/216.49  |- skos__scopeNote mesh__D031667
% 216.34/216.49       A plant genus of the family ORCHIDACEAE that contains dihydroayapin %28%COUMARINS%29% and phenanthraquinones.%A%    
% 216.34/216.49  |- skos__broader mesh__D031667smesh__D029595
% 216.34/216.49  |- mesh__historyNote mesh__D031667 2003   
% 216.34/216.49  |- mesh__publicMeSHNote mesh__D031667 2003   
% 216.34/216.49  |- skos__annotation mesh__D031667
% 216.34/216.49       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.34/216.49  |- mesh__dateEstablished mesh__D031667 2003-01-01
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D031667 2004
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D050821 2006B
% 216.34/216.49  |- mesh__recordOriginator mesh__D050821 DRC
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D050821 2006
% 216.34/216.49  |- mesh__historyNote mesh__D050821 2006   
% 216.34/216.49  |- skos__scopeNote mesh__D050821
% 216.34/216.49       A POU domain factor that activates neuronal cell GENETIC TRANSCRIPTION of GENES encoding NEUROFILAMENT PROTEINS, alpha internexin, and SYNAPTOSOMAL-ASSOCIATED PROTEIN 25. Mutations in the Brn-3c gene have been associated with DEAFNESS.%A%    
% 216.34/216.49  |- mesh__recordMaintainer mesh__D050821 ags
% 216.34/216.49  |- skos__broader mesh__D050821smesh__D050818
% 216.34/216.49  |- rdf__type mesh__D050821sskos__Concept
% 216.34/216.49  |- mesh__dateEstablished mesh__D050821 2006-01-01
% 216.34/216.49  |- mesh__recordAuthorizer mesh__D050821 ags
% 216.34/216.49  |- mesh__dateCreated mesh__D050821 2005-06-30
% 216.34/216.49  |- mesh__dateRevised mesh__D050821 2005-08-03
% 216.34/216.49  |- skos__hiddenLabel mesh__D050821 Brn-3C, Transcription Factor
% 216.34/216.49  |- skos__altLabel mesh__D050821 Brn-3c Transcription Factor
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D050821 2006A
% 216.34/216.49  |- skos__hiddenLabel mesh__D050821 Brn 3c Transcription Factor
% 216.34/216.49  |- skos__prefLabel mesh__D050821 Transcription Factor Brn-3C
% 216.34/216.49  |- skos__hiddenLabel mesh__D050821 Transcription Factor, Pou4f3
% 216.34/216.49  |- skos__hiddenLabel mesh__D050821 Transcription Factor Brn 3C
% 216.34/216.49  |- skos__altLabel mesh__D050821 POU Domain, Class 4, Transcription Factor 3
% 216.34/216.49  |- skos__altLabel mesh__D050821 Pou4f3 Transcription Factor
% 216.34/216.49  |- skos__hiddenLabel mesh__D050821 Transcription Factor, Brn-3c
% 216.34/216.49  |- mesh__publicMeSHNote mesh__D050821
% 216.34/216.49       2006; TRANSCRIPTION FACTOR BRN-3C was indexed under TRANSCRIPTION FACTORS %26% DNA-BINDING PROTEINS 1992-2005%A%  
% 216.34/216.49  |- mesh__activeMeSHYear mesh__D003976 2006
% 216.34/216.49  |- mesh__recordOriginator mesh__D003976 NLM
% 216.34/216.49  |- skos__annotation mesh__D003976 TN 111 for eff on insects   
% 216.34/216.49  |- mesh__historyNote mesh__D003976
% 216.34/216.49       91%28%75%29%; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1975-90%A%  
% 216.34/216.49  |- skos__scopeNote mesh__D003976
% 216.34/216.49       A cholinesterase inhibitor that is used as an organothiophosphorus insecticide.%A%    
% 216.34/216.49  |- mesh__recordMaintainer mesh__D003976 ssb
% 216.34/216.49  |- skos__broader mesh__D003976smesh__D009946
% 216.34/216.49  |- mesh__recordAuthorizer mesh__D003976 sjn
% 216.34/216.49  |- mesh__publicMeSHNote mesh__D003976
% 216.34/216.49       91; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1975-90%A%  
% 216.34/216.49  |- rdf__type mesh__D003976sskos__Concept
% 216.34/216.49  |- skos__altLabel mesh__D003976 Dimpylate
% 216.34/216.49  |- mesh__dateEstablished mesh__D003976 1991-01-01
% 216.34/216.49  |- mesh__dateRevised mesh__D003976 2005-06-30
% 216.34/216.49  |- skos__historyNote mesh__D003976 Pyrimidines %28%1973-1974%29%
% 216.34/216.49  |- skos__prefLabel mesh__D003976 Diazinon
% 216.34/216.49  |- mesh__dateCreated mesh__D003976 1974-11-11
% 216.34/216.49  |- skos__historyNote mesh__D003976
% 216.34/216.49       Insecticides, Organothiophosphate %28%1973-1974%29%
% 216.34/216.49  |- skos__altLabel mesh__D003976 Neotsidol
% 216.34/216.49  |- skos__altLabel mesh__D003178 C 3 Nephritic Factor
% 216.34/216.49  |- mesh__dateRevised mesh__D003178 2005-06-30
% 216.34/216.49  |- mesh__dateEstablished mesh__D003178 1991-01-01
% 216.34/216.50  |- rdf__type mesh__D003178sskos__Concept
% 216.34/216.50  |- mesh__recordOriginator mesh__D003178 RLS
% 216.34/216.50  |- skos__altLabel mesh__D003178 C3 Nephritic Factor
% 216.34/216.50  |- skos__broader mesh__D003178smesh__D003169
% 216.34/216.50  |- mesh__recordAuthorizer mesh__D003178 sjn
% 216.34/216.50  |- mesh__dateCreated mesh__D003178 1977-05-20
% 216.34/216.50  |- mesh__historyNote mesh__D003178 2006 %28%1978%29%   
% 216.34/216.50  |- mesh__recordMaintainer mesh__D003178 lkt
% 216.34/216.50  |- skos__scopeNote mesh__D003178
% 216.34/216.50       An IgG autoantibody against the ALTERNATIVE COMPLEMENT C3 CONVERTASE %28%C3bBb%29%, found in serum of patients with MESANGIOCAPILLARY GLOMERULONEPHRITIS. The binding of this autoantibody to C3bBb stabilizes the enzyme thus reduces the actions of C3b inactivators %28%COMPLEMENT FACTOR H; COMPLEMENT FACTOR I%29%. This abnormally stabilized enzyme induces a continuous COMPLEMENT ACTIVATION and generation of C3b thereby promoting the assembly of MEMBRANE ATTACK COMPLEX and cytolysis.%A%    
% 216.34/216.50  |- skos__historyNote mesh__D003178 Blood Proteins %28%1966-1977%29%
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D003178 2006
% 216.34/216.50  |- skos__broader mesh__D003178smesh__D001323
% 216.34/216.50  |- mesh__publicMeSHNote mesh__D003178
% 216.34/216.50       2006; see COMPLEMENT 3 NEPHRITIC FACTOR 1991-2005, see COMPLEMENT INACTIVATORS 1978-1990%A%  
% 216.34/216.50  |- skos__prefLabel mesh__D003178 Complement C3 Nephritic Factor
% 216.34/216.50  |- skos__altLabel mesh__D003178 Complement 3 Nephritic Factor
% 216.34/216.50  |- skos__historyNote mesh__D003178 Complement 3 %28%1975-1977%29%
% 216.34/216.50  |- skos__hiddenLabel mesh__D008661 Metabolism Inborn Errors
% 216.34/216.50  |- skos__hiddenLabel mesh__D008661 Errors, Inborn Metabolism
% 216.34/216.50  |- mesh__recordAuthorizer mesh__D008661 sjn
% 216.34/216.50  |- skos__annotation mesh__D008661
% 216.34/216.50       GEN: prefer specific types; differentiate from DEFICIENCY DISEASES; DF: METAB INBORN ERR%A%  
% 216.34/216.50  |- skos__hiddenLabel mesh__D008661 Errors Metabolisms, Inborn
% 216.34/216.50  |- skos__hiddenLabel mesh__D008661 Inborn Errors Metabolisms
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D008661 2006
% 216.34/216.50  |- skos__hiddenLabel mesh__D008661 Error, Inborn Metabolism
% 216.34/216.50  |- mesh__publicMeSHNote mesh__D008661 65   
% 216.34/216.50  |- skos__altLabel mesh__D008661 Metabolism Errors, Inborn
% 216.34/216.50  |- mesh__dateCreated mesh__D008661 1999-01-01
% 216.34/216.50  |- skos__broader mesh__D008661smesh__D030342
% 216.34/216.50  |- skos__hiddenLabel mesh__D008661 Metabolisms, Inborn Errors
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D008661 2005
% 216.34/216.50  |- skos__hiddenLabel mesh__D008661 Inborn Errors Metabolism
% 216.34/216.50  |- mesh__dateRevised mesh__D008661 2001-07-25
% 216.34/216.50  |- skos__scopeNote mesh__D008661
% 216.34/216.50       Errors in metabolic processes resulting from inborn genetic mutations that are inherited or acquired in utero.%A%    
% 216.34/216.50  |- skos__hiddenLabel mesh__D008661 Inborn Metabolism Errors
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D008661 2002
% 216.34/216.50  |- skos__hiddenLabel mesh__D008661 Errors Metabolism, Inborn
% 216.34/216.50  |- skos__hiddenLabel mesh__D008661 Metabolism Inborn Error
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D008661 2004
% 216.34/216.50  |- skos__hiddenLabel mesh__D008661 Inborn Metabolism Error
% 216.34/216.50  |- skos__altLabel mesh__D008661 Inborn Errors of Metabolism
% 216.34/216.50  |- skos__hiddenLabel mesh__D008661 Metabolism Error, Inborn
% 216.34/216.50  |- rdf__type mesh__D008661sskos__Concept
% 216.34/216.50  |- mesh__recordOriginator mesh__D008661 NLM
% 216.34/216.50  |- mesh__dateEstablished mesh__D008661 1965-01-01
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D008661 2003
% 216.34/216.50  |- skos__prefLabel mesh__D008661 Metabolism, Inborn Errors
% 216.34/216.50  |- mesh__recordMaintainer mesh__D008661 nns
% 216.34/216.50  |- skos__broader mesh__D008661smesh__D008659
% 216.34/216.50  |- mesh__historyNote mesh__D008661 65   
% 216.34/216.50  |- mesh__dateEstablished mesh__D007569 1966-01-01
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D007569 2003
% 216.34/216.50  |- mesh__recordMaintainer mesh__D007569 kle
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D007569 2000
% 216.34/216.50  |- skos__scopeNote mesh__D007569
% 216.34/216.50       Congenital absence of or defects in structures of the jaw.%A%    
% 216.34/216.50  |- mesh__dateCreated mesh__D007569 1977-12-07
% 216.34/216.50  |- rdf__type mesh__D007569sskos__Concept
% 216.34/216.50  |- mesh__recordAuthorizer mesh__D007569 sjn
% 216.34/216.50  |- mesh__publicMeSHNote mesh__D007569 66   
% 216.34/216.50  |- skos__altLabel mesh__D007569 Abnormalities, Jaw
% 216.34/216.50  |- skos__broader mesh__D007569smesh__D007571
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D007569 2002
% 216.34/216.50  |- skos__hiddenLabel mesh__D007569 Jaw Abnormality
% 216.34/216.50  |- mesh__dateRevised mesh__D007569 1999-11-03
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D007569 2006
% 216.34/216.50  |- mesh__recordOriginator mesh__D007569 AEP
% 216.34/216.50  |- skos__annotation mesh__D007569
% 216.34/216.50       GEN only: prefer specifics: MAXILLA /abnorm or MANDIBLE /abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 216.34/216.50  |- skos__hiddenLabel mesh__D007569 Abnormality, Jaw
% 216.34/216.50  |- mesh__historyNote mesh__D007569 66   
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D007569 2004
% 216.34/216.50  |- skos__broader mesh__D007569smesh__D019767
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D007569 2005
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D007569 2001
% 216.34/216.50  |- skos__prefLabel mesh__D007569 Jaw Abnormalities
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D018291 2004
% 216.34/216.50  |- mesh__dateRevised mesh__D018291 1999-11-03
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D018291 2006
% 216.34/216.50  |- skos__scopeNote mesh__D018291
% 216.34/216.50       A multilocular tumor with mucin secreting epithelium. They are most often found in the ovary, but are also found in the pancreas, appendix, and rarely, retroperitoneal and in the urinary bladder. They are considered to have low-grade malignant potential.%A%    
% 216.34/216.50  |- skos__hiddenLabel mesh__D018291 Mucinous Cystadenoma
% 216.34/216.50  |- skos__prefLabel mesh__D018291 Cystadenoma, Mucinous
% 216.34/216.50  |- skos__hiddenLabel mesh__D018291 Mucinous Cystadenomas
% 216.34/216.50  |- skos__hiddenLabel mesh__D018291 Cystadenomas, Mucinous
% 216.34/216.50  |- rdf__type mesh__D018291sskos__Concept
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D018291 2000
% 216.34/216.50  |- mesh__publicMeSHNote mesh__D018291 94, 63-81   
% 216.34/216.50  |- mesh__historyNote mesh__D018291 94, 63-81   
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D018291 2001
% 216.34/216.50  |- mesh__dateEstablished mesh__D018291 1994-01-01
% 216.34/216.50  |- skos__historyNote mesh__D018291 Cystadenoma %28%1966-1993%29%
% 216.34/216.50  |- skos__broader mesh__D018291smesh__D003537
% 216.34/216.50  |- mesh__dateCreated mesh__D018291 1993-06-25
% 216.34/216.50  |- skos__annotation mesh__D018291
% 216.34/216.50       coord IM with OVARIAN NEOPLASMS %28%IM%29% or other organ/neoplasm term %28%IM%29% if applicable%A%  
% 216.34/216.50  |- mesh__recordMaintainer mesh__D018291 KEV
% 216.34/216.50  |- mesh__onlineNote mesh__D018291
% 216.34/216.50       use CYSTADENOMA to search CYSTADENOMA, MUCINOUS 1966-93   
% 216.34/216.50  |- mesh__recordAuthorizer mesh__D018291 sjn
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D018291 2003
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D018291 2002
% 216.34/216.50  |- mesh__recordOriginator mesh__D018291 PLS
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D018291 2005
% 216.34/216.50  |- mesh__dateRevised mesh__D026723 2005-07-27
% 216.34/216.50  |- skos__prefLabel mesh__D026723 Polyadenylation
% 216.34/216.50  |- mesh__recordMaintainer mesh__D026723 ags
% 216.34/216.50  |- skos__hiddenLabel mesh__D026723 Polyadenylations
% 216.34/216.50  |- mesh__recordOriginator mesh__D026723 nns
% 216.34/216.50  |- mesh__dateCreated mesh__D026723 2001-07-25
% 216.34/216.50  |- mesh__recordAuthorizer mesh__D026723 ags
% 216.34/216.50  |- skos__historyNote mesh__D026723
% 216.34/216.50       RNA, Messenger/metabolism %28%1974-2001%29%
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D026723 2006A
% 216.34/216.50  |- mesh__historyNote mesh__D026723 2002   
% 216.34/216.50  |- skos__broader mesh__D026723smesh__D026721
% 216.34/216.50  |- mesh__publicMeSHNote mesh__D026723 2002   
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D026723 2005
% 216.34/216.50  |- skos__scopeNote mesh__D026723
% 216.34/216.50       The addition of a tail of polyadenylic acid %28%POLY A%29% to the 3%27% end of mRNA %28%RNA, MESSENGER%29%. Polyadenylation involves recognizing the processing site signal, %28%AAUAAA%29%, and cleaving of the mRNA to create a 3%27% OH terminal end to which poly A polymerase %28%POLYNUCLEOTIDE ADENYLYTRANSFERASE%29% adds 60-200 adenylate residues. The 3%27% end processing of some messenger RNAs, such as histone mRNA, is carried out by a different process that does not include the addition of poly A as described here.%A%    
% 216.34/216.50  |- mesh__dateEstablished mesh__D026723 2002-01-01
% 216.34/216.50  |- skos__historyNote mesh__D026723 Poly A/metabolism %28%1975-2001%29%
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D026723 2006
% 216.34/216.50  |- rdf__type mesh__D026723sskos__Concept
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D004271 2005
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D004271 1998
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D004271 2004
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D004271 1997
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D004271 2002
% 216.34/216.50  |- mesh__recordMaintainer mesh__D004271 KEV
% 216.34/216.50  |- skos__altLabel mesh__D004271 Fungal DNA
% 216.34/216.50  |- mesh__publicMeSHNote mesh__D004271 80   
% 216.34/216.50  |- mesh__historyNote mesh__D004271 80   
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D004271 2003
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D004271 1996
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D004271 2001
% 216.34/216.50  |- skos__broader mesh__D004271smesh__D004247
% 216.34/216.50  |- rdf__type mesh__D004271sskos__Concept
% 216.34/216.50  |- skos__scopeNote mesh__D004271
% 216.34/216.50       Deoxyribonucleic acid that makes up the genetic material of fungi.%A%    
% 216.34/216.50  |- skos__annotation mesh__D004271
% 216.34/216.50       IM; coord with specific fungus %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 216.34/216.50  |- mesh__dateEstablished mesh__D004271 1980-01-01
% 216.34/216.50  |- skos__prefLabel mesh__D004271 DNA, Fungal
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D004271 2000
% 216.34/216.50  |- mesh__recordOriginator mesh__D004271 RLS
% 216.34/216.50  |- mesh__dateCreated mesh__D004271 1979-05-23
% 216.34/216.50  |- mesh__recordAuthorizer mesh__D004271 PLS
% 216.34/216.50  |- skos__historyNote mesh__D004271 DNA %28%1966-1979%29%
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D004271 2006
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D004271 1999
% 216.34/216.50  |- mesh__dateRevised mesh__D004271 1995-06-08
% 216.34/216.50  |- skos__broader mesh__D012703smesh__D015373
% 216.34/216.50  |- skos__annotation mesh__D012703
% 216.34/216.50       restrict to classification of micro-organisms: do not use for blood typing %28% = BLOOD GROUPING AND CROSSMATCHING%29%; NIM; coord with organism /class, not /immunol%A%  
% 216.34/216.50  |- skos__historyNote mesh__D012703
% 216.34/216.50       Bacteriological Techniques %28%1966-1967%29%
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D012703 2005
% 216.34/216.50  |- mesh__recordAuthorizer mesh__D012703 sjn
% 216.34/216.50  |- mesh__dateEstablished mesh__D012703 1970-01-01
% 216.34/216.50  |- mesh__recordOriginator mesh__D012703 NLM
% 216.34/216.50  |- mesh__historyNote mesh__D012703 70%28%68%29%   
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D012703 2003
% 216.34/216.50  |- skos__prefLabel mesh__D012703 Serotyping
% 216.34/216.50  |- mesh__publicMeSHNote mesh__D012703 70   
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D012703 2006
% 216.34/216.50  |- skos__broader mesh__D012703smesh__D007158
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D012703 2001
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D012703 2004
% 216.34/216.50  |- rdf__type mesh__D012703sskos__Concept
% 216.34/216.50  |- skos__hiddenLabel mesh__D012703 Serotypings
% 216.34/216.50  |- mesh__recordMaintainer mesh__D012703 TAP
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D012703 2002
% 216.34/216.50  |- mesh__dateCreated mesh__D012703 1999-01-01
% 216.34/216.50  |- skos__historyNote mesh__D012703 Antigens %28%1966-1967%29%
% 216.34/216.50  |- mesh__dateRevised mesh__D012703 2000-06-22
% 216.34/216.50  |- mesh__publicMeSHNote mesh__D017997
% 216.34/216.50       94; was see SRS-A 1983-93; LEUKOTRIENE C1 %26% LEUKOTRIENES C were see SRS-A 1983-93%A%  
% 216.34/216.50  |- mesh__recordOriginator mesh__D017997 TPW
% 216.34/216.50  |- mesh__dateEstablished mesh__D017997 1994-01-01
% 216.34/216.50  |- mesh__dateRevised mesh__D017997 2005-06-30
% 216.34/216.50  |- skos__altLabel mesh__D017997 Leukotriene C-1
% 216.34/216.50  |- skos__altLabel mesh__D017997 Leukotriene C-4
% 216.34/216.50  |- skos__prefLabel mesh__D017997 Leukotriene C4
% 216.34/216.50  |- skos__altLabel mesh__D017997 Leukotriene C
% 216.34/216.50  |- skos__broader mesh__D017997smesh__D013189
% 216.34/216.50  |- skos__scopeNote mesh__D017997
% 216.34/216.50       The conjugation product of LEUKOTRIENE A4 and glutathione. It is the major arachidonic acid metabolite in macrophages and human mast cells as well as in antigen-sensitized lung tissue. It stimulates mucus secretion in the lung, and produces contractions of nonvascular and some vascular smooth muscle. %28%From Dictionary of Prostaglandins and Related Compounds, 1990%29%%A%    
% 216.34/216.50  |- skos__annotation mesh__D017997
% 216.34/216.50       /biosyn /physiol permitted; DF: note short X ref   
% 216.34/216.50  |- skos__hiddenLabel mesh__D017997 Leukotriene C 1
% 216.34/216.50  |- skos__hiddenLabel mesh__D017997 Leukotriene C 4
% 216.34/216.50  |- mesh__recordAuthorizer mesh__D017997 sjn
% 216.34/216.50  |- mesh__onlineNote mesh__D017997
% 216.34/216.50       use SRS-A to search LEUKOTRIENE C1, LEUKOTRIENE C4 %26% LEUKOTRIENES C 1983-93%A%  
% 216.34/216.50  |- mesh__recordMaintainer mesh__D017997 ssb
% 216.34/216.50  |- mesh__dateCreated mesh__D017997 1993-06-04
% 216.34/216.50  |- skos__historyNote mesh__D017997 SRS-A %28%1981-1993%29%
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D017997 2006
% 216.34/216.50  |- skos__altLabel mesh__D017997 LTC4
% 216.34/216.50  |- rdf__type mesh__D017997sskos__Concept
% 216.34/216.50  |- mesh__historyNote mesh__D017997
% 216.34/216.50       94; was see SRS-A 1983-93; LEUKOTRIENE C1 %26% LEUKOTRIENES C were see SRS-A 1983-93%A%  
% 216.34/216.50  |- rdf__type mesh__D031668sskos__Concept
% 216.34/216.50  |- mesh__dateEstablished mesh__D031668 2003-01-01
% 216.34/216.50  |- mesh__dateRevised mesh__D031668 2004-07-07
% 216.34/216.50  |- mesh__recordMaintainer mesh__D031668 ssb
% 216.34/216.50  |- skos__altLabel mesh__D031668 Tien ma
% 216.34/216.50  |- mesh__recordAuthorizer mesh__D031668 sjn
% 216.34/216.50  |- skos__annotation mesh__D031668
% 216.34/216.50       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.34/216.50  |- mesh__recordOriginator mesh__D031668 ssb
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D031668 2006
% 216.34/216.50  |- mesh__dateCreated mesh__D031668 2002-07-03
% 216.34/216.50  |- mesh__historyNote mesh__D031668 2003%28%2002%29%   
% 216.34/216.50  |- skos__scopeNote mesh__D031668
% 216.34/216.50       A plant genus of the family ORCHIDACEAE which depends on the fungus Armillaria mellea to complete its life cycle. It is an ingredient of Zhenxuanyin %28%DRUGS, CHINESE HERBAL%29%.%A%    
% 216.34/216.50  |- skos__prefLabel mesh__D031668 Gastrodia
% 216.34/216.50  |- mesh__publicMeSHNote mesh__D031668
% 216.34/216.50       2003; GASTRODIA ELATA EXTRACT was indexed under DRUGS, CHINESE HERBAL 2002-2004%A%  
% 216.34/216.50  |- skos__broader mesh__D031668smesh__D029595
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D031668 2005
% 216.34/216.50  |- skos__hiddenLabel mesh__D050822 gp130, Signal Transducer
% 216.34/216.50  |- skos__altLabel mesh__D050822 gp130 Signal Transducer
% 216.34/216.50  |- skos__hiddenLabel mesh__D050822 Receptor gp130, Cytokine
% 216.34/216.50  |- skos__hiddenLabel mesh__D050822 gp130, Signal-Transducing Receptor
% 216.34/216.50  |- skos__scopeNote mesh__D050822
% 216.34/216.50       A cytokine receptor that mediates SIGNAL TRANSDUCTION PATHWAYS for a diverse group of ligands including: INTERLEUKIN 6; INTERLEUKIN 11; LEUKEMIA INHIBITORY FACTOR; ONCOSTATIN M; and CILIARY NEUROTROPHIC FACTOR. The gp130 receptor acts through the formation of oligomeric complexes of itself with a variety of receptors.%A%    
% 216.34/216.50  |- skos__broader mesh__D050822smesh__D015703
% 216.34/216.50  |- mesh__recordMaintainer mesh__D050822 DRC
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D050822 2006
% 216.34/216.50  |- mesh__recordOriginator mesh__D050822 DRC
% 216.34/216.50  |- mesh__publicMeSHNote mesh__D050822
% 216.34/216.50       2006; CYTOKINE RECEPTOR GP130 was indexed under ANTIGENS, CD %26% MEMBRANES GLYCOPROTEINS 1990-2005%A%  
% 216.34/216.50  |- skos__altLabel mesh__D050822 CD130 Antigens
% 216.34/216.50  |- skos__hiddenLabel mesh__D050822 Receptor gp130, Signal-Transducing
% 216.34/216.50  |- skos__altLabel mesh__D050822 IL6ST gp130
% 216.34/216.50  |- rdf__type mesh__D050822sskos__Concept
% 216.34/216.50  |- skos__hiddenLabel mesh__D050822 gp130, Cytokine Receptor
% 216.34/216.50  |- skos__hiddenLabel mesh__D050822 gp130 IL 6 Family Receptor
% 216.34/216.50  |- mesh__historyNote mesh__D050822 2006%28%1990%29%   
% 216.34/216.50  |- skos__hiddenLabel mesh__D050822 Signal Transducing Receptor gp130
% 216.34/216.50  |- skos__prefLabel mesh__D050822 Cytokine Receptor gp130
% 216.34/216.50  |- skos__hiddenLabel mesh__D050822 Signal Transducer, gp130
% 216.34/216.50  |- skos__altLabel mesh__D050822 gp130 Transducing Protein
% 216.34/216.50  |- skos__altLabel mesh__D050822 Signal Transducer gp130
% 216.34/216.50  |- skos__altLabel mesh__D050822 IL-6 Receptor Signal Transducer gp130
% 216.34/216.50  |- skos__altLabel mesh__D050822 IL-6 Family Receptor gp130
% 216.34/216.50  |- skos__altLabel mesh__D050822 gp130 IL-6 Family Receptor
% 216.34/216.50  |- skos__broader mesh__D050822smesh__D018121
% 216.34/216.50  |- skos__altLabel mesh__D050822 Antigens, CD130
% 216.34/216.50  |- mesh__dateCreated mesh__D050822 2005-06-30
% 216.34/216.50  |- skos__altLabel mesh__D050822 Signal-Transducing Receptor gp130
% 216.34/216.50  |- mesh__dateEstablished mesh__D050822 2006-01-01
% 216.34/216.50  |- mesh__recordAuthorizer mesh__D050822 sjn
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D003179 2006A
% 216.34/216.50  |- mesh__recordOriginator mesh__D003179 RLS
% 216.34/216.50  |- skos__altLabel mesh__D003179 C3b Complement
% 216.34/216.50  |- rdf__type mesh__D003179sskos__Concept
% 216.34/216.50  |- skos__broader mesh__D003179smesh__D003176
% 216.34/216.50  |- skos__hiddenLabel mesh__D003179 C3b, Inactivated
% 216.34/216.50  |- skos__altLabel mesh__D003179 C3bi
% 216.34/216.50  |- skos__hiddenLabel mesh__D003179 Component 3b, Complement
% 216.34/216.50  |- skos__prefLabel mesh__D003179 Complement C3b
% 216.34/216.50  |- skos__historyNote mesh__D003179 Complement %28%1968-1974%29%
% 216.34/216.50  |- skos__altLabel mesh__D003179 Complement Component 3b
% 216.34/216.50  |- skos__scopeNote mesh__D003179
% 216.34/216.50       The larger fragment generated from the cleavage of  COMPLEMENT C3 by C3 CONVERTASE. It is a constituent of the ALTERNATIVE PATHWAY C3 CONVERTASE %28%C3bBb%29%, and COMPLEMENT C5 CONVERTASES in both the classical %28%C4b2a3b%29% and the alternative %28%C3bBb3b%29% pathway. C3b participates in IMMUNE ADHERENCE REACTION and enhances PHAGOCYTOSIS. It can be inactivated %28%iC3b%29% or cleaved by various proteases to yield fragments such as COMPLEMENT C3C; COMPLEMENT C3D; C3e; C3f; and C3g.%A%    
% 216.34/216.50  |- skos__annotation mesh__D003179
% 216.34/216.50       /antag: consider COMPLEMENT C3B INACTIVATOR PROTEINS   
% 216.34/216.50  |- mesh__publicMeSHNote mesh__D003179 2006; see COMPLEMENT 3B 1978-2005   
% 216.34/216.50  |- skos__altLabel mesh__D003179 Complement 3b
% 216.34/216.50  |- mesh__recordAuthorizer mesh__D003179 ags
% 216.34/216.50  |- skos__related mesh__D003179smesh__D017463
% 216.34/216.50  |- mesh__dateRevised mesh__D003179 2005-07-11
% 216.34/216.50  |- mesh__dateCreated mesh__D003179 1977-05-17
% 216.34/216.50  |- skos__hiddenLabel mesh__D003179 Complement, C3b
% 216.34/216.50  |- mesh__dateEstablished mesh__D003179 1978-01-01
% 216.34/216.50  |- skos__historyNote mesh__D003179 Complement 3 %28%1975-1977%29%
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D003179 2006
% 216.34/216.50  |- skos__altLabel mesh__D003179 iC3b
% 216.34/216.50  |- mesh__historyNote mesh__D003179 2006 %28%1978%29%   
% 216.34/216.50  |- skos__hiddenLabel mesh__D003179 C3b, Complement
% 216.34/216.50  |- mesh__recordMaintainer mesh__D003179 ags
% 216.34/216.50  |- skos__scopeNote mesh__D008662
% 216.34/216.50       The articulation between a metacarpal bone and a phalanx.%A%    
% 216.34/216.50  |- mesh__dateEstablished mesh__D008662 1990-01-01
% 216.34/216.50  |- mesh__dateRevised mesh__D008662 2005-06-30
% 216.34/216.50  |- skos__hiddenLabel mesh__D008662 Metacarpophalangeal Joints
% 216.34/216.50  |- rdf__type mesh__D008662sskos__Concept
% 216.34/216.50  |- skos__historyNote mesh__D008662 Finger Joint %28%1966-1976%29%
% 216.34/216.50  |- skos__hiddenLabel mesh__D008662 Joints, Metacarpophalangeal
% 216.34/216.50  |- mesh__recordOriginator mesh__D008662 MM
% 216.34/216.50  |- mesh__recordAuthorizer mesh__D008662 sjn
% 216.34/216.50  |- skos__prefLabel mesh__D008662 Metacarpophalangeal Joint
% 216.34/216.50  |- skos__broader mesh__D008662smesh__D050823
% 216.34/216.50  |- mesh__historyNote mesh__D008662
% 216.34/216.50       90%28%77%29%; was see under FINGER JOINT 1977-89   
% 216.34/216.50  |- mesh__dateCreated mesh__D008662 1976-04-27
% 216.34/216.50  |- mesh__publicMeSHNote mesh__D008662
% 216.34/216.50       90%28%77%29%; was see under FINGER JOINT 1977-89   
% 216.34/216.50  |- mesh__recordMaintainer mesh__D008662 ags
% 216.34/216.50  |- skos__hiddenLabel mesh__D008662 Joint, Metacarpophalangeal
% 216.34/216.50  |- skos__annotation mesh__D008662 primates only   
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D008662 2006
% 216.34/216.50  |- skos__historyNote mesh__D008662 Metacarpus %28%1966-1976%29%
% 216.34/216.50  |- mesh__recordMaintainer mesh__D032761 ags
% 216.34/216.50  |- mesh__recordAuthorizer mesh__D032761 sjn
% 216.34/216.50  |- skos__hiddenLabel mesh__D032761 Experiment, Animal
% 216.34/216.50  |- skos__scopeNote mesh__D032761
% 216.34/216.50       The use of animals as investigational subjects.     
% 216.34/216.50  |- skos__related mesh__D032761smesh__D023401
% 216.34/216.50  |- mesh__dateCreated mesh__D032761 2002-07-02
% 216.34/216.50  |- skos__hiddenLabel mesh__D032761 Experiments, Animal
% 216.34/216.50  |- mesh__recordOriginator mesh__D032761 jrf
% 216.34/216.50  |- rdf__type mesh__D032761sskos__Concept
% 216.34/216.50  |- skos__altLabel mesh__D032761 Animal Research
% 216.34/216.50  |- skos__altLabel mesh__D032761 Animal Experimental Use
% 216.34/216.50  |- skos__historyNote mesh__D032761 Animal Welfare %28%1978-2002%29%
% 216.34/216.50  |- skos__hiddenLabel mesh__D032761 Animal Experiment
% 216.34/216.50  |- skos__related mesh__D032761smesh__D032984
% 216.34/216.50  |- skos__hiddenLabel mesh__D032761 Experimental Uses, Animal
% 216.34/216.50  |- skos__prefLabel mesh__D032761 Animal Experimentation
% 216.34/216.50  |- skos__broader mesh__D032761smesh__D035843
% 216.34/216.50  |- skos__hiddenLabel mesh__D032761 Experimentation, Animal
% 216.34/216.50  |- mesh__publicMeSHNote mesh__D032761
% 216.34/216.50       2003; see ANIMAL WELFARE 1987-2002; for ANIMAL EXPERIMENTS see ANIMAL 1978-2003%A%  
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D032761 2006
% 216.34/216.50  |- skos__related mesh__D032761smesh__D023421
% 216.34/216.50  |- mesh__dateRevised mesh__D032761 2003-07-09
% 216.34/216.50  |- skos__annotation mesh__D032761
% 216.34/216.50       IM for moral, legal, ethical, social, and religious aspects of experiments on animals; do not routinely add for specific research studies involving animals%A%  
% 216.34/216.50  |- mesh__historyNote mesh__D032761
% 216.34/216.50       2003; use ANIMAL WELFARE 1987-2002; for ANIMAL EXPERIMENTS use ANIMALS 1978-2003%A%  
% 216.34/216.50  |- skos__related mesh__D032761smesh__D026688
% 216.34/216.50  |- skos__hiddenLabel mesh__D032761 Research, Animal
% 216.34/216.50  |- mesh__dateEstablished mesh__D032761 2003-01-01
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D032761 2004
% 216.34/216.50  |- skos__broader mesh__D032761smesh__D008919
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D032761 2005
% 216.34/216.50  |- skos__hiddenLabel mesh__D032761 Animal Experimental Uses
% 216.34/216.50  |- skos__hiddenLabel mesh__D032761 Experimental Use, Animal
% 216.34/216.50  |- skos__hiddenLabel mesh__D018292 Papillary Cystadenomas
% 216.34/216.50  |- mesh__historyNote mesh__D018292 94, 63-81   
% 216.34/216.50  |- rdf__type mesh__D018292sskos__Concept
% 216.34/216.50  |- skos__hiddenLabel mesh__D018292 Papillary Cystadenoma
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D018292 2002
% 216.34/216.50  |- skos__historyNote mesh__D018292 Cystadenoma %28%1966-1993%29%
% 216.34/216.50  |- mesh__onlineNote mesh__D018292
% 216.34/216.50       use CYSTADENOMA to search CYSTADENOMA, PAPILLARY 1966-93   
% 216.34/216.50  |- skos__scopeNote mesh__D018292 A benign neoplasm of the ovary.     
% 216.34/216.50  |- mesh__publicMeSHNote mesh__D018292 94, 63-81   
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D018292 2003
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D018292 1996
% 216.34/216.50  |- skos__historyNote mesh__D018292 Adenolymphoma %28%1966-1993%29%
% 216.34/216.50  |- skos__annotation mesh__D018292
% 216.34/216.50       /blood supply /chem /secret /ultrastruct permitted; coord IM with probably OVARIAN NEOPLASMS %28%IM%29%%A%  
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D018292 2000
% 216.34/216.50  |- mesh__dateEstablished mesh__D018292 1994-01-01
% 216.34/216.50  |- skos__prefLabel mesh__D018292 Cystadenoma, Papillary
% 216.34/216.50  |- skos__hiddenLabel mesh__D018292 Cystadenomas, Papillary
% 216.34/216.50  |- mesh__recordMaintainer mesh__D018292 KEV
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D018292 2005
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D018292 2004
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D018292 1998
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D018292 1997
% 216.34/216.50  |- mesh__dateRevised mesh__D018292 1995-06-08
% 216.34/216.50  |- mesh__recordAuthorizer mesh__D018292 PLS
% 216.34/216.50  |- mesh__recordOriginator mesh__D018292 PLS
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D018292 2001
% 216.34/216.50  |- mesh__dateCreated mesh__D018292 1993-06-25
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D018292 2006
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D018292 1999
% 216.34/216.50  |- skos__broader mesh__D018292smesh__D003537
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D026724 2006
% 216.34/216.50  |- mesh__recordOriginator mesh__D026724 hjn
% 216.34/216.50  |- rdf__type mesh__D026724sskos__Concept
% 216.34/216.50  |- mesh__dateCreated mesh__D026724 2001-07-25
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D026724 2005
% 216.34/216.50  |- skos__related mesh__D026724smesh__D017041
% 216.34/216.50  |- skos__broader mesh__D026724smesh__D004989
% 216.34/216.50  |- skos__related mesh__D026724smesh__D010380
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D026724 2004
% 216.34/216.50  |- mesh__recordAuthorizer mesh__D026724 sjn
% 216.34/216.50  |- skos__historyNote mesh__D026724 Ethics %28%1979-2001%29%
% 216.34/216.50  |- skos__scopeNote mesh__D026724
% 216.34/216.50       A formal process of examination of patient care or research proposals for conformity with ethical standards.  The review is usually conducted by an organized clinical or research ethics committee %28%CLINICAL ETHICS COMMITTEES or RESEARCH ETHICS COMMITTEES%29%, sometimes by a subset of such a committee, an ad hoc group, or an individual ethicist %28%ETHICISTS%29%.%A%    
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D026724 2003
% 216.34/216.50  |- mesh__recordMaintainer mesh__D026724 jrf
% 216.34/216.50  |- mesh__dateEstablished mesh__D026724 2002-01-01
% 216.34/216.50  |- mesh__historyNote mesh__D026724 2002; use ETHICS 1993-2001   
% 216.34/216.50  |- mesh__publicMeSHNote mesh__D026724 2002; see ETHICS 1993-2001   
% 216.34/216.50  |- skos__prefLabel mesh__D026724 Ethical Review
% 216.34/216.50  |- mesh__dateRevised mesh__D026724 2002-07-03
% 216.34/216.50  |- skos__hiddenLabel mesh__D026724 Review, Ethical
% 216.34/216.50  |- skos__historyNote mesh__D004272 Mitochondria %28%1966-1972%29%
% 216.34/216.50  |- skos__altLabel mesh__D004272 Mitochondrial DNA
% 216.34/216.50  |- mesh__dateRevised mesh__D004272 2005-06-30
% 216.34/216.50  |- skos__annotation mesh__D004272
% 216.34/216.50       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 216.34/216.50  |- skos__broader mesh__D004272smesh__D004270
% 216.34/216.50  |- mesh__publicMeSHNote mesh__D004272 74   
% 216.34/216.50  |- mesh__recordMaintainer mesh__D004272 nns
% 216.34/216.50  |- mesh__historyNote mesh__D004272 74%28%73%29%   
% 216.34/216.50  |- skos__historyNote mesh__D004272 DNA %28%1966-1972%29%
% 216.34/216.50  |- rdf__type mesh__D004272sskos__Concept
% 216.34/216.50  |- skos__prefLabel mesh__D004272 DNA, Mitochondrial
% 216.34/216.50  |- mesh__dateEstablished mesh__D004272 1974-01-01
% 216.34/216.50  |- mesh__recordOriginator mesh__D004272 NLM
% 216.34/216.50  |- skos__altLabel mesh__D004272 mtDNA
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D004272 2006
% 216.34/216.50  |- skos__scopeNote mesh__D004272
% 216.34/216.50       Double-stranded DNA of MITOCHONDRIA. In eukaryotes, the mitochondrial GENOME is circular and codes for ribosomal RNAs, transfer RNAs, and about 10 proteins.%A%    
% 216.34/216.50  |- mesh__dateCreated mesh__D004272 1999-01-01
% 216.34/216.50  |- mesh__recordAuthorizer mesh__D004272 sjn
% 216.34/216.50  |- skos__related mesh__D004272smesh__D050259
% 216.34/216.50  |- skos__prefLabel mesh__D012704 Serous Membrane
% 216.34/216.50  |- mesh__activeMeSHYear mesh__D012704 2006
% 216.34/216.50  |- rdf__type mesh__D012704sskos__Concept
% 216.34/216.50  |- mesh__recordOriginator mesh__D012704 NLM
% 216.34/216.50  |- mesh__recordAuthorizer mesh__D012704 sjn
% 216.34/216.50  |- mesh__dateRevised mesh__D012704 2005-06-30
% 216.34/216.50  |- skos__hiddenLabel mesh__D012704 Membrane, Serous
% 216.34/216.50  |- skos__hiddenLabel mesh__D012704 Membranes, Serous
% 216.34/216.50  |- mesh__dateCreated mesh__D012704 1999-01-01
% 216.34/216.50  |- skos__scopeNote mesh__D012704
% 216.34/216.50       A thin lining of closed cavities of the body, consisting of a single layer of squamous epithelial cells %28%MESOTHELIUM%29% resting on a thin layer of CONNECTIVE TISSUE, and covered with secreted clear fluid from blood and lymph vessels. Major serous membranes in the body include PERICARDIUM; PERITONEUM; and PLEURA.%A%    
% 216.34/216.50  |- skos__broader mesh__D012704smesh__D008566
% 216.34/216.50  |- mesh__recordMaintainer mesh__D012704 lkt
% 216.34/216.50  |- skos__altLabel mesh__D012704 Serous Membranes
% 216.34/216.50  |- skos__altLabel mesh__D012704 Serosa
% 216.34/216.50  |- skos__annotation mesh__D012704
% 216.34/216.50       general: prefer specific membrane; inflammation = SEROSITIS%A%  
% 216.34/216.50  |- skos__historyNote mesh__D017998 SRS-A %28%1982-1993%29%
% 216.34/216.50  |- mesh__recordAuthorizer mesh__D017998 sjn
% 216.34/216.50  |- skos__broader mesh__D017998smesh__D013189
% 216.34/216.50  |- skos__scopeNote mesh__D017998
% 216.34/216.50       One of the biologically active principles of SRS-A. It is generated from LEUKOTRIENE C4 after partial hydrolysis of the peptide chain, i.e., cleavage of the gamma-glutamyl portion. Its biological actions include stimulation of vascular and nonvascular smooth muscle, and increases in vascular permeability. %28%From Dictionary of Prostaglandins and Related Compounds, 1990%29%%A%    
% 216.34/216.51  |- skos__altLabel mesh__D017998 Leukotriene D
% 216.34/216.51  |- mesh__publicMeSHNote mesh__D017998
% 216.34/216.51       94; was see SRS-A 1983-93; LEUKOTRIENES D was see SRS-A 1983-93%A%  
% 216.34/216.51  |- mesh__dateEstablished mesh__D017998 1994-01-01
% 216.34/216.51  |- skos__altLabel mesh__D017998 Leukotriene D-4
% 216.34/216.51  |- mesh__onlineNote mesh__D017998
% 216.34/216.51       use SRS-A to search LEUKOTRIENE D4 %26% LEUKOTRIENES D 1983-93%A%  
% 216.34/216.51  |- skos__hiddenLabel mesh__D017998 Leukotriene D 4
% 216.34/216.51  |- skos__prefLabel mesh__D017998 Leukotriene D4
% 216.34/216.51  |- mesh__historyNote mesh__D017998
% 216.34/216.51       94; was see SRS-A 1983-93; LEUKOTRIENES D was see SRS-A 1983-93%A%  
% 216.34/216.51  |- skos__altLabel mesh__D017998 LTD4
% 216.34/216.51  |- mesh__recordMaintainer mesh__D017998 ssb
% 216.34/216.51  |- mesh__dateRevised mesh__D017998 2005-06-30
% 216.34/216.51  |- mesh__recordOriginator mesh__D017998 TPW
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D017998 2006
% 216.34/216.51  |- mesh__dateCreated mesh__D017998 1993-06-04
% 216.34/216.51  |- skos__annotation mesh__D017998
% 216.34/216.51       /biosyn /physiol permitted; DF: note short X ref   
% 216.34/216.51  |- rdf__type mesh__D017998sskos__Concept
% 216.34/216.51  |- skos__broader mesh__D031669smesh__D029595
% 216.34/216.51  |- skos__scopeNote mesh__D031669
% 216.34/216.51       A plant genus of the family ORCHIDACEAE that is the source of the familiar flavoring used in foods and medicines %28%FLAVORING AGENTS%29%.%A%    
% 216.34/216.51  |- mesh__publicMeSHNote mesh__D031669 2003   
% 216.34/216.51  |- skos__annotation mesh__D031669
% 216.34/216.51       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.34/216.51  |- mesh__dateEstablished mesh__D031669 2003-01-01
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D031669 2004
% 216.34/216.51  |- skos__prefLabel mesh__D031669 Vanilla
% 216.34/216.51  |- mesh__historyNote mesh__D031669 2003   
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D031669 2006
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D031669 2003
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D031669 2005
% 216.34/216.51  |- rdf__type mesh__D031669sskos__Concept
% 216.34/216.51  |- mesh__dateCreated mesh__D031669 2002-07-03
% 216.34/216.51  |- skos__hiddenLabel mesh__D050823 Joints, Intermetacarpal
% 216.34/216.51  |- skos__prefLabel mesh__D050823 Hand Joints
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D050823 2006
% 216.34/216.51  |- mesh__dateCreated mesh__D050823 2005-06-30
% 216.34/216.51  |- mesh__dateEstablished mesh__D050823 2006-01-01
% 216.34/216.51  |- mesh__recordAuthorizer mesh__D050823 sjn
% 216.34/216.51  |- skos__hiddenLabel mesh__D050823 Intermetacarpal Joint
% 216.34/216.51  |- rdf__type mesh__D050823sskos__Concept
% 216.34/216.51  |- skos__annotation mesh__D050823 primates only   
% 216.34/216.51  |- skos__broader mesh__D050823smesh__D007596
% 216.34/216.51  |- skos__hiddenLabel mesh__D050823 Joints, Hand
% 216.34/216.51  |- skos__scopeNote mesh__D050823
% 216.34/216.51       The articulations extending from the WRIST distally to the FINGERS. These include the WRIST JOINT; CARPAL JOINTS; METACARPOPHALANGEAL JOINT; and FINGER JOINT.%A%    
% 216.34/216.51  |- mesh__historyNote mesh__D050823 2006   
% 216.34/216.51  |- mesh__recordOriginator mesh__D050823 ags
% 216.34/216.51  |- skos__historyNote mesh__D050823 specific hand joints %28%1968-2005%29%
% 216.34/216.51  |- skos__hiddenLabel mesh__D050823 Joint, Intermetacarpal
% 216.34/216.51  |- mesh__recordMaintainer mesh__D050823 ags
% 216.34/216.51  |- mesh__publicMeSHNote mesh__D050823 2006   
% 216.34/216.51  |- skos__prefLabel mesh__D003978 Diazomethane
% 216.34/216.51  |- skos__historyNote mesh__D003978 Methane %28%1966%29%
% 216.34/216.51  |- mesh__dateEstablished mesh__D003978 1968-01-01
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003978 1997
% 216.34/216.51  |- mesh__historyNote mesh__D003978 68%28%67%29%   
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003978 2002
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003978 1996
% 216.34/216.51  |- mesh__dateRevised mesh__D003978 1992-05-13
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003978 2006
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003978 2001
% 216.34/216.51  |- mesh__recordMaintainer mesh__D003978 TAP
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003978 2005
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003978 2000
% 216.34/216.51  |- skos__altLabel mesh__D003978 Diazirine
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003978 1995
% 216.34/216.51  |- mesh__publicMeSHNote mesh__D003978 68   
% 216.34/216.51  |- mesh__recordAuthorizer mesh__D003978 PLS
% 216.34/216.51  |- mesh__recordOriginator mesh__D003978 NLM
% 216.34/216.51  |- rdf__type mesh__D003978sskos__Concept
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003978 2004
% 216.34/216.51  |- skos__broader mesh__D003978smesh__D003979
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003978 1999
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003978 1994
% 216.34/216.51  |- mesh__dateCreated mesh__D003978 1999-01-01
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003978 2003
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003978 1998
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003978 1993
% 216.34/216.51  |- skos__broader mesh__D008663smesh__D006225
% 216.34/216.51  |- rdf__type mesh__D008663sskos__Concept
% 216.34/216.51  |- skos__prefLabel mesh__D008663 Metacarpus
% 216.34/216.51  |- skos__related mesh__D008663smesh__D050279
% 216.34/216.51  |- mesh__recordOriginator mesh__D008663 NLM
% 216.34/216.51  |- mesh__dateRevised mesh__D008663 2005-06-30
% 216.34/216.51  |- mesh__recordMaintainer mesh__D008663 ags
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D008663 2006
% 216.34/216.51  |- mesh__recordAuthorizer mesh__D008663 sjn
% 216.34/216.51  |- skos__annotation mesh__D008663
% 216.34/216.51       not restricted to primates; METACARPUS refers to the anatomical region, METACARPAL BONES is available for the bones%A%  
% 216.34/216.51  |- mesh__dateCreated mesh__D008663 1999-01-01
% 216.34/216.51  |- skos__scopeNote mesh__D008663
% 216.34/216.51       The region of the HAND between the WRIST and the FINGERS.%A%    
% 216.34/216.51  |- skos__broader mesh__D000680smesh__D009573
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D000680 2001
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D000680 2004
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D000680 2002
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D000680 2005
% 216.34/216.51  |- mesh__recordMaintainer mesh__D000680 CCR
% 216.34/216.51  |- mesh__recordAuthorizer mesh__D000680 sjn
% 216.34/216.51  |- rdf__type mesh__D000680sskos__Concept
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D000680 2006
% 216.34/216.51  |- mesh__recordOriginator mesh__D000680 NLM
% 216.34/216.51  |- skos__prefLabel mesh__D000680 Amyl Nitrite
% 216.34/216.51  |- skos__scopeNote mesh__D000680
% 216.34/216.51       A vasodilator that is administered by inhalation. It is also used recreationally due to its supposed ability to induce euphoria and act as an aphrodisiac.%A%    
% 216.34/216.51  |- skos__hiddenLabel mesh__D000680 Nitrite, Amyl
% 216.34/216.51  |- mesh__dateRevised mesh__D000680 2000-06-21
% 216.34/216.51  |- mesh__dateCreated mesh__D000680 1999-01-01
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D000680 2003
% 216.34/216.51  |- skos__altLabel mesh__D032762 Self-Experimentation
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D032762 2005
% 216.34/216.51  |- skos__hiddenLabel mesh__D032762 Self Experimentation
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D032762 2003
% 216.34/216.51  |- rdf__type mesh__D032762sskos__Concept
% 216.34/216.51  |- mesh__dateCreated mesh__D032762 2002-07-02
% 216.34/216.51  |- mesh__recordOriginator mesh__D032762 jrf
% 216.34/216.51  |- skos__scopeNote mesh__D032762
% 216.34/216.51       Intentionally using oneself as a research subject.     
% 216.34/216.51  |- skos__broader mesh__D032762smesh__D006805
% 216.34/216.51  |- skos__prefLabel mesh__D032762 Autoexperimentation
% 216.34/216.51  |- mesh__recordAuthorizer mesh__D032762 jls
% 216.34/216.51  |- mesh__historyNote mesh__D032762
% 216.34/216.51       2003; use HUMAN EXPERIMENTATION 1999-2002   
% 216.34/216.51  |- mesh__publicMeSHNote mesh__D032762
% 216.34/216.51       2003; see HUMAN EXPERIMENTATION 1999-2002   
% 216.34/216.51  |- mesh__dateRevised mesh__D032762 2002-10-31
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D032762 2006
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D032762 2003A
% 216.34/216.51  |- mesh__dateEstablished mesh__D032762 2003-01-01
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D032762 2004
% 216.34/216.51  |- mesh__recordMaintainer mesh__D032762 jls
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D018293 2000
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D018293 2003
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D018293 1996
% 216.34/216.51  |- mesh__recordAuthorizer mesh__D018293 PLS
% 216.34/216.51  |- skos__broader mesh__D018293smesh__D003537
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D018293 2001
% 216.34/216.51  |- mesh__dateCreated mesh__D018293 1993-06-25
% 216.34/216.51  |- skos__hiddenLabel mesh__D018293 Cystadenomas, Serous
% 216.34/216.51  |- mesh__recordMaintainer mesh__D018293 KEV
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D018293 2005
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D018293 2004
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D018293 1998
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D018293 1997
% 216.34/216.51  |- mesh__dateRevised mesh__D018293 1995-06-08
% 216.34/216.51  |- skos__scopeNote mesh__D018293
% 216.34/216.51       A cystic tumor of the ovary, containing thin, clear, yellow serous fluid and varying amounts of solid tissue, with a malignant potential several times greater than that of mucinous cystadenoma %28%CYSTADENOMA, MUCINOUS%29%. It can be unilocular, parvilocular, or multilocular. It is often bilateral and papillary. The cysts may vary greatly in size. %28%Dorland, 27th ed; from Hughes, Obstetric-Gynecologic Terminology, 1972%29%%A%    
% 216.34/216.51  |- mesh__recordOriginator mesh__D018293 PLS
% 216.34/216.51  |- mesh__historyNote mesh__D018293 94   
% 216.34/216.51  |- skos__annotation mesh__D018293
% 216.34/216.51       /blood supply /chem /secret /ultrastruct permitted; coord IM with probably OVARIAN NEOPLASMS %28%IM%29%%A%  
% 216.34/216.51  |- mesh__publicMeSHNote mesh__D018293 94   
% 216.34/216.51  |- skos__hiddenLabel mesh__D018293 Serous Cystadenoma
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D018293 2006
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D018293 1999
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D018293 2002
% 216.34/216.51  |- skos__prefLabel mesh__D018293 Cystadenoma, Serous
% 216.34/216.51  |- rdf__type mesh__D018293sskos__Concept
% 216.34/216.51  |- mesh__dateEstablished mesh__D018293 1994-01-01
% 216.34/216.51  |- skos__historyNote mesh__D018293 Cystadenoma %28%1966-1993%29%
% 216.34/216.51  |- skos__hiddenLabel mesh__D018293 Serous Cystadenomas
% 216.34/216.51  |- skos__broader mesh__D005123Q000293smesh__D005123
% 216.34/216.51  |- mesh__preferredCombination mesh__D005123Q000293smesh__D005131
% 216.34/216.51  |- rdf__type mesh__D005123Q000293smesh__CompoundConcept
% 216.34/216.51  |- skos__broader mesh__D004273smesh__D004247
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D004273 2004
% 216.34/216.51  |- skos__prefLabel mesh__D004273 DNA, Neoplasm
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D004273 1997
% 216.34/216.51  |- mesh__recordAuthorizer mesh__D004273 PLS
% 216.34/216.51  |- skos__scopeNote mesh__D004273 DNA present in neoplastic tissue.     
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D004273 2001
% 216.34/216.51  |- mesh__dateRevised mesh__D004273 1995-03-16
% 216.34/216.51  |- skos__annotation mesh__D004273
% 216.34/216.51       IM; coord with required neoplasm term%28%s%29% %28%IM%29%; /drug eff /ultrastruct permitted; Manual 24.4.4.2; DF: DNA NEOPL%A%  
% 216.34/216.51  |- rdf__type mesh__D004273sskos__Concept
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D004273 2005
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D004273 1998
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D004273 2002
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D004273 2006
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D004273 1999
% 216.34/216.51  |- mesh__recordMaintainer mesh__D004273 TGC
% 216.34/216.51  |- mesh__dateCreated mesh__D004273 1999-01-01
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D004273 2003
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D004273 1996
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D004273 2000
% 216.34/216.51  |- skos__altLabel mesh__D004273 Neoplasm DNA
% 216.34/216.51  |- mesh__recordOriginator mesh__D004273 NLM
% 216.34/216.51  |- skos__scopeNote mesh__D012705
% 216.34/216.51       A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the natural environment %28%soil, water, and plant surfaces%29% or as an opportunistic human pathogen.%A%    
% 216.34/216.51  |- skos__prefLabel mesh__D012705 Serratia
% 216.34/216.51  |- mesh__recordMaintainer mesh__D012705 SYSTEM
% 216.34/216.51  |- mesh__dateCreated mesh__D012705 1999-01-01
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D012705 2006
% 216.34/216.51  |- rdf__type mesh__D012705sskos__Concept
% 216.34/216.51  |- skos__broader mesh__D012705smesh__D004755
% 216.34/216.51  |- mesh__recordAuthorizer mesh__D012705 sjn
% 216.34/216.51  |- mesh__recordOriginator mesh__D012705 NLM
% 216.34/216.51  |- mesh__dateRevised mesh__D012705 2005-06-30
% 216.34/216.51  |- skos__annotation mesh__D012705
% 216.34/216.51       in water, soil, food; infection = SERRATIA INFECTIONS   
% 216.34/216.51  |- skos__prefLabel mesh__D017999 Leukotriene E4
% 216.34/216.51  |- mesh__publicMeSHNote mesh__D017999
% 216.34/216.51       94; LEUKOTRIENE E was indexed under SRS-A/*ANALOGS %26% DERIVATIVES 1983-93 %26% ARACHIDONIC ACIDS 1980-82%A%  
% 216.34/216.51  |- skos__altLabel mesh__D017999 Leukotriene E-4
% 216.34/216.51  |- mesh__recordAuthorizer mesh__D017999 sjn
% 216.34/216.51  |- mesh__onlineNote mesh__D017999
% 216.34/216.51       use LEUKOTRIENE E4 %28%NM%29% to search LEUKOTRIENE E 1980-93   
% 216.34/216.51  |- skos__historyNote mesh__D017999 Arachidonic Acids %28%1980-1982%29%
% 216.34/216.51  |- skos__scopeNote mesh__D017999
% 216.34/216.51       A biologically active principle of SRS-A that is formed from LEUKOTRIENE D4 via a peptidase reaction that removes the glycine residue. The biological actions of LTE4 are similar to LTC4 and LTD4. %28%From Dictionary of Prostaglandins and Related Compounds, 1990%29%%A%    
% 216.34/216.51  |- skos__hiddenLabel mesh__D017999 Leukotriene E 4
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D017999 2006
% 216.34/216.51  |- mesh__dateCreated mesh__D017999 1993-06-21
% 216.34/216.51  |- skos__altLabel mesh__D017999 Leukotriene E
% 216.34/216.51  |- mesh__dateEstablished mesh__D017999 1994-01-01
% 216.34/216.51  |- rdf__type mesh__D017999sskos__Concept
% 216.34/216.51  |- skos__altLabel mesh__D017999 LTE4
% 216.34/216.51  |- mesh__historyNote mesh__D017999
% 216.34/216.51       94; was LEUKOTRIENE E %28%NM%29% 1980-93   
% 216.34/216.51  |- skos__historyNote mesh__D017999
% 216.34/216.51       SRS-A/analogs %26% derivatives %28%1983-1993%29%
% 216.34/216.51  |- mesh__recordMaintainer mesh__D017999 ssb
% 216.34/216.51  |- mesh__recordOriginator mesh__D017999 TPW
% 216.34/216.51  |- mesh__dateRevised mesh__D017999 2005-06-30
% 216.34/216.51  |- skos__broader mesh__D017999smesh__D013189
% 216.34/216.51  |- skos__annotation mesh__D017999
% 216.34/216.51       /biosyn /physiol permitted; DF: note short X ref   
% 216.34/216.51  |- skos__hiddenLabel mesh__D050824 Joint, Carpal
% 216.34/216.51  |- skos__prefLabel mesh__D050824 Carpal Joints
% 216.34/216.51  |- mesh__historyNote mesh__D050824 2006   
% 216.34/216.51  |- mesh__recordOriginator mesh__D050824 ags
% 216.34/216.51  |- skos__annotation mesh__D050824 vertebrates only   
% 216.34/216.51  |- skos__hiddenLabel mesh__D050824 Intercarpal Joint
% 216.34/216.51  |- skos__hiddenLabel mesh__D050824 Joint, Intercarpal
% 216.34/216.51  |- mesh__dateEstablished mesh__D050824 2006-01-01
% 216.34/216.51  |- skos__hiddenLabel mesh__D050824 Joints, Intercarpal
% 216.34/216.51  |- mesh__dateCreated mesh__D050824 2005-06-30
% 216.34/216.51  |- mesh__recordAuthorizer mesh__D050824 ags
% 216.34/216.51  |- mesh__publicMeSHNote mesh__D050824 2006   
% 216.34/216.51  |- skos__hiddenLabel mesh__D050824 Joints, Carpal
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D050824 2006
% 216.34/216.51  |- skos__broader mesh__D050824smesh__D050823
% 216.34/216.51  |- mesh__recordMaintainer mesh__D050824 ags
% 216.34/216.51  |- mesh__dateRevised mesh__D050824 2005-07-28
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D050824 2006A
% 216.34/216.51  |- skos__scopeNote mesh__D050824
% 216.34/216.51       The articulations between the various CARPAL BONES. This does not include the WRIST JOINT which consists of the articulations between the RADIUS; ULNA; and proximal CARPAL BONES.%A%    
% 216.34/216.51  |- rdf__type mesh__D050824sskos__Concept
% 216.34/216.51  |- skos__hiddenLabel mesh__D050824 Carpal Joint
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003979 1996
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003979 2006
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003979 2005
% 216.34/216.51  |- skos__broader mesh__D003979smesh__D001391
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003979 1995
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003979 2002
% 216.34/216.51  |- skos__prefLabel mesh__D003979 Diazonium Compounds
% 216.34/216.51  |- mesh__publicMeSHNote mesh__D003979 68   
% 216.34/216.51  |- rdf__type mesh__D003979sskos__Concept
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003979 2004
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003979 1999
% 216.34/216.51  |- mesh__dateRevised mesh__D003979 1992-05-13
% 216.34/216.51  |- mesh__dateCreated mesh__D003979 1999-01-01
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003979 1994
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003979 2001
% 216.34/216.51  |- mesh__recordMaintainer mesh__D003979 TAP
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003979 2003
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003979 1993
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003979 2000
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003979 1998
% 216.34/216.51  |- mesh__recordAuthorizer mesh__D003979 PLS
% 216.34/216.51  |- mesh__dateEstablished mesh__D003979 1968-01-01
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D003979 1997
% 216.34/216.51  |- skos__annotation mesh__D003979 DF: DIAZONIUM CPDS   
% 216.34/216.51  |- mesh__historyNote mesh__D003979 68   
% 216.34/216.51  |- skos__hiddenLabel mesh__D003979 Compounds, Diazonium
% 216.34/216.51  |- mesh__recordOriginator mesh__D003979 NLM
% 216.34/216.51  |- mesh__publicMeSHNote mesh__D008664 65   
% 216.34/216.51  |- mesh__historyNote mesh__D008664 65   
% 216.34/216.51  |- mesh__dateRevised mesh__D008664 2001-07-25
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D008664 2004
% 216.34/216.51  |- skos__broader mesh__D008664smesh__D008661
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D008664 2002
% 216.34/216.51  |- rdf__type mesh__D008664sskos__Concept
% 216.34/216.51  |- mesh__recordAuthorizer mesh__D008664 sjn
% 216.34/216.51  |- skos__altLabel mesh__D008664 Metal Metabolism, Inborn Error
% 216.34/216.51  |- mesh__recordMaintainer mesh__D008664 nns
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D008664 2005
% 216.34/216.51  |- skos__prefLabel mesh__D008664 Metal Metabolism, Inborn Errors
% 216.34/216.51  |- mesh__dateCreated mesh__D008664 1999-01-01
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D008664 2006
% 216.34/216.51  |- skos__annotation mesh__D008664
% 216.34/216.51       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific metal /metab %28%IM%29%; DF: METAL METAB INBORN ERR%A%  
% 216.34/216.51  |- mesh__recordOriginator mesh__D008664 NLM
% 216.34/216.51  |- mesh__dateEstablished mesh__D008664 1965-01-01
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D008664 2003
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D000681 2004
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D000681 2005
% 216.34/216.51  |- skos__annotation mesh__D000681
% 216.34/216.51       amylase isoenzymes: index under AMYLASES %28%IM%29% + ISOENZYMES %28%IM%29%, not ISOAMYLASE; amylases/blood: consider HYPERAMYLASEMIA%A%  
% 216.34/216.51  |- mesh__historyNote mesh__D000681 78; was AMYLASE 1963-77   
% 216.34/216.51  |- mesh__recordMaintainer mesh__D000681 ssb
% 216.34/216.51  |- mesh__dateRevised mesh__D000681 2003-07-09
% 216.34/216.51  |- rdf__type mesh__D000681sskos__Concept
% 216.34/216.51  |- skos__broader mesh__D000681smesh__D006026
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D000681 2006
% 216.34/216.51  |- mesh__onlineNote mesh__D000681 use AMYLASES to search AMYLASE 1966-77   
% 216.34/216.51  |- skos__altLabel mesh__D000681 Amylase
% 216.34/216.51  |- skos__scopeNote mesh__D000681
% 216.34/216.51       A group of amylolytic enzymes that cleave starch, glycogen, and related alpha-1,4-glucans. %28%Stedman, 25th ed%29% EC 3.2.1.-.%A%    
% 216.34/216.51  |- skos__altLabel mesh__D000681 Diastase
% 216.34/216.51  |- mesh__recordAuthorizer mesh__D000681 sjn
% 216.34/216.51  |- skos__prefLabel mesh__D000681 Amylases
% 216.34/216.51  |- mesh__publicMeSHNote mesh__D000681 78; was AMYLASE 1963-77   
% 216.34/216.51  |- mesh__recordOriginator mesh__D000681 NLM
% 216.34/216.51  |- mesh__dateCreated mesh__D000681 1999-01-01
% 216.34/216.51  |- skos__broader mesh__D013000smesh__D004191
% 216.34/216.51  |- mesh__historyNote mesh__D013000 98; use explode 1970-97   
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D013000 2003
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D013000 2001
% 216.34/216.51  |- mesh__dateCreated mesh__D013000 1999-01-01
% 216.34/216.51  |- mesh__publicMeSHNote mesh__D013000 98   
% 216.34/216.51  |- mesh__dateEstablished mesh__D013000 1998-01-01
% 216.34/216.51  |- skos__prefLabel mesh__D013000 Psychiatric Somatic Therapies
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D013000 2005
% 216.34/216.51  |- skos__hiddenLabel mesh__D013000 Somatic Therapy, Psychiatric
% 216.34/216.51  |- skos__altLabel mesh__D013000 Psychiatric Somatic Therapy
% 216.34/216.51  |- mesh__recordOriginator mesh__D013000 NLM
% 216.34/216.51  |- skos__historyNote mesh__D013000
% 216.34/216.51       specific somatic therapy %28%1969-1997%29%
% 216.34/216.51  |- skos__scopeNote mesh__D013000
% 216.34/216.51       The biologic treatment of mental disorders %28%e.g., ELECTROCONVULSIVE THERAPY%29%, in contrast with psychotherapy. %28%Stone, American Psychiatric Glossary, 1988, p159%29%%A%    
% 216.34/216.51  |- mesh__recordMaintainer mesh__D013000 TGC
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D013000 2000
% 216.34/216.51  |- mesh__dateRevised mesh__D013000 1997-06-20
% 216.34/216.51  |- mesh__recordAuthorizer mesh__D013000 SJN
% 216.34/216.51  |- skos__altLabel mesh__D013000 Therapies, Psychiatric Somatic
% 216.34/216.51  |- skos__altLabel mesh__D013000 Somatic Therapies, Psychiatric
% 216.34/216.51  |- rdf__type mesh__D013000sskos__Concept
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D013000 1999
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D013000 2004
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D013000 1998
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D013000 2002
% 216.34/216.51  |- skos__annotation mesh__D013000
% 216.34/216.51       %22%biol treatment of ment disord%22%; GEN or unspecified; prefer specifics; DF: PSYCHIATRIC SOMATIC THER%A%  
% 216.34/216.51  |- skos__hiddenLabel mesh__D013000 Therapy, Psychiatric Somatic
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D013000 2006
% 216.34/216.51  |- mesh__recordAuthorizer mesh__D032763 jls
% 216.34/216.51  |- skos__hiddenLabel mesh__D032763 Behavioral Manipulations
% 216.34/216.51  |- skos__broader mesh__D032763smesh__D004191
% 216.34/216.51  |- skos__related mesh__D032763smesh__D001521
% 216.34/216.51  |- skos__hiddenLabel mesh__D032763 Behavior Controls
% 216.34/216.51  |- skos__related mesh__D032763smesh__D003216
% 216.34/216.51  |- mesh__dateEstablished mesh__D032763 2003-01-01
% 216.34/216.51  |- mesh__recordMaintainer mesh__D032763 jls
% 216.34/216.51  |- skos__related mesh__D032763smesh__D010565
% 216.34/216.51  |- rdf__type mesh__D032763sskos__Concept
% 216.34/216.51  |- mesh__dateCreated mesh__D032763 2002-07-02
% 216.34/216.51  |- skos__broader mesh__D032763smesh__D012927
% 216.34/216.51  |- skos__scopeNote mesh__D032763
% 216.34/216.51       Manipulation of the behavior of persons or animals by biomedical, physical, psychological, or social means, including for nontherapeutic reasons.%A%    
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D032763 2003A
% 216.34/216.51  |- mesh__recordOriginator mesh__D032763 jrf
% 216.34/216.51  |- skos__prefLabel mesh__D032763 Behavior Control
% 216.34/216.51  |- mesh__publicMeSHNote mesh__D032763 2003; see BEHAVIOR 1997-2002   
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D032763 2005
% 216.34/216.51  |- skos__related mesh__D032763smesh__D003068
% 216.34/216.51  |- mesh__historyNote mesh__D032763 2003; use BEHAVIOR 1997-2002   
% 216.34/216.51  |- skos__hiddenLabel mesh__D032763 Manipulation, Behavioral
% 216.34/216.51  |- skos__altLabel mesh__D032763 Behavioral Manipulation
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D032763 2003
% 216.34/216.51  |- skos__hiddenLabel mesh__D032763 Manipulations, Behavioral
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D032763 2006
% 216.34/216.51  |- mesh__dateRevised mesh__D032763 2002-10-31
% 216.34/216.51  |- skos__broader mesh__D032763smesh__D013812
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D032763 2004
% 216.34/216.51  |- mesh__historyNote mesh__D018294 98; use explode 1994-97   
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D018294 2005
% 216.34/216.51  |- mesh__recordOriginator mesh__D018294 PLS
% 216.34/216.51  |- mesh__dateRevised mesh__D018294 2004-07-13
% 216.34/216.51  |- skos__altLabel mesh__D018294 Adnexal and Skin Appendage Neoplasms
% 216.34/216.51  |- mesh__dateEstablished mesh__D018294 1998-01-01
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D018294 2006
% 216.34/216.51  |- skos__broader mesh__D018294smesh__D009375
% 216.34/216.51  |- skos__scopeNote mesh__D018294
% 216.34/216.51       Neoplasms composed of sebaceous or sweat gland tissue or tissue of other skin appendages. The concept does not refer to neoplasms located in the sebaceous or sweat glands or in the other skin appendages.%A%    
% 216.34/216.51  |- mesh__recordMaintainer mesh__D018294 sjn
% 216.34/216.51  |- rdf__type mesh__D018294sskos__Concept
% 216.34/216.51  |- skos__historyNote mesh__D018294 specific neoplasm %28%1966-1997%29%
% 216.34/216.51  |- mesh__dateCreated mesh__D018294 1993-08-26
% 216.34/216.51  |- mesh__recordAuthorizer mesh__D018294 sjn
% 216.34/216.51  |- skos__annotation mesh__D018294
% 216.34/216.51       neopl composed of sebaceous or sweat gland tissue or tissue of skin appendages, NOT neopl located in these sites; indexing policy: Manual section 24; also TN Suppl: Tumor Key for human %26% corresponding vet tumors %28%does not contain exper tumors%29%; TN 135: correct use of tissue type terms; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; DF: NEOPL ADNEXAL SKIN APPENDAGE%A%  
% 216.34/216.51  |- mesh__publicMeSHNote mesh__D018294 98   
% 216.34/216.51  |- skos__prefLabel mesh__D018294 Neoplasms, Adnexal and Skin Appendage
% 216.34/216.51  |- skos__related mesh__D004274smesh__D005818
% 216.34/216.51  |- skos__hiddenLabel mesh__D004274 DNA Research, Recombinant
% 216.34/216.51  |- skos__hiddenLabel mesh__D004274 Joint, Recombination
% 216.34/216.51  |- skos__annotation mesh__D004274
% 216.34/216.51       IM; /drug eff /ultrastruct permitted; formed by in vitro joining of DNA from 2 different species: do not confuse with RECOMBINATION, GENETIC %28%within same species%29%; for guidelines for preventing hazards of recombinant DNA research, coord IM with CONTAINMENT OF BIOHAZARDS %28%IM%29% if by MeSH definition %28%procedures, facilities, programs, equipmt, etc.%29%; for ethical, moral or religious aspects of DNA research: coord with specific ethical, moral or religious aspect %28%IM%29%; for legal aspects, coord with LEGISLATION %28%IM%29%, not LEGISLATION, DRUG nor LEGISLATION, MEDICAL%A%  
% 216.34/216.51  |- skos__hiddenLabel mesh__D004274 Spliced Genes
% 216.34/216.51  |- skos__hiddenLabel mesh__D004274 Research, Recombinant DNA
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D004274 2005
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D004274 1998
% 216.34/216.51  |- mesh__publicMeSHNote mesh__D004274 77   
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D004274 2006
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D004274 2000
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D004274 1999
% 216.34/216.51  |- mesh__dateCreated mesh__D004274 1977-04-22
% 216.34/216.51  |- mesh__recordAuthorizer mesh__D004274 PLS
% 216.34/216.51  |- skos__prefLabel mesh__D004274 DNA, Recombinant
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D004274 2003
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D004274 1996
% 216.34/216.51  |- skos__altLabel mesh__D004274 Recombinant DNA
% 216.34/216.51  |- mesh__historyNote mesh__D004274 77   
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D004274 2001
% 216.34/216.51  |- skos__broader mesh__D004274smesh__D004247
% 216.34/216.51  |- skos__historyNote mesh__D004274 Recombination, Genetic %28%1968-1976%29%
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D004274 2004
% 216.34/216.51  |- mesh__activeMeSHYear mesh__D004274 1997
% 216.34/216.51  |- mesh__dateEstablished mesh__D004274 1977-01-01
% 216.34/216.51  |- skos__related mesh__D004274smesh__D005822
% 216.34/216.51  |- mesh__recordMaintainer mesh__D004274 KEV
% 216.34/216.51  |- mesh__recordOriginator mesh__D004274 RLS
% 216.34/216.51  |- skos__scopeNote mesh__D004274
% 216.34/216.51       Biologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected.%A%    
% 216.34/216.51  |- skos__historyNote mesh__D004274 DNA %28%1966-1976%29%
% 216.34/216.51  |- mesh__dateRevised mesh__D004274 1995-06-01
% 216.34/216.51  |- rdf__type mesh__D004274sskos__Concept
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D004274 2002
% 216.34/216.52  |- mesh__recordMaintainer mesh__D012706 SYSTEM
% 216.34/216.52  |- skos__broader mesh__D012706smesh__D012705
% 216.34/216.52  |- mesh__dateRevised mesh__D012706 2005-06-30
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D012706 2006
% 216.34/216.52  |- mesh__dateCreated mesh__D012706 1999-01-01
% 216.34/216.52  |- rdf__type mesh__D012706sskos__Concept
% 216.34/216.52  |- skos__scopeNote mesh__D012706
% 216.34/216.52       A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in soil, water, food, and clinical specimens. It is a prominent opportunistic pathogen for hospitalized patients.%A%    
% 216.34/216.52  |- skos__prefLabel mesh__D012706 Serratia marcescens
% 216.34/216.52  |- skos__annotation mesh__D012706
% 216.34/216.52       in water, soil, dairy products, insects; do not use /blood-csf-urine; opportunistic; infection: coord IM with SERRATIA INFECTIONS %28%IM%29%%A%  
% 216.34/216.52  |- mesh__recordAuthorizer mesh__D012706 sjn
% 216.34/216.52  |- mesh__recordOriginator mesh__D012706 NLM
% 216.34/216.52  |- skos__hiddenLabel mesh__D050825 SNAP 25B Protein
% 216.34/216.52  |- skos__altLabel mesh__D050825 SNAP25 Protein
% 216.34/216.52  |- skos__historyNote mesh__D050825 Nerve Tissue Proteins %28%1989-2005%29%
% 216.34/216.52  |- mesh__historyNote mesh__D050825 2006 %28%1990%29%   
% 216.34/216.52  |- skos__broader mesh__D050825smesh__D050766
% 216.34/216.52  |- skos__hiddenLabel mesh__D050825 Synaptosomal Associated Protein 25
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D050825 2006
% 216.34/216.52  |- skos__prefLabel mesh__D050825 Synaptosomal-Associated Protein 25
% 216.34/216.52  |- mesh__dateEstablished mesh__D050825 2006-01-01
% 216.34/216.52  |- mesh__publicMeSHNote mesh__D050825
% 216.34/216.52       2006; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25 was indexed under MEMBRANE PROTEINS and NERVE TISSUE PROTEINS 1990-2005%A%  
% 216.34/216.52  |- mesh__recordOriginator mesh__D050825 DRC
% 216.34/216.52  |- mesh__dateCreated mesh__D050825 2005-06-30
% 216.34/216.52  |- rdf__type mesh__D050825sskos__Concept
% 216.34/216.52  |- skos__broader mesh__D050825smesh__D050767
% 216.34/216.52  |- mesh__recordAuthorizer mesh__D050825 sjn
% 216.34/216.52  |- skos__annotation mesh__D050825 see SCR for organism-specific terms   
% 216.34/216.52  |- skos__altLabel mesh__D050825 SNAP-25 Protein
% 216.34/216.52  |- mesh__recordMaintainer mesh__D050825 DRC
% 216.34/216.52  |- skos__hiddenLabel mesh__D050825 SNAP 25 Protein
% 216.34/216.52  |- skos__historyNote mesh__D050825 Membrane Proteins %28%1989-2005%29%
% 216.34/216.52  |- skos__scopeNote mesh__D050825
% 216.34/216.52       A ubiquitous target SNARE protein that interacts with SYNTAXIN and SYNAPTOBREVIN. It is a core component of the machinery for intracellular MEMBRANE FUSION. The sequence contains 2 SNARE domains, one is the prototype for the Qb-SNARES, and the other is the prototype for the Qc-SNARES.%A%    
% 216.34/216.52  |- mesh__dateCreated mesh__D008665 1976-04-16
% 216.34/216.52  |- mesh__dateEstablished mesh__D008665 1977-01-01
% 216.34/216.52  |- mesh__publicMeSHNote mesh__D008665 77   
% 216.34/216.52  |- skos__historyNote mesh__D008665 Porphyrins %28%1966-1976%29%
% 216.34/216.52  |- skos__historyNote mesh__D008665
% 216.34/216.52       Organometallic Compounds %28%1968-1976%29%
% 216.34/216.52  |- mesh__recordOriginator mesh__D008665 RLS
% 216.34/216.52  |- skos__prefLabel mesh__D008665 Metalloporphyrins
% 216.34/216.52  |- mesh__recordAuthorizer mesh__D008665 sjn
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D008665 2006
% 216.34/216.52  |- skos__broader mesh__D008665smesh__D011166
% 216.34/216.52  |- skos__annotation mesh__D008665
% 216.34/216.52       pigments %28%porphyrins%29% %22%combined with a metal ion%22%; iron porphyrins = HEME or HEMIN, magnesium porphyrins = CHLOROPHYLL%A%  
% 216.34/216.52  |- mesh__recordMaintainer mesh__D008665 ssb
% 216.34/216.52  |- skos__scopeNote mesh__D008665
% 216.34/216.52       Porphyrins which are combined with a metal ion. The metal is bound equally to all four nitrogen atoms of the pyrrole rings. They possess characteristic absorption spectra which can be utilized for identification or quantitative estimation of porphyrins and porphyrin-bound compounds.%A%    
% 216.34/216.52  |- mesh__historyNote mesh__D008665 77   
% 216.34/216.52  |- rdf__type mesh__D008665sskos__Concept
% 216.34/216.52  |- skos__historyNote mesh__D008665 specific porphyrin %28%1966-1976%29%
% 216.34/216.52  |- mesh__dateRevised mesh__D008665 2005-06-30
% 216.34/216.52  |- skos__broader mesh__D000682smesh__D046912
% 216.34/216.52  |- mesh__historyNote mesh__D000682
% 216.34/216.52       68; was AMYLOID SUBSTANCE 1963-67 %28%Cat C heading only 1966-67, Cat A heading only 1963-64%29%%A%  
% 216.34/216.52  |- skos__hiddenLabel mesh__D000682 Substance, Amyloid
% 216.34/216.52  |- mesh__recordOriginator mesh__D000682 NLM
% 216.34/216.52  |- mesh__dateEstablished mesh__D000682 1968-01-01
% 216.34/216.52  |- mesh__dateCreated mesh__D000682 1999-01-01
% 216.34/216.52  |- skos__broader mesh__D000682smesh__D011506
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D000682 2006A
% 216.34/216.52  |- skos__prefLabel mesh__D000682 Amyloid
% 216.34/216.52  |- skos__scopeNote mesh__D000682
% 216.34/216.52       A type of extracellularly deposited substance composed of an amyloid protein and additional components including HEPARAN SULFATE PROTEOGLYCAN; LAMININ; COLLAGEN TYPE IV; SERUM AMYLOID P-COMPONENT; and APOLIPOPROTEINS E which together form characteristic amyloid fibrils. The core of amyloid fibrils is formed by the stacking of overlapping beta-pleated sheet domains of the amyloid protein.  There are many different amyloid proteins that have been found forming the core of the fibrils in vivo. However, amyloid can be formed from any protein that exposes beta-pleated strand conformations during unfolding or refolding. A common characteristic of amyloid is the ability to bind such dyes as CONGO RED and thioflavine.%A%    
% 216.34/216.52  |- skos__hiddenLabel mesh__D000682 Fibrils, Amyloid
% 216.34/216.52  |- mesh__publicMeSHNote mesh__D000682 68; was AMYLOID SUBSTANCE 1963-67   
% 216.34/216.52  |- mesh__dateRevised mesh__D000682 2005-07-29
% 216.34/216.52  |- mesh__recordAuthorizer mesh__D000682 ags
% 216.34/216.52  |- mesh__onlineNote mesh__D000682
% 216.34/216.52       use AMYLOID to search AMYLOID SUBSTANCE 1966-67 %28%as Cat C heading%29%%A%  
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D000682 2005
% 216.34/216.52  |- skos__altLabel mesh__D000682 Amyloid Substance
% 216.34/216.52  |- rdf__type mesh__D000682sskos__Concept
% 216.34/216.52  |- mesh__recordMaintainer mesh__D000682 ags
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D000682 2006
% 216.34/216.52  |- skos__related mesh__D000682smesh__D000686
% 216.34/216.52  |- skos__hiddenLabel mesh__D000682 Proteins, Amyloid
% 216.34/216.52  |- mesh__recordOriginator mesh__D013001 EC
% 216.34/216.52  |- skos__altLabel mesh__D013001 Briquet Syndrome
% 216.34/216.52  |- mesh__publicMeSHNote mesh__D013001 81   
% 216.34/216.52  |- skos__hiddenLabel mesh__D013001 Somatization Disorders
% 216.34/216.52  |- mesh__recordMaintainer mesh__D013001 nns
% 216.34/216.52  |- skos__scopeNote mesh__D013001
% 216.34/216.52       Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by a general medical condition, by the direct effects of a substance, or by another mental disorder. The symptoms must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. %28%APA, DSM-IV%29%%A%    
% 216.34/216.52  |- skos__broader mesh__D013001smesh__D001523
% 216.34/216.52  |- skos__hiddenLabel mesh__D013001 Somatoform Disorder
% 216.34/216.52  |- mesh__dateRevised mesh__D013001 2001-07-25
% 216.34/216.52  |- skos__hiddenLabel mesh__D013001 Syndrome, Briquet
% 216.34/216.52  |- skos__prefLabel mesh__D013001 Somatoform Disorders
% 216.34/216.52  |- mesh__dateCreated mesh__D013001 1980-05-21
% 216.34/216.52  |- skos__annotation mesh__D013001
% 216.34/216.52       differentiate from FACTITIOUS DISORDERS and PSYCHOPHYSIOLOGIC DISORDERS%A%  
% 216.34/216.52  |- rdf__type mesh__D013001sskos__Concept
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D013001 2003
% 216.34/216.52  |- mesh__dateEstablished mesh__D013001 1981-01-01
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D013001 2005
% 216.34/216.52  |- mesh__recordAuthorizer mesh__D013001 sjn
% 216.34/216.52  |- mesh__historyNote mesh__D013001 81   
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D013001 2004
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D013001 2002
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D013001 2006
% 216.34/216.52  |- rdf__type mesh__D032764sskos__Concept
% 216.34/216.52  |- mesh__dateCreated mesh__D032764 2002-07-03
% 216.34/216.52  |- skos__historyNote mesh__D032764 Ethical Analysis %28%2002%29%
% 216.34/216.52  |- skos__broader mesh__D032764smesh__D026689
% 216.34/216.52  |- skos__scopeNote mesh__D032764
% 216.34/216.52       A method of ETHICAL ANALYSIS that emphasizes practical problem solving through examining individual cases that are considered to be representative; sometimes used to denote specious argument or rationalization.  Differentiate from casuistics, which is the recording and study of cases and disease.%A%    
% 216.34/216.52  |- skos__historyNote mesh__D032764 Ethics %28%1989-2001%29%
% 216.34/216.52  |- mesh__dateEstablished mesh__D032764 2003-01-01
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D032764 2005
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D032764 2003
% 216.34/216.52  |- skos__prefLabel mesh__D032764 Casuistry
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D032764 2006
% 216.34/216.52  |- mesh__publicMeSHNote mesh__D032764
% 216.34/216.52       2003; see ETHICAL ANALYSIS 2002; see ETHICS 1992-2001   
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D032764 2004
% 216.34/216.52  |- skos__annotation mesh__D032764
% 216.34/216.52       do not confuse with %22%casuistics,%22% the recording and study of cases of  disease, or with CAUSALITY%A%  
% 216.34/216.52  |- mesh__historyNote mesh__D032764
% 216.34/216.52       2003; use ETHICAL ANALYSIS 2002; use ETHICS 1992-2001   
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D018295 2001
% 216.34/216.52  |- mesh__publicMeSHNote mesh__D018295 94   
% 216.34/216.52  |- mesh__recordAuthorizer mesh__D018295 sjn
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D018295 2004
% 216.34/216.52  |- mesh__recordOriginator mesh__D018295 PLS
% 216.34/216.52  |- skos__broader mesh__D018295smesh__D009375
% 216.34/216.52  |- mesh__dateRevised mesh__D018295 1999-11-03
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D018295 2000
% 216.34/216.52  |- mesh__dateEstablished mesh__D018295 1994-01-01
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D018295 2003
% 216.34/216.52  |- skos__hiddenLabel mesh__D018295 Neoplasm, Basal Cell
% 216.34/216.52  |- skos__hiddenLabel mesh__D018295 Cell Neoplasm, Basal
% 216.34/216.52  |- mesh__recordMaintainer mesh__D018295 nns
% 216.34/216.52  |- skos__hiddenLabel mesh__D018295 Basal Cell Neoplasm
% 216.34/216.52  |- mesh__historyNote mesh__D018295 94   
% 216.34/216.52  |- skos__hiddenLabel mesh__D018295 Cancers, Basal Cell
% 216.34/216.52  |- mesh__dateCreated mesh__D018295 1993-06-03
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D018295 2006
% 216.34/216.52  |- skos__hiddenLabel mesh__D018295 Cell Neoplasms, Basal
% 216.34/216.52  |- skos__hiddenLabel mesh__D018295 Cancer, Basal Cell
% 216.34/216.52  |- skos__annotation mesh__D018295
% 216.34/216.52       coord IM with precoord organ/neopl term %28%IM%29%; DF: NEOPL BASAL CELL%A%  
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D018295 2002
% 216.34/216.52  |- skos__hiddenLabel mesh__D018295 Cell Cancer, Basal
% 216.34/216.52  |- skos__hiddenLabel mesh__D018295 Basal Cell Cancers
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D018295 2005
% 216.34/216.52  |- rdf__type mesh__D018295sskos__Concept
% 216.34/216.52  |- skos__altLabel mesh__D018295 Basal Cell Neoplasms
% 216.34/216.52  |- skos__hiddenLabel mesh__D018295 Cell Cancers, Basal
% 216.34/216.52  |- skos__scopeNote mesh__D018295
% 216.34/216.52       Neoplasms composed of cells from the deepest layer of the epidermis. The concept does not refer to neoplasms located in the stratum basale.%A%    
% 216.34/216.52  |- skos__prefLabel mesh__D018295 Neoplasms, Basal Cell
% 216.34/216.52  |- mesh__dateCreated mesh__D004275 1984-05-24
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D004275 2006
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D004275 2002
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D004275 2003
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D004275 2006B
% 216.34/216.52  |- skos__broader mesh__D004275smesh__D004247
% 216.34/216.52  |- skos__historyNote mesh__D004275 DNA %28%1966-1984%29%
% 216.34/216.52  |- skos__annotation mesh__D004275
% 216.34/216.52       DNA, RIBOSOMAL SPACER is also available   
% 216.34/216.52  |- mesh__recordAuthorizer mesh__D004275 ags
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D004275 2004
% 216.34/216.52  |- mesh__recordMaintainer mesh__D004275 ags
% 216.34/216.52  |- skos__related mesh__D004275smesh__D014158
% 216.34/216.52  |- skos__historyNote mesh__D004275 Ribosomes %28%1966-1984%29%
% 216.34/216.52  |- mesh__publicMeSHNote mesh__D004275 85   
% 216.34/216.52  |- skos__prefLabel mesh__D004275 DNA, Ribosomal
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D004275 2001
% 216.34/216.52  |- skos__altLabel mesh__D004275 rDNA
% 216.34/216.52  |- skos__altLabel mesh__D004275 Ribosomal DNA
% 216.34/216.52  |- mesh__dateRevised mesh__D004275 2005-07-28
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D004275 2005
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D004275 2006A
% 216.34/216.52  |- rdf__type mesh__D004275sskos__Concept
% 216.34/216.52  |- skos__scopeNote mesh__D004275
% 216.34/216.52       DNA sequences encoding RIBOSOMAL RNA and the segments of DNA separating the individual ribosomal RNA genes, referred to as RIBOSOMAL SPACER DNA.%A%    
% 216.34/216.52  |- mesh__recordOriginator mesh__D004275 RLS
% 216.34/216.52  |- mesh__historyNote mesh__D004275 85   
% 216.34/216.52  |- mesh__dateEstablished mesh__D004275 1985-01-01
% 216.34/216.52  |- rdf__type mesh__D012707sskos__Concept
% 216.34/216.52  |- skos__hiddenLabel mesh__D012707 Tumor, Sertoli Cell
% 216.34/216.52  |- mesh__recordAuthorizer mesh__D012707 sjn
% 216.34/216.52  |- mesh__recordOriginator mesh__D012707 NLM
% 216.34/216.52  |- skos__broader mesh__D012707smesh__D018310
% 216.34/216.52  |- skos__prefLabel mesh__D012707 Sertoli Cell Tumor
% 216.34/216.52  |- skos__scopeNote mesh__D012707
% 216.34/216.52       Gonadal neoplasm composed entirely of SERTOLI CELLS or may have a component of GRANULOSA CELLS. Some of the Sertoli cell tumors produce ESTROGEN or ANDROGENS, but seldom in sufficient quantity to cause clinical symptoms such as FEMINIZATION or masculinization %28%VIRILISM%29%.%A%    
% 216.34/216.52  |- skos__annotation mesh__D012707
% 216.34/216.52       coordinate IM with TESTICULAR NEOPLASMS %28%IM%29% in male or OVARIAN NEOPLASMS %28%IM%29% if in female%A%  
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D012707 2006
% 216.34/216.52  |- mesh__dateRevised mesh__D012707 2004-07-07
% 216.34/216.52  |- mesh__dateCreated mesh__D012707 1999-01-01
% 216.34/216.52  |- mesh__recordMaintainer mesh__D012707 lkt
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D012707 2005
% 216.34/216.52  |- mesh__dateCreated mesh__D050826 2005-06-30
% 216.34/216.52  |- mesh__recordMaintainer mesh__D050826 DRC
% 216.34/216.52  |- mesh__dateEstablished mesh__D050826 2006-01-01
% 216.34/216.52  |- mesh__recordAuthorizer mesh__D050826 sjn
% 216.34/216.52  |- mesh__recordOriginator mesh__D050826 DRC
% 216.34/216.52  |- skos__broader mesh__D050826smesh__D048868
% 216.34/216.52  |- mesh__publicMeSHNote mesh__D050826 2006   
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D050826 2006
% 216.34/216.52  |- skos__scopeNote mesh__D050826
% 216.34/216.52       A family of structurally related proteins that are induced by CYTOKINES and negatively regulate cytokine-mediated SIGNAL TRANSDUCTION PATHWAYS.  SOCS proteins contain a central SH2 DOMAIN and a C-terminal region of homology known as the SOCS box.%A%    
% 216.34/216.52  |- skos__prefLabel mesh__D050826 Suppressor of Cytokine Signaling Proteins
% 216.34/216.52  |- mesh__historyNote mesh__D050826 2006   
% 216.34/216.52  |- rdf__type mesh__D050826sskos__Concept
% 216.34/216.52  |- skos__altLabel mesh__D050826 SOCS Proteins
% 216.34/216.52  |- skos__altLabel mesh__D050826 Suppressors of Cytokine Signaling Proteins
% 216.34/216.52  |- skos__altLabel mesh__D008666 Metallo-Endoproteinases
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D008666 2006
% 216.34/216.52  |- skos__prefLabel mesh__D008666 Metalloendopeptidases
% 216.34/216.52  |- skos__historyNote mesh__D008666
% 216.34/216.52       Peptide Peptidohydrolases %28%1966-1987%29%
% 216.34/216.52  |- mesh__dateRevised mesh__D008666 2003-07-09
% 216.34/216.52  |- skos__broader mesh__D008666smesh__D010450
% 216.34/216.52  |- mesh__recordMaintainer mesh__D008666 jmp
% 216.34/216.52  |- skos__altLabel mesh__D008666 Metalloendopeptidase
% 216.34/216.52  |- mesh__recordOriginator mesh__D008666 RLS
% 216.34/216.52  |- mesh__historyNote mesh__D008666 2000%28%1988%29%   
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D008666 2004
% 216.34/216.52  |- mesh__publicMeSHNote mesh__D008666
% 216.34/216.52       2000; see METALLOPROTEINASES 1988-1999   
% 216.34/216.52  |- rdf__type mesh__D008666sskos__Concept
% 216.34/216.52  |- mesh__dateCreated mesh__D008666 1987-05-04
% 216.34/216.52  |- skos__broader mesh__D008666smesh__D045726
% 216.34/216.52  |- mesh__recordAuthorizer mesh__D008666 sjn
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D008666 2005
% 216.34/216.52  |- skos__scopeNote mesh__D008666
% 216.34/216.52       ENDOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism.%A%    
% 216.34/216.52  |- mesh__dateEstablished mesh__D008666 1988-01-01
% 216.34/216.52  |- skos__hiddenLabel mesh__D000683 Serum Amyloid P Component
% 216.34/216.52  |- skos__hiddenLabel mesh__D000683 Amyloid P-Component, Serum
% 216.34/216.52  |- mesh__dateCreated mesh__D000683 1986-04-14
% 216.34/216.52  |- skos__historyNote mesh__D000683 Amyloid %28%1966-1986%29%
% 216.34/216.52  |- mesh__recordAuthorizer mesh__D000683 sjn
% 216.34/216.52  |- skos__broader mesh__D000683smesh__D000209
% 216.34/216.52  |- skos__hiddenLabel mesh__D000683 P-Component, Serum Amyloid
% 216.34/216.52  |- mesh__recordMaintainer mesh__D000683 jmp
% 216.34/216.52  |- skos__broader mesh__D000683smesh__D006023
% 216.34/216.52  |- skos__scopeNote mesh__D000683
% 216.34/216.52       Amyloid P component is a small, non-fibrillar glycoprotein found in normal serum and in all amyloid deposits. It has a pentagonal %28%pentaxin%29% structure. It is an acute phase protein, modulates immunologic responses, inhibits ELASTASE, and has been suggested as an indicator of LIVER DISEASE.%A%    
% 216.34/216.52  |- skos__hiddenLabel mesh__D000683 P Component, Amyloid
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D000683 2005
% 216.34/216.52  |- mesh__recordOriginator mesh__D000683 RLS
% 216.34/216.52  |- skos__broader mesh__D000683smesh__D000682
% 216.34/216.52  |- mesh__dateRevised mesh__D000683 2004-07-07
% 216.34/216.52  |- rdf__type mesh__D000683sskos__Concept
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D000683 2006
% 216.34/216.52  |- mesh__historyNote mesh__D000683 87   
% 216.34/216.52  |- skos__annotation mesh__D000683 /biosyn /physiol permitted   
% 216.34/216.52  |- skos__altLabel mesh__D000683 Amyloid P Component
% 216.34/216.52  |- mesh__publicMeSHNote mesh__D000683 87   
% 216.34/216.52  |- skos__prefLabel mesh__D000683 Serum Amyloid P-Component
% 216.34/216.52  |- mesh__dateEstablished mesh__D000683 1987-01-01
% 216.34/216.52  |- mesh__recordMaintainer mesh__D013800 PLS
% 216.34/216.52  |- skos__broader mesh__D013800smesh__D003415
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D013800 2002
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D013800 1995
% 216.34/216.52  |- skos__hiddenLabel mesh__D013800 Thefts
% 216.34/216.52  |- skos__altLabel mesh__D013800 Stealing
% 216.34/216.52  |- skos__prefLabel mesh__D013800 Theft
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D013800 1999
% 216.34/216.52  |- mesh__publicMeSHNote mesh__D013800 78   
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D013800 1994
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D013800 1997
% 216.34/216.52  |- skos__hiddenLabel mesh__D013800 Stealings
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D013800 1998
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D013800 2006
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D013800 2001
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D013800 1996
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D013800 2004
% 216.34/216.52  |- mesh__historyNote mesh__D013800 78   
% 216.34/216.52  |- rdf__type mesh__D013800sskos__Concept
% 216.34/216.52  |- mesh__recordOriginator mesh__D013800 EC
% 216.34/216.52  |- skos__scopeNote mesh__D013800 Unlawful act of taking property.     
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D013800 2005
% 216.34/216.52  |- mesh__recordAuthorizer mesh__D013800 NLM
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D013800 2000
% 216.34/216.52  |- mesh__dateRevised mesh__D013800 1993-06-05
% 216.34/216.52  |- mesh__dateCreated mesh__D013800 1977-05-12
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D013800 2003
% 216.34/216.52  |- mesh__dateEstablished mesh__D013800 1978-01-01
% 216.34/216.52  |- skos__annotation mesh__D013002
% 216.34/216.52       neurotransmitters; GEN or unspecified; prefer specifics; /biosyn /physiol permitted%A%  
% 216.34/216.52  |- skos__related mesh__D013002smesh__D017451
% 216.34/216.52  |- skos__altLabel mesh__D013002 Insulin-Like Growth Factors
% 216.34/216.52  |- skos__historyNote mesh__D013002 Sulfates/metabolism %28%1966-1970%29%
% 216.34/216.52  |- skos__altLabel mesh__D013002 Sulfation Factor
% 216.34/216.52  |- mesh__dateRevised mesh__D013002 2005-06-30
% 216.34/216.52  |- skos__altLabel mesh__D013002 Somatomedin
% 216.34/216.52  |- skos__broader mesh__D013002smesh__D036341
% 216.34/216.52  |- skos__broader mesh__D013002smesh__D006133
% 216.34/216.52  |- skos__broader mesh__D013002smesh__D001798
% 216.34/216.52  |- rdf__type mesh__D013002sskos__Concept
% 216.34/216.52  |- skos__hiddenLabel mesh__D013002 Factor, Sulfation
% 216.34/216.52  |- mesh__dateCreated mesh__D013002 1999-01-01
% 216.34/216.52  |- mesh__onlineNote mesh__D013002
% 216.34/216.52       use SOMATOMEDINS to search SOMATOMEDIN 1973-81 %26% SULFATION FACTOR 1971-72 %28%as Prov 1971-72%29%%A%  
% 216.34/216.52  |- mesh__dateEstablished mesh__D013002 1973-01-01
% 216.34/216.52  |- skos__hiddenLabel mesh__D013002 Factors, Insulin-Like Growth
% 216.34/216.52  |- mesh__historyNote mesh__D013002
% 216.34/216.52       82; was SOMATOMEDIN 1973-81, was SULFATION FACTOR 1971-72 %28%Prov%29%%A%  
% 216.34/216.52  |- skos__hiddenLabel mesh__D013002 Growth Factors, Insulin-Like
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D013002 2006
% 216.34/216.52  |- skos__altLabel mesh__D013002 Insulin Like Growth Factors
% 216.34/216.52  |- mesh__publicMeSHNote mesh__D013002 82; was SOMATOMEDIN 1973-81   
% 216.34/216.52  |- skos__prefLabel mesh__D013002 Somatomedins
% 216.34/216.52  |- skos__scopeNote mesh__D013002
% 216.34/216.52       Insulin-like polypeptides made by the liver and some fibroblasts and released into the blood when stimulated by SOMATOTROPIN. They cause sulfate incorporation into collagen, RNA, and DNA synthesis, which are prerequisites to cell division and growth of the organism.%A%    
% 216.34/216.52  |- mesh__recordMaintainer mesh__D013002 ssb
% 216.34/216.52  |- mesh__recordOriginator mesh__D013002 NLM
% 216.34/216.52  |- mesh__recordAuthorizer mesh__D013002 sjn
% 216.34/216.52  |- skos__historyNote mesh__D013002 Blood Proteins %28%1966-1970%29%
% 216.34/216.52  |- skos__broader mesh__D018296smesh__D018295
% 216.34/216.52  |- mesh__recordOriginator mesh__D018296 PLS
% 216.34/216.52  |- skos__scopeNote mesh__D018296
% 216.34/216.52       A tumor composed of cells resembling those of the hair matrix, which undergo %27%mummification%27% and may calcify. It is a relatively uncommon tumor, which may occur at any age from infancy. The majority of patients are under 20, and females are affected more than males. The lesion is usually a solitary deep dermal or subcutaneous tumor 3-30 mm in diameter, situated in the head, neck, or upper extremity. %28%From Rook et al., Textbook of Dermatology, 4th ed, p2401%29%%A%    
% 216.34/216.52  |- mesh__dateCreated mesh__D018296 1993-06-25
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D018296 2003
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D018296 1996
% 216.34/216.52  |- skos__historyNote mesh__D018296 Skin Neoplasms %28%1966-1993%29%
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D018296 2006
% 216.34/216.52  |- mesh__historyNote mesh__D018296 94   
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D018296 2001
% 216.34/216.52  |- mesh__publicMeSHNote mesh__D018296 94   
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D018296 1999
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D018296 2000
% 216.34/216.52  |- skos__annotation mesh__D018296
% 216.34/216.52       benign or malignant; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with SKIN NEOPLASMS %28%IM%29% + HAIR DISEASES %28%IM%29%%A%  
% 216.34/216.52  |- mesh__dateEstablished mesh__D018296 1994-01-01
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D018296 2005
% 216.34/216.52  |- mesh__recordAuthorizer mesh__D018296 PLS
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D018296 1998
% 216.34/216.52  |- rdf__type mesh__D018296sskos__Concept
% 216.34/216.52  |- skos__prefLabel mesh__D018296 Pilomatrixoma
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D018296 2002
% 216.34/216.52  |- mesh__recordMaintainer mesh__D018296 KEV
% 216.34/216.52  |- skos__hiddenLabel mesh__D018296 Pilomatrixomas
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D018296 2004
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D018296 1997
% 216.34/216.52  |- mesh__dateRevised mesh__D018296 1995-06-08
% 216.34/216.52  |- skos__broader mesh__D004276smesh__D020080
% 216.34/216.52  |- rdf__type mesh__D004276sskos__Concept
% 216.34/216.52  |- skos__hiddenLabel mesh__D004276 DNA, Satellite I
% 216.34/216.52  |- skos__scopeNote mesh__D004276
% 216.34/216.52       Highly repetitive DNA sequences found in HETEROCHROMATIN, mainly near centromeres. They are composed of simple sequences %28%very short%29% %28%see MINISATELLITE REPEATS%29% repeated in tandem many times to form large blocks of sequence. Additionally, following the accumulation of mutations, these blocks of repeats have been repeated in tandem themselves. The degree of repetition is on the order of 1000 to 10 million at each locus. Loci are few, usually one or two per chromosome. They were called satellites since in density gradients, they often sediment as distinct, satellite bands separate from the bulk of genomic DNA owing to a distinct BASE COMPOSITION.%A%    
% 216.34/216.52  |- skos__historyNote mesh__D004276 DNA %28%1966-1974%29%
% 216.34/216.52  |- skos__altLabel mesh__D004276 Satellite DNA
% 216.34/216.52  |- mesh__recordAuthorizer mesh__D004276 sjn
% 216.34/216.52  |- mesh__recordMaintainer mesh__D004276 nns
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D004276 2006
% 216.34/216.52  |- mesh__historyNote mesh__D004276
% 216.34/216.52       80%28%75%29%; was see under DNA 1975-79   
% 216.34/216.52  |- skos__hiddenLabel mesh__D004276 I DNAs, Satellite
% 216.34/216.52  |- mesh__dateRevised mesh__D004276 2005-06-30
% 216.34/216.52  |- skos__hiddenLabel mesh__D004276 DNAs, Satellite
% 216.34/216.52  |- skos__prefLabel mesh__D004276 DNA, Satellite
% 216.34/216.52  |- mesh__dateCreated mesh__D004276 1974-11-11
% 216.34/216.52  |- skos__hiddenLabel mesh__D004276 I DNA, Satellite
% 216.34/216.52  |- mesh__publicMeSHNote mesh__D004276 80; was see under DNA 1975-79   
% 216.34/216.52  |- skos__hiddenLabel mesh__D004276 DNAs, Satellite I
% 216.34/216.52  |- skos__related mesh__D004276smesh__D002503
% 216.34/216.52  |- skos__hiddenLabel mesh__D004276 Satellite DNAs
% 216.34/216.52  |- skos__broader mesh__D004276smesh__D021901
% 216.34/216.52  |- skos__broader mesh__D004276smesh__D004247
% 216.34/216.52  |- mesh__dateEstablished mesh__D004276 1980-01-01
% 216.34/216.52  |- mesh__recordOriginator mesh__D004276 NLM
% 216.34/216.52  |- skos__hiddenLabel mesh__D004276 Satellite I DNAs
% 216.34/216.52  |- mesh__recordMaintainer mesh__D012708 lkt
% 216.34/216.52  |- skos__hiddenLabel mesh__D012708 Cells, Sertoli
% 216.34/216.52  |- mesh__historyNote mesh__D012708 68%28%64%29%   
% 216.34/216.52  |- mesh__publicMeSHNote mesh__D012708 68   
% 216.34/216.52  |- mesh__dateEstablished mesh__D012708 1968-01-01
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D012708 2004
% 216.34/216.52  |- skos__broader mesh__D012708smesh__D004847
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D012708 2006
% 216.34/216.52  |- mesh__recordOriginator mesh__D012708 NLM
% 216.34/216.52  |- mesh__dateRevised mesh__D012708 2002-07-03
% 216.34/216.52  |- mesh__recordAuthorizer mesh__D012708 sjn
% 216.34/216.52  |- skos__broader mesh__D012708smesh__D013737
% 216.34/216.52  |- mesh__dateCreated mesh__D012708 1999-01-01
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D012708 2003
% 216.34/216.52  |- skos__prefLabel mesh__D012708 Sertoli Cells
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D012708 2005
% 216.34/216.52  |- rdf__type mesh__D012708sskos__Concept
% 216.34/216.52  |- skos__scopeNote mesh__D012708
% 216.34/216.52       Supporting cells projecting inward from the basement membrane of SEMINIFEROUS TUBULES. They surround and nourish the developing male germ cells and secrete ANDROGEN-BINDING PROTEIN. Their tight junctions with the SPERMATOGONIA and SPERMATOCYTES provide a BLOOD-TESTIS BARRIER.%A%    
% 216.34/216.52  |- skos__broader mesh__D050827smesh__D050765
% 216.34/216.52  |- skos__altLabel mesh__D050827 Syntaxin-1C Protein
% 216.34/216.52  |- skos__hiddenLabel mesh__D050827 Syntaxin 1B Protein
% 216.34/216.52  |- mesh__recordMaintainer mesh__D050827 nns
% 216.34/216.52  |- skos__altLabel mesh__D050827 Syntaxin 1A
% 216.34/216.52  |- mesh__publicMeSHNote mesh__D050827
% 216.34/216.52       2006; SYNTAXIN 1 was indexed under ANTIGENS, SURFACE and NERVE TISSUE PROTEINS 1993-2005, and MEMBRANE PROTEINS 1992%A%  
% 216.34/216.52  |- mesh__activeMeSHYear mesh__D050827 2006
% 216.34/216.52  |- mesh__dateCreated mesh__D050827 2005-06-30
% 216.34/216.52  |- mesh__recordOriginator mesh__D050827 nns
% 216.34/216.52  |- mesh__dateEstablished mesh__D050827 2006-01-01
% 216.34/216.52  |- skos__hiddenLabel mesh__D050827 Neuronal Cell Membrane Antigen, HPC 1
% 216.34/216.52  |- mesh__recordAuthorizer mesh__D050827 sjn
% 216.34/216.52  |- skos__hiddenLabel mesh__D050827 Syntaxin 1C
% 216.34/216.52  |- skos__altLabel mesh__D050827 Syntaxin A Protein
% 216.34/216.52  |- mesh__historyNote mesh__D050827 2006 %28%1992%29%   
% 216.34/216.52  |- skos__altLabel mesh__D050827 P35B Antigen
% 216.34/216.52  |- skos__scopeNote mesh__D050827
% 216.34/216.52       A neuronal cell membrane protein that combines with SNAP-25 and SYNAPTOBREVIN 2 to form a SNARE complex that leads to EXOCYTOSIS.%A%    
% 216.34/216.52  |- rdf__type mesh__D050827sskos__Concept
% 216.34/216.52  |- skos__historyNote mesh__D050827 Nerve Tissue Proteins %28%1995-2005%29%
% 216.34/216.52  |- skos__annotation mesh__D050827 see SCR for organism-specific terms   
% 216.34/216.52  |- skos__hiddenLabel mesh__D050827 Syntaxin 1B
% 216.34/216.52  |- skos__hiddenLabel mesh__D050827 Syntaxin 1A Protein
% 216.34/216.52  |- skos__hiddenLabel mesh__D050827 HPC 1 Protein
% 216.34/216.52  |- skos__altLabel mesh__D050827 Syntaxin-2 Protein
% 216.34/216.52  |- skos__altLabel mesh__D050827 Syntaxin-1B Protein
% 216.34/216.52  |- skos__hiddenLabel mesh__D050827 Syntaxin 2
% 216.34/216.52  |- skos__altLabel mesh__D050827 Neuronal Cell Membrane Antigen, HPC-1
% 216.34/216.52  |- skos__altLabel mesh__D050827 HPC-1 Protein
% 216.34/216.52  |- skos__altLabel mesh__D050827 Syntaxin 1 Protein
% 216.34/216.52  |- skos__prefLabel mesh__D050827 Syntaxin 1
% 216.34/216.52  |- skos__hiddenLabel mesh__D050827 Syntaxin 1C Protein
% 216.34/216.52  |- skos__historyNote mesh__D050827 Antigens, Surface %28%1995-2005%29%
% 216.34/216.52  |- skos__altLabel mesh__D050827 Syntaxin-1A Protein
% 216.34/216.52  |- skos__hiddenLabel mesh__D050827 Syntaxin 2 Protein
% 216.34/216.52  |- skos__altLabel mesh__D050827 p35b Protein
% 216.34/216.52  |- mesh__recordAuthorizer mesh__D008667 sjn
% 216.34/216.52  |- mesh__dateEstablished mesh__D008667 1973-01-01
% 216.34/216.52  |- skos__broader mesh__D008667smesh__D011506
% 216.34/216.52  |- skos__scopeNote mesh__D008667
% 216.34/216.52       Proteins that have one or more tightly bound metal ions forming part of their structure. %28%Dorland, 28th ed%29%%A%    
% 216.34/216.52  |- mesh__publicMeSHNote mesh__D008667 73   
% 216.34/216.52  |- skos__historyNote mesh__D008667 specific metal %28%1966-1972%29%
% 216.34/216.53  |- rdf__type mesh__D008667sskos__Concept
% 216.34/216.53  |- mesh__recordMaintainer mesh__D008667 SYSTEM
% 216.34/216.53  |- skos__historyNote mesh__D008667 Proteins %28%1966-1972%29%
% 216.34/216.53  |- mesh__recordOriginator mesh__D008667 NLM
% 216.34/216.53  |- mesh__dateRevised mesh__D008667 2005-06-30
% 216.34/216.53  |- skos__annotation mesh__D008667
% 216.34/216.53       coord IM with specific metal %28%IM%29%   
% 216.34/216.53  |- mesh__historyNote mesh__D008667 73   
% 216.34/216.53  |- mesh__dateCreated mesh__D008667 1999-01-01
% 216.34/216.53  |- skos__prefLabel mesh__D008667 Metalloproteins
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D008667 2006
% 216.34/216.53  |- mesh__historyNote mesh__D027821 2002   
% 216.34/216.53  |- mesh__recordAuthorizer mesh__D027821 sjn
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D027821 2004
% 216.34/216.53  |- mesh__dateRevised mesh__D027821 2003-07-09
% 216.34/216.53  |- skos__altLabel mesh__D027821 Kumquat
% 216.34/216.53  |- mesh__dateCreated mesh__D027821 2001-07-25
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D027821 2005
% 216.34/216.53  |- mesh__recordMaintainer mesh__D027821 ssb
% 216.34/216.53  |- skos__altLabel mesh__D027821 Claussena
% 216.34/216.53  |- skos__annotation mesh__D027821
% 216.34/216.53       X ref FAGARA: FAGARA HORRIDA see GLEDITSIA is also available; see also X refs at ZANTHOXYLUM for other species of FAGARA; unspecified FAGARA goes here; prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D027821 2006
% 216.34/216.53  |- skos__scopeNote mesh__D027821
% 216.34/216.53       A plant family in the order Sapindales that grows in warmer regions and has conspicuous flowers. Fagara species have been reclassified, most to ZANTHOXYLUM, some to Melicope or GLEDITSIA. The common name of stinkwood used for Zieria is also used for OCOTEA.%A%    
% 216.34/216.53  |- skos__broader mesh__D027821smesh__D019684
% 216.34/216.53  |- skos__historyNote mesh__D027821 Plants, Medicinal %28%1966-2001%29%
% 216.34/216.53  |- mesh__publicMeSHNote mesh__D027821 2002   
% 216.34/216.53  |- mesh__dateEstablished mesh__D027821 2002-01-01
% 216.34/216.53  |- skos__prefLabel mesh__D027821 Rutaceae
% 216.34/216.53  |- skos__altLabel mesh__D027821 Lime, Australian Wild
% 216.34/216.53  |- mesh__recordOriginator mesh__D027821 ssb
% 216.34/216.53  |- skos__altLabel mesh__D027821 Australian Wild Lime
% 216.34/216.53  |- rdf__type mesh__D027821sskos__Concept
% 216.34/216.53  |- skos__altLabel mesh__D013801 Theileriosis
% 216.34/216.53  |- skos__hiddenLabel mesh__D013801 Coast Fever, East
% 216.34/216.53  |- skos__scopeNote mesh__D013801
% 216.34/216.53       Infection of cattle, sheep, or goats with protozoa of the genus THEILERIA. This infection results in an acute or chronic febrile condition.%A%    
% 216.34/216.53  |- mesh__dateEstablished mesh__D013801 1968-01-01
% 216.34/216.53  |- mesh__recordMaintainer mesh__D013801 TGC
% 216.34/216.53  |- mesh__onlineNote mesh__D013801
% 216.34/216.53       use THEILERIASIS to search GONDERIASIS 1975-91, CORRIDOR DISEASE 1968-78, and EAST COAST FEVER 1968-81%A%  
% 216.34/216.53  |- skos__broader mesh__D013801smesh__D002418
% 216.34/216.53  |- skos__prefLabel mesh__D013801 Theileriasis
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D013801 2006
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D013801 2002
% 216.34/216.53  |- skos__broader mesh__D013801smesh__D011529
% 216.34/216.53  |- mesh__recordAuthorizer mesh__D013801 sjn
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D013801 2004
% 216.34/216.53  |- rdf__type mesh__D013801sskos__Concept
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D013801 2005
% 216.34/216.53  |- skos__hiddenLabel mesh__D013801 Disease, Corridor
% 216.34/216.53  |- mesh__historyNote mesh__D013801
% 216.34/216.53       68; GONDERIASIS was see THEILERIASIS 1975-91; CORRIDOR DISEASE was see under THEILERIASIS 1968-78; EAST COAST FEVER was see under THEILERIASIS 1968-81%A%  
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D013801 2003
% 216.34/216.53  |- mesh__dateRevised mesh__D013801 2000-06-22
% 216.34/216.53  |- mesh__publicMeSHNote mesh__D013801
% 216.34/216.53       68; GONDERIASIS was see THEILERIASIS 1975-91   
% 216.34/216.53  |- skos__hiddenLabel mesh__D013801 Fever, East Coast
% 216.34/216.53  |- skos__hiddenLabel mesh__D013801 Theileriases
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D013801 2001
% 216.34/216.53  |- skos__hiddenLabel mesh__D013801 Theilerioses
% 216.34/216.53  |- mesh__dateCreated mesh__D013801 1999-01-01
% 216.34/216.53  |- mesh__recordOriginator mesh__D013801 NLM
% 216.34/216.53  |- skos__historyNote mesh__D013801 Protozoan Infections %28%1966-1967%29%
% 216.34/216.53  |- skos__broader mesh__D013801smesh__D017282
% 216.34/216.53  |- rdf__type mesh__D013003sskos__Concept
% 216.34/216.53  |- mesh__dateCreated mesh__D013003 1999-01-01
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D013003 2003
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D013003 2001
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D013003 1999
% 216.34/216.53  |- mesh__recordAuthorizer mesh__D013003 SJN
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D013003 2005
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D013003 2004
% 216.34/216.53  |- mesh__recordOriginator mesh__D013003 NLM
% 216.34/216.53  |- mesh__recordMaintainer mesh__D013003 MSR
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D013003 2006
% 216.34/216.53  |- skos__prefLabel mesh__D013003 Somatosensory Cortex
% 216.34/216.53  |- mesh__historyNote mesh__D013003 71   
% 216.34/216.53  |- mesh__dateRevised mesh__D013003 1998-06-11
% 216.34/216.53  |- mesh__dateEstablished mesh__D013003 1971-01-01
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D013003 2002
% 216.34/216.53  |- skos__scopeNote mesh__D013003
% 216.34/216.53       Area of the parietal lobe concerned with receiving general sensations. It lies posterior to the central sulcus.%A%    
% 216.34/216.53  |- mesh__publicMeSHNote mesh__D013003 71   
% 216.34/216.53  |- skos__historyNote mesh__D013003 Cerebral Cortex %28%1966-1970%29%
% 216.34/216.53  |- skos__broader mesh__D013003smesh__D010296
% 216.34/216.53  |- skos__hiddenLabel mesh__D013003 Cortex, Somatosensory
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D013003 2000
% 216.34/216.53  |- mesh__historyNote mesh__D018297 98; use explode 1994-97   
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D018297 2005
% 216.34/216.53  |- rdf__type mesh__D018297sskos__Concept
% 216.34/216.53  |- mesh__dateRevised mesh__D018297 2004-07-13
% 216.34/216.53  |- skos__scopeNote mesh__D018297
% 216.34/216.53       Neoplasms containing cyst-like formations or producing mucin or serum.%A%    
% 216.34/216.53  |- skos__broader mesh__D018297smesh__D009375
% 216.34/216.53  |- mesh__recordOriginator mesh__D018297 PLS
% 216.34/216.53  |- mesh__recordAuthorizer mesh__D018297 sjn
% 216.34/216.53  |- skos__prefLabel mesh__D018297 Neoplasms, Cystic, Mucinous, and Serous
% 216.34/216.53  |- mesh__publicMeSHNote mesh__D018297 98   
% 216.34/216.53  |- mesh__dateEstablished mesh__D018297 1998-01-01
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D018297 2006
% 216.34/216.53  |- mesh__dateCreated mesh__D018297 1993-08-26
% 216.34/216.53  |- mesh__recordMaintainer mesh__D018297 sjn
% 216.34/216.53  |- skos__annotation mesh__D018297
% 216.34/216.53       neopl containing cyst-like formations or producing mucin or serum; indexing policy: Manual section 24; also TN Suppl: Tumor Key for human %26% corresponding vet tumors %28%does not contain exper tumors%29%; TN 135: correct use of tissue type terms; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; DF: NEOPL CYSTIC MUCINOUS SEROUS%A%  
% 216.34/216.53  |- skos__broader mesh__D051920smesh__D015703
% 216.34/216.53  |- skos__altLabel mesh__D051920
% 216.34/216.53       Killer Cell Lectin-Like Receptor Subfamily D, Member 1
% 216.34/216.53  |- skos__hiddenLabel mesh__D051920
% 216.34/216.53       Killer Cell Lectin Like Receptor Subfamily D, Member 1
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D051920 2006
% 216.34/216.53  |- mesh__recordOriginator mesh__D051920 DRC
% 216.34/216.53  |- rdf__type mesh__D051920sskos__Concept
% 216.34/216.53  |- skos__hiddenLabel mesh__D051920 CD94, Antigen
% 216.34/216.53  |- skos__altLabel mesh__D051920 Antigen CD94
% 216.34/216.53  |- mesh__historyNote mesh__D051920 2006%28%1995%29%   
% 216.34/216.53  |- skos__prefLabel mesh__D051920 Antigens, CD94
% 216.34/216.53  |- skos__scopeNote mesh__D051920
% 216.34/216.53       A C-type lectin that associates with NKG2 proteins to form receptors for HLA-E antigen on NATURAL KILLER CELLS.%A%    
% 216.34/216.53  |- skos__broader mesh__D051920smesh__D037181
% 216.34/216.53  |- mesh__recordAuthorizer mesh__D051920 sjn
% 216.34/216.53  |- skos__altLabel mesh__D051920 CD94 Antigen
% 216.34/216.53  |- skos__hiddenLabel mesh__D051920 Antigen, CD94
% 216.34/216.53  |- mesh__dateEstablished mesh__D051920 2006-01-01
% 216.34/216.53  |- skos__altLabel mesh__D051920 CD94 Antigens
% 216.34/216.53  |- mesh__publicMeSHNote mesh__D051920
% 216.34/216.53       2006; ANTIGENS, CD94 was indexed under ANTIGENS, CD %26% LECTINS, C-TYPE 2003-2005, %26% under MEMBRANE GLYCOPROTEINS 1995-2002%A%  
% 216.34/216.53  |- mesh__dateCreated mesh__D051920 2005-06-30
% 216.34/216.53  |- mesh__recordMaintainer mesh__D051920 DRC
% 216.34/216.53  |- skos__altLabel mesh__D051122 SR-B Proteins
% 216.34/216.53  |- skos__broader mesh__D051122smesh__D051116
% 216.34/216.53  |- skos__prefLabel mesh__D051122 Scavenger Receptors, Class B
% 216.34/216.53  |- mesh__historyNote mesh__D051122 2006%28%2005%29%   
% 216.34/216.53  |- mesh__recordOriginator mesh__D051122 DRC
% 216.34/216.53  |- mesh__dateEstablished mesh__D051122 2006-01-01
% 216.34/216.53  |- mesh__recordMaintainer mesh__D051122 DRC
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D051122 2006
% 216.34/216.53  |- skos__scopeNote mesh__D051122
% 216.34/216.53       A family of scavenger receptors that are predominately localized to CAVEOLAE of the PLASMA MEMBRANE and bind HIGH DENSITY LIPOPROTEINS.%A%    
% 216.34/216.53  |- mesh__recordAuthorizer mesh__D051122 sjn
% 216.34/216.53  |- rdf__type mesh__D051122sskos__Concept
% 216.34/216.53  |- mesh__dateCreated mesh__D051122 2005-06-30
% 216.34/216.53  |- mesh__publicMeSHNote mesh__D051122
% 216.34/216.53       2006; SCAVENGER RECEPTORS, CLASS B was indexed under RECEPTORS, IMMUNOLOGIC 2005%A%  
% 216.34/216.53  |- skos__hiddenLabel mesh__D004277 DNA, Single Stranded
% 216.34/216.53  |- mesh__publicMeSHNote mesh__D004277 74   
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D004277 2006
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D004277 1999
% 216.34/216.53  |- skos__scopeNote mesh__D004277
% 216.34/216.53       A single chain of deoxyribonucleotides that occurs in some bacteria and viruses. It usually exists as a covalently closed circle.%A%    
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D004277 2002
% 216.34/216.53  |- mesh__recordOriginator mesh__D004277 NLM
% 216.34/216.53  |- skos__historyNote mesh__D004277 DNA %28%1966-1971%29%
% 216.34/216.53  |- skos__hiddenLabel mesh__D004277 Single Stranded DNA
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D004277 2005
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D004277 1998
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D004277 2004
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D004277 1997
% 216.34/216.53  |- mesh__dateCreated mesh__D004277 1999-01-01
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D004277 2003
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D004277 1996
% 216.34/216.53  |- skos__historyNote mesh__D004277 DNA, Bacterial %28%1966-1971%29%
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D004277 2001
% 216.34/216.53  |- skos__altLabel mesh__D004277 Single-Stranded DNA
% 216.34/216.53  |- mesh__dateEstablished mesh__D004277 1974-01-01
% 216.34/216.53  |- skos__broader mesh__D004277smesh__D004247
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D004277 1995
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D004277 2000
% 216.34/216.53  |- mesh__dateRevised mesh__D004277 1992-05-13
% 216.34/216.53  |- mesh__historyNote mesh__D004277 74%28%72%29%   
% 216.34/216.53  |- rdf__type mesh__D004277sskos__Concept
% 216.34/216.53  |- mesh__recordMaintainer mesh__D004277 TGC
% 216.34/216.53  |- skos__historyNote mesh__D004277 DNA, Viral %28%1966-1971%29%
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D004277 1994
% 216.34/216.53  |- mesh__recordAuthorizer mesh__D004277 PLS
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D004277 1993
% 216.34/216.53  |- skos__prefLabel mesh__D004277 DNA, Single-Stranded
% 216.34/216.53  |- skos__annotation mesh__D004277 IM; /drug eff /ultrastruct permitted   
% 216.34/216.53  |- skos__prefLabel mesh__D012709 Serum Albumin
% 216.34/216.53  |- mesh__dateRevised mesh__D012709 2005-06-30
% 216.34/216.53  |- skos__related mesh__D012709smesh__D017457
% 216.34/216.53  |- mesh__dateCreated mesh__D012709 1999-01-01
% 216.34/216.53  |- skos__hiddenLabel mesh__D012709 Albumin, Serum
% 216.34/216.53  |- mesh__recordMaintainer mesh__D012709 DRC
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D012709 2006
% 216.34/216.53  |- skos__scopeNote mesh__D012709
% 216.34/216.53       A major protein in the BLOOD. It is important in maintaining the colloidal osmotic pressure and transporting large organic molecules.%A%    
% 216.34/216.53  |- skos__broader mesh__D012709smesh__D000209
% 216.34/216.53  |- rdf__type mesh__D012709sskos__Concept
% 216.34/216.53  |- skos__broader mesh__D012709smesh__D001798
% 216.34/216.53  |- skos__broader mesh__D012709smesh__D000418
% 216.34/216.53  |- mesh__recordOriginator mesh__D012709 NLM
% 216.34/216.53  |- mesh__recordAuthorizer mesh__D012709 sjn
% 216.34/216.53  |- skos__hiddenLabel mesh__D009760 Positional Nystagmus
% 216.34/216.53  |- skos__hiddenLabel mesh__D009760 Caloric Nystagmus
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D009760 2005
% 216.34/216.53  |- skos__annotation mesh__D009760
% 216.34/216.53       note category: NYSTAGMUS, PATHOLOGIC and NYSTAGMUS, CONGENITAL are available for the disease%A%  
% 216.34/216.53  |- skos__hiddenLabel mesh__D009760 Physiological Nystagmus
% 216.34/216.53  |- skos__altLabel mesh__D009760 Physiologic Nystagmus
% 216.34/216.53  |- mesh__dateRevised mesh__D009760 2003-07-09
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D009760 2006
% 216.34/216.53  |- skos__scopeNote mesh__D009760
% 216.34/216.53       Involuntary rhythmical movements of the eyes in the normal person. These can be naturally occurring as in end-position %28%end-point, end-stage, or deviational%29% nystagmus or induced by the optokinetic drum %28%NYSTAGMUS, OPTOKINETIC%29%, caloric test, or a rotating chair.%A%    
% 216.34/216.53  |- skos__altLabel mesh__D009760 Nystagmus, Barany%27%s
% 216.34/216.53  |- mesh__publicMeSHNote mesh__D009760
% 216.34/216.53       83; NYSTAGMUS, BARANY was NYSTAGMUS, BARANY%27%S 1993-97   
% 216.34/216.53  |- mesh__recordMaintainer mesh__D009760 nns
% 216.34/216.53  |- skos__hiddenLabel mesh__D009760 Nystagmus, Post Rotatory
% 216.34/216.53  |- skos__hiddenLabel mesh__D009760 End-Position Nystagmus
% 216.34/216.53  |- skos__hiddenLabel mesh__D009760 Nystagmus, Baranys
% 216.34/216.53  |- skos__historyNote mesh__D009760 Eye Movements %28%1966-1982%29%
% 216.34/216.53  |- mesh__dateEstablished mesh__D009760 1983-01-01
% 216.34/216.53  |- rdf__type mesh__D009760sskos__Concept
% 216.34/216.53  |- skos__hiddenLabel mesh__D009760 Barany Nystagmus
% 216.34/216.53  |- skos__hiddenLabel mesh__D009760 Post-Rotatory Nystagmus
% 216.34/216.53  |- skos__broader mesh__D009760smesh__D005133
% 216.34/216.53  |- skos__related mesh__D009760smesh__D009759
% 216.34/216.53  |- mesh__recordAuthorizer mesh__D009760 sjn
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D009760 2004
% 216.34/216.53  |- mesh__recordOriginator mesh__D009760 RC
% 216.34/216.53  |- skos__hiddenLabel mesh__D009760 Nystagmus, End Position
% 216.34/216.53  |- skos__hiddenLabel mesh__D009760 Barany%27%s Nystagmus
% 216.34/216.53  |- skos__altLabel mesh__D009760 Nystagmus, Physiological
% 216.34/216.53  |- skos__related mesh__D009760smesh__D004584
% 216.34/216.53  |- skos__prefLabel mesh__D009760 Nystagmus, Physiologic
% 216.34/216.53  |- mesh__dateCreated mesh__D009760 1982-04-28
% 216.34/216.53  |- skos__hiddenLabel mesh__D009760 Thermal Nystagmus
% 216.34/216.53  |- mesh__historyNote mesh__D009760
% 216.34/216.53       83; NYSTAGMUS, BARANY was NYSTAGMUS, BARANY%27%S 1993-97   
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D050828 2006A
% 216.34/216.53  |- rdf__type mesh__D050828sskos__Concept
% 216.34/216.53  |- skos__scopeNote mesh__D050828
% 216.34/216.53       A family of structurally related proteins that are constitutively expressed and that negatively regulate cytokine-mediated SIGNAL TRANSDUCTION PATHWAYS. PIAS proteins inhibit the activity of SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION.%A%    
% 216.34/216.53  |- mesh__publicMeSHNote mesh__D050828
% 216.34/216.53       2006; PROTEIN INHIBITORS OF ACTIVATED STAT was indexed under PROTEINS 1998-2005%A%  
% 216.34/216.53  |- mesh__recordAuthorizer mesh__D050828 ags
% 216.34/216.53  |- skos__altLabel mesh__D050828 PIAS Proteins
% 216.34/216.53  |- mesh__dateEstablished mesh__D050828 2006-01-01
% 216.34/216.53  |- mesh__dateRevised mesh__D050828 2005-07-13
% 216.34/216.53  |- mesh__historyNote mesh__D050828 2006%28%1998%29%   
% 216.34/216.53  |- mesh__recordOriginator mesh__D050828 DRC
% 216.34/216.53  |- skos__prefLabel mesh__D050828 Protein Inhibitors of Activated STAT
% 216.34/216.53  |- mesh__dateCreated mesh__D050828 2005-06-30
% 216.34/216.53  |- skos__broader mesh__D050828smesh__D048868
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D050828 2006
% 216.34/216.53  |- skos__altLabel mesh__D050828 PIAS1 Protein
% 216.34/216.53  |- mesh__recordMaintainer mesh__D050828 ags
% 216.34/216.53  |- skos__prefLabel mesh__D008668 Metallothionein
% 216.34/216.53  |- mesh__historyNote mesh__D008668
% 216.34/216.53       84%28%75%29%; was see under METALLOPROTEINS 1975-83   
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D008668 2006
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D008668 2001
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D008668 2004
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D008668 2005
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D008668 1999
% 216.34/216.53  |- skos__historyNote mesh__D008668 Metalloproteins %28%1973-1974%29%
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D008668 2000
% 216.34/216.53  |- mesh__dateEstablished mesh__D008668 1984-01-01
% 216.34/216.53  |- skos__broader mesh__D008668smesh__D008667
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D008668 2003
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D008668 1998
% 216.34/216.53  |- mesh__dateCreated mesh__D008668 1974-11-19
% 216.34/216.53  |- rdf__type mesh__D008668sskos__Concept
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D008668 2002
% 216.34/216.53  |- mesh__recordAuthorizer mesh__D008668 SJN
% 216.34/216.53  |- skos__scopeNote mesh__D008668
% 216.34/216.53       A low-molecular-weight %28%approx. 10 kD%29% protein occurring in the cytoplasm of kidney cortex and liver. It is rich in cysteinyl residues and contains no aromatic amino acids. Metallothionein shows high affinity for bivalent heavy metals.%A%    
% 216.34/216.53  |- mesh__dateRevised mesh__D008668 1997-06-20
% 216.34/216.53  |- skos__annotation mesh__D008668 /biosyn /physiol permitted   
% 216.34/216.53  |- mesh__recordOriginator mesh__D008668 NLM
% 216.34/216.53  |- mesh__recordMaintainer mesh__D008668 ADP
% 216.34/216.53  |- mesh__publicMeSHNote mesh__D008668
% 216.34/216.53       84; was see under METALLOPROTEINS 1975-83   
% 216.34/216.53  |- skos__altLabel mesh__D000685 Amyloid Protein AA
% 216.34/216.53  |- mesh__dateEstablished mesh__D000685 1987-01-01
% 216.34/216.53  |- skos__hiddenLabel mesh__D000685
% 216.34/216.53       Amyloid A Protein Related Serum Component
% 216.34/216.53  |- mesh__recordOriginator mesh__D000685 RLS
% 216.34/216.53  |- skos__altLabel mesh__D000685 Amyloid A Precursor
% 216.34/216.53  |- skos__broader mesh__D000685smesh__D000682
% 216.34/216.53  |- skos__altLabel mesh__D000685 Amyloid-Related Serum Protein %28%SAA%29%
% 216.34/216.53  |- skos__historyNote mesh__D000685 Blood Proteins %28%1966-1978%29%
% 216.34/216.53  |- skos__broader mesh__D000685smesh__D000209
% 216.34/216.53  |- mesh__historyNote mesh__D000685 2005%28%1979%29%   
% 216.34/216.53  |- mesh__recordMaintainer mesh__D000685 nns
% 216.34/216.53  |- mesh__dateCreated mesh__D000685 1978-05-16
% 216.34/216.53  |- skos__altLabel mesh__D000685 Amyloid Fibril Protein AA
% 216.34/216.53  |- skos__altLabel mesh__D000685 Amyloid A Protein-Related Serum Component
% 216.34/216.53  |- mesh__publicMeSHNote mesh__D000685
% 216.34/216.53       2005; see AMYLOID PROTEIN SAA 1987-2004; see AMYLOID 1979-1986; for AMYLOID PROTEIN AA see AMYLOID PROTEIN AA 1988-2004; AMYLOID PROTEIN AA PRECURSOR was indexed under AMYLOID PROTEIN AA %26% APOLIPOPROTEINS 1996-2004%A%  
% 216.34/216.53  |- skos__altLabel mesh__D000685 Serum A Related Protein
% 216.34/216.53  |- skos__altLabel mesh__D000685 Amyloid Protein AA Precursor
% 216.34/216.53  |- skos__prefLabel mesh__D000685 Serum Amyloid A Protein
% 216.34/216.53  |- rdf__type mesh__D000685sskos__Concept
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D000685 2006
% 216.34/216.53  |- skos__altLabel mesh__D000685 Amyloid Serum Protein SAA
% 216.34/216.53  |- mesh__dateRevised mesh__D000685 2004-07-07
% 216.34/216.53  |- mesh__recordAuthorizer mesh__D000685 sjn
% 216.34/216.53  |- skos__altLabel mesh__D000685 Serum Amyloid Protein A
% 216.34/216.53  |- skos__historyNote mesh__D000685 Amyloid %28%1966-1978%29%
% 216.34/216.53  |- skos__scopeNote mesh__D000685
% 216.34/216.53       An ACUTE PHASE REACTION protein present in low concentrations in normal sera, but found at higher concentrations in sera of older persons and in patients with AMYLOIDOSIS.  It is the circulating precusor of amyloid A protein, which is found deposited in AA type AMYLOID FIBRILS.%A%    
% 216.34/216.53  |- skos__altLabel mesh__D000685 Amyloid Protein SAA
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D000685 2005
% 216.34/216.53  |- skos__altLabel mesh__D000685 Serum Amyloid A
% 216.34/216.53  |- skos__annotation mesh__D019390
% 216.34/216.53       regulatory proteins; do not confuse with ARRESTIN   
% 216.34/216.53  |- mesh__publicMeSHNote mesh__D019390 97   
% 216.34/216.53  |- skos__prefLabel mesh__D019390 Arrestins
% 216.34/216.53  |- rdf__type mesh__D019390sskos__Concept
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D019390 2006
% 216.34/216.53  |- mesh__recordMaintainer mesh__D019390 SYSTEM
% 216.34/216.53  |- mesh__recordAuthorizer mesh__D019390 sjn
% 216.34/216.53  |- mesh__dateEstablished mesh__D019390 1997-01-01
% 216.34/216.53  |- skos__broader mesh__D019390smesh__D008565
% 216.34/216.53  |- mesh__recordOriginator mesh__D019390 AGS
% 216.34/216.53  |- mesh__historyNote mesh__D019390 97   
% 216.34/216.53  |- skos__historyNote mesh__D019390 Eye Proteins %28%1992-1996%29%
% 216.34/216.53  |- mesh__dateRevised mesh__D019390 2005-06-30
% 216.34/216.53  |- skos__historyNote mesh__D019390 Antigens %28%1992-1996%29%
% 216.34/216.53  |- skos__scopeNote mesh__D019390
% 216.34/216.53       Regulatory proteins that down-regulate phosphorylated G-protein membrane receptors, including rod and cone photoreceptors and adrenergic receptors.%A%    
% 216.34/216.53  |- skos__broader mesh__D019390smesh__D005136
% 216.34/216.53  |- mesh__dateCreated mesh__D019390 1996-06-10
% 216.34/216.53  |- skos__scopeNote mesh__D033061
% 216.34/216.53       Services provided by an individual ethicist %28%ETHICISTS%29% or an ethics team or committee %28%ETHICS COMMITTEES, CLINICAL%29% to address the ethical issues involved in a specific clinical case. The central purpose is to improve the process and outcomes of patients%27% care by helping to identify, analyze, and resolve ethical problems.%A%    
% 216.34/216.53  |- skos__historyNote mesh__D033061 Ethical Review %28%2002%29%
% 216.34/216.53  |- skos__hiddenLabel mesh__D033061 Consultation, Ethics
% 216.34/216.53  |- skos__historyNote mesh__D033061 Ethics Committees %28%1992-2001%29%
% 216.34/216.53  |- rdf__type mesh__D033061sskos__Concept
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D033061 2004
% 216.34/216.53  |- skos__hiddenLabel mesh__D033061 Consultations, Ethics
% 216.34/216.53  |- skos__hiddenLabel mesh__D033061 Ethics Consultations
% 216.34/216.53  |- skos__broader mesh__D033061smesh__D026724
% 216.34/216.53  |- skos__prefLabel mesh__D033061 Ethics Consultation
% 216.34/216.53  |- skos__historyNote mesh__D033061
% 216.34/216.53       Referral and Consultation %28%1988-2001%29%
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D033061 2006
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D033061 2003
% 216.34/216.53  |- mesh__dateEstablished mesh__D033061 2003-01-01
% 216.34/216.53  |- mesh__publicMeSHNote mesh__D033061 2003; see ETHICAL REVIEW 2002   
% 216.34/216.53  |- skos__related mesh__D033061smesh__D026690
% 216.34/216.53  |- mesh__dateCreated mesh__D033061 2002-07-03
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D033061 2005
% 216.34/216.53  |- skos__broader mesh__D033061smesh__D012017
% 216.34/216.53  |- mesh__historyNote mesh__D033061 2003; use ETHICAL REVIEW 2002   
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D027822 2006
% 216.34/216.53  |- skos__altLabel mesh__D027822 Heteropyxidaceae
% 216.34/216.53  |- skos__prefLabel mesh__D027822 Myrtaceae
% 216.34/216.53  |- mesh__publicMeSHNote mesh__D027822 2002   
% 216.34/216.53  |- skos__historyNote mesh__D027822 Plants, Medicinal %28%1968-2001%29%
% 216.34/216.53  |- skos__scopeNote mesh__D027822
% 216.34/216.53       The myrtle plant family of the order Myrtales.  It includes several aromatic medicinal plants such as EUCALYPTUS.%A%    
% 216.34/216.53  |- skos__annotation mesh__D027822
% 216.34/216.53       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.34/216.53  |- mesh__historyNote mesh__D027822 2002   
% 216.34/216.53  |- mesh__dateEstablished mesh__D027822 2002-01-01
% 216.34/216.53  |- mesh__recordAuthorizer mesh__D027822 sjn
% 216.34/216.53  |- rdf__type mesh__D027822sskos__Concept
% 216.34/216.53  |- mesh__dateRevised mesh__D027822 2005-06-30
% 216.34/216.53  |- mesh__recordOriginator mesh__D027822 ssb
% 216.34/216.53  |- skos__altLabel mesh__D027822 Mirtaceae
% 216.34/216.53  |- mesh__dateCreated mesh__D027822 2001-07-25
% 216.34/216.53  |- mesh__recordMaintainer mesh__D027822 ssb
% 216.34/216.53  |- skos__broader mesh__D027822smesh__D019684
% 216.34/216.53  |- mesh__recordOriginator mesh__D005370 NLM
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D005370 2004
% 216.34/216.53  |- skos__prefLabel mesh__D005370 Filarioidea
% 216.34/216.53  |- mesh__recordMaintainer mesh__D005370 ags
% 216.34/216.53  |- rdf__type mesh__D005370sskos__Concept
% 216.34/216.53  |- mesh__recordAuthorizer mesh__D005370 sjn
% 216.34/216.53  |- mesh__dateCreated mesh__D005370 1999-01-01
% 216.34/216.53  |- skos__broader mesh__D005370smesh__D017177
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D005370 2006
% 216.34/216.53  |- mesh__dateRevised mesh__D005370 2003-07-09
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D005370 2005
% 216.34/216.53  |- skos__scopeNote mesh__D005370
% 216.34/216.53       A superfamily of nematodes of the suborder SPIRURINA. Its organisms possess a filiform body and a mouth surrounded by papillae.%A%    
% 216.34/216.53  |- skos__annotation mesh__D005370
% 216.34/216.53       infection = FILARIASIS but see note there; coord with specific helminth term %28%ANTIGENS, HELMINTH, etc%29% if pertinent: /drug eff: consider FILARICIDES%A%  
% 216.34/216.53  |- skos__hiddenLabel mesh__D027024 Bacterial Topoisomerase I
% 216.34/216.53  |- mesh__historyNote mesh__D027024 2002   
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D027024 2005
% 216.34/216.53  |- rdf__type mesh__D027024sskos__Concept
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D027024 2004
% 216.34/216.53  |- skos__altLabel mesh__D027024 DNA Topoisomerase I, Bacterial
% 216.34/216.53  |- mesh__dateRevised mesh__D027024 2005-07-13
% 216.34/216.53  |- mesh__recordAuthorizer mesh__D027024 ags
% 216.34/216.53  |- mesh__publicMeSHNote mesh__D027024 2002   
% 216.34/216.53  |- skos__broader mesh__D027024smesh__D004264
% 216.34/216.53  |- skos__prefLabel mesh__D027024 DNA Topoisomerases, Type I, Bacterial
% 216.34/216.53  |- skos__scopeNote mesh__D027024
% 216.34/216.53       Bacterial enzymes of the DNA TOPOISOMERASES, TYPE I class that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. These bacterial enzymes reduce the topological stress in the DNA structure by relaxing negatively, but not positively, supercoiled DNA.%A%    
% 216.34/216.53  |- skos__altLabel mesh__D027024 Topoisomerase I, Bacterial
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D027024 2006A
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D027024 2006
% 216.34/216.53  |- mesh__recordMaintainer mesh__D027024 ags
% 216.34/216.53  |- skos__historyNote mesh__D027024 DNA Topoisomerase %28%1977-2001%29%
% 216.34/216.53  |- mesh__recordOriginator mesh__D027024 lkt
% 216.34/216.53  |- skos__altLabel mesh__D027024 Omega Protein, Topoisomerase I
% 216.34/216.53  |- mesh__dateCreated mesh__D027024 2001-07-25
% 216.34/216.53  |- mesh__dateEstablished mesh__D027024 2002-01-01
% 216.34/216.53  |- skos__prefLabel mesh__D013802 Thelazioidea
% 216.34/216.53  |- mesh__dateEstablished mesh__D013802 1986-01-01
% 216.34/216.53  |- mesh__recordOriginator mesh__D013802 EC
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D013802 2005
% 216.34/216.53  |- mesh__publicMeSHNote mesh__D013802
% 216.34/216.53       86; GNATHOSTOMA %26% THELAZIA were see under SPIRUROIDEA 1963-85%A%  
% 216.34/216.53  |- mesh__recordMaintainer mesh__D013802 ags
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D013802 2006
% 216.34/216.53  |- skos__broader mesh__D013802smesh__D017177
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D013802 2004
% 216.34/216.53  |- rdf__type mesh__D013802sskos__Concept
% 216.34/216.53  |- skos__scopeNote mesh__D013802
% 216.34/216.53       A superfamily of parasitic nematodes which includes three genera: Thelazia, Spirocerca, and GNATHOSTOMA. Only Thelazia and GNATHOSTOMA occasionally occur in man.%A%    
% 216.34/216.53  |- skos__annotation mesh__D013802
% 216.34/216.53       a superfamily of nematodes; infection: coord IM with SPIRURIDA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 216.34/216.53  |- mesh__onlineNote mesh__D013802
% 216.34/216.53       use THELAZIOIDEA to search THELAZIA 1975-85; use SPIRUROIDEA 1966-74%A%  
% 216.34/216.53  |- mesh__dateRevised mesh__D013802 2003-07-09
% 216.34/216.53  |- mesh__recordAuthorizer mesh__D013802 sjn
% 216.34/216.53  |- mesh__historyNote mesh__D013802
% 216.34/216.53       86; GNATHOSTOMA %26% THELAZIA were see under SPIRUROIDEA 1963-85%A%  
% 216.34/216.53  |- mesh__dateCreated mesh__D013802 1985-03-21
% 216.34/216.53  |- mesh__dateCreated mesh__D013004 1974-11-11
% 216.34/216.53  |- skos__altLabel mesh__D013004 Cyclic Somatostatin
% 216.34/216.53  |- skos__broader mesh__D013004smesh__D010905
% 216.34/216.53  |- skos__altLabel mesh__D013004 SRIH-14
% 216.34/216.53  |- mesh__activeMeSHYear mesh__D013004 2006
% 216.34/216.53  |- skos__hiddenLabel mesh__D013004 Sheep Somatostatin
% 216.34/216.53  |- skos__hiddenLabel mesh__D013004 Somatotropin Release Inhibiting Hormone
% 216.34/216.53  |- skos__historyNote mesh__D013004
% 216.34/216.53       Somatotropin Releasing Hormone/antagonists %26% inhibitors %28%1974%29%
% 216.34/216.53  |- skos__broader mesh__D013004smesh__D009479
% 216.34/216.53  |- skos__altLabel mesh__D013004 Somatostatin-14
% 216.34/216.53  |- mesh__dateEstablished mesh__D013004 1975-09-01
% 216.34/216.54  |- skos__hiddenLabel mesh__D013004 Somatostatin 14
% 216.34/216.54  |- mesh__historyNote mesh__D013004 99   
% 216.34/216.54  |- mesh__recordMaintainer mesh__D013004 ssb
% 216.34/216.54  |- skos__prefLabel mesh__D013004 Somatostatin
% 216.34/216.54  |- mesh__recordOriginator mesh__D013004 NLM
% 216.34/216.54  |- skos__scopeNote mesh__D013004
% 216.34/216.54       A polypeptide hormone produced in the HYPOTHALAMUS, and other tissues and organs. It inhibits the release of growth hormone %28%SOMATOTROPIN%29%, and also modulates important physiological functions of the kidney, pancreas, and gastrointestinal tract. Somatostatin receptors are widely expressed throughout the body. Somatostatin also acts as a neurotransmitter in the central and peripheral nervous systems.%A%    
% 216.34/216.54  |- mesh__publicMeSHNote mesh__D013004 99   
% 216.34/216.54  |- mesh__onlineNote mesh__D013004
% 216.34/216.54       use SOMATOSTATIN to search SOMATOTROPIN RELEASE INHIBITING HORMONE 1975-84%A%  
% 216.34/216.54  |- mesh__recordAuthorizer mesh__D013004 sjn
% 216.34/216.54  |- skos__related mesh__D013004smesh__D017481
% 216.34/216.54  |- skos__altLabel mesh__D013004 Somatostatin, Cyclic
% 216.34/216.54  |- skos__historyNote mesh__D013004
% 216.34/216.54       Somatotropin/antagonists %26% inhibitors %28%1973-1974%29%
% 216.34/216.54  |- skos__broader mesh__D013004smesh__D010187
% 216.34/216.54  |- skos__broader mesh__D013004smesh__D036361
% 216.34/216.54  |- skos__altLabel mesh__D013004 Somatotropin Release-Inhibiting Hormone
% 216.34/216.54  |- rdf__type mesh__D013004sskos__Concept
% 216.34/216.54  |- skos__altLabel mesh__D013004 SRIH
% 216.34/216.54  |- mesh__dateRevised mesh__D013004 2005-06-30
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D018298 2000
% 216.34/216.54  |- mesh__recordAuthorizer mesh__D018298 PLS
% 216.34/216.54  |- skos__hiddenLabel mesh__D018298 Tumor, Mucoepidermoid
% 216.34/216.54  |- mesh__recordMaintainer mesh__D018298 KEV
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D018298 2004
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D018298 1997
% 216.34/216.54  |- mesh__dateRevised mesh__D018298 1995-06-08
% 216.34/216.54  |- skos__hiddenLabel mesh__D018298 Tumors, Mucoepidermoid
% 216.34/216.54  |- mesh__recordOriginator mesh__D018298 PLS
% 216.34/216.54  |- skos__scopeNote mesh__D018298
% 216.34/216.54       A malignant epithelial tumor of glandular tissue, especially the salivary glands, characterized by acini with mucus-producing cells and by the presence of malignant squamous elements. Most mucoepidermoid tumors are low-grade lesions readily cured by adequate excision. They may appear in any age group. They grow slowly. If high-grade, they behave aggressively, widely infiltrating the salivary gland and producing lymph node and distant metastases. %28%Dorland, 27th ed; from DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p575%29%%A%    
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D018298 2002
% 216.34/216.54  |- skos__historyNote mesh__D018298 Carcinoma %28%1967-1993%29%
% 216.34/216.54  |- skos__annotation mesh__D018298
% 216.34/216.54       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D018298 2003
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D018298 1996
% 216.34/216.54  |- skos__hiddenLabel mesh__D018298 Mucoepidermoid Tumors
% 216.34/216.54  |- mesh__dateCreated mesh__D018298 1993-06-28
% 216.34/216.54  |- mesh__historyNote mesh__D018298 94   
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D018298 2006
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D018298 1999
% 216.34/216.54  |- skos__prefLabel mesh__D018298 Mucoepidermoid Tumor
% 216.34/216.54  |- skos__historyNote mesh__D018298 Myoepithelioma %28%1966-1974%29%
% 216.34/216.54  |- mesh__dateEstablished mesh__D018298 1994-01-01
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D018298 2001
% 216.34/216.54  |- mesh__publicMeSHNote mesh__D018298 94   
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D018298 2005
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D018298 1998
% 216.34/216.54  |- rdf__type mesh__D018298sskos__Concept
% 216.34/216.54  |- skos__broader mesh__D018298smesh__D018297
% 216.34/216.54  |- mesh__recordAuthorizer mesh__D051921 sjn
% 216.34/216.54  |- skos__prefLabel mesh__D051921 Fos-Related Antigen-2
% 216.34/216.54  |- mesh__dateEstablished mesh__D051921 2006-01-01
% 216.34/216.54  |- mesh__recordMaintainer mesh__D051921 DRC
% 216.34/216.54  |- mesh__dateCreated mesh__D051921 2005-06-30
% 216.34/216.54  |- skos__broader mesh__D051921smesh__D050976
% 216.34/216.54  |- mesh__publicMeSHNote mesh__D051921
% 216.34/216.54       2006; FOS-RELATED ANTIGEN-2 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1993-2005%A%  
% 216.34/216.54  |- mesh__historyNote mesh__D051921 2006%28%1993%29%   
% 216.34/216.54  |- skos__scopeNote mesh__D051921
% 216.34/216.54       A basic-leucine zipper transcription factor that is closely related to C-FOS PROTEINS. It forms heterodimeric complexes with C-JUN PROTEINS to regulate GENE transcription.%A%    
% 216.34/216.54  |- skos__hiddenLabel mesh__D051921 Fos Related Antigen 2
% 216.34/216.54  |- mesh__recordOriginator mesh__D051921 DRC
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D051921 2006
% 216.34/216.54  |- skos__hiddenLabel mesh__D051921 Transcription Factor, Fra-2
% 216.34/216.54  |- rdf__type mesh__D051921sskos__Concept
% 216.34/216.54  |- skos__altLabel mesh__D051921 Fra-2 Transcription Factor
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004278 2003
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004278 1996
% 216.34/216.54  |- skos__broader mesh__D004278smesh__D004270
% 216.34/216.54  |- mesh__publicMeSHNote mesh__D004278 78   
% 216.34/216.54  |- mesh__recordOriginator mesh__D004278 RLS
% 216.34/216.54  |- skos__prefLabel mesh__D004278 DNA, Superhelical
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004278 2000
% 216.34/216.54  |- mesh__dateRevised mesh__D004278 1992-05-13
% 216.34/216.54  |- skos__scopeNote mesh__D004278
% 216.34/216.54       Circular duplex DNA isolated from viruses, bacteria and mitochondria in supercoiled or supertwisted form. This superhelical DNA is endowed with free energy. During transcription, the magnitude of RNA initiation is proportional to the DNA superhelicity.%A%    
% 216.34/216.54  |- mesh__recordAuthorizer mesh__D004278 PLS
% 216.34/216.54  |- skos__hiddenLabel mesh__D004278 Supercoiled DNA
% 216.34/216.54  |- mesh__historyNote mesh__D004278 78   
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004278 1995
% 216.34/216.54  |- skos__hiddenLabel mesh__D004278 Superhelical DNA
% 216.34/216.54  |- mesh__dateCreated mesh__D004278 1977-05-17
% 216.34/216.54  |- skos__historyNote mesh__D004278 DNA %28%1966-1977%29%
% 216.34/216.54  |- skos__altLabel mesh__D004278 DNA, Supercoiled
% 216.34/216.54  |- mesh__dateEstablished mesh__D004278 1978-01-01
% 216.34/216.54  |- rdf__type mesh__D004278sskos__Concept
% 216.34/216.54  |- skos__altLabel mesh__D004278 DNA, Supertwisted
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004278 2002
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004278 1994
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004278 1993
% 216.34/216.54  |- skos__annotation mesh__D004278 IM; /drug eff /ultrastruct permitted   
% 216.34/216.54  |- mesh__recordMaintainer mesh__D004278 TGC
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004278 2006
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004278 1999
% 216.34/216.54  |- skos__historyNote mesh__D004278 DNA, Circular %28%1973-1977%29%
% 216.34/216.54  |- skos__hiddenLabel mesh__D004278 Supertwisted DNA
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004278 2005
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004278 1998
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004278 2004
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004278 1997
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004278 2001
% 216.34/216.54  |- mesh__recordAuthorizer mesh__D009761 sjn
% 216.34/216.54  |- mesh__recordMaintainer mesh__D009761 ssb
% 216.34/216.54  |- mesh__dateRevised mesh__D009761 2004-07-07
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D009761 2006
% 216.34/216.54  |- mesh__dateCreated mesh__D009761 1999-01-01
% 216.34/216.54  |- skos__scopeNote mesh__D009761
% 216.34/216.54       Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3.%A%    
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D009761 2005
% 216.34/216.54  |- rdf__type mesh__D009761sskos__Concept
% 216.34/216.54  |- skos__prefLabel mesh__D009761 Nystatin
% 216.34/216.54  |- mesh__recordOriginator mesh__D009761 NLM
% 216.34/216.54  |- skos__broader mesh__D009761smesh__D018942
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D008669 2004
% 216.34/216.54  |- skos__hiddenLabel mesh__D008669 Heavy Industry
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D008669 2005
% 216.34/216.54  |- mesh__recordMaintainer mesh__D008669 JLS
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D008669 1999
% 216.34/216.54  |- mesh__dateRevised mesh__D008669 1997-06-20
% 216.34/216.54  |- mesh__recordOriginator mesh__D008669 NLM
% 216.34/216.54  |- skos__hiddenLabel mesh__D008669 Industry, Heavy
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D008669 2003
% 216.34/216.54  |- skos__scopeNote mesh__D008669
% 216.34/216.54       The science, art, or technology dealing with processes involved in the separation of metals from their ores, the technique of making or compounding the alloys, the techniques of working or heat-treating metals, and the mining of metals. It includes industrial metallurgy as well as metallurgical techniques employed in the preparation and working of metals used in dentistry, with special reference to orthodontic and prosthodontic appliances. %28%From Jablonski, Dictionary of Dentistry, 1992, p494%29%%A%    
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D008669 1998
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D008669 2001
% 216.34/216.54  |- rdf__type mesh__D008669sskos__Concept
% 216.34/216.54  |- skos__prefLabel mesh__D008669 Metallurgy
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D008669 2000
% 216.34/216.54  |- skos__broader mesh__D008669smesh__D019652
% 216.34/216.54  |- skos__altLabel mesh__D008669 Heavy Industries
% 216.34/216.54  |- skos__annotation mesh__D008669
% 216.34/216.54       SPEC: SPEC qualif; note X ref HEAVY INDUSTRIES for iron, steel, etc., industries; in dent lit, the working %26% manipulation of metals for orthodontic or prosthodontic appliances is probably DENTAL SOLDERING but if not soldering, coord specific appliance %28%IM%29% + METALLURGY %28%NIM%29%%A%  
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D008669 2006
% 216.34/216.54  |- mesh__dateCreated mesh__D008669 1999-01-01
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D008669 2002
% 216.34/216.54  |- mesh__recordAuthorizer mesh__D008669 SJN
% 216.34/216.54  |- skos__scopeNote mesh__D000686
% 216.34/216.54       A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.%A%    
% 216.34/216.54  |- skos__broader mesh__D000686smesh__D008659
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D000686 2005
% 216.34/216.54  |- skos__prefLabel mesh__D000686 Amyloidosis
% 216.34/216.54  |- skos__annotation mesh__D000686
% 216.34/216.54       coord IM with organ/dis precoord %28%IM%29%; /genet: consider also AMYLOIDOSIS, HEREDITARY%A%  
% 216.34/216.54  |- skos__hiddenLabel mesh__D000686 Amyloidoses
% 216.34/216.54  |- mesh__recordMaintainer mesh__D000686 nns
% 216.34/216.54  |- skos__related mesh__D000686smesh__D000682
% 216.34/216.54  |- rdf__type mesh__D000686sskos__Concept
% 216.34/216.54  |- mesh__recordAuthorizer mesh__D000686 sjn
% 216.34/216.54  |- mesh__dateCreated mesh__D000686 1999-01-01
% 216.34/216.54  |- skos__related mesh__D000686smesh__D008232
% 216.34/216.54  |- mesh__recordOriginator mesh__D000686 NLM
% 216.34/216.54  |- mesh__dateRevised mesh__D000686 2004-07-07
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D000686 2006
% 216.34/216.54  |- skos__related mesh__D000686smesh__D010265
% 216.34/216.54  |- skos__related mesh__D033062smesh__D007398
% 216.34/216.54  |- skos__hiddenLabel mesh__D033062 Companion
% 216.34/216.54  |- mesh__historyNote mesh__D033062
% 216.34/216.54       2003; use INTERPERSONAL RELATIONS 1980-2002   
% 216.34/216.54  |- mesh__dateRevised mesh__D033062 2003-07-25
% 216.34/216.54  |- rdf__type mesh__D033062sskos__Concept
% 216.34/216.54  |- skos__hiddenLabel mesh__D033062 Friendships
% 216.34/216.54  |- skos__hiddenLabel mesh__D033062 Friend
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D033062 2004
% 216.34/216.54  |- mesh__publicMeSHNote mesh__D033062
% 216.34/216.54       2003; see INTERPERSONAL RELATIONS 1980-2002   
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D033062 2006
% 216.34/216.54  |- skos__prefLabel mesh__D033062 Friends
% 216.34/216.54  |- mesh__recordMaintainer mesh__D033062 sjn
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D033062 2005
% 216.34/216.54  |- mesh__dateCreated mesh__D033062 2002-07-02
% 216.34/216.54  |- mesh__recordAuthorizer mesh__D033062 sjn
% 216.34/216.54  |- skos__annotation mesh__D033062
% 216.34/216.54       for Society of Friends, or Quakers, use PROTESTANTISM   
% 216.34/216.54  |- skos__historyNote mesh__D033062
% 216.34/216.54       Interpersonal Relations %28%1995-2002%29%
% 216.34/216.54  |- mesh__recordOriginator mesh__D033062 jrf
% 216.34/216.54  |- mesh__dateEstablished mesh__D033062 2003-01-01
% 216.34/216.54  |- skos__scopeNote mesh__D033062
% 216.34/216.54       Persons whom one knows, likes, and trusts.     
% 216.34/216.54  |- skos__broader mesh__D033062smesh__D009272
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D027823 2005
% 216.34/216.54  |- skos__annotation mesh__D027823
% 216.34/216.54       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.34/216.54  |- skos__scopeNote mesh__D027823
% 216.34/216.54       The buckthorn plant family, of the order Rhamnales, includes some species with edible fruits and some that are medicinal.%A%    
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D027823 2006
% 216.34/216.54  |- mesh__dateEstablished mesh__D027823 2002-01-01
% 216.34/216.54  |- mesh__publicMeSHNote mesh__D027823 2002   
% 216.34/216.54  |- rdf__type mesh__D027823sskos__Concept
% 216.34/216.54  |- skos__historyNote mesh__D027823 Plants, Medicinal %28%1968-2001%29%
% 216.34/216.54  |- mesh__dateRevised mesh__D027823 2002-07-02
% 216.34/216.54  |- skos__prefLabel mesh__D027823 Rhamnaceae
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D027823 2003
% 216.34/216.54  |- mesh__historyNote mesh__D027823 2002   
% 216.34/216.54  |- mesh__dateCreated mesh__D027823 2001-07-25
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D027823 2004
% 216.34/216.54  |- skos__broader mesh__D027823smesh__D019684
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D046788 2006
% 216.34/216.54  |- mesh__recordAuthorizer mesh__D046788 jls
% 216.34/216.54  |- skos__prefLabel mesh__D046788 Patellofemoral Pain Syndrome
% 216.34/216.54  |- skos__altLabel mesh__D046788 Anterior Knee Pain Syndrome
% 216.34/216.54  |- mesh__recordOriginator mesh__D046788 ags
% 216.34/216.54  |- mesh__publicMeSHNote mesh__D046788 2005   
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D046788 2005
% 216.34/216.54  |- skos__scopeNote mesh__D046788
% 216.34/216.54       A syndrome characterized by retropatellar or peripatellar PAIN resulting from physical and biochemical changes in the patellofemoral joint. The pain is most prominent when ascending or descending stairs, squatting, or sitting with flexed knees. There is a lack of consensus on the etiology and treatment. The syndrome is often confused with %28%or accompanied by%29% CHONDROMALACIA PATELLAE, the latter describing a pathological condition of the CARTILAGE and not a syndrome.%A%    
% 216.34/216.54  |- mesh__dateRevised mesh__D046788 2004-07-30
% 216.34/216.54  |- skos__historyNote mesh__D046788 Knee Joint %28%1982-2004%29%
% 216.34/216.54  |- skos__historyNote mesh__D046788 Syndrome %28%1984-2004%29%
% 216.34/216.54  |- mesh__historyNote mesh__D046788 2005   
% 216.34/216.54  |- skos__broader mesh__D046788smesh__D007592
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D046788 2005A
% 216.34/216.54  |- skos__altLabel mesh__D046788 Patellofemoral Syndrome
% 216.34/216.54  |- skos__hiddenLabel mesh__D046788 Pain Syndrome, Patellofemoral
% 216.34/216.54  |- mesh__dateCreated mesh__D046788 2004-07-07
% 216.34/216.54  |- rdf__type mesh__D046788sskos__Concept
% 216.34/216.54  |- skos__related mesh__D046788smesh__D046789
% 216.34/216.54  |- mesh__recordMaintainer mesh__D046788 jls
% 216.34/216.54  |- mesh__dateEstablished mesh__D046788 2005-01-01
% 216.34/216.54  |- mesh__dateCreated mesh__D005371 1999-01-01
% 216.34/216.54  |- mesh__onlineNote mesh__D005371
% 216.34/216.54       use FILING to search FILES AND FILING 1966-84   
% 216.34/216.54  |- mesh__historyNote mesh__D005371 85; was FILES AND FILING 1963-84   
% 216.34/216.54  |- skos__broader mesh__D005371smesh__D004282
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D005371 2006
% 216.34/216.54  |- skos__annotation mesh__D005371 IM   
% 216.34/216.54  |- mesh__recordOriginator mesh__D005371 NLM
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D005371 2005
% 216.34/216.54  |- mesh__dateRevised mesh__D005371 2002-07-03
% 216.34/216.54  |- mesh__publicMeSHNote mesh__D005371 85; was FILES AND FILING 1963-84   
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D005371 2004
% 216.34/216.54  |- skos__scopeNote mesh__D005371
% 216.34/216.54       Collections of related records treated as a unit; ordering of such files.%A%    
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D005371 2003
% 216.34/216.54  |- mesh__recordMaintainer mesh__D005371 TAP
% 216.34/216.54  |- mesh__recordAuthorizer mesh__D005371 sjn
% 216.34/216.54  |- skos__hiddenLabel mesh__D005371 Filings
% 216.34/216.54  |- skos__prefLabel mesh__D005371 Filing
% 216.34/216.54  |- rdf__type mesh__D005371sskos__Concept
% 216.34/216.54  |- mesh__recordAuthorizer mesh__D027025 ags
% 216.34/216.54  |- mesh__dateCreated mesh__D027025 2001-07-25
% 216.34/216.54  |- skos__altLabel mesh__D027025 Topoisomerase I, Eukaryotic
% 216.34/216.54  |- mesh__historyNote mesh__D027025 2002   
% 216.34/216.54  |- mesh__publicMeSHNote mesh__D027025 2002   
% 216.34/216.54  |- skos__hiddenLabel mesh__D027025 Eukaryotic Topoisomerase I
% 216.34/216.54  |- skos__broader mesh__D027025smesh__D004264
% 216.34/216.54  |- mesh__dateRevised mesh__D027025 2005-07-13
% 216.34/216.54  |- skos__prefLabel mesh__D027025 DNA Topoisomerases, Type I, Eukaryotic
% 216.34/216.54  |- mesh__recordMaintainer mesh__D027025 ags
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D027025 2006
% 216.34/216.54  |- mesh__recordOriginator mesh__D027025 lkt
% 216.34/216.54  |- skos__historyNote mesh__D027025 DNA Topoisomerase %28%1978-2001%29%
% 216.34/216.54  |- skos__altLabel mesh__D027025 DNA Topoisomerase I, Eukaryotic
% 216.34/216.54  |- mesh__dateEstablished mesh__D027025 2002-01-01
% 216.34/216.54  |- skos__scopeNote mesh__D027025
% 216.34/216.54       Eukaryotic enzymes of the DNA TOPOISOMERASES, TYPE I class that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. These eukaryotic enzymes reduce the topological stress in the DNA structure by relaxing both negatively and positively supercoiled DNA.%A%    
% 216.34/216.54  |- rdf__type mesh__D027025sskos__Concept
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D027025 2005
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D027025 2004
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D027025 2006A
% 216.34/216.54  |- skos__broader mesh__D013803smesh__D011386
% 216.34/216.54  |- mesh__recordAuthorizer mesh__D013803 sjn
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D013803 2003
% 216.34/216.54  |- skos__scopeNote mesh__D013803
% 216.34/216.54       A projective technique which focuses primarily on the dynamics of interpersonal relationships. It consists of a series of 31 pictures that depict various social situations and interpersonal relations. A subset is selected by the examiner and presented to the subject who is asked to tell a story about each picture. The stories are interpreted in terms of the subject%27%s relations to authority figures, to contemporaries of both sexes, and in terms of the compromises between external demands and the needs of the id, the ego, and the superego. %28%From Campbell, Psychiatric Dictionary, 1996%29%%A%    
% 216.34/216.54  |- skos__hiddenLabel mesh__D013803 Test, Thematic Apperception
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D013803 2006
% 216.34/216.54  |- skos__hiddenLabel mesh__D013803 Apperception Tests, Thematic
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D013803 2000
% 216.34/216.54  |- rdf__type mesh__D013803sskos__Concept
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D013803 2004
% 216.34/216.54  |- mesh__dateCreated mesh__D013803 1999-01-01
% 216.34/216.54  |- skos__prefLabel mesh__D013803 Thematic Apperception Test
% 216.34/216.54  |- mesh__recordMaintainer mesh__D013803 adp
% 216.34/216.54  |- mesh__dateRevised mesh__D013803 1999-11-08
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D013803 2001
% 216.34/216.54  |- skos__hiddenLabel mesh__D013803 Apperception Test, Thematic
% 216.34/216.54  |- mesh__recordOriginator mesh__D013803 NLM
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D013803 2002
% 216.34/216.54  |- skos__hiddenLabel mesh__D013803 Tests, Thematic Apperception
% 216.34/216.54  |- skos__hiddenLabel mesh__D013803 Thematic Apperception Tests
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D013803 2005
% 216.34/216.54  |- rdf__type mesh__D013005sskos__Concept
% 216.34/216.54  |- skos__broader mesh__D013005smesh__D018273
% 216.34/216.54  |- mesh__dateRevised mesh__D013005 2005-07-01
% 216.34/216.54  |- skos__annotation mesh__D013005
% 216.34/216.54       coord IM with PANCREATIC NEOPLASMS %28%IM%29% or other precoord organ/neopl term %28%IM%29% if primary; this is a delta cell tumor%A%  
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D013005 2006
% 216.34/216.54  |- skos__scopeNote mesh__D013005
% 216.34/216.54       A SOMATOSTATIN-secreting tumor derived from the pancreatic delta cells %28%SOMATOSTATIN-SECRETING CELLS%29%. It is also found in the INTESTINE. Somatostatinomas are associated with DIABETES MELLITUS; CHOLELITHIASIS; STEATORRHEA; and HYPOCHLORHYDRIA. The majority of somatostatinomas have the potential for METASTASIS.%A%    
% 216.34/216.54  |- mesh__dateCreated mesh__D013005 1981-05-20
% 216.34/216.54  |- mesh__publicMeSHNote mesh__D013005
% 216.34/216.54       91; was see under ISLET CELL TUMOR 1982-90   
% 216.34/216.54  |- mesh__recordMaintainer mesh__D013005 sjn
% 216.34/216.54  |- mesh__historyNote mesh__D013005
% 216.34/216.54       91%28%82%29%; was see under ISLET CELL TUMOR 1982-90   
% 216.34/216.54  |- mesh__recordOriginator mesh__D013005 VDK
% 216.34/216.54  |- skos__broader mesh__D013005smesh__D018278
% 216.34/216.54  |- mesh__dateEstablished mesh__D013005 1991-01-01
% 216.34/216.54  |- skos__hiddenLabel mesh__D013005 Somatostatinomas
% 216.34/216.54  |- mesh__recordAuthorizer mesh__D013005 sjn
% 216.34/216.54  |- skos__historyNote mesh__D013005 Islet Cell Tumor %28%1966-1981%29%
% 216.34/216.54  |- skos__prefLabel mesh__D013005 Somatostatinoma
% 216.34/216.54  |- mesh__dateCreated mesh__D018299 1993-08-26
% 216.34/216.54  |- skos__altLabel mesh__D018299 Ductal, Lobular, and Medullary Neoplasms
% 216.34/216.54  |- mesh__historyNote mesh__D018299 98; use explode 1994-97   
% 216.34/216.54  |- mesh__recordAuthorizer mesh__D018299 sjn
% 216.34/216.54  |- mesh__dateEstablished mesh__D018299 1998-01-01
% 216.34/216.54  |- mesh__recordMaintainer mesh__D018299 sjn
% 216.34/216.54  |- skos__broader mesh__D018299smesh__D009375
% 216.34/216.54  |- mesh__recordOriginator mesh__D018299 PLS
% 216.34/216.54  |- skos__prefLabel mesh__D018299 Neoplasms, Ductal, Lobular, and Medullary
% 216.34/216.54  |- mesh__publicMeSHNote mesh__D018299 98   
% 216.34/216.54  |- skos__scopeNote mesh__D018299
% 216.34/216.54       Neoplasms, usually carcinoma, located within the center of an organ or within small lobes, and in the case of the breast, intraductally. The emphasis of the name is on the location of the neoplastic tissue rather than on its histological type. Most cancers of this type are located in the breast.%A%    
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D018299 2005
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D018299 2006
% 216.34/216.54  |- mesh__dateRevised mesh__D018299 2004-07-13
% 216.34/216.54  |- skos__annotation mesh__D018299
% 216.34/216.54       name refers to anatomical site within organ; GEN or unspecified; prefer specifics; indexing policy: Manual section 24; also TN Suppl: Tumor Key for human %26% corresponding vet tumors %28%does not contain exper tumors%29%; TN 135: correct use of tissue type terms; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; DF: NEOPL DUCTAL LOBULAR MEDULLARY%A%  
% 216.34/216.54  |- rdf__type mesh__D018299sskos__Concept
% 216.34/216.54  |- mesh__historyNote mesh__D051922 2006%28%1988%29%   
% 216.34/216.54  |- mesh__recordAuthorizer mesh__D051922 sjn
% 216.34/216.54  |- skos__altLabel mesh__D051922 P%28%II%29% Nitrogen Regulatory Proteins
% 216.34/216.54  |- skos__prefLabel mesh__D051922 PII Nitrogen Regulatory Proteins
% 216.34/216.54  |- skos__altLabel mesh__D051922 Nitrogen Regulatory Proteins
% 216.34/216.54  |- mesh__dateEstablished mesh__D051922 2006-01-01
% 216.34/216.54  |- skos__altLabel mesh__D051922 Nitrogen-Regulated Response Proteins
% 216.34/216.54  |- skos__scopeNote mesh__D051922
% 216.34/216.54       A family of signal transducing adaptor proteins that control the METABOLISM of NITROGEN. They are primarily found in prokaryotes.%A%    
% 216.34/216.54  |- mesh__recordMaintainer mesh__D051922 DRC
% 216.34/216.54  |- mesh__dateCreated mesh__D051922 2005-06-30
% 216.34/216.54  |- mesh__recordOriginator mesh__D051922 DRC
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D051922 2006
% 216.34/216.54  |- mesh__publicMeSHNote mesh__D051922
% 216.34/216.54       2006; NITROGEN REGULATORY PROTEINS was indexed under BACTERIAL PROTEINS %26% DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS %26% TRANS-ACTIVATORS 1988-2005%A%  
% 216.34/216.54  |- skos__hiddenLabel mesh__D051922 Nitrogen Regulated Response Proteins
% 216.34/216.54  |- skos__broader mesh__D051922smesh__D048868
% 216.34/216.54  |- rdf__type mesh__D051922sskos__Concept
% 216.34/216.54  |- skos__altLabel mesh__D051124 SR-CI Protein
% 216.34/216.54  |- mesh__dateEstablished mesh__D051124 2006-01-01
% 216.34/216.54  |- mesh__recordAuthorizer mesh__D051124 sjn
% 216.34/216.54  |- skos__broader mesh__D051124smesh__D051116
% 216.34/216.54  |- skos__altLabel mesh__D051124 SR-C Proteins
% 216.34/216.54  |- skos__prefLabel mesh__D051124 Scavenger Receptors, Class C
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D051124 2006
% 216.34/216.54  |- mesh__publicMeSHNote mesh__D051124
% 216.34/216.54       2006; SCAVENGER RECEPTORS, CLASS C was indexed under RECEPTORS, IMMUNOLOGIC 2005%A%  
% 216.34/216.54  |- skos__altLabel mesh__D051124 Scavenger Receptor Class C Type I
% 216.34/216.54  |- mesh__historyNote mesh__D051124 2006%28%2005%29%   
% 216.34/216.54  |- skos__scopeNote mesh__D051124
% 216.34/216.54       A family of scavenger receptors with broad polyanionic ligand binding properties that are expressed in embryonic insect MACROPHAGES.%A%    
% 216.34/216.54  |- mesh__recordMaintainer mesh__D051124 DRC
% 216.34/216.54  |- rdf__type mesh__D051124sskos__Concept
% 216.34/216.54  |- mesh__recordOriginator mesh__D051124 DRC
% 216.34/216.54  |- mesh__dateCreated mesh__D051124 2005-06-30
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004279 2001
% 216.34/216.54  |- skos__broader mesh__D004279smesh__D004247
% 216.34/216.54  |- skos__altLabel mesh__D004279 Viral DNA
% 216.34/216.54  |- rdf__type mesh__D004279sskos__Concept
% 216.34/216.54  |- skos__scopeNote mesh__D004279
% 216.34/216.54       Deoxyribonucleic acid that makes up the genetic material of viruses.%A%    
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004279 2000
% 216.34/216.54  |- mesh__dateRevised mesh__D004279 1995-06-08
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004279 2006
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004279 1999
% 216.34/216.54  |- mesh__recordAuthorizer mesh__D004279 PLS
% 216.34/216.54  |- skos__annotation mesh__D004279
% 216.34/216.54       IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 216.34/216.54  |- skos__prefLabel mesh__D004279 DNA, Viral
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004279 2005
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004279 2004
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004279 2002
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004279 1997
% 216.34/216.54  |- mesh__recordMaintainer mesh__D004279 KEV
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004279 1998
% 216.34/216.54  |- mesh__dateCreated mesh__D004279 1999-01-01
% 216.34/216.54  |- mesh__recordOriginator mesh__D004279 NLM
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004279 2003
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D004279 1996
% 216.34/216.54  |- mesh__recordMaintainer mesh__D009762 NLM
% 216.34/216.54  |- mesh__dateRevised mesh__D009762 2005-07-06
% 216.34/216.54  |- skos__hiddenLabel mesh__D009762 o Aminoazotoluene
% 216.34/216.54  |- mesh__historyNote mesh__D009762
% 216.34/216.54       91%28%76%29%; was see under AZO COMPOUNDS 1976-90   
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D009762 2006
% 216.34/216.54  |- skos__prefLabel mesh__D009762 o-Aminoazotoluene
% 216.34/216.54  |- skos__annotation mesh__D009762 D25-26 qualif   
% 216.34/216.54  |- mesh__recordAuthorizer mesh__D009762 NLM
% 216.34/216.54  |- skos__hiddenLabel mesh__D009762 ortho Aminoazotoluene
% 216.34/216.54  |- mesh__publicMeSHNote mesh__D009762
% 216.34/216.54       91; was see under AZO COMPOUNDS 1976-90   
% 216.34/216.54  |- skos__historyNote mesh__D009762 Toluidines %28%1972-1975%29%
% 216.34/216.54  |- rdf__type mesh__D009762sskos__Concept
% 216.34/216.54  |- skos__altLabel mesh__D009762 ortho-Aminoazotoluene
% 216.34/216.54  |- mesh__dateCreated mesh__D009762 1975-07-21
% 216.34/216.54  |- mesh__dateEstablished mesh__D009762 1991-01-01
% 216.34/216.54  |- skos__broader mesh__D009762smesh__D001391
% 216.34/216.54  |- skos__historyNote mesh__D009762 Azo Compounds %28%1968-1975%29%
% 216.34/216.54  |- mesh__recordOriginator mesh__D009762 RLS
% 216.34/216.54  |- skos__scopeNote mesh__D009762
% 216.34/216.54       An azo dye with carcinogenic properties.     
% 216.34/216.54  |- mesh__recordAuthorizer mesh__D000687 sjn
% 216.34/216.54  |- mesh__dateEstablished mesh__D000687 1974-01-01
% 216.34/216.54  |- rdf__type mesh__D000687sskos__Concept
% 216.34/216.54  |- mesh__recordOriginator mesh__D000687 NLM
% 216.34/216.54  |- mesh__dateCreated mesh__D000687 1999-01-01
% 216.34/216.54  |- skos__prefLabel mesh__D000687 Amylopectin
% 216.34/216.54  |- mesh__dateRevised mesh__D000687 2004-07-07
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D000687 2006
% 216.34/216.54  |- skos__scopeNote mesh__D000687 A highly branched glucan in starch.     
% 216.34/216.54  |- skos__broader mesh__D000687smesh__D013213
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D000687 2005
% 216.34/216.54  |- mesh__historyNote mesh__D000687 74   
% 216.34/216.54  |- mesh__publicMeSHNote mesh__D000687 74   
% 216.34/216.54  |- mesh__recordMaintainer mesh__D000687 jmp
% 216.34/216.54  |- mesh__activeMeSHYear mesh__D019392 2006
% 216.34/216.54  |- skos__prefLabel mesh__D019392 Cytochrome P-450 CYP2E1
% 216.34/216.54  |- skos__altLabel mesh__D019392 Dimethylnitrosamine N-Demethylase
% 216.34/216.54  |- rdf__type mesh__D019392sskos__Concept
% 216.34/216.54  |- mesh__publicMeSHNote mesh__D019392
% 216.34/216.54       97; DIMETHYLNITROSAMINE N-DEMETHYLASE was indexed under CYTOCHROME P-450 %26% OXIDOREDUCTASES, N-DEMETHYLATING 1975-96, NITROSAMINES 1972-76, %26% OXIDOREDUCTASES 1972-74; 4-NITROPHENOL-2-HYDROXYLASE was indexed under CYTOCHROME P-450 %26% HYDROXYLASES 1984-96%A%  
% 216.34/216.54  |- skos__hiddenLabel mesh__D019392 Cytochrome P 450 CYP2E1
% 216.34/216.54  |- mesh__recordAuthorizer mesh__D019392 sjn
% 216.34/216.54  |- mesh__historyNote mesh__D019392
% 216.34/216.54       97; was DIMETHYLNITROSAMIME N-DEMETHYLASE %28%NM%29% 1972-96 %26% was 4-NITROPHENOL-2-HYDROXYLASE %28%NM%29% 1984-96%A%  
% 216.34/216.54  |- skos__altLabel mesh__D019392 Cytochrome P-450-J
% 216.34/216.54  |- mesh__dateRevised mesh__D019392 2005-06-30
% 216.34/216.54  |- skos__annotation mesh__D019392
% 216.34/216.54       do not confuse with other cytochrome P-450 CYP%27%s   
% 216.34/216.54  |- skos__altLabel mesh__D019392 Cytochrome P-450 %28%ALC%29%
% 216.34/216.54  |- skos__altLabel mesh__D019392 CYP 2E1
% 216.34/216.54  |- mesh__dateCreated mesh__D019392 1996-06-24
% 216.34/216.54  |- skos__altLabel mesh__D019392 CYP IIE1
% 216.34/216.54  |- mesh__recordOriginator mesh__D019392 ADP
% 216.34/216.54  |- skos__broader mesh__D019392smesh__D001189
% 216.34/216.54  |- skos__historyNote mesh__D019392 Hydroxylases %28%1984-1996%29%
% 216.34/216.54  |- skos__altLabel mesh__D019392 CYP2E1
% 216.34/216.54  |- skos__hiddenLabel mesh__D019392 N Nitrosodimethylamine Demethylase
% 216.34/216.54  |- skos__hiddenLabel mesh__D019392 Cytochrome P 450 J
% 216.34/216.55  |- skos__altLabel mesh__D019392 N-Nitrosodimethylamine Demethylase
% 216.34/216.55  |- mesh__dateEstablished mesh__D019392 1997-01-01
% 216.34/216.55  |- skos__altLabel mesh__D019392 CYPIIE1
% 216.34/216.55  |- mesh__onlineNote mesh__D019392
% 216.34/216.55       use CYTOCHROME P-450 CYP2E1 %28%NM%29% to search DIMETHYLNITROSAMINE N-DEMETHYLASE 1980-96 %26% 4-NITROPHENOL-2-HYDROXYLASE 1984-96%A%  
% 216.34/216.55  |- skos__altLabel mesh__D019392 Cytochrome P450 2E1
% 216.34/216.55  |- skos__broader mesh__D019392smesh__D010089
% 216.34/216.55  |- mesh__recordMaintainer mesh__D019392 jmp
% 216.34/216.55  |- skos__historyNote mesh__D019392
% 216.34/216.55       Oxidoreductases, N-Demethylating %28%1975-1996%29%
% 216.34/216.55  |- skos__hiddenLabel mesh__D019392 Cytochrome P 450 IIE1
% 216.34/216.55  |- skos__scopeNote mesh__D019392
% 216.34/216.55       An ethanol-inducible cytochrome P450 enzyme that metabolizes several precarcinogens, drugs, and solvents to reactive metabolites. Substrates include alcohol; NITROSAMINES; BENZENE; URETHANE; and other low molecular weight compounds. CYP2E1 has been used as an enzyme marker in the study of alcohol abuse.%A%    
% 216.34/216.55  |- skos__hiddenLabel mesh__D019392 Dimethylnitrosamine N Demethylase
% 216.34/216.55  |- skos__historyNote mesh__D019392 Oxidoreductases %28%1972-1974%29%
% 216.34/216.55  |- skos__altLabel mesh__D019392 Cytochrome P-450 IIE1
% 216.34/216.55  |- skos__historyNote mesh__D019392 Nitrosamines %28%1972-1976%29%
% 216.34/216.55  |- skos__historyNote mesh__D019392 Cytochrome P-450 %28%1975-1996%29%
% 216.34/216.55  |- skos__hiddenLabel mesh__D019392 4 Nitrophenol 2 Hydroxylase
% 216.34/216.55  |- skos__altLabel mesh__D019392 4-Nitrophenol-2-Hydroxylase
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D027824 2006
% 216.34/216.55  |- mesh__dateEstablished mesh__D027824 2002-01-01
% 216.34/216.55  |- mesh__publicMeSHNote mesh__D027824 2002   
% 216.34/216.55  |- rdf__type mesh__D027824sskos__Concept
% 216.34/216.55  |- skos__altLabel mesh__D027824 Serviceberry
% 216.34/216.55  |- skos__annotation mesh__D027824
% 216.34/216.55       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D027824 2003
% 216.34/216.55  |- skos__scopeNote mesh__D027824
% 216.34/216.55       The rose plant family in the order ROSALES and class Magnoliopsida. They are generally woody plants. A number of the species of this family contain cyanogenic compounds.%A%    
% 216.34/216.55  |- skos__altLabel mesh__D027824 Quince
% 216.34/216.55  |- mesh__recordAuthorizer mesh__D027824 sjn
% 216.34/216.55  |- skos__altLabel mesh__D027824 Mountain Mahogany
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D027824 2004
% 216.34/216.55  |- skos__prefLabel mesh__D027824 Rosaceae
% 216.34/216.55  |- mesh__recordOriginator mesh__D027824 ssb
% 216.34/216.55  |- skos__altLabel mesh__D027824 Mahogany, Mountain
% 216.34/216.55  |- mesh__dateRevised mesh__D027824 2002-07-02
% 216.34/216.55  |- skos__broader mesh__D027824smesh__D019685
% 216.34/216.55  |- mesh__historyNote mesh__D027824 2002   
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D027824 2005
% 216.34/216.55  |- mesh__recordMaintainer mesh__D027824 ssb
% 216.34/216.55  |- skos__historyNote mesh__D027824 Plants, Medicinal %28%1966-2001%29%
% 216.34/216.55  |- mesh__dateCreated mesh__D027824 2001-07-25
% 216.34/216.55  |- skos__altLabel mesh__D027824 Quince, Flowering
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D005372 2006
% 216.34/216.55  |- skos__historyNote mesh__D005372 Lactones %28%1966-1974%29%
% 216.34/216.55  |- skos__scopeNote mesh__D005372
% 216.34/216.55       A complex of polyene antibiotics obtained from Streptomyces filipinensis. Filipin III alters membrane function by interfering with membrane sterols, inhibits mitochondrial respiration, and is proposed as an antifungal agent. Filipins I, II, and IV are less important.%A%    
% 216.34/216.55  |- skos__historyNote mesh__D005372 Fatty Acids, Essential %28%1966-1971%29%
% 216.34/216.55  |- mesh__dateEstablished mesh__D005372 1991-01-01
% 216.34/216.55  |- mesh__publicMeSHNote mesh__D005372
% 216.34/216.55       91; was see under ANTIBIOTICS, ANTIFUNGAL 1990-90; was see under POLYENES 1975-89%A%  
% 216.34/216.55  |- mesh__dateRevised mesh__D005372 2003-07-30
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D005372 2005
% 216.34/216.55  |- skos__altLabel mesh__D005372 Desoxylagosin
% 216.34/216.55  |- mesh__historyNote mesh__D005372
% 216.34/216.55       91%28%75%29%; was see under ANTIBIOTICS, ANTIFUNGAL 1990-90; was see under POLYENES 1975-89%A%  
% 216.34/216.55  |- mesh__recordAuthorizer mesh__D005372 NLM
% 216.34/216.55  |- skos__hiddenLabel mesh__D005372 NSC 3364
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D005372 2004
% 216.34/216.55  |- mesh__dateCreated mesh__D005372 1974-11-19
% 216.34/216.55  |- skos__altLabel mesh__D005372 Filimarisin
% 216.34/216.55  |- skos__altLabel mesh__D005372 Filipin III
% 216.34/216.55  |- skos__broader mesh__D005372smesh__D011090
% 216.34/216.55  |- mesh__recordOriginator mesh__D005372 NLM
% 216.34/216.55  |- skos__historyNote mesh__D005372 Polyenes %28%1966-1974%29%
% 216.34/216.55  |- skos__hiddenLabel mesh__D005372 U 5956
% 216.34/216.55  |- mesh__recordMaintainer mesh__D005372 SYSTEM
% 216.34/216.55  |- rdf__type mesh__D005372sskos__Concept
% 216.34/216.55  |- skos__hiddenLabel mesh__D005372 U5956
% 216.34/216.55  |- skos__historyNote mesh__D005372
% 216.34/216.55       Fatty Acids, Unsaturated %28%1972-1974%29%
% 216.34/216.55  |- skos__hiddenLabel mesh__D005372 NSC3364
% 216.34/216.55  |- skos__prefLabel mesh__D005372 Filipin
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D046789 2005
% 216.34/216.55  |- mesh__dateEstablished mesh__D046789 2005-01-01
% 216.34/216.55  |- skos__historyNote mesh__D046789 Cartilage Diseases %28%1968-2004%29%
% 216.34/216.55  |- mesh__recordOriginator mesh__D046789 ags
% 216.34/216.55  |- mesh__dateCreated mesh__D046789 2004-07-19
% 216.34/216.55  |- mesh__recordMaintainer mesh__D046789 ags
% 216.34/216.55  |- rdf__type mesh__D046789sskos__Concept
% 216.34/216.55  |- mesh__recordAuthorizer mesh__D046789 sjn
% 216.34/216.55  |- skos__scopeNote mesh__D046789
% 216.34/216.55       A degeneration of the ARTICULAR CARTILAGE of the PATELLA, caused by a decrease in sulfated MUCOPOLYSACCHARIDES in the ground substance. When accompanied by pain, it is sometimes considered part of or confused with PATELLOFEMORAL PAIN SYNDROME.%A%    
% 216.34/216.55  |- skos__related mesh__D046789smesh__D046788
% 216.34/216.55  |- mesh__historyNote mesh__D046789 2005   
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D046789 2006
% 216.34/216.55  |- skos__prefLabel mesh__D046789 Chondromalacia Patellae
% 216.34/216.55  |- skos__broader mesh__D046789smesh__D002357
% 216.34/216.55  |- mesh__publicMeSHNote mesh__D046789 2005   
% 216.34/216.55  |- skos__scopeNote mesh__D013804
% 216.34/216.55       Chelating agent and inhibitor of cellular respiration.     
% 216.34/216.55  |- mesh__publicMeSHNote mesh__D013804
% 216.34/216.55       91; was see under THIOPHENES 1975-90   
% 216.34/216.55  |- mesh__historyNote mesh__D013804
% 216.34/216.55       91%28%75%29%; was see under THIOPHENES 1975-90   
% 216.34/216.55  |- mesh__dateCreated mesh__D013804 1974-11-19
% 216.34/216.55  |- skos__historyNote mesh__D013804 Hydrocarbons, Fluorinated %28%1974%29%
% 216.34/216.55  |- mesh__recordMaintainer mesh__D013804 ssb
% 216.34/216.55  |- mesh__recordAuthorizer mesh__D013804 sjn
% 216.34/216.55  |- skos__historyNote mesh__D013804 Thiophenes %28%1971-1974%29%
% 216.34/216.55  |- skos__broader mesh__D013804smesh__D002074
% 216.34/216.55  |- skos__altLabel mesh__D013804 Trifluorothienylacetone
% 216.34/216.55  |- skos__annotation mesh__D013804 D25-26 qualif   
% 216.34/216.55  |- mesh__dateRevised mesh__D013804 2005-06-30
% 216.34/216.55  |- skos__prefLabel mesh__D013804 Thenoyltrifluoroacetone
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D013804 2006
% 216.34/216.55  |- skos__historyNote mesh__D013804 Butanones %28%1971-1974%29%
% 216.34/216.55  |- rdf__type mesh__D013804sskos__Concept
% 216.34/216.55  |- mesh__recordOriginator mesh__D013804 NLM
% 216.34/216.55  |- mesh__dateEstablished mesh__D013804 1991-01-01
% 216.34/216.55  |- skos__broader mesh__D013804smesh__D013876
% 216.34/216.55  |- mesh__dateCreated mesh__D013006 1999-01-01
% 216.34/216.55  |- skos__altLabel mesh__D013006 Recombinant Pituitary Growth Hormones
% 216.34/216.55  |- mesh__historyNote mesh__D013006 2003 %28%1966%29%   
% 216.34/216.55  |- skos__altLabel mesh__D013006 Recombinant Growth Hormones
% 216.34/216.55  |- mesh__dateRevised mesh__D013006 2004-07-13
% 216.34/216.55  |- mesh__publicMeSHNote mesh__D013006
% 216.34/216.55       2003; see SOMATOTROPIN 1966-2002; for GROWTH HORMONE, RECOMBINANT see SOMATOTROPINS, RECOMBINANT 1997-2002%A%  
% 216.34/216.55  |- skos__altLabel mesh__D013006 Pituitary Growth Hormones, Recombinant
% 216.34/216.55  |- skos__hiddenLabel mesh__D013006 Growth Hormones, Recombinant
% 216.34/216.55  |- skos__altLabel mesh__D013006 Somatotropin, Recombinant
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D013006 2006
% 216.34/216.55  |- skos__prefLabel mesh__D013006 Growth Hormone
% 216.34/216.55  |- skos__hiddenLabel mesh__D013006 Recombinant Somatotropin
% 216.34/216.55  |- skos__altLabel mesh__D013006 Recombinant Somatotropins
% 216.34/216.55  |- mesh__recordOriginator mesh__D013006 NLM
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D013006 2005
% 216.34/216.55  |- mesh__recordMaintainer mesh__D013006 sjn
% 216.34/216.55  |- skos__related mesh__D013006smesh__D011986
% 216.34/216.55  |- skos__annotation mesh__D013006
% 216.34/216.55       despite X ref, coord with RECOMBINANT PROTEINS for recombinant somatotropin; HUMAN GROWTH HORMONE is also available%A%  
% 216.34/216.55  |- skos__altLabel mesh__D013006 Growth Hormone, Pituitary
% 216.34/216.55  |- skos__altLabel mesh__D013006 Somatotropin
% 216.34/216.55  |- mesh__recordAuthorizer mesh__D013006 sjn
% 216.34/216.55  |- skos__altLabel mesh__D013006 Somatotropins, Recombinant
% 216.34/216.55  |- skos__altLabel mesh__D013006 Recombinant Growth Hormone
% 216.34/216.55  |- skos__scopeNote mesh__D013006
% 216.34/216.55       A polypeptide that is secreted by the adenohypophysis %28%PITUITARY GLAND, ANTERIOR%29%. Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth.  Species-specific growth hormones have been synthesized.%A%    
% 216.34/216.55  |- skos__broader mesh__D013006smesh__D010908
% 216.34/216.55  |- rdf__type mesh__D013006sskos__Concept
% 216.34/216.55  |- skos__altLabel mesh__D013006 Pituitary Growth Hormone
% 216.34/216.55  |- skos__altLabel mesh__D013006 Growth Hormones Pituitary, Recombinant
% 216.34/216.55  |- mesh__recordOriginator mesh__D009763 NLM
% 216.34/216.55  |- mesh__onlineNote mesh__D009763
% 216.34/216.55       use O-CHLOROBENZYLIDENEMALONITRILE to search O-CHLOROBENZYLIDENE MALONITRILE 1975-90%A%  
% 216.34/216.55  |- mesh__dateRevised mesh__D009763 2003-03-21
% 216.34/216.55  |- skos__hiddenLabel mesh__D009763 o Chlorobenzylidene malonotrile
% 216.34/216.55  |- skos__hiddenLabel mesh__D009763 2 Chlorobenzylidene Malonitrile
% 216.34/216.55  |- skos__hiddenLabel mesh__D009763 2 Chlorobenzylidenemalonitrile
% 216.34/216.55  |- skos__historyNote mesh__D009763 Nitriles %28%1970-1974%29%
% 216.34/216.55  |- skos__hiddenLabel mesh__D009763 Malonitrile, o-Chlorobenzylidene
% 216.34/216.55  |- skos__altLabel mesh__D009763 CS Tear Gas
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D009763 2005
% 216.34/216.55  |- skos__broader mesh__D009763smesh__D009570
% 216.34/216.55  |- mesh__recordMaintainer mesh__D009763 ags
% 216.34/216.55  |- skos__hiddenLabel mesh__D009763 malonotrile, o-Chlorobenzylidene
% 216.34/216.55  |- skos__hiddenLabel mesh__D009763 Malonitrile, ortho-Chlorobenzylidene
% 216.34/216.55  |- mesh__recordAuthorizer mesh__D009763 ags
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D009763 2006
% 216.34/216.55  |- rdf__type mesh__D009763sskos__Concept
% 216.34/216.55  |- mesh__dateCreated mesh__D009763 1974-11-14
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D009763 2001
% 216.34/216.55  |- skos__altLabel mesh__D009763 2-Chlorobenzylidene Malonitrile
% 216.34/216.55  |- mesh__dateEstablished mesh__D009763 1991-01-01
% 216.34/216.55  |- skos__altLabel mesh__D009763 ortho-Chlorobenzylidenemalonitrile
% 216.34/216.55  |- skos__altLabel mesh__D009763 ortho-Chlorobenzylidene Malonitrile
% 216.34/216.55  |- skos__prefLabel mesh__D009763 o-Chlorobenzylidenemalonitrile
% 216.34/216.55  |- skos__hiddenLabel mesh__D009763 o Chlorobenzylidene Malonitrile
% 216.34/216.55  |- mesh__historyNote mesh__D009763
% 216.34/216.55       91%28%75%29%; was O-CHLOROBENZYLIDENE MALONITRILE see under NITRILES 1975-90%A%  
% 216.34/216.55  |- skos__scopeNote mesh__D009763
% 216.34/216.55       A riot control agent which causes temporary irritation of the eyes and the mucosal surface of the respiratory tract. It is a more potent irritant than OMEGA-CHLOROACETOPHENONE, but less incapacitating.%A%    
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D009763 2002
% 216.34/216.55  |- skos__hiddenLabel mesh__D009763 o Chlorobenzylidenemalonitrile
% 216.34/216.55  |- skos__hiddenLabel mesh__D009763 Malonitrile, 2-Chlorobenzylidene
% 216.34/216.55  |- mesh__publicMeSHNote mesh__D009763
% 216.34/216.55       91; was O-CHLOROBENZYLIDENE MALONITRILE see under NITRILES 1975-90%A%  
% 216.34/216.55  |- skos__altLabel mesh__D009763 2-Chlorobenzylidenemalonitrile
% 216.34/216.55  |- skos__altLabel mesh__D009763 o-Chlorobenzylidene Malonitrile
% 216.34/216.55  |- skos__hiddenLabel mesh__D009763 Tear Gas, CS
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D009763 2003
% 216.34/216.55  |- skos__altLabel mesh__D009763 o-Chlorobenzylidene malonotrile
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D009763 2003A
% 216.34/216.55  |- skos__hiddenLabel mesh__D009763 ortho Chlorobenzylidene Malonitrile
% 216.34/216.55  |- skos__historyNote mesh__D009763 Benzyl Compounds %28%1972-1974%29%
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D009763 2003B
% 216.34/216.55  |- skos__hiddenLabel mesh__D009763 ortho Chlorobenzylidenemalonitrile
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D009763 2004
% 216.34/216.55  |- skos__hiddenLabel mesh__D001780 Coagulation Test, Blood
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D001780 2004
% 216.34/216.55  |- skos__broader mesh__D001780smesh__D006403
% 216.34/216.55  |- mesh__recordOriginator mesh__D001780 NLM
% 216.34/216.55  |- mesh__dateCreated mesh__D001780 1999-01-01
% 216.34/216.55  |- mesh__recordAuthorizer mesh__D001780 sjn
% 216.34/216.55  |- skos__hiddenLabel mesh__D001780 Test, Blood Coagulation
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D001780 2006
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D001780 2005
% 216.34/216.55  |- skos__altLabel mesh__D001780 Coagulation Tests, Blood
% 216.34/216.55  |- mesh__recordMaintainer mesh__D001780 nns
% 216.34/216.55  |- skos__annotation mesh__D001780
% 216.34/216.55       GEN: prefer specifics; NIM; coord with disease /blood, not /physiopathol; DF: BLOOD COAG TESTS%A%  
% 216.34/216.55  |- mesh__dateRevised mesh__D001780 2003-07-09
% 216.34/216.55  |- skos__related mesh__D001780smesh__D001777
% 216.34/216.55  |- rdf__type mesh__D001780sskos__Concept
% 216.34/216.55  |- skos__scopeNote mesh__D001780
% 216.34/216.55       Laboratory tests for evaluating the individual%27%s clotting mechanism.%A%    
% 216.34/216.55  |- skos__hiddenLabel mesh__D001780 Blood Coagulation Test
% 216.34/216.55  |- skos__prefLabel mesh__D001780 Blood Coagulation Tests
% 216.34/216.55  |- skos__altLabel mesh__D001780 Tests, Blood Coagulation
% 216.34/216.55  |- mesh__dateEstablished mesh__D033862 2003-01-01
% 216.34/216.55  |- mesh__recordMaintainer mesh__D033862 SYSTEM
% 216.34/216.55  |- mesh__dateRevised mesh__D033862 2005-06-30
% 216.34/216.55  |- skos__hiddenLabel mesh__D033862 Iron Binding Proteins
% 216.34/216.55  |- mesh__historyNote mesh__D033862
% 216.34/216.55       2003; use IRON-BINDING PROTEINS %28%NM%29% 1980-2002   
% 216.34/216.55  |- skos__broader mesh__D033862smesh__D002352
% 216.34/216.55  |- mesh__recordOriginator mesh__D033862 jmp
% 216.34/216.55  |- mesh__publicMeSHNote mesh__D033862
% 216.34/216.55       2003; IRON-BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-2002%A%  
% 216.34/216.55  |- skos__broader mesh__D033862smesh__D008667
% 216.34/216.55  |- skos__prefLabel mesh__D033862 Iron-Binding Proteins
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D033862 2006
% 216.34/216.55  |- mesh__recordAuthorizer mesh__D033862 sjn
% 216.34/216.55  |- rdf__type mesh__D033862sskos__Concept
% 216.34/216.55  |- mesh__dateCreated mesh__D033862 2002-07-03
% 216.34/216.55  |- skos__scopeNote mesh__D033862
% 216.34/216.55       Proteins that specifically bind to IRON.     
% 216.34/216.55  |- skos__prefLabel mesh__D000688 Amylose
% 216.34/216.55  |- mesh__dateCreated mesh__D000688 1999-01-01
% 216.34/216.55  |- skos__scopeNote mesh__D000688 An unbranched glucan in starch.     
% 216.34/216.55  |- mesh__recordAuthorizer mesh__D000688 sjn
% 216.34/216.55  |- mesh__dateRevised mesh__D000688 2004-07-07
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D000688 2006
% 216.34/216.55  |- mesh__recordOriginator mesh__D000688 NLM
% 216.34/216.55  |- mesh__dateEstablished mesh__D000688 1974-01-01
% 216.34/216.55  |- skos__broader mesh__D000688smesh__D013213
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D000688 2005
% 216.34/216.55  |- mesh__historyNote mesh__D000688 74   
% 216.34/216.55  |- mesh__recordMaintainer mesh__D000688 jmp
% 216.34/216.55  |- mesh__publicMeSHNote mesh__D000688 74   
% 216.34/216.55  |- rdf__type mesh__D000688sskos__Concept
% 216.34/216.55  |- skos__broader mesh__D019393smesh__D019390
% 216.34/216.55  |- skos__historyNote mesh__D019393 Antigens %28%1981-1996%29%
% 216.34/216.55  |- skos__hiddenLabel mesh__D019393 S Antigen, Retinal
% 216.34/216.55  |- mesh__recordOriginator mesh__D019393 AGS
% 216.34/216.55  |- skos__prefLabel mesh__D019393 Arrestin
% 216.34/216.55  |- mesh__historyNote mesh__D019393
% 216.34/216.55       97; was S ANTIGEN, RETINAL %28%NM%29% 1981-96   
% 216.34/216.55  |- mesh__onlineNote mesh__D019393
% 216.34/216.55       use ARRESTIN %28%NM%29% to search S ANTIGEN, RETINAL 1981-96   
% 216.34/216.55  |- mesh__recordAuthorizer mesh__D019393 sjn
% 216.34/216.55  |- mesh__dateRevised mesh__D019393 2005-06-30
% 216.34/216.55  |- skos__hiddenLabel mesh__D019393 Retinal S Antigen
% 216.34/216.55  |- skos__altLabel mesh__D019393 S-Antigen, Retinal
% 216.34/216.55  |- skos__scopeNote mesh__D019393
% 216.34/216.55       A 48-Kd protein of the outer segment of the retinal rods and a component of the phototransduction cascade. Arrestin quenches G-protein activation by binding to phosphorylated photolyzed rhodopsin. Arrestin causes experimental autoimmune uveitis when injected into laboratory animals.%A%    
% 216.34/216.55  |- skos__historyNote mesh__D019393 Eye Proteins %28%1983-1996%29%
% 216.34/216.55  |- mesh__dateEstablished mesh__D019393 1997-01-01
% 216.34/216.55  |- skos__annotation mesh__D019393
% 216.34/216.55       an eye protein; do not confuse with ARRESTINS   
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D019393 2006
% 216.34/216.55  |- mesh__recordMaintainer mesh__D019393 ssb
% 216.34/216.55  |- rdf__type mesh__D019393sskos__Concept
% 216.34/216.55  |- mesh__dateCreated mesh__D019393 1996-06-10
% 216.34/216.55  |- skos__broader mesh__D019393smesh__D000954
% 216.34/216.55  |- mesh__publicMeSHNote mesh__D019393
% 216.34/216.55       97; S ANTIGEN, RETINAL was indexed under ANTIGENS %26% EYE PROTEINS 1981-96%A%  
% 216.34/216.55  |- skos__altLabel mesh__D019393 Retinal S-Antigen
% 216.34/216.55  |- mesh__dateEstablished mesh__D027825 2002-01-01
% 216.34/216.55  |- skos__prefLabel mesh__D027825 Crataegus
% 216.34/216.55  |- mesh__publicMeSHNote mesh__D027825
% 216.34/216.55       2002; see Rosales 1998-2001; see PLANTS, MEDICINAL 1986-1997; for HAWTHORN see ROSALES 1998-2001%A%  
% 216.34/216.55  |- skos__broader mesh__D027825smesh__D027824
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D027825 2006
% 216.34/216.55  |- mesh__recordOriginator mesh__D027825 ssb
% 216.34/216.55  |- skos__scopeNote mesh__D027825
% 216.34/216.55       A genus in the family ROSACEAE of shrubs and small trees native to the North Temperate Zone. It is best known for a traditional medication for the heart.%A%    
% 216.34/216.55  |- rdf__type mesh__D027825sskos__Concept
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D027825 2005
% 216.34/216.55  |- mesh__historyNote mesh__D027825
% 216.34/216.55       2002; use Rosales 1998-2001, use PLANTS, MEDICINAL 1986-1997; for HAWTHORN use ROSALES 1998-2001%A%  
% 216.34/216.55  |- skos__annotation mesh__D027825
% 216.34/216.55       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D027825 2004
% 216.34/216.55  |- skos__historyNote mesh__D027825 Rosales %28%1988-2001%29%
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D027825 2003
% 216.34/216.55  |- mesh__recordMaintainer mesh__D027825 ssb
% 216.34/216.55  |- mesh__dateCreated mesh__D027825 2001-07-25
% 216.34/216.55  |- mesh__recordAuthorizer mesh__D027825 sjn
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D027825 2002
% 216.34/216.55  |- mesh__recordOriginator mesh__D005373 NLM
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D005373 2006
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D005373 2001
% 216.34/216.55  |- skos__prefLabel mesh__D005373 Film Dosimetry
% 216.34/216.55  |- skos__scopeNote mesh__D005373
% 216.34/216.55       Use of a device %28%film badge%29% for measuring exposure of individuals to radiation. It is usually made of metal, plastic, or paper and loaded with one or more pieces of x-ray film.%A%    
% 216.34/216.55  |- skos__altLabel mesh__D005373 Film Badge Dosimetry
% 216.34/216.55  |- skos__hiddenLabel mesh__D005373 Dosimetries, Film Badge
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D005373 2003
% 216.34/216.55  |- skos__hiddenLabel mesh__D005373 Film Dosimetries
% 216.34/216.55  |- skos__broader mesh__D005373smesh__D011834
% 216.34/216.55  |- skos__hiddenLabel mesh__D005373 Dosimetry, Film
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D005373 2004
% 216.34/216.55  |- mesh__historyNote mesh__D005373
% 216.34/216.55       79; was FILM BADGE 1971-78 %28%Prov 1971-73%29%   
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D005373 1998
% 216.34/216.55  |- mesh__onlineNote mesh__D005373
% 216.34/216.55       use FILM DOSIMETRY to search FILM BADGE 1971-78 %28%as Prov 1971-73%29%%A%  
% 216.34/216.55  |- mesh__dateEstablished mesh__D005373 1974-01-01
% 216.34/216.55  |- skos__hiddenLabel mesh__D005373 Badge Dosimetry, Film
% 216.34/216.55  |- mesh__dateCreated mesh__D005373 1999-01-01
% 216.34/216.55  |- skos__hiddenLabel mesh__D005373 Dosimetry, Film Badge
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D005373 2002
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D005373 1999
% 216.34/216.55  |- skos__hiddenLabel mesh__D005373 Badge, Film
% 216.34/216.55  |- mesh__dateRevised mesh__D005373 1997-06-20
% 216.34/216.55  |- skos__hiddenLabel mesh__D005373 Film Badges
% 216.34/216.55  |- skos__hiddenLabel mesh__D005373 Badge Dosimetries, Film
% 216.34/216.55  |- skos__hiddenLabel mesh__D005373 Film Badge Dosimetries
% 216.34/216.55  |- rdf__type mesh__D005373sskos__Concept
% 216.34/216.55  |- skos__hiddenLabel mesh__D005373 Dosimetries, Film
% 216.34/216.55  |- mesh__publicMeSHNote mesh__D005373 79; was FILM BADGE 1974-78   
% 216.34/216.55  |- mesh__recordAuthorizer mesh__D005373 SJN
% 216.34/216.55  |- skos__historyNote mesh__D005373 Radiation Monitoring %28%1966-1970%29%
% 216.34/216.55  |- skos__hiddenLabel mesh__D005373 Badges, Film
% 216.34/216.55  |- mesh__recordMaintainer mesh__D005373 TPW
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D005373 2000
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D005373 2005
% 216.34/216.55  |- mesh__recordOriginator mesh__D013805 NLM
% 216.34/216.55  |- skos__annotation mesh__D013805
% 216.34/216.55       a bronchodilator %26% vasodilator alkaloid   
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D013805 2005
% 216.34/216.55  |- mesh__recordMaintainer mesh__D013805 ssb
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D013805 2006
% 216.34/216.55  |- rdf__type mesh__D013805sskos__Concept
% 216.34/216.55  |- mesh__recordAuthorizer mesh__D013805 sjn
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D013805 2004
% 216.34/216.55  |- mesh__dateCreated mesh__D013805 1999-01-01
% 216.34/216.55  |- skos__broader mesh__D013805smesh__D014970
% 216.34/216.55  |- skos__scopeNote mesh__D013805
% 216.34/216.55       3,7-Dimethylxanthine. The principle alkaloid in Theobroma cacao %28%the cacao bean%29% and other plants. A xanthine alkaloid that is used as a bronchodilator and as a vasodilator. It has a weaker diuretic activity than THEOPHYLLINE and is also a less powerful stimulant of smooth muscle. It has practically no stimulant effect on the central nervous system. It was formerly used as a diuretic and in the treatment of angina pectoris and hypertension. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, pp1318-9%29%%A%    
% 216.34/216.55  |- skos__prefLabel mesh__D013805 Theobromine
% 216.34/216.55  |- mesh__dateRevised mesh__D013805 2003-07-09
% 216.34/216.55  |- skos__altLabel mesh__D013007 GHRH 1-44
% 216.34/216.55  |- mesh__onlineNote mesh__D013007
% 216.34/216.55       use SOMATOTROPIN-RELEASING HORMONE to search SOMATOTROPIN RELEASING HORMONE 1974-90%A%  
% 216.34/216.55  |- skos__hiddenLabel mesh__D013007 Hormone, Growth Hormone-Releasing
% 216.34/216.55  |- skos__hiddenLabel mesh__D013007 Somatotropin Releasing Factor 44
% 216.34/216.55  |- skos__broader mesh__D013007smesh__D010906
% 216.34/216.55  |- skos__altLabel mesh__D013007 Growth Hormone-Releasing Factor 44
% 216.34/216.55  |- mesh__dateEstablished mesh__D013007 1974-01-01
% 216.34/216.55  |- skos__altLabel mesh__D013007 GRF 1-44
% 216.34/216.55  |- skos__altLabel mesh__D013007 Somatocrinin
% 216.34/216.55  |- skos__hiddenLabel mesh__D013007 Growth Hormone Releasing Factor 44
% 216.34/216.55  |- skos__hiddenLabel mesh__D013007 Hormone, Somatotropin-Releasing
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D013007 2006
% 216.34/216.55  |- skos__broader mesh__D013007smesh__D009479
% 216.34/216.55  |- skos__hiddenLabel mesh__D013007 Somatotropin Releasing Hormone
% 216.34/216.55  |- skos__hiddenLabel mesh__D013007 Growth Hormone Releasing Factor
% 216.34/216.55  |- mesh__recordMaintainer mesh__D013007 ssb
% 216.34/216.55  |- skos__hiddenLabel mesh__D013007 Growth Hormone Releasing Hormone
% 216.34/216.55  |- skos__altLabel mesh__D013007 Growth Hormone-Releasing Factor
% 216.34/216.55  |- mesh__dateRevised mesh__D013007 2005-06-30
% 216.34/216.55  |- skos__altLabel mesh__D013007 Growth Hormone-Releasing Hormone
% 216.34/216.55  |- skos__prefLabel mesh__D013007 Somatotropin-Releasing Hormone
% 216.34/216.55  |- mesh__historyNote mesh__D013007
% 216.34/216.55       91; was SOMATOTROPIN RELEASING HORMONE 1974-90   
% 216.34/216.55  |- rdf__type mesh__D013007sskos__Concept
% 216.34/216.55  |- mesh__publicMeSHNote mesh__D013007
% 216.34/216.55       91; was SOMATOTROPIN RELEASING HORMONE 1974-90   
% 216.34/216.55  |- skos__hiddenLabel mesh__D013007 Factor, Growth Hormone-Releasing
% 216.34/216.55  |- skos__annotation mesh__D013007 DF: SRH   
% 216.34/216.55  |- mesh__recordOriginator mesh__D013007 NLM
% 216.34/216.55  |- mesh__dateCreated mesh__D013007 1999-01-01
% 216.34/216.55  |- skos__scopeNote mesh__D013007
% 216.34/216.55       Hypothalamic peptide that regulates the synthesis and secretion of GROWTH HORMONE in the anterior pituitary gland.%A%    
% 216.34/216.55  |- skos__altLabel mesh__D013007 Somatoliberin
% 216.34/216.55  |- mesh__recordAuthorizer mesh__D013007 sjn
% 216.34/216.55  |- mesh__historyNote mesh__D051126 2006%28%2005%29%   
% 216.34/216.55  |- rdf__type mesh__D051126sskos__Concept
% 216.34/216.55  |- mesh__recordMaintainer mesh__D051126 DRC
% 216.34/216.55  |- skos__altLabel mesh__D051126 SR-D Proteins
% 216.34/216.55  |- mesh__recordOriginator mesh__D051126 DRC
% 216.34/216.55  |- mesh__dateEstablished mesh__D051126 2006-01-01
% 216.34/216.55  |- mesh__dateCreated mesh__D051126 2005-06-30
% 216.34/216.55  |- mesh__recordAuthorizer mesh__D051126 sjn
% 216.34/216.55  |- skos__broader mesh__D051126smesh__D051116
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D051126 2006
% 216.34/216.55  |- skos__scopeNote mesh__D051126
% 216.34/216.55       A class of scavenger receptors that are specific for oxidized LOW-DENSITY LIPOPROTEINS and apoptotic cells. They are expressed almost exclusively in INTRACELLULAR MEMBRANES of MACROPHAGES.%A%    
% 216.34/216.55  |- skos__prefLabel mesh__D051126 Scavenger Receptors, Class D
% 216.34/216.55  |- mesh__publicMeSHNote mesh__D051126
% 216.34/216.55       2006; SCAVENGER RECEPTORS, CLASS D was indexed under RECEPTORS, IMMUNOLOGIC 2005%A%  
% 216.34/216.55  |- skos__hiddenLabel mesh__D009764 ortho Phthalic Aldehyde
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D009764 2004
% 216.34/216.55  |- skos__altLabel mesh__D009764 ortho-Phthalaldehyde
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D009764 2002
% 216.34/216.55  |- skos__historyNote mesh__D009764 Aldehydes %28%1966-1976%29%
% 216.34/216.55  |- skos__scopeNote mesh__D009764
% 216.34/216.55       A reagent that forms fluorescent conjugation products with primary amines. It is used for the detection of many biogenic amines, peptides, and proteins in nanogram quantities in body fluids.%A%    
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D009764 2003
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D009764 2001
% 216.34/216.55  |- mesh__recordOriginator mesh__D009764 RLS
% 216.34/216.55  |- skos__broader mesh__D009764smesh__D010795
% 216.34/216.55  |- mesh__dateEstablished mesh__D009764 1991-01-01
% 216.34/216.55  |- skos__altLabel mesh__D009764 Orthophthaldialdehyde
% 216.34/216.55  |- mesh__dateRevised mesh__D009764 1998-06-10
% 216.34/216.55  |- skos__hiddenLabel mesh__D009764 o Phthaldialdehyde
% 216.34/216.55  |- mesh__dateCreated mesh__D009764 1976-04-27
% 216.34/216.55  |- skos__broader mesh__D009764smesh__D000447
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D009764 2000
% 216.34/216.55  |- mesh__publicMeSHNote mesh__D009764
% 216.34/216.55       91; was see under ALDEHYDES 1977-90   
% 216.34/216.55  |- mesh__historyNote mesh__D009764
% 216.34/216.55       91%28%77%29%; was see under ALDEHYDES 1977-90   
% 216.34/216.55  |- mesh__recordMaintainer mesh__D009764 JAG
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D009764 2006
% 216.34/216.55  |- skos__historyNote mesh__D009764 Phthalic Acids %28%1966-1976%29%
% 216.34/216.55  |- skos__hiddenLabel mesh__D009764 Aldehyde, ortho-Phthalic
% 216.34/216.55  |- skos__prefLabel mesh__D009764 o-Phthalaldehyde
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D009764 2005
% 216.34/216.55  |- skos__hiddenLabel mesh__D009764 ortho Phthalaldehyde
% 216.34/216.55  |- mesh__recordAuthorizer mesh__D009764 SJN
% 216.34/216.55  |- skos__altLabel mesh__D009764 ortho-Phthalic Aldehyde
% 216.34/216.55  |- skos__altLabel mesh__D009764 o-Phthaldialdehyde
% 216.34/216.55  |- rdf__type mesh__D009764sskos__Concept
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D009764 1999
% 216.34/216.55  |- skos__hiddenLabel mesh__D009764 o Phthalaldehyde
% 216.34/216.55  |- skos__hiddenLabel mesh__D001781 Phereses
% 216.34/216.55  |- skos__scopeNote mesh__D001781
% 216.34/216.55       Any procedure in which blood is withdrawn from a donor, a portion is separated and retained and the remainder is returned to the donor.%A%    
% 216.34/216.55  |- skos__hiddenLabel mesh__D001781 Blood Component Removals
% 216.34/216.55  |- skos__hiddenLabel mesh__D001781 Removal, Blood Component
% 216.34/216.55  |- skos__broader mesh__D001781smesh__D013812
% 216.34/216.55  |- skos__hiddenLabel mesh__D001781 Removals, Blood Component
% 216.34/216.55  |- mesh__publicMeSHNote mesh__D001781
% 216.34/216.55       86; PLATELETPHERESIS was see under CELL SEPARATION 1981-85; was see under BLOOD TRANSFUSION 1979-80; was see PLASMAPHERESIS 1978%A%  
% 216.34/216.55  |- skos__hiddenLabel mesh__D001781 Component Removals, Blood
% 216.34/216.55  |- mesh__activeMeSHYear mesh__D001781 2006
% 216.34/216.55  |- skos__altLabel mesh__D001781 Apheresis
% 216.34/216.55  |- skos__hiddenLabel mesh__D001781 Aphereses
% 216.34/216.55  |- mesh__dateCreated mesh__D001781 1980-05-12
% 216.34/216.55  |- skos__annotation mesh__D001781
% 216.34/216.55       GEN or unspecified only; prefer specifics LEUKAPHERESIS; PLASMAPHERESIS; PLATELETPHERESIS; do not use /util except by MeSH definition; erythrocytapheresis, erythrapheresis: coord with ERYTHROCYTE TRANSFUSION%A%  
% 216.34/216.55  |- skos__altLabel mesh__D001781 Pheresis
% 216.34/216.55  |- mesh__recordAuthorizer mesh__D001781 sjn
% 216.34/216.56  |- mesh__recordOriginator mesh__D001781 SMH
% 216.34/216.56  |- rdf__type mesh__D001781sskos__Concept
% 216.34/216.56  |- skos__hiddenLabel mesh__D001781 Component Removal, Blood
% 216.34/216.56  |- mesh__dateEstablished mesh__D001781 1986-01-01
% 216.34/216.56  |- mesh__historyNote mesh__D001781 86; was NON MESH before 1986   
% 216.34/216.56  |- mesh__recordMaintainer mesh__D001781 lkt
% 216.34/216.56  |- skos__prefLabel mesh__D001781 Blood Component Removal
% 216.34/216.56  |- mesh__dateRevised mesh__D001781 2005-06-30
% 216.34/216.56  |- skos__related mesh__D001781smesh__D019650
% 216.34/216.56  |- rdf__type mesh__D014100sskos__Concept
% 216.34/216.56  |- mesh__dateEstablished mesh__D014100 1991-01-01
% 216.34/216.56  |- mesh__dateRevised mesh__D014100 2003-07-09
% 216.34/216.56  |- mesh__historyNote mesh__D014100
% 216.34/216.56       91%28%75%29%; was see under DENTIFRICES 1975-90   
% 216.34/216.56  |- mesh__onlineNote mesh__D014100 search DENTIFRICES 1966-74   
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D014100 2004
% 216.34/216.56  |- mesh__recordOriginator mesh__D014100 NLM
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D014100 2006
% 216.34/216.56  |- skos__broader mesh__D014100smesh__D003802
% 216.34/216.56  |- mesh__publicMeSHNote mesh__D014100
% 216.34/216.56       91; was see under DENTIFRICES 1975-90   
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D014100 2005
% 216.34/216.56  |- mesh__recordAuthorizer mesh__D014100 sjn
% 216.34/216.56  |- skos__prefLabel mesh__D014100 Toothpaste
% 216.34/216.56  |- skos__scopeNote mesh__D014100
% 216.34/216.56       A dentifrice in paste form; usually contains binder, humectant, an abrasive, a detergent, flavoring agent and often caries preventives, anti-infective agents or other medicaments.%A%    
% 216.34/216.56  |- mesh__recordMaintainer mesh__D014100 ssb
% 216.34/216.56  |- mesh__dateCreated mesh__D014100 1999-01-01
% 216.34/216.56  |- mesh__dateCreated mesh__D033863 2002-07-03
% 216.34/216.56  |- skos__scopeNote mesh__D033863
% 216.34/216.56       A class of carrier proteins that bind to TRANSFERRIN. Many strains of pathogenic bacteria utilize transferrin-binding proteins to acquire their supply of iron from serum.%A%    
% 216.34/216.56  |- mesh__dateEstablished mesh__D033863 2003-01-01
% 216.34/216.56  |- mesh__dateRevised mesh__D033863 2005-06-30
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D033863 2006
% 216.34/216.56  |- mesh__recordOriginator mesh__D033863 jmp
% 216.34/216.56  |- skos__historyNote mesh__D033863 Iron-Binding Proteins %28%1980-2002%29%
% 216.34/216.56  |- rdf__type mesh__D033863sskos__Concept
% 216.34/216.56  |- skos__prefLabel mesh__D033863 Transferrin-Binding Proteins
% 216.34/216.56  |- skos__hiddenLabel mesh__D033863 Transferrin Binding Proteins
% 216.34/216.56  |- mesh__publicMeSHNote mesh__D033863
% 216.34/216.56       2003; TRANSFERRIN-BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-2002%A%  
% 216.34/216.56  |- mesh__recordMaintainer mesh__D033863 SYSTEM
% 216.34/216.56  |- mesh__historyNote mesh__D033863
% 216.34/216.56       2003; use IRON-BINDING PROTEINS %28%NM%29% 1980-2002   
% 216.34/216.56  |- mesh__recordAuthorizer mesh__D033863 sjn
% 216.34/216.56  |- skos__broader mesh__D033863smesh__D002352
% 216.34/216.56  |- mesh__onlineNote mesh__D019394
% 216.34/216.56       use KI-67 ANTIGEN %28%NM%29% to search ANTIGEN KI67 1988-96   
% 216.34/216.56  |- skos__hiddenLabel mesh__D019394 MIB 1 Protein
% 216.34/216.56  |- skos__altLabel mesh__D019394 Antigen Ki-67
% 216.34/216.56  |- skos__hiddenLabel mesh__D019394 Ki 67 Antigen
% 216.34/216.56  |- mesh__historyNote mesh__D019394
% 216.34/216.56       97; was ANTIGEN KI67 %28%NM%29% 1988-96   
% 216.34/216.56  |- mesh__recordMaintainer mesh__D019394 ssb
% 216.34/216.56  |- skos__hiddenLabel mesh__D019394 Ki67, Antigen
% 216.34/216.56  |- mesh__dateCreated mesh__D019394 1996-06-10
% 216.34/216.56  |- skos__prefLabel mesh__D019394 Ki-67 Antigen
% 216.34/216.56  |- skos__broader mesh__D019394smesh__D014408
% 216.34/216.56  |- mesh__publicMeSHNote mesh__D019394
% 216.34/216.56       97; ANTIGEN KI67 was indexed under NEOPLASM PROTEINS 1994-96, NUCLEAR PROTEINS 1992-96 %26% ANTIGENS, SURFACE 1988-91%A%  
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D019394 2006
% 216.34/216.56  |- skos__hiddenLabel mesh__D019394 MIB 1 Antigen
% 216.34/216.56  |- skos__hiddenLabel mesh__D019394 Ki-67, Antigen
% 216.34/216.56  |- rdf__type mesh__D019394sskos__Concept
% 216.34/216.56  |- mesh__recordOriginator mesh__D019394 AGS
% 216.34/216.56  |- skos__hiddenLabel mesh__D019394 Antigen, Ki-67
% 216.34/216.56  |- skos__hiddenLabel mesh__D019394 Antigen Ki 67
% 216.34/216.56  |- skos__scopeNote mesh__D019394
% 216.34/216.56       A CELL CYCLE and tumor growth marker which can be readily detected using IMMUNOCYTOCHEMISTRY methods. Ki-67 is a nuclear antigen present only in the nuclei of cycling cells.%A%    
% 216.34/216.56  |- skos__historyNote mesh__D019394 Nuclear Proteins %28%1992-1996%29%
% 216.34/216.56  |- skos__altLabel mesh__D019394 MIB-1 Protein
% 216.34/216.56  |- skos__hiddenLabel mesh__D019394 Antigen, MIB-1
% 216.34/216.56  |- skos__broader mesh__D019394smesh__D034961
% 216.34/216.56  |- mesh__recordAuthorizer mesh__D019394 sjn
% 216.34/216.56  |- skos__historyNote mesh__D019394 Antigens, Surface %28%1988-1991%29%
% 216.34/216.56  |- skos__altLabel mesh__D019394 MIB-1 Antigen
% 216.34/216.56  |- mesh__dateRevised mesh__D019394 2005-06-30
% 216.34/216.56  |- skos__annotation mesh__D019394
% 216.34/216.56       X ref MIB-1 ANTIGEN: MIB-1 antibody is available in the SCR%A%  
% 216.34/216.56  |- skos__altLabel mesh__D019394 Antigen Ki67
% 216.34/216.56  |- mesh__dateEstablished mesh__D019394 1997-01-01
% 216.34/216.56  |- skos__historyNote mesh__D019394 Neoplasm Proteins %28%1994-1996%29%
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D027826 2006
% 216.34/216.56  |- mesh__dateCreated mesh__D027826 2001-07-25
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D027826 2002
% 216.34/216.56  |- skos__altLabel mesh__D027826 Rose
% 216.34/216.56  |- rdf__type mesh__D027826sskos__Concept
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D027826 2005
% 216.34/216.56  |- skos__annotation mesh__D027826
% 216.34/216.56       do not confuse with roseroot = Rhodiola; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.34/216.56  |- skos__scopeNote mesh__D027826
% 216.34/216.56       A plant genus in the family ROSACEAE and order Rosales.  This should not be confused with the genus RHODIOLA which is sometimes called roseroot.%A%    
% 216.34/216.56  |- mesh__historyNote mesh__D027826
% 216.34/216.56       2002; use Rosales 1998-2001, use PLANTS, MEDICINAL 1986-1997%A%  
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D027826 2004
% 216.34/216.56  |- skos__prefLabel mesh__D027826 Rosa
% 216.34/216.56  |- skos__broader mesh__D027826smesh__D027824
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D027826 2003
% 216.34/216.56  |- skos__historyNote mesh__D027826 Rosales %28%1998-2001%29%
% 216.34/216.56  |- mesh__dateEstablished mesh__D027826 2002-01-01
% 216.34/216.56  |- mesh__publicMeSHNote mesh__D027826
% 216.34/216.56       2002; see Rosales 1988-2001, see PLANTS, MEDICINAL 1986-1997%A%  
% 216.34/216.56  |- mesh__dateEstablished mesh__D005374 1975-01-01
% 216.34/216.56  |- skos__broader mesh__D005374smesh__D002627
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D005374 2003
% 216.34/216.56  |- skos__annotation mesh__D005374
% 216.34/216.56       NIM; includes filtration of fluids, gases %26% radiations; not for electrical or electronic filtering; filters: index FILTRATION /instrum; HEMOFILTRATION %26% ULTRAFILTRATION are available; note ACETATE-FREE BIOFILTRATION see HEMODIAFILTRATION%A%  
% 216.34/216.56  |- skos__broader mesh__D005374smesh__D001703
% 216.34/216.56  |- mesh__onlineNote mesh__D005374
% 216.34/216.56       use FILTRATION to search FILTERS 1966-74   
% 216.34/216.56  |- skos__prefLabel mesh__D005374 Filtration
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D005374 2004
% 216.34/216.56  |- mesh__recordOriginator mesh__D005374 NLM
% 216.34/216.56  |- mesh__dateRevised mesh__D005374 2002-07-03
% 216.34/216.56  |- mesh__dateCreated mesh__D005374 1999-01-01
% 216.34/216.56  |- mesh__recordMaintainer mesh__D005374 lkt
% 216.34/216.56  |- skos__broader mesh__D005374smesh__D002623
% 216.34/216.56  |- skos__scopeNote mesh__D005374
% 216.34/216.56       A process of separating particulate matter from a fluid, such as air or a liquid, by passing the fluid carrier through a medium that will not pass the particulates. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 216.34/216.56  |- rdf__type mesh__D005374sskos__Concept
% 216.34/216.56  |- mesh__recordAuthorizer mesh__D005374 sjn
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D005374 2005
% 216.34/216.56  |- skos__hiddenLabel mesh__D005374 Filtrations
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D005374 2006
% 216.34/216.56  |- mesh__historyNote mesh__D005374
% 216.34/216.56       70; FILTERS was see under FILTRATION 1970-74, was heading 1963-69%A%  
% 216.34/216.56  |- mesh__publicMeSHNote mesh__D005374
% 216.34/216.56       70; FILTERS was see under FILTRATION 1970-74, was heading 1963-69%A%  
% 216.34/216.56  |- skos__hiddenLabel mesh__D013806 Theo24
% 216.34/216.56  |- mesh__recordOriginator mesh__D013806 NLM
% 216.34/216.56  |- mesh__recordAuthorizer mesh__D013806 sjn
% 216.34/216.56  |- skos__hiddenLabel mesh__D013806 Theophyllinate, Glycine
% 216.34/216.56  |- mesh__recordMaintainer mesh__D013806 ssb
% 216.34/216.56  |- skos__broader mesh__D013806smesh__D014970
% 216.34/216.56  |- skos__hiddenLabel mesh__D013806 1,3 Dimethylxanthine
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D013806 2004
% 216.34/216.56  |- skos__altLabel mesh__D013806
% 216.34/216.56       3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione
% 216.34/216.56  |- skos__prefLabel mesh__D013806 Theophylline
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D013806 2006
% 216.34/216.56  |- skos__hiddenLabel mesh__D013806 Quibron TSR
% 216.34/216.56  |- skos__hiddenLabel mesh__D013806 Glycinate, Theophylline Sodium
% 216.34/216.56  |- mesh__dateCreated mesh__D013806 1999-01-01
% 216.34/216.56  |- mesh__dateRevised mesh__D013806 2003-07-09
% 216.34/216.56  |- skos__altLabel mesh__D013806 Theo-Dur
% 216.34/216.56  |- rdf__type mesh__D013806sskos__Concept
% 216.34/216.56  |- skos__hiddenLabel mesh__D013806 Theo Dur
% 216.34/216.56  |- skos__hiddenLabel mesh__D013806 SloPhyllin
% 216.34/216.56  |- skos__hiddenLabel mesh__D013806 Constant T
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D013806 2005
% 216.34/216.56  |- skos__hiddenLabel mesh__D013806 Theo 24
% 216.34/216.56  |- skos__scopeNote mesh__D013806
% 216.34/216.56       A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities.  Theophylline inhibits the 3%27%,5%27%-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLATE CYCLASE and cyclic AMP.%A%    
% 216.34/216.56  |- skos__hiddenLabel mesh__D013806 SomophyllinT
% 216.34/216.56  |- skos__altLabel mesh__D013806 1,3-Dimethylxanthine
% 216.34/216.56  |- skos__hiddenLabel mesh__D013806 Sodium Glycinate, Theophylline
% 216.34/216.56  |- skos__altLabel mesh__D013806 Nuelin
% 216.34/216.56  |- skos__hiddenLabel mesh__D013806 Somophyllin T
% 216.34/216.56  |- skos__hiddenLabel mesh__D013806 Quibron T SR
% 216.34/216.56  |- skos__hiddenLabel mesh__D013806 ConstantT
% 216.34/216.56  |- skos__hiddenLabel mesh__D013806 Slo Phyllin
% 216.34/216.56  |- skos__hiddenLabel mesh__D013008 Endomorphs
% 216.34/216.56  |- skos__hiddenLabel mesh__D013008 Types, Body
% 216.34/216.56  |- skos__hiddenLabel mesh__D013008 Mesomorphs
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D013008 2005
% 216.34/216.56  |- skos__hiddenLabel mesh__D013008 Body Type
% 216.34/216.56  |- skos__altLabel mesh__D013008 Body Types
% 216.34/216.56  |- mesh__recordOriginator mesh__D013008 NLM
% 216.34/216.56  |- skos__broader mesh__D013008smesh__D001824
% 216.34/216.56  |- skos__broader mesh__D013008smesh__D010829
% 216.34/216.56  |- rdf__type mesh__D013008sskos__Concept
% 216.34/216.56  |- mesh__recordAuthorizer mesh__D013008 sjn
% 216.34/216.56  |- mesh__recordMaintainer mesh__D013008 nns
% 216.34/216.56  |- skos__hiddenLabel mesh__D013008 Build, Body
% 216.34/216.56  |- mesh__dateCreated mesh__D013008 1999-01-01
% 216.34/216.56  |- skos__prefLabel mesh__D013008 Somatotypes
% 216.34/216.56  |- mesh__dateRevised mesh__D013008 2004-07-07
% 216.34/216.56  |- skos__scopeNote mesh__D013008
% 216.34/216.56       A particular category of body build, determined on the basis of certain physical characteristics. The three basic body types are ectomorph %28%thin physique%29%, endomorph %28%rounded physique%29%, and mesomorph %28%athletic physique%29%. The typology was devised by the American psychologist William Herbert Sheldon %28%1899-1977%29%. Somatotypes have been related to personality in early studies.%A%    
% 216.34/216.56  |- skos__altLabel mesh__D013008 Body Build
% 216.34/216.56  |- skos__hiddenLabel mesh__D013008 Builds, Body
% 216.34/216.56  |- skos__hiddenLabel mesh__D013008 Body Builds
% 216.34/216.56  |- skos__hiddenLabel mesh__D013008 Ectomorphs
% 216.34/216.56  |- skos__hiddenLabel mesh__D013008 Type, Body
% 216.34/216.56  |- skos__annotation mesh__D013008
% 216.34/216.56       note category; IM; only /genet /physiol /psychol   
% 216.34/216.56  |- skos__hiddenLabel mesh__D013008 Somatotype
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D013008 2006
% 216.34/216.56  |- skos__altLabel mesh__D051925 CD79 Antigens
% 216.34/216.56  |- mesh__publicMeSHNote mesh__D051925
% 216.34/216.56       2006; ANTIGENS, CD79 was indexed under RECEPTORS, ANTIGEN, B-CELL %26% ANTIGENS, CD 2003-2005, %26% under MEMBRANE GLYCOPROTEINS 1990-2002%A%  
% 216.34/216.56  |- skos__altLabel mesh__D051925 CD79 Antigen
% 216.34/216.56  |- skos__hiddenLabel mesh__D051925 Antigen, CD79a
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D051925 2006
% 216.34/216.56  |- mesh__recordAuthorizer mesh__D051925 sjn
% 216.34/216.56  |- skos__altLabel mesh__D051925 Immunoglobulin-Associated Alpha Protein
% 216.34/216.56  |- skos__hiddenLabel mesh__D051925 Antigen, CD79b
% 216.34/216.56  |- skos__altLabel mesh__D051925 CD79a Antigens
% 216.34/216.56  |- skos__altLabel mesh__D051925 Immunoglobulin-Associated Beta Protein
% 216.34/216.56  |- mesh__dateEstablished mesh__D051925 2006-01-01
% 216.34/216.56  |- skos__broader mesh__D051925smesh__D011947
% 216.34/216.56  |- mesh__recordOriginator mesh__D051925 DRC
% 216.34/216.56  |- rdf__type mesh__D051925sskos__Concept
% 216.34/216.56  |- mesh__dateCreated mesh__D051925 2005-06-30
% 216.34/216.56  |- skos__altLabel mesh__D051925 IgM-Alpha Component
% 216.34/216.56  |- skos__hiddenLabel mesh__D051925 Immunoglobulin Associated Alpha Protein
% 216.34/216.56  |- skos__altLabel mesh__D051925 Igbeta Antigen
% 216.34/216.56  |- skos__prefLabel mesh__D051925 Antigens, CD79
% 216.34/216.56  |- skos__hiddenLabel mesh__D051925 Immunoglobulin Associated Beta Protein
% 216.34/216.56  |- skos__hiddenLabel mesh__D051925 IgM Alpha Component
% 216.34/216.56  |- skos__altLabel mesh__D051925 CD79b Antigen
% 216.34/216.56  |- skos__altLabel mesh__D051925
% 216.34/216.56       B-Cell Antigen Receptor Complex Associated Protein Beta-Chain
% 216.34/216.56  |- skos__altLabel mesh__D051925 CD79b Antigens
% 216.34/216.56  |- skos__hiddenLabel mesh__D051925
% 216.34/216.56       B Cell Antigen Receptor Complex Associated Protein Beta Chain
% 216.34/216.56  |- skos__hiddenLabel mesh__D051925 Antigen, Igbeta
% 216.34/216.56  |- mesh__historyNote mesh__D051925 2006%28%1990%29%   
% 216.34/216.56  |- skos__scopeNote mesh__D051925
% 216.34/216.56       A component of the B-cell antigen receptor that is involved in B-cell antigen receptor heavy chain transport to the PLASMA MEMBRANE. It is expressed almost exclusively in B-LYMPHOCYTES and serves as a useful marker for B-cell NEOPLASMS.%A%    
% 216.34/216.56  |- skos__broader mesh__D051925smesh__D015703
% 216.34/216.56  |- skos__hiddenLabel mesh__D051925 Antigen, CD79
% 216.34/216.56  |- skos__altLabel mesh__D051925 CD79a Antigen
% 216.34/216.56  |- mesh__recordMaintainer mesh__D051925 DRC
% 216.34/216.56  |- mesh__dateEstablished mesh__D051127 2006-01-01
% 216.34/216.56  |- skos__prefLabel mesh__D051127 Scavenger Receptors, Class E
% 216.34/216.56  |- mesh__recordAuthorizer mesh__D051127 sjn
% 216.34/216.56  |- rdf__type mesh__D051127sskos__Concept
% 216.34/216.56  |- skos__altLabel mesh__D051127 SR-EI Proteins
% 216.34/216.56  |- skos__hiddenLabel mesh__D051127 SR EI Proteins
% 216.34/216.56  |- mesh__recordMaintainer mesh__D051127 DRC
% 216.34/216.56  |- mesh__historyNote mesh__D051127 2006%28%2000%29%   
% 216.34/216.56  |- skos__hiddenLabel mesh__D051127
% 216.34/216.56       Lectin Like Oxidized Low Density Lipoprotein Receptor 1
% 216.34/216.56  |- skos__scopeNote mesh__D051127
% 216.34/216.56       A class of oxidized LDL receptors that contain LECTIN-like extracellular domains.%A%    
% 216.34/216.56  |- mesh__publicMeSHNote mesh__D051127
% 216.34/216.56       2006; SCAVENGER RECEPTORS, CLASS E was indexed under RECEPTORS, IMMUNOLOGIC 2005; SCAVENGER RECEPTORS, CLASS E, TYPE I %26% SR-EI PROTEINS were indexed under RECEPTORS, LDL 2005; LECTIN-LIKE OXIDIZED LOW-DENSITY LIPOPROTEIN RECEPTOR-1 was indexed under RECEPTORS, LDL 2000-2005;%A%  
% 216.34/216.56  |- skos__broader mesh__D051127smesh__D051116
% 216.34/216.56  |- skos__altLabel mesh__D051127
% 216.34/216.56       Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1
% 216.34/216.56  |- skos__altLabel mesh__D051127 SR-E Proteins
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D051127 2006
% 216.34/216.56  |- skos__broader mesh__D051127smesh__D051131
% 216.34/216.56  |- mesh__dateCreated mesh__D051127 2005-06-30
% 216.34/216.56  |- mesh__recordOriginator mesh__D051127 DRC
% 216.34/216.56  |- skos__prefLabel mesh__D009765 Obesity
% 216.34/216.56  |- mesh__recordOriginator mesh__D009765 NLM
% 216.34/216.56  |- skos__related mesh__D009765smesh__D001067
% 216.34/216.56  |- skos__broader mesh__D009765smesh__D044343
% 216.34/216.56  |- skos__related mesh__D009765smesh__D001835
% 216.34/216.56  |- mesh__dateCreated mesh__D009765 1999-01-01
% 216.34/216.56  |- mesh__recordAuthorizer mesh__D009765 sjn
% 216.34/216.56  |- mesh__dateRevised mesh__D009765 2005-06-30
% 216.34/216.56  |- skos__related mesh__D009765smesh__D004038
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D009765 2006
% 216.34/216.56  |- skos__related mesh__D009765smesh__D019440
% 216.34/216.56  |- skos__annotation mesh__D009765
% 216.34/216.56       OBESITY, MORBID is also available; obese hyperglycemic mice go under MICE, OBESE: do not index under OBESITY or HYPERGLYCEMIA unless particularly discussed as diseases%A%  
% 216.34/216.56  |- skos__related mesh__D009765smesh__D012885
% 216.34/216.56  |- skos__scopeNote mesh__D009765
% 216.34/216.56       A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese %28%MORBID OBESITY%29%.%A%    
% 216.34/216.56  |- mesh__recordMaintainer mesh__D009765 lkt
% 216.34/216.56  |- rdf__type mesh__D009765sskos__Concept
% 216.34/216.56  |- skos__related mesh__D009765smesh__D015187
% 216.34/216.56  |- skos__broader mesh__D009765smesh__D050177
% 216.34/216.56  |- mesh__recordMaintainer mesh__D001782 jls
% 216.34/216.56  |- mesh__dateRevised mesh__D001782 2005-06-30
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D001782 2006
% 216.34/216.56  |- skos__hiddenLabel mesh__D001782 Donor, Blood
% 216.34/216.56  |- skos__hiddenLabel mesh__D001782 Blood Donations
% 216.34/216.56  |- skos__annotation mesh__D001782 IM   
% 216.34/216.56  |- skos__prefLabel mesh__D001782 Blood Donors
% 216.34/216.56  |- rdf__type mesh__D001782sskos__Concept
% 216.34/216.56  |- skos__hiddenLabel mesh__D001782 Blood Donor
% 216.34/216.56  |- mesh__dateCreated mesh__D001782 1999-01-01
% 216.34/216.56  |- skos__hiddenLabel mesh__D001782 Donation, Blood
% 216.34/216.56  |- mesh__recordAuthorizer mesh__D001782 sjn
% 216.34/216.56  |- mesh__recordOriginator mesh__D001782 NLM
% 216.34/216.56  |- skos__hiddenLabel mesh__D001782 Donations, Blood
% 216.34/216.56  |- skos__hiddenLabel mesh__D001782 Donors, Blood
% 216.34/216.56  |- skos__broader mesh__D001782smesh__D014019
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D028121 2003
% 216.34/216.56  |- mesh__dateEstablished mesh__D028121 2002-01-01
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D028121 2004
% 216.34/216.56  |- skos__annotation mesh__D028121
% 216.34/216.56       infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29%   
% 216.34/216.56  |- mesh__historyNote mesh__D028121 2002   
% 216.34/216.56  |- skos__historyNote mesh__D028121 Poxviridae %28%1991-1993%29%
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D028121 2002
% 216.34/216.56  |- skos__broader mesh__D028121smesh__D018150
% 216.34/216.56  |- skos__prefLabel mesh__D028121 Canarypox virus
% 216.34/216.56  |- skos__hiddenLabel mesh__D028121 Canarypox viruses
% 216.34/216.56  |- mesh__dateCreated mesh__D028121 2001-07-25
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D028121 2005
% 216.34/216.56  |- rdf__type mesh__D028121sskos__Concept
% 216.34/216.56  |- mesh__publicMeSHNote mesh__D028121 2002   
% 216.34/216.56  |- skos__scopeNote mesh__D028121
% 216.34/216.56       A species of AVIPOXVIRUS, subfamily CHORDOPOXVIRINAE. Canarypox virus vectors are used in vaccine and immunotherapy research.%A%    
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D028121 2006
% 216.34/216.56  |- skos__historyNote mesh__D028121 Avipoxvirus %28%1994-2001%29%
% 216.34/216.56  |- skos__scopeNote mesh__D014101
% 216.34/216.56       A genus of the Torpedinidae family consisting of several species. Members of this family have powerful electric organs and are commonly called electric rays.%A%    
% 216.34/216.56  |- mesh__dateEstablished mesh__D014101 1982-01-01
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D014101 2004
% 216.34/216.56  |- mesh__recordOriginator mesh__D014101 EC
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D014101 2006
% 216.34/216.56  |- mesh__publicMeSHNote mesh__D014101 1982   
% 216.34/216.56  |- mesh__historyNote mesh__D014101 1982   
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D014101 2005
% 216.34/216.56  |- skos__hiddenLabel mesh__D014101 Rays, Electric
% 216.34/216.56  |- skos__altLabel mesh__D014101 Electric Rays
% 216.34/216.56  |- skos__annotation mesh__D014101
% 216.34/216.56       do not confuse X ref ELECTRIC RAYS with RAYS %28%FISH%29% see SKATES %28%FISH%29%%A%  
% 216.34/216.56  |- skos__historyNote mesh__D014101 Fishes %28%1968-1981%29%
% 216.34/216.56  |- skos__prefLabel mesh__D014101 Torpedo
% 216.34/216.56  |- mesh__dateCreated mesh__D014101 1981-05-19
% 216.34/216.56  |- mesh__recordMaintainer mesh__D014101 ags
% 216.34/216.56  |- skos__broader mesh__D014101smesh__D004555
% 216.34/216.56  |- rdf__type mesh__D014101sskos__Concept
% 216.34/216.56  |- mesh__recordAuthorizer mesh__D014101 sjn
% 216.34/216.56  |- mesh__dateRevised mesh__D014101 2003-07-09
% 216.34/216.56  |- skos__broader mesh__D014101smesh__D018940
% 216.34/216.56  |- mesh__recordOriginator mesh__D005375 EC
% 216.34/216.56  |- mesh__dateRevised mesh__D005375 1993-09-16
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D005375 2002
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D005375 1996
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D005375 2005
% 216.34/216.56  |- rdf__type mesh__D005375sskos__Concept
% 216.34/216.56  |- mesh__dateEstablished mesh__D005375 1991-01-01
% 216.34/216.56  |- skos__hiddenLabel mesh__D005375 Financial Audits
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D005375 1997
% 216.34/216.56  |- mesh__recordAuthorizer mesh__D005375 NLM
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D005375 2006
% 216.34/216.56  |- skos__hiddenLabel mesh__D005375 Audits, Financial
% 216.34/216.56  |- mesh__historyNote mesh__D005375
% 216.34/216.56       91%28%78%29%; was see under ACCOUNTING 1978-90   
% 216.34/216.56  |- skos__hiddenLabel mesh__D005375 Audit, Financial
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D005375 2000
% 216.34/216.56  |- mesh__recordMaintainer mesh__D005375 PLS
% 216.34/216.56  |- skos__scopeNote mesh__D005375
% 216.34/216.56       An examination, review and verification of all financial accounts.%A%    
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D005375 1995
% 216.34/216.56  |- mesh__publicMeSHNote mesh__D005375
% 216.34/216.56       91; was see under ACCOUNTING 1978-90   
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D005375 2003
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D005375 2001
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D005375 1998
% 216.34/216.56  |- skos__broader mesh__D005375smesh__D000066
% 216.34/216.56  |- mesh__dateCreated mesh__D005375 1977-05-05
% 216.34/216.56  |- skos__prefLabel mesh__D005375 Financial Audit
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D005375 2004
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D005375 1999
% 216.34/216.56  |- skos__prefLabel mesh__D013009 Somnambulism
% 216.34/216.56  |- skos__historyNote mesh__D013009 Sleep Disorders %28%1966-1968%29%
% 216.34/216.56  |- rdf__type mesh__D013009sskos__Concept
% 216.34/216.56  |- skos__altLabel mesh__D013009 Sleep Walking Disorder
% 216.34/216.56  |- mesh__dateRevised mesh__D013009 1999-11-03
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D013009 2002
% 216.34/216.56  |- skos__altLabel mesh__D013009 Nocturnal Wandering
% 216.34/216.56  |- mesh__dateCreated mesh__D013009 1999-01-01
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D013009 2004
% 216.34/216.56  |- mesh__dateEstablished mesh__D013009 1969-01-01
% 216.34/216.56  |- skos__altLabel mesh__D013009 Sleep Walking
% 216.34/216.56  |- mesh__recordMaintainer mesh__D013009 KEV
% 216.34/216.56  |- mesh__recordOriginator mesh__D013009 NLM
% 216.34/216.56  |- skos__altLabel mesh__D013009 Sleepwalking
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D013009 2003
% 216.34/216.56  |- skos__hiddenLabel mesh__D013009 Sleep Walking Disorders
% 216.34/216.56  |- skos__broader mesh__D013009smesh__D020921
% 216.34/216.56  |- mesh__recordAuthorizer mesh__D013009 sjn
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D013009 2001
% 216.34/216.56  |- skos__scopeNote mesh__D013009
% 216.34/216.56       A parasomnia characterized by a partial arousal that occurs during stage IV of non-REM sleep. Affected individuals exhibit semipurposeful behaviors such as ambulation and are difficult to fully awaken. Children are primarily affected, with a peak age range of 4-6 years.%A%    
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D013009 2006
% 216.34/216.56  |- skos__hiddenLabel mesh__D013009 Wandering, Nocturnal
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D013009 2000
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D013009 2005
% 216.34/216.56  |- mesh__publicMeSHNote mesh__D013009 69   
% 216.34/216.56  |- mesh__historyNote mesh__D013009 69   
% 216.34/216.56  |- skos__altLabel mesh__D051926 CD147 Antigens
% 216.34/216.56  |- mesh__historyNote mesh__D051926 2006%28%1990%29%   
% 216.34/216.56  |- skos__broader mesh__D051926smesh__D015703
% 216.34/216.56  |- mesh__recordOriginator mesh__D051926 DRC
% 216.34/216.56  |- rdf__type mesh__D051926sskos__Concept
% 216.34/216.56  |- mesh__recordMaintainer mesh__D051926 DRC
% 216.34/216.56  |- skos__altLabel mesh__D051926 Basigin Protein
% 216.34/216.56  |- skos__broader mesh__D051926smesh__D000951
% 216.34/216.56  |- skos__altLabel mesh__D051926 Emmprin Protein
% 216.34/216.56  |- skos__altLabel mesh__D051926
% 216.34/216.56       Extracellular Matrix Metalloproteinase Inducer %28%EMMPRIN%29%
% 216.34/216.56  |- mesh__recordAuthorizer mesh__D051926 sjn
% 216.34/216.56  |- skos__broader mesh__D051926smesh__D008562
% 216.34/216.56  |- mesh__dateEstablished mesh__D051926 2006-01-01
% 216.34/216.56  |- skos__altLabel mesh__D051926 Basigin
% 216.34/216.56  |- skos__prefLabel mesh__D051926 Antigens, CD147
% 216.34/216.56  |- mesh__dateCreated mesh__D051926 2005-06-30
% 216.34/216.56  |- skos__altLabel mesh__D051926 Emmprin
% 216.34/216.56  |- skos__hiddenLabel mesh__D051926 Antigen, CD147
% 216.34/216.56  |- skos__scopeNote mesh__D051926
% 216.34/216.56       A widely distributed cell surface transmembrane glycoprotein that stimulates the synthesis of MATRIX METALLOPROTEINASES. It is found at high levels on the surface of malignant NEOPLASMS and may play a role as a mediator of malignant cell behavior.%A%    
% 216.34/216.56  |- mesh__publicMeSHNote mesh__D051926
% 216.34/216.56       2006; ANTIGENS, CD147 was indexed under ANTIGENS, CD 2005, under ANTIGENS, SURFACE %26%  BLOOD PROTEINS 1990-2004, under MEMBRANE GLYCOPROTEINS 1993-2004, %26% under GLYCOPROTEINS 1990-1992%A%  
% 216.34/216.56  |- skos__altLabel mesh__D051926 CD147 Antigen
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D051926 2006
% 216.34/216.56  |- mesh__dateCreated mesh__D051128 2005-06-30
% 216.34/216.56  |- mesh__dateEstablished mesh__D051128 2006-01-01
% 216.34/216.56  |- mesh__recordAuthorizer mesh__D051128 sjn
% 216.34/216.56  |- mesh__publicMeSHNote mesh__D051128
% 216.34/216.56       2006; SCAVENGER RECEPTORS, CLASS F was indexed under RECEPTORS, IMMUNOLOGIC 2005%A%  
% 216.34/216.56  |- mesh__historyNote mesh__D051128 2006%28%2005%29%   
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D051128 2006
% 216.34/216.56  |- mesh__recordMaintainer mesh__D051128 DRC
% 216.34/216.56  |- skos__scopeNote mesh__D051128
% 216.34/216.56       A group of structurally related scavenger receptors expressed predominately by ENDOTHELIAL CELLS. They-contain repeats of EPIDERMAL GROWTH FACTOR-like cysteine-rich motifs in their extracellular domains.%A%    
% 216.34/216.56  |- skos__altLabel mesh__D051128 SR-F Proteins
% 216.34/216.56  |- mesh__recordOriginator mesh__D051128 DRC
% 216.34/216.56  |- skos__prefLabel mesh__D051128 Scavenger Receptors, Class F
% 216.34/216.56  |- skos__broader mesh__D051128smesh__D051116
% 216.34/216.56  |- rdf__type mesh__D051128sskos__Concept
% 216.34/216.56  |- mesh__dateRevised mesh__D001783 2003-07-09
% 216.34/216.56  |- rdf__type mesh__D001783sskos__Concept
% 216.34/216.56  |- skos__annotation mesh__D001783
% 216.34/216.56       usually NIM; coord with disease /physiopathol, not /blood%A%  
% 216.34/216.56  |- skos__scopeNote mesh__D001783
% 216.34/216.56       A value equal to the total volume flow divided by the cross-sectional area of the vascular bed.%A%    
% 216.34/216.56  |- mesh__dateCreated mesh__D001783 1999-01-01
% 216.34/216.56  |- mesh__recordAuthorizer mesh__D001783 sjn
% 216.34/216.56  |- mesh__recordOriginator mesh__D001783 NLM
% 216.34/216.56  |- mesh__recordMaintainer mesh__D001783 nns
% 216.34/216.56  |- skos__hiddenLabel mesh__D001783 Velocities, Blood Flow
% 216.34/216.56  |- skos__hiddenLabel mesh__D001783 Blood Flow Velocities
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D001783 2004
% 216.34/216.56  |- skos__broader mesh__D001783smesh__D003935
% 216.34/216.56  |- skos__hiddenLabel mesh__D001783 Velocity, Blood Flow
% 216.34/216.56  |- skos__hiddenLabel mesh__D001783 Flow Velocities, Blood
% 216.34/216.56  |- mesh__historyNote mesh__D001783 was in Cat E only 1963-85   
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D001783 2005
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D001783 2006
% 216.34/216.56  |- skos__prefLabel mesh__D001783 Blood Flow Velocity
% 216.34/216.56  |- skos__broader mesh__D001783smesh__D045472
% 216.34/216.56  |- skos__hiddenLabel mesh__D001783 Flow Velocity, Blood
% 216.34/216.56  |- mesh__recordAuthorizer mesh__D014900 sjn
% 216.34/216.56  |- skos__broader mesh__D014900smesh__D017691
% 216.34/216.56  |- mesh__dateCreated mesh__D014900 1999-01-01
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D014900 2002
% 216.34/216.56  |- skos__prefLabel mesh__D014900 West Indies
% 216.34/216.56  |- skos__altLabel mesh__D014900 British Virgin Islands
% 216.34/216.56  |- mesh__activeMeSHYear mesh__D014900 2006
% 216.34/216.56  |- mesh__dateRevised mesh__D014900 2001-07-25
% 216.34/216.57  |- mesh__activeMeSHYear mesh__D014900 2004
% 216.34/216.57  |- skos__scopeNote mesh__D014900
% 216.34/216.57       Islands lying between southeastern North America and northern South America, enclosing the Caribbean Sea. They comprise the Greater Antilles %28%CUBA; DOMINICAN REPUBLIC; HAITI; JAMAICA; and PUERTO RICO%29%, the Lesser Antilles %28%ANTIGUA and the other Leeward Islands, BARBADOS; MARTINIQUE and the other Windward Islands, NETHERLANDS ANTILLES; VIRGIN ISLANDS OF THE UNITED STATES, and the islands north of Venezuela which include TRINIDAD AND TOBAGO%29%, and the BAHAMAS. %28%From Webster%27%s New Geographical Dictionary, 1988, p1330%29%%A%    
% 216.34/216.57  |- skos__annotation mesh__D014900
% 216.34/216.57       the indentions can be grouped as the Greater Antilles, the Lesser Antilles %26% the Bahamas: see MeSH definition%A%  
% 216.34/216.57  |- mesh__activeMeSHYear mesh__D014900 2005
% 216.34/216.57  |- skos__altLabel mesh__D014900 Caribbean Islands
% 216.34/216.57  |- mesh__recordOriginator mesh__D014900 NLM
% 216.34/216.57  |- mesh__activeMeSHYear mesh__D014900 2003
% 216.34/216.57  |- mesh__recordMaintainer mesh__D014900 mdb
% 216.34/216.57  |- rdf__type mesh__D014900sskos__Concept
% 216.34/216.57  |- mesh__activeMeSHYear mesh__D014102 2004
% 216.34/216.57  |- mesh__activeMeSHYear mesh__D014102 2002
% 216.34/216.57  |- mesh__activeMeSHYear mesh__D014102 2006
% 216.34/216.57  |- mesh__dateCreated mesh__D014102 1999-01-01
% 216.34/216.57  |- mesh__recordAuthorizer mesh__D014102 sjn
% 216.34/216.57  |- mesh__dateRevised mesh__D014102 1999-11-08
% 216.34/216.57  |- skos__broader mesh__D014102smesh__D020763
% 216.34/216.57  |- mesh__publicMeSHNote mesh__D014102 68   
% 216.34/216.57  |- mesh__dateEstablished mesh__D014102 1968-01-01
% 216.34/216.57  |- skos__prefLabel mesh__D014102 Torsion
% 216.34/216.57  |- mesh__activeMeSHYear mesh__D014102 2000
% 216.34/216.57  |- skos__hiddenLabel mesh__D014102 Torsions
% 216.34/216.57  |- mesh__activeMeSHYear mesh__D014102 2001
% 216.34/216.57  |- skos__scopeNote mesh__D014102
% 216.34/216.57       A twisting or rotation of a bodily part or member on its axis.%A%    
% 216.34/216.57  |- rdf__type mesh__D014102sskos__Concept
% 216.34/216.57  |- mesh__activeMeSHYear mesh__D014102 2003
% 216.34/216.57  |- mesh__historyNote mesh__D014102 68%28%63%29%   
% 216.34/216.57  |- skos__annotation mesh__D014102
% 216.34/216.57       never IM; when NIM, use any Cat C qualif pertinent; coord with organ/dis precoord %28%IM%29%%A%  
% 216.34/216.57  |- mesh__activeMeSHYear mesh__D014102 2005
% 216.34/216.57  |- mesh__recordMaintainer mesh__D014102 KEV
% 216.34/216.57  |- mesh__recordOriginator mesh__D014102 NLM
% 216.34/216.57  |- skos__related mesh__D019396smesh__D007633
% 216.34/216.57  |- skos__hiddenLabel mesh__D019396 Antigen, Tissue Polypeptide
% 216.34/216.57  |- mesh__dateCreated mesh__D019396 1996-06-10
% 216.34/216.57  |- skos__historyNote mesh__D019396 Peptides %28%1978-1996%29%
% 216.34/216.57  |- skos__prefLabel mesh__D019396 Tissue Polypeptide Antigen
% 216.34/216.57  |- skos__scopeNote mesh__D019396
% 216.34/216.57       Serological tumor marker composed of a molecular complex of cytokeratins 8, 18, and 19. It is used in the diagnosis and staging of bronchogenic carcinoma.%A%    
% 216.34/216.57  |- skos__broader mesh__D019396smesh__D000951
% 216.34/216.57  |- mesh__historyNote mesh__D019396
% 216.34/216.57       97; was TISSUE POLYPEPTIDE ANTIGEN %28%NM%29% 1978-96   
% 216.34/216.57  |- mesh__recordAuthorizer mesh__D019396 sjn
% 216.34/216.57  |- skos__broader mesh__D019396smesh__D014408
% 216.34/216.57  |- skos__broader mesh__D019396smesh__D010455
% 216.34/216.57  |- mesh__dateRevised mesh__D019396 2005-06-30
% 216.34/216.57  |- mesh__onlineNote mesh__D019396
% 216.34/216.57       use TISSUE POLYPEPTIDE ANTIGEN %28%NM%29% to search TISSUE PEPTIDE ANTIGEN 1980-96%A%  
% 216.34/216.57  |- skos__hiddenLabel mesh__D019396 Antigen, TPA
% 216.34/216.57  |- mesh__activeMeSHYear mesh__D019396 2006
% 216.34/216.57  |- mesh__recordMaintainer mesh__D019396 ssb
% 216.34/216.57  |- rdf__type mesh__D019396sskos__Concept
% 216.34/216.57  |- mesh__recordOriginator mesh__D019396 AGS
% 216.34/216.57  |- mesh__publicMeSHNote mesh__D019396
% 216.34/216.57       97; TISSUE POLYPEPTIDE ANTIGEN was indexed under PEPTIDES 1978-96%A%  
% 216.34/216.57  |- mesh__dateEstablished mesh__D019396 1997-01-01
% 216.34/216.57  |- skos__altLabel mesh__D019396 TPA Antigen
% 216.34/216.57  |- mesh__activeMeSHYear mesh__D005376 2005
% 216.34/216.57  |- skos__hiddenLabel mesh__D005376 Endowment
% 216.34/216.57  |- rdf__type mesh__D005376sskos__Concept
% 216.34/216.57  |- mesh__historyNote mesh__D005376 78   
% 216.34/216.57  |- mesh__activeMeSHYear mesh__D005376 1997
% 216.34/216.57  |- skos__hiddenLabel mesh__D005376 Management, Financial
% 216.34/216.57  |- mesh__recordOriginator mesh__D005376 EC
% 216.34/216.57  |- mesh__recordAuthorizer mesh__D005376 NLM
% 216.34/216.57  |- mesh__activeMeSHYear mesh__D005376 2006
% 216.34/216.57  |- mesh__dateRevised mesh__D005376 1993-09-16
% 216.34/216.57  |- mesh__activeMeSHYear mesh__D005376 2002
% 216.34/216.57  |- skos__prefLabel mesh__D005376 Financial Management
% 216.34/216.57  |- mesh__activeMeSHYear mesh__D005376 1995
% 216.34/216.57  |- mesh__activeMeSHYear mesh__D005376 2003
% 216.34/216.57  |- mesh__activeMeSHYear mesh__D005376 1998
% 216.34/216.57  |- skos__broader mesh__D005376smesh__D004467
% 216.34/216.57  |- mesh__dateCreated mesh__D005376 1977-05-05
% 216.34/216.57  |- skos__hiddenLabel mesh__D005376 Financial Activity
% 216.42/216.57  |- skos__hiddenLabel mesh__D005376 Fund
% 216.42/216.57  |- skos__related mesh__D005376smesh__D007182
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D005376 2004
% 216.42/216.57  |- skos__hiddenLabel mesh__D005376 Activities, Financial
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D005376 2000
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D005376 1999
% 216.42/216.57  |- mesh__recordMaintainer mesh__D005376 PLS
% 216.42/216.57  |- skos__hiddenLabel mesh__D005376 Activity, Financial
% 216.42/216.57  |- skos__scopeNote mesh__D005376
% 216.42/216.57       The obtaining and management of funds for institutional needs and responsibility for fiscal affairs.%A%    
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D005376 2001
% 216.42/216.57  |- mesh__dateEstablished mesh__D005376 1978-01-01
% 216.42/216.57  |- mesh__publicMeSHNote mesh__D005376 78   
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D005376 1996
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D013808 1991
% 216.42/216.57  |- mesh__dateEstablished mesh__D013808 1969-01-01
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D013808 2002
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D013808 1997
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D013808 2001
% 216.42/216.57  |- skos__hiddenLabel mesh__D013808 Therapeutic Communities
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D013808 1999
% 216.42/216.57  |- mesh__historyNote mesh__D013808 69%28%67%29%   
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D013808 1996
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D013808 1998
% 216.42/216.57  |- mesh__publicMeSHNote mesh__D013808 69   
% 216.42/216.57  |- skos__hiddenLabel mesh__D013808 Communities, Therapeutic
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D013808 2000
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D013808 1993
% 216.42/216.57  |- mesh__recordOriginator mesh__D013808 NLM
% 216.42/216.57  |- skos__annotation mesh__D013808 no qualif   
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D013808 1995
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D013808 2004
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D013808 1992
% 216.42/216.57  |- skos__historyNote mesh__D013808 Psychotherapy, Group %28%1966%29%
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D013808 2006
% 216.42/216.57  |- skos__altLabel mesh__D013808 Community, Therapeutic
% 216.42/216.57  |- skos__broader mesh__D013808smesh__D008884
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D013808 1994
% 216.42/216.57  |- mesh__dateCreated mesh__D013808 1999-01-01
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D013808 2003
% 216.42/216.57  |- rdf__type mesh__D013808sskos__Concept
% 216.42/216.57  |- skos__historyNote mesh__D013808 Psychotherapy %28%1966%29%
% 216.42/216.57  |- skos__prefLabel mesh__D013808 Therapeutic Community
% 216.42/216.57  |- mesh__dateRevised mesh__D013808 1990-02-16
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D013808 2005
% 216.42/216.57  |- mesh__recordAuthorizer mesh__D013808 PLS
% 216.42/216.57  |- skos__scopeNote mesh__D013808
% 216.42/216.57       Psychotherapeutic technique which emphasizes socioenvironmental and interpersonal influences in the resocialization and rehabilitation of the patient. The setting is usually a hospital unit or ward in which professional and nonprofessional staff interact with the patients.%A%    
% 216.42/216.57  |- mesh__recordMaintainer mesh__D013808 PLS
% 216.42/216.57  |- skos__altLabel mesh__D010510 Parodontosis
% 216.42/216.57  |- skos__broader mesh__D010510smesh__D009059
% 216.42/216.57  |- skos__annotation mesh__D010510
% 216.42/216.57       X ref PARODONTOSIS is in foreign lit; %22%periodontosis%22% also seen in foreign lit, meaning %22%periodontal disease%22%, should not be confused with PERIODONTOSIS see PERIODONTITIS, JUVENILE; inflamm dis = PERIODONTITIS%A%  
% 216.42/216.57  |- skos__hiddenLabel mesh__D010510 Parodontoses
% 216.42/216.57  |- mesh__dateRevised mesh__D010510 1999-11-03
% 216.42/216.57  |- skos__hiddenLabel mesh__D010510 Diseases, Periodontal
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D010510 2006
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D010510 2002
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D010510 2004
% 216.42/216.57  |- skos__prefLabel mesh__D010510 Periodontal Diseases
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D010510 2005
% 216.42/216.57  |- mesh__recordMaintainer mesh__D010510 kle
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D010510 2003
% 216.42/216.57  |- skos__hiddenLabel mesh__D010510 Periodontal Disease
% 216.42/216.57  |- rdf__type mesh__D010510sskos__Concept
% 216.42/216.57  |- skos__hiddenLabel mesh__D010510 Disease, Periodontal
% 216.42/216.57  |- mesh__publicMeSHNote mesh__D010510
% 216.42/216.57       65; was PERIODONTAL DISEASE 1963-64   
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D010510 2001
% 216.42/216.57  |- mesh__recordOriginator mesh__D010510 NLM
% 216.42/216.57  |- mesh__historyNote mesh__D010510 65; was PERIODONTAL DISEASE 1963-64   
% 216.42/216.57  |- mesh__dateCreated mesh__D010510 1999-01-01
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D010510 2000
% 216.42/216.57  |- mesh__recordAuthorizer mesh__D010510 sjn
% 216.42/216.57  |- mesh__dateEstablished mesh__D010510 1965-01-01
% 216.42/216.57  |- mesh__dateCreated mesh__D051927 2005-06-30
% 216.42/216.57  |- mesh__dateEstablished mesh__D051927 2006-01-01
% 216.42/216.57  |- mesh__historyNote mesh__D051927 2006%28%1990%29%   
% 216.42/216.57  |- rdf__type mesh__D051927sskos__Concept
% 216.42/216.57  |- skos__hiddenLabel mesh__D051927 CD24, Heat-Stable Antigen
% 216.42/216.57  |- skos__broader mesh__D051927smesh__D015815
% 216.42/216.57  |- skos__broader mesh__D051927smesh__D000951
% 216.42/216.57  |- skos__altLabel mesh__D051927 Nectadrin
% 216.42/216.57  |- mesh__recordMaintainer mesh__D051927 DRC
% 216.42/216.57  |- skos__prefLabel mesh__D051927 Antigens, CD24
% 216.42/216.57  |- skos__altLabel mesh__D051927 Heat-Stable Antigen CD24
% 216.42/216.57  |- skos__broader mesh__D051927smesh__D015703
% 216.42/216.57  |- skos__altLabel mesh__D051927 CD24 Antigens
% 216.42/216.57  |- mesh__publicMeSHNote mesh__D051927
% 216.42/216.57       2006; ANTIGENS, CD24 was indexed under ANTIGENS, CD %26% MEMBRANE GLYCOPROTEINS 1992-2005, %26% under ANTIGENS, DIFFERENTIATION 1990-1991%A%  
% 216.42/216.57  |- mesh__recordOriginator mesh__D051927 DRC
% 216.42/216.57  |- skos__hiddenLabel mesh__D051927 Heat Stable Antigen CD24
% 216.42/216.57  |- mesh__recordAuthorizer mesh__D051927 sjn
% 216.42/216.57  |- skos__scopeNote mesh__D051927
% 216.42/216.57       A cell adhesion protein that was originally identified as a heat stable antigen in mice. It is involved in METASTASIS and is highly expressed in many NEOPLASMS.%A%    
% 216.42/216.57  |- skos__altLabel mesh__D051927 CD24 Antigen
% 216.42/216.57  |- skos__hiddenLabel mesh__D051927 Antigen, CD24
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D051927 2006
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D009767 2006
% 216.42/216.57  |- skos__broader mesh__D009767smesh__D009765
% 216.42/216.57  |- mesh__dateRevised mesh__D009767 2005-06-30
% 216.42/216.57  |- skos__related mesh__D009767smesh__D015905
% 216.42/216.57  |- skos__related mesh__D009767smesh__D015390
% 216.42/216.57  |- skos__annotation mesh__D009767 /surg: consider also BARIATRIC SURGERY   
% 216.42/216.57  |- mesh__recordOriginator mesh__D009767 VDK
% 216.42/216.57  |- mesh__recordMaintainer mesh__D009767 lkt
% 216.42/216.57  |- rdf__type mesh__D009767sskos__Concept
% 216.42/216.57  |- mesh__historyNote mesh__D009767 87   
% 216.42/216.57  |- mesh__dateCreated mesh__D009767 1986-04-18
% 216.42/216.57  |- skos__prefLabel mesh__D009767 Obesity, Morbid
% 216.42/216.57  |- skos__related mesh__D009767smesh__D015904
% 216.42/216.57  |- mesh__publicMeSHNote mesh__D009767 87   
% 216.42/216.57  |- skos__altLabel mesh__D009767 Morbid Obesity
% 216.42/216.57  |- skos__historyNote mesh__D009767 Obesity %28%1966-1986%29%
% 216.42/216.57  |- skos__scopeNote mesh__D009767
% 216.42/216.57       The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.%A%    
% 216.42/216.57  |- skos__related mesh__D009767smesh__D007581
% 216.42/216.57  |- skos__hiddenLabel mesh__D009767 Morbid Obesities
% 216.42/216.57  |- skos__hiddenLabel mesh__D009767 Obesities, Morbid
% 216.42/216.57  |- mesh__dateEstablished mesh__D009767 1987-01-01
% 216.42/216.57  |- skos__related mesh__D009767smesh__D015391
% 216.42/216.57  |- mesh__recordAuthorizer mesh__D009767 sjn
% 216.42/216.57  |- skos__prefLabel mesh__D001784 Blood Gas Analysis
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D001784 2003
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D001784 1998
% 216.42/216.57  |- mesh__recordAuthorizer mesh__D001784 SJN
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D001784 2004
% 216.42/216.57  |- skos__altLabel mesh__D001784 Analysis, Blood Gas
% 216.42/216.57  |- mesh__dateRevised mesh__D001784 1997-06-20
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D001784 1999
% 216.42/216.57  |- mesh__recordOriginator mesh__D001784 NLM
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D001784 2005
% 216.42/216.57  |- skos__scopeNote mesh__D001784
% 216.42/216.57       Measurement of oxygen and carbon dioxide in the blood.     
% 216.42/216.57  |- skos__broader mesh__D001784smesh__D001774
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D001784 2006
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D001784 2000
% 216.42/216.57  |- skos__hiddenLabel mesh__D001784 Gas Analyses, Blood
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D001784 2001
% 216.42/216.57  |- skos__hiddenLabel mesh__D001784 Gas Analysis, Blood
% 216.42/216.57  |- skos__broader mesh__D001784smesh__D012129
% 216.42/216.57  |- rdf__type mesh__D001784sskos__Concept
% 216.42/216.57  |- skos__hiddenLabel mesh__D001784 Analyses, Blood Gas
% 216.42/216.57  |- skos__hiddenLabel mesh__D001784 Blood Gas Analyses
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D001784 2002
% 216.42/216.57  |- mesh__recordMaintainer mesh__D001784 PXP
% 216.42/216.57  |- skos__annotation mesh__D001784
% 216.42/216.57       for determ of oxygen %26% carbon dioxide in the blood; NIM; coord with disease /blood, not /physiopathol%A%  
% 216.42/216.57  |- mesh__dateCreated mesh__D001784 1999-01-01
% 216.42/216.57  |- skos__historyNote mesh__D028921
% 216.42/216.57       Amidohydrolases/deficiency %28%1983-2001%29%
% 216.42/216.57  |- mesh__publicMeSHNote mesh__D028921 2002   
% 216.42/216.57  |- skos__altLabel mesh__D028921
% 216.42/216.57       Deficiency, Multiple Carboxylase, Late-Onset
% 216.42/216.57  |- skos__prefLabel mesh__D028921 Biotinidase Deficiency
% 216.42/216.57  |- skos__altLabel mesh__D028921 Multiple Carboxylase Deficiency, Late-Onset
% 216.42/216.57  |- skos__hiddenLabel mesh__D028921 Biotinidase Deficiencies
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D028921 2003
% 216.42/216.57  |- mesh__historyNote mesh__D028921 2002   
% 216.42/216.57  |- skos__broader mesh__D028921smesh__D009100
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D028921 2004
% 216.42/216.57  |- mesh__recordAuthorizer mesh__D028921 sjn
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D028921 2002
% 216.42/216.57  |- skos__altLabel mesh__D028921 Deficiency, Biotinidase
% 216.42/216.57  |- skos__scopeNote mesh__D028921
% 216.42/216.57       The late onset form of MULTIPLE CARBOXYLASE DEFICIENCY %28%deficiency of the activities of biotin-dependent enzymes propionyl-CoA carboxylase, methylcrotonyl-CoA carboxylase, and PYRUVATE CARBOXYLASE%29% due to a defect or deficiency in biotinidase which is essential for recycling BIOTIN.%A%    
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D028921 2005
% 216.42/216.57  |- skos__related mesh__D028921smesh__D001710
% 216.42/216.57  |- skos__altLabel mesh__D028921
% 216.42/216.57       Carboxylase Deficiency, Multiple, Late-Onset
% 216.42/216.57  |- mesh__recordOriginator mesh__D028921 nns
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D028921 2006
% 216.42/216.57  |- skos__hiddenLabel mesh__D028921
% 216.42/216.57       Multiple Carboxylase Deficiency, Late Onset
% 216.42/216.57  |- skos__hiddenLabel mesh__D028921 Deficiencies, Biotinidase
% 216.42/216.57  |- mesh__dateCreated mesh__D028921 2001-08-03
% 216.42/216.57  |- mesh__dateEstablished mesh__D028921 2002-01-01
% 216.42/216.57  |- mesh__recordMaintainer mesh__D028921 jls
% 216.42/216.57  |- rdf__type mesh__D028921sskos__Concept
% 216.42/216.57  |- skos__historyNote mesh__D020140 Lysosomes %28%1964-1999%29%
% 216.42/216.57  |- skos__broader mesh__D020140smesh__D016464
% 216.42/216.57  |- mesh__dateEstablished mesh__D020140 2000-01-01
% 216.42/216.57  |- mesh__historyNote mesh__D020140 2000   
% 216.42/216.57  |- skos__broader mesh__D020140smesh__D020739
% 216.42/216.57  |- skos__historyNote mesh__D020140 Brain Diseases %28%1964-1999%29%
% 216.42/216.57  |- skos__altLabel mesh__D020140 Nervous System Lysosomal Storage Diseases
% 216.42/216.57  |- skos__prefLabel mesh__D020140 Lysosomal Storage Diseases, Nervous System
% 216.42/216.57  |- skos__scopeNote mesh__D020140
% 216.42/216.57       A group of enzymatic disorders affecting the nervous system and to a variable degree the skeletal system, lymphoreticular system, and other organs. The conditions are marked by an abnormal accumulation of catabolic material within lysosomes.%A%    
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D020140 2002
% 216.42/216.57  |- skos__altLabel mesh__D020140 Lysosomal Enzyme Disorders, Nervous System
% 216.42/216.57  |- mesh__dateRevised mesh__D020140 2001-07-25
% 216.42/216.57  |- skos__annotation mesh__D020140 GEN: prefer specifics   
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D020140 2003
% 216.42/216.57  |- skos__historyNote mesh__D020140
% 216.42/216.57       Lysosomal Storage Diseases %28%1992-1999%29%
% 216.42/216.57  |- mesh__recordOriginator mesh__D020140 KEV
% 216.42/216.57  |- mesh__publicMeSHNote mesh__D020140 2000   
% 216.42/216.57  |- mesh__dateCreated mesh__D020140 1999-11-03
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D020140 2004
% 216.42/216.57  |- skos__altLabel mesh__D020140 Nervous System Lysosomal Enzyme Disorders
% 216.42/216.57  |- mesh__recordMaintainer mesh__D020140 nns
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D020140 2005
% 216.42/216.57  |- skos__historyNote mesh__D020140 Sphingolipidoses %28%1974-1999%29%
% 216.42/216.57  |- rdf__type mesh__D020140sskos__Concept
% 216.42/216.57  |- mesh__recordAuthorizer mesh__D020140 sjn
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D020140 2006
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D014901 2006
% 216.42/216.57  |- mesh__recordOriginator mesh__D014901 NLM
% 216.42/216.57  |- skos__broader mesh__D014901smesh__D004671
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D014901 2006A
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D014901 2004
% 216.42/216.57  |- mesh__publicMeSHNote mesh__D014901
% 216.42/216.57       1991; see TOGAVIRUS INFECTIONS 1981-1990, see ARBOVIRUS INFECTIONS 1966-80%A%  
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D014901 2005
% 216.42/216.57  |- skos__prefLabel mesh__D014901 West Nile Fever
% 216.42/216.57  |- mesh__historyNote mesh__D014901 1991%28%1966%29%   
% 216.42/216.57  |- skos__broader mesh__D014901smesh__D018177
% 216.42/216.57  |- rdf__type mesh__D014901sskos__Concept
% 216.42/216.57  |- mesh__dateEstablished mesh__D014901 1991-01-01
% 216.42/216.57  |- skos__scopeNote mesh__D014901
% 216.42/216.57       A mosquito-borne viral illness caused by the WEST NILE VIRUS, a FLAVIVIRUS and endemic to regions of Africa, Asia, and Europe. Common clinical features include HEADACHE; FEVER; maculopapular rash; gastrointestinal symptoms; and lymphadenopathy. MENINGITIS; ENCEPHALITIS; and MYELITIS may also occur. The disease may occasionally be fatal or leave survivors with residual neurologic deficits. %28%From Joynt, Clinical Neurology, 1996, Ch26, p13; Lancet 1998 Sep 5;352%28%9130%29%:767-71%29%%A%    
% 216.42/216.57  |- mesh__recordMaintainer mesh__D014901 ags
% 216.42/216.57  |- mesh__recordAuthorizer mesh__D014901 ags
% 216.42/216.57  |- mesh__dateCreated mesh__D014901 1999-01-01
% 216.42/216.57  |- skos__altLabel mesh__D014901 West Nile Fever Encephalitis
% 216.42/216.57  |- mesh__dateRevised mesh__D014901 2005-07-15
% 216.42/216.57  |- mesh__recordAuthorizer mesh__D047088 sjn
% 216.42/216.57  |- mesh__publicMeSHNote mesh__D047088 2005   
% 216.42/216.57  |- skos__broader mesh__D047088smesh__D011161
% 216.42/216.57  |- skos__prefLabel mesh__D047088 Dysidea
% 216.42/216.57  |- mesh__dateCreated mesh__D047088 2004-07-07
% 216.42/216.57  |- mesh__recordMaintainer mesh__D047088 ags
% 216.42/216.57  |- skos__historyNote mesh__D047088 Porifera %28%1980-2004%29%
% 216.42/216.57  |- mesh__dateEstablished mesh__D047088 2005-01-01
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D047088 2006
% 216.42/216.57  |- skos__scopeNote mesh__D047088
% 216.42/216.57       A genus of SPONGES in the family Dysideidae, in which all skeletal fibers are filled with detritus.%A%    
% 216.42/216.57  |- mesh__recordOriginator mesh__D047088 ags
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D047088 2005
% 216.42/216.57  |- mesh__historyNote mesh__D047088 2005   
% 216.42/216.57  |- rdf__type mesh__D047088sskos__Concept
% 216.42/216.57  |- mesh__dateCreated mesh__D014103 1999-01-01
% 216.42/216.57  |- mesh__recordOriginator mesh__D014103 NLM
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D014103 2002
% 216.42/216.57  |- skos__hiddenLabel mesh__D014103 Intermittent Torticollis
% 216.42/216.57  |- mesh__recordAuthorizer mesh__D014103 sjn
% 216.42/216.57  |- skos__broader mesh__D014103smesh__D004421
% 216.42/216.57  |- skos__hiddenLabel mesh__D014103 Torticollis, Spasmodic
% 216.42/216.57  |- skos__hiddenLabel mesh__D014103 Psychogenic Torticollis
% 216.42/216.57  |- mesh__dateRevised mesh__D014103 2001-07-25
% 216.42/216.57  |- rdf__type mesh__D014103sskos__Concept
% 216.42/216.57  |- skos__prefLabel mesh__D014103 Torticollis
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D014103 2003
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D014103 2005
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D014103 2004
% 216.42/216.57  |- skos__broader mesh__D014103smesh__D020821
% 216.42/216.57  |- mesh__recordMaintainer mesh__D014103 lkt
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D014103 2006
% 216.42/216.57  |- skos__altLabel mesh__D014103 Wryneck
% 216.42/216.57  |- skos__scopeNote mesh__D014103
% 216.42/216.57       A symptom, not a disease, of a twisted neck. In most instances, the head is tipped toward one side and the chin rotated toward the other. The involuntary muscle contractions in the neck region of patients with torticollis can be due to congenital defects, trauma, inflammation, tumors, and neurological or other factors.%A%    
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D019397 2003
% 216.42/216.57  |- mesh__dateEstablished mesh__D019397 1997-01-01
% 216.42/216.57  |- skos__broader mesh__D019397smesh__D001187
% 216.42/216.57  |- skos__annotation mesh__D019397 device simulating pancreas activity   
% 216.42/216.57  |- skos__prefLabel mesh__D019397 Pancreas, Artificial
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D019397 2001
% 216.42/216.57  |- mesh__publicMeSHNote mesh__D019397 97   
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D019397 2006
% 216.42/216.57  |- rdf__type mesh__D019397sskos__Concept
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D019397 2000
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D019397 1999
% 216.42/216.57  |- mesh__dateCreated mesh__D019397 1996-06-10
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D019397 2005
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D019397 1998
% 216.42/216.57  |- skos__historyNote mesh__D019397 Artificial Organs %28%1972-1996%29%
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D019397 2002
% 216.42/216.57  |- skos__altLabel mesh__D019397 Artificial Pancreas
% 216.42/216.57  |- mesh__historyNote mesh__D019397 97   
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D019397 2004
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D019397 1997
% 216.42/216.57  |- skos__scopeNote mesh__D019397
% 216.42/216.57       Devices for simulating the activity of the pancreas. They can be either electromechanical, consisting of a glucose sensor, computer, and insulin pump or bioartificial, consisting of isolated islets of Langerhans in an artificial membrane.%A%    
% 216.42/216.57  |- skos__historyNote mesh__D005377 Financial Management %28%1978-1981%29%
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D005377 2002
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D005377 1998
% 216.42/216.57  |- mesh__recordOriginator mesh__D005377 EC
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D005377 1997
% 216.42/216.57  |- mesh__publicMeSHNote mesh__D005377
% 216.42/216.57       91; was see under FINANCIAL MANAGEMENT 1982-90   
% 216.42/216.57  |- rdf__type mesh__D005377sskos__Concept
% 216.42/216.57  |- mesh__historyNote mesh__D005377
% 216.42/216.57       91%28%82%29%; was see under FINANCIAL MANAGEMENT 1982-90   
% 216.42/216.57  |- skos__broader mesh__D005377smesh__D005376
% 216.42/216.57  |- mesh__recordMaintainer mesh__D005377 KEV
% 216.42/216.57  |- skos__altLabel mesh__D005377 Management, Hospital Financial
% 216.42/216.57  |- skos__altLabel mesh__D005377 Hospital Financial Managements
% 216.42/216.57  |- mesh__dateCreated mesh__D005377 1981-02-26
% 216.42/216.57  |- skos__broader mesh__D005377smesh__D006739
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D005377 2006
% 216.42/216.57  |- mesh__dateEstablished mesh__D005377 1991-01-01
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D005377 2001
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D005377 2005
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D005377 2004
% 216.42/216.57  |- skos__altLabel mesh__D005377 Hospital Financial Management
% 216.42/216.57  |- skos__altLabel mesh__D005377 Managements, Hospital Financial
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D005377 2000
% 216.42/216.57  |- skos__scopeNote mesh__D005377
% 216.42/216.57       The obtaining and management of funds for hospital needs and responsibility for fiscal affairs.%A%    
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D005377 2003
% 216.42/216.57  |- mesh__recordAuthorizer mesh__D005377 PLS
% 216.42/216.57  |- skos__prefLabel mesh__D005377 Financial Management, Hospital
% 216.42/216.57  |- skos__altLabel mesh__D005377 Financial Managements, Hospital
% 216.42/216.57  |- mesh__dateRevised mesh__D005377 1996-06-10
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D005377 1999
% 216.42/216.57  |- mesh__recordMaintainer mesh__D010511 TGC
% 216.42/216.57  |- mesh__dateRevised mesh__D010511 1996-06-10
% 216.42/216.57  |- skos__altLabel mesh__D010511 Dressings, Periodontal
% 216.42/216.57  |- skos__hiddenLabel mesh__D010511 Periodontal Dressing
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D010511 2005
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D010511 1999
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D010511 2001
% 216.42/216.57  |- skos__historyNote mesh__D010511 Dental Materials %28%1966-1970%29%
% 216.42/216.57  |- mesh__recordOriginator mesh__D010511 NLM
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D010511 2003
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D010511 1997
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D010511 2006
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D010511 2002
% 216.42/216.57  |- mesh__activeMeSHYear mesh__D010511 2004
% 216.42/216.57  |- mesh__recordAuthorizer mesh__D010511 PLS
% 216.42/216.57  |- skos__scopeNote mesh__D010511
% 216.42/216.57       Surgical dressings, after periodontal surgery, applied to the necks of teeth and the adjacent tissue to cover and protect the surgical wound. %28%Boucher%27%s Clinical Dental Terminology, 4th ed, p218%29%%A%    
% 216.42/216.57  |- mesh__dateCreated mesh__D010511 1999-01-01
% 216.42/216.57  |- skos__hiddenLabel mesh__D010511 Dressing, Periodontal
% 216.42/216.57  |- skos__annotation mesh__D010511 after periodontal surg; D25-26 qualif   
% 216.42/216.57  |- mesh__dateEstablished mesh__D010511 1973-01-01
% 216.42/216.57  |- rdf__type mesh__D010511sskos__Concept
% 216.42/216.57  |- mesh__historyNote mesh__D010511 73%28%71%29%   
% 216.42/216.57  |- mesh__publicMeSHNote mesh__D010511 73   
% 216.42/216.57  |- skos__prefLabel mesh__D010511 Periodontal Dressings
% 216.42/216.57  |- skos__broader mesh__D010511smesh__D010517
% 216.42/216.58  |- mesh__activeMeSHYear mesh__D010511 1998
% 216.42/216.58  |- mesh__activeMeSHYear mesh__D010511 2000
% 216.42/216.58  |- skos__altLabel mesh__D051928 CD47 Antigen
% 216.42/216.58  |- skos__scopeNote mesh__D051928
% 216.42/216.58       A ubiquitously expressed membrane glycoprotein. It interacts with a variety of INTEGRINS and mediates responses to EXTRACELLULAR MATRIX PROTEINS.%A%    
% 216.42/216.58  |- skos__hiddenLabel mesh__D051928 CD47, Thrombospondin-1 Receptor
% 216.42/216.58  |- skos__prefLabel mesh__D051928 Antigens, CD47
% 216.42/216.58  |- mesh__dateCreated mesh__D051928 2005-06-30
% 216.42/216.58  |- mesh__dateEstablished mesh__D051928 2006-01-01
% 216.42/216.58  |- skos__altLabel mesh__D051928 Integrin-Associated Protein p50
% 216.42/216.58  |- skos__altLabel mesh__D051928 IAP-50 Antigen
% 216.42/216.58  |- skos__altLabel mesh__D051928 CD47 Antigens
% 216.42/216.58  |- mesh__recordOriginator mesh__D051928 DRC
% 216.42/216.58  |- mesh__historyNote mesh__D051928 2006%28%1993%29%   
% 216.42/216.58  |- mesh__recordMaintainer mesh__D051928 DRC
% 216.42/216.58  |- skos__hiddenLabel mesh__D051928 Antigen, IAP-50
% 216.42/216.58  |- skos__broader mesh__D051928smesh__D015703
% 216.42/216.58  |- skos__hiddenLabel mesh__D051928 IAP 50 Antigen
% 216.42/216.58  |- skos__altLabel mesh__D051928 Thrombospondin-1 Receptor CD47
% 216.42/216.58  |- mesh__activeMeSHYear mesh__D051928 2006
% 216.42/216.58  |- skos__hiddenLabel mesh__D051928 Antigen, CD47
% 216.42/216.58  |- skos__broader mesh__D051928smesh__D008562
% 216.42/216.58  |- rdf__type mesh__D051928sskos__Concept
% 216.42/216.58  |- mesh__publicMeSHNote mesh__D051928
% 216.42/216.58       2006; ANTIGENS, CD47 was indexed under ANTIGENS, CD 2005, %26% under CARRIER PROTEINS 1993-2004%A%  
% 216.42/216.58  |- skos__hiddenLabel mesh__D051928 Integrin Associated Protein p50
% 216.42/216.58  |- mesh__recordAuthorizer mesh__D051928 sjn
% 216.42/216.58  |- mesh__dateEstablished mesh__D009768 1991-01-01
% 216.42/216.58  |- mesh__recordMaintainer mesh__D009768 lkw
% 216.42/216.58  |- skos__broader mesh__D009768smesh__D011726
% 216.42/216.58  |- rdf__type mesh__D009768sskos__Concept
% 216.42/216.58  |- mesh__recordAuthorizer mesh__D009768 sjn
% 216.42/216.58  |- skos__altLabel mesh__D009768 Merck Brand of Obidoxime Chloride
% 216.42/216.58  |- skos__altLabel mesh__D009768 Obidoxim
% 216.42/216.58  |- skos__hiddenLabel mesh__D009768 Chloride, Obidoxime
% 216.42/216.58  |- skos__scopeNote mesh__D009768
% 216.42/216.58       Cholinesterase reactivator occurring in two interchangeable isomeric forms, syn and anti.%A%    
% 216.42/216.58  |- skos__historyNote mesh__D009768 Oximes %28%1971%29%
% 216.42/216.58  |- skos__historyNote mesh__D009768 Cholinesterase Reactivators %28%1971%29%
% 216.42/216.58  |- mesh__dateRevised mesh__D009768 2004-07-07
% 216.42/216.58  |- skos__broader mesh__D009768smesh__D010091
% 216.42/216.58  |- mesh__dateCreated mesh__D009768 1999-01-01
% 216.42/216.58  |- mesh__activeMeSHYear mesh__D009768 2005
% 216.42/216.58  |- mesh__publicMeSHNote mesh__D009768
% 216.42/216.58       91; was OBIDOXIME see under OXIMES 1978-90; was TOXOGONIN see under OXIMES 1975-77%A%  
% 216.42/216.58  |- skos__prefLabel mesh__D009768 Obidoxime Chloride
% 216.42/216.58  |- mesh__activeMeSHYear mesh__D009768 2006
% 216.42/216.58  |- mesh__historyNote mesh__D009768
% 216.42/216.58       91; was OBIDOXIME see under OXIMES 1978-90; was TOXOGONIN see under OXIMES 1972-77 %28%Prov 1972-74%29%%A%  
% 216.42/216.58  |- mesh__onlineNote mesh__D009768
% 216.42/216.58       use OBIDOXIME CHLORIDE to search OBIDOXIME 1978-90 %26% TOXOGONIN 1972-77 %28%as Prov 1972-74%29%%A%  
% 216.42/216.58  |- mesh__recordOriginator mesh__D009768 NLM
% 216.42/216.58  |- skos__hiddenLabel mesh__D001785 Cutaneous Oximetries
% 216.42/216.58  |- skos__hiddenLabel mesh__D001785 Oximetry, Cutaneous
% 216.42/216.58  |- mesh__activeMeSHYear mesh__D001785 2005
% 216.42/216.58  |- skos__historyNote mesh__D001785
% 216.42/216.58       Monitoring, Physiological %28%1966-1986%29%
% 216.42/216.58  |- skos__altLabel mesh__D001785 Transcutaneous Oximetry
% 216.42/216.58  |- skos__historyNote mesh__D001785 Carbon Dioxide/blood %28%1966-1986%29%
% 216.42/216.58  |- skos__hiddenLabel mesh__D001785 Capnometry, Transcutaneous
% 216.42/216.58  |- mesh__activeMeSHYear mesh__D001785 2000
% 216.42/216.58  |- skos__prefLabel mesh__D001785 Blood Gas Monitoring, Transcutaneous
% 216.42/216.58  |- skos__broader mesh__D001785smesh__D010092
% 216.42/216.58  |- rdf__type mesh__D001785sskos__Concept
% 216.42/216.58  |- skos__hiddenLabel mesh__D001785 Oximetries, Transcutaneous
% 216.42/216.58  |- skos__hiddenLabel mesh__D001785 Oximetries, Cutaneous
% 216.42/216.58  |- skos__altLabel mesh__D001785 Transcutaneous Blood Gas Monitoring
% 216.42/216.58  |- skos__altLabel mesh__D001785
% 216.42/216.58       Carbon Dioxide Partial Pressure Determination, Transcutaneous
% 216.42/216.58  |- mesh__activeMeSHYear mesh__D001785 2004
% 216.42/216.58  |- mesh__recordAuthorizer mesh__D001785 SJN
% 216.42/216.58  |- mesh__recordOriginator mesh__D001785 SH
% 216.42/216.58  |- skos__altLabel mesh__D001785 Oximetry, Transcutaneous
% 216.42/216.58  |- mesh__dateRevised mesh__D001785 1997-06-20
% 216.42/216.58  |- skos__historyNote mesh__D001785 Partial Pressure %28%1966-1986%29%
% 216.42/216.58  |- skos__hiddenLabel mesh__D001785 Transcutaneous Capnometries
% 216.42/216.58  |- skos__hiddenLabel mesh__D001785 Capnometries, Transcutaneous
% 216.42/216.58  |- mesh__historyNote mesh__D001785 87   
% 216.42/216.58  |- mesh__dateCreated mesh__D001785 1986-06-20
% 216.42/216.58  |- mesh__activeMeSHYear mesh__D001785 2003
% 216.43/216.58  |- mesh__recordMaintainer mesh__D001785 PXP
% 216.43/216.58  |- skos__historyNote mesh__D001785 Oxygen/blood %28%1966-1986%29%
% 216.43/216.58  |- skos__scopeNote mesh__D001785
% 216.43/216.58       The noninvasive measurement or determination of the partial pressure %28%tension%29% of oxygen and/or carbon dioxide locally in the capillaries of a tissue by the application to the skin of a special set of electrodes. These electrodes contain photoelectric sensors capable of picking up the specific wavelengths of radiation emitted by oxygenated versus reduced hemoglobin.%A%    
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D001785 1999
% 216.43/216.58  |- skos__annotation mesh__D001785
% 216.43/216.58       NIM; coord with disease /blood, not /physiopathol; when IM, do not coord with OXYGEN /blood or CARBON DIOXIDE /blood; DF: TCPO2%A%  
% 216.43/216.58  |- mesh__publicMeSHNote mesh__D001785 87   
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D001785 2002
% 216.43/216.58  |- mesh__dateEstablished mesh__D001785 1987-01-01
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D001785 1998
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D001785 2006
% 216.43/216.58  |- skos__altLabel mesh__D001785
% 216.43/216.58       Oxygen Partial Pressure Determination, Transcutaneous
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D001785 2001
% 216.43/216.58  |- skos__hiddenLabel mesh__D001785 Transcutaneous Oximetries
% 216.43/216.58  |- skos__scopeNote mesh__D034161
% 216.43/216.58       Infection involving the tissues or organs in the PELVIS.%A%    
% 216.43/216.58  |- skos__hiddenLabel mesh__D034161 Pelvic Infections
% 216.43/216.58  |- mesh__dateCreated mesh__D034161 2002-07-03
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D034161 2004
% 216.43/216.58  |- mesh__publicMeSHNote mesh__D034161 2003; see ADNEXITIS 1990-2002   
% 216.43/216.58  |- mesh__dateEstablished mesh__D034161 2003-01-01
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D034161 2006
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D034161 2003
% 216.43/216.58  |- skos__broader mesh__D034161smesh__D007239
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D034161 2005
% 216.43/216.58  |- skos__altLabel mesh__D034161 Infection, Pelvic
% 216.43/216.58  |- mesh__historyNote mesh__D034161 2003; use ADNEXITIS 1990-2002   
% 216.43/216.58  |- skos__hiddenLabel mesh__D034161 Infections, Pelvic
% 216.43/216.58  |- rdf__type mesh__D034161sskos__Concept
% 216.43/216.58  |- skos__historyNote mesh__D034161 Adnexitis %28%1967-2002%29%
% 216.43/216.58  |- skos__prefLabel mesh__D034161 Pelvic Infection
% 216.43/216.58  |- skos__altLabel mesh__D028922
% 216.43/216.58       Deficiency, Multiple Carboxylase, Neonatal Form
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D028922 2004
% 216.43/216.58  |- skos__altLabel mesh__D028922
% 216.43/216.58       Carboxylase Deficiency, Multiple, Neonatal Form
% 216.43/216.58  |- skos__altLabel mesh__D028922
% 216.43/216.58       Multiple Carboxylase Deficiency, Neonatal Form
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D028922 2005
% 216.43/216.58  |- skos__altLabel mesh__D028922 Deficiency, Holocarboxylase Synthetase
% 216.43/216.58  |- skos__hiddenLabel mesh__D028922 Holocarboxylase Synthetase Deficiencies
% 216.43/216.58  |- skos__hiddenLabel mesh__D028922 Deficiencies, Holocarboxylase Synthetase
% 216.43/216.58  |- skos__scopeNote mesh__D028922
% 216.43/216.58       The neonatal form of MULTIPLE CARBOXYLASE DEFICIENCY that is caused by a defect or deficiency in holocarboxylase synthetase. HLCS is the enzyme that covalently links biotin to the biotin dependent carboxylases %28%propionyl-CoA-carboxylase, pyruvate carboxylase, and beta-methylcrotonyl-CoA carboxylase%29%.%A%    
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D028922 2006
% 216.43/216.58  |- mesh__historyNote mesh__D028922 2002   
% 216.43/216.58  |- skos__broader mesh__D028922smesh__D009100
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D028922 2002
% 216.43/216.58  |- skos__prefLabel mesh__D028922 Holocarboxylase Synthetase Deficiency
% 216.43/216.58  |- mesh__dateEstablished mesh__D028922 2002-01-01
% 216.43/216.58  |- skos__related mesh__D028922smesh__D001710
% 216.43/216.58  |- rdf__type mesh__D028922sskos__Concept
% 216.43/216.58  |- mesh__dateCreated mesh__D028922 2001-07-25
% 216.43/216.58  |- mesh__publicMeSHNote mesh__D028922 2002   
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D028922 2003
% 216.43/216.58  |- skos__related mesh__D006470smesh__D018962
% 216.43/216.58  |- mesh__dateCreated mesh__D006470 1999-01-01
% 216.43/216.58  |- skos__altLabel mesh__D006470 Bleeding
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D006470 2002
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D006470 2006
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D006470 2005
% 216.43/216.58  |- skos__prefLabel mesh__D006470 Hemorrhage
% 216.43/216.58  |- skos__related mesh__D006470smesh__D001815
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D006470 2004
% 216.43/216.58  |- skos__annotation mesh__D006470
% 216.43/216.58       GEN or unspecified; prefer specifics; coord IM with organ/dis precoord %28%IM%29%, not organ /blood supply; consider also terms for presence of blood within cavities, as HEMOTHORAX; HEMATOCOLPOS; etc.%A%  
% 216.43/216.58  |- skos__scopeNote mesh__D006470
% 216.43/216.58       Bleeding or escape of blood from a vessel.     
% 216.43/216.58  |- mesh__recordOriginator mesh__D006470 NLM
% 216.43/216.58  |- skos__broader mesh__D006470smesh__D010335
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D006470 2003
% 216.43/216.58  |- rdf__type mesh__D006470sskos__Concept
% 216.43/216.58  |- skos__hiddenLabel mesh__D006470 Hemorrhages
% 216.43/216.58  |- mesh__recordMaintainer mesh__D006470 lkt
% 216.43/216.58  |- mesh__dateRevised mesh__D006470 2001-07-25
% 216.43/216.58  |- mesh__recordAuthorizer mesh__D006470 sjn
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D020141 2002
% 216.43/216.58  |- skos__broader mesh__D020141smesh__D014652
% 216.43/216.58  |- skos__prefLabel mesh__D020141 Vascular Hemostatic Disorders
% 216.43/216.58  |- rdf__type mesh__D020141sskos__Concept
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D020141 2006
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D020141 2001
% 216.43/216.58  |- skos__hiddenLabel mesh__D020141 Disorder, Vascular Hemostatic
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D020141 2005
% 216.43/216.58  |- skos__scopeNote mesh__D020141
% 216.43/216.58       Alterations in the mechanical integrity or structure of the blood vessels leading to bleeding disorders.%A%    
% 216.43/216.58  |- skos__hiddenLabel mesh__D020141 Disorders, Vascular Hemostatic
% 216.43/216.58  |- skos__hiddenLabel mesh__D020141 Vascular Hemostatic Disorder
% 216.43/216.58  |- skos__hiddenLabel mesh__D020141 Hemostatic Disorder, Vascular
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D020141 2000
% 216.43/216.58  |- mesh__dateEstablished mesh__D020141 1999-01-01
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D020141 2004
% 216.43/216.58  |- mesh__dateCreated mesh__D020141 1998-06-11
% 216.43/216.58  |- skos__hiddenLabel mesh__D020141 Hemostatic Disorders, Vascular
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D020141 2003
% 216.43/216.58  |- mesh__publicMeSHNote mesh__D020141 99   
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D020141 1999
% 216.43/216.58  |- skos__broader mesh__D020141smesh__D006474
% 216.43/216.58  |- mesh__historyNote mesh__D020141 99   
% 216.43/216.58  |- mesh__historyNote mesh__D014902
% 216.43/216.58       1973 %28%1965%29%; for KUNJIN VIRUS use ENCEPHALITIS VIRUSES, JAPANESE 1994-2001%A%  
% 216.43/216.58  |- mesh__dateRevised mesh__D014902 2003-07-09
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D014902 2005
% 216.43/216.58  |- skos__annotation mesh__D014902 infection = WEST NILE FEVER   
% 216.43/216.58  |- mesh__recordOriginator mesh__D014902 NLM
% 216.43/216.58  |- rdf__type mesh__D014902sskos__Concept
% 216.43/216.58  |- mesh__publicMeSHNote mesh__D014902
% 216.43/216.58       1973; for KUNJIN VIRUS see ENCEPHALITIS VIRUSES, JAPANESE 1994-2001%A%  
% 216.43/216.58  |- mesh__dateEstablished mesh__D014902 1973-01-01
% 216.43/216.58  |- skos__broader mesh__D014902smesh__D018349
% 216.43/216.58  |- skos__prefLabel mesh__D014902 West Nile virus
% 216.43/216.58  |- skos__related mesh__D014902smesh__D014901
% 216.43/216.58  |- mesh__recordAuthorizer mesh__D014902 sjn
% 216.43/216.58  |- mesh__recordMaintainer mesh__D014902 ags
% 216.43/216.58  |- mesh__dateCreated mesh__D014902 1999-01-01
% 216.43/216.58  |- skos__altLabel mesh__D014902 Egypt 101 virus
% 216.43/216.58  |- skos__scopeNote mesh__D014902
% 216.43/216.58       A species of FLAVIVIRUS, one of the Japanese encephalitis virus group %28%ENCEPHALITIS VIRUSES, JAPANESE%29%. It can infect birds and mammals. In humans, it is seen most frequently in Africa, Asia, and Europe presenting as a silent infection or undifferentiated fever %28%WEST NILE FEVER%29%. The virus appeared in North America for the first time in 1999. It is transmitted mainly by CULEX spp mosquitoes which feed primarily on birds, but it can also be carried by the Asian Tiger mosquito, AEDES albopictus, which feeds mainly on mammals.%A%    
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D014902 2006
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D014902 2004
% 216.43/216.58  |- skos__broader mesh__D047089smesh__D011161
% 216.43/216.58  |- skos__scopeNote mesh__D047089
% 216.43/216.58       A genus of SPONGES in the family Axinellidae, comprised of a choanosomal skeleton differentiated in the axial and extra-axial region. The type species is Axinella polypoides.%A%    
% 216.43/216.58  |- skos__historyNote mesh__D047089 Porifera %28%1973-2004%29%
% 216.43/216.58  |- mesh__recordMaintainer mesh__D047089 ags
% 216.43/216.58  |- mesh__dateCreated mesh__D047089 2004-07-19
% 216.43/216.58  |- mesh__recordAuthorizer mesh__D047089 sjn
% 216.43/216.58  |- skos__prefLabel mesh__D047089 Axinella
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D047089 2006
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D047089 2005
% 216.43/216.58  |- rdf__type mesh__D047089sskos__Concept
% 216.43/216.58  |- mesh__dateEstablished mesh__D047089 2005-01-01
% 216.43/216.58  |- mesh__recordOriginator mesh__D047089 ags
% 216.43/216.58  |- mesh__publicMeSHNote mesh__D047089 2005   
% 216.43/216.58  |- mesh__historyNote mesh__D047089 2005   
% 216.43/216.58  |- skos__broader mesh__D014104smesh__D014754
% 216.43/216.58  |- rdf__type mesh__D014104sskos__Concept
% 216.43/216.58  |- skos__scopeNote mesh__D014104
% 216.43/216.58       The intentional infliction of physical or mental suffering upon an individual or individuals, including the torture of animals.%A%    
% 216.43/216.58  |- mesh__dateRevised mesh__D014104 2003-07-09
% 216.43/216.58  |- mesh__publicMeSHNote mesh__D014104
% 216.43/216.58       84; was see under AGGRESSION 1975-83   
% 216.43/216.58  |- mesh__recordMaintainer mesh__D014104 jls
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D014104 2005
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D014104 2004
% 216.43/216.58  |- skos__related mesh__D014104smesh__D045809
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D014104 2006
% 216.43/216.58  |- mesh__recordOriginator mesh__D014104 NLM
% 216.43/216.58  |- mesh__historyNote mesh__D014104
% 216.43/216.58       84%28%75%29%; was see under AGGRESSION 1975-83   
% 216.43/216.58  |- mesh__dateEstablished mesh__D014104 1984-01-01
% 216.43/216.58  |- mesh__dateCreated mesh__D014104 1974-11-11
% 216.43/216.58  |- skos__prefLabel mesh__D014104 Torture
% 216.43/216.58  |- mesh__recordAuthorizer mesh__D014104 sjn
% 216.43/216.58  |- skos__annotation mesh__D014104
% 216.43/216.58       of humans or animals; physical or mental torture   
% 216.43/216.58  |- skos__related mesh__D019398smesh__D019313
% 216.43/216.58  |- mesh__recordAuthorizer mesh__D019398 ags
% 216.43/216.58  |- mesh__recordMaintainer mesh__D019398 ags
% 216.43/216.58  |- skos__hiddenLabel mesh__D019398 BRCA1 Genes
% 216.43/216.58  |- mesh__dateRevised mesh__D019398 2005-07-14
% 216.43/216.58  |- mesh__dateEstablished mesh__D019398 1997-01-01
% 216.43/216.58  |- skos__annotation mesh__D019398 BRCA stands for %22%BReast CAncer%22%   
% 216.43/216.58  |- mesh__historyNote mesh__D019398 97   
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D019398 2006A
% 216.43/216.58  |- skos__broader mesh__D019398smesh__D016147
% 216.43/216.58  |- skos__scopeNote mesh__D019398
% 216.43/216.58       A tumor suppressor gene %28%GENES, TUMOR SUPPRESSOR%29% located on human chromosome 17 at locus 17q21. Mutations of this gene are associated with the formation of familial breast and ovarian cancer. It encodes a large, nuclear protein that is a component of DNA repair pathways.%A%    
% 216.43/216.58  |- skos__historyNote mesh__D019398
% 216.43/216.58       Genes, Suppressor, Tumor %28%1993-1996%29%
% 216.43/216.58  |- mesh__publicMeSHNote mesh__D019398 97   
% 216.43/216.58  |- skos__prefLabel mesh__D019398 Genes, BRCA1
% 216.43/216.58  |- skos__altLabel mesh__D019398 BRCA1 Gene
% 216.43/216.58  |- skos__hiddenLabel mesh__D019398 Gene, BRCA1
% 216.43/216.58  |- mesh__dateCreated mesh__D019398 1996-06-10
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D019398 2006
% 216.43/216.58  |- mesh__recordOriginator mesh__D019398 TPW
% 216.43/216.58  |- rdf__type mesh__D019398sskos__Concept
% 216.43/216.58  |- rdf__type mesh__D005378sskos__Concept
% 216.43/216.58  |- skos__related mesh__D005378smesh__D037921
% 216.43/216.58  |- skos__hiddenLabel mesh__D005378 Support, Financial
% 216.43/216.58  |- skos__scopeNote mesh__D005378
% 216.43/216.58       The provision of monetary resources including money or capital and credit; obtaining or furnishing money or capital for a purchase or enterprise and the funds so obtained. %28%From Random House Unabridged Dictionary, 2d ed.%29%%A%    
% 216.43/216.58  |- skos__hiddenLabel mesh__D005378 Supports, Financial
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D005378 2006
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D005378 2003A
% 216.43/216.58  |- mesh__recordAuthorizer mesh__D005378 jls
% 216.43/216.58  |- mesh__dateEstablished mesh__D005378 1996-01-01
% 216.43/216.58  |- skos__historyNote mesh__D005378
% 216.43/216.58       specific forms of support %28%1975-1995%29%
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D005378 2005
% 216.43/216.58  |- mesh__recordOriginator mesh__D005378 NLM
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D005378 2004
% 216.43/216.58  |- skos__hiddenLabel mesh__D005378 Financial Supports
% 216.43/216.58  |- mesh__publicMeSHNote mesh__D005378 96   
% 216.43/216.58  |- mesh__historyNote mesh__D005378 96; was NON MESH 1975-95   
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D005378 2003
% 216.43/216.58  |- mesh__dateRevised mesh__D005378 2002-10-31
% 216.43/216.58  |- skos__broader mesh__D005378smesh__D004467
% 216.43/216.58  |- skos__prefLabel mesh__D005378 Financial Support
% 216.43/216.58  |- mesh__dateCreated mesh__D005378 1999-01-01
% 216.43/216.58  |- mesh__recordMaintainer mesh__D005378 jls
% 216.43/216.58  |- mesh__recordMaintainer mesh__D002080 ags
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D002080 2004
% 216.43/216.58  |- mesh__dateCreated mesh__D002080 1974-12-12
% 216.43/216.58  |- rdf__type mesh__D002080sskos__Concept
% 216.43/216.58  |- skos__scopeNote mesh__D002080
% 216.43/216.58       Slender-bodies diurnal insects having large, broad wings often strikingly colored and patterned.%A%    
% 216.43/216.58  |- mesh__publicMeSHNote mesh__D002080
% 216.43/216.58       91; was see under LEPIDOPTERA 1975-90   
% 216.43/216.58  |- skos__annotation mesh__D002080 /microbiol /parasitol /virol permitted   
% 216.43/216.58  |- mesh__recordOriginator mesh__D002080 NLM
% 216.43/216.58  |- mesh__dateEstablished mesh__D002080 1991-01-01
% 216.43/216.58  |- skos__broader mesh__D002080smesh__D007915
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D002080 2006
% 216.43/216.58  |- mesh__dateRevised mesh__D002080 2003-07-09
% 216.43/216.58  |- skos__prefLabel mesh__D002080 Butterflies
% 216.43/216.58  |- mesh__historyNote mesh__D002080
% 216.43/216.58       91%28%75%29%; was see under LEPIDOPTERA 1975-90   
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D002080 2005
% 216.43/216.58  |- mesh__recordAuthorizer mesh__D002080 sjn
% 216.43/216.58  |- skos__annotation mesh__D010512
% 216.43/216.58       no qualif; for gingival X refs do not coord with GINGIVA unless particularly discussed%A%  
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D010512 2003
% 216.43/216.58  |- mesh__historyNote mesh__D010512 70%28%66%29%   
% 216.43/216.58  |- mesh__recordAuthorizer mesh__D010512 SJN
% 216.43/216.58  |- skos__hiddenLabel mesh__D010512 Gingival Indices
% 216.43/216.58  |- skos__altLabel mesh__D010512 CPITN
% 216.43/216.58  |- skos__altLabel mesh__D010512 Gingival Bleeding on Probing
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D010512 2006
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D010512 2000
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D010512 2004
% 216.43/216.58  |- skos__hiddenLabel mesh__D010512 Indices, Gingival
% 216.43/216.58  |- skos__scopeNote mesh__D010512
% 216.43/216.58       A numerical rating scale for classifying the periodontal status of a person or population with a single figure which takes into consideration prevalence as well as severity of the condition. It is based upon probe measurement of periodontal pockets and on gingival tissue status.%A%    
% 216.43/216.58  |- mesh__dateCreated mesh__D010512 1999-01-01
% 216.43/216.58  |- skos__hiddenLabel mesh__D010512 Index, Periodontal
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D010512 2001
% 216.43/216.58  |- mesh__recordOriginator mesh__D010512 NLM
% 216.43/216.58  |- skos__altLabel mesh__D010512 Gingival Indexes
% 216.43/216.58  |- rdf__type mesh__D010512sskos__Concept
% 216.43/216.58  |- skos__hiddenLabel mesh__D010512 Periodontal Indices
% 216.43/216.58  |- skos__altLabel mesh__D010512 Periodontal Indexes
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D010512 2002
% 216.43/216.58  |- skos__prefLabel mesh__D010512 Periodontal Index
% 216.43/216.58  |- mesh__dateEstablished mesh__D010512 1970-01-01
% 216.43/216.58  |- skos__broader mesh__D010512smesh__D003753
% 216.43/216.58  |- skos__hiddenLabel mesh__D010512 Indexes, Periodontal
% 216.43/216.58  |- skos__broader mesh__D010512smesh__D010517
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D010512 1998
% 216.43/216.58  |- mesh__recordMaintainer mesh__D010512 TGC
% 216.43/216.58  |- skos__hiddenLabel mesh__D010512 Index, Gingival
% 216.43/216.58  |- skos__hiddenLabel mesh__D010512 Indices, Periodontal
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D010512 2005
% 216.43/216.58  |- mesh__publicMeSHNote mesh__D010512 70   
% 216.43/216.58  |- skos__hiddenLabel mesh__D010512 Indexes, Gingival
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D010512 1999
% 216.43/216.58  |- mesh__dateRevised mesh__D010512 1997-06-20
% 216.43/216.58  |- skos__scopeNote mesh__D051929
% 216.43/216.58       A cell adhesion molecule of the immunoglobulin superfamily that is expressed in ENDOTHELIAL CELLS and is involved in INTERCELLULAR JUNCTIONS.%A%    
% 216.43/216.58  |- skos__hiddenLabel mesh__D051929 Antigen, CD146
% 216.43/216.58  |- skos__altLabel mesh__D051929 S-Endo 1 Endothelial-Associated Antigen
% 216.43/216.58  |- skos__altLabel mesh__D051929 Melanoma Cell Adhesion Molecule
% 216.43/216.58  |- skos__broader mesh__D051929smesh__D015703
% 216.43/216.58  |- skos__prefLabel mesh__D051929 Antigens, CD146
% 216.43/216.58  |- skos__altLabel mesh__D051929 CD146 Antigens
% 216.43/216.58  |- mesh__recordOriginator mesh__D051929 DRC
% 216.43/216.58  |- mesh__dateEstablished mesh__D051929 2006-01-01
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D051929 2006
% 216.43/216.58  |- skos__altLabel mesh__D051929 Gicerin
% 216.43/216.58  |- mesh__recordAuthorizer mesh__D051929 sjn
% 216.43/216.58  |- skos__altLabel mesh__D051929 Glycoprotein MUC18
% 216.43/216.58  |- mesh__dateCreated mesh__D051929 2005-06-30
% 216.43/216.58  |- skos__altLabel mesh__D051929 CD146 Antigen
% 216.43/216.58  |- mesh__recordMaintainer mesh__D051929 DRC
% 216.43/216.58  |- rdf__type mesh__D051929sskos__Concept
% 216.43/216.58  |- mesh__publicMeSHNote mesh__D051929
% 216.43/216.58       2006; ANTIGENS, CD146 was indexed under CD ANTIGENS %26% NEURAL CELL ADHESION MOLECULES 2005, %26% under MEMBRANE GLYCOPROTEINS 1990-2004, %26% under NEOPLASM PROTEINS 1993-2002%A%  
% 216.43/216.58  |- mesh__historyNote mesh__D051929 2006%28%1990%29%   
% 216.43/216.58  |- skos__broader mesh__D051929smesh__D015815
% 216.43/216.58  |- skos__hiddenLabel mesh__D051929 MUC18, Glycoprotein
% 216.43/216.58  |- mesh__historyNote mesh__D009769 69   
% 216.43/216.58  |- mesh__dateRevised mesh__D009769 1994-05-23
% 216.43/216.58  |- skos__hiddenLabel mesh__D009769 Relationships, Object
% 216.43/216.58  |- skos__hiddenLabel mesh__D009769 Attachment, Object
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D009769 1996
% 216.43/216.58  |- mesh__recordAuthorizer mesh__D009769 PLS
% 216.43/216.58  |- mesh__dateEstablished mesh__D009769 1969-01-01
% 216.43/216.58  |- skos__altLabel mesh__D009769 Bonding
% 216.43/216.58  |- skos__altLabel mesh__D009769 Bonding %28%Psychology%29%
% 216.43/216.58  |- skos__historyNote mesh__D009769 Psychoanalytic Theory %28%1966-1968%29%
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D009769 2003
% 216.43/216.58  |- skos__hiddenLabel mesh__D009769 Bondings, Pyschological
% 216.43/216.58  |- skos__hiddenLabel mesh__D009769 Relation, Symbiotic %28%Psychology%29%
% 216.43/216.58  |- skos__hiddenLabel mesh__D009769 Object Attachments
% 216.43/216.58  |- skos__altLabel mesh__D009769 Bonding, Psychological
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D009769 2002
% 216.43/216.58  |- skos__hiddenLabel mesh__D009769 Relationship, Object
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D009769 1997
% 216.43/216.58  |- skos__hiddenLabel mesh__D009769 Object Relationships
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D009769 1998
% 216.43/216.58  |- skos__hiddenLabel mesh__D009769 Relations, Object
% 216.43/216.58  |- skos__hiddenLabel mesh__D009769 Psychological Bonding
% 216.43/216.58  |- skos__hiddenLabel mesh__D009769 Relations, Symbiotic %28%Psychology%29%
% 216.43/216.58  |- skos__hiddenLabel mesh__D009769 Object Relation
% 216.43/216.58  |- skos__hiddenLabel mesh__D009769 Attachments, Object
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D009769 2004
% 216.43/216.58  |- skos__altLabel mesh__D009769 Object Relationship
% 216.43/216.58  |- skos__hiddenLabel mesh__D009769 Bondings %28%Psychology%29%
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D009769 2005
% 216.43/216.58  |- skos__altLabel mesh__D009769 Bonds, Emotional
% 216.43/216.58  |- skos__historyNote mesh__D009769 Parent-Child Relations %28%1966-1968%29%
% 216.43/216.58  |- skos__broader mesh__D009769smesh__D011574
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D009769 1999
% 216.43/216.58  |- skos__scopeNote mesh__D009769
% 216.43/216.58       Emotional attachment to someone or something in the environment.%A%    
% 216.43/216.58  |- skos__annotation mesh__D009769 no qualif   
% 216.43/216.58  |- skos__altLabel mesh__D009769 Pyschological Bonding
% 216.43/216.58  |- mesh__recordOriginator mesh__D009769 NLM
% 216.43/216.58  |- skos__hiddenLabel mesh__D009769 Symbiotic Relation %28%Psychology%29%
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D009769 2006
% 216.43/216.58  |- mesh__publicMeSHNote mesh__D009769 69   
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D009769 1995
% 216.43/216.58  |- rdf__type mesh__D009769sskos__Concept
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D009769 2000
% 216.43/216.58  |- skos__hiddenLabel mesh__D009769 Relation, Object
% 216.43/216.58  |- skos__prefLabel mesh__D009769 Object Attachment
% 216.43/216.58  |- mesh__recordMaintainer mesh__D009769 AGS
% 216.43/216.58  |- skos__hiddenLabel mesh__D009769 Bond, Emotional
% 216.43/216.58  |- mesh__activeMeSHYear mesh__D009769 2001
% 216.43/216.58  |- skos__hiddenLabel mesh__D009769 Emotional Bond
% 216.43/216.58  |- skos__hiddenLabel mesh__D009769 Bonding, Pyschological
% 216.43/216.58  |- mesh__dateCreated mesh__D009769 1999-01-01
% 216.43/216.59  |- skos__hiddenLabel mesh__D009769 Pyschological Bondings
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D001786 2006
% 216.43/216.59  |- skos__altLabel mesh__D001786 Glucose, Blood
% 216.43/216.59  |- rdf__type mesh__D001786sskos__Concept
% 216.43/216.59  |- mesh__historyNote mesh__D001786 80; was BLOOD SUGAR 1963-79   
% 216.43/216.59  |- skos__broader mesh__D001786smesh__D005947
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D001786 2005
% 216.43/216.59  |- skos__related mesh__D001786smesh__D005951
% 216.43/216.59  |- mesh__dateRevised mesh__D001786 2004-07-07
% 216.43/216.59  |- skos__related mesh__D001786smesh__D007003
% 216.43/216.59  |- mesh__onlineNote mesh__D001786
% 216.43/216.59       use BLOOD GLUCOSE to search BLOOD SUGAR 1966-79   
% 216.43/216.59  |- skos__scopeNote mesh__D001786 Glucose in blood.     
% 216.43/216.59  |- skos__related mesh__D001786smesh__D015309
% 216.43/216.59  |- mesh__publicMeSHNote mesh__D001786 80; was BLOOD SUGAR 1963-79   
% 216.43/216.59  |- skos__related mesh__D001786smesh__D038321
% 216.43/216.59  |- mesh__recordOriginator mesh__D001786 NLM
% 216.43/216.59  |- mesh__recordAuthorizer mesh__D001786 sjn
% 216.43/216.59  |- mesh__dateCreated mesh__D001786 1999-01-01
% 216.43/216.59  |- skos__prefLabel mesh__D001786 Blood Glucose
% 216.43/216.59  |- mesh__recordMaintainer mesh__D001786 ssb
% 216.43/216.59  |- skos__related mesh__D001786smesh__D006943
% 216.43/216.59  |- skos__related mesh__D001786smesh__D006442
% 216.43/216.59  |- skos__altLabel mesh__D001786 Blood Sugar
% 216.43/216.59  |- skos__hiddenLabel mesh__D001786 Sugar, Blood
% 216.43/216.59  |- skos__related mesh__D020940smesh__D004365
% 216.43/216.59  |- mesh__publicMeSHNote mesh__D020940 2000   
% 216.43/216.59  |- mesh__recordMaintainer mesh__D020940 ags
% 216.43/216.59  |- rdf__type mesh__D020940sskos__Concept
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D020940 2006
% 216.43/216.59  |- mesh__dateCreated mesh__D020940 1999-11-03
% 216.43/216.59  |- mesh__dateEstablished mesh__D020940 2000-01-01
% 216.43/216.59  |- mesh__dateRevised mesh__D020940 2005-06-30
% 216.43/216.59  |- skos__altLabel mesh__D020940 Ganoderma lucidum
% 216.43/216.59  |- skos__broader mesh__D020940smesh__D032902
% 216.43/216.59  |- mesh__recordOriginator mesh__D020940 ags
% 216.43/216.59  |- mesh__historyNote mesh__D020940 2000   
% 216.43/216.59  |- mesh__recordAuthorizer mesh__D020940 sjn
% 216.43/216.59  |- skos__scopeNote mesh__D020940
% 216.43/216.59       A mushroom, Ganoderma lucidum, of the POLYPORALES order of basidiomycetous fungi. It has long been used in traditional Chinese medicine in various forms. Contains STEROLS; COUMARINS; MANNITOL; POLYSACCHARIDES; and triterpenoids.%A%    
% 216.43/216.59  |- skos__historyNote mesh__D020940 Basidiomycota %28%1979-1999%29%
% 216.43/216.59  |- skos__prefLabel mesh__D020940 Reishi
% 216.43/216.59  |- skos__broader mesh__D047888smesh__D000943
% 216.43/216.59  |- skos__broader mesh__D047888smesh__D018124
% 216.43/216.59  |- skos__altLabel mesh__D047888 Antigens, CD120a
% 216.43/216.59  |- skos__scopeNote mesh__D047888
% 216.43/216.59       A tumor necrosis factor receptor subtype that is constitutively expressed in most tissues. It is the key mediator of tumor necrosis factor signaling in the vast majority of cells. The activated receptor signals by associating with TNF RECEPTOR-ASSOCIATED FACTORS.%A%    
% 216.43/216.59  |- mesh__dateCreated mesh__D047888 2004-07-15
% 216.43/216.59  |- skos__altLabel mesh__D047888 Tumor Necrosis Factor Receptor Type 1
% 216.43/216.59  |- mesh__dateEstablished mesh__D047888 2005-01-01
% 216.43/216.59  |- skos__altLabel mesh__D047888
% 216.43/216.59       Tumor Necrosis Factor Receptor Superfamily, Member 1A
% 216.43/216.59  |- mesh__dateRevised mesh__D047888 2005-06-30
% 216.43/216.59  |- rdf__type mesh__D047888sskos__Concept
% 216.43/216.59  |- mesh__recordAuthorizer mesh__D047888 sjn
% 216.43/216.59  |- skos__altLabel mesh__D047888 Tumor Necrosis Factor Receptor 1A
% 216.43/216.59  |- skos__altLabel mesh__D047888 Receptor%28%55%29%, TNF
% 216.43/216.59  |- skos__hiddenLabel mesh__D047888 120a Antigen, CD
% 216.43/216.59  |- skos__altLabel mesh__D047888 TNF-sR55
% 216.43/216.59  |- skos__historyNote mesh__D047888
% 216.43/216.59       Tumor Necrosis Factor Receptors %28%1994-2004%29%
% 216.43/216.59  |- skos__altLabel mesh__D047888 TNFRSF1A
% 216.43/216.59  |- skos__altLabel mesh__D047888 TNFR p60
% 216.43/216.59  |- skos__historyNote mesh__D047888 Antigens, CD %28%1994-2004%29%
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D047888 2006
% 216.43/216.59  |- skos__altLabel mesh__D047888 CD120a Antigen
% 216.43/216.59  |- mesh__recordOriginator mesh__D047888 jmp
% 216.43/216.59  |- skos__altLabel mesh__D047888 TNFR1
% 216.43/216.59  |- skos__hiddenLabel mesh__D047888 Antigen, CD120a
% 216.43/216.59  |- skos__hiddenLabel mesh__D047888 Receptor, TNFRSF1A
% 216.43/216.59  |- skos__altLabel mesh__D047888 TNF Receptor p55
% 216.43/216.59  |- skos__altLabel mesh__D047888 CD 120a Antigen
% 216.43/216.59  |- skos__altLabel mesh__D047888 CD120a Antigens
% 216.43/216.59  |- skos__prefLabel mesh__D047888 Receptors, Tumor Necrosis Factor, Type I
% 216.43/216.59  |- mesh__recordMaintainer mesh__D047888 ssb
% 216.43/216.59  |- skos__broader mesh__D047888smesh__D015703
% 216.43/216.59  |- skos__altLabel mesh__D047888
% 216.43/216.59       TNFRSF1A %28%Tumor Necrosis Factor Receptor Superfamily, Member 1A%29%
% 216.43/216.59  |- skos__altLabel mesh__D047888 TNFR-I
% 216.43/216.59  |- skos__hiddenLabel mesh__D047888 Receptor p55, TNF
% 216.43/216.59  |- mesh__historyNote mesh__D047888 2005%28%1994%29%   
% 216.43/216.59  |- mesh__publicMeSHNote mesh__D047888
% 216.43/216.59       2005; TUMOR NECROSIS FACTOR RECEPTOR TYPE I %28%now RECEPTORS, TUMOR NECROSIS FACTOR TYPE I%29% was indexed under ANTIGENS, CD %26% TUMOR NECROSIS FACTOR RECEPTORS 1994-2004%A%  
% 216.43/216.59  |- skos__altLabel mesh__D047888 Tumor Necrosis Factor Receptor 55
% 216.43/216.59  |- skos__altLabel mesh__D047888 Tumor Necrosis Factor Receptor Type I
% 216.43/216.59  |- skos__hiddenLabel mesh__D047888 Antigen, CD 120a
% 216.43/216.59  |- skos__altLabel mesh__D047888 TNFRSF1A Receptor
% 216.43/216.59  |- skos__annotation mesh__D006471
% 216.43/216.59       coord IM with specific intestinal dis %28%IM%29%, as colonic hemorrhage = GASTROINTESTINAL HEMORRHAGE %28%IM%29% + COLONIC DISEASES %28%IM%29%; rectal bleeding: see note under RECTUM; X ref HEMATOCHEZIA is red blood in the feces when bleeding is from the lower bowel: do not coord with FECES unless feces are particularly discussed%A%  
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D006471 2006
% 216.43/216.59  |- mesh__publicMeSHNote mesh__D006471
% 216.43/216.59       90; was HEMORRHAGE, GASTROINTESTINAL 1966-89   
% 216.43/216.59  |- skos__scopeNote mesh__D006471
% 216.43/216.59       Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.%A%    
% 216.43/216.59  |- mesh__recordMaintainer mesh__D006471 lkt
% 216.43/216.59  |- mesh__recordAuthorizer mesh__D006471 sjn
% 216.43/216.59  |- mesh__onlineNote mesh__D006471
% 216.43/216.59       use GASTROINTESTINAL HEMORRHAGE to search HEMORRHAGE, GASTROINTESTINAL 1966-89%A%  
% 216.43/216.59  |- skos__related mesh__D006471smesh__D016558
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D006471 2005
% 216.43/216.59  |- mesh__historyNote mesh__D006471
% 216.43/216.59       90; was HEMORRHAGE, GASTROINTESTINAL 1966-89   
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D006471 2004
% 216.43/216.59  |- skos__hiddenLabel mesh__D006471 Gastrointestinal Hemorrhages
% 216.43/216.59  |- skos__prefLabel mesh__D006471 Gastrointestinal Hemorrhage
% 216.43/216.59  |- rdf__type mesh__D006471sskos__Concept
% 216.43/216.59  |- mesh__dateRevised mesh__D006471 2003-07-09
% 216.43/216.59  |- skos__broader mesh__D006471smesh__D006470
% 216.43/216.59  |- skos__altLabel mesh__D006471 Hemorrhage, Gastrointestinal
% 216.43/216.59  |- mesh__dateCreated mesh__D006471 1999-01-01
% 216.43/216.59  |- mesh__recordOriginator mesh__D006471 NLM
% 216.43/216.59  |- skos__hiddenLabel mesh__D006471 Hematochezias
% 216.43/216.59  |- skos__broader mesh__D007568Q000254smesh__D007568
% 216.43/216.59  |- mesh__preferredCombination mesh__D007568Q000254smesh__D008445
% 216.43/216.59  |- rdf__type mesh__D007568Q000254smesh__CompoundConcept
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014903 1998
% 216.43/216.59  |- mesh__recordAuthorizer mesh__D014903 SJN
% 216.43/216.59  |- skos__broader mesh__D014903smesh__D001061
% 216.43/216.59  |- mesh__dateRevised mesh__D014903 1997-06-20
% 216.43/216.59  |- mesh__dateCreated mesh__D014903 1999-01-01
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014903 1999
% 216.43/216.59  |- skos__prefLabel mesh__D014903 West Virginia
% 216.43/216.59  |- skos__broader mesh__D014903smesh__D015144
% 216.43/216.59  |- mesh__recordMaintainer mesh__D014903 PXP
% 216.43/216.59  |- rdf__type mesh__D014903sskos__Concept
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014903 2000
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014903 2005
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014903 2001
% 216.43/216.59  |- mesh__recordOriginator mesh__D014903 NLM
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014903 2003
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014903 2006
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014903 2002
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014903 2004
% 216.43/216.59  |- mesh__historyNote mesh__D014105 73%28%72%29%   
% 216.43/216.59  |- skos__broader mesh__D014105smesh__D014050
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014105 2003
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014105 2005
% 216.43/216.59  |- skos__annotation mesh__D014105 DF: TOSYL CPDS   
% 216.43/216.59  |- skos__hiddenLabel mesh__D014105 Compounds, Tosyl
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014105 2004
% 216.43/216.59  |- skos__altLabel mesh__D014105 Toluenesulfonyl Compounds
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014105 2006
% 216.43/216.59  |- mesh__recordMaintainer mesh__D014105 TGC
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014105 2000
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014105 1996
% 216.43/216.59  |- skos__prefLabel mesh__D014105 Tosyl Compounds
% 216.43/216.59  |- skos__broader mesh__D014105smesh__D013450
% 216.43/216.59  |- mesh__dateRevised mesh__D014105 1992-05-20
% 216.43/216.59  |- mesh__dateCreated mesh__D014105 1999-01-01
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014105 1998
% 216.43/216.59  |- skos__hiddenLabel mesh__D014105 Compounds, Toluenesulfonyl
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014105 2001
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014105 1997
% 216.43/216.59  |- mesh__recordAuthorizer mesh__D014105 PLS
% 216.43/216.59  |- mesh__dateEstablished mesh__D014105 1973-01-01
% 216.43/216.59  |- mesh__publicMeSHNote mesh__D014105 73   
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014105 1994
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014105 1999
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014105 1993
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014105 1995
% 216.43/216.59  |- mesh__recordOriginator mesh__D014105 NLM
% 216.43/216.59  |- skos__historyNote mesh__D014105 Toluene %28%1966-1971%29%
% 216.43/216.59  |- skos__historyNote mesh__D014105 Sulfones %28%1966-1971%29%
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014105 2002
% 216.43/216.59  |- rdf__type mesh__D014105sskos__Concept
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D005379 1995
% 216.43/216.59  |- mesh__recordMaintainer mesh__D005379 PLS
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D005379 2004
% 216.43/216.59  |- mesh__dateEstablished mesh__D005379 1991-01-01
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D005379 2005
% 216.43/216.59  |- skos__hiddenLabel mesh__D005379 Construction Financings
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D005379 2001
% 216.43/216.59  |- skos__hiddenLabel mesh__D005379 Loan, Construction
% 216.43/216.59  |- skos__hiddenLabel mesh__D005379 Issues, Construction Bond
% 216.43/216.59  |- skos__hiddenLabel mesh__D005379 Financings, Construction
% 216.43/216.59  |- skos__hiddenLabel mesh__D005379 Construction Financing
% 216.43/216.59  |- skos__prefLabel mesh__D005379 Financing, Construction
% 216.43/216.59  |- mesh__recordAuthorizer mesh__D005379 NLM
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D005379 2003
% 216.43/216.59  |- skos__hiddenLabel mesh__D005379 Construction Bond Issues
% 216.43/216.59  |- mesh__publicMeSHNote mesh__D005379
% 216.43/216.59       91; was see under FINANCIAL MANAGEMENT 1978-90   
% 216.43/216.59  |- skos__hiddenLabel mesh__D005379 Construction Bond Issue
% 216.43/216.59  |- skos__hiddenLabel mesh__D005379 Bond Issue, Construction
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D005379 2000
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D005379 1999
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D005379 1997
% 216.43/216.59  |- mesh__recordOriginator mesh__D005379 EC
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D005379 1998
% 216.43/216.59  |- mesh__dateCreated mesh__D005379 1977-05-05
% 216.43/216.59  |- skos__hiddenLabel mesh__D005379 Issue, Construction Bond
% 216.43/216.59  |- rdf__type mesh__D005379sskos__Concept
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D005379 2002
% 216.43/216.59  |- skos__scopeNote mesh__D005379
% 216.43/216.59       Funding resources and procedures for capital improvement or the construction of facilities.%A%    
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D005379 1996
% 216.43/216.59  |- skos__hiddenLabel mesh__D005379 Construction Loan
% 216.43/216.59  |- mesh__historyNote mesh__D005379
% 216.43/216.59       91%28%78%29%; was see under FINANCIAL MANAGEMENT 1978-90   
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D005379 2006
% 216.43/216.59  |- skos__broader mesh__D005379smesh__D005376
% 216.43/216.59  |- mesh__dateRevised mesh__D005379 1993-09-16
% 216.43/216.59  |- skos__hiddenLabel mesh__D005379 Loans, Construction
% 216.43/216.59  |- skos__historyNote mesh__D005379 Financing, Government %28%1968-1977%29%
% 216.43/216.59  |- mesh__dateCreated mesh__D002081 1999-01-01
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D002081 2003
% 216.43/216.59  |- skos__prefLabel mesh__D002081 Buttocks
% 216.43/216.59  |- mesh__recordAuthorizer mesh__D002081 sjn
% 216.43/216.59  |- skos__hiddenLabel mesh__D002081 Regions, Gluteal
% 216.43/216.59  |- skos__broader mesh__D002081smesh__D035002
% 216.43/216.59  |- mesh__recordOriginator mesh__D002081 NLM
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D002081 2006
% 216.43/216.59  |- skos__hiddenLabel mesh__D002081 Gluteal Regions
% 216.43/216.59  |- skos__hiddenLabel mesh__D002081 Region, Gluteal
% 216.43/216.59  |- mesh__dateRevised mesh__D002081 2002-07-02
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D002081 2005
% 216.43/216.59  |- skos__hiddenLabel mesh__D002081 Buttock
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D002081 2004
% 216.43/216.59  |- skos__annotation mesh__D002081 few qualif apply; usually NIM as site   
% 216.43/216.59  |- rdf__type mesh__D002081sskos__Concept
% 216.43/216.59  |- mesh__recordMaintainer mesh__D002081 TGC
% 216.43/216.59  |- skos__hiddenLabel mesh__D010513 Ligaments, Periodontal
% 216.43/216.59  |- skos__annotation mesh__D010513
% 216.43/216.59       intraligamental anesthesia or periodontal ligament injection %28%PDLI%29%: coord IM with ANESTHESIA, DENTAL %28%IM%29%%A%  
% 216.43/216.59  |- mesh__dateEstablished mesh__D010513 1973-01-01
% 216.43/216.59  |- mesh__historyNote mesh__D010513 73%28%72%29%   
% 216.43/216.59  |- rdf__type mesh__D010513sskos__Concept
% 216.43/216.59  |- mesh__recordMaintainer mesh__D010513 nns
% 216.43/216.59  |- skos__hiddenLabel mesh__D010513 Alveolodental Ligaments
% 216.43/216.59  |- skos__hiddenLabel mesh__D010513 Alveolodental Membranes
% 216.43/216.59  |- skos__altLabel mesh__D010513 Alveolodental Ligament
% 216.43/216.59  |- skos__prefLabel mesh__D010513 Periodontal Ligament
% 216.43/216.59  |- skos__hiddenLabel mesh__D010513 Ligament, Periodontal
% 216.43/216.59  |- mesh__publicMeSHNote mesh__D010513 73   
% 216.43/216.59  |- skos__scopeNote mesh__D010513
% 216.43/216.59       The fibrous CONNECTIVE TISSUE surrounding the TOOTH ROOT, separating it from and attaching it to the alveolar bone %28%ALVEOLAR PROCESS%29%.%A%    
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D010513 2005
% 216.43/216.59  |- skos__historyNote mesh__D010513 Periodontium %28%1966-1971%29%
% 216.43/216.59  |- skos__broader mesh__D010513smesh__D010519
% 216.43/216.59  |- skos__hiddenLabel mesh__D010513 Periodontal Ligaments
% 216.43/216.59  |- skos__altLabel mesh__D010513 Alveolodental Membrane
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D010513 2006
% 216.43/216.59  |- mesh__dateRevised mesh__D010513 2004-07-07
% 216.43/216.59  |- skos__related mesh__D010513smesh__D017622
% 216.43/216.59  |- skos__hiddenLabel mesh__D010513 Membranes, Alveolodental
% 216.43/216.59  |- skos__hiddenLabel mesh__D010513 Membrane, Alveolodental
% 216.43/216.59  |- skos__hiddenLabel mesh__D010513 Ligament, Alveolodental
% 216.43/216.59  |- skos__hiddenLabel mesh__D010513 Ligaments, Alveolodental
% 216.43/216.59  |- mesh__recordOriginator mesh__D010513 NLM
% 216.43/216.59  |- mesh__dateCreated mesh__D010513 1999-01-01
% 216.43/216.59  |- mesh__recordAuthorizer mesh__D010513 sjn
% 216.43/216.59  |- mesh__dateCreated mesh__D034961 2002-07-02
% 216.43/216.59  |- skos__altLabel mesh__D034961 Nuclear Antigens
% 216.43/216.59  |- skos__broader mesh__D034961smesh__D000941
% 216.43/216.59  |- skos__hiddenLabel mesh__D034961 Antigens, Extractable Nuclear
% 216.43/216.59  |- mesh__recordOriginator mesh__D034961 jmp
% 216.43/216.59  |- mesh__recordAuthorizer mesh__D034961 sjn
% 216.43/216.59  |- skos__scopeNote mesh__D034961
% 216.43/216.59       Immunologically detectable substances found in the CELL NUCLEUS.%A%    
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D034961 2006
% 216.43/216.59  |- mesh__historyNote mesh__D034961
% 216.43/216.59       2003; use NUCLEAR ANTIGENS %28%NM%29% 1981-2002   
% 216.43/216.59  |- mesh__publicMeSHNote mesh__D034961
% 216.43/216.59       2003; NUCLEAR ANTIGENS was indexed under NUCLEAR PROTEINS 1981-2002%A%  
% 216.43/216.59  |- skos__prefLabel mesh__D034961 Antigens, Nuclear
% 216.43/216.59  |- mesh__recordMaintainer mesh__D034961 ssb
% 216.43/216.59  |- skos__related mesh__D034961smesh__D001324
% 216.43/216.59  |- rdf__type mesh__D034961sskos__Concept
% 216.43/216.59  |- mesh__dateEstablished mesh__D034961 2003-01-01
% 216.43/216.59  |- skos__historyNote mesh__D034961 Nuclear Proteins %28%1981-2002%29%
% 216.43/216.59  |- mesh__dateRevised mesh__D034961 2005-06-30
% 216.43/216.59  |- skos__annotation mesh__D034961
% 216.43/216.59       coord NIM with specific antigen/organism heading %28%IM%29%   
% 216.43/216.59  |- skos__hiddenLabel mesh__D034961 Nuclear Antigens, Extractable
% 216.43/216.59  |- skos__broader mesh__D034961smesh__D009687
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D001787 2001
% 216.43/216.59  |- skos__hiddenLabel mesh__D001787 Group Incompatibility, Blood
% 216.43/216.59  |- skos__scopeNote mesh__D001787
% 216.43/216.59       A mismatch between donor and recipient blood. Antibodies present in the recipient%27%s serum are directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is hemolyzed. %28%From Saunders Dictionary %26% Encyclopedia of Laboratory Medicine and Technology, 1984%29%%A%    
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D001787 2004
% 216.43/216.59  |- skos__hiddenLabel mesh__D001787 Incompatibility, Blood Group
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D001787 2000
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D001787 1995
% 216.43/216.59  |- skos__hiddenLabel mesh__D001787 Incompatibilities, Blood Group
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D001787 2003
% 216.43/216.59  |- skos__hiddenLabel mesh__D001787 Blood Group Incompatibilities
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D001787 1999
% 216.43/216.59  |- skos__prefLabel mesh__D001787 Blood Group Incompatibility
% 216.43/216.59  |- mesh__recordAuthorizer mesh__D001787 PLS
% 216.43/216.59  |- mesh__recordMaintainer mesh__D001787 TGC
% 216.43/216.59  |- mesh__dateCreated mesh__D001787 1999-01-01
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D001787 1998
% 216.43/216.59  |- skos__annotation mesh__D001787
% 216.43/216.59       coord IM with specific blood group %28%IM%29%   
% 216.43/216.59  |- mesh__dateRevised mesh__D001787 1994-05-24
% 216.43/216.59  |- skos__broader mesh__D001787smesh__D006402
% 216.43/216.59  |- skos__hiddenLabel mesh__D001787 Group Incompatibilities, Blood
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D001787 1997
% 216.43/216.59  |- skos__broader mesh__D001787smesh__D007154
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D001787 2006
% 216.43/216.59  |- mesh__recordOriginator mesh__D001787 NLM
% 216.43/216.59  |- rdf__type mesh__D001787sskos__Concept
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D001787 1996
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D001787 2002
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D001787 2005
% 216.43/216.59  |- mesh__dateEstablished mesh__D020941 2000-01-01
% 216.43/216.59  |- skos__altLabel mesh__D020941 Persistent Neonatal Myasthenia Gravis
% 216.43/216.59  |- skos__altLabel mesh__D020941 Myasthenia Gravis, Persistent, Neonatal
% 216.43/216.59  |- mesh__publicMeSHNote mesh__D020941 2000   
% 216.43/216.59  |- skos__hiddenLabel mesh__D020941 Myasthenia Gravis, Antenatal
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D020941 2002
% 216.43/216.59  |- skos__altLabel mesh__D020941 Myasthenia Gravis, Transient, Neonatal
% 216.43/216.59  |- mesh__historyNote mesh__D020941 2000   
% 216.43/216.59  |- skos__altLabel mesh__D020941 Neonatal Myasthenia Gravis, Persistent
% 216.43/216.59  |- skos__prefLabel mesh__D020941 Myasthenia Gravis, Neonatal
% 216.43/216.59  |- mesh__dateCreated mesh__D020941 1999-11-03
% 216.43/216.59  |- skos__altLabel mesh__D020941 Neonatal Myasthenia Gravis, Transient
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D020941 2003
% 216.43/216.59  |- skos__historyNote mesh__D020941 Myasthenia Gravis %28%1965-1999%29%
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D020941 2000
% 216.43/216.59  |- skos__scopeNote mesh__D020941
% 216.43/216.59       A disorder of neuromuscular transmission that occurs in a minority of newborns born to women with myasthenia gravis. Clinical features are usually present at birth or develop in the first 3 days of life and consist of hypotonia and impaired respiratory, suck, and swallowing abilities. This condition is associated with the passive transfer of acetylcholine receptor antibodies through the placenta. In the majority of infants the myasthenic weakness resolves %28%i.e., transient neonatal myasthenia gravis%29% although this disorder may rarely continue beyond the neonatal period %28%i.e., persistent neonatal myasthenia gravis%29%. %28%From Menkes, Textbook of Child Neurology, 5th ed, p823; Neurology 1997 Jan;48%28%1%29%:50-4%29%%A%    
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D020941 2004
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D020941 2005
% 216.43/216.59  |- skos__broader mesh__D020941smesh__D009157
% 216.43/216.59  |- skos__altLabel mesh__D020941 Neonatal Myasthenia Gravis
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D020941 2001
% 216.43/216.59  |- rdf__type mesh__D020941sskos__Concept
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D020941 2006
% 216.43/216.59  |- skos__altLabel mesh__D020941 Transient Neonatal Myasthenia Gravis
% 216.43/216.59  |- skos__prefLabel mesh__D047889 Receptors, Tumor Necrosis Factor, Type II
% 216.43/216.59  |- skos__broader mesh__D047889smesh__D018124
% 216.43/216.59  |- skos__altLabel mesh__D047889 Antigens, CD120b
% 216.43/216.59  |- mesh__recordAuthorizer mesh__D047889 sjn
% 216.43/216.59  |- mesh__historyNote mesh__D047889 2005%28%1994%29%   
% 216.43/216.59  |- skos__altLabel mesh__D047889
% 216.43/216.59       Tumor Necrosis Factor Receptor Superfamily, Member 1B
% 216.43/216.59  |- skos__hiddenLabel mesh__D047889 Receptor, TNFRSF1B
% 216.43/216.59  |- skos__altLabel mesh__D047889 Tumor Necrosis Factor Receptor Type 2
% 216.43/216.59  |- mesh__dateRevised mesh__D047889 2005-06-30
% 216.43/216.59  |- skos__altLabel mesh__D047889 TNF-R2
% 216.43/216.59  |- skos__scopeNote mesh__D047889
% 216.43/216.59       A tumor necrosis factor receptor subtype that is expressed primarily in IMMUNE SYSTEM cells. It has specificity for membrane-bound form of TUMOR NECROSIS FACTORS and mediates intracellular-signaling through TNF RECEPTOR ASSOCIATED FACTORS.%A%    
% 216.43/216.59  |- skos__altLabel mesh__D047889 TNFR2
% 216.43/216.59  |- mesh__recordMaintainer mesh__D047889 ssb
% 216.43/216.59  |- rdf__type mesh__D047889sskos__Concept
% 216.43/216.59  |- skos__altLabel mesh__D047889 TNFRSF1B Receptor
% 216.43/216.59  |- skos__historyNote mesh__D047889 Antigens, CD %28%1994-2004%29%
% 216.43/216.59  |- mesh__dateEstablished mesh__D047889 2005-01-01
% 216.43/216.59  |- skos__altLabel mesh__D047889 Tumor Necrosis Factor Receptor Type II
% 216.43/216.59  |- skos__altLabel mesh__D047889 TNFR p75
% 216.43/216.59  |- skos__altLabel mesh__D047889 Tumor Necrosis Factor Receptor 2
% 216.43/216.59  |- mesh__publicMeSHNote mesh__D047889
% 216.43/216.59       2005; TUMOR NECROSIS FACTOR RECEPTOR II %28%now RECEPTORS, TUMOR NECROSIS FACTOR II%29% was indexed under ANTIGENS, CD 1994-2004%A%  
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D047889 2006
% 216.43/216.59  |- skos__hiddenLabel mesh__D047889 Antigen, CD120b
% 216.43/216.59  |- mesh__recordOriginator mesh__D047889 jmp
% 216.43/216.59  |- mesh__dateCreated mesh__D047889 2004-07-15
% 216.43/216.59  |- skos__altLabel mesh__D047889 TNF-RII
% 216.43/216.59  |- skos__altLabel mesh__D047889 CD120b Antigens
% 216.43/216.59  |- skos__altLabel mesh__D047889 CD 120b Antigen
% 216.43/216.59  |- skos__altLabel mesh__D047889 CD120b Antigen
% 216.43/216.59  |- skos__hiddenLabel mesh__D047889 Antigen, CD 120b
% 216.43/216.59  |- skos__hiddenLabel mesh__D047889 120b Antigen, CD
% 216.43/216.59  |- skos__altLabel mesh__D047889 Tumor Necrosis Factor Receptor 75
% 216.43/216.59  |- skos__broader mesh__D047889smesh__D015703
% 216.43/216.59  |- skos__altLabel mesh__D047889 TNF-R75
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D006472 2004
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D006472 2000
% 216.43/216.59  |- skos__prefLabel mesh__D006472 Oral Hemorrhage
% 216.43/216.59  |- skos__broader mesh__D006472smesh__D009059
% 216.43/216.59  |- mesh__dateEstablished mesh__D006472 1967-01-01
% 216.43/216.59  |- rdf__type mesh__D006472sskos__Concept
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D006472 2003
% 216.43/216.59  |- mesh__dateRevised mesh__D006472 1999-11-03
% 216.43/216.59  |- mesh__historyNote mesh__D006472 90; was HEMORRHAGE, ORAL 1967-89   
% 216.43/216.59  |- mesh__recordOriginator mesh__D006472 NLM
% 216.43/216.59  |- mesh__dateCreated mesh__D006472 1999-01-01
% 216.43/216.59  |- skos__altLabel mesh__D006472 Hemorrhage, Oral
% 216.43/216.59  |- mesh__publicMeSHNote mesh__D006472 90; was HEMORRHAGE, ORAL 1967-89   
% 216.43/216.59  |- skos__hiddenLabel mesh__D006472 Oral Hemorrhages
% 216.43/216.59  |- mesh__recordAuthorizer mesh__D006472 sjn
% 216.43/216.59  |- skos__scopeNote mesh__D006472
% 216.43/216.59       Bleeding from the blood vessels of the mouth, which may occur as a result of injuries to the mouth, accidents in oral surgery, or diseases of the gums.%A%    
% 216.43/216.59  |- mesh__onlineNote mesh__D006472
% 216.43/216.59       use ORAL HEMORRHAGE to search HEMORRHAGE, ORAL 1967-89   
% 216.43/216.59  |- skos__annotation mesh__D006472
% 216.43/216.59       not hemorrh from the mouth but hemorrh of oral tissue; do not confuse with BLEEDING ON PROBING, GINGIVAL see PERIODONTAL INDEX%A%  
% 216.43/216.59  |- skos__historyNote mesh__D006472 Hemorrhage %28%1966%29%
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D006472 2006
% 216.43/216.59  |- mesh__recordMaintainer mesh__D006472 KEV
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D006472 2002
% 216.43/216.59  |- skos__broader mesh__D006472smesh__D006470
% 216.43/216.59  |- skos__broader mesh__D006472smesh__D009912
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D006472 2005
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D006472 2001
% 216.43/216.59  |- skos__historyNote mesh__D020143 Sandhoff Disease %28%1966-1999%29%
% 216.43/216.59  |- mesh__dateCreated mesh__D020143 1999-11-08
% 216.43/216.59  |- mesh__recordMaintainer mesh__D020143 jmp
% 216.43/216.59  |- skos__broader mesh__D020143smesh__D005733
% 216.43/216.59  |- skos__altLabel mesh__D020143 G%28%M2%29% Gangliosidoses
% 216.43/216.59  |- skos__scopeNote mesh__D020143
% 216.43/216.59       Inherited diseases characterized by the accumulation of G%28%M2%29% GANGLIOSIDE in central nervous system lysosomes and variably in other tissues. Subtypes include the BETA-N-ACETYLHEXOSAMINIDASE deficiency variants TAY-SACHS DISEASE and SANDHOFF DISEASE, as well as the TAY-SACHS DISEASE, AB VARIANT and an adult onset form of GM2 Gangliosidosis.%A%    
% 216.43/216.59  |- skos__hiddenLabel mesh__D020143 GM2, Gangliosidoses
% 216.43/216.59  |- rdf__type mesh__D020143sskos__Concept
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D020143 2006
% 216.43/216.59  |- skos__related mesh__D020143smesh__D001619
% 216.43/216.59  |- skos__hiddenLabel mesh__D020143 Gangliosidoses, GM2
% 216.43/216.59  |- mesh__dateRevised mesh__D020143 2004-07-07
% 216.43/216.59  |- mesh__publicMeSHNote mesh__D020143 2000   
% 216.43/216.59  |- skos__altLabel mesh__D020143 GM2 Gangliosidosis
% 216.43/216.59  |- skos__prefLabel mesh__D020143 Gangliosidoses GM2
% 216.43/216.59  |- mesh__recordOriginator mesh__D020143 KEV
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D020143 2005
% 216.43/216.59  |- mesh__dateEstablished mesh__D020143 2000-01-01
% 216.43/216.59  |- mesh__historyNote mesh__D020143 2000   
% 216.43/216.59  |- skos__hiddenLabel mesh__D020143 Gangliosidosis, GM2
% 216.43/216.59  |- mesh__recordAuthorizer mesh__D020143 sjn
% 216.43/216.59  |- skos__historyNote mesh__D020143 Tay-Sachs Disease %28%1966-1999%29%
% 216.43/216.59  |- skos__hiddenLabel mesh__D020143 GM2 Gangliosidoses
% 216.43/216.59  |- mesh__dateRevised mesh__D014904 1995-02-21
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014904 1999
% 216.43/216.59  |- mesh__activeMeSHYear mesh__D014904 2002
% 216.43/216.59  |- rdf__type mesh__D014904sskos__Concept
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014904 1997
% 216.43/216.60  |- mesh__dateCreated mesh__D014904 1987-03-09
% 216.43/216.60  |- mesh__recordMaintainer mesh__D014904 TGC
% 216.43/216.60  |- skos__broader mesh__D014904smesh__D001315
% 216.43/216.60  |- skos__scopeNote mesh__D014904
% 216.43/216.60       A state in western Australia. Its capital is Perth. It was first visited by the Dutch in 1616 but the English took possession in 1791 and permanent colonization began in 1829. It was a penal settlement 1850-1888, became part of the colonial government in 1886, and was granted self government in 1890. %28%From Webster%27%s New Geographical Dictionary, 1988, p1329%29%%A%    
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014904 2005
% 216.43/216.60  |- mesh__historyNote mesh__D014904 88   
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014904 2003
% 216.43/216.60  |- skos__historyNote mesh__D014904 Australia %28%1966-1987%29%
% 216.43/216.60  |- mesh__recordOriginator mesh__D014904 EC
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014904 2006
% 216.43/216.60  |- mesh__recordAuthorizer mesh__D014904 PLS
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014904 2000
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014904 2004
% 216.43/216.60  |- skos__prefLabel mesh__D014904 Western Australia
% 216.43/216.60  |- mesh__dateEstablished mesh__D014904 1988-01-01
% 216.43/216.60  |- skos__annotation mesh__D014904 a state of Australia   
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014904 1998
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014904 2001
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014904 1996
% 216.43/216.60  |- mesh__dateCreated mesh__D014106 1974-11-19
% 216.43/216.60  |- skos__historyNote mesh__D014106 Tosyl Compounds %28%1972-1974%29%
% 216.43/216.60  |- skos__historyNote mesh__D014106 Arginine %28%1972-1974%29%
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014106 2003
% 216.43/216.60  |- skos__scopeNote mesh__D014106
% 216.43/216.60       Arginine derivative which is a substrate for many proteolytic enzymes. As a substrate for the esterase from the first component of complement, it inhibits the action of C%28%l%29% on C%28%4%29%.%A%    
% 216.43/216.60  |- skos__altLabel mesh__D014106 Methyl N-alpha-Tosyl-L-Arginate
% 216.43/216.60  |- skos__hiddenLabel mesh__D014106 N-alpha-Tosyl-L-Arginate, Methyl
% 216.43/216.60  |- mesh__dateRevised mesh__D014106 2001-07-25
% 216.43/216.60  |- skos__broader mesh__D014106smesh__D014050
% 216.43/216.60  |- mesh__recordMaintainer mesh__D014106 nns
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014106 2005
% 216.43/216.60  |- skos__hiddenLabel mesh__D014106 Ester, Tosylarginine Methyl
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014106 2004
% 216.43/216.60  |- mesh__historyNote mesh__D014106
% 216.43/216.60       91%28%75%29%; was see under ARGININE 1975-90   
% 216.43/216.60  |- mesh__publicMeSHNote mesh__D014106 91; was see under ARGININE 1975-90   
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014106 2006
% 216.43/216.60  |- skos__hiddenLabel mesh__D014106 Methyl Ester, Tosylarginine
% 216.43/216.60  |- mesh__dateEstablished mesh__D014106 1991-01-01
% 216.43/216.60  |- mesh__recordOriginator mesh__D014106 NLM
% 216.43/216.60  |- skos__broader mesh__D014106smesh__D001120
% 216.43/216.60  |- skos__altLabel mesh__D014106 TAME
% 216.43/216.60  |- skos__broader mesh__D014106smesh__D014105
% 216.43/216.60  |- rdf__type mesh__D014106sskos__Concept
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014106 2002
% 216.43/216.60  |- skos__hiddenLabel mesh__D014106 Methyl N alpha Tosyl L Arginate
% 216.43/216.60  |- mesh__recordAuthorizer mesh__D014106 sjn
% 216.43/216.60  |- skos__prefLabel mesh__D014106 Tosylarginine Methyl Ester
% 216.43/216.60  |- mesh__dateRevised mesh__D002880 2005-07-11
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002880 2005
% 216.43/216.60  |- skos__broader mesh__D002880smesh__D002906
% 216.43/216.60  |- mesh__dateCreated mesh__D002880 1986-06-19
% 216.43/216.60  |- skos__scopeNote mesh__D002880
% 216.43/216.60       A specific pair of GROUP C CHROMOSOMES of the human chromosome classification.%A%    
% 216.43/216.60  |- skos__altLabel mesh__D002880 Chromosome 11
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002880 2006A
% 216.43/216.60  |- mesh__dateEstablished mesh__D002880 1987-01-01
% 216.43/216.60  |- mesh__recordMaintainer mesh__D002880 ags
% 216.43/216.60  |- mesh__recordOriginator mesh__D002880 SCD
% 216.43/216.60  |- skos__historyNote mesh__D002880
% 216.43/216.60       Chromosomes, Human, 6-12 %28%1968-1986%29%
% 216.43/216.60  |- rdf__type mesh__D002880sskos__Concept
% 216.43/216.60  |- mesh__historyNote mesh__D002880 87   
% 216.43/216.60  |- skos__prefLabel mesh__D002880 Chromosomes, Human, Pair 11
% 216.43/216.60  |- mesh__recordAuthorizer mesh__D002880 ags
% 216.43/216.60  |- mesh__publicMeSHNote mesh__D002880 87   
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002880 2006
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002082 2002
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002082 1994
% 216.43/216.60  |- skos__prefLabel mesh__D002082 Butylamines
% 216.43/216.60  |- skos__broader mesh__D002082smesh__D000588
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002082 1995
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002082 2000
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002082 2005
% 216.43/216.60  |- mesh__dateEstablished mesh__D002082 1966-01-01
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002082 1998
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002082 2006
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002082 1993
% 216.43/216.60  |- mesh__dateCreated mesh__D002082 1999-01-01
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002082 1999
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002082 2001
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002082 2003
% 216.43/216.60  |- mesh__historyNote mesh__D002082 66   
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002082 1996
% 216.43/216.60  |- mesh__recordMaintainer mesh__D002082 TGC
% 216.43/216.60  |- mesh__recordAuthorizer mesh__D002082 PLS
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002082 2004
% 216.43/216.60  |- mesh__publicMeSHNote mesh__D002082 66   
% 216.43/216.60  |- mesh__dateRevised mesh__D002082 1992-05-08
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002082 1997
% 216.43/216.60  |- rdf__type mesh__D002082sskos__Concept
% 216.43/216.60  |- mesh__recordOriginator mesh__D002082 NLM
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010514 2001
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010514 1994
% 216.43/216.60  |- skos__historyNote mesh__D010514 Periodontitis %28%1966-1978%29%
% 216.43/216.60  |- mesh__dateCreated mesh__D010514 1978-02-28
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010514 1992
% 216.43/216.60  |- skos__broader mesh__D010514smesh__D010518
% 216.43/216.60  |- skos__hiddenLabel mesh__D010514 Pockets, Periodontal
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010514 2002
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010514 1998
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010514 1995
% 216.43/216.60  |- skos__historyNote mesh__D010514 Periodontal Diseases %28%1972-1978%29%
% 216.43/216.60  |- mesh__recordAuthorizer mesh__D010514 PLS
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010514 1996
% 216.43/216.60  |- mesh__recordOriginator mesh__D010514 SMH
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010514 1993
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010514 1999
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010514 2005
% 216.43/216.60  |- mesh__recordMaintainer mesh__D010514 TGC
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010514 1997
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010514 2003
% 216.43/216.60  |- skos__annotation mesh__D010514
% 216.43/216.60       do not confuse with GINGIVAL POCKET: read MeSH definition%A%  
% 216.43/216.60  |- mesh__historyNote mesh__D010514
% 216.43/216.60       91%28%79%29%; was see under PERIODONTITIS 1979-90   
% 216.43/216.60  |- mesh__dateEstablished mesh__D010514 1991-01-01
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010514 2006
% 216.43/216.60  |- mesh__publicMeSHNote mesh__D010514
% 216.43/216.60       91; was see under PERIODONTITIS 1979-90   
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010514 2004
% 216.43/216.60  |- skos__altLabel mesh__D010514 Pocket, Periodontal
% 216.43/216.60  |- skos__prefLabel mesh__D010514 Periodontal Pocket
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010514 2000
% 216.43/216.60  |- skos__hiddenLabel mesh__D010514 Periodontal Pockets
% 216.43/216.60  |- skos__historyNote mesh__D010514 Gingival Pocket %28%1975-1978%29%
% 216.43/216.60  |- mesh__dateRevised mesh__D010514 1991-06-18
% 216.43/216.60  |- rdf__type mesh__D010514sskos__Concept
% 216.43/216.60  |- skos__scopeNote mesh__D010514
% 216.43/216.60       An abnormal extension of a gingival sulcus accompanied by the apical migration of the epithelial attachment and bone resorption.%A%    
% 216.43/216.60  |- skos__historyNote mesh__D001788 Blood Transfusion %28%1966-1979%29%
% 216.43/216.60  |- mesh__dateEstablished mesh__D001788 1980-01-01
% 216.43/216.60  |- skos__historyNote mesh__D001788 Paternity %28%1966-1979%29%
% 216.43/216.60  |- mesh__dateCreated mesh__D001788 1979-04-27
% 216.43/216.60  |- skos__hiddenLabel mesh__D001788 Grouping, Blood
% 216.43/216.60  |- skos__hiddenLabel mesh__D001788 Blood Crossmatching
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D001788 1998
% 216.43/216.60  |- mesh__recordMaintainer mesh__D001788 PXP
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D001788 2002
% 216.43/216.60  |- skos__altLabel mesh__D001788 Blood Grouping
% 216.43/216.60  |- skos__broader mesh__D001788smesh__D006403
% 216.43/216.60  |- skos__hiddenLabel mesh__D001788 Typing, Blood
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D001788 2006
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D001788 2001
% 216.43/216.60  |- mesh__recordOriginator mesh__D001788 SMH
% 216.43/216.60  |- rdf__type mesh__D001788sskos__Concept
% 216.43/216.60  |- skos__historyNote mesh__D001788
% 216.43/216.60       Blood Group Incompatibility %28%1966-1979%29%
% 216.43/216.60  |- skos__prefLabel mesh__D001788 Blood Grouping and Crossmatching
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D001788 2005
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D001788 2000
% 216.43/216.60  |- mesh__publicMeSHNote mesh__D001788 80   
% 216.43/216.60  |- skos__historyNote mesh__D001788
% 216.43/216.60       specific blood-group system %28%1966-1979%29%
% 216.43/216.60  |- mesh__historyNote mesh__D001788 80   
% 216.43/216.60  |- skos__annotation mesh__D001788 DF: BLOOD GROUPING or short X ref   
% 216.43/216.60  |- mesh__recordAuthorizer mesh__D001788 SJN
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D001788 2004
% 216.43/216.60  |- skos__scopeNote mesh__D001788
% 216.43/216.60       Testing erythrocytes to determine presence or absence of blood-group antigens, testing of serum to determine the presence or absence of antibodies to these antigens, and selecting biocompatible blood by crossmatching samples from the donor against samples from the recipient. Crossmatching is performed prior to transfusion.%A%    
% 216.43/216.60  |- mesh__dateRevised mesh__D001788 1997-06-20
% 216.43/216.60  |- skos__broader mesh__D001788smesh__D006650
% 216.43/216.60  |- skos__historyNote mesh__D001788 Blood Groups %28%1966-1979%29%
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D001788 2003
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D001788 1999
% 216.43/216.60  |- skos__historyNote mesh__D020942 Basidiomycota %28%1970-1998%29%
% 216.43/216.60  |- skos__altLabel mesh__D020942 Lentinus edodes
% 216.43/216.60  |- mesh__publicMeSHNote mesh__D020942 2000; see LENTINUS 1999   
% 216.43/216.60  |- rdf__type mesh__D020942sskos__Concept
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D020942 2006
% 216.43/216.60  |- mesh__recordOriginator mesh__D020942 ags
% 216.43/216.60  |- mesh__dateEstablished mesh__D020942 2000-01-01
% 216.43/216.60  |- mesh__recordAuthorizer mesh__D020942 sjn
% 216.43/216.60  |- skos__prefLabel mesh__D020942 Shiitake Mushrooms
% 216.43/216.60  |- mesh__dateCreated mesh__D020942 1999-11-08
% 216.43/216.60  |- skos__scopeNote mesh__D020942
% 216.43/216.60       Mushrooms in the order AGARICALES containing B vitamins, cortinelin, and the polysaccharide LENTINAN.%A%    
% 216.43/216.60  |- mesh__recordMaintainer mesh__D020942 SYSTEM
% 216.43/216.60  |- skos__broader mesh__D020942smesh__D020074
% 216.43/216.60  |- mesh__historyNote mesh__D020942 2000; use LENTINUS 1999   
% 216.43/216.60  |- mesh__dateRevised mesh__D020942 2005-06-30
% 216.43/216.60  |- skos__historyNote mesh__D020942 Lentinus %28%1999%29%
% 216.43/216.60  |- skos__altLabel mesh__D020942 Lentinula edodes
% 216.43/216.60  |- rdf__type mesh__D006473sskos__Concept
% 216.43/216.60  |- skos__broader mesh__D006473smesh__D011644
% 216.43/216.60  |- mesh__dateCreated mesh__D006473 1999-01-01
% 216.43/216.60  |- skos__broader mesh__D006473smesh__D007744
% 216.43/216.60  |- skos__altLabel mesh__D006473 Hemorrhage, Postpartum
% 216.43/216.60  |- skos__scopeNote mesh__D006473
% 216.43/216.60       Excess blood loss from uterine bleeding associated with OBSTETRIC LABOR or CHILDBIRTH. It is defined as blood loss greater than 500 ml or of the amount that adversely affects the maternal physiology, such as BLOOD PRESSURE and HEMATOCRIT. Postpartum hemorrhage is divided into two categories, immediate %28%within first 24 hours after birth%29% or delayed %28%after 24 hours postpartum%29%.%A%    
% 216.43/216.60  |- skos__hiddenLabel mesh__D006473 Postpartum Hemorrhage, Immediate
% 216.43/216.60  |- skos__hiddenLabel mesh__D006473 Hemorrhage, Immediate Postpartum
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D006473 2006
% 216.43/216.60  |- mesh__publicMeSHNote mesh__D006473
% 216.43/216.60       90; was HEMORRHAGE, POSTPARTUM 1963-89   
% 216.43/216.60  |- mesh__recordMaintainer mesh__D006473 lkt
% 216.43/216.60  |- mesh__recordOriginator mesh__D006473 NLM
% 216.43/216.60  |- skos__broader mesh__D006473smesh__D014592
% 216.43/216.60  |- skos__hiddenLabel mesh__D006473 Hemorrhage, Delayed Postpartum
% 216.43/216.60  |- mesh__recordAuthorizer mesh__D006473 sjn
% 216.43/216.60  |- skos__hiddenLabel mesh__D006473 Postpartum Hemorrhage, Delayed
% 216.43/216.60  |- mesh__onlineNote mesh__D006473
% 216.43/216.60       use POSTPARTUM HEMORRHAGE to search HEMORRHAGE, POSTPARTUM 1966-89%A%  
% 216.43/216.60  |- skos__prefLabel mesh__D006473 Postpartum Hemorrhage
% 216.43/216.60  |- mesh__dateRevised mesh__D006473 2005-06-30
% 216.43/216.60  |- mesh__historyNote mesh__D006473
% 216.43/216.60       90; was HEMORRHAGE, POSTPARTUM 1963-89   
% 216.43/216.60  |- skos__annotation mesh__D006473 check the tags FEMALE %26% PREGNANCY   
% 216.43/216.60  |- skos__altLabel mesh__D020144 Vascular Diseases, Basal Ganglia
% 216.43/216.60  |- skos__altLabel mesh__D020144 Basal Ganglia Vascular Disease
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D020144 2003
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D020144 2001
% 216.43/216.60  |- skos__broader mesh__D020144smesh__D001480
% 216.43/216.60  |- skos__hiddenLabel mesh__D020144 Lenticulostriate Vascular Disease
% 216.43/216.60  |- skos__annotation mesh__D020144
% 216.43/216.60       coord IM with specific disease and site %28%IM%29% if applicable%A%  
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D020144 2000
% 216.43/216.60  |- rdf__type mesh__D020144sskos__Concept
% 216.43/216.60  |- skos__altLabel mesh__D020144 Vascular Disease, Basal Ganglia
% 216.43/216.60  |- skos__altLabel mesh__D020144 Cerebrovascular Disease, Basal Ganglia
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D020144 2006
% 216.43/216.60  |- skos__historyNote mesh__D020144
% 216.43/216.60       Cerebrovascular Disorders %28%1966-1999%29%
% 216.43/216.60  |- skos__prefLabel mesh__D020144 Basal Ganglia Cerebrovascular Disease
% 216.43/216.60  |- mesh__dateCreated mesh__D020144 1999-11-04
% 216.43/216.60  |- skos__scopeNote mesh__D020144
% 216.43/216.60       Infarction, hemorrhage, ischemia, or hypoxia of any component of the BASAL GANGLIA of the brain. Clinical manifestations may include involuntary or dyskinetic movements and hemiparesis %28%secondary to involvement of the INTERNAL CAPSULE%29%. Etiologies include atherosclerosis, hypertension, inflammatory conditions %28%e.g., vasculitis%29%, and emboli of arterial or cardiac origin. Lacunar infarctions frequently occur in the basal ganglia. Hemorrhages in this region are associated with hypertension, but may also result from the rupture of vascular malformations.%A%    
% 216.43/216.60  |- skos__altLabel mesh__D020144 Lenticulostriate Vascular Diseases
% 216.43/216.60  |- skos__broader mesh__D020144smesh__D002561
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D020144 2005
% 216.43/216.60  |- mesh__dateEstablished mesh__D020144 2000-01-01
% 216.43/216.60  |- mesh__historyNote mesh__D020144 2000   
% 216.43/216.60  |- skos__altLabel mesh__D020144 Vascular Diseases, Lenticulostriate
% 216.43/216.60  |- skos__hiddenLabel mesh__D020144 Lenticulostriate Disease, Vascular
% 216.43/216.60  |- skos__hiddenLabel mesh__D020144 Vascular Lenticulostriate Diseases
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D020144 2004
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D020144 2002
% 216.43/216.60  |- skos__hiddenLabel mesh__D020144 Vascular Disease, Lenticulostriate
% 216.43/216.60  |- mesh__publicMeSHNote mesh__D020144 2000   
% 216.43/216.60  |- skos__hiddenLabel mesh__D020144 Vascular Lenticulostriate Disease
% 216.43/216.60  |- skos__broader mesh__D014905smesh__D018947
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014905 2000
% 216.43/216.60  |- mesh__historyNote mesh__D014905 99; was WESTERN SAMOA 1975-98   
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014905 2005
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014905 2003
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014905 2006
% 216.43/216.60  |- skos__scopeNote mesh__D014905
% 216.43/216.60       An island group and constitutional monarchy in the southwest central Pacific Ocean. The capital is Apia. The islands were jointly administered by England, the United States, and Germany 1889-99, with the chief islands of Savai%27%i and Upolu recognized as German until 1919. Western Samoa gained independence in 1962 and assumed its present formal name in 1997.%A%    
% 216.43/216.60  |- skos__annotation mesh__D014905
% 216.43/216.60       a monarchy; do not confuse with SAMOA, the island group in Polynesia; AMERICAN SAMOA is also available%A%  
% 216.43/216.60  |- mesh__recordOriginator mesh__D014905 NLM
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014905 2001
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014905 2004
% 216.43/216.60  |- skos__altLabel mesh__D014905 Samoa, Independent State
% 216.43/216.60  |- mesh__recordMaintainer mesh__D014905 JLS
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014905 2002
% 216.43/216.60  |- skos__prefLabel mesh__D014905 Independent State of Samoa
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014905 1999
% 216.43/216.60  |- mesh__dateCreated mesh__D014905 1999-01-01
% 216.43/216.60  |- skos__altLabel mesh__D014905 Western Samoa
% 216.43/216.60  |- mesh__dateRevised mesh__D014905 1998-06-10
% 216.43/216.60  |- mesh__recordAuthorizer mesh__D014905 SJN
% 216.43/216.60  |- rdf__type mesh__D014905sskos__Concept
% 216.43/216.60  |- mesh__dateCreated mesh__D014107 1974-11-19
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014107 2001
% 216.43/216.60  |- rdf__type mesh__D014107sskos__Concept
% 216.43/216.60  |- skos__altLabel mesh__D014107 TLCK
% 216.43/216.60  |- skos__altLabel mesh__D014107 Chlorotosylamidoaminoheptanone
% 216.43/216.60  |- skos__broader mesh__D014107smesh__D014050
% 216.43/216.60  |- mesh__historyNote mesh__D014107
% 216.43/216.60       91%28%75%29%; was see under AMINO ACID CHLOROMETHYL KETONES 1977-90; was see under LYSINE 1975-76%A%  
% 216.43/216.60  |- skos__hiddenLabel mesh__D014107 Ketone, Tosyllysine Chloromethyl
% 216.43/216.60  |- mesh__publicMeSHNote mesh__D014107
% 216.43/216.60       91; was see under AMINO ACID CHLOROMETHYL KETONES 1977-90; was see under LYSINE 1975-76%A%  
% 216.43/216.60  |- skos__broader mesh__D014107smesh__D000590
% 216.43/216.60  |- mesh__recordAuthorizer mesh__D014107 sjn
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014107 2004
% 216.43/216.60  |- mesh__recordMaintainer mesh__D014107 sjn
% 216.43/216.60  |- skos__altLabel mesh__D014107 Tosyllysyl Chloromethane
% 216.43/216.60  |- skos__prefLabel mesh__D014107 Tosyllysine Chloromethyl Ketone
% 216.43/216.60  |- mesh__dateRevised mesh__D014107 2000-06-22
% 216.43/216.60  |- skos__scopeNote mesh__D014107
% 216.43/216.60       An inhibitor of SERINE ENDOPEPTIDASES. Acts as an alkylating agent and is known to interfere with the translation process.%A%    
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014107 2003
% 216.43/216.60  |- skos__broader mesh__D014107smesh__D014105
% 216.43/216.60  |- skos__hiddenLabel mesh__D014107 Chloromethyl Ketone, Tosyllysine
% 216.43/216.60  |- skos__historyNote mesh__D014107 Lysine %28%1974%29%
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014107 2002
% 216.43/216.60  |- skos__historyNote mesh__D014107 Chlorine %28%1974%29%
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014107 2006
% 216.43/216.60  |- skos__historyNote mesh__D014107 Tosyl Compounds %28%1974%29%
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D014107 2005
% 216.43/216.60  |- skos__hiddenLabel mesh__D014107 Chloromethane, Tosyllysyl
% 216.43/216.60  |- mesh__dateEstablished mesh__D014107 1991-01-01
% 216.43/216.60  |- mesh__recordOriginator mesh__D014107 NLM
% 216.43/216.60  |- mesh__dateCreated mesh__D002881 1986-06-19
% 216.43/216.60  |- skos__prefLabel mesh__D002881 Chromosomes, Human, Pair 12
% 216.43/216.60  |- mesh__publicMeSHNote mesh__D002881 87   
% 216.43/216.60  |- skos__scopeNote mesh__D002881
% 216.43/216.60       A specific pair of GROUP C CHROMSOMES of the human chromosome classification.%A%    
% 216.43/216.60  |- skos__altLabel mesh__D002881 Chromosome 12
% 216.43/216.60  |- mesh__dateRevised mesh__D002881 2005-07-11
% 216.43/216.60  |- mesh__recordMaintainer mesh__D002881 ags
% 216.43/216.60  |- mesh__recordOriginator mesh__D002881 SCD
% 216.43/216.60  |- rdf__type mesh__D002881sskos__Concept
% 216.43/216.60  |- mesh__historyNote mesh__D002881 87   
% 216.43/216.60  |- mesh__recordAuthorizer mesh__D002881 ags
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002881 2006A
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002881 2006
% 216.43/216.60  |- mesh__dateEstablished mesh__D002881 1987-01-01
% 216.43/216.60  |- skos__historyNote mesh__D002881
% 216.43/216.60       Chromosomes, Human, 6-12 %28%1968-1986%29%
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002881 2005
% 216.43/216.60  |- skos__broader mesh__D002881smesh__D002906
% 216.43/216.60  |- skos__prefLabel mesh__D002083 Butylated Hydroxyanisole
% 216.43/216.60  |- mesh__dateEstablished mesh__D002083 1987-01-01
% 216.43/216.60  |- skos__hiddenLabel mesh__D002083 Nipantiox 1 F
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002083 2005
% 216.43/216.60  |- mesh__recordMaintainer mesh__D002083 CCR
% 216.43/216.60  |- mesh__recordOriginator mesh__D002083 NLM
% 216.43/216.60  |- skos__hiddenLabel mesh__D002083 AMIF72
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002083 2002
% 216.43/216.60  |- skos__scopeNote mesh__D002083
% 216.43/216.60       Mixture of 2- and 3-tert-butyl-4-methoxyphenols that is used as an antioxidant in foods, cosmetics, and pharmaceuticals.%A%    
% 216.43/216.60  |- mesh__publicMeSHNote mesh__D002083 87; was see under ANISOLES 1973-86   
% 216.43/216.60  |- skos__altLabel mesh__D002083 %28%1,1-Dimethylethyl%29%-4-methoxyphenol
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002083 2006
% 216.43/216.60  |- skos__hiddenLabel mesh__D002083 AMIF 72
% 216.43/216.60  |- mesh__dateCreated mesh__D002083 1999-01-01
% 216.43/216.60  |- skos__altLabel mesh__D002083 Butyl Methoxyphenol
% 216.43/216.60  |- skos__broader mesh__D002083smesh__D000840
% 216.43/216.60  |- skos__hiddenLabel mesh__D002083 Nipantiox 1F
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002083 2003
% 216.43/216.60  |- mesh__onlineNote mesh__D002083 search ANISOLES 1973-74   
% 216.43/216.60  |- skos__annotation mesh__D002083 D25-26 qualif; DF: BHA   
% 216.43/216.60  |- mesh__dateRevised mesh__D002083 2000-06-21
% 216.43/216.60  |- skos__hiddenLabel mesh__D002083 Methoxyphenol, Butyl
% 216.43/216.60  |- skos__altLabel mesh__D002083 BHA
% 216.43/216.60  |- skos__hiddenLabel mesh__D002083 Hydroxyanisole, Butylated
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002083 2004
% 216.43/216.60  |- mesh__recordAuthorizer mesh__D002083 sjn
% 216.43/216.60  |- skos__altLabel mesh__D002083 Butylhydroxyanisole
% 216.43/216.60  |- rdf__type mesh__D002083sskos__Concept
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D002083 2001
% 216.43/216.60  |- mesh__historyNote mesh__D002083
% 216.43/216.60       87%28%75%29%; was see under ANISOLES 1973-86   
% 216.43/216.60  |- rdf__type mesh__D010515sskos__Concept
% 216.43/216.60  |- skos__hiddenLabel mesh__D010515 Periodontal Prostheses
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010515 2001
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010515 2000
% 216.43/216.60  |- skos__hiddenLabel mesh__D010515 Prostheses, Periodontal
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010515 1999
% 216.43/216.60  |- skos__annotation mesh__D010515
% 216.43/216.60       do not use /util except by MeSH definition   
% 216.43/216.60  |- mesh__dateCreated mesh__D010515 1999-01-01
% 216.43/216.60  |- mesh__recordMaintainer mesh__D010515 PXP
% 216.43/216.60  |- mesh__publicMeSHNote mesh__D010515 66   
% 216.43/216.60  |- skos__hiddenLabel mesh__D010515 Prosthesis, Periodontal
% 216.43/216.60  |- mesh__recordOriginator mesh__D010515 NLM
% 216.43/216.60  |- mesh__historyNote mesh__D010515 66   
% 216.43/216.60  |- skos__broader mesh__D010515smesh__D010517
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010515 1998
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010515 2004
% 216.43/216.60  |- mesh__dateRevised mesh__D010515 1997-06-20
% 216.43/216.60  |- skos__broader mesh__D010515smesh__D017266
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010515 2006
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010515 2003
% 216.43/216.60  |- skos__scopeNote mesh__D010515
% 216.43/216.60       Any restorative and replacement device that is used as a therapeutic aid in the treatment of periodontal disease. It is an adjunct to other forms of periodontal therapy and does not cure periodontal disease by itself. %28%Boucher%27%s Clinical Dental Terminology, 3d ed%29%%A%    
% 216.43/216.60  |- skos__prefLabel mesh__D010515 Periodontal Prosthesis
% 216.43/216.60  |- mesh__dateEstablished mesh__D010515 1966-01-01
% 216.43/216.60  |- mesh__recordAuthorizer mesh__D010515 SJN
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010515 2002
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D010515 2005
% 216.43/216.60  |- skos__prefLabel mesh__D015200 Fluoroimmunoassay
% 216.43/216.60  |- skos__annotation mesh__D015200
% 216.43/216.60       used with reference to the FLUORESCENT ANTIBODY TECHNIQUE where it is indented; NIM%A%  
% 216.43/216.60  |- skos__hiddenLabel mesh__D015200 Fluoroimmunoassays
% 216.43/216.60  |- mesh__dateEstablished mesh__D015200 1989-01-01
% 216.43/216.60  |- mesh__recordOriginator mesh__D015200 EJB
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D015200 2002
% 216.43/216.60  |- skos__historyNote mesh__D015200 Immunoassay %28%1975-1988%29%
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D015200 2004
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D015200 1999
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D015200 2001
% 216.43/216.60  |- skos__hiddenLabel mesh__D015200 Assays, Time-Resolved Immunofluorometric
% 216.43/216.60  |- skos__hiddenLabel mesh__D015200 Assay, Immunofluorometric
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D015200 2006
% 216.43/216.60  |- skos__hiddenLabel mesh__D015200 Time Resolved Immunofluorometric Assay
% 216.43/216.60  |- skos__hiddenLabel mesh__D015200 Immunofluorometric Assay, Time-Resolved
% 216.43/216.60  |- mesh__recordMaintainer mesh__D015200 PXP
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D015200 2003
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D015200 1998
% 216.43/216.60  |- skos__historyNote mesh__D015200
% 216.43/216.60       Fluorescent Antibody Technique %28%1975-1988%29%
% 216.43/216.60  |- skos__historyNote mesh__D015200 Fluorometry %28%1975-1988%29%
% 216.43/216.60  |- skos__hiddenLabel mesh__D015200 Time-Resolved Immunofluorometric Assays
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D015200 2005
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D015200 2000
% 216.43/216.60  |- skos__broader mesh__D015200smesh__D005455
% 216.43/216.60  |- skos__hiddenLabel mesh__D015200 Immunofluorometric Assays
% 216.43/216.60  |- mesh__publicMeSHNote mesh__D015200 89   
% 216.43/216.60  |- mesh__dateCreated mesh__D015200 1988-04-30
% 216.43/216.60  |- skos__altLabel mesh__D015200 Immunofluorometric Assay
% 216.43/216.60  |- skos__hiddenLabel mesh__D015200 Immunofluorometric Assays, Time-Resolved
% 216.43/216.60  |- mesh__recordAuthorizer mesh__D015200 SJN
% 216.43/216.60  |- skos__scopeNote mesh__D015200
% 216.43/216.60       The use of fluorescence spectrometry to obtain quantitative results for the FLUORESCENT ANTIBODY TECHNIQUE. One advantage over the other methods %28%e.g., radioimmunoassay%29% is its extreme sensitivity, with a detection limit on the order of tenths of microgram/liter.%A%    
% 216.43/216.60  |- mesh__dateRevised mesh__D015200 1997-06-20
% 216.43/216.60  |- mesh__historyNote mesh__D015200 89   
% 216.43/216.60  |- rdf__type mesh__D015200sskos__Concept
% 216.43/216.60  |- skos__historyNote mesh__D015200
% 216.43/216.60       Spectrometry, Fluorescence %28%1975-1988%29%
% 216.43/216.60  |- skos__hiddenLabel mesh__D015200 Assay, Time-Resolved Immunofluorometric
% 216.43/216.60  |- skos__hiddenLabel mesh__D015200 Assays, Immunofluorometric
% 216.43/216.60  |- mesh__dateRevised mesh__D001789 2005-06-30
% 216.43/216.60  |- skos__hiddenLabel mesh__D001789 Antigens, Blood Group
% 216.43/216.60  |- skos__related mesh__D001789smesh__D003298
% 216.43/216.60  |- skos__broader mesh__D001789smesh__D007519
% 216.43/216.60  |- mesh__activeMeSHYear mesh__D001789 2006
% 216.43/216.60  |- skos__prefLabel mesh__D001789 Blood Group Antigens
% 216.43/216.60  |- skos__hiddenLabel mesh__D001789 Groups, Blood
% 216.43/216.60  |- rdf__type mesh__D001789sskos__Concept
% 216.43/216.60  |- skos__broader mesh__D001789smesh__D000954
% 216.43/216.60  |- mesh__recordOriginator mesh__D001789 NLM
% 216.43/216.60  |- mesh__recordAuthorizer mesh__D001789 sjn
% 216.43/216.60  |- mesh__recordMaintainer mesh__D001789 ssb
% 216.43/216.60  |- skos__scopeNote mesh__D001789
% 216.43/216.60       Sets of cell surface antigens located on BLOOD CELLS. They are usually membrane GLYCOPROTEINS or GLYCOLIPIDS that are antigenically distinguished by their carbohydrate moieties.%A%    
% 216.43/216.60  |- skos__annotation mesh__D001789
% 216.43/216.60       human or animal; blood group of animal: coord animal /blood %28%not /immunol%29% %28%IM%29% + BLOOD GROUP ANTIGENS %28%IM%29%; blood group in a disease: coord BLOOD GROUP ANTIGENS or specific blood group %28%IM%29% + disease /blood %28%IM%29%, not /immunol nor /genet%A%  
% 216.43/216.60  |- mesh__dateCreated mesh__D001789 1999-01-01
% 216.43/216.60  |- skos__related mesh__D001789smesh__D007518
% 216.43/216.60  |- skos__broader mesh__D020943smesh__D015658
% 216.43/216.61  |- skos__hiddenLabel mesh__D020943 CNS Vasculitides, HIV-1-Associated
% 216.43/216.61  |- skos__hiddenLabel mesh__D020943 CNS Vasculitis, HIV Associated
% 216.43/216.61  |- mesh__dateEstablished mesh__D020943 2000-01-01
% 216.43/216.61  |- skos__hiddenLabel mesh__D020943 HIV-Associated CNS Vasculitides
% 216.43/216.61  |- skos__altLabel mesh__D020943
% 216.43/216.61       Vasculitis of the Central Nervous System, HIV-Associated
% 216.43/216.61  |- mesh__recordAuthorizer mesh__D020943 sjn
% 216.43/216.61  |- skos__hiddenLabel mesh__D020943 CNS Vasculitides, HIV-Associated
% 216.43/216.61  |- mesh__historyNote mesh__D020943 2000   
% 216.43/216.61  |- mesh__dateCreated mesh__D020943 1999-11-08
% 216.43/216.61  |- skos__altLabel mesh__D020943 CNS Vasculitis, HIV-Associated
% 216.43/216.61  |- skos__altLabel mesh__D020943 HIV-1-Associated CNS Vasculitis
% 216.43/216.61  |- skos__hiddenLabel mesh__D020943 CNS Vasculitis, HIV-1-Associated
% 216.43/216.61  |- skos__scopeNote mesh__D020943
% 216.43/216.61       Inflammation of blood vessels of the CENTRAL NERVOUS SYSTEM that occurs in association with the ACQUIRED IMMUNODEFICIENCY SYNDROME. In children, this condition may be associated with INTRACRANIAL ANEURYSM formation. Cerebral vasculitis in this setting is frequently associated with AIDS-RELATED OPPORTUNISTIC INFECTIONS including varicella, CMV, fungal, tuberculosis, and syphilis. %28%From Neurol Clin 1997 Nov;15%28%4%29%:927-44; Neurology 1998 Aug;51%28%2%29%:560-5%29%%A%    
% 216.43/216.61  |- skos__hiddenLabel mesh__D020943 HIV-Associated CNS Vasculitis
% 216.43/216.61  |- skos__broader mesh__D020943smesh__D001167
% 216.43/216.61  |- skos__hiddenLabel mesh__D020943 Vasculitides, HIV-1-Associated CNS
% 216.43/216.61  |- skos__annotation mesh__D020943 DF: AIDS ARTERITIS CNS   
% 216.43/216.61  |- skos__hiddenLabel mesh__D020943 Vasculitis, HIV-Associated CNS
% 216.43/216.61  |- skos__hiddenLabel mesh__D020943
% 216.43/216.61       Vasculitis of the Central Nervous System, HIV Associated
% 216.43/216.61  |- skos__hiddenLabel mesh__D020943 Vasculitides, HIV-Associated CNS
% 216.43/216.61  |- skos__altLabel mesh__D020943
% 216.43/216.61       Cerebral Aneurysmal Arteriopathy, AIDS-Associated
% 216.43/216.61  |- mesh__recordMaintainer mesh__D020943 ags
% 216.43/216.61  |- rdf__type mesh__D020943sskos__Concept
% 216.43/216.61  |- skos__hiddenLabel mesh__D020943
% 216.43/216.61       Cerebral Aneurysmal Arteriopathy, AIDS Associated
% 216.43/216.61  |- skos__historyNote mesh__D020943
% 216.43/216.61       Acquired Immunodeficiency Syndrome %28%1987-1999%29%
% 216.43/216.61  |- skos__altLabel mesh__D020943 Central Nervous System AIDS Arteritis
% 216.43/216.61  |- skos__broader mesh__D020943smesh__D020293
% 216.43/216.61  |- skos__prefLabel mesh__D020943 AIDS Arteritis, Central Nervous System
% 216.43/216.61  |- skos__hiddenLabel mesh__D020943 HIV-1-Associated CNS Vasculitides
% 216.46/216.61  |- mesh__publicMeSHNote mesh__D020943 2000   
% 216.46/216.61  |- skos__related mesh__D020943smesh__D000163
% 216.46/216.61  |- skos__hiddenLabel mesh__D020943 HIV 1 Associated CNS Vasculitis
% 216.46/216.61  |- mesh__dateRevised mesh__D020943 2005-06-30
% 216.46/216.61  |- skos__historyNote mesh__D020943 Vasculitis %28%1987-1999%29%
% 216.46/216.61  |- skos__hiddenLabel mesh__D020943 Vasculitis, HIV-1-Associated CNS
% 216.46/216.61  |- mesh__recordOriginator mesh__D020943 KEV
% 216.46/216.61  |- skos__hiddenLabel mesh__D020943
% 216.46/216.61       AIDS Associated Cerebral Aneurysmal Arteriopathy
% 216.46/216.61  |- skos__hiddenLabel mesh__D020943
% 216.46/216.61       HIV Associated Vasculitis of the Central Nervous System
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D020943 2006
% 216.46/216.61  |- mesh__historyNote mesh__D006474 99%28%63%29%   
% 216.46/216.61  |- skos__hiddenLabel mesh__D006474 Hemorrhagic Disorder
% 216.46/216.61  |- mesh__dateRevised mesh__D006474 1999-11-03
% 216.46/216.61  |- skos__related mesh__D006474smesh__D020141
% 216.46/216.61  |- mesh__recordAuthorizer mesh__D006474 sjn
% 216.46/216.61  |- skos__broader mesh__D006474smesh__D006402
% 216.46/216.61  |- mesh__recordMaintainer mesh__D006474 kle
% 216.46/216.61  |- skos__hiddenLabel mesh__D006474 Hemorrhagic Diatheses
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D006474 2000
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D006474 2005
% 216.46/216.61  |- mesh__publicMeSHNote mesh__D006474
% 216.46/216.61       99; see HEMORRHAGIC DIATHESIS 1963-98   
% 216.46/216.61  |- skos__scopeNote mesh__D006474
% 216.46/216.61       Spontaneous or near spontaneous bleeding caused by a defect in clotting mechanisms %28%BLOOD COAGULATION DISORDERS%29% or another abnormality causing a structural flaw in the blood vessels %28%VASCULAR HEMOSTATIC DISORDERS%29%.%A%    
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D006474 2006
% 216.46/216.61  |- skos__annotation mesh__D006474
% 216.46/216.61       %22%predisposition to abnormal hemostasis%22%; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D006474 2001
% 216.46/216.61  |- skos__hiddenLabel mesh__D006474 Disorders, Hemorrhagic
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D006474 2003
% 216.46/216.61  |- skos__hiddenLabel mesh__D006474 Diatheses, Hemorrhagic
% 216.46/216.61  |- skos__hiddenLabel mesh__D006474 Diathesis, Hemorrhagic
% 216.46/216.61  |- skos__prefLabel mesh__D006474 Hemorrhagic Disorders
% 216.46/216.61  |- skos__altLabel mesh__D006474 Hemorrhagic Diathesis
% 216.46/216.61  |- skos__hiddenLabel mesh__D006474 Disorder, Hemorrhagic
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D006474 2004
% 216.46/216.61  |- mesh__dateCreated mesh__D006474 1999-01-01
% 216.46/216.61  |- mesh__recordOriginator mesh__D006474 NLM
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D006474 2002
% 216.46/216.61  |- rdf__type mesh__D006474sskos__Concept
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D020145 2003
% 216.46/216.61  |- skos__hiddenLabel mesh__D020145 Basal Ganglia Hematoma
% 216.46/216.61  |- skos__hiddenLabel mesh__D020145 Hematomas, Basal Ganglia
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D020145 2000
% 216.46/216.61  |- skos__annotation mesh__D020145
% 216.46/216.61       coord IM with site %28%IM%29% if given; PUTAMINAL HEMORRHAGE is also available%A%  
% 216.46/216.61  |- rdf__type mesh__D020145sskos__Concept
% 216.46/216.61  |- mesh__dateCreated mesh__D020145 1999-11-03
% 216.46/216.61  |- skos__historyNote mesh__D020145
% 216.46/216.61       Cerebrovascular Disorders %28%1966-1999%29%
% 216.46/216.61  |- skos__historyNote mesh__D020145 Cerebral Hemorrhage %28%1966-1999%29%
% 216.46/216.61  |- mesh__historyNote mesh__D020145 2000   
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D020145 2006
% 216.46/216.61  |- skos__altLabel mesh__D020145 Hemorrhage, Basal Ganglia
% 216.46/216.61  |- mesh__dateEstablished mesh__D020145 2000-01-01
% 216.46/216.61  |- skos__broader mesh__D020145smesh__D020144
% 216.46/216.61  |- skos__prefLabel mesh__D020145 Basal Ganglia Hemorrhage
% 216.46/216.61  |- skos__scopeNote mesh__D020145
% 216.46/216.61       Extravasation of blood into a basal ganglia nucleus %28%e.g., caudate, globus pallidus, amygdala, putamen, and claustrum%29%. Clinical manifestations may include acute hemiparesis, movement disorders, headache and/or alterations of consciousness. Hypertension and vascular malformations are relatively common causes of this condition. Pathologically, these hemorrhages are associated with lipohyalinosis of small blood vessels and Charcot-Bouchard microaneurysm formation. %28%Adams et al., Principles of Neurology, 6th ed, p836%29%%A%    
% 216.46/216.61  |- skos__altLabel mesh__D020145 Hematoma, Basal Ganglia
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D020145 2005
% 216.46/216.61  |- mesh__publicMeSHNote mesh__D020145 2000   
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D020145 2002
% 216.46/216.61  |- skos__broader mesh__D020145smesh__D002543
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D020145 2004
% 216.46/216.61  |- skos__hiddenLabel mesh__D020145 Hemorrhages, Basal Ganglia
% 216.46/216.61  |- skos__hiddenLabel mesh__D020145 Basal Ganglia Hemorrhages
% 216.46/216.61  |- skos__hiddenLabel mesh__D020145 Basal Ganglia Hematomas
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D020145 2001
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D014906 2006
% 216.46/216.61  |- mesh__historyNote mesh__D014906
% 216.46/216.61       91%28%75%29%; was see under SURFACE-ACTIVE AGENTS 1975-90   
% 216.46/216.61  |- mesh__dateRevised mesh__D014906 2003-07-09
% 216.46/216.61  |- mesh__recordMaintainer mesh__D014906 ssb
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D014906 2004
% 216.46/216.61  |- skos__broader mesh__D014906smesh__D013501
% 216.46/216.61  |- skos__scopeNote mesh__D014906
% 216.46/216.61       A surfactant that renders a surface wettable by water or enhances the spreading of water over the surface; used in foods and cosmetics; important in contrast media; also with contact lenses, dentures, and some prostheses. Synonyms: humectants; hydrating agents.%A%    
% 216.46/216.61  |- mesh__dateEstablished mesh__D014906 1991-01-01
% 216.46/216.61  |- skos__hiddenLabel mesh__D014906 Agents, Wetting
% 216.46/216.61  |- mesh__publicMeSHNote mesh__D014906
% 216.46/216.61       91; was see under SURFACE-ACTIVE AGENTS 1975-90   
% 216.46/216.61  |- skos__annotation mesh__D014906
% 216.46/216.61       D25-26 qualif; also called %22%hydrating agents%22% but do not confuse these with intravenous solutions for rehydrating dehydrated subjects%A%  
% 216.46/216.61  |- mesh__dateCreated mesh__D014906 1999-01-01
% 216.46/216.61  |- mesh__recordOriginator mesh__D014906 NLM
% 216.46/216.61  |- rdf__type mesh__D014906sskos__Concept
% 216.46/216.61  |- mesh__onlineNote mesh__D014906 search SURFACE-ACTIVE AGENTS 1966-74   
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D014906 2005
% 216.46/216.61  |- mesh__recordAuthorizer mesh__D014906 sjn
% 216.46/216.61  |- skos__prefLabel mesh__D014906 Wetting Agents
% 216.46/216.61  |- mesh__historyNote mesh__D014108
% 216.46/216.61       91%28%75%29%; was see under AMINO ACID CHLOROMETHYL KETONES 1977-90; was see under PHENYLALANINE 1975-76%A%  
% 216.46/216.61  |- skos__broader mesh__D014108smesh__D000590
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D014108 2004
% 216.46/216.61  |- mesh__recordMaintainer mesh__D014108 CCR
% 216.46/216.61  |- skos__altLabel mesh__D014108 Chlorophenyltosylamidobutanone
% 216.46/216.61  |- mesh__recordOriginator mesh__D014108 NLM
% 216.46/216.61  |- mesh__dateRevised mesh__D014108 2000-06-22
% 216.46/216.61  |- mesh__dateCreated mesh__D014108 1974-11-19
% 216.46/216.61  |- skos__broader mesh__D014108smesh__D014105
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D014108 2001
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D014108 2003
% 216.46/216.61  |- skos__altLabel mesh__D014108 Tosylphenylalanyl Chloromethane
% 216.46/216.61  |- skos__altLabel mesh__D014108 TPCK
% 216.46/216.61  |- skos__broader mesh__D014108smesh__D014050
% 216.46/216.61  |- mesh__recordAuthorizer mesh__D014108 sjn
% 216.46/216.61  |- skos__scopeNote mesh__D014108
% 216.46/216.61       An inhibitor of Serine Endopeptidases. Acts as alkylating agent and is known to interfere with the translation process.%A%    
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D014108 2006
% 216.46/216.61  |- skos__historyNote mesh__D014108 Tosyl Compounds %28%1973-1974%29%
% 216.46/216.61  |- skos__hiddenLabel mesh__D014108 Ketone, Tosylphenylalanyl Chloromethyl
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D014108 2005
% 216.46/216.61  |- skos__hiddenLabel mesh__D014108 Chloromethyl Ketone, Tosylphenylalanyl
% 216.46/216.61  |- skos__prefLabel mesh__D014108 Tosylphenylalanyl Chloromethyl Ketone
% 216.46/216.61  |- mesh__dateEstablished mesh__D014108 1991-01-01
% 216.46/216.61  |- mesh__publicMeSHNote mesh__D014108
% 216.46/216.61       91; was see under AMINO ACID CHLOROMETHYL KETONES 1977-90; was see under PHENYLALANINE 1975-76%A%  
% 216.46/216.61  |- skos__historyNote mesh__D014108 Chlorine %28%1974%29%
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D014108 2002
% 216.46/216.61  |- skos__hiddenLabel mesh__D014108 Chloromethane, Tosylphenylalanyl
% 216.46/216.61  |- rdf__type mesh__D014108sskos__Concept
% 216.46/216.61  |- skos__historyNote mesh__D014108 Phenylalanine %28%1972-1974%29%
% 216.46/216.61  |- skos__altLabel mesh__D002882 Chromosome 13
% 216.46/216.61  |- mesh__dateCreated mesh__D002882 1986-06-19
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D002882 2006A
% 216.46/216.61  |- mesh__publicMeSHNote mesh__D002882 87   
% 216.46/216.61  |- mesh__recordMaintainer mesh__D002882 ags
% 216.46/216.61  |- mesh__recordAuthorizer mesh__D002882 ags
% 216.46/216.61  |- mesh__historyNote mesh__D002882 87   
% 216.46/216.61  |- skos__historyNote mesh__D002882
% 216.46/216.61       Chromosomes, Human, 13-15 %28%1968-1986%29%
% 216.46/216.61  |- mesh__dateEstablished mesh__D002882 1987-01-01
% 216.46/216.61  |- mesh__recordOriginator mesh__D002882 SCD
% 216.46/216.61  |- skos__broader mesh__D002882smesh__D002901
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D002882 2005
% 216.46/216.61  |- rdf__type mesh__D002882sskos__Concept
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D002882 2006
% 216.46/216.61  |- skos__scopeNote mesh__D002882
% 216.46/216.61       A specific pair of GROUP D CHROMOSOMES of the human chromosome classification.%A%    
% 216.46/216.61  |- mesh__dateRevised mesh__D002882 2005-07-13
% 216.46/216.61  |- skos__prefLabel mesh__D002882 Chromosomes, Human, Pair 13
% 216.46/216.61  |- skos__broader mesh__D002084smesh__D003408
% 216.46/216.61  |- mesh__recordAuthorizer mesh__D002084 sjn
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D002084 2004
% 216.46/216.61  |- skos__altLabel mesh__D002084 2,6-Di-tert-butyl-p-cresol
% 216.46/216.61  |- skos__hiddenLabel mesh__D002084 2,6 Di t butyl 4 methylphenol
% 216.46/216.61  |- skos__annotation mesh__D002084
% 216.46/216.61       consider IONONES if C13-norisoprenoid or ionanes are discussed; DF: BHT;%A%  
% 216.46/216.61  |- skos__prefLabel mesh__D002084 Butylated Hydroxytoluene
% 216.46/216.61  |- rdf__type mesh__D002084sskos__Concept
% 216.46/216.61  |- skos__altLabel mesh__D002084 2,6-Di-t-butyl-4-methylphenol
% 216.46/216.61  |- mesh__historyNote mesh__D002084
% 216.46/216.61       80%28%75%29%; was see under CRESOLS 1973-79   
% 216.46/216.61  |- skos__altLabel mesh__D002084 4-Methyl-2,6-ditertbutylphenol
% 216.46/216.61  |- skos__altLabel mesh__D002084 Ionol
% 216.46/216.61  |- skos__historyNote mesh__D002084 Cresols %28%1966-1974%29%
% 216.46/216.61  |- mesh__onlineNote mesh__D002084 search CRESOLS 1973-74   
% 216.46/216.61  |- mesh__recordOriginator mesh__D002084 NLM
% 216.46/216.61  |- mesh__dateEstablished mesh__D002084 1980-01-01
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D002084 2005
% 216.46/216.61  |- skos__hiddenLabel mesh__D002084 Hydroxytoluene, Butylated
% 216.46/216.61  |- skos__altLabel mesh__D002084 Butylhydroxytoluene
% 216.46/216.61  |- skos__scopeNote mesh__D002084
% 216.46/216.61       A di-tert-butyl PHENOL with antioxidant properties.     
% 216.46/216.61  |- mesh__publicMeSHNote mesh__D002084 80; was see under CRESOLS 1973-79   
% 216.46/216.61  |- skos__altLabel mesh__D002084
% 216.46/216.61       2,6-Bis%28%1,1-dimethylethyl%29%-4-methylphenol
% 216.46/216.61  |- skos__hiddenLabel mesh__D002084 4 Methyl 2,6 ditertbutylphenol
% 216.46/216.61  |- skos__altLabel mesh__D002084 BHT
% 216.46/216.61  |- skos__hiddenLabel mesh__D002084 2,6 Di tert butyl p cresol
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D002084 2006
% 216.46/216.61  |- mesh__recordMaintainer mesh__D002084 ssb
% 216.46/216.61  |- mesh__dateRevised mesh__D002084 2003-07-09
% 216.46/216.61  |- mesh__dateCreated mesh__D002084 1999-01-01
% 216.46/216.61  |- skos__altLabel mesh__D010516 Splints, Periodontal
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D010516 2002
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D010516 1999
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D010516 1996
% 216.46/216.61  |- skos__annotation mesh__D010516
% 216.46/216.61       do not use /util except by MeSH definition   
% 216.46/216.61  |- mesh__dateCreated mesh__D010516 1999-01-01
% 216.46/216.61  |- skos__broader mesh__D010516smesh__D010515
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D010516 1993
% 216.46/216.61  |- mesh__recordAuthorizer mesh__D010516 PLS
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D010516 2001
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D010516 1998
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D010516 2004
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D010516 2000
% 216.46/216.61  |- skos__prefLabel mesh__D010516 Periodontal Splints
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D010516 1995
% 216.46/216.61  |- mesh__dateEstablished mesh__D010516 1991-01-01
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D010516 1992
% 216.46/216.61  |- skos__hiddenLabel mesh__D010516 Splint, Periodontal
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D010516 2006
% 216.46/216.61  |- mesh__dateRevised mesh__D010516 1991-05-15
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D010516 2003
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D010516 1994
% 216.46/216.61  |- mesh__recordOriginator mesh__D010516 NLM
% 216.46/216.61  |- mesh__historyNote mesh__D010516
% 216.46/216.61       91%28%80%29%; was see under PERIODONTAL PROSTHESIS 1980-90; was SPLINTS, PERIODONTAL see under PERIODONTAL PROSTHESIS 1966-79%A%  
% 216.46/216.61  |- mesh__onlineNote mesh__D010516
% 216.46/216.61       use PERIODONTAL SPLINTS to search SPLINTS, PERIODONTAL 1975-79; use PERIODONTAL PROSTHESIS 1966-74%A%  
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D010516 2005
% 216.46/216.61  |- mesh__recordMaintainer mesh__D010516 PLS
% 216.46/216.61  |- rdf__type mesh__D010516sskos__Concept
% 216.46/216.61  |- mesh__publicMeSHNote mesh__D010516
% 216.46/216.61       91; was see under PERIODONTAL PROSTHESIS 1980-90; was SPLINTS, PERIODONTAL see under PERIODONTAL PROSTHESIS 1966-79%A%  
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D010516 1997
% 216.46/216.61  |- skos__hiddenLabel mesh__D010516 Periodontal Splint
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D029221 2005
% 216.46/216.61  |- rdf__type mesh__D029221sskos__Concept
% 216.46/216.61  |- skos__broader mesh__D029221smesh__D026443
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D029221 2004
% 216.46/216.61  |- mesh__recordMaintainer mesh__D029221 ssb
% 216.46/216.61  |- skos__historyNote mesh__D029221 Mental Healing %28%1983-2001%29%
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D029221 2002
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D029221 2003
% 216.46/216.61  |- skos__prefLabel mesh__D029221 Faith Healing
% 216.46/216.61  |- mesh__dateCreated mesh__D029221 2001-07-25
% 216.46/216.61  |- mesh__recordAuthorizer mesh__D029221 sjn
% 216.46/216.61  |- skos__hiddenLabel mesh__D029221 Healing, Prayer
% 216.46/216.61  |- mesh__publicMeSHNote mesh__D029221 2002; see MENTAL HEALING 1983-2001   
% 216.46/216.61  |- mesh__dateEstablished mesh__D029221 2002-01-01
% 216.46/216.61  |- mesh__recordOriginator mesh__D029221 ssb
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D029221 2006
% 216.46/216.61  |- skos__scopeNote mesh__D029221
% 216.46/216.61       The use of faith and spirit to cure disease.     
% 216.46/216.61  |- mesh__historyNote mesh__D029221 2002; use MENTAL HEALING 1983-2001   
% 216.46/216.61  |- skos__hiddenLabel mesh__D029221 Healing, Faith
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D015201 2006
% 216.46/216.61  |- mesh__dateRevised mesh__D015201 2001-07-25
% 216.46/216.61  |- mesh__recordAuthorizer mesh__D015201 sjn
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D015201 2003
% 216.46/216.61  |- mesh__recordMaintainer mesh__D015201 ags
% 216.46/216.61  |- skos__hiddenLabel mesh__D015201 Meta Analysis
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D015201 2005
% 216.46/216.61  |- skos__scopeNote mesh__D015201
% 216.46/216.61       A quantitative method of combining the results of independent studies %28%usually drawn from the published literature%29% and synthesizing summaries and conclusions which may be used to evaluate therapeutic effectiveness, plan new studies, etc., with application chiefly in the areas of research and medicine.%A%    
% 216.46/216.61  |- skos__historyNote mesh__D015201 Statistics %28%1980-1988%29%
% 216.46/216.61  |- mesh__historyNote mesh__D015201 89   
% 216.46/216.61  |- skos__historyNote mesh__D015201
% 216.46/216.61       Outcome and Process Assessment %28%1977-1979%29%
% 216.46/216.61  |- mesh__publicMeSHNote mesh__D015201 89   
% 216.46/216.61  |- skos__altLabel mesh__D015201 Clinical Trial Overviews
% 216.46/216.61  |- skos__prefLabel mesh__D015201 Meta-Analysis
% 216.46/216.61  |- mesh__dateCreated mesh__D015201 1988-04-30
% 216.46/216.61  |- mesh__recordOriginator mesh__D015201 EJB
% 216.46/216.61  |- skos__hiddenLabel mesh__D015201 Overview, Clinical Trial
% 216.46/216.61  |- skos__hiddenLabel mesh__D015201 Clinical Trial Overview
% 216.46/216.61  |- rdf__type mesh__D015201sskos__Concept
% 216.46/216.61  |- skos__annotation mesh__D015201
% 216.46/216.61       IM for articles %26% books on meta-analysis as a type of study design: do not confuse with Publication Type META-ANALYSIS; no qualif; DF: META ANAL%A%  
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D015201 2002
% 216.46/216.61  |- skos__broader mesh__D015201smesh__D012107
% 216.46/216.61  |- skos__related mesh__D015201smesh__D012196
% 216.46/216.61  |- skos__historyNote mesh__D015201 Research Design %28%1980-1988%29%
% 216.46/216.61  |- skos__hiddenLabel mesh__D015201 Meta-Analyses
% 216.46/216.61  |- skos__historyNote mesh__D015201 Research %28%1980-1982%29%
% 216.46/216.61  |- mesh__dateEstablished mesh__D015201 1989-01-01
% 216.46/216.61  |- skos__altLabel mesh__D015201 Overviews, Clinical Trial
% 216.46/216.61  |- skos__altLabel mesh__D015201 Data Pooling
% 216.46/216.61  |- skos__historyNote mesh__D015201 Follow-Up Studies %28%1977-1979%29%
% 216.46/216.61  |- skos__broader mesh__D015201smesh__D015340
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D015201 2004
% 216.46/216.61  |- skos__related mesh__D015201smesh__D017594
% 216.46/216.61  |- skos__hiddenLabel mesh__D015201 Data Poolings
% 216.46/216.61  |- skos__related mesh__D020944smesh__D012838
% 216.46/216.61  |- mesh__dateRevised mesh__D020944 2001-07-25
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D020944 2004
% 216.46/216.61  |- skos__scopeNote mesh__D020944
% 216.46/216.61       The plant Silybum marianum in the family ASTERACEAE containing the bioflavonoid complex SILYMARIN. For centuries this has been used traditionally to treat liver disease.  Silybum marianum %28%L.%29% Gaertn. = Carduus marianus L.%A%    
% 216.46/216.61  |- mesh__historyNote mesh__D020944 2000   
% 216.46/216.61  |- skos__prefLabel mesh__D020944 Milk Thistle
% 216.46/216.61  |- skos__historyNote mesh__D020944 Plants, Medicinal %28%1968-1999%29%
% 216.46/216.61  |- skos__annotation mesh__D020944
% 216.46/216.61       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D020944 2003
% 216.46/216.61  |- mesh__recordMaintainer mesh__D020944 ssb
% 216.46/216.61  |- mesh__dateCreated mesh__D020944 1999-11-03
% 216.46/216.61  |- rdf__type mesh__D020944sskos__Concept
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D020944 2006
% 216.46/216.61  |- skos__altLabel mesh__D020944 Silybum marianum
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D020944 2002
% 216.46/216.61  |- mesh__recordOriginator mesh__D020944 ags
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D020944 2005
% 216.46/216.61  |- mesh__publicMeSHNote mesh__D020944 2000   
% 216.46/216.61  |- skos__broader mesh__D020944smesh__D019659
% 216.46/216.61  |- mesh__dateEstablished mesh__D020944 2000-01-01
% 216.46/216.61  |- mesh__recordAuthorizer mesh__D020944 sjn
% 216.46/216.61  |- skos__altLabel mesh__D020944 Carduus marianus
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D006475 2005
% 216.46/216.61  |- skos__scopeNote mesh__D006475
% 216.46/216.61       A self-limited hemorrhagic disorder of the first days of life, caused by a deficiency of the vitamin K-dependent blood coagulation factors II, VII, IX, and X. %28%Dorland, 27th ed%29%%A%    
% 216.46/216.61  |- mesh__recordOriginator mesh__D006475 NLM
% 216.46/216.61  |- skos__hiddenLabel mesh__D006475 Newborn Hemorrhagic Diseases
% 216.46/216.61  |- skos__broader mesh__D006475smesh__D007232
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D006475 2006
% 216.46/216.61  |- skos__broader mesh__D006475smesh__D014813
% 216.46/216.61  |- mesh__recordMaintainer mesh__D006475 lkt
% 216.46/216.61  |- skos__broader mesh__D006475smesh__D007228
% 216.46/216.61  |- mesh__recordAuthorizer mesh__D006475 sjn
% 216.46/216.61  |- skos__prefLabel mesh__D006475 Hemorrhagic Disease of Newborn
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D006475 2004
% 216.46/216.61  |- mesh__dateCreated mesh__D006475 1999-01-01
% 216.46/216.61  |- skos__hiddenLabel mesh__D006475 Newborn Hemorrhagic Disease
% 216.46/216.61  |- mesh__dateRevised mesh__D006475 2003-07-09
% 216.46/216.61  |- rdf__type mesh__D006475sskos__Concept
% 216.46/216.61  |- skos__annotation mesh__D006475
% 216.46/216.61       do not confuse with HEMOLYTIC DISEASE OF NEWBORN see ERYTHROBLASTOSIS, FETAL; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 216.46/216.61  |- mesh__dateEstablished mesh__D020146 2000-01-01
% 216.46/216.61  |- skos__hiddenLabel mesh__D020146 Hemorrhage, Putaminal
% 216.46/216.61  |- skos__hiddenLabel mesh__D020146 Putaminal Brain Hemorrhage
% 216.46/216.61  |- mesh__historyNote mesh__D020146 2000   
% 216.46/216.61  |- skos__hiddenLabel mesh__D020146 Hematomas, Putaminal
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D020146 2000
% 216.46/216.61  |- skos__hiddenLabel mesh__D020146 Hemorrhages, Putaminal Brain
% 216.46/216.61  |- rdf__type mesh__D020146sskos__Concept
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D020146 2005
% 216.46/216.61  |- skos__broader mesh__D020146smesh__D020145
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D020146 2001
% 216.46/216.61  |- skos__hiddenLabel mesh__D020146 Putamen Hemorrhage
% 216.46/216.61  |- skos__altLabel mesh__D020146 Putaminal Hematoma
% 216.46/216.61  |- skos__scopeNote mesh__D020146
% 216.46/216.61       Bleeding into the PUTAMEN, a BASAL GANGLIA nucleus. This is a relatively common site of spontaneous intracranial hemorrhage and is associated with chronic HYPERTENSION and lipohyalinosis of small blood vessels in the putamen. Clinical manifestations vary with the size of hemorrhage, but include hemiparesis, headache, and alterations of consciousness.%A%    
% 216.46/216.61  |- skos__related mesh__D020146smesh__D011699
% 216.46/216.61  |- skos__historyNote mesh__D020146 Cerebral Hemorrhage %28%1966-1999%29%
% 216.46/216.61  |- skos__historyNote mesh__D020146 Putamen %28%1976-1999%29%
% 216.46/216.61  |- skos__hiddenLabel mesh__D020146 Hemorrhages, Putamen
% 216.46/216.61  |- skos__hiddenLabel mesh__D020146 Hematoma, Putaminal
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D020146 2006
% 216.46/216.61  |- skos__hiddenLabel mesh__D020146 Hemorrhages, Putaminal
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D020146 2003
% 216.46/216.61  |- skos__altLabel mesh__D020146 Brain Hemorrhage, Putaminal
% 216.46/216.61  |- skos__altLabel mesh__D020146 Hemorrhage, Putamen
% 216.46/216.61  |- skos__hiddenLabel mesh__D020146 Putaminal Brain Hemorrhages
% 216.46/216.61  |- skos__hiddenLabel mesh__D020146 Putamen Hemorrhages
% 216.46/216.61  |- skos__hiddenLabel mesh__D020146 Brain Hemorrhages, Putaminal
% 216.46/216.61  |- mesh__publicMeSHNote mesh__D020146 2000   
% 216.46/216.61  |- skos__hiddenLabel mesh__D020146 Hemorrhage, Putaminal Brain
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D020146 2002
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D020146 2004
% 216.46/216.61  |- skos__hiddenLabel mesh__D020146 Putaminal Hematomas
% 216.46/216.61  |- mesh__dateCreated mesh__D020146 1999-11-03
% 216.46/216.61  |- skos__historyNote mesh__D020146
% 216.46/216.61       Cerebrovascular Disorders %28%1966-1999%29%
% 216.46/216.61  |- skos__hiddenLabel mesh__D020146 Putaminal Hemorrhages
% 216.46/216.61  |- skos__prefLabel mesh__D020146 Putaminal Hemorrhage
% 216.46/216.61  |- skos__altLabel mesh__D014907 Ziphiidae
% 216.46/216.61  |- rdf__type mesh__D014907sskos__Concept
% 216.46/216.61  |- skos__altLabel mesh__D014907 Eschrichtius robustus
% 216.46/216.61  |- skos__hiddenLabel mesh__D014907 Southern Right Whale
% 216.46/216.61  |- skos__altLabel mesh__D014907 Eubalaena australis
% 216.46/216.61  |- skos__altLabel mesh__D014907 North Atlantic Right Whale
% 216.46/216.61  |- skos__hiddenLabel mesh__D014907 Narwhal
% 216.46/216.61  |- skos__altLabel mesh__D014907 Caperea
% 216.46/216.61  |- skos__hiddenLabel mesh__D014907 Giant Bottle Nosed Whales
% 216.46/216.61  |- skos__hiddenLabel mesh__D014907 Sperm Whale, Dwarf
% 216.46/216.61  |- skos__hiddenLabel mesh__D014907 Sperm Whales, Pygmy
% 216.46/216.61  |- skos__prefLabel mesh__D014907 Whales
% 216.46/216.61  |- skos__broader mesh__D014907smesh__D002591
% 216.46/216.61  |- skos__hiddenLabel mesh__D014907 Right Whale, Pygmy
% 216.46/216.61  |- mesh__recordOriginator mesh__D014907 NLM
% 216.46/216.61  |- mesh__activeMeSHYear mesh__D014907 2006A
% 216.46/216.61  |- skos__hiddenLabel mesh__D014907 Right Whales, Pygmy
% 216.46/216.61  |- mesh__publicMeSHNote mesh__D014907 91; was see under CETACEA 1975-90   
% 216.46/216.61  |- skos__hiddenLabel mesh__D014907 Whale
% 216.46/216.61  |- skos__hiddenLabel mesh__D014907 Dwarf Sperm Whales
% 216.46/216.61  |- skos__hiddenLabel mesh__D014907 Grey Whales
% 216.46/216.61  |- skos__hiddenLabel mesh__D014907 Pygmy Right Whales
% 216.46/216.61  |- skos__hiddenLabel mesh__D014907 Bottle-Nosed Whales, Giant
% 216.46/216.61  |- skos__hiddenLabel mesh__D014907 Giant Bottle-Nosed Whale
% 216.46/216.61  |- skos__hiddenLabel mesh__D014907 Pygmy Sperm Whales
% 216.46/216.61  |- skos__hiddenLabel mesh__D014907 Whales, Southern Right
% 216.46/216.61  |- skos__hiddenLabel mesh__D014907 Bottle-Nosed Whale, Giant
% 216.46/216.61  |- mesh__dateRevised mesh__D014907 2005-07-13
% 216.46/216.61  |- skos__hiddenLabel mesh__D014907 Southern Right Whales
% 216.46/216.61  |- skos__altLabel mesh__D014907 Grey Whale
% 216.46/216.61  |- skos__hiddenLabel mesh__D014907 Sperm Whales, Dwarf
% 216.46/216.61  |- skos__altLabel mesh__D014907 Ziphius
% 216.46/216.61  |- mesh__onlineNote mesh__D014907 search CETACEA 1966-74   
% 216.46/216.61  |- mesh__recordAuthorizer mesh__D014907 ags
% 216.46/216.61  |- skos__hiddenLabel mesh__D014907 Whale, Southern Right
% 216.46/216.61  |- mesh__dateEstablished mesh__D014907 1991-01-01
% 216.46/216.62  |- skos__hiddenLabel mesh__D014907 Gray Whales
% 216.46/216.62  |- mesh__historyNote mesh__D014907
% 216.46/216.62       91%28%75%29%; was see under CETACEA 1975-90   
% 216.46/216.62  |- skos__annotation mesh__D014907
% 216.46/216.62       some dolphins are misnamed %22%whales%22%: note FALSE KILLER WHALE; PYGMY KILLER WHALE; and MELON-HEADED WHALE; are entry terms to DOLPHINS;  PILOT WHALES; and KILLER WHALE; both types of dolphin, are also available%A%  
% 216.46/216.62  |- skos__altLabel mesh__D014907 Monodon monoceros
% 216.46/216.62  |- skos__hiddenLabel mesh__D014907 Sperm Whale, Pygmy
% 216.46/216.62  |- skos__hiddenLabel mesh__D014907 Whale, Grey
% 216.46/216.62  |- skos__hiddenLabel mesh__D014907 Whales, Grey
% 216.46/216.62  |- skos__hiddenLabel mesh__D014907 Goose Beaked Whale
% 216.46/216.62  |- skos__hiddenLabel mesh__D014907 Right Whales, Southern
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D014907 2006
% 216.46/216.62  |- skos__hiddenLabel mesh__D014907 Beaked Whale
% 216.46/216.62  |- skos__scopeNote mesh__D014907
% 216.46/216.62       Large marine mammals of the order CETACEA. In the past, they were commercially valued for whale oil, for their flesh as human food and in ANIMAL FEED and FERTILIZERS, and for baleen. Today, there is a moratorium on most commercial whaling, as all species are either listed as endangered or threatened.%A%    
% 216.46/216.62  |- mesh__dateCreated mesh__D014907 1999-01-01
% 216.46/216.62  |- skos__altLabel mesh__D014907 Berardius
% 216.46/216.62  |- skos__hiddenLabel mesh__D014907 Goose-Beaked Whales
% 216.46/216.62  |- mesh__recordMaintainer mesh__D014907 ags
% 216.46/216.62  |- skos__related mesh__D014907smesh__D018648
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D014109 2006
% 216.46/216.62  |- skos__annotation mesh__D014109 usually NIM; DF: TOTAL LUNG CAPAC   
% 216.46/216.62  |- skos__broader mesh__D014109smesh__D044702
% 216.46/216.62  |- skos__hiddenLabel mesh__D014109 Lung Capacities, Total
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D014109 2005
% 216.46/216.62  |- mesh__dateCreated mesh__D014109 1974-12-12
% 216.46/216.62  |- skos__broader mesh__D014109smesh__D008176
% 216.46/216.62  |- skos__scopeNote mesh__D014109
% 216.46/216.62       The volume of air contained in the lungs at the end of a maximal inspiration. It is the equivalent to each of the following sums: VITAL CAPACITY plus RESIDUAL VOLUME; INSPIRATORY CAPACITY plus FUNCTIONAL RESIDUAL CAPACITY; TIDAL VOLUME plus INSPIRATORY RESERVE VOLUME plus functional residual capacity; or tidal volume plus inspiratory reserve volume plus EXPIRATORY RESERVE VOLUME plus residual volume.%A%    
% 216.46/216.62  |- rdf__type mesh__D014109sskos__Concept
% 216.46/216.62  |- mesh__recordOriginator mesh__D014109 NLM
% 216.46/216.62  |- mesh__dateEstablished mesh__D014109 1991-01-01
% 216.46/216.62  |- mesh__historyNote mesh__D014109
% 216.46/216.62       91%28%75%29%; was see under LUNG VOLUME MEASUREMENTS 1975-90   
% 216.46/216.62  |- mesh__dateRevised mesh__D014109 2003-07-09
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D014109 2004
% 216.46/216.62  |- mesh__publicMeSHNote mesh__D014109
% 216.46/216.62       91; was see under LUNG VOLUME MEASUREMENTS 1975-90   
% 216.46/216.62  |- skos__hiddenLabel mesh__D014109 Capacity, Total Lung
% 216.46/216.62  |- mesh__recordMaintainer mesh__D014109 nns
% 216.46/216.62  |- mesh__recordAuthorizer mesh__D014109 sjn
% 216.46/216.62  |- skos__hiddenLabel mesh__D014109 Total Lung Capacities
% 216.46/216.62  |- skos__prefLabel mesh__D014109 Total Lung Capacity
% 216.46/216.62  |- skos__hiddenLabel mesh__D014109 Capacities, Total Lung
% 216.46/216.62  |- skos__altLabel mesh__D014109 Lung Capacity, Total
% 216.46/216.62  |- skos__scopeNote mesh__D002883
% 216.46/216.62       A specific pair of GROUP D CHROMOSOMES of the human chromosome classification.%A%    
% 216.46/216.62  |- mesh__dateRevised mesh__D002883 2005-07-13
% 216.46/216.62  |- mesh__recordMaintainer mesh__D002883 ags
% 216.46/216.62  |- skos__prefLabel mesh__D002883 Chromosomes, Human, Pair 14
% 216.46/216.62  |- mesh__recordAuthorizer mesh__D002883 ags
% 216.46/216.62  |- mesh__historyNote mesh__D002883 87   
% 216.46/216.62  |- mesh__recordOriginator mesh__D002883 SCD
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D002883 2006A
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D002883 2005
% 216.46/216.62  |- rdf__type mesh__D002883sskos__Concept
% 216.46/216.62  |- mesh__publicMeSHNote mesh__D002883 87   
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D002883 2006
% 216.46/216.62  |- skos__historyNote mesh__D002883
% 216.46/216.62       Chromosomes, Human, 13-15 %28%1968-1986%29%
% 216.46/216.62  |- mesh__dateEstablished mesh__D002883 1987-01-01
% 216.46/216.62  |- skos__broader mesh__D002883smesh__D002901
% 216.46/216.62  |- mesh__dateCreated mesh__D002883 1986-06-19
% 216.46/216.62  |- skos__altLabel mesh__D002883 Chromosome 14
% 216.46/216.62  |- skos__historyNote mesh__D002085 Alcohols, Butyl %28%1974%29%
% 216.46/216.62  |- skos__scopeNote mesh__D002085
% 216.46/216.62       A substituted carcinogenic nitrosamine.     
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D002085 2004
% 216.46/216.62  |- rdf__type mesh__D002085sskos__Concept
% 216.46/216.62  |- skos__hiddenLabel mesh__D002085 N Nitrosobutyl 4 hydroxybutylamine
% 216.46/216.62  |- mesh__dateEstablished mesh__D002085 1991-01-01
% 216.46/216.62  |- skos__annotation mesh__D002085 D25-26 qualif   
% 216.46/216.62  |- mesh__recordAuthorizer mesh__D002085 sjn
% 216.46/216.62  |- skos__altLabel mesh__D002085 Butylbutanolnitrosamine
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D002085 2001
% 216.46/216.62  |- mesh__dateCreated mesh__D002085 1974-11-19
% 216.46/216.62  |- mesh__recordMaintainer mesh__D002085 CCR
% 216.46/216.62  |- skos__altLabel mesh__D002085 N-Butyl-N-%28%4-hydroxybutyl%29%nitrosamine
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D002085 2005
% 216.46/216.62  |- skos__historyNote mesh__D002085 Nitrosamines %28%1974%29%
% 216.46/216.62  |- skos__prefLabel mesh__D002085 Butylhydroxybutylnitrosamine
% 216.46/216.62  |- mesh__historyNote mesh__D002085
% 216.46/216.62       91%28%75%29%; was see under NITROSAMINES 1975-90   
% 216.46/216.62  |- skos__altLabel mesh__D002085
% 216.46/216.62       N-Nitroso-N-butyl-%28%4-hydroxybutyl%29%amine
% 216.46/216.62  |- mesh__publicMeSHNote mesh__D002085
% 216.46/216.62       91; was see under NITROSAMINES 1975-90   
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D002085 2006
% 216.46/216.62  |- mesh__recordOriginator mesh__D002085 NLM
% 216.46/216.62  |- skos__altLabel mesh__D002085 N-Nitrosobutyl-4-hydroxybutylamine
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D002085 2002
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D002085 2003
% 216.46/216.62  |- mesh__dateRevised mesh__D002085 2000-06-22
% 216.46/216.62  |- skos__broader mesh__D002085smesh__D009602
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010517 2004
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010517 1995
% 216.46/216.62  |- skos__scopeNote mesh__D010517
% 216.46/216.62       A dental specialty concerned with the histology, physiology, and pathology of the tissues that support, attach, and surround the teeth, and of the treatment and prevention of disease affecting these tissues.%A%    
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010517 2006
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010517 1992
% 216.46/216.62  |- mesh__recordOriginator mesh__D010517 NLM
% 216.46/216.62  |- skos__annotation mesh__D010517 SPEC: SPEC qualif   
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010517 2003
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010517 1994
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010517 2005
% 216.46/216.62  |- mesh__publicMeSHNote mesh__D010517 65   
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010517 1991
% 216.46/216.62  |- skos__hiddenLabel mesh__D010517 Periodontic
% 216.46/216.62  |- skos__prefLabel mesh__D010517 Periodontics
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010517 2002
% 216.46/216.62  |- rdf__type mesh__D010517sskos__Concept
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010517 1990
% 216.46/216.62  |- skos__broader mesh__D010517smesh__D013039
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010517 1997
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010517 2001
% 216.46/216.62  |- mesh__recordMaintainer mesh__D010517 TGC
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010517 1999
% 216.46/216.62  |- mesh__recordAuthorizer mesh__D010517 PLS
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010517 1996
% 216.46/216.62  |- skos__broader mesh__D010517smesh__D003813
% 216.46/216.62  |- mesh__dateEstablished mesh__D010517 1965-01-01
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010517 1998
% 216.46/216.62  |- mesh__dateCreated mesh__D010517 1999-01-01
% 216.46/216.62  |- mesh__dateRevised mesh__D010517 1989-05-15
% 216.46/216.62  |- mesh__historyNote mesh__D010517 65   
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010517 2000
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010517 1993
% 216.46/216.62  |- rdf__type mesh__D029222sskos__Concept
% 216.46/216.62  |- mesh__publicMeSHNote mesh__D029222 2002   
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D029222 2004
% 216.46/216.62  |- skos__related mesh__D029222smesh__D026322
% 216.46/216.62  |- mesh__historyNote mesh__D029222 2002   
% 216.46/216.62  |- mesh__dateEstablished mesh__D029222 2002-01-01
% 216.46/216.62  |- skos__broader mesh__D029222smesh__D031701
% 216.46/216.62  |- mesh__dateCreated mesh__D029222 2001-07-25
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D029222 2005
% 216.46/216.62  |- skos__scopeNote mesh__D029222
% 216.46/216.62       A plant species in the PIPERACEAE plant family.  It is a common spice on foods and is used medicinally to increase gastrointestinal assimilation of other supplements and drugs. PIPERINE is a key component.  Black pepper is picked unripe and heaped for a few days to ferment. White Pepper is the ripe fruit dehulled by maceration in water.%A%    
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D029222 2006
% 216.46/216.62  |- skos__prefLabel mesh__D029222 Piper nigrum
% 216.46/216.62  |- mesh__dateRevised mesh__D029222 2002-07-03
% 216.46/216.62  |- skos__annotation mesh__D029222
% 216.46/216.62       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D029222 2003
% 216.46/216.62  |- skos__historyNote mesh__D015202 Genes, Structural %28%1983-1988%29%
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D015202 2005
% 216.46/216.62  |- skos__related mesh__D015202smesh__D016297
% 216.46/216.62  |- mesh__dateRevised mesh__D015202 2004-07-30
% 216.46/216.62  |- skos__altLabel mesh__D015202 Genetic Engineering, Protein
% 216.46/216.62  |- mesh__publicMeSHNote mesh__D015202 89   
% 216.46/216.62  |- mesh__recordMaintainer mesh__D015202 jls
% 216.46/216.62  |- skos__hiddenLabel mesh__D015202 Engineering, Protein Genetic
% 216.46/216.62  |- skos__broader mesh__D015202smesh__D005818
% 216.46/216.62  |- mesh__dateCreated mesh__D015202 1988-04-30
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D015202 2005A
% 216.46/216.62  |- rdf__type mesh__D015202sskos__Concept
% 216.46/216.62  |- skos__historyNote mesh__D015202 Mutation %28%1983-1988%29%
% 216.46/216.62  |- skos__related mesh__D015202smesh__D019020
% 216.46/216.62  |- skos__prefLabel mesh__D015202 Protein Engineering
% 216.46/216.62  |- mesh__historyNote mesh__D015202 89   
% 216.46/216.62  |- mesh__recordAuthorizer mesh__D015202 jls
% 216.46/216.62  |- mesh__dateEstablished mesh__D015202 1989-01-01
% 216.46/216.62  |- mesh__recordOriginator mesh__D015202 EJB
% 216.46/216.62  |- skos__altLabel mesh__D015202 Genetic Engineering of Proteins
% 216.46/216.62  |- skos__historyNote mesh__D015202 Genetic Intervention %28%1983-1988%29%
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D015202 2004
% 216.46/216.62  |- skos__hiddenLabel mesh__D015202 Protein Genetic Engineering
% 216.46/216.62  |- skos__altLabel mesh__D015202 Proteins, Genetic Engineering
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D015202 2006
% 216.46/216.62  |- skos__hiddenLabel mesh__D015202 Engineering, Protein
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D015202 2003
% 216.46/216.62  |- skos__scopeNote mesh__D015202
% 216.46/216.62       Procedures by which protein structure and function are changed or created in vitro by altering existing or synthesizing new structural genes that direct the synthesis of proteins with sought-after properties. Such procedures may include the design of MOLECULAR MODELS of proteins using COMPUTER GRAPHICS or other molecular modeling techniques; site-specific mutagenesis %28%MUTAGENESIS, SITE-SPECIFIC%29% of existing genes; and DIRECTED MOLECULAR EVOLUTION techniques to create new genes.%A%    
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D020945 2004
% 216.46/216.62  |- skos__broader mesh__D020945smesh__D008590
% 216.46/216.62  |- skos__altLabel mesh__D020945 Central Nervous System Lupus
% 216.46/216.62  |- mesh__historyNote mesh__D020945 2000   
% 216.46/216.62  |- mesh__publicMeSHNote mesh__D020945 2000   
% 216.46/216.62  |- skos__hiddenLabel mesh__D020945 Meningoencephalitis, Lupus
% 216.46/216.62  |- skos__altLabel mesh__D020945 Central Nervous System Lupus Vasculitis
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D020945 2003
% 216.46/216.62  |- skos__altLabel mesh__D020945
% 216.46/216.62       Systemic Lupus Erythematosis, Central Nervous System
% 216.46/216.62  |- skos__hiddenLabel mesh__D020945 Meningoencephalitides, Lupus
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D020945 2001
% 216.46/216.62  |- skos__broader mesh__D020945smesh__D008180
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D020945 2006
% 216.46/216.62  |- skos__scopeNote mesh__D020945
% 216.46/216.62       Disorders of the brain and spinal cord that are associated with LUPUS ERYTHEMATOSUS, SYSTEMIC. Clinical manifestations may include neurobehavioral dysfunction; SEIZURES; cranial neuropathies %28%see CRANIAL NERVE DISEASES%29%; hypothalamic dysfunction; focal motor deficits; MYELITIS, TRANSVERSE, and other disorders. Pathologic features include multiple microinfarctions involving the CEREBRAL CORTEX; DIENCEPHALON; and BRAIN STEM %28%see also BRAIN INFARCTION%29%. %28%From Adams et al., Principles of Neurology, 6th ed, pp858-9%29%%A%    
% 216.46/216.62  |- rdf__type mesh__D020945sskos__Concept
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D020945 2005
% 216.46/216.62  |- skos__prefLabel mesh__D020945 Lupus Vasculitis, Central Nervous System
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D020945 2000
% 216.46/216.62  |- skos__broader mesh__D020945smesh__D020293
% 216.46/216.62  |- skos__historyNote mesh__D020945
% 216.46/216.62       Lupus Erythematosus, Systemic %28%1965-1999%29%
% 216.46/216.62  |- mesh__dateEstablished mesh__D020945 2000-01-01
% 216.46/216.62  |- skos__hiddenLabel mesh__D020945 Lupus Meningoencephalitides
% 216.46/216.62  |- mesh__dateCreated mesh__D020945 1999-11-03
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D020945 2002
% 216.46/216.62  |- skos__altLabel mesh__D020945
% 216.46/216.62       Central Nervous System Systemic Lupus Erythematosis
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D006476 2003
% 216.46/216.62  |- mesh__dateEstablished mesh__D006476 1987-01-01
% 216.46/216.62  |- skos__annotation mesh__D006476
% 216.46/216.62       infection = HANTAVIRUS INFECTIONS or specifics   
% 216.46/216.62  |- mesh__historyNote mesh__D006476
% 216.46/216.62       92; was HEMORRHAGIC FEVER VIRUS, EPIDEMIC 1977-91 %28%see under RNA VIRUSES 1978-86, see under ARBOVIRUSES 1977%29%; was EPIDEMIC HEMORRHAGIC FEVER VIRUS see under ARBOVIRUSES 1975-76, see under ARBOVIRUS 1965-74, see under ARBORVIRUSES 1963-64%A%  
% 216.46/216.62  |- skos__prefLabel mesh__D006476 Hantavirus
% 216.46/216.62  |- mesh__dateRevised mesh__D006476 2001-07-25
% 216.46/216.62  |- mesh__publicMeSHNote mesh__D006476
% 216.46/216.62       92; was HEMORRHAGIC FEVER VIRUS, EPIDEMIC 1977-91 %28%see under RNA VIRUSES 1978-86, see under ARBOVIRUSES 1977%29%; was EPIDEMIC HEMORRHAGIC FEVER VIRUS see under ARBOVIRUSES 1975-76, see under ARBOVIRUS 1965-74, %26% see under ARBOVIRUSES 1963-64%A%  
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D006476 2004
% 216.46/216.62  |- mesh__dateCreated mesh__D006476 1999-01-01
% 216.46/216.62  |- rdf__type mesh__D006476sskos__Concept
% 216.46/216.62  |- mesh__recordMaintainer mesh__D006476 ags
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D006476 2002
% 216.46/216.62  |- mesh__recordOriginator mesh__D006476 NLM
% 216.46/216.62  |- skos__scopeNote mesh__D006476
% 216.46/216.62       A genus of the family BUNYAVIRIDAE causing HANTAVIRUS INFECTIONS, first identified during the Korean war. Infection is found primarily in rodents and humans. Transmission does not appear to involve arthropods. HANTAAN VIRUS is the type species.%A%    
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D006476 2005
% 216.46/216.62  |- skos__broader mesh__D006476smesh__D002043
% 216.46/216.62  |- skos__hiddenLabel mesh__D006476 Hantaviruses
% 216.46/216.62  |- skos__hiddenLabel mesh__D006476 Dobrava Belgrade Virus
% 216.46/216.62  |- mesh__onlineNote mesh__D006476
% 216.46/216.62       use HANTAVIRUS to search HEMORRHAGIC FEVER VIRUS, EPIDEMIC 1977-91 %26% EPIDEMIC HEMORRHAGIC FEVER VIRUS 1975-76; use ARBOVIRUSES 1966-74%A%  
% 216.46/216.62  |- mesh__recordAuthorizer mesh__D006476 sjn
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D006476 2006
% 216.46/216.62  |- skos__hiddenLabel mesh__D020147 Coagulation Proteins Disorder
% 216.46/216.62  |- skos__hiddenLabel mesh__D020147 Protein Disorder, Coagulation
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D020147 2002
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D020147 2005
% 216.46/216.62  |- mesh__historyNote mesh__D020147 99   
% 216.46/216.62  |- skos__scopeNote mesh__D020147
% 216.46/216.62       Hemorrhagic and thrombotic disorders resulting from abnormalities or deficiencies of coagulation proteins.%A%    
% 216.46/216.62  |- skos__altLabel mesh__D020147 Coagulation Proteins Disorders
% 216.46/216.62  |- skos__hiddenLabel mesh__D020147 Disorders, Coagulation Proteins
% 216.46/216.62  |- skos__historyNote mesh__D020147
% 216.46/216.62       Blood Coagulation Disorders %28%1966-1998%29%
% 216.46/216.62  |- mesh__dateCreated mesh__D020147 1998-06-10
% 216.46/216.62  |- skos__hiddenLabel mesh__D020147 Disorder, Coagulation Protein
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D020147 2006
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D020147 2000
% 216.46/216.62  |- skos__hiddenLabel mesh__D020147 Coagulation Protein Disorder
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D020147 2003
% 216.46/216.62  |- skos__hiddenLabel mesh__D020147 Proteins Disorder, Coagulation
% 216.46/216.62  |- skos__broader mesh__D020147smesh__D001778
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D020147 2001
% 216.46/216.62  |- mesh__publicMeSHNote mesh__D020147 99   
% 216.46/216.62  |- skos__hiddenLabel mesh__D020147 Disorders, Coagulation Protein
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D020147 2004
% 216.46/216.62  |- skos__annotation mesh__D020147
% 216.46/216.62       GEN: prefer specifics; coord IM with coag factor %28%IM%29%   
% 216.46/216.62  |- mesh__dateEstablished mesh__D020147 1999-01-01
% 216.46/216.62  |- skos__hiddenLabel mesh__D020147 Disorder, Coagulation Proteins
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D020147 1999
% 216.46/216.62  |- skos__hiddenLabel mesh__D020147 Proteins Disorders, Coagulation
% 216.46/216.62  |- skos__hiddenLabel mesh__D020147 Protein Disorders, Coagulation
% 216.46/216.62  |- skos__prefLabel mesh__D020147 Coagulation Protein Disorders
% 216.46/216.62  |- skos__altLabel mesh__D020147 Blood Coagulation Factor Deficiencies
% 216.46/216.62  |- rdf__type mesh__D020147sskos__Concept
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D014908 2006
% 216.46/216.62  |- mesh__recordOriginator mesh__D014908 NLM
% 216.46/216.62  |- mesh__dateCreated mesh__D014908 1999-01-01
% 216.46/216.62  |- skos__prefLabel mesh__D014908 Triticum
% 216.46/216.62  |- mesh__dateRevised mesh__D014908 2005-07-01
% 216.46/216.62  |- skos__broader mesh__D014908smesh__D002523
% 216.46/216.62  |- mesh__recordAuthorizer mesh__D014908 sjn
% 216.46/216.62  |- rdf__type mesh__D014908sskos__Concept
% 216.46/216.62  |- skos__annotation mesh__D014908
% 216.46/216.62       wheat germ: index under TRITICUM, not TRITICUM /embryol; do not confuse X ref WHEAT with FAGOPYRUM nor TRITICUM with the rye-wheat hybrid TRITICALE see CEREALS; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.46/216.62  |- skos__broader mesh__D014908smesh__D006109
% 216.46/216.62  |- mesh__recordMaintainer mesh__D014908 sjn
% 216.46/216.62  |- skos__scopeNote mesh__D014908
% 216.46/216.62       A plant genus of the family POACEAE that is the source of wheat grain. A hybrid with rye %28%SECALE CEREALE%29% is called TRITICALE.%A%    
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D011610 2003
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D011610 1999
% 216.46/216.62  |- skos__prefLabel mesh__D011610 Psychosocial Deprivation
% 216.46/216.62  |- rdf__type mesh__D011610sskos__Concept
% 216.46/216.62  |- mesh__publicMeSHNote mesh__D011610 72   
% 216.46/216.62  |- skos__broader mesh__D011610smesh__D011593
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D011610 1997
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D011610 1998
% 216.46/216.62  |- skos__scopeNote mesh__D011610
% 216.46/216.62       The absence of appropriate stimuli in the physical or social environment which are necessary for the emotional, social, and intellectual development of the individual.%A%    
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D011610 1996
% 216.46/216.62  |- skos__annotation mesh__D011610 no qualif   
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D011610 2002
% 216.46/216.62  |- skos__historyNote mesh__D011610 Cultural Deprivation %28%1968%29%
% 216.46/216.62  |- mesh__recordAuthorizer mesh__D011610 PLS
% 216.46/216.62  |- skos__hiddenLabel mesh__D011610 Deprivation, Psychosocial
% 216.46/216.62  |- mesh__dateEstablished mesh__D011610 1972-01-01
% 216.46/216.62  |- skos__broader mesh__D011610smesh__D003469
% 216.46/216.62  |- mesh__dateRevised mesh__D011610 1994-06-28
% 216.46/216.62  |- mesh__dateCreated mesh__D011610 1999-01-01
% 216.46/216.62  |- mesh__historyNote mesh__D011610 72%28%69%29%   
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D011610 2006
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D011610 2001
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D011610 2004
% 216.46/216.62  |- skos__hiddenLabel mesh__D011610 Psychosocial Deprivations
% 216.46/216.62  |- mesh__recordMaintainer mesh__D011610 PLS
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D011610 2005
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D011610 1995
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D011610 2000
% 216.46/216.62  |- mesh__recordOriginator mesh__D011610 NLM
% 216.46/216.62  |- skos__hiddenLabel mesh__D011610 Deprivations, Psychosocial
% 216.46/216.62  |- skos__broader mesh__D002884smesh__D002901
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D002884 2006
% 216.46/216.62  |- skos__altLabel mesh__D002884 Chromosome 15
% 216.46/216.62  |- skos__scopeNote mesh__D002884
% 216.46/216.62       A specific pair of GROUP D CHROMOSOMES of the human chromosome classification.%A%    
% 216.46/216.62  |- mesh__dateRevised mesh__D002884 2005-07-13
% 216.46/216.62  |- mesh__dateCreated mesh__D002884 1986-06-19
% 216.46/216.62  |- skos__prefLabel mesh__D002884 Chromosomes, Human, Pair 15
% 216.46/216.62  |- mesh__recordAuthorizer mesh__D002884 ags
% 216.46/216.62  |- mesh__historyNote mesh__D002884 87   
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D002884 2006A
% 216.46/216.62  |- skos__historyNote mesh__D002884
% 216.46/216.62       Chromosomes, Human, 13-15 %28%1968-1986%29%
% 216.46/216.62  |- mesh__recordOriginator mesh__D002884 SCD
% 216.46/216.62  |- mesh__publicMeSHNote mesh__D002884 87   
% 216.46/216.62  |- mesh__dateEstablished mesh__D002884 1987-01-01
% 216.46/216.62  |- mesh__recordMaintainer mesh__D002884 ags
% 216.46/216.62  |- rdf__type mesh__D002884sskos__Concept
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D002884 2005
% 216.46/216.62  |- mesh__publicMeSHNote mesh__D002086
% 216.46/216.62       91; was see under SCOPOLAMINE DERIVATIVES 1978-90; was see under SCOPOLAMINE 1976-77%A%  
% 216.46/216.62  |- skos__hiddenLabel mesh__D002086 Hyoscine N Butylbromide
% 216.46/216.62  |- mesh__dateRevised mesh__D002086 2000-06-22
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D002086 2005
% 216.46/216.62  |- skos__broader mesh__D002086smesh__D012602
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D002086 2004
% 216.46/216.62  |- mesh__dateCreated mesh__D002086 1975-07-18
% 216.46/216.62  |- mesh__recordMaintainer mesh__D002086 TWD
% 216.46/216.62  |- skos__historyNote mesh__D002086 Scopolamine %28%1969-1975%29%
% 216.46/216.62  |- skos__scopeNote mesh__D002086
% 216.46/216.62       Antimuscarinic quaternary ammonium derivative of scopolamine used to treat cramps in gastrointestinal, urinary, uterine, and biliary tracts, and to facilitate radiologic visualization of the gastrointestinal tract.%A%    
% 216.46/216.62  |- skos__hiddenLabel mesh__D002086 N-Butylbromide, Hyoscine
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D002086 2003
% 216.46/216.62  |- skos__historyNote mesh__D002086 Bromine %28%1972-1974%29%
% 216.46/216.62  |- skos__hiddenLabel mesh__D002086 Bromide, Butylscopolammonium
% 216.46/216.62  |- skos__altLabel mesh__D002086 Hyoscinbutylbromide
% 216.46/216.62  |- skos__altLabel mesh__D002086 Scopolaminebutylbromide
% 216.46/216.62  |- skos__altLabel mesh__D002086 N-Butylscopolammonium Bromide
% 216.46/216.62  |- rdf__type mesh__D002086sskos__Concept
% 216.46/216.62  |- mesh__recordOriginator mesh__D002086 SH
% 216.46/216.62  |- skos__hiddenLabel mesh__D002086 Bromide, N-Butylscopolammonium
% 216.46/216.62  |- skos__hiddenLabel mesh__D002086 N Butylscopolammonium Bromide
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D002086 2002
% 216.46/216.62  |- skos__altLabel mesh__D002086 Hyoscine N-Butylbromide
% 216.46/216.62  |- skos__altLabel mesh__D002086 Butylscopolamine
% 216.46/216.62  |- skos__prefLabel mesh__D002086 Butylscopolammonium Bromide
% 216.46/216.62  |- mesh__dateEstablished mesh__D002086 1991-01-01
% 216.46/216.62  |- mesh__recordAuthorizer mesh__D002086 sjn
% 216.46/216.62  |- skos__historyNote mesh__D002086 Scopolamine Derivatives %28%1975%29%
% 216.46/216.62  |- mesh__historyNote mesh__D002086
% 216.46/216.62       91%28%76%29%; was see under SCOPOLAMINE DERIVATIVES 1978-90; was see under SCOPOLAMINE 1976-77%A%  
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D002086 2006
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D002086 2001
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010518 2003
% 216.46/216.62  |- mesh__dateEstablished mesh__D010518 1965-01-01
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010518 2005
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010518 2000
% 216.46/216.62  |- mesh__onlineNote mesh__D010518
% 216.46/216.62       use PERIODONTITIS to search PERICEMENTITIS 1969-78   
% 216.46/216.62  |- rdf__type mesh__D010518sskos__Concept
% 216.46/216.62  |- mesh__recordOriginator mesh__D010518 NLM
% 216.46/216.62  |- skos__hiddenLabel mesh__D010518 Periodontitides
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010518 1997
% 216.46/216.62  |- mesh__recordMaintainer mesh__D010518 TGC
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010518 1999
% 216.46/216.62  |- mesh__publicMeSHNote mesh__D010518 65   
% 216.46/216.62  |- mesh__historyNote mesh__D010518
% 216.46/216.62       65; PERICEMENTITIS was see under PERIODONTITIS 1969-78   
% 216.46/216.62  |- skos__related mesh__D010518smesh__D013357
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010518 2002
% 216.46/216.62  |- mesh__dateCreated mesh__D010518 1999-01-01
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010518 1998
% 216.46/216.62  |- skos__annotation mesh__D010518
% 216.46/216.62       PERIODONTITIS, JUVENILE is also available with ref to teen-agers %26% young adults%A%  
% 216.46/216.62  |- skos__hiddenLabel mesh__D010518 Pericementitides
% 216.46/216.62  |- mesh__dateRevised mesh__D010518 1996-06-10
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010518 2004
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010518 2001
% 216.46/216.62  |- skos__prefLabel mesh__D010518 Periodontitis
% 216.46/216.62  |- skos__scopeNote mesh__D010518
% 216.46/216.62       Inflammatory reaction of the tissues surrounding a tooth %28%periodontium%29%, usually resulting from the extension of gingival inflammation %28%gingivitis%29% into the periodontium. %28%From Dorland, 27th ed%29%%A%    
% 216.46/216.62  |- skos__broader mesh__D010518smesh__D010510
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D010518 2006
% 216.46/216.62  |- mesh__recordAuthorizer mesh__D010518 PLS
% 216.46/216.62  |- skos__historyNote mesh__D029223 Insect Viruses %28%1990-2001%29%
% 216.46/216.62  |- mesh__dateEstablished mesh__D029223 2002-01-01
% 216.46/216.62  |- skos__broader mesh__D029223smesh__D004267
% 216.46/216.62  |- mesh__historyNote mesh__D029223 2002   
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D029223 2005
% 216.46/216.62  |- skos__broader mesh__D029223smesh__D007304
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D029223 2002
% 216.46/216.62  |- skos__prefLabel mesh__D029223 Ascoviridae
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D029223 2006
% 216.46/216.62  |- skos__scopeNote mesh__D029223
% 216.46/216.62       A family of insect viruses causing disease in lepidopterous larvae, most commonly from species of the owlet moth family Noctuidae. There is one genus:  Ascovirus.%A%    
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D029223 2003
% 216.46/216.62  |- mesh__dateCreated mesh__D029223 2001-07-25
% 216.46/216.62  |- mesh__publicMeSHNote mesh__D029223 2002   
% 216.46/216.62  |- rdf__type mesh__D029223sskos__Concept
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D029223 2004
% 216.46/216.62  |- mesh__historyNote mesh__D048188 2005   
% 216.46/216.62  |- mesh__activeMeSHYear mesh__D048188 2005
% 216.46/216.62  |- skos__prefLabel mesh__D048188 Locusta migratoria
% 216.46/216.62  |- rdf__type mesh__D048188sskos__Concept
% 216.46/216.62  |- mesh__recordAuthorizer mesh__D048188 sjn
% 216.46/216.62  |- mesh__publicMeSHNote mesh__D048188 2005   
% 216.46/216.62  |- skos__historyNote mesh__D048188 Grasshoppers %28%1972-2004%29%
% 216.46/216.62  |- mesh__dateEstablished mesh__D048188 2005-01-01
% 216.49/216.62  |- skos__scopeNote mesh__D048188
% 216.49/216.62       A species of migratory Old World locusts, in the family ACRIDIDAE, that are important pests in Africa and Asia.%A%    
% 216.49/216.62  |- mesh__recordOriginator mesh__D048188 ags
% 216.49/216.62  |- skos__broader mesh__D048188smesh__D006110
% 216.49/216.62  |- skos__historyNote mesh__D048188 Insects %28%1965-1971%29%
% 216.49/216.62  |- mesh__activeMeSHYear mesh__D048188 2006
% 216.49/216.62  |- mesh__dateCreated mesh__D048188 2004-07-07
% 216.49/216.62  |- mesh__recordMaintainer mesh__D048188 ags
% 216.49/216.62  |- skos__hiddenLabel mesh__D015203 Validity and Reliability
% 216.49/216.62  |- skos__scopeNote mesh__D015203
% 216.49/216.62       The statistical reproducibility of measurements %28%often in a clinical context%29%, including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.%A%    
% 216.49/216.62  |- skos__altLabel mesh__D015203 Reproducibility of Findings
% 216.49/216.62  |- mesh__publicMeSHNote mesh__D015203 89   
% 216.49/216.62  |- skos__broader mesh__D015203smesh__D012106
% 216.49/216.62  |- skos__hiddenLabel mesh__D015203 Validities %28%Epidemiology%29%
% 216.49/216.62  |- rdf__type mesh__D015203sskos__Concept
% 216.49/216.62  |- mesh__dateRevised mesh__D015203 2001-07-25
% 216.49/216.62  |- mesh__activeMeSHYear mesh__D015203 2003
% 216.49/216.62  |- mesh__dateEstablished mesh__D015203 1989-01-01
% 216.49/216.62  |- skos__annotation mesh__D015203
% 216.49/216.62       IM GEN only; coord NIM with specific disease or specific non-disease term %28%IM%29%; no qualif%A%  
% 216.49/216.62  |- mesh__activeMeSHYear mesh__D015203 2005
% 216.49/216.62  |- mesh__recordAuthorizer mesh__D015203 sjn
% 216.49/216.63  |- skos__broader mesh__D015203smesh__D005069
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D015203 2004
% 216.49/216.63  |- skos__broader mesh__D015203smesh__D015340
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D015203 2002
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D015203 2006
% 216.49/216.63  |- mesh__recordMaintainer mesh__D015203 ags
% 216.49/216.63  |- mesh__dateCreated mesh__D015203 1988-04-30
% 216.49/216.63  |- mesh__recordOriginator mesh__D015203 EJB
% 216.49/216.63  |- mesh__historyNote mesh__D015203 89   
% 216.49/216.63  |- skos__hiddenLabel mesh__D015203 Reliabilities %28%Epidemiology%29%
% 216.49/216.63  |- skos__prefLabel mesh__D015203 Reproducibility of Results
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D020946 2004
% 216.49/216.63  |- mesh__dateEstablished mesh__D020946 2000-01-01
% 216.49/216.63  |- skos__scopeNote mesh__D020946
% 216.49/216.63       Genus of coniferous yew trees or shrubs, several species of which have medicinal uses. Notable is the Pacific yew, Taxus brevifolia, which is used to make the anti-neoplastic drug taxol %28%PACLITAXEL%29%.%A%    
% 216.49/216.63  |- mesh__publicMeSHNote mesh__D020946 2000   
% 216.49/216.63  |- skos__prefLabel mesh__D020946 Taxus
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D020946 2005
% 216.49/216.63  |- skos__historyNote mesh__D020946 Plants, Medicinal %28%1971-1999%29%
% 216.49/216.63  |- mesh__recordOriginator mesh__D020946 ags
% 216.49/216.63  |- mesh__dateCreated mesh__D020946 1999-11-03
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D020946 2006
% 216.49/216.63  |- rdf__type mesh__D020946sskos__Concept
% 216.49/216.63  |- mesh__dateRevised mesh__D020946 2002-07-03
% 216.49/216.63  |- mesh__recordAuthorizer mesh__D020946 sjn
% 216.49/216.63  |- mesh__historyNote mesh__D020946 2000   
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D020946 2003
% 216.49/216.63  |- mesh__recordMaintainer mesh__D020946 ssb
% 216.49/216.63  |- skos__historyNote mesh__D020946 Trees %28%1965-1999%29%
% 216.49/216.63  |- skos__broader mesh__D020946smesh__D032490
% 216.49/216.63  |- skos__broader mesh__D006477smesh__D018050
% 216.49/216.63  |- mesh__recordAuthorizer mesh__D006477 sjn
% 216.49/216.63  |- mesh__dateCreated mesh__D006477 1999-01-01
% 216.49/216.63  |- skos__altLabel mesh__D006477 Tacaribe Complex Viruses
% 216.49/216.63  |- skos__historyNote mesh__D006477 Arboviruses %28%1966-1974%29%
% 216.49/216.63  |- rdf__type mesh__D006477sskos__Concept
% 216.49/216.63  |- mesh__dateEstablished mesh__D006477 1991-01-01
% 216.49/216.63  |- mesh__historyNote mesh__D006477 2002 %28%1973%29%   
% 216.49/216.63  |- skos__altLabel mesh__D006477 New World Arenaviruses
% 216.49/216.63  |- skos__altLabel mesh__D006477 Hemorrhagic Fever Virus, Bolivian
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D006477 2005
% 216.49/216.63  |- skos__altLabel mesh__D006477 American Hemorrhagic Fever Virus
% 216.49/216.63  |- mesh__recordMaintainer mesh__D006477 sjn
% 216.49/216.63  |- skos__prefLabel mesh__D006477 Arenaviruses, New World
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D006477 2006
% 216.49/216.63  |- mesh__dateRevised mesh__D006477 2004-07-13
% 216.49/216.63  |- skos__scopeNote mesh__D006477
% 216.49/216.63       One of two groups of viruses in the ARENAVIRUS genus and considered part of the New World complex. It includes JUNIN VIRUS; PICHINDE VIRUS; Amapari virus, and Machupo virus among others. They are the cause of human hemorrhagic fevers mostly in Central and South America.%A%    
% 216.49/216.63  |- mesh__recordOriginator mesh__D006477 NLM
% 216.49/216.63  |- skos__altLabel mesh__D006477 Hemorrhagic Fever Viruses, American
% 216.49/216.63  |- mesh__publicMeSHNote mesh__D006477
% 216.49/216.63       2002; see TACARIBE COMPLEX VIRUSES 1994-2001, see HEMORRHAGIC FEVER VIRUSES, AMERICAN 1991-1993, see ARENAVIRIDAE 1981-1990, see  ARENAVIRUSES 1978-1980, see RNA VIRUSES 1977, see ARBOVIRUSES 1975-1976, see ARBOVIRUS 1973-1974%A%  
% 216.49/216.63  |- skos__annotation mesh__D006477
% 216.49/216.63       infection: coord IM with ARENAVIRIDAE INFECTIONS %28%IM%29%   
% 216.49/216.63  |- skos__hiddenLabel mesh__D020148 Acid, Butanoic
% 216.49/216.63  |- mesh__dateRevised mesh__D020148 2003-07-09
% 216.49/216.63  |- skos__hiddenLabel mesh__D020148 Acid, Butyric
% 216.49/216.63  |- skos__broader mesh__D020148smesh__D002088
% 216.49/216.63  |- skos__altLabel mesh__D020148 Butanoic Acid
% 216.49/216.63  |- mesh__publicMeSHNote mesh__D020148
% 216.49/216.63       99; BUTYRIC ACID was indexed under BUTYRIC ACIDS 1981-98   
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D020148 2004
% 216.49/216.63  |- mesh__historyNote mesh__D020148
% 216.49/216.63       99; use BUTYRIC ACID %28%NM%29% 1981-98   
% 216.49/216.63  |- skos__scopeNote mesh__D020148
% 216.49/216.63       A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.%A%    
% 216.49/216.63  |- rdf__type mesh__D020148sskos__Concept
% 216.49/216.63  |- skos__annotation mesh__D020148 BUTYRIC ACIDS is also available   
% 216.49/216.63  |- mesh__dateCreated mesh__D020148 1998-06-10
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D020148 2005
% 216.49/216.63  |- skos__historyNote mesh__D020148 Butyric Acids %28%1981-1998%29%
% 216.49/216.63  |- skos__prefLabel mesh__D020148 Butyric Acid
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D020148 2006
% 216.49/216.63  |- mesh__dateEstablished mesh__D020148 1999-01-01
% 216.49/216.63  |- mesh__historyNote mesh__D014909 87   
% 216.49/216.63  |- mesh__dateEstablished mesh__D014909 1987-01-01
% 216.49/216.63  |- skos__altLabel mesh__D014909 Triticum Vulgare Lectins
% 216.49/216.63  |- skos__historyNote mesh__D014909 Lectins %28%1966-1986%29%
% 216.49/216.63  |- mesh__dateCreated mesh__D014909 1986-06-25
% 216.49/216.63  |- rdf__type mesh__D014909sskos__Concept
% 216.49/216.63  |- skos__prefLabel mesh__D014909 Wheat Germ Agglutinins
% 216.49/216.63  |- skos__altLabel mesh__D014909 Agglutinins, Wheat Germ
% 216.49/216.63  |- mesh__dateRevised mesh__D014909 2005-06-30
% 216.49/216.63  |- skos__altLabel mesh__D014909 Lectins, Wheat Germ
% 216.49/216.63  |- skos__altLabel mesh__D014909 Lectins, Triticum Vulgare
% 216.49/216.63  |- mesh__publicMeSHNote mesh__D014909 87   
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D014909 2006
% 216.49/216.63  |- mesh__recordOriginator mesh__D014909 SH
% 216.49/216.63  |- skos__broader mesh__D014909smesh__D037121
% 216.49/216.63  |- skos__altLabel mesh__D014909 Wheat Germ Lectins
% 216.49/216.63  |- mesh__recordMaintainer mesh__D014909 ssb
% 216.49/216.63  |- mesh__recordAuthorizer mesh__D014909 sjn
% 216.49/216.63  |- skos__scopeNote mesh__D014909
% 216.49/216.63       Lectins purified from the germinating seeds of common wheat %28%Triticum vulgare%29%; these bind to certain carbohydrate moieties on cell surface glycoproteins and are used to identify certain cell populations and inhibit or promote some immunological or physiological activities. There are at least two isoforms of this lectin.%A%    
% 216.49/216.63  |- skos__related mesh__D011611smesh__D011603
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D011611 1998
% 216.49/216.63  |- skos__broader mesh__D011611smesh__D011570
% 216.49/216.63  |- mesh__recordMaintainer mesh__D011611 TGC
% 216.49/216.63  |- mesh__recordOriginator mesh__D011611 NLM
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D011611 2000
% 216.49/216.63  |- mesh__dateRevised mesh__D011611 1996-06-10
% 216.49/216.63  |- skos__altLabel mesh__D011611 Medicine, Psychosomatic
% 216.49/216.63  |- skos__annotation mesh__D011611
% 216.49/216.63       SPEC: SPEC qualif; differentiate from PSYCHOPHYSIOLOGIC DISORDERS, the patient; MIND-BODY RELATIONS %28%PHYSIOLOGY%29% see PSYCHOPHYSIOLOGY is available; also Manual 27.12; DF: PSYCHOSOMATIC MED%A%  
% 216.49/216.63  |- mesh__dateCreated mesh__D011611 1999-01-01
% 216.49/216.63  |- skos__scopeNote mesh__D011611
% 216.49/216.63       A system of medicine which aims at discovering the exact nature of the relationship between the emotions and bodily function, affirming the principle that the mind and body are one.%A%    
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D011611 2006
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D011611 2002
% 216.49/216.63  |- mesh__recordAuthorizer mesh__D011611 PLS
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D011611 2004
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D011611 2005
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D011611 2003
% 216.49/216.63  |- skos__related mesh__D011611smesh__D011602
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D011611 1999
% 216.49/216.63  |- rdf__type mesh__D011611sskos__Concept
% 216.49/216.63  |- skos__prefLabel mesh__D011611 Psychosomatic Medicine
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D011611 1997
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D011611 2001
% 216.49/216.63  |- mesh__dateEstablished mesh__D002885 1987-01-01
% 216.49/216.63  |- skos__broader mesh__D002885smesh__D002902
% 216.49/216.63  |- skos__altLabel mesh__D002885 Chromosome 16
% 216.49/216.63  |- mesh__dateCreated mesh__D002885 1986-06-19
% 216.49/216.63  |- skos__scopeNote mesh__D002885
% 216.49/216.63       A specific pair of GROUP E CHROMOSOMES of the human chromosome classification.%A%    
% 216.49/216.63  |- skos__historyNote mesh__D002885
% 216.49/216.63       Chromosomes, Human, 16-18 %28%1968-1986%29%
% 216.49/216.63  |- mesh__recordAuthorizer mesh__D002885 ags
% 216.49/216.63  |- mesh__historyNote mesh__D002885 87   
% 216.49/216.63  |- skos__prefLabel mesh__D002885 Chromosomes, Human, Pair 16
% 216.49/216.63  |- mesh__recordOriginator mesh__D002885 SCD
% 216.49/216.63  |- mesh__dateRevised mesh__D002885 2005-07-13
% 216.49/216.63  |- mesh__recordMaintainer mesh__D002885 ags
% 216.49/216.63  |- rdf__type mesh__D002885sskos__Concept
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D002885 2005
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D002885 2006
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D002885 2006A
% 216.49/216.63  |- mesh__publicMeSHNote mesh__D002885 87   
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D035261 2005
% 216.49/216.63  |- skos__altLabel mesh__D035261 Aerial Parts, Plant
% 216.49/216.63  |- mesh__publicMeSHNote mesh__D035261 2003   
% 216.49/216.63  |- mesh__dateCreated mesh__D035261 2002-07-02
% 216.49/216.63  |- mesh__historyNote mesh__D035261 2003   
% 216.49/216.63  |- skos__prefLabel mesh__D035261 Plant Components, Aerial
% 216.49/216.63  |- rdf__type mesh__D035261sskos__Concept
% 216.49/216.63  |- skos__altLabel mesh__D035261 Aerial Plant Components
% 216.49/216.63  |- skos__broader mesh__D035261smesh__D018514
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D035261 2004
% 216.49/216.63  |- skos__annotation mesh__D035261 coord with specific plant   
% 216.49/216.63  |- mesh__dateEstablished mesh__D035261 2003-01-01
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D035261 2006
% 216.49/216.63  |- skos__scopeNote mesh__D035261
% 216.49/216.63       The above-ground plant without the roots.     
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D035261 2003
% 216.49/216.63  |- mesh__dateCreated mesh__D002087 1999-01-01
% 216.49/216.63  |- mesh__historyNote mesh__D002087
% 216.49/216.63       63; for BUTYRATE and N-BUTYRATE use BUTYRATES %28%NM%29% 1981-98%A%  
% 216.49/216.63  |- rdf__type mesh__D002087sskos__Concept
% 216.49/216.63  |- skos__scopeNote mesh__D002087 Salts and esters of butyric acid     
% 216.49/216.63  |- skos__prefLabel mesh__D002087 Butyrates
% 216.49/216.63  |- mesh__recordOriginator mesh__D002087 NLM
% 216.49/216.63  |- mesh__recordMaintainer mesh__D002087 ssb
% 216.49/216.63  |- mesh__dateRevised mesh__D002087 2003-07-09
% 216.49/216.63  |- mesh__publicMeSHNote mesh__D002087
% 216.49/216.63       63; BUTYRATE and N-BUTYRATE were indexed under BUTYRIC ACIDS 1981-98%A%  
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D002087 2006
% 216.49/216.63  |- skos__broader mesh__D002087smesh__D020148
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D002087 2005
% 216.49/216.63  |- skos__hiddenLabel mesh__D002087 n Butyrate
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D002087 2004
% 216.49/216.63  |- mesh__recordAuthorizer mesh__D002087 sjn
% 216.49/216.63  |- mesh__historyNote mesh__D010519
% 216.49/216.63       TOOTH SUPPORTING STRUCTURES was heading 1965-67   
% 216.49/216.63  |- skos__hiddenLabel mesh__D010519 Structure, Tooth Supporting
% 216.49/216.63  |- mesh__recordMaintainer mesh__D010519 lkt
% 216.49/216.63  |- skos__hiddenLabel mesh__D010519 Supporting Structure, Tooth
% 216.49/216.63  |- mesh__dateCreated mesh__D010519 1999-01-01
% 216.49/216.63  |- rdf__type mesh__D010519sskos__Concept
% 216.49/216.63  |- mesh__onlineNote mesh__D010519
% 216.49/216.63       use PERIODONTIUM to search TOOTH SUPPORTING STRUCTURES 1966-67%A%  
% 216.49/216.63  |- mesh__publicMeSHNote mesh__D010519
% 216.49/216.63       TOOTH SUPPORTING STRUCTURES was heading 1965-67   
% 216.49/216.63  |- skos__altLabel mesh__D010519 Paradentium
% 216.49/216.63  |- mesh__dateRevised mesh__D010519 2003-07-09
% 216.49/216.63  |- skos__hiddenLabel mesh__D010519 Tooth Supporting Structure
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D010519 2005
% 216.49/216.63  |- mesh__recordOriginator mesh__D010519 NLM
% 216.49/216.63  |- skos__altLabel mesh__D010519 Tooth Supporting Structures
% 216.49/216.63  |- mesh__recordAuthorizer mesh__D010519 sjn
% 216.49/216.63  |- skos__hiddenLabel mesh__D010519 Supporting Structures, Tooth
% 216.49/216.63  |- skos__prefLabel mesh__D010519 Periodontium
% 216.49/216.63  |- skos__broader mesh__D010519smesh__D003817
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D010519 2004
% 216.49/216.63  |- skos__hiddenLabel mesh__D010519 Paradentiums
% 216.49/216.63  |- skos__hiddenLabel mesh__D010519 Periodontiums
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D010519 2006
% 216.49/216.63  |- skos__annotation mesh__D010519 inflammation = PERIODONTITIS   
% 216.49/216.63  |- skos__hiddenLabel mesh__D010519 Structures, Tooth Supporting
% 216.49/216.63  |- skos__broader mesh__D007570smesh__D007571
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D007570 1994
% 216.49/216.63  |- mesh__recordMaintainer mesh__D007570 TAP
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D007570 1999
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D007570 2004
% 216.49/216.63  |- skos__historyNote mesh__D007570 Cysts %28%1966-1979%29%
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D007570 1995
% 216.49/216.63  |- skos__hiddenLabel mesh__D007570 Cyst, Jaw
% 216.49/216.63  |- mesh__dateEstablished mesh__D007570 1980-01-01
% 216.49/216.63  |- mesh__recordOriginator mesh__D007570 SMH
% 216.49/216.63  |- mesh__dateCreated mesh__D007570 1979-04-25
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D007570 2005
% 216.49/216.63  |- mesh__publicMeSHNote mesh__D007570 80   
% 216.49/216.63  |- skos__prefLabel mesh__D007570 Jaw Cysts
% 216.49/216.63  |- mesh__dateRevised mesh__D007570 1990-06-05
% 216.49/216.63  |- skos__historyNote mesh__D007570 specific jaw disease
% 216.49/216.63  |- skos__historyNote mesh__D007570 Jaw Neoplasms %28%1967-1979%29%
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D007570 2000
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D007570 1996
% 216.49/216.63  |- skos__historyNote mesh__D007570 Bone Cysts %28%1966-1979%29%
% 216.49/216.63  |- mesh__recordAuthorizer mesh__D007570 PLS
% 216.49/216.63  |- skos__historyNote mesh__D007570 specific jaw neoplasm
% 216.49/216.63  |- skos__hiddenLabel mesh__D007570 Jaw Cyst
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D007570 2006
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D007570 1991
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D007570 1992
% 216.49/216.63  |- skos__scopeNote mesh__D007570
% 216.49/216.63       Saccular lesions lined with epithelium and contained within pathologically formed cavities in the jaw; also nonepithelial cysts %28%pseudocysts%29% as they apply to the jaw, e.g., traumatic or solitary cyst, static bone cavity, and aneurysmal bone cyst. True jaw cysts are classified as odontogenic or nonodontogenic.%A%    
% 216.49/216.63  |- skos__broader mesh__D007570smesh__D001845
% 216.49/216.63  |- skos__annotation mesh__D007570
% 216.49/216.63       non-neoplastic; /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/dis term %28%IM%29%%A%  
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D007570 2001
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D007570 1997
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D007570 1993
% 216.49/216.63  |- rdf__type mesh__D007570sskos__Concept
% 216.49/216.63  |- mesh__historyNote mesh__D007570 80   
% 216.49/216.63  |- skos__hiddenLabel mesh__D007570 Cysts, Jaw
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D007570 2002
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D007570 1998
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D007570 2003
% 216.49/216.63  |- skos__historyNote mesh__D007570 Jaw Diseases %28%1967-1979%29%
% 216.49/216.63  |- mesh__dateCreated mesh__D021241 2000-06-22
% 216.49/216.63  |- mesh__historyNote mesh__D021241 2001   
% 216.49/216.63  |- skos__scopeNote mesh__D021241
% 216.49/216.63       A mass spectrometry technique used for analysis of nonvolatile compounds such as proteins and macromolecules. The technique involves preparing electrically charged droplets from analyte molecules dissolved in solvent. The electrically charged droplets enter a vacuum chamber where the solvent is evaporated. Evaporation of solvent reduces the droplet size, thereby increasing the coulombic repulsion within the droplet. As the charged droplets get smaller, the excess charge within them causes them to disintegrate and release analyte molecules. The volatilized analyte molecules are then analyzed by mass spectrometry.%A%    
% 216.49/216.63  |- rdf__type mesh__D021241sskos__Concept
% 216.49/216.63  |- mesh__publicMeSHNote mesh__D021241 2001   
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D021241 2003
% 216.49/216.63  |- skos__altLabel mesh__D021241 Electrospray Ionization Mass Spectrometry
% 216.49/216.63  |- mesh__dateEstablished mesh__D021241 2001-01-01
% 216.49/216.63  |- skos__historyNote mesh__D021241
% 216.49/216.63       Spectrum Analysis, Mass %28%1985-2000%29%
% 216.49/216.63  |- skos__broader mesh__D021241smesh__D013058
% 216.49/216.63  |- skos__altLabel mesh__D021241 ESI Mass Spectrometry
% 216.49/216.63  |- skos__prefLabel mesh__D021241
% 216.49/216.63       Spectrometry, Mass, Electrospray Ionization
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D021241 2004
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D021241 2005
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D021241 2006
% 216.49/216.63  |- skos__hiddenLabel mesh__D021241 Spectrometry, ESI Mass
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D021241 2001
% 216.49/216.63  |- skos__hiddenLabel mesh__D021241 Mass Spectrometry, ESI
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D021241 2002
% 216.49/216.63  |- skos__scopeNote mesh__D048189
% 216.49/216.63       The smallest species of TAPEWORMS. It is the only cestode that parasitizes humans without requiring an intermediate host.%A%    
% 216.49/216.63  |- mesh__publicMeSHNote mesh__D048189 2005   
% 216.49/216.63  |- mesh__recordOriginator mesh__D048189 ags
% 216.49/216.63  |- skos__annotation mesh__D048189
% 216.49/216.63       infection: coordinate %28%IM%29% with HYMENOLEPIASIS %28%IM%29%   
% 216.49/216.63  |- skos__prefLabel mesh__D048189 Hymenolepis nana
% 216.49/216.63  |- mesh__historyNote mesh__D048189 2005   
% 216.49/216.63  |- skos__broader mesh__D048189smesh__D006926
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D048189 2006
% 216.49/216.63  |- mesh__dateCreated mesh__D048189 2004-07-07
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D048189 2005
% 216.49/216.63  |- rdf__type mesh__D048189sskos__Concept
% 216.49/216.63  |- mesh__recordMaintainer mesh__D048189 ags
% 216.49/216.63  |- skos__historyNote mesh__D048189 Cestoda %28%1965-1979%29%
% 216.49/216.63  |- skos__historyNote mesh__D048189 Hymenolepis %28%1979-2004%29%
% 216.49/216.63  |- mesh__dateEstablished mesh__D048189 2005-01-01
% 216.49/216.63  |- mesh__recordAuthorizer mesh__D048189 sjn
% 216.49/216.63  |- mesh__recordOriginator mesh__D015204 EJB
% 216.49/216.63  |- rdf__type mesh__D015204sskos__Concept
% 216.49/216.63  |- mesh__historyNote mesh__D015204 89   
% 216.49/216.63  |- skos__historyNote mesh__D015204 Spectrometry, Gamma %28%1973-1988%29%
% 216.49/216.63  |- skos__prefLabel mesh__D015204 Spectroscopy, Mossbauer
% 216.49/216.63  |- skos__annotation mesh__D015204 a type of spectrum anal; NIM   
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D015204 2003
% 216.49/216.63  |- mesh__dateEstablished mesh__D015204 1989-01-01
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D015204 2005
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D015204 2004
% 216.49/216.63  |- skos__broader mesh__D015204smesh__D013051
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D015204 2006
% 216.49/216.63  |- mesh__dateCreated mesh__D015204 1988-04-30
% 216.49/216.63  |- skos__altLabel mesh__D015204 Mossbauer Spectroscopy
% 216.49/216.63  |- skos__scopeNote mesh__D015204
% 216.49/216.63       A spectroscopic technique which uses the Mossbauer effect %28%inelastic scattering of gamma radiation resulting from interaction with heavy nuclei%29% to monitor the small variations in the interaction between an atomic nucleus and its environment. Such variations may be induced by changes in temperature, pressure, chemical state, molecular conformation, molecular interaction, or physical site. It is particularly useful for studies of structure-activity relationship in metalloproteins, mobility of heavy metals, and the state of whole tissue and cell membranes.%A%    
% 216.49/216.63  |- mesh__recordMaintainer mesh__D015204 lkt
% 216.49/216.63  |- skos__altLabel mesh__D015204 Nuclear Gamma Resonance Spectroscopy
% 216.49/216.63  |- mesh__recordAuthorizer mesh__D015204 sjn
% 216.49/216.63  |- skos__historyNote mesh__D015204 Spectrum Analysis %28%1966-1988%29%
% 216.49/216.63  |- mesh__publicMeSHNote mesh__D015204 89   
% 216.49/216.63  |- mesh__dateRevised mesh__D015204 2002-07-03
% 216.49/216.63  |- skos__hiddenLabel mesh__D020947 Oil, Tea Tree
% 216.49/216.63  |- skos__altLabel mesh__D020947 Melaleuca alternifolia Oil
% 216.49/216.63  |- mesh__historyNote mesh__D020947
% 216.49/216.63       2000; use TEA TREE OIL %28%NM%29% 1993-1999   
% 216.49/216.63  |- skos__historyNote mesh__D020947 Plant Oils %28%1990-1999%29%
% 216.49/216.63  |- skos__hiddenLabel mesh__D020947 Oil, Melaleuca alternifolia
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D020947 2006
% 216.49/216.63  |- skos__historyNote mesh__D020947 Oils, Volatile %28%1990-1999%29%
% 216.49/216.63  |- rdf__type mesh__D020947sskos__Concept
% 216.49/216.63  |- mesh__dateRevised mesh__D020947 2005-06-30
% 216.49/216.63  |- skos__prefLabel mesh__D020947 Tea Tree Oil
% 216.49/216.63  |- mesh__recordOriginator mesh__D020947 ags
% 216.49/216.63  |- skos__broader mesh__D020947smesh__D010938
% 216.49/216.63  |- mesh__dateCreated mesh__D020947 1999-11-03
% 216.49/216.63  |- mesh__publicMeSHNote mesh__D020947
% 216.49/216.63       2000; TEA TREE OIL was indexed under OILS, VOLATILE %26% PLANT OILS 1993-1999%A%  
% 216.49/216.63  |- skos__scopeNote mesh__D020947
% 216.49/216.63       Essential oil extracted from Melaleuca alternifolia %28%tea tree%29%. It is used as a topical antimicrobial due to the presence of terpineol.%A%    
% 216.49/216.63  |- mesh__recordAuthorizer mesh__D020947 sjn
% 216.49/216.63  |- mesh__dateEstablished mesh__D020947 2000-01-01
% 216.49/216.63  |- skos__broader mesh__D020947smesh__D009822
% 216.49/216.63  |- mesh__recordMaintainer mesh__D020947 ssb
% 216.49/216.63  |- skos__prefLabel mesh__D006478 Hemorrhagic Fever, American
% 216.49/216.63  |- mesh__dateCreated mesh__D006478 1976-05-05
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D006478 2005
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D006478 2004
% 216.49/216.63  |- skos__hiddenLabel mesh__D006478 Argentinian Hemorrhagic Fever
% 216.49/216.63  |- skos__hiddenLabel mesh__D006478 Fever, Bolivian Hemorrhagic
% 216.49/216.63  |- skos__scopeNote mesh__D006478
% 216.49/216.63       Diseases caused by American hemorrhagic fever viruses %28%ARENAVIRUSES, NEW WORLD%29%.%A%    
% 216.49/216.63  |- mesh__recordOriginator mesh__D006478 FPG
% 216.49/216.63  |- skos__hiddenLabel mesh__D006478 Fever, American Hemorrhagic
% 216.49/216.63  |- skos__hiddenLabel mesh__D006478 Fever, Argentinian Hemorrhagic
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D006478 2003
% 216.49/216.63  |- skos__broader mesh__D006478smesh__D001117
% 216.49/216.63  |- mesh__recordAuthorizer mesh__D006478 sjn
% 216.49/216.63  |- mesh__recordMaintainer mesh__D006478 sjn
% 216.49/216.63  |- mesh__onlineNote mesh__D006478
% 216.49/216.63       use HEMORRHAGIC FEVER, AMERICAN to search HEMORRHAGIC FEVER, ARGENTINIAN %26% HEMORRHAGIC FEVER, BOLIVIAN 1975-77; search HEMORRHAGIC FEVERS, VIRAL 1966-76%A%  
% 216.49/216.63  |- rdf__type mesh__D006478sskos__Concept
% 216.49/216.63  |- skos__broader mesh__D006478smesh__D006482
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D006478 2002
% 216.49/216.63  |- mesh__historyNote mesh__D006478
% 216.49/216.63       77; HEMORRHAGIC FEVER, ARGENTINIAN %26% HEMORRHAGIC FEVER, BOLIVIAN were see under EPIDEMIC HEMORRHAGIC FEVER 1975-76; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76%A%  
% 216.49/216.63  |- mesh__publicMeSHNote mesh__D006478
% 216.49/216.63       77; HEMORRHAGIC FEVER, ARGENTINIAN %26% HEMORRHAGIC FEVER, BOLIVIAN were see under EPIDEMIC HEMORRHAGIC FEVER 1975-76; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76%A%  
% 216.49/216.63  |- skos__historyNote mesh__D006478
% 216.49/216.63       Hemorrhagic Fevers, Viral %28%1966-1976%29%
% 216.49/216.63  |- mesh__dateEstablished mesh__D006478 1977-01-01
% 216.49/216.63  |- skos__hiddenLabel mesh__D006478 American Hemorrhagic Fever
% 216.49/216.63  |- mesh__dateRevised mesh__D006478 2001-08-03
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D006478 2006
% 216.49/216.63  |- skos__annotation mesh__D006478 caused by ARENAVIRUSES, NEW WORLD   
% 216.49/216.63  |- skos__hiddenLabel mesh__D006478 Bolivian Hemorrhagic Fever
% 216.49/216.63  |- skos__hiddenLabel mesh__D020149 Syndromes, Manganese Neurotoxicity
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D020149 2004
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D020149 2001
% 216.49/216.63  |- skos__hiddenLabel mesh__D020149 Manganese Neurotoxicity Syndrome
% 216.49/216.63  |- skos__altLabel mesh__D020149 Nervous System Poisoning, Manganese
% 216.49/216.63  |- mesh__historyNote mesh__D020149 2000   
% 216.49/216.63  |- skos__broader mesh__D020149smesh__D011041
% 216.49/216.63  |- rdf__type mesh__D020149sskos__Concept
% 216.49/216.63  |- skos__historyNote mesh__D020149 Parkinson Disease %28%1966-1999%29%
% 216.49/216.63  |- skos__scopeNote mesh__D020149
% 216.49/216.63       Manganese poisoning is associated with chronic inhalation of manganese particles by individuals who work with manganese ore. Clinical features include CONFUSION; HALLUCINATIONS; and an extrapyramidal syndrome %28%PARKINSON DISEASE, SECONDARY%29% that includes rigidity; DYSTONIA; retropulsion; and TREMOR. %28%Adams, Principles of Neurology, 6th ed, p1213%29%%A%    
% 216.49/216.63  |- mesh__dateEstablished mesh__D020149 2000-01-01
% 216.49/216.63  |- skos__hiddenLabel mesh__D020149 Syndrome, Manganese Neurotoxicity
% 216.49/216.63  |- skos__altLabel mesh__D020149 Poisoning, Manganese
% 216.49/216.63  |- skos__prefLabel mesh__D020149 Manganese Poisoning
% 216.49/216.63  |- skos__annotation mesh__D020149
% 216.49/216.63       coord IM with specific manganese cpd %28%IM%29% if given   
% 216.49/216.63  |- skos__broader mesh__D020149smesh__D020260
% 216.49/216.63  |- skos__historyNote mesh__D020149 Manganese %28%1966-1999%29%
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D020149 2005
% 216.49/216.63  |- mesh__dateCreated mesh__D020149 1999-11-03
% 216.49/216.63  |- mesh__publicMeSHNote mesh__D020149 2000   
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D020149 2002
% 216.49/216.63  |- skos__altLabel mesh__D020149 Nervous System Diseases, Manganese-Induced
% 216.49/216.63  |- skos__related mesh__D020149smesh__D010300
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D020149 2006
% 216.49/216.63  |- skos__hiddenLabel mesh__D020149 Manganese Neurotoxicity Syndromes
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D020149 2003
% 216.49/216.63  |- skos__hiddenLabel mesh__D020149 Neurotoxicity Syndromes, Manganese
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D020149 2000
% 216.49/216.63  |- skos__hiddenLabel mesh__D020149
% 216.49/216.63       Nervous System Diseases, Manganese Induced
% 216.49/216.63  |- skos__altLabel mesh__D020149 Neurotoxicity Syndrome, Manganese
% 216.49/216.63  |- skos__broader mesh__D005176Q000172smesh__D005176
% 216.49/216.63  |- mesh__preferredCombination mesh__D005176Q000172smesh__D005177
% 216.49/216.63  |- rdf__type mesh__D005176Q000172smesh__CompoundConcept
% 216.49/216.63  |- skos__broader mesh__D003180smesh__D003169
% 216.49/216.63  |- skos__prefLabel mesh__D003180 Complement C3b Inactivator Proteins
% 216.49/216.63  |- mesh__dateCreated mesh__D003180 1977-05-17
% 216.49/216.63  |- mesh__recordAuthorizer mesh__D003180 sjn
% 216.49/216.63  |- skos__hiddenLabel mesh__D003180 Inhibitors, Complement 3b
% 216.49/216.63  |- skos__historyNote mesh__D003180 Serum Globulins %28%1970-1977%29%
% 216.49/216.63  |- skos__hiddenLabel mesh__D003180 Inactivators, C3b
% 216.49/216.63  |- skos__altLabel mesh__D003180 Complement 3b Inactivators
% 216.49/216.63  |- skos__altLabel mesh__D003180 Complement C3b Inactivators
% 216.49/216.63  |- mesh__historyNote mesh__D003180 2006 %28%1978%29%   
% 216.49/216.63  |- skos__hiddenLabel mesh__D003180 Factors, Conglutinogen Activating
% 216.49/216.63  |- skos__altLabel mesh__D003180 Conglutinogen Activating Factors
% 216.49/216.63  |- mesh__activeMeSHYear mesh__D003180 2006
% 216.49/216.63  |- mesh__recordMaintainer mesh__D003180 lkt
% 216.49/216.63  |- skos__scopeNote mesh__D003180
% 216.49/216.63       Endogenous proteins that inhibit or inactivate COMPLEMENT C3B. They include COMPLEMENT FACTOR H and COMPLEMENT FACTOR I %28%C3b/C4b inactivator%29%. They cleave or promote the cleavage of C3b into inactive fragments, and thus are important in the down-regulation of COMPLEMENT ACTIVATION and its cytolytic sequence.%A%    
% 216.49/216.63  |- skos__historyNote mesh__D003180 Complement 3 %28%1975-1977%29%
% 216.49/216.63  |- skos__altLabel mesh__D003180 C3b Inactivators
% 216.49/216.63  |- skos__hiddenLabel mesh__D003180 Inactivators, Complement 3b
% 216.49/216.63  |- mesh__dateRevised mesh__D003180 2005-06-30
% 216.49/216.63  |- rdf__type mesh__D003180sskos__Concept
% 216.49/216.63  |- skos__altLabel mesh__D003180 C3b Inhibitors
% 216.49/216.63  |- mesh__dateEstablished mesh__D003180 1978-01-01
% 216.49/216.63  |- mesh__publicMeSHNote mesh__D003180
% 216.49/216.63       2006; see COMPLEMENT 3B INACTIVATORS 1978-2005   
% 216.49/216.63  |- skos__altLabel mesh__D003180 Complement 3b Inhibitors
% 216.49/216.63  |- skos__hiddenLabel mesh__D003180 Inactivators, Complement C3b
% 216.49/216.63  |- skos__hiddenLabel mesh__D003180 Inhibitors, C3b
% 216.49/216.63  |- mesh__recordOriginator mesh__D003180 RLS
% 216.49/216.63  |- skos__annotation mesh__D003180 DF: C3B INACT   
% 216.49/216.63  |- skos__altLabel mesh__D003180 Complement C3b Inhibitor Proteins
% 216.49/216.64  |- skos__hiddenLabel mesh__D011612 Psychosurgeries
% 216.49/216.64  |- mesh__dateCreated mesh__D011612 1999-01-01
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D011612 2000
% 216.49/216.64  |- skos__hiddenLabel mesh__D011612 Topectomies
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D011612 2005
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D011612 2001
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D011612 2003
% 216.49/216.64  |- mesh__recordMaintainer mesh__D011612 PXP
% 216.49/216.64  |- skos__annotation mesh__D011612
% 216.49/216.64       coord IM with specific lobe /surg %28%NIM%29%; DF: PSYCHOSURG   
% 216.49/216.64  |- skos__broader mesh__D011612smesh__D013000
% 216.49/216.64  |- skos__scopeNote mesh__D011612
% 216.49/216.64       Treatment of chronic, severe and intractable psychiatric disorders by surgical removal or interruption of certain areas or pathways in the brain, especially in the prefrontal lobes.%A%    
% 216.49/216.64  |- skos__prefLabel mesh__D011612 Psychosurgery
% 216.49/216.64  |- mesh__recordOriginator mesh__D011612 NLM
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D011612 2006
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D011612 2002
% 216.49/216.64  |- skos__hiddenLabel mesh__D011612 Leukotomies
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D011612 2004
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D011612 1998
% 216.49/216.64  |- skos__hiddenLabel mesh__D011612 Lobotomies
% 216.49/216.64  |- skos__altLabel mesh__D011612 Leucotomy
% 216.49/216.64  |- skos__hiddenLabel mesh__D011612 Gyrectomies
% 216.49/216.64  |- mesh__dateRevised mesh__D011612 1997-06-20
% 216.49/216.64  |- skos__hiddenLabel mesh__D011612 Leucotomies
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D011612 1999
% 216.49/216.64  |- mesh__recordAuthorizer mesh__D011612 SJN
% 216.49/216.64  |- rdf__type mesh__D011612sskos__Concept
% 216.49/216.64  |- skos__broader mesh__D011612smesh__D019635
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D002886 2006
% 216.49/216.64  |- mesh__dateCreated mesh__D002886 1986-06-19
% 216.49/216.64  |- skos__broader mesh__D002886smesh__D002902
% 216.49/216.64  |- skos__historyNote mesh__D002886
% 216.49/216.64       Chromosomes, Human, 16-18 %28%1968-1986%29%
% 216.49/216.64  |- skos__prefLabel mesh__D002886 Chromosomes, Human, Pair 17
% 216.49/216.64  |- mesh__historyNote mesh__D002886 87   
% 216.49/216.64  |- skos__scopeNote mesh__D002886
% 216.49/216.64       A specific pair of GROUP E CHROMOSOMES of the human chromosome classification.%A%    
% 216.49/216.64  |- mesh__recordAuthorizer mesh__D002886 ags
% 216.49/216.64  |- mesh__dateRevised mesh__D002886 2005-07-13
% 216.49/216.64  |- skos__altLabel mesh__D002886 Chromosome 17
% 216.49/216.64  |- rdf__type mesh__D002886sskos__Concept
% 216.49/216.64  |- mesh__recordMaintainer mesh__D002886 ags
% 216.49/216.64  |- mesh__recordOriginator mesh__D002886 SCD
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D002886 2006A
% 216.49/216.64  |- mesh__publicMeSHNote mesh__D002886 87   
% 216.49/216.64  |- mesh__dateEstablished mesh__D002886 1987-01-01
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D002886 2005
% 216.49/216.64  |- skos__prefLabel mesh__D035262 Cranial Fossa, Anterior
% 216.49/216.64  |- rdf__type mesh__D035262sskos__Concept
% 216.49/216.64  |- skos__altLabel mesh__D035262 Anterior Cranial Fossa
% 216.49/216.64  |- skos__hiddenLabel mesh__D035262 Fossa, Anterior Cranial
% 216.49/216.64  |- mesh__historyNote mesh__D035262 2003   
% 216.49/216.64  |- skos__annotation mesh__D035262
% 216.49/216.64       NIM when merely locational; neopl: coord IM with SKULL BASE NEOPLASMS %28%IM%29%%A%  
% 216.49/216.64  |- mesh__dateCreated mesh__D035262 2002-07-02
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D035262 2004
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D035262 2006
% 216.49/216.64  |- skos__broader mesh__D035262smesh__D019291
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D035262 2003
% 216.49/216.64  |- skos__scopeNote mesh__D035262
% 216.49/216.64       The compartment containing the inferior part and anterior extremities of the frontal lobes %28%FRONTAL LOBE%29% of the cerebral hemispheres. It is formed mainly by orbital parts of the FRONTAL BONE and the lesser wings of the SPHENOID BONE.%A%    
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D035262 2005
% 216.49/216.64  |- mesh__publicMeSHNote mesh__D035262 2003   
% 216.49/216.64  |- mesh__dateEstablished mesh__D035262 2003-01-01
% 216.49/216.64  |- skos__broader mesh__D002088smesh__D000144
% 216.49/216.64  |- mesh__dateRevised mesh__D002088 2003-07-09
% 216.49/216.64  |- skos__historyNote mesh__D002088 Butyrates %28%1968-1974%29%
% 216.49/216.64  |- skos__scopeNote mesh__D002088
% 216.49/216.64       4-carbon acids, salts, and derivatives of BUTYRIC ACID.%A%    
% 216.49/216.64  |- mesh__dateEstablished mesh__D002088 1991-01-01
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D002088 2006
% 216.49/216.64  |- mesh__recordAuthorizer mesh__D002088 sjn
% 216.49/216.64  |- skos__hiddenLabel mesh__D002088 Acids, Butanoic
% 216.49/216.64  |- skos__hiddenLabel mesh__D002088 Acids, Butyric
% 216.49/216.64  |- mesh__dateCreated mesh__D002088 1974-11-11
% 216.49/216.64  |- skos__altLabel mesh__D002088 Butanoic Acids
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D002088 2005
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D002088 2004
% 216.49/216.64  |- skos__prefLabel mesh__D002088 Butyric Acids
% 216.49/216.64  |- skos__annotation mesh__D002088 BUTYRIC ACID is also available   
% 216.49/216.64  |- mesh__historyNote mesh__D002088
% 216.49/216.64       91%28%75%29%; was see under BUTYRATES 1975-90   
% 216.49/216.64  |- mesh__recordOriginator mesh__D002088 NLM
% 216.49/216.64  |- rdf__type mesh__D002088sskos__Concept
% 216.49/216.64  |- mesh__publicMeSHNote mesh__D002088
% 216.49/216.64       91; was see under BUTYRATES 1975-90   
% 216.49/216.64  |- mesh__recordMaintainer mesh__D002088 ssb
% 216.49/216.64  |- skos__broader mesh__D002088smesh__D005232
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D007571 2005
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D007571 2004
% 216.49/216.64  |- skos__broader mesh__D007571smesh__D009140
% 216.49/216.64  |- rdf__type mesh__D007571sskos__Concept
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D007571 1994
% 216.49/216.64  |- mesh__historyNote mesh__D007571 67   
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D007571 1993
% 216.49/216.64  |- skos__historyNote mesh__D007571 Jaw %28%1966%29%
% 216.49/216.64  |- skos__prefLabel mesh__D007571 Jaw Diseases
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D007571 2003
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D007571 1999
% 216.49/216.64  |- mesh__dateCreated mesh__D007571 1999-01-01
% 216.49/216.64  |- mesh__dateRevised mesh__D007571 1990-05-29
% 216.49/216.64  |- skos__hiddenLabel mesh__D007571 Jaw Disease
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D007571 1992
% 216.49/216.64  |- skos__historyNote mesh__D007571 Mandible %28%1966%29%
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D007571 1998
% 216.49/216.64  |- skos__hiddenLabel mesh__D007571 Disease, Jaw
% 216.49/216.64  |- skos__annotation mesh__D007571 GEN   
% 216.49/216.64  |- skos__hiddenLabel mesh__D007571 Diseases, Jaw
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D007571 2002
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D007571 1997
% 216.49/216.64  |- skos__broader mesh__D007571smesh__D009057
% 216.49/216.64  |- mesh__dateEstablished mesh__D007571 1967-01-01
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D007571 2006
% 216.49/216.64  |- mesh__recordAuthorizer mesh__D007571 NLM
% 216.49/216.64  |- skos__historyNote mesh__D007571 Maxilla %28%1966%29%
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D007571 1991
% 216.49/216.64  |- mesh__recordOriginator mesh__D007571 NLM
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D007571 2001
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D007571 1996
% 216.49/216.64  |- mesh__recordMaintainer mesh__D007571 PLS
% 216.49/216.64  |- mesh__publicMeSHNote mesh__D007571 67   
% 216.49/216.64  |- skos__historyNote mesh__D007571 Bone Diseases %28%1966%29%
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D007571 2000
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D007571 1995
% 216.49/216.64  |- skos__broader mesh__D006346Q000002smesh__D006346
% 216.49/216.64  |- mesh__preferredCombination mesh__D006346Q000002smesh__D006343
% 216.49/216.64  |- rdf__type mesh__D006346Q000002smesh__CompoundConcept
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D048988 2006
% 216.49/216.64  |- skos__altLabel mesh__D048988 Photokeratectomy
% 216.49/216.64  |- rdf__type mesh__D048988sskos__Concept
% 216.49/216.64  |- mesh__historyNote mesh__D048988
% 216.49/216.64       2005; for PHOTOKERATECTOMY use KERATECTOMY, PHOTOREFRACTIVE, EXCIMER LlASER 1996-2004%A%  
% 216.49/216.64  |- skos__historyNote mesh__D048988 Cornea/surgery %28%1987-2004%29%
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D048988 2005
% 216.49/216.64  |- mesh__recordOriginator mesh__D048988 lkt
% 216.49/216.64  |- mesh__recordMaintainer mesh__D048988 lkt
% 216.49/216.64  |- skos__historyNote mesh__D048988 Laser Surgery %28%1987-2004%29%
% 216.49/216.64  |- skos__prefLabel mesh__D048988 Keratectomy, Laser
% 216.49/216.64  |- skos__broader mesh__D048988smesh__D007833
% 216.49/216.64  |- skos__altLabel mesh__D048988 Laser Keratectomy
% 216.49/216.64  |- skos__altLabel mesh__D048988 Photorefractive Keratectomy
% 216.49/216.64  |- mesh__dateCreated mesh__D048988 2004-07-07
% 216.49/216.64  |- skos__hiddenLabel mesh__D048988 Laser Keratectomies
% 216.49/216.64  |- skos__hiddenLabel mesh__D048988 Keratectomies, Laser
% 216.49/216.64  |- mesh__recordAuthorizer mesh__D048988 sjn
% 216.49/216.64  |- skos__scopeNote mesh__D048988
% 216.49/216.64       Application of laser techniques %28%LASERS%29% to reduce or reshape the CORNEA to correct REFRACTIVE ERRORS of the EYE, such as MYOPIA and ASTIGMATISM.%A%    
% 216.49/216.64  |- mesh__dateEstablished mesh__D048988 2005-01-01
% 216.49/216.64  |- mesh__publicMeSHNote mesh__D048988
% 216.49/216.64       2005; for PHOTOKERATECTOMY see KERATECTOMY, PHOTOREFRACTIVE, EXCIMER LlASER 1996-2004%A%  
% 216.49/216.64  |- skos__broader mesh__D007828Q000295smesh__D007828
% 216.49/216.64  |- mesh__preferredCombination mesh__D007828Q000295smesh__D020704
% 216.49/216.64  |- rdf__type mesh__D007828Q000295smesh__CompoundConcept
% 216.49/216.64  |- mesh__recordAuthorizer mesh__D015205 SJN
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D015205 2005
% 216.49/216.64  |- mesh__dateRevised mesh__D015205 1997-06-20
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D015205 2004
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D015205 1999
% 216.49/216.64  |- skos__prefLabel mesh__D015205 Northwestern United States
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D015205 2006
% 216.49/216.64  |- mesh__dateCreated mesh__D015205 1988-04-30
% 216.49/216.64  |- mesh__recordOriginator mesh__D015205 EC
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D015205 2002
% 216.49/216.64  |- skos__scopeNote mesh__D015205
% 216.49/216.64       The geographic area of the northwestern region of the United States. The states usually included in this region are Idaho, Montana, Oregon, Washington, and Wyoming.%A%    
% 216.49/216.64  |- skos__broader mesh__D015205smesh__D014481
% 216.49/216.64  |- mesh__historyNote mesh__D015205 89   
% 216.49/216.64  |- skos__altLabel mesh__D015205 Northwest U.S.
% 216.49/216.64  |- mesh__recordMaintainer mesh__D015205 PXP
% 216.49/216.64  |- rdf__type mesh__D015205sskos__Concept
% 216.49/216.64  |- skos__annotation mesh__D015205
% 216.49/216.64       includes Idaho, Mont, Ore, Wash, Wyo; specify as needed but use NORTHWESTERN UNITED STATES when text uses the term; do not confuse with PACIFIC STATES: see note there; DF: note short X ref      CATALOG: use for 4 or more states%A%  
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D015205 2000
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D015205 2003
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D015205 1998
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D015205 2001
% 216.49/216.64  |- skos__altLabel mesh__D015205 Northwest US
% 216.49/216.64  |- mesh__dateEstablished mesh__D015205 1989-01-01
% 216.49/216.64  |- skos__altLabel mesh__D020948 Uncaria tomentosa
% 216.49/216.64  |- mesh__historyNote mesh__D020948 2000   
% 216.49/216.64  |- mesh__dateRevised mesh__D020948 2002-07-03
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D020948 2003
% 216.49/216.64  |- mesh__recordAuthorizer mesh__D020948 sjn
% 216.49/216.64  |- skos__prefLabel mesh__D020948 Cat%27%s Claw
% 216.49/216.64  |- mesh__recordMaintainer mesh__D020948 ssb
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D020948 2004
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D020948 2005
% 216.49/216.64  |- skos__historyNote mesh__D020948 Plants, Medicinal %28%1985-1999%29%
% 216.49/216.64  |- mesh__dateEstablished mesh__D020948 2000-01-01
% 216.49/216.64  |- mesh__publicMeSHNote mesh__D020948 2000   
% 216.49/216.64  |- mesh__dateCreated mesh__D020948 1999-11-03
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D020948 2006
% 216.49/216.64  |- skos__broader mesh__D020948smesh__D032070
% 216.49/216.64  |- skos__scopeNote mesh__D020948
% 216.49/216.64       A vine %28%Uncaria tomentosa%29% indigenous to the Amazon rainforest whose name is derived from its hook-like thorns. It contains oxindole alkaloids and glycosides and has many medicinal uses.%A%    
% 216.49/216.64  |- rdf__type mesh__D020948sskos__Concept
% 216.49/216.64  |- mesh__recordOriginator mesh__D020948 ags
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D031670 2004
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D031670 2005
% 216.49/216.64  |- mesh__historyNote mesh__D031670 2003   
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D031670 2003
% 216.49/216.64  |- mesh__dateEstablished mesh__D031670 2003-01-01
% 216.49/216.64  |- rdf__type mesh__D031670sskos__Concept
% 216.49/216.64  |- skos__annotation mesh__D031670
% 216.49/216.64       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.49/216.64  |- skos__scopeNote mesh__D031670
% 216.49/216.64       The broom-rape plant family of the order Scrophulariales, subclass Asteridae, class Magnoliopsida.%A%    
% 216.49/216.64  |- mesh__publicMeSHNote mesh__D031670 2003   
% 216.49/216.64  |- skos__broader mesh__D031670smesh__D019684
% 216.49/216.64  |- skos__prefLabel mesh__D031670 Orobanchaceae
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D031670 2006
% 216.49/216.64  |- mesh__dateCreated mesh__D031670 2002-07-03
% 216.49/216.64  |- mesh__publicMeSHNote mesh__D006479
% 216.49/216.64       78; was see under ARBOVIRUS INFECTIONS 1977; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76%A%  
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D006479 2003
% 216.49/216.64  |- skos__annotation mesh__D006479
% 216.49/216.64       caused by the Crimean-Congo hemorrhagic fever virus, a species of Nairovirus%A%  
% 216.49/216.64  |- skos__broader mesh__D006479smesh__D002044
% 216.49/216.64  |- mesh__historyNote mesh__D006479
% 216.49/216.64       78%28%77%29%; was see under ARBOVIRUS INFECTIONS 1977; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76%A%  
% 216.49/216.64  |- mesh__recordAuthorizer mesh__D006479 PLS
% 216.49/216.64  |- skos__altLabel mesh__D006479 Congo Virus Infection
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D006479 2001
% 216.49/216.64  |- skos__scopeNote mesh__D006479
% 216.49/216.64       A severe, often fatal disease in humans caused by the Crimean-Congo hemorrhagic fever virus %28%HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO%29%.%A%    
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D006479 1994
% 216.49/216.64  |- rdf__type mesh__D006479sskos__Concept
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D006479 1999
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D006479 2000
% 216.49/216.64  |- skos__hiddenLabel mesh__D006479 Congo Virus Infections
% 216.49/216.64  |- skos__hiddenLabel mesh__D006479 Hemorrhagic Fevers, Crimean
% 216.49/216.64  |- mesh__recordOriginator mesh__D006479 FPG
% 216.49/216.64  |- skos__broader mesh__D006479smesh__D017282
% 216.49/216.64  |- mesh__recordMaintainer mesh__D006479 TGC
% 216.49/216.64  |- skos__hiddenLabel mesh__D006479 Fevers, Crimean Hemorrhagic
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D006479 1997
% 216.49/216.64  |- skos__altLabel mesh__D006479 Infection, Congo Virus
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D006479 1998
% 216.49/216.64  |- mesh__dateEstablished mesh__D006479 1978-01-01
% 216.49/216.64  |- skos__hiddenLabel mesh__D006479 Crimean Hemorrhagic Fever
% 216.49/216.64  |- mesh__dateRevised mesh__D006479 1993-06-02
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D006479 2006
% 216.49/216.64  |- skos__broader mesh__D006479smesh__D006482
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D006479 2002
% 216.49/216.64  |- mesh__onlineNote mesh__D006479
% 216.49/216.64       search HEMORRHAGIC FEVERS, VIRAL 1966-76   
% 216.49/216.64  |- skos__prefLabel mesh__D006479 Hemorrhagic Fever, Crimean
% 216.49/216.64  |- skos__hiddenLabel mesh__D006479 Infections, Congo Virus
% 216.49/216.64  |- skos__hiddenLabel mesh__D006479 Fever, Crimean Hemorrhagic
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D006479 1996
% 216.49/216.64  |- skos__historyNote mesh__D006479
% 216.49/216.64       Hemorrhagic Fevers, Viral %28%1966-1976%29%
% 216.49/216.64  |- mesh__dateCreated mesh__D006479 1976-04-27
% 216.49/216.64  |- skos__hiddenLabel mesh__D006479 Crimean Hemorrhagic Fevers
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D006479 2004
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D006479 2005
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D006479 1995
% 216.49/216.64  |- skos__hiddenLabel mesh__D003181 Pro complement 4
% 216.49/216.64  |- skos__historyNote mesh__D003181 Protein Binding %28%1966-1974%29%
% 216.49/216.64  |- rdf__type mesh__D003181sskos__Concept
% 216.49/216.64  |- skos__hiddenLabel mesh__D003181 C4, Complement
% 216.49/216.64  |- mesh__dateEstablished mesh__D003181 1978-01-01
% 216.49/216.64  |- skos__hiddenLabel mesh__D003181 Pro C4
% 216.49/216.64  |- skos__altLabel mesh__D003181 Complement Component 4
% 216.49/216.64  |- skos__hiddenLabel mesh__D003181 Component 4, Complement
% 216.49/216.64  |- skos__altLabel mesh__D003181 C4 Complement Component
% 216.49/216.64  |- skos__prefLabel mesh__D003181 Complement C4
% 216.49/216.64  |- skos__hiddenLabel mesh__D003181 Complement, C4
% 216.49/216.64  |- mesh__publicMeSHNote mesh__D003181
% 216.49/216.64       2006; see COMPLEMENT 4 1978-2005, see COMPLEMENT 1975-1977; COMPLEMENT C4, PRECURSOR was indexed under COMPLEMENT 4 1980-2005%A%  
% 216.49/216.64  |- mesh__recordAuthorizer mesh__D003181 sjn
% 216.49/216.64  |- skos__altLabel mesh__D003181 Complement 4
% 216.49/216.64  |- mesh__historyNote mesh__D003181 2006 %28%1975%29%   
% 216.49/216.64  |- mesh__recordMaintainer mesh__D003181 lkt
% 216.49/216.64  |- skos__historyNote mesh__D003181 Complement %28%1968-1974%29%
% 216.49/216.64  |- skos__scopeNote mesh__D003181
% 216.49/216.64       A glycoprotein that is important in the activation of CLASSICAL COMPLEMENT PATHWAY. C4 is cleaved by the activated COMPLEMENT C1S into COMPLEMENT C4A and COMPLEMENT C4B.%A%    
% 216.49/216.64  |- mesh__recordOriginator mesh__D003181 NLM
% 216.49/216.64  |- skos__altLabel mesh__D003181 Pro-complement 4
% 216.49/216.64  |- skos__altLabel mesh__D003181 Pro-C4
% 216.49/216.64  |- skos__altLabel mesh__D003181 C4 Complement
% 216.49/216.64  |- mesh__dateCreated mesh__D003181 1974-11-11
% 216.49/216.64  |- skos__hiddenLabel mesh__D003181 Complement Component, C4
% 216.49/216.64  |- skos__hiddenLabel mesh__D003181 Component, C4 Complement
% 216.49/216.64  |- skos__broader mesh__D003181smesh__D003165
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D003181 2006
% 216.49/216.64  |- mesh__dateRevised mesh__D003181 2005-06-30
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D011613 2005
% 216.49/216.64  |- skos__prefLabel mesh__D011613 Psychotherapy
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D011613 2003
% 216.49/216.64  |- skos__annotation mesh__D011613 SPEC qualif   
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D011613 2006
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D011613 2000
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D011613 2004
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D011613 1998
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D011613 1996
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D011613 2001
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D011613 1999
% 216.49/216.64  |- rdf__type mesh__D011613sskos__Concept
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D011613 1997
% 216.49/216.64  |- mesh__dateRevised mesh__D011613 1995-05-23
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D011613 2002
% 216.49/216.64  |- mesh__recordOriginator mesh__D011613 NLM
% 216.49/216.64  |- mesh__recordAuthorizer mesh__D011613 PLS
% 216.49/216.64  |- skos__scopeNote mesh__D011613
% 216.49/216.64       A generic term for the treatment of mental illness or emotional disturbances primarily by verbal or nonverbal communication.%A%    
% 216.49/216.64  |- mesh__dateCreated mesh__D011613 1999-01-01
% 216.49/216.64  |- mesh__recordMaintainer mesh__D011613 KEV
% 216.49/216.64  |- skos__hiddenLabel mesh__D011613 Psychotherapies
% 216.49/216.64  |- skos__broader mesh__D011613smesh__D004191
% 216.49/216.64  |- mesh__publicMeSHNote mesh__D002887 87   
% 216.49/216.64  |- skos__historyNote mesh__D002887
% 216.49/216.64       Chromosomes, Human, 16-18 %28%1968-1986%29%
% 216.49/216.64  |- mesh__recordMaintainer mesh__D002887 ags
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D002887 2006
% 216.49/216.64  |- mesh__dateCreated mesh__D002887 1986-06-19
% 216.49/216.64  |- skos__broader mesh__D002887smesh__D002902
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D002887 2006A
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D002887 2005
% 216.49/216.64  |- mesh__dateRevised mesh__D002887 2005-07-13
% 216.49/216.64  |- mesh__recordAuthorizer mesh__D002887 ags
% 216.49/216.64  |- skos__altLabel mesh__D002887 Chromosome 18
% 216.49/216.64  |- mesh__dateEstablished mesh__D002887 1987-01-01
% 216.49/216.64  |- mesh__recordOriginator mesh__D002887 SCD
% 216.49/216.64  |- skos__scopeNote mesh__D002887
% 216.49/216.64       A specific pair of GROUP E CHROMOSOMES of the human chromosome classification.%A%    
% 216.49/216.64  |- rdf__type mesh__D002887sskos__Concept
% 216.49/216.64  |- mesh__historyNote mesh__D002887 87   
% 216.49/216.64  |- skos__prefLabel mesh__D002887 Chromosomes, Human, Pair 18
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D035263 2004
% 216.49/216.64  |- mesh__dateEstablished mesh__D035263 2003-01-01
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D035263 2006
% 216.49/216.64  |- skos__broader mesh__D035263smesh__D035261
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D035263 2003
% 216.49/216.64  |- mesh__dateCreated mesh__D035263 2002-07-03
% 216.49/216.64  |- skos__annotation mesh__D035263 coord with specific plant   
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D035263 2005
% 216.49/216.64  |- skos__scopeNote mesh__D035263
% 216.49/216.64       Tops of plants when in flower, including the stems, leaves and blooms.%A%    
% 216.49/216.64  |- mesh__publicMeSHNote mesh__D035263 2003   
% 216.49/216.64  |- mesh__historyNote mesh__D035263 2003   
% 216.49/216.64  |- skos__prefLabel mesh__D035263 Flowering Tops
% 216.49/216.64  |- rdf__type mesh__D035263sskos__Concept
% 216.49/216.64  |- mesh__recordOriginator mesh__D007572 NLM
% 216.49/216.64  |- skos__hiddenLabel mesh__D007572 Jaw Fracture
% 216.49/216.64  |- mesh__recordAuthorizer mesh__D007572 sjn
% 216.49/216.64  |- skos__prefLabel mesh__D007572 Jaw Fractures
% 216.49/216.64  |- mesh__dateEstablished mesh__D007572 1966-01-01
% 216.49/216.64  |- mesh__historyNote mesh__D007572 66   
% 216.49/216.64  |- mesh__dateCreated mesh__D007572 1999-01-01
% 216.49/216.64  |- skos__scopeNote mesh__D007572 Fractures of the upper or lower jaw.     
% 216.49/216.64  |- skos__hiddenLabel mesh__D007572 Fracture, Jaw
% 216.49/216.64  |- skos__broader mesh__D007572smesh__D008446
% 216.49/216.64  |- mesh__dateRevised mesh__D007572 2005-06-30
% 216.49/216.64  |- mesh__publicMeSHNote mesh__D007572 66   
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D007572 2006
% 216.49/216.64  |- mesh__recordMaintainer mesh__D007572 ssb
% 216.49/216.64  |- skos__hiddenLabel mesh__D007572 Fractures, Jaw
% 216.49/216.64  |- skos__annotation mesh__D007572 GEN   
% 216.49/216.64  |- skos__broader mesh__D007572smesh__D012887
% 216.49/216.64  |- rdf__type mesh__D007572sskos__Concept
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D015206 1999
% 216.49/216.64  |- mesh__dateEstablished mesh__D015206 1989-01-01
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D015206 2005
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D015206 2004
% 216.49/216.64  |- skos__annotation mesh__D015206
% 216.49/216.64       includes Ariz, Calif, Colo, Nev, N Mex, Tex, Utah; specify as needed but use SOUTHWESTERN UNITED STATES when text uses the term; DF: note short X ref      CATALOG: use for 4 or more states%A%  
% 216.49/216.64  |- mesh__recordOriginator mesh__D015206 EC
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D015206 2002
% 216.49/216.64  |- mesh__dateCreated mesh__D015206 1988-04-30
% 216.49/216.64  |- skos__scopeNote mesh__D015206
% 216.49/216.64       The geographic area of the southwestern region of the United States. The states usually included in this region are Arizona, California, Colorado, Nevada, New Mexico, Texas, and Utah.%A%    
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D015206 2006
% 216.49/216.64  |- skos__broader mesh__D015206smesh__D014481
% 216.49/216.64  |- rdf__type mesh__D015206sskos__Concept
% 216.49/216.64  |- skos__altLabel mesh__D015206 Southwest U.S.
% 216.49/216.64  |- mesh__historyNote mesh__D015206 89   
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D015206 2000
% 216.49/216.64  |- skos__altLabel mesh__D015206 Southwest US
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D015206 2001
% 216.49/216.64  |- mesh__recordMaintainer mesh__D015206 PXP
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D015206 1998
% 216.49/216.64  |- mesh__recordAuthorizer mesh__D015206 SJN
% 216.49/216.64  |- mesh__dateRevised mesh__D015206 1997-06-20
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D015206 2003
% 216.49/216.64  |- skos__prefLabel mesh__D015206 Southwestern United States
% 216.49/216.64  |- skos__hiddenLabel mesh__D020949 Usnea barbatas
% 216.49/216.64  |- mesh__recordOriginator mesh__D020949 ags
% 216.49/216.64  |- skos__hiddenLabel mesh__D020949 barbata, Usnea
% 216.49/216.64  |- skos__prefLabel mesh__D020949 Usnea
% 216.49/216.64  |- mesh__recordAuthorizer mesh__D020949 sjn
% 216.49/216.64  |- mesh__dateEstablished mesh__D020949 2000-01-01
% 216.49/216.64  |- mesh__activeMeSHYear mesh__D020949 2006
% 216.49/216.64  |- rdf__type mesh__D020949sskos__Concept
% 216.49/216.64  |- skos__hiddenLabel mesh__D020949 barbatas, Usnea
% 216.49/216.64  |- skos__hiddenLabel mesh__D020949 Usneas
% 216.49/216.64  |- mesh__recordMaintainer mesh__D020949 SYSTEM
% 216.49/216.64  |- skos__historyNote mesh__D020949 Lichens %28%1967-1999%29%
% 216.49/216.64  |- skos__broader mesh__D020949smesh__D008011
% 216.49/216.64  |- mesh__historyNote mesh__D020949 2000   
% 216.49/216.64  |- mesh__publicMeSHNote mesh__D020949 2000   
% 216.49/216.64  |- mesh__dateCreated mesh__D020949 1999-11-08
% 216.49/216.65  |- mesh__dateRevised mesh__D020949 2005-06-30
% 216.49/216.65  |- skos__scopeNote mesh__D020949
% 216.49/216.65       A genus of lichens containing usnic acid and mucilage. Usnea barbata has been used as an herbal medicine.%A%    
% 216.49/216.65  |- rdf__type mesh__D031671sskos__Concept
% 216.49/216.65  |- mesh__publicMeSHNote mesh__D031671 2003   
% 216.49/216.65  |- skos__annotation mesh__D031671
% 216.49/216.65       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.49/216.65  |- skos__broader mesh__D031671smesh__D031670
% 216.49/216.65  |- skos__prefLabel mesh__D031671 Cistanche
% 216.49/216.65  |- mesh__dateCreated mesh__D031671 2002-07-03
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D031671 2006
% 216.49/216.65  |- mesh__dateEstablished mesh__D031671 2003-01-01
% 216.49/216.65  |- mesh__historyNote mesh__D031671 2003   
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D031671 2004
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D031671 2005
% 216.49/216.65  |- skos__scopeNote mesh__D031671
% 216.49/216.65       A plant genus of the family OROBANCHACEAE. Members contain phenylethanoid glycosides.%A%    
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D031671 2003
% 216.49/216.65  |- mesh__dateCreated mesh__D003980 1999-01-01
% 216.49/216.65  |- mesh__dateRevised mesh__D003980 2000-06-22
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D003980 2002
% 216.49/216.65  |- mesh__historyNote mesh__D003980
% 216.49/216.65       91%28%65%29%; was see under AZO COMPOUNDS 1965-90   
% 216.49/216.65  |- rdf__type mesh__D003980sskos__Concept
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D003980 2004
% 216.49/216.65  |- mesh__publicMeSHNote mesh__D003980
% 216.49/216.65       91; was see under AZO COMPOUNDS 1965-90   
% 216.49/216.65  |- skos__broader mesh__D003980smesh__D001391
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D003980 2003
% 216.49/216.65  |- mesh__recordMaintainer mesh__D003980 CCR
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D003980 2001
% 216.49/216.65  |- mesh__dateEstablished mesh__D003980 1991-01-01
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D003980 2006
% 216.49/216.65  |- mesh__recordOriginator mesh__D003980 NLM
% 216.49/216.65  |- skos__scopeNote mesh__D003980
% 216.49/216.65       An amino acid that inhibits phosphate-activated glutaminase and interferes with glutamine metabolism. It is an antineoplastic antibiotic produced by an unidentified species of Streptomyces from Peruvian soil. %28%From Merck Index, 11th ed%29%%A%    
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D003980 2005
% 216.49/216.65  |- mesh__recordAuthorizer mesh__D003980 sjn
% 216.49/216.65  |- skos__prefLabel mesh__D003980 Diazooxonorleucine
% 216.49/216.65  |- skos__hiddenLabel mesh__D003980 6 Diazo 5 oxo L norleucine
% 216.49/216.65  |- skos__altLabel mesh__D003980 6-Diazo-5-oxo-L-norleucine
% 216.49/216.65  |- skos__broader mesh__D003980smesh__D009646
% 216.49/216.65  |- skos__hiddenLabel mesh__D003182 Pro complement 5
% 216.49/216.65  |- mesh__recordMaintainer mesh__D003182 ags
% 216.49/216.65  |- mesh__dateEstablished mesh__D003182 1978-01-01
% 216.49/216.65  |- skos__scopeNote mesh__D003182
% 216.49/216.65       C5 plays a central role in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C5 is cleaved by C5 CONVERTASE into COMPLEMENT C5A and COMPLEMENT C5B. The smaller fragment C5a is an ANAPHYLATOXIN and mediator of inflammatory process. The major fragment C5b binds to the membrane initiating the spontaneous assembly of the late complement components, C5-C9, into the MEMBRANE ATTACK COMPLEX.%A%    
% 216.49/216.65  |- skos__hiddenLabel mesh__D003182 Component 5, Complement
% 216.49/216.65  |- skos__altLabel mesh__D003182 C5 Complement
% 216.49/216.65  |- mesh__publicMeSHNote mesh__D003182
% 216.49/216.65       2006; see COMPLEMENT 5 1978-2005, see COMPLEMENT 1975-1977; COMPLEMENT C5, PRECURSOR was indexed under COMPLEMENT 5 1991-2005%A%  
% 216.49/216.65  |- skos__altLabel mesh__D003182 Complement Component 5
% 216.49/216.65  |- skos__altLabel mesh__D003182 Precursor C5
% 216.49/216.65  |- skos__hiddenLabel mesh__D003182 Complement, C5
% 216.49/216.65  |- skos__altLabel mesh__D003182 Pro-complement 5
% 216.49/216.65  |- skos__historyNote mesh__D003182 Complement %28%1968-1974%29%
% 216.49/216.65  |- skos__altLabel mesh__D003182 Complement 5
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D003182 2006A
% 216.49/216.65  |- skos__hiddenLabel mesh__D003182 Precursor Complement C5
% 216.49/216.65  |- skos__historyNote mesh__D003182 Histamine Liberation %28%1966-1974%29%
% 216.49/216.65  |- mesh__dateCreated mesh__D003182 1974-11-11
% 216.49/216.65  |- skos__hiddenLabel mesh__D003182 C5, Complement
% 216.49/216.65  |- skos__hiddenLabel mesh__D003182 C5, Precursor
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D003182 2006
% 216.49/216.65  |- skos__broader mesh__D003182smesh__D003165
% 216.49/216.65  |- skos__hiddenLabel mesh__D003182 Pro C5
% 216.49/216.65  |- skos__altLabel mesh__D003182 Pro-C5
% 216.49/216.65  |- mesh__historyNote mesh__D003182 2006 %28%1975%29%   
% 216.49/216.65  |- mesh__dateRevised mesh__D003182 2005-07-11
% 216.49/216.65  |- skos__prefLabel mesh__D003182 Complement C5
% 216.49/216.65  |- mesh__recordAuthorizer mesh__D003182 ags
% 216.49/216.65  |- skos__hiddenLabel mesh__D003182 C5, Precursor Complement
% 216.49/216.65  |- mesh__recordOriginator mesh__D003182 NLM
% 216.49/216.65  |- rdf__type mesh__D003182sskos__Concept
% 216.49/216.65  |- skos__annotation mesh__D011614 DF: PSYCHOTHER BRIEF   
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011614 1998
% 216.49/216.65  |- skos__broader mesh__D011614smesh__D011613
% 216.49/216.65  |- skos__altLabel mesh__D011614 Psychotherapy, Short-Term
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011614 2002
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011614 1996
% 216.49/216.65  |- mesh__recordOriginator mesh__D011614 NLM
% 216.49/216.65  |- mesh__recordAuthorizer mesh__D011614 PLS
% 216.49/216.65  |- skos__historyNote mesh__D011614 Psychotherapy %28%1966-1972%29%
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011614 1999
% 216.49/216.65  |- rdf__type mesh__D011614sskos__Concept
% 216.49/216.65  |- skos__hiddenLabel mesh__D011614 Short Term Psychotherapy
% 216.49/216.65  |- skos__hiddenLabel mesh__D011614 Psychotherapies, Short-Term
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011614 1997
% 216.49/216.65  |- skos__altLabel mesh__D011614 Brief Psychotherapy
% 216.49/216.65  |- mesh__recordMaintainer mesh__D011614 TGC
% 216.49/216.65  |- mesh__dateCreated mesh__D011614 1999-01-01
% 216.49/216.65  |- mesh__publicMeSHNote mesh__D011614 73   
% 216.49/216.65  |- skos__scopeNote mesh__D011614
% 216.49/216.65       Any form of psychotherapy designed to produce therapeutic change within a minimal amount of time, generally not more than 20 sessions.%A%    
% 216.49/216.65  |- mesh__historyNote mesh__D011614 73   
% 216.49/216.65  |- skos__prefLabel mesh__D011614 Psychotherapy, Brief
% 216.49/216.65  |- mesh__dateEstablished mesh__D011614 1973-01-01
% 216.49/216.65  |- skos__hiddenLabel mesh__D011614 Psychotherapies, Brief
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011614 2000
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011614 2005
% 216.49/216.65  |- mesh__dateRevised mesh__D011614 1995-05-31
% 216.49/216.65  |- skos__altLabel mesh__D011614 Short-Term Psychotherapy
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011614 2003
% 216.49/216.65  |- skos__hiddenLabel mesh__D011614 Short-Term Psychotherapies
% 216.49/216.65  |- skos__hiddenLabel mesh__D011614 Psychotherapy, Short Term
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011614 2006
% 216.49/216.65  |- skos__hiddenLabel mesh__D011614 Brief Psychotherapies
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011614 2004
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011614 2001
% 216.49/216.65  |- mesh__recordMaintainer mesh__D002888 ags
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D002888 2006
% 216.49/216.65  |- mesh__dateCreated mesh__D002888 1986-06-19
% 216.49/216.65  |- mesh__publicMeSHNote mesh__D002888 87   
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D002888 2005
% 216.49/216.65  |- mesh__recordAuthorizer mesh__D002888 ags
% 216.49/216.65  |- mesh__recordOriginator mesh__D002888 SCD
% 216.49/216.65  |- skos__prefLabel mesh__D002888 Chromosomes, Human, Pair 19
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D002888 2006A
% 216.49/216.65  |- rdf__type mesh__D002888sskos__Concept
% 216.49/216.65  |- skos__broader mesh__D002888smesh__D002903
% 216.49/216.65  |- mesh__dateRevised mesh__D002888 2005-07-13
% 216.49/216.65  |- mesh__historyNote mesh__D002888 87   
% 216.49/216.65  |- skos__historyNote mesh__D002888
% 216.49/216.65       Chromosomes, Human, 19-20 %28%1968-1986%29%
% 216.49/216.65  |- mesh__dateEstablished mesh__D002888 1987-01-01
% 216.49/216.65  |- skos__scopeNote mesh__D002888
% 216.49/216.65       A specific pair of GROUP F CHROMOSOMES of the human chromosome classification.%A%    
% 216.49/216.65  |- skos__altLabel mesh__D002888 Chromosome 19
% 216.49/216.65  |- mesh__dateCreated mesh__D035264 2002-07-02
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D035264 2003
% 216.49/216.65  |- skos__annotation mesh__D035264 coord with specific plant   
% 216.49/216.65  |- skos__altLabel mesh__D035264 Carpal, Plant
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D035264 2005
% 216.49/216.65  |- skos__altLabel mesh__D035264 Filament, Flower
% 216.49/216.65  |- mesh__publicMeSHNote mesh__D035264 2003   
% 216.49/216.65  |- mesh__dateEstablished mesh__D035264 2003-01-01
% 216.49/216.65  |- skos__altLabel mesh__D035264 Stigma, Plant
% 216.49/216.65  |- skos__altLabel mesh__D035264 Carpals, Plant
% 216.49/216.65  |- skos__altLabel mesh__D035264 Blooms, Plant
% 216.49/216.65  |- skos__prefLabel mesh__D035264 Flowers
% 216.49/216.65  |- skos__altLabel mesh__D035264 Blossoms
% 216.49/216.65  |- skos__broader mesh__D035264smesh__D035263
% 216.49/216.65  |- skos__altLabel mesh__D035264 Stamen, Plant
% 216.49/216.65  |- rdf__type mesh__D035264sskos__Concept
% 216.49/216.65  |- skos__altLabel mesh__D035264 Sepals, Plant
% 216.49/216.65  |- skos__altLabel mesh__D035264 Style, Plant
% 216.49/216.65  |- skos__altLabel mesh__D035264 Ovary, Plant
% 216.49/216.65  |- skos__altLabel mesh__D035264 Anther, Plant
% 216.49/216.65  |- skos__scopeNote mesh__D035264 The reproductive organs of plants.     
% 216.49/216.65  |- skos__altLabel mesh__D035264 Petals, Plant
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D035264 2004
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D035264 2006
% 216.49/216.65  |- mesh__historyNote mesh__D035264 2003   
% 216.49/216.65  |- skos__historyNote mesh__D007573 Mandibular Neoplasms %28%1966%29%
% 216.49/216.65  |- skos__altLabel mesh__D007573 Jaw Cancer
% 216.49/216.65  |- skos__altLabel mesh__D007573 Neoplasms, Jaw
% 216.49/216.65  |- skos__hiddenLabel mesh__D007573 Neoplasm, Jaw
% 216.49/216.65  |- mesh__dateEstablished mesh__D007573 1967-01-01
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D007573 2006
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D007573 2002
% 216.49/216.65  |- mesh__publicMeSHNote mesh__D007573 67   
% 216.49/216.65  |- skos__prefLabel mesh__D007573 Jaw Neoplasms
% 216.49/216.65  |- mesh__recordOriginator mesh__D007573 NLM
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D007573 2005
% 216.49/216.65  |- skos__broader mesh__D007573smesh__D012888
% 216.49/216.65  |- skos__broader mesh__D007573smesh__D007571
% 216.49/216.65  |- skos__hiddenLabel mesh__D007573 Jaw Neoplasm
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D007573 2001
% 216.49/216.65  |- mesh__recordMaintainer mesh__D007573 nns
% 216.49/216.65  |- rdf__type mesh__D007573sskos__Concept
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D007573 2004
% 216.49/216.65  |- mesh__recordAuthorizer mesh__D007573 sjn
% 216.49/216.65  |- skos__hiddenLabel mesh__D007573 Cancer, Jaw
% 216.49/216.65  |- skos__annotation mesh__D007573
% 216.49/216.65       GEN: prefer specific precoord; coord IM with histol type of neopl %28%IM%29%%A%  
% 216.49/216.65  |- skos__hiddenLabel mesh__D007573 Cancers, Jaw
% 216.49/216.65  |- skos__hiddenLabel mesh__D007573 Jaw Cancers
% 216.49/216.65  |- mesh__dateRevised mesh__D007573 2000-06-22
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D007573 2003
% 216.49/216.65  |- mesh__dateCreated mesh__D007573 1999-01-01
% 216.49/216.65  |- mesh__historyNote mesh__D007573 67   
% 216.49/216.65  |- skos__altLabel mesh__D007573 Cancer of the Jaw
% 216.49/216.65  |- skos__historyNote mesh__D007573 Jaw %28%1966%29%
% 216.49/216.65  |- skos__scopeNote mesh__D007573
% 216.49/216.65       Cancers or tumors of the MAXILLA or MANDIBLE unspecified. For neoplasms of the maxilla, MAXILLARY NEOPLASMS is available and of the mandible, MANDIBULAR NEOPLASMS is available.%A%    
% 216.49/216.65  |- skos__historyNote mesh__D007573 Maxillary Neoplasms %28%1966%29%
% 216.49/216.65  |- skos__broader mesh__D004876Q000506smesh__D004876
% 216.49/216.65  |- mesh__preferredCombination mesh__D004876Q000506smesh__D004881
% 216.49/216.65  |- rdf__type mesh__D004876Q000506smesh__CompoundConcept
% 216.49/216.65  |- skos__hiddenLabel mesh__D015207 Osteoarthritides, Hip
% 216.49/216.65  |- skos__prefLabel mesh__D015207 Osteoarthritis, Hip
% 216.49/216.65  |- skos__altLabel mesh__D015207 Coxarthrosis
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D015207 2006
% 216.49/216.65  |- skos__broader mesh__D015207smesh__D010003
% 216.49/216.65  |- mesh__recordMaintainer mesh__D015207 ags
% 216.49/216.65  |- skos__hiddenLabel mesh__D015207 Hip Osteoarthritis
% 216.49/216.65  |- mesh__recordAuthorizer mesh__D015207 sjn
% 216.49/216.65  |- mesh__dateRevised mesh__D015207 2005-06-30
% 216.49/216.65  |- rdf__type mesh__D015207sskos__Concept
% 216.49/216.65  |- skos__historyNote mesh__D015207 Hip Joint %28%1966-1988%29%
% 216.49/216.65  |- mesh__publicMeSHNote mesh__D015207 89   
% 216.49/216.65  |- mesh__recordOriginator mesh__D015207 EC
% 216.49/216.65  |- skos__historyNote mesh__D015207 Hip %28%1966-1988%29%
% 216.49/216.65  |- skos__scopeNote mesh__D015207
% 216.49/216.65       Noninflammatory degenerative disease of the hip joint which usually appears in late middle or old age. It is characterized by growth or maturational disturbances in the femoral neck and head, as well as acetabular dysplasia. A dominant symptom is pain on weight-bearing or motion.%A%    
% 216.49/216.65  |- skos__historyNote mesh__D015207 Osteoarthritis %28%1966-1988%29%
% 216.49/216.65  |- skos__hiddenLabel mesh__D015207 Coxarthroses
% 216.49/216.65  |- mesh__historyNote mesh__D015207 89   
% 216.49/216.65  |- mesh__dateEstablished mesh__D015207 1989-01-01
% 216.49/216.65  |- skos__hiddenLabel mesh__D015207 Hip Osteoarthritides
% 216.49/216.65  |- mesh__dateCreated mesh__D015207 1988-05-02
% 216.49/216.65  |- skos__annotation mesh__D031672
% 216.49/216.65       X ref BROOM RAPE: several other Broom terms are also available; check text and MeSH; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.49/216.65  |- skos__altLabel mesh__D031672 Broom Rape
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D031672 2006
% 216.49/216.65  |- mesh__dateCreated mesh__D031672 2002-07-02
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D031672 2004
% 216.49/216.65  |- skos__altLabel mesh__D031672 Broomrape
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D031672 2005
% 216.49/216.65  |- skos__prefLabel mesh__D031672 Orobanche
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D031672 2003
% 216.49/216.65  |- skos__scopeNote mesh__D031672
% 216.49/216.65       A plant genus of the family OROBANCHACEAE. Lacking chlorophyll, they are nonphotosynthetic parasitic plants. The common name is similar to Broom or Scotch Broom %28%CYTISUS%29% or Butcher%27%s Broom %28%RUSCUS%29% or Desert Broom %28%BACCHARIS%29% or Spanish Broom %28%SPARTIUM%29% or Brome %28%BROMUS%29%.%A%    
% 216.49/216.65  |- mesh__dateEstablished mesh__D031672 2003-01-01
% 216.49/216.65  |- rdf__type mesh__D031672sskos__Concept
% 216.49/216.65  |- mesh__historyNote mesh__D031672 2003   
% 216.49/216.65  |- mesh__publicMeSHNote mesh__D031672 2003   
% 216.49/216.65  |- skos__broader mesh__D031672smesh__D031670
% 216.49/216.65  |- mesh__recordAuthorizer mesh__D003981 sjn
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D003981 2006
% 216.49/216.65  |- skos__prefLabel mesh__D003981 Diazoxide
% 216.49/216.65  |- mesh__dateRevised mesh__D003981 2005-06-30
% 216.49/216.65  |- skos__broader mesh__D003981smesh__D001581
% 216.49/216.65  |- mesh__historyNote mesh__D003981 67%28%63%29%   
% 216.49/216.65  |- skos__scopeNote mesh__D003981
% 216.49/216.65       A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.%A%    
% 216.49/216.65  |- mesh__dateCreated mesh__D003981 1999-01-01
% 216.49/216.65  |- mesh__publicMeSHNote mesh__D003981 67   
% 216.49/216.65  |- rdf__type mesh__D003981sskos__Concept
% 216.49/216.65  |- mesh__recordMaintainer mesh__D003981 ssb
% 216.49/216.65  |- mesh__recordOriginator mesh__D003981 NLM
% 216.49/216.65  |- mesh__dateEstablished mesh__D003981 1967-01-01
% 216.49/216.65  |- mesh__recordAuthorizer mesh__D003183 sjn
% 216.49/216.65  |- skos__scopeNote mesh__D003183
% 216.49/216.65       A 105-kDa serum glycoprotein with significant homology to the other late complement components, C7-C9. It is a polypeptide chain cross-linked by 32 disulfide bonds. C6 is the next complement component to bind to the membrane-bound COMPLEMENT C5B in the assembly of MEMBRANE ATTACK COMPLEX. It is encoded by gene C6.%A%    
% 216.49/216.65  |- skos__altLabel mesh__D003183 Complement 6
% 216.49/216.65  |- mesh__dateCreated mesh__D003183 1974-11-11
% 216.49/216.65  |- skos__altLabel mesh__D003183 C6 Complement
% 216.49/216.65  |- mesh__recordOriginator mesh__D003183 NLM
% 216.49/216.65  |- skos__altLabel mesh__D003183 Complement Component 6
% 216.49/216.65  |- mesh__historyNote mesh__D003183 2006 %28%1975%29%   
% 216.49/216.65  |- skos__historyNote mesh__D003183 Complement %28%1968-1974%29%
% 216.49/216.65  |- mesh__recordMaintainer mesh__D003183 lkt
% 216.49/216.65  |- mesh__dateRevised mesh__D003183 2005-06-30
% 216.49/216.65  |- skos__hiddenLabel mesh__D003183 Complement, C6
% 216.49/216.65  |- skos__hiddenLabel mesh__D003183 Component 6, Complement
% 216.49/216.65  |- skos__prefLabel mesh__D003183 Complement C6
% 216.49/216.65  |- mesh__dateEstablished mesh__D003183 1978-01-01
% 216.49/216.65  |- mesh__publicMeSHNote mesh__D003183
% 216.49/216.65       2006; see COMPLEMENT 6 1978-2005, see COMPLEMENT 1975-1977%A%  
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D003183 2006
% 216.49/216.65  |- skos__hiddenLabel mesh__D003183 C6, Complement
% 216.49/216.65  |- skos__broader mesh__D003183smesh__D003165
% 216.49/216.65  |- rdf__type mesh__D003183sskos__Concept
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011615 1999
% 216.49/216.65  |- rdf__type mesh__D011615sskos__Concept
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011615 1997
% 216.49/216.65  |- skos__scopeNote mesh__D011615
% 216.49/216.65       A form of therapy in which two or more patients participate under the guidance of one or more psychotherapists for the purpose of treating emotional disturbances, social maladjustments, and psychotic states.%A%    
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011615 2001
% 216.49/216.65  |- mesh__recordMaintainer mesh__D011615 TGC
% 216.49/216.65  |- mesh__dateCreated mesh__D011615 1999-01-01
% 216.49/216.65  |- mesh__recordOriginator mesh__D011615 NLM
% 216.49/216.65  |- skos__altLabel mesh__D011615 Group Psychotherapy
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011615 2002
% 216.49/216.65  |- skos__prefLabel mesh__D011615 Psychotherapy, Group
% 216.49/216.65  |- mesh__recordAuthorizer mesh__D011615 PLS
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011615 2005
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011615 2003
% 216.49/216.65  |- skos__annotation mesh__D011615
% 216.49/216.65       differentiate from multiple: group = more than one patient, multiple = more than one therapist; DF: PSYCHOTHER GROUP%A%  
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011615 2006
% 216.49/216.65  |- skos__altLabel mesh__D011615 Group Therapy
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011615 2004
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011615 1998
% 216.49/216.65  |- skos__broader mesh__D011615smesh__D012960
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011615 2000
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D011615 1996
% 216.49/216.65  |- mesh__dateRevised mesh__D011615 1995-05-31
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D016300 1998
% 216.49/216.65  |- mesh__dateRevised mesh__D016300 1997-06-20
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D016300 2000
% 216.49/216.65  |- skos__historyNote mesh__D016300 Radiography, Dental %28%1968-1990%29%
% 216.49/216.65  |- mesh__dateEstablished mesh__D016300 1991-01-01
% 216.49/216.65  |- skos__hiddenLabel mesh__D016300 Radiographies, Bitewing
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D016300 2004
% 216.49/216.65  |- mesh__publicMeSHNote mesh__D016300 91   
% 216.49/216.65  |- skos__broader mesh__D016300smesh__D011861
% 216.49/216.65  |- skos__annotation mesh__D016300
% 216.49/216.65       do not use /util except by MeSH definition; DF: RADIOGR BITEWING%A%  
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D016300 2006
% 216.49/216.65  |- mesh__recordMaintainer mesh__D016300 PXP
% 216.49/216.65  |- mesh__dateCreated mesh__D016300 1990-05-29
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D016300 2003
% 216.49/216.65  |- mesh__recordOriginator mesh__D016300 MXR
% 216.49/216.65  |- skos__altLabel mesh__D016300 Bitewing Radiography
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D016300 2005
% 216.49/216.65  |- mesh__recordAuthorizer mesh__D016300 SJN
% 216.49/216.65  |- skos__prefLabel mesh__D016300 Radiography, Bitewing
% 216.49/216.65  |- rdf__type mesh__D016300sskos__Concept
% 216.49/216.65  |- skos__scopeNote mesh__D016300
% 216.49/216.65       Technique involving the passage of X-rays through oral structures to create a film record while a central tab or wing of dental X-ray film is being held between upper and lower teeth.%A%    
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D016300 2002
% 216.49/216.65  |- mesh__historyNote mesh__D016300 91   
% 216.49/216.65  |- skos__hiddenLabel mesh__D016300 Bitewing Radiographies
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D016300 2001
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D016300 1999
% 216.49/216.65  |- mesh__recordOriginator mesh__D002889 SCD
% 216.49/216.65  |- mesh__dateEstablished mesh__D002889 1987-01-01
% 216.49/216.65  |- mesh__dateRevised mesh__D002889 2004-07-13
% 216.49/216.65  |- rdf__type mesh__D002889sskos__Concept
% 216.49/216.65  |- skos__historyNote mesh__D002889
% 216.49/216.65       Chromosomes, Human, 1-3 %28%1968-1986%29%
% 216.49/216.65  |- mesh__historyNote mesh__D002889 87   
% 216.49/216.65  |- skos__broader mesh__D002889smesh__D002900
% 216.49/216.65  |- mesh__recordAuthorizer mesh__D002889 sjn
% 216.49/216.65  |- skos__scopeNote mesh__D002889
% 216.49/216.65       A specific pair of human chromosomes in group A %28%CHROMOSOMES, HUMAN, 1-3%29% of the human chromosome classification.%A%    
% 216.49/216.65  |- mesh__recordMaintainer mesh__D002889 sjn
% 216.49/216.65  |- skos__prefLabel mesh__D002889 Chromosomes, Human, Pair 2
% 216.49/216.65  |- skos__altLabel mesh__D002889 Chromosome 2
% 216.49/216.65  |- mesh__publicMeSHNote mesh__D002889 87   
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D002889 2006
% 216.49/216.65  |- mesh__dateCreated mesh__D002889 1986-06-19
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D002889 2005
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D007574 2006
% 216.49/216.65  |- skos__hiddenLabel mesh__D007574 Bite Registrations
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D007574 1996
% 216.49/216.65  |- skos__annotation mesh__D007574 NIM; DF: JAW RELAT RECORD   
% 216.49/216.65  |- skos__prefLabel mesh__D007574 Jaw Relation Record
% 216.49/216.65  |- skos__altLabel mesh__D007574 Record, Jaw Relation
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D007574 2005
% 216.49/216.65  |- rdf__type mesh__D007574sskos__Concept
% 216.49/216.65  |- mesh__recordAuthorizer mesh__D007574 PLS
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D007574 2004
% 216.49/216.65  |- skos__hiddenLabel mesh__D007574 Registration, Bite
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D007574 2002
% 216.49/216.65  |- mesh__recordMaintainer mesh__D007574 PLS
% 216.49/216.65  |- skos__altLabel mesh__D007574 Records, Jaw Relation
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D007574 2003
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D007574 1999
% 216.49/216.65  |- skos__scopeNote mesh__D007574
% 216.49/216.65       A registration of any positional relationship of the mandible in reference to the maxillae. These records may be any of the many vertical, horizontal, or orientation relations. %28%Jablonski, Illustrated Dictionary of Dentistry%29%%A%    
% 216.49/216.65  |- skos__hiddenLabel mesh__D007574 Registrations, Bite
% 216.49/216.65  |- mesh__recordOriginator mesh__D007574 NLM
% 216.49/216.65  |- mesh__dateCreated mesh__D007574 1999-01-01
% 216.49/216.65  |- mesh__dateRevised mesh__D007574 1995-03-13
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D007574 2001
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D007574 1998
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D007574 2000
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D007574 1997
% 216.49/216.65  |- skos__hiddenLabel mesh__D007574 Jaw Relation Records
% 216.49/216.65  |- mesh__historyNote mesh__D007574 70   
% 216.49/216.65  |- mesh__dateEstablished mesh__D007574 1970-01-01
% 216.49/216.65  |- skos__broader mesh__D007574smesh__D003813
% 216.49/216.65  |- mesh__publicMeSHNote mesh__D007574 70   
% 216.49/216.65  |- skos__historyNote mesh__D007574 Dental Occlusion %28%1966-1969%29%
% 216.49/216.65  |- mesh__recordMaintainer mesh__D015208 TGC
% 216.49/216.65  |- mesh__dateRevised mesh__D015208 1995-02-23
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D015208 1999
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D015208 2003
% 216.49/216.65  |- skos__hiddenLabel mesh__D015208 Inhalation Injuries, Smoke
% 216.49/216.65  |- skos__altLabel mesh__D015208 Injury, Smoke Inhalation
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D015208 1998
% 216.49/216.65  |- skos__altLabel mesh__D015208 Inhalation Injury, Smoke
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D015208 2002
% 216.49/216.65  |- skos__hiddenLabel mesh__D015208 Injuries, Smoke Inhalation
% 216.49/216.65  |- skos__scopeNote mesh__D015208
% 216.49/216.65       Pulmonary injury following the breathing in of toxic smoke from burning materials such as plastics, synthetics, building materials, etc. This injury is the most frequent cause of death in burn patients.%A%    
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D015208 2006
% 216.49/216.65  |- mesh__recordOriginator mesh__D015208 EC
% 216.49/216.65  |- mesh__onlineNote mesh__D015208
% 216.49/216.65       search SMOKE INHALATION under BURNS, INHALATION 1966-88   
% 216.49/216.65  |- skos__historyNote mesh__D015208 Burns, Inhalation %28%1966-1988%29%
% 216.49/216.65  |- rdf__type mesh__D015208sskos__Concept
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D015208 2005
% 216.49/216.65  |- mesh__dateCreated mesh__D015208 1988-05-02
% 216.49/216.65  |- skos__annotation mesh__D015208
% 216.49/216.65       BURNS, INHALATION is also available; DF: SMOKE INHAL INJ   
% 216.49/216.65  |- mesh__publicMeSHNote mesh__D015208
% 216.49/216.65       89; was SMOKE INHALATION see BURNS, INHALATION 1963-88   
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D015208 1997
% 216.49/216.65  |- mesh__historyNote mesh__D015208
% 216.49/216.65       89; was SMOKE INHALATION see BURNS, INHALATION 1963-88   
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D015208 2001
% 216.49/216.65  |- mesh__recordAuthorizer mesh__D015208 PLS
% 216.49/216.65  |- skos__prefLabel mesh__D015208 Smoke Inhalation Injury
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D015208 1996
% 216.49/216.65  |- skos__hiddenLabel mesh__D015208 Smoke Inhalation Injuries
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D015208 2000
% 216.49/216.65  |- mesh__dateEstablished mesh__D015208 1989-01-01
% 216.49/216.65  |- skos__broader mesh__D015208smesh__D002059
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D015208 2004
% 216.49/216.65  |- skos__prefLabel mesh__D031673 Pandanaceae
% 216.49/216.65  |- mesh__publicMeSHNote mesh__D031673 2003   
% 216.49/216.65  |- skos__broader mesh__D031673smesh__D019684
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D031673 2006
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D031673 2004
% 216.49/216.65  |- mesh__dateCreated mesh__D031673 2002-07-03
% 216.49/216.65  |- mesh__activeMeSHYear mesh__D031673 2005
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D031673 2003
% 216.49/216.66  |- rdf__type mesh__D031673sskos__Concept
% 216.49/216.66  |- skos__scopeNote mesh__D031673
% 216.49/216.66       A plant family of the order Pandanales, subclass Arecidae, class Liliopsida %28%monocotyledons%29%.%A%    
% 216.49/216.66  |- mesh__dateEstablished mesh__D031673 2003-01-01
% 216.49/216.66  |- skos__annotation mesh__D031673
% 216.49/216.66       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.49/216.66  |- mesh__historyNote mesh__D031673 2003   
% 216.49/216.66  |- mesh__dateEstablished mesh__D003982 1991-01-01
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D003982 2005
% 216.49/216.66  |- skos__altLabel mesh__D003982 Dideoxykanamycin B
% 216.49/216.66  |- mesh__recordAuthorizer mesh__D003982 sjn
% 216.49/216.66  |- skos__hiddenLabel mesh__D003982 Sulfate, Dibekacin
% 216.49/216.66  |- mesh__onlineNote mesh__D003982
% 216.49/216.66       use DIBEKACIN to search DIDEOXYKANAMYCIN B 1975-84   
% 216.49/216.66  |- mesh__recordOriginator mesh__D003982 PLS
% 216.49/216.66  |- mesh__historyNote mesh__D003982
% 216.49/216.66       91%28%85%29%; was see under KANAMYCIN 1985-90; was DIDEOXYKANAMYCIN B see under KANAMYCIN 1975-84%A%  
% 216.49/216.66  |- skos__altLabel mesh__D003982 Dibekacin Sulphate
% 216.49/216.66  |- skos__hiddenLabel mesh__D003982 B, 3%27%,4%27%-Dideoxykanamycin
% 216.49/216.66  |- skos__hiddenLabel mesh__D003982 3%27%,4%27% Dideoxykanamycin B
% 216.49/216.66  |- mesh__dateCreated mesh__D003982 1974-11-19
% 216.49/216.66  |- skos__broader mesh__D003982smesh__D007612
% 216.49/216.66  |- skos__historyNote mesh__D003982 Kanamycin %28%1973-1974%29%
% 216.49/216.66  |- rdf__type mesh__D003982sskos__Concept
% 216.49/216.66  |- skos__prefLabel mesh__D003982 Dibekacin
% 216.49/216.66  |- skos__scopeNote mesh__D003982
% 216.49/216.66       Analog of KANAMYCIN with antitubercular as well as broad-spectrum antimicrobial properties.%A%    
% 216.49/216.66  |- mesh__dateRevised mesh__D003982 2004-07-07
% 216.49/216.66  |- skos__historyNote mesh__D003982 Deoxy Sugars %28%1974%29%
% 216.49/216.66  |- mesh__publicMeSHNote mesh__D003982
% 216.49/216.66       91; was see under KANAMYCIN 1985-90; was DIDEOXYKANAMYCIN B see under KANAMYCIN 1975-84%A%  
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D003982 2006
% 216.49/216.66  |- skos__altLabel mesh__D003982 3%27%,4%27%-Dideoxykanamycin B
% 216.49/216.66  |- skos__hiddenLabel mesh__D003982 Sulphate, Dibekacin
% 216.49/216.66  |- mesh__recordMaintainer mesh__D003982 ssb
% 216.49/216.66  |- skos__altLabel mesh__D003184 C7 Complement
% 216.49/216.66  |- skos__altLabel mesh__D003184 Complement 7
% 216.49/216.66  |- mesh__dateCreated mesh__D003184 1974-11-11
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D003184 2006A
% 216.49/216.66  |- skos__historyNote mesh__D003184 Chemotaxis %28%1966-1974%29%
% 216.49/216.66  |- mesh__dateRevised mesh__D003184 2005-07-19
% 216.49/216.66  |- skos__scopeNote mesh__D003184
% 216.49/216.66       A 93-kDa serum glycoprotein encoded by C7 gene. It is a polypeptide chain with 28 disulfide bridges. In the formation of MEMBRANE ATTACK COMPLEX; C7 is the next component to bind the C5b-6 complex forming a trimolecular complex C5b-7 which is lipophilic, resembles an integral membrane protein, and serves as an anchor for the late complement components, C8 and C9.%A%    
% 216.49/216.66  |- skos__hiddenLabel mesh__D003184 C7, Complement
% 216.49/216.66  |- skos__historyNote mesh__D003184 Complement %28%1968-1974%29%
% 216.49/216.66  |- skos__hiddenLabel mesh__D003184 Complement, C7
% 216.49/216.66  |- mesh__recordAuthorizer mesh__D003184 ags
% 216.49/216.66  |- skos__altLabel mesh__D003184 Complement Component 7
% 216.49/216.66  |- mesh__dateEstablished mesh__D003184 1978-01-01
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D003184 2006
% 216.49/216.66  |- mesh__recordOriginator mesh__D003184 NLM
% 216.49/216.66  |- skos__broader mesh__D003184smesh__D003165
% 216.49/216.66  |- mesh__historyNote mesh__D003184 2006 %28%1975%29%   
% 216.49/216.66  |- mesh__recordMaintainer mesh__D003184 ags
% 216.49/216.66  |- rdf__type mesh__D003184sskos__Concept
% 216.49/216.66  |- mesh__publicMeSHNote mesh__D003184
% 216.49/216.66       2006; see COMPLEMENT 7 1978-2005, see COMPLEMENT 1975-1977%A%  
% 216.49/216.66  |- skos__historyNote mesh__D003184 Neutrophils %28%1966-1974%29%
% 216.49/216.66  |- skos__hiddenLabel mesh__D003184 Component 7, Complement
% 216.49/216.66  |- skos__prefLabel mesh__D003184 Complement C7
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011616 1997
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011616 2002
% 216.49/216.66  |- mesh__dateCreated mesh__D011616 1999-01-01
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011616 2005
% 216.49/216.66  |- mesh__dateEstablished mesh__D011616 1973-01-01
% 216.49/216.66  |- skos__prefLabel mesh__D011616 Psychotherapy, Multiple
% 216.49/216.66  |- skos__annotation mesh__D011616
% 216.49/216.66       differentiate from group: multiple = more than one therapist, group = more than one patient; DF: PSYCHOTHER MULTIPLE%A%  
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011616 1999
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011616 1996
% 216.49/216.66  |- rdf__type mesh__D011616sskos__Concept
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011616 2001
% 216.49/216.66  |- mesh__dateRevised mesh__D011616 1995-05-31
% 216.49/216.66  |- mesh__recordAuthorizer mesh__D011616 PLS
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011616 2000
% 216.49/216.66  |- mesh__historyNote mesh__D011616 73   
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011616 1998
% 216.49/216.66  |- skos__scopeNote mesh__D011616
% 216.49/216.66       The use of more than one therapist at one time in individual or group psychotherapy.%A%    
% 216.49/216.66  |- skos__historyNote mesh__D011616 Psychotherapy %28%1966-1972%29%
% 216.49/216.66  |- skos__altLabel mesh__D011616 Multiple Psychotherapy
% 216.49/216.66  |- mesh__recordOriginator mesh__D011616 NLM
% 216.49/216.66  |- skos__hiddenLabel mesh__D011616 Multiple Psychotherapies
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011616 2004
% 216.49/216.66  |- skos__hiddenLabel mesh__D011616 Psychotherapies, Multiple
% 216.49/216.66  |- mesh__publicMeSHNote mesh__D011616 73   
% 216.49/216.66  |- skos__broader mesh__D011616smesh__D011613
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011616 2006
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011616 2003
% 216.49/216.66  |- mesh__recordMaintainer mesh__D011616 TGC
% 216.49/216.66  |- skos__historyNote mesh__D011616 Psychotherapy, Group %28%1966-1972%29%
% 216.49/216.66  |- mesh__dateEstablished mesh__D016301 1991-01-01
% 216.49/216.66  |- skos__broader mesh__D016301smesh__D010510
% 216.49/216.66  |- skos__hiddenLabel mesh__D016301 Loss, Periodontal Bone
% 216.49/216.66  |- skos__altLabel mesh__D016301 Periodontal Resorption
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D016301 2004
% 216.49/216.66  |- skos__altLabel mesh__D016301 Periodontal Bone Loss
% 216.49/216.66  |- mesh__recordAuthorizer mesh__D016301 sjn
% 216.49/216.66  |- skos__hiddenLabel mesh__D016301 Losses, Periodontal Bone
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D016301 2006
% 216.49/216.66  |- mesh__onlineNote mesh__D016301
% 216.49/216.66       use BONE RESORPTION to search ALVEOLAR BONE LOSS 1987-90   
% 216.49/216.66  |- mesh__recordOriginator mesh__D016301 MXR
% 216.49/216.66  |- skos__hiddenLabel mesh__D016301 Alveolar Resorptions
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D016301 2005
% 216.49/216.66  |- skos__hiddenLabel mesh__D016301 Resorptions, Alveolar
% 216.49/216.66  |- skos__altLabel mesh__D016301 Bone Loss, Periodontal
% 216.49/216.66  |- skos__hiddenLabel mesh__D016301 Bone Losses, Alveolar
% 216.49/216.66  |- mesh__recordMaintainer mesh__D016301 nns
% 216.49/216.66  |- rdf__type mesh__D016301sskos__Concept
% 216.49/216.66  |- skos__related mesh__D016301smesh__D001862
% 216.49/216.66  |- mesh__publicMeSHNote mesh__D016301
% 216.49/216.66       91; was see BONE RESORPTION 1987-90   
% 216.49/216.66  |- mesh__dateRevised mesh__D016301 2003-07-09
% 216.49/216.66  |- skos__hiddenLabel mesh__D016301 Periodontal Resorptions
% 216.49/216.66  |- skos__hiddenLabel mesh__D016301 Periodontal Bone Losses
% 216.49/216.66  |- skos__broader mesh__D016301smesh__D001862
% 216.49/216.66  |- skos__annotation mesh__D016301
% 216.49/216.66       coord IM with MANDIBULAR DISEASES or MAXILLARY DISEASES %28%IM or NIM%29%%A%  
% 216.49/216.66  |- mesh__historyNote mesh__D016301 91; was see BONE RESORPTION 1987-90   
% 216.49/216.66  |- skos__hiddenLabel mesh__D016301 Loss, Alveolar Bone
% 216.49/216.66  |- skos__hiddenLabel mesh__D016301 Bone Losses, Periodontal
% 216.49/216.66  |- skos__prefLabel mesh__D016301 Alveolar Bone Loss
% 216.49/216.66  |- skos__historyNote mesh__D016301 Bone Resorption %28%1966-1990%29%
% 216.49/216.66  |- skos__hiddenLabel mesh__D016301 Resorption, Alveolar
% 216.49/216.66  |- skos__hiddenLabel mesh__D016301 Resorptions, Periodontal
% 216.49/216.66  |- skos__altLabel mesh__D016301 Alveolar Resorption
% 216.49/216.66  |- skos__hiddenLabel mesh__D016301 Resorption, Periodontal
% 216.49/216.66  |- skos__hiddenLabel mesh__D016301 Alveolar Bone Losses
% 216.49/216.66  |- skos__altLabel mesh__D016301 Bone Loss, Alveolar
% 216.49/216.66  |- mesh__dateCreated mesh__D016301 1990-05-25
% 216.49/216.66  |- skos__scopeNote mesh__D016301
% 216.49/216.66       The resorption of bone in the supporting structures of the MAXILLA or MANDIBLE.%A%    
% 216.49/216.66  |- skos__hiddenLabel mesh__D016301 Losses, Alveolar Bone
% 216.49/216.66  |- skos__prefLabel mesh__D007575 Jaw, Edentulous
% 216.49/216.66  |- mesh__dateCreated mesh__D007575 1979-04-25
% 216.49/216.66  |- mesh__publicMeSHNote mesh__D007575
% 216.49/216.66       80; was included in MOUTH, EDENTULOUS 1965-79   
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D007575 2003
% 216.49/216.66  |- mesh__recordAuthorizer mesh__D007575 sjn
% 216.49/216.66  |- skos__broader mesh__D007575smesh__D007571
% 216.49/216.66  |- mesh__historyNote mesh__D007575
% 216.49/216.66       80; was included in MOUTH, EDENTULOUS 1965-79   
% 216.49/216.66  |- mesh__onlineNote mesh__D007575 search MOUTH, EDENTULOUS 1966-79   
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D007575 2004
% 216.49/216.66  |- skos__scopeNote mesh__D007575
% 216.49/216.66       The total absence of teeth from either the mandible or the maxilla, but not both. Total absence of teeth from both is MOUTH, EDENTULOUS. Partial absence of teeth in either is JAW, EDENTULOUS, PARTIALLY.%A%    
% 216.49/216.66  |- rdf__type mesh__D007575sskos__Concept
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D007575 2002
% 216.49/216.66  |- skos__hiddenLabel mesh__D007575 Jaws, Edentulous
% 216.49/216.66  |- mesh__dateEstablished mesh__D007575 1980-01-01
% 216.49/216.66  |- skos__broader mesh__D007575smesh__D009066
% 216.49/216.66  |- skos__hiddenLabel mesh__D007575 Edentulous Jaws
% 216.49/216.66  |- mesh__recordMaintainer mesh__D007575 jls
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D007575 2005
% 216.49/216.66  |- skos__annotation mesh__D007575
% 216.49/216.66       note category: do not confuse with ANODONTIA %28%see note there%29%; = total absence of teeth from mandible or maxilla; partial absence of teeth from mandible or maxilla = JAW, EDENTULOUS, PARTIALLY; total absence of teeth from both jaws = MOUTH, EDENTULOUS; coord IM with MANDIBLE %28%NIM%29% or MAXILLA %28%NIM%29%%A%  
% 216.49/216.66  |- mesh__dateRevised mesh__D007575 1999-11-03
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D007575 2000
% 216.49/216.66  |- mesh__recordOriginator mesh__D007575 SMH
% 216.49/216.66  |- skos__historyNote mesh__D007575 Mouth, Edentulous %28%1966-1979%29%
% 216.49/216.66  |- skos__hiddenLabel mesh__D007575 Edentulous Jaw
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D007575 2006
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D007575 2001
% 216.49/216.66  |- skos__hiddenLabel mesh__D015209 Cholangiitides, Sclerosing
% 216.49/216.66  |- skos__hiddenLabel mesh__D015209 Cholangitides, Sclerosing
% 216.49/216.66  |- skos__hiddenLabel mesh__D015209 Sclerosing Cholangiitides
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D015209 2006
% 216.49/216.66  |- skos__hiddenLabel mesh__D015209 Sclerosing Cholangitides
% 216.49/216.66  |- mesh__publicMeSHNote mesh__D015209 89   
% 216.49/216.66  |- rdf__type mesh__D015209sskos__Concept
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D015209 2005
% 216.49/216.66  |- skos__hiddenLabel mesh__D015209 Sclerosing Cholangitis
% 216.49/216.66  |- skos__hiddenLabel mesh__D015209 Sclerosing Cholangiitis
% 216.49/216.66  |- skos__prefLabel mesh__D015209 Cholangitis, Sclerosing
% 216.49/216.66  |- mesh__recordOriginator mesh__D015209 EC
% 216.49/216.66  |- mesh__historyNote mesh__D015209 89   
% 216.49/216.66  |- mesh__dateRevised mesh__D015209 2003-07-09
% 216.49/216.66  |- mesh__dateEstablished mesh__D015209 1989-01-01
% 216.49/216.66  |- mesh__dateCreated mesh__D015209 1988-05-04
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D015209 2004
% 216.49/216.66  |- skos__altLabel mesh__D015209 Cholangiitis, Sclerosing
% 216.49/216.66  |- skos__historyNote mesh__D015209 Cholangitis %28%1966-1988%29%
% 216.49/216.66  |- skos__scopeNote mesh__D015209
% 216.49/216.66       Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.%A%    
% 216.49/216.66  |- skos__broader mesh__D015209smesh__D002761
% 216.49/216.66  |- mesh__recordAuthorizer mesh__D015209 sjn
% 216.49/216.66  |- skos__historyNote mesh__D015209 Sclerosis %28%1966-1988%29%
% 216.49/216.66  |- mesh__recordMaintainer mesh__D015209 lkt
% 216.49/216.66  |- mesh__publicMeSHNote mesh__D031674 2003   
% 216.49/216.66  |- mesh__dateEstablished mesh__D031674 2003-01-01
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D031674 2005
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D031674 2003
% 216.49/216.66  |- skos__prefLabel mesh__D031674 Argemone
% 216.49/216.66  |- skos__scopeNote mesh__D031674
% 216.49/216.66       A plant genus of the family PAPAVERACEAE that contains isoquinoline alkaloids.%A%    
% 216.49/216.66  |- mesh__historyNote mesh__D031674 2003   
% 216.49/216.66  |- mesh__dateCreated mesh__D031674 2002-07-02
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D031674 2006
% 216.49/216.66  |- skos__broader mesh__D031674smesh__D028101
% 216.49/216.66  |- skos__altLabel mesh__D031674 Poppy, Prickly
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D031674 2004
% 216.49/216.66  |- rdf__type mesh__D031674sskos__Concept
% 216.49/216.66  |- skos__altLabel mesh__D031674 Prickly Poppy
% 216.49/216.66  |- skos__annotation mesh__D031674
% 216.49/216.66       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.49/216.66  |- skos__prefLabel mesh__D003983 Dibenzylchlorethamine
% 216.49/216.66  |- skos__altLabel mesh__D003983 Dibenzyl Chlorethylamine
% 216.49/216.66  |- skos__hiddenLabel mesh__D003983 Chlorethylamine, Dibenzyl
% 216.49/216.66  |- skos__scopeNote mesh__D003983 An alpha adrenergic antagonist.     
% 216.49/216.66  |- mesh__historyNote mesh__D003983 2005%28%1963%29%   
% 216.49/216.66  |- mesh__dateRevised mesh__D003983 2004-07-07
% 216.49/216.66  |- mesh__dateEstablished mesh__D003983 1966-01-01
% 216.49/216.66  |- rdf__type mesh__D003983sskos__Concept
% 216.49/216.66  |- mesh__recordOriginator mesh__D003983 NLM
% 216.49/216.66  |- mesh__publicMeSHNote mesh__D003983
% 216.49/216.66       2005; see SYMPATHOLYTICS 1963-1965, see DIBENAMINE 1966-2004%A%  
% 216.49/216.66  |- mesh__recordAuthorizer mesh__D003983 sjn
% 216.49/216.66  |- skos__broader mesh__D003983smesh__D005021
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D003983 2005
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D003983 2006
% 216.49/216.66  |- mesh__recordMaintainer mesh__D003983 jmp
% 216.49/216.66  |- mesh__dateCreated mesh__D003983 1999-01-01
% 216.49/216.66  |- mesh__dateCreated mesh__D050030 2005-06-30
% 216.49/216.66  |- mesh__recordMaintainer mesh__D050030 ags
% 216.49/216.66  |- mesh__recordAuthorizer mesh__D050030 ags
% 216.49/216.66  |- mesh__dateRevised mesh__D050030 2005-07-18
% 216.49/216.66  |- rdf__type mesh__D050030sskos__Concept
% 216.49/216.66  |- mesh__recordOriginator mesh__D050030 nns
% 216.49/216.66  |- skos__annotation mesh__D050030
% 216.49/216.66       do not confuse with ANDERSEN DISEASE see GLYCOGEN STORAGE DISEASE TYPE IV%A%  
% 216.49/216.66  |- mesh__publicMeSHNote mesh__D050030 2006   
% 216.49/216.66  |- skos__altLabel mesh__D050030 Long QT Syndrome 7
% 216.49/216.66  |- skos__broader mesh__D050030smesh__D020513
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D050030 2006
% 216.49/216.66  |- skos__prefLabel mesh__D050030 Andersen Syndrome
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D050030 2006A
% 216.49/216.66  |- mesh__dateEstablished mesh__D050030 2006-01-01
% 216.49/216.66  |- mesh__historyNote mesh__D050030 2006   
% 216.49/216.66  |- skos__hiddenLabel mesh__D050030 Syndrome, Andersen
% 216.49/216.66  |- skos__scopeNote mesh__D050030
% 216.49/216.66       A clinical triad consisting of potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. It results from mutations in the KCNJ2 gene which codes for the INWARD RECTIFIER POTASSIUM CHANNELS subfamily J, member 2 %28%KCNJ2 protein, human.%29%%A%    
% 216.49/216.66  |- skos__broader mesh__D050030smesh__D008133
% 216.49/216.66  |- skos__altLabel mesh__D003185 Complement Component C8 alpha Chain
% 216.49/216.66  |- mesh__dateEstablished mesh__D003185 1978-01-01
% 216.49/216.66  |- skos__altLabel mesh__D003185 C8 Complement
% 216.49/216.66  |- skos__historyNote mesh__D003185 Hemolysis %28%1966-1974%29%
% 216.49/216.66  |- skos__hiddenLabel mesh__D003185 C8, Complement
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D003185 2006
% 216.49/216.66  |- mesh__dateRevised mesh__D003185 2005-06-30
% 216.49/216.66  |- skos__broader mesh__D003185smesh__D003165
% 216.49/216.66  |- skos__historyNote mesh__D003185 Bacteriolysis %28%1966-1974%29%
% 216.49/216.66  |- mesh__publicMeSHNote mesh__D003185
% 216.49/216.66       2006; see COMPLEMENT 8 1978-2005; see COMPLEMENT 1975-1977%A%  
% 216.49/216.66  |- rdf__type mesh__D003185sskos__Concept
% 216.49/216.66  |- skos__prefLabel mesh__D003185 Complement C8
% 216.49/216.66  |- skos__hiddenLabel mesh__D003185 Component 8, Complement
% 216.49/216.66  |- skos__hiddenLabel mesh__D003185 Complement, C8
% 216.49/216.66  |- skos__scopeNote mesh__D003185
% 216.49/216.66       A 150-kDa serum glycoprotein composed of three subunits with each encoded by a different gene %28%C8A; C8B; and C8G%29%. This heterotrimer contains a disulfide-linked C8alpha-C8gamma heterodimer and a noncovalently associated C8beta chain. C8 is the next component to bind the C5-7 complex forming C5b-8 that binds COMPLEMENT C9 and acts as a catalyst in the polymerization of C9.%A%    
% 216.49/216.66  |- mesh__recordAuthorizer mesh__D003185 sjn
% 216.49/216.66  |- mesh__dateCreated mesh__D003185 1974-11-11
% 216.49/216.66  |- skos__altLabel mesh__D003185 Complement Component 8
% 216.49/216.66  |- skos__historyNote mesh__D003185 Complement %28%1968-1974%29%
% 216.49/216.66  |- mesh__historyNote mesh__D003185 2006 %28%1975%29%   
% 216.49/216.66  |- skos__altLabel mesh__D003185 Complement 8
% 216.49/216.66  |- mesh__recordMaintainer mesh__D003185 lkt
% 216.49/216.66  |- mesh__recordOriginator mesh__D003185 NLM
% 216.49/216.66  |- skos__altLabel mesh__D003185 Complement Component C8 gamma Chain
% 216.49/216.66  |- skos__altLabel mesh__D003185 Complement Component C8 beta Chain
% 216.49/216.66  |- skos__hiddenLabel mesh__D011617 Psychotherapies, Rational-Emotive
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011617 1999
% 216.49/216.66  |- skos__altLabel mesh__D011617 Rational Psychotherapy
% 216.49/216.66  |- mesh__dateEstablished mesh__D011617 1991-01-01
% 216.49/216.66  |- skos__hiddenLabel mesh__D011617 Rational Emotive Psychotherapy
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011617 1996
% 216.49/216.66  |- mesh__recordAuthorizer mesh__D011617 jls
% 216.49/216.66  |- skos__broader mesh__D011617smesh__D011613
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011617 1998
% 216.49/216.66  |- rdf__type mesh__D011617sskos__Concept
% 216.49/216.66  |- mesh__historyNote mesh__D011617
% 216.49/216.66       91%28%77%29%; was see under PSYCHOTHERAPY 1977-90   
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011617 2002
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011617 2005A
% 216.49/216.66  |- skos__historyNote mesh__D011617 Psychotherapy %28%1966-1976%29%
% 216.49/216.66  |- mesh__recordMaintainer mesh__D011617 jls
% 216.49/216.66  |- mesh__dateCreated mesh__D011617 1976-04-13
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011617 2001
% 216.49/216.66  |- skos__hiddenLabel mesh__D011617 Rational Psychotherapies
% 216.49/216.66  |- skos__altLabel mesh__D011617 Rational-Emotive Psychotherapy
% 216.49/216.66  |- skos__prefLabel mesh__D011617 Psychotherapy, Rational-Emotive
% 216.49/216.66  |- skos__altLabel mesh__D011617 Psychotherapy, Rational
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011617 2004
% 216.49/216.66  |- mesh__dateRevised mesh__D011617 2005-06-20
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011617 2000
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011617 2006
% 216.49/216.66  |- mesh__recordOriginator mesh__D011617 EC
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011617 2003
% 216.49/216.66  |- mesh__publicMeSHNote mesh__D011617
% 216.49/216.66       91; was see under PSYCHOTHERAPY 1977-90   
% 216.49/216.66  |- skos__annotation mesh__D011617 DF: PSYCHOTHER RATIONAL   
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011617 2005
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D011617 1997
% 216.49/216.66  |- skos__scopeNote mesh__D011617
% 216.49/216.66       The replacement of illogical and unrealistic ideas with more realistic and adaptive ones through direct intervention and confrontation by the therapist.%A%    
% 216.49/216.66  |- skos__hiddenLabel mesh__D011617 Psychotherapies, Rational
% 216.49/216.66  |- skos__hiddenLabel mesh__D011617 Rational-Emotive Psychotherapies
% 216.49/216.66  |- skos__hiddenLabel mesh__D011617 Psychotherapy, Rational Emotive
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D016302 2005
% 216.49/216.66  |- mesh__dateRevised mesh__D016302 1993-06-02
% 216.49/216.66  |- skos__broader mesh__D016302smesh__D007574
% 216.49/216.66  |- rdf__type mesh__D016302sskos__Concept
% 216.49/216.66  |- skos__historyNote mesh__D016302
% 216.49/216.66       Dental Occlusion, Centric %28%1966-1990%29%
% 216.49/216.66  |- mesh__onlineNote mesh__D016302
% 216.49/216.66       use DENTAL OCCLUSION, CENTRIC to search CENTRIC RELATION 1975-90%A%  
% 216.49/216.66  |- skos__annotation mesh__D016302 NIM; no qualif; DF: CENTRIC RELAT   
% 216.49/216.66  |- mesh__recordOriginator mesh__D016302 MXR
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D016302 1997
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D016302 2002
% 216.49/216.66  |- mesh__recordMaintainer mesh__D016302 TAP
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D016302 1999
% 216.49/216.66  |- mesh__dateCreated mesh__D016302 1990-05-25
% 216.49/216.66  |- skos__altLabel mesh__D016302 Relation, Dental Centric
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D016302 1996
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D016302 1995
% 216.49/216.66  |- skos__prefLabel mesh__D016302 Centric Relation
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D016302 2001
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D016302 1998
% 216.49/216.66  |- mesh__historyNote mesh__D016302
% 216.49/216.66       91; was see DENTAL OCCLUSION, CENTRIC 1975-90   
% 216.49/216.66  |- skos__altLabel mesh__D016302 Relation, Centric
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D016302 1994
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D016302 2004
% 216.49/216.66  |- skos__altLabel mesh__D016302 Centric Relation, Dental
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D016302 2000
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D016302 2006
% 216.49/216.66  |- mesh__dateEstablished mesh__D016302 1991-01-01
% 216.49/216.66  |- mesh__recordAuthorizer mesh__D016302 PLS
% 216.49/216.66  |- mesh__publicMeSHNote mesh__D016302
% 216.49/216.66       91; was see DENTAL OCCLUSION, CENTRIC 1975-90   
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D016302 2003
% 216.49/216.66  |- skos__scopeNote mesh__D016302
% 216.49/216.66       The location of the maxillary and the mandibular condyles when they are in their most posterior and superior positions in their fossae of the temporomandibular joint.%A%    
% 216.49/216.66  |- skos__altLabel mesh__D016302 Dental Centric Relation
% 216.49/216.66  |- skos__annotation mesh__D007576
% 216.49/216.66       see note on JAW, EDENTULOUS for definition; coord IM with MANDIBLE %28%NIM%29% or MAXILLA %28%NIM%29%%A%  
% 216.49/216.66  |- mesh__dateRevised mesh__D007576 1999-11-03
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D007576 2000
% 216.49/216.66  |- mesh__recordOriginator mesh__D007576 SMH
% 216.49/216.66  |- skos__broader mesh__D007576smesh__D007575
% 216.49/216.66  |- skos__historyNote mesh__D007576 Mouth, Edentulous %28%1966-1979%29%
% 216.49/216.66  |- mesh__onlineNote mesh__D007576 search MOUTH, EDENTULOUS 1966-79   
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D007576 2004
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D007576 2001
% 216.49/216.66  |- rdf__type mesh__D007576sskos__Concept
% 216.49/216.66  |- mesh__dateCreated mesh__D007576 1979-04-25
% 216.49/216.66  |- skos__prefLabel mesh__D007576 Jaw, Edentulous, Partially
% 216.49/216.66  |- mesh__dateEstablished mesh__D007576 1980-01-01
% 216.49/216.66  |- mesh__recordAuthorizer mesh__D007576 sjn
% 216.49/216.66  |- mesh__historyNote mesh__D007576
% 216.49/216.66       80; was included in MOUTH, EDENTULOUS 1965-79   
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D007576 2005
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D007576 2002
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D007576 2006
% 216.49/216.66  |- mesh__publicMeSHNote mesh__D007576
% 216.49/216.66       80; was included in MOUTH, EDENTULOUS 1965-79   
% 216.49/216.66  |- skos__scopeNote mesh__D007576
% 216.49/216.66       Absence of teeth from a portion of the mandible and/or maxilla.%A%    
% 216.49/216.66  |- mesh__recordMaintainer mesh__D007576 jls
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D007576 2003
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D012710 2006
% 216.49/216.66  |- mesh__recordOriginator mesh__D012710 NLM
% 216.49/216.66  |- skos__broader mesh__D012710smesh__D012709
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D012710 2004
% 216.49/216.66  |- mesh__recordAuthorizer mesh__D012710 PLS
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D012710 2005
% 216.49/216.66  |- skos__prefLabel mesh__D012710 Serum Albumin, Bovine
% 216.49/216.66  |- mesh__recordMaintainer mesh__D012710 TGC
% 216.49/216.66  |- rdf__type mesh__D012710sskos__Concept
% 216.49/216.66  |- skos__annotation mesh__D012710
% 216.49/216.66       serum albumin from cows used often in research   
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D012710 2001
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D012710 2003
% 216.49/216.66  |- skos__scopeNote mesh__D012710
% 216.49/216.66       Serum albumin from cows, commonly used in in vitro biological studies. %28%From Stedman, 25th ed%29%%A%    
% 216.49/216.66  |- skos__hiddenLabel mesh__D012710 Albumin, Bovine Serum
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D012710 2000
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D012710 1999
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D012710 1997
% 216.49/216.66  |- mesh__dateCreated mesh__D012710 1999-01-01
% 216.49/216.66  |- mesh__dateRevised mesh__D012710 1995-03-20
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D012710 1998
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D012710 2002
% 216.49/216.66  |- skos__hiddenLabel mesh__D012710 Bovine Serum Albumin
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D012710 1996
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D031675 2005
% 216.49/216.66  |- skos__altLabel mesh__D031675 Poppy, California
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D031675 2003
% 216.49/216.66  |- skos__prefLabel mesh__D031675 Eschscholzia
% 216.49/216.66  |- mesh__dateCreated mesh__D031675 2002-07-03
% 216.49/216.66  |- skos__broader mesh__D031675smesh__D028101
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D031675 2006
% 216.49/216.66  |- mesh__dateEstablished mesh__D031675 2003-01-01
% 216.49/216.66  |- mesh__activeMeSHYear mesh__D031675 2004
% 216.49/216.66  |- skos__scopeNote mesh__D031675
% 216.49/216.66       A plant genus of the family PAPAVERACEAE that contains benzo%5B%c%5D%phenanthridine alkaloids.%A%    
% 216.49/216.66  |- rdf__type mesh__D031675sskos__Concept
% 216.49/216.66  |- mesh__historyNote mesh__D031675 2003   
% 216.49/216.66  |- skos__annotation mesh__D031675
% 216.49/216.66       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.49/216.66  |- mesh__publicMeSHNote mesh__D031675 2003   
% 216.49/216.66  |- skos__broader mesh__D005916Q000097smesh__D005916
% 216.49/216.66  |- mesh__preferredCombination mesh__D005916Q000097smesh__D012712
% 216.49/216.66  |- rdf__type mesh__D005916Q000097smesh__CompoundConcept
% 216.49/216.66  |- skos__broader mesh__D003984smesh__D006575
% 216.49/216.66  |- skos__scopeNote mesh__D003984
% 216.49/216.66       Compounds with two BENZENE rings fused to AZEPINES.     
% 216.49/216.66  |- mesh__dateRevised mesh__D003984 2004-07-07
% 216.49/216.66  |- mesh__recordMaintainer mesh__D003984 ssb
% 216.49/216.66  |- skos__related mesh__D003984smesh__D001552
% 216.49/216.66  |- skos__prefLabel mesh__D003984 Dibenzazepines
% 216.49/216.67  |- rdf__type mesh__D003984sskos__Concept
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D003984 2005
% 216.49/216.67  |- mesh__publicMeSHNote mesh__D003984 68   
% 216.49/216.67  |- mesh__historyNote mesh__D003984 68   
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D003984 2006
% 216.49/216.67  |- mesh__recordOriginator mesh__D003984 NLM
% 216.49/216.67  |- mesh__dateCreated mesh__D003984 1999-01-01
% 216.49/216.67  |- skos__related mesh__D003984smesh__D001381
% 216.49/216.67  |- mesh__recordAuthorizer mesh__D003984 sjn
% 216.49/216.67  |- mesh__dateEstablished mesh__D003984 1968-01-01
% 216.49/216.67  |- mesh__dateEstablished mesh__D050031 2006-01-01
% 216.49/216.67  |- rdf__type mesh__D050031sskos__Concept
% 216.49/216.67  |- skos__prefLabel mesh__D050031 Hashimoto Disease
% 216.49/216.67  |- skos__hiddenLabel mesh__D050031 Thyroiditides, Hashimoto
% 216.49/216.67  |- skos__hiddenLabel mesh__D050031 Disease, Hashimoto%27%s
% 216.49/216.67  |- skos__hiddenLabel mesh__D050031 Thyroiditides, Chronic Lymphocytic
% 216.49/216.67  |- mesh__recordMaintainer mesh__D050031 lkt
% 216.49/216.67  |- skos__hiddenLabel mesh__D050031 Chronic Lymphocytic Thyroiditides
% 216.49/216.67  |- skos__hiddenLabel mesh__D050031 Lymphocytic Thyroiditides, Chronic
% 216.49/216.67  |- skos__hiddenLabel mesh__D050031 Hashimotos Disease
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D050031 2006
% 216.49/216.67  |- skos__altLabel mesh__D050031 Hashimoto%27%s Disease
% 216.49/216.67  |- mesh__publicMeSHNote mesh__D050031
% 216.49/216.67       2006; see THYROIDITIS, AUTOIMMUNE 1975-2005   
% 216.49/216.67  |- skos__hiddenLabel mesh__D050031 Thyroiditis, Chronic Lymphocytic
% 216.49/216.67  |- skos__hiddenLabel mesh__D050031 Lymphocytic Thyroiditis, Chronic
% 216.49/216.67  |- skos__altLabel mesh__D050031 Chronic Lymphocytic Thyroiditis
% 216.49/216.67  |- mesh__dateCreated mesh__D050031 2005-06-30
% 216.49/216.67  |- skos__hiddenLabel mesh__D050031 Hashimoto Thyroiditides
% 216.49/216.67  |- mesh__historyNote mesh__D050031
% 216.49/216.67       2006; use THYROIDITIS, AUTOIMMUNE 1975-2005   
% 216.49/216.67  |- skos__altLabel mesh__D050031 Hashimoto Thyroiditis
% 216.49/216.67  |- skos__broader mesh__D050031smesh__D013967
% 216.49/216.67  |- skos__hiddenLabel mesh__D050031 Disease, Hashimoto
% 216.49/216.67  |- skos__scopeNote mesh__D050031
% 216.49/216.67       Chronic autoimmune thyroiditis, characterized by the presence of high serum thyroid AUTOANTIBODIES; GOITER; and HYPOTHYROIDISM.%A%    
% 216.49/216.67  |- mesh__recordAuthorizer mesh__D050031 sjn
% 216.49/216.67  |- skos__hiddenLabel mesh__D050031 Thyroiditis, Hashimoto
% 216.49/216.67  |- mesh__recordOriginator mesh__D050031 lkt
% 216.49/216.67  |- skos__historyNote mesh__D050031
% 216.49/216.67       Thyroiditis, Autoimmune %28%1964-2005%29%
% 216.49/216.67  |- mesh__historyNote mesh__D003186 2006 %28%1975%29%   
% 216.49/216.67  |- mesh__recordMaintainer mesh__D003186 lkt
% 216.49/216.67  |- mesh__recordOriginator mesh__D003186 NLM
% 216.49/216.67  |- skos__scopeNote mesh__D003186
% 216.49/216.67       A 63-kDa serum glycoprotein encoded by gene C9. Monomeric C9 %28%mC9%29% binds the C5b-8 complex to form C5b-9 which catalyzes the polymerization of C9 forming C5b-p9 %28%MEMBRANE ATTACK COMPLEX%29% and transmembrane channels leading to lysis of the target cell. Patients with C9 deficiency suffer from recurrent bacterial infections.%A%    
% 216.49/216.67  |- rdf__type mesh__D003186sskos__Concept
% 216.49/216.67  |- skos__prefLabel mesh__D003186 Complement C9
% 216.49/216.67  |- skos__altLabel mesh__D003186 Complement 9
% 216.49/216.67  |- skos__historyNote mesh__D003186 Hemolysis %28%1966-1974%29%
% 216.49/216.67  |- mesh__dateCreated mesh__D003186 1974-11-11
% 216.49/216.67  |- mesh__dateRevised mesh__D003186 2005-06-30
% 216.49/216.67  |- skos__historyNote mesh__D003186 specific cell
% 216.49/216.67  |- skos__historyNote mesh__D003186 Bacteriolysis %28%1966-1974%29%
% 216.49/216.67  |- skos__hiddenLabel mesh__D003186 Component 9, Complement
% 216.49/216.67  |- skos__altLabel mesh__D003186 C9 Complement
% 216.49/216.67  |- skos__altLabel mesh__D003186 Complement Component 9
% 216.49/216.67  |- skos__historyNote mesh__D003186 Complement %28%1968-1974%29%
% 216.49/216.67  |- mesh__dateEstablished mesh__D003186 1978-01-01
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D003186 2006
% 216.49/216.67  |- mesh__recordAuthorizer mesh__D003186 sjn
% 216.49/216.67  |- skos__broader mesh__D003186smesh__D003165
% 216.49/216.67  |- skos__hiddenLabel mesh__D003186 C9, Complement
% 216.49/216.67  |- mesh__publicMeSHNote mesh__D003186
% 216.49/216.67       2006; see COMPLEMENT 9 1978-2005, see COMPLEMENT 1975-1977%A%  
% 216.49/216.67  |- skos__hiddenLabel mesh__D003186 Complement, C9
% 216.49/216.67  |- skos__hiddenLabel mesh__D011618 Disorders, Schizoaffective
% 216.49/216.67  |- mesh__onlineNote mesh__D011618
% 216.49/216.67       use PSYCHOTIC DISORDERS to search PSYCHOSES 1966-80   
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D011618 2000
% 216.49/216.67  |- skos__hiddenLabel mesh__D011618 Reactive Psychosis, Brief
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D011618 2004
% 216.49/216.67  |- skos__hiddenLabel mesh__D011618 Brief Reactive Psychosis
% 216.49/216.67  |- skos__hiddenLabel mesh__D011618 Psychotic Disorder
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D011618 2006
% 216.49/216.67  |- skos__hiddenLabel mesh__D011618 Disorders, Psychotic
% 216.49/216.67  |- mesh__recordOriginator mesh__D011618 NLM
% 216.49/216.67  |- skos__hiddenLabel mesh__D011618 Schizophreniform Disorder
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D011618 2003
% 216.49/216.67  |- skos__hiddenLabel mesh__D011618 Psychoses, Brief Reactive
% 216.49/216.67  |- skos__hiddenLabel mesh__D011618 Brief Reactive Psychoses
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D011618 2005
% 216.49/216.67  |- mesh__recordMaintainer mesh__D011618 jls
% 216.49/216.67  |- skos__hiddenLabel mesh__D011618 Schizoaffective Disorders
% 216.49/216.67  |- mesh__dateCreated mesh__D011618 1999-01-01
% 216.49/216.67  |- skos__hiddenLabel mesh__D011618 Disorder, Schizophreniform
% 216.49/216.67  |- skos__hiddenLabel mesh__D011618 Disorder, Schizoaffective
% 216.49/216.67  |- skos__prefLabel mesh__D011618 Psychotic Disorders
% 216.49/216.67  |- mesh__recordAuthorizer mesh__D011618 sjn
% 216.49/216.67  |- mesh__dateRevised mesh__D011618 1999-11-03
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D011618 2002
% 216.49/216.67  |- skos__hiddenLabel mesh__D011618 Reactive Psychoses, Brief
% 216.49/216.67  |- skos__scopeNote mesh__D011618
% 216.49/216.67       Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. %28%From DSM-IV, 1994%29%%A%    
% 216.49/216.67  |- skos__altLabel mesh__D011618 Psychoses
% 216.49/216.67  |- rdf__type mesh__D011618sskos__Concept
% 216.49/216.67  |- skos__hiddenLabel mesh__D011618 Disorders, Schizophreniform
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D011618 2001
% 216.49/216.67  |- skos__hiddenLabel mesh__D011618 Disorder, Psychotic
% 216.49/216.67  |- skos__broader mesh__D011618smesh__D019967
% 216.49/216.67  |- skos__annotation mesh__D011618
% 216.49/216.67       puerperal psychoses = PSYCHOTIC DISORDERS %28%IM%29% + PUERPERAL DISORDERS %28%IM%29%; psychoses or psychotic disord in children = CHILD DEVELOPMENT DISORDERS, PERVASIVE%A%  
% 216.49/216.67  |- mesh__publicMeSHNote mesh__D011618 81; was PSYCHOSES 1963-80   
% 216.49/216.67  |- mesh__historyNote mesh__D011618 81; was PSYCHOSES 1963-80   
% 216.49/216.67  |- skos__hiddenLabel mesh__D049288 Muscular Dystrophy, Limb Girdle
% 216.49/216.67  |- mesh__historyNote mesh__D049288
% 216.49/216.67       2005; use MUSCULAR DYSTROPHIES 2000-2004   
% 216.49/216.67  |- skos__prefLabel mesh__D049288 Muscular Dystrophies, Limb-Girdle
% 216.49/216.67  |- skos__altLabel mesh__D049288 Limb-Girdle Muscular Dystrophies
% 216.49/216.67  |- mesh__recordAuthorizer mesh__D049288 sjn
% 216.49/216.67  |- skos__scopeNote mesh__D049288
% 216.49/216.67       A heterogenous group of inherited muscular dystrophy that can be autosomal dominant or autosomal recessive. There are many forms %28%called LGMDs%29% involving genes encoding muscle membrane proteins such as the sarcoglycan %28%SARCOGLYCANS%29% complex that interacts with DYSTROPHIN. The disease is characterized by progressing wasting and weakness of the proximal muscles of arms and legs around the HIPS and SHOULDERS %28%the pelvic and shoulder girdles%29%.%A%    
% 216.49/216.67  |- mesh__dateCreated mesh__D049288 2004-07-07
% 216.49/216.67  |- mesh__publicMeSHNote mesh__D049288
% 216.49/216.67       2005; see MUSCULAR DYSTROPHIES 2000-2004   
% 216.49/216.67  |- mesh__dateEstablished mesh__D049288 2005-01-01
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D049288 2006
% 216.49/216.67  |- mesh__recordOriginator mesh__D049288 lkt
% 216.49/216.67  |- mesh__recordMaintainer mesh__D049288 ags
% 216.49/216.67  |- rdf__type mesh__D049288sskos__Concept
% 216.49/216.67  |- skos__hiddenLabel mesh__D049288 Muscular Dystrophies, Limb Girdle
% 216.49/216.67  |- skos__altLabel mesh__D049288 Muscular Dystrophy, Limb-Girdle
% 216.49/216.67  |- skos__hiddenLabel mesh__D049288 Limb Girdle Muscular Dystrophy
% 216.49/216.67  |- skos__broader mesh__D049288smesh__D009136
% 216.49/216.67  |- mesh__dateRevised mesh__D049288 2005-06-30
% 216.49/216.67  |- skos__historyNote mesh__D049288 Muscular Dystrophies %28%1966-2004%29%
% 216.49/216.67  |- skos__altLabel mesh__D049288 Limb-Girdle Muscular Dystrophy
% 216.49/216.67  |- skos__hiddenLabel mesh__D049288 Limb Girdle Muscular Dystrophies
% 216.49/216.67  |- mesh__publicMeSHNote mesh__D016303 91   
% 216.49/216.67  |- skos__prefLabel mesh__D016303 Clinical Pharmacy Information Systems
% 216.49/216.67  |- skos__broader mesh__D016303smesh__D006751
% 216.49/216.67  |- skos__altLabel mesh__D016303 Information Systems, Clinical Pharmacy
% 216.49/216.67  |- skos__scopeNote mesh__D016303
% 216.49/216.67       Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative activities associated with the provision and utilization of clinical pharmacy services.%A%    
% 216.49/216.67  |- mesh__recordOriginator mesh__D016303 JHM
% 216.49/216.67  |- mesh__dateRevised mesh__D016303 2005-06-30
% 216.49/216.67  |- mesh__recordMaintainer mesh__D016303 ags
% 216.49/216.67  |- mesh__dateCreated mesh__D016303 1990-05-25
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D016303 2006
% 216.49/216.67  |- mesh__dateEstablished mesh__D016303 1991-01-01
% 216.49/216.67  |- skos__annotation mesh__D016303 DF: CLIN PHARM INFORMATION SYSTEMS   
% 216.49/216.67  |- skos__broader mesh__D016303smesh__D008331
% 216.49/216.67  |- mesh__recordAuthorizer mesh__D016303 sjn
% 216.49/216.67  |- skos__broader mesh__D016303smesh__D004346
% 216.49/216.67  |- rdf__type mesh__D016303sskos__Concept
% 216.49/216.67  |- skos__related mesh__D016303smesh__D008510
% 216.49/216.67  |- mesh__historyNote mesh__D016303 91   
% 216.49/216.67  |- skos__historyNote mesh__D007577 Polyomaviruses %28%1971-1982%29%
% 216.49/216.67  |- mesh__historyNote mesh__D007577 2002, 1983-1993   
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007577 2002
% 216.49/216.67  |- mesh__dateRevised mesh__D007577 2001-08-03
% 216.49/216.67  |- mesh__recordOriginator mesh__D007577 RC
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007577 2005
% 216.49/216.67  |- skos__hiddenLabel mesh__D007577 Polyomavirus JC, Human
% 216.49/216.67  |- skos__prefLabel mesh__D007577 JC Virus
% 216.49/216.67  |- skos__annotation mesh__D007577
% 216.49/216.67       do not confuse with JAMESTOWN CANYON VIRUS %28%see ENCEPHALITIS VIRUS, CALIFORNIA%29%; infection: coord IM with POLYOMAVIRUS INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% but consider also LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL%A%  
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007577 2006
% 216.49/216.67  |- mesh__dateCreated mesh__D007577 1982-04-26
% 216.49/216.67  |- skos__scopeNote mesh__D007577
% 216.49/216.67       A species of POLYOMAVIRUS, originally isolated from the brain of a patient with progressive multifocal leukoencephalopathy. The patient%27%s initials J.C. gave the virus its name. Infection is not accompanied by any apparent illness but serious demyelinating disease can appear later, probably following reactivation of latent virus.%A%    
% 216.49/216.67  |- skos__historyNote mesh__D007577 Papovaviridae %28%1971-1982%29%
% 216.49/216.67  |- mesh__dateEstablished mesh__D007577 1991-01-01
% 216.49/216.67  |- skos__broader mesh__D007577smesh__D011120
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007577 2003
% 216.49/216.67  |- skos__altLabel mesh__D007577 Human Polyomavirus JC
% 216.49/216.67  |- rdf__type mesh__D007577sskos__Concept
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007577 2004
% 216.49/216.67  |- mesh__recordAuthorizer mesh__D007577 sjn
% 216.49/216.67  |- mesh__recordMaintainer mesh__D007577 sjn
% 216.49/216.67  |- mesh__publicMeSHNote mesh__D007577
% 216.49/216.67       2002; see POLYOMAVIRUS HOMINIS 2 1994-2001, see JC VIRUS 1983-93%A%  
% 216.49/216.67  |- skos__altLabel mesh__D007577 Polyomavirus, JC
% 216.49/216.67  |- skos__altLabel mesh__D007577 Polyomavirus hominis 2
% 216.49/216.67  |- skos__altLabel mesh__D007577 JC polyomavirus
% 216.49/216.67  |- skos__hiddenLabel mesh__D012711 Radioiodinated Serum Albumin
% 216.49/216.67  |- skos__prefLabel mesh__D012711 Serum Albumin, Radio-Iodinated
% 216.49/216.67  |- skos__altLabel mesh__D012711 Serum Albumin, Radioiodinated
% 216.49/216.67  |- skos__hiddenLabel mesh__D012711 Serum Albumin, Radio Iodinated
% 216.49/216.67  |- mesh__recordMaintainer mesh__D012711 sjn
% 216.49/216.67  |- mesh__dateCreated mesh__D012711 1999-01-01
% 216.49/216.67  |- mesh__recordOriginator mesh__D012711 NLM
% 216.49/216.67  |- mesh__recordAuthorizer mesh__D012711 sjn
% 216.49/216.67  |- skos__hiddenLabel mesh__D012711 Albumin, Radioiodinated Serum
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D012711 2006
% 216.49/216.67  |- skos__scopeNote mesh__D012711
% 216.49/216.67       Normal human serum albumin mildly iodinated with radioactive iodine %28%131-I%29% which has a half-life of 8 days, and emits beta and gamma rays. It is used as a diagnostic aid in blood volume determination. %28%from Merck Index, 11th ed%29%%A%    
% 216.49/216.67  |- skos__broader mesh__D012711smesh__D007457
% 216.49/216.67  |- skos__altLabel mesh__D012711 %28%131%29%I-MAA
% 216.49/216.67  |- mesh__dateRevised mesh__D012711 2004-07-13
% 216.49/216.67  |- skos__hiddenLabel mesh__D012711 Radio-Iodinated Serum Albumin
% 216.49/216.67  |- rdf__type mesh__D012711sskos__Concept
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D012711 2005
% 216.49/216.67  |- skos__broader mesh__D012711smesh__D012709
% 216.49/216.67  |- skos__hiddenLabel mesh__D012711 Albumin, Radio-Iodinated Serum
% 216.49/216.67  |- skos__annotation mesh__D012711 DF: RISA   
% 216.49/216.67  |- skos__broader mesh__D050830smesh__D000594
% 216.49/216.67  |- skos__hiddenLabel mesh__D050830 Oxidase, L-Amino Acid
% 216.49/216.67  |- skos__altLabel mesh__D050830
% 216.49/216.67       L-Amino Acid-Oxygen Oxidoreductase %28%Deaminating%29%
% 216.49/216.67  |- mesh__dateEstablished mesh__D050830 2006-01-01
% 216.49/216.67  |- mesh__recordAuthorizer mesh__D050830 sjn
% 216.49/216.67  |- skos__hiddenLabel mesh__D050830 Acid Oxidase, L-Amino
% 216.49/216.67  |- mesh__dateCreated mesh__D050830 2005-06-30
% 216.49/216.67  |- skos__prefLabel mesh__D050830 L-Amino Acid Oxidase
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D050830 2006
% 216.49/216.67  |- mesh__recordOriginator mesh__D050830 AKE
% 216.49/216.67  |- skos__hiddenLabel mesh__D050830 Ophio Amino Acid Oxidase
% 216.49/216.67  |- skos__altLabel mesh__D050830 Ophio-Amino-Acid Oxidase
% 216.49/216.67  |- skos__hiddenLabel mesh__D050830 Oxidase, Ophio-Amino-Acid
% 216.49/216.67  |- rdf__type mesh__D050830sskos__Concept
% 216.49/216.67  |- skos__hiddenLabel mesh__D050830 L Amino Acid Oxidase
% 216.49/216.67  |- mesh__historyNote mesh__D050830 2006%28%1974%29%   
% 216.49/216.67  |- skos__scopeNote mesh__D050830
% 216.49/216.67       An enzyme that catalyzes the oxidative deamination of L-amino acids to KETO ACIDS with the generation of AMMONIA and HYDROGEN PEROXIDE. L-amino acid oxidase is widely distributed in and is thought to contribute to the toxicity of SNAKE VENOMS.%A%    
% 216.49/216.67  |- mesh__recordMaintainer mesh__D050830 AKE
% 216.49/216.67  |- skos__altLabel mesh__D050830 Apoxin I
% 216.49/216.67  |- mesh__publicMeSHNote mesh__D050830
% 216.49/216.67       2006; L-AMINO ACID OXIDASE was indexed under AMINO ACID OXIDOREDUCTASES 1974-2004%A%  
% 216.49/216.67  |- skos__altLabel mesh__D050830 Apoxin-I
% 216.49/216.67  |- mesh__dateEstablished mesh__D050032 2006-01-01
% 216.49/216.67  |- skos__hiddenLabel mesh__D050032 Thyroiditis, Post-partum
% 216.49/216.67  |- mesh__publicMeSHNote mesh__D050032 2006   
% 216.49/216.67  |- mesh__historyNote mesh__D050032 2006   
% 216.49/216.67  |- skos__hiddenLabel mesh__D050032 Thyroiditides, Postpartum
% 216.49/216.67  |- skos__hiddenLabel mesh__D050032 Thyroiditides, Post-partum
% 216.49/216.67  |- mesh__recordMaintainer mesh__D050032 lkt
% 216.49/216.67  |- skos__hiddenLabel mesh__D050032 Post partum Thyroiditis
% 216.49/216.67  |- skos__scopeNote mesh__D050032
% 216.49/216.67       Transient autoimmune thyroiditis occurring in the POSTPARTUM PERIOD. It is characterized by the presence of high titers of AUTOANTIBODIES against THYROID PEROXIDASE and THYROGLOBULIN. Clinical signs include the triphasic thyroid hormone pattern: beginning with THYROTOXICOSIS, followed with HYPOTHYROIDISM, then return to euthyroid state by 1 year postpartum.%A%    
% 216.49/216.67  |- skos__altLabel mesh__D050032 Post-partum Thyroiditis
% 216.49/216.67  |- skos__broader mesh__D050032smesh__D011644
% 216.49/216.67  |- skos__annotation mesh__D050032 check the tag FEMALE   
% 216.49/216.67  |- skos__prefLabel mesh__D050032 Postpartum Thyroiditis
% 216.49/216.67  |- skos__hiddenLabel mesh__D050032 Post-partum Thyroiditides
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D050032 2006
% 216.49/216.67  |- mesh__dateCreated mesh__D050032 2005-06-30
% 216.49/216.67  |- mesh__recordAuthorizer mesh__D050032 sjn
% 216.49/216.67  |- skos__hiddenLabel mesh__D050032 Postpartum Thyroiditides
% 216.49/216.67  |- skos__historyNote mesh__D050032 Thyroiditis %28%1983-2005%29%
% 216.49/216.67  |- mesh__recordOriginator mesh__D050032 lkt
% 216.49/216.67  |- skos__hiddenLabel mesh__D050032 Thyroiditis, Postpartum
% 216.49/216.67  |- skos__broader mesh__D050032smesh__D013967
% 216.49/216.67  |- rdf__type mesh__D050032sskos__Concept
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D036361 2003
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D036361 2006
% 216.49/216.67  |- mesh__dateRevised mesh__D036361 2004-07-30
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D036361 2004
% 216.49/216.67  |- mesh__publicMeSHNote mesh__D036361 2003   
% 216.49/216.67  |- mesh__historyNote mesh__D036361 2003   
% 216.49/216.67  |- mesh__dateCreated mesh__D036361 2002-07-03
% 216.49/216.67  |- skos__related mesh__D036361smesh__D018000
% 216.49/216.67  |- skos__prefLabel mesh__D036361 Peptide Hormones
% 216.49/216.67  |- rdf__type mesh__D036361sskos__Concept
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D036361 2005A
% 216.49/216.67  |- mesh__recordMaintainer mesh__D036361 jls
% 216.49/216.67  |- skos__scopeNote mesh__D036361
% 216.49/216.67       Hormones synthesized from amino acids. They are distinguished from INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS in that their actions are systemic.%A%    
% 216.49/216.67  |- mesh__recordAuthorizer mesh__D036361 jls
% 216.49/216.67  |- mesh__recordOriginator mesh__D036361 jmp
% 216.49/216.67  |- skos__related mesh__D036361smesh__D036341
% 216.49/216.67  |- mesh__dateEstablished mesh__D036361 2003-01-01
% 216.49/216.67  |- skos__broader mesh__D036361smesh__D006728
% 216.49/216.67  |- skos__hiddenLabel mesh__D036361 Hormones, Polypeptide
% 216.49/216.67  |- skos__altLabel mesh__D036361 Hormones, Peptide
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D036361 2005
% 216.49/216.67  |- skos__broader mesh__D036361smesh__D010455
% 216.49/216.67  |- mesh__dateRevised mesh__D003187 2003-07-09
% 216.49/216.67  |- mesh__dateCreated mesh__D003187 1999-01-01
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D003187 2006
% 216.49/216.67  |- mesh__dateEstablished mesh__D003187 1991-01-01
% 216.49/216.67  |- skos__scopeNote mesh__D003187
% 216.49/216.67       Distensibility measure of a chamber such as the lungs %28%LUNG COMPLIANCE%29% or bladder. Compliance is expressed as a change in volume per unit change in pressure.%A%    
% 216.49/216.67  |- skos__annotation mesh__D003187
% 216.49/216.67       NIM; note category; LUNG COMPLIANCE is available; do not confuse with PATIENT COMPLIANCE%A%  
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D003187 2005
% 216.49/216.67  |- mesh__recordAuthorizer mesh__D003187 sjn
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D003187 2004
% 216.49/216.67  |- mesh__publicMeSHNote mesh__D003187
% 216.49/216.67       91; was see under ELASTICITY 1970-90   
% 216.49/216.67  |- rdf__type mesh__D003187sskos__Concept
% 216.49/216.67  |- mesh__onlineNote mesh__D003187
% 216.49/216.67       use ELASTICITY to search COMPLIANCE 1968-74 %28%as Prov 1968-69%29%%A%  
% 216.49/216.67  |- mesh__recordOriginator mesh__D003187 NLM
% 216.49/216.67  |- mesh__historyNote mesh__D003187
% 216.49/216.67       91%28%68%29%; was see under ELASTICITY 1968-90 %28%Prov 1968-69%29%   
% 216.49/216.67  |- mesh__recordMaintainer mesh__D003187 nns
% 216.49/216.67  |- skos__prefLabel mesh__D003187 Compliance
% 216.49/216.67  |- skos__broader mesh__D003187smesh__D004548
% 216.49/216.67  |- skos__hiddenLabel mesh__D011619 Drugs, Psychoactive
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D011619 2006
% 216.49/216.67  |- skos__altLabel mesh__D011619 Psychoactive Agents
% 216.49/216.67  |- skos__annotation mesh__D011619
% 216.49/216.67       GEN or unspecified; prefer specific groups or specific drugs; relation to PSYCHOPHARMACOLOGY: Manual 27.13%A%  
% 216.49/216.67  |- skos__altLabel mesh__D011619 Psychopharmaceuticals
% 216.49/216.67  |- mesh__dateCreated mesh__D011619 1999-01-01
% 216.49/216.67  |- mesh__recordMaintainer mesh__D011619 ssb
% 216.49/216.67  |- skos__hiddenLabel mesh__D011619 Drugs, Psychotropic
% 216.49/216.67  |- mesh__recordOriginator mesh__D011619 NLM
% 216.49/216.67  |- rdf__type mesh__D011619sskos__Concept
% 216.49/216.67  |- skos__altLabel mesh__D011619 Psychoactive Drugs
% 216.49/216.67  |- mesh__dateEstablished mesh__D011619 1975-01-01
% 216.49/216.67  |- mesh__publicMeSHNote mesh__D011619
% 216.49/216.67       75; was see under ANTIDEPRESSIVE AGENTS %26% TRANQUILIZING AGENTS 1974%A%  
% 216.49/216.67  |- mesh__onlineNote mesh__D011619
% 216.49/216.67       search ANTIDEPRESSIVE AGENTS %26% TRANQUILIZING AGENTS 1974   
% 216.49/216.67  |- mesh__historyNote mesh__D011619
% 216.49/216.67       75; was see under ANTIDEPRESSIVE AGENTS %26% TRANQUILIZING AGENTS 1974%A%  
% 216.49/216.67  |- mesh__dateRevised mesh__D011619 2005-06-30
% 216.49/216.67  |- skos__prefLabel mesh__D011619 Psychotropic Drugs
% 216.49/216.67  |- skos__broader mesh__D011619smesh__D002491
% 216.49/216.67  |- skos__hiddenLabel mesh__D011619 Agents, Psychoactive
% 216.49/216.67  |- mesh__recordAuthorizer mesh__D011619 sjn
% 216.49/216.67  |- skos__scopeNote mesh__D011619
% 216.49/216.67       A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents %28%including the antipsychotics and anti-anxiety agents%29%.%A%    
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D008670 1998
% 216.49/216.67  |- skos__broader mesh__D008670smesh__D007287
% 216.49/216.67  |- skos__scopeNote mesh__D008670
% 216.49/216.67       Electropositive chemical elements characterized by ductility, malleability, luster, and conductance of heat and electricity. They can replace the hydrogen of an acid and form bases with hydroxyl radicals. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 216.49/216.67  |- skos__annotation mesh__D008670
% 216.49/216.67       GEN only: prefer specific metal groups or specific metals; allergic reactions to metals is probably DERMATITIS, CONTACT, not DRUG HYPERSENSITIVITY%A%  
% 216.49/216.67  |- mesh__recordMaintainer mesh__D008670 JLS
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D008670 1999
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D008670 2003
% 216.49/216.67  |- mesh__onlineNote mesh__D008670 pre-explosion = METALS %28%PX%29%   
% 216.49/216.67  |- rdf__type mesh__D008670sskos__Concept
% 216.49/216.67  |- mesh__recordOriginator mesh__D008670 NLM
% 216.49/216.67  |- skos__prefLabel mesh__D008670 Metals
% 216.49/216.67  |- mesh__recordAuthorizer mesh__D008670 SJN
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D008670 2000
% 216.49/216.67  |- mesh__dateCreated mesh__D008670 1999-01-01
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D008670 2004
% 216.49/216.67  |- mesh__dateRevised mesh__D008670 1997-06-20
% 216.49/216.67  |- skos__related mesh__D008670smesh__D009942
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D008670 2001
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D008670 2005
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D008670 2002
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D008670 2006
% 216.49/216.67  |- mesh__dateRevised mesh__D022341 2005-06-30
% 216.49/216.67  |- mesh__recordOriginator mesh__D022341 ags
% 216.49/216.67  |- mesh__dateCreated mesh__D022341 2000-06-22
% 216.49/216.67  |- skos__prefLabel mesh__D022341 Yellow Fever Vaccine
% 216.49/216.67  |- mesh__publicMeSHNote mesh__D022341 2001   
% 216.49/216.67  |- mesh__recordMaintainer mesh__D022341 ssb
% 216.49/216.67  |- skos__broader mesh__D022341smesh__D014765
% 216.49/216.67  |- mesh__historyNote mesh__D022341 2001   
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D022341 2006
% 216.49/216.67  |- mesh__recordAuthorizer mesh__D022341 sjn
% 216.49/216.67  |- skos__hiddenLabel mesh__D022341 Fever Vaccine, Yellow
% 216.49/216.67  |- skos__scopeNote mesh__D022341
% 216.49/216.67       Vaccine used to prevent YELLOW FEVER. It consists of a live attenuated 17D strain of the YELLOW FEVER VIRUS.%A%    
% 216.49/216.67  |- skos__hiddenLabel mesh__D022341 Vaccine, Yellow Fever
% 216.49/216.67  |- rdf__type mesh__D022341sskos__Concept
% 216.49/216.67  |- mesh__dateEstablished mesh__D022341 2001-01-01
% 216.49/216.67  |- skos__historyNote mesh__D022341 Viral Vaccines %28%1965-2000%29%
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D049289 2006
% 216.49/216.67  |- rdf__type mesh__D049289sskos__Concept
% 216.49/216.67  |- skos__altLabel mesh__D049289 Hexosaminidase Activator
% 216.49/216.67  |- skos__altLabel mesh__D049289 GM2 Activator Protein
% 216.49/216.67  |- mesh__dateCreated mesh__D049289 2004-07-08
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D049289 2005
% 216.49/216.67  |- skos__scopeNote mesh__D049289
% 216.49/216.67       An essential cofactor for the degradation of G%28%M2%29%GANGLIOSIDE by lysosomal BETA-N-ACETYLHEXOSAMINIDASE. Genetic mutations resulting in loss of G%28%M2%29% activator protein are one of the causes of TAY-SACHS DISEASE, AB VARIANT.%A%    
% 216.49/216.67  |- skos__prefLabel mesh__D049289 G%28%M2%29% Activator Protein
% 216.49/216.67  |- mesh__recordAuthorizer mesh__D049289 sjn
% 216.49/216.67  |- mesh__dateEstablished mesh__D049289 2005-01-01
% 216.49/216.67  |- mesh__recordMaintainer mesh__D049289 jmp
% 216.49/216.67  |- skos__hiddenLabel mesh__D049289 Activator Protein, GM2
% 216.49/216.67  |- mesh__publicMeSHNote mesh__D049289
% 216.49/216.67       2005; G%28%M2%29% ACTIVATOR PROTEIN was indexed under PROTEINS 1983-2004%A%  
% 216.49/216.67  |- skos__historyNote mesh__D049289 Proteins %28%1983-2004%29%
% 216.49/216.67  |- mesh__recordOriginator mesh__D049289 jmp
% 216.49/216.67  |- skos__altLabel mesh__D049289 GM%28%2%29% Activating Protein
% 216.49/216.67  |- mesh__historyNote mesh__D049289 2005%28%1983%29%   
% 216.49/216.67  |- skos__broader mesh__D049289smesh__D049128
% 216.49/216.67  |- skos__prefLabel mesh__D016304 Hospitals, Private
% 216.49/216.67  |- mesh__dateEstablished mesh__D016304 1991-01-01
% 216.49/216.67  |- skos__hiddenLabel mesh__D016304 Hospital, Private
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D016304 2001
% 216.49/216.67  |- mesh__recordAuthorizer mesh__D016304 sjn
% 216.49/216.67  |- skos__historyNote mesh__D016304 Hospitals, Proprietary %28%1975-1990%29%
% 216.49/216.67  |- skos__hiddenLabel mesh__D016304 Private Hospital
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D016304 2003
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D016304 2005
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D016304 2004
% 216.49/216.67  |- skos__annotation mesh__D016304
% 216.49/216.67       non-government profit or not-for-profit; coord NIM with special hosp %28%e.g., HOSPITALS, CHRONIC DISEASE%29% or med specialty %28%IM or NIM%29% if pertinent; specify geog%A%  
% 216.49/216.67  |- mesh__publicMeSHNote mesh__D016304 91   
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D016304 2002
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D016304 2006
% 216.49/216.67  |- mesh__dateCreated mesh__D016304 1990-06-26
% 216.49/216.67  |- skos__broader mesh__D016304smesh__D006761
% 216.49/216.67  |- mesh__recordMaintainer mesh__D016304 kle
% 216.49/216.67  |- mesh__recordOriginator mesh__D016304 JHM
% 216.49/216.67  |- skos__altLabel mesh__D016304 Private Hospitals
% 216.49/216.67  |- skos__scopeNote mesh__D016304
% 216.49/216.67       A class of hospitals that includes profit or not-for-profit hospitals that are controlled by a legal entity other than a government agency. %28%Hospital Administration Terminology, AHA, 2d ed%29%%A%    
% 216.49/216.67  |- rdf__type mesh__D016304sskos__Concept
% 216.49/216.67  |- mesh__dateRevised mesh__D016304 1999-11-03
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D016304 2000
% 216.49/216.67  |- mesh__historyNote mesh__D016304 91   
% 216.49/216.67  |- skos__prefLabel mesh__D007578 Jealousy
% 216.49/216.67  |- mesh__recordMaintainer mesh__D007578 TGC
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007578 1997
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007578 1994
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007578 2006
% 216.49/216.67  |- mesh__recordAuthorizer mesh__D007578 PLS
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007578 2002
% 216.49/216.67  |- skos__scopeNote mesh__D007578
% 216.49/216.67       An irrational reaction compounded of grief, loss of self-esteem, enmity against the rival and self criticism.%A%    
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007578 1995
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007578 2003
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007578 1991
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007578 1998
% 216.49/216.67  |- mesh__dateCreated mesh__D007578 1999-01-01
% 216.49/216.67  |- skos__broader mesh__D007578smesh__D004644
% 216.49/216.67  |- mesh__dateRevised mesh__D007578 1989-04-28
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007578 1992
% 216.49/216.67  |- rdf__type mesh__D007578sskos__Concept
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007578 2004
% 216.49/216.67  |- skos__annotation mesh__D007578 human %26% animal; no qualif   
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007578 2000
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007578 1999
% 216.49/216.67  |- skos__hiddenLabel mesh__D007578 Jealousies
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007578 1993
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007578 2001
% 216.49/216.67  |- mesh__recordOriginator mesh__D007578 NLM
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007578 1996
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007578 2005
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D007578 1990
% 216.49/216.67  |- mesh__dateCreated mesh__D004280 1975-07-18
% 216.49/216.67  |- skos__altLabel mesh__D004280 Fresenius Brand of Dobutamine Hydrochloride
% 216.49/216.67  |- skos__altLabel mesh__D004280 Rovi Brand of Dobutamine Hydrochloride
% 216.49/216.67  |- mesh__historyNote mesh__D004280
% 216.49/216.67       86%28%76%29%; was see under CATECHOLAMINES 1976-85   
% 216.49/216.67  |- skos__hiddenLabel mesh__D004280 Hydrobromide, Dobutamine
% 216.49/216.67  |- mesh__activeMeSHYear mesh__D004280 2006
% 216.49/216.67  |- skos__broader mesh__D004280smesh__D002395
% 216.49/216.67  |- skos__historyNote mesh__D004280 Phenols %28%1974-1975%29%
% 216.49/216.67  |- mesh__recordAuthorizer mesh__D004280 sjn
% 216.49/216.68  |- skos__altLabel mesh__D004280 Inibsa Brand of Dobutamine Hydrochloride
% 216.49/216.68  |- mesh__dateEstablished mesh__D004280 1986-01-01
% 216.49/216.68  |- skos__hiddenLabel mesh__D004280 Dobutamin ratiopharm
% 216.49/216.68  |- skos__altLabel mesh__D004280 Juste Brand of Dobutamine Hydrochloride
% 216.49/216.68  |- skos__altLabel mesh__D004280 Solvay Brand of Dobutamine Hydrochloride
% 216.49/216.68  |- skos__altLabel mesh__D004280 Pisa Brand of Dobutamine Hydrochloride
% 216.49/216.68  |- skos__hiddenLabel mesh__D004280 Lactobionate, Dobutamine
% 216.49/216.68  |- skos__altLabel mesh__D004280
% 216.49/216.68       Dobutamine Tartrate %28%1:1%29%, %28%S-%28%R*,R*%29%%29%-Isomer
% 216.49/216.68  |- skos__hiddenLabel mesh__D004280 Tartrate, Dobutamine
% 216.49/216.68  |- skos__hiddenLabel mesh__D004280 Hydrochloride, Dobutamine
% 216.49/216.68  |- skos__altLabel mesh__D004280 Irisfarma Brand of Dobutamine Hydrochloride
% 216.49/216.68  |- skos__historyNote mesh__D004280 Catecholamines %28%1974-1975%29%
% 216.49/216.68  |- skos__scopeNote mesh__D004280
% 216.49/216.68       A beta-2 agonist catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after myocardial infarction or open heart surgery.%A%    
% 216.49/216.68  |- skos__altLabel mesh__D004280
% 216.49/216.68       ratiopharm Brand of Dobutamine Hydrochloride
% 216.49/216.68  |- mesh__dateRevised mesh__D004280 2005-06-30
% 216.49/216.68  |- skos__broader mesh__D004280smesh__D010627
% 216.49/216.68  |- skos__altLabel mesh__D004280 Hexal Brand of Dobutamine Hydrochloride
% 216.49/216.68  |- mesh__publicMeSHNote mesh__D004280
% 216.49/216.68       86; was see under CATECHOLAMINES 1976-85   
% 216.49/216.68  |- skos__altLabel mesh__D004280 Kendrick Brand of Dobutamine Hydrochloride
% 216.49/216.68  |- mesh__recordOriginator mesh__D004280 SH
% 216.49/216.68  |- skos__historyNote mesh__D004280 Phenethylamines %28%1974-1975%29%
% 216.49/216.68  |- rdf__type mesh__D004280sskos__Concept
% 216.49/216.68  |- skos__altLabel mesh__D004280 Eli Lilly Brand of Dobutamine Hydrochloride
% 216.49/216.68  |- mesh__recordMaintainer mesh__D004280 jls
% 216.49/216.68  |- skos__prefLabel mesh__D004280 Dobutamine
% 216.49/216.68  |- skos__altLabel mesh__D004280 Lilly Brand of Dobutamine Hydrochloride
% 216.49/216.68  |- skos__altLabel mesh__D004280
% 216.49/216.68       Boehringer Ingelheim Brand of Dobutamine Hydrochloride
% 216.49/216.68  |- mesh__dateEstablished mesh__D012712 1970-01-01
% 216.49/216.68  |- skos__broader mesh__D012712smesh__D001798
% 216.49/216.68  |- mesh__dateCreated mesh__D012712 1999-01-01
% 216.49/216.68  |- skos__scopeNote mesh__D012712
% 216.49/216.68       All blood proteins except albumin %28% = SERUM ALBUMIN, which is not a globulin%29% and FIBRINOGEN %28%which is not in the serum%29%. The serum globulins are subdivided into ALPHA-GLOBULINS; BETA-GLOBULINS; and GAMMA-GLOBULINS on the basis of their electrophoretic mobilities. %28%From Dorland, 28th ed%29%%A%    
% 216.49/216.68  |- mesh__recordMaintainer mesh__D012712 mdb
% 216.49/216.68  |- skos__broader mesh__D012712smesh__D005916
% 216.49/216.68  |- skos__prefLabel mesh__D012712 Serum Globulins
% 216.49/216.68  |- mesh__dateRevised mesh__D012712 2001-07-25
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D012712 2006
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D012712 2002
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D012712 2004
% 216.49/216.68  |- rdf__type mesh__D012712sskos__Concept
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D012712 2005
% 216.49/216.68  |- skos__hiddenLabel mesh__D012712 Globulins, Serum
% 216.49/216.68  |- mesh__publicMeSHNote mesh__D012712 70; was SERUM GLOBULIN 1963-69   
% 216.49/216.68  |- mesh__onlineNote mesh__D012712
% 216.49/216.68       use SERUM GLOBULINS to search SERUM GLOBULIN 1966-69   
% 216.49/216.68  |- mesh__recordOriginator mesh__D012712 NLM
% 216.49/216.68  |- mesh__historyNote mesh__D012712 70; was SERUM GLOBULIN 1963-69   
% 216.49/216.68  |- mesh__recordAuthorizer mesh__D012712 sjn
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D012712 2003
% 216.49/216.68  |- skos__annotation mesh__D012712
% 216.49/216.68       blood proteins; GEN or unspecified; prefer specific   
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D003986 2004
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D003986 1994
% 216.49/216.68  |- skos__prefLabel mesh__D003986 Dibenzocycloheptenes
% 216.49/216.68  |- mesh__historyNote mesh__D003986 68   
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D003986 2002
% 216.49/216.68  |- mesh__publicMeSHNote mesh__D003986 68   
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D003986 2005
% 216.49/216.68  |- mesh__dateCreated mesh__D003986 1999-01-01
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D003986 1995
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D003986 1996
% 216.49/216.68  |- skos__broader mesh__D003986smesh__D001567
% 216.49/216.68  |- mesh__recordAuthorizer mesh__D003986 PLS
% 216.49/216.68  |- skos__scopeNote mesh__D003986
% 216.49/216.68       A family of tricyclic hydrocarbons whose members include many of the commonly used tricyclic antidepressants %28%ANTIDEPRESSIVE AGENTS, TRICYCLIC%29%.%A%    
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D003986 2006
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D003986 1997
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D003986 1998
% 216.49/216.68  |- mesh__dateEstablished mesh__D003986 1968-01-01
% 216.49/216.68  |- mesh__recordMaintainer mesh__D003986 PLS
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D003986 2000
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D003986 2003
% 216.49/216.68  |- rdf__type mesh__D003986sskos__Concept
% 216.49/216.68  |- mesh__dateRevised mesh__D003986 1993-06-03
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D003986 1999
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D003986 2001
% 216.49/216.68  |- mesh__recordOriginator mesh__D003986 NLM
% 216.49/216.68  |- skos__scopeNote mesh__D050033
% 216.49/216.68       Defective development of the THYROID GLAND. This concept includes thyroid agenesis %28%aplasia%29%, hypoplasia, or an ectopic gland %28%LINGUAL THYROID%29%. Clinical signs usually are those of CONGENITAL HYPOTHYROIDISM.%A%    
% 216.49/216.68  |- mesh__dateEstablished mesh__D050033 2006-01-01
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D050033 2006
% 216.49/216.68  |- skos__hiddenLabel mesh__D050033 Agenesis, Thyroid
% 216.49/216.68  |- mesh__historyNote mesh__D050033 2006   
% 216.49/216.68  |- mesh__recordMaintainer mesh__D050033 lkt
% 216.49/216.68  |- skos__broader mesh__D050033smesh__D013959
% 216.49/216.68  |- mesh__recordOriginator mesh__D050033 lkt
% 216.49/216.68  |- skos__hiddenLabel mesh__D050033 Dysgenesis, Thyroid
% 216.49/216.68  |- skos__prefLabel mesh__D050033 Thyroid Dysgenesis
% 216.49/216.68  |- rdf__type mesh__D050033sskos__Concept
% 216.49/216.68  |- mesh__dateCreated mesh__D050033 2005-06-30
% 216.49/216.68  |- mesh__recordAuthorizer mesh__D050033 sjn
% 216.49/216.68  |- skos__historyNote mesh__D050033 Thyroid Gland %28%1966-2005%29%
% 216.49/216.68  |- skos__broader mesh__D050033smesh__D000013
% 216.49/216.68  |- mesh__publicMeSHNote mesh__D050033 2006   
% 216.49/216.68  |- skos__prefLabel mesh__D003188 Composite Resins
% 216.49/216.68  |- skos__historyNote mesh__D003188 Resins %28%1966-1971%29%
% 216.49/216.68  |- skos__historyNote mesh__D003188 Dental Materials %28%1966-1971%29%
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D003188 2005
% 216.49/216.68  |- skos__hiddenLabel mesh__D003188 Resins, Composite
% 216.49/216.68  |- mesh__recordMaintainer mesh__D003188 jmp
% 216.49/216.68  |- rdf__type mesh__D003188sskos__Concept
% 216.49/216.68  |- skos__scopeNote mesh__D003188
% 216.49/216.68       Synthetic resins, containing an inert filler, that are widely used in dentistry.%A%    
% 216.49/216.68  |- skos__broader mesh__D003188smesh__D003764
% 216.49/216.68  |- skos__broader mesh__D003188smesh__D012117
% 216.49/216.68  |- mesh__publicMeSHNote mesh__D003188 73   
% 216.49/216.68  |- mesh__recordAuthorizer mesh__D003188 sjn
% 216.49/216.68  |- mesh__dateRevised mesh__D003188 2004-07-07
% 216.49/216.68  |- mesh__recordOriginator mesh__D003188 NLM
% 216.49/216.68  |- mesh__dateEstablished mesh__D003188 1973-01-01
% 216.49/216.68  |- mesh__dateCreated mesh__D003188 1999-01-01
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D003188 2006
% 216.49/216.68  |- mesh__historyNote mesh__D003188 73%28%72%29%   
% 216.49/216.68  |- skos__altLabel mesh__D008671 Actinides
% 216.49/216.68  |- mesh__recordAuthorizer mesh__D008671 sjn
% 216.49/216.68  |- mesh__recordMaintainer mesh__D008671 jmp
% 216.49/216.68  |- mesh__recordOriginator mesh__D008671 RLS
% 216.49/216.68  |- skos__hiddenLabel mesh__D008671 Actinoid Metals
% 216.49/216.68  |- skos__broader mesh__D008671smesh__D004602
% 216.49/216.68  |- skos__annotation mesh__D008671 GEN: prefer specifics   
% 216.49/216.68  |- rdf__type mesh__D008671sskos__Concept
% 216.49/216.68  |- skos__altLabel mesh__D008671 Metals, Actinide
% 216.49/216.68  |- skos__hiddenLabel mesh__D008671 Elements, Actinoid Series
% 216.49/216.68  |- skos__hiddenLabel mesh__D008671 Actinide Metals
% 216.49/216.68  |- skos__prefLabel mesh__D008671 Actinoid Series Elements
% 216.49/216.68  |- mesh__dateRevised mesh__D008671 2005-06-30
% 216.49/216.68  |- mesh__publicMeSHNote mesh__D008671
% 216.49/216.68       2002; see METALS, ACTINIDE 1994-2001, see METALS, ACTINOID 1976-1993%A%  
% 216.49/216.68  |- mesh__dateCreated mesh__D008671 1975-07-18
% 216.49/216.68  |- mesh__dateEstablished mesh__D008671 1994-01-01
% 216.49/216.68  |- mesh__historyNote mesh__D008671 2002%28%1976%29%   
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D008671 2006
% 216.49/216.68  |- skos__scopeNote mesh__D008671
% 216.49/216.68       A series of radioactive elements from ACTINIUM, atomic number 89, to and including LAWRENCIUM, atomic number 103.%A%    
% 216.49/216.68  |- skos__broader mesh__D008671smesh__D008670
% 216.49/216.68  |- skos__altLabel mesh__D008671 Actinoids
% 216.49/216.68  |- skos__historyNote mesh__D008671 Metals %28%1966-1975%29%
% 216.49/216.68  |- skos__broader mesh__D008671smesh__D004603
% 216.49/216.68  |- skos__altLabel mesh__D008671 Metals, Actinoid
% 216.49/216.68  |- skos__altLabel mesh__D016305 TP-5
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D016305 2003
% 216.49/216.68  |- mesh__recordOriginator mesh__D016305 AGS
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D016305 2005
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D016305 2004
% 216.49/216.68  |- skos__scopeNote mesh__D016305
% 216.49/216.68       Synthetic pentapeptide corresponding to the amino acids 32-36 of thymopoietin and exhibiting the full biological activity of the natural hormone. It is an immunomodulator which has been studied for possible use in the treatment of rheumatoid arthritis, AIDS, and other primary immunodeficiencies.%A%    
% 216.49/216.68  |- skos__prefLabel mesh__D016305 Thymopentin
% 216.49/216.68  |- mesh__recordAuthorizer mesh__D016305 sjn
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D016305 2006
% 216.49/216.68  |- mesh__dateCreated mesh__D016305 1990-05-29
% 216.49/216.68  |- skos__broader mesh__D016305smesh__D013946
% 216.49/216.68  |- mesh__recordMaintainer mesh__D016305 ssb
% 216.49/216.68  |- rdf__type mesh__D016305sskos__Concept
% 216.49/216.68  |- skos__historyNote mesh__D016305 Peptide Fragments %28%1981-1990%29%
% 216.49/216.68  |- skos__historyNote mesh__D016305 Oligopeptides %28%1980-1981%29%
% 216.49/216.68  |- skos__altLabel mesh__D016305 Thymopoietin Pentapeptide
% 216.49/216.68  |- mesh__publicMeSHNote mesh__D016305 91   
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D016305 2002
% 216.49/216.68  |- mesh__historyNote mesh__D016305 91   
% 216.49/216.68  |- mesh__dateRevised mesh__D016305 2001-07-25
% 216.49/216.68  |- skos__historyNote mesh__D016305 Thymopoietins %28%1981-1990%29%
% 216.49/216.68  |- mesh__dateEstablished mesh__D016305 1991-01-01
% 216.49/216.68  |- skos__hiddenLabel mesh__D016305 Pentapeptide, Thymopoietin
% 216.49/216.68  |- skos__prefLabel mesh__D046790 Pancreas, Exocrine
% 216.49/216.68  |- skos__scopeNote mesh__D046790
% 216.49/216.68       The major component %28%about 80%25%%29% of the PANCREAS composed of acinar functional units of tubular and spherical cells. The acinar cells synthesize and secrete several digestive enzymes such as TRYPSINOGEN; LIPASE; AMYLASE; and RIBONUCLEASE. Secretion from the exocrine pancreas drains into the pancreatic ductal system and empties into the DUODENUM.%A%    
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D046790 2006
% 216.49/216.68  |- skos__broader mesh__D046790smesh__D010179
% 216.49/216.68  |- rdf__type mesh__D046790sskos__Concept
% 216.49/216.68  |- mesh__recordAuthorizer mesh__D046790 sjn
% 216.49/216.68  |- mesh__recordMaintainer mesh__D046790 lkt
% 216.49/216.68  |- skos__broader mesh__D046790smesh__D005088
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D046790 2005
% 216.49/216.68  |- mesh__recordOriginator mesh__D046790 lkt
% 216.49/216.68  |- mesh__dateEstablished mesh__D046790 2005-01-01
% 216.49/216.68  |- mesh__dateCreated mesh__D046790 2004-07-07
% 216.49/216.68  |- mesh__historyNote mesh__D046790 2005; use PANCREAS 1998-2004   
% 216.49/216.68  |- skos__historyNote mesh__D046790 Pancreas %28%1965-2004%29%
% 216.49/216.68  |- skos__altLabel mesh__D046790 Exocrine Pancreas
% 216.49/216.68  |- mesh__publicMeSHNote mesh__D046790 2005; see PANCREAS 1998-2004   
% 216.49/216.68  |- mesh__dateCreated mesh__D007579 1979-04-27
% 216.49/216.68  |- mesh__recordOriginator mesh__D007579 SMH
% 216.49/216.68  |- mesh__recordMaintainer mesh__D007579 lkt
% 216.49/216.68  |- mesh__dateRevised mesh__D007579 2003-07-09
% 216.49/216.68  |- skos__historyNote mesh__D007579 specific intestinal disease
% 216.49/216.68  |- skos__hiddenLabel mesh__D007579 Diseases, Jejunal
% 216.49/216.68  |- skos__hiddenLabel mesh__D007579 Disease, Jejunal
% 216.49/216.68  |- skos__scopeNote mesh__D007579
% 216.49/216.68       Pathological development in the JEJUNUM region of the SMALL INTESTINE.%A%    
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D007579 2006
% 216.49/216.68  |- mesh__recordAuthorizer mesh__D007579 sjn
% 216.49/216.68  |- mesh__publicMeSHNote mesh__D007579 80   
% 216.49/216.68  |- skos__historyNote mesh__D007579 Jejunum %28%1966-1979%29%
% 216.49/216.68  |- skos__hiddenLabel mesh__D007579 Jejunal Disease
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D007579 2004
% 216.49/216.68  |- mesh__historyNote mesh__D007579 80   
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D007579 2005
% 216.49/216.68  |- skos__annotation mesh__D007579
% 216.49/216.68       inflamm dis or jejunitis: coord IM with ENTERITIS %28%IM%29%   
% 216.49/216.68  |- skos__prefLabel mesh__D007579 Jejunal Diseases
% 216.49/216.68  |- rdf__type mesh__D007579sskos__Concept
% 216.49/216.68  |- skos__historyNote mesh__D007579 Intestinal Diseases %28%1966-1979%29%
% 216.49/216.68  |- skos__broader mesh__D007579smesh__D007410
% 216.49/216.68  |- mesh__dateEstablished mesh__D007579 1980-01-01
% 216.49/216.68  |- skos__hiddenLabel mesh__D004281 Acids, Docosahexenoic
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D004281 2006
% 216.49/216.68  |- mesh__recordOriginator mesh__D004281 RLS
% 216.49/216.68  |- skos__hiddenLabel mesh__D004281 Acids, Docosahexaenoic
% 216.49/216.68  |- mesh__recordMaintainer mesh__D004281 ssb
% 216.49/216.68  |- skos__historyNote mesh__D004281 Fatty Acids %28%1966-1972%29%
% 216.49/216.68  |- mesh__publicMeSHNote mesh__D004281 88   
% 216.49/216.68  |- skos__altLabel mesh__D004281 Docosahexenoic Acids
% 216.49/216.68  |- mesh__recordAuthorizer mesh__D004281 sjn
% 216.49/216.68  |- rdf__type mesh__D004281sskos__Concept
% 216.49/216.68  |- skos__historyNote mesh__D004281
% 216.49/216.68       Fatty Acids, Unsaturated %28%1973-1987%29%
% 216.49/216.68  |- skos__broader mesh__D004281smesh__D015525
% 216.49/216.68  |- skos__prefLabel mesh__D004281 Docosahexaenoic Acids
% 216.49/216.68  |- mesh__dateRevised mesh__D004281 2005-06-30
% 216.49/216.68  |- mesh__historyNote mesh__D004281 88   
% 216.49/216.68  |- skos__scopeNote mesh__D004281
% 216.49/216.68       C22-unsaturated fatty acids found predominantly in FISH OILS.%A%    
% 216.49/216.68  |- mesh__dateEstablished mesh__D004281 1988-01-01
% 216.49/216.68  |- mesh__dateCreated mesh__D004281 1987-03-31
% 216.49/216.68  |- skos__hiddenLabel mesh__D012713 Sickness, Serum
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D012713 1999
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D012713 2000
% 216.49/216.68  |- mesh__recordOriginator mesh__D012713 NLM
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D012713 1997
% 216.49/216.68  |- mesh__dateRevised mesh__D012713 1993-06-03
% 216.49/216.68  |- skos__broader mesh__D012713smesh__D003875
% 216.49/216.68  |- skos__hiddenLabel mesh__D012713 Sicknesses, Serum
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D012713 2005
% 216.49/216.68  |- skos__scopeNote mesh__D012713
% 216.49/216.68       Immune complex disease caused by the administration of foreign serum or serum proteins and characterized by fever, lymphadenopathy, arthralgia, and urticaria. When they are complexed to protein carriers, some drugs can also cause serum sickness when they act as haptens inducing antibody responses.%A%    
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D012713 2001
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D012713 2003
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D012713 2006
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D012713 2002
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D012713 2004
% 216.49/216.68  |- mesh__recordMaintainer mesh__D012713 TGC
% 216.49/216.68  |- rdf__type mesh__D012713sskos__Concept
% 216.49/216.68  |- skos__hiddenLabel mesh__D012713 Serum Sicknesses
% 216.49/216.68  |- skos__broader mesh__D012713smesh__D007105
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D012713 1994
% 216.49/216.68  |- mesh__recordAuthorizer mesh__D012713 PLS
% 216.49/216.68  |- mesh__dateCreated mesh__D012713 1999-01-01
% 216.49/216.68  |- skos__annotation mesh__D012713 an immune complex dis   
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D012713 1998
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D012713 1995
% 216.49/216.68  |- skos__prefLabel mesh__D012713 Serum Sickness
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D012713 1996
% 216.49/216.68  |- rdf__type mesh__D050832sskos__Concept
% 216.49/216.68  |- skos__broader mesh__D050832smesh__D048868
% 216.49/216.68  |- skos__hiddenLabel mesh__D050832 IFN Stimulated Gene Factor 3 Complex
% 216.49/216.68  |- skos__prefLabel mesh__D050832 Interferon-Stimulated Gene Factor 3
% 216.49/216.68  |- skos__broader mesh__D050832smesh__D014157
% 216.49/216.68  |- mesh__recordMaintainer mesh__D050832 DRC
% 216.49/216.68  |- mesh__publicMeSHNote mesh__D050832
% 216.49/216.68       2006; INTERFERON-STIMULATED GENE FACTOR 3 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005%A%  
% 216.49/216.68  |- mesh__dateEstablished mesh__D050832 2006-01-01
% 216.49/216.68  |- skos__hiddenLabel mesh__D050832 Interferon Stimulated Gene Factor 3
% 216.49/216.68  |- skos__broader mesh__D050832smesh__D004268
% 216.49/216.68  |- skos__scopeNote mesh__D050832
% 216.49/216.68       A multimeric complex that functions as a ligand-dependent transcription factor. ISGF3 is assembled in the CYTOPLASM and translocated to the CELL NUCLEUS in response to INTERFERON signaling. It consists of ISGF3-GAMMA and ISGF3-ALPHA, and it regulates expression of many interferon-responsive GENES.%A%    
% 216.49/216.68  |- skos__altLabel mesh__D050832 IFN-Stimulated Gene Factor 3 Complex
% 216.49/216.68  |- skos__altLabel mesh__D050832 ISGF3 Factor
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D050832 2006
% 216.49/216.68  |- mesh__recordOriginator mesh__D050832 DRC
% 216.49/216.68  |- skos__altLabel mesh__D050832 Transcription Factor ISGF3
% 216.49/216.68  |- skos__altLabel mesh__D050832 ISGF3 Transcription Factor
% 216.49/216.68  |- mesh__dateCreated mesh__D050832 2005-06-30
% 216.49/216.68  |- mesh__recordAuthorizer mesh__D050832 sjn
% 216.49/216.68  |- mesh__historyNote mesh__D050832 2006%28%1990%29%   
% 216.49/216.68  |- skos__hiddenLabel mesh__D050832 Transcription Factor, ISGF3
% 216.49/216.68  |- skos__hiddenLabel mesh__D050832 ISGF3, Transcription Factor
% 216.49/216.68  |- mesh__publicMeSHNote mesh__D003987 68   
% 216.49/216.68  |- mesh__dateCreated mesh__D003987 1999-01-01
% 216.49/216.68  |- mesh__recordOriginator mesh__D003987 NLM
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D003987 2006
% 216.49/216.68  |- mesh__historyNote mesh__D003987 68   
% 216.49/216.68  |- skos__broader mesh__D003987smesh__D006575
% 216.49/216.68  |- mesh__recordAuthorizer mesh__D003987 sjn
% 216.49/216.68  |- mesh__dateEstablished mesh__D003987 1968-01-01
% 216.49/216.68  |- rdf__type mesh__D003987sskos__Concept
% 216.49/216.68  |- mesh__recordMaintainer mesh__D003987 ssb
% 216.49/216.68  |- skos__broader mesh__D003987smesh__D013841
% 216.49/216.68  |- mesh__dateRevised mesh__D003987 2005-06-30
% 216.49/216.68  |- skos__prefLabel mesh__D003987 Dibenzothiazepines
% 216.49/216.68  |- rdf__type mesh__D050034sskos__Concept
% 216.49/216.68  |- skos__broader mesh__D050034smesh__D045283
% 216.49/216.68  |- skos__altLabel mesh__D050034 Anti-Diuretic Agents
% 216.49/216.68  |- mesh__recordMaintainer mesh__D050034 ssb
% 216.49/216.68  |- skos__hiddenLabel mesh__D050034 Agents, Antidiuretic
% 216.49/216.68  |- mesh__recordAuthorizer mesh__D050034 sjn
% 216.49/216.68  |- skos__historyNote mesh__D050034 Diuretics %28%1965-2005%29%
% 216.49/216.68  |- skos__hiddenLabel mesh__D050034 Agents, Anti-Diuretic
% 216.49/216.68  |- skos__hiddenLabel mesh__D050034 Anti Diuretic Agents
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D050034 2006
% 216.49/216.68  |- skos__prefLabel mesh__D050034 Antidiuretic Agents
% 216.49/216.68  |- mesh__publicMeSHNote mesh__D050034 2006   
% 216.49/216.68  |- mesh__dateCreated mesh__D050034 2005-06-30
% 216.49/216.68  |- mesh__historyNote mesh__D050034 2006   
% 216.49/216.68  |- skos__scopeNote mesh__D050034
% 216.49/216.68       Agents that reduce the excretion of URINE, most notably the octapeptide VASOPRESSINS.%A%    
% 216.49/216.68  |- mesh__recordOriginator mesh__D050034 ssb
% 216.49/216.68  |- mesh__dateEstablished mesh__D050034 2006-01-01
% 216.49/216.68  |- skos__hiddenLabel mesh__D003189 BW 4880
% 216.49/216.68  |- skos__hiddenLabel mesh__D003189 Preparation 4880
% 216.49/216.68  |- mesh__recordOriginator mesh__D003189 NLM
% 216.49/216.68  |- skos__hiddenLabel mesh__D003189 p Methoxy N methylphenethylamine
% 216.49/216.68  |- skos__altLabel mesh__D003189 BW 48-80
% 216.49/216.68  |- mesh__historyNote mesh__D003189 2001%28%1963%29%   
% 216.49/216.68  |- skos__altLabel mesh__D003189 Agent 48-80
% 216.49/216.68  |- skos__hiddenLabel mesh__D003189 Compound 4880
% 216.49/216.68  |- skos__hiddenLabel mesh__D003189 Agent 48 80
% 216.49/216.68  |- mesh__dateRevised mesh__D003189 2005-06-30
% 216.49/216.68  |- skos__hiddenLabel mesh__D003189 Preparation 48 80
% 216.49/216.68  |- skos__hiddenLabel mesh__D003189 Compound 48 80
% 216.49/216.68  |- skos__hiddenLabel mesh__D003189 Agent 4880
% 216.49/216.68  |- mesh__dateCreated mesh__D003189 1999-01-01
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D003189 2006
% 216.49/216.68  |- skos__hiddenLabel mesh__D003189 BW 48 80
% 216.49/216.68  |- skos__prefLabel mesh__D003189 p-Methoxy-N-methylphenethylamine
% 216.49/216.68  |- skos__broader mesh__D003189smesh__D010627
% 216.49/216.68  |- mesh__dateEstablished mesh__D003189 1966-01-01
% 216.49/216.68  |- skos__scopeNote mesh__D003189
% 216.49/216.68       A potent mast cell degranulator. It is involved in histamine release.%A%    
% 216.49/216.68  |- skos__altLabel mesh__D003189 Preparation 48-80
% 216.49/216.68  |- rdf__type mesh__D003189sskos__Concept
% 216.49/216.68  |- mesh__recordMaintainer mesh__D003189 ags
% 216.49/216.68  |- mesh__recordAuthorizer mesh__D003189 sjn
% 216.49/216.68  |- mesh__publicMeSHNote mesh__D003189 2001; see COMPOUND 48-80 1963-2000   
% 216.49/216.68  |- mesh__publicMeSHNote mesh__D008672 76   
% 216.49/216.68  |- skos__altLabel mesh__D008672 Group 1 Elements
% 216.49/216.68  |- mesh__recordMaintainer mesh__D008672 jmp
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D008672 2005
% 216.49/216.68  |- mesh__historyNote mesh__D008672 76; was NON MESH before 1976   
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D008672 2004
% 216.49/216.68  |- skos__broader mesh__D008672smesh__D008670
% 216.49/216.68  |- skos__altLabel mesh__D008672 Alkali Metals
% 216.49/216.68  |- rdf__type mesh__D008672sskos__Concept
% 216.49/216.68  |- mesh__recordAuthorizer mesh__D008672 sjn
% 216.49/216.68  |- mesh__recordOriginator mesh__D008672 RLS
% 216.49/216.68  |- skos__historyNote mesh__D008672 Metals %28%1966-1975%29%
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D008672 2003
% 216.49/216.68  |- skos__annotation mesh__D008672
% 216.49/216.68       do not confuse with METALS, ALKALINE EARTH; GEN: prefer specifics%A%  
% 216.49/216.68  |- skos__scopeNote mesh__D008672
% 216.49/216.68       Metals that constitute group 1%28%formerly group Ia%29% of the periodic table. They are the most strongly electropositive of the metals. Note that HYDROGEN is not considered an alkali metal even though it falls under the group 1 heading in the periodic table.%A%    
% 216.49/216.68  |- mesh__dateEstablished mesh__D008672 1976-01-01
% 216.49/216.68  |- skos__prefLabel mesh__D008672 Metals, Alkali
% 216.49/216.68  |- mesh__dateRevised mesh__D008672 2001-07-25
% 216.49/216.68  |- skos__hiddenLabel mesh__D008672 Elements, Group 1
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D008672 2002
% 216.49/216.68  |- mesh__dateCreated mesh__D008672 1975-07-23
% 216.49/216.68  |- skos__broader mesh__D008672smesh__D004602
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D008672 2006
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D016306 2000
% 216.49/216.68  |- skos__prefLabel mesh__D016306 Vena Cava Filters
% 216.49/216.68  |- skos__hiddenLabel mesh__D016306 Umbrella Filter
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D016306 2003
% 216.49/216.68  |- skos__altLabel mesh__D016306 Filters, Inferior Vena Cava
% 216.49/216.68  |- skos__historyNote mesh__D016306 Vena Cava, Inferior %28%1972-1990%29%
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D016306 2001
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D016306 2005
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D016306 2004
% 216.49/216.68  |- skos__hiddenLabel mesh__D016306 Filter, Vena Cava
% 216.49/216.68  |- skos__scopeNote mesh__D016306
% 216.49/216.68       Mechanical devices inserted in the inferior vena cava that prevent the migration of blood clots from deep venous thrombosis of the leg.%A%    
% 216.49/216.68  |- skos__hiddenLabel mesh__D016306 Filters, Vena Cava
% 216.49/216.68  |- mesh__recordAuthorizer mesh__D016306 SJN
% 216.49/216.68  |- skos__altLabel mesh__D016306 Inferior Vena Cava Filters
% 216.49/216.68  |- skos__altLabel mesh__D016306 Inferior Vena Cava Filter
% 216.49/216.68  |- mesh__recordOriginator mesh__D016306 PXP
% 216.49/216.68  |- rdf__type mesh__D016306sskos__Concept
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D016306 2006
% 216.49/216.68  |- skos__hiddenLabel mesh__D016306 Vena Cava Filter
% 216.49/216.68  |- skos__hiddenLabel mesh__D016306 Filter, Umbrella
% 216.49/216.68  |- skos__historyNote mesh__D016306 Pulmonary Embolism %28%1972-1990%29%
% 216.49/216.68  |- mesh__dateCreated mesh__D016306 1990-05-29
% 216.49/216.68  |- skos__hiddenLabel mesh__D016306 Filters, Umbrella
% 216.49/216.68  |- skos__hiddenLabel mesh__D016306 Cava Filters, Vena
% 216.49/216.68  |- mesh__recordMaintainer mesh__D016306 PXP
% 216.49/216.68  |- skos__hiddenLabel mesh__D016306 Cava Filter, Vena
% 216.49/216.68  |- skos__altLabel mesh__D016306 Filter, Inferior Vena Cava
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D016306 1998
% 216.49/216.68  |- mesh__dateEstablished mesh__D016306 1991-01-01
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D016306 2002
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D016306 1999
% 216.49/216.68  |- mesh__publicMeSHNote mesh__D016306 91   
% 216.49/216.68  |- skos__broader mesh__D016306smesh__D019736
% 216.49/216.68  |- skos__historyNote mesh__D016306
% 216.49/216.68       Filtration/instrumentation %28%1972-1990%29%
% 216.49/216.68  |- mesh__historyNote mesh__D016306 91   
% 216.49/216.68  |- mesh__dateRevised mesh__D016306 1997-06-20
% 216.49/216.68  |- mesh__dateEstablished mesh__D004282 1966-01-01
% 216.49/216.68  |- mesh__publicMeSHNote mesh__D004282
% 216.49/216.68       66; was see under BIBLIOGRAPHY 1963-65   
% 216.49/216.68  |- skos__hiddenLabel mesh__D004282 Documentations
% 216.49/216.68  |- mesh__historyNote mesh__D004282
% 216.49/216.68       66; was see under BIBLIOGRAPHY 1963-65   
% 216.49/216.68  |- rdf__type mesh__D004282sskos__Concept
% 216.49/216.68  |- skos__prefLabel mesh__D004282 Documentation
% 216.49/216.68  |- mesh__recordMaintainer mesh__D004282 jls
% 216.49/216.68  |- skos__scopeNote mesh__D004282
% 216.49/216.68       Systematic organization, storage, retrieval, and dissemination of specialized information, especially of a scientific or technical nature %28%From ALA Glossary of Library and Information Science, 1983%29%. It often involves authenticating or validating information.%A%    
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D004282 2006
% 216.49/216.68  |- skos__annotation mesh__D004282 med docum: do not coord with MEDICINE   
% 216.49/216.68  |- mesh__recordOriginator mesh__D004282 NLM
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D004282 2005
% 216.49/216.68  |- mesh__recordAuthorizer mesh__D004282 sjn
% 216.49/216.68  |- mesh__dateCreated mesh__D004282 1999-01-01
% 216.49/216.68  |- skos__broader mesh__D004282smesh__D007255
% 216.49/216.68  |- mesh__dateRevised mesh__D004282 2004-07-19
% 216.49/216.68  |- skos__related mesh__D004282smesh__D011996
% 216.49/216.68  |- mesh__publicMeSHNote mesh__D012714
% 216.49/216.68       98; see SERYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A%  
% 216.49/216.68  |- skos__hiddenLabel mesh__D012714 Seryl tRNA Synthetase
% 216.49/216.68  |- mesh__activeMeSHYear mesh__D012714 2005
% 216.49/216.69  |- skos__broader mesh__D012714smesh__D000604
% 216.49/216.69  |- skos__altLabel mesh__D012714 Seryl T RNA Synthetase
% 216.49/216.69  |- skos__hiddenLabel mesh__D012714 Ser tRNA Ligase
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D012714 2006
% 216.49/216.69  |- skos__hiddenLabel mesh__D012714 Synthetase, Seryl-tRNA
% 216.49/216.69  |- mesh__recordAuthorizer mesh__D012714 sjn
% 216.49/216.69  |- mesh__recordOriginator mesh__D012714 NLM
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D012714 2004
% 216.49/216.69  |- skos__hiddenLabel mesh__D012714 Ligase, Serine-tRNA
% 216.49/216.69  |- skos__prefLabel mesh__D012714 Serine-tRNA Ligase
% 216.49/216.69  |- rdf__type mesh__D012714sskos__Concept
% 216.49/216.69  |- skos__altLabel mesh__D012714 Ser-tRNA Ligase
% 216.49/216.69  |- mesh__recordMaintainer mesh__D012714 ssb
% 216.49/216.69  |- mesh__dateCreated mesh__D012714 1974-11-19
% 216.49/216.69  |- skos__historyNote mesh__D012714 Serine %28%1973-1974%29%
% 216.49/216.69  |- skos__historyNote mesh__D012714
% 216.49/216.69       Amino Acyl T RNA Synthetases %28%1973-1974%29%
% 216.49/216.69  |- mesh__dateRevised mesh__D012714 2003-07-09
% 216.49/216.69  |- skos__hiddenLabel mesh__D012714 Ligase, Ser-tRNA
% 216.49/216.69  |- skos__scopeNote mesh__D012714
% 216.49/216.69       An enzyme that activates serine with its specific transfer RNA. EC 6.1.1.11.%A%    
% 216.49/216.69  |- skos__hiddenLabel mesh__D012714 Serine tRNA Ligase
% 216.49/216.69  |- skos__altLabel mesh__D012714 Seryl-tRNA Synthetase
% 216.49/216.69  |- mesh__historyNote mesh__D012714 98%28%75%29%   
% 216.49/216.69  |- mesh__dateEstablished mesh__D012714 1991-01-01
% 216.49/216.69  |- skos__altLabel mesh__D050833 ISGF3-alpha Protein
% 216.49/216.69  |- mesh__dateCreated mesh__D050833 2005-06-30
% 216.49/216.69  |- mesh__recordAuthorizer mesh__D050833 sjn
% 216.49/216.69  |- mesh__historyNote mesh__D050833 2006%28%1990%29%   
% 216.49/216.69  |- skos__altLabel mesh__D050833 ISGF3 alpha Subunit
% 216.49/216.69  |- skos__broader mesh__D050833smesh__D050832
% 216.49/216.69  |- skos__hiddenLabel mesh__D050833 ISGF3 alpha Protein
% 216.49/216.69  |- skos__hiddenLabel mesh__D050833
% 216.49/216.69       Interferon Stimulated Gene Factor 3, alpha Subunit
% 216.49/216.69  |- mesh__recordMaintainer mesh__D050833 DRC
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D050833 2006
% 216.49/216.69  |- mesh__recordOriginator mesh__D050833 DRC
% 216.49/216.69  |- skos__prefLabel mesh__D050833
% 216.49/216.69       Interferon-Stimulated Gene Factor 3, alpha Subunit
% 216.49/216.69  |- rdf__type mesh__D050833sskos__Concept
% 216.49/216.69  |- mesh__dateEstablished mesh__D050833 2006-01-01
% 216.49/216.69  |- mesh__publicMeSHNote mesh__D050833
% 216.49/216.69       2006; ISGF ALPHA SUBUNIT %26% ISGF-ALPHA PROTEIN were indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005%A%  
% 216.49/216.69  |- skos__scopeNote mesh__D050833
% 216.49/216.69       A heterodimeric complex of STAT1 PROTEIN and STAT2 PROTEIN that interacts with ISGF3GAMMA and is a subunit of the ISGF3 COMPLEX.%A%    
% 216.49/216.69  |- mesh__dateRevised mesh__D003988 2005-06-30
% 216.49/216.69  |- mesh__dateEstablished mesh__D003988 1968-01-01
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D003988 2006
% 216.49/216.69  |- skos__prefLabel mesh__D003988 Dibenzothiepins
% 216.49/216.69  |- mesh__recordOriginator mesh__D003988 NLM
% 216.49/216.69  |- mesh__recordMaintainer mesh__D003988 ssb
% 216.49/216.69  |- skos__broader mesh__D003988smesh__D013846
% 216.49/216.69  |- mesh__historyNote mesh__D003988 68   
% 216.49/216.69  |- mesh__recordAuthorizer mesh__D003988 sjn
% 216.49/216.69  |- mesh__publicMeSHNote mesh__D003988 68   
% 216.49/216.69  |- skos__broader mesh__D003988smesh__D006575
% 216.49/216.69  |- rdf__type mesh__D003988sskos__Concept
% 216.49/216.69  |- mesh__dateCreated mesh__D003988 1999-01-01
% 216.49/216.69  |- mesh__dateEstablished mesh__D050035 2006-01-01
% 216.49/216.69  |- mesh__recordOriginator mesh__D050035 lkt
% 216.49/216.69  |- mesh__recordMaintainer mesh__D050035 lkt
% 216.49/216.69  |- skos__broader mesh__D050035smesh__D007006
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D050035 2006
% 216.49/216.69  |- skos__altLabel mesh__D050035 Infantilism, Sexual
% 216.49/216.69  |- mesh__recordAuthorizer mesh__D050035 sjn
% 216.49/216.69  |- skos__scopeNote mesh__D050035
% 216.49/216.69       The permanent lack of SEXUAL DEVELOPMENT in an individual. This defect is usually observed at an age after expected PUBERTY.%A%    
% 216.49/216.69  |- rdf__type mesh__D050035sskos__Concept
% 216.49/216.69  |- skos__altLabel mesh__D050035 Infantilism, Genital
% 216.49/216.69  |- mesh__publicMeSHNote mesh__D050035
% 216.49/216.69       2006; see HYPOGONADISM 1984-2005; see INFANTILISM 1963-1983%A%  
% 216.49/216.69  |- skos__prefLabel mesh__D050035 Sexual Infantilism
% 216.49/216.69  |- mesh__historyNote mesh__D050035
% 216.49/216.69       2006; use HYPOGONADISM 1984-2005; use INFANTILISM 1963-1983%A%  
% 216.49/216.69  |- mesh__dateCreated mesh__D050035 2005-06-30
% 216.49/216.69  |- skos__historyNote mesh__D050035 Hypogonadism %28%1969-2005%29%
% 216.49/216.69  |- skos__annotation mesh__D008673
% 216.49/216.69       do not confuse with METALS, ALKALI; GEN: prefer specifics%A%  
% 216.49/216.69  |- mesh__dateRevised mesh__D008673 2001-07-25
% 216.49/216.69  |- skos__scopeNote mesh__D008673
% 216.49/216.69       Metals that constitute the group 2 %28%formerly group IIa%29% of the periodic table.%A%    
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D008673 2002
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D008673 2004
% 216.49/216.69  |- skos__broader mesh__D008673smesh__D004602
% 216.49/216.69  |- rdf__type mesh__D008673sskos__Concept
% 216.49/216.69  |- skos__hiddenLabel mesh__D008673 Elements, Group 2
% 216.49/216.69  |- mesh__publicMeSHNote mesh__D008673 76   
% 216.49/216.69  |- mesh__dateCreated mesh__D008673 1975-07-18
% 216.49/216.69  |- skos__hiddenLabel mesh__D008673 Earth Metals, Alkaline
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D008673 2003
% 216.49/216.69  |- mesh__historyNote mesh__D008673 76; was NON MESH before 1976   
% 216.49/216.69  |- skos__broader mesh__D008673smesh__D008670
% 216.49/216.69  |- skos__altLabel mesh__D008673 Group 2 Elements
% 216.49/216.69  |- skos__prefLabel mesh__D008673 Metals, Alkaline Earth
% 216.49/216.69  |- mesh__recordOriginator mesh__D008673 RLS
% 216.49/216.69  |- mesh__recordAuthorizer mesh__D008673 sjn
% 216.49/216.69  |- skos__historyNote mesh__D008673 Metals %28%1966-1975%29%
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D008673 2006
% 216.49/216.69  |- mesh__recordMaintainer mesh__D008673 jmp
% 216.49/216.69  |- mesh__dateEstablished mesh__D008673 1976-01-01
% 216.49/216.69  |- skos__altLabel mesh__D008673 Alkaline Earth Metals
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D008673 2005
% 216.49/216.69  |- skos__broader mesh__D000690smesh__D016472
% 216.49/216.69  |- mesh__dateCreated mesh__D000690 1999-01-01
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D000690 2003
% 216.49/216.69  |- skos__hiddenLabel mesh__D000690 Lateral Scleroses, Amyotrophic
% 216.49/216.69  |- skos__scopeNote mesh__D000690
% 216.49/216.69       A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. %28%From Adams et al., Principles of Neurology, 6th ed, pp1089-94%29%%A%    
% 216.49/216.69  |- skos__hiddenLabel mesh__D000690 Gehrigs Disease
% 216.49/216.69  |- skos__altLabel mesh__D000690 Lou Gehrig%27%s Disease
% 216.49/216.69  |- skos__hiddenLabel mesh__D000690 Lou Gehrigs Disease
% 216.49/216.69  |- skos__altLabel mesh__D000690 Guam Form of Amyotrophic Lateral Sclerosis
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D000690 2006
% 216.49/216.69  |- skos__prefLabel mesh__D000690 Amyotrophic Lateral Sclerosis
% 216.49/216.69  |- rdf__type mesh__D000690sskos__Concept
% 216.49/216.69  |- mesh__recordAuthorizer mesh__D000690 sjn
% 216.49/216.69  |- skos__hiddenLabel mesh__D000690 Gehrig Disease
% 216.49/216.69  |- skos__altLabel mesh__D000690
% 216.49/216.69       Motor Neuron Disease, Amyotrophic Lateral Sclerosis
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D000690 2005
% 216.49/216.69  |- mesh__recordOriginator mesh__D000690 NLM
% 216.49/216.69  |- skos__altLabel mesh__D000690 ALS %28%Amyotrophic Lateral Sclerosis%29%
% 216.49/216.69  |- skos__altLabel mesh__D000690 Lou Gehrig Disease
% 216.49/216.69  |- skos__hiddenLabel mesh__D000690 Sclerosis, Amyotrophic Lateral
% 216.49/216.69  |- skos__altLabel mesh__D000690 Gehrig%27%s Disease
% 216.49/216.69  |- mesh__recordMaintainer mesh__D000690 mdb
% 216.49/216.69  |- skos__altLabel mesh__D000690 Dementia With Amyotrophic Lateral Sclerosis
% 216.49/216.69  |- mesh__dateRevised mesh__D000690 2002-07-02
% 216.49/216.69  |- skos__broader mesh__D000690smesh__D013118
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D000690 2004
% 216.49/216.69  |- skos__broader mesh__D009206Q000736smesh__D009206
% 216.49/216.69  |- mesh__preferredCombination mesh__D009206Q000736smesh__D004452
% 216.49/216.69  |- rdf__type mesh__D009206Q000736smesh__CompoundConcept
% 216.49/216.69  |- rdf__type mesh__D004283sskos__Concept
% 216.49/216.69  |- mesh__recordAuthorizer mesh__D004283 sjn
% 216.49/216.69  |- skos__altLabel mesh__D004283 Canine Diseases
% 216.49/216.69  |- skos__annotation mesh__D004283
% 216.49/216.69       IM GEN or unspecified; coord IM with specific dis /vet %28%IM%29% or specific dog dis %28%IM%29%; for abnormalities or injuries, index under DOGS /abnorm or DOGS /inj; don%27%t forget also DOGS %28%NIM%29% %26% check tag ANIMALS; DF: DOG DIS%A%  
% 216.49/216.69  |- skos__hiddenLabel mesh__D004283 Disease, Canine
% 216.49/216.69  |- mesh__dateRevised mesh__D004283 2003-07-30
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D004283 2006
% 216.49/216.69  |- skos__prefLabel mesh__D004283 Dog Diseases
% 216.49/216.69  |- skos__broader mesh__D004283smesh__D000820
% 216.49/216.69  |- skos__hiddenLabel mesh__D004283 Diseases, Dog
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D004283 2005
% 216.49/216.69  |- skos__scopeNote mesh__D004283
% 216.49/216.69       Diseases of the domestic dog %28%Canis familiaris%29%. This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used.%A%    
% 216.49/216.69  |- mesh__dateCreated mesh__D004283 1999-01-01
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D004283 2004
% 216.49/216.69  |- skos__hiddenLabel mesh__D004283 Dog Disease
% 216.49/216.69  |- skos__hiddenLabel mesh__D004283 Disease, Dog
% 216.49/216.69  |- mesh__recordOriginator mesh__D004283 NLM
% 216.49/216.69  |- mesh__recordMaintainer mesh__D004283 ags
% 216.49/216.69  |- skos__hiddenLabel mesh__D004283 Diseases, Canine
% 216.49/216.69  |- skos__hiddenLabel mesh__D004283 Canine Disease
% 216.49/216.69  |- skos__broader mesh__D012715smesh__D010938
% 216.49/216.69  |- mesh__dateCreated mesh__D012715 1999-01-01
% 216.49/216.69  |- mesh__historyNote mesh__D012715
% 216.49/216.69       91%28%87%29%66; was see under PLANT OILS 1987-90; was heading 1966-86%A%  
% 216.49/216.69  |- mesh__publicMeSHNote mesh__D012715
% 216.49/216.69       91; was see under PLANT OILS 1987-90; was heading 1966-86%A%  
% 216.49/216.69  |- skos__broader mesh__D012715smesh__D004042
% 216.49/216.69  |- skos__hiddenLabel mesh__D012715 Oil, Sesame
% 216.49/216.69  |- skos__scopeNote mesh__D012715
% 216.49/216.69       The refined fixed oil obtained from the seed of one or more cultivated varieties of Sesamum indicum. It is used as a solvent and oleaginous vehicle for drugs and has been used internally as a laxative and externally as a skin softener. It is used also in the manufacture of margarine, soap, and cosmetics. %28%Dorland, 28th ed %26% Random House Unabridged Dictionary, 2d ed%29%%A%    
% 216.49/216.69  |- mesh__recordAuthorizer mesh__D012715 sjn
% 216.49/216.69  |- mesh__recordOriginator mesh__D012715 NLM
% 216.49/216.69  |- skos__hiddenLabel mesh__D012715 Sesame Oils
% 216.49/216.69  |- mesh__dateEstablished mesh__D012715 1991-01-01
% 216.49/216.69  |- skos__broader mesh__D012715smesh__D005224
% 216.49/216.69  |- skos__hiddenLabel mesh__D012715 Oils, Sesame
% 216.49/216.69  |- mesh__dateRevised mesh__D012715 2005-06-30
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D012715 2006
% 216.49/216.69  |- mesh__recordMaintainer mesh__D012715 ssb
% 216.49/216.69  |- skos__prefLabel mesh__D012715 Sesame Oil
% 216.49/216.69  |- skos__annotation mesh__D012715 an unsaturated fat   
% 216.49/216.69  |- rdf__type mesh__D012715sskos__Concept
% 216.49/216.69  |- mesh__dateRevised mesh__D017400 2005-06-30
% 216.49/216.69  |- mesh__publicMeSHNote mesh__D017400 93   
% 216.49/216.69  |- skos__altLabel mesh__D017400 Serpulina innocens
% 216.49/216.69  |- mesh__recordOriginator mesh__D017400 PXP
% 216.49/216.69  |- skos__historyNote mesh__D017400 Treponema %28%1980-1992%29%
% 216.49/216.69  |- mesh__recordMaintainer mesh__D017400 SYSTEM
% 216.49/216.69  |- skos__annotation mesh__D017400
% 216.49/216.69       a genus of the family SPIROCHAETACEAE; infection: coord IM with SPIROCHAETALES INFECTIONS %28%IM%29%%A%  
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D017400 2006
% 216.49/216.69  |- mesh__historyNote mesh__D017400 93   
% 216.49/216.69  |- skos__prefLabel mesh__D017400 Serpulina
% 216.49/216.69  |- mesh__dateCreated mesh__D017400 1992-05-22
% 216.49/216.69  |- mesh__dateEstablished mesh__D017400 1993-01-01
% 216.49/216.69  |- skos__scopeNote mesh__D017400
% 216.49/216.69       A genus of spiral bacteria of the family SPIROCHAETACEAE. This genus contains two species, SERPULINA HYODYSENTERIAE and Serpulina innocens, which were formerly classified as Treponema hyodysenteriae and Treponema innocens, respectively. When researchers determined that T. hyodysenteriae and T. innocens did not belong to the genus Treponema, the new genus was named Serpula. Within a short time, however, it was discovered that Serpula was already the name of a fungal genus and thus, Serpula was changed to Serpulina.%A%    
% 216.49/216.69  |- skos__altLabel mesh__D017400 Serpula innocens
% 216.49/216.69  |- mesh__recordAuthorizer mesh__D017400 sjn
% 216.49/216.69  |- rdf__type mesh__D017400sskos__Concept
% 216.49/216.69  |- skos__broader mesh__D017400smesh__D013143
% 216.49/216.69  |- rdf__type mesh__D050834sskos__Concept
% 216.49/216.69  |- skos__hiddenLabel mesh__D050834
% 216.49/216.69       Interferon Stimulated Gene Factor 3, gamma Subunit
% 216.49/216.69  |- skos__hiddenLabel mesh__D050834 ISRE Binding Protein p48
% 216.49/216.69  |- skos__hiddenLabel mesh__D050834 ISGF3gamma, p48
% 216.49/216.69  |- skos__altLabel mesh__D050834 ISGF3G Protein
% 216.49/216.69  |- skos__scopeNote mesh__D050834
% 216.49/216.69       An interferon regulatory factor that recruits STAT1 PROTEIN and STAT2 PROTEIN heterodimers to interferon-stimulated response elements and functions as an immediate-early protein.%A%    
% 216.49/216.69  |- skos__hiddenLabel mesh__D050834 Interferon Regulatory Factor 9
% 216.49/216.69  |- skos__prefLabel mesh__D050834
% 216.49/216.69       Interferon-Stimulated Gene Factor 3, gamma Subunit
% 216.49/216.69  |- skos__broader mesh__D050834smesh__D050832
% 216.49/216.69  |- skos__hiddenLabel mesh__D050834 Regulatory Factor-9, Interferon
% 216.49/216.69  |- skos__hiddenLabel mesh__D050834 p48, ISRE-Binding Protein
% 216.49/216.69  |- mesh__dateEstablished mesh__D050834 2006-01-01
% 216.49/216.69  |- mesh__dateCreated mesh__D050834 2005-06-30
% 216.49/216.69  |- skos__altLabel mesh__D050834 p48 ISGF3gamma
% 216.49/216.69  |- skos__hiddenLabel mesh__D050834 ISRE-Binding Protein, p48
% 216.49/216.69  |- skos__broader mesh__D050834smesh__D050835
% 216.49/216.69  |- skos__altLabel mesh__D050834 ISRE-Binding Protein p48
% 216.49/216.69  |- skos__altLabel mesh__D050834 Interferon Regulatory Factor-9
% 216.49/216.69  |- mesh__recordAuthorizer mesh__D050834 ags
% 216.49/216.69  |- mesh__recordMaintainer mesh__D050834 ags
% 216.49/216.69  |- skos__altLabel mesh__D050834 p48 ISRE-Binding Protein
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D050834 2006A
% 216.49/216.69  |- skos__altLabel mesh__D050834 ISGF3 gamma Subunit
% 216.49/216.69  |- mesh__publicMeSHNote mesh__D050834
% 216.49/216.69       2006; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005%A%  
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D050834 2006
% 216.49/216.69  |- mesh__dateRevised mesh__D050834 2005-07-18
% 216.49/216.69  |- mesh__recordOriginator mesh__D050834 DRC
% 216.49/216.69  |- mesh__historyNote mesh__D050834 2006   
% 216.49/216.69  |- skos__hiddenLabel mesh__D050834 p48 ISRE Binding Protein
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D003989 1997
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D003989 1996
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D003989 2006
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D003989 2002
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D003989 2005
% 216.49/216.69  |- mesh__dateRevised mesh__D003989 1992-05-13
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D003989 2001
% 216.49/216.69  |- mesh__publicMeSHNote mesh__D003989 68   
% 216.49/216.69  |- mesh__recordMaintainer mesh__D003989 TAP
% 216.49/216.69  |- skos__broader mesh__D003989smesh__D006575
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D003989 1995
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D003989 2004
% 216.49/216.69  |- rdf__type mesh__D003989sskos__Concept
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D003989 2000
% 216.49/216.69  |- mesh__dateCreated mesh__D003989 1999-01-01
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D003989 2003
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D003989 1999
% 216.49/216.69  |- mesh__recordOriginator mesh__D003989 NLM
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D003989 1994
% 216.49/216.69  |- mesh__recordAuthorizer mesh__D003989 PLS
% 216.49/216.69  |- skos__prefLabel mesh__D003989 Dibenzoxazepines
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D003989 1998
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D003989 1993
% 216.49/216.69  |- mesh__historyNote mesh__D003989 68   
% 216.49/216.69  |- mesh__dateEstablished mesh__D003989 1968-01-01
% 216.49/216.69  |- skos__annotation mesh__D008674 GEN: prefer specifics   
% 216.49/216.69  |- skos__prefLabel mesh__D008674 Metals, Rare Earth
% 216.49/216.69  |- skos__historyNote mesh__D008674 Metals %28%1966-1975%29%
% 216.49/216.69  |- mesh__dateEstablished mesh__D008674 1976-01-01
% 216.49/216.69  |- mesh__recordMaintainer mesh__D008674 ags
% 216.49/216.69  |- skos__scopeNote mesh__D008674
% 216.49/216.69       A group of elements that include SCANDIUM; YTTRIUM; and the LANTHANOID SERIES ELEMENTS. Historically, the rare earth metals got their name from the fact that they were never found in their pure elemental form, but as an oxide. In addition they were very difficult to purify. They are not truly rare and comprise about 25%25% of the metals in the earth%27%s crust.%A%    
% 216.49/216.69  |- mesh__dateRevised mesh__D008674 2005-07-29
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D008674 2006
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D008674 2002
% 216.49/216.69  |- mesh__dateCreated mesh__D008674 1975-07-23
% 216.49/216.69  |- skos__broader mesh__D008674smesh__D004602
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D008674 2005
% 216.49/216.69  |- skos__altLabel mesh__D008674 Rare Earth Metals
% 216.49/216.69  |- mesh__publicMeSHNote mesh__D008674 76   
% 216.49/216.69  |- skos__hiddenLabel mesh__D008674 Earth Metals, Rare
% 216.49/216.69  |- skos__broader mesh__D008674smesh__D008670
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D008674 2004
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D008674 2006A
% 216.49/216.69  |- mesh__recordAuthorizer mesh__D008674 ags
% 216.49/216.69  |- rdf__type mesh__D008674sskos__Concept
% 216.49/216.69  |- mesh__recordOriginator mesh__D008674 RLS
% 216.49/216.69  |- mesh__historyNote mesh__D008674 76; was NON MESH before 1976   
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D008674 2003
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D000691 2006
% 216.49/216.69  |- rdf__type mesh__D000691sskos__Concept
% 216.49/216.69  |- skos__historyNote mesh__D000691 Alkaloids %28%1974%29%
% 216.49/216.69  |- mesh__historyNote mesh__D000691
% 216.49/216.69       91%28%75%29%; was see under PIPERIDINES 1975-90   
% 216.49/216.69  |- skos__broader mesh__D000691smesh__D010880
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D000691 2005
% 216.49/216.69  |- mesh__dateEstablished mesh__D000691 1991-01-01
% 216.49/216.69  |- skos__altLabel mesh__D000691 Neonicotine
% 216.49/216.69  |- skos__historyNote mesh__D000691 Pyridines %28%1973-1974%29%
% 216.49/216.69  |- mesh__recordMaintainer mesh__D000691 ssb
% 216.49/216.69  |- mesh__publicMeSHNote mesh__D000691
% 216.49/216.69       91; was see under PIPERIDINES 1975-90   
% 216.49/216.69  |- mesh__dateRevised mesh__D000691 2004-07-08
% 216.49/216.69  |- mesh__recordAuthorizer mesh__D000691 sjn
% 216.49/216.69  |- skos__scopeNote mesh__D000691 A piperidine botanical insecticide.     
% 216.49/216.69  |- mesh__recordOriginator mesh__D000691 NLM
% 216.49/216.69  |- skos__prefLabel mesh__D000691 Anabasine
% 216.49/216.69  |- mesh__dateCreated mesh__D000691 1974-11-19
% 216.49/216.69  |- skos__historyNote mesh__D000691 Piperidines %28%1969-1974%29%
% 216.49/216.69  |- skos__hiddenLabel mesh__D016308 2 Alanyl Leucine Enkephalin
% 216.49/216.69  |- mesh__dateCreated mesh__D016308 1990-06-28
% 216.49/216.69  |- skos__historyNote mesh__D016308 Enkephalins %28%1977-1982%29%
% 216.49/216.69  |- mesh__recordMaintainer mesh__D016308 ssb
% 216.49/216.69  |- skos__altLabel mesh__D016308 Leu-Enkephalin-2-Ala
% 216.49/216.69  |- skos__altLabel mesh__D016308 Enkephalin-Leu,Ala%28%2%29%
% 216.49/216.69  |- skos__hiddenLabel mesh__D016308 Leu Enkephalin 2 Ala
% 216.49/216.69  |- skos__hiddenLabel mesh__D016308 BW 180C
% 216.49/216.69  |- skos__hiddenLabel mesh__D016308 Enkephalin, 2-Alanyl-Leucine
% 216.49/216.69  |- skos__hiddenLabel mesh__D016308 Leucine Enkephalin 2 Alanine
% 216.49/216.69  |- skos__altLabel mesh__D016308 5-Leucine-2-Alanine Enkephalin
% 216.49/216.69  |- skos__altLabel mesh__D016308 DADLE
% 216.49/216.69  |- skos__hiddenLabel mesh__D016308 Enkephalin, 5-Leucine-2-Alanine
% 216.49/216.69  |- mesh__dateEstablished mesh__D016308 1991-01-01
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D016308 2002
% 216.49/216.69  |- mesh__historyNote mesh__D016308 91   
% 216.49/216.69  |- skos__hiddenLabel mesh__D016308 5 Leucine 2 Alanine Enkephalin
% 216.49/216.69  |- skos__hiddenLabel mesh__D016308 Enkephalin-2-Alanine, Leucine
% 216.49/216.69  |- skos__altLabel mesh__D016308 Leucine Enkephalin-2-Alanine
% 216.49/216.69  |- mesh__publicMeSHNote mesh__D016308 91   
% 216.49/216.69  |- skos__hiddenLabel mesh__D016308 Enkephalin, Leucine 2 Alanine
% 216.49/216.69  |- mesh__dateRevised mesh__D016308 2001-07-25
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D016308 2003
% 216.49/216.69  |- skos__broader mesh__D016308smesh__D004743
% 216.49/216.69  |- skos__scopeNote mesh__D016308
% 216.49/216.69       A delta-selective opioid %28%ANALGESICS, OPIOID%29%. It can cause transient depression of mean arterial blood pressure and heart rate.%A%    
% 216.49/216.69  |- skos__historyNote mesh__D016308 Enkephalin, Leucine %28%1983-1990%29%
% 216.49/216.69  |- mesh__recordOriginator mesh__D016308 RLS
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D016308 2005
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D016308 2004
% 216.49/216.69  |- skos__altLabel mesh__D016308 D-Ala%28%2%29%-D-Leu%28%5%29%-Enkephalin
% 216.49/216.69  |- skos__prefLabel mesh__D016308 Enkephalin, Leucine-2-Alanine
% 216.49/216.69  |- skos__hiddenLabel mesh__D016308 BW180C
% 216.49/216.69  |- mesh__recordAuthorizer mesh__D016308 sjn
% 216.49/216.69  |- skos__hiddenLabel mesh__D016308 Leucine-2-Alanine Enkephalin
% 216.49/216.69  |- skos__annotation mesh__D016308 DF: DADLE   
% 216.49/216.69  |- skos__altLabel mesh__D016308 2-Alanyl-Leucine Enkephalin
% 216.49/216.69  |- rdf__type mesh__D016308sskos__Concept
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D016308 2006
% 216.49/216.69  |- skos__broader mesh__D009206Q000737smesh__D009206
% 216.49/216.69  |- rdf__type mesh__D009206Q000737smesh__CompoundConcept
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D013010 2006
% 216.49/216.69  |- mesh__onlineNote mesh__D013010
% 216.49/216.69       search ULTRASONICS 1974 %26% VIBRATION 1969-73   
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D013010 2003
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D013010 2005
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D013010 2000
% 216.49/216.69  |- skos__prefLabel mesh__D013010 Sonication
% 216.49/216.69  |- mesh__recordOriginator mesh__D013010 NLM
% 216.49/216.69  |- mesh__dateEstablished mesh__D013010 1991-01-01
% 216.49/216.69  |- mesh__recordAuthorizer mesh__D013010 PLS
% 216.49/216.69  |- mesh__dateRevised mesh__D013010 1992-05-18
% 216.49/216.69  |- mesh__publicMeSHNote mesh__D013010
% 216.49/216.69       91; was see under ULTRASONICS 1974-90; was see under VIBRATION 1969-73%A%  
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D013010 1997
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D013010 1999
% 216.49/216.69  |- rdf__type mesh__D013010sskos__Concept
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D013010 1993
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D013010 1996
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D013010 1995
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D013010 1998
% 216.49/216.69  |- skos__broader mesh__D013010smesh__D014465
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D013010 2002
% 216.49/216.69  |- mesh__recordMaintainer mesh__D013010 TAP
% 216.49/216.69  |- mesh__historyNote mesh__D013010
% 216.49/216.69       91%28%75%29%; was see under ULTRASONICS 1974-90; was see under VIBRATION 1969-73%A%  
% 216.49/216.69  |- skos__hiddenLabel mesh__D013010 Sonications
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D013010 1994
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D013010 2004
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D013010 2001
% 216.49/216.69  |- mesh__dateCreated mesh__D013010 1999-01-01
% 216.49/216.69  |- skos__altLabel mesh__D004284 Dogfishes
% 216.49/216.69  |- mesh__publicMeSHNote mesh__D004284 91; was see under SHARKS 1975-90   
% 216.49/216.69  |- mesh__historyNote mesh__D004284
% 216.49/216.69       91%28%75%29%; was see under SHARKS 1975-90   
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D004284 2005
% 216.49/216.69  |- mesh__dateCreated mesh__D004284 1999-01-01
% 216.49/216.69  |- mesh__recordOriginator mesh__D004284 NLM
% 216.49/216.69  |- mesh__dateRevised mesh__D004284 2004-07-07
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D004284 2006
% 216.49/216.69  |- skos__broader mesh__D004284smesh__D012754
% 216.49/216.69  |- mesh__recordAuthorizer mesh__D004284 sjn
% 216.49/216.69  |- mesh__dateEstablished mesh__D004284 1991-01-01
% 216.49/216.69  |- skos__altLabel mesh__D004284 Squalidae
% 216.49/216.69  |- mesh__onlineNote mesh__D004284 search SHARKS 1966-74   
% 216.49/216.69  |- mesh__recordMaintainer mesh__D004284 ags
% 216.49/216.69  |- skos__prefLabel mesh__D004284 Dogfish
% 216.49/216.69  |- skos__scopeNote mesh__D004284
% 216.49/216.69       Sharks of the family Squalidae, also called dogfish sharks. They comprise at least eight genera and 44 species. Their LIVER is valued for its oil and its flesh is often made into fertilizer.%A%    
% 216.49/216.69  |- rdf__type mesh__D004284sskos__Concept
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D012716 1992
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D012716 1998
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D012716 1995
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D012716 2001
% 216.49/216.69  |- skos__hiddenLabel mesh__D012716 Bone, Sesamoid
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D012716 1996
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D012716 1993
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D012716 1999
% 216.49/216.69  |- skos__hiddenLabel mesh__D012716 Bones, Sesamoid
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D012716 2002
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D012716 1997
% 216.49/216.69  |- skos__broader mesh__D012716smesh__D001842
% 216.49/216.69  |- skos__prefLabel mesh__D012716 Sesamoid Bones
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D012716 2005
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D012716 2003
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D012716 1990
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D012716 2006
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D012716 2004
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D012716 1991
% 216.49/216.69  |- rdf__type mesh__D012716sskos__Concept
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D012716 1989
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D012716 2000
% 216.49/216.69  |- skos__hiddenLabel mesh__D012716 Sesamoid Bone
% 216.49/216.69  |- mesh__activeMeSHYear mesh__D012716 1994
% 216.49/216.69  |- mesh__dateCreated mesh__D012716 1999-01-01
% 216.49/216.69  |- mesh__dateEstablished mesh__D017401 1993-01-01
% 216.49/216.69  |- rdf__type mesh__D017401sskos__Concept
% 216.49/216.69  |- mesh__historyNote mesh__D017401 93   
% 216.49/216.69  |- skos__scopeNote mesh__D017401
% 216.49/216.69       A species of anaerobic, spiral bacteria that was formerly classified as Treponema hyodysenteriae %28%and for a short while, Serpula hyodysenteriae%29%. This organism is the agent of swine dysentery.%A%    
% 216.49/216.69  |- mesh__recordAuthorizer mesh__D017401 sjn
% 216.49/216.69  |- mesh__recordMaintainer mesh__D017401 SYSTEM
% 216.49/216.69  |- mesh__dateCreated mesh__D017401 1992-05-22
% 216.49/216.69  |- skos__altLabel mesh__D017401 Treponema hyodysenteriae
% 216.49/216.69  |- skos__broader mesh__D017401smesh__D017400
% 216.49/216.69  |- mesh__dateRevised mesh__D017401 2005-06-30
% 216.49/216.69  |- mesh__recordOriginator mesh__D017401 PXP
% 216.49/216.69  |- skos__prefLabel mesh__D017401 Serpulina hyodysenteriae
% 216.49/216.70  |- mesh__publicMeSHNote mesh__D017401 93   
% 216.49/216.70  |- skos__annotation mesh__D017401
% 216.49/216.70       formerly classified as a Treponema; infection: coord IM with SPIROCHAETALES INFECTIONS %28%IM%29%%A%  
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D017401 2006
% 216.49/216.70  |- skos__altLabel mesh__D017401 Serpula hyodysenteriae
% 216.49/216.70  |- skos__historyNote mesh__D017401 Treponema %28%1974-1992%29%
% 216.49/216.70  |- skos__scopeNote mesh__D050835
% 216.49/216.70       A family of transcription factors that share an N-terminal HELIX-TURN-HELIX MOTIF and bind INTERFERON-inducible PROMOTERS to control GENE expression. IRF proteins bind specific DNA sequences such as interferon-stimulated response elements, interferon regulatory elements, and the interferon consensus sequence.%A%    
% 216.49/216.70  |- mesh__historyNote mesh__D050835 2006   
% 216.49/216.70  |- skos__broader mesh__D050835smesh__D048868
% 216.49/216.70  |- skos__broader mesh__D050835smesh__D004268
% 216.49/216.70  |- skos__broader mesh__D050835smesh__D014157
% 216.49/216.70  |- mesh__publicMeSHNote mesh__D050835 2006   
% 216.49/216.70  |- skos__prefLabel mesh__D050835 Interferon Regulatory Factors
% 216.49/216.70  |- skos__hiddenLabel mesh__D050835 Transcription Factors, IRF
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D050835 2006
% 216.49/216.70  |- mesh__dateEstablished mesh__D050835 2006-01-01
% 216.49/216.70  |- mesh__dateCreated mesh__D050835 2005-06-30
% 216.49/216.70  |- mesh__recordAuthorizer mesh__D050835 sjn
% 216.49/216.70  |- mesh__recordOriginator mesh__D050835 DRC
% 216.49/216.70  |- skos__altLabel mesh__D050835 IRF Transcription Factors
% 216.49/216.70  |- rdf__type mesh__D050835sskos__Concept
% 216.49/216.70  |- mesh__recordMaintainer mesh__D050835 DRC
% 216.49/216.70  |- skos__scopeNote mesh__D008675
% 216.49/216.70       Profound physical changes during maturation of living organisms from the immature forms to the adult forms, such as from TADPOLES to frogs; CATERPILLARS to BUTTERFLIES.%A%    
% 216.49/216.70  |- skos__altLabel mesh__D008675 Biological Metamorphosis
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D008675 2006
% 216.49/216.70  |- mesh__dateRevised mesh__D008675 2004-07-07
% 216.49/216.70  |- skos__prefLabel mesh__D008675 Metamorphosis, Biological
% 216.49/216.70  |- mesh__recordMaintainer mesh__D008675 lkt
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D008675 2005
% 216.49/216.70  |- mesh__recordAuthorizer mesh__D008675 sjn
% 216.49/216.70  |- skos__annotation mesh__D008675 Manual 22.5; DF: METAMORPHOSIS BIOL   
% 216.49/216.70  |- skos__hiddenLabel mesh__D008675 Metamorphoses, Biological
% 216.49/216.70  |- mesh__dateCreated mesh__D008675 1999-01-01
% 216.49/216.70  |- skos__hiddenLabel mesh__D008675 Biological Metamorphoses
% 216.49/216.70  |- rdf__type mesh__D008675sskos__Concept
% 216.49/216.70  |- mesh__recordOriginator mesh__D008675 NLM
% 216.49/216.70  |- skos__broader mesh__D008675smesh__D009024
% 216.49/216.70  |- skos__scopeNote mesh__D013011
% 216.49/216.70       Mold and yeast inhibitor. Used as a fungistatic agent for foods, especially cheeses.%A%    
% 216.49/216.70  |- skos__hiddenLabel mesh__D013011 Acid, Sorbic
% 216.49/216.70  |- skos__prefLabel mesh__D013011 Sorbic Acid
% 216.49/216.70  |- skos__annotation mesh__D013011
% 216.49/216.70       D25-26 qualif; POLYSORBATES is available   
% 216.49/216.70  |- mesh__dateEstablished mesh__D013011 1991-01-01
% 216.49/216.70  |- mesh__dateRevised mesh__D013011 2003-07-09
% 216.49/216.70  |- skos__altLabel mesh__D013011 Hexadienoic Acid
% 216.49/216.70  |- rdf__type mesh__D013011sskos__Concept
% 216.49/216.70  |- skos__historyNote mesh__D013011 Caproates %28%1969-1974%29%
% 216.49/216.70  |- skos__broader mesh__D013011smesh__D005231
% 216.49/216.70  |- skos__historyNote mesh__D013011 Fatty Acids, Unsaturated %28%1974%29%
% 216.49/216.70  |- skos__hiddenLabel mesh__D013011 Acid, Propenylacrylic
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D013011 2004
% 216.49/216.70  |- mesh__historyNote mesh__D013011
% 216.49/216.70       91%28%75%29%; was see under FATTY ACIDS, UNSATURATED 1975-90   
% 216.49/216.70  |- mesh__publicMeSHNote mesh__D013011
% 216.49/216.70       91; was see under FATTY ACIDS, UNSATURATED 1975-90   
% 216.49/216.70  |- skos__hiddenLabel mesh__D013011 Sorbate, Sodium
% 216.49/216.70  |- mesh__recordOriginator mesh__D013011 NLM
% 216.49/216.70  |- skos__hiddenLabel mesh__D013011 Acid, Hexadienoic
% 216.49/216.70  |- mesh__recordAuthorizer mesh__D013011 sjn
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D013011 2006
% 216.49/216.70  |- skos__hiddenLabel mesh__D013011 Sorbate, Potassium
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D013011 2005
% 216.49/216.70  |- mesh__recordMaintainer mesh__D013011 ssb
% 216.49/216.70  |- mesh__dateCreated mesh__D013011 1974-11-19
% 216.49/216.70  |- skos__altLabel mesh__D013011 Propenylacrylic Acid
% 216.49/216.70  |- skos__altLabel mesh__D004285 Canis familiaris
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D004285 2005
% 216.49/216.70  |- mesh__dateCreated mesh__D004285 1999-01-01
% 216.49/216.70  |- mesh__dateRevised mesh__D004285 2004-07-07
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D004285 2006
% 216.49/216.70  |- skos__hiddenLabel mesh__D004285 familiaris, Canis
% 216.49/216.70  |- skos__scopeNote mesh__D004285
% 216.49/216.70       The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. %28%Walker%27%s Mammals of the World, 5th ed, p1065%29%%A%    
% 216.49/216.70  |- mesh__considerAlso mesh__D004285 consider also terms at CANINE   
% 216.49/216.70  |- skos__hiddenLabel mesh__D004285 Dog
% 216.49/216.70  |- skos__broader mesh__D004285smesh__D046028
% 216.49/216.70  |- mesh__recordOriginator mesh__D004285 NLM
% 216.49/216.70  |- mesh__recordMaintainer mesh__D004285 ags
% 216.49/216.70  |- mesh__recordAuthorizer mesh__D004285 sjn
% 216.49/216.70  |- skos__annotation mesh__D004285
% 216.49/216.70       check tag: no qualif; when IM, qualif permitted; TN 3: spelling of breeds%A%  
% 216.49/216.70  |- rdf__type mesh__D004285sskos__Concept
% 216.49/216.70  |- skos__prefLabel mesh__D004285 Dogs
% 216.49/216.70  |- skos__prefLabel mesh__D012717 Sesquiterpenes
% 216.49/216.70  |- skos__annotation mesh__D012717 GEN; prefer specifics   
% 216.49/216.70  |- mesh__publicMeSHNote mesh__D012717 74   
% 216.49/216.70  |- rdf__type mesh__D012717sskos__Concept
% 216.49/216.70  |- mesh__recordMaintainer mesh__D012717 ssb
% 216.49/216.70  |- mesh__recordOriginator mesh__D012717 NLM
% 216.49/216.70  |- mesh__recordAuthorizer mesh__D012717 sjn
% 216.49/216.70  |- mesh__dateEstablished mesh__D012717 1974-01-01
% 216.49/216.70  |- mesh__dateRevised mesh__D012717 2003-07-09
% 216.49/216.70  |- skos__broader mesh__D012717smesh__D013729
% 216.49/216.70  |- mesh__historyNote mesh__D012717 74   
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D012717 2004
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D012717 2006
% 216.49/216.70  |- mesh__dateCreated mesh__D012717 1999-01-01
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D012717 2005
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D017402 1997
% 216.49/216.70  |- mesh__historyNote mesh__D017402 93   
% 216.49/216.70  |- skos__prefLabel mesh__D017402 Chlorofluorocarbons
% 216.49/216.70  |- mesh__recordMaintainer mesh__D017402 AGS
% 216.49/216.70  |- mesh__dateRevised mesh__D017402 1993-06-04
% 216.49/216.70  |- mesh__recordAuthorizer mesh__D017402 PLS
% 216.49/216.70  |- skos__broader mesh__D017402smesh__D006843
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D017402 1999
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D017402 2002
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D017402 1996
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D017402 1995
% 216.49/216.70  |- mesh__dateEstablished mesh__D017402 1993-01-01
% 216.49/216.70  |- mesh__dateCreated mesh__D017402 1992-05-13
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D017402 1998
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D017402 2004
% 216.49/216.70  |- skos__annotation mesh__D017402
% 216.49/216.70       do not confuse with FLUOROCARBONS nor HYDROCARBONS, CHLORINATED nor HYDROCARBONS, FLUORINATED; DF: CFCS%A%  
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D017402 2001
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D017402 1994
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D017402 2006
% 216.49/216.70  |- mesh__recordOriginator mesh__D017402 TPW
% 216.49/216.70  |- skos__broader mesh__D017402smesh__D006845
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D017402 2003
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D017402 2000
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D017402 2005
% 216.49/216.70  |- mesh__publicMeSHNote mesh__D017402 93   
% 216.49/216.70  |- skos__scopeNote mesh__D017402
% 216.49/216.70       A series of hydrocarbons containing both chlorine and fluorine. These have been used as refrigerants, blowing agents, cleaning fluids, solvents, and as fire extinguishing agents. They have been shown to cause stratospheric ozone depletion and have been banned for many uses.%A%    
% 216.49/216.70  |- rdf__type mesh__D017402sskos__Concept
% 216.49/216.70  |- mesh__historyNote mesh__D050836 2006%28%1989%29%   
% 216.49/216.70  |- mesh__recordAuthorizer mesh__D050836 sjn
% 216.49/216.70  |- skos__altLabel mesh__D050836 Histone Nuclear Factor M
% 216.49/216.70  |- skos__broader mesh__D050836smesh__D050835
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D050836 2006
% 216.49/216.70  |- mesh__recordMaintainer mesh__D050836 DRC
% 216.49/216.70  |- skos__hiddenLabel mesh__D050836 Interferon Regulatory Factor 2
% 216.49/216.70  |- skos__hiddenLabel mesh__D050836 Transcription Factor, IRF-2
% 216.49/216.70  |- mesh__recordOriginator mesh__D050836 DRC
% 216.49/216.70  |- rdf__type mesh__D050836sskos__Concept
% 216.49/216.70  |- skos__altLabel mesh__D050836 HINF-M Transcription Factor
% 216.49/216.70  |- mesh__publicMeSHNote mesh__D050836
% 216.49/216.70       2006; INTERFERON REGULATORY FACTOR-2 was indexed under DNA-BINDING PROTEINS; REPRESSOR PROTEINS; %26% TRANSCRIPTION FACTORS 1989-2005%A%  
% 216.49/216.70  |- skos__prefLabel mesh__D050836 Interferon Regulatory Factor-2
% 216.49/216.70  |- skos__scopeNote mesh__D050836
% 216.49/216.70       An interferon regulatory factor that represses transcription of TYPE I INTERFERONS and activates transcription of HISTONE H4.%A%    
% 216.49/216.70  |- skos__altLabel mesh__D050836 IRF-2 Transcription Factor
% 216.49/216.70  |- skos__hiddenLabel mesh__D050836 IRF 2 Transcription Factor
% 216.49/216.70  |- skos__hiddenLabel mesh__D050836 HINF M Transcription Factor
% 216.49/216.70  |- skos__hiddenLabel mesh__D050836 Transcription Factor, HINF-M
% 216.49/216.70  |- mesh__dateEstablished mesh__D050836 2006-01-01
% 216.49/216.70  |- mesh__dateCreated mesh__D050836 2005-06-30
% 216.49/216.70  |- skos__broader mesh__D008676smesh__D004837
% 216.49/216.70  |- skos__altLabel mesh__D008676 Metadrenaline
% 216.49/216.70  |- skos__scopeNote mesh__D008676
% 216.49/216.70       Product of epinephrine O-methylation. It is a commonly occurring, pharmacologically and physiologically inactive metabolite of epinephrine.%A%    
% 216.49/216.70  |- skos__historyNote mesh__D008676 Epinephrine %28%1974%29%
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D008676 2006
% 216.49/216.70  |- mesh__dateRevised mesh__D008676 2000-06-22
% 216.49/216.70  |- mesh__dateCreated mesh__D008676 1974-11-11
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D008676 2001
% 216.49/216.70  |- mesh__recordOriginator mesh__D008676 NLM
% 216.49/216.70  |- mesh__historyNote mesh__D008676
% 216.49/216.70       91%28%75%29%; was see under EPINEPHRINE 1975-90   
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D008676 2003
% 216.49/216.70  |- skos__prefLabel mesh__D008676 Metanephrine
% 216.49/216.70  |- skos__historyNote mesh__D008676 Methyl Ethers %28%1974%29%
% 216.49/216.70  |- mesh__dateEstablished mesh__D008676 1991-01-01
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D008676 2004
% 216.49/216.70  |- mesh__publicMeSHNote mesh__D008676
% 216.49/216.70       91; was see under EPINEPHRINE 1975-90   
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D008676 2002
% 216.49/216.70  |- rdf__type mesh__D008676sskos__Concept
% 216.49/216.70  |- mesh__recordAuthorizer mesh__D008676 sjn
% 216.49/216.70  |- mesh__recordMaintainer mesh__D008676 CCR
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D008676 2005
% 216.49/216.70  |- mesh__recordMaintainer mesh__D000693 PXP
% 216.49/216.70  |- mesh__dateRevised mesh__D000693 1997-06-20
% 216.49/216.70  |- mesh__recordAuthorizer mesh__D000693 SJN
% 216.49/216.70  |- skos__scopeNote mesh__D000693
% 216.49/216.70       The complete absence, or %28%loosely%29% the paucity, of gaseous or dissolved elemental oxygen in a given place or environment. %28%From Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed%29%%A%    
% 216.49/216.70  |- mesh__dateCreated mesh__D000693 1999-01-01
% 216.49/216.70  |- skos__annotation mesh__D000693 almost never IM   
% 216.49/216.70  |- mesh__recordOriginator mesh__D000693 NLM
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D000693 2003
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D000693 2004
% 216.49/216.70  |- mesh__dateEstablished mesh__D000693 1991-01-01
% 216.49/216.70  |- mesh__publicMeSHNote mesh__D000693
% 216.49/216.70       91; was see under METABOLISM 1971-90   
% 216.49/216.70  |- skos__broader mesh__D000693smesh__D001669
% 216.49/216.70  |- skos__historyNote mesh__D000693 Oxygen %28%1966-1970%29%
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D000693 2000
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D000693 2005
% 216.49/216.70  |- skos__hiddenLabel mesh__D000693 Anaerobioses
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D000693 2001
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D000693 2006
% 216.49/216.70  |- rdf__type mesh__D000693sskos__Concept
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D000693 1998
% 216.49/216.70  |- mesh__historyNote mesh__D000693
% 216.49/216.70       91%28%71%29%; was see under METABOLISM 1971-90   
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D000693 2002
% 216.49/216.70  |- skos__prefLabel mesh__D000693 Anaerobiosis
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D000693 1999
% 216.49/216.70  |- skos__altLabel mesh__D013810 Clinical Equivalency
% 216.49/216.70  |- mesh__historyNote mesh__D013810 70   
% 216.49/216.70  |- skos__historyNote mesh__D013810 Pharmacology %28%1966-1969%29%
% 216.49/216.70  |- skos__altLabel mesh__D013810 Bioequivalence
% 216.49/216.70  |- mesh__recordOriginator mesh__D013810 NLM
% 216.49/216.70  |- mesh__publicMeSHNote mesh__D013810 70   
% 216.49/216.70  |- mesh__recordAuthorizer mesh__D013810 sjn
% 216.49/216.70  |- skos__altLabel mesh__D013810 Equivalencies, Therapeutic
% 216.49/216.70  |- skos__altLabel mesh__D013810 Equivalencies, Clinical
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D013810 2006
% 216.49/216.70  |- rdf__type mesh__D013810sskos__Concept
% 216.49/216.70  |- skos__altLabel mesh__D013810 Equivalency, Therapeutic
% 216.49/216.70  |- skos__hiddenLabel mesh__D013810 Equivalency, Generic
% 216.49/216.70  |- skos__hiddenLabel mesh__D013810 Equivalencies, Generic
% 216.49/216.70  |- mesh__dateEstablished mesh__D013810 1970-01-01
% 216.49/216.70  |- skos__prefLabel mesh__D013810 Therapeutic Equivalency
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D013810 2005
% 216.49/216.70  |- skos__historyNote mesh__D013810 Drugs %28%1966-1969%29%
% 216.49/216.70  |- skos__altLabel mesh__D013810 Clinical Equivalencies
% 216.49/216.70  |- skos__altLabel mesh__D013810 Therapeutic Equivalencies
% 216.49/216.70  |- skos__annotation mesh__D013810
% 216.49/216.70       NIM with specific drug /pharmacokin %28%IM%29%; no qualif; DF: THER EQUIVALENCY%A%  
% 216.49/216.70  |- skos__broader mesh__D013810smesh__D010599
% 216.49/216.70  |- skos__altLabel mesh__D013810 Generic Equivalency
% 216.49/216.70  |- mesh__dateRevised mesh__D013810 2004-07-07
% 216.49/216.70  |- skos__scopeNote mesh__D013810
% 216.49/216.70       The relative equivalency in the efficacy of different modes of treatment of a disease, most often used to compare the efficacy of different pharmaceuticals to treat a given disease.%A%    
% 216.49/216.70  |- skos__hiddenLabel mesh__D013810 Generic Equivalencies
% 216.49/216.70  |- skos__hiddenLabel mesh__D013810 Bioequivalences
% 216.49/216.70  |- mesh__recordMaintainer mesh__D013810 ssb
% 216.49/216.70  |- skos__altLabel mesh__D013810 Equivalency, Clinical
% 216.49/216.70  |- mesh__dateCreated mesh__D013810 1999-01-01
% 216.49/216.70  |- skos__altLabel mesh__D013012 Glucitol
% 216.49/216.70  |- rdf__type mesh__D013012sskos__Concept
% 216.49/216.70  |- mesh__recordMaintainer mesh__D013012 CCR
% 216.49/216.70  |- skos__altLabel mesh__D013012 Medefield Brand of Sorbitol
% 216.49/216.70  |- skos__altLabel mesh__D013012 Baxter Brand of Sorbitol
% 216.49/216.70  |- mesh__dateCreated mesh__D013012 1999-01-01
% 216.49/216.70  |- mesh__dateRevised mesh__D013012 2005-06-30
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D013012 2006
% 216.49/216.70  |- skos__altLabel mesh__D013012 Pharmacia Brand of Sorbitol
% 216.49/216.70  |- skos__scopeNote mesh__D013012
% 216.49/216.70       A polyhydric alcohol with about half the sweetness of sucrose. Sorbitol occurs naturally and is also produced synthetically from glucose. It was formerly used as a diuretic and may still be used as a laxative and in irrigating solutions for some surgical procedures. It is also used in many manufacturing processes, as a pharmaceutical aid, and in several research applications.%A%    
% 216.49/216.70  |- skos__broader mesh__D013012smesh__D013402
% 216.49/216.70  |- skos__altLabel mesh__D013012 Trommsdorff Brand of Sorbitol
% 216.49/216.70  |- mesh__recordOriginator mesh__D013012 NLM
% 216.49/216.70  |- mesh__recordAuthorizer mesh__D013012 sjn
% 216.49/216.70  |- skos__prefLabel mesh__D013012 Sorbitol
% 216.49/216.70  |- mesh__dateRevised mesh__D051131 2005-07-19
% 216.49/216.70  |- skos__scopeNote mesh__D051131
% 216.49/216.70       A group of cell-surface receptors for oxidatively modified LOW-DENSITY LIPOPROTEINS. The group includes certain SCAVENGER RECEPTORS that contribute to the pathogenesis of ATHEROSCLEROSIS by uptake of oxidized LDL.%A%    
% 216.49/216.70  |- mesh__publicMeSHNote mesh__D051131
% 216.49/216.70       2006; RECEPTORS, OXIDIZED LDL was indexd under RECEPTORS, LDL 1997-2004%A%  
% 216.49/216.70  |- skos__altLabel mesh__D051131 Oxidized LDL Receptor
% 216.49/216.70  |- skos__altLabel mesh__D051131 Oxidized LDL Receptors
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D051131 2006
% 216.49/216.70  |- skos__hiddenLabel mesh__D051131 Receptor, Ox-LDL
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D051131 2006A
% 216.49/216.70  |- mesh__dateEstablished mesh__D051131 2006-01-01
% 216.49/216.70  |- mesh__recordOriginator mesh__D051131 DRC
% 216.49/216.70  |- skos__altLabel mesh__D051131 Receptor, Oxidized LDL
% 216.49/216.70  |- mesh__dateCreated mesh__D051131 2005-06-30
% 216.49/216.70  |- mesh__historyNote mesh__D051131 2006%28%1997%29%   
% 216.49/216.70  |- skos__prefLabel mesh__D051131 Receptors, Oxidized LDL
% 216.49/216.70  |- skos__broader mesh__D051131smesh__D011973
% 216.49/216.70  |- mesh__recordAuthorizer mesh__D051131 ags
% 216.49/216.70  |- skos__hiddenLabel mesh__D051131 Ox LDL Receptor
% 216.49/216.70  |- skos__altLabel mesh__D051131 Ox-LDL Receptor
% 216.49/216.70  |- skos__hiddenLabel mesh__D051131 LDL Receptors, Oxidized
% 216.49/216.70  |- skos__hiddenLabel mesh__D051131 LDL Receptor, Oxidized
% 216.49/216.70  |- rdf__type mesh__D051131sskos__Concept
% 216.49/216.70  |- mesh__recordMaintainer mesh__D051131 ags
% 216.49/216.70  |- skos__altLabel mesh__D051131 Receptor, LDL, Oxidized
% 216.49/216.70  |- skos__prefLabel mesh__D004286 Dolichol
% 216.49/216.70  |- mesh__recordAuthorizer mesh__D004286 sjn
% 216.49/216.70  |- skos__broader mesh__D004286smesh__D013729
% 216.49/216.70  |- mesh__publicMeSHNote mesh__D004286
% 216.49/216.70       89; was see under DITERPENES 1975-88   
% 216.49/216.70  |- mesh__historyNote mesh__D004286
% 216.49/216.70       89%28%75%29%; was see under DITERPENES 1975-88   
% 216.49/216.70  |- skos__broader mesh__D004286smesh__D005233
% 216.49/216.70  |- mesh__recordMaintainer mesh__D004286 ssb
% 216.49/216.70  |- mesh__dateRevised mesh__D004286 2005-06-30
% 216.49/216.70  |- mesh__recordOriginator mesh__D004286 MEG
% 216.49/216.70  |- skos__scopeNote mesh__D004286
% 216.49/216.70       Eicosamethyl octacontanonadecasen-1-o1. Polyprenol found in animal tissues that contains about 20 isoprene residues, the one carrying the alcohol group being saturated.%A%    
% 216.49/216.70  |- rdf__type mesh__D004286sskos__Concept
% 216.49/216.70  |- skos__historyNote mesh__D004286 Fatty Alcohols %28%1974%29%
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D004286 2006
% 216.49/216.70  |- mesh__dateCreated mesh__D004286 1974-11-19
% 216.49/216.70  |- mesh__dateEstablished mesh__D004286 1989-01-01
% 216.49/216.70  |- skos__historyNote mesh__D004286 Diterpenes %28%1974%29%
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D012718 2002
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D012718 1997
% 216.49/216.70  |- mesh__publicMeSHNote mesh__D012718 65   
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D012718 1999
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D012718 2001
% 216.49/216.70  |- mesh__dateRevised mesh__D012718 1993-06-04
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D012718 1996
% 216.49/216.70  |- skos__broader mesh__D012718smesh__D007858
% 216.49/216.70  |- mesh__historyNote mesh__D012718 65   
% 216.49/216.70  |- mesh__recordOriginator mesh__D012718 NLM
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D012718 1998
% 216.49/216.70  |- skos__hiddenLabel mesh__D012718 Sets %28%Psychology%29%
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D012718 2004
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D012718 2000
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D012718 2006
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D012718 1995
% 216.49/216.70  |- mesh__recordMaintainer mesh__D012718 JLS
% 216.49/216.70  |- skos__altLabel mesh__D012718 Set
% 216.49/216.70  |- mesh__dateCreated mesh__D012718 1999-01-01
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D012718 2003
% 216.49/216.70  |- mesh__dateEstablished mesh__D012718 1965-01-01
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D012718 2005
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D012718 1994
% 216.49/216.70  |- mesh__recordAuthorizer mesh__D012718 PLS
% 216.49/216.70  |- skos__scopeNote mesh__D012718
% 216.49/216.70       Readiness to think or respond in a predetermined way when confronted with a problem or stimulus situation.%A%    
% 216.49/216.70  |- skos__prefLabel mesh__D012718 Set %28%Psychology%29%
% 216.49/216.70  |- skos__annotation mesh__D012718 no qualif; DF: SET   
% 216.49/216.70  |- rdf__type mesh__D012718sskos__Concept
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D017403 2004
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D017403 2006
% 216.49/216.70  |- mesh__dateRevised mesh__D017403 2000-06-22
% 216.49/216.70  |- skos__scopeNote mesh__D017403
% 216.49/216.70       A technique that localizes specific nucleic acid sequences within intact chromosomes, eukaryotic cells, or bacterial cells through the use of specific nucleic acid-labeled probes.%A%    
% 216.49/216.70  |- skos__altLabel mesh__D017403 Hybridization in Situ
% 216.49/216.70  |- skos__hiddenLabel mesh__D017403 In Situ Hybridizations
% 216.49/216.70  |- mesh__publicMeSHNote mesh__D017403 93   
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D017403 2003
% 216.49/216.70  |- mesh__dateCreated mesh__D017403 1992-05-20
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D017403 2005
% 216.49/216.70  |- skos__broader mesh__D017403smesh__D013194
% 216.49/216.70  |- skos__hiddenLabel mesh__D017403 Hybridizations, In Situ
% 216.49/216.70  |- mesh__dateEstablished mesh__D017403 1993-01-01
% 216.49/216.70  |- rdf__type mesh__D017403sskos__Concept
% 216.49/216.70  |- mesh__historyNote mesh__D017403 93   
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D017403 2002
% 216.49/216.70  |- skos__historyNote mesh__D017403
% 216.49/216.70       Nucleic Acid Hybridization %28%1971-1992%29%
% 216.49/216.70  |- skos__prefLabel mesh__D017403 In Situ Hybridization
% 216.49/216.70  |- skos__broader mesh__D017403smesh__D009693
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D017403 2001
% 216.49/216.70  |- skos__hiddenLabel mesh__D017403 Hybridization, In Situ
% 216.49/216.70  |- skos__annotation mesh__D017403 to locate specific nucleic acid seq   
% 216.49/216.70  |- mesh__recordMaintainer mesh__D050837 ags
% 216.49/216.70  |- mesh__recordOriginator mesh__D050837 jmp
% 216.49/216.70  |- mesh__dateCreated mesh__D050837 2005-06-30
% 216.49/216.70  |- rdf__type mesh__D050837sskos__Concept
% 216.49/216.70  |- skos__prefLabel mesh__D050837
% 216.49/216.70       Oxidoreductases Acting on Aldehyde or Oxo Group Donors
% 216.49/216.70  |- mesh__dateRevised mesh__D050837 2005-07-22
% 216.49/216.70  |- skos__historyNote mesh__D050837 Oxidoreductases %28%1963-2005%29%
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D050837 2006A
% 216.49/216.70  |- skos__broader mesh__D050837smesh__D010088
% 216.49/216.70  |- mesh__historyNote mesh__D050837 2006   
% 216.49/216.70  |- mesh__recordAuthorizer mesh__D050837 ags
% 216.49/216.70  |- mesh__publicMeSHNote mesh__D050837 2006   
% 216.49/216.70  |- skos__scopeNote mesh__D050837
% 216.49/216.70       A broad category of oxidoreductases that either reduce double bonds or oxidize single bonds between OXYGEN and CARBON in organic compounds.%A%    
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D050837 2006
% 216.49/216.70  |- mesh__dateEstablished mesh__D050837 2006-01-01
% 216.49/216.70  |- mesh__dateCreated mesh__D047090 2004-07-07
% 216.49/216.70  |- mesh__publicMeSHNote mesh__D047090 2005; see LACTAMS 1996-2004   
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D047090 2006
% 216.49/216.70  |- skos__historyNote mesh__D047090 Lactams %28%1974-2004%29%
% 216.49/216.70  |- skos__hiddenLabel mesh__D047090 beta Lactams
% 216.49/216.70  |- mesh__recordOriginator mesh__D047090 ssb
% 216.49/216.70  |- skos__broader mesh__D047090smesh__D007769
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D047090 2005
% 216.49/216.70  |- rdf__type mesh__D047090sskos__Concept
% 216.49/216.70  |- mesh__recordAuthorizer mesh__D047090 sjn
% 216.49/216.70  |- skos__prefLabel mesh__D047090 beta-Lactams
% 216.49/216.70  |- mesh__recordMaintainer mesh__D047090 ssb
% 216.49/216.70  |- skos__scopeNote mesh__D047090
% 216.49/216.70       Four-membered cyclic AMIDES, best known for the PENICILLINS based on a bicyclo-thiazolidine, and including monocyclic MONOBACTAMS. BETA-LACTAMASES hydrolyze the beta lactam ring, accounting for BETA-LACTAM RESISTANCE of infective bacteria.%A%    
% 216.49/216.70  |- mesh__historyNote mesh__D047090 2005; use LACTAMS 1996-2004   
% 216.49/216.70  |- mesh__dateEstablished mesh__D047090 2005-01-01
% 216.49/216.70  |- mesh__recordMaintainer mesh__D008677 nns
% 216.49/216.70  |- mesh__dateCreated mesh__D008677 1977-05-10
% 216.49/216.70  |- skos__prefLabel mesh__D008677 Metaphase
% 216.49/216.70  |- mesh__recordOriginator mesh__D008677 AEP
% 216.49/216.70  |- skos__historyNote mesh__D008677 Cell Division %28%1966-1974%29%
% 216.49/216.70  |- rdf__type mesh__D008677sskos__Concept
% 216.49/216.70  |- skos__annotation mesh__D008677
% 216.49/216.70       coordinate with specific cell /cytol; permitted with microorganisms; M PHASE = either M PHASE see CELL DIVISION,  MITOTIC or MEIOTIC M PHASE, check text%A%  
% 216.49/216.70  |- mesh__dateEstablished mesh__D008677 1981-01-01
% 216.49/216.70  |- skos__hiddenLabel mesh__D008677 Metaphases
% 216.49/216.70  |- mesh__dateRevised mesh__D008677 2005-06-30
% 216.49/216.70  |- skos__scopeNote mesh__D008677
% 216.49/216.70       The phase of cell nucleus division following PROMETAPHASE, in which the CHROMOSOMES line up across the equatorial plane of the MITOTIC SPINDLE APPARATUS prior to separation.%A%    
% 216.49/216.70  |- mesh__publicMeSHNote mesh__D008677
% 216.49/216.70       81; was see under CELL CYCLE 1978-80, was see MITOSIS 1975-77%A%  
% 216.49/216.70  |- skos__historyNote mesh__D008677 Mitosis %28%1968-1977%29%
% 216.49/216.70  |- mesh__historyNote mesh__D008677
% 216.49/216.70       81%28%78%29%; was see under CELL CYCLE 1978-80, was see MITOSIS 1975-77%A%  
% 216.49/216.70  |- mesh__onlineNote mesh__D008677 search MITOSIS 1975-77   
% 216.49/216.70  |- skos__broader mesh__D008677smesh__D048750
% 216.49/216.70  |- skos__broader mesh__D008677smesh__D008938
% 216.49/216.70  |- mesh__recordAuthorizer mesh__D008677 sjn
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D008677 2006
% 216.49/216.70  |- skos__scopeNote mesh__D000694 Tumors or cancer of the anal gland.     
% 216.49/216.70  |- skos__historyNote mesh__D000694 Anus Neoplasms %28%1966-1967%29%
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D000694 2004
% 216.49/216.70  |- skos__broader mesh__D000694smesh__D000820
% 216.49/216.70  |- skos__altLabel mesh__D000694 Neoplasms, Perianal Gland
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D000694 2005
% 216.49/216.70  |- skos__annotation mesh__D000694
% 216.49/216.70       coord IM with histol type of neopl %28%IM%29%; do not confuse with ANUS NEOPLASMS; coord with ANAL SACS for anal sac neoplasms; don%27%t forget check tag ANIMALS%A%  
% 216.49/216.70  |- skos__hiddenLabel mesh__D000694 Neoplasm, Anal Gland
% 216.49/216.70  |- skos__altLabel mesh__D000694 Perianal Gland Neoplasms
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D000694 2006
% 216.49/216.70  |- rdf__type mesh__D000694sskos__Concept
% 216.49/216.70  |- skos__broader mesh__D000694smesh__D009371
% 216.49/216.70  |- mesh__recordAuthorizer mesh__D000694 sjn
% 216.49/216.70  |- skos__altLabel mesh__D000694 Neoplasms, Circumanal Gland
% 216.49/216.70  |- skos__hiddenLabel mesh__D000694 Circumanal Gland Neoplasm
% 216.49/216.70  |- mesh__dateRevised mesh__D000694 2003-07-30
% 216.49/216.70  |- skos__broader mesh__D000694smesh__D001005
% 216.49/216.70  |- skos__prefLabel mesh__D000694 Anal Gland Neoplasms
% 216.49/216.70  |- mesh__recordOriginator mesh__D000694 NLM
% 216.49/216.70  |- skos__altLabel mesh__D000694 Circumanal Gland Neoplasms
% 216.49/216.70  |- mesh__dateEstablished mesh__D000694 1968-01-01
% 216.49/216.70  |- mesh__historyNote mesh__D000694 68   
% 216.49/216.70  |- mesh__dateCreated mesh__D000694 1999-01-01
% 216.49/216.70  |- skos__hiddenLabel mesh__D000694 Neoplasm, Circumanal Gland
% 216.49/216.70  |- skos__hiddenLabel mesh__D000694 Anal Gland Neoplasm
% 216.49/216.70  |- skos__hiddenLabel mesh__D000694 Perianal Gland Neoplasm
% 216.49/216.70  |- skos__altLabel mesh__D000694 Neoplasms, Anal Gland
% 216.49/216.70  |- mesh__publicMeSHNote mesh__D000694 68   
% 216.49/216.70  |- mesh__recordMaintainer mesh__D000694 lkt
% 216.49/216.70  |- skos__hiddenLabel mesh__D000694 Neoplasm, Perianal Gland
% 216.49/216.70  |- rdf__type mesh__D013811sskos__Concept
% 216.49/216.70  |- mesh__activeMeSHYear mesh__D013811 2006
% 216.49/216.70  |- mesh__dateRevised mesh__D013811 1997-06-20
% 216.49/216.71  |- mesh__activeMeSHYear mesh__D013811 2004
% 216.49/216.71  |- mesh__publicMeSHNote mesh__D013811 98   
% 216.49/216.71  |- mesh__activeMeSHYear mesh__D013811 2005
% 216.49/216.71  |- mesh__recordAuthorizer mesh__D013811 SJN
% 216.49/216.71  |- mesh__recordOriginator mesh__D013811 NLM
% 216.49/216.71  |- mesh__activeMeSHYear mesh__D013811 2001
% 216.49/216.71  |- mesh__activeMeSHYear mesh__D013811 2003
% 216.49/216.71  |- skos__altLabel mesh__D013811 Therapeutic Process, Psychiatric
% 216.49/216.71  |- skos__annotation mesh__D013811
% 216.49/216.71       GEN or unspecified; prefer specifics; DF: PSYCHOTHER PROCESSES%A%  
% 216.49/216.71  |- skos__altLabel mesh__D013811 Therapeutic Processes, Psychiatric
% 216.49/216.71  |- mesh__activeMeSHYear mesh__D013811 2000
% 216.49/216.71  |- mesh__dateEstablished mesh__D013811 1998-01-01
% 216.49/216.71  |- skos__broader mesh__D013811smesh__D011613
% 216.49/216.71  |- skos__altLabel mesh__D013811 Psychiatric Therapeutic Processes
% 216.49/216.71  |- mesh__historyNote mesh__D013811 98; use explode 1971-97   
% 216.49/216.71  |- mesh__activeMeSHYear mesh__D013811 1999
% 216.49/216.71  |- mesh__recordMaintainer mesh__D013811 TGC
% 216.49/216.71  |- skos__scopeNote mesh__D013811
% 216.49/216.71       Experiential, attitudinal, emotional, or behavioral phenomena occurring during the course of treatment. They apply to the patient or therapist %28%i.e., nurse, doctor, etc.%29% individually or to their interaction. %28%American Psychological Association: Thesaurus of Psychological Index Terms, 1994%29%%A%    
% 216.49/216.71  |- skos__altLabel mesh__D013811 Processes, Psychiatric Therapeutic
% 216.49/216.71  |- skos__hiddenLabel mesh__D013811 Psychotherapeutic Process
% 216.49/216.71  |- skos__altLabel mesh__D013811 Process, Psychotherapeutic
% 216.49/216.71  |- skos__historyNote mesh__D013811 Psychotherapy %28%1966-1997%29%
% 216.49/216.71  |- skos__altLabel mesh__D013811 Process, Psychiatric Therapeutic
% 216.49/216.71  |- skos__altLabel mesh__D013811 Psychiatric Therapeutic Process
% 216.49/216.71  |- mesh__activeMeSHYear mesh__D013811 1998
% 216.49/216.71  |- mesh__dateCreated mesh__D013811 1999-01-01
% 216.49/216.71  |- skos__altLabel mesh__D013811 Processes, Psychotherapeutic
% 216.49/216.71  |- mesh__activeMeSHYear mesh__D013811 2002
% 216.49/216.71  |- skos__prefLabel mesh__D013811 Psychotherapeutic Processes
% 216.49/216.71  |- rdf__type mesh__D013013sskos__Concept
% 216.49/216.71  |- skos__hiddenLabel mesh__D013013 L Sorbose
% 216.49/216.71  |- mesh__recordMaintainer mesh__D013013 ssb
% 216.49/216.71  |- skos__broader mesh__D013013smesh__D006601
% 216.49/216.71  |- skos__broader mesh__D013013smesh__D007661
% 216.49/216.71  |- mesh__recordAuthorizer mesh__D013013 sjn
% 216.49/216.71  |- mesh__dateRevised mesh__D013013 2004-07-07
% 216.49/216.71  |- mesh__activeMeSHYear mesh__D013013 2005
% 216.49/216.71  |- mesh__recordOriginator mesh__D013013 NLM
% 216.49/216.71  |- mesh__activeMeSHYear mesh__D013013 2006
% 216.49/216.71  |- skos__hiddenLabel mesh__D013013 D Sorbose
% 216.49/216.71  |- skos__altLabel mesh__D013013 D-Sorbose
% 216.49/216.71  |- skos__prefLabel mesh__D013013 Sorbose
% 216.49/216.71  |- mesh__dateCreated mesh__D013013 1999-01-01
% 216.49/216.71  |- mesh__recordMaintainer mesh__D051930 DRC
% 216.49/216.71  |- skos__broader mesh__D051930smesh__D052116
% 216.49/216.71  |- mesh__recordOriginator mesh__D051930 DRC
% 216.49/216.71  |- skos__prefLabel mesh__D051930 Antigens, CD164
% 216.49/216.71  |- mesh__publicMeSHNote mesh__D051930
% 216.49/216.71       2006; ANTIGENS, CD164 was indexed under CD ANTIGENS %26% NEURAL CELL ADHESION MOLECULES 2005, %26% under MEMBRANE GLYCOPROTEINS 1990-2004, %26% under NEOPLASM PROTEINS 1993-2002%A%  
% 216.49/216.71  |- skos__broader mesh__D051930smesh__D015815
% 216.49/216.71  |- mesh__recordAuthorizer mesh__D051930 sjn
% 216.49/216.71  |- skos__hiddenLabel mesh__D051930 Antigen, CD164
% 216.49/216.71  |- mesh__dateEstablished mesh__D051930 2006-01-01
% 216.49/216.71  |- skos__scopeNote mesh__D051930
% 216.49/216.71       A sialomucin protein that functions as a cell adhesion molecule. It is a negative regulator of certain types of HEMATOPOIETIC STEM CELLS.%A%    
% 216.49/216.71  |- mesh__historyNote mesh__D051930 2006%28%1990%29%   
% 216.49/216.71  |- mesh__dateCreated mesh__D051930 2005-06-30
% 216.49/216.71  |- skos__broader mesh__D051930smesh__D015703
% 216.49/216.71  |- rdf__type mesh__D051930sskos__Concept
% 216.49/216.71  |- skos__altLabel mesh__D051930 Endolyn
% 216.49/216.71  |- mesh__activeMeSHYear mesh__D051930 2006
% 216.49/216.71  |- skos__altLabel mesh__D051930 CD164 Antigens
% 216.49/216.71  |- skos__altLabel mesh__D051930 CD164 Antigen
% 216.49/216.71  |- skos__hiddenLabel mesh__D004287 Monophosphate Mannose, Dolichol
% 216.49/216.71  |- skos__hiddenLabel mesh__D004287
% 216.49/216.71       Dolichyl Alpha D Mannopyranosyl Phosphate
% 216.49/216.71  |- skos__altLabel mesh__D004287 Dolicholphosphate Mannose
% 216.49/216.71  |- mesh__dateEstablished mesh__D004287 1991-01-01
% 216.49/216.71  |- skos__scopeNote mesh__D004287
% 216.49/216.71       A lipophilic glycosyl carrier of the monosaccharide mannose in the biosynthesis of oligosaccharide phospholipids and glycoproteins.%A%    
% 216.49/216.71  |- skos__historyNote mesh__D004287 Diterpenes %28%1974%29%
% 216.49/216.71  |- skos__hiddenLabel mesh__D004287 Phosphoryl Dolichol, Mannosyl
% 216.49/216.71  |- skos__hiddenLabel mesh__D004287 Phosphate, Dolichyl Mannopyranosyl
% 216.57/216.77  |- skos__hiddenLabel mesh__D004287 Dolichol, Mannosyl Phosphoryl
% 216.57/216.77  |- rdf__type mesh__D004287sskos__Concept
% 216.57/216.77  |- skos__hiddenLabel mesh__D004287
% 216.57/216.77       Alpha-D-Mannopyranosyl Phosphate, Dolichyl
% 216.57/216.77  |- skos__hiddenLabel mesh__D004287 D Mannopyranosyldolichyl
% 216.57/216.77  |- mesh__recordAuthorizer mesh__D004287 sjn
% 216.57/216.77  |- skos__historyNote mesh__D004287 Dolichol %28%1975-1977%29%
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D004287 2005
% 216.57/216.77  |- skos__hiddenLabel mesh__D004287 Phosphate, Dolichyl Mannosyl
% 216.57/216.77  |- skos__altLabel mesh__D004287 Dolichyl Alpha-D-Mannopyranosyl Phosphate
% 216.57/216.77  |- skos__broader mesh__D004287smesh__D011103
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D004287 2006
% 216.57/216.77  |- skos__hiddenLabel mesh__D004287 Mannose, Dolicholphosphate
% 216.57/216.77  |- skos__altLabel mesh__D004287 Dolichyl Mannopyranosyl Phosphate
% 216.57/216.77  |- skos__altLabel mesh__D004287 D-Mannopyranosyldolichyl
% 216.57/216.77  |- mesh__recordMaintainer mesh__D004287 ssb
% 216.57/216.77  |- mesh__recordOriginator mesh__D004287 RLS
% 216.57/216.77  |- mesh__dateRevised mesh__D004287 2004-07-07
% 216.57/216.77  |- skos__hiddenLabel mesh__D004287 Mannose, Dolichol Monophosphate
% 216.57/216.77  |- skos__hiddenLabel mesh__D004287 Mannopyranosyl Phosphate, Dolichyl
% 216.57/216.77  |- mesh__dateCreated mesh__D004287 1977-05-16
% 216.57/216.77  |- skos__altLabel mesh__D004287 Dolichyl Mannosyl Phosphate
% 216.57/216.77  |- mesh__historyNote mesh__D004287
% 216.57/216.77       91%28%78%29%; was see under POLYISOPRENYL PHOSPHATE SUGARS 1978-90%A%  
% 216.57/216.77  |- skos__altLabel mesh__D004287 Mannosyl Phosphoryl Dolichol
% 216.57/216.77  |- skos__hiddenLabel mesh__D004287
% 216.57/216.77       Phosphate, Dolichyl Alpha-D-Mannopyranosyl
% 216.57/216.77  |- skos__prefLabel mesh__D004287 Dolichol Monophosphate Mannose
% 216.57/216.77  |- skos__historyNote mesh__D004287 Hexosephosphates %28%1966-1977%29%
% 216.57/216.77  |- skos__altLabel mesh__D004287 Mannolipid
% 216.57/216.77  |- skos__hiddenLabel mesh__D004287 Mannosyl Phosphate, Dolichyl
% 216.57/216.77  |- mesh__publicMeSHNote mesh__D004287
% 216.57/216.77       91; was see under POLYISOPRENYL PHOSPHATE SUGARS 1978-90   
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D012719 2000
% 216.57/216.77  |- mesh__recordAuthorizer mesh__D012719 ags
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D012719 2004
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D012719 2006
% 216.57/216.77  |- mesh__dateCreated mesh__D012719 1999-01-01
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D012719 2003
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D012719 2006A
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D012719 2005
% 216.57/216.77  |- skos__hiddenLabel mesh__D012719 Setariases
% 216.57/216.77  |- mesh__dateRevised mesh__D012719 2005-07-29
% 216.57/216.77  |- mesh__publicMeSHNote mesh__D012719
% 216.57/216.77       91; was see under FILARIASIS 1975-90   
% 216.57/216.77  |- rdf__type mesh__D012719sskos__Concept
% 216.57/216.77  |- skos__broader mesh__D012719smesh__D005368
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D012719 2002
% 216.57/216.77  |- mesh__dateEstablished mesh__D012719 1991-01-01
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D012719 2001
% 216.57/216.77  |- mesh__historyNote mesh__D012719
% 216.57/216.77       91%28%75%29%; was see under FILARIASIS 1975-90   
% 216.57/216.77  |- mesh__recordOriginator mesh__D012719 NLM
% 216.57/216.77  |- mesh__recordMaintainer mesh__D012719 ags
% 216.57/216.77  |- mesh__onlineNote mesh__D012719 search FILARIASIS 1968-74   
% 216.57/216.77  |- skos__annotation mesh__D012719 /drug ther: consider FILARICIDES   
% 216.57/216.77  |- skos__broader mesh__D012719smesh__D006374
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D012719 1999
% 216.57/216.77  |- skos__prefLabel mesh__D012719 Setariasis
% 216.57/216.77  |- skos__scopeNote mesh__D012719
% 216.57/216.77       Infection with nematodes of the genus Setaria. This condition is usually seen in cattle and equines and is of little pathogenic significance, although migration of the worm to the eye may lead to blindness.%A%    
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D009770 2005
% 216.57/216.77  |- skos__hiddenLabel mesh__D009770 Behavior, Obsessive
% 216.57/216.77  |- skos__prefLabel mesh__D009770 Obsessive Behavior
% 216.57/216.77  |- skos__scopeNote mesh__D009770
% 216.57/216.77       Persistent, unwanted idea or impulse which is considered normal when it does not markedly interfere with mental processes or emotional adjustment.%A%    
% 216.57/216.77  |- mesh__historyNote mesh__D009770
% 216.57/216.77       91%28%75%29%; was see under COMPULSIVE BEHAVIOR 1975-90; OBSESSION was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-78%A%  
% 216.57/216.77  |- mesh__recordOriginator mesh__D009770 NLM
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D009770 2006
% 216.57/216.77  |- mesh__dateEstablished mesh__D009770 1991-01-01
% 216.57/216.77  |- rdf__type mesh__D009770sskos__Concept
% 216.57/216.77  |- skos__hiddenLabel mesh__D009770 Behaviors, Obsessive
% 216.57/216.77  |- skos__hiddenLabel mesh__D009770 Obsession
% 216.57/216.77  |- mesh__recordAuthorizer mesh__D009770 sjn
% 216.57/216.77  |- mesh__publicMeSHNote mesh__D009770
% 216.57/216.77       91; was see under COMPULSIVE BEHAVIOR 1975-90; OBSESSION was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-78%A%  
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D009770 2003
% 216.57/216.77  |- skos__hiddenLabel mesh__D009770 Obsessive Behaviors
% 216.57/216.77  |- mesh__dateCreated mesh__D009770 1999-01-01
% 216.57/216.77  |- skos__broader mesh__D009770smesh__D001526
% 216.57/216.77  |- mesh__dateRevised mesh__D009770 2002-07-02
% 216.57/216.77  |- mesh__onlineNote mesh__D009770
% 216.57/216.77       use COMPULSIVE BEHAVIOR to search OBSESSIVE BEHAVIOR 1968-74; use OBSESSIVE-COMPULSIVE BEHAVIOR to search OBSESSION 1968-74%A%  
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D009770 2004
% 216.57/216.77  |- skos__annotation mesh__D009770 use Cat F3 qualif   
% 216.57/216.77  |- mesh__recordMaintainer mesh__D009770 JLS
% 216.57/216.77  |- mesh__dateCreated mesh__D023441 2000-06-22
% 216.57/216.77  |- skos__prefLabel mesh__D023441 Local Lymph Node Assay
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D023441 2004
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D023441 2005
% 216.57/216.77  |- mesh__publicMeSHNote mesh__D023441 2001   
% 216.57/216.77  |- mesh__dateEstablished mesh__D023441 2001-01-01
% 216.57/216.77  |- skos__scopeNote mesh__D023441
% 216.57/216.77       The local lymph node assay %28%LLNA%29% is an alternative method for the identification of chemicals that have the ability to cause skin sensitization and allergic contact dermatitis. Endpoints have been established so fewer animals are required and less painful procedures are used.%A%    
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D023441 2001
% 216.57/216.77  |- mesh__historyNote mesh__D023441 2001   
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D023441 2006
% 216.57/216.77  |- skos__altLabel mesh__D023441 LLNA
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D023441 2002
% 216.57/216.77  |- skos__broader mesh__D023441smesh__D012882
% 216.57/216.77  |- rdf__type mesh__D023441sskos__Concept
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D023441 2003
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D017404 2003
% 216.57/216.77  |- mesh__recordAuthorizer mesh__D017404 sjn
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D017404 2001
% 216.57/216.77  |- skos__hiddenLabel mesh__D017404 Technique, FISH
% 216.57/216.77  |- skos__altLabel mesh__D017404 In Situ Hybridization, Fluorescent
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D017404 2005
% 216.57/216.77  |- skos__broader mesh__D017404smesh__D020732
% 216.57/216.77  |- skos__altLabel mesh__D017404 FISH Technique
% 216.57/216.77  |- skos__historyNote mesh__D017404
% 216.57/216.77       Nucleic Acid Hybridization %28%1977-1992%29%
% 216.57/216.77  |- skos__altLabel mesh__D017404 Hybridization in Situ, Fluorescence
% 216.57/216.77  |- skos__hiddenLabel mesh__D017404 Technic, FISH
% 216.57/216.77  |- skos__altLabel mesh__D017404 Fluorescent in Situ Hybridization
% 216.57/216.77  |- skos__hiddenLabel mesh__D017404 FISH Techniques
% 216.57/216.77  |- skos__historyNote mesh__D017404
% 216.57/216.77       Microscopy, Fluorescence %28%1977-1992%29%
% 216.57/216.77  |- rdf__type mesh__D017404sskos__Concept
% 216.57/216.77  |- skos__altLabel mesh__D017404 Hybridization in Situ, Fluorescent
% 216.57/216.77  |- mesh__historyNote mesh__D017404 93   
% 216.57/216.77  |- mesh__publicMeSHNote mesh__D017404 93   
% 216.57/216.77  |- skos__prefLabel mesh__D017404 In Situ Hybridization, Fluorescence
% 216.57/216.77  |- skos__hiddenLabel mesh__D017404 Techniques, FISH
% 216.57/216.77  |- mesh__dateCreated mesh__D017404 1992-05-20
% 216.57/216.77  |- skos__broader mesh__D017404smesh__D017403
% 216.57/216.77  |- mesh__recordMaintainer mesh__D017404 ags
% 216.57/216.77  |- skos__altLabel mesh__D017404 FISH Technic
% 216.57/216.77  |- mesh__dateEstablished mesh__D017404 1993-01-01
% 216.57/216.77  |- skos__hiddenLabel mesh__D017404 FISH Technics
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D017404 2004
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D017404 2002
% 216.57/216.77  |- skos__scopeNote mesh__D017404
% 216.57/216.77       A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.%A%    
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D017404 2006
% 216.57/216.77  |- mesh__dateRevised mesh__D017404 2000-06-22
% 216.57/216.77  |- mesh__recordOriginator mesh__D017404 PXP
% 216.57/216.77  |- skos__hiddenLabel mesh__D017404 Technics, FISH
% 216.57/216.77  |- mesh__publicMeSHNote mesh__D050838
% 216.57/216.77       2006; INTERFERON REGULATORY FACTOR-3 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1996-2005%A%  
% 216.57/216.77  |- skos__hiddenLabel mesh__D050838 IRF 3 Transcription Factor
% 216.57/216.77  |- mesh__historyNote mesh__D050838 2006%28%1996%29%   
% 216.57/216.77  |- rdf__type mesh__D050838sskos__Concept
% 216.57/216.77  |- mesh__dateRevised mesh__D050838 2005-07-21
% 216.57/216.77  |- skos__broader mesh__D050838smesh__D050835
% 216.57/216.77  |- skos__scopeNote mesh__D050838
% 216.57/216.77       An interferon regulatory factor that is expressed constitutively and undergoes POST-TRANSLATIONAL MODIFICATION following viral infection. PHOSPHORYLATION of IRF-3 causes the protein to be translocated from the CYTOPLASM to CELL NUCLEUS where it binds DNA, and activates transcription.%A%    
% 216.57/216.77  |- skos__altLabel mesh__D050838 IFN-Regulatory Factor 3
% 216.57/216.77  |- mesh__recordAuthorizer mesh__D050838 ags
% 216.57/216.77  |- skos__hiddenLabel mesh__D050838 IFN Regulatory Factor 3
% 216.57/216.77  |- mesh__dateEstablished mesh__D050838 2006-01-01
% 216.57/216.77  |- mesh__dateCreated mesh__D050838 2005-06-30
% 216.57/216.77  |- skos__altLabel mesh__D050838 IRF-3 Transcription Factor
% 216.57/216.77  |- skos__prefLabel mesh__D050838 Interferon Regulatory Factor-3
% 216.57/216.77  |- mesh__recordOriginator mesh__D050838 DRC
% 216.57/216.77  |- skos__hiddenLabel mesh__D050838 Interferon Regulatory Factor 3
% 216.57/216.77  |- skos__broader mesh__D050838smesh__D010750
% 216.57/216.77  |- mesh__recordMaintainer mesh__D050838 ags
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D050838 2006A
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D050838 2006
% 216.57/216.77  |- skos__hiddenLabel mesh__D050838 Transcription Factor, IRF-3
% 216.57/216.77  |- mesh__recordMaintainer mesh__D047091 ssb
% 216.57/216.77  |- rdf__type mesh__D047091sskos__Concept
% 216.57/216.77  |- skos__historyNote mesh__D047091 Blood Proteins %28%1979-2004%29%
% 216.57/216.77  |- skos__prefLabel mesh__D047091 Eosinophil Granule Proteins
% 216.57/216.77  |- mesh__dateEstablished mesh__D047091 2005-01-01
% 216.57/216.77  |- skos__hiddenLabel mesh__D047091 Granule Proteins, Eosinophil
% 216.57/216.77  |- skos__broader mesh__D047091smesh__D007162
% 216.57/216.77  |- mesh__recordOriginator mesh__D047091 jmp
% 216.57/216.77  |- mesh__publicMeSHNote mesh__D047091
% 216.57/216.77       2005; EOSINOPHIL GRANULE PROTEINS was indexed under BLOOD PROTEINS %26% RIBONUCLEASES 1979-2004%A%  
% 216.57/216.77  |- skos__scopeNote mesh__D047091
% 216.57/216.77       Proteins found in EOSINOPHIL granules. They are primarily basic proteins that play a role in host defense and the proinflammatory actions of activated eosinophils.%A%    
% 216.57/216.77  |- mesh__dateRevised mesh__D047091 2005-06-30
% 216.57/216.77  |- skos__hiddenLabel mesh__D047091 Antigen, EG2
% 216.57/216.77  |- mesh__recordAuthorizer mesh__D047091 sjn
% 216.57/216.77  |- mesh__historyNote mesh__D047091 2005%28%1979%29%   
% 216.57/216.77  |- mesh__dateCreated mesh__D047091 2004-07-07
% 216.57/216.77  |- skos__historyNote mesh__D047091 Ribonucleases %28%1979-2004%29%
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D047091 2006
% 216.57/216.77  |- skos__scopeNote mesh__D008678
% 216.57/216.77       The branch of philosophy that treats of first principles, including ontology %28%the nature of existence or being%29% and cosmology %28%the origin and structure of the universe%29%. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D008678 1996
% 216.57/216.77  |- rdf__type mesh__D008678sskos__Concept
% 216.57/216.77  |- skos__prefLabel mesh__D008678 Metaphysics
% 216.57/216.77  |- mesh__recordMaintainer mesh__D008678 TGC
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D008678 2002
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D008678 1997
% 216.57/216.77  |- mesh__recordAuthorizer mesh__D008678 PLS
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D008678 2005
% 216.57/216.77  |- skos__annotation mesh__D008678 only /hist   
% 216.57/216.77  |- mesh__dateCreated mesh__D008678 1999-01-01
% 216.57/216.77  |- skos__broader mesh__D008678smesh__D010684
% 216.57/216.77  |- skos__hiddenLabel mesh__D008678 Metaphysic
% 216.57/216.77  |- mesh__dateRevised mesh__D008678 1995-05-18
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D008678 2006
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D008678 1998
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D008678 2000
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D008678 2003
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D008678 2001
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D008678 1999
% 216.57/216.77  |- mesh__recordOriginator mesh__D008678 NLM
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D008678 2004
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D000695 2005
% 216.57/216.77  |- skos__annotation mesh__D000695
% 216.57/216.77       for neopl, coord with ANAL GLAND NEOPLASMS   
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D000695 2006
% 216.57/216.77  |- rdf__type mesh__D000695sskos__Concept
% 216.57/216.77  |- mesh__recordMaintainer mesh__D000695 sjn
% 216.57/216.77  |- skos__prefLabel mesh__D000695 Anal Sacs
% 216.57/216.77  |- skos__broader mesh__D000695smesh__D000825
% 216.57/216.77  |- mesh__dateEstablished mesh__D000695 1968-01-01
% 216.57/216.77  |- mesh__dateRevised mesh__D000695 2004-07-13
% 216.57/216.77  |- mesh__dateCreated mesh__D000695 1999-01-01
% 216.57/216.77  |- mesh__recordAuthorizer mesh__D000695 sjn
% 216.57/216.77  |- skos__historyNote mesh__D000695 Anus %28%1966-1967%29%
% 216.57/216.77  |- skos__hiddenLabel mesh__D000695 Anal Sac
% 216.57/216.77  |- mesh__publicMeSHNote mesh__D000695 68   
% 216.57/216.77  |- skos__altLabel mesh__D000695 Anal Glands, Animal
% 216.57/216.77  |- mesh__recordOriginator mesh__D000695 NLM
% 216.57/216.77  |- skos__hiddenLabel mesh__D000695 Anal Gland, Animal
% 216.57/216.77  |- skos__historyNote mesh__D000695 Carnivora %28%1966-1967%29%
% 216.57/216.77  |- skos__scopeNote mesh__D000695
% 216.57/216.77        A pair of anal glands or sacs, located on either side of the ANUS, that produce and store a dark, foul-smelling fluid in carnivorous animals such as  MEPHITIDAE and DOGS. The expelled fluid is used as a defensive repellent %28%in skunks%29% or a material to mark territory %28%in dogs%29%.%A%    
% 216.57/216.77  |- mesh__historyNote mesh__D000695 68   
% 216.57/216.77  |- skos__hiddenLabel mesh__D005380 Public Financing
% 216.57/216.77  |- skos__hiddenLabel mesh__D005380 Aids, Federal
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D005380 2006
% 216.57/216.77  |- mesh__recordMaintainer mesh__D005380 ags
% 216.57/216.77  |- mesh__dateEstablished mesh__D005380 1968-01-01
% 216.57/216.77  |- skos__annotation mesh__D005380
% 216.57/216.77       specify geog for the govt; CATALOG: Use NAF entry for specific laws%A%  
% 216.57/216.77  |- skos__hiddenLabel mesh__D005380 Government Subsidy
% 216.57/216.77  |- mesh__dateCreated mesh__D005380 1999-01-01
% 216.57/216.77  |- skos__altLabel mesh__D005380 Government Financing
% 216.57/216.77  |- mesh__recordAuthorizer mesh__D005380 sjn
% 216.57/216.77  |- mesh__historyNote mesh__D005380
% 216.57/216.77       68; FEDERAL AID see FINANCIAL SUPPORT 1994-2000   
% 216.57/216.77  |- skos__hiddenLabel mesh__D005380 Hill Burton Act
% 216.57/216.77  |- skos__altLabel mesh__D005380 Financing, Public
% 216.57/216.77  |- skos__broader mesh__D005380smesh__D005381
% 216.57/216.77  |- skos__hiddenLabel mesh__D005380 Aid, Federal
% 216.57/216.77  |- skos__hiddenLabel mesh__D005380 Act, Hill-Burton
% 216.57/216.77  |- skos__scopeNote mesh__D005380
% 216.57/216.77       Federal, state, or local government organized methods of financial assistance.%A%    
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D005380 2004
% 216.57/216.77  |- skos__prefLabel mesh__D005380 Financing, Government
% 216.57/216.77  |- rdf__type mesh__D005380sskos__Concept
% 216.57/216.77  |- skos__hiddenLabel mesh__D005380 Government Subsidies
% 216.57/216.77  |- skos__hiddenLabel mesh__D005380 Subsidy, Government
% 216.57/216.77  |- mesh__publicMeSHNote mesh__D005380 68   
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D005380 2005
% 216.57/216.77  |- mesh__recordOriginator mesh__D005380 NLM
% 216.57/216.77  |- mesh__dateRevised mesh__D005380 2003-07-09
% 216.57/216.77  |- skos__historyNote mesh__D005380 Social Welfare %28%1966-1967%29%
% 216.57/216.77  |- skos__hiddenLabel mesh__D005380 Federal Aids
% 216.57/216.77  |- skos__annotation mesh__D013812
% 216.57/216.77       avoid: too general: prefer /ther with diseases: Manual 19.7+, 19.8.72; DF: THER%A%  
% 216.57/216.77  |- mesh__dateCreated mesh__D013812 1999-01-01
% 216.57/216.77  |- skos__hiddenLabel mesh__D013812 Therapeutic
% 216.57/216.77  |- mesh__dateRevised mesh__D013812 2005-06-30
% 216.57/216.77  |- skos__scopeNote mesh__D013812
% 216.57/216.77       Procedures concerned with the remedial treatment or prevention of diseases.%A%    
% 216.57/216.77  |- mesh__recordMaintainer mesh__D013812 lkt
% 216.57/216.77  |- rdf__type mesh__D013812sskos__Concept
% 216.57/216.77  |- mesh__runningHead mesh__D013812
% 216.57/216.77       E2 - PROCEDURES AND TECHNIQUES-THERAPEUTIC   
% 216.57/216.77  |- mesh__activeMeSHYear mesh__D013812 2006
% 216.57/216.77  |- mesh__recordOriginator mesh__D013812 NLM
% 216.57/216.77  |- skos__prefLabel mesh__D013812 Therapeutics
% 216.57/216.77  |- mesh__recordAuthorizer mesh__D013812 sjn
% 216.57/216.78  |- skos__hiddenLabel mesh__D013812 Treatments
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 SOS Regions
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 Box, SOS
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 Response, SOS
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 SOS Repairs
% 216.57/216.78  |- skos__altLabel mesh__D013014 SOS Response
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 SOS Responses %28%Genetics%29%
% 216.57/216.78  |- mesh__recordMaintainer mesh__D013014 AGS
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 Functions, SOS
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 SOS Functions
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 SOS Systems
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013014 2006
% 216.57/216.78  |- mesh__dateCreated mesh__D013014 1986-06-19
% 216.57/216.78  |- skos__altLabel mesh__D013014 SOS Repair
% 216.57/216.78  |- mesh__historyNote mesh__D013014
% 216.57/216.78       91%28%87%29%; was see under DNA REPAIR 1987-90   
% 216.57/216.78  |- mesh__publicMeSHNote mesh__D013014
% 216.57/216.78       91; was see under DNA REPAIR 1987-90   
% 216.57/216.78  |- skos__altLabel mesh__D013014 SOS System
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 SOS Inductions
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 Region, SOS
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 Inductions, SOS
% 216.57/216.78  |- mesh__recordAuthorizer mesh__D013014 sjn
% 216.57/216.78  |- skos__annotation mesh__D013014 DF: SOS RESPONSE   
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013014 2005
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 Function, SOS
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013014 2004
% 216.57/216.78  |- rdf__type mesh__D013014sskos__Concept
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 Responses, SOS %28%Genetics%29%
% 216.57/216.78  |- skos__historyNote mesh__D013014 DNA Repair %28%1975-1986%29%
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 Response, SOS %28%Genetics%29%
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 System, SOS
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 SOS Responses
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 Responses, SOS
% 216.57/216.78  |- skos__altLabel mesh__D013014 SOS Function
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 Repairs, SOS
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013014 2003
% 216.57/216.78  |- mesh__dateEstablished mesh__D013014 1991-01-01
% 216.57/216.78  |- skos__prefLabel mesh__D013014 SOS Response %28%Genetics%29%
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 Repair, SOS
% 216.57/216.78  |- skos__scopeNote mesh__D013014
% 216.57/216.78       An error-prone mechanism or set of functions for repairing damaged microbial DNA. SOS functions %28%a concept reputedly derived from the SOS of the international distress signal%29% are involved in DNA repair and mutagenesis, in cell division inhibition, in recovery of normal physiological conditions after DNA repair, and possibly in cell death when DNA damage is extensive.%A%    
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 Systems, SOS
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 Induction, SOS
% 216.57/216.78  |- skos__altLabel mesh__D013014 SOS Induction
% 216.57/216.78  |- skos__historyNote mesh__D013014 DNA, Bacterial %28%1975-1986%29%
% 216.57/216.78  |- mesh__dateRevised mesh__D013014 2002-07-02
% 216.57/216.78  |- mesh__recordOriginator mesh__D013014 SCD
% 216.57/216.78  |- skos__broader mesh__D013014smesh__D004260
% 216.57/216.78  |- skos__hiddenLabel mesh__D013014 Regions, SOS
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D037462 2006
% 216.57/216.78  |- mesh__dateRevised mesh__D037462 2003-07-09
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D037462 2004
% 216.57/216.78  |- skos__broader mesh__D037462smesh__D003063
% 216.57/216.78  |- rdf__type mesh__D037462sskos__Concept
% 216.57/216.78  |- skos__historyNote mesh__D037462 Cnidaria %28%1968-2002%29%
% 216.57/216.78  |- skos__altLabel mesh__D037462 Jellyfish, Box
% 216.57/216.78  |- mesh__dateEstablished mesh__D037462 2003-01-01
% 216.57/216.78  |- mesh__historyNote mesh__D037462 2003   
% 216.57/216.78  |- skos__prefLabel mesh__D037462 Cubozoa
% 216.57/216.78  |- mesh__dateCreated mesh__D037462 2002-07-02
% 216.57/216.78  |- skos__altLabel mesh__D037462 Box Jellyfish
% 216.57/216.78  |- skos__altLabel mesh__D037462 Sea Wasps
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D037462 2005
% 216.57/216.78  |- skos__scopeNote mesh__D037462
% 216.57/216.78       The class of box jellyfish, in the phylum CNIDARIA, characterized by their cube shape, and considered the most venomous jellyfish.%A%    
% 216.57/216.78  |- mesh__publicMeSHNote mesh__D037462 2003   
% 216.57/216.78  |- mesh__dateRevised mesh__D004288 2005-06-30
% 216.57/216.78  |- skos__historyNote mesh__D004288
% 216.57/216.78       Organophosphorus Compounds %28%1971-1977%29%
% 216.57/216.78  |- skos__broader mesh__D004288smesh__D004286
% 216.57/216.78  |- skos__hiddenLabel mesh__D004288 Monophosphates, Dolichol
% 216.57/216.78  |- skos__historyNote mesh__D004288 Dolichol %28%1975-1977%29%
% 216.57/216.78  |- skos__prefLabel mesh__D004288 Dolichol Phosphates
% 216.57/216.78  |- mesh__recordOriginator mesh__D004288 RLS
% 216.57/216.78  |- mesh__publicMeSHNote mesh__D004288
% 216.57/216.78       91; was see under POLYISOPRENYL PHOSPHATES 1978-90   
% 216.57/216.78  |- rdf__type mesh__D004288sskos__Concept
% 216.57/216.78  |- mesh__dateEstablished mesh__D004288 1991-01-01
% 216.57/216.78  |- skos__historyNote mesh__D004288 Diterpenes %28%1974%29%
% 216.57/216.78  |- skos__hiddenLabel mesh__D004288 Phosphates, Dolichol
% 216.57/216.78  |- mesh__recordMaintainer mesh__D004288 ssb
% 216.57/216.78  |- skos__broader mesh__D004288smesh__D011106
% 216.57/216.78  |- mesh__historyNote mesh__D004288
% 216.57/216.78       91%28%78%29%; was see under POLYISOPRENYL PHOSPHATES 1978-90   
% 216.57/216.78  |- skos__scopeNote mesh__D004288 Phosphoric acid esters of dolichol.     
% 216.57/216.78  |- mesh__recordAuthorizer mesh__D004288 sjn
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D004288 2006
% 216.57/216.78  |- mesh__dateCreated mesh__D004288 1977-05-16
% 216.57/216.78  |- skos__hiddenLabel mesh__D009771 Obsessive-Compulsive Neuroses
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D009771 1998
% 216.57/216.78  |- rdf__type mesh__D009771sskos__Concept
% 216.57/216.78  |- mesh__recordMaintainer mesh__D009771 JLS
% 216.57/216.78  |- mesh__recordAuthorizer mesh__D009771 SJN
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D009771 2003
% 216.57/216.78  |- mesh__dateCreated mesh__D009771 1999-01-01
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D009771 1999
% 216.57/216.78  |- skos__hiddenLabel mesh__D009771 Neurosis, Obsessive Compulsive
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D009771 2000
% 216.57/216.78  |- skos__broader mesh__D009771smesh__D001008
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D009771 2004
% 216.57/216.78  |- skos__prefLabel mesh__D009771 Obsessive-Compulsive Disorder
% 216.57/216.78  |- skos__scopeNote mesh__D009771
% 216.57/216.78       An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension.%A%    
% 216.57/216.78  |- skos__hiddenLabel mesh__D009771 Obsessive-Compulsive Disorders
% 216.57/216.78  |- skos__hiddenLabel mesh__D009771 Obsessive Compulsive Disorder
% 216.57/216.78  |- mesh__publicMeSHNote mesh__D009771
% 216.57/216.78       81; was NEUROSES, OBSESSIVE-COMPULSIVE 1963-80; OBSESSION was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-78%A%  
% 216.57/216.78  |- mesh__historyNote mesh__D009771
% 216.57/216.78       81; was NEUROSES, OBSESSIVE-COMPULSIVE 1963-80; OBSESSION was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-78%A%  
% 216.57/216.78  |- skos__hiddenLabel mesh__D009771 Disorder, Obsessive-Compulsive
% 216.57/216.78  |- mesh__dateRevised mesh__D009771 1997-06-20
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D009771 2001
% 216.57/216.78  |- skos__hiddenLabel mesh__D009771 Neuroses, Obsessive-Compulsive
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D009771 2005
% 216.57/216.78  |- mesh__recordOriginator mesh__D009771 NLM
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D009771 2002
% 216.57/216.78  |- mesh__onlineNote mesh__D009771
% 216.57/216.78       use OBSESSIVE-COMPULSIVE DISORDER to search NEUROSES, OBSESSIVE-COMPULSIVE 1966-80 %26% OBSESSION 1966-78%A%  
% 216.57/216.78  |- skos__hiddenLabel mesh__D009771 Disorders, Obsessive-Compulsive
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D009771 2006
% 216.57/216.78  |- skos__hiddenLabel mesh__D009771 Obsessive-Compulsive Neurosis
% 216.57/216.78  |- mesh__dateRevised mesh__D017405 1997-06-20
% 216.57/216.78  |- skos__hiddenLabel mesh__D017405
% 216.57/216.78       alpha Trans Inducing Factor, Herpes Simplex Virus 1
% 216.57/216.78  |- skos__historyNote mesh__D017405 Trans-Activators %28%1991-1992%29%
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D017405 1999
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D017405 2001
% 216.57/216.78  |- skos__hiddenLabel mesh__D017405 Factor, alpha-Trans Inducing
% 216.57/216.78  |- skos__hiddenLabel mesh__D017405
% 216.57/216.78       Herpes Simplex Virus Trans Activator Vmw65
% 216.57/216.78  |- skos__hiddenLabel mesh__D017405 VP-16, HSV-1 Protein
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D017405 2006
% 216.57/216.78  |- mesh__recordMaintainer mesh__D017405 KEV
% 216.57/216.78  |- rdf__type mesh__D017405sskos__Concept
% 216.57/216.78  |- skos__historyNote mesh__D017405 Viral Proteins %28%1984-1990%29%
% 216.57/216.78  |- mesh__recordAuthorizer mesh__D017405 SJN
% 216.57/216.78  |- skos__hiddenLabel mesh__D017405 VP16, HSV-1 Protein
% 216.57/216.78  |- skos__altLabel mesh__D017405 Vmw65 Protein
% 216.57/216.78  |- mesh__onlineNote mesh__D017405
% 216.57/216.78       use TRANS-ACTIVATORS to search HERPES SIMPLEX VIRUS TRANSCRIPTIONAL ACTIVATOR VMW65 1991-92; use HERPES SIMPLEX VIRUS PROTEIN VMW65 %28%NM%29% to search ALPHA-TRANS INDUCING FACTOR, HERPES SIMPLEX VIRUS 1 1987-96 %26% HERPES SIMPLEX VIRUS TYPE 2 PROTEIN VP16 1991-92%A%  
% 216.57/216.78  |- mesh__recordOriginator mesh__D017405 AGS
% 216.57/216.78  |- skos__hiddenLabel mesh__D017405 Protein VP-16, HSV-1
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D017405 1998
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D017405 2000
% 216.57/216.78  |- skos__altLabel mesh__D017405 Herpes Simplex Virus Protein VP 16
% 216.57/216.78  |- mesh__dateCreated mesh__D017405 1992-05-20
% 216.57/216.78  |- skos__hiddenLabel mesh__D017405 HSV 1 Protein VP 16
% 216.57/216.78  |- skos__altLabel mesh__D017405 Herpes Simplex Virus Type 2 Protein VP16
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D017405 2005
% 216.57/216.78  |- skos__scopeNote mesh__D017405
% 216.57/216.78       Trans-acting protein that combines with host factors to induce immediate early gene transcription in herpes simplex virus.%A%    
% 216.57/216.78  |- skos__altLabel mesh__D017405
% 216.57/216.78       Herpes Simplex Virus Transcriptional Activator Vmw65
% 216.57/216.78  |- skos__altLabel mesh__D017405 HSV-1 Protein VP16
% 216.57/216.78  |- skos__altLabel mesh__D017405 alpha-Trans Inducing Factor
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D017405 2004
% 216.57/216.78  |- skos__broader mesh__D017405smesh__D015534
% 216.57/216.78  |- skos__hiddenLabel mesh__D017405 HSV 1 Protein VP16
% 216.57/216.78  |- skos__annotation mesh__D017405 a trans-activator; DF: HSV VMW65   
% 216.57/216.78  |- skos__hiddenLabel mesh__D017405 alpha Trans Inducing Factor
% 216.57/216.78  |- skos__altLabel mesh__D017405
% 216.57/216.78       alpha-Trans-Inducing Factor, Herpes Simplex Virus 1
% 216.57/216.78  |- skos__altLabel mesh__D017405 VP16 Protein
% 216.57/216.78  |- skos__hiddenLabel mesh__D017405 HSV-1, alpha-TIF
% 216.57/216.78  |- skos__hiddenLabel mesh__D017405 Protein VP16, HSV-1
% 216.57/216.78  |- skos__altLabel mesh__D017405 Herpes Simplex Virus Protein VP16
% 216.57/216.78  |- mesh__historyNote mesh__D017405
% 216.57/216.78       93; was HERPES SIMPLEX VIRUS TRANSCRIPTIONAL ACTIVATOR VMW65 see TRANS-ACTIVATORS 1991-92; was also ALPHA-TRANS INDUCING FACTOR, HERPES SIMPLEX VIRUS 1 %28%NM%29% 1987-96; HERPES SIMPLEX VIRUS PROTEIN VP16 was HERPES SIMPLEX VIRUS TYPE 2 PROTEIN VP16 %28%NM%29% 1991-92%A%  
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D017405 2003
% 216.57/216.78  |- skos__hiddenLabel mesh__D017405 alpha TIF HSV 1
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D017405 2002
% 216.57/216.78  |- skos__prefLabel mesh__D017405 Herpes Simplex Virus Protein Vmw65
% 216.57/216.78  |- skos__hiddenLabel mesh__D017405 Protein, VP16
% 216.57/216.78  |- mesh__dateEstablished mesh__D017405 1993-01-01
% 216.57/216.78  |- skos__hiddenLabel mesh__D017405 Protein, Vmw65
% 216.57/216.78  |- skos__altLabel mesh__D017405 HSV-1 Protein VP-16
% 216.57/216.78  |- skos__altLabel mesh__D017405 alpha-TIF HSV-1
% 216.57/216.78  |- skos__altLabel mesh__D017405 Herpes Simplex Virus Trans-Activator Vmw65
% 216.57/216.78  |- mesh__publicMeSHNote mesh__D017405
% 216.57/216.78       93; was HERPES SIMPLEX VIRUS TRANSCRIPTIONAL ACTIVATOR VMW65 see TRANS-ACTIVATORS 1991-92; ALPHA-TRANS INDUCING FACTOR, HERPES SIMPLEX VIRUS 1 was indexed under HERPES SIMPLEX VIRUS PROTEIN VMW65 1993-96 %26% VIRAL PROTEINS 1987-92; HERPES SIMPLEX VIRUS TYPE 2 PROTEIN VP16 was indexed under VIRAL PROTEINS 1991-92%A%  
% 216.57/216.78  |- skos__hiddenLabel mesh__D017405 Inducing Factor, alpha-Trans
% 216.57/216.78  |- mesh__publicMeSHNote mesh__D050839
% 216.57/216.78       2006; DNA-BINDING PROTEINS 1997-2005   
% 216.57/216.78  |- skos__hiddenLabel mesh__D050839 Transcription Factor, IRF-7A
% 216.57/216.78  |- skos__broader mesh__D050839smesh__D050835
% 216.57/216.78  |- skos__hiddenLabel mesh__D050839 IRF 7 Transcription Factor
% 216.57/216.78  |- skos__hiddenLabel mesh__D050839 IRF 7C Transcription Factor
% 216.57/216.78  |- skos__prefLabel mesh__D050839 Interferon Regulatory Factor-7
% 216.57/216.78  |- mesh__recordOriginator mesh__D050839 DRC
% 216.57/216.78  |- skos__hiddenLabel mesh__D050839 Factor, IRF-7C Transcription
% 216.57/216.78  |- skos__broader mesh__D050839smesh__D010750
% 216.57/216.78  |- skos__hiddenLabel mesh__D050839 Transcription Factor, IRF-7C
% 216.57/216.78  |- skos__hiddenLabel mesh__D050839 IRF 7B Transcription Factor
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D050839 2006
% 216.57/216.78  |- mesh__recordMaintainer mesh__D050839 DRC
% 216.57/216.78  |- mesh__dateEstablished mesh__D050839 2006-01-01
% 216.57/216.78  |- mesh__dateCreated mesh__D050839 2005-06-30
% 216.57/216.78  |- mesh__historyNote mesh__D050839 2006%28%1997%29%   
% 216.57/216.78  |- mesh__recordAuthorizer mesh__D050839 sjn
% 216.57/216.78  |- skos__scopeNote mesh__D050839
% 216.57/216.78       An interferon regulatory factor that is induced by INTERFERONS as well as LMP-1 protein from EPSTEIN-BARR VIRUS. IRF-7 undergoes PHOSPHORYLATION prior to nuclear translocation and it activates GENETIC TRANSCRIPTION of multiple interferon GENES.%A%    
% 216.57/216.78  |- skos__hiddenLabel mesh__D050839 Interferon Regulatory Factor 7
% 216.57/216.78  |- skos__hiddenLabel mesh__D050839 IRF 7A Transcription Factor
% 216.57/216.78  |- skos__hiddenLabel mesh__D050839 Transcription Factor, IRF-7B
% 216.57/216.78  |- skos__altLabel mesh__D050839 IRF-7 Transcription Factor
% 216.57/216.78  |- rdf__type mesh__D050839sskos__Concept
% 216.57/216.78  |- mesh__recordOriginator mesh__D008679 NLM
% 216.57/216.78  |- skos__broader mesh__D008679smesh__D010335
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D008679 2005
% 216.57/216.78  |- mesh__dateCreated mesh__D008679 1999-01-01
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D008679 2006
% 216.57/216.78  |- skos__related mesh__D008679smesh__D009193
% 216.57/216.78  |- mesh__recordAuthorizer mesh__D008679 sjn
% 216.57/216.78  |- mesh__recordMaintainer mesh__D008679 lkt
% 216.57/216.78  |- mesh__dateRevised mesh__D008679 2003-07-09
% 216.57/216.78  |- skos__annotation mesh__D008679
% 216.57/216.78       NIM; coord with organ /pathol %28%IM%29%   
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D008679 2004
% 216.57/216.78  |- rdf__type mesh__D008679sskos__Concept
% 216.57/216.78  |- skos__prefLabel mesh__D008679 Metaplasia
% 216.57/216.78  |- skos__scopeNote mesh__D008679
% 216.57/216.78       A condition in which there is a change of one adult cell type to another similar adult cell type.%A%    
% 216.57/216.78  |- skos__prefLabel mesh__D005381 Financing, Organized
% 216.57/216.78  |- skos__broader mesh__D005381smesh__D004467
% 216.57/216.78  |- rdf__type mesh__D005381sskos__Concept
% 216.57/216.78  |- skos__hiddenLabel mesh__D005381 Financing, Community
% 216.57/216.78  |- mesh__dateCreated mesh__D005381 1999-01-01
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D005381 2002
% 216.57/216.78  |- skos__annotation mesh__D005381 IM   
% 216.57/216.78  |- skos__altLabel mesh__D005381 Organized Financing
% 216.57/216.78  |- mesh__dateRevised mesh__D005381 1999-11-03
% 216.57/216.78  |- mesh__recordOriginator mesh__D005381 NLM
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D005381 2006
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D005381 2001
% 216.57/216.78  |- skos__historyNote mesh__D005381 Insurance %28%1966-1967%29%
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D005381 2005
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D005381 2000
% 216.57/216.78  |- skos__scopeNote mesh__D005381 All organized methods of funding.     
% 216.57/216.78  |- mesh__publicMeSHNote mesh__D005381 68   
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D005381 2004
% 216.57/216.78  |- skos__hiddenLabel mesh__D005381 Grant
% 216.57/216.78  |- mesh__historyNote mesh__D005381 68   
% 216.57/216.78  |- mesh__recordAuthorizer mesh__D005381 sjn
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D005381 2003
% 216.57/216.78  |- mesh__dateEstablished mesh__D005381 1968-01-01
% 216.57/216.78  |- mesh__recordMaintainer mesh__D005381 kle
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013813 2005
% 216.57/216.78  |- skos__hiddenLabel mesh__D013813
% 216.57/216.78       Protocol-Directed Therapies, Computer-Assisted
% 216.57/216.78  |- skos__hiddenLabel mesh__D013813
% 216.57/216.78       Therapy, Computer Assisted Protocol Directed
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013813 1992
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013813 2000
% 216.57/216.78  |- skos__hiddenLabel mesh__D013813 Therapies, Computer-Assisted
% 216.57/216.78  |- skos__hiddenLabel mesh__D013813
% 216.57/216.78       Therapies, Computer-Assisted Protocol-Directed
% 216.57/216.78  |- skos__hiddenLabel mesh__D013813
% 216.57/216.78       Computer Assisted Protocol Directed Therapy
% 216.57/216.78  |- skos__altLabel mesh__D013813 Computer-Assisted Protocol-Directed Therapy
% 216.57/216.78  |- skos__hiddenLabel mesh__D013813
% 216.57/216.78       Protocol Directed Therapy, Computer Assisted
% 216.57/216.78  |- skos__broader mesh__D013813smesh__D003658
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013813 1995
% 216.57/216.78  |- mesh__recordMaintainer mesh__D013813 TGC
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013813 2006
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013813 1993
% 216.57/216.78  |- mesh__publicMeSHNote mesh__D013813 87   
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013813 2001
% 216.57/216.78  |- skos__prefLabel mesh__D013813 Therapy, Computer-Assisted
% 216.57/216.78  |- skos__hiddenLabel mesh__D013813 Therapy, Computer Assisted
% 216.57/216.78  |- skos__annotation mesh__D013813
% 216.57/216.78       IM; SPEC: SPEC qualif; DRUG THERAPY, COMPUTER-ASSISTED %26% RADIOTHERAPY, COMPUTER-ASSISTED are also available%A%  
% 216.57/216.78  |- skos__altLabel mesh__D013813
% 216.57/216.78       Protocol-Directed Therapy, Computer-Assisted
% 216.57/216.78  |- skos__hiddenLabel mesh__D013813 Computer Assisted Therapy
% 216.57/216.78  |- rdf__type mesh__D013813sskos__Concept
% 216.57/216.78  |- skos__hiddenLabel mesh__D013813 Computer-Assisted Therapies
% 216.57/216.78  |- mesh__dateRevised mesh__D013813 1991-05-15
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013813 1996
% 216.57/216.78  |- mesh__historyNote mesh__D013813 87   
% 216.57/216.78  |- mesh__dateEstablished mesh__D013813 1987-01-01
% 216.57/216.78  |- mesh__recordOriginator mesh__D013813 EC
% 216.57/216.78  |- skos__altLabel mesh__D013813 Computer-Assisted Therapy
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013813 2002
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013813 1997
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013813 2003
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013813 1998
% 216.57/216.78  |- mesh__recordAuthorizer mesh__D013813 PLS
% 216.57/216.78  |- mesh__dateCreated mesh__D013813 1986-06-17
% 216.57/216.78  |- skos__scopeNote mesh__D013813
% 216.57/216.78       Computer systems utilized as adjuncts in the treatment of disease.%A%    
% 216.57/216.78  |- skos__altLabel mesh__D013813
% 216.57/216.78       Therapy, Computer-Assisted Protocol-Directed
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013813 2004
% 216.57/216.78  |- skos__hiddenLabel mesh__D013813
% 216.57/216.78       Computer-Assisted Protocol-Directed Therapies
% 216.57/216.78  |- skos__broader mesh__D013813smesh__D013812
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013813 1994
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013813 1999
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013015 2002
% 216.57/216.78  |- skos__hiddenLabel mesh__D013015 Monohydrochloride, Sotalol
% 216.57/216.78  |- skos__hiddenLabel mesh__D013015 Hydrochloride, Sotalol
% 216.57/216.78  |- skos__prefLabel mesh__D013015 Sotalol
% 216.57/216.78  |- mesh__recordMaintainer mesh__D013015 CCR
% 216.57/216.78  |- skos__hiddenLabel mesh__D013015 MJ1999
% 216.57/216.78  |- mesh__dateCreated mesh__D013015 1999-01-01
% 216.57/216.78  |- rdf__type mesh__D013015sskos__Concept
% 216.57/216.78  |- skos__hiddenLabel mesh__D013015 MJ 1999
% 216.57/216.78  |- mesh__dateEstablished mesh__D013015 1973-01-01
% 216.57/216.78  |- mesh__historyNote mesh__D013015 73%28%72%29%   
% 216.57/216.78  |- skos__historyNote mesh__D013015 Sympatholytics %28%1966-1971%29%
% 216.57/216.78  |- skos__historyNote mesh__D013015 Amino Alcohols %28%1966-1971%29%
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013015 2003
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013015 2001
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013015 2005
% 216.57/216.78  |- mesh__dateRevised mesh__D013015 2000-06-22
% 216.57/216.78  |- mesh__publicMeSHNote mesh__D013015 73   
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013015 2004
% 216.57/216.78  |- skos__scopeNote mesh__D013015
% 216.57/216.78       An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.%A%    
% 216.57/216.78  |- mesh__recordAuthorizer mesh__D013015 sjn
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D013015 2006
% 216.57/216.78  |- mesh__recordOriginator mesh__D013015 NLM
% 216.57/216.78  |- skos__broader mesh__D013015smesh__D004983
% 216.57/216.78  |- skos__altLabel mesh__D013015 Sotalol Monohydrochloride
% 216.57/216.78  |- skos__altLabel mesh__D004289 Grampus griseus
% 216.57/216.78  |- skos__altLabel mesh__D004289 Steno bredanensis
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 False Killer Whales
% 216.57/216.78  |- rdf__type mesh__D004289sskos__Concept
% 216.57/216.78  |- skos__altLabel mesh__D004289 Lagenodelphis hosei
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Tucuxi Dolphins
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 White Sided Dolphins
% 216.57/216.78  |- skos__altLabel mesh__D004289 Yangtze River Dolphin
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Melon Headed Whale
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Rough-Toothed Dolphins
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Marine Dolphin
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Dolphin, Ocean
% 216.57/216.78  |- skos__altLabel mesh__D004289 Orcaella brevirostris
% 216.57/216.78  |- skos__altLabel mesh__D004289 False Killer Whale
% 216.57/216.78  |- mesh__dateCreated mesh__D004289 1999-01-01
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Dolphins, Piebald
% 216.57/216.78  |- skos__altLabel mesh__D004289 Pigmy Killer Whale
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Dolphin, Humpback
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Dolphins, Amazon River
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Dolphin, Yangtze River
% 216.57/216.78  |- skos__altLabel mesh__D004289 Pseudorca crassidens
% 216.57/216.78  |- skos__altLabel mesh__D004289 Amazon River Dolphins
% 216.57/216.78  |- skos__altLabel mesh__D004289 Lipotes vexillifer
% 216.57/216.78  |- skos__altLabel mesh__D004289 Inia geoffrensis
% 216.57/216.78  |- skos__altLabel mesh__D004289 Lagenorhynchus albirostris
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Dolphin, Marine
% 216.57/216.78  |- skos__altLabel mesh__D004289 Sotalia fluviatilis
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Dolphin, Ganges
% 216.57/216.78  |- mesh__recordOriginator mesh__D004289 NLM
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Rough Toothed Dolphin
% 216.57/216.78  |- skos__altLabel mesh__D004289 Peponocephala electra
% 216.57/216.78  |- skos__altLabel mesh__D004289 Feresa attenuata
% 216.57/216.78  |- skos__altLabel mesh__D004289 Cephalorhynchus
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Fraser Dolphin
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Humpback Dolphin
% 216.57/216.78  |- mesh__recordMaintainer mesh__D004289 ags
% 216.57/216.78  |- skos__altLabel mesh__D004289 Delphinidae
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Dolphin, Irrawaddy River
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Whales, Melon-Headed
% 216.57/216.78  |- mesh__dateEstablished mesh__D004289 1968-01-01
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Killer Whales, False
% 216.57/216.78  |- skos__broader mesh__D004289smesh__D002591
% 216.57/216.78  |- skos__scopeNote mesh__D004289
% 216.57/216.78       Mammals of the families Delphinidae %28%ocean dolphins%29%, Iniidae, Lipotidae, Pontoporiidae, and Platanistidae %28%all river dolphins%29%. Among the most well-known species are the BOTTLE-NOSED DOLPHIN and the KILLER WHALE %28%a dolphin%29%. The common name dolphin is applied to small cetaceans having a beaklike snout and a slender, streamlined body, whereas PORPOISES are small cetaceans with a blunt snout and rather stocky body. %28%From Walker%27%s Mammals of the World, 5th ed, pp978-9%29%%A%    
% 216.57/216.78  |- mesh__dateRevised mesh__D004289 2005-06-30
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Ocean Dolphin
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Frasers Dolphin
% 216.57/216.78  |- mesh__recordAuthorizer mesh__D004289 sjn
% 216.57/216.78  |- skos__historyNote mesh__D004289 Cetacea %28%1966-1967%29%
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Dolphin, La Plata
% 216.57/216.78  |- skos__altLabel mesh__D004289 Langenorhynchus obliquidens
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Dolphin, Ganges River
% 216.57/216.78  |- skos__altLabel mesh__D004289 Franciscana
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 River Dolphin, Chinese
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Dolphins, Ocean
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Dolphins, Amazon
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Risso Dolphin
% 216.57/216.78  |- skos__prefLabel mesh__D004289 Dolphins
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 White Beaked Dolphins
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Dolphins, Right Whale
% 216.57/216.78  |- mesh__publicMeSHNote mesh__D004289 1968   
% 216.57/216.78  |- skos__altLabel mesh__D004289 Many-Toothed Blackfish
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Whale, Melon Headed
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Dolphins, Marine
% 216.57/216.78  |- skos__altLabel mesh__D004289 Lagenorhynchus acutus
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Dolphins, Tucuxi
% 216.57/216.78  |- skos__altLabel mesh__D004289 Ganges River Dolphin
% 216.57/216.78  |- skos__altLabel mesh__D004289 Platanista
% 216.57/216.78  |- skos__altLabel mesh__D004289 Planista gangetica
% 216.57/216.78  |- skos__altLabel mesh__D004289 Gray Grampus
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 White-Beaked Dolphin
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Dolphin
% 216.57/216.78  |- mesh__historyNote mesh__D004289 1968   
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D004289 2006
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Dolphins, Humpback
% 216.57/216.78  |- skos__altLabel mesh__D004289 Marine Dolphins
% 216.57/216.78  |- skos__altLabel mesh__D004289 Melon-Headed Whale
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Melon-Headed Whales
% 216.57/216.78  |- skos__altLabel mesh__D004289 Lissodelphis
% 216.57/216.78  |- skos__altLabel mesh__D004289 Humpback Dolphins
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Pigmy Killer Whales
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 White-Sided Dolphin
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Killer Whale, False
% 216.57/216.78  |- skos__altLabel mesh__D004289 Pontoporia blainvillei
% 216.57/216.78  |- skos__annotation mesh__D004289
% 216.57/216.78       do not confuse with DOLPHIN FISH see PERCIFORMES; note %22%whales%22% X refs: these are common misnomers and are taxonomically DOLPHINS not WHALES%A%  
% 216.57/216.78  |- skos__altLabel mesh__D004289 Baiji
% 216.57/216.78  |- skos__hiddenLabel mesh__D004289 Dolphin, Tucuxi
% 216.57/216.78  |- skos__altLabel mesh__D009772 Obstetric Forceps
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D009772 2002
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D009772 2003
% 216.57/216.78  |- mesh__recordMaintainer mesh__D009772 PXP
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D009772 1999
% 216.57/216.78  |- mesh__dateCreated mesh__D009772 1999-01-01
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D009772 2004
% 216.57/216.78  |- skos__prefLabel mesh__D009772 Obstetrical Forceps
% 216.57/216.78  |- skos__scopeNote mesh__D009772
% 216.57/216.78       Surgical instrument designed to extract the newborn by the head from the maternal passages without injury to it or the mother.%A%    
% 216.57/216.78  |- skos__hiddenLabel mesh__D009772 Obstetrical Forcep
% 216.57/216.78  |- skos__hiddenLabel mesh__D009772 Obstetric Forcep
% 216.57/216.78  |- skos__broader mesh__D009772smesh__D013525
% 216.57/216.78  |- mesh__recordAuthorizer mesh__D009772 SJN
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D009772 2005
% 216.57/216.78  |- skos__hiddenLabel mesh__D009772 Forceps, Obstetric
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D009772 2000
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D009772 2006
% 216.57/216.78  |- skos__hiddenLabel mesh__D009772 Forceps, Obstetrical
% 216.57/216.78  |- mesh__dateRevised mesh__D009772 1997-06-20
% 216.57/216.78  |- skos__hiddenLabel mesh__D009772 Forcep, Obstetric
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D009772 2001
% 216.57/216.78  |- skos__hiddenLabel mesh__D009772 Forcep, Obstetrical
% 216.57/216.78  |- mesh__recordOriginator mesh__D009772 NLM
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D009772 1998
% 216.57/216.78  |- rdf__type mesh__D009772sskos__Concept
% 216.57/216.78  |- skos__hiddenLabel mesh__D017406 Sexual Harassments
% 216.57/216.78  |- skos__hiddenLabel mesh__D017406 Harrassments, Sexual
% 216.57/216.78  |- mesh__activeMeSHYear mesh__D017406 2006
% 216.57/216.79  |- skos__scopeNote mesh__D017406
% 216.57/216.79       A form of discrimination in the workplace which violates the Civil Rights Act of 1964. Sexual harassment takes two forms: quid pro quo, where the employee must submit to sexual advances in exchange for job benefits or be penalized for refusing; or a hostile environment, where the atmosphere of the workplace is offensive and affects the employee%27%s well-being. Offensive sexual conduct may include unwelcome advances, comments, touching, questions about marital status and sex practices, etc. Both men and women may be aggressors or victims. %28%Slee and Slee, Health Care Terms, 2d ed, p.404%29%. While civil rights legislation deals with sexual harassment in the workplace, the behavior is not restricted to this; it may take place outside the work environment: in schools and colleges, athletics, and other social milieus and activities.%A%    
% 216.57/216.79  |- skos__annotation mesh__D017406
% 216.57/216.79       HARASSMENT, NONSEXUAL see SOCIAL BEHAVIOR is also available%A%  
% 216.57/216.79  |- mesh__dateRevised mesh__D017406 2004-07-07
% 216.57/216.79  |- skos__hiddenLabel mesh__D017406 Sexual Harrassments
% 216.57/216.79  |- skos__hiddenLabel mesh__D017406 Harrassment, Sexual
% 216.57/216.79  |- mesh__recordMaintainer mesh__D017406 lkt
% 216.57/216.79  |- rdf__type mesh__D017406sskos__Concept
% 216.57/216.79  |- mesh__recordAuthorizer mesh__D017406 sjn
% 216.57/216.79  |- skos__prefLabel mesh__D017406 Sexual Harassment
% 216.57/216.79  |- skos__altLabel mesh__D017406 Harassment, Sexual
% 216.57/216.79  |- mesh__dateEstablished mesh__D017406 1993-01-01
% 216.57/216.79  |- mesh__historyNote mesh__D017406 93   
% 216.57/216.79  |- mesh__recordOriginator mesh__D017406 TGC
% 216.57/216.79  |- mesh__dateCreated mesh__D017406 1992-05-22
% 216.57/216.79  |- skos__altLabel mesh__D017406 Sexual Harrassment
% 216.64/216.79  |- skos__hiddenLabel mesh__D017406 Harassments, Sexual
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D017406 2005
% 216.64/216.79  |- mesh__publicMeSHNote mesh__D017406 93   
% 216.64/216.79  |- skos__broader mesh__D017406smesh__D012725
% 216.64/216.79  |- skos__historyNote mesh__D017406 Sex Behavior %28%1979-1992%29%
% 216.64/216.79  |- skos__historyNote mesh__D047093 Ribonucleases %28%1981-2004%29%
% 216.64/216.79  |- skos__altLabel mesh__D047093 MBP Protein, Eosinophil
% 216.64/216.79  |- mesh__dateRevised mesh__D047093 2005-06-30
% 216.64/216.79  |- mesh__publicMeSHNote mesh__D047093
% 216.64/216.79       2005; EOSINOPHIL BASIC PROTEIN was indexed under BLOOD PROTEINS %26% RIBONUCLEASES 1981-2004%A%  
% 216.64/216.79  |- mesh__dateCreated mesh__D047093 2004-07-07
% 216.64/216.79  |- mesh__recordAuthorizer mesh__D047093 sjn
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D047093 2006
% 216.64/216.79  |- skos__scopeNote mesh__D047093
% 216.64/216.79       One of several basic proteins released from EOSINOPHIL cytoplasmic granules. Eosinophil major basic protein is a 14-kDa cytotoxic peptide with a pI of 10.9. In addition to its direct cytotoxic effects, it stimulates the release of variety of INFLAMMATION MEDIATORS.%A%    
% 216.64/216.79  |- rdf__type mesh__D047093sskos__Concept
% 216.64/216.79  |- mesh__dateEstablished mesh__D047093 2005-01-01
% 216.64/216.79  |- mesh__recordMaintainer mesh__D047093 ssb
% 216.64/216.79  |- skos__hiddenLabel mesh__D047093 Eosinophil MBP Protein
% 216.64/216.79  |- mesh__historyNote mesh__D047093 2005%28%1981%29%   
% 216.64/216.79  |- skos__prefLabel mesh__D047093 Eosinophil Major Basic Protein
% 216.64/216.79  |- skos__altLabel mesh__D047093 Eosinophil Basic Protein
% 216.64/216.79  |- skos__broader mesh__D047093smesh__D047091
% 216.64/216.79  |- skos__altLabel mesh__D047093 Major Basic Protein, Eosinophil
% 216.64/216.79  |- mesh__recordOriginator mesh__D047093 jmp
% 216.64/216.79  |- skos__historyNote mesh__D047093 Blood Proteins %28%1981-2004%29%
% 216.64/216.79  |- skos__hiddenLabel mesh__D047093 Basic Protein, Eosinophil
% 216.64/216.79  |- mesh__recordOriginator mesh__D000697 NLM
% 216.64/216.79  |- mesh__publicMeSHNote mesh__D000697
% 216.64/216.79       95; was ANALEPTICS 1963-94; CENTRAL NERVOUS SYSTEM STIMULANTS was see ANALEPTICS 1985-94%A%  
% 216.64/216.79  |- skos__altLabel mesh__D000697 Analeptic Agents
% 216.64/216.79  |- mesh__recordMaintainer mesh__D000697 ssb
% 216.64/216.79  |- skos__hiddenLabel mesh__D000697 Drugs, Analeptic
% 216.64/216.79  |- skos__scopeNote mesh__D000697
% 216.64/216.79       A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.%A%    
% 216.64/216.79  |- rdf__type mesh__D000697sskos__Concept
% 216.64/216.79  |- skos__prefLabel mesh__D000697 Central Nervous System Stimulants
% 216.64/216.79  |- mesh__dateCreated mesh__D000697 1999-01-01
% 216.64/216.79  |- skos__hiddenLabel mesh__D000697 Stimulants, Central
% 216.64/216.79  |- skos__annotation mesh__D000697
% 216.64/216.79       GEN or unspecified; prefer specifics; consider also CENTRAL NERVOUS SYSTEM /drug eff %26% BRAIN /drug eff; DF: CNS STIMULANTS%A%  
% 216.64/216.79  |- mesh__historyNote mesh__D000697
% 216.64/216.79       95; was ANALEPTICS 1963-94; CENTRAL NERVOUS SYSTEM STIMULANTS was see ANALEPTICS 1985-94%A%  
% 216.64/216.79  |- skos__altLabel mesh__D000697 Central Stimulants
% 216.64/216.79  |- skos__altLabel mesh__D000697 Analeptic Drugs
% 216.64/216.79  |- mesh__dateRevised mesh__D000697 2005-06-30
% 216.64/216.79  |- skos__hiddenLabel mesh__D000697 Agents, Analeptic
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D000697 2006
% 216.64/216.79  |- mesh__onlineNote mesh__D000697
% 216.64/216.79       use CENTRAL NERVOUS SYSTEM STIMULANTS to search ANALEPTICS 1966-94%A%  
% 216.64/216.79  |- skos__broader mesh__D000697smesh__D045505
% 216.64/216.79  |- skos__broader mesh__D000697smesh__D002491
% 216.64/216.79  |- mesh__recordAuthorizer mesh__D000697 sjn
% 216.64/216.79  |- mesh__recordMaintainer mesh__D005382 mdb
% 216.64/216.79  |- skos__scopeNote mesh__D005382
% 216.64/216.79       Payment by individuals or their family for health care services which are not covered by a third-party payer, either insurance or medical assistance.%A%    
% 216.64/216.79  |- skos__hiddenLabel mesh__D005382 Personal Financing
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D005382 2006
% 216.64/216.79  |- skos__hiddenLabel mesh__D005382 Expenditures, Personal
% 216.64/216.79  |- skos__historyNote mesh__D005382 Economics %28%1966-1967%29%
% 216.64/216.79  |- mesh__dateRevised mesh__D005382 2001-07-25
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D005382 2005
% 216.64/216.79  |- mesh__publicMeSHNote mesh__D005382 68   
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D005382 2002
% 216.64/216.79  |- skos__annotation mesh__D005382
% 216.64/216.79       restricted to a person%27%s payment of health care expenditures: read MeSH definition; not for the personal finances of physicans %26% other health care professionals: index under PHYSICIANS; DENTISTS; NURSES; PHARMACISTS; etc., for personal non-professional expenses or under PRACTICE MANAGEMENT, MEDICAL; PRACTICE MANAGEMENT, DENTAL %26% similar headings for finances assoc with professional practice%A%  
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D005382 2004
% 216.64/216.79  |- mesh__recordOriginator mesh__D005382 NLM
% 216.64/216.79  |- mesh__dateEstablished mesh__D005382 1968-01-01
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D005382 2003
% 216.64/216.79  |- skos__hiddenLabel mesh__D005382 Personal Expenditure
% 216.64/216.79  |- skos__prefLabel mesh__D005382 Financing, Personal
% 216.64/216.79  |- skos__hiddenLabel mesh__D005382 Expenditure, Personal
% 216.64/216.79  |- rdf__type mesh__D005382sskos__Concept
% 216.64/216.79  |- mesh__historyNote mesh__D005382 68   
% 216.64/216.79  |- mesh__recordAuthorizer mesh__D005382 sjn
% 216.64/216.79  |- skos__broader mesh__D005382smesh__D004467
% 216.64/216.79  |- mesh__dateCreated mesh__D005382 1999-01-01
% 216.64/216.79  |- mesh__recordMaintainer mesh__D013814 TGC
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013814 2000
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013814 1997
% 216.64/216.79  |- mesh__historyNote mesh__D013814 74%28%71%29%   
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013814 2005
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013814 2001
% 216.64/216.79  |- mesh__dateRevised mesh__D013814 1989-06-14
% 216.64/216.79  |- mesh__recordOriginator mesh__D013814 NLM
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013814 2003
% 216.64/216.79  |- skos__hiddenLabel mesh__D013814 Conductivity, Thermal
% 216.64/216.79  |- skos__hiddenLabel mesh__D013814 Conductivities, Thermal
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013814 2006
% 216.64/216.79  |- rdf__type mesh__D013814sskos__Concept
% 216.64/216.79  |- skos__hiddenLabel mesh__D013814 Thermal Conductivities
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013814 2002
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013814 2004
% 216.64/216.79  |- skos__prefLabel mesh__D013814 Thermal Conductivity
% 216.64/216.79  |- skos__historyNote mesh__D013814 Physics %28%1966-1970%29%
% 216.64/216.79  |- mesh__publicMeSHNote mesh__D013814 74   
% 216.64/216.79  |- skos__broader mesh__D013814smesh__D010825
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013814 1994
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013814 1990
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013814 1992
% 216.64/216.79  |- mesh__dateEstablished mesh__D013814 1974-01-01
% 216.64/216.79  |- skos__historyNote mesh__D013814 Heat %28%1966-1970%29%
% 216.64/216.79  |- skos__annotation mesh__D013814 NIM; no qualif   
% 216.64/216.79  |- mesh__dateCreated mesh__D013814 1999-01-01
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013814 1998
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013814 1995
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013814 1991
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013814 1993
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013814 1996
% 216.64/216.79  |- mesh__recordAuthorizer mesh__D013814 PLS
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013814 1999
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013016 1998
% 216.64/216.79  |- mesh__recordOriginator mesh__D013016 NLM
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013016 1997
% 216.64/216.79  |- skos__hiddenLabel mesh__D013016 Sounds
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013016 1994
% 216.64/216.79  |- rdf__type mesh__D013016sskos__Concept
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013016 1999
% 216.64/216.79  |- mesh__dateCreated mesh__D013016 1999-01-01
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013016 2002
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013016 1993
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013016 1995
% 216.64/216.79  |- skos__broader mesh__D013016smesh__D000162
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013016 2003
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013016 2005
% 216.64/216.79  |- skos__related mesh__D013016smesh__D000161
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013016 2004
% 216.64/216.79  |- mesh__recordMaintainer mesh__D013016 TAP
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013016 2006
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013016 2000
% 216.64/216.79  |- skos__prefLabel mesh__D013016 Sound
% 216.64/216.79  |- mesh__dateRevised mesh__D013016 1992-05-18
% 216.64/216.79  |- mesh__recordAuthorizer mesh__D013016 PLS
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013016 2001
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013016 1996
% 216.64/216.79  |- mesh__considerAlso mesh__D013016 consider also terms at PHON-   
% 216.64/216.79  |- skos__related mesh__D013016smesh__D009622
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D051135 2006
% 216.64/216.79  |- mesh__recordMaintainer mesh__D051135 DRC
% 216.64/216.79  |- skos__broader mesh__D051135smesh__D004268
% 216.64/216.79  |- mesh__dateCreated mesh__D051135 2005-06-30
% 216.64/216.79  |- mesh__historyNote mesh__D051135 2006%28%1992%29%   
% 216.64/216.79  |- skos__hiddenLabel mesh__D051135 Recombinase, Rad51
% 216.64/216.79  |- rdf__type mesh__D051135sskos__Concept
% 216.64/216.79  |- skos__scopeNote mesh__D051135
% 216.64/216.79       A Rec A recombinase found in eukaryotes. Rad51 is involved in DNA REPAIR of double-strand breaks.%A%    
% 216.64/216.79  |- skos__prefLabel mesh__D051135 Rad51 Recombinase
% 216.64/216.79  |- mesh__dateEstablished mesh__D051135 2006-01-01
% 216.64/216.79  |- mesh__recordAuthorizer mesh__D051135 sjn
% 216.64/216.79  |- mesh__recordOriginator mesh__D051135 DRC
% 216.64/216.79  |- skos__altLabel mesh__D051135 RAD51 Protein
% 216.64/216.79  |- skos__broader mesh__D051135smesh__D011938
% 216.64/216.79  |- mesh__publicMeSHNote mesh__D051135
% 216.64/216.79       2006; RAD51 RECOMBINASE was indexed under DNA-BINDING PROTEINS 1996-2005, %26% under FUNGAL PROTEINS 1992-1995%A%  
% 216.64/216.79  |- skos__annotation mesh__D009773
% 216.64/216.79       SPEC: SPEC qualif; check also tag PREGNANCY   
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D009773 1995
% 216.64/216.79  |- skos__altLabel mesh__D009773 Nursing, Obstetrical
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D009773 2000
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D009773 2005
% 216.64/216.79  |- mesh__publicMeSHNote mesh__D009773 67   
% 216.64/216.79  |- rdf__type mesh__D009773sskos__Concept
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D009773 1994
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D009773 2004
% 216.64/216.79  |- mesh__recordMaintainer mesh__D009773 TGC
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D009773 1993
% 216.64/216.79  |- mesh__recordOriginator mesh__D009773 NLM
% 216.64/216.79  |- skos__historyNote mesh__D009773 Nursing %28%1966%29%
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D009773 1999
% 216.64/216.79  |- skos__prefLabel mesh__D009773 Obstetrical Nursing
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D009773 2003
% 216.64/216.79  |- skos__broader mesh__D009773smesh__D013041
% 216.64/216.79  |- mesh__dateEstablished mesh__D009773 1967-01-01
% 216.64/216.79  |- skos__scopeNote mesh__D009773
% 216.64/216.79       Nursing care given to the pregnant patient before, after, or during childbirth.%A%    
% 216.64/216.79  |- skos__altLabel mesh__D009773 Obstetric Nursing
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D009773 1998
% 216.64/216.79  |- skos__historyNote mesh__D009773 Obstetrics %28%1966%29%
% 216.64/216.79  |- skos__historyNote mesh__D009773 Nursing Care %28%1966%29%
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D009773 1997
% 216.64/216.79  |- skos__hiddenLabel mesh__D009773 Obstetric Nursings
% 216.64/216.79  |- skos__hiddenLabel mesh__D009773 Nursings, Obstetrical
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D009773 2002
% 216.64/216.79  |- mesh__dateRevised mesh__D009773 1992-05-22
% 216.64/216.79  |- skos__hiddenLabel mesh__D009773 Obstetrical Nursings
% 216.64/216.79  |- skos__hiddenLabel mesh__D009773 Nursings, Obstetric
% 216.64/216.79  |- mesh__historyNote mesh__D009773 67   
% 216.64/216.79  |- mesh__recordAuthorizer mesh__D009773 PLS
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D009773 1996
% 216.64/216.79  |- skos__broader mesh__D009773smesh__D009732
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D009773 2006
% 216.64/216.79  |- skos__altLabel mesh__D009773 Nursing, Obstetric
% 216.64/216.79  |- mesh__dateCreated mesh__D009773 1999-01-01
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D009773 2001
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D001790 2002
% 216.64/216.79  |- mesh__recordOriginator mesh__D001790 NLM
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D001790 2004
% 216.64/216.79  |- mesh__dateCreated mesh__D001790 1999-01-01
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D001790 1999
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D001790 2003
% 216.64/216.79  |- mesh__recordAuthorizer mesh__D001790 SJN
% 216.64/216.79  |- skos__hiddenLabel mesh__D001790 Blood Physiologies
% 216.64/216.79  |- skos__prefLabel mesh__D001790 Blood Physiology
% 216.64/216.79  |- mesh__recordMaintainer mesh__D001790 NNS
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D001790 2001
% 216.64/216.79  |- skos__hiddenLabel mesh__D001790 Physiologies, Blood
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D001790 2006
% 216.64/216.79  |- skos__altLabel mesh__D001790 Physiology, Blood
% 216.64/216.79  |- mesh__historyNote mesh__D001790 98; use explode 1970-97   
% 216.64/216.79  |- mesh__dateRevised mesh__D001790 1998-06-10
% 216.64/216.79  |- skos__scopeNote mesh__D001790
% 216.64/216.79       Observable characteristics of blood activities and functions, such as BLOOD GROUPS, coagulation processes, etc.%A%    
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D001790 2005
% 216.64/216.79  |- mesh__dateEstablished mesh__D001790 1998-01-01
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D001790 2000
% 216.64/216.79  |- skos__historyNote mesh__D001790 Blood/physiology %28%1966-1997%29%
% 216.64/216.79  |- mesh__publicMeSHNote mesh__D001790 98   
% 216.64/216.79  |- rdf__type mesh__D001790sskos__Concept
% 216.64/216.79  |- skos__broader mesh__D001790smesh__D002943
% 216.64/216.79  |- skos__annotation mesh__D001790
% 216.64/216.79       GEN or unspecified; prefer specifics; DF: BLOOD PHYSIOL   
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D017407 2002
% 216.64/216.79  |- rdf__type mesh__D017407sskos__Concept
% 216.64/216.79  |- skos__broader mesh__D017407smesh__D012456
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D017407 1998
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D017407 1997
% 216.64/216.79  |- mesh__dateRevised mesh__D017407 1994-05-05
% 216.64/216.79  |- mesh__dateCreated mesh__D017407 1992-05-20
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D017407 1999
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D017407 2000
% 216.64/216.79  |- skos__historyNote mesh__D017407 Parental Leave %28%1988-1992%29%
% 216.64/216.79  |- mesh__onlineNote mesh__D017407
% 216.64/216.79       use PARENTAL LEAVE to search FAMILY LEAVE 1992   
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D017407 2003
% 216.64/216.79  |- skos__annotation mesh__D017407
% 216.64/216.79       to care for sibs, parents or other family members: do not confuse with PARENTAL LEAVE%A%  
% 216.64/216.79  |- mesh__publicMeSHNote mesh__D017407 93; was see PARENTAL LEAVE 1992   
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D017407 2001
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D017407 2005
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D017407 1995
% 216.64/216.79  |- mesh__dateEstablished mesh__D017407 1993-01-01
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D017407 2004
% 216.64/216.79  |- skos__hiddenLabel mesh__D017407 Leave, Family
% 216.64/216.79  |- skos__prefLabel mesh__D017407 Family Leave
% 216.64/216.79  |- mesh__recordAuthorizer mesh__D017407 PLS
% 216.64/216.79  |- mesh__recordOriginator mesh__D017407 TGC
% 216.64/216.79  |- mesh__historyNote mesh__D017407 93; was see PARENTAL LEAVE 1992   
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D017407 2006
% 216.64/216.79  |- skos__historyNote mesh__D017407 Family %28%1988-1991%29%
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D017407 1996
% 216.64/216.79  |- mesh__recordMaintainer mesh__D017407 TGC
% 216.64/216.79  |- skos__scopeNote mesh__D017407
% 216.64/216.79       The authorized absence from work of a family member to attend the illness or participate in the care of a parent, a sibling, or other family member. For the care of a parent for a child or for pre- or postnatal leave of a parent, PARENTAL LEAVE is available.%A%    
% 216.64/216.79  |- mesh__recordAuthorizer mesh__D000698 PLS
% 216.64/216.79  |- rdf__type mesh__D000698sskos__Concept
% 216.64/216.79  |- mesh__dateCreated mesh__D000698 1999-01-01
% 216.64/216.79  |- mesh__recordMaintainer mesh__D000698 PLS
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D000698 1989
% 216.64/216.79  |- skos__prefLabel mesh__D000698 Analgesia
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D000698 1995
% 216.64/216.79  |- mesh__recordOriginator mesh__D000698 NLM
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D000698 1991
% 216.64/216.79  |- skos__annotation mesh__D000698
% 216.64/216.79       do not use /util except by MeSH definition   
% 216.64/216.79  |- skos__hiddenLabel mesh__D000698 Analgesias
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D000698 2006
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D000698 1999
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D000698 1994
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D000698 2002
% 216.64/216.79  |- mesh__dateRevised mesh__D000698 1991-11-02
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D000698 1990
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D000698 2005
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D000698 1993
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D000698 1998
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D000698 2001
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D000698 2004
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D000698 1992
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D000698 1997
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D000698 2000
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D000698 2003
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D000698 1996
% 216.64/216.79  |- skos__broader mesh__D000698smesh__D000760
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D005383 2001
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D005383 2004
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D005383 1994
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D005383 2000
% 216.64/216.79  |- mesh__recordAuthorizer mesh__D005383 PLS
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D005383 1993
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D005383 1999
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D005383 2003
% 216.64/216.79  |- skos__prefLabel mesh__D005383 Finger Injuries
% 216.64/216.79  |- skos__scopeNote mesh__D005383
% 216.64/216.79       General or unspecified injuries involving the fingers.     
% 216.64/216.79  |- skos__altLabel mesh__D005383 Injuries, Finger
% 216.64/216.79  |- skos__hiddenLabel mesh__D005383 Finger Injury
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D005383 1992
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D005383 1998
% 216.64/216.79  |- rdf__type mesh__D005383sskos__Concept
% 216.64/216.79  |- mesh__dateCreated mesh__D005383 1999-01-01
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D005383 1997
% 216.64/216.79  |- mesh__recordMaintainer mesh__D005383 PXP
% 216.64/216.79  |- skos__broader mesh__D005383smesh__D006230
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D005383 2006
% 216.64/216.79  |- skos__annotation mesh__D005383 consider also THUMB /inj   
% 216.64/216.79  |- skos__hiddenLabel mesh__D005383 Injury, Finger
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D005383 1996
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D005383 2002
% 216.64/216.79  |- mesh__dateRevised mesh__D005383 1990-11-10
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D005383 1995
% 216.64/216.79  |- mesh__recordOriginator mesh__D005383 NLM
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D005383 2005
% 216.64/216.79  |- mesh__dateCreated mesh__D013815 1976-04-27
% 216.64/216.79  |- mesh__historyNote mesh__D013815 77   
% 216.64/216.79  |- mesh__recordAuthorizer mesh__D013815 SJN
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013815 2005
% 216.64/216.79  |- skos__scopeNote mesh__D013815
% 216.64/216.79       Measurement of blood flow based on induction at one point of the circulation of a known change in the intravascular heat content of flowing blood and detection of the resultant change in temperature at a point downstream.%A%    
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013815 2003
% 216.64/216.79  |- rdf__type mesh__D013815sskos__Concept
% 216.64/216.79  |- mesh__recordOriginator mesh__D013815 SMH
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013815 2006
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013815 2000
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013815 2004
% 216.64/216.79  |- skos__hiddenLabel mesh__D013815 Thermodilutions
% 216.64/216.79  |- skos__annotation mesh__D013815 NIM   
% 216.64/216.79  |- mesh__publicMeSHNote mesh__D013815 77   
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013815 2001
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013815 1998
% 216.64/216.79  |- skos__historyNote mesh__D013815 Cardiac Output %28%1966-1976%29%
% 216.64/216.79  |- skos__prefLabel mesh__D013815 Thermodilution
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013815 2002
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013815 1999
% 216.64/216.79  |- mesh__dateRevised mesh__D013815 1997-06-20
% 216.64/216.79  |- skos__broader mesh__D013815smesh__D007201
% 216.64/216.79  |- skos__historyNote mesh__D013815
% 216.64/216.79       Indicator Dilution Techniques %28%1967-1976%29%
% 216.64/216.79  |- mesh__dateEstablished mesh__D013815 1977-01-01
% 216.64/216.79  |- mesh__recordMaintainer mesh__D013815 PXP
% 216.64/216.79  |- skos__related mesh__D013017smesh__D004455
% 216.64/216.79  |- skos__prefLabel mesh__D013017 Sound Localization
% 216.64/216.79  |- rdf__type mesh__D013017sskos__Concept
% 216.64/216.79  |- skos__hiddenLabel mesh__D013017 Localization, Auditory
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013017 2002
% 216.64/216.79  |- mesh__recordMaintainer mesh__D013017 ags
% 216.64/216.79  |- mesh__dateCreated mesh__D013017 1978-12-14
% 216.64/216.79  |- skos__hiddenLabel mesh__D013017 Auditory Localizations
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013017 2003
% 216.64/216.79  |- skos__altLabel mesh__D013017 Auditory Localization
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013017 2000
% 216.64/216.79  |- mesh__recordOriginator mesh__D013017 RC
% 216.64/216.79  |- mesh__dateRevised mesh__D013017 1999-11-03
% 216.64/216.79  |- skos__historyNote mesh__D013017 Hearing %28%1966%29%
% 216.64/216.79  |- mesh__historyNote mesh__D013017
% 216.64/216.79       91%28%80%29%; was see under AUDITORY PERCEPTION 1980-90   
% 216.64/216.79  |- mesh__dateEstablished mesh__D013017 1991-01-01
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013017 2005
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013017 2004
% 216.64/216.79  |- skos__historyNote mesh__D013017 Auditory Perception %28%1967-1979%29%
% 216.64/216.79  |- skos__annotation mesh__D013017
% 216.64/216.79       do not confuse with ECHOLOCATION %28%animal only%29%   
% 216.64/216.79  |- skos__scopeNote mesh__D013017
% 216.64/216.79       Ability to determine the specific location of a sound source.%A%    
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013017 2001
% 216.64/216.79  |- skos__broader mesh__D013017smesh__D001307
% 216.64/216.79  |- skos__hiddenLabel mesh__D013017 Localization, Sound
% 216.64/216.79  |- skos__hiddenLabel mesh__D013017 Localizations, Sound
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D013017 2006
% 216.64/216.79  |- skos__historyNote mesh__D013017 Perception %28%1966%29%
% 216.64/216.79  |- mesh__recordAuthorizer mesh__D013017 sjn
% 216.64/216.79  |- skos__hiddenLabel mesh__D013017 Sound Localizations
% 216.64/216.79  |- skos__hiddenLabel mesh__D013017 Localizations, Auditory
% 216.64/216.79  |- mesh__publicMeSHNote mesh__D013017
% 216.64/216.79       91; was see under AUDITORY PERCEPTION 1980-90   
% 216.64/216.79  |- skos__altLabel mesh__D018500 Diabetes Insipidus, Nephrogenic, Type II
% 216.64/216.79  |- skos__altLabel mesh__D018500 Nephrogenic Diabetes Insipidus
% 216.64/216.79  |- mesh__publicMeSHNote mesh__D018500 95   
% 216.64/216.79  |- mesh__recordAuthorizer mesh__D018500 sjn
% 216.64/216.79  |- skos__annotation mesh__D018500
% 216.64/216.79       do not confuse with DIABETIC NEPHROPATHIES which refers to diabetes mellitus or with DIABETES INSIPIDUS, NEUROGENIC%A%  
% 216.64/216.79  |- rdf__type mesh__D018500sskos__Concept
% 216.64/216.79  |- mesh__recordMaintainer mesh__D018500 lkt
% 216.64/216.79  |- mesh__historyNote mesh__D018500 95   
% 216.64/216.79  |- mesh__dateCreated mesh__D018500 1994-04-16
% 216.64/216.79  |- mesh__dateRevised mesh__D018500 2005-06-30
% 216.64/216.79  |- mesh__dateEstablished mesh__D018500 1995-01-01
% 216.64/216.79  |- skos__altLabel mesh__D018500 Diabetes Insipidus, Nephrogenic, Type I
% 216.64/216.79  |- skos__prefLabel mesh__D018500 Diabetes Insipidus, Nephrogenic
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D018500 2006
% 216.64/216.79  |- skos__historyNote mesh__D018500 Diabetes Insipidus %28%1966-1994%29%
% 216.64/216.79  |- mesh__recordOriginator mesh__D018500 TGC
% 216.64/216.79  |- skos__scopeNote mesh__D018500
% 216.64/216.79       A genetic or acquired polyuric disorder characterized by persistent hypotonic urine and HYPOKALEMIA. This condition is due to renal tubular insensitivity to VASOPRESSIN and failure to reduce urine volume. It may be the result of mutations of genes encoding VASOPRESSIN RECEPTORS or aquaporin-2 %28%AQUAPORINS%29%; KIDNEY DISEASES; adverse drug effects; or complications from PREGNANCY.%A%    
% 216.64/216.79  |- skos__broader mesh__D018500smesh__D003919
% 216.64/216.79  |- mesh__activeMeSHYear mesh__D009774 2002
% 216.64/216.79  |- skos__scopeNote mesh__D009774
% 216.64/216.79       A medical-surgical specialty concerned with management and care of women during pregnancy, parturition, and the puerperium.%A%    
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009774 2004
% 216.64/216.80  |- mesh__recordMaintainer mesh__D009774 TGC
% 216.64/216.80  |- mesh__dateRevised mesh__D009774 1997-06-20
% 216.64/216.80  |- skos__broader mesh__D009774smesh__D013043
% 216.64/216.80  |- skos__related mesh__D009774smesh__D013513
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009774 1999
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009774 2001
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009774 2003
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009774 2000
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009774 1998
% 216.64/216.80  |- skos__related mesh__D009774smesh__D011248
% 216.64/216.80  |- mesh__recordOriginator mesh__D009774 NLM
% 216.64/216.80  |- skos__prefLabel mesh__D009774 Obstetrics
% 216.64/216.80  |- mesh__recordAuthorizer mesh__D009774 SJN
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009774 2006
% 216.64/216.80  |- mesh__dateCreated mesh__D009774 1999-01-01
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009774 2005
% 216.64/216.80  |- skos__annotation mesh__D009774
% 216.64/216.80       SPEC: SPEC qualif; do not use for %22%obstetric diseases%22% %28% = probably PREGNANCY COMPLICATIONS, etc.%29%%A%  
% 216.64/216.80  |- rdf__type mesh__D009774sskos__Concept
% 216.64/216.80  |- mesh__dateRevised mesh__D001791 1998-06-10
% 216.64/216.80  |- skos__prefLabel mesh__D001791 Blood Platelet Disorders
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D001791 2000
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D001791 2006
% 216.64/216.80  |- skos__scopeNote mesh__D001791
% 216.64/216.80       Disorders caused by abnormalities in platelet count or function.%A%    
% 216.64/216.80  |- skos__hiddenLabel mesh__D001791 Platelet Disorders, Blood
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D001791 2005
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D001791 2002
% 216.64/216.80  |- skos__altLabel mesh__D001791 Thrombocytopathy
% 216.64/216.80  |- mesh__historyNote mesh__D001791
% 216.64/216.80       67%28%64%29%; THROMBOCYTOPATHY was see under BLOOD PLATELET DISORDERS 1967-85, was heading 1963-66%A%  
% 216.64/216.80  |- rdf__type mesh__D001791sskos__Concept
% 216.64/216.80  |- skos__hiddenLabel mesh__D001791 Disorders, Blood Platelet
% 216.64/216.80  |- mesh__recordOriginator mesh__D001791 NLM
% 216.64/216.80  |- skos__hiddenLabel mesh__D001791 Disorder, Blood Platelet
% 216.64/216.80  |- skos__hiddenLabel mesh__D001791 Thrombocytopathies
% 216.64/216.80  |- mesh__recordMaintainer mesh__D001791 NNS
% 216.64/216.80  |- skos__annotation mesh__D001791
% 216.64/216.80       do not use as coord for platelet factor defic: use COAGULATION PROTEIN DISORDERS%A%  
% 216.64/216.80  |- skos__broader mesh__D001791smesh__D006402
% 216.64/216.80  |- skos__hiddenLabel mesh__D001791 Platelet Disorder, Blood
% 216.64/216.80  |- mesh__recordAuthorizer mesh__D001791 SJN
% 216.64/216.80  |- mesh__publicMeSHNote mesh__D001791
% 216.64/216.80       67; THROMBOCYTOPATHY was see under BLOOD PLATELET DISORDERS 1967-85, was heading 1963-66%A%  
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D001791 2004
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D001791 2001
% 216.64/216.80  |- mesh__onlineNote mesh__D001791
% 216.64/216.80       use BLOOD PLATELET DISORDERS to search THROMBOCYTOPATHY 1966-85%A%  
% 216.64/216.80  |- mesh__dateEstablished mesh__D001791 1967-01-01
% 216.64/216.80  |- mesh__dateCreated mesh__D001791 1999-01-01
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D001791 1999
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D001791 2003
% 216.64/216.80  |- skos__hiddenLabel mesh__D001791 Blood Platelet Disorder
% 216.64/216.80  |- skos__scopeNote mesh__D017408
% 216.64/216.80       A systematic statement of policy rules or principles. Guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by convening expert panels. The text may be cursive or in outline form but is generally a comprehensive guide to problems and approaches in any field of activity. For guidelines in the field of health care and clinical medicine, PRACTICE GUIDELINES is available.%A%    
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D017408 2003
% 216.64/216.80  |- mesh__recordOriginator mesh__D017408 TGC
% 216.64/216.80  |- mesh__dateCreated mesh__D017408 1992-05-22
% 216.64/216.80  |- skos__annotation mesh__D017408
% 216.64/216.80       IM for articles %26% books on form, value, use %26% creation of guidelines as a procedural policy: do not confuse with Publication Type GUIDELINE; for guidelines in health care %26% clin med use PRACTICE GUIDELINES; Manual 17.57, 17.94%A%  
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D017408 2005
% 216.64/216.80  |- mesh__recordMaintainer mesh__D017408 jrf
% 216.64/216.80  |- mesh__dateRevised mesh__D017408 2001-07-25
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D017408 2004
% 216.64/216.80  |- skos__broader mesh__D017408smesh__D011785
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D017408 2002
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D017408 2006
% 216.64/216.80  |- mesh__publicMeSHNote mesh__D017408 93   
% 216.64/216.80  |- rdf__type mesh__D017408sskos__Concept
% 216.64/216.80  |- skos__prefLabel mesh__D017408 Guidelines
% 216.64/216.80  |- mesh__dateEstablished mesh__D017408 1993-01-01
% 216.64/216.80  |- mesh__historyNote mesh__D017408 93   
% 216.64/216.80  |- mesh__recordAuthorizer mesh__D017408 sjn
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014110 1994
% 216.64/216.80  |- rdf__type mesh__D014110sskos__Concept
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014110 2000
% 216.64/216.80  |- mesh__recordOriginator mesh__D014110 NLM
% 216.64/216.80  |- mesh__recordMaintainer mesh__D014110 sjn
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014110 2004
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014110 2003A
% 216.64/216.80  |- mesh__dateRevised mesh__D014110 2002-10-23
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014110 2006
% 216.64/216.80  |- skos__prefLabel mesh__D014110 Touch
% 216.64/216.80  |- skos__broader mesh__D014110smesh__D010465
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014110 2003
% 216.64/216.80  |- mesh__recordAuthorizer mesh__D014110 sjn
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014110 2005
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014110 1997
% 216.64/216.80  |- skos__scopeNote mesh__D014110
% 216.64/216.80       Sensation or perception by which contact with objects, animate or inanimate, gives evidence as to certain qualities or characteristics.%A%    
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014110 1999
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014110 2002
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014110 1996
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014110 1993
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014110 1995
% 216.64/216.80  |- skos__broader mesh__D014110smesh__D012677
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014110 1998
% 216.64/216.80  |- mesh__dateCreated mesh__D014110 1999-01-01
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014110 2001
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D000699 2006
% 216.64/216.80  |- skos__altLabel mesh__D000699 Pain Indifference, Congenital
% 216.64/216.80  |- mesh__historyNote mesh__D000699
% 216.64/216.80       96; was ANALGESIA, CONGENITAL 1964-95 %28%Prov 1964-72%29%; PAIN INSENSITIVITY, CONGENITAL was see ANALGESIA, CONGENITAL 1973-95%A%  
% 216.64/216.80  |- mesh__dateEstablished mesh__D000699 1973-01-01
% 216.64/216.80  |- skos__hiddenLabel mesh__D000699 Congenital Pain Indifference
% 216.64/216.80  |- skos__broader mesh__D000699smesh__D030342
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D000699 2005
% 216.64/216.80  |- skos__prefLabel mesh__D000699 Pain Insensitivity, Congenital
% 216.64/216.80  |- skos__altLabel mesh__D000699 Insensitivity, Congenital Pain
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D000699 2004
% 216.64/216.80  |- skos__annotation mesh__D000699
% 216.64/216.80       congenital insensitivity to pain with anhidrosis = HSAN IV see NEUROPATHIES, HEREDITARY SENSORY AND AUTONOMIC; DF: PAIN INSENSITIVITY CONGEN%A%  
% 216.64/216.80  |- mesh__publicMeSHNote mesh__D000699
% 216.64/216.80       96; was ANALGESIA, CONGENITAL 1973-95; PAIN INSENSITIVITY, CONGENITAL was see ANALGESIA, CONGENITAL 1973-95%A%  
% 216.64/216.80  |- skos__altLabel mesh__D000699 Analgesia, Congenital
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D000699 2003
% 216.64/216.80  |- skos__related mesh__D000699smesh__D009477
% 216.64/216.80  |- mesh__recordAuthorizer mesh__D000699 sjn
% 216.64/216.80  |- skos__scopeNote mesh__D000699
% 216.64/216.80       A syndrome characterized by indifference to PAIN despite the ability to distinguish noxious from nonnoxious stimuli. Absent corneal reflexes and MENTAL RETARDATION may be associated. Familial forms with autosomal recessive and autosomal dominant patterns of inheritance have been described. %28%Adams et al., Principles of Neurology, 6th ed, p1343%29%%A%    
% 216.64/216.80  |- mesh__recordOriginator mesh__D000699 NLM
% 216.64/216.80  |- skos__altLabel mesh__D000699 Congenital Indifference to Pain
% 216.64/216.80  |- mesh__onlineNote mesh__D000699
% 216.64/216.80       use PAIN INSENSITIVITY, CONGENITAL to search ANALGESIA, CONGENITAL 1966-95 %28%as Prov 1966-72%29%%A%  
% 216.64/216.80  |- rdf__type mesh__D000699sskos__Concept
% 216.64/216.80  |- skos__altLabel mesh__D000699 Congenital Analgesia
% 216.64/216.80  |- mesh__dateCreated mesh__D000699 1999-01-01
% 216.64/216.80  |- skos__hiddenLabel mesh__D000699 Congenital Pain Indifferences
% 216.64/216.80  |- mesh__dateRevised mesh__D000699 2001-07-25
% 216.64/216.80  |- skos__altLabel mesh__D000699 Congenital Pain Insensitivity
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D000699 2002
% 216.64/216.80  |- mesh__recordMaintainer mesh__D000699 nns
% 216.64/216.80  |- skos__broader mesh__D000699smesh__D010523
% 216.64/216.80  |- skos__hiddenLabel mesh__D005384 Hand Interphalangeal Joints
% 216.64/216.80  |- skos__hiddenLabel mesh__D005384 Finger Interphalangeal Joints
% 216.64/216.80  |- skos__altLabel mesh__D005384 Interphalangeal Joint of Hand
% 216.64/216.80  |- mesh__recordOriginator mesh__D005384 NLM
% 216.64/216.80  |- mesh__historyNote mesh__D005384 65   
% 216.64/216.80  |- mesh__dateRevised mesh__D005384 2005-06-30
% 216.64/216.80  |- skos__broader mesh__D005384smesh__D050823
% 216.64/216.80  |- mesh__recordMaintainer mesh__D005384 ags
% 216.64/216.80  |- mesh__publicMeSHNote mesh__D005384 65   
% 216.64/216.80  |- rdf__type mesh__D005384sskos__Concept
% 216.64/216.80  |- skos__hiddenLabel mesh__D005384 Finger Joints
% 216.64/216.80  |- mesh__dateCreated mesh__D005384 1999-01-01
% 216.64/216.80  |- skos__hiddenLabel mesh__D005384 Finger Interphalangeal Joint
% 216.64/216.80  |- skos__hiddenLabel mesh__D005384 Hand Interphalangeal Joint
% 216.64/216.80  |- skos__annotation mesh__D005384
% 216.64/216.80       primates only: TN 117; TN 238: differentiation from FINGERS %26% indexing instructions%A%  
% 216.64/216.80  |- mesh__recordAuthorizer mesh__D005384 sjn
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D005384 2006
% 216.64/216.80  |- skos__hiddenLabel mesh__D005384 Joints, Finger
% 216.64/216.80  |- skos__prefLabel mesh__D005384 Finger Joint
% 216.64/216.80  |- skos__altLabel mesh__D005384 Interphalangeal Joint of Finger
% 216.64/216.80  |- skos__scopeNote mesh__D005384
% 216.64/216.80       The articulation between the head of one phalanx and the base of the one distal to it, in each finger.%A%    
% 216.64/216.80  |- skos__hiddenLabel mesh__D005384 Joint, Finger
% 216.64/216.80  |- mesh__dateEstablished mesh__D005384 1965-01-01
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013816 2002
% 216.64/216.80  |- mesh__dateCreated mesh__D013816 1999-01-01
% 216.64/216.80  |- skos__broader mesh__D013816smesh__D010825
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013816 1998
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013816 1999
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013816 1997
% 216.64/216.80  |- mesh__recordAuthorizer mesh__D013816 PLS
% 216.64/216.80  |- mesh__recordMaintainer mesh__D013816 TPW
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013816 2000
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013816 2005
% 216.64/216.80  |- skos__annotation mesh__D013816 no qualif   
% 216.64/216.80  |- mesh__dateRevised mesh__D013816 1996-06-10
% 216.64/216.80  |- skos__hiddenLabel mesh__D013816 Thermodynamic
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013816 2003
% 216.64/216.80  |- rdf__type mesh__D013816sskos__Concept
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013816 2006
% 216.64/216.80  |- skos__scopeNote mesh__D013816
% 216.64/216.80       A rigorously mathematical analysis of energy relationships %28%heat, work, temperature, and equilibrium%29%. It describes systems whose states are determined by thermal parameters, such as temperature, in addition to mechanical and electromagnetic parameters. %28%From Hawley%27%s Condensed Chemical Dictionary, 12th ed%29%%A%    
% 216.64/216.80  |- mesh__recordOriginator mesh__D013816 NLM
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013816 2001
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013816 2004
% 216.64/216.80  |- skos__prefLabel mesh__D013816 Thermodynamics
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013018 2006
% 216.64/216.80  |- mesh__recordOriginator mesh__D013018 RC
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013018 1996
% 216.64/216.80  |- skos__hiddenLabel mesh__D013018 Sonographies, Sound
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013018 2005
% 216.64/216.80  |- skos__prefLabel mesh__D013018 Sound Spectrography
% 216.64/216.80  |- skos__hiddenLabel mesh__D013018 Sound Sonography
% 216.64/216.80  |- mesh__historyNote mesh__D013018 80   
% 216.64/216.80  |- skos__hiddenLabel mesh__D013018 Sound Sonographies
% 216.64/216.80  |- skos__scopeNote mesh__D013018
% 216.64/216.80       The graphic registration of the frequency and intensity of sounds, such as speech, infant crying, and animal vocalizations.%A%    
% 216.64/216.80  |- rdf__type mesh__D013018sskos__Concept
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013018 2001
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013018 1999
% 216.64/216.80  |- mesh__dateEstablished mesh__D013018 1980-01-01
% 216.64/216.80  |- mesh__dateRevised mesh__D013018 1994-05-27
% 216.64/216.80  |- skos__altLabel mesh__D013018 Speech Sonography
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013018 2000
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013018 1998
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013018 2004
% 216.64/216.80  |- mesh__recordAuthorizer mesh__D013018 PLS
% 216.64/216.80  |- mesh__publicMeSHNote mesh__D013018 80   
% 216.64/216.80  |- skos__altLabel mesh__D013018 Sonography, Sound
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013018 1995
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013018 2003
% 216.64/216.80  |- skos__annotation mesh__D013018
% 216.64/216.80       NIM; includes %22%speech, infant crying %26% animal vocalizations%22%; DF: SOUND SPECTROGR%A%  
% 216.64/216.80  |- skos__broader mesh__D013018smesh__D008919
% 216.64/216.80  |- mesh__dateCreated mesh__D013018 1978-12-14
% 216.64/216.80  |- mesh__recordMaintainer mesh__D013018 TGC
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013018 2002
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013018 1997
% 216.64/216.80  |- skos__hiddenLabel mesh__D013018 Spectrography, Sound
% 216.64/216.80  |- mesh__onlineNote mesh__D018501
% 216.64/216.80       use ANTI-INFLAMMATORY AGENTS to search ANTI-RHEUMATIC AGENTS 1987-94%A%  
% 216.64/216.80  |- skos__hiddenLabel mesh__D018501 Antirheumatic Drugs, Disease Modifying
% 216.64/216.80  |- skos__altLabel mesh__D018501 DMARD
% 216.64/216.80  |- skos__altLabel mesh__D018501 Disease-Modifying Second-Line Drugs
% 216.64/216.80  |- mesh__recordOriginator mesh__D018501 TPW
% 216.64/216.80  |- rdf__type mesh__D018501sskos__Concept
% 216.64/216.80  |- skos__hiddenLabel mesh__D018501 Drugs, Antirheumatic
% 216.64/216.80  |- mesh__historyNote mesh__D018501
% 216.64/216.80       95; was ANTI-RHEUMATIC AGENTS see ANTI-INFLAMMATORY AGENTS 1987-94%A%  
% 216.64/216.80  |- skos__broader mesh__D018501smesh__D045506
% 216.64/216.80  |- skos__hiddenLabel mesh__D018501 Agents, Anti-Rheumatic
% 216.64/216.80  |- skos__prefLabel mesh__D018501 Antirheumatic Agents
% 216.64/216.80  |- skos__hiddenLabel mesh__D018501 Anti Rheumatic Agents
% 216.64/216.80  |- skos__hiddenLabel mesh__D018501 Agents, Antirheumatic
% 216.64/216.80  |- skos__hiddenLabel mesh__D018501 Second Line Drugs, Disease Modifying
% 216.64/216.80  |- skos__scopeNote mesh__D018501
% 216.64/216.80       Drugs that are used to treat RHEUMATOID ARTHRITIS.     
% 216.64/216.80  |- skos__hiddenLabel mesh__D018501 Disease Modifying Second Line Drugs
% 216.64/216.80  |- skos__hiddenLabel mesh__D018501 Drugs, Disease-Modifying Second-Line
% 216.64/216.80  |- mesh__publicMeSHNote mesh__D018501
% 216.64/216.80       95; was ANTI-RHEUMATIC AGENTS see ANTI-INFLAMMATORY AGENTS 1987-94%A%  
% 216.64/216.80  |- mesh__recordAuthorizer mesh__D018501 sjn
% 216.64/216.80  |- skos__hiddenLabel mesh__D018501 Drugs, Disease-Modifying Antirheumatic
% 216.64/216.80  |- skos__altLabel mesh__D018501 Anti-Rheumatic Drugs
% 216.64/216.80  |- skos__altLabel mesh__D018501 Antirheumatic Drugs
% 216.64/216.80  |- mesh__recordMaintainer mesh__D018501 ssb
% 216.64/216.80  |- skos__hiddenLabel mesh__D018501 Anti Rheumatic Drugs
% 216.64/216.80  |- skos__hiddenLabel mesh__D018501 Disease Modifying Antirheumatic Drugs
% 216.64/216.80  |- skos__altLabel mesh__D018501 Disease-Modifying Antirheumatic Drugs
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D018501 2006
% 216.64/216.80  |- mesh__dateCreated mesh__D018501 1994-06-01
% 216.64/216.80  |- skos__hiddenLabel mesh__D018501 Drugs, Anti-Rheumatic
% 216.64/216.80  |- mesh__dateRevised mesh__D018501 2005-06-30
% 216.64/216.80  |- skos__altLabel mesh__D018501 Anti-Rheumatic Agents
% 216.64/216.80  |- skos__related mesh__D018501smesh__D007166
% 216.64/216.80  |- skos__related mesh__D018501smesh__D000962
% 216.64/216.80  |- mesh__dateEstablished mesh__D018501 1995-01-01
% 216.64/216.80  |- skos__altLabel mesh__D018501 Second-Line Drugs, Disease-Modifying
% 216.64/216.80  |- mesh__historyNote mesh__D051137 2006%28%1983%29%   
% 216.64/216.80  |- skos__prefLabel mesh__D051137 Selenium-Binding Proteins
% 216.64/216.80  |- mesh__publicMeSHNote mesh__D051137
% 216.64/216.80       2006; SELENIUM-BINDING PROTEINS was indexed as CARRIER PROTEINS 1983-2005%A%  
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D051137 2006
% 216.64/216.80  |- skos__scopeNote mesh__D051137
% 216.64/216.80       A group of proteins that covalently attach to selenium or SELENIUM-containing compounds.%A%    
% 216.64/216.80  |- mesh__recordMaintainer mesh__D051137 DRC
% 216.64/216.80  |- skos__altLabel mesh__D051137 Se-Binding Proteins
% 216.64/216.80  |- rdf__type mesh__D051137sskos__Concept
% 216.64/216.80  |- mesh__dateEstablished mesh__D051137 2006-01-01
% 216.64/216.80  |- skos__hiddenLabel mesh__D051137 Se Binding Proteins
% 216.64/216.80  |- skos__hiddenLabel mesh__D051137 Selenium Binding Proteins
% 216.64/216.80  |- mesh__dateCreated mesh__D051137 2005-06-30
% 216.64/216.80  |- skos__broader mesh__D051137smesh__D011506
% 216.64/216.80  |- mesh__recordAuthorizer mesh__D051137 sjn
% 216.64/216.80  |- mesh__recordOriginator mesh__D051137 DRC
% 216.64/216.80  |- skos__altLabel mesh__D009775 Obstetrics, Gynecology Department, Hospital
% 216.64/216.80  |- mesh__dateEstablished mesh__D009775 1991-01-01
% 216.64/216.80  |- skos__prefLabel mesh__D009775
% 216.64/216.80       Obstetrics and Gynecology Department, Hospital
% 216.64/216.80  |- mesh__dateCreated mesh__D009775 1977-05-19
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009775 1997
% 216.64/216.80  |- skos__hiddenLabel mesh__D009775 Department, Obstetrics
% 216.64/216.80  |- skos__altLabel mesh__D009775
% 216.64/216.80       Hospital Obstetrics and Gynecology Department
% 216.64/216.80  |- mesh__historyNote mesh__D009775
% 216.64/216.80       91%28%Aug 77%29%; was see under HOSPITAL DEPARTMENTS 1977-90   
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009775 2006
% 216.64/216.80  |- mesh__publicMeSHNote mesh__D009775
% 216.64/216.80       91; was see under HOSPITAL DEPARTMENTS Aug 1977-90   
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009775 1996
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009775 2002
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009775 1995
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009775 2005
% 216.64/216.80  |- skos__annotation mesh__D009775
% 216.64/216.80       check also tag PREGNANCY for obstet aspect; DF: OBSTET GYNECOL DEP or OBSTET DEP%A%  
% 216.64/216.80  |- skos__historyNote mesh__D009775 Obstetrics %28%1966-Jul 1977%29%
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009775 2001
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009775 1994
% 216.64/216.80  |- mesh__recordAuthorizer mesh__D009775 PLS
% 216.64/216.80  |- skos__scopeNote mesh__D009775
% 216.64/216.80       Hospital department responsible for the administration and management of services provided for obstetric and gynecologic patients.%A%    
% 216.64/216.80  |- skos__hiddenLabel mesh__D009775 Departments, Obstetrics
% 216.64/216.80  |- skos__historyNote mesh__D009775
% 216.64/216.80       Hospital Departments %28%1968-Jul 1977%29%
% 216.64/216.80  |- rdf__type mesh__D009775sskos__Concept
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009775 2004
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009775 1999
% 216.64/216.80  |- skos__broader mesh__D009775smesh__D006748
% 216.64/216.80  |- mesh__recordOriginator mesh__D009775 EC
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009775 1993
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009775 2000
% 216.64/216.80  |- mesh__dateRevised mesh__D009775 1992-05-15
% 216.64/216.80  |- mesh__recordMaintainer mesh__D009775 TGC
% 216.64/216.80  |- skos__historyNote mesh__D009775 Gynecology %28%1966-Jul 1977%29%
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009775 2003
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D009775 1998
% 216.64/216.80  |- skos__hiddenLabel mesh__D009775 Obstetrics Departments
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D001792 2001
% 216.64/216.80  |- mesh__recordAuthorizer mesh__D001792 PLS
% 216.64/216.80  |- skos__broader mesh__D001792smesh__D001773
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D001792 2005
% 216.64/216.80  |- skos__related mesh__D001792smesh__D010973
% 216.64/216.80  |- skos__hiddenLabel mesh__D001792 Platelet
% 216.64/216.80  |- skos__prefLabel mesh__D001792 Blood Platelets
% 216.64/216.80  |- skos__related mesh__D001792smesh__D010974
% 216.64/216.80  |- skos__related mesh__D001792smesh__D010983
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D001792 2000
% 216.64/216.80  |- rdf__type mesh__D001792sskos__Concept
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D001792 1997
% 216.64/216.80  |- skos__related mesh__D001792smesh__D015539
% 216.64/216.80  |- skos__altLabel mesh__D001792 Thrombocytes
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D001792 1996
% 216.64/216.80  |- skos__related mesh__D001792smesh__D010979
% 216.64/216.80  |- skos__hiddenLabel mesh__D001792 Thrombocyte
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D001792 2004
% 216.64/216.80  |- skos__related mesh__D001792smesh__D010975
% 216.64/216.80  |- skos__hiddenLabel mesh__D001792 Platelets, Blood
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D001792 2002
% 216.64/216.80  |- skos__scopeNote mesh__D001792
% 216.64/216.80       Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation.%A%    
% 216.64/216.80  |- skos__related mesh__D001792smesh__D017713
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D001792 1999
% 216.64/216.80  |- mesh__dateCreated mesh__D001792 1999-01-01
% 216.64/216.80  |- mesh__recordOriginator mesh__D001792 NLM
% 216.64/216.80  |- skos__related mesh__D001792smesh__D013921
% 216.64/216.80  |- mesh__considerAlso mesh__D001792
% 216.64/216.80       consider also terms at PLATELET and THROMBOCYT-   
% 216.64/216.80  |- skos__hiddenLabel mesh__D001792 Blood Platelet
% 216.64/216.80  |- skos__altLabel mesh__D001792 Platelets
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D001792 2003
% 216.64/216.80  |- skos__related mesh__D001792smesh__D010976
% 216.64/216.80  |- skos__annotation mesh__D001792
% 216.64/216.80       A 11 qualif; decrease in no. of platelets = THROMBOCYTOPENIA, increase = THROMBOCYTOSIS; platelet factors %26% defic: TN 228%A%  
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D001792 1998
% 216.64/216.80  |- mesh__dateRevised mesh__D001792 1995-02-22
% 216.64/216.80  |- skos__related mesh__D001792smesh__D013922
% 216.64/216.80  |- skos__hiddenLabel mesh__D001792 Platelet, Blood
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D001792 2006
% 216.64/216.80  |- mesh__recordMaintainer mesh__D001792 TGC
% 216.64/216.80  |- skos__altLabel mesh__D017409 Sulfentanil
% 216.64/216.80  |- skos__altLabel mesh__D017409 Janssen Brand of Sufentanil Citrate
% 216.64/216.80  |- mesh__dateEstablished mesh__D017409 1993-01-01
% 216.64/216.80  |- skos__scopeNote mesh__D017409
% 216.64/216.80       An opioid analgesic that is used as an adjunct in anesthesia, in balanced anesthesia, and as a primary anesthetic agent.%A%    
% 216.64/216.80  |- skos__historyNote mesh__D017409
% 216.64/216.80       Fentanyl/analogs %26% derivatives %28%1979-1992%29%
% 216.64/216.80  |- mesh__recordAuthorizer mesh__D017409 sjn
% 216.64/216.80  |- mesh__recordOriginator mesh__D017409 TPW
% 216.64/216.80  |- skos__hiddenLabel mesh__D017409 R30730
% 216.64/216.80  |- skos__prefLabel mesh__D017409 Sufentanil
% 216.64/216.80  |- skos__altLabel mesh__D017409 Taylor Brand of Sufentanil Citrate
% 216.64/216.80  |- skos__altLabel mesh__D017409 Hameln Brand of Sufentanil Citrate
% 216.64/216.80  |- mesh__recordMaintainer mesh__D017409 CCR
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D017409 2006
% 216.64/216.80  |- skos__altLabel mesh__D017409 ratiopharm Brand of Sufentanil Citrate
% 216.64/216.80  |- mesh__dateCreated mesh__D017409 1992-05-22
% 216.64/216.80  |- rdf__type mesh__D017409sskos__Concept
% 216.64/216.80  |- skos__hiddenLabel mesh__D017409 Citrate, Sufentanil
% 216.64/216.80  |- mesh__publicMeSHNote mesh__D017409
% 216.64/216.80       93; SULFENTANIL was indexed under FENTANYL/analogs %26% derivatives 1979-92 %26% ANILIDES %26% PIPERIDINES 1977-78%A%  
% 216.64/216.80  |- mesh__dateRevised mesh__D017409 2005-06-30
% 216.64/216.80  |- mesh__onlineNote mesh__D017409
% 216.64/216.80       use SUFENTANIL %28%NM%29% to search SULFENTANIL 1979-92   
% 216.64/216.80  |- skos__historyNote mesh__D017409 Piperidines %28%1977-1978%29%
% 216.64/216.80  |- skos__altLabel mesh__D017409 Curamed Brand of Sufentanil
% 216.64/216.80  |- mesh__historyNote mesh__D017409
% 216.64/216.80       93; was SULFENTANIL %28%NM%29% 1977-92   
% 216.64/216.80  |- skos__broader mesh__D017409smesh__D005283
% 216.64/216.80  |- skos__altLabel mesh__D017409 curasan Brand of Sufentanil Citrate
% 216.64/216.80  |- skos__historyNote mesh__D017409 Anilides %28%1977-1978%29%
% 216.64/216.80  |- skos__hiddenLabel mesh__D017409 R 30730
% 216.64/216.80  |- skos__altLabel mesh__D017409 Sulfentanyl
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014111 2002
% 216.64/216.80  |- mesh__dateEstablished mesh__D014111 1966-01-01
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014111 2004
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014111 2001
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014111 2006
% 216.64/216.80  |- mesh__dateRevised mesh__D014111 1997-06-20
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014111 2003
% 216.64/216.80  |- skos__prefLabel mesh__D014111 Tourniquets
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014111 2005
% 216.64/216.80  |- skos__broader mesh__D014111smesh__D004864
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014111 2000
% 216.64/216.80  |- mesh__recordOriginator mesh__D014111 NLM
% 216.64/216.80  |- mesh__recordAuthorizer mesh__D014111 SJN
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014111 1999
% 216.64/216.80  |- mesh__historyNote mesh__D014111 66%28%63%29%   
% 216.64/216.80  |- mesh__recordMaintainer mesh__D014111 PXP
% 216.64/216.80  |- skos__scopeNote mesh__D014111
% 216.64/216.80       Devices for the compression of a blood vessel by application around an extremity to control the circulation and prevent the flow of blood to or from the distal area. %28%From Dorland, 28th ed%29%%A%    
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D014111 1998
% 216.64/216.80  |- mesh__publicMeSHNote mesh__D014111 66   
% 216.64/216.80  |- mesh__dateCreated mesh__D014111 1999-01-01
% 216.64/216.80  |- skos__hiddenLabel mesh__D014111 Tourniquet
% 216.64/216.80  |- rdf__type mesh__D014111sskos__Concept
% 216.64/216.80  |- rdf__type mesh__D005385sskos__Concept
% 216.64/216.80  |- skos__annotation mesh__D005385
% 216.64/216.80       primates only: TN 117; /inj = FINGER INJURIES but consider also THUMB /inj; TN 238: differentiation from FINGER JOINT %26% indexing instructions; NIM when merely locational as in HAND DERMATOSES %28%IM%29%%A%  
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D005385 2005
% 216.64/216.80  |- mesh__recordOriginator mesh__D005385 NLM
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D005385 2006
% 216.64/216.80  |- mesh__dateRevised mesh__D005385 2002-07-03
% 216.64/216.80  |- mesh__recordMaintainer mesh__D005385 PLS
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D005385 2003
% 216.64/216.80  |- skos__broader mesh__D005385smesh__D006225
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D005385 2004
% 216.64/216.80  |- skos__hiddenLabel mesh__D005385 Finger
% 216.64/216.80  |- mesh__recordAuthorizer mesh__D005385 sjn
% 216.64/216.80  |- skos__prefLabel mesh__D005385 Fingers
% 216.64/216.80  |- mesh__dateCreated mesh__D005385 1999-01-01
% 216.64/216.80  |- mesh__dateEstablished mesh__D013817 1967-01-01
% 216.64/216.80  |- mesh__activeMeSHYear mesh__D013817 2001
% 216.64/216.80  |- mesh__dateCreated mesh__D013817 1999-01-01
% 216.64/216.80  |- skos__broader mesh__D013817smesh__D003952
% 216.64/216.80  |- skos__scopeNote mesh__D013817
% 216.64/216.80       Measurement of the regional temperature of the body or an organ by infrared sensing devices, based on self-emanating infrared radiation.%A%    
% 216.64/216.80  |- skos__hiddenLabel mesh__D013817 Thermographies
% 216.64/216.80  |- mesh__recordOriginator mesh__D013817 NLM
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D013817 1999
% 216.64/216.81  |- skos__prefLabel mesh__D013817 Thermography
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D013817 2002
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D013817 2005
% 216.64/216.81  |- mesh__dateRevised mesh__D013817 1997-06-20
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D013817 2003
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D013817 2006
% 216.64/216.81  |- mesh__recordMaintainer mesh__D013817 PXP
% 216.64/216.81  |- mesh__recordAuthorizer mesh__D013817 SJN
% 216.64/216.81  |- rdf__type mesh__D013817sskos__Concept
% 216.64/216.81  |- skos__annotation mesh__D013817
% 216.64/216.81       in diag coord IM with disease /diag, not /radiogr; do not use /util except by MeSH definition; DF: THERMOGR%A%  
% 216.64/216.81  |- mesh__publicMeSHNote mesh__D013817 67   
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D013817 2004
% 216.64/216.81  |- mesh__historyNote mesh__D013817 67%28%65%29%   
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D013817 2000
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D013817 1998
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D013019 2005
% 216.64/216.81  |- rdf__type mesh__D013019sskos__Concept
% 216.64/216.81  |- mesh__recordAuthorizer mesh__D013019 SJN
% 216.64/216.81  |- skos__prefLabel mesh__D013019 South Africa
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D013019 2002
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D013019 1999
% 216.64/216.81  |- mesh__dateCreated mesh__D013019 1999-01-01
% 216.64/216.81  |- skos__altLabel mesh__D013019 Union of South Africa
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D013019 1998
% 216.64/216.81  |- skos__scopeNote mesh__D013019
% 216.64/216.81       A republic in southern Africa, the southernmost part of Africa. It has three capitals: Pretoria %28%administrative%29%, Cape Town %28%legislative%29%, and Bloemfontein %28%judicial%29%. The history is a fabric interwoven with hostile activity among the native tribes, particularly the Zulus, the Boers %28%Dutch settlers%29%, and the British. Officially the Republic of South Africa since 1960, it was called the Union of South Africa 1910-1960.%A%    
% 216.64/216.81  |- skos__broader mesh__D013019smesh__D000353
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D013019 2004
% 216.64/216.81  |- mesh__recordOriginator mesh__D013019 NLM
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D013019 2001
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D013019 2003
% 216.64/216.81  |- skos__annotation mesh__D013019
% 216.64/216.81       official name is Republic of South Africa; X ref UNION OF SOUTH AFRICA was its former name; do not confuse with geog designation AFRICA, SOUTHERN%A%  
% 216.64/216.81  |- skos__altLabel mesh__D013019 Republic of South Africa
% 216.64/216.81  |- mesh__recordMaintainer mesh__D013019 TGC
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D013019 2000
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D013019 2006
% 216.64/216.81  |- mesh__dateRevised mesh__D013019 1997-06-20
% 216.64/216.81  |- skos__scopeNote mesh__D018502
% 216.64/216.81       A species of gram-positive, coccoid bacteria isolated from abscesses in submaxillary glands and mucopurulent discharges of the upper respiratory tract of horses. This organism belongs to Group C streptococci with regards to antigen response and is known to cause strangles. The subspecies S. zooepidemicus is also considered a pathogen of horses.%A%    
% 216.64/216.81  |- mesh__recordOriginator mesh__D018502 PXP
% 216.64/216.81  |- skos__historyNote mesh__D018502 Streptococcus %28%1967-1994%29%
% 216.64/216.81  |- mesh__dateRevised mesh__D018502 2005-06-30
% 216.64/216.81  |- mesh__dateCreated mesh__D018502 1994-02-28
% 216.64/216.81  |- rdf__type mesh__D018502sskos__Concept
% 216.64/216.81  |- mesh__recordMaintainer mesh__D018502 SYSTEM
% 216.64/216.81  |- skos__broader mesh__D018502smesh__D013291
% 216.64/216.81  |- mesh__publicMeSHNote mesh__D018502 95   
% 216.64/216.81  |- skos__annotation mesh__D018502
% 216.64/216.81       infection: coord IM with STREPTOCOCCAL INFECTIONS %28%IM%29%; DF: STREP EQUI%A%  
% 216.64/216.81  |- mesh__recordAuthorizer mesh__D018502 sjn
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D018502 2006
% 216.64/216.81  |- skos__prefLabel mesh__D018502 Streptococcus equi
% 216.64/216.81  |- mesh__dateEstablished mesh__D018502 1995-01-01
% 216.64/216.81  |- mesh__historyNote mesh__D018502 95   
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D051936 2006
% 216.64/216.81  |- mesh__recordOriginator mesh__D051936 DRC
% 216.64/216.81  |- skos__broader mesh__D051936smesh__D002868
% 216.64/216.81  |- rdf__type mesh__D051936sskos__Concept
% 216.64/216.81  |- skos__altLabel mesh__D051936 CENP-B Protein
% 216.64/216.81  |- skos__hiddenLabel mesh__D051936 CENP B Protein
% 216.64/216.81  |- mesh__recordAuthorizer mesh__D051936 sjn
% 216.64/216.81  |- mesh__recordMaintainer mesh__D051936 DRC
% 216.64/216.81  |- skos__altLabel mesh__D051936 Centromere Autoantigen 80K
% 216.64/216.81  |- mesh__dateEstablished mesh__D051936 2006-01-01
% 216.64/216.81  |- mesh__dateCreated mesh__D051936 2005-06-30
% 216.64/216.81  |- skos__prefLabel mesh__D051936 Centromere Protein B
% 216.64/216.81  |- skos__scopeNote mesh__D051936
% 216.64/216.81       A DNA-binding protein that interacts with a 17-base pair sequence known as the CENP-B box motif. The protein is localized constitutively to the CENTROMERE and plays an important role in its maintenance.%A%    
% 216.64/216.81  |- mesh__publicMeSHNote mesh__D051936
% 216.64/216.81       2006; CENTROMERE PROTEIN B was indexed under AUTOANTIGENS %26% CHROMOSOMAL PROTEINS, NON-HISTONE %26% DNA-BINDING PROTEINS 1987-2005%A%  
% 216.64/216.81  |- skos__broader mesh__D051936smesh__D001324
% 216.64/216.81  |- skos__broader mesh__D051936smesh__D004268
% 216.64/216.81  |- skos__related mesh__D051936smesh__D002503
% 216.64/216.81  |- mesh__historyNote mesh__D051936 2006%28%1987%29%   
% 216.64/216.81  |- skos__broader mesh__D005123Q000502smesh__D005123
% 216.64/216.81  |- mesh__preferredCombination mesh__D005123Q000502smesh__D009799
% 216.64/216.81  |- rdf__type mesh__D005123Q000502smesh__CompoundConcept
% 216.64/216.81  |- skos__hiddenLabel mesh__D009776 Nerves, Obturator
% 216.64/216.81  |- skos__hiddenLabel mesh__D009776 Nerve, Obturator
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009776 2006
% 216.64/216.81  |- mesh__recordOriginator mesh__D009776 NLM
% 216.64/216.81  |- skos__prefLabel mesh__D009776 Obturator Nerve
% 216.64/216.81  |- mesh__dateCreated mesh__D009776 1999-01-01
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009776 2005
% 216.64/216.81  |- skos__broader mesh__D009776smesh__D008160
% 216.64/216.81  |- mesh__recordMaintainer mesh__D009776 kle
% 216.64/216.81  |- mesh__recordAuthorizer mesh__D009776 sjn
% 216.64/216.81  |- rdf__type mesh__D009776sskos__Concept
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009776 2004
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009776 2002
% 216.64/216.81  |- mesh__dateRevised mesh__D009776 1999-11-03
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009776 2003
% 216.64/216.81  |- skos__annotation mesh__D009776
% 216.64/216.81       dis: coord IM with PERIPHERAL NERVOUS SYSTEM DISEASES %28%IM%29%; neopl: coord IM with PERIPHERAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009776 2001
% 216.64/216.81  |- skos__hiddenLabel mesh__D009776 Obturator Nerves
% 216.64/216.81  |- skos__scopeNote mesh__D009776
% 216.64/216.81       A nerve originating in the lumbar spinal cord %28%L2 to L4%29% and traveling through the lumbar plexus to the lower extremity. The obturator nerve provides motor innervation to the adductor muscles of the thigh and cutaneous sensory innervation of the inner thigh.%A%    
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009776 2000
% 216.64/216.81  |- mesh__recordAuthorizer mesh__D001793 sjn
% 216.64/216.81  |- skos__scopeNote mesh__D001793
% 216.64/216.81       The process by which blood or its components are kept viable outside of the organism from which they are derived %28%i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism%29%.%A%    
% 216.64/216.81  |- mesh__recordOriginator mesh__D001793 NLM
% 216.64/216.81  |- skos__prefLabel mesh__D001793 Blood Preservation
% 216.64/216.81  |- mesh__dateCreated mesh__D001793 1999-01-01
% 216.64/216.81  |- rdf__type mesh__D001793sskos__Concept
% 216.64/216.81  |- mesh__recordMaintainer mesh__D001793 nns
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D001793 2003
% 216.64/216.81  |- skos__hiddenLabel mesh__D001793 Blood Preservations
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D001793 2004
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D001793 2002
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D001793 2005
% 216.64/216.81  |- skos__broader mesh__D001793smesh__D014021
% 216.64/216.81  |- skos__hiddenLabel mesh__D001793 Preservation, Blood
% 216.64/216.81  |- skos__hiddenLabel mesh__D001793 Preservations, Blood
% 216.64/216.81  |- mesh__dateRevised mesh__D001793 2001-07-25
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D001793 2006
% 216.64/216.81  |- skos__annotation mesh__D001793
% 216.64/216.81       preserv of whole blood or specific cellular elements; coord IM with specific cell %28%IM%29%; cryopreservation of blood: coord IM with CRYOPRESERVATION %28%IM%29%%A%  
% 216.64/216.81  |- skos__annotation mesh__D042601
% 216.64/216.81       note X refs VENULES, LYMPHATIC: do not coord with VENULES which are restricted to blood vessels%A%  
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D042601 2004
% 216.64/216.81  |- mesh__historyNote mesh__D042601
% 216.64/216.81       2004; for LYMPHATIC VESSELS, LYMPHATIC CAPILLARIES, LYMPHATIC VENULES %26% VENULES, POSTCAPILLARY use LYMPHATIC SYSTEM 1997-2002%A%  
% 216.64/216.81  |- skos__prefLabel mesh__D042601 Lymphatic Vessels
% 216.64/216.81  |- skos__scopeNote mesh__D042601
% 216.64/216.81       Tubular vessels that are involved in the transport of LYMPH and LYMPHOCYTES.%A%    
% 216.64/216.81  |- skos__hiddenLabel mesh__D042601 Venule, Lymphatic
% 216.64/216.81  |- mesh__recordOriginator mesh__D042601 jmp
% 216.64/216.81  |- mesh__dateCreated mesh__D042601 2003-07-09
% 216.64/216.81  |- skos__hiddenLabel mesh__D042601 Capillary, Lymphatic
% 216.64/216.81  |- rdf__type mesh__D042601sskos__Concept
% 216.64/216.81  |- skos__altLabel mesh__D042601 Venules, Lymphatic
% 216.64/216.81  |- skos__hiddenLabel mesh__D042601 Vessels, Lymphatic
% 216.64/216.81  |- skos__broader mesh__D042601smesh__D008208
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D042601 2006
% 216.64/216.81  |- skos__hiddenLabel mesh__D042601 Lymphatic Capillary
% 216.64/216.81  |- mesh__recordAuthorizer mesh__D042601 sjn
% 216.64/216.81  |- skos__hiddenLabel mesh__D042601 Lymphatic Vessel
% 216.64/216.81  |- skos__hiddenLabel mesh__D042601 Vessel, Lymphatic
% 216.64/216.81  |- skos__altLabel mesh__D042601 Capillaries, Lymphatic
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D042601 2005
% 216.64/216.81  |- skos__hiddenLabel mesh__D042601 Lymphatic Venule
% 216.64/216.81  |- mesh__recordMaintainer mesh__D042601 jmp
% 216.64/216.81  |- mesh__publicMeSHNote mesh__D042601
% 216.64/216.81       2004; for LYMPHATIC VESSELS, LYMPHATIC CAPILLARIES, LYMPHATIC VENULES %26% VENULES, POSTCAPILLARY see LYMPHATIC SYSTEM 1997-2002%A%  
% 216.64/216.81  |- mesh__dateEstablished mesh__D042601 2004-01-01
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D014910 2003
% 216.64/216.81  |- skos__hiddenLabel mesh__D014910 Chairs, Wheel
% 216.64/216.81  |- mesh__dateEstablished mesh__D014910 1976-01-01
% 216.64/216.81  |- skos__prefLabel mesh__D014910 Wheelchairs
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D014910 1998
% 216.64/216.81  |- mesh__publicMeSHNote mesh__D014910 76; was WHEEL CHAIRS 1963-75   
% 216.64/216.81  |- mesh__recordAuthorizer mesh__D014910 PLS
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D014910 2000
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D014910 1995
% 216.64/216.81  |- mesh__recordOriginator mesh__D014910 SMH
% 216.64/216.81  |- mesh__dateRevised mesh__D014910 1992-05-18
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D014910 2004
% 216.64/216.81  |- skos__altLabel mesh__D014910 Wheel Chairs
% 216.64/216.81  |- skos__hiddenLabel mesh__D014910 Chair, Wheel
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D014910 1999
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D014910 2001
% 216.64/216.81  |- rdf__type mesh__D014910sskos__Concept
% 216.64/216.81  |- mesh__recordMaintainer mesh__D014910 PLS
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D014910 1996
% 216.64/216.81  |- mesh__historyNote mesh__D014910 76; was WHEEL CHAIRS 1963-75   
% 216.64/216.81  |- skos__hiddenLabel mesh__D014910 Wheel Chair
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D014910 1993
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D014910 1997
% 216.64/216.81  |- mesh__onlineNote mesh__D014910
% 216.64/216.81       use WHEELCHAIRS to search WHEEL CHAIRS 1966-75   
% 216.64/216.81  |- skos__hiddenLabel mesh__D014910 Wheelchair
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D014910 2005
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D014910 2002
% 216.64/216.81  |- skos__broader mesh__D014910smesh__D012656
% 216.64/216.81  |- mesh__dateCreated mesh__D014910 1975-07-18
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D014910 2006
% 216.64/216.81  |- skos__scopeNote mesh__D014910
% 216.64/216.81       Chairs mounted on wheels and designed to be propelled by the occupant.%A%    
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D014910 1994
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D014112 2005
% 216.64/216.81  |- skos__broader mesh__D014112smesh__D006843
% 216.64/216.81  |- mesh__recordAuthorizer mesh__D014112 sjn
% 216.64/216.81  |- skos__historyNote mesh__D014112 Insecticides %28%1966-1972%29%
% 216.64/216.81  |- skos__scopeNote mesh__D014112
% 216.64/216.81       A very complex, but reproducible mixture of at least 177 C10 polychloro derivatives, having an approximate overall empirical formula of C10-H10-Cl8. It is used as an insecticide and may reasonably be anticipated to be a carcinogen: Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%. %28%From Merck Index, 11th ed%29%%A%    
% 216.64/216.81  |- skos__broader mesh__D014112smesh__D009636
% 216.64/216.81  |- mesh__recordMaintainer mesh__D014112 ssb
% 216.64/216.81  |- mesh__dateCreated mesh__D014112 1999-01-01
% 216.64/216.81  |- skos__altLabel mesh__D014112 Polychlorocamphene
% 216.64/216.81  |- rdf__type mesh__D014112sskos__Concept
% 216.64/216.81  |- mesh__historyNote mesh__D014112
% 216.64/216.81       91%28%72%29%; was see under INSECTICIDES, ORGANOCHLORINE 1972-90%A%  
% 216.64/216.81  |- mesh__dateEstablished mesh__D014112 1991-01-01
% 216.64/216.81  |- mesh__dateRevised mesh__D014112 2004-07-07
% 216.64/216.81  |- skos__annotation mesh__D014112 TN 111 for eff on insects   
% 216.64/216.81  |- skos__prefLabel mesh__D014112 Toxaphene
% 216.64/216.81  |- mesh__recordOriginator mesh__D014112 NLM
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D014112 2006
% 216.64/216.81  |- mesh__publicMeSHNote mesh__D014112
% 216.64/216.81       91; was see under INSECTICIDES, ORGANOCHLORINE 1972-90   
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D005386 2005
% 216.64/216.81  |- mesh__recordMaintainer mesh__D005386 TPW
% 216.64/216.81  |- rdf__type mesh__D005386sskos__Concept
% 216.64/216.81  |- mesh__recordAuthorizer mesh__D005386 sjn
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D005386 2006
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D005386 2003
% 216.64/216.81  |- skos__hiddenLabel mesh__D005386 Sucking, Finger
% 216.64/216.81  |- skos__hiddenLabel mesh__D005386 Sucking, Thumb
% 216.64/216.81  |- skos__altLabel mesh__D005386 Thumb Sucking
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D005386 2004
% 216.64/216.81  |- skos__scopeNote mesh__D005386
% 216.64/216.81       Sucking of the finger. This is one of the most common manipulations of the body found in young children.%A%    
% 216.64/216.81  |- mesh__dateRevised mesh__D005386 2002-07-03
% 216.64/216.81  |- mesh__recordOriginator mesh__D005386 NLM
% 216.64/216.81  |- mesh__dateCreated mesh__D005386 1999-01-01
% 216.64/216.81  |- skos__prefLabel mesh__D005386 Fingersucking
% 216.64/216.81  |- skos__altLabel mesh__D005386 Finger Sucking
% 216.64/216.81  |- skos__broader mesh__D005386smesh__D006184
% 216.64/216.81  |- skos__broader mesh__D013818smesh__D002623
% 216.64/216.81  |- skos__annotation mesh__D013818 NIM   
% 216.64/216.81  |- mesh__recordOriginator mesh__D013818 SMH
% 216.64/216.81  |- skos__prefLabel mesh__D013818 Thermogravimetry
% 216.64/216.81  |- skos__scopeNote mesh__D013818
% 216.64/216.81       Technique whereby the weight of a sample can be followed over a period of time while its temperature is being changed %28%usually increased at a constant rate%29%.%A%    
% 216.64/216.81  |- mesh__dateCreated mesh__D013818 1976-04-13
% 216.64/216.81  |- mesh__dateEstablished mesh__D013818 1991-01-01
% 216.64/216.81  |- mesh__recordAuthorizer mesh__D013818 sjn
% 216.64/216.81  |- mesh__recordMaintainer mesh__D013818 lkt
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D013818 2004
% 216.64/216.81  |- mesh__dateRevised mesh__D013818 2002-07-03
% 216.64/216.81  |- skos__hiddenLabel mesh__D013818 Thermogravimetries
% 216.64/216.81  |- mesh__publicMeSHNote mesh__D013818
% 216.64/216.81       91; was see under CHEMISTRY, ANALYTICAL 1977-90   
% 216.64/216.81  |- mesh__historyNote mesh__D013818
% 216.64/216.81       91%28%77%29%; was see under CHEMISTRY, ANALYTICAL 1977-90   
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D013818 2006
% 216.64/216.81  |- skos__historyNote mesh__D013818 Heat %28%1966-1976%29%
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D013818 2003
% 216.64/216.81  |- rdf__type mesh__D013818sskos__Concept
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D013818 2005
% 216.64/216.81  |- mesh__recordMaintainer mesh__D018503 nns
% 216.64/216.81  |- skos__historyNote mesh__D018503 Genes, Protozoan %28%1993-1994%29%
% 216.64/216.81  |- skos__scopeNote mesh__D018503
% 216.64/216.81       The complete genetic complement contained in a set of CHROMOSOMES in a protozoan %28%PROTOZOA%29%.%A%    
% 216.64/216.81  |- skos__historyNote mesh__D018503 DNA, Protozoan %28%1991-1994%29%
% 216.64/216.81  |- skos__historyNote mesh__D018503 specific protozoa %28%1966-1990%29%
% 216.64/216.81  |- rdf__type mesh__D018503sskos__Concept
% 216.64/216.81  |- skos__hiddenLabel mesh__D018503 Genomes, Protozoan
% 216.64/216.81  |- mesh__dateEstablished mesh__D018503 1995-01-01
% 216.64/216.81  |- skos__hiddenLabel mesh__D018503 Protozoan Genomes
% 216.64/216.81  |- skos__related mesh__D018503smesh__D017125
% 216.64/216.81  |- mesh__dateRevised mesh__D018503 2005-06-30
% 216.64/216.81  |- skos__altLabel mesh__D018503 Protozoan Genome
% 216.64/216.81  |- skos__broader mesh__D018503smesh__D016678
% 216.64/216.81  |- skos__historyNote mesh__D018503 DNA %28%1966-1990%29%
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D018503 2006
% 216.64/216.81  |- skos__prefLabel mesh__D018503 Genome, Protozoan
% 216.64/216.81  |- mesh__historyNote mesh__D018503 95   
% 216.64/216.81  |- mesh__recordOriginator mesh__D018503 PXP
% 216.64/216.81  |- mesh__publicMeSHNote mesh__D018503 95   
% 216.64/216.81  |- mesh__recordAuthorizer mesh__D018503 sjn
% 216.64/216.81  |- skos__historyNote mesh__D018503 Genes %28%1966-1992%29%
% 216.64/216.81  |- skos__annotation mesh__D018503
% 216.64/216.81       coordinate IM with specific protozoan /genet %28%IM%29%   
% 216.64/216.81  |- mesh__dateCreated mesh__D018503 1994-02-28
% 216.64/216.81  |- skos__hiddenLabel mesh__D010520 Periodontoses
% 216.64/216.81  |- skos__scopeNote mesh__D010520
% 216.64/216.81       Localized periodontitis in teenagers and young adults. The onset is during the circumpubertal period but the diagnosis can be made beyond puberty. Lesions are confined predominantly to the first permanent molars or incisors and the distribution of lesions is usually symmetrical. The gingiva may appear normal. The lesions are highly active immediately following puberty but later destruction may slow or cease spontaneously. The disease is four times more prevalent in females than males and more prevalent in African Americans than in other races or ethnic groups. %28%From Schluger et al., Periodontal Diseases, 2d ed, p61%29%%A%    
% 216.64/216.81  |- skos__prefLabel mesh__D010520 Periodontitis, Juvenile
% 216.64/216.81  |- skos__hiddenLabel mesh__D010520 Juvenile Periodontitides
% 216.64/216.81  |- mesh__recordOriginator mesh__D010520 RC
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D010520 2002
% 216.64/216.81  |- mesh__dateEstablished mesh__D010520 1991-01-01
% 216.64/216.81  |- skos__broader mesh__D010520smesh__D010518
% 216.64/216.81  |- mesh__historyNote mesh__D010520
% 216.64/216.81       97; was PERIODONTOSIS 1984-96 %28%see under PERIODONTAL DISEASES 1984-90%29%, was see PERIODONTAL DISEASES 1966-83; PERIODONTITIS, JUVENILE was see PERIODONTOSIS 1984-96%A%  
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D010520 2006
% 216.64/216.81  |- skos__historyNote mesh__D010520 Periodontal Diseases %28%1966-1983%29%
% 216.64/216.81  |- skos__hiddenLabel mesh__D010520 Juvenile Periodontitis
% 216.64/216.81  |- mesh__publicMeSHNote mesh__D010520
% 216.64/216.81       97; was PERIODONTOSIS 1984-96 %28%see under PERIODONTAL DISEASES 1984-90%29%, was see PERIODONTAL DISEASES 1966-83; PERIODONTITIS, JUVENILE was see PERIODONTOSIS 1984-96%A%  
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D010520 2004
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D010520 2005
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D010520 2003
% 216.64/216.81  |- rdf__type mesh__D010520sskos__Concept
% 216.64/216.81  |- skos__annotation mesh__D010520
% 216.64/216.81       usually in teenagers %26% young adults: note ages in text %26% check proper tags; do not confuse X ref PERIODONTOSIS with %22%periodontosis%22% seen in foreign lit, meaning %22%periodontal disease%22% %26% indexed under PERIODONTAL DISEASES%A%  
% 216.64/216.81  |- mesh__dateRevised mesh__D010520 2001-07-25
% 216.64/216.81  |- mesh__onlineNote mesh__D010520
% 216.64/216.81       use PERIODONTITIS, JUVENILE to search PERIODONTOSIS 1984-96; search PERIODONTAL DISEASES 1966-83%A%  
% 216.64/216.81  |- mesh__recordMaintainer mesh__D010520 ags
% 216.64/216.81  |- mesh__recordAuthorizer mesh__D010520 sjn
% 216.64/216.81  |- skos__altLabel mesh__D010520 Periodontitis, Circumpubertal
% 216.64/216.81  |- mesh__dateCreated mesh__D010520 1983-04-21
% 216.64/216.81  |- skos__hiddenLabel mesh__D051937 DARPP 32 Protein
% 216.64/216.81  |- mesh__publicMeSHNote mesh__D051937
% 216.64/216.81       2006; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN was indexed under NERVE TISSUE PROTEINS %26% PHOSPHOPROTEINS 1984-2005%A%  
% 216.64/216.81  |- skos__altLabel mesh__D051937 DARPP-32 Protein
% 216.64/216.81  |- skos__altLabel mesh__D051937
% 216.64/216.81       Dopamine and Adenosine 3%27%,5%27%-Monophosphate-Regulated Phosphoprotein
% 216.64/216.81  |- skos__broader mesh__D051937smesh__D009419
% 216.64/216.81  |- skos__hiddenLabel mesh__D051937
% 216.64/216.81       Dopamine  and Cyclic AMP Regulated Phosphoprotein Mr 32,000
% 216.64/216.81  |- skos__scopeNote mesh__D051937
% 216.64/216.81       A phosphoprotein that was initially identified as a major target of DOPAMINE activated ADENYLYL CYCLASE in the CORPUS STRIATUM. It regulates the activities of PROTEIN PHOSPHATASE-1 and PROTEIN KINASE A, and it is a key mediator of the biochemical, electrophysiological, transcriptional, and behavioral effects of DOPAMINE.%A%    
% 216.64/216.81  |- skos__hiddenLabel mesh__D051937
% 216.64/216.81       Dopamine and cAMP Regulated Phosphoprotein 32
% 216.64/216.81  |- mesh__recordMaintainer mesh__D051937 DRC
% 216.64/216.81  |- skos__altLabel mesh__D051937
% 216.64/216.81       Dopamine- and Cyclic AMP-Regulated Phosphoprotein Mr 32,000
% 216.64/216.81  |- skos__prefLabel mesh__D051937
% 216.64/216.81       Dopamine and cAMP-Regulated Phosphoprotein 32
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D051937 2006
% 216.64/216.81  |- mesh__recordAuthorizer mesh__D051937 sjn
% 216.64/216.81  |- skos__hiddenLabel mesh__D051937
% 216.64/216.81       Dopamine and cAMP Regulated Phosphoprotein
% 216.64/216.81  |- mesh__recordOriginator mesh__D051937 DRC
% 216.64/216.81  |- skos__broader mesh__D051937smesh__D010750
% 216.64/216.81  |- mesh__dateEstablished mesh__D051937 2006-01-01
% 216.64/216.81  |- mesh__historyNote mesh__D051937 2006%28%1984%29%   
% 216.64/216.81  |- rdf__type mesh__D051937sskos__Concept
% 216.64/216.81  |- skos__hiddenLabel mesh__D051937
% 216.64/216.81       Dopamine and Adenosine 3%27%,5%27% Monophosphate Regulated Phosphoprotein
% 216.64/216.81  |- skos__altLabel mesh__D051937 Dopamine and cAMP-Regulated Phosphoprotein
% 216.64/216.81  |- mesh__dateCreated mesh__D051937 2005-06-30
% 216.64/216.81  |- mesh__dateEstablished mesh__D048190 2005-01-01
% 216.64/216.81  |- mesh__historyNote mesh__D048190 2005   
% 216.64/216.81  |- mesh__publicMeSHNote mesh__D048190 2005   
% 216.64/216.81  |- skos__prefLabel mesh__D048190 Hymenolepis diminuta
% 216.64/216.81  |- skos__altLabel mesh__D048190 Rat Tapeworm
% 216.64/216.81  |- mesh__recordMaintainer mesh__D048190 ags
% 216.64/216.81  |- mesh__recordOriginator mesh__D048190 ags
% 216.64/216.81  |- skos__broader mesh__D048190smesh__D006926
% 216.64/216.81  |- mesh__dateCreated mesh__D048190 2004-07-07
% 216.64/216.81  |- skos__historyNote mesh__D048190 Hymenolepis %28%1979-2004%29%
% 216.64/216.81  |- skos__historyNote mesh__D048190 Insects %28%1965-1978%29%
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D048190 2005
% 216.64/216.81  |- skos__scopeNote mesh__D048190
% 216.64/216.81       A species of tapeworm %28%TAPEWORMS%29% infecting RATS and MICE but rarely causing disease in humans. Its life cycle involves RODENTS as the definitive host and BEETLES as the intermediate host.%A%    
% 216.64/216.81  |- rdf__type mesh__D048190sskos__Concept
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D048190 2006
% 216.64/216.81  |- mesh__recordAuthorizer mesh__D048190 sjn
% 216.64/216.81  |- skos__annotation mesh__D048190
% 216.64/216.81       infection: coordinate %28%IM%29% with HYMENOLEPIASIS %28%IM%29%   
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009777 2000
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009777 2006
% 216.64/216.81  |- skos__hiddenLabel mesh__D009777 Occipital Bones
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009777 2001
% 216.64/216.81  |- skos__hiddenLabel mesh__D009777 Bones, Basilar
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009777 1995
% 216.64/216.81  |- skos__hiddenLabel mesh__D009777 Basilar Bones
% 216.64/216.81  |- skos__hiddenLabel mesh__D009777 Bones, Occipital
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009777 2003
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009777 1998
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009777 1992
% 216.64/216.81  |- mesh__recordMaintainer mesh__D009777 TGC
% 216.64/216.81  |- skos__broader mesh__D009777smesh__D012886
% 216.64/216.81  |- rdf__type mesh__D009777sskos__Concept
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009777 2004
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009777 1999
% 216.64/216.81  |- mesh__recordOriginator mesh__D009777 NLM
% 216.64/216.81  |- skos__annotation mesh__D009777
% 216.64/216.81       fractures: coord OCCIPITAL BONE /inj %28%IM%29% + SKULL FRACTURES %28%IM%29%; neopl: coord IM with SKULL NEOPLASMS %28%IM%29%%A%  
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009777 1993
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009777 2002
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009777 1996
% 216.64/216.81  |- mesh__recordAuthorizer mesh__D009777 PLS
% 216.64/216.81  |- mesh__dateRevised mesh__D009777 1991-01-07
% 216.64/216.81  |- skos__prefLabel mesh__D009777 Occipital Bone
% 216.64/216.81  |- mesh__dateCreated mesh__D009777 1999-01-01
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009777 2005
% 216.64/216.81  |- skos__hiddenLabel mesh__D009777 Bone, Basilar
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009777 1997
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D009777 1994
% 216.64/216.81  |- skos__hiddenLabel mesh__D009777 Bone, Occipital
% 216.64/216.81  |- skos__hiddenLabel mesh__D001794 Pressure, Diastolic
% 216.64/216.81  |- mesh__recordAuthorizer mesh__D001794 ags
% 216.64/216.81  |- mesh__dateCreated mesh__D001794 1999-01-01
% 216.64/216.81  |- rdf__type mesh__D001794sskos__Concept
% 216.64/216.81  |- skos__hiddenLabel mesh__D001794 Pressure, Systolic
% 216.64/216.81  |- mesh__dateRevised mesh__D001794 2005-08-01
% 216.64/216.81  |- skos__hiddenLabel mesh__D001794 Pressure, Blood
% 216.64/216.81  |- skos__hiddenLabel mesh__D001794 Pressures, Systolic
% 216.64/216.81  |- mesh__recordOriginator mesh__D001794 NLM
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D001794 2004
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D001794 2006A
% 216.64/216.81  |- skos__related mesh__D001794smesh__D006973
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D001794 2005
% 216.64/216.81  |- skos__hiddenLabel mesh__D001794 Pressure, Pulse
% 216.64/216.81  |- skos__related mesh__D001794smesh__D007022
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D001794 2006B
% 216.64/216.81  |- skos__prefLabel mesh__D001794 Blood Pressure
% 216.64/216.81  |- skos__annotation mesh__D001794
% 216.64/216.81       GEN; note specifics; %22%arterial%22% pressure = BLOOD PRESSURE and not also ARTERIES unless a specific artery; pressure within a specific vessel:  coord vessel /physiol %28%IM%29% + BLOOD PRESSURE %28%NIM%29%; do not add SYSTOLE; DIASTOLE; or PULSE unless particularly discussed; with diseases coord IM with disease /physiopathol %28%IM%29%, not /blood %28%IM%29%:  Manual 23.28; blood pressure vs HYPERTENSION %26% HYPOTENSION:  Manual 23.27+%A%  
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D001794 2006
% 216.64/216.81  |- skos__broader mesh__D001794smesh__D045472
% 216.64/216.81  |- skos__scopeNote mesh__D001794
% 216.64/216.81       PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS.%A%    
% 216.64/216.81  |- mesh__recordMaintainer mesh__D001794 ags
% 216.64/216.81  |- mesh__publicMeSHNote mesh__D042602 2004   
% 216.64/216.81  |- mesh__dateEstablished mesh__D042602 2004-01-01
% 216.64/216.81  |- mesh__recordMaintainer mesh__D042602 SYSTEM
% 216.64/216.81  |- skos__historyNote mesh__D042602 Burkholderia cepacia %28%1999-2003%29%
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D042602 2006
% 216.64/216.81  |- mesh__recordOriginator mesh__D042602 ags
% 216.64/216.81  |- skos__scopeNote mesh__D042602
% 216.64/216.81       A group of phenotypically similar but genotypically distinct species %28%genomovars%29% in the genus BURKHOLDERIA. They are found in water, soil, and the rhizosphere of crop plants. They can act as opportunistic human pathogens and as plant growth promoting and biocontrol agents.%A%    
% 216.64/216.81  |- mesh__recordAuthorizer mesh__D042602 sjn
% 216.64/216.81  |- skos__broader mesh__D042602smesh__D019117
% 216.64/216.81  |- mesh__historyNote mesh__D042602 2004   
% 216.64/216.81  |- mesh__dateRevised mesh__D042602 2005-06-30
% 216.64/216.81  |- skos__prefLabel mesh__D042602 Burkholderia cepacia complex
% 216.64/216.81  |- mesh__dateCreated mesh__D042602 2003-07-09
% 216.64/216.81  |- rdf__type mesh__D042602sskos__Concept
% 216.64/216.81  |- skos__annotation mesh__D042602
% 216.64/216.81       infection: coord IM with BURKHOLDERIA INFECTIONS %28%IM%29%   
% 216.64/216.81  |- mesh__dateEstablished mesh__D020150 2000-01-01
% 216.64/216.81  |- skos__scopeNote mesh__D020150
% 216.64/216.81       A rare movement disorder developed during PREGNANCY, characterized by involuntary jerky motion %28%CHOREA%29% and inability to maintain stable position of body parts %28%ATHETOSIS%29%. RHEUMATIC FEVER and collagen vascular disorders are frequently associated with this disease. Chorea may vary from mild to severe and occurs in approximately 1 per 2,000 to 3,000 pregnancies. %28%From Md Med J 1997 Sep;46%28%8%29%:436-9%29%%A%    
% 216.64/216.81  |- skos__hiddenLabel mesh__D020150 Pregnancy-Associated Choreoathetoses
% 216.64/216.81  |- skos__altLabel mesh__D020150 Choreoathetosis, Pregnancy-Associated
% 216.64/216.81  |- mesh__activeMeSHYear mesh__D020150 2006
% 216.64/216.81  |- skos__historyNote mesh__D020150
% 216.64/216.81       Pregnancy Complications/diagnosis %28%1966-1999%29%
% 216.64/216.81  |- skos__broader mesh__D020150smesh__D011248
% 216.64/216.81  |- skos__hiddenLabel mesh__D020150 Chorea Gravidarums
% 216.64/216.81  |- mesh__historyNote mesh__D020150 2000   
% 216.64/216.81  |- skos__hiddenLabel mesh__D020150 Choreas, Pregnancy-Induced
% 216.64/216.81  |- skos__hiddenLabel mesh__D020150 Chorea, Pregnancy Induced
% 216.64/216.81  |- mesh__recordMaintainer mesh__D020150 lkt
% 216.64/216.81  |- skos__broader mesh__D020150smesh__D020822
% 216.64/216.81  |- skos__altLabel mesh__D020150 Chorea, Pregnancy-Induced
% 216.64/216.81  |- skos__historyNote mesh__D020150 Chorea/diagnosis %28%1966-1999%29%
% 216.64/216.81  |- skos__annotation mesh__D020150 check the tags FEMALE %26% PREGNANCY   
% 216.64/216.81  |- mesh__publicMeSHNote mesh__D020150 2000   
% 216.64/216.81  |- skos__hiddenLabel mesh__D020150 Pregnancy-Associated Choreoathetosis
% 216.64/216.81  |- skos__hiddenLabel mesh__D020150 Choreoathetosis, Pregnancy Associated
% 216.64/216.81  |- skos__hiddenLabel mesh__D020150 Choreoathetoses, Pregnancy-Associated
% 216.64/216.81  |- skos__prefLabel mesh__D020150 Chorea Gravidarum
% 216.64/216.81  |- skos__hiddenLabel mesh__D020150 Pregnancy-Induced Choreas
% 216.64/216.81  |- mesh__recordOriginator mesh__D020150 KEV
% 216.64/216.81  |- skos__broader mesh__D020150smesh__D001480
% 216.64/216.81  |- mesh__dateRevised mesh__D020150 2005-06-30
% 216.64/216.81  |- mesh__dateCreated mesh__D020150 1999-11-03
% 216.64/216.81  |- skos__hiddenLabel mesh__D020150 Pregnancy-Induced Chorea
% 216.64/216.82  |- mesh__recordAuthorizer mesh__D020150 sjn
% 216.64/216.82  |- skos__hiddenLabel mesh__D020150 Gravidarum, Chorea
% 216.64/216.82  |- rdf__type mesh__D020150sskos__Concept
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D014911 2001
% 216.64/216.82  |- mesh__recordOriginator mesh__D014911 NLM
% 216.64/216.82  |- mesh__publicMeSHNote mesh__D014911 73; was WHIPLASH INJURY 1963-72   
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D014911 2006
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D014911 2000
% 216.64/216.82  |- skos__altLabel mesh__D014911 Injuries, Whiplash
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D014911 2004
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D014911 2005
% 216.64/216.82  |- skos__hiddenLabel mesh__D014911 Injury, Whiplash
% 216.64/216.82  |- mesh__dateEstablished mesh__D014911 1973-01-01
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D014911 2003
% 216.64/216.82  |- skos__scopeNote mesh__D014911
% 216.64/216.82       Hyperextension injury to the neck, often the result of being struck from behind by a fast-moving vehicle, in an automobile accident. %28%From Segen, The Dictionary of Modern Medicine, 1992%29%%A%    
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D014911 1999
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D014911 2002
% 216.64/216.82  |- rdf__type mesh__D014911sskos__Concept
% 216.64/216.82  |- mesh__historyNote mesh__D014911 73; was WHIPLASH INJURY 1963-72   
% 216.64/216.82  |- mesh__recordMaintainer mesh__D014911 TGC
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D014911 1998
% 216.64/216.82  |- skos__hiddenLabel mesh__D014911 Whiplash Injury
% 216.64/216.82  |- skos__broader mesh__D014911smesh__D019838
% 216.64/216.82  |- mesh__recordAuthorizer mesh__D014911 SJN
% 216.64/216.82  |- skos__prefLabel mesh__D014911 Whiplash Injuries
% 216.64/216.82  |- mesh__onlineNote mesh__D014911
% 216.64/216.82       use WHIPLASH INJURIES to search WHIPLASH INJURY 1966-72   
% 216.64/216.82  |- mesh__dateRevised mesh__D014911 1997-06-20
% 216.64/216.82  |- mesh__dateCreated mesh__D014911 1999-01-01
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005387 2000
% 216.64/216.82  |- skos__broader mesh__D005387smesh__D005060
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005387 1995
% 216.64/216.82  |- mesh__recordAuthorizer mesh__D005387 PLS
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005387 2003
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005387 2001
% 216.64/216.82  |- mesh__recordOriginator mesh__D005387 NLM
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005387 1998
% 216.64/216.82  |- skos__prefLabel mesh__D005387 Finland
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005387 2004
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005387 1999
% 216.64/216.82  |- mesh__dateCreated mesh__D005387 1999-01-01
% 216.64/216.82  |- mesh__dateRevised mesh__D005387 1994-02-28
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005387 2002
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005387 1996
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005387 2005
% 216.64/216.82  |- rdf__type mesh__D005387sskos__Concept
% 216.64/216.82  |- mesh__recordMaintainer mesh__D005387 TGC
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005387 1997
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005387 2006
% 216.64/216.82  |- mesh__recordAuthorizer mesh__D013819 PLS
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D013819 1997
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D013819 2002
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D013819 1999
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D013819 1996
% 216.64/216.82  |- mesh__publicMeSHNote mesh__D013819 73   
% 216.64/216.82  |- mesh__historyNote mesh__D013819 73%28%71%29%   
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D013819 2001
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D013819 1998
% 216.64/216.82  |- mesh__dateRevised mesh__D013819 1992-05-18
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D013819 1993
% 216.64/216.82  |- skos__historyNote mesh__D013819 Luminescence %28%1966-1970%29%
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D013819 1995
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D013819 2004
% 216.64/216.82  |- skos__hiddenLabel mesh__D013819 Dosimetries, Thermoluminescent
% 216.64/216.82  |- skos__prefLabel mesh__D013819 Thermoluminescent Dosimetry
% 216.64/216.82  |- skos__broader mesh__D013819smesh__D011834
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D013819 2000
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D013819 2006
% 216.64/216.82  |- mesh__dateEstablished mesh__D013819 1973-01-01
% 216.64/216.82  |- skos__hiddenLabel mesh__D013819 Thermoluminescent Dosimetries
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D013819 1994
% 216.64/216.82  |- mesh__dateCreated mesh__D013819 1999-01-01
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D013819 2003
% 216.64/216.82  |- mesh__recordOriginator mesh__D013819 NLM
% 216.64/216.82  |- rdf__type mesh__D013819sskos__Concept
% 216.64/216.82  |- skos__historyNote mesh__D013819 Radiometry %28%1966-1970%29%
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D013819 2005
% 216.64/216.82  |- skos__historyNote mesh__D013819 Radiation Monitoring %28%1966-1970%29%
% 216.64/216.82  |- mesh__recordMaintainer mesh__D013819 TAP
% 216.64/216.82  |- skos__hiddenLabel mesh__D013819 Dosimetry, Thermoluminescent
% 216.64/216.82  |- skos__scopeNote mesh__D024541
% 216.64/216.82       An order of bottom fishes with short, small, spinous dorsal fins. It is comprised of one family %28%Batrachoididae%29% and about 70 species.%A%    
% 216.64/216.82  |- mesh__historyNote mesh__D024541 2002   
% 216.64/216.82  |- mesh__dateEstablished mesh__D024541 2002-01-01
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D024541 2004
% 216.64/216.82  |- mesh__publicMeSHNote mesh__D024541 2002   
% 216.64/216.82  |- mesh__dateRevised mesh__D024541 2003-07-09
% 216.64/216.82  |- skos__broader mesh__D024541smesh__D005399
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D024541 2005
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D024541 2006
% 216.64/216.82  |- rdf__type mesh__D024541sskos__Concept
% 216.64/216.82  |- skos__altLabel mesh__D024541 Toadfishes
% 216.64/216.82  |- mesh__dateCreated mesh__D024541 2001-07-25
% 216.64/216.82  |- skos__prefLabel mesh__D024541 Batrachoidiformes
% 216.64/216.82  |- skos__scopeNote mesh__D018504
% 216.64/216.82       Systems that provide for the maintenance of life in an isolated living chamber through reutilization of the material available, in particular, by means of a cycle wherein exhaled carbon dioxide, urine, and other waste matter are converted chemically or by photosynthesis into oxygen, water, and food. %28%NASA Thesaurus, 1988%29%%A%    
% 216.64/216.82  |- skos__broader mesh__D018504smesh__D004780
% 216.64/216.82  |- skos__related mesh__D018504smesh__D018505
% 216.64/216.82  |- skos__hiddenLabel mesh__D018504 Systems, Closed Ecological
% 216.64/216.82  |- mesh__recordMaintainer mesh__D018504 nns
% 216.64/216.82  |- skos__hiddenLabel mesh__D018504 Projects, Breadboard
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D018504 2004
% 216.64/216.82  |- skos__annotation mesh__D018504
% 216.64/216.82       IM; coord with SPACE FLIGHT %28%IM%29% or SUBMARINE MEDICINE %28%IM%29%, if pertinent%A%  
% 216.64/216.82  |- skos__hiddenLabel mesh__D018504 Breadboard Projects
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D018504 2006
% 216.64/216.82  |- skos__altLabel mesh__D018504 CELSS
% 216.64/216.82  |- mesh__recordAuthorizer mesh__D018504 sjn
% 216.64/216.82  |- skos__hiddenLabel mesh__D018504 Closed Ecological System
% 216.64/216.82  |- mesh__recordOriginator mesh__D018504 JLS
% 216.64/216.82  |- mesh__dateEstablished mesh__D018504 1995-01-01
% 216.64/216.82  |- mesh__dateCreated mesh__D018504 1994-06-24
% 216.64/216.82  |- skos__hiddenLabel mesh__D018504 Ecological System, Closed
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D018504 2005
% 216.64/216.82  |- mesh__publicMeSHNote mesh__D018504
% 216.64/216.82       95; SEALED CABIN ECOLOGY was heading 1963-94   
% 216.64/216.82  |- skos__altLabel mesh__D018504 Closed Ecological Systems
% 216.64/216.82  |- mesh__historyNote mesh__D018504
% 216.64/216.82       95; SEALED CABIN ECOLOGY was heading 1963-94   
% 216.64/216.82  |- mesh__dateRevised mesh__D018504 2003-07-09
% 216.64/216.82  |- skos__hiddenLabel mesh__D018504 Ecology, Sealed Cabin
% 216.64/216.82  |- skos__hiddenLabel mesh__D018504 System, Closed Ecological
% 216.64/216.82  |- skos__prefLabel mesh__D018504 Ecological Systems, Closed
% 216.64/216.82  |- rdf__type mesh__D018504sskos__Concept
% 216.64/216.82  |- skos__hiddenLabel mesh__D018504 Project, Breadboard
% 216.64/216.82  |- skos__hiddenLabel mesh__D018504 Cabin Ecology, Sealed
% 216.64/216.82  |- skos__hiddenLabel mesh__D018504 Sealed Cabin Ecologies
% 216.64/216.82  |- skos__hiddenLabel mesh__D018504 Cabin Ecologies, Sealed
% 216.64/216.82  |- skos__broader mesh__D018504smesh__D017753
% 216.64/216.82  |- skos__historyNote mesh__D018504
% 216.64/216.82       Environment, Controlled %28%1973-1994%29%
% 216.64/216.82  |- skos__related mesh__D018504smesh__D020378
% 216.64/216.82  |- mesh__onlineNote mesh__D018504
% 216.64/216.82       use ECOLOGICAL SYSTEMS, CLOSED to search SEALED CABIN ECOLOGY 1966-94%A%  
% 216.64/216.82  |- skos__hiddenLabel mesh__D018504 Ecologies, Sealed Cabin
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D010521 2006
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D010521 2001
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D010521 1991
% 216.64/216.82  |- skos__annotation mesh__D010521
% 216.64/216.82       inflammation = PERIOSTITIS; dental = PERIODONTAL LIGAMENT%A%  
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D010521 2004
% 216.64/216.82  |- skos__prefLabel mesh__D010521 Periosteum
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D010521 2005
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D010521 2000
% 216.64/216.82  |- mesh__recordOriginator mesh__D010521 NLM
% 216.64/216.82  |- skos__broader mesh__D010521smesh__D001842
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D010521 2003
% 216.64/216.82  |- rdf__type mesh__D010521sskos__Concept
% 216.64/216.82  |- mesh__dateCreated mesh__D010521 1999-01-01
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D010521 1990
% 216.64/216.82  |- skos__hiddenLabel mesh__D010521 Periosteums
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D010521 1995
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D010521 1993
% 216.64/216.82  |- mesh__recordAuthorizer mesh__D010521 PLS
% 216.64/216.82  |- mesh__dateRevised mesh__D010521 1989-04-04
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D010521 1999
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D010521 1994
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D010521 2002
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D010521 1992
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D010521 1997
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D010521 1998
% 216.64/216.82  |- mesh__recordMaintainer mesh__D010521 TGC
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D010521 1996
% 216.64/216.82  |- skos__altLabel mesh__D051938 Syntaxin Binding Protein Munc18
% 216.64/216.82  |- skos__prefLabel mesh__D051938 Munc18 Proteins
% 216.64/216.82  |- skos__altLabel mesh__D051938 Munc18b Protein
% 216.64/216.82  |- skos__broader mesh__D051938smesh__D033921
% 216.64/216.82  |- mesh__dateCreated mesh__D051938 2005-06-30
% 216.64/216.82  |- mesh__publicMeSHNote mesh__D051938
% 216.64/216.82       2006; MUNC18 PROTEINS was indexed under NERVE TISSUE PROTEINS %26% VESICULAR TRANSPORT PROTEINS 2005, %26% under MEMBRANE PROTEINS 1992-2004%A%  
% 216.64/216.82  |- skos__altLabel mesh__D051938 Munc18 Syntaxin Binding Proteins
% 216.64/216.82  |- skos__altLabel mesh__D051938 Munc-18b Protein
% 216.64/216.82  |- skos__altLabel mesh__D051938 Munc-18 Proteins
% 216.64/216.82  |- skos__hiddenLabel mesh__D051938 Munc 18 Proteins
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D051938 2006
% 216.64/216.82  |- mesh__recordOriginator mesh__D051938 DRC
% 216.64/216.82  |- skos__altLabel mesh__D051938 Munc18a Protein
% 216.64/216.82  |- rdf__type mesh__D051938sskos__Concept
% 216.64/216.82  |- skos__altLabel mesh__D051938 Munc18c Protein
% 216.64/216.82  |- mesh__historyNote mesh__D051938 2006%28%1992%29%   
% 216.64/216.82  |- skos__hiddenLabel mesh__D051938 Sec1 Munc18 Protein Family
% 216.64/216.82  |- skos__altLabel mesh__D051938 Sec1-Munc18 Protein Family
% 216.64/216.82  |- mesh__recordMaintainer mesh__D051938 DRC
% 216.64/216.82  |- mesh__recordAuthorizer mesh__D051938 sjn
% 216.64/216.82  |- mesh__dateEstablished mesh__D051938 2006-01-01
% 216.64/216.82  |- skos__scopeNote mesh__D051938
% 216.64/216.82       A family of proteins involved in intracellular membrane trafficking. They interact with SYNTAXINS and play important roles in vesicular docking and fusion during EXOCYTOSIS. Their name derives from the fact that they are related to Unc-18 protein, C elegans.%A%    
% 216.64/216.82  |- mesh__historyNote mesh__D048191 2005   
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D048191 2006
% 216.64/216.82  |- skos__historyNote mesh__D048191 Lactobacillus %28%1965-2004%29%
% 216.64/216.82  |- mesh__recordAuthorizer mesh__D048191 sjn
% 216.64/216.82  |- mesh__dateCreated mesh__D048191 2004-07-07
% 216.64/216.82  |- mesh__dateEstablished mesh__D048191 2005-01-01
% 216.64/216.82  |- skos__broader mesh__D048191smesh__D007778
% 216.64/216.82  |- mesh__publicMeSHNote mesh__D048191 2005   
% 216.64/216.82  |- mesh__recordOriginator mesh__D048191 ags
% 216.64/216.82  |- skos__prefLabel mesh__D048191 Lactobacillus plantarum
% 216.64/216.82  |- mesh__recordMaintainer mesh__D048191 SYSTEM
% 216.64/216.82  |- skos__scopeNote mesh__D048191
% 216.64/216.82       A species of rod-shaped, LACTIC ACID bacteria used in PROBIOTICS and SILAGE production.%A%    
% 216.64/216.82  |- mesh__dateRevised mesh__D048191 2005-06-30
% 216.64/216.82  |- rdf__type mesh__D048191sskos__Concept
% 216.64/216.82  |- skos__scopeNote mesh__D009778
% 216.64/216.82       Posterior part of the cerebral hemisphere.     
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D009778 2003
% 216.64/216.82  |- skos__hiddenLabel mesh__D009778 Occipital Lobes
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D009778 2000
% 216.64/216.82  |- rdf__type mesh__D009778sskos__Concept
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D009778 2004
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D009778 1999
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D009778 2001
% 216.64/216.82  |- skos__prefLabel mesh__D009778 Occipital Lobe
% 216.64/216.82  |- skos__broader mesh__D009778smesh__D002540
% 216.64/216.82  |- mesh__dateRevised mesh__D009778 1998-06-10
% 216.64/216.82  |- mesh__recordAuthorizer mesh__D009778 SJN
% 216.64/216.82  |- mesh__dateCreated mesh__D009778 1999-01-01
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D009778 2005
% 216.64/216.82  |- skos__hiddenLabel mesh__D009778 Lobe, Occipital
% 216.64/216.82  |- mesh__recordOriginator mesh__D009778 NLM
% 216.64/216.82  |- skos__annotation mesh__D009778
% 216.64/216.82       dis: coord IM with BRAIN DISEASES %28%IM%29%; neopl: coord IM with BRAIN NEOPLASMS %28%IM%29%%A%  
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D009778 2002
% 216.64/216.82  |- skos__hiddenLabel mesh__D009778 Lobes, Occipital
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D009778 2006
% 216.64/216.82  |- mesh__recordMaintainer mesh__D009778 MSR
% 216.64/216.82  |- skos__broader mesh__D001795smesh__D003935
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D001795 2001
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D001795 1999
% 216.64/216.82  |- skos__hiddenLabel mesh__D001795 Determinations, Blood Pressure
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D001795 2005
% 216.64/216.82  |- skos__broader mesh__D001795smesh__D010808
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D001795 2002
% 216.64/216.82  |- mesh__recordMaintainer mesh__D001795 PXP
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D001795 2006
% 216.64/216.82  |- skos__annotation mesh__D001795 NIM; see note on BLOOD PRESSURE   
% 216.64/216.82  |- skos__hiddenLabel mesh__D001795 Determination, Blood Pressure
% 216.64/216.82  |- mesh__recordAuthorizer mesh__D001795 SJN
% 216.64/216.82  |- skos__prefLabel mesh__D001795 Blood Pressure Determination
% 216.64/216.82  |- mesh__dateRevised mesh__D001795 1997-06-20
% 216.64/216.82  |- mesh__dateCreated mesh__D001795 1999-01-01
% 216.64/216.82  |- rdf__type mesh__D001795sskos__Concept
% 216.64/216.82  |- mesh__recordOriginator mesh__D001795 NLM
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D001795 2003
% 216.64/216.82  |- skos__hiddenLabel mesh__D001795 Blood Pressure Determinations
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D001795 2000
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D001795 1998
% 216.64/216.82  |- skos__scopeNote mesh__D001795
% 216.64/216.82       Techniques for measuring blood pressure.     
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D001795 2004
% 216.64/216.82  |- skos__hiddenLabel mesh__D006480 Hemorrhagic Nephroso-Nephritides
% 216.64/216.82  |- mesh__historyNote mesh__D006480
% 216.64/216.82       1995 %28%1977%29%; for NEUROPATHIA EPIDEMICA use HANTAVIRUS INFECTIONS 1994-2001%A%  
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D006480 2003
% 216.64/216.82  |- skos__hiddenLabel mesh__D006480 Hemorrhagic Nephroso Nephritis
% 216.64/216.82  |- skos__altLabel mesh__D006480 HFRS
% 216.64/216.82  |- mesh__recordOriginator mesh__D006480 FPG
% 216.64/216.82  |- rdf__type mesh__D006480sskos__Concept
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D006480 2004
% 216.64/216.82  |- skos__broader mesh__D006480smesh__D006482
% 216.64/216.82  |- mesh__dateCreated mesh__D006480 1976-04-27
% 216.64/216.82  |- skos__hiddenLabel mesh__D006480 Nephroso-Nephritis, Hemorrhagic
% 216.64/216.82  |- skos__broader mesh__D006480smesh__D018778
% 216.64/216.82  |- mesh__dateEstablished mesh__D006480 1977-01-01
% 216.64/216.82  |- skos__altLabel mesh__D006480 Hemorrhagic Nephroso-Nephritis
% 216.64/216.82  |- mesh__recordMaintainer mesh__D006480 sjn
% 216.64/216.82  |- skos__hiddenLabel mesh__D006480 Epidemic Hemorrhagic Fever
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D006480 2005
% 216.64/216.82  |- skos__hiddenLabel mesh__D006480 Hemorrhagic Fevers, Epidemic
% 216.64/216.82  |- skos__altLabel mesh__D006480 Hemorrhagic Fever, Korean
% 216.64/216.82  |- skos__altLabel mesh__D006480 Hemorrhagic Fever, Epidemic
% 216.64/216.82  |- skos__historyNote mesh__D006480
% 216.64/216.82       Hemorrhagic Fevers, Viral %28%1966-1976%29%
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D006480 2006
% 216.64/216.82  |- skos__prefLabel mesh__D006480 Hemorrhagic Fever with Renal Syndrome
% 216.64/216.82  |- mesh__publicMeSHNote mesh__D006480
% 216.64/216.82       1995; see HEMORRHAGIC FEVER, EPIDEMIC 1977-1994, see HEMORRHAGIC FEVERS, VIRAL 1966-1976; for NEUROPATHIA EPIDEMICA see HANTAVIRUS INFECTIONS 1994-2001; for EPIDEMIC HEMORRHAGIC FEVER see EPIDEMIC HEMORRHAGIC FEVER 1963-1976%A%  
% 216.64/216.82  |- skos__hiddenLabel mesh__D006480 Nephroso-Nephritides, Hemorrhagic
% 216.64/216.82  |- skos__hiddenLabel mesh__D006480 Korean Hemorrhagic Fever
% 216.64/216.82  |- mesh__recordAuthorizer mesh__D006480 sjn
% 216.64/216.82  |- mesh__dateRevised mesh__D006480 2002-07-03
% 216.64/216.82  |- skos__hiddenLabel mesh__D006480 Epidemic Hemorrhagic Fevers
% 216.64/216.82  |- skos__scopeNote mesh__D006480
% 216.64/216.82       An acute febrile disease occurring predominately in Asia. It is characterized by fever, prostration, vomiting, hemorrhagic phenonema, shock, and renal failure. It is caused by any one of several closely related species of the genus Hantavirus. The most severe form is caused by HANTAAN VIRUS whose natural host is the rodent Apodemus agrarius. Milder forms are caused by SEOUL VIRUS and transmitted by the rodents Rattus rattus and R. norvegicus, and the PUUMALA VIRUS with transmission by Clethrionomys galreolus.%A%    
% 216.64/216.82  |- mesh__historyNote mesh__D020151 99   
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D020151 2003
% 216.64/216.82  |- mesh__recordAuthorizer mesh__D020151 sjn
% 216.64/216.82  |- skos__historyNote mesh__D020151 Blood Proteins %28%1981-1987%29%
% 216.64/216.82  |- mesh__dateEstablished mesh__D020151 1999-01-01
% 216.64/216.82  |- skos__prefLabel mesh__D020151 Protein C Deficiency
% 216.64/216.82  |- skos__scopeNote mesh__D020151
% 216.64/216.82       An absence or deficiency in PROTEIN C which leads to impaired regulation of blood coagulation. It is associated with an increased risk of severe or premature thrombosis. %28%Stedman%27%s Med. Dict., 26th ed.%29%%A%    
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D020151 2004
% 216.64/216.82  |- skos__broader mesh__D020151smesh__D001796
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D020151 2005
% 216.64/216.82  |- skos__hiddenLabel mesh__D020151 Deficiencies, Protein C
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D020151 2002
% 216.64/216.82  |- rdf__type mesh__D020151sskos__Concept
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D020151 2006
% 216.64/216.82  |- mesh__dateRevised mesh__D020151 2001-07-25
% 216.64/216.82  |- skos__hiddenLabel mesh__D020151 Protein C Deficiencies
% 216.64/216.82  |- skos__related mesh__D020151smesh__D020016
% 216.64/216.82  |- skos__broader mesh__D020151smesh__D019851
% 216.64/216.82  |- mesh__dateCreated mesh__D020151 1998-06-10
% 216.64/216.82  |- skos__broader mesh__D020151smesh__D025861
% 216.64/216.82  |- skos__historyNote mesh__D020151 Protein C %28%1987-1998%29%
% 216.64/216.82  |- skos__altLabel mesh__D020151 Deficiency, Protein C
% 216.64/216.82  |- skos__annotation mesh__D020151 DF: PROTEIN C DEFIC   
% 216.64/216.82  |- mesh__publicMeSHNote mesh__D020151 99   
% 216.64/216.82  |- skos__historyNote mesh__D020151 Glycoproteins %28%1981-1987%29%
% 216.64/216.82  |- mesh__recordMaintainer mesh__D020151 nns
% 216.64/216.82  |- mesh__recordOriginator mesh__D020151 NNS
% 216.64/216.82  |- mesh__recordMaintainer mesh__D014912 sjn
% 216.64/216.82  |- skos__scopeNote mesh__D014912
% 216.64/216.82       A myodegeneration most frequent in calves and lambs whose dams have been fed during gestation or longer on feeds, especially legumes %28%FABACEAE%29%, grown in certain areas where selenium is either deficient or unavailable in the soil. It has been recorded in many countries. It has been produced experimentally in several species of animals on low-selenium intake. A similar myopathy occurs naturally in goats, deer, foals, and dogs but proof of the etiology is lacking. %28%Merck Veterinary Manual, 5th ed%29%%A%    
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D014912 2004
% 216.64/216.82  |- skos__broader mesh__D014912smesh__D009137
% 216.64/216.82  |- skos__hiddenLabel mesh__D014912 Diseases, White Muscle
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D014912 2005
% 216.64/216.82  |- skos__hiddenLabel mesh__D014912 Disease, White Muscle
% 216.64/216.82  |- mesh__onlineNote mesh__D014912
% 216.64/216.82       search MUSCULAR DYSTROPHY, ANIMAL 1970-74   
% 216.64/216.82  |- mesh__recordOriginator mesh__D014912 NLM
% 216.64/216.82  |- skos__hiddenLabel mesh__D014912 White Muscle Diseases
% 216.64/216.82  |- mesh__dateEstablished mesh__D014912 1991-01-01
% 216.64/216.82  |- mesh__dateRevised mesh__D014912 2003-07-30
% 216.64/216.82  |- mesh__publicMeSHNote mesh__D014912
% 216.64/216.82       91; was see under MUSCULAR DYSTROPHY, ANIMAL 1975-90   
% 216.64/216.82  |- rdf__type mesh__D014912sskos__Concept
% 216.64/216.82  |- skos__hiddenLabel mesh__D014912 Muscle Disease, White
% 216.64/216.82  |- mesh__recordAuthorizer mesh__D014912 sjn
% 216.64/216.82  |- skos__hiddenLabel mesh__D014912 Muscle Diseases, White
% 216.64/216.82  |- skos__annotation mesh__D014912
% 216.64/216.82       a form of musc dystrophy usually in calves %26% lambs; manifest of selenium defic; check tag ANIMALS; coord IM with precoord animal/dis term %28%IM%29% + animal %28%NIM%29% or with animal %28%IM%29% in absence of precoord%A%  
% 216.64/216.82  |- skos__prefLabel mesh__D014912 White Muscle Disease
% 216.64/216.82  |- mesh__dateCreated mesh__D014912 1999-01-01
% 216.64/216.82  |- mesh__historyNote mesh__D014912
% 216.64/216.82       91%28%75%29%; was see under MUSCULAR DYSTROPHY, ANIMAL 1975-90   
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D014912 2006
% 216.64/216.82  |- mesh__recordMaintainer mesh__D014114 ags
% 216.64/216.82  |- skos__scopeNote mesh__D014114
% 216.64/216.82       An ascarid nematode found primarily in the small intestine of the larger Felidae as well as dogs and cats. It differs from TOXOCARA in that the larvae do not migrate through the lungs. It does occasionally produce visceral larva migrans %28%LARVA MIGRANS, VISCERAL%29% in man, although more rarely than does Toxocara.%A%    
% 216.64/216.82  |- skos__annotation mesh__D014114
% 216.64/216.82       a genus of nematodes; do not confuse with TOXOCARA, also a nematode genus; infection = TOXASCARIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 216.64/216.82  |- rdf__type mesh__D014114sskos__Concept
% 216.64/216.82  |- mesh__publicMeSHNote mesh__D014114 72   
% 216.64/216.82  |- mesh__dateRevised mesh__D014114 2003-07-09
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D014114 2005
% 216.64/216.82  |- mesh__recordOriginator mesh__D014114 NLM
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D014114 2004
% 216.64/216.82  |- skos__broader mesh__D014114smesh__D001199
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D014114 2006
% 216.64/216.82  |- mesh__dateEstablished mesh__D014114 1972-01-01
% 216.64/216.82  |- mesh__dateCreated mesh__D014114 1999-01-01
% 216.64/216.82  |- mesh__recordAuthorizer mesh__D014114 sjn
% 216.64/216.82  |- skos__historyNote mesh__D014114 Nematoda %28%1966-1971%29%
% 216.64/216.82  |- skos__prefLabel mesh__D014114 Toxascaris
% 216.64/216.82  |- mesh__historyNote mesh__D014114 72   
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005388 1998
% 216.64/216.82  |- skos__broader mesh__D005388smesh__D005390
% 216.64/216.82  |- skos__hiddenLabel mesh__D005388 Extinguishing System, Fire
% 216.64/216.82  |- mesh__dateCreated mesh__D005388 1977-05-05
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005388 2004
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005388 1999
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005388 2000
% 216.64/216.82  |- skos__scopeNote mesh__D005388
% 216.64/216.82       Automatic or hand operated equipment used to control and extinguish fires.%A%    
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005388 1993
% 216.64/216.82  |- mesh__recordAuthorizer mesh__D005388 PLS
% 216.64/216.82  |- skos__historyNote mesh__D005388 Fires %28%1966-Jul 1977%29%
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005388 2001
% 216.64/216.82  |- skos__hiddenLabel mesh__D005388 Fire Extinguishing System
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005388 1996
% 216.64/216.82  |- mesh__publicMeSHNote mesh__D005388
% 216.64/216.82       91; was see under FIRES Aug 1977-90   
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005388 2005
% 216.64/216.82  |- rdf__type mesh__D005388sskos__Concept
% 216.64/216.82  |- mesh__dateEstablished mesh__D005388 1991-01-01
% 216.64/216.82  |- skos__prefLabel mesh__D005388 Fire Extinguishing Systems
% 216.64/216.82  |- skos__hiddenLabel mesh__D005388 System, Fire Extinguishing
% 216.64/216.82  |- mesh__dateRevised mesh__D005388 1992-05-15
% 216.64/216.82  |- skos__hiddenLabel mesh__D005388 Systems, Fire Extinguishing
% 216.64/216.82  |- mesh__recordMaintainer mesh__D005388 TAP
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005388 1997
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005388 1994
% 216.64/216.82  |- mesh__recordOriginator mesh__D005388 EC
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005388 2006
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005388 2002
% 216.64/216.82  |- skos__hiddenLabel mesh__D005388 Extinguishing Systems, Fire
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005388 1995
% 216.64/216.82  |- mesh__historyNote mesh__D005388
% 216.64/216.82       91%28%Aug 77%29%; was see under FIRES 1977-90   
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D005388 2003
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D002090 2005
% 216.64/216.82  |- mesh__historyNote mesh__D002090 66   
% 216.64/216.82  |- mesh__recordMaintainer mesh__D002090 ssb
% 216.64/216.82  |- mesh__dateEstablished mesh__D002090 1966-01-01
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D002090 2004
% 216.64/216.82  |- mesh__publicMeSHNote mesh__D002090 66   
% 216.64/216.82  |- mesh__recordOriginator mesh__D002090 NLM
% 216.64/216.82  |- mesh__dateCreated mesh__D002090 1999-01-01
% 216.64/216.82  |- rdf__type mesh__D002090sskos__Concept
% 216.64/216.82  |- skos__scopeNote mesh__D002090
% 216.64/216.82       Compounds containing phenyl-1-butanone.     
% 216.64/216.82  |- skos__broader mesh__D002090smesh__D007659
% 216.64/216.82  |- skos__prefLabel mesh__D002090 Butyrophenones
% 216.64/216.82  |- skos__related mesh__D002090smesh__D014150
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D002090 2006
% 216.64/216.82  |- mesh__recordAuthorizer mesh__D002090 sjn
% 216.64/216.82  |- mesh__dateRevised mesh__D002090 2003-07-09
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D018505 2004
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D018505 2002
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D018505 2006
% 216.64/216.82  |- mesh__recordAuthorizer mesh__D018505 PLS
% 216.64/216.82  |- mesh__dateRevised mesh__D018505 1995-05-25
% 216.64/216.82  |- mesh__recordOriginator mesh__D018505 JLS
% 216.64/216.82  |- skos__prefLabel mesh__D018505 Waste Management
% 216.64/216.82  |- mesh__historyNote mesh__D018505 95   
% 216.64/216.82  |- skos__hiddenLabel mesh__D018505 Waste Managements
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D018505 2003
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D018505 2001
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D018505 2005
% 216.64/216.82  |- mesh__recordMaintainer mesh__D018505 PLS
% 216.64/216.82  |- skos__broader mesh__D018505smesh__D012498
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D018505 1997
% 216.64/216.82  |- skos__scopeNote mesh__D018505
% 216.64/216.82       Disposal, processing, controlling, recycling, and reusing the solid, liquid, and gaseous wastes of plants, animals, humans, and other organisms. It includes control within a closed ecological system to maintain a habitable environment.%A%    
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D018505 2000
% 216.64/216.82  |- mesh__publicMeSHNote mesh__D018505 95   
% 216.64/216.82  |- rdf__type mesh__D018505sskos__Concept
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D018505 1999
% 216.64/216.82  |- skos__hiddenLabel mesh__D018505 Managements, Waste
% 216.64/216.82  |- mesh__dateEstablished mesh__D018505 1995-01-01
% 216.64/216.82  |- skos__hiddenLabel mesh__D018505 Management, Waste
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D018505 1996
% 216.64/216.82  |- skos__historyNote mesh__D018505 Refuse Disposal %28%1966-1994%29%
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D018505 1998
% 216.64/216.82  |- mesh__dateCreated mesh__D018505 1994-06-07
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D010522 2005
% 216.64/216.82  |- skos__prefLabel mesh__D010522 Periostitis
% 216.64/216.82  |- mesh__activeMeSHYear mesh__D010522 2003
% 216.64/216.83  |- rdf__type mesh__D010522sskos__Concept
% 216.64/216.83  |- mesh__dateCreated mesh__D010522 1999-01-01
% 216.64/216.83  |- mesh__dateRevised mesh__D010522 2002-07-03
% 216.64/216.83  |- mesh__recordOriginator mesh__D010522 NLM
% 216.64/216.83  |- mesh__recordAuthorizer mesh__D010522 sjn
% 216.64/216.83  |- mesh__recordMaintainer mesh__D010522 TGC
% 216.64/216.83  |- skos__annotation mesh__D010522 inflamm of the periosteum   
% 216.64/216.83  |- skos__hiddenLabel mesh__D010522 Periostitides
% 216.64/216.83  |- skos__broader mesh__D010522smesh__D001850
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D010522 2006
% 216.64/216.83  |- skos__scopeNote mesh__D010522
% 216.64/216.83       Inflammation of the periosteum. The condition is generally chronic, and is marked by tenderness and swelling of the bone and an aching pain. Acute periostitis is due to infection, is characterized by diffuse suppuration, severe pain, and constitutional symptoms, and usually results in necrosis. %28%Dorland, 27th ed%29%%A%    
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D010522 2004
% 216.64/216.83  |- mesh__recordOriginator mesh__D051939 DRC
% 216.64/216.83  |- skos__altLabel mesh__D051939 PhyB Phytochrome
% 216.64/216.83  |- mesh__recordAuthorizer mesh__D051939 sjn
% 216.64/216.83  |- mesh__publicMeSHNote mesh__D051939
% 216.64/216.83       2006; PHYTOCHROME B was indexed under PHOTORECEPTORS %26% PHYTOCHROME %26% TRANSCRIPTION FACTORS 1991-2005, %26% under PLANT PROTEINS 1991-2004%A%  
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D051939 2006
% 216.64/216.83  |- skos__broader mesh__D051939smesh__D010834
% 216.64/216.83  |- skos__scopeNote mesh__D051939
% 216.64/216.83       A plant photo regulatory protein that exists in two forms that are reversibly interconvertible by LIGHT. In response to light it moves to the CELL NUCLEUS and regulates transcription of target genes. Phytochrome B plays an important role in shade avoidance and mediates plant de-etiolation in red light.%A%    
% 216.64/216.83  |- rdf__type mesh__D051939sskos__Concept
% 216.64/216.83  |- mesh__dateEstablished mesh__D051939 2006-01-01
% 216.64/216.83  |- mesh__dateCreated mesh__D051939 2005-06-30
% 216.64/216.83  |- mesh__historyNote mesh__D051939 2006%28%1991%29%   
% 216.64/216.83  |- skos__altLabel mesh__D051939 Phytochrome B Protein
% 216.64/216.83  |- skos__hiddenLabel mesh__D051939 Phytochrome, PhyB
% 216.64/216.83  |- skos__prefLabel mesh__D051939 Phytochrome B
% 216.64/216.83  |- mesh__recordMaintainer mesh__D051939 DRC
% 216.64/216.83  |- skos__broader mesh__D009779smesh__D001458
% 216.64/216.83  |- skos__hiddenLabel mesh__D009779 Occlusive Dressing
% 216.64/216.83  |- skos__prefLabel mesh__D009779 Occlusive Dressings
% 216.64/216.83  |- mesh__dateEstablished mesh__D009779 1967-01-01
% 216.64/216.83  |- skos__hiddenLabel mesh__D009779 Bandage, Occlusive
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D009779 2002
% 216.64/216.83  |- skos__hiddenLabel mesh__D009779 Occlusive Bandage
% 216.64/216.83  |- mesh__recordOriginator mesh__D009779 NLM
% 216.64/216.83  |- mesh__dateCreated mesh__D009779 1999-01-01
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D009779 2005
% 216.64/216.83  |- mesh__dateRevised mesh__D009779 1997-06-20
% 216.64/216.83  |- skos__annotation mesh__D009779 to protect wounds from air or bact   
% 216.64/216.83  |- skos__scopeNote mesh__D009779
% 216.64/216.83       Material, usually gauze or absorbent cotton, used to cover and protect wounds, to seal them from contact with air or bacteria. %28%From Dorland, 27th ed%29%%A%    
% 216.64/216.83  |- skos__hiddenLabel mesh__D009779 Spray-On Dressings
% 216.64/216.83  |- skos__hiddenLabel mesh__D009779 Dressing, Occlusive
% 216.64/216.83  |- skos__hiddenLabel mesh__D009779 Dressing, Spray-On
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D009779 2006
% 216.64/216.83  |- skos__hiddenLabel mesh__D009779 Spray-On Dressing
% 216.64/216.83  |- skos__hiddenLabel mesh__D009779 Dressings, Spray On
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D009779 2000
% 216.64/216.83  |- mesh__publicMeSHNote mesh__D009779 67   
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D009779 2003
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D009779 1998
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D009779 2001
% 216.64/216.83  |- skos__altLabel mesh__D009779 Dressings, Occlusive
% 216.64/216.83  |- skos__hiddenLabel mesh__D009779 Occlusive Bandages
% 216.64/216.83  |- rdf__type mesh__D009779sskos__Concept
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D009779 2004
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D009779 1999
% 216.64/216.83  |- mesh__historyNote mesh__D009779 67%28%63%29%   
% 216.64/216.83  |- mesh__recordAuthorizer mesh__D009779 SJN
% 216.64/216.83  |- mesh__recordMaintainer mesh__D009779 PXP
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001796 1995
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001796 2006
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001796 2000
% 216.64/216.83  |- mesh__recordMaintainer mesh__D001796 TGC
% 216.64/216.83  |- skos__hiddenLabel mesh__D001796 Protein Disorder, Blood
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001796 2001
% 216.64/216.83  |- skos__annotation mesh__D001796 GEN: avoid: prefer specifics   
% 216.64/216.83  |- skos__prefLabel mesh__D001796 Blood Protein Disorders
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001796 1996
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001796 2002
% 216.64/216.83  |- mesh__dateCreated mesh__D001796 1999-01-01
% 216.64/216.83  |- rdf__type mesh__D001796sskos__Concept
% 216.64/216.83  |- skos__hiddenLabel mesh__D001796 Blood Protein Disorder
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001796 1997
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001796 1992
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001796 2003
% 216.64/216.83  |- skos__broader mesh__D001796smesh__D006402
% 216.64/216.83  |- skos__hiddenLabel mesh__D001796 Disorders, Blood Protein
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001796 1998
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001796 1993
% 216.64/216.83  |- skos__hiddenLabel mesh__D001796 Protein Disorders, Blood
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001796 2004
% 216.64/216.83  |- skos__hiddenLabel mesh__D001796 Disorder, Blood Protein
% 216.64/216.83  |- mesh__recordAuthorizer mesh__D001796 PLS
% 216.64/216.83  |- mesh__dateRevised mesh__D001796 1991-08-23
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001796 1994
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001796 1999
% 216.64/216.83  |- mesh__recordOriginator mesh__D001796 NLM
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001796 2005
% 216.64/216.83  |- skos__scopeNote mesh__D020950
% 216.64/216.83       A genus of trees in the VERBENACEAE %28%sometimes classified in the LAMIACEAE%29% family containing assorted flavonoids with possible analgesic and antineoplastic properties. The fruit of these trees is used in herbal preparations.%A%    
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D020950 2005
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D020950 2004
% 216.64/216.83  |- skos__altLabel mesh__D020950 Chasteberry Tree
% 216.64/216.83  |- mesh__dateEstablished mesh__D020950 2000-01-01
% 216.64/216.83  |- rdf__type mesh__D020950sskos__Concept
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D020950 2006
% 216.64/216.83  |- skos__historyNote mesh__D020950 Plants, Medicinal %28%1970-1999%29%
% 216.64/216.83  |- skos__altLabel mesh__D020950 Chastetree
% 216.64/216.83  |- mesh__dateCreated mesh__D020950 1999-11-03
% 216.64/216.83  |- mesh__recordMaintainer mesh__D020950 sjn
% 216.64/216.83  |- mesh__recordOriginator mesh__D020950 ags
% 216.64/216.83  |- mesh__dateRevised mesh__D020950 2002-07-03
% 216.64/216.83  |- mesh__recordAuthorizer mesh__D020950 sjn
% 216.64/216.83  |- skos__prefLabel mesh__D020950 Vitex
% 216.64/216.83  |- mesh__historyNote mesh__D020950 2000   
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D020950 2003
% 216.64/216.83  |- skos__broader mesh__D020950smesh__D029648
% 216.64/216.83  |- mesh__publicMeSHNote mesh__D020950 2000   
% 216.64/216.83  |- mesh__publicMeSHNote mesh__D006481
% 216.64/216.83       78; was see under ARBOVIRUS INFECTIONS 1977; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76%A%  
% 216.64/216.83  |- rdf__type mesh__D006481sskos__Concept
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006481 1998
% 216.64/216.83  |- mesh__dateEstablished mesh__D006481 1978-01-01
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006481 2004
% 216.64/216.83  |- mesh__dateCreated mesh__D006481 1976-04-27
% 216.64/216.83  |- skos__scopeNote mesh__D006481
% 216.64/216.83       Infection with the Omsk hemorrhagic fever virus, a Flavivirus.%A%    
% 216.64/216.83  |- skos__prefLabel mesh__D006481 Hemorrhagic Fever, Omsk
% 216.64/216.83  |- skos__hiddenLabel mesh__D006481 Omsk Hemorrhagic Fever
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006481 1994
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006481 1999
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006481 2005
% 216.64/216.83  |- mesh__recordOriginator mesh__D006481 FPG
% 216.64/216.83  |- skos__broader mesh__D006481smesh__D018177
% 216.64/216.83  |- skos__hiddenLabel mesh__D006481 Fever, Omsk Hemorrhagic
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006481 2000
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006481 1995
% 216.64/216.83  |- mesh__recordMaintainer mesh__D006481 AGS
% 216.64/216.83  |- skos__broader mesh__D006481smesh__D006482
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006481 2006
% 216.64/216.83  |- mesh__dateRevised mesh__D006481 1993-06-04
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006481 2001
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006481 1996
% 216.64/216.83  |- mesh__recordAuthorizer mesh__D006481 PLS
% 216.64/216.83  |- skos__annotation mesh__D006481 caused by a flavivirus   
% 216.64/216.83  |- mesh__onlineNote mesh__D006481
% 216.64/216.83       search HEMORRHAGIC FEVERS, VIRAL 1966-76   
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006481 2002
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006481 1997
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006481 2003
% 216.64/216.83  |- skos__historyNote mesh__D006481
% 216.64/216.83       Hemorrhagic Fevers, Viral %28%1966-1976%29%
% 216.64/216.83  |- skos__broader mesh__D006481smesh__D017282
% 216.64/216.83  |- mesh__historyNote mesh__D006481
% 216.64/216.83       78%28%77%29%; was see under ARBOVIRUS INFECTIONS 1977; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76%A%  
% 216.64/216.83  |- skos__historyNote mesh__D020152
% 216.64/216.83       Antithrombins/deficiency %28%1971-1978%29%
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D020152 2004
% 216.64/216.83  |- skos__hiddenLabel mesh__D020152 Antithrombin 3 Deficiencies
% 216.64/216.83  |- mesh__historyNote mesh__D020152 99   
% 216.64/216.83  |- mesh__dateCreated mesh__D020152 1998-06-18
% 216.64/216.83  |- skos__hiddenLabel mesh__D020152 Deficiencies, Antithrombin III
% 216.64/216.83  |- mesh__recordMaintainer mesh__D020152 nns
% 216.64/216.83  |- skos__hiddenLabel mesh__D020152 Antithrombin III Deficiencies
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D020152 2005
% 216.64/216.83  |- skos__altLabel mesh__D020152 Deficiency, Antithrombin III
% 216.64/216.83  |- skos__broader mesh__D020152smesh__D001796
% 216.64/216.83  |- mesh__recordAuthorizer mesh__D020152 sjn
% 216.64/216.83  |- rdf__type mesh__D020152sskos__Concept
% 216.64/216.83  |- mesh__dateEstablished mesh__D020152 1999-01-01
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D020152 2006
% 216.64/216.83  |- skos__historyNote mesh__D020152
% 216.64/216.83       Antithrombin III/deficiency %28%1979-1998%29%
% 216.64/216.83  |- skos__broader mesh__D020152smesh__D019851
% 216.64/216.83  |- skos__broader mesh__D020152smesh__D025861
% 216.64/216.83  |- mesh__publicMeSHNote mesh__D020152 99   
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D020152 2002
% 216.64/216.83  |- skos__hiddenLabel mesh__D020152 Deficiencies, Antithrombin 3
% 216.64/216.83  |- mesh__recordOriginator mesh__D020152 NNS
% 216.64/216.83  |- skos__scopeNote mesh__D020152
% 216.64/216.83       An absence or reduced level of Antithrombin III leading to an increased risk for thrombosis.%A%    
% 216.64/216.83  |- mesh__dateRevised mesh__D020152 2001-07-25
% 216.64/216.83  |- skos__hiddenLabel mesh__D020152 Deficiency, Antithrombin 3
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D020152 2003
% 216.64/216.83  |- skos__prefLabel mesh__D020152 Antithrombin III Deficiency
% 216.64/216.83  |- skos__altLabel mesh__D020152 Antithrombin 3 Deficiency
% 216.64/216.83  |- skos__broader mesh__D014115smesh__D007239
% 216.64/216.83  |- rdf__type mesh__D014115sskos__Concept
% 216.64/216.83  |- mesh__recordMaintainer mesh__D014115 sjn
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D014115 2006
% 216.64/216.83  |- skos__related mesh__D014115smesh__D011225
% 216.64/216.83  |- mesh__dateCreated mesh__D014115 1999-01-01
% 216.64/216.83  |- skos__prefLabel mesh__D014115 Toxemia
% 216.64/216.83  |- mesh__recordOriginator mesh__D014115 NLM
% 216.64/216.83  |- mesh__dateRevised mesh__D014115 2005-07-01
% 216.64/216.83  |- skos__scopeNote mesh__D014115
% 216.64/216.83       A condition produced by the presence of toxins or other harmful substances in the BLOOD.%A%    
% 216.64/216.83  |- mesh__recordAuthorizer mesh__D014115 sjn
% 216.64/216.83  |- skos__hiddenLabel mesh__D014115 Toxemias
% 216.64/216.83  |- mesh__dateCreated mesh__D005389 1986-04-18
% 216.64/216.83  |- skos__broader mesh__D005389smesh__D008420
% 216.64/216.83  |- skos__prefLabel mesh__D005389 Firearms
% 216.64/216.83  |- mesh__dateRevised mesh__D005389 1997-06-20
% 216.64/216.83  |- skos__annotation mesh__D005389
% 216.64/216.83       ballistics goes here only if pertinent to nature of firearm; wound ballistics goes under BALLISTICS, WOUND see WOUNDS, GUNSHOT %26% FORENSIC MEDICINE if pertinent%A%  
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D005389 2005
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D005389 2004
% 216.64/216.83  |- skos__related mesh__D005389smesh__D014948
% 216.64/216.83  |- mesh__recordAuthorizer mesh__D005389 SJN
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D005389 2000
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D005389 2003
% 216.64/216.83  |- mesh__historyNote mesh__D005389 87   
% 216.64/216.83  |- mesh__recordOriginator mesh__D005389 VDK
% 216.64/216.83  |- skos__scopeNote mesh__D005389
% 216.64/216.83       Small-arms weapons, including handguns, pistols, revolvers, rifles, shotguns, etc.%A%    
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D005389 1999
% 216.64/216.83  |- mesh__recordMaintainer mesh__D005389 JLS
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D005389 2002
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D005389 1998
% 216.64/216.83  |- mesh__dateEstablished mesh__D005389 1987-01-01
% 216.64/216.83  |- rdf__type mesh__D005389sskos__Concept
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D005389 2006
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D005389 2001
% 216.64/216.83  |- mesh__publicMeSHNote mesh__D005389 87   
% 216.64/216.83  |- mesh__recordAuthorizer mesh__D002091 sjn
% 216.64/216.83  |- mesh__publicMeSHNote mesh__D002091
% 216.64/216.83       91; was see under CHOLINESTERASES 1975-90   
% 216.64/216.83  |- rdf__type mesh__D002091sskos__Concept
% 216.64/216.83  |- skos__historyNote mesh__D002091 Cholinesterases %28%1973-1974%29%
% 216.64/216.83  |- skos__scopeNote mesh__D002091
% 216.64/216.83       An aspect of cholinesterase %28%EC 3.1.1.8%29%.     
% 216.64/216.83  |- mesh__historyNote mesh__D002091
% 216.64/216.83       91%28%75%29%; was see under CHOLINESTERASES 1975-90   
% 216.64/216.83  |- skos__broader mesh__D002091smesh__D002802
% 216.64/216.83  |- skos__annotation mesh__D002091
% 216.64/216.83       /antag = CHOLINESTERASE INHIBITORS %28%IM%29% + BUTYRYLCHOLINESTERASE %28%NIM with no qualif%29%%A%  
% 216.64/216.83  |- skos__prefLabel mesh__D002091 Butyrylcholinesterase
% 216.64/216.83  |- mesh__recordMaintainer mesh__D002091 ssb
% 216.64/216.83  |- mesh__dateEstablished mesh__D002091 1991-01-01
% 216.64/216.83  |- skos__historyNote mesh__D002091 Butyrates %28%1973-1974%29%
% 216.64/216.83  |- mesh__recordOriginator mesh__D002091 NLM
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D002091 2006
% 216.64/216.83  |- mesh__dateRevised mesh__D002091 2003-07-09
% 216.64/216.83  |- mesh__dateCreated mesh__D002091 1974-11-19
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D002091 2005
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D002091 2004
% 216.64/216.83  |- skos__altLabel mesh__D018506 Regulation, Gene Expression, Plant
% 216.64/216.83  |- skos__altLabel mesh__D018506 Plant Gene Expression Regulation
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D018506 2004
% 216.64/216.83  |- mesh__historyNote mesh__D018506 95   
% 216.64/216.83  |- skos__scopeNote mesh__D018506
% 216.64/216.83       Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in plants.%A%    
% 216.64/216.83  |- skos__altLabel mesh__D018506 Regulation of Gene Expression, Plant
% 216.64/216.83  |- mesh__dateCreated mesh__D018506 1994-02-28
% 216.64/216.83  |- skos__historyNote mesh__D018506 Genes, Regulator %28%1973-1980%29%
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D018506 2003
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D018506 2006
% 216.64/216.83  |- mesh__recordOriginator mesh__D018506 PXP
% 216.64/216.83  |- rdf__type mesh__D018506sskos__Concept
% 216.64/216.83  |- mesh__recordAuthorizer mesh__D018506 sjn
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D018506 2005
% 216.64/216.83  |- skos__historyNote mesh__D018506 specific plant %28%1973-1994%29%
% 216.64/216.83  |- mesh__publicMeSHNote mesh__D018506 95   
% 216.64/216.83  |- skos__prefLabel mesh__D018506 Gene Expression Regulation, Plant
% 216.64/216.83  |- skos__broader mesh__D018506smesh__D005786
% 216.64/216.83  |- mesh__dateRevised mesh__D018506 2002-07-03
% 216.64/216.83  |- mesh__dateEstablished mesh__D018506 1995-01-01
% 216.64/216.83  |- mesh__recordMaintainer mesh__D018506 NDW
% 216.64/216.83  |- skos__historyNote mesh__D018506
% 216.64/216.83       Gene Expression Regulation %28%1981-1994%29%
% 216.64/216.83  |- skos__annotation mesh__D018506
% 216.64/216.83       coord IM with specific plant /genet %28%IM%29%; DF: GENE EXPRESSION REG PLANT%A%  
% 216.64/216.83  |- mesh__historyNote mesh__D010523 1994   
% 216.64/216.83  |- skos__hiddenLabel mesh__D010523 Nerve Diseases, Peripheral
% 216.64/216.83  |- skos__altLabel mesh__D010523
% 216.64/216.83       PNS %28%Peripheral Nervous System%29% Diseases
% 216.64/216.83  |- rdf__type mesh__D010523sskos__Concept
% 216.64/216.83  |- skos__annotation mesh__D010523
% 216.64/216.83       GEN: prefer specifics; coord IM with specific nerve %28%IM%29%; %22%diabetic peripheral neuropathy%22%: index only under DIABETIC NEUROPATHIES; DF: PNS DIS%A%  
% 216.64/216.83  |- skos__altLabel mesh__D010523 Peripheral Nerve Diseases
% 216.64/216.83  |- mesh__recordMaintainer mesh__D010523 ags
% 216.64/216.83  |- skos__prefLabel mesh__D010523 Peripheral Nervous System Diseases
% 216.64/216.83  |- skos__hiddenLabel mesh__D010523 Neuropathy, Peripheral
% 216.64/216.83  |- skos__altLabel mesh__D010523 Peripheral Nervous System Disease
% 216.64/216.83  |- skos__scopeNote mesh__D010523
% 216.64/216.83       Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.%A%    
% 216.64/216.83  |- skos__altLabel mesh__D010523 Peripheral Nervous System Disorders
% 216.64/216.83  |- skos__broader mesh__D010523smesh__D009468
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D010523 2000
% 216.64/216.83  |- mesh__dateRevised mesh__D010523 1999-12-08
% 216.64/216.83  |- skos__altLabel mesh__D010523 PNS Diseases
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D010523 2005
% 216.64/216.83  |- mesh__recordAuthorizer mesh__D010523 ags
% 216.64/216.83  |- skos__hiddenLabel mesh__D010523 PNS Disease
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D010523 2001
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D010523 2003
% 216.64/216.83  |- skos__hiddenLabel mesh__D010523 Peripheral Neuropathy
% 216.64/216.83  |- skos__hiddenLabel mesh__D010523 Nerve Disease, Peripheral
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D010523 2000A
% 216.64/216.83  |- mesh__recordOriginator mesh__D010523 NLM
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D010523 2006
% 216.64/216.83  |- mesh__publicMeSHNote mesh__D010523
% 216.64/216.83       1994; see PERIPHERAL NERVE DISEASES 1963-1993   
% 216.64/216.83  |- mesh__dateCreated mesh__D010523 1999-01-01
% 216.64/216.83  |- skos__hiddenLabel mesh__D010523 Peripheral Nerve Disease
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D010523 2002
% 216.64/216.83  |- skos__altLabel mesh__D010523 Peripheral Neuropathies
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D010523 2004
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001797 2005
% 216.64/216.83  |- skos__broader mesh__D001797smesh__D001774
% 216.64/216.83  |- skos__hiddenLabel mesh__D001797 Protein Electrophoreses, Blood
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001797 2001
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001797 2006
% 216.64/216.83  |- skos__hiddenLabel mesh__D001797 Electrophoreses, Blood Protein
% 216.64/216.83  |- skos__hiddenLabel mesh__D001797 Protein Electrophoresis, Blood
% 216.64/216.83  |- mesh__dateCreated mesh__D001797 1999-01-01
% 216.64/216.83  |- rdf__type mesh__D001797sskos__Concept
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001797 2002
% 216.64/216.83  |- skos__prefLabel mesh__D001797 Blood Protein Electrophoresis
% 216.64/216.83  |- skos__hiddenLabel mesh__D001797 Blood Protein Electrophoreses
% 216.64/216.83  |- skos__annotation mesh__D001797
% 216.64/216.83       NIM; electrophoresis of hemoglobin goes here + HEMOGLOBINS /anal%A%  
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001797 2003
% 216.64/216.83  |- mesh__recordMaintainer mesh__D001797 PXP
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001797 1998
% 216.64/216.83  |- mesh__recordAuthorizer mesh__D001797 SJN
% 216.64/216.83  |- mesh__dateRevised mesh__D001797 1997-06-20
% 216.64/216.83  |- mesh__recordOriginator mesh__D001797 NLM
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001797 2004
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001797 1999
% 216.64/216.83  |- skos__scopeNote mesh__D001797
% 216.64/216.83       Electrophoresis applied to blood proteins.     
% 216.64/216.83  |- skos__related mesh__D001797smesh__D007122
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D001797 2000
% 216.64/216.83  |- skos__hiddenLabel mesh__D001797 Electrophoresis, Blood Protein
% 216.64/216.83  |- mesh__dateCreated mesh__D006482 1977-05-13
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006482 2004
% 216.64/216.83  |- skos__hiddenLabel mesh__D006482 Viral Hemorrhagic Fever
% 216.64/216.83  |- skos__hiddenLabel mesh__D006482 Fever, Viral Hemorrhagic
% 216.64/216.83  |- skos__annotation mesh__D006482
% 216.64/216.83       GEN or unspecified; prefer specifics; if renal involvement, dis is probably HEMORRHAGIC FEVER WITH RENAL SYNDROME%A%  
% 216.64/216.83  |- mesh__onlineNote mesh__D006482
% 216.64/216.83       use HEMORRHAGIC FEVERS, VIRAL to search EPIDEMIC HEMORRHAGIC FEVER 1966-76; search specifics 1977%A%  
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006482 2003
% 216.64/216.83  |- rdf__type mesh__D006482sskos__Concept
% 216.64/216.83  |- mesh__publicMeSHNote mesh__D006482
% 216.64/216.83       78; was EPIDEMIC HEMORRHAGIC FEVER 1963-76; several specifics became headings %26% x-refs as of 1977%A%  
% 216.64/216.83  |- skos__broader mesh__D006482smesh__D012327
% 216.64/216.83  |- skos__prefLabel mesh__D006482 Hemorrhagic Fevers, Viral
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006482 1999
% 216.64/216.83  |- mesh__recordOriginator mesh__D006482 AEP
% 216.64/216.83  |- skos__scopeNote mesh__D006482
% 216.64/216.83       A group of viral diseases of diverse etiology but having many similar clinical characteristics; increased capillary permeability, leukopenia, and thrombocytopenia are common to all. Hemorrhagic fevers are characterized by sudden onset, fever, headache, generalized myalgia, backache, conjunctivitis, and severe prostration, followed by various hemorrhagic symptoms. Hemorrhagic fever with kidney involvement is HEMORRHAGIC FEVER WITH RENAL SYNDROME.%A%    
% 216.64/216.83  |- skos__historyNote mesh__D006482 specific hemorrhagic fever %28%1977%29%
% 216.64/216.83  |- skos__hiddenLabel mesh__D006482 Hemorrhagic Fever, Viral
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006482 2002
% 216.64/216.83  |- mesh__historyNote mesh__D006482
% 216.64/216.83       78; was EPIDEMIC HEMORRHAGIC FEVER 1963-76; several specifics became headings %26% x-refs as of 1977%A%  
% 216.64/216.83  |- mesh__recordAuthorizer mesh__D006482 PLS
% 216.64/216.83  |- mesh__dateRevised mesh__D006482 1996-06-10
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006482 1998
% 216.64/216.83  |- mesh__dateEstablished mesh__D006482 1978-01-01
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006482 2006
% 216.64/216.83  |- skos__hiddenLabel mesh__D006482 Viral Hemorrhagic Fevers
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006482 2001
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006482 1997
% 216.64/216.83  |- mesh__recordMaintainer mesh__D006482 TGC
% 216.64/216.83  |- skos__hiddenLabel mesh__D006482 Fevers, Viral Hemorrhagic
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006482 2000
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D006482 2005
% 216.64/216.83  |- skos__related mesh__D014914smesh__D001777
% 216.64/216.83  |- skos__prefLabel mesh__D014914 Whole Blood Coagulation Time
% 216.64/216.83  |- skos__scopeNote mesh__D014914
% 216.64/216.83       The time required by whole blood to produce a visible clot.%A%    
% 216.64/216.83  |- mesh__recordAuthorizer mesh__D014914 sjn
% 216.64/216.83  |- mesh__dateCreated mesh__D014914 1979-03-08
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D014914 2006
% 216.64/216.83  |- mesh__recordOriginator mesh__D014914 SMH
% 216.64/216.83  |- skos__broader mesh__D014914smesh__D001780
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D014914 2004
% 216.64/216.83  |- skos__altLabel mesh__D014914 Coagulation Time, Whole Blood
% 216.64/216.83  |- mesh__dateRevised mesh__D014914 2003-07-09
% 216.64/216.83  |- skos__altLabel mesh__D014914 Blood Coagulation Time, Whole
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D014914 2005
% 216.64/216.83  |- skos__broader mesh__D014914smesh__D045122
% 216.64/216.83  |- mesh__recordMaintainer mesh__D014914 nns
% 216.64/216.83  |- mesh__publicMeSHNote mesh__D014914
% 216.64/216.83       91; was see under BLOOD COAGULATION TESTS 1980-90   
% 216.64/216.83  |- skos__historyNote mesh__D014914
% 216.64/216.83       Blood Coagulation Tests %28%1966-1979%29%
% 216.64/216.83  |- mesh__historyNote mesh__D014914
% 216.64/216.83       91%28%80%29%; was see under BLOOD COAGULATION TESTS 1980-90   
% 216.64/216.83  |- rdf__type mesh__D014914sskos__Concept
% 216.64/216.83  |- skos__annotation mesh__D014914 usually NIM; DF: WHOLE BLOOD COAG TIME   
% 216.64/216.83  |- skos__altLabel mesh__D014914 Activated Coagulation Time, Whole Blood
% 216.64/216.83  |- mesh__dateEstablished mesh__D014914 1991-01-01
% 216.64/216.83  |- skos__historyNote mesh__D014914 Blood Coagulation %28%1966-1979%29%
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D014116 2006
% 216.64/216.83  |- mesh__recordOriginator mesh__D014116 NLM
% 216.64/216.83  |- mesh__dateCreated mesh__D014116 1999-01-01
% 216.64/216.83  |- skos__related mesh__D014116smesh__D011042
% 216.64/216.83  |- skos__broader mesh__D014116smesh__D010600
% 216.64/216.83  |- mesh__recordAuthorizer mesh__D014116 sjn
% 216.64/216.83  |- mesh__recordMaintainer mesh__D014116 nns
% 216.64/216.83  |- skos__prefLabel mesh__D014116 Toxicology
% 216.64/216.83  |- skos__annotation mesh__D014116
% 216.64/216.83       SPEC only: prefer /adv eff-pois-tox with specific D terms: Manual 19.7+, 19.8.73, 19.9+; DF: TOXICOL%A%  
% 216.64/216.83  |- rdf__type mesh__D014116sskos__Concept
% 216.64/216.83  |- mesh__dateRevised mesh__D014116 2002-07-03
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D014116 2003
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D014116 2005
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D014116 2004
% 216.64/216.83  |- skos__scopeNote mesh__D014116
% 216.64/216.83       The science concerned with the detection, chemical composition, and biological action of toxic substances or poisons and the treatment and prevention of toxic manifestations.%A%    
% 216.64/216.83  |- skos__related mesh__D014116smesh__D010597
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D002890 2006
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D002890 2005
% 216.64/216.83  |- skos__historyNote mesh__D002890
% 216.64/216.83       Chromosomes, Human, 19-20 %28%1968-1986%29%
% 216.64/216.83  |- mesh__dateCreated mesh__D002890 1986-06-19
% 216.64/216.83  |- mesh__recordMaintainer mesh__D002890 ags
% 216.64/216.83  |- mesh__dateRevised mesh__D002890 2005-07-13
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D002890 2006A
% 216.64/216.83  |- skos__prefLabel mesh__D002890 Chromosomes, Human, Pair 20
% 216.64/216.83  |- mesh__recordOriginator mesh__D002890 SCD
% 216.64/216.83  |- skos__altLabel mesh__D002890 Chromosome 20
% 216.64/216.83  |- rdf__type mesh__D002890sskos__Concept
% 216.64/216.83  |- mesh__dateEstablished mesh__D002890 1987-01-01
% 216.64/216.83  |- skos__broader mesh__D002890smesh__D002903
% 216.64/216.83  |- mesh__publicMeSHNote mesh__D002890 87   
% 216.64/216.83  |- mesh__recordAuthorizer mesh__D002890 ags
% 216.64/216.83  |- mesh__historyNote mesh__D002890 87   
% 216.64/216.83  |- skos__scopeNote mesh__D002890
% 216.64/216.83       A specific pair of GROUP F CHROMOSOMES of the human chromosome classification.%A%    
% 216.64/216.83  |- skos__prefLabel mesh__D002092 Butyrylthiocholine
% 216.64/216.83  |- mesh__dateEstablished mesh__D002092 1991-01-01
% 216.64/216.83  |- mesh__activeMeSHYear mesh__D002092 2006
% 216.64/216.83  |- mesh__publicMeSHNote mesh__D002092 91; was see under CHOLINE 1975-90   
% 216.64/216.83  |- skos__historyNote mesh__D002092 Butyrates %28%1972-1974%29%
% 216.64/216.83  |- skos__historyNote mesh__D002092 Sulfhydryl Compounds %28%1972-1974%29%
% 216.64/216.83  |- mesh__recordAuthorizer mesh__D002092 sjn
% 216.64/216.83  |- skos__altLabel mesh__D002092
% 216.64/216.83       %28%2-Mercaptoethyl%29%Trimethylammonium Butyrate
% 216.64/216.83  |- skos__historyNote mesh__D002092 Choline %28%1968-1974%29%
% 216.64/216.83  |- skos__scopeNote mesh__D002092
% 216.64/216.83       A sulfur-containing analog of butyrylcholine which is hydrolyzed by butyrylcholinesterase to butyrate and thiocholine. It is used as a reagent in the determination of butyrylcholinesterase activity.%A%    
% 216.64/216.83  |- mesh__historyNote mesh__D002092
% 216.64/216.83       91%28%75%29%; was see under CHOLINE 1975-90   
% 216.64/216.83  |- skos__hiddenLabel mesh__D002092 Iodide, S-Butyrylthiocholine
% 216.64/216.83  |- rdf__type mesh__D002092sskos__Concept
% 216.64/216.83  |- mesh__recordMaintainer mesh__D002092 ssb
% 216.64/216.83  |- skos__hiddenLabel mesh__D002092 S Butyrylthiocholine Iodide
% 216.64/216.83  |- skos__broader mesh__D002092smesh__D013860
% 216.64/216.83  |- mesh__dateRevised mesh__D002092 2005-06-30
% 216.64/216.83  |- mesh__recordOriginator mesh__D002092 NLM
% 216.64/216.83  |- mesh__dateCreated mesh__D002092 1974-11-19
% 216.64/216.83  |- skos__altLabel mesh__D018507 Embryologic Gene Expression Regulation
% 216.64/216.83  |- skos__annotation mesh__D018507
% 216.64/216.83       developmental includes embryonic; DF: GENE EXPRESSION REG DEVELOPMENTAL%A%  
% 216.64/216.83  |- skos__altLabel mesh__D018507 Regulation, Gene Expression, Embryologic
% 216.64/216.84  |- mesh__historyNote mesh__D018507 95   
% 216.64/216.84  |- skos__scopeNote mesh__D018507
% 216.64/216.84       Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action during the developmental stages of an organism.%A%    
% 216.64/216.84  |- skos__broader mesh__D018507smesh__D005786
% 216.64/216.84  |- skos__altLabel mesh__D018507
% 216.64/216.84       Regulation of Gene Expression, Developmental
% 216.64/216.84  |- skos__historyNote mesh__D018507 Genes, Regulator %28%1973-1980%29%
% 216.64/216.84  |- mesh__dateEstablished mesh__D018507 1995-01-01
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D018507 2006
% 216.64/216.84  |- skos__altLabel mesh__D018507 Developmental Gene Expression Regulation
% 216.64/216.84  |- rdf__type mesh__D018507sskos__Concept
% 216.64/216.84  |- skos__related mesh__D018507smesh__D050437
% 216.64/216.84  |- mesh__dateRevised mesh__D018507 2005-06-30
% 216.64/216.84  |- mesh__recordMaintainer mesh__D018507 nns
% 216.64/216.84  |- skos__altLabel mesh__D018507 Regulation, Gene Expression, Developmental
% 216.64/216.84  |- skos__historyNote mesh__D018507
% 216.64/216.84       Gene Expression Regulation %28%1981-1994%29%
% 216.64/216.84  |- mesh__recordOriginator mesh__D018507 PXP
% 216.64/216.84  |- skos__prefLabel mesh__D018507 Gene Expression Regulation, Developmental
% 216.64/216.84  |- mesh__recordAuthorizer mesh__D018507 sjn
% 216.64/216.84  |- mesh__dateCreated mesh__D018507 1994-02-28
% 216.64/216.84  |- mesh__publicMeSHNote mesh__D018507 95   
% 216.64/216.84  |- skos__altLabel mesh__D018507 Regulation of Gene Expression, Embryologic
% 216.64/216.84  |- skos__altLabel mesh__D018507 Gene Expression Regulation, Embryologic
% 216.64/216.84  |- skos__hiddenLabel mesh__D010524 Nerve Neoplasm, Peripheral
% 216.64/216.84  |- mesh__recordAuthorizer mesh__D010524 sjn
% 216.64/216.84  |- mesh__recordOriginator mesh__D010524 NLM
% 216.64/216.84  |- skos__hiddenLabel mesh__D010524 Nerve Tumor, Peripheral
% 216.64/216.84  |- skos__hiddenLabel mesh__D010524 Nerve Tumors, Peripheral
% 216.64/216.84  |- skos__hiddenLabel mesh__D010524 Nerve Neoplasms, Peripheral
% 216.64/216.84  |- skos__annotation mesh__D010524
% 216.64/216.84       coordinate IM with specific peripheral nerve %28%IM%29% + histological type of neoplasm %28%IM%29%%A%  
% 216.64/216.84  |- skos__broader mesh__D010524smesh__D010523
% 216.64/216.84  |- skos__scopeNote mesh__D010524
% 216.64/216.84       Neoplasms which arise from peripheral nerve tissue. This includes NEUROFIBROMAS; SCHWANNOMAS; GRANULAR CELL TUMORS; and malignant peripheral NERVE SHEATH NEOPLASMS. %28%From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp1750-1%29%%A%    
% 216.64/216.84  |- skos__hiddenLabel mesh__D010524 Peripheral Nerve Tumor
% 216.64/216.84  |- skos__hiddenLabel mesh__D010524 Neoplasms, Peripheral Nerve
% 216.64/216.84  |- skos__broader mesh__D010524smesh__D009423
% 216.64/216.84  |- skos__hiddenLabel mesh__D010524 Tumors, Peripheral Nerve
% 216.64/216.84  |- mesh__recordMaintainer mesh__D010524 sjn
% 216.64/216.84  |- skos__altLabel mesh__D010524 Peripheral Nervous System Benign Neoplasms
% 216.64/216.84  |- skos__prefLabel mesh__D010524 Peripheral Nervous System Neoplasms
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D010524 2006
% 216.64/216.84  |- mesh__dateCreated mesh__D010524 1999-01-01
% 216.64/216.84  |- skos__hiddenLabel mesh__D010524 Neoplasm, Peripheral Nerve
% 216.64/216.84  |- skos__altLabel mesh__D010524 Peripheral Nerve Tumors
% 216.64/216.84  |- skos__hiddenLabel mesh__D010524 Tumor, Peripheral Nerve
% 216.64/216.84  |- skos__altLabel mesh__D010524 Peripheral Nerve Neoplasms
% 216.64/216.84  |- rdf__type mesh__D010524sskos__Concept
% 216.64/216.84  |- mesh__historyNote mesh__D010524 2000%28%1966%29%   
% 216.64/216.84  |- skos__altLabel mesh__D010524
% 216.64/216.84       Peripheral Nervous System Malignant Neoplasms
% 216.64/216.84  |- mesh__dateRevised mesh__D010524 2005-07-01
% 216.64/216.84  |- mesh__publicMeSHNote mesh__D010524
% 216.64/216.84       2000; see PERIPHERAL NERVE NEOPLASMS 1966-1999   
% 216.64/216.84  |- skos__hiddenLabel mesh__D010524 Peripheral Nerve Neoplasm
% 216.64/216.84  |- mesh__recordAuthorizer mesh__D001798 sjn
% 216.64/216.84  |- mesh__recordOriginator mesh__D001798 NLM
% 216.64/216.84  |- mesh__dateCreated mesh__D001798 1999-01-01
% 216.64/216.84  |- skos__annotation mesh__D001798
% 216.64/216.84       GEN: avoid: prefer specifics; electrophoresis = BLOOD PROTEIN   ELECTROPHORESIS%A%  
% 216.64/216.84  |- skos__hiddenLabel mesh__D001798 Proteins, Serum
% 216.64/216.84  |- skos__hiddenLabel mesh__D001798 Proteins, Blood
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D001798 2006
% 216.64/216.84  |- skos__prefLabel mesh__D001798 Blood Proteins
% 216.64/216.84  |- skos__scopeNote mesh__D001798
% 216.64/216.84       Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins.%A%    
% 216.64/216.84  |- skos__broader mesh__D001798smesh__D011506
% 216.64/216.84  |- rdf__type mesh__D001798sskos__Concept
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D001798 2005
% 216.64/216.84  |- mesh__onlineNote mesh__D001798
% 216.64/216.84       pre-explosion = BLOOD PROTEINS %28%PX%29%   
% 216.64/216.84  |- skos__hiddenLabel mesh__D001798 Proteins, Plasma
% 216.64/216.84  |- mesh__dateRevised mesh__D001798 2004-07-07
% 216.64/216.84  |- skos__related mesh__D001798smesh__D015843
% 216.64/216.84  |- skos__related mesh__D001798smesh__D011485
% 216.64/216.84  |- mesh__recordMaintainer mesh__D001798 ags
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D006483 2003
% 216.64/216.84  |- skos__altLabel mesh__D006483 Haemorrhagic Bacteremia
% 216.64/216.84  |- rdf__type mesh__D006483sskos__Concept
% 216.64/216.84  |- skos__hiddenLabel mesh__D006483 Septicemia, Haemorrhagic
% 216.64/216.84  |- skos__altLabel mesh__D006483 Septicemia, Hemorrhagic
% 216.64/216.84  |- skos__broader mesh__D006483smesh__D016470
% 216.64/216.84  |- mesh__dateCreated mesh__D006483 1999-01-01
% 216.64/216.84  |- skos__annotation mesh__D006483
% 216.64/216.84       coord %28%IM%29% with PASTEURELLA MULTOCIDA %28%IM%29% or specific organism /infection term %28%IM%29% if pertinent%A%  
% 216.64/216.84  |- skos__altLabel mesh__D006483 Hemorrhagic Septicaemia
% 216.64/216.84  |- skos__altLabel mesh__D006483 Bacteremia, Hemorrhagic
% 216.64/216.84  |- mesh__dateEstablished mesh__D006483 1991-01-01
% 216.64/216.84  |- mesh__recordOriginator mesh__D006483 NLM
% 216.64/216.84  |- mesh__recordMaintainer mesh__D006483 jls
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D006483 2006
% 216.64/216.84  |- skos__hiddenLabel mesh__D006483 Septicaemia, Hemorrhagic
% 216.64/216.84  |- mesh__recordAuthorizer mesh__D006483 jls
% 216.64/216.84  |- mesh__historyNote mesh__D006483 2003, 1975-1991   
% 216.64/216.84  |- skos__scopeNote mesh__D006483
% 216.64/216.84       Any of several bacterial diseases, usually caused by PASTEURELLA MULTOCIDA, marked by the presence of hemorrhagic areas in the subcutaneous tissues, serous membranes, muscles, lymph glands, and throughout the internal organs. The diseases primarily affect animals and rarely humans.%A%    
% 216.64/216.84  |- skos__hiddenLabel mesh__D006483 Septicaemia, Haemorrhagic
% 216.64/216.84  |- skos__hiddenLabel mesh__D006483 Bacteremia, Haemorrhagic
% 216.64/216.84  |- skos__altLabel mesh__D006483 Haemorrhagic Septicaemia
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D006483 2005A
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D006483 2005
% 216.64/216.84  |- skos__broader mesh__D006483smesh__D010326
% 216.64/216.84  |- mesh__publicMeSHNote mesh__D006483
% 216.64/216.84       2003, 1975-1991; see HEMORRHAGIC BACTEREMIA 1992-2002, see HEMORRHAGIC SEPTICEMIA 1990-1991, see PASTEURELLA INFECTIONS 1975-1990%A%  
% 216.64/216.84  |- mesh__dateRevised mesh__D006483 2004-07-27
% 216.64/216.84  |- skos__related mesh__D006483smesh__D031941
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D006483 2004
% 216.64/216.84  |- skos__prefLabel mesh__D006483 Hemorrhagic Septicemia
% 216.64/216.84  |- skos__altLabel mesh__D006483 Haemorrhagic Septicemia
% 216.64/216.84  |- skos__hiddenLabel mesh__D014915 Whole Body Counters
% 216.64/216.84  |- skos__hiddenLabel mesh__D014915 Counting, Whole-Body
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D014915 2005
% 216.64/216.84  |- skos__historyNote mesh__D014915 Radiometry %28%1966-1970%29%
% 216.64/216.84  |- skos__hiddenLabel mesh__D014915 Counters, Whole-Body
% 216.64/216.84  |- mesh__recordOriginator mesh__D014915 NLM
% 216.64/216.84  |- skos__broader mesh__D014915smesh__D011874
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D014915 2006
% 216.64/216.84  |- mesh__onlineNote mesh__D014915
% 216.64/216.84       use WHOLE-BODY COUNTING to search WHOLE BODY COUNTING 1979-91, WHOLE BODY COUNTERS 1973-78, %26% WHOLE BODY COUNTER 1971-72 %28%as Prov%29%%A%  
% 216.64/216.84  |- skos__hiddenLabel mesh__D014915 Whole Body Counting
% 216.64/216.84  |- skos__hiddenLabel mesh__D014915 Counter, Whole-Body
% 216.64/216.84  |- mesh__recordAuthorizer mesh__D014915 sjn
% 216.64/216.84  |- mesh__dateEstablished mesh__D014915 1973-01-01
% 216.64/216.84  |- skos__broader mesh__D014915smesh__D012588
% 216.64/216.84  |- skos__prefLabel mesh__D014915 Whole-Body Counting
% 216.64/216.84  |- mesh__dateRevised mesh__D014915 2004-07-13
% 216.64/216.84  |- mesh__recordMaintainer mesh__D014915 sjn
% 216.64/216.84  |- mesh__publicMeSHNote mesh__D014915
% 216.64/216.84       91; was WHOLE BODY COUNTING 1979-91; was WHOLE BODY COUNTERS 1973-78%A%  
% 216.64/216.84  |- mesh__historyNote mesh__D014915
% 216.64/216.84       92; was WHOLE BODY COUNTING 1979-91; was WHOLE BODY COUNTERS 1973-78; was WHOLE BODY COUNTER 1971-72 %28%Prov%29%%A%  
% 216.64/216.84  |- mesh__dateCreated mesh__D014915 1999-01-01
% 216.64/216.84  |- rdf__type mesh__D014915sskos__Concept
% 216.64/216.84  |- skos__scopeNote mesh__D014915
% 216.64/216.84       Measurement of radioactivity in the entire human body.     
% 216.64/216.84  |- skos__hiddenLabel mesh__D014915 Whole-Body Counter
% 216.64/216.84  |- skos__scopeNote mesh__D014117
% 216.64/216.84       A curare alkaloid that is a very potent competitive nicotinic antagonist at the neuromuscular junction.%A%    
% 216.64/216.84  |- mesh__recordAuthorizer mesh__D014117 sjn
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D014117 2006
% 216.64/216.84  |- mesh__dateRevised mesh__D014117 2005-06-30
% 216.64/216.84  |- mesh__publicMeSHNote mesh__D014117
% 216.64/216.84       63; CALABASH CURARE was see TOXIFERINE 1966-94   
% 216.64/216.84  |- skos__annotation mesh__D014117 a neuromusc nondepolarizing agent   
% 216.64/216.84  |- skos__broader mesh__D014117smesh__D000644
% 216.64/216.84  |- mesh__historyNote mesh__D014117
% 216.64/216.84       63; CALABASH CURARE was see TOXIFERINE 1966-94   
% 216.64/216.84  |- skos__broader mesh__D014117smesh__D003472
% 216.64/216.84  |- mesh__onlineNote mesh__D014117
% 216.64/216.84       use TOXIFERINE to search CALABASH CURARE 1966-94   
% 216.64/216.84  |- rdf__type mesh__D014117sskos__Concept
% 216.64/216.84  |- skos__prefLabel mesh__D014117 Toxiferine
% 216.64/216.84  |- mesh__recordOriginator mesh__D014117 NLM
% 216.64/216.84  |- mesh__recordMaintainer mesh__D014117 ssb
% 216.64/216.84  |- mesh__dateCreated mesh__D014117 1999-01-01
% 216.64/216.84  |- skos__broader mesh__D019600smesh__D019581
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D019600 2005
% 216.64/216.84  |- skos__annotation mesh__D019600
% 216.64/216.84       abnormal neuronal structures: do not confuse with NEUROPIL, a %22%felt%22% of interwoven neuronal components %26% neuroglia: read MeSH definitions; A 11 qualif except /cytol; /genet permitted%A%  
% 216.64/216.84  |- skos__scopeNote mesh__D019600
% 216.64/216.84       Abnormal structures located chiefly in distal dendrites and, along with NEUROFIBRILLARY TANGLES and SENILE PLAQUES, constitute the three morphological hallmarks of ALZHEIMER DISEASE. Neuropil threads are made up of straight and paired helical filaments which consist of abnormally phosphorylated microtubule-associated tau proteins. It has been suggested that the threads have a major role in the cognitive impairment seen in Alzheimer disease.%A%    
% 216.64/216.84  |- mesh__publicMeSHNote mesh__D019600 98   
% 216.64/216.84  |- skos__broader mesh__D019600smesh__D008870
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D019600 2006
% 216.64/216.84  |- mesh__historyNote mesh__D019600 98   
% 216.64/216.84  |- skos__prefLabel mesh__D019600 Neuropil Threads
% 216.64/216.84  |- mesh__dateCreated mesh__D019600 1997-06-20
% 216.64/216.84  |- mesh__dateRevised mesh__D019600 2004-07-07
% 216.64/216.84  |- mesh__dateEstablished mesh__D019600 1998-01-01
% 216.64/216.84  |- rdf__type mesh__D019600sskos__Concept
% 216.64/216.84  |- skos__hiddenLabel mesh__D019600 Neuropil Thread
% 216.64/216.84  |- mesh__recordMaintainer mesh__D019600 jmp
% 216.64/216.84  |- mesh__recordOriginator mesh__D019600 AGS
% 216.64/216.84  |- mesh__recordAuthorizer mesh__D019600 sjn
% 216.64/216.84  |- skos__altLabel mesh__D052236
% 216.64/216.84       Fanconi Anemia Group D2 Complementing Protein
% 216.64/216.84  |- skos__broader mesh__D052236smesh__D010750
% 216.64/216.84  |- rdf__type mesh__D052236sskos__Concept
% 216.64/216.84  |- skos__broader mesh__D052236smesh__D009687
% 216.64/216.84  |- skos__scopeNote mesh__D052236
% 216.64/216.84       A Fanconi anemia complementation group protein that undergoes mono-ubiquitination by FANCL PROTEIN in response to DNA DAMAGE. Also, in response to IONIZING RADIATION it can undergo PHOSPHORYLATION by ATAXIA TELANGIECTASIA MUTATED PROTEIN. Modified FANCD2 interacts with BRCA2 PROTEIN in a stable complex with CHROMATIN, and it is involved in DNA REPAIR by homologous RECOMBINATION.%A%    
% 216.64/216.84  |- skos__broader mesh__D052236smesh__D051856
% 216.64/216.84  |- skos__prefLabel mesh__D052236
% 216.64/216.84       Fanconi Anemia Complementation Group D2 Protein
% 216.64/216.84  |- mesh__recordMaintainer mesh__D052236 DRC
% 216.64/216.84  |- mesh__dateCreated mesh__D052236 2005-06-30
% 216.64/216.84  |- skos__altLabel mesh__D052236 Fanconi Anemia Group D2 Protein
% 216.64/216.84  |- mesh__recordAuthorizer mesh__D052236 sjn
% 216.64/216.84  |- mesh__historyNote mesh__D052236 2006%28%2001%29%   
% 216.64/216.84  |- mesh__dateEstablished mesh__D052236 2006-01-01
% 216.64/216.84  |- skos__altLabel mesh__D052236 FANCD2 Protein
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D052236 2006
% 216.64/216.84  |- mesh__recordOriginator mesh__D052236 DRC
% 216.64/216.84  |- mesh__publicMeSHNote mesh__D052236
% 216.64/216.84       2006; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN was indexed under NUCLEAR PROTEINS 2001-2005%A%  
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D002891 2005
% 216.64/216.84  |- mesh__dateEstablished mesh__D002891 1987-01-01
% 216.64/216.84  |- skos__scopeNote mesh__D002891
% 216.64/216.84       A specific pair of GROUP G CHROMOSOMES of the human chromosome classification.%A%    
% 216.64/216.84  |- mesh__publicMeSHNote mesh__D002891 87   
% 216.64/216.84  |- mesh__dateCreated mesh__D002891 1986-06-19
% 216.64/216.84  |- skos__altLabel mesh__D002891 Chromosome 21
% 216.64/216.84  |- mesh__recordMaintainer mesh__D002891 ags
% 216.64/216.84  |- skos__prefLabel mesh__D002891 Chromosomes, Human, Pair 21
% 216.64/216.84  |- skos__broader mesh__D002891smesh__D002904
% 216.64/216.84  |- mesh__recordOriginator mesh__D002891 SCD
% 216.64/216.84  |- rdf__type mesh__D002891sskos__Concept
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D002891 2006A
% 216.64/216.84  |- skos__historyNote mesh__D002891
% 216.64/216.84       Chromosomes, Human, 21-22 %28%1968-1986%29%
% 216.64/216.84  |- mesh__dateRevised mesh__D002891 2005-07-14
% 216.64/216.84  |- mesh__recordAuthorizer mesh__D002891 ags
% 216.64/216.84  |- mesh__historyNote mesh__D002891 87   
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D002891 2006
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D002093 2006
% 216.64/216.84  |- skos__altLabel mesh__D002093 BW284C51
% 216.64/216.84  |- mesh__dateCreated mesh__D002093 1974-11-19
% 216.64/216.84  |- mesh__historyNote mesh__D002093 2005%28%1975%29%   
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D002093 2005
% 216.64/216.84  |- skos__altLabel mesh__D002093 BW-284-C-51
% 216.64/216.84  |- skos__broader mesh__D002093smesh__D000814
% 216.64/216.84  |- skos__prefLabel mesh__D002093
% 216.64/216.84       Benzenaminium, 4,4%27%-%28%3-oxo-1,5-pentanediyl%29%bis%28%N,N-dimethyl-N-2-propenyl-%29%, Dibromide
% 216.64/216.84  |- mesh__dateRevised mesh__D002093 2004-07-07
% 216.64/216.84  |- skos__historyNote mesh__D002093 Aniline Compounds %28%1971-1974%29%
% 216.64/216.84  |- rdf__type mesh__D002093sskos__Concept
% 216.64/216.84  |- skos__historyNote mesh__D002093 Allyl Compounds %28%1971-1974%29%
% 216.64/216.84  |- mesh__recordAuthorizer mesh__D002093 sjn
% 216.64/216.84  |- mesh__recordOriginator mesh__D002093 SH
% 216.64/216.84  |- mesh__recordMaintainer mesh__D002093 jmp
% 216.64/216.84  |- skos__historyNote mesh__D002093 Ketones %28%1971-1974%29%
% 216.64/216.84  |- mesh__publicMeSHNote mesh__D002093
% 216.64/216.84       2005; see BW 284 C 51 1991-2004; see ANILINE COMPOUNDS 1975-1990%A%  
% 216.64/216.84  |- mesh__dateEstablished mesh__D002093 1991-01-01
% 216.64/216.84  |- skos__scopeNote mesh__D002093 Proposed cholinesterase inhibitor.     
% 216.64/216.84  |- skos__broader mesh__D018508smesh__D018505
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D018508 2006
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D018508 1998
% 216.64/216.84  |- mesh__publicMeSHNote mesh__D018508 95   
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D018508 1997
% 216.64/216.84  |- mesh__recordOriginator mesh__D018508 JLS
% 216.64/216.84  |- rdf__type mesh__D018508sskos__Concept
% 216.64/216.84  |- mesh__recordAuthorizer mesh__D018508 PLS
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D018508 2002
% 216.64/216.84  |- mesh__recordMaintainer mesh__D018508 PLS
% 216.64/216.84  |- skos__prefLabel mesh__D018508 Water Purification
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D018508 1999
% 216.64/216.84  |- skos__scopeNote mesh__D018508
% 216.64/216.84       Any of several processes in which undesirable impurities in water are removed or neutralized; for example, chlorination, filtration, primary treatment, ion exchange, and distillation. It includes treatment of waste water to provide potable and hygiene water in a controlled or closed environment as well as provision of public drinking water supplies. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 216.64/216.84  |- mesh__dateEstablished mesh__D018508 1995-01-01
% 216.64/216.84  |- skos__historyNote mesh__D018508 Water Pollution %28%1966-1994%29%
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D018508 2000
% 216.64/216.84  |- mesh__dateCreated mesh__D018508 1994-06-07
% 216.64/216.84  |- skos__historyNote mesh__D018508 Water %28%1966-1994%29%
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D018508 1995
% 216.64/216.84  |- skos__hiddenLabel mesh__D018508 Purification, Water
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D018508 2003
% 216.64/216.84  |- skos__hiddenLabel mesh__D018508 Water Purifications
% 216.64/216.84  |- mesh__dateRevised mesh__D018508 1994-07-20
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D018508 2001
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D018508 2005
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D018508 2004
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D018508 1996
% 216.64/216.84  |- skos__broader mesh__D018508smesh__D014881
% 216.64/216.84  |- mesh__historyNote mesh__D018508 95   
% 216.64/216.84  |- skos__hiddenLabel mesh__D018508 Purifications, Water
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D010525 2000
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D010525 2005
% 216.64/216.84  |- skos__annotation mesh__D010525
% 216.64/216.84       GEN only; do not use as coord for specific nerves indexed with organ /innerv%A%  
% 216.64/216.84  |- skos__hiddenLabel mesh__D010525 Epineuriums
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D010525 2003
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D010525 2006
% 216.64/216.84  |- mesh__dateCreated mesh__D010525 1999-01-01
% 216.64/216.84  |- mesh__recordMaintainer mesh__D010525 RAZ
% 216.64/216.84  |- skos__related mesh__D010525smesh__D009412
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D010525 2001
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D010525 2004
% 216.64/216.84  |- skos__hiddenLabel mesh__D010525 Endoneuriums
% 216.64/216.84  |- mesh__recordAuthorizer mesh__D010525 PLS
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D010525 2002
% 216.64/216.84  |- mesh__recordOriginator mesh__D010525 NLM
% 216.64/216.84  |- skos__hiddenLabel mesh__D010525 Nerves, Peripheral
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D010525 1994
% 216.64/216.84  |- rdf__type mesh__D010525sskos__Concept
% 216.64/216.84  |- skos__scopeNote mesh__D010525
% 216.64/216.84       The nerves outside of the brain and spinal cord, including the autonomic, cranial, and spinal nerves. Peripheral nerves contain non-neuronal cells and connective tissue as well as axons. The connective tissue layers include, from the outside to the inside, the epineurium, the perineurium, and the endoneurium.%A%    
% 216.64/216.84  |- skos__prefLabel mesh__D010525 Peripheral Nerves
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D010525 1998
% 216.64/216.84  |- skos__hiddenLabel mesh__D010525 Nerve, Peripheral
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D010525 1995
% 216.64/216.84  |- skos__hiddenLabel mesh__D010525 Peripheral Nerve
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D010525 1996
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D010525 1999
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D010525 1997
% 216.64/216.84  |- mesh__dateRevised mesh__D010525 1993-06-18
% 216.64/216.84  |- skos__broader mesh__D010525smesh__D017933
% 216.64/216.84  |- skos__hiddenLabel mesh__D010525 Perineuriums
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D015210 2004
% 216.64/216.84  |- skos__hiddenLabel mesh__D015210 Arthritides, Gouty
% 216.64/216.84  |- skos__broader mesh__D015210smesh__D006073
% 216.64/216.84  |- mesh__recordOriginator mesh__D015210 EC
% 216.64/216.84  |- skos__historyNote mesh__D015210 Arthritis %28%1966-1988%29%
% 216.64/216.84  |- skos__hiddenLabel mesh__D015210 Gouty Arthritides
% 216.64/216.84  |- mesh__onlineNote mesh__D015210
% 216.64/216.84       use ARTHRITIS, GOUTY to search GOUTY ARTHRITIS 1989   
% 216.64/216.84  |- rdf__type mesh__D015210sskos__Concept
% 216.64/216.84  |- mesh__historyNote mesh__D015210 90; was GOUTY ARTHRITIS 1989   
% 216.64/216.84  |- skos__altLabel mesh__D015210 Gouty Arthritis
% 216.64/216.84  |- mesh__dateRevised mesh__D015210 2001-07-25
% 216.64/216.84  |- skos__scopeNote mesh__D015210
% 216.64/216.84       Arthritis, especially of the great toe, as a result of gout. Acute gouty arthritis often is precipitated by trauma, infection, surgery, etc. The initial attacks are usually monoarticular but later attacks are often polyarticular.%A%    
% 216.64/216.84  |- skos__prefLabel mesh__D015210 Arthritis, Gouty
% 216.64/216.84  |- mesh__recordAuthorizer mesh__D015210 sjn
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D015210 2005
% 216.64/216.84  |- mesh__recordMaintainer mesh__D015210 nns
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D015210 2002
% 216.64/216.84  |- skos__historyNote mesh__D015210 Gout %28%1966-1988%29%
% 216.64/216.84  |- mesh__publicMeSHNote mesh__D015210 90; was GOUTY ARTHRITIS 1989   
% 216.64/216.84  |- mesh__dateCreated mesh__D015210 1988-05-04
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D015210 2003
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D015210 2006
% 216.64/216.84  |- mesh__dateEstablished mesh__D015210 1989-01-01
% 216.64/216.84  |- skos__annotation mesh__D015210 arthritis caused by gout   
% 216.64/216.84  |- skos__altLabel mesh__D001799 Erythrocyte Sedimentation
% 216.64/216.84  |- skos__hiddenLabel mesh__D001799 Sedimentation, Erythrocyte
% 216.64/216.84  |- skos__annotation mesh__D001799
% 216.64/216.84       NIM; /drug eff /rad eff permitted; coord with disease /blood, not /physiopathol%A%  
% 216.64/216.84  |- skos__broader mesh__D001799smesh__D006403
% 216.64/216.84  |- skos__hiddenLabel mesh__D001799 Erythrocyte Sedimentation Rates
% 216.64/216.84  |- skos__hiddenLabel mesh__D001799 Sedimentation, Blood
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D001799 2006
% 216.64/216.84  |- mesh__recordOriginator mesh__D001799 NLM
% 216.64/216.84  |- mesh__recordAuthorizer mesh__D001799 sjn
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D001799 2002
% 216.64/216.84  |- rdf__type mesh__D001799sskos__Concept
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D001799 2005
% 216.64/216.84  |- skos__prefLabel mesh__D001799 Blood Sedimentation
% 216.64/216.84  |- skos__hiddenLabel mesh__D001799 Sedimentation Rate, Erythrocyte
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D001799 2001
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D001799 2004
% 216.64/216.84  |- skos__hiddenLabel mesh__D001799 Sedimentation Rates, Erythrocyte
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D001799 2000
% 216.64/216.84  |- skos__hiddenLabel mesh__D001799 Rate, Erythrocyte Sedimentation
% 216.64/216.84  |- mesh__dateRevised mesh__D001799 1999-11-03
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D001799 2003
% 216.64/216.84  |- mesh__recordMaintainer mesh__D001799 KEV
% 216.64/216.84  |- skos__scopeNote mesh__D001799
% 216.64/216.84       Measurement of rate of settling of erythrocytes in anticoagulated blood.%A%    
% 216.64/216.84  |- skos__hiddenLabel mesh__D001799 Rates, Erythrocyte Sedimentation
% 216.64/216.84  |- mesh__dateCreated mesh__D001799 1999-01-01
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D020953 2003
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D020953 2000
% 216.64/216.84  |- skos__annotation mesh__D020953
% 216.64/216.84       coord IM with species %28%IM%29% and specific site/dis term %28%IM%29% if pertinent%A%  
% 216.64/216.84  |- skos__broader mesh__D020953smesh__D001228
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D020953 2004
% 216.64/216.84  |- skos__prefLabel mesh__D020953 Neuroaspergillosis
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D020953 2005
% 216.64/216.84  |- skos__broader mesh__D020953smesh__D020314
% 216.64/216.84  |- skos__related mesh__D020953smesh__D003389
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D020953 2001
% 216.64/216.84  |- skos__altLabel mesh__D020953 Nervous System Invasive Aspergillosis
% 216.64/216.84  |- rdf__type mesh__D020953sskos__Concept
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D020953 2006
% 216.64/216.84  |- skos__scopeNote mesh__D020953
% 216.64/216.84       Infections of the nervous system caused by fungi of the genus ASPERGILLUS, most commonly ASPERGILLUS FUMIGATUS. Aspergillus infections may occur in immunocompetent hosts, but are more prevalent in individuals with IMMUNOLOGIC DEFICIENCY SYNDROMES. The organism may spread to the nervous system from focal infections in the lung, mastoid region, sinuses, inner ear, bones, eyes, gastrointestinal tract, and heart. Sinus infections may be locally invasive and enter the intracranial compartment, producing MENINGITIS, FUNGAL; cranial neuropathies; and abscesses in the frontal lobes of the brain. %28%From Joynt, Clinical Neurology, 1998, Ch 27, pp62-3%29%%A%    
% 216.64/216.84  |- mesh__dateEstablished mesh__D020953 2000-01-01
% 216.64/216.84  |- mesh__publicMeSHNote mesh__D020953 2000   
% 216.64/216.84  |- skos__historyNote mesh__D020953 Aspergillosis %28%1966-1999%29%
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D020953 2002
% 216.64/216.84  |- skos__hiddenLabel mesh__D020953 Neuroaspergilloses
% 216.64/216.84  |- mesh__dateCreated mesh__D020953 1999-11-03
% 216.64/216.84  |- mesh__historyNote mesh__D020953 2000   
% 216.64/216.84  |- mesh__recordMaintainer mesh__D006484 PLS
% 216.64/216.84  |- skos__hiddenLabel mesh__D006484 Hemorrhoid
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D006484 1992
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D006484 1998
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D006484 2006
% 216.64/216.84  |- skos__broader mesh__D006484smesh__D012002
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D006484 2002
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D006484 1997
% 216.64/216.84  |- skos__prefLabel mesh__D006484 Hemorrhoids
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D006484 2005
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D006484 2001
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D006484 1996
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D006484 2004
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D006484 2000
% 216.64/216.84  |- skos__broader mesh__D006484smesh__D014652
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D006484 1995
% 216.64/216.84  |- mesh__dateRevised mesh__D006484 1990-05-29
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D006484 1991
% 216.64/216.84  |- skos__scopeNote mesh__D006484
% 216.64/216.84       Varicosities of the hemorrhoidal venous plexuses.     
% 216.64/216.84  |- rdf__type mesh__D006484sskos__Concept
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D006484 2003
% 216.64/216.84  |- mesh__recordOriginator mesh__D006484 NLM
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D006484 1994
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D006484 1993
% 216.64/216.84  |- mesh__dateCreated mesh__D006484 1999-01-01
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D006484 1999
% 216.64/216.84  |- mesh__recordAuthorizer mesh__D006484 NLM
% 216.64/216.84  |- rdf__type mesh__D020155sskos__Concept
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D020155 2006
% 216.64/216.84  |- skos__hiddenLabel mesh__D020155 beta Hydroxybutyric Acid
% 216.64/216.84  |- mesh__publicMeSHNote mesh__D020155
% 216.64/216.84       99; 3-HYDROXYBUTYRIC ACID was indexed under HYDROXYBUTYRATES 1966-98%A%  
% 216.64/216.84  |- mesh__dateRevised mesh__D020155 2003-07-09
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D020155 2005
% 216.64/216.84  |- skos__hiddenLabel mesh__D020155 3 Hydroxybutyrate
% 216.64/216.84  |- skos__altLabel mesh__D020155 beta-Hydroxybutyrate
% 216.64/216.84  |- skos__historyNote mesh__D020155 Hydroxybutyrates %28%1966-1998%29%
% 216.64/216.84  |- mesh__dateEstablished mesh__D020155 1999-01-01
% 216.64/216.84  |- skos__hiddenLabel mesh__D020155 Acid, beta-Hydroxybutyric
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D020155 2004
% 216.64/216.84  |- mesh__dateCreated mesh__D020155 1998-06-11
% 216.64/216.84  |- skos__hiddenLabel mesh__D020155 beta Hydroxybutyrate
% 216.64/216.84  |- skos__prefLabel mesh__D020155 3-Hydroxybutyric Acid
% 216.64/216.84  |- skos__hiddenLabel mesh__D020155 Acid, 3-Hydroxybutyric
% 216.64/216.84  |- skos__broader mesh__D020155smesh__D002088
% 216.64/216.84  |- skos__hiddenLabel mesh__D020155 3 Hydroxybutyric Acid
% 216.64/216.84  |- mesh__historyNote mesh__D020155
% 216.64/216.84       99; use 3-HYDROXYBUTYRIC ACID %28%NM%29% 1980-98   
% 216.64/216.84  |- skos__broader mesh__D020155smesh__D006880
% 216.64/216.84  |- skos__altLabel mesh__D020155 beta-Hydroxybutyric Acid
% 216.64/216.84  |- skos__scopeNote mesh__D020155
% 216.64/216.84       BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver and occurs at high levels in the blood and urine in KETOSIS. %28%From Dorland%27%s, 28th ed%29%%A%    
% 216.64/216.84  |- mesh__onlineNote mesh__D014916
% 216.64/216.84       use WHOLE-BODY IRRADIATION to search WHOLE BODY IRRADIATION 1982-90%A%  
% 216.64/216.84  |- skos__scopeNote mesh__D014916
% 216.64/216.84       Irradiation of the whole body with ionizing or non-ionizing radiation. It is applicable to humans or animals but not to microorganisms.%A%    
% 216.64/216.84  |- skos__hiddenLabel mesh__D014916 Whole-Body Radiations
% 216.64/216.84  |- mesh__activeMeSHYear mesh__D014916 2006
% 216.64/216.84  |- skos__annotation mesh__D014916
% 216.64/216.84       in rad experiments IM when point of article is irrad of entire animal %26% coord with organ or process /rad eff %28%IM or NIM%29%; no qualif when NIM; in radiother coord IM with disease /radiother %28%IM%29%; TN 198: when not to use; DF: WHOLE BODY IRRAD%A%  
% 216.64/216.84  |- mesh__dateCreated mesh__D014916 1981-02-27
% 216.64/216.84  |- skos__hiddenLabel mesh__D014916 Whole Body Radiation
% 216.64/216.84  |- skos__altLabel mesh__D014916 Total Body Irradiation
% 216.64/216.84  |- mesh__publicMeSHNote mesh__D014916
% 216.64/216.84       91; was WHOLE BODY IRRADIATION 1982-90   
% 216.64/216.84  |- skos__hiddenLabel mesh__D014916 Whole-Body Irradiations
% 216.64/216.84  |- mesh__dateRevised mesh__D014916 2005-06-30
% 216.64/216.84  |- skos__altLabel mesh__D014916 Whole-Body Radiation
% 216.64/216.84  |- skos__broader mesh__D014916smesh__D011878
% 216.64/216.84  |- skos__hiddenLabel mesh__D014916 Irradiation, Whole Body
% 216.64/216.84  |- skos__related mesh__D014916smesh__D015182
% 216.64/216.84  |- skos__hiddenLabel mesh__D014916 Whole Body Irradiation
% 216.64/216.84  |- skos__prefLabel mesh__D014916 Whole-Body Irradiation
% 216.64/216.85  |- rdf__type mesh__D014916sskos__Concept
% 216.64/216.85  |- skos__hiddenLabel mesh__D014916 Total Body Irradiations
% 216.64/216.85  |- skos__hiddenLabel mesh__D014916 Irradiations, Whole-Body
% 216.64/216.85  |- skos__altLabel mesh__D014916 Radiation, Whole-Body
% 216.64/216.85  |- mesh__recordMaintainer mesh__D014916 lkt
% 216.64/216.85  |- mesh__dateEstablished mesh__D014916 1982-01-01
% 216.64/216.85  |- skos__hiddenLabel mesh__D014916 Radiation, Whole Body
% 216.64/216.85  |- skos__hiddenLabel mesh__D014916 Radiations, Whole-Body
% 216.64/216.85  |- mesh__recordAuthorizer mesh__D014916 sjn
% 216.64/216.85  |- skos__hiddenLabel mesh__D014916 Irradiations, Total Body
% 216.64/216.85  |- skos__broader mesh__D014916smesh__D008919
% 216.64/216.85  |- skos__altLabel mesh__D014916 Irradiation, Whole-Body
% 216.64/216.85  |- skos__altLabel mesh__D014916 Irradiation, Total Body
% 216.64/216.85  |- mesh__historyNote mesh__D014916
% 216.64/216.85       91; was WHOLE BODY IRRADIATION 1982-90   
% 216.64/216.85  |- mesh__recordOriginator mesh__D014916 SMH
% 216.64/216.85  |- skos__related mesh__D014916smesh__D017619
% 216.64/216.85  |- skos__scopeNote mesh__D014118
% 216.64/216.85       Specific, characterizable, poisonous chemicals, often PROTEINS, with specific biological properties, including immunogenicity, produced by microbes, higher plants %28%PLANTS, TOXIC%29%, or ANIMALS.%A%    
% 216.64/216.85  |- skos__annotation mesh__D014118
% 216.64/216.85       general or unspecified; prefer specifics; /antag permitted but consider also ANTITOXINS%A%  
% 216.64/216.85  |- mesh__recordOriginator mesh__D014118 NLM
% 216.64/216.85  |- mesh__publicMeSHNote mesh__D014118
% 216.64/216.85       2006; see TOXINS 1966-2005, see TOXINS AND ANTITOXINS 1963-1965%A%  
% 216.64/216.85  |- skos__related mesh__D014118smesh__D000992
% 216.64/216.85  |- skos__related mesh__D014118smesh__D000931
% 216.64/216.85  |- mesh__recordMaintainer mesh__D014118 ssb
% 216.64/216.85  |- mesh__dateEstablished mesh__D014118 1966-01-01
% 216.64/216.85  |- skos__prefLabel mesh__D014118 Toxins, Biological
% 216.64/216.85  |- mesh__recordAuthorizer mesh__D014118 sjn
% 216.64/216.85  |- rdf__type mesh__D014118sskos__Concept
% 216.64/216.85  |- skos__broader mesh__D014118smesh__D001685
% 216.64/216.85  |- skos__related mesh__D014118smesh__D014121
% 216.64/216.85  |- mesh__dateRevised mesh__D014118 2005-06-30
% 216.64/216.85  |- mesh__historyNote mesh__D014118 2006%28%1966%29%   
% 216.64/216.85  |- mesh__dateCreated mesh__D014118 1999-01-01
% 216.64/216.85  |- skos__hiddenLabel mesh__D014118 Biological Toxins
% 216.64/216.85  |- skos__related mesh__D014118smesh__D009676
% 216.64/216.85  |- skos__altLabel mesh__D014118 Toxins
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D014118 2006
% 216.64/216.85  |- rdf__type mesh__D019601sskos__Concept
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D019601 2004
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D019601 1999
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D019601 2001
% 216.64/216.85  |- skos__prefLabel mesh__D019601 Pacific States
% 216.64/216.85  |- skos__broader mesh__D019601smesh__D014481
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D019601 2002
% 216.64/216.85  |- skos__annotation mesh__D019601
% 216.64/216.85       includes Alaska, Calif, Hawaii, Ore, Wash; specify as needed but use PACIFIC STATES when the text uses the term; do not confuse with PACIFIC NORTHWEST see NORTHWESTERN UNITED STATES      CATALOG: use for 4 or more states%A%  
% 216.64/216.85  |- skos__scopeNote mesh__D019601
% 216.64/216.85       The geographic designation for states bordering on or located in the Pacific Ocean. The states so designated are Alaska, California, Hawaii, Oregon, and Washington. %28%U.S. Geologic Survey telephone communication%29%%A%    
% 216.64/216.85  |- mesh__dateEstablished mesh__D019601 1998-01-01
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D019601 2005
% 216.64/216.85  |- mesh__dateCreated mesh__D019601 1997-06-20
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D019601 2003
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D019601 2006
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D019601 1998
% 216.64/216.85  |- mesh__historyNote mesh__D019601 98   
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D019601 2000
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002892 2006A
% 216.64/216.85  |- mesh__recordOriginator mesh__D002892 SCD
% 216.64/216.85  |- mesh__dateRevised mesh__D002892 2005-07-14
% 216.64/216.85  |- skos__related mesh__D002892smesh__D010677
% 216.64/216.85  |- rdf__type mesh__D002892sskos__Concept
% 216.64/216.85  |- mesh__dateEstablished mesh__D002892 1987-01-01
% 216.64/216.85  |- mesh__recordAuthorizer mesh__D002892 ags
% 216.64/216.85  |- mesh__historyNote mesh__D002892 87   
% 216.64/216.85  |- skos__altLabel mesh__D002892 Chromosome 22
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002892 2006
% 216.64/216.85  |- mesh__publicMeSHNote mesh__D002892 87   
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002892 2005
% 216.64/216.85  |- skos__scopeNote mesh__D002892
% 216.64/216.85       A specific pair of GROUP G CHROMOSOMES of the human chromosome classification.%A%    
% 216.64/216.85  |- mesh__dateCreated mesh__D002892 1986-06-19
% 216.64/216.85  |- skos__broader mesh__D002892smesh__D002904
% 216.64/216.85  |- skos__historyNote mesh__D002892
% 216.64/216.85       Chromosomes, Human, 21-22 %28%1968-1986%29%
% 216.64/216.85  |- skos__prefLabel mesh__D002892 Chromosomes, Human, Pair 22
% 216.64/216.85  |- mesh__recordMaintainer mesh__D002892 ags
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002094 2006
% 216.64/216.85  |- skos__altLabel mesh__D002094 Byelorussian SSR
% 216.64/216.85  |- skos__broader mesh__D002094smesh__D005061
% 216.64/216.85  |- mesh__dateCreated mesh__D002094 1999-01-01
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002094 1999
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002094 2001
% 216.64/216.85  |- skos__annotation mesh__D002094
% 216.64/216.85       variant spellings %28%Byelorussia, Belorussia, etc.%29% permitted in translations of historical articles; use Byelarus as spelling in translations of current articles%A%  
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002094 2003
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002094 1996
% 216.64/216.85  |- mesh__recordAuthorizer mesh__D002094 PLS
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002094 2004
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002094 1997
% 216.64/216.85  |- skos__broader mesh__D002094smesh__D014586
% 216.64/216.85  |- rdf__type mesh__D002094sskos__Concept
% 216.64/216.85  |- mesh__recordOriginator mesh__D002094 NLM
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002094 2002
% 216.64/216.85  |- skos__altLabel mesh__D002094 Belorussian SSR
% 216.64/216.85  |- mesh__historyNote mesh__D002094
% 216.64/216.85       93; was BYELORUSSIAN S.S.R. 1982-92; was BELORUSSIA 1963-81%A%  
% 216.64/216.85  |- skos__altLabel mesh__D002094 Belorussian S.S.R.
% 216.64/216.85  |- mesh__dateRevised mesh__D002094 1994-03-17
% 216.64/216.85  |- skos__altLabel mesh__D002094 Belorussia
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002094 1995
% 216.64/216.85  |- mesh__recordMaintainer mesh__D002094 PLS
% 216.64/216.85  |- skos__prefLabel mesh__D002094 Byelarus
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002094 2000
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002094 2005
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002094 1998
% 216.64/216.85  |- skos__altLabel mesh__D002094 Belarus
% 216.64/216.85  |- mesh__onlineNote mesh__D002094
% 216.64/216.85       use BYELARUS to search BYELORUSSIAN S.S.R. 1982-92 %26% BELORUSSIA 1966-81%A%  
% 216.64/216.85  |- skos__broader mesh__D002094smesh__D017517
% 216.64/216.85  |- skos__altLabel mesh__D002094 Byelorussian S.S.R.
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D018509 2001
% 216.64/216.85  |- mesh__dateCreated mesh__D018509 1994-02-28
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D018509 2003
% 216.64/216.85  |- mesh__recordMaintainer mesh__D018509 KEV
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D018509 2005
% 216.64/216.85  |- mesh__publicMeSHNote mesh__D018509 95   
% 216.64/216.85  |- skos__historyNote mesh__D018509 DNA %28%1966-1994%29%
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D018509 2004
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D018509 1996
% 216.64/216.85  |- mesh__historyNote mesh__D018509 95   
% 216.64/216.85  |- mesh__recordAuthorizer mesh__D018509 PLS
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D018509 2002
% 216.64/216.85  |- mesh__dateRevised mesh__D018509 1995-06-08
% 216.64/216.85  |- mesh__dateEstablished mesh__D018509 1995-01-01
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D018509 2006
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D018509 1998
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D018509 1997
% 216.64/216.85  |- skos__prefLabel mesh__D018509 DNA, Helminth
% 216.64/216.85  |- skos__broader mesh__D018509smesh__D004247
% 216.64/216.85  |- rdf__type mesh__D018509sskos__Concept
% 216.64/216.85  |- skos__altLabel mesh__D018509 Helminth DNA
% 216.64/216.85  |- skos__scopeNote mesh__D018509
% 216.64/216.85       Deoxyribonucleic acid that makes up the genetic material of helminths.%A%    
% 216.64/216.85  |- skos__annotation mesh__D018509
% 216.64/216.85       IM; coord with specific helminth %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D018509 1999
% 216.64/216.85  |- mesh__recordOriginator mesh__D018509 AGS
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D018509 2000
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D010526 2006
% 216.64/216.85  |- skos__prefLabel mesh__D010526 Periplaneta
% 216.64/216.85  |- skos__broader mesh__D010526smesh__D003058
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D010526 2004
% 216.64/216.85  |- rdf__type mesh__D010526sskos__Concept
% 216.64/216.85  |- mesh__dateCreated mesh__D010526 1974-12-12
% 216.64/216.85  |- mesh__publicMeSHNote mesh__D010526 91; see COCKROACHES 1975-90   
% 216.64/216.85  |- skos__altLabel mesh__D010526 American Cockroaches
% 216.64/216.85  |- mesh__dateRevised mesh__D010526 2003-07-09
% 216.64/216.85  |- mesh__historyNote mesh__D010526
% 216.64/216.85       91%28%75%29%; for PERIPLANETA AMERICANA use COCKROACHES 1995-97%A%  
% 216.64/216.85  |- mesh__recordMaintainer mesh__D010526 ags
% 216.64/216.85  |- skos__scopeNote mesh__D010526
% 216.64/216.85       A genus in the family Blattidae containing several species, the most common being P. americana, the American cockroach.%A%    
% 216.64/216.85  |- skos__annotation mesh__D010526
% 216.64/216.85       do not use /drug eff for insecticides: TN 111   
% 216.64/216.85  |- mesh__recordAuthorizer mesh__D010526 sjn
% 216.64/216.85  |- mesh__recordOriginator mesh__D010526 NLM
% 216.64/216.85  |- mesh__dateEstablished mesh__D010526 1991-01-01
% 216.64/216.85  |- skos__altLabel mesh__D010526 American Cockroach
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D010526 2005
% 216.64/216.85  |- skos__broader mesh__D015211smesh__D000015
% 216.64/216.85  |- skos__hiddenLabel mesh__D015211 Zellweger Like Syndrome
% 216.64/216.85  |- skos__historyNote mesh__D015211
% 216.64/216.85       Abnormalities, Multiple %28%1968-1988%29%
% 216.64/216.85  |- skos__historyNote mesh__D015211 Kidney Diseases %28%1966-1988%29%
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D015211 2006
% 216.64/216.85  |- mesh__dateRevised mesh__D015211 2004-07-07
% 216.64/216.85  |- skos__hiddenLabel mesh__D015211 Zellwegers Syndrome
% 216.64/216.85  |- skos__scopeNote mesh__D015211
% 216.64/216.85       An autosomal recessive disorder due to defects in PEROXISOME biogenesis which involves more than 13 genes encoding peroxin proteins of the peroxisomal membrane and matrix. Zellweger syndrome is typically seen in the neonatal period with features such as dysmorphic skull; MUSCLE HYPOTONIA; SENSORINEURAL HEARING LOSS; visual compromise; SEIZURES; progressive degeneration of the KIDNEYS and the LIVER. Zellweger-like syndrome refers to phenotypes resembling the neonatal Zellweger syndrome but seen in children or adults with apparently intact peroxisome biogenesis.%A%    
% 216.64/216.85  |- mesh__dateCreated mesh__D015211 1988-05-04
% 216.64/216.85  |- skos__historyNote mesh__D015211 Liver Diseases %28%1966-1988%29%
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D015211 2005
% 216.64/216.85  |- skos__historyNote mesh__D015211 Brain Diseases %28%1966-1988%29%
% 216.64/216.85  |- skos__prefLabel mesh__D015211 Zellweger Syndrome
% 216.64/216.85  |- skos__altLabel mesh__D015211 Zellweger%27%s Syndrome
% 216.64/216.85  |- skos__altLabel mesh__D015211 Cerebro-Hepato-Renal Syndrome
% 216.64/216.85  |- skos__broader mesh__D015211smesh__D018901
% 216.64/216.85  |- mesh__publicMeSHNote mesh__D015211 1989   
% 216.64/216.85  |- skos__hiddenLabel mesh__D015211 Cerebro Hepato Renal Syndrome
% 216.64/216.85  |- mesh__recordOriginator mesh__D015211 EC
% 216.64/216.85  |- skos__hiddenLabel mesh__D015211 Cerebro-Hepato-Renal Syndromes
% 216.64/216.85  |- rdf__type mesh__D015211sskos__Concept
% 216.64/216.85  |- skos__altLabel mesh__D015211 Cerebrohepatorenal Syndrome
% 216.64/216.85  |- skos__broader mesh__D015211smesh__D008107
% 216.64/216.85  |- mesh__recordMaintainer mesh__D015211 lkt
% 216.64/216.85  |- mesh__historyNote mesh__D015211 1989   
% 216.64/216.85  |- skos__altLabel mesh__D015211 Zellweger Disease
% 216.64/216.85  |- mesh__dateEstablished mesh__D015211 1989-01-01
% 216.64/216.85  |- skos__broader mesh__D015211smesh__D007674
% 216.64/216.85  |- skos__hiddenLabel mesh__D015211 Cerebrohepatorenal Syndromes
% 216.64/216.85  |- mesh__recordAuthorizer mesh__D015211 sjn
% 216.64/216.85  |- skos__broader mesh__D016685Q000031smesh__D016685
% 216.64/216.85  |- mesh__preferredCombination mesh__D016685Q000031smesh__D008937
% 216.64/216.85  |- rdf__type mesh__D016685Q000031smesh__CompoundConcept
% 216.64/216.85  |- skos__prefLabel mesh__D020954 Single-Parent Family
% 216.64/216.85  |- skos__hiddenLabel mesh__D020954 One-Parent Families
% 216.64/216.85  |- mesh__recordMaintainer mesh__D020954 sjn
% 216.64/216.85  |- mesh__dateRevised mesh__D020954 2003-07-22
% 216.64/216.85  |- skos__hiddenLabel mesh__D020954 Family, Single Parent
% 216.64/216.85  |- skos__related mesh__D020954smesh__D015406
% 216.64/216.85  |- skos__broader mesh__D020954smesh__D005190
% 216.64/216.85  |- skos__hiddenLabel mesh__D020954 One Parent Families
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D020954 2004
% 216.64/216.85  |- skos__altLabel mesh__D020954 Family, Single-Parent
% 216.64/216.85  |- skos__scopeNote mesh__D020954
% 216.64/216.85       A household that includes children and is headed by one adult.%A%    
% 216.64/216.85  |- skos__altLabel mesh__D020954 Single Parent Family
% 216.64/216.85  |- mesh__historyNote mesh__D020954
% 216.64/216.85       2000; use SINGLE PARENT %28%1989-1999%29%   
% 216.64/216.85  |- skos__hiddenLabel mesh__D020954 Family, One Parent
% 216.64/216.85  |- skos__hiddenLabel mesh__D020954 Single Parent Families
% 216.64/216.85  |- skos__hiddenLabel mesh__D020954 Families, Single-Parent
% 216.64/216.85  |- skos__hiddenLabel mesh__D020954 Families, One-Parent
% 216.64/216.85  |- mesh__dateCreated mesh__D020954 1999-11-03
% 216.64/216.85  |- mesh__publicMeSHNote mesh__D020954
% 216.64/216.85       2000; see SINGLE PARENT %28%1989-1999%29%   
% 216.64/216.85  |- rdf__type mesh__D020954sskos__Concept
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D020954 2006
% 216.64/216.85  |- skos__altLabel mesh__D020954 One Parent Family
% 216.64/216.85  |- mesh__dateEstablished mesh__D020954 2000-01-01
% 216.64/216.85  |- mesh__recordOriginator mesh__D020954 jls
% 216.64/216.85  |- skos__hiddenLabel mesh__D020954 Single-Parent Families
% 216.64/216.85  |- mesh__recordAuthorizer mesh__D020954 sjn
% 216.64/216.85  |- skos__hiddenLabel mesh__D020954 Families, Single Parent
% 216.64/216.85  |- skos__hiddenLabel mesh__D020954 Families, One Parent
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D020954 2005
% 216.64/216.85  |- skos__historyNote mesh__D020954 Single Parent %28%1989-1999%29%
% 216.64/216.85  |- skos__hiddenLabel mesh__D020954 Family, One-Parent
% 216.64/216.85  |- mesh__dateRevised mesh__D006485 1992-05-19
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D006485 1997
% 216.64/216.85  |- mesh__historyNote mesh__D006485 66%28%63%29%   
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D006485 2005
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D006485 1996
% 216.64/216.85  |- skos__broader mesh__D006485smesh__D008667
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D006485 2004
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D006485 1995
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D006485 2002
% 216.64/216.85  |- rdf__type mesh__D006485sskos__Concept
% 216.64/216.85  |- mesh__dateEstablished mesh__D006485 1966-01-01
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D006485 2003
% 216.64/216.85  |- mesh__recordAuthorizer mesh__D006485 PLS
% 216.64/216.85  |- skos__related mesh__D006485smesh__D012806
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D006485 1994
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D006485 2001
% 216.64/216.85  |- mesh__publicMeSHNote mesh__D006485 66   
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D006485 1993
% 216.64/216.85  |- mesh__recordMaintainer mesh__D006485 TAP
% 216.64/216.85  |- mesh__dateCreated mesh__D006485 1999-01-01
% 216.64/216.85  |- skos__annotation mesh__D006485 a metalloprotein   
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D006485 1999
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D006485 2000
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D006485 1998
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D006485 2006
% 216.64/216.85  |- skos__prefLabel mesh__D006485 Hemosiderin
% 216.64/216.85  |- mesh__recordOriginator mesh__D006485 NLM
% 216.64/216.85  |- skos__altLabel mesh__D020156 2-Hydroxybenzoic Acid
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D020156 2002
% 216.64/216.85  |- skos__altLabel mesh__D020156 ortho-Hydroxybenzoic Acid
% 216.64/216.85  |- mesh__publicMeSHNote mesh__D020156
% 216.64/216.85       99; SALICYLIC ACID was indexed under SALICYLIC ACIDS 1981-98%A%  
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D020156 2006
% 216.64/216.85  |- skos__hiddenLabel mesh__D020156 Acid, 2-Hydroxybenzoic
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D020156 2001
% 216.64/216.85  |- mesh__dateEstablished mesh__D020156 1999-01-01
% 216.64/216.85  |- skos__prefLabel mesh__D020156 Salicylic Acid
% 216.64/216.85  |- skos__hiddenLabel mesh__D020156 Acid, ortho-Hydroxybenzoic
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D020156 2005
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D020156 2000
% 216.64/216.85  |- skos__hiddenLabel mesh__D020156 Acid, Salicylic
% 216.64/216.85  |- skos__scopeNote mesh__D020156
% 216.64/216.85       A compound obtained from the bark of the white willow and wintergreen leaves, and also prepared synthetically. It has bacteriostatic, fungicidal, and keratolytic actions. Its salts, the salicylates, are used as analgesics. %28%From Dorland%27%s, 28th ed%29%%A%    
% 216.64/216.85  |- skos__hiddenLabel mesh__D020156 2 Hydroxybenzoic Acid
% 216.64/216.85  |- skos__hiddenLabel mesh__D020156 Acid, o-Hydroxybenzoic
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D020156 2004
% 216.64/216.85  |- skos__broader mesh__D020156smesh__D012461
% 216.64/216.85  |- skos__altLabel mesh__D020156 o-Hydroxybenzoic Acid
% 216.64/216.85  |- mesh__dateCreated mesh__D020156 1998-06-11
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D020156 2003
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D020156 1999
% 216.64/216.85  |- mesh__historyNote mesh__D020156
% 216.64/216.85       99; use SALICYLIC ACID %28%NM%29% 1981-98   
% 216.64/216.85  |- skos__hiddenLabel mesh__D020156 ortho Hydroxybenzoic Acid
% 216.64/216.85  |- skos__hiddenLabel mesh__D020156 o Hydroxybenzoic Acid
% 216.64/216.85  |- rdf__type mesh__D020156sskos__Concept
% 216.64/216.85  |- skos__annotation mesh__D020156 SALICYLIC ACIDS is also available   
% 216.64/216.85  |- skos__historyNote mesh__D020156 Salicylic Acids %28%1981-1998%29%
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D014917 1996
% 216.64/216.85  |- skos__prefLabel mesh__D014917 Whooping Cough
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D014917 1999
% 216.64/216.85  |- skos__altLabel mesh__D014917 Pertussis
% 216.64/216.85  |- mesh__recordMaintainer mesh__D014917 KEV
% 216.64/216.85  |- mesh__dateCreated mesh__D014917 1999-01-01
% 216.64/216.85  |- skos__annotation mesh__D014917 caused by Bordetella pertussis   
% 216.64/216.85  |- skos__scopeNote mesh__D014917
% 216.64/216.85       A respiratory infection caused by BORDETELLA PERTUSSIS and characterized by paroxysmal coughing ending in a prolonged crowing intake of breath.%A%    
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D014917 1997
% 216.64/216.85  |- rdf__type mesh__D014917sskos__Concept
% 216.64/216.85  |- mesh__dateRevised mesh__D014917 1995-05-25
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D014917 2005
% 216.64/216.85  |- skos__hiddenLabel mesh__D014917 Pertusses
% 216.64/216.85  |- mesh__recordAuthorizer mesh__D014917 PLS
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D014917 2000
% 216.64/216.85  |- skos__broader mesh__D014917smesh__D012141
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D014917 2003
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D014917 2006
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D014917 2001
% 216.64/216.85  |- skos__related mesh__D014917smesh__D010567
% 216.64/216.85  |- skos__hiddenLabel mesh__D014917 Cough, Whooping
% 216.64/216.85  |- skos__broader mesh__D014917smesh__D001885
% 216.64/216.85  |- mesh__recordOriginator mesh__D014917 NLM
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D014917 2004
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D014917 1998
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D014917 2002
% 216.64/216.85  |- skos__scopeNote mesh__D014119
% 216.64/216.85       A genus of ascarid nematodes commonly parasitic in the intestines of cats and dogs.%A%    
% 216.64/216.85  |- mesh__dateCreated mesh__D014119 1999-01-01
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D014119 2006
% 216.64/216.85  |- skos__prefLabel mesh__D014119 Toxocara
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D014119 2005
% 216.64/216.85  |- mesh__recordOriginator mesh__D014119 NLM
% 216.64/216.85  |- mesh__recordMaintainer mesh__D014119 ags
% 216.64/216.85  |- rdf__type mesh__D014119sskos__Concept
% 216.64/216.85  |- mesh__dateRevised mesh__D014119 2003-07-09
% 216.64/216.85  |- mesh__recordAuthorizer mesh__D014119 sjn
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D014119 2004
% 216.64/216.85  |- skos__annotation mesh__D014119
% 216.64/216.85       a genus of nematodes common in cat %26% dog intestine but TOXOCARA CANIS is available; do not confuse with TOXASCARIS, also a nematode genus; infection = TOXOCARIASIS %28%not to be confused with TOXASCARIASIS%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 216.64/216.85  |- skos__broader mesh__D014119smesh__D001199
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D019602 2000
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D019602 2001
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D019602 2005
% 216.64/216.85  |- skos__scopeNote mesh__D019602 Edible or potable substances.     
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D019602 2002
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D019602 2006
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D019602 2003
% 216.64/216.85  |- mesh__runningHead mesh__D019602 J2 - FOOD AND BEVERAGES   
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D019602 1998
% 216.64/216.85  |- mesh__historyNote mesh__D019602 98   
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D019602 2004
% 216.64/216.85  |- skos__hiddenLabel mesh__D019602 Beverages and Food
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D019602 1999
% 216.64/216.85  |- skos__prefLabel mesh__D019602 Food and Beverages
% 216.64/216.85  |- mesh__dateEstablished mesh__D019602 1998-01-01
% 216.64/216.85  |- rdf__type mesh__D019602sskos__Concept
% 216.64/216.85  |- skos__annotation mesh__D019602
% 216.64/216.85       not used for indexing      CATALOG: do not use   
% 216.64/216.85  |- mesh__dateCreated mesh__D019602 1997-06-20
% 216.64/216.85  |- skos__altLabel mesh__D002893 Chromosome 3
% 216.64/216.85  |- mesh__historyNote mesh__D002893 87   
% 216.64/216.85  |- mesh__dateRevised mesh__D002893 2004-07-13
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002893 2006
% 216.64/216.85  |- skos__historyNote mesh__D002893
% 216.64/216.85       Chromosomes, Human, 1-3 %28%1968-1986%29%
% 216.64/216.85  |- skos__scopeNote mesh__D002893
% 216.64/216.85       A specific pair of human chromosomes in group A %28%CHROMOSOMES, HUMAN, 1-3%29% of the human chromosome classification.%A%    
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002893 2005
% 216.64/216.85  |- mesh__dateEstablished mesh__D002893 1987-01-01
% 216.64/216.85  |- mesh__dateCreated mesh__D002893 1986-06-19
% 216.64/216.85  |- mesh__recordMaintainer mesh__D002893 sjn
% 216.64/216.85  |- mesh__publicMeSHNote mesh__D002893 87   
% 216.64/216.85  |- mesh__recordAuthorizer mesh__D002893 sjn
% 216.64/216.85  |- mesh__recordOriginator mesh__D002893 SCD
% 216.64/216.85  |- skos__broader mesh__D002893smesh__D002900
% 216.64/216.85  |- rdf__type mesh__D002893sskos__Concept
% 216.64/216.85  |- skos__prefLabel mesh__D002893 Chromosomes, Human, Pair 3
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002095 2000
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002095 1996
% 216.64/216.85  |- mesh__recordMaintainer mesh__D002095 TGC
% 216.64/216.85  |- mesh__historyNote mesh__D002095 74%28%69%29%   
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002095 2004
% 216.64/216.85  |- skos__broader mesh__D002095smesh__D011009
% 216.64/216.85  |- mesh__dateEstablished mesh__D002095 1974-01-01
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002095 1997
% 216.64/216.85  |- rdf__type mesh__D002095sskos__Concept
% 216.64/216.85  |- skos__prefLabel mesh__D002095 Byssinosis
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002095 2001
% 216.64/216.85  |- mesh__publicMeSHNote mesh__D002095 74   
% 216.64/216.85  |- skos__scopeNote mesh__D002095
% 216.64/216.85       An airway obstruction due to the dust inhaled during the processing of cotton.%A%    
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002095 1994
% 216.64/216.85  |- skos__historyNote mesh__D002095 Pneumoconiosis %28%1966-1968%29%
% 216.64/216.85  |- skos__annotation mesh__D002095
% 216.64/216.85       pneumoconiosis from cotton dust fibers; do not coord with OCCUPATIONAL DISEASES%A%  
% 216.64/216.85  |- mesh__recordAuthorizer mesh__D002095 PLS
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002095 1995
% 216.64/216.85  |- skos__hiddenLabel mesh__D002095 Byssinoses
% 216.64/216.85  |- mesh__dateRevised mesh__D002095 1993-03-03
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002095 2005
% 216.64/216.85  |- mesh__recordOriginator mesh__D002095 NLM
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002095 2002
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002095 1998
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002095 2006
% 216.64/216.85  |- mesh__dateCreated mesh__D002095 1999-01-01
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002095 1999
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D002095 2003
% 216.64/216.85  |- mesh__recordOriginator mesh__D010527 NLM
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D010527 2004
% 216.64/216.85  |- mesh__recordMaintainer mesh__D010527 ags
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D010527 2006
% 216.64/216.85  |- skos__scopeNote mesh__D010527
% 216.64/216.85       An order of ungulates having an odd number of toes, including the horse, tapir, and rhinoceros. %28%Dorland, 27th ed%29%%A%    
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D010527 2005
% 216.64/216.85  |- skos__broader mesh__D010527smesh__D008322
% 216.64/216.85  |- skos__hiddenLabel mesh__D010527 Perissodactylas
% 216.64/216.85  |- rdf__type mesh__D010527sskos__Concept
% 216.64/216.85  |- skos__prefLabel mesh__D010527 Perissodactyla
% 216.64/216.85  |- skos__annotation mesh__D010527
% 216.64/216.85       includes EQUIDAE %28%HORSES, asses, donkeys, mules, zebras%29%, tapirs, rhinoceroses; IM; qualif permitted%A%  
% 216.64/216.85  |- mesh__dateCreated mesh__D010527 1999-01-01
% 216.64/216.85  |- mesh__recordAuthorizer mesh__D010527 sjn
% 216.64/216.85  |- mesh__dateRevised mesh__D010527 2003-07-09
% 216.64/216.85  |- skos__prefLabel mesh__D015212 Inflammatory Bowel Diseases
% 216.64/216.85  |- mesh__dateCreated mesh__D015212 1988-05-04
% 216.64/216.85  |- mesh__recordMaintainer mesh__D015212 lkt
% 216.64/216.85  |- skos__scopeNote mesh__D015212
% 216.64/216.85       Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.%A%    
% 216.64/216.85  |- mesh__activeMeSHYear mesh__D015212 2005
% 216.64/216.85  |- skos__hiddenLabel mesh__D015212 Inflammatory Bowel Disease
% 216.64/216.85  |- skos__historyNote mesh__D015212 Crohn Disease %28%1980-1988%29%
% 216.64/216.85  |- mesh__recordAuthorizer mesh__D015212 sjn
% 216.64/216.85  |- mesh__publicMeSHNote mesh__D015212 89   
% 216.64/216.85  |- mesh__historyNote mesh__D015212 89   
% 216.64/216.85  |- rdf__type mesh__D015212sskos__Concept
% 216.64/216.85  |- skos__broader mesh__D015212smesh__D005759
% 216.64/216.85  |- skos__broader mesh__D015212smesh__D007410
% 216.64/216.85  |- skos__historyNote mesh__D015212 Colitis, Ulcerative %28%1966-1988%29%
% 216.64/216.85  |- skos__altLabel mesh__D015212 Bowel Diseases, Inflammatory
% 216.64/216.86  |- mesh__dateRevised mesh__D015212 2003-07-09
% 216.64/216.86  |- mesh__dateEstablished mesh__D015212 1989-01-01
% 216.64/216.86  |- mesh__recordOriginator mesh__D015212 EC
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D015212 2004
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D015212 2006
% 216.64/216.86  |- skos__broader mesh__D020955smesh__D019578
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D020955 2004
% 216.64/216.86  |- skos__altLabel mesh__D020955 Striatonigral Atrophy
% 216.64/216.86  |- skos__prefLabel mesh__D020955 Striatonigral Degeneration
% 216.64/216.86  |- skos__scopeNote mesh__D020955
% 216.64/216.86       A sporadic neurodegenerative disease with onset in middle-age characterized clinically by Parkinsonian features %28%e.g., MUSCLE RIGIDITY; HYPOKINESIA; stooped posture%29% and HYPOTENSION. This condition is considered a clinical variant of MULTIPLE SYSTEM ATROPHY. Pathologic features include a prominent loss of neurons in the zona compacta of the SUBSTANTIA NIGRA and PUTAMEN. %28%From Adams et al., Principles of Neurology, 6th ed, p1075-6%29%%A%    
% 216.64/216.86  |- skos__hiddenLabel mesh__D020955 Striatonigral Degenerations
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D020955 2001
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D020955 2003
% 216.64/216.86  |- mesh__publicMeSHNote mesh__D020955
% 216.64/216.86       2000; see MULTIPLE SYSTEM ATROPHY 1998-1999   
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D020955 2000
% 216.64/216.86  |- skos__related mesh__D020955smesh__D020734
% 216.64/216.86  |- mesh__historyNote mesh__D020955
% 216.64/216.86       2000; use MULTIPLE SYSTEM ATROPHY 1998-1999   
% 216.64/216.86  |- rdf__type mesh__D020955sskos__Concept
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D020955 2006
% 216.64/216.86  |- skos__hiddenLabel mesh__D020955 Degeneration, Striatonigral
% 216.64/216.86  |- skos__hiddenLabel mesh__D020955 Atrophies, Striatonigral
% 216.64/216.86  |- mesh__dateEstablished mesh__D020955 2000-01-01
% 216.64/216.86  |- skos__historyNote mesh__D020955 Substantia Nigra %28%1970-1999%29%
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D020955 2005
% 216.64/216.86  |- skos__historyNote mesh__D020955
% 216.64/216.86       Multiple System Atrophy %28%1998-1999%29%
% 216.64/216.86  |- skos__hiddenLabel mesh__D020955 Atrophy, Striatonigral
% 216.64/216.86  |- skos__hiddenLabel mesh__D020955 Striatonigral Atrophies
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D020955 2002
% 216.64/216.86  |- skos__historyNote mesh__D020955 Parkinson Disease %28%1970-1993%29%
% 216.64/216.86  |- mesh__dateCreated mesh__D020955 1999-11-04
% 216.64/216.86  |- mesh__recordMaintainer mesh__D006486 TGC
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D006486 1997
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D006486 2003
% 216.64/216.86  |- skos__annotation mesh__D006486
% 216.64/216.86       a form of tissue iron accumulation in total body iron overload%A%  
% 216.64/216.86  |- skos__scopeNote mesh__D006486
% 216.64/216.86       Conditions in which there is a generalized increase in the iron stores of body tissues, particularly of liver and the reticuloendothelial system, without demonstrable tissue damage. The name refers to the presence of stainable iron in the tissue in the form of hemosiderin.%A%    
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D006486 2004
% 216.64/216.86  |- mesh__dateCreated mesh__D006486 1999-01-01
% 216.64/216.86  |- skos__hiddenLabel mesh__D006486 Hemosideroses
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D006486 2002
% 216.64/216.86  |- mesh__recordOriginator mesh__D006486 NLM
% 216.64/216.86  |- skos__broader mesh__D006486smesh__D019190
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D006486 1998
% 216.64/216.86  |- mesh__dateRevised mesh__D006486 1996-02-12
% 216.64/216.86  |- rdf__type mesh__D006486sskos__Concept
% 216.64/216.86  |- mesh__recordAuthorizer mesh__D006486 PLS
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D006486 1999
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D006486 2005
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D006486 2000
% 216.64/216.86  |- skos__prefLabel mesh__D006486 Hemosiderosis
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D006486 2006
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D006486 2001
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D020157 2006
% 216.64/216.86  |- skos__scopeNote mesh__D020157
% 216.64/216.86       Disorders characterized by defective transport of amino acids across cell membranes. These include deficits in transport across brush-border epithelial cell membranes of the small intestine %28%MICROVILLI%29% and KIDNEY TUBULES; transport across the basolateral membrane; and transport across the membranes of intracellular organelles. %28%From Nippon Rinsho 1992 Jul;50%28%7%29%:1587-92%29%%A%    
% 216.64/216.86  |- mesh__dateEstablished mesh__D020157 2000-01-01
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D020157 2005
% 216.64/216.86  |- skos__historyNote mesh__D020157
% 216.64/216.86       Brain Diseases, Metabolic %28%1977-1999%29%
% 216.64/216.86  |- skos__historyNote mesh__D020157 Brain Diseases %28%1966-1976%29%
% 216.64/216.86  |- mesh__publicMeSHNote mesh__D020157 2000   
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D020157 2002
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D020157 2004
% 216.64/216.86  |- mesh__dateRevised mesh__D020157 2001-07-25
% 216.64/216.86  |- skos__prefLabel mesh__D020157 Amino Acid Transport Disorders, Inborn
% 216.64/216.86  |- mesh__recordAuthorizer mesh__D020157 sjn
% 216.64/216.86  |- mesh__recordMaintainer mesh__D020157 nns
% 216.64/216.86  |- skos__altLabel mesh__D020157 Transport Disorders, Amino Acid, Inborn
% 216.64/216.86  |- skos__annotation mesh__D020157 DF: AA TRANSPORT DIS INBORN   
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D020157 2003
% 216.64/216.86  |- mesh__recordOriginator mesh__D020157 KEV
% 216.64/216.86  |- rdf__type mesh__D020157sskos__Concept
% 216.64/216.86  |- mesh__dateCreated mesh__D020157 1999-11-08
% 216.64/216.86  |- skos__altLabel mesh__D020157 Inborn Transport Disorders, Amino Acid
% 216.64/216.86  |- skos__broader mesh__D020157smesh__D008661
% 216.64/216.86  |- skos__altLabel mesh__D020157 Inherited Amino Acid Transport Disorders
% 216.64/216.86  |- mesh__historyNote mesh__D020157 2000   
% 216.64/216.86  |- mesh__dateCreated mesh__D014918 1999-01-01
% 216.64/216.86  |- skos__broader mesh__D014918smesh__D007603
% 216.64/216.86  |- mesh__recordOriginator mesh__D014918 NLM
% 216.64/216.86  |- rdf__type mesh__D014918sskos__Concept
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D014918 2005
% 216.64/216.86  |- skos__hiddenLabel mesh__D014918 Inheritances
% 216.64/216.86  |- skos__scopeNote mesh__D014918
% 216.64/216.86       Legal documents that are declarations of individuals%27% wishes regarding the disposal of their property or estate after death; esp: written instruments, legally executed, by which dispositions are made of estates. LIVING WILLS are written declarations regarding prolongation of life by extraordinary means.%A%    
% 216.64/216.86  |- mesh__dateRevised mesh__D014918 2002-07-03
% 216.64/216.86  |- mesh__recordAuthorizer mesh__D014918 sjn
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D014918 2003
% 216.64/216.86  |- mesh__recordMaintainer mesh__D014918 nns
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D014918 2006
% 216.64/216.86  |- skos__annotation mesh__D014918
% 216.64/216.86       do not confuse X ref INHERITANCE with HEREDITY   
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D014918 2004
% 216.64/216.86  |- skos__prefLabel mesh__D014918 Wills
% 216.64/216.86  |- mesh__dateEstablished mesh__D019603 1998-01-01
% 216.64/216.86  |- mesh__recordOriginator mesh__D019603 AGS
% 216.64/216.86  |- mesh__recordMaintainer mesh__D019603 SYSTEM
% 216.64/216.86  |- rdf__type mesh__D019603sskos__Concept
% 216.64/216.86  |- mesh__dateRevised mesh__D019603 2005-06-30
% 216.64/216.86  |- skos__prefLabel mesh__D019603 Thermoplasmales
% 216.64/216.86  |- skos__scopeNote mesh__D019603
% 216.64/216.86       An order of aerobic, thermophilic archaea, in the kingdom EURYARCHAEOTA, characterized by the absence of a cell wall. Two genera have been described: THERMOPLASMA and Picrophilus.%A%    
% 216.64/216.86  |- mesh__dateCreated mesh__D019603 1997-06-20
% 216.64/216.86  |- mesh__publicMeSHNote mesh__D019603 98   
% 216.64/216.86  |- skos__annotation mesh__D019603
% 216.64/216.86       an order of the kingdom of Euryarchaeota, of the domain of Archaea%A%  
% 216.64/216.86  |- skos__altLabel mesh__D019603 Thermoplasmatales
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D019603 2006
% 216.64/216.86  |- skos__broader mesh__D019603smesh__D019605
% 216.64/216.86  |- mesh__historyNote mesh__D019603 98   
% 216.64/216.86  |- mesh__recordAuthorizer mesh__D019603 sjn
% 216.64/216.86  |- mesh__dateRevised mesh__D011620 2005-06-30
% 216.64/216.86  |- skos__prefLabel mesh__D011620 Psyllium
% 216.64/216.86  |- mesh__recordAuthorizer mesh__D011620 sjn
% 216.64/216.86  |- mesh__historyNote mesh__D011620 was in Cat B %26% D 1963-77   
% 216.64/216.86  |- rdf__type mesh__D011620sskos__Concept
% 216.64/216.86  |- skos__broader mesh__D011620smesh__D010936
% 216.64/216.86  |- skos__hiddenLabel mesh__D011620 Seed, Plantago
% 216.64/216.86  |- skos__hiddenLabel mesh__D011620 Gum, Ispaghule
% 216.64/216.86  |- mesh__recordMaintainer mesh__D011620 ssb
% 216.64/216.86  |- skos__annotation mesh__D011620 drug only; plant source is PLANTAGO   
% 216.64/216.86  |- mesh__dateCreated mesh__D011620 1999-01-01
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D011620 2006
% 216.64/216.86  |- skos__scopeNote mesh__D011620
% 216.64/216.86       Dried, ripe seeds of Plantago psyllium, P. indica, and P. ovata %28%Plantaginaceae%29%. Plantain seeds swell in water and are used as demulcents and bulk laxatives.%A%    
% 216.64/216.86  |- mesh__recordOriginator mesh__D011620 NLM
% 216.64/216.86  |- mesh__recordOriginator mesh__D052239 DRC
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D052239 2006
% 216.64/216.86  |- mesh__dateCreated mesh__D052239 2005-06-30
% 216.64/216.86  |- mesh__dateEstablished mesh__D052239 2006-01-01
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D052239 2006A
% 216.64/216.86  |- mesh__publicMeSHNote mesh__D052239
% 216.64/216.86       2006; FANCONI ANEMIA COMPLEMENTATION GROUP E PROTEIN was indexed under NUCLEAR PROTEINS 2000-2005%A%  
% 216.64/216.86  |- skos__altLabel mesh__D052239
% 216.64/216.86       Fanconi Anemia Group E Complementing Protein
% 216.64/216.86  |- rdf__type mesh__D052239sskos__Concept
% 216.64/216.86  |- skos__broader mesh__D052239smesh__D009687
% 216.64/216.86  |- mesh__historyNote mesh__D052239 2006%28%2000%29%   
% 216.64/216.86  |- skos__altLabel mesh__D052239 Fanconi Anemia Group E Protein
% 216.64/216.86  |- skos__scopeNote mesh__D052239
% 216.64/216.86       A Fanconi anemia complementation group protein that interacts with FANCC PROTEIN and FANCD2 PROTEIN. It promotes the accumulation of FANCC protein in the CELL NUCLEUS.%A%    
% 216.64/216.86  |- mesh__recordAuthorizer mesh__D052239 ags
% 216.64/216.86  |- skos__broader mesh__D052239smesh__D051856
% 216.64/216.86  |- skos__altLabel mesh__D052239 FANCE Protein
% 216.64/216.86  |- mesh__dateRevised mesh__D052239 2005-07-21
% 216.64/216.86  |- mesh__recordMaintainer mesh__D052239 ags
% 216.64/216.86  |- skos__prefLabel mesh__D052239
% 216.64/216.86       Fanconi Anemia Complementation Group E Protein
% 216.64/216.86  |- skos__scopeNote mesh__D049290
% 216.64/216.86       A form of GM2 gangliosidosis resulting from a lack of G%28%M2%29% ACTIVATOR PROTEIN function, usually due to genetic mutations. The AB variant designation refers to the elevated levels of HEXOSAMINIDASE A and HEXOSAMINIDASE B proteins that occur in tissues that lack of G%28%M2%29% ACTIVATOR PROTEIN.%A%    
% 216.64/216.86  |- skos__altLabel mesh__D049290 AB Variant Gangliosidosis GM2
% 216.64/216.86  |- skos__related mesh__D049290smesh__D049289
% 216.64/216.86  |- mesh__historyNote mesh__D049290
% 216.64/216.86       2005%28%2000%29%; use GANGLIOSIDOSES GM2 2000-2004   
% 216.64/216.86  |- rdf__type mesh__D049290sskos__Concept
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D049290 2006
% 216.64/216.86  |- skos__historyNote mesh__D049290 Gangliosidoses %28%2000-2004%29%
% 216.64/216.86  |- skos__altLabel mesh__D049290 Deficiency Disease, GM2 Protein Activator
% 216.64/216.86  |- skos__altLabel mesh__D049290 GM2 Protein Activator Deficiency Disease
% 216.64/216.86  |- skos__prefLabel mesh__D049290 Tay-Sachs Disease, AB Variant
% 216.64/216.86  |- mesh__recordAuthorizer mesh__D049290 sjn
% 216.64/216.86  |- skos__altLabel mesh__D049290 Gangliosidosis GM2, AB Variant
% 216.64/216.86  |- mesh__dateEstablished mesh__D049290 2005-01-01
% 216.64/216.86  |- mesh__recordOriginator mesh__D049290 jmp
% 216.64/216.86  |- mesh__recordMaintainer mesh__D049290 jmp
% 216.64/216.86  |- skos__altLabel mesh__D049290 Gangliosidosis GM2, Type AB
% 216.64/216.86  |- mesh__dateCreated mesh__D049290 2004-07-07
% 216.64/216.86  |- mesh__publicMeSHNote mesh__D049290
% 216.64/216.86       2005; see GANGLIOSIDOSES GM2 2000-2004   
% 216.64/216.86  |- skos__broader mesh__D049290smesh__D020143
% 216.64/216.86  |- skos__altLabel mesh__D049290 GM2 Activator Deficiency Disease
% 216.64/216.86  |- skos__hiddenLabel mesh__D049290 Tay Sachs Disease, AB Variant
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D049290 2005
% 216.64/216.86  |- skos__altLabel mesh__D049290
% 216.64/216.86       Hexosaminidase Activator Protein Deficiency Disease
% 216.64/216.86  |- mesh__dateEstablished mesh__D002894 1987-01-01
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D002894 2005
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D002894 2006
% 216.64/216.86  |- skos__altLabel mesh__D002894 Chromosome 4
% 216.64/216.86  |- mesh__dateCreated mesh__D002894 1986-06-19
% 216.64/216.86  |- skos__broader mesh__D002894smesh__D002905
% 216.64/216.86  |- skos__prefLabel mesh__D002894 Chromosomes, Human, Pair 4
% 216.64/216.86  |- mesh__recordMaintainer mesh__D002894 ags
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D002894 2006A
% 216.64/216.86  |- mesh__dateRevised mesh__D002894 2005-07-11
% 216.64/216.86  |- skos__scopeNote mesh__D002894
% 216.64/216.86       A specific pair of GROUP B CHROMOSOMES of the human chromosome classification.%A%    
% 216.64/216.86  |- mesh__recordAuthorizer mesh__D002894 ags
% 216.64/216.86  |- mesh__publicMeSHNote mesh__D002894 87   
% 216.64/216.86  |- skos__historyNote mesh__D002894
% 216.64/216.86       Chromosomes, Human, 4-5 %28%1968-1986%29%
% 216.64/216.86  |- mesh__historyNote mesh__D002894 87   
% 216.64/216.86  |- mesh__recordOriginator mesh__D002894 SCD
% 216.64/216.86  |- rdf__type mesh__D002894sskos__Concept
% 216.64/216.86  |- mesh__recordMaintainer mesh__D002096 jmp
% 216.64/216.86  |- mesh__publicMeSHNote mesh__D002096 84; was see under PEPTIDES 1977-83   
% 216.64/216.86  |- mesh__recordOriginator mesh__D002096 RLS
% 216.64/216.86  |- skos__scopeNote mesh__D002096
% 216.64/216.86       A 31-amino acid peptide which connects the A and B chains of proinsulin. The exact composition of the peptide is species dependent. In beta cells proinsulin is enzymatically converted to insulin with the liberation of the C-peptide. An immunoassay has been developed for assessing pancreatic beta cell secretory function in diabetic patients in whom circulating insulin antibodies and exogenous insulin interfere with insulin immunoassay.%A%    
% 216.64/216.86  |- skos__broader mesh__D002096smesh__D011384
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D002096 2005
% 216.64/216.86  |- skos__annotation mesh__D002096
% 216.64/216.86       from proinsulin only: not for peptide fragments from other proteins %28% = PEPTIDE FRAGMENTS%29%%A%  
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D002096 2006
% 216.64/216.86  |- mesh__dateRevised mesh__D002096 2003-07-09
% 216.64/216.86  |- skos__historyNote mesh__D002096 Proinsulin %28%1975-1976%29%
% 216.64/216.86  |- mesh__recordAuthorizer mesh__D002096 sjn
% 216.64/216.86  |- skos__prefLabel mesh__D002096 C-Peptide
% 216.64/216.86  |- mesh__dateEstablished mesh__D002096 1984-01-01
% 216.64/216.86  |- skos__historyNote mesh__D002096 Peptides %28%1973-1976%29%
% 216.64/216.86  |- mesh__historyNote mesh__D002096
% 216.64/216.86       84%28%77%29%; was see under PEPTIDES 1977-83   
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D002096 2004
% 216.64/216.86  |- skos__altLabel mesh__D002096 Connecting Peptide
% 216.64/216.86  |- mesh__dateCreated mesh__D002096 1976-04-16
% 216.64/216.86  |- rdf__type mesh__D002096sskos__Concept
% 216.64/216.86  |- skos__hiddenLabel mesh__D002096 C Peptide
% 216.64/216.86  |- skos__hiddenLabel mesh__D002096 Peptide, Connecting
% 216.64/216.86  |- mesh__dateCreated mesh__D043702 2003-07-09
% 216.64/216.86  |- skos__hiddenLabel mesh__D043702 Processes, Musculoskeletal Physiologic
% 216.64/216.86  |- skos__hiddenLabel mesh__D043702 Processes, Musculoskeletal Physiological
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D043702 2006
% 216.64/216.86  |- skos__scopeNote mesh__D043702
% 216.64/216.86       Biological actions and events that support the functions of the MUSCULOSKELETAL SYSTEM.%A%    
% 216.64/216.86  |- skos__hiddenLabel mesh__D043702 Physiologic Process, Musculoskeletal
% 216.64/216.86  |- rdf__type mesh__D043702sskos__Concept
% 216.64/216.86  |- mesh__dateEstablished mesh__D043702 2004-01-01
% 216.64/216.86  |- skos__annotation mesh__D043702 not used for indexing or cataloging   
% 216.64/216.86  |- mesh__publicMeSHNote mesh__D043702 2004   
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D043702 2005
% 216.64/216.86  |- skos__hiddenLabel mesh__D043702 Physiologic Processes, Musculoskeletal
% 216.64/216.86  |- skos__hiddenLabel mesh__D043702 Process, Musculoskeletal Physiologic
% 216.64/216.86  |- skos__altLabel mesh__D043702 Musculoskeletal Physiological Processes
% 216.64/216.86  |- skos__altLabel mesh__D043702 Musculoskeletal Physiological Process
% 216.64/216.86  |- skos__hiddenLabel mesh__D043702 Physiological Processes, Musculoskeletal
% 216.64/216.86  |- skos__altLabel mesh__D043702 Musculoskeletal Physiologic Process
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D043702 2004
% 216.64/216.86  |- skos__hiddenLabel mesh__D043702 Process, Musculoskeletal Physiological
% 216.64/216.86  |- mesh__historyNote mesh__D043702 2004   
% 216.64/216.86  |- skos__hiddenLabel mesh__D043702 Physiological Process, Musculoskeletal
% 216.64/216.86  |- skos__prefLabel mesh__D043702 Musculoskeletal Physiologic Processes
% 216.64/216.86  |- skos__broader mesh__D043702smesh__D009142
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D010528 2000
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D010528 2006
% 216.64/216.86  |- mesh__dateEstablished mesh__D010528 1991-01-01
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D010528 2003
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D010528 1994
% 216.64/216.86  |- mesh__dateRevised mesh__D010528 1992-05-15
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D010528 2005
% 216.64/216.86  |- mesh__recordOriginator mesh__D010528 NLM
% 216.64/216.86  |- mesh__historyNote mesh__D010528
% 216.64/216.86       91%28%75%29%; was see under GASTROINTESTINAL MOTILITY 1975-90   
% 216.64/216.86  |- skos__hiddenLabel mesh__D010528 Peristalses
% 216.64/216.86  |- rdf__type mesh__D010528sskos__Concept
% 216.64/216.86  |- skos__annotation mesh__D010528
% 216.64/216.86       restrict to digestive system, not other organs; esophageal peristalsis = ESOPHAGUS /physiol %28%IM%29% + PERISTALSIS %28%NIM%29%%A%  
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D010528 1997
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D010528 2002
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D010528 1999
% 216.64/216.86  |- mesh__onlineNote mesh__D010528
% 216.64/216.86       search GASTROINTESTINAL MOTILITY 1967-74   
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D010528 1996
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D010528 2001
% 216.64/216.86  |- mesh__dateCreated mesh__D010528 1999-01-01
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D010528 1998
% 216.64/216.86  |- skos__broader mesh__D010528smesh__D005769
% 216.64/216.86  |- skos__prefLabel mesh__D010528 Peristalsis
% 216.64/216.86  |- mesh__recordMaintainer mesh__D010528 TAP
% 216.64/216.86  |- mesh__recordAuthorizer mesh__D010528 PLS
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D010528 1993
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D010528 2004
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D010528 1995
% 216.64/216.86  |- mesh__publicMeSHNote mesh__D010528
% 216.64/216.86       91; was see under GASTROINTESTINAL MOTILITY 1975-90   
% 216.64/216.86  |- rdf__type mesh__D015213sskos__Concept
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D015213 2002
% 216.64/216.86  |- skos__hiddenLabel mesh__D015213 Mechanism, Neuroimmune
% 216.64/216.86  |- mesh__dateRevised mesh__D015213 1998-06-10
% 216.64/216.86  |- skos__altLabel mesh__D015213 Neuroimmune Process
% 216.64/216.86  |- skos__historyNote mesh__D015213 Immunity or specific %28%1982-1988%29%
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D015213 2001
% 216.64/216.86  |- mesh__dateEstablished mesh__D015213 1989-01-01
% 216.64/216.86  |- skos__scopeNote mesh__D015213
% 216.64/216.86       Influences of the nervous system %28%brain, spinal cord, autonomic and peripheral nervous systems%29% upon the immune system, principally by biochemical %28%i.e., neurotransmitters, receptors, etc.%29% and by direct neural routes. This is a two-way information transfer system.%A%    
% 216.64/216.86  |- skos__historyNote mesh__D015213 Neurosecretory Systems %28%1987-1988%29%
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D015213 2004
% 216.64/216.86  |- skos__altLabel mesh__D015213 Neuroimmune Mechanisms
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D015213 2006
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D015213 2000
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D015213 1999
% 216.64/216.86  |- mesh__recordOriginator mesh__D015213 SCD
% 216.64/216.86  |- skos__related mesh__D015213smesh__D020078
% 216.64/216.86  |- skos__hiddenLabel mesh__D015213 Mechanisms, Neuroimmune
% 216.64/216.86  |- skos__broader mesh__D015213smesh__D009424
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D015213 2003
% 216.64/216.86  |- skos__broader mesh__D015213smesh__D007109
% 216.64/216.86  |- skos__historyNote mesh__D015213
% 216.64/216.86       Immune System or specific %28%1982-1988%29%
% 216.64/216.86  |- mesh__dateCreated mesh__D015213 1988-05-04
% 216.64/216.86  |- skos__hiddenLabel mesh__D015213 Process, Neuroimmune
% 216.64/216.86  |- skos__altLabel mesh__D015213 Neuroimmune Processes
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D015213 2005
% 216.64/216.86  |- skos__prefLabel mesh__D015213 Neuroimmunomodulation
% 216.64/216.86  |- mesh__recordAuthorizer mesh__D015213 SJN
% 216.64/216.86  |- mesh__historyNote mesh__D015213 89   
% 216.64/216.86  |- skos__hiddenLabel mesh__D015213 Neuroimmune Mechanism
% 216.64/216.86  |- mesh__publicMeSHNote mesh__D015213 89   
% 216.64/216.86  |- skos__historyNote mesh__D015213
% 216.64/216.86       Neuroregulators or specific %28%1983-1988%29%
% 216.64/216.86  |- skos__annotation mesh__D015213
% 216.64/216.86       eff of nervous system on immune system; DF: NEUROIMMUNOMOD%A%  
% 216.64/216.86  |- mesh__recordMaintainer mesh__D015213 NDW
% 216.64/216.86  |- skos__altLabel mesh__D039661 GPIIIa
% 216.64/216.86  |- skos__hiddenLabel mesh__D039661 Integrin, beta3C
% 216.64/216.86  |- skos__related mesh__D039661smesh__D039302
% 216.64/216.86  |- mesh__historyNote mesh__D039661
% 216.64/216.86       2003; use INTEGRIN BETA3 %28%NM%29% 1989-2002; for PLATELET MEMBRANE GLYCPROTEIN IIIA use PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX 1996-2002%A%  
% 216.64/216.86  |- skos__historyNote mesh__D039661
% 216.64/216.86       Receptors, Endogenous Substances %28%1989%29%
% 216.64/216.86  |- skos__hiddenLabel mesh__D039661 Glycoprotein IIIa, Platelet
% 216.64/216.86  |- skos__altLabel mesh__D039661 beta3A Integrin
% 216.64/216.86  |- skos__hiddenLabel mesh__D039661 Integrin, beta3B
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D039661 2006
% 216.64/216.86  |- skos__altLabel mesh__D039661 beta%28%3%29% Integrin
% 216.64/216.86  |- skos__broader mesh__D039661smesh__D039641
% 216.64/216.86  |- skos__altLabel mesh__D039661 CD61 Antigens
% 216.64/216.86  |- mesh__dateCreated mesh__D039661 2002-07-02
% 216.64/216.86  |- mesh__recordAuthorizer mesh__D039661 sjn
% 216.64/216.86  |- skos__scopeNote mesh__D039661
% 216.64/216.86       An integrin beta subunit of approximately 85-kDa in size which has been found in INTEGRIN ALPHAIIB-containing and INTEGRIN ALPHAV-containing heterodimers. Integrin beta3 occurs as three alternatively spliced isoforms, designated beta3A-C.%A%    
% 216.64/216.86  |- skos__altLabel mesh__D039661 beta3C Integrin
% 216.64/216.86  |- skos__historyNote mesh__D039661
% 216.64/216.86       Platelet Membrane Glycoproteins %28%1987-2002%29%
% 216.64/216.86  |- mesh__dateRevised mesh__D039661 2005-06-30
% 216.64/216.86  |- skos__altLabel mesh__D039661 beta3B Integrin
% 216.64/216.86  |- mesh__recordMaintainer mesh__D039661 ssb
% 216.64/216.86  |- skos__related mesh__D039661smesh__D019039
% 216.64/216.86  |- skos__altLabel mesh__D039661 beta3 Integrin
% 216.64/216.86  |- mesh__recordOriginator mesh__D039661 MDJ
% 216.64/216.86  |- skos__historyNote mesh__D039661 Integrins %28%1990-2002%29%
% 216.64/216.86  |- skos__altLabel mesh__D039661 Platelet Membrane Glycoprotein IIIa
% 216.64/216.86  |- skos__altLabel mesh__D039661 Platelet GPIIIa
% 216.64/216.86  |- mesh__dateEstablished mesh__D039661 2003-01-01
% 216.64/216.86  |- mesh__publicMeSHNote mesh__D039661
% 216.64/216.86       2003; INTEGRIN BETA3 was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1989, INTEGRINS 1990-1995, PLATELET MEMBRANE GLYCOPROTEINS %26% ANTIGENS, CD 1996-2002; for PLATELET MEMBRANE GLYCPROTEIN IIIA see PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX 1996-2002%A%  
% 216.64/216.86  |- skos__altLabel mesh__D039661 CD61 Antigen
% 216.64/216.86  |- skos__hiddenLabel mesh__D039661 Integrin, beta3
% 216.64/216.86  |- skos__hiddenLabel mesh__D039661 Integrin, beta3A
% 216.64/216.86  |- skos__prefLabel mesh__D039661 Integrin beta3
% 216.64/216.86  |- rdf__type mesh__D039661sskos__Concept
% 216.64/216.86  |- skos__broader mesh__D039661smesh__D015703
% 216.64/216.86  |- skos__altLabel mesh__D039661 Platelet Glycoprotein IIIa
% 216.64/216.86  |- skos__historyNote mesh__D039661 Antigens, CD %28%1996-2002%29%
% 216.64/216.86  |- skos__hiddenLabel mesh__D039661 beta3, Integrin
% 216.64/216.86  |- skos__altLabel mesh__D039661 Antigens, CD61
% 216.64/216.86  |- skos__hiddenLabel mesh__D039661 Antigen, CD61
% 216.64/216.86  |- skos__hiddenLabel mesh__D006487 Hemostases
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D006487 2004
% 216.64/216.86  |- mesh__dateCreated mesh__D006487 1999-01-01
% 216.64/216.86  |- mesh__historyNote mesh__D006487 was in Cat E only 1963-75   
% 216.64/216.86  |- mesh__dateRevised mesh__D006487 2003-07-09
% 216.64/216.86  |- mesh__recordMaintainer mesh__D006487 nns
% 216.64/216.86  |- skos__annotation mesh__D006487
% 216.64/216.86       note Cat G, a physiol process; differentiate from HEMOSTATIC TECHNIQUES and specifics, Cat E; coord HEMOSTASIS in diseases with disease /blood, not /physiopathol%A%  
% 216.64/216.86  |- rdf__type mesh__D006487sskos__Concept
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D006487 2005
% 216.64/216.86  |- mesh__recordOriginator mesh__D006487 NLM
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D006487 2006
% 216.64/216.86  |- skos__prefLabel mesh__D006487 Hemostasis
% 216.64/216.86  |- skos__scopeNote mesh__D006487
% 216.64/216.86       The process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements %28%eg. ERYTHROCYTE AGGREGATION%29%, and the process of BLOOD COAGULATION.%A%    
% 216.64/216.86  |- skos__broader mesh__D006487smesh__D045123
% 216.64/216.86  |- mesh__recordAuthorizer mesh__D006487 sjn
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D020158 2006
% 216.64/216.86  |- skos__altLabel mesh__D020158 Type III Nonketotic Hyperglycinemia
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D020158 2003
% 216.64/216.86  |- mesh__recordOriginator mesh__D020158 KEV
% 216.64/216.86  |- skos__altLabel mesh__D020158 Nonketotic Hyperglycinemia, Type I
% 216.64/216.86  |- skos__altLabel mesh__D020158 Type I Nonketotic Hyperglycinemia
% 216.64/216.86  |- skos__altLabel mesh__D020158 Nonketotic Hyperglycinemia, Type III
% 216.64/216.86  |- skos__prefLabel mesh__D020158 Hyperglycinemia, Nonketotic
% 216.64/216.86  |- mesh__publicMeSHNote mesh__D020158 2000   
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D020158 2002
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D020158 2004
% 216.64/216.86  |- skos__broader mesh__D020158smesh__D000592
% 216.64/216.86  |- mesh__dateRevised mesh__D020158 2001-07-25
% 216.64/216.86  |- mesh__dateCreated mesh__D020158 1999-11-03
% 216.64/216.86  |- skos__scopeNote mesh__D020158
% 216.64/216.86       An autosomal recessive metabolic disorder caused by deficiencies in the mitochondrial GLYCINE cleavage system; an enzyme system with four components: P-, T-, H-, and L-proteins. Deficiency of the P-protein is the most prevalent form. Neonatal and juvenile presentations have been reported. Neonatal onset is more common and may be fatal. Clinical features include SEIZURES; hypotonia; APNEA; and COMA. When the illness presents in childhood there tends to be an associated progressive DEMENTIA accompanied by extrapyramidal signs. %28%Menkes, Textbook of Child Neurology, 5th ed, p46; Jpn J Hum Genet 1997 Mar;42%28%1%29%:13-22%29%%A%    
% 216.64/216.86  |- mesh__dateEstablished mesh__D020158 2000-01-01
% 216.64/216.86  |- skos__altLabel mesh__D020158 Type II Nonketotic Hyperglycinemia
% 216.64/216.86  |- mesh__historyNote mesh__D020158 2000   
% 216.64/216.86  |- mesh__recordMaintainer mesh__D020158 nns
% 216.64/216.86  |- skos__broader mesh__D020158smesh__D020739
% 216.64/216.86  |- rdf__type mesh__D020158sskos__Concept
% 216.64/216.86  |- skos__altLabel mesh__D020158 Nonketotic Hyperglycinemia
% 216.64/216.86  |- skos__hiddenLabel mesh__D020158 Nonketotic Hyperglycinemias
% 216.64/216.86  |- skos__hiddenLabel mesh__D020158 Hyperglycinemias, Nonketotic
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D020158 2005
% 216.64/216.86  |- mesh__recordAuthorizer mesh__D020158 sjn
% 216.64/216.86  |- skos__historyNote mesh__D020158
% 216.64/216.86       Amino Acid Metabolism, Inborn Errors %28%1966-1998%29%
% 216.64/216.86  |- skos__altLabel mesh__D020158 Nonketotic Hyperglycinemia, Type II
% 216.64/216.86  |- skos__broader mesh__D014919smesh__D000392
% 216.64/216.86  |- mesh__dateCreated mesh__D014919 1999-01-01
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D014919 2001
% 216.64/216.86  |- skos__hiddenLabel mesh__D014919 Winds
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D014919 1997
% 216.64/216.86  |- rdf__type mesh__D014919sskos__Concept
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D014919 1999
% 216.64/216.86  |- mesh__onlineNote mesh__D014919
% 216.64/216.86       search AIR MOVEMENTS 1974 %26% WEATHER 1969-73   
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D014919 2000
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D014919 1996
% 216.64/216.86  |- mesh__dateEstablished mesh__D014919 1991-01-01
% 216.64/216.86  |- mesh__publicMeSHNote mesh__D014919
% 216.64/216.86       91; was see under AIR MOVEMENTS 1974-90; was see under WEATHER 1969-73%A%  
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D014919 1998
% 216.64/216.86  |- mesh__dateRevised mesh__D014919 1991-06-13
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D014919 1993
% 216.64/216.86  |- mesh__historyNote mesh__D014919
% 216.64/216.86       91%28%75%29%; was see under AIR MOVEMENTS 1974-90; was see under WEATHER 1969-73%A%  
% 216.64/216.86  |- mesh__recordOriginator mesh__D014919 NLM
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D014919 1995
% 216.64/216.86  |- skos__broader mesh__D014919smesh__D014887
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D014919 2004
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D014919 1992
% 216.64/216.86  |- skos__annotation mesh__D014919
% 216.64/216.86       no qualif; for cyclones, typhoons %26% hurricanes consider NATURAL DISASTERS%A%  
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D014919 2006
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D014919 1994
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D014919 2003
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D014919 2002
% 216.64/216.86  |- mesh__activeMeSHYear mesh__D014919 2005
% 216.64/216.86  |- skos__prefLabel mesh__D014919 Wind
% 216.64/216.86  |- mesh__recordMaintainer mesh__D014919 TGC
% 216.64/216.86  |- mesh__recordAuthorizer mesh__D014919 PLS
% 216.64/216.86  |- mesh__historyNote mesh__D025641 2002   
% 216.64/216.86  |- skos__scopeNote mesh__D025641
% 216.64/216.86       An icosahedral RNA satellite virus which requires an obligatory Tobacco necrosis virus %28%see NECROVIRUS%29% for its replication.%A%    
% 216.64/216.86  |- skos__altLabel mesh__D025641 Tobacco Necrosis Virus Satellite
% 216.64/216.86  |- mesh__publicMeSHNote mesh__D025641 2002   
% 216.64/216.86  |- mesh__dateEstablished mesh__D025641 2002-01-01
% 216.64/216.86  |- skos__prefLabel mesh__D025641 Tobacco necrosis satellite virus
% 216.64/216.86  |- skos__historyNote mesh__D025641 Plant Viruses %28%1965-2001%29%
% 216.64/216.86  |- skos__broader mesh__D025641smesh__D012526
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D025641 2004
% 216.64/216.87  |- mesh__dateCreated mesh__D025641 2001-07-25
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D025641 2002
% 216.64/216.87  |- skos__altLabel mesh__D025641 Satellite Tobacco Necrosis Virus
% 216.64/216.87  |- skos__historyNote mesh__D025641 Satellite Viruses %28%1968-2001%29%
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D025641 2003
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D025641 2006
% 216.64/216.87  |- rdf__type mesh__D025641sskos__Concept
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D025641 2005
% 216.64/216.87  |- mesh__historyNote mesh__D011621 66   
% 216.64/216.87  |- rdf__type mesh__D011621sskos__Concept
% 216.64/216.87  |- mesh__recordOriginator mesh__D011621 NLM
% 216.64/216.87  |- skos__prefLabel mesh__D011621 Pteridines
% 216.64/216.87  |- mesh__dateEstablished mesh__D011621 1966-01-01
% 216.64/216.87  |- mesh__recordAuthorizer mesh__D011621 sjn
% 216.64/216.87  |- mesh__dateRevised mesh__D011621 2003-07-09
% 216.64/216.87  |- skos__scopeNote mesh__D011621
% 216.64/216.87       Compounds based on pyrazino%5B%2,3-d%5D%pyrimidine which is a pyrimidine fused to a pyrazine, containing four NITROGEN atoms.%A%    
% 216.64/216.87  |- mesh__dateCreated mesh__D011621 1999-01-01
% 216.64/216.87  |- mesh__publicMeSHNote mesh__D011621 66   
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D011621 2006
% 216.64/216.87  |- skos__altLabel mesh__D011621 Pyrazinopyrimidines
% 216.64/216.87  |- mesh__recordMaintainer mesh__D011621 ssb
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D011621 2004
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D011621 2005
% 216.64/216.87  |- skos__broader mesh__D011621smesh__D006574
% 216.64/216.87  |- mesh__publicMeSHNote mesh__D049291 2005   
% 216.64/216.87  |- mesh__historyNote mesh__D049291 2005   
% 216.64/216.87  |- mesh__recordOriginator mesh__D049291 ags
% 216.64/216.87  |- skos__annotation mesh__D049291 non neoplastic   
% 216.64/216.87  |- skos__scopeNote mesh__D049291
% 216.64/216.87       Tumor-like sterile accumulation of serum in a tissue, organ, or cavity. It results from a tissue insult and is the product of tissue inflammation. It most commonly occurs following MASTECTOMY.%A%    
% 216.64/216.87  |- skos__prefLabel mesh__D049291 Seroma
% 216.64/216.87  |- mesh__dateCreated mesh__D049291 2004-07-07
% 216.64/216.87  |- skos__related mesh__D049291smesh__D005122
% 216.64/216.87  |- mesh__recordMaintainer mesh__D049291 ags
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D049291 2005
% 216.64/216.87  |- mesh__recordAuthorizer mesh__D049291 sjn
% 216.64/216.87  |- mesh__dateEstablished mesh__D049291 2005-01-01
% 216.64/216.87  |- skos__broader mesh__D049291smesh__D007249
% 216.64/216.87  |- rdf__type mesh__D049291sskos__Concept
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D049291 2006
% 216.64/216.87  |- skos__hiddenLabel mesh__D049291 Seromas
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D002895 2006
% 216.64/216.87  |- mesh__recordMaintainer mesh__D002895 sjn
% 216.64/216.87  |- skos__prefLabel mesh__D002895 Chromosomes, Human, Pair 5
% 216.64/216.87  |- mesh__dateEstablished mesh__D002895 1987-01-01
% 216.64/216.87  |- skos__broader mesh__D002895smesh__D002905
% 216.64/216.87  |- skos__altLabel mesh__D002895 Chromosome 5
% 216.64/216.87  |- mesh__dateCreated mesh__D002895 1986-06-19
% 216.64/216.87  |- mesh__recordAuthorizer mesh__D002895 sjn
% 216.64/216.87  |- mesh__historyNote mesh__D002895 87   
% 216.64/216.87  |- mesh__recordOriginator mesh__D002895 SCD
% 216.64/216.87  |- rdf__type mesh__D002895sskos__Concept
% 216.64/216.87  |- mesh__dateRevised mesh__D002895 2004-07-13
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D002895 2005
% 216.64/216.87  |- skos__scopeNote mesh__D002895
% 216.64/216.87       One of the two pairs of human chromosomes in the group B class %28%CHROMOSOMES, HUMAN, 4-5%29%.%A%    
% 216.64/216.87  |- mesh__publicMeSHNote mesh__D002895 87   
% 216.64/216.87  |- skos__historyNote mesh__D002895
% 216.64/216.87       Chromosomes, Human, 4-5 %28%1968-1986%29%
% 216.64/216.87  |- rdf__type mesh__D043703sskos__Concept
% 216.64/216.87  |- skos__hiddenLabel mesh__D043703 Phenomena, Musculoskeletal Physiologic
% 216.64/216.87  |- skos__altLabel mesh__D043703 Musculoskeletal Physiological Phenomena
% 216.64/216.87  |- mesh__publicMeSHNote mesh__D043703 2004   
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D043703 2005
% 216.64/216.87  |- skos__broader mesh__D043703smesh__D009142
% 216.64/216.87  |- skos__hiddenLabel mesh__D043703 Physiologic Phenomenon, Musculoskeletal
% 216.64/216.87  |- skos__prefLabel mesh__D043703 Musculoskeletal Physiologic Phenomena
% 216.64/216.87  |- skos__scopeNote mesh__D043703
% 216.64/216.87       Observable or measurable characteristics of the MUSCULOSKELETAL SYSTEM.%A%    
% 216.64/216.87  |- skos__hiddenLabel mesh__D043703 Phenomena, Musculoskeletal Physiological
% 216.64/216.87  |- mesh__dateEstablished mesh__D043703 2004-01-01
% 216.64/216.87  |- skos__hiddenLabel mesh__D043703 Phenomenon, Musculoskeletal Physiologic
% 216.64/216.87  |- skos__annotation mesh__D043703 not used for indexing or cataloging   
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D043703 2004
% 216.64/216.87  |- skos__hiddenLabel mesh__D043703 Physiological Phenomena, Musculoskeletal
% 216.64/216.87  |- skos__altLabel mesh__D043703 Musculoskeletal Physiological Phenomenon
% 216.64/216.87  |- skos__hiddenLabel mesh__D043703 Physiologic Phenomena, Musculoskeletal
% 216.64/216.87  |- skos__altLabel mesh__D043703 Musculoskeletal Physiologic Phenomenon
% 216.64/216.87  |- skos__hiddenLabel mesh__D043703
% 216.64/216.87       Phenomenon, Musculoskeletal Physiological
% 216.64/216.87  |- mesh__dateCreated mesh__D043703 2003-07-09
% 216.64/216.87  |- skos__hiddenLabel mesh__D043703
% 216.64/216.87       Physiological Phenomenon, Musculoskeletal
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D043703 2006
% 216.64/216.87  |- mesh__historyNote mesh__D043703 2004   
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D002097 1998
% 216.64/216.87  |- mesh__recordAuthorizer mesh__D002097 PLS
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D002097 2006
% 216.64/216.87  |- skos__prefLabel mesh__D002097 C-Reactive Protein
% 216.64/216.87  |- skos__broader mesh__D002097smesh__D007162
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D002097 1999
% 216.64/216.87  |- mesh__recordMaintainer mesh__D002097 PLS
% 216.64/216.87  |- skos__annotation mesh__D002097
% 216.64/216.87       an acute phase protein; /drug eff /ultrastruct permitted   
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D002097 2002
% 216.64/216.87  |- mesh__recordOriginator mesh__D002097 NLM
% 216.64/216.87  |- mesh__dateCreated mesh__D002097 1999-01-01
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D002097 1993
% 216.64/216.87  |- skos__hiddenLabel mesh__D002097 Protein, C-Reactive
% 216.64/216.87  |- skos__broader mesh__D002097smesh__D000209
% 216.64/216.87  |- skos__hiddenLabel mesh__D002097 C Reactive Protein
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D002097 2003
% 216.64/216.87  |- mesh__dateRevised mesh__D002097 1992-10-30
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D002097 1996
% 216.64/216.87  |- skos__broader mesh__D002097smesh__D000418
% 216.64/216.87  |- skos__scopeNote mesh__D002097
% 216.64/216.87       A plasma protein that circulates in increased amounts during inflammation and after tissue damage.%A%    
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D002097 2004
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D002097 1997
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D002097 1994
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D002097 2000
% 216.64/216.87  |- rdf__type mesh__D002097sskos__Concept
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D002097 2001
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D002097 1995
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D002097 2005
% 216.64/216.87  |- skos__related mesh__D010529smesh__D001202
% 216.64/216.87  |- skos__prefLabel mesh__D010529 Peritoneal Cavity
% 216.64/216.87  |- rdf__type mesh__D010529sskos__Concept
% 216.64/216.87  |- mesh__dateRevised mesh__D010529 2002-07-02
% 216.64/216.87  |- skos__annotation mesh__D010529
% 216.64/216.87       %22%peritoneal cells%22% = probably PERITONEAL CAVITY /cytol or ASCITIC FLUID /pathol if pertinent; note PERITONEAL FLUID see ASCITIC FLUID; /inj is probably PERITONEUM /inj%A%  
% 216.64/216.87  |- mesh__recordMaintainer mesh__D010529 MXR
% 216.64/216.87  |- skos__broader mesh__D010529smesh__D010537
% 216.64/216.87  |- mesh__dateCreated mesh__D010529 1999-01-01
% 216.64/216.87  |- skos__scopeNote mesh__D010529
% 216.64/216.87       The space enclosed by the peritoneum. It is divided into two portions, the greater sac and the lesser sac or omental bursa, which lies behind the STOMACH. The two sacs are connected by the foramen of Winslow, or epiploic foramen.%A%    
% 216.64/216.87  |- skos__hiddenLabel mesh__D010529 Bursa, Omental
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D010529 2004
% 216.64/216.87  |- skos__hiddenLabel mesh__D010529 Sac, Greater
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D010529 2006
% 216.64/216.87  |- mesh__recordAuthorizer mesh__D010529 sjn
% 216.64/216.87  |- mesh__recordOriginator mesh__D010529 NLM
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D010529 2003
% 216.64/216.87  |- skos__hiddenLabel mesh__D010529 Sac, Lesser
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D010529 2005
% 216.64/216.87  |- skos__altLabel mesh__D010529 Omental Bursa
% 216.64/216.87  |- skos__hiddenLabel mesh__D010529 Cavity, Peritoneal
% 216.64/216.87  |- skos__related mesh__D010529smesh__D010535
% 216.64/216.87  |- mesh__historyNote mesh__D007580 80   
% 216.64/216.87  |- rdf__type mesh__D007580sskos__Concept
% 216.64/216.87  |- skos__hiddenLabel mesh__D007580 Jejunal Cancers
% 216.64/216.87  |- mesh__recordMaintainer mesh__D007580 lkt
% 216.64/216.87  |- mesh__dateEstablished mesh__D007580 1980-01-01
% 216.64/216.87  |- skos__broader mesh__D007580smesh__D007414
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D007580 2004
% 216.64/216.87  |- skos__historyNote mesh__D007580 Jejunum %28%1966-1979%29%
% 216.64/216.87  |- mesh__recordOriginator mesh__D007580 VDK
% 216.64/216.87  |- skos__hiddenLabel mesh__D007580 Cancers, Jejunal
% 216.64/216.87  |- mesh__publicMeSHNote mesh__D007580 80   
% 216.64/216.87  |- skos__annotation mesh__D007580
% 216.64/216.87       coord IM with histol type of neopl %28%IM%29%   
% 216.64/216.87  |- skos__altLabel mesh__D007580 Cancer, Jejunal
% 216.64/216.87  |- skos__hiddenLabel mesh__D007580 Jejunum Cancer
% 216.64/216.87  |- mesh__dateRevised mesh__D007580 2003-07-09
% 216.64/216.87  |- skos__hiddenLabel mesh__D007580 Neoplasms, Jejunal
% 216.64/216.87  |- skos__altLabel mesh__D007580 Jejunal Cancer
% 216.64/216.87  |- mesh__dateCreated mesh__D007580 1979-04-25
% 216.64/216.87  |- skos__broader mesh__D007580smesh__D007579
% 216.64/216.87  |- skos__altLabel mesh__D007580 Cancer of Jejunum
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D007580 2005
% 216.64/216.87  |- mesh__recordAuthorizer mesh__D007580 sjn
% 216.64/216.87  |- skos__historyNote mesh__D007580 Intestinal Neoplasms %28%1966-1979%29%
% 216.64/216.87  |- skos__prefLabel mesh__D007580 Jejunal Neoplasms
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D007580 2006
% 216.64/216.87  |- skos__hiddenLabel mesh__D007580 Jejunal Neoplasm
% 216.64/216.87  |- skos__scopeNote mesh__D007580
% 216.64/216.87       Tumors or cancer in the JEJUNUM region of the small intestine %28%INTESTINE, SMALL%29%.%A%    
% 216.64/216.87  |- skos__hiddenLabel mesh__D007580 Neoplasm, Jejunal
% 216.64/216.87  |- skos__hiddenLabel mesh__D007580 Jejunum Cancers
% 216.64/216.87  |- mesh__historyNote mesh__D015214
% 216.64/216.87       89; LEU ANTIGENS, MYELOMONOCYTIC, LEU-M1 ANTIGENS, LEU-M2 ANTIGENS, %26% LEU-M4 ANTIGENS were see ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94%A%  
% 216.64/216.87  |- skos__prefLabel mesh__D015214 Antigens, Differentiation, Myelomonocytic
% 216.64/216.87  |- skos__broader mesh__D015214smesh__D000943
% 216.64/216.87  |- skos__altLabel mesh__D015214 Antigens, Myelomonocytic, Differentiation
% 216.64/216.87  |- mesh__dateEstablished mesh__D015214 1989-01-01
% 216.64/216.87  |- skos__historyNote mesh__D015214 Antigens, Neoplasm %28%1975-1988%29%
% 216.64/216.87  |- skos__hiddenLabel mesh__D015214 Antigens, Myelomonocytic Differentiation
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D015214 2006
% 216.64/216.87  |- mesh__recordOriginator mesh__D015214 SCD
% 216.64/216.87  |- mesh__onlineNote mesh__D015214
% 216.64/216.87       use ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC to search LEU ANTIGENS, MYELOMONOCYTIC, LEU-M1 ANTIGENS, LEU-M2 ANTIGENS, %26% LEU-M4 ANTIGENS 1989-94%A%  
% 216.64/216.87  |- skos__altLabel mesh__D015214 Myelomonocytic Differentiation Antigens
% 216.64/216.87  |- skos__annotation mesh__D015214
% 216.64/216.87       DF: MM DIFFER ANTIGENS or ANTIGENS DIFFER MM   
% 216.64/216.87  |- mesh__dateCreated mesh__D015214 1988-05-04
% 216.64/216.87  |- skos__historyNote mesh__D015214 Granulocytes %28%1978-1988%29%
% 216.64/216.87  |- mesh__dateRevised mesh__D015214 2005-06-30
% 216.64/216.87  |- mesh__publicMeSHNote mesh__D015214
% 216.64/216.87       89; LEU ANTIGENS, MYELOMONOCYTIC, LEU-M1 ANTIGENS, LEU-M2 ANTIGENS, %26% LEU-M4 ANTIGENS were see ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94%A%  
% 216.64/216.87  |- skos__historyNote mesh__D015214 Antigens, Surface %28%1979-1988%29%
% 216.64/216.87  |- mesh__recordAuthorizer mesh__D015214 sjn
% 216.64/216.87  |- skos__scopeNote mesh__D015214
% 216.64/216.87       Surface antigens expressed on myeloid cells of the granulocyte-monocyte-histiocyte series during differentiation. Analysis of their reactivity in normal and malignant myelomonocytic cells is useful in identifying and classifying human leukemias and lymphomas.%A%    
% 216.64/216.87  |- rdf__type mesh__D015214sskos__Concept
% 216.64/216.87  |- skos__historyNote mesh__D015214 Monocytes %28%1976-1988%29%
% 216.64/216.87  |- skos__altLabel mesh__D015214 Differentiation Antigens, Myelomonocytic
% 216.64/216.87  |- mesh__recordMaintainer mesh__D015214 ssb
% 216.64/216.87  |- mesh__dateEstablished mesh__D020957 2000-01-01
% 216.64/216.87  |- mesh__dateCreated mesh__D020957 1999-11-03
% 216.64/216.87  |- skos__prefLabel mesh__D020957 Nunavut
% 216.64/216.87  |- skos__broader mesh__D020957smesh__D002170
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D020957 2004
% 216.64/216.87  |- skos__scopeNote mesh__D020957
% 216.64/216.87       A self-governing territory formed from the central and eastern portions of the Northwest Territories. It was officially established April 1, 1999. The capital is Iqaluit.%A%    
% 216.64/216.87  |- mesh__recordMaintainer mesh__D020957 sjn
% 216.64/216.87  |- mesh__historyNote mesh__D020957 2000   
% 216.64/216.87  |- mesh__recordAuthorizer mesh__D020957 sjn
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D020957 2006
% 216.64/216.87  |- rdf__type mesh__D020957sskos__Concept
% 216.64/216.87  |- mesh__dateRevised mesh__D020957 2003-07-22
% 216.64/216.87  |- mesh__recordOriginator mesh__D020957 jls
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D020957 2005
% 216.64/216.87  |- skos__prefLabel mesh__D039662 Prokaryotic Initiation Factors
% 216.64/216.87  |- skos__historyNote mesh__D039662 Bacterial Proteins %28%1966-1972%29%
% 216.64/216.87  |- mesh__historyNote mesh__D039662 2003   
% 216.64/216.87  |- mesh__dateCreated mesh__D039662 2002-07-03
% 216.64/216.87  |- skos__annotation mesh__D039662 GEN or unspecified; prefer specifics   
% 216.64/216.87  |- skos__altLabel mesh__D039662 Peptide Initiation Factors, Prokaryotic
% 216.64/216.87  |- mesh__publicMeSHNote mesh__D039662 2003   
% 216.64/216.87  |- mesh__recordAuthorizer mesh__D039662 sjn
% 216.64/216.87  |- skos__hiddenLabel mesh__D039662 Initiation Factors, Prokaryotic
% 216.64/216.87  |- skos__scopeNote mesh__D039662
% 216.64/216.87        Peptide initiation factors from prokaryotic organisms. Only three factors are needed for translation initiation in prokaryotic organisms, which occurs by a far simpler process than in  PEPTIDE CHAIN INITIATION, TRANSLATIONAL of eukaryotic organisms.%A%    
% 216.64/216.87  |- mesh__dateRevised mesh__D039662 2005-06-30
% 216.64/216.87  |- skos__historyNote mesh__D039662
% 216.64/216.87       Peptide Initiation Factors %28%1973-2002%29%
% 216.64/216.87  |- mesh__dateEstablished mesh__D039662 2003-01-01
% 216.64/216.87  |- rdf__type mesh__D039662sskos__Concept
% 216.64/216.87  |- mesh__recordMaintainer mesh__D039662 SYSTEM
% 216.64/216.87  |- mesh__recordOriginator mesh__D039662 jmp
% 216.64/216.87  |- skos__broader mesh__D039662smesh__D010448
% 216.64/216.87  |- skos__altLabel mesh__D039662 Translation Initiation Factors, Prokaryotic
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D039662 2006
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D006488 2002
% 216.64/216.87  |- mesh__dateRevised mesh__D006488 1991-05-15
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D006488 1999
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D006488 2005
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D006488 1993
% 216.64/216.87  |- skos__scopeNote mesh__D006488
% 216.64/216.87       Control of bleeding during or after surgery.     
% 216.64/216.87  |- mesh__recordAuthorizer mesh__D006488 PLS
% 216.64/216.87  |- skos__hiddenLabel mesh__D006488 Surgical Hemostases
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D006488 1996
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D006488 2006
% 216.64/216.87  |- mesh__dateCreated mesh__D006488 1975-07-25
% 216.64/216.87  |- skos__broader mesh__D006488smesh__D006489
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D006488 2000
% 216.64/216.87  |- mesh__historyNote mesh__D006488
% 216.64/216.87       76; was indexed under HEMOSTASIS 1963-75 %28%Cat E heading%29%   
% 216.64/216.87  |- skos__broader mesh__D006488smesh__D013514
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D006488 1997
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D006488 1994
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D006488 2003
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D006488 2001
% 216.64/216.87  |- skos__annotation mesh__D006488
% 216.64/216.87       = perop or postop control of bleeding; do not use /util except by MeSH%A%  
% 216.64/216.87  |- mesh__recordMaintainer mesh__D006488 TGC
% 216.64/216.87  |- mesh__onlineNote mesh__D006488
% 216.64/216.87       search HEMOSTASIS 1966-75 %28%as Cat E heading%29%   
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D006488 2004
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D006488 1995
% 216.64/216.87  |- mesh__dateEstablished mesh__D006488 1976-01-01
% 216.64/216.87  |- mesh__publicMeSHNote mesh__D006488
% 216.64/216.87       76; was indexed under HEMOSTASIS 1963-75   
% 216.64/216.87  |- skos__hiddenLabel mesh__D006488 Hemostases, Surgical
% 216.64/216.87  |- skos__historyNote mesh__D006488 Hemostasis %28%1966-1975%29%
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D006488 1998
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D006488 1992
% 216.64/216.87  |- skos__prefLabel mesh__D006488 Hemostasis, Surgical
% 216.64/216.87  |- mesh__recordOriginator mesh__D006488 SMH
% 216.64/216.87  |- skos__altLabel mesh__D006488 Surgical Hemostasis
% 216.64/216.87  |- rdf__type mesh__D006488sskos__Concept
% 216.64/216.87  |- skos__hiddenLabel mesh__D020159 Citrullinemias, Classical
% 216.64/216.87  |- mesh__recordMaintainer mesh__D020159 nns
% 216.64/216.87  |- mesh__dateEstablished mesh__D020159 2000-01-01
% 216.64/216.87  |- skos__scopeNote mesh__D020159
% 216.64/216.87       A group of diseases related to a deficiency of the enzyme ARGININOSUCCINATE SYNTHASE which causes an elevation of serum levels of CITRULLINE. In neonates, clinical manifestations include lethargy, hypotonia, and SEIZURES. Milder forms also occur. Childhood and adult forms may present with recurrent episodes of intermittent weakness, lethargy, ATAXIA, behavioral changes, and DYSARTHRIA. %28%From Menkes, Textbook of Child Neurology, 5th ed, p49%29%%A%    
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D020159 2005
% 216.64/216.87  |- skos__hiddenLabel mesh__D020159 Citrullinemia, Late Onset
% 216.64/216.87  |- skos__hiddenLabel mesh__D020159 Neonatal Citrullinemia
% 216.64/216.87  |- skos__altLabel mesh__D020159 Citrullinemia, Late-Onset
% 216.64/216.87  |- skos__prefLabel mesh__D020159 Citrullinemia
% 216.64/216.87  |- skos__historyNote mesh__D020159
% 216.64/216.87       Amino Acid Metabolism, Inborn Errors %28%1965-1999%29%
% 216.64/216.87  |- skos__altLabel mesh__D020159
% 216.64/216.87       Deficiency Disease, Argininosuccinate Synthase
% 216.64/216.87  |- skos__altLabel mesh__D020159
% 216.64/216.87       Complete Argininosuccinic Acid Synthetase Deficiency Disease
% 216.64/216.87  |- skos__altLabel mesh__D020159 Citrullinuria
% 216.64/216.87  |- skos__altLabel mesh__D020159
% 216.64/216.87       Partial Argininosuccinic Acid Synthetase Deficiency Disease
% 216.64/216.87  |- skos__broader mesh__D020159smesh__D020739
% 216.64/216.87  |- skos__hiddenLabel mesh__D020159 Late-Onset Citrullinemias
% 216.64/216.87  |- skos__hiddenLabel mesh__D020159 Citrullinemias
% 216.64/216.87  |- skos__related mesh__D020159smesh__D001124
% 216.64/216.87  |- skos__altLabel mesh__D020159
% 216.64/216.87       Argininosuccinic Acid Synthetase Deficiency Disease
% 216.64/216.87  |- skos__hiddenLabel mesh__D020159 Neonatal Citrullinemias
% 216.64/216.87  |- skos__altLabel mesh__D020159
% 216.64/216.87       Argininosuccinate Synthase Deficiency Disease
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D020159 2004
% 216.64/216.87  |- mesh__historyNote mesh__D020159 2000   
% 216.64/216.87  |- mesh__publicMeSHNote mesh__D020159 2000   
% 216.64/216.87  |- skos__altLabel mesh__D020159 Citrullinemia, Classical
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D020159 2003
% 216.64/216.87  |- skos__historyNote mesh__D020159
% 216.64/216.87       Argininosuccinate Synthase/deficiency %28%1975-1999%29%
% 216.64/216.87  |- mesh__dateRevised mesh__D020159 2001-07-25
% 216.64/216.87  |- mesh__dateCreated mesh__D020159 1999-11-03
% 216.64/216.87  |- rdf__type mesh__D020159sskos__Concept
% 216.64/216.87  |- skos__altLabel mesh__D020159 Citrullinemia, Neonatal
% 216.64/216.87  |- skos__hiddenLabel mesh__D020159 Late-Onset Citrullinemia
% 216.64/216.87  |- skos__altLabel mesh__D020159
% 216.64/216.87       Deficiency, Argininosuccinic Acid Synthetase, Complete
% 216.64/216.87  |- mesh__recordOriginator mesh__D020159 KEV
% 216.64/216.87  |- skos__altLabel mesh__D020159
% 216.64/216.87       Deficiency, Argininosuccinic Acid Synthetase, Partial
% 216.64/216.87  |- mesh__recordAuthorizer mesh__D020159 sjn
% 216.64/216.87  |- skos__hiddenLabel mesh__D020159 Citrullinurias
% 216.64/216.87  |- skos__hiddenLabel mesh__D020159 Citrullinemias, Late-Onset
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D020159 2002
% 216.64/216.87  |- skos__broader mesh__D020159smesh__D000592
% 216.64/216.87  |- skos__altLabel mesh__D020159
% 216.64/216.87       Deficiency Disease, Argininosuccinic Acid Synthase
% 216.64/216.87  |- skos__hiddenLabel mesh__D020159 Classical Citrullinemias
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D020159 2006
% 216.64/216.87  |- skos__altLabel mesh__D020159
% 216.64/216.87       Argininosuccinic Acid Synthase Deficiency Disease
% 216.64/216.87  |- skos__hiddenLabel mesh__D020159 Citrullinemias, Neonatal
% 216.64/216.87  |- skos__hiddenLabel mesh__D020159 Classical Citrullinemia
% 216.64/216.87  |- skos__altLabel mesh__D003190 Care, Comprehensive Dental
% 216.64/216.87  |- skos__broader mesh__D003190smesh__D003191
% 216.64/216.87  |- rdf__type mesh__D003190sskos__Concept
% 216.64/216.87  |- mesh__historyNote mesh__D003190 73   
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D003190 2002
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D003190 2003
% 216.64/216.87  |- mesh__dateEstablished mesh__D003190 1973-01-01
% 216.64/216.87  |- skos__historyNote mesh__D003190
% 216.64/216.87       Comprehensive Health Care %28%1968-1971%29%
% 216.64/216.87  |- mesh__recordOriginator mesh__D003190 NLM
% 216.64/216.87  |- skos__prefLabel mesh__D003190 Comprehensive Dental Care
% 216.64/216.87  |- mesh__dateCreated mesh__D003190 1999-01-01
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D003190 2004
% 216.64/216.87  |- mesh__dateRevised mesh__D003190 2000-06-22
% 216.64/216.87  |- skos__scopeNote mesh__D003190
% 216.64/216.87       Providing for the full range of dental health services for diagnosis, treatment, follow-up, and rehabilitation of patients.%A%    
% 216.64/216.87  |- skos__altLabel mesh__D003190 Dental Care, Comprehensive
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D003190 2005
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D003190 2006
% 216.64/216.87  |- skos__annotation mesh__D003190 DF: COMPREHENSIVE DENT CARE   
% 216.64/216.87  |- mesh__recordMaintainer mesh__D003190 jls
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D003190 2001
% 216.64/216.87  |- mesh__recordAuthorizer mesh__D003190 sjn
% 216.64/216.87  |- mesh__publicMeSHNote mesh__D003190 73   
% 216.64/216.87  |- mesh__historyNote mesh__D019605 1998   
% 216.64/216.87  |- mesh__dateCreated mesh__D019605 1997-06-20
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D019605 2006
% 216.64/216.87  |- mesh__dateEstablished mesh__D019605 1998-01-01
% 216.64/216.87  |- rdf__type mesh__D019605sskos__Concept
% 216.64/216.87  |- mesh__recordAuthorizer mesh__D019605 sjn
% 216.64/216.87  |- skos__prefLabel mesh__D019605 Euryarchaeota
% 216.64/216.87  |- skos__scopeNote mesh__D019605
% 216.64/216.87       A phylum of ARCHAEA comprising at least seven classes: Methanobacteria, Methanococci, Halobacteria %28%extreme halophiles%29%,  Archaeoglobi %28%sulfate-reducing species%29%, Methanopyri, and the thermophiles: Thermoplasmata, and Thermococci.%A%    
% 216.64/216.87  |- mesh__publicMeSHNote mesh__D019605
% 216.64/216.87       1998; for METHANOBACTERIA see METHANOGENS 1979-2003   
% 216.64/216.87  |- mesh__recordOriginator mesh__D019605 AGS
% 216.64/216.87  |- mesh__recordMaintainer mesh__D019605 SYSTEM
% 216.64/216.87  |- mesh__dateRevised mesh__D019605 2005-06-30
% 216.64/216.87  |- skos__broader mesh__D019605smesh__D001105
% 216.64/216.87  |- skos__annotation mesh__D019605
% 216.64/216.87       do not confuse X ref METHANOBACTERIA %28%a class name%29% with METHANOBACTERIUM, the genus%A%  
% 216.64/216.87  |- skos__scopeNote mesh__D011622
% 216.64/216.87       Compounds based on 2-amino-4-hydroxypteridine.     
% 216.64/216.87  |- mesh__recordMaintainer mesh__D011622 ssb
% 216.64/216.87  |- mesh__dateCreated mesh__D011622 1999-01-01
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D011622 2006
% 216.64/216.87  |- skos__broader mesh__D011622smesh__D010860
% 216.64/216.87  |- mesh__recordOriginator mesh__D011622 NLM
% 216.64/216.87  |- mesh__dateRevised mesh__D011622 2005-06-30
% 216.64/216.87  |- rdf__type mesh__D011622sskos__Concept
% 216.64/216.87  |- mesh__recordAuthorizer mesh__D011622 sjn
% 216.64/216.87  |- skos__broader mesh__D011622smesh__D011621
% 216.64/216.87  |- skos__prefLabel mesh__D011622 Pterins
% 216.64/216.87  |- mesh__dateEstablished mesh__D049292 2005-01-01
% 216.64/216.87  |- mesh__recordMaintainer mesh__D049292 ags
% 216.64/216.87  |- rdf__type mesh__D049292sskos__Concept
% 216.64/216.87  |- mesh__recordAuthorizer mesh__D049292 ags
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D049292 2006
% 216.64/216.87  |- mesh__historyNote mesh__D049292 2005   
% 216.64/216.87  |- mesh__publicMeSHNote mesh__D049292 2005   
% 216.64/216.87  |- skos__prefLabel mesh__D049292 Leukoaraiosis
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D049292 2005
% 216.64/216.87  |- skos__scopeNote mesh__D049292
% 216.64/216.87       Non-specific white matter changes in the BRAIN, often seen after age 65. Changes include loss of AXONS; MYELIN pallor, GLIOSIS, loss of ependymal cells, and enlarged perivascular spaces. Leukoaraiosis is a risk factor for DEMENTIA and CEREBROVASCULAR DISORDERS.%A%    
% 216.64/216.87  |- mesh__dateCreated mesh__D049292 2004-07-07
% 216.64/216.87  |- skos__broader mesh__D049292smesh__D010335
% 216.64/216.87  |- mesh__recordOriginator mesh__D049292 ags
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D049292 2006A
% 216.64/216.87  |- skos__hiddenLabel mesh__D049292 Leukoaraioses
% 216.64/216.87  |- mesh__dateRevised mesh__D049292 2005-07-12
% 216.64/216.87  |- skos__scopeNote mesh__D002896
% 216.64/216.87       A specific pair GROUP C CHROMSOMES of the human chromosome classification.%A%    
% 216.64/216.87  |- mesh__recordAuthorizer mesh__D002896 ags
% 216.64/216.87  |- skos__prefLabel mesh__D002896 Chromosomes, Human, Pair 6
% 216.64/216.87  |- mesh__recordMaintainer mesh__D002896 ags
% 216.64/216.87  |- mesh__historyNote mesh__D002896 87   
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D002896 2006A
% 216.64/216.87  |- mesh__dateRevised mesh__D002896 2005-07-11
% 216.64/216.87  |- mesh__recordOriginator mesh__D002896 SCD
% 216.64/216.87  |- rdf__type mesh__D002896sskos__Concept
% 216.64/216.87  |- mesh__publicMeSHNote mesh__D002896 87   
% 216.64/216.87  |- skos__historyNote mesh__D002896
% 216.64/216.87       Chromosomes, Human, 6-12 %28%1968-1986%29%
% 216.64/216.87  |- mesh__dateEstablished mesh__D002896 1987-01-01
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D002896 2005
% 216.64/216.87  |- mesh__activeMeSHYear mesh__D002896 2006
% 216.64/216.87  |- mesh__dateCreated mesh__D002896 1986-06-19
% 216.64/216.87  |- skos__broader mesh__D002896smesh__D002906
% 216.64/216.87  |- skos__altLabel mesh__D002896 Chromosome 6
% 216.64/216.88  |- skos__altLabel mesh__D043704 Adenosine A%28%2B%29% Receptor
% 216.64/216.88  |- skos__hiddenLabel mesh__D043704 A2B Receptor, Adenosine
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D043704 2004
% 216.64/216.88  |- mesh__publicMeSHNote mesh__D043704
% 216.64/216.88       2004; ADENOSINE A2B RECEPTOR was indexed under RECEPTORS, PURINERGIC P1 1997-2003%A%  
% 216.64/216.88  |- skos__broader mesh__D043704smesh__D043683
% 216.64/216.88  |- skos__altLabel mesh__D043704 Adenosine A2B Receptor
% 216.64/216.88  |- skos__scopeNote mesh__D043704
% 216.64/216.88       A subclass of adenosine A2 receptors found in the CECUM, the COLON, the BLADDER, and a variety of other tissues. It is generally considered to be a low affinity receptor for ADENOSINE that couples to the GS, STIMULATORY G-PROTEIN.%A%    
% 216.64/216.88  |- skos__prefLabel mesh__D043704 Receptor, Adenosine A2B
% 216.64/216.88  |- mesh__historyNote mesh__D043704
% 216.64/216.88       2004; use RECEPTOR, ADENSINE A2B %28%NM%29% 1997-2003   
% 216.64/216.88  |- mesh__dateCreated mesh__D043704 2003-07-09
% 216.64/216.88  |- skos__hiddenLabel mesh__D043704 A2B Receptors, Adenosine
% 216.64/216.88  |- skos__altLabel mesh__D043704 Adenosine A2B Receptors
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D043704 2006
% 216.64/216.88  |- skos__hiddenLabel mesh__D043704 Receptors, Adenosine A2B
% 216.64/216.88  |- mesh__dateEstablished mesh__D043704 2004-01-01
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D043704 2005
% 216.64/216.88  |- rdf__type mesh__D043704sskos__Concept
% 216.64/216.88  |- skos__historyNote mesh__D043704
% 216.64/216.88       Receptors, Purinergic P1 %28%1997-2003%29%
% 216.64/216.88  |- skos__hiddenLabel mesh__D007581 Bypass, Jejuno-Ileal
% 216.64/216.88  |- skos__hiddenLabel mesh__D007581 Jejuno Ileal Bypass
% 216.64/216.88  |- skos__historyNote mesh__D007581 Jejunum %28%1966-1985%29%
% 216.64/216.88  |- skos__hiddenLabel mesh__D007581 Bypass, Ileojejunal
% 216.64/216.88  |- mesh__dateCreated mesh__D007581 1985-06-17
% 216.64/216.88  |- skos__hiddenLabel mesh__D007581 Jejunoileal Bypasses
% 216.64/216.88  |- mesh__dateRevised mesh__D007581 2005-06-30
% 216.64/216.88  |- skos__hiddenLabel mesh__D007581 Bypasses, Intestinal
% 216.64/216.88  |- skos__broader mesh__D007581smesh__D050110
% 216.64/216.88  |- skos__hiddenLabel mesh__D007581 Ileojejunal Bypasses
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D007581 2006
% 216.64/216.88  |- mesh__dateEstablished mesh__D007581 1986-01-01
% 216.64/216.88  |- mesh__recordOriginator mesh__D007581 SH
% 216.64/216.88  |- mesh__recordMaintainer mesh__D007581 lkt
% 216.64/216.88  |- skos__hiddenLabel mesh__D007581 Bypasses, Ileojejunal
% 216.64/216.88  |- skos__hiddenLabel mesh__D007581 Bypass, Intestinal
% 216.64/216.88  |- skos__historyNote mesh__D007581 Ileum %28%1966-1985%29%
% 216.64/216.88  |- skos__hiddenLabel mesh__D007581 Intestinal Bypasses
% 216.64/216.88  |- skos__scopeNote mesh__D007581
% 216.64/216.88       A procedure consisting of the SURGICAL ANASTOMOSIS of the proximal part of the JEJUNUM to the distal portion of the ILEUM, so as to bypass the nutrient-absorptive segment of the SMALL INTESTINE. Due to the severe malnutrition and life-threatening metabolic complications, this method is no longer used to treat MORBID OBESITY.%A%    
% 216.64/216.88  |- skos__altLabel mesh__D007581 Ileojejunal Bypass
% 216.64/216.88  |- skos__hiddenLabel mesh__D007581 Bypasses, Jejunoileal
% 216.64/216.88  |- skos__hiddenLabel mesh__D007581 Bypass, Jejunoileal
% 216.64/216.88  |- rdf__type mesh__D007581sskos__Concept
% 216.64/216.88  |- skos__historyNote mesh__D007581 Obesity %28%1966-1985%29%
% 216.64/216.88  |- skos__altLabel mesh__D007581 Jejuno-Ileal Bypass
% 216.64/216.88  |- skos__prefLabel mesh__D007581 Jejunoileal Bypass
% 216.64/216.88  |- mesh__recordAuthorizer mesh__D007581 sjn
% 216.64/216.88  |- mesh__publicMeSHNote mesh__D007581 86   
% 216.64/216.88  |- skos__broader mesh__D007581smesh__D013505
% 216.64/216.88  |- skos__broader mesh__D007581smesh__D000714
% 216.64/216.88  |- skos__hiddenLabel mesh__D007581 Jejuno-Ileal Bypasses
% 216.64/216.88  |- skos__hiddenLabel mesh__D007581 Bypasses, Jejuno-Ileal
% 216.64/216.88  |- mesh__historyNote mesh__D007581 86   
% 216.64/216.88  |- skos__historyNote mesh__D015215
% 216.64/216.88       Thymidine/analogs %26% derivatives %28%1975-1988%29%
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D015215 2003
% 216.64/216.88  |- skos__broader mesh__D015215smesh__D013936
% 216.64/216.88  |- skos__altLabel mesh__D015215 Azidothymidine
% 216.64/216.88  |- skos__altLabel mesh__D015215 BWA-509U
% 216.64/216.88  |- skos__hiddenLabel mesh__D015215 Antiviral AZT
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D015215 2005
% 216.64/216.88  |- mesh__dateEstablished mesh__D015215 1989-01-01
% 216.64/216.88  |- mesh__recordAuthorizer mesh__D015215 sjn
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D015215 2004
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D015215 2002
% 216.64/216.88  |- skos__scopeNote mesh__D015215
% 216.64/216.88       A dideoxynucleoside compound in which the 3%27%-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia.%A%    
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D015215 2006
% 216.64/216.88  |- skos__hiddenLabel mesh__D015215 3%27% Azido 2%27%,3%27% Dideoxythymidine
% 216.64/216.88  |- mesh__historyNote mesh__D015215 89   
% 216.64/216.88  |- skos__altLabel mesh__D015215 3%27%-Azido-2%27%,3%27%-Dideoxythymidine
% 216.64/216.88  |- skos__hiddenLabel mesh__D015215 Antiviral, AZT
% 216.64/216.88  |- mesh__recordOriginator mesh__D015215 RLS
% 216.64/216.88  |- skos__altLabel mesh__D015215 AZT %28%Antiviral%29%
% 216.64/216.88  |- skos__altLabel mesh__D015215 AZT Antiviral
% 216.64/216.88  |- skos__broader mesh__D015215smesh__D015224
% 216.64/216.88  |- skos__prefLabel mesh__D015215 Zidovudine
% 216.64/216.88  |- skos__hiddenLabel mesh__D015215 3%27% Azido 3%27% deoxythymidine
% 216.64/216.88  |- skos__altLabel mesh__D015215 3%27%-Azido-3%27%-deoxythymidine
% 216.64/216.88  |- skos__altLabel mesh__D015215 AZT, Antiviral
% 216.64/216.88  |- mesh__publicMeSHNote mesh__D015215 89   
% 216.64/216.88  |- rdf__type mesh__D015215sskos__Concept
% 216.64/216.88  |- mesh__dateRevised mesh__D015215 2001-07-25
% 216.64/216.88  |- mesh__dateCreated mesh__D015215 1988-05-09
% 216.64/216.88  |- mesh__recordMaintainer mesh__D015215 ssb
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D020958 2000
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D020958 2001
% 216.64/216.88  |- mesh__historyNote mesh__D020958 2000   
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D020958 2003
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D020958 2002
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D020958 2004
% 216.64/216.88  |- mesh__dateEstablished mesh__D020958 2000-01-01
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D020958 2005
% 216.64/216.88  |- skos__prefLabel mesh__D020958 Australian Capital Territory
% 216.64/216.88  |- skos__broader mesh__D020958smesh__D001315
% 216.64/216.88  |- skos__historyNote mesh__D020958 Australia %28%1990-1999%29%
% 216.64/216.88  |- mesh__dateCreated mesh__D020958 1999-11-03
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D020958 2006
% 216.64/216.88  |- skos__scopeNote mesh__D020958
% 216.64/216.88       A territory of Australia consisting of Canberra, the national capital and surrounding land. It lies geographically within NEW SOUTH WALES and was established by law in 1988.%A%    
% 216.64/216.88  |- rdf__type mesh__D020958sskos__Concept
% 216.64/216.88  |- mesh__recordAuthorizer mesh__D039663 sjn
% 216.64/216.88  |- mesh__dateRevised mesh__D039663 2005-06-30
% 216.64/216.88  |- skos__prefLabel mesh__D039663 Integrin beta4
% 216.64/216.88  |- skos__altLabel mesh__D039663 Integrin beta%28%4%29%
% 216.64/216.88  |- mesh__recordMaintainer mesh__D039663 ssb
% 216.64/216.88  |- skos__altLabel mesh__D039663 Antigens, CD104
% 216.64/216.88  |- rdf__type mesh__D039663sskos__Concept
% 216.64/216.88  |- skos__historyNote mesh__D039663 Integrins %28%1994-2002%29%
% 216.64/216.88  |- skos__historyNote mesh__D039663 Antigens, CD %28%1996-2002%29%
% 216.64/216.88  |- skos__hiddenLabel mesh__D039663 Antigen, CD104
% 216.64/216.88  |- skos__altLabel mesh__D039663 CD104 Antigen
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D039663 2006
% 216.64/216.88  |- skos__broader mesh__D039663smesh__D015703
% 216.64/216.88  |- skos__broader mesh__D039663smesh__D039641
% 216.64/216.88  |- skos__scopeNote mesh__D039663
% 216.64/216.88       Also known as CD104 antigen, this protein is distinguished from other beta integrins by its relatively long cytoplasmic domain %28%approximately 1000 amino acids vs. approximately 50%29%.  Five alternatively spliced isoforms have been described.%A%    
% 216.64/216.88  |- skos__altLabel mesh__D039663 beta4 Integrin
% 216.64/216.88  |- skos__hiddenLabel mesh__D039663 beta4, Integrin
% 216.64/216.88  |- mesh__historyNote mesh__D039663
% 216.64/216.88       2003; use INTEGRIN BETA4 %28%NM%29% 1994-2002   
% 216.64/216.88  |- skos__altLabel mesh__D039663 CD104 Antigens
% 216.64/216.88  |- mesh__publicMeSHNote mesh__D039663
% 216.64/216.88       2003; INTEGRIN BETA4 was indexed under ANTIGENS, CD 1996-2002 %26% INTEGRINS 1994-1995%A%  
% 216.64/216.88  |- mesh__dateCreated mesh__D039663 2002-07-02
% 216.64/216.88  |- mesh__dateEstablished mesh__D039663 2003-01-01
% 216.64/216.88  |- mesh__recordOriginator mesh__D039663 MDJ
% 216.64/216.88  |- skos__hiddenLabel mesh__D039663 Integrin, beta4
% 216.64/216.88  |- mesh__dateRevised mesh__D006489 1999-11-03
% 216.64/216.88  |- skos__hiddenLabel mesh__D006489 Technics, Hemostatic
% 216.64/216.88  |- skos__historyNote mesh__D006489 Hemostasis %28%1966-1975%29%
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D006489 2006
% 216.64/216.88  |- mesh__dateCreated mesh__D006489 1975-07-25
% 216.64/216.88  |- mesh__recordOriginator mesh__D006489 SMH
% 216.64/216.88  |- mesh__historyNote mesh__D006489
% 216.64/216.88       91; was HEMOSTATIC TECHNICS 1976-90; was indexed under HEMOSTASIS 1963-75 %28%Cat E heading%29%%A%  
% 216.64/216.88  |- skos__scopeNote mesh__D006489 Techniques for controlling bleeding.     
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D006489 2002
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D006489 2003
% 216.64/216.88  |- skos__hiddenLabel mesh__D006489 Technique, Hemostatic
% 216.64/216.88  |- skos__altLabel mesh__D006489 Hemostatic Technics
% 216.64/216.88  |- skos__annotation mesh__D006489
% 216.64/216.88       differentiate from HEMOSTASIS, a physiol process in Cat G; do not use /util except by MeSH definition%A%  
% 216.64/216.88  |- mesh__recordAuthorizer mesh__D006489 sjn
% 216.64/216.88  |- mesh__recordMaintainer mesh__D006489 kle
% 216.64/216.88  |- skos__broader mesh__D006489smesh__D013812
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D006489 2004
% 216.64/216.88  |- skos__prefLabel mesh__D006489 Hemostatic Techniques
% 216.64/216.88  |- skos__hiddenLabel mesh__D006489 Techniques, Hemostatic
% 216.64/216.88  |- skos__hiddenLabel mesh__D006489 Technic, Hemostatic
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D006489 2000
% 216.64/216.88  |- skos__hiddenLabel mesh__D006489 Hemostatic Technic
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D006489 2001
% 216.64/216.88  |- rdf__type mesh__D006489sskos__Concept
% 216.64/216.88  |- mesh__onlineNote mesh__D006489
% 216.64/216.88       use HEMOSTATIC TECHNIQUES to search HEMOSTATIC TECHNICS 1976-90; search HEMOSTASIS 1966-75 %28%as Cat E heading%29%%A%  
% 216.64/216.88  |- skos__hiddenLabel mesh__D006489 Hemostatic Technique
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D006489 2005
% 216.64/216.88  |- mesh__publicMeSHNote mesh__D006489
% 216.64/216.88       91; was HEMOSTATIC TECHNICS 1976-90; was indexed under HEMOSTASIS 1963-75%A%  
% 216.64/216.88  |- mesh__dateEstablished mesh__D006489 1976-01-01
% 216.64/216.88  |- mesh__publicMeSHNote mesh__D003191 68   
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D003191 2006
% 216.64/216.88  |- skos__altLabel mesh__D003191 Comprehensive Healthcare
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D003191 2001
% 216.64/216.88  |- mesh__dateCreated mesh__D003191 1999-01-01
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D003191 2005
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D003191 2000
% 216.64/216.88  |- skos__scopeNote mesh__D003191
% 216.64/216.88       Providing for the full range of personal health services for diagnosis, treatment, follow-up and rehabilitation of patients.%A%    
% 216.64/216.88  |- rdf__type mesh__D003191sskos__Concept
% 216.64/216.88  |- mesh__recordAuthorizer mesh__D003191 sjn
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D003191 2004
% 216.64/216.88  |- mesh__dateEstablished mesh__D003191 1968-01-01
% 216.64/216.88  |- skos__historyNote mesh__D003191
% 216.64/216.88       Community Health Services %28%1966-1967%29%
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D003191 2003
% 216.64/216.88  |- mesh__recordOriginator mesh__D003191 NLM
% 216.64/216.88  |- skos__annotation mesh__D003191 IM   
% 216.64/216.88  |- skos__hiddenLabel mesh__D003191 Healthcare, Comprehensive
% 216.64/216.88  |- mesh__historyNote mesh__D003191 68   
% 216.64/216.88  |- mesh__recordMaintainer mesh__D003191 kle
% 216.64/216.88  |- skos__broader mesh__D003191smesh__D010346
% 216.64/216.88  |- mesh__dateRevised mesh__D003191 1999-11-03
% 216.64/216.88  |- skos__historyNote mesh__D003191 specific service %28%1966-1967%29%
% 216.64/216.88  |- skos__prefLabel mesh__D003191 Comprehensive Health Care
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D003191 2002
% 216.64/216.88  |- skos__hiddenLabel mesh__D003191 Health Care, Comprehensive
% 216.64/216.88  |- mesh__publicMeSHNote mesh__D019606 98   
% 216.64/216.88  |- mesh__dateCreated mesh__D019606 1997-06-20
% 216.64/216.88  |- skos__hiddenLabel mesh__D019606 Phosphorus Amino Acids
% 216.64/216.88  |- skos__broader mesh__D019606smesh__D000596
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D019606 2000
% 216.64/216.88  |- mesh__historyNote mesh__D019606 98   
% 216.64/216.88  |- skos__prefLabel mesh__D019606 Phosphoamino Acids
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D019606 2004
% 216.64/216.88  |- mesh__dateEstablished mesh__D019606 1998-01-01
% 216.64/216.88  |- skos__historyNote mesh__D019606 Amino Acids %28%1966-1997%29%
% 216.64/216.88  |- skos__altLabel mesh__D019606 Amino Acids, Phosphorus
% 216.64/216.88  |- rdf__type mesh__D019606sskos__Concept
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D019606 2003
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D019606 2006
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D019606 1999
% 216.64/216.88  |- skos__hiddenLabel mesh__D019606 Acids, Phosphorus Amino
% 216.64/216.88  |- skos__hiddenLabel mesh__D019606 Acids, Phosphoamino
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D019606 2005
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D019606 1998
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D019606 2002
% 216.64/216.88  |- skos__scopeNote mesh__D019606
% 216.64/216.88       Amino acids that contain phosphorus as an integral part of the molecule.%A%    
% 216.64/216.88  |- skos__annotation mesh__D019606
% 216.64/216.88       amino acids containing phosphorus; GEN or unspecified; prefer specifics%A%  
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D019606 2001
% 216.64/216.88  |- skos__altLabel mesh__D011623 Folyl Conjugate Synthetase
% 216.64/216.88  |- skos__prefLabel mesh__D011623 gamma-Glutamyl Hydrolase
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D011623 2006
% 216.64/216.88  |- skos__altLabel mesh__D011623 Folate Conjugase
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D011623 2004
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D011623 2005
% 216.64/216.88  |- skos__altLabel mesh__D011623 Folate Hydrolyzing Enzyme
% 216.64/216.88  |- skos__altLabel mesh__D011623 Conjugase
% 216.64/216.88  |- mesh__dateCreated mesh__D011623 1974-11-19
% 216.64/216.88  |- skos__altLabel mesh__D011623 Pteroyl Polyglutamate Hydrolase
% 216.64/216.88  |- rdf__type mesh__D011623sskos__Concept
% 216.64/216.88  |- skos__altLabel mesh__D011623 Folacin Conjugase
% 216.64/216.88  |- mesh__dateEstablished mesh__D011623 1991-01-01
% 216.64/216.88  |- skos__broader mesh__D011623smesh__D002268
% 216.64/216.88  |- skos__historyNote mesh__D011623 Carboxypeptidases %28%1972-1974%29%
% 216.64/216.88  |- mesh__recordMaintainer mesh__D011623 jmp
% 216.64/216.88  |- mesh__historyNote mesh__D011623 2000%28%1975%29%   
% 216.64/216.88  |- skos__scopeNote mesh__D011623
% 216.64/216.88       Catalyzes the hydrolysis of pteroylpolyglutamic acids in gamma linkage to pterolylmonoglutamic acid and free glutamic acid. EC 3.4.19.9.%A%    
% 216.64/216.88  |- mesh__publicMeSHNote mesh__D011623
% 216.64/216.88       2000; see PTEROYL POLYGLUTAMATE HYDROLASE 1991-1999; for GAMMA-GLUTAMYL HYDROLASE see PTEROYL POLYGLUTAMATE HYDROLASE 1987-1999; see CYSTEINE PROTEINASES 1975-1990%A%  
% 216.64/216.88  |- skos__altLabel mesh__D011623 Folylpolyglutamate Hydrolase
% 216.64/216.88  |- mesh__recordOriginator mesh__D011623 NLM
% 216.64/216.88  |- skos__historyNote mesh__D011623 Folic Acid %28%1972-1974%29%
% 216.64/216.88  |- skos__altLabel mesh__D011623 Carboxypeptidase G
% 216.64/216.88  |- mesh__dateRevised mesh__D011623 2003-07-09
% 216.64/216.88  |- skos__hiddenLabel mesh__D011623 gamma Glutamyl Hydrolase
% 216.64/216.88  |- skos__historyNote mesh__D011623 Glutamates %28%1972-1974%29%
% 216.64/216.88  |- skos__altLabel mesh__D011623 Folyl Poly-gamma-Glutamate Carboxypeptidase
% 216.64/216.88  |- skos__altLabel mesh__D011623 Folyl Polyglutamate Cleavage Enzyme
% 216.64/216.88  |- mesh__recordAuthorizer mesh__D011623 sjn
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D049293 2006
% 216.64/216.88  |- mesh__recordMaintainer mesh__D049293 jls
% 216.64/216.88  |- skos__scopeNote mesh__D049293
% 216.64/216.88       NATIONAL LIBRARY OF MEDICINE service for health professionals and consumers. It links extensive information from the National Institutes of Health and other reviewed sources of information on specific diseases and conditions.%A%    
% 216.64/216.88  |- mesh__publicMeSHNote mesh__D049293 2005   
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D049293 2005
% 216.64/216.88  |- mesh__dateCreated mesh__D049293 2004-07-07
% 216.64/216.88  |- mesh__recordOriginator mesh__D049293 jls
% 216.64/216.88  |- skos__historyNote mesh__D049293 MEDLINE %28%2000-2004%29%
% 216.64/216.88  |- mesh__dateEstablished mesh__D049293 2005-01-01
% 216.64/216.88  |- mesh__recordAuthorizer mesh__D049293 sjn
% 216.64/216.88  |- mesh__historyNote mesh__D049293 2005   
% 216.64/216.88  |- skos__annotation mesh__D049293 CATALOG: Use NAF entry   
% 216.64/216.88  |- skos__prefLabel mesh__D049293 MedlinePlus
% 216.64/216.88  |- skos__broader mesh__D049293smesh__D016247
% 216.64/216.88  |- skos__historyNote mesh__D049293 Internet %28%2000-2004%29%
% 216.64/216.88  |- rdf__type mesh__D049293sskos__Concept
% 216.64/216.88  |- mesh__historyNote mesh__D002897 87   
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D002897 2006A
% 216.64/216.88  |- mesh__recordAuthorizer mesh__D002897 ags
% 216.64/216.88  |- mesh__publicMeSHNote mesh__D002897 87   
% 216.64/216.88  |- rdf__type mesh__D002897sskos__Concept
% 216.64/216.88  |- skos__altLabel mesh__D002897 Chromosome 7
% 216.64/216.88  |- mesh__recordMaintainer mesh__D002897 ags
% 216.64/216.88  |- mesh__dateEstablished mesh__D002897 1987-01-01
% 216.64/216.88  |- mesh__recordOriginator mesh__D002897 SCD
% 216.64/216.88  |- mesh__dateRevised mesh__D002897 2005-07-11
% 216.64/216.88  |- skos__historyNote mesh__D002897
% 216.64/216.88       Chromosomes, Human, 6-12 %28%1968-1986%29%
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D002897 2005
% 216.64/216.88  |- skos__scopeNote mesh__D002897
% 216.64/216.88       A specific pair of GROUP C CHROMOSOMES of the human chromosome classification.%A%    
% 216.64/216.88  |- mesh__dateCreated mesh__D002897 1986-06-19
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D002897 2006
% 216.64/216.88  |- skos__broader mesh__D002897smesh__D002906
% 216.64/216.88  |- skos__prefLabel mesh__D002897 Chromosomes, Human, Pair 7
% 216.64/216.88  |- mesh__onlineNote mesh__D002099
% 216.64/216.88       use CACAO to search CHOCOLATE %26% COCOA 1966-84   
% 216.64/216.88  |- mesh__dateEstablished mesh__D002099 1991-01-01
% 216.64/216.88  |- skos__annotation mesh__D002099
% 216.64/216.88       as plant %26% as chocolate or cocoa; selected qualif from Cat B6 %26% Cat J2; coord IM with CANDY %28%IM%29% for chocolate candy or with BEVERAGES %28%IM%29% for chocolate drinks%A%  
% 216.64/216.88  |- mesh__historyNote mesh__D002099
% 216.64/216.88       91%28%86%29%63; was see under PLANTS, EDIBLE 1986-90; CHOCOLATE %26% COCOA were see under CACAO 1963-84%A%  
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D002099 2006
% 216.64/216.88  |- skos__altLabel mesh__D002099 Theobroma cacao
% 216.64/216.88  |- skos__broader mesh__D002099smesh__D029643
% 216.64/216.88  |- mesh__publicMeSHNote mesh__D002099
% 216.64/216.88       91,63-85; was see under PLANTS, EDIBLE 1986-90; CHOCOLATE %26% COCOA were see under CACAO 1963-84%A%  
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D002099 2005
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D002099 2004
% 216.64/216.88  |- skos__prefLabel mesh__D002099 Cacao
% 216.64/216.88  |- mesh__dateRevised mesh__D002099 2002-07-03
% 216.64/216.88  |- mesh__recordAuthorizer mesh__D002099 sjn
% 216.64/216.88  |- mesh__dateCreated mesh__D002099 1999-01-01
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D002099 2003
% 216.64/216.88  |- skos__scopeNote mesh__D002099
% 216.64/216.88       A tree of the family Sterculiaceae %28%or Byttneriaceae%29%, usually Theobroma cacao, or its seeds, which after fermentation and roasting, yield cocoa and chocolate.%A%    
% 216.64/216.88  |- rdf__type mesh__D002099sskos__Concept
% 216.64/216.88  |- mesh__recordOriginator mesh__D002099 NLM
% 216.64/216.88  |- mesh__recordMaintainer mesh__D002099 ssb
% 216.64/216.88  |- skos__broader mesh__D043705smesh__D043683
% 216.64/216.88  |- mesh__recordMaintainer mesh__D043705 jmp
% 216.64/216.88  |- mesh__dateCreated mesh__D043705 2003-07-09
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D043705 2006
% 216.64/216.88  |- skos__scopeNote mesh__D043705
% 216.64/216.88       A subclass of adenosine A2 receptors found in LEUKOCYTES, the SPLEEN, the THYMUS and a variety of other tissues. It is generally considered to be a receptor for ADENOSINE that couples to the GS, STIMULATORY G-PROTEIN.%A%    
% 216.64/216.88  |- skos__altLabel mesh__D043705 Adenosine A2A Receptor
% 216.64/216.88  |- skos__historyNote mesh__D043705
% 216.64/216.88       Receptors, Purinergic P1 %28%1994-2003%29%
% 216.64/216.88  |- mesh__recordAuthorizer mesh__D043705 sjn
% 216.64/216.88  |- skos__hiddenLabel mesh__D043705 A2A Receptor, Adenosine
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D043705 2005
% 216.64/216.88  |- rdf__type mesh__D043705sskos__Concept
% 216.64/216.88  |- mesh__publicMeSHNote mesh__D043705
% 216.64/216.88       2004; ADENSOSINE A%28%2A%29% RECEPTOR was indexed under RECEPTORS, PURINERGIC P1 1994-2003%A%  
% 216.64/216.88  |- skos__hiddenLabel mesh__D043705 Receptors, Adenosine A2A
% 216.64/216.88  |- skos__altLabel mesh__D043705 Adenosine A2A Receptors
% 216.64/216.88  |- skos__hiddenLabel mesh__D043705 A2A Receptors, Adenosine
% 216.64/216.88  |- mesh__historyNote mesh__D043705
% 216.64/216.88       2004; use RECEPTOR, ADENOSINE A2A %28%NM%29% 1994-2003   
% 216.64/216.88  |- mesh__recordOriginator mesh__D043705 jmp
% 216.64/216.88  |- mesh__dateRevised mesh__D043705 2004-07-07
% 216.64/216.88  |- skos__prefLabel mesh__D043705 Receptor, Adenosine A2A
% 216.64/216.88  |- mesh__dateEstablished mesh__D043705 2004-01-01
% 216.64/216.88  |- skos__altLabel mesh__D043705 Adenosine A%28%2A%29% Receptor
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D007582 2006
% 216.64/216.88  |- skos__annotation mesh__D007582
% 216.64/216.88       do not use /util except by MeSH definition; JEJUNOILEAL BYPASS %26% PANCREATICOJEJUNOSTOMY are available%A%  
% 216.64/216.88  |- skos__broader mesh__D007582smesh__D004766
% 216.64/216.88  |- mesh__recordMaintainer mesh__D007582 PXP
% 216.64/216.88  |- skos__prefLabel mesh__D007582 Jejunostomy
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D007582 2001
% 216.64/216.88  |- mesh__recordOriginator mesh__D007582 SCD
% 216.64/216.88  |- mesh__recordAuthorizer mesh__D007582 SJN
% 216.64/216.88  |- mesh__dateRevised mesh__D007582 1997-06-20
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D007582 2002
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D007582 1998
% 216.64/216.88  |- rdf__type mesh__D007582sskos__Concept
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D007582 2003
% 216.64/216.88  |- mesh__dateCreated mesh__D007582 1987-03-19
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D007582 1999
% 216.64/216.88  |- mesh__historyNote mesh__D007582 88   
% 216.64/216.88  |- mesh__dateEstablished mesh__D007582 1988-01-01
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D007582 2004
% 216.64/216.88  |- skos__historyNote mesh__D007582 Jejunum/surgery %28%1966-1987%29%
% 216.64/216.88  |- skos__scopeNote mesh__D007582
% 216.64/216.88       Surgical formation of an opening through the abdominal wall into the jejunum, usually for enteral hyperalimentation.%A%    
% 216.64/216.88  |- skos__hiddenLabel mesh__D007582 Jejunostomies
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D007582 2005
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D007582 2000
% 216.64/216.88  |- mesh__publicMeSHNote mesh__D007582 88   
% 216.64/216.88  |- skos__prefLabel mesh__D020959 Polyethylene
% 216.64/216.88  |- skos__altLabel mesh__D020959 Polythene
% 216.64/216.88  |- skos__hiddenLabel mesh__D020959 Polyethylene, Low-Density
% 216.64/216.88  |- mesh__recordMaintainer mesh__D020959 jmp
% 216.64/216.88  |- skos__scopeNote mesh__D020959
% 216.64/216.88       A vinyl polymer made from ethylene. It can be branched or linear. Branched or low-density polyethylene is tough and pliable but not to the same degree as linear polyethylene. Linear or high-density polyethylene has a greater hardness and tensile strength. Polyethylene is used in a variety of products, including implants and prostheses.%A%    
% 216.64/216.88  |- skos__historyNote mesh__D020959 Polymers %28%1978-1982%29%
% 216.64/216.88  |- mesh__dateCreated mesh__D020959 1999-11-09
% 216.64/216.88  |- skos__broader mesh__D020959smesh__D011095
% 216.64/216.88  |- skos__hiddenLabel mesh__D020959 Low Density Polyethylene
% 216.64/216.88  |- mesh__recordAuthorizer mesh__D020959 sjn
% 216.64/216.88  |- mesh__dateEstablished mesh__D020959 2000-01-01
% 216.64/216.88  |- mesh__publicMeSHNote mesh__D020959
% 216.64/216.88       2000; POLYTHENE was indexed under POLYETHYLENES %26%  POLYPROPYLENES 1983-1999 %26% POLYMERS 1978-1982%A%  
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D020959 2005
% 216.64/216.88  |- mesh__historyNote mesh__D020959
% 216.64/216.88       2000; for POLYTHENE use PLASTIPORE %28%NM%29% 1978-1999   
% 216.64/216.88  |- skos__historyNote mesh__D020959 Polyethylenes %28%1983-1999%29%
% 216.64/216.88  |- mesh__recordOriginator mesh__D020959 adp
% 216.64/216.88  |- skos__historyNote mesh__D020959 Polypropylenes %28%1983-1999%29%
% 216.64/216.88  |- skos__altLabel mesh__D020959 LDPE
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D020959 2006
% 216.64/216.88  |- rdf__type mesh__D020959sskos__Concept
% 216.64/216.88  |- mesh__dateRevised mesh__D020959 2004-07-07
% 216.64/216.88  |- skos__hiddenLabel mesh__D020959 High Density Polyethylene
% 216.64/216.88  |- skos__altLabel mesh__D020959 HDPE
% 216.64/216.88  |- skos__hiddenLabel mesh__D020959 Polyethylene, High-Density
% 216.64/216.88  |- skos__annotation mesh__D020959 POLYETHYLENES is available   
% 216.64/216.88  |- skos__scopeNote mesh__D031681
% 216.64/216.88       A plant genus of the family PAPAVERACEAE. S. canadensis is the source of sanguinarine extract used in MOUTHWASHES.%A%    
% 216.64/216.88  |- mesh__dateCreated mesh__D031681 2002-07-02
% 216.64/216.88  |- skos__annotation mesh__D031681
% 216.64/216.88       X ref REDROOT: REDROOT PIGWEED see AMARANTHUS is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.64/216.88  |- skos__prefLabel mesh__D031681 Sanguinaria
% 216.64/216.88  |- rdf__type mesh__D031681sskos__Concept
% 216.64/216.88  |- mesh__publicMeSHNote mesh__D031681 2003   
% 216.64/216.88  |- skos__altLabel mesh__D031681 Bloodroot
% 216.64/216.88  |- skos__altLabel mesh__D031681 Redroot
% 216.64/216.88  |- skos__altLabel mesh__D031681 Puccoon, Red
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D031681 2006
% 216.64/216.88  |- mesh__historyNote mesh__D031681 2003   
% 216.64/216.88  |- mesh__dateEstablished mesh__D031681 2003-01-01
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D031681 2004
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D031681 2005
% 216.64/216.88  |- skos__broader mesh__D031681smesh__D028101
% 216.64/216.88  |- skos__altLabel mesh__D031681 Red Puccoon
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D031681 2003
% 216.64/216.88  |- skos__prefLabel mesh__D003990 Dibenzoxepins
% 216.64/216.88  |- mesh__activeMeSHYear mesh__D003990 2001
% 216.64/216.88  |- mesh__recordMaintainer mesh__D003990 TAP
% 216.64/216.88  |- mesh__dateEstablished mesh__D003990 1968-01-01
% 216.64/216.88  |- mesh__dateCreated mesh__D003990 1999-01-01
% 216.64/216.89  |- mesh__activeMeSHYear mesh__D003990 1996
% 216.64/216.89  |- mesh__historyNote mesh__D003990 68   
% 216.64/216.89  |- mesh__activeMeSHYear mesh__D003990 1998
% 216.64/216.89  |- mesh__recordOriginator mesh__D003990 NLM
% 216.64/216.89  |- skos__broader mesh__D003990smesh__D006575
% 216.64/216.89  |- mesh__activeMeSHYear mesh__D003990 2002
% 216.64/216.89  |- mesh__activeMeSHYear mesh__D003990 1997
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003990 1994
% 216.75/216.89  |- mesh__recordAuthorizer mesh__D003990 PLS
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003990 1999
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003990 2003
% 216.75/216.89  |- rdf__type mesh__D003990sskos__Concept
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003990 1993
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003990 2005
% 216.75/216.89  |- mesh__dateRevised mesh__D003990 1992-05-13
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003990 1995
% 216.75/216.89  |- mesh__publicMeSHNote mesh__D003990 68   
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003990 2004
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003990 2006
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003990 2000
% 216.75/216.89  |- rdf__type mesh__D003192sskos__Concept
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003192 2004
% 216.75/216.89  |- mesh__dateEstablished mesh__D003192 1968-01-01
% 216.75/216.89  |- skos__hiddenLabel mesh__D003192 Behaviors, Compulsive
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003192 2003
% 216.75/216.89  |- skos__altLabel mesh__D003192 Behavior, Compulsive
% 216.75/216.89  |- mesh__recordAuthorizer mesh__D003192 sjn
% 216.75/216.89  |- skos__prefLabel mesh__D003192 Compulsive Behavior
% 216.75/216.89  |- skos__broader mesh__D003192smesh__D007175
% 216.75/216.89  |- skos__annotation mesh__D003192 use Cat F3 qualif   
% 216.75/216.89  |- mesh__recordMaintainer mesh__D003192 JLS
% 216.75/216.89  |- mesh__dateRevised mesh__D003192 2002-07-02
% 216.75/216.89  |- skos__related mesh__D003192smesh__D009771
% 216.75/216.89  |- mesh__recordOriginator mesh__D003192 NLM
% 216.75/216.89  |- mesh__historyNote mesh__D003192 68   
% 216.75/216.89  |- mesh__publicMeSHNote mesh__D003192 68   
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003192 2006
% 216.75/216.89  |- skos__scopeNote mesh__D003192
% 216.75/216.89       The behavior of performing an act persistently and repetitively without it leading to reward or pleasure. The act is usually a small, circumscribed behavior, almost ritualistic, yet not pathologically disturbing. Examples of compulsive behavior include twirling of hair, checking something constantly, not wanting pennies in change, straightening tilted pictures, etc.%A%    
% 216.75/216.89  |- skos__hiddenLabel mesh__D003192 Compulsive Behaviors
% 216.75/216.89  |- mesh__dateCreated mesh__D003192 1999-01-01
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003192 2005
% 216.75/216.89  |- skos__altLabel mesh__D019607 Cruciferae
% 216.75/216.89  |- mesh__publicMeSHNote mesh__D019607 2003; see CRUCIFERAE 1998-2002   
% 216.75/216.89  |- rdf__type mesh__D019607sskos__Concept
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D019607 2006
% 216.75/216.89  |- mesh__dateCreated mesh__D019607 1997-06-20
% 216.75/216.89  |- mesh__dateRevised mesh__D019607 2004-07-19
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D019607 2005
% 216.75/216.89  |- mesh__dateEstablished mesh__D019607 1998-01-01
% 216.75/216.89  |- skos__altLabel mesh__D019607 Cress
% 216.75/216.89  |- skos__prefLabel mesh__D019607 Brassicaceae
% 216.75/216.89  |- mesh__recordAuthorizer mesh__D019607 sjn
% 216.75/216.89  |- skos__scopeNote mesh__D019607
% 216.75/216.89       A plant family of the order Capparales, subclass Dilleniidae, class Magnoliopsida. They are mostly herbaceous plants with peppery-flavored leaves, due to gluconapin %28%GLUCOSINOLATES%29% and its hydrolysis product butenylisotrhiocyanate. The family includes many plants of economic importance that have been extensively altered and domesticated by humans. Flowers have 4 petals. Podlike fruits contain a number of seeds. Cress is a general term used for many in the Brassicacea family. Rockcress is usually ARABIS; Bittercress is usually CARDAMINE; Yellowcress is usually RORIPPA; Pennycress is usually THLASPI; Watercress refers to NASTURTIUM; or RORIPPA or TROPAEOLUM; Gardencress refers to LEPIDIUM; Indiancress refers to TROPAEOLUM.%A%    
% 216.75/216.89  |- mesh__recordOriginator mesh__D019607 JLS
% 216.75/216.89  |- mesh__recordMaintainer mesh__D019607 jls
% 216.75/216.89  |- skos__broader mesh__D019607smesh__D019684
% 216.75/216.89  |- skos__annotation mesh__D019607
% 216.75/216.89       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.75/216.89  |- mesh__historyNote mesh__D019607 2003%28%1998%29%   
% 216.75/216.89  |- skos__hiddenLabel mesh__D011624 Polyglutamates, Folate
% 216.75/216.89  |- skos__hiddenLabel mesh__D011624 Folates, Polyglutamate
% 216.75/216.89  |- skos__hiddenLabel mesh__D011624 Acids, Pteroylpolyglutamic
% 216.75/216.89  |- mesh__dateRevised mesh__D011624 2005-06-30
% 216.75/216.89  |- skos__prefLabel mesh__D011624 Pteroylpolyglutamic Acids
% 216.75/216.89  |- mesh__recordOriginator mesh__D011624 RLS
% 216.75/216.89  |- skos__altLabel mesh__D011624 Pteroylpolyglutamates
% 216.75/216.89  |- mesh__recordMaintainer mesh__D011624 ssb
% 216.75/216.89  |- skos__historyNote mesh__D011624 Glutamates %28%1966-1978%29%
% 216.75/216.89  |- skos__scopeNote mesh__D011624
% 216.75/216.89       Derivatives of folic acid %28%pteroylglutamic acid%29%. In gamma-glutamyl linkage they are found in many tissues. They are converted to folic acid by the action of pteroylpolyglutamate hydrolase or synthesized from folic acid by the action of folate polyglutamate synthetase. Synthetic pteroylpolyglutamic acids, which are in alpha-glutamyl linkage, are active in bacterial growth assays.%A%    
% 216.75/216.89  |- mesh__recordAuthorizer mesh__D011624 sjn
% 216.75/216.89  |- skos__historyNote mesh__D011624 Folic Acid %28%1966-1978%29%
% 216.75/216.89  |- rdf__type mesh__D011624sskos__Concept
% 216.75/216.89  |- skos__annotation mesh__D011624
% 216.75/216.89       deficiency: coordinate PTEROYLPOLYGLUTAMIC ACIDS /defic %28%IM%29% with FOLIC ACID DEFICIENCY %28%IM%29%%A%  
% 216.75/216.89  |- mesh__dateCreated mesh__D011624 1978-05-19
% 216.75/216.89  |- mesh__historyNote mesh__D011624
% 216.75/216.89       91%28%79%29%; was see under FOLIC ACID 1979-90   
% 216.75/216.89  |- skos__broader mesh__D011624smesh__D005492
% 216.75/216.89  |- mesh__publicMeSHNote mesh__D011624
% 216.75/216.89       91; was see under FOLIC ACID 1979-90   
% 216.75/216.89  |- mesh__dateEstablished mesh__D011624 1991-01-01
% 216.75/216.89  |- skos__altLabel mesh__D011624 Polyglutamate Folates
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D011624 2006
% 216.75/216.89  |- skos__altLabel mesh__D049294 Phospholipid Translocating Protein
% 216.75/216.89  |- skos__historyNote mesh__D049294 Carrier Proteins %28%1979-2004%29%
% 216.75/216.89  |- skos__hiddenLabel mesh__D049294 Translocator, Aminophospholipid
% 216.75/216.89  |- skos__broader mesh__D049294smesh__D002352
% 216.75/216.89  |- skos__hiddenLabel mesh__D049294 Transporter, Aminophospholipid
% 216.75/216.89  |- mesh__recordMaintainer mesh__D049294 jmp
% 216.75/216.89  |- skos__altLabel mesh__D049294 Phospholipid Exchange Proteins
% 216.75/216.89  |- skos__hiddenLabel mesh__D049294 Translocase, Aminophospholipid
% 216.75/216.89  |- skos__altLabel mesh__D049294 Lecithin Transfer Protein
% 216.75/216.89  |- skos__altLabel mesh__D049294 Phosphatidylinositol Exchange Protein
% 216.75/216.89  |- mesh__dateRevised mesh__D049294 2005-06-30
% 216.75/216.89  |- skos__altLabel mesh__D049294 Phospholipid Exchange Protein
% 216.75/216.89  |- mesh__recordOriginator mesh__D049294 jmp
% 216.75/216.89  |- skos__altLabel mesh__D049294 Aminophospholipid Transporter
% 216.75/216.89  |- mesh__historyNote mesh__D049294 2005%28%1978%29%   
% 216.75/216.89  |- skos__altLabel mesh__D049294 Phospholipid Transfer Protein
% 216.75/216.89  |- skos__altLabel mesh__D049294 Phosphatidylcholine Exchange Protein
% 216.75/216.89  |- skos__altLabel mesh__D049294 Phosphatidyl Transfer Protein
% 216.75/216.89  |- mesh__dateEstablished mesh__D049294 2005-01-01
% 216.75/216.89  |- skos__hiddenLabel mesh__D049294 Transfer Proteins, Phospholipid
% 216.75/216.89  |- skos__hiddenLabel mesh__D049294 Translocase, Phosphatidylserine
% 216.75/216.89  |- rdf__type mesh__D049294sskos__Concept
% 216.75/216.89  |- skos__scopeNote mesh__D049294
% 216.75/216.89       A ubiquitous family of proteins that transport PHOSPHOLIPIDS such as PHOSPHATIDYLINOSITOL and PHOSPHATIDYLCHOLINE between membranes. They play an important role in phospholipid metabolism during vesicular transport and SIGNAL TRANSDUCTION.%A%    
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D049294 2006
% 216.75/216.89  |- skos__altLabel mesh__D049294 Aminophospholipid Translocase
% 216.75/216.89  |- skos__historyNote mesh__D049294 Membrane Proteins %28%1979-2004%29%
% 216.75/216.89  |- skos__broader mesh__D049294smesh__D008565
% 216.75/216.89  |- skos__prefLabel mesh__D049294 Phospholipid Transfer Proteins
% 216.75/216.89  |- skos__altLabel mesh__D049294 Phosphatidylinositol Transfer Protein
% 216.75/216.89  |- skos__altLabel mesh__D049294 Aminophospholipid Flippase
% 216.75/216.89  |- mesh__recordAuthorizer mesh__D049294 sjn
% 216.75/216.89  |- mesh__dateCreated mesh__D049294 2004-07-07
% 216.75/216.89  |- mesh__publicMeSHNote mesh__D049294
% 216.75/216.89       2005; PHOSPHATIDYLINOSITOL TRANSFER PROTEINS was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1979-2004; PHOSPHATIDYLCHOLINE EXCHANGE PROTEIN was indexed CARRIER PROTEINS 1978-2004; PHOSPHOLIPID EXCHANGE PROTEINS was indexed under  PHOSPHOLIPID TRANSFER PROTEINS 2005, MEMBRANE PROTEINS %26% CARRIER PROTEINS 1979-2004%A%  
% 216.75/216.89  |- skos__altLabel mesh__D049294 Phosphatidylcholine Transfer Protein
% 216.75/216.89  |- skos__altLabel mesh__D049294 Aminophospholipid Translocator
% 216.75/216.89  |- skos__hiddenLabel mesh__D049294 Scramblase, Phospholipid
% 216.75/216.89  |- rdf__type mesh__D002898sskos__Concept
% 216.75/216.89  |- mesh__recordMaintainer mesh__D002898 ags
% 216.75/216.89  |- mesh__recordOriginator mesh__D002898 SCD
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D002898 2006A
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D002898 2005
% 216.75/216.89  |- mesh__publicMeSHNote mesh__D002898 87   
% 216.75/216.89  |- skos__prefLabel mesh__D002898 Chromosomes, Human, Pair 8
% 216.75/216.89  |- mesh__dateEstablished mesh__D002898 1987-01-01
% 216.75/216.89  |- skos__altLabel mesh__D002898 Chromosome 8
% 216.75/216.89  |- mesh__dateCreated mesh__D002898 1986-06-19
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D002898 2006
% 216.75/216.89  |- mesh__dateRevised mesh__D002898 2005-07-11
% 216.75/216.89  |- skos__broader mesh__D002898smesh__D002906
% 216.75/216.89  |- skos__historyNote mesh__D002898
% 216.75/216.89       Chromosomes, Human, 6-12 %28%1968-1986%29%
% 216.75/216.89  |- mesh__historyNote mesh__D002898 87   
% 216.75/216.89  |- skos__scopeNote mesh__D002898
% 216.75/216.89       A specific pair of GROUP C CHROMOSOMES of the human chromosome classification.%A%    
% 216.75/216.89  |- mesh__recordAuthorizer mesh__D002898 ags
% 216.75/216.89  |- mesh__recordMaintainer mesh__D007583 lkt
% 216.75/216.89  |- skos__broader mesh__D007583smesh__D007421
% 216.75/216.89  |- skos__scopeNote mesh__D007583
% 216.75/216.89       The middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum.%A%    
% 216.75/216.89  |- mesh__dateRevised mesh__D007583 2003-07-09
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D007583 2006
% 216.75/216.89  |- mesh__recordOriginator mesh__D007583 NLM
% 216.75/216.89  |- mesh__recordAuthorizer mesh__D007583 sjn
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D007583 2005
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D007583 2004
% 216.75/216.89  |- skos__broader mesh__D007583smesh__D041741
% 216.75/216.89  |- rdf__type mesh__D007583sskos__Concept
% 216.75/216.89  |- skos__prefLabel mesh__D007583 Jejunum
% 216.75/216.89  |- skos__hiddenLabel mesh__D007583 Jejunums
% 216.75/216.89  |- skos__annotation mesh__D007583
% 216.75/216.89       inflammation or jejunitis = JEJUNAL DISEASES %28%IM%29% + ENTERITIS %28%IM%29%; jejuno-ileal bypass or shunt or jejuno-ileostomy in obesity: index under JEJUNOILEAL BYPASS %28%note XR ref%29%%A%  
% 216.75/216.89  |- mesh__dateCreated mesh__D007583 1999-01-01
% 216.75/216.89  |- skos__related mesh__D007583smesh__D007582
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D015217 2005
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D015217 2004
% 216.75/216.89  |- mesh__dateEstablished mesh__D015217 1989-01-01
% 216.75/216.89  |- mesh__dateRevised mesh__D015217 2001-07-25
% 216.75/216.89  |- skos__historyNote mesh__D015217 Cholesterol Esters %28%1978-1988%29%
% 216.75/216.89  |- mesh__recordAuthorizer mesh__D015217 sjn
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D015217 2006
% 216.75/216.89  |- skos__broader mesh__D015217smesh__D008064
% 216.75/216.89  |- skos__historyNote mesh__D015217
% 216.75/216.89       Lipid Metabolism, Inborn Errors %28%1966-1988%29%
% 216.75/216.89  |- skos__scopeNote mesh__D015217
% 216.75/216.89       A rare benign adult form of inherited lysosomal lipid storage disease that is due to deficiency of acid lipase. It results in an accumulation of neutral lipids, particularly cholesterol esters, within cells %28%particularly leukocytes, fibroblasts, and liver cells%29%. It is an allelic variant of WOLMAN DISEASE.%A%    
% 216.75/216.89  |- mesh__recordMaintainer mesh__D015217 nns
% 216.75/216.89  |- mesh__recordOriginator mesh__D015217 EJB
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D015217 2002
% 216.75/216.89  |- rdf__type mesh__D015217sskos__Concept
% 216.75/216.89  |- mesh__publicMeSHNote mesh__D015217 89   
% 216.75/216.89  |- skos__altLabel mesh__D015217 Cholesteryl Ester Storage Disease
% 216.75/216.89  |- skos__historyNote mesh__D015217 Lipase %28%1966-1988%29%
% 216.75/216.89  |- mesh__historyNote mesh__D015217 89   
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D015217 2003
% 216.75/216.89  |- skos__prefLabel mesh__D015217 Cholesterol Ester Storage Disease
% 216.75/216.89  |- skos__historyNote mesh__D015217 Lipoidosis %28%1966-1988%29%
% 216.75/216.89  |- mesh__dateCreated mesh__D015217 1988-05-11
% 216.75/216.89  |- skos__broader mesh__D015217smesh__D016464
% 216.75/216.89  |- skos__annotation mesh__D015217
% 216.75/216.89       a lysosomal storage dis; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 216.75/216.89  |- skos__historyNote mesh__D039665
% 216.75/216.89       Peptide Initiation Factors %28%1979-2002%29%
% 216.75/216.89  |- skos__altLabel mesh__D039665 Peptide Initiation Factor IF-3
% 216.75/216.89  |- mesh__publicMeSHNote mesh__D039665
% 216.75/216.89       2003; PEPTIDE INITIATION FACTOR 3 %28%now PROKARYOTIC INITIATION FACTOR-3%29% was indexed under PEPTIDE INITIATION FACTORS 1979-2002; TIF IF3 %26% TRANSLATION INITIATION FACTOR 3 were indexed under PEPTIDE INITIATION FACTORS 1994-2002%A%  
% 216.75/216.89  |- skos__hiddenLabel mesh__D039665 Peptide Initiation Factor IF 3
% 216.75/216.89  |- skos__altLabel mesh__D039665 Peptide Initiation Factor 3
% 216.75/216.89  |- mesh__recordMaintainer mesh__D039665 ags
% 216.75/216.89  |- mesh__recordAuthorizer mesh__D039665 ags
% 216.75/216.89  |- skos__hiddenLabel mesh__D039665 IF-3, Initiation Factor
% 216.75/216.89  |- skos__hiddenLabel mesh__D039665 Initiation Factor IF 3
% 216.75/216.89  |- mesh__recordOriginator mesh__D039665 jmp
% 216.75/216.89  |- skos__hiddenLabel mesh__D039665 Prokaryotic Initiation Factor 3
% 216.75/216.89  |- rdf__type mesh__D039665sskos__Concept
% 216.75/216.89  |- skos__altLabel mesh__D039665 Prokaryotic Peptide Initiation Factor-3
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D039665 2004
% 216.75/216.89  |- skos__hiddenLabel mesh__D039665 Initiation Factor-3, Prokaryotic
% 216.75/216.89  |- skos__hiddenLabel mesh__D039665 Prokaryotic Peptide Initiation Factor 3
% 216.75/216.89  |- skos__altLabel mesh__D039665 Translation Initiation Factor 3
% 216.75/216.89  |- skos__altLabel mesh__D039665 Initiation Factor IF-3
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D039665 2006
% 216.75/216.89  |- mesh__dateEstablished mesh__D039665 2003-01-01
% 216.75/216.89  |- mesh__dateCreated mesh__D039665 2002-07-03
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D039665 2003
% 216.75/216.89  |- mesh__historyNote mesh__D039665
% 216.75/216.89       2003; use PROKARYOTIC INITIATION FACTOR-3 %28%NM%29% 1979-2002; for TIF IF3 %26% TRANSLATION INITIATION FACTOR 3 use EUKARYOTIC INITIATION FACTOR-3 %28%NM%29% 1994-2002%A%  
% 216.75/216.89  |- skos__altLabel mesh__D039665 TIF IF3
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D039665 2005
% 216.75/216.89  |- skos__prefLabel mesh__D039665 Prokaryotic Initiation Factor-3
% 216.75/216.89  |- mesh__dateRevised mesh__D039665 2005-07-11
% 216.75/216.89  |- skos__broader mesh__D039665smesh__D039662
% 216.75/216.89  |- skos__scopeNote mesh__D039665
% 216.75/216.89       A prokaryotic initiation factor that plays a role in recycling of ribosomal subunits for a new round of translational initiation. It binds to 16S RIBOSOMAL RNA and stimulates the dissociation of vacant 70S ribosomes. It may also be involved in the preferential binding of initiator tRNA to the 30S initiation complex.%A%    
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D039665 2006A
% 216.75/216.89  |- skos__altLabel mesh__D003991
% 216.75/216.89       2,5-Dibromo-3-methyl-6-isopropyl-p-benzoquinone
% 216.75/216.89  |- mesh__recordAuthorizer mesh__D003991 sjn
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003991 2003
% 216.75/216.89  |- skos__historyNote mesh__D003991 Bromine %28%1974%29%
% 216.75/216.89  |- mesh__dateEstablished mesh__D003991 1991-01-01
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003991 2006
% 216.75/216.89  |- skos__scopeNote mesh__D003991
% 216.75/216.89       At low concentrations, this compound inhibits reduction of conventional hydrophilic electron acceptors, probably acting as a plastoquinone antagonist. At higher concentrations, it acts as an electron acceptor, intercepting electrons either before or at the site of its inhibitory activity.%A%    
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003991 2002
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003991 2005
% 216.75/216.89  |- mesh__dateCreated mesh__D003991 1974-11-19
% 216.75/216.89  |- skos__prefLabel mesh__D003991 Dibromothymoquinone
% 216.75/216.89  |- skos__historyNote mesh__D003991 Quinones %28%1973-1974%29%
% 216.75/216.89  |- skos__hiddenLabel mesh__D003991
% 216.75/216.89       2,5 Dibromo 3 methyl 6 isopropyl p benzoquinone
% 216.75/216.89  |- mesh__publicMeSHNote mesh__D003991 91; was see under QUINONES 1975-90   
% 216.75/216.89  |- skos__broader mesh__D003991smesh__D016227
% 216.75/216.89  |- mesh__recordMaintainer mesh__D003991 CCR
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003991 2001
% 216.75/216.89  |- mesh__dateRevised mesh__D003991 2000-06-22
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003991 2004
% 216.75/216.89  |- rdf__type mesh__D003991sskos__Concept
% 216.75/216.89  |- mesh__historyNote mesh__D003991
% 216.75/216.89       91%28%75%29%; was see under QUINONES 1975-90   
% 216.75/216.89  |- mesh__recordOriginator mesh__D003991 MEG
% 216.75/216.89  |- skos__hiddenLabel mesh__D003193 Personality, Obsessive-Compulsive
% 216.75/216.89  |- skos__hiddenLabel mesh__D003193 Personality, Anankastic
% 216.75/216.89  |- skos__hiddenLabel mesh__D003193 Obsessive-Compulsive Personalities
% 216.75/216.89  |- skos__hiddenLabel mesh__D003193 Disorder, Compulsive Personality
% 216.75/216.89  |- mesh__recordOriginator mesh__D003193 NLM
% 216.75/216.89  |- skos__hiddenLabel mesh__D003193 Compulsive Personality Disorders
% 216.75/216.89  |- skos__hiddenLabel mesh__D003193 Personality Disorders, Compulsive
% 216.75/216.89  |- skos__scopeNote mesh__D003193
% 216.75/216.89       A personality disorder characterized by an emotionally constricted manner that is unduly conventional, serious, formal, and stingy, by preoccupation with trivial details, rules, order, organization, schedules, and lists, by stubborn insistence on having things one%27%s own way without regard for the effects on others, by excessive devotion to work and productivity to the detriment of interpersonal relationships, and by indecisiveness due to fear of making mistakes. %28%Dorland, 27th ed%29%%A%    
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003193 2006
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003193 1999
% 216.75/216.89  |- mesh__onlineNote mesh__D003193
% 216.75/216.89       use COMPULSIVE PERSONALITY DISORDER to search OBSESSIVE-COMPULSIVE PERSONALITY 1975-80; use COMPULSIVE BEHAVIOR 1969-74%A%  
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003193 2002
% 216.75/216.89  |- mesh__dateRevised mesh__D003193 1997-06-20
% 216.75/216.89  |- skos__hiddenLabel mesh__D003193 Personality, Compulsive
% 216.75/216.89  |- mesh__dateCreated mesh__D003193 1999-01-01
% 216.75/216.89  |- skos__hiddenLabel mesh__D003193 Obsessive Compulsive Personality
% 216.75/216.89  |- skos__hiddenLabel mesh__D003193 Personalities, Obsessive-Compulsive
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003193 2005
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003193 1998
% 216.75/216.89  |- mesh__recordAuthorizer mesh__D003193 SJN
% 216.75/216.89  |- skos__hiddenLabel mesh__D003193 Disorders, Compulsive Personality
% 216.75/216.89  |- mesh__dateEstablished mesh__D003193 1991-01-01
% 216.75/216.89  |- rdf__type mesh__D003193sskos__Concept
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003193 2001
% 216.75/216.89  |- skos__altLabel mesh__D003193 Anankastic Personality
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003193 2004
% 216.75/216.89  |- skos__prefLabel mesh__D003193 Compulsive Personality Disorder
% 216.75/216.89  |- skos__hiddenLabel mesh__D003193 Personalities, Compulsive
% 216.75/216.89  |- skos__hiddenLabel mesh__D003193 Compulsive Personalities
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003193 2000
% 216.75/216.89  |- skos__hiddenLabel mesh__D003193 Personalities, Anankastic
% 216.75/216.89  |- skos__hiddenLabel mesh__D003193 Anankastic Personalities
% 216.75/216.89  |- skos__altLabel mesh__D003193 Personality Disorder, Compulsive
% 216.75/216.89  |- skos__broader mesh__D003193smesh__D010554
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003193 2003
% 216.75/216.89  |- mesh__recordMaintainer mesh__D003193 JLS
% 216.75/216.89  |- mesh__historyNote mesh__D003193
% 216.75/216.89       91%28%81%29%; was see under PERSONALITY DISORDERS 1981-90; was OBSESSIVE-COMPULSIVE PERSONALITY see under PERSONALITY DISORDERS 1975-80 %26% see under COMPULSIVE BEHAVIOR 1969-74%A%  
% 216.75/216.89  |- mesh__publicMeSHNote mesh__D003193
% 216.75/216.89       91; was see under PERSONALITY DISORDERS 1981-90; was OBSESSIVE-COMPULSIVE PERSONALITY see under PERSONALITY DISORDERS 1975-80 %26% see under COMPULSIVE BEHAVIOR 1969-74%A%  
% 216.75/216.89  |- mesh__recordMaintainer mesh__D019608 SYSTEM
% 216.75/216.89  |- skos__annotation mesh__D019608
% 216.75/216.89       an order of the kingdom of Euryarchaeota, of the domain of Archaea%A%  
% 216.75/216.89  |- skos__broader mesh__D019608smesh__D019605
% 216.75/216.89  |- rdf__type mesh__D019608sskos__Concept
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D019608 2006
% 216.75/216.89  |- mesh__dateCreated mesh__D019608 1997-06-20
% 216.75/216.89  |- skos__prefLabel mesh__D019608 Archaeoglobales
% 216.75/216.89  |- skos__scopeNote mesh__D019608
% 216.75/216.89       An order of extremely thermophilic, sulfate-reducing archaea, in the kingdom EURYARCHAEOTA. The single family Archaeoglobaceae contains one genus ARCHAEOGLOBUS.%A%    
% 216.75/216.89  |- mesh__dateRevised mesh__D019608 2005-06-30
% 216.75/216.89  |- mesh__publicMeSHNote mesh__D019608 98   
% 216.75/216.89  |- mesh__dateEstablished mesh__D019608 1998-01-01
% 216.75/216.89  |- mesh__recordOriginator mesh__D019608 AGS
% 216.75/216.89  |- mesh__historyNote mesh__D019608 98   
% 216.75/216.89  |- mesh__recordAuthorizer mesh__D019608 sjn
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D011625 2001
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D011625 1999
% 216.75/216.89  |- rdf__type mesh__D011625sskos__Concept
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D011625 2002
% 216.75/216.89  |- mesh__recordOriginator mesh__D011625 NLM
% 216.75/216.89  |- mesh__recordMaintainer mesh__D011625 TPW
% 216.75/216.89  |- skos__broader mesh__D011625smesh__D003229
% 216.75/216.89  |- mesh__dateCreated mesh__D011625 1999-01-01
% 216.75/216.89  |- skos__annotation mesh__D011625
% 216.75/216.89       a conjunctival dis, not a structure; pterygium of other organs: index under specific organ /abnorm%A%  
% 216.75/216.89  |- mesh__dateRevised mesh__D011625 1997-06-20
% 216.75/216.89  |- mesh__recordAuthorizer mesh__D011625 SJN
% 216.75/216.89  |- skos__hiddenLabel mesh__D011625 Pterygiums
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D011625 2005
% 216.75/216.89  |- skos__scopeNote mesh__D011625
% 216.75/216.89       An abnormal triangular fold of membrane in the interpalpebral fissure, extending from the conjunctiva to the cornea, being immovably united to the cornea at its apex, firmly attached to the sclera throughout its middle portion, and merged with the conjunctiva at its base. %28%Dorland, 27th ed%29%%A%    
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D011625 2003
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D011625 2006
% 216.75/216.89  |- skos__prefLabel mesh__D011625 Pterygium
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D011625 2000
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D011625 2004
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D011625 1998
% 216.75/216.89  |- skos__broader mesh__D002104Q000506smesh__D002104
% 216.75/216.89  |- mesh__preferredCombination mesh__D002104Q000506smesh__D002105
% 216.75/216.89  |- rdf__type mesh__D002104Q000506smesh__CompoundConcept
% 216.75/216.89  |- mesh__recordAuthorizer mesh__D002899 ags
% 216.75/216.89  |- mesh__recordOriginator mesh__D002899 SCD
% 216.75/216.89  |- rdf__type mesh__D002899sskos__Concept
% 216.75/216.89  |- mesh__dateEstablished mesh__D002899 1987-01-01
% 216.75/216.89  |- mesh__dateRevised mesh__D002899 2005-07-11
% 216.75/216.89  |- mesh__historyNote mesh__D002899 87   
% 216.75/216.89  |- skos__altLabel mesh__D002899 Chromosome 9
% 216.75/216.89  |- mesh__recordMaintainer mesh__D002899 ags
% 216.75/216.89  |- mesh__publicMeSHNote mesh__D002899 87   
% 216.75/216.89  |- skos__broader mesh__D002899smesh__D002906
% 216.75/216.89  |- skos__scopeNote mesh__D002899
% 216.75/216.89       A specific pair of GROUP C CHROMSOMES of the human chromosome classification.%A%    
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D002899 2006
% 216.75/216.89  |- mesh__dateCreated mesh__D002899 1986-06-19
% 216.75/216.89  |- skos__prefLabel mesh__D002899 Chromosomes, Human, Pair 9
% 216.75/216.89  |- skos__historyNote mesh__D002899
% 216.75/216.89       Chromosomes, Human, 6-12 %28%1968-1986%29%
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D002899 2006A
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D002899 2005
% 216.75/216.89  |- mesh__recordAuthorizer mesh__D015218 PLS
% 216.75/216.89  |- rdf__type mesh__D015218sskos__Concept
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D015218 2000
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D015218 1996
% 216.75/216.89  |- skos__altLabel mesh__D015218 Sternocostoclavicular Hyperostosis
% 216.75/216.89  |- skos__historyNote mesh__D015218 Bone Diseases %28%1975-1988%29%
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D015218 2001
% 216.75/216.89  |- mesh__publicMeSHNote mesh__D015218
% 216.75/216.89       90; was STERNOCOSTOCLAVICULAR HYPEROSTOSIS 1989   
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D015218 1998
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D015218 2003
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D015218 1997
% 216.75/216.89  |- skos__prefLabel mesh__D015218 Hyperostosis, Sternocostoclavicular
% 216.75/216.89  |- mesh__dateCreated mesh__D015218 1988-05-11
% 216.75/216.89  |- mesh__onlineNote mesh__D015218
% 216.75/216.89       use HYPEROSTOSIS, STERNOCOSTOCLAVICULAR to search STERNOCOSTOCLAVICULAR HYPEROSTOSIS 1989%A%  
% 216.75/216.89  |- skos__scopeNote mesh__D015218
% 216.75/216.89       A rare, benign rheumatologic disorder or syndrome characterized by hyperostosis and soft tissue ossification between the clavicles and the anterior part of the upper ribs. It is often associated with the dermatologic disorder palmoplantar pustulosis, particularly in Japan. Careful diagnosis is required to distinguish it from psoriatic arthritis, OSTEITIS DEFORMANS, and other diseases. Spondylitis of pustulosis palmaris et plantaris is one of the possible causes; also, evidence suggests one origin may be bone infection. Bone imaging is especially useful for diagnosis. It was originally described by Sonozaki in 1974.%A%    
% 216.75/216.89  |- mesh__recordOriginator mesh__D015218 EJB
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D015218 2005
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D015218 2004
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D015218 1999
% 216.75/216.89  |- skos__annotation mesh__D015218 a type of rheum dis; DF: SCCH   
% 216.75/216.89  |- mesh__dateEstablished mesh__D015218 1989-01-01
% 216.75/216.89  |- skos__historyNote mesh__D015218 Sternum %28%1975-1988%29%
% 216.75/216.89  |- skos__historyNote mesh__D015218 Clavicle %28%1975-1988%29%
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D015218 1994
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D015218 1993
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D015218 2002
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D015218 2006
% 216.75/216.89  |- skos__hiddenLabel mesh__D015218 Sternocostoclavicular Hyperostoses
% 216.75/216.89  |- mesh__recordMaintainer mesh__D015218 PLS
% 216.75/216.89  |- skos__broader mesh__D015218smesh__D012216
% 216.75/216.89  |- skos__hiddenLabel mesh__D015218 Hyperostoses, Sternocostoclavicular
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D015218 1995
% 216.75/216.89  |- mesh__historyNote mesh__D015218
% 216.75/216.89       90; was STERNOCOSTOCLAVICULAR HYPEROSTOSIS 1989   
% 216.75/216.89  |- mesh__dateRevised mesh__D015218 1992-05-20
% 216.75/216.89  |- skos__broader mesh__D015218smesh__D015576
% 216.75/216.89  |- mesh__dateEstablished mesh__D031683 2003-01-01
% 216.75/216.89  |- skos__annotation mesh__D031683
% 216.75/216.89       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D031683 2004
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D031683 2005
% 216.75/216.89  |- mesh__historyNote mesh__D031683 2003   
% 216.75/216.89  |- skos__prefLabel mesh__D031683 Passifloraceae
% 216.75/216.89  |- skos__broader mesh__D031683smesh__D019684
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D031683 2003
% 216.75/216.89  |- rdf__type mesh__D031683sskos__Concept
% 216.75/216.89  |- mesh__publicMeSHNote mesh__D031683 2003   
% 216.75/216.89  |- mesh__dateCreated mesh__D031683 2002-07-03
% 216.75/216.89  |- skos__scopeNote mesh__D031683
% 216.75/216.89       A plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida that are herbaceous or woody vines, shrubs, and trees, mostly of warm regions. Many have tendrils in leaf axils. Leaves are alternate. Flowers have 3-5 sepals, petals and stamens. Nearly all species have seeds that bear a fleshy appendage called an aril.%A%    
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D031683 2006
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003992 2006
% 216.75/216.89  |- skos__altLabel mesh__D003992 Cinchocaine
% 216.75/216.89  |- mesh__recordOriginator mesh__D003992 NLM
% 216.75/216.89  |- skos__scopeNote mesh__D003992
% 216.75/216.89       A local anesthetic of the amide type now generally used for surface anesthesia. It is one of the most potent and toxic of the long-acting local anesthetics and its parenteral use is restricted to spinal anesthesia. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1006%29%%A%    
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003992 2005
% 216.75/216.89  |- mesh__recordAuthorizer mesh__D003992 sjn
% 216.75/216.89  |- skos__broader mesh__D003992smesh__D011804
% 216.75/216.89  |- mesh__dateRevised mesh__D003992 2003-07-09
% 216.75/216.89  |- skos__broader mesh__D003992smesh__D000577
% 216.75/216.89  |- mesh__dateCreated mesh__D003992 1999-01-01
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003992 2004
% 216.75/216.89  |- skos__prefLabel mesh__D003992 Dibucaine
% 216.75/216.89  |- rdf__type mesh__D003992sskos__Concept
% 216.75/216.89  |- mesh__recordMaintainer mesh__D003992 ssb
% 216.75/216.89  |- skos__hiddenLabel mesh__D003194 Computerized Self-Instruction Programs
% 216.75/216.89  |- skos__annotation mesh__D003194
% 216.75/216.89       DIAGNOSIS, COMPUTER-ASSISTED is also available   
% 216.75/216.89  |- skos__hiddenLabel mesh__D003194 Computerized Programmed Instruction
% 216.75/216.89  |- skos__broader mesh__D003194smesh__D011380
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003194 2006
% 216.75/216.89  |- mesh__activeMeSHYear mesh__D003194 1999
% 216.75/216.90  |- skos__altLabel mesh__D003194 Self-Instruction Programs, Computerized
% 216.75/216.90  |- mesh__recordMaintainer mesh__D003194 PXP
% 216.75/216.90  |- skos__hiddenLabel mesh__D003194 Instructions, Computer-Assisted
% 216.75/216.90  |- mesh__dateCreated mesh__D003194 1999-01-01
% 216.75/216.90  |- skos__prefLabel mesh__D003194 Computer-Assisted Instruction
% 216.75/216.90  |- mesh__onlineNote mesh__D003194
% 216.75/216.90       use COMPUTER-ASSISTED INSTRUCTION to search COMPUTER ASSISTED INSTRUCTION 1974-90%A%  
% 216.75/216.90  |- skos__hiddenLabel mesh__D003194 Self Instruction Programs, Computerized
% 216.75/216.90  |- mesh__dateEstablished mesh__D003194 1974-01-01
% 216.75/216.90  |- mesh__recordOriginator mesh__D003194 NLM
% 216.75/216.90  |- mesh__activeMeSHYear mesh__D003194 2005
% 216.75/216.90  |- mesh__activeMeSHYear mesh__D003194 1998
% 216.75/216.90  |- skos__hiddenLabel mesh__D003194 Computerized Self-Instruction Program
% 216.75/216.90  |- skos__hiddenLabel mesh__D003194 Computer Assisted Instruction
% 216.75/216.90  |- skos__scopeNote mesh__D003194
% 216.75/216.90       A self-learning technique, usually online, involving interaction of the student with programmed instructional materials.%A%    
% 216.75/216.90  |- rdf__type mesh__D003194sskos__Concept
% 216.75/216.90  |- mesh__publicMeSHNote mesh__D003194
% 216.75/216.90       91; was COMPUTER ASSISTED INSTRUCTION 1974-90   
% 216.75/216.90  |- mesh__activeMeSHYear mesh__D003194 2004
% 216.75/216.90  |- skos__hiddenLabel mesh__D003194 Program, Computerized Self-Instruction
% 216.76/216.90  |- skos__hiddenLabel mesh__D003194 Programs, Computerized Self-Instruction
% 216.76/216.90  |- skos__hiddenLabel mesh__D003194 Computer-Assisted Instructions
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D003194 2002
% 216.76/216.90  |- mesh__dateRevised mesh__D003194 1997-06-20
% 216.76/216.90  |- skos__hiddenLabel mesh__D003194 Self-Instruction Program, Computerized
% 216.76/216.90  |- skos__hiddenLabel mesh__D003194 Instruction, Computer-Assisted
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D003194 2003
% 216.76/216.90  |- mesh__recordAuthorizer mesh__D003194 SJN
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D003194 2001
% 216.76/216.90  |- skos__hiddenLabel mesh__D003194 Instruction, Computerized Programmed
% 216.76/216.90  |- mesh__historyNote mesh__D003194
% 216.76/216.90       91; was COMPUTER ASSISTED INSTRUCTION 1974-90   
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D003194 2000
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D019609 2006
% 216.76/216.90  |- mesh__recordOriginator mesh__D019609 AGS
% 216.76/216.90  |- skos__scopeNote mesh__D019609
% 216.76/216.90       A genus of extremely thermophilic, sulfate-reducing archaea, in the family Archaeoglobaceae.%A%    
% 216.76/216.90  |- mesh__recordAuthorizer mesh__D019609 sjn
% 216.76/216.90  |- skos__broader mesh__D019609smesh__D019608
% 216.76/216.90  |- mesh__dateCreated mesh__D019609 1997-06-20
% 216.76/216.90  |- skos__prefLabel mesh__D019609 Archaeoglobus
% 216.76/216.90  |- mesh__dateRevised mesh__D019609 2005-06-30
% 216.76/216.90  |- mesh__historyNote mesh__D019609 98   
% 216.76/216.90  |- mesh__publicMeSHNote mesh__D019609 98   
% 216.76/216.90  |- mesh__recordMaintainer mesh__D019609 SYSTEM
% 216.76/216.90  |- skos__annotation mesh__D019609
% 216.76/216.90       a genus of archaea, extremely thermophilic   
% 216.76/216.90  |- mesh__dateEstablished mesh__D019609 1998-01-01
% 216.76/216.90  |- rdf__type mesh__D019609sskos__Concept
% 216.76/216.90  |- skos__annotation mesh__D011626
% 216.76/216.90       /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 216.76/216.90  |- skos__hiddenLabel mesh__D011626 Muscles, Pterygoid
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D011626 2005
% 216.76/216.90  |- skos__hiddenLabel mesh__D011626 Muscle, Pterygoid
% 216.76/216.90  |- skos__hiddenLabel mesh__D011626 Pterygoid Muscle
% 216.76/216.90  |- mesh__historyNote mesh__D011626
% 216.76/216.90       91%28%80%29%; was see under MASTICATORY MUSCLES 1980-90   
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D011626 2003
% 216.76/216.90  |- skos__historyNote mesh__D011626 Muscles %28%1966-1979%29%
% 216.76/216.90  |- mesh__recordOriginator mesh__D011626 SMH
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D011626 2006
% 216.76/216.90  |- mesh__dateEstablished mesh__D011626 1991-01-01
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D011626 2004
% 216.76/216.90  |- mesh__dateRevised mesh__D011626 2001-07-25
% 216.76/216.90  |- skos__historyNote mesh__D011626 Masticatory Muscles %28%1966-1979%29%
% 216.76/216.90  |- skos__historyNote mesh__D011626 Facial Muscles %28%1966-1979%29%
% 216.76/216.90  |- skos__prefLabel mesh__D011626 Pterygoid Muscles
% 216.76/216.90  |- skos__broader mesh__D011626smesh__D008410
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D011626 2002
% 216.76/216.90  |- rdf__type mesh__D011626sskos__Concept
% 216.76/216.90  |- skos__scopeNote mesh__D011626
% 216.76/216.90       Two of the masticatory muscles: the internal, or medial, pterygoid muscle and external, or lateral, pterygoid muscle. Action of the former is closing the jaws and that of the latter is opening the jaws, protruding the mandible, and moving the mandible from side to side.%A%    
% 216.76/216.90  |- mesh__recordAuthorizer mesh__D011626 sjn
% 216.76/216.90  |- mesh__publicMeSHNote mesh__D011626
% 216.76/216.90       91; was see under MASTICATORY MUSCLES 1980-90   
% 216.76/216.90  |- mesh__dateCreated mesh__D011626 1979-03-12
% 216.76/216.90  |- mesh__recordMaintainer mesh__D011626 nns
% 216.76/216.90  |- mesh__recordAuthorizer mesh__D044002 sjn
% 216.76/216.90  |- mesh__dateEstablished mesh__D044002 2004-01-01
% 216.76/216.90  |- skos__altLabel mesh__D044002 Mosses
% 216.76/216.90  |- skos__historyNote mesh__D044002 Plants %28%1983-2003%29%
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D044002 2006
% 216.76/216.90  |- mesh__dateCreated mesh__D044002 2003-07-09
% 216.76/216.90  |- rdf__type mesh__D044002sskos__Concept
% 216.76/216.90  |- mesh__publicMeSHNote mesh__D044002
% 216.76/216.90       2004; for MUSCI see BRYOPSIDA 1996-2003   
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D044002 2005
% 216.76/216.90  |- skos__scopeNote mesh__D044002
% 216.76/216.90       A division of the plant kingdom. Bryophyta contains the subdivision, Musci, which contains the classes: Andreaeopsida, BRYOPSIDA, and SPHAGNOPSIDA.%A%    
% 216.76/216.90  |- mesh__recordOriginator mesh__D044002 ssb
% 216.76/216.90  |- skos__prefLabel mesh__D044002 Bryophyta
% 216.76/216.90  |- mesh__historyNote mesh__D044002
% 216.76/216.90       2004; for MUSCI use BRYOPSIDA 1996-2003   
% 216.76/216.90  |- mesh__recordMaintainer mesh__D044002 ssb
% 216.76/216.90  |- skos__broader mesh__D044002smesh__D019669
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D044002 2004
% 216.76/216.90  |- skos__annotation mesh__D044002
% 216.76/216.90       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.76/216.90  |- skos__altLabel mesh__D044002 Mosses, Granite
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D016311 1998
% 216.76/216.90  |- skos__hiddenLabel mesh__D016311 Outlier, DRG
% 216.76/216.90  |- skos__altLabel mesh__D016311 Outliers, Diagnosis-Related Group
% 216.76/216.90  |- skos__hiddenLabel mesh__D016311 Outliers, Diagnostic-Related Group
% 216.76/216.90  |- mesh__recordAuthorizer mesh__D016311 SJN
% 216.76/216.90  |- skos__historyNote mesh__D016311
% 216.76/216.90       Costs and Cost Analysis %28%1986-1990%29%
% 216.76/216.90  |- skos__altLabel mesh__D016311 DRG Outliers
% 216.76/216.90  |- skos__broader mesh__D016311smesh__D003953
% 216.76/216.90  |- skos__hiddenLabel mesh__D016311 Outlier, Diagnosis-Related Group
% 216.76/216.90  |- mesh__recordOriginator mesh__D016311 JHM
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D016311 2000
% 216.76/216.90  |- skos__hiddenLabel mesh__D016311 Diagnosis Related Group Outliers
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D016311 1999
% 216.76/216.90  |- skos__scopeNote mesh__D016311
% 216.76/216.90       In health care reimbursement, especially in the prospective payment system, those patients who require an unusually long hospital stay or whose stay generates unusually high costs.%A%    
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D016311 2001
% 216.76/216.90  |- mesh__dateEstablished mesh__D016311 1991-01-01
% 216.76/216.90  |- skos__hiddenLabel mesh__D016311 Outliers, Diagnosis Related Group
% 216.76/216.90  |- skos__hiddenLabel mesh__D016311 Diagnostic-Related Group Outlier
% 216.76/216.90  |- skos__hiddenLabel mesh__D016311 Diagnostic Related Group Outliers
% 216.76/216.90  |- mesh__recordMaintainer mesh__D016311 PXP
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D016311 2005
% 216.76/216.90  |- skos__prefLabel mesh__D016311 Outliers, DRG
% 216.76/216.90  |- skos__altLabel mesh__D016311 Diagnostic-Related Group Outliers
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D016311 2002
% 216.76/216.90  |- mesh__dateRevised mesh__D016311 1997-06-20
% 216.76/216.90  |- skos__altLabel mesh__D016311 Diagnosis-Related Group Outliers
% 216.76/216.90  |- skos__historyNote mesh__D016311
% 216.76/216.90       Diagnosis-Related Groups %28%1986-1990%29%
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D016311 2003
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D016311 2006
% 216.76/216.90  |- mesh__dateCreated mesh__D016311 1990-05-29
% 216.76/216.90  |- mesh__publicMeSHNote mesh__D016311
% 216.76/216.90       91; DIAGNOSIS-RELATED GROUP OUTLIERS was DIAGNOSTIC RELATED GROUP OUTLIERS 1991%A%  
% 216.76/216.90  |- skos__hiddenLabel mesh__D016311 Diagnosis-Related Group Outlier
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D016311 2004
% 216.76/216.90  |- skos__annotation mesh__D016311
% 216.76/216.90       a concept in health care reimbursement; outliers as a statist concept, index under STATISTICS or specific statist term%A%  
% 216.76/216.90  |- skos__hiddenLabel mesh__D016311 Outlier, Diagnostic-Related Group
% 216.76/216.90  |- rdf__type mesh__D016311sskos__Concept
% 216.76/216.90  |- mesh__historyNote mesh__D016311
% 216.76/216.90       91; DIAGNOSIS-RELATED GROUP OUTLIERS was DIAGNOSTIC RELATED GROUP OUTLIERS 1991%A%  
% 216.76/216.90  |- skos__hiddenLabel mesh__D016311 DRG Outlier
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D007585 2004
% 216.76/216.90  |- skos__scopeNote mesh__D007585
% 216.76/216.90       An ethnic group with historical ties to the land of ISRAEL and the religion of JUDAISM.%A%    
% 216.76/216.90  |- rdf__type mesh__D007585sskos__Concept
% 216.76/216.90  |- mesh__dateCreated mesh__D007585 1999-01-01
% 216.76/216.90  |- mesh__recordAuthorizer mesh__D007585 jls
% 216.76/216.90  |- skos__prefLabel mesh__D007585 Jews
% 216.76/216.90  |- skos__annotation mesh__D007585 specify geog if relevant   
% 216.76/216.90  |- mesh__dateRevised mesh__D007585 2003-10-30
% 216.76/216.90  |- skos__related mesh__D007585smesh__D007599
% 216.76/216.90  |- skos__broader mesh__D007585smesh__D005006
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D007585 2004B
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D007585 2006
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D007585 2004A
% 216.76/216.90  |- mesh__recordMaintainer mesh__D007585 jls
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D007585 2005
% 216.76/216.90  |- mesh__recordOriginator mesh__D007585 NLM
% 216.76/216.90  |- skos__hiddenLabel mesh__D007585 Jew
% 216.76/216.90  |- skos__hiddenLabel mesh__D015219 Futile Substrate Cyclings
% 216.76/216.90  |- skos__hiddenLabel mesh__D015219 Substrate Cycling, Futile
% 216.76/216.90  |- skos__hiddenLabel mesh__D015219 Cyclings, Substrate
% 216.76/216.90  |- mesh__dateCreated mesh__D015219 1988-05-11
% 216.76/216.90  |- skos__hiddenLabel mesh__D015219 Futile Substrate Cycle
% 216.76/216.90  |- skos__hiddenLabel mesh__D015219 Substrate Cyclings
% 216.76/216.90  |- skos__hiddenLabel mesh__D015219 Substrate Cycles, Futile
% 216.76/216.90  |- skos__altLabel mesh__D015219 Futile Substrate Cycles
% 216.76/216.90  |- skos__hiddenLabel mesh__D015219 Cycle, Futile
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D015219 1999
% 216.76/216.90  |- skos__hiddenLabel mesh__D015219 Cyclings, Futile Substrate
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D015219 2000
% 216.76/216.90  |- skos__prefLabel mesh__D015219 Substrate Cycling
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D015219 2006
% 216.76/216.90  |- skos__hiddenLabel mesh__D015219 Cycling, Futile Substrate
% 216.76/216.90  |- skos__hiddenLabel mesh__D015219 Cycling, Substrate
% 216.76/216.90  |- skos__hiddenLabel mesh__D015219 Cycling, Futile
% 216.76/216.90  |- mesh__recordMaintainer mesh__D015219 PXP
% 216.76/216.90  |- mesh__recordOriginator mesh__D015219 EJB
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D015219 1998
% 216.76/216.90  |- skos__historyNote mesh__D015219 Energy Metabolism %28%1975-1988%29%
% 216.76/216.90  |- mesh__publicMeSHNote mesh__D015219 89   
% 216.76/216.90  |- skos__altLabel mesh__D015219 Futile Cycling
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D015219 2005
% 216.76/216.90  |- mesh__dateRevised mesh__D015219 1997-06-20
% 216.76/216.90  |- skos__annotation mesh__D015219
% 216.76/216.90       restricted to enzyme activity; almost never IM; coord NIM with specific enzyme %28%IM%29%%A%  
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D015219 2004
% 216.76/216.90  |- skos__historyNote mesh__D015219
% 216.76/216.90       specific substance/metabolism %28%1975-1988%29%
% 216.76/216.90  |- skos__scopeNote mesh__D015219
% 216.76/216.90       A set of opposing, nonequilibrium reactions catalyzed by different enzymes which act simultaneously, with at least one of the reactions driven by ATP hydrolysis. The results of the cycle are that ATP energy is depleted, heat is produced and no net substrate-to-product conversion is achieved. Examples of substrate cycling are cycling of gluconeogenesis and glycolysis pathways and cycling of the triglycerides and fatty acid pathways. Rates of substrate cycling may be increased many-fold in association with hypermetabolic states resulting from severe burns, cold exposure, hyperthyroidism, or acute exercise.%A%    
% 216.76/216.90  |- skos__hiddenLabel mesh__D015219 Substrate Cycle, Futile
% 216.76/216.90  |- skos__broader mesh__D015219smesh__D004734
% 216.76/216.90  |- mesh__historyNote mesh__D015219 89   
% 216.76/216.90  |- skos__hiddenLabel mesh__D015219 Cycles, Futile Substrate
% 216.76/216.90  |- skos__hiddenLabel mesh__D015219 Cyclings, Futile
% 216.76/216.90  |- skos__hiddenLabel mesh__D015219 Substrate Cyclings, Futile
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D015219 2002
% 216.76/216.90  |- skos__hiddenLabel mesh__D015219 Cycles, Futile
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D015219 2003
% 216.76/216.90  |- mesh__dateEstablished mesh__D015219 1989-01-01
% 216.76/216.90  |- skos__hiddenLabel mesh__D015219 Cycle, Futile Substrate
% 216.76/216.90  |- mesh__recordAuthorizer mesh__D015219 SJN
% 216.76/216.90  |- rdf__type mesh__D015219sskos__Concept
% 216.76/216.90  |- skos__hiddenLabel mesh__D015219 Futile Cyclings
% 216.76/216.90  |- skos__hiddenLabel mesh__D015219 Futile Cycle
% 216.76/216.90  |- skos__altLabel mesh__D015219 Futile Substrate Cycling
% 216.76/216.90  |- skos__broader mesh__D015219smesh__D008660
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D015219 2001
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D031684 2006
% 216.76/216.90  |- skos__altLabel mesh__D031684 Uncaria procumbens
% 216.76/216.90  |- mesh__dateEstablished mesh__D031684 2003-01-01
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D031684 2004
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D031684 2005
% 216.76/216.90  |- mesh__historyNote mesh__D031684 2003   
% 216.76/216.90  |- skos__altLabel mesh__D031684 Devils Claw
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D031684 2003
% 216.76/216.90  |- rdf__type mesh__D031684sskos__Concept
% 216.76/216.90  |- skos__prefLabel mesh__D031684 Harpagophytum
% 216.76/216.90  |- skos__scopeNote mesh__D031684
% 216.76/216.90       A plant genus of the family PEDALIACEAE. Members contain harpagoside and are the source of extract WS 1531.%A%    
% 216.76/216.90  |- skos__annotation mesh__D031684
% 216.76/216.90       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.76/216.90  |- mesh__publicMeSHNote mesh__D031684 2003   
% 216.76/216.90  |- mesh__dateCreated mesh__D031684 2002-07-03
% 216.76/216.90  |- skos__broader mesh__D031684smesh__D029601
% 216.76/216.90  |- mesh__historyNote mesh__D003993
% 216.76/216.90       91%28%77%29%; was see under PHTHALIC ACIDS 1977-90   
% 216.76/216.90  |- skos__hiddenLabel mesh__D003993 Phthalate, Dibutyl
% 216.76/216.90  |- skos__broader mesh__D003993smesh__D010795
% 216.76/216.90  |- rdf__type mesh__D003993sskos__Concept
% 216.76/216.90  |- skos__altLabel mesh__D003993 Di-n-Butyl Phthalate
% 216.76/216.90  |- mesh__recordMaintainer mesh__D003993 ssb
% 216.76/216.90  |- skos__hiddenLabel mesh__D003993 Phthalate, Di-n-Butyl
% 216.76/216.90  |- skos__prefLabel mesh__D003993 Dibutyl Phthalate
% 216.76/216.90  |- skos__scopeNote mesh__D003993
% 216.76/216.90       A plasticizer used in most plastics and found in water, air, soil, plants and animals. It may have some adverse effects with long-term exposure.%A%    
% 216.76/216.90  |- skos__hiddenLabel mesh__D003993 Phthalate, Butyl
% 216.76/216.90  |- mesh__recordAuthorizer mesh__D003993 sjn
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D003993 2006
% 216.76/216.90  |- mesh__dateEstablished mesh__D003993 1991-01-01
% 216.76/216.90  |- mesh__publicMeSHNote mesh__D003993
% 216.76/216.90       91; was see under PHTHALIC ACIDS 1977-90   
% 216.76/216.90  |- mesh__recordOriginator mesh__D003993 SH
% 216.76/216.90  |- mesh__dateRevised mesh__D003993 2005-06-30
% 216.76/216.90  |- skos__altLabel mesh__D003993 Butyl Phthalate
% 216.76/216.90  |- skos__hiddenLabel mesh__D003993 Di n Butyl Phthalate
% 216.76/216.90  |- skos__historyNote mesh__D003993 Phthalic Acids %28%1969-1976%29%
% 216.76/216.90  |- mesh__dateCreated mesh__D003993 1976-04-13
% 216.76/216.90  |- skos__broader mesh__D003195smesh__D003199
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D003195 2005
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Systems, Distributed
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Intranet
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Distributed Database
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Database, Distributed
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D003195 2006
% 216.76/216.90  |- mesh__dateCreated mesh__D003195 1986-06-18
% 216.76/216.90  |- skos__scopeNote mesh__D003195
% 216.76/216.90       A system containing any combination of computers, computer terminals, printers, audio or visual display devices, or telephones interconnected by telecommunications equipment or cables: used to transmit or receive information. %28%Random House Unabridged Dictionary, 2d ed%29%%A%    
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Networks, Computer Communication
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Communication Network, Computer
% 216.76/216.90  |- skos__prefLabel mesh__D003195 Computer Communication Networks
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Protocol, Network Communication
% 216.76/216.90  |- mesh__recordMaintainer mesh__D003195 jls
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Network Management, Computer
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Management, Computer Network
% 216.76/216.90  |- mesh__publicMeSHNote mesh__D003195
% 216.76/216.90       1991; see COMPUTER SYSTEMS 1987-1990   
% 216.76/216.90  |- mesh__historyNote mesh__D003195
% 216.76/216.90       1991%28%1987%29%; use COMPUTER SYSTEMS 1987-1990   
% 216.76/216.90  |- rdf__type mesh__D003195sskos__Concept
% 216.76/216.90  |- mesh__recordAuthorizer mesh__D003195 sjn
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Network, Telecommunication
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Protocols, Network Communication
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Networks, Telecommunication
% 216.76/216.90  |- mesh__dateRevised mesh__D003195 2004-07-07
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Computer Communication Network
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Communication Networks, Computer
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Distributed System
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Telecommunication Network
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Distributed Databases
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Network Communication Protocol
% 216.76/216.90  |- mesh__dateEstablished mesh__D003195 1991-01-01
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 System, Distributed
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Network, Computer Communication
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Extranet
% 216.76/216.90  |- mesh__recordOriginator mesh__D003195 EC
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Communication Protocols, Network
% 216.76/216.90  |- skos__hiddenLabel mesh__D003195 Communication Protocol, Network
% 216.76/216.90  |- skos__prefLabel mesh__D011627 Puberty
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D011627 2005
% 216.76/216.90  |- skos__related mesh__D011627smesh__D012741
% 216.76/216.90  |- mesh__recordAuthorizer mesh__D011627 sjn
% 216.76/216.90  |- skos__annotation mesh__D011627
% 216.76/216.90       human only: for animal use AGING; GROWTH or SEX MATURATION%A%  
% 216.76/216.90  |- skos__broader mesh__D011627smesh__D046468
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D011627 2006
% 216.76/216.90  |- mesh__dateRevised mesh__D011627 2004-07-13
% 216.76/216.90  |- rdf__type mesh__D011627sskos__Concept
% 216.76/216.90  |- mesh__recordMaintainer mesh__D011627 sjn
% 216.76/216.90  |- skos__hiddenLabel mesh__D011627 Puberties
% 216.76/216.90  |- mesh__dateCreated mesh__D011627 1999-01-01
% 216.76/216.90  |- mesh__recordOriginator mesh__D011627 NLM
% 216.76/216.90  |- skos__scopeNote mesh__D011627
% 216.76/216.90       A period in the human life in which the development of the hypothalamic-pituitary-gonadal system takes place and reaches full maturity. The onset of synchronized endocrine events in puberty lead to the capacity for reproduction %28%FERTILITY%29%, development of secondary SEX CHARACTERISTICS, and other changes seen in ADOLESCENT DEVELOPMENT.%A%    
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D044003 2006
% 216.76/216.90  |- mesh__recordAuthorizer mesh__D044003 sjn
% 216.76/216.90  |- mesh__dateCreated mesh__D044003 2003-07-09
% 216.76/216.90  |- mesh__dateEstablished mesh__D044003 2004-01-01
% 216.76/216.90  |- skos__broader mesh__D044003smesh__D044002
% 216.76/216.90  |- rdf__type mesh__D044003sskos__Concept
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D044003 2005
% 216.76/216.90  |- mesh__publicMeSHNote mesh__D044003
% 216.76/216.90       2004; for SPHAGNUM see BRYOPSIDA 1996-2003; see PLANTS 1986-1995%A%  
% 216.76/216.90  |- skos__historyNote mesh__D044003 Bryopsida %28%1995-2003%29%
% 216.76/216.90  |- mesh__recordOriginator mesh__D044003 ssb
% 216.76/216.90  |- skos__prefLabel mesh__D044003 Sphagnopsida
% 216.76/216.90  |- mesh__historyNote mesh__D044003
% 216.76/216.90       2004; for SPHAGNUM use BRYOPSIDA 1996-2003, use PLANTS 1986-1995%A%  
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D044003 2004
% 216.76/216.90  |- skos__annotation mesh__D044003
% 216.76/216.90       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.76/216.90  |- skos__altLabel mesh__D044003 Mosses, Peat
% 216.76/216.90  |- skos__altLabel mesh__D044003 Peat Moss
% 216.76/216.90  |- skos__altLabel mesh__D044003 Moss, Sphagnum
% 216.76/216.90  |- mesh__recordMaintainer mesh__D044003 ssb
% 216.76/216.90  |- skos__scopeNote mesh__D044003
% 216.76/216.90       A class of BRYOPHYTA which is best known for Sphagnum forming PEAT bogs.%A%    
% 216.76/216.90  |- skos__altLabel mesh__D016312 Patient Noncompliance
% 216.76/216.90  |- skos__hiddenLabel mesh__D016312 Refusals, Treatment
% 216.76/216.90  |- skos__historyNote mesh__D016312 Cooperative Behavior %28%1971-1974%29%
% 216.76/216.90  |- skos__broader mesh__D016312smesh__D010342
% 216.76/216.90  |- mesh__onlineNote mesh__D016312
% 216.76/216.90       use PATIENT COMPLIANCE to search PATIENT NON-COMPLIANCE 1982-90; use PATIENT DROPOUTS to search PATIENT NON-COMPLIANCE 1975-81%A%  
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D016312 2003A
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D016312 2004
% 216.76/216.90  |- skos__broader mesh__D016312smesh__D015438
% 216.76/216.90  |- skos__altLabel mesh__D016312 Patient Refusal of Treatment
% 216.76/216.90  |- skos__altLabel mesh__D016312 Patient Non-Adherence
% 216.76/216.90  |- mesh__publicMeSHNote mesh__D016312
% 216.76/216.90       91; PATIENT NON-COMPLIANCE was see PATIENT COMPLIANCE 1982-90 %26% was see PATIENT DROPOUTS 1975-81%A%  
% 216.76/216.90  |- skos__altLabel mesh__D016312 Patient Nonadherence
% 216.76/216.90  |- skos__hiddenLabel mesh__D016312 Non-Adherence, Patient
% 216.76/216.90  |- skos__hiddenLabel mesh__D016312 Non-Compliance, Patient
% 216.76/216.90  |- skos__hiddenLabel mesh__D016312 Patient Non Adherence
% 216.76/216.90  |- skos__historyNote mesh__D016312 Patient Compliance %28%1975-1990%29%
% 216.76/216.90  |- mesh__dateCreated mesh__D016312 1990-05-29
% 216.76/216.90  |- mesh__dateRevised mesh__D016312 2002-11-06
% 216.76/216.90  |- skos__related mesh__D016312smesh__D007258
% 216.76/216.90  |- skos__hiddenLabel mesh__D016312 Refusal, Treatment
% 216.76/216.90  |- skos__altLabel mesh__D016312 Refusal of Treatment
% 216.76/216.90  |- mesh__dateEstablished mesh__D016312 1991-01-01
% 216.76/216.90  |- mesh__historyNote mesh__D016312
% 216.76/216.90       91; PATIENT NON-COMPLIANCE was see PATIENT COMPLIANCE 1982-90 %26% was see PATIENT DROPOUTS 1975-81%A%  
% 216.76/216.90  |- skos__related mesh__D016312smesh__D010352
% 216.76/216.90  |- mesh__recordOriginator mesh__D016312 TGC
% 216.76/216.90  |- skos__related mesh__D016312smesh__D016743
% 216.76/216.90  |- skos__hiddenLabel mesh__D016312 Nonadherence, Patient
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D016312 2005
% 216.76/216.90  |- skos__related mesh__D016312smesh__D010349
% 216.76/216.90  |- skos__hiddenLabel mesh__D016312 Noncompliance, Patient
% 216.76/216.90  |- mesh__recordAuthorizer mesh__D016312 sjn
% 216.76/216.90  |- skos__prefLabel mesh__D016312 Treatment Refusal
% 216.76/216.90  |- skos__hiddenLabel mesh__D016312 Patient Non Compliance
% 216.76/216.90  |- skos__scopeNote mesh__D016312
% 216.76/216.90       Patient or client refusal of or resistance to medical, psychological, or psychiatric treatment. %28%APA, Thesaurus of Psychological Index Terms, 8th ed.%29%%A%    
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D016312 2006
% 216.76/216.90  |- skos__annotation mesh__D016312
% 216.76/216.90       do not confuse with PHYSICIAN REFUSAL TO TREAT see REFUSAL TO TREAT%A%  
% 216.76/216.90  |- rdf__type mesh__D016312sskos__Concept
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D016312 2003
% 216.76/216.90  |- mesh__recordMaintainer mesh__D016312 sjn
% 216.76/216.90  |- skos__broader mesh__D016312smesh__D028701
% 216.76/216.90  |- skos__hiddenLabel mesh__D016312 Treatment Refusals
% 216.76/216.90  |- rdf__type mesh__D007586sskos__Concept
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D007586 2006
% 216.76/216.90  |- skos__broader mesh__D007586smesh__D010559
% 216.76/216.90  |- skos__hiddenLabel mesh__D007586 Application, Job
% 216.76/216.90  |- skos__hiddenLabel mesh__D007586 Employment Applications
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D007586 1992
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D007586 2001
% 216.76/216.90  |- skos__hiddenLabel mesh__D007586 Applications, Employment
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D007586 1997
% 216.76/216.90  |- skos__historyNote mesh__D007586 Personnel Management %28%1966-1982%29%
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D007586 1993
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D007586 2002
% 216.76/216.90  |- skos__altLabel mesh__D007586 Employment Application
% 216.76/216.90  |- mesh__dateRevised mesh__D007586 1991-06-10
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D007586 1998
% 216.76/216.90  |- skos__prefLabel mesh__D007586 Job Application
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D007586 2003
% 216.76/216.90  |- mesh__dateEstablished mesh__D007586 1991-01-01
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D007586 1994
% 216.76/216.90  |- mesh__recordAuthorizer mesh__D007586 PLS
% 216.76/216.90  |- skos__hiddenLabel mesh__D007586 Applications, Job
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D007586 1999
% 216.76/216.90  |- skos__historyNote mesh__D007586 Employment %28%1970-1982%29%
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D007586 2004
% 216.76/216.90  |- skos__hiddenLabel mesh__D007586 Resumes, Job
% 216.76/216.90  |- mesh__recordMaintainer mesh__D007586 PLS
% 216.76/216.90  |- skos__hiddenLabel mesh__D007586 Job Resumes
% 216.76/216.90  |- mesh__publicMeSHNote mesh__D007586
% 216.76/216.90       91; was see under PERSONNEL MANAGEMENT 1983-90   
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D007586 1995
% 216.76/216.90  |- skos__hiddenLabel mesh__D007586 Application, Employment
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D007586 2005
% 216.76/216.90  |- mesh__dateCreated mesh__D007586 1982-04-28
% 216.76/216.90  |- skos__hiddenLabel mesh__D007586 Job Applications
% 216.76/216.90  |- mesh__recordOriginator mesh__D007586 EC
% 216.76/216.90  |- skos__scopeNote mesh__D007586
% 216.76/216.90       Process of applying for employment. It includes written application for employment or personal appearance.%A%    
% 216.76/216.90  |- skos__hiddenLabel mesh__D007586 Job Resume
% 216.76/216.90  |- mesh__historyNote mesh__D007586
% 216.76/216.90       91%28%83%29%; was see under PERSONNEL MANAGEMENT 1983-90   
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D007586 2000
% 216.76/216.90  |- skos__annotation mesh__D007586 no qualif   
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D007586 1996
% 216.76/216.90  |- skos__annotation mesh__D012720
% 216.76/216.90       no qualif; TRAUMA SEVERITY INDICES is also available but do not confuse with TRIAGE, emerg selection of patients by priority of need%A%  
% 216.76/216.90  |- skos__hiddenLabel mesh__D012720 Index Severities, Illness
% 216.76/216.90  |- skos__broader mesh__D012720smesh__D006305
% 216.76/216.90  |- mesh__activeMeSHYear mesh__D012720 2005
% 216.76/216.90  |- mesh__publicMeSHNote mesh__D012720
% 216.76/216.90       89; was see under DIAGNOSTIC RELATED GROUPS 1986-88; was SEVERITY OF ILLNESS CLASSIFICATION see CASE MIX 1984-85%A%  
% 216.76/216.90  |- skos__scopeNote mesh__D012720
% 216.76/216.90       Levels of severity of illness within a diagnostic group which are established by various measurement criteria.%A%    
% 216.76/216.90  |- skos__hiddenLabel mesh__D012720 Illness Index Severity
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D012720 2002
% 216.76/216.91  |- mesh__recordMaintainer mesh__D012720 PXP
% 216.76/216.91  |- skos__hiddenLabel mesh__D012720 Illness Index Severities
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D012720 2006
% 216.76/216.91  |- mesh__recordOriginator mesh__D012720 EC
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D012720 2003
% 216.76/216.91  |- skos__hiddenLabel mesh__D012720 Index Severity, Illness
% 216.76/216.91  |- rdf__type mesh__D012720sskos__Concept
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D012720 2000
% 216.76/216.91  |- mesh__dateEstablished mesh__D012720 1989-01-01
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D012720 2004
% 216.76/216.91  |- mesh__historyNote mesh__D012720
% 216.76/216.91       89%28%86%29%; was see under DIAGNOSTIC RELATED GROUPS 1986-88; was SEVERITY OF ILLNESS CLASSIFICATION see CASE MIX 1984-85%A%  
% 216.76/216.91  |- mesh__recordAuthorizer mesh__D012720 sjn
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D012720 2001
% 216.76/216.91  |- mesh__onlineNote mesh__D012720
% 216.76/216.91       search DIAGNOSTIC RELATED GROUPS 1984-85   
% 216.76/216.91  |- mesh__dateRevised mesh__D012720 1999-11-03
% 216.76/216.91  |- skos__prefLabel mesh__D012720 Severity of Illness Index
% 216.76/216.91  |- mesh__dateCreated mesh__D012720 1985-05-23
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D031685 2005
% 216.76/216.91  |- mesh__dateCreated mesh__D031685 2002-07-03
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D031685 2003
% 216.76/216.91  |- rdf__type mesh__D031685sskos__Concept
% 216.76/216.91  |- skos__prefLabel mesh__D031685 Sesamum
% 216.76/216.91  |- mesh__dateEstablished mesh__D031685 2003-01-01
% 216.76/216.91  |- skos__annotation mesh__D031685
% 216.76/216.91       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.76/216.91  |- mesh__historyNote mesh__D031685 2003   
% 216.76/216.91  |- skos__scopeNote mesh__D031685
% 216.76/216.91       A plant genus of the family PEDALIACEAE that is the source of the edible seed and SESAME OIL.%A%    
% 216.76/216.91  |- mesh__publicMeSHNote mesh__D031685 2003   
% 216.76/216.91  |- skos__broader mesh__D031685smesh__D029601
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D031685 2006
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D031685 2004
% 216.76/216.91  |- skos__hiddenLabel mesh__D003994
% 216.76/216.91       Adenosine-3%27%,5%27%-Monophosphate, Dibutyryl
% 216.76/216.91  |- skos__broader mesh__D003994smesh__D000242
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003994 2004
% 216.76/216.91  |- rdf__type mesh__D003994sskos__Concept
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003994 2002
% 216.76/216.91  |- mesh__dateEstablished mesh__D003994 1974-01-01
% 216.76/216.91  |- skos__hiddenLabel mesh__D003994 N%27%,O%27% Dibutyryl cAMP
% 216.76/216.91  |- skos__altLabel mesh__D003994 %28%But%29%%28%2%29% cAMP
% 216.76/216.91  |- skos__prefLabel mesh__D003994 Bucladesine
% 216.76/216.91  |- skos__altLabel mesh__D003994 Dibutyryl Adenosine 3,5 Monophosphate
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003994 2003
% 216.76/216.91  |- skos__hiddenLabel mesh__D003994 AMP, Dibutyryl Cyclic
% 216.76/216.91  |- skos__altLabel mesh__D003994
% 216.76/216.91       Dibutyryl Adenosine-3%27%,5%27%-Monophosphate
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003994 2006
% 216.76/216.91  |- skos__hiddenLabel mesh__D003994 Sodium Salt Bucladesine
% 216.76/216.91  |- mesh__recordMaintainer mesh__D003994 ssb
% 216.76/216.91  |- mesh__historyNote mesh__D003994 94; was DIBUTYRYL CYCLIC AMP 1974-93   
% 216.76/216.91  |- skos__altLabel mesh__D003994 N%27%,O%27%-Dibutyryl-cAMP
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003994 2005
% 216.76/216.91  |- mesh__publicMeSHNote mesh__D003994
% 216.76/216.91       94; was DIBUTYRYL CYCLIC AMP 1974-93   
% 216.76/216.91  |- skos__hiddenLabel mesh__D003994 Cyclic AMP, Dibutyryl
% 216.76/216.91  |- skos__annotation mesh__D003994 DF: DIBU CYCL AMP   
% 216.76/216.91  |- mesh__recordOriginator mesh__D003994 NLM
% 216.76/216.91  |- mesh__recordAuthorizer mesh__D003994 sjn
% 216.76/216.91  |- skos__hiddenLabel mesh__D003994
% 216.76/216.91       Dibutyryl Adenosine 3%27%,5%27% Monophosphate
% 216.76/216.91  |- skos__altLabel mesh__D003994
% 216.76/216.91       N%28%6%29%,0%28%2%27%%29%-Dibutyryl Cyclic AMP
% 216.76/216.91  |- skos__scopeNote mesh__D003994
% 216.76/216.91       A cyclic nucleotide derivative that mimics the action of endogenous CYCLIC AMP and is capable of permeating the cell membrane. It has vasodilator properties and is used as a cardiac stimulant. %28%From Merck Index, 11th ed%29%%A%    
% 216.76/216.91  |- skos__hiddenLabel mesh__D003994 Monosodium Salt Bucladesine
% 216.76/216.91  |- mesh__dateCreated mesh__D003994 1999-01-01
% 216.76/216.91  |- skos__altLabel mesh__D003994 Dibutyryl Cyclic AMP
% 216.76/216.91  |- skos__hiddenLabel mesh__D003994 Disodium Salt Bucladesine
% 216.76/216.91  |- mesh__onlineNote mesh__D003994
% 216.76/216.91       use BUCLADESINE to search DIBUTYRYL CYCLIC AMP 1974-93   
% 216.76/216.91  |- mesh__dateRevised mesh__D003994 2001-07-25
% 216.76/216.91  |- mesh__dateCreated mesh__D003196 1986-06-18
% 216.76/216.91  |- skos__scopeNote mesh__D003196
% 216.76/216.91       The process of pictorial communication, between human and computers, in which the computer input and output have the form of charts, drawings, or other appropriate pictorial representation.%A%    
% 216.76/216.91  |- mesh__recordOriginator mesh__D003196 EC
% 216.76/216.91  |- mesh__dateRevised mesh__D003196 2004-07-13
% 216.76/216.91  |- mesh__publicMeSHNote mesh__D003196 87   
% 216.76/216.91  |- mesh__historyNote mesh__D003196 87   
% 216.76/216.91  |- rdf__type mesh__D003196sskos__Concept
% 216.76/216.91  |- mesh__dateEstablished mesh__D003196 1987-01-01
% 216.76/216.91  |- skos__hiddenLabel mesh__D003196 Graphics, Computer
% 216.76/216.91  |- skos__broader mesh__D003196smesh__D003626
% 216.76/216.91  |- skos__hiddenLabel mesh__D003196 Computer Graphic
% 216.76/216.91  |- skos__prefLabel mesh__D003196 Computer Graphics
% 216.76/216.91  |- skos__broader mesh__D003196smesh__D003205
% 216.76/216.91  |- mesh__recordAuthorizer mesh__D003196 sjn
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003196 2005
% 216.76/216.91  |- skos__hiddenLabel mesh__D003196 Graphic, Computer
% 216.76/216.91  |- mesh__recordMaintainer mesh__D003196 sjn
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003196 2006
% 216.76/216.91  |- rdf__type mesh__D044802sskos__Concept
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D044802 2006
% 216.76/216.91  |- mesh__historyNote mesh__D044802 2004   
% 216.76/216.91  |- mesh__dateCreated mesh__D044802 2003-07-09
% 216.76/216.91  |- mesh__publicMeSHNote mesh__D044802 2004   
% 216.76/216.91  |- mesh__dateEstablished mesh__D044802 2004-01-01
% 216.76/216.91  |- skos__prefLabel mesh__D044802 Euglena longa
% 216.76/216.91  |- skos__scopeNote mesh__D044802
% 216.76/216.91       A species of ALGAE in the genus EUGLENA, family Euglenaceae. It is a colorless heterotrophic flagellate.%A%    
% 216.76/216.91  |- skos__altLabel mesh__D044802 Astasia longa
% 216.76/216.91  |- skos__broader mesh__D044802smesh__D005055
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D044802 2004
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D044802 2005
% 216.76/216.91  |- mesh__publicMeSHNote mesh__D011628 81   
% 216.76/216.91  |- skos__scopeNote mesh__D011628
% 216.76/216.91       The lack of development of SEXUAL MATURATION in boys and girls at a chronological age that is 2.5 standard deviations above the mean age at onset of PUBERTY in a population. Delayed puberty can be classified by defects in the hypothalamic LHRH pulse generator, the PITUITARY GLAND, or the GONADS. These patients will undergo spontaneous but delayed puberty whereas patients with SEXUAL INFANTILISM will not.%A%    
% 216.76/216.91  |- skos__annotation mesh__D011628 human only   
% 216.76/216.91  |- mesh__dateEstablished mesh__D011628 1981-01-01
% 216.76/216.91  |- mesh__dateRevised mesh__D011628 2005-06-30
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D011628 2006
% 216.76/216.91  |- skos__altLabel mesh__D011628 Delayed Puberty
% 216.76/216.91  |- mesh__recordOriginator mesh__D011628 VDK
% 216.76/216.91  |- skos__prefLabel mesh__D011628 Puberty, Delayed
% 216.76/216.91  |- mesh__recordAuthorizer mesh__D011628 sjn
% 216.76/216.91  |- mesh__historyNote mesh__D011628 81   
% 216.76/216.91  |- skos__broader mesh__D011628smesh__D006058
% 216.76/216.91  |- mesh__dateCreated mesh__D011628 1980-05-09
% 216.76/216.91  |- mesh__recordMaintainer mesh__D011628 lkt
% 216.76/216.91  |- rdf__type mesh__D011628sskos__Concept
% 216.76/216.91  |- skos__historyNote mesh__D011628 Puberty %28%1966-1980%29%
% 216.76/216.91  |- rdf__type mesh__D044004sskos__Concept
% 216.76/216.91  |- mesh__dateCreated mesh__D044004 2003-07-09
% 216.76/216.91  |- mesh__historyNote mesh__D044004 2004   
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D044004 2006
% 216.76/216.91  |- mesh__dateEstablished mesh__D044004 2004-01-01
% 216.76/216.91  |- skos__scopeNote mesh__D044004
% 216.76/216.91       A group of XANTHENES that contain a 9-keto OXYGEN.     
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D044004 2005
% 216.76/216.91  |- mesh__publicMeSHNote mesh__D044004 2004   
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D044004 2004
% 216.76/216.91  |- skos__hiddenLabel mesh__D044004 9 Oxoxanthene
% 216.76/216.91  |- skos__historyNote mesh__D044004 Xanthenes %28%1963-2003%29%
% 216.76/216.91  |- skos__broader mesh__D044004smesh__D014966
% 216.76/216.91  |- skos__prefLabel mesh__D044004 Xanthones
% 216.76/216.91  |- skos__altLabel mesh__D044004 9-Oxoxanthene
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 v-abl Oncogene
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 Gene, abl
% 216.76/216.91  |- mesh__recordOriginator mesh__D016313 AGS
% 216.76/216.91  |- mesh__recordMaintainer mesh__D016313 nns
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 Proto-Oncogenes, c-abl
% 216.76/216.91  |- skos__altLabel mesh__D016313 abl Genes
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 bcr-abl Proto-Oncogene
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 abl Gene
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 Oncogene, bcr-v-abl
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 Proto-Oncogene, bcr-abl
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 v abl Genes
% 216.76/216.91  |- skos__altLabel mesh__D016313 v-abl Genes
% 216.76/216.91  |- skos__altLabel mesh__D016313 c-abl Proto-Oncogenes
% 216.76/216.91  |- skos__related mesh__D016313smesh__D016044
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 Proto-Oncogenes, bcr-abl
% 216.76/216.91  |- mesh__publicMeSHNote mesh__D016313 91   
% 216.76/216.91  |- mesh__dateCreated mesh__D016313 1990-06-28
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 Genes, v-abl
% 216.76/216.91  |- skos__altLabel mesh__D016313 v-abl Oncogenes
% 216.76/216.91  |- skos__prefLabel mesh__D016313 Genes, abl
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 Proto-Oncogene, c-abl
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 Oncogene, abl
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 Oncogenes, abl
% 216.76/216.91  |- mesh__dateEstablished mesh__D016313 1991-01-01
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 bcr v abl Oncogenes
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 v abl Oncogenes
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 c abl Genes
% 216.76/216.91  |- skos__related mesh__D016313smesh__D016315
% 216.76/216.91  |- mesh__dateRevised mesh__D016313 2005-06-30
% 216.76/216.91  |- skos__annotation mesh__D016313
% 216.76/216.91       abl stands for %22%ABelson Leukemia%22%   
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 Gene, c-abl
% 216.76/216.91  |- skos__scopeNote mesh__D016313
% 216.76/216.91       Retrovirus-associated DNA sequences %28%abl%29% originally isolated from the Abelson murine leukemia virus %28%Ab-MuLV%29%. The proto-oncogene abl %28%c-abl%29% codes for a protein that is a member of the tyrosine kinase family. The human c-abl gene is located at 9q34.1 on the long arm of chromosome 9. It is activated by translocation to bcr on chromosome 22 in chronic myelogenous leukemia.%A%    
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 c-abl Gene
% 216.76/216.91  |- mesh__historyNote mesh__D016313 91   
% 216.76/216.91  |- skos__historyNote mesh__D016313 Oncogenes %28%1982-1990%29%
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 c abl Proto Oncogenes
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 Oncogenes, bcr-v-abl
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D016313 2006
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 Genes, c-abl
% 216.76/216.91  |- mesh__recordAuthorizer mesh__D016313 sjn
% 216.76/216.91  |- rdf__type mesh__D016313sskos__Concept
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 v-abl Gene
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 c-abl Proto-Oncogene
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 bcr abl Proto Oncogenes
% 216.76/216.91  |- skos__broader mesh__D016313smesh__D011519
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 Oncogene, v-abl
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 abl Oncogenes
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 Gene, v-abl
% 216.76/216.91  |- skos__related mesh__D016313smesh__D016374
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 Oncogenes, v-abl
% 216.76/216.91  |- skos__hiddenLabel mesh__D016313 bcr-v-abl Oncogene
% 216.76/216.91  |- skos__scopeNote mesh__D007587
% 216.76/216.91       Statement of the position requirements, qualifications for the position, wage range, and any special conditions expected of the employee.%A%    
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D007587 1993
% 216.76/216.91  |- skos__hiddenLabel mesh__D007587 Description, Position
% 216.76/216.91  |- skos__hiddenLabel mesh__D007587 Job Descriptions
% 216.76/216.91  |- mesh__recordMaintainer mesh__D007587 TAP
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D007587 1996
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D007587 2005
% 216.76/216.91  |- mesh__recordOriginator mesh__D007587 EC
% 216.76/216.91  |- skos__hiddenLabel mesh__D007587 Position Descriptions
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D007587 2000
% 216.76/216.91  |- mesh__publicMeSHNote mesh__D007587
% 216.76/216.91       91; was see under PERSONNEL MANAGEMENT Aug 1977-90   
% 216.76/216.91  |- mesh__dateEstablished mesh__D007587 1991-01-01
% 216.76/216.91  |- skos__hiddenLabel mesh__D007587 Description, Job
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D007587 1997
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D007587 1994
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D007587 2006
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D007587 2001
% 216.76/216.91  |- mesh__historyNote mesh__D007587
% 216.76/216.91       91%28%Aug 77%29%; was see under PERSONNEL MANAGEMENT 1977-90   
% 216.76/216.91  |- skos__hiddenLabel mesh__D007587 Descriptions, Job
% 216.76/216.91  |- skos__altLabel mesh__D007587 Position Description
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D007587 1995
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D007587 2003
% 216.76/216.91  |- skos__hiddenLabel mesh__D007587 Descriptions, Position
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D007587 1998
% 216.76/216.91  |- skos__prefLabel mesh__D007587 Job Description
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D007587 2004
% 216.76/216.91  |- mesh__recordAuthorizer mesh__D007587 PLS
% 216.76/216.91  |- mesh__dateRevised mesh__D007587 1992-05-14
% 216.76/216.91  |- rdf__type mesh__D007587sskos__Concept
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D007587 2002
% 216.76/216.91  |- skos__broader mesh__D007587smesh__D010559
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D007587 1999
% 216.76/216.91  |- mesh__dateCreated mesh__D007587 1977-05-11
% 216.76/216.91  |- skos__related mesh__D026741smesh__D026241
% 216.76/216.91  |- mesh__historyNote mesh__D026741 2006 %28%2002%29%   
% 216.76/216.91  |- rdf__type mesh__D026741sskos__Concept
% 216.76/216.91  |- mesh__recordMaintainer mesh__D026741 lkt
% 216.76/216.91  |- mesh__dateCreated mesh__D026741 2001-07-25
% 216.76/216.91  |- skos__hiddenLabel mesh__D026741 Physical Therapy Technique
% 216.76/216.91  |- skos__scopeNote mesh__D026741
% 216.76/216.91       Therapeutic modalities frequently used by physical therapists or physiotherapists to promote, maintain, or restore the physical and physiological well-being of an individual.%A%    
% 216.76/216.91  |- mesh__dateEstablished mesh__D026741 2002-01-01
% 216.76/216.91  |- skos__related mesh__D026741smesh__D026201
% 216.76/216.91  |- skos__hiddenLabel mesh__D026741 Physiotherapies %28%Techniques%29%
% 216.76/216.91  |- skos__annotation mesh__D026741
% 216.76/216.91       general or unspecified; prefer specifics; SPEC = PHYSICAL THERAPY %28%SPECIALTY%29%%A%  
% 216.76/216.91  |- skos__hiddenLabel mesh__D026741 Modality, Physical Therapy
% 216.76/216.91  |- skos__altLabel mesh__D026741 Physiotherapy %28%Techniques%29%
% 216.76/216.91  |- mesh__publicMeSHNote mesh__D026741
% 216.76/216.91       2006; see PHYSICAL THERAPY TECHNIQUES 2002-2005, see PHYSICAL THERAPY 1963-2001%A%  
% 216.76/216.91  |- skos__hiddenLabel mesh__D026741 Techniques, Physical Therapy
% 216.76/216.91  |- mesh__dateRevised mesh__D026741 2005-06-30
% 216.76/216.91  |- skos__prefLabel mesh__D026741 Physical Therapy Modalities
% 216.76/216.91  |- mesh__recordOriginator mesh__D026741 ssb
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D026741 2006
% 216.76/216.91  |- mesh__recordAuthorizer mesh__D026741 sjn
% 216.76/216.91  |- skos__altLabel mesh__D026741 Physical Therapy Techniques
% 216.76/216.91  |- skos__hiddenLabel mesh__D026741 Physical Therapy Modality
% 216.76/216.91  |- skos__hiddenLabel mesh__D026741 Modalities, Physical Therapy
% 216.76/216.91  |- skos__related mesh__D026741smesh__D011182
% 216.76/216.91  |- skos__broader mesh__D026741smesh__D013812
% 216.76/216.91  |- skos__altLabel mesh__D012721 Novartis Brand of Carbaril
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 Fido%27%s FreeItch
% 216.76/216.91  |- skos__broader mesh__D012721smesh__D002219
% 216.76/216.91  |- skos__altLabel mesh__D012721
% 216.76/216.91       David Veterinary Laboratories Brand of Carbaril
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 Carbaril Novartis Brand
% 216.76/216.91  |- mesh__recordAuthorizer mesh__D012721 sjn
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 Carbaril Cl%C3%%A9%ment Brand
% 216.76/216.91  |- skos__altLabel mesh__D012721 Avicopharma Brand of Carbaril
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 Fido%27%s Free Itch
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 Carbaril Coophavet Brand
% 216.76/216.91  |- skos__broader mesh__D012721smesh__D009281
% 216.76/216.91  |- skos__historyNote mesh__D012721 Insecticides %28%1966-1970%29%
% 216.76/216.91  |- mesh__dateEstablished mesh__D012721 1974-01-01
% 216.76/216.91  |- mesh__onlineNote mesh__D012721
% 216.76/216.91       use CARBARYL to search SEVIN 1971-91 %28%as Prov 1971-73%29%   
% 216.76/216.91  |- mesh__publicMeSHNote mesh__D012721
% 216.76/216.91       92; was SEVIN 1974-91; CARBARYL was see SEVIN 1976-91; SEVIN was see CARBARYL 1991-95%A%  
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D012721 2006
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 G Wizz
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 Carbaril Mavlab Brand
% 216.76/216.91  |- skos__altLabel mesh__D012721 Cl%C3%%A9%ment Brand of Carbaril
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 Lyddy, Joseph
% 216.76/216.91  |- skos__altLabel mesh__D012721 Virbac Brand of Carbaril
% 216.76/216.91  |- mesh__dateCreated mesh__D012721 1999-01-01
% 216.76/216.91  |- skos__prefLabel mesh__D012721 Carbaryl
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 DogNet Insecticide Poudre
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 18, Concentrat VO
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 Carbaril Biov%C3%%A9% Brand
% 216.76/216.91  |- mesh__dateRevised mesh__D012721 2004-07-07
% 216.76/216.91  |- skos__altLabel mesh__D012721 IntraVeno Brand of Carbaril
% 216.76/216.91  |- mesh__recordOriginator mesh__D012721 NLM
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 insecticide Moureau, Poudre
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 Dog Net Insecticide Poudre
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 Carbaril Sanofi Brand
% 216.76/216.91  |- skos__altLabel mesh__D012721 V%C3%%A9%toquinol Brand of Carbaril
% 216.76/216.91  |- skos__altLabel mesh__D012721 1-Naphthyl-N-methylcarbamate
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 insecticide Vetoquinol, Poudre
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 Carbaril Sogeval Brand
% 216.76/216.91  |- skos__altLabel mesh__D012721 Joseph Lyddy
% 216.76/216.91  |- mesh__historyNote mesh__D012721
% 216.76/216.91       92; was SEVIN 1971-91 %28%Prov 1971-73%29%; CARBARYL was see SEVIN 1976-91; SEVIN was see CARBARYL 1991-95%A%  
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 Carbaril V%C3%%A9%toquinol Brand
% 216.76/216.91  |- skos__altLabel mesh__D012721 Carbaril
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 Moureau, Poudre insecticide
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 VO 18, Concentrat
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 GWizz
% 216.76/216.91  |- skos__altLabel mesh__D012721 Sanofi Brand of Carbaril
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 Carbaril Avicopharma Brand
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 Carbaril Virbac Brand
% 216.76/216.91  |- skos__altLabel mesh__D012721 Mavlab Brand of Carbaril
% 216.76/216.91  |- skos__annotation mesh__D012721 TN 111 for eff on insects   
% 216.76/216.91  |- skos__altLabel mesh__D012721 Biov%C3%%A9% Brand of Carbaril
% 216.76/216.91  |- rdf__type mesh__D012721sskos__Concept
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 Vetoquinol, Poudre insecticide
% 216.76/216.91  |- skos__historyNote mesh__D012721 Carbamates %28%1966-1970%29%
% 216.76/216.91  |- skos__scopeNote mesh__D012721
% 216.76/216.91       A carbamate insecticide and parasiticide. It is a potent anticholinesterase agent belonging to the carbamate group of reversible cholinesterase inhibitors. It has a particularly low toxicity from dermal absorption and is used for control of head lice in some countries.%A%    
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 Carbaril Ornis Brand
% 216.76/216.91  |- skos__altLabel mesh__D012721 Sogeval Brand of Carbaril
% 216.76/216.91  |- mesh__recordMaintainer mesh__D012721 ssb
% 216.76/216.91  |- skos__hiddenLabel mesh__D012721 Carbaril IntraVeno Brand
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D012721 2005
% 216.76/216.91  |- skos__altLabel mesh__D012721 Ornis Brand of Carbaril
% 216.76/216.91  |- skos__altLabel mesh__D012721 Coophavet Brand of Carbaril
% 216.76/216.91  |- rdf__type mesh__D031686sskos__Concept
% 216.76/216.91  |- skos__scopeNote mesh__D031686
% 216.76/216.91       A plant genus of the family ASTERACEAE. The common name of marigold is also used for CALENDULA.%A%    
% 216.76/216.91  |- skos__annotation mesh__D031686
% 216.76/216.91       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.76/216.91  |- mesh__dateCreated mesh__D031686 2002-07-03
% 216.76/216.91  |- skos__altLabel mesh__D031686 Pericon
% 216.76/216.91  |- mesh__publicMeSHNote mesh__D031686 2003   
% 216.76/216.91  |- mesh__dateEstablished mesh__D031686 2003-01-01
% 216.76/216.91  |- skos__broader mesh__D031686smesh__D019659
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D031686 2005
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D031686 2003
% 216.76/216.91  |- mesh__historyNote mesh__D031686 2003   
% 216.76/216.91  |- skos__prefLabel mesh__D031686 Tagetes
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D031686 2006
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D031686 2004
% 216.76/216.91  |- mesh__historyNote mesh__D003995
% 216.76/216.91       91%28%78%29%; was see under GUANOSINE CYCLIC MONOPHOSPHATE 1980-90; was see under GUANOSINE CYCLIC-3%27%,5%27%-MONOPHOSPHATE 1978-79%A%  
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003995 1994
% 216.76/216.91  |- skos__hiddenLabel mesh__D003995 GMP, Dibutyryl Cyclic
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003995 1999
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003995 2004
% 216.76/216.91  |- skos__prefLabel mesh__D003995 Dibutyryl Cyclic GMP
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003995 2002
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003995 1995
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003995 2005
% 216.76/216.91  |- skos__hiddenLabel mesh__D003995 Cyclic GMP, Dibutyryl
% 216.76/216.91  |- skos__annotation mesh__D003995 DF: DIBU CYCL GMP   
% 216.76/216.91  |- skos__altLabel mesh__D003995
% 216.76/216.91       Dibutyryl Guanosine-3%27%,5%27%-Monophosphate
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003995 2006
% 216.76/216.91  |- mesh__recordAuthorizer mesh__D003995 PLS
% 216.76/216.91  |- skos__historyNote mesh__D003995
% 216.76/216.91       Guanosine Cyclic Monophosphate %28%1971-1977%29%
% 216.76/216.91  |- skos__hiddenLabel mesh__D003995
% 216.76/216.91       Dibutyryl Guanosine 3%27%,5%27% Monophosphate
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003995 1996
% 216.76/216.91  |- mesh__recordMaintainer mesh__D003995 PLS
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003995 1997
% 216.76/216.91  |- mesh__recordOriginator mesh__D003995 RLS
% 216.76/216.91  |- skos__scopeNote mesh__D003995
% 216.76/216.91       N-%28%1-Oxobutyl%29%-cyclic 3%27%,5%27%-%28%hydrogen phosphate%29%-2%27%-butanoate guanosine. A derivative of cyclic GMP. It has a higher resistance to extracellular and intracellular phosphodiesterase than cyclic GMP.%A%    
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003995 2000
% 216.76/216.91  |- skos__hiddenLabel mesh__D003995
% 216.76/216.91       Guanosine-3%27%,5%27%-Monophosphate, Dibutyryl
% 216.76/216.91  |- skos__altLabel mesh__D003995 Dibutyryl Guanosine 3,5 Monophosphate
% 216.76/216.91  |- skos__broader mesh__D003995smesh__D006152
% 216.76/216.91  |- mesh__publicMeSHNote mesh__D003995
% 216.76/216.91       91; was see under GUANOSINE CYCLIC MONOPHOSPHATE 1980-90; was see under GUANOSINE CYCLIC-3%27%,5%27%-MONOPHOSPHATE 1978-79%A%  
% 216.76/216.91  |- mesh__dateCreated mesh__D003995 1977-05-20
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003995 1998
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003995 2003
% 216.76/216.91  |- mesh__dateRevised mesh__D003995 1993-06-03
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003995 2001
% 216.76/216.91  |- mesh__dateEstablished mesh__D003995 1991-01-01
% 216.76/216.91  |- rdf__type mesh__D003995sskos__Concept
% 216.76/216.91  |- mesh__dateRevised mesh__D003197 2004-07-07
% 216.76/216.91  |- mesh__recordAuthorizer mesh__D003197 sjn
% 216.76/216.91  |- skos__prefLabel mesh__D003197 Computer Literacy
% 216.76/216.91  |- skos__broader mesh__D003197smesh__D003142
% 216.76/216.91  |- mesh__recordOriginator mesh__D003197 EC
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003197 2005
% 216.76/216.91  |- skos__hiddenLabel mesh__D003197 Literacies, Computer
% 216.76/216.91  |- mesh__dateEstablished mesh__D003197 1987-01-01
% 216.76/216.91  |- skos__hiddenLabel mesh__D003197 Literacy, Computer
% 216.76/216.91  |- skos__annotation mesh__D003197 IM; no qualif   
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D003197 2006
% 216.76/216.91  |- mesh__publicMeSHNote mesh__D003197 87   
% 216.76/216.91  |- mesh__dateCreated mesh__D003197 1986-06-18
% 216.76/216.91  |- skos__scopeNote mesh__D003197
% 216.76/216.91       General learning, knowledge, and fluency with computer terms; also, becoming familiar with how computers operate and how they are programmed.%A%    
% 216.76/216.91  |- mesh__historyNote mesh__D003197 87   
% 216.76/216.91  |- mesh__recordMaintainer mesh__D003197 jls
% 216.76/216.91  |- skos__hiddenLabel mesh__D003197 Computer Literacies
% 216.76/216.91  |- rdf__type mesh__D003197sskos__Concept
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D011629 2006
% 216.76/216.91  |- skos__prefLabel mesh__D011629 Puberty, Precocious
% 216.76/216.91  |- skos__broader mesh__D011629smesh__D006058
% 216.76/216.91  |- mesh__dateRevised mesh__D011629 2005-06-30
% 216.76/216.91  |- mesh__recordOriginator mesh__D011629 NLM
% 216.76/216.91  |- rdf__type mesh__D011629sskos__Concept
% 216.76/216.91  |- mesh__dateCreated mesh__D011629 1999-01-01
% 216.76/216.91  |- mesh__recordAuthorizer mesh__D011629 sjn
% 216.76/216.91  |- skos__scopeNote mesh__D011629
% 216.76/216.91       Development of SEXUAL MATURATION in boys and girls at a chronological age that is 2.5 standard deviations below the mean age at onset of PUBERTY in the population. This early maturation of the hypothalamic-pituitary-gonadal axis results in sexual precocity, elevated serum levels of GONADOTROPINS and GONADAL STEROID HORMONES such as ESTRADIOL and TESTOSTERONE.%A%    
% 216.76/216.91  |- skos__altLabel mesh__D011629 Precocious Puberty
% 216.76/216.91  |- mesh__recordMaintainer mesh__D011629 lkt
% 216.76/216.91  |- skos__annotation mesh__D011629 human only   
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D008680 2006
% 216.76/216.91  |- skos__altLabel mesh__D008680 m-Hydroxynorephedrine
% 216.76/216.91  |- skos__altLabel mesh__D008680 Merck Brand of Metaraminol Bitartrate
% 216.76/216.91  |- skos__altLabel mesh__D008680
% 216.76/216.91       Merck Sharp %26% Dohme Brand of Metaraminol Bitartrate
% 216.76/216.91  |- skos__altLabel mesh__D008680 meta-Hydroxynorephedrine
% 216.76/216.91  |- mesh__dateRevised mesh__D008680 2005-06-30
% 216.76/216.91  |- skos__prefLabel mesh__D008680 Metaraminol
% 216.76/216.91  |- mesh__recordMaintainer mesh__D008680 CCR
% 216.76/216.91  |- rdf__type mesh__D008680sskos__Concept
% 216.76/216.91  |- mesh__recordOriginator mesh__D008680 NLM
% 216.76/216.91  |- skos__altLabel mesh__D008680 Metaradrin
% 216.76/216.91  |- skos__broader mesh__D008680smesh__D010665
% 216.76/216.91  |- mesh__dateCreated mesh__D008680 1999-01-01
% 216.76/216.91  |- skos__scopeNote mesh__D008680
% 216.76/216.91       An adrenergic agonist that acts predominantly at alpha adrenergic receptors and also stimulates the release of norepinephrine. It has been used primarily as a vasoconstrictor in the treatment of hypotension.%A%    
% 216.76/216.91  |- mesh__recordAuthorizer mesh__D008680 sjn
% 216.76/216.91  |- skos__altLabel mesh__D008680 Isophenylephrine
% 216.76/216.91  |- skos__hiddenLabel mesh__D008680 meta Hydroxynorephedrine
% 216.76/216.91  |- skos__hiddenLabel mesh__D008680 m Hydroxynorephedrine
% 216.76/216.91  |- skos__hiddenLabel mesh__D008680 Bitartrate, Metaraminol
% 216.76/216.91  |- skos__scopeNote mesh__D044005
% 216.76/216.91       A group of ISOQUINOLINES in which the nitrogen containing ring is protonated. They derive from the non-enzymatic Pictet-Spengler condensation of CATECHOLAMINES with ALDEHYDES.%A%    
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D044005 2005
% 216.76/216.91  |- mesh__publicMeSHNote mesh__D044005 2004   
% 216.76/216.91  |- skos__prefLabel mesh__D044005 Tetrahydroisoquinolines
% 216.76/216.91  |- mesh__activeMeSHYear mesh__D044005 2004
% 216.76/216.91  |- skos__hiddenLabel mesh__D044005 Tetrahydro Isoquinolines
% 216.76/216.91  |- skos__altLabel mesh__D044005 Tetrahydro-Isoquinolines
% 216.76/216.91  |- skos__historyNote mesh__D044005 Isoquinolines %28%1969-2003%29%
% 216.76/216.91  |- mesh__dateEstablished mesh__D044005 2004-01-01
% 216.76/216.92  |- mesh__historyNote mesh__D044005 2004   
% 216.76/216.92  |- skos__altLabel mesh__D044005 1,2,3,4-Tetrahydroisoquinolines
% 216.76/216.92  |- skos__broader mesh__D044005smesh__D007546
% 216.76/216.92  |- rdf__type mesh__D044005sskos__Concept
% 216.76/216.92  |- mesh__dateCreated mesh__D044005 2003-07-09
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D044005 2006
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D016314 2001
% 216.76/216.92  |- mesh__recordMaintainer mesh__D016314 TWD
% 216.76/216.92  |- mesh__recordAuthorizer mesh__D016314 sjn
% 216.76/216.92  |- mesh__dateRevised mesh__D016314 2000-06-22
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D016314 2004
% 216.76/216.92  |- skos__scopeNote mesh__D016314
% 216.76/216.92       A kappa opioid receptor agonist. The compound has analgesic action and shows positive inotropic effects on the electrically stimulated left atrium. It also affects various types of behavior in mammals such as locomotion, rearing, and grooming.%A%    
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D016314 2006
% 216.76/216.92  |- mesh__dateEstablished mesh__D016314 1991-01-01
% 216.76/216.92  |- skos__hiddenLabel mesh__D016314 Win 35197 2
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D016314 2003
% 216.76/216.92  |- mesh__publicMeSHNote mesh__D016314 91   
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D016314 2005
% 216.76/216.92  |- rdf__type mesh__D016314sskos__Concept
% 216.76/216.92  |- skos__broader mesh__D016314smesh__D003496
% 216.76/216.92  |- mesh__historyNote mesh__D016314 91   
% 216.76/216.92  |- mesh__recordOriginator mesh__D016314 RLS
% 216.76/216.92  |- skos__altLabel mesh__D016314 Ethylketazocine
% 216.76/216.92  |- skos__prefLabel mesh__D016314 Ethylketocyclazocine
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D016314 2002
% 216.76/216.92  |- mesh__dateCreated mesh__D016314 1990-05-25
% 216.76/216.92  |- skos__historyNote mesh__D016314 Cyclazocine %28%1966-1990%29%
% 216.76/216.92  |- skos__hiddenLabel mesh__D016314 Win351972
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007588 2005
% 216.76/216.92  |- skos__hiddenLabel mesh__D007588 Satisfactions, Job
% 216.76/216.92  |- skos__historyNote mesh__D007588 Personal Satisfaction %28%1972-1975%29%
% 216.76/216.92  |- mesh__historyNote mesh__D007588 76   
% 216.76/216.92  |- skos__altLabel mesh__D007588 Work Satisfaction
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007588 2002
% 216.76/216.92  |- mesh__recordMaintainer mesh__D007588 JLS
% 216.76/216.92  |- skos__scopeNote mesh__D007588
% 216.76/216.92       Personal satisfaction relative to the work situation.     
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007588 2006
% 216.76/216.92  |- skos__hiddenLabel mesh__D007588 Work Satisfactions
% 216.76/216.92  |- skos__prefLabel mesh__D007588 Job Satisfaction
% 216.76/216.92  |- mesh__publicMeSHNote mesh__D007588 76   
% 216.76/216.92  |- skos__hiddenLabel mesh__D007588 Job Satisfactions
% 216.76/216.92  |- mesh__recordAuthorizer mesh__D007588 SJN
% 216.76/216.92  |- mesh__dateRevised mesh__D007588 1997-06-20
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007588 2003
% 216.76/216.92  |- skos__hiddenLabel mesh__D007588 Satisfaction, Work
% 216.76/216.92  |- mesh__recordOriginator mesh__D007588 EC
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007588 2000
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007588 1998
% 216.76/216.92  |- skos__hiddenLabel mesh__D007588 Satisfaction, Job
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007588 2004
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007588 2001
% 216.76/216.92  |- rdf__type mesh__D007588sskos__Concept
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007588 1999
% 216.76/216.92  |- skos__broader mesh__D007588smesh__D011590
% 216.76/216.92  |- mesh__dateEstablished mesh__D007588 1976-01-01
% 216.76/216.92  |- skos__hiddenLabel mesh__D007588 Satisfactions, Work
% 216.76/216.92  |- mesh__dateCreated mesh__D007588 1975-07-25
% 216.76/216.92  |- skos__annotation mesh__D007588 no qualif   
% 216.76/216.92  |- mesh__recordOriginator mesh__D004290 NLM
% 216.76/216.92  |- skos__prefLabel mesh__D004290 2,5-Dimethoxy-4-Methylamphetamine
% 216.76/216.92  |- mesh__dateEstablished mesh__D004290 1991-01-01
% 216.76/216.92  |- skos__altLabel mesh__D004290
% 216.76/216.92       1-%28%2,5-Dimethoxy-4-Methylphenyl%29%-2-Aminopropane
% 216.76/216.92  |- mesh__recordAuthorizer mesh__D004290 sjn
% 216.76/216.92  |- mesh__dateCreated mesh__D004290 1999-01-01
% 216.76/216.92  |- rdf__type mesh__D004290sskos__Concept
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D004290 2005
% 216.76/216.92  |- skos__altLabel mesh__D004290 DOM
% 216.76/216.92  |- mesh__recordMaintainer mesh__D004290 jls
% 216.76/216.92  |- skos__broader mesh__D004290smesh__D000662
% 216.76/216.92  |- skos__scopeNote mesh__D004290
% 216.76/216.92       A psychedelic phenyl isopropylamine derivative, commonly called DOM, whose mood-altering effects and mechanism of action may be similar to those of LSD.%A%    
% 216.76/216.92  |- skos__annotation mesh__D004290 DF: 2 5 DOM   
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D004290 2006
% 216.76/216.92  |- mesh__historyNote mesh__D004290 2001%28%1973%29%   
% 216.76/216.92  |- mesh__dateRevised mesh__D004290 2004-07-19
% 216.76/216.92  |- skos__hiddenLabel mesh__D004290 2,5 Dimethoxy 4 Methylamphetamine
% 216.76/216.92  |- mesh__publicMeSHNote mesh__D004290
% 216.76/216.92       2001; see DOM 1991-2000 %26% AMPHETAMINES 1973-90   
% 216.76/216.92  |- skos__altLabel mesh__D004290 2 5 DOM
% 216.76/216.92  |- mesh__recordMaintainer mesh__D012722 ssb
% 216.76/216.92  |- skos__broader mesh__D012722smesh__D014866
% 216.76/216.92  |- skos__hiddenLabel mesh__D012722 Sludges
% 216.76/216.92  |- mesh__dateCreated mesh__D012722 1999-01-01
% 216.76/216.92  |- skos__annotation mesh__D012722
% 216.76/216.92       X ref SLUDGE: usually mudlike ooze in sewage but non-sewage sludge is indexed under other specific waste term%A%  
% 216.76/216.92  |- skos__broader mesh__D012722smesh__D018505
% 216.76/216.92  |- skos__prefLabel mesh__D012722 Sewage
% 216.76/216.92  |- skos__scopeNote mesh__D012722
% 216.76/216.92       Refuse liquid or waste matter carried off by sewers. %28%Webster, 3d ed%29%%A%    
% 216.76/216.92  |- mesh__recordOriginator mesh__D012722 NLM
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D012722 2006
% 216.76/216.92  |- mesh__recordAuthorizer mesh__D012722 sjn
% 216.76/216.92  |- mesh__dateRevised mesh__D012722 2005-06-30
% 216.76/216.92  |- rdf__type mesh__D012722sskos__Concept
% 216.76/216.92  |- skos__hiddenLabel mesh__D050841 Glycine Decarboxylase P-protein
% 216.76/216.92  |- mesh__dateEstablished mesh__D050841 2006-01-01
% 216.76/216.92  |- rdf__type mesh__D050841sskos__Concept
% 216.76/216.92  |- skos__broader mesh__D050841smesh__D050959
% 216.76/216.92  |- skos__altLabel mesh__D050841 P-protein, Glycine Decarboxylase
% 216.76/216.92  |- skos__hiddenLabel mesh__D050841 Decarboxylase, Glycine
% 216.76/216.92  |- skos__hiddenLabel mesh__D050841 Glycine Cleavage System P Protein
% 216.76/216.92  |- skos__hiddenLabel mesh__D050841 Decarboxylase P-protein, Glycine
% 216.76/216.92  |- skos__altLabel mesh__D050841 Glycine Decarboxylase Complex P-Protein
% 216.76/216.92  |- skos__prefLabel mesh__D050841
% 216.76/216.92       Glycine Dehydrogenase %28%Decarboxylating%29%
% 216.76/216.92  |- mesh__recordMaintainer mesh__D050841 AKE
% 216.76/216.92  |- mesh__recordOriginator mesh__D050841 AKE
% 216.76/216.92  |- mesh__recordAuthorizer mesh__D050841 sjn
% 216.76/216.92  |- skos__scopeNote mesh__D050841
% 216.76/216.92       A PYRIDOXAL PHOSPHATE dependent enzyme that catalyzes the decarboxylation of GLYCINE with the transfer of an aminomethyl group to the LIPOIC ACID moiety of the GLYCINE DECARBOXYLASE COMPLEX H-PROTEIN. Defects in P-protein are the cause of non-ketotic hyperglycinemia. It is one of four subunits of the glycine decarboxylase complex.%A%    
% 216.76/216.92  |- mesh__dateCreated mesh__D050841 2005-06-30
% 216.76/216.92  |- skos__altLabel mesh__D050841 Glycine Cleavage System P-Protein
% 216.76/216.92  |- skos__altLabel mesh__D050841 Glycine Decarboxylase
% 216.76/216.92  |- mesh__publicMeSHNote mesh__D050841
% 216.76/216.92       2006; GLYCINE DEHYDROGENASE %28%DECARBOXYLATING%29% was indexed under AMINO ACID OXIDOREDUCTASES 1990-2005%A%  
% 216.76/216.92  |- skos__hiddenLabel mesh__D050841 Glycine Decarboxylase Complex P Protein
% 216.76/216.92  |- skos__hiddenLabel mesh__D050841 P protein, Glycine Decarboxylase
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D050841 2006
% 216.76/216.92  |- mesh__historyNote mesh__D050841 2006   
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003996 2005
% 216.76/216.92  |- mesh__recordMaintainer mesh__D003996 ADP
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003996 2001
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003996 2006
% 216.76/216.92  |- mesh__dateCreated mesh__D003996 1999-01-01
% 216.76/216.92  |- mesh__recordOriginator mesh__D003996 NLM
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003996 2002
% 216.76/216.92  |- mesh__publicMeSHNote mesh__D003996
% 216.76/216.92       91; was see under BENZOATES 1972-90   
% 216.76/216.92  |- mesh__dateRevised mesh__D003996 1998-06-10
% 216.76/216.92  |- mesh__historyNote mesh__D003996
% 216.76/216.92       91%28%72%29%; was see under BENZOATES 1972-90   
% 216.76/216.92  |- skos__historyNote mesh__D003996 Herbicides %28%1966-1971%29%
% 216.76/216.92  |- skos__scopeNote mesh__D003996 A chlorinated organic herbicide.     
% 216.76/216.92  |- skos__historyNote mesh__D003996 Benzoates %28%1966-1971%29%
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003996 2003
% 216.76/216.92  |- mesh__dateEstablished mesh__D003996 1991-01-01
% 216.76/216.92  |- skos__prefLabel mesh__D003996 Dicamba
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003996 1999
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003996 2004
% 216.76/216.92  |- rdf__type mesh__D003996sskos__Concept
% 216.76/216.92  |- mesh__recordAuthorizer mesh__D003996 SJN
% 216.76/216.92  |- skos__broader mesh__D003996smesh__D020185
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003996 2000
% 216.76/216.92  |- mesh__recordMaintainer mesh__D003198 jls
% 216.76/216.92  |- skos__altLabel mesh__D003198 Computerized Models
% 216.76/216.92  |- skos__hiddenLabel mesh__D003198 Model, Computerized
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003198 2005
% 216.76/216.92  |- skos__broader mesh__D003198smesh__D003205
% 216.76/216.92  |- skos__altLabel mesh__D003198 Computer Models
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003198 2006
% 216.76/216.92  |- mesh__recordAuthorizer mesh__D003198 sjn
% 216.76/216.92  |- mesh__dateCreated mesh__D003198 1986-06-18
% 216.76/216.92  |- skos__hiddenLabel mesh__D003198 Models, Computerized
% 216.76/216.92  |- skos__hiddenLabel mesh__D003198 Computer Model
% 216.76/216.92  |- mesh__recordOriginator mesh__D003198 EC
% 216.76/216.92  |- skos__hiddenLabel mesh__D003198 Computer Simulations
% 216.76/216.92  |- skos__hiddenLabel mesh__D003198 Simulations, Computer
% 216.76/216.92  |- mesh__historyNote mesh__D003198 87   
% 216.76/216.92  |- skos__scopeNote mesh__D003198
% 216.76/216.92       Computer-based representation of physical systems and phenomena such as chemical processes.%A%    
% 216.76/216.92  |- mesh__dateEstablished mesh__D003198 1987-01-01
% 216.76/216.92  |- rdf__type mesh__D003198sskos__Concept
% 216.76/216.92  |- skos__prefLabel mesh__D003198 Computer Simulation
% 216.76/216.92  |- skos__hiddenLabel mesh__D003198 Simulation, Computer
% 216.76/216.92  |- mesh__publicMeSHNote mesh__D003198 87   
% 216.76/216.92  |- skos__hiddenLabel mesh__D003198 Computerized Model
% 216.76/216.92  |- skos__related mesh__D003198smesh__D008962
% 216.76/216.92  |- mesh__dateRevised mesh__D003198 2004-07-07
% 216.76/216.92  |- skos__annotation mesh__D003198 coord with specific models heading   
% 216.76/216.92  |- skos__hiddenLabel mesh__D003198 Model, Computer
% 216.76/216.92  |- skos__altLabel mesh__D003198 Models, Computer
% 216.76/216.92  |- skos__annotation mesh__D008681
% 216.76/216.92       a superfamily of nematodes; infection: coord IM with STRONGYLIDA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 216.76/216.92  |- rdf__type mesh__D008681sskos__Concept
% 216.76/216.92  |- skos__prefLabel mesh__D008681 Metastrongyloidea
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D008681 2004
% 216.76/216.92  |- mesh__dateCreated mesh__D008681 1999-01-01
% 216.76/216.92  |- mesh__recordOriginator mesh__D008681 NLM
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D008681 2005
% 216.76/216.92  |- mesh__recordMaintainer mesh__D008681 ags
% 216.76/216.92  |- skos__broader mesh__D008681smesh__D017183
% 216.76/216.92  |- skos__scopeNote mesh__D008681
% 216.76/216.92       A superfamily of nematodes of the order STRONGYLIDA. Characteristics include a fluid-filled outer layer of cuticle and a reduced mouth and bursa.%A%    
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D008681 2006
% 216.76/216.92  |- mesh__dateRevised mesh__D008681 2003-07-09
% 216.76/216.92  |- mesh__recordAuthorizer mesh__D008681 sjn
% 216.76/216.92  |- skos__hiddenLabel mesh__D044006 Receptor, PGI2
% 216.76/216.92  |- skos__altLabel mesh__D044006 Receptors, Prostacyclin
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D044006 2004
% 216.76/216.92  |- skos__hiddenLabel mesh__D044006 Receptors, Prostaglandins X
% 216.76/216.92  |- skos__altLabel mesh__D044006 Prostaglandins X Receptors
% 216.76/216.92  |- skos__hiddenLabel mesh__D044006 Prostaglandin I2 Receptor
% 216.76/216.92  |- skos__hiddenLabel mesh__D044006 Epoprostenol Receptors
% 216.76/216.92  |- skos__hiddenLabel mesh__D044006 Prostacyclin Receptors
% 216.76/216.92  |- skos__altLabel mesh__D044006 Prostaglandin I2 Receptors
% 216.76/216.92  |- skos__hiddenLabel mesh__D044006 Receptor, Prostacyclin
% 216.76/216.92  |- mesh__publicMeSHNote mesh__D044006
% 216.76/216.92       2004; PROSTACYCLIN RECEPTOR %28%now RECEPTORS, EPOPROSTENOL%29% was indexed under RECEPTORS, PROSTAGLANDIN 1981-2002%A%  
% 216.76/216.92  |- skos__hiddenLabel mesh__D044006 Receptors, PGI2
% 216.76/216.92  |- skos__altLabel mesh__D044006 Receptor, Prostaglandin I2
% 216.76/216.92  |- mesh__historyNote mesh__D044006
% 216.76/216.92       2004; use RECEPTORS, EPOPROSTENOL %28%NM%29% 1981-2002   
% 216.76/216.92  |- skos__annotation mesh__D044006 DF: PGI2 RECEPT   
% 216.76/216.92  |- skos__broader mesh__D044006smesh__D011982
% 216.76/216.92  |- rdf__type mesh__D044006sskos__Concept
% 216.76/216.92  |- skos__prefLabel mesh__D044006 Receptors, Epoprostenol
% 216.76/216.92  |- skos__historyNote mesh__D044006
% 216.76/216.92       Receptors, Prostaglandin %28%1981-2003%29%
% 216.76/216.92  |- mesh__dateCreated mesh__D044006 2003-07-09
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D044006 2006
% 216.76/216.92  |- skos__altLabel mesh__D044006 Prostacyclin Receptor
% 216.76/216.92  |- skos__altLabel mesh__D044006 PGI2 Receptor
% 216.76/216.92  |- mesh__dateEstablished mesh__D044006 2004-01-01
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D044006 2005
% 216.76/216.92  |- skos__altLabel mesh__D044006 PGI2 Receptors
% 216.76/216.92  |- skos__hiddenLabel mesh__D044006 Receptors, Prostaglandin I2
% 216.76/216.92  |- skos__scopeNote mesh__D044006
% 216.76/216.92       Cell surface receptors for EPOPROSTENOL. They are coupled to HETEROTRIMERIC G-PROTEINS.%A%    
% 216.76/216.92  |- skos__hiddenLabel mesh__D016315 Proto-Oncogene Products, abl
% 216.76/216.92  |- skos__related mesh__D016315smesh__D016044
% 216.76/216.92  |- skos__hiddenLabel mesh__D016315 abl Proto Oncogene Proteins
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D016315 2006
% 216.76/216.92  |- mesh__dateCreated mesh__D016315 1990-06-19
% 216.76/216.92  |- skos__hiddenLabel mesh__D016315 Proto Oncogene Proteins abl
% 216.76/216.92  |- mesh__dateEstablished mesh__D016315 1991-01-01
% 216.76/216.92  |- skos__hiddenLabel mesh__D016315 Proto Oncogene Proteins c abl
% 216.76/216.92  |- skos__hiddenLabel mesh__D016315 abl, Proto-Oncogene Proteins
% 216.76/216.92  |- mesh__recordAuthorizer mesh__D016315 sjn
% 216.76/216.92  |- skos__altLabel mesh__D016315 c-abl Proteins
% 216.76/216.92  |- rdf__type mesh__D016315sskos__Concept
% 216.76/216.92  |- mesh__recordOriginator mesh__D016315 AGS
% 216.76/216.92  |- mesh__historyNote mesh__D016315 91   
% 216.76/216.92  |- skos__broader mesh__D016315smesh__D011518
% 216.76/216.92  |- skos__hiddenLabel mesh__D016315 c abl Proteins
% 216.76/216.92  |- skos__historyNote mesh__D016315 Neoplasm Proteins %28%1983-1985%29%
% 216.76/216.92  |- skos__broader mesh__D016315smesh__D011505
% 216.76/216.92  |- skos__hiddenLabel mesh__D016315 Proto-Oncogene Proteins, abl
% 216.76/216.92  |- skos__scopeNote mesh__D016315
% 216.76/216.92       Non-receptor tyrosine kinases encoded by the c-abl gene. They are distributed in both the cytoplasm and the nucleus. c-Abl plays a role in normal hematopoiesis especially of the myeloid lineage. Oncogenic transformation of c-abl arises when specific N-terminal amino acids are deleted, releasing the kinase from negative regulation.%A%    
% 216.76/216.92  |- skos__hiddenLabel mesh__D016315 Products, abl Proto-Oncogene
% 216.76/216.92  |- mesh__publicMeSHNote mesh__D016315 91   
% 216.76/216.92  |- skos__altLabel mesh__D016315 abl Proto-Oncogene Products
% 216.76/216.92  |- skos__altLabel mesh__D016315 Proto-Oncogene Proteins abl
% 216.76/216.92  |- skos__hiddenLabel mesh__D016315 abl Proto Oncogene Products
% 216.76/216.92  |- mesh__recordMaintainer mesh__D016315 DRC
% 216.76/216.92  |- skos__hiddenLabel mesh__D016315 c-abl, Proto-Oncogene Proteins
% 216.76/216.92  |- skos__hiddenLabel mesh__D016315 Proteins abl, Proto-Oncogene
% 216.76/216.92  |- skos__altLabel mesh__D016315 abl Proto-Oncogene Proteins
% 216.76/216.92  |- skos__prefLabel mesh__D016315 Proto-Oncogene Proteins c-abl
% 216.76/216.92  |- mesh__dateRevised mesh__D016315 2005-06-30
% 216.76/216.92  |- skos__historyNote mesh__D016315
% 216.76/216.92       Proto-Oncogene Proteins %28%1986-1990%29%
% 216.76/216.92  |- skos__hiddenLabel mesh__D007589 Hyper-IgE Syndromes
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007589 1995
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007589 2003
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007589 2001
% 216.76/216.92  |- mesh__recordOriginator mesh__D007589 NLM
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007589 1998
% 216.76/216.92  |- mesh__dateCreated mesh__D007589 1999-01-01
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007589 2004
% 216.76/216.92  |- skos__altLabel mesh__D007589
% 216.76/216.92       Hyperimmunoglobulin E-Recurrent Infection Syndrome
% 216.76/216.92  |- rdf__type mesh__D007589sskos__Concept
% 216.76/216.92  |- skos__hiddenLabel mesh__D007589 Syndrome, Job%27%s
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007589 1999
% 216.76/216.92  |- skos__annotation mesh__D007589 a phagocyte bactericidal syndrome   
% 216.76/216.92  |- mesh__dateRevised mesh__D007589 1993-06-02
% 216.76/216.92  |- mesh__onlineNote mesh__D007589
% 216.76/216.92       search PHAGOCYTE BACTERICIDAL DYSFUNCTION 1972-74   
% 216.76/216.92  |- skos__hiddenLabel mesh__D007589 Hyper IgE Syndrome
% 216.76/216.92  |- mesh__recordAuthorizer mesh__D007589 PLS
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007589 2002
% 216.76/216.92  |- skos__hiddenLabel mesh__D007589
% 216.76/216.92       Hyperimmunoglobulin E Recurrent Infection Syndrome
% 216.76/216.92  |- skos__hiddenLabel mesh__D007589 Jobs Syndrome
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007589 1996
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007589 2005
% 216.76/216.92  |- mesh__publicMeSHNote mesh__D007589
% 216.76/216.92       91; was see under PHAGOCYTE BACTERICIDAL DYSFUNCTION 1975-90%A%  
% 216.76/216.92  |- skos__hiddenLabel mesh__D007589 Syndrome, Hyper-IgE
% 216.76/216.92  |- skos__hiddenLabel mesh__D007589 Job Syndrome
% 216.76/216.92  |- mesh__recordMaintainer mesh__D007589 TGC
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007589 1997
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007589 1994
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007589 2006
% 216.76/216.92  |- skos__broader mesh__D007589smesh__D010585
% 216.76/216.92  |- skos__scopeNote mesh__D007589
% 216.76/216.92       A disorder of neutrophils characterized by the presence of abnormal or absent chemotactic responses and hyperimmunoglobulinemia E. It is transmitted as an autosomal recessive trait and most cases reported have been in girls.%A%    
% 216.76/216.92  |- mesh__historyNote mesh__D007589
% 216.76/216.92       91%28%75%29%; was see under PHAGOCYTE BACTERICIDAL DYSFUNCTION 1975-90%A%  
% 216.76/216.92  |- skos__altLabel mesh__D007589 Hyper-IgE Syndrome
% 216.76/216.92  |- skos__prefLabel mesh__D007589 Job%27%s Syndrome
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D007589 2000
% 216.76/216.92  |- mesh__dateEstablished mesh__D007589 1991-01-01
% 216.76/216.92  |- skos__broader mesh__D014812Q000172smesh__D014812
% 216.76/216.92  |- mesh__preferredCombination mesh__D014812Q000172smesh__D014813
% 216.76/216.92  |- rdf__type mesh__D014812Q000172smesh__CompoundConcept
% 216.76/216.92  |- mesh__publicMeSHNote mesh__D004291
% 216.76/216.92       91; was see under SOCIAL DOMINANCE 1969-90; was see under DOMINANCE, SOCIAL 1968%A%  
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D004291 2004
% 216.76/216.92  |- rdf__type mesh__D004291sskos__Concept
% 216.76/216.92  |- skos__prefLabel mesh__D004291 Dominance-Subordination
% 216.76/216.92  |- mesh__dateCreated mesh__D004291 1999-01-01
% 216.76/216.92  |- mesh__historyNote mesh__D004291
% 216.76/216.92       91%28%75%29%; was see under SOCIAL DOMINANCE 1969-90; was see under DOMINANCE, SOCIAL 1968%A%  
% 216.76/216.92  |- mesh__recordOriginator mesh__D004291 NLM
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D004291 2005
% 216.76/216.92  |- skos__scopeNote mesh__D004291
% 216.76/216.92       Relationship between individuals when one individual threatens or becomes aggressive and the other individual remains passive or attempts to escape.%A%    
% 216.76/216.92  |- mesh__recordMaintainer mesh__D004291 JLS
% 216.76/216.92  |- mesh__onlineNote mesh__D004291 search SOCIAL DOMINANCE 1968-74   
% 216.76/216.92  |- mesh__recordAuthorizer mesh__D004291 sjn
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D004291 2006
% 216.76/216.92  |- skos__annotation mesh__D004291 human %26% animal; no qualif   
% 216.76/216.92  |- skos__hiddenLabel mesh__D004291 Dominance Subordination
% 216.76/216.92  |- skos__broader mesh__D004291smesh__D012930
% 216.76/216.92  |- mesh__dateRevised mesh__D004291 2002-07-03
% 216.76/216.92  |- skos__hiddenLabel mesh__D004291 Dominance-Subordinations
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D004291 2003
% 216.76/216.92  |- mesh__dateEstablished mesh__D004291 1991-01-01
% 216.76/216.92  |- skos__related mesh__D012723smesh__D012727
% 216.76/216.92  |- skos__hiddenLabel mesh__D012723 Sex, Genotypic
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D012723 2006
% 216.76/216.92  |- skos__scopeNote mesh__D012723
% 216.76/216.92       The totality of characteristics of reproductive structure, functions, PHENOTYPE, and GENOTYPE, differentiating the MALE from the FEMALE organism.%A%    
% 216.76/216.92  |- skos__prefLabel mesh__D012723 Sex
% 216.76/216.92  |- skos__related mesh__D012723smesh__D011606
% 216.76/216.92  |- rdf__type mesh__D012723sskos__Concept
% 216.76/216.92  |- skos__hiddenLabel mesh__D012723 Sex, Phenotypic
% 216.76/216.92  |- skos__broader mesh__D012723smesh__D012098
% 216.76/216.92  |- skos__related mesh__D012723smesh__D007989
% 216.76/216.92  |- skos__related mesh__D012723smesh__D012725
% 216.76/216.92  |- mesh__dateRevised mesh__D012723 2005-07-01
% 216.76/216.92  |- skos__annotation mesh__D012723
% 216.76/216.92       differentiate from SEX FACTORS, largely statist in concept; sex therapy: coord PSYCHOTHERAPY %28%IM%29% + SEXUAL DYSFUNCTION, PHYSIOLOGICAL /ther or PSYCHOSEXUAL DYSFUNCTIONS /ther or their indentions /ther %28%IM%29%%A%  
% 216.76/216.92  |- skos__related mesh__D012723smesh__D012071
% 216.76/216.92  |- skos__related mesh__D012723smesh__D012732
% 216.76/216.92  |- mesh__dateCreated mesh__D012723 1999-01-01
% 216.76/216.92  |- mesh__recordOriginator mesh__D012723 NLM
% 216.76/216.92  |- mesh__recordMaintainer mesh__D012723 sjn
% 216.76/216.92  |- mesh__recordAuthorizer mesh__D012723 sjn
% 216.76/216.92  |- rdf__type mesh__D050842sskos__Concept
% 216.76/216.92  |- skos__altLabel mesh__D050842 Glutamic-Gamma-Semialdehyde Dehydrogenase
% 216.76/216.92  |- skos__hiddenLabel mesh__D050842
% 216.76/216.92       Dehydrogenase, Glutamyl-Gamma-Semialdehyde
% 216.76/216.92  |- mesh__publicMeSHNote mesh__D050842
% 216.76/216.92       2006; 1-PYRROLINE-5-CARBOXYLATE DEHYDROGENASE was indexed under AMINE OXIDOREDUCTASES 1981-2004%A%  
% 216.76/216.92  |- skos__hiddenLabel mesh__D050842 Dehydrogenase, 1-Pyrroline-5-Carboxylate
% 216.76/216.92  |- mesh__historyNote mesh__D050842 2006%28%1981%29%   
% 216.76/216.92  |- mesh__recordMaintainer mesh__D050842 AKE
% 216.76/216.92  |- skos__hiddenLabel mesh__D050842
% 216.76/216.92       NADP+ Specific 8 Glutamate Semialdehyde Dehydrogenase
% 216.76/216.92  |- skos__altLabel mesh__D050842
% 216.76/216.92       Delta%28%1%29%-Pyrroline-5-Carboxylate Dehydrogenase
% 216.76/216.92  |- skos__scopeNote mesh__D050842
% 216.76/216.92       An enzyme that catalyzes the oxidation of 1-pyrroline-5-carboxylate to L-GLUTAMATE in the presence of NAD. Defects in the enzyme are the cause of hyperprolinemia II.%A%    
% 216.76/216.92  |- skos__hiddenLabel mesh__D050842
% 216.76/216.92       Dehydrogenase, Glutamic-Gamma-Semialdehyde
% 216.76/216.92  |- skos__broader mesh__D050842smesh__D000587
% 216.76/216.92  |- skos__altLabel mesh__D050842 Glutamyl-Gamma-Semialdehyde Dehydrogenase
% 216.76/216.92  |- skos__hiddenLabel mesh__D050842
% 216.76/216.92       Glutamyl Gamma Semialdehyde Dehydrogenase
% 216.76/216.92  |- skos__hiddenLabel mesh__D050842
% 216.76/216.92       Glutamic Gamma Semialdehyde Dehydrogenase
% 216.76/216.92  |- mesh__dateEstablished mesh__D050842 2006-01-01
% 216.76/216.92  |- mesh__recordAuthorizer mesh__D050842 sjn
% 216.76/216.92  |- skos__prefLabel mesh__D050842 1-Pyrroline-5-Carboxylate Dehydrogenase
% 216.76/216.92  |- skos__hiddenLabel mesh__D050842 Dehydrogenase, GGS
% 216.76/216.92  |- mesh__dateCreated mesh__D050842 2005-06-30
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D050842 2006
% 216.76/216.92  |- mesh__recordOriginator mesh__D050842 AKE
% 216.76/216.92  |- skos__altLabel mesh__D050842 GGS Dehydrogenase
% 216.76/216.92  |- skos__hiddenLabel mesh__D050842 1 Pyrroline 5 Carboxylate Dehydrogenase
% 216.76/216.92  |- skos__altLabel mesh__D050842
% 216.76/216.92       NADP+ Specific 8-Glutamate Semialdehyde Dehydrogenase
% 216.76/216.92  |- skos__altLabel mesh__D003997 3,5-Dicarbethoxy-1,4-Dihydrocollidine
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003997 2001
% 216.76/216.92  |- skos__prefLabel mesh__D003997 Dicarbethoxydihydrocollidine
% 216.76/216.92  |- skos__altLabel mesh__D003997 Diethoxycarbonyldihydrocollidine
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003997 2005
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003997 1995
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003997 1996
% 216.76/216.92  |- skos__broader mesh__D003997smesh__D004095
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003997 2002
% 216.76/216.92  |- mesh__publicMeSHNote mesh__D003997
% 216.76/216.92       91; was see under DIHYDROPYRIDINES 1975-90   
% 216.76/216.92  |- mesh__dateCreated mesh__D003997 1974-11-19
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003997 2006
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003997 1997
% 216.76/216.92  |- mesh__dateRevised mesh__D003997 1992-05-13
% 216.76/216.92  |- mesh__recordAuthorizer mesh__D003997 PLS
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003997 1998
% 216.76/216.92  |- mesh__dateEstablished mesh__D003997 1991-01-01
% 216.76/216.92  |- skos__altLabel mesh__D003997
% 216.76/216.92       3,5-Diethoxycarbonyl-1,4-Dihydro-2,4,6-Trimethylpyridine
% 216.76/216.92  |- skos__scopeNote mesh__D003997
% 216.76/216.92       1,4-Dihydro-2,4,6-trimethyl-3,5-pyridinedicarboxylic acid diethyl ester.%A%    
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003997 2003
% 216.76/216.92  |- rdf__type mesh__D003997sskos__Concept
% 216.76/216.92  |- skos__historyNote mesh__D003997 Dicarboxylic Acids %28%1972-1974%29%
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003997 1993
% 216.76/216.92  |- skos__historyNote mesh__D003997 Pyridines %28%1972-1974%29%
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003997 1999
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003997 2000
% 216.76/216.92  |- mesh__recordOriginator mesh__D003997 MEG
% 216.76/216.92  |- mesh__historyNote mesh__D003997
% 216.76/216.92       91%28%75%29%; was see under DIHYDROPYRIDINES 1975-90   
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003997 2004
% 216.76/216.92  |- mesh__activeMeSHYear mesh__D003997 1994
% 216.76/216.92  |- mesh__recordMaintainer mesh__D003997 TAP
% 216.76/216.92  |- skos__broader mesh__D011188Q000172smesh__D011188
% 216.76/216.92  |- mesh__preferredCombination mesh__D011188Q000172smesh__D011191
% 216.76/216.92  |- rdf__type mesh__D011188Q000172smesh__CompoundConcept
% 216.76/216.92  |- skos__hiddenLabel mesh__D003199 Evaluation, Computer Systems
% 216.76/216.92  |- skos__hiddenLabel mesh__D003199 System, Real-Time
% 216.76/216.92  |- skos__hiddenLabel mesh__D003199 Computer Systems Evaluations
% 216.76/216.92  |- skos__hiddenLabel mesh__D003199 Architecture, Computer
% 216.76/216.92  |- mesh__dateRevised mesh__D003199 2004-07-07
% 216.76/216.92  |- mesh__historyNote mesh__D003199 87   
% 216.76/216.92  |- mesh__recordMaintainer mesh__D003199 jls
% 216.78/216.92  |- skos__hiddenLabel mesh__D003199 Computer System
% 216.78/216.92  |- skos__scopeNote mesh__D003199
% 216.78/216.92       Systems composed of a computer or computers, peripheral equipment, such as disks, printers, and terminals, and telecommunications capabilities.%A%    
% 216.78/216.92  |- skos__hiddenLabel mesh__D003199 Systems, Computer
% 216.78/216.92  |- skos__hiddenLabel mesh__D003199 Systems, Real-Time
% 216.78/216.92  |- skos__hiddenLabel mesh__D003199 Real-Time System
% 216.78/216.92  |- mesh__recordOriginator mesh__D003199 EC
% 216.78/216.92  |- skos__hiddenLabel mesh__D003199 System, Computer
% 216.78/216.92  |- mesh__publicMeSHNote mesh__D003199 87   
% 216.78/216.92  |- mesh__dateEstablished mesh__D003199 1987-01-01
% 216.78/216.92  |- skos__hiddenLabel mesh__D003199 Computer Architectures
% 216.78/216.92  |- mesh__activeMeSHYear mesh__D003199 2006
% 216.78/216.92  |- skos__hiddenLabel mesh__D003199 Evaluations, Computer Systems
% 216.78/216.92  |- skos__broader mesh__D003199smesh__D003205
% 216.78/216.92  |- skos__prefLabel mesh__D003199 Computer Systems
% 216.78/216.92  |- mesh__activeMeSHYear mesh__D003199 2005
% 216.78/216.92  |- mesh__recordAuthorizer mesh__D003199 sjn
% 216.78/216.92  |- skos__hiddenLabel mesh__D003199 Architectures, Computer
% 216.78/216.92  |- skos__hiddenLabel mesh__D003199 Real Time Systems
% 216.78/216.92  |- mesh__dateCreated mesh__D003199 1986-06-18
% 216.78/216.92  |- skos__altLabel mesh__D003199 Organization, Computer Systems
% 216.78/216.92  |- rdf__type mesh__D003199sskos__Concept
% 216.78/216.92  |- skos__hiddenLabel mesh__D003199 Development, Computer Systems
% 216.78/216.93  |- skos__annotation mesh__D003199 IM   
% 216.78/216.93  |- skos__annotation mesh__D008682
% 216.78/216.93       do not confuse with METATARSUS, the anatomical region   
% 216.78/216.93  |- skos__hiddenLabel mesh__D008682 Metatarsal
% 216.78/216.93  |- mesh__recordOriginator mesh__D008682 EC
% 216.78/216.93  |- mesh__dateEstablished mesh__D008682 1988-01-01
% 216.78/216.93  |- skos__hiddenLabel mesh__D008682 Metatarsal Bone
% 216.78/216.93  |- skos__broader mesh__D008682smesh__D005529
% 216.78/216.93  |- mesh__recordAuthorizer mesh__D008682 sjn
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D008682 2006
% 216.78/216.93  |- mesh__dateCreated mesh__D008682 1987-04-02
% 216.78/216.93  |- mesh__recordMaintainer mesh__D008682 ags
% 216.78/216.93  |- skos__prefLabel mesh__D008682 Metatarsal Bones
% 216.78/216.93  |- mesh__historyNote mesh__D008682 88   
% 216.78/216.93  |- skos__hiddenLabel mesh__D008682 Bones, Metatarsal
% 216.78/216.93  |- mesh__publicMeSHNote mesh__D008682 88   
% 216.78/216.93  |- rdf__type mesh__D008682sskos__Concept
% 216.78/216.93  |- mesh__dateRevised mesh__D008682 2005-06-30
% 216.78/216.93  |- skos__altLabel mesh__D008682 Metatarsals
% 216.78/216.93  |- skos__hiddenLabel mesh__D008682 Bone, Metatarsal
% 216.78/216.93  |- skos__scopeNote mesh__D008682
% 216.78/216.93       The five long bones of the METATARSUS, articulating with the TARSAL BONES proximally and the PHALANGES OF TOES distally.%A%    
% 216.78/216.93  |- skos__related mesh__D008682smesh__D008684
% 216.78/216.93  |- skos__prefLabel mesh__D044007 Moraxellaceae
% 216.78/216.93  |- mesh__recordAuthorizer mesh__D044007 sjn
% 216.78/216.93  |- mesh__historyNote mesh__D044007 2004   
% 216.78/216.93  |- mesh__recordOriginator mesh__D044007 ags
% 216.78/216.93  |- skos__broader mesh__D044007smesh__D016946
% 216.78/216.93  |- mesh__dateEstablished mesh__D044007 2004-01-01
% 216.78/216.93  |- skos__scopeNote mesh__D044007
% 216.78/216.93       A family of gram-negative, aerobic bacteria in the order Pseudomonadales. Some strains are parasites of the mucosal membranes of animals and humans; others are found in association with food products or in the environment.%A%    
% 216.78/216.93  |- rdf__type mesh__D044007sskos__Concept
% 216.78/216.93  |- skos__annotation mesh__D044007 infection = MORAXELLACEAE INFECTIONS   
% 216.78/216.93  |- mesh__dateCreated mesh__D044007 2003-07-09
% 216.78/216.93  |- mesh__recordMaintainer mesh__D044007 SYSTEM
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D044007 2006
% 216.78/216.93  |- skos__broader mesh__D044007smesh__D020563
% 216.78/216.93  |- mesh__publicMeSHNote mesh__D044007 2004   
% 216.78/216.93  |- mesh__dateRevised mesh__D044007 2005-06-30
% 216.78/216.93  |- skos__prefLabel mesh__D016316 Guanfacine
% 216.78/216.93  |- skos__historyNote mesh__D016316 Phenylacetates %28%1966-1990%29%
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D016316 2002
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D016316 2006
% 216.78/216.93  |- mesh__publicMeSHNote mesh__D016316 91   
% 216.78/216.93  |- skos__hiddenLabel mesh__D016316 Monohydrochloride, Guanfacine
% 216.78/216.93  |- mesh__dateCreated mesh__D016316 1990-05-29
% 216.78/216.93  |- skos__historyNote mesh__D016316
% 216.78/216.93       Adrenergic alpha Agonists %28%1969-1990%29%
% 216.78/216.93  |- skos__broader mesh__D016316smesh__D010648
% 216.78/216.93  |- mesh__dateRevised mesh__D016316 2000-06-22
% 216.78/216.93  |- rdf__type mesh__D016316sskos__Concept
% 216.78/216.93  |- skos__scopeNote mesh__D016316
% 216.78/216.93       A centrally acting antihypertensive agent. The drug lowers both systolic and diastolic blood pressure by activating the central nervous system alpha-2 adrenoreceptors, which results in reduced sympathetic outflow leading to reduced vascular tone. Its adverse reactions include dry mouth, sedation, and constipation.%A%    
% 216.78/216.93  |- skos__broader mesh__D016316smesh__D006146
% 216.78/216.93  |- mesh__recordOriginator mesh__D016316 RLS
% 216.78/216.93  |- mesh__recordMaintainer mesh__D016316 CCR
% 216.78/216.93  |- mesh__historyNote mesh__D016316 91   
% 216.78/216.93  |- mesh__dateEstablished mesh__D016316 1991-01-01
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D016316 2001
% 216.78/216.93  |- mesh__recordAuthorizer mesh__D016316 sjn
% 216.78/216.93  |- skos__historyNote mesh__D016316 Guanidines %28%1966-1990%29%
% 216.78/216.93  |- skos__hiddenLabel mesh__D016316 Hydrochloride, Guanfacine
% 216.78/216.93  |- skos__hiddenLabel mesh__D016316 BS 100 141
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D016316 2003
% 216.78/216.93  |- skos__historyNote mesh__D016316
% 216.78/216.93       Antihypertensive Agents %28%1966-1990%29%
% 216.78/216.93  |- skos__hiddenLabel mesh__D016316 BS100141
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D016316 2005
% 216.78/216.93  |- skos__altLabel mesh__D016316 Guanfacine Monohydrochloride
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D016316 2004
% 216.78/216.93  |- mesh__recordMaintainer mesh__D032781 sjn
% 216.78/216.93  |- skos__broader mesh__D032781smesh__D004995
% 216.78/216.93  |- mesh__recordAuthorizer mesh__D032781 sjn
% 216.78/216.93  |- mesh__recordOriginator mesh__D032781 jrf
% 216.78/216.93  |- skos__hiddenLabel mesh__D032781 Professional Ethics Code
% 216.78/216.93  |- skos__hiddenLabel mesh__D032781 Ethics Code, Professional
% 216.78/216.93  |- skos__hiddenLabel mesh__D032781 Oaths, Ethical
% 216.78/216.93  |- skos__hiddenLabel mesh__D032781 Ethical Oath
% 216.78/216.93  |- skos__altLabel mesh__D032781 Ethical Codes
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D032781 2004
% 216.78/216.93  |- skos__hiddenLabel mesh__D032781 Code, Ethical
% 216.78/216.93  |- skos__hiddenLabel mesh__D032781 Codes, Ethical
% 216.78/216.93  |- mesh__dateCreated mesh__D032781 2002-07-03
% 216.78/216.93  |- rdf__type mesh__D032781sskos__Concept
% 216.78/216.93  |- skos__hiddenLabel mesh__D032781 Oath, Ethical
% 216.78/216.93  |- skos__hiddenLabel mesh__D032781 Ethical Directive
% 216.78/216.93  |- mesh__dateEstablished mesh__D032781 2003-01-01
% 216.78/216.93  |- skos__hiddenLabel mesh__D032781 Ethical Code
% 216.78/216.93  |- skos__annotation mesh__D032781
% 216.78/216.93       if text of code and issuing organization are present, index also GUIDELINE %28%PT%29%%A%  
% 216.78/216.93  |- skos__prefLabel mesh__D032781 Codes of Ethics
% 216.78/216.93  |- skos__hiddenLabel mesh__D032781 Ethics Code
% 216.78/216.93  |- mesh__historyNote mesh__D032781
% 216.78/216.93       2003; use ETHICS, PROFESSIONAL 1991-2001   
% 216.78/216.93  |- mesh__publicMeSHNote mesh__D032781
% 216.78/216.93       2003; see ETHICS, PROFESSIONAL 1991-2001   
% 216.78/216.93  |- skos__hiddenLabel mesh__D032781 Professional Ethics Codes
% 216.78/216.93  |- skos__scopeNote mesh__D032781
% 216.78/216.93       Systematic statements of principles or rules of appropriate professional conduct, usually established by professional societies.%A%    
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D032781 2005
% 216.78/216.93  |- skos__hiddenLabel mesh__D032781 Ethics Codes, Professional
% 216.78/216.93  |- skos__altLabel mesh__D032781 Code of Ethics
% 216.78/216.93  |- skos__hiddenLabel mesh__D032781 Directives, Ethical
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D032781 2006
% 216.78/216.93  |- skos__historyNote mesh__D032781 Ethics, Professional %28%1974-2002%29%
% 216.78/216.93  |- mesh__dateRevised mesh__D032781 2003-07-25
% 216.78/216.93  |- skos__hiddenLabel mesh__D032781 Directive, Ethical
% 216.78/216.93  |- skos__broader mesh__D032781smesh__D017408
% 216.78/216.93  |- skos__hiddenLabel mesh__D032781 Ethics Codes
% 216.78/216.93  |- skos__scopeNote mesh__D004292
% 216.78/216.93       Dominance of one cerebral hemisphere over the other in cerebral functions.%A%    
% 216.78/216.93  |- skos__hiddenLabel mesh__D004292 Mirror Writings
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004292 2004
% 216.78/216.93  |- skos__broader mesh__D004292smesh__D009424
% 216.78/216.93  |- mesh__onlineNote mesh__D004292
% 216.78/216.93       use DOMINANCE, CEREBRAL to search DOMINANCE 1966 %28%as Prov%29%; to search MIRROR WRITING use DOMINANCE, CEREBRAL 1975 %26% HANDWRITING 1966-74%A%  
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004292 2003
% 216.78/216.93  |- skos__broader mesh__D004292smesh__D011603
% 216.78/216.93  |- rdf__type mesh__D004292sskos__Concept
% 216.78/216.93  |- skos__prefLabel mesh__D004292 Dominance, Cerebral
% 216.78/216.93  |- mesh__publicMeSHNote mesh__D004292
% 216.78/216.93       67; MIRROR WRITING was see under HANDWRITING 1963-75   
% 216.78/216.93  |- skos__related mesh__D004292smesh__D001037
% 216.78/216.93  |- skos__hiddenLabel mesh__D004292 Dominances, Cerebral
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004292 1999
% 216.78/216.93  |- mesh__dateEstablished mesh__D004292 1967-01-01
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004292 2002
% 216.78/216.93  |- mesh__recordOriginator mesh__D004292 NLM
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004292 1998
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004292 2006
% 216.78/216.93  |- skos__hiddenLabel mesh__D004292 Writing, Mirror
% 216.78/216.93  |- mesh__historyNote mesh__D004292
% 216.78/216.93       67; was DOMINANCE 1965-66 %28%Prov%29%; MIRROR WRITING was see under HANDWRITING 1963-75%A%  
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004292 2001
% 216.78/216.93  |- skos__hiddenLabel mesh__D004292 Cerebral Dominances
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004292 1997
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004292 2005
% 216.78/216.93  |- skos__altLabel mesh__D004292 Cerebral Dominance
% 216.78/216.93  |- mesh__dateRevised mesh__D004292 1995-05-18
% 216.78/216.93  |- mesh__recordAuthorizer mesh__D004292 PLS
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004292 2000
% 216.78/216.93  |- skos__hiddenLabel mesh__D004292 Writings, Mirror
% 216.78/216.93  |- mesh__recordMaintainer mesh__D004292 TAP
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004292 1996
% 216.78/216.93  |- mesh__dateCreated mesh__D004292 1999-01-01
% 216.78/216.93  |- skos__broader mesh__D012724smesh__D010675
% 216.78/216.93  |- skos__hiddenLabel mesh__D012724 Sexual Pheromones
% 216.78/216.93  |- mesh__recordAuthorizer mesh__D012724 sjn
% 216.78/216.93  |- rdf__type mesh__D012724sskos__Concept
% 216.78/216.93  |- mesh__recordOriginator mesh__D012724 NLM
% 216.78/216.93  |- skos__annotation mesh__D012724
% 216.78/216.93       human %26% animal pheromones; for opposite sex of same species%A%  
% 216.78/216.93  |- mesh__dateEstablished mesh__D012724 1991-01-01
% 216.78/216.93  |- mesh__dateRevised mesh__D012724 2005-06-30
% 216.78/216.93  |- skos__historyNote mesh__D012724 Sex Behavior %28%1966-1967%29%
% 216.78/216.93  |- skos__altLabel mesh__D012724 Pheromones, Sexual
% 216.78/216.93  |- mesh__historyNote mesh__D012724
% 216.78/216.93       91%28%75%29%; was see under PHEROMONES 1975-90   
% 216.78/216.93  |- mesh__onlineNote mesh__D012724 search PHEROMONES 1968-74   
% 216.78/216.93  |- skos__historyNote mesh__D012724 Pheromones %28%1968-1974%29%
% 216.78/216.93  |- mesh__dateCreated mesh__D012724 1999-01-01
% 216.78/216.93  |- skos__prefLabel mesh__D012724 Sex Attractants
% 216.78/216.93  |- skos__altLabel mesh__D012724 Sex Pheromones
% 216.78/216.93  |- mesh__recordMaintainer mesh__D012724 ssb
% 216.78/216.93  |- skos__scopeNote mesh__D012724
% 216.78/216.93       Pheromones that elicit sexual attraction or mating behavior usually in members of the opposite sex in the same species.%A%    
% 216.78/216.93  |- skos__hiddenLabel mesh__D012724 Pheromones, Sex
% 216.78/216.93  |- skos__historyNote mesh__D012724 Behavior, Animal %28%1966-1967%29%
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D012724 2006
% 216.78/216.93  |- mesh__publicMeSHNote mesh__D012724
% 216.78/216.93       91; was see under PHEROMONES 1975-90   
% 216.78/216.93  |- skos__hiddenLabel mesh__D012724 Attractants, Sex
% 216.78/216.93  |- skos__prefLabel mesh__D003998 Dicarboxylic Acids
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D003998 1998
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D003998 2000
% 216.78/216.93  |- mesh__dateEstablished mesh__D003998 1968-01-01
% 216.78/216.93  |- mesh__historyNote mesh__D003998 68%28%65%29%   
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D003998 2003
% 216.78/216.93  |- mesh__recordMaintainer mesh__D003998 TAP
% 216.78/216.93  |- rdf__type mesh__D003998sskos__Concept
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D003998 1993
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D003998 1999
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D003998 2001
% 216.78/216.93  |- mesh__recordOriginator mesh__D003998 NLM
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D003998 2004
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D003998 1994
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D003998 2002
% 216.78/216.93  |- mesh__publicMeSHNote mesh__D003998 68   
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D003998 2005
% 216.78/216.93  |- mesh__dateCreated mesh__D003998 1999-01-01
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D003998 1995
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D003998 1996
% 216.78/216.93  |- mesh__dateRevised mesh__D003998 1992-05-13
% 216.78/216.93  |- skos__hiddenLabel mesh__D003998 Acids, Dicarboxylic
% 216.78/216.93  |- skos__broader mesh__D003998smesh__D000144
% 216.78/216.93  |- mesh__recordAuthorizer mesh__D003998 PLS
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D003998 2006
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D003998 1997
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D008683 2005
% 216.78/216.93  |- skos__hiddenLabel mesh__D008683 Joint, Metatarsophalangeal
% 216.78/216.93  |- skos__broader mesh__D008683smesh__D033023
% 216.78/216.93  |- mesh__publicMeSHNote mesh__D008683
% 216.78/216.93       90%28%75%29%; was see under TOE JOINT 1966-89   
% 216.78/216.93  |- skos__prefLabel mesh__D008683 Metatarsophalangeal Joint
% 216.78/216.93  |- skos__hiddenLabel mesh__D008683 Metatarsophalangeal Joints
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D008683 2006
% 216.78/216.93  |- skos__annotation mesh__D008683 primates only   
% 216.78/216.93  |- mesh__recordOriginator mesh__D008683 NLM
% 216.78/216.93  |- mesh__dateEstablished mesh__D008683 1990-01-01
% 216.78/216.93  |- skos__historyNote mesh__D008683 Toe Joint %28%1966-1974%29%
% 216.78/216.93  |- skos__historyNote mesh__D008683 Metatarsus %28%1966-1974%29%
% 216.78/216.93  |- skos__scopeNote mesh__D008683
% 216.78/216.93       The articulation between a metatarsal bone %28%METATARSAL BONES%29% and a phalanx.%A%    
% 216.78/216.93  |- mesh__dateRevised mesh__D008683 2002-07-03
% 216.78/216.93  |- mesh__recordAuthorizer mesh__D008683 sjn
% 216.78/216.93  |- rdf__type mesh__D008683sskos__Concept
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D008683 2003
% 216.78/216.93  |- mesh__historyNote mesh__D008683
% 216.78/216.93       90%28%75%29%; was see under TOE JOINT 1966-89   
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D008683 2004
% 216.78/216.93  |- mesh__dateCreated mesh__D008683 1999-01-01
% 216.78/216.93  |- mesh__recordMaintainer mesh__D008683 TAP
% 216.78/216.93  |- skos__hiddenLabel mesh__D008683 Joints, Metatarsophalangeal
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004293 2003
% 216.78/216.93  |- mesh__recordAuthorizer mesh__D004293 PLS
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004293 2000
% 216.78/216.93  |- skos__annotation mesh__D004293
% 216.78/216.93       with Haiti = Hispaniola, a hist name for the island in the Greater Antilles in the West Indies; do not confuse with DOMINICA, also in the West Indies%A%  
% 216.78/216.93  |- rdf__type mesh__D004293sskos__Concept
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004293 1999
% 216.78/216.93  |- skos__scopeNote mesh__D004293
% 216.78/216.93       A republic in the Greater Antilles in the West Indies. Its capital is Santo Domingo. With Haiti, it forms the island of Hispaniola - the Dominican Republic occupying the eastern two thirds, and Haiti, the western third. It was created in 1844 after a revolt against the rule of President Boyer over the entire island of Hispaniola, itself visited by Columbus in 1492 and settled the next year. Except for a brief period of annexation to Spain %28%1861-65%29%, it has been independent, though closely associated with the United States. Its name comes from the Spanish Santo Domingo, Holy Sunday, with reference to its discovery on a Sunday. %28%From Webster%27%s New Geographical Dictionary, 1988, p338, 506 %26% Room, Brewer%27%s Dictionary of Names, 1992, p151%29%%A%    
% 216.78/216.93  |- skos__prefLabel mesh__D004293 Dominican Republic
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004293 2006
% 216.78/216.93  |- mesh__recordMaintainer mesh__D004293 TGC
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004293 1998
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004293 1997
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004293 2005
% 216.78/216.93  |- skos__broader mesh__D004293smesh__D014900
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004293 2002
% 216.78/216.93  |- mesh__dateCreated mesh__D004293 1999-01-01
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004293 2004
% 216.78/216.93  |- mesh__recordOriginator mesh__D004293 NLM
% 216.78/216.93  |- mesh__dateRevised mesh__D004293 1996-06-10
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004293 2001
% 216.78/216.93  |- skos__related mesh__D012725smesh__D012723
% 216.78/216.93  |- skos__hiddenLabel mesh__D012725 Behavior, Premarital Sex
% 216.78/216.93  |- skos__broader mesh__D012725smesh__D001519
% 216.78/216.93  |- rdf__type mesh__D012725sskos__Concept
% 216.78/216.93  |- skos__hiddenLabel mesh__D012725 Sex, Anal
% 216.78/216.93  |- skos__hiddenLabel mesh__D012725 Activities, Sexual
% 216.78/216.93  |- skos__altLabel mesh__D012725 Sex Behavior
% 216.78/216.93  |- skos__hiddenLabel mesh__D012725 Activity, Sexual
% 216.78/216.93  |- mesh__dateCreated mesh__D012725 1999-01-01
% 216.78/216.93  |- skos__related mesh__D012725smesh__D043762
% 216.78/216.93  |- skos__hiddenLabel mesh__D012725 Orientation, Sexual
% 216.78/216.93  |- skos__altLabel mesh__D012725 Sexual Activity
% 216.78/216.93  |- skos__prefLabel mesh__D012725 Sexual Behavior
% 216.78/216.93  |- mesh__historyNote mesh__D012725 2004 %28%1966%29%   
% 216.78/216.93  |- mesh__recordOriginator mesh__D012725 NLM
% 216.78/216.93  |- skos__scopeNote mesh__D012725 Sexual activities of humans.     
% 216.78/216.93  |- skos__hiddenLabel mesh__D012725 Behavior, Sexual
% 216.78/216.93  |- mesh__publicMeSHNote mesh__D012725 2004; see SEX BEHAVIOR 1966-2003   
% 216.78/216.93  |- skos__hiddenLabel mesh__D012725 Behavior, Sex
% 216.78/216.93  |- skos__hiddenLabel mesh__D012725 Sex, Oral
% 216.78/216.93  |- skos__altLabel mesh__D012725 Sexual Activities
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D012725 2005
% 216.78/216.93  |- mesh__dateRevised mesh__D012725 2005-07-29
% 216.78/216.93  |- skos__related mesh__D012725smesh__D012747
% 216.78/216.93  |- skos__broader mesh__D012725smesh__D012098
% 216.78/216.93  |- skos__altLabel mesh__D012725 Sex Orientation
% 216.78/216.93  |- mesh__recordMaintainer mesh__D012725 ags
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D012725 2006A
% 216.78/216.93  |- skos__annotation mesh__D012725
% 216.78/216.93       human only: SEX BEHAVIOR, ANIMAL is available; do not confuse X ref SEXUAL ORIENTATION with GENDER IDENTITY %28%see note there%29%%A%  
% 216.78/216.93  |- mesh__recordAuthorizer mesh__D012725 ags
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D012725 2006
% 216.78/216.93  |- rdf__type mesh__D017410sskos__Concept
% 216.78/216.93  |- mesh__publicMeSHNote mesh__D017410 93   
% 216.78/216.93  |- skos__annotation mesh__D017410
% 216.78/216.93       IM for articles %26% books on the form, value, use %26% creation of guidelines as a procedural policy to aid health practitioners in patient care decisions: do not confuse with Publication Type PRACTICE GUIDELINE; Manual 17.94.5%A%  
% 216.78/216.93  |- mesh__dateRevised mesh__D017410 2003-07-09
% 216.78/216.93  |- mesh__recordOriginator mesh__D017410 TGC
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D017410 2005
% 216.78/216.93  |- skos__prefLabel mesh__D017410 Practice Guidelines
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D017410 2006
% 216.78/216.93  |- skos__hiddenLabel mesh__D017410 Guidelines, Practice
% 216.78/216.93  |- mesh__historyNote mesh__D017410 93   
% 216.78/216.93  |- mesh__recordMaintainer mesh__D017410 ags
% 216.78/216.93  |- mesh__dateCreated mesh__D017410 1992-05-22
% 216.78/216.93  |- skos__scopeNote mesh__D017410
% 216.78/216.93       Directions or principles presenting current or future rules of policy for assisting health care practitioners in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery.%A%    
% 216.78/216.93  |- skos__broader mesh__D017410smesh__D017408
% 216.78/216.93  |- skos__related mesh__D017410smesh__D032921
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D017410 2004
% 216.78/216.93  |- mesh__recordAuthorizer mesh__D017410 sjn
% 216.78/216.93  |- mesh__dateEstablished mesh__D017410 1993-01-01
% 216.78/216.93  |- skos__historyNote mesh__D003999 Acetates %28%1966-1977%29%
% 216.78/216.93  |- skos__altLabel mesh__D003999 Dichloroacetic Acid
% 216.78/216.93  |- skos__hiddenLabel mesh__D003999 Dichloroacetate, Potassium
% 216.78/216.93  |- rdf__type mesh__D003999sskos__Concept
% 216.78/216.93  |- skos__historyNote mesh__D003999 Acetic Acids %28%1968-1977%29%
% 216.78/216.93  |- mesh__dateCreated mesh__D003999 1977-05-20
% 216.78/216.93  |- skos__broader mesh__D003999smesh__D000085
% 216.78/216.93  |- mesh__dateEstablished mesh__D003999 1991-01-01
% 216.78/216.93  |- skos__hiddenLabel mesh__D003999 Acid, Dichloroacetic
% 216.78/216.93  |- mesh__dateRevised mesh__D003999 2005-06-30
% 216.78/216.93  |- skos__hiddenLabel mesh__D003999 Acid, Bichloroacetic
% 216.78/216.93  |- mesh__historyNote mesh__D003999
% 216.78/216.93       91%28%78%29%; was see under ACETIC ACIDS 1978-90   
% 216.78/216.93  |- mesh__recordOriginator mesh__D003999 RLS
% 216.78/216.93  |- mesh__publicMeSHNote mesh__D003999
% 216.78/216.93       91; was see under ACETIC ACIDS 1978-90   
% 216.78/216.93  |- skos__scopeNote mesh__D003999
% 216.78/216.93       A derivative of acetic acid which increases the activity of pyruvate dehydrogenase and rate of lipogenesis. It is used in organic synthesis, pharmaceuticals, and medicine.%A%    
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D003999 2006
% 216.78/216.93  |- skos__prefLabel mesh__D003999 Dichloroacetate
% 216.78/216.93  |- mesh__recordMaintainer mesh__D003999 exl
% 216.78/216.93  |- mesh__recordAuthorizer mesh__D003999 sjn
% 216.78/216.93  |- skos__hiddenLabel mesh__D003999 Dichloroacetate, Sodium
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D008684 2003
% 216.78/216.93  |- skos__scopeNote mesh__D008684
% 216.78/216.93       The part of the foot between the tarsa and the TOES.     
% 216.78/216.93  |- skos__prefLabel mesh__D008684 Metatarsus
% 216.78/216.93  |- skos__broader mesh__D008684smesh__D005545
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D008684 2006
% 216.78/216.93  |- mesh__recordMaintainer mesh__D008684 KEV
% 216.78/216.93  |- mesh__recordOriginator mesh__D008684 NLM
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D008684 2005
% 216.78/216.93  |- mesh__dateCreated mesh__D008684 1999-01-01
% 216.78/216.93  |- skos__related mesh__D008684smesh__D008682
% 216.78/216.93  |- rdf__type mesh__D008684sskos__Concept
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D008684 2004
% 216.78/216.93  |- mesh__dateRevised mesh__D008684 2002-07-03
% 216.78/216.93  |- skos__annotation mesh__D008684
% 216.78/216.93       not restricted to primates; METATARSUS refers to the anat area, METATARSAL BONES is available for the bones%A%  
% 216.78/216.93  |- mesh__recordAuthorizer mesh__D008684 sjn
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D016318 2006
% 216.78/216.93  |- skos__scopeNote mesh__D016318
% 216.78/216.93       An agonist at two subsets of excitatory amino acid receptors, ionotropic receptors that directly control membrane channels and metabotropic receptors that indirectly mediate calcium mobilization from intracellular stores. The compound is obtained from the seeds and fruit of Quisqualis chinensis.%A%    
% 216.78/216.93  |- rdf__type mesh__D016318sskos__Concept
% 216.78/216.93  |- skos__broader mesh__D016318smesh__D010069
% 216.78/216.93  |- mesh__dateCreated mesh__D016318 1990-05-29
% 216.78/216.93  |- mesh__dateEstablished mesh__D016318 1991-01-01
% 216.78/216.93  |- skos__historyNote mesh__D016318 Oxadiazoles %28%1966-1990%29%
% 216.78/216.93  |- mesh__publicMeSHNote mesh__D016318 91   
% 216.78/216.93  |- mesh__historyNote mesh__D016318 91   
% 216.78/216.93  |- mesh__dateRevised mesh__D016318 2005-06-30
% 216.78/216.93  |- skos__historyNote mesh__D016318
% 216.78/216.93       Neuromuscular Depolarizing Agents %28%1970-1990%29%
% 216.78/216.93  |- mesh__recordAuthorizer mesh__D016318 sjn
% 216.78/216.93  |- mesh__recordOriginator mesh__D016318 RLS
% 216.78/216.93  |- skos__historyNote mesh__D016318 Convulsants %28%1975-1990%29%
% 216.78/216.93  |- skos__broader mesh__D016318smesh__D000596
% 216.78/216.93  |- skos__prefLabel mesh__D016318 Quisqualic Acid
% 216.78/216.93  |- mesh__recordMaintainer mesh__D016318 ssb
% 216.78/216.93  |- skos__broader mesh__D013020smesh__D000569
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D013020 2000
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D013020 1996
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D013020 1999
% 216.78/216.93  |- rdf__type mesh__D013020sskos__Concept
% 216.78/216.93  |- mesh__recordMaintainer mesh__D013020 KEV
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D013020 2001
% 216.78/216.93  |- mesh__recordOriginator mesh__D013020 NLM
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D013020 1997
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D013020 2005
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D013020 2002
% 216.78/216.93  |- mesh__dateRevised mesh__D013020 1995-05-23
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D013020 2003
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D013020 2006
% 216.78/216.93  |- mesh__recordAuthorizer mesh__D013020 PLS
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D013020 2004
% 216.78/216.93  |- skos__prefLabel mesh__D013020 South America
% 216.78/216.93  |- skos__annotation mesh__D013020
% 216.78/216.93       each So. Amer. country is available as a heading   
% 216.78/216.93  |- mesh__dateCreated mesh__D013020 1999-01-01
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D013020 1998
% 216.78/216.93  |- skos__historyNote mesh__D004294 Piperidines %28%1977-1981%29%
% 216.78/216.93  |- mesh__dateRevised mesh__D004294 2005-06-30
% 216.78/216.93  |- skos__hiddenLabel mesh__D004294 R33812
% 216.78/216.93  |- skos__hiddenLabel mesh__D004294 PMSDomperidone
% 216.78/216.93  |- skos__scopeNote mesh__D004294
% 216.78/216.93       A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.%A%    
% 216.78/216.93  |- skos__hiddenLabel mesh__D004294 PMS Domperidone
% 216.78/216.93  |- rdf__type mesh__D004294sskos__Concept
% 216.78/216.93  |- skos__hiddenLabel mesh__D004294 Nu Domperidone
% 216.78/216.93  |- skos__altLabel mesh__D004294 Nu-Domperidone
% 216.78/216.93  |- skos__prefLabel mesh__D004294 Domperidone
% 216.78/216.93  |- skos__altLabel mesh__D004294 P%C3%%A9%ridys
% 216.78/216.93  |- skos__altLabel mesh__D004294 Gastrocure
% 216.78/216.93  |- skos__altLabel mesh__D004294 Domperidon Stada
% 216.78/216.93  |- skos__altLabel mesh__D004294 Novo-Domperidone
% 216.78/216.93  |- skos__altLabel mesh__D004294 ratio-Domperidone
% 216.78/216.93  |- mesh__activeMeSHYear mesh__D004294 2006
% 216.78/216.93  |- mesh__recordOriginator mesh__D004294 SH
% 216.78/216.93  |- skos__hiddenLabel mesh__D004294 Novo Domperidone
% 216.78/216.93  |- mesh__publicMeSHNote mesh__D004294 82   
% 216.78/216.93  |- skos__broader mesh__D004294smesh__D010880
% 216.78/216.93  |- mesh__recordAuthorizer mesh__D004294 sjn
% 216.78/216.93  |- skos__altLabel mesh__D004294 PMS-Domperidone
% 216.78/216.93  |- skos__hiddenLabel mesh__D004294 Stada, Domperidon
% 216.78/216.93  |- skos__hiddenLabel mesh__D004294 ratioDomperidone
% 216.78/216.93  |- skos__hiddenLabel mesh__D004294 Maleate, Domperidone
% 216.78/216.93  |- skos__hiddenLabel mesh__D004294 NovoDomperidone
% 216.78/216.93  |- skos__hiddenLabel mesh__D004294 AL, Domperidon
% 216.78/216.93  |- skos__hiddenLabel mesh__D004294 ratio Domperidone
% 216.78/216.93  |- skos__hiddenLabel mesh__D004294 Hexal, Domperidon
% 216.78/216.93  |- skos__broader mesh__D004294smesh__D001562
% 216.78/216.93  |- skos__historyNote mesh__D004294 Antiemetics %28%1977-1981%29%
% 216.78/216.93  |- skos__altLabel mesh__D004294 Nauzelin
% 216.78/216.93  |- skos__hiddenLabel mesh__D004294 R33,812
% 216.78/216.93  |- skos__historyNote mesh__D004294 Benzimidazoles %28%1977-1981%29%
% 216.78/216.93  |- mesh__recordMaintainer mesh__D004294 exl
% 216.78/216.93  |- skos__hiddenLabel mesh__D004294 NuDomperidone
% 216.78/216.93  |- skos__altLabel mesh__D004294 Domperidon-TEVA
% 216.78/216.93  |- skos__hiddenLabel mesh__D004294 DomperidonTEVA
% 216.78/216.93  |- skos__altLabel mesh__D004294 Domperidon Hexal
% 216.78/216.93  |- skos__altLabel mesh__D004294 Domidon
% 216.78/216.93  |- skos__hiddenLabel mesh__D004294 Monohydrochloride, Domperidone
% 216.78/216.93  |- mesh__dateEstablished mesh__D004294 1982-01-01
% 216.78/216.93  |- skos__altLabel mesh__D004294 Domperidon
% 216.78/216.93  |- skos__hiddenLabel mesh__D004294 ApoDomperidone
% 216.78/216.93  |- mesh__historyNote mesh__D004294 82   
% 216.78/216.93  |- skos__hiddenLabel mesh__D004294 Gamir, Domperidona
% 216.78/216.94  |- mesh__dateCreated mesh__D004294 1981-05-13
% 216.78/216.94  |- skos__hiddenLabel mesh__D004294 Apo Domperidone
% 216.78/216.94  |- skos__altLabel mesh__D004294 Apo-Domperidone
% 216.78/216.94  |- skos__altLabel mesh__D004294 Domperidona Gamir
% 216.78/216.94  |- skos__altLabel mesh__D004294 Domperidon AL
% 216.78/216.94  |- skos__hiddenLabel mesh__D004294 Domperidon TEVA
% 216.78/216.94  |- skos__altLabel mesh__D004294 R-33812
% 216.78/216.94  |- mesh__dateCreated mesh__D012726 1999-01-01
% 216.78/216.94  |- skos__hiddenLabel mesh__D012726 Animal Mating Behaviors
% 216.78/216.94  |- skos__hiddenLabel mesh__D012726 Behaviors, Animal Mating
% 216.78/216.94  |- skos__hiddenLabel mesh__D012726 Behavior, Animal Mating
% 216.78/216.94  |- mesh__historyNote mesh__D012726 68   
% 216.78/216.94  |- mesh__recordMaintainer mesh__D012726 TAP
% 216.78/216.94  |- mesh__dateRevised mesh__D012726 2002-07-02
% 216.78/216.94  |- skos__historyNote mesh__D012726 Behavior, Animal %28%1966-1967%29%
% 216.78/216.94  |- skos__scopeNote mesh__D012726 Sexual activities of animals.     
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D012726 2005
% 216.78/216.94  |- skos__broader mesh__D012726smesh__D003259
% 216.78/216.94  |- skos__hiddenLabel mesh__D012726 Sex Behaviors, Animal
% 216.78/216.94  |- skos__hiddenLabel mesh__D012726 Mating Behaviors, Animal
% 216.78/216.94  |- skos__hiddenLabel mesh__D012726 Behavior, Animal Sex
% 216.78/216.94  |- skos__hiddenLabel mesh__D012726 Animal Sex Behaviors
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D012726 2003
% 216.78/216.94  |- mesh__publicMeSHNote mesh__D012726 68   
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D012726 2006
% 216.78/216.94  |- mesh__recordAuthorizer mesh__D012726 sjn
% 216.78/216.94  |- mesh__recordOriginator mesh__D012726 NLM
% 216.78/216.94  |- skos__historyNote mesh__D012726 Sex Behavior %28%1966-1967%29%
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D012726 2004
% 216.78/216.94  |- mesh__dateEstablished mesh__D012726 1968-01-01
% 216.78/216.94  |- skos__hiddenLabel mesh__D012726 Behaviors, Animal Sex
% 216.78/216.94  |- rdf__type mesh__D012726sskos__Concept
% 216.78/216.94  |- skos__hiddenLabel mesh__D012726 Animal Mating Behavior
% 216.78/216.94  |- skos__hiddenLabel mesh__D012726 Animal Sex Behavior
% 216.78/216.94  |- skos__prefLabel mesh__D012726 Sex Behavior, Animal
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D045102 2006
% 216.78/216.94  |- rdf__type mesh__D045102sskos__Concept
% 216.78/216.94  |- mesh__dateRevised mesh__D045102 2005-06-30
% 216.78/216.94  |- skos__annotation mesh__D045102
% 216.78/216.94       do not confuse with METHYLENETETRAHYDROFOLATE DEHYDROGENASE %28%NADP%29%%A%  
% 216.78/216.94  |- mesh__recordAuthorizer mesh__D045102 sjn
% 216.78/216.94  |- skos__historyNote mesh__D045102
% 216.78/216.94       Methylenetetrahydrofolate Reductase %28%1989-2003%29%
% 216.78/216.94  |- skos__hiddenLabel mesh__D045102
% 216.78/216.94       NADH Dependent 5,10 Methylenetetrahydrofolate Reductase
% 216.78/216.94  |- skos__altLabel mesh__D045102
% 216.78/216.94       NADH-Dependent 5,10-Methylenetetrahydrofolate Reductase
% 216.78/216.94  |- skos__prefLabel mesh__D045102
% 216.78/216.94       Methylenetetrahydrofolate Dehydrogenase %28%NAD+%29%
% 216.78/216.94  |- skos__broader mesh__D045102smesh__D000587
% 216.78/216.94  |- skos__altLabel mesh__D045102
% 216.78/216.94       5,10-Methylenetetrahydrofolate-Reductase %28%NADH%29%
% 216.78/216.94  |- skos__altLabel mesh__D045102
% 216.78/216.94       5,10-Methylenetetrahydrofolate:NAD Oxidoreductase
% 216.78/216.94  |- mesh__dateEstablished mesh__D045102 2004-01-01
% 216.78/216.94  |- skos__scopeNote mesh__D045102
% 216.78/216.94       A NAD-dependent oxidoreductase that catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5,10-methenyl-tetrahdyrofolate. It has been found in a variety of microorganisms.%A%    
% 216.78/216.94  |- skos__historyNote mesh__D045102 Oxidoreductases %28%1999-2003%29%
% 216.78/216.94  |- mesh__historyNote mesh__D045102
% 216.78/216.94       2004; use METHYLENETETRAHYDROFOLATE DEHYDROGENASE %28%NADP%29% 1989-2003; for 5,10-METHYLENETETRAHYDROFOLATE-REDUCTASE %28%NADH%29% use METHYLENETETRAHYDROFOLATE DEHYDROGENASE %28%NAD+%29% %28%NM%29% 1999-2003;%A%  
% 216.78/216.94  |- skos__hiddenLabel mesh__D045102
% 216.78/216.94       5,10-Methylenetetrahydrofolate Reductase, NADH-Dependent
% 216.78/216.94  |- mesh__recordMaintainer mesh__D045102 jmp
% 216.78/216.94  |- skos__hiddenLabel mesh__D045102
% 216.78/216.94       5,10 Methylenetetrahydrofolate:NAD Oxidoreductase
% 216.78/216.94  |- mesh__recordOriginator mesh__D045102 AKE
% 216.78/216.94  |- mesh__publicMeSHNote mesh__D045102
% 216.78/216.94       2004; see METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1989-2003; 5,10-METHYLENETETRAHYDROFOLATE-REDUCTASE %28%NADH%29% was indexed under OXIDOREDUCTASES 1999-2003%A%  
% 216.78/216.94  |- skos__hiddenLabel mesh__D045102
% 216.78/216.94       Oxidoreductase, 5,10-Methylenetetrahydrofolate:NAD
% 216.78/216.94  |- skos__altLabel mesh__D045102
% 216.78/216.94       Methylenetetrahydrofolate Dehydrogenase %28%NAD%29%
% 216.78/216.94  |- mesh__dateCreated mesh__D045102 2003-07-09
% 216.78/216.94  |- mesh__dateCreated mesh__D017411 1992-05-22
% 216.78/216.94  |- mesh__publicMeSHNote mesh__D017411
% 216.78/216.94       93; SMALL RIBONUCLEOPROTEINS was indexed under RIBONUCLEOPROTEINS 1982-92%A%  
% 216.78/216.94  |- mesh__onlineNote mesh__D017411
% 216.78/216.94       use RIBONUCLEOPROTEINS, SMALL NUCLEAR %28%NM%29% to search SMALL RIBONUCLEOPROTEINS 1981-92%A%  
% 216.78/216.94  |- mesh__dateEstablished mesh__D017411 1993-01-01
% 216.78/216.94  |- mesh__recordMaintainer mesh__D017411 SYSTEM
% 216.78/216.94  |- mesh__recordOriginator mesh__D017411 PXP
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D017411 2006
% 216.78/216.94  |- mesh__recordAuthorizer mesh__D017411 sjn
% 216.78/216.94  |- skos__hiddenLabel mesh__D017411 Ribonucleoprotein, Small Nuclear
% 216.78/216.94  |- skos__hiddenLabel mesh__D017411 RNP, Small Nuclear
% 216.78/216.94  |- skos__altLabel mesh__D017411 Small Nuclear Ribonucleoprotein
% 216.78/216.94  |- skos__prefLabel mesh__D017411 Ribonucleoproteins, Small Nuclear
% 216.78/216.94  |- skos__hiddenLabel mesh__D017411 Nuclear RNP, Small
% 216.78/216.94  |- mesh__historyNote mesh__D017411
% 216.78/216.94       93; was SMALL RIBONUCLEOPROTEINS %28%NM%29% 1982-92   
% 216.78/216.94  |- skos__altLabel mesh__D017411 Small Nuclear Ribonucleoprotein Particle
% 216.78/216.94  |- skos__broader mesh__D017411smesh__D012261
% 216.78/216.94  |- skos__scopeNote mesh__D017411
% 216.78/216.94       Highly conserved nuclear RNA-protein complexes that function in RNA processing in the nucleus, including pre-mRNA splicing and pre-mRNA 3%27%-end processing in the nucleoplasm, and pre-rRNA processing in the nucleolus %28%see RIBONUCLEOPROTEINS, SMALL NUCLEOLAR%29%.%A%    
% 216.78/216.94  |- mesh__dateRevised mesh__D017411 2005-06-30
% 216.78/216.94  |- skos__altLabel mesh__D017411 Small Nuclear Ribonucleoproteins
% 216.78/216.94  |- skos__hiddenLabel mesh__D017411 Nuclear Ribonucleoproteins, Small
% 216.78/216.94  |- rdf__type mesh__D017411sskos__Concept
% 216.78/216.94  |- skos__altLabel mesh__D017411 snRNP
% 216.78/216.94  |- skos__historyNote mesh__D017411 Ribonucleoproteins %28%1981-1992%29%
% 216.78/216.94  |- skos__altLabel mesh__D017411 Small Nuclear RNP
% 216.78/216.94  |- skos__hiddenLabel mesh__D017411 Nuclear Ribonucleoprotein, Small
% 216.78/216.94  |- skos__broader mesh__D008685smesh__D004777
% 216.78/216.94  |- skos__hiddenLabel mesh__D008685 Meteorologic Factor
% 216.78/216.94  |- mesh__dateRevised mesh__D008685 1993-06-04
% 216.78/216.94  |- skos__annotation mesh__D008685 no qualif; DF: METEOROL FACTORS   
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D008685 1996
% 216.78/216.94  |- mesh__dateCreated mesh__D008685 1976-05-19
% 216.78/216.94  |- skos__hiddenLabel mesh__D008685 Meteorological Factor
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D008685 2006
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D008685 1995
% 216.78/216.94  |- mesh__onlineNote mesh__D008685
% 216.78/216.94       use METEOROLOGICAL FACTORS to search METEOROLOGY 1975-76; use WEATHER 1966-74%A%  
% 216.78/216.94  |- skos__hiddenLabel mesh__D008685 Factor, Meteorological
% 216.78/216.94  |- skos__hiddenLabel mesh__D008685 Factors, Meteorological
% 216.78/216.94  |- mesh__historyNote mesh__D008685
% 216.78/216.94       77; was METEOROLOGY see under WEATHER 1963-76   
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D008685 2005
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D008685 1994
% 216.78/216.94  |- rdf__type mesh__D008685sskos__Concept
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D008685 2002
% 216.78/216.94  |- skos__prefLabel mesh__D008685 Meteorological Factors
% 216.78/216.94  |- skos__scopeNote mesh__D008685
% 216.78/216.94       The atmospheric phenomena which pertain to climate and weather.%A%    
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D008685 2004
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D008685 1999
% 216.78/216.94  |- skos__historyNote mesh__D008685 Weather %28%1966-1974%29%
% 216.78/216.94  |- mesh__recordMaintainer mesh__D008685 JLS
% 216.78/216.94  |- mesh__recordAuthorizer mesh__D008685 PLS
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D008685 2001
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D008685 2003
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D008685 1998
% 216.78/216.94  |- mesh__dateEstablished mesh__D008685 1977-01-01
% 216.78/216.94  |- skos__hiddenLabel mesh__D008685 Factors, Meteorologic
% 216.78/216.94  |- skos__hiddenLabel mesh__D008685 Factor, Meteorologic
% 216.78/216.94  |- skos__altLabel mesh__D008685 Meteorologic Factors
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D008685 2000
% 216.78/216.94  |- mesh__recordOriginator mesh__D008685 EC
% 216.78/216.94  |- mesh__publicMeSHNote mesh__D008685
% 216.78/216.94       77; was METEOROLOGY see under WEATHER 1963-76   
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D008685 1997
% 216.78/216.94  |- mesh__dateEstablished mesh__D016319 1991-01-01
% 216.78/216.94  |- mesh__historyNote mesh__D016319 91   
% 216.78/216.94  |- mesh__recordAuthorizer mesh__D016319 sjn
% 216.78/216.94  |- skos__hiddenLabel mesh__D016319 Casting, Corrosion
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D016319 2001
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D016319 2003
% 216.78/216.94  |- skos__broader mesh__D016319smesh__D016628
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D016319 2005
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D016319 2004
% 216.78/216.94  |- skos__hiddenLabel mesh__D016319 Corrosion Castings
% 216.78/216.94  |- mesh__dateCreated mesh__D016319 1990-05-25
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D016319 2002
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D016319 2006
% 216.78/216.94  |- skos__prefLabel mesh__D016319 Corrosion Casting
% 216.78/216.94  |- rdf__type mesh__D016319sskos__Concept
% 216.78/216.94  |- mesh__recordOriginator mesh__D016319 MXR
% 216.78/216.94  |- skos__scopeNote mesh__D016319
% 216.78/216.94       A tissue preparation technique that involves the injecting of plastic %28%acrylates%29% into blood vessels or other hollow viscera and treating the tissue with a caustic substance. This results in a negative copy or a solid replica of the enclosed space of the tissue that is ready for viewing under a scanning electron microscope.%A%    
% 216.78/216.94  |- skos__hiddenLabel mesh__D016319 Castings, Corrosion
% 216.78/216.94  |- mesh__publicMeSHNote mesh__D016319 91   
% 216.78/216.94  |- mesh__dateRevised mesh__D016319 2000-06-22
% 216.78/216.94  |- mesh__recordMaintainer mesh__D016319 TAP
% 216.78/216.94  |- rdf__type mesh__D027041sskos__Concept
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D027041 2006
% 216.78/216.94  |- skos__altLabel mesh__D027041 Somatic Hypermutation, Ig
% 216.78/216.94  |- skos__historyNote mesh__D027041 Mutation %28%1981-2001%29%
% 216.78/216.94  |- skos__hiddenLabel mesh__D027041 Somatic Hypermutations, Ig
% 216.78/216.94  |- skos__prefLabel mesh__D027041 Somatic Hypermutation, Immunoglobulin
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D027041 2005
% 216.78/216.94  |- skos__altLabel mesh__D027041 Ig Somatic Hypermutation
% 216.78/216.94  |- mesh__dateCreated mesh__D027041 2001-07-25
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D027041 2004
% 216.78/216.94  |- skos__broader mesh__D027041smesh__D007125
% 216.78/216.94  |- skos__hiddenLabel mesh__D027041 Hypermutations, Immunoglobulin Somatic
% 216.78/216.94  |- skos__hiddenLabel mesh__D027041 Hypermutations, Ig Somatic
% 216.78/216.94  |- skos__altLabel mesh__D027041 Hypermutation, Somatic, Immunoglobulin
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D027041 2003
% 216.78/216.94  |- skos__hiddenLabel mesh__D027041 Hypermutation, Immunoglobulin Somatic
% 216.78/216.94  |- skos__hiddenLabel mesh__D027041 Somatic Hypermutations, Immunoglobulin
% 216.78/216.94  |- skos__broader mesh__D027041smesh__D016296
% 216.78/216.94  |- skos__related mesh__D027041smesh__D015322
% 216.78/216.94  |- skos__hiddenLabel mesh__D027041 Immunoglobulin Somatic Hypermutations
% 216.78/216.94  |- mesh__historyNote mesh__D027041 2002   
% 216.78/216.94  |- mesh__dateRevised mesh__D027041 2002-07-03
% 216.78/216.94  |- mesh__publicMeSHNote mesh__D027041 2002   
% 216.78/216.94  |- mesh__dateEstablished mesh__D027041 2002-01-01
% 216.78/216.94  |- skos__scopeNote mesh__D027041
% 216.78/216.94       A programmed mutation process whereby changes are introduced to the nucleotide sequence of immunoglobulin gene DNA during development.%A%    
% 216.78/216.94  |- skos__altLabel mesh__D027041 Immunoglobulin Somatic Hypermutation
% 216.78/216.94  |- skos__hiddenLabel mesh__D027041 Hypermutation, Ig Somatic
% 216.78/216.94  |- skos__hiddenLabel mesh__D027041 Ig Somatic Hypermutations
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013021 2002
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013021 1997
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013021 2001
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013021 1999
% 216.78/216.94  |- mesh__dateRevised mesh__D013021 1995-02-21
% 216.78/216.94  |- skos__prefLabel mesh__D013021 South Australia
% 216.78/216.94  |- skos__broader mesh__D013021smesh__D001315
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013021 1996
% 216.78/216.94  |- rdf__type mesh__D013021sskos__Concept
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013021 1998
% 216.78/216.94  |- mesh__recordOriginator mesh__D013021 EC
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013021 2000
% 216.78/216.94  |- mesh__historyNote mesh__D013021 88   
% 216.78/216.94  |- mesh__dateEstablished mesh__D013021 1988-01-01
% 216.78/216.94  |- mesh__recordAuthorizer mesh__D013021 PLS
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013021 2004
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013021 2006
% 216.78/216.94  |- mesh__dateCreated mesh__D013021 1987-03-09
% 216.78/216.94  |- skos__scopeNote mesh__D013021
% 216.78/216.94       A state in south central Australia. Its capital is Adelaide. It was probably first visited by F. Thyssen in 1627. Later discoveries in 1802 and 1830 opened up the southern part. It became a British province in 1836 with this self-descriptive name and became a state in 1901. %28%From Webster%27%s New Geographical Dictionary, 1988, p1135%29%%A%    
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013021 2003
% 216.78/216.94  |- mesh__recordMaintainer mesh__D013021 TGC
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013021 2005
% 216.78/216.94  |- skos__annotation mesh__D013021 a state of Australia   
% 216.78/216.94  |- skos__historyNote mesh__D013021 Australia %28%1966-1987%29%
% 216.78/216.94  |- mesh__publicMeSHNote mesh__D051140
% 216.78/216.94       2006; SELENOPROTEINS was indexed under PROTEINS 1989-2005, %26% under SELENIUM 1982-1992, %26% under CARRIER PROTEINS 1982-1988%A%  
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D051140 2006
% 216.78/216.94  |- mesh__recordAuthorizer mesh__D051140 sjn
% 216.78/216.94  |- skos__broader mesh__D051140smesh__D011506
% 216.78/216.94  |- mesh__dateCreated mesh__D051140 2005-06-30
% 216.78/216.94  |- mesh__recordMaintainer mesh__D051140 DRC
% 216.78/216.94  |- mesh__historyNote mesh__D051140 2006%28%1982%29%   
% 216.78/216.94  |- mesh__recordOriginator mesh__D051140 DRC
% 216.78/216.94  |- skos__altLabel mesh__D051140 Selenoprotein
% 216.78/216.94  |- rdf__type mesh__D051140sskos__Concept
% 216.78/216.94  |- mesh__dateEstablished mesh__D051140 2006-01-01
% 216.78/216.94  |- skos__prefLabel mesh__D051140 Selenoproteins
% 216.78/216.94  |- skos__scopeNote mesh__D051140
% 216.78/216.94       Selenoproteins are proteins that specifically incorporate SELENOCYSTEINE into their amino acid chain.  Most selenoproteins are enzymes with the selenocysteine residues being responsible for their catalytic functions.%A%    
% 216.78/216.94  |- skos__annotation mesh__D051140 general; prefer specifics   
% 216.78/216.94  |- skos__hiddenLabel mesh__D004295 beta Hydroxytyrosine
% 216.78/216.94  |- skos__altLabel mesh__D004295 beta-Hydroxytyrosine
% 216.78/216.94  |- mesh__dateCreated mesh__D004295 1999-01-01
% 216.78/216.94  |- skos__broader mesh__D004295smesh__D014443
% 216.78/216.94  |- mesh__recordMaintainer mesh__D004295 ssb
% 216.78/216.94  |- skos__scopeNote mesh__D004295
% 216.78/216.94       A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.%A%    
% 216.78/216.94  |- skos__broader mesh__D004295smesh__D010649
% 216.78/216.94  |- skos__annotation mesh__D004295
% 216.78/216.94       check text to see if LEVODOPA; %28%L-DOPA%29%; is not meant instead%A%  
% 216.78/216.94  |- mesh__publicMeSHNote mesh__D004295 2002; see DOPA 1966-2001   
% 216.78/216.94  |- skos__altLabel mesh__D004295 Dopa
% 216.78/216.94  |- mesh__recordOriginator mesh__D004295 NLM
% 216.78/216.94  |- skos__hiddenLabel mesh__D004295 3,4 Dihydroxyphenylalanine
% 216.78/216.94  |- mesh__historyNote mesh__D004295
% 216.78/216.94       2002%28%1966%29%; for BETA-HYDROXYTYROSINE use DIHYDOXYPHENYLALANINE %28%NM%29% 1989-1991%A%  
% 216.78/216.94  |- rdf__type mesh__D004295sskos__Concept
% 216.78/216.94  |- mesh__recordAuthorizer mesh__D004295 sjn
% 216.78/216.94  |- skos__prefLabel mesh__D004295 Dihydroxyphenylalanine
% 216.78/216.94  |- skos__altLabel mesh__D004295 3-Hydroxy-DL-tyrosine
% 216.78/216.94  |- skos__altLabel mesh__D004295 3,4-Dihydroxyphenylalanine
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D004295 2006
% 216.78/216.94  |- mesh__dateRevised mesh__D004295 2005-06-30
% 216.78/216.94  |- skos__related mesh__D004295smesh__D004296
% 216.78/216.94  |- skos__broader mesh__D004295smesh__D002395
% 216.78/216.94  |- skos__related mesh__D004295smesh__D004298
% 216.78/216.94  |- skos__hiddenLabel mesh__D004295 3 Hydroxy DL tyrosine
% 216.78/216.94  |- skos__scopeNote mesh__D012727
% 216.78/216.94       Those characteristics that distinguish one SEX from the other. The primary sex characteristics are the OVARIES and TESTES and their related hormones. Secondary sex characteristics are those which are masculine or feminine but not directly related to reproduction.%A%    
% 216.78/216.94  |- skos__altLabel mesh__D012727 Sex Differences
% 216.78/216.94  |- mesh__recordOriginator mesh__D012727 NLM
% 216.78/216.94  |- mesh__recordAuthorizer mesh__D012727 sjn
% 216.78/216.94  |- skos__hiddenLabel mesh__D012727 Differences, Sex
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D012727 2005
% 216.78/216.94  |- skos__broader mesh__D012727smesh__D012098
% 216.78/216.94  |- skos__altLabel mesh__D012727 Sex Dimorphism
% 216.78/216.94  |- skos__hiddenLabel mesh__D012727 Difference, Sex
% 216.78/216.94  |- skos__hiddenLabel mesh__D012727 Sex Difference
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D012727 2006
% 216.78/216.94  |- skos__prefLabel mesh__D012727 Sex Characteristics
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D012727 2004
% 216.78/216.94  |- skos__hiddenLabel mesh__D012727 Characteristics, Sex
% 216.78/216.94  |- rdf__type mesh__D012727sskos__Concept
% 216.78/216.94  |- skos__hiddenLabel mesh__D012727 Sex Characteristic
% 216.78/216.94  |- skos__hiddenLabel mesh__D012727 Sex Dimorphisms
% 216.78/216.94  |- mesh__recordMaintainer mesh__D012727 lkt
% 216.78/216.94  |- skos__related mesh__D012727smesh__D012723
% 216.78/216.94  |- mesh__dateCreated mesh__D012727 1999-01-01
% 216.78/216.94  |- skos__hiddenLabel mesh__D012727 Characteristic, Sex
% 216.78/216.94  |- skos__annotation mesh__D012727
% 216.78/216.94       no qualif; for anat or physiol differences between male %26% female; differentiate from SEX DETERMINATION %28%GENETICS%29% %28%factors determining male or female%29%, SEX DIFFERENTIATION %28%for differentiation of male from female during embryogenesis%29%, SEX DISTRIBUTION %28%for usually statistical psychol, social, etc., differences between men %26% women%29%, SEX FACTORS %28%for usually sex as an etiol or physiol factor%29%%A%  
% 216.78/216.94  |- mesh__dateRevised mesh__D012727 2003-07-09
% 216.78/216.94  |- skos__hiddenLabel mesh__D012727 Dimorphism, Sex
% 216.78/216.94  |- skos__hiddenLabel mesh__D012727 Dimorphisms, Sex
% 216.78/216.94  |- skos__historyNote mesh__D045103 Oxidoreductases %28%1974-1986%29%
% 216.78/216.94  |- skos__prefLabel mesh__D045103
% 216.78/216.94       5,10-Methylenetetrahydrofolate Reductase %28%FADH2%29%
% 216.78/216.94  |- skos__historyNote mesh__D045103 Tetrahydrofolates %28%1974-1982%29%
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D045103 2006
% 216.78/216.94  |- rdf__type mesh__D045103sskos__Concept
% 216.78/216.94  |- mesh__dateEstablished mesh__D045103 2004-01-01
% 216.78/216.94  |- skos__scopeNote mesh__D045103
% 216.78/216.94       An FAD-dependent oxidoreductase found primarily in BACTERIA. It is specific for the reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate. This enzyme was formerly listed as EC 1.1.1.68 and 1.1.99.15.%A%    
% 216.78/216.94  |- skos__altLabel mesh__D045103
% 216.78/216.94       5,10-Methylenetetrahydrofolate Reductase %28%FADH%29%
% 216.78/216.94  |- skos__historyNote mesh__D045103
% 216.78/216.94       Alcohol Oxidoreductases %28%1974-2003%29%
% 216.78/216.94  |- mesh__dateRevised mesh__D045103 2005-06-30
% 216.78/216.94  |- skos__broader mesh__D045103smesh__D010088
% 216.78/216.94  |- mesh__recordMaintainer mesh__D045103 ags
% 216.78/216.94  |- mesh__publicMeSHNote mesh__D045103
% 216.78/216.94       2004; 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE %28%FADH2%29% was indexed under OXIDOREDUCTASES 1987-2003, under ALCOHOL OXIDOREDUCTASES 1974-1986, under TETRAHYDROFOLATES 1974-1982  %26% under FOLIC ACIDS 1970-1973%A%  
% 216.78/216.94  |- mesh__recordAuthorizer mesh__D045103 sjn
% 216.78/216.94  |- skos__historyNote mesh__D045103 Folic Acid %28%1970-1973%29%
% 216.78/216.94  |- mesh__recordOriginator mesh__D045103 AKE
% 216.78/216.94  |- mesh__historyNote mesh__D045103
% 216.78/216.94       2004; use 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE %28%FADH2%29% %28%NM%29% 1980-2003%A%  
% 216.78/216.94  |- mesh__dateCreated mesh__D045103 2003-07-09
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D017412 2006
% 216.78/216.94  |- skos__scopeNote mesh__D017412
% 216.78/216.94       A nuclear RNA-protein complex that plays a role in RNA processing. In the nucleoplasm, the U1 snRNP along with other small nuclear ribonucleoproteins %28%U2, U4-U6, and U5%29% assemble into SPLICEOSOMES that remove introns from pre-mRNA by splicing. The U1 snRNA forms base pairs with conserved sequence motifs at the 5%27%-splice site and recognizes both the 5%27%- and 3%27%-splice sites and may have a fundamental role in aligning the two sites for the splicing reaction.%A%    
% 216.78/216.94  |- mesh__dateCreated mesh__D017412 1992-05-22
% 216.78/216.94  |- skos__prefLabel mesh__D017412 Ribonucleoprotein, U1 Small Nuclear
% 216.78/216.94  |- mesh__dateEstablished mesh__D017412 1993-01-01
% 216.78/216.94  |- skos__altLabel mesh__D017412 Ribonucleoproteins, Small, U1
% 216.78/216.94  |- mesh__recordAuthorizer mesh__D017412 sjn
% 216.78/216.94  |- skos__historyNote mesh__D017412 Ribonucleoproteins %28%1975-1992%29%
% 216.78/216.94  |- rdf__type mesh__D017412sskos__Concept
% 216.78/216.94  |- skos__altLabel mesh__D017412 Small Nuclear Ribonucleoproteins, U1
% 216.78/216.94  |- mesh__dateRevised mesh__D017412 2005-06-30
% 216.78/216.94  |- mesh__historyNote mesh__D017412
% 216.78/216.94       2000; U1 SNRNP was U1-RNP %28%SY%29% to SMALL RIBONUCLEOPROTEINS %28%NM%29% 1982-92%A%  
% 216.78/216.94  |- mesh__publicMeSHNote mesh__D017412
% 216.78/216.94       2000; RIBONUCLEOPROTEINS, SMALL, U1 was heading 1993-1999; U1-RNP was indexed under RIBONUCLEOPROTEINS 1982-92%A%  
% 216.78/216.94  |- skos__altLabel mesh__D017412 U1 snRNP
% 216.78/216.94  |- skos__altLabel mesh__D017412 U1 Small Nuclear Ribonucleoproteins
% 216.78/216.94  |- mesh__recordMaintainer mesh__D017412 SYSTEM
% 216.78/216.94  |- mesh__recordOriginator mesh__D017412 PXP
% 216.78/216.94  |- skos__broader mesh__D017412smesh__D017411
% 216.78/216.94  |- skos__broader mesh__D009141Q000502smesh__D009141
% 216.78/216.94  |- mesh__preferredCombination mesh__D009141Q000502smesh__D009142
% 216.78/216.94  |- rdf__type mesh__D009141Q000502smesh__CompoundConcept
% 216.78/216.94  |- skos__broader mesh__D008686smesh__D030762
% 216.78/216.94  |- skos__scopeNote mesh__D008686
% 216.78/216.94       The period following ESTRUS during which the phenomena of estrus subside in those animals in which pregnancy or pseudopregnancy does not occur.%A%    
% 216.78/216.94  |- mesh__recordOriginator mesh__D008686 NLM
% 216.78/216.94  |- rdf__type mesh__D008686sskos__Concept
% 216.78/216.94  |- mesh__dateCreated mesh__D008686 1974-11-11
% 216.78/216.94  |- skos__annotation mesh__D008686 non-primate mammals only   
% 216.78/216.94  |- mesh__recordAuthorizer mesh__D008686 sjn
% 216.78/216.94  |- mesh__dateEstablished mesh__D008686 1991-01-01
% 216.78/216.94  |- mesh__recordMaintainer mesh__D008686 lkt
% 216.78/216.94  |- mesh__dateRevised mesh__D008686 2004-07-07
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D008686 2006
% 216.78/216.94  |- mesh__publicMeSHNote mesh__D008686 91; was see under ESTRUS 1975-90   
% 216.78/216.94  |- skos__prefLabel mesh__D008686 Metestrus
% 216.78/216.94  |- mesh__historyNote mesh__D008686
% 216.78/216.94       91%28%75%29%; was see under ESTRUS 1975-90   
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D008686 2005
% 216.78/216.94  |- skos__altLabel mesh__D027042 P1-Derived Artificial Chromosomes
% 216.78/216.94  |- skos__hiddenLabel mesh__D027042 Artificial Chromosome, P1-Derived
% 216.78/216.94  |- mesh__historyNote mesh__D027042 2002   
% 216.78/216.94  |- skos__altLabel mesh__D027042 P1 Bacteriophage Artificial Chromosomes
% 216.78/216.94  |- skos__broader mesh__D027042smesh__D022201
% 216.78/216.94  |- skos__hiddenLabel mesh__D027042 P1-Derived Artificial Chromosome
% 216.78/216.94  |- mesh__recordAuthorizer mesh__D027042 ags
% 216.78/216.94  |- skos__altLabel mesh__D027042 PAC %28%Chromosome%29%
% 216.78/216.94  |- mesh__dateRevised mesh__D027042 2005-07-22
% 216.78/216.94  |- skos__hiddenLabel mesh__D027042 Chromosomes, P1-Derived Artificial
% 216.78/216.94  |- mesh__publicMeSHNote mesh__D027042 2002   
% 216.78/216.94  |- skos__hiddenLabel mesh__D027042 P1 Derived Artificial Chromosomes
% 216.78/216.94  |- skos__hiddenLabel mesh__D027042 Artificial Chromosomes, P1-Derived
% 216.78/216.94  |- mesh__recordOriginator mesh__D027042 nns
% 216.78/216.94  |- mesh__dateEstablished mesh__D027042 2002-01-01
% 216.78/216.94  |- rdf__type mesh__D027042sskos__Concept
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D027042 2006
% 216.78/216.94  |- mesh__dateCreated mesh__D027042 2001-07-25
% 216.78/216.94  |- skos__altLabel mesh__D027042 PACs %28%Chromosomes%29%
% 216.78/216.94  |- skos__scopeNote mesh__D027042
% 216.78/216.94       DNA constructs that are derived from the DNA of BACTERIOPHAGE P1. They can carry large amounts %28%about 100-300 kilobases%29% of other sequence for a variety of bioengineering purposes.%A%    
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D027042 2005
% 216.78/216.94  |- skos__altLabel mesh__D027042 Chromosomes, P1 Bacteriophage Artificial
% 216.78/216.94  |- skos__altLabel mesh__D027042 Bacteriophage P1 Artificial Chromosomes
% 216.78/216.94  |- skos__hiddenLabel mesh__D027042 Chromosome, P1-Derived Artificial
% 216.78/216.94  |- skos__altLabel mesh__D027042 Artificial Chromosomes, P1 Bacteriophage
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D027042 2006A
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D027042 2004
% 216.78/216.94  |- mesh__recordMaintainer mesh__D027042 ags
% 216.78/216.94  |- skos__prefLabel mesh__D027042 Chromosomes, Artificial, P1 Bacteriophage
% 216.78/216.94  |- skos__broader mesh__D013820smesh__D008666
% 216.78/216.94  |- mesh__recordAuthorizer mesh__D013820 sjn
% 216.78/216.94  |- mesh__recordOriginator mesh__D013820 NLM
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013820 2004
% 216.78/216.94  |- mesh__recordMaintainer mesh__D013820 jmp
% 216.78/216.94  |- skos__hiddenLabel mesh__D013820 S, Thermolysin
% 216.78/216.94  |- mesh__dateCreated mesh__D013820 1999-01-01
% 216.78/216.94  |- skos__prefLabel mesh__D013820 Thermolysin
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013820 2005
% 216.78/216.94  |- skos__scopeNote mesh__D013820
% 216.78/216.94       A thermostable extracellular metalloendopeptidase containing four calcium ions. %28%Enzyme Nomenclature, 1992%29% 3.4.24.27.%A%    
% 216.78/216.94  |- mesh__historyNote mesh__D013820 73%28%71%29%   
% 216.78/216.94  |- skos__historyNote mesh__D013820
% 216.78/216.94       Peptide Peptidohydrolases %28%1966-1970%29%
% 216.78/216.94  |- mesh__publicMeSHNote mesh__D013820 73   
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013820 2006
% 216.78/216.94  |- mesh__dateEstablished mesh__D013820 1973-01-01
% 216.78/216.94  |- rdf__type mesh__D013820sskos__Concept
% 216.78/216.94  |- mesh__dateRevised mesh__D013820 2003-07-09
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013022 1999
% 216.78/216.94  |- rdf__type mesh__D013022sskos__Concept
% 216.78/216.94  |- mesh__recordAuthorizer mesh__D013022 SJN
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013022 1998
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013022 2002
% 216.78/216.94  |- skos__broader mesh__D013022smesh__D001061
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013022 2004
% 216.78/216.94  |- skos__prefLabel mesh__D013022 South Carolina
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013022 2001
% 216.78/216.94  |- mesh__dateCreated mesh__D013022 1999-01-01
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013022 2006
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013022 2003
% 216.78/216.94  |- skos__broader mesh__D013022smesh__D015144
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013022 2005
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D013022 2000
% 216.78/216.94  |- mesh__recordOriginator mesh__D013022 NLM
% 216.78/216.94  |- mesh__recordMaintainer mesh__D013022 PXP
% 216.78/216.94  |- mesh__dateRevised mesh__D013022 1997-06-20
% 216.78/216.94  |- skos__broader mesh__D004296smesh__D001142
% 216.78/216.94  |- mesh__dateEstablished mesh__D004296 1991-01-01
% 216.78/216.94  |- mesh__historyNote mesh__D004296
% 216.78/216.94       91%28%80%29%63; was see under AROMATIC AMINO ACID DECARBOXYLASES 1980-90; was heading 1963-79%A%  
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D004296 2004
% 216.78/216.94  |- mesh__recordMaintainer mesh__D004296 ssb
% 216.78/216.94  |- skos__scopeNote mesh__D004296
% 216.78/216.94       One of the AROMATIC-L-AMINO-ACID DECARBOXYLASES, this enzyme is responsible for the conversion of dopa to dopamine. It is of clinical importance in the treatment of Parkinson%27%s disease. EC 4.1.1.28.%A%    
% 216.78/216.94  |- skos__prefLabel mesh__D004296 Dopa Decarboxylase
% 216.78/216.94  |- rdf__type mesh__D004296sskos__Concept
% 216.78/216.94  |- mesh__dateRevised mesh__D004296 2003-07-09
% 216.78/216.94  |- skos__hiddenLabel mesh__D004296 Decarboxylase, Dopa
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D004296 2005
% 216.78/216.94  |- mesh__dateCreated mesh__D004296 1999-01-01
% 216.78/216.94  |- mesh__recordOriginator mesh__D004296 NLM
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D004296 2006
% 216.78/216.94  |- mesh__recordAuthorizer mesh__D004296 sjn
% 216.78/216.94  |- mesh__publicMeSHNote mesh__D004296
% 216.78/216.94       91,63-79; was see under AROMATIC AMINO ACID DECARBOXYLASES 1980-90; was heading 1963-79%A%  
% 216.78/216.94  |- skos__altLabel mesh__D012728 Chromatin, Sex
% 216.78/216.94  |- mesh__recordMaintainer mesh__D012728 nns
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D012728 2006
% 216.78/216.94  |- skos__hiddenLabel mesh__D012728 Sex Chromatins
% 216.78/216.94  |- mesh__activeMeSHYear mesh__D012728 2004
% 216.78/216.94  |- skos__altLabel mesh__D012728 Barr Bodies
% 216.78/216.94  |- skos__broader mesh__D012728smesh__D006570
% 216.78/216.94  |- mesh__recordOriginator mesh__D012728 NLM
% 216.78/216.94  |- skos__broader mesh__D012728smesh__D012730
% 216.78/216.94  |- mesh__recordAuthorizer mesh__D012728 sjn
% 216.78/216.94  |- rdf__type mesh__D012728sskos__Concept
% 216.78/216.94  |- skos__hiddenLabel mesh__D012728 Bodies, Barr
% 216.78/216.94  |- skos__hiddenLabel mesh__D012728 Chromatins, Sex
% 216.78/216.94  |- mesh__dateCreated mesh__D012728 1999-01-01
% 216.78/216.94  |- skos__annotation mesh__D012728
% 216.78/216.94       A 11 qualif except /cytol; /genet /isol permitted   
% 216.78/216.94  |- mesh__dateRevised mesh__D012728 2003-07-09
% 216.78/216.95  |- skos__related mesh__D012728smesh__D012732
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D012728 2005
% 216.78/216.95  |- skos__scopeNote mesh__D012728
% 216.78/216.95       In the interphase nucleus, a condensed mass of chromatin representing an inactivated X chromosome. Each X CHROMOSOME, in excess of one, forms  sex chromatin %28%Barr body%29% in the mammalian nucleus. %28%from King %26% Stansfield, A Dictionary of Genetics, 4th ed%29%%A%    
% 216.78/216.95  |- skos__prefLabel mesh__D012728 Sex Chromatin
% 216.78/216.95  |- skos__altLabel mesh__D017413 Small Nuclear Ribonucleoproteins, U2
% 216.78/216.95  |- mesh__recordMaintainer mesh__D017413 SYSTEM
% 216.78/216.95  |- mesh__recordOriginator mesh__D017413 PXP
% 216.78/216.95  |- skos__altLabel mesh__D017413 U2 snRNP
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D017413 2006
% 216.78/216.95  |- skos__scopeNote mesh__D017413
% 216.78/216.95       A nuclear RNA-protein complex that plays a role in RNA processing. In the nucleoplasm, the U2 snRNP along with other small nuclear ribonucleoproteins %28%U1, U4-U6, and U5%29% assemble into SPLICEOSOMES that remove introns from pre-mRNA by splicing. The U2 snRNA forms base pairs with conserved sequence motifs at the branch point, which associates with a heat- and RNAase-sensitive factor in an early step of splicing.%A%    
% 216.78/216.95  |- skos__prefLabel mesh__D017413 Ribonucleoprotein, U2 Small Nuclear
% 216.78/216.95  |- mesh__publicMeSHNote mesh__D017413
% 216.78/216.95       2000; RIBONUCLEOPROTEINS, SMALL, U2 was heading 1993-1999;  SNRNP-U2 was indexed under RIBONUCLEOPROTEINS 1982-92%A%  
% 216.78/216.95  |- rdf__type mesh__D017413sskos__Concept
% 216.78/216.95  |- mesh__dateEstablished mesh__D017413 1993-01-01
% 216.78/216.95  |- mesh__historyNote mesh__D017413
% 216.78/216.95       2000; U2 SNRNP was SNRNP-U2 %28%SY%29% to SMALL RIBONUCLEOPROTEINS %28%NM%29% 1982-92%A%  
% 216.78/216.95  |- mesh__recordAuthorizer mesh__D017413 sjn
% 216.78/216.95  |- skos__altLabel mesh__D017413 Ribonucleoproteins, Small, U2
% 216.78/216.95  |- skos__broader mesh__D017413smesh__D017411
% 216.78/216.95  |- skos__historyNote mesh__D017413 Ribonucleoproteins %28%1975-1992%29%
% 216.78/216.95  |- skos__altLabel mesh__D017413 U2 Small Nuclear Ribonucleoproteins
% 216.78/216.95  |- mesh__dateCreated mesh__D017413 1992-05-22
% 216.78/216.95  |- mesh__dateRevised mesh__D017413 2005-06-30
% 216.78/216.95  |- mesh__dateCreated mesh__D008687 1999-01-01
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D008687 2004
% 216.78/216.95  |- rdf__type mesh__D008687sskos__Concept
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D008687 2002
% 216.78/216.95  |- mesh__dateRevised mesh__D008687 2000-08-22
% 216.78/216.95  |- skos__annotation mesh__D008687 a hypoglycemic   
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D008687 1998
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D008687 2003
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D008687 2001
% 216.78/216.95  |- mesh__recordMaintainer mesh__D008687 sjn
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D008687 1997
% 216.78/216.95  |- skos__altLabel mesh__D008687 Dimethylbiguanidine
% 216.78/216.95  |- skos__prefLabel mesh__D008687 Metformin
% 216.78/216.95  |- mesh__recordOriginator mesh__D008687 NLM
% 216.78/216.95  |- skos__broader mesh__D008687smesh__D001645
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D008687 2001A
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D008687 2000
% 216.78/216.95  |- skos__scopeNote mesh__D008687
% 216.78/216.95       A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves  glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p289%29%%A%    
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D008687 1996
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D008687 2006
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D008687 2005
% 216.78/216.95  |- mesh__recordAuthorizer mesh__D008687 sjn
% 216.78/216.95  |- skos__altLabel mesh__D008687 Dimethylguanylguanidine
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D008687 1999
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D027841 2005
% 216.78/216.95  |- mesh__recordAuthorizer mesh__D027841 sjn
% 216.78/216.95  |- mesh__publicMeSHNote mesh__D027841
% 216.78/216.95       2002; see Rosales 1998-2001, see SPICES 1993-1997;   
% 216.78/216.95  |- rdf__type mesh__D027841sskos__Concept
% 216.78/216.95  |- mesh__dateCreated mesh__D027841 2001-07-25
% 216.78/216.95  |- skos__prefLabel mesh__D027841 Pimenta
% 216.78/216.95  |- mesh__dateRevised mesh__D027841 2004-07-07
% 216.78/216.95  |- mesh__recordOriginator mesh__D027841 ssb
% 216.78/216.95  |- mesh__dateEstablished mesh__D027841 2002-01-01
% 216.78/216.95  |- skos__altLabel mesh__D027841 Pimenta officinalis
% 216.78/216.95  |- skos__broader mesh__D027841smesh__D027822
% 216.78/216.95  |- mesh__historyNote mesh__D027841
% 216.78/216.95       2002; use Rosales 1998-2001, use SPICES 1993-1997;   
% 216.78/216.95  |- skos__scopeNote mesh__D027841
% 216.78/216.95       A plant genus in the family MYRTACEAE, order Myrtales, subclass Rosidae.  It is best known for allspice from the dried berry of Pimenta diocia.%A%    
% 216.78/216.95  |- skos__annotation mesh__D027841
% 216.78/216.95       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D027841 2006
% 216.78/216.95  |- mesh__recordMaintainer mesh__D027841 ssb
% 216.78/216.95  |- skos__historyNote mesh__D027841 Rosales %28%1998-2001%29%
% 216.78/216.95  |- mesh__dateCreated mesh__D013821 1999-01-01
% 216.78/216.95  |- skos__prefLabel mesh__D013821 Thermometers
% 216.78/216.95  |- mesh__recordAuthorizer mesh__D013821 sjn
% 216.78/216.95  |- mesh__recordOriginator mesh__D013821 NLM
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D013821 2005
% 216.78/216.95  |- skos__hiddenLabel mesh__D013821 Thermometer
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D013821 2002
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D013821 2006
% 216.78/216.95  |- rdf__type mesh__D013821sskos__Concept
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D013821 2003
% 216.78/216.95  |- skos__scopeNote mesh__D013821
% 216.78/216.95       Measuring instruments for determining the temperature of matter. Most thermometers used in the field of medicine are designed for measuring body temperature or for use in the clinical laboratory. %28%From UMDNS, 1999%29%%A%    
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D013821 2000
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D013821 2004
% 216.78/216.95  |- mesh__recordMaintainer mesh__D013821 adp
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D013821 2001
% 216.78/216.95  |- mesh__dateRevised mesh__D013821 1999-11-08
% 216.78/216.95  |- skos__broader mesh__D013821smesh__D004864
% 216.78/216.95  |- skos__broader mesh__D014123Q000662smesh__D014123
% 216.78/216.95  |- mesh__preferredCombination mesh__D014123Q000662smesh__D014124
% 216.78/216.95  |- rdf__type mesh__D014123Q000662smesh__CompoundConcept
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D013023 2004
% 216.78/216.95  |- mesh__dateCreated mesh__D013023 1999-01-01
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D013023 2000
% 216.78/216.95  |- mesh__recordOriginator mesh__D013023 NLM
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D013023 2006
% 216.78/216.95  |- skos__broader mesh__D013023smesh__D015146
% 216.78/216.95  |- mesh__recordMaintainer mesh__D013023 PXP
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D013023 2003
% 216.78/216.95  |- mesh__dateRevised mesh__D013023 1997-06-20
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D013023 2005
% 216.78/216.95  |- mesh__recordAuthorizer mesh__D013023 SJN
% 216.78/216.95  |- skos__prefLabel mesh__D013023 South Dakota
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D013023 2002
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D013023 1999
% 216.78/216.95  |- rdf__type mesh__D013023sskos__Concept
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D013023 2001
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D013023 1998
% 216.78/216.95  |- mesh__recordMaintainer mesh__D051940 DRC
% 216.78/216.95  |- skos__hiddenLabel mesh__D051940 Costimulatory Molecule, B70
% 216.78/216.95  |- skos__hiddenLabel mesh__D051940 Costimulatory Molecule, B7-2
% 216.78/216.95  |- mesh__recordOriginator mesh__D051940 DRC
% 216.78/216.95  |- skos__prefLabel mesh__D051940 Antigens, CD86
% 216.78/216.95  |- mesh__recordAuthorizer mesh__D051940 sjn
% 216.78/216.95  |- skos__hiddenLabel mesh__D051940 Antigen, CD86
% 216.78/216.95  |- skos__hiddenLabel mesh__D051940 Antigen, B7 2
% 216.78/216.95  |- skos__broader mesh__D051940smesh__D008562
% 216.78/216.95  |- mesh__dateEstablished mesh__D051940 2006-01-01
% 216.78/216.95  |- skos__altLabel mesh__D051940 CD86 Antigens
% 216.78/216.95  |- skos__altLabel mesh__D051940 Antigen, B7-2
% 216.78/216.95  |- skos__altLabel mesh__D051940 Early T Cell Costimulatory Molecule 1
% 216.78/216.95  |- skos__hiddenLabel mesh__D051940 B7 2 Antigen
% 216.78/216.95  |- mesh__dateCreated mesh__D051940 2005-06-30
% 216.78/216.95  |- skos__altLabel mesh__D051940 B7-2 Antigen
% 216.78/216.95  |- skos__broader mesh__D051940smesh__D015703
% 216.78/216.95  |- skos__altLabel mesh__D051940 CD86 Antigen
% 216.78/216.95  |- skos__scopeNote mesh__D051940
% 216.78/216.95       A CD antigen that plays a role in T-lymphocyte proliferation and interleukin 2 production. It is a co-stimulatory ligand for the CD28 ANTIGEN on T-LYMPHOCYTES and initiates T-cell activation and immune response.%A%    
% 216.78/216.95  |- mesh__publicMeSHNote mesh__D051940
% 216.78/216.95       2006; ANTIGENS, CD86 was indexed under MEMBRANE GLYCOPROTEINS %26% ANTIGENS, CD 1996-2005, %26% under B-CELL ACTIVATION ANTIGEN 1993-1995%A%  
% 216.78/216.95  |- mesh__historyNote mesh__D051940 2006%28%1993%29%   
% 216.78/216.95  |- skos__altLabel mesh__D051940 B7-2 Costimulatory Molecule
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D051940 2006
% 216.78/216.95  |- skos__altLabel mesh__D051940 B70 Costimulatory Molecule
% 216.78/216.95  |- rdf__type mesh__D051940sskos__Concept
% 216.78/216.95  |- skos__altLabel mesh__D051142 Retinol Ester Synthetase
% 216.78/216.95  |- skos__hiddenLabel mesh__D051142 Synthetase, Retinol-Palmitate
% 216.78/216.95  |- skos__altLabel mesh__D051142 Acyl CoA-Retinol Acyltransferase
% 216.78/216.95  |- mesh__recordMaintainer mesh__D051142 AKE
% 216.78/216.95  |- skos__prefLabel mesh__D051142 Retinol O-Fatty-Acyltransferase
% 216.78/216.95  |- skos__broader mesh__D051142smesh__D000217
% 216.78/216.95  |- skos__scopeNote mesh__D051142
% 216.78/216.95       An enzyme that catalyzes the acyl group transfer of acyl COENZYME A to RETINOL to generate COENZYME A and a retinyl ester.%A%    
% 216.78/216.95  |- mesh__publicMeSHNote mesh__D051142
% 216.78/216.95       2006; RETINOL O-FATTY-ACYLTRANSFERASE was indexed under ACYLTRANSFERASES 1982-2005, %26% under PALMITATES %26% VITAMIN A 1977-1981%A%  
% 216.78/216.95  |- skos__hiddenLabel mesh__D051142 CoA-Retinol Acyltransferase, Acyl
% 216.78/216.95  |- skos__hiddenLabel mesh__D051142
% 216.78/216.95       Fatty Acyl Coenzyme A Retinol Acyltransferase
% 216.78/216.95  |- skos__altLabel mesh__D051142
% 216.78/216.95       Fatty Acyl Coenzyme A-Retinol Acyltransferase
% 216.78/216.95  |- skos__hiddenLabel mesh__D051142 Synthetase, Retinol Stearate
% 216.78/216.95  |- skos__hiddenLabel mesh__D051142 Acyltransferase, Acyl CoA-Retinol
% 216.78/216.95  |- skos__hiddenLabel mesh__D051142 Synthetase, Retinol Ester
% 216.78/216.95  |- skos__hiddenLabel mesh__D051142 Stearate Synthetase, Retinol
% 216.78/216.95  |- skos__hiddenLabel mesh__D051142 Retinol Fatty Acyltransferase
% 216.78/216.95  |- skos__altLabel mesh__D051142 Retinol Fatty-Acyltransferase
% 216.78/216.95  |- rdf__type mesh__D051142sskos__Concept
% 216.78/216.95  |- mesh__recordOriginator mesh__D051142 AKE
% 216.78/216.95  |- skos__hiddenLabel mesh__D051142 Acyl CoA Retinol Acyltransferase
% 216.78/216.95  |- mesh__dateEstablished mesh__D051142 2006-01-01
% 216.78/216.95  |- mesh__historyNote mesh__D051142 2006%28%1977%29%   
% 216.78/216.95  |- skos__hiddenLabel mesh__D051142 Ester Synthetase, Retinol
% 216.78/216.95  |- mesh__recordAuthorizer mesh__D051142 sjn
% 216.78/216.95  |- skos__hiddenLabel mesh__D051142 Retinol O Fatty Acyltransferase
% 216.78/216.95  |- skos__hiddenLabel mesh__D051142 O-Fatty-Acyltransferase, Retinol
% 216.78/216.95  |- mesh__dateCreated mesh__D051142 2005-06-30
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D051142 2006
% 216.78/216.95  |- skos__hiddenLabel mesh__D051142 Retinol Palmitate Synthetase
% 216.78/216.95  |- skos__hiddenLabel mesh__D051142 Fatty-Acyltransferase, Retinol
% 216.78/216.95  |- skos__historyNote mesh__D012729 Sex %28%1966-1967%29%
% 216.78/216.95  |- skos__scopeNote mesh__D012729
% 216.78/216.95       Abnormal number or structure of the SEX CHROMOSOMES. Many sex chromosome aberrations, but not all, are the cause of SEX CHROMOSOME DISORDERS.%A%    
% 216.78/216.95  |- skos__altLabel mesh__D012729 Abnormalities, Sex Chromosome
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D012729 2004
% 216.78/216.95  |- skos__hiddenLabel mesh__D012729 Sex Chromosome Abnormality
% 216.78/216.95  |- mesh__dateRevised mesh__D012729 2002-07-02
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D012729 2006
% 216.78/216.95  |- skos__historyNote mesh__D012729
% 216.78/216.95       Chromosome Abnormalities %28%1966-1967%29%
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D012729 2003
% 216.78/216.95  |- mesh__dateCreated mesh__D012729 1999-01-01
% 216.78/216.95  |- skos__prefLabel mesh__D012729 Sex Chromosome Aberrations
% 216.78/216.95  |- skos__related mesh__D012729smesh__D025064
% 216.78/216.95  |- skos__altLabel mesh__D012729 Sex Chromosome Abnormalities
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D012729 2005
% 216.78/216.95  |- skos__hiddenLabel mesh__D012729 Abnormality, Sex Chromosome
% 216.78/216.95  |- skos__altLabel mesh__D012729 Chromosome Abnormalities, Sex
% 216.78/216.95  |- skos__annotation mesh__D012729
% 216.78/216.95       coord with specific sex chromosome %28%IM%29%   
% 216.78/216.95  |- rdf__type mesh__D012729sskos__Concept
% 216.78/216.95  |- skos__hiddenLabel mesh__D012729 Sex Chromosome Aberration
% 216.78/216.95  |- mesh__historyNote mesh__D012729 1968   
% 216.78/216.95  |- mesh__recordMaintainer mesh__D012729 nns
% 216.78/216.95  |- skos__hiddenLabel mesh__D012729 Chromosome Abnormality, Sex
% 216.78/216.95  |- mesh__recordAuthorizer mesh__D012729 sjn
% 216.78/216.95  |- mesh__recordOriginator mesh__D012729 NLM
% 216.78/216.95  |- skos__hiddenLabel mesh__D012729 Chromosome Aberration, Sex
% 216.78/216.95  |- skos__hiddenLabel mesh__D012729 Aberrations, Sex Chromosome
% 216.78/216.95  |- skos__broader mesh__D012729smesh__D002869
% 216.78/216.95  |- mesh__dateEstablished mesh__D012729 1968-01-01
% 216.78/216.95  |- skos__hiddenLabel mesh__D012729 Aberration, Sex Chromosome
% 216.78/216.95  |- skos__hiddenLabel mesh__D012729 Chromosome Aberrations, Sex
% 216.78/216.95  |- mesh__publicMeSHNote mesh__D012729
% 216.78/216.95       1968; see SEX CHROMOSOME ABNORMALITIES 1968-2001   
% 216.78/216.95  |- skos__related mesh__D009780smesh__D008551
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D009780 2006
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D009780 2001
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D009780 2005
% 216.78/216.95  |- mesh__recordOriginator mesh__D009780 NLM
% 216.78/216.95  |- mesh__recordAuthorizer mesh__D009780 SJN
% 216.78/216.95  |- skos__prefLabel mesh__D009780 Occult Blood
% 216.78/216.95  |- skos__hiddenLabel mesh__D009780 Blood, Occult
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D009780 2000
% 216.78/216.95  |- rdf__type mesh__D009780sskos__Concept
% 216.78/216.95  |- skos__broader mesh__D009780smesh__D003942
% 216.78/216.95  |- skos__scopeNote mesh__D009780
% 216.78/216.95       Chemical, spectroscopic, or microscopic detection of extremely small amounts of blood.%A%    
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D009780 1999
% 216.78/216.95  |- mesh__dateRevised mesh__D009780 1997-06-20
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D009780 2004
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D009780 1998
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D009780 2002
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D009780 2003
% 216.78/216.95  |- mesh__recordMaintainer mesh__D009780 PXP
% 216.78/216.95  |- skos__annotation mesh__D009780
% 216.78/216.95       IM; no qualif; if fecal occult blood, do not coord with FECES%A%  
% 216.78/216.95  |- mesh__dateCreated mesh__D009780 1999-01-01
% 216.78/216.95  |- skos__altLabel mesh__D017414 U6 Small Nuclear Ribonucleoproteins
% 216.78/216.95  |- mesh__dateCreated mesh__D017414 1992-05-22
% 216.78/216.95  |- mesh__dateRevised mesh__D017414 2005-06-30
% 216.78/216.95  |- skos__prefLabel mesh__D017414 Ribonucleoprotein, U4-U6 Small Nuclear
% 216.78/216.95  |- skos__historyNote mesh__D017414 Ribonucleoproteins %28%1982-1992%29%
% 216.78/216.95  |- skos__altLabel mesh__D017414 U4 Small Nuclear Ribonucleoproteins
% 216.78/216.95  |- skos__scopeNote mesh__D017414
% 216.78/216.95       A nuclear RNA-protein complex that plays a role in RNA processing. In the nucleoplasm, the U4-U6 snRNP along with the U5 snRNP preassemble into a single 25S particle that binds to the U1 and U2 snRNPs and the substrate to form mature SPLICEOSOMES. There is also evidence for the existence of individual U4 or U6 snRNPs in addition to their organization as a U4-U6 snRNP.%A%    
% 216.78/216.95  |- mesh__publicMeSHNote mesh__D017414
% 216.78/216.95       2000; RIBONUCLEOPROTEINS, SMALL, U4-U6 was heading 1993-1999;  U4 RNP %26% U6 RNP were indexed under RIBONUCLEPROTEINS 1982-92%A%  
% 216.78/216.95  |- skos__hiddenLabel mesh__D017414 Small Nuclear Ribonucleoproteins, U4 U6
% 216.78/216.95  |- rdf__type mesh__D017414sskos__Concept
% 216.78/216.95  |- skos__altLabel mesh__D017414 Ribonucleoproteins, U6 Small Nuclear
% 216.78/216.95  |- skos__altLabel mesh__D017414 Small Nuclear Ribonucleoproteins, U4
% 216.78/216.95  |- skos__altLabel mesh__D017414 U4-U6 snRNP
% 216.78/216.95  |- skos__altLabel mesh__D017414 Small Nuclear Ribonucleoproteins, U4-U6
% 216.78/216.95  |- skos__broader mesh__D017414smesh__D017411
% 216.78/216.95  |- skos__hiddenLabel mesh__D017414 Ribonucleoprotein, U4 U6 Small Nuclear
% 216.78/216.95  |- skos__altLabel mesh__D017414 Ribonucleoproteins, Small, U4-U6
% 216.78/216.95  |- mesh__historyNote mesh__D017414
% 216.78/216.95       2000; U4 SNRNP was U4 RNP %28%SY%29% to SMALL NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 1982-92; U6 SNRNP was U6 RNP %28%SY%29% to SMALL NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 1982-92%A%  
% 216.78/216.95  |- mesh__dateEstablished mesh__D017414 1993-01-01
% 216.78/216.95  |- mesh__recordMaintainer mesh__D017414 SYSTEM
% 216.78/216.95  |- skos__altLabel mesh__D017414 Small Nuclear Ribonucleoproteins, U6
% 216.78/216.95  |- skos__altLabel mesh__D017414 Ribonucleoproteins, U4 Small Nuclear
% 216.78/216.95  |- mesh__recordOriginator mesh__D017414 PXP
% 216.78/216.95  |- skos__altLabel mesh__D017414 U4-U6 Small Nuclear Ribonucleoproteins
% 216.78/216.95  |- mesh__recordAuthorizer mesh__D017414 sjn
% 216.78/216.95  |- skos__hiddenLabel mesh__D017414 U4 U6 Small Nuclear Ribonucleoproteins
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D017414 2006
% 216.78/216.95  |- rdf__type mesh__D008688sskos__Concept
% 216.78/216.95  |- mesh__recordAuthorizer mesh__D008688 sjn
% 216.78/216.95  |- skos__broader mesh__D008688smesh__D000644
% 216.78/216.95  |- skos__annotation mesh__D008688
% 216.78/216.95       ganglionic stimulants; DF: METHACHOLINE CPDS   
% 216.78/216.95  |- mesh__recordMaintainer mesh__D008688 ssb
% 216.78/216.95  |- skos__prefLabel mesh__D008688 Methacholine Compounds
% 216.78/216.95  |- skos__hiddenLabel mesh__D008688 Compounds, Methacholine
% 216.78/216.95  |- mesh__onlineNote mesh__D008688
% 216.78/216.95       use METHACHOLINE COMPOUNDS to search MECHOLYL BROMIDE 1966-76%A%  
% 216.78/216.95  |- skos__scopeNote mesh__D008688
% 216.78/216.95       A group of compounds that are derivatives of beta-methylacetylcholine %28%methacholine%29%.%A%    
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D008688 2006
% 216.78/216.95  |- mesh__dateCreated mesh__D008688 1999-01-01
% 216.78/216.95  |- mesh__dateRevised mesh__D008688 2005-06-30
% 216.78/216.95  |- skos__broader mesh__D008688smesh__D050337
% 216.78/216.95  |- mesh__recordOriginator mesh__D008688 NLM
% 216.78/216.95  |- mesh__publicMeSHNote mesh__D008688
% 216.78/216.95       MECHOLYL BROMIDE was see under METHACHOLINE COMPOUNDS 1963-76%A%  
% 216.78/216.95  |- mesh__historyNote mesh__D008688
% 216.78/216.95       MECHOLYL BROMIDE was see under METHACHOLINE COMPOUNDS 1963-76%A%  
% 216.78/216.95  |- mesh__dateCreated mesh__D033081 2002-07-03
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D033081 2003
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D033081 2006
% 216.78/216.95  |- mesh__historyNote mesh__D033081 2003   
% 216.78/216.95  |- skos__hiddenLabel mesh__D033081 Strength, Shear
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D033081 2004
% 216.78/216.95  |- skos__historyNote mesh__D033081 Biomechanics %28%1974-2002%29%
% 216.78/216.95  |- mesh__dateEstablished mesh__D033081 2003-01-01
% 216.78/216.95  |- skos__broader mesh__D033081smesh__D019563
% 216.78/216.95  |- skos__broader mesh__D033081smesh__D001696
% 216.78/216.95  |- skos__scopeNote mesh__D033081
% 216.78/216.95       The internal resistance of a material to moving some parts of it parallel to a fixed plane, in contrast to stretching %28%TENSILE STRENGTH%29% or compression %28%COMPRESSIVE STRENGTH%29%. Ionic crystals are brittle because, when subjected to shear, ions of the same charge are brought next to each other, which causes repulsion.%A%    
% 216.78/216.95  |- skos__prefLabel mesh__D033081 Shear Strength
% 216.78/216.95  |- rdf__type mesh__D033081sskos__Concept
% 216.78/216.95  |- mesh__publicMeSHNote mesh__D033081 2003   
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D033081 2005
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D027842 2004
% 216.78/216.95  |- skos__scopeNote mesh__D027842
% 216.78/216.95       A plant genus in the family MYRTACEAE, order Myrtales, subclass Rosidae.  It is best known for cloves, which is the flower bud that is the source of an oil rich in EUGENOL.  The botanical name has varied: Syzygium aromaticum %28%L.%29% Merr. %26% L. M. Perry = Eugenia caryophyllata Thunb. = Caryophyllus aromaticus L.  The Eugenia-Syzygium name is discussed in Amer. J. Bot 59:423 1972.%A%    
% 216.78/216.95  |- skos__broader mesh__D027842smesh__D027822
% 216.78/216.95  |- mesh__recordOriginator mesh__D027842 ssb
% 216.78/216.95  |- mesh__recordMaintainer mesh__D027842 ssb
% 216.78/216.95  |- skos__prefLabel mesh__D027842 Eugenia
% 216.78/216.95  |- mesh__dateEstablished mesh__D027842 2002-01-01
% 216.78/216.95  |- mesh__dateRevised mesh__D027842 2003-07-09
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D027842 2006
% 216.78/216.95  |- mesh__recordAuthorizer mesh__D027842 sjn
% 216.78/216.95  |- mesh__publicMeSHNote mesh__D027842
% 216.78/216.95       2004; see CLOVE 2002-2004, see ROSALES 1988-2001, see SPICES 1993-1997%A%  
% 216.78/216.95  |- skos__annotation mesh__D027842
% 216.78/216.95       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.78/216.95  |- mesh__historyNote mesh__D027842
% 216.78/216.95       2004%28%2002%29%; use ROSALES 1998-2001, use SPICES 1993-1997   
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D027842 2005
% 216.78/216.95  |- mesh__dateCreated mesh__D027842 2001-07-25
% 216.78/216.95  |- skos__altLabel mesh__D027842 Syzygium
% 216.78/216.95  |- skos__historyNote mesh__D027842 Rosales %28%1998-2001%29%
% 216.78/216.95  |- rdf__type mesh__D027842sskos__Concept
% 216.78/216.95  |- skos__altLabel mesh__D027842 Caryophyllus
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D005390 2005
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D005390 2001
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D005390 1996
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D005390 2006
% 216.78/216.95  |- mesh__recordMaintainer mesh__D005390 TAP
% 216.78/216.95  |- skos__related mesh__D005390smesh__D002059
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D005390 2002
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D005390 1997
% 216.78/216.95  |- skos__prefLabel mesh__D005390 Fires
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D005390 1993
% 216.78/216.95  |- skos__hiddenLabel mesh__D005390 Fire
% 216.78/216.95  |- mesh__dateCreated mesh__D005390 1999-01-01
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D005390 2003
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D005390 1998
% 216.78/216.95  |- skos__related mesh__D005390smesh__D015208
% 216.78/216.95  |- mesh__recordAuthorizer mesh__D005390 PLS
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D005390 1994
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D005390 2004
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D005390 1999
% 216.78/216.95  |- skos__broader mesh__D005390smesh__D004190
% 216.78/216.95  |- rdf__type mesh__D005390sskos__Concept
% 216.78/216.95  |- mesh__dateRevised mesh__D005390 1992-05-15
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D005390 2000
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D005390 1995
% 216.78/216.95  |- mesh__recordOriginator mesh__D005390 NLM
% 216.78/216.95  |- skos__historyNote mesh__D013822 Bacteria %28%1966-1974%29%
% 216.78/216.95  |- skos__scopeNote mesh__D013822
% 216.78/216.95       A genus of facultatively anaerobic heterotrophic archaea, in the order THERMOPLASMALES, isolated from self-heating coal refuse piles and acid hot springs. They are thermophilic and can grow both with and without sulfur.%A%    
% 216.78/216.95  |- mesh__publicMeSHNote mesh__D013822 76   
% 216.78/216.95  |- skos__historyNote mesh__D013822 Mycoplasmatales %28%1975%29%
% 216.78/216.95  |- mesh__recordMaintainer mesh__D013822 SYSTEM
% 216.78/216.95  |- mesh__historyNote mesh__D013822 76   
% 216.78/216.95  |- mesh__dateRevised mesh__D013822 2005-06-30
% 216.78/216.95  |- mesh__recordOriginator mesh__D013822 JW
% 216.78/216.95  |- skos__prefLabel mesh__D013822 Thermoplasma
% 216.78/216.95  |- skos__broader mesh__D013822smesh__D019603
% 216.78/216.95  |- mesh__dateCreated mesh__D013822 1975-07-21
% 216.78/216.95  |- mesh__dateEstablished mesh__D013822 1976-01-01
% 216.78/216.95  |- mesh__recordAuthorizer mesh__D013822 sjn
% 216.78/216.95  |- skos__annotation mesh__D013822
% 216.78/216.95       a genus of archaea found in burning slag %26% hot springs   
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D013822 2006
% 216.78/216.95  |- rdf__type mesh__D013822sskos__Concept
% 216.78/216.95  |- skos__broader mesh__D013024smesh__D005224
% 216.78/216.95  |- skos__altLabel mesh__D013024 Soya Oil
% 216.78/216.95  |- mesh__historyNote mesh__D013024
% 216.78/216.95       91%28%87%29%; was see under PLANT OILS 1987-90   
% 216.78/216.95  |- mesh__recordAuthorizer mesh__D013024 sjn
% 216.78/216.95  |- skos__hiddenLabel mesh__D013024 Oil, Soy Bean
% 216.78/216.95  |- mesh__dateEstablished mesh__D013024 1991-01-01
% 216.78/216.95  |- skos__broader mesh__D013024smesh__D010938
% 216.78/216.95  |- mesh__recordMaintainer mesh__D013024 DRC
% 216.78/216.95  |- skos__hiddenLabel mesh__D013024 Oil, Soybean
% 216.78/216.95  |- skos__hiddenLabel mesh__D013024 Soya Oils
% 216.78/216.95  |- skos__historyNote mesh__D013024 Oils %28%1966-1986%29%
% 216.78/216.95  |- skos__hiddenLabel mesh__D013024 Oils, Soybean
% 216.78/216.95  |- skos__scopeNote mesh__D013024 Oil from soybean or soybean plant.     
% 216.78/216.95  |- rdf__type mesh__D013024sskos__Concept
% 216.78/216.95  |- skos__broader mesh__D013024smesh__D004042
% 216.78/216.95  |- skos__hiddenLabel mesh__D013024 Oil, Soya
% 216.78/216.95  |- mesh__recordOriginator mesh__D013024 RLS
% 216.78/216.95  |- skos__altLabel mesh__D013024 Soy Bean Oil
% 216.78/216.95  |- skos__hiddenLabel mesh__D013024 Oils, Soya
% 216.78/216.95  |- skos__hiddenLabel mesh__D013024 Oils, Soy Bean
% 216.78/216.95  |- skos__hiddenLabel mesh__D013024 Soy Bean Oils
% 216.78/216.95  |- skos__hiddenLabel mesh__D013024 Soybean Oils
% 216.78/216.95  |- mesh__publicMeSHNote mesh__D013024
% 216.78/216.95       91; was see under PLANT OILS 1987-90   
% 216.78/216.95  |- mesh__dateRevised mesh__D013024 2005-06-30
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D013024 2006
% 216.78/216.95  |- skos__prefLabel mesh__D013024 Soybean Oil
% 216.78/216.95  |- mesh__dateCreated mesh__D013024 1986-06-03
% 216.78/216.95  |- skos__hiddenLabel mesh__D051941 Antigen, CD135
% 216.78/216.95  |- skos__scopeNote mesh__D051941
% 216.78/216.95       A receptor tyrosine kinase that is involved in HEMATOPOIESIS. It is closely related to FMS PROTO-ONCOGENE PROTEIN and is commonly mutated in acute MYELOID LEUKEMIA.%A%    
% 216.78/216.95  |- mesh__dateCreated mesh__D051941 2005-06-30
% 216.78/216.95  |- skos__hiddenLabel mesh__D051941 Fetal Liver Kinase 3
% 216.78/216.95  |- skos__broader mesh__D051941smesh__D020794
% 216.78/216.95  |- skos__broader mesh__D051941smesh__D015703
% 216.78/216.95  |- skos__altLabel mesh__D051941 CD135 Antigens
% 216.78/216.95  |- mesh__recordMaintainer mesh__D051941 DRC
% 216.78/216.95  |- skos__altLabel mesh__D051941 Fetal Liver Kinase-3
% 216.78/216.95  |- skos__altLabel mesh__D051941 Fetal Liver Kinase-2
% 216.78/216.95  |- skos__altLabel mesh__D051941 Stem Cell Tyrosine Kinase 1
% 216.78/216.95  |- skos__prefLabel mesh__D051941 fms-Like Tyrosine Kinase 3
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D051941 2006
% 216.78/216.95  |- rdf__type mesh__D051941sskos__Concept
% 216.78/216.95  |- mesh__publicMeSHNote mesh__D051941
% 216.78/216.95       2006; FMS-LIKE TYROSINE KINASE 3 was indexed under PROTO-ONCOGENE PROTEINS 1999-2005, %26% under RECEPTOR PROTEIN-TYROSINE KINASES 2005, %26% under PROTEIN-TYROSINE KINASE %26% RECEPTORS, CELL SURFACE 1999-2004%A%  
% 216.78/216.95  |- mesh__recordAuthorizer mesh__D051941 sjn
% 216.78/216.95  |- skos__altLabel mesh__D051941 Antigens, CD135
% 216.78/216.95  |- mesh__dateEstablished mesh__D051941 2006-01-01
% 216.78/216.95  |- skos__broader mesh__D051941smesh__D011518
% 216.78/216.95  |- skos__hiddenLabel mesh__D051941 fms Like Tyrosine Kinase 3
% 216.78/216.95  |- mesh__recordOriginator mesh__D051941 DRC
% 216.78/216.95  |- mesh__historyNote mesh__D051941 2006%28%1999%29%   
% 216.78/216.95  |- skos__hiddenLabel mesh__D051941 Fetal Liver Kinase 2
% 216.78/216.95  |- skos__altLabel mesh__D051941 CD135 Antigen
% 216.78/216.95  |- rdf__type mesh__D004298sskos__Concept
% 216.78/216.95  |- skos__altLabel mesh__D004298 3,4-Dihydroxyphenethylamine
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D004298 2006
% 216.78/216.95  |- mesh__dateCreated mesh__D004298 1999-01-01
% 216.78/216.95  |- skos__broader mesh__D004298smesh__D002395
% 216.78/216.95  |- skos__hiddenLabel mesh__D004298 3,4 Dihydroxyphenethylamine
% 216.78/216.95  |- skos__altLabel mesh__D004298 Hydroxytyramine
% 216.78/216.95  |- skos__related mesh__D004298smesh__D007980
% 216.78/216.95  |- skos__prefLabel mesh__D004298 Dopamine
% 216.78/216.95  |- mesh__recordOriginator mesh__D004298 NLM
% 216.78/216.95  |- skos__related mesh__D004298smesh__D011954
% 216.78/216.95  |- skos__altLabel mesh__D004298 4-%28%2-Aminoethyl%29%-1,2-benzenediol
% 216.78/216.95  |- mesh__recordAuthorizer mesh__D004298 sjn
% 216.78/216.95  |- skos__scopeNote mesh__D004298
% 216.78/216.95       One of the catecholamine NEUROTRANSMITTERS in the brain.  It is derived from tyrosine and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors %28%RECEPTORS, DOPAMINE%29% mediate its action.%A%    
% 216.78/216.95  |- skos__hiddenLabel mesh__D004298 Hydrochloride, Dopamine
% 216.78/216.95  |- skos__related mesh__D004298smesh__D015259
% 216.78/216.95  |- mesh__recordMaintainer mesh__D004298 ssb
% 216.78/216.95  |- mesh__dateRevised mesh__D004298 2005-06-30
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D009781 2006
% 216.78/216.95  |- skos__annotation mesh__D009781 IM   
% 216.78/216.95  |- skos__broader mesh__D009781smesh__D006809
% 216.78/216.95  |- mesh__dateRevised mesh__D009781 2001-07-25
% 216.78/216.95  |- rdf__type mesh__D009781sskos__Concept
% 216.78/216.95  |- skos__prefLabel mesh__D009781 Occultism
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D009781 2003
% 216.78/216.95  |- mesh__dateCreated mesh__D009781 1999-01-01
% 216.78/216.95  |- mesh__recordMaintainer mesh__D009781 ssb
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D009781 2004
% 216.78/216.95  |- mesh__recordOriginator mesh__D009781 NLM
% 216.78/216.95  |- mesh__activeMeSHYear mesh__D009781 2002
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D009781 2005
% 216.78/216.96  |- skos__broader mesh__D009781smesh__D026443
% 216.78/216.96  |- skos__hiddenLabel mesh__D009781 Occultisms
% 216.78/216.96  |- mesh__recordAuthorizer mesh__D009781 sjn
% 216.78/216.96  |- skos__altLabel mesh__D017415 U5 Small Nuclear Ribonucleoproteins
% 216.78/216.96  |- skos__scopeNote mesh__D017415
% 216.78/216.96       A nuclear RNA-protein complex that plays a role in RNA processing. In the nucleoplasm, the U5 snRNP along with U4-U6 snRNP preassemble into a single 25S particle that binds to the U1 and U2 snRNPs and the substrate to form SPLICEOSOMES.%A%    
% 216.78/216.96  |- skos__broader mesh__D017415smesh__D017411
% 216.78/216.96  |- mesh__publicMeSHNote mesh__D017415
% 216.78/216.96       2000; RIBONUCLEOPROTEINS, SMALL, U5 was heading 1993-1999; U5 SNRNP was indexed under RIBONUCLEOPROTEINS 1982-92%A%  
% 216.78/216.96  |- skos__altLabel mesh__D017415 U5 snRNP
% 216.78/216.96  |- mesh__onlineNote mesh__D017415
% 216.78/216.96       use RIBONUCLEOPROTEINS, SMALL NUCLEAR %28%NM%29% to search U5 SNRNP 1982-92%A%  
% 216.78/216.96  |- mesh__recordAuthorizer mesh__D017415 sjn
% 216.78/216.96  |- skos__altLabel mesh__D017415 Ribonucleoproteins, Small, U5
% 216.78/216.96  |- mesh__historyNote mesh__D017415
% 216.78/216.96       2000; U5 SNRNP was SY to SMALL RIBONUCLEOPROTEINS %28%NM%29% 1982-92%A%  
% 216.78/216.96  |- mesh__dateRevised mesh__D017415 2005-06-30
% 216.78/216.96  |- skos__altLabel mesh__D017415 Small Nuclear Ribonucleoproteins, U5
% 216.78/216.96  |- skos__historyNote mesh__D017415 Ribonucleoproteins %28%1982-1992%29%
% 216.78/216.96  |- mesh__recordMaintainer mesh__D017415 SYSTEM
% 216.78/216.96  |- skos__prefLabel mesh__D017415 Ribonucleoprotein, U5 Small Nuclear
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D017415 2006
% 216.78/216.96  |- mesh__recordOriginator mesh__D017415 PXP
% 216.78/216.96  |- mesh__dateCreated mesh__D017415 1992-06-03
% 216.78/216.96  |- rdf__type mesh__D017415sskos__Concept
% 216.78/216.96  |- mesh__dateEstablished mesh__D017415 1993-01-01
% 216.78/216.96  |- mesh__recordOriginator mesh__D008689 NLM
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D008689 2005
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D008689 1997
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D008689 1994
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D008689 2002
% 216.78/216.96  |- mesh__publicMeSHNote mesh__D008689
% 216.78/216.96       91; was see under ACRYLATES 1975-90   
% 216.78/216.96  |- skos__historyNote mesh__D008689 Acrylates %28%1968-1974%29%
% 216.78/216.96  |- skos__broader mesh__D008689smesh__D000179
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D008689 2006
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D008689 1995
% 216.78/216.96  |- mesh__recordAuthorizer mesh__D008689 PLS
% 216.78/216.96  |- mesh__dateCreated mesh__D008689 1974-11-11
% 216.78/216.96  |- mesh__dateRevised mesh__D008689 1992-05-18
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D008689 1998
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D008689 2003
% 216.78/216.96  |- skos__related mesh__D008689smesh__D011109
% 216.78/216.96  |- mesh__recordMaintainer mesh__D008689 TAP
% 216.78/216.96  |- mesh__dateEstablished mesh__D008689 1991-01-01
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D008689 2000
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D008689 1999
% 216.78/216.96  |- skos__scopeNote mesh__D008689
% 216.78/216.96       Acrylic acids or acrylates which are substituted in the C-2 position with a methyl group.%A%    
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D008689 1993
% 216.78/216.96  |- rdf__type mesh__D008689sskos__Concept
% 216.78/216.96  |- mesh__historyNote mesh__D008689
% 216.78/216.96       91%28%75%29%; was see under ACRYLATES 1975-90   
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D008689 2004
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D008689 2001
% 216.78/216.96  |- skos__prefLabel mesh__D008689 Methacrylates
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D008689 1996
% 216.78/216.96  |- mesh__recordOriginator mesh__D027843 ssb
% 216.78/216.96  |- skos__prefLabel mesh__D027843 Vitis
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D027843 2003
% 216.78/216.96  |- skos__related mesh__D027843smesh__D014920
% 216.78/216.96  |- mesh__dateEstablished mesh__D027843 2002-01-01
% 216.78/216.96  |- skos__annotation mesh__D027843
% 216.78/216.96       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D027843 2006
% 216.78/216.96  |- skos__broader mesh__D027843smesh__D027844
% 216.78/216.96  |- mesh__publicMeSHNote mesh__D027843
% 216.78/216.96       2002; for GRAPES see Rosales 1988-2001, see FRUIT 1983-1997, see GRAPES 1963-1982%A%  
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D027843 2005
% 216.78/216.96  |- mesh__recordMaintainer mesh__D027843 ssb
% 216.78/216.96  |- mesh__dateRevised mesh__D027843 2002-07-03
% 216.78/216.96  |- skos__historyNote mesh__D027843 Rosales %28%1998-2001%29%
% 216.78/216.96  |- rdf__type mesh__D027843sskos__Concept
% 216.78/216.96  |- mesh__historyNote mesh__D027843
% 216.78/216.96       2002; for GRAPES use Rosales 1998-2001, use FRUIT 1983-1997, use GRAPES 1963-1982%A%  
% 216.78/216.96  |- mesh__recordAuthorizer mesh__D027843 sjn
% 216.78/216.96  |- skos__scopeNote mesh__D027843
% 216.78/216.96       A plant genus in the family VITACEAE, order Rhamnales, subclass Rosidae. It is a woody vine cultivated worldwide. It is best known for grapes, the edible fruit and used to make WINE and raisins.%A%    
% 216.78/216.96  |- mesh__dateCreated mesh__D027843 2001-07-25
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D027843 2004
% 216.78/216.96  |- skos__hiddenLabel mesh__D005391 Firesetting Behaviors
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D005391 2003
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D005391 1998
% 216.78/216.96  |- skos__prefLabel mesh__D005391 Firesetting Behavior
% 216.78/216.96  |- skos__hiddenLabel mesh__D005391 Behavior, Firesetting
% 216.78/216.96  |- mesh__recordOriginator mesh__D005391 EC
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D005391 2000
% 216.78/216.96  |- skos__historyNote mesh__D005391 Fires %28%1966-1975%29%
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D005391 2004
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D005391 1999
% 216.78/216.96  |- rdf__type mesh__D005391sskos__Concept
% 216.78/216.96  |- skos__hiddenLabel mesh__D005391 Arsons
% 216.78/216.96  |- mesh__publicMeSHNote mesh__D005391
% 216.78/216.96       91; was see under IMPULSE CONTROL DISORDERS 1981-90; was see under COMPULSIVE BEHAVIOR 1976-80%A%  
% 216.78/216.96  |- skos__altLabel mesh__D005391 Pyromania
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D005391 2001
% 216.78/216.96  |- skos__hiddenLabel mesh__D005391 Behaviors, Firesetting
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D005391 2005
% 216.78/216.96  |- skos__scopeNote mesh__D005391 A compulsion to set fires.     
% 216.78/216.96  |- mesh__dateEstablished mesh__D005391 1991-01-01
% 216.78/216.96  |- skos__broader mesh__D005391smesh__D007174
% 216.78/216.96  |- mesh__dateCreated mesh__D005391 1975-07-21
% 216.78/216.96  |- mesh__dateRevised mesh__D005391 1997-06-20
% 216.78/216.96  |- mesh__recordAuthorizer mesh__D005391 SJN
% 216.78/216.96  |- skos__hiddenLabel mesh__D005391 Pyromanias
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D005391 2002
% 216.78/216.96  |- mesh__recordMaintainer mesh__D005391 JLS
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D005391 2006
% 216.78/216.96  |- mesh__historyNote mesh__D005391
% 216.78/216.96       91%28%76%29%; was see under IMPULSE CONTROL DISORDERS 1981-90; was see under COMPULSIVE BEHAVIOR 1976-80%A%  
% 216.78/216.96  |- mesh__recordMaintainer mesh__D013823 RAZ
% 216.78/216.96  |- skos__scopeNote mesh__D013823
% 216.78/216.96       Cellular receptors which mediate the sense of temperature. Thermoreceptors in vertebrates are mostly located under the skin. In mammals there are separate types of thermoreceptors for cold and for warmth and NOCICEPTORS which detect cold or heat extreme enough to cause pain.%A%    
% 216.78/216.96  |- skos__historyNote mesh__D013823 Temperature Sense %28%1966-1970%29%
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013823 1999
% 216.78/216.96  |- skos__annotation mesh__D013823
% 216.78/216.96       sensory receptors for temperature; DF: THERMORECEPT   
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013823 1994
% 216.78/216.96  |- mesh__publicMeSHNote mesh__D013823 74   
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013823 1997
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013823 1998
% 216.78/216.96  |- mesh__dateCreated mesh__D013823 1999-01-01
% 216.78/216.96  |- skos__related mesh__D013823smesh__D001833
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013823 1996
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013823 2002
% 216.78/216.96  |- skos__prefLabel mesh__D013823 Thermoreceptors
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013823 2006
% 216.78/216.96  |- rdf__type mesh__D013823sskos__Concept
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013823 2004
% 216.78/216.96  |- mesh__dateEstablished mesh__D013823 1974-01-01
% 216.78/216.96  |- skos__hiddenLabel mesh__D013823 Thermoreceptor
% 216.78/216.96  |- skos__broader mesh__D013823smesh__D011984
% 216.78/216.96  |- mesh__historyNote mesh__D013823 74%28%71%29%   
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013823 2005
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013823 2003
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013823 2001
% 216.78/216.96  |- mesh__dateRevised mesh__D013823 1993-06-21
% 216.78/216.96  |- mesh__recordOriginator mesh__D013823 NLM
% 216.78/216.96  |- mesh__recordAuthorizer mesh__D013823 PLS
% 216.78/216.96  |- skos__historyNote mesh__D013823 Receptors, Sensory %28%1966-1970%29%
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013823 2000
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013823 1995
% 216.78/216.96  |- skos__prefLabel mesh__D013025 Soybeans
% 216.78/216.96  |- skos__altLabel mesh__D013025 Soy Beans
% 216.78/216.96  |- mesh__historyNote mesh__D013025
% 216.78/216.96       86; was SOY BEANS 1963-85; was in Cat J only 1963-80   
% 216.78/216.96  |- mesh__onlineNote mesh__D013025
% 216.78/216.96       use SOYBEANS to search SOY BEANS 1966-85   
% 216.78/216.96  |- mesh__dateCreated mesh__D013025 1999-01-01
% 216.78/216.96  |- skos__hiddenLabel mesh__D013025 Soy Bean
% 216.78/216.96  |- skos__broader mesh__D013025smesh__D007887
% 216.78/216.96  |- skos__hiddenLabel mesh__D013025 Soybean
% 216.78/216.96  |- rdf__type mesh__D013025sskos__Concept
% 216.78/216.96  |- skos__scopeNote mesh__D013025
% 216.78/216.96       An annual legume or the seeds of this plant.     
% 216.78/216.96  |- mesh__recordMaintainer mesh__D013025 ssb
% 216.78/216.96  |- skos__annotation mesh__D013025
% 216.78/216.96       as plant %26% food; selected qualif from Cat B6 %26% Cat J2   
% 216.78/216.96  |- mesh__recordAuthorizer mesh__D013025 sjn
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013025 2005
% 216.78/216.96  |- mesh__dateRevised mesh__D013025 2004-07-07
% 216.78/216.96  |- mesh__recordOriginator mesh__D013025 NLM
% 216.78/216.96  |- skos__hiddenLabel mesh__D013025 Beans, Soy
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013025 2006
% 216.78/216.96  |- mesh__publicMeSHNote mesh__D013025 86; was SOY BEANS 1963-85   
% 216.78/216.96  |- skos__broader mesh__D013025smesh__D000821
% 216.78/216.96  |- skos__hiddenLabel mesh__D013025 Bean, Soy
% 216.78/216.96  |- skos__altLabel mesh__D051942 Phytochrome A Protein
% 216.78/216.96  |- skos__broader mesh__D051942smesh__D017346
% 216.78/216.96  |- mesh__publicMeSHNote mesh__D051942
% 216.78/216.96       2006; PHYTOCHROME A was indexed under PHYTOCHROME 1994-2005, %26% under PROTEIN-SERINE-THREONINE KINASES 2005%A%  
% 216.78/216.96  |- skos__prefLabel mesh__D051942 Phytochrome A
% 216.78/216.96  |- skos__broader mesh__D051942smesh__D010834
% 216.78/216.96  |- mesh__dateCreated mesh__D051942 2005-06-30
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D051942 2006
% 216.78/216.96  |- rdf__type mesh__D051942sskos__Concept
% 216.78/216.96  |- skos__altLabel mesh__D051942 Phytochrome A3 Protein
% 216.78/216.96  |- skos__altLabel mesh__D051942 PhyA Phytochrome
% 216.78/216.96  |- skos__scopeNote mesh__D051942
% 216.78/216.96       The primary plant photoreceptor responsible for perceiving and mediating responses to far-red light. It is a PROTEIN-SERINE-THREONINE KINASE that is translocated to the CELL NUCLEUS in response to light signals.%A%    
% 216.78/216.96  |- mesh__recordMaintainer mesh__D051942 DRC
% 216.78/216.96  |- skos__hiddenLabel mesh__D051942 Phytochrome, PhyA
% 216.78/216.96  |- mesh__recordOriginator mesh__D051942 DRC
% 216.78/216.96  |- skos__altLabel mesh__D051942 PhyA4 Protein
% 216.78/216.96  |- skos__altLabel mesh__D051942 PhyA3 Protein
% 216.78/216.96  |- mesh__historyNote mesh__D051942 2006%28%1994%29%   
% 216.78/216.96  |- mesh__recordAuthorizer mesh__D051942 sjn
% 216.78/216.96  |- skos__altLabel mesh__D051942 Phytochrome A4 Protein
% 216.78/216.96  |- mesh__dateEstablished mesh__D051942 2006-01-01
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D004299 2006
% 216.78/216.96  |- mesh__historyNote mesh__D004299 73%28%71%29%   
% 216.78/216.96  |- mesh__dateCreated mesh__D004299 1999-01-01
% 216.78/216.96  |- skos__hiddenLabel mesh__D004299 Dopamine beta Monooxygenase
% 216.78/216.96  |- mesh__recordMaintainer mesh__D004299 ssb
% 216.78/216.96  |- mesh__dateRevised mesh__D004299 2004-07-07
% 216.78/216.96  |- mesh__publicMeSHNote mesh__D004299 73   
% 216.78/216.96  |- skos__altLabel mesh__D004299 Dopamine beta-Monooxygenase
% 216.78/216.96  |- skos__hiddenLabel mesh__D004299 Dopamine beta Hydroxylase
% 216.78/216.96  |- skos__broader mesh__D004299smesh__D006899
% 216.78/216.96  |- mesh__dateEstablished mesh__D004299 1973-01-01
% 216.78/216.96  |- skos__prefLabel mesh__D004299 Dopamine beta-Hydroxylase
% 216.78/216.96  |- mesh__recordOriginator mesh__D004299 NLM
% 216.78/216.96  |- skos__hiddenLabel mesh__D004299 beta-Monooxygenase, Dopamine
% 216.78/216.96  |- rdf__type mesh__D004299sskos__Concept
% 216.78/216.96  |- mesh__recordAuthorizer mesh__D004299 sjn
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D004299 2005
% 216.78/216.96  |- skos__hiddenLabel mesh__D004299 beta-Hydroxylase, Dopamine
% 216.78/216.96  |- skos__historyNote mesh__D004299 Hydroxylases %28%1966-1970%29%
% 216.78/216.96  |- mesh__historyNote mesh__D009782 82; was INDUSTRIAL DENTISTRY 1965-81   
% 216.78/216.96  |- skos__scopeNote mesh__D009782
% 216.78/216.96       The branch of dentistry concerned with maintaining oral health of employees in occupational environments.%A%    
% 216.78/216.96  |- mesh__recordAuthorizer mesh__D009782 sjn
% 216.78/216.96  |- mesh__publicMeSHNote mesh__D009782
% 216.78/216.96       82; was INDUSTRIAL DENTISTRY 1965-81   
% 216.78/216.96  |- rdf__type mesh__D009782sskos__Concept
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D009782 2003
% 216.78/216.96  |- mesh__dateCreated mesh__D009782 1999-01-01
% 216.78/216.96  |- skos__altLabel mesh__D009782 Dentistry, Occupational
% 216.78/216.96  |- mesh__dateEstablished mesh__D009782 1965-01-01
% 216.78/216.96  |- skos__hiddenLabel mesh__D009782 Industrial Dentistries
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D009782 2004
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D009782 2000
% 216.78/216.96  |- skos__annotation mesh__D009782 SPEC: SPEC qualif; DF: OCCUP DENT   
% 216.78/216.96  |- skos__broader mesh__D009782smesh__D003813
% 216.78/216.96  |- skos__prefLabel mesh__D009782 Occupational Dentistry
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D009782 2005
% 216.78/216.96  |- mesh__dateRevised mesh__D009782 1999-11-03
% 216.78/216.96  |- mesh__recordMaintainer mesh__D009782 kle
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D009782 2001
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D009782 2006
% 216.78/216.96  |- skos__altLabel mesh__D009782 Industrial Dentistry
% 216.78/216.96  |- skos__hiddenLabel mesh__D009782 Dentistries, Occupational
% 216.78/216.96  |- mesh__recordOriginator mesh__D009782 NLM
% 216.78/216.96  |- skos__hiddenLabel mesh__D009782 Occupational Dentistries
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D009782 2002
% 216.78/216.96  |- mesh__onlineNote mesh__D009782
% 216.78/216.96       use OCCUPATIONAL DENTISTRY to search INDUSTRIAL DENTISTRY 1966-81%A%  
% 216.78/216.96  |- skos__hiddenLabel mesh__D009782 Dentistries, Industrial
% 216.78/216.96  |- mesh__historyNote mesh__D033881
% 216.78/216.96       2003; use IRON-BINDING PROTEINS %28%NM%29% 1986-2002   
% 216.78/216.96  |- skos__scopeNote mesh__D033881
% 216.78/216.96       A subtype of bacterial transferrin-binding protein found in bacteria. It forms a cell surface receptor complex with TRANSFERRIN-BINDING PROTEIN B.%A%    
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D033881 2003
% 216.78/216.96  |- skos__altLabel mesh__D033881 Tbp1 Transferrin-Binding Protein
% 216.78/216.96  |- skos__hiddenLabel mesh__D033881 Transferrin Binding Protein A
% 216.78/216.96  |- skos__hiddenLabel mesh__D033881 TbpA Transferrin Binding Protein
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D033881 2004
% 216.78/216.96  |- skos__broader mesh__D033881smesh__D033901
% 216.78/216.96  |- mesh__dateEstablished mesh__D033881 2003-01-01
% 216.78/216.96  |- mesh__publicMeSHNote mesh__D033881
% 216.78/216.96       2003; TBP1 PROTEIN %28%now TRANSFERRIN-BINDING PROTEIN A%29% was indexed under CARRIER PROTEINS 1986-2002%A%  
% 216.78/216.96  |- rdf__type mesh__D033881sskos__Concept
% 216.78/216.96  |- skos__altLabel mesh__D033881 TbpA Transferrin-Binding Protein
% 216.78/216.96  |- mesh__dateCreated mesh__D033881 2002-07-03
% 216.78/216.96  |- skos__hiddenLabel mesh__D033881 Transferrin-Binding Protein, Tbp1
% 216.78/216.96  |- skos__prefLabel mesh__D033881 Transferrin-Binding Protein A
% 216.78/216.96  |- skos__hiddenLabel mesh__D033881 Tbp1 Transferrin Binding Protein
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D033881 2005
% 216.78/216.96  |- skos__historyNote mesh__D033881 Iron-Binding Proteins %28%1986-2002%29%
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D033881 2006
% 216.78/216.96  |- skos__scopeNote mesh__D027844
% 216.78/216.96       A plant family of the order Rhamnales, subclass Rosidae, class Magnoliopsida, best known for the VITIS genus, the source of grapes.%A%    
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D027844 2005
% 216.78/216.96  |- skos__prefLabel mesh__D027844 Vitaceae
% 216.78/216.96  |- skos__broader mesh__D027844smesh__D019684
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D027844 2006
% 216.78/216.96  |- skos__annotation mesh__D027844
% 216.78/216.96       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.78/216.96  |- skos__historyNote mesh__D027844 Plants, Medicinal %28%1966-2001%29%
% 216.78/216.96  |- mesh__publicMeSHNote mesh__D027844 2002   
% 216.78/216.96  |- mesh__dateEstablished mesh__D027844 2002-01-01
% 216.78/216.96  |- rdf__type mesh__D027844sskos__Concept
% 216.78/216.96  |- mesh__historyNote mesh__D027844 2002   
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D027844 2003
% 216.78/216.96  |- mesh__dateCreated mesh__D027844 2001-07-25
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D027844 2004
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D027844 2002
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D005392 2003
% 216.78/216.96  |- skos__prefLabel mesh__D005392 First Aid
% 216.78/216.96  |- mesh__dateRevised mesh__D005392 1999-11-03
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D005392 2004
% 216.78/216.96  |- rdf__type mesh__D005392sskos__Concept
% 216.78/216.96  |- skos__hiddenLabel mesh__D005392 Aid, First
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D005392 2005
% 216.78/216.96  |- skos__hiddenLabel mesh__D005392 First Aids
% 216.78/216.96  |- mesh__recordOriginator mesh__D005392 NLM
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D005392 2000
% 216.78/216.96  |- skos__broader mesh__D005392smesh__D004638
% 216.78/216.96  |- mesh__recordMaintainer mesh__D005392 kle
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D005392 2006
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D005392 2001
% 216.78/216.96  |- mesh__recordAuthorizer mesh__D005392 sjn
% 216.78/216.96  |- skos__hiddenLabel mesh__D005392 Aids, First
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D005392 2002
% 216.78/216.96  |- mesh__dateCreated mesh__D005392 1999-01-01
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013824 2006
% 216.78/216.96  |- mesh__publicMeSHNote mesh__D013824 78   
% 216.78/216.96  |- rdf__type mesh__D013824sskos__Concept
% 216.78/216.96  |- mesh__recordAuthorizer mesh__D013824 sjn
% 216.78/216.96  |- skos__broader mesh__D013824smesh__D016946
% 216.78/216.96  |- skos__historyNote mesh__D013824 Bacteria %28%1966-1975%29%
% 216.78/216.96  |- mesh__historyNote mesh__D013824 78   
% 216.78/216.96  |- skos__prefLabel mesh__D013824 Thermus
% 216.78/216.96  |- mesh__dateEstablished mesh__D013824 1978-01-01
% 216.78/216.96  |- mesh__recordOriginator mesh__D013824 AEP
% 216.78/216.96  |- skos__historyNote mesh__D013824
% 216.78/216.96       Gram-Negative Aerobic Bacteria %28%1976-1977%29%
% 216.78/216.96  |- mesh__dateCreated mesh__D013824 1977-03-01
% 216.78/216.96  |- skos__scopeNote mesh__D013824
% 216.78/216.96       Gram-negative aerobic rods found in warm water %28%40-79 degrees C%29% such as hot springs, hot water tanks, and thermally polluted rivers.%A%    
% 216.78/216.96  |- mesh__dateRevised mesh__D013824 2005-06-30
% 216.78/216.96  |- mesh__recordMaintainer mesh__D013824 SYSTEM
% 216.78/216.96  |- skos__annotation mesh__D013824
% 216.78/216.96       in hot springs, hot-water tanks, thermally polluted waters%A%  
% 216.78/216.96  |- skos__prefLabel mesh__D013026 Space Flight
% 216.78/216.96  |- skos__hiddenLabel mesh__D013026 Exploration, Space
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013026 2002
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013026 1998
% 216.78/216.96  |- skos__annotation mesh__D013026 SPEC: SPEC qualif   
% 216.78/216.96  |- skos__related mesh__D013026smesh__D018504
% 216.78/216.96  |- skos__altLabel mesh__D013026 Spaceflight
% 216.78/216.96  |- skos__hiddenLabel mesh__D013026 Space Explorations
% 216.78/216.96  |- skos__hiddenLabel mesh__D013026 Explorations, Space
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013026 1999
% 216.78/216.96  |- mesh__dateCreated mesh__D013026 1999-01-01
% 216.78/216.96  |- rdf__type mesh__D013026sskos__Concept
% 216.78/216.96  |- skos__related mesh__D013026smesh__D014893
% 216.78/216.96  |- skos__broader mesh__D013026smesh__D001359
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013026 2003
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013026 2000
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013026 2005
% 216.78/216.96  |- skos__hiddenLabel mesh__D013026 Spaceflights
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013026 2004
% 216.78/216.96  |- mesh__dateRevised mesh__D013026 1997-06-20
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013026 2001
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D013026 2006
% 216.78/216.96  |- skos__scopeNote mesh__D013026
% 216.78/216.96       Travel beyond the earth%27%s atmosphere.     
% 216.78/216.96  |- mesh__recordMaintainer mesh__D013026 JLS
% 216.78/216.96  |- skos__hiddenLabel mesh__D013026 Flight, Space
% 216.78/216.96  |- skos__hiddenLabel mesh__D013026 Flights, Space
% 216.78/216.96  |- skos__related mesh__D013026smesh__D018480
% 216.78/216.96  |- skos__related mesh__D013026smesh__D018531
% 216.78/216.96  |- skos__hiddenLabel mesh__D013026 Space Flights
% 216.78/216.96  |- mesh__recordAuthorizer mesh__D013026 SJN
% 216.78/216.96  |- mesh__recordOriginator mesh__D013026 NLM
% 216.78/216.96  |- skos__related mesh__D013026smesh__D005118
% 216.78/216.96  |- skos__prefLabel mesh__D051943 Antennapedia Homeodomain Protein
% 216.78/216.96  |- skos__scopeNote mesh__D051943
% 216.78/216.96       Antennapedia homeodomain protein is a homeobox protein involved in limb patterning in ARTHROPODS. Mutations in the gene for the antennapedia homeodomain protein are associated with the conversion of antenna to leg or leg to antenna DROSOPHILA.%A%    
% 216.78/216.96  |- mesh__recordMaintainer mesh__D051943 ags
% 216.78/216.96  |- mesh__recordOriginator mesh__D051943 DRC
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D051943 2006A
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D051943 2006
% 216.78/216.96  |- mesh__historyNote mesh__D051943 2006%28%1990%29%   
% 216.78/216.96  |- mesh__publicMeSHNote mesh__D051943
% 216.78/216.96       2006; ANTENNAPEDIA HOMEODOMAIN PROTEIN was indexed under NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005, under HOMEODOMAIN PROTEINS 1997-2005, %26% under DNA-BINDING PROTEINS 1990-1996%A%  
% 216.78/216.96  |- rdf__type mesh__D051943sskos__Concept
% 216.78/216.96  |- skos__broader mesh__D051943smesh__D009687
% 216.78/216.96  |- mesh__dateEstablished mesh__D051943 2006-01-01
% 216.78/216.96  |- mesh__recordAuthorizer mesh__D051943 ags
% 216.78/216.96  |- mesh__dateCreated mesh__D051943 2005-06-30
% 216.78/216.96  |- skos__broader mesh__D051943smesh__D014157
% 216.78/216.96  |- mesh__dateRevised mesh__D051943 2005-07-08
% 216.78/216.96  |- skos__altLabel mesh__D051943 Antennapedia Protein
% 216.78/216.96  |- skos__broader mesh__D051943smesh__D018398
% 216.78/216.96  |- skos__hiddenLabel mesh__D009783 Industrial Dermatoses
% 216.78/216.96  |- skos__annotation mesh__D009783
% 216.78/216.96       do not restrict to -itis: use as if %22%dermatoses%22%; coord with specific skin dis with /chem ind; includes housewives%27% dermatoses caused by housekeeping agents; DF: DERMATITIS OCCUP%A%  
% 216.78/216.96  |- mesh__publicMeSHNote mesh__D009783
% 216.78/216.96       93; was OCCUPATIONAL DERMATITIS 1963-92   
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D009783 2005
% 216.78/216.96  |- mesh__recordOriginator mesh__D009783 NLM
% 216.78/216.96  |- mesh__dateRevised mesh__D009783 2002-07-03
% 216.78/216.96  |- skos__broader mesh__D009783smesh__D003877
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D009783 2006
% 216.78/216.96  |- skos__altLabel mesh__D009783 Dermatosis, Industrial
% 216.78/216.96  |- skos__broader mesh__D009783smesh__D009784
% 216.78/216.96  |- mesh__recordAuthorizer mesh__D009783 sjn
% 216.78/216.96  |- skos__hiddenLabel mesh__D009783 Dermatitides, Occupational
% 216.78/216.96  |- mesh__historyNote mesh__D009783
% 216.78/216.96       93; was OCCUPATIONAL DERMATITIS 1963-92   
% 216.78/216.96  |- skos__scopeNote mesh__D009783
% 216.78/216.96       A recurrent contact dermatitis caused by substances found in the work place.%A%    
% 216.78/216.96  |- mesh__onlineNote mesh__D009783
% 216.78/216.96       use DERMATITIS, OCCUPATIONAL to search OCCUPATIONAL DERMATITIS 1966-92%A%  
% 216.78/216.96  |- skos__hiddenLabel mesh__D009783 Dermatoses, Industrial
% 216.78/216.96  |- mesh__recordMaintainer mesh__D009783 ags
% 216.78/216.96  |- rdf__type mesh__D009783sskos__Concept
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D009783 2003
% 216.78/216.96  |- mesh__dateCreated mesh__D009783 1999-01-01
% 216.78/216.96  |- skos__altLabel mesh__D009783 Occupational Dermatitis
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D009783 2004
% 216.78/216.96  |- skos__prefLabel mesh__D009783 Dermatitis, Occupational
% 216.78/216.96  |- skos__hiddenLabel mesh__D009783 Occupational Dermatitides
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D033882 2003
% 216.78/216.96  |- skos__hiddenLabel mesh__D033882 TbpB Transferrin Binding Protein
% 216.78/216.96  |- skos__scopeNote mesh__D033882
% 216.78/216.96       A subtype of bacterial transferrin-binding protein found in bacteria. It forms a cell surface receptor complex with TRANSFERRIN-BINDING PROTEIN A.%A%    
% 216.78/216.96  |- skos__altLabel mesh__D033882 TbpB Transferrin-Binding Protein
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D033882 2004
% 216.78/216.96  |- skos__hiddenLabel mesh__D033882 Tbp2 Transferrin Binding Protein
% 216.78/216.96  |- rdf__type mesh__D033882sskos__Concept
% 216.78/216.96  |- skos__hiddenLabel mesh__D033882 Transferrin Binding Protein B
% 216.78/216.96  |- mesh__publicMeSHNote mesh__D033882
% 216.78/216.96       2003; TRANSFERRIN-BINDING PROTEIN B was indexed under CARRIER PROTEINS 1986-2002%A%  
% 216.78/216.96  |- skos__hiddenLabel mesh__D033882 Transferrin-Binding Protein, TbpB
% 216.78/216.96  |- skos__prefLabel mesh__D033882 Transferrin-Binding Protein B
% 216.78/216.96  |- skos__broader mesh__D033882smesh__D033901
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D033882 2005
% 216.78/216.96  |- mesh__dateEstablished mesh__D033882 2003-01-01
% 216.78/216.96  |- skos__historyNote mesh__D033882 Iron-Binding Proteins %28%1986-2002%29%
% 216.78/216.96  |- skos__hiddenLabel mesh__D033882 Transferrin Binding Protein 2
% 216.78/216.96  |- mesh__dateCreated mesh__D033882 2002-07-03
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D033882 2006
% 216.78/216.96  |- skos__altLabel mesh__D033882 Tbp2 Transferrin-Binding Protein
% 216.78/216.96  |- mesh__historyNote mesh__D033882
% 216.78/216.96       2003; use IRON-BINDING PROTEINS %28%NM%29% 1986-2002   
% 216.78/216.96  |- skos__hiddenLabel mesh__D033882 Transferrin-Binding Protein, Tbp2
% 216.78/216.96  |- skos__altLabel mesh__D033882 Transferrin-Binding Protein 2
% 216.78/216.96  |- skos__historyNote mesh__D027845 Rosales %28%1998-2001%29%
% 216.78/216.96  |- skos__broader mesh__D027845smesh__D027824
% 216.78/216.96  |- skos__scopeNote mesh__D027845
% 216.78/216.96       A plant genus in the family ROSACEAE, order Rosales, subclass Rosidae.  It is best known as a source of the edible fruit %28%apple%29% and is cultivated in temperate climates worldwide.%A%    
% 216.78/216.96  |- mesh__historyNote mesh__D027845
% 216.78/216.96       2002; for APPLE use Rosales 1998-2001, use FRUIT 1963-1997%A%  
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D027845 2005
% 216.78/216.96  |- skos__annotation mesh__D027845
% 216.78/216.96       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.78/216.96  |- mesh__dateRevised mesh__D027845 2003-07-09
% 216.78/216.96  |- mesh__recordMaintainer mesh__D027845 ssb
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D027845 2006
% 216.78/216.96  |- mesh__dateEstablished mesh__D027845 2002-01-01
% 216.78/216.96  |- rdf__type mesh__D027845sskos__Concept
% 216.78/216.96  |- skos__prefLabel mesh__D027845 Malus
% 216.78/216.96  |- mesh__recordOriginator mesh__D027845 ssb
% 216.78/216.96  |- mesh__recordAuthorizer mesh__D027845 sjn
% 216.78/216.96  |- mesh__dateCreated mesh__D027845 2001-07-25
% 216.78/216.96  |- mesh__publicMeSHNote mesh__D027845
% 216.78/216.96       2002; for APPLE see Rosales 1988-2001, see FRUIT 1963-1997%A%  
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D027845 2004
% 216.78/216.96  |- mesh__dateRevised mesh__D005393 2003-07-30
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D005393 2005
% 216.78/216.96  |- mesh__activeMeSHYear mesh__D005393 2004
% 216.78/216.96  |- mesh__recordAuthorizer mesh__D005393 sjn
% 216.78/216.97  |- mesh__recordMaintainer mesh__D005393 ags
% 216.78/216.97  |- skos__annotation mesh__D005393
% 216.78/216.97       IM GEN or unspecified; coord IM with specific dis /vet %28%IM%29% %26% specific fish %28%IM%29%; for abnormalities or injuries, index under FISHES /abnorm or FISHES /inj; don%27%t forget also FISHES %28%NIM%29% %26% check tag ANIMALS; DF: FISH DIS%A%  
% 216.78/216.97  |- skos__hiddenLabel mesh__D005393 Fish Disease
% 216.78/216.97  |- rdf__type mesh__D005393sskos__Concept
% 216.78/216.97  |- skos__historyNote mesh__D005393 Animal Diseases %28%1966-1969%29%
% 216.78/216.97  |- skos__broader mesh__D005393smesh__D000820
% 216.78/216.97  |- skos__historyNote mesh__D005393 Fishes %28%1966-1969%29%
% 216.78/216.97  |- mesh__dateCreated mesh__D005393 1999-01-01
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D005393 2006
% 216.78/216.97  |- skos__hiddenLabel mesh__D005393 Disease, Fish
% 216.78/216.97  |- skos__scopeNote mesh__D005393
% 216.78/216.97       Diseases of freshwater, marine, hatchery or aquarium fish. This term includes diseases of both teleosts %28%true fish%29% and elasmobranchs %28%sharks, rays and skates%29%.%A%    
% 216.78/216.97  |- skos__prefLabel mesh__D005393 Fish Diseases
% 216.78/216.97  |- mesh__publicMeSHNote mesh__D005393 72   
% 216.78/216.97  |- skos__hiddenLabel mesh__D005393 Diseases, Fish
% 216.78/216.97  |- mesh__dateEstablished mesh__D005393 1972-01-01
% 216.78/216.97  |- mesh__historyNote mesh__D005393 72%28%70%29%   
% 216.78/216.97  |- mesh__recordOriginator mesh__D005393 NLM
% 216.78/216.97  |- mesh__recordAuthorizer mesh__D013027 PLS
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013027 2003
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013027 2001
% 216.78/216.97  |- skos__hiddenLabel mesh__D013027 Space Maintenances
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013027 2005
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013027 2004
% 216.78/216.97  |- skos__annotation mesh__D013027
% 216.78/216.97       note category: dental %28%mouth %26% teeth%29% context only   
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013027 2006
% 216.78/216.97  |- mesh__recordOriginator mesh__D013027 NLM
% 216.78/216.97  |- mesh__dateRevised mesh__D013027 1992-05-18
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013027 2002
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013027 1996
% 216.78/216.97  |- mesh__dateEstablished mesh__D013027 1972-01-01
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013027 1998
% 216.78/216.97  |- skos__hiddenLabel mesh__D013027 Maintenances, Space
% 216.78/216.97  |- mesh__publicMeSHNote mesh__D013027 72   
% 216.78/216.97  |- skos__broader mesh__D013027smesh__D009973
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013027 1997
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013027 1994
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013027 1999
% 216.78/216.97  |- mesh__dateCreated mesh__D013027 1999-01-01
% 216.78/216.97  |- rdf__type mesh__D013027sskos__Concept
% 216.78/216.97  |- skos__hiddenLabel mesh__D013027 Maintenance, Space
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013027 2000
% 216.78/216.97  |- mesh__recordMaintainer mesh__D013027 TAP
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013027 1993
% 216.78/216.97  |- skos__prefLabel mesh__D013027 Space Maintenance
% 216.78/216.97  |- mesh__historyNote mesh__D013027 72%28%65%29%   
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013027 1995
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018510 2001
% 216.78/216.97  |- mesh__recordAuthorizer mesh__D018510 PLS
% 216.78/216.97  |- mesh__publicMeSHNote mesh__D018510 95   
% 216.78/216.97  |- skos__annotation mesh__D018510
% 216.78/216.97       IM; coord with specific helminth; /drug eff /ultrastruct permitted%A%  
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018510 2004
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018510 1998
% 216.78/216.97  |- mesh__dateCreated mesh__D018510 1994-04-21
% 216.78/216.97  |- skos__prefLabel mesh__D018510 RNA, Helminth
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018510 2002
% 216.78/216.97  |- skos__altLabel mesh__D018510 Helminth RNA
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018510 1996
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018510 1999
% 216.78/216.97  |- rdf__type mesh__D018510sskos__Concept
% 216.78/216.97  |- mesh__dateRevised mesh__D018510 1995-06-08
% 216.78/216.97  |- mesh__recordOriginator mesh__D018510 AGS
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018510 1997
% 216.78/216.97  |- mesh__historyNote mesh__D018510 95   
% 216.78/216.97  |- mesh__recordMaintainer mesh__D018510 KEV
% 216.78/216.97  |- skos__broader mesh__D018510smesh__D012313
% 216.78/216.97  |- skos__scopeNote mesh__D018510
% 216.78/216.97       Ribonucleic acid in helminths having regulatory and catalytic roles as well as involvement in protein synthesis.%A%    
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018510 2005
% 216.78/216.97  |- mesh__dateEstablished mesh__D018510 1995-01-01
% 216.78/216.97  |- skos__historyNote mesh__D018510 RNA %28%1966-1994%29%
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018510 2000
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018510 2003
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018510 2006
% 216.78/216.97  |- skos__hiddenLabel mesh__D051146 Galactosyltransferase, Ceramide
% 216.78/216.97  |- mesh__recordOriginator mesh__D051146 AKE
% 216.78/216.97  |- skos__prefLabel mesh__D051146 N-Acylsphingosine Galactosyltransferase
% 216.78/216.97  |- skos__hiddenLabel mesh__D051146
% 216.78/216.97       Galactose-N-Acylsphingosine Galactosyltransferase, UDP
% 216.78/216.97  |- mesh__recordMaintainer mesh__D051146 AKE
% 216.78/216.97  |- skos__hiddenLabel mesh__D051146
% 216.78/216.97       Galactosyltransferase, UDP Galactose-N-Acylsphingosine
% 216.78/216.97  |- mesh__dateEstablished mesh__D051146 2006-01-01
% 216.78/216.97  |- skos__hiddenLabel mesh__D051146 Galactosyltransferase, N-Acylsphingosine
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D051146 2006
% 216.78/216.97  |- skos__hiddenLabel mesh__D051146
% 216.78/216.97       UDP Galactose N Acylsphingosine Galactosyltransferase
% 216.78/216.97  |- skos__hiddenLabel mesh__D051146 N Acylsphingosine Galactosyltransferase
% 216.78/216.97  |- mesh__recordAuthorizer mesh__D051146 sjn
% 216.78/216.97  |- skos__broader mesh__D051146smesh__D005700
% 216.78/216.97  |- rdf__type mesh__D051146sskos__Concept
% 216.78/216.97  |- mesh__publicMeSHNote mesh__D051146
% 216.78/216.97       2006; N-ACYLSPHINGOSINE GALACTOSYLTRANSFERASE was indexed under GALACTOSYLTRANSFERASES 1980-2005, %26% under CERAMIDES 1979-1982%A%  
% 216.78/216.97  |- mesh__historyNote mesh__D051146 2006%28%1980%29% use CERAMIDES 1979   
% 216.78/216.97  |- skos__altLabel mesh__D051146 Ceramide Galactosyltransferase
% 216.78/216.97  |- skos__altLabel mesh__D051146
% 216.78/216.97       UDP Galactose-N-Acylsphingosine Galactosyltransferase
% 216.78/216.97  |- mesh__dateCreated mesh__D051146 2005-06-30
% 216.78/216.97  |- skos__scopeNote mesh__D051146
% 216.78/216.97       An enzyme that catalyzes the conversion of UDP-galactose and N-acylsphingosine to D-galactosylceramide and UDP.%A%    
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D009784 2005
% 216.78/216.97  |- mesh__recordAuthorizer mesh__D009784 SJN
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D009784 2000
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D009784 2006
% 216.78/216.97  |- skos__scopeNote mesh__D009784
% 216.78/216.97       Diseases due to factors involved in one%27%s employment. %28%From Dorland, 28th ed%29%%A%    
% 216.78/216.97  |- skos__annotation mesh__D009784
% 216.78/216.97       the patient or disease: differentiate from INDUSTRY %28%the realm of labor, capital %26% trade%29% %26% OCCUPATIONAL MEDICINE %28%the med specialty%29%: Manual 31.14, 31.16; coord IM with specific dis %28%IM%29%; DF: OCCUP DIS%A%  
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D009784 2001
% 216.78/216.97  |- skos__broader mesh__D009784smesh__D007280
% 216.78/216.97  |- mesh__recordOriginator mesh__D009784 NLM
% 216.78/216.97  |- rdf__type mesh__D009784sskos__Concept
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D009784 2002
% 216.78/216.97  |- mesh__recordMaintainer mesh__D009784 NDW
% 216.78/216.97  |- skos__hiddenLabel mesh__D009784 Occupational Disease
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D009784 2003
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D009784 1999
% 216.78/216.97  |- mesh__dateCreated mesh__D009784 1999-01-01
% 216.78/216.97  |- skos__prefLabel mesh__D009784 Occupational Diseases
% 216.78/216.97  |- skos__hiddenLabel mesh__D009784 Disease, Occupational
% 216.78/216.97  |- skos__altLabel mesh__D009784 Diseases, Occupational
% 216.78/216.97  |- mesh__dateRevised mesh__D009784 1998-06-10
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D009784 2004
% 216.78/216.97  |- skos__related mesh__D009784smesh__D000062
% 216.78/216.97  |- skos__scopeNote mesh__D017418
% 216.78/216.97       Works consisting of studies using a quantitative method of combining the results of independent studies %28%usually drawn from the published literature%29% and synthesizing summaries and conclusions which may be used to evaluate therapeutic effectiveness, plan new studies, etc. It is often an overview of clinical trials. It is usually called a meta-analysis by the author or sponsoring body and should be differentiated from reviews of literature.%A%    
% 216.78/216.97  |- skos__annotation mesh__D017418
% 216.78/216.97       publication type only; for meta-analyses as a subject or research method, index under main heading META-ANALYSIS; Manual 26.26.6.1%A%  
% 216.78/216.97  |- mesh__recordOriginator mesh__D017418 TGC
% 216.78/216.97  |- mesh__dateRevised mesh__D017418 2005-06-30
% 216.78/216.97  |- mesh__dateCreated mesh__D017418 1995-06-23
% 216.78/216.97  |- skos__altLabel mesh__D017418 Meta-Analysis %28%PT%29%
% 216.78/216.97  |- skos__broader mesh__D017418smesh__D052182
% 216.78/216.97  |- skos__prefLabel mesh__D017418 Meta-Analysis %5B%Publication Type%5D%
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D017418 2006
% 216.78/216.97  |- rdf__type mesh__D017418sskos__Concept
% 216.78/216.97  |- mesh__historyNote mesh__D017418 1993   
% 216.78/216.97  |- mesh__recordMaintainer mesh__D017418 jls
% 216.78/216.97  |- mesh__recordAuthorizer mesh__D017418 sjn
% 216.78/216.97  |- mesh__dateEstablished mesh__D017418 1996-01-01
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D014120 2000
% 216.78/216.97  |- skos__annotation mesh__D014120
% 216.78/216.97       an Ascaridida infect but differentiate from TOXASCARIASIS, also an Ascaridida infect; coord IM with species %28%IM%29%; in animals but check tag ANIMAL; in man, probably is LARVA MIGRANS, VISCERAL%A%  
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D014120 2004
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D014120 2001
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D014120 1996
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D014120 1999
% 216.78/216.97  |- mesh__onlineNote mesh__D014120 search ASCARIASIS 1967-74   
% 216.78/216.97  |- mesh__recordOriginator mesh__D014120 NLM
% 216.78/216.97  |- mesh__recordMaintainer mesh__D014120 TGC
% 216.78/216.97  |- mesh__historyNote mesh__D014120
% 216.78/216.97       89%28%75%29%; was see under ASCARIASIS 1967-88   
% 216.78/216.97  |- skos__hiddenLabel mesh__D014120 Toxocariases
% 216.78/216.97  |- mesh__publicMeSHNote mesh__D014120
% 216.78/216.97       89; was see under ASCARIASIS 1967-88   
% 216.78/216.97  |- skos__broader mesh__D014120smesh__D006374
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D014120 2002
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D014120 1997
% 216.78/216.97  |- skos__prefLabel mesh__D014120 Toxocariasis
% 216.78/216.97  |- mesh__dateEstablished mesh__D014120 1989-01-01
% 216.78/216.97  |- rdf__type mesh__D014120sskos__Concept
% 216.78/216.97  |- mesh__dateRevised mesh__D014120 1994-02-08
% 216.78/216.97  |- skos__broader mesh__D014120smesh__D017191
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D014120 2005
% 216.78/216.97  |- mesh__recordAuthorizer mesh__D014120 PLS
% 216.78/216.97  |- mesh__dateCreated mesh__D014120 1999-01-01
% 216.78/216.97  |- skos__scopeNote mesh__D014120
% 216.78/216.97       Infection by round worms of the genus TOXOCARA, usually found in wild and domesticated cats and dogs and foxes, except for the larvae, which may produce visceral and ocular larva migrans in man.%A%    
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D014120 1995
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D014120 2003
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D014120 2006
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D014120 1998
% 216.78/216.97  |- mesh__dateRevised mesh__D000100 2000-06-21
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D000100 2004
% 216.78/216.97  |- mesh__recordOriginator mesh__D000100 NLM
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D000100 2005
% 216.78/216.97  |- skos__broader mesh__D000100smesh__D014283
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D000100 2001
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D000100 2006
% 216.78/216.97  |- skos__hiddenLabel mesh__D000100 Acid, Acetrizoic
% 216.78/216.97  |- mesh__dateCreated mesh__D000100 1999-01-01
% 216.78/216.97  |- skos__scopeNote mesh__D000100
% 216.78/216.97       An iodinated radiographic contrast medium used as acetrizoate sodium in HYSTEROSALPINGOGRAPHY.%A%    
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D000100 2002
% 216.78/216.97  |- mesh__recordAuthorizer mesh__D000100 sjn
% 216.78/216.97  |- skos__hiddenLabel mesh__D000100 Sodium, Acetrizoate
% 216.78/216.97  |- skos__prefLabel mesh__D000100 Acetrizoic Acid
% 216.78/216.97  |- rdf__type mesh__D000100sskos__Concept
% 216.78/216.97  |- skos__hiddenLabel mesh__D000100 300, Visotrast
% 216.78/216.97  |- mesh__recordMaintainer mesh__D000100 adp
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D000100 2003
% 216.78/216.97  |- skos__hiddenLabel mesh__D000100 400, Visotrast
% 216.78/216.97  |- mesh__recordAuthorizer mesh__D005394 SJN
% 216.78/216.97  |- mesh__dateRevised mesh__D005394 1997-06-20
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D005394 2001
% 216.78/216.97  |- mesh__recordOriginator mesh__D005394 NLM
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D005394 2003
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D005394 1999
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D005394 2000
% 216.78/216.97  |- rdf__type mesh__D005394sskos__Concept
% 216.78/216.97  |- skos__prefLabel mesh__D005394 Fish Flour
% 216.78/216.97  |- mesh__onlineNote mesh__D005394 search FISH PRODUCTS 1968-74   
% 216.78/216.97  |- skos__broader mesh__D005394smesh__D005396
% 216.78/216.97  |- skos__scopeNote mesh__D005394
% 216.78/216.97       A flour made of pulverized, dried fish or fish parts.     
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D005394 1998
% 216.78/216.97  |- skos__hiddenLabel mesh__D005394 Flour, Fish
% 216.78/216.97  |- skos__annotation mesh__D005394
% 216.78/216.97       not for %22%fish meal%22%, which is indexed under FISH PRODUCTS%A%  
% 216.78/216.97  |- skos__hiddenLabel mesh__D005394 Flours, Fish
% 216.78/216.97  |- mesh__dateCreated mesh__D005394 1999-01-01
% 216.78/216.97  |- mesh__dateEstablished mesh__D005394 1991-01-01
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D005394 2006
% 216.78/216.97  |- mesh__publicMeSHNote mesh__D005394
% 216.78/216.97       91; was see under FISH PRODUCTS 1975-90   
% 216.78/216.97  |- skos__hiddenLabel mesh__D005394 Fish Flours
% 216.78/216.97  |- mesh__historyNote mesh__D005394
% 216.78/216.97       91%28%75%29%; was see under FISH PRODUCTS 1975-90   
% 216.78/216.97  |- mesh__recordMaintainer mesh__D005394 JLS
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D005394 2005
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D005394 2002
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D005394 2004
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013826 2004
% 216.78/216.97  |- skos__hiddenLabel mesh__D013826 Theta Rhythms
% 216.78/216.97  |- mesh__dateEstablished mesh__D013826 1991-01-01
% 216.78/216.97  |- skos__hiddenLabel mesh__D013826 Rhythm, Theta
% 216.78/216.97  |- skos__annotation mesh__D013826 in EEG   
% 216.78/216.97  |- skos__scopeNote mesh__D013826
% 216.78/216.97       One of four types of brain waves, characterized by a frequency of 4-7 Hz, usually observed in the temporal lobes when the individual is awake, but relaxed and sleepy.%A%    
% 216.78/216.97  |- mesh__recordMaintainer mesh__D013826 KEV
% 216.78/216.97  |- mesh__historyNote mesh__D013826
% 216.78/216.97       91%28%75%29%; was see under ELECTROENCEPHALOGRAPHY 1975-90   
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013826 2000
% 216.78/216.97  |- skos__altLabel mesh__D013826 Electroencephalography, Theta Rhythm
% 216.78/216.97  |- skos__broader mesh__D013826smesh__D004569
% 216.78/216.97  |- mesh__publicMeSHNote mesh__D013826
% 216.78/216.97       91; was see under ELECTROENCEPHALOGRAPHY 1975-90   
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013826 2005
% 216.78/216.97  |- mesh__dateCreated mesh__D013826 1974-12-12
% 216.78/216.97  |- skos__prefLabel mesh__D013826 Theta Rhythm
% 216.78/216.97  |- mesh__recordAuthorizer mesh__D013826 sjn
% 216.78/216.97  |- mesh__dateRevised mesh__D013826 1999-11-03
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013826 2001
% 216.78/216.97  |- skos__hiddenLabel mesh__D013826 Rhythms, Theta
% 216.78/216.97  |- mesh__recordOriginator mesh__D013826 NLM
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013826 2003
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013826 2006
% 216.78/216.97  |- rdf__type mesh__D013826sskos__Concept
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013826 2002
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013028 1993
% 216.78/216.97  |- skos__broader mesh__D013028smesh__D014796
% 216.78/216.97  |- skos__broader mesh__D013028smesh__D010465
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013028 2003
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013028 1995
% 216.78/216.97  |- mesh__recordOriginator mesh__D013028 NLM
% 216.78/216.97  |- skos__hiddenLabel mesh__D013028 Space Perceptions
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013028 2005
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013028 2004
% 216.78/216.97  |- skos__hiddenLabel mesh__D013028 Perceptions, Space
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013028 1996
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013028 2002
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013028 2006
% 216.78/216.97  |- mesh__dateRevised mesh__D013028 1992-05-18
% 216.78/216.97  |- skos__scopeNote mesh__D013028
% 216.78/216.97       The awareness of the spatial properties of objects; includes physical space.%A%    
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013028 1998
% 216.78/216.97  |- skos__prefLabel mesh__D013028 Space Perception
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013028 1997
% 216.78/216.97  |- skos__hiddenLabel mesh__D013028 Perception, Space
% 216.78/216.97  |- mesh__dateCreated mesh__D013028 1999-01-01
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013028 2000
% 216.78/216.97  |- rdf__type mesh__D013028sskos__Concept
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013028 1999
% 216.78/216.97  |- mesh__recordMaintainer mesh__D013028 TAP
% 216.78/216.97  |- mesh__recordAuthorizer mesh__D013028 PLS
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013028 1994
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D013028 2001
% 216.78/216.97  |- mesh__dateEstablished mesh__D018511 1995-01-01
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018511 2000
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018511 1996
% 216.78/216.97  |- mesh__dateCreated mesh__D018511 1994-06-07
% 216.78/216.97  |- rdf__type mesh__D018511sskos__Concept
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018511 1999
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018511 2001
% 216.78/216.97  |- skos__hiddenLabel mesh__D018511 Systems Integrations
% 216.78/216.97  |- skos__broader mesh__D018511smesh__D013597
% 216.78/216.97  |- mesh__publicMeSHNote mesh__D018511 95   
% 216.78/216.97  |- skos__annotation mesh__D018511 no qualif   
% 216.78/216.97  |- skos__scopeNote mesh__D018511
% 216.78/216.97       The procedures involved in combining separately developed modules, components, or subsystems so that they work together as a complete system. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018511 1997
% 216.78/216.97  |- mesh__historyNote mesh__D018511 95   
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018511 2002
% 216.78/216.97  |- skos__broader mesh__D018511smesh__D012586
% 216.78/216.97  |- skos__hiddenLabel mesh__D018511 Integrations, Systems
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018511 2005
% 216.78/216.97  |- skos__prefLabel mesh__D018511 Systems Integration
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018511 2003
% 216.78/216.97  |- skos__hiddenLabel mesh__D018511 Integration, Systems
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018511 2006
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018511 1995
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018511 2004
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D018511 1998
% 216.78/216.97  |- skos__broader mesh__D019826Q000031smesh__D019826
% 216.78/216.97  |- mesh__preferredCombination mesh__D019826Q000031smesh__D002793
% 216.78/216.97  |- rdf__type mesh__D019826Q000031smesh__CompoundConcept
% 216.78/216.97  |- skos__hiddenLabel mesh__D051147 GM1 Synthase, Ganglioside
% 216.78/216.97  |- skos__altLabel mesh__D051147
% 216.78/216.97       UDP-Galactose-GM2 Ganglioside Beta-1-3-Galactosyltransferase
% 216.78/216.97  |- skos__broader mesh__D051147smesh__D005700
% 216.78/216.97  |- skos__hiddenLabel mesh__D051147
% 216.78/216.97       Galactosyltransferase, UDP Galactose-Ceramide
% 216.78/216.97  |- skos__hiddenLabel mesh__D051147
% 216.78/216.97       Beta-1-3-Galactosyltransferase, UDP-Galactose-GM2 Ganglioside
% 216.78/216.97  |- mesh__historyNote mesh__D051147 2006%28%1980%29%   
% 216.78/216.97  |- mesh__recordOriginator mesh__D051147 AKE
% 216.78/216.97  |- skos__altLabel mesh__D051147
% 216.78/216.97       UDP Galactose-Ceramide Galactosyltransferase
% 216.78/216.97  |- skos__hiddenLabel mesh__D051147 Synthase, Ganglioside GM1
% 216.78/216.97  |- skos__altLabel mesh__D051147 UDP Galactose-GM2 Galactosyltransferase
% 216.78/216.97  |- skos__hiddenLabel mesh__D051147 Galactosyltransferase, UDP Galactose-GM2
% 216.78/216.97  |- skos__altLabel mesh__D051147 Ganglioside GM1 Synthase
% 216.78/216.97  |- mesh__publicMeSHNote mesh__D051147
% 216.78/216.97       2006; GANGLIOSIDE GALACTOSYLTRANSFERASE was indexed under GALACTOSYLTRANSFERASES 1981-2005, CERAMIDES 1975-1980,  HEXOSYLTRANSFERASES 1973-1976, %26% under GALACTOSE 1973-1975 %26% UDP SUGARS 1973-1975%A%  
% 216.78/216.97  |- skos__hiddenLabel mesh__D051147 UDPGal GM2 Beta1 3 Galactosyltransferase
% 216.78/216.97  |- skos__hiddenLabel mesh__D051147 Galactosyltransferase, Ganglioside
% 216.78/216.97  |- mesh__recordMaintainer mesh__D051147 AKE
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D051147 2006
% 216.78/216.97  |- skos__prefLabel mesh__D051147 Ganglioside Galactosyltransferase
% 216.78/216.97  |- skos__hiddenLabel mesh__D051147 UDP Galactose GM2 Galactosyltransferase
% 216.78/216.97  |- skos__hiddenLabel mesh__D051147
% 216.78/216.97       Galactose-Ceramide Galactosyltransferase, UDP
% 216.78/216.97  |- skos__hiddenLabel mesh__D051147
% 216.78/216.97       UDP Galactose GM2 Ganglioside Beta 1 3 Galactosyltransferase
% 216.78/216.97  |- skos__hiddenLabel mesh__D051147
% 216.78/216.97       Beta1-3-Galactosyltransferase, UDPGal-GM2
% 216.78/216.97  |- skos__altLabel mesh__D051147 UDPGal-GM2 Beta1-3-Galactosyltransferase
% 216.78/216.97  |- mesh__dateCreated mesh__D051147 2005-06-30
% 216.78/216.97  |- skos__hiddenLabel mesh__D051147
% 216.78/216.97       Ganglioside Beta-1-3-Galactosyltransferase, UDP-Galactose-GM2
% 216.78/216.97  |- skos__hiddenLabel mesh__D051147 Galactose-GM2 Galactosyltransferase, UDP
% 216.78/216.97  |- skos__altLabel mesh__D051147
% 216.78/216.97       UDPGalactose-N-Acetylgalactosaminyl-%28%N-Acetylneuraminyl%29%-Galactosyl-Glucosyl-Ceramide Galactosyltransferase
% 216.78/216.97  |- mesh__dateEstablished mesh__D051147 2006-01-01
% 216.78/216.97  |- mesh__recordAuthorizer mesh__D051147 sjn
% 216.78/216.97  |- rdf__type mesh__D051147sskos__Concept
% 216.78/216.97  |- skos__hiddenLabel mesh__D051147
% 216.78/216.97       UDP Galactose Ceramide Galactosyltransferase
% 216.78/216.97  |- skos__scopeNote mesh__D051147
% 216.78/216.97       Catalyzes the final step in the galactocerebroside biosynthesis pathway.%A%    
% 216.78/216.97  |- skos__annotation mesh__D045908
% 216.78/216.97       human %26% animal; if in animal, use/vet   
% 216.78/216.97  |- skos__broader mesh__D045908smesh__D011213
% 216.78/216.97  |- skos__scopeNote mesh__D045908
% 216.78/216.97       A viral disease infecting PRIMATES and RODENTS. Its clinical presentation in humans is similar to SMALLPOX including FEVER; HEADACHE; COUGH; and a painful RASH. It is caused by MONKEYPOX VIRUS and is usually transmitted to humans through BITES or via contact with an animal%27%s BLOOD. Interhuman transmission is relatively low %28%significantly less than smallpox%29%.%A%    
% 216.78/216.97  |- skos__prefLabel mesh__D045908 Monkeypox
% 216.78/216.97  |- skos__broader mesh__D045908smesh__D012376
% 216.78/216.97  |- mesh__dateEstablished mesh__D045908 2004-01-01
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D045908 2004
% 216.78/216.97  |- mesh__dateCreated mesh__D045908 2003-07-09
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D045908 2005
% 216.78/216.97  |- mesh__historyNote mesh__D045908 2004   
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D045908 2006
% 216.78/216.97  |- skos__broader mesh__D045908smesh__D018419
% 216.78/216.97  |- skos__altLabel mesh__D045908 Monkey Pox
% 216.78/216.97  |- skos__historyNote mesh__D045908 Poxviridae Infections %28%1967-2003%29%
% 216.78/216.97  |- mesh__publicMeSHNote mesh__D045908 2004   
% 216.78/216.97  |- rdf__type mesh__D045908sskos__Concept
% 216.78/216.97  |- skos__broader mesh__D009785smesh__D013041
% 216.78/216.97  |- mesh__recordAuthorizer mesh__D009785 sjn
% 216.78/216.97  |- mesh__recordMaintainer mesh__D009785 kle
% 216.78/216.97  |- skos__altLabel mesh__D009785 Nursing, Occupational Health
% 216.78/216.97  |- mesh__publicMeSHNote mesh__D009785 79; was INDUSTRIAL NURSING 1963-78   
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D009785 2002
% 216.78/216.97  |- skos__hiddenLabel mesh__D009785 Nursings, Industrial
% 216.78/216.97  |- skos__hiddenLabel mesh__D009785 Health Nursings, Occupational
% 216.78/216.97  |- mesh__onlineNote mesh__D009785
% 216.78/216.97       use OCCUPATIONAL HEALTH NURSING to search INDUSTRIAL NURSING 1966-78%A%  
% 216.78/216.97  |- skos__hiddenLabel mesh__D009785 Industrial Nursings
% 216.78/216.97  |- skos__hiddenLabel mesh__D009785 Health Nursing, Occupational
% 216.78/216.97  |- skos__scopeNote mesh__D009785
% 216.78/216.97       The practice of nursing in the work environment.     
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D009785 2006
% 216.78/216.97  |- skos__broader mesh__D009785smesh__D009732
% 216.78/216.97  |- skos__prefLabel mesh__D009785 Occupational Health Nursing
% 216.78/216.97  |- mesh__dateCreated mesh__D009785 1999-01-01
% 216.78/216.97  |- mesh__historyNote mesh__D009785 79; was INDUSTRIAL NURSING 1963-78   
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D009785 2001
% 216.78/216.97  |- skos__hiddenLabel mesh__D009785 Occupational Health Nursings
% 216.78/216.97  |- skos__altLabel mesh__D009785 Nursing, Industrial
% 216.78/216.97  |- skos__hiddenLabel mesh__D009785 Nursings, Occupational Health
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D009785 2005
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D009785 2000
% 216.78/216.97  |- mesh__dateRevised mesh__D009785 1999-11-03
% 216.78/216.97  |- rdf__type mesh__D009785sskos__Concept
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D009785 2004
% 216.78/216.97  |- mesh__recordOriginator mesh__D009785 NLM
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D009785 2003
% 216.78/216.97  |- skos__annotation mesh__D009785
% 216.78/216.97       SPEC: SPEC qualif; DF: OCCUP HEALTH NURS   
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D017419 1994
% 216.78/216.97  |- skos__prefLabel mesh__D017419 Potassium, Dietary
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D017419 2001
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D017419 2005
% 216.78/216.97  |- mesh__dateRevised mesh__D017419 1993-06-02
% 216.78/216.97  |- mesh__dateEstablished mesh__D017419 1993-01-01
% 216.78/216.97  |- mesh__recordMaintainer mesh__D017419 TPW
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D017419 2004
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D017419 1995
% 216.78/216.97  |- mesh__recordOriginator mesh__D017419 TPW
% 216.78/216.97  |- skos__altLabel mesh__D017419 Dietary Potassium
% 216.78/216.97  |- skos__broader mesh__D017419smesh__D017680
% 216.78/216.97  |- mesh__dateCreated mesh__D017419 1992-05-22
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D017419 2006
% 216.78/216.97  |- rdf__type mesh__D017419sskos__Concept
% 216.78/216.97  |- mesh__recordAuthorizer mesh__D017419 PLS
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D017419 1996
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D017419 2002
% 216.78/216.97  |- mesh__publicMeSHNote mesh__D017419 93   
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D017419 1998
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D017419 1997
% 216.78/216.97  |- skos__annotation mesh__D017419
% 216.78/216.97       /adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with disease /diet ther%A%  
% 216.78/216.97  |- skos__scopeNote mesh__D017419
% 216.78/216.97       Potassium or potassium compounds used in foods or as foods.%A%    
% 216.78/216.97  |- mesh__historyNote mesh__D017419 93   
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D017419 2000
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D017419 1999
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D017419 2003
% 216.78/216.97  |- skos__historyNote mesh__D017419 Potassium %28%1966-1992%29%
% 216.78/216.97  |- mesh__historyNote mesh__D028141 2002   
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D028141 2003
% 216.78/216.97  |- mesh__dateEstablished mesh__D028141 2002-01-01
% 216.78/216.97  |- skos__annotation mesh__D028141
% 216.78/216.97       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D028141 2002
% 216.78/216.97  |- mesh__publicMeSHNote mesh__D028141 2002   
% 216.78/216.97  |- rdf__type mesh__D028141sskos__Concept
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D028141 2006
% 216.78/216.97  |- skos__scopeNote mesh__D028141
% 216.78/216.97       The Barberry plant family of the order Ranunculales, subclass Magnoliidae, class Magnoliopsida. The shrubs have spiny leaves.%A%    
% 216.78/216.97  |- mesh__dateCreated mesh__D028141 2001-07-25
% 216.78/216.97  |- skos__broader mesh__D028141smesh__D019684
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D028141 2005
% 216.78/216.97  |- mesh__activeMeSHYear mesh__D028141 2004
% 216.78/216.97  |- skos__prefLabel mesh__D028141 Berberidaceae
% 216.78/216.97  |- skos__hiddenLabel mesh__D014121 Deactivated Toxins
% 216.78/216.97  |- skos__related mesh__D014121smesh__D014118
% 216.78/216.97  |- skos__broader mesh__D014121smesh__D014612
% 216.78/216.97  |- mesh__recordMaintainer mesh__D014121 ssb
% 216.78/216.98  |- skos__annotation mesh__D014121
% 216.78/216.98       GEN or unspecified; prefer specifics; coord IM with specific organism /immunol %28%IM%29%%A%  
% 216.78/216.98  |- mesh__publicMeSHNote mesh__D014121
% 216.78/216.98       66; TOXINS AND ANTITOXINS was heading 1963-65   
% 216.78/216.98  |- mesh__recordOriginator mesh__D014121 NLM
% 216.78/216.98  |- rdf__type mesh__D014121sskos__Concept
% 216.78/216.98  |- mesh__historyNote mesh__D014121
% 216.78/216.98       66; TOXINS AND ANTITOXINS was heading 1963-65   
% 216.78/216.98  |- skos__scopeNote mesh__D014121
% 216.78/216.98       Preparations of pathogenic organisms or their derivatives made nontoxic and intended for active immunologic prophylaxis. They include deactivated toxins.%A%    
% 216.78/216.98  |- mesh__dateCreated mesh__D014121 1999-01-01
% 216.78/216.98  |- mesh__dateRevised mesh__D014121 2005-06-30
% 216.78/216.98  |- skos__prefLabel mesh__D014121 Toxoids
% 216.78/216.98  |- mesh__recordAuthorizer mesh__D014121 sjn
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D014121 2006
% 216.78/216.98  |- mesh__dateEstablished mesh__D014121 1966-01-01
% 216.78/216.98  |- skos__historyNote mesh__D000101 Acetyltransferases %28%1973-1974%29%
% 216.78/216.98  |- skos__prefLabel mesh__D000101 Acetyl-CoA C-Acetyltransferase
% 216.78/216.98  |- skos__hiddenLabel mesh__D000101 Acetyl CoA Acetyltransferase
% 216.78/216.98  |- skos__altLabel mesh__D000101 Acetoacetyl CoA Thiolase
% 216.78/216.98  |- skos__related mesh__D000101smesh__D000102
% 216.78/216.98  |- skos__broader mesh__D000101smesh__D000123
% 216.78/216.98  |- skos__altLabel mesh__D000101 Acetyl-CoA Acetyltransferase
% 216.78/216.98  |- rdf__type mesh__D000101sskos__Concept
% 216.78/216.98  |- mesh__publicMeSHNote mesh__D000101
% 216.78/216.98       98%28%75%29%; see ACETYL-COA ACETYLTRANSFERASE 1991-97; see ACETYLTRANSFERASES 1975-90%A%  
% 216.78/216.98  |- skos__hiddenLabel mesh__D000101 Thiolase, Acetoacetyl CoA
% 216.78/216.98  |- skos__historyNote mesh__D000101 Acetyl Coenzyme A %28%1973-1974%29%
% 216.78/216.98  |- skos__hiddenLabel mesh__D000101 Acetyl CoA C Acetyltransferase
% 216.78/216.98  |- mesh__recordOriginator mesh__D000101 NLM
% 216.78/216.98  |- skos__scopeNote mesh__D000101
% 216.78/216.98       An enzyme that catalyzes the formation of acetoacetyl-CoA from two molecules of ACETYL COA. Some enzymes called thiolase or thiolase-I have referred to this activity or to the activity of ACETYL-COA C-ACYLTRANSFERASE.%A%    
% 216.78/216.98  |- skos__hiddenLabel mesh__D000101 C-Acetyltransferase, Acetyl-CoA
% 216.78/216.98  |- mesh__recordMaintainer mesh__D000101 nns
% 216.78/216.98  |- mesh__historyNote mesh__D000101 98%28%75%29%   
% 216.78/216.98  |- mesh__dateEstablished mesh__D000101 1991-01-01
% 216.78/216.98  |- skos__historyNote mesh__D000101 Acetoacetates %28%1974%29%
% 216.78/216.98  |- skos__altLabel mesh__D000101 Acetyl Coenzyme A Acetyltransferase
% 216.78/216.98  |- skos__hiddenLabel mesh__D000101 Acetyltransferase, Acetyl-CoA
% 216.78/216.98  |- mesh__dateRevised mesh__D000101 2004-07-07
% 216.78/216.98  |- mesh__dateCreated mesh__D000101 1974-11-19
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D000101 2005
% 216.78/216.98  |- skos__hiddenLabel mesh__D000101 CoA Thiolase, Acetoacetyl
% 216.78/216.98  |- skos__annotation mesh__D000101
% 216.78/216.98       do not confuse with ACETYL-COA C-ACYLTRANSFERASE   
% 216.78/216.98  |- mesh__recordAuthorizer mesh__D000101 sjn
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D000101 2006
% 216.78/216.98  |- mesh__dateEstablished mesh__D027847 2002-01-01
% 216.78/216.98  |- mesh__publicMeSHNote mesh__D027847 2002   
% 216.78/216.98  |- mesh__dateRevised mesh__D027847 2005-07-13
% 216.78/216.98  |- skos__altLabel mesh__D027847 Topoisomerase 1, Archaeal
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D027847 2004
% 216.78/216.98  |- mesh__recordAuthorizer mesh__D027847 ags
% 216.78/216.98  |- mesh__historyNote mesh__D027847 2002   
% 216.78/216.98  |- mesh__dateCreated mesh__D027847 2001-07-25
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D027847 2005
% 216.78/216.98  |- skos__prefLabel mesh__D027847 DNA Topoisomerases, Type I, Archaeal
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D027847 2006A
% 216.78/216.98  |- skos__scopeNote mesh__D027847
% 216.78/216.98       Archaeal enzymes of the DNA TOPOISOMERASES, TYPE I class that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. These archaeal enzymes reduce the topological stress in the DNA structure by relaxing negatively, but not positively, supercoiled DNA.%A%    
% 216.78/216.98  |- skos__broader mesh__D027847smesh__D004264
% 216.78/216.98  |- skos__altLabel mesh__D027847 DNA Topoisomerase 1, Archaeal
% 216.78/216.98  |- mesh__recordOriginator mesh__D027847 lkt
% 216.78/216.98  |- mesh__recordMaintainer mesh__D027847 ags
% 216.78/216.98  |- skos__broader mesh__D027847smesh__D019843
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D027847 2006
% 216.78/216.98  |- skos__hiddenLabel mesh__D027847 Archaeal Topoisomerase 1
% 216.78/216.98  |- skos__historyNote mesh__D027847 DNA Topoisomerase %28%1984-2001%29%
% 216.78/216.98  |- rdf__type mesh__D027847sskos__Concept
% 216.78/216.98  |- rdf__type mesh__D052240sskos__Concept
% 216.78/216.98  |- mesh__recordAuthorizer mesh__D052240 sjn
% 216.78/216.98  |- mesh__dateCreated mesh__D052240 2005-06-30
% 216.78/216.98  |- skos__broader mesh__D052240smesh__D051856
% 216.78/216.98  |- mesh__publicMeSHNote mesh__D052240
% 216.78/216.98       2006; FANCONI ANEMIA COMPLEMENTATION GROUP L PROTEIN was indexed under LIGASES 2003-2005%A%  
% 216.78/216.98  |- skos__altLabel mesh__D052240 Fanconi Anemia Group L Protein
% 216.78/216.98  |- mesh__historyNote mesh__D052240 2006%28%2003%29%   
% 216.78/216.98  |- skos__broader mesh__D052240smesh__D044767
% 216.78/216.98  |- mesh__recordOriginator mesh__D052240 DRC
% 216.78/216.98  |- mesh__recordMaintainer mesh__D052240 DRC
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D052240 2006
% 216.78/216.98  |- skos__prefLabel mesh__D052240
% 216.78/216.98       Fanconi Anemia Complementation Group L Protein
% 216.78/216.98  |- skos__altLabel mesh__D052240 PHD Finger Protein 9
% 216.78/216.98  |- skos__altLabel mesh__D052240 Ubiquitin Ligase Protein PHF9
% 216.78/216.98  |- skos__altLabel mesh__D052240 FANCL Protein
% 216.78/216.98  |- skos__scopeNote mesh__D052240
% 216.78/216.98       An E3 UBIQUITIN LIGASE that plays a key role in the DNA damage response pathway of FANCONI ANEMIA PROTEINS. It is associated with mono-ubiquitination of FANCD2 PROTEIN and the redistribution of FANCD2 to nuclear foci containing BRCA1 PROTEIN.%A%    
% 216.78/216.98  |- mesh__dateEstablished mesh__D052240 2006-01-01
% 216.78/216.98  |- skos__altLabel mesh__D052240
% 216.78/216.98       Fanconi Anemia Group L Complementing Protein
% 216.78/216.98  |- mesh__publicMeSHNote mesh__D005395 83; was FISH LIVER OILS 1963-82   
% 216.78/216.98  |- mesh__dateCreated mesh__D005395 1999-01-01
% 216.78/216.98  |- mesh__historyNote mesh__D005395 83; was FISH LIVER OILS 1963-82   
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D005395 2006
% 216.78/216.98  |- skos__prefLabel mesh__D005395 Fish Oils
% 216.78/216.98  |- skos__hiddenLabel mesh__D005395 Oils, Fish Liver
% 216.78/216.98  |- skos__hiddenLabel mesh__D005395 Liver Oils, Fish
% 216.78/216.98  |- mesh__recordMaintainer mesh__D005395 ssb
% 216.78/216.98  |- mesh__dateRevised mesh__D005395 2003-07-09
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D005395 2005
% 216.78/216.98  |- skos__annotation mesh__D005395
% 216.78/216.98       coord IM with specific fish %28%NIM%29%   
% 216.78/216.98  |- mesh__recordOriginator mesh__D005395 NLM
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D005395 2004
% 216.78/216.98  |- skos__hiddenLabel mesh__D005395 Oils, Fish
% 216.78/216.98  |- skos__broader mesh__D005395smesh__D009821
% 216.78/216.98  |- mesh__onlineNote mesh__D005395
% 216.78/216.98       use FISH OILS to search FISH LIVER OILS 1966-82   
% 216.78/216.98  |- mesh__recordAuthorizer mesh__D005395 sjn
% 216.78/216.98  |- rdf__type mesh__D005395sskos__Concept
% 216.78/216.98  |- skos__scopeNote mesh__D005395
% 216.78/216.98       Oils high in unsaturated fats extracted from the bodies of fish or fish parts, especially the livers. Those from the liver are usually high in vitamin A. The oils are used as dietary supplements, in soaps and detergents, as protective coatings, and as a base for other food products such as vegetable shortenings.%A%    
% 216.78/216.98  |- mesh__recordOriginator mesh__D013827 NLM
% 216.78/216.98  |- skos__broader mesh__D013827smesh__D052160
% 216.78/216.98  |- mesh__dateCreated mesh__D013827 1999-01-01
% 216.78/216.98  |- mesh__publicMeSHNote mesh__D013827 65   
% 216.78/216.98  |- skos__altLabel mesh__D013827 Thibendole
% 216.78/216.98  |- skos__scopeNote mesh__D013827
% 216.78/216.98       2-Substituted benzimidazole first introduced in 1962. It is active against a variety of nematodes and is the drug of choice for strongyloidiasis. It has CNS side effects and hepatototoxic potential. %28%From Smith and Reynard, Textbook of Pharmacology, 1992, p919%29%%A%    
% 216.78/216.98  |- mesh__recordMaintainer mesh__D013827 ssb
% 216.78/216.98  |- skos__broader mesh__D013827smesh__D013844
% 216.78/216.98  |- mesh__historyNote mesh__D013827 65%28%63%29%   
% 216.78/216.98  |- skos__altLabel mesh__D013827 2-%28%4%27%-Thiazolyl%29%Benzimidazole
% 216.78/216.98  |- mesh__dateRevised mesh__D013827 2005-06-30
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D013827 2006
% 216.78/216.98  |- skos__prefLabel mesh__D013827 Thiabendazole
% 216.78/216.98  |- mesh__dateEstablished mesh__D013827 1965-01-01
% 216.78/216.98  |- rdf__type mesh__D013827sskos__Concept
% 216.78/216.98  |- skos__altLabel mesh__D013827 Tiabendazol
% 216.78/216.98  |- skos__broader mesh__D013827smesh__D001562
% 216.78/216.98  |- mesh__recordAuthorizer mesh__D013827 sjn
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D013029 2005
% 216.78/216.98  |- mesh__recordAuthorizer mesh__D013029 PLS
% 216.78/216.98  |- mesh__dateCreated mesh__D013029 1977-03-01
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D013029 2004
% 216.78/216.98  |- skos__annotation mesh__D013029
% 216.78/216.98       IM GEN only; coord NIM with specific disease %28%IM%29%; no qualif; specify geog if pertinent%A%  
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D013029 2001
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D013029 1996
% 216.78/216.98  |- skos__scopeNote mesh__D013029
% 216.78/216.98       A statistically significant excess of cases of a disease, occurring within a limited space-time continuum.%A%    
% 216.78/216.98  |- skos__hiddenLabel mesh__D013029 Clusterings, Space-Time
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D013029 2006
% 216.78/216.98  |- skos__hiddenLabel mesh__D013029 Space-Time Clusterings
% 216.78/216.98  |- skos__related mesh__D013029smesh__D004196
% 216.78/216.98  |- mesh__dateEstablished mesh__D013029 1978-01-01
% 216.78/216.98  |- skos__broader mesh__D013029smesh__D016000
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D013029 1998
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D013029 1997
% 216.78/216.98  |- mesh__recordOriginator mesh__D013029 AEP
% 216.78/216.98  |- skos__hiddenLabel mesh__D013029 Clustering, Space-Time
% 216.78/216.98  |- mesh__recordMaintainer mesh__D013029 TGC
% 216.78/216.98  |- skos__prefLabel mesh__D013029 Space-Time Clustering
% 216.78/216.98  |- rdf__type mesh__D013029sskos__Concept
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D013029 1999
% 216.78/216.98  |- skos__hiddenLabel mesh__D013029 Space Time Clustering
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D013029 2002
% 216.78/216.98  |- mesh__historyNote mesh__D013029 78   
% 216.78/216.98  |- skos__historyNote mesh__D013029 Statistics %28%1966-1977%29%
% 216.78/216.98  |- mesh__publicMeSHNote mesh__D013029 78   
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D013029 2003
% 216.78/216.98  |- mesh__dateRevised mesh__D013029 1994-04-11
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D013029 1995
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D013029 2000
% 216.78/216.98  |- mesh__historyNote mesh__D018512 95   
% 216.78/216.98  |- mesh__recordAuthorizer mesh__D018512 SJN
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D018512 2005
% 216.78/216.98  |- mesh__dateEstablished mesh__D018512 1995-01-01
% 216.78/216.98  |- skos__scopeNote mesh__D018512
% 216.78/216.98       The presence of parasites %28%especially malarial parasites%29% in the blood. %28%Dorland, 27th ed%29%%A%    
% 216.78/216.98  |- skos__prefLabel mesh__D018512 Parasitemia
% 216.78/216.98  |- skos__annotation mesh__D018512
% 216.78/216.98       coord with specific parasitic disease or specific parasite if specific parasite dis is not in MeSH %28%do not use /blood to indicate -emia%29%%A%  
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D018512 2003
% 216.78/216.98  |- mesh__recordMaintainer mesh__D018512 PXP
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D018512 2006
% 216.78/216.98  |- skos__historyNote mesh__D018512 specific organism %28%1966-1994%29%
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D018512 2000
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D018512 2004
% 216.78/216.98  |- mesh__dateRevised mesh__D018512 1998-06-10
% 216.78/216.98  |- mesh__dateCreated mesh__D018512 1994-05-12
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D018512 2001
% 216.78/216.98  |- mesh__recordOriginator mesh__D018512 PXP
% 216.78/216.98  |- mesh__publicMeSHNote mesh__D018512 95   
% 216.78/216.98  |- skos__broader mesh__D018512smesh__D012687
% 216.78/216.98  |- skos__hiddenLabel mesh__D018512 Parasitemias
% 216.78/216.98  |- rdf__type mesh__D018512sskos__Concept
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D018512 1999
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D018512 2002
% 216.78/216.98  |- skos__historyNote mesh__D018512
% 216.78/216.98       specific parasitic disease/blood %28%1966-1994%29%
% 216.78/216.98  |- skos__broader mesh__D018512smesh__D010272
% 216.78/216.98  |- skos__hiddenLabel mesh__D009786 Service, Employee Health
% 216.78/216.98  |- skos__hiddenLabel mesh__D009786 Employment Based Services
% 216.78/216.98  |- skos__altLabel mesh__D009786 Health Services, Employee
% 216.78/216.98  |- skos__altLabel mesh__D009786 Employee Health Services
% 216.78/216.98  |- mesh__historyNote mesh__D009786 68   
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D009786 2002
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D009786 2004
% 216.78/216.98  |- mesh__dateRevised mesh__D009786 1999-11-03
% 216.78/216.98  |- skos__prefLabel mesh__D009786 Occupational Health Services
% 216.78/216.98  |- mesh__recordMaintainer mesh__D009786 kle
% 216.78/216.98  |- skos__hiddenLabel mesh__D009786 Health Service, Employee
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D009786 2005
% 216.78/216.98  |- skos__altLabel mesh__D009786 Health Services, Occupational
% 216.78/216.98  |- skos__historyNote mesh__D009786 Occupational Medicine %28%1966-1967%29%
% 216.78/216.98  |- skos__hiddenLabel mesh__D009786 Health Service, Occupational
% 216.78/216.98  |- mesh__recordAuthorizer mesh__D009786 sjn
% 216.78/216.98  |- skos__hiddenLabel mesh__D009786
% 216.78/216.98       Program, Employee Assistance %28%Health Care%29%
% 216.78/216.98  |- skos__broader mesh__D009786smesh__D003153
% 216.78/216.98  |- skos__hiddenLabel mesh__D009786 Occupational Health Service
% 216.78/216.98  |- skos__hiddenLabel mesh__D009786 Service, Occupational Health
% 216.78/216.98  |- mesh__recordOriginator mesh__D009786 NLM
% 216.78/216.98  |- skos__altLabel mesh__D009786 Services, Employee Health
% 216.78/216.98  |- skos__hiddenLabel mesh__D009786 Services, Employment Based
% 216.78/216.98  |- skos__hiddenLabel mesh__D009786 Employment-Based Service
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D009786 2006
% 216.78/216.98  |- mesh__dateEstablished mesh__D009786 1968-01-01
% 216.78/216.98  |- skos__hiddenLabel mesh__D009786
% 216.78/216.98       Employee Assistance Program %28%Health Care%29%
% 216.78/216.98  |- mesh__dateCreated mesh__D009786 1999-01-01
% 216.78/216.98  |- skos__hiddenLabel mesh__D009786
% 216.78/216.98       Assistance Programs, Employee %28%Health Care%29%
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D009786 2000
% 216.78/216.98  |- skos__hiddenLabel mesh__D009786
% 216.78/216.98       Assistance Program, Employee %28%Health Care%29%
% 216.78/216.98  |- skos__altLabel mesh__D009786 Services, Occupational Health
% 216.78/216.98  |- skos__hiddenLabel mesh__D009786
% 216.78/216.98       Programs, Employee Assistance %28%Health Care%29%
% 216.78/216.98  |- skos__hiddenLabel mesh__D009786 Employee Health Service
% 216.78/216.98  |- skos__altLabel mesh__D009786 Services, Employment-Based
% 216.78/216.98  |- skos__hiddenLabel mesh__D009786 Service, Employment-Based
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D009786 2001
% 216.78/216.98  |- mesh__publicMeSHNote mesh__D009786 68   
% 216.78/216.98  |- rdf__type mesh__D009786sskos__Concept
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D009786 2003
% 216.78/216.98  |- skos__scopeNote mesh__D009786
% 216.78/216.98       Health services for employees, usually provided by the employer at the place of work.%A%    
% 216.78/216.98  |- skos__annotation mesh__D009786 IM; DF: OCCUP HEALTH SERV   
% 216.78/216.98  |- mesh__dateCreated mesh__D028142 2001-07-25
% 216.78/216.98  |- skos__prefLabel mesh__D028142 Berberis
% 216.78/216.98  |- mesh__dateEstablished mesh__D028142 2002-01-01
% 216.78/216.98  |- skos__scopeNote mesh__D028142
% 216.78/216.98       A plant genus in the family BERBERIDACEAE. The common names of Barberry or Oregon Grape are also used for MAHONIA. The similar-named Bayberry is the unrelated MYRICA. Oregon Grape was classified by Pursh as a Berberis but Nuttall claimed it is different enough to call it a new genus, MAHONIA. Botanists insist on this name while horticulturists stay with Mahonia. They are shrubs with yellow wood and usually three-branched spines at the base of leafstalks. Flowers are yellow, six-petaled and fruit is a berry with one to several seeds. Members contain BERBERINE.%A%    
% 216.78/216.98  |- mesh__publicMeSHNote mesh__D028142 2002   
% 216.78/216.98  |- mesh__historyNote mesh__D028142 2002   
% 216.78/216.98  |- mesh__dateRevised mesh__D028142 2002-07-02
% 216.78/216.98  |- rdf__type mesh__D028142sskos__Concept
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D028142 2006
% 216.78/216.98  |- mesh__recordMaintainer mesh__D028142 ssb
% 216.78/216.98  |- skos__historyNote mesh__D028142 Plants, Medicinal %28%1966-2001%29%
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D028142 2005
% 216.78/216.98  |- skos__broader mesh__D028142smesh__D028141
% 216.78/216.98  |- skos__altLabel mesh__D028142 Barberry
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D028142 2004
% 216.78/216.98  |- mesh__recordAuthorizer mesh__D028142 sjn
% 216.78/216.98  |- skos__annotation mesh__D028142
% 216.78/216.98       X ref BARBERRY: HOLLYLEAVED BARBERRY see MAHONIA is also available; BAYBERRY see MYRICA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.78/216.98  |- mesh__recordOriginator mesh__D028142 ssb
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D028142 2003
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D014920 2006
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D014920 2000
% 216.78/216.98  |- skos__prefLabel mesh__D014920 Wine
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D014920 2003
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D014920 2001
% 216.78/216.98  |- skos__scopeNote mesh__D014920
% 216.78/216.98       Fermented juice of fresh grapes or of other fruit or plant products used as a beverage.%A%    
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D014920 1998
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D014920 2004
% 216.78/216.98  |- rdf__type mesh__D014920sskos__Concept
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D014920 1999
% 216.78/216.98  |- skos__broader mesh__D014920smesh__D000434
% 216.78/216.98  |- mesh__recordAuthorizer mesh__D014920 SJN
% 216.78/216.98  |- mesh__recordOriginator mesh__D014920 NLM
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D014920 2002
% 216.78/216.98  |- mesh__recordMaintainer mesh__D014920 JLS
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D014920 2005
% 216.78/216.98  |- mesh__dateCreated mesh__D014920 1999-01-01
% 216.78/216.98  |- mesh__dateRevised mesh__D014920 1997-06-20
% 216.78/216.98  |- skos__hiddenLabel mesh__D014920 Wines
% 216.78/216.98  |- mesh__recordAuthorizer mesh__D014122 sjn
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D014122 2005
% 216.78/216.98  |- skos__prefLabel mesh__D014122 Toxoplasma
% 216.78/216.98  |- skos__broader mesh__D014122smesh__D021745
% 216.78/216.98  |- skos__annotation mesh__D014122
% 216.78/216.98       infection = TOXOPLASMOSIS %26% its specifics; /drug eff: consider also COCCIDIOSTATS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 216.78/216.98  |- mesh__recordMaintainer mesh__D014122 ags
% 216.78/216.98  |- skos__scopeNote mesh__D014122
% 216.78/216.98       A genus of protozoa parasitic to birds and mammals. T. gondii is one of the most common infectious pathogenic animal parasites of man.%A%    
% 216.78/216.98  |- rdf__type mesh__D014122sskos__Concept
% 216.78/216.98  |- mesh__dateCreated mesh__D014122 1999-01-01
% 216.78/216.98  |- mesh__dateRevised mesh__D014122 2003-07-09
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D014122 2004
% 216.78/216.98  |- mesh__recordOriginator mesh__D014122 NLM
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D014122 2006
% 216.78/216.98  |- skos__annotation mesh__D000900
% 216.78/216.98       GEN or unspecified; resistance to antibiotics = DRUG RESISTANCE, BACTERIAL or specifics; preop use of antibiotics for prev of infect: index under ANTIBIOTIC PROPHYLAXIS %28%IM%29% + specific antibiotic /ther use %28%IM%29%%A%  
% 216.78/216.98  |- mesh__recordOriginator mesh__D000900 NLM
% 216.78/216.98  |- skos__hiddenLabel mesh__D000900 Agents, Anti-Bacterial
% 216.78/216.98  |- skos__altLabel mesh__D000900 Bacteriocides
% 216.78/216.98  |- skos__hiddenLabel mesh__D000900 Anti Bacterial Agents
% 216.78/216.98  |- mesh__publicMeSHNote mesh__D000900 2004; see ANTIBIOTICS 1963-2003   
% 216.78/216.98  |- rdf__type mesh__D000900sskos__Concept
% 216.78/216.98  |- skos__hiddenLabel mesh__D000900 Agents, Antimycobacterial
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D000900 2004
% 216.78/216.98  |- skos__hiddenLabel mesh__D000900 Agents, Anti-Mycobacterial
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D000900 2005
% 216.78/216.98  |- skos__hiddenLabel mesh__D000900 Anti Mycobacterial Agents
% 216.78/216.98  |- skos__scopeNote mesh__D000900
% 216.78/216.98       Substances that reduce the growth or reproduction of BACTERIA.%A%    
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D000900 2006
% 216.78/216.98  |- mesh__recordAuthorizer mesh__D000900 sjn
% 216.78/216.98  |- skos__hiddenLabel mesh__D000900 Agents, Antibacterial
% 216.78/216.98  |- mesh__dateRevised mesh__D000900 2003-07-09
% 216.78/216.98  |- skos__broader mesh__D000900smesh__D000890
% 216.78/216.98  |- mesh__recordMaintainer mesh__D000900 ssb
% 216.78/216.98  |- mesh__historyNote mesh__D000900 2004%28%1963%29%   
% 216.78/216.98  |- skos__prefLabel mesh__D000900 Anti-Bacterial Agents
% 216.78/216.98  |- skos__altLabel mesh__D000900 Antibacterial Agents
% 216.78/216.98  |- skos__hiddenLabel mesh__D000900 Agents, Bacteriocidal
% 216.78/216.98  |- skos__altLabel mesh__D000900 Antimycobacterial Agents
% 216.78/216.98  |- mesh__dateCreated mesh__D000900 1999-01-01
% 216.78/216.98  |- mesh__recordMaintainer mesh__D000102 nns
% 216.78/216.98  |- skos__historyNote mesh__D000102 Acyltransferases %28%1973-1974%29%
% 216.78/216.98  |- skos__altLabel mesh__D000102 Acetyl Coenzyme A Acyltransferase
% 216.78/216.98  |- skos__prefLabel mesh__D000102 Acetyl-CoA C-Acyltransferase
% 216.78/216.98  |- mesh__dateCreated mesh__D000102 1974-11-19
% 216.78/216.98  |- skos__altLabel mesh__D000102 3-Oxoacyl CoA Thiolase
% 216.78/216.98  |- skos__altLabel mesh__D000102 2-Methylacetoacetyl CoA Thiolase
% 216.78/216.98  |- skos__altLabel mesh__D000102 Acetyl CoA Acyltransferase
% 216.78/216.98  |- skos__historyNote mesh__D000102 Acetyl Coenzyme A %28%1973-1974%29%
% 216.78/216.98  |- skos__altLabel mesh__D000102 3-Ketothiolase
% 216.78/216.98  |- skos__altLabel mesh__D000102 beta-Ketothiolase
% 216.78/216.98  |- skos__hiddenLabel mesh__D000102 beta Ketothiolase
% 216.78/216.98  |- mesh__publicMeSHNote mesh__D000102
% 216.78/216.98       98; use ACETYL COA ACYLTRANSFERASE 1991-97, ACYLTRANSFERASES 1975-90%A%  
% 216.78/216.98  |- mesh__historyNote mesh__D000102 98%28%75%29%   
% 216.78/216.98  |- skos__related mesh__D000102smesh__D000101
% 216.78/216.98  |- skos__hiddenLabel mesh__D000102 Thiolase, 3-Oxoacyl CoA
% 216.78/216.98  |- skos__hiddenLabel mesh__D000102 CoA Thiolase, 2-Methylacetoacetyl
% 216.78/216.98  |- skos__broader mesh__D000102smesh__D000217
% 216.78/216.98  |- skos__hiddenLabel mesh__D000102 Acyltransferase, Acetyl CoA
% 216.78/216.98  |- skos__hiddenLabel mesh__D000102 CoA Thiolase, 3-Ketoacyl
% 216.78/216.98  |- skos__hiddenLabel mesh__D000102 Thiolase, beta-Ketoacyl
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D000102 2006
% 216.78/216.98  |- mesh__recordOriginator mesh__D000102 NLM
% 216.78/216.98  |- skos__altLabel mesh__D000102 3-Oxoacyl-Coenzyme A Thiolase
% 216.78/216.98  |- rdf__type mesh__D000102sskos__Concept
% 216.78/216.98  |- skos__hiddenLabel mesh__D000102 CoA Thiolase, 3-Oxoacyl
% 216.78/216.98  |- skos__hiddenLabel mesh__D000102 Acetyl CoA C Acyltransferase
% 216.78/216.98  |- mesh__recordAuthorizer mesh__D000102 sjn
% 216.78/216.98  |- skos__scopeNote mesh__D000102
% 216.78/216.98       Enzyme that catalyzes the final step of fatty acid oxidation in which ACETYL COA is released and the CoA ester of a fatty acid two carbons shorter is formed.%A%    
% 216.78/216.98  |- skos__hiddenLabel mesh__D000102 Thiolase, 2-Methylacetoacetyl CoA
% 216.78/216.98  |- skos__hiddenLabel mesh__D000102 CoA Acyltransferase, Acetyl
% 216.78/216.98  |- skos__altLabel mesh__D000102 beta-Ketoacyl Thiolase
% 216.78/216.98  |- skos__hiddenLabel mesh__D000102 beta Ketoacyl Thiolase
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D000102 2005
% 216.78/216.98  |- skos__hiddenLabel mesh__D000102 C-Acyltransferase, Acetyl-CoA
% 216.78/216.98  |- skos__hiddenLabel mesh__D000102 Thiolase, 3-Ketoacyl CoA
% 216.78/216.98  |- skos__annotation mesh__D000102
% 216.78/216.98       do not confuse with ACETYL-COA C-ACETYLTRANSFERASE   
% 216.78/216.98  |- skos__hiddenLabel mesh__D000102 Thiolase, 3-Oxoacyl-Coenzyme A
% 216.78/216.98  |- skos__altLabel mesh__D000102 3-Ketoacyl CoA Thiolase
% 216.78/216.98  |- mesh__dateEstablished mesh__D000102 1991-01-01
% 216.78/216.98  |- mesh__dateRevised mesh__D000102 2004-07-07
% 216.78/216.98  |- skos__broader mesh__D020352Q000031smesh__D020352
% 216.78/216.98  |- mesh__preferredCombination mesh__D020352Q000031smesh__D010071
% 216.78/216.98  |- rdf__type mesh__D020352Q000031smesh__CompoundConcept
% 216.78/216.98  |- skos__altLabel mesh__D052241 XRCC9 Protein
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D052241 2006
% 216.78/216.98  |- mesh__publicMeSHNote mesh__D052241
% 216.78/216.98       2006; FANCONI ANEMIA COMPLEMENTATION GROUP G PROTEIN was indexed under DNA-BINDING PROTEINS 1997-2005%A%  
% 216.78/216.98  |- skos__prefLabel mesh__D052241
% 216.78/216.98       Fanconi Anemia Complementation Group G Protein
% 216.78/216.98  |- mesh__dateEstablished mesh__D052241 2006-01-01
% 216.78/216.98  |- skos__altLabel mesh__D052241
% 216.78/216.98       Fanconi Anemia Group G Complementing Protein
% 216.78/216.98  |- skos__broader mesh__D052241smesh__D010750
% 216.78/216.98  |- skos__scopeNote mesh__D052241
% 216.78/216.98       A Fanconi anemia complementation group protein that undergoes PHOSPHORYLATION by CDC2 PROTEIN KINASE during MITOSIS. It forms a complex with other FANCONI ANEMIA PROTEINS and helps protect CELLS from DNA DAMAGE by genotoxic agents.%A%    
% 216.78/216.98  |- skos__hiddenLabel mesh__D052241
% 216.78/216.98       X Ray Repair Complementing Defective Repair In Chinese Hamster Cells 9 Protein
% 216.78/216.98  |- mesh__recordAuthorizer mesh__D052241 sjn
% 216.78/216.98  |- skos__altLabel mesh__D052241 Fanconi Anemia Group G Protein
% 216.78/216.98  |- mesh__dateCreated mesh__D052241 2005-06-30
% 216.78/216.98  |- rdf__type mesh__D052241sskos__Concept
% 216.78/216.98  |- mesh__recordMaintainer mesh__D052241 DRC
% 216.78/216.98  |- skos__altLabel mesh__D052241 FANCG Protein
% 216.78/216.98  |- skos__broader mesh__D052241smesh__D051856
% 216.78/216.98  |- mesh__historyNote mesh__D052241 2006%28%1997%29%   
% 216.78/216.98  |- skos__altLabel mesh__D052241
% 216.78/216.98       X-Ray Repair Complementing Defective Repair In Chinese Hamster Cells 9 Protein
% 216.78/216.98  |- mesh__recordOriginator mesh__D052241 DRC
% 216.78/216.98  |- mesh__dateCreated mesh__D005396 1999-01-01
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D005396 2006
% 216.78/216.98  |- skos__hiddenLabel mesh__D005396 Products, Fish
% 216.78/216.98  |- mesh__recordMaintainer mesh__D005396 JLS
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D005396 2005
% 216.78/216.98  |- skos__scopeNote mesh__D005396
% 216.78/216.98       Food products manufactured from fish %28%e.g., FISH FLOUR, fish meal%29%.%A%    
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D005396 2004
% 216.78/216.98  |- mesh__publicMeSHNote mesh__D005396 68   
% 216.78/216.98  |- skos__broader mesh__D005396smesh__D017747
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D005396 2002
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D005396 2003
% 216.78/216.98  |- skos__historyNote mesh__D005396 Fishes %28%1966-1967%29%
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D005396 1999
% 216.78/216.98  |- rdf__type mesh__D005396sskos__Concept
% 216.78/216.98  |- skos__annotation mesh__D005396
% 216.78/216.98       %22%food products manufactured from fish %28%e.g., FISH FLOUR, fish meal%29%%22% but for canned fish coord FISHES %28%IM%29% or specific fish %28%IM%29% + FOOD PRESERVATION %28%IM%29%; coord IM with fish source %28%NIM%29%%A%  
% 216.78/216.98  |- mesh__dateRevised mesh__D005396 1997-06-20
% 216.78/216.98  |- mesh__dateEstablished mesh__D005396 1968-01-01
% 216.78/216.98  |- mesh__recordAuthorizer mesh__D005396 SJN
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D005396 2001
% 216.78/216.98  |- mesh__recordOriginator mesh__D005396 NLM
% 216.78/216.98  |- skos__hiddenLabel mesh__D005396 Fish Product
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D005396 2000
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D005396 1998
% 216.78/216.98  |- mesh__historyNote mesh__D005396 68   
% 216.78/216.98  |- skos__hiddenLabel mesh__D005396 Product, Fish
% 216.78/216.98  |- skos__prefLabel mesh__D005396 Fish Products
% 216.78/216.98  |- skos__altLabel mesh__D013828 Amithiozone
% 216.78/216.98  |- skos__altLabel mesh__D013828 Thiacetazone
% 216.78/216.98  |- skos__altLabel mesh__D013828 Thioacetazon
% 216.78/216.98  |- skos__altLabel mesh__D013828 TBI-698
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D013828 2005
% 216.78/216.98  |- mesh__dateRevised mesh__D013828 2000-06-21
% 216.78/216.98  |- skos__hiddenLabel mesh__D013828 TB I698
% 216.78/216.98  |- skos__scopeNote mesh__D013828
% 216.78/216.98       A thiosemicarbazone that is used in association with other antimycobacterial agents in the initial and continuation phases of antituberculosis regimens. Thiacetazone containing regimens are less effective than the short-course regimen recommended by the International Union Against Tuberculosis and are used in some developing countries to reduce drug costs. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p217%29%%A%    
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D013828 2003
% 216.78/216.98  |- mesh__historyNote mesh__D013828
% 216.78/216.98       96; was THIACETAZONE 1963-95 %28%Prov 1963-67%29%; THIOACETAZON was see THIACETAZONE 1977-95%A%  
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D013828 2006
% 216.78/216.98  |- mesh__recordMaintainer mesh__D013828 CCR
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D013828 2001
% 216.78/216.98  |- skos__prefLabel mesh__D013828 Thioacetazone
% 216.78/216.98  |- rdf__type mesh__D013828sskos__Concept
% 216.78/216.98  |- mesh__dateEstablished mesh__D013828 1968-01-01
% 216.78/216.98  |- mesh__recordAuthorizer mesh__D013828 sjn
% 216.78/216.98  |- mesh__recordOriginator mesh__D013828 NLM
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D013828 2004
% 216.78/216.98  |- skos__broader mesh__D013828smesh__D013882
% 216.78/216.98  |- mesh__activeMeSHYear mesh__D013828 2002
% 216.78/216.98  |- skos__hiddenLabel mesh__D013828 TB I 698
% 216.78/216.98  |- mesh__dateCreated mesh__D013828 1999-01-01
% 216.78/216.98  |- skos__hiddenLabel mesh__D013828 TBI 698
% 216.78/216.98  |- mesh__publicMeSHNote mesh__D013828
% 216.78/216.98       96; was THIACETAZONE 1968-95; THIOACETAZON was see THIACETAZONE 1977-95%A%  
% 216.78/216.99  |- skos__hiddenLabel mesh__D013828 TBI698
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D010530 2001
% 216.78/216.99  |- mesh__historyNote mesh__D010530 66%28%64%29%   
% 216.78/216.99  |- skos__related mesh__D010530smesh__D007688
% 216.78/216.99  |- mesh__dateEstablished mesh__D010530 1966-01-01
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D010530 2004
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D010530 2005
% 216.78/216.99  |- mesh__publicMeSHNote mesh__D010530 66   
% 216.78/216.99  |- skos__hiddenLabel mesh__D010530 Dialyses, Peritoneal
% 216.78/216.99  |- mesh__recordAuthorizer mesh__D010530 sjn
% 216.78/216.99  |- mesh__recordOriginator mesh__D010530 NLM
% 216.78/216.99  |- skos__broader mesh__D010530smesh__D006435
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D010530 2003
% 216.78/216.99  |- rdf__type mesh__D010530sskos__Concept
% 216.78/216.99  |- skos__hiddenLabel mesh__D010530 Dialysis, Peritoneal
% 216.78/216.99  |- mesh__dateRevised mesh__D010530 2000-06-22
% 216.78/216.99  |- skos__hiddenLabel mesh__D010530 Peritoneal Dialyses
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D010530 2002
% 216.78/216.99  |- mesh__dateCreated mesh__D010530 1999-01-01
% 216.78/216.99  |- skos__scopeNote mesh__D010530
% 216.78/216.99       Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure.%A%    
% 216.78/216.99  |- skos__prefLabel mesh__D010530 Peritoneal Dialysis
% 216.78/216.99  |- skos__related mesh__D010530smesh__D015314
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D010530 2006
% 216.78/216.99  |- mesh__recordMaintainer mesh__D010530 RAZ
% 216.78/216.99  |- mesh__historyNote mesh__D051149 2006%28%1982%29%   
% 216.78/216.99  |- mesh__recordAuthorizer mesh__D051149 ags
% 216.78/216.99  |- mesh__recordMaintainer mesh__D051149 ags
% 216.78/216.99  |- mesh__dateEstablished mesh__D051149 2006-01-01
% 216.78/216.99  |- rdf__type mesh__D051149sskos__Concept
% 216.78/216.99  |- mesh__dateCreated mesh__D051149 2005-06-30
% 216.78/216.99  |- mesh__dateRevised mesh__D051149 2005-07-08
% 216.78/216.99  |- mesh__recordOriginator mesh__D051149 DRC
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D051149 2006A
% 216.78/216.99  |- mesh__publicMeSHNote mesh__D051149
% 216.78/216.99       2006; SELENOPROTEIN P was indexed under PROTEINS 1989-2005, %26% under SELENIUM 1982-1992, %26% under CARRIER PROTEINS 1982-1988%A%  
% 216.78/216.99  |- skos__scopeNote mesh__D051149
% 216.78/216.99       An extracellular selenoprotein that contains most of the SELENIUM in PLASMA. Selenoprotein P functions as an antioxidant and appears to transport selenium from the LIVER to peripheral tissues.%A%    
% 216.78/216.99  |- skos__broader mesh__D051149smesh__D051140
% 216.78/216.99  |- skos__prefLabel mesh__D051149 Selenoprotein P
% 216.78/216.99  |- skos__altLabel mesh__D051149 SelP Protein
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D051149 2006
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D009787 2001
% 216.78/216.99  |- skos__related mesh__D009787smesh__D009784
% 216.78/216.99  |- skos__altLabel mesh__D009787 Medicine, Industrial
% 216.78/216.99  |- skos__scopeNote mesh__D009787
% 216.78/216.99       Medical specialty concerned with the promotion and maintenance of the physical and mental health of employees in occupational settings.%A%    
% 216.78/216.99  |- rdf__type mesh__D009787sskos__Concept
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D009787 2004
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D009787 2000
% 216.78/216.99  |- mesh__publicMeSHNote mesh__D009787
% 216.78/216.99       79; was INDUSTRIAL MEDICINE 1963-78   
% 216.78/216.99  |- mesh__historyNote mesh__D009787 79; was INDUSTRIAL MEDICINE 1963-78   
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D009787 2003
% 216.78/216.99  |- skos__annotation mesh__D009787
% 216.78/216.99       SPEC: SPEC qualif; do not confuse with OCCUPATIONAL HEALTH, the health of the worker; Manual 31.14: relation to INDUSTRY %26% OCCUPATIONAL DISEASES; DF: OCCUP MED%A%  
% 216.78/216.99  |- mesh__recordOriginator mesh__D009787 NLM
% 216.78/216.99  |- skos__related mesh__D009787smesh__D009786
% 216.78/216.99  |- skos__broader mesh__D009787smesh__D011315
% 216.78/216.99  |- mesh__onlineNote mesh__D009787
% 216.78/216.99       use OCCUPATIONAL MEDICINE to search INDUSTRIAL MEDICINE 1966-78%A%  
% 216.78/216.99  |- mesh__recordMaintainer mesh__D009787 kle
% 216.78/216.99  |- mesh__recordAuthorizer mesh__D009787 sjn
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D009787 2006
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D009787 2002
% 216.78/216.99  |- skos__related mesh__D009787smesh__D011482
% 216.78/216.99  |- skos__altLabel mesh__D009787 Medicine, Occupational
% 216.78/216.99  |- skos__altLabel mesh__D009787 Industrial Medicine
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D009787 2005
% 216.78/216.99  |- mesh__dateCreated mesh__D009787 1999-01-01
% 216.78/216.99  |- mesh__dateRevised mesh__D009787 1999-11-03
% 216.78/216.99  |- skos__prefLabel mesh__D009787 Occupational Medicine
% 216.78/216.99  |- skos__historyNote mesh__D028941 Coronavirus %28%1993-2001%29%
% 216.78/216.99  |- skos__broader mesh__D028941smesh__D017934
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D028941 2004
% 216.78/216.99  |- mesh__dateEstablished mesh__D028941 2002-01-01
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D028941 2003
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D028941 2006
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D028941 2002
% 216.78/216.99  |- skos__scopeNote mesh__D028941
% 216.78/216.99       A species in the genus CORONAVIRUS causing the common cold and possibly nervous system infections in humans. It lacks hemagglutinin-esterase.%A%    
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D028941 2005
% 216.78/216.99  |- skos__altLabel mesh__D028941 Human coronavirus 229E
% 216.78/216.99  |- rdf__type mesh__D028941sskos__Concept
% 216.78/216.99  |- skos__annotation mesh__D028941
% 216.78/216.99       infection: coord IM with CORONAVIRUS INFECTIONS %28%IM%29% + COMMON COLD %28%IM%29% if appropriate%A%  
% 216.78/216.99  |- mesh__dateCreated mesh__D028941 2001-07-25
% 216.78/216.99  |- skos__prefLabel mesh__D028941 Coronavirus 229E, Human
% 216.78/216.99  |- mesh__historyNote mesh__D028941 2002   
% 216.78/216.99  |- mesh__publicMeSHNote mesh__D028941 2002   
% 216.78/216.99  |- rdf__type mesh__D028143sskos__Concept
% 216.78/216.99  |- mesh__dateEstablished mesh__D028143 2002-01-01
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D028143 2006
% 216.78/216.99  |- mesh__recordAuthorizer mesh__D028143 sjn
% 216.78/216.99  |- skos__scopeNote mesh__D028143
% 216.78/216.99       A plant genus in the family BERBERIDACEAE. Oregon Grape was discovered in North America and classified by Pursh as a BERBERIS but Nuttall claimed it is different enough to call it a new genus, MAHONIA.  Now botanists insist on Berberis while horticulturists stay with this genus.  It is a source of BERBERINE.%A%    
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D028143 2005
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D028143 2004
% 216.78/216.99  |- skos__altLabel mesh__D028143 Barberry, Hollyleaved
% 216.78/216.99  |- mesh__dateCreated mesh__D028143 2001-07-25
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D028143 2003
% 216.78/216.99  |- skos__altLabel mesh__D028143 Hollyleaved Barberry
% 216.78/216.99  |- skos__prefLabel mesh__D028143 Mahonia
% 216.78/216.99  |- mesh__recordOriginator mesh__D028143 ssb
% 216.78/216.99  |- skos__historyNote mesh__D028143 Plants, Medicinal %28%1966-2001%29%
% 216.78/216.99  |- mesh__historyNote mesh__D028143 2002   
% 216.78/216.99  |- mesh__dateRevised mesh__D028143 2002-07-02
% 216.78/216.99  |- skos__broader mesh__D028143smesh__D028141
% 216.78/216.99  |- mesh__recordMaintainer mesh__D028143 ssb
% 216.78/216.99  |- skos__annotation mesh__D028143
% 216.78/216.99       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.78/216.99  |- mesh__publicMeSHNote mesh__D028143 2002   
% 216.78/216.99  |- skos__hiddenLabel mesh__D020160 Benzoate, Sodium
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D020160 2000
% 216.78/216.99  |- skos__scopeNote mesh__D020160
% 216.78/216.99       The sodium salt of BENZOIC ACID. It is used as an antifungal preservative in pharmaceutical preparations and foods. It may also be used as a test for liver function.%A%    
% 216.78/216.99  |- mesh__publicMeSHNote mesh__D020160
% 216.78/216.99       99; SODIUM BENZOATE was indexed under BENZOATES 1980-98   
% 216.78/216.99  |- skos__broader mesh__D020160smesh__D001565
% 216.78/216.99  |- skos__prefLabel mesh__D020160 Sodium Benzoate
% 216.78/216.99  |- mesh__dateCreated mesh__D020160 1998-06-11
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D020160 2004
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D020160 2002
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D020160 1999
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D020160 2003
% 216.78/216.99  |- skos__historyNote mesh__D020160 Benzoates %28%1980-1998%29%
% 216.78/216.99  |- mesh__historyNote mesh__D020160
% 216.78/216.99       99; for SODIUM BENZOATE use BENZOIC ACID %28%NM%29% 1980-98   
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D020160 2006
% 216.78/216.99  |- mesh__dateEstablished mesh__D020160 1999-01-01
% 216.78/216.99  |- rdf__type mesh__D020160sskos__Concept
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D020160 2001
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D020160 2005
% 216.78/216.99  |- rdf__type mesh__D014921sskos__Concept
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014921 1992
% 216.78/216.99  |- mesh__recordOriginator mesh__D014921 NLM
% 216.78/216.99  |- mesh__dateEstablished mesh__D014921 1968-01-01
% 216.78/216.99  |- skos__historyNote mesh__D014921 Birds %28%1966-1967%29%
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014921 2002
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014921 1999
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014921 1996
% 216.78/216.99  |- skos__annotation mesh__D014921 for bird, insect or bat   
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014921 1993
% 216.78/216.99  |- mesh__historyNote mesh__D014921 68   
% 216.78/216.99  |- mesh__dateRevised mesh__D014921 1978-11-07
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014921 2005
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014921 2000
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014921 1991
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014921 1997
% 216.78/216.99  |- mesh__dateCreated mesh__D014921 1999-01-01
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014921 1989
% 216.78/216.99  |- skos__prefLabel mesh__D014921 Wing
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014921 2006
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014921 2001
% 216.78/216.99  |- mesh__publicMeSHNote mesh__D014921 68   
% 216.78/216.99  |- skos__hiddenLabel mesh__D014921 Wings
% 216.78/216.99  |- mesh__recordMaintainer mesh__D014921 GJB
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014921 2003
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014921 1994
% 216.78/216.99  |- mesh__recordAuthorizer mesh__D014921 NLM
% 216.78/216.99  |- skos__broader mesh__D014921smesh__D005552
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014921 1998
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014921 2004
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014921 1990
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014921 1995
% 216.78/216.99  |- skos__broader mesh__D012723Q000193smesh__D012723
% 216.78/216.99  |- mesh__preferredCombination mesh__D012723Q000193smesh__D012736
% 216.78/216.99  |- rdf__type mesh__D012723Q000193smesh__CompoundConcept
% 216.78/216.99  |- skos__altLabel mesh__D014123 Toxoplasma gondii Infection
% 216.78/216.99  |- mesh__recordOriginator mesh__D014123 NLM
% 216.78/216.99  |- mesh__recordAuthorizer mesh__D014123 sjn
% 216.78/216.99  |- rdf__type mesh__D014123sskos__Concept
% 216.78/216.99  |- mesh__dateCreated mesh__D014123 1999-01-01
% 216.78/216.99  |- skos__scopeNote mesh__D014123
% 216.78/216.99       The acquired form of infection by Toxoplasma gondii in animals and man.%A%    
% 216.78/216.99  |- skos__hiddenLabel mesh__D014123 Toxoplasmoses
% 216.78/216.99  |- mesh__recordMaintainer mesh__D014123 TGC
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014123 2002
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014123 2004
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014123 2001
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014123 2006
% 216.78/216.99  |- skos__annotation mesh__D014123 GEN or unspecified; prefer specifics   
% 216.78/216.99  |- skos__altLabel mesh__D014123 Infection, Toxoplasma gondii
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014123 2003
% 216.78/216.99  |- skos__hiddenLabel mesh__D014123 Toxoplasma gondii Infections
% 216.78/216.99  |- skos__hiddenLabel mesh__D014123 Infections, Toxoplasma gondii
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014123 2005
% 216.78/216.99  |- skos__prefLabel mesh__D014123 Toxoplasmosis
% 216.78/216.99  |- mesh__dateRevised mesh__D014123 2000-06-22
% 216.78/216.99  |- skos__broader mesh__D014123smesh__D003048
% 216.78/216.99  |- rdf__type mesh__D000103sskos__Concept
% 216.78/216.99  |- skos__scopeNote mesh__D000103
% 216.78/216.99       A carboxylating enzyme that catalyzes the conversion of ATP, acetyl-CoA, and HCO3- to ADP, orthophosphate, and malonyl-CoA. It is a biotinyl-protein that also catalyzes transcarboxylation. The plant enzyme also carboxylates propanoyl-CoA and butanoyl-CoA %28%From Enzyme Nomenclature, 1992%29% EC 6.4.1.2.%A%    
% 216.78/216.99  |- mesh__dateEstablished mesh__D000103 1991-01-01
% 216.78/216.99  |- mesh__publicMeSHNote mesh__D000103 91; was see under LIGASES 1973-90   
% 216.78/216.99  |- mesh__dateRevised mesh__D000103 2003-07-09
% 216.78/216.99  |- skos__hiddenLabel mesh__D000103 Acetyl CoA Carboxylase
% 216.78/216.99  |- skos__prefLabel mesh__D000103 Acetyl-CoA Carboxylase
% 216.78/216.99  |- mesh__historyNote mesh__D000103
% 216.78/216.99       91%28%73%29%; was see under LIGASES 1973-90   
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D000103 2004
% 216.78/216.99  |- mesh__recordOriginator mesh__D000103 NLM
% 216.78/216.99  |- skos__hiddenLabel mesh__D000103 Carboxylase, Acetyl-CoA
% 216.78/216.99  |- mesh__dateCreated mesh__D000103 1999-01-01
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D000103 2005
% 216.78/216.99  |- skos__altLabel mesh__D000103 Acetyl Coenzyme A Carboxylase
% 216.78/216.99  |- skos__broader mesh__D000103smesh__D019735
% 216.78/216.99  |- mesh__recordMaintainer mesh__D000103 ssb
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D000103 2006
% 216.78/216.99  |- mesh__recordAuthorizer mesh__D000103 sjn
% 216.78/216.99  |- skos__altLabel mesh__D052242 ACRP30 Protein
% 216.78/216.99  |- skos__altLabel mesh__D052242 apM-1 Protein
% 216.78/216.99  |- skos__hiddenLabel mesh__D052242 apM 1 Protein
% 216.78/216.99  |- skos__hiddenLabel mesh__D052242
% 216.78/216.99       Adipocyte Complement Related Protein 30 kDa
% 216.78/216.99  |- mesh__recordOriginator mesh__D052242 lkt
% 216.78/216.99  |- skos__scopeNote mesh__D052242
% 216.78/216.99       A 30-kDa COMPLEMENT C1Q-related protein, the most abundant gene product secreted by FAT CELLS of the white ADIPOSE TISSUE. Adiponectin modulates several physiological processes, such as metabolism of GLUCOSE and FATTY ACIDS, and immune responses. Decreased plasma adiponectin levels are associated with INSULIN RESISTANCE; TYPE 2 DIABETES MELLITUS; OBESITY; and ATHEROSCLEROSIS.%A%    
% 216.78/216.99  |- skos__prefLabel mesh__D052242 Adiponectin
% 216.78/216.99  |- skos__hiddenLabel mesh__D052242 Protein, ACRP30
% 216.78/216.99  |- mesh__recordMaintainer mesh__D052242 lkt
% 216.78/216.99  |- skos__hiddenLabel mesh__D052242 Protein, apM-1
% 216.78/216.99  |- mesh__dateEstablished mesh__D052242 2006-01-01
% 216.78/216.99  |- rdf__type mesh__D052242sskos__Concept
% 216.78/216.99  |- mesh__publicMeSHNote mesh__D052242
% 216.78/216.99       2006; ADIPONECTIN was indexed under INTRACELULAR SIGNALING PEPTIDES AND PROTEINS 1996-2005%A%  
% 216.78/216.99  |- skos__broader mesh__D052242smesh__D036361
% 216.78/216.99  |- mesh__recordAuthorizer mesh__D052242 sjn
% 216.78/216.99  |- mesh__historyNote mesh__D052242 2006 %28%1996%29%   
% 216.78/216.99  |- mesh__dateCreated mesh__D052242 2005-06-30
% 216.78/216.99  |- skos__altLabel mesh__D052242 Adipose Most Abundant Gene Transcript 1
% 216.78/216.99  |- skos__altLabel mesh__D052242 Adipocyte Complement-Related Protein 30-kDa
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D052242 2006
% 216.78/216.99  |- skos__altLabel mesh__D052242
% 216.78/216.99       Adipocyte, C1q and Collagen Domain Containing Protein
% 216.78/216.99  |- mesh__recordOriginator mesh__D005397 SH
% 216.78/216.99  |- skos__scopeNote mesh__D005397
% 216.78/216.99       Venoms produced by FISHES, including SHARKS and sting rays, usually delivered by spines. They contain various substances, including very labile toxins that affect the HEART specifically and all MUSCLES generally.%A%    
% 216.78/216.99  |- mesh__dateRevised mesh__D005397 2005-06-30
% 216.78/216.99  |- skos__hiddenLabel mesh__D005397 Venoms, Fish
% 216.78/216.99  |- skos__prefLabel mesh__D005397 Fish Venoms
% 216.78/216.99  |- skos__annotation mesh__D005397
% 216.78/216.99       /antag permitted but consider also ANTIVENINS   
% 216.78/216.99  |- mesh__historyNote mesh__D005397 78   
% 216.78/216.99  |- skos__hiddenLabel mesh__D005397 Venom, Fish
% 216.78/216.99  |- mesh__recordAuthorizer mesh__D005397 sjn
% 216.78/216.99  |- skos__altLabel mesh__D005397 Fish Venom
% 216.78/216.99  |- skos__broader mesh__D005397smesh__D014688
% 216.78/216.99  |- skos__historyNote mesh__D005397 Venoms %28%1966-1977%29%
% 216.78/216.99  |- mesh__dateEstablished mesh__D005397 1978-01-01
% 216.78/216.99  |- mesh__recordMaintainer mesh__D005397 ssb
% 216.78/216.99  |- rdf__type mesh__D005397sskos__Concept
% 216.78/216.99  |- skos__broader mesh__D005397smesh__D008387
% 216.78/216.99  |- mesh__dateCreated mesh__D005397 1977-04-22
% 216.78/216.99  |- mesh__publicMeSHNote mesh__D005397 78   
% 216.78/216.99  |- skos__historyNote mesh__D005397 Fishes %28%1966-1977%29%
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D005397 2006
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D013829 2006
% 216.78/216.99  |- mesh__recordMaintainer mesh__D013829 ssb
% 216.78/216.99  |- mesh__historyNote mesh__D013829
% 216.78/216.99       91%28%71%29%; was see under THIAZINES 1971-90   
% 216.78/216.99  |- skos__broader mesh__D013829smesh__D013843
% 216.78/216.99  |- rdf__type mesh__D013829sskos__Concept
% 216.78/216.99  |- mesh__dateRevised mesh__D013829 2005-06-30
% 216.78/216.99  |- mesh__dateCreated mesh__D013829 1999-01-01
% 216.78/216.99  |- mesh__dateEstablished mesh__D013829 1991-01-01
% 216.78/216.99  |- skos__prefLabel mesh__D013829 Thiadiazines
% 216.78/216.99  |- mesh__recordAuthorizer mesh__D013829 sjn
% 216.78/216.99  |- mesh__recordOriginator mesh__D013829 NLM
% 216.78/216.99  |- mesh__publicMeSHNote mesh__D013829
% 216.78/216.99       91; was see under THIAZINES 1971-90   
% 216.78/216.99  |- skos__historyNote mesh__D013829 Heterocyclic Compounds %28%1966-1970%29%
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D018514 1998
% 216.78/216.99  |- skos__prefLabel mesh__D018514 Plant Components
% 216.78/216.99  |- mesh__dateRevised mesh__D018514 1997-06-20
% 216.78/216.99  |- mesh__recordMaintainer mesh__D018514 TGC
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D018514 2000
% 216.78/216.99  |- skos__scopeNote mesh__D018514
% 216.78/216.99       The anatomical components of a plant, including SEEDS.     
% 216.78/216.99  |- mesh__recordAuthorizer mesh__D018514 SJN
% 216.78/216.99  |- skos__historyNote mesh__D018514
% 216.78/216.99       specific plant/anatomy %26% histology %28%1966-1997%29%
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D018514 2004
% 216.78/216.99  |- skos__broader mesh__D018514smesh__D010944
% 216.78/216.99  |- skos__historyNote mesh__D018514
% 216.78/216.99       Plants/anatomy %26% histology %28%1966-1997%29%
% 216.78/216.99  |- mesh__dateCreated mesh__D018514 1994-05-24
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D018514 2006
% 216.78/216.99  |- mesh__dateEstablished mesh__D018514 1998-01-01
% 216.78/216.99  |- mesh__publicMeSHNote mesh__D018514 98   
% 216.78/216.99  |- skos__annotation mesh__D018514
% 216.78/216.99       GEN or unspecified; prefer specific anat part   
% 216.78/216.99  |- mesh__recordOriginator mesh__D018514 JLS
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D018514 2003
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D018514 2005
% 216.78/216.99  |- skos__altLabel mesh__D018514 Plant Structures
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D018514 2002
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D018514 1999
% 216.78/216.99  |- rdf__type mesh__D018514sskos__Concept
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D018514 2001
% 216.78/216.99  |- mesh__historyNote mesh__D018514 98; use explode 1995-97   
% 216.78/216.99  |- skos__historyNote mesh__D010531 Peritoneal Dialysis %28%1978-1981%29%
% 216.78/216.99  |- skos__scopeNote mesh__D010531
% 216.78/216.99       Portable peritoneal dialysis using the continuous %28%24 hours a day, 7 days a week%29% presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution.%A%    
% 216.78/216.99  |- skos__altLabel mesh__D010531 CAPD
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D010531 2006
% 216.78/216.99  |- mesh__recordAuthorizer mesh__D010531 sjn
% 216.78/216.99  |- skos__broader mesh__D010531smesh__D000553
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D010531 2004
% 216.78/216.99  |- mesh__recordOriginator mesh__D010531 SMH
% 216.78/216.99  |- skos__prefLabel mesh__D010531 Peritoneal Dialysis, Continuous Ambulatory
% 216.78/216.99  |- mesh__historyNote mesh__D010531
% 216.78/216.99       86%28%82%29%; was see under PERITONEAL DIALYSIS 1982-85   
% 216.78/216.99  |- mesh__dateCreated mesh__D010531 1981-03-02
% 216.78/216.99  |- mesh__publicMeSHNote mesh__D010531
% 216.78/216.99       86; was see under PERITONEAL DIALYSIS 1982-85   
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D010531 2005
% 216.78/216.99  |- mesh__recordMaintainer mesh__D010531 PXP
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D010531 2003
% 216.78/216.99  |- skos__broader mesh__D010531smesh__D010530
% 216.78/216.99  |- rdf__type mesh__D010531sskos__Concept
% 216.78/216.99  |- mesh__dateRevised mesh__D010531 2000-06-22
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D010531 2002
% 216.78/216.99  |- skos__altLabel mesh__D010531 Continuous Ambulatory Peritoneal Dialysis
% 216.78/216.99  |- mesh__dateEstablished mesh__D010531 1986-01-01
% 216.78/216.99  |- skos__historyNote mesh__D010531 Ambulatory Care %28%1978-1981%29%
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D010531 2001
% 216.78/216.99  |- skos__prefLabel mesh__D009788 Occupational Therapy
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D009788 1999
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D009788 2002
% 216.78/216.99  |- skos__altLabel mesh__D009788 Therapy, Occupational
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D009788 2003
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D009788 1998
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D009788 2001
% 216.78/216.99  |- mesh__recordAuthorizer mesh__D009788 PLS
% 216.78/216.99  |- skos__broader mesh__D009788smesh__D016390
% 216.78/216.99  |- skos__scopeNote mesh__D009788
% 216.78/216.99       The field concerned with utilizing craft or work activities in the rehabilitation of patients. Occupational therapy can also refer to the activities themselves.%A%    
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D009788 1997
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D009788 2000
% 216.78/216.99  |- skos__broader mesh__D009788smesh__D012046
% 216.78/216.99  |- skos__hiddenLabel mesh__D009788 Occupational Therapies
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D009788 2006
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D009788 1996
% 216.78/216.99  |- mesh__recordOriginator mesh__D009788 NLM
% 216.78/216.99  |- mesh__dateCreated mesh__D009788 1999-01-01
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D009788 2005
% 216.78/216.99  |- mesh__dateRevised mesh__D009788 1995-05-18
% 216.78/216.99  |- skos__annotation mesh__D009788
% 216.78/216.99       SPEC: SPEC qualif; /nurs /psychol permitted; do not use /util except by MeSH definition; coord IM with dis /rehabil %28%IM%29%, not /ther; DF: OCCUP THER%A%  
% 216.78/216.99  |- mesh__recordMaintainer mesh__D009788 KEV
% 216.78/216.99  |- rdf__type mesh__D009788sskos__Concept
% 216.78/216.99  |- skos__hiddenLabel mesh__D009788 Therapies, Occupational
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D009788 2004
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D034181 2004
% 216.78/216.99  |- skos__scopeNote mesh__D034181
% 216.78/216.99       A plant genus of the family BERBERIDACEAE which is used in DRUGS, CHINESE HERBAL. Members contain flavonol glycosides including epimedins, icariin and noricariin.%A%    
% 216.78/216.99  |- mesh__dateEstablished mesh__D034181 2003-01-01
% 216.78/216.99  |- rdf__type mesh__D034181sskos__Concept
% 216.78/216.99  |- mesh__dateCreated mesh__D034181 2002-07-03
% 216.78/216.99  |- mesh__historyNote mesh__D034181 2003   
% 216.78/216.99  |- mesh__publicMeSHNote mesh__D034181 2003   
% 216.78/216.99  |- skos__prefLabel mesh__D034181 Epimedium
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D034181 2005
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D034181 2003
% 216.78/216.99  |- skos__broader mesh__D034181smesh__D028141
% 216.78/216.99  |- skos__annotation mesh__D034181
% 216.78/216.99       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D034181 2006
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D028144 2005
% 216.78/216.99  |- skos__prefLabel mesh__D028144 Podophyllum peltatum
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D028144 2004
% 216.78/216.99  |- skos__altLabel mesh__D028144 May Apple
% 216.78/216.99  |- skos__altLabel mesh__D028144 Mandrake, American
% 216.78/216.99  |- mesh__recordMaintainer mesh__D028144 ags
% 216.78/216.99  |- skos__broader mesh__D028144smesh__D011035
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D028144 2002
% 216.78/216.99  |- skos__historyNote mesh__D028144 Podophyllum %28%1985-2001%29%
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D028144 2003
% 216.78/216.99  |- skos__scopeNote mesh__D028144
% 216.78/216.99       A plant of the genus PODOPHYLLUM, family BERBERIDACEAE %28%sometimes classified as Podophyllaceae%29%  which is the source of PODOPHYLLIN and of PODOPHYLLOTOXIN that inhibits DNA TOPOISOMERASES, TYPE II.  It is different from the European mandrake, MANDRAGORA.%A%    
% 216.78/216.99  |- mesh__historyNote mesh__D028144
% 216.78/216.99       2002; for MANDRAKE, AMERICAN use Podophyllum 1985-2001   
% 216.78/216.99  |- mesh__recordAuthorizer mesh__D028144 ags
% 216.78/216.99  |- mesh__recordOriginator mesh__D028144 ssb
% 216.78/216.99  |- mesh__publicMeSHNote mesh__D028144
% 216.78/216.99       2002; for MANDRAKE, AMERICAN see Podophyllum 1985-2001   
% 216.78/216.99  |- skos__annotation mesh__D028144
% 216.78/216.99       do not confuse X refs MANDRAKE, AMERICAN with MANDRAKE, EUROPEAN see MANDRAGORA;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.78/216.99  |- mesh__dateCreated mesh__D028144 2001-07-25
% 216.78/216.99  |- mesh__dateRevised mesh__D028144 2005-07-13
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D028144 2006A
% 216.78/216.99  |- rdf__type mesh__D028144sskos__Concept
% 216.78/216.99  |- mesh__dateEstablished mesh__D028144 2002-01-01
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D028144 2006
% 216.78/216.99  |- skos__broader mesh__D006490smesh__D003029
% 216.78/216.99  |- mesh__recordMaintainer mesh__D006490 ssb
% 216.78/216.99  |- rdf__type mesh__D006490sskos__Concept
% 216.78/216.99  |- mesh__recordOriginator mesh__D006490 NLM
% 216.78/216.99  |- skos__related mesh__D006490smesh__D014662
% 216.78/216.99  |- skos__prefLabel mesh__D006490 Hemostatics
% 216.78/216.99  |- mesh__recordAuthorizer mesh__D006490 sjn
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D006490 2006
% 216.78/216.99  |- mesh__dateRevised mesh__D006490 2005-06-30
% 216.78/216.99  |- mesh__dateCreated mesh__D006490 1999-01-01
% 216.78/216.99  |- skos__scopeNote mesh__D006490
% 216.78/216.99       Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure.%A%    
% 216.78/216.99  |- skos__prefLabel mesh__D020161 Physical Chromosome Mapping
% 216.78/216.99  |- mesh__recordAuthorizer mesh__D020161 sjn
% 216.78/216.99  |- mesh__recordOriginator mesh__D020161 NDW
% 216.78/216.99  |- mesh__dateRevised mesh__D020161 1999-11-03
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D020161 2000
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D020161 2003
% 216.78/216.99  |- skos__broader mesh__D020161smesh__D002874
% 216.78/216.99  |- skos__hiddenLabel mesh__D020161 Mapping, Physical Chromosome
% 216.78/216.99  |- skos__historyNote mesh__D020161 Chromosome Mapping %28%1968-1998%29%
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D020161 2001
% 216.78/216.99  |- skos__hiddenLabel mesh__D020161 Mappings, Physical Chromosome
% 216.78/216.99  |- mesh__publicMeSHNote mesh__D020161
% 216.78/216.99       99; for PHYSICAL MAPPING %28%GENETICS%29% see RESTRICTION MAPPING 1997-98%A%  
% 216.78/216.99  |- mesh__dateEstablished mesh__D020161 1999-01-01
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D020161 2004
% 216.78/216.99  |- skos__hiddenLabel mesh__D020161 Physical Mappings %28%Genetics%29%
% 216.78/216.99  |- skos__hiddenLabel mesh__D020161 Chromosome Mappings, Physical
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D020161 2002
% 216.78/216.99  |- mesh__recordMaintainer mesh__D020161 ags
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D020161 2005
% 216.78/216.99  |- skos__altLabel mesh__D020161 Physical Mapping %28%Genetics%29%
% 216.78/216.99  |- rdf__type mesh__D020161sskos__Concept
% 216.78/216.99  |- mesh__historyNote mesh__D020161
% 216.78/216.99       99; for PHYSICAL MAPPING %28%GENETICS%29% use RESTRICTION MAPPING 1997-98%A%  
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D020161 2006
% 216.78/216.99  |- mesh__dateCreated mesh__D020161 1998-06-10
% 216.78/216.99  |- skos__scopeNote mesh__D020161
% 216.78/216.99       Mapping of the linear order of genes on a chromosome with units indicating their distances by using methods other than genetic recombination. These methods include nucleotide sequencing, overlapping deletions in polytene chromosomes, and electron micrography of heteroduplex DNA. %28%From King %26% Stansfield, A Dictionary of Genetics, 5th ed%29%%A%    
% 216.78/216.99  |- skos__altLabel mesh__D020161 Chromosome Mapping, Physical
% 216.78/216.99  |- skos__hiddenLabel mesh__D020161 Physical Chromosome Mappings
% 216.78/216.99  |- skos__prefLabel mesh__D014922 Wisconsin
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014922 2005
% 216.78/216.99  |- mesh__recordAuthorizer mesh__D014922 SJN
% 216.78/216.99  |- mesh__recordOriginator mesh__D014922 NLM
% 216.78/216.99  |- mesh__dateCreated mesh__D014922 1999-01-01
% 216.78/216.99  |- mesh__activeMeSHYear mesh__D014922 2002
% 216.78/216.99  |- skos__broader mesh__D014922smesh__D015146
% 216.78/216.99  |- skos__broader mesh__D014922smesh__D006114
% 216.78/216.99  |- mesh__recordMaintainer mesh__D014922 PXP
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014922 2006
% 216.78/217.00  |- mesh__dateRevised mesh__D014922 1997-06-20
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014922 2003
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014922 2000
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014922 1998
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014922 2004
% 216.78/217.00  |- rdf__type mesh__D014922sskos__Concept
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014922 2001
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014922 1999
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014124 2001
% 216.78/217.00  |- skos__broader mesh__D014124smesh__D011529
% 216.78/217.00  |- skos__annotation mesh__D014124
% 216.78/217.00       exper or vet; /congen permitted: do not coord with TOXOPLASMOSIS, CONGENITAL%A%  
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014124 2004
% 216.78/217.00  |- mesh__recordMaintainer mesh__D014124 TGC
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014124 2006
% 216.78/217.00  |- skos__hiddenLabel mesh__D014124 Animal Toxoplasmosis
% 216.78/217.00  |- skos__prefLabel mesh__D014124 Toxoplasmosis, Animal
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014124 2003
% 216.78/217.00  |- skos__broader mesh__D014124smesh__D014123
% 216.78/217.00  |- mesh__recordOriginator mesh__D014124 NLM
% 216.78/217.00  |- skos__scopeNote mesh__D014124
% 216.78/217.00       Acquired infection of non-human animals by organisms of the genus TOXOPLASMA.%A%    
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014124 2005
% 216.78/217.00  |- mesh__dateRevised mesh__D014124 2000-06-21
% 216.78/217.00  |- mesh__recordAuthorizer mesh__D014124 sjn
% 216.78/217.00  |- skos__hiddenLabel mesh__D014124 Toxoplasmoses, Animal
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014124 2002
% 216.78/217.00  |- rdf__type mesh__D014124sskos__Concept
% 216.78/217.00  |- mesh__dateCreated mesh__D014124 1999-01-01
% 216.78/217.00  |- skos__hiddenLabel mesh__D014124 Animal Toxoplasmoses
% 216.78/217.00  |- mesh__dateRevised mesh__D000902 2003-07-09
% 216.78/217.00  |- mesh__dateEstablished mesh__D000902 1967-01-01
% 216.78/217.00  |- mesh__recordAuthorizer mesh__D000902 sjn
% 216.78/217.00  |- mesh__recordMaintainer mesh__D000902 ssb
% 216.78/217.00  |- skos__broader mesh__D000902smesh__D000935
% 216.78/217.00  |- mesh__historyNote mesh__D000902 67   
% 216.78/217.00  |- skos__historyNote mesh__D000902 Antibiotics %28%1966%29%
% 216.78/217.00  |- mesh__dateCreated mesh__D000902 1999-01-01
% 216.78/217.00  |- mesh__publicMeSHNote mesh__D000902 67   
% 216.78/217.00  |- skos__hiddenLabel mesh__D000902 Antifungal Antibiotics
% 216.78/217.00  |- skos__prefLabel mesh__D000902 Antibiotics, Antifungal
% 216.78/217.00  |- rdf__type mesh__D000902sskos__Concept
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D000902 2004
% 216.78/217.00  |- mesh__recordOriginator mesh__D000902 NLM
% 216.78/217.00  |- skos__historyNote mesh__D000902 Antifungal Agents %28%1966%29%
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D000902 2005
% 216.78/217.00  |- skos__scopeNote mesh__D000902
% 216.78/217.00       Antibiotics inhibiting the growth of or killing fungi and used in the treatment of various fungal diseases.%A%    
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D000902 2006
% 216.78/217.00  |- skos__hiddenLabel mesh__D000104 Acetyl CoA Acylase
% 216.78/217.00  |- skos__hiddenLabel mesh__D000104 Acetyl CoA Deacylase
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D000104 2006
% 216.78/217.00  |- skos__broader mesh__D000104smesh__D013869
% 216.78/217.00  |- mesh__historyNote mesh__D000104
% 216.78/217.00       91%28%78%29%; was see under THIOLESTER HYDROLASES 1978-90   
% 216.78/217.00  |- rdf__type mesh__D000104sskos__Concept
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D000104 2005
% 216.78/217.00  |- skos__altLabel mesh__D000104 Acetyl-CoA Deacylase
% 216.78/217.00  |- mesh__recordAuthorizer mesh__D000104 sjn
% 216.78/217.00  |- skos__prefLabel mesh__D000104 Acetyl-CoA Hydrolase
% 216.78/217.00  |- skos__hiddenLabel mesh__D000104 Deacylase, Acetyl-CoA
% 216.78/217.00  |- skos__scopeNote mesh__D000104
% 216.78/217.00       An enzyme that catalyzes reversibly the hydrolysis of acetyl-CoA to yield CoA and acetate. The enzyme is involved in the oxidation of fatty acids. EC 3.1.2.1.%A%    
% 216.78/217.00  |- mesh__publicMeSHNote mesh__D000104
% 216.78/217.00       91; was see under THIOLESTER HYDROLASES 1978-90   
% 216.78/217.00  |- skos__hiddenLabel mesh__D000104 Acetyl CoA Hydrolase
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D000104 2004
% 216.78/217.00  |- skos__altLabel mesh__D000104 Acetyl Coenzyme A Hydrolase
% 216.78/217.00  |- skos__altLabel mesh__D000104 Acetyl-CoA Acylase
% 216.78/217.00  |- mesh__dateEstablished mesh__D000104 1991-01-01
% 216.78/217.00  |- skos__hiddenLabel mesh__D000104 Acylase, Acetyl-CoA
% 216.78/217.00  |- mesh__recordOriginator mesh__D000104 RLS
% 216.78/217.00  |- skos__hiddenLabel mesh__D000104 Hydrolase, Acetyl-CoA
% 216.78/217.00  |- mesh__dateRevised mesh__D000104 2003-07-09
% 216.78/217.00  |- skos__historyNote mesh__D000104 Thiolester Hydrolases %28%1973-1977%29%
% 216.78/217.00  |- mesh__dateCreated mesh__D000104 1977-05-17
% 216.78/217.00  |- mesh__recordMaintainer mesh__D000104 ssb
% 216.78/217.00  |- skos__broader mesh__D005165Q000172smesh__D005165
% 216.78/217.00  |- mesh__preferredCombination mesh__D005165Q000172smesh__D005166
% 216.78/217.00  |- rdf__type mesh__D005165Q000172smesh__CompoundConcept
% 216.78/217.00  |- mesh__historyNote mesh__D052243 2006 %28%2001%29%   
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D052243 2006
% 216.78/217.00  |- skos__scopeNote mesh__D052243
% 216.78/217.00       A 12-kDa cysteine-rich polypeptide hormone secreted by FAT CELLS in the ADIPOSE TISSUE. It is the founding member of the resistin-like molecule %28%RELM%29% hormone family. Resistin suppresses the ability of INSULIN to stimulate cellular GLUCOSE uptake.%A%    
% 216.78/217.00  |- mesh__recordOriginator mesh__D052243 lkt
% 216.78/217.00  |- mesh__publicMeSHNote mesh__D052243
% 216.78/217.00       2006; RESISTIN was indexed under HORMONES, ECTOPIC 2001-2005%A%  
% 216.78/217.00  |- rdf__type mesh__D052243sskos__Concept
% 216.78/217.00  |- skos__altLabel mesh__D052243
% 216.78/217.00       Adipocyte Cysteine-Rich Secreted Protein FIZZ3
% 216.78/217.00  |- mesh__recordMaintainer mesh__D052243 lkt
% 216.78/217.00  |- mesh__dateEstablished mesh__D052243 2006-01-01
% 216.78/217.00  |- skos__prefLabel mesh__D052243 Resistin
% 216.78/217.00  |- mesh__recordAuthorizer mesh__D052243 sjn
% 216.78/217.00  |- skos__broader mesh__D052243smesh__D036361
% 216.78/217.00  |- skos__hiddenLabel mesh__D052243
% 216.78/217.00       Adipocyte Cysteine Rich Secreted Protein FIZZ3
% 216.78/217.00  |- mesh__dateCreated mesh__D052243 2005-06-30
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D005398 2003
% 216.78/217.00  |- mesh__dateRevised mesh__D005398 1999-11-03
% 216.78/217.00  |- skos__broader mesh__D005398smesh__D017756
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D005398 2000
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D005398 2004
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D005398 2001
% 216.78/217.00  |- skos__scopeNote mesh__D005398
% 216.78/217.00       Places for cultivation and harvesting of fish, particularly in sea waters. %28%from McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 216.78/217.00  |- mesh__recordOriginator mesh__D005398 NLM
% 216.78/217.00  |- mesh__dateCreated mesh__D005398 1999-01-01
% 216.78/217.00  |- rdf__type mesh__D005398sskos__Concept
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D005398 2005
% 216.78/217.00  |- mesh__recordAuthorizer mesh__D005398 sjn
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D005398 2002
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D005398 2006
% 216.78/217.00  |- mesh__recordMaintainer mesh__D005398 kle
% 216.78/217.00  |- skos__prefLabel mesh__D005398 Fisheries
% 216.78/217.00  |- skos__annotation mesh__D005398 specify geog if pertinent   
% 216.78/217.00  |- skos__hiddenLabel mesh__D005398 Fishery
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D018515 2004
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D018515 2006
% 216.78/217.00  |- mesh__recordMaintainer mesh__D018515 PXP
% 216.78/217.00  |- mesh__recordOriginator mesh__D018515 JLS
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D018515 2003
% 216.78/217.00  |- skos__altLabel mesh__D018515 Plant Leaf
% 216.78/217.00  |- mesh__historyNote mesh__D018515 95   
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D018515 2005
% 216.78/217.00  |- mesh__dateRevised mesh__D018515 2002-07-03
% 216.78/217.00  |- mesh__publicMeSHNote mesh__D018515 95   
% 216.78/217.00  |- mesh__recordAuthorizer mesh__D018515 sjn
% 216.78/217.00  |- skos__prefLabel mesh__D018515 Plant Leaves
% 216.78/217.00  |- skos__historyNote mesh__D018515 Plants %28%1966-1994%29%
% 216.78/217.00  |- skos__annotation mesh__D018515
% 216.78/217.00       part of a plant shoot; IM GEN or unspecified; coord probably IM in genetics %26% space physiol, NIM in pharmacognosy, with specific plant %28%IM or NIM%29%%A%  
% 216.78/217.00  |- rdf__type mesh__D018515sskos__Concept
% 216.78/217.00  |- skos__broader mesh__D018515smesh__D035261
% 216.78/217.00  |- mesh__dateEstablished mesh__D018515 1995-01-01
% 216.78/217.00  |- mesh__dateCreated mesh__D018515 1994-06-07
% 216.78/217.00  |- skos__scopeNote mesh__D018515
% 216.78/217.00       Expanded structures, usually green, of vascular plants, characteristically consisting of a bladelike expansion attached to a stem, and functioning as the principal organ of photosynthesis and transpiration. %28%American Heritage Dictionary, 2d ed%29%%A%    
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D010532 2005
% 216.78/217.00  |- rdf__type mesh__D010532sskos__Concept
% 216.78/217.00  |- skos__hiddenLabel mesh__D010532 Peritoneal Disease
% 216.78/217.00  |- mesh__dateCreated mesh__D010532 1999-01-01
% 216.78/217.00  |- mesh__recordAuthorizer mesh__D010532 sjn
% 216.78/217.00  |- mesh__recordOriginator mesh__D010532 NLM
% 216.78/217.00  |- skos__annotation mesh__D010532 inflamm dis = PERITONITIS   
% 216.78/217.00  |- mesh__dateRevised mesh__D010532 2004-07-07
% 216.78/217.00  |- skos__scopeNote mesh__D010532
% 216.78/217.00       Pathological processes involving the PERITONEUM.     
% 216.78/217.00  |- mesh__recordMaintainer mesh__D010532 lkt
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D010532 2006
% 216.78/217.00  |- skos__prefLabel mesh__D010532 Peritoneal Diseases
% 216.78/217.00  |- skos__broader mesh__D010532smesh__D004066
% 216.78/217.00  |- skos__broader mesh__D007719Q000293smesh__D007719
% 216.78/217.00  |- mesh__preferredCombination mesh__D007719Q000293smesh__D007718
% 216.78/217.00  |- rdf__type mesh__D007719Q000293smesh__CompoundConcept
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D009789 1999
% 216.78/217.00  |- mesh__dateCreated mesh__D009789 1977-05-19
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D009789 2002
% 216.78/217.00  |- skos__altLabel mesh__D009789 Occupational Therapy Departments, Hospital
% 216.78/217.00  |- mesh__historyNote mesh__D009789
% 216.78/217.00       91%28%Aug 77%29%; was see under HOSPITAL DEPARTMENTS 1977-90   
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D009789 1996
% 216.78/217.00  |- mesh__recordAuthorizer mesh__D009789 PLS
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D009789 2005
% 216.78/217.00  |- mesh__publicMeSHNote mesh__D009789
% 216.78/217.00       91; was see under HOSPITAL DEPARTMENTS Aug 1977-90   
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D009789 1997
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D009789 2000
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D009789 2006
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D009789 2001
% 216.78/217.00  |- skos__historyNote mesh__D009789
% 216.78/217.00       Occupational Therapy %28%1966-Jul 1977%29%
% 216.78/217.00  |- mesh__recordOriginator mesh__D009789 EC
% 216.78/217.00  |- skos__annotation mesh__D009789 DF: OCCUP THER DEP   
% 216.78/217.00  |- mesh__dateEstablished mesh__D009789 1991-01-01
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D009789 2003
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D009789 1998
% 216.78/217.00  |- mesh__dateRevised mesh__D009789 1995-05-18
% 216.78/217.00  |- skos__altLabel mesh__D009789 Hospital Occupational Therapy Department
% 216.78/217.00  |- mesh__recordMaintainer mesh__D009789 KEV
% 216.78/217.00  |- skos__broader mesh__D009789smesh__D006748
% 216.78/217.00  |- skos__scopeNote mesh__D009789
% 216.78/217.00       Hospital department responsible for the administration and provision of any occupational or work activity for remedial purposes.%A%    
% 216.78/217.00  |- skos__historyNote mesh__D009789
% 216.78/217.00       Hospital Departments %28%1968-Jul 1977%29%
% 216.78/217.00  |- skos__prefLabel mesh__D009789 Occupational Therapy Department, Hospital
% 216.78/217.00  |- rdf__type mesh__D009789sskos__Concept
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D009789 2004
% 216.78/217.00  |- mesh__historyNote mesh__D034182 2003   
% 216.78/217.00  |- rdf__type mesh__D034182sskos__Concept
% 216.78/217.00  |- mesh__publicMeSHNote mesh__D034182 2003   
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D034182 2005
% 216.78/217.00  |- skos__annotation mesh__D034182
% 216.78/217.00       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D034182 2003
% 216.78/217.00  |- mesh__dateEstablished mesh__D034182 2003-01-01
% 216.78/217.00  |- skos__broader mesh__D034182smesh__D019684
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D034182 2006
% 216.78/217.00  |- skos__scopeNote mesh__D034182
% 216.78/217.00       A plant genus of the family Cuscutaceae. It is a threadlike climbing parasitic plant that is used in DRUGS, CHINESE HERBAL.%A%    
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D034182 2004
% 216.78/217.00  |- skos__altLabel mesh__D034182 Dodder
% 216.78/217.00  |- mesh__dateCreated mesh__D034182 2002-07-03
% 216.78/217.00  |- skos__prefLabel mesh__D034182 Cuscuta
% 216.78/217.00  |- mesh__recordOriginator mesh__D020960 adp
% 216.78/217.00  |- mesh__dateCreated mesh__D020960 1999-11-03
% 216.78/217.00  |- mesh__publicMeSHNote mesh__D020960 2000   
% 216.78/217.00  |- skos__altLabel mesh__D020960 omega-Conotoxin
% 216.78/217.00  |- mesh__dateRevised mesh__D020960 2005-06-30
% 216.78/217.00  |- skos__hiddenLabel mesh__D020960 omega Conotoxins
% 216.78/217.00  |- mesh__dateEstablished mesh__D020960 2000-01-01
% 216.78/217.00  |- skos__scopeNote mesh__D020960
% 216.78/217.00       A family of structurally related neurotoxic peptides from mollusk venom that inhibit voltage-activated entry of calcium into the presynaptic membrane. They selectively inhibit N-, P-, and Q-type calcium channels.%A%    
% 216.78/217.00  |- mesh__recordAuthorizer mesh__D020960 sjn
% 216.78/217.00  |- skos__historyNote mesh__D020960 Mollusk Venoms %28%1989-1996%29%
% 216.78/217.00  |- skos__prefLabel mesh__D020960 omega-Conotoxins
% 216.78/217.00  |- skos__historyNote mesh__D020960 Peptides %28%1992-1999%29%
% 216.78/217.00  |- skos__hiddenLabel mesh__D020960 omega Conotoxin
% 216.78/217.00  |- mesh__recordMaintainer mesh__D020960 ssb
% 216.78/217.00  |- mesh__historyNote mesh__D020960 2000   
% 216.78/217.00  |- skos__broader mesh__D020960smesh__D020916
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D020960 2006
% 216.78/217.00  |- rdf__type mesh__D020960sskos__Concept
% 216.78/217.00  |- skos__prefLabel mesh__D028145 Caulophyllum
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D028145 2003
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D028145 2004
% 216.78/217.00  |- skos__annotation mesh__D028145
% 216.78/217.00       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.78/217.00  |- mesh__dateEstablished mesh__D028145 2002-01-01
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D028145 2002
% 216.78/217.00  |- mesh__historyNote mesh__D028145 2002   
% 216.78/217.00  |- skos__altLabel mesh__D028145 Cohosh, Blue
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D028145 2005
% 216.78/217.00  |- skos__altLabel mesh__D028145 Blue Cohosh
% 216.78/217.00  |- skos__scopeNote mesh__D028145
% 216.78/217.00       A plant genus of the family BERBERIDACEAE %28%sometimes classified as Leonticaceae%29%, most notably Caulophyllum thalictroides %28%L.%29% Michx.%A%    
% 216.78/217.00  |- skos__broader mesh__D028145smesh__D028141
% 216.78/217.00  |- mesh__dateCreated mesh__D028145 2001-07-25
% 216.78/217.00  |- skos__historyNote mesh__D028145 Plants, Medicinal %28%1967-2001%29%
% 216.78/217.00  |- mesh__publicMeSHNote mesh__D028145 2002   
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D028145 2006
% 216.78/217.00  |- rdf__type mesh__D028145sskos__Concept
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D006491 2003
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D006491 2004
% 216.78/217.00  |- rdf__type mesh__D006491sskos__Concept
% 216.78/217.00  |- skos__broader mesh__D006491smesh__D010995
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D006491 2003A
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D006491 2000
% 216.78/217.00  |- mesh__dateRevised mesh__D006491 2002-10-23
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D006491 2005
% 216.78/217.00  |- skos__prefLabel mesh__D006491 Hemothorax
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D006491 2001
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D006491 2006
% 216.78/217.00  |- skos__scopeNote mesh__D006491 Hemorrhage within the pleural cavity.     
% 216.78/217.00  |- mesh__recordOriginator mesh__D006491 NLM
% 216.78/217.00  |- mesh__dateCreated mesh__D006491 1999-01-01
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D006491 2002
% 216.78/217.00  |- mesh__recordMaintainer mesh__D006491 sjn
% 216.78/217.00  |- skos__broader mesh__D006491smesh__D006470
% 216.78/217.00  |- mesh__recordAuthorizer mesh__D006491 sjn
% 216.78/217.00  |- skos__broader mesh__D020162smesh__D000592
% 216.78/217.00  |- skos__altLabel mesh__D020162 Argininemia
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D020162 2006A
% 216.78/217.00  |- skos__altLabel mesh__D020162 Arginase Deficiency Disease
% 216.78/217.00  |- skos__hiddenLabel mesh__D020162 Hyperargininemias
% 216.78/217.00  |- mesh__dateCreated mesh__D020162 1999-11-03
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D020162 2004
% 216.78/217.00  |- mesh__recordOriginator mesh__D020162 KEV
% 216.78/217.00  |- mesh__recordMaintainer mesh__D020162 ags
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D020162 2005
% 216.78/217.00  |- skos__hiddenLabel mesh__D020162 Arginase Deficiency Diseases
% 216.78/217.00  |- skos__historyNote mesh__D020162
% 216.78/217.00       Amino Acid Metabolism, Inborn Errors %28%1966-1999%29%
% 216.78/217.00  |- mesh__dateEstablished mesh__D020162 2000-01-01
% 216.78/217.00  |- skos__prefLabel mesh__D020162 Hyperargininemia
% 216.78/217.00  |- skos__related mesh__D020162smesh__D001119
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D020162 2006
% 216.78/217.00  |- rdf__type mesh__D020162sskos__Concept
% 216.78/217.00  |- skos__broader mesh__D020162smesh__D020739
% 216.78/217.00  |- skos__altLabel mesh__D020162 Deficiency Disease, Arginase
% 216.78/217.00  |- mesh__dateRevised mesh__D020162 2005-07-18
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D020162 2002
% 216.78/217.00  |- skos__hiddenLabel mesh__D020162 Deficiency Diseases, Arginase
% 216.78/217.00  |- mesh__historyNote mesh__D020162 2000   
% 216.78/217.00  |- skos__scopeNote mesh__D020162
% 216.78/217.00       A rare autosomal recessive disorder of the urea cycle. It is caused by a deficiency of the hepatic enzyme ARGINASE. Arginine is elevated in the blood and cerebrospinal fluid, and periodic hyperammonemia may occur. Disease onset is usually in infancy or early childhood. Clinical manifestations include seizures, microcephaly, progressive mental impairment, hypotonia, ataxia, spastic diplegia, and quadriparesis. %28%From Hum Genet 1993 Mar;91%28%1%29%:1-5; Menkes, Textbook of Child Neurology, 5th ed, p51%29%%A%    
% 216.78/217.00  |- mesh__recordAuthorizer mesh__D020162 ags
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D020162 2003
% 216.78/217.00  |- mesh__publicMeSHNote mesh__D020162 2000   
% 216.78/217.00  |- skos__scopeNote mesh__D014923
% 216.78/217.00       A rare, X-linked immunodeficiency syndrome characterized by eczema, thrombocytopenic purpura, and recurrent pyogenic infection. It is seen exclusively in young boys. Typically, IMMUNOGLOBULIN M levels are low and IMMUNOGLOBULIN A and IMMUNOGLOBULIN E levels are elevated. Lymphoreticular malignancies are common.%A%    
% 216.78/217.00  |- rdf__type mesh__D014923sskos__Concept
% 216.78/217.00  |- skos__broader mesh__D014923smesh__D007153
% 216.78/217.00  |- mesh__recordMaintainer mesh__D014923 sjn
% 216.78/217.00  |- skos__broader mesh__D014923smesh__D006474
% 216.78/217.00  |- skos__hiddenLabel mesh__D014923 Syndrome, Wiskott-Aldrich
% 216.78/217.00  |- skos__broader mesh__D014923smesh__D025861
% 216.78/217.00  |- skos__hiddenLabel mesh__D014923 Wiskott Aldrich Syndrome
% 216.78/217.00  |- mesh__dateCreated mesh__D014923 1999-01-01
% 216.78/217.00  |- mesh__recordOriginator mesh__D014923 NLM
% 216.78/217.00  |- skos__broader mesh__D014923smesh__D011696
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014923 2006
% 216.78/217.00  |- mesh__onlineNote mesh__D014923
% 216.78/217.00       use WISKOTT-ALDRICH SYNDROME to search ALDRICH SYNDROME 1966-84%A%  
% 216.78/217.00  |- skos__altLabel mesh__D014923 Aldrich Syndrome
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014923 2004
% 216.78/217.00  |- mesh__publicMeSHNote mesh__D014923 85; was ALDRICH SYNDROME 1963-84   
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014923 2005
% 216.78/217.00  |- mesh__dateRevised mesh__D014923 2002-07-02
% 216.78/217.00  |- mesh__recordAuthorizer mesh__D014923 sjn
% 216.78/217.00  |- mesh__historyNote mesh__D014923 85; was ALDRICH SYNDROME 1963-84   
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014923 2003
% 216.78/217.00  |- skos__hiddenLabel mesh__D014923 Syndrome, Aldrich
% 216.78/217.00  |- skos__prefLabel mesh__D014923 Wiskott-Aldrich Syndrome
% 216.78/217.00  |- skos__broader mesh__D014923smesh__D040181
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014125 2004
% 216.78/217.00  |- skos__hiddenLabel mesh__D014125 Toxoplasmoses, Fetal
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014125 2002
% 216.78/217.00  |- skos__hiddenLabel mesh__D014125 Toxoplasma Infection, Congenital
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014125 2006
% 216.78/217.00  |- skos__altLabel mesh__D014125 Toxoplasma Infections, Congenital
% 216.78/217.00  |- skos__annotation mesh__D014125 /vet = TOXOPLASMOSIS, ANIMAL /congen   
% 216.78/217.00  |- skos__broader mesh__D014125smesh__D020808
% 216.78/217.00  |- skos__altLabel mesh__D014125 Toxoplasmosis, Prenatal
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014125 2003
% 216.78/217.00  |- skos__broader mesh__D014125smesh__D014123
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014125 2001
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014125 2005
% 216.78/217.00  |- mesh__recordMaintainer mesh__D014125 sjn
% 216.78/217.00  |- skos__hiddenLabel mesh__D014125 Toxoplasmoses, Prenatal
% 216.78/217.00  |- skos__hiddenLabel mesh__D014125 Infection, Congenital Toxoplasma
% 216.78/217.00  |- skos__hiddenLabel mesh__D014125 Congenital Toxoplasmoses
% 216.78/217.00  |- skos__altLabel mesh__D014125 Congenital Toxoplasmosis
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D014125 2003A
% 216.78/217.00  |- skos__altLabel mesh__D014125 Congenital Toxoplasma gondii Infection
% 216.78/217.00  |- skos__broader mesh__D014125smesh__D007232
% 216.78/217.00  |- rdf__type mesh__D014125sskos__Concept
% 216.78/217.00  |- skos__hiddenLabel mesh__D014125 Toxoplasmoses, Congenital
% 216.78/217.00  |- mesh__recordOriginator mesh__D014125 NLM
% 216.78/217.00  |- skos__hiddenLabel mesh__D014125 Prenatal Toxoplasmoses
% 216.78/217.00  |- skos__altLabel mesh__D014125 Congenital Infection, Toxoplasma gondii
% 216.78/217.00  |- mesh__dateCreated mesh__D014125 1999-01-01
% 216.78/217.00  |- skos__hiddenLabel mesh__D014125 Prenatal Toxoplasmosis
% 216.78/217.00  |- mesh__dateRevised mesh__D014125 2002-09-24
% 216.78/217.00  |- mesh__recordAuthorizer mesh__D014125 sjn
% 216.78/217.00  |- skos__scopeNote mesh__D014125
% 216.78/217.00       Prenatal protozoal infection with TOXOPLASMA gondii which is associated with injury to the developing fetal nervous system. The severity of this condition is related to the stage of pregnancy during which the infection occurs; first trimester infections are associated with a greater degree of neurologic dysfunction. Clinical features include HYDROCEPHALUS; MICROCEPHALY; deafness; cerebral calcifications; SEIZURES; and psychomotor retardation. Signs of a systemic infection may also be present at birth, including fever, rash, and hepatosplenomegaly. %28%From Adams et al., Principles of Neurology, 6th ed, p735%29%%A%    
% 216.78/217.00  |- skos__hiddenLabel mesh__D014125 Fetal Toxoplasmoses
% 216.78/217.00  |- skos__altLabel mesh__D014125 Congenital Toxoplasma Infections
% 216.78/217.00  |- skos__hiddenLabel mesh__D014125 Infections, Congenital Toxoplasma
% 216.78/217.00  |- skos__hiddenLabel mesh__D014125 Fetal Toxoplasmosis
% 216.78/217.00  |- skos__hiddenLabel mesh__D014125 Congenital Toxoplasma Infection
% 216.78/217.00  |- skos__prefLabel mesh__D014125 Toxoplasmosis, Congenital
% 216.78/217.00  |- skos__historyNote mesh__D000903 Antibiotics %28%1966%29%
% 216.78/217.00  |- mesh__recordOriginator mesh__D000903 NLM
% 216.78/217.00  |- mesh__dateCreated mesh__D000903 1999-01-01
% 216.78/217.00  |- skos__annotation mesh__D000903 GEN: prefer specifics   
% 216.78/217.00  |- mesh__publicMeSHNote mesh__D000903 67   
% 216.78/217.00  |- skos__broader mesh__D000903smesh__D000970
% 216.78/217.00  |- mesh__historyNote mesh__D000903 67   
% 216.78/217.00  |- mesh__recordAuthorizer mesh__D000903 sjn
% 216.78/217.00  |- skos__altLabel mesh__D000903 Cytotoxic Antibiotics
% 216.78/217.00  |- mesh__recordMaintainer mesh__D000903 ssb
% 216.78/217.00  |- skos__prefLabel mesh__D000903 Antibiotics, Antineoplastic
% 216.78/217.00  |- rdf__type mesh__D000903sskos__Concept
% 216.78/217.00  |- mesh__dateRevised mesh__D000903 2005-06-30
% 216.78/217.00  |- skos__altLabel mesh__D000903 Antineoplastic Antibiotics
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D000903 2006
% 216.78/217.00  |- mesh__dateEstablished mesh__D000903 1967-01-01
% 216.78/217.00  |- skos__scopeNote mesh__D000903
% 216.78/217.00       Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms.%A%    
% 216.78/217.00  |- skos__historyNote mesh__D000903 Antineoplastic Agents %28%1966%29%
% 216.78/217.00  |- skos__historyNote mesh__D000105 Coenzyme A %28%1966-1972%29%
% 216.78/217.00  |- rdf__type mesh__D000105sskos__Concept
% 216.78/217.00  |- mesh__historyNote mesh__D000105
% 216.78/217.00       78%28%73%29%; was see under COENZYME A 1975-77   
% 216.78/217.00  |- skos__altLabel mesh__D000105 Acetyl-CoA
% 216.78/217.00  |- mesh__recordOriginator mesh__D000105 NLM
% 216.78/217.00  |- skos__prefLabel mesh__D000105 Acetyl Coenzyme A
% 216.78/217.00  |- mesh__dateCreated mesh__D000105 1999-01-01
% 216.78/217.00  |- mesh__recordMaintainer mesh__D000105 ags
% 216.78/217.00  |- skos__broader mesh__D000105smesh__D000214
% 216.78/217.00  |- skos__altLabel mesh__D000105 Acetyl CoA
% 216.78/217.00  |- mesh__recordAuthorizer mesh__D000105 sjn
% 216.78/217.00  |- mesh__dateRevised mesh__D000105 2005-07-06
% 216.78/217.00  |- mesh__dateEstablished mesh__D000105 1978-01-01
% 216.78/217.00  |- skos__hiddenLabel mesh__D000105 Coenzyme A, Acetyl
% 216.78/217.00  |- skos__hiddenLabel mesh__D000105 CoA, Acetyl
% 216.78/217.00  |- mesh__publicMeSHNote mesh__D000105
% 216.78/217.00       78; was see under COENZYME A 1975-77   
% 216.78/217.00  |- skos__scopeNote mesh__D000105
% 216.78/217.00       Acetyl CoA participates in the biosynthesis of fatty acids and sterols, in the oxidation of fatty acids and in the metabolism of many amino acids. It also acts as a biological acetylating agent.%A%    
% 216.78/217.00  |- skos__annotation mesh__D000105 do not confuse with ACYL COENZYME A   
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D000105 2006
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D052244 2006
% 216.78/217.00  |- mesh__dateEstablished mesh__D052244 2006-01-01
% 216.78/217.00  |- mesh__publicMeSHNote mesh__D052244 2006   
% 216.78/217.00  |- skos__altLabel mesh__D052244 Endocrine Disrupting Chemicals
% 216.78/217.00  |- skos__hiddenLabel mesh__D052244 Disruptors, Endocrine
% 216.78/217.00  |- mesh__dateCreated mesh__D052244 2005-06-30
% 216.78/217.00  |- rdf__type mesh__D052244sskos__Concept
% 216.78/217.00  |- skos__historyNote mesh__D052244
% 216.78/217.00       Endocrine System/drug effects %28%1997-2005%29%
% 216.78/217.00  |- skos__hiddenLabel mesh__D052244 Chemicals, Endocrine Disrupting
% 216.78/217.00  |- skos__prefLabel mesh__D052244 Endocrine Disruptors
% 216.78/217.00  |- mesh__recordOriginator mesh__D052244 nns
% 216.78/217.00  |- skos__related mesh__D052244smesh__D006730
% 216.78/217.00  |- skos__broader mesh__D052244smesh__D004785
% 216.78/217.00  |- skos__scopeNote mesh__D052244
% 216.78/217.00       Exogenous agents, synthetic and naturally occurring, which are capable of disrupting the functions of the ENDOCRINE SYSTEM including the maintenance of HOMEOSTASIS and the regulation of developmental processes.  Endocrine disruptors are compounds that can mimic HORMONES, or enhance or block the binding of hormones to their receptors, or otherwise lead to activating or inhibiting the endocrine signaling pathways and hormone metabolism.%A%    
% 216.78/217.00  |- mesh__recordMaintainer mesh__D052244 nns
% 216.78/217.00  |- skos__historyNote mesh__D052244
% 216.78/217.00       Endocrine Glands/drug effects %28%1993-2005%29%
% 216.78/217.00  |- mesh__recordAuthorizer mesh__D052244 sjn
% 216.78/217.00  |- skos__broader mesh__D052244smesh__D045505
% 216.78/217.00  |- mesh__historyNote mesh__D052244 2006   
% 216.78/217.00  |- mesh__recordMaintainer mesh__D005399 ags
% 216.78/217.00  |- mesh__publicMeSHNote mesh__D005399 1968; see FISH 1963-1967   
% 216.78/217.00  |- skos__scopeNote mesh__D005399
% 216.78/217.00       A group of cold-blooded, aquatic vertebrates having gills, fins, a cartilaginous or bony endoskeleton, and elongated bodies covered with scales.%A%    
% 216.78/217.00  |- mesh__recordAuthorizer mesh__D005399 sjn
% 216.78/217.00  |- mesh__dateCreated mesh__D005399 1999-01-01
% 216.78/217.00  |- rdf__type mesh__D005399sskos__Concept
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D005399 2005
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D005399 2006
% 216.78/217.00  |- skos__annotation mesh__D005399
% 216.78/217.00       GEN or unspecified; prefer specifics; canned fish: see note on FISH PRODUCTS%A%  
% 216.78/217.00  |- mesh__dateRevised mesh__D005399 2003-07-09
% 216.78/217.00  |- skos__broader mesh__D005399smesh__D014714
% 216.78/217.00  |- mesh__dateEstablished mesh__D005399 1968-01-01
% 216.78/217.00  |- skos__prefLabel mesh__D005399 Fishes
% 216.78/217.00  |- mesh__recordOriginator mesh__D005399 NLM
% 216.78/217.00  |- mesh__historyNote mesh__D005399 1968 %28%1963%29%   
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D005399 2004
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D018516 2005
% 216.78/217.00  |- skos__annotation mesh__D018516
% 216.78/217.00       at base of a leaf: from the Latin for cushion; IM GEN or unspecified; coord probably IM in genetics %26% space physiol, NIM in pharmacognosy, with specific plant %28%IM or NIM%29%%A%  
% 216.78/217.00  |- rdf__type mesh__D018516sskos__Concept
% 216.78/217.00  |- mesh__dateCreated mesh__D018516 1994-06-07
% 216.78/217.00  |- skos__scopeNote mesh__D018516
% 216.78/217.00       A group of cells at the base of a leaf in certain plants that, by rapidly losing water, brings about changes in the position of the leaves. %28%Concise Dictionary of Biology, 1990%29%%A%    
% 216.78/217.00  |- mesh__recordMaintainer mesh__D018516 PXP
% 216.78/217.00  |- skos__prefLabel mesh__D018516 Pulvinus
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D018516 2004
% 216.78/217.00  |- mesh__activeMeSHYear mesh__D018516 2006
% 216.78/217.00  |- mesh__dateRevised mesh__D018516 2002-07-03
% 216.78/217.00  |- mesh__publicMeSHNote mesh__D018516 95   
% 216.78/217.01  |- mesh__recordAuthorizer mesh__D018516 sjn
% 216.78/217.01  |- mesh__recordOriginator mesh__D018516 JLS
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D018516 2003
% 216.78/217.01  |- mesh__dateEstablished mesh__D018516 1995-01-01
% 216.78/217.01  |- mesh__historyNote mesh__D018516 95   
% 216.78/217.01  |- skos__broader mesh__D018516smesh__D018515
% 216.78/217.01  |- skos__historyNote mesh__D018516 Plants %28%1966-1994%29%
% 216.78/217.01  |- skos__hiddenLabel mesh__D010533 Lavages, Peritoneal
% 216.78/217.01  |- mesh__historyNote mesh__D010533 88   
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D010533 1993
% 216.78/217.01  |- mesh__recordAuthorizer mesh__D010533 PLS
% 216.78/217.01  |- skos__scopeNote mesh__D010533
% 216.78/217.01       Washing out of the peritoneal cavity. The procedure is a diagnostic as well as a therapeutic technique following abdominal trauma or inflammation.%A%    
% 216.78/217.01  |- skos__hiddenLabel mesh__D010533 Peritoneal Lavages
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D010533 1999
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D010533 1994
% 216.78/217.01  |- mesh__recordOriginator mesh__D010533 SCD
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D010533 2002
% 216.78/217.01  |- skos__hiddenLabel mesh__D010533 Irrigations, Peritoneal
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D010533 1997
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D010533 1992
% 216.78/217.01  |- skos__altLabel mesh__D010533 Lavage, Peritoneal
% 216.78/217.01  |- skos__prefLabel mesh__D010533 Peritoneal Lavage
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D010533 1998
% 216.78/217.01  |- mesh__recordMaintainer mesh__D010533 PLS
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D010533 1996
% 216.78/217.01  |- skos__historyNote mesh__D010533 Irrigation %28%1966-1987%29%
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D010533 2006
% 216.78/217.01  |- mesh__publicMeSHNote mesh__D010533 88   
% 216.78/217.01  |- mesh__dateCreated mesh__D010533 1987-03-27
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D010533 2001
% 216.78/217.01  |- skos__broader mesh__D010533smesh__D007507
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D010533 1991
% 216.78/217.01  |- skos__hiddenLabel mesh__D010533 Peritoneal Irrigations
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D010533 2004
% 216.78/217.01  |- skos__altLabel mesh__D010533 Irrigation, Peritoneal
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D010533 2005
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D010533 2000
% 216.78/217.01  |- mesh__dateEstablished mesh__D010533 1988-01-01
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D010533 2003
% 216.78/217.01  |- skos__historyNote mesh__D010533 Peritoneal Cavity %28%1966-1987%29%
% 216.78/217.01  |- rdf__type mesh__D010533sskos__Concept
% 216.78/217.01  |- skos__altLabel mesh__D010533 Peritoneal Irrigation
% 216.78/217.01  |- skos__annotation mesh__D010533
% 216.78/217.01       do not use /util except by MeSH definition   
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D010533 1995
% 216.78/217.01  |- mesh__dateRevised mesh__D010533 1990-02-16
% 216.78/217.01  |- skos__altLabel mesh__D020961 Lewy Body Disease, Diffuse
% 216.78/217.01  |- skos__annotation mesh__D020961
% 216.78/217.01       LEWY BODY PARKINSON DISEASE see PARKINSON DISEASE is also available%A%  
% 216.78/217.01  |- skos__scopeNote mesh__D020961
% 216.78/217.01       A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present. %28%From Neurology 1997;48:376-380; Neurology 1996;47:1113-1124%29%%A%    
% 216.78/217.01  |- skos__broader mesh__D020961smesh__D003704
% 216.78/217.01  |- skos__related mesh__D020961smesh__D016631
% 216.78/217.01  |- mesh__publicMeSHNote mesh__D020961
% 216.78/217.01       2000; see PARKINSON DISEASE 1992-1999; for DIFFUSE LEWY BODY DISEASE %26% LEWY BODY DISEASE, DIFFUSE see PARKINSON DISEASE 1992-1999%A%  
% 216.78/217.01  |- mesh__dateEstablished mesh__D020961 2000-01-01
% 216.78/217.01  |- skos__broader mesh__D020961smesh__D019636
% 216.78/217.01  |- skos__hiddenLabel mesh__D020961 Lewy Body Dementia
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D020961 2002
% 216.78/217.01  |- skos__altLabel mesh__D020961 Lewy Body Type Senile Dementia
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D020961 2004
% 216.78/217.01  |- skos__historyNote mesh__D020961
% 216.78/217.01       Parkinson Disease, Secondary %28%1984-1999%29%
% 216.78/217.01  |- skos__altLabel mesh__D020961 Cortical Lewy Body Disease
% 216.78/217.01  |- mesh__historyNote mesh__D020961
% 216.78/217.01       2000; use PARKINSON DISEASE 1992-1999; for DIFFUSE LEWY BODY DISEASE %26% LEWY BODY DISEASE, DIFFUSE use PARKINSON DISEASE 1992-1999%A%  
% 216.78/217.01  |- mesh__dateCreated mesh__D020961 1999-11-08
% 216.78/217.01  |- skos__prefLabel mesh__D020961 Lewy Body Disease
% 216.78/217.01  |- mesh__dateRevised mesh__D020961 2001-07-25
% 216.78/217.01  |- skos__altLabel mesh__D020961 Diffuse Lewy Body Disease
% 216.78/217.01  |- skos__historyNote mesh__D020961 Parkinson Disease %28%1977-1999%29%
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D020961 2003
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D020961 2006
% 216.78/217.01  |- mesh__recordAuthorizer mesh__D020961 sjn
% 216.78/217.01  |- mesh__recordMaintainer mesh__D020961 ags
% 216.78/217.01  |- rdf__type mesh__D020961sskos__Concept
% 216.78/217.01  |- skos__altLabel mesh__D020961 Dementia, Lewy Body
% 216.78/217.01  |- mesh__recordOriginator mesh__D020961 KEV
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D020961 2005
% 216.78/217.01  |- skos__historyNote mesh__D020961 Alzheimer Disease %28%1979-1999%29%
% 216.78/217.01  |- skos__altLabel mesh__D020961 Lewy Body Disease, Cortical
% 216.78/217.01  |- skos__broader mesh__D020961smesh__D020734
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D006492 2005
% 216.78/217.01  |- mesh__recordOriginator mesh__D006492 NLM
% 216.78/217.01  |- skos__altLabel mesh__D006492 Hexamethylphosphoramide
% 216.78/217.01  |- mesh__recordMaintainer mesh__D006492 CCR
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D006492 2002
% 216.78/217.01  |- skos__historyNote mesh__D006492 Dimethylamines %28%1972-1974%29%
% 216.78/217.01  |- skos__broader mesh__D006492smesh__D009943
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D006492 2006
% 216.78/217.01  |- mesh__publicMeSHNote mesh__D006492
% 216.78/217.01       91; was see under ORGANOPHOSPHORUS COMPOUNDS 1975-90   
% 216.78/217.01  |- mesh__recordAuthorizer mesh__D006492 sjn
% 216.78/217.01  |- skos__altLabel mesh__D006492 Hexametapol
% 216.78/217.01  |- skos__hiddenLabel mesh__D006492 Triamide, Hexamethylphosphoric
% 216.78/217.01  |- skos__scopeNote mesh__D006492
% 216.78/217.01       A chemosterilant agent that is anticipated to be a carcinogen.%A%    
% 216.78/217.01  |- skos__annotation mesh__D006492 = HExaMethylPhosphorAmide   
% 216.78/217.01  |- mesh__dateCreated mesh__D006492 1974-11-19
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D006492 2003
% 216.78/217.01  |- mesh__dateRevised mesh__D006492 2000-06-22
% 216.78/217.01  |- skos__prefLabel mesh__D006492 Hempa
% 216.78/217.01  |- mesh__historyNote mesh__D006492
% 216.78/217.01       91%28%75%29%; was see under ORGANOPHOSPHORUS COMPOUNDS 1975-90   
% 216.78/217.01  |- skos__historyNote mesh__D006492
% 216.78/217.01       Organophosphorus Compounds %28%1972-1974%29%
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D006492 2004
% 216.78/217.01  |- rdf__type mesh__D006492sskos__Concept
% 216.78/217.01  |- skos__altLabel mesh__D006492 HMPA
% 216.78/217.01  |- mesh__dateEstablished mesh__D006492 1991-01-01
% 216.78/217.01  |- skos__altLabel mesh__D006492 Hexamethylphosphoric Triamide
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D006492 2001
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D020163 2002
% 216.78/217.01  |- skos__annotation mesh__D020163
% 216.78/217.01       consider also ORNITHINE CARBAMOYLTRANSFERASE /defic   
% 216.78/217.01  |- skos__related mesh__D020163smesh__D009954
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D020163 2006
% 216.78/217.01  |- rdf__type mesh__D020163sskos__Concept
% 216.78/217.01  |- mesh__dateRevised mesh__D020163 2001-07-25
% 216.78/217.01  |- mesh__dateEstablished mesh__D020163 2000-01-01
% 216.78/217.01  |- mesh__historyNote mesh__D020163 2000   
% 216.78/217.01  |- mesh__publicMeSHNote mesh__D020163 2000   
% 216.78/217.01  |- skos__historyNote mesh__D020163
% 216.78/217.01       Ornithine Carbamoyltransferase/deficiency %28%1966-1999%29%
% 216.78/217.01  |- skos__broader mesh__D020163smesh__D020739
% 216.78/217.01  |- mesh__recordOriginator mesh__D020163 KEV
% 216.78/217.01  |- mesh__dateCreated mesh__D020163 1999-11-03
% 216.78/217.01  |- skos__altLabel mesh__D020163
% 216.78/217.01       Ornithine Transcarbamylase Deficiency Disease
% 216.78/217.01  |- skos__altLabel mesh__D020163
% 216.78/217.01       Deficiency Disease, Ornithine Transcarbamylase
% 216.78/217.01  |- mesh__recordMaintainer mesh__D020163 nns
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D020163 2003
% 216.78/217.01  |- skos__broader mesh__D020163smesh__D000592
% 216.78/217.01  |- skos__scopeNote mesh__D020163
% 216.78/217.01       An inherited urea cycle disorder associated with deficiency of the enzyme ORNITHINE CARBAMOYLTRANSFERASE, transmitted as a sex-linked trait and featuring elevations of amino acids and ammonia in the serum. Clinical features, which are more prominent in males, include seizures, behavioral alterations, episodic vomiting, lethargy, and coma. %28%Menkes, Textbook of Child Neurology, 5th ed, pp49-50%29%%A%    
% 216.78/217.01  |- mesh__recordAuthorizer mesh__D020163 sjn
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D020163 2004
% 216.78/217.01  |- skos__altLabel mesh__D020163
% 216.78/217.01       Deficiency Disease, Ornithine Carbamoyltransferase
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D020163 2005
% 216.78/217.01  |- skos__prefLabel mesh__D020163
% 216.78/217.01       Ornithine Carbamoyltransferase Deficiency Disease
% 216.78/217.01  |- skos__prefLabel mesh__D014924 Wissler%27%s Syndrome
% 216.78/217.01  |- mesh__recordMaintainer mesh__D014924 PLS
% 216.78/217.01  |- skos__hiddenLabel mesh__D014924 Wissler Syndrome
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D014924 1998
% 216.78/217.01  |- skos__broader mesh__D014924smesh__D012213
% 216.78/217.01  |- skos__annotation mesh__D014924 a form of rheumatic fever   
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D014924 1996
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D014924 2002
% 216.78/217.01  |- skos__broader mesh__D014924smesh__D006967
% 216.78/217.01  |- skos__scopeNote mesh__D014924
% 216.78/217.01       A rheumatic syndrome of possibly allergic origin, usually affecting children and adolescents, and characterized by high fever, exanthema, arthralgia, leukocytosis, and increased sedimentation rate.%A%    
% 216.78/217.01  |- skos__altLabel mesh__D014924 Wissler-Fanconi Syndrome
% 216.78/217.01  |- mesh__dateCreated mesh__D014924 1999-01-01
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D014924 2006
% 216.78/217.01  |- skos__altLabel mesh__D014924 Subsepsis Hyperergica
% 216.78/217.01  |- mesh__publicMeSHNote mesh__D014924 65   
% 216.78/217.01  |- skos__hiddenLabel mesh__D014924 Wissler Fanconi Syndrome
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D014924 2004
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D014924 2005
% 216.78/217.01  |- skos__hiddenLabel mesh__D014924 Wisslers Syndrome
% 216.78/217.01  |- skos__hiddenLabel mesh__D014924 Syndrome, Wissler-Fanconi
% 216.78/217.01  |- skos__hiddenLabel mesh__D014924 Syndrome, Wissler%27%s
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D014924 2001
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D014924 2003
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D014924 1995
% 216.78/217.01  |- mesh__dateRevised mesh__D014924 1992-05-22
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D014924 2000
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D014924 1993
% 216.78/217.01  |- rdf__type mesh__D014924sskos__Concept
% 216.78/217.01  |- mesh__recordOriginator mesh__D014924 NLM
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D014924 1999
% 216.78/217.01  |- skos__altLabel mesh__D014924 Subsepsis Allergica
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D014924 1997
% 216.78/217.01  |- mesh__recordAuthorizer mesh__D014924 PLS
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D014924 1994
% 216.78/217.01  |- mesh__historyNote mesh__D014924 65%28%64%29%   
% 216.78/217.01  |- mesh__dateEstablished mesh__D014924 1965-01-01
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D014126 2004
% 216.78/217.01  |- skos__broader mesh__D014126smesh__D015822
% 216.78/217.01  |- mesh__recordOriginator mesh__D014126 NLM
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D014126 2002
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D014126 2006
% 216.78/217.01  |- mesh__recordAuthorizer mesh__D014126 sjn
% 216.78/217.01  |- skos__prefLabel mesh__D014126 Toxoplasmosis, Ocular
% 216.78/217.01  |- mesh__dateCreated mesh__D014126 1999-01-01
% 216.78/217.01  |- skos__scopeNote mesh__D014126
% 216.78/217.01       Infection caused by the protozoan parasite TOXOPLASMA in which there is extensive connective tissue proliferation, the retina surrounding the lesions remains normal, and the ocular media remain clear. Chorioretinitis may be associated with all forms of toxoplasmosis, but is usually a late sequel of congenital toxoplasmosis. The severe ocular lesions in infants may lead to blindness.%A%    
% 216.78/217.01  |- skos__hiddenLabel mesh__D014126 Toxoplasmoses, Ocular
% 216.78/217.01  |- mesh__recordMaintainer mesh__D014126 PXP
% 216.78/217.01  |- rdf__type mesh__D014126sskos__Concept
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D014126 2001
% 216.78/217.01  |- skos__broader mesh__D014126smesh__D014123
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D014126 2003
% 216.78/217.01  |- skos__annotation mesh__D014126
% 216.78/217.01       /congen permitted: do not coord with TOXOPLASMOSIS, CONGENITAL%A%  
% 216.78/217.01  |- skos__hiddenLabel mesh__D014126 Ocular Toxoplasmoses
% 216.78/217.01  |- mesh__dateRevised mesh__D014126 2000-06-22
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D014126 2005
% 216.78/217.01  |- skos__altLabel mesh__D014126 Ocular Toxoplasmosis
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D000904 2005
% 216.78/217.01  |- skos__historyNote mesh__D000904 Antibiotics %28%1966-1974%29%
% 216.78/217.01  |- skos__broader mesh__D000904smesh__D000900
% 216.78/217.01  |- mesh__recordOriginator mesh__D000904 NLM
% 216.78/217.01  |- skos__broader mesh__D000904smesh__D000995
% 216.78/217.01  |- skos__hiddenLabel mesh__D000904 Antitubercular Antibiotics
% 216.78/217.01  |- mesh__dateCreated mesh__D000904 1999-01-01
% 216.78/217.01  |- mesh__recordMaintainer mesh__D000904 ssb
% 216.78/217.01  |- skos__prefLabel mesh__D000904 Antibiotics, Antitubercular
% 216.78/217.01  |- mesh__publicMeSHNote mesh__D000904 75   
% 216.78/217.01  |- skos__historyNote mesh__D000904 Antitubercular Agents %28%1966-1974%29%
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D000904 2004
% 216.78/217.01  |- mesh__dateRevised mesh__D000904 2003-07-09
% 216.78/217.01  |- mesh__historyNote mesh__D000904 75   
% 216.78/217.01  |- mesh__recordAuthorizer mesh__D000904 sjn
% 216.78/217.01  |- mesh__dateEstablished mesh__D000904 1975-09-01
% 216.78/217.01  |- rdf__type mesh__D000904sskos__Concept
% 216.78/217.01  |- skos__scopeNote mesh__D000904
% 216.78/217.01       Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic.%A%    
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D000904 2006
% 216.78/217.01  |- skos__historyNote mesh__D000106 Coenzyme A Synthetases %28%1974-1975%29%
% 216.78/217.01  |- skos__hiddenLabel mesh__D000106 Enzyme, Acetyl Activating
% 216.78/217.01  |- skos__altLabel mesh__D000106 Acetyl CoA Synthetase
% 216.78/217.01  |- mesh__recordOriginator mesh__D000106 RLS
% 216.78/217.01  |- skos__altLabel mesh__D000106 Acetyl Coenzyme A Synthetase
% 216.78/217.01  |- mesh__dateRevised mesh__D000106 2003-07-09
% 216.78/217.01  |- skos__altLabel mesh__D000106 Acetothiokinase
% 216.78/217.01  |- mesh__dateEstablished mesh__D000106 1991-01-01
% 216.78/217.01  |- skos__scopeNote mesh__D000106
% 216.78/217.01       An enzyme that catalyzes the formation of CoA derivatives from ATP, acetate, and CoA to form AMP, pyrophosphate, and acetyl CoA. It acts also on propionates and acrylates. EC 6.2.1.1.%A%    
% 216.78/217.01  |- mesh__publicMeSHNote mesh__D000106
% 216.78/217.01       95; was ACETYL COENZYME A SYNTHETASE 1991-94; was see under  COENZYME A SYNTHETASES 1976-90%A%  
% 216.78/217.01  |- skos__altLabel mesh__D000106 Acetate Thiokinase
% 216.78/217.01  |- skos__hiddenLabel mesh__D000106 CoA Synthetase, Acetyl
% 216.78/217.01  |- skos__altLabel mesh__D000106 Acetyl Activating Enzyme
% 216.78/217.01  |- mesh__recordMaintainer mesh__D000106 ssb
% 216.78/217.01  |- skos__broader mesh__D000106smesh__D003066
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D000106 2006
% 216.78/217.01  |- skos__prefLabel mesh__D000106 Acetate-CoA Ligase
% 216.78/217.01  |- rdf__type mesh__D000106sskos__Concept
% 216.78/217.01  |- mesh__onlineNote mesh__D000106
% 216.78/217.01       use ACETATE-COA LIGASE to search ACETYL COENZYME A SYNTHETASE 1991-94%A%  
% 216.78/217.01  |- skos__hiddenLabel mesh__D000106 Acetate CoA Ligase
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D000106 2005
% 216.78/217.01  |- mesh__dateCreated mesh__D000106 1975-07-18
% 216.78/217.01  |- skos__historyNote mesh__D000106 Acetyl Coenzyme A %28%1974-1975%29%
% 216.78/217.01  |- skos__hiddenLabel mesh__D000106 Ligase, Acetate-CoA
% 216.78/217.01  |- mesh__historyNote mesh__D000106
% 216.78/217.01       95; was ACETYL COENZYME A SYNTHETASE 1991-94; was see under COENZYME A SYNTHETASES 1976-90%A%  
% 216.78/217.01  |- skos__hiddenLabel mesh__D000106 Activating Enzyme, Acetyl
% 216.78/217.01  |- skos__hiddenLabel mesh__D000106 Synthetase, Acetyl CoA
% 216.78/217.01  |- skos__hiddenLabel mesh__D000106 Thiokinase, Acetate
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D000106 2004
% 216.78/217.01  |- mesh__recordAuthorizer mesh__D000106 sjn
% 216.78/217.01  |- skos__broader mesh__D052245smesh__D006319
% 216.78/217.01  |- rdf__type mesh__D052245sskos__Concept
% 216.78/217.01  |- mesh__recordAuthorizer mesh__D052245 sjn
% 216.78/217.01  |- skos__broader mesh__D052245smesh__D012174
% 216.78/217.01  |- mesh__recordOriginator mesh__D052245 nns
% 216.78/217.01  |- mesh__historyNote mesh__D052245 2006   
% 216.78/217.01  |- mesh__dateEstablished mesh__D052245 2006-01-01
% 216.78/217.01  |- skos__historyNote mesh__D052245 Syndrome %28%1972-2005%29%
% 216.78/217.01  |- mesh__dateCreated mesh__D052245 2005-06-30
% 216.78/217.01  |- skos__historyNote mesh__D052245
% 216.78/217.01       Hearing Loss, Sensorineural %28%1983-2005%29%
% 216.78/217.01  |- skos__historyNote mesh__D052245 Retinitis Pigmentosa %28%1972-2005%29%
% 216.78/217.01  |- skos__hiddenLabel mesh__D052245 Syndrome, Usher
% 216.78/217.01  |- skos__prefLabel mesh__D052245 Usher Syndromes
% 216.78/217.01  |- mesh__recordMaintainer mesh__D052245 nns
% 216.78/217.01  |- skos__scopeNote mesh__D052245
% 216.78/217.01       Autosomal recessive hereditary disorders characterized by congenital SENSORINEURAL HEARING LOSS and RETINITIS PIGMENTOSA. Genetically and symptomatically heterogeneous, clinical classes include type I, type II, and type III. Their severity, age of onset of retinitis pigmentosa and the degree of vestibular dysfunction are variable.%A%    
% 216.78/217.01  |- skos__hiddenLabel mesh__D052245 Syndromes, Usher
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D052245 2006
% 216.78/217.01  |- skos__historyNote mesh__D052245 Deafness %28%1972-2005%29%
% 216.78/217.01  |- skos__altLabel mesh__D052245 Usher Syndrome
% 216.78/217.01  |- mesh__publicMeSHNote mesh__D052245 2006   
% 216.78/217.01  |- skos__prefLabel mesh__D046208 Microchip Analytical Procedures
% 216.78/217.01  |- mesh__recordAuthorizer mesh__D046208 sjn
% 216.78/217.01  |- mesh__publicMeSHNote mesh__D046208 2005   
% 216.78/217.01  |- skos__hiddenLabel mesh__D046208 Analysis, Microchip
% 216.78/217.01  |- skos__hiddenLabel mesh__D046208 Analytical Devices, Microchip
% 216.78/217.01  |- skos__hiddenLabel mesh__D046208 Analytical Device, Microchip
% 216.78/217.01  |- skos__hiddenLabel mesh__D046208 Analytical Devices, Nanochip
% 216.78/217.01  |- skos__hiddenLabel mesh__D046208 Microchip Analytical Device
% 216.78/217.01  |- skos__hiddenLabel mesh__D046208 Analytical Device, Nanochip
% 216.78/217.01  |- skos__hiddenLabel mesh__D046208 Device, Microchip Analytical
% 216.78/217.01  |- skos__hiddenLabel mesh__D046208 Procedure, Microchip Analytical
% 216.78/217.01  |- mesh__recordMaintainer mesh__D046208 nns
% 216.78/217.01  |- mesh__historyNote mesh__D046208 2005   
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D046208 2006
% 216.78/217.01  |- skos__hiddenLabel mesh__D046208 Devices, Nanochip Analytical
% 216.78/217.01  |- skos__broader mesh__D046208smesh__D002623
% 216.78/217.01  |- rdf__type mesh__D046208sskos__Concept
% 216.78/217.01  |- skos__annotation mesh__D046208
% 216.78/217.01       DNA CHIPS see OLIGONUCLEOTIDE SEQUENCE ANALYSIS and PROTEIN CHIPS see PROTEIN ARRAY ANALYSIS are also available%A%  
% 216.78/217.01  |- skos__hiddenLabel mesh__D046208 Nanochip Analytical Device
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D046208 2005
% 216.78/217.01  |- skos__hiddenLabel mesh__D046208 Analytical Procedure, Microchip
% 216.78/217.01  |- skos__scopeNote mesh__D046208
% 216.78/217.01       The preparation and analysis of samples on miniaturized devices.%A%    
% 216.78/217.01  |- skos__hiddenLabel mesh__D046208 Analyses, Microchip
% 216.78/217.01  |- mesh__dateCreated mesh__D046208 2004-07-07
% 216.78/217.01  |- skos__hiddenLabel mesh__D046208 Analytical Procedures, Microchip
% 216.78/217.01  |- skos__related mesh__D046208smesh__D036103
% 216.78/217.01  |- skos__hiddenLabel mesh__D046208 Lab-On-A-Chips
% 216.78/217.01  |- skos__hiddenLabel mesh__D046208 Devices, Microchip Analytical
% 216.78/217.01  |- mesh__dateEstablished mesh__D046208 2005-01-01
% 216.78/217.01  |- skos__hiddenLabel mesh__D046208 Microchip Analytical Procedure
% 216.78/217.01  |- skos__altLabel mesh__D046208 Microchip Analysis
% 216.78/217.01  |- skos__hiddenLabel mesh__D046208 Device, Nanochip Analytical
% 216.78/217.01  |- skos__hiddenLabel mesh__D046208 Procedures, Microchip Analytical
% 216.78/217.01  |- skos__broader mesh__D046208smesh__D008919
% 216.78/217.01  |- skos__hiddenLabel mesh__D046208 Lab On A Chip
% 216.78/217.01  |- skos__related mesh__D046208smesh__D008846
% 216.78/217.01  |- mesh__recordOriginator mesh__D046208 nns
% 216.78/217.01  |- mesh__recordOriginator mesh__D018517 JLS
% 216.78/217.01  |- skos__altLabel mesh__D018517 Plant Root
% 216.78/217.01  |- skos__annotation mesh__D018517
% 216.78/217.01       coordinate with specific plant if pertinent   
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D018517 2005
% 216.78/217.01  |- rdf__type mesh__D018517sskos__Concept
% 216.78/217.01  |- skos__scopeNote mesh__D018517
% 216.78/217.01       The usually underground portions of a plant that serve as support, store food, and through which water and mineral nutrients enter the plant. %28%From American Heritage Dictionary, 1982; Concise Dictionary of Biology, 1990%29%%A%    
% 216.78/217.01  |- skos__historyNote mesh__D018517 Plants %28%1966-1994%29%
% 216.78/217.01  |- skos__prefLabel mesh__D018517 Plant Roots
% 216.78/217.01  |- mesh__recordMaintainer mesh__D018517 ssb
% 216.78/217.01  |- mesh__dateCreated mesh__D018517 1994-06-07
% 216.78/217.01  |- mesh__recordAuthorizer mesh__D018517 sjn
% 216.78/217.01  |- mesh__publicMeSHNote mesh__D018517 95   
% 216.78/217.01  |- mesh__dateRevised mesh__D018517 2004-07-07
% 216.78/217.01  |- skos__broader mesh__D018517smesh__D018514
% 216.78/217.01  |- mesh__historyNote mesh__D018517 95   
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D018517 2006
% 216.78/217.01  |- mesh__dateEstablished mesh__D018517 1995-01-01
% 216.78/217.01  |- skos__hiddenLabel mesh__D010534 Neoplasm, Peritoneal
% 216.78/217.01  |- skos__prefLabel mesh__D010534 Peritoneal Neoplasms
% 216.78/217.01  |- mesh__recordMaintainer mesh__D010534 lkt
% 216.78/217.01  |- skos__broader mesh__D010534smesh__D000008
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D010534 2006
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D010534 2004
% 216.78/217.01  |- skos__scopeNote mesh__D010534 Tumors or cancer of the PERITONEUM.     
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D010534 2005
% 216.78/217.01  |- skos__broader mesh__D010534smesh__D004067
% 216.78/217.01  |- skos__broader mesh__D010534smesh__D010532
% 216.78/217.01  |- rdf__type mesh__D010534sskos__Concept
% 216.78/217.01  |- mesh__dateCreated mesh__D010534 1999-01-01
% 216.78/217.01  |- mesh__dateRevised mesh__D010534 2003-07-09
% 216.78/217.01  |- skos__hiddenLabel mesh__D010534 Peritoneal Neoplasm
% 216.78/217.01  |- skos__annotation mesh__D010534
% 216.78/217.01       coord IM with histol type of neopl %28%IM%29%   
% 216.78/217.01  |- mesh__recordAuthorizer mesh__D010534 sjn
% 216.78/217.01  |- mesh__recordOriginator mesh__D010534 NLM
% 216.78/217.01  |- skos__hiddenLabel mesh__D010534 Neoplasms, Peritoneal
% 216.78/217.01  |- mesh__dateRevised mesh__D034982 2005-06-30
% 216.78/217.01  |- skos__broader mesh__D034982smesh__D004268
% 216.78/217.01  |- skos__historyNote mesh__D034982 Bacterial Proteins %28%1981-2002%29%
% 216.78/217.01  |- skos__altLabel mesh__D034982 Host Factor Protein
% 216.78/217.01  |- skos__prefLabel mesh__D034982 Integration Host Factors
% 216.78/217.01  |- mesh__recordOriginator mesh__D034982 jmp
% 216.78/217.01  |- mesh__dateEstablished mesh__D034982 2003-01-01
% 216.78/217.01  |- mesh__dateCreated mesh__D034982 2002-07-03
% 216.78/217.01  |- mesh__recordAuthorizer mesh__D034982 sjn
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D034982 2006
% 216.78/217.01  |- skos__altLabel mesh__D034982 Host Factors
% 216.78/217.01  |- mesh__publicMeSHNote mesh__D034982
% 216.78/217.01       2003; INTEGRATION HOST FACTOR was indexed under BACTERIAL PROTEINS 1985-2002; HOST FACTOR was indexed under CARRIER PROTEINS 1981-2002%A%  
% 216.78/217.01  |- skos__altLabel mesh__D034982 Integration Host Factor
% 216.78/217.01  |- skos__altLabel mesh__D034982 Host Factor
% 216.78/217.01  |- skos__hiddenLabel mesh__D034982 Host Factors, Integration
% 216.78/217.01  |- skos__scopeNote mesh__D034982
% 216.78/217.01       Bacterial proteins that are used by BACTERIOPHAGES to incorporate their DNA into the DNA of the %22%host%22% bacteria. They are DNA-binding proteins that function in genetic recombination as well as in transcriptional and translational regulation.%A%    
% 216.78/217.01  |- rdf__type mesh__D034982sskos__Concept
% 216.78/217.01  |- skos__hiddenLabel mesh__D034982 Factors, Integration Host
% 216.78/217.01  |- skos__broader mesh__D034982smesh__D001426
% 216.78/217.01  |- skos__annotation mesh__D034982 see SCR for organism-specific terms   
% 216.78/217.01  |- mesh__recordMaintainer mesh__D034982 SYSTEM
% 216.78/217.01  |- mesh__historyNote mesh__D034982
% 216.78/217.01       2003; use INTEGRATION HOST FACTORS %28%NM%29% 1981-2002   
% 216.78/217.01  |- skos__historyNote mesh__D034982 Carrier Proteins %28%1981-2002%29%
% 216.78/217.01  |- skos__historyNote mesh__D020962 Guanosine Triphosphate %28%1972-1984%29%
% 216.78/217.01  |- skos__historyNote mesh__D020962 Guanine Nucleotides %28%1966-1984%29%
% 216.78/217.01  |- mesh__recordAuthorizer mesh__D020962 sjn
% 216.78/217.01  |- skos__prefLabel mesh__D020962 Heterotrimeric GTP-Binding Proteins
% 216.78/217.01  |- skos__historyNote mesh__D020962
% 216.78/217.01       Receptors, Cell Surface %28%1973-1984%29%
% 216.78/217.01  |- skos__hiddenLabel mesh__D020962 Heterotrimeric GTP Binding Proteins
% 216.78/217.01  |- skos__broader mesh__D020962smesh__D019204
% 216.78/217.01  |- mesh__historyNote mesh__D020962 2000   
% 216.78/217.01  |- skos__hiddenLabel mesh__D020962 Heterotrimeric G Proteins
% 216.78/217.01  |- mesh__publicMeSHNote mesh__D020962 2000   
% 216.78/217.01  |- mesh__dateCreated mesh__D020962 1999-11-05
% 216.78/217.01  |- skos__scopeNote mesh__D020962
% 216.78/217.01       GTP-BINDING PROTEINS that contain three non-identical subunits. They are found associated with members of the seven transmembrane domain superfamily of G-PROTEIN-COUPLED RECEPTORS. Upon activation the GTP-BINDING PROTEIN ALPHA SUBUNIT of the complex dissociates leaving a dimer of a GTP-BINDING PROTEIN BETA SUBUNIT bound to a GTP-BINDING PROTEIN GAMMA SUBUNIT.%A%    
% 216.78/217.01  |- skos__hiddenLabel mesh__D020962 GTP-Binding Proteins, Heterotrimeric
% 216.78/217.01  |- skos__historyNote mesh__D020962 GTP-Binding Proteins %28%1985-1999%29%
% 216.78/217.01  |- skos__broader mesh__D020962smesh__D008565
% 216.78/217.01  |- skos__hiddenLabel mesh__D020962 G-Proteins, Heterotrimeric
% 216.78/217.01  |- mesh__recordMaintainer mesh__D020962 SYSTEM
% 216.78/217.01  |- mesh__recordOriginator mesh__D020962 jmp
% 216.78/217.01  |- skos__historyNote mesh__D020962 Adenylate Cyclase %28%1968-1984%29%
% 216.78/217.01  |- skos__historyNote mesh__D020962 Carrier Proteins %28%1966-1984%29%
% 216.78/217.01  |- mesh__dateEstablished mesh__D020962 2000-01-01
% 216.78/217.01  |- skos__broader mesh__D020962smesh__D047908
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D020962 2006
% 216.78/217.01  |- rdf__type mesh__D020962sskos__Concept
% 216.78/217.01  |- skos__annotation mesh__D020962
% 216.78/217.01       GEN or unspecified; prefer specifics; DF: HET G PROTEINS   
% 216.78/217.01  |- mesh__dateRevised mesh__D020962 2005-06-30
% 216.78/217.01  |- skos__altLabel mesh__D020962 Heterotrimeric G-Proteins
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D006493 2006
% 216.78/217.01  |- mesh__dateCreated mesh__D006493 1999-01-01
% 216.78/217.01  |- mesh__recordMaintainer mesh__D006493 ssb
% 216.78/217.01  |- skos__hiddenLabel mesh__D006493 alpha Heparin
% 216.78/217.01  |- skos__scopeNote mesh__D006493
% 216.78/217.01       A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts.%A%    
% 216.78/217.01  |- skos__broader mesh__D006493smesh__D006025
% 216.78/217.01  |- mesh__recordOriginator mesh__D006493 NLM
% 216.78/217.01  |- mesh__historyNote mesh__D006493
% 216.78/217.01       /therapeutic use was HEPARIN, THERAPEUTIC 1965   
% 216.78/217.01  |- mesh__dateRevised mesh__D006493 2004-07-07
% 216.78/217.01  |- mesh__recordAuthorizer mesh__D006493 sjn
% 216.78/217.01  |- mesh__publicMeSHNote mesh__D006493
% 216.78/217.01       /therapeutic use was HEPARIN, THERAPEUTIC 1965   
% 216.78/217.01  |- rdf__type mesh__D006493sskos__Concept
% 216.78/217.01  |- skos__hiddenLabel mesh__D006493 Heparin, Sodium
% 216.78/217.01  |- skos__prefLabel mesh__D006493 Heparin
% 216.78/217.01  |- skos__altLabel mesh__D006493 Heparinic Acid
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D006493 2005
% 216.78/217.01  |- skos__annotation mesh__D020164
% 216.78/217.01       not used for indexing      CATALOG: do not use   
% 216.78/217.01  |- mesh__publicMeSHNote mesh__D020164 99   
% 216.78/217.01  |- skos__scopeNote mesh__D020164
% 216.78/217.01       A group of pharmacologic activities, effects on living systems and the environment, and modes of employment of drugs and chemicals. They are broken into actions, which describe their effects, and uses, which describe how they are employed.%A%    
% 216.78/217.01  |- mesh__dateCreated mesh__D020164 1998-06-10
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D020164 2004
% 216.78/217.01  |- skos__prefLabel mesh__D020164 Chemical Actions and Uses
% 216.78/217.01  |- mesh__recordMaintainer mesh__D020164 ssb
% 216.78/217.01  |- mesh__recordOriginator mesh__D020164 ADP
% 216.78/217.01  |- mesh__historyNote mesh__D020164 99   
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D020164 2005
% 216.78/217.01  |- mesh__recordAuthorizer mesh__D020164 sjn
% 216.78/217.01  |- mesh__dateRevised mesh__D020164 2003-07-09
% 216.78/217.01  |- mesh__activeMeSHYear mesh__D020164 2006
% 216.78/217.01  |- mesh__dateEstablished mesh__D020164 1999-01-01
% 216.78/217.01  |- rdf__type mesh__D020164sskos__Concept
% 216.78/217.01  |- mesh__runningHead mesh__D020164 D27 - CHEMICAL ACTIONS AND USES   
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D014925 2006
% 216.78/217.02  |- skos__related mesh__D014925smesh__D027641
% 216.78/217.02  |- skos__hiddenLabel mesh__D014925 Humor and Wit
% 216.78/217.02  |- mesh__recordMaintainer mesh__D014925 ssb
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D014925 2004
% 216.78/217.02  |- skos__broader mesh__D014925smesh__D008091
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D014925 2005
% 216.78/217.02  |- mesh__recordOriginator mesh__D014925 NLM
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D014925 2003
% 216.78/217.02  |- skos__related mesh__D014925smesh__D002359
% 216.78/217.02  |- mesh__recordAuthorizer mesh__D014925 sjn
% 216.78/217.02  |- rdf__type mesh__D014925sskos__Concept
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D014925 2002
% 216.78/217.02  |- skos__annotation mesh__D014925 IM   
% 216.78/217.02  |- skos__related mesh__D014925smesh__D007845
% 216.78/217.02  |- skos__scopeNote mesh__D014925
% 216.78/217.02       The faculty of expressing the amusing, clever, or comical or the keen perception and cleverly apt expression of connections between ideas that awaken amusement and pleasure. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 216.78/217.02  |- skos__prefLabel mesh__D014925 Wit and Humor
% 216.78/217.02  |- skos__related mesh__D014925smesh__D002325
% 216.78/217.02  |- mesh__dateRevised mesh__D014925 2001-07-25
% 216.78/217.02  |- mesh__dateCreated mesh__D014925 1999-01-01
% 216.78/217.02  |- skos__scopeNote mesh__D014127
% 216.78/217.02       4-Amino-5-cyano-7-%28%D-ribofuranosyl%29%-7H- pyrrolo%28%2,3-d%29%pyrimidine. Antibiotic antimetabolite isolated from Streptomyces toyocaensis cultures. It is an analog of adenosine, blocks RNA synthesis and ribosome function, and is used mainly as a tool in biochemistry.%A%    
% 216.78/217.02  |- mesh__historyNote mesh__D014127
% 216.78/217.02       91%28%75%29%; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1981-90; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-80%A%  
% 216.78/217.02  |- mesh__recordAuthorizer mesh__D014127 PLS
% 216.78/217.02  |- skos__historyNote mesh__D014127 Pyrimidine Nucleosides %28%1974%29%
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D014127 1998
% 216.78/217.02  |- skos__historyNote mesh__D014127 Pyrroles %28%1966-1974%29%
% 216.78/217.02  |- mesh__dateEstablished mesh__D014127 1991-01-01
% 216.78/217.02  |- mesh__publicMeSHNote mesh__D014127
% 216.78/217.02       91; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1981-90; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-80%A%  
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D014127 1997
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D014127 1999
% 216.78/217.02  |- mesh__recordOriginator mesh__D014127 NLM
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D014127 2002
% 216.78/217.02  |- skos__broader mesh__D014127smesh__D012263
% 216.78/217.02  |- skos__historyNote mesh__D014127 Nucleosides %28%1966-1972%29%
% 216.78/217.02  |- skos__prefLabel mesh__D014127 Toyocamycin
% 216.78/217.02  |- rdf__type mesh__D014127sskos__Concept
% 216.78/217.02  |- mesh__dateRevised mesh__D014127 1995-06-08
% 216.78/217.02  |- skos__altLabel mesh__D014127 Toyokamycin
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D014127 2003
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D014127 2000
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D014127 2005
% 216.78/217.02  |- skos__altLabel mesh__D014127 Deazacyanoadenosine
% 216.78/217.02  |- skos__annotation mesh__D014127
% 216.78/217.02       an antineoplastic antibiotic %26% antimetabolite   
% 216.78/217.02  |- mesh__dateCreated mesh__D014127 1974-11-19
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D014127 2004
% 216.78/217.02  |- mesh__recordMaintainer mesh__D014127 JRT
% 216.78/217.02  |- skos__historyNote mesh__D014127 Ribonucleosides %28%1973-1974%29%
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D014127 2001
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D014127 2006
% 216.78/217.02  |- skos__historyNote mesh__D014127 Nitriles %28%1966-1974%29%
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D014127 1996
% 216.78/217.02  |- skos__broader mesh__D019610smesh__D002620
% 216.78/217.02  |- skos__hiddenLabel mesh__D019610 Protection, Cell
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D019610 2005
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D019610 2004
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D019610 1999
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D019610 2002
% 216.78/217.02  |- rdf__type mesh__D019610sskos__Concept
% 216.78/217.02  |- skos__scopeNote mesh__D019610
% 216.78/217.02       The process by which chemical compounds provide protection to cells against harmful agents.%A%    
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D019610 2003
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D019610 1998
% 216.78/217.02  |- skos__annotation mesh__D019610
% 216.78/217.02       coordinate with specific agent and specific cell   
% 216.78/217.02  |- mesh__dateEstablished mesh__D019610 1998-01-01
% 216.78/217.02  |- skos__altLabel mesh__D019610 Cell Protection
% 216.78/217.02  |- skos__prefLabel mesh__D019610 Cytoprotection
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D019610 2001
% 216.78/217.02  |- mesh__dateCreated mesh__D019610 1997-06-20
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D019610 2000
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D019610 2006
% 216.78/217.02  |- mesh__historyNote mesh__D019610 98   
% 216.78/217.02  |- mesh__publicMeSHNote mesh__D019610 98   
% 216.78/217.02  |- mesh__dateEstablished mesh__D000107 1991-01-01
% 216.78/217.02  |- skos__annotation mesh__D000107
% 216.78/217.02       almost never IM; enzymatic acetylation: coord NIM with ACETYLTRANSFERASES %28%IM%29% + substrate %28%NIM%29% or specific acetyltransferase %28%IM%29%%A%  
% 216.78/217.02  |- mesh__recordAuthorizer mesh__D000107 sjn
% 216.78/217.02  |- skos__broader mesh__D000107smesh__D000215
% 216.78/217.02  |- skos__prefLabel mesh__D000107 Acetylation
% 216.78/217.02  |- skos__historyNote mesh__D000107 Chemistry, Organic %28%1966-1972%29%
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D000107 2006
% 216.78/217.02  |- rdf__type mesh__D000107sskos__Concept
% 216.78/217.02  |- skos__hiddenLabel mesh__D000107 Acetylations
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D000107 2005
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D000107 2002
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D000107 2004
% 216.78/217.02  |- mesh__historyNote mesh__D000107
% 216.78/217.02       91%28%73%29%; was see under CHEMISTRY, ORGANIC 1973-90   
% 216.78/217.02  |- mesh__publicMeSHNote mesh__D000107
% 216.78/217.02       91; was see under CHEMISTRY, ORGANIC 1973-90   
% 216.78/217.02  |- mesh__dateCreated mesh__D000107 1999-01-01
% 216.78/217.02  |- mesh__recordOriginator mesh__D000107 NLM
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D000107 2001
% 216.78/217.02  |- mesh__dateRevised mesh__D000107 1999-11-03
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D000107 2003
% 216.78/217.02  |- skos__scopeNote mesh__D000107
% 216.78/217.02       Formation of an acetyl derivative. %28%Stedman, 25th ed%29%     
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D000107 2000
% 216.78/217.02  |- mesh__recordMaintainer mesh__D000107 ags
% 216.78/217.02  |- skos__hiddenLabel mesh__D052246 COX 2 Inhibitors
% 216.78/217.02  |- mesh__recordAuthorizer mesh__D052246 ags
% 216.78/217.02  |- skos__scopeNote mesh__D052246
% 216.78/217.02       A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2.%A%    
% 216.78/217.02  |- skos__altLabel mesh__D052246 COX2 Inhibitors
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D052246 2006A
% 216.78/217.02  |- skos__hiddenLabel mesh__D052246 Inhibitors, Cyclooxygenase 2
% 216.78/217.02  |- mesh__publicMeSHNote mesh__D052246
% 216.78/217.02       2006; see CYCLOOXYGENASE INHIBITORS 2005   
% 216.78/217.02  |- skos__altLabel mesh__D052246 Cyclooxygenase-2 Inhibitors
% 216.78/217.02  |- mesh__dateEstablished mesh__D052246 2006-01-01
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D052246 2006
% 216.78/217.02  |- skos__prefLabel mesh__D052246 Cyclooxygenase 2 Inhibitors
% 216.78/217.02  |- skos__hiddenLabel mesh__D052246 2 Inhibitors, Cyclooxygenase
% 216.78/217.02  |- mesh__historyNote mesh__D052246 2006   
% 216.78/217.02  |- skos__hiddenLabel mesh__D052246 Inhibitors, COX-2
% 216.78/217.02  |- mesh__recordMaintainer mesh__D052246 ags
% 216.78/217.02  |- rdf__type mesh__D052246sskos__Concept
% 216.78/217.02  |- skos__altLabel mesh__D052246 Coxibs
% 216.78/217.02  |- mesh__dateRevised mesh__D052246 2005-11-09
% 216.78/217.02  |- mesh__dateCreated mesh__D052246 2005-06-30
% 216.78/217.02  |- skos__hiddenLabel mesh__D052246 Inhibitors, Cyclooxygenase-2
% 216.78/217.02  |- mesh__recordOriginator mesh__D052246 jmp
% 216.78/217.02  |- skos__broader mesh__D052246smesh__D016861
% 216.78/217.02  |- skos__altLabel mesh__D052246 COX-2 Inhibitors
% 216.78/217.02  |- skos__hiddenLabel mesh__D052246 Inhibitors, COX2
% 216.78/217.02  |- skos__broader mesh__D000843Q000293smesh__D000843
% 216.78/217.02  |- mesh__preferredCombination mesh__D000843Q000293smesh__D016512
% 216.78/217.02  |- rdf__type mesh__D000843Q000293smesh__CompoundConcept
% 216.78/217.02  |- mesh__publicMeSHNote mesh__D046209 2005   
% 216.78/217.02  |- mesh__dateEstablished mesh__D046209 2005-01-01
% 216.78/217.02  |- skos__altLabel mesh__D046209 Microchip Electrophoresis
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D046209 2005
% 216.78/217.02  |- mesh__dateCreated mesh__D046209 2004-07-07
% 216.78/217.02  |- mesh__recordAuthorizer mesh__D046209 sjn
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D046209 2006
% 216.78/217.02  |- skos__broader mesh__D046209smesh__D046210
% 216.78/217.02  |- rdf__type mesh__D046209sskos__Concept
% 216.78/217.02  |- mesh__recordOriginator mesh__D046209 nns
% 216.78/217.02  |- mesh__recordMaintainer mesh__D046209 nns
% 216.78/217.02  |- skos__prefLabel mesh__D046209 Electrophoresis, Microchip
% 216.78/217.02  |- mesh__historyNote mesh__D046209 2005   
% 216.78/217.02  |- skos__annotation mesh__D046209
% 216.78/217.02       coord with MICROARRAY ANALYSIS if pertinent   
% 216.78/217.02  |- skos__broader mesh__D046209smesh__D019075
% 216.78/217.02  |- skos__hiddenLabel mesh__D046209 Microchip Electrophoreses
% 216.78/217.02  |- skos__scopeNote mesh__D046209
% 216.78/217.02       A highly miniaturized version of ELECTROPHORESIS performed in a microfluidic device.%A%    
% 216.78/217.02  |- skos__hiddenLabel mesh__D046209 Electrophoreses, Microchip
% 216.78/217.02  |- mesh__recordMaintainer mesh__D018518 PXP
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D018518 1998
% 216.78/217.02  |- mesh__dateEstablished mesh__D018518 1995-01-01
% 216.78/217.02  |- skos__prefLabel mesh__D018518 Plant Root Cap
% 216.78/217.02  |- mesh__dateCreated mesh__D018518 1994-06-07
% 216.78/217.02  |- skos__scopeNote mesh__D018518
% 216.78/217.02       A cone-shaped structure in plants made up of a mass of meristematic cells that covers and protects the tip of a growing root. It is the putative site of gravity sensing in plant roots.%A%    
% 216.78/217.02  |- skos__historyNote mesh__D018518 Plants %28%1966-1994%29%
% 216.78/217.02  |- skos__annotation mesh__D018518
% 216.78/217.02       composed of meristem cells; IM GEN or unspecified; coord probably IM in genetics %26% space physiol, NIM in pharmacognosy, with specific plant %28%IM or NIM%29%%A%  
% 216.78/217.02  |- mesh__recordAuthorizer mesh__D018518 PLS
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D018518 2002
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D018518 2004
% 216.78/217.02  |- skos__broader mesh__D018518smesh__D018519
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D018518 2001
% 216.78/217.02  |- mesh__dateRevised mesh__D018518 1996-06-10
% 216.78/217.02  |- mesh__historyNote mesh__D018518 95   
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D018518 2003
% 216.78/217.02  |- skos__altLabel mesh__D018518 Plant Root Caps
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D018518 2006
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D018518 1997
% 216.78/217.02  |- mesh__recordOriginator mesh__D018518 JLS
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D018518 2000
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D018518 2005
% 216.78/217.02  |- rdf__type mesh__D018518sskos__Concept
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D018518 1999
% 216.78/217.02  |- mesh__publicMeSHNote mesh__D018518 95   
% 216.78/217.02  |- skos__altLabel mesh__D010535 Laparoscopic Surgical Procedures
% 216.78/217.02  |- skos__altLabel mesh__D010535 Laparoscopic Surgery
% 216.78/217.02  |- skos__scopeNote mesh__D010535
% 216.78/217.02       A procedure in which a laparoscope %28%LAPAROSCOPES%29% is inserted through a small incision near the navel to examine the abdominal and pelvic organs in the PERITONEAL CAVITY. If appropriate, biopsy or surgery can be performed during laparoscopy.%A%    
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D010535 2005
% 216.78/217.02  |- skos__hiddenLabel mesh__D010535 Laparoscopic Surgeries
% 216.78/217.02  |- skos__altLabel mesh__D010535 Peritoneoscopy
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D010535 2003
% 216.78/217.02  |- skos__hiddenLabel mesh__D010535 Celioscopies
% 216.78/217.02  |- mesh__dateRevised mesh__D010535 2002-07-03
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D010535 2006
% 216.78/217.02  |- mesh__recordAuthorizer mesh__D010535 sjn
% 216.78/217.02  |- mesh__dateCreated mesh__D010535 1999-01-01
% 216.78/217.02  |- skos__broader mesh__D010535smesh__D004724
% 216.78/217.02  |- skos__hiddenLabel mesh__D010535 Laparoscopies
% 216.78/217.02  |- skos__altLabel mesh__D010535 Surgical Procedure, Laparoscopic
% 216.78/217.02  |- mesh__recordOriginator mesh__D010535 NLM
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D010535 2004
% 216.78/217.02  |- skos__prefLabel mesh__D010535 Laparoscopy
% 216.78/217.02  |- mesh__historyNote mesh__D010535
% 216.78/217.02       1993, 1971-1977; use PERITONEOSCOPY 1978-1992   
% 216.78/217.02  |- rdf__type mesh__D010535sskos__Concept
% 216.78/217.02  |- skos__altLabel mesh__D010535 Procedures, Laparoscopic Surgical
% 216.78/217.02  |- skos__hiddenLabel mesh__D010535 Surgeries, Laparoscopic
% 216.78/217.02  |- skos__altLabel mesh__D010535 Surgery, Laparoscopic
% 216.78/217.02  |- mesh__publicMeSHNote mesh__D010535
% 216.78/217.02       1993, 1973-1977; for SURGICAL PROCEDURES, LAPAROSCOPIC and LAPAROSCOPIC SURGICAL PROCEDURES see SURGICAL PROCEDURES, LAPROSCOPIC 1998-1999, see SURGERY, LAPAROSCOPIC 1993-1997; for PERITONEOSCOPY see PERITONEOSCOPY 1963-1992%A%  
% 216.78/217.02  |- skos__altLabel mesh__D010535 Procedure, Laparoscopic Surgical
% 216.78/217.02  |- skos__altLabel mesh__D010535 Celioscopy
% 216.78/217.02  |- mesh__recordMaintainer mesh__D010535 lkt
% 216.78/217.02  |- skos__altLabel mesh__D010535 Laparoscopic Surgical Procedure
% 216.78/217.02  |- skos__hiddenLabel mesh__D010535 Peritoneoscopies
% 216.78/217.02  |- skos__altLabel mesh__D015220 Voltage-Dependent Calcium Channels
% 216.78/217.02  |- mesh__historyNote mesh__D015220
% 216.78/217.02       89; RECEPTORS, CALCIUM CHANNEL BLOCKER was heading 1993 %28%was CALCIUM CHANNEL BLOCKER RECEPTOR %28%NM%29% 1983-92%29%; CALCIUM CHANNEL ANTAGONIST RECEPTORS, CALCIUM CHANNEL BLOCKER RECEPTORS %26% RECEPTORS, CALCIUM CHANNEL ANTAGONIST were see RECEPTORS, CALCIUM CHANNEL BLOCKER 1993%A%  
% 216.78/217.02  |- mesh__dateEstablished mesh__D015220 1989-01-01
% 216.78/217.02  |- skos__altLabel mesh__D015220 Ion Channel, Calcium
% 216.78/217.02  |- mesh__recordMaintainer mesh__D015220 SYSTEM
% 216.78/217.02  |- skos__altLabel mesh__D015220 Calcium Channel Blocker Receptor
% 216.78/217.02  |- skos__altLabel mesh__D015220 Calcium Channel Antagonist Receptors
% 216.78/217.02  |- skos__related mesh__D015220smesh__D002120
% 216.78/217.02  |- skos__altLabel mesh__D015220 Calcium Channel Blocker Receptors
% 216.78/217.02  |- skos__altLabel mesh__D015220 Calcium Channel
% 216.78/217.02  |- skos__altLabel mesh__D015220 Receptors, Calcium Channel Antagonist
% 216.78/217.02  |- mesh__recordOriginator mesh__D015220 EJB
% 216.78/217.02  |- mesh__dateCreated mesh__D015220 1988-05-12
% 216.78/217.02  |- mesh__dateRevised mesh__D015220 2005-06-30
% 216.78/217.02  |- skos__related mesh__D015220smesh__D020013
% 216.78/217.02  |- rdf__type mesh__D015220sskos__Concept
% 216.78/217.02  |- mesh__onlineNote mesh__D015220
% 216.78/217.02       use CALCIUM CHANNELS to search RECEPTORS, CALCIUM CHANNEL BLOCKER, CALCIUM CHANNEL ANTAGONIST RECEPTORS, CALCIUM CHANNEL BLOCKER RECEPTORS %26% RECEPTORS, CALCIUM CHANNEL ANTAGONIST 1993; use CALCIUM CHANNELS %28%NM%29% to search RECEPTORS, CALCIUM CHANNEL BLOCKER 1983-93%A%  
% 216.78/217.02  |- skos__altLabel mesh__D015220 VDCC
% 216.78/217.02  |- skos__altLabel mesh__D015220 Calcium Channel Antagonist Receptor
% 216.78/217.02  |- mesh__recordAuthorizer mesh__D015220 sjn
% 216.78/217.02  |- mesh__publicMeSHNote mesh__D015220
% 216.78/217.02       89; RECEPTORS, CALCIUM CHANNEL BLOCKER was heading 1993 %28%was CALCIUM CHANNEL BLOCKER RECEPTOR %28%NM%29% 1983-92, was indexed under RECEPTORS, NICOTINIC 1983-92%29%; CALCIUM CHANNEL ANTAGONIST RECEPTORS, CALCIUM CHANNEL BLOCKER RECEPTORS %26% RECEPTORS, CALCIUM CHANNEL ANTAGONIST were see RECEPTORS, CALCIUM CHANNEL BLOCKER 1993%A%  
% 216.78/217.02  |- skos__hiddenLabel mesh__D015220 Calcium Ion Channel
% 216.78/217.02  |- skos__historyNote mesh__D015220 Calcium %28%1979-1988%29%
% 216.78/217.02  |- skos__annotation mesh__D015220
% 216.78/217.02       L-, N-, P-, Q-, R-, %26% T-Type CALCIUM CHANNELS are available; DF: CA CHANNELS%A%  
% 216.78/217.02  |- skos__altLabel mesh__D015220 Ion Channels, Calcium
% 216.78/217.02  |- skos__scopeNote mesh__D015220
% 216.78/217.02       Voltage-dependent cell membrane glycoproteins selectively permeable to calcium ions. They are categorized as L-, T-, N-, P-, Q-, and R-types based on the activation and inactivation kinetics, ion specificity, and sensitivity to drugs and toxins. The L- and T-types are present throughout the cardiovascular and central nervous systems and the N-, P-, Q-, %26% R-types are located in neuronal tissue.%A%    
% 216.78/217.02  |- skos__hiddenLabel mesh__D015220 Calcium Ion Channels
% 216.78/217.02  |- skos__hiddenLabel mesh__D015220 Calcium Channels, Voltage-Dependent
% 216.78/217.02  |- skos__altLabel mesh__D015220 Receptors, Calcium Channel Blocker
% 216.78/217.02  |- skos__prefLabel mesh__D015220 Calcium Channels
% 216.78/217.02  |- skos__broader mesh__D015220smesh__D007473
% 216.78/217.02  |- skos__related mesh__D015220smesh__D000252
% 216.78/217.02  |- skos__hiddenLabel mesh__D015220 Voltage Dependent Calcium Channels
% 216.78/217.02  |- skos__hiddenLabel mesh__D015220 Channels, Voltage-Dependent Calcium
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D015220 2006
% 216.78/217.02  |- skos__related mesh__D015220smesh__D002121
% 216.78/217.02  |- skos__historyNote mesh__D015220 Ion Channels %28%1979-1988%29%
% 216.78/217.02  |- rdf__type mesh__D001200sskos__Concept
% 216.78/217.02  |- skos__scopeNote mesh__D001200
% 216.78/217.02       A genus of nematodes of the superfamily ASCARIDOIDEA whose species usually inhabit the intestine.%A%    
% 216.78/217.02  |- mesh__recordOriginator mesh__D001200 NLM
% 216.78/217.02  |- skos__broader mesh__D001200smesh__D001199
% 216.78/217.02  |- mesh__dateRevised mesh__D001200 2003-07-09
% 216.78/217.02  |- mesh__dateCreated mesh__D001200 1999-01-01
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D001200 2004
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D001200 2005
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D001200 2006
% 216.78/217.02  |- skos__annotation mesh__D001200
% 216.78/217.02       a genus of nematodes; do not confuse with ASCARIDIA, another genus, both belonging to the superfamily of ASCARIDOIDEA; do not confuse with ACARI %28%mites %26% ticks%29% or ACARUS %28%mites%29%; infection = ASCARIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 216.78/217.02  |- mesh__recordAuthorizer mesh__D001200 sjn
% 216.78/217.02  |- mesh__recordMaintainer mesh__D001200 ags
% 216.78/217.02  |- skos__prefLabel mesh__D001200 Ascaris
% 216.78/217.02  |- skos__broader mesh__D005502Q000382smesh__D005502
% 216.78/217.02  |- mesh__preferredCombination mesh__D005502Q000382smesh__D005516
% 216.78/217.02  |- rdf__type mesh__D005502Q000382smesh__CompoundConcept
% 216.78/217.02  |- skos__broader mesh__D020963smesh__D019204
% 216.78/217.02  |- skos__hiddenLabel mesh__D020963 Factors, GTPase-Linked Elongation
% 216.78/217.02  |- mesh__historyNote mesh__D020963 2000%28%1975%29%   
% 216.78/217.02  |- skos__scopeNote mesh__D020963
% 216.78/217.02       Factors that utilize energy from the hydrolysis of GTP to GDP for peptide chain elongation. EC 3.6.1.-.%A%    
% 216.78/217.02  |- mesh__dateCreated mesh__D020963 1999-11-03
% 216.78/217.02  |- skos__hiddenLabel mesh__D020963
% 216.78/217.02       Elongation Factors, Guanosinetriphosphatase-Linked
% 216.78/217.02  |- skos__hiddenLabel mesh__D020963 Elongation Factors, GTPase-Linked
% 216.78/217.02  |- skos__hiddenLabel mesh__D020963
% 216.78/217.02       Factors, Guanosinetriphosphatase-Linked Elongation
% 216.78/217.02  |- skos__historyNote mesh__D020963 Guanosine Triphosphate %28%1969-1974%29%
% 216.78/217.02  |- mesh__recordAuthorizer mesh__D020963 sjn
% 216.78/217.02  |- skos__historyNote mesh__D020963
% 216.78/217.02       Phosphoric Monoester Hydrolases %28%1969-1974%29%
% 216.78/217.02  |- mesh__recordMaintainer mesh__D020963 SYSTEM
% 216.78/217.02  |- mesh__dateEstablished mesh__D020963 2000-01-01
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D020963 2006
% 216.78/217.02  |- rdf__type mesh__D020963sskos__Concept
% 216.78/217.02  |- skos__hiddenLabel mesh__D020963
% 216.78/217.02       Guanosinetriphosphatase Linked Elongation Factors
% 216.78/217.02  |- skos__historyNote mesh__D020963 GTP Phosphohydrolases %28%1975-1999%29%
% 216.78/217.02  |- skos__hiddenLabel mesh__D020963 GTPase Linked Elongation Factors
% 216.78/217.02  |- skos__hiddenLabel mesh__D020963
% 216.78/217.02       GTP Phosphohydrolase Linked Elongation Factors
% 216.78/217.02  |- skos__altLabel mesh__D020963
% 216.78/217.02       Guanosinetriphosphatase-Linked Elongation Factors
% 216.78/217.02  |- skos__altLabel mesh__D020963 GTPase-Linked Elongation Factors
% 216.78/217.02  |- skos__broader mesh__D020963smesh__D010445
% 216.78/217.02  |- mesh__publicMeSHNote mesh__D020963
% 216.78/217.02       2000; see GTP PHOSPHOHYDROLASE 1975-1999   
% 216.78/217.02  |- mesh__recordOriginator mesh__D020963 jmp
% 216.78/217.02  |- skos__prefLabel mesh__D020963
% 216.78/217.02       GTP Phosphohydrolase-Linked Elongation Factors
% 216.78/217.02  |- mesh__dateRevised mesh__D020963 2005-06-30
% 216.78/217.02  |- mesh__dateRevised mesh__D006494 2005-06-30
% 216.78/217.02  |- mesh__recordMaintainer mesh__D006494 ssb
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D006494 2006
% 216.78/217.02  |- skos__annotation mesh__D006494 DF: HEPARIN ANTAG   
% 216.78/217.02  |- skos__hiddenLabel mesh__D006494 Antagonists, Heparin
% 216.78/217.02  |- skos__broader mesh__D006494smesh__D045504
% 216.78/217.02  |- skos__scopeNote mesh__D006494
% 216.78/217.02       Coagulant substances inhibiting the anticoagulant action of heparin.%A%    
% 216.78/217.02  |- skos__prefLabel mesh__D006494 Heparin Antagonists
% 216.78/217.02  |- mesh__recordOriginator mesh__D006494 NLM
% 216.78/217.02  |- skos__broader mesh__D006494smesh__D003029
% 216.78/217.02  |- rdf__type mesh__D006494sskos__Concept
% 216.78/217.02  |- mesh__recordAuthorizer mesh__D006494 sjn
% 216.78/217.02  |- mesh__dateCreated mesh__D006494 1999-01-01
% 216.78/217.02  |- skos__historyNote mesh__D020165
% 216.78/217.02       Amino Acid Metabolism, Inborn Errors %28%1975-1999%29%
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D020165 2002
% 216.78/217.02  |- mesh__publicMeSHNote mesh__D020165 2000   
% 216.78/217.02  |- skos__altLabel mesh__D020165
% 216.78/217.02       Carbamyl-Phosphate Synthetase I Deficiency Disease
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D020165 2006
% 216.78/217.02  |- rdf__type mesh__D020165sskos__Concept
% 216.78/217.02  |- skos__related mesh__D020165smesh__D002222
% 216.78/217.02  |- skos__altLabel mesh__D020165
% 216.78/217.02       Carbamoylphosphate Synthetase I Deficiency Disease
% 216.78/217.02  |- mesh__dateEstablished mesh__D020165 2000-01-01
% 216.78/217.02  |- skos__broader mesh__D020165smesh__D000592
% 216.78/217.02  |- skos__altLabel mesh__D020165
% 216.78/217.02       Deficiency Disease, Carbamoyl Phosphate Synthase %28%Ammonia%29%
% 216.78/217.02  |- mesh__recordAuthorizer mesh__D020165 sjn
% 216.78/217.02  |- skos__historyNote mesh__D020165
% 216.78/217.02       Carbamoyl-Phosphate Synthase %28%Ammonia%29%/deficiency %28%1989-1999%29%
% 216.78/217.02  |- skos__altLabel mesh__D020165
% 216.78/217.02       Deficiency Disease, Carbamoylphosphate Synthetase I
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D020165 2005
% 216.78/217.02  |- skos__altLabel mesh__D020165
% 216.78/217.02       Carbamoyl-Phosphate Synthetase I Deficiency Disease
% 216.78/217.02  |- mesh__recordMaintainer mesh__D020165 nns
% 216.78/217.02  |- skos__prefLabel mesh__D020165
% 216.78/217.02       Carbamoyl-Phosphate Synthase I Deficiency Disease
% 216.78/217.02  |- mesh__recordOriginator mesh__D020165 KEV
% 216.78/217.02  |- skos__scopeNote mesh__D020165
% 216.78/217.02       A urea cycle disorder manifesting in infancy as lethargy, emesis, seizures, alterations of muscle tone, abnormal eye movements, and an elevation of serum ammonia. The disorder is caused by a reduction in the activity of hepatic mitochondrial CARBAMOYL-PHOSPHATE SYNTHASE %28%AMMONIA%29%. %28%Menkes, Textbook of Child Neurology, 5th ed, pp50-1%29%%A%    
% 216.78/217.02  |- mesh__historyNote mesh__D020165 2000   
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D020165 2004
% 216.78/217.02  |- skos__altLabel mesh__D020165
% 216.78/217.02       Carbamoyl Phosphate Synthase %28%Ammonia%29% Deficiency Disease
% 216.78/217.02  |- skos__broader mesh__D020165smesh__D020739
% 216.78/217.02  |- skos__altLabel mesh__D020165
% 216.78/217.02       Deficiency Disease, Carbamoyl-Phosphate Synthase
% 216.78/217.02  |- skos__altLabel mesh__D020165
% 216.78/217.02       Deficiency Disease, Carbamyl Phosphate Synthetase
% 216.78/217.02  |- skos__annotation mesh__D020165
% 216.78/217.02       consider also CARBAMOYL-PHOSPHATE SYNTHASE %28%AMMONIA%29%/defic; DF: CP SYNTHASE I DEFIC DIS%A%  
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D020165 2003
% 216.78/217.02  |- skos__altLabel mesh__D020165
% 216.78/217.02       Carbamyl Phosphate Synthetase Deficiency Disease
% 216.78/217.02  |- skos__hiddenLabel mesh__D020165
% 216.78/217.02       Deficiency Disease, Carbamoyl Phosphate Synthase
% 216.78/217.02  |- mesh__dateCreated mesh__D020165 1999-11-05
% 216.78/217.02  |- skos__hiddenLabel mesh__D020165
% 216.78/217.02       Carbamyl Phosphate Synthetase I Deficiency Disease
% 216.78/217.02  |- mesh__dateRevised mesh__D020165 2001-07-25
% 216.78/217.02  |- skos__hiddenLabel mesh__D020165
% 216.78/217.02       Carbamoyl Phosphate Synthetase I Deficiency Disease
% 216.78/217.02  |- skos__historyNote mesh__D020165
% 216.78/217.02       Metabolism, Inborn Errors %28%1970-1974%29%
% 216.78/217.02  |- mesh__recordMaintainer mesh__D014128 ssb
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D014128 2006
% 216.78/217.02  |- mesh__recordOriginator mesh__D014128 NLM
% 216.78/217.02  |- mesh__dateRevised mesh__D014128 2004-07-07
% 216.78/217.02  |- skos__prefLabel mesh__D014128 Chromomycin A3
% 216.78/217.02  |- mesh__recordAuthorizer mesh__D014128 sjn
% 216.78/217.02  |- mesh__historyNote mesh__D014128
% 216.78/217.02       91%28%75%29%; was TOYOMICIN see under CHROMOMYCINS 1975-90   
% 216.78/217.02  |- rdf__type mesh__D014128sskos__Concept
% 216.78/217.02  |- skos__altLabel mesh__D014128 Toyomycin
% 216.78/217.02  |- skos__scopeNote mesh__D014128
% 216.78/217.02       Glycosidic antibiotic from Streptomyces griseus used as a fluorescent stain of DNA and as an antineoplastic agent.%A%    
% 216.78/217.02  |- mesh__publicMeSHNote mesh__D014128
% 216.78/217.02       91; was TOYOMICIN see under CHROMOMYCINS 1975-90   
% 216.78/217.02  |- skos__broader mesh__D014128smesh__D002865
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D014128 2005
% 216.78/217.02  |- mesh__onlineNote mesh__D014128
% 216.78/217.02       use CHROMOMYCINS to search TOYOMICIN 1973-90   
% 216.78/217.02  |- mesh__dateEstablished mesh__D014128 1991-01-01
% 216.78/217.02  |- mesh__dateCreated mesh__D014128 1999-01-01
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D000906 2006B
% 216.78/217.02  |- mesh__recordAuthorizer mesh__D000906 ags
% 216.78/217.02  |- skos__related mesh__D000906smesh__D000937
% 216.78/217.02  |- mesh__dateRevised mesh__D000906 2005-07-18
% 216.78/217.02  |- rdf__type mesh__D000906sskos__Concept
% 216.78/217.02  |- mesh__recordMaintainer mesh__D000906 ags
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D000906 2006
% 216.78/217.02  |- skos__broader mesh__D000906smesh__D007136
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D000906 2006A
% 216.78/217.02  |- skos__scopeNote mesh__D000906
% 216.78/217.02       Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN %28%or a very similar shape%29% that induced their synthesis in cells of the lymphoid series %28%especially PLASMA CELLS%29%.%A%    
% 216.78/217.02  |- skos__prefLabel mesh__D000906 Antibodies
% 216.78/217.02  |- skos__annotation mesh__D000906
% 216.78/217.02       antibodies to IMMUNOGLOBULIN A;  IMMUNOGLOBULIN G;  etc. = ANTIBODIES, ANTI-IDIOTYPIC %28%IM%29% + IMMUNOGLOBULIN A;  IMMUNOGLOBULIN G; etc. %28%IM%29%; ANTIBODY-TOXIN CONJUGATES is available as toxin carrier: see note there%A%  
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D000906 2006C
% 216.78/217.02  |- mesh__onlineNote mesh__D000906 pre-explosion = ANTIBODIES %28%PX%29%   
% 216.78/217.02  |- mesh__dateCreated mesh__D000906 1999-01-01
% 216.78/217.02  |- mesh__recordOriginator mesh__D000906 NLM
% 216.78/217.02  |- mesh__recordOriginator mesh__D019611 AGS
% 216.78/217.02  |- skos__broader mesh__D019611smesh__D019609
% 216.78/217.02  |- skos__annotation mesh__D019611 a species of archaea   
% 216.78/217.02  |- rdf__type mesh__D019611sskos__Concept
% 216.78/217.02  |- mesh__recordMaintainer mesh__D019611 SYSTEM
% 216.78/217.02  |- mesh__recordAuthorizer mesh__D019611 sjn
% 216.78/217.02  |- mesh__publicMeSHNote mesh__D019611 98   
% 216.78/217.02  |- mesh__dateRevised mesh__D019611 2005-06-30
% 216.78/217.02  |- skos__historyNote mesh__D019611 Archaea %28%1991-1997%29%
% 216.78/217.02  |- skos__prefLabel mesh__D019611 Archaeoglobus fulgidus
% 216.78/217.02  |- skos__scopeNote mesh__D019611
% 216.78/217.02       A species of extremely thermophilic, sulfur-reducing archaea. It grows at a maximum temperature of 95 degrees C. in marine or deep-sea geothermal areas.%A%    
% 216.78/217.02  |- mesh__dateCreated mesh__D019611 1997-06-20
% 216.78/217.02  |- mesh__dateEstablished mesh__D019611 1998-01-01
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D019611 2006
% 216.78/217.02  |- mesh__historyNote mesh__D019611 98   
% 216.78/217.02  |- mesh__dateRevised mesh__D000108 2005-06-30
% 216.78/217.02  |- skos__hiddenLabel mesh__D000108 Acetyl L Carnitine
% 216.78/217.02  |- skos__hiddenLabel mesh__D000108 Sigma Tau brand of Acetyl L Carnitine
% 216.78/217.02  |- skos__historyNote mesh__D000108 Carnitine %28%1966-1977%29%
% 216.78/217.02  |- skos__annotation mesh__D000108
% 216.78/217.02       deficiency: coordinate ACETYLCARNITINE /defic %28%IM%29% with VITAMIN B DEFICIENCY %28%IM%29%%A%  
% 216.78/217.02  |- skos__scopeNote mesh__D000108
% 216.78/217.02       An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.%A%    
% 216.78/217.02  |- skos__hiddenLabel mesh__D000108 Carnitine, Acetyl
% 216.78/217.02  |- mesh__activeMeSHYear mesh__D000108 2006
% 216.78/217.02  |- skos__broader mesh__D000108smesh__D002331
% 216.78/217.02  |- rdf__type mesh__D000108sskos__Concept
% 216.78/217.02  |- mesh__dateEstablished mesh__D000108 1991-01-01
% 216.78/217.02  |- skos__altLabel mesh__D000108 Glaxo Brand of Acetyl L-Carnitine
% 216.78/217.02  |- skos__altLabel mesh__D000108 Sigma-Tau brand of Acetyl L-Carnitine
% 216.78/217.02  |- mesh__recordAuthorizer mesh__D000108 sjn
% 216.78/217.02  |- skos__prefLabel mesh__D000108 Acetylcarnitine
% 216.78/217.02  |- mesh__publicMeSHNote mesh__D000108
% 216.78/217.02       1991; see CARNITINE 1978-1990; MEDOSAN was indexed under ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL 1988-2003%A%  
% 216.78/217.02  |- skos__altLabel mesh__D000108 Levocarnitine Acetyl
% 216.78/217.02  |- mesh__historyNote mesh__D000108
% 216.78/217.02       1991%28%1978%29%; use CARNITINE 1978-1990; for MEDOSAN use ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL %28%NM%29% 1988-2003%A%  
% 216.88/217.02  |- skos__altLabel mesh__D000108 Acetyl Carnitine
% 216.88/217.02  |- mesh__recordMaintainer mesh__D000108 ssb
% 216.88/217.02  |- skos__hiddenLabel mesh__D000108 Glaxo Brand of Acetyl L Carnitine
% 216.88/217.02  |- mesh__dateCreated mesh__D000108 1977-05-17
% 216.88/217.02  |- mesh__recordOriginator mesh__D000108 RLS
% 216.88/217.02  |- skos__altLabel mesh__D052247 NOS-II
% 216.88/217.02  |- mesh__dateCreated mesh__D052247 2005-06-30
% 216.88/217.02  |- skos__altLabel mesh__D052247 Nitric Oxide Synthase II
% 216.88/217.02  |- skos__broader mesh__D052247smesh__D019001
% 216.88/217.02  |- mesh__recordOriginator mesh__D052247 jmp
% 216.88/217.02  |- mesh__activeMeSHYear mesh__D052247 2006
% 216.88/217.02  |- skos__altLabel mesh__D052247 INOS Enzyme
% 216.88/217.02  |- mesh__recordMaintainer mesh__D052247 jmp
% 216.88/217.02  |- rdf__type mesh__D052247sskos__Concept
% 216.88/217.03  |- mesh__publicMeSHNote mesh__D052247
% 216.88/217.03       2006; INDUCIBLE NITRIC OXIDE SYNTHASE was indexed under NITRIC-OXIDE SYNTHASE 1998-2005; NITRIC OXIDE SYNTHASE II was indexed under NITRIC-OXIDE SYNTHASE 2001-2005%A%  
% 216.88/217.03  |- skos__prefLabel mesh__D052247 Nitric Oxide Synthase Type II
% 216.88/217.03  |- skos__altLabel mesh__D052247 Nitric Oxide Synthase, Type II
% 216.88/217.03  |- mesh__dateEstablished mesh__D052247 2006-01-01
% 216.88/217.03  |- mesh__recordAuthorizer mesh__D052247 sjn
% 216.88/217.03  |- skos__altLabel mesh__D052247 Inducible NOS Protein
% 216.88/217.03  |- skos__altLabel mesh__D052247 Inducible Nitric Oxide Synthase
% 216.88/217.03  |- mesh__historyNote mesh__D052247 2006   
% 216.88/217.03  |- skos__scopeNote mesh__D052247
% 216.88/217.03       A CALCIUM-independent subtype of nitric oxide synthase that may play a role in immune function. It is an inducible enzyme whose expression is transcriptionally regulated by a variety of CYTOKINES.%A%    
% 216.88/217.03  |- skos__hiddenLabel mesh__D052247 NOS II
% 216.88/217.03  |- mesh__recordMaintainer mesh__D018519 JLS
% 216.88/217.03  |- skos__broader mesh__D018519smesh__D018517
% 216.88/217.03  |- skos__annotation mesh__D018519 coord with specific plant   
% 216.88/217.03  |- skos__broader mesh__D018519smesh__D018547
% 216.88/217.03  |- mesh__dateCreated mesh__D018519 1994-06-07
% 216.88/217.03  |- mesh__recordAuthorizer mesh__D018519 sjn
% 216.88/217.03  |- skos__scopeNote mesh__D018519
% 216.88/217.03       A group of plant cells that are capable of dividing infinitely and whose main function is the production of new growth at the growing tip of a root or stem. %28%From Concise Dictionary of Biology, 1990%29%%A%    
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D018519 2003
% 216.88/217.03  |- mesh__publicMeSHNote mesh__D018519 95   
% 216.88/217.03  |- skos__broader mesh__D018519smesh__D018520
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D018519 2005
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D018519 2004
% 216.88/217.03  |- mesh__dateRevised mesh__D018519 2002-07-03
% 216.88/217.03  |- mesh__historyNote mesh__D018519 95   
% 216.88/217.03  |- skos__prefLabel mesh__D018519 Meristem
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D018519 2006
% 216.88/217.03  |- skos__historyNote mesh__D018519 Plants %28%1966-1994%29%
% 216.88/217.03  |- mesh__dateEstablished mesh__D018519 1995-01-01
% 216.88/217.03  |- mesh__recordOriginator mesh__D018519 JLS
% 216.88/217.03  |- skos__altLabel mesh__D018519 Meristems
% 216.88/217.03  |- rdf__type mesh__D018519sskos__Concept
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D010536 2001
% 216.88/217.03  |- mesh__recordMaintainer mesh__D010536 PXP
% 216.88/217.03  |- skos__historyNote mesh__D010536 Vena Cava, Superior %28%1975-1980%29%
% 216.88/217.03  |- skos__hiddenLabel mesh__D010536 Ascites Shunts, Peritoneovenous
% 216.88/217.03  |- mesh__historyNote mesh__D010536
% 216.88/217.03       86%28%81%29%; was see under VASCULAR SURGERY 1981-85   
% 216.88/217.03  |- mesh__publicMeSHNote mesh__D010536
% 216.88/217.03       86; was see under VASCULAR SURGERY 1981-85   
% 216.88/217.03  |- skos__historyNote mesh__D010536 Peritoneal Cavity %28%1975-1980%29%
% 216.88/217.03  |- skos__altLabel mesh__D010536 Ascites Shunt, Peritoneovenous
% 216.88/217.03  |- skos__historyNote mesh__D010536 Jugular Veins %28%1975-1980%29%
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D010536 2000
% 216.88/217.03  |- skos__hiddenLabel mesh__D010536 Peritoneo-Venous Shunts
% 216.88/217.03  |- skos__scopeNote mesh__D010536
% 216.88/217.03       An operation for the continuous emptying of ascitic fluid into the venous system. Fluid removal is based on intraperitoneal and intrathoracic superior vena cava pressure differentials and is performed via a pressure-sensitive one-way valve connected to a tube traversing the subcutaneous tissue of the chest wall to the neck where it enters the internal jugular vein and terminates in the superior vena cava. It is used in the treatment of intractable ascites.%A%    
% 216.88/217.03  |- skos__prefLabel mesh__D010536 Peritoneovenous Shunt
% 216.88/217.03  |- skos__broader mesh__D010536smesh__D014656
% 216.88/217.03  |- skos__hiddenLabel mesh__D010536 Shunts, Peritoneo-Venous
% 216.88/217.03  |- mesh__recordAuthorizer mesh__D010536 SJN
% 216.88/217.03  |- skos__historyNote mesh__D010536 Peritoneum %28%1975-1980%29%
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D010536 1999
% 216.88/217.03  |- mesh__dateRevised mesh__D010536 1997-06-20
% 216.88/217.03  |- skos__broader mesh__D010536smesh__D000714
% 216.88/217.03  |- mesh__recordOriginator mesh__D010536 SMH
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D010536 2004
% 216.88/217.03  |- skos__historyNote mesh__D010536 Ascites %28%1975-1980%29%
% 216.88/217.03  |- skos__hiddenLabel mesh__D010536 Shunts, Peritoneovenous
% 216.88/217.03  |- skos__hiddenLabel mesh__D010536 Shunt, Peritoneovenous
% 216.88/217.03  |- skos__hiddenLabel mesh__D010536 Peritoneovenous Ascites Shunt
% 216.88/217.03  |- skos__annotation mesh__D010536
% 216.88/217.03       do not use /util except by MeSH definition   
% 216.88/217.03  |- rdf__type mesh__D010536sskos__Concept
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D010536 1998
% 216.88/217.03  |- skos__hiddenLabel mesh__D010536 Shunts, Peritoneovenous Ascites
% 216.88/217.03  |- mesh__dateCreated mesh__D010536 1980-05-15
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D010536 2003
% 216.88/217.03  |- skos__hiddenLabel mesh__D010536 Peritoneovenous Ascites Shunts
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D010536 2006
% 216.88/217.03  |- skos__hiddenLabel mesh__D010536 Peritoneovenous Shunts
% 216.88/217.03  |- skos__altLabel mesh__D010536 Peritoneo-Venous Shunt
% 216.88/217.03  |- mesh__dateEstablished mesh__D010536 1986-01-01
% 216.88/217.03  |- skos__hiddenLabel mesh__D010536 Shunt, Peritoneo-Venous
% 216.88/217.03  |- skos__broader mesh__D010536smesh__D013505
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D010536 2002
% 216.88/217.03  |- skos__hiddenLabel mesh__D010536 Shunt, Peritoneovenous Ascites
% 216.88/217.03  |- skos__hiddenLabel mesh__D010536 Shunt, LeVeen
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D010536 2005
% 216.88/217.03  |- skos__hiddenLabel mesh__D010536 Peritoneo Venous Shunt
% 216.88/217.03  |- mesh__publicMeSHNote mesh__D029241
% 216.88/217.03       2002; see OPTIC ATROPHIES, HEREDITARY 2000-2001   
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D029241 2005
% 216.88/217.03  |- skos__hiddenLabel mesh__D029241 Dominant Optic Atrophies
% 216.88/217.03  |- skos__broader mesh__D029241smesh__D015418
% 216.88/217.03  |- mesh__historyNote mesh__D029241
% 216.88/217.03       2002; use OPTIC ATROPHIES, HEREDITARY 2000-2001   
% 216.88/217.03  |- skos__broader mesh__D029241smesh__D028361
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D029241 2006
% 216.88/217.03  |- skos__altLabel mesh__D029241 Optic Atrophy Type 1
% 216.88/217.03  |- skos__historyNote mesh__D029241
% 216.88/217.03       Optic Atrophy, Hereditary %28%1989-2001%29%
% 216.88/217.03  |- mesh__dateEstablished mesh__D029241 2002-01-01
% 216.88/217.03  |- skos__altLabel mesh__D029241
% 216.88/217.03       Optic Atrophy, Hereditary, Autosomal Dominant
% 216.88/217.03  |- skos__altLabel mesh__D029241 Optic Atrophy, Kjer Type
% 216.88/217.03  |- skos__altLabel mesh__D029241 Autosomal Dominant Optic Atrophy
% 216.88/217.03  |- skos__hiddenLabel mesh__D029241 Optic Atrophy, Dominant
% 216.88/217.03  |- rdf__type mesh__D029241sskos__Concept
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D029241 2002
% 216.88/217.03  |- skos__scopeNote mesh__D029241
% 216.88/217.03       Dominant optic atrophy is a hereditary optic neuropathy causing decreased visual acuity, color vision deficits, a centrocecal scotoma, and optic nerve pallor %28%Hum. Genet. 1998; 102: 79-86%29%. Mutations leading to this condition have been mapped to the OPA1 gene at chromosome 3q28-q29. OPA1 codes for a dynamin-related GTPase that localizes to mitochondria.%A%    
% 216.88/217.03  |- skos__hiddenLabel mesh__D029241 Optic Atrophies, Dominant
% 216.88/217.03  |- mesh__dateCreated mesh__D029241 2001-07-25
% 216.88/217.03  |- skos__historyNote mesh__D029241 Optic Atrophy %28%1971-2001%29%
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D029241 2003
% 216.88/217.03  |- skos__prefLabel mesh__D029241 Optic Atrophy, Autosomal Dominant
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D029241 2004
% 216.88/217.03  |- skos__altLabel mesh__D029241 Dominant Optic Atrophy
% 216.88/217.03  |- skos__hiddenLabel mesh__D015221 Channels, Potassium
% 216.88/217.03  |- rdf__type mesh__D015221sskos__Concept
% 216.88/217.03  |- skos__broader mesh__D015221smesh__D007473
% 216.88/217.03  |- skos__altLabel mesh__D015221 Potassium Ion Channels
% 216.88/217.03  |- skos__related mesh__D015221smesh__D000254
% 216.88/217.03  |- skos__historyNote mesh__D015221 Potassium %28%1979-1988%29%
% 216.88/217.03  |- mesh__recordOriginator mesh__D015221 EJB
% 216.88/217.03  |- skos__altLabel mesh__D015221 Ion Channels, Potassium
% 216.88/217.03  |- skos__hiddenLabel mesh__D015221 Channels, Potassium Ion
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D015221 2006
% 216.88/217.03  |- skos__historyNote mesh__D015221 Ion Channels %28%1979-1988%29%
% 216.88/217.03  |- mesh__dateEstablished mesh__D015221 1989-01-01
% 216.88/217.03  |- mesh__publicMeSHNote mesh__D015221 89   
% 216.88/217.03  |- skos__hiddenLabel mesh__D015221 Channel, Potassium Ion
% 216.88/217.03  |- mesh__dateRevised mesh__D015221 2005-06-30
% 216.88/217.03  |- mesh__historyNote mesh__D015221 89   
% 216.88/217.03  |- skos__altLabel mesh__D015221 Potassium Channel
% 216.88/217.03  |- skos__hiddenLabel mesh__D015221 Potassium Ion Channel
% 216.88/217.03  |- skos__altLabel mesh__D015221 Ion Channel, Potassium
% 216.88/217.03  |- skos__hiddenLabel mesh__D015221 Channel, Potassium
% 216.88/217.03  |- skos__annotation mesh__D015221 DF: K CHANNELS   
% 216.88/217.03  |- mesh__recordAuthorizer mesh__D015221 sjn
% 216.88/217.03  |- mesh__recordMaintainer mesh__D015221 SYSTEM
% 216.88/217.03  |- skos__prefLabel mesh__D015221 Potassium Channels
% 216.88/217.03  |- mesh__dateCreated mesh__D015221 1988-05-12
% 216.88/217.03  |- skos__scopeNote mesh__D015221
% 216.88/217.03       Cell membrane glycoproteins that are selectively permeable to potassium ions. At least eight major groups of K channels exist and they are made up of dozens of different subunits.%A%    
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D001201 2003
% 216.88/217.03  |- mesh__recordMaintainer mesh__D001201 KEV
% 216.88/217.03  |- mesh__dateCreated mesh__D001201 1999-01-01
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D001201 2004
% 216.88/217.03  |- mesh__recordOriginator mesh__D001201 NLM
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D001201 2000
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D001201 2005
% 216.88/217.03  |- skos__prefLabel mesh__D001201 Ascites
% 216.88/217.03  |- skos__annotation mesh__D001201
% 216.88/217.03       do not index here for routine liver cirrhosis or Ehrlich ascites tumor; text must discuss ascites especially; chylous ascites: index CHYLOPERITONEUM%A%  
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D001201 2001
% 216.88/217.03  |- mesh__dateRevised mesh__D001201 1999-11-03
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D001201 2006
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D001201 2002
% 216.88/217.03  |- skos__scopeNote mesh__D001201
% 216.88/217.03       Accumulation or retention of free fluid within the peritoneal cavity.%A%    
% 216.88/217.03  |- rdf__type mesh__D001201sskos__Concept
% 216.88/217.03  |- skos__broader mesh__D001201smesh__D010335
% 216.88/217.03  |- mesh__recordAuthorizer mesh__D001201 sjn
% 216.88/217.03  |- skos__hiddenLabel mesh__D020964 Resorption, Embryo
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D020964 2006
% 216.88/217.03  |- skos__altLabel mesh__D020964 Disintegration of Blastocyst
% 216.88/217.03  |- rdf__type mesh__D020964sskos__Concept
% 216.88/217.03  |- mesh__recordOriginator mesh__D020964 ndw
% 216.88/217.03  |- mesh__dateEstablished mesh__D020964 2000-01-01
% 216.88/217.03  |- mesh__dateCreated mesh__D020964 1999-11-03
% 216.88/217.03  |- skos__related mesh__D020964smesh__D005313
% 216.88/217.03  |- mesh__publicMeSHNote mesh__D020964
% 216.88/217.03       2000; see EMBRYO RESORPTION 1991-1999   
% 216.88/217.03  |- mesh__dateRevised mesh__D020964 2005-06-30
% 216.88/217.03  |- skos__prefLabel mesh__D020964 Embryo Loss
% 216.88/217.03  |- mesh__historyNote mesh__D020964 2000%28%1991%29%   
% 216.88/217.03  |- skos__scopeNote mesh__D020964
% 216.88/217.03       Early pregnancy loss during the EMBRYO stage of development. In the human, this period comprises the second through eighth week after fertilization.%A%    
% 216.88/217.03  |- skos__hiddenLabel mesh__D020964 Disintegration, Blastocyst
% 216.88/217.03  |- mesh__recordAuthorizer mesh__D020964 sjn
% 216.88/217.03  |- skos__hiddenLabel mesh__D020964 Death, Embryo
% 216.88/217.03  |- skos__altLabel mesh__D020964 Disintegration of Embryo
% 216.88/217.03  |- skos__related mesh__D020964smesh__D000026
% 216.88/217.03  |- skos__broader mesh__D020964smesh__D000022
% 216.88/217.03  |- mesh__recordMaintainer mesh__D020964 lkt
% 216.88/217.03  |- skos__broader mesh__D020964smesh__D003643
% 216.88/217.03  |- skos__hiddenLabel mesh__D020964 Embryo Deaths
% 216.88/217.03  |- mesh__publicMeSHNote mesh__D006495
% 216.88/217.03       94; was ENOXAPARIN 1992-93, was HEPARIN, LOW MOLECULAR WEIGHT 1988-91; HEPARIN, LOW MOLECULAR WEIGHT was see ENOXAPARIN 1992-93; LOW-MOLECULAR-WEIGHT HEPARIN was LOW MOLECULAR WEIGHT HEPARIN 1988-93%A%  
% 216.88/217.03  |- mesh__onlineNote mesh__D006495
% 216.88/217.03       use HEPARIN, LOW-MOLECULAR-WEIGHT to search ENOXAPARIN 1990-93 %26% HEPARIN, LOW MOLECULAR WEIGHT 1988-93%A%  
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D006495 2006
% 216.88/217.03  |- mesh__historyNote mesh__D006495
% 216.88/217.03       94; was ENOXAPARIN 1992-93, was HEPARIN, LOW MOLECULAR WEIGHT 1988-91; HEPARIN, LOW MOLECULAR WEIGHT was see ENOXAPARIN 1992-93; LOW-MOLECULAR-WEIGHT HEPARIN was LOW MOLECULAR WEIGHT HEPARIN 1988-93%A%  
% 216.88/217.03  |- mesh__dateCreated mesh__D006495 1987-03-25
% 216.88/217.03  |- mesh__recordAuthorizer mesh__D006495 sjn
% 216.88/217.03  |- skos__broader mesh__D006495smesh__D006493
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D006495 2005
% 216.88/217.03  |- skos__altLabel mesh__D006495 Low-Molecular-Weight Heparin
% 216.88/217.03  |- skos__scopeNote mesh__D006495
% 216.88/217.03       Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism.%A%    
% 216.88/217.03  |- skos__prefLabel mesh__D006495 Heparin, Low-Molecular-Weight
% 216.88/217.03  |- mesh__recordMaintainer mesh__D006495 ssb
% 216.88/217.03  |- mesh__dateRevised mesh__D006495 2004-07-07
% 216.88/217.03  |- skos__altLabel mesh__D006495 LMWH
% 216.88/217.03  |- rdf__type mesh__D006495sskos__Concept
% 216.88/217.03  |- skos__hiddenLabel mesh__D006495 Heparin, Low Molecular Weight
% 216.88/217.03  |- skos__annotation mesh__D006495
% 216.88/217.03       /antag = probably HEPARIN ANTAGONISTS; DF: note short X ref%A%  
% 216.88/217.03  |- mesh__dateEstablished mesh__D006495 1988-01-01
% 216.88/217.03  |- skos__historyNote mesh__D006495 Heparin %28%1966-1987%29%
% 216.88/217.03  |- mesh__recordOriginator mesh__D006495 RLS
% 216.88/217.03  |- skos__altLabel mesh__D006495 Low Molecular Weight Heparin
% 216.88/217.03  |- skos__hiddenLabel mesh__D014927 Wolff Parkinson White Syndrome
% 216.88/217.03  |- mesh__recordMaintainer mesh__D014927 PLS
% 216.88/217.03  |- skos__altLabel mesh__D014927 WPW Syndrome
% 216.88/217.03  |- skos__broader mesh__D014927smesh__D011226
% 216.88/217.03  |- rdf__type mesh__D014927sskos__Concept
% 216.88/217.03  |- skos__annotation mesh__D014927
% 216.88/217.03       short PR interval %26% long QRS interval with delta wave; see PRE-EXCITATION SYNDROMES for other ECG notes%A%  
% 216.88/217.03  |- skos__scopeNote mesh__D014927
% 216.88/217.03       A form of pre-excitation characterized by a short PR interval and a long QRS interval with a delta wave.%A%    
% 216.88/217.03  |- mesh__dateCreated mesh__D014927 1999-01-01
% 216.88/217.03  |- mesh__dateRevised mesh__D014927 1999-11-03
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014927 2000
% 216.88/217.03  |- skos__prefLabel mesh__D014927 Wolff-Parkinson-White Syndrome
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014927 2005
% 216.88/217.03  |- skos__hiddenLabel mesh__D014927 Wolf Parkinson White Syndrome
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014927 2001
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014927 2003
% 216.88/217.03  |- skos__hiddenLabel mesh__D014927 Syndrome, Wolf-Parkinson-White
% 216.88/217.03  |- skos__hiddenLabel mesh__D014927 Syndrome, Wolff-Parkinson-White
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014927 2006
% 216.88/217.03  |- mesh__recordOriginator mesh__D014927 NLM
% 216.88/217.03  |- skos__altLabel mesh__D014927 Wolf-Parkinson-White Syndrome
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014927 2002
% 216.88/217.03  |- skos__hiddenLabel mesh__D014927 Syndrome, WPW
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014927 2004
% 216.88/217.03  |- mesh__recordAuthorizer mesh__D014927 sjn
% 216.88/217.03  |- skos__historyNote mesh__D014129 Ciliary Body %28%1966-1976%29%
% 216.88/217.03  |- skos__annotation mesh__D014129
% 216.88/217.03       in the eye: do not confuse with other trabeculae   
% 216.88/217.03  |- mesh__recordMaintainer mesh__D014129 RRC
% 216.88/217.03  |- skos__hiddenLabel mesh__D014129 Meshworks, Trabecular
% 216.88/217.03  |- skos__historyNote mesh__D014129 Anterior Chamber %28%1966-1976%29%
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014129 1991
% 216.88/217.03  |- skos__hiddenLabel mesh__D014129 Trabecular Meshworks
% 216.88/217.03  |- mesh__dateCreated mesh__D014129 1976-04-27
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014129 1995
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014129 2001
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014129 1989
% 216.88/217.03  |- mesh__recordOriginator mesh__D014129 MM
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014129 2003
% 216.88/217.03  |- mesh__publicMeSHNote mesh__D014129 77   
% 216.88/217.03  |- skos__historyNote mesh__D014129 Uvea %28%1966-1976%29%
% 216.88/217.03  |- mesh__dateRevised mesh__D014129 1984-06-06
% 216.88/217.03  |- skos__scopeNote mesh__D014129
% 216.88/217.03       A porelike structure surrounding the entire circumference of the anterior chamber through which aqueous humor circulates to the canal of Schlemm.%A%    
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014129 1996
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014129 2005
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014129 2004
% 216.88/217.03  |- skos__hiddenLabel mesh__D014129 Meshwork, Trabecular
% 216.88/217.03  |- mesh__dateEstablished mesh__D014129 1977-01-01
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014129 2002
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014129 1998
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014129 1997
% 216.88/217.03  |- mesh__historyNote mesh__D014129 77   
% 216.88/217.03  |- mesh__recordAuthorizer mesh__D014129 CAB
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014129 1990
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014129 2006
% 216.88/217.03  |- skos__broader mesh__D014129smesh__D000869
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014129 1992
% 216.88/217.03  |- skos__prefLabel mesh__D014129 Trabecular Meshwork
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014129 1999
% 216.88/217.03  |- rdf__type mesh__D014129sskos__Concept
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014129 1994
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014129 2000
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D014129 1993
% 216.88/217.03  |- rdf__type mesh__D000907sskos__Concept
% 216.88/217.03  |- skos__prefLabel mesh__D000907 Antibodies, Bacterial
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D000907 2006
% 216.88/217.03  |- mesh__recordOriginator mesh__D000907 NLM
% 216.88/217.03  |- skos__altLabel mesh__D000907 Bacterial Antibodies
% 216.88/217.03  |- mesh__recordMaintainer mesh__D000907 ssb
% 216.88/217.03  |- skos__annotation mesh__D000907
% 216.88/217.03       coordinate IM with specific bacterium /immunol %28%IM%29%; do not coordinate with ANTIBODY FORMATION for /biosyn; DF: ANTIBODIES BACT%A%  
% 216.88/217.03  |- mesh__recordAuthorizer mesh__D000907 sjn
% 216.88/217.03  |- mesh__publicMeSHNote mesh__D000907 73   
% 216.88/217.03  |- skos__historyNote mesh__D000907 Antibodies %28%1966-1972%29%
% 216.88/217.03  |- mesh__dateEstablished mesh__D000907 1973-01-01
% 216.88/217.03  |- mesh__dateCreated mesh__D000907 1999-01-01
% 216.88/217.03  |- skos__broader mesh__D000907smesh__D000906
% 216.88/217.03  |- mesh__historyNote mesh__D000907 73   
% 216.88/217.03  |- mesh__dateRevised mesh__D000907 2005-06-30
% 216.88/217.03  |- skos__scopeNote mesh__D000907
% 216.88/217.03       Immunoglobulins induced by substances elaborated by BACTERIA that have an antigenic activity.%A%    
% 216.88/217.03  |- skos__broader mesh__D019612smesh__D002523
% 216.88/217.03  |- mesh__recordMaintainer mesh__D019612 ssb
% 216.88/217.03  |- skos__scopeNote mesh__D019612
% 216.88/217.03       A plant genus of the family POLYGONACEAE that is used as a cereal grain. Although the seeds are used as cereal, the plant is not one of the cereal grasses %28%POACEAE%29%.%A%    
% 216.88/217.03  |- skos__broader mesh__D019612smesh__D000821
% 216.88/217.03  |- mesh__recordAuthorizer mesh__D019612 sjn
% 216.88/217.03  |- skos__annotation mesh__D019612
% 216.88/217.03       coordinate with specific PLANT COMPONENTS term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 216.88/217.03  |- mesh__dateRevised mesh__D019612 2005-06-30
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D019612 2006
% 216.88/217.03  |- mesh__historyNote mesh__D019612 2006%28%1998%29%   
% 216.88/217.03  |- mesh__recordOriginator mesh__D019612 JLS
% 216.88/217.03  |- mesh__publicMeSHNote mesh__D019612 2006; see BARLEY 1998-2005   
% 216.88/217.03  |- mesh__dateCreated mesh__D019612 1997-06-20
% 216.88/217.03  |- mesh__dateEstablished mesh__D019612 1998-01-01
% 216.88/217.03  |- skos__broader mesh__D019612smesh__D019664
% 216.88/217.03  |- rdf__type mesh__D019612sskos__Concept
% 216.88/217.03  |- skos__prefLabel mesh__D019612 Fagopyrum
% 216.88/217.03  |- skos__hiddenLabel mesh__D000109 L-Tartrate, Acetylcholine
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D000109 2006
% 216.88/217.03  |- mesh__dateCreated mesh__D000109 1999-01-01
% 216.88/217.03  |- skos__hiddenLabel mesh__D000109 Acetylcholine L Tartrate
% 216.88/217.03  |- rdf__type mesh__D000109sskos__Concept
% 216.88/217.03  |- skos__hiddenLabel mesh__D000109 Iodide, Acetylcholine
% 216.88/217.03  |- mesh__dateRevised mesh__D000109 2005-06-30
% 216.88/217.03  |- skos__related mesh__D000109smesh__D011950
% 216.88/217.03  |- mesh__recordOriginator mesh__D000109 NLM
% 216.88/217.03  |- skos__altLabel mesh__D000109 Acetylcholine Picrate
% 216.88/217.03  |- mesh__historyNote mesh__D000109
% 216.88/217.03       1998; for MIOCHOL use ACETYLCHOLINE %28%NM%29% 1981-1997; for CHLOROACETYLCHOLINE use ACETYLCHOLINE %28%NM%29% 1969-2000; for BROMOACETYLCHOLINE use ACETYLCHOLINE %28%NM%29% 1969-2000%A%  
% 216.88/217.03  |- skos__altLabel mesh__D000109 Alcon Brand of Acetylcholine Chloride
% 216.88/217.03  |- skos__altLabel mesh__D000109 Iolab Brand of Acetylcholine Chloride
% 216.88/217.03  |- skos__broader mesh__D000109smesh__D001679
% 216.88/217.03  |- skos__altLabel mesh__D000109
% 216.88/217.03       2-%28%Acetyloxy%29%-N,N,N-trimethylethanaminium
% 216.88/217.03  |- mesh__publicMeSHNote mesh__D000109
% 216.88/217.03       1998; MIOCHOL %28%now ACETYLCHOLINE%29% was indexed under ACETYLCHOLINE %26% MANNITOL 1981-97; CHLOROACETYLCHOLINE was indexed under ACETYLCHOLINE 1975-2000 %26% under CHLORINE 1974-1975; BROMOACETYLCHOLINE was indexed under ACETYLCHOLINE/analogs %26% derivatives 1974-2000 %26% ACETYLCHOLINE 1969-1974%A%  
% 216.88/217.03  |- skos__altLabel mesh__D000109 Chloroacetylcholine
% 216.88/217.03  |- skos__scopeNote mesh__D000109
% 216.88/217.03       A neurotransmitter. Acetylcholine in vertebrates is the major transmitter at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. It is generally not used as an administered drug because it is broken down very rapidly by cholinesterases, but it is useful in some ophthalmological applications.%A%    
% 216.88/217.03  |- skos__altLabel mesh__D000109 Bromoacetylcholine
% 216.88/217.03  |- skos__prefLabel mesh__D000109 Acetylcholine
% 216.88/217.03  |- skos__altLabel mesh__D000109
% 216.88/217.03       Bournonville Brand of Acetylcholine Chloride
% 216.88/217.03  |- skos__related mesh__D000109smesh__D018678
% 216.88/217.03  |- mesh__recordAuthorizer mesh__D000109 sjn
% 216.88/217.03  |- skos__hiddenLabel mesh__D000109 Fluoride, Acetylcholine
% 216.88/217.03  |- skos__hiddenLabel mesh__D000109 Cusi, Acetilcolina
% 216.88/217.03  |- skos__altLabel mesh__D000109 Ciba Vision Brand of Acetylcholine Chloride
% 216.88/217.03  |- skos__annotation mesh__D000109 /biosyn /physiol permitted   
% 216.88/217.03  |- skos__hiddenLabel mesh__D000109 Hydroxide, Acetylcholine
% 216.88/217.03  |- mesh__recordMaintainer mesh__D000109 ssb
% 216.88/217.03  |- skos__hiddenLabel mesh__D000109 Perchlorate, Acetylcholine
% 216.88/217.03  |- skos__hiddenLabel mesh__D000109 Bromide, Acetylcholine
% 216.88/217.03  |- mesh__recordOriginator mesh__D052248 jmp
% 216.88/217.03  |- skos__altLabel mesh__D052248 NCNOS Enzyme
% 216.88/217.03  |- skos__scopeNote mesh__D052248
% 216.88/217.03       A CALCIUM-dependent, constitutively-expressed form of nitric acid synthase found primarily in NERVE TISSUE.%A%    
% 216.88/217.03  |- mesh__dateEstablished mesh__D052248 2006-01-01
% 216.88/217.03  |- mesh__recordMaintainer mesh__D052248 ags
% 216.88/217.03  |- mesh__recordAuthorizer mesh__D052248 ags
% 216.88/217.03  |- skos__altLabel mesh__D052248 Neural Constitutive Nitric Oxide Synthase
% 216.88/217.03  |- skos__altLabel mesh__D052248 nNOS Enzyme
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D052248 2006A
% 216.88/217.03  |- skos__altLabel mesh__D052248 Nitric Oxide Synthase, Type I
% 216.88/217.03  |- mesh__publicMeSHNote mesh__D052248
% 216.88/217.03       2006; NEURONAL CONSTITUTIVE NITRIC OXIDE SYNTHASE was indexed under NITRIC-OXIDE SYNTHASE 1998-2005%A%  
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D052248 2006
% 216.88/217.03  |- mesh__dateRevised mesh__D052248 2005-07-21
% 216.88/217.03  |- rdf__type mesh__D052248sskos__Concept
% 216.88/217.03  |- skos__broader mesh__D052248smesh__D019001
% 216.88/217.03  |- mesh__dateCreated mesh__D052248 2005-06-30
% 216.88/217.03  |- mesh__historyNote mesh__D052248 2006%28%1998%29%   
% 216.88/217.03  |- skos__altLabel mesh__D052248 Neuronal Nitric Oxide Synthase
% 216.88/217.03  |- skos__altLabel mesh__D052248 NOS1 protein
% 216.88/217.03  |- skos__prefLabel mesh__D052248 Nitric Oxide Synthase Type I
% 216.88/217.03  |- rdf__type mesh__D010537sskos__Concept
% 216.88/217.03  |- skos__related mesh__D010537smesh__D010535
% 216.88/217.03  |- skos__altLabel mesh__D010537 Parietal Peritoneum
% 216.88/217.03  |- mesh__recordMaintainer mesh__D010537 lkt
% 216.88/217.03  |- skos__broader mesh__D010537smesh__D012704
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D010537 2005
% 216.88/217.03  |- skos__annotation mesh__D010537
% 216.88/217.03       do not confuse with PERITONEAL CAVITY; %22%peritoneal cells%22% = probably PERITONEAL CAVITY/cytol or PERITONEAL FLUID %28%see ASCITIC FLUID%29%/pathol but not PERITONEUM/cytol; inflammation = PERITONITIS; PERITONEAL LAVAGE is available%A%  
% 216.88/217.03  |- skos__scopeNote mesh__D010537
% 216.88/217.03       A membrane of squamous EPITHELIAL CELLS, the mesothelial cells, covered by apical MICROVILLI that allow rapid absorption of fluid and particles in the PERITONEAL CAVITY. The peritoneum is divided into parietal and visceral components. The parietal peritoneum covers the inside of the ABDOMINAL WALL. The visceral peritoneum covers the intraperitoneal organs. The double-layered peritoneum forms the MESENTERY that suspends these organs from the abdominal wall.%A%    
% 216.88/217.03  |- skos__related mesh__D010537smesh__D001202
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D010537 2006
% 216.88/217.03  |- mesh__dateCreated mesh__D010537 1999-01-01
% 216.88/217.03  |- skos__prefLabel mesh__D010537 Peritoneum
% 216.88/217.03  |- skos__broader mesh__D010537smesh__D034841
% 216.88/217.03  |- skos__altLabel mesh__D010537 Visceral Peritoneum
% 216.88/217.03  |- mesh__recordAuthorizer mesh__D010537 sjn
% 216.88/217.03  |- mesh__dateRevised mesh__D010537 2004-07-07
% 216.88/217.03  |- mesh__recordOriginator mesh__D010537 NLM
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D029242 2003
% 216.88/217.03  |- skos__altLabel mesh__D029242 Leber%27%s Hereditary Optic Neuropathy
% 216.88/217.03  |- skos__broader mesh__D029242smesh__D028361
% 216.88/217.03  |- skos__prefLabel mesh__D029242 Optic Atrophy, Hereditary, Leber
% 216.88/217.03  |- mesh__dateEstablished mesh__D029242 2002-01-01
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D029242 2002
% 216.88/217.03  |- skos__altLabel mesh__D029242 Optic Atrophy, Leber, Hereditary
% 216.88/217.03  |- skos__altLabel mesh__D029242 Leber Hereditary Optic Atrophy
% 216.88/217.03  |- skos__scopeNote mesh__D029242
% 216.88/217.03       A maternally linked genetic disorder that presents in mid-life as acute or subacute central vision loss leading to central scotoma and blindness. The disease has been associated with missense mutations in the mtDNA, in genes for Complex I, III, and IV polypeptides, that can act autonomously or in association with each other to cause the disease. %28%from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim/, MIM%23%535000 %28%April 17, 2001%29%%29%%A%    
% 216.88/217.03  |- skos__historyNote mesh__D029242 Optic Atrophy/genetics %28%1977-1988%29%
% 216.88/217.03  |- skos__hiddenLabel mesh__D029242 Optic Atrophy, Leber
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D029242 2006
% 216.88/217.03  |- mesh__publicMeSHNote mesh__D029242
% 216.88/217.03       2002; see OPTIC ATROPHIES, HEREDITARY 1999-2001   
% 216.88/217.03  |- skos__altLabel mesh__D029242 Leber Hereditary Optic Neuropathy
% 216.88/217.03  |- skos__broader mesh__D029242smesh__D015418
% 216.88/217.03  |- skos__hiddenLabel mesh__D029242 Lebers Optic Atrophy
% 216.88/217.03  |- skos__altLabel mesh__D029242 Leber%27%s Hereditary Optic Atrophy
% 216.88/217.03  |- mesh__dateCreated mesh__D029242 2001-07-25
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D029242 2005
% 216.88/217.03  |- mesh__historyNote mesh__D029242
% 216.88/217.03       2002; use OPTIC ATROPHIES, HEREDITARY 1999-2001   
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D029242 2004
% 216.88/217.03  |- skos__altLabel mesh__D029242 Leber%27%s Optic Atrophy
% 216.88/217.03  |- rdf__type mesh__D029242sskos__Concept
% 216.88/217.03  |- skos__historyNote mesh__D029242
% 216.88/217.03       Optic Atrophies, Hereditary %28%1989-2001%29%
% 216.88/217.03  |- skos__hiddenLabel mesh__D029242 Optic Atrophy, Leber%27%s
% 216.88/217.03  |- skos__altLabel mesh__D029242 Leber Optic Atrophy
% 216.88/217.03  |- skos__historyNote mesh__D015222 Sodium %28%1979-1988%29%
% 216.88/217.03  |- skos__annotation mesh__D015222
% 216.88/217.03       /biosyn /drug eff /physiol /rad eff /ultrastruct permitted; DF: NA CHANNELS%A%  
% 216.88/217.03  |- skos__hiddenLabel mesh__D015222 Channels, Sodium
% 216.88/217.03  |- skos__related mesh__D015222smesh__D000254
% 216.88/217.03  |- mesh__recordAuthorizer mesh__D015222 sjn
% 216.88/217.03  |- skos__altLabel mesh__D015222 Sodium Ion Channels
% 216.88/217.03  |- skos__altLabel mesh__D015222 Sodium Channel
% 216.88/217.03  |- skos__altLabel mesh__D015222 Ion Channel, Sodium
% 216.88/217.03  |- skos__hiddenLabel mesh__D015222 Channel, Sodium
% 216.88/217.03  |- skos__broader mesh__D015222smesh__D007473
% 216.88/217.03  |- mesh__activeMeSHYear mesh__D015222 2006
% 216.88/217.03  |- skos__altLabel mesh__D015222 Ion Channels, Sodium
% 216.88/217.04  |- skos__historyNote mesh__D015222 Ion Channels %28%1979-1988%29%
% 216.88/217.04  |- mesh__publicMeSHNote mesh__D015222 89   
% 216.88/217.04  |- mesh__dateEstablished mesh__D015222 1989-01-01
% 216.88/217.04  |- skos__hiddenLabel mesh__D015222 Channel, Sodium Ion
% 216.88/217.04  |- skos__prefLabel mesh__D015222 Sodium Channels
% 216.88/217.04  |- mesh__recordMaintainer mesh__D015222 SYSTEM
% 216.88/217.04  |- mesh__recordOriginator mesh__D015222 EJB
% 216.88/217.04  |- skos__scopeNote mesh__D015222
% 216.88/217.04       Cell membrane glycoproteins selective for sodium ions. Fast sodium current is associated with the action potential in neural membranes.%A%    
% 216.88/217.04  |- skos__hiddenLabel mesh__D015222 Channels, Sodium Ion
% 216.88/217.04  |- mesh__dateCreated mesh__D015222 1988-05-12
% 216.88/217.04  |- skos__hiddenLabel mesh__D015222 Sodium Ion Channel
% 216.88/217.04  |- rdf__type mesh__D015222sskos__Concept
% 216.88/217.04  |- mesh__dateRevised mesh__D015222 2005-06-30
% 216.88/217.04  |- mesh__historyNote mesh__D015222 89   
% 216.88/217.04  |- skos__altLabel mesh__D001202 Peritoneal Effusion
% 216.88/217.04  |- mesh__historyNote mesh__D001202
% 216.88/217.04       68; was in Cat A 1968-83; PERITONEAL EFFUSION was PERITONEAL FLUID see under ASCITIC FLUID 1968-83%A%  
% 216.88/217.04  |- skos__hiddenLabel mesh__D001202 Peritoneal Effusions
% 216.88/217.04  |- skos__hiddenLabel mesh__D001202 Fluids, Peritoneal
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D001202 2006
% 216.88/217.04  |- skos__altLabel mesh__D001202 Peritoneal Fluid
% 216.88/217.04  |- skos__hiddenLabel mesh__D001202 Fluid, Peritoneal
% 216.88/217.04  |- skos__hiddenLabel mesh__D001202 Effusion, Peritoneal
% 216.88/217.04  |- skos__scopeNote mesh__D001202
% 216.88/217.04       The serous fluid of ASCITES, the accumulation of fluids in the PERITONEAL CAVITY.%A%    
% 216.88/217.04  |- skos__broader mesh__D001202smesh__D001826
% 216.88/217.04  |- skos__prefLabel mesh__D001202 Ascitic Fluid
% 216.88/217.04  |- skos__hiddenLabel mesh__D001202 Effusions, Peritoneal
% 216.88/217.04  |- mesh__recordAuthorizer mesh__D001202 sjn
% 216.88/217.04  |- mesh__dateRevised mesh__D001202 2004-07-07
% 216.88/217.04  |- skos__hiddenLabel mesh__D001202 Ascitic Fluids
% 216.88/217.04  |- rdf__type mesh__D001202sskos__Concept
% 216.88/217.04  |- skos__historyNote mesh__D001202 Ascites %28%1966-1967%29%
% 216.88/217.04  |- skos__hiddenLabel mesh__D001202 Fluids, Ascitic
% 216.88/217.04  |- skos__hiddenLabel mesh__D001202 Peritoneal Fluids
% 216.88/217.04  |- mesh__dateEstablished mesh__D001202 1968-01-01
% 216.88/217.04  |- mesh__recordOriginator mesh__D001202 NLM
% 216.88/217.04  |- mesh__onlineNote mesh__D001202
% 216.88/217.04       use ASCITIC FLUID to search PERITONEAL FLUID 1968-89   
% 216.88/217.04  |- mesh__dateCreated mesh__D001202 1999-01-01
% 216.88/217.04  |- skos__hiddenLabel mesh__D001202 Fluid, Ascitic
% 216.88/217.04  |- skos__related mesh__D001202smesh__D010533
% 216.88/217.04  |- mesh__recordMaintainer mesh__D001202 lkt
% 216.88/217.04  |- mesh__publicMeSHNote mesh__D001202 68   
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D001202 2005
% 216.88/217.04  |- skos__altLabel mesh__D006496 Ateroid
% 216.88/217.04  |- skos__prefLabel mesh__D006496 Heparinoids
% 216.88/217.04  |- mesh__dateRevised mesh__D006496 2004-07-07
% 216.88/217.04  |- rdf__type mesh__D006496sskos__Concept
% 216.88/217.04  |- mesh__recordOriginator mesh__D006496 NLM
% 216.88/217.04  |- mesh__dateCreated mesh__D006496 1999-01-01
% 216.88/217.04  |- skos__broader mesh__D006496smesh__D006493
% 216.88/217.04  |- skos__altLabel mesh__D006496 Heparinoid
% 216.88/217.04  |- skos__scopeNote mesh__D006496
% 216.88/217.04       Heparin derivatives. The term has also been used more loosely to include naturally occurring and synthetic highly-sulphated polysaccharides of similar structure. Heparinoid preparations have been used for a wide range of applications including as anticoagulants and anti-inflammatories and they have been claimed to have hypolipidemic properties. %28%From Martindale, The Extra Pharmacopoeia, 30th, p232%29%%A%    
% 216.88/217.04  |- mesh__recordAuthorizer mesh__D006496 sjn
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D006496 2006
% 216.88/217.04  |- mesh__publicMeSHNote mesh__D006496 96; was HEPARANOID 1963-95   
% 216.88/217.04  |- mesh__recordMaintainer mesh__D006496 ssb
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D006496 2005
% 216.88/217.04  |- mesh__historyNote mesh__D006496 96; was HEPARANOID 1963-95   
% 216.88/217.04  |- skos__historyNote mesh__D020167 Lysine/metabolism %28%1966-1999%29%
% 216.88/217.04  |- skos__hiddenLabel mesh__D020167 Hyperlysinemias, Familial
% 216.88/217.04  |- skos__related mesh__D020167smesh__D012443
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D020167 2006
% 216.88/217.04  |- skos__hiddenLabel mesh__D020167 Periodic Hyperlysinemias
% 216.88/217.04  |- mesh__historyNote mesh__D020167 2000   
% 216.88/217.04  |- mesh__publicMeSHNote mesh__D020167 2000   
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D020167 2002
% 216.88/217.04  |- skos__broader mesh__D020167smesh__D020739
% 216.88/217.04  |- mesh__dateRevised mesh__D020167 2001-07-25
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D020167 2005
% 216.88/217.04  |- skos__altLabel mesh__D020167
% 216.88/217.04       Deficiency Disease, Lysine Alpha-Ketoglutarate Reductase
% 216.88/217.04  |- mesh__recordAuthorizer mesh__D020167 sjn
% 216.88/217.04  |- skos__hiddenLabel mesh__D020167 Hyperlysinemias, Periodic
% 216.88/217.04  |- skos__prefLabel mesh__D020167 Hyperlysinemias
% 216.88/217.04  |- skos__scopeNote mesh__D020167
% 216.88/217.04       A group of inherited metabolic disorders which have in common elevations of serum LYSINE levels. Enzyme deficiencies of alpha-aminoadipic semialdehyde dehydrogenase and the SACCHAROPINE DEHYDROGENASES have been associated with hyperlysinemia. Clinical manifestations include mental retardation, recurrent emesis, hypotonia, lethargy, diarrhea, and developmental delay. %28%From Menkes, Textbook of Child Neurology, 5th ed, p56%29%%A%    
% 216.88/217.04  |- skos__hiddenLabel mesh__D020167 Familial Hyperlysinemias
% 216.88/217.04  |- skos__historyNote mesh__D020167
% 216.88/217.04       Amino Acid Metabolism, Inborn Errors %28%1965-1999%29%
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D020167 2004
% 216.88/217.04  |- skos__altLabel mesh__D020167
% 216.88/217.04       Deficiency Disease, Saccharopine Dehydrogenase
% 216.88/217.04  |- mesh__recordMaintainer mesh__D020167 nns
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D020167 2003
% 216.88/217.04  |- skos__hiddenLabel mesh__D020167
% 216.88/217.04       Deficiency Disease, Alpha Aminoadipic Semialdehyde
% 216.88/217.04  |- skos__hiddenLabel mesh__D020167
% 216.88/217.04       Lysine Alpha Ketoglutarate Reductase Deficiency Disease
% 216.88/217.04  |- mesh__recordOriginator mesh__D020167 KEV
% 216.88/217.04  |- skos__hiddenLabel mesh__D020167 Hyperlysinemia
% 216.88/217.04  |- skos__hiddenLabel mesh__D020167 Periodic Hyperlysinemia
% 216.88/217.04  |- skos__hiddenLabel mesh__D020167 Familial Hyperlysinemia
% 216.88/217.04  |- skos__hiddenLabel mesh__D020167
% 216.88/217.04       Alpha Aminoadipic Semialdehyde Deficiency Disease
% 216.88/217.04  |- skos__altLabel mesh__D020167
% 216.88/217.04       Deficiency Disease, Alpha-Aminoadipic Semialdehyde
% 216.88/217.04  |- rdf__type mesh__D020167sskos__Concept
% 216.88/217.04  |- mesh__dateCreated mesh__D020167 1999-11-03
% 216.88/217.04  |- skos__broader mesh__D020167smesh__D000592
% 216.88/217.04  |- skos__altLabel mesh__D020167 Hyperlysinemia, Familial
% 216.88/217.04  |- mesh__dateEstablished mesh__D020167 2000-01-01
% 216.88/217.04  |- skos__hiddenLabel mesh__D020167
% 216.88/217.04       Deficiency Disease, Lysine Alpha Ketoglutarate Reductase
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D014928 2002
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D014928 1999
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D014928 1996
% 216.88/217.04  |- mesh__dateRevised mesh__D014928 1991-01-08
% 216.88/217.04  |- mesh__recordOriginator mesh__D014928 NLM
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D014928 1993
% 216.88/217.04  |- mesh__recordMaintainer mesh__D014928 TGC
% 216.88/217.04  |- rdf__type mesh__D014928sskos__Concept
% 216.88/217.04  |- skos__hiddenLabel mesh__D014928 Duct, Wolffian
% 216.88/217.04  |- skos__hiddenLabel mesh__D014928 Gartners Ducts
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D014928 1997
% 216.88/217.04  |- mesh__dateCreated mesh__D014928 1999-01-01
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D014928 2005
% 216.88/217.04  |- skos__hiddenLabel mesh__D014928 Ducts, Gartner%27%s
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D014928 2003
% 216.88/217.04  |- skos__prefLabel mesh__D014928 Wolffian Duct
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D014928 2006
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D014928 2000
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D014928 1994
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D014928 2004
% 216.88/217.04  |- skos__broader mesh__D014928smesh__D004622
% 216.88/217.04  |- skos__hiddenLabel mesh__D014928 Gartner Ducts
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D014928 2001
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D014928 1998
% 216.88/217.04  |- mesh__recordAuthorizer mesh__D014928 PLS
% 216.88/217.04  |- skos__scopeNote mesh__D014928
% 216.88/217.04       An excretory duct of the embryonic kidney.     
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D014928 1992
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D014928 1995
% 216.88/217.04  |- mesh__publicMeSHNote mesh__D019613 98   
% 216.88/217.04  |- mesh__dateRevised mesh__D019613 2005-06-30
% 216.88/217.04  |- skos__broader mesh__D019613smesh__D006216
% 216.88/217.04  |- mesh__dateEstablished mesh__D019613 1998-01-01
% 216.88/217.04  |- skos__prefLabel mesh__D019613 Haloarcula
% 216.88/217.04  |- mesh__dateCreated mesh__D019613 1997-06-20
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D019613 2006
% 216.88/217.04  |- mesh__historyNote mesh__D019613 98   
% 216.88/217.04  |- skos__scopeNote mesh__D019613
% 216.88/217.04       A genus of HALOBACTERIACEAE distinguished from other genera in the family by the presence of specific derivatives of TGD-2 polar lipids. Haloarcula are found in neutral saline environments such as salt lakes, marine salterns, and saline soils.%A%    
% 216.88/217.04  |- rdf__type mesh__D019613sskos__Concept
% 216.88/217.04  |- mesh__recordOriginator mesh__D019613 AGS
% 216.88/217.04  |- mesh__recordAuthorizer mesh__D019613 sjn
% 216.88/217.04  |- mesh__recordMaintainer mesh__D019613 SYSTEM
% 216.88/217.04  |- skos__annotation mesh__D019613
% 216.88/217.04       a genus of archaea %22%found in neutral saline environments%22%%A%  
% 216.88/217.04  |- skos__historyNote mesh__D019613 Archaea %28%1990-1997%29%
% 216.88/217.04  |- mesh__publicMeSHNote mesh__D000908 73   
% 216.88/217.04  |- rdf__type mesh__D000908sskos__Concept
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D000908 2006
% 216.88/217.04  |- mesh__dateRevised mesh__D000908 2005-06-30
% 216.88/217.04  |- mesh__dateEstablished mesh__D000908 1973-01-01
% 216.88/217.04  |- mesh__dateCreated mesh__D000908 1999-01-01
% 216.88/217.04  |- mesh__recordMaintainer mesh__D000908 ssb
% 216.88/217.04  |- skos__broader mesh__D000908smesh__D000906
% 216.88/217.04  |- skos__annotation mesh__D000908
% 216.88/217.04       coordinate IM with specific fungus /immunol %28%IM%29%; do not coordinate with ANTIBODY FORMATION for /biosyn%A%  
% 216.88/217.04  |- mesh__recordOriginator mesh__D000908 NLM
% 216.88/217.04  |- skos__historyNote mesh__D000908 Antibodies %28%1966-1972%29%
% 216.88/217.04  |- skos__prefLabel mesh__D000908 Antibodies, Fungal
% 216.88/217.04  |- mesh__historyNote mesh__D000908 73   
% 216.88/217.04  |- skos__altLabel mesh__D000908 Fungal Antibodies
% 216.88/217.04  |- skos__scopeNote mesh__D000908
% 216.88/217.04       Immunoglobulins induced by substances elaborated by FUNGI that have an antigenic activity.%A%    
% 216.88/217.04  |- mesh__recordAuthorizer mesh__D000908 sjn
% 216.88/217.04  |- mesh__dateCreated mesh__D011630 1999-01-01
% 216.88/217.04  |- mesh__recordOriginator mesh__D011630 NLM
% 216.88/217.04  |- mesh__recordAuthorizer mesh__D011630 sjn
% 216.88/217.04  |- rdf__type mesh__D011630sskos__Concept
% 216.88/217.04  |- mesh__recordMaintainer mesh__D011630 ags
% 216.88/217.04  |- skos__hiddenLabel mesh__D011630 Bone, Pubic
% 216.88/217.04  |- skos__prefLabel mesh__D011630 Pubic Bone
% 216.88/217.04  |- skos__hiddenLabel mesh__D011630 Bones, Pubic
% 216.88/217.04  |- skos__hiddenLabel mesh__D011630 Pubic Bones
% 216.88/217.04  |- skos__broader mesh__D011630smesh__D010384
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D011630 2006
% 216.88/217.04  |- mesh__dateRevised mesh__D011630 2005-06-30
% 216.88/217.04  |- skos__broader mesh__D001877Q000145smesh__D001877
% 216.88/217.04  |- mesh__preferredCombination mesh__D001877Q000145smesh__D001867
% 216.88/217.04  |- rdf__type mesh__D001877Q000145smesh__CompoundConcept
% 216.88/217.04  |- skos__prefLabel mesh__D010538 Peritonitis
% 216.88/217.04  |- skos__hiddenLabel mesh__D010538 Peritonitis, Secondary
% 216.88/217.04  |- mesh__recordAuthorizer mesh__D010538 sjn
% 216.88/217.04  |- mesh__recordOriginator mesh__D010538 NLM
% 216.88/217.04  |- skos__hiddenLabel mesh__D010538 Peritonitis, Primary
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D010538 2005
% 216.88/217.04  |- skos__broader mesh__D010538smesh__D010532
% 216.88/217.04  |- mesh__recordMaintainer mesh__D010538 lkt
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D010538 2006
% 216.88/217.04  |- mesh__dateCreated mesh__D010538 1999-01-01
% 216.88/217.04  |- skos__scopeNote mesh__D010538
% 216.88/217.04       INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs.%A%    
% 216.88/217.04  |- mesh__dateRevised mesh__D010538 2004-07-07
% 216.88/217.04  |- rdf__type mesh__D010538sskos__Concept
% 216.88/217.04  |- rdf__type mesh__D015223sskos__Concept
% 216.88/217.04  |- skos__scopeNote mesh__D015223
% 216.88/217.04       The severe infantile form of inherited lysosomal lipid storage diseases, due to deficiency of acid lipase. It results in accumulation of neutral lipids, particularly cholesterol esters, within cells %28%particularly leukocytes, fibroblasts, and liver cells%29%. An allelic variant of CHOLESTEROL ESTER STORAGE DISEASE, it is also known as Wolman%27%s xanthomatosis.%A%    
% 216.88/217.04  |- skos__broader mesh__D015223smesh__D014973
% 216.88/217.04  |- skos__historyNote mesh__D015223 Lipoidosis %28%1966-1988%29%
% 216.88/217.04  |- skos__hiddenLabel mesh__D015223 Xanthomatosis, Wolmans
% 216.88/217.04  |- skos__historyNote mesh__D015223
% 216.88/217.04       Lipid Metabolism, Inborn Errors %28%1966-1988%29%
% 216.88/217.04  |- skos__altLabel mesh__D015223 Wolman%27%s Disease
% 216.88/217.04  |- skos__prefLabel mesh__D015223 Wolman Disease
% 216.88/217.04  |- skos__annotation mesh__D015223
% 216.88/217.04       a lysosomal storage dis; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 216.88/217.04  |- skos__historyNote mesh__D015223 Cholesterol Esters %28%1978-1988%29%
% 216.88/217.04  |- mesh__dateEstablished mesh__D015223 1989-01-01
% 216.88/217.04  |- mesh__dateRevised mesh__D015223 2001-07-25
% 216.88/217.04  |- skos__broader mesh__D015223smesh__D007232
% 216.88/217.04  |- mesh__recordAuthorizer mesh__D015223 sjn
% 216.88/217.04  |- skos__broader mesh__D015223smesh__D008064
% 216.88/217.04  |- skos__historyNote mesh__D015223 Xanthomatosis %28%1966-1988%29%
% 216.88/217.04  |- skos__hiddenLabel mesh__D015223 Xanthomatoses, Familial
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D015223 2004
% 216.88/217.04  |- skos__hiddenLabel mesh__D015223 Wolmans Disease
% 216.88/217.04  |- skos__altLabel mesh__D015223 Xanthomatosis, Wolman%27%s
% 216.88/217.04  |- skos__hiddenLabel mesh__D015223 Familial Xanthomatoses
% 216.88/217.04  |- skos__hiddenLabel mesh__D015223 Disease, Wolman
% 216.88/217.04  |- skos__hiddenLabel mesh__D015223 Xanthomatosis, Wolman
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D015223 2006
% 216.88/217.04  |- skos__altLabel mesh__D015223 Xanthomatosis, Familial
% 216.88/217.04  |- mesh__dateCreated mesh__D015223 1988-05-12
% 216.88/217.04  |- mesh__historyNote mesh__D015223 89   
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D015223 2003
% 216.88/217.04  |- skos__historyNote mesh__D015223 Lipase %28%1966-1988%29%
% 216.88/217.04  |- skos__hiddenLabel mesh__D015223 Familial Xanthomatosis
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D015223 2005
% 216.88/217.04  |- mesh__recordMaintainer mesh__D015223 nns
% 216.88/217.04  |- skos__broader mesh__D015223smesh__D016464
% 216.88/217.04  |- skos__hiddenLabel mesh__D015223 Wolman%27%s Xanthomatosis
% 216.88/217.04  |- skos__hiddenLabel mesh__D015223 Disease, Wolman%27%s
% 216.88/217.04  |- mesh__recordOriginator mesh__D015223 EJB
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D015223 2002
% 216.88/217.04  |- mesh__publicMeSHNote mesh__D015223 89   
% 216.88/217.04  |- skos__annotation mesh__D001203
% 216.88/217.04       GEN or unspecified; prefer specifics; infection coord IM with MYCOSES %28%IM%29% or specific mycosis %28%IM%29%%A%  
% 216.88/217.04  |- mesh__dateRevised mesh__D001203 2005-06-30
% 216.88/217.04  |- skos__prefLabel mesh__D001203 Ascomycota
% 216.88/217.04  |- skos__altLabel mesh__D001203 Ascomycetes
% 216.88/217.04  |- mesh__recordAuthorizer mesh__D001203 sjn
% 216.88/217.04  |- mesh__recordMaintainer mesh__D001203 SYSTEM
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D001203 2006
% 216.88/217.04  |- rdf__type mesh__D001203sskos__Concept
% 216.88/217.04  |- mesh__recordOriginator mesh__D001203 NLM
% 216.88/217.04  |- mesh__dateCreated mesh__D001203 1999-01-01
% 216.88/217.04  |- mesh__publicMeSHNote mesh__D001203
% 216.88/217.04       99; see ASCOMYCETES 1963-98; for COCHLIOBOLUS %26% SCLEROTINA see ASCOMYCETES 1975-85%A%  
% 216.88/217.04  |- skos__scopeNote mesh__D001203
% 216.88/217.04       A phylum of fungi which have cross-walls or septa in the mycelium. The perfect state is characterized by the formation of a saclike cell %28%ascus%29% containing ascospores. Most pathogenic fungi with a known perfect state belong to this phylum.%A%    
% 216.88/217.04  |- mesh__historyNote mesh__D001203 99%28%75%29%   
% 216.88/217.04  |- skos__broader mesh__D001203smesh__D005658
% 216.88/217.04  |- skos__altLabel mesh__D020966 Spinobulbar Atrophy
% 216.88/217.04  |- mesh__publicMeSHNote mesh__D020966 2000   
% 216.88/217.04  |- skos__altLabel mesh__D020966 Atrophy, Spinopontine
% 216.88/217.04  |- skos__scopeNote mesh__D020966
% 216.88/217.04       Disorders characterized by an abnormal reduction in muscle volume due to a decrease in the size or number of muscle fibers. Atrophy may result from diseases intrinsic to muscle tissue %28%e.g., MUSCULAR DYSTROPHY%29% or secondary to PERIPHERAL NERVOUS SYSTEM DISEASES that impair innervation to muscle tissue %28%e.g., MUSCULAR ATROPHY, SPINAL%29%.%A%    
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D020966 2005
% 216.88/217.04  |- mesh__dateRevised mesh__D020966 2000-06-21
% 216.88/217.04  |- skos__hiddenLabel mesh__D020966 Spinobulbar Atrophies
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D020966 2001
% 216.88/217.04  |- skos__hiddenLabel mesh__D020966 Atrophy, Spinobulbar
% 216.88/217.04  |- skos__hiddenLabel mesh__D020966 Muscular Atrophies, Spinobulbar
% 216.88/217.04  |- skos__hiddenLabel mesh__D020966 Atrophies, Disuse
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D020966 2006
% 216.88/217.04  |- rdf__type mesh__D020966sskos__Concept
% 216.88/217.04  |- skos__hiddenLabel mesh__D020966 Disorder, Atrophic Muscular
% 216.88/217.04  |- skos__hiddenLabel mesh__D020966 Atrophy, Spinobulbar Muscular
% 216.88/217.04  |- skos__prefLabel mesh__D020966 Muscular Disorders, Atrophic
% 216.88/217.04  |- skos__hiddenLabel mesh__D020966 Muscular Disorder, Atrophic
% 216.88/217.04  |- mesh__recordMaintainer mesh__D020966 sjn
% 216.88/217.04  |- skos__broader mesh__D020966smesh__D009468
% 216.88/217.04  |- skos__altLabel mesh__D020966 Spinobulbar Muscular Atrophy
% 216.88/217.04  |- mesh__recordAuthorizer mesh__D020966 sjn
% 216.88/217.04  |- skos__hiddenLabel mesh__D020966 Disorders, Atrophic Muscular
% 216.88/217.04  |- skos__broader mesh__D020966smesh__D009135
% 216.88/217.04  |- mesh__dateEstablished mesh__D020966 2000-01-01
% 216.88/217.04  |- skos__hiddenLabel mesh__D020966 Atrophies, Spinobulbar
% 216.88/217.04  |- mesh__recordOriginator mesh__D020966 KEV
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D020966 2003
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D020966 2002
% 216.88/217.04  |- skos__altLabel mesh__D020966 Atrophic Muscular Disorders
% 216.88/217.04  |- skos__hiddenLabel mesh__D020966 Atrophic Muscular Disorder
% 216.88/217.04  |- skos__hiddenLabel mesh__D020966 Disuse Atrophies
% 216.88/217.04  |- skos__hiddenLabel mesh__D020966 Disuse Atrophy
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D020966 2004
% 216.88/217.04  |- skos__hiddenLabel mesh__D020966 Atrophies, Spinopontine
% 216.88/217.04  |- skos__hiddenLabel mesh__D020966 Spinopontine Atrophies
% 216.88/217.04  |- skos__hiddenLabel mesh__D020966 Atrophies, Spinobulbar Muscular
% 216.88/217.04  |- skos__related mesh__D020966smesh__D009133
% 216.88/217.04  |- skos__hiddenLabel mesh__D020966 Spinobulbar Muscular Atrophies
% 216.88/217.04  |- skos__historyNote mesh__D020966 Muscular Atrophy %28%1966-1999%29%
% 216.88/217.04  |- mesh__dateCreated mesh__D020966 1999-11-03
% 216.88/217.04  |- skos__altLabel mesh__D020966 Muscular Atrophy, Spinobulbar
% 216.88/217.04  |- mesh__historyNote mesh__D020966 2000   
% 216.88/217.04  |- skos__broader mesh__D006497smesh__D006025
% 216.88/217.04  |- mesh__dateRevised mesh__D006497 2004-07-07
% 216.88/217.04  |- mesh__publicMeSHNote mesh__D006497
% 216.88/217.04       91; was see under MUCOPOLYSACCHARIDES 1972-90   
% 216.88/217.04  |- mesh__recordMaintainer mesh__D006497 ssb
% 216.88/217.04  |- rdf__type mesh__D006497sskos__Concept
% 216.88/217.04  |- skos__hiddenLabel mesh__D006497 Sulfate, Heparan
% 216.88/217.04  |- skos__scopeNote mesh__D006497
% 216.88/217.04       A heteropolysaccharide that is similar in structure to HEPARIN. It accumulates in individuals with MUCOPOLYSACCHARIDOSIS.%A%    
% 216.88/217.04  |- mesh__dateCreated mesh__D006497 1999-01-01
% 216.88/217.04  |- skos__hiddenLabel mesh__D006497 Sulfate, Heparitin
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D006497 2006
% 216.88/217.04  |- skos__annotation mesh__D006497
% 216.88/217.04       do not confuse X ref HEPARAN SULFATE with HEPARAN SULFATE PROTEOGLYCAN%A%  
% 216.88/217.04  |- mesh__recordOriginator mesh__D006497 NLM
% 216.88/217.04  |- mesh__dateEstablished mesh__D006497 1991-01-01
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D006497 2005
% 216.88/217.04  |- skos__prefLabel mesh__D006497 Heparitin Sulfate
% 216.88/217.04  |- skos__altLabel mesh__D006497 Heparan Sulfate
% 216.88/217.04  |- mesh__historyNote mesh__D006497
% 216.88/217.04       91%28%72%29%; was see under MUCOPOLYSACCHARIDES 1972-90   
% 216.88/217.04  |- mesh__recordAuthorizer mesh__D006497 sjn
% 216.88/217.04  |- skos__historyNote mesh__D006497 Mucopolysaccharides %28%1966-1971%29%
% 216.88/217.04  |- mesh__historyNote mesh__D020168 99; use P-GLYCOPROTEIN 1995-98   
% 216.88/217.04  |- skos__scopeNote mesh__D020168
% 216.88/217.04       A 170-kDa transmembrane glycoprotein from the superfamily of ATP-BINDING CASSETTE TRANSPORTERS. It serves as an ATP-dependent efflux pump for a variety of chemicals, including many ANTINEOPLASTIC AGENTS. Overexpression of this glycoprotein is associated with multidrug resistance %28%see DRUG RESISTANCE, MULTIPLE%29%.%A%    
% 216.88/217.04  |- mesh__recordOriginator mesh__D020168 ADP
% 216.88/217.04  |- skos__prefLabel mesh__D020168 P-Glycoprotein
% 216.88/217.04  |- skos__altLabel mesh__D020168 Multidrug Resistance Protein 1
% 216.88/217.04  |- mesh__dateCreated mesh__D020168 1998-07-20
% 216.88/217.04  |- skos__historyNote mesh__D020168 P-Glycoprotein %28%1995-1998%29%
% 216.88/217.04  |- mesh__recordMaintainer mesh__D020168 jmp
% 216.88/217.04  |- skos__altLabel mesh__D020168 PGY-1 Protein
% 216.88/217.04  |- skos__broader mesh__D020168smesh__D029365
% 216.88/217.04  |- skos__annotation mesh__D020168 P-GLYCOPROTEINS is also available   
% 216.88/217.04  |- rdf__type mesh__D020168sskos__Concept
% 216.88/217.04  |- skos__altLabel mesh__D020168 P-gp
% 216.88/217.04  |- skos__related mesh__D020168smesh__D018432
% 216.88/217.04  |- skos__broader mesh__D020168smesh__D018435
% 216.88/217.04  |- skos__hiddenLabel mesh__D020168 P Glycoprotein
% 216.88/217.04  |- skos__altLabel mesh__D020168 MDR1 Protein
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D020168 2006
% 216.88/217.04  |- mesh__recordAuthorizer mesh__D020168 sjn
% 216.88/217.04  |- mesh__dateEstablished mesh__D020168 1999-01-01
% 216.88/217.04  |- mesh__publicMeSHNote mesh__D020168
% 216.88/217.04       99; P-GLYCOPROTEIN was indexed under P-GLYCOPROTEIN 1995-98, CARRIER PROTEINS %26% MEMBRANE GLYCOPROTEINS 1980-94, GLYCOPROTEINS 1980-87, and MEMBRANE PROTEINS 1980-82%A%  
% 216.88/217.04  |- mesh__dateRevised mesh__D020168 2005-06-30
% 216.88/217.04  |- skos__hiddenLabel mesh__D020168 PGY 1 Protein
% 216.88/217.04  |- skos__altLabel mesh__D020168
% 216.88/217.04       ATP-Binding Cassette, Sub-Family B, Member 1
% 216.88/217.04  |- skos__broader mesh__D014929smesh__D015418
% 216.88/217.04  |- mesh__dateRevised mesh__D014929 2005-06-30
% 216.88/217.04  |- skos__broader mesh__D014929smesh__D003919
% 216.88/217.04  |- mesh__recordOriginator mesh__D014929 VDK
% 216.88/217.04  |- skos__prefLabel mesh__D014929 Wolfram Syndrome
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D014929 2006
% 216.88/217.04  |- mesh__dateEstablished mesh__D014929 1986-01-01
% 216.88/217.04  |- mesh__dateCreated mesh__D014929 1985-03-11
% 216.88/217.04  |- skos__altLabel mesh__D014929 DIDMOAD
% 216.88/217.04  |- skos__historyNote mesh__D014929
% 216.88/217.04       Diabetes Mellitus, Insulin-Dependent %28%1984-1985%29%
% 216.88/217.04  |- skos__broader mesh__D014929smesh__D003922
% 216.88/217.04  |- skos__historyNote mesh__D014929 Deafness %28%1966-1985%29%
% 216.88/217.04  |- skos__historyNote mesh__D014929 Optic Atrophy %28%1966-1985%29%
% 216.88/217.04  |- mesh__historyNote mesh__D014929 86   
% 216.88/217.04  |- mesh__recordMaintainer mesh__D014929 lkt
% 216.88/217.04  |- skos__hiddenLabel mesh__D014929 Syndrome, Wolfram
% 216.88/217.04  |- mesh__recordAuthorizer mesh__D014929 sjn
% 216.88/217.04  |- skos__historyNote mesh__D014929 Diabetes Insipidus %28%1966-1985%29%
% 216.88/217.04  |- rdf__type mesh__D014929sskos__Concept
% 216.88/217.04  |- skos__broader mesh__D014929smesh__D000015
% 216.88/217.04  |- skos__scopeNote mesh__D014929
% 216.88/217.04       A hereditary condition characterized by multiple symptoms including those of DIABETES INSIPIDUS; DIABETES MELLITUS; OPTIC ATROPHY; and DEAFNESS. This syndrome is also known as DIDMOAD %28%first letter of each word%29% and is usually associated with VASOPRESSIN deficiency. It is caused by mutations in gene WFS1 encoding wolframin, a 100-kDa transmembrane protein.%A%    
% 216.88/217.04  |- mesh__publicMeSHNote mesh__D014929 86   
% 216.88/217.04  |- mesh__recordAuthorizer mesh__D019614 sjn
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D019614 2006
% 216.88/217.04  |- skos__historyNote mesh__D019614 Halobacterium %28%1990-1997%29%
% 216.88/217.04  |- mesh__dateRevised mesh__D019614 2005-06-30
% 216.88/217.04  |- skos__broader mesh__D019614smesh__D019613
% 216.88/217.04  |- mesh__dateEstablished mesh__D019614 1998-01-01
% 216.88/217.04  |- rdf__type mesh__D019614sskos__Concept
% 216.88/217.04  |- skos__prefLabel mesh__D019614 Haloarcula marismortui
% 216.88/217.04  |- skos__annotation mesh__D019614
% 216.88/217.04       a species of halophilic archaea; marismortui is Latin for Dead Sea%A%  
% 216.88/217.04  |- mesh__dateCreated mesh__D019614 1997-06-20
% 216.88/217.04  |- mesh__historyNote mesh__D019614
% 216.88/217.04       98; HALOBACTERIUM MARISMORTUI was see HALOBACTERIUM 1992-97%A%  
% 216.88/217.04  |- skos__altLabel mesh__D019614 Halobacterium marismortui
% 216.88/217.04  |- mesh__recordMaintainer mesh__D019614 SYSTEM
% 216.88/217.04  |- mesh__publicMeSHNote mesh__D019614
% 216.88/217.04       98; HALOBACTERIUM MARISMORTUI was see HALOBACTERIUM 1992-97%A%  
% 216.88/217.04  |- skos__scopeNote mesh__D019614
% 216.88/217.04       A species of halophilic archaea distinguished by its production of acid from sugar. This species was previously called Halobacterium marismortui.%A%    
% 216.88/217.04  |- mesh__recordOriginator mesh__D019614 AGS
% 216.88/217.04  |- mesh__recordAuthorizer mesh__D000909 ags
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D000909 2006A
% 216.88/217.04  |- skos__prefLabel mesh__D000909 Antibodies, Helminth
% 216.88/217.04  |- skos__broader mesh__D000909smesh__D000906
% 216.88/217.04  |- skos__historyNote mesh__D000909 IgE %28%1971-1987%29%
% 216.88/217.04  |- mesh__dateRevised mesh__D000909 2005-07-18
% 216.88/217.04  |- mesh__recordOriginator mesh__D000909 SCD
% 216.88/217.04  |- mesh__publicMeSHNote mesh__D000909 88   
% 216.88/217.04  |- skos__scopeNote mesh__D000909
% 216.88/217.04       Antibodies produced by human or animal cells following clinical or experimental exposure to parasitic HELMINTH ANTIGENS. The IMMUNOGLOBULIN E class of immunoglobulins is usually formed and released, but IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; and IMMUNOGLOBULIN A may also occur.%A%    
% 216.88/217.04  |- skos__historyNote mesh__D000909 Antibodies %28%1966-1987%29%
% 216.88/217.04  |- skos__altLabel mesh__D000909 Helminth Antibodies
% 216.88/217.04  |- mesh__recordMaintainer mesh__D000909 ags
% 216.88/217.04  |- skos__historyNote mesh__D000909
% 216.88/217.04       Antigens, Helminth/immunology %28%1985-1987%29%
% 216.88/217.04  |- mesh__dateCreated mesh__D000909 1987-03-20
% 216.88/217.04  |- rdf__type mesh__D000909sskos__Concept
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D000909 2006
% 216.88/217.04  |- mesh__historyNote mesh__D000909 88   
% 216.88/217.04  |- mesh__dateEstablished mesh__D000909 1988-01-01
% 216.88/217.04  |- skos__annotation mesh__D000909
% 216.88/217.04       coordinate IM with specific helminth /immunol %28%IM%29%; do not coordinate with ANTIBODY FORMATION for /biosyn%A%  
% 216.88/217.04  |- mesh__dateCreated mesh__D011631 1999-01-01
% 216.88/217.04  |- mesh__recordOriginator mesh__D011631 NLM
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D011631 2006
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D011631 2003
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D011631 1998
% 216.88/217.04  |- skos__related mesh__D011631smesh__D013567
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D011631 2000
% 216.88/217.04  |- skos__hiddenLabel mesh__D011631 Pubic Symphyses
% 216.88/217.04  |- rdf__type mesh__D011631sskos__Concept
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D011631 2004
% 216.88/217.04  |- skos__prefLabel mesh__D011631 Pubic Symphysis
% 216.88/217.04  |- skos__hiddenLabel mesh__D011631 Symphyses, Pubic
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D011631 1999
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D011631 2001
% 216.88/217.04  |- skos__broader mesh__D011631smesh__D007596
% 216.88/217.04  |- mesh__recordMaintainer mesh__D011631 TPW
% 216.88/217.04  |- skos__hiddenLabel mesh__D011631 Symphysis, Pubic
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D011631 2005
% 216.88/217.04  |- mesh__recordAuthorizer mesh__D011631 SJN
% 216.88/217.04  |- mesh__dateRevised mesh__D011631 1997-06-20
% 216.88/217.04  |- mesh__activeMeSHYear mesh__D011631 2002
% 216.88/217.04  |- skos__broader mesh__D035281smesh__D018517
% 216.88/217.04  |- mesh__dateCreated mesh__D035281 2002-07-03
% 216.88/217.04  |- mesh__dateRevised mesh__D035281 2004-07-13
% 216.88/217.04  |- mesh__recordMaintainer mesh__D035281 sjn
% 216.88/217.04  |- mesh__historyNote mesh__D035281 2003   
% 216.88/217.04  |- rdf__type mesh__D035281sskos__Concept
% 216.88/217.04  |- mesh__publicMeSHNote mesh__D035281 2003   
% 216.88/217.04  |- skos__annotation mesh__D035281 coord with specific plant   
% 216.88/217.04  |- skos__prefLabel mesh__D035281 Plant Tubers
% 216.88/217.05  |- skos__historyNote mesh__D035281 Plant Roots %28%1995-2002%29%
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D035281 2005
% 216.88/217.05  |- skos__altLabel mesh__D035281 Tubers, Plant
% 216.88/217.05  |- skos__scopeNote mesh__D035281
% 216.88/217.05       An enlarged underground root or stem of some plants. It is usually rich in carbohydrates.  Some, such as POTATOES, are important human FOOD. They may reproduce vegetatively from buds.%A%    
% 216.88/217.05  |- mesh__dateEstablished mesh__D035281 2003-01-01
% 216.88/217.05  |- mesh__recordOriginator mesh__D035281 ssb
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D035281 2006
% 216.88/217.05  |- mesh__recordAuthorizer mesh__D035281 sjn
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D010539 2001
% 216.88/217.05  |- skos__annotation mesh__D010539
% 216.88/217.05       coord NIM with substance /pharmacokin %28%IM%29% or /metab %28%IM%29% or tissue /metab %28%IM%29%; for nonbiological material coord with substance /chem %28%IM%29%; note VASCULAR PERMEABILITY see CAPILLARY PERMEABILITY%A%  
% 216.88/217.05  |- rdf__type mesh__D010539sskos__Concept
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D010539 2000
% 216.88/217.05  |- skos__prefLabel mesh__D010539 Permeability
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D010539 1999
% 216.88/217.05  |- mesh__dateRevised mesh__D010539 1998-06-10
% 216.88/217.05  |- skos__scopeNote mesh__D010539
% 216.88/217.05       Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions.%A%    
% 216.88/217.05  |- mesh__dateCreated mesh__D010539 1999-01-01
% 216.88/217.05  |- skos__hiddenLabel mesh__D010539 Permeabilities
% 216.88/217.05  |- mesh__recordOriginator mesh__D010539 NLM
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D010539 2004
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D010539 2006
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D010539 2003
% 216.88/217.05  |- skos__broader mesh__D010539smesh__D002627
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D010539 2002
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D010539 2005
% 216.88/217.05  |- mesh__recordAuthorizer mesh__D010539 SJN
% 216.88/217.05  |- mesh__recordMaintainer mesh__D010539 ADP
% 216.88/217.05  |- mesh__historyNote mesh__D007590
% 216.88/217.05       90%28%76%29%; was see under RUNNING 1980-89; was see under SPORTS 1976-79%A%  
% 216.88/217.05  |- mesh__dateRevised mesh__D007590 2003-07-09
% 216.88/217.05  |- mesh__recordAuthorizer mesh__D007590 sjn
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D007590 2006
% 216.88/217.05  |- skos__scopeNote mesh__D007590
% 216.88/217.05       Running at a low rate of speed. It can be done as a means of conditioning or for general health and well being.%A%    
% 216.88/217.05  |- skos__broader mesh__D007590smesh__D012420
% 216.88/217.05  |- skos__annotation mesh__D007590
% 216.88/217.05       human %26% animal; /inj: coord IM with specific inj %28%IM%29%; /physiol permitted%A%  
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D007590 2005
% 216.88/217.05  |- mesh__recordMaintainer mesh__D007590 nns
% 216.88/217.05  |- skos__prefLabel mesh__D007590 Jogging
% 216.88/217.05  |- skos__hiddenLabel mesh__D007590 Joggings
% 216.88/217.05  |- mesh__dateCreated mesh__D007590 1975-07-25
% 216.88/217.05  |- rdf__type mesh__D007590sskos__Concept
% 216.88/217.05  |- mesh__dateEstablished mesh__D007590 1990-01-01
% 216.88/217.05  |- mesh__recordOriginator mesh__D007590 JW
% 216.88/217.05  |- skos__historyNote mesh__D007590 Physical Fitness %28%1966-1975%29%
% 216.88/217.05  |- mesh__publicMeSHNote mesh__D007590
% 216.88/217.05       90; was see under RUNNING 1980-89; was see under SPORTS 1976-79%A%  
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D007590 2004
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D021261 2006
% 216.88/217.05  |- skos__hiddenLabel mesh__D021261 Parasitic Sensitivity Test
% 216.88/217.05  |- skos__prefLabel mesh__D021261 Parasitic Sensitivity Tests
% 216.88/217.05  |- skos__broader mesh__D021261smesh__D010274
% 216.88/217.05  |- skos__hiddenLabel mesh__D021261 Tests, Parasitic Sensitivity
% 216.88/217.05  |- skos__hiddenLabel mesh__D021261 Sensitivity Test, Parasite
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D021261 2005
% 216.88/217.05  |- skos__broader mesh__D021261smesh__D004353
% 216.88/217.05  |- mesh__recordMaintainer mesh__D021261 jls
% 216.88/217.05  |- skos__hiddenLabel mesh__D021261 Parasite Sensitivity Test
% 216.88/217.05  |- skos__annotation mesh__D021261
% 216.88/217.05       IM when general; NIM with specific drug %28%IM%29% %26% specific parasite %28%IM%29%; MICROBIAL SENSITIVITY TESTS is also available%A%  
% 216.88/217.05  |- rdf__type mesh__D021261sskos__Concept
% 216.88/217.05  |- skos__hiddenLabel mesh__D021261 Sensitivity Test, Parasitic
% 216.88/217.05  |- mesh__historyNote mesh__D021261 2001   
% 216.88/217.05  |- mesh__dateCreated mesh__D021261 2000-06-22
% 216.88/217.05  |- skos__hiddenLabel mesh__D021261 Tests, Parasite Sensitivity
% 216.88/217.05  |- mesh__dateEstablished mesh__D021261 2001-01-01
% 216.88/217.05  |- skos__altLabel mesh__D021261 Protozoa Drug Sensitivity Tests
% 216.88/217.05  |- skos__altLabel mesh__D021261 Drug Sensitivity Tests, Protozoal
% 216.88/217.05  |- skos__hiddenLabel mesh__D021261 Sensitivity Tests, Parasite
% 216.88/217.05  |- skos__hiddenLabel mesh__D021261 Test, Parasitic Sensitivity
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D021261 2004
% 216.88/217.05  |- skos__historyNote mesh__D021261 Parasitology %28%1967-2000%29%
% 216.88/217.05  |- mesh__publicMeSHNote mesh__D021261 2001   
% 216.88/217.05  |- mesh__recordAuthorizer mesh__D021261 sjn
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D021261 2002
% 216.88/217.05  |- skos__altLabel mesh__D021261 Parasite Sensitivity Tests
% 216.88/217.05  |- skos__hiddenLabel mesh__D021261 Test, Parasite Sensitivity
% 216.88/217.05  |- skos__altLabel mesh__D021261 Drug Sensitivity Tests, Helminth
% 216.88/217.05  |- mesh__dateRevised mesh__D021261 2001-07-25
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D021261 2003
% 216.88/217.05  |- skos__scopeNote mesh__D021261
% 216.88/217.05       Tests that demonstrate the relative effectiveness of chemotherapeutic agents against specific parasites.%A%    
% 216.88/217.05  |- skos__altLabel mesh__D021261 Drug Sensitivity Tests, Parasitic
% 216.88/217.05  |- mesh__recordOriginator mesh__D021261 jmp
% 216.88/217.05  |- skos__broader mesh__D015224smesh__D003853
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D015224 2002
% 216.88/217.05  |- skos__annotation mesh__D015224 antivirals %26% antimetabolites   
% 216.88/217.05  |- mesh__dateRevised mesh__D015224 1995-06-08
% 216.88/217.05  |- mesh__dateEstablished mesh__D015224 1989-01-01
% 216.88/217.05  |- skos__scopeNote mesh__D015224
% 216.88/217.05       Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5%27%-triphosphates and act as chain-terminating inhibitors of viral reverse transcription.%A%    
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D015224 1997
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D015224 2004
% 216.88/217.05  |- skos__historyNote mesh__D015224 Deoxyribonucleosides %28%1971-1988%29%
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D015224 2001
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D015224 1999
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D015224 2006
% 216.88/217.05  |- mesh__dateCreated mesh__D015224 1988-05-12
% 216.88/217.05  |- mesh__recordAuthorizer mesh__D015224 PLS
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D015224 1996
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D015224 2003
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D015224 2000
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D015224 1998
% 216.88/217.05  |- skos__hiddenLabel mesh__D015224 2%27%,3%27% Dideoxynucleosides
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D015224 2005
% 216.88/217.05  |- mesh__publicMeSHNote mesh__D015224 89   
% 216.88/217.05  |- skos__prefLabel mesh__D015224 Dideoxynucleosides
% 216.88/217.05  |- mesh__recordMaintainer mesh__D015224 JRT
% 216.88/217.05  |- mesh__historyNote mesh__D015224 89   
% 216.88/217.05  |- skos__altLabel mesh__D015224 ddNus
% 216.88/217.05  |- rdf__type mesh__D015224sskos__Concept
% 216.88/217.05  |- mesh__recordOriginator mesh__D015224 RLS
% 216.88/217.05  |- mesh__historyNote mesh__D001204
% 216.88/217.05       91%28%75%29%; was see under OXIDOREDUCTASES 1975-90   
% 216.88/217.05  |- skos__historyNote mesh__D001204 Oxidoreductases %28%1973-1974%29%
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D001204 2006
% 216.88/217.05  |- rdf__type mesh__D001204sskos__Concept
% 216.88/217.05  |- skos__prefLabel mesh__D001204 Ascorbate Oxidase
% 216.88/217.05  |- mesh__recordMaintainer mesh__D001204 ssb
% 216.88/217.05  |- skos__altLabel mesh__D001204 Ascorbino Dehydrogenase
% 216.88/217.05  |- mesh__recordAuthorizer mesh__D001204 sjn
% 216.88/217.05  |- skos__historyNote mesh__D001204 Ascorbic Acid %28%1973-1974%29%
% 216.88/217.05  |- skos__hiddenLabel mesh__D001204 Dehydrogenase, Ascorbino
% 216.88/217.05  |- mesh__publicMeSHNote mesh__D001204
% 216.88/217.05       91; was see under OXIDOREDUCTASES 1975-90   
% 216.88/217.05  |- skos__broader mesh__D001204smesh__D010088
% 216.88/217.05  |- mesh__dateCreated mesh__D001204 1974-11-19
% 216.88/217.05  |- skos__scopeNote mesh__D001204
% 216.88/217.05       An enzyme that converts ascorbic acid to dehydroascorbic acid. EC 1.10.3.3.%A%    
% 216.88/217.05  |- mesh__dateRevised mesh__D001204 2003-07-09
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D001204 2004
% 216.88/217.05  |- mesh__dateEstablished mesh__D001204 1991-01-01
% 216.88/217.05  |- mesh__recordOriginator mesh__D001204 NLM
% 216.88/217.05  |- skos__altLabel mesh__D001204 Ascorbase
% 216.88/217.05  |- skos__hiddenLabel mesh__D001204 Oxidase, Ascorbate
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D001204 2005
% 216.88/217.05  |- skos__hiddenLabel mesh__D020967 Congenita, Paramyotonia
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D020967 2005
% 216.88/217.05  |- skos__hiddenLabel mesh__D020967 Disease, Eulenburg
% 216.88/217.05  |- mesh__publicMeSHNote mesh__D020967 2000   
% 216.88/217.05  |- skos__hiddenLabel mesh__D020967 Disorder, Myotonic
% 216.88/217.05  |- skos__hiddenLabel mesh__D020967 Myotonic Myopathies
% 216.88/217.05  |- skos__hiddenLabel mesh__D020967 Fluctuans, Myotonia
% 216.88/217.05  |- mesh__recordMaintainer mesh__D020967 ags
% 216.88/217.05  |- skos__scopeNote mesh__D020967
% 216.88/217.05       Diseases characterized by MYOTONIA, which may be inherited or acquired. Myotonia may be restricted to certain muscles %28%e.g., intrinsic hand muscles%29% or occur as a generalized condition. These disorders may be associated with abnormal muscle SODIUM CHANNEL and CHLORIDE CHANNELS. MYOTONIC DYSTROPHY and MYOTONIA CONGENITA represent two relatively common forms of this disorder. Proximal myotonic myopathy often presents with myotonia and muscle pain in early adulthood and later in life thigh muscle weakness and cataracts develop. %28%From Adams et al., Principles of Neurology, 6th ed, p1392%29%%A%    
% 216.88/217.05  |- skos__historyNote mesh__D020967 Myotonic Dystrophy %28%1965-1999%29%
% 216.88/217.05  |- skos__hiddenLabel mesh__D020967 Proximal Myotonic Myopathies
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D020967 2006
% 216.88/217.05  |- skos__hiddenLabel mesh__D020967 Myopathy, Myotonic
% 216.88/217.05  |- skos__hiddenLabel mesh__D020967 Paramyotonia Congenitas
% 216.88/217.05  |- rdf__type mesh__D020967sskos__Concept
% 216.88/217.05  |- skos__altLabel mesh__D020967 Proximal Myotonic Myopathy
% 216.88/217.05  |- skos__hiddenLabel mesh__D020967 Eulenburgs Disease
% 216.88/217.05  |- mesh__dateRevised mesh__D020967 2001-07-25
% 216.88/217.05  |- mesh__dateEstablished mesh__D020967 2000-01-01
% 216.88/217.05  |- skos__altLabel mesh__D020967 PROMM %28%Proximal Myotonic Myopathy%29%
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D020967 2003
% 216.88/217.05  |- mesh__recordAuthorizer mesh__D020967 sjn
% 216.88/217.05  |- skos__broader mesh__D020967smesh__D009135
% 216.88/217.05  |- skos__prefLabel mesh__D020967 Myotonic Disorders
% 216.88/217.05  |- mesh__recordOriginator mesh__D020967 KEV
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D020967 2002
% 216.88/217.05  |- skos__hiddenLabel mesh__D020967
% 216.88/217.05       PROMMs %28%Proximal Myotonic Myopathy%29%
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D020967 2004
% 216.88/217.05  |- skos__hiddenLabel mesh__D020967 Disorders, Myotonic
% 216.88/217.05  |- skos__hiddenLabel mesh__D020967 Myotonic Disorder
% 216.88/217.05  |- skos__hiddenLabel mesh__D020967 Myotonic Myopathies, Proximal
% 216.88/217.05  |- skos__hiddenLabel mesh__D020967 Myopathy, Proximal Myotonic
% 216.88/217.05  |- mesh__historyNote mesh__D020967 2000   
% 216.88/217.05  |- skos__hiddenLabel mesh__D020967 Disease, Eulenburg%27%s
% 216.88/217.05  |- skos__hiddenLabel mesh__D020967 Myopathies, Proximal Myotonic
% 216.88/217.05  |- skos__altLabel mesh__D020967 Eulenburg Disease
% 216.88/217.05  |- mesh__dateCreated mesh__D020967 1999-11-03
% 216.88/217.05  |- skos__hiddenLabel mesh__D020967 Myotonic Myopathy
% 216.88/217.05  |- skos__altLabel mesh__D020967 Eulenburg%27%s Disease
% 216.88/217.05  |- skos__altLabel mesh__D020967 Myopathies, Myotonic
% 216.88/217.05  |- rdf__type mesh__D006498sskos__Concept
% 216.88/217.05  |- skos__related mesh__D006498smesh__D008115
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006498 1999
% 216.88/217.05  |- skos__broader mesh__D006498smesh__D013505
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006498 2005
% 216.88/217.05  |- skos__hiddenLabel mesh__D006498 Hepatectomies
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006498 2000
% 216.88/217.05  |- mesh__dateRevised mesh__D006498 1997-06-20
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006498 2006
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006498 2001
% 216.88/217.05  |- mesh__recordMaintainer mesh__D006498 PXP
% 216.88/217.05  |- skos__scopeNote mesh__D006498
% 216.88/217.05       Excision of all or part of the liver. %28%Dorland, 28th ed%29%%A%    
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006498 2003
% 216.88/217.05  |- skos__prefLabel mesh__D006498 Hepatectomy
% 216.88/217.05  |- mesh__recordAuthorizer mesh__D006498 SJN
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006498 2004
% 216.88/217.05  |- mesh__dateCreated mesh__D006498 1999-01-01
% 216.88/217.05  |- skos__annotation mesh__D006498
% 216.88/217.05       do not use /util except by MeSH definition   
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006498 2002
% 216.88/217.05  |- mesh__recordOriginator mesh__D006498 NLM
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006498 1998
% 216.88/217.05  |- mesh__dateEstablished mesh__D020169 1999-01-01
% 216.88/217.05  |- skos__prefLabel mesh__D020169 Caspases
% 216.88/217.05  |- mesh__dateRevised mesh__D020169 2005-06-30
% 216.88/217.05  |- mesh__recordOriginator mesh__D020169 ADP
% 216.88/217.05  |- rdf__type mesh__D020169sskos__Concept
% 216.88/217.05  |- mesh__publicMeSHNote mesh__D020169 99   
% 216.88/217.05  |- skos__annotation mesh__D020169 CASPASE 1 is also available   
% 216.88/217.05  |- skos__broader mesh__D020169smesh__D003546
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D020169 2006
% 216.88/217.05  |- mesh__dateCreated mesh__D020169 1998-06-10
% 216.88/217.05  |- skos__related mesh__D020169smesh__D017209
% 216.88/217.05  |- skos__broader mesh__D020169smesh__D051017
% 216.88/217.05  |- skos__scopeNote mesh__D020169
% 216.88/217.05       A family of intracellular CYSTEINE ENDOPEPTIDASES. They play a key role in inflammation and mammalian APOPTOSIS. They are specific for aspartic acid at the P1 position. They are divided into two classes based on the lengths of their N-terminal prodomains. Caspases-1,-2,-4,-5,-8, and -10 have long prodomains and -3,-6,-7,-9 have short prodomains. EC 3.4.22.-.%A%    
% 216.88/217.05  |- mesh__historyNote mesh__D020169 99   
% 216.88/217.05  |- mesh__recordAuthorizer mesh__D020169 sjn
% 216.88/217.05  |- mesh__recordMaintainer mesh__D020169 DRC
% 216.88/217.05  |- skos__historyNote mesh__D020169 Cysteine Proteinases %28%1997-1998%29%
% 216.88/217.05  |- mesh__dateCreated mesh__D019615 1997-07-02
% 216.88/217.05  |- mesh__publicMeSHNote mesh__D019615 98   
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D019615 2006
% 216.88/217.05  |- skos__prefLabel mesh__D019615 Crenarchaeota
% 216.88/217.05  |- mesh__historyNote mesh__D019615 98   
% 216.88/217.05  |- mesh__recordAuthorizer mesh__D019615 sjn
% 216.88/217.05  |- mesh__recordOriginator mesh__D019615 NDW
% 216.88/217.05  |- skos__annotation mesh__D019615 a kingdom of the domain Archaea   
% 216.88/217.05  |- mesh__dateEstablished mesh__D019615 1998-01-01
% 216.88/217.05  |- skos__scopeNote mesh__D019615
% 216.88/217.05       A kingdom in the domain ARCHAEA comprised of thermoacidophilic, sulfur-dependent organisms. The two orders are SULFOLOBALES and THERMOPROTEALES.%A%    
% 216.88/217.05  |- mesh__recordMaintainer mesh__D019615 SYSTEM
% 216.88/217.05  |- skos__historyNote mesh__D019615 Archaea %28%1990-1997%29%
% 216.88/217.05  |- rdf__type mesh__D019615sskos__Concept
% 216.88/217.05  |- mesh__dateRevised mesh__D019615 2005-06-30
% 216.88/217.05  |- skos__broader mesh__D019615smesh__D001105
% 216.88/217.05  |- mesh__publicMeSHNote mesh__D011632 68   
% 216.88/217.05  |- mesh__dateEstablished mesh__D011632 1968-01-01
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D011632 2001
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D011632 2006
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D011632 2000
% 216.88/217.05  |- skos__annotation mesh__D011632 specify geog   
% 216.88/217.05  |- mesh__recordMaintainer mesh__D011632 kle
% 216.88/217.05  |- mesh__dateCreated mesh__D011632 1999-01-01
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D011632 2004
% 216.88/217.05  |- mesh__recordOriginator mesh__D011632 NLM
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D011632 2005
% 216.88/217.05  |- skos__hiddenLabel mesh__D011632 Assistance, Public
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D011632 2003
% 216.88/217.05  |- rdf__type mesh__D011632sskos__Concept
% 216.88/217.05  |- skos__prefLabel mesh__D011632 Public Assistance
% 216.88/217.05  |- mesh__recordAuthorizer mesh__D011632 sjn
% 216.88/217.05  |- skos__historyNote mesh__D011632 Public Health %28%1966-1967%29%
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D011632 2002
% 216.88/217.05  |- skos__broader mesh__D011632smesh__D005380
% 216.88/217.05  |- skos__related mesh__D011632smesh__D012946
% 216.88/217.05  |- skos__scopeNote mesh__D011632
% 216.88/217.05       Financial assistance to impoverished persons for the essentials of living through federal, state or local government programs.%A%    
% 216.88/217.05  |- mesh__dateRevised mesh__D011632 1999-11-03
% 216.88/217.05  |- mesh__historyNote mesh__D011632 68   
% 216.88/217.05  |- skos__historyNote mesh__D011632 Social Welfare %28%1966-1967%29%
% 216.88/217.05  |- mesh__onlineNote mesh__D007591
% 216.88/217.05       use JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS to search JOINT COMMISSION ON ACCREDITATION OF HOSPITALS 1979-88%A%  
% 216.88/217.05  |- mesh__recordAuthorizer mesh__D007591 SJN
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D007591 2002
% 216.88/217.05  |- mesh__dateRevised mesh__D007591 1997-06-20
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D007591 2005
% 216.88/217.05  |- skos__broader mesh__D007591smesh__D000068
% 216.88/217.05  |- mesh__dateEstablished mesh__D007591 1991-01-01
% 216.88/217.05  |- skos__altLabel mesh__D007591 JCAHO
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D007591 2006
% 216.88/217.05  |- mesh__recordMaintainer mesh__D007591 TPW
% 216.88/217.05  |- mesh__historyNote mesh__D007591
% 216.88/217.05       91%28%89%29%; was see under ACCREDITATION 1989-90; was JOINT COMMISSION ON ACCREDITATION OF HOSPITALS see under ACCREDITATION 1979-88%A%  
% 216.88/217.05  |- skos__altLabel mesh__D007591
% 216.88/217.05       Joint Commission on Accreditation, Healthcare Organizations
% 216.88/217.05  |- skos__prefLabel mesh__D007591
% 216.88/217.05       Joint Commission on Accreditation of Healthcare Organizations
% 216.88/217.05  |- skos__altLabel mesh__D007591
% 216.88/217.05       Joint Commission on Accreditation, Health Care Organizations
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D007591 2000
% 216.88/217.05  |- mesh__dateCreated mesh__D007591 1978-05-04
% 216.88/217.05  |- skos__scopeNote mesh__D007591
% 216.88/217.05       A private, voluntary, not-for-profit organization which establishes standards for the operation of health facilities and services, conducts surveys, and awards accreditation.%A%    
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D007591 2003
% 216.88/217.05  |- rdf__type mesh__D007591sskos__Concept
% 216.88/217.05  |- skos__altLabel mesh__D007591
% 216.88/217.05       Joint Commission of Accreditation, Health Care Organizations
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D007591 1998
% 216.88/217.05  |- skos__annotation mesh__D007591
% 216.88/217.05       add UNITED STATES %28%NIM%29%; DF: note short x ref;      CATALOG: use NAF entry%A%  
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D007591 2001
% 216.88/217.05  |- skos__altLabel mesh__D007591
% 216.88/217.05       Joint Commission on Accreditation of Health Care Organizations
% 216.88/217.05  |- mesh__publicMeSHNote mesh__D007591
% 216.88/217.05       91; was see under ACCREDITATION 1989-90; was JOINT COMMISSION ON ACCREDITATION OF HOSPITALS see under ACCREDITATION 1979-88%A%  
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D007591 2004
% 216.88/217.05  |- mesh__recordOriginator mesh__D007591 EC
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D007591 1999
% 216.88/217.05  |- mesh__recordAuthorizer mesh__D015225 sjn
% 216.88/217.05  |- skos__broader mesh__D015225smesh__D003943
% 216.88/217.05  |- mesh__historyNote mesh__D015225 89   
% 216.88/217.05  |- skos__related mesh__D015225smesh__D050781
% 216.88/217.05  |- skos__prefLabel mesh__D015225 Magnetoencephalography
% 216.88/217.05  |- mesh__recordMaintainer mesh__D015225 ssb
% 216.88/217.05  |- mesh__recordOriginator mesh__D015225 EJB
% 216.88/217.05  |- mesh__publicMeSHNote mesh__D015225 89   
% 216.88/217.05  |- rdf__type mesh__D015225sskos__Concept
% 216.88/217.05  |- skos__historyNote mesh__D015225 Magnetics %28%1983-1988%29%
% 216.88/217.05  |- skos__annotation mesh__D015225 DF: MAGNETOENCEPHALOGR   
% 216.88/217.05  |- skos__scopeNote mesh__D015225
% 216.88/217.05       The measurement of magnetic fields over the head generated by electric currents in the brain. As in any electrical conductor, electric fields in the brain are accompanied by orthogonal magnetic fields. The measurement of these fields provides information about the localization of brain activity which is complementary to that provided by electroencephalography. Magnetoencephalography may be used alone or together with electroencephalography, for measurement of spontaneous or evoked activity, and for research or clinical purposes.%A%    
% 216.88/217.05  |- mesh__dateEstablished mesh__D015225 1989-01-01
% 216.88/217.05  |- mesh__dateRevised mesh__D015225 2005-06-30
% 216.88/217.05  |- skos__historyNote mesh__D015225 Brain %28%1983-1988%29%
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D015225 2006
% 216.88/217.05  |- mesh__dateCreated mesh__D015225 1988-05-12
% 216.88/217.05  |- skos__hiddenLabel mesh__D001205 Ascorbate, Sodium
% 216.88/217.05  |- skos__hiddenLabel mesh__D001205 L Ascorbic Acid
% 216.88/217.05  |- mesh__recordOriginator mesh__D001205 NLM
% 216.88/217.05  |- skos__altLabel mesh__D001205 Ascorbic Acid, Monosodium Salt
% 216.88/217.05  |- mesh__recordMaintainer mesh__D001205 ssb
% 216.88/217.05  |- skos__altLabel mesh__D001205 Vitamin C
% 216.88/217.05  |- mesh__dateCreated mesh__D001205 1999-01-01
% 216.88/217.05  |- skos__scopeNote mesh__D001205
% 216.88/217.05       A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant.%A%    
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D001205 2006
% 216.88/217.05  |- rdf__type mesh__D001205sskos__Concept
% 216.88/217.05  |- skos__broader mesh__D001205smesh__D013400
% 216.88/217.05  |- skos__hiddenLabel mesh__D001205 Ascorbate, Ferrous
% 216.88/217.05  |- mesh__publicMeSHNote mesh__D001205
% 216.88/217.05       /therapeutic use was ASCORBIC ACID, THERAPEUTIC 1965   
% 216.88/217.05  |- skos__prefLabel mesh__D001205 Ascorbic Acid
% 216.88/217.05  |- skos__hiddenLabel mesh__D001205 Acid, L-Ascorbic
% 216.88/217.05  |- mesh__historyNote mesh__D001205
% 216.88/217.05       /therapeutic use was ASCORBIC ACID, THERAPEUTIC 1965   
% 216.88/217.05  |- skos__hiddenLabel mesh__D001205 Acid, Ascorbic
% 216.88/217.05  |- mesh__dateRevised mesh__D001205 2005-06-30
% 216.88/217.05  |- skos__altLabel mesh__D001205 L-Ascorbic Acid
% 216.88/217.05  |- mesh__recordAuthorizer mesh__D001205 sjn
% 216.88/217.05  |- skos__annotation mesh__D001205
% 216.88/217.05       /defic = ASCORBIC ACID DEFICIENCY or SCURVY   
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Brachial Plexus Neuritides
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Neuralgic Amyotrophies
% 216.88/217.05  |- skos__altLabel mesh__D020968 Neuritis, Brachial Plexus
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Neuralgias, Amyotrophic
% 216.88/217.05  |- skos__scopeNote mesh__D020968
% 216.88/217.05       A syndrome associated with inflammation of the BRACHIAL PLEXUS. Clinical features include severe pain in the shoulder region which may be accompanied by MUSCLE WEAKNESS and loss of sensation in the upper extremity. This condition may be associated with VIRUS DISEASES; IMMUNIZATION; SURGERY; heroin use %28%see HEROIN DEPENDENCE%29%; and other conditions. The term brachial neuralgia generally refers to pain associated with brachial plexus injury. %28%From Adams et al., Principles of Neurology, 6th ed, pp1355-6%29%%A%    
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D020968 2001
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Neuralgias, Brachial
% 216.88/217.05  |- skos__altLabel mesh__D020968 Parsonage-Aldren-Turner Syndrome
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Cervico Brachial Neuralgia
% 216.88/217.05  |- skos__broader mesh__D020968smesh__D020516
% 216.88/217.05  |- skos__historyNote mesh__D020968 Neuritis %28%1965-1999%29%
% 216.88/217.05  |- skos__historyNote mesh__D020968 Brachial Plexus %28%1965-1999%29%
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Neuralgia, Cervicobrachial
% 216.88/217.05  |- skos__altLabel mesh__D020968 Shoulder-Girdle Neuropathy
% 216.88/217.05  |- mesh__dateCreated mesh__D020968 1999-11-05
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D020968 2005
% 216.88/217.05  |- skos__broader mesh__D020968smesh__D009443
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Neuropathy, Shoulder-Girdle
% 216.88/217.05  |- skos__altLabel mesh__D020968 Cervicobrachial Neuralgia
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Neuralgias, Cervico-Brachial
% 216.88/217.05  |- skos__altLabel mesh__D020968 Amyotrophy, Neuralgic
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Neuralgias, Cervicobrachial
% 216.88/217.05  |- mesh__dateEstablished mesh__D020968 2000-01-01
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Amyotrophies, Neuralgic
% 216.88/217.05  |- skos__prefLabel mesh__D020968 Brachial Plexus Neuritis
% 216.88/217.05  |- mesh__historyNote mesh__D020968
% 216.88/217.05       2000; for CERVICO-BRACHIAL NEURALGIA use BRACHIAL PLEXUS NEURITIS 1965-1999; for BRACHIAL NEURALGIA; NEURALGIC AMYOTROPHY; PARSONAGE-TURNER SYNDROME; %26% SHOULDER-GIRDLE NEUROPATHY use BRACHIAL PLEXUS NEURITIS 1989-1999; for BRACHIAL NEURALGIA use CERVICO-BRACHIAL NEURALGIA 1988-1999%A%  
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D020968 2006
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Cervicobrachial Neuralgias
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D020968 2002
% 216.88/217.05  |- rdf__type mesh__D020968sskos__Concept
% 216.88/217.05  |- mesh__publicMeSHNote mesh__D020968
% 216.88/217.05       2000; for CERVICO-BRACHIAL NEURALGIA see CERVICO-BRACHIAL NEURALGIA 1965-1999; for BRACHIAL NEURALGIA; NEURALGIC AMYOTROPHY; PARSONAGE-TURNER SYNDROME; %26% SHOULDER-GIRDLE NEUROPATHY see CERVICO-BRACHIAL NEURALGIA 1988-1999; for BRACHIAL NEURALGIA see CERVICO-BRACHIAL NEURALGIA 1988-1999%A%  
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Amyotrophic Neuralgia
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Parsonage Aldren Turner Syndrome
% 216.88/217.05  |- skos__altLabel mesh__D020968 Brachial Neuritis
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Brachial Neuritides
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Parsonage Turner Syndrome
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Syndrome, Parsonage-Turner
% 216.88/217.05  |- skos__altLabel mesh__D020968 Neuralgic Amyotrophy
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D020968 2003
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Shoulder Girdle Neuropathy
% 216.88/217.05  |- skos__related mesh__D020968smesh__D020516
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Neuritis, Brachial
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Neuritides, Brachial Plexus
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Amyotrophic Neuralgias
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Syndrome, Parsonage-Aldren-Turner
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Cervico-Brachial Neuralgias
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Neuralgia, Brachial
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Shoulder-Girdle Neuropathies
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D020968 2004
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Neuralgia, Cervico-Brachial
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D020968 2000
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Neuritides, Brachial
% 216.88/217.05  |- skos__altLabel mesh__D020968 Parsonage-Turner Syndrome
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Neuropathies, Shoulder-Girdle
% 216.88/217.05  |- skos__hiddenLabel mesh__D020968 Brachial Neuralgias
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006499 2005
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006499 1993
% 216.88/217.05  |- skos__hiddenLabel mesh__D006499 Arteries, Hepatic
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006499 2002
% 216.88/217.05  |- mesh__recordOriginator mesh__D006499 NLM
% 216.88/217.05  |- skos__related mesh__D006499smesh__D008102
% 216.88/217.05  |- skos__prefLabel mesh__D006499 Hepatic Artery
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006499 1996
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006499 2006
% 216.88/217.05  |- mesh__recordAuthorizer mesh__D006499 PLS
% 216.88/217.05  |- skos__broader mesh__D006499smesh__D001158
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006499 1997
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006499 1994
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006499 2003
% 216.88/217.05  |- skos__hiddenLabel mesh__D006499 Hepatic Arteries
% 216.88/217.05  |- skos__hiddenLabel mesh__D006499 Artery, Hepatic
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006499 2000
% 216.88/217.05  |- mesh__dateRevised mesh__D006499 1992-05-15
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006499 2004
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006499 1995
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006499 2001
% 216.88/217.05  |- mesh__dateCreated mesh__D006499 1999-01-01
% 216.88/217.05  |- mesh__recordMaintainer mesh__D006499 TAP
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006499 1998
% 216.88/217.05  |- rdf__type mesh__D006499sskos__Concept
% 216.88/217.05  |- skos__scopeNote mesh__D006499
% 216.88/217.05       A branch of the celiac artery that distributes to the stomach, pancreas, duodenum, liver, gallbladder, and greater omentum.%A%    
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D006499 1999
% 216.88/217.05  |- skos__altLabel mesh__D019616 Thoracic Surgical Procedure
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D019616 2004
% 216.88/217.05  |- skos__broader mesh__D019616smesh__D013514
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D019616 2001
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D019616 2006
% 216.88/217.05  |- skos__altLabel mesh__D019616 Surgical Procedure, Thoracic
% 216.88/217.05  |- mesh__dateCreated mesh__D019616 1997-06-20
% 216.88/217.05  |- mesh__historyNote mesh__D019616 98   
% 216.88/217.05  |- skos__historyNote mesh__D019616 Thoracic Surgery %28%1980-1997%29%
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D019616 2003
% 216.88/217.05  |- mesh__activeMeSHYear mesh__D019616 2000
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D019616 2005
% 216.88/217.06  |- skos__prefLabel mesh__D019616 Thoracic Surgical Procedures
% 216.88/217.06  |- skos__altLabel mesh__D019616 Surgical Procedures, Thoracic
% 216.88/217.06  |- mesh__publicMeSHNote mesh__D019616 98   
% 216.88/217.06  |- rdf__type mesh__D019616sskos__Concept
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D019616 1999
% 216.88/217.06  |- skos__altLabel mesh__D019616 Procedure, Thoracic Surgical
% 216.88/217.06  |- skos__scopeNote mesh__D019616
% 216.88/217.06       Surgery performed on the thoracic organs, most commonly the lungs and the heart.%A%    
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D019616 1998
% 216.88/217.06  |- skos__annotation mesh__D019616
% 216.88/217.06       note category: do not confuse with THORACIC SURGERY, the surg specialty; GEN or unspecified; prefer specifics; DF: THORACIC SURG PROCEDURES%A%  
% 216.88/217.06  |- mesh__dateEstablished mesh__D019616 1998-01-01
% 216.88/217.06  |- skos__related mesh__D019616smesh__D013903
% 216.88/217.06  |- skos__altLabel mesh__D019616 Procedures, Thoracic Surgical
% 216.88/217.06  |- skos__historyNote mesh__D019616 Thorax/surgery %28%1966-1979%29%
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D019616 2002
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D011633 2006
% 216.88/217.06  |- mesh__recordAuthorizer mesh__D011633 SJN
% 216.88/217.06  |- mesh__dateRevised mesh__D011633 1997-06-20
% 216.88/217.06  |- mesh__dateCreated mesh__D011633 1999-01-01
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D011633 2004
% 216.88/217.06  |- skos__broader mesh__D011633smesh__D012499
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D011633 2005
% 216.88/217.06  |- skos__hiddenLabel mesh__D011633 Facilities, Public
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D011633 2001
% 216.88/217.06  |- mesh__recordMaintainer mesh__D011633 TGC
% 216.88/217.06  |- skos__annotation mesh__D011633 GEN or unspecified; prefer specifics   
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D011633 2003
% 216.88/217.06  |- rdf__type mesh__D011633sskos__Concept
% 216.88/217.06  |- skos__hiddenLabel mesh__D011633 Facility, Public
% 216.88/217.06  |- skos__scopeNote mesh__D011633
% 216.88/217.06       An area of recreation or hygiene for use by the public.%A%    
% 216.88/217.06  |- skos__prefLabel mesh__D011633 Public Facilities
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D011633 1999
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D011633 2000
% 216.88/217.06  |- mesh__publicMeSHNote mesh__D011633 98   
% 216.88/217.06  |- mesh__dateEstablished mesh__D011633 1998-01-01
% 216.88/217.06  |- mesh__recordOriginator mesh__D011633 NLM
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D011633 1998
% 216.88/217.06  |- skos__hiddenLabel mesh__D011633 Public Facility
% 216.88/217.06  |- mesh__historyNote mesh__D011633 98; use explode 1970-97   
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D011633 2002
% 216.88/217.06  |- skos__broader mesh__D005773Q000295smesh__D005773
% 216.88/217.06  |- mesh__preferredCombination mesh__D005773Q000295smesh__D020699
% 216.88/217.06  |- rdf__type mesh__D005773Q000295smesh__CompoundConcept
% 216.88/217.06  |- mesh__historyNote mesh__D007592
% 216.88/217.06       SHOULDER ARTHROSES was heading 1963-64   
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007592 2001
% 216.88/217.06  |- mesh__dateCreated mesh__D007592 1999-01-01
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007592 2006
% 216.88/217.06  |- skos__annotation mesh__D007592
% 216.88/217.06       GEN; prefer specifics; inflamm dis = ARTHRITIS   
% 216.88/217.06  |- mesh__recordMaintainer mesh__D007592 TPW
% 216.88/217.06  |- mesh__recordAuthorizer mesh__D007592 SJN
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007592 2002
% 216.88/217.06  |- mesh__publicMeSHNote mesh__D007592
% 216.88/217.06       SHOULDER ARTHROSES was heading 1963-64   
% 216.88/217.06  |- mesh__dateRevised mesh__D007592 1997-06-20
% 216.88/217.06  |- skos__broader mesh__D007592smesh__D009140
% 216.88/217.06  |- skos__hiddenLabel mesh__D007592 Joint Disease
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007592 2003
% 216.88/217.06  |- rdf__type mesh__D007592sskos__Concept
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007592 1998
% 216.88/217.06  |- skos__hiddenLabel mesh__D007592 Diseases, Joint
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007592 2004
% 216.88/217.06  |- mesh__recordOriginator mesh__D007592 NLM
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007592 1999
% 216.88/217.06  |- skos__prefLabel mesh__D007592 Joint Diseases
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007592 2000
% 216.88/217.06  |- skos__hiddenLabel mesh__D007592 Disease, Joint
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007592 2005
% 216.88/217.06  |- skos__altLabel mesh__D015226 Bis%28%5%27%-Nucleosidyl%29%Oligophosphates
% 216.88/217.06  |- mesh__recordAuthorizer mesh__D015226 PLS
% 216.88/217.06  |- skos__hiddenLabel mesh__D015226 Polyphosphates, Dinucleoside
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015226 1994
% 216.88/217.06  |- skos__hiddenLabel mesh__D015226 Phosphates, Dinucleoside
% 216.88/217.06  |- skos__hiddenLabel mesh__D015226 Diphosphates, Dinucleoside
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015226 2000
% 216.88/217.06  |- skos__prefLabel mesh__D015226 Dinucleoside Phosphates
% 216.88/217.06  |- mesh__publicMeSHNote mesh__D015226 89   
% 216.88/217.06  |- skos__altLabel mesh__D015226 Bis%28%5%27%-Nucleosidyl%29%Tetraphosphate
% 216.88/217.06  |- rdf__type mesh__D015226sskos__Concept
% 216.88/217.06  |- skos__hiddenLabel mesh__D015226 Tetraphosphates, Dinucleoside
% 216.88/217.06  |- skos__hiddenLabel mesh__D015226 Oligophosphates, Dinucleoside
% 216.88/217.06  |- mesh__dateRevised mesh__D015226 1992-05-13
% 216.88/217.06  |- mesh__recordOriginator mesh__D015226 RLS
% 216.88/217.06  |- skos__hiddenLabel mesh__D015226 Phosphates, Deoxydinucleoside
% 216.88/217.06  |- skos__hiddenLabel mesh__D015226 Monophosphates, Dinucleoside
% 216.88/217.06  |- mesh__historyNote mesh__D015226 89   
% 216.88/217.06  |- skos__scopeNote mesh__D015226
% 216.88/217.06       A group of compounds which consist of a nucleotide molecule to which an additional nucleoside is attached through the phosphate molecule%28%s%29%. The nucleotide can contain any number of phosphates.%A%    
% 216.88/217.06  |- skos__historyNote mesh__D015226 Oligonucleotides %28%1972-1988%29%
% 216.88/217.06  |- skos__broader mesh__D015226smesh__D009711
% 216.88/217.06  |- mesh__dateEstablished mesh__D015226 1989-01-01
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015226 1997
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015226 2004
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015226 2002
% 216.88/217.06  |- skos__hiddenLabel mesh__D015226 Triphosphates, Dinucleoside
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015226 1999
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015226 2006
% 216.88/217.06  |- mesh__dateCreated mesh__D015226 1988-05-12
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015226 1993
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015226 2003
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015226 1996
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015226 1995
% 216.88/217.06  |- mesh__recordMaintainer mesh__D015226 TGC
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015226 2001
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015226 1998
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015226 2005
% 216.88/217.06  |- skos__hiddenLabel mesh__D001206 Vitamin C Deficiencies
% 216.88/217.06  |- mesh__recordAuthorizer mesh__D001206 sjn
% 216.88/217.06  |- mesh__dateCreated mesh__D001206 1999-01-01
% 216.88/217.06  |- skos__annotation mesh__D001206 note X ref; DF: ASCORBIC ACID DEFIC   
% 216.88/217.06  |- skos__altLabel mesh__D001206 Deficiency, Ascorbic Acid
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D001206 2006
% 216.88/217.06  |- rdf__type mesh__D001206sskos__Concept
% 216.88/217.06  |- skos__hiddenLabel mesh__D001206 Ascorbic Acid Deficiencies
% 216.88/217.06  |- skos__altLabel mesh__D001206 Vitamin C Deficiency
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D001206 2005
% 216.88/217.06  |- mesh__recordOriginator mesh__D001206 NLM
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D001206 2004
% 216.88/217.06  |- skos__altLabel mesh__D001206 Deficiency, Vitamin C
% 216.88/217.06  |- skos__scopeNote mesh__D001206
% 216.88/217.06       A condition due to a dietary deficiency of ascorbic acid %28%vitamin C%29%, characterized by malaise, lethargy, and weakness. As the disease progresses, joints, muscles, and subcutaneous tissues may become the sites of hemorrhage. Ascorbic acid deficiency frequently develops into SCURVY in young children fed unsupplemented cow%27%s milk exclusively during their first year. It develops also commonly in chronic alcoholism. %28%Cecil Textbook of Medicine, 19th ed, p1177%29%%A%    
% 216.88/217.06  |- skos__hiddenLabel mesh__D001206 Deficiencies, Vitamin C
% 216.88/217.06  |- skos__broader mesh__D001206smesh__D001361
% 216.88/217.06  |- skos__related mesh__D001206smesh__D012614
% 216.88/217.06  |- mesh__recordMaintainer mesh__D001206 lkt
% 216.88/217.06  |- skos__prefLabel mesh__D001206 Ascorbic Acid Deficiency
% 216.88/217.06  |- mesh__dateRevised mesh__D001206 2003-07-09
% 216.88/217.06  |- skos__hiddenLabel mesh__D001206 Deficiencies, Ascorbic Acid
% 216.88/217.06  |- mesh__publicMeSHNote mesh__D020969 2000   
% 216.88/217.06  |- mesh__historyNote mesh__D020969 2000   
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D020969 2003
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D020969 2001
% 216.88/217.06  |- skos__hiddenLabel mesh__D020969 Disease Attribute
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D020969 2006
% 216.88/217.06  |- rdf__type mesh__D020969sskos__Concept
% 216.88/217.06  |- skos__hiddenLabel mesh__D020969 Attribute, Disease
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D020969 2005
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D020969 2000
% 216.88/217.06  |- mesh__dateEstablished mesh__D020969 2000-01-01
% 216.88/217.06  |- skos__annotation mesh__D020969 not used for indexing or cataloging   
% 216.88/217.06  |- skos__scopeNote mesh__D020969
% 216.88/217.06       Clinical characteristics of disease or illness.     
% 216.88/217.06  |- skos__prefLabel mesh__D020969 Disease Attributes
% 216.88/217.06  |- mesh__dateCreated mesh__D020969 1999-11-03
% 216.88/217.06  |- skos__hiddenLabel mesh__D020969 Attributes, Disease
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D020969 2002
% 216.88/217.06  |- skos__broader mesh__D020969smesh__D010335
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D020969 2004
% 216.88/217.06  |- skos__historyNote mesh__D047308 Echinodermata %28%1965-2004%29%
% 216.88/217.06  |- mesh__publicMeSHNote mesh__D047308 2005   
% 216.88/217.06  |- mesh__recordMaintainer mesh__D047308 ags
% 216.88/217.06  |- mesh__dateEstablished mesh__D047308 2005-01-01
% 216.88/217.06  |- mesh__dateCreated mesh__D047308 2004-07-07
% 216.88/217.06  |- skos__broader mesh__D047308smesh__D012617
% 216.88/217.06  |- mesh__historyNote mesh__D047308 2005   
% 216.88/217.06  |- rdf__type mesh__D047308sskos__Concept
% 216.88/217.06  |- skos__historyNote mesh__D047308 Sea Urchins %28%1971-2004%29%
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D047308 2006
% 216.88/217.06  |- skos__scopeNote mesh__D047308
% 216.88/217.06       A genus of SEA URCHINS in the family Arbaciidae. They have only one spheridium %28%stalked body%29% per ambulacral area %28%contains tube feet%29%; most sea urchins have several spheridia per area.%A%    
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D047308 2005
% 216.88/217.06  |- mesh__recordOriginator mesh__D047308 ags
% 216.88/217.06  |- skos__prefLabel mesh__D047308 Arbacia
% 216.88/217.06  |- mesh__recordAuthorizer mesh__D047308 sjn
% 216.88/217.06  |- skos__altLabel mesh__D019617 Halobacterium halobium
% 216.88/217.06  |- mesh__dateCreated mesh__D019617 1997-06-20
% 216.88/217.06  |- skos__scopeNote mesh__D019617
% 216.88/217.06       A species of halophilic archaea found in salt lakes. Some strains form a PURPLE MEMBRANE under anaerobic conditions.%A%    
% 216.88/217.06  |- mesh__publicMeSHNote mesh__D019617
% 216.88/217.06       2003; see HALOBACTERIUM SALINARIUM 1998-2002; for HALOBACTERIUM HALOBIUM see HALOBACTERIA HALOBIUM 1992-2003%A%  
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D019617 2006
% 216.88/217.06  |- rdf__type mesh__D019617sskos__Concept
% 216.88/217.06  |- mesh__recordAuthorizer mesh__D019617 sjn
% 216.88/217.06  |- skos__annotation mesh__D019617 DF: HALOBACT SALINARUM   
% 216.88/217.06  |- mesh__recordMaintainer mesh__D019617 SYSTEM
% 216.88/217.06  |- mesh__historyNote mesh__D019617 2003 %28%1998%29%   
% 216.88/217.06  |- mesh__dateEstablished mesh__D019617 1998-01-01
% 216.88/217.06  |- skos__historyNote mesh__D019617 Halobacterium halobium %28%1993-1997%29%
% 216.88/217.06  |- skos__historyNote mesh__D019617 Halobacterium %28%1985-1993%29%
% 216.88/217.06  |- mesh__recordOriginator mesh__D019617 AGS
% 216.88/217.06  |- skos__prefLabel mesh__D019617 Halobacterium salinarum
% 216.88/217.06  |- skos__broader mesh__D019617smesh__D006217
% 216.88/217.06  |- mesh__dateRevised mesh__D019617 2005-06-30
% 216.88/217.06  |- skos__related mesh__D011634smesh__D011315
% 216.88/217.06  |- mesh__recordOriginator mesh__D011634 NLM
% 216.88/217.06  |- skos__prefLabel mesh__D011634 Public Health
% 216.88/217.06  |- mesh__onlineNote mesh__D011634
% 216.88/217.06       pre-explosion = PUBLIC HEALTH %28%PX%29%   
% 216.88/217.06  |- mesh__recordAuthorizer mesh__D011634 sjn
% 216.88/217.06  |- skos__hiddenLabel mesh__D011634 Health, Public
% 216.88/217.06  |- skos__broader mesh__D011634smesh__D006262
% 216.88/217.06  |- skos__broader mesh__D011634smesh__D013040
% 216.88/217.06  |- skos__related mesh__D011634smesh__D012936
% 216.88/217.06  |- skos__broader mesh__D011634smesh__D004778
% 216.88/217.06  |- mesh__dateRevised mesh__D011634 2003-07-09
% 216.88/217.06  |- skos__related mesh__D011634smesh__D015047
% 216.88/217.06  |- skos__scopeNote mesh__D011634
% 216.88/217.06       Branch of medicine concerned with the prevention and control of disease and disability, and the promotion of physical and mental health of the population on the international, national, state, or municipal level.%A%    
% 216.88/217.06  |- mesh__recordMaintainer mesh__D011634 nns
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D011634 2006
% 216.88/217.06  |- skos__annotation mesh__D011634
% 216.88/217.06       SPEC; SPEC qualif; a venerable hist %26% modern concept of the health %26% health problems of %22%the public%22%: do not confuse with NATIONAL HEALTH PROGRAMS%A%  
% 216.88/217.06  |- mesh__dateCreated mesh__D011634 1999-01-01
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D011634 2004
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D011634 2005
% 216.88/217.06  |- skos__altLabel mesh__D011634
% 216.88/217.06       Environment, Preventive Medicine %26% Public Health
% 216.88/217.06  |- rdf__type mesh__D011634sskos__Concept
% 216.88/217.06  |- skos__hiddenLabel mesh__D007593 Joint Hypermobilities
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007593 2000
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007593 1999
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007593 1994
% 216.88/217.06  |- mesh__dateEstablished mesh__D007593 1983-01-01
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007593 2006
% 216.88/217.06  |- skos__hiddenLabel mesh__D007593 Joint Laxities
% 216.88/217.06  |- skos__hiddenLabel mesh__D007593 Joint Instabilities
% 216.88/217.06  |- skos__scopeNote mesh__D007593
% 216.88/217.06       Lack of stability of a joint or joint prosthesis. Factors involved are intra-articular disease and integrity of extra-articular structures such as joint capsule, ligaments, and muscles.%A%    
% 216.88/217.06  |- skos__hiddenLabel mesh__D007593 Laxities, Joint
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007593 1993
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007593 1998
% 216.88/217.06  |- skos__hiddenLabel mesh__D007593 Instabilities, Joint
% 216.88/217.06  |- skos__historyNote mesh__D007593 Joint Diseases %28%1966-1982%29%
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007593 1991
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007593 2005
% 216.88/217.06  |- skos__altLabel mesh__D007593 Instability, Joint
% 216.88/217.06  |- skos__hiddenLabel mesh__D007593 Joint Hypermobility
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007593 1997
% 216.88/217.06  |- mesh__dateCreated mesh__D007593 1982-04-27
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007593 1992
% 216.88/217.06  |- skos__hiddenLabel mesh__D007593 Hypermobilities, Joint
% 216.88/217.06  |- mesh__publicMeSHNote mesh__D007593 83   
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007593 2004
% 216.88/217.06  |- skos__broader mesh__D007593smesh__D007592
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007593 2002
% 216.88/217.06  |- skos__historyNote mesh__D007593 Ligaments, Articular %28%1966-1982%29%
% 216.88/217.06  |- skos__hiddenLabel mesh__D007593 Joint Laxity
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007593 1996
% 216.88/217.06  |- skos__altLabel mesh__D007593 Laxity, Joint
% 216.88/217.06  |- skos__prefLabel mesh__D007593 Joint Instability
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007593 2003
% 216.88/217.06  |- rdf__type mesh__D007593sskos__Concept
% 216.88/217.06  |- mesh__dateRevised mesh__D007593 1990-06-05
% 216.88/217.06  |- mesh__recordOriginator mesh__D007593 RC
% 216.88/217.06  |- mesh__recordMaintainer mesh__D007593 TGC
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007593 2001
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007593 1995
% 216.88/217.06  |- skos__annotation mesh__D007593 note category   
% 216.88/217.06  |- mesh__recordAuthorizer mesh__D007593 PLS
% 216.88/217.06  |- mesh__historyNote mesh__D007593 83   
% 216.88/217.06  |- skos__historyNote mesh__D015227
% 216.88/217.06       Lipid Peroxides/metabolism %28%1980-1988%29%
% 216.88/217.06  |- mesh__recordAuthorizer mesh__D015227 PLS
% 216.88/217.06  |- skos__historyNote mesh__D015227 Lipids/metabolism %28%1966-1988%29%
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015227 2000
% 216.88/217.06  |- mesh__publicMeSHNote mesh__D015227 89   
% 216.88/217.06  |- rdf__type mesh__D015227sskos__Concept
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015227 2001
% 216.88/217.06  |- skos__hiddenLabel mesh__D015227 Peroxidation, Lipid
% 216.88/217.06  |- mesh__dateCreated mesh__D015227 1988-05-12
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015227 1996
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015227 2003
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015227 1998
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015227 2005
% 216.88/217.06  |- mesh__dateEstablished mesh__D015227 1989-01-01
% 216.88/217.06  |- skos__scopeNote mesh__D015227
% 216.88/217.06       Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor.%A%    
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015227 1997
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015227 2004
% 216.88/217.06  |- skos__hiddenLabel mesh__D015227 Peroxidations, Lipid
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015227 2006
% 216.88/217.06  |- skos__prefLabel mesh__D015227 Lipid Peroxidation
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015227 1994
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015227 2002
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015227 1999
% 216.88/217.06  |- mesh__recordMaintainer mesh__D015227 TAP
% 216.88/217.06  |- mesh__recordOriginator mesh__D015227 EJB
% 216.88/217.06  |- mesh__dateRevised mesh__D015227 1992-05-18
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015227 1993
% 216.88/217.06  |- mesh__historyNote mesh__D015227 89   
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D015227 1995
% 216.88/217.06  |- skos__hiddenLabel mesh__D015227 Lipid Peroxidations
% 216.88/217.06  |- skos__broader mesh__D015227smesh__D010084
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D001207 2004
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D001207 1997
% 216.88/217.06  |- mesh__publicMeSHNote mesh__D001207
% 216.88/217.06       91; was see under ANTISEPSIS 1975-90   
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D001207 2003
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D001207 1996
% 216.88/217.06  |- skos__annotation mesh__D001207
% 216.88/217.06       differentiate from ANTISEPSIS: ANTISEPSIS is the destruction of pathogens, ASEPSIS is the prev of their invasion%A%  
% 216.88/217.06  |- skos__scopeNote mesh__D001207
% 216.88/217.06       The prevention of access by infecting organisms to the locus of potential infection.%A%    
% 216.88/217.06  |- mesh__recordAuthorizer mesh__D001207 PLS
% 216.88/217.06  |- mesh__dateRevised mesh__D001207 1992-03-25
% 216.88/217.06  |- mesh__onlineNote mesh__D001207 search ANTISEPSIS 1966-74   
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D001207 2002
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D001207 1995
% 216.88/217.06  |- mesh__dateCreated mesh__D001207 1999-01-01
% 216.88/217.06  |- mesh__dateEstablished mesh__D001207 1991-01-01
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D001207 2006
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D001207 1999
% 216.88/217.06  |- rdf__type mesh__D001207sskos__Concept
% 216.88/217.06  |- mesh__recordOriginator mesh__D001207 NLM
% 216.88/217.06  |- mesh__recordMaintainer mesh__D001207 TAP
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D001207 2001
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D001207 1994
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D001207 2000
% 216.88/217.06  |- mesh__historyNote mesh__D001207
% 216.88/217.06       91%28%75%29%; was see under ANTISEPSIS 1975-90   
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D001207 1993
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D001207 2005
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D001207 1998
% 216.88/217.06  |- skos__broader mesh__D001207smesh__D000985
% 216.88/217.06  |- skos__prefLabel mesh__D001207 Asepsis
% 216.88/217.06  |- skos__broader mesh__D019301Q000031smesh__D019301
% 216.88/217.06  |- mesh__preferredCombination mesh__D019301Q000031smesh__D009829
% 216.88/217.06  |- rdf__type mesh__D019301Q000031smesh__CompoundConcept
% 216.88/217.06  |- mesh__publicMeSHNote mesh__D047309
% 216.88/217.06       2005, 1963-2003; see FLAVONOIDS 2004   
% 216.88/217.06  |- skos__historyNote mesh__D047309 Flavonoids %28%2004%29%
% 216.88/217.06  |- skos__scopeNote mesh__D047309 A group of 4-keto-FLAVONOIDS.     
% 216.88/217.06  |- mesh__recordAuthorizer mesh__D047309 sjn
% 216.88/217.06  |- mesh__dateRevised mesh__D047309 2005-06-30
% 216.88/217.06  |- mesh__dateCreated mesh__D047309 2004-07-07
% 216.88/217.06  |- rdf__type mesh__D047309sskos__Concept
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D047309 2006
% 216.88/217.06  |- skos__prefLabel mesh__D047309 Flavones
% 216.88/217.06  |- mesh__recordMaintainer mesh__D047309 ssb
% 216.88/217.06  |- mesh__historyNote mesh__D047309 2005, 1963-2003; use FLAVONOIDS 2004   
% 216.88/217.06  |- mesh__dateEstablished mesh__D047309 2005-01-01
% 216.88/217.06  |- skos__broader mesh__D047309smesh__D005419
% 216.88/217.06  |- mesh__recordOriginator mesh__D047309 ssb
% 216.88/217.06  |- skos__altLabel mesh__D047309 2-Phenyl-2-Ene-Benzopyran-4-One Compounds
% 216.88/217.06  |- skos__historyNote mesh__D047309 Flavones %28%1963-2003%29%
% 216.88/217.06  |- skos__scopeNote mesh__D011635
% 216.88/217.06       Management of public health organizations or agencies.     
% 216.88/217.06  |- skos__prefLabel mesh__D011635 Public Health Administration
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D011635 2000
% 216.88/217.06  |- mesh__recordMaintainer mesh__D011635 kle
% 216.88/217.06  |- skos__broader mesh__D011635smesh__D009934
% 216.88/217.06  |- mesh__recordOriginator mesh__D011635 NLM
% 216.88/217.06  |- mesh__recordAuthorizer mesh__D011635 sjn
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D011635 2006
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D011635 2002
% 216.88/217.06  |- mesh__dateRevised mesh__D011635 1999-11-03
% 216.88/217.06  |- mesh__dateCreated mesh__D011635 1999-01-01
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D011635 2004
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D011635 2005
% 216.88/217.06  |- skos__annotation mesh__D011635
% 216.88/217.06       SPEC: SPEC qualif; DF: PUBLIC HEALTH ADMIN   
% 216.88/217.06  |- rdf__type mesh__D011635sskos__Concept
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D011635 2003
% 216.88/217.06  |- skos__altLabel mesh__D011635 Administration, Public Health
% 216.88/217.06  |- skos__related mesh__D011635smesh__D003153
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D011635 2001
% 216.88/217.06  |- skos__altLabel mesh__D016320 Drug Abuse Treatment Centers
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D016320 2004
% 216.88/217.06  |- skos__hiddenLabel mesh__D016320 Treatment Center, Drug
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D016320 2002
% 216.88/217.06  |- skos__broader mesh__D016320smesh__D012047
% 216.88/217.06  |- rdf__type mesh__D016320sskos__Concept
% 216.88/217.06  |- skos__scopeNote mesh__D016320
% 216.88/217.06       Health facilities providing therapy and/or rehabilitation for substance-dependent individuals. Methadone distribution centers are included.%A%    
% 216.88/217.06  |- skos__hiddenLabel mesh__D016320 Center, Drug Treatment
% 216.88/217.06  |- skos__annotation mesh__D016320 IM   
% 216.88/217.06  |- skos__prefLabel mesh__D016320 Substance Abuse Treatment Centers
% 216.88/217.06  |- mesh__dateCreated mesh__D016320 1990-05-25
% 216.88/217.06  |- mesh__dateEstablished mesh__D016320 1991-01-01
% 216.88/217.06  |- skos__hiddenLabel mesh__D016320 Drug Treatment Center
% 216.88/217.06  |- skos__altLabel mesh__D016320 Treatment Centers, Drug
% 216.88/217.06  |- skos__altLabel mesh__D016320 Drug Treatment Centers
% 216.88/217.06  |- skos__hiddenLabel mesh__D016320 Centers, Drug Rehabilitation
% 216.88/217.06  |- mesh__dateRevised mesh__D016320 1999-11-03
% 216.88/217.06  |- skos__altLabel mesh__D016320 Treatment Centers, Substance Abuse
% 216.88/217.06  |- skos__broader mesh__D016320smesh__D003151
% 216.88/217.06  |- skos__altLabel mesh__D016320 Drug Rehabilitation Centers
% 216.88/217.06  |- mesh__recordOriginator mesh__D016320 MXR
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D016320 2005
% 216.88/217.06  |- mesh__publicMeSHNote mesh__D016320
% 216.88/217.06       94; was DRUG TREATMENT CENTERS 1991-93; SUBSTANCE ABUSE TREATMENT CENTERS was see DRUG TREATMENT CENTERS 1991-93%A%  
% 216.88/217.06  |- skos__hiddenLabel mesh__D016320 Center, Drug Rehabilitation
% 216.88/217.06  |- skos__altLabel mesh__D016320 Treatment Centers, Drug Abuse
% 216.88/217.06  |- mesh__recordAuthorizer mesh__D016320 sjn
% 216.88/217.06  |- mesh__historyNote mesh__D016320
% 216.88/217.06       94; was DRUG TREATMENT CENTERS 1991-93; SUBSTANCE ABUSE TREATMENT CENTERS was see DRUG TREATMENT CENTERS 1991-93%A%  
% 216.88/217.06  |- mesh__onlineNote mesh__D016320
% 216.88/217.06       use SUBSTANCE ABUSE TREATMENT CENTERS to search DRUG TREATMENT CENTERS 1991-93%A%  
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D016320 2000
% 216.88/217.06  |- mesh__recordMaintainer mesh__D016320 kle
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D016320 2003
% 216.88/217.06  |- skos__altLabel mesh__D016320 Rehabilitation Center, Drug
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D016320 2006
% 216.88/217.06  |- skos__hiddenLabel mesh__D016320 Centers, Drug Treatment
% 216.88/217.06  |- skos__altLabel mesh__D016320 Rehabilitation Centers, Drug
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D016320 2001
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D002300 2000
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D002300 1997
% 216.88/217.06  |- skos__prefLabel mesh__D002300 Cardiac Care Facilities
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D002300 1993
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D002300 1996
% 216.88/217.06  |- mesh__dateRevised mesh__D002300 1992-05-07
% 216.88/217.06  |- rdf__type mesh__D002300sskos__Concept
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D002300 2004
% 216.88/217.06  |- skos__hiddenLabel mesh__D002300 Facility, Cardiac Care
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D002300 2002
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D002300 1999
% 216.88/217.06  |- mesh__recordAuthorizer mesh__D002300 PLS
% 216.88/217.06  |- mesh__recordMaintainer mesh__D002300 TGC
% 216.88/217.06  |- mesh__dateEstablished mesh__D002300 1991-01-01
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D002300 1995
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D002300 2003
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D002300 1998
% 216.88/217.06  |- mesh__historyNote mesh__D002300
% 216.88/217.06       91%28%Aug 77%29%; was see under HOSPITALS, SPECIAL 1977-90   
% 216.88/217.06  |- mesh__recordOriginator mesh__D002300 EC
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D002300 2006
% 216.88/217.06  |- mesh__publicMeSHNote mesh__D002300
% 216.88/217.06       91; was see under HOSPITALS, SPECIAL Aug 1977-90   
% 216.88/217.06  |- skos__hiddenLabel mesh__D002300 Cardiac Care Facility
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D002300 1994
% 216.88/217.06  |- skos__hiddenLabel mesh__D002300 Facilities, Cardiac Care
% 216.88/217.06  |- skos__scopeNote mesh__D002300
% 216.88/217.06       Institutions specializing in the care of patients with heart disorders.%A%    
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D002300 2001
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D002300 2005
% 216.88/217.06  |- mesh__dateCreated mesh__D002300 1977-05-19
% 216.88/217.06  |- skos__broader mesh__D002300smesh__D006782
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007594 2004
% 216.88/217.06  |- skos__prefLabel mesh__D007594 Joint Loose Bodies
% 216.88/217.06  |- mesh__historyNote mesh__D007594
% 216.88/217.06       91%28%83%29%; was see under JOINT DISEASES 1983-90   
% 216.88/217.06  |- mesh__activeMeSHYear mesh__D007594 1999
% 216.88/217.06  |- skos__historyNote mesh__D007594 Joint Diseases %28%1966-1982%29%
% 216.88/217.07  |- skos__historyNote mesh__D007594 Osteochondritis %28%1966-1982%29%
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D007594 2005
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D007594 2000
% 216.88/217.07  |- skos__scopeNote mesh__D007594
% 216.88/217.07       Fibrous, bony, cartilaginous and osteocartilaginous fragments in a synovial joint. Major causes are osteochondritis dissecans, synovial chondromatosis, osteophytes, fractured articular surfaces and damaged menisci.%A%    
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D007594 2006
% 216.88/217.07  |- mesh__dateCreated mesh__D007594 1982-04-22
% 216.88/217.07  |- mesh__dateEstablished mesh__D007594 1991-01-01
% 216.88/217.07  |- mesh__recordMaintainer mesh__D007594 TPW
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D007594 2001
% 216.88/217.07  |- skos__hiddenLabel mesh__D007594 Loose Body, Joint
% 216.88/217.07  |- skos__altLabel mesh__D007594 Loose Bodies, Joint
% 216.88/217.07  |- skos__hiddenLabel mesh__D007594 Joint Loose Body
% 216.88/217.07  |- mesh__recordAuthorizer mesh__D007594 SJN
% 216.88/217.07  |- mesh__recordOriginator mesh__D007594 RC
% 216.88/217.07  |- skos__broader mesh__D007594smesh__D007592
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D007594 2002
% 216.88/217.07  |- mesh__dateRevised mesh__D007594 1997-06-20
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D007594 2003
% 216.88/217.07  |- mesh__publicMeSHNote mesh__D007594
% 216.88/217.07       91; was see under JOINT DISEASES 1983-90   
% 216.88/217.07  |- rdf__type mesh__D007594sskos__Concept
% 216.88/217.07  |- skos__historyNote mesh__D007594 Knee Joint %28%1966-1982%29%
% 216.88/217.07  |- skos__annotation mesh__D007594
% 216.88/217.07       note category: %22%fragments in a synovial joint%22%   
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D007594 1998
% 216.88/217.07  |- skos__historyNote mesh__D007594 Synovial Membrane %28%1966-1982%29%
% 216.88/217.07  |- skos__annotation mesh__D015228
% 216.88/217.07       high blood triglyceride levels; consider also HYPERTRIGLYCERIDEMIA, FAMILIAL see HYPERLIPOPROTEINEMIA TYPE IV %26% the adult-onset hypertriglyceridemia of HYPERLIPOPROTEINEMIA TYPE V %26% the triglyceride-rich lipoproteins of LIPOPROTEIN LIPASE DEFICIENCY, FAMILIAL%A%  
% 216.88/217.07  |- rdf__type mesh__D015228sskos__Concept
% 216.88/217.07  |- mesh__publicMeSHNote mesh__D015228 89   
% 216.88/217.07  |- mesh__dateCreated mesh__D015228 1988-05-12
% 216.88/217.07  |- mesh__recordAuthorizer mesh__D015228 sjn
% 216.88/217.07  |- mesh__recordMaintainer mesh__D015228 lkt
% 216.88/217.07  |- mesh__dateRevised mesh__D015228 2005-06-30
% 216.88/217.07  |- skos__broader mesh__D015228smesh__D006949
% 216.88/217.07  |- skos__scopeNote mesh__D015228
% 216.88/217.07       Condition of elevated triglyceride concentration in the blood; an inherited form occurs in familial hyperlipoproteinemia IIb and HYPERLIPOPROTEINEMIA TYPE IV. It has been linked to higher risk of heart disease and arteriosclerosis.%A%    
% 216.88/217.07  |- mesh__recordOriginator mesh__D015228 EJB
% 216.88/217.07  |- mesh__dateEstablished mesh__D015228 1989-01-01
% 216.88/217.07  |- skos__historyNote mesh__D015228 Hyperlipidemia %28%1966-1988%29%
% 216.88/217.07  |- skos__prefLabel mesh__D015228 Hypertriglyceridemia
% 216.88/217.07  |- skos__historyNote mesh__D015228 Triglycerides %28%1966-1988%29%
% 216.88/217.07  |- skos__hiddenLabel mesh__D015228 Hypertriglyceridemias
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D015228 2006
% 216.88/217.07  |- mesh__historyNote mesh__D015228 89   
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D001208 2003
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D001208 2000
% 216.88/217.07  |- skos__prefLabel mesh__D001208 Asia
% 216.88/217.07  |- mesh__dateCreated mesh__D001208 1999-01-01
% 216.88/217.07  |- skos__broader mesh__D001208smesh__D005842
% 216.88/217.07  |- mesh__recordMaintainer mesh__D001208 TGC
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D001208 2006
% 216.88/217.07  |- mesh__dateRevised mesh__D001208 1996-06-10
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D001208 1999
% 216.88/217.07  |- mesh__recordAuthorizer mesh__D001208 PLS
% 216.88/217.07  |- rdf__type mesh__D001208sskos__Concept
% 216.88/217.07  |- skos__annotation mesh__D001208
% 216.88/217.07       several geog subdivisions %26% all Asiatic countries are available as headings%A%  
% 216.88/217.07  |- skos__scopeNote mesh__D001208
% 216.88/217.07       The largest of the continents. It was known to the Romans more specifically as what we know today as Asia Minor. The name comes from at least two possible sources: from the Assyrian asu %28%to rise%29% or from the Sanskrit usa %28%dawn%29%, both with reference to its being the land of the rising sun, i.e., eastern as opposed to Europe, to the west. %28%From Webster%27%s New Geographical Dictionary, 1988, p82 %26% Room, Brewer%27%s Dictionary of Names, 1992, p34%29%%A%    
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D001208 2005
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D001208 1998
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D001208 2002
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D001208 2004
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D001208 1997
% 216.88/217.07  |- mesh__recordOriginator mesh__D001208 NLM
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D001208 2001
% 216.88/217.07  |- mesh__recordAuthorizer mesh__D019619 sjn
% 216.88/217.07  |- skos__historyNote mesh__D019619 Archaea %28%1980-1997%29%
% 216.88/217.07  |- mesh__recordMaintainer mesh__D019619 SYSTEM
% 216.88/217.07  |- skos__annotation mesh__D019619
% 216.88/217.07       an order of the kingdom of Crenarchaeota, of the domain Archaea%A%  
% 216.88/217.07  |- skos__broader mesh__D019619smesh__D019615
% 216.88/217.07  |- skos__scopeNote mesh__D019619
% 216.88/217.07       An order of CRENARCHAEOTA comprised of rod, disc, or spherical shaped, nonseptate, anaerobic, extreme thermophiles and found in solfataric hot waters, mud holes, and superheated submarine environments.%A%    
% 216.88/217.07  |- mesh__historyNote mesh__D019619 98   
% 216.88/217.07  |- mesh__dateCreated mesh__D019619 1997-07-02
% 216.88/217.07  |- mesh__dateRevised mesh__D019619 2005-06-30
% 216.88/217.07  |- rdf__type mesh__D019619sskos__Concept
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D019619 2006
% 216.88/217.07  |- mesh__publicMeSHNote mesh__D019619 98   
% 216.88/217.07  |- skos__prefLabel mesh__D019619 Thermoproteales
% 216.88/217.07  |- mesh__dateEstablished mesh__D019619 1998-01-01
% 216.88/217.07  |- mesh__recordOriginator mesh__D019619 NDW
% 216.88/217.07  |- skos__broader mesh__D011636smesh__D004778
% 216.88/217.07  |- skos__related mesh__D011636smesh__D006267
% 216.88/217.07  |- mesh__dateRevised mesh__D011636 1999-11-03
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D011636 2000
% 216.88/217.07  |- mesh__dateCreated mesh__D011636 1999-01-01
% 216.88/217.07  |- skos__altLabel mesh__D011636 Dentistry, Public Health
% 216.88/217.07  |- skos__scopeNote mesh__D011636
% 216.88/217.07       A dental specialty concerned with the prevention of disease and the maintenance of oral health through promoting organized dental health programs at a community, state, or federal level.%A%    
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D011636 2005
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D011636 2001
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D011636 2003
% 216.88/217.07  |- skos__annotation mesh__D011636
% 216.88/217.07       SPEC: SPEC qualif; DF: PUBLIC HEALTH DENT   
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D011636 2006
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D011636 2002
% 216.88/217.07  |- mesh__recordMaintainer mesh__D011636 kle
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D011636 2004
% 216.88/217.07  |- mesh__recordOriginator mesh__D011636 NLM
% 216.88/217.07  |- skos__broader mesh__D011636smesh__D013039
% 216.88/217.07  |- rdf__type mesh__D011636sskos__Concept
% 216.88/217.07  |- mesh__recordAuthorizer mesh__D011636 sjn
% 216.88/217.07  |- skos__prefLabel mesh__D011636 Public Health Dentistry
% 216.88/217.07  |- skos__hiddenLabel mesh__D016321 Aged, Dentistry for
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D016321 2000
% 216.88/217.07  |- rdf__type mesh__D016321sskos__Concept
% 216.88/217.07  |- skos__annotation mesh__D016321
% 216.88/217.07       = professional care by a professional; do not confuse with GERIATRIC DENTISTRY, the specialty; check tag AGED; DF: DENT CARE AGED%A%  
% 216.88/217.07  |- mesh__recordMaintainer mesh__D016321 kle
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D016321 2001
% 216.88/217.07  |- mesh__dateEstablished mesh__D016321 1991-01-01
% 216.88/217.07  |- skos__historyNote mesh__D016321 Dental Health Services %28%1978-1990%29%
% 216.88/217.07  |- skos__historyNote mesh__D016321 Dental Care %28%1973-1990%29%
% 216.88/217.07  |- skos__altLabel mesh__D016321 Dentistry for Aged
% 216.88/217.07  |- skos__scopeNote mesh__D016321
% 216.88/217.07       The giving of attention to the special dental needs of the elderly for proper maintenance or treatment. The dental care may include the services provided by dental specialists.%A%    
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D016321 2002
% 216.88/217.07  |- mesh__recordOriginator mesh__D016321 MXR
% 216.88/217.07  |- mesh__publicMeSHNote mesh__D016321 91   
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D016321 2005
% 216.88/217.07  |- skos__altLabel mesh__D016321 Dental Care for Elderly
% 216.88/217.07  |- mesh__dateCreated mesh__D016321 1990-05-25
% 216.88/217.07  |- skos__historyNote mesh__D016321
% 216.88/217.07       Health Services for the Aged %28%1981-1990%29%
% 216.88/217.07  |- skos__broader mesh__D016321smesh__D003729
% 216.88/217.07  |- mesh__historyNote mesh__D016321 91   
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D016321 2003
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D016321 2006
% 216.88/217.07  |- mesh__dateRevised mesh__D016321 1999-11-03
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D016321 2004
% 216.88/217.07  |- skos__prefLabel mesh__D016321 Dental Care for Aged
% 216.88/217.07  |- skos__historyNote mesh__D016321
% 216.88/217.07       Health Services Needs and Demand %28%1978-1990%29%
% 216.88/217.07  |- mesh__recordAuthorizer mesh__D016321 sjn
% 216.88/217.07  |- skos__altLabel mesh__D002301 Cardiotonic Steroids
% 216.88/217.07  |- skos__broader mesh__D002301smesh__D002297
% 216.88/217.07  |- skos__broader mesh__D002301smesh__D006027
% 216.88/217.07  |- skos__prefLabel mesh__D002301 Cardiac Glycosides
% 216.88/217.07  |- mesh__recordAuthorizer mesh__D002301 sjn
% 216.88/217.07  |- rdf__type mesh__D002301sskos__Concept
% 216.88/217.07  |- mesh__dateRevised mesh__D002301 2004-07-07
% 216.88/217.07  |- mesh__recordOriginator mesh__D002301 NLM
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D002301 2005
% 216.88/217.07  |- skos__annotation mesh__D002301 cardiotonics   
% 216.88/217.07  |- skos__hiddenLabel mesh__D002301 Glycosides, Cardiac
% 216.88/217.07  |- mesh__dateCreated mesh__D002301 1999-01-01
% 216.88/217.07  |- skos__hiddenLabel mesh__D002301 Steroids, Cardiotonic
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D002301 2006
% 216.88/217.07  |- skos__scopeNote mesh__D002301
% 216.88/217.07       Substances obtained from species of Digitalis, Strophanthus, and other plants that contain specific steroid glycosides or their semisynthetic derivatives and used in congestive heart failure. They increase the force of cardiac contraction without significantly affecting other parameters, but are very toxic at larger doses. Their mechanism of action usually involves inhibition of the Na%28%+%29%-K%28%+%29%-exchanging ATPase and they are often used in cell biological studies for that purpose.%A%    
% 216.88/217.07  |- mesh__recordMaintainer mesh__D002301 ssb
% 216.88/217.07  |- skos__historyNote mesh__D007595 specific joint %28%1966-1970%29%
% 216.88/217.07  |- skos__hiddenLabel mesh__D007595 Prosthesis, Joint
% 216.88/217.07  |- mesh__dateRevised mesh__D007595 2004-07-13
% 216.88/217.07  |- skos__prefLabel mesh__D007595 Joint Prosthesis
% 216.88/217.07  |- rdf__type mesh__D007595sskos__Concept
% 216.88/217.07  |- skos__annotation mesh__D007595
% 216.88/217.07       HIP PROSTHESIS %26% KNEE PROSTHESIS are also available   
% 216.88/217.07  |- mesh__dateEstablished mesh__D007595 1971-01-01
% 216.88/217.07  |- mesh__dateCreated mesh__D007595 1999-01-01
% 216.88/217.07  |- skos__hiddenLabel mesh__D007595 Prostheses, Joint
% 216.88/217.07  |- skos__historyNote mesh__D007595 Prosthesis %28%1966-1970%29%
% 216.88/217.07  |- skos__scopeNote mesh__D007595
% 216.88/217.07       Prostheses used to partially or totally replace a human or animal joint. %28%from UMDNS, 1999%29%%A%    
% 216.88/217.07  |- mesh__recordMaintainer mesh__D007595 sjn
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D007595 2006
% 216.88/217.07  |- mesh__recordOriginator mesh__D007595 NLM
% 216.88/217.07  |- skos__related mesh__D007595smesh__D019643
% 216.88/217.07  |- skos__hiddenLabel mesh__D007595 Joint Prostheses
% 216.88/217.07  |- mesh__historyNote mesh__D007595 71   
% 216.88/217.07  |- mesh__recordAuthorizer mesh__D007595 sjn
% 216.88/217.07  |- skos__broader mesh__D007595smesh__D019736
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D007595 2005
% 216.88/217.07  |- mesh__publicMeSHNote mesh__D007595 71   
% 216.88/217.07  |- skos__altLabel mesh__D015229 Viral Sexually Transmitted Diseases
% 216.88/217.07  |- skos__historyNote mesh__D015229
% 216.88/217.07       Sexually Transmitted Diseases %28%1987-1988%29%
% 216.88/217.07  |- skos__hiddenLabel mesh__D015229 Disease, Viral Venereal
% 216.88/217.07  |- mesh__publicMeSHNote mesh__D015229 89   
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D015229 1996
% 216.88/217.07  |- mesh__recordAuthorizer mesh__D015229 PLS
% 216.88/217.07  |- mesh__recordMaintainer mesh__D015229 PLS
% 216.88/217.07  |- mesh__historyNote mesh__D015229 89   
% 216.88/217.07  |- mesh__dateRevised mesh__D015229 1991-06-19
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D015229 2000
% 216.88/217.07  |- mesh__dateCreated mesh__D015229 1988-05-12
% 216.88/217.07  |- skos__historyNote mesh__D015229 Venereal Diseases %28%1966-1986%29%
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D015229 1998
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D015229 2003
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D015229 1997
% 216.88/217.07  |- skos__altLabel mesh__D015229 Venereal Diseases, Viral
% 216.88/217.07  |- skos__hiddenLabel mesh__D015229 Venereal Disease, Viral
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D015229 2001
% 216.88/217.07  |- skos__broader mesh__D015229smesh__D012749
% 216.88/217.07  |- skos__scopeNote mesh__D015229
% 216.88/217.07       Viral diseases which are transmitted or propagated by sexual conduct.%A%    
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D015229 1992
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D015229 2005
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D015229 1999
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D015229 2004
% 216.88/217.07  |- mesh__dateEstablished mesh__D015229 1989-01-01
% 216.88/217.07  |- skos__annotation mesh__D015229
% 216.88/217.07       GEN: prefer specifics; DF: SEX TRANSM DIS VIRAL   
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D015229 1994
% 216.88/217.07  |- skos__hiddenLabel mesh__D015229 Diseases, Viral Venereal
% 216.88/217.07  |- skos__altLabel mesh__D015229 Sexually Transmitted Disease, Viral
% 216.88/217.07  |- skos__hiddenLabel mesh__D015229 Viral Venereal Disease
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D015229 1993
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D015229 2006
% 216.88/217.07  |- skos__prefLabel mesh__D015229 Sexually Transmitted Diseases, Viral
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D015229 1995
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D015229 2002
% 216.88/217.07  |- mesh__recordOriginator mesh__D015229 EJB
% 216.88/217.07  |- rdf__type mesh__D015229sskos__Concept
% 216.88/217.07  |- skos__altLabel mesh__D015229 Viral Venereal Diseases
% 216.88/217.07  |- skos__altLabel mesh__D015229 Viral Sexually Transmitted Disease
% 216.88/217.07  |- mesh__recordMaintainer mesh__D001209 mdb
% 216.88/217.07  |- mesh__recordAuthorizer mesh__D001209 sjn
% 216.88/217.07  |- skos__scopeNote mesh__D001209
% 216.88/217.07       The geographical area of Asia comprising KAZAKHSTAN; KYRGYZSTAN; TAJIKISTAN; TURKMENISTAN; and UZBEKISTAN. The desert region of Kara Kum %28%Qara Qum%29% is largely in Turkmenistan and the desert region of Kyzyl Kum %28%Kizil Kum or Qizil Qum%29%, is in Uzbekistan and Kazakhstan. %28%From Webster%27%s New Geographical Dictionary, 1988, p233, 590, 636%29%%A%    
% 216.88/217.07  |- mesh__dateCreated mesh__D001209 1981-02-27
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D001209 2005
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D001209 2006
% 216.88/217.07  |- rdf__type mesh__D001209sskos__Concept
% 216.88/217.07  |- mesh__recordOriginator mesh__D001209 SMH
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D001209 2003
% 216.88/217.07  |- skos__prefLabel mesh__D001209 Asia, Central
% 216.88/217.07  |- skos__broader mesh__D001209smesh__D001208
% 216.88/217.07  |- skos__annotation mesh__D001209 a geog area; prefer specific countries   
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D001209 2002
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D001209 2004
% 216.88/217.07  |- mesh__historyNote mesh__D001209 82   
% 216.88/217.07  |- mesh__dateEstablished mesh__D001209 1982-01-01
% 216.88/217.07  |- mesh__dateRevised mesh__D001209 2001-07-25
% 216.88/217.07  |- mesh__recordAuthorizer mesh__D050050 sjn
% 216.88/217.07  |- skos__altLabel mesh__D050050 Carbonylation, Protein
% 216.88/217.07  |- rdf__type mesh__D050050sskos__Concept
% 216.88/217.07  |- skos__altLabel mesh__D050050 Carbonylated Protein Formation
% 216.88/217.07  |- skos__hiddenLabel mesh__D050050 Carbonyl Formation, Protein
% 216.88/217.07  |- skos__hiddenLabel mesh__D050050 Protein Formation, Carbonylated
% 216.88/217.07  |- skos__altLabel mesh__D050050 Protein Carbonyl Formation
% 216.88/217.07  |- mesh__publicMeSHNote mesh__D050050 2006   
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D050050 2006
% 216.88/217.07  |- skos__hiddenLabel mesh__D050050 Carbonylations, Protein
% 216.88/217.07  |- mesh__dateEstablished mesh__D050050 2006-01-01
% 216.88/217.07  |- mesh__historyNote mesh__D050050 2006   
% 216.88/217.07  |- skos__hiddenLabel mesh__D050050 Protein Carbonylations
% 216.88/217.07  |- skos__scopeNote mesh__D050050
% 216.88/217.07       The appearance of carbonyl groups %28%such as aldehyde or ketone groups%29% in PROTEINS as the result of several oxidative modification reactions. It is a standard marker for OXIDATIVE STRESS. Carbonylated proteins tend to be more hydrophobic and resistant to proteolysis.%A%    
% 216.88/217.07  |- skos__hiddenLabel mesh__D050050 Formation, Protein Carbonyl
% 216.88/217.07  |- skos__prefLabel mesh__D050050 Protein Carbonylation
% 216.88/217.07  |- mesh__recordOriginator mesh__D050050 nns
% 216.88/217.07  |- skos__hiddenLabel mesh__D050050 Formation, Carbonylated Protein
% 216.88/217.07  |- mesh__recordMaintainer mesh__D050050 nns
% 216.88/217.07  |- mesh__dateCreated mesh__D050050 2005-06-30
% 216.88/217.07  |- skos__broader mesh__D050050smesh__D018384
% 216.88/217.07  |- mesh__recordAuthorizer mesh__D011637 sjn
% 216.88/217.07  |- skos__hiddenLabel mesh__D011637 Nurses, Public Health
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D011637 2005
% 216.88/217.07  |- skos__annotation mesh__D011637 SPEC: SPEC qualif   
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D011637 2003
% 216.88/217.07  |- skos__prefLabel mesh__D011637 Public Health Nursing
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D011637 2006
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D011637 2000
% 216.88/217.07  |- mesh__dateRevised mesh__D011637 1999-11-03
% 216.88/217.07  |- skos__broader mesh__D011637smesh__D013041
% 216.88/217.07  |- skos__hiddenLabel mesh__D011637 Nurse, Public Health
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D011637 2004
% 216.88/217.07  |- rdf__type mesh__D011637sskos__Concept
% 216.88/217.07  |- skos__hiddenLabel mesh__D011637 Public Health Nurse
% 216.88/217.07  |- skos__altLabel mesh__D011637 Nursing, Public Health
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D011637 2001
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D011637 2002
% 216.88/217.07  |- mesh__recordMaintainer mesh__D011637 kle
% 216.88/217.07  |- skos__scopeNote mesh__D011637
% 216.88/217.07       The field of nursing focusing on the health of the community through educational and preventive programs, as well as providing treatment and diagnostic services.%A%    
% 216.88/217.07  |- mesh__recordOriginator mesh__D011637 NLM
% 216.88/217.07  |- mesh__dateCreated mesh__D011637 1999-01-01
% 216.88/217.07  |- mesh__dateEstablished mesh__D016322 1991-01-01
% 216.88/217.07  |- skos__hiddenLabel mesh__D016322 Enhancer, HIV-1
% 216.88/217.07  |- skos__hiddenLabel mesh__D016322 HIV NF kappa B Binding Site
% 216.88/217.07  |- skos__altLabel mesh__D016322 NF-kB-Binding Site, HIV
% 216.88/217.07  |- mesh__dateRevised mesh__D016322 2005-06-30
% 216.88/217.07  |- mesh__recordOriginator mesh__D016322 AGS
% 216.88/217.07  |- skos__broader mesh__D016322smesh__D004742
% 216.88/217.07  |- mesh__publicMeSHNote mesh__D016322 1991   
% 216.88/217.07  |- skos__altLabel mesh__D016322 NF-kB Binding Site, HIV
% 216.88/217.07  |- skos__hiddenLabel mesh__D016322 NF kappa B Binding Site, HIV
% 216.88/217.07  |- mesh__recordMaintainer mesh__D016322 nns
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D016322 2006
% 216.88/217.07  |- mesh__recordAuthorizer mesh__D016322 sjn
% 216.88/217.07  |- skos__broader mesh__D016322smesh__D016325
% 216.88/217.07  |- skos__prefLabel mesh__D016322 HIV Enhancer
% 216.88/217.07  |- skos__related mesh__D016322smesh__D016328
% 216.88/217.07  |- skos__related mesh__D016322smesh__D016325
% 216.88/217.07  |- skos__hiddenLabel mesh__D016322 NF-kB-Binding Sites, HIV
% 216.88/217.07  |- skos__hiddenLabel mesh__D016322 NF kB Binding Site, HIV
% 216.88/217.07  |- skos__hiddenLabel mesh__D016322 HIV Enhancers
% 216.88/217.07  |- skos__hiddenLabel mesh__D016322 Enhancers, HIV
% 216.88/217.07  |- skos__altLabel mesh__D016322 HIV NF-kappa B-Binding Site
% 216.88/217.07  |- skos__scopeNote mesh__D016322
% 216.88/217.07       Cis-acting regulatory sequences in the HIV long terminal repeat %28%LTR%29% which play a major role in induction or augmentation of HIV gene expression in response to environmental stimuli such as mitogens, phorbol esters, or other viruses. The HIV enhancer is the binding site for many cellular transcription factors including the nuclear factor NF-kappa B.%A%    
% 216.88/217.07  |- rdf__type mesh__D016322sskos__Concept
% 216.88/217.07  |- skos__historyNote mesh__D016322
% 216.88/217.07       Enhancer Elements %28%Genetics%29% %28%1986-1990%29%
% 216.88/217.07  |- skos__hiddenLabel mesh__D016322 HIV NF-kB-Binding Sites
% 216.88/217.07  |- mesh__historyNote mesh__D016322 1991   
% 216.88/217.07  |- mesh__dateCreated mesh__D016322 1990-06-28
% 216.88/217.07  |- skos__hiddenLabel mesh__D016322 Sites, HIV NF-kB-Binding
% 216.88/217.07  |- skos__hiddenLabel mesh__D016322 HIV NF-kB-Binding Site
% 216.88/217.07  |- skos__hiddenLabel mesh__D016322 HIV 1 Enhancer
% 216.88/217.07  |- skos__hiddenLabel mesh__D016322 Site, HIV NF-kB-Binding
% 216.88/217.07  |- skos__hiddenLabel mesh__D016322 Enhancers, HIV-1
% 216.88/217.07  |- skos__hiddenLabel mesh__D016322 Enhancer, HIV
% 216.88/217.07  |- skos__hiddenLabel mesh__D016322 HIV-1 Enhancers
% 216.88/217.07  |- mesh__publicMeSHNote mesh__D002302 67   
% 216.88/217.07  |- skos__hiddenLabel mesh__D002302 Outputs, Cardiac
% 216.88/217.07  |- rdf__type mesh__D002302sskos__Concept
% 216.88/217.07  |- mesh__dateEstablished mesh__D002302 1967-01-01
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D002302 2004
% 216.88/217.07  |- skos__broader mesh__D002302smesh__D006334
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D002302 2005
% 216.88/217.07  |- mesh__dateCreated mesh__D002302 1999-01-01
% 216.88/217.07  |- mesh__recordAuthorizer mesh__D002302 sjn
% 216.88/217.07  |- skos__prefLabel mesh__D002302 Cardiac Output
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D002302 2006
% 216.88/217.07  |- skos__broader mesh__D002302smesh__D045472
% 216.88/217.07  |- skos__annotation mesh__D002302
% 216.88/217.07       a physiol concept: do not confuse with the C14 diseases CARDIAC OUTPUT, HIGH or CARDIAC OUTPUT, LOW%A%  
% 216.88/217.07  |- skos__hiddenLabel mesh__D002302 Cardiac Outputs
% 216.88/217.07  |- mesh__dateRevised mesh__D002302 2003-07-09
% 216.88/217.07  |- mesh__recordOriginator mesh__D002302 NLM
% 216.88/217.07  |- mesh__recordMaintainer mesh__D002302 nns
% 216.88/217.07  |- mesh__historyNote mesh__D002302 67%28%64%29%   
% 216.88/217.07  |- skos__hiddenLabel mesh__D002302 Output, Cardiac
% 216.88/217.07  |- skos__scopeNote mesh__D002302
% 216.88/217.07       The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters %28%volume%29% per minute so as not to be confused with STROKE VOLUME %28%volume per beat%29%.%A%    
% 216.88/217.07  |- mesh__recordAuthorizer mesh__D007596 SJN
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D007596 2001
% 216.88/217.07  |- skos__related mesh__D007596smesh__D001175
% 216.88/217.07  |- mesh__dateRevised mesh__D007596 1997-06-20
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D007596 2003
% 216.88/217.07  |- skos__prefLabel mesh__D007596 Joints
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D007596 2000
% 216.88/217.07  |- mesh__considerAlso mesh__D007596 consider also terms at ARTHR-   
% 216.88/217.07  |- mesh__dateCreated mesh__D007596 1999-01-01
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D007596 1999
% 216.88/217.07  |- skos__broader mesh__D007596smesh__D012863
% 216.88/217.07  |- skos__related mesh__D007596smesh__D001182
% 216.88/217.07  |- mesh__recordMaintainer mesh__D007596 TGC
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D007596 1998
% 216.88/217.07  |- skos__hiddenLabel mesh__D007596 Joint
% 216.88/217.07  |- mesh__publicMeSHNote mesh__D007596
% 216.88/217.07       STERNOCOSTAL JOINTS was see under RIBS 1963-78   
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D007596 2006
% 216.88/217.07  |- skos__related mesh__D007596smesh__D001178
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D007596 2005
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D007596 2002
% 216.88/217.07  |- skos__annotation mesh__D007596
% 216.88/217.07       GEN; joints of animals: TN 117; differentiation of sites %26% joints: TN 238; inflammation = ARTHRITIS; /surg: consider also ARTHROPLASTY; joint revision: index as ARTHROPLASTY %28%IM%29% + REOPERATION %28%NIM%29%%A%  
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D007596 2004
% 216.88/217.07  |- rdf__type mesh__D007596sskos__Concept
% 216.88/217.07  |- mesh__recordOriginator mesh__D007596 NLM
% 216.88/217.07  |- skos__hiddenLabel mesh__D040421 Phones, Mobile
% 216.88/217.07  |- skos__hiddenLabel mesh__D040421 Cellular Phones, Portable
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D040421 2005
% 216.88/217.07  |- skos__altLabel mesh__D040421 Car Phone
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D040421 2004
% 216.88/217.07  |- mesh__dateCreated mesh__D040421 2002-07-03
% 216.88/217.07  |- rdf__type mesh__D040421sskos__Concept
% 216.88/217.07  |- mesh__publicMeSHNote mesh__D040421 2003   
% 216.88/217.07  |- skos__hiddenLabel mesh__D040421 Transportable Cellular Phones
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D040421 2006
% 216.88/217.07  |- skos__prefLabel mesh__D040421 Cellular Phone
% 216.88/217.07  |- skos__hiddenLabel mesh__D040421 Telephones, Cellular
% 216.88/217.07  |- skos__hiddenLabel mesh__D040421 Phone, Cellular
% 216.88/217.07  |- skos__hiddenLabel mesh__D040421 Phones, Cellular
% 216.88/217.07  |- skos__hiddenLabel mesh__D040421 Phones, Cell
% 216.88/217.07  |- skos__hiddenLabel mesh__D040421 Mobile Phones
% 216.88/217.07  |- skos__hiddenLabel mesh__D040421 Portable Cellular Phones
% 216.88/217.07  |- skos__hiddenLabel mesh__D040421 Phone, Cell
% 216.88/217.07  |- skos__hiddenLabel mesh__D040421 Cellular Phone, Portable
% 216.88/217.07  |- skos__hiddenLabel mesh__D040421 Cell Phones
% 216.88/217.07  |- skos__historyNote mesh__D040421 Telephone %28%1991-2002%29%
% 216.88/217.07  |- skos__scopeNote mesh__D040421
% 216.88/217.07       Analog or digital communications device in which the user has a wireless connection from a telephone to a nearby transmitter. It is termed cellular because the service area is divided into multiple %22%cells.%22% As the user moves from one cell area to another, the call is transferred to the local transmitter.%A%    
% 216.88/217.07  |- skos__hiddenLabel mesh__D040421 Cellular Phones
% 216.88/217.07  |- skos__altLabel mesh__D040421 Cell Phone
% 216.88/217.07  |- skos__hiddenLabel mesh__D040421 Cellular Telephones
% 216.88/217.07  |- skos__altLabel mesh__D040421 Telephone, Cellular
% 216.88/217.07  |- skos__broader mesh__D040421smesh__D013689
% 216.88/217.07  |- skos__hiddenLabel mesh__D040421 Phone, Car
% 216.88/217.07  |- mesh__historyNote mesh__D040421 2003   
% 216.88/217.07  |- mesh__dateEstablished mesh__D040421 2003-01-01
% 216.88/217.07  |- skos__hiddenLabel mesh__D040421 Car Phones
% 216.88/217.07  |- skos__hiddenLabel mesh__D040421 Phone, Mobile
% 216.88/217.07  |- skos__hiddenLabel mesh__D040421 Cellular Phones, Transportable
% 216.88/217.07  |- skos__hiddenLabel mesh__D040421 Cellular Phone, Transportable
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D040421 2003
% 216.88/217.07  |- skos__hiddenLabel mesh__D040421 Phones, Car
% 216.88/217.07  |- skos__hiddenLabel mesh__D040421 Cellular Telephone
% 216.88/217.07  |- skos__hiddenLabel mesh__D012730 Chromosome, Sex
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D012730 2006
% 216.88/217.07  |- mesh__publicMeSHNote mesh__D012730 68   
% 216.88/217.07  |- skos__annotation mesh__D012730
% 216.88/217.07       X chromosome /abnorm = SEX CHROMOSOME ABERRATIONS %28%IM%29% + X CHROMOSOME %28%IM%29%; Y chromosome /abnorm = SEX CHROMOSOME ABERRATIONS %28%IM%29% + Y CHROMOSOME %28%IM%29%; A 11 qualif except /cytol /transpl; /genet permitted%A%  
% 216.88/217.07  |- mesh__dateRevised mesh__D012730 2002-07-03
% 216.88/217.07  |- skos__hiddenLabel mesh__D012730 Gonosome
% 216.88/217.07  |- mesh__dateEstablished mesh__D012730 1968-01-01
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D012730 2003
% 216.88/217.07  |- skos__hiddenLabel mesh__D012730 Chromosomes, Sex
% 216.88/217.07  |- mesh__recordAuthorizer mesh__D012730 sjn
% 216.88/217.07  |- mesh__recordOriginator mesh__D012730 NLM
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D012730 2004
% 216.88/217.07  |- rdf__type mesh__D012730sskos__Concept
% 216.88/217.07  |- skos__historyNote mesh__D012730 Sex Chromatin %28%1966-1967%29%
% 216.88/217.07  |- mesh__historyNote mesh__D012730 68   
% 216.88/217.07  |- skos__altLabel mesh__D012730 Gonosomes
% 216.88/217.07  |- skos__hiddenLabel mesh__D012730 Sex Chromosome
% 216.88/217.07  |- skos__scopeNote mesh__D012730
% 216.88/217.07       The homologous chromosomes that are dissimilar in the heterogametic sex. There are the X CHROMOSOME, the Y CHROMOSOME, and the W, Z chromosomes %28%in animals in which the female is the heterogametic sex %28%the silkworm moth Bombyx mori, for example%29%%29%. In such cases the W chromosome is the female-determining and the male is ZZ. %28%From King %26% Stansfield, A Dictionary of Genetics, 4th ed%29%%A%    
% 216.88/217.07  |- skos__historyNote mesh__D012730 Chromosomes %28%1966-1967%29%
% 216.88/217.07  |- skos__prefLabel mesh__D012730 Sex Chromosomes
% 216.88/217.07  |- mesh__recordMaintainer mesh__D012730 sjn
% 216.88/217.07  |- mesh__activeMeSHYear mesh__D012730 2005
% 216.88/217.07  |- mesh__dateCreated mesh__D012730 1999-01-01
% 216.88/217.07  |- skos__broader mesh__D012730smesh__D002875
% 216.88/217.08  |- skos__annotation mesh__D050051
% 216.88/217.08       note entry terms: TRP refers to transient receptor potential not TRYPTOPHAN%A%  
% 216.88/217.08  |- skos__hiddenLabel mesh__D050051 Cation Channels, TRP
% 216.88/217.08  |- mesh__publicMeSHNote mesh__D050051 2006   
% 216.88/217.08  |- skos__altLabel mesh__D050051 TRP Membrane Proteins
% 216.88/217.08  |- skos__hiddenLabel mesh__D050051 Membrane Proteins, TRP
% 216.88/217.08  |- skos__historyNote mesh__D050051 Ion Channels %28%1995-2005%29%
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D050051 2006
% 216.88/217.08  |- mesh__recordMaintainer mesh__D050051 ssb
% 216.88/217.08  |- skos__prefLabel mesh__D050051 Transient Receptor Potential Channels
% 216.88/217.08  |- skos__hiddenLabel mesh__D050051 Proteins, TRP Membrane
% 216.88/217.08  |- mesh__dateCreated mesh__D050051 2005-06-30
% 216.88/217.08  |- mesh__recordOriginator mesh__D050051 ssb
% 216.88/217.08  |- mesh__recordAuthorizer mesh__D050051 sjn
% 216.88/217.08  |- skos__broader mesh__D050051smesh__D007473
% 216.88/217.08  |- skos__scopeNote mesh__D050051
% 216.88/217.08       A broad group of eukaryotic six-transmembrane cation channels that are classified by sequence homology because their functional involvement with SENSATION is varied. They have only weak voltage sensitivity and ion selectivity. They are named after a DROSOPHILA mutant that displayed transient receptor potentials in response to light. A 25-amino-acid motif containing a TRP box %28%EWKFAR%29% just C-terminal to S6 is found in TRPC, TRPV and TRPM subgroups.  ANKYRIN repeats are found in TRPC, TRPV %26% TRPN subgroups. Some are functionally associated with TYROSINE KINASE or PHOSPHOLIPASE C.%A%    
% 216.88/217.08  |- mesh__dateEstablished mesh__D050051 2006-01-01
% 216.88/217.08  |- skos__historyNote mesh__D050051 Calcium Channels %28%1989-2005%29%
% 216.88/217.08  |- skos__altLabel mesh__D050051 TRP Cation Channels
% 216.88/217.08  |- skos__hiddenLabel mesh__D050051 Channels, TRP Cation
% 216.88/217.08  |- rdf__type mesh__D050051sskos__Concept
% 216.88/217.08  |- mesh__historyNote mesh__D050051 2006   
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D011638 2002
% 216.88/217.08  |- mesh__recordMaintainer mesh__D011638 kle
% 216.88/217.08  |- skos__broader mesh__D011638smesh__D006798
% 216.88/217.08  |- rdf__type mesh__D011638sskos__Concept
% 216.88/217.08  |- mesh__recordOriginator mesh__D011638 NLM
% 216.88/217.08  |- mesh__dateEstablished mesh__D011638 1968-01-01
% 216.88/217.08  |- mesh__recordAuthorizer mesh__D011638 sjn
% 216.88/217.08  |- mesh__dateRevised mesh__D011638 1999-11-03
% 216.88/217.08  |- skos__prefLabel mesh__D011638 Public Housing
% 216.88/217.08  |- mesh__dateCreated mesh__D011638 1999-01-01
% 216.88/217.08  |- skos__annotation mesh__D011638 specify geog if pertinent   
% 216.88/217.08  |- mesh__historyNote mesh__D011638 68   
% 216.88/217.08  |- skos__hiddenLabel mesh__D011638 Housing, Public
% 216.88/217.08  |- mesh__publicMeSHNote mesh__D011638 68   
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D011638 2000
% 216.88/217.08  |- skos__historyNote mesh__D011638 Housing %28%1966-1967%29%
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D011638 2005
% 216.88/217.08  |- skos__scopeNote mesh__D011638
% 216.88/217.08       Housing subsidized by tax funds, usually intended for low income persons or families.%A%    
% 216.88/217.08  |- skos__historyNote mesh__D011638 Social Welfare %28%1966-1967%29%
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D011638 2003
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D011638 2006
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D011638 2001
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D011638 2004
% 216.88/217.08  |- mesh__recordOriginator mesh__D016323 MXR
% 216.88/217.08  |- mesh__publicMeSHNote mesh__D016323 91   
% 216.88/217.08  |- skos__historyNote mesh__D016323 Tooth, Deciduous %28%1966-1990%29%
% 216.88/217.08  |- mesh__historyNote mesh__D016323 91   
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D016323 2006
% 216.88/217.08  |- mesh__dateCreated mesh__D016323 1990-05-25
% 216.88/217.08  |- mesh__dateRevised mesh__D016323 2003-07-09
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D016323 2004
% 216.88/217.08  |- skos__broader mesh__D016323smesh__D003817
% 216.88/217.08  |- rdf__type mesh__D016323sskos__Concept
% 216.88/217.08  |- skos__scopeNote mesh__D016323
% 216.88/217.08       The teeth first in order or time of development that will be replaced by permanent dentition upon their loss.%A%    
% 216.88/217.08  |- skos__related mesh__D016323smesh__D014094
% 216.88/217.08  |- skos__annotation mesh__D016323
% 216.88/217.08       see note at DENTITION; do not confuse X ref DENTITION, DECIDUOUS with TOOTH, DECIDUOUS; no qualif%A%  
% 216.88/217.08  |- skos__hiddenLabel mesh__D016323 Primary Dentition
% 216.88/217.08  |- mesh__recordAuthorizer mesh__D016323 sjn
% 216.88/217.08  |- mesh__recordMaintainer mesh__D016323 lkt
% 216.88/217.08  |- skos__prefLabel mesh__D016323 Dentition, Primary
% 216.88/217.08  |- skos__hiddenLabel mesh__D016323 Deciduous Dentition
% 216.88/217.08  |- mesh__dateEstablished mesh__D016323 1991-01-01
% 216.88/217.08  |- skos__altLabel mesh__D016323 Dentition, Deciduous
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D016323 2005
% 216.88/217.08  |- mesh__recordAuthorizer mesh__D002303 SJN
% 216.88/217.08  |- skos__altLabel mesh__D002303 Low Cardiac Output
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002303 2000
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002303 1999
% 216.88/217.08  |- mesh__historyNote mesh__D002303 80   
% 216.88/217.08  |- mesh__dateCreated mesh__D002303 1979-04-24
% 216.88/217.08  |- skos__annotation mesh__D002303
% 216.88/217.08       note category: do not confuse with CARDIAC OUTPUT, a physiol concept; note X ref LOW CARDIAC OUTPUT SYNDROME: do not add SYNDROME%A%  
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002303 2004
% 216.88/217.08  |- mesh__recordMaintainer mesh__D002303 TGC
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002303 2001
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002303 2005
% 216.88/217.08  |- mesh__publicMeSHNote mesh__D002303 80   
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002303 2002
% 216.88/217.08  |- skos__prefLabel mesh__D002303 Cardiac Output, Low
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002303 2006
% 216.88/217.08  |- mesh__recordOriginator mesh__D002303 VDK
% 216.88/217.08  |- skos__scopeNote mesh__D002303
% 216.88/217.08       A state of subnormal or depressed cardiac output, usually seen in patients with heart failure secondary to coronary artery, hypertensive, primary myocardial, valvular, or pericardial disease.%A%    
% 216.88/217.08  |- skos__historyNote mesh__D002303 Cardiac Output %28%1966-1979%29%
% 216.88/217.08  |- skos__hiddenLabel mesh__D002303 Output, Low Cardiac
% 216.88/217.08  |- mesh__dateEstablished mesh__D002303 1980-01-01
% 216.88/217.08  |- skos__broader mesh__D002303smesh__D006331
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002303 1998
% 216.88/217.08  |- mesh__dateRevised mesh__D002303 1997-06-20
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002303 2003
% 216.88/217.08  |- rdf__type mesh__D002303sskos__Concept
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007597 2006
% 216.88/217.08  |- mesh__recordAuthorizer mesh__D007597 PLS
% 216.88/217.08  |- skos__prefLabel mesh__D007597 Jordan
% 216.88/217.08  |- skos__broader mesh__D007597smesh__D008877
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007597 1997
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007597 2002
% 216.88/217.08  |- mesh__recordMaintainer mesh__D007597 PLS
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007597 2005
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007597 1996
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007597 2001
% 216.88/217.08  |- mesh__recordOriginator mesh__D007597 NLM
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007597 1995
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007597 2004
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007597 1994
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007597 2000
% 216.88/217.08  |- rdf__type mesh__D007597sskos__Concept
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007597 2003
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007597 1999
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007597 1993
% 216.88/217.08  |- mesh__dateRevised mesh__D007597 1992-05-20
% 216.88/217.08  |- mesh__dateCreated mesh__D007597 1999-01-01
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007597 1998
% 216.88/217.08  |- skos__scopeNote mesh__D012731
% 216.88/217.08       Advice and support given to individuals to help them understand and resolve their sexual adjustment problems. It excludes treatment for PSYCHOSEXUAL DISORDERS or PSYCHOSEXUAL DYSFUNCTION.%A%    
% 216.88/217.08  |- skos__broader mesh__D012731smesh__D003376
% 216.88/217.08  |- skos__hiddenLabel mesh__D012731 Sex Counselings
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D012731 2006
% 216.88/217.08  |- mesh__dateCreated mesh__D012731 1987-02-26
% 216.88/217.08  |- mesh__recordAuthorizer mesh__D012731 sjn
% 216.88/217.08  |- skos__hiddenLabel mesh__D012731 Counselings, Sex
% 216.88/217.08  |- mesh__dateEstablished mesh__D012731 1988-01-01
% 216.88/217.08  |- rdf__type mesh__D012731sskos__Concept
% 216.88/217.08  |- skos__historyNote mesh__D012731 Counseling %28%1966-1987%29%
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D012731 2004
% 216.88/217.08  |- mesh__publicMeSHNote mesh__D012731 88   
% 216.88/217.08  |- skos__historyNote mesh__D012731 Psychotherapy %28%1966-1987%29%
% 216.88/217.08  |- mesh__recordMaintainer mesh__D012731 lkt
% 216.88/217.08  |- skos__broader mesh__D012731smesh__D044347
% 216.88/217.08  |- mesh__historyNote mesh__D012731 88   
% 216.88/217.08  |- skos__altLabel mesh__D012731 Counseling, Sex
% 216.88/217.08  |- mesh__recordOriginator mesh__D012731 EC
% 216.88/217.08  |- mesh__dateRevised mesh__D012731 2003-07-09
% 216.88/217.08  |- skos__prefLabel mesh__D012731 Sex Counseling
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D012731 2005
% 216.88/217.08  |- skos__broader mesh__D005172Q000172smesh__D005172
% 216.88/217.08  |- mesh__preferredCombination mesh__D005172Q000172smesh__D005173
% 216.88/217.08  |- rdf__type mesh__D005172Q000172smesh__CompoundConcept
% 216.88/217.08  |- skos__broader mesh__D011506Q000172smesh__D011506
% 216.88/217.08  |- mesh__preferredCombination mesh__D011506Q000172smesh__D011488
% 216.88/217.08  |- rdf__type mesh__D011506Q000172smesh__CompoundConcept
% 216.88/217.08  |- mesh__dateCreated mesh__D036381 2002-07-03
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D036381 2005
% 216.88/217.08  |- mesh__historyNote mesh__D036381 2003   
% 216.88/217.08  |- skos__prefLabel mesh__D036381 Diarylheptanoids
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D036381 2003
% 216.88/217.08  |- rdf__type mesh__D036381sskos__Concept
% 216.88/217.08  |- skos__broader mesh__D036381smesh__D006841
% 216.88/217.08  |- mesh__dateEstablished mesh__D036381 2003-01-01
% 216.88/217.08  |- skos__scopeNote mesh__D036381
% 216.88/217.08       A group of compounds consisting of two aromatic rings separated by seven carbons %28%HEPTANES%29% and having various substituents. The best known member is CURCUMIN.%A%    
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D036381 2006
% 216.88/217.08  |- skos__broader mesh__D036381smesh__D006536
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D036381 2004
% 216.88/217.08  |- mesh__publicMeSHNote mesh__D036381 2003   
% 216.88/217.08  |- skos__prefLabel mesh__D050052 TRPC Cation Channels
% 216.88/217.08  |- skos__hiddenLabel mesh__D050052 Cation Channels, TRPC
% 216.88/217.08  |- mesh__recordOriginator mesh__D050052 ssb
% 216.88/217.08  |- skos__hiddenLabel mesh__D050052 Channels, TRPC Cation
% 216.88/217.08  |- skos__hiddenLabel mesh__D050052 Channel, TRP
% 216.88/217.08  |- skos__broader mesh__D050052smesh__D050051
% 216.88/217.08  |- skos__altLabel mesh__D050052
% 216.88/217.08       Transient Receptor Potential Channels, Type C
% 216.88/217.08  |- mesh__recordMaintainer mesh__D050052 ssb
% 216.88/217.08  |- skos__hiddenLabel mesh__D050052 Protein, TRP
% 216.88/217.08  |- mesh__historyNote mesh__D050052 2006%28%1996%29%   
% 216.88/217.08  |- mesh__dateCreated mesh__D050052 2005-06-30
% 216.88/217.08  |- skos__altLabel mesh__D050052 TRP Protein
% 216.88/217.08  |- skos__scopeNote mesh__D050052
% 216.88/217.08       A subgroup of TRP cation channels that contain 3-4 ANKYRIN repeats and a conserved C-terminal domain. Members are highly expressed in the CENTRAL NERVOUS SYSTEM. Selectivity for calcium over sodium ranges from 0.5 to 10.%A%    
% 216.88/217.08  |- rdf__type mesh__D050052sskos__Concept
% 216.88/217.08  |- mesh__recordAuthorizer mesh__D050052 sjn
% 216.88/217.08  |- mesh__publicMeSHNote mesh__D050052
% 216.88/217.08       2006; TRP CHANNEL was indexed under CALCIUM CHANNELS 1995-2005%A%  
% 216.88/217.08  |- skos__historyNote mesh__D050052 Ion Channels %28%1995-2005%29%
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D050052 2006
% 216.88/217.08  |- mesh__dateEstablished mesh__D050052 2006-01-01
% 216.88/217.08  |- skos__hiddenLabel mesh__D011639 Polls, Public Opinion
% 216.88/217.08  |- skos__scopeNote mesh__D011639
% 216.88/217.08       The attitude of a significant portion of a population toward any given proposition, based upon a measurable amount of factual evidence, and involving some degree of reflection, analysis, and reasoning.%A%    
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D011639 1999
% 216.88/217.08  |- rdf__type mesh__D011639sskos__Concept
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D011639 2001
% 216.88/217.08  |- mesh__dateEstablished mesh__D011639 1968-01-01
% 216.88/217.08  |- skos__broader mesh__D011639smesh__D012927
% 216.88/217.08  |- skos__hiddenLabel mesh__D011639 Opinion Poll, Public
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D011639 2002
% 216.88/217.08  |- skos__annotation mesh__D011639 no qualif   
% 216.88/217.08  |- skos__hiddenLabel mesh__D011639 Poll, Public Opinion
% 216.88/217.08  |- skos__hiddenLabel mesh__D011639 Groups, Pro-Choice
% 216.88/217.08  |- skos__hiddenLabel mesh__D011639 Group, Pro-Choice
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D011639 2005
% 216.88/217.08  |- skos__prefLabel mesh__D011639 Public Opinion
% 216.88/217.08  |- mesh__recordMaintainer mesh__D011639 JLS
% 216.88/217.08  |- mesh__dateCreated mesh__D011639 1999-01-01
% 216.88/217.08  |- skos__hiddenLabel mesh__D011639 Opinion Polls, Public
% 216.88/217.08  |- skos__historyNote mesh__D011639 Attitude %28%1966-1967%29%
% 216.88/217.08  |- mesh__recordOriginator mesh__D011639 NLM
% 216.88/217.08  |- skos__hiddenLabel mesh__D011639 Interest Group
% 216.88/217.08  |- mesh__publicMeSHNote mesh__D011639 68   
% 216.88/217.08  |- mesh__recordAuthorizer mesh__D011639 SJN
% 216.88/217.08  |- mesh__dateRevised mesh__D011639 1997-06-20
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D011639 2003
% 216.88/217.08  |- skos__hiddenLabel mesh__D011639 Pro-Choice Group
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D011639 2006
% 216.88/217.08  |- skos__hiddenLabel mesh__D011639 Group, Interest
% 216.88/217.08  |- skos__hiddenLabel mesh__D011639 Opinion, Public
% 216.88/217.08  |- skos__hiddenLabel mesh__D011639 Public Opinion Poll
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D011639 1998
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D011639 2004
% 216.88/217.08  |- skos__hiddenLabel mesh__D011639 Groups, Interest
% 216.88/217.08  |- skos__hiddenLabel mesh__D011639 Pro Choice Groups
% 216.88/217.08  |- mesh__historyNote mesh__D011639 68   
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D011639 2000
% 216.88/217.08  |- skos__related mesh__D011639smesh__D001294
% 216.88/217.08  |- skos__altLabel mesh__D008690 Methyleneoxytetracycline
% 216.88/217.08  |- skos__altLabel mesh__D008690
% 216.88/217.08       Zambon Brand of Methacycline Monohydrochloride
% 216.88/217.08  |- mesh__recordMaintainer mesh__D008690 CCR
% 216.88/217.08  |- rdf__type mesh__D008690sskos__Concept
% 216.88/217.08  |- mesh__dateEstablished mesh__D008690 1968-01-01
% 216.88/217.08  |- mesh__dateRevised mesh__D008690 2005-06-30
% 216.88/217.08  |- skos__altLabel mesh__D008690
% 216.88/217.08       Teofarma Brand of Methacycline Monohydrochloride
% 216.88/217.08  |- mesh__recordOriginator mesh__D008690 NLM
% 216.88/217.08  |- skos__prefLabel mesh__D008690 Methacycline
% 216.88/217.08  |- skos__hiddenLabel mesh__D008690 Monohydrochloride, Methacycline
% 216.88/217.08  |- skos__scopeNote mesh__D008690
% 216.88/217.08       A broad-spectrum semisynthetic antibiotic related to TETRACYCLINE but excreted more slowly and maintaining effective blood levels for a more extended period.%A%    
% 216.88/217.08  |- skos__broader mesh__D008690smesh__D013754
% 216.88/217.08  |- mesh__recordAuthorizer mesh__D008690 sjn
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D008690 2006
% 216.88/217.08  |- mesh__dateCreated mesh__D008690 1999-01-01
% 216.88/217.08  |- mesh__historyNote mesh__D008690 68%28%65%29%   
% 216.88/217.08  |- skos__altLabel mesh__D008690 Metacycline
% 216.88/217.08  |- mesh__publicMeSHNote mesh__D008690 68   
% 216.88/217.08  |- skos__scopeNote mesh__D022361
% 216.88/217.08       Vaccines or candidate vaccines used to prevent or treat both enterotoxigenic and enteropathogenic Escherichia coli infections.%A%    
% 216.88/217.08  |- skos__hiddenLabel mesh__D022361 Vaccines, E coli
% 216.88/217.08  |- skos__prefLabel mesh__D022361 Escherichia coli Vaccines
% 216.88/217.08  |- mesh__recordOriginator mesh__D022361 ags
% 216.88/217.08  |- mesh__dateCreated mesh__D022361 2000-06-21
% 216.88/217.08  |- skos__broader mesh__D022361smesh__D001428
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D022361 2006
% 216.88/217.08  |- mesh__recordAuthorizer mesh__D022361 sjn
% 216.88/217.08  |- mesh__recordMaintainer mesh__D022361 ssb
% 216.88/217.08  |- rdf__type mesh__D022361sskos__Concept
% 216.88/217.08  |- skos__altLabel mesh__D022361 E coli Vaccines
% 216.88/217.08  |- mesh__dateEstablished mesh__D022361 2001-01-01
% 216.88/217.08  |- skos__altLabel mesh__D022361 Escherichia coli Vaccine
% 216.88/217.08  |- skos__hiddenLabel mesh__D022361 Vaccine, Escherichia coli
% 216.88/217.08  |- mesh__dateRevised mesh__D022361 2005-06-30
% 216.88/217.08  |- skos__hiddenLabel mesh__D022361 Vaccines, Escherichia coli
% 216.88/217.08  |- mesh__publicMeSHNote mesh__D022361
% 216.88/217.08       2001; ESCHERICHIA COLI VACCINE was indexed under BACTERIAL VACCINES 1983-2000%A%  
% 216.88/217.08  |- skos__historyNote mesh__D022361 Bacterial Vaccines %28%1971-2000%29%
% 216.88/217.08  |- mesh__historyNote mesh__D022361
% 216.88/217.08       2001; use ESCHERICHIA COLI VACCINES %28%NM%29% to search ESCHERICHIA COLI VACCINE 1983-2000%A%  
% 216.88/217.08  |- skos__broader mesh__D016324smesh__D040481
% 216.88/217.08  |- skos__hiddenLabel mesh__D016324 Sequence-Tagged Site
% 216.88/217.08  |- skos__hiddenLabel mesh__D016324 Sites, Sequence-Tagged
% 216.88/217.08  |- skos__hiddenLabel mesh__D016324 Site, Sequence-Tagged
% 216.88/217.08  |- skos__prefLabel mesh__D016324 Sequence Tagged Sites
% 216.88/217.08  |- mesh__recordOriginator mesh__D016324 PXP
% 216.88/217.08  |- skos__related mesh__D016324smesh__D020224
% 216.88/217.08  |- skos__hiddenLabel mesh__D016324 Sequence Tagged Site
% 216.88/217.08  |- skos__scopeNote mesh__D016324
% 216.88/217.08       Short tracts of DNA sequence that are used as landmarks in GENOME mapping. In most instances, 200 to 500 base pairs of sequence define a Sequence Tagged Site %28%STS%29% that is operationally unique in the human genome %28%i.e., can be specifically detected by the polymerase chain reaction in the presence of all other genomic sequences%29%. The overwhelming advantage of STSs over mapping landmarks defined in other ways is that the means of testing for the presence of a particular STS can be completely described as information in a database.%A%    
% 216.88/217.08  |- mesh__recordMaintainer mesh__D016324 nns
% 216.88/217.08  |- mesh__dateEstablished mesh__D016324 1991-01-01
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D016324 2006
% 216.88/217.08  |- mesh__publicMeSHNote mesh__D016324 91   
% 216.88/217.08  |- mesh__dateCreated mesh__D016324 1990-05-29
% 216.88/217.08  |- skos__annotation mesh__D016324 no qualif; DF: SEQ TAGGED SITES   
% 216.88/217.08  |- mesh__dateRevised mesh__D016324 2005-06-30
% 216.88/217.08  |- rdf__type mesh__D016324sskos__Concept
% 216.88/217.08  |- mesh__historyNote mesh__D016324 91   
% 216.88/217.08  |- skos__hiddenLabel mesh__D016324 Tagged Sites, Sequence
% 216.88/217.08  |- skos__altLabel mesh__D016324 Sequence-Tagged Sites
% 216.88/217.08  |- skos__hiddenLabel mesh__D016324 Tagged Site, Sequence
% 216.88/217.08  |- skos__hiddenLabel mesh__D016324 Site, Sequence Tagged
% 216.88/217.08  |- mesh__recordAuthorizer mesh__D016324 sjn
% 216.88/217.08  |- skos__hiddenLabel mesh__D016324 Sites, Sequence Tagged
% 216.88/217.08  |- mesh__recordMaintainer mesh__D002304 TGC
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002304 2005
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002304 1995
% 216.88/217.08  |- mesh__dateEstablished mesh__D002304 1978-01-01
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002304 1996
% 216.88/217.08  |- skos__scopeNote mesh__D002304
% 216.88/217.08       Regulation of the rate of contraction of the heart muscles by an artificial pacemaker.%A%    
% 216.88/217.08  |- skos__altLabel mesh__D002304 Pacing, Cardiac, Artificial
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002304 2006
% 216.88/217.08  |- skos__broader mesh__D002304smesh__D013812
% 216.88/217.08  |- skos__prefLabel mesh__D002304 Cardiac Pacing, Artificial
% 216.88/217.08  |- skos__hiddenLabel mesh__D002304 Pacings, Artificial Cardiac
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002304 1997
% 216.88/217.08  |- skos__annotation mesh__D002304
% 216.88/217.08       do not use /util except by MeSH definition   
% 216.88/217.08  |- skos__hiddenLabel mesh__D002304 Artificial Cardiac Pacing
% 216.88/217.08  |- skos__related mesh__D002304smesh__D010138
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002304 2000
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002304 1998
% 216.88/217.08  |- mesh__recordOriginator mesh__D002304 SMH
% 216.88/217.08  |- rdf__type mesh__D002304sskos__Concept
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002304 2003
% 216.88/217.08  |- skos__hiddenLabel mesh__D002304 Artificial Cardiac Pacings
% 216.88/217.08  |- mesh__publicMeSHNote mesh__D002304 78   
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002304 1993
% 216.88/217.08  |- mesh__historyNote mesh__D002304 78   
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002304 2001
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002304 1999
% 216.88/217.08  |- skos__historyNote mesh__D002304 Pacemaker, Artificial %28%1966-1977%29%
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002304 2004
% 216.88/217.08  |- mesh__dateRevised mesh__D002304 1992-05-07
% 216.88/217.08  |- mesh__dateCreated mesh__D002304 1977-04-22
% 216.88/217.08  |- skos__hiddenLabel mesh__D002304 Pacing, Artificial Cardiac
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002304 1994
% 216.88/217.08  |- mesh__recordAuthorizer mesh__D002304 PLS
% 216.88/217.08  |- skos__hiddenLabel mesh__D002304 Cardiac Pacings, Artificial
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D002304 2002
% 216.88/217.08  |- skos__altLabel mesh__D007598 Dental Journalism
% 216.88/217.08  |- skos__broader mesh__D007598smesh__D020452
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007598 2005
% 216.88/217.08  |- skos__prefLabel mesh__D007598 Journalism, Dental
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007598 2004
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007598 2002
% 216.88/217.08  |- mesh__historyNote mesh__D007598
% 216.88/217.08       91%28%64%29%; was see under PUBLISHING 1964-90   
% 216.88/217.08  |- rdf__type mesh__D007598sskos__Concept
% 216.88/217.08  |- mesh__dateRevised mesh__D007598 1998-06-10
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007598 2003
% 216.88/217.08  |- mesh__dateEstablished mesh__D007598 1991-01-01
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007598 1999
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007598 2001
% 216.88/217.08  |- mesh__recordOriginator mesh__D007598 NLM
% 216.88/217.08  |- mesh__dateCreated mesh__D007598 1999-01-01
% 216.88/217.08  |- mesh__recordAuthorizer mesh__D007598 SJN
% 216.88/217.08  |- mesh__publicMeSHNote mesh__D007598
% 216.88/217.08       91; was see under PUBLISHING 1964-90   
% 216.88/217.08  |- skos__annotation mesh__D007598
% 216.88/217.08       writing for or in dent publ or on dent subjects; dental journals go under PERIODICALS %26% required coord, not here; DF: JOURNALISM DENT%A%  
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007598 2000
% 216.88/217.08  |- mesh__recordMaintainer mesh__D007598 JLS
% 216.88/217.08  |- skos__altLabel mesh__D007598 Periodicals Publishing, Dental
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D007598 2006
% 216.88/217.08  |- skos__altLabel mesh__D007598 Publishing, Dental Periodicals
% 216.88/217.08  |- skos__scopeNote mesh__D007598
% 216.88/217.08       Content, management, editing, policies, and printing of dental periodicals such as journals, newsletters, tabloids, and bulletins.%A%    
% 216.88/217.08  |- skos__hiddenLabel mesh__D012732 Sex Determination Technique
% 216.88/217.08  |- mesh__publicMeSHNote mesh__D012732 98; see SEX DETERMINATION 1963-97   
% 216.88/217.08  |- skos__broader mesh__D012732smesh__D020732
% 216.88/217.08  |- skos__hiddenLabel mesh__D012732 Sex Determinations %28%Analysis%29%
% 216.88/217.08  |- skos__hiddenLabel mesh__D012732 Technic, Sex Determination
% 216.88/217.08  |- skos__hiddenLabel mesh__D012732 Techniques, Sex Determination
% 216.88/217.08  |- rdf__type mesh__D012732sskos__Concept
% 216.88/217.08  |- skos__hiddenLabel mesh__D012732 Technique, Sex Determination
% 216.88/217.08  |- skos__prefLabel mesh__D012732 Sex Determination %28%Analysis%29%
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D012732 2004
% 216.88/217.08  |- skos__hiddenLabel mesh__D012732 Technics, Sex Determination
% 216.88/217.08  |- mesh__recordAuthorizer mesh__D012732 sjn
% 216.88/217.08  |- mesh__recordOriginator mesh__D012732 NLM
% 216.88/217.08  |- skos__broader mesh__D012732smesh__D003942
% 216.88/217.08  |- skos__altLabel mesh__D012732 Sex Determination Technics
% 216.88/217.08  |- skos__hiddenLabel mesh__D012732 Determinations, Sex %28%Analysis%29%
% 216.88/217.08  |- mesh__dateCreated mesh__D012732 1999-01-01
% 216.88/217.08  |- skos__hiddenLabel mesh__D012732 Determination, Sex %28%Analysis%29%
% 216.88/217.08  |- skos__hiddenLabel mesh__D012732 Sex Determination Technic
% 216.88/217.08  |- mesh__historyNote mesh__D012732 98%28%63%29%   
% 216.88/217.08  |- skos__scopeNote mesh__D012732
% 216.88/217.08       Validation of the SEX of an individual by inspection of the GONADS and/or by genetic tests.%A%    
% 216.88/217.08  |- skos__altLabel mesh__D012732 Sex Determination Techniques
% 216.88/217.08  |- skos__related mesh__D012732smesh__D012723
% 216.88/217.08  |- mesh__dateRevised mesh__D012732 2003-07-09
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D012732 2005
% 216.88/217.08  |- skos__annotation mesh__D012732
% 216.88/217.08       validation of sex by exam of gonads or genet tests; do not confuse with SEX DETERMINATION %28%GENETICS%29% which is establishment of sex at fertilization; DF: SEX DETERMINATION ANAL%A%  
% 216.88/217.08  |- mesh__recordMaintainer mesh__D012732 lkt
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D012732 2006
% 216.88/217.08  |- skos__broader mesh__D036382smesh__D036342
% 216.88/217.08  |- mesh__dateEstablished mesh__D036382 2003-01-01
% 216.88/217.08  |- skos__altLabel mesh__D036382 EPLG1
% 216.88/217.08  |- mesh__historyNote mesh__D036382
% 216.88/217.08       2003; use EPHRIN-A1 %28%NM%29% 1990-2002   
% 216.88/217.08  |- skos__hiddenLabel mesh__D036382 RPTK Ligand, Eck
% 216.88/217.08  |- skos__hiddenLabel mesh__D036382 Ligand, Eck
% 216.88/217.08  |- skos__hiddenLabel mesh__D036382 LERK 1 Protein
% 216.88/217.08  |- mesh__dateRevised mesh__D036382 2005-06-30
% 216.88/217.08  |- mesh__publicMeSHNote mesh__D036382
% 216.88/217.08       2003; ENDOTHELIUM SECRETED PROTEIN B61 %28%now Ephrin-A1%29% was indexed under PROTEINS 1990-2002,%A%  
% 216.88/217.08  |- rdf__type mesh__D036382sskos__Concept
% 216.88/217.08  |- skos__altLabel mesh__D036382 Endothelium Secreted Protein B61
% 216.88/217.08  |- skos__altLabel mesh__D036382 Eck Ligand
% 216.88/217.08  |- skos__prefLabel mesh__D036382 Ephrin-A1
% 216.88/217.08  |- skos__altLabel mesh__D036382 Eck RPTK Ligand
% 216.88/217.08  |- skos__altLabel mesh__D036382 Epl1 Protein
% 216.88/217.08  |- skos__altLabel mesh__D036382 B61 Secreted Protein, Endothelium
% 216.88/217.08  |- skos__historyNote mesh__D036382 Proteins %28%1990-2002%29%
% 216.88/217.08  |- mesh__recordMaintainer mesh__D036382 ssb
% 216.88/217.08  |- mesh__recordOriginator mesh__D036382 jmp
% 216.88/217.08  |- skos__scopeNote mesh__D036382
% 216.88/217.08       An ephrin that was originally identified as the product of an early response gene induced by TUMOR NECROSIS FACTORS. It is linked to the CELL MEMBRANE via a GLYCOINOSITOL PHOSPHOLIPID MEMBRANE ANCHOR and binds EPHA2 RECEPTOR with high affinity. During embryogenesis high levels of ephrin-A1 are expressed in LUNG, KIDNEY, SALIVARY GLANDS and INTESTINE.%A%    
% 216.88/217.08  |- skos__hiddenLabel mesh__D036382 Ephrin A1
% 216.88/217.08  |- mesh__recordAuthorizer mesh__D036382 sjn
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D036382 2006
% 216.88/217.08  |- mesh__dateCreated mesh__D036382 2002-07-02
% 216.88/217.08  |- skos__altLabel mesh__D036382 LERK-1 Protein
% 216.88/217.08  |- mesh__recordAuthorizer mesh__D050053 sjn
% 216.88/217.08  |- skos__broader mesh__D050053smesh__D050051
% 216.88/217.08  |- skos__scopeNote mesh__D050053
% 216.88/217.08       A subgroup of TRP cation channels named after melastatin protein. They have the TRP domain but lack ANKYRIN repeats. Enzyme domains in the C-terminus leads to them being called chanzymes.%A%    
% 216.88/217.08  |- mesh__recordMaintainer mesh__D050053 ssb
% 216.88/217.08  |- mesh__recordOriginator mesh__D050053 ssb
% 216.88/217.08  |- mesh__dateEstablished mesh__D050053 2006-01-01
% 216.88/217.08  |- mesh__historyNote mesh__D050053 2006   
% 216.88/217.08  |- rdf__type mesh__D050053sskos__Concept
% 216.88/217.08  |- skos__hiddenLabel mesh__D050053 Cation Channels, TRPM
% 216.88/217.08  |- skos__altLabel mesh__D050053
% 216.88/217.08       Transient Receptor Potential Channels, Type M
% 216.88/217.08  |- skos__prefLabel mesh__D050053 TRPM Cation Channels
% 216.88/217.08  |- mesh__publicMeSHNote mesh__D050053 2006   
% 216.88/217.08  |- skos__historyNote mesh__D050053 Ion Channels %28%1995-2005%29%
% 216.88/217.08  |- mesh__dateCreated mesh__D050053 2005-06-30
% 216.88/217.08  |- skos__hiddenLabel mesh__D050053 Channels, TRPM Cation
% 216.88/217.08  |- mesh__activeMeSHYear mesh__D050053 2006
% 216.88/217.08  |- skos__altLabel mesh__D008691
% 216.88/217.08       Pharmascience Brand of Methadone Hydrochloride
% 216.88/217.08  |- skos__scopeNote mesh__D008691
% 216.88/217.08       A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. It also has a depressant action on the cough center and may be given to control intractable cough associated with terminal lung cancer. Methadone is also used as part of the treatment of dependence on opioid drugs, although prolonged use of methadone itself may result in dependence. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3%29%%A%    
% 216.88/217.08  |- skos__altLabel mesh__D008691
% 216.88/217.08       GlaxoSmithKline Brand of Methadone Hydrochloride
% 216.88/217.09  |- skos__altLabel mesh__D008691 Martindale Brand of Methadone Hydrochloride
% 216.88/217.09  |- skos__altLabel mesh__D008691 Esteve Brand of Methadone Hydrochloride
% 216.88/217.09  |- skos__hiddenLabel mesh__D008691 Hydrochloride, Methadone
% 216.88/217.09  |- mesh__recordMaintainer mesh__D008691 CCR
% 216.88/217.09  |- skos__broader mesh__D008691smesh__D007659
% 216.88/217.09  |- skos__altLabel mesh__D008691 Roxane Brand of Methadone Hydrochloride
% 216.88/217.09  |- skos__altLabel mesh__D008691 Rosemont Brand of Methadone Hydrochloride
% 216.88/217.09  |- skos__altLabel mesh__D008691 Generics Brand of Methadone Hydrochloride
% 216.88/217.09  |- mesh__dateRevised mesh__D008691 2005-06-30
% 216.88/217.09  |- skos__altLabel mesh__D008691 Yamanouchi Brand of Methadone Hydrochloride
% 216.88/217.09  |- skos__altLabel mesh__D008691 addiCare Brand of Methadone Hydrochloride
% 216.88/217.09  |- skos__annotation mesh__D008691
% 216.88/217.09       with disease term, use /rehabil rather than /drug ther   
% 216.88/217.09  |- mesh__recordOriginator mesh__D008691 NLM
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D008691 2006
% 216.88/217.09  |- skos__altLabel mesh__D008691 Pinewood Brand of Methadone Hydrochloride
% 216.88/217.09  |- mesh__dateCreated mesh__D008691 1999-01-01
% 216.88/217.09  |- skos__altLabel mesh__D008691 Phymet
% 216.88/217.09  |- skos__altLabel mesh__D008691
% 216.88/217.09       Mallinckrodt Brand of Methadone Hydrochloride
% 216.88/217.09  |- skos__altLabel mesh__D008691 Biomet Brand of Methadone Hydrochloride
% 216.88/217.09  |- mesh__recordAuthorizer mesh__D008691 sjn
% 216.88/217.09  |- rdf__type mesh__D008691sskos__Concept
% 216.88/217.09  |- skos__prefLabel mesh__D008691 Methadone
% 216.88/217.09  |- skos__prefLabel mesh__D022362 Hepatitis A Vaccines
% 216.88/217.09  |- mesh__dateCreated mesh__D022362 2000-06-21
% 216.88/217.09  |- skos__scopeNote mesh__D022362
% 216.88/217.09       Vaccines or candidate vaccines used to prevent infection with hepatitis A virus %28%HEPATOVIRUS%29%.%A%    
% 216.88/217.09  |- skos__broader mesh__D022362smesh__D014761
% 216.88/217.09  |- skos__altLabel mesh__D022362 Hepatitis A Vaccine
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D022362 2006
% 216.88/217.09  |- mesh__recordOriginator mesh__D022362 ags
% 216.88/217.09  |- skos__hiddenLabel mesh__D022362 Vaccine, Hepatitis A
% 216.88/217.09  |- skos__altLabel mesh__D022362 Hepatovirus Vaccines
% 216.88/217.09  |- rdf__type mesh__D022362sskos__Concept
% 216.88/217.09  |- skos__historyNote mesh__D022362
% 216.88/217.09       Viral Hepatitis Vaccines %28%1987-2000%29%
% 216.88/217.09  |- mesh__historyNote mesh__D022362
% 216.88/217.09       2001; use HEPATITIS A VACCINES %28%NM%29% to search HEPATITIS A VACCINE 1992-2000%A%  
% 216.88/217.09  |- mesh__dateEstablished mesh__D022362 2001-01-01
% 216.88/217.09  |- mesh__recordAuthorizer mesh__D022362 sjn
% 216.88/217.09  |- mesh__recordMaintainer mesh__D022362 ssb
% 216.88/217.09  |- mesh__publicMeSHNote mesh__D022362
% 216.88/217.09       2001; Hepatitis A Vaccine was indexed under VIRAL HEPATITIS VACCINES 1992-2000%A%  
% 216.88/217.09  |- skos__hiddenLabel mesh__D022362 Vaccines, Hepatovirus
% 216.88/217.09  |- skos__hiddenLabel mesh__D022362 Vaccines, Hepatitis A
% 216.88/217.09  |- mesh__dateRevised mesh__D022362 2005-06-30
% 216.88/217.09  |- skos__altLabel mesh__D016325 Human Immunodeficiency Virus LTR
% 216.88/217.09  |- skos__historyNote mesh__D016325
% 216.88/217.09       Repetitive Sequences, Nucleic Acid %28%1986-1990%29%
% 216.88/217.09  |- mesh__recordOriginator mesh__D016325 AGS
% 216.88/217.09  |- rdf__type mesh__D016325sskos__Concept
% 216.88/217.09  |- skos__related mesh__D016325smesh__D015696
% 216.88/217.09  |- mesh__recordMaintainer mesh__D016325 NLM
% 216.88/217.09  |- skos__altLabel mesh__D016325 LTR, Human Immunodeficiency Virus
% 216.88/217.09  |- skos__altLabel mesh__D016325 TAR Element, HIV
% 216.88/217.09  |- skos__altLabel mesh__D016325 Trans-Activation Responsive Region, HIV
% 216.88/217.09  |- skos__hiddenLabel mesh__D016325 TAR Elements, HIV
% 216.88/217.09  |- skos__scopeNote mesh__D016325
% 216.88/217.09       Regulatory sequences important for viral replication that are located on each end of the HIV genome. The LTR includes the HIV ENHANCER, promoter, and other sequences. Specific regions in the LTR include the negative regulatory element %28%NRE%29%, NF-kappa B binding sites , Sp1 binding sites, TATA BOX, and trans-acting responsive element %28%TAR%29%. The binding of both cellular and viral proteins to these regions regulates HIV transcription.%A%    
% 216.88/217.09  |- skos__altLabel mesh__D016325 HIV Trans-Acting Responsive Region
% 216.88/217.09  |- skos__hiddenLabel mesh__D016325 Trans Activation Responsive Region, HIV
% 216.88/217.09  |- skos__hiddenLabel mesh__D016325 Trans Activation Responsive Element, HIV
% 216.88/217.09  |- skos__hiddenLabel mesh__D016325 Sp1-Binding Sites, HIV
% 216.88/217.09  |- mesh__dateCreated mesh__D016325 1990-06-28
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D016325 2006
% 216.88/217.09  |- skos__hiddenLabel mesh__D016325 HIV TAR Elements
% 216.88/217.09  |- skos__broader mesh__D016325smesh__D020079
% 216.88/217.09  |- skos__annotation mesh__D016325 DF: HIV LTR or HIV TAR   
% 216.88/217.09  |- skos__related mesh__D016325smesh__D016329
% 216.88/217.09  |- mesh__dateEstablished mesh__D016325 1991-01-01
% 216.88/217.09  |- skos__related mesh__D016325smesh__D015693
% 216.88/217.09  |- skos__related mesh__D016325smesh__D016322
% 216.88/217.09  |- skos__hiddenLabel mesh__D016325 HIV Sp1 Binding Site
% 216.88/217.09  |- mesh__historyNote mesh__D016325 91   
% 216.88/217.09  |- skos__altLabel mesh__D016325 HIV Negative Regulatory Element
% 216.88/217.09  |- mesh__dateRevised mesh__D016325 2005-07-06
% 216.88/217.09  |- skos__hiddenLabel mesh__D016325 Sp1 Binding Site, HIV
% 216.88/217.09  |- skos__hiddenLabel mesh__D016325 HIV Sp1-Binding Sites
% 216.88/217.09  |- skos__hiddenLabel mesh__D016325 Trans Acting Responsive Region, HIV
% 216.88/217.09  |- skos__altLabel mesh__D016325 Trans-Activation Responsive Element, HIV
% 216.88/217.09  |- mesh__publicMeSHNote mesh__D016325 91   
% 216.88/217.09  |- skos__hiddenLabel mesh__D016325 HIV 1 LTR
% 216.88/217.09  |- skos__hiddenLabel mesh__D016325 LTR, HIV-1
% 216.88/217.09  |- skos__altLabel mesh__D016325 HIV Sp1-Binding Site
% 216.88/217.09  |- skos__altLabel mesh__D016325 Long Terminal Repeat, HIV
% 216.88/217.09  |- skos__altLabel mesh__D016325
% 216.88/217.09       Human Immunodeficiency Virus Long Terminal Repeat
% 216.88/217.09  |- mesh__recordAuthorizer mesh__D016325 NLM
% 216.88/217.09  |- skos__hiddenLabel mesh__D016325 HIV TAR Element
% 216.88/217.09  |- skos__prefLabel mesh__D016325 HIV Long Terminal Repeat
% 216.88/217.09  |- skos__hiddenLabel mesh__D016325 HIV Trans Acting Responsive Region
% 216.88/217.09  |- skos__hiddenLabel mesh__D002305 Cardiac Tamponades
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002305 1991
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002305 2006
% 216.88/217.09  |- skos__prefLabel mesh__D002305 Cardiac Tamponade
% 216.88/217.09  |- skos__annotation mesh__D002305
% 216.88/217.09       compression of heart from pericardial effusion or hemopericardium%A%  
% 216.88/217.09  |- mesh__recordOriginator mesh__D002305 NLM
% 216.88/217.09  |- mesh__recordAuthorizer mesh__D002305 NLM
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002305 1997
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002305 2002
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002305 1992
% 216.88/217.09  |- skos__broader mesh__D002305smesh__D006331
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002305 1998
% 216.88/217.09  |- rdf__type mesh__D002305sskos__Concept
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002305 2003
% 216.88/217.09  |- skos__hiddenLabel mesh__D002305 Tamponade, Cardiac
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002305 1993
% 216.88/217.09  |- skos__hiddenLabel mesh__D002305 Tamponades, Cardiac
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002305 1999
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002305 2004
% 216.88/217.09  |- mesh__dateCreated mesh__D002305 1999-01-01
% 216.88/217.09  |- mesh__dateRevised mesh__D002305 1990-05-29
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002305 1994
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002305 2000
% 216.88/217.09  |- mesh__recordMaintainer mesh__D002305 PLS
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002305 2005
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002305 1995
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002305 1996
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002305 2001
% 216.88/217.09  |- skos__broader mesh__D007599smesh__D012067
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D007599 2003
% 216.88/217.09  |- skos__related mesh__D007599smesh__D007585
% 216.88/217.09  |- mesh__recordAuthorizer mesh__D007599 sjn
% 216.88/217.09  |- mesh__dateCreated mesh__D007599 1999-01-01
% 216.88/217.09  |- skos__hiddenLabel mesh__D007599 Jewish Ethic
% 216.88/217.09  |- skos__scopeNote mesh__D007599
% 216.88/217.09       The religion of the Jews characterized by belief in one God and in the mission of the Jews to teach the Fatherhood of God as revealed in the Hebrew Scriptures. %28%Webster, 3d ed%29%%A%    
% 216.88/217.09  |- skos__hiddenLabel mesh__D007599 Ethic, Jewish
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D007599 2004
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D007599 2002
% 216.88/217.09  |- rdf__type mesh__D007599sskos__Concept
% 216.88/217.09  |- skos__annotation mesh__D007599
% 216.88/217.09       the religion: JEWS are the ethnic group; specify geog if pertinent%A%  
% 216.88/217.09  |- skos__prefLabel mesh__D007599 Judaism
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D007599 2005
% 216.88/217.09  |- mesh__dateRevised mesh__D007599 1999-11-03
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D007599 2000
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D007599 2006
% 216.88/217.09  |- skos__hiddenLabel mesh__D007599 Ethics, Jewish
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D007599 2001
% 216.88/217.09  |- mesh__recordMaintainer mesh__D007599 kle
% 216.88/217.09  |- mesh__recordOriginator mesh__D007599 NLM
% 216.88/217.09  |- skos__broader mesh__D012733smesh__D046468
% 216.88/217.09  |- mesh__dateRevised mesh__D012733 2005-07-29
% 216.88/217.09  |- skos__prefLabel mesh__D012733 Sex Differentiation
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D012733 2006A
% 216.88/217.09  |- mesh__recordMaintainer mesh__D012733 ags
% 216.88/217.09  |- skos__related mesh__D012733smesh__D019849
% 216.88/217.09  |- skos__scopeNote mesh__D012733
% 216.88/217.09       Differentiation of male and female tissues and organs during embryogenesis, but after sex determination %28%SEX DETERMINATION %28%GENETICS%29%;%29%.%A%    
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D012733 2006
% 216.88/217.09  |- mesh__dateCreated mesh__D012733 1974-11-11
% 216.88/217.09  |- skos__annotation mesh__D012733
% 216.88/217.09       do not confuse with related sex concepts: see note under SEX CHARACTERISTICS; DF: SEX DIFFER%A%  
% 216.88/217.09  |- mesh__dateEstablished mesh__D012733 1975-09-01
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D012733 2005
% 216.88/217.09  |- skos__altLabel mesh__D012733 Differentiation, Sex
% 216.88/217.09  |- rdf__type mesh__D012733sskos__Concept
% 216.88/217.09  |- mesh__publicMeSHNote mesh__D012733 75   
% 216.88/217.09  |- skos__historyNote mesh__D012733 Gonads/embryology %28%1966-1974%29%
% 216.88/217.09  |- mesh__recordAuthorizer mesh__D012733 ags
% 216.88/217.09  |- mesh__historyNote mesh__D012733 75   
% 216.88/217.09  |- skos__broader mesh__D012733smesh__D005314
% 216.88/217.09  |- mesh__recordOriginator mesh__D012733 NLM
% 216.88/217.09  |- skos__altLabel mesh__D036383 Cek7 Ligand
% 216.88/217.09  |- skos__altLabel mesh__D036383 ELF-1 Protein, Mammalian
% 216.88/217.09  |- skos__hiddenLabel mesh__D036383 Mammalian ELF-1 Protein
% 216.88/217.09  |- skos__hiddenLabel mesh__D036383 RPTK Ligand, Cek7
% 216.88/217.09  |- skos__hiddenLabel mesh__D036383 ELF 1 Protein, Mammalian
% 216.88/217.09  |- skos__altLabel mesh__D036383 Cek7 RPTK Ligand
% 216.88/217.09  |- rdf__type mesh__D036383sskos__Concept
% 216.88/217.09  |- mesh__publicMeSHNote mesh__D036383
% 216.88/217.09       2003; LERK-6 PROTEIN %28%now EPHRIN-A2%29% was indexed under TRANSCRIPTION FACTORS 1998-2002; EPH LIGAND FAMILY 1 PROTEIN, MAMMALIAN %28%now EPHRIN-A2%29% was indexed under TRANSCRIPTION FACTORS 1998-2002, PROTEINS 1994-1997%A%  
% 216.88/217.09  |- skos__altLabel mesh__D036383 Eph Ligand Family 1 Protein, Mammalian
% 216.88/217.09  |- skos__hiddenLabel mesh__D036383 Ligand, Cek7 RPTK
% 216.88/217.09  |- mesh__dateEstablished mesh__D036383 2003-01-01
% 216.88/217.09  |- skos__hiddenLabel mesh__D036383 LERK 6 Protein
% 216.88/217.09  |- skos__historyNote mesh__D036383 Transcription Factors %28%1998-2002%29%
% 216.88/217.09  |- skos__prefLabel mesh__D036383 Ephrin-A2
% 216.88/217.09  |- mesh__dateRevised mesh__D036383 2005-06-30
% 216.88/217.09  |- mesh__historyNote mesh__D036383
% 216.88/217.09       2003; use EPHRIN-A2 %28%NM%29% 1994-2002   
% 216.88/217.09  |- skos__scopeNote mesh__D036383
% 216.88/217.09       A GLYCOINOSITOL PHOSPHOLIPID MEMBRANE ANCHOR-containing ephrin with a high affinity for the EPHA3 RECEPTOR.  Early in embryogenesis it is expressed at high levels in the MESENCEPHALON; SOMITES; branchial arches, and LIMB BUD.%A%    
% 216.88/217.09  |- skos__historyNote mesh__D036383 Proteins %28%1994-1997%29%
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D036383 2006
% 216.88/217.09  |- mesh__dateCreated mesh__D036383 2002-07-03
% 216.88/217.09  |- skos__hiddenLabel mesh__D036383 Ligand, Cek7
% 216.88/217.09  |- skos__altLabel mesh__D036383 EPLG6 Gene Product
% 216.88/217.09  |- skos__hiddenLabel mesh__D036383 Ephrin A2
% 216.88/217.09  |- skos__broader mesh__D036383smesh__D036342
% 216.88/217.09  |- mesh__recordMaintainer mesh__D036383 ssb
% 216.88/217.09  |- mesh__recordOriginator mesh__D036383 jmp
% 216.88/217.09  |- skos__altLabel mesh__D036383 LERK-6 Protein
% 216.88/217.09  |- mesh__recordAuthorizer mesh__D036383 sjn
% 216.88/217.09  |- skos__hiddenLabel mesh__D008692 Levo alpha Acetylmethadol
% 216.88/217.09  |- mesh__publicMeSHNote mesh__D008692
% 216.88/217.09       91; was see under METHADONE 1975-90   
% 216.88/217.09  |- skos__hiddenLabel mesh__D008692 Hydrochloride, Levomethadyl Acetate
% 216.88/217.09  |- skos__hiddenLabel mesh__D008692 Acetate Hydrochloride, Levomethadyl
% 216.88/217.09  |- skos__altLabel mesh__D008692 N-LAMM
% 216.88/217.09  |- skos__historyNote mesh__D008692 Methadone %28%1973-1974%29%
% 216.88/217.09  |- skos__altLabel mesh__D008692 Levomethadyl Acetate
% 216.88/217.09  |- skos__altLabel mesh__D008692 Alphacetylmethadol
% 216.88/217.09  |- skos__altLabel mesh__D008692 LAAM
% 216.88/217.09  |- skos__hiddenLabel mesh__D008692 N LAMM
% 216.88/217.09  |- mesh__recordAuthorizer mesh__D008692 sjn
% 216.88/217.09  |- skos__altLabel mesh__D008692 Acetylmethadol
% 216.88/217.09  |- skos__altLabel mesh__D008692
% 216.88/217.09       6-%28%Dimethylamino%29%-4,4-Diphenyl-3-Heptanol Acetate
% 216.88/217.09  |- mesh__dateRevised mesh__D008692 2004-07-07
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D008692 2005
% 216.88/217.09  |- skos__historyNote mesh__D008692 Acetic Acids %28%1973-1974%29%
% 216.88/217.09  |- skos__prefLabel mesh__D008692 Methadyl Acetate
% 216.88/217.09  |- skos__broader mesh__D008692smesh__D008691
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D008692 2006
% 216.88/217.09  |- skos__hiddenLabel mesh__D008692 Acetate, Levomethadyl
% 216.88/217.09  |- mesh__dateCreated mesh__D008692 1974-11-19
% 216.88/217.09  |- skos__scopeNote mesh__D008692
% 216.88/217.09       A narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence.%A%    
% 216.88/217.09  |- skos__altLabel mesh__D008692 Levo-alpha-Acetylmethadol
% 216.88/217.09  |- mesh__dateEstablished mesh__D008692 1991-01-01
% 216.88/217.09  |- skos__hiddenLabel mesh__D008692 Acetate, Methadyl
% 216.88/217.09  |- skos__altLabel mesh__D008692 Levamethadyl
% 216.88/217.09  |- skos__altLabel mesh__D008692
% 216.88/217.09       Roxane Brand of Levomethadyl Acetate Hydrochloride
% 216.88/217.09  |- mesh__recordMaintainer mesh__D008692 CCR
% 216.88/217.09  |- rdf__type mesh__D008692sskos__Concept
% 216.88/217.09  |- mesh__recordOriginator mesh__D008692 NLM
% 216.88/217.09  |- mesh__historyNote mesh__D008692
% 216.88/217.09       91%28%75%29%; was see under METHADONE 1975-90   
% 216.88/217.09  |- skos__historyNote mesh__D016326 Extracellular Matrix %28%1984-1990%29%
% 216.88/217.09  |- skos__prefLabel mesh__D016326 Extracellular Matrix Proteins
% 216.88/217.09  |- rdf__type mesh__D016326sskos__Concept
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D016326 2006A
% 216.88/217.09  |- mesh__historyNote mesh__D016326 91   
% 216.88/217.09  |- mesh__dateRevised mesh__D016326 2005-07-14
% 216.88/217.09  |- mesh__recordOriginator mesh__D016326 MXR
% 216.88/217.09  |- mesh__recordAuthorizer mesh__D016326 ags
% 216.88/217.09  |- skos__annotation mesh__D016326 /drug eff /ultrastruct permitted   
% 216.88/217.09  |- skos__broader mesh__D016326smesh__D012596
% 216.88/217.09  |- skos__scopeNote mesh__D016326
% 216.88/217.09       Macromolecular organic compounds that contain carbon, hydrogen, oxygen, nitrogen, and usually, sulfur. These macromolecules %28%proteins%29% form an intricate meshwork in which cells are embedded to construct tissues. Variations in the relative types of macromolecules and their organization determine the type of extracellular matrix, each adapted to the functional requirements of the tissue. The two main classes of macromolecules that form the extracellular matrix are: glycosaminoglycans, usually linked to proteins %28%proteoglycans%29%, and fibrous proteins %28%e.g., COLLAGEN; ELASTIN; FIBRONECTINS; and LAMININ%29%.%A%    
% 216.88/217.09  |- skos__related mesh__D016326smesh__D016024
% 216.88/217.09  |- skos__hiddenLabel mesh__D016326 Proteins, Extracellular Matrix
% 216.88/217.09  |- mesh__recordMaintainer mesh__D016326 ags
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D016326 2006
% 216.88/217.09  |- mesh__dateEstablished mesh__D016326 1991-01-01
% 216.88/217.09  |- mesh__dateCreated mesh__D016326 1990-06-17
% 216.88/217.09  |- skos__hiddenLabel mesh__D016326 Matrix Proteins, Extracellular
% 216.88/217.09  |- mesh__publicMeSHNote mesh__D016326 91   
% 216.88/217.09  |- skos__broader mesh__D002306smesh__D045472
% 216.88/217.09  |- skos__hiddenLabel mesh__D002306 Volume, Cardiac
% 216.88/217.09  |- mesh__recordAuthorizer mesh__D002306 sjn
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002306 2006
% 216.88/217.09  |- skos__hiddenLabel mesh__D002306 Cardiac Volumes
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002306 2005
% 216.88/217.09  |- skos__hiddenLabel mesh__D002306 Volume, Heart
% 216.88/217.09  |- mesh__dateCreated mesh__D002306 1999-01-01
% 216.88/217.09  |- mesh__recordOriginator mesh__D002306 NLM
% 216.88/217.09  |- mesh__publicMeSHNote mesh__D002306 72   
% 216.88/217.09  |- skos__related mesh__D002306smesh__D013318
% 216.88/217.09  |- mesh__historyNote mesh__D002306 72%28%68%29%   
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002306 2004
% 216.88/217.09  |- rdf__type mesh__D002306sskos__Concept
% 216.88/217.09  |- mesh__dateRevised mesh__D002306 2003-07-09
% 216.88/217.09  |- skos__hiddenLabel mesh__D002306 Volumes, Heart
% 216.88/217.09  |- mesh__recordMaintainer mesh__D002306 nns
% 216.88/217.09  |- skos__historyNote mesh__D002306 Heart/physiology %28%1966-1967%29%
% 216.88/217.09  |- mesh__dateEstablished mesh__D002306 1972-01-01
% 216.88/217.09  |- skos__scopeNote mesh__D002306
% 216.88/217.09       The volume of the HEART, usually relating to the volume of BLOOD contained within it at various periods of the cardiac cycle. The amount of blood ejected from a ventricle at each beat is STROKE VOLUME.%A%    
% 216.88/217.09  |- skos__altLabel mesh__D002306 Heart Volume
% 216.88/217.09  |- skos__historyNote mesh__D002306 Cardiac Output %28%1966-1967%29%
% 216.88/217.09  |- skos__hiddenLabel mesh__D002306 Heart Volumes
% 216.88/217.09  |- skos__hiddenLabel mesh__D002306 Volumes, Cardiac
% 216.88/217.09  |- skos__prefLabel mesh__D002306 Cardiac Volume
% 216.88/217.09  |- skos__historyNote mesh__D048408 Algae %28%1965-1971%29%
% 216.88/217.09  |- mesh__recordAuthorizer mesh__D048408 sjn
% 216.88/217.09  |- skos__historyNote mesh__D048408 Chlorella %28%1971-2004%29%
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D048408 2006
% 216.88/217.09  |- mesh__recordMaintainer mesh__D048408 SYSTEM
% 216.88/217.09  |- rdf__type mesh__D048408sskos__Concept
% 216.88/217.09  |- skos__prefLabel mesh__D048408 Chlorella vulgaris
% 216.88/217.09  |- mesh__dateRevised mesh__D048408 2005-06-30
% 216.88/217.09  |- mesh__dateEstablished mesh__D048408 2005-01-01
% 216.88/217.09  |- skos__scopeNote mesh__D048408
% 216.88/217.09       A species of green microalgae in the family Chlorellaceae. It is used as a model organism for PHOTOSYNTHESIS, and as a food supplement %28%DIETARY SUPPLEMENTS%29%.%A%    
% 216.88/217.09  |- mesh__historyNote mesh__D048408 2005   
% 216.88/217.09  |- mesh__dateCreated mesh__D048408 2004-07-07
% 216.88/217.09  |- skos__broader mesh__D048408smesh__D002708
% 216.88/217.09  |- mesh__publicMeSHNote mesh__D048408 2005   
% 216.88/217.09  |- mesh__recordOriginator mesh__D048408 ags
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D012734 2006
% 216.88/217.09  |- mesh__recordOriginator mesh__D012734 NLM
% 216.88/217.09  |- mesh__recordAuthorizer mesh__D012734 sjn
% 216.88/217.09  |- mesh__recordMaintainer mesh__D012734 sjn
% 216.88/217.09  |- skos__hiddenLabel mesh__D012734 Disorders, Sexual Differentiation
% 216.88/217.09  |- rdf__type mesh__D012734sskos__Concept
% 216.88/217.09  |- skos__hiddenLabel mesh__D012734 Sexual Differentiation Disorder
% 216.88/217.09  |- skos__hiddenLabel mesh__D012734 Disorder, Sex Differentiation
% 216.88/217.09  |- skos__hiddenLabel mesh__D012734 Differentiation Disorders, Sex
% 216.88/217.09  |- skos__hiddenLabel mesh__D012734 Disorders, Sex Differentiation
% 216.88/217.09  |- skos__annotation mesh__D012734
% 216.88/217.09       organic in nature: differentiate from SEXUAL DYSFUNCTION, PHYSIOLOGICAL %28%related to coitus%29%; DF: SEX DIFFER DIS%A%  
% 216.88/217.09  |- skos__altLabel mesh__D012734 Sexual Differentiation Disorders
% 216.88/217.09  |- skos__hiddenLabel mesh__D012734 Differentiation Disorder, Sexual
% 216.88/217.09  |- mesh__dateRevised mesh__D012734 2005-07-01
% 216.88/217.09  |- skos__hiddenLabel mesh__D012734 Disorder, Sexual Differentiation
% 216.88/217.09  |- skos__hiddenLabel mesh__D012734 Differentiation Disorders, Sexual
% 216.88/217.09  |- skos__broader mesh__D012734smesh__D006058
% 216.88/217.09  |- skos__broader mesh__D012734smesh__D014564
% 216.88/217.09  |- mesh__dateCreated mesh__D012734 1999-01-01
% 216.88/217.09  |- skos__hiddenLabel mesh__D012734 Differentiation Disorder, Sex
% 216.88/217.09  |- skos__scopeNote mesh__D012734
% 216.88/217.09       Abnormalities in development of the GONADS, the genital tracts, and the external GENITALIA. Disorders of sexual differentiation are due to genetic defects or endocrine imbalance. Sex-determining genes %28%GENE, SRY%29% dictate the gonadal SEX whereas the fetal TESTICULAR HORMONES determine the somatic sex during SEX DIFFERENTIATION.%A%    
% 216.88/217.09  |- skos__prefLabel mesh__D012734 Sex Differentiation Disorders
% 216.88/217.09  |- skos__hiddenLabel mesh__D012734 Sex Differentiation Disorder
% 216.88/217.09  |- skos__related mesh__D012734smesh__D014189
% 216.88/217.09  |- skos__altLabel mesh__D036384 LERK-3
% 216.88/217.09  |- skos__altLabel mesh__D036384 EPLG3
% 216.88/217.09  |- mesh__dateCreated mesh__D036384 2002-07-03
% 216.88/217.09  |- skos__scopeNote mesh__D036384
% 216.88/217.09       A GLYCOINOSITOL PHOSPHOLIPID MEMBRANE ANCHOR containing ephrin with a high affinity for the EPHA3 RECEPTOR; EPHA5 RECEPTOR; EPHA6 RECEPTOR; EPHA7 RECEPTOR; and EPHA8 RECEPTOR. It is found primarily in NERVE TISSUE.%A%    
% 216.88/217.09  |- skos__historyNote mesh__D036384 Membrane Proteins %28%1995-2002%29%
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D036384 2006
% 216.88/217.09  |- mesh__recordOriginator mesh__D036384 jmp
% 216.88/217.09  |- skos__altLabel mesh__D036384 Epl3 %28%Protein%29%
% 216.88/217.09  |- skos__prefLabel mesh__D036384 Ephrin-A3
% 216.88/217.09  |- mesh__recordMaintainer mesh__D036384 ssb
% 216.88/217.09  |- mesh__dateEstablished mesh__D036384 2003-01-01
% 216.88/217.09  |- skos__hiddenLabel mesh__D036384 LERK 3
% 216.88/217.09  |- mesh__recordAuthorizer mesh__D036384 sjn
% 216.88/217.09  |- skos__hiddenLabel mesh__D036384 Ephrin A3
% 216.88/217.09  |- skos__broader mesh__D036384smesh__D036342
% 216.88/217.09  |- skos__hiddenLabel mesh__D036384 LERK 3 Protein
% 216.88/217.09  |- mesh__publicMeSHNote mesh__D036384
% 216.88/217.09       2003; LERK-3 PROTEIN %28%now EPHRIN-A3%29% was indexed under MEMBRANE PROTEINS 1995-2002%A%  
% 216.88/217.09  |- rdf__type mesh__D036384sskos__Concept
% 216.88/217.09  |- mesh__historyNote mesh__D036384
% 216.88/217.09       2003; use EPHRIN-A3 %28%NM%29% 1995-2002   
% 216.88/217.09  |- mesh__dateRevised mesh__D036384 2005-06-30
% 216.88/217.09  |- skos__altLabel mesh__D036384 LERK-3 Protein
% 216.88/217.09  |- mesh__historyNote mesh__D008693
% 216.88/217.09       91%28%75%29%; was see under THIOUREA 1975-90   
% 216.88/217.09  |- mesh__recordMaintainer mesh__D008693 CCR
% 216.88/217.09  |- skos__broader mesh__D008693smesh__D013890
% 216.88/217.09  |- skos__scopeNote mesh__D008693
% 216.88/217.09       A dithiobiurea compound with anti-gonadotropic activity.%A%    
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D008693 2005
% 216.88/217.09  |- mesh__recordOriginator mesh__D008693 NLM
% 216.88/217.09  |- mesh__dateCreated mesh__D008693 1974-11-11
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D008693 2001
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D008693 2006
% 216.88/217.09  |- skos__altLabel mesh__D008693 Metallibure
% 216.88/217.09  |- mesh__recordAuthorizer mesh__D008693 sjn
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D008693 2002
% 216.88/217.09  |- mesh__dateEstablished mesh__D008693 1991-01-01
% 216.88/217.09  |- skos__hiddenLabel mesh__D008693 ICI33,828
% 216.88/217.09  |- rdf__type mesh__D008693sskos__Concept
% 216.88/217.09  |- skos__hiddenLabel mesh__D008693 ICI 33,828
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D008693 2003
% 216.88/217.09  |- skos__altLabel mesh__D008693 Metallibur
% 216.88/217.09  |- mesh__publicMeSHNote mesh__D008693 91; was see under THIOUREA 1975-90   
% 216.88/217.09  |- skos__prefLabel mesh__D008693 Methallibure
% 216.88/217.09  |- skos__historyNote mesh__D008693 Thiourea %28%1973-1974%29%
% 216.88/217.09  |- mesh__dateRevised mesh__D008693 2000-06-21
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D008693 2004
% 216.88/217.09  |- skos__historyNote mesh__D008693 Allyl Compounds %28%1973-1974%29%
% 216.88/217.09  |- skos__historyNote mesh__D002307
% 216.88/217.09       Plethysmography, Impedance %28%1966-1978%29%
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002307 2006
% 216.88/217.09  |- skos__hiddenLabel mesh__D002307 Cardiographies, Impedance
% 216.88/217.09  |- skos__altLabel mesh__D002307 Plethysmography, Impedance, Transthoracic
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002307 2002
% 216.88/217.09  |- skos__broader mesh__D002307smesh__D006334
% 216.88/217.09  |- skos__historyNote mesh__D002307 Cardiac Output %28%1966-1978%29%
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002307 2005
% 216.88/217.09  |- skos__broader mesh__D002307smesh__D010992
% 216.88/217.09  |- skos__hiddenLabel mesh__D002307
% 216.88/217.09       Plethysmographies, Transthoracic Impedance
% 216.88/217.09  |- skos__hiddenLabel mesh__D002307 Transthoracic Impedances
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002307 2001
% 216.88/217.09  |- mesh__recordOriginator mesh__D002307 SMH
% 216.88/217.09  |- mesh__dateEstablished mesh__D002307 1991-01-01
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002307 2004
% 216.88/217.09  |- rdf__type mesh__D002307sskos__Concept
% 216.88/217.09  |- skos__hiddenLabel mesh__D002307 Impedances, Transthoracic
% 216.88/217.09  |- skos__altLabel mesh__D002307 Transthoracic Impedance Plethysmography
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002307 2000
% 216.88/217.09  |- skos__prefLabel mesh__D002307 Cardiography, Impedance
% 216.88/217.09  |- skos__hiddenLabel mesh__D002307
% 216.88/217.09       Impedance Plethysmographies, Transthoracic
% 216.88/217.09  |- skos__altLabel mesh__D002307 Impedance Plethysmography, Transthoracic
% 216.88/217.09  |- skos__altLabel mesh__D002307 Impedance Cardiography
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002307 1999
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002307 2003
% 216.88/217.09  |- skos__scopeNote mesh__D002307
% 216.88/217.09       A type of impedance plethysmography in which bioelectrical impedance is measured between electrodes positioned around the neck and around the lower thorax. It is used principally to calculate stroke volume and cardiac volume, but it is also related to myocardial contractility, thoracic fluid content, and circulation to the extremities.%A%    
% 216.88/217.09  |- mesh__dateCreated mesh__D002307 1977-11-23
% 216.88/217.09  |- mesh__publicMeSHNote mesh__D002307
% 216.88/217.09       91; was see under PLETHYSMOGRAPHY, IMPEDANCE 1979-90   
% 216.88/217.09  |- skos__annotation mesh__D002307
% 216.88/217.09       NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: CARDIOGR IMPEDANCE%A%  
% 216.88/217.09  |- mesh__dateRevised mesh__D002307 1997-06-20
% 216.88/217.09  |- skos__hiddenLabel mesh__D002307 Impedance Cardiographies
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D002307 1998
% 216.88/217.09  |- skos__altLabel mesh__D002307 Plethysmography, Transthoracic Impedance
% 216.88/217.09  |- mesh__historyNote mesh__D002307
% 216.88/217.09       91%28%79%29%; was see under PLETHYSMOGRAPHY, IMPEDANCE 1979-90   
% 216.88/217.09  |- mesh__recordAuthorizer mesh__D002307 SJN
% 216.88/217.09  |- skos__hiddenLabel mesh__D002307
% 216.88/217.09       Transthoracic Impedance Plethysmographies
% 216.88/217.09  |- skos__hiddenLabel mesh__D002307 Transthoracic Impedance
% 216.88/217.09  |- skos__altLabel mesh__D002307 Impedance, Transthoracic
% 216.88/217.09  |- mesh__recordMaintainer mesh__D002307 PXP
% 216.88/217.09  |- mesh__recordMaintainer mesh__D048409 SYSTEM
% 216.88/217.09  |- skos__scopeNote mesh__D048409
% 216.88/217.09       A species of gram-negative bacteria, in the family Aeromonadaceae. It is strictly parasitic and often pathogenic causing FURUNCULOSIS in SALMONIDS and ulcer disease in GOLDFISH.%A%    
% 216.88/217.09  |- skos__annotation mesh__D048409
% 216.88/217.09       infection: coordinate IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29% and FURUNCULOSIS %28%IM%29% if pertinent%A%  
% 216.88/217.09  |- mesh__historyNote mesh__D048409 2005   
% 216.88/217.09  |- mesh__recordOriginator mesh__D048409 ags
% 216.88/217.09  |- mesh__dateCreated mesh__D048409 2004-07-07
% 216.88/217.09  |- mesh__recordAuthorizer mesh__D048409 sjn
% 216.88/217.09  |- mesh__publicMeSHNote mesh__D048409 2005   
% 216.88/217.09  |- skos__historyNote mesh__D048409 Aeromonas %28%1966-2004%29%
% 216.88/217.09  |- mesh__dateEstablished mesh__D048409 2005-01-01
% 216.88/217.09  |- mesh__activeMeSHYear mesh__D048409 2006
% 216.88/217.09  |- rdf__type mesh__D048409sskos__Concept
% 216.88/217.09  |- skos__broader mesh__D048409smesh__D000333
% 216.88/217.09  |- mesh__dateRevised mesh__D048409 2005-06-30
% 216.88/217.09  |- skos__prefLabel mesh__D048409 Aeromonas salmonicida
% 216.88/217.09  |- skos__scopeNote mesh__D012735
% 216.88/217.09       Physiological disturbances in normal sexual performance in either the male or the female.%A%    
% 216.88/217.09  |- mesh__publicMeSHNote mesh__D012735 2006; see SEX DISORDERS 1963-2005   
% 216.88/217.09  |- skos__hiddenLabel mesh__D012735 Physiological Sexual Disorders
% 216.88/217.09  |- mesh__dateCreated mesh__D012735 1999-01-01
% 216.88/217.09  |- skos__broader mesh__D012735smesh__D005831
% 216.88/217.09  |- mesh__recordAuthorizer mesh__D012735 sjn
% 216.88/217.09  |- skos__prefLabel mesh__D012735 Sexual Dysfunction, Physiological
% 216.88/217.10  |- skos__hiddenLabel mesh__D012735 Physiological Sexual Disorder
% 216.88/217.10  |- skos__hiddenLabel mesh__D012735 Physiological Sexual Dysfunction
% 216.88/217.10  |- mesh__recordOriginator mesh__D012735 NLM
% 216.88/217.10  |- skos__altLabel mesh__D012735 Sexual Dysfunctions, Physiological
% 216.88/217.10  |- skos__hiddenLabel mesh__D012735 Sexual Disorder, Physiological
% 216.88/217.10  |- mesh__activeMeSHYear mesh__D012735 2006
% 216.88/217.10  |- mesh__dateRevised mesh__D012735 2005-06-30
% 216.88/217.10  |- skos__annotation mesh__D012735
% 216.88/217.10       related to coitus: differentiate from SEX DIFFERENTIATION DISORDERS %28%gonadal%29%%A%  
% 216.88/217.10  |- skos__broader mesh__D012735smesh__D005832
% 216.88/217.10  |- skos__altLabel mesh__D012735 Sex Disorders
% 216.88/217.10  |- rdf__type mesh__D012735sskos__Concept
% 216.88/217.10  |- skos__hiddenLabel mesh__D012735 Physiological Sexual Dysfunctions
% 216.88/217.10  |- mesh__historyNote mesh__D012735 2006 %28%1963%29%   
% 216.88/217.10  |- mesh__recordMaintainer mesh__D012735 lkt
% 216.88/217.10  |- skos__altLabel mesh__D012735 Sexual Disorders, Physiological
% 216.88/217.10  |- mesh__activeMeSHYear mesh__D036385 2006
% 216.88/217.10  |- mesh__dateRevised mesh__D036385 2005-06-30
% 216.88/217.10  |- skos__altLabel mesh__D036385 EPLG4
% 216.88/217.10  |- skos__hiddenLabel mesh__D036385 LERK 4 Protein
% 216.88/217.10  |- skos__hiddenLabel mesh__D036385 Ephrin A4
% 216.88/217.10  |- skos__altLabel mesh__D036385 Epl4 Protein
% 216.88/217.10  |- skos__broader mesh__D036385smesh__D036342
% 216.88/217.10  |- skos__prefLabel mesh__D036385 Ephrin-A4
% 216.88/217.10  |- mesh__dateCreated mesh__D036385 2002-07-03
% 216.88/217.10  |- skos__scopeNote mesh__D036385
% 216.88/217.10       A GLYCOINOSITOL PHOSPHOLIPID MEMBRANE ANCHOR containing ephrin found in variety of adult tissue such as KIDNEY; LUNG; COLON and OVARY. During embryonic development, ephrin-A4 is expressed in the HIPPOCAMPUS and CEREBRAL CORTEX. It binds preferentially to ephA receptors %28%EPH FAMILY RECEPTORS%29% with the exception of the EPHA1 RECEPTOR.%A%    
% 216.88/217.10  |- mesh__publicMeSHNote mesh__D036385
% 216.88/217.10       2003; LERK-4 PROTEIN %28%now EPHRIN-A4%29% was indexed under MEMBRANE PROTEINS 1995-2002%A%  
% 216.88/217.10  |- mesh__recordOriginator mesh__D036385 jmp
% 216.88/217.10  |- skos__historyNote mesh__D036385 Membrane Proteins %28%1995-2002%29%
% 216.88/217.10  |- mesh__recordMaintainer mesh__D036385 ssb
% 216.88/217.10  |- rdf__type mesh__D036385sskos__Concept
% 216.88/217.10  |- skos__altLabel mesh__D036385 LERK-4 Protein
% 216.88/217.10  |- mesh__dateEstablished mesh__D036385 2003-01-01
% 216.88/217.10  |- mesh__recordAuthorizer mesh__D036385 sjn
% 216.96/217.10  |- skos__altLabel mesh__D036385 LERK-4
% 216.96/217.10  |- mesh__historyNote mesh__D036385
% 216.96/217.10       2003; use EPHRIN-A4 %28%NM%29% 1995-2002   
% 216.96/217.10  |- skos__broader mesh__D003400smesh__D033364
% 216.96/217.10  |- skos__prefLabel mesh__D003400 Astacoidea
% 216.96/217.10  |- rdf__type mesh__D003400sskos__Concept
% 216.96/217.10  |- mesh__publicMeSHNote mesh__D003400 2003; see CRAYFISH 1972-2002   
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D003400 2004
% 216.96/217.10  |- mesh__historyNote mesh__D003400 2003 %28%1972%29%   
% 216.96/217.10  |- mesh__recordOriginator mesh__D003400 NLM
% 216.96/217.10  |- skos__historyNote mesh__D003400 Crustacea %28%1966-1971%29%
% 216.96/217.10  |- mesh__dateRevised mesh__D003400 2003-07-09
% 216.96/217.10  |- mesh__recordMaintainer mesh__D003400 ags
% 216.96/217.10  |- mesh__dateCreated mesh__D003400 1999-01-01
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D003400 2006
% 216.96/217.10  |- mesh__recordAuthorizer mesh__D003400 sjn
% 216.96/217.10  |- mesh__dateEstablished mesh__D003400 1972-01-01
% 216.96/217.10  |- skos__scopeNote mesh__D003400
% 216.96/217.10       A superfamily of various freshwater CRUSTACEA, in the infraorder Astacidea, comprising the crayfish. Common genera include Astacus and Procambarus. Crayfish resemble lobsters, but are usually much smaller.%A%    
% 216.96/217.10  |- skos__altLabel mesh__D003400 Crayfish
% 216.96/217.10  |- skos__annotation mesh__D003400
% 216.96/217.10       as animal %26% food; IM; as food, coord IM with SHELLFISH %28%IM%29%%A%  
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D003400 2005
% 216.96/217.10  |- mesh__recordMaintainer mesh__D008694 CCR
% 216.96/217.10  |- rdf__type mesh__D008694sskos__Concept
% 216.96/217.10  |- mesh__dateRevised mesh__D008694 2005-06-30
% 216.96/217.10  |- skos__scopeNote mesh__D008694
% 216.96/217.10       A central nervous system stimulant and sympathomimetic with actions and uses similar to DEXTROAMPHETAMINE. The smokable form is a drug of abuse and is referred to as crank, crystal, crystal meth, ice, and speed.%A%    
% 216.96/217.10  |- skos__altLabel mesh__D008694 Methylamphetamine
% 216.96/217.10  |- skos__altLabel mesh__D008694 Deoxyephedrine
% 216.96/217.10  |- skos__altLabel mesh__D008694
% 216.96/217.10       Abbott Brand of Methamphetamine Hydrochloride
% 216.96/217.10  |- mesh__recordOriginator mesh__D008694 NLM
% 216.96/217.10  |- skos__prefLabel mesh__D008694 Methamphetamine
% 216.96/217.10  |- mesh__dateCreated mesh__D008694 1999-01-01
% 216.96/217.10  |- skos__altLabel mesh__D008694 N-Methylamphetamine
% 216.96/217.10  |- skos__broader mesh__D008694smesh__D000662
% 216.96/217.10  |- mesh__recordAuthorizer mesh__D008694 sjn
% 216.96/217.10  |- skos__altLabel mesh__D008694 Metamfetamine
% 216.96/217.10  |- skos__hiddenLabel mesh__D008694 N Methylamphetamine
% 216.96/217.10  |- skos__annotation mesh__D008694
% 216.96/217.10       a CNS stimulant; smokable crystal methamphetamine, called %22%ice%22% by drug abusers, goes here%A%  
% 216.96/217.10  |- skos__hiddenLabel mesh__D008694 Hydrochloride, Methamphetamine
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D008694 2006
% 216.96/217.10  |- skos__altLabel mesh__D008694
% 216.96/217.10       Langly Brand of Methamphetamine Hydrochloride
% 216.96/217.10  |- skos__altLabel mesh__D008694 Desoxyephedrine
% 216.96/217.10  |- skos__hiddenLabel mesh__D016328 NF-kB, Transcription Factor
% 216.96/217.10  |- skos__broader mesh__D016328smesh__D009687
% 216.96/217.10  |- skos__hiddenLabel mesh__D016328 Ig EBP 1
% 216.96/217.10  |- mesh__historyNote mesh__D016328 91   
% 216.96/217.10  |- skos__hiddenLabel mesh__D016328 NF kappaB
% 216.96/217.10  |- skos__scopeNote mesh__D016328
% 216.96/217.10       Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA.%A%    
% 216.96/217.10  |- skos__historyNote mesh__D016328 Transcription Factors %28%1987-1990%29%
% 216.96/217.10  |- skos__broader mesh__D016328smesh__D004268
% 216.96/217.10  |- skos__hiddenLabel mesh__D016328 Immunoglobulin Enhancer Binding Protein
% 216.96/217.10  |- skos__hiddenLabel mesh__D016328 NF kB
% 216.96/217.10  |- mesh__recordMaintainer mesh__D016328 NLM
% 216.96/217.10  |- skos__altLabel mesh__D016328 Nuclear Factor kappa B
% 216.96/217.10  |- mesh__publicMeSHNote mesh__D016328 91   
% 216.96/217.10  |- mesh__dateRevised mesh__D016328 2005-07-06
% 216.96/217.10  |- skos__altLabel mesh__D016328 Transcription Factor NF-kB
% 216.96/217.10  |- mesh__dateEstablished mesh__D016328 1991-01-01
% 216.96/217.10  |- skos__related mesh__D016328smesh__D020672
% 216.96/217.10  |- skos__hiddenLabel mesh__D016328 Transcription Factor NF kB
% 216.96/217.10  |- skos__broader mesh__D016328smesh__D014157
% 216.96/217.10  |- skos__historyNote mesh__D016328 DNA-Binding Proteins %28%1987-1990%29%
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D016328 2006
% 216.96/217.10  |- mesh__recordAuthorizer mesh__D016328 NLM
% 216.96/217.10  |- mesh__dateCreated mesh__D016328 1990-06-19
% 216.96/217.10  |- skos__altLabel mesh__D016328 kappa B Enhancer Binding Protein
% 216.96/217.10  |- rdf__type mesh__D016328sskos__Concept
% 216.96/217.10  |- skos__altLabel mesh__D016328 Immunoglobulin Enhancer-Binding Protein
% 216.96/217.10  |- skos__annotation mesh__D016328 DF: NFKB   
% 216.96/217.10  |- skos__hiddenLabel mesh__D016328 Factor NF-kB, Transcription
% 216.96/217.10  |- skos__altLabel mesh__D016328 NF-kB
% 216.96/217.10  |- skos__hiddenLabel mesh__D016328 Enhancer-Binding Protein, Immunoglobulin
% 216.96/217.10  |- skos__prefLabel mesh__D016328 NF-kappa B
% 216.96/217.10  |- mesh__recordOriginator mesh__D016328 AGS
% 216.96/217.10  |- skos__altLabel mesh__D016328 NF-kappaB
% 216.96/217.10  |- rdf__type mesh__D002308sskos__Concept
% 216.96/217.10  |- skos__related mesh__D002308smesh__D017153
% 216.96/217.10  |- skos__related mesh__D002308smesh__D013588
% 216.96/217.10  |- mesh__dateRevised mesh__D002308 2005-06-30
% 216.96/217.10  |- mesh__recordOriginator mesh__D002308 NLM
% 216.96/217.10  |- skos__related mesh__D002308smesh__D016736
% 216.96/217.10  |- mesh__recordMaintainer mesh__D002308 ssb
% 216.96/217.10  |- skos__prefLabel mesh__D002308 Cardiolipins
% 216.96/217.10  |- mesh__historyNote mesh__D002308
% 216.96/217.10       73%28%72%29%; DIPHOSPHATIDYL GLYCEROLS was see PHOSPHATIDYL GLYCEROLS 1975-76%A%  
% 216.96/217.10  |- skos__historyNote mesh__D002308 Phospholipids %28%1966-1971%29%
% 216.96/217.10  |- mesh__dateEstablished mesh__D002308 1973-01-01
% 216.96/217.10  |- mesh__publicMeSHNote mesh__D002308
% 216.96/217.10       73; DIPHOSPHATIDYL GLYCEROLS was see PHOSPHATIDYL GLYCEROLS 1975-76%A%  
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D002308 2006
% 216.96/217.10  |- skos__altLabel mesh__D002308 Cardiolipin
% 216.96/217.10  |- skos__broader mesh__D002308smesh__D006241
% 216.96/217.10  |- skos__scopeNote mesh__D002308
% 216.96/217.10       Acidic phospholipids composed of two molecules of phosphatidic acid covalently linked to a molecule of glycerol. They occur primarily in mitochondrial inner membranes and in bacterial plasma membranes. They are the main antigenic components of the Wassermann-type antigen that is used in nontreponemal SYPHILIS SERODIAGNOSIS.%A%    
% 216.96/217.10  |- mesh__recordAuthorizer mesh__D002308 sjn
% 216.96/217.10  |- mesh__dateCreated mesh__D002308 1999-01-01
% 216.96/217.10  |- skos__broader mesh__D002308smesh__D010715
% 216.96/217.10  |- mesh__onlineNote mesh__D002308
% 216.96/217.10       search CARDIOLIPINS %26% PHOSPHATIDYLGLYCEROLS 1975-76   
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013030 1998
% 216.96/217.10  |- mesh__recordOriginator mesh__D013030 NLM
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013030 1996
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013030 2001
% 216.96/217.10  |- rdf__type mesh__D013030sskos__Concept
% 216.96/217.10  |- skos__broader mesh__D013030smesh__D005060
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013030 1999
% 216.96/217.10  |- mesh__recordMaintainer mesh__D013030 KEV
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013030 1997
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013030 2002
% 216.96/217.10  |- mesh__dateRevised mesh__D013030 1995-05-23
% 216.96/217.10  |- mesh__recordAuthorizer mesh__D013030 PLS
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013030 2005
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013030 2003
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013030 2006
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013030 2004
% 216.96/217.10  |- mesh__dateCreated mesh__D013030 1999-01-01
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013030 2000
% 216.96/217.10  |- skos__prefLabel mesh__D013030 Spain
% 216.96/217.10  |- skos__altLabel mesh__D012736 Education, Sex
% 216.96/217.10  |- skos__hiddenLabel mesh__D012736 Instructor, Family Planning
% 216.96/217.10  |- mesh__dateCreated mesh__D012736 1999-01-01
% 216.96/217.10  |- skos__altLabel mesh__D012736 Education, Family Planning
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D012736 2006
% 216.96/217.10  |- skos__prefLabel mesh__D012736 Sex Education
% 216.96/217.10  |- skos__broader mesh__D012736smesh__D044347
% 216.96/217.10  |- skos__hiddenLabel mesh__D012736 Instructors, Family Planning
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D012736 2005
% 216.96/217.10  |- mesh__recordAuthorizer mesh__D012736 sjn
% 216.96/217.10  |- mesh__recordMaintainer mesh__D012736 sjn
% 216.96/217.10  |- rdf__type mesh__D012736sskos__Concept
% 216.96/217.10  |- mesh__recordOriginator mesh__D012736 NLM
% 216.96/217.10  |- skos__hiddenLabel mesh__D012736 Family Planning Instructor
% 216.96/217.10  |- skos__broader mesh__D012736smesh__D006266
% 216.96/217.10  |- skos__hiddenLabel mesh__D012736 Training, Family Planning
% 216.96/217.10  |- skos__scopeNote mesh__D012736
% 216.96/217.10       Education which increases the knowledge of the functional, structural, and behavioral aspects of human reproduction.%A%    
% 216.96/217.10  |- mesh__dateRevised mesh__D012736 2004-07-13
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D017421 2005
% 216.96/217.10  |- mesh__recordOriginator mesh__D017421 PXP
% 216.96/217.10  |- mesh__recordAuthorizer mesh__D017421 sjn
% 216.96/217.10  |- skos__hiddenLabel mesh__D017421 Sequence Analyses
% 216.96/217.10  |- mesh__dateEstablished mesh__D017421 1993-01-01
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D017421 2000
% 216.96/217.10  |- mesh__dateRevised mesh__D017421 1999-11-03
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D017421 2003
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D017421 2006
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D017421 2001
% 216.96/217.10  |- mesh__historyNote mesh__D017421 93   
% 216.96/217.10  |- mesh__recordMaintainer mesh__D017421 nns
% 216.96/217.10  |- skos__historyNote mesh__D017421 Amino Acid Sequence %28%1966-1992%29%
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D017421 2004
% 216.96/217.10  |- mesh__publicMeSHNote mesh__D017421 93   
% 216.96/217.10  |- skos__altLabel mesh__D017421 Analysis, Sequence
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D017421 2002
% 216.96/217.10  |- skos__historyNote mesh__D017421 Base Sequence %28%1971-1992%29%
% 216.96/217.10  |- skos__hiddenLabel mesh__D017421 Analyses, Sequence
% 216.96/217.10  |- skos__altLabel mesh__D017421 Determinations, Sequence
% 216.96/217.10  |- skos__altLabel mesh__D017421 Sequence Determination
% 216.96/217.10  |- rdf__type mesh__D017421sskos__Concept
% 216.96/217.10  |- skos__scopeNote mesh__D017421
% 216.96/217.10       A multistage process that includes the determination of a sequence %28%protein, carbohydrate, etc.%29%, its fragmentation and analysis, and the interpretation of the resulting sequence information.%A%    
% 216.96/217.10  |- skos__annotation mesh__D017421
% 216.96/217.10       GEN or unspecified; prefer specifics; DF: SEQ ANAL   
% 216.96/217.10  |- skos__broader mesh__D017421smesh__D005821
% 216.96/217.10  |- mesh__dateCreated mesh__D017421 1992-05-22
% 216.96/217.10  |- skos__prefLabel mesh__D017421 Sequence Analysis
% 216.96/217.10  |- skos__altLabel mesh__D017421 Determination, Sequence
% 216.96/217.10  |- mesh__dateRevised mesh__D036386 2005-07-08
% 216.96/217.10  |- skos__hiddenLabel mesh__D036386 Ephrin A5
% 216.96/217.10  |- skos__scopeNote mesh__D036386
% 216.96/217.10       A GLYCOINOSITOL PHOSPHOLIPID MEMBRANE ANCHOR containing ephrin found in developing tectum. It has been shown to mediate the bundling of cortical axons and repel the axonal growth of retinal ganglia axons. It is found in a variety of adult tissues of BRAIN; HEART; and KIDNEY.%A%    
% 216.96/217.10  |- skos__broader mesh__D036386smesh__D036342
% 216.96/217.10  |- mesh__historyNote mesh__D036386
% 216.96/217.10       2003; use EPHRIN-A5 %28%NM%29% 1998-2002; for REPUSLSIVE AXONAL GUIDANCE PROTEIN use EPHRIN-A4 %28%NM%29% 1995-2002%A%  
% 216.96/217.10  |- mesh__recordAuthorizer mesh__D036386 ags
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D036386 2006
% 216.96/217.10  |- skos__hiddenLabel mesh__D036386 AL 1 Protein
% 216.96/217.10  |- mesh__recordOriginator mesh__D036386 jmp
% 216.96/217.10  |- skos__altLabel mesh__D036386 REK7 Ligand AL-1
% 216.96/217.10  |- skos__altLabel mesh__D036386 LERK-7 Protein
% 216.96/217.10  |- mesh__recordMaintainer mesh__D036386 ags
% 216.96/217.10  |- skos__historyNote mesh__D036386 Transcription Factors %28%1995-2002%29%
% 216.96/217.10  |- skos__altLabel mesh__D036386 AL-1
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D036386 2006A
% 216.96/217.10  |- rdf__type mesh__D036386sskos__Concept
% 216.96/217.10  |- mesh__dateCreated mesh__D036386 2002-07-02
% 216.96/217.10  |- skos__hiddenLabel mesh__D036386 LERK 7 Protein
% 216.96/217.10  |- skos__prefLabel mesh__D036386 Ephrin-A5
% 216.96/217.10  |- skos__altLabel mesh__D036386 AL-1 Protein
% 216.96/217.10  |- skos__altLabel mesh__D036386 Repulsive Axon Guidance Signal Protein
% 216.96/217.10  |- mesh__publicMeSHNote mesh__D036386
% 216.96/217.10       2003; EPHRIN-A5 was indexed under MEMBRANE PROTEINS %28%1998-2002%29%; REPUSLSIVE AXONAL GUIDANCE PROTEIN was indexed under TRANSCRIPTION FACTORS 1995-2002%A%  
% 216.96/217.10  |- skos__hiddenLabel mesh__D036386 REK7 Ligand AL 1
% 216.96/217.10  |- skos__altLabel mesh__D036386 RAGS Protein
% 216.96/217.10  |- mesh__dateEstablished mesh__D036386 2003-01-01
% 216.96/217.10  |- skos__historyNote mesh__D036386 Membrane Proteins %28%1995-2002%29%
% 216.96/217.10  |- rdf__type mesh__D003401sskos__Concept
% 216.96/217.10  |- skos__annotation mesh__D003401
% 216.96/217.10       do not confuse with CREATININE; CREATINE PHOSPHATE see PHOSPHOCREATINE%A%  
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D003401 2004
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D003401 2002
% 216.96/217.10  |- skos__broader mesh__D003401smesh__D000596
% 216.96/217.10  |- skos__scopeNote mesh__D003401
% 216.96/217.10       An amino acid that occurs in vertebrate tissues and in urine.  In muscle tissue, creatine generally occurs as phosphocreatine.  Creatine is excreted as CREATININE in the urine.%A%    
% 216.96/217.10  |- mesh__historyNote mesh__D003401
% 216.96/217.10       68; CREATINE AND CREATININE was heading 1963-67   
% 216.96/217.10  |- skos__broader mesh__D003401smesh__D006146
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D003401 2003
% 216.96/217.10  |- mesh__dateRevised mesh__D003401 2000-06-22
% 216.96/217.10  |- mesh__onlineNote mesh__D003401
% 216.96/217.10       use CREATINE to search CREATINE AND CREATININE 1966-67   
% 216.96/217.10  |- mesh__dateCreated mesh__D003401 1999-01-01
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D003401 2006
% 216.96/217.10  |- mesh__recordOriginator mesh__D003401 NLM
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D003401 2001
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D003401 2005
% 216.96/217.10  |- mesh__publicMeSHNote mesh__D003401
% 216.96/217.10       68; CREATINE AND CREATININE was heading 1963-67   
% 216.96/217.10  |- mesh__recordMaintainer mesh__D003401 CCR
% 216.96/217.10  |- skos__prefLabel mesh__D003401 Creatine
% 216.96/217.10  |- mesh__dateEstablished mesh__D003401 1968-01-01
% 216.96/217.10  |- mesh__recordAuthorizer mesh__D003401 sjn
% 216.96/217.10  |- mesh__recordAuthorizer mesh__D008695 sjn
% 216.96/217.10  |- rdf__type mesh__D008695sskos__Concept
% 216.96/217.10  |- mesh__dateEstablished mesh__D008695 1991-01-01
% 216.96/217.10  |- mesh__recordMaintainer mesh__D008695 lkt
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D008695 2004
% 216.96/217.10  |- mesh__onlineNote mesh__D008695 search ANABOLIC STEROIDS 1966-74   
% 216.96/217.10  |- skos__altLabel mesh__D008695 Methylandrostenediol
% 216.96/217.10  |- mesh__dateCreated mesh__D008695 1999-01-01
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D008695 2005
% 216.96/217.10  |- skos__scopeNote mesh__D008695
% 216.96/217.10       A synthetic steroid with anabolic and androgenic properties. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1188%29%%A%    
% 216.96/217.10  |- mesh__historyNote mesh__D008695
% 216.96/217.10       91%28%75%29%; was see under ANDROSTENEDIOLS 1975-90; was see under ANABOLIC STEROIDS 1964-74%A%  
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D008695 2006
% 216.96/217.10  |- mesh__recordOriginator mesh__D008695 NLM
% 216.96/217.10  |- mesh__dateRevised mesh__D008695 2003-07-09
% 216.96/217.10  |- mesh__publicMeSHNote mesh__D008695
% 216.96/217.10       91; was see under ANDROSTENEDIOLS 1975-90; was see under ANABOLIC STEROIDS 1964-74%A%  
% 216.96/217.10  |- skos__broader mesh__D008695smesh__D000734
% 216.96/217.10  |- skos__prefLabel mesh__D008695 Methandriol
% 216.96/217.10  |- skos__altLabel mesh__D016329 Specificity Protein 1 Transcription Factor
% 216.96/217.10  |- mesh__historyNote mesh__D016329 2006%28%1991%29%   
% 216.96/217.10  |- skos__annotation mesh__D016329
% 216.96/217.10       /drug eff /ultrastruct permitted; in titles %26% translations use SP1 %28%the figure one%29%, not SPl %28%the letter l%29%%A%  
% 216.96/217.10  |- skos__historyNote mesh__D016329 DNA-Binding Proteins %28%1986-1990%29%
% 216.96/217.10  |- skos__historyNote mesh__D016329 Transcription Factors %28%1986-1990%29%
% 216.96/217.10  |- skos__broader mesh__D016329smesh__D051703
% 216.96/217.10  |- mesh__publicMeSHNote mesh__D016329
% 216.96/217.10       2006; see TRANSCRIPTION FACTOR, SP1 1991-2005   
% 216.96/217.10  |- skos__altLabel mesh__D016329 Transcription Factor, Sp1
% 216.96/217.10  |- mesh__recordMaintainer mesh__D016329 DRC
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D016329 2006
% 216.96/217.10  |- mesh__dateCreated mesh__D016329 1990-06-19
% 216.96/217.10  |- skos__prefLabel mesh__D016329 Sp1 Transcription Factor
% 216.96/217.10  |- rdf__type mesh__D016329sskos__Concept
% 216.96/217.10  |- skos__scopeNote mesh__D016329
% 216.96/217.10       Promoter-specific RNA polymerase II transcription factor that binds to the GC box, one of the upstream PROMOTER elements, in mammalian cells. The binding of Sp1 is necessary for the initiation of transcription in the promoters of a variety of cellular and viral GENES.%A%    
% 216.96/217.10  |- mesh__recordOriginator mesh__D016329 AGS
% 216.96/217.10  |- mesh__dateRevised mesh__D016329 2005-06-30
% 216.96/217.10  |- mesh__dateEstablished mesh__D016329 1991-01-01
% 216.96/217.10  |- mesh__recordAuthorizer mesh__D016329 sjn
% 216.96/217.10  |- skos__prefLabel mesh__D002309 Cardiology
% 216.96/217.10  |- skos__hiddenLabel mesh__D002309
% 216.96/217.10       Disease, Cardiovascular %28%Specialty%29%
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D002309 2000
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D002309 1994
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D002309 1998
% 216.96/217.10  |- skos__related mesh__D002309smesh__D006331
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D002309 1997
% 216.96/217.10  |- mesh__recordOriginator mesh__D002309 NLM
% 216.96/217.10  |- skos__hiddenLabel mesh__D002309
% 216.96/217.10       Diseases, Cardiovascular %28%Specialty%29%
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D002309 2006
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D002309 1996
% 216.96/217.10  |- skos__hiddenLabel mesh__D002309
% 216.96/217.10       Cardiovascular Diseases %28%Specialty%29%
% 216.96/217.10  |- skos__related mesh__D002309smesh__D014652
% 216.96/217.10  |- skos__altLabel mesh__D002309 Cardiovascular Disease %28%Specialty%29%
% 216.96/217.10  |- skos__broader mesh__D002309smesh__D007388
% 216.96/217.10  |- skos__annotation mesh__D002309 SPEC: SPEC qualif; DF: CARDIOL   
% 216.96/217.10  |- mesh__dateCreated mesh__D002309 1999-01-01
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D002309 2005
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D002309 2002
% 216.96/217.10  |- skos__related mesh__D002309smesh__D002318
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D002309 2004
% 216.96/217.10  |- rdf__type mesh__D002309sskos__Concept
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D002309 1995
% 216.96/217.10  |- mesh__recordAuthorizer mesh__D002309 PLS
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D002309 2001
% 216.96/217.10  |- mesh__dateRevised mesh__D002309 1993-06-04
% 216.96/217.10  |- skos__scopeNote mesh__D002309
% 216.96/217.10       The study of the heart, its physiology, and its functions.%A%    
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D002309 1999
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D002309 2003
% 216.96/217.10  |- mesh__recordMaintainer mesh__D002309 JLS
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013031 2003
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013031 1994
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013031 2006
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013031 2000
% 216.96/217.10  |- skos__scopeNote mesh__D013031
% 216.96/217.10       Infection of animals, including fish and man, with a developmental stage of Diphyllobothrium. This stage has recently been referred to as a plerocercoid but the name sparganum has persisted. Therefore, infection of fish or other animals with the plerocercoid larvae is sparganosis. Fish-eating mammals, including man, are the final hosts.%A%    
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013031 2004
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013031 1995
% 216.96/217.10  |- skos__annotation mesh__D013031
% 216.96/217.10       tapeworm infect; see note under SPARGANUM; infect at larval stage: DIPHYLLOBOTHRIASIS is infect by adult%A%  
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013031 2001
% 216.96/217.10  |- mesh__recordOriginator mesh__D013031 NLM
% 216.96/217.10  |- skos__prefLabel mesh__D013031 Sparganosis
% 216.96/217.10  |- mesh__dateCreated mesh__D013031 1999-01-01
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013031 1998
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013031 2002
% 216.96/217.10  |- skos__broader mesh__D013031smesh__D004169
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013031 1996
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013031 1999
% 216.96/217.10  |- skos__related mesh__D013031smesh__D004169
% 216.96/217.10  |- mesh__recordMaintainer mesh__D013031 TGC
% 216.96/217.10  |- mesh__dateRevised mesh__D013031 1993-06-03
% 216.96/217.10  |- rdf__type mesh__D013031sskos__Concept
% 216.96/217.10  |- mesh__recordAuthorizer mesh__D013031 PLS
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013031 1997
% 216.96/217.10  |- skos__hiddenLabel mesh__D013031 Sparganoses
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D013031 2005
% 216.96/217.10  |- skos__broader mesh__D051150smesh__D051140
% 216.96/217.10  |- skos__prefLabel mesh__D051150 Selenoprotein R
% 216.96/217.10  |- mesh__recordAuthorizer mesh__D051150 sjn
% 216.96/217.10  |- mesh__publicMeSHNote mesh__D051150
% 216.96/217.10       2006; SELENOPROTEIN R was indexed under PROTEINS 2005   
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D051150 2006
% 216.96/217.10  |- mesh__dateCreated mesh__D051150 2005-06-30
% 216.96/217.10  |- mesh__recordMaintainer mesh__D051150 DRC
% 216.96/217.10  |- skos__broader mesh__D051150smesh__D010088
% 216.96/217.10  |- skos__scopeNote mesh__D051150
% 216.96/217.10       A zinc-containing stereo-specific methionine sulfoxide reductase.%A%    
% 216.96/217.10  |- mesh__recordOriginator mesh__D051150 DRC
% 216.96/217.10  |- rdf__type mesh__D051150sskos__Concept
% 216.96/217.10  |- mesh__dateEstablished mesh__D051150 2006-01-01
% 216.96/217.10  |- skos__altLabel mesh__D051150 SelR Protein
% 216.96/217.10  |- mesh__historyNote mesh__D051150 2006%28%2005%29%   
% 216.96/217.10  |- mesh__recordAuthorizer mesh__D012737 sjn
% 216.96/217.10  |- mesh__recordOriginator mesh__D012737 NLM
% 216.96/217.10  |- skos__prefLabel mesh__D012737 Sex Factors
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D012737 2005
% 216.96/217.10  |- skos__broader mesh__D012737smesh__D015981
% 216.96/217.10  |- skos__annotation mesh__D012737
% 216.96/217.10       NIM; no qualif; human %26% animal; related to cause %26% effect: do not confuse with SEX DISTRIBUTION which is largely statistical; see also note under SEX CHARACTERISTICS; Manual 35.6+; relation to MALE; FEMALE: Manual 18.9.5%A%  
% 216.96/217.10  |- mesh__publicMeSHNote mesh__D012737 68   
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D012737 2006
% 216.96/217.10  |- mesh__dateRevised mesh__D012737 2004-07-13
% 216.96/217.10  |- skos__hiddenLabel mesh__D012737 Factor, Sex
% 216.96/217.10  |- skos__hiddenLabel mesh__D012737 Factors, Sex
% 216.96/217.10  |- mesh__historyNote mesh__D012737 68   
% 216.96/217.10  |- mesh__dateEstablished mesh__D012737 1968-01-01
% 216.96/217.10  |- rdf__type mesh__D012737sskos__Concept
% 216.96/217.10  |- skos__scopeNote mesh__D012737
% 216.96/217.10       Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances.%A%    
% 216.96/217.10  |- mesh__dateCreated mesh__D012737 1999-01-01
% 216.96/217.10  |- mesh__recordMaintainer mesh__D012737 sjn
% 216.96/217.10  |- skos__hiddenLabel mesh__D012737 Sex Factor
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D017422 2003
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D017422 2006
% 216.96/217.10  |- skos__annotation mesh__D017422 DF: SEQ ANAL DNA   
% 216.96/217.10  |- skos__altLabel mesh__D017422 Determination, DNA Sequence
% 216.96/217.10  |- mesh__dateCreated mesh__D017422 1992-05-22
% 216.96/217.10  |- mesh__historyNote mesh__D017422 93   
% 216.96/217.10  |- skos__altLabel mesh__D017422 DNA Sequence Determinations
% 216.96/217.10  |- skos__historyNote mesh__D017422 Amino Acid Sequence %28%1966-1992%29%
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D017422 2004
% 216.96/217.10  |- mesh__recordAuthorizer mesh__D017422 sjn
% 216.96/217.10  |- skos__altLabel mesh__D017422 DNA Sequence Analysis
% 216.96/217.10  |- mesh__dateEstablished mesh__D017422 1993-01-01
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D017422 2000
% 216.96/217.10  |- mesh__dateRevised mesh__D017422 1999-11-03
% 216.96/217.10  |- skos__hiddenLabel mesh__D017422 Analyses, DNA Sequence
% 216.96/217.10  |- rdf__type mesh__D017422sskos__Concept
% 216.96/217.10  |- skos__altLabel mesh__D017422 Determinations, DNA Sequence
% 216.96/217.10  |- skos__altLabel mesh__D017422 Analysis, DNA Sequence
% 216.96/217.10  |- skos__historyNote mesh__D017422 DNA %28%1966-1992%29%
% 216.96/217.10  |- skos__hiddenLabel mesh__D017422 Sequence Analyses, DNA
% 216.96/217.10  |- mesh__activeMeSHYear mesh__D017422 2001
% 216.96/217.11  |- skos__broader mesh__D017422smesh__D017421
% 216.96/217.11  |- skos__prefLabel mesh__D017422 Sequence Analysis, DNA
% 216.96/217.11  |- mesh__recordMaintainer mesh__D017422 nns
% 216.96/217.11  |- skos__hiddenLabel mesh__D017422 DNA Sequence Analyses
% 216.96/217.11  |- mesh__publicMeSHNote mesh__D017422 93   
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D017422 2002
% 216.96/217.11  |- skos__scopeNote mesh__D017422
% 216.96/217.11       A multistage process that includes DNA cloning, physical mapping, subcloning, sequencing, and information analysis.%A%    
% 216.96/217.11  |- skos__historyNote mesh__D017422 Base Sequence %28%1971-1992%29%
% 216.96/217.11  |- skos__altLabel mesh__D017422 DNA Sequence Determination
% 216.96/217.11  |- mesh__recordOriginator mesh__D017422 PXP
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D017422 2005
% 216.96/217.11  |- skos__altLabel mesh__D017422 Sequence Determination, DNA
% 216.96/217.11  |- rdf__type mesh__D050856sskos__Concept
% 216.96/217.11  |- skos__hiddenLabel mesh__D050856 IRF 1 Transcription Factor
% 216.96/217.11  |- skos__altLabel mesh__D050856 Interferon-Stimulated Gene Factor 1
% 216.96/217.11  |- skos__altLabel mesh__D050856 MyD32 Protein
% 216.96/217.11  |- mesh__dateRevised mesh__D050856 2005-08-02
% 216.96/217.11  |- skos__scopeNote mesh__D050856
% 216.96/217.11       An interferon regulatory factor that binds upstream TRANSCRIPTIONAL REGULATORY ELEMENTS in the GENES for INTERFERON-ALPHA and INTERFERON-BETA. It functions as a transcriptional activator for the INTERFERON TYPE I genes.%A%    
% 216.96/217.11  |- skos__hiddenLabel mesh__D050856 Transcription Factor, IRF-1
% 216.96/217.11  |- skos__hiddenLabel mesh__D050856 Transcription Factor, ISGF1
% 216.96/217.11  |- mesh__recordAuthorizer mesh__D050856 ags
% 216.96/217.11  |- skos__hiddenLabel mesh__D050856 Factor, IRF-1 Transcription
% 216.96/217.11  |- skos__prefLabel mesh__D050856 Interferon Regulatory Factor-1
% 216.96/217.11  |- skos__hiddenLabel mesh__D050856 Factor, ISGF1 Transcription
% 216.96/217.11  |- skos__hiddenLabel mesh__D050856 Interferon Stimulated Gene Factor 1
% 216.96/217.11  |- skos__hiddenLabel mesh__D050856 IRF 1 Protein
% 216.96/217.11  |- skos__altLabel mesh__D050856 IREBF1 Protein
% 216.96/217.11  |- mesh__historyNote mesh__D050856 2006%28%1989%29%   
% 216.96/217.11  |- skos__broader mesh__D050856smesh__D050835
% 216.96/217.11  |- skos__hiddenLabel mesh__D050856 Transcription Factor, IREBF1
% 216.96/217.11  |- mesh__dateEstablished mesh__D050856 2006-01-01
% 216.96/217.11  |- skos__hiddenLabel mesh__D050856 Interferon Regulatory Factor 1
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D050856 2006
% 216.96/217.11  |- skos__altLabel mesh__D050856 IRF-1 Transcription Factor
% 216.96/217.11  |- mesh__recordOriginator mesh__D050856 DRC
% 216.96/217.11  |- skos__altLabel mesh__D050856 IREBF1 Transcription Factor
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D050856 2006A
% 216.96/217.11  |- mesh__publicMeSHNote mesh__D050856
% 216.96/217.11       2006; INTERFERON REGULATORY FACTOR was indexed under DNA-BINDING PROTEINS 1990-2005; PHOSPHOPROTEINS 1990-2005; %26% PROTEINS 1989%A%  
% 216.96/217.11  |- mesh__recordMaintainer mesh__D050856 ags
% 216.96/217.11  |- mesh__dateCreated mesh__D050856 2005-06-30
% 216.96/217.11  |- skos__altLabel mesh__D050856 IRF-1 Protein
% 216.96/217.11  |- skos__broader mesh__D050856smesh__D050976
% 216.96/217.11  |- skos__altLabel mesh__D050856 ISGF1 Transcription Factor
% 216.96/217.11  |- mesh__publicMeSHNote mesh__D036387
% 216.96/217.11       2003; EPHRIN-B1 was indexed under MEMBRANE PROTEINS 1998-2002, PROTEINS 1994-1997%A%  
% 216.96/217.11  |- skos__altLabel mesh__D036387 LERK-2 Protein
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D036387 2006
% 216.96/217.11  |- skos__scopeNote mesh__D036387
% 216.96/217.11       A transmembrane domain containing ephrin that is specific for EPHB1 RECEPTOR; EPHB2 RECEPTOR and EPHB3 RECEPTOR. It is widely expressed in a variety of developing and adult tissues.%A%    
% 216.96/217.11  |- mesh__dateEstablished mesh__D036387 2003-01-01
% 216.96/217.11  |- skos__hiddenLabel mesh__D036387 Ligand, Cek5
% 216.96/217.11  |- skos__altLabel mesh__D036387 Elk-L Protein
% 216.96/217.11  |- skos__altLabel mesh__D036387 Cek5 RPTK Ligand
% 216.96/217.11  |- mesh__recordAuthorizer mesh__D036387 sjn
% 216.96/217.11  |- skos__altLabel mesh__D036387 elk Ligand
% 216.96/217.11  |- skos__altLabel mesh__D036387 EFNB1 Gene Product
% 216.96/217.11  |- skos__altLabel mesh__D036387 Eph Family Receptor Interacting Protein B1
% 216.96/217.11  |- skos__altLabel mesh__D036387 Cek5 Ligand
% 216.96/217.11  |- skos__hiddenLabel mesh__D036387 Ligand, Cek5 RPTK
% 216.96/217.11  |- skos__prefLabel mesh__D036387 Ephrin-B1
% 216.96/217.11  |- mesh__dateCreated mesh__D036387 2002-07-03
% 216.96/217.11  |- mesh__historyNote mesh__D036387
% 216.96/217.11       2003; use EPHRIN-B1 %28%NM%29% 1994-2002   
% 216.96/217.11  |- rdf__type mesh__D036387sskos__Concept
% 216.96/217.11  |- mesh__recordOriginator mesh__D036387 jmp
% 216.96/217.11  |- skos__hiddenLabel mesh__D036387 Ephrin B1
% 216.96/217.11  |- skos__hiddenLabel mesh__D036387 LERK 2 Protein
% 216.96/217.11  |- mesh__dateRevised mesh__D036387 2005-06-30
% 216.96/217.11  |- mesh__recordMaintainer mesh__D036387 ssb
% 216.96/217.11  |- skos__hiddenLabel mesh__D036387 Elk L Protein
% 216.96/217.11  |- skos__historyNote mesh__D036387 Proteins %28%1994-1997%29%
% 216.96/217.11  |- skos__broader mesh__D036387smesh__D036342
% 216.96/217.11  |- skos__historyNote mesh__D036387 Membrane Proteins %28%1998-2002%29%
% 216.96/217.11  |- skos__hiddenLabel mesh__D036387 RPTK Ligand, Cek5
% 216.96/217.11  |- skos__hiddenLabel mesh__D036387 Ligand, elk
% 216.96/217.11  |- skos__hiddenLabel mesh__D003402 Phosphocreatine Phosphotransferase, ADP
% 216.96/217.11  |- rdf__type mesh__D003402sskos__Concept
% 216.96/217.11  |- mesh__recordOriginator mesh__D003402 NLM
% 216.96/217.11  |- mesh__dateCreated mesh__D003402 1999-01-01
% 216.96/217.11  |- mesh__recordMaintainer mesh__D003402 AKE
% 216.96/217.11  |- skos__altLabel mesh__D003402 ATP Creatine Phosphotransferase
% 216.96/217.11  |- skos__hiddenLabel mesh__D003402 Macro Creatine Kinase
% 216.96/217.11  |- mesh__recordAuthorizer mesh__D003402 sjn
% 216.96/217.11  |- skos__broader mesh__D003402smesh__D017852
% 216.96/217.11  |- skos__hiddenLabel mesh__D003402 Kinase, Creatine
% 216.96/217.11  |- skos__altLabel mesh__D003402 ADP Phosphocreatine Phosphotransferase
% 216.96/217.11  |- skos__prefLabel mesh__D003402 Creatine Kinase
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D003402 2006
% 216.96/217.11  |- skos__hiddenLabel mesh__D003402 Phosphotransferase, ADP Phosphocreatine
% 216.96/217.11  |- skos__altLabel mesh__D003402 Creatine Phosphokinase
% 216.96/217.11  |- skos__hiddenLabel mesh__D003402 Phosphotransferase, ATP Creatine
% 216.96/217.11  |- skos__scopeNote mesh__D003402
% 216.96/217.11       A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins.%A%    
% 216.96/217.11  |- mesh__dateRevised mesh__D003402 2005-06-30
% 216.96/217.11  |- skos__hiddenLabel mesh__D003402 Creatine Phosphotransferase, ATP
% 216.96/217.11  |- skos__hiddenLabel mesh__D003402 Phosphokinase, Creatine
% 216.96/217.11  |- skos__altLabel mesh__D008696 Methandienone
% 216.96/217.11  |- mesh__recordOriginator mesh__D008696 NLM
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D008696 2005
% 216.96/217.11  |- mesh__dateEstablished mesh__D008696 1965-01-01
% 216.96/217.11  |- mesh__historyNote mesh__D008696 65%28%63%29%   
% 216.96/217.11  |- mesh__dateCreated mesh__D008696 1999-01-01
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D008696 2004
% 216.96/217.11  |- mesh__dateRevised mesh__D008696 2003-07-09
% 216.96/217.11  |- rdf__type mesh__D008696sskos__Concept
% 216.96/217.11  |- skos__prefLabel mesh__D008696 Methandrostenolone
% 216.96/217.11  |- mesh__recordAuthorizer mesh__D008696 sjn
% 216.96/217.11  |- skos__altLabel mesh__D008696 Metandienone
% 216.96/217.11  |- skos__broader mesh__D008696smesh__D000730
% 216.96/217.11  |- skos__altLabel mesh__D008696 Dehydromethyltestosterone
% 216.96/217.11  |- mesh__publicMeSHNote mesh__D008696 65   
% 216.96/217.11  |- skos__scopeNote mesh__D008696
% 216.96/217.11       A synthetic steroid with anabolic properties that are more pronounced than its androgenic effects. It has little progestational activity. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1188%29%%A%    
% 216.96/217.11  |- mesh__recordMaintainer mesh__D008696 lkt
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D008696 2006
% 216.96/217.11  |- mesh__recordOriginator mesh__D041521 ags
% 216.96/217.11  |- skos__scopeNote mesh__D041521
% 216.96/217.11       An order of CRENARCHAEOTA comprised of irregular coccoid to disc-shaped, hyperthermophiles, and found in submarine hydrothermal systems and solfataric hot springs.%A%    
% 216.96/217.11  |- mesh__dateCreated mesh__D041521 2003-07-09
% 216.96/217.11  |- rdf__type mesh__D041521sskos__Concept
% 216.96/217.11  |- mesh__recordMaintainer mesh__D041521 SYSTEM
% 216.96/217.11  |- mesh__publicMeSHNote mesh__D041521 2004   
% 216.96/217.11  |- mesh__recordAuthorizer mesh__D041521 sjn
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D041521 2006
% 216.96/217.11  |- mesh__historyNote mesh__D041521 2004   
% 216.96/217.11  |- skos__prefLabel mesh__D041521 Desulfurococcales
% 216.96/217.11  |- mesh__dateEstablished mesh__D041521 2004-01-01
% 216.96/217.11  |- skos__broader mesh__D041521smesh__D019615
% 216.96/217.11  |- mesh__dateRevised mesh__D041521 2005-06-30
% 216.96/217.11  |- skos__broader mesh__D004198Q000235smesh__D004198
% 216.96/217.11  |- mesh__preferredCombination mesh__D004198Q000235smesh__D020022
% 216.96/217.11  |- rdf__type mesh__D004198Q000235smesh__CompoundConcept
% 216.96/217.11  |- mesh__publicMeSHNote mesh__D013830
% 216.96/217.11       73; METHAZOLAMIDE was see under CARBONIC ANHYDRASE INHIBITORS 1965-74%A%  
% 216.96/217.11  |- mesh__dateEstablished mesh__D013830 1973-01-01
% 216.96/217.11  |- mesh__recordAuthorizer mesh__D013830 sjn
% 216.96/217.11  |- mesh__recordOriginator mesh__D013830 NLM
% 216.96/217.11  |- mesh__dateCreated mesh__D013830 1999-01-01
% 216.96/217.11  |- mesh__recordMaintainer mesh__D013830 ssb
% 216.96/217.11  |- skos__broader mesh__D013830smesh__D013844
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D013830 2006
% 216.96/217.11  |- skos__historyNote mesh__D013830 Heterocyclic Compounds %28%1966-1970%29%
% 216.96/217.11  |- skos__annotation mesh__D013830
% 216.96/217.11       includes thiadiazolines, thiadiazolidines   
% 216.96/217.11  |- mesh__historyNote mesh__D013830 73%28%71%29%   
% 216.96/217.11  |- skos__prefLabel mesh__D013830 Thiadiazoles
% 216.96/217.11  |- rdf__type mesh__D013830sskos__Concept
% 216.96/217.11  |- mesh__dateRevised mesh__D013830 2005-06-30
% 216.96/217.11  |- skos__annotation mesh__D013032
% 216.96/217.11       infection = SPARGANOSIS; coord with precoord helminth terms %28%ANTIGENS, HELMINTH, etc%29% if pertinent%A%  
% 216.96/217.11  |- mesh__recordMaintainer mesh__D013032 ags
% 216.96/217.11  |- skos__prefLabel mesh__D013032 Sparganum
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D013032 2004
% 216.96/217.11  |- mesh__publicMeSHNote mesh__D013032
% 216.96/217.11       79; was see under CESTODA 1965-78; was see under TAPEWORMS 1963-64%A%  
% 216.96/217.11  |- mesh__dateRevised mesh__D013032 2003-07-09
% 216.96/217.11  |- skos__broader mesh__D013032smesh__D004170
% 216.96/217.11  |- mesh__dateCreated mesh__D013032 1999-01-01
% 216.96/217.11  |- mesh__onlineNote mesh__D013032 search CESTODA 1966-74   
% 216.96/217.11  |- skos__historyNote mesh__D013032 Cestoda %28%1966-1974%29%
% 216.96/217.11  |- mesh__historyNote mesh__D013032
% 216.96/217.11       79%28%75%29%; was see under CESTODA 1965-78; was see under TAPEWORMS 1963-64%A%  
% 216.96/217.11  |- skos__broader mesh__D013032smesh__D013146
% 216.96/217.11  |- skos__altLabel mesh__D013032 Plerocercoid Larvae
% 216.96/217.11  |- skos__scopeNote mesh__D013032
% 216.96/217.11       The larval form of the diphyllobothriid tapeworms of the genus DIPHYLLOBOTHRIUM and SPIROMETRA. Fish-eating mammals and man are the final hosts.%A%    
% 216.96/217.11  |- rdf__type mesh__D013032sskos__Concept
% 216.96/217.11  |- mesh__recordAuthorizer mesh__D013032 sjn
% 216.96/217.11  |- mesh__recordOriginator mesh__D013032 NLM
% 216.96/217.11  |- skos__historyNote mesh__D013032 Diphyllobothrium %28%1966-1974%29%
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D013032 2005
% 216.96/217.11  |- mesh__dateEstablished mesh__D013032 1979-01-01
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D013032 2006
% 216.96/217.11  |- skos__broader mesh__D005528Q000293smesh__D005528
% 216.96/217.11  |- mesh__preferredCombination mesh__D005528Q000293smesh__D018409
% 216.96/217.11  |- rdf__type mesh__D005528Q000293smesh__CompoundConcept
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D051151 2006
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D051151 2006A
% 216.96/217.11  |- skos__altLabel mesh__D051151 SelW Protein
% 216.96/217.11  |- mesh__dateEstablished mesh__D051151 2006-01-01
% 216.96/217.11  |- mesh__historyNote mesh__D051151 2006%28%2005%29%   
% 216.96/217.11  |- skos__prefLabel mesh__D051151 Selenoprotein W
% 216.96/217.11  |- mesh__dateCreated mesh__D051151 2005-06-30
% 216.96/217.11  |- mesh__recordOriginator mesh__D051151 DRC
% 216.96/217.11  |- skos__scopeNote mesh__D051151
% 216.96/217.11       A single SELENOCYSTEINE containing protein that binds reduced GLUTATHIONE and can act as an antioxidant.%A%    
% 216.96/217.11  |- rdf__type mesh__D051151sskos__Concept
% 216.96/217.11  |- mesh__recordMaintainer mesh__D051151 ags
% 216.96/217.11  |- mesh__publicMeSHNote mesh__D051151
% 216.96/217.11       2006; SELENOPROTEIN W was indexed under PROTEINS 2005   
% 216.96/217.11  |- mesh__dateRevised mesh__D051151 2005-07-08
% 216.96/217.11  |- skos__broader mesh__D051151smesh__D051140
% 216.96/217.11  |- mesh__recordAuthorizer mesh__D051151 ags
% 216.96/217.11  |- skos__historyNote mesh__D012738 Protein Binding %28%1974-1975%29%
% 216.96/217.11  |- mesh__historyNote mesh__D012738
% 216.96/217.11       77; SEX STEROID-BINDING PROTEIN was SEX-STEROID-BINDING PROTEIN %28%NM%29% 1981-91; ESTRADIOL-BINDING GLOBULIN %26% TESTOSTERONE-BINDING GLOBULIN were see SEX HORMONE-BINDING GLOBULIN 1977-92%A%  
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D012738 2000
% 216.96/217.11  |- skos__historyNote mesh__D012738 Beta Globulins %28%1974-1976%29%
% 216.96/217.11  |- skos__hiddenLabel mesh__D012738 Binding Globulin, Testosterone-Estradiol
% 216.96/217.11  |- skos__hiddenLabel mesh__D012738 Globulin, Sex Hormone-Binding
% 216.96/217.11  |- mesh__dateRevised mesh__D012738 2004-08-02
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D012738 2005A
% 216.96/217.11  |- skos__prefLabel mesh__D012738 Sex Hormone-Binding Globulin
% 216.96/217.11  |- skos__historyNote mesh__D012738 Sex Hormones %28%1974-1976%29%
% 216.96/217.11  |- skos__broader mesh__D012738smesh__D002352
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D012738 2000A
% 216.96/217.11  |- skos__annotation mesh__D012738
% 216.96/217.11       does not refer to all sex hormones: refers to a specific protein in the blood binding only testosterone or estradiol; for other sex hormone-binding globulins consider ANDROGEN-BINDING PROTEIN %26% PROGESTERONE-BINDING GLOBULIN; DF: SHBG%A%  
% 216.96/217.11  |- skos__hiddenLabel mesh__D012738 Testosterone Estradiol Binding Globulin
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D012738 2004
% 216.96/217.11  |- skos__broader mesh__D012738smesh__D001609
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D012738 2005B
% 216.96/217.11  |- mesh__dateEstablished mesh__D012738 1977-01-01
% 216.96/217.11  |- mesh__dateCreated mesh__D012738 1976-04-16
% 216.96/217.11  |- mesh__publicMeSHNote mesh__D012738
% 216.96/217.11       77; SEX-STEROID-BINDING PROTEIN was indexed under CARRIER PROTEINS 1981-91; ESTRADIOL-BINDING GLOBULIN %26% TESTOSTERONE-BINDING GLOBULIN were see SEX HORMONE-BINDING GLOBULIN 1977-92%A%  
% 216.96/217.11  |- skos__historyNote mesh__D012738 Glycoproteins %28%1974-1975%29%
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D012738 2003
% 216.96/217.11  |- skos__hiddenLabel mesh__D012738 Hormone-Binding Globulin, Sex
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D012738 2006
% 216.96/217.11  |- mesh__onlineNote mesh__D012738
% 216.96/217.11       use SEX HORMONE-BINDING GLOBULIN %28%NM%29% to search SEX-STEROID-BINDING PROTEIN 1981-91; use SEX HORMONE-BINDING GLOBULIN to search ESTRADIOL-BINDING GLOBULIN %26% TESTOSTERONE-BINDING GLOBULIN 1977-92%A%  
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D012738 2002
% 216.96/217.11  |- skos__hiddenLabel mesh__D012738 Sex Hormone Binding Globulin
% 216.96/217.11  |- skos__scopeNote mesh__D012738
% 216.96/217.11       A glycoprotein migrating as a beta-globulin. Its molecular weight, 52,000 or 95,000-115,000, indicates that it exists as a dimer. The protein binds testosterone, dihydrotestosterone, and estradiol in the plasma. Sex hormone-binding protein has the same amino acid sequence as ANDROGEN-BINDING PROTEIN. They differ by their sites of synthesis and post-translational oligosaccharide modifications.%A%    
% 216.96/217.11  |- skos__hiddenLabel mesh__D012738 Steroid-Binding Protein, Sex
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D012738 2005
% 216.96/217.11  |- rdf__type mesh__D012738sskos__Concept
% 216.96/217.11  |- mesh__recordAuthorizer mesh__D012738 jls
% 216.96/217.11  |- skos__hiddenLabel mesh__D012738 Sex Steroid Binding Protein
% 216.96/217.11  |- skos__historyNote mesh__D012738 Carrier Proteins %28%1971-1991%29%
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D012738 2001
% 216.96/217.11  |- skos__hiddenLabel mesh__D012738 Globulin, Testosterone-Estradiol Binding
% 216.96/217.11  |- skos__altLabel mesh__D012738 Sex Steroid-Binding Protein
% 216.96/217.11  |- skos__related mesh__D012738smesh__D000727
% 216.96/217.11  |- skos__altLabel mesh__D012738 Testosterone-Estradiol Binding Globulin
% 216.96/217.11  |- mesh__recordMaintainer mesh__D012738 jls
% 216.96/217.11  |- mesh__recordOriginator mesh__D012738 RLS
% 216.96/217.11  |- rdf__type mesh__D017423sskos__Concept
% 216.96/217.11  |- mesh__publicMeSHNote mesh__D017423 93   
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D017423 2002
% 216.96/217.11  |- skos__historyNote mesh__D017423 Base Sequence %28%1971-1992%29%
% 216.96/217.11  |- skos__broader mesh__D017423smesh__D017421
% 216.96/217.11  |- skos__altLabel mesh__D017423 Determinations, RNA Sequence
% 216.96/217.11  |- skos__altLabel mesh__D017423 Analysis, RNA Sequence
% 216.96/217.11  |- skos__hiddenLabel mesh__D017423 Analyses, RNA Sequence
% 216.96/217.11  |- skos__scopeNote mesh__D017423
% 216.96/217.11       A multistage process that includes RNA cloning, physical mapping, subcloning, sequencing, and information analysis.%A%    
% 216.96/217.11  |- skos__hiddenLabel mesh__D017423 RNA Sequence Analyses
% 216.96/217.11  |- skos__altLabel mesh__D017423 RNA Sequence Determinations
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D017423 2005
% 216.96/217.11  |- mesh__dateCreated mesh__D017423 1992-05-22
% 216.96/217.11  |- skos__prefLabel mesh__D017423 Sequence Analysis, RNA
% 216.96/217.11  |- skos__annotation mesh__D017423 DF: SEQ ANAL RNA   
% 216.96/217.11  |- mesh__dateEstablished mesh__D017423 1993-01-01
% 216.96/217.11  |- mesh__dateRevised mesh__D017423 1999-11-03
% 216.96/217.11  |- skos__hiddenLabel mesh__D017423 Sequence Analyses, RNA
% 216.96/217.11  |- mesh__recordOriginator mesh__D017423 PXP
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D017423 2003
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D017423 2006
% 216.96/217.11  |- mesh__recordAuthorizer mesh__D017423 sjn
% 216.96/217.11  |- skos__altLabel mesh__D017423 Determination, RNA Sequence
% 216.96/217.11  |- mesh__recordMaintainer mesh__D017423 nns
% 216.96/217.11  |- mesh__historyNote mesh__D017423 93   
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D017423 2000
% 216.96/217.11  |- skos__altLabel mesh__D017423 Sequence Determination, RNA
% 216.96/217.11  |- skos__altLabel mesh__D017423 RNA Sequence Analysis
% 216.96/217.11  |- skos__historyNote mesh__D017423 RNA %28%1966-1992%29%
% 216.96/217.11  |- skos__historyNote mesh__D017423 Amino Acid Sequence %28%1966-1992%29%
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D017423 2004
% 216.96/217.11  |- skos__altLabel mesh__D017423 RNA Sequence Determination
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D017423 2001
% 216.96/217.11  |- skos__historyNote mesh__D050857 Membrane Glycoproteins %28%1991-2005%29%
% 216.96/217.11  |- skos__historyNote mesh__D050857
% 216.96/217.11       Calcium-Binding Proteins %28%1991-2005%29%
% 216.96/217.11  |- mesh__recordAuthorizer mesh__D050857 sjn
% 216.96/217.11  |- mesh__dateCreated mesh__D050857 2005-06-30
% 216.96/217.11  |- skos__altLabel mesh__D050857 Synaptotagmin 3
% 216.96/217.11  |- skos__altLabel mesh__D050857 Synaptotagmin 8
% 216.96/217.11  |- skos__prefLabel mesh__D050857 Synaptotagmins
% 216.96/217.11  |- skos__altLabel mesh__D050857 SytIV Protein
% 216.96/217.11  |- skos__altLabel mesh__D050857 Synaptotagmin 9
% 216.96/217.11  |- skos__altLabel mesh__D050857 Synaptotagmin 4
% 216.96/217.11  |- skos__altLabel mesh__D050857 Synaptotagmin 7
% 216.96/217.11  |- skos__broader mesh__D050857smesh__D033921
% 216.96/217.11  |- skos__altLabel mesh__D050857 Synaptotagmin 14
% 216.96/217.11  |- skos__altLabel mesh__D050857 Synaptotagmin 5
% 216.96/217.11  |- skos__altLabel mesh__D050857 Synaptotagmin 13
% 216.96/217.11  |- skos__altLabel mesh__D050857 SytXIII Protein
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D050857 2006
% 216.96/217.11  |- mesh__publicMeSHNote mesh__D050857
% 216.96/217.11       2006; SYNAPTOTAGMIN was indexed under CALCIUM-BINDING PROTEINS, MEMBRANE GLYCOPROTEINS %26% NERVE TISSUE PROTEINS 1991-2005%A%  
% 216.96/217.11  |- mesh__recordMaintainer mesh__D050857 DRC
% 216.96/217.11  |- skos__altLabel mesh__D050857 Synaptotagmin
% 216.96/217.11  |- mesh__recordOriginator mesh__D050857 DRC
% 216.96/217.11  |- mesh__historyNote mesh__D050857 2006%28%1991%29%   
% 216.96/217.11  |- skos__altLabel mesh__D050857 Tagmin
% 216.96/217.11  |- skos__altLabel mesh__D050857 Synaptotagmin 15
% 216.96/217.11  |- skos__broader mesh__D050857smesh__D002135
% 216.96/217.11  |- skos__altLabel mesh__D050857 Synaptotagmin 6
% 216.96/217.11  |- skos__altLabel mesh__D050857 Synaptotagmin 11
% 216.96/217.11  |- skos__scopeNote mesh__D050857
% 216.96/217.11       A family of vesicular transport proteins characterized by an N-terminal transmembrane region and two C-terminal calcium-binding domains.%A%    
% 216.96/217.11  |- skos__altLabel mesh__D050857 Synaptotagmin 12
% 216.96/217.11  |- mesh__dateEstablished mesh__D050857 2006-01-01
% 216.96/217.11  |- rdf__type mesh__D050857sskos__Concept
% 216.96/217.11  |- skos__historyNote mesh__D050857 Nerve Tissue Proteins %28%1991-2005%29%
% 216.96/217.11  |- skos__altLabel mesh__D050857 SytVII Protein
% 216.96/217.11  |- skos__altLabel mesh__D036388 LERK-5 Gene Product
% 216.96/217.11  |- mesh__recordMaintainer mesh__D036388 ags
% 216.96/217.11  |- rdf__type mesh__D036388sskos__Concept
% 216.96/217.11  |- skos__hiddenLabel mesh__D036388 Ephrin B2
% 216.96/217.11  |- skos__altLabel mesh__D036388 Efbn2 Gene Product
% 216.96/217.11  |- skos__hiddenLabel mesh__D036388 Mammalian ELF-2 Protein
% 216.96/217.11  |- skos__hiddenLabel mesh__D036388 ELF-2, Mammalian
% 216.96/217.11  |- skos__altLabel mesh__D036388 ELF-2 Protein, Mammalian
% 216.96/217.11  |- skos__altLabel mesh__D036388 LERK-5 Protein
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D036388 2006A
% 216.96/217.11  |- skos__historyNote mesh__D036388 Membrane Proteins %28%1995-2002%29%
% 216.96/217.11  |- mesh__dateEstablished mesh__D036388 2003-01-01
% 216.96/217.11  |- mesh__publicMeSHNote mesh__D036388
% 216.96/217.11       2003; EPH LIGAND FAMILY 2 PROTEIN, MAMMALIAN %28%now EPHRIN-B2%29% was indexed under MEMBRANE PROTEINS 1995-2002; LERK-5 PROTEIN %28%now EPHRIN-B2%29% was indexed under MEMBRANE PROTEINS 1996-2002%A%  
% 216.96/217.11  |- skos__altLabel mesh__D036388 Eplg5 Protein
% 216.96/217.11  |- mesh__dateRevised mesh__D036388 2005-07-08
% 216.96/217.11  |- skos__hiddenLabel mesh__D036388 Mammalian ELF 2
% 216.96/217.11  |- skos__hiddenLabel mesh__D036388 LERK 5 Protein
% 216.96/217.11  |- skos__altLabel mesh__D036388 Htk Ligand
% 216.96/217.11  |- skos__hiddenLabel mesh__D036388 LERK 5 Gene Product
% 216.96/217.11  |- skos__broader mesh__D036388smesh__D036342
% 216.96/217.11  |- skos__scopeNote mesh__D036388
% 216.96/217.11       A transmembrane domain containing ephrin that binds with high affinity to EPHB1 RECEPTOR; EPHB3 RECEPTOR; and EPHB4 RECEPTOR. Expression of ephrin-B2 occurs in a variety of adult tissues. During embryogenesis, high levels of ephrin-B2 is seen in the PROSENCEPHALON; RHOMBENCEPHALON; developing SOMITES; LIMB BUD; and bronchial arches.%A%    
% 216.96/217.11  |- skos__hiddenLabel mesh__D036388 Ligand, Htk
% 216.96/217.11  |- skos__altLabel mesh__D036388 Mammalian ELF-2
% 216.96/217.11  |- mesh__recordAuthorizer mesh__D036388 ags
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D036388 2006
% 216.96/217.11  |- skos__altLabel mesh__D036388 Eplg5 Gene Product
% 216.96/217.11  |- mesh__dateCreated mesh__D036388 2002-07-03
% 216.96/217.11  |- mesh__historyNote mesh__D036388
% 216.96/217.11       2003; use EPHRIN-B2 %28%NM%29% 1995-2002   
% 216.96/217.11  |- skos__hiddenLabel mesh__D036388 ELF 2 Protein, Mammalian
% 216.96/217.11  |- skos__prefLabel mesh__D036388 Ephrin-B2
% 216.96/217.11  |- mesh__recordOriginator mesh__D036388 jmp
% 216.96/217.11  |- skos__altLabel mesh__D036388 HTKL Protein
% 216.96/217.11  |- mesh__dateCreated mesh__D008697 1999-01-01
% 216.96/217.11  |- skos__prefLabel mesh__D008697 Methane
% 216.96/217.11  |- rdf__type mesh__D008697sskos__Concept
% 216.96/217.11  |- mesh__dateRevised mesh__D008697 2005-06-30
% 216.96/217.11  |- mesh__recordMaintainer mesh__D008697 ssb
% 216.96/217.11  |- mesh__recordOriginator mesh__D008697 NLM
% 216.96/217.11  |- skos__scopeNote mesh__D008697
% 216.96/217.11       The simplest saturated hydrocarbon. It is a colorless, flammable gas, slightly soluble in water. It is one of the chief constituents of natural gas and is formed in the decomposition of organic matter. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 216.96/217.11  |- skos__broader mesh__D008697smesh__D000473
% 216.96/217.11  |- mesh__recordAuthorizer mesh__D008697 sjn
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D008697 2006
% 216.96/217.11  |- rdf__type mesh__D041522sskos__Concept
% 216.96/217.11  |- mesh__historyNote mesh__D041522 2004   
% 216.96/217.11  |- mesh__dateCreated mesh__D041522 2003-07-09
% 216.96/217.11  |- skos__prefLabel mesh__D041522 Aeropyrum
% 216.96/217.11  |- mesh__publicMeSHNote mesh__D041522 2004   
% 216.96/217.11  |- skos__historyNote mesh__D041522 Desulfurococcaceae %28%2000-2003%29%
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D041522 2006
% 216.96/217.11  |- skos__scopeNote mesh__D041522
% 216.96/217.11       A genus of anaerobic, chemolithotropic coccoid ARCHAEA, in the family DESULFUROCOCCACEAE. They live in marine environments.%A%    
% 216.96/217.11  |- mesh__dateRevised mesh__D041522 2005-06-30
% 216.96/217.11  |- mesh__recordMaintainer mesh__D041522 SYSTEM
% 216.96/217.11  |- skos__historyNote mesh__D041522 Archaea %28%1996-1999%29%
% 216.96/217.11  |- mesh__recordOriginator mesh__D041522 ags
% 216.96/217.11  |- skos__historyNote mesh__D041522 Crenarchaeota %28%1997-2002%29%
% 216.96/217.11  |- skos__broader mesh__D041522smesh__D019620
% 216.96/217.11  |- mesh__dateEstablished mesh__D041522 2004-01-01
% 216.96/217.11  |- mesh__recordAuthorizer mesh__D041522 sjn
% 216.96/217.11  |- mesh__recordOriginator mesh__D013831 NLM
% 216.96/217.11  |- mesh__recordAuthorizer mesh__D013831 sjn
% 216.96/217.11  |- mesh__dateCreated mesh__D013831 1999-01-01
% 216.96/217.11  |- skos__altLabel mesh__D013831 Aneurin
% 216.96/217.11  |- skos__broader mesh__D013831smesh__D011743
% 216.96/217.11  |- skos__hiddenLabel mesh__D013831 Mononitrate, Thiamine
% 216.96/217.11  |- skos__scopeNote mesh__D013831
% 216.96/217.11       3-%28%%28%4-Amino-2-methyl-5-pyrimidinyl%29%methyl%29%-5-%28%2- hydroxyethyl%29%-4-methylthiazolium chloride.%A%    
% 216.96/217.11  |- mesh__recordMaintainer mesh__D013831 ssb
% 216.96/217.11  |- skos__broader mesh__D013831smesh__D013844
% 216.96/217.11  |- skos__prefLabel mesh__D013831 Thiamine
% 216.96/217.11  |- skos__altLabel mesh__D013831 Vitamin B 1
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D013831 2006
% 216.96/217.11  |- rdf__type mesh__D013831sskos__Concept
% 216.96/217.11  |- mesh__dateRevised mesh__D013831 2005-06-30
% 216.96/217.11  |- skos__altLabel mesh__D013831 Vitamin B1
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D013033 2000
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D013033 1998
% 216.96/217.11  |- mesh__recordAuthorizer mesh__D013033 PLS
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D013033 2004
% 216.96/217.11  |- skos__historyNote mesh__D013033 Antibiotics %28%1974%29%
% 216.96/217.11  |- skos__historyNote mesh__D013033 Ribonucleosides %28%1974%29%
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D013033 2006
% 216.96/217.11  |- skos__annotation mesh__D013033 an antineoplastic antibiotic   
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D013033 2003
% 216.96/217.11  |- mesh__recordMaintainer mesh__D013033 JRT
% 216.96/217.11  |- mesh__publicMeSHNote mesh__D013033
% 216.96/217.11       91; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90   
% 216.96/217.11  |- mesh__historyNote mesh__D013033
% 216.96/217.11       91%28%75%29%; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90%A%  
% 216.96/217.11  |- skos__prefLabel mesh__D013033 Sparsomycin
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D013033 2005
% 216.96/217.11  |- skos__scopeNote mesh__D013033
% 216.96/217.11       An antitumor antibiotic produced by Streptomyces sparsogenes. It inhibits protein synthesis in 70S and 80S ribosomal systems.%A%    
% 216.96/217.11  |- skos__broader mesh__D013033smesh__D011744
% 216.96/217.11  |- mesh__dateCreated mesh__D013033 1974-11-19
% 216.96/217.11  |- mesh__dateEstablished mesh__D013033 1991-01-01
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D013033 2002
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D013033 2001
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D013033 1997
% 216.96/217.11  |- skos__historyNote mesh__D013033 Antibiotics, Antineoplastic %28%1974%29%
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D013033 1999
% 216.96/217.11  |- rdf__type mesh__D013033sskos__Concept
% 216.96/217.11  |- mesh__dateRevised mesh__D013033 1995-06-08
% 216.96/217.11  |- mesh__activeMeSHYear mesh__D013033 1996
% 216.96/217.11  |- mesh__recordOriginator mesh__D013033 NLM
% 216.96/217.11  |- skos__hiddenLabel mesh__D051152
% 216.96/217.11       Testosterone Repressed Prostate Message 2 Protein
% 216.96/217.11  |- skos__altLabel mesh__D051152 Complement Lysis Inhibitor
% 216.96/217.11  |- skos__altLabel mesh__D051152 ApoJ Protein
% 216.96/217.11  |- skos__altLabel mesh__D051152 SP 40,40 Protein
% 216.96/217.12  |- mesh__recordOriginator mesh__D051152 DRC
% 216.96/217.12  |- skos__hiddenLabel mesh__D051152 Ionizing Radiation Induced Protein 8
% 216.96/217.12  |- skos__altLabel mesh__D051152 Apolipoprotein J
% 216.96/217.12  |- skos__hiddenLabel mesh__D051152 Radiation-Induced Protein-8, Ionizing
% 216.96/217.12  |- rdf__type mesh__D051152sskos__Concept
% 216.96/217.12  |- mesh__dateEstablished mesh__D051152 2006-01-01
% 216.96/217.12  |- skos__altLabel mesh__D051152
% 216.96/217.12       Testosterone-Repressed Prostate Message-2 Protein
% 216.96/217.12  |- skos__altLabel mesh__D051152 Sulfated Glycoprotein 2
% 216.96/217.12  |- skos__altLabel mesh__D051152 Ionizing Radiation-Induced Protein-8
% 216.96/217.12  |- mesh__historyNote mesh__D051152 2006%28%1980%29%   
% 216.96/217.12  |- skos__prefLabel mesh__D051152 Clusterin
% 216.96/217.12  |- mesh__publicMeSHNote mesh__D051152
% 216.96/217.12       2006; CLUSTERIN was indexed under GLYCOPROTEINS %26% MOLECULAR CHAPERONES 1981-2005, %26% under SALIVARY PROTEINS 1980%A%  
% 216.96/217.12  |- skos__altLabel mesh__D051152 MAC393 Antigen
% 216.96/217.12  |- skos__scopeNote mesh__D051152
% 216.96/217.12       A highly conserved heterodimeric glycoprotein that is differentially expressed during many severe physiological disturbance states such as CANCER; APOPTOSIS; and various NEUROLOGICAL DISORDERS. Clusterin is ubiquitously expressed and appears to function as a secreted MOLECULAR CHAPERONE.%A%    
% 216.96/217.12  |- skos__altLabel mesh__D051152 TRPM-2 Protein
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D051152 2006
% 216.96/217.12  |- skos__hiddenLabel mesh__D051152 SGP 2 Protein
% 216.96/217.12  |- skos__hiddenLabel mesh__D051152 Complement Associated Protein SP 40,40
% 216.96/217.12  |- skos__altLabel mesh__D051152 Complement-Associated Protein SP-40,40
% 216.96/217.12  |- mesh__recordAuthorizer mesh__D051152 sjn
% 216.96/217.12  |- skos__hiddenLabel mesh__D051152 X Ray Inducible Protein 8
% 216.96/217.12  |- skos__hiddenLabel mesh__D051152 TRPM 2 Protein
% 216.96/217.12  |- skos__hiddenLabel mesh__D051152 SP-40,40, Complement-Associated Protein
% 216.96/217.12  |- skos__hiddenLabel mesh__D051152 40,40 Protein, SP
% 216.96/217.12  |- skos__altLabel mesh__D051152 Sulfated Glycoprotein-2
% 216.96/217.12  |- mesh__recordMaintainer mesh__D051152 DRC
% 216.96/217.12  |- skos__altLabel mesh__D051152 XIP8 Protein
% 216.96/217.12  |- mesh__dateCreated mesh__D051152 2005-06-30
% 216.96/217.12  |- skos__altLabel mesh__D051152 SGP-2 Protein
% 216.96/217.12  |- skos__broader mesh__D051152smesh__D006023
% 216.96/217.12  |- skos__broader mesh__D051152smesh__D018832
% 216.96/217.12  |- skos__altLabel mesh__D051152 X-Ray-Inducible Protein 8
% 216.96/217.12  |- rdf__type mesh__D012739sskos__Concept
% 216.96/217.12  |- mesh__recordMaintainer mesh__D012739 lkt
% 216.96/217.12  |- skos__hiddenLabel mesh__D012739 Hormones, Gonadal Steroid
% 216.96/217.12  |- mesh__dateCreated mesh__D012739 1999-01-01
% 216.96/217.12  |- mesh__dateRevised mesh__D012739 2003-07-09
% 216.96/217.12  |- skos__hiddenLabel mesh__D012739 Steroid Hormones, Gonadal
% 216.96/217.12  |- skos__hiddenLabel mesh__D012739 Hormones, Sex Steroid
% 216.96/217.12  |- skos__broader mesh__D012739smesh__D042341
% 216.96/217.12  |- mesh__publicMeSHNote mesh__D012739 2004; see SEX HORMONES 1963-2003   
% 216.96/217.12  |- skos__prefLabel mesh__D012739 Gonadal Steroid Hormones
% 216.96/217.12  |- skos__annotation mesh__D012739
% 216.96/217.12       GEN or unspecified; prefer specific groups or specific hormone%A%  
% 216.96/217.12  |- skos__altLabel mesh__D012739 Sex Hormones
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D012739 2005
% 216.96/217.12  |- skos__hiddenLabel mesh__D012739 Steroid Hormones, Sex
% 216.96/217.12  |- mesh__recordAuthorizer mesh__D012739 sjn
% 216.96/217.12  |- mesh__recordOriginator mesh__D012739 NLM
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D012739 2006
% 216.96/217.12  |- skos__scopeNote mesh__D012739
% 216.96/217.12       Steroid hormones produced by the GONADS. They stimulate reproductive organs, germ cell maturation, and the secondary sex characteristics in the males and the females. The major sex steroid hormones include ESTRADIOL; PROGESTERONE; and TESTOSTERONE.%A%    
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D012739 2004
% 216.96/217.12  |- skos__altLabel mesh__D012739 Sex Steroid Hormones
% 216.96/217.12  |- mesh__historyNote mesh__D012739 2004 %28%1963%29%   
% 216.96/217.12  |- skos__annotation mesh__D009790
% 216.96/217.12       SPEC: SPEC qualif; OCCUPATIONS are not necessarily %22%industrial%22%; differentiate from OCCUPATIONAL GROUPS: OCCUPATIONS is for the occup itself, OCCUPATIONAL GROUPS is for the collective members of an occup; relation to INDUSTRY; INDUSTRIAL MEDICINE %28%see OCCUPATIONAL MEDICINE%29% %26% OCCUPATIONAL DISEASES: Manual 31.13-31.16; BURNOUT, PROFESSIONAL is available; DF: OCCUP%A%  
% 216.96/217.12  |- skos__related mesh__D009790smesh__D017132
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D009790 2006
% 216.96/217.12  |- skos__hiddenLabel mesh__D009790 Vocation
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D009790 2005
% 216.96/217.12  |- mesh__historyNote mesh__D009790
% 216.96/217.12       68; was OCCUPATIONS AND PROFESSIONS 1963-67   
% 216.96/217.12  |- mesh__recordOriginator mesh__D009790 NLM
% 216.96/217.12  |- rdf__type mesh__D009790sskos__Concept
% 216.96/217.12  |- skos__broader mesh__D009790smesh__D012959
% 216.96/217.12  |- skos__related mesh__D009790smesh__D009274
% 216.96/217.12  |- mesh__dateRevised mesh__D009790 2001-07-25
% 216.96/217.12  |- mesh__recordAuthorizer mesh__D009790 sjn
% 216.96/217.12  |- mesh__dateEstablished mesh__D009790 1968-01-01
% 216.96/217.12  |- skos__hiddenLabel mesh__D009790 Occupation
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D009790 2002
% 216.96/217.12  |- mesh__publicMeSHNote mesh__D009790
% 216.96/217.12       68; was OCCUPATIONS AND PROFESSIONS 1963-67   
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D009790 2004
% 216.96/217.12  |- mesh__recordMaintainer mesh__D009790 mdb
% 216.96/217.12  |- mesh__dateCreated mesh__D009790 1999-01-01
% 216.96/217.12  |- skos__related mesh__D009790smesh__D006281
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D009790 2003
% 216.96/217.12  |- skos__prefLabel mesh__D009790 Occupations
% 216.96/217.12  |- mesh__onlineNote mesh__D009790
% 216.96/217.12       use OCCUPATIONS to search OCCUPATIONS AND PROFESSIONS 1966-67%A%  
% 216.96/217.12  |- skos__scopeNote mesh__D009790
% 216.96/217.12       Crafts, trades, professions, or other means of earning a living.%A%    
% 216.96/217.12  |- skos__hiddenLabel mesh__D023461 Cell, Myeloid Stem
% 216.96/217.12  |- skos__altLabel mesh__D023461 Stem Cells, Myeloid
% 216.96/217.12  |- mesh__dateEstablished mesh__D023461 2001-01-01
% 216.96/217.12  |- skos__scopeNote mesh__D023461
% 216.96/217.12       One of the two stem cells derived from HEMATOPOIETIC STEM CELLS - the other being the lymphoid progenitor cell. Derived from these myeloid progenitor cells are the ERYTHROID PROGENITOR CELLS and the MYELOID CELLS; %28%MONOCYTES and GRANULOCYTES%29%.%A%    
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D023461 2006
% 216.96/217.12  |- skos__hiddenLabel mesh__D023461 Myeloid Stem Cell
% 216.96/217.12  |- skos__hiddenLabel mesh__D023461 Stem Cell, Myeloid
% 216.96/217.12  |- skos__hiddenLabel mesh__D023461 Myeloid Stem Cells
% 216.96/217.12  |- mesh__recordAuthorizer mesh__D023461 ags
% 216.96/217.12  |- mesh__dateCreated mesh__D023461 2000-06-22
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D023461 2005
% 216.96/217.12  |- mesh__dateRevised mesh__D023461 2005-07-20
% 216.96/217.12  |- skos__hiddenLabel mesh__D023461 Myeloid Progenitor Cell
% 216.96/217.12  |- mesh__publicMeSHNote mesh__D023461 2001   
% 216.96/217.12  |- skos__broader mesh__D023461smesh__D006412
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D023461 2006A
% 216.96/217.12  |- skos__hiddenLabel mesh__D023461 Cells, Myeloid Progenitor
% 216.96/217.12  |- skos__broader mesh__D023461smesh__D022423
% 216.96/217.12  |- skos__historyNote mesh__D023461
% 216.96/217.12       Hematopoietic Stem Cells %28%1978-2000%29%
% 216.96/217.12  |- rdf__type mesh__D023461sskos__Concept
% 216.96/217.12  |- skos__hiddenLabel mesh__D023461 Progenitor Cells, Myeloid
% 216.96/217.12  |- skos__hiddenLabel mesh__D023461 Progenitor Cell, Myeloid
% 216.96/217.12  |- mesh__historyNote mesh__D023461 2001   
% 216.96/217.12  |- skos__hiddenLabel mesh__D023461 Cells, Myeloid Stem
% 216.96/217.12  |- mesh__recordMaintainer mesh__D023461 ags
% 216.96/217.12  |- mesh__recordOriginator mesh__D023461 nns
% 216.96/217.12  |- skos__hiddenLabel mesh__D023461 Cell, Myeloid Progenitor
% 216.96/217.12  |- skos__prefLabel mesh__D023461 Myeloid Progenitor Cells
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D023461 2004
% 216.96/217.12  |- rdf__type mesh__D050858sskos__Concept
% 216.96/217.12  |- mesh__publicMeSHNote mesh__D050858
% 216.96/217.12       2006; BETALAINS was under AMMONIUM COMPOUNDS 1982-2005, BETALAIN PIGMENTS was under PIGMENTS 1982-2004%A%  
% 216.96/217.12  |- mesh__historyNote mesh__D050858 2006 %28%1972%29%   
% 216.96/217.12  |- mesh__dateEstablished mesh__D050858 2006-01-01
% 216.96/217.12  |- skos__broader mesh__D050858smesh__D000644
% 216.96/217.12  |- mesh__dateCreated mesh__D050858 2005-06-30
% 216.96/217.12  |- skos__scopeNote mesh__D050858
% 216.96/217.12       Compounds derived from TYROSINE via betalamic acid, including BETAXANTHINS and BETACYANINS. They are found in the Caryophyllales order of PLANTS and some BASIDIOMYCETES.%A%    
% 216.96/217.12  |- mesh__recordAuthorizer mesh__D050858 ags
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D050858 2006A
% 216.96/217.12  |- skos__broader mesh__D050858smesh__D010880
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D050858 2006
% 216.96/217.12  |- mesh__recordOriginator mesh__D050858 ssb
% 216.96/217.12  |- mesh__recordMaintainer mesh__D050858 ags
% 216.96/217.12  |- skos__prefLabel mesh__D050858 Betalains
% 216.96/217.12  |- mesh__dateRevised mesh__D050858 2005-07-11
% 216.96/217.12  |- skos__historyNote mesh__D050858 Ammonium Compounds %28%1972-2005%29%
% 216.96/217.12  |- skos__broader mesh__D050858smesh__D014443
% 216.96/217.12  |- skos__hiddenLabel mesh__D036389 LERK 8 Protein
% 216.96/217.12  |- skos__hiddenLabel mesh__D036389 Gene Product, EPLG8
% 216.96/217.12  |- mesh__recordOriginator mesh__D036389 jmp
% 216.96/217.12  |- mesh__dateRevised mesh__D036389 2005-06-30
% 216.96/217.12  |- skos__prefLabel mesh__D036389 Ephrin-B3
% 216.96/217.12  |- mesh__publicMeSHNote mesh__D036389
% 216.96/217.12       2003; EPHRIN-B3 was indexed under MEMBRANE PROTEINS 1998-2002; LERK-8 PROTEIN %28%now EPHRIN-B3%29% was indexed under MEMBRANE PROTEINS 1997-2002%A%  
% 216.96/217.12  |- mesh__recordMaintainer mesh__D036389 ssb
% 216.96/217.12  |- skos__broader mesh__D036389smesh__D036342
% 216.96/217.12  |- skos__altLabel mesh__D036389 LERK-8 Protein
% 216.96/217.12  |- skos__altLabel mesh__D036389 LERK-8
% 216.96/217.12  |- skos__hiddenLabel mesh__D036389 Ephrin B3
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D036389 2006
% 216.96/217.12  |- skos__scopeNote mesh__D036389
% 216.96/217.12       A transmembrane domain containing ephrin. Although originally found to be specific for the EPHB3 RECEPTOR it has since been shown to bind a variety of EPH FAMILY RECEPTORS. During embryogenesis ephrin-B3 is expressed at high levels in the ventral neural tube. In adult tissues, it is found primarily in the BRAIN and HEART.%A%    
% 216.96/217.12  |- mesh__dateEstablished mesh__D036389 2003-01-01
% 216.96/217.12  |- skos__altLabel mesh__D036389 EFNB3
% 216.96/217.12  |- mesh__historyNote mesh__D036389
% 216.96/217.12       2003; use EPHRIN-B3 %28%NM%29% 1997-2002   
% 216.96/217.12  |- mesh__recordAuthorizer mesh__D036389 sjn
% 216.96/217.12  |- skos__altLabel mesh__D036389 EPLG8 Gene Product
% 216.96/217.12  |- rdf__type mesh__D036389sskos__Concept
% 216.96/217.12  |- mesh__dateCreated mesh__D036389 2002-07-03
% 216.96/217.12  |- skos__historyNote mesh__D036389 Membrane Proteins %28%1997-2002%29%
% 216.96/217.12  |- mesh__recordOriginator mesh__D003404 NLM
% 216.96/217.12  |- skos__annotation mesh__D003404 do not confuse with CREATINE   
% 216.96/217.12  |- mesh__historyNote mesh__D003404
% 216.96/217.12       68; CREATINE AND CREATININE was heading 1963-67   
% 216.96/217.12  |- skos__broader mesh__D003404smesh__D007093
% 216.96/217.12  |- mesh__onlineNote mesh__D003404
% 216.96/217.12       search CREATINE AND CREATININE under CREATINE 1966-67   
% 216.96/217.12  |- skos__hiddenLabel mesh__D003404 Salt, Creatinine Sulfate
% 216.96/217.12  |- skos__prefLabel mesh__D003404 Creatinine
% 216.96/217.12  |- mesh__recordAuthorizer mesh__D003404 sjn
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D003404 2006
% 216.96/217.12  |- mesh__publicMeSHNote mesh__D003404
% 216.96/217.12       68; CREATINE AND CREATININE was heading 1963-67   
% 216.96/217.12  |- mesh__dateEstablished mesh__D003404 1968-01-01
% 216.96/217.12  |- mesh__recordMaintainer mesh__D003404 ssb
% 216.96/217.12  |- skos__hiddenLabel mesh__D003404 Sulfate Salt, Creatinine
% 216.96/217.12  |- rdf__type mesh__D003404sskos__Concept
% 216.96/217.12  |- mesh__dateCreated mesh__D003404 1999-01-01
% 216.96/217.12  |- mesh__dateRevised mesh__D003404 2005-06-30
% 216.96/217.12  |- skos__scopeNote mesh__D008698
% 216.96/217.12       Organic salts or esters of methanesulfonic acid.     
% 216.96/217.12  |- mesh__recordAuthorizer mesh__D008698 sjn
% 216.96/217.12  |- skos__altLabel mesh__D008698 Mesilates
% 216.96/217.12  |- skos__prefLabel mesh__D008698 Mesylates
% 216.96/217.12  |- mesh__recordMaintainer mesh__D008698 lkt
% 216.96/217.12  |- mesh__dateRevised mesh__D008698 2001-07-25
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D008698 2006
% 216.96/217.12  |- skos__altLabel mesh__D008698 Mesilate
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D008698 2002
% 216.96/217.12  |- mesh__onlineNote mesh__D008698
% 216.96/217.12       use MESYLATES to search METHANESULFONATES 1974-93   
% 216.96/217.12  |- mesh__historyNote mesh__D008698 94; was METHANESULFONATES 1974-93   
% 216.96/217.12  |- skos__altLabel mesh__D008698 Mesylate
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D008698 2005
% 216.96/217.12  |- mesh__dateEstablished mesh__D008698 1974-01-01
% 216.96/217.12  |- mesh__dateCreated mesh__D008698 1999-01-01
% 216.96/217.12  |- skos__altLabel mesh__D008698 Methanesulfonates
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D008698 2004
% 216.96/217.12  |- skos__altLabel mesh__D008698 Methylenesulfonates
% 216.96/217.12  |- mesh__recordOriginator mesh__D008698 NLM
% 216.96/217.12  |- rdf__type mesh__D008698sskos__Concept
% 216.96/217.12  |- skos__broader mesh__D008698smesh__D000476
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D008698 2003
% 216.96/217.12  |- mesh__publicMeSHNote mesh__D008698 94; was METHANESULFONATES 1974-93   
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D041523 2006
% 216.96/217.12  |- mesh__historyNote mesh__D041523
% 216.96/217.12       2004; for PYRODICTIUM use DESULFUROCOCCACEAE 1998-2003   
% 216.96/217.12  |- mesh__dateEstablished mesh__D041523 2004-01-01
% 216.96/217.12  |- mesh__recordMaintainer mesh__D041523 SYSTEM
% 216.96/217.12  |- mesh__recordAuthorizer mesh__D041523 sjn
% 216.96/217.12  |- skos__scopeNote mesh__D041523
% 216.96/217.12       A family of archaea, in the order DESULFUROCOCCALES consisting of anaerobic coccoid to disc-shaped cells. They grow either chemolithoautotrophically or by FERMENTATION. Three genera are recognized: Pyrodictium, Hyperthermus, and Pyrolobus.%A%    
% 216.96/217.12  |- skos__prefLabel mesh__D041523 Pyrodictiaceae
% 216.96/217.12  |- mesh__dateRevised mesh__D041523 2005-06-30
% 216.96/217.12  |- mesh__recordOriginator mesh__D041523 ags
% 216.96/217.12  |- rdf__type mesh__D041523sskos__Concept
% 216.96/217.12  |- mesh__dateCreated mesh__D041523 2003-07-09
% 216.96/217.12  |- mesh__publicMeSHNote mesh__D041523
% 216.96/217.12       2004; for PYRODICTIUM see DESULFUROCOCCACEAE 1998-2003   
% 216.96/217.12  |- skos__broader mesh__D041523smesh__D041521
% 216.96/217.12  |- skos__related mesh__D013832smesh__D001602
% 216.96/217.12  |- skos__scopeNote mesh__D013832
% 216.96/217.12       A nutritional condition produced by a deficiency of THIAMINE in the diet, characterized by anorexia, irritability, and weight loss. Later, patients experience weakness, peripheral neuropathy, headache, and tachycardia. In addition to being caused by a poor diet, thiamine deficiency in the United States most commonly occurs as a result of alcoholism, since ethanol interferes with thiamine absorption. In countries relying on polished rice as a dietary staple, BERIBERI prevalence is very high. %28%From Cecil Textbook of Medicine, 19th ed, p1171%29%%A%    
% 216.96/217.12  |- skos__hiddenLabel mesh__D013832 Deficiencies, Thiamine
% 216.96/217.12  |- skos__hiddenLabel mesh__D013832 Thiamine Deficiencies
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D013832 2006
% 216.96/217.12  |- rdf__type mesh__D013832sskos__Concept
% 216.96/217.12  |- mesh__dateRevised mesh__D013832 2003-07-09
% 216.96/217.12  |- mesh__recordMaintainer mesh__D013832 lkt
% 216.96/217.12  |- mesh__recordOriginator mesh__D013832 NLM
% 216.96/217.12  |- mesh__recordAuthorizer mesh__D013832 sjn
% 216.96/217.12  |- skos__prefLabel mesh__D013832 Thiamine Deficiency
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D013832 2004
% 216.96/217.12  |- skos__annotation mesh__D013832 a vitamin B defic; DF: THIAMINE DEFIC   
% 216.96/217.12  |- skos__broader mesh__D013832smesh__D014804
% 216.96/217.12  |- mesh__dateCreated mesh__D013832 1999-01-01
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D013832 2005
% 216.96/217.12  |- skos__altLabel mesh__D013832 Deficiency, Thiamine
% 216.96/217.12  |- skos__altLabel mesh__D013034 Genisteine Alkaloid
% 216.96/217.12  |- skos__altLabel mesh__D013034 Sparteine, %28%-%29%-Isomer
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D013034 2006
% 216.96/217.12  |- skos__scopeNote mesh__D013034
% 216.96/217.12       A quinolizidine alkaloid isolated from several FABACEAE including LUPINUS; SPARTIUM; and CYTISUS. It has been used as an oxytocic and an anti-arrhythmia agent. It has also been of interest as an indicator of CYP2D6 genotype.%A%    
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D013034 2003
% 216.96/217.12  |- skos__broader mesh__D013034smesh__D000470
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D013034 2005
% 216.96/217.12  |- mesh__recordOriginator mesh__D013034 NLM
% 216.96/217.12  |- skos__hiddenLabel mesh__D013034 L Sparteine
% 216.96/217.12  |- mesh__recordAuthorizer mesh__D013034 sjn
% 216.96/217.12  |- skos__altLabel mesh__D013034 beta-Isosparteine
% 216.96/217.12  |- skos__altLabel mesh__D013034 alpha-Isosparteine
% 216.96/217.12  |- mesh__publicMeSHNote mesh__D013034
% 216.96/217.12       1963; PACHYCARPINE was indexed under SPARTEINE 1973-2001   
% 216.96/217.12  |- skos__prefLabel mesh__D013034 Sparteine
% 216.96/217.12  |- mesh__recordMaintainer mesh__D013034 ssb
% 216.96/217.12  |- skos__altLabel mesh__D013034 D-sparteine
% 216.96/217.12  |- skos__altLabel mesh__D013034 L-Sparteine
% 216.96/217.12  |- skos__hiddenLabel mesh__D013034 beta Isosparteine
% 216.96/217.12  |- rdf__type mesh__D013034sskos__Concept
% 216.96/217.12  |- skos__altLabel mesh__D013034
% 216.96/217.12       Sparteine, %28%7S-%28%7alpha,7aalpha,14alpha,14abeta%29%%29%-Isomer
% 216.96/217.12  |- skos__hiddenLabel mesh__D013034 alpha Isosparteine
% 216.96/217.12  |- skos__altLabel mesh__D013034
% 216.96/217.12       Pachycarpine Sulfate %5B%1:1%5D%, Pentahydrate, %28%7S-%28%7alpha,7aalpha,14alpha,14abeta%29%%29%-Isomer
% 216.96/217.12  |- skos__altLabel mesh__D013034 Pachycarpine
% 216.96/217.12  |- skos__hiddenLabel mesh__D013034 D sparteine
% 216.96/217.12  |- mesh__dateRevised mesh__D013034 2002-07-02
% 216.96/217.12  |- mesh__historyNote mesh__D013034
% 216.96/217.12       1963; for PACHYCARPINE use SPARTEINE%28%NM%29% 1973-2001   
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D013034 2004
% 216.96/217.12  |- skos__broader mesh__D013034smesh__D011807
% 216.96/217.12  |- mesh__dateCreated mesh__D013034 1999-01-01
% 216.96/217.12  |- skos__altLabel mesh__D013034 Sparteine, %28%+%29%-Isomer
% 216.96/217.12  |- mesh__recordMaintainer mesh__D051153 DRC
% 216.96/217.12  |- skos__prefLabel mesh__D051153 Wnt Proteins
% 216.96/217.12  |- mesh__dateCreated mesh__D051153 2005-06-30
% 216.96/217.12  |- rdf__type mesh__D051153sskos__Concept
% 216.96/217.12  |- skos__altLabel mesh__D051153 Wnt Factors
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D051153 2006
% 216.96/217.12  |- mesh__historyNote mesh__D051153 2006%28%1987%29%   
% 216.96/217.12  |- mesh__dateEstablished mesh__D051153 2006-01-01
% 216.96/217.12  |- skos__scopeNote mesh__D051153
% 216.96/217.12       Wnt proteins are a large family of secreted glycoproteins that play essential roles in EMBRYONIC AND FETAL DEVELOPMENT, and tissue maintenance. They bind to FRIZZLED RECEPTORS and act as PARACRINE PROTEIN FACTORS to initiate a variety of SIGNAL TRANSDUCTION PATHWAYS. The canonical Wnt signaling pathway stabilizes the transcriptional coactivator BETA CATENIN.%A%    
% 216.96/217.12  |- mesh__publicMeSHNote mesh__D051153
% 216.96/217.12       2006; WNT PROTEINS was indexed under INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 2005, %26% under PROTO-ONCOGENE PROTEINS 1987-2005%A%  
% 216.96/217.12  |- mesh__recordAuthorizer mesh__D051153 sjn
% 216.96/217.12  |- mesh__recordOriginator mesh__D051153 DRC
% 216.96/217.12  |- skos__altLabel mesh__D051153 Wingless Type Proteins
% 216.96/217.12  |- skos__broader mesh__D051153smesh__D036341
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D009791 2002
% 216.96/217.12  |- mesh__publicMeSHNote mesh__D009791 68   
% 216.96/217.12  |- mesh__dateEstablished mesh__D009791 1968-01-01
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D009791 1995
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D009791 1998
% 216.96/217.12  |- skos__prefLabel mesh__D009791 Oceanography
% 216.96/217.12  |- skos__annotation mesh__D009791 SPEC: SPEC qualif; DF: OCEANOGR   
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D009791 2004
% 216.96/217.12  |- mesh__dateCreated mesh__D009791 1999-01-01
% 216.96/217.12  |- skos__hiddenLabel mesh__D009791 Oceanographies
% 216.96/217.12  |- mesh__recordMaintainer mesh__D009791 TGC
% 216.96/217.12  |- skos__historyNote mesh__D009791 Marine Biology %28%1966-1967%29%
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D009791 2001
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D009791 2003
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D009791 1997
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D009791 2000
% 216.96/217.12  |- mesh__dateRevised mesh__D009791 1994-06-30
% 216.96/217.12  |- mesh__recordOriginator mesh__D009791 NLM
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D009791 1996
% 216.96/217.12  |- mesh__historyNote mesh__D009791 68   
% 216.96/217.12  |- skos__related mesh__D009791smesh__D008386
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D009791 2006
% 216.96/217.12  |- mesh__recordAuthorizer mesh__D009791 PLS
% 216.96/217.12  |- skos__broader mesh__D009791smesh__D005843
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D009791 2005
% 216.96/217.12  |- rdf__type mesh__D009791sskos__Concept
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D009791 1999
% 216.96/217.12  |- skos__historyNote mesh__D009791 Submarine Medicine %28%1966-1967%29%
% 216.96/217.12  |- skos__scopeNote mesh__D009791
% 216.96/217.12       The science that deals with the ocean and its phenomena. %28%Webster, 3d ed%29%%A%    
% 216.96/217.12  |- skos__related mesh__D009791smesh__D013366
% 216.96/217.12  |- mesh__dateRevised mesh__D050859 2005-07-11
% 216.96/217.12  |- mesh__historyNote mesh__D050859 2006   
% 216.96/217.12  |- mesh__recordAuthorizer mesh__D050859 ags
% 216.96/217.12  |- mesh__publicMeSHNote mesh__D050859 2006   
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D050859 2006
% 216.96/217.12  |- mesh__recordOriginator mesh__D050859 ssb
% 216.96/217.12  |- mesh__recordMaintainer mesh__D050859 ags
% 216.96/217.12  |- mesh__dateEstablished mesh__D050859 2006-01-01
% 216.96/217.12  |- mesh__dateCreated mesh__D050859 2005-06-30
% 216.96/217.12  |- skos__scopeNote mesh__D050859
% 216.96/217.12       Conjugates of betalamic acid with cyclo-dopa, both of which derive from TYROSINE. They appear similar to INDOLES but are biosynthesized by a different path and contain N+. Members are red or violet COLORING AGENTS found in the Caryophyllales order of PLANTS and some BASIDIOMYCETES.%A%    
% 216.96/217.12  |- skos__prefLabel mesh__D050859 Betacyanins
% 216.96/217.12  |- rdf__type mesh__D050859sskos__Concept
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D050859 2006A
% 216.96/217.12  |- skos__broader mesh__D050859smesh__D050858
% 216.96/217.12  |- skos__annotation mesh__D003405
% 216.96/217.12       human %26% animal %28%espec primates%29%; no qualif   
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D003405 1993
% 216.96/217.12  |- mesh__recordAuthorizer mesh__D003405 PLS
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D003405 1999
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D003405 2006
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D003405 1991
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D003405 1994
% 216.96/217.12  |- rdf__type mesh__D003405sskos__Concept
% 216.96/217.12  |- skos__broader mesh__D003405smesh__D013850
% 216.96/217.12  |- mesh__dateCreated mesh__D003405 1999-01-01
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D003405 2000
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D003405 1995
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D003405 1996
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D003405 2003
% 216.96/217.12  |- mesh__recordOriginator mesh__D003405 NLM
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D003405 2001
% 216.96/217.12  |- skos__hiddenLabel mesh__D003405 Creativenesses
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D003405 1997
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D003405 2004
% 216.96/217.12  |- mesh__recordMaintainer mesh__D003405 TGC
% 216.96/217.12  |- mesh__dateRevised mesh__D003405 1989-04-28
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D003405 1992
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D003405 2002
% 216.96/217.12  |- skos__prefLabel mesh__D003405 Creativeness
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D003405 1998
% 216.96/217.12  |- skos__scopeNote mesh__D003405
% 216.96/217.12       The ability to construct new ideas or images.     
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D003405 2005
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D003405 1990
% 216.96/217.12  |- skos__broader mesh__D003405smesh__D010551
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D013833 2006
% 216.96/217.12  |- rdf__type mesh__D013833sskos__Concept
% 216.96/217.12  |- skos__hiddenLabel mesh__D013833 Monophosphate, Thiamine
% 216.96/217.12  |- mesh__recordOriginator mesh__D013833 RLS
% 216.96/217.12  |- skos__hiddenLabel mesh__D013833 Phosphoester, Thiamine
% 216.96/217.12  |- skos__historyNote mesh__D013833 Thiamine %28%1966-1978%29%
% 216.96/217.12  |- mesh__publicMeSHNote mesh__D013833 91; was see under THIAMINE 1979-90   
% 216.96/217.12  |- skos__prefLabel mesh__D013833 Thiamine Monophosphate
% 216.96/217.12  |- skos__annotation mesh__D013833
% 216.96/217.12       deficiency: coordinate THIAMINE MONOPHOSPHATE /defic %28%IM%29% with THIAMINE DEFICIENCY %28%IM%29%%A%  
% 216.96/217.12  |- skos__broader mesh__D013833smesh__D013831
% 216.96/217.12  |- mesh__dateEstablished mesh__D013833 1991-01-01
% 216.96/217.12  |- skos__historyNote mesh__D013833
% 216.96/217.12       Organophosphorus Compounds %28%1971-1978%29%
% 216.96/217.12  |- mesh__dateRevised mesh__D013833 2005-06-30
% 216.96/217.12  |- mesh__recordAuthorizer mesh__D013833 sjn
% 216.96/217.12  |- mesh__recordMaintainer mesh__D013833 ssb
% 216.96/217.12  |- skos__scopeNote mesh__D013833
% 216.96/217.12       Thiamine dihydrogen phosphate ester. The monophosphate ester of thiamine. Synonyms: monophosphothiamine; vitamin B1 monophosphate.%A%    
% 216.96/217.12  |- mesh__historyNote mesh__D013833
% 216.96/217.12       91%28%79%29%; was see under THIAMINE 1979-90   
% 216.96/217.12  |- mesh__dateCreated mesh__D013833 1977-12-22
% 216.96/217.12  |- skos__altLabel mesh__D013833 Thiamine Phosphoester
% 216.96/217.12  |- mesh__dateRevised mesh__D013035 2001-07-25
% 216.96/217.12  |- skos__hiddenLabel mesh__D013035 Spasms, Muscular
% 216.96/217.12  |- skos__scopeNote mesh__D013035
% 216.96/217.12       An involuntary contraction of a muscle or group of muscles. Spasms may involve skeletal muscle %28%MUSCLE, SKELETAL%29% or smooth muscle %28%MUSCLE, SMOOTH%29%.%A%    
% 216.96/217.12  |- skos__hiddenLabel mesh__D013035 Muscle Spasms
% 216.96/217.12  |- skos__hiddenLabel mesh__D013035 Generalized Spasm
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D013035 2002
% 216.96/217.12  |- skos__hiddenLabel mesh__D013035 Spasms, Muscle
% 216.96/217.12  |- skos__hiddenLabel mesh__D013035 Spasms, Ciliary Body
% 216.96/217.12  |- skos__hiddenLabel mesh__D013035 Ciliary Body Spasm
% 216.96/217.12  |- rdf__type mesh__D013035sskos__Concept
% 216.96/217.12  |- skos__hiddenLabel mesh__D013035 Muscular Spasms
% 216.96/217.12  |- skos__hiddenLabel mesh__D013035 Spasm, Muscle
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D013035 2004
% 216.96/217.12  |- mesh__dateCreated mesh__D013035 1999-01-01
% 216.96/217.12  |- mesh__recordAuthorizer mesh__D013035 sjn
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D013035 2006
% 216.96/217.12  |- skos__hiddenLabel mesh__D013035 Generalized Spasms
% 216.96/217.12  |- mesh__recordOriginator mesh__D013035 NLM
% 216.96/217.12  |- skos__related mesh__D013035smesh__D009128
% 216.96/217.12  |- skos__hiddenLabel mesh__D013035 Spasms, Generalized
% 216.96/217.12  |- skos__hiddenLabel mesh__D013035 Spasm, Muscular
% 216.96/217.12  |- mesh__recordMaintainer mesh__D013035 nns
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D013035 2003
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D013035 2005
% 216.96/217.12  |- skos__hiddenLabel mesh__D013035 Spasms
% 216.96/217.12  |- skos__prefLabel mesh__D013035 Spasm
% 216.96/217.12  |- skos__broader mesh__D013035smesh__D020879
% 216.96/217.12  |- skos__annotation mesh__D013035
% 216.96/217.12       GEN or unspecified only; coord IM with specific organ/dis %28%IM%29%; spasms in infants: index SPASMS, INFANTILE if an epileptic seizure %28%see MeSH definition%29% or SPASM + INFANT if non-epileptic such as in tetany or vitamin defic; %22%facial spasm%22% = SPASM %28%IM%29% + FACIAL MUSCLES %28%IM%29% but %22%hemifacial spasm%22% = HEMIFACIAL SPASM; also available are BRONCHIAL SPASM %26% ESOPHAGEAL SPASM, DIFFUSE%A%  
% 216.96/217.12  |- skos__altLabel mesh__D013035 Muscular Spasm
% 216.96/217.12  |- skos__hiddenLabel mesh__D013035 Ciliary Body Spasms
% 216.96/217.12  |- skos__altLabel mesh__D013035 Muscle Spasm
% 216.96/217.12  |- skos__related mesh__D013035smesh__D009120
% 216.96/217.12  |- skos__historyNote mesh__D037483 Hemagglutinins %28%1994-2002%29%
% 216.96/217.12  |- mesh__publicMeSHNote mesh__D037483
% 216.96/217.12       2003; GALECTIN 1 was indexed under HEMAGLUTININS 1994-2002%A%  
% 216.96/217.12  |- rdf__type mesh__D037483sskos__Concept
% 216.96/217.12  |- skos__altLabel mesh__D037483 L1-Lac Lectin
% 216.96/217.12  |- skos__altLabel mesh__D037483 LGALS1
% 216.96/217.12  |- skos__hiddenLabel mesh__D037483 Galactoside Binding Lectin 1
% 216.96/217.12  |- skos__hiddenLabel mesh__D037483 Lectin, L-14
% 216.96/217.12  |- mesh__dateCreated mesh__D037483 2002-07-03
% 216.96/217.12  |- skos__altLabel mesh__D037483 Galactoside-Binding Lectin 1
% 216.96/217.12  |- skos__hiddenLabel mesh__D037483 L1 Lac Lectin
% 216.96/217.12  |- skos__broader mesh__D037483smesh__D037161
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D037483 2005
% 216.96/217.12  |- skos__hiddenLabel mesh__D037483 Lectin, L1-Lac
% 216.96/217.12  |- skos__prefLabel mesh__D037483 Galectin 1
% 216.96/217.12  |- skos__altLabel mesh__D037483 Galectin-1
% 216.96/217.12  |- skos__altLabel mesh__D037483 L-14 Lectin
% 216.96/217.12  |- skos__scopeNote mesh__D037483
% 216.96/217.12       A galectin found abundantly in smooth muscle %28%MUSCLE, SMOOTH%29% and SKELETAL MUSCLE and many other tissues. It occurs as a homodimer with two 14-kDa subunits.%A%    
% 216.96/217.12  |- mesh__historyNote mesh__D037483
% 216.96/217.12       2003; use GALECTIN 1 %28%NM%29% 1994-2002   
% 216.96/217.12  |- mesh__dateRevised mesh__D037483 2004-07-07
% 216.96/217.12  |- mesh__activeMeSHYear mesh__D037483 2006
% 216.96/217.12  |- mesh__recordMaintainer mesh__D037483 jmp
% 216.96/217.13  |- skos__hiddenLabel mesh__D037483 Lectin 1, Galactoside-Binding
% 216.96/217.13  |- skos__altLabel mesh__D037483 Galaptin
% 216.96/217.13  |- mesh__recordAuthorizer mesh__D037483 sjn
% 216.96/217.13  |- mesh__dateEstablished mesh__D037483 2003-01-01
% 216.96/217.13  |- mesh__recordOriginator mesh__D037483 jmp
% 216.96/217.13  |- skos__hiddenLabel mesh__D051154
% 216.96/217.13       Proto Oncogene Protein Int 1 Related Protein
% 216.96/217.13  |- mesh__dateCreated mesh__D051154 2005-06-30
% 216.96/217.13  |- mesh__publicMeSHNote mesh__D051154
% 216.96/217.13       2006; WNT2 PROTEIN was indexed under INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 2005 %26% under PROTO-ONCOGENE PROTEINS 2004-2005%A%  
% 216.96/217.13  |- mesh__recordMaintainer mesh__D051154 ags
% 216.96/217.13  |- mesh__dateRevised mesh__D051154 2005-08-02
% 216.96/217.13  |- mesh__recordAuthorizer mesh__D051154 ags
% 216.96/217.13  |- skos__hiddenLabel mesh__D051154 Wnt 2 Proto oncogene Protein
% 216.96/217.13  |- skos__hiddenLabel mesh__D051154 Proto Oncogene Protein Wnt 2
% 216.96/217.13  |- skos__scopeNote mesh__D051154
% 216.96/217.13       A proto-oncogene protein and member of the Wnt family of proteins. It is frequently up-regulated in human GASTRIC CANCER and is a tumor marker %28%TUMOR MARKERS, BIOLOGICAL%29% of gastric and COLORECTAL CANCER.%A%    
% 216.96/217.13  |- skos__hiddenLabel mesh__D051154 Proto-oncogene Protein, Wnt-2
% 216.96/217.13  |- skos__altLabel mesh__D051154 Wnt-2 Protein
% 216.96/217.13  |- skos__altLabel mesh__D051154
% 216.96/217.13       Proto-Oncogene Protein Int-1 Related Protein
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D051154 2006A
% 216.96/217.13  |- skos__broader mesh__D051154smesh__D051153
% 216.96/217.13  |- mesh__dateEstablished mesh__D051154 2006-01-01
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D051154 2006
% 216.96/217.13  |- skos__hiddenLabel mesh__D051154 Wnt-2, Proto-Oncogene Protein
% 216.96/217.13  |- skos__broader mesh__D051154smesh__D011518
% 216.96/217.13  |- skos__hiddenLabel mesh__D051154 Wnt 2 Protein
% 216.96/217.13  |- skos__prefLabel mesh__D051154 Wnt2 Protein
% 216.96/217.13  |- skos__altLabel mesh__D051154 Proto-Oncogene Protein Wnt-2
% 216.96/217.13  |- mesh__recordOriginator mesh__D051154 DRC
% 216.96/217.13  |- skos__altLabel mesh__D051154 Wnt-2 Proto-oncogene Protein
% 216.96/217.13  |- rdf__type mesh__D051154sskos__Concept
% 216.96/217.13  |- mesh__historyNote mesh__D051154 2006%28%2004%29%   
% 216.96/217.13  |- mesh__recordAuthorizer mesh__D009792 sjn
% 216.96/217.13  |- skos__prefLabel mesh__D009792 Oceans and Seas
% 216.96/217.13  |- skos__related mesh__D009792smesh__D012623
% 216.96/217.13  |- mesh__dateCreated mesh__D009792 1986-04-02
% 216.96/217.13  |- mesh__historyNote mesh__D009792 87   
% 216.96/217.13  |- skos__broader mesh__D009792smesh__D005842
% 216.96/217.13  |- mesh__recordOriginator mesh__D009792 RC
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D009792 2006
% 216.96/217.13  |- mesh__dateEstablished mesh__D009792 1987-01-01
% 216.96/217.13  |- skos__scopeNote mesh__D009792
% 216.96/217.13       Geographic locations providing habitat for marine organisms.%A%    
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D009792 2005
% 216.96/217.13  |- rdf__type mesh__D009792sskos__Concept
% 216.96/217.13  |- skos__annotation mesh__D009792
% 216.96/217.13       for specific oceans or seas that are not a main heading, index only under OCEANS AND SEAS and not also under a geographic term; example: Indian Ocean = OCEANS AND SEAS and not also INDIA%A%  
% 216.96/217.13  |- skos__altLabel mesh__D009792 Seas and Oceans
% 216.96/217.13  |- mesh__recordMaintainer mesh__D009792 ssb
% 216.96/217.13  |- mesh__dateRevised mesh__D009792 2004-07-07
% 216.96/217.13  |- mesh__dateCreated mesh__D017426 1995-06-23
% 216.96/217.13  |- skos__broader mesh__D017426smesh__D016430
% 216.96/217.13  |- mesh__historyNote mesh__D017426 1993   
% 216.96/217.13  |- skos__altLabel mesh__D017426 Clinical Trial, Phase I
% 216.96/217.13  |- mesh__recordAuthorizer mesh__D017426 sjn
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D017426 2006
% 216.96/217.13  |- skos__annotation mesh__D017426
% 216.96/217.13       publication type only; phase I clinical trials as a subject are indexed under the main heading CLINICAL TRIALS, PHASE I; Manual 26.26.2+;  CATALOG: do not use%A%  
% 216.96/217.13  |- mesh__dateRevised mesh__D017426 2005-06-30
% 216.96/217.13  |- skos__prefLabel mesh__D017426
% 216.96/217.13       Clinical Trial, Phase I %5B%Publication Type%5D%
% 216.96/217.13  |- mesh__recordMaintainer mesh__D017426 jls
% 216.96/217.13  |- mesh__recordOriginator mesh__D017426 TGC
% 216.96/217.13  |- skos__scopeNote mesh__D017426
% 216.96/217.13       Work that is the report of a pre-planned, usually controlled, clinical study of the safety and efficacy of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques based on a small number of healthy persons and conducted over the period of about a year in either the United States or a foreign country.%A%    
% 216.96/217.13  |- mesh__dateEstablished mesh__D017426 1996-01-01
% 216.96/217.13  |- skos__altLabel mesh__D017426 Clinical Trial, Phase I %28%PT%29%
% 216.96/217.13  |- rdf__type mesh__D017426sskos__Concept
% 216.96/217.13  |- skos__broader mesh__D007223Q000523smesh__D007223
% 216.96/217.13  |- mesh__preferredCombination mesh__D007223Q000523smesh__D002666
% 216.96/217.13  |- rdf__type mesh__D007223Q000523smesh__CompoundConcept
% 216.96/217.13  |- skos__annotation mesh__D003406
% 216.96/217.13       %22%recognition of professional or technical competence%22% through various measures: see MeSH definition%A%  
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003406 2002
% 216.96/217.13  |- mesh__recordMaintainer mesh__D003406 PLS
% 216.96/217.13  |- mesh__historyNote mesh__D003406 80; was NON MESH before 1980   
% 216.96/217.13  |- rdf__type mesh__D003406sskos__Concept
% 216.96/217.13  |- mesh__publicMeSHNote mesh__D003406 80   
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003406 1996
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003406 1995
% 216.96/217.13  |- mesh__dateRevised mesh__D003406 1993-09-16
% 216.96/217.13  |- mesh__recordAuthorizer mesh__D003406 NLM
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003406 2003
% 216.96/217.13  |- skos__broader mesh__D003406smesh__D011785
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003406 1997
% 216.96/217.13  |- skos__broader mesh__D003406smesh__D012926
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003406 2004
% 216.96/217.13  |- skos__prefLabel mesh__D003406 Credentialing
% 216.96/217.13  |- mesh__dateCreated mesh__D003406 1978-05-08
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003406 2000
% 216.96/217.13  |- skos__scopeNote mesh__D003406
% 216.96/217.13       The recognition of professional or technical competence through registration, certification, licensure, admission to association membership, the award of a diploma or degree, etc.%A%    
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003406 1998
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003406 2005
% 216.96/217.13  |- mesh__recordOriginator mesh__D003406 EC
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003406 2001
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003406 1999
% 216.96/217.13  |- mesh__dateEstablished mesh__D003406 1980-01-01
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003406 2006
% 216.96/217.13  |- skos__hiddenLabel mesh__D013834 Phosphohydrolase, Thiamine Pyrophosphate
% 216.96/217.13  |- mesh__recordOriginator mesh__D013834 NLM
% 216.96/217.13  |- skos__altLabel mesh__D013834 Thiamine Pyrophosphate Phosphohydrolase
% 216.96/217.13  |- mesh__recordAuthorizer mesh__D013834 sjn
% 216.96/217.13  |- skos__hiddenLabel mesh__D013834 Pyrophosphatase, Thiamine
% 216.96/217.13  |- mesh__dateRevised mesh__D013834 2003-07-09
% 216.96/217.13  |- mesh__dateCreated mesh__D013834 1974-11-19
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D013834 2006
% 216.96/217.13  |- skos__broader mesh__D013834smesh__D011755
% 216.96/217.13  |- rdf__type mesh__D013834sskos__Concept
% 216.96/217.13  |- skos__hiddenLabel mesh__D013834 Pyrophosphate Phosphohydrolase, Thiamine
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D013834 2004
% 216.96/217.13  |- skos__annotation mesh__D013834
% 216.96/217.13       do not confuse with THIAMINE PYROPHOSPHATE; DF: note short X ref%A%  
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D013834 2005
% 216.96/217.13  |- mesh__historyNote mesh__D013834
% 216.96/217.13       91%28%75%29%; was see under PYROPHOSPHATASES 1975-90   
% 216.96/217.13  |- skos__historyNote mesh__D013834 Thiamine Pyrophosphate %28%1973-1974%29%
% 216.96/217.13  |- mesh__publicMeSHNote mesh__D013834
% 216.96/217.13       91; was see under PYROPHOSPHATASES 1975-90   
% 216.96/217.13  |- skos__historyNote mesh__D013834 Pyrophosphatases %28%1973-1974%29%
% 216.96/217.13  |- skos__prefLabel mesh__D013834 Thiamine Pyrophosphatase
% 216.96/217.13  |- skos__scopeNote mesh__D013834
% 216.96/217.13       An enzyme that hydrolyzes thiamine pyrophosphate to thiamine monophosphate plus inorganic phosphate. EC 3.6.1.-.%A%    
% 216.96/217.13  |- mesh__dateEstablished mesh__D013834 1991-01-01
% 216.96/217.13  |- mesh__recordMaintainer mesh__D013834 ssb
% 216.96/217.13  |- skos__altLabel mesh__D013834 TPPase
% 216.96/217.13  |- skos__hiddenLabel mesh__D046210 Microfluidic Analytical Technique
% 216.96/217.13  |- skos__hiddenLabel mesh__D046210 Lab-On-A-Chip, Microfluidic
% 216.96/217.13  |- skos__hiddenLabel mesh__D046210 Analytical Technique, Microfluidic
% 216.96/217.13  |- skos__altLabel mesh__D046210 Microfluidic Lab-On-A-Chip
% 216.96/217.13  |- mesh__recordAuthorizer mesh__D046210 sjn
% 216.96/217.13  |- skos__hiddenLabel mesh__D046210 Device, Microfluidic
% 216.96/217.13  |- mesh__publicMeSHNote mesh__D046210 2005   
% 216.96/217.13  |- mesh__recordOriginator mesh__D046210 nns
% 216.96/217.13  |- skos__hiddenLabel mesh__D046210 Microfluidic Analyses
% 216.96/217.13  |- skos__hiddenLabel mesh__D046210 Lab-On-A-Chips, Microfluidic
% 216.96/217.13  |- skos__hiddenLabel mesh__D046210 Microfluidic Device
% 216.96/217.13  |- skos__hiddenLabel mesh__D046210 Technique, Microfluidic Analytical
% 216.96/217.13  |- skos__hiddenLabel mesh__D046210 Devices, Microfluidic
% 216.96/217.13  |- skos__hiddenLabel mesh__D046210 Microfluidic Lab-On-A-Chips
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D046210 2006
% 216.96/217.13  |- mesh__dateEstablished mesh__D046210 2005-01-01
% 216.96/217.13  |- skos__scopeNote mesh__D046210
% 216.96/217.13       Methods utilizing the principles of MICROFLUIDICS for sample handling, reagent mixing, and separation and detection of specific components in fluids.%A%    
% 216.96/217.13  |- skos__altLabel mesh__D046210 Microfluidic Microchips
% 216.96/217.13  |- skos__hiddenLabel mesh__D046210 Analysis, Microfluidic
% 216.96/217.13  |- mesh__dateCreated mesh__D046210 2004-07-07
% 216.96/217.13  |- skos__hiddenLabel mesh__D046210 Microfluidic Microchip
% 216.96/217.13  |- mesh__recordMaintainer mesh__D046210 nns
% 216.96/217.13  |- skos__broader mesh__D046210smesh__D046208
% 216.96/217.13  |- skos__hiddenLabel mesh__D046210 Microchips, Microfluidic
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D046210 2005
% 216.96/217.13  |- skos__hiddenLabel mesh__D046210 Analytical Techniques, Microfluidic
% 216.96/217.13  |- skos__hiddenLabel mesh__D046210 Microchip, Microfluidic
% 216.96/217.13  |- skos__hiddenLabel mesh__D046210 Analyses, Microfluidic
% 216.96/217.13  |- skos__hiddenLabel mesh__D046210 Microfluidic Lab On A Chip
% 216.96/217.13  |- skos__altLabel mesh__D046210 Microfluidic Analysis
% 216.96/217.13  |- mesh__historyNote mesh__D046210 2005   
% 216.96/217.13  |- skos__prefLabel mesh__D046210 Microfluidic Analytical Techniques
% 216.96/217.13  |- skos__related mesh__D046210smesh__D044085
% 216.96/217.13  |- skos__hiddenLabel mesh__D046210 Techniques, Microfluidic Analytical
% 216.96/217.13  |- rdf__type mesh__D046210sskos__Concept
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Spasm, Nodding
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D013036 2003
% 216.96/217.13  |- mesh__dateCreated mesh__D013036 1976-05-05
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Syndrome, Cryptogenic West
% 216.96/217.13  |- skos__scopeNote mesh__D013036
% 216.96/217.13       An epileptic syndrome characterized by the triad of infantile spasms, hypsarrhythmia, and arrest of psychomotor development at seizure onset. The majority present between 3-12 months of age, with spasms consisting of combinations of brief flexor or extensor movements of the head, trunk, and limbs. The condition is divided into two forms: cryptogenic %28%idiopathic%29% and symptomatic %28%secondary to a known disease process such as intrauterine infections; nervous system abnormalities; BRAIN DISEASES, METABOLIC, INBORN; prematurity; perinatal asphyxia; TUBEROUS SCLEROSIS; etc.%29%. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp744-8%29%%A%    
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Infantile Spasms, Symptomatic
% 216.96/217.13  |- mesh__dateEstablished mesh__D013036 1977-01-01
% 216.96/217.13  |- mesh__historyNote mesh__D013036 1977%28%1963%29%   
% 216.96/217.13  |- mesh__dateRevised mesh__D013036 1999-12-08
% 216.96/217.13  |- skos__altLabel mesh__D013036 Cryptogenic West Syndrome
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 West Syndrome, Symptomatic
% 216.96/217.13  |- skos__broader mesh__D013036smesh__D004829
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Infantile Spasms, Cryptogenic
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D013036 2004
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Lightning Attack
% 216.96/217.13  |- skos__historyNote mesh__D013036 Epilepsy %28%1966-1976%29%
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Jackknife Seizure
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Spasm, Cryptogenic Infantile
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Nodding Spasms
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Seizures, Salaam
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D013036 2000A
% 216.96/217.13  |- skos__altLabel mesh__D013036 Infantile Spasms
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Infantile Spasm, Cryptogenic
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Spasms, Cryptogenic Infantile
% 216.96/217.13  |- skos__historyNote mesh__D013036 Infant %28%1966-1976%29%
% 216.96/217.13  |- skos__historyNote mesh__D013036 Child, Preschool %28%1966-1976%29%
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Infantile Spasm, Symptomatic
% 216.96/217.13  |- mesh__recordMaintainer mesh__D013036 ags
% 216.96/217.13  |- skos__historyNote mesh__D013036 Epilepsy, Petit Mal %28%1966-1976%29%
% 216.96/217.13  |- rdf__type mesh__D013036sskos__Concept
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Spasms, Nodding
% 216.96/217.13  |- skos__altLabel mesh__D013036 Salaam Seizures
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D013036 2000
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Attack, Lightning
% 216.96/217.13  |- skos__altLabel mesh__D013036 Lightning Attacks
% 216.96/217.13  |- mesh__recordAuthorizer mesh__D013036 ags
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Attacks, Lightning
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Cryptogenic Infantile Spasm
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 West Syndrome, Cryptogenic
% 216.96/217.13  |- skos__annotation mesh__D013036
% 216.96/217.13       epileptic seizures only: do not confuse with SPASM + INFANT for non-epileptic seizures in inf such as in tetany or vitamin defic; check tag INFANT or INFANT, NEWBORN%A%  
% 216.96/217.13  |- mesh__recordOriginator mesh__D013036 MM
% 216.96/217.13  |- skos__historyNote mesh__D013036 Convulsions %28%1966-1976%29%
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Spasm, Symptomatic Infantile
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D013036 2005
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Infantile Spasm
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D013036 2001
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Symptomatic Infantile Spasm
% 216.96/217.13  |- skos__historyNote mesh__D013036 Myoclonus %28%1966-1976%29%
% 216.96/217.13  |- skos__historyNote mesh__D013036 Infant, Newborn %28%1966-1976%29%
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Seizure, Jackknife
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Attacks, Salaam
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Syndrome, West
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Spasms, Symptomatic Infantile
% 216.96/217.13  |- skos__altLabel mesh__D013036 Symptomatic West Syndrome
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Hypsarrhythmias
% 216.96/217.13  |- skos__prefLabel mesh__D013036 Spasms, Infantile
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Syndrome, Symptomatic West
% 216.96/217.13  |- mesh__publicMeSHNote mesh__D013036 1977; see HYPSARRHYTHMIA 1963-76   
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D013036 2006
% 216.96/217.13  |- skos__hiddenLabel mesh__D013036 Seizures, Jackknife
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D013036 2002
% 216.96/217.13  |- skos__altLabel mesh__D013036 West Syndrome
% 216.96/217.13  |- skos__hiddenLabel mesh__D051155 Proto Oncogene Protein Wnt 1
% 216.96/217.13  |- skos__broader mesh__D051155smesh__D051153
% 216.96/217.13  |- mesh__dateEstablished mesh__D051155 2006-01-01
% 216.96/217.13  |- mesh__recordAuthorizer mesh__D051155 sjn
% 216.96/217.13  |- mesh__publicMeSHNote mesh__D051155
% 216.96/217.13       2006; WNT1 PROTEIN was indexed under INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 2005; %26% under PROTO-ONCOGENE PROTEINS 1987-2005%A%  
% 216.96/217.13  |- skos__broader mesh__D051155smesh__D011518
% 216.96/217.13  |- mesh__recordMaintainer mesh__D051155 DRC
% 216.96/217.13  |- skos__hiddenLabel mesh__D051155 Proto Oncogene Protein Int 1
% 216.96/217.13  |- skos__hiddenLabel mesh__D051155 Wnt 1 Protein
% 216.96/217.13  |- skos__altLabel mesh__D051155 Wnt1 Proto-Oncogene Protein
% 216.96/217.13  |- skos__altLabel mesh__D051155 Proto-Oncogene Protein Wnt-1
% 216.96/217.13  |- skos__altLabel mesh__D051155 Proto-Oncogene Protein Int-1
% 216.96/217.13  |- mesh__recordOriginator mesh__D051155 DRC
% 216.96/217.13  |- skos__scopeNote mesh__D051155
% 216.96/217.13       A proto-oncogene protein and member of the Wnt family of proteins. It is expressed in the caudal MIDBRAIN and is essential for proper development of the entire mid-/hindbrain region.%A%    
% 216.96/217.13  |- skos__hiddenLabel mesh__D051155 Proto-Oncogene Protein, Wnt1
% 216.96/217.13  |- skos__prefLabel mesh__D051155 Wnt1 Protein
% 216.96/217.13  |- skos__hiddenLabel mesh__D051155 Int-1, Proto-Oncogene Protein
% 216.96/217.13  |- skos__altLabel mesh__D051155 Wnt-1 Protein
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D051155 2006
% 216.96/217.13  |- mesh__dateCreated mesh__D051155 2005-06-30
% 216.96/217.13  |- skos__altLabel mesh__D051155 c-int Protein
% 216.96/217.13  |- skos__hiddenLabel mesh__D051155 Wnt1 Proto Oncogene Protein
% 216.96/217.13  |- rdf__type mesh__D051155sskos__Concept
% 216.96/217.13  |- mesh__historyNote mesh__D051155 2006%28%1987%29%   
% 216.96/217.13  |- skos__hiddenLabel mesh__D051155 Wnt-1, Proto-Oncogene Protein
% 216.96/217.13  |- mesh__publicMeSHNote mesh__D009793 74   
% 216.96/217.13  |- mesh__dateEstablished mesh__D009793 1974-01-01
% 216.96/217.13  |- skos__historyNote mesh__D009793 Mycotoxins %28%1967-1970%29%
% 216.96/217.13  |- mesh__recordOriginator mesh__D009793 NLM
% 216.96/217.13  |- mesh__recordAuthorizer mesh__D009793 sjn
% 216.96/217.13  |- skos__broader mesh__D009793smesh__D009183
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D009793 2006
% 216.96/217.13  |- skos__scopeNote mesh__D009793
% 216.96/217.13       Toxins produced by Aspergillus ochraceus. Occurring widely, ochratoxins have been found as natural contaminants on storage grains, corn, peanuts, cottonseed, and decaying vegetation. They are produced by several other species of Aspergillus as well as by Penicillium viridicatum.%A%    
% 216.96/217.13  |- mesh__historyNote mesh__D009793 74%28%71%29%   
% 216.96/217.13  |- rdf__type mesh__D009793sskos__Concept
% 216.96/217.13  |- skos__prefLabel mesh__D009793 Ochratoxins
% 216.96/217.13  |- mesh__dateRevised mesh__D009793 2005-06-30
% 216.96/217.13  |- mesh__dateCreated mesh__D009793 1999-01-01
% 216.96/217.13  |- skos__annotation mesh__D009793
% 216.96/217.13       /antag permitted but consider also ANTITOXINS   
% 216.96/217.13  |- skos__broader mesh__D009793smesh__D003374
% 216.96/217.13  |- mesh__recordMaintainer mesh__D009793 ssb
% 216.96/217.13  |- skos__historyNote mesh__D009793 Coumarins %28%1966-1970%29%
% 216.96/217.13  |- mesh__dateEstablished mesh__D017427 1996-01-01
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D017427 2006
% 216.96/217.13  |- mesh__recordOriginator mesh__D017427 TGC
% 216.96/217.13  |- skos__altLabel mesh__D017427 Clinical Trial, Phase II %28%PT%29%
% 216.96/217.13  |- skos__prefLabel mesh__D017427
% 216.96/217.13       Clinical Trial, Phase II %5B%Publication Type%5D%
% 216.96/217.13  |- mesh__dateCreated mesh__D017427 1995-06-23
% 216.96/217.13  |- rdf__type mesh__D017427sskos__Concept
% 216.96/217.13  |- mesh__historyNote mesh__D017427 1993   
% 216.96/217.13  |- skos__broader mesh__D017427smesh__D016430
% 216.96/217.13  |- skos__scopeNote mesh__D017427
% 216.96/217.13       Work that is a report of a pre-planned, usually controlled, clinical study of the safety and efficacy of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques based on several hundred volunteers, including a limited number of patients, and conducted over a period of about two years in either the United States or a foreign country.%A%    
% 216.96/217.13  |- skos__altLabel mesh__D017427 Clinical Trial, Phase II
% 216.96/217.13  |- skos__annotation mesh__D017427
% 216.96/217.13       publication type only; phase II clinical trials as a subject are indexed under the main heading CLINICAL TRIALS, PHASE II; Manual 26.26.2+;  CATALOG: do not use%A%  
% 216.96/217.13  |- mesh__recordAuthorizer mesh__D017427 sjn
% 216.96/217.13  |- mesh__recordMaintainer mesh__D017427 jls
% 216.96/217.13  |- mesh__dateRevised mesh__D017427 2005-06-30
% 216.96/217.13  |- mesh__dateCreated mesh__D003407 1999-01-01
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003407 2001
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003407 1999
% 216.96/217.13  |- mesh__onlineNote mesh__D003407 search CRESOLS 1966-74   
% 216.96/217.13  |- mesh__historyNote mesh__D003407
% 216.96/217.13       91%28%75%29%; was see under CRESOLS 1975-90   
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003407 2006
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003407 2000
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003407 1994
% 216.96/217.13  |- mesh__recordOriginator mesh__D003407 NLM
% 216.96/217.13  |- mesh__recordAuthorizer mesh__D003407 PLS
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003407 1993
% 216.96/217.13  |- rdf__type mesh__D003407sskos__Concept
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003407 1998
% 216.96/217.13  |- mesh__dateRevised mesh__D003407 1992-05-11
% 216.96/217.13  |- mesh__dateEstablished mesh__D003407 1991-01-01
% 216.96/217.13  |- mesh__recordMaintainer mesh__D003407 TGC
% 216.96/217.13  |- mesh__publicMeSHNote mesh__D003407 91; was see under CRESOLS 1975-90   
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003407 2005
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003407 1997
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003407 2004
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003407 1996
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003407 2003
% 216.96/217.13  |- skos__broader mesh__D003407smesh__D003408
% 216.96/217.13  |- skos__hiddenLabel mesh__D003407 Creosote, Beechwood
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003407 2002
% 216.96/217.13  |- skos__prefLabel mesh__D003407 Creosote
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D003407 1995
% 216.96/217.13  |- skos__annotation mesh__D013835
% 216.96/217.13       do not confuse with THIAMINE PYROPHOSPHATASE; deficiency: coordinate THIAMINE PYROPHOSPHATE /defic %28%IM%29% with THIAMINE DEFICIENCY %28%IM%29%%A%  
% 216.96/217.13  |- skos__altLabel mesh__D013835 Thiamine Diphosphate
% 216.96/217.13  |- rdf__type mesh__D013835sskos__Concept
% 216.96/217.13  |- skos__scopeNote mesh__D013835
% 216.96/217.13       The coenzyme form of Vitamin B1 present in many animal tissues. It is a required intermediate in the PYRUVATE DEHYDROGENASE COMPLEX and the KETOGLUTARATE DEHYDROGENASE COMPLEX.%A%    
% 216.96/217.13  |- mesh__recordOriginator mesh__D013835 NLM
% 216.96/217.13  |- skos__altLabel mesh__D013835 Cocarboxylase
% 216.96/217.13  |- skos__broader mesh__D013835smesh__D013831
% 216.96/217.13  |- mesh__recordAuthorizer mesh__D013835 ags
% 216.96/217.13  |- skos__hiddenLabel mesh__D013835 Pyrophosphate, Thiamine
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D013835 2006A
% 216.96/217.13  |- skos__broader mesh__D013835smesh__D003067
% 216.96/217.13  |- mesh__recordMaintainer mesh__D013835 ags
% 216.96/217.13  |- skos__prefLabel mesh__D013835 Thiamine Pyrophosphate
% 216.96/217.13  |- mesh__dateCreated mesh__D013835 1999-01-01
% 216.96/217.13  |- mesh__dateRevised mesh__D013835 2005-07-11
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D013835 2006
% 216.96/217.13  |- rdf__type mesh__D013037sskos__Concept
% 216.96/217.13  |- skos__hiddenLabel mesh__D013037 Behaviors, Spatial
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D013037 2003
% 216.96/217.13  |- skos__prefLabel mesh__D013037 Spatial Behavior
% 216.96/217.13  |- skos__scopeNote mesh__D013037
% 216.96/217.13       Reactions of an individual or groups of individuals with relation to the immediate surrounding area including the animate or inanimate objects within that area.%A%    
% 216.96/217.13  |- mesh__recordAuthorizer mesh__D013037 sjn
% 216.96/217.13  |- mesh__recordOriginator mesh__D013037 NLM
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D013037 2005
% 216.96/217.13  |- mesh__historyNote mesh__D013037
% 216.96/217.13       68; PROXEMICS was heading 1975-96 %28%see under SPATIAL BEHAVIOR 1975-90%29%%A%  
% 216.96/217.13  |- skos__historyNote mesh__D013037
% 216.96/217.13       Adaptation, Psychological %28%1966-1967%29%
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D013037 2004
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D013037 2006
% 216.96/217.13  |- skos__hiddenLabel mesh__D013037 Spatial Behaviors
% 216.96/217.13  |- mesh__dateRevised mesh__D013037 2002-07-02
% 216.96/217.13  |- skos__hiddenLabel mesh__D013037 Behavior, Spatial
% 216.96/217.13  |- skos__broader mesh__D013037smesh__D012961
% 216.96/217.13  |- skos__historyNote mesh__D013037 Psychotherapy %28%1966-1967%29%
% 216.96/217.13  |- skos__hiddenLabel mesh__D013037 Proxemic
% 216.96/217.13  |- mesh__publicMeSHNote mesh__D013037
% 216.96/217.13       68; PROXEMICS was heading 1975-96 %28%see under SPATIAL BEHAVIOR 1975-90%29%%A%  
% 216.96/217.13  |- mesh__dateEstablished mesh__D013037 1968-01-01
% 216.96/217.13  |- skos__broader mesh__D013037smesh__D001519
% 216.96/217.13  |- mesh__recordMaintainer mesh__D013037 PXP
% 216.96/217.13  |- skos__annotation mesh__D013037 human %26% animal   
% 216.96/217.13  |- mesh__dateCreated mesh__D013037 1999-01-01
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D018520 2003
% 216.96/217.13  |- mesh__recordMaintainer mesh__D018520 PXP
% 216.96/217.13  |- mesh__dateCreated mesh__D018520 1994-06-07
% 216.96/217.13  |- skos__historyNote mesh__D018520 Plants %28%1966-1994%29%
% 216.96/217.13  |- rdf__type mesh__D018520sskos__Concept
% 216.96/217.13  |- mesh__recordOriginator mesh__D018520 JLS
% 216.96/217.13  |- skos__prefLabel mesh__D018520 Plant Shoots
% 216.96/217.13  |- mesh__historyNote mesh__D018520 95   
% 216.96/217.13  |- skos__scopeNote mesh__D018520
% 216.96/217.13       New immature growth of a plant including stem, leaves and tips of branches.%A%    
% 216.96/217.13  |- skos__broader mesh__D018520smesh__D035261
% 216.96/217.13  |- mesh__dateEstablished mesh__D018520 1995-01-01
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D018520 2006
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D018520 2005
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D018520 2004
% 216.96/217.13  |- skos__annotation mesh__D018520
% 216.96/217.13       for new root growth use MERISTEM; coord with specific plant%A%  
% 216.96/217.13  |- mesh__dateRevised mesh__D018520 2002-07-03
% 216.96/217.13  |- mesh__publicMeSHNote mesh__D018520 95   
% 216.96/217.13  |- mesh__recordAuthorizer mesh__D018520 sjn
% 216.96/217.13  |- skos__historyNote mesh__D004500 Education %28%1966%29%
% 216.96/217.13  |- mesh__recordMaintainer mesh__D004500 kle
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D004500 2001
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D004500 2006
% 216.96/217.13  |- mesh__recordAuthorizer mesh__D004500 sjn
% 216.96/217.13  |- mesh__publicMeSHNote mesh__D004500 70   
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D004500 2000
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D004500 2005
% 216.96/217.13  |- mesh__dateEstablished mesh__D004500 1970-01-01
% 216.96/217.13  |- skos__broader mesh__D004500smesh__D004517
% 216.96/217.13  |- rdf__type mesh__D004500sskos__Concept
% 216.96/217.13  |- mesh__recordOriginator mesh__D004500 NLM
% 216.96/217.13  |- skos__altLabel mesh__D004500 Graduate Education
% 216.96/217.13  |- skos__annotation mesh__D004500
% 216.96/217.13       differentiate from EDUCATION, CONTINUING: see note on EDUCATION, CONTINUING; DF: EDUC GRAD%A%  
% 216.96/217.13  |- skos__hiddenLabel mesh__D004500 Graduate Educations
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D004500 2002
% 216.96/217.13  |- skos__hiddenLabel mesh__D004500 Educations, Graduate
% 216.96/217.13  |- mesh__dateCreated mesh__D004500 1999-01-01
% 216.96/217.13  |- mesh__dateRevised mesh__D004500 1999-11-03
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D004500 2004
% 216.96/217.13  |- skos__prefLabel mesh__D004500 Education, Graduate
% 216.96/217.13  |- mesh__historyNote mesh__D004500 70%28%67%29%   
% 216.96/217.13  |- skos__scopeNote mesh__D004500
% 216.96/217.13       Studies beyond the bachelor%27%s degree at an institution having graduate programs for the purpose of preparing for entrance into a specific field, and obtaining a higher degree.%A%    
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D004500 2003
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D009794 2005
% 216.96/217.13  |- mesh__dateRevised mesh__D009794 2001-07-25
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D009794 2006
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D009794 2002
% 216.96/217.13  |- rdf__type mesh__D009794sskos__Concept
% 216.96/217.13  |- mesh__recordOriginator mesh__D009794 NLM
% 216.96/217.13  |- mesh__dateCreated mesh__D009794 1999-01-01
% 216.96/217.13  |- skos__prefLabel mesh__D009794 Ochronosis
% 216.96/217.13  |- mesh__recordAuthorizer mesh__D009794 sjn
% 216.96/217.13  |- mesh__recordMaintainer mesh__D009794 nns
% 216.96/217.13  |- skos__scopeNote mesh__D009794
% 216.96/217.13       A disease in which the metabolic products of phenylalanine and tyrosine accumulate, resulting in the deposition of HOMOGENTISIC ACID %28%a brown-black pigment%29% in the connective tissue. It occurs in ALKAPTONURIA, but has also been observed in connection with exposure to certain chemicals %28%e.g., phenol, trinitrophenol, benzene derivatives%29%.%A%    
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D009794 2003
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D009794 2004
% 216.96/217.13  |- skos__hiddenLabel mesh__D009794 Ochronoses
% 216.96/217.13  |- skos__broader mesh__D009794smesh__D008659
% 216.96/217.13  |- mesh__recordOriginator mesh__D017428 TGC
% 216.96/217.13  |- mesh__dateRevised mesh__D017428 2005-06-30
% 216.96/217.13  |- skos__prefLabel mesh__D017428
% 216.96/217.13       Clinical Trial, Phase III %5B%Publication Type%5D%
% 216.96/217.13  |- mesh__dateCreated mesh__D017428 1995-06-23
% 216.96/217.13  |- mesh__activeMeSHYear mesh__D017428 2006
% 216.96/217.13  |- skos__altLabel mesh__D017428 Clinical Trial, Phase III %28%PT%29%
% 216.96/217.13  |- rdf__type mesh__D017428sskos__Concept
% 216.96/217.13  |- skos__scopeNote mesh__D017428
% 216.96/217.13       Work that is a report of a pre-planned, usually controlled, clinical study of the safety and efficacy of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques after phase II trials. A large enough group of patients is studied and closely monitored by physicians for adverse response to long-term exposure, over a period of about three years in either the United States or a foreign country.%A%    
% 216.96/217.13  |- mesh__historyNote mesh__D017428 1993   
% 216.96/217.13  |- skos__broader mesh__D017428smesh__D016430
% 216.96/217.13  |- skos__annotation mesh__D017428
% 216.96/217.13       publication type only; phase III clinical trials as a subject are indexed under the main heading CLINICAL TRIALS, PHASE III; Manual 26.26.2+; CATALOG: do not use%A%  
% 216.96/217.14  |- mesh__recordAuthorizer mesh__D017428 sjn
% 216.96/217.14  |- mesh__recordMaintainer mesh__D017428 jls
% 216.96/217.14  |- skos__altLabel mesh__D017428 Clinical Trial, Phase III
% 216.96/217.14  |- mesh__dateEstablished mesh__D017428 1996-01-01
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D003408 2002
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D003408 1993
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D003408 1998
% 216.96/217.14  |- rdf__type mesh__D003408sskos__Concept
% 216.96/217.14  |- mesh__recordMaintainer mesh__D003408 TGC
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D003408 2005
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D003408 1997
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D003408 2001
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D003408 2004
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D003408 2000
% 216.96/217.14  |- mesh__recordOriginator mesh__D003408 NLM
% 216.96/217.14  |- skos__prefLabel mesh__D003408 Cresols
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D003408 1996
% 216.96/217.14  |- mesh__recordAuthorizer mesh__D003408 PLS
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D003408 2003
% 216.96/217.14  |- mesh__dateRevised mesh__D003408 1992-05-11
% 216.96/217.14  |- skos__broader mesh__D003408smesh__D010636
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D003408 1995
% 216.96/217.14  |- mesh__dateCreated mesh__D003408 1999-01-01
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D003408 1999
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D003408 2006
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D003408 1994
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D014130 2006
% 216.96/217.14  |- skos__historyNote mesh__D014130
% 216.96/217.14       Trabecular Meshwork/surgery %28%1977-1987%29%
% 216.96/217.14  |- skos__annotation mesh__D014130
% 216.96/217.14       refers to trabecular meshwork of eye only; do not use /util except by MeSH definition%A%  
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D014130 2004
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D014130 2001
% 216.96/217.14  |- skos__hiddenLabel mesh__D014130 Trabeculoplasties
% 216.96/217.14  |- skos__historyNote mesh__D014130 Glaucoma/surgery %28%1966-1987%29%
% 216.96/217.14  |- skos__hiddenLabel mesh__D014130 Goniotomies
% 216.96/217.14  |- mesh__recordOriginator mesh__D014130 SCD
% 216.96/217.14  |- mesh__recordAuthorizer mesh__D014130 jls
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D014130 1998
% 216.96/217.14  |- mesh__publicMeSHNote mesh__D014130 88   
% 216.96/217.14  |- mesh__recordMaintainer mesh__D014130 jls
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D014130 2002
% 216.96/217.14  |- skos__hiddenLabel mesh__D014130 Trabeculectomies
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D014130 1999
% 216.96/217.14  |- skos__altLabel mesh__D014130 Trabeculoplasty
% 216.96/217.14  |- mesh__dateCreated mesh__D014130 1987-03-25
% 216.96/217.14  |- skos__historyNote mesh__D014130 Sclera/surgery %28%1966-1987%29%
% 216.96/217.14  |- skos__hiddenLabel mesh__D014130 Trabeculotomies
% 216.96/217.14  |- skos__broader mesh__D014130smesh__D018463
% 216.96/217.14  |- rdf__type mesh__D014130sskos__Concept
% 216.96/217.14  |- mesh__historyNote mesh__D014130 88   
% 216.96/217.14  |- mesh__dateRevised mesh__D014130 2004-08-02
% 216.96/217.14  |- skos__historyNote mesh__D014130 Ciliary Body/surgery %28%1966-1987%29%
% 216.96/217.14  |- skos__scopeNote mesh__D014130
% 216.96/217.14       Any surgical procedure for treatment of glaucoma by means of puncture or reshaping of the trabecular meshwork. It includes goniotomy, trabeculectomy, and laser perforation.%A%    
% 216.96/217.14  |- skos__prefLabel mesh__D014130 Trabeculectomy
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D014130 2000
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D014130 2005
% 216.96/217.14  |- mesh__dateEstablished mesh__D014130 1988-01-01
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D014130 2003
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D014130 2005A
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D000110 2006
% 216.96/217.14  |- mesh__recordOriginator mesh__D000110 NLM
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D000110 2005
% 216.96/217.14  |- mesh__recordMaintainer mesh__D000110 ags
% 216.96/217.14  |- mesh__dateRevised mesh__D000110 2005-07-07
% 216.96/217.14  |- skos__scopeNote mesh__D000110
% 216.96/217.14       An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7.%A%    
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D000110 2006A
% 216.96/217.14  |- rdf__type mesh__D000110sskos__Concept
% 216.96/217.14  |- skos__broader mesh__D000110smesh__D002802
% 216.96/217.14  |- mesh__dateCreated mesh__D000110 1999-01-01
% 216.96/217.14  |- skos__annotation mesh__D000110
% 216.96/217.14       reactivation or reactivators: coord NIM %28%with no qualif%29% with CHOLINESTERASE REACTIVATORS %28%IM%29%%A%  
% 216.96/217.14  |- skos__altLabel mesh__D000110 Acetylcholine Hydrolase
% 216.96/217.14  |- skos__hiddenLabel mesh__D000110 Hydrolase, Acetylcholine
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D000110 2004
% 216.96/217.14  |- mesh__recordAuthorizer mesh__D000110 ags
% 216.96/217.14  |- skos__prefLabel mesh__D000110 Acetylcholinesterase
% 216.96/217.14  |- skos__broader mesh__D013836smesh__D017854
% 216.96/217.14  |- mesh__publicMeSHNote mesh__D013836
% 216.96/217.14       94; was THIAMINE PYROPHOSPHOKINASE 1979-93 %28%see under PHOSPHOTRANSFERASES, ATP 1979-90%29%%A%  
% 216.96/217.14  |- skos__altLabel mesh__D013836 Thiamine Pyrophosphokinase
% 216.96/217.14  |- mesh__historyNote mesh__D013836
% 216.96/217.14       94; was THIAMINE PYROPHOSPHOKINASE 1979-93 %28%see under PHOSPHOTRANSFERASES, ATP 1979-90%29%%A%  
% 216.96/217.14  |- skos__hiddenLabel mesh__D013836 Pyrophosphokinase, Thiamine
% 216.96/217.14  |- mesh__recordOriginator mesh__D013836 RLS
% 216.96/217.14  |- skos__prefLabel mesh__D013836 Thiamin Pyrophosphokinase
% 216.96/217.14  |- mesh__dateEstablished mesh__D013836 1991-01-01
% 216.96/217.14  |- skos__annotation mesh__D013836
% 216.96/217.14       do not confuse with THIAMINE PYROPHOSPHATASE nor with thiamine diphosphate kinase%A%  
% 216.96/217.14  |- mesh__recordMaintainer mesh__D013836 ssb
% 216.96/217.14  |- mesh__onlineNote mesh__D013836
% 216.96/217.14       use THIAMIN PYROPHOSPHOKINASE to search THIAMINE PYROPHOSPHOKINASE 1979-93%A%  
% 216.96/217.14  |- mesh__dateRevised mesh__D013836 2003-07-09
% 216.96/217.14  |- skos__scopeNote mesh__D013836
% 216.96/217.14       An enzyme that catalyzes the formation of thiamine pyrophosphate from ATP and thiamine. EC 2.7.6.2.%A%    
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D013836 2006
% 216.96/217.14  |- mesh__recordAuthorizer mesh__D013836 sjn
% 216.96/217.14  |- rdf__type mesh__D013836sskos__Concept
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D013836 2004
% 216.96/217.14  |- skos__historyNote mesh__D013836 Phosphotransferases %28%1966-1973%29%
% 216.96/217.14  |- mesh__dateCreated mesh__D013836 1977-12-22
% 216.96/217.14  |- skos__historyNote mesh__D013836 Thiamine %28%1966-1978%29%
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D013836 2005
% 216.96/217.14  |- skos__hiddenLabel mesh__D013836 Pyrophosphokinase, Thiamin
% 216.96/217.14  |- skos__historyNote mesh__D013836
% 216.96/217.14       Phosphotransferases, ATP %28%1974-1978%29%
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D013038 2005
% 216.96/217.14  |- skos__broader mesh__D013038smesh__D006281
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D013038 2004
% 216.96/217.14  |- skos__hiddenLabel mesh__D013038 Specialist
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D013038 2006
% 216.96/217.14  |- skos__annotation mesh__D013038
% 216.96/217.14       concept of specializing in any field, medical or non-med; for general articles on specialism as a philosophy vis-%C3%%A0%-vis %22%generalism%22%; for articles on %22%X as a specialty%22% coord IM with field or subject %28%IM%29%; for medical specialties, use SPECIALTIES, MEDICAL%A%  
% 216.96/217.14  |- skos__scopeNote mesh__D013038
% 216.96/217.14       The limitation of practice or study to a particular branch of medicine, dentistry, or other health profession. It is philosophically distinct from the generalist theory in which familiarity with a wide cross-section of the particular discipline is advocated.%A%    
% 216.96/217.14  |- mesh__recordAuthorizer mesh__D013038 sjn
% 216.96/217.14  |- skos__prefLabel mesh__D013038 Specialism
% 216.96/217.14  |- mesh__recordOriginator mesh__D013038 NLM
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D013038 2002
% 216.96/217.14  |- mesh__dateCreated mesh__D013038 1999-01-01
% 216.96/217.14  |- mesh__dateRevised mesh__D013038 2001-08-13
% 216.96/217.14  |- rdf__type mesh__D013038sskos__Concept
% 216.96/217.14  |- mesh__recordMaintainer mesh__D013038 jls
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D013038 2003
% 216.96/217.14  |- skos__broader mesh__D019266Q000172smesh__D019266
% 216.96/217.14  |- mesh__preferredCombination mesh__D019266Q000172smesh__D007501Q000172
% 216.96/217.14  |- rdf__type mesh__D019266Q000172smesh__CompoundConcept
% 216.96/217.14  |- mesh__dateCreated mesh__D018521 1994-05-24
% 216.96/217.14  |- mesh__recordOriginator mesh__D018521 JLS
% 216.96/217.14  |- mesh__dateRevised mesh__D018521 1998-06-10
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D018521 2001
% 216.96/217.14  |- skos__prefLabel mesh__D018521 Plant Physiology
% 216.96/217.14  |- skos__hiddenLabel mesh__D018521 Physiologies, Plant
% 216.96/217.14  |- skos__broader mesh__D018521smesh__D001687
% 216.96/217.14  |- mesh__recordMaintainer mesh__D018521 NNS
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D018521 2000
% 216.96/217.14  |- mesh__historyNote mesh__D018521 98; use explode 1995-97   
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D018521 2006
% 216.96/217.14  |- skos__scopeNote mesh__D018521
% 216.96/217.14       Physiological functions characteristic of plants.     
% 216.96/217.14  |- skos__annotation mesh__D018521
% 216.96/217.14       GEN or unspecified; prefer specifics; DF: PLANT PHYSIOL   
% 216.96/217.14  |- skos__hiddenLabel mesh__D018521 Plant Physiologies
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D018521 2005
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D018521 2004
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D018521 2002
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D018521 2003
% 216.96/217.14  |- mesh__dateEstablished mesh__D018521 1998-01-01
% 216.96/217.14  |- mesh__publicMeSHNote mesh__D018521 98   
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D018521 1999
% 216.96/217.14  |- mesh__recordAuthorizer mesh__D018521 SJN
% 216.96/217.14  |- skos__historyNote mesh__D018521 Plants/physiology %28%1966-1997%29%
% 216.96/217.14  |- skos__altLabel mesh__D018521 Physiology, Plant
% 216.96/217.14  |- rdf__type mesh__D018521sskos__Concept
% 216.96/217.14  |- rdf__type mesh__D004501sskos__Concept
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D004501 2002
% 216.96/217.14  |- mesh__dateCreated mesh__D004501 1999-01-01
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D004501 2004
% 216.96/217.14  |- skos__altLabel mesh__D004501 Medical Education
% 216.96/217.14  |- mesh__recordMaintainer mesh__D004501 kle
% 216.96/217.14  |- skos__scopeNote mesh__D004501
% 216.96/217.14       Use for general articles concerning medical education.     
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D004501 2001
% 216.96/217.14  |- mesh__recordAuthorizer mesh__D004501 sjn
% 216.96/217.14  |- skos__prefLabel mesh__D004501 Education, Medical
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D004501 2003
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D004501 2000
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D004501 2006
% 216.96/217.14  |- skos__broader mesh__D004501smesh__D004517
% 216.96/217.14  |- mesh__recordOriginator mesh__D004501 NLM
% 216.96/217.14  |- mesh__dateRevised mesh__D004501 1999-11-03
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D004501 2005
% 216.96/217.14  |- skos__annotation mesh__D004501
% 216.96/217.14       Manual 19.8.28, 30.7.4, 34.16; DF: EDUC MED   
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D051157 2006
% 216.96/217.14  |- mesh__historyNote mesh__D051157 2006%28%1998%29%   
% 216.96/217.14  |- mesh__dateCreated mesh__D051157 2005-06-30
% 216.96/217.14  |- mesh__publicMeSHNote mesh__D051157
% 216.96/217.14       2006; FRIZZLED RECEPTOR was indexed under PROTEINS 1998-2005%A%  
% 216.96/217.14  |- rdf__type mesh__D051157sskos__Concept
% 216.96/217.14  |- skos__altLabel mesh__D051157 Frizzled Receptor
% 216.96/217.14  |- skos__hiddenLabel mesh__D051157 Receptor, Frizzled
% 216.96/217.14  |- skos__hiddenLabel mesh__D051157 Receptors, Frizzled
% 216.96/217.14  |- mesh__dateEstablished mesh__D051157 2006-01-01
% 216.96/217.14  |- mesh__recordMaintainer mesh__D051157 DRC
% 216.96/217.14  |- mesh__recordAuthorizer mesh__D051157 sjn
% 216.96/217.14  |- skos__altLabel mesh__D051157 Frizzled Proteins
% 216.96/217.14  |- skos__scopeNote mesh__D051157
% 216.96/217.14       A family of seven-pass transmembrane cell-surface receptors.  They contain an extracellular cysteine-rich domain and are receptors for WNT PROTEINS.  Frizzled receptors often couple with HETEROTRIMERIC G PROTEINS and regulate multiple SIGNAL TRANSDUCTION PATHWAYS.%A%    
% 216.96/217.14  |- skos__broader mesh__D051157smesh__D011956
% 216.96/217.14  |- skos__prefLabel mesh__D051157 Frizzled Receptors
% 216.96/217.14  |- mesh__recordOriginator mesh__D051157 DRC
% 216.96/217.14  |- skos__historyNote mesh__D009795 Alkanes %28%1966-1977%29%
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D009795 1994
% 216.96/217.14  |- rdf__type mesh__D009795sskos__Concept
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D009795 1999
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D009795 1995
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D009795 2003
% 216.96/217.14  |- mesh__publicMeSHNote mesh__D009795 78   
% 216.96/217.14  |- skos__broader mesh__D009795smesh__D000473
% 216.96/217.14  |- skos__historyNote mesh__D009795 Hydrocarbons %28%1966-1977%29%
% 216.96/217.14  |- skos__annotation mesh__D009795
% 216.96/217.14       does not include octenes %28% = ALKENES%29%, octadienes %28% = ALKADIENES%29%, octatrienes or octatetraenes %28% = POLYENES%29%%A%  
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D009795 2000
% 216.96/217.14  |- mesh__recordMaintainer mesh__D009795 TAP
% 216.96/217.14  |- mesh__dateRevised mesh__D009795 1992-05-19
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D009795 2004
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D009795 1996
% 216.96/217.14  |- mesh__recordAuthorizer mesh__D009795 PLS
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D009795 2001
% 216.96/217.14  |- mesh__dateCreated mesh__D009795 1977-05-20
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D009795 1997
% 216.96/217.14  |- mesh__historyNote mesh__D009795 78   
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D009795 2005
% 216.96/217.14  |- mesh__dateEstablished mesh__D009795 1978-01-01
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D009795 2002
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D009795 1993
% 216.96/217.14  |- skos__prefLabel mesh__D009795 Octanes
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D009795 2006
% 216.96/217.14  |- mesh__recordOriginator mesh__D009795 RLS
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D009795 1998
% 216.96/217.14  |- skos__scopeNote mesh__D009795
% 216.96/217.14       Eight-carbon saturated hydrocarbon group of the methane series. Include isomers and derivatives.%A%    
% 216.96/217.14  |- mesh__recordMaintainer mesh__D017429 jls
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D017429 2006
% 216.96/217.14  |- mesh__dateEstablished mesh__D017429 1996-01-01
% 216.96/217.14  |- rdf__type mesh__D017429sskos__Concept
% 216.96/217.14  |- mesh__recordOriginator mesh__D017429 TGC
% 216.96/217.14  |- mesh__dateRevised mesh__D017429 2005-06-30
% 216.96/217.14  |- skos__annotation mesh__D017429
% 216.96/217.14       publication type only; phase IV clinical trials as a  subject are indexed under the main heading CLINICAL TRIALS, PHASE IV; Manual 26.26.2+; CATALOG: do not use%A%  
% 216.96/217.14  |- skos__scopeNote mesh__D017429
% 216.96/217.14       Work that is a report of a planned post-marketing study of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale after clinical trials, phases I, II, and III. These studies, conducted in the United States or a foreign country, often garner additional data about the safety and efficacy of a product.%A%    
% 216.96/217.14  |- mesh__dateCreated mesh__D017429 1995-06-23
% 216.96/217.14  |- skos__broader mesh__D017429smesh__D016430
% 216.96/217.14  |- skos__altLabel mesh__D017429 Clinical Trial, Phase IV %28%PT%29%
% 216.96/217.14  |- skos__altLabel mesh__D017429 Clinical Trial, Phase IV
% 216.96/217.14  |- mesh__historyNote mesh__D017429 1993   
% 216.96/217.14  |- mesh__recordAuthorizer mesh__D017429 sjn
% 216.96/217.14  |- skos__prefLabel mesh__D017429
% 216.96/217.14       Clinical Trial, Phase IV %5B%Publication Type%5D%
% 216.96/217.14  |- skos__prefLabel mesh__D003409 Congenital Hypothyroidism
% 216.96/217.14  |- skos__altLabel mesh__D003409 Cretinism
% 216.96/217.14  |- skos__broader mesh__D003409smesh__D001849
% 216.96/217.14  |- skos__broader mesh__D003409smesh__D007037
% 216.96/217.14  |- mesh__publicMeSHNote mesh__D003409 2006; see CRETINISM 1966-2005   
% 216.96/217.14  |- mesh__recordAuthorizer mesh__D003409 ags
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D003409 2006B
% 216.96/217.14  |- skos__hiddenLabel mesh__D003409 Hypothyroidism, Congenital
% 216.96/217.14  |- mesh__dateCreated mesh__D003409 1999-01-01
% 216.96/217.14  |- mesh__dateRevised mesh__D003409 2005-08-02
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D003409 2006A
% 216.96/217.14  |- skos__scopeNote mesh__D003409
% 216.96/217.14       A condition in infancy or early childhood due to an in-utero deficiency of THYROID HORMONES that can be caused by genetic or environmental factors, such as thyroid dysgenesis or HYPOTHYROIDISM in infants of mothers treated with THIOURACIL during pregnancy. Endemic cretinism is the result of iodine deficiency. Clinical symptoms include severe MENTAL RETARDATION, impaired skeletal development, short stature, and MYXEDEMA.%A%    
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D003409 2006
% 216.96/217.14  |- skos__related mesh__D003409smesh__D009230
% 216.96/217.14  |- rdf__type mesh__D003409sskos__Concept
% 216.96/217.14  |- skos__hiddenLabel mesh__D003409 Cretinism, Endemic
% 216.96/217.14  |- mesh__recordOriginator mesh__D003409 NLM
% 216.96/217.14  |- mesh__recordMaintainer mesh__D003409 ags
% 216.96/217.14  |- mesh__historyNote mesh__D003409 2006 %28%1966%29%   
% 216.96/217.14  |- skos__broader mesh__D003409smesh__D004392
% 216.96/217.14  |- mesh__recordMaintainer mesh__D014131 ssb
% 216.96/217.14  |- skos__scopeNote mesh__D014131
% 216.96/217.14       A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 216.96/217.14  |- skos__altLabel mesh__D014131 Biometals
% 216.96/217.14  |- mesh__dateRevised mesh__D014131 2005-06-30
% 216.96/217.14  |- skos__broader mesh__D014131smesh__D018977
% 216.96/217.14  |- rdf__type mesh__D014131sskos__Concept
% 216.96/217.14  |- mesh__recordOriginator mesh__D014131 NLM
% 216.96/217.14  |- mesh__recordAuthorizer mesh__D014131 sjn
% 216.96/217.14  |- skos__prefLabel mesh__D014131 Trace Elements
% 216.96/217.14  |- skos__related mesh__D014131smesh__D018977
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D014131 2006
% 216.96/217.14  |- mesh__dateCreated mesh__D014131 1999-01-01
% 216.96/217.14  |- skos__hiddenLabel mesh__D014131 Elements, Trace
% 216.96/217.14  |- skos__annotation mesh__D014131
% 216.96/217.14       do not coordinate with METALS for %22%trace metals%22% nor with MINERALS for %22%trace minerals%22%; do not confuse with %22%tracers%22% used for detection or with trace amounts of substances in tissue, food, etc.%A%  
% 216.96/217.14  |- skos__altLabel mesh__D000111 Azupharma Brand of Acetylcysteine
% 216.96/217.14  |- skos__altLabel mesh__D000111 ac-Pharma Brand of Acetylcysteine
% 216.96/217.14  |- mesh__recordOriginator mesh__D000111 NLM
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Krewel Brand
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 AL, Acetylcystein
% 216.96/217.14  |- skos__altLabel mesh__D000111 Pfleger Brand of Acetylcysteine
% 216.96/217.14  |- skos__altLabel mesh__D000111 Chiron Brand of Acetylcysteine Sodium Salt
% 216.96/217.14  |- skos__altLabel mesh__D000111 Zambon Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Atid Brand
% 216.96/217.14  |- skos__altLabel mesh__D000111 N-Acetyl-L-cysteine
% 216.96/217.14  |- skos__altLabel mesh__D000111 Klinge Brand of Acetylcysteine
% 216.96/217.14  |- mesh__dateRevised mesh__D000111 2005-06-30
% 216.96/217.14  |- skos__altLabel mesh__D000111 Alcon Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Monoammonium Salt Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Betapharm Brand
% 216.96/217.14  |- skos__altLabel mesh__D000111 Temmler Brand of Acetylcysteine
% 216.96/217.14  |- skos__altLabel mesh__D000111 Mucosol
% 216.96/217.14  |- skos__altLabel mesh__D000111 Lichtenstein Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 GNR Pharma Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 ac Pharma Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Fresenius Brand
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Zambon Brand
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Lichtenstein Brand
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Broncho Fips
% 216.96/217.14  |- skos__altLabel mesh__D000111 Disphar Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Sanigen, Muco
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Farmasan Brand
% 216.96/217.14  |- skos__altLabel mesh__D000111
% 216.96/217.14       Bristol-Myers Squibb Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Monosodium Salt Acetylcysteine
% 216.96/217.14  |- skos__altLabel mesh__D000111 Jenapharm
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Merck Brand
% 216.96/217.14  |- skos__altLabel mesh__D000111 UPSA Brand of Acetylcysteine
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D000111 2006
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Inpharzam Brand
% 216.96/217.14  |- skos__altLabel mesh__D000111 Genac
% 216.96/217.14  |- skos__altLabel mesh__D000111 Larylin NAC
% 216.96/217.14  |- skos__altLabel mesh__D000111 Inpharzam Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 BronchoFips
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 M Pectil
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Whitehall Brand
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Roberts Brand
% 216.96/217.14  |- skos__altLabel mesh__D000111 Heumann Brand of Acetylcysteine
% 216.96/217.14  |- skos__altLabel mesh__D000111 Roberts Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Mucopect, Dampo
% 216.96/217.14  |- skos__altLabel mesh__D000111 Produpharm Lappe Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Zinc, Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Alcon Brand
% 216.96/217.14  |- skos__altLabel mesh__D000111 Intra Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 N Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Lindopharm Brand
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Zambon, NAC
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 NAC, Bisolvon
% 216.96/217.14  |- skos__altLabel mesh__D000111 Roxane Brand of Acetylcysteine Sodium Salt
% 216.96/217.14  |- skos__altLabel mesh__D000111 Thiemann Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine ac-Pharma Brand
% 216.96/217.14  |- skos__altLabel mesh__D000111 Pharbita Brand of Acetylcysteine
% 216.96/217.14  |- skos__altLabel mesh__D000111 NAC Zambon
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Pfleger Brand
% 216.96/217.14  |- skos__altLabel mesh__D000111 Farmasan Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 MPectil
% 216.96/217.14  |- skos__altLabel mesh__D000111 Hermes Brand of Acetylcysteine
% 216.96/217.14  |- mesh__recordAuthorizer mesh__D000111 sjn
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Aluid Brand
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 AL, NAC
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Sodium, Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine UPSA Brand
% 216.96/217.14  |- skos__altLabel mesh__D000111 Lindopharm Brand of Acetylcysteine
% 216.96/217.14  |- skos__altLabel mesh__D000111 Atid Brand of Acetylcysteine
% 216.96/217.14  |- skos__altLabel mesh__D000111 Bromuc
% 216.96/217.14  |- skos__altLabel mesh__D000111 Bioiberica Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Bioiberica Brand
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Heumann, Acetylcystein
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Atid, Acetylcystein
% 216.96/217.14  |- skos__altLabel mesh__D000111 Optipect Hustengetr%C3%%A4%nk
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Trommsdorff Brand
% 216.96/217.14  |- skos__altLabel mesh__D000111 N-Acetylcysteine
% 216.96/217.14  |- mesh__dateCreated mesh__D000111 1999-01-01
% 216.96/217.14  |- mesh__publicMeSHNote mesh__D000111 66   
% 216.96/217.14  |- skos__altLabel mesh__D000111 Merck Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Bouchara Brand
% 216.96/217.14  |- skos__altLabel mesh__D000111 Whitehall Brand of Acetylcysteine
% 216.96/217.14  |- skos__altLabel mesh__D000111 Roche Nicholas Brand of Acetylcysteine
% 216.96/217.14  |- mesh__dateEstablished mesh__D000111 1966-01-01
% 216.96/217.14  |- skos__altLabel mesh__D000111 Centrafarm Brand of Acetylcysteine
% 216.96/217.14  |- skos__altLabel mesh__D000111 Dey Brand of Acetylcysteine Sodium Salt
% 216.96/217.14  |- skos__altLabel mesh__D000111 GNR-Pharma Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Guerbet Brand
% 216.96/217.14  |- skos__altLabel mesh__D000111 Krewel Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 N Acetyl L cysteine
% 216.96/217.14  |- mesh__recordMaintainer mesh__D000111 ssb
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Pharbita Brand
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcystein, mentopin
% 216.96/217.14  |- skos__prefLabel mesh__D000111 Acetylcysteine
% 216.96/217.14  |- skos__altLabel mesh__D000111 Acetylin
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Trom, Acetylcystein
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111
% 216.96/217.14       Bristol Myers Squibb Brand of Acetylcysteine Sodium Salt
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine GNR-Pharma Brand
% 216.96/217.14  |- skos__altLabel mesh__D000111 Oberlin Brand of Acetylcysteine
% 216.96/217.14  |- skos__altLabel mesh__D000111 Bouchara Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Zyma Brand
% 216.96/217.14  |- skos__altLabel mesh__D000111 Zyma Brand of Acetylcysteine
% 216.96/217.14  |- skos__altLabel mesh__D000111 Betapharm Brand of Acetylcysteine
% 216.96/217.14  |- skos__altLabel mesh__D000111 Muco Sanigen
% 216.96/217.14  |- skos__altLabel mesh__D000111 Mercapturic Acid
% 216.96/217.14  |- skos__altLabel mesh__D000111
% 216.96/217.14       G%C3%%A9%n%C3%%A9%vrier Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Intra Brand
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Hermes Brand
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Centrafarm Brand
% 216.96/217.14  |- skos__altLabel mesh__D000111 Teva Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Disphar Brand
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Heumann Brand
% 216.96/217.14  |- skos__broader mesh__D000111smesh__D003545
% 216.96/217.14  |- skos__altLabel mesh__D000111
% 216.96/217.14       Bristol-Myers Squibb Brand of Acetylcysteine Sodium Salt
% 216.96/217.14  |- skos__altLabel mesh__D000111 Siran
% 216.96/217.14  |- skos__altLabel mesh__D000111 Aluid Brand of Acetylcysteine
% 216.96/217.14  |- skos__altLabel mesh__D000111 Allen %26% Hanburys Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 GNR, Ac%C3%%A9%tylcyst%C3%%A9%ine
% 216.96/217.14  |- skos__altLabel mesh__D000111 Trommsdorff Brand of Acetylcysteine
% 216.96/217.14  |- skos__scopeNote mesh__D000111
% 216.96/217.14       The N-acetyl derivative of CYSTEINE.  It is used as a mucolytic agent to reduce the viscosity of mucous secretions. It has also been shown to have antiviral effects in patients with HIV due to inhibition of viral stimulation by reactive oxygen intermediates.%A%    
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Temmler Brand
% 216.96/217.14  |- skos__altLabel mesh__D000111 Guerbet Brand of Acetylcysteine
% 216.96/217.14  |- skos__altLabel mesh__D000111 NAC
% 216.96/217.14  |- mesh__historyNote mesh__D000111 66%28%64%29%   
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Teva Brand
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111
% 216.96/217.14       Bristol Myers Squibb Brand of Acetylcysteine
% 216.96/217.14  |- skos__altLabel mesh__D000111 NAC AL
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Hustengetr%C3%%A4%nk, Optipect
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Oberlin Brand
% 216.96/217.14  |- skos__altLabel mesh__D000111
% 216.96/217.14       Boehringer Ingelheim Brand of Acetylcysteine
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 NAC, Larylin
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Klinge Brand
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Azupharma Brand
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acetylcysteine Thiemann Brand
% 216.96/217.14  |- rdf__type mesh__D000111sskos__Concept
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Acid, Mercapturic
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111
% 216.96/217.14       Acetylcysteine G%C3%%A9%n%C3%%A9%vrier Brand
% 216.96/217.14  |- skos__hiddenLabel mesh__D000111 Hydrochloride, Acetylcysteine
% 216.96/217.14  |- skos__altLabel mesh__D000111 Fresenius Brand of Acetylcysteine
% 216.96/217.14  |- skos__broader mesh__D052250smesh__D019001
% 216.96/217.14  |- mesh__recordMaintainer mesh__D052250 jmp
% 216.96/217.14  |- mesh__recordOriginator mesh__D052250 jmp
% 216.96/217.14  |- skos__altLabel mesh__D052250 ENOS Enzyme
% 216.96/217.14  |- rdf__type mesh__D052250sskos__Concept
% 216.96/217.14  |- skos__scopeNote mesh__D052250
% 216.96/217.14       A CALCIUM-dependent, constitutively-expressed form of nitric acid synthase found primarily in ENDOTHELIAL CELLS.%A%    
% 216.96/217.14  |- skos__altLabel mesh__D052250 Endothelial Nitric Oxide Synthase
% 216.96/217.14  |- mesh__historyNote mesh__D052250 2006%28%1998%29%   
% 216.96/217.14  |- mesh__dateEstablished mesh__D052250 2006-01-01
% 216.96/217.14  |- mesh__dateCreated mesh__D052250 2005-06-30
% 216.96/217.14  |- mesh__publicMeSHNote mesh__D052250
% 216.96/217.14       2006; ENDOTHELIAL CONSTITUTIVE NITRIC OXIDE SYNTHASE was indexed UNDER NITRIC-OXIDE SYNTHASE 1998-2005%A%  
% 216.96/217.14  |- skos__altLabel mesh__D052250
% 216.96/217.14       Endothelial Constitutive Nitric Oxide Synthase
% 216.96/217.14  |- mesh__activeMeSHYear mesh__D052250 2006
% 216.96/217.14  |- mesh__recordAuthorizer mesh__D052250 sjn
% 216.96/217.15  |- skos__altLabel mesh__D052250 Nitric Oxide Synthase, Type III
% 216.96/217.15  |- skos__altLabel mesh__D052250 ECNOS Enzyme
% 216.96/217.15  |- skos__prefLabel mesh__D052250 Nitric Oxide Synthase Type III
% 216.96/217.15  |- skos__prefLabel mesh__D013837 Thiamin-Triphosphatase
% 216.96/217.15  |- skos__scopeNote mesh__D013837
% 216.96/217.15       An enzyme present in nerve tissue. It catalyzes reversibly the formation of thiamine diphosphate and orthophosphate from thiamine triphosphate. EC 3.6.1.28.%A%    
% 216.96/217.15  |- mesh__historyNote mesh__D013837
% 216.96/217.15       94; was THIAMINE TRIPHOSPHATASE 1979-93 %28%see under PHOSPHATASES 1979-90%29%%A%  
% 216.96/217.15  |- mesh__dateEstablished mesh__D013837 1991-01-01
% 216.96/217.15  |- skos__historyNote mesh__D013837 Thiamine Pyrophosphate %28%1977-1978%29%
% 216.96/217.15  |- mesh__dateRevised mesh__D013837 2003-07-09
% 216.96/217.15  |- skos__historyNote mesh__D013837 Thiamine %28%1966-1976%29%
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D013837 2006
% 216.96/217.15  |- rdf__type mesh__D013837sskos__Concept
% 216.96/217.15  |- skos__historyNote mesh__D013837 Phosphoric Acids %28%1968-1976%29%
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D013837 2004
% 216.96/217.15  |- mesh__publicMeSHNote mesh__D013837
% 216.96/217.15       94; was THIAMINE TRIPHOSPHATASE 1979-93 %28%see under PHOSPHATASES 1979-90%29%%A%  
% 216.96/217.15  |- mesh__onlineNote mesh__D013837
% 216.96/217.15       use THIAMIN-TRIPHOSPHATASE to search THIAMINE TRIPHOSPHATASE 1979-93%A%  
% 216.96/217.15  |- mesh__dateCreated mesh__D013837 1977-12-22
% 216.96/217.15  |- mesh__recordOriginator mesh__D013837 RLS
% 216.96/217.15  |- skos__altLabel mesh__D013837 Thiamine Triphosphatase
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D013837 2005
% 216.96/217.15  |- mesh__recordMaintainer mesh__D013837 ssb
% 216.96/217.15  |- skos__annotation mesh__D013837
% 216.96/217.15       do not confuse with THIAMINE TRIPHOSPHATE   
% 216.96/217.15  |- skos__historyNote mesh__D013837 Phosphatases %28%1966-1978%29%
% 216.96/217.15  |- skos__hiddenLabel mesh__D013837 Thiamin Triphosphatase
% 216.96/217.15  |- skos__broader mesh__D013837smesh__D017766
% 216.96/217.15  |- mesh__recordAuthorizer mesh__D013837 sjn
% 216.96/217.15  |- skos__scopeNote mesh__D013039
% 216.96/217.15       Various branches of dental practice limited to specialized areas.%A%    
% 216.96/217.15  |- mesh__dateRevised mesh__D013039 1999-11-03
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D013039 2001
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D013039 2005
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D013039 2004
% 216.96/217.15  |- mesh__recordOriginator mesh__D013039 NLM
% 216.96/217.15  |- mesh__recordAuthorizer mesh__D013039 sjn
% 216.96/217.15  |- mesh__historyNote mesh__D013039 68   
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D013039 2006
% 216.96/217.15  |- skos__altLabel mesh__D013039 Dental Specialties
% 216.96/217.15  |- skos__altLabel mesh__D013039 Specialty, Dental
% 216.96/217.15  |- skos__broader mesh__D013039smesh__D003813
% 216.96/217.15  |- skos__prefLabel mesh__D013039 Specialties, Dental
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D013039 2002
% 216.96/217.15  |- mesh__publicMeSHNote mesh__D013039 68   
% 216.96/217.15  |- mesh__dateCreated mesh__D013039 1999-01-01
% 216.96/217.15  |- skos__annotation mesh__D013039
% 216.96/217.15       SPEC: SPEC qualif; coord IM with field or subject %28%IM%29%; DF: SPECIALTIES DENT%A%  
% 216.96/217.15  |- rdf__type mesh__D013039sskos__Concept
% 216.96/217.15  |- skos__altLabel mesh__D013039 Dental Specialty
% 216.96/217.15  |- mesh__dateEstablished mesh__D013039 1968-01-01
% 216.96/217.15  |- mesh__recordMaintainer mesh__D013039 kle
% 216.96/217.15  |- skos__historyNote mesh__D013039 Specialism %28%1966-1967%29%
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D013039 2000
% 216.96/217.15  |- skos__historyNote mesh__D013039 Dentistry %28%1966-1967%29%
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D013039 2003
% 216.96/217.15  |- mesh__recordOriginator mesh__D018522 JLS
% 216.96/217.15  |- skos__annotation mesh__D018522
% 216.96/217.15       directional growth of a plant in response to gravity   
% 216.96/217.15  |- skos__hiddenLabel mesh__D018522 Gravitropisms
% 216.96/217.15  |- mesh__historyNote mesh__D018522 95   
% 216.96/217.15  |- skos__prefLabel mesh__D018522 Gravitropism
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D018522 2005
% 216.96/217.15  |- skos__broader mesh__D018522smesh__D018523
% 216.96/217.15  |- mesh__dateRevised mesh__D018522 2004-07-07
% 216.96/217.15  |- skos__hiddenLabel mesh__D018522 Geotropisms
% 216.96/217.15  |- mesh__dateEstablished mesh__D018522 1995-01-01
% 216.96/217.15  |- skos__scopeNote mesh__D018522
% 216.96/217.15       The directional growth of organisms in response to gravity. In plants, the main root is positively gravitropic %28%growing downwards%29% and a main stem is negatively gravitropic %28%growing upwards%29%, irrespective of the positions in which they are placed. Plant gravitropism is thought to be controlled by auxin %28%AUXINS%29%, a plant growth substance. %28%From Concise Dictionary of Biology, 1990%29%%A%    
% 216.96/217.15  |- mesh__recordMaintainer mesh__D018522 nns
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D018522 2006
% 216.96/217.15  |- mesh__publicMeSHNote mesh__D018522 95   
% 216.96/217.15  |- mesh__recordAuthorizer mesh__D018522 sjn
% 216.96/217.15  |- mesh__dateCreated mesh__D018522 1994-06-07
% 216.96/217.15  |- rdf__type mesh__D018522sskos__Concept
% 216.96/217.15  |- skos__broader mesh__D051956smesh__D014157
% 216.96/217.15  |- mesh__recordAuthorizer mesh__D051956 sjn
% 216.96/217.15  |- skos__altLabel mesh__D051956 Goosecoid Transcription Factor
% 216.96/217.15  |- skos__altLabel mesh__D051956 Goosecoid Homeodomain Protein
% 216.96/217.15  |- mesh__publicMeSHNote mesh__D051956
% 216.96/217.15       2006; GOOSECOID PROTEIN was indexed under REPRESSOR PROTEINS %26% TRANSCRIPTION FACTORS 1992-2005, %26% under HOMEODOMAIN PROTEINS 2005, %26% under DNA-BINDING PROTEINS 1992-2004%A%  
% 216.96/217.15  |- skos__hiddenLabel mesh__D051956 Transcription Factor, Goosecoid
% 216.96/217.15  |- skos__hiddenLabel mesh__D051956 Homeodomain Protein, Goosecoid
% 216.96/217.15  |- skos__scopeNote mesh__D051956
% 216.96/217.15       Goosecoid protein is a homeodomain protein that was first identified in XENOPUS. It is found in the SPEMANN ORGANIZER of VERTEBRATES and plays an important role in neuronal CELL DIFFERENTIATION and ORGANOGENESIS.%A%    
% 216.96/217.15  |- mesh__dateEstablished mesh__D051956 2006-01-01
% 216.96/217.15  |- mesh__dateCreated mesh__D051956 2005-06-30
% 216.96/217.15  |- mesh__historyNote mesh__D051956 2006%28%1992%29%   
% 216.96/217.15  |- mesh__recordOriginator mesh__D051956 DRC
% 216.96/217.15  |- mesh__recordMaintainer mesh__D051956 DRC
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D051956 2006
% 216.96/217.15  |- skos__broader mesh__D051956smesh__D018398
% 216.96/217.15  |- rdf__type mesh__D051956sskos__Concept
% 216.96/217.15  |- skos__prefLabel mesh__D051956 Goosecoid Protein
% 216.96/217.15  |- mesh__recordOriginator mesh__D004502 NLM
% 216.96/217.15  |- skos__scopeNote mesh__D004502
% 216.96/217.15       Educational programs designed to inform physicians of recent advances in their field.%A%    
% 216.96/217.15  |- mesh__dateCreated mesh__D004502 1999-01-01
% 216.96/217.15  |- mesh__dateRevised mesh__D004502 1999-11-03
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D004502 2004
% 216.96/217.15  |- skos__prefLabel mesh__D004502 Education, Medical, Continuing
% 216.96/217.15  |- mesh__onlineNote mesh__D004502
% 216.96/217.15       use EDUCATION, MEDICAL, CONTINUING %26% EDUCATION, MEDICAL, GRADUATE to search EDUCATION, MEDICAL, POSTGRADUATE 1966-74%A%  
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D004502 2002
% 216.96/217.15  |- skos__broader mesh__D004502smesh__D004501
% 216.96/217.15  |- mesh__dateEstablished mesh__D004502 1966-01-01
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D004502 2003
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D004502 2006
% 216.96/217.15  |- mesh__recordMaintainer mesh__D004502 kle
% 216.96/217.15  |- skos__annotation mesh__D004502
% 216.96/217.15       differentiate from EDUCATION, MEDICAL, GRADUATE: see note on EDUCATION, CONTINUING; DF: EDUC MED CONTINUING%A%  
% 216.96/217.15  |- mesh__historyNote mesh__D004502
% 216.96/217.15       66; EDUCATION, MEDICAL, POSTGRADUATE was see under EDUCATION, MEDICAL, CONTINUING %26% EDUCATION, MEDICAL, GRADUATE 1966-74, was heading 1963-65%A%  
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D004502 2001
% 216.96/217.15  |- skos__altLabel mesh__D004502 Medical Education, Continuing
% 216.96/217.15  |- mesh__recordAuthorizer mesh__D004502 sjn
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D004502 2005
% 216.96/217.15  |- skos__altLabel mesh__D004502 Continuing Medical Education
% 216.96/217.15  |- skos__broader mesh__D004502smesh__D004496
% 216.96/217.15  |- rdf__type mesh__D004502sskos__Concept
% 216.96/217.15  |- mesh__publicMeSHNote mesh__D004502
% 216.96/217.15       66; EDUCATION, MEDICAL, POSTGRADUATE was see under EDUCATION, MEDICAL, CONTINUING %26% EDUCATION, MEDICAL, GRADUATE 1966-74, was heading 1963-65%A%  
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D004502 2000
% 216.96/217.15  |- skos__altLabel mesh__D004502 Education, Continuing Medical
% 216.96/217.15  |- mesh__recordOriginator mesh__D009796 NLM
% 216.96/217.15  |- mesh__recordAuthorizer mesh__D009796 sjn
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D009796 2004
% 216.96/217.15  |- mesh__onlineNote mesh__D009796 search CAPRYLATES 1968-74   
% 216.96/217.15  |- skos__hiddenLabel mesh__D009796 Acids, Octanoic
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D009796 2005
% 216.96/217.15  |- skos__prefLabel mesh__D009796 Octanoic Acids
% 216.96/217.15  |- mesh__historyNote mesh__D009796
% 216.96/217.15       91%28%75%29%; was see under CAPRYLATES 1975-90   
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D009796 2006
% 216.96/217.15  |- mesh__dateEstablished mesh__D009796 1991-01-01
% 216.96/217.15  |- mesh__recordMaintainer mesh__D009796 ssb
% 216.96/217.15  |- mesh__dateRevised mesh__D009796 2003-07-09
% 216.96/217.15  |- skos__broader mesh__D009796smesh__D002210
% 216.96/217.15  |- mesh__publicMeSHNote mesh__D009796
% 216.96/217.15       91; was see under CAPRYLATES 1975-90   
% 216.96/217.15  |- rdf__type mesh__D009796sskos__Concept
% 216.96/217.15  |- mesh__dateCreated mesh__D009796 1999-01-01
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D042621 2006
% 216.96/217.15  |- skos__broader mesh__D042621smesh__D016946
% 216.96/217.15  |- skos__prefLabel mesh__D042621 Comamonadaceae
% 216.96/217.15  |- mesh__recordAuthorizer mesh__D042621 sjn
% 216.96/217.15  |- skos__scopeNote mesh__D042621
% 216.96/217.15       A family of gram-negative aerobic bacteria in the class BETA PROTEOBACTERIA, encompassing the acidovorans rRNA complex. Some species are pathogenic for PLANTS.%A%    
% 216.96/217.15  |- mesh__dateRevised mesh__D042621 2005-06-30
% 216.96/217.15  |- mesh__dateEstablished mesh__D042621 2004-01-01
% 216.96/217.15  |- mesh__historyNote mesh__D042621 2004   
% 216.96/217.15  |- rdf__type mesh__D042621sskos__Concept
% 216.96/217.15  |- mesh__recordMaintainer mesh__D042621 SYSTEM
% 216.96/217.15  |- skos__broader mesh__D042621smesh__D020562
% 216.96/217.15  |- mesh__dateCreated mesh__D042621 2003-07-09
% 216.96/217.15  |- mesh__publicMeSHNote mesh__D042621 2004   
% 216.96/217.15  |- mesh__recordOriginator mesh__D042621 ags
% 216.96/217.15  |- skos__hiddenLabel mesh__D014930 Women Groups
% 216.96/217.15  |- skos__hiddenLabel mesh__D014930 Group, Women%27%s
% 216.96/217.15  |- mesh__recordOriginator mesh__D014930 NLM
% 216.96/217.15  |- mesh__recordMaintainer mesh__D014930 ags
% 216.96/217.15  |- skos__broader mesh__D014930smesh__D009272
% 216.96/217.15  |- skos__hiddenLabel mesh__D014930 Groups, Women%27%s
% 216.96/217.15  |- skos__altLabel mesh__D014930 Woman
% 216.96/217.15  |- mesh__recordAuthorizer mesh__D014930 sjn
% 216.96/217.15  |- rdf__type mesh__D014930sskos__Concept
% 216.96/217.15  |- skos__scopeNote mesh__D014930
% 216.96/217.15       Human adult females as cultural, psychological, sociological, political, and economic entities.%A%    
% 216.96/217.15  |- skos__annotation mesh__D014930
% 216.96/217.15       for women only as a cultural, social, sociological, political, economic force; distinguish from the check tag FEMALE; when indexing WOMEN, check the tags HUMANS %26% FEMALE; Manual 18.9.6, 34.12%A%  
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014930 2006
% 216.96/217.15  |- mesh__dateRevised mesh__D014930 2005-06-30
% 216.96/217.15  |- mesh__dateCreated mesh__D014930 1999-01-01
% 216.96/217.15  |- skos__hiddenLabel mesh__D014930 Women%27%s Group
% 216.96/217.15  |- skos__prefLabel mesh__D014930 Women
% 216.96/217.15  |- skos__related mesh__D014132smesh__D007442
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014132 2005
% 216.96/217.15  |- skos__broader mesh__D014132smesh__D012137
% 216.96/217.15  |- mesh__recordAuthorizer mesh__D014132 PLS
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014132 2006
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014132 2003
% 216.96/217.15  |- mesh__dateRevised mesh__D014132 1996-06-10
% 216.96/217.15  |- mesh__dateCreated mesh__D014132 1999-01-01
% 216.96/217.15  |- skos__annotation mesh__D014132
% 216.96/217.15       /surg: consider also TRACHEOSTOMY %26% TRACHEOTOMY; inflammation = TRACHEITIS; tracheal cyst = TRACHEAL CYST see MEDIASTINAL CYST%A%  
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014132 2000
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014132 1998
% 216.96/217.15  |- skos__related mesh__D014132smesh__D014140
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014132 2004
% 216.96/217.15  |- skos__hiddenLabel mesh__D014132 Tracheas
% 216.96/217.15  |- mesh__recordMaintainer mesh__D014132 TGC
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014132 2001
% 216.96/217.15  |- skos__related mesh__D014132smesh__D000770
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014132 1999
% 216.96/217.15  |- skos__prefLabel mesh__D014132 Trachea
% 216.96/217.15  |- skos__related mesh__D014132smesh__D014139
% 216.96/217.15  |- mesh__recordOriginator mesh__D014132 NLM
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014132 2002
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014132 1997
% 216.96/217.15  |- rdf__type mesh__D014132sskos__Concept
% 216.96/217.15  |- skos__scopeNote mesh__D014132
% 216.96/217.15       The cartilaginous and membranous tube descending from the larynx and branching into the right and left main bronchi.%A%    
% 216.96/217.15  |- skos__altLabel mesh__D000910 Heterophile Antibodies
% 216.96/217.15  |- skos__scopeNote mesh__D000910
% 216.96/217.15       Antibodies elicited in a different species from which the antigen originated. These antibodies are directed against a wide variety of interspecies-specific antigens, the best known of which are Forssman, Hanganutziu-Deicher %28%H-D%29%, and Paul-Bunnell %28%P-B%29%. Incidence of antibodies to these antigens--i.e., the phenomenon of heterophile antibody response--is useful in the serodiagnosis, pathogenesis, and prognosis of infection and latent infectious states as well as in cancer classification.%A%    
% 216.96/217.15  |- mesh__recordOriginator mesh__D000910 NLM
% 216.96/217.15  |- skos__altLabel mesh__D000910 Heterologous Antibodies
% 216.96/217.15  |- skos__annotation mesh__D000910
% 216.96/217.15       do not coordinate with ANTIBODY FORMATION for /biosyn   
% 216.96/217.15  |- skos__hiddenLabel mesh__D000910 Heterophil Antibodies
% 216.96/217.15  |- rdf__type mesh__D000910sskos__Concept
% 216.96/217.15  |- mesh__recordMaintainer mesh__D000910 DRC
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D000910 2006
% 216.96/217.15  |- skos__hiddenLabel mesh__D000910 Heterotypic Antibodies
% 216.96/217.15  |- skos__altLabel mesh__D000910 Antibodies, Heterophil
% 216.96/217.15  |- skos__altLabel mesh__D000910 Antibodies, Xenogeneic
% 216.96/217.15  |- skos__altLabel mesh__D000910 Heteroantibodies
% 216.96/217.15  |- mesh__recordAuthorizer mesh__D000910 sjn
% 216.96/217.15  |- skos__altLabel mesh__D000910 Xenoantibodies
% 216.96/217.15  |- skos__altLabel mesh__D000910 Antibodies, Xenogenic
% 216.96/217.15  |- skos__hiddenLabel mesh__D000910 Xenogenic Antibodies
% 216.96/217.15  |- skos__altLabel mesh__D000910 H-D Antibodies
% 216.96/217.15  |- mesh__dateRevised mesh__D000910 2005-06-30
% 216.96/217.15  |- skos__prefLabel mesh__D000910 Antibodies, Heterophile
% 216.96/217.15  |- skos__hiddenLabel mesh__D000910 Xenogeneic Antibodies
% 216.96/217.15  |- mesh__publicMeSHNote mesh__D000910
% 216.96/217.15       1987; see ANTIBODIES, HETEROTYPIC 1964-1986; FORSSMAN ANTIBODY was indexed under ANTIBODIES, HETEROPHILE 1985-2004%A%  
% 216.96/217.15  |- skos__broader mesh__D000910smesh__D000906
% 216.96/217.15  |- skos__hiddenLabel mesh__D000910 Antibody, Forssman
% 216.96/217.15  |- mesh__dateEstablished mesh__D000910 1972-01-01
% 216.96/217.15  |- skos__altLabel mesh__D000910 P-B Antibodies
% 216.96/217.15  |- skos__altLabel mesh__D000910 Antibodies, Heterologous
% 216.96/217.15  |- skos__altLabel mesh__D000910 Antibodies, Heterotypic
% 216.96/217.15  |- mesh__historyNote mesh__D000910 1987 %28%1964%29%   
% 216.96/217.15  |- skos__altLabel mesh__D000910 Heterogenetic Antibodies
% 216.96/217.15  |- mesh__dateCreated mesh__D000910 1999-01-01
% 216.96/217.15  |- skos__altLabel mesh__D000910 Antibodies, Heterogenetic
% 216.96/217.15  |- skos__broader mesh__D000112smesh__D004074
% 216.96/217.15  |- rdf__type mesh__D000112sskos__Concept
% 216.96/217.15  |- mesh__dateEstablished mesh__D000112 1991-01-01
% 216.96/217.15  |- skos__scopeNote mesh__D000112
% 216.96/217.15       Cardioactive derivatives of lanatoside A or of DIGITOXIN. They are used for fast digitalization in congestive heart failure.%A%    
% 216.96/217.15  |- mesh__onlineNote mesh__D000112
% 216.96/217.15       use ACETYLDIGITOXINS to search ACETYLDIGITOXIN 1975-79 %26% DIGITOXIN 1966-74%A%  
% 216.96/217.15  |- skos__altLabel mesh__D000112 Desglucolanatosides A
% 216.96/217.15  |- mesh__historyNote mesh__D000112
% 216.96/217.15       91%28%80%29%; was see under DIGITOXIN 1980-90; was ACETYLDIGITOXIN see under DIGITOXIN 1966-79%A%  
% 216.96/217.15  |- skos__hiddenLabel mesh__D000112 Monoacetate, Digitoxin
% 216.96/217.15  |- skos__hiddenLabel mesh__D000112 alpha Acetyldigitoxin
% 216.96/217.15  |- skos__annotation mesh__D000112 do not confuse with ACETYLDIGOXINS   
% 216.96/217.15  |- mesh__publicMeSHNote mesh__D000112
% 216.96/217.15       91; was see under DIGITOXIN 1980-90; was ACETYLDIGITOXIN see under DIGITOXIN 1966-79%A%  
% 216.96/217.15  |- mesh__recordOriginator mesh__D000112 NLM
% 216.96/217.15  |- mesh__dateRevised mesh__D000112 2004-07-07
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D000112 2005
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D000112 2006
% 216.96/217.15  |- skos__prefLabel mesh__D000112 Acetyldigitoxins
% 216.96/217.15  |- mesh__recordMaintainer mesh__D000112 ssb
% 216.96/217.15  |- mesh__dateCreated mesh__D000112 1999-01-01
% 216.96/217.15  |- mesh__recordAuthorizer mesh__D000112 sjn
% 216.96/217.15  |- mesh__dateRevised mesh__D013838 2005-06-30
% 216.96/217.15  |- skos__historyNote mesh__D013838
% 216.96/217.15       Organophosphorus Compounds %28%1971-1978%29%
% 216.96/217.15  |- skos__hiddenLabel mesh__D013838 Triphosphate, Thiamin
% 216.96/217.15  |- mesh__dateCreated mesh__D013838 1977-12-22
% 216.96/217.15  |- mesh__recordOriginator mesh__D013838 RLS
% 216.96/217.15  |- skos__historyNote mesh__D013838 Thiamine %28%1966-1978%29%
% 216.96/217.15  |- skos__scopeNote mesh__D013838
% 216.96/217.15       3-%28%%28%4-Amino-2-methyl-5-pyrimidinyl%29%methyl%29%-4-methyl-5-%28%4,6,8,8-tetrahydroxy-3,5,7-trioxa-4,6,8-triphosphaoct-1-yl%29%thiazolium hydroxide, inner salt, P,P%27%,P%27%%27%-trioxide. The triphosphate ester of thiamine. In Leigh%27%s disease, this compound is present in decreased amounts in the brain due to a metabolic block in its formation.%A%    
% 216.96/217.15  |- mesh__recordAuthorizer mesh__D013838 sjn
% 216.96/217.15  |- skos__altLabel mesh__D013838 Thiamin Triphosphate
% 216.96/217.15  |- mesh__publicMeSHNote mesh__D013838 91; was see under THIAMINE 1979-90   
% 216.96/217.15  |- skos__prefLabel mesh__D013838 Thiamine Triphosphate
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D013838 2006
% 216.96/217.15  |- rdf__type mesh__D013838sskos__Concept
% 216.96/217.15  |- mesh__historyNote mesh__D013838
% 216.96/217.15       91%28%79%29%; was see under THIAMINE 1979-90   
% 216.96/217.15  |- skos__annotation mesh__D013838
% 216.96/217.15       do not confuse with THIAMIN TRIPHOSPHATASE; deficiency: coordinate THIAMINE TRIPHOSPHATE /defic %28%IM%29% with THIAMINE DEFICIENCY %28%IM%29%%A%  
% 216.96/217.15  |- mesh__dateEstablished mesh__D013838 1991-01-01
% 216.96/217.15  |- mesh__recordMaintainer mesh__D013838 ssb
% 216.96/217.15  |- skos__hiddenLabel mesh__D013838 Triphosphate, Thiamine
% 216.96/217.15  |- skos__broader mesh__D013838smesh__D013831
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D018523 2005
% 216.96/217.15  |- mesh__dateRevised mesh__D018523 2004-07-07
% 216.96/217.15  |- skos__annotation mesh__D018523
% 216.96/217.15       directional growth toward or away from a stimulus   
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D018523 2006
% 216.96/217.15  |- skos__scopeNote mesh__D018523
% 216.96/217.15       The directional growth of an organism in response to an external stimulus such as light, touch, or gravity. Growth towards the stimulus is a positive tropism; growth away from the stimulus is a negative tropism. %28%From Concise Dictionary of Biology, 1990%29%%A%    
% 216.96/217.15  |- mesh__dateEstablished mesh__D018523 1995-01-01
% 216.96/217.15  |- skos__prefLabel mesh__D018523 Tropism
% 216.96/217.15  |- mesh__recordMaintainer mesh__D018523 nns
% 216.96/217.15  |- mesh__dateCreated mesh__D018523 1994-06-07
% 216.96/217.15  |- rdf__type mesh__D018523sskos__Concept
% 216.96/217.15  |- skos__broader mesh__D018523smesh__D006128
% 216.96/217.15  |- mesh__publicMeSHNote mesh__D018523 95   
% 216.96/217.15  |- mesh__recordAuthorizer mesh__D018523 sjn
% 216.96/217.15  |- mesh__recordOriginator mesh__D018523 JLS
% 216.96/217.15  |- skos__broader mesh__D018523smesh__D018521
% 216.96/217.15  |- skos__hiddenLabel mesh__D018523 Tropisms
% 216.96/217.15  |- mesh__historyNote mesh__D018523 95   
% 216.96/217.15  |- skos__scopeNote mesh__D051957
% 216.96/217.15       A homeodomain protein that interacts with TATA-BOX BINDING PROTEIN. It represses GENETIC TRANSCRIPTION of target GENES and plays a critical role in ODONTOGENESIS.%A%    
% 216.96/217.15  |- mesh__recordOriginator mesh__D051957 DRC
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D051957 2006
% 216.96/217.15  |- skos__altLabel mesh__D051957 Homeobox 7.1 Protein
% 216.96/217.15  |- mesh__publicMeSHNote mesh__D051957
% 216.96/217.15       2006; MSX1 TRANSCRIPTION FACTOR was indexed under TRANSCRIPTION FACTORS 1993-2005, %26% under HOMEODOMAIN PROTEINS 2005, %26% under REPRESSOR PROTEINS 1993-2004 %26% DNA-BINDING PROTEINS 1993-1994%A%  
% 216.96/217.15  |- rdf__type mesh__D051957sskos__Concept
% 216.96/217.15  |- skos__prefLabel mesh__D051957 MSX1 Transcription Factor
% 216.96/217.15  |- mesh__recordAuthorizer mesh__D051957 sjn
% 216.96/217.15  |- skos__hiddenLabel mesh__D051957 Transcription Factor, MSX1
% 216.96/217.15  |- mesh__dateEstablished mesh__D051957 2006-01-01
% 216.96/217.15  |- skos__broader mesh__D051957smesh__D014157
% 216.96/217.15  |- skos__altLabel mesh__D051957 Msh Homeo Box Homolog 1 Protein
% 216.96/217.15  |- mesh__recordMaintainer mesh__D051957 DRC
% 216.96/217.15  |- mesh__dateCreated mesh__D051957 2005-06-30
% 216.96/217.15  |- skos__broader mesh__D051957smesh__D018398
% 216.96/217.15  |- mesh__historyNote mesh__D051957 2006%28%1993%29%   
% 216.96/217.15  |- mesh__historyNote mesh__D004503
% 216.96/217.15       66; EDUCATION, MEDICAL, POSTGRADUATE was see under EDUCATION, MEDICAL, CONTINUING %26% EDUCATION, MEDICAL, GRADUATE 1966-74; was heading 1963-65%A%  
% 216.96/217.15  |- mesh__dateEstablished mesh__D004503 1966-01-01
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D004503 2002
% 216.96/217.15  |- mesh__dateRevised mesh__D004503 1999-11-03
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D004503 2004
% 216.96/217.15  |- mesh__publicMeSHNote mesh__D004503
% 216.96/217.15       66; EDUCATION, MEDICAL, POSTGRADUATE was see under EDUCATION, MEDICAL, CONTINUING %26% EDUCATION, MEDICAL, GRADUATE 1966-74; was heading 1963-65%A%  
% 216.96/217.15  |- mesh__onlineNote mesh__D004503
% 216.96/217.15       use EDUCATION, MEDICAL, GRADUATE %26% EDUCATION, MEDICAL, CONTINUING to search EDUCATION, MEDICAL, POSTGRADUATE 1966-74%A%  
% 216.96/217.15  |- skos__altLabel mesh__D004503 Medical Education, Graduate
% 216.96/217.15  |- skos__scopeNote mesh__D004503
% 216.96/217.15       Educational programs for medical graduates entering a specialty. They include formal specialty training as well as academic work in the clinical and basic medical sciences, and may lead to board certification or an advanced medical degree.%A%    
% 216.96/217.15  |- skos__annotation mesh__D004503
% 216.96/217.15       differentiate from EDUCATION, MEDICAL, CONTINUING: see note on EDUCATION, CONTINUING; Manual 34.22; DF: EDUC MED GRAD%A%  
% 216.96/217.15  |- skos__broader mesh__D004503smesh__D004501
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D004503 2003
% 216.96/217.15  |- skos__prefLabel mesh__D004503 Education, Medical, Graduate
% 216.96/217.15  |- mesh__recordAuthorizer mesh__D004503 sjn
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D004503 2001
% 216.96/217.15  |- mesh__recordMaintainer mesh__D004503 kle
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D004503 2006
% 216.96/217.15  |- rdf__type mesh__D004503sskos__Concept
% 216.96/217.15  |- skos__altLabel mesh__D004503 Education, Graduate Medical
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D004503 2000
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D004503 2005
% 216.96/217.15  |- mesh__recordOriginator mesh__D004503 NLM
% 216.96/217.15  |- skos__altLabel mesh__D004503 Graduate Medical Education
% 216.96/217.15  |- mesh__dateCreated mesh__D004503 1999-01-01
% 216.96/217.15  |- skos__broader mesh__D004503smesh__D004500
% 216.96/217.15  |- skos__hiddenLabel mesh__D042622 Expansion, DNA Repeat
% 216.96/217.15  |- skos__hiddenLabel mesh__D042622 Repeat Expansion, DNA
% 216.96/217.15  |- skos__scopeNote mesh__D042622
% 216.96/217.15       An increase number of repeats of a genomic, tandemly repeated DNA sequence from one generation to the next.%A%    
% 216.96/217.15  |- skos__hiddenLabel mesh__D042622 DNA Repeat Expansions
% 216.96/217.15  |- mesh__recordMaintainer mesh__D042622 nns
% 216.96/217.15  |- skos__hiddenLabel mesh__D042622 DNA Repeats, Expanded
% 216.96/217.15  |- rdf__type mesh__D042622sskos__Concept
% 216.96/217.15  |- mesh__dateCreated mesh__D042622 2003-07-25
% 216.96/217.15  |- skos__hiddenLabel mesh__D042622 Repeat Expansions, DNA
% 216.96/217.15  |- mesh__recordAuthorizer mesh__D042622 sjn
% 216.96/217.15  |- skos__related mesh__D042622smesh__D043283
% 216.96/217.15  |- mesh__dateRevised mesh__D042622 2005-06-30
% 216.96/217.15  |- skos__hiddenLabel mesh__D042622 Repeat, Expanded DNA
% 216.96/217.15  |- mesh__publicMeSHNote mesh__D042622 2004   
% 216.96/217.15  |- skos__historyNote mesh__D042622
% 216.96/217.15       Repetitive Sequences, Nucleic Acid or specifics %28%1993-2003%29%
% 216.96/217.15  |- skos__related mesh__D042622smesh__D002873
% 216.96/217.15  |- skos__broader mesh__D042622smesh__D043243
% 216.96/217.15  |- skos__broader mesh__D042622smesh__D020080
% 216.96/217.15  |- skos__prefLabel mesh__D042622 DNA Repeat Expansion
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D042622 2006
% 216.96/217.15  |- mesh__recordOriginator mesh__D042622 nns
% 216.96/217.15  |- mesh__dateEstablished mesh__D042622 2004-01-01
% 216.96/217.15  |- mesh__historyNote mesh__D042622 2004   
% 216.96/217.15  |- skos__broader mesh__D042622smesh__D009154
% 216.96/217.15  |- skos__broader mesh__D042622smesh__D016296
% 216.96/217.15  |- skos__hiddenLabel mesh__D042622 Expanded DNA Repeat
% 216.96/217.15  |- skos__hiddenLabel mesh__D042622 DNA Repeat, Expanded
% 216.96/217.15  |- skos__hiddenLabel mesh__D042622 Expansions, DNA Repeat
% 216.96/217.15  |- skos__hiddenLabel mesh__D042622 Repeats, Expanded DNA
% 216.96/217.15  |- skos__hiddenLabel mesh__D020170 Enzyme, Interleukin-1 Converting
% 216.96/217.15  |- skos__altLabel mesh__D020170 Interleukin-1beta Converting Enzyme
% 216.96/217.15  |- skos__hiddenLabel mesh__D020170 Convertase, IL-1 beta
% 216.96/217.15  |- skos__altLabel mesh__D020170 IL-1 beta-Converting Enzyme
% 216.96/217.15  |- skos__historyNote mesh__D020170 Cysteine Proteinases %28%1995-1998%29%
% 216.96/217.15  |- skos__hiddenLabel mesh__D020170 beta Convertase, IL-1
% 216.96/217.15  |- skos__altLabel mesh__D020170 Interleukin-1 Converting Enzyme
% 216.96/217.15  |- mesh__dateCreated mesh__D020170 1998-06-10
% 216.96/217.15  |- skos__hiddenLabel mesh__D020170 Interleukin 1 Converting Enzyme
% 216.96/217.15  |- skos__related mesh__D020170smesh__D007375
% 216.96/217.15  |- skos__altLabel mesh__D020170 IL-1 beta Convertase
% 216.96/217.15  |- skos__prefLabel mesh__D020170 Caspase 1
% 216.96/217.15  |- skos__historyNote mesh__D020170 Metalloproteinases %28%1989-1994%29%
% 216.96/217.15  |- mesh__recordOriginator mesh__D020170 ADP
% 216.96/217.15  |- mesh__publicMeSHNote mesh__D020170
% 216.96/217.15       99; INTERLEUKIN 1BETA CONVERTING ENZYME %28%now CASPASE 1%29% was indexed under CYSTEINE PROTEINASES 1995-98 %26% METALLOPROTEINASES 1989-94%A%  
% 216.96/217.15  |- mesh__recordMaintainer mesh__D020170 DRC
% 216.96/217.15  |- skos__hiddenLabel mesh__D020170 Protease, ICE
% 216.96/217.15  |- skos__hiddenLabel mesh__D020170 beta-Converting Enzyme, IL-1
% 216.96/217.15  |- skos__hiddenLabel mesh__D020170 Converting Enzyme, Interleukin-1
% 216.96/217.15  |- skos__altLabel mesh__D020170 IL1BC
% 216.96/217.15  |- mesh__recordAuthorizer mesh__D020170 sjn
% 216.96/217.15  |- skos__altLabel mesh__D020170 CASP1
% 216.96/217.15  |- mesh__dateRevised mesh__D020170 2005-06-30
% 216.96/217.15  |- skos__broader mesh__D020170smesh__D020169
% 216.96/217.15  |- skos__hiddenLabel mesh__D020170 IL 1 beta Converting Enzyme
% 216.96/217.15  |- mesh__historyNote mesh__D020170 99; use CASPASE 1 %28%NM%29% 1989-98   
% 216.96/217.15  |- skos__hiddenLabel mesh__D020170 Enzyme, Interleukin-1beta Converting
% 216.96/217.15  |- skos__scopeNote mesh__D020170
% 216.96/217.15       A member of the caspase family that is highly specific for interleukin-1beta %28%INTERLEUKIN-1%29%. It plays a role in inflammation and mammalian APOPTOSIS. Interleukin-1beta converting enzyme is frequently abbreviated ICE. EC 3.4.22.36%A%    
% 216.96/217.15  |- skos__hiddenLabel mesh__D020170 Enzyme, IL-1 beta-Converting
% 216.96/217.15  |- skos__related mesh__D020170smesh__D017209
% 216.96/217.15  |- skos__hiddenLabel mesh__D020170 1, Caspase
% 216.96/217.15  |- skos__hiddenLabel mesh__D020170 Interleukin 1beta Converting Enzyme
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D020170 2006
% 216.96/217.15  |- mesh__dateEstablished mesh__D020170 1999-01-01
% 216.96/217.15  |- rdf__type mesh__D020170sskos__Concept
% 216.96/217.15  |- skos__hiddenLabel mesh__D020170 IL 1 beta Convertase
% 216.96/217.15  |- skos__hiddenLabel mesh__D020170 Converting Enzyme, Interleukin-1beta
% 216.96/217.15  |- skos__altLabel mesh__D020170 ICE Protease
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014931 2004
% 216.96/217.15  |- mesh__dateCreated mesh__D014931 1983-06-06
% 216.96/217.15  |- mesh__publicMeSHNote mesh__D014931 91; was see under WOMEN 1984-90   
% 216.96/217.15  |- skos__prefLabel mesh__D014931 Women, Working
% 216.96/217.15  |- rdf__type mesh__D014931sskos__Concept
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014931 1999
% 216.96/217.15  |- skos__hiddenLabel mesh__D014931 Working Woman
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014931 1996
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014931 2000
% 216.96/217.15  |- skos__broader mesh__D014931smesh__D014930
% 216.96/217.15  |- skos__scopeNote mesh__D014931
% 216.96/217.15       Women who are engaged in gainful activities usually outside the home.%A%    
% 216.96/217.15  |- mesh__recordAuthorizer mesh__D014931 PLS
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014931 2005
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014931 1997
% 216.96/217.15  |- mesh__dateRevised mesh__D014931 1995-06-09
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014931 2001
% 216.96/217.15  |- skos__historyNote mesh__D014931 Women %28%1966-1983%29%
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014931 2006
% 216.96/217.15  |- mesh__recordOriginator mesh__D014931 EC
% 216.96/217.15  |- skos__altLabel mesh__D014931 Woman, Working
% 216.96/217.15  |- mesh__dateEstablished mesh__D014931 1991-01-01
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014931 2003
% 216.96/217.15  |- mesh__historyNote mesh__D014931
% 216.96/217.15       91%28%84%29%; was see under WOMEN 1984-90   
% 216.96/217.15  |- mesh__recordMaintainer mesh__D014931 PLS
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014931 1998
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014931 2002
% 216.96/217.15  |- skos__altLabel mesh__D014931 Working Women
% 216.96/217.15  |- mesh__activeMeSHYear mesh__D014133 2002
% 216.96/217.16  |- mesh__publicMeSHNote mesh__D014133 68   
% 216.96/217.16  |- mesh__recordAuthorizer mesh__D014133 NLM
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014133 1992
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014133 2006
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014133 2003
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014133 1995
% 216.96/217.16  |- mesh__dateCreated mesh__D014133 1999-01-01
% 216.96/217.16  |- skos__annotation mesh__D014133 inflamm dis = TRACHEITIS   
% 216.96/217.16  |- mesh__historyNote mesh__D014133 68   
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014133 1998
% 216.96/217.16  |- skos__hiddenLabel mesh__D014133 Disease, Tracheal
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014133 1993
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014133 2004
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014133 1996
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014133 1999
% 216.96/217.16  |- skos__historyNote mesh__D014133
% 216.96/217.16       Respiratory Tract Diseases %28%1966-1967%29%
% 216.96/217.16  |- mesh__dateEstablished mesh__D014133 1968-01-01
% 216.96/217.16  |- skos__historyNote mesh__D014133 Trachea %28%1966-1967%29%
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014133 2000
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014133 1997
% 216.96/217.16  |- rdf__type mesh__D014133sskos__Concept
% 216.96/217.16  |- skos__prefLabel mesh__D014133 Tracheal Diseases
% 216.96/217.16  |- skos__hiddenLabel mesh__D014133 Tracheal Disease
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014133 2001
% 216.96/217.16  |- mesh__dateRevised mesh__D014133 1990-05-29
% 216.96/217.16  |- skos__hiddenLabel mesh__D014133 Diseases, Tracheal
% 216.96/217.16  |- skos__broader mesh__D014133smesh__D012140
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014133 2005
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014133 1994
% 216.96/217.16  |- mesh__recordOriginator mesh__D014133 NLM
% 216.96/217.16  |- mesh__recordMaintainer mesh__D014133 PLS
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014133 1991
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D000911 2006
% 216.96/217.16  |- mesh__recordMaintainer mesh__D000911 ssb
% 216.96/217.16  |- skos__scopeNote mesh__D000911
% 216.96/217.16       Antibodies produced by clones of cells such as those isolated after hybridization of activated B LYMPHOCYTES with neoplastic cells. These hybrids are often referred to as HYBRIDOMAS.%A%    
% 216.96/217.16  |- mesh__dateEstablished mesh__D000911 1982-01-01
% 216.96/217.16  |- mesh__dateCreated mesh__D000911 1981-05-20
% 216.96/217.16  |- skos__prefLabel mesh__D000911 Antibodies, Monoclonal
% 216.96/217.16  |- skos__broader mesh__D000911smesh__D000906
% 216.96/217.16  |- mesh__recordAuthorizer mesh__D000911 sjn
% 216.96/217.16  |- mesh__publicMeSHNote mesh__D000911 82   
% 216.96/217.16  |- skos__altLabel mesh__D000911 Monoclonal Antibodies
% 216.96/217.16  |- skos__historyNote mesh__D000911 Antibodies %28%1975-1981%29%
% 216.96/217.16  |- skos__annotation mesh__D000911
% 216.96/217.16       do not coordinate with ANTIBODY FORMATION for biosyn; ANTIBODY-TOXIN CONJUGATES is available as a toxin carrier: see note there%A%  
% 216.96/217.16  |- mesh__historyNote mesh__D000911 82   
% 216.96/217.16  |- skos__related mesh__D000911smesh__D006825
% 216.96/217.16  |- mesh__recordOriginator mesh__D000911 SAG
% 216.96/217.16  |- rdf__type mesh__D000911sskos__Concept
% 216.96/217.16  |- skos__historyNote mesh__D000911 B Lymphocytes %28%1975-1981%29%
% 216.96/217.16  |- mesh__dateRevised mesh__D000911 2005-06-30
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 Medice Brand of beta Acetyldigoxin
% 216.96/217.16  |- skos__altLabel mesh__D000113 R.A.N. Brand of beta-Acetyldigoxin
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 R.A.N. Brand of beta Acetyldigoxin
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 beta-Acetyldigoxin Hormosan Brand
% 216.96/217.16  |- rdf__type mesh__D000113sskos__Concept
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 Wolff Brand of beta Acetyldigoxin
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 beta-Acetyldigoxin corax Brand
% 216.96/217.16  |- skos__historyNote mesh__D000113 Digoxin %28%1966-1978%29%
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 alpha Acetyldigoxin
% 216.96/217.16  |- skos__annotation mesh__D000113
% 216.96/217.16       Digitalis glycosides; do not confuse with ACETYLDIGITOXINS; alpha isomer %26% beta isomer go here%A%  
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 Stada Brand of beta Acetyldigoxin
% 216.96/217.16  |- skos__altLabel mesh__D000113 Medice Brand of beta-Acetyldigoxin
% 216.96/217.16  |- skos__altLabel mesh__D000113 Stada Brand of beta-Acetyldigoxin
% 216.96/217.16  |- skos__broader mesh__D000113smesh__D004077
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 Didier, Digoxin
% 216.96/217.16  |- mesh__recordAuthorizer mesh__D000113 sjn
% 216.96/217.16  |- skos__prefLabel mesh__D000113 Acetyldigoxins
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D000113 2006
% 216.96/217.16  |- mesh__dateRevised mesh__D000113 2004-07-07
% 216.96/217.16  |- skos__altLabel mesh__D000113 Wolff Brand of beta-Acetyldigoxin
% 216.96/217.16  |- skos__altLabel mesh__D000113 ct-Arzneimittel Brand of beta-Acetyldigoxin
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 Lilly Brand of beta Acetyldigoxin
% 216.96/217.16  |- skos__altLabel mesh__D000113 ASTA Medica Brand of beta-Acetyldigoxin
% 216.96/217.16  |- mesh__publicMeSHNote mesh__D000113 91; was see under DIGOXIN 1979-90   
% 216.96/217.16  |- mesh__historyNote mesh__D000113
% 216.96/217.16       91%28%79%29%; was see under DIGOXIN 1979-90   
% 216.96/217.16  |- mesh__recordMaintainer mesh__D000113 ssb
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113
% 216.96/217.16       ct Arzneimittel Brand of beta Acetyldigoxin
% 216.96/217.16  |- mesh__recordOriginator mesh__D000113 SH
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D000113 2005
% 216.96/217.16  |- skos__altLabel mesh__D000113 Desglucolanatosides C
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 beta-Acetyldigoxin gepepharm Brand
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 ASTA Medica Brand of beta Acetyldigoxin
% 216.96/217.16  |- skos__altLabel mesh__D000113 Lilly Brand of beta-Acetyldigoxin
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 beta-Acetyldigoxin R.A.N. Brand
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 beta-Acetyldigoxin Medice Brand
% 216.96/217.16  |- mesh__dateEstablished mesh__D000113 1991-01-01
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 beta Acetyldigoxin
% 216.96/217.16  |- skos__altLabel mesh__D000113 corax Brand of beta-Acetyldigoxin
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 beta Acetyldigoxin ratiopharm
% 216.96/217.16  |- skos__altLabel mesh__D000113 gepepharm Brand of beta-Acetyldigoxin
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 ct, digox von
% 216.96/217.16  |- mesh__dateCreated mesh__D000113 1978-03-16
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 beta-Acetyldigoxin Wolff Brand
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 von ct, digox
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 ratiopharm Brand of beta Acetyldigoxin
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 Hormosan Brand of beta Acetyldigoxin
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 beta-Acetyldigoxin Stada Brand
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 beta-Acetyldigoxin ct-Arzneimittel Brand
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 beta-Acetyldigoxin ratiopharm Brand
% 216.96/217.16  |- skos__altLabel mesh__D000113 ratiopharm Brand of beta-Acetyldigoxin
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 betaAcetyldigoxinratiopharm
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 gepepharm Brand of beta Acetyldigoxin
% 216.96/217.16  |- skos__scopeNote mesh__D000113
% 216.96/217.16       Alpha- or beta-acetyl derivatives of DIGOXIN or lanatoside C from Digitalis lanata. They are better absorbed and longer acting than digoxin and are used in congestive heart failure.%A%    
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 N, Gladixol
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 beta-Acetyldigoxin Lilly Brand
% 216.96/217.16  |- skos__altLabel mesh__D000113 Hormosan Brand of beta-Acetyldigoxin
% 216.96/217.16  |- skos__hiddenLabel mesh__D000113 corax Brand of beta Acetyldigoxin
% 216.96/217.16  |- mesh__dateEstablished mesh__D038581 2003-01-01
% 216.96/217.16  |- mesh__publicMeSHNote mesh__D038581 2003   
% 216.96/217.16  |- mesh__historyNote mesh__D038581 2003   
% 216.96/217.16  |- skos__broader mesh__D038581smesh__D009345
% 216.96/217.16  |- skos__scopeNote mesh__D038581
% 216.96/217.16       Strains of Neisseria meningitidis which, in the United States, causes disease in mostly adults and the elderly. Serogroup Y strains are associated with PNEUMONIA.%A%    
% 216.96/217.16  |- mesh__recordAuthorizer mesh__D038581 sjn
% 216.96/217.16  |- skos__altLabel mesh__D038581 Meningococci, Serogroup Y
% 216.96/217.16  |- mesh__recordMaintainer mesh__D038581 SYSTEM
% 216.96/217.16  |- skos__historyNote mesh__D038581 Neisseria meningitidis %28%1974-2002%29%
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D038581 2006
% 216.96/217.16  |- skos__altLabel mesh__D038581 Meningococcus, Serogroup Y
% 216.96/217.16  |- mesh__recordOriginator mesh__D038581 ags
% 216.96/217.16  |- skos__annotation mesh__D038581
% 216.96/217.16       infection: coord IM with MENINGITIS, MENINGOCOCCAL %28%IM%29% or, if not meningitis, MENINGOCOCCAL INFECTIONS %28%IM%29%%A%  
% 216.96/217.16  |- rdf__type mesh__D038581sskos__Concept
% 216.96/217.16  |- skos__prefLabel mesh__D038581 Neisseria meningitidis, Serogroup Y
% 216.96/217.16  |- mesh__dateCreated mesh__D038581 2002-07-03
% 216.96/217.16  |- mesh__dateRevised mesh__D038581 2005-06-30
% 216.96/217.16  |- skos__altLabel mesh__D013839 Zambon Brand of Thiamphenicol
% 216.96/217.16  |- skos__scopeNote mesh__D013839
% 216.96/217.16       A methylsulfonyl analog of CHLORAMPHENICOL. It is an antibiotic and immunosuppressive agent.%A%    
% 216.96/217.16  |- skos__historyNote mesh__D013839 Acetamides %28%1973-1974%29%
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D013839 2006
% 216.96/217.16  |- skos__historyNote mesh__D013839 Phenethylamines %28%1968-1974%29%
% 216.96/217.16  |- mesh__dateRevised mesh__D013839 2005-06-30
% 216.96/217.16  |- rdf__type mesh__D013839sskos__Concept
% 216.96/217.16  |- mesh__publicMeSHNote mesh__D013839
% 216.96/217.16       79; was see under ANTIBIOTICS 1975-78   
% 216.96/217.16  |- mesh__dateCreated mesh__D013839 1974-11-11
% 216.96/217.16  |- skos__prefLabel mesh__D013839 Thiamphenicol
% 216.96/217.16  |- mesh__recordOriginator mesh__D013839 NLM
% 216.96/217.16  |- mesh__recordAuthorizer mesh__D013839 sjn
% 216.96/217.16  |- mesh__recordMaintainer mesh__D013839 CCR
% 216.96/217.16  |- skos__altLabel mesh__D013839 Sanofi Brand of Thiamphenicol
% 216.96/217.16  |- skos__historyNote mesh__D013839 Sulfones %28%1966-1974%29%
% 216.96/217.16  |- skos__broader mesh__D013839smesh__D002701
% 216.96/217.16  |- skos__altLabel mesh__D013839 Dextrosulfenidol
% 216.96/217.16  |- mesh__dateEstablished mesh__D013839 1979-01-01
% 216.96/217.16  |- mesh__historyNote mesh__D013839
% 216.96/217.16       79%28%75%29%; was see under ANTIBIOTICS 1975-78   
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D024561 2004
% 216.96/217.16  |- mesh__recordAuthorizer mesh__D024561 ags
% 216.96/217.16  |- mesh__publicMeSHNote mesh__D024561 2002   
% 216.96/217.16  |- skos__scopeNote mesh__D024561
% 216.96/217.16       A group of invertebrate chordates %28%CHORDATA, NONVERTEBRATE%29% in the subphylum Craniota. They include the single order Myxiniformes, which comprise various HAGFISHES.%A%    
% 216.96/217.16  |- skos__broader mesh__D024561smesh__D002816
% 216.96/217.16  |- skos__prefLabel mesh__D024561 Hyperotreti
% 216.96/217.16  |- mesh__dateRevised mesh__D024561 2005-07-12
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D024561 2006
% 216.96/217.16  |- mesh__dateEstablished mesh__D024561 2002-01-01
% 216.96/217.16  |- mesh__dateCreated mesh__D024561 2001-08-03
% 216.96/217.16  |- rdf__type mesh__D024561sskos__Concept
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D024561 2005
% 216.96/217.16  |- mesh__recordMaintainer mesh__D024561 ags
% 216.96/217.16  |- mesh__recordOriginator mesh__D024561 ags
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D024561 2006A
% 216.96/217.16  |- mesh__historyNote mesh__D024561 2002   
% 216.96/217.16  |- skos__scopeNote mesh__D018524
% 216.96/217.16       The directional growth of organisms in response to light. In plants, aerial shoots usually grow towards light. The phototropic response is thought to be controlled by auxin %28%= AUXINS%29%, a plant growth substance. %28%From Concise Dictionary of Biology, 1990%29%%A%    
% 216.96/217.16  |- mesh__publicMeSHNote mesh__D018524 95   
% 216.96/217.16  |- mesh__recordAuthorizer mesh__D018524 sjn
% 216.96/217.16  |- mesh__dateCreated mesh__D018524 1994-06-07
% 216.96/217.16  |- skos__hiddenLabel mesh__D018524 Phototropisms
% 216.96/217.16  |- skos__historyNote mesh__D018524 Plants %28%1966-1994%29%
% 216.96/217.16  |- rdf__type mesh__D018524sskos__Concept
% 216.96/217.16  |- mesh__recordOriginator mesh__D018524 JLS
% 216.96/217.16  |- mesh__historyNote mesh__D018524 95   
% 216.96/217.16  |- skos__hiddenLabel mesh__D018524 Heliotropisms
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D018524 2005
% 216.96/217.16  |- mesh__dateRevised mesh__D018524 2004-07-07
% 216.96/217.16  |- mesh__dateEstablished mesh__D018524 1995-01-01
% 216.96/217.16  |- skos__broader mesh__D018524smesh__D018523
% 216.96/217.16  |- skos__prefLabel mesh__D018524 Phototropism
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D018524 2006
% 216.96/217.16  |- skos__annotation mesh__D018524
% 216.96/217.16       directional growth of a plant in response to light   
% 216.96/217.16  |- mesh__recordMaintainer mesh__D018524 nns
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D010541 2005
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D010541 2006
% 216.96/217.16  |- mesh__publicMeSHNote mesh__D010541 91; was see under ATTITUDE 1975-90   
% 216.96/217.16  |- skos__scopeNote mesh__D010541
% 216.96/217.16       The attitude that grants freedom of expression and activity to another individual, but not necessarily with sanction or approval.%A%    
% 216.96/217.16  |- mesh__dateEstablished mesh__D010541 1991-01-01
% 216.96/217.16  |- mesh__recordAuthorizer mesh__D010541 sjn
% 216.96/217.16  |- mesh__recordOriginator mesh__D010541 NLM
% 216.96/217.16  |- skos__prefLabel mesh__D010541 Permissiveness
% 216.96/217.16  |- mesh__dateCreated mesh__D010541 1974-11-11
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D010541 2003
% 216.96/217.16  |- skos__broader mesh__D010541smesh__D012919
% 216.96/217.16  |- mesh__historyNote mesh__D010541
% 216.96/217.16       91%28%75%29%; was see under ATTITUDE 1975-90   
% 216.96/217.16  |- skos__hiddenLabel mesh__D010541 Permissivenesses
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D010541 2004
% 216.96/217.16  |- skos__annotation mesh__D010541 no qualif   
% 216.96/217.16  |- rdf__type mesh__D010541sskos__Concept
% 216.96/217.16  |- mesh__recordMaintainer mesh__D010541 JLS
% 216.96/217.16  |- mesh__dateRevised mesh__D010541 2002-07-03
% 216.96/217.16  |- mesh__publicMeSHNote mesh__D051958
% 216.96/217.16       2006; NUCLEAR RECEPTOR COACTIVATOR 2 was indexed under TRANSCRIPTION FACTORS 1996-2005%A%  
% 216.96/217.16  |- rdf__type mesh__D051958sskos__Concept
% 216.96/217.16  |- skos__broader mesh__D051958smesh__D014157
% 216.96/217.16  |- skos__hiddenLabel mesh__D051958
% 216.96/217.16       Glucocorticoid Receptor Interacting Protein 1
% 216.96/217.16  |- skos__altLabel mesh__D051958
% 216.96/217.16       Glucocorticoid Receptor-Interacting Protein 1
% 216.96/217.16  |- mesh__recordAuthorizer mesh__D051958 sjn
% 216.96/217.16  |- skos__altLabel mesh__D051958 Steroid Receptor Coactivator SRC2
% 216.96/217.16  |- mesh__dateEstablished mesh__D051958 2006-01-01
% 216.96/217.16  |- skos__scopeNote mesh__D051958
% 216.96/217.16       A transcription factor that partners with ligand bound GLUCOCORTICOID RECEPTORS and ESTROGEN RECEPTORS to stimulate GENETIC TRANSCRIPTION. It plays an important role in FERTILITY as well as in METABOLISM of LIPIDS.%A%    
% 216.96/217.16  |- skos__altLabel mesh__D051958 Transcription Intermediary Factor 2
% 216.96/217.16  |- mesh__historyNote mesh__D051958 2006%28%1996%29%   
% 216.96/217.16  |- skos__prefLabel mesh__D051958 Nuclear Receptor Coactivator 2
% 216.96/217.16  |- skos__altLabel mesh__D051958 Steroid Receptor Coactivator-2
% 216.96/217.16  |- skos__hiddenLabel mesh__D051958 Steroid Receptor Coactivator 2
% 216.96/217.16  |- mesh__recordOriginator mesh__D051958 DRC
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D051958 2006
% 216.96/217.16  |- mesh__recordMaintainer mesh__D051958 DRC
% 216.96/217.16  |- mesh__dateCreated mesh__D051958 2005-06-30
% 216.96/217.16  |- mesh__recordMaintainer mesh__D004504 kle
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D004504 2003
% 216.96/217.16  |- mesh__historyNote mesh__D004504 73%28%71%29%   
% 216.96/217.16  |- mesh__publicMeSHNote mesh__D004504 73   
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D004504 2002
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D004504 2004
% 216.96/217.16  |- mesh__recordOriginator mesh__D004504 NLM
% 216.96/217.16  |- skos__scopeNote mesh__D004504
% 216.96/217.16       The period of medical education in a medical school. In the United States it follows the baccalaureate degree and precedes the granting of the M.D.%A%    
% 216.96/217.16  |- skos__broader mesh__D004504smesh__D004501
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D004504 2005
% 216.96/217.16  |- mesh__dateCreated mesh__D004504 1999-01-01
% 216.96/217.16  |- skos__historyNote mesh__D004504 Education, Medical %28%1966-1970%29%
% 216.96/217.16  |- mesh__dateEstablished mesh__D004504 1973-01-01
% 216.96/217.16  |- skos__altLabel mesh__D004504 Undergraduate Medical Education
% 216.96/217.16  |- skos__altLabel mesh__D004504 Education, Undergraduate Medical
% 216.96/217.16  |- skos__annotation mesh__D004504 DF: EDUC MED UNDERGRAD   
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D004504 2006
% 216.96/217.16  |- rdf__type mesh__D004504sskos__Concept
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D004504 2000
% 216.96/217.16  |- skos__altLabel mesh__D004504 Medical Education, Undergraduate
% 216.96/217.16  |- mesh__dateRevised mesh__D004504 1999-11-03
% 216.96/217.16  |- skos__prefLabel mesh__D004504 Education, Medical, Undergraduate
% 216.96/217.16  |- mesh__recordAuthorizer mesh__D004504 sjn
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D004504 2001
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D009798 2004
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D009798 2001
% 216.96/217.16  |- mesh__dateRevised mesh__D009798 1998-06-10
% 216.96/217.16  |- skos__broader mesh__D009798smesh__D005128
% 216.96/217.16  |- skos__prefLabel mesh__D009798 Ocular Hypertension
% 216.96/217.16  |- skos__hiddenLabel mesh__D009798 Glaucomas, Suspect
% 216.96/217.16  |- mesh__recordOriginator mesh__D009798 RC
% 216.96/217.16  |- skos__scopeNote mesh__D009798
% 216.96/217.16       A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma.%A%    
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D009798 2003
% 216.96/217.16  |- skos__hiddenLabel mesh__D009798 Ocular Hypertensions
% 216.96/217.16  |- skos__hiddenLabel mesh__D009798 Suspect Glaucoma
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D009798 2000
% 216.96/217.16  |- mesh__historyNote mesh__D009798 83   
% 216.96/217.16  |- mesh__publicMeSHNote mesh__D009798 83   
% 216.96/217.16  |- skos__annotation mesh__D009798
% 216.96/217.16       do not equate with GLAUCOMA; do not confuse with OCULAR HYPOTENSION%A%  
% 216.96/217.16  |- skos__historyNote mesh__D009798 Glaucoma %28%1966-1982%29%
% 216.96/217.16  |- skos__hiddenLabel mesh__D009798 Suspect Glaucomas
% 216.96/217.16  |- skos__altLabel mesh__D009798 Hypertension, Ocular
% 216.96/217.16  |- mesh__dateCreated mesh__D009798 1982-04-22
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D009798 2006
% 216.96/217.16  |- mesh__dateEstablished mesh__D009798 1983-01-01
% 216.96/217.16  |- skos__hiddenLabel mesh__D009798 Hypertensions, Ocular
% 216.96/217.16  |- skos__historyNote mesh__D009798 Intraocular Pressure %28%1966-1982%29%
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D009798 2005
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D009798 1999
% 216.96/217.16  |- mesh__recordMaintainer mesh__D009798 NDW
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D009798 2002
% 216.96/217.16  |- rdf__type mesh__D009798sskos__Concept
% 216.96/217.16  |- mesh__recordAuthorizer mesh__D009798 SJN
% 216.96/217.16  |- skos__scopeNote mesh__D020171
% 216.96/217.16       A mitosporic Leotiales fungal genus of plant pathogens. It has teleomorphs in the genus Botryotina.%A%    
% 216.96/217.16  |- mesh__dateEstablished mesh__D020171 1999-01-01
% 216.96/217.16  |- mesh__recordMaintainer mesh__D020171 SYSTEM
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D020171 2006
% 216.96/217.16  |- skos__historyNote mesh__D020171 Mitosporic Fungi %28%1965-1998%29%
% 216.96/217.16  |- skos__broader mesh__D020171smesh__D003904
% 216.96/217.16  |- rdf__type mesh__D020171sskos__Concept
% 216.96/217.16  |- mesh__dateCreated mesh__D020171 1998-06-10
% 216.96/217.16  |- mesh__historyNote mesh__D020171 99; use MITOSPORIC FUNGI 1975-98   
% 216.96/217.16  |- skos__prefLabel mesh__D020171 Botrytis
% 216.96/217.16  |- mesh__publicMeSHNote mesh__D020171
% 216.96/217.16       99; see HYPHOMYCETES 1986-98, see MONILIALES 1975-85   
% 216.96/217.16  |- mesh__recordOriginator mesh__D020171 AGS
% 216.96/217.16  |- mesh__dateRevised mesh__D020171 2005-06-30
% 216.96/217.16  |- mesh__recordAuthorizer mesh__D020171 sjn
% 216.96/217.16  |- skos__hiddenLabel mesh__D014932 Health Service, Woman%27%s
% 216.96/217.16  |- skos__hiddenLabel mesh__D014932 Health Services, Women
% 216.96/217.16  |- mesh__historyNote mesh__D014932
% 216.96/217.16       89%28%88%29%; was see under HEALTH SERVICES 1988   
% 216.96/217.16  |- skos__hiddenLabel mesh__D014932 Woman Health Services
% 216.96/217.16  |- skos__hiddenLabel mesh__D014932 Health Services, Woman
% 216.96/217.16  |- skos__hiddenLabel mesh__D014932 Woman%27%s Health Service
% 216.96/217.16  |- skos__hiddenLabel mesh__D014932 Health Service, Women%27%s
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014932 2005
% 216.96/217.16  |- skos__hiddenLabel mesh__D014932 Service, Women%27%s Health
% 216.96/217.16  |- mesh__recordAuthorizer mesh__D014932 sjn
% 216.96/217.16  |- mesh__dateEstablished mesh__D014932 1989-01-01
% 216.96/217.16  |- mesh__recordMaintainer mesh__D014932 sjn
% 216.96/217.16  |- skos__prefLabel mesh__D014932 Women%27%s Health Services
% 216.96/217.16  |- mesh__dateRevised mesh__D014932 2004-07-13
% 216.96/217.16  |- skos__altLabel mesh__D014932 Woman%27%s Health Services
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014932 2006
% 216.96/217.16  |- skos__altLabel mesh__D014932 Services, Woman%27%s Health
% 216.96/217.16  |- skos__hiddenLabel mesh__D014932 Services, Womans Health
% 216.96/217.16  |- mesh__publicMeSHNote mesh__D014932
% 216.96/217.16       89; was see under HEALTH SERVICES 1988   
% 216.96/217.16  |- skos__hiddenLabel mesh__D014932 Services, Women Health
% 216.96/217.16  |- skos__altLabel mesh__D014932 Health Services, Woman%27%s
% 216.96/217.16  |- skos__hiddenLabel mesh__D014932 Services, Woman Health
% 216.96/217.16  |- skos__hiddenLabel mesh__D014932 Health Services, Womans
% 216.96/217.16  |- skos__hiddenLabel mesh__D014932 Women%27%s Health Service
% 216.96/217.16  |- skos__scopeNote mesh__D014932
% 216.96/217.16       Organized services to provide health care to women. It excludes maternal care services for which MATERNAL HEALTH SERVICES is available.%A%    
% 216.96/217.16  |- skos__annotation mesh__D014932
% 216.96/217.16        does not include maternal care services: index under MATERNAL HEALTH SERVICES; check also tags  HUMANS and FEMALE; DF: WOMENS HEALTH SERV%A%  
% 216.96/217.16  |- mesh__dateCreated mesh__D014932 1987-05-04
% 216.96/217.16  |- skos__hiddenLabel mesh__D014932 Women Health Services
% 216.96/217.16  |- skos__hiddenLabel mesh__D014932 Service, Woman%27%s Health
% 216.96/217.16  |- skos__broader mesh__D014932smesh__D006296
% 216.96/217.16  |- skos__altLabel mesh__D014932 Services, Women%27%s Health
% 216.96/217.16  |- mesh__recordOriginator mesh__D014932 EC
% 216.96/217.16  |- skos__hiddenLabel mesh__D014932 Services, Womens Health
% 216.96/217.16  |- skos__altLabel mesh__D014932 Health Services, Women%27%s
% 216.96/217.16  |- rdf__type mesh__D014932sskos__Concept
% 216.96/217.16  |- skos__broader mesh__D020170Q000031smesh__D020170
% 216.96/217.16  |- mesh__preferredCombination mesh__D020170Q000031smesh__D020169
% 216.96/217.16  |- rdf__type mesh__D020170Q000031smesh__CompoundConcept
% 216.96/217.16  |- rdf__type mesh__D014134sskos__Concept
% 216.96/217.16  |- mesh__dateCreated mesh__D014134 1999-01-01
% 216.96/217.16  |- skos__broader mesh__D014134smesh__D012142
% 216.96/217.16  |- skos__hiddenLabel mesh__D014134 Neoplasms, Tracheal
% 216.96/217.16  |- mesh__dateRevised mesh__D014134 1995-06-08
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014134 2000
% 216.96/217.16  |- skos__prefLabel mesh__D014134 Tracheal Neoplasms
% 216.96/217.16  |- mesh__recordMaintainer mesh__D014134 KEV
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014134 2004
% 216.96/217.16  |- mesh__recordOriginator mesh__D014134 NLM
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014134 2006
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014134 2003
% 216.96/217.16  |- mesh__recordAuthorizer mesh__D014134 PLS
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014134 2005
% 216.96/217.16  |- skos__hiddenLabel mesh__D014134 Neoplasm, Tracheal
% 216.96/217.16  |- skos__broader mesh__D014134smesh__D006258
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014134 1997
% 216.96/217.16  |- skos__broader mesh__D014134smesh__D014133
% 216.96/217.16  |- skos__annotation mesh__D014134
% 216.96/217.16       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%  
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014134 1999
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014134 2002
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014134 1996
% 216.96/217.16  |- skos__hiddenLabel mesh__D014134 Tracheal Neoplasm
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014134 1998
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D014134 2001
% 216.96/217.16  |- skos__prefLabel mesh__D000912 Antibodies, Neoplasm
% 216.96/217.16  |- mesh__recordAuthorizer mesh__D000912 sjn
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D000912 2006
% 216.96/217.16  |- mesh__recordMaintainer mesh__D000912 ssb
% 216.96/217.16  |- mesh__dateEstablished mesh__D000912 1973-01-01
% 216.96/217.16  |- skos__hiddenLabel mesh__D000912 Antibodies, Tumor
% 216.96/217.16  |- skos__altLabel mesh__D000912 Neoplasm Antibodies
% 216.96/217.16  |- mesh__dateRevised mesh__D000912 2005-06-30
% 216.96/217.16  |- mesh__dateCreated mesh__D000912 1999-01-01
% 216.96/217.16  |- skos__broader mesh__D000912smesh__D000906
% 216.96/217.16  |- skos__historyNote mesh__D000912 Antibodies %28%1966-1972%29%
% 216.96/217.16  |- mesh__recordOriginator mesh__D000912 NLM
% 216.96/217.16  |- skos__annotation mesh__D000912
% 216.96/217.16       coordinate IM with required neoplasm terms with /immunol %28%IM%29%; do not coordinate with ANTIBODY FORMATION for /biosyn; DF: ANTIBODIES NEOPL%A%  
% 216.96/217.16  |- rdf__type mesh__D000912sskos__Concept
% 216.96/217.16  |- skos__scopeNote mesh__D000912
% 216.96/217.16       Immunoglobulins induced by antigens specific for tumors other than the normally occurring HISTOCOMPATIBILITY ANTIGENS.%A%    
% 216.96/217.16  |- mesh__publicMeSHNote mesh__D000912 73   
% 216.96/217.16  |- mesh__historyNote mesh__D000912 73   
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D000114 2001
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D000114 1995
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D000114 1996
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D000114 2004
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D000114 2002
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D000114 1997
% 216.96/217.16  |- mesh__dateCreated mesh__D000114 1999-01-01
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D000114 2005
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D000114 1998
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D000114 2006
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D000114 1993
% 216.96/217.16  |- rdf__type mesh__D000114sskos__Concept
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D000114 1999
% 216.96/217.16  |- skos__broader mesh__D000114smesh__D000480
% 216.96/217.16  |- skos__prefLabel mesh__D000114 Acetylene
% 216.96/217.16  |- mesh__recordOriginator mesh__D000114 NLM
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D000114 2000
% 216.96/217.16  |- mesh__recordAuthorizer mesh__D000114 PLS
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D000114 1994
% 216.96/217.16  |- mesh__dateRevised mesh__D000114 1992-05-07
% 216.96/217.16  |- mesh__recordMaintainer mesh__D000114 TAP
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D000114 2003
% 216.96/217.16  |- skos__altLabel mesh__D038582 Meningococcus, Serogroup W135
% 216.96/217.16  |- skos__annotation mesh__D038582
% 216.96/217.16       infection: coord IM with MENINGITIS, MENINGOCOCCAL %28%IM%29% or, if not meningitis, MENINGOCOCCAL INFECTIONS %28%IM%29%%A%  
% 216.96/217.16  |- skos__altLabel mesh__D038582 Meningococcus, Serogroup W-135
% 216.96/217.16  |- mesh__activeMeSHYear mesh__D038582 2006
% 216.96/217.16  |- mesh__dateRevised mesh__D038582 2005-06-30
% 216.96/217.16  |- mesh__dateCreated mesh__D038582 2002-07-03
% 216.96/217.16  |- mesh__dateEstablished mesh__D038582 2003-01-01
% 216.96/217.16  |- mesh__recordMaintainer mesh__D038582 SYSTEM
% 216.96/217.16  |- rdf__type mesh__D038582sskos__Concept
% 216.96/217.16  |- skos__altLabel mesh__D038582 Neisseria meningitidis, Serogroup W135
% 216.96/217.16  |- skos__broader mesh__D038582smesh__D009345
% 216.96/217.16  |- mesh__historyNote mesh__D038582 2003   
% 216.96/217.16  |- skos__scopeNote mesh__D038582
% 216.96/217.16       Strains of Neisseria meningitidis found mostly in Africa.%A%    
% 216.96/217.16  |- skos__historyNote mesh__D038582 Neisseria meningitidis %28%1976-2002%29%
% 216.96/217.16  |- mesh__publicMeSHNote mesh__D038582 2003   
% 216.96/217.16  |- mesh__recordAuthorizer mesh__D038582 sjn
% 216.96/217.16  |- skos__prefLabel mesh__D038582 Neisseria meningitidis, Serogroup W-135
% 216.96/217.16  |- mesh__recordOriginator mesh__D038582 ags
% 216.96/217.17  |- mesh__dateCreated mesh__D018525 1994-06-07
% 216.96/217.17  |- rdf__type mesh__D018525sskos__Concept
% 216.96/217.17  |- skos__hiddenLabel mesh__D018525 Germinations
% 216.96/217.17  |- mesh__recordOriginator mesh__D018525 JLS
% 216.96/217.17  |- mesh__historyNote mesh__D018525 95   
% 216.96/217.17  |- mesh__dateRevised mesh__D018525 2002-07-03
% 216.96/217.17  |- skos__broader mesh__D018525smesh__D018521
% 216.96/217.17  |- skos__scopeNote mesh__D018525
% 216.96/217.17       The initial stages of the growth of SEEDS into a SEEDLING. The embryonic shoot %28%plumule%29% and embryonic PLANT ROOTS %28%radicle%29% emerge and grow upwards and downwards respectively. Food reserves for germination come from endosperm tissue within the seed and/or from the seed leaves %28%COTYLEDON%29%. %28%Concise Dictionary of Biology, 1990%29%%A%    
% 216.96/217.17  |- mesh__publicMeSHNote mesh__D018525 95   
% 216.96/217.17  |- mesh__recordAuthorizer mesh__D018525 sjn
% 216.96/217.17  |- mesh__activeMeSHYear mesh__D018525 2005
% 216.96/217.17  |- skos__prefLabel mesh__D018525 Germination
% 216.96/217.17  |- mesh__recordMaintainer mesh__D018525 ssb
% 216.96/217.17  |- skos__historyNote mesh__D018525 Plants %28%1966-1994%29%
% 216.96/217.17  |- skos__annotation mesh__D018525 initial stages of seed growth   
% 216.96/217.17  |- mesh__activeMeSHYear mesh__D018525 2006
% 216.96/217.17  |- mesh__activeMeSHYear mesh__D018525 2003
% 216.96/217.17  |- mesh__activeMeSHYear mesh__D018525 2004
% 216.96/217.17  |- skos__related mesh__D018525smesh__D036226
% 216.96/217.17  |- mesh__dateEstablished mesh__D018525 1995-01-01
% 216.96/217.17  |- skos__hiddenLabel mesh__D010542 Mouse, White Footed
% 216.96/217.17  |- mesh__recordOriginator mesh__D010542 EC
% 216.96/217.17  |- skos__prefLabel mesh__D010542 Peromyscus
% 216.96/217.17  |- mesh__recordAuthorizer mesh__D010542 sjn
% 216.96/217.17  |- skos__scopeNote mesh__D010542
% 216.96/217.17       A genus of the subfamily SIGMODONTINAE consisting of 49 species. Two of these are widely used in medical research. They are P. leucopus, or the white-footed mouse, and P. maniculatus, or the deer mouse.%A%    
% 216.96/217.17  |- mesh__dateCreated mesh__D010542 1977-05-12
% 216.96/217.17  |- skos__hiddenLabel mesh__D010542 White-Footed Mouse
% 216.96/217.17  |- mesh__activeMeSHYear mesh__D010542 2006
% 216.96/217.17  |- skos__hiddenLabel mesh__D010542 Mice, White Footed
% 216.96/217.17  |- skos__historyNote mesh__D010542 Mice %28%1966-1977%29%
% 216.96/217.17  |- mesh__dateEstablished mesh__D010542 1978-01-01
% 216.96/217.17  |- mesh__recordMaintainer mesh__D010542 sjn
% 216.96/217.17  |- skos__altLabel mesh__D010542 Mouse, White-Footed
% 216.96/217.17  |- skos__altLabel mesh__D010542 Mouse, Deer
% 216.96/217.17  |- rdf__type mesh__D010542sskos__Concept
% 216.96/217.17  |- skos__annotation mesh__D010542
% 216.96/217.17       NIM when exper animal: no qualif; when IM, qualif permitted; do not check tag MICE%A%  
% 216.96/217.17  |- skos__hiddenLabel mesh__D010542 White-Footed Mice
% 216.96/217.17  |- mesh__publicMeSHNote mesh__D010542 78   
% 216.96/217.17  |- skos__hiddenLabel mesh__D010542 Deer Mice
% 216.96/217.17  |- skos__hiddenLabel mesh__D010542 Deer Mouse
% 216.96/217.17  |- mesh__dateRevised mesh__D010542 2005-07-01
% 216.96/217.17  |- mesh__historyNote mesh__D010542 78   
% 216.96/217.17  |- skos__broader mesh__D010542smesh__D016205
% 216.96/217.17  |- skos__altLabel mesh__D051959 Hu Antigens
% 216.96/217.17  |- mesh__recordMaintainer mesh__D051959 ags
% 216.96/217.17  |- mesh__activeMeSHYear mesh__D051959 2006A
% 216.96/217.17  |- mesh__activeMeSHYear mesh__D051959 2006
% 216.96/217.17  |- mesh__publicMeSHNote mesh__D051959
% 216.96/217.17       2006; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS was indexed under NERVE TISSUE PROTEINS %26% RNA-BINDING PROTEINS 1991-2005; ELAV PROTEIN was indexed under RIBONUCLEOPROTEINS 1991-2005%A%  
% 216.96/217.17  |- mesh__dateEstablished mesh__D051959 2006-01-01
% 216.96/217.17  |- mesh__recordOriginator mesh__D051959 DRC
% 216.96/217.17  |- rdf__type mesh__D051959sskos__Concept
% 216.96/217.17  |- mesh__dateCreated mesh__D051959 2005-06-30
% 216.96/217.17  |- skos__altLabel mesh__D051959 HuD Antigen
% 216.96/217.17  |- skos__scopeNote mesh__D051959
% 216.96/217.17       A family of RNA-binding proteins that are homologues of ELAV protein, Drosophila. They were initially identified in humans as the targets of autoantibodies in patients with PARANEOPLASTIC ENCEPHALOMYELITIS. They are thought to regulate GENE EXPRESSION at the post-transcriptional level.%A%    
% 216.96/217.17  |- mesh__historyNote mesh__D051959 2006%28%1991%29%   
% 216.96/217.17  |- skos__prefLabel mesh__D051959
% 216.96/217.17       Hu Paraneoplastic Encephalomyelitis Antigens
% 216.96/217.17  |- skos__broader mesh__D051959smesh__D016601
% 216.96/217.17  |- skos__altLabel mesh__D051959 ELAV Protein
% 216.96/217.17  |- skos__broader mesh__D051959smesh__D009419
% 216.96/217.17  |- skos__altLabel mesh__D051959 ELAV Proteins
% 216.96/217.17  |- mesh__recordAuthorizer mesh__D051959 ags
% 216.96/217.17  |- mesh__dateRevised mesh__D051959 2005-07-27
% 216.96/217.17  |- mesh__dateEstablished mesh__D004505 1998-01-01
% 216.96/217.17  |- mesh__activeMeSHYear mesh__D004505 2004
% 216.96/217.17  |- mesh__activeMeSHYear mesh__D004505 1998
% 216.96/217.17  |- mesh__historyNote mesh__D004505 98; use explode 1967-97   
% 216.96/217.17  |- mesh__dateRevised mesh__D004505 1997-06-20
% 216.96/217.17  |- skos__scopeNote mesh__D004505
% 216.96/217.17       Education and training outside of that for the professions.%A%    
% 216.96/217.17  |- skos__altLabel mesh__D004505 Nonprofessional Education
% 216.96/217.17  |- mesh__activeMeSHYear mesh__D004505 2001
% 216.96/217.17  |- mesh__activeMeSHYear mesh__D004505 2005
% 216.96/217.17  |- mesh__activeMeSHYear mesh__D004505 1999
% 216.96/217.17  |- skos__broader mesh__D004505smesh__D004493
% 216.96/217.17  |- mesh__dateCreated mesh__D004505 1999-01-01
% 216.96/217.17  |- mesh__activeMeSHYear mesh__D004505 2002
% 216.96/217.17  |- mesh__recordOriginator mesh__D004505 NLM
% 217.02/217.17  |- rdf__type mesh__D004505sskos__Concept
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D004505 2006
% 217.02/217.17  |- skos__annotation mesh__D004505
% 217.02/217.17       GEN or unspecified; prefer specifics; coord IM with specific occupation /educ %28%IM%29%; DF: EDUC NONPROFESSIONAL%A%  
% 217.02/217.17  |- mesh__publicMeSHNote mesh__D004505 98   
% 217.02/217.17  |- mesh__recordMaintainer mesh__D004505 TGC
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D004505 2003
% 217.02/217.17  |- mesh__recordAuthorizer mesh__D004505 SJN
% 217.02/217.17  |- skos__prefLabel mesh__D004505 Education, Nonprofessional
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D004505 2000
% 217.02/217.17  |- skos__hiddenLabel mesh__D009799 Physiology, Visual
% 217.02/217.17  |- mesh__recordMaintainer mesh__D009799 nns
% 217.02/217.17  |- mesh__recordOriginator mesh__D009799 NLM
% 217.02/217.17  |- skos__broader mesh__D009799smesh__D009143
% 217.02/217.17  |- mesh__recordAuthorizer mesh__D009799 sjn
% 217.02/217.17  |- skos__altLabel mesh__D009799 Physiology, Ocular
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D009799 2006
% 217.02/217.17  |- mesh__dateCreated mesh__D009799 1999-01-01
% 217.02/217.17  |- skos__annotation mesh__D009799
% 217.02/217.17       GEN or unspecified; prefer specifics; DF: OCULAR PHYSIOL   
% 217.02/217.17  |- skos__hiddenLabel mesh__D009799 Physiology, Eye
% 217.02/217.17  |- skos__prefLabel mesh__D009799 Ocular Physiology
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D009799 2005
% 217.02/217.17  |- skos__historyNote mesh__D009799 Eye/physiology %28%1966-1997%29%
% 217.02/217.17  |- mesh__publicMeSHNote mesh__D009799 98   
% 217.02/217.17  |- skos__altLabel mesh__D009799 Physiology of the Eye
% 217.02/217.17  |- rdf__type mesh__D009799sskos__Concept
% 217.02/217.17  |- mesh__dateRevised mesh__D009799 2003-07-09
% 217.02/217.17  |- skos__altLabel mesh__D009799 Visual Physiology
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D009799 2004
% 217.02/217.17  |- skos__scopeNote mesh__D009799
% 217.02/217.17       Functions, activities, and properties of the EYE as a whole or of any of its parts.%A%    
% 217.02/217.17  |- mesh__historyNote mesh__D009799 98; use explode 1975-97   
% 217.02/217.17  |- mesh__dateEstablished mesh__D009799 1998-01-01
% 217.02/217.17  |- skos__altLabel mesh__D009799 Eye Physiology
% 217.02/217.17  |- skos__broader mesh__D006493Q000037smesh__D006493
% 217.02/217.17  |- mesh__preferredCombination mesh__D006493Q000037smesh__D006494
% 217.02/217.17  |- rdf__type mesh__D006493Q000037smesh__CompoundConcept
% 217.02/217.17  |- mesh__recordOriginator mesh__D020172 AGS
% 217.02/217.17  |- skos__historyNote mesh__D020172 Mitosporic Fungi %28%1966-1998%29%
% 217.02/217.17  |- skos__scopeNote mesh__D020172
% 217.02/217.17       A mitosporic fungal genus commonly isolated from soil. Some species are the cause of wilt diseases in many different plants.%A%    
% 217.02/217.17  |- mesh__dateRevised mesh__D020172 2005-06-30
% 217.02/217.17  |- mesh__recordAuthorizer mesh__D020172 sjn
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D020172 2006
% 217.02/217.17  |- rdf__type mesh__D020172sskos__Concept
% 217.02/217.17  |- mesh__dateEstablished mesh__D020172 1999-01-01
% 217.02/217.17  |- skos__prefLabel mesh__D020172 Verticillium
% 217.02/217.17  |- skos__broader mesh__D020172smesh__D003904
% 217.02/217.17  |- mesh__historyNote mesh__D020172 99; use MITOSPORIC FUNGI 1975-98   
% 217.02/217.17  |- mesh__dateCreated mesh__D020172 1998-06-11
% 217.02/217.17  |- mesh__recordMaintainer mesh__D020172 SYSTEM
% 217.02/217.17  |- mesh__publicMeSHNote mesh__D020172
% 217.02/217.17       99; see HYPHOMYCETES 1986-98, see MONILIALES 1975-85   
% 217.02/217.17  |- skos__annotation mesh__D014933 specify geog   
% 217.02/217.17  |- skos__historyNote mesh__D014933 Human Rights %28%1973-1976%29%
% 217.02/217.17  |- mesh__recordOriginator mesh__D014933 EC
% 217.02/217.17  |- skos__historyNote mesh__D014933 Civil Rights %28%1968-1976%29%
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014933 2006
% 217.02/217.17  |- mesh__publicMeSHNote mesh__D014933 77   
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014933 2001
% 217.02/217.17  |- skos__related mesh__D014933smesh__D019513
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014933 2003
% 217.02/217.17  |- skos__hiddenLabel mesh__D014933 Status, Women%27%s
% 217.02/217.17  |- skos__broader mesh__D014933smesh__D006806
% 217.02/217.17  |- mesh__recordMaintainer mesh__D014933 kle
% 217.02/217.17  |- skos__hiddenLabel mesh__D014933 Right, Woman%27%s
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014933 2004
% 217.02/217.17  |- skos__hiddenLabel mesh__D014933 Rights, Women%27%s
% 217.02/217.17  |- skos__hiddenLabel mesh__D014933 Woman%27%s Right
% 217.02/217.17  |- rdf__type mesh__D014933sskos__Concept
% 217.02/217.17  |- skos__scopeNote mesh__D014933
% 217.02/217.17       The rights of women to equal status pertaining to social, economic, and educational opportunities afforded by society.%A%    
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014933 2002
% 217.02/217.17  |- skos__prefLabel mesh__D014933 Women%27%s Rights
% 217.02/217.17  |- skos__hiddenLabel mesh__D014933 Liberation, Women%27%s
% 217.02/217.17  |- skos__altLabel mesh__D014933 Woman%27%s Rights
% 217.02/217.17  |- mesh__dateCreated mesh__D014933 1976-05-05
% 217.02/217.17  |- mesh__recordAuthorizer mesh__D014933 sjn
% 217.02/217.17  |- mesh__dateEstablished mesh__D014933 1977-01-01
% 217.02/217.17  |- skos__hiddenLabel mesh__D014933 Women Status
% 217.02/217.17  |- skos__hiddenLabel mesh__D014933 Woman Rights
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014933 2005
% 217.02/217.17  |- skos__hiddenLabel mesh__D014933 Rights, Woman%27%s
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014933 2000
% 217.02/217.17  |- mesh__historyNote mesh__D014933 77   
% 217.02/217.17  |- mesh__dateRevised mesh__D014933 1999-11-03
% 217.02/217.17  |- skos__hiddenLabel mesh__D014933 Women%27%s Right
% 217.02/217.17  |- skos__hiddenLabel mesh__D014933 Right, Women%27%s
% 217.02/217.17  |- mesh__recordMaintainer mesh__D014135 PLS
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014135 2004
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014135 2001
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014135 2006
% 217.02/217.17  |- skos__prefLabel mesh__D014135 Tracheal Stenosis
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014135 2003
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014135 2000
% 217.02/217.17  |- mesh__dateRevised mesh__D014135 1990-05-29
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014135 2005
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014135 1997
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014135 1991
% 217.02/217.17  |- skos__broader mesh__D014135smesh__D014133
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014135 1999
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014135 1993
% 217.02/217.17  |- mesh__recordOriginator mesh__D014135 NLM
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014135 1996
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014135 1995
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014135 1998
% 217.02/217.17  |- skos__hiddenLabel mesh__D014135 Stenosis, Tracheal
% 217.02/217.17  |- mesh__dateCreated mesh__D014135 1999-01-01
% 217.02/217.17  |- rdf__type mesh__D014135sskos__Concept
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014135 1992
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014135 1994
% 217.02/217.17  |- skos__hiddenLabel mesh__D014135 Tracheal Stenoses
% 217.02/217.17  |- skos__hiddenLabel mesh__D014135 Stenoses, Tracheal
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014135 2002
% 217.02/217.17  |- mesh__recordAuthorizer mesh__D014135 NLM
% 217.02/217.17  |- skos__scopeNote mesh__D000913
% 217.02/217.17       Antibodies produced by human or animal cells following clinical or experimental exposure to parasitic PROTOZOAN ANTIGENS.%A%    
% 217.02/217.17  |- skos__broader mesh__D000913smesh__D000906
% 217.02/217.17  |- mesh__recordAuthorizer mesh__D000913 sjn
% 217.02/217.17  |- mesh__recordMaintainer mesh__D000913 ssb
% 217.02/217.17  |- mesh__recordOriginator mesh__D000913 SCD
% 217.02/217.17  |- mesh__dateRevised mesh__D000913 2005-06-30
% 217.02/217.17  |- rdf__type mesh__D000913sskos__Concept
% 217.02/217.17  |- skos__historyNote mesh__D000913 Antibodies %28%1966-1987%29%
% 217.02/217.17  |- mesh__publicMeSHNote mesh__D000913 88   
% 217.02/217.17  |- skos__annotation mesh__D000913
% 217.02/217.17       coordinate IM with specific protozoan /immunol %28%IM%29%; do not coordinate with ANTIBODY FORMATION for /biosyn%A%  
% 217.02/217.17  |- skos__prefLabel mesh__D000913 Antibodies, Protozoan
% 217.02/217.17  |- mesh__dateEstablished mesh__D000913 1988-01-01
% 217.02/217.17  |- mesh__historyNote mesh__D000913 88   
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D000913 2006
% 217.02/217.17  |- skos__historyNote mesh__D000913
% 217.02/217.17       Antigens, Protozoan/immunology %28%1985-1987%29%
% 217.02/217.17  |- skos__altLabel mesh__D000913 Protozoan Antibodies
% 217.02/217.17  |- mesh__dateCreated mesh__D000913 1987-03-16
% 217.02/217.17  |- skos__prefLabel mesh__D000115 Acetylesterase
% 217.02/217.17  |- mesh__recordOriginator mesh__D000115 NLM
% 217.02/217.17  |- skos__hiddenLabel mesh__D000115 Esterase 17
% 217.02/217.17  |- skos__altLabel mesh__D000115 Esterase-17
% 217.02/217.17  |- skos__broader mesh__D000115smesh__D002265
% 217.02/217.17  |- mesh__dateCreated mesh__D000115 1999-01-01
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D000115 2005
% 217.02/217.17  |- skos__altLabel mesh__D000115 Acetylase
% 217.02/217.17  |- mesh__recordMaintainer mesh__D000115 ssb
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D000115 2006
% 217.02/217.17  |- mesh__recordAuthorizer mesh__D000115 sjn
% 217.02/217.17  |- skos__hiddenLabel mesh__D000115 Esterase, Acid
% 217.02/217.17  |- rdf__type mesh__D000115sskos__Concept
% 217.02/217.17  |- skos__altLabel mesh__D000115 Acetate Esterase
% 217.02/217.17  |- skos__hiddenLabel mesh__D000115 Esterase, Acetate
% 217.02/217.17  |- skos__altLabel mesh__D000115 Acid Esterase
% 217.02/217.17  |- mesh__dateRevised mesh__D000115 2003-07-09
% 217.02/217.17  |- skos__scopeNote mesh__D000115
% 217.02/217.17       An enzyme that catalyzes the conversion of acetate esters and water to alcohols and acetate. EC 3.1.1.6.%A%    
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D000115 2004
% 217.02/217.17  |- skos__hiddenLabel mesh__D018526 Transpirations, Plant
% 217.02/217.17  |- mesh__historyNote mesh__D018526 95   
% 217.02/217.17  |- skos__hiddenLabel mesh__D018526 Transpiration, Plant
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D018526 1999
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D018526 2005
% 217.02/217.17  |- rdf__type mesh__D018526sskos__Concept
% 217.02/217.17  |- skos__hiddenLabel mesh__D018526 Plant Transpirations
% 217.02/217.17  |- skos__annotation mesh__D018526 loss of water vapor in plants   
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D018526 1996
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D018526 1995
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D018526 2002
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D018526 1998
% 217.02/217.17  |- skos__prefLabel mesh__D018526 Plant Transpiration
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D018526 2001
% 217.02/217.17  |- mesh__dateCreated mesh__D018526 1994-06-07
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D018526 2000
% 217.02/217.17  |- mesh__publicMeSHNote mesh__D018526 95   
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D018526 2004
% 217.02/217.17  |- skos__broader mesh__D018526smesh__D018521
% 217.02/217.17  |- skos__scopeNote mesh__D018526
% 217.02/217.17       The loss of water vapor by plants to the atmosphere. It occurs mainly from the leaves through pores %28%stomata%29% whose primary function is gas exchange. The water is replaced by a continuous column of water moving upwards from the roots within the xylem vessels. %28%Concise Dictionary of Biology, 1990%29%%A%    
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D018526 2006
% 217.02/217.17  |- mesh__dateEstablished mesh__D018526 1995-01-01
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D018526 1997
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D018526 2003
% 217.02/217.17  |- mesh__dateCreated mesh__D010543 1999-01-01
% 217.02/217.17  |- mesh__recordMaintainer mesh__D010543 ags
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D010543 2002
% 217.02/217.17  |- skos__broader mesh__D010543smesh__D012584
% 217.02/217.17  |- skos__hiddenLabel mesh__D010543 Nerves, Peroneal
% 217.02/217.17  |- skos__scopeNote mesh__D010543
% 217.02/217.17       The lateral of the two terminal branches of the sciatic nerve. The peroneal %28%or fibular%29% nerve provides motor and sensory innervation to parts of the leg and foot.%A%    
% 217.02/217.17  |- skos__hiddenLabel mesh__D010543 Nerves, Fibular
% 217.02/217.17  |- mesh__publicMeSHNote mesh__D010543 72   
% 217.02/217.17  |- skos__hiddenLabel mesh__D010543 Peroneal Nerves
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D010543 2001
% 217.02/217.17  |- skos__annotation mesh__D010543
% 217.02/217.17       dis = PERONEAL NEUROPATHIES %28%IM%29%; neopl = PERONEAL NEUROPATHIES %28%IM%29% + PERIPHERAL NERVOUS SYSTEM NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 217.02/217.17  |- skos__hiddenLabel mesh__D010543 Fibular Nerves
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D010543 2006
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D010543 2000
% 217.02/217.17  |- mesh__recordOriginator mesh__D010543 NLM
% 217.02/217.17  |- mesh__recordAuthorizer mesh__D010543 sjn
% 217.02/217.17  |- skos__altLabel mesh__D010543 Fibular Nerve
% 217.02/217.17  |- mesh__historyNote mesh__D010543 72%28%71%29%   
% 217.02/217.17  |- skos__historyNote mesh__D010543 Leg/innervation %28%1966-1970%29%
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D010543 2004
% 217.02/217.17  |- skos__hiddenLabel mesh__D010543 Nerve, Fibular
% 217.02/217.17  |- mesh__dateEstablished mesh__D010543 1972-01-01
% 217.02/217.17  |- skos__historyNote mesh__D010543 Spinal Nerves %28%1966-1970%29%
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D010543 2005
% 217.02/217.17  |- skos__hiddenLabel mesh__D010543 Nerve, Peroneal
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D010543 2003
% 217.02/217.17  |- skos__prefLabel mesh__D010543 Peroneal Nerve
% 217.02/217.17  |- mesh__dateRevised mesh__D010543 1999-11-03
% 217.02/217.17  |- rdf__type mesh__D010543sskos__Concept
% 217.02/217.17  |- rdf__type mesh__D004506sskos__Concept
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D004506 2006
% 217.02/217.17  |- mesh__dateRevised mesh__D004506 1999-11-03
% 217.02/217.17  |- skos__broader mesh__D004506smesh__D004517
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D004506 2000
% 217.02/217.17  |- skos__altLabel mesh__D004506 Nursing Education
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D004506 2003
% 217.02/217.17  |- mesh__recordAuthorizer mesh__D004506 sjn
% 217.02/217.17  |- mesh__recordMaintainer mesh__D004506 kle
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D004506 2001
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D004506 2004
% 217.02/217.17  |- skos__hiddenLabel mesh__D004506 Educations, Nursing
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D004506 2002
% 217.02/217.17  |- mesh__recordOriginator mesh__D004506 NLM
% 217.02/217.17  |- skos__hiddenLabel mesh__D004506 Nursing Educations
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D004506 2005
% 217.02/217.17  |- skos__annotation mesh__D004506 GEN: prefer specific; DF: EDUC NURS   
% 217.02/217.17  |- skos__prefLabel mesh__D004506 Education, Nursing
% 217.02/217.17  |- mesh__dateCreated mesh__D004506 1999-01-01
% 217.02/217.17  |- skos__scopeNote mesh__D004506
% 217.02/217.17       Use for general articles concerning nursing education.     
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014934 2003
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014934 2000
% 217.02/217.17  |- skos__broader mesh__D014934smesh__D003252
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014934 1998
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014934 2004
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014934 2001
% 217.02/217.17  |- rdf__type mesh__D014934sskos__Concept
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014934 1999
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014934 2005
% 217.02/217.17  |- mesh__recordMaintainer mesh__D014934 JLS
% 217.02/217.17  |- skos__annotation mesh__D014934 no qualif   
% 217.02/217.17  |- mesh__recordAuthorizer mesh__D014934 SJN
% 217.02/217.17  |- mesh__dateCreated mesh__D014934 1999-01-01
% 217.02/217.17  |- skos__hiddenLabel mesh__D014934 Woods
% 217.02/217.17  |- mesh__recordOriginator mesh__D014934 NLM
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014934 2002
% 217.02/217.17  |- skos__prefLabel mesh__D014934 Wood
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014934 2006
% 217.02/217.17  |- mesh__dateRevised mesh__D014934 1997-06-20
% 217.02/217.17  |- rdf__type mesh__D047310sskos__Concept
% 217.02/217.17  |- skos__broader mesh__D047310smesh__D047309
% 217.02/217.17  |- mesh__dateEstablished mesh__D047310 2005-01-01
% 217.02/217.17  |- mesh__dateCreated mesh__D047310 2004-07-08
% 217.02/217.17  |- mesh__historyNote mesh__D047310 2005 %28%2000%29%   
% 217.02/217.17  |- mesh__publicMeSHNote mesh__D047310
% 217.02/217.17       2005; APIGENIN was indexed under FLAVONOIDS 2000-2004   
% 217.02/217.17  |- skos__scopeNote mesh__D047310
% 217.02/217.17       5,7,4%27%-trihydroxy-flavone, one of the FLAVONES.     
% 217.02/217.17  |- skos__historyNote mesh__D047310 Flavonoids %28%1967-2004%29%
% 217.02/217.17  |- mesh__recordOriginator mesh__D047310 ssb
% 217.02/217.17  |- skos__prefLabel mesh__D047310 Apigenin
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D047310 2006
% 217.02/217.17  |- mesh__dateRevised mesh__D047310 2005-06-30
% 217.02/217.17  |- mesh__recordAuthorizer mesh__D047310 sjn
% 217.02/217.17  |- mesh__recordMaintainer mesh__D047310 ssb
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014136 1997
% 217.02/217.17  |- skos__broader mesh__D014136smesh__D014133
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014136 1999
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014136 1993
% 217.02/217.17  |- mesh__recordMaintainer mesh__D014136 PLS
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014136 1996
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014136 1995
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014136 2002
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014136 1998
% 217.02/217.17  |- mesh__dateCreated mesh__D014136 1999-01-01
% 217.02/217.17  |- rdf__type mesh__D014136sskos__Concept
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014136 1992
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014136 1994
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014136 2001
% 217.02/217.17  |- mesh__recordAuthorizer mesh__D014136 NLM
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014136 2004
% 217.02/217.17  |- skos__hiddenLabel mesh__D014136 Tracheitides
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014136 2000
% 217.02/217.17  |- skos__broader mesh__D014136smesh__D012141
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014136 2006
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014136 1991
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014136 2003
% 217.02/217.17  |- skos__prefLabel mesh__D014136 Tracheitis
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D014136 2005
% 217.02/217.17  |- mesh__dateRevised mesh__D014136 1990-05-29
% 217.02/217.17  |- mesh__recordOriginator mesh__D014136 NLM
% 217.02/217.17  |- skos__scopeNote mesh__D000914
% 217.02/217.17       Immunoglobulins produced as a response to VIRAL ANTIGENS; includes all classes of immunoglobulins elicited by all viral components.%A%    
% 217.02/217.17  |- mesh__dateRevised mesh__D000914 2005-06-30
% 217.02/217.17  |- skos__broader mesh__D000914smesh__D000906
% 217.02/217.17  |- skos__altLabel mesh__D000914 Viral Antibodies
% 217.02/217.17  |- skos__prefLabel mesh__D000914 Antibodies, Viral
% 217.02/217.17  |- mesh__recordOriginator mesh__D000914 NLM
% 217.02/217.17  |- mesh__historyNote mesh__D000914 73   
% 217.02/217.17  |- rdf__type mesh__D000914sskos__Concept
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D000914 2006
% 217.02/217.17  |- mesh__publicMeSHNote mesh__D000914 73   
% 217.02/217.17  |- mesh__dateEstablished mesh__D000914 1973-01-01
% 217.02/217.17  |- mesh__recordAuthorizer mesh__D000914 sjn
% 217.02/217.17  |- mesh__recordMaintainer mesh__D000914 ssb
% 217.02/217.17  |- mesh__dateCreated mesh__D000914 1999-01-01
% 217.02/217.17  |- skos__annotation mesh__D000914
% 217.02/217.17       coordinate IM with specific virus /immunol %28%IM%29%; do not coordinate with ANTIBODY FORMATION for /biosyn%A%  
% 217.02/217.17  |- skos__historyNote mesh__D000914 Antibodies %28%1966-1972%29%
% 217.02/217.17  |- skos__altLabel mesh__D000116 2-Acetamido-2-D-galactopyranose
% 217.02/217.17  |- mesh__dateEstablished mesh__D000116 1991-01-01
% 217.02/217.17  |- skos__altLabel mesh__D000116 N-Acetyl-D-Galactosamine
% 217.02/217.17  |- mesh__publicMeSHNote mesh__D000116
% 217.02/217.17       91; was see under GALACTOSAMINE 1975-90   
% 217.02/217.17  |- mesh__recordMaintainer mesh__D000116 ssb
% 217.02/217.17  |- mesh__recordOriginator mesh__D000116 NLM
% 217.02/217.17  |- mesh__dateRevised mesh__D000116 2004-07-07
% 217.02/217.17  |- mesh__historyNote mesh__D000116
% 217.02/217.17       91%28%75%29%; was see under GALACTOSAMINE 1975-90   
% 217.02/217.17  |- skos__broader mesh__D000116smesh__D005688
% 217.02/217.17  |- skos__scopeNote mesh__D000116
% 217.02/217.17       The N-acetyl derivative of galactosamine.     
% 217.02/217.17  |- skos__historyNote mesh__D000116 Galactosamine %28%1973-1974%29%
% 217.02/217.17  |- skos__hiddenLabel mesh__D000116 2 Acetamido 2 D galactopyranose
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D000116 2006
% 217.02/217.17  |- skos__prefLabel mesh__D000116 Acetylgalactosamine
% 217.02/217.17  |- skos__hiddenLabel mesh__D000116 2 Acetamido 2 Deoxy D Galactose
% 217.02/217.17  |- rdf__type mesh__D000116sskos__Concept
% 217.02/217.17  |- skos__hiddenLabel mesh__D000116 N Acetyl D Galactosamine
% 217.02/217.17  |- skos__altLabel mesh__D000116 2-Acetamido-2-Deoxy-D-Galactose
% 217.02/217.17  |- mesh__activeMeSHYear mesh__D000116 2005
% 217.02/217.18  |- mesh__dateCreated mesh__D000116 1974-11-19
% 217.02/217.18  |- mesh__recordAuthorizer mesh__D000116 sjn
% 217.02/217.18  |- skos__hiddenLabel mesh__D000116 2 Acetamido 2 Deoxygalactose
% 217.02/217.18  |- skos__altLabel mesh__D000116 2-Acetamido-2-Deoxygalactose
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D018527 1995
% 217.02/217.18  |- rdf__type mesh__D018527sskos__Concept
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D018527 1998
% 217.02/217.18  |- mesh__dateEstablished mesh__D018527 1995-01-01
% 217.02/217.18  |- skos__historyNote mesh__D018527 Plants %28%1966-1994%29%
% 217.02/217.18  |- skos__scopeNote mesh__D018527
% 217.02/217.18       A technique for growing plants in culture solutions rather than in soil. The roots are immersed in an aerated solution containing the correct proportions of essential mineral salts. %28%From Concise Dictionary of Biology, 1990%29%%A%    
% 217.02/217.18  |- mesh__dateCreated mesh__D018527 1994-06-07
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D018527 2002
% 217.02/217.18  |- skos__annotation mesh__D018527
% 217.02/217.18       a plant-growing method; SPEC: SPEC qualif   
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D018527 2004
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D018527 2001
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D018527 2006
% 217.02/217.18  |- skos__prefLabel mesh__D018527 Hydroponics
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D018527 1997
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D018527 2003
% 217.02/217.18  |- skos__hiddenLabel mesh__D018527 Hydroponic
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D018527 2005
% 217.02/217.18  |- mesh__historyNote mesh__D018527 95   
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D018527 2000
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D018527 1999
% 217.02/217.18  |- mesh__publicMeSHNote mesh__D018527 95   
% 217.02/217.18  |- skos__broader mesh__D018527smesh__D000383
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D018527 1996
% 217.02/217.18  |- mesh__recordMaintainer mesh__D010544 ssb
% 217.02/217.18  |- skos__broader mesh__D010544smesh__D010088
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D010544 2006
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D010544 2004
% 217.02/217.18  |- skos__annotation mesh__D010544
% 217.02/217.18       a subclass of oxidoreductases: do not confuse with PEROXIDASE, a peroxiductase synthesized by leukocytes%A%  
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D010544 2005
% 217.02/217.18  |- rdf__type mesh__D010544sskos__Concept
% 217.02/217.18  |- skos__prefLabel mesh__D010544 Peroxidases
% 217.02/217.18  |- mesh__recordOriginator mesh__D010544 NLM
% 217.02/217.18  |- mesh__dateCreated mesh__D010544 1999-01-01
% 217.02/217.18  |- mesh__recordAuthorizer mesh__D010544 sjn
% 217.02/217.18  |- mesh__dateRevised mesh__D010544 2003-07-09
% 217.02/217.18  |- mesh__recordOriginator mesh__D004507 NLM
% 217.02/217.18  |- mesh__dateEstablished mesh__D004507 1971-01-01
% 217.02/217.18  |- skos__hiddenLabel mesh__D004507 Associate Nursing Educations
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D004507 2003
% 217.02/217.18  |- mesh__historyNote mesh__D004507
% 217.02/217.18       71; EDUCATION, NURSING, DEGREE PROGRAMS was heading 1967-70%A%  
% 217.02/217.18  |- skos__hiddenLabel mesh__D004507 Nursing Educations, Associate
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D004507 2004
% 217.02/217.18  |- mesh__dateRevised mesh__D004507 1999-11-03
% 217.02/217.18  |- skos__broader mesh__D004507smesh__D004506
% 217.02/217.18  |- skos__altLabel mesh__D004507 Associate Nursing Education
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D004507 2000
% 217.02/217.18  |- skos__altLabel mesh__D004507 Nursing Education, Associate
% 217.02/217.18  |- skos__hiddenLabel mesh__D004507 Educations, Associate Nursing
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D004507 2005
% 217.02/217.18  |- skos__hiddenLabel mesh__D004507 Education, Associate Nursing
% 217.02/217.18  |- mesh__dateCreated mesh__D004507 1999-01-01
% 217.02/217.18  |- mesh__recordAuthorizer mesh__D004507 sjn
% 217.02/217.18  |- skos__annotation mesh__D004507
% 217.02/217.18       2-yr community or junior college program; DF: EDUC NURS ASSOCIATE%A%  
% 217.02/217.18  |- mesh__recordMaintainer mesh__D004507 kle
% 217.02/217.18  |- skos__prefLabel mesh__D004507 Education, Nursing, Associate
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D004507 2001
% 217.02/217.18  |- skos__scopeNote mesh__D004507
% 217.02/217.18       A two-year program in nursing education in a community or junior college leading to an A.D. %28%Associate Degree%29%. Graduates of this program are eligible for state examination for licensure as RN %28%Registered Nurse%29%.%A%    
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D004507 2006
% 217.02/217.18  |- rdf__type mesh__D004507sskos__Concept
% 217.02/217.18  |- mesh__onlineNote mesh__D004507
% 217.02/217.18       search EDUCATION, NURSING, DEGREE PROGRAMS under EDUCATION, NURSING, BACCALAUREATE 1967-70%A%  
% 217.02/217.18  |- mesh__publicMeSHNote mesh__D004507
% 217.02/217.18       71; EDUCATION, NURSING, DEGREE PROGRAMS was heading 1967-70%A%  
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D004507 2002
% 217.02/217.18  |- mesh__dateCreated mesh__D014935 1999-01-01
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D014935 2006
% 217.02/217.18  |- mesh__recordOriginator mesh__D014935 NLM
% 217.02/217.18  |- skos__scopeNote mesh__D014935
% 217.02/217.18       The hair of SHEEP or other animals that is used for weaving.%A%    
% 217.02/217.18  |- skos__broader mesh__D014935smesh__D008420
% 217.02/217.18  |- mesh__recordAuthorizer mesh__D014935 sjn
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D014935 2005
% 217.02/217.18  |- skos__broader mesh__D014935smesh__D006197
% 217.02/217.18  |- skos__broader mesh__D014935smesh__D013784
% 217.02/217.18  |- mesh__dateRevised mesh__D014935 2004-07-08
% 217.02/217.18  |- skos__annotation mesh__D014935
% 217.02/217.18       as animal hair %26% as textile; not for ASBESTOS wool nor for STEEL wool%A%  
% 217.02/217.18  |- rdf__type mesh__D014935sskos__Concept
% 217.02/217.18  |- skos__broader mesh__D014935smesh__D000825
% 217.02/217.18  |- skos__prefLabel mesh__D014935 Wool
% 217.02/217.18  |- skos__hiddenLabel mesh__D014935 Wools
% 217.02/217.18  |- mesh__recordMaintainer mesh__D014935 ssb
% 217.02/217.18  |- mesh__dateRevised mesh__D047311 2005-06-30
% 217.02/217.18  |- mesh__recordAuthorizer mesh__D047311 sjn
% 217.02/217.18  |- mesh__dateEstablished mesh__D047311 2005-01-01
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D047311 2006
% 217.02/217.18  |- mesh__recordMaintainer mesh__D047311 ssb
% 217.02/217.18  |- mesh__recordOriginator mesh__D047311 ssb
% 217.02/217.18  |- skos__historyNote mesh__D047311 Flavonoids %28%1981-2004%29%
% 217.02/217.18  |- skos__broader mesh__D047311smesh__D047309
% 217.02/217.18  |- rdf__type mesh__D047311sskos__Concept
% 217.02/217.18  |- skos__altLabel mesh__D047311 3%27%,4%27%,5,7-Tetrahydroxyflavone
% 217.02/217.18  |- skos__scopeNote mesh__D047311
% 217.02/217.18       5,7,3%27%,4%27%-tetrahydroxy-flavone, one of the FLAVONES.     
% 217.02/217.18  |- mesh__publicMeSHNote mesh__D047311
% 217.02/217.18       2005; LUTEOLIN was indexed under FLAVONOIDS 1981-2004   
% 217.02/217.18  |- skos__altLabel mesh__D047311 3%27%,4%27%,5,7-Tetrahydroxy-Flavone
% 217.02/217.18  |- skos__prefLabel mesh__D047311 Luteolin
% 217.02/217.18  |- mesh__dateCreated mesh__D047311 2004-07-08
% 217.02/217.18  |- mesh__historyNote mesh__D047311 2005 %28%1981%29%   
% 217.02/217.18  |- skos__altLabel mesh__D047311 Luteoline
% 217.02/217.18  |- skos__historyNote mesh__D014137 Bronchi/abnormalities %28%1966-1986%29%
% 217.02/217.18  |- skos__hiddenLabel mesh__D014137 Tracheobronchomegalies
% 217.02/217.18  |- skos__broader mesh__D014137smesh__D001982
% 217.02/217.18  |- skos__altLabel mesh__D014137 Mounier-Kuhn Syndrome
% 217.02/217.18  |- rdf__type mesh__D014137sskos__Concept
% 217.02/217.18  |- skos__scopeNote mesh__D014137
% 217.02/217.18       A rare and probably congenital condition characterized by great enlargement of the lumen of the trachea and the larger bronchi.%A%    
% 217.02/217.18  |- mesh__recordOriginator mesh__D014137 VDK
% 217.02/217.18  |- mesh__dateCreated mesh__D014137 1986-06-23
% 217.02/217.18  |- mesh__recordAuthorizer mesh__D014137 sjn
% 217.02/217.18  |- skos__prefLabel mesh__D014137 Tracheobronchomegaly
% 217.02/217.18  |- mesh__dateEstablished mesh__D014137 1991-01-01
% 217.02/217.18  |- mesh__historyNote mesh__D014137
% 217.02/217.18       91%28%87%29%; was see under TRACHEAL DISEASES 1987-90   
% 217.02/217.18  |- skos__historyNote mesh__D014137 Trachea/abnormalities %28%1966-1986%29%
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D014137 2004
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D014137 2002
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D014137 2006
% 217.02/217.18  |- mesh__dateRevised mesh__D014137 1999-11-03
% 217.02/217.18  |- mesh__publicMeSHNote mesh__D014137
% 217.02/217.18       91; was see under TRACHEAL DISEASES 1987-90   
% 217.02/217.18  |- skos__hiddenLabel mesh__D014137 Syndrome, Mounier-Kuhn
% 217.02/217.18  |- skos__broader mesh__D014137smesh__D015619
% 217.02/217.18  |- skos__annotation mesh__D014137
% 217.02/217.18       enlarged trachea lumen %26% larger bronchi; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 217.02/217.18  |- skos__hiddenLabel mesh__D014137 Mounier Kuhn Syndrome
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D014137 2003
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D014137 2001
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D014137 2005
% 217.02/217.18  |- skos__broader mesh__D014137smesh__D014133
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D014137 2000
% 217.02/217.18  |- mesh__recordMaintainer mesh__D014137 kle
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D000915 2000
% 217.02/217.18  |- skos__hiddenLabel mesh__D000915 Affinities, Antibody
% 217.02/217.18  |- skos__scopeNote mesh__D000915
% 217.02/217.18       A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of %22%avidity,%22% which refers to the strength of the antigen-antibody bond after formation of reversible complexes.%A%    
% 217.02/217.18  |- skos__hiddenLabel mesh__D000915 Avidities, Antibody
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D000915 2004
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D000915 2001
% 217.02/217.18  |- mesh__dateRevised mesh__D000915 1999-11-03
% 217.02/217.18  |- skos__historyNote mesh__D000915 Antibodies %28%1966-1978%29%
% 217.02/217.18  |- rdf__type mesh__D000915sskos__Concept
% 217.02/217.18  |- mesh__recordMaintainer mesh__D000915 ags
% 217.02/217.18  |- mesh__dateCreated mesh__D000915 1977-12-02
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D000915 2006
% 217.02/217.18  |- skos__historyNote mesh__D000915
% 217.02/217.18       Binding Sites, Antibody %28%1973-1978%29%
% 217.02/217.18  |- skos__prefLabel mesh__D000915 Antibody Affinity
% 217.02/217.18  |- mesh__dateEstablished mesh__D000915 1979-01-01
% 217.02/217.18  |- skos__altLabel mesh__D000915 Avidity, Antibody
% 217.02/217.18  |- skos__annotation mesh__D000915
% 217.02/217.18       do not confuse with BINDING SITES, ANTIBODY or ANTIGENIC DETERMINANTS%A%  
% 217.02/217.18  |- mesh__publicMeSHNote mesh__D000915 79   
% 217.02/217.18  |- mesh__recordOriginator mesh__D000915 AEP
% 217.02/217.18  |- skos__broader mesh__D000915smesh__D000937
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D000915 2002
% 217.02/217.18  |- skos__historyNote mesh__D000915 Antigenic Determinants %28%1970-1978%29%
% 217.02/217.18  |- skos__historyNote mesh__D000915
% 217.02/217.18       Antigen-Antibody Reactions %28%1966-1978%29%
% 217.02/217.18  |- skos__altLabel mesh__D000915 Affinity, Antibody
% 217.02/217.18  |- skos__hiddenLabel mesh__D000915 Antibody Avidities
% 217.02/217.18  |- skos__hiddenLabel mesh__D000915 Antibody Affinities
% 217.02/217.18  |- mesh__historyNote mesh__D000915 79   
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D000915 2003
% 217.02/217.18  |- mesh__recordAuthorizer mesh__D000915 sjn
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D000915 2005
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D019620 2006
% 217.02/217.18  |- mesh__dateRevised mesh__D019620 2005-06-30
% 217.02/217.18  |- mesh__historyNote mesh__D019620 1998   
% 217.02/217.18  |- rdf__type mesh__D019620sskos__Concept
% 217.02/217.18  |- mesh__recordOriginator mesh__D019620 NDW
% 217.02/217.18  |- mesh__publicMeSHNote mesh__D019620 1998   
% 217.02/217.18  |- skos__prefLabel mesh__D019620 Desulfurococcaceae
% 217.02/217.18  |- skos__scopeNote mesh__D019620
% 217.02/217.18       A family of archaea, in the order DESULFUROCOCCALES, consisting of anaerobic cocci which utilize peptides, proteins or carbohydrates facultatively by sulfur respiration or fermentation. There are eight genera: AEROPYRUM, Desulfurococcus, Ignicoccus, Staphylothermus, Stetteria, Sulfophoboccus, Thermodiscus, and Thermosphaera. %28%From Bergey%27%s Manual of Systematic Bacteriology, 2d ed%29%%A%    
% 217.02/217.18  |- mesh__dateEstablished mesh__D019620 1998-01-01
% 217.02/217.18  |- mesh__dateCreated mesh__D019620 1997-06-20
% 217.02/217.18  |- mesh__recordMaintainer mesh__D019620 SYSTEM
% 217.02/217.18  |- mesh__recordAuthorizer mesh__D019620 sjn
% 217.02/217.18  |- skos__broader mesh__D019620smesh__D041521
% 217.02/217.18  |- mesh__recordAuthorizer mesh__D000117 sjn
% 217.02/217.18  |- skos__hiddenLabel mesh__D000117 2 Acetamido 2 Deoxy D Glucose
% 217.02/217.18  |- skos__hiddenLabel mesh__D000117 2 Acetamido 2 Deoxyglucose
% 217.02/217.18  |- skos__scopeNote mesh__D000117
% 217.02/217.18       The N-acetyl derivative of glucosamine.     
% 217.02/217.18  |- mesh__dateRevised mesh__D000117 2004-07-07
% 217.02/217.18  |- mesh__dateCreated mesh__D000117 1974-11-11
% 217.02/217.18  |- skos__prefLabel mesh__D000117 Acetylglucosamine
% 217.02/217.18  |- skos__broader mesh__D000117smesh__D005944
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D000117 2006
% 217.02/217.18  |- skos__altLabel mesh__D000117 2-Acetamido-2-Deoxy-D-Glucose
% 217.02/217.18  |- rdf__type mesh__D000117sskos__Concept
% 217.02/217.18  |- skos__historyNote mesh__D000117 Glucosamine %28%1973-1974%29%
% 217.02/217.18  |- mesh__recordMaintainer mesh__D000117 ssb
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D000117 2005
% 217.02/217.18  |- mesh__recordOriginator mesh__D000117 NLM
% 217.02/217.18  |- skos__altLabel mesh__D000117 2-Acetamido-2-Deoxyglucose
% 217.02/217.18  |- mesh__publicMeSHNote mesh__D000117
% 217.02/217.18       91; was see under GLUCOSAMINE 1975-90   
% 217.02/217.18  |- skos__hiddenLabel mesh__D000117 N Acetyl D Glucosamine
% 217.02/217.18  |- skos__altLabel mesh__D000117 N-Acetyl-D-Glucosamine
% 217.02/217.18  |- mesh__dateEstablished mesh__D000117 1991-01-01
% 217.02/217.18  |- mesh__historyNote mesh__D000117
% 217.02/217.18       91%28%75%29%; was see under GLUCOSAMINE 1975-90   
% 217.02/217.18  |- mesh__recordOriginator mesh__D005600 AEP
% 217.02/217.18  |- skos__historyNote mesh__D005600 Sex Chromosomes %28%1968-1982%29%
% 217.02/217.18  |- skos__hiddenLabel mesh__D005600 Syndromes, FRAXA
% 217.02/217.18  |- rdf__type mesh__D005600sskos__Concept
% 217.02/217.18  |- mesh__recordAuthorizer mesh__D005600 sjn
% 217.02/217.18  |- skos__hiddenLabel mesh__D005600 Martin Bell Syndrome
% 217.02/217.18  |- skos__historyNote mesh__D005600 X Chromosome %28%1978-1982%29%
% 217.02/217.18  |- skos__related mesh__D005600smesh__D008607
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D005600 2006
% 217.02/217.18  |- skos__hiddenLabel mesh__D005600 Syndrome, Fragile X
% 217.02/217.18  |- skos__related mesh__D005600smesh__D019680
% 217.02/217.18  |- skos__hiddenLabel mesh__D005600 FRAXA Syndromes
% 217.02/217.18  |- skos__hiddenLabel mesh__D005600 Syndromes, Fragile X
% 217.02/217.18  |- skos__hiddenLabel mesh__D005600 Syndrome, FRAXA
% 217.02/217.18  |- skos__broader mesh__D005600smesh__D038901
% 217.02/217.18  |- skos__scopeNote mesh__D005600
% 217.02/217.18       A condition characterized genotypically by mutation of the distal end of the long arm of the X chromosome %28%at gene loci FRAXA or FRAXE%29% and phenotypically by cognitive impairment, hyperactivity, SEIZURES, language delay, and enlargement of the ears, head, and testes. MENTAL RETARDATION occurs in nearly all males and roughly 50%25% of females with the full mutation of FRAXA. %28%From Menkes, Textbook of Child Neurology, 5th ed, p226%29%%A%    
% 217.02/217.18  |- mesh__historyNote mesh__D005600
% 217.02/217.18       91%28%83%29%; was see under SEX CHROMOSOME ABNORMALITIES 1983-90%A%  
% 217.02/217.18  |- skos__hiddenLabel mesh__D005600 Syndromes, FRAXE
% 217.02/217.18  |- skos__hiddenLabel mesh__D005600 Syndrome, Martin-Bell
% 217.02/217.18  |- skos__hiddenLabel mesh__D005600 Syndrome, FRAXE
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D005600 2005
% 217.02/217.18  |- skos__hiddenLabel mesh__D005600 Fragile X Syndromes
% 217.02/217.18  |- skos__altLabel mesh__D005600 Martin-Bell Syndrome
% 217.02/217.18  |- mesh__dateEstablished mesh__D005600 1991-01-01
% 217.02/217.18  |- skos__broader mesh__D005600smesh__D025064
% 217.02/217.18  |- mesh__dateCreated mesh__D005600 1982-04-22
% 217.02/217.18  |- skos__hiddenLabel mesh__D005600 FRAXE Syndromes
% 217.02/217.18  |- skos__related mesh__D005600smesh__D002873
% 217.02/217.18  |- skos__historyNote mesh__D005600
% 217.02/217.18       Mental Retardation/genetics %28%1966-1982%29%
% 217.02/217.18  |- skos__prefLabel mesh__D005600 Fragile X Syndrome
% 217.02/217.18  |- mesh__dateRevised mesh__D005600 2003-07-09
% 217.02/217.18  |- skos__related mesh__D005600smesh__D043283
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D005600 2004
% 217.02/217.18  |- mesh__recordMaintainer mesh__D005600 nns
% 217.02/217.18  |- mesh__publicMeSHNote mesh__D005600
% 217.02/217.18       91; was see under SEX CHROMOSOME ABNORMALITIES 1983-90   
% 217.02/217.18  |- mesh__dateRevised mesh__D052256 2005-08-01
% 217.02/217.18  |- skos__broader mesh__D052256smesh__D013708
% 217.02/217.18  |- skos__hiddenLabel mesh__D052256 Tendinoses
% 217.02/217.18  |- skos__hiddenLabel mesh__D052256 Tendinopathies
% 217.02/217.18  |- mesh__publicMeSHNote mesh__D052256
% 217.02/217.18       2006; for TENDINITIS see TENDINITIS 1965-2005, see TENDONITIS 1963-1964%A%  
% 217.02/217.18  |- mesh__historyNote mesh__D052256 2006   
% 217.02/217.18  |- mesh__recordOriginator mesh__D052256 ags
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D052256 2006A
% 217.02/217.18  |- mesh__recordAuthorizer mesh__D052256 ags
% 217.02/217.18  |- skos__altLabel mesh__D052256 Tendonitis
% 217.02/217.18  |- skos__broader mesh__D052256smesh__D009135
% 217.02/217.18  |- skos__scopeNote mesh__D052256
% 217.02/217.18       Clinical syndrome describing overuse tendon injuries characterized by a combination of PAIN, diffuse or localized swelling, and impaired performance. Distinguishing tendinosis from tendinitis is clinically difficult and can be made only after histopathological examination.%A%    
% 217.02/217.18  |- mesh__dateCreated mesh__D052256 2005-06-30
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D052256 2006
% 217.02/217.18  |- mesh__dateEstablished mesh__D052256 2006-01-01
% 217.02/217.18  |- skos__hiddenLabel mesh__D052256 Tendinitides
% 217.02/217.18  |- skos__hiddenLabel mesh__D052256 Tendonitides
% 217.02/217.18  |- rdf__type mesh__D052256sskos__Concept
% 217.02/217.18  |- mesh__recordMaintainer mesh__D052256 ags
% 217.02/217.18  |- skos__prefLabel mesh__D052256 Tendinopathy
% 217.02/217.18  |- skos__historyNote mesh__D052256 Tendon Injuries %28%1976-2005%29%
% 217.02/217.18  |- mesh__recordMaintainer mesh__D018528 jmp
% 217.02/217.18  |- mesh__dateEstablished mesh__D018528 1995-01-01
% 217.02/217.18  |- skos__scopeNote mesh__D018528
% 217.02/217.18       A family of MEMBRANE TRANSPORT PROTEINS that require ATP hydrolysis for the transport of substrates across membranes. The protein family derives its name from the ATP-binding domain found on the protein.%A%    
% 217.02/217.18  |- skos__broader mesh__D018528smesh__D008562
% 217.02/217.18  |- mesh__recordOriginator mesh__D018528 AGS
% 217.02/217.18  |- skos__broader mesh__D018528smesh__D026901
% 217.02/217.18  |- skos__hiddenLabel mesh__D018528 Transporters, ABC
% 217.02/217.18  |- skos__historyNote mesh__D018528 Carrier Proteins %28%1990-1994%29%
% 217.02/217.18  |- mesh__dateRevised mesh__D018528 2005-06-30
% 217.02/217.18  |- skos__prefLabel mesh__D018528 ATP-Binding Cassette Transporters
% 217.02/217.18  |- mesh__historyNote mesh__D018528 2002%28%1995%29%   
% 217.02/217.18  |- mesh__recordAuthorizer mesh__D018528 sjn
% 217.02/217.18  |- mesh__dateCreated mesh__D018528 1994-04-16
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D018528 2006
% 217.02/217.18  |- skos__altLabel mesh__D018528 ABC Transporters
% 217.02/217.18  |- skos__hiddenLabel mesh__D018528 ATP Binding Cassette Transporters
% 217.02/217.18  |- skos__hiddenLabel mesh__D018528 Transporters, ATP-Binding Cassette
% 217.02/217.18  |- rdf__type mesh__D018528sskos__Concept
% 217.02/217.18  |- mesh__publicMeSHNote mesh__D018528
% 217.02/217.18       2002; see ABC TRANSPORTERS 1995-2001   
% 217.02/217.18  |- skos__related mesh__D010545smesh__D008054
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D010545 2006
% 217.02/217.18  |- skos__related mesh__D010545smesh__D001585
% 217.02/217.18  |- skos__broader mesh__D010545smesh__D005609
% 217.02/217.18  |- skos__broader mesh__D010545smesh__D017382
% 217.02/217.18  |- mesh__recordOriginator mesh__D010545 NLM
% 217.02/217.18  |- skos__broader mesh__D010545smesh__D009930
% 217.02/217.18  |- mesh__recordAuthorizer mesh__D010545 sjn
% 217.02/217.18  |- rdf__type mesh__D010545sskos__Concept
% 217.02/217.18  |- skos__prefLabel mesh__D010545 Peroxides
% 217.02/217.18  |- mesh__dateCreated mesh__D010545 1999-01-01
% 217.02/217.18  |- mesh__recordMaintainer mesh__D010545 ssb
% 217.02/217.18  |- skos__related mesh__D010545smesh__D017382
% 217.02/217.18  |- skos__scopeNote mesh__D010545
% 217.02/217.18       A group of compounds that contain a bivalent O-O group, i.e., the oxygen atoms are univalent. They can either be inorganic or organic in nature. Such compounds release atomic %28%nascent%29% oxygen readily. Thus they are strong oxidizing agents and fire hazards when in contact with combustible materials, especially under high-temperature conditions. The chief industrial uses of peroxides are as oxidizing agents, bleaching agents, and initiators of polymerization. %28%From Hawley%27%s Condensed Chemical Dictionary, 11th ed%29%%A%    
% 217.02/217.18  |- skos__broader mesh__D010545smesh__D010087
% 217.02/217.18  |- mesh__dateRevised mesh__D010545 2005-06-30
% 217.02/217.18  |- skos__hiddenLabel mesh__D004508 Educations, Baccalaureate Nursing
% 217.02/217.18  |- mesh__dateRevised mesh__D004508 1999-11-03
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D004508 2006
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D004508 2000
% 217.02/217.18  |- skos__prefLabel mesh__D004508 Education, Nursing, Baccalaureate
% 217.02/217.18  |- rdf__type mesh__D004508sskos__Concept
% 217.02/217.18  |- skos__hiddenLabel mesh__D004508 Education, Baccalaureate Nursing
% 217.02/217.18  |- mesh__recordAuthorizer mesh__D004508 sjn
% 217.02/217.18  |- skos__scopeNote mesh__D004508
% 217.02/217.18       A four-year program in nursing education in a college or university leading to a B.S.N. %28%Bachelor of Science in Nursing%29%. Graduates are eligible for state examination for licensure as RN %28%Registered Nurse%29%.%A%    
% 217.02/217.18  |- skos__hiddenLabel mesh__D004508 Nursing Educations, Baccalaureate
% 217.02/217.18  |- mesh__historyNote mesh__D004508
% 217.02/217.18       71; EDUCATION, NURSING, DEGREE PROGRAMS was heading 1967-70%A%  
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D004508 2005
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D004508 2004
% 217.02/217.18  |- skos__altLabel mesh__D004508 External Degree Programs, Nursing
% 217.02/217.18  |- mesh__recordOriginator mesh__D004508 NLM
% 217.02/217.18  |- mesh__dateCreated mesh__D004508 1999-01-01
% 217.02/217.18  |- skos__hiddenLabel mesh__D004508 Baccalaureate Nursing Educations
% 217.02/217.18  |- mesh__onlineNote mesh__D004508
% 217.02/217.18       use EDUCATION, NURSING, BACCALAUREATE to search EDUCATION, NURSING, DEGREE PROGRAMS 1967-70%A%  
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D004508 2003
% 217.02/217.18  |- skos__broader mesh__D004508smesh__D004506
% 217.02/217.18  |- mesh__recordMaintainer mesh__D004508 kle
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D004508 2002
% 217.02/217.18  |- mesh__dateEstablished mesh__D004508 1971-01-01
% 217.02/217.18  |- skos__annotation mesh__D004508
% 217.02/217.18       4-yr program leading to BS; DF: EDUC NURS BACCALAUREATE   
% 217.02/217.18  |- skos__altLabel mesh__D004508 Nursing Education, Baccalaureate
% 217.02/217.18  |- skos__altLabel mesh__D004508 Baccalaureate Nursing Education
% 217.02/217.18  |- mesh__publicMeSHNote mesh__D004508
% 217.02/217.18       71; EDUCATION, NURSING, DEGREE PROGRAMS was heading 1967-70%A%  
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D004508 2001
% 217.02/217.18  |- rdf__type mesh__D015230sskos__Concept
% 217.02/217.18  |- skos__altLabel mesh__D015230 11-Dehydroprostaglandin F2alpha
% 217.02/217.18  |- skos__broader mesh__D015230smesh__D011457
% 217.02/217.18  |- skos__hiddenLabel mesh__D015230 11 Dehydroprostaglandin F2 alpha
% 217.02/217.18  |- mesh__dateRevised mesh__D015230 2005-06-30
% 217.02/217.18  |- skos__altLabel mesh__D015230 11-Dehydroprostaglandin F2 alpha
% 217.02/217.18  |- mesh__recordMaintainer mesh__D015230 ssb
% 217.02/217.18  |- mesh__recordAuthorizer mesh__D015230 sjn
% 217.02/217.18  |- mesh__historyNote mesh__D015230 89   
% 217.02/217.18  |- mesh__dateCreated mesh__D015230 1988-05-12
% 217.02/217.18  |- skos__historyNote mesh__D015230 Prostaglandins %28%1966-1977%29%
% 217.02/217.18  |- skos__scopeNote mesh__D015230
% 217.02/217.18       The principal cyclooxygenase metabolite of arachidonic acid. It is released upon activation of mast cells and is also synthesized by alveolar macrophages. Among its many biological actions, the most important are its bronchoconstrictor, platelet-activating-factor-inhibitory, and cytotoxic effects.%A%    
% 217.02/217.18  |- skos__hiddenLabel mesh__D015230 F2 alpha, 11-Dehydroprostaglandin
% 217.02/217.18  |- skos__prefLabel mesh__D015230 Prostaglandin D2
% 217.02/217.18  |- skos__historyNote mesh__D015230 Prostaglandins D %28%1978-1988%29%
% 217.02/217.18  |- skos__hiddenLabel mesh__D015230 D2, Prostaglandin
% 217.02/217.18  |- skos__annotation mesh__D015230 /biosyn /physiol permitted; DF: PGD2   
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D015230 2006
% 217.02/217.18  |- skos__hiddenLabel mesh__D015230 alpha, 11-Dehydroprostaglandin F2
% 217.02/217.18  |- mesh__recordOriginator mesh__D015230 RLS
% 217.02/217.18  |- skos__hiddenLabel mesh__D015230 F2alpha, 11-Dehydroprostaglandin
% 217.02/217.18  |- mesh__dateEstablished mesh__D015230 1989-01-01
% 217.02/217.18  |- skos__altLabel mesh__D015230 PGD2
% 217.02/217.18  |- mesh__publicMeSHNote mesh__D015230 89   
% 217.02/217.18  |- skos__hiddenLabel mesh__D015230 11 Dehydroprostaglandin F2alpha
% 217.02/217.18  |- skos__altLabel mesh__D001210 Southeast Asia
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D001210 2006
% 217.02/217.18  |- mesh__recordMaintainer mesh__D001210 mdb
% 217.02/217.18  |- skos__scopeNote mesh__D001210
% 217.02/217.18       The geographical area of Asia comprising BORNEO; BRUNEI; CAMBODIA; INDONESIA; LAOS; MALAYSIA; the MEKONG VALLEY; MYANMAR %28%formerly Burma%29%, the PHILIPPINES; SINGAPORE; THAILAND; and VIETNAM.%A%    
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D001210 2005
% 217.02/217.18  |- mesh__dateCreated mesh__D001210 1999-01-01
% 217.02/217.18  |- rdf__type mesh__D001210sskos__Concept
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D001210 2002
% 217.02/217.18  |- skos__broader mesh__D001210smesh__D001208
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D001210 2004
% 217.02/217.18  |- mesh__recordOriginator mesh__D001210 NLM
% 217.02/217.18  |- skos__altLabel mesh__D001210 Southeastern Asia
% 217.02/217.18  |- mesh__recordAuthorizer mesh__D001210 sjn
% 217.02/217.18  |- skos__prefLabel mesh__D001210 Asia, Southeastern
% 217.02/217.18  |- mesh__dateRevised mesh__D001210 2001-07-25
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D001210 2003
% 217.02/217.18  |- skos__annotation mesh__D001210 a geog area; prefer specific countries   
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D014936 2005
% 217.02/217.18  |- skos__hiddenLabel mesh__D014936 Tests, Word Association
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D014936 2001
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D014936 2003
% 217.02/217.18  |- skos__broader mesh__D014936smesh__D010556
% 217.02/217.18  |- skos__prefLabel mesh__D014936 Word Association Tests
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D014936 2000
% 217.02/217.18  |- skos__hiddenLabel mesh__D014936 Word Association Test
% 217.02/217.18  |- mesh__historyNote mesh__D014936 69   
% 217.02/217.18  |- rdf__type mesh__D014936sskos__Concept
% 217.02/217.18  |- mesh__recordOriginator mesh__D014936 NLM
% 217.02/217.18  |- skos__hiddenLabel mesh__D014936 Association Test, Word
% 217.02/217.18  |- mesh__dateEstablished mesh__D014936 1969-01-01
% 217.02/217.18  |- mesh__recordAuthorizer mesh__D014936 sjn
% 217.02/217.18  |- skos__hiddenLabel mesh__D014936 Association Tests, Word
% 217.02/217.18  |- mesh__recordMaintainer mesh__D014936 ndw
% 217.02/217.18  |- skos__annotation mesh__D014936 DF: WORD ASSOC TESTS   
% 217.02/217.18  |- mesh__publicMeSHNote mesh__D014936 69   
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D014936 2002
% 217.02/217.18  |- skos__scopeNote mesh__D014936
% 217.02/217.18       Lists of words to which individuals are asked to respond ascertaining the conceptual meaning held by the individual.%A%    
% 217.02/217.18  |- mesh__dateCreated mesh__D014936 1999-01-01
% 217.02/217.18  |- skos__historyNote mesh__D014936 Association %28%1966-1968%29%
% 217.02/217.18  |- skos__hiddenLabel mesh__D014936 Test, Word Association
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D014936 2006
% 217.02/217.18  |- mesh__dateRevised mesh__D014936 1999-11-03
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D014936 2004
% 217.02/217.18  |- skos__altLabel mesh__D014138 Esophagotracheal Fistula
% 217.02/217.18  |- mesh__publicMeSHNote mesh__D014138 65   
% 217.02/217.18  |- rdf__type mesh__D014138sskos__Concept
% 217.02/217.18  |- skos__annotation mesh__D014138 fistula policy: Manual 23.19+   
% 217.02/217.18  |- mesh__recordMaintainer mesh__D014138 lkt
% 217.02/217.18  |- skos__hiddenLabel mesh__D014138 Fistula, Tracheoesophageal
% 217.02/217.18  |- skos__hiddenLabel mesh__D014138 Esophagotracheal Fistulas
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D014138 2005
% 217.02/217.18  |- mesh__historyNote mesh__D014138 65%28%63%29%   
% 217.02/217.18  |- skos__broader mesh__D014138smesh__D014133
% 217.02/217.18  |- mesh__dateRevised mesh__D014138 2003-07-09
% 217.02/217.18  |- mesh__dateEstablished mesh__D014138 1965-01-01
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D014138 2004
% 217.02/217.18  |- skos__prefLabel mesh__D014138 Tracheoesophageal Fistula
% 217.02/217.18  |- skos__hiddenLabel mesh__D014138 Fistulas, Tracheoesophageal
% 217.02/217.18  |- mesh__activeMeSHYear mesh__D014138 2006
% 217.02/217.18  |- mesh__recordOriginator mesh__D014138 NLM
% 217.02/217.18  |- skos__broader mesh__D014138smesh__D016156
% 217.02/217.18  |- mesh__recordAuthorizer mesh__D014138 sjn
% 217.02/217.18  |- skos__hiddenLabel mesh__D014138 Fistula, Esophagotracheal
% 217.02/217.18  |- skos__scopeNote mesh__D014138
% 217.02/217.18       Abnormal passage between the ESOPHAGUS and the TRACHEA, acquired or congenital, often associated with ESOPHAGEAL ATRESIA.%A%    
% 217.02/217.18  |- mesh__dateCreated mesh__D014138 1999-01-01
% 217.02/217.24  |- skos__broader mesh__D014138smesh__D004937
% 217.02/217.24  |- skos__hiddenLabel mesh__D014138 Fistulas, Esophagotracheal
% 217.02/217.24  |- skos__hiddenLabel mesh__D014138 Tracheoesophageal Fistulas
% 217.02/217.24  |- mesh__recordOriginator mesh__D000916 AEP
% 217.02/217.24  |- mesh__activeMeSHYear mesh__D000916 2004
% 217.02/217.24  |- mesh__publicMeSHNote mesh__D000916 80   
% 217.02/217.24  |- skos__scopeNote mesh__D000916
% 217.02/217.24       The phenomenon of immense variability characteristic of ANTIBODIES, which enables the IMMUNE SYSTEM to react specifically against the essentially unlimited kinds of ANTIGENS it encounters. Antibody diversity is accounted for by three main theories: %28%1%29% the Germ Line Theory, which holds that each antibody-producing cell has genes coding for all possible antibody specificities, but expresses only the one stimulated by antigen; %28%2%29% the Somatic Mutation Theory, which holds that antibody-producing cells contain only a few genes, which produce antibody diversity by mutation; and %28%3%29% the Gene Rearrangement Theory, which holds that antibody diversity is generated by the rearrangement of VARIABLE REGION gene segments during the differentiation of the ANTIBODY-PRODUCING CELLS.%A%    
% 217.02/217.24  |- mesh__recordMaintainer mesh__D000916 TAP
% 217.02/217.24  |- mesh__activeMeSHYear mesh__D000916 2003
% 217.02/217.24  |- mesh__recordAuthorizer mesh__D000916 sjn
% 217.02/217.24  |- rdf__type mesh__D000916sskos__Concept
% 217.02/217.24  |- skos__broader mesh__D000916smesh__D007125
% 217.02/217.24  |- skos__hiddenLabel mesh__D000916 Theories, Germ Line
% 217.02/217.24  |- mesh__activeMeSHYear mesh__D000916 2006
% 217.02/217.24  |- skos__hiddenLabel mesh__D000916 Germ Line Theories
% 217.02/217.24  |- skos__hiddenLabel mesh__D000916 Antibody Diversities
% 217.02/217.24  |- skos__prefLabel mesh__D000916 Antibody Diversity
% 217.02/217.24  |- mesh__activeMeSHYear mesh__D000916 2005
% 217.02/217.24  |- skos__hiddenLabel mesh__D000916 Theory, Germ Line
% 217.02/217.24  |- mesh__dateRevised mesh__D000916 2002-07-02
% 217.02/217.24  |- mesh__dateEstablished mesh__D000916 1980-01-01
% 217.02/217.24  |- mesh__historyNote mesh__D000916 80   
% 217.02/217.24  |- skos__historyNote mesh__D000916 Antibody Specificity %28%1970-1979%29%
% 217.02/217.24  |- skos__hiddenLabel mesh__D000916 Diversities, Antibody
% 217.02/217.24  |- skos__historyNote mesh__D000916 Antibodies %28%1966-1969%29%
% 217.02/217.24  |- skos__broader mesh__D000916smesh__D014644
% 217.02/217.24  |- skos__hiddenLabel mesh__D000916 Diversity, Antibody
% 217.02/217.24  |- mesh__dateCreated mesh__D000916 1979-02-23
% 217.02/217.24  |- skos__broader mesh__D000916smesh__D007109
% 217.02/217.24  |- mesh__recordAuthorizer mesh__D019621 sjn
% 217.02/217.24  |- skos__historyNote mesh__D019621 Archaea %28%1989-1997%29%
% 217.02/217.24  |- skos__annotation mesh__D019621
% 217.02/217.24       a genus of Halobacteriaceae, extremely halophilic   
% 217.02/217.24  |- mesh__publicMeSHNote mesh__D019621 98   
% 217.02/217.24  |- skos__broader mesh__D019621smesh__D006216
% 217.02/217.24  |- mesh__recordOriginator mesh__D019621 AGS
% 217.02/217.24  |- mesh__dateRevised mesh__D019621 2005-06-30
% 217.02/217.25  |- mesh__recordMaintainer mesh__D019621 SYSTEM
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D019621 2006
% 217.02/217.25  |- mesh__historyNote mesh__D019621 98   
% 217.02/217.25  |- skos__prefLabel mesh__D019621 Haloferax
% 217.02/217.25  |- mesh__dateEstablished mesh__D019621 1998-01-01
% 217.02/217.25  |- skos__historyNote mesh__D019621 Halobacteriaceae %28%1990-1997%29%
% 217.02/217.25  |- rdf__type mesh__D019621sskos__Concept
% 217.02/217.25  |- skos__scopeNote mesh__D019621
% 217.02/217.25       A genus of extremely halophilic HALOBACTERIACEAE which are chemoheterotropic and strictly aerobic. They are found in neutral saline environments such as salt lakes %28%especially the Dead Sea%29% and marine salterns.%A%    
% 217.02/217.25  |- mesh__dateCreated mesh__D019621 1997-06-20
% 217.02/217.25  |- skos__altLabel mesh__D000118 NAGase
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D000118 2006
% 217.02/217.25  |- mesh__recordOriginator mesh__D000118 NLM
% 217.02/217.25  |- skos__hiddenLabel mesh__D000118 beta D N acetylglucosaminidase
% 217.02/217.25  |- mesh__historyNote mesh__D000118
% 217.02/217.25       91%28%75%29%; was see under GLUCOSAMINIDASE 1975-90   
% 217.02/217.25  |- skos__altLabel mesh__D000118 N-Ac-beta-Glucosaminidase
% 217.02/217.25  |- rdf__type mesh__D000118sskos__Concept
% 217.02/217.25  |- skos__hiddenLabel mesh__D000118 N Acetyl beta D glucosaminidase
% 217.02/217.25  |- skos__altLabel mesh__D000118 Beta-N-Acetylglucosaminidase
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D000118 2005
% 217.02/217.25  |- skos__hiddenLabel mesh__D000118 N,N Diacetylchitobiase
% 217.02/217.25  |- skos__broader mesh__D000118smesh__D006596
% 217.02/217.25  |- mesh__recordAuthorizer mesh__D000118 sjn
% 217.02/217.25  |- skos__altLabel mesh__D000118 N-Acetyl-beta-D-glucosaminidase
% 217.02/217.25  |- skos__prefLabel mesh__D000118 Acetylglucosaminidase
% 217.02/217.25  |- skos__scopeNote mesh__D000118
% 217.02/217.25       2-Acetamido-2-deoxy-beta-D-glucoside acetamidodeoxygluco-hydrolase. Catalyzes the hydrolysis of terminal, non-reducing 2-acetamido-2-deoxy-beta-glucose residues in chitobiose and higher analogs as well as in glycoproteins. Has been used widely in structural studies on bacterial cell walls and in the study of diseases such as mucolipidosis and various inflammatory disorders of muscle and connective tissue.%A%    
% 217.02/217.25  |- skos__hiddenLabel mesh__D000118 N Ac beta Glucosaminidase
% 217.02/217.25  |- skos__hiddenLabel mesh__D000118 Beta N Acetylglucosaminidase
% 217.02/217.25  |- skos__historyNote mesh__D000118 Acetamides %28%1973-1974%29%
% 217.02/217.25  |- mesh__publicMeSHNote mesh__D000118
% 217.02/217.25       91; was see under GLUCOSAMINIDASE 1975-90   
% 217.02/217.25  |- skos__altLabel mesh__D000118 Beta-D-Acetamido-2-Deoxyglucosidase
% 217.02/217.25  |- mesh__recordMaintainer mesh__D000118 jmp
% 217.02/217.25  |- mesh__dateEstablished mesh__D000118 1991-01-01
% 217.02/217.25  |- skos__altLabel mesh__D000118 Chitobiase
% 217.02/217.25  |- skos__altLabel mesh__D000118 N,N-Diacetylchitobiase
% 217.02/217.25  |- skos__historyNote mesh__D000118 Glucosaminidase %28%1972-1974%29%
% 217.02/217.25  |- mesh__dateRevised mesh__D000118 2004-07-07
% 217.02/217.25  |- skos__hiddenLabel mesh__D000118 Beta D Acetamido 2 Deoxyglucosidase
% 217.02/217.25  |- skos__altLabel mesh__D000118 beta-D-N-acetylglucosaminidase
% 217.02/217.25  |- mesh__dateCreated mesh__D000118 1974-11-11
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D005601 2006
% 217.02/217.25  |- skos__prefLabel mesh__D005601 Framycetin
% 217.02/217.25  |- skos__altLabel mesh__D005601 Framycetin Sulfate
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D005601 2005
% 217.02/217.25  |- mesh__recordMaintainer mesh__D005601 ssb
% 217.02/217.25  |- mesh__recordAuthorizer mesh__D005601 sjn
% 217.02/217.25  |- skos__altLabel mesh__D005601 Antibiotic 10676
% 217.02/217.25  |- mesh__recordOriginator mesh__D005601 NLM
% 217.02/217.25  |- mesh__dateRevised mesh__D005601 2004-07-07
% 217.02/217.25  |- mesh__publicMeSHNote mesh__D005601 68   
% 217.02/217.25  |- skos__hiddenLabel mesh__D005601 Sulfate, Neomycin B
% 217.02/217.25  |- mesh__dateEstablished mesh__D005601 1968-01-01
% 217.02/217.25  |- skos__scopeNote mesh__D005601
% 217.02/217.25       A component of NEOMYCIN that is produced by Streptomyces fradiae. On hydrolysis it yields neamine and neobiosamine B. %28%From Merck Index, 11th ed%29%%A%    
% 217.02/217.25  |- mesh__historyNote mesh__D005601 68%28%63%29%   
% 217.02/217.25  |- skos__hiddenLabel mesh__D005601 Sulfate, Framycetin
% 217.02/217.25  |- mesh__dateCreated mesh__D005601 1999-01-01
% 217.02/217.25  |- skos__broader mesh__D005601smesh__D009355
% 217.02/217.25  |- skos__altLabel mesh__D005601 Neomycin B
% 217.02/217.25  |- rdf__type mesh__D005601sskos__Concept
% 217.02/217.25  |- skos__historyNote mesh__D018529 Enteral Nutrition %28%1969-1994%29%
% 217.02/217.25  |- mesh__recordAuthorizer mesh__D018529 sjn
% 217.02/217.25  |- skos__broader mesh__D018529smesh__D044623
% 217.02/217.25  |- mesh__publicMeSHNote mesh__D018529 95   
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D018529 2004
% 217.02/217.25  |- skos__prefLabel mesh__D018529 Nutritional Support
% 217.02/217.25  |- skos__hiddenLabel mesh__D018529 Feeding, Artificial
% 217.02/217.25  |- mesh__dateEstablished mesh__D018529 1995-01-01
% 217.02/217.25  |- mesh__dateCreated mesh__D018529 1994-04-16
% 217.02/217.25  |- mesh__historyNote mesh__D018529 95   
% 217.02/217.25  |- skos__hiddenLabel mesh__D018529 Support, Nutritional
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D018529 2006
% 217.02/217.25  |- mesh__recordOriginator mesh__D018529 TGC
% 217.02/217.25  |- mesh__recordMaintainer mesh__D018529 lkt
% 217.02/217.25  |- rdf__type mesh__D018529sskos__Concept
% 217.02/217.25  |- skos__scopeNote mesh__D018529
% 217.02/217.25       The administration of nutrients for assimilation and utilization by a patient by means other than normal eating. It does not include FLUID THERAPY which normalizes body fluids to restore WATER-ELECTROLYTE BALANCE.%A%    
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D018529 2005
% 217.02/217.25  |- skos__annotation mesh__D018529 GEN or unspecified; prefer specifics   
% 217.02/217.25  |- mesh__dateRevised mesh__D018529 2003-07-09
% 217.02/217.25  |- skos__historyNote mesh__D018529 Parenteral Nutrition %28%1966-1994%29%
% 217.02/217.25  |- skos__altLabel mesh__D010546 Chlorpiprazine
% 217.02/217.25  |- rdf__type mesh__D010546sskos__Concept
% 217.02/217.25  |- mesh__dateCreated mesh__D010546 1999-01-01
% 217.02/217.25  |- skos__broader mesh__D010546smesh__D010640
% 217.02/217.25  |- mesh__recordAuthorizer mesh__D010546 sjn
% 217.02/217.25  |- mesh__recordOriginator mesh__D010546 NLM
% 217.02/217.25  |- skos__altLabel mesh__D010546 Perfenazine
% 217.02/217.25  |- skos__prefLabel mesh__D010546 Perphenazine
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D010546 2006
% 217.02/217.25  |- mesh__recordMaintainer mesh__D010546 ssb
% 217.02/217.25  |- skos__scopeNote mesh__D010546
% 217.02/217.25       An antipsychotic phenothiazine derivative with actions and uses similar to those of CHLORPROMAZINE.%A%    
% 217.02/217.25  |- mesh__dateRevised mesh__D010546 2005-06-30
% 217.02/217.25  |- skos__annotation mesh__D004509
% 217.02/217.25       differentiate from EDUCATION, NURSING, GRADUATE: see note on EDUCATION, CONTINUING; special courses, workshops, etc.; DF: EDUC NURS CONTINUING%A%  
% 217.02/217.25  |- skos__altLabel mesh__D004509 Post-Basic Nursing Education
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D004509 2005
% 217.02/217.25  |- mesh__publicMeSHNote mesh__D004509 66   
% 217.02/217.25  |- skos__altLabel mesh__D004509 Education, Nursing, Post-Registration
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D004509 2001
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D004509 2004
% 217.02/217.25  |- mesh__dateRevised mesh__D004509 1999-11-03
% 217.02/217.25  |- skos__altLabel mesh__D004509 Nursing Education, Post-Registration
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D004509 2000
% 217.02/217.25  |- skos__hiddenLabel mesh__D004509 Nursing Education, Post Registration
% 217.02/217.25  |- mesh__recordAuthorizer mesh__D004509 sjn
% 217.02/217.25  |- mesh__dateCreated mesh__D004509 1999-01-01
% 217.02/217.25  |- skos__altLabel mesh__D004509 Post-Registration Nursing Education
% 217.02/217.25  |- skos__prefLabel mesh__D004509 Education, Nursing, Continuing
% 217.02/217.25  |- skos__hiddenLabel mesh__D004509 Post Basic Nursing Education
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D004509 2003
% 217.02/217.25  |- skos__hiddenLabel mesh__D004509 Post Registration Nursing Education
% 217.02/217.25  |- skos__related mesh__D004509smesh__D013041
% 217.02/217.25  |- mesh__historyNote mesh__D004509 66   
% 217.02/217.25  |- mesh__dateEstablished mesh__D004509 1966-01-01
% 217.02/217.25  |- skos__hiddenLabel mesh__D004509 Education, Post-Basic Nursing
% 217.02/217.25  |- mesh__recordOriginator mesh__D004509 NLM
% 217.02/217.25  |- skos__altLabel mesh__D004509 Education, Nursing, Post-Basic
% 217.02/217.25  |- skos__scopeNote mesh__D004509
% 217.02/217.25       Educational programs designed to inform nurses of recent advances in their fields.%A%    
% 217.02/217.25  |- skos__altLabel mesh__D004509 Nursing Education, Post-Basic
% 217.02/217.25  |- skos__hiddenLabel mesh__D004509 Nursing Education, Post Basic
% 217.02/217.25  |- skos__broader mesh__D004509smesh__D004506
% 217.02/217.25  |- skos__altLabel mesh__D004509 Continuing Nursing Education
% 217.02/217.25  |- skos__hiddenLabel mesh__D004509 Education, Continuing Nursing
% 217.02/217.25  |- mesh__recordMaintainer mesh__D004509 kle
% 217.02/217.25  |- rdf__type mesh__D004509sskos__Concept
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D004509 2006
% 217.02/217.25  |- skos__hiddenLabel mesh__D004509 Education, Post-Registration Nursing
% 217.02/217.25  |- skos__broader mesh__D004509smesh__D004496
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D004509 2002
% 217.02/217.25  |- skos__altLabel mesh__D004509 Nursing Education, Continuing
% 217.02/217.25  |- skos__altLabel mesh__D015231 Bacterial Sexually Transmitted Diseases
% 217.02/217.25  |- mesh__dateCreated mesh__D015231 1988-05-12
% 217.02/217.25  |- skos__hiddenLabel mesh__D015231 Disease, Bacterial Venereal
% 217.02/217.25  |- skos__hiddenLabel mesh__D015231 Bacterial Venereal Disease
% 217.02/217.25  |- skos__altLabel mesh__D015231 Sexually Transmitted Disease, Bacterial
% 217.02/217.25  |- skos__annotation mesh__D015231
% 217.02/217.25       GEN: prefer specifics; DF: SEX TRANSM DIS BACT   
% 217.02/217.25  |- mesh__dateRevised mesh__D015231 1994-02-08
% 217.02/217.25  |- rdf__type mesh__D015231sskos__Concept
% 217.02/217.25  |- skos__broader mesh__D015231smesh__D001424
% 217.02/217.25  |- skos__historyNote mesh__D015231
% 217.02/217.25       Sexually Transmitted Diseases %28%1987-1988%29%
% 217.02/217.25  |- skos__prefLabel mesh__D015231 Sexually Transmitted Diseases, Bacterial
% 217.02/217.25  |- skos__altLabel mesh__D015231 Bacterial Sexually Transmitted Disease
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D015231 1995
% 217.02/217.25  |- skos__broader mesh__D015231smesh__D012749
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D015231 1998
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D015231 2005
% 217.02/217.25  |- skos__altLabel mesh__D015231 Venereal Diseases, Bacterial
% 217.02/217.25  |- mesh__recordMaintainer mesh__D015231 PXP
% 217.02/217.25  |- skos__altLabel mesh__D015231 Bacterial Venereal Diseases
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D015231 2000
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D015231 2003
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D015231 1996
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D015231 1999
% 217.02/217.25  |- mesh__recordOriginator mesh__D015231 EJB
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D015231 2006
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D015231 2001
% 217.02/217.25  |- mesh__historyNote mesh__D015231 89   
% 217.02/217.25  |- skos__scopeNote mesh__D015231
% 217.02/217.25       Bacterial diseases transmitted or propagated by sexual conduct.%A%    
% 217.02/217.25  |- mesh__dateEstablished mesh__D015231 1989-01-01
% 217.02/217.25  |- skos__hiddenLabel mesh__D015231 Venereal Disease, Bacterial
% 217.02/217.25  |- skos__historyNote mesh__D015231 Venereal Diseases %28%1966-1986%29%
% 217.02/217.25  |- mesh__publicMeSHNote mesh__D015231 89   
% 217.02/217.25  |- skos__hiddenLabel mesh__D015231 Diseases, Bacterial Venereal
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D015231 1997
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D015231 2004
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D015231 2002
% 217.02/217.25  |- mesh__recordAuthorizer mesh__D015231 PLS
% 217.02/217.25  |- skos__annotation mesh__D001211
% 217.02/217.25       a geog area; prefer specific countries; MIDDLE EAST is also available%A%  
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D001211 2005
% 217.02/217.25  |- mesh__dateCreated mesh__D001211 1999-01-01
% 217.02/217.25  |- rdf__type mesh__D001211sskos__Concept
% 217.02/217.25  |- mesh__recordAuthorizer mesh__D001211 sjn
% 217.02/217.25  |- mesh__dateRevised mesh__D001211 2001-07-25
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D001211 2004
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D001211 2002
% 217.02/217.25  |- skos__scopeNote mesh__D001211
% 217.02/217.25       The geographical designation for the countries of the MIDDLE EAST and the countries BANGLADESH; BHUTAN; INDIA; NEPAL; PAKISTAN; and SRI LANKA. %28%From Random House Unabridged Dictionary, 2d ed, 1993 %26% Webster%27%s New Geographical Dictionary, 1988%29%%A%    
% 217.02/217.25  |- skos__broader mesh__D001211smesh__D001208
% 217.02/217.25  |- skos__prefLabel mesh__D001211 Asia, Western
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D001211 2003
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D001211 2006
% 217.02/217.25  |- mesh__recordMaintainer mesh__D001211 mdb
% 217.02/217.25  |- mesh__recordOriginator mesh__D001211 NLM
% 217.02/217.25  |- skos__altLabel mesh__D001211 Western Asia
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176 Fumarylacetoacetase Deficiency Diseases
% 217.02/217.25  |- skos__prefLabel mesh__D020176 Tyrosinemias
% 217.02/217.25  |- skos__altLabel mesh__D020176 Hereditary Tyrosinemia, Type III
% 217.02/217.25  |- mesh__recordOriginator mesh__D020176 KEV
% 217.02/217.25  |- rdf__type mesh__D020176sskos__Concept
% 217.02/217.25  |- mesh__dateCreated mesh__D020176 1999-11-04
% 217.02/217.25  |- mesh__publicMeSHNote mesh__D020176 2000   
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176 Disease, Fumarylacetoacetase Deficiency
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176 Type I Tyrosinemias
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176 Type III Tyrosinemia
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D020176 2005
% 217.02/217.25  |- mesh__dateRevised mesh__D020176 2001-07-25
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176 Diseases, Fumarylacetoacetase Deficiency
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176 Hypertyrosinemias, Type I
% 217.02/217.25  |- skos__altLabel mesh__D020176
% 217.02/217.25       4 Hydroxyphenylpyruvate Dioxygenase Deficiency Disease
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176 Tyrosinemias, Type I
% 217.02/217.25  |- skos__altLabel mesh__D020176 Hypertyrosinemia, Type I
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176 Type I Hypertyrosinemias
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D020176 2004
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176 Type II Tyrosinemia
% 217.02/217.25  |- skos__broader mesh__D020176smesh__D000592
% 217.02/217.25  |- skos__altLabel mesh__D020176
% 217.02/217.25       Deficiency Disease, 4-Hydroxyphenol Pyruvic Acid Oxidase
% 217.02/217.25  |- skos__altLabel mesh__D020176
% 217.02/217.25       4-Hydroxyphenol Pyruvic Acid Oxidase Deficiency Disease
% 217.02/217.25  |- skos__scopeNote mesh__D020176
% 217.02/217.25       A group of disorders which have in common elevations of tyrosine in the blood and urine secondary to an enzyme deficiency. Type I tyrosinemia features episodic weakness, self-mutilation, hepatic necrosis, renal tubular injury, and seizures and is caused by a deficiency of the enzyme fumarylacetoacetase. Type II tyrosinemia features mental retardation, painful corneal ulcers, and keratoses of the palms and plantar surfaces and is caused by a deficiency of the enzyme TYROSINE TRANSAMINASE. Type III tyrosinemia features mental retardation and is caused by a deficiency of the enzyme 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE. %28%Menkes, Textbook of Child Neurology, 5th ed, pp42-3%29%%A%    
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176 Tyrosinemia, Hereditary
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D020176 2002
% 217.02/217.25  |- mesh__recordAuthorizer mesh__D020176 sjn
% 217.02/217.25  |- skos__altLabel mesh__D020176 Tyrosinemias, Hereditary
% 217.02/217.25  |- skos__historyNote mesh__D020176
% 217.02/217.25       Amino Acid Metabolism, Inborn Errors %28%1967-1999%29%
% 217.02/217.25  |- skos__altLabel mesh__D020176 Deficiency Disease, Fumarylacetoacetase
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D020176 2003
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176 Hereditary Tyrosinemia
% 217.02/217.25  |- skos__broader mesh__D020176smesh__D020739
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176 Type II Tyrosinemias
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176 Type I Tyrosinemia
% 217.02/217.25  |- skos__altLabel mesh__D020176 Tyrosine Transaminase Deficiency Disease
% 217.02/217.25  |- skos__altLabel mesh__D020176 Fumarylacetoacetase Deficiency Disease
% 217.02/217.25  |- skos__altLabel mesh__D020176 Hereditary Tyrosinemia, Type I
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176 Hereditary Tyrosinemias
% 217.02/217.25  |- skos__annotation mesh__D020176
% 217.02/217.25       note X refs: consider also TYROSINE TRANSAMINASE /defic or other enzymes /defic%A%  
% 217.02/217.25  |- mesh__historyNote mesh__D020176 2000   
% 217.02/217.25  |- mesh__dateEstablished mesh__D020176 2000-01-01
% 217.02/217.25  |- skos__altLabel mesh__D020176 Deficiency Disease, Tyrosine Transaminase
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176
% 217.02/217.25       Deficiency Disease, 4 Hydroxyphenol Pyruvic Acid Oxidase
% 217.02/217.25  |- mesh__recordMaintainer mesh__D020176 nns
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176 Tyrosinemias, Type III
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176 Type I Hypertyrosinemia
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176 Tyrosinemias, Type II
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176 Tyrosinemia
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D020176 2006
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176
% 217.02/217.25       4 Hydroxyphenol Pyruvic Acid Oxidase Deficiency Disease
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176 Type III Tyrosinemias
% 217.02/217.25  |- skos__hiddenLabel mesh__D020176 Deficiency Diseases, Fumarylacetoacetase
% 217.02/217.25  |- skos__altLabel mesh__D020176 Hereditary Tyrosinemia, Type II
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014937 1999
% 217.02/217.25  |- mesh__dateRevised mesh__D014937 1992-05-18
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014937 1994
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014937 1997
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014937 2002
% 217.02/217.25  |- mesh__recordMaintainer mesh__D014937 TGC
% 217.02/217.25  |- skos__broader mesh__D014937smesh__D006802
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014937 1998
% 217.02/217.25  |- mesh__dateEstablished mesh__D014937 1966-01-01
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014937 1996
% 217.02/217.25  |- skos__related mesh__D014937smesh__D004651
% 217.02/217.25  |- mesh__dateCreated mesh__D014937 1999-01-01
% 217.02/217.25  |- skos__related mesh__D014937smesh__D004526
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014937 2006
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014937 2001
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014937 2004
% 217.02/217.25  |- skos__scopeNote mesh__D014937 Productive or purposeful activities.     
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014937 2000
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014937 2005
% 217.02/217.25  |- mesh__publicMeSHNote mesh__D014937 66; was see under EXERTION 1963-65   
% 217.02/217.25  |- mesh__historyNote mesh__D014937 66; was see under EXERTION 1963-65   
% 217.02/217.25  |- skos__prefLabel mesh__D014937 Work
% 217.02/217.25  |- mesh__recordOriginator mesh__D014937 NLM
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014937 2003
% 217.02/217.25  |- mesh__recordAuthorizer mesh__D014937 PLS
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014937 1995
% 217.02/217.25  |- skos__annotation mesh__D014937
% 217.02/217.25       purposeful activity: differentiate from EXERTION %28%physiol effort%29%, EMPLOYMENT %28%for pay%29%, ENERGY EXPENDITURE %28%metab%29%; /physiol permitted; BURNOUT, PROFESSIONAL is available%A%  
% 217.02/217.25  |- rdf__type mesh__D014937sskos__Concept
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014937 1993
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014139 2001
% 217.02/217.25  |- rdf__type mesh__D014139sskos__Concept
% 217.02/217.25  |- mesh__publicMeSHNote mesh__D014139
% 217.02/217.25       88,63-66; was see TRACHEOTOMY 1967-87   
% 217.02/217.25  |- mesh__recordMaintainer mesh__D014139 PXP
% 217.02/217.25  |- skos__broader mesh__D014139smesh__D010030
% 217.02/217.25  |- mesh__dateCreated mesh__D014139 1987-03-25
% 217.02/217.25  |- skos__annotation mesh__D014139
% 217.02/217.25       do not use /util except by MeSH definition; do not confuse with TRACHEOTOMY%A%  
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014139 2003
% 217.02/217.25  |- skos__hiddenLabel mesh__D014139 Tracheostomies
% 217.02/217.25  |- skos__broader mesh__D014139smesh__D013517
% 217.02/217.25  |- mesh__dateEstablished mesh__D014139 1988-01-01
% 217.02/217.25  |- mesh__historyNote mesh__D014139 88,63-66; was see TRACHEOTOMY 1967-87   
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014139 2002
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014139 2005
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014139 2004
% 217.02/217.25  |- mesh__recordOriginator mesh__D014139 SCD
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014139 1998
% 217.02/217.25  |- mesh__onlineNote mesh__D014139 search TRACHEOTOMY 1966-87   
% 217.02/217.25  |- skos__historyNote mesh__D014139 Tracheotomy %28%1966-1987%29%
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014139 2006
% 217.02/217.25  |- mesh__recordAuthorizer mesh__D014139 SJN
% 217.02/217.25  |- mesh__dateRevised mesh__D014139 1997-06-20
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014139 2000
% 217.02/217.25  |- skos__scopeNote mesh__D014139
% 217.02/217.25       Surgical formation of an opening into the trachea through the neck, or the opening so created.%A%    
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D014139 1999
% 217.02/217.25  |- skos__prefLabel mesh__D014139 Tracheostomy
% 217.02/217.25  |- skos__broader mesh__D014139smesh__D019616
% 217.02/217.25  |- mesh__recordMaintainer mesh__D000917 ags
% 217.02/217.25  |- skos__hiddenLabel mesh__D000917 Formation, Antibody
% 217.02/217.25  |- mesh__recordOriginator mesh__D000917 NLM
% 217.02/217.25  |- skos__annotation mesh__D000917
% 217.02/217.25       GEN only: do not use as coord for formation of specific antibodies%A%  
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D000917 2003
% 217.02/217.25  |- rdf__type mesh__D000917sskos__Concept
% 217.02/217.25  |- skos__altLabel mesh__D000917 Antibody Response
% 217.02/217.25  |- skos__hiddenLabel mesh__D000917 Response, Antibody
% 217.02/217.25  |- skos__hiddenLabel mesh__D000917 Antibody Responses
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D000917 2006
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D000917 2005
% 217.02/217.25  |- skos__prefLabel mesh__D000917 Antibody Formation
% 217.02/217.25  |- mesh__recordAuthorizer mesh__D000917 sjn
% 217.02/217.25  |- skos__scopeNote mesh__D000917
% 217.02/217.25       The proliferation and differentiation of B-LYMPHOCYTES into PLASMA CELLS or memory cells. On stimulation by ANTIGENS, those cells then produce ANTIBODIES.%A%    
% 217.02/217.25  |- skos__altLabel mesh__D000917 Antibody Production
% 217.02/217.25  |- skos__hiddenLabel mesh__D000917 Responses, Antibody
% 217.02/217.25  |- skos__hiddenLabel mesh__D000917 Humoral Immunities
% 217.02/217.25  |- skos__broader mesh__D000917smesh__D007109
% 217.02/217.25  |- mesh__dateCreated mesh__D000917 1999-01-01
% 217.02/217.25  |- skos__hiddenLabel mesh__D000917 Immunities, Humoral
% 217.02/217.25  |- skos__hiddenLabel mesh__D000917 Humoral Immunity
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D000917 2004
% 217.02/217.25  |- mesh__dateRevised mesh__D000917 2002-07-02
% 217.02/217.25  |- skos__hiddenLabel mesh__D000917 Production, Antibody
% 217.02/217.25  |- mesh__dateCreated mesh__D019622 1997-06-20
% 217.02/217.25  |- mesh__recordMaintainer mesh__D019622 SYSTEM
% 217.02/217.25  |- mesh__recordAuthorizer mesh__D019622 sjn
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D019622 2006
% 217.02/217.25  |- mesh__historyNote mesh__D019622 98   
% 217.02/217.25  |- skos__annotation mesh__D019622
% 217.02/217.25       a species of Haloferax found in the Dead Sea; volcanii refers to B.E. Volcani, discoverer of life in the Dead Sea%A%  
% 217.02/217.25  |- mesh__publicMeSHNote mesh__D019622 98   
% 217.02/217.25  |- mesh__recordOriginator mesh__D019622 AGS
% 217.02/217.25  |- mesh__dateRevised mesh__D019622 2005-06-30
% 217.02/217.25  |- rdf__type mesh__D019622sskos__Concept
% 217.02/217.25  |- skos__historyNote mesh__D019622 Archaea %28%1990-1997%29%
% 217.02/217.25  |- skos__scopeNote mesh__D019622
% 217.02/217.25       A species of halophilic archaea found in the Dead Sea.     
% 217.02/217.25  |- skos__broader mesh__D019622smesh__D019621
% 217.02/217.25  |- skos__historyNote mesh__D019622 Halobacteriaceae %28%1992-1997%29%
% 217.02/217.25  |- skos__prefLabel mesh__D019622 Haloferax volcanii
% 217.02/217.25  |- mesh__dateEstablished mesh__D019622 1998-01-01
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D000119 2005
% 217.02/217.25  |- skos__hiddenLabel mesh__D000119
% 217.02/217.25       N Acetyl Muramyl L Alanyl D Glutamic alpha Amide
% 217.02/217.25  |- mesh__recordMaintainer mesh__D000119 ssb
% 217.02/217.25  |- skos__scopeNote mesh__D000119
% 217.02/217.25       Peptidoglycan immunoadjuvant originally isolated from bacterial cell wall fragments; also acts as pyrogen and may cause arthritis; stimulates both humoral and cellular immunity.%A%    
% 217.02/217.25  |- skos__broader mesh__D000119smesh__D009112
% 217.02/217.25  |- skos__annotation mesh__D000119 /biosyn permitted; DF: AMAIG   
% 217.02/217.25  |- mesh__dateEstablished mesh__D000119 1983-01-01
% 217.02/217.25  |- skos__historyNote mesh__D000119 Peptides %28%1966-1970%29%
% 217.02/217.25  |- skos__historyNote mesh__D000119 Glycopeptides %28%1971-1978%29%
% 217.02/217.25  |- skos__historyNote mesh__D000119 Polysaccharides %28%1966-1970%29%
% 217.02/217.25  |- mesh__recordAuthorizer mesh__D000119 sjn
% 217.02/217.25  |- skos__hiddenLabel mesh__D000119 Mur NAc L Ala D isoGln
% 217.02/217.25  |- skos__altLabel mesh__D000119 Muramyl Dipeptide
% 217.02/217.25  |- mesh__dateRevised mesh__D000119 2004-07-07
% 217.02/217.25  |- skos__hiddenLabel mesh__D000119 Dipeptide, Muramyl
% 217.02/217.25  |- mesh__historyNote mesh__D000119
% 217.02/217.25       83%28%79%29%; was see under GLYCOPEPTIDES 1979-82   
% 217.02/217.25  |- skos__altLabel mesh__D000119 N-Acetylmuramyl-L-Alanyl-D-Isoglutamine
% 217.02/217.25  |- mesh__dateCreated mesh__D000119 1978-02-01
% 217.02/217.25  |- skos__altLabel mesh__D000119
% 217.02/217.25       N-Acetyl-Muramyl-L-Alanyl-D-Glutamic-alpha-Amide
% 217.02/217.25  |- mesh__recordOriginator mesh__D000119 SH
% 217.02/217.25  |- skos__hiddenLabel mesh__D000119 N Acetylmuramyl L Alanyl D Isoglutamine
% 217.02/217.25  |- skos__altLabel mesh__D000119 Acetylmuramyl Alanyl Isoglutamine
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D000119 2006
% 217.02/217.25  |- skos__prefLabel mesh__D000119 Acetylmuramyl-Alanyl-Isoglutamine
% 217.02/217.25  |- skos__hiddenLabel mesh__D000119 Isoglutamine, Acetylmuramyl Alanyl
% 217.02/217.25  |- skos__hiddenLabel mesh__D000119 Alanyl Isoglutamine, Acetylmuramyl
% 217.02/217.25  |- mesh__publicMeSHNote mesh__D000119
% 217.02/217.25       83; was see under GLYCOPEPTIDES 1979-82   
% 217.02/217.25  |- skos__broader mesh__D000119smesh__D006020
% 217.02/217.25  |- rdf__type mesh__D000119sskos__Concept
% 217.02/217.25  |- skos__scopeNote mesh__D005602
% 217.02/217.25       A country in western Europe bordered by the Atlantic Ocean, the English Channel, the Mediterranean Sea, and the countries of Belgium, Germany, Italy, Spain, Switzerland, the principalities of Andorra and Monaco, and by the duchy of Luxembourg. Its capital is Paris.%A%    
% 217.02/217.25  |- mesh__recordMaintainer mesh__D005602 adp
% 217.02/217.25  |- skos__altLabel mesh__D005602 Saint Pierre and Miquelon
% 217.02/217.25  |- mesh__dateCreated mesh__D005602 1999-01-01
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D005602 2004
% 217.02/217.25  |- skos__altLabel mesh__D005602 Miquelon and St. Pierre
% 217.02/217.25  |- skos__broader mesh__D005602smesh__D005060
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D005602 2001
% 217.02/217.25  |- rdf__type mesh__D005602sskos__Concept
% 217.02/217.25  |- skos__annotation mesh__D005602 PARIS is also available   
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D005602 2003
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D005602 2000
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D005602 2006
% 217.02/217.25  |- skos__prefLabel mesh__D005602 France
% 217.02/217.25  |- mesh__dateRevised mesh__D005602 1999-11-08
% 217.02/217.25  |- mesh__recordAuthorizer mesh__D005602 sjn
% 217.02/217.25  |- mesh__historyNote mesh__D005602
% 217.02/217.25       1978; for SAINT PIERRE AND MIQUELON use CANADA 1996-1999   
% 217.02/217.25  |- mesh__recordOriginator mesh__D005602 NLM
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D005602 2005
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D005602 2002
% 217.02/217.25  |- skos__altLabel mesh__D005602 Miquelon and Saint Pierre
% 217.02/217.25  |- mesh__recordOriginator mesh__D010547 AEP
% 217.02/217.25  |- skos__scopeNote mesh__D010547
% 217.02/217.25       A syndrome of persistent PULMONARY HYPERTENSION in the newborn infant %28%INFANT, NEWBORN%29% without demonstrable HEART DISEASES. This neonatal condition can be caused by severe pulmonary vasoconstriction %28%reactive type%29%, hypertrophy of pulmonary arterial muscle %28%hypertrophic type%29%, or abnormally developed pulmonary arterioles %28%hypoplastic type%29%. The newborn patient exhibits CYANOSIS and ACIDOSIS due to the persistence of fetal circulatory pattern of right-to-left shunting of blood through a patent ductus arteriosus %28%DUCTUS ARTERIOSUS, PATENT%29% and at times a patent foramen ovale %28%FORAMEN OVALE, PATENT%29%.%A%    
% 217.02/217.25  |- mesh__dateRevised mesh__D010547 2004-07-13
% 217.02/217.25  |- rdf__type mesh__D010547sskos__Concept
% 217.02/217.25  |- skos__broader mesh__D010547smesh__D007232
% 217.02/217.25  |- skos__annotation mesh__D010547
% 217.02/217.25        also known as PPHN; check the tags  HUMANS %26% INFANT, NEWBORN; DF: PFC SYNDROME%A%  
% 217.02/217.25  |- mesh__recordMaintainer mesh__D010547 sjn
% 217.02/217.25  |- mesh__publicMeSHNote mesh__D010547 80   
% 217.02/217.25  |- mesh__dateCreated mesh__D010547 1979-02-28
% 217.02/217.25  |- skos__prefLabel mesh__D010547 Persistent Fetal Circulation Syndrome
% 217.02/217.25  |- mesh__historyNote mesh__D010547 80   
% 217.02/217.25  |- skos__historyNote mesh__D010547 Pulmonary Circulation %28%1966-1979%29%
% 217.02/217.25  |- skos__broader mesh__D010547smesh__D006976
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D010547 2005
% 217.02/217.25  |- skos__historyNote mesh__D010547
% 217.02/217.25       Hypertension, Pulmonary %28%1966-1979%29%
% 217.02/217.25  |- skos__altLabel mesh__D010547 Persistent Fetal Circulation
% 217.02/217.25  |- skos__altLabel mesh__D010547
% 217.02/217.25       Persistent Pulmonary Hypertension of Newborn
% 217.02/217.25  |- skos__altLabel mesh__D010547 Fetal Circulation, Persistent
% 217.02/217.25  |- mesh__activeMeSHYear mesh__D010547 2006
% 217.02/217.25  |- mesh__dateEstablished mesh__D010547 1980-01-01
% 217.02/217.25  |- mesh__recordAuthorizer mesh__D010547 sjn
% 217.02/217.25  |- skos__altLabel mesh__D010547
% 217.02/217.25       Hypertension, Pulmonary, of Newborn, Persistent
% 217.02/217.25  |- skos__historyNote mesh__D010547
% 217.02/217.25       Ductus Arteriosus, Patent %28%1966-1979%29%
% 217.02/217.25  |- skos__altLabel mesh__D010547 Circulation, Persistent Fetal
% 217.02/217.25  |- skos__broader mesh__D010727Q000037smesh__D010727
% 217.02/217.26  |- mesh__preferredCombination mesh__D010727Q000037smesh__D010726
% 217.02/217.26  |- rdf__type mesh__D010727Q000037smesh__CompoundConcept
% 217.02/217.26  |- rdf__type mesh__D015232sskos__Concept
% 217.02/217.26  |- skos__altLabel mesh__D015232 PGE2
% 217.02/217.26  |- skos__scopeNote mesh__D015232
% 217.02/217.26       The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa.%A%    
% 217.02/217.26  |- skos__prefLabel mesh__D015232 Dinoprostone
% 217.02/217.26  |- skos__hiddenLabel mesh__D015232 E2alpha, Prostaglandin
% 217.02/217.26  |- skos__altLabel mesh__D015232 PGE2 alpha
% 217.02/217.26  |- skos__hiddenLabel mesh__D015232 E2 alpha, Prostaglandin
% 217.02/217.26  |- skos__hiddenLabel mesh__D015232 Gel, Prepidil
% 217.02/217.26  |- skos__hiddenLabel mesh__D015232 alpha, Prostaglandin E2
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D015232 2006
% 217.02/217.26  |- skos__historyNote mesh__D015232 Prostaglandins E %28%1975-1988%29%
% 217.02/217.26  |- skos__hiddenLabel mesh__D015232 E2, Prostaglandin
% 217.02/217.26  |- mesh__recordOriginator mesh__D015232 RLS
% 217.02/217.26  |- skos__altLabel mesh__D015232 PGE2alpha
% 217.02/217.26  |- mesh__dateEstablished mesh__D015232 1989-01-01
% 217.02/217.26  |- skos__altLabel mesh__D015232 Prostaglandin E2
% 217.02/217.26  |- mesh__publicMeSHNote mesh__D015232 89   
% 217.02/217.26  |- skos__annotation mesh__D015232
% 217.02/217.26       do not confuse with DINOPROST; /biosyn /physiol permitted%A%  
% 217.02/217.26  |- skos__altLabel mesh__D015232 Prostaglandin E2alpha
% 217.02/217.26  |- mesh__recordMaintainer mesh__D015232 ssb
% 217.02/217.26  |- skos__broader mesh__D015232smesh__D011458
% 217.02/217.26  |- skos__historyNote mesh__D015232 Prostaglandins %28%1966-1974%29%
% 217.02/217.26  |- mesh__dateCreated mesh__D015232 1988-05-12
% 217.02/217.26  |- skos__altLabel mesh__D015232 Prostaglandin E2 alpha
% 217.02/217.26  |- mesh__historyNote mesh__D015232 89   
% 217.02/217.26  |- mesh__dateRevised mesh__D015232 2005-06-30
% 217.02/217.26  |- mesh__recordAuthorizer mesh__D015232 sjn
% 217.02/217.26  |- skos__hiddenLabel mesh__D015232 alpha, PGE2
% 217.02/217.26  |- mesh__recordOriginator mesh__D001212 RLS
% 217.02/217.26  |- rdf__type mesh__D001212sskos__Concept
% 217.02/217.26  |- skos__related mesh__D001212smesh__D037263
% 217.02/217.26  |- mesh__historyNote mesh__D001212 85   
% 217.02/217.26  |- skos__historyNote mesh__D001212 Glycoproteins %28%1966-1984%29%
% 217.02/217.26  |- mesh__dateCreated mesh__D001212 1984-05-30
% 217.02/217.26  |- skos__altLabel mesh__D001212 Desialylated Glycoproteins
% 217.02/217.26  |- mesh__publicMeSHNote mesh__D001212 85   
% 217.02/217.26  |- skos__hiddenLabel mesh__D001212 Glycoproteins, Desialylated
% 217.02/217.26  |- mesh__recordAuthorizer mesh__D001212 ags
% 217.02/217.26  |- skos__prefLabel mesh__D001212 Asialoglycoproteins
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D001212 2006A
% 217.02/217.26  |- mesh__recordMaintainer mesh__D001212 ags
% 217.02/217.26  |- skos__scopeNote mesh__D001212
% 217.02/217.26       Endogenous glycoproteins from which SIALIC ACID has been removed by the action of sialidases. They bind tightly to the ASIALOGLYCOPROTEIN RECEPTOR which is located on hepatocyte plasma membranes. After internalization by adsorptive ENDOCYTOSIS they are delivered to LYSOSOMES for degradation. Therefore receptor-mediated clearance of asialoglycoproteins is an important aspect of the turnover of plasma glycoproteins. They are elevated in serum of patients with HEPATIC CIRRHOSIS or HEPATITIS.%A%    
% 217.02/217.26  |- mesh__dateEstablished mesh__D001212 1985-01-01
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D001212 2006
% 217.02/217.26  |- mesh__dateRevised mesh__D001212 2005-07-13
% 217.02/217.26  |- skos__broader mesh__D001212smesh__D006023
% 217.02/217.26  |- skos__prefLabel mesh__D020177 Hypersomnolence, Idiopathic
% 217.02/217.26  |- skos__hiddenLabel mesh__D020177 Hypersomnolence, Idiopathic CNS
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D020177 2000A
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D020177 2004
% 217.02/217.26  |- skos__broader mesh__D020177smesh__D006970
% 217.02/217.26  |- mesh__dateRevised mesh__D020177 1999-12-16
% 217.02/217.26  |- mesh__dateCreated mesh__D020177 1999-11-08
% 217.02/217.26  |- skos__hiddenLabel mesh__D020177 CNS Hypersomnolence, Idiopathic
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D020177 2003
% 217.02/217.26  |- skos__scopeNote mesh__D020177
% 217.02/217.26       A sleep disorder of central nervous system origin characterized by prolonged nocturnal sleep and periods of daytime drowsiness. Affected individuals experience difficulty with awakening in the morning and may have associated sleep drunkenness, automatic behaviors, and memory disturbances. This condition differs from narcolepsy in that daytime sleep periods are longer, there is no association with CATAPLEXY, and the multiple sleep latency onset test does not record sleep-onset rapid eye movement sleep. %28%From Chokroverty, Sleep Disorders Medicine, 1994, pp319-20; Psychiatry Clin Neurosci 1998 Apr:52%28%2%29%:125-129%29%%A%    
% 217.02/217.26  |- skos__altLabel mesh__D020177 Idiopathic Hypersomnia
% 217.02/217.26  |- skos__hiddenLabel mesh__D020177 CNS Hypersomnolences, Idiopathic
% 217.02/217.26  |- skos__hiddenLabel mesh__D020177 Idiopathic CNS Hypersomnolences
% 217.02/217.26  |- skos__hiddenLabel mesh__D020177 Idiopathic Hypersomnolences
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D020177 2002
% 217.02/217.26  |- skos__hiddenLabel mesh__D020177 Hypersomnolences, Idiopathic CNS
% 217.02/217.26  |- mesh__publicMeSHNote mesh__D020177 2000   
% 217.02/217.26  |- skos__hiddenLabel mesh__D020177 Hypersomnia, Idiopathic
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D020177 2006
% 217.02/217.26  |- skos__altLabel mesh__D020177 Hypersomnolence, CNS, Idiopathic
% 217.02/217.26  |- rdf__type mesh__D020177sskos__Concept
% 217.02/217.26  |- skos__hiddenLabel mesh__D020177 Idiopathic Hypersomnolence
% 217.02/217.26  |- skos__hiddenLabel mesh__D020177 Hypersomnolences, Idiopathic
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D020177 2001
% 217.02/217.26  |- mesh__dateEstablished mesh__D020177 2000-01-01
% 217.02/217.26  |- skos__altLabel mesh__D020177 Idiopathic CNS Hypersomnolence
% 217.02/217.26  |- skos__historyNote mesh__D020177
% 217.02/217.26       Disorders of Excessive Somnolence %28%1975-1999%29%
% 217.02/217.26  |- skos__hiddenLabel mesh__D020177 Idiopathic Hypersomnias
% 217.02/217.26  |- skos__altLabel mesh__D020177
% 217.02/217.26       Idiopathic Central Nervous System Hypersomnolence
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D020177 2005
% 217.02/217.26  |- mesh__recordAuthorizer mesh__D020177 ags
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D020177 2000
% 217.02/217.26  |- mesh__recordOriginator mesh__D020177 KEV
% 217.02/217.26  |- mesh__historyNote mesh__D020177 2000   
% 217.02/217.26  |- skos__hiddenLabel mesh__D020177 Hypersomnias, Idiopathic
% 217.02/217.26  |- mesh__recordMaintainer mesh__D020177 ags
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D014938 1998
% 217.02/217.26  |- mesh__dateEstablished mesh__D014938 1986-01-01
% 217.02/217.26  |- mesh__publicMeSHNote mesh__D014938
% 217.02/217.26       86; was see under DISABILITY EVALUATION 1966-85   
% 217.02/217.26  |- skos__scopeNote mesh__D014938
% 217.02/217.26       Assessment of physiological capacities in relation to job requirements. It is usually done by measuring certain physiological %28%e.g., circulatory and respiratory%29% variables during a gradually increasing workload until specific limitations occur with respect to those variables.%A%    
% 217.02/217.26  |- skos__historyNote mesh__D014938 Disability Evaluation %28%1966-1974%29%
% 217.02/217.26  |- skos__hiddenLabel mesh__D014938 Capacity Evaluation, Work
% 217.02/217.26  |- skos__hiddenLabel mesh__D014938 Work Capacity Evaluations
% 217.02/217.26  |- mesh__dateCreated mesh__D014938 1999-01-01
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D014938 2006
% 217.02/217.26  |- skos__prefLabel mesh__D014938 Work Capacity Evaluation
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D014938 2002
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D014938 2004
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D014938 2005
% 217.02/217.26  |- mesh__recordAuthorizer mesh__D014938 SJN
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D014938 2003
% 217.02/217.26  |- skos__annotation mesh__D014938 no qualif; DF: WORK CAPAC EVALUATION   
% 217.02/217.26  |- skos__altLabel mesh__D014938 Evaluation, Work Capacity
% 217.02/217.26  |- mesh__recordMaintainer mesh__D014938 PXP
% 217.02/217.26  |- skos__hiddenLabel mesh__D014938 Evaluations, Work Capacity
% 217.02/217.26  |- skos__hiddenLabel mesh__D014938 Capacity Evaluations, Work
% 217.02/217.26  |- mesh__onlineNote mesh__D014938 search DISABILITY EVALUATION 1966-74   
% 217.02/217.26  |- rdf__type mesh__D014938sskos__Concept
% 217.02/217.26  |- mesh__dateRevised mesh__D014938 1997-06-20
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D014938 2001
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D014938 1999
% 217.02/217.26  |- skos__broader mesh__D014938smesh__D004185
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D014938 2000
% 217.02/217.26  |- mesh__historyNote mesh__D014938
% 217.02/217.26       86%28%75%29%; was see under DISABILITY EVALUATION 1966-85   
% 217.02/217.26  |- mesh__recordOriginator mesh__D014938 NLM
% 217.02/217.26  |- mesh__dateRevised mesh__D019623 2005-06-30
% 217.02/217.26  |- mesh__dateEstablished mesh__D019623 1998-01-01
% 217.02/217.26  |- mesh__dateCreated mesh__D019623 1997-06-20
% 217.02/217.26  |- skos__annotation mesh__D019623
% 217.02/217.26       a species of Haloferax of the family Halobacteriaceae   
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D019623 2006
% 217.02/217.26  |- mesh__historyNote mesh__D019623 98   
% 217.02/217.26  |- mesh__recordOriginator mesh__D019623 AGS
% 217.02/217.26  |- skos__prefLabel mesh__D019623 Haloferax mediterranei
% 217.02/217.26  |- skos__scopeNote mesh__D019623
% 217.02/217.26       A species of halophilic archaea found in the Mediterranean Sea. It produces bacteriocins active against a range of other halobacteria.%A%    
% 217.02/217.26  |- rdf__type mesh__D019623sskos__Concept
% 217.02/217.26  |- mesh__recordMaintainer mesh__D019623 SYSTEM
% 217.02/217.26  |- mesh__recordAuthorizer mesh__D019623 sjn
% 217.02/217.26  |- skos__broader mesh__D019623smesh__D019621
% 217.02/217.26  |- mesh__publicMeSHNote mesh__D019623 98   
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D000918 2005
% 217.02/217.26  |- skos__historyNote mesh__D000918 Antibodies %28%1966-1969%29%
% 217.02/217.26  |- mesh__dateEstablished mesh__D000918 1972-01-01
% 217.02/217.26  |- mesh__dateRevised mesh__D000918 2002-07-02
% 217.02/217.26  |- skos__related mesh__D000918smesh__D018033
% 217.02/217.26  |- skos__broader mesh__D000918smesh__D007109
% 217.02/217.26  |- skos__related mesh__D000918smesh__D037182
% 217.02/217.26  |- skos__hiddenLabel mesh__D000918 Antibody Specificities
% 217.02/217.26  |- mesh__dateCreated mesh__D000918 1999-01-01
% 217.02/217.26  |- mesh__historyNote mesh__D000918 72%28%70%29%   
% 217.02/217.26  |- mesh__recordOriginator mesh__D000918 NLM
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D000918 2004
% 217.02/217.26  |- skos__annotation mesh__D000918
% 217.02/217.26       coord IM with specific antibody %28%IM%29%   
% 217.02/217.26  |- skos__hiddenLabel mesh__D000918 Specificities, Antibody
% 217.02/217.26  |- skos__prefLabel mesh__D000918 Antibody Specificity
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D000918 2003
% 217.02/217.26  |- skos__hiddenLabel mesh__D000918 Specificity, Antibody
% 217.02/217.26  |- mesh__publicMeSHNote mesh__D000918 72   
% 217.02/217.26  |- skos__scopeNote mesh__D000918
% 217.02/217.26       The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site.%A%    
% 217.02/217.26  |- rdf__type mesh__D000918sskos__Concept
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D000918 2006
% 217.02/217.26  |- mesh__recordMaintainer mesh__D000918 ags
% 217.02/217.26  |- mesh__recordAuthorizer mesh__D000918 sjn
% 217.02/217.26  |- skos__hiddenLabel mesh__D011640 Policy, Public
% 217.02/217.26  |- skos__scopeNote mesh__D011640
% 217.02/217.26       A course or method of action selected, usually by a government, from among alternatives to guide and determine present and future decisions.%A%    
% 217.02/217.26  |- skos__hiddenLabel mesh__D011640 Protection, Social
% 217.02/217.26  |- skos__hiddenLabel mesh__D011640 Social Policies
% 217.02/217.26  |- mesh__dateEstablished mesh__D011640 1978-01-01
% 217.02/217.26  |- skos__related mesh__D011640smesh__D012926
% 217.02/217.26  |- skos__prefLabel mesh__D011640 Public Policy
% 217.02/217.26  |- skos__hiddenLabel mesh__D011640 Policy, Migration
% 217.02/217.26  |- skos__hiddenLabel mesh__D011640 Policies, Migration
% 217.02/217.26  |- skos__hiddenLabel mesh__D011640 Development Policies
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D011640 2003
% 217.02/217.26  |- mesh__recordAuthorizer mesh__D011640 sjn
% 217.02/217.26  |- skos__hiddenLabel mesh__D011640 Population Policies
% 217.02/217.26  |- skos__hiddenLabel mesh__D011640 Policy, Development
% 217.02/217.26  |- mesh__dateRevised mesh__D011640 2001-07-25
% 217.02/217.26  |- skos__hiddenLabel mesh__D011640 Policy, Social
% 217.02/217.26  |- mesh__recordMaintainer mesh__D011640 jrf
% 217.02/217.26  |- mesh__publicMeSHNote mesh__D011640 78   
% 217.02/217.26  |- mesh__historyNote mesh__D011640 78   
% 217.02/217.26  |- skos__hiddenLabel mesh__D011640 Policy, Population
% 217.02/217.26  |- skos__hiddenLabel mesh__D011640 Policies, Public
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D011640 2004
% 217.02/217.26  |- skos__hiddenLabel mesh__D011640 Migration Policies
% 217.02/217.26  |- skos__hiddenLabel mesh__D011640 Policies, Development
% 217.02/217.26  |- skos__broader mesh__D011640smesh__D011049
% 217.02/217.26  |- rdf__type mesh__D011640sskos__Concept
% 217.02/217.26  |- skos__hiddenLabel mesh__D011640 Public Policies
% 217.02/217.26  |- skos__hiddenLabel mesh__D011640 Policies, Social
% 217.02/217.26  |- skos__hiddenLabel mesh__D011640 Policies, Population
% 217.02/217.26  |- mesh__dateCreated mesh__D011640 1977-04-22
% 217.02/217.26  |- skos__hiddenLabel mesh__D011640 Policies
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D011640 2005
% 217.02/217.26  |- skos__annotation mesh__D011640
% 217.02/217.26       no qualif; specify state or country or other body if pertinent%A%  
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D011640 2002
% 217.02/217.26  |- mesh__recordOriginator mesh__D011640 EC
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D011640 2006
% 217.02/217.26  |- mesh__recordOriginator mesh__D005603 JW
% 217.02/217.26  |- mesh__historyNote mesh__D005603 76   
% 217.02/217.26  |- skos__prefLabel mesh__D005603 Francisella
% 217.02/217.26  |- mesh__dateRevised mesh__D005603 2005-06-30
% 217.02/217.26  |- skos__broader mesh__D005603smesh__D020563
% 217.02/217.26  |- rdf__type mesh__D005603sskos__Concept
% 217.02/217.26  |- skos__scopeNote mesh__D005603
% 217.02/217.26       The lone genus of bacteria in the family Francisellaceae,  frequently found in natural waters. It can be parasitic in humans, other MAMMALS; BIRDS; and ARTHROPODS.%A%    
% 217.02/217.26  |- mesh__publicMeSHNote mesh__D005603 76   
% 217.02/217.26  |- skos__historyNote mesh__D005603 Pasteurella %28%1966-1975%29%
% 217.02/217.26  |- mesh__recordAuthorizer mesh__D005603 sjn
% 217.02/217.26  |- mesh__dateEstablished mesh__D005603 1976-01-01
% 217.02/217.26  |- mesh__dateCreated mesh__D005603 1975-07-25
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D005603 2006
% 217.02/217.26  |- mesh__recordMaintainer mesh__D005603 SYSTEM
% 217.02/217.26  |- skos__annotation mesh__D005603
% 217.02/217.26       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 217.02/217.26  |- skos__broader mesh__D005603smesh__D016946
% 217.02/217.26  |- skos__hiddenLabel mesh__D043722 Phenomena, Ocular Physiologic
% 217.02/217.26  |- skos__hiddenLabel mesh__D043722 Physiological Phenomenons, Ocular
% 217.02/217.26  |- skos__hiddenLabel mesh__D043722 Phenomena, Ocular Physiological
% 217.02/217.26  |- skos__hiddenLabel mesh__D043722 Phenomenon, Ocular Physiologic
% 217.02/217.26  |- skos__hiddenLabel mesh__D043722 Phenomenas, Ocular Physiologic
% 217.02/217.26  |- skos__hiddenLabel mesh__D043722 Physiologic Phenomena, Ocular
% 217.02/217.26  |- skos__scopeNote mesh__D043722
% 217.02/217.26       Observable or measurable characteristics of the ocular system.%A%    
% 217.02/217.26  |- skos__hiddenLabel mesh__D043722 Ocular Physiological Phenomenons
% 217.02/217.26  |- skos__altLabel mesh__D043722 Ocular Physiological Phenomena
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D043722 2004
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D043722 2005
% 217.02/217.26  |- skos__altLabel mesh__D043722 Ocular Physiological Phenomenon
% 217.02/217.26  |- mesh__historyNote mesh__D043722 2004   
% 217.02/217.26  |- skos__broader mesh__D043722smesh__D009799
% 217.02/217.26  |- skos__hiddenLabel mesh__D043722 Physiologic Phenomenon, Ocular
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D043722 2006
% 217.02/217.26  |- skos__prefLabel mesh__D043722 Ocular Physiologic Phenomena
% 217.02/217.26  |- skos__hiddenLabel mesh__D043722 Physiological Phenomenon, Ocular
% 217.02/217.26  |- skos__hiddenLabel mesh__D043722 Physiological Phenomena, Ocular
% 217.02/217.26  |- skos__annotation mesh__D043722 not used for indexing or cataloging   
% 217.02/217.26  |- rdf__type mesh__D043722sskos__Concept
% 217.02/217.26  |- mesh__dateEstablished mesh__D043722 2004-01-01
% 217.02/217.26  |- mesh__dateCreated mesh__D043722 2003-07-09
% 217.02/217.26  |- skos__hiddenLabel mesh__D043722 Phenomenons, Ocular Physiological
% 217.02/217.26  |- skos__hiddenLabel mesh__D043722 Phenomenon, Ocular Physiological
% 217.02/217.26  |- skos__altLabel mesh__D043722 Ocular Physiologic Phenomenon
% 217.02/217.26  |- mesh__publicMeSHNote mesh__D043722 2004   
% 217.02/217.26  |- mesh__historyNote mesh__D010548 68   
% 217.02/217.26  |- mesh__recordOriginator mesh__D010548 NLM
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D010548 2002
% 217.02/217.26  |- skos__historyNote mesh__D010548
% 217.02/217.26       Community Health Services %28%1966-1967%29%
% 217.02/217.26  |- skos__scopeNote mesh__D010548 Health care provided to individuals.     
% 217.02/217.26  |- mesh__publicMeSHNote mesh__D010548 68   
% 217.02/217.26  |- mesh__dateRevised mesh__D010548 1999-11-03
% 217.02/217.26  |- skos__hiddenLabel mesh__D010548 Health Service, Personal
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D010548 2005
% 217.02/217.26  |- mesh__recordMaintainer mesh__D010548 kle
% 217.02/217.26  |- skos__altLabel mesh__D010548 Services, Personal Health
% 217.02/217.26  |- skos__annotation mesh__D010548 IM; DF: PERSONAL HEALTH SERV   
% 217.02/217.26  |- skos__prefLabel mesh__D010548 Personal Health Services
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D010548 2003
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D010548 2006
% 217.02/217.26  |- mesh__dateCreated mesh__D010548 1999-01-01
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D010548 2000
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D010548 2004
% 217.02/217.26  |- skos__altLabel mesh__D010548 Health Services, Personal
% 217.02/217.26  |- skos__hiddenLabel mesh__D010548 Service, Personal Health
% 217.02/217.26  |- skos__historyNote mesh__D010548 specific service %28%1966-1967%29%
% 217.02/217.26  |- skos__hiddenLabel mesh__D010548 Personal Health Service
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D010548 2001
% 217.02/217.26  |- rdf__type mesh__D010548sskos__Concept
% 217.02/217.26  |- skos__broader mesh__D010548smesh__D006296
% 217.02/217.26  |- mesh__recordAuthorizer mesh__D010548 sjn
% 217.02/217.26  |- mesh__dateEstablished mesh__D010548 1968-01-01
% 217.02/217.26  |- mesh__recordAuthorizer mesh__D015233 PLS
% 217.02/217.26  |- mesh__historyNote mesh__D015233 89   
% 217.02/217.26  |- skos__hiddenLabel mesh__D015233 Probabilistic Model
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D015233 1996
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D015233 2003
% 217.02/217.26  |- skos__prefLabel mesh__D015233 Models, Statistical
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D015233 1999
% 217.02/217.26  |- skos__historyNote mesh__D015233 Models, Biological %28%1966-1988%29%
% 217.02/217.26  |- mesh__dateEstablished mesh__D015233 1989-01-01
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D015233 2006
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D015233 2001
% 217.02/217.26  |- mesh__publicMeSHNote mesh__D015233 89   
% 217.02/217.26  |- skos__altLabel mesh__D015233 Statistical Models
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D015233 1995
% 217.02/217.26  |- skos__historyNote mesh__D015233 Models, Theoretical %28%1966-1988%29%
% 217.02/217.26  |- skos__hiddenLabel mesh__D015233 Model, Two-Parameter
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D015233 1998
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D015233 2005
% 217.02/217.26  |- skos__hiddenLabel mesh__D015233 Binomial Model
% 217.02/217.26  |- skos__hiddenLabel mesh__D015233 Models, Probabilistic
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D015233 2000
% 217.02/217.26  |- skos__scopeNote mesh__D015233
% 217.02/217.26       Statistical formulations or analyses which, when applied to data and found to fit the data, are then used to verify the assumptions and parameters used in the analysis. Examples of statistical models are the linear model, binomial model, polynomial model, two-parameter model, etc.%A%    
% 217.02/217.26  |- skos__broader mesh__D015233smesh__D013223
% 217.02/217.26  |- skos__historyNote mesh__D015233 Statistics %28%1966-1988%29%
% 217.02/217.26  |- skos__hiddenLabel mesh__D015233 Model, Probabilistic
% 217.02/217.26  |- rdf__type mesh__D015233sskos__Concept
% 217.02/217.26  |- skos__hiddenLabel mesh__D015233 Binomial Models
% 217.02/217.26  |- skos__broader mesh__D015233smesh__D008962
% 217.02/217.26  |- mesh__recordMaintainer mesh__D015233 PLS
% 217.02/217.26  |- skos__hiddenLabel mesh__D015233 Model, Polynomial
% 217.02/217.26  |- skos__hiddenLabel mesh__D015233 Model, Binomial
% 217.02/217.26  |- skos__altLabel mesh__D015233 Probabilistic Models
% 217.02/217.26  |- skos__altLabel mesh__D015233 Model, Statistical
% 217.02/217.26  |- skos__altLabel mesh__D015233 Statistical Model
% 217.02/217.26  |- skos__related mesh__D015233smesh__D015201
% 217.02/217.26  |- mesh__dateCreated mesh__D015233 1988-05-13
% 217.02/217.26  |- skos__hiddenLabel mesh__D015233 Two Parameter Models
% 217.02/217.26  |- mesh__dateRevised mesh__D015233 1994-06-16
% 217.02/217.26  |- skos__annotation mesh__D015233
% 217.02/217.26       IM; no qualif; TN 128: definition %26% relation to MODELS, THEORETICAL%A%  
% 217.02/217.26  |- skos__hiddenLabel mesh__D015233 Polynomial Model
% 217.02/217.26  |- mesh__recordOriginator mesh__D015233 EJB
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D015233 1997
% 217.02/217.26  |- skos__hiddenLabel mesh__D015233 Models, Two-Parameter
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D015233 2004
% 217.02/217.26  |- skos__hiddenLabel mesh__D015233 Two-Parameter Model
% 217.02/217.26  |- skos__hiddenLabel mesh__D015233 Polynomial Models
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D015233 2002
% 217.02/217.26  |- skos__historyNote mesh__D001213
% 217.02/217.26       specific Asia heading %28%1966-1974%29% /ethnology %28%1975-1980%29%
% 217.02/217.26  |- mesh__recordMaintainer mesh__D001213 jls
% 217.02/217.26  |- skos__hiddenLabel mesh__D001213 American, Chinese
% 217.02/217.26  |- mesh__dateEstablished mesh__D001213 1981-01-01
% 217.02/217.26  |- mesh__dateRevised mesh__D001213 2004-07-07
% 217.02/217.26  |- mesh__publicMeSHNote mesh__D001213 81   
% 217.02/217.26  |- skos__hiddenLabel mesh__D001213 Americans, Korean
% 217.02/217.26  |- skos__hiddenLabel mesh__D001213 American, Asian
% 217.02/217.26  |- mesh__recordOriginator mesh__D001213 SMH
% 217.02/217.26  |- mesh__historyNote mesh__D001213 81   
% 217.02/217.26  |- skos__prefLabel mesh__D001213 Asian Americans
% 217.02/217.26  |- skos__hiddenLabel mesh__D001213 American, Korean
% 217.02/217.26  |- skos__annotation mesh__D001213
% 217.02/217.26       Asian includes Far East, Southeast Asia, %26% the Indian subcontinent; despite X refs specify NIM CHINA /ethnol, JAPAN /ethnol, KOREA/ethnol, or other Asiatic country with /ethnol when pertinent%A%  
% 217.02/217.26  |- skos__broader mesh__D001213smesh__D005006
% 217.02/217.26  |- skos__hiddenLabel mesh__D001213 Americans, Japanese
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D001213 2005
% 217.02/217.26  |- skos__historyNote mesh__D001213 specific state %28%1966-1980%29%
% 217.02/217.26  |- skos__hiddenLabel mesh__D001213 Chinese American
% 217.02/217.26  |- skos__hiddenLabel mesh__D001213 Japanese American
% 217.02/217.26  |- skos__hiddenLabel mesh__D001213 American, Japanese
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D001213 2006
% 217.02/217.26  |- skos__hiddenLabel mesh__D001213 Korean American
% 217.02/217.26  |- skos__hiddenLabel mesh__D001213 Americans, Asian
% 217.02/217.26  |- skos__hiddenLabel mesh__D001213 Americans, Chinese
% 217.02/217.26  |- mesh__recordAuthorizer mesh__D001213 sjn
% 217.02/217.26  |- mesh__dateCreated mesh__D001213 1980-05-12
% 217.02/217.26  |- skos__historyNote mesh__D001213 United States %28%1966-1980%29%
% 217.02/217.26  |- skos__scopeNote mesh__D001213
% 217.02/217.26       Persons living in the United States having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent.%A%    
% 217.02/217.26  |- rdf__type mesh__D001213sskos__Concept
% 217.02/217.26  |- skos__historyNote mesh__D001213 Ethnic Groups %28%1968-1974%29%
% 217.02/217.26  |- skos__broader mesh__D001213smesh__D044466
% 217.02/217.26  |- skos__hiddenLabel mesh__D001213 Asian American
% 217.02/217.26  |- mesh__dateRevised mesh__D039681 2005-06-30
% 217.02/217.26  |- mesh__recordAuthorizer mesh__D039681 sjn
% 217.02/217.26  |- skos__scopeNote mesh__D039681
% 217.02/217.26       A type of COUMARINS with added pyran ring%28%s%29%.     
% 217.02/217.26  |- mesh__recordOriginator mesh__D039681 ssb
% 217.02/217.26  |- rdf__type mesh__D039681sskos__Concept
% 217.02/217.26  |- mesh__recordMaintainer mesh__D039681 ssb
% 217.02/217.26  |- mesh__dateCreated mesh__D039681 2002-07-03
% 217.02/217.26  |- skos__broader mesh__D039681smesh__D003374
% 217.02/217.26  |- skos__broader mesh__D039681smesh__D011714
% 217.02/217.26  |- mesh__dateEstablished mesh__D039681 2003-01-01
% 217.02/217.26  |- mesh__publicMeSHNote mesh__D039681 2003   
% 217.02/217.26  |- mesh__historyNote mesh__D039681 2003   
% 217.02/217.26  |- skos__prefLabel mesh__D039681 Pyranocoumarins
% 217.02/217.26  |- skos__historyNote mesh__D039681 Coumarins %28%1977-2002%29%
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D039681 2006
% 217.02/217.26  |- skos__hiddenLabel mesh__D020178 Sleep Disorder, Shift Work
% 217.02/217.26  |- skos__related mesh__D020178smesh__D001683
% 217.02/217.26  |- skos__altLabel mesh__D020178 Disturbed Nyctohemeral Rhythm
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D020178 2004
% 217.02/217.26  |- skos__hiddenLabel mesh__D020178 Sleep Wake Cycle Disorders
% 217.02/217.26  |- mesh__dateCreated mesh__D020178 1999-11-08
% 217.02/217.26  |- skos__hiddenLabel mesh__D020178 Sleep Disorders, Shift-Work
% 217.02/217.26  |- skos__hiddenLabel mesh__D020178 Nyctohemeral Rhythm, Disturbed
% 217.02/217.26  |- skos__altLabel mesh__D020178 Sleep-Wake Schedule Disorders
% 217.02/217.26  |- skos__hiddenLabel mesh__D020178 Nyctohemeral Rhythms, Disturbed
% 217.02/217.26  |- skos__hiddenLabel mesh__D020178 Shift Work Sleep Disorder
% 217.02/217.26  |- skos__hiddenLabel mesh__D020178 Sleep Wake Disorder, Non 24 Hour
% 217.02/217.26  |- skos__hiddenLabel mesh__D020178 Sleep-Wake Cycle Disorder
% 217.02/217.26  |- mesh__dateEstablished mesh__D020178 2000-01-01
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D020178 2005
% 217.02/217.26  |- skos__altLabel mesh__D020178 Circadian Rhythm Sleep Disorders
% 217.02/217.26  |- mesh__recordAuthorizer mesh__D020178 sjn
% 217.02/217.26  |- skos__altLabel mesh__D020178 Sleep-Wake Disorder, Non-24 Hour
% 217.02/217.26  |- skos__altLabel mesh__D020178 Sleep-Wake Cycle Disorders
% 217.02/217.26  |- skos__hiddenLabel mesh__D020178 Disturbed Nyctohemeral Rhythms
% 217.02/217.26  |- skos__hiddenLabel mesh__D020178 Cycle Disorders, Sleep-Wake
% 217.02/217.26  |- skos__hiddenLabel mesh__D020178 Cycle Disorder, Sleep-Wake
% 217.02/217.26  |- skos__hiddenLabel mesh__D020178 Sleep-Wake Schedule Disorder
% 217.02/217.26  |- skos__altLabel mesh__D020178 Sleep Disorder, Shift-Work
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D020178 2006
% 217.02/217.26  |- mesh__recordMaintainer mesh__D020178 sjn
% 217.02/217.26  |- mesh__recordOriginator mesh__D020178 KEV
% 217.02/217.26  |- skos__broader mesh__D020178smesh__D009784
% 217.02/217.26  |- mesh__dateRevised mesh__D020178 2003-07-22
% 217.02/217.26  |- skos__hiddenLabel mesh__D020178 Shift-Work Sleep Disorders
% 217.02/217.26  |- rdf__type mesh__D020178sskos__Concept
% 217.02/217.26  |- skos__scopeNote mesh__D020178
% 217.02/217.26       Dyssomnias associated with disruption of the normal 24 hour sleep wake cycle secondary to travel %28%e.g., JET LAG SYNDROME%29%, shift work, or other causes.%A%    
% 217.02/217.26  |- mesh__publicMeSHNote mesh__D020178 2000   
% 217.02/217.26  |- skos__prefLabel mesh__D020178 Sleep Disorders, Circadian Rhythm
% 217.02/217.26  |- skos__broader mesh__D020178smesh__D021081
% 217.02/217.26  |- skos__related mesh__D020178smesh__D014940
% 217.02/217.26  |- skos__broader mesh__D020178smesh__D020920
% 217.02/217.26  |- skos__hiddenLabel mesh__D020178 Non 24 Hour Sleep Wake Disorder
% 217.02/217.26  |- skos__hiddenLabel mesh__D020178 Sleep Wake Schedule Disorders
% 217.02/217.26  |- mesh__historyNote mesh__D020178 2000   
% 217.02/217.26  |- mesh__publicMeSHNote mesh__D014939 72   
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D014939 2005
% 217.02/217.26  |- mesh__dateEstablished mesh__D014939 1972-01-01
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D014939 2006
% 217.02/217.26  |- mesh__historyNote mesh__D014939 72%28%71%29%   
% 217.02/217.26  |- mesh__recordOriginator mesh__D014939 NLM
% 217.02/217.26  |- mesh__activeMeSHYear mesh__D014939 2004
% 217.02/217.26  |- mesh__dateRevised mesh__D014939 2003-07-09
% 217.02/217.26  |- skos__hiddenLabel mesh__D014939 Breathing Work
% 217.02/217.26  |- mesh__recordAuthorizer mesh__D014939 sjn
% 217.02/217.26  |- skos__broader mesh__D014939smesh__D044702
% 217.02/217.26  |- skos__broader mesh__D014939smesh__D012129
% 217.02/217.26  |- skos__hiddenLabel mesh__D014939 Breathing Works
% 217.02/217.26  |- skos__historyNote mesh__D014939 Respiration %28%1966-1970%29%
% 217.02/217.27  |- rdf__type mesh__D014939sskos__Concept
% 217.02/217.27  |- mesh__recordMaintainer mesh__D014939 nns
% 217.02/217.27  |- mesh__dateCreated mesh__D014939 1999-01-01
% 217.02/217.27  |- skos__scopeNote mesh__D014939
% 217.02/217.27       RESPIRATORY MUSCLE contraction during INHALATION. The work is accomplished in three phases: LUNG COMPLIANCE work, that required to expand the LUNGS against its elastic forces; tissue resistance work, that required to overcome the viscosity of the lung and chest wall structures; and  AIRWAY RESISTANCE work, that required to overcome airway resistance during the movement of air into the lungs. Work of breathing does not refer to expiration, which is entirely a passive process caused by elastic recoil of the lung and chest cage. %28%Guyton, Textbook of Medical Physiology, 8th ed, p406%29%%A%    
% 217.02/217.27  |- skos__prefLabel mesh__D014939 Work of Breathing
% 217.02/217.27  |- skos__prefLabel mesh__D019624 Thermoproteaceae
% 217.02/217.27  |- mesh__activeMeSHYear mesh__D019624 2006
% 217.02/217.27  |- mesh__dateRevised mesh__D019624 2005-06-30
% 217.02/217.27  |- mesh__recordOriginator mesh__D019624 NDW
% 217.02/217.27  |- mesh__dateCreated mesh__D019624 1997-06-20
% 217.02/217.27  |- mesh__dateEstablished mesh__D019624 1998-01-01
% 217.02/217.27  |- mesh__historyNote mesh__D019624 1998   
% 217.02/217.27  |- rdf__type mesh__D019624sskos__Concept
% 217.02/217.27  |- mesh__recordMaintainer mesh__D019624 SYSTEM
% 217.02/217.27  |- mesh__publicMeSHNote mesh__D019624 1998   
% 217.02/217.27  |- skos__broader mesh__D019624smesh__D019619
% 217.02/217.27  |- skos__scopeNote mesh__D019624
% 217.02/217.27       A family of THERMOPROTEALES consisting of variable length rigid rods without septa. They grow either chemolithoautotrophically or by sulfur respiration. The four genera are: PYROBACULUM, THERMOPROTEUS, Caldivirga, and Thermocladium. %28%From Bergey%27%s Manual of Systematic Bacteriology, 2d ed%29%%A%    
% 217.02/217.27  |- mesh__recordAuthorizer mesh__D019624 sjn
% 217.02/217.27  |- mesh__dateCreated mesh__D000919 1979-03-07
% 217.02/217.27  |- mesh__recordMaintainer mesh__D000919 PXP
% 217.02/217.27  |- mesh__activeMeSHYear mesh__D000919 1998
% 217.02/217.27  |- mesh__dateEstablished mesh__D000919 1991-01-01
% 217.02/217.27  |- mesh__historyNote mesh__D000919
% 217.02/217.27       91%28%80%29%; was see under FLUORESCENT ANTIBODY TECHNIQUE 1980-90%A%  
% 217.02/217.27  |- mesh__activeMeSHYear mesh__D000919 2002
% 217.02/217.27  |- mesh__dateRevised mesh__D000919 1997-06-20
% 217.02/217.27  |- skos__hiddenLabel mesh__D000919 Urinary Antibody Coated Bacteria Test
% 217.02/217.27  |- skos__broader mesh__D000919smesh__D005455
% 217.02/217.27  |- skos__historyNote mesh__D000919 Bacteriuria %28%1974-1979%29%
% 217.02/217.27  |- mesh__activeMeSHYear mesh__D000919 2004
% 217.02/217.27  |- skos__scopeNote mesh__D000919
% 217.02/217.27       Fluorescent antibody technique for visualizing antibody-bacteria complexes in urine. The presence or absence of antibody-coated bacteria in urine correlates with localization of urinary tract infection in the kidney or bladder, respectively.%A%    
% 217.02/217.27  |- skos__historyNote mesh__D000919
% 217.02/217.27       Urinary Tract Infections %28%1974-1979%29%
% 217.02/217.27  |- mesh__publicMeSHNote mesh__D000919
% 217.02/217.27       91; was see under FLUORESCENT ANTIBODY TECHNIQUE 1980-90   
% 217.02/217.27  |- skos__historyNote mesh__D000919 Pyelonephritis %28%1974-1979%29%
% 217.02/217.27  |- mesh__activeMeSHYear mesh__D000919 2003
% 217.02/217.27  |- mesh__activeMeSHYear mesh__D000919 2001
% 217.02/217.27  |- rdf__type mesh__D000919sskos__Concept
% 217.02/217.27  |- skos__altLabel mesh__D000919 Urinary Antibody-Coated Bacteria Test
% 217.02/217.27  |- mesh__activeMeSHYear mesh__D000919 2006
% 217.02/217.27  |- skos__annotation mesh__D000919 DF: ACBU   
% 217.02/217.27  |- skos__altLabel mesh__D000919 Antibody Coated Bacteria Test, Urinary
% 217.02/217.27  |- mesh__recordAuthorizer mesh__D000919 SJN
% 217.02/217.27  |- skos__broader mesh__D000919smesh__D003950
% 217.02/217.27  |- skos__prefLabel mesh__D000919 Antibody-Coated Bacteria Test, Urinary
% 217.02/217.27  |- mesh__activeMeSHYear mesh__D000919 2000
% 217.02/217.27  |- mesh__recordOriginator mesh__D000919 SMH
% 217.02/217.27  |- mesh__activeMeSHYear mesh__D000919 2005
% 217.02/217.27  |- mesh__activeMeSHYear mesh__D000919 1999
% 217.02/217.27  |- skos__historyNote mesh__D000919 Antibodies, Bacterial %28%1974-1979%29%
% 217.02/217.27  |- mesh__activeMeSHYear mesh__D011641 1998
% 217.02/217.27  |- mesh__activeMeSHYear mesh__D011641 2004
% 217.02/217.27  |- mesh__activeMeSHYear mesh__D011641 1999
% 217.02/217.27  |- rdf__type mesh__D011641sskos__Concept
% 217.02/217.27  |- mesh__activeMeSHYear mesh__D011641 2002
% 217.02/217.27  |- skos__altLabel mesh__D011641 Relations, Client-Staff
% 217.02/217.27  |- mesh__recordAuthorizer mesh__D011641 SJN
% 217.02/217.27  |- mesh__dateRevised mesh__D011641 1997-06-20
% 217.02/217.27  |- mesh__activeMeSHYear mesh__D011641 2005
% 217.02/217.27  |- mesh__recordMaintainer mesh__D011641 JLS
% 217.02/217.27  |- mesh__recordOriginator mesh__D011641 NLM
% 217.02/217.27  |- mesh__activeMeSHYear mesh__D011641 2006
% 217.02/217.27  |- skos__scopeNote mesh__D011641
% 217.02/217.27       Relations of an individual, association, organization, hospital, or corporation with the publics which it must take into consideration in carrying out its functions. Publics may include consumers, patients, pressure groups, departments, etc.%A%    
% 217.02/217.27  |- skos__hiddenLabel mesh__D011641 Relation, Client-Staff
% 217.02/217.27  |- skos__hiddenLabel mesh__D011641 Client-Staff Relation
% 217.02/217.27  |- skos__hiddenLabel mesh__D011641 Client Staff Relations
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D011641 2000
% 217.12/217.27  |- skos__hiddenLabel mesh__D011641 Relations, Client Staff
% 217.12/217.27  |- mesh__publicMeSHNote mesh__D011641
% 217.12/217.27       NEWS MEDIA RELATIONS was see PUBLIC RELATIONS 1978-93   
% 217.12/217.27  |- mesh__onlineNote mesh__D011641
% 217.12/217.27       use PUBLIC RELATIONS to search NEWS MEDIA RELATIONS 1978-93%A%  
% 217.12/217.27  |- skos__altLabel mesh__D011641 Relations, Public
% 217.12/217.27  |- mesh__dateCreated mesh__D011641 1999-01-01
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D011641 2003
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D011641 2001
% 217.12/217.27  |- skos__prefLabel mesh__D011641 Public Relations
% 217.12/217.27  |- mesh__historyNote mesh__D011641
% 217.12/217.27       NEWS MEDIA RELATIONS was see PUBLIC RELATIONS 1978-93   
% 217.12/217.27  |- skos__broader mesh__D011641smesh__D009934
% 217.12/217.27  |- skos__annotation mesh__D011641 DF: PUBLIC RELAT   
% 217.12/217.27  |- rdf__type mesh__D005604sskos__Concept
% 217.12/217.27  |- skos__altLabel mesh__D005604 Pasteurella tularensis
% 217.12/217.27  |- skos__broader mesh__D005604smesh__D005603
% 217.12/217.27  |- mesh__recordOriginator mesh__D005604 JW
% 217.12/217.27  |- skos__scopeNote mesh__D005604
% 217.12/217.27       The etiologic agent of TULAREMIA in man and other warm-blooded animals.%A%    
% 217.12/217.27  |- mesh__dateRevised mesh__D005604 2005-06-30
% 217.12/217.27  |- mesh__dateCreated mesh__D005604 1975-07-25
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D005604 2006
% 217.12/217.27  |- skos__annotation mesh__D005604 infection = TULAREMIA   
% 217.12/217.27  |- mesh__recordMaintainer mesh__D005604 SYSTEM
% 217.12/217.27  |- skos__prefLabel mesh__D005604 Francisella tularensis
% 217.12/217.27  |- mesh__recordAuthorizer mesh__D005604 sjn
% 217.12/217.27  |- mesh__publicMeSHNote mesh__D005604
% 217.12/217.27       76; was PASTEURELLA TULARENSIS 1963-75   
% 217.12/217.27  |- mesh__dateEstablished mesh__D005604 1976-01-01
% 217.12/217.27  |- mesh__onlineNote mesh__D005604
% 217.12/217.27       use FRANCISELLA TULARENSIS to search PASTEURELLA TULARENSIS 1966-75%A%  
% 217.12/217.27  |- mesh__historyNote mesh__D005604
% 217.12/217.27       76; was PASTEURELLA TULARENSIS 1963-75   
% 217.12/217.27  |- skos__scopeNote mesh__D043723
% 217.12/217.27       Biological action and events that support the functions of the EYE and VISION.%A%    
% 217.12/217.27  |- skos__annotation mesh__D043723 not used for indexing or cataloging   
% 217.12/217.27  |- skos__hiddenLabel mesh__D043723 Process, Ocular Physiologic
% 217.12/217.27  |- mesh__dateEstablished mesh__D043723 2004-01-01
% 217.12/217.27  |- skos__hiddenLabel mesh__D043723 Physiologic Process, Ocular
% 217.12/217.27  |- skos__altLabel mesh__D043723 Ocular Physiological Process
% 217.12/217.27  |- skos__hiddenLabel mesh__D043723 Processes, Ocular Physiological
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D043723 2004
% 217.12/217.27  |- skos__hiddenLabel mesh__D043723 Physiological Process, Ocular
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D043723 2005
% 217.12/217.27  |- skos__broader mesh__D043723smesh__D009799
% 217.12/217.27  |- skos__hiddenLabel mesh__D043723 Processes, Ocular Physiologic
% 217.12/217.27  |- skos__hiddenLabel mesh__D043723 Physiologic Processes, Ocular
% 217.12/217.27  |- skos__hiddenLabel mesh__D043723 Physiological Processes, Ocular
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D043723 2006
% 217.12/217.27  |- skos__hiddenLabel mesh__D043723 Process, Ocular Physiological
% 217.12/217.27  |- skos__altLabel mesh__D043723 Ocular Physiologic Process
% 217.12/217.27  |- rdf__type mesh__D043723sskos__Concept
% 217.12/217.27  |- skos__altLabel mesh__D043723 Ocular Physiological Processes
% 217.12/217.27  |- mesh__dateCreated mesh__D043723 2003-07-09
% 217.12/217.27  |- mesh__publicMeSHNote mesh__D043723 2004   
% 217.12/217.27  |- mesh__historyNote mesh__D043723 2004   
% 217.12/217.27  |- skos__prefLabel mesh__D043723 Ocular Physiologic Processes
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D010549 2005
% 217.12/217.27  |- mesh__publicMeSHNote mesh__D010549 72   
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D010549 2003
% 217.12/217.27  |- skos__scopeNote mesh__D010549
% 217.12/217.27       The individual%27%s experience of a sense of fulfillment of a need or want and the quality or state of being satisfied.%A%    
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D010549 2006
% 217.12/217.27  |- mesh__dateCreated mesh__D010549 1999-01-01
% 217.12/217.27  |- skos__prefLabel mesh__D010549 Personal Satisfaction
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D010549 2004
% 217.12/217.27  |- mesh__dateRevised mesh__D010549 2002-07-03
% 217.12/217.27  |- mesh__recordAuthorizer mesh__D010549 sjn
% 217.12/217.27  |- mesh__recordOriginator mesh__D010549 NLM
% 217.12/217.27  |- rdf__type mesh__D010549sskos__Concept
% 217.12/217.27  |- skos__annotation mesh__D010549 no qualif   
% 217.12/217.27  |- skos__historyNote mesh__D010549 Attitude %28%1966-1969%29%
% 217.12/217.27  |- skos__hiddenLabel mesh__D010549 Satisfaction, Personal
% 217.12/217.27  |- mesh__historyNote mesh__D010549 72%28%70%29%   
% 217.12/217.27  |- mesh__recordMaintainer mesh__D010549 jls
% 217.12/217.27  |- skos__broader mesh__D010549smesh__D001519
% 217.12/217.27  |- mesh__dateEstablished mesh__D010549 1972-01-01
% 217.12/217.27  |- mesh__recordOriginator mesh__D015234 SCD
% 217.12/217.27  |- skos__broader mesh__D015234smesh__D006680
% 217.12/217.27  |- skos__hiddenLabel mesh__D015234 Antigens, HLA A
% 217.12/217.27  |- skos__altLabel mesh__D015234 HLA-A
% 217.12/217.27  |- mesh__recordMaintainer mesh__D015234 ssb
% 217.12/217.27  |- skos__historyNote mesh__D015234
% 217.12/217.27       Histocompatibility Antigens %28%1975-1980%29%
% 217.12/217.27  |- skos__broader mesh__D015234smesh__D015395
% 217.12/217.27  |- rdf__type mesh__D015234sskos__Concept
% 217.12/217.27  |- skos__altLabel mesh__D015234 Antigens, HLA-A
% 217.12/217.27  |- skos__historyNote mesh__D015234 HLA Antigens %28%1975-1988%29%
% 217.12/217.27  |- mesh__dateRevised mesh__D015234 2005-06-30
% 217.12/217.27  |- skos__prefLabel mesh__D015234 HLA-A Antigens
% 217.12/217.27  |- mesh__historyNote mesh__D015234 89   
% 217.12/217.27  |- skos__scopeNote mesh__D015234
% 217.12/217.27       Polymorphic class I human histocompatibility %28%HLA%29% surface antigens present on almost all nucleated cells. At least 20 antigens have been identified which are encoded by the A locus of multiple alleles on chromosome 6. They serve as targets for T-cell cytolytic responses and are involved with acceptance or rejection of tissue/organ grafts.%A%    
% 217.12/217.27  |- mesh__recordAuthorizer mesh__D015234 sjn
% 217.12/217.27  |- mesh__dateCreated mesh__D015234 1988-05-14
% 217.12/217.27  |- skos__hiddenLabel mesh__D015234 HLA A Antigens
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D015234 2006
% 217.12/217.27  |- skos__annotation mesh__D015234
% 217.12/217.27       assoc with acceptance or rejection of tissue or organ grafts; DF: HLA A%A%  
% 217.12/217.27  |- mesh__dateEstablished mesh__D015234 1989-01-01
% 217.12/217.27  |- mesh__publicMeSHNote mesh__D015234 89   
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D039682 2005
% 217.12/217.27  |- skos__scopeNote mesh__D039682
% 217.12/217.27       Defective metabolism leading to fat maldistribution in patients infected with HIV. The etiology appears to be multifactorial and probably involves some combination of infection-induced alterations in metabolism, direct effects of antiretroviral therapy, and patient-related factors.%A%    
% 217.12/217.27  |- skos__hiddenLabel mesh__D039682 HIV Associated Lipodystrophy
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D039682 2003
% 217.12/217.27  |- skos__historyNote mesh__D039682 Lipodystrophy %28%1998-2002%29%
% 217.12/217.27  |- skos__altLabel mesh__D039682 Lipodystrophy Syndrome
% 217.12/217.27  |- skos__altLabel mesh__D039682 HIV-Associated Lipodystrophy
% 217.12/217.27  |- skos__hiddenLabel mesh__D039682 Lipodystrophy, HIV-Associated
% 217.12/217.27  |- rdf__type mesh__D039682sskos__Concept
% 217.12/217.27  |- mesh__publicMeSHNote mesh__D039682 2003   
% 217.12/217.27  |- skos__hiddenLabel mesh__D039682 HIV Associated Lipodystrophy Syndrome
% 217.12/217.27  |- skos__prefLabel mesh__D039682 HIV-Associated Lipodystrophy Syndrome
% 217.12/217.27  |- skos__hiddenLabel mesh__D039682 Lipodystrophy Syndrome, HIV
% 217.12/217.27  |- skos__broader mesh__D039682smesh__D008060
% 217.12/217.27  |- skos__altLabel mesh__D039682 HIV Lipodystrophy Syndrome
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D039682 2006
% 217.12/217.27  |- skos__hiddenLabel mesh__D039682 Lipodystrophy Syndrome, HIV-Associated
% 217.12/217.27  |- mesh__dateCreated mesh__D039682 2002-07-03
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D039682 2004
% 217.12/217.27  |- mesh__dateEstablished mesh__D039682 2003-01-01
% 217.12/217.27  |- skos__broader mesh__D039682smesh__D015658
% 217.12/217.27  |- mesh__historyNote mesh__D039682 2003   
% 217.12/217.27  |- skos__broader mesh__D020179smesh__D021081
% 217.12/217.27  |- mesh__recordOriginator mesh__D020179 KEV
% 217.12/217.27  |- mesh__dateCreated mesh__D020179 1999-11-08
% 217.12/217.27  |- rdf__type mesh__D020179sskos__Concept
% 217.12/217.27  |- skos__altLabel mesh__D020179 Time Zone Change Syndrome
% 217.12/217.27  |- skos__hiddenLabel mesh__D020179 Time Zone Syndromes
% 217.12/217.27  |- skos__historyNote mesh__D020179 Sleep Disorders %28%1974-1999%29%
% 217.12/217.27  |- mesh__dateEstablished mesh__D020179 2000-01-01
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D020179 2006
% 217.12/217.27  |- skos__broader mesh__D020179smesh__D020178
% 217.12/217.27  |- mesh__historyNote mesh__D020179 2000   
% 217.12/217.27  |- mesh__publicMeSHNote mesh__D020179 2000   
% 217.12/217.27  |- skos__prefLabel mesh__D020179 Jet Lag Syndrome
% 217.12/217.27  |- mesh__recordMaintainer mesh__D020179 sjn
% 217.12/217.27  |- skos__hiddenLabel mesh__D020179 Jet Lag Syndromes
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D020179 2005
% 217.12/217.27  |- skos__related mesh__D020179smesh__D014195
% 217.12/217.27  |- skos__altLabel mesh__D020179 Time Zone Syndrome
% 217.12/217.27  |- mesh__recordAuthorizer mesh__D020179 sjn
% 217.12/217.27  |- skos__scopeNote mesh__D020179
% 217.12/217.27       A chronobiologic disorder resulting from rapid travel across a number of time zones, characterized by insomnia or hypersomnolence, fatigue, behavioral symptoms, headaches, and gastrointestinal disturbances. %28%From Cooper, Sleep, 1994, pp593-8%29%%A%    
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D020179 2004
% 217.12/217.27  |- mesh__dateRevised mesh__D020179 2003-07-22
% 217.12/217.27  |- mesh__publicMeSHNote mesh__D025662 2002   
% 217.12/217.27  |- mesh__dateCreated mesh__D025662 2001-08-03
% 217.12/217.27  |- skos__historyNote mesh__D025662 Adenoviridae %28%1966-2001%29%
% 217.12/217.27  |- mesh__recordOriginator mesh__D025662 ags
% 217.12/217.27  |- mesh__historyNote mesh__D025662 2002   
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D025662 2004
% 217.12/217.27  |- skos__annotation mesh__D025662
% 217.12/217.27       infection: coord IM with ADENOVIRIDAE INFECTIONS %28%IM%29%   
% 217.12/217.27  |- skos__hiddenLabel mesh__D025662 Porcine Adenovirus
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D025662 2003
% 217.12/217.27  |- skos__hiddenLabel mesh__D025662 Adenovirus, Porcine
% 217.12/217.27  |- skos__altLabel mesh__D025662 Porcine Adenoviruses
% 217.12/217.27  |- rdf__type mesh__D025662sskos__Concept
% 217.12/217.27  |- skos__scopeNote mesh__D025662
% 217.12/217.27       Species of the genus MASTADENOVIRUS, causing neurological disease in pigs.%A%    
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D025662 2006
% 217.12/217.27  |- skos__broader mesh__D025662smesh__D017921
% 217.12/217.27  |- skos__historyNote mesh__D025662 Mastadenovirus %28%1993-2001%29%
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D025662 2002
% 217.12/217.27  |- mesh__recordAuthorizer mesh__D025662 sjn
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D025662 2005
% 217.12/217.27  |- mesh__dateEstablished mesh__D025662 2002-01-01
% 217.12/217.27  |- mesh__recordMaintainer mesh__D025662 jls
% 217.12/217.27  |- skos__prefLabel mesh__D025662 Adenoviruses, Porcine
% 217.12/217.27  |- rdf__type mesh__D019625sskos__Concept
% 217.12/217.27  |- mesh__recordOriginator mesh__D019625 AGS
% 217.12/217.27  |- mesh__recordAuthorizer mesh__D019625 sjn
% 217.12/217.27  |- mesh__recordMaintainer mesh__D019625 SYSTEM
% 217.12/217.27  |- skos__scopeNote mesh__D019625
% 217.12/217.27       A genus of extremely halophilic HALOBACTERIACEAE with coccoid cells occurring singly or as pairs, tetrads, or irregular clusters. They are found in neutral salt lakes, marine salterns, saline soils and seawater.%A%    
% 217.12/217.27  |- skos__annotation mesh__D019625
% 217.12/217.27       a genus of Halobacteriaceae, extremely halophilic   
% 217.12/217.27  |- skos__broader mesh__D019625smesh__D006216
% 217.12/217.27  |- mesh__publicMeSHNote mesh__D019625 98   
% 217.12/217.27  |- mesh__dateRevised mesh__D019625 2005-06-30
% 217.12/217.27  |- mesh__dateEstablished mesh__D019625 1998-01-01
% 217.12/217.27  |- mesh__dateCreated mesh__D019625 1997-06-20
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D019625 2006
% 217.12/217.27  |- mesh__historyNote mesh__D019625 98   
% 217.12/217.27  |- skos__prefLabel mesh__D019625 Halococcus
% 217.12/217.27  |- mesh__historyNote mesh__D011642 98; use explode 1975-97   
% 217.12/217.27  |- rdf__type mesh__D011642sskos__Concept
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D011642 2004
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D011642 1999
% 217.12/217.27  |- skos__historyNote mesh__D011642 specific publication %28%1966-1997%29%
% 217.12/217.27  |- mesh__publicMeSHNote mesh__D011642 98   
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D011642 2002
% 217.12/217.27  |- mesh__recordAuthorizer mesh__D011642 SJN
% 217.12/217.27  |- mesh__dateRevised mesh__D011642 1997-06-20
% 217.12/217.27  |- skos__annotation mesh__D011642
% 217.12/217.27       avoid: too general; prefer specifics; the published material itself: differentiate from PUBLISHING, the industry%A%  
% 217.12/217.27  |- skos__hiddenLabel mesh__D011642 Publication
% 217.12/217.27  |- mesh__recordOriginator mesh__D011642 NLM
% 217.12/217.27  |- mesh__dateEstablished mesh__D011642 1998-01-01
% 217.12/217.27  |- mesh__recordMaintainer mesh__D011642 TGC
% 217.12/217.27  |- skos__broader mesh__D011642smesh__D003146
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D011642 2005
% 217.12/217.27  |- skos__prefLabel mesh__D011642 Publications
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D011642 2000
% 217.12/217.27  |- skos__scopeNote mesh__D011642
% 217.12/217.27       Copies of a work or document distributed to the public by sale, rental, lease, or lending. %28%From ALA Glossary of Library and Information Science, 1983, p181%29%%A%    
% 217.12/217.27  |- mesh__dateCreated mesh__D011642 1999-01-01
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D011642 2006
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D011642 2001
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D011642 2003
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D011642 1998
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D005605 1998
% 217.12/217.27  |- rdf__type mesh__D005605sskos__Concept
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D005605 2002
% 217.12/217.27  |- skos__annotation mesh__D005605 naturally radioactive; IM   
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D005605 2004
% 217.12/217.27  |- mesh__recordOriginator mesh__D005605 NLM
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D005605 1999
% 217.12/217.27  |- skos__broader mesh__D005605smesh__D004603
% 217.12/217.27  |- skos__scopeNote mesh__D005605
% 217.12/217.27       Francium. A radioactive alkali metal with the atomic symbol Fr, atomic number 87, and atomic weight 223. The mass numbers of other known isotopes are 204-213, 217-222, and 224. Its valence is +1.%A%    
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D005605 2005
% 217.12/217.27  |- skos__broader mesh__D005605smesh__D008672
% 217.12/217.27  |- mesh__dateCreated mesh__D005605 1999-01-01
% 217.12/217.27  |- skos__prefLabel mesh__D005605 Francium
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D005605 2006
% 217.12/217.27  |- mesh__recordAuthorizer mesh__D005605 PLS
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D005605 2000
% 217.12/217.27  |- mesh__recordMaintainer mesh__D005605 JLS
% 217.12/217.27  |- skos__broader mesh__D005605smesh__D019216
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D005605 1997
% 217.12/217.27  |- mesh__dateRevised mesh__D005605 1996-06-10
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D005605 2001
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D005605 2003
% 217.12/217.27  |- skos__prefLabel mesh__D015235 HLA-B Antigens
% 217.12/217.27  |- skos__altLabel mesh__D015235 HLA-B
% 217.12/217.27  |- rdf__type mesh__D015235sskos__Concept
% 217.12/217.27  |- mesh__dateCreated mesh__D015235 1988-05-14
% 217.12/217.27  |- skos__hiddenLabel mesh__D015235 Antigens, HLA B
% 217.12/217.27  |- skos__broader mesh__D015235smesh__D006680
% 217.12/217.27  |- mesh__dateEstablished mesh__D015235 1989-01-01
% 217.12/217.27  |- mesh__dateRevised mesh__D015235 2005-06-30
% 217.12/217.27  |- mesh__historyNote mesh__D015235 89   
% 217.12/217.27  |- skos__historyNote mesh__D015235
% 217.12/217.27       Histocompatibility Antigens %28%1975-1981%29%
% 217.12/217.27  |- skos__altLabel mesh__D015235 Antigens, HLA-B
% 217.12/217.27  |- skos__hiddenLabel mesh__D015235 HLA B Antigens
% 217.12/217.27  |- skos__annotation mesh__D015235
% 217.12/217.27       assoc with predisposition to rheumatoid %26% other autoimmune disord; DF: HLA B%A%  
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D015235 2006
% 217.12/217.27  |- skos__historyNote mesh__D015235 HLA Antigens %28%1975-1988%29%
% 217.12/217.27  |- mesh__recordOriginator mesh__D015235 SCD
% 217.12/217.27  |- mesh__recordMaintainer mesh__D015235 ssb
% 217.12/217.27  |- mesh__publicMeSHNote mesh__D015235 89   
% 217.12/217.27  |- skos__scopeNote mesh__D015235
% 217.12/217.27       Class I human histocompatibility %28%HLA%29% surface antigens encoded by more than 30 detectable alleles on locus B of the HLA complex, the most polymorphic of all the HLA specificities. Several of these antigens %28%e.g., HLA-B27, -B7, -B8%29% are strongly associated with predisposition to rheumatoid and other autoimmune disorders. Like other class I HLA determinants, they are involved in the cellular immune reactivity of cytolytic T lymphocytes.%A%    
% 217.12/217.27  |- mesh__recordAuthorizer mesh__D015235 sjn
% 217.12/217.27  |- skos__broader mesh__D015235smesh__D015395
% 217.12/217.27  |- skos__broader mesh__D014801Q000172smesh__D014801
% 217.12/217.27  |- mesh__preferredCombination mesh__D014801Q000172smesh__D014802
% 217.12/217.27  |- rdf__type mesh__D014801Q000172smesh__CompoundConcept
% 217.12/217.27  |- skos__hiddenLabel mesh__D001215 Asparaginase Speywood Brand
% 217.12/217.27  |- mesh__dateRevised mesh__D001215 2003-07-09
% 217.12/217.27  |- mesh__dateCreated mesh__D001215 1999-01-01
% 217.12/217.27  |- skos__altLabel mesh__D001215 Christiaens Brand of Asparaginase
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D001215 2005
% 217.12/217.27  |- skos__hiddenLabel mesh__D001215 Asparaginase medac Brand
% 217.12/217.27  |- skos__altLabel mesh__D001215 Asparagine Deaminase
% 217.12/217.27  |- skos__altLabel mesh__D001215 Bayer Brand of Asparaginase
% 217.12/217.27  |- skos__hiddenLabel mesh__D001215 Asparaginase Sanfer Brand
% 217.12/217.27  |- mesh__publicMeSHNote mesh__D001215 68   
% 217.12/217.27  |- skos__broader mesh__D001215smesh__D000581
% 217.12/217.27  |- skos__hiddenLabel mesh__D001215 Asparaginase Bayer Brand
% 217.12/217.27  |- skos__altLabel mesh__D001215 Merck Brand of Asparaginase
% 217.12/217.27  |- skos__prefLabel mesh__D001215 Asparaginase
% 217.12/217.27  |- skos__altLabel mesh__D001215 Asparaginase II
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D001215 2004
% 217.12/217.27  |- mesh__recordMaintainer mesh__D001215 ssb
% 217.12/217.27  |- mesh__recordOriginator mesh__D001215 NLM
% 217.12/217.27  |- skos__hiddenLabel mesh__D001215 Asparaginase Bellon Brand
% 217.12/217.27  |- mesh__recordAuthorizer mesh__D001215 sjn
% 217.12/217.27  |- mesh__dateEstablished mesh__D001215 1968-01-01
% 217.12/217.27  |- skos__hiddenLabel mesh__D001215 Asparaginase Ispen Brand
% 217.12/217.27  |- skos__altLabel mesh__D001215 Sanfer Brand of Asparaginase
% 217.12/217.27  |- skos__historyNote mesh__D001215 Amidohydrolases %28%1966-1967%29%
% 217.12/217.27  |- skos__altLabel mesh__D001215 Speywood Brand of Asparaginase
% 217.12/217.27  |- skos__altLabel mesh__D001215 Ispen Brand of Asparaginase
% 217.12/217.27  |- skos__hiddenLabel mesh__D001215 Deaminase, Asparagine
% 217.12/217.27  |- skos__altLabel mesh__D001215 Bellon Brand of Asparaginase
% 217.12/217.27  |- mesh__historyNote mesh__D001215 68   
% 217.12/217.27  |- skos__hiddenLabel mesh__D001215 Asparaginase Christiaens Brand
% 217.12/217.27  |- skos__altLabel mesh__D001215 medac Brand of Asparaginase
% 217.12/217.27  |- skos__scopeNote mesh__D001215
% 217.12/217.27       A hydrolase enzyme that converts L-asparagine and water to L-aspartate and NH3.  EC 3.5.1.1.%A%    
% 217.12/217.27  |- skos__hiddenLabel mesh__D001215
% 217.12/217.27       Rh%C3%%B4%ne Poulenc Rorer Brand of Asparaginase
% 217.12/217.27  |- skos__hiddenLabel mesh__D001215 Asparaginase Merck Brand
% 217.12/217.27  |- skos__hiddenLabel mesh__D001215 medac, Asparaginase
% 217.12/217.27  |- skos__altLabel mesh__D001215
% 217.12/217.27       Rh%C3%%B4%ne-Poulenc Rorer Brand of Asparaginase
% 217.12/217.27  |- skos__altLabel mesh__D001215 Leunase
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D001215 2006
% 217.12/217.27  |- rdf__type mesh__D001215sskos__Concept
% 217.12/217.27  |- skos__altLabel mesh__D001215 Colaspase
% 217.12/217.27  |- skos__related mesh__D011643smesh__D010506
% 217.12/217.27  |- skos__related mesh__D011643smesh__D015713
% 217.12/217.27  |- mesh__dateRevised mesh__D011643 2002-07-03
% 217.12/217.27  |- mesh__recordMaintainer mesh__D011643 hjn
% 217.12/217.27  |- skos__scopeNote mesh__D011643
% 217.12/217.27       %22%The business or profession of the commercial production and issuance of literature%22% %28%Webster%27%s 3d%29%. It includes the publisher, publication processes, editing and editors. Production may be by conventional printing methods or by electronic publishing.%A%    
% 217.12/217.27  |- skos__broader mesh__D011643smesh__D007254
% 217.12/217.27  |- skos__annotation mesh__D011643
% 217.12/217.27       the industry %26% the dissemination of knowledge %26% research; printing %26% disseminating textual material: do not confuse with WRITING %28%the act, profession or product%29% or with AUTHORSHIP %28%identity as author%29%; med publishing: do not coord with MEDICINE; RETRACTION OF PUBLICATION is also available%A%  
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D011643 2005
% 217.12/217.27  |- skos__hiddenLabel mesh__D011643 Publishings, Electronic
% 217.12/217.27  |- mesh__dateCreated mesh__D011643 1999-01-01
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D011643 2006
% 217.12/217.27  |- mesh__recordOriginator mesh__D011643 NLM
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D011643 2003
% 217.12/217.27  |- mesh__recordAuthorizer mesh__D011643 sjn
% 217.12/217.27  |- skos__hiddenLabel mesh__D011643 Electronic Publishings
% 217.12/217.27  |- skos__prefLabel mesh__D011643 Publishing
% 217.12/217.27  |- rdf__type mesh__D011643sskos__Concept
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D011643 2004
% 217.12/217.27  |- skos__related mesh__D011643smesh__D001870
% 217.12/217.27  |- skos__altLabel mesh__D011643 Publishing, Electronic
% 217.12/217.27  |- mesh__dateRevised mesh__D005606 2002-07-03
% 217.12/217.27  |- mesh__dateEstablished mesh__D005606 1991-01-01
% 217.12/217.27  |- skos__scopeNote mesh__D005606
% 217.12/217.27       A plant genus of the family RHAMNACEAE. Several species have been reclassified to the FRANGULA genus.  It is often called buckthorn but should not be confused with other plants called that.%A%    
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D005606 2005
% 217.12/217.27  |- skos__broader mesh__D005606smesh__D027823
% 217.12/217.27  |- mesh__publicMeSHNote mesh__D005606
% 217.12/217.27       1991; see PLANTS, TOXIC 1986-1990, see FRANGULA 1963-1990%A%  
% 217.12/217.27  |- mesh__dateCreated mesh__D005606 1999-01-01
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D005606 2006
% 217.12/217.27  |- mesh__recordOriginator mesh__D005606 NLM
% 217.12/217.27  |- mesh__recordAuthorizer mesh__D005606 sjn
% 217.12/217.27  |- skos__annotation mesh__D005606
% 217.12/217.27       RHAMMUS FRANGULA and RHAMMUS PURSHIANA see FRANGULA are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.12/217.27  |- skos__prefLabel mesh__D005606 Rhamnus
% 217.12/217.27  |- mesh__historyNote mesh__D005606 1991%28%1963%29%   
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D005606 2003
% 217.12/217.27  |- rdf__type mesh__D005606sskos__Concept
% 217.12/217.27  |- mesh__activeMeSHYear mesh__D005606 2004
% 217.12/217.27  |- mesh__recordMaintainer mesh__D005606 ssb
% 217.12/217.27  |- mesh__dateCreated mesh__D015236 1988-05-14
% 217.12/217.27  |- skos__altLabel mesh__D015236 HLA-C
% 217.12/217.28  |- skos__annotation mesh__D015236
% 217.12/217.28       assoc with donor/recipient crossmatching; DF: HLA C   
% 217.12/217.28  |- skos__hiddenLabel mesh__D015236 HLA C Antigens
% 217.12/217.28  |- skos__prefLabel mesh__D015236 HLA-C Antigens
% 217.12/217.28  |- mesh__recordAuthorizer mesh__D015236 sjn
% 217.12/217.28  |- skos__broader mesh__D015236smesh__D015395
% 217.12/217.28  |- mesh__dateEstablished mesh__D015236 1989-01-01
% 217.12/217.28  |- skos__scopeNote mesh__D015236
% 217.12/217.28       Class I human histocompatibility %28%HLA%29% antigens encoded by a small cluster of structural genes at the C locus on chromosome 6. They have significantly lower immunogenicity than the HLA-A and -B determinants and are therefore of minor importance in donor/recipient crossmatching. Their primary role is their high-risk association with certain disease manifestations %28%e.g., spondylarthritis, psoriasis, multiple myeloma%29%.%A%    
% 217.12/217.28  |- skos__historyNote mesh__D015236 HLA Antigens %28%1977-1988%29%
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D015236 2006
% 217.12/217.28  |- skos__broader mesh__D015236smesh__D006680
% 217.12/217.28  |- mesh__recordOriginator mesh__D015236 SCD
% 217.12/217.28  |- skos__hiddenLabel mesh__D015236 Antigens, HLA C
% 217.12/217.28  |- mesh__dateRevised mesh__D015236 2005-06-30
% 217.12/217.28  |- mesh__publicMeSHNote mesh__D015236 89   
% 217.12/217.28  |- mesh__historyNote mesh__D015236 89   
% 217.12/217.28  |- rdf__type mesh__D015236sskos__Concept
% 217.12/217.28  |- skos__altLabel mesh__D015236 Antigens, HLA-C
% 217.12/217.28  |- mesh__recordMaintainer mesh__D015236 ssb
% 217.12/217.28  |- mesh__dateRevised mesh__D001216 2001-07-25
% 217.12/217.28  |- rdf__type mesh__D001216sskos__Concept
% 217.12/217.28  |- mesh__recordAuthorizer mesh__D001216 sjn
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D001216 2006
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D001216 2002
% 217.12/217.28  |- skos__broader mesh__D001216smesh__D021542
% 217.12/217.28  |- mesh__recordMaintainer mesh__D001216 nns
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D001216 2003
% 217.12/217.28  |- skos__scopeNote mesh__D001216
% 217.12/217.28       A non-essential amino acid that is involved in the metabolic control of cell functions in nerve and brain tissue. It is biosynthesized from ASPARTIC ACID and AMMONIA by asparagine synthetase. %28%From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed%29%%A%    
% 217.12/217.28  |- skos__broader mesh__D001216smesh__D024361
% 217.12/217.28  |- mesh__dateCreated mesh__D001216 1999-01-01
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D001216 2004
% 217.12/217.28  |- skos__prefLabel mesh__D001216 Asparagine
% 217.12/217.28  |- skos__broader mesh__D001216smesh__D000599
% 217.12/217.28  |- skos__annotation mesh__D001216 /biosyn /physiol permitted   
% 217.12/217.28  |- skos__altLabel mesh__D001216 L-Asparagine
% 217.12/217.28  |- mesh__recordOriginator mesh__D001216 NLM
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D001216 2005
% 217.12/217.28  |- rdf__type mesh__D011644sskos__Concept
% 217.12/217.28  |- mesh__recordAuthorizer mesh__D011644 sjn
% 217.12/217.28  |- mesh__recordMaintainer mesh__D011644 lkt
% 217.12/217.28  |- skos__prefLabel mesh__D011644 Puerperal Disorders
% 217.12/217.28  |- skos__hiddenLabel mesh__D011644 Disorders, Puerperal
% 217.12/217.28  |- skos__broader mesh__D011644smesh__D011248
% 217.12/217.28  |- skos__scopeNote mesh__D011644
% 217.12/217.28       Disorders or diseases associated with PUERPERIUM, the six-to-eight-week period immediately after PARTURITION in humans.%A%    
% 217.12/217.28  |- skos__hiddenLabel mesh__D011644 Disorder, Puerperal
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D011644 2006
% 217.12/217.28  |- skos__hiddenLabel mesh__D011644 Puerperal Disorder
% 217.12/217.28  |- mesh__dateCreated mesh__D011644 1999-01-01
% 217.12/217.28  |- mesh__dateRevised mesh__D011644 2005-06-30
% 217.12/217.28  |- mesh__recordOriginator mesh__D011644 NLM
% 217.12/217.28  |- skos__annotation mesh__D011644
% 217.12/217.28       check the tag FEMALE; puerperal psychoses: coordinate IM with PSYCHOTIC DISORDERS %28%IM%29%%A%  
% 217.12/217.28  |- skos__altLabel mesh__D005607 Healthcare Fraud
% 217.12/217.28  |- mesh__publicMeSHNote mesh__D005607
% 217.12/217.28       91; was see under CRIME Aug 1977-90; KICKBACKS was see CRIME 1992-93%A%  
% 217.12/217.28  |- skos__related mesh__D005607smesh__D008192
% 217.12/217.28  |- skos__hiddenLabel mesh__D005607 Frauds
% 217.12/217.28  |- mesh__recordOriginator mesh__D005607 EC
% 217.12/217.28  |- mesh__recordMaintainer mesh__D005607 jrf
% 217.12/217.28  |- skos__altLabel mesh__D005607 Fraud, Health Care
% 217.12/217.28  |- skos__annotation mesh__D005607
% 217.12/217.28       note FRAUD, SCIENTIFIC see SCIENTIFIC MISCONDUCT   
% 217.12/217.28  |- skos__hiddenLabel mesh__D005607 Health Care Frauds
% 217.12/217.28  |- mesh__dateRevised mesh__D005607 2001-07-25
% 217.12/217.28  |- mesh__dateCreated mesh__D005607 1977-05-05
% 217.12/217.28  |- skos__broader mesh__D005607smesh__D003415
% 217.12/217.28  |- skos__prefLabel mesh__D005607 Fraud
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005607 2003
% 217.12/217.28  |- mesh__historyNote mesh__D005607
% 217.12/217.28       91%28%Aug 77%29%; was see under CRIME 1977-90; KICKBACKS was see CRIME 1992-93%A%  
% 217.12/217.28  |- skos__related mesh__D005607smesh__D028743
% 217.12/217.28  |- rdf__type mesh__D005607sskos__Concept
% 217.12/217.28  |- skos__scopeNote mesh__D005607
% 217.12/217.28       Exploitation through misrepresentation of the facts or concealment of the purposes of the exploiter.%A%    
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005607 2004
% 217.12/217.28  |- skos__related mesh__D005607smesh__D011781
% 217.12/217.28  |- skos__hiddenLabel mesh__D005607 Frauds, Health Care
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005607 2002
% 217.12/217.28  |- mesh__recordAuthorizer mesh__D005607 sjn
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005607 2005
% 217.12/217.28  |- mesh__dateEstablished mesh__D005607 1991-01-01
% 217.12/217.28  |- mesh__onlineNote mesh__D005607 use CRIME to search KICKBACKS 1992-93   
% 217.12/217.28  |- skos__hiddenLabel mesh__D005607 Kickback
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005607 2006
% 217.12/217.28  |- skos__broader mesh__D001608Q000506smesh__D001608
% 217.12/217.28  |- mesh__preferredCombination mesh__D001608Q000506smesh__D001607
% 217.12/217.28  |- rdf__type mesh__D001608Q000506smesh__CompoundConcept
% 217.12/217.28  |- mesh__historyNote mesh__D015237 89   
% 217.12/217.28  |- skos__historyNote mesh__D015237 Prostaglandins F %28%1975-1988%29%
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D015237 2006
% 217.12/217.28  |- skos__altLabel mesh__D015237 PGF2alpha
% 217.12/217.28  |- skos__hiddenLabel mesh__D015237 alpha, PGF2
% 217.12/217.28  |- mesh__publicMeSHNote mesh__D015237 89   
% 217.12/217.28  |- skos__altLabel mesh__D015237 Prostaglandin F2
% 217.12/217.28  |- skos__historyNote mesh__D015237 Prostaglandins %28%1966-1974%29%
% 217.12/217.28  |- mesh__recordMaintainer mesh__D015237 ssb
% 217.12/217.28  |- skos__altLabel mesh__D015237 Prostaglandin F2alpha
% 217.12/217.28  |- skos__annotation mesh__D015237
% 217.12/217.28       do not confuse with DINOPROSTONE; /biosyn /physiol permitted%A%  
% 217.12/217.28  |- rdf__type mesh__D015237sskos__Concept
% 217.12/217.28  |- mesh__recordAuthorizer mesh__D015237 sjn
% 217.12/217.28  |- mesh__dateCreated mesh__D015237 1988-05-14
% 217.12/217.28  |- skos__hiddenLabel mesh__D015237 F2 alpha, Prostaglandin
% 217.12/217.28  |- skos__hiddenLabel mesh__D015237 F2alpha, Prostaglandin
% 217.12/217.28  |- skos__hiddenLabel mesh__D015237 9alpha,11beta PGF2
% 217.12/217.28  |- skos__altLabel mesh__D015237 PGF2 alpha
% 217.12/217.28  |- skos__altLabel mesh__D015237 9alpha,11beta-PGF2
% 217.12/217.28  |- skos__altLabel mesh__D015237 Prostaglandin F2 alpha
% 217.12/217.28  |- mesh__dateEstablished mesh__D015237 1989-01-01
% 217.12/217.28  |- mesh__recordOriginator mesh__D015237 RLS
% 217.12/217.28  |- skos__related mesh__D015237smesh__D028441
% 217.12/217.28  |- skos__broader mesh__D015237smesh__D011460
% 217.12/217.28  |- skos__scopeNote mesh__D015237
% 217.12/217.28       A naturally occurring prostaglandin that has oxytocic, luteolytic, and abortifacient activities. Due to its vasocontractile properties, the compound has a variety of other biological actions.%A%    
% 217.12/217.28  |- skos__prefLabel mesh__D015237 Dinoprost
% 217.12/217.28  |- skos__altLabel mesh__D015237 PGF2
% 217.12/217.28  |- mesh__dateRevised mesh__D015237 2005-06-30
% 217.12/217.28  |- mesh__recordMaintainer mesh__D001217 ssb
% 217.12/217.28  |- skos__altLabel mesh__D001217 Asparagine Synthetase
% 217.12/217.28  |- skos__broader mesh__D001217smesh__D019732
% 217.12/217.28  |- rdf__type mesh__D001217sskos__Concept
% 217.12/217.28  |- skos__hiddenLabel mesh__D001217 Synthase, Asparagine
% 217.12/217.28  |- mesh__recordOriginator mesh__D001217 NLM
% 217.12/217.28  |- mesh__publicMeSHNote mesh__D001217
% 217.12/217.28       95: was ASPARAGINE SYNTHETASE 1975-94 %28%see under LIGASES 1975-90%29%%A%  
% 217.12/217.28  |- skos__altLabel mesh__D001217 Asparagine Synthase
% 217.12/217.28  |- mesh__dateEstablished mesh__D001217 1991-01-01
% 217.12/217.28  |- mesh__onlineNote mesh__D001217
% 217.12/217.28       use ASPARTATE-AMMONIA LIGASE to search ASPARAGINE SYNTHETASE 1975-94%A%  
% 217.12/217.28  |- skos__hiddenLabel mesh__D001217 Synthetase B, Asparagine
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D001217 2006
% 217.12/217.28  |- mesh__dateCreated mesh__D001217 1974-11-19
% 217.12/217.28  |- mesh__dateRevised mesh__D001217 2003-07-09
% 217.12/217.28  |- skos__historyNote mesh__D001217 Aspartic Acid %28%1973-1974%29%
% 217.12/217.28  |- skos__historyNote mesh__D001217 Ligases %28%1973-1974%29%
% 217.12/217.28  |- mesh__recordAuthorizer mesh__D001217 sjn
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D001217 2005
% 217.12/217.28  |- skos__prefLabel mesh__D001217 Aspartate-Ammonia Ligase
% 217.12/217.28  |- skos__hiddenLabel mesh__D001217 Ligase, Aspartate-Ammonia
% 217.12/217.28  |- mesh__historyNote mesh__D001217
% 217.12/217.28       95; was ASPARAGINE SYNTHETASE 1975-94 %28%see under LIGASES 1975-90%29%%A%  
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D001217 2004
% 217.12/217.28  |- skos__hiddenLabel mesh__D001217 Aspartate Ammonia Ligase
% 217.12/217.28  |- skos__scopeNote mesh__D001217
% 217.12/217.28       An enzyme that catalyzes the formation of asparagine from ammonia and aspartic acid, in the presence of ATP. EC 6.3.1.1.%A%    
% 217.12/217.28  |- skos__historyNote mesh__D001217 Ammonia %28%1973-1974%29%
% 217.12/217.28  |- skos__hiddenLabel mesh__D001217 Synthetase, Asparagine
% 217.12/217.28  |- mesh__dateRevised mesh__D006700 2002-07-03
% 217.12/217.28  |- skos__historyNote mesh__D006700 Delivery %28%1966-1982%29%
% 217.12/217.28  |- skos__hiddenLabel mesh__D006700 Home Childbirths
% 217.12/217.28  |- skos__hiddenLabel mesh__D006700 Home Delivery
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D006700 2003
% 217.12/217.28  |- mesh__recordMaintainer mesh__D006700 PXP
% 217.12/217.28  |- skos__scopeNote mesh__D006700 Childbirth taking place in the home.     
% 217.12/217.28  |- skos__prefLabel mesh__D006700 Home Childbirth
% 217.12/217.28  |- rdf__type mesh__D006700sskos__Concept
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D006700 2005
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D006700 2004
% 217.12/217.28  |- skos__hiddenLabel mesh__D006700 Childbirths, Home
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D006700 2006
% 217.12/217.28  |- skos__altLabel mesh__D006700 Delivery, Home
% 217.12/217.28  |- mesh__dateCreated mesh__D006700 1982-05-05
% 217.12/217.28  |- skos__hiddenLabel mesh__D006700 Home Deliveries
% 217.12/217.28  |- mesh__historyNote mesh__D006700
% 217.12/217.28       91%28%83%29%; was see under DELIVERY 1983-90   
% 217.12/217.28  |- skos__altLabel mesh__D006700 Childbirth at Home
% 217.12/217.28  |- skos__altLabel mesh__D006700 Childbirths at Home
% 217.12/217.28  |- mesh__publicMeSHNote mesh__D006700 91; was see under DELIVERY 1983-90   
% 217.12/217.28  |- skos__hiddenLabel mesh__D006700 Deliveries, Home
% 217.12/217.28  |- mesh__recordOriginator mesh__D006700 EC
% 217.12/217.28  |- skos__broader mesh__D006700smesh__D036861
% 217.12/217.28  |- skos__hiddenLabel mesh__D006700 Childbirth, Home
% 217.12/217.28  |- mesh__dateEstablished mesh__D006700 1991-01-01
% 217.12/217.28  |- mesh__recordAuthorizer mesh__D006700 sjn
% 217.12/217.28  |- mesh__dateRevised mesh__D011645 2005-06-30
% 217.12/217.28  |- skos__hiddenLabel mesh__D011645 Infections, Puerperal
% 217.12/217.28  |- skos__broader mesh__D011645smesh__D011644
% 217.12/217.28  |- mesh__recordOriginator mesh__D011645 NLM
% 217.12/217.28  |- mesh__recordAuthorizer mesh__D011645 sjn
% 217.12/217.28  |- skos__scopeNote mesh__D011645
% 217.12/217.28       An infection occurring in PUERPERIUM, the period of 6-8 weeks after giving birth.%A%    
% 217.12/217.28  |- skos__broader mesh__D011645smesh__D011251
% 217.12/217.28  |- mesh__recordMaintainer mesh__D011645 lkt
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D011645 2006
% 217.12/217.28  |- skos__hiddenLabel mesh__D011645 Puerperal Infections
% 217.12/217.28  |- mesh__dateCreated mesh__D011645 1999-01-01
% 217.12/217.28  |- skos__annotation mesh__D011645
% 217.12/217.28       general or unspecified; coordinate IM with specific infection %28%IM%29%; check the tag FEMALE%A%  
% 217.12/217.28  |- skos__altLabel mesh__D011645 Infection, Puerperal
% 217.12/217.28  |- skos__prefLabel mesh__D011645 Puerperal Infection
% 217.12/217.28  |- rdf__type mesh__D011645sskos__Concept
% 217.12/217.28  |- mesh__recordOriginator mesh__D005608 NLM
% 217.12/217.28  |- skos__scopeNote mesh__D005608
% 217.12/217.28       Spontaneous verbalization of whatever comes to mind.     
% 217.12/217.28  |- skos__hiddenLabel mesh__D005608 Free Associations
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005608 2003
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005608 1998
% 217.12/217.28  |- mesh__recordMaintainer mesh__D005608 TGC
% 217.12/217.28  |- mesh__historyNote mesh__D005608 69   
% 217.12/217.28  |- rdf__type mesh__D005608sskos__Concept
% 217.12/217.28  |- skos__hiddenLabel mesh__D005608 Associations, Free
% 217.12/217.28  |- mesh__publicMeSHNote mesh__D005608 69   
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005608 2004
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005608 1999
% 217.12/217.28  |- mesh__recordAuthorizer mesh__D005608 PLS
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005608 2000
% 217.12/217.28  |- skos__annotation mesh__D005608 no qualif; DF: FREE ASSOC   
% 217.12/217.28  |- skos__broader mesh__D005608smesh__D011575
% 217.12/217.28  |- skos__altLabel mesh__D005608 Association, Free
% 217.12/217.28  |- skos__historyNote mesh__D005608 Association %28%1966-1968%29%
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005608 2005
% 217.12/217.28  |- skos__prefLabel mesh__D005608 Free Association
% 217.12/217.28  |- mesh__dateEstablished mesh__D005608 1969-01-01
% 217.12/217.28  |- mesh__dateCreated mesh__D005608 1999-01-01
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005608 2001
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005608 2006
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005608 1995
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005608 1996
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005608 2002
% 217.12/217.28  |- mesh__dateRevised mesh__D005608 1994-05-12
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005608 1997
% 217.12/217.28  |- skos__historyNote mesh__D016330 Aged %28%1977-1990%29%
% 217.12/217.28  |- skos__altLabel mesh__D016330 Frail Elders
% 217.12/217.28  |- mesh__dateRevised mesh__D016330 2005-10-11
% 217.12/217.28  |- skos__scopeNote mesh__D016330
% 217.12/217.28       Older adults or aged individuals who are lacking in general strength and are unusually susceptible to disease or to other infirmity.%A%    
% 217.12/217.28  |- skos__hiddenLabel mesh__D016330 Elders, Frail
% 217.12/217.28  |- skos__historyNote mesh__D016330 Aged, 80 and over %28%1987-1990%29%
% 217.12/217.28  |- mesh__recordMaintainer mesh__D016330 ags
% 217.12/217.28  |- mesh__recordAuthorizer mesh__D016330 ags
% 217.12/217.28  |- skos__annotation mesh__D016330
% 217.12/217.28       check the tags AGED or AGED, 80 AND OVER   
% 217.12/217.28  |- skos__hiddenLabel mesh__D016330 Older Adults, Frail
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D016330 2002
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D016330 2006A
% 217.12/217.28  |- skos__related mesh__D016330smesh__D018577
% 217.12/217.28  |- mesh__dateCreated mesh__D016330 1990-05-25
% 217.12/217.28  |- mesh__publicMeSHNote mesh__D016330 91   
% 217.12/217.28  |- skos__related mesh__D016330smesh__D006299
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D016330 2003
% 217.12/217.28  |- skos__hiddenLabel mesh__D016330 Elderly, Functionally-Impaired
% 217.12/217.28  |- mesh__historyNote mesh__D016330 91   
% 217.12/217.28  |- skos__hiddenLabel mesh__D016330 Frail Elder
% 217.12/217.28  |- skos__hiddenLabel mesh__D016330 Adult, Frail Older
% 217.12/217.28  |- rdf__type mesh__D016330sskos__Concept
% 217.12/217.28  |- skos__hiddenLabel mesh__D016330 Elder, Frail
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D016330 2004
% 217.12/217.28  |- mesh__recordOriginator mesh__D016330 MXR
% 217.12/217.28  |- skos__hiddenLabel mesh__D016330 Older Adult, Frail
% 217.12/217.28  |- skos__broader mesh__D016330smesh__D000368
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D016330 2005
% 217.12/217.28  |- skos__historyNote mesh__D016330
% 217.12/217.28       Health Services for the Aged %28%1983-1990%29%
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D016330 2000
% 217.12/217.28  |- mesh__dateEstablished mesh__D016330 1991-01-01
% 217.12/217.28  |- skos__hiddenLabel mesh__D016330 Functionally Impaired Elderly
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D016330 1998
% 217.12/217.28  |- skos__altLabel mesh__D016330 Elderly, Frail
% 217.12/217.28  |- skos__prefLabel mesh__D016330 Frail Elderly
% 217.12/217.28  |- skos__hiddenLabel mesh__D016330 Adults, Frail Older
% 217.12/217.28  |- skos__hiddenLabel mesh__D016330 Frail Older Adult
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D016330 2006
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D016330 2001
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D016330 1999
% 217.12/217.28  |- skos__historyNote mesh__D016330
% 217.12/217.28       Health Services Needs and Demand %28%1986-1990%29%
% 217.12/217.28  |- mesh__publicMeSHNote mesh__D030001 2002   
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D030001 2006A
% 217.12/217.28  |- mesh__historyNote mesh__D030001 2002   
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D030001 2006
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D030001 2005
% 217.12/217.28  |- skos__prefLabel mesh__D030001 Foeniculum
% 217.12/217.28  |- rdf__type mesh__D030001sskos__Concept
% 217.12/217.28  |- mesh__recordOriginator mesh__D030001 ssb
% 217.12/217.28  |- mesh__dateCreated mesh__D030001 2001-07-25
% 217.12/217.28  |- skos__broader mesh__D030001smesh__D019661
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D030001 2006B
% 217.12/217.28  |- mesh__recordAuthorizer mesh__D030001 ags
% 217.12/217.28  |- skos__annotation mesh__D030001
% 217.12/217.28       X ref FENNEL: FENNEL, DOG see ANTHEMIS are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.12/217.28  |- mesh__dateEstablished mesh__D030001 2002-01-01
% 217.12/217.28  |- skos__scopeNote mesh__D030001
% 217.12/217.28       A plant genus of the family APIACEAE used in SPICES.     
% 217.12/217.28  |- mesh__dateRevised mesh__D030001 2005-07-15
% 217.12/217.28  |- mesh__recordMaintainer mesh__D030001 ags
% 217.12/217.28  |- mesh__recordOriginator mesh__D002310 VDK
% 217.12/217.28  |- mesh__recordMaintainer mesh__D002310 lkt
% 217.12/217.28  |- skos__broader mesh__D002310smesh__D020751
% 217.12/217.28  |- mesh__historyNote mesh__D002310 79   
% 217.12/217.28  |- mesh__dateEstablished mesh__D002310 1979-01-01
% 217.12/217.28  |- skos__prefLabel mesh__D002310 Cardiomyopathy, Alcoholic
% 217.12/217.28  |- skos__historyNote mesh__D002310 Heart Diseases %28%1966-1978%29%
% 217.12/217.28  |- skos__historyNote mesh__D002310 Alcoholism %28%1966-1978%29%
% 217.12/217.28  |- rdf__type mesh__D002310sskos__Concept
% 217.12/217.28  |- mesh__recordAuthorizer mesh__D002310 sjn
% 217.12/217.28  |- skos__historyNote mesh__D002310 Myocardial Diseases %28%1966-1978%29%
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D002310 2006
% 217.12/217.28  |- skos__broader mesh__D002310smesh__D009202
% 217.12/217.28  |- skos__scopeNote mesh__D002310
% 217.12/217.28       Disease of CARDIAC MUSCLE resulted from chronic excessive alcohol consumption. Myocardial damage can be caused by: %28%1%29% a toxic effect of alcohol; %28%2%29% malnutrition in alcoholics such as THIAMINE DEFICIENCY; or %28%3%29% toxic effect of additives in alcoholic beverages such as COBALT. This disease is usually manifested by DYSPNEA and palpitations with CARDIOMEGALY and congestive heart failure %28%HEART FAILURE, CONGESTIVE%29%.%A%    
% 217.12/217.28  |- skos__altLabel mesh__D002310 Alcoholic Cardiomyopathy
% 217.12/217.28  |- mesh__dateRevised mesh__D002310 2004-07-07
% 217.12/217.28  |- mesh__dateCreated mesh__D002310 1978-05-19
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D002310 2005
% 217.12/217.28  |- mesh__publicMeSHNote mesh__D002310 79   
% 217.12/217.28  |- mesh__publicMeSHNote mesh__D015238 89   
% 217.12/217.28  |- mesh__recordOriginator mesh__D015238 RLS
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D015238 2005
% 217.12/217.28  |- skos__broader mesh__D015238smesh__D019885
% 217.12/217.28  |- mesh__dateRevised mesh__D015238 2003-07-09
% 217.12/217.28  |- skos__historyNote mesh__D015238 Sulfurtransferases %28%1966-1988%29%
% 217.12/217.28  |- mesh__historyNote mesh__D015238 89   
% 217.12/217.28  |- rdf__type mesh__D015238sskos__Concept
% 217.12/217.28  |- mesh__dateCreated mesh__D015238 1988-05-14
% 217.12/217.28  |- mesh__recordMaintainer mesh__D015238 ssb
% 217.12/217.28  |- mesh__dateEstablished mesh__D015238 1989-01-01
% 217.12/217.28  |- mesh__recordAuthorizer mesh__D015238 sjn
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D015238 2004
% 217.12/217.28  |- skos__annotation mesh__D015238 do not confuse with SULFURTRANSFERASES   
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D015238 2006
% 217.12/217.28  |- skos__prefLabel mesh__D015238 Sulfotransferases
% 217.12/217.28  |- skos__scopeNote mesh__D015238
% 217.12/217.28       Enzymes which transfer sulfate groups to various acceptor molecules. They are involved in posttranslational sulfation of proteins and sulfate conjugation of exogenous chemicals and bile acids. EC 2.8.2.%A%    
% 217.12/217.28  |- skos__hiddenLabel mesh__D001218 Gold, Hermesetas
% 217.12/217.28  |- skos__broader mesh__D001218smesh__D004151
% 217.12/217.28  |- skos__historyNote mesh__D001218 Dipeptides %28%1974-1975%29%
% 217.12/217.28  |- rdf__type mesh__D001218sskos__Concept
% 217.12/217.28  |- mesh__dateEstablished mesh__D001218 1991-01-01
% 217.12/217.28  |- skos__hiddenLabel mesh__D001218 Aspartame Prodes Brand
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D001218 2006
% 217.12/217.28  |- mesh__recordMaintainer mesh__D001218 ssb
% 217.12/217.28  |- skos__historyNote mesh__D001218 Phenylalanine %28%1974%29%
% 217.12/217.28  |- skos__altLabel mesh__D001218 Aspartylphenylalanine Methyl Ester
% 217.12/217.28  |- skos__hiddenLabel mesh__D001218 Aspartame Fuca Brand
% 217.12/217.28  |- skos__hiddenLabel mesh__D001218 Aspartame Muro Brand
% 217.12/217.28  |- skos__altLabel mesh__D001218 Hermes Brand of Aspartame
% 217.12/217.28  |- skos__altLabel mesh__D001218
% 217.12/217.28       Di%C3%%A9%t%C3%%A9%tiques et Sant%C3%%A9% Brand of Aspartame
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D001218 2005
% 217.12/217.28  |- skos__hiddenLabel mesh__D001218 SC 18862
% 217.12/217.28  |- skos__hiddenLabel mesh__D001218 Aspartylphenylalanine, Methyl
% 217.12/217.28  |- mesh__historyNote mesh__D001218
% 217.12/217.28       91%28%75%29%; was see under DIPEPTIDES 1975-90   
% 217.12/217.28  |- mesh__recordOriginator mesh__D001218 NLM
% 217.12/217.28  |- skos__hiddenLabel mesh__D001218 Aspartame Hermes Brand
% 217.12/217.28  |- skos__altLabel mesh__D001218 Prodes Brand of Aspartame
% 217.12/217.28  |- skos__scopeNote mesh__D001218
% 217.12/217.28       Flavoring agent sweeter than sugar, metabolized as PHENYLALANINE and ASPARTIC ACID.%A%    
% 217.12/217.28  |- mesh__publicMeSHNote mesh__D001218
% 217.12/217.28       91; was see under DIPEPTIDES 1975-90   
% 217.12/217.28  |- skos__hiddenLabel mesh__D001218 Tri Sweet
% 217.12/217.28  |- mesh__dateCreated mesh__D001218 1974-11-19
% 217.12/217.28  |- skos__hiddenLabel mesh__D001218 TriSweet
% 217.12/217.28  |- mesh__recordAuthorizer mesh__D001218 sjn
% 217.12/217.28  |- mesh__dateRevised mesh__D001218 2004-07-07
% 217.12/217.28  |- skos__historyNote mesh__D001218 Aspartic Acid %28%1974%29%
% 217.12/217.28  |- skos__hiddenLabel mesh__D001218 SC18862
% 217.12/217.28  |- skos__altLabel mesh__D001218 Fuca Brand of Aspartame
% 217.12/217.28  |- skos__hiddenLabel mesh__D001218 Methyl Ester, Aspartylphenylalanine
% 217.12/217.28  |- skos__altLabel mesh__D001218 Muro Brand of Aspartame
% 217.12/217.28  |- skos__altLabel mesh__D001218 Methyl Aspartylphenylalanine
% 217.12/217.28  |- skos__annotation mesh__D001218 D25-26 qualif   
% 217.12/217.28  |- skos__prefLabel mesh__D001218 Aspartame
% 217.12/217.28  |- skos__hiddenLabel mesh__D006701 Non-Professional Home Care
% 217.12/217.28  |- skos__hiddenLabel mesh__D006701 Care, Nonprofessional Home
% 217.12/217.28  |- skos__hiddenLabel mesh__D006701 Home Care, Non Professional
% 217.12/217.28  |- skos__broader mesh__D006701smesh__D009732
% 217.12/217.28  |- mesh__dateCreated mesh__D006701 1999-01-01
% 217.12/217.28  |- skos__hiddenLabel mesh__D006701 Nonprofessional Home Care
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D006701 2001
% 217.12/217.28  |- skos__altLabel mesh__D006701 Home Care, Non-Professional
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D006701 2004
% 217.12/217.28  |- skos__scopeNote mesh__D006701
% 217.12/217.28       Nursing care given to an individual in the home. The care may be provided by a family member or a friend. Home nursing as care by a non-professional is differentiated from HOME CARE SERVICES provided by professionals: visiting nurse, home health agencies, hospital, or other organized community group.%A%    
% 217.12/217.28  |- skos__broader mesh__D006701smesh__D006699
% 217.12/217.28  |- rdf__type mesh__D006701sskos__Concept
% 217.12/217.28  |- mesh__recordAuthorizer mesh__D006701 sjn
% 217.12/217.28  |- skos__altLabel mesh__D006701 Home Care, Nonprofessional
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D006701 2000
% 217.12/217.28  |- skos__prefLabel mesh__D006701 Home Nursing
% 217.12/217.28  |- skos__hiddenLabel mesh__D006701 Care, Non-Professional Home
% 217.12/217.28  |- mesh__publicMeSHNote mesh__D006701 66; was NURSING, HOME 1963-65   
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D006701 2003
% 217.12/217.28  |- mesh__recordMaintainer mesh__D006701 kle
% 217.12/217.28  |- mesh__dateRevised mesh__D006701 1999-11-03
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D006701 2006
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D006701 2002
% 217.12/217.28  |- mesh__historyNote mesh__D006701 66; was NURSING, HOME 1963-65   
% 217.12/217.28  |- skos__altLabel mesh__D006701 Nursing, Home
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D006701 2005
% 217.12/217.28  |- skos__annotation mesh__D006701
% 217.12/217.28       by non-professionals only %28%family, friends, etc.%29%: do not confuse with HOME CARE SERVICES %28%by professional: visiting nurse, public health nurse, etc.%29%%A%  
% 217.12/217.28  |- mesh__dateEstablished mesh__D006701 1966-01-01
% 217.12/217.28  |- mesh__recordOriginator mesh__D006701 NLM
% 217.12/217.28  |- skos__altLabel mesh__D044022 Endothelin A Receptors
% 217.12/217.28  |- mesh__dateEstablished mesh__D044022 2004-01-01
% 217.12/217.28  |- skos__altLabel mesh__D044022 Receptor, Endothelin-1
% 217.12/217.28  |- skos__scopeNote mesh__D044022
% 217.12/217.28       A subtype of endothelin receptor found predominantly in the VASCULAR SMOOTH MUSCLE. It has a high affinity for ENDOTHELIN-1 and ENDOTHELIN-2.%A%    
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D044022 2004
% 217.12/217.28  |- skos__historyNote mesh__D044022 Receptors, Endothelin %28%1993-2003%29%
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D044022 2005
% 217.12/217.28  |- skos__prefLabel mesh__D044022 Receptor, Endothelin A
% 217.12/217.28  |- mesh__historyNote mesh__D044022
% 217.12/217.28       2004; use RECEPTOR, ENDOTHELIN A %28%NM%29% 1993-2003   
% 217.12/217.28  |- skos__hiddenLabel mesh__D044022 Endothelin-1 Receptor
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D044022 2006
% 217.12/217.28  |- rdf__type mesh__D044022sskos__Concept
% 217.12/217.28  |- skos__broader mesh__D044022smesh__D017466
% 217.12/217.28  |- mesh__dateCreated mesh__D044022 2003-07-09
% 217.12/217.28  |- skos__hiddenLabel mesh__D044022 Receptors, Endothelin A
% 217.12/217.28  |- mesh__publicMeSHNote mesh__D044022
% 217.12/217.28       2004; ENDOTHELIN A RECEPTOR was indexed under RECEPTORS, ENDOTHELIN 1993-2003%A%  
% 217.12/217.28  |- skos__hiddenLabel mesh__D044022 Receptor, Endothelin 1
% 217.12/217.28  |- skos__hiddenLabel mesh__D044022 Endothelin A Receptor
% 217.12/217.28  |- mesh__recordMaintainer mesh__D005609 TGC
% 217.12/217.28  |- skos__hiddenLabel mesh__D005609 Radicals, Free
% 217.12/217.28  |- mesh__dateEstablished mesh__D005609 1976-01-01
% 217.12/217.28  |- skos__scopeNote mesh__D005609
% 217.12/217.28       Highly reactive molecules with an unsatisfied electron valence pair. Free radicals are produced in both normal and pathological processes. They are proven or suspected agents of tissue damage in a wide variety of circumstances including radiation, damage from environment chemicals, and aging. Natural and pharmacological prevention of free radical damage is being actively investigated.%A%    
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005609 1996
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005609 2005
% 217.12/217.28  |- skos__annotation mesh__D005609 IM GEN only; usually NIM with coord IM   
% 217.12/217.28  |- skos__broader mesh__D005609smesh__D009930
% 217.12/217.28  |- skos__historyNote mesh__D005609 Chemistry %28%1966%29%
% 217.12/217.28  |- skos__prefLabel mesh__D005609 Free Radicals
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005609 2004
% 217.12/217.28  |- skos__broader mesh__D005609smesh__D007287
% 217.12/217.28  |- mesh__recordOriginator mesh__D005609 NLM
% 217.12/217.28  |- mesh__recordAuthorizer mesh__D005609 PLS
% 217.12/217.28  |- mesh__publicMeSHNote mesh__D005609 76   
% 217.12/217.28  |- rdf__type mesh__D005609sskos__Concept
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005609 2003
% 217.12/217.28  |- mesh__dateCreated mesh__D005609 1999-01-01
% 217.12/217.28  |- skos__related mesh__D005609smesh__D019097
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005609 1999
% 217.12/217.28  |- mesh__activeMeSHYear mesh__D005609 2002
% 217.12/217.28  |- skos__historyNote mesh__D005609 Chemistry, Physical %28%1966%29%
% 217.12/217.28  |- skos__historyNote mesh__D005609 Electron Spin Resonance %28%1966%29%
% 217.12/217.28  |- mesh__historyNote mesh__D005609 76%28%67%29%   
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D005609 1998
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D005609 2001
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D005609 2006
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D005609 1997
% 217.12/217.29  |- mesh__dateRevised mesh__D005609 1995-05-31
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D005609 2000
% 217.12/217.29  |- skos__annotation mesh__D016331
% 217.12/217.29       do not use /util except by MeSH definition; DF: HPN   
% 217.12/217.29  |- skos__altLabel mesh__D016331 Home Parenteral Nutrition
% 217.12/217.29  |- mesh__publicMeSHNote mesh__D016331
% 217.12/217.29       92; was HOME PARENTERAL NUTRITION 1991   
% 217.12/217.29  |- mesh__historyNote mesh__D016331
% 217.12/217.29       92; was HOME PARENTERAL NUTRITION 1991   
% 217.12/217.29  |- skos__hiddenLabel mesh__D016331 Feeding, Home Parenteral
% 217.12/217.29  |- skos__altLabel mesh__D016331 Parenteral Feeding, Home
% 217.12/217.29  |- mesh__recordOriginator mesh__D016331 MXR
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D016331 2006
% 217.12/217.29  |- mesh__dateEstablished mesh__D016331 1991-01-01
% 217.12/217.29  |- mesh__dateCreated mesh__D016331 1990-05-29
% 217.12/217.29  |- skos__historyNote mesh__D016331 Parenteral Feeding %28%1974-1990%29%
% 217.12/217.29  |- mesh__dateRevised mesh__D016331 2003-07-09
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D016331 2005
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D016331 2004
% 217.12/217.29  |- skos__broader mesh__D016331smesh__D006699
% 217.12/217.29  |- mesh__onlineNote mesh__D016331
% 217.12/217.29       use PARENTERAL NUTRITION, HOME to search HOME PARENTERAL NUTRITION 1991%A%  
% 217.12/217.29  |- rdf__type mesh__D016331sskos__Concept
% 217.12/217.29  |- skos__scopeNote mesh__D016331
% 217.12/217.29       The at-home administering of nutrients for assimilation and utilization by a patient who cannot maintain adequate nutrition by enteral feeding alone. Nutrients are administered via a route other than the alimentary canal %28%e.g., intravenously, subcutaneously%29%.%A%    
% 217.12/217.29  |- skos__altLabel mesh__D016331 Nutrition, Home Parenteral
% 217.12/217.29  |- mesh__recordAuthorizer mesh__D016331 sjn
% 217.12/217.29  |- skos__broader mesh__D016331smesh__D010288
% 217.12/217.29  |- skos__prefLabel mesh__D016331 Parenteral Nutrition, Home
% 217.12/217.29  |- mesh__recordMaintainer mesh__D016331 lkt
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D030002 2005
% 217.12/217.29  |- mesh__dateCreated mesh__D030002 2001-07-25
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D030002 2003
% 217.12/217.29  |- mesh__dateRevised mesh__D030002 2002-07-03
% 217.12/217.29  |- rdf__type mesh__D030002sskos__Concept
% 217.12/217.29  |- skos__annotation mesh__D030002
% 217.12/217.29       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.12/217.29  |- skos__prefLabel mesh__D030002 Heracleum
% 217.12/217.29  |- skos__scopeNote mesh__D030002
% 217.12/217.29       A plant genus of the family APIACEAE. Members contain COUMARINS.%A%    
% 217.12/217.29  |- mesh__historyNote mesh__D030002 2002   
% 217.12/217.29  |- mesh__dateEstablished mesh__D030002 2002-01-01
% 217.12/217.29  |- mesh__publicMeSHNote mesh__D030002 2002   
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D030002 2006
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D030002 2004
% 217.12/217.29  |- skos__broader mesh__D030002smesh__D019661
% 217.12/217.29  |- skos__broader mesh__D002311smesh__D009202
% 217.12/217.29  |- skos__altLabel mesh__D002311 Dilated Cardiomyopathy
% 217.12/217.29  |- mesh__dateCreated mesh__D002311 1983-05-31
% 217.12/217.29  |- rdf__type mesh__D002311sskos__Concept
% 217.12/217.29  |- mesh__recordAuthorizer mesh__D002311 sjn
% 217.12/217.29  |- skos__hiddenLabel mesh__D002311 Congestive Cardiomyopathies
% 217.12/217.29  |- skos__hiddenLabel mesh__D002311 Cardiomyopathies, Dilated
% 217.12/217.29  |- mesh__historyNote mesh__D002311 2005 %28%1984%29%   
% 217.12/217.29  |- mesh__recordOriginator mesh__D002311 VDK
% 217.12/217.29  |- skos__altLabel mesh__D002311 Congestive Cardiomyopathy
% 217.12/217.29  |- mesh__recordMaintainer mesh__D002311 lkt
% 217.12/217.29  |- skos__broader mesh__D002311smesh__D006333
% 217.12/217.29  |- skos__hiddenLabel mesh__D002311 Cardiomyopathies, Congestive
% 217.12/217.29  |- mesh__dateEstablished mesh__D002311 1986-01-01
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D002311 2006
% 217.12/217.29  |- skos__hiddenLabel mesh__D002311 Dilated Cardiomyopathies
% 217.12/217.29  |- skos__historyNote mesh__D002311 Myocardial Diseases %28%1979-1983%29%
% 217.12/217.29  |- skos__hiddenLabel mesh__D002311 Idiopathic Cardiomyopathy, Familial
% 217.12/217.29  |- skos__historyNote mesh__D002311
% 217.12/217.29       Heart Failure, Congestive %28%1966-1983%29%
% 217.12/217.29  |- mesh__dateRevised mesh__D002311 2004-07-07
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D002311 2005
% 217.12/217.29  |- skos__hiddenLabel mesh__D002311 Cardiomyopathies, Familial Idiopathic
% 217.12/217.29  |- skos__annotation mesh__D002311
% 217.12/217.29       note X ref CARDIOMYOPATHY, CONGESTIVE: do not confuse with HEART FAILURE, CONGESTIVE%A%  
% 217.12/217.29  |- skos__altLabel mesh__D002311 Cardiomyopathy, Dilated, CMD1A
% 217.12/217.29  |- skos__altLabel mesh__D002311 Cardiomyopathy, Dilated, LMNA
% 217.12/217.29  |- skos__altLabel mesh__D002311
% 217.12/217.29       Cardiomyopathy, Dilated, with Conduction Deffect1
% 217.12/217.29  |- skos__hiddenLabel mesh__D002311 Idiopathic Cardiomyopathies, Familial
% 217.12/217.29  |- skos__prefLabel mesh__D002311 Cardiomyopathy, Dilated
% 217.12/217.29  |- skos__hiddenLabel mesh__D002311 Familial Idiopathic Cardiomyopathies
% 217.12/217.29  |- skos__broader mesh__D002311smesh__D006332
% 217.12/217.29  |- skos__hiddenLabel mesh__D002311 Familial Idiopathic Cardiomyopathy
% 217.12/217.29  |- mesh__publicMeSHNote mesh__D002311
% 217.12/217.29       2005; see CARDIOMYOPATHY, CONGESTIVE 1986-2004, see HEART FAILURE, CONGESTIVE 1984-1985%A%  
% 217.12/217.29  |- skos__altLabel mesh__D002311 Cardiomyopathy, Congestive
% 217.12/217.29  |- skos__scopeNote mesh__D002311
% 217.12/217.29       A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, contractile dysfunction of the left or both HEART VENTRICLES, and congestive heart failure %28%HEART FAILURE, CONGESTIVE%29% symptoms. Risk factors include ETHANOL and TOBACCO abuse, PREGNANCY; HYPERTENSION; INFECTION; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.%A%    
% 217.12/217.29  |- skos__hiddenLabel mesh__D015239 Sulfotransferase B, Catecholamine
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D015239 2006
% 217.12/217.29  |- skos__altLabel mesh__D015239 Aryl Sulfotransferase
% 217.12/217.29  |- skos__altLabel mesh__D015239 Phenol Sulfotransferase
% 217.12/217.29  |- skos__scopeNote mesh__D015239
% 217.12/217.29       A sulfotransferase that catalyzes the sulfation of a phenol in the presence of 3%27%-phosphoadenylylsulfate as sulfate donor to yield an aryl sulfate and adenosine 3%27%,5%27%-bisphosphate. A number of aromatic compounds can act as acceptors; however, organic hydroxylamines are not substrates. Sulfate conjugation by this enzyme is a major pathway for the biotransformation of phenolic and catechol drugs as well as neurotransmitters. EC 2.8.2.1.%A%    
% 217.12/217.29  |- skos__hiddenLabel mesh__D015239 Sulfotransferase P, Phenol
% 217.12/217.29  |- skos__altLabel mesh__D015239 Phenolsulfokinase
% 217.12/217.29  |- mesh__publicMeSHNote mesh__D015239 89   
% 217.12/217.29  |- skos__historyNote mesh__D015239 Sulfurtransferases %28%1972-1988%29%
% 217.12/217.29  |- mesh__recordOriginator mesh__D015239 RLS
% 217.12/217.29  |- skos__altLabel mesh__D015239 Sulfokinase
% 217.12/217.29  |- rdf__type mesh__D015239sskos__Concept
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D015239 2005
% 217.12/217.29  |- skos__broader mesh__D015239smesh__D015238
% 217.12/217.29  |- skos__historyNote mesh__D015239 Transferases %28%1966-1971%29%
% 217.12/217.29  |- skos__altLabel mesh__D015239 Phenol Sulfokinase
% 217.12/217.29  |- skos__hiddenLabel mesh__D015239 Sulphotransferase, Acetaminophen
% 217.12/217.29  |- mesh__dateRevised mesh__D015239 2003-07-09
% 217.12/217.29  |- skos__hiddenLabel mesh__D015239 Sulfotransferase, Aryl
% 217.12/217.29  |- skos__altLabel mesh__D015239 Phenol Sulfotransferase P
% 217.12/217.29  |- mesh__historyNote mesh__D015239 89   
% 217.12/217.29  |- skos__hiddenLabel mesh__D015239 Sulfotransferase M, Phenol
% 217.12/217.29  |- mesh__dateCreated mesh__D015239 1988-05-14
% 217.12/217.29  |- mesh__recordMaintainer mesh__D015239 ssb
% 217.12/217.29  |- skos__hiddenLabel mesh__D015239 Sulfotransferase A, Catecholamine
% 217.12/217.29  |- mesh__recordAuthorizer mesh__D015239 sjn
% 217.12/217.29  |- skos__prefLabel mesh__D015239 Arylsulfotransferase
% 217.12/217.29  |- skos__hiddenLabel mesh__D015239 Sulfotransferase, Flavonoid
% 217.12/217.29  |- skos__hiddenLabel mesh__D015239 Sulfotransferase, Dopamine
% 217.12/217.29  |- mesh__dateEstablished mesh__D015239 1989-01-01
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D015239 2004
% 217.12/217.29  |- skos__hiddenLabel mesh__D015239 Sulfotransferase, Phenol
% 217.12/217.29  |- skos__altLabel mesh__D001219 Serum Glutamic-Oxaloacetic Transaminase
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D001219 2005
% 217.12/217.29  |- skos__hiddenLabel mesh__D001219 Transaminase, Aspartate
% 217.12/217.29  |- skos__hiddenLabel mesh__D001219 Apoaminotransferase, Aspartate
% 217.12/217.29  |- skos__altLabel mesh__D001219 Glutamate-Aspartate Transaminase
% 217.12/217.29  |- mesh__recordAuthorizer mesh__D001219 sjn
% 217.12/217.29  |- skos__altLabel mesh__D001219 L-Aspartate-2-Oxoglutarate Aminotransferase
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D001219 2004
% 217.12/217.29  |- skos__prefLabel mesh__D001219 Aspartate Aminotransferases
% 217.12/217.29  |- skos__hiddenLabel mesh__D001219 Transaminase, Serum Glutamic-Oxaloacetic
% 217.12/217.29  |- skos__altLabel mesh__D001219 Glutamic-Oxaloacetic Transaminase
% 217.12/217.29  |- skos__hiddenLabel mesh__D001219
% 217.12/217.29       Aminotransferase, L-Aspartate-2-Oxoglutarate
% 217.12/217.29  |- skos__hiddenLabel mesh__D001219 Transaminase, Glutamic-Oxaloacetic
% 217.12/217.29  |- skos__broader mesh__D001219smesh__D000637
% 217.12/217.29  |- skos__hiddenLabel mesh__D001219 Glutamic Oxaloacetic Transaminase
% 217.12/217.29  |- mesh__recordMaintainer mesh__D001219 ssb
% 217.12/217.29  |- skos__hiddenLabel mesh__D001219 Aminotransferase, Aspartate
% 217.12/217.29  |- skos__altLabel mesh__D001219 Aspartate Aminotransferase
% 217.12/217.29  |- skos__altLabel mesh__D001219 Aspartate Transaminase
% 217.12/217.29  |- skos__hiddenLabel mesh__D001219 Aminotransferases, Aspartate
% 217.12/217.29  |- skos__scopeNote mesh__D001219
% 217.12/217.29       Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1.%A%    
% 217.12/217.29  |- skos__hiddenLabel mesh__D001219 Serum Glutamic Oxaloacetic Transaminase
% 217.12/217.29  |- rdf__type mesh__D001219sskos__Concept
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D001219 2006
% 217.12/217.29  |- skos__hiddenLabel mesh__D001219 Glutamate Aspartate Transaminase
% 217.12/217.29  |- skos__hiddenLabel mesh__D001219 Glutamic-Oxaloacetic Transaminase, Serum
% 217.12/217.29  |- skos__hiddenLabel mesh__D001219
% 217.12/217.29       L Aspartate 2 Oxoglutarate Aminotransferase
% 217.12/217.29  |- skos__annotation mesh__D001219 note specifics   
% 217.12/217.29  |- mesh__dateRevised mesh__D001219 2003-07-09
% 217.12/217.29  |- mesh__historyNote mesh__D001219 2002%28%1963%29%   
% 217.12/217.29  |- mesh__publicMeSHNote mesh__D001219
% 217.12/217.29       2002; see ASPARTATE TRANSAMINASE 1998-2002, see ASPARTATE AMINOTRANSFERASE 1963-1997%A%  
% 217.12/217.29  |- skos__altLabel mesh__D001219 Aspartate Apoaminotransferase
% 217.12/217.29  |- mesh__recordOriginator mesh__D001219 NLM
% 217.12/217.29  |- mesh__dateCreated mesh__D001219 1999-01-01
% 217.12/217.29  |- skos__hiddenLabel mesh__D001219 Transaminase, Glutamate-Aspartate
% 217.12/217.29  |- skos__scopeNote mesh__D006702
% 217.12/217.29       Instinctual patterns of activity related to a specific area including ability of certain animals to return to a given place when displaced from it, often over great distances using navigational clues such as those used in migration %28%ANIMAL MIGRATION%29%.%A%    
% 217.12/217.29  |- skos__hiddenLabel mesh__D006702 Behavior, Homing
% 217.12/217.29  |- skos__historyNote mesh__D006702 Behavior, Animal %28%1966-1967%29%
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D006702 2004
% 217.12/217.29  |- skos__hiddenLabel mesh__D006702 Ranges, Home
% 217.12/217.29  |- mesh__dateEstablished mesh__D006702 1968-01-01
% 217.12/217.29  |- mesh__recordOriginator mesh__D006702 NLM
% 217.12/217.29  |- rdf__type mesh__D006702sskos__Concept
% 217.12/217.29  |- skos__hiddenLabel mesh__D006702 Behaviors, Homing
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D006702 2003
% 217.12/217.29  |- skos__related mesh__D006702smesh__D025041
% 217.12/217.29  |- mesh__publicMeSHNote mesh__D006702 98; see HOME RANGE 1968-97   
% 217.12/217.29  |- skos__hiddenLabel mesh__D006702 Home Ranges
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D006702 2006
% 217.12/217.29  |- mesh__recordMaintainer mesh__D006702 ags
% 217.12/217.29  |- mesh__dateRevised mesh__D006702 2002-07-02
% 217.12/217.29  |- skos__hiddenLabel mesh__D006702 Homing Behaviors
% 217.12/217.29  |- mesh__recordAuthorizer mesh__D006702 sjn
% 217.12/217.29  |- skos__hiddenLabel mesh__D006702 Range, Home
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D006702 2005
% 217.12/217.29  |- skos__prefLabel mesh__D006702 Homing Behavior
% 217.12/217.29  |- skos__broader mesh__D006702smesh__D001522
% 217.12/217.29  |- mesh__historyNote mesh__D006702 98;%28%68%29%   
% 217.12/217.29  |- mesh__dateCreated mesh__D006702 1999-01-01
% 217.12/217.29  |- skos__broader mesh__D011647smesh__D014900
% 217.12/217.29  |- mesh__dateCreated mesh__D011647 1999-01-01
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D011647 2004
% 217.12/217.29  |- skos__scopeNote mesh__D011647
% 217.12/217.29       An island in the Greater Antilles in the West Indies. Its capital is San Juan. It is a self-governing commonwealth in union with the United States. It was discovered by Columbus in 1493 but no colonization was attempted until 1508. It belonged to Spain until ceded to the United States in 1898. It became a commonwealth with autonomy in internal affairs in 1952. Columbus named the island San Juan for St. John%27%s Day, the Monday he arrived, and the bay Puerto Rico, rich harbor. The island became Puerto Rico officially in 1932. %28%From Webster%27%s New Geographical Dictionary, 1988, p987 %26% Room, Brewer%27%s Dictionary of Names, 1992, p436%29%%A%    
% 217.12/217.29  |- mesh__recordAuthorizer mesh__D011647 PLS
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D011647 2005
% 217.12/217.29  |- skos__annotation mesh__D011647
% 217.12/217.29       an island in the Greater Antilles in the West Indies; for Puerto Rico as a geog entity %28%as in epidemiol articles%29% %26% for Puerto Ricans in Puerto Rico; for Puerto Ricans living in the United States as an ethnic group, coord PUERTO RICO /ethnol %28%NIM%29% + HISPANIC AMERICANS %28%IM%29%%A%  
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D011647 2003
% 217.12/217.29  |- rdf__type mesh__D011647sskos__Concept
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D011647 1999
% 217.12/217.29  |- mesh__recordMaintainer mesh__D011647 TGC
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D011647 1997
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D011647 2001
% 217.12/217.29  |- mesh__dateRevised mesh__D011647 1995-02-21
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D011647 2000
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D011647 1998
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D011647 1996
% 217.12/217.29  |- mesh__recordOriginator mesh__D011647 NLM
% 217.12/217.29  |- skos__prefLabel mesh__D011647 Puerto Rico
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D011647 2006
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D011647 2002
% 217.12/217.29  |- skos__hiddenLabel mesh__D044023 Endothelin B 2 Receptors
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D044023 2005
% 217.12/217.29  |- mesh__dateEstablished mesh__D044023 2004-01-01
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D044023 2006
% 217.12/217.29  |- skos__hiddenLabel mesh__D044023 Receptors, Endothelin B
% 217.12/217.29  |- skos__altLabel mesh__D044023 Endothelin B-2 Receptors
% 217.12/217.29  |- skos__prefLabel mesh__D044023 Receptor, Endothelin B
% 217.12/217.29  |- mesh__recordOriginator mesh__D044023 jmp
% 217.12/217.29  |- rdf__type mesh__D044023sskos__Concept
% 217.12/217.29  |- skos__altLabel mesh__D044023 Endothelin B Receptors
% 217.12/217.29  |- skos__historyNote mesh__D044023 Receptors, Endothelin %28%1993-2003%29%
% 217.12/217.29  |- skos__broader mesh__D044023smesh__D017466
% 217.12/217.29  |- mesh__dateCreated mesh__D044023 2003-07-09
% 217.12/217.29  |- skos__scopeNote mesh__D044023
% 217.12/217.29       A subtype of endothelin receptor found predominantly in the KIDNEY. It may play a role in reducing systemic ENDOTHELIN levels.%A%    
% 217.12/217.29  |- skos__hiddenLabel mesh__D044023 Receptors, Endothelin B-2
% 217.12/217.29  |- skos__altLabel mesh__D044023 Endothelin B-2 Receptor
% 217.12/217.29  |- skos__hiddenLabel mesh__D044023 Endothelin B 2 Receptor
% 217.12/217.29  |- mesh__historyNote mesh__D044023
% 217.12/217.29       2004; use RECEPTOR, ENDOTHELIN B %28%NM%29% 1993-2003   
% 217.12/217.29  |- mesh__recordMaintainer mesh__D044023 jmp
% 217.12/217.29  |- skos__hiddenLabel mesh__D044023 Receptor, Endothelin B-2
% 217.12/217.29  |- mesh__publicMeSHNote mesh__D044023
% 217.12/217.29       2004; ENDOTHELIN B RECEPTOR  was indexed under RECEPTORS, ENDOTHELIN 1993-2003; ENDOTHELIN B-2 RECEPTOR was indexed under RECEPTORS, ENDOTHELIN 1998-2003%A%  
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D044023 2004
% 217.12/217.29  |- skos__hiddenLabel mesh__D044023 Endothelin B Receptor
% 217.12/217.29  |- mesh__recordAuthorizer mesh__D044023 sjn
% 217.12/217.29  |- skos__hiddenLabel mesh__D030801 Engineered Animals, Genetically
% 217.12/217.29  |- skos__hiddenLabel mesh__D030801 Transgenic Founder Animal
% 217.12/217.29  |- skos__hiddenLabel mesh__D030801 Transgenic Founder Animals
% 217.12/217.29  |- skos__annotation mesh__D030801 coord with specific animal /genet   
% 217.12/217.29  |- skos__hiddenLabel mesh__D030801 Animal, Transgenic
% 217.12/217.29  |- skos__altLabel mesh__D030801 Genetically Modified Animals
% 217.12/217.29  |- mesh__dateRevised mesh__D030801 2005-06-30
% 217.12/217.29  |- skos__hiddenLabel mesh__D030801 Founder Animal, Transgenic
% 217.12/217.29  |- mesh__historyNote mesh__D030801 2002   
% 217.12/217.29  |- skos__hiddenLabel mesh__D030801 Animals, GMO
% 217.12/217.29  |- skos__hiddenLabel mesh__D030801 Engineered Animal, Genetically
% 217.12/217.29  |- skos__hiddenLabel mesh__D030801 Animal, Genetically Modified
% 217.12/217.29  |- skos__related mesh__D030801smesh__D019076
% 217.12/217.29  |- skos__hiddenLabel mesh__D030801 Animal, Genetically Engineered
% 217.12/217.29  |- mesh__dateCreated mesh__D030801 2001-07-25
% 217.12/217.29  |- skos__related mesh__D030801smesh__D005818
% 217.12/217.29  |- skos__hiddenLabel mesh__D030801 Genetically Modified Animal
% 217.12/217.29  |- skos__altLabel mesh__D030801 Genetically Engineered Animals
% 217.12/217.29  |- skos__hiddenLabel mesh__D030801 Animal, GMO
% 217.12/217.29  |- skos__hiddenLabel mesh__D030801 Animals, Genetically Engineered
% 217.12/217.29  |- skos__hiddenLabel mesh__D030801 Modified Animal, Genetically
% 217.12/217.29  |- skos__hiddenLabel mesh__D030801 Animals, Transgenic Founder
% 217.12/217.29  |- skos__hiddenLabel mesh__D030801 Genetically Engineered Animal
% 217.12/217.29  |- skos__broader mesh__D030801smesh__D030781
% 217.12/217.29  |- mesh__dateEstablished mesh__D030801 2002-01-01
% 217.12/217.29  |- skos__hiddenLabel mesh__D030801 Transgenic Animal
% 217.12/217.29  |- mesh__recordOriginator mesh__D030801 nns
% 217.12/217.29  |- rdf__type mesh__D030801sskos__Concept
% 217.12/217.29  |- skos__prefLabel mesh__D030801 Animals, Genetically Modified
% 217.12/217.29  |- skos__hiddenLabel mesh__D030801 Modified Animals, Genetically
% 217.12/217.29  |- skos__scopeNote mesh__D030801
% 217.12/217.29       ANIMALS whose GENOME has been altered by GENETIC ENGINEERING, or their offspring.%A%    
% 217.12/217.29  |- mesh__recordMaintainer mesh__D030801 jls
% 217.12/217.29  |- skos__altLabel mesh__D030801 GMO Animals
% 217.12/217.29  |- skos__altLabel mesh__D030801 Transgenic Animals
% 217.12/217.29  |- skos__hiddenLabel mesh__D030801 Animal, Transgenic Founder
% 217.12/217.29  |- skos__related mesh__D030801smesh__D030841
% 217.12/217.29  |- skos__hiddenLabel mesh__D030801 GMO Animal
% 217.12/217.29  |- mesh__recordAuthorizer mesh__D030801 sjn
% 217.12/217.29  |- mesh__publicMeSHNote mesh__D030801
% 217.12/217.29       2002; ANIMALS, TRANSGENIC was heading 1988-2001   
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D030801 2006
% 217.12/217.29  |- skos__hiddenLabel mesh__D016332 Donations, Fetal Tissue
% 217.12/217.29  |- mesh__recordOriginator mesh__D016332 PXP
% 217.12/217.29  |- skos__hiddenLabel mesh__D016332 Graftings, Fetal Tissue
% 217.12/217.29  |- skos__related mesh__D016332smesh__D033042
% 217.12/217.29  |- skos__hiddenLabel mesh__D016332 Fetal Tissue Graftings
% 217.12/217.29  |- skos__hiddenLabel mesh__D016332 Fetal Tissue Donations
% 217.12/217.29  |- skos__annotation mesh__D016332
% 217.12/217.29       fetal or embryonic; do not use /util except by MeSH definition; coord IM with specific tissue in Cat A16 /transpl %28%IM or NIM%29% or specific fetal organ /embryol %28%IM or NIM%29% + specific fetal organ /transpl %28%IM or NIM%29%; do not coord with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; transpl of fetal brain tissue: coord IM with BRAIN TISSUE TRANSPLANTATION %28%IM%29% + specific brain tissue /transpl + /embryol if pertinent %28%IM or NIM%29%%A%  
% 217.12/217.29  |- skos__hiddenLabel mesh__D016332 Tissue Graftings, Fetal
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D016332 2005
% 217.12/217.29  |- skos__broader mesh__D016332smesh__D016378
% 217.12/217.29  |- skos__prefLabel mesh__D016332 Fetal Tissue Transplantation
% 217.12/217.29  |- mesh__recordAuthorizer mesh__D016332 sjn
% 217.12/217.29  |- skos__hiddenLabel mesh__D016332 Tissue Transplantation, Fetal
% 217.12/217.29  |- mesh__historyNote mesh__D016332 91   
% 217.12/217.29  |- mesh__dateRevised mesh__D016332 2002-07-03
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D016332 2003
% 217.12/217.29  |- skos__hiddenLabel mesh__D016332 Tissue Donation, Fetal
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D016332 2006
% 217.12/217.29  |- skos__hiddenLabel mesh__D016332 Tissue Donations, Fetal
% 217.12/217.29  |- skos__altLabel mesh__D016332 Grafting, Fetal Tissue
% 217.12/217.29  |- skos__hiddenLabel mesh__D016332 Fetal Tissue Grafting
% 217.12/217.29  |- skos__hiddenLabel mesh__D016332 Tissue Grafting, Fetal
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D016332 2004
% 217.12/217.29  |- skos__scopeNote mesh__D016332
% 217.12/217.29       Transference of fetal tissue between individuals of the same species or between individuals of different species.%A%    
% 217.12/217.29  |- skos__historyNote mesh__D016332 Fetus %28%1968-1990%29%
% 217.12/217.29  |- skos__altLabel mesh__D016332 Transplantation, Fetal Tissue
% 217.12/217.29  |- mesh__recordMaintainer mesh__D016332 jrf
% 217.12/217.29  |- mesh__publicMeSHNote mesh__D016332 91   
% 217.12/217.29  |- skos__hiddenLabel mesh__D016332 Tissue Transplantations, Fetal
% 217.12/217.29  |- rdf__type mesh__D016332sskos__Concept
% 217.12/217.29  |- skos__historyNote mesh__D016332
% 217.12/217.29       Transplantation, Homologous %28%1968-1990%29%
% 217.12/217.29  |- skos__hiddenLabel mesh__D016332 Transplantations, Fetal Tissue
% 217.12/217.29  |- skos__hiddenLabel mesh__D016332 Donation, Fetal Tissue
% 217.12/217.29  |- mesh__dateCreated mesh__D016332 1990-05-25
% 217.12/217.29  |- skos__hiddenLabel mesh__D016332 Fetal Tissue Transplantations
% 217.12/217.29  |- mesh__dateEstablished mesh__D016332 1991-01-01
% 217.12/217.29  |- skos__broader mesh__D030003smesh__D019661
% 217.12/217.29  |- mesh__dateCreated mesh__D030003 2001-07-25
% 217.12/217.29  |- mesh__dateRevised mesh__D030003 2002-07-03
% 217.12/217.29  |- skos__scopeNote mesh__D030003 A plant genus of the family APIACEAE.     
% 217.12/217.29  |- mesh__dateEstablished mesh__D030003 2002-01-01
% 217.12/217.29  |- skos__annotation mesh__D030003
% 217.12/217.29       note X ref ALPINE LOVAGE: LOVAGE see LIGUSTICUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.12/217.29  |- mesh__publicMeSHNote mesh__D030003 2002   
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D030003 2006
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D030003 2004
% 217.12/217.29  |- mesh__historyNote mesh__D030003 2002   
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D030003 2005
% 217.12/217.29  |- skos__altLabel mesh__D030003 Lovage
% 217.12/217.29  |- skos__prefLabel mesh__D030003 Levisticum
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D030003 2003
% 217.12/217.29  |- rdf__type mesh__D030003sskos__Concept
% 217.12/217.29  |- skos__hiddenLabel mesh__D002312 Septal Hypertrophies, Asymmetric
% 217.12/217.29  |- skos__hiddenLabel mesh__D002312
% 217.12/217.29       Obstructive Cardiomyopathies, Hypertrophic
% 217.12/217.29  |- skos__hiddenLabel mesh__D002312 Cardiomyopathies, Hypertrophic
% 217.12/217.29  |- skos__altLabel mesh__D002312 IHSS
% 217.12/217.29  |- skos__prefLabel mesh__D002312 Cardiomyopathy, Hypertrophic
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D002312 2006
% 217.12/217.29  |- skos__altLabel mesh__D002312
% 217.12/217.29       Subvalvular Stenosis, Idiopathic Hypertrophic
% 217.12/217.29  |- skos__broader mesh__D002312smesh__D009202
% 217.12/217.29  |- mesh__recordAuthorizer mesh__D002312 ags
% 217.12/217.29  |- skos__hiddenLabel mesh__D002312 Asymmetric Septal Hypertrophies
% 217.12/217.29  |- skos__hiddenLabel mesh__D002312 IHSSs
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D002312 2005
% 217.12/217.29  |- mesh__dateCreated mesh__D002312 1999-01-01
% 217.12/217.29  |- skos__hiddenLabel mesh__D002312
% 217.12/217.29       Hypertrophic Obstructive Cardiomyopathies
% 217.12/217.29  |- skos__scopeNote mesh__D002312
% 217.12/217.29       A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy %28%HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR%29%, frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; %28%FAMILIAL HYPERTROPHIC CARDIOMYOPATHY%29%.%A%    
% 217.12/217.29  |- skos__hiddenLabel mesh__D002312 Hypertrophy, Asymmetric Septal
% 217.12/217.29  |- mesh__historyNote mesh__D002312
% 217.12/217.29       86; was IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1966-85%A%  
% 217.12/217.29  |- skos__hiddenLabel mesh__D002312 Hypertrophic Cardiomyopathies
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D002312 2006A
% 217.12/217.29  |- mesh__recordMaintainer mesh__D002312 ags
% 217.12/217.29  |- mesh__recordOriginator mesh__D002312 NLM
% 217.12/217.29  |- skos__altLabel mesh__D002312
% 217.12/217.29       Idiopathic Hypertrophic Subvalvular Stenosis
% 217.12/217.29  |- skos__hiddenLabel mesh__D002312
% 217.12/217.29       Cardiomyopathies, Hypertrophic Obstructive
% 217.12/217.29  |- mesh__publicMeSHNote mesh__D002312
% 217.12/217.29       86; was IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1966-85%A%  
% 217.12/217.29  |- skos__hiddenLabel mesh__D002312 Obstructive Cardiomyopathy, Hypertrophic
% 217.12/217.29  |- skos__hiddenLabel mesh__D002312 Hypertrophies, Asymmetric Septal
% 217.12/217.29  |- skos__hiddenLabel mesh__D002312 Hypertrophic Cardiomyopathy
% 217.12/217.29  |- mesh__dateRevised mesh__D002312 2005-07-20
% 217.12/217.29  |- mesh__dateEstablished mesh__D002312 1966-01-01
% 217.12/217.29  |- rdf__type mesh__D002312sskos__Concept
% 217.12/217.29  |- skos__hiddenLabel mesh__D002312 Hypertrophic Obstructive Cardiomyopathy
% 217.12/217.29  |- skos__broader mesh__D002312smesh__D001020
% 217.12/217.29  |- skos__annotation mesh__D002312
% 217.12/217.29       do not confuse with CARDIAC HYPERTROPHY see CARDIOMEGALY   
% 217.12/217.29  |- mesh__onlineNote mesh__D002312
% 217.12/217.29       use CARDIOMYOPATHY, HYPERTROPHIC to search IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1966-85%A%  
% 217.12/217.29  |- skos__hiddenLabel mesh__D002312 Septal Hypertrophy, Asymmetric
% 217.12/217.29  |- skos__altLabel mesh__D002312 Cardiomyopathy, Hypertrophic Obstructive
% 217.12/217.29  |- skos__annotation mesh__D012740 no qualif   
% 217.12/217.29  |- skos__hiddenLabel mesh__D012740 Manuals, Sex
% 217.12/217.29  |- rdf__type mesh__D012740sskos__Concept
% 217.12/217.29  |- mesh__recordAuthorizer mesh__D012740 sjn
% 217.12/217.29  |- skos__hiddenLabel mesh__D012740 Manual, Sex
% 217.12/217.29  |- mesh__recordMaintainer mesh__D012740 ags
% 217.12/217.29  |- skos__prefLabel mesh__D012740 Sex Manuals
% 217.12/217.29  |- skos__broader mesh__D012740smesh__D008370
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D012740 2005
% 217.12/217.29  |- skos__hiddenLabel mesh__D012740 Sex Manual
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D012740 2006
% 217.12/217.29  |- mesh__recordOriginator mesh__D012740 NLM
% 217.12/217.29  |- mesh__dateCreated mesh__D012740 1999-01-01
% 217.12/217.29  |- skos__scopeNote mesh__D012740
% 217.12/217.29       Books used for sex education and procedural instruction.%A%    
% 217.12/217.29  |- mesh__dateRevised mesh__D012740 2004-07-07
% 217.12/217.29  |- mesh__recordMaintainer mesh__D006703 PLS
% 217.12/217.29  |- mesh__recordOriginator mesh__D006703 EC
% 217.12/217.29  |- rdf__type mesh__D006703sskos__Concept
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D006703 1996
% 217.12/217.29  |- skos__hiddenLabel mesh__D006703 Alcoholics, Skid Row
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D006703 2004
% 217.12/217.29  |- skos__hiddenLabel mesh__D006703 Homeless Person
% 217.12/217.29  |- skos__prefLabel mesh__D006703 Homeless Persons
% 217.12/217.29  |- mesh__dateCreated mesh__D006703 1985-03-20
% 217.12/217.29  |- skos__hiddenLabel mesh__D006703 Skid Row Alcoholic
% 217.12/217.29  |- skos__hiddenLabel mesh__D006703 Person, Homeless
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D006703 2001
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D006703 2003
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D006703 1999
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D006703 2000
% 217.12/217.29  |- mesh__historyNote mesh__D006703
% 217.12/217.29       86; SKID ROW ALCOHOLICS was heading 1975-95 %28%see under ALCOHOLISM 1975%29%%A%  
% 217.12/217.29  |- skos__annotation mesh__D006703
% 217.12/217.29       not for nomads; note X ref SKID ROW ALCOHOLICS: do not coord with ALCOHOLISM unless particularly discussed as the disease%A%  
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D006703 1998
% 217.12/217.29  |- mesh__publicMeSHNote mesh__D006703
% 217.12/217.29       86; SKID ROW ALCOHOLICS was heading 1975-95 %28%see under ALCOHOLISM 1975%29%%A%  
% 217.12/217.29  |- skos__hiddenLabel mesh__D006703 People, Street
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D006703 2006
% 217.12/217.29  |- skos__hiddenLabel mesh__D006703 Alcoholic, Skid Row
% 217.12/217.29  |- skos__broader mesh__D006703smesh__D009272
% 217.12/217.29  |- skos__historyNote mesh__D006703
% 217.12/217.29       Transients and Migrants %28%1966-1985%29%
% 217.12/217.29  |- skos__hiddenLabel mesh__D006703 Persons, Homeless
% 217.12/217.29  |- mesh__recordAuthorizer mesh__D006703 PLS
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D006703 2005
% 217.12/217.29  |- mesh__dateRevised mesh__D006703 1995-07-07
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D006703 2002
% 217.12/217.29  |- skos__scopeNote mesh__D006703
% 217.12/217.29       Persons who have no permanent residence. The concept excludes nomadic peoples.%A%    
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D006703 1997
% 217.12/217.29  |- mesh__dateEstablished mesh__D006703 1986-01-01
% 217.12/217.29  |- mesh__dateCreated mesh__D044822 2003-07-09
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D044822 2005
% 217.12/217.29  |- skos__hiddenLabel mesh__D044822 Diversity, Biological
% 217.12/217.29  |- mesh__dateEstablished mesh__D044822 2004-01-01
% 217.12/217.29  |- skos__prefLabel mesh__D044822 Biodiversity
% 217.12/217.29  |- skos__scopeNote mesh__D044822
% 217.12/217.29       The variety of all native living organisms and their various forms and interrelationships.%A%    
% 217.12/217.29  |- skos__broader mesh__D044822smesh__D017753
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D044822 2004
% 217.12/217.29  |- skos__altLabel mesh__D044822 Biological Diversity
% 217.12/217.29  |- mesh__historyNote mesh__D044822 2004; use ECOSYSTEM 1996-2003   
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D044822 2006
% 217.12/217.29  |- rdf__type mesh__D044822sskos__Concept
% 217.12/217.29  |- mesh__publicMeSHNote mesh__D044822 2004; see ECOSYSTEM 1996-2003   
% 217.12/217.29  |- skos__broader mesh__D011648smesh__D014412
% 217.12/217.29  |- mesh__activeMeSHYear mesh__D011648 2004
% 217.12/217.29  |- skos__altLabel mesh__D011648 Jaagsiekte
% 217.12/217.29  |- skos__altLabel mesh__D011648 Adenomatosis, Pulmonary, Ovine
% 217.12/217.30  |- mesh__recordOriginator mesh__D011648 NLM
% 217.12/217.30  |- skos__altLabel mesh__D011648 Pulmonary Ovine Adenomatosis
% 217.12/217.30  |- skos__hiddenLabel mesh__D011648 Adenomatosis, Pulmonary Ovine
% 217.12/217.30  |- skos__altLabel mesh__D011648 Ovine Pulmonary Carcinoma
% 217.12/217.30  |- rdf__type mesh__D011648sskos__Concept
% 217.12/217.30  |- skos__hiddenLabel mesh__D011648 Adenomatoses, Pulmonary Ovine
% 217.12/217.30  |- skos__historyNote mesh__D011648 Sheep Diseases %28%1966-1967%29%
% 217.12/217.30  |- skos__hiddenLabel mesh__D011648 Pulmonary Carcinomas, Ovine
% 217.12/217.30  |- mesh__recordAuthorizer mesh__D011648 sjn
% 217.12/217.30  |- skos__broader mesh__D011648smesh__D012192
% 217.12/217.30  |- skos__altLabel mesh__D011648 Adenomatosis, Ovine Pulmonary
% 217.12/217.30  |- mesh__recordMaintainer mesh__D011648 ags
% 217.16/217.30  |- mesh__dateEstablished mesh__D011648 1968-01-01
% 217.16/217.30  |- skos__broader mesh__D011648smesh__D000230
% 217.16/217.30  |- skos__scopeNote mesh__D011648
% 217.16/217.30       A contagious, neoplastic, pulmonary disease of sheep characterized by hyperplasia and hypertrophy of pneumocytes and epithelial cells of the lung. It is caused by OVINE PULMONARY ADENOCARCINOMA VIRUS.%A%    
% 217.16/217.30  |- mesh__historyNote mesh__D011648 1968   
% 217.16/217.30  |- skos__hiddenLabel mesh__D011648 Carcinomas, Ovine Pulmonary
% 217.16/217.30  |- skos__annotation mesh__D011648
% 217.16/217.30       caused by a retrovirus; don%27%t forget also SHEEP %28%NIM%29% %26% check tag ANIMALS; DF: PULM ADENOMATOSIS OVINE%A%  
% 217.16/217.30  |- skos__altLabel mesh__D011648 Ovine Pulmonary Adenomatosis
% 217.16/217.30  |- skos__hiddenLabel mesh__D011648 Ovine Pulmonary Adenomatoses
% 217.16/217.30  |- skos__hiddenLabel mesh__D011648 Pulmonary Ovine Adenomatoses
% 217.16/217.30  |- skos__hiddenLabel mesh__D011648 Ovine Adenomatoses, Pulmonary
% 217.16/217.30  |- skos__hiddenLabel mesh__D011648 Pulmonary Adenomatoses, Ovine
% 217.16/217.30  |- mesh__dateCreated mesh__D011648 1999-01-01
% 217.16/217.30  |- skos__broader mesh__D011648smesh__D012757
% 217.16/217.30  |- skos__hiddenLabel mesh__D011648 Ovine Adenomatosis, Pulmonary
% 217.16/217.30  |- skos__hiddenLabel mesh__D011648 Pulmonary Carcinoma, Ovine
% 217.16/217.30  |- skos__hiddenLabel mesh__D011648 Adenomatoses, Ovine Pulmonary
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D011648 2005
% 217.16/217.30  |- skos__prefLabel mesh__D011648 Pulmonary Adenomatosis, Ovine
% 217.16/217.30  |- skos__hiddenLabel mesh__D011648 Ovine Pulmonary Carcinomas
% 217.16/217.30  |- mesh__publicMeSHNote mesh__D011648 1968   
% 217.16/217.30  |- mesh__dateRevised mesh__D011648 2003-07-30
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D011648 2006
% 217.16/217.30  |- skos__altLabel mesh__D011648 Carcinoma, Ovine Pulmonary
% 217.16/217.30  |- skos__broader mesh__D002784Q000737smesh__D002784
% 217.16/217.30  |- rdf__type mesh__D002784Q000737smesh__CompoundConcept
% 217.16/217.30  |- mesh__dateCreated mesh__D044024 2003-07-09
% 217.16/217.30  |- skos__historyNote mesh__D044024 Naphthalenes %28%1965-2003%29%
% 217.16/217.30  |- mesh__publicMeSHNote mesh__D044024 2004   
% 217.16/217.30  |- mesh__dateEstablished mesh__D044024 2004-01-01
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D044024 2004
% 217.16/217.30  |- skos__broader mesh__D044024smesh__D013764
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D044024 2005
% 217.16/217.30  |- mesh__historyNote mesh__D044024 2004   
% 217.16/217.30  |- skos__scopeNote mesh__D044024
% 217.16/217.30       A group of TETRAHYDRONAPHTHALENES containing a keto oxygen.%A%    
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D044024 2006
% 217.16/217.30  |- skos__prefLabel mesh__D044024 Tetralones
% 217.16/217.30  |- rdf__type mesh__D044024sskos__Concept
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D016333 2005
% 217.16/217.30  |- skos__altLabel mesh__D016333 HIV Proteinase
% 217.16/217.30  |- mesh__historyNote mesh__D016333 91   
% 217.16/217.30  |- skos__hiddenLabel mesh__D016333 Protease, HTLV-III
% 217.16/217.30  |- skos__historyNote mesh__D016333
% 217.16/217.30       Peptide Peptidohydrolases %28%1987-1990%29%
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D016333 2006
% 217.16/217.30  |- mesh__dateRevised mesh__D016333 2004-07-13
% 217.16/217.30  |- skos__broader mesh__D016333smesh__D015684
% 217.16/217.30  |- mesh__recordOriginator mesh__D016333 AGS
% 217.16/217.30  |- skos__hiddenLabel mesh__D016333 Proteinase, HIV
% 217.16/217.30  |- mesh__dateCreated mesh__D016333 1990-06-07
% 217.16/217.30  |- skos__hiddenLabel mesh__D016333 HIV 1 Protease
% 217.16/217.30  |- mesh__recordAuthorizer mesh__D016333 sjn
% 217.16/217.30  |- skos__altLabel mesh__D016333 HTLV-III Protease
% 217.16/217.30  |- skos__hiddenLabel mesh__D016333 Protease, HIV-1
% 217.16/217.30  |- skos__hiddenLabel mesh__D016333 HTLV III Protease
% 217.16/217.30  |- rdf__type mesh__D016333sskos__Concept
% 217.16/217.30  |- skos__broader mesh__D016333smesh__D016282
% 217.16/217.30  |- skos__prefLabel mesh__D016333 HIV Protease
% 217.16/217.30  |- mesh__recordMaintainer mesh__D016333 sjn
% 217.16/217.30  |- skos__scopeNote mesh__D016333
% 217.16/217.30       Enzyme of the human immunodeficiency virus that is required for post-translational cleavage of gag and gag-pol precursor polyproteins into functional products needed for viral assembly. HIV protease is an aspartic protease encoded by the amino terminus of the pol gene. EC 3.4.23.-%A%    
% 217.16/217.30  |- mesh__dateEstablished mesh__D016333 1991-01-01
% 217.16/217.30  |- skos__historyNote mesh__D016333 Gene Products, pol %28%1990%29%
% 217.16/217.30  |- skos__hiddenLabel mesh__D016333 Protease, HIV
% 217.16/217.30  |- mesh__publicMeSHNote mesh__D016333 91   
% 217.16/217.30  |- skos__annotation mesh__D030004
% 217.16/217.30       note X ref ALPINE LOVAGE: LOVAGE see LEVISTICUM is also available;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.16/217.30  |- mesh__dateRevised mesh__D030004 2002-07-02
% 217.16/217.30  |- mesh__historyNote mesh__D030004 2002   
% 217.16/217.30  |- mesh__dateCreated mesh__D030004 2001-07-25
% 217.16/217.30  |- skos__prefLabel mesh__D030004 Ligusticum
% 217.16/217.30  |- skos__altLabel mesh__D030004 Lovage, Alpine
% 217.16/217.30  |- skos__altLabel mesh__D030004 Alpine Lovage
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D030004 2005
% 217.16/217.30  |- mesh__publicMeSHNote mesh__D030004 2002   
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D030004 2003
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D030004 2006
% 217.16/217.30  |- skos__broader mesh__D030004smesh__D019661
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D030004 2004
% 217.16/217.30  |- mesh__dateEstablished mesh__D030004 2002-01-01
% 217.16/217.30  |- rdf__type mesh__D030004sskos__Concept
% 217.16/217.30  |- skos__scopeNote mesh__D030004 A plant genus of the family APIACEAE.     
% 217.16/217.30  |- mesh__recordMaintainer mesh__D002313 lkt
% 217.16/217.30  |- skos__hiddenLabel mesh__D002313 Restrictive Cardiomyopathies
% 217.16/217.30  |- skos__scopeNote mesh__D002313
% 217.16/217.30       A form of CARDIAC MUSCLE disease in which the ventricular walls are excessively rigid, impeding ventricular filling. It is marked by reduced diastolic volume of either or both ventricles but normal or nearly normal systolic function. It may be idiopathic or associated with other diseases %28%ENDOMYOCARDIAL FIBROSIS or AMYLOIDOSIS%29% causing interstitial fibrosis.%A%    
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D002313 2006
% 217.16/217.30  |- mesh__publicMeSHNote mesh__D002313 86   
% 217.16/217.30  |- skos__hiddenLabel mesh__D002313 Restrictive Cardiomyopathy
% 217.16/217.30  |- mesh__dateCreated mesh__D002313 1985-03-11
% 217.16/217.30  |- mesh__historyNote mesh__D002313 86   
% 217.16/217.30  |- mesh__recordAuthorizer mesh__D002313 sjn
% 217.16/217.30  |- skos__prefLabel mesh__D002313 Cardiomyopathy, Restrictive
% 217.16/217.30  |- mesh__dateEstablished mesh__D002313 1986-01-01
% 217.16/217.30  |- skos__broader mesh__D002313smesh__D009202
% 217.16/217.30  |- rdf__type mesh__D002313sskos__Concept
% 217.16/217.30  |- skos__hiddenLabel mesh__D002313 Cardiomyopathies, Restrictive
% 217.16/217.30  |- mesh__dateRevised mesh__D002313 2004-07-07
% 217.16/217.30  |- skos__historyNote mesh__D002313 Myocardial Diseases %28%1979-1985%29%
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D002313 2005
% 217.16/217.30  |- mesh__recordOriginator mesh__D002313 VDK
% 217.16/217.30  |- rdf__type mesh__D026761sskos__Concept
% 217.16/217.30  |- skos__hiddenLabel mesh__D026761 Therapies, Physical %28%Specialty%29%
% 217.16/217.30  |- mesh__historyNote mesh__D026761 2002   
% 217.16/217.30  |- mesh__recordAuthorizer mesh__D026761 sjn
% 217.16/217.30  |- mesh__dateCreated mesh__D026761 2001-07-25
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D026761 2006
% 217.16/217.30  |- skos__hiddenLabel mesh__D026761 Physiotherapies %28%Specialty%29%
% 217.16/217.30  |- mesh__dateRevised mesh__D026761 2005-07-01
% 217.16/217.30  |- skos__altLabel mesh__D026761 Physiotherapy %28%Specialty%29%
% 217.16/217.30  |- skos__scopeNote mesh__D026761
% 217.16/217.30       The auxiliary health profession which makes use of PHYSICAL THERAPY MODALITIES to prevent, correct, and alleviate movement dysfunction of anatomic or physiologic origin.%A%    
% 217.16/217.30  |- skos__annotation mesh__D026761
% 217.16/217.30       SPEC only; for therapy use MUSCULOSKELETAL MANIPULATIONS or PHYSICAL THERAPY MODALITIES or their specifics%A%  
% 217.16/217.30  |- skos__hiddenLabel mesh__D026761 Physical Therapies %28%Specialty%29%
% 217.16/217.30  |- mesh__recordOriginator mesh__D026761 ssb
% 217.16/217.30  |- skos__broader mesh__D026761smesh__D016390
% 217.16/217.30  |- mesh__dateEstablished mesh__D026761 2002-01-01
% 217.16/217.30  |- skos__historyNote mesh__D026761
% 217.16/217.30       Physical Therapy Techniques %28%1963-2001%29%
% 217.16/217.30  |- skos__hiddenLabel mesh__D026761 Therapy, Physical %28%Specialty%29%
% 217.16/217.30  |- mesh__publicMeSHNote mesh__D026761
% 217.16/217.30       2002; see PHYSICAL THERAPY 1963-2001   
% 217.16/217.30  |- skos__prefLabel mesh__D026761 Physical Therapy %28%Specialty%29%
% 217.16/217.30  |- mesh__recordMaintainer mesh__D026761 sjn
% 217.16/217.30  |- mesh__recordOriginator mesh__D012741 NLM
% 217.16/217.30  |- skos__related mesh__D012741smesh__D011627
% 217.16/217.30  |- skos__prefLabel mesh__D012741 Sexual Maturation
% 217.16/217.30  |- skos__broader mesh__D012741smesh__D046468
% 217.16/217.30  |- mesh__historyNote mesh__D012741 2005 %28%1975%29%   
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D012741 2005
% 217.16/217.30  |- mesh__recordAuthorizer mesh__D012741 sjn
% 217.16/217.30  |- mesh__dateEstablished mesh__D012741 1975-09-01
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D012741 2006
% 217.16/217.30  |- skos__hiddenLabel mesh__D012741 Maturation, Sex
% 217.16/217.30  |- skos__hiddenLabel mesh__D012741 Maturation, Sexual
% 217.16/217.30  |- mesh__dateRevised mesh__D012741 2004-07-07
% 217.16/217.30  |- skos__annotation mesh__D012741 human %26% animal   
% 217.16/217.30  |- mesh__publicMeSHNote mesh__D012741 2005; see SEX MATURATION 1975-2004   
% 217.16/217.30  |- mesh__recordMaintainer mesh__D012741 lkt
% 217.16/217.30  |- mesh__dateCreated mesh__D012741 1974-11-11
% 217.16/217.30  |- skos__altLabel mesh__D012741 Sex Maturation
% 217.16/217.30  |- skos__scopeNote mesh__D012741
% 217.16/217.30       Achievement of full sexual capacity in animals and in humans.%A%    
% 217.16/217.30  |- skos__historyNote mesh__D012741 Puberty %28%1966-1974%29%
% 217.16/217.30  |- rdf__type mesh__D012741sskos__Concept
% 217.16/217.30  |- mesh__recordAuthorizer mesh__D006704 PLS
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D006704 1998
% 217.16/217.30  |- mesh__publicMeSHNote mesh__D006704
% 217.16/217.30       91; was see under HOME CARE SERVICES 1973-90   
% 217.16/217.30  |- mesh__dateRevised mesh__D006704 1995-05-22
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D006704 2006
% 217.16/217.30  |- skos__scopeNote mesh__D006704
% 217.16/217.30       Non-medical support services, such as food preparation and bathing, given by trained personnel to disabled, sick or convalescent individuals in their home.%A%    
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D006704 2002
% 217.16/217.30  |- mesh__historyNote mesh__D006704
% 217.16/217.30       91%28%73%29%; was see under HOME CARE SERVICES 1973-90   
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D006704 2005
% 217.16/217.30  |- skos__hiddenLabel mesh__D006704 Service, Homemaker
% 217.16/217.30  |- mesh__recordOriginator mesh__D006704 NLM
% 217.16/217.30  |- mesh__dateCreated mesh__D006704 1999-01-01
% 217.16/217.30  |- skos__altLabel mesh__D006704 Services, Homemaker
% 217.16/217.30  |- skos__annotation mesh__D006704
% 217.16/217.30       %22%non-med support services%22% in the home; DF: HOMEMAKER SERV%A%  
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D006704 1997
% 217.16/217.30  |- skos__hiddenLabel mesh__D006704 Homemaker Service
% 217.16/217.30  |- rdf__type mesh__D006704sskos__Concept
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D006704 2001
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D006704 1996
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D006704 2004
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D006704 2000
% 217.16/217.30  |- skos__historyNote mesh__D006704 Home Care Services %28%1966-1972%29%
% 217.16/217.30  |- mesh__dateEstablished mesh__D006704 1991-01-01
% 217.16/217.30  |- skos__prefLabel mesh__D006704 Homemaker Services
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D006704 2003
% 217.16/217.30  |- skos__broader mesh__D006704smesh__D006699
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D006704 1999
% 217.16/217.30  |- mesh__recordMaintainer mesh__D006704 KEV
% 217.16/217.30  |- mesh__recordMaintainer mesh__D050860 ags
% 217.16/217.30  |- skos__broader mesh__D050860smesh__D050858
% 217.16/217.30  |- skos__prefLabel mesh__D050860 Betaxanthins
% 217.16/217.30  |- mesh__recordAuthorizer mesh__D050860 ags
% 217.16/217.30  |- mesh__recordOriginator mesh__D050860 ssb
% 217.16/217.30  |- mesh__dateCreated mesh__D050860 2005-06-30
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D050860 2006
% 217.16/217.30  |- mesh__historyNote mesh__D050860 2006   
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D050860 2006A
% 217.16/217.30  |- mesh__dateEstablished mesh__D050860 2006-01-01
% 217.16/217.30  |- rdf__type mesh__D050860sskos__Concept
% 217.16/217.30  |- skos__scopeNote mesh__D050860
% 217.16/217.30       Conjugates of betalamic acid with AMINO ACIDS. Some of them are yellow COLORING AGENTS in the Caryophyllales order of PLANTS. This should not be confused with xanthin which is a term used for CAROTENES nor with XANTHINES.%A%    
% 217.16/217.30  |- mesh__dateRevised mesh__D050860 2005-07-11
% 217.16/217.30  |- mesh__publicMeSHNote mesh__D050860 2006   
% 217.16/217.30  |- skos__altLabel mesh__D011649 Pulmonary Alveolar Proteinoses
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D011649 2001
% 217.16/217.30  |- rdf__type mesh__D011649sskos__Concept
% 217.16/217.30  |- skos__altLabel mesh__D011649 Alveolar Proteinoses, Pulmonary
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D011649 1999
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D011649 2002
% 217.16/217.30  |- skos__broader mesh__D011649smesh__D008171
% 217.16/217.30  |- mesh__recordOriginator mesh__D011649 NLM
% 217.16/217.30  |- mesh__recordMaintainer mesh__D011649 NDW
% 217.16/217.30  |- mesh__recordAuthorizer mesh__D011649 SJN
% 217.16/217.30  |- mesh__dateCreated mesh__D011649 1999-01-01
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D011649 2005
% 217.16/217.30  |- skos__scopeNote mesh__D011649
% 217.16/217.30       A chronic lung disease characterized by dyspnea, productive cough, chest pain, weakness, weight loss, and hemoptysis, and by the filling of the distal alveoli with a bland, eosinophilic, proteinaceous material that prevents ventilation of affected areas. %28%Dorland, 28th ed%29%%A%    
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D011649 2003
% 217.16/217.30  |- skos__altLabel mesh__D011649 Proteinoses, Pulmonary Alveolar
% 217.16/217.30  |- mesh__dateRevised mesh__D011649 1998-06-10
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D011649 2006
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D011649 2000
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D011649 2004
% 217.16/217.30  |- skos__prefLabel mesh__D011649 Pulmonary Alveolar Proteinosis
% 217.16/217.30  |- skos__altLabel mesh__D011649 Proteinosis, Pulmonary Alveolar
% 217.16/217.30  |- skos__altLabel mesh__D011649 Alveolar Proteinosis, Pulmonary
% 217.16/217.30  |- skos__annotation mesh__D011649 DF: PULM ALVEOLAR PROTEINOSIS   
% 217.16/217.30  |- skos__altLabel mesh__D016334 Genes, rap
% 217.16/217.30  |- mesh__publicMeSHNote mesh__D016334
% 217.16/217.30       93; was GENES, RAP 1991-92; GENES, VPR was see GENES, RAP 1991-92%A%  
% 217.16/217.30  |- skos__hiddenLabel mesh__D016334 Gene, R
% 217.16/217.30  |- skos__annotation mesh__D016334
% 217.16/217.30       vpr stands for %22%Viral Protein R%22%; in X ref GENES, RAP, rap stands for %22%R Activation Protein%22%%A%  
% 217.16/217.30  |- skos__altLabel mesh__D016334 Genes, R
% 217.16/217.30  |- rdf__type mesh__D016334sskos__Concept
% 217.16/217.30  |- skos__historyNote mesh__D016334 Genes, Viral %28%1989-1990%29%
% 217.16/217.30  |- skos__broader mesh__D016334smesh__D005809
% 217.16/217.30  |- skos__hiddenLabel mesh__D016334 rap Genes
% 217.16/217.30  |- skos__hiddenLabel mesh__D016334 Gene, vpr
% 217.16/217.30  |- mesh__onlineNote mesh__D016334
% 217.16/217.30       use GENES, VPR to search GENES, RAP 1991-92   
% 217.16/217.30  |- skos__hiddenLabel mesh__D016334 Gene, rap
% 217.16/217.30  |- skos__scopeNote mesh__D016334
% 217.16/217.30       DNA sequences that form the coding region for a trans-activator protein that specifies rapid growth in human immunodeficiency virus %28%HIV%29%. vpr is short for viral protein R, where R is undefined.%A%    
% 217.16/217.30  |- skos__altLabel mesh__D016334 vpr Genes
% 217.16/217.30  |- mesh__historyNote mesh__D016334
% 217.16/217.30       93; was GENES, RAP 1991-92; GENES, VPR was see GENES, RAP 1991-92%A%  
% 217.16/217.30  |- mesh__dateEstablished mesh__D016334 1991-01-01
% 217.16/217.30  |- mesh__dateRevised mesh__D016334 2005-06-30
% 217.16/217.30  |- mesh__recordOriginator mesh__D016334 AGS
% 217.16/217.30  |- skos__hiddenLabel mesh__D016334 rap Gene
% 217.16/217.30  |- skos__broader mesh__D016334smesh__D005814
% 217.16/217.30  |- skos__altLabel mesh__D016334 vpr Gene
% 217.16/217.30  |- mesh__recordMaintainer mesh__D016334 nns
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D016334 2006
% 217.16/217.30  |- mesh__recordAuthorizer mesh__D016334 sjn
% 217.16/217.30  |- skos__hiddenLabel mesh__D016334 R Genes
% 217.16/217.30  |- mesh__dateCreated mesh__D016334 1990-05-29
% 217.16/217.30  |- skos__hiddenLabel mesh__D016334 R Gene
% 217.16/217.30  |- skos__prefLabel mesh__D016334 Genes, vpr
% 217.16/217.30  |- skos__annotation mesh__D030005
% 217.16/217.30       do not confuse with other snakeroots such as ASARUM; ARISTOLOCHIA; and Polygala; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.16/217.30  |- skos__altLabel mesh__D030005 Sanicle
% 217.16/217.30  |- skos__scopeNote mesh__D030005
% 217.16/217.30       A plant genus of the family Apiaceae.  Commonly called snakeroot but that name is used for many other plants such as ASARUM; ARISTOLOCHIA; and Polygala.%A%    
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D030005 2005
% 217.16/217.30  |- mesh__publicMeSHNote mesh__D030005 2002   
% 217.16/217.30  |- skos__prefLabel mesh__D030005 Sanicula
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D030005 2003
% 217.16/217.30  |- mesh__historyNote mesh__D030005 2002   
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D030005 2006
% 217.16/217.30  |- mesh__dateCreated mesh__D030005 2001-07-25
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D030005 2004
% 217.16/217.30  |- mesh__dateEstablished mesh__D030005 2002-01-01
% 217.16/217.30  |- rdf__type mesh__D030005sskos__Concept
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D030005 2002
% 217.16/217.30  |- skos__broader mesh__D030005smesh__D019661
% 217.16/217.30  |- mesh__publicMeSHNote mesh__D002314 88   
% 217.16/217.30  |- skos__historyNote mesh__D002314 Isotonic Solutions %28%1966-1987%29%
% 217.16/217.30  |- skos__altLabel mesh__D002314 Cardioplegic Solution
% 217.16/217.30  |- skos__broader mesh__D002314smesh__D019999
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D002314 2006
% 217.16/217.30  |- skos__hiddenLabel mesh__D002314 Solutions, Cardioplegic
% 217.16/217.30  |- mesh__historyNote mesh__D002314 88   
% 217.16/217.30  |- mesh__recordMaintainer mesh__D002314 ssb
% 217.16/217.30  |- skos__broader mesh__D002314smesh__D002317
% 217.16/217.30  |- mesh__dateEstablished mesh__D002314 1988-01-01
% 217.16/217.30  |- skos__annotation mesh__D002314
% 217.16/217.30       D25-26 qualif; coord IM with specific drug in solution %28%IM%29%; DF: CARDIOPLEGIC SOL%A%  
% 217.16/217.30  |- mesh__recordAuthorizer mesh__D002314 sjn
% 217.16/217.30  |- mesh__dateCreated mesh__D002314 1987-05-04
% 217.16/217.30  |- mesh__recordOriginator mesh__D002314 RLS
% 217.16/217.30  |- skos__historyNote mesh__D002314 Hypotonic Solutions %28%1966-1987%29%
% 217.16/217.30  |- skos__historyNote mesh__D002314 Heart Arrest, Induced %28%1966-1987%29%
% 217.16/217.30  |- skos__prefLabel mesh__D002314 Cardioplegic Solutions
% 217.16/217.30  |- rdf__type mesh__D002314sskos__Concept
% 217.16/217.30  |- skos__historyNote mesh__D002314 Hypertonic Solutions %28%1966-1987%29%
% 217.16/217.30  |- mesh__dateRevised mesh__D002314 2005-06-30
% 217.16/217.30  |- skos__hiddenLabel mesh__D002314 Solution, Cardioplegic
% 217.16/217.30  |- skos__scopeNote mesh__D002314
% 217.16/217.30       Solutions which, upon administration, will temporarily arrest cardiac activity. They are used in the performance of heart surgery.%A%    
% 217.16/217.30  |- skos__prefLabel mesh__D026762 Maize streak virus
% 217.16/217.30  |- mesh__historyNote mesh__D026762 2002   
% 217.16/217.30  |- mesh__dateCreated mesh__D026762 2001-07-25
% 217.16/217.30  |- skos__broader mesh__D026762smesh__D017791
% 217.16/217.30  |- skos__historyNote mesh__D026762 Plant Viruses %28%1984-1993%29%
% 217.16/217.30  |- skos__scopeNote mesh__D026762
% 217.16/217.30       The type species of genus Mastrevirus, family GEMINIVIRIDAE.%A%    
% 217.16/217.30  |- mesh__dateEstablished mesh__D026762 2002-01-01
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D026762 2002
% 217.16/217.30  |- skos__historyNote mesh__D026762 Geminiviridae %28%1994-2001%29%
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D026762 2003
% 217.16/217.30  |- skos__hiddenLabel mesh__D026762 Maize streak viruses
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D026762 2005
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D026762 2004
% 217.16/217.30  |- rdf__type mesh__D026762sskos__Concept
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D026762 2006
% 217.16/217.30  |- mesh__publicMeSHNote mesh__D026762 2002   
% 217.16/217.30  |- skos__broader mesh__D012742smesh__D003415
% 217.16/217.30  |- skos__hiddenLabel mesh__D012742 Abuse, Sexual
% 217.16/217.30  |- mesh__dateRevised mesh__D012742 1995-05-23
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D012742 1999
% 217.16/217.30  |- skos__hiddenLabel mesh__D012742 Offense, Sex
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D012742 1996
% 217.16/217.30  |- skos__historyNote mesh__D012742 Criminology %28%1966-1967%29%
% 217.16/217.30  |- skos__hiddenLabel mesh__D012742 Offenses, Sex
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D012742 2002
% 217.16/217.30  |- skos__prefLabel mesh__D012742 Sex Offenses
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D012742 2005
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D012742 1997
% 217.16/217.30  |- mesh__dateCreated mesh__D012742 1999-01-01
% 217.16/217.30  |- mesh__publicMeSHNote mesh__D012742 68   
% 217.16/217.30  |- mesh__recordMaintainer mesh__D012742 KEV
% 217.16/217.30  |- mesh__recordAuthorizer mesh__D012742 PLS
% 217.16/217.30  |- skos__hiddenLabel mesh__D012742 Sex Offense
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D012742 2006
% 217.16/217.30  |- mesh__historyNote mesh__D012742 68   
% 217.16/217.30  |- mesh__dateEstablished mesh__D012742 1968-01-01
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D012742 2000
% 217.16/217.30  |- skos__hiddenLabel mesh__D012742 Sexual Abuses
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D012742 2003
% 217.16/217.30  |- rdf__type mesh__D012742sskos__Concept
% 217.16/217.30  |- mesh__recordOriginator mesh__D012742 NLM
% 217.16/217.30  |- skos__historyNote mesh__D012742 Paraphilias %28%1966-1967%29%
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D012742 2001
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D012742 1998
% 217.16/217.30  |- skos__scopeNote mesh__D012742
% 217.16/217.30       Any violation of established legal or moral codes in respect to sexual behavior.%A%    
% 217.16/217.30  |- skos__hiddenLabel mesh__D012742 Abuses, Sexual
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D012742 2004
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D006705 2006
% 217.16/217.30  |- mesh__recordAuthorizer mesh__D006705 sjn
% 217.16/217.30  |- skos__prefLabel mesh__D006705 Homeopathy
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D006705 2005
% 217.16/217.30  |- skos__broader mesh__D006705smesh__D000529
% 217.16/217.30  |- mesh__dateCreated mesh__D006705 1999-01-01
% 217.16/217.30  |- skos__related mesh__D006705smesh__D005571
% 217.16/217.30  |- mesh__dateRevised mesh__D006705 2001-07-25
% 217.16/217.30  |- skos__altLabel mesh__D006705 Homoeopathy
% 217.16/217.30  |- skos__scopeNote mesh__D006705
% 217.16/217.30       A system of therapeutics founded by Samuel Hahnemann %28%1755-1843%29%, based on the Law of Similars where %22%like cures like%22%. Diseases are treated by highly diluted substances that cause, in healthy persons, symptoms like those of the disease to be treated. The dilutions are repeated so many times that there is less than one molecule per dose and it is suggested that benefit is from the energetic life force of the original substance.%A%    
% 217.16/217.30  |- rdf__type mesh__D006705sskos__Concept
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D006705 2002
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D006705 2004
% 217.16/217.30  |- skos__related mesh__D006705smesh__D010603
% 217.16/217.30  |- mesh__recordOriginator mesh__D006705 NLM
% 217.16/217.30  |- skos__broader mesh__D006705smesh__D026443
% 217.16/217.30  |- mesh__recordMaintainer mesh__D006705 ssb
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D006705 2003
% 217.16/217.30  |- mesh__recordAuthorizer mesh__D050861 sjn
% 217.16/217.30  |- mesh__recordOriginator mesh__D050861 DRC
% 217.16/217.30  |- skos__broader mesh__D050861smesh__D050857
% 217.16/217.30  |- skos__scopeNote mesh__D050861
% 217.16/217.30       A vesicular transport protein that was originally characterized as an inositol polyphosphate binding protein. Synaptotagmin II helps regulate EXOCYTOSIS of SYNAPTIC VESICLES and appears to serve as a calcium sensor to trigger NEUROTRANSMITTER release. It also acts as a nerve cell receptor for certain BOTULINUM TOXINS.%A%    
% 217.16/217.30  |- mesh__publicMeSHNote mesh__D050861
% 217.16/217.30       2006; SYNAPTOTAGMIN II was indexed under NERVE TISSUE PROTEINS 1991-2005%A%  
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D050861 2006
% 217.16/217.30  |- mesh__recordMaintainer mesh__D050861 DRC
% 217.16/217.30  |- rdf__type mesh__D050861sskos__Concept
% 217.16/217.30  |- skos__altLabel mesh__D050861 Synaptotagmin 2
% 217.16/217.30  |- mesh__dateCreated mesh__D050861 2005-06-30
% 217.16/217.30  |- mesh__dateEstablished mesh__D050861 2006-01-01
% 217.16/217.30  |- mesh__historyNote mesh__D050861 2006%28%1991%29%   
% 217.16/217.30  |- skos__prefLabel mesh__D050861 Synaptotagmin II
% 217.16/217.30  |- skos__broader mesh__D011351Q000295smesh__D011351
% 217.16/217.30  |- mesh__preferredCombination mesh__D011351Q000295smesh__D020700
% 217.16/217.30  |- rdf__type mesh__D011351Q000295smesh__CompoundConcept
% 217.16/217.30  |- skos__hiddenLabel mesh__D016335 Motifs, Zinc Finger
% 217.16/217.30  |- skos__hiddenLabel mesh__D016335 Zinc Finger Motif
% 217.16/217.30  |- mesh__recordAuthorizer mesh__D016335 sjn
% 217.16/217.30  |- mesh__recordMaintainer mesh__D016335 nns
% 217.16/217.30  |- mesh__dateRevised mesh__D016335 2004-07-07
% 217.16/217.30  |- skos__hiddenLabel mesh__D016335 Fingers, Zinc
% 217.16/217.30  |- skos__scopeNote mesh__D016335
% 217.16/217.30       Motifs in DNA- and RNA-binding proteins whose amino acids are folded into a single structural unit around a zinc atom. In the classic zinc finger, one zinc atom is bound to two cysteines and two histidines. In between the cysteines and histidines are 12 residues which form a DNA binding fingertip. By variations in the composition of the sequences in the fingertip and the number and spacing of tandem repeats of the motif, zinc fingers can form a large number of different sequence specific binding sites.%A%    
% 217.16/217.30  |- mesh__dateEstablished mesh__D016335 1991-01-01
% 217.16/217.30  |- skos__historyNote mesh__D016335 DNA-Binding Proteins %28%1987-1990%29%
% 217.16/217.30  |- mesh__recordOriginator mesh__D016335 PXP
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D016335 2005
% 217.16/217.30  |- skos__broader mesh__D016335smesh__D020816
% 217.16/217.30  |- mesh__publicMeSHNote mesh__D016335 91   
% 217.16/217.30  |- mesh__historyNote mesh__D016335 91   
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D016335 2006
% 217.16/217.30  |- skos__prefLabel mesh__D016335 Zinc Fingers
% 217.16/217.30  |- skos__historyNote mesh__D016335
% 217.16/217.30       Molecular Sequence Data %28%1988-1990%29%
% 217.16/217.30  |- mesh__dateCreated mesh__D016335 1990-05-29
% 217.16/217.30  |- skos__altLabel mesh__D016335 Zinc Finger Motifs
% 217.16/217.30  |- skos__hiddenLabel mesh__D016335 Motif, Zinc Finger
% 217.16/217.30  |- skos__historyNote mesh__D016335 Amino Acid Sequence %28%1987-1990%29%
% 217.16/217.30  |- skos__hiddenLabel mesh__D016335 Zinc Finger
% 217.16/217.30  |- rdf__type mesh__D016335sskos__Concept
% 217.16/217.30  |- skos__hiddenLabel mesh__D016335 Finger, Zinc
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D030006 2006
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D030006 2004
% 217.16/217.30  |- skos__scopeNote mesh__D030006
% 217.16/217.30       A plant genus of the family APOCYNACEAE. Species of this genus contain YOHIMBINE.%A%    
% 217.16/217.30  |- mesh__activeMeSHYear mesh__D030006 2002
% 217.16/217.31  |- rdf__type mesh__D030006sskos__Concept
% 217.16/217.31  |- skos__broader mesh__D030006smesh__D029062
% 217.16/217.31  |- mesh__dateEstablished mesh__D030006 2002-01-01
% 217.16/217.31  |- skos__prefLabel mesh__D030006 Amsonia
% 217.16/217.31  |- mesh__historyNote mesh__D030006 2002   
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D030006 2005
% 217.16/217.31  |- mesh__publicMeSHNote mesh__D030006 2002   
% 217.16/217.31  |- mesh__dateCreated mesh__D030006 2001-07-25
% 217.16/217.31  |- skos__annotation mesh__D030006
% 217.16/217.31       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D030006 2003
% 217.16/217.31  |- mesh__historyNote mesh__D002315
% 217.16/217.31       77%28%75%29%; was see under EXTRACORPOREAL CIRCULATION 1967-76   
% 217.16/217.31  |- mesh__recordOriginator mesh__D002315 NLM
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D002315 2002
% 217.16/217.31  |- skos__related mesh__D002315smesh__D018611
% 217.16/217.31  |- mesh__recordMaintainer mesh__D002315 PXP
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D002315 2006
% 217.16/217.31  |- skos__hiddenLabel mesh__D002315 Heart Lung Bypass
% 217.16/217.31  |- skos__annotation mesh__D002315
% 217.16/217.31       diverts blood from right atrium: consider also HEART BYPASS, LEFT which diverts blood from left atrium; /instrum: consider also HEART-LUNG MACHINE; do not use /util except by MeSH definition; DF: CARDIOPULM BYPASS%A%  
% 217.16/217.31  |- skos__prefLabel mesh__D002315 Cardiopulmonary Bypass
% 217.16/217.31  |- mesh__dateEstablished mesh__D002315 1977-01-01
% 217.16/217.31  |- skos__related mesh__D002315smesh__D006355
% 217.16/217.31  |- skos__hiddenLabel mesh__D002315 Bypasses, Heart-Lung
% 217.16/217.31  |- skos__altLabel mesh__D002315 Bypass, Cardiopulmonary
% 217.16/217.31  |- skos__altLabel mesh__D002315 Heart-Lung Bypass
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D002315 1998
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D002315 2003
% 217.16/217.31  |- mesh__dateRevised mesh__D002315 1997-06-20
% 217.16/217.31  |- rdf__type mesh__D002315sskos__Concept
% 217.16/217.31  |- mesh__recordAuthorizer mesh__D002315 SJN
% 217.16/217.31  |- skos__hiddenLabel mesh__D002315 Cardiopulmonary Bypasses
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D002315 2000
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D002315 1999
% 217.16/217.31  |- skos__scopeNote mesh__D002315
% 217.16/217.31       Diversion of the flow of blood from the entrance of the right atrium directly to the aorta %28%or femoral artery%29% via an oxygenator thus bypassing both the heart and lungs.%A%    
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D002315 2004
% 217.16/217.31  |- mesh__dateCreated mesh__D002315 1999-01-01
% 217.16/217.31  |- mesh__publicMeSHNote mesh__D002315
% 217.16/217.31       77; was see under EXTRACORPOREAL CIRCULATION 1967-76   
% 217.16/217.31  |- mesh__onlineNote mesh__D002315
% 217.16/217.31       search EXTRACORPOREAL CIRCULATION 1967-74   
% 217.16/217.31  |- skos__broader mesh__D002315smesh__D005112
% 217.16/217.31  |- skos__historyNote mesh__D002315
% 217.16/217.31       Extracorporeal Circulation %28%1967-1976%29%
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D002315 2001
% 217.16/217.31  |- skos__hiddenLabel mesh__D002315 Bypass, Heart-Lung
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D002315 2005
% 217.16/217.31  |- skos__hiddenLabel mesh__D002315 Heart-Lung Bypasses
% 217.16/217.31  |- skos__hiddenLabel mesh__D002315 Bypasses, Cardiopulmonary
% 217.16/217.31  |- mesh__recordAuthorizer mesh__D007000 sjn
% 217.16/217.31  |- mesh__historyNote mesh__D007000 68   
% 217.16/217.31  |- mesh__recordMaintainer mesh__D007000 ags
% 217.16/217.31  |- mesh__recordOriginator mesh__D007000 NLM
% 217.16/217.31  |- skos__historyNote mesh__D007000 Myiasis %28%1966-1967%29%
% 217.16/217.31  |- skos__scopeNote mesh__D007000
% 217.16/217.31       Infestation with larvae of the genus Hypoderma, the warble fly.%A%    
% 217.16/217.31  |- skos__hiddenLabel mesh__D007000 Hypodermyiases
% 217.16/217.31  |- mesh__dateEstablished mesh__D007000 1968-01-01
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D007000 2006
% 217.16/217.31  |- skos__annotation mesh__D007000 Hypoderma is indexed under DIPTERA   
% 217.16/217.31  |- mesh__dateCreated mesh__D007000 1999-01-01
% 217.16/217.31  |- rdf__type mesh__D007000sskos__Concept
% 217.16/217.31  |- mesh__dateRevised mesh__D007000 2005-06-30
% 217.16/217.31  |- skos__broader mesh__D007000smesh__D009198
% 217.16/217.31  |- mesh__publicMeSHNote mesh__D007000 68   
% 217.16/217.31  |- skos__prefLabel mesh__D007000 Hypodermyiasis
% 217.16/217.31  |- mesh__recordMaintainer mesh__D012743 lkt
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D012743 2005
% 217.16/217.31  |- skos__hiddenLabel mesh__D012743 Selection, Sex
% 217.16/217.31  |- skos__hiddenLabel mesh__D012743 Predetermination, Sex
% 217.16/217.31  |- skos__broader mesh__D012743smesh__D005818
% 217.16/217.31  |- skos__annotation mesh__D012743
% 217.16/217.31       do not confuse with SEX DETERMINATION %28%ANALYSIS%29%: analysis of sex genotype%A%  
% 217.16/217.31  |- skos__prefLabel mesh__D012743 Sex Preselection
% 217.16/217.31  |- skos__hiddenLabel mesh__D012743 Preselection, Sex
% 217.16/217.31  |- mesh__recordOriginator mesh__D012743 NLM
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D012743 2006
% 217.16/217.31  |- mesh__dateEstablished mesh__D012743 1991-01-01
% 217.16/217.31  |- rdf__type mesh__D012743sskos__Concept
% 217.16/217.31  |- skos__altLabel mesh__D012743 Sex Predetermination
% 217.16/217.31  |- mesh__dateRevised mesh__D012743 2003-07-09
% 217.16/217.31  |- mesh__dateCreated mesh__D012743 1974-11-19
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D012743 2004
% 217.16/217.31  |- mesh__historyNote mesh__D012743
% 217.16/217.31       91%28%75%29%; was see under GENETIC ENGINEERING 1975-90   
% 217.16/217.31  |- mesh__recordAuthorizer mesh__D012743 sjn
% 217.16/217.31  |- skos__scopeNote mesh__D012743
% 217.16/217.31       Methods for controlling genetic SEX of offspring. It may include SEX DETERMINATION %28%GENETICS%29% and other means.%A%    
% 217.16/217.31  |- mesh__publicMeSHNote mesh__D012743
% 217.16/217.31       91; was see under GENETIC ENGINEERING 1975-90   
% 217.16/217.31  |- skos__altLabel mesh__D012743 Sex Selection
% 217.16/217.31  |- skos__related mesh__D012743smesh__D019849
% 217.16/217.31  |- mesh__recordOriginator mesh__D006706 NLM
% 217.16/217.31  |- mesh__recordMaintainer mesh__D006706 adp
% 217.16/217.31  |- skos__prefLabel mesh__D006706 Homeostasis
% 217.16/217.31  |- mesh__dateRevised mesh__D006706 2000-06-21
% 217.16/217.31  |- skos__related mesh__D006706smesh__D015213
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D006706 2001
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D006706 2003
% 217.16/217.31  |- mesh__recordAuthorizer mesh__D006706 sjn
% 217.16/217.31  |- rdf__type mesh__D006706sskos__Concept
% 217.16/217.31  |- skos__altLabel mesh__D006706 Autoregulation
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D006706 2002
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D006706 2004
% 217.16/217.31  |- skos__scopeNote mesh__D006706
% 217.16/217.31       The processes whereby  the internal environment of an organism tends to remain balanced and stable.%A%    
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D006706 2005
% 217.16/217.31  |- skos__broader mesh__D006706smesh__D010829
% 217.16/217.31  |- mesh__dateCreated mesh__D006706 1999-01-01
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D006706 2006
% 217.16/217.31  |- mesh__publicMeSHNote mesh__D050862
% 217.16/217.31       2006; for SULFITE REDUCTASES see SULFITE REDUCTASES 1980-2005; for SULFITE OXIDASES see SULFITE OXIDASES 1980-2005; for SULFITE DEHYDROGENASES see SULFITE OXIDASES 1980-2005%A%  
% 217.16/217.31  |- skos__altLabel mesh__D050862 Sulfite Oxidases
% 217.16/217.31  |- skos__hiddenLabel mesh__D050862 Dehydrogenases, Sulfite
% 217.16/217.31  |- skos__hiddenLabel mesh__D050862 Reductases, Sulfite
% 217.16/217.31  |- mesh__dateEstablished mesh__D050862 2006-01-01
% 217.16/217.31  |- mesh__recordOriginator mesh__D050862 jmp
% 217.16/217.31  |- skos__broader mesh__D050862smesh__D010088
% 217.16/217.31  |- mesh__recordAuthorizer mesh__D050862 sjn
% 217.16/217.31  |- mesh__recordMaintainer mesh__D050862 jmp
% 217.16/217.31  |- skos__scopeNote mesh__D050862
% 217.16/217.31       Oxidoreductases with specificity for oxidation or reduction of SULFUR COMPOUNDS.%A%    
% 217.16/217.31  |- skos__prefLabel mesh__D050862
% 217.16/217.31       Oxidoreductases Acting on Sulfur Group Donors
% 217.16/217.31  |- skos__hiddenLabel mesh__D050862 Oxidases, Sulfite
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D050862 2006
% 217.16/217.31  |- mesh__dateCreated mesh__D050862 2005-06-30
% 217.16/217.31  |- mesh__historyNote mesh__D050862 2006%28%1980%29%   
% 217.16/217.31  |- rdf__type mesh__D050862sskos__Concept
% 217.16/217.31  |- skos__broader mesh__D016336smesh__D015534
% 217.16/217.31  |- skos__hiddenLabel mesh__D016336 R Gene Product
% 217.16/217.31  |- skos__altLabel mesh__D016336 vpr Gene Products
% 217.16/217.31  |- skos__altLabel mesh__D016336 HIV-1 vpr Gene Products
% 217.16/217.31  |- skos__historyNote mesh__D016336 Retroviridae Proteins %28%1990%29%
% 217.16/217.31  |- skos__altLabel mesh__D016336 Gene Product, vpr
% 217.16/217.31  |- mesh__dateRevised mesh__D016336 2005-06-30
% 217.16/217.31  |- rdf__type mesh__D016336sskos__Concept
% 217.16/217.31  |- skos__annotation mesh__D016336
% 217.16/217.31       Vpr stands for %22%viral protein R%22%; in X ref GENE PRODUCTS, RAP, Rap stands for %22%R activation protein%22%%A%  
% 217.16/217.31  |- skos__altLabel mesh__D016336 HIV vpr Gene Product
% 217.16/217.31  |- skos__altLabel mesh__D016336 vpr Protein
% 217.16/217.31  |- skos__altLabel mesh__D016336 rap Gene Products
% 217.16/217.31  |- skos__altLabel mesh__D016336 R Gene Products
% 217.16/217.31  |- skos__altLabel mesh__D016336 Gene Products, R
% 217.16/217.31  |- mesh__recordAuthorizer mesh__D016336 sjn
% 217.16/217.31  |- mesh__recordMaintainer mesh__D016336 SYSTEM
% 217.16/217.31  |- skos__hiddenLabel mesh__D016336 HIV 1 vpr Gene Products
% 217.16/217.31  |- skos__scopeNote mesh__D016336
% 217.16/217.31       Trans-acting proteins which accelerate virus replication in HIV. The vpr proteins act in trans to increase the levels of HIV specified proteins. vpr is short for viral protein R, where R is undefined.%A%    
% 217.16/217.31  |- mesh__publicMeSHNote mesh__D016336
% 217.16/217.31       93; was GENE PRODUCT, RAP 1991-92; GENE PRODUCTS, VPR %26% RAP PROTEIN %26% HIV RAP GENE PRODUCT were see GENE PRODUCTS, RAP 1991-92%A%  
% 217.16/217.31  |- skos__prefLabel mesh__D016336 Gene Products, vpr
% 217.16/217.31  |- skos__altLabel mesh__D016336 Gene Products, rap
% 217.16/217.31  |- skos__altLabel mesh__D016336 Gene Product, R
% 217.16/217.31  |- mesh__recordOriginator mesh__D016336 AGS
% 217.16/217.31  |- mesh__dateEstablished mesh__D016336 1991-01-01
% 217.16/217.31  |- mesh__onlineNote mesh__D016336
% 217.16/217.31       use GENE PRODUCTS, VPR to search GENE PRODUCTS, RAP %26% RAP PROTEIN %26% HIV RAP GENE PRODUCT 1991-92%A%  
% 217.16/217.31  |- skos__altLabel mesh__D016336 Viral Protein R, HIV
% 217.16/217.31  |- skos__hiddenLabel mesh__D016336 vpr Gene Product
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D016336 2006
% 217.16/217.31  |- skos__hiddenLabel mesh__D016336 rap Gene Product
% 217.16/217.31  |- mesh__dateCreated mesh__D016336 1990-06-19
% 217.16/217.31  |- skos__altLabel mesh__D016336 Gene Product, rap
% 217.16/217.31  |- mesh__historyNote mesh__D016336
% 217.16/217.31       93; was GENE PRODUCTS, RAP 1991-92; GENE PRODUCTS, VPR %26% RAP PROTEIN %26% HIV RAP GENE PRODUCT were see GENE PRODUCTS, RAP 1991-92%A%  
% 217.16/217.31  |- skos__scopeNote mesh__D030007
% 217.16/217.31       A plant genus of the family APOCYNACEAE. It is a very poisonous plant that contains cardioactive agents.%A%    
% 217.16/217.31  |- skos__annotation mesh__D030007
% 217.16/217.31       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.16/217.31  |- mesh__dateCreated mesh__D030007 2001-07-25
% 217.16/217.31  |- skos__prefLabel mesh__D030007 Nerium
% 217.16/217.31  |- rdf__type mesh__D030007sskos__Concept
% 217.16/217.31  |- mesh__dateEstablished mesh__D030007 2002-01-01
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D030007 2002
% 217.16/217.31  |- skos__broader mesh__D030007smesh__D029062
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D030007 2005
% 217.16/217.31  |- mesh__publicMeSHNote mesh__D030007 2002   
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D030007 2003
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D030007 2006
% 217.16/217.31  |- skos__altLabel mesh__D030007 Oleander
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D030007 2004
% 217.16/217.31  |- mesh__historyNote mesh__D030007 2002   
% 217.16/217.31  |- skos__altLabel mesh__D002316 Cardiotonic Drugs
% 217.16/217.31  |- rdf__type mesh__D002316sskos__Concept
% 217.16/217.31  |- skos__altLabel mesh__D002316 Cardiac Stimulants
% 217.16/217.31  |- skos__altLabel mesh__D002316 Myocardial Stimulants
% 217.16/217.31  |- mesh__dateRevised mesh__D002316 2005-07-11
% 217.16/217.31  |- mesh__dateEstablished mesh__D002316 1980-01-01
% 217.16/217.31  |- skos__altLabel mesh__D002316 Inotropic Agents, Positive Cardiac
% 217.16/217.31  |- skos__prefLabel mesh__D002316 Cardiotonic Agents
% 217.16/217.31  |- mesh__recordAuthorizer mesh__D002316 ags
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D002316 2006A
% 217.16/217.31  |- mesh__historyNote mesh__D002316 80   
% 217.16/217.31  |- mesh__publicMeSHNote mesh__D002316 80   
% 217.16/217.31  |- skos__historyNote mesh__D002316 specific drug or agent %28%1966-1979%29%
% 217.16/217.31  |- skos__altLabel mesh__D002316 Cardioprotective Agents
% 217.16/217.31  |- skos__altLabel mesh__D002316 Cardiotonics
% 217.16/217.31  |- mesh__recordOriginator mesh__D002316 SH
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D002316 2006
% 217.16/217.31  |- skos__historyNote mesh__D002316 Cardiac Glycosides %28%1966-1979%29%
% 217.16/217.31  |- skos__broader mesh__D002316smesh__D020011
% 217.16/217.31  |- skos__scopeNote mesh__D002316
% 217.16/217.31       Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure %28%HEART FAILURE, CONGESTIVE%29%.%A%    
% 217.16/217.31  |- skos__historyNote mesh__D002316 Sympathomimetics %28%1966-1979%29%
% 217.16/217.31  |- mesh__recordMaintainer mesh__D002316 ags
% 217.16/217.31  |- mesh__dateCreated mesh__D002316 1979-02-28
% 217.16/217.31  |- skos__broader mesh__D002316smesh__D002317
% 217.16/217.31  |- skos__scopeNote mesh__D007001
% 217.16/217.31       A complex network of nerve fibers in the pelvic region. The hypogastric plexus distributes sympathetic fibers from the lumbar paravertebral ganglia and the aortic plexus, parasympathetic fibers from the pelvic nerve, and visceral afferents. The bilateral pelvic plexus is in its lateral extent.%A%    
% 217.16/217.31  |- skos__hiddenLabel mesh__D007001 Plexus, Hypogastric
% 217.16/217.31  |- mesh__dateRevised mesh__D007001 1993-06-18
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D007001 1994
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D007001 1999
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D007001 2005
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D007001 2000
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D007001 1995
% 217.16/217.31  |- mesh__recordMaintainer mesh__D007001 RAZ
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D007001 2006
% 217.16/217.31  |- mesh__recordAuthorizer mesh__D007001 PLS
% 217.16/217.31  |- mesh__dateCreated mesh__D007001 1999-01-01
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D007001 2001
% 217.16/217.31  |- mesh__recordOriginator mesh__D007001 NLM
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D007001 1996
% 217.16/217.31  |- rdf__type mesh__D007001sskos__Concept
% 217.16/217.31  |- skos__hiddenLabel mesh__D007001 Plexus, Pelvic
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D007001 2002
% 217.16/217.31  |- skos__annotation mesh__D007001
% 217.16/217.31       a network of autonomic nerve fibers in the pelvic region   
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D007001 1997
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D007001 2003
% 217.16/217.31  |- skos__prefLabel mesh__D007001 Hypogastric Plexus
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D007001 2004
% 217.16/217.31  |- skos__broader mesh__D007001smesh__D017776
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D007001 1998
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D012744 2006
% 217.16/217.31  |- mesh__dateEstablished mesh__D012744 1968-01-01
% 217.16/217.31  |- skos__prefLabel mesh__D012744 Sex Ratio
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D012744 2003
% 217.16/217.31  |- rdf__type mesh__D012744sskos__Concept
% 217.16/217.31  |- skos__hiddenLabel mesh__D012744 Ratio, Sex
% 217.16/217.31  |- skos__historyNote mesh__D012744 Sex %28%1966-1967%29%
% 217.16/217.31  |- mesh__historyNote mesh__D012744 68   
% 217.16/217.31  |- mesh__recordMaintainer mesh__D012744 jls
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D012744 2004
% 217.16/217.31  |- mesh__recordOriginator mesh__D012744 NLM
% 217.16/217.31  |- skos__scopeNote mesh__D012744 The number of males per 100 females.     
% 217.16/217.31  |- skos__broader mesh__D012744smesh__D017678
% 217.16/217.31  |- mesh__dateRevised mesh__D012744 2002-07-03
% 217.16/217.31  |- skos__hiddenLabel mesh__D012744 Sex Ratios
% 217.16/217.31  |- skos__broader mesh__D012744smesh__D040341
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D012744 2005
% 217.16/217.31  |- skos__hiddenLabel mesh__D012744 Ratios, Sex
% 217.16/217.31  |- mesh__dateCreated mesh__D012744 1999-01-01
% 217.16/217.31  |- mesh__recordAuthorizer mesh__D012744 sjn
% 217.16/217.31  |- mesh__publicMeSHNote mesh__D012744 68   
% 217.16/217.31  |- mesh__dateRevised mesh__D006707 1999-11-03
% 217.16/217.31  |- mesh__dateEstablished mesh__D006707 1968-01-01
% 217.16/217.31  |- skos__hiddenLabel mesh__D006707 Home, Old Age
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D006707 2003
% 217.16/217.31  |- skos__scopeNote mesh__D006707
% 217.16/217.31       Geriatric long-term care facilities which provide supervision and assistance in activities of daily living with medical and nursing services when required.%A%    
% 217.16/217.31  |- rdf__type mesh__D006707sskos__Concept
% 217.16/217.31  |- skos__hiddenLabel mesh__D006707 Old Age Home
% 217.16/217.31  |- mesh__recordOriginator mesh__D006707 NLM
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D006707 2000
% 217.16/217.31  |- mesh__historyNote mesh__D006707 68; was OLD AGE HOMES 1963-67   
% 217.16/217.31  |- mesh__onlineNote mesh__D006707
% 217.16/217.31       use HOMES FOR THE AGED to search OLD AGE HOMES 1966-67   
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D006707 2004
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D006707 2001
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D006707 2005
% 217.16/217.31  |- mesh__recordAuthorizer mesh__D006707 sjn
% 217.16/217.31  |- mesh__dateCreated mesh__D006707 1999-01-01
% 217.16/217.31  |- skos__annotation mesh__D006707
% 217.16/217.31       nursing homes for the aged: coord IM with NURSING HOMES %28%IM%29%; check also tag AGED%A%  
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D006707 2002
% 217.16/217.31  |- mesh__publicMeSHNote mesh__D006707 68; was OLD AGE HOMES 1963-67   
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D006707 2006
% 217.16/217.31  |- skos__related mesh__D006707smesh__D016852
% 217.16/217.31  |- skos__hiddenLabel mesh__D006707 Homes, Old Age
% 217.16/217.31  |- mesh__recordMaintainer mesh__D006707 kle
% 217.16/217.31  |- skos__altLabel mesh__D006707 Old Age Homes
% 217.16/217.31  |- skos__broader mesh__D006707smesh__D012112
% 217.16/217.31  |- skos__prefLabel mesh__D006707 Homes for the Aged
% 217.16/217.31  |- skos__altLabel mesh__D050863 Synaptic Vesicle Protein p65
% 217.16/217.31  |- mesh__historyNote mesh__D050863 2006%28%1991%29%   
% 217.16/217.31  |- skos__altLabel mesh__D050863 p65 Protein
% 217.16/217.31  |- skos__altLabel mesh__D050863 Synaptotagmin 1
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D050863 2006
% 217.16/217.31  |- rdf__type mesh__D050863sskos__Concept
% 217.16/217.31  |- mesh__publicMeSHNote mesh__D050863
% 217.16/217.31       2006; SYNAPTOTAGMIN I was indexed under CALCIUM-BINDING PROTEINS, MEMRANE GLYCOPROTEINS, %26% NERVE TISSUE PROTEINS 1991-2005%A%  
% 217.16/217.31  |- mesh__dateEstablished mesh__D050863 2006-01-01
% 217.16/217.31  |- mesh__recordAuthorizer mesh__D050863 sjn
% 217.16/217.31  |- mesh__recordOriginator mesh__D050863 DRC
% 217.16/217.31  |- skos__prefLabel mesh__D050863 Synaptotagmin I
% 217.16/217.31  |- mesh__dateCreated mesh__D050863 2005-06-30
% 217.16/217.31  |- mesh__recordMaintainer mesh__D050863 DRC
% 217.16/217.31  |- skos__scopeNote mesh__D050863
% 217.16/217.31       A vesicular transport protein expressed predominately in NEURONS. Synaptotagmin helps regulate EXOCYTOSIS of SYNAPTIC VESICLES and appears to serve as a calcium sensor to trigger NEUROTRANSMITTER release. It also acts as a nerve cell receptor for certain BOTULINUM TOXINS.%A%    
% 217.16/217.31  |- skos__broader mesh__D050863smesh__D050857
% 217.16/217.31  |- rdf__type mesh__D016337sskos__Concept
% 217.16/217.31  |- mesh__historyNote mesh__D016337 91   
% 217.16/217.31  |- mesh__publicMeSHNote mesh__D016337 91   
% 217.16/217.31  |- mesh__recordAuthorizer mesh__D016337 ags
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D016337 2006A
% 217.16/217.31  |- skos__broader mesh__D016337smesh__D004798
% 217.16/217.31  |- skos__altLabel mesh__D016337 Catalytic RNA
% 217.16/217.31  |- skos__scopeNote mesh__D016337
% 217.16/217.31       RNA that has catalytic activity. The catalytic RNA sequence folds to form a complex surface that can function as an enzyme in reactions with itself and other molecules. It may function even in the absence of protein. There are numerous examples of RNA species that are acted upon by catalytic RNA, however the scope of this enzyme class is not limited to a particular type of substrate.%A%    
% 217.16/217.31  |- mesh__recordOriginator mesh__D016337 PXP
% 217.16/217.31  |- mesh__recordMaintainer mesh__D016337 ags
% 217.16/217.31  |- skos__altLabel mesh__D016337 Ribozymes
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D016337 2004
% 217.16/217.31  |- mesh__dateEstablished mesh__D016337 1991-01-01
% 217.16/217.31  |- skos__historyNote mesh__D016337 RNA, Ribosomal %28%1986-1990%29%
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D016337 2006
% 217.16/217.31  |- skos__historyNote mesh__D016337 RNA Splicing %28%1986-1990%29%
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D016337 2005
% 217.16/217.31  |- mesh__dateCreated mesh__D016337 1990-05-29
% 217.16/217.31  |- skos__broader mesh__D016337smesh__D022661
% 217.16/217.31  |- mesh__dateRevised mesh__D016337 2005-07-13
% 217.16/217.31  |- skos__prefLabel mesh__D016337 RNA, Catalytic
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D030008 2006
% 217.16/217.31  |- skos__altLabel mesh__D030008 Vinca rosea
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D030008 2003
% 217.16/217.31  |- mesh__dateCreated mesh__D030008 2001-07-25
% 217.16/217.31  |- mesh__dateEstablished mesh__D030008 2002-01-01
% 217.16/217.31  |- mesh__recordAuthorizer mesh__D030008 sjn
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D030008 2005
% 217.16/217.31  |- skos__annotation mesh__D030008
% 217.16/217.31       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.16/217.31  |- skos__altLabel mesh__D030008 Periwinkle, Madagascar
% 217.16/217.31  |- mesh__publicMeSHNote mesh__D030008 2002   
% 217.16/217.31  |- mesh__historyNote mesh__D030008 2002   
% 217.16/217.31  |- rdf__type mesh__D030008sskos__Concept
% 217.16/217.31  |- mesh__recordMaintainer mesh__D030008 ssb
% 217.16/217.31  |- skos__scopeNote mesh__D030008
% 217.16/217.31       A plant genus of the family Apocynaceae. It is the source of VINCA ALKALOIDS, used in leukemia chemotherapy.%A%    
% 217.16/217.31  |- mesh__recordOriginator mesh__D030008 ssb
% 217.16/217.31  |- mesh__dateRevised mesh__D030008 2002-07-03
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D030008 2004
% 217.16/217.31  |- skos__broader mesh__D030008smesh__D029062
% 217.16/217.31  |- skos__prefLabel mesh__D030008 Catharanthus
% 217.16/217.31  |- skos__hiddenLabel mesh__D002317 Drugs, Cardiovascular
% 217.16/217.31  |- mesh__onlineNote mesh__D002317
% 217.16/217.31       consider also CARDIOVASCULAR SYSTEM /DE   
% 217.16/217.31  |- mesh__dateCreated mesh__D002317 1999-01-01
% 217.16/217.31  |- mesh__historyNote mesh__D002317 79; was NON MESH before 1979   
% 217.16/217.31  |- mesh__publicMeSHNote mesh__D002317 79   
% 217.16/217.31  |- mesh__dateRevised mesh__D002317 2005-08-15
% 217.16/217.31  |- mesh__recordAuthorizer mesh__D002317 sjn
% 217.16/217.31  |- skos__prefLabel mesh__D002317 Cardiovascular Agents
% 217.16/217.31  |- skos__altLabel mesh__D002317 Cardiovascular Drugs
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D002317 2006A
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D002317 2006
% 217.16/217.31  |- mesh__recordMaintainer mesh__D002317 sjn
% 217.16/217.31  |- skos__broader mesh__D002317smesh__D045506
% 217.16/217.31  |- mesh__recordOriginator mesh__D002317 NLM
% 217.16/217.31  |- skos__scopeNote mesh__D002317
% 217.16/217.31       Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume.%A%    
% 217.16/217.31  |- rdf__type mesh__D002317sskos__Concept
% 217.16/217.31  |- skos__hiddenLabel mesh__D002317 Agents, Cardiovascular
% 217.16/217.31  |- mesh__dateEstablished mesh__D002317 1979-01-01
% 217.16/217.31  |- skos__hiddenLabel mesh__D007002 Nerves, Hypoglossal
% 217.16/217.31  |- skos__scopeNote mesh__D007002
% 217.16/217.31       The 12th cranial nerve. The hypoglossal nerve originates in the hypoglossal nucleus of the medulla and supplies motor innervation to all of the muscles of the tongue except the palatoglossus %28%which is supplied by the vagus%29%. This nerve also contains proprioceptive afferents from the tongue muscles.%A%    
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D007002 2003
% 217.16/217.31  |- skos__annotation mesh__D007002
% 217.16/217.31       neopl = HYPOGLOSSAL NERVE DISEASES %28%IM%29% + CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 217.16/217.31  |- skos__hiddenLabel mesh__D007002 Nerves, Twelfth Cranial
% 217.16/217.31  |- skos__prefLabel mesh__D007002 Hypoglossal Nerve
% 217.16/217.31  |- mesh__dateCreated mesh__D007002 1999-01-01
% 217.16/217.31  |- skos__altLabel mesh__D007002 Cranial Nerve XII
% 217.16/217.31  |- skos__broader mesh__D007002smesh__D003391
% 217.16/217.31  |- skos__altLabel mesh__D007002 Twelfth Cranial Nerve
% 217.16/217.31  |- mesh__recordMaintainer mesh__D007002 ags
% 217.16/217.31  |- skos__hiddenLabel mesh__D007002 XII, Cranial Nerve
% 217.16/217.31  |- skos__hiddenLabel mesh__D007002 Nerve XII, Cranial
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D007002 2002
% 217.16/217.31  |- skos__hiddenLabel mesh__D007002 Cranial Nerve, Twelfth
% 217.16/217.31  |- skos__hiddenLabel mesh__D007002 Nerve, Hypoglossal
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D007002 2006
% 217.16/217.31  |- mesh__recordAuthorizer mesh__D007002 sjn
% 217.16/217.31  |- skos__hiddenLabel mesh__D007002 Nerve, Twelfth Cranial
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D007002 2001
% 217.16/217.31  |- rdf__type mesh__D007002sskos__Concept
% 217.16/217.31  |- skos__hiddenLabel mesh__D007002 Cranial Nerve XIIs
% 217.16/217.31  |- mesh__dateRevised mesh__D007002 1999-11-03
% 217.16/217.31  |- skos__hiddenLabel mesh__D007002 Twelfth Cranial Nerves
% 217.16/217.31  |- skos__hiddenLabel mesh__D007002 Nerve XIIs, Cranial
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D007002 2000
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D007002 2005
% 217.16/217.31  |- skos__hiddenLabel mesh__D007002 Hypoglossal Nerves
% 217.16/217.31  |- skos__hiddenLabel mesh__D007002 Cranial Nerves, Twelfth
% 217.16/217.31  |- mesh__recordOriginator mesh__D007002 NLM
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D007002 2004
% 217.16/217.31  |- skos__hiddenLabel mesh__D007002 XIIs, Cranial Nerve
% 217.16/217.31  |- mesh__dateEstablished mesh__D012745 1973-01-01
% 217.16/217.31  |- skos__scopeNote mesh__D012745
% 217.16/217.31       Complete or partial change from one sex to another with regard to gonadal development. Gonadal sex reversal may occur naturally or be induced by factors such as steroids, temperature, and autosomal abnormalities during the critical period of gonadal differentiation %28%SEX DIFFERENTIATION%29% in some species.%A%    
% 217.16/217.31  |- mesh__dateCreated mesh__D012745 1999-01-01
% 217.16/217.31  |- skos__hiddenLabel mesh__D012745 Gonadal Sex Reversal
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D012745 2006
% 217.16/217.31  |- mesh__recordAuthorizer mesh__D012745 sjn
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D012745 2004
% 217.16/217.31  |- mesh__publicMeSHNote mesh__D012745 73   
% 217.16/217.31  |- skos__historyNote mesh__D012745
% 217.16/217.31       Sex Determination %28%Genetics%29% %28%1966-1972%29%
% 217.16/217.31  |- rdf__type mesh__D012745sskos__Concept
% 217.16/217.31  |- skos__broader mesh__D012745smesh__D012098
% 217.16/217.31  |- skos__prefLabel mesh__D012745 Sex Reversal, Gonadal
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D012745 2005
% 217.16/217.31  |- skos__annotation mesh__D012745
% 217.16/217.31       do not confuse with GONADAL DYSGENESIS and its specifics   
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D012745 2003
% 217.16/217.31  |- mesh__historyNote mesh__D012745 73   
% 217.16/217.31  |- mesh__dateRevised mesh__D012745 2001-07-25
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D012745 2002
% 217.16/217.31  |- mesh__recordMaintainer mesh__D012745 lkt
% 217.16/217.31  |- mesh__recordOriginator mesh__D012745 NLM
% 217.16/217.31  |- mesh__recordAuthorizer mesh__D006708 sjn
% 217.16/217.31  |- skos__hiddenLabel mesh__D006708 Genocides
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D006708 2002
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D006708 2005
% 217.16/217.31  |- mesh__dateCreated mesh__D006708 1999-01-01
% 217.16/217.31  |- skos__broader mesh__D006708smesh__D003415
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D006708 2006
% 217.16/217.31  |- skos__prefLabel mesh__D006708 Homicide
% 217.16/217.31  |- skos__broader mesh__D006708smesh__D012940
% 217.16/217.31  |- skos__hiddenLabel mesh__D006708 Wrongful Deaths
% 217.16/217.31  |- mesh__recordMaintainer mesh__D006708 jrf
% 217.16/217.31  |- skos__hiddenLabel mesh__D006708 Death, Wrongful
% 217.16/217.31  |- skos__scopeNote mesh__D006708 The killing of one person by another.     
% 217.16/217.31  |- mesh__recordOriginator mesh__D006708 NLM
% 217.16/217.31  |- skos__hiddenLabel mesh__D006708 Killings
% 217.16/217.31  |- skos__hiddenLabel mesh__D006708 Deaths, Wrongful
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D006708 2003
% 217.16/217.31  |- skos__hiddenLabel mesh__D006708 Murders
% 217.16/217.31  |- skos__hiddenLabel mesh__D006708 Homicides
% 217.16/217.31  |- rdf__type mesh__D006708sskos__Concept
% 217.16/217.31  |- mesh__dateRevised mesh__D006708 2001-07-25
% 217.16/217.31  |- mesh__activeMeSHYear mesh__D006708 2004
% 217.16/217.31  |- skos__broader mesh__D017430smesh__D014408
% 217.16/217.32  |- skos__altLabel mesh__D017430 Prostate Specific Antigen
% 217.16/217.32  |- skos__broader mesh__D017430smesh__D029584
% 217.16/217.32  |- skos__related mesh__D017430smesh__D011471
% 217.16/217.32  |- mesh__recordMaintainer mesh__D017430 ssb
% 217.16/217.32  |- mesh__onlineNote mesh__D017430
% 217.16/217.32       use PROSTATE-SPECIFIC ANTIGEN %28%NM%29% to search PROSTATE CANCER SPECIFIC ANTIGENS 1982-92 %26% SEMENOGELASE 1980-95%A%  
% 217.16/217.32  |- mesh__historyNote mesh__D017430
% 217.16/217.32       93; was PROSTATE CANCER SPECIFIC ANTIGENS %28%NM%29% 1982-92; SEMENOGELASE was NM 1976-95%A%  
% 217.16/217.32  |- skos__hiddenLabel mesh__D017430 Kallikrein, hK3
% 217.16/217.32  |- mesh__dateCreated mesh__D017430 1992-05-22
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D017430 2006
% 217.16/217.32  |- skos__annotation mesh__D017430
% 217.16/217.32       do not confuse with prostate-specific acid phosphatase %28% = PROSTATE + ACID PHOSPHATASE%29%%A%  
% 217.16/217.32  |- mesh__publicMeSHNote mesh__D017430
% 217.16/217.32       93; PROSTATE CANCER SPECIFIC ANTIGENS was indexed under ANTIGENS, NEOPLASM 1982-92; SEMENOGELASE was indexed under PROSTATE-SPECIFIC ANTIGEN 1988-95 %26% PEPTIDE PEPTIDOHYDROLASE 1976-87%A%  
% 217.16/217.32  |- mesh__recordOriginator mesh__D017430 AGS
% 217.16/217.32  |- mesh__recordAuthorizer mesh__D017430 sjn
% 217.16/217.32  |- skos__altLabel mesh__D017430 Seminin
% 217.16/217.32  |- skos__prefLabel mesh__D017430 Prostate-Specific Antigen
% 217.16/217.32  |- skos__altLabel mesh__D017430 hK3 Kallikrein
% 217.16/217.32  |- skos__broader mesh__D017430smesh__D000951
% 217.16/217.32  |- skos__altLabel mesh__D017430 Semenogelase
% 217.16/217.32  |- rdf__type mesh__D017430sskos__Concept
% 217.16/217.32  |- skos__scopeNote mesh__D017430
% 217.16/217.32       A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer.%A%    
% 217.16/217.32  |- skos__hiddenLabel mesh__D017430 gamma Seminoprotein
% 217.16/217.32  |- mesh__dateRevised mesh__D017430 2005-06-30
% 217.16/217.32  |- mesh__dateEstablished mesh__D017430 1993-01-01
% 217.16/217.32  |- skos__altLabel mesh__D017430 Kallikrein hK3
% 217.16/217.32  |- skos__broader mesh__D017430smesh__D007610
% 217.16/217.32  |- skos__historyNote mesh__D017430 Antigens, Neoplasm %28%1982-1992%29%
% 217.16/217.32  |- skos__altLabel mesh__D017430 gamma-Seminoprotein
% 217.16/217.32  |- skos__broader mesh__D031101smesh__D029067
% 217.16/217.32  |- skos__annotation mesh__D031101
% 217.16/217.32       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.16/217.32  |- skos__altLabel mesh__D031101 Condurango
% 217.16/217.32  |- mesh__publicMeSHNote mesh__D031101 2003   
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D031101 2006
% 217.16/217.32  |- mesh__dateCreated mesh__D031101 2002-07-03
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D031101 2004
% 217.16/217.32  |- skos__scopeNote mesh__D031101
% 217.16/217.32       A plant genus of the family ASCLEPIADACEAE. Members contain pregnane glycosides %28%marsdekoiside %26% marstomentosides, maryal%29% and  hainaneosides %28%SAPONINS%29%.%A%    
% 217.16/217.32  |- rdf__type mesh__D031101sskos__Concept
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D031101 2005
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D031101 2003
% 217.16/217.32  |- skos__prefLabel mesh__D031101 Marsdenia
% 217.16/217.32  |- mesh__dateEstablished mesh__D031101 2003-01-01
% 217.16/217.32  |- mesh__historyNote mesh__D031101 2003   
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D050864 2006
% 217.16/217.32  |- mesh__publicMeSHNote mesh__D050864
% 217.16/217.32       2006; NADPH-SULFITE REDUCTASE was indexed under SULFITE REDUCTASES 1983-2005%A%  
% 217.16/217.32  |- mesh__recordMaintainer mesh__D050864 jmp
% 217.16/217.32  |- mesh__recordAuthorizer mesh__D050864 sjn
% 217.16/217.32  |- skos__historyNote mesh__D050864
% 217.16/217.32       Oxidoreductases Acting on Sulfur Group Donors %28%1983-2005%29%
% 217.16/217.32  |- skos__scopeNote mesh__D050864
% 217.16/217.32       A NADPH-dependent oxidase that reduces hydrogen sulfite to HYDROGEN SULFIDE. It is found in many microoganisms.%A%    
% 217.16/217.32  |- rdf__type mesh__D050864sskos__Concept
% 217.16/217.32  |- skos__hiddenLabel mesh__D050864 NADPH Sulfite Reductase
% 217.16/217.32  |- skos__altLabel mesh__D050864 NADPH-Sulfite Reductase
% 217.16/217.32  |- skos__prefLabel mesh__D050864 Sulfite Reductase %28%NADPH%29%
% 217.16/217.32  |- mesh__dateCreated mesh__D050864 2005-06-30
% 217.16/217.32  |- skos__hiddenLabel mesh__D050864 Reductase, NADPH-Sulfite
% 217.16/217.32  |- mesh__historyNote mesh__D050864 2006%28%1983%29%   
% 217.16/217.32  |- skos__broader mesh__D050864smesh__D050862
% 217.16/217.32  |- mesh__dateEstablished mesh__D050864 2006-01-01
% 217.16/217.32  |- mesh__recordOriginator mesh__D050864 jmp
% 217.16/217.32  |- skos__broader mesh__D003410smesh__D000015
% 217.16/217.32  |- mesh__dateEstablished mesh__D003410 1966-01-01
% 217.16/217.32  |- mesh__onlineNote mesh__D003410
% 217.16/217.32       use CRI-DU-CHAT SYNDROME to search CRYING CAT SYNDROME 1966-76%A%  
% 217.16/217.32  |- skos__altLabel mesh__D003410 Chromosome 5p- Syndrome
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 Chromosome 5p- Syndromes
% 217.16/217.32  |- skos__altLabel mesh__D003410 5p Deletion Syndrome
% 217.16/217.32  |- rdf__type mesh__D003410sskos__Concept
% 217.16/217.32  |- mesh__dateCreated mesh__D003410 1999-01-01
% 217.16/217.32  |- skos__scopeNote mesh__D003410
% 217.16/217.32       An infantile syndrome characterized by a cat-like cry, failure to thrive, microcephaly, MENTAL RETARDATION, spastic quadriparesis, micro- and retrognathia, glossoptosis, bilateral epicanthus, hypertelorism, and tiny external genitalia. It is caused by a deletion of the short arm of chromosome 5 %28%5p-%29%.%A%    
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 Syndromes, Cri-du-Chat
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 Syndromes, 5p Deletion
% 217.16/217.32  |- mesh__dateRevised mesh__D003410 2001-07-25
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D003410 2005
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 5p Deletion Syndromes
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 Cri du Chat Syndrome
% 217.16/217.32  |- mesh__recordAuthorizer mesh__D003410 sjn
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 Chromosome 5p  Syndrome
% 217.16/217.32  |- mesh__recordOriginator mesh__D003410 NLM
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 5p  Syndrome
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 Syndromes, 5p-
% 217.16/217.32  |- skos__altLabel mesh__D003410 Chromosome 5 Short Arm Deletion Syndrome
% 217.16/217.32  |- skos__prefLabel mesh__D003410 Cri-du-Chat Syndrome
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 Syndromes, Chromosome 5p-
% 217.16/217.32  |- skos__altLabel mesh__D003410
% 217.16/217.32       Deletion of Short Arm of Chromosome 5 Syndrome
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D003410 2006
% 217.16/217.32  |- skos__altLabel mesh__D003410 5p- Syndrome
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 Cri-du-Chat Syndromes
% 217.16/217.32  |- skos__broader mesh__D003410smesh__D025063
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 Syndrome, Chromosome 5p-
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 Deletion Syndrome, 5p
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D003410 2003
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 5p- Syndrome, Chromosome
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 Syndromes, Crying Cat
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D003410 2002
% 217.16/217.32  |- mesh__publicMeSHNote mesh__D003410
% 217.16/217.32       77; was CRYING CAT SYNDROME 1964-76   
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 5p- Syndromes, Chromosome
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 Deletion Syndromes, 5p
% 217.16/217.32  |- mesh__recordMaintainer mesh__D003410 nns
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 5p- Syndromes
% 217.16/217.32  |- mesh__historyNote mesh__D003410 77; was CRYING CAT SYNDROME 1964-76   
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 Syndrome, Crying Cat
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D003410 2004
% 217.16/217.32  |- skos__related mesh__D003410smesh__D008607
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 Syndrome, 5p Deletion
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 Syndrome, Cri-du-Chat
% 217.16/217.32  |- skos__altLabel mesh__D003410 Crying Cat Syndrome
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 Syndrome, 5p-
% 217.16/217.32  |- skos__hiddenLabel mesh__D003410 Crying Cat Syndromes
% 217.16/217.32  |- skos__broader mesh__D003410smesh__D008607
% 217.16/217.32  |- mesh__recordAuthorizer mesh__D016338 sjn
% 217.16/217.32  |- skos__broader mesh__D016338smesh__D005814
% 217.16/217.32  |- skos__hiddenLabel mesh__D016338 Gene, vpu
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D016338 2006
% 217.16/217.32  |- mesh__recordOriginator mesh__D016338 AGS
% 217.16/217.32  |- skos__broader mesh__D016338smesh__D005809
% 217.16/217.32  |- skos__prefLabel mesh__D016338 Genes, vpu
% 217.16/217.32  |- mesh__dateEstablished mesh__D016338 1991-01-01
% 217.16/217.32  |- skos__annotation mesh__D016338 vpu stands for %22%Viral Protein U%22%   
% 217.16/217.32  |- skos__hiddenLabel mesh__D016338 vpu Gene
% 217.16/217.32  |- mesh__recordMaintainer mesh__D016338 sjn
% 217.16/217.32  |- skos__altLabel mesh__D016338 vpu Genes
% 217.16/217.32  |- mesh__dateCreated mesh__D016338 1990-05-29
% 217.16/217.32  |- mesh__publicMeSHNote mesh__D016338 91   
% 217.16/217.32  |- rdf__type mesh__D016338sskos__Concept
% 217.16/217.32  |- skos__scopeNote mesh__D016338
% 217.16/217.32       DNA sequences that form the coding region for the HIV-1 regulatory protein vpu %28%viral protein U%29% that greatly increases the export of virus particles from infected cells. The vpu genes are not present in HIV-2 or SIMIAN IMMUNODEFICIENCY VIRUS.%A%    
% 217.16/217.32  |- skos__historyNote mesh__D016338 Genes, Viral %28%1988-1990%29%
% 217.16/217.32  |- mesh__historyNote mesh__D016338 91   
% 217.16/217.32  |- mesh__dateRevised mesh__D016338 2005-07-01
% 217.16/217.32  |- skos__broader mesh__D030009smesh__D029062
% 217.16/217.32  |- mesh__dateEstablished mesh__D030009 2002-01-01
% 217.16/217.32  |- mesh__publicMeSHNote mesh__D030009 2002   
% 217.16/217.32  |- rdf__type mesh__D030009sskos__Concept
% 217.16/217.32  |- mesh__dateCreated mesh__D030009 2001-07-25
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D030009 2002
% 217.16/217.32  |- skos__annotation mesh__D030009
% 217.16/217.32       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.16/217.32  |- mesh__historyNote mesh__D030009 2002   
% 217.16/217.32  |- skos__scopeNote mesh__D030009
% 217.16/217.32       A plant genus of the family APOCYNACEAE. It contains ellipticine.%A%    
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D030009 2004
% 217.16/217.32  |- skos__prefLabel mesh__D030009 Aspidosperma
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D030009 2006
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D030009 2003
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D030009 2005
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D002318 2004
% 217.16/217.32  |- mesh__recordOriginator mesh__D002318 NLM
% 217.16/217.32  |- mesh__dateRevised mesh__D002318 1997-06-20
% 217.16/217.32  |- mesh__recordMaintainer mesh__D002318 TGC
% 217.16/217.32  |- skos__hiddenLabel mesh__D002318 Disease, Cardiovascular
% 217.16/217.32  |- rdf__type mesh__D002318sskos__Concept
% 217.16/217.32  |- mesh__recordAuthorizer mesh__D002318 SJN
% 217.16/217.32  |- mesh__runningHead mesh__D002318 C14 - DISEASES-CARDIOVASCULAR   
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D002318 1999
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D002318 2003
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D002318 2002
% 217.16/217.32  |- skos__annotation mesh__D002318
% 217.16/217.32       GEN: avoid; prefer specifics; /diag: consider also DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; DF: CARDIOVASC DIS%A%  
% 217.16/217.32  |- skos__hiddenLabel mesh__D002318 Cardiovascular Disease
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D002318 1998
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D002318 2001
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D002318 2006
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D002318 2000
% 217.16/217.32  |- skos__hiddenLabel mesh__D002318 Diseases, Cardiovascular
% 217.16/217.32  |- mesh__dateCreated mesh__D002318 1999-01-01
% 217.16/217.32  |- skos__prefLabel mesh__D002318 Cardiovascular Diseases
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D002318 2005
% 217.16/217.32  |- mesh__onlineNote mesh__D002318
% 217.16/217.32       pre-explosion = CARDIOVASCULAR DISEASES %28%PX%29%   
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D013040 2001
% 217.16/217.32  |- mesh__publicMeSHNote mesh__D013040 68   
% 217.16/217.32  |- skos__altLabel mesh__D013040 Medical Specialty
% 217.16/217.32  |- mesh__dateEstablished mesh__D013040 1968-01-01
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D013040 2000
% 217.16/217.32  |- skos__prefLabel mesh__D013040 Specialties, Medical
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D013040 2006
% 217.16/217.32  |- mesh__dateRevised mesh__D013040 1999-11-03
% 217.16/217.32  |- skos__scopeNote mesh__D013040
% 217.16/217.32       Various branches of medical practice limited to specialized areas.%A%    
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D013040 2004
% 217.16/217.32  |- skos__hiddenLabel mesh__D013040 Medical Speciality
% 217.16/217.32  |- skos__altLabel mesh__D013040 Medical Specialties
% 217.16/217.32  |- skos__annotation mesh__D013040
% 217.16/217.32       SPEC: SPEC qualif; coord IM with field or subject %28%IM%29%; with biog: Manual 32.16.9, 34.4; policy: Manual 28.5, 28.7; DF: SPECIALTIES MED%A%  
% 217.16/217.32  |- skos__altLabel mesh__D013040 Medical Specialities
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D013040 2005
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D013040 2002
% 217.16/217.32  |- skos__altLabel mesh__D013040 Specialty, Medical
% 217.16/217.32  |- skos__altLabel mesh__D013040 Specialities, Medical
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D013040 2003
% 217.16/217.32  |- mesh__historyNote mesh__D013040 68   
% 217.16/217.32  |- skos__broader mesh__D013040smesh__D008511
% 217.16/217.32  |- skos__hiddenLabel mesh__D013040 Speciality, Medical
% 217.16/217.32  |- rdf__type mesh__D013040sskos__Concept
% 217.16/217.32  |- mesh__recordMaintainer mesh__D013040 kle
% 217.16/217.32  |- mesh__recordAuthorizer mesh__D013040 sjn
% 217.16/217.32  |- skos__historyNote mesh__D013040 Specialism %28%1966-1967%29%
% 217.16/217.32  |- mesh__recordOriginator mesh__D013040 NLM
% 217.16/217.32  |- mesh__dateCreated mesh__D013040 1999-01-01
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D007801 2005
% 217.16/217.32  |- skos__prefLabel mesh__D007801 Langerhans Cells
% 217.16/217.32  |- skos__historyNote mesh__D007801 Cytoplasmic Granules %28%1966-1968%29%
% 217.16/217.32  |- skos__hiddenLabel mesh__D007801 Cells, Langerhans
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D007801 2004
% 217.16/217.32  |- skos__annotation mesh__D007801
% 217.16/217.32       A 11 qualif; cutaneous cells: do not confuse with ISLETS OF LANGERHANS %28%pancreas%29% nor with GIANT CELLS, LANGHANS %28%macrophages%29%%A%  
% 217.16/217.32  |- mesh__historyNote mesh__D007801 73%28%69%29%   
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D007801 2006
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D007801 2000
% 217.16/217.32  |- mesh__recordAuthorizer mesh__D007801 PLS
% 217.16/217.32  |- mesh__publicMeSHNote mesh__D007801 73   
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D007801 2001
% 217.16/217.32  |- mesh__recordOriginator mesh__D007801 NLM
% 217.16/217.32  |- mesh__dateCreated mesh__D007801 1999-01-01
% 217.16/217.32  |- skos__scopeNote mesh__D007801
% 217.16/217.32       Recirculating, dendritic, antigen-presenting cells containing characteristic racket-shaped granules %28%Birbeck granules%29%. They are found principally in the stratum spinosum of the epidermis and are rich in Class II major histocompatibility complex molecules.%A%    
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D007801 1996
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D007801 1991
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D007801 1998
% 217.16/217.32  |- skos__broader mesh__D007801smesh__D003713
% 217.16/217.32  |- skos__historyNote mesh__D007801 Epithelium %28%1966-1968%29%
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D007801 1997
% 217.16/217.32  |- mesh__dateEstablished mesh__D007801 1973-01-01
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D007801 1992
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D007801 1994
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D007801 1999
% 217.16/217.32  |- mesh__dateRevised mesh__D007801 1990-05-29
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D007801 2002
% 217.16/217.32  |- rdf__type mesh__D007801sskos__Concept
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D007801 1993
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D007801 1995
% 217.16/217.32  |- skos__historyNote mesh__D007801 Skin %28%1966-1968%29%
% 217.16/217.32  |- mesh__recordMaintainer mesh__D007801 TGC
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D007801 2003
% 217.16/217.32  |- skos__hiddenLabel mesh__D007003 Hypoglycemia, Fasting
% 217.16/217.32  |- skos__altLabel mesh__D007003 Reactive Hypoglycemia
% 217.16/217.32  |- mesh__dateCreated mesh__D007003 1999-01-01
% 217.16/217.32  |- mesh__recordOriginator mesh__D007003 NLM
% 217.16/217.32  |- skos__altLabel mesh__D007003 Postabsorptive Hypoglycemia
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D007003 2006
% 217.16/217.32  |- skos__hiddenLabel mesh__D007003 Hypoglycemia, Postabsorptive
% 217.16/217.32  |- skos__scopeNote mesh__D007003
% 217.16/217.32       A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.%A%    
% 217.16/217.32  |- skos__broader mesh__D007003smesh__D044882
% 217.16/217.32  |- skos__hiddenLabel mesh__D007003 Hypoglycemia, Postprandial
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D007003 2005
% 217.16/217.32  |- mesh__recordMaintainer mesh__D007003 lkt
% 217.16/217.32  |- mesh__dateRevised mesh__D007003 2003-07-09
% 217.16/217.32  |- rdf__type mesh__D007003sskos__Concept
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D007003 2004
% 217.16/217.32  |- skos__hiddenLabel mesh__D007003 Hypoglycemia, Reactive
% 217.16/217.32  |- mesh__recordAuthorizer mesh__D007003 sjn
% 217.16/217.32  |- skos__prefLabel mesh__D007003 Hypoglycemia
% 217.16/217.32  |- mesh__recordMaintainer mesh__D012746 lkt
% 217.16/217.32  |- mesh__recordOriginator mesh__D012746 NLM
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D012746 2006
% 217.16/217.32  |- mesh__publicMeSHNote mesh__D012746
% 217.16/217.32       91; was see under SEX BEHAVIOR 1975-90; CELIBACY was heading 1963-67%A%  
% 217.16/217.32  |- rdf__type mesh__D012746sskos__Concept
% 217.16/217.32  |- skos__scopeNote mesh__D012746 Refraining from SEXUAL INTERCOURSE.     
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D012746 2005
% 217.16/217.32  |- mesh__dateRevised mesh__D012746 2004-07-07
% 217.16/217.32  |- mesh__dateCreated mesh__D012746 1974-11-11
% 217.16/217.32  |- mesh__dateEstablished mesh__D012746 1991-01-01
% 217.16/217.32  |- mesh__recordAuthorizer mesh__D012746 sjn
% 217.16/217.32  |- skos__altLabel mesh__D012746 Celibacy
% 217.16/217.32  |- skos__hiddenLabel mesh__D012746 Abstinence, Sexual
% 217.16/217.32  |- skos__prefLabel mesh__D012746 Sexual Abstinence
% 217.16/217.32  |- skos__broader mesh__D012746smesh__D012725
% 217.16/217.32  |- skos__hiddenLabel mesh__D012746 Abstinence, Postpartum
% 217.16/217.32  |- mesh__historyNote mesh__D012746
% 217.16/217.32       91%28%75%29%; was see under SEX BEHAVIOR 1975-90; CELIBACY was heading 1963-67%A%  
% 217.16/217.32  |- mesh__historyNote mesh__D045122 2004   
% 217.16/217.32  |- skos__annotation mesh__D045122 not used for indexing or cataloging   
% 217.16/217.32  |- skos__broader mesh__D045122smesh__D001790
% 217.16/217.32  |- skos__hiddenLabel mesh__D045122 Physiologic Phenomena, Blood
% 217.16/217.32  |- skos__hiddenLabel mesh__D045122 Physiological Phenomenon, Blood
% 217.16/217.32  |- mesh__dateEstablished mesh__D045122 2004-01-01
% 217.16/217.32  |- skos__hiddenLabel mesh__D045122 Phenomena, Blood Physiologic
% 217.16/217.32  |- skos__prefLabel mesh__D045122 Blood Physiologic Phenomena
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D045122 2004
% 217.16/217.32  |- skos__altLabel mesh__D045122 Blood Physiological Phenomenon
% 217.16/217.32  |- skos__scopeNote mesh__D045122
% 217.16/217.32       Observable or measurable characteristics of the BLOOD.     
% 217.16/217.32  |- mesh__dateCreated mesh__D045122 2003-07-09
% 217.16/217.32  |- rdf__type mesh__D045122sskos__Concept
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D045122 2006
% 217.16/217.32  |- mesh__publicMeSHNote mesh__D045122 2004   
% 217.16/217.32  |- skos__hiddenLabel mesh__D045122 Phenomenon, Blood Physiological
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D045122 2005
% 217.16/217.32  |- skos__broader mesh__D019815Q000031smesh__D019815
% 217.16/217.32  |- mesh__preferredCombination mesh__D019815Q000031smesh__D019816
% 217.16/217.32  |- rdf__type mesh__D019815Q000031smesh__CompoundConcept
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D006709 2005
% 217.16/217.32  |- mesh__recordMaintainer mesh__D006709 nns
% 217.16/217.32  |- mesh__dateRevised mesh__D006709 2001-07-25
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D006709 2006
% 217.16/217.32  |- skos__prefLabel mesh__D006709 Homoarginine
% 217.16/217.32  |- mesh__recordAuthorizer mesh__D006709 sjn
% 217.16/217.32  |- skos__historyNote mesh__D006709 Guanidines %28%1972-1974%29%
% 217.16/217.32  |- skos__broader mesh__D006709smesh__D001120
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D006709 2002
% 217.16/217.32  |- mesh__dateEstablished mesh__D006709 1991-01-01
% 217.16/217.32  |- mesh__dateCreated mesh__D006709 1974-11-19
% 217.16/217.32  |- mesh__publicMeSHNote mesh__D006709 91; was see under ARGININE 1975-90   
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D006709 2003
% 217.16/217.32  |- rdf__type mesh__D006709sskos__Concept
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D006709 2004
% 217.16/217.32  |- mesh__recordOriginator mesh__D006709 NLM
% 217.16/217.32  |- skos__historyNote mesh__D006709 Aminocaproic Acids %28%1972-1974%29%
% 217.16/217.32  |- mesh__historyNote mesh__D006709
% 217.16/217.32       91%28%75%29%; was see under ARGININE 1975-90   
% 217.16/217.32  |- mesh__historyNote mesh__D017431 93   
% 217.16/217.32  |- mesh__dateRevised mesh__D017431 2005-06-30
% 217.16/217.32  |- skos__broader mesh__D017431smesh__D016147
% 217.16/217.32  |- skos__historyNote mesh__D017431
% 217.16/217.32       Genes, Suppressor, Tumor %28%1991-1992%29%
% 217.16/217.32  |- mesh__publicMeSHNote mesh__D017431 93   
% 217.16/217.32  |- mesh__dateCreated mesh__D017431 1992-05-20
% 217.16/217.32  |- rdf__type mesh__D017431sskos__Concept
% 217.16/217.32  |- mesh__recordMaintainer mesh__D017431 nns
% 217.16/217.32  |- skos__annotation mesh__D017431
% 217.16/217.32       MCC stands for %22%Mutated in Colorectal Cancer%22%   
% 217.16/217.32  |- skos__related mesh__D017431smesh__D016163
% 217.16/217.32  |- skos__scopeNote mesh__D017431
% 217.16/217.32       Tumor suppressor genes located in the 5q21 region on the long arm of human chromosome 5. The mutation of these genes is associated with the formation of colorectal cancer %28%MCC stands for mutated in colorectal cancer%29%.%A%    
% 217.16/217.32  |- skos__hiddenLabel mesh__D017431 Gene, MCC
% 217.16/217.32  |- skos__prefLabel mesh__D017431 Genes, MCC
% 217.16/217.32  |- mesh__recordOriginator mesh__D017431 AGS
% 217.16/217.32  |- mesh__dateEstablished mesh__D017431 1993-01-01
% 217.16/217.32  |- skos__hiddenLabel mesh__D017431 MCC Genes
% 217.16/217.32  |- skos__hiddenLabel mesh__D017431 MCC Gene
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D017431 2006
% 217.16/217.32  |- mesh__recordAuthorizer mesh__D017431 sjn
% 217.16/217.32  |- mesh__dateEstablished mesh__D031102 2003-01-01
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D031102 2005A
% 217.16/217.32  |- mesh__historyNote mesh__D031102 2003   
% 217.16/217.32  |- mesh__publicMeSHNote mesh__D031102 2003   
% 217.16/217.32  |- skos__scopeNote mesh__D031102
% 217.16/217.32       A plant genus of the family ASCLEPIADACEAE. It is a source of PREGNANES. It is sometimes an adulterant of commercial sarsaparilla.%A%    
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D031102 2006
% 217.16/217.32  |- mesh__recordAuthorizer mesh__D031102 jls
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D031102 2004
% 217.16/217.32  |- rdf__type mesh__D031102sskos__Concept
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D031102 2005
% 217.16/217.32  |- skos__altLabel mesh__D031102 Sarsaparilla, East Indian
% 217.16/217.32  |- mesh__dateCreated mesh__D031102 2002-07-02
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D031102 2003
% 217.16/217.32  |- skos__broader mesh__D031102smesh__D029067
% 217.16/217.32  |- mesh__recordMaintainer mesh__D031102 jls
% 217.16/217.32  |- skos__annotation mesh__D031102
% 217.16/217.32       do not confuse with Sarsaparilla = SMILAX or Wild Sarsaparilla = ARALIA; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.16/217.32  |- mesh__dateRevised mesh__D031102 2004-07-27
% 217.16/217.32  |- skos__altLabel mesh__D031102 Anantamul
% 217.16/217.32  |- skos__altLabel mesh__D031102 Periploca indica
% 217.16/217.32  |- mesh__recordOriginator mesh__D031102 ssb
% 217.16/217.32  |- skos__prefLabel mesh__D031102 Hemidesmus
% 217.16/217.32  |- skos__hiddenLabel mesh__D003411 Lemming
% 217.16/217.32  |- skos__hiddenLabel mesh__D003411 Arvicoline
% 217.16/217.32  |- skos__hiddenLabel mesh__D003411 Red-Backed Mice
% 217.16/217.32  |- skos__hiddenLabel mesh__D003411 Muskrat
% 217.16/217.32  |- mesh__recordOriginator mesh__D003411 EC
% 217.16/217.32  |- skos__hiddenLabel mesh__D003411 Mouse, Red Backed
% 217.16/217.32  |- skos__hiddenLabel mesh__D003411 Mice, Red Backed
% 217.16/217.32  |- rdf__type mesh__D003411sskos__Concept
% 217.16/217.32  |- mesh__dateRevised mesh__D003411 2005-06-30
% 217.16/217.32  |- skos__hiddenLabel mesh__D003411 Microtine
% 217.16/217.32  |- mesh__historyNote mesh__D003411
% 217.16/217.32       2006 %28%1991%29%; for VOLES %26% MICROTUS use RODENTS 1975-1981   
% 217.16/217.32  |- skos__altLabel mesh__D003411 Arvicolines
% 217.16/217.32  |- mesh__publicMeSHNote mesh__D003411
% 217.16/217.32       2006; see MICROTINAE 1991-2005, see CRICETIDAE 1982-1990; for VOLES %26%  MICROTUS see RODENTS 1975-1981%A%  
% 217.16/217.32  |- mesh__recordMaintainer mesh__D003411 ags
% 217.16/217.32  |- skos__altLabel mesh__D003411 Microtines
% 217.16/217.32  |- skos__broader mesh__D003411smesh__D009115
% 217.16/217.32  |- skos__historyNote mesh__D003411 Rodentia %28%1966-1981%29%
% 217.16/217.32  |- skos__altLabel mesh__D003411 Microtus
% 217.16/217.32  |- skos__altLabel mesh__D003411 Ondatra zibethicus
% 217.16/217.32  |- mesh__dateEstablished mesh__D003411 1982-01-01
% 217.16/217.32  |- skos__hiddenLabel mesh__D003411 Vole
% 217.16/217.32  |- skos__prefLabel mesh__D003411 Arvicolinae
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D003411 2006
% 217.16/217.32  |- skos__altLabel mesh__D003411 Lemmings
% 217.16/217.32  |- skos__annotation mesh__D003411
% 217.16/217.32       for entry term MICE, RED-BACKED %26% other species commonly called %22%mouse%22% but taxonomically ARVICOLINAE, do not check tag MICE%A%  
% 217.16/217.32  |- skos__historyNote mesh__D003411 Rats %28%1966-1981%29%
% 217.16/217.32  |- mesh__recordAuthorizer mesh__D003411 sjn
% 217.16/217.32  |- skos__altLabel mesh__D003411 Mouse, Red-Backed
% 217.16/217.32  |- skos__scopeNote mesh__D003411
% 217.16/217.32       A subfamily of MURIDAE found nearly world-wide and consisting of about 20 genera. Voles, lemmings, and muskrats are members.%A%    
% 217.16/217.32  |- skos__altLabel mesh__D003411 Microtinae
% 217.16/217.32  |- skos__hiddenLabel mesh__D003411 Red-Backed Mouse
% 217.16/217.32  |- mesh__dateCreated mesh__D003411 1981-05-14
% 217.16/217.32  |- skos__broader mesh__D016339smesh__D013058
% 217.16/217.32  |- mesh__recordOriginator mesh__D016339 PXP
% 217.16/217.32  |- skos__altLabel mesh__D016339 Fast Atom Bombardment Mass Spectrometry
% 217.16/217.32  |- skos__altLabel mesh__D016339 Spectroscopy, Mass, Fast Atom Bombardment
% 217.16/217.32  |- skos__scopeNote mesh__D016339
% 217.16/217.32       A mass spectrometric technique that is used for the analysis of a wide range of biomolecules, such as glycoalkaloids, glycoproteins, polysaccharides, and peptides. Positive and negative fast atom bombardment spectra are recorded on a mass spectrometer fitted with an atom gun with xenon as the customary beam. The mass spectra obtained contain molecular weight recognition as well as sequence information.%A%    
% 217.16/217.32  |- mesh__recordMaintainer mesh__D016339 lkt
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D016339 2004
% 217.16/217.32  |- mesh__dateEstablished mesh__D016339 1991-01-01
% 217.16/217.32  |- mesh__dateRevised mesh__D016339 2002-07-03
% 217.16/217.32  |- skos__altLabel mesh__D016339 Mass Spectrometry, Fast Atom Bombardment
% 217.16/217.32  |- mesh__activeMeSHYear mesh__D016339 2003
% 217.19/217.32  |- mesh__activeMeSHYear mesh__D016339 2006
% 217.19/217.32  |- rdf__type mesh__D016339sskos__Concept
% 217.19/217.32  |- mesh__activeMeSHYear mesh__D016339 2005
% 217.19/217.32  |- mesh__dateCreated mesh__D016339 1990-05-29
% 217.19/217.32  |- mesh__publicMeSHNote mesh__D016339 91   
% 217.19/217.32  |- skos__historyNote mesh__D016339
% 217.19/217.32       Spectrum Analysis, Mass %28%1982-1990%29%
% 217.19/217.32  |- skos__prefLabel mesh__D016339 Spectrometry, Mass, Fast Atom Bombardment
% 217.19/217.32  |- mesh__recordAuthorizer mesh__D016339 sjn
% 217.19/217.32  |- mesh__historyNote mesh__D016339 91   
% 217.19/217.32  |- skos__annotation mesh__D016339
% 217.19/217.32       a type of mass spectrum anal; NIM; DF: FABMS   
% 217.19/217.32  |- skos__altLabel mesh__D016339 Fast Atom Bombardment Mass Spectroscopy
% 217.19/217.32  |- skos__altLabel mesh__D016339 Mass Spectroscopy, Fast Atom Bombardment
% 217.19/217.32  |- mesh__recordOriginator mesh__D027061 lkt
% 217.19/217.32  |- mesh__activeMeSHYear mesh__D027061 2006A
% 217.19/217.32  |- mesh__dateRevised mesh__D027061 2005-07-13
% 217.19/217.32  |- mesh__activeMeSHYear mesh__D027061 2004
% 217.19/217.32  |- skos__altLabel mesh__D027061 Topoisomerase II, Bacterial
% 217.19/217.32  |- mesh__recordMaintainer mesh__D027061 ags
% 217.19/217.32  |- skos__hiddenLabel mesh__D027061 Bacterial Topoisomerase II
% 217.19/217.32  |- mesh__recordAuthorizer mesh__D027061 ags
% 217.19/217.32  |- mesh__activeMeSHYear mesh__D027061 2005
% 217.19/217.32  |- mesh__dateCreated mesh__D027061 2001-07-25
% 217.19/217.32  |- skos__scopeNote mesh__D027061
% 217.19/217.32       Bacterial enzymes of the DNA TOPOISOMERASES, TYPE II class that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA duplex. Bacterial DNA topoisomerases in the Type II class exist as heterotetramers of 2 subunits, such as 2 gyrA and 2 gyrB in DNA GYRASE.%A%    
% 217.19/217.32  |- skos__prefLabel mesh__D027061 DNA Topoisomerases, Type II, Bacterial
% 217.19/217.32  |- skos__altLabel mesh__D027061 DNA Topoisomerase II, Bacterial
% 217.19/217.33  |- mesh__dateEstablished mesh__D027061 2002-01-01
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D027061 2006
% 217.19/217.33  |- skos__historyNote mesh__D027061
% 217.19/217.33       DNA Topoisomerase %28%ATP-Hydrolysing%29% %28%1979-2001%29%
% 217.19/217.33  |- mesh__historyNote mesh__D027061 2002   
% 217.19/217.33  |- rdf__type mesh__D027061sskos__Concept
% 217.19/217.33  |- skos__broader mesh__D027061smesh__D004250
% 217.19/217.33  |- mesh__publicMeSHNote mesh__D027061 2002   
% 217.19/217.33  |- mesh__onlineNote mesh__D002319
% 217.19/217.33       pre-explosion = CARDIOVASCULAR SYSTEM %28%PX%29%   
% 217.19/217.33  |- mesh__recordOriginator mesh__D002319 NLM
% 217.19/217.33  |- skos__scopeNote mesh__D002319
% 217.19/217.33       The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body.%A%    
% 217.19/217.33  |- skos__hiddenLabel mesh__D002319 Systems, Cardiovascular
% 217.19/217.33  |- skos__hiddenLabel mesh__D002319 Cardiovascular Systems
% 217.19/217.33  |- skos__related mesh__D002319smesh__D001775
% 217.19/217.33  |- mesh__recordMaintainer mesh__D002319 nns
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D002319 2006
% 217.19/217.33  |- skos__hiddenLabel mesh__D002319 System, Cardiovascular
% 217.19/217.33  |- mesh__runningHead mesh__D002319 A7 - ANATOMY-CARDIOVASCULAR SYSTEM   
% 217.19/217.33  |- mesh__dateCreated mesh__D002319 1999-01-01
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D002319 2005
% 217.19/217.33  |- skos__annotation mesh__D002319
% 217.19/217.33       GEN or unspecified; prefer specifics; /abnorm = CARDIOVASCULAR ABNORMALITIES but consider also specific artery or vein with /abnorm; DF: CARDIOVASC SYSTEM%A%  
% 217.19/217.33  |- skos__prefLabel mesh__D002319 Cardiovascular System
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D002319 2004
% 217.19/217.33  |- mesh__recordAuthorizer mesh__D002319 sjn
% 217.19/217.33  |- rdf__type mesh__D002319sskos__Concept
% 217.19/217.33  |- mesh__dateRevised mesh__D002319 2003-07-09
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D013041 2000
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D013041 2005
% 217.19/217.33  |- skos__historyNote mesh__D013041 Nursing %28%1966-1970%29%
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D013041 2003
% 217.19/217.33  |- mesh__recordMaintainer mesh__D013041 kle
% 217.19/217.33  |- mesh__recordAuthorizer mesh__D013041 sjn
% 217.19/217.33  |- skos__altLabel mesh__D013041 Nursing Specialty
% 217.19/217.33  |- mesh__recordOriginator mesh__D013041 NLM
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D013041 2006
% 217.19/217.33  |- skos__scopeNote mesh__D013041
% 217.19/217.33       Various branches of nursing practice limited to specialized areas.%A%    
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D013041 2004
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D013041 2001
% 217.19/217.33  |- mesh__dateEstablished mesh__D013041 1973-01-01
% 217.19/217.33  |- mesh__dateCreated mesh__D013041 1999-01-01
% 217.19/217.33  |- mesh__publicMeSHNote mesh__D013041 73   
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D013041 2002
% 217.19/217.33  |- skos__altLabel mesh__D013041 Specialty, Nursing
% 217.19/217.33  |- skos__prefLabel mesh__D013041 Specialties, Nursing
% 217.19/217.33  |- skos__altLabel mesh__D013041 Nursing Specialties
% 217.19/217.33  |- mesh__historyNote mesh__D013041 73%28%71%29%   
% 217.19/217.33  |- skos__annotation mesh__D013041
% 217.19/217.33       SPEC: SPEC qualif; coord IM with type of nursing or subject%A%  
% 217.19/217.33  |- rdf__type mesh__D013041sskos__Concept
% 217.19/217.33  |- skos__broader mesh__D013041smesh__D009729
% 217.19/217.33  |- mesh__dateRevised mesh__D013041 1999-11-03
% 217.19/217.33  |- rdf__type mesh__D007802sskos__Concept
% 217.19/217.33  |- skos__related mesh__D007802smesh__D019303
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D007802 2004
% 217.19/217.33  |- skos__related mesh__D007802smesh__D012813
% 217.19/217.33  |- skos__hiddenLabel mesh__D007802 Languages
% 217.19/217.33  |- skos__prefLabel mesh__D007802 Language
% 217.19/217.33  |- skos__broader mesh__D007802smesh__D003142
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D007802 2003
% 217.19/217.33  |- mesh__recordAuthorizer mesh__D007802 sjn
% 217.19/217.33  |- skos__annotation mesh__D007802
% 217.19/217.33       what is spoken or written; do not confuse with LINGUISTICS %28%see note there%29% or SPEECH %28%language as it comes out of the mouth%29%; no qualif%A%  
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D007802 2006
% 217.19/217.33  |- skos__scopeNote mesh__D007802
% 217.19/217.33       A verbal or nonverbal means of communicating ideas or feelings.%A%    
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D007802 2005
% 217.19/217.33  |- mesh__recordMaintainer mesh__D007802 TGC
% 217.19/217.33  |- mesh__dateCreated mesh__D007802 1999-01-01
% 217.19/217.33  |- mesh__recordOriginator mesh__D007802 NLM
% 217.19/217.33  |- mesh__dateRevised mesh__D007802 2002-07-03
% 217.19/217.33  |- skos__hiddenLabel mesh__D007004 Drugs, Antidiabetic
% 217.19/217.33  |- mesh__onlineNote mesh__D007004
% 217.19/217.33       use HYPOGLYCEMIC AGENTS to search ANTIDIABETICS 1966-75   
% 217.19/217.33  |- mesh__recordOriginator mesh__D007004 RLS
% 217.19/217.33  |- skos__hiddenLabel mesh__D007004 Agents, Antidiabetic
% 217.19/217.33  |- mesh__dateCreated mesh__D007004 1975-07-25
% 217.19/217.33  |- mesh__recordMaintainer mesh__D007004 ssb
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D007004 2005
% 217.19/217.33  |- skos__hiddenLabel mesh__D007004 Drugs, Hypoglycemic
% 217.19/217.33  |- mesh__recordAuthorizer mesh__D007004 sjn
% 217.19/217.33  |- rdf__type mesh__D007004sskos__Concept
% 217.19/217.33  |- skos__altLabel mesh__D007004 Hypoglycemics
% 217.19/217.33  |- skos__hiddenLabel mesh__D007004 Agents, Hypoglycemic
% 217.19/217.33  |- skos__scopeNote mesh__D007004
% 217.19/217.33       Agents which lower the blood glucose level.     
% 217.19/217.33  |- skos__altLabel mesh__D007004 Antidiabetic Agents
% 217.19/217.33  |- skos__altLabel mesh__D007004 Hypoglycemic Drugs
% 217.19/217.33  |- skos__prefLabel mesh__D007004 Hypoglycemic Agents
% 217.19/217.33  |- mesh__dateRevised mesh__D007004 2004-07-07
% 217.19/217.33  |- mesh__publicMeSHNote mesh__D007004
% 217.19/217.33       76; was see under ANTIDIABETICS 1968-74; ANTIDIABETICS was heading 1963-75%A%  
% 217.19/217.33  |- skos__broader mesh__D007004smesh__D045505
% 217.19/217.33  |- mesh__dateEstablished mesh__D007004 1976-01-01
% 217.19/217.33  |- mesh__historyNote mesh__D007004
% 217.19/217.33       76; was NON MESH 1975, was see under ANTIDIABETICS 1968-74; ANTIDIABETICS was heading 1963-75%A%  
% 217.19/217.33  |- skos__altLabel mesh__D007004 Antidiabetic Drugs
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D007004 2006
% 217.19/217.33  |- mesh__recordOriginator mesh__D012747 EC
% 217.19/217.33  |- mesh__recordMaintainer mesh__D012747 TGC
% 217.19/217.33  |- skos__hiddenLabel mesh__D012747 Partners, Multiple
% 217.19/217.33  |- mesh__recordAuthorizer mesh__D012747 SJN
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D012747 1999
% 217.19/217.33  |- skos__broader mesh__D012747smesh__D009272
% 217.19/217.33  |- skos__hiddenLabel mesh__D012747 Partners, Sexual
% 217.19/217.33  |- mesh__publicMeSHNote mesh__D012747 88   
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D012747 2002
% 217.19/217.33  |- mesh__historyNote mesh__D012747 88   
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D012747 1998
% 217.19/217.33  |- mesh__dateRevised mesh__D012747 1997-06-20
% 217.19/217.33  |- skos__scopeNote mesh__D012747
% 217.19/217.33       Married or single individuals who share sexual relations.%A%    
% 217.19/217.33  |- skos__hiddenLabel mesh__D012747 Sexual Partner
% 217.19/217.33  |- skos__historyNote mesh__D012747 Sex Behavior %28%1966-1987%29%
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D012747 2006
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D012747 2001
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D012747 2004
% 217.19/217.33  |- rdf__type mesh__D012747sskos__Concept
% 217.19/217.33  |- skos__hiddenLabel mesh__D012747 Partner, Sexual
% 217.19/217.33  |- skos__prefLabel mesh__D012747 Sexual Partners
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D012747 2000
% 217.19/217.33  |- mesh__dateEstablished mesh__D012747 1988-01-01
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D012747 2005
% 217.19/217.33  |- mesh__dateCreated mesh__D012747 1987-02-26
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D012747 2003
% 217.19/217.33  |- skos__hiddenLabel mesh__D045123 Processes, Blood Physiologic
% 217.19/217.33  |- skos__hiddenLabel mesh__D045123 Physiologic Processes, Blood
% 217.19/217.33  |- skos__hiddenLabel mesh__D045123 Processes, Blood Physiological
% 217.19/217.33  |- mesh__historyNote mesh__D045123 2004   
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D045123 2004
% 217.19/217.33  |- skos__annotation mesh__D045123 not used for indexing or cataloging   
% 217.19/217.33  |- skos__hiddenLabel mesh__D045123 Physiological Processes, Blood
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D045123 2005
% 217.19/217.33  |- skos__altLabel mesh__D045123 Blood Physiological Processes
% 217.19/217.33  |- mesh__dateCreated mesh__D045123 2003-07-09
% 217.19/217.33  |- rdf__type mesh__D045123sskos__Concept
% 217.19/217.33  |- skos__broader mesh__D045123smesh__D001790
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D045123 2006
% 217.19/217.33  |- mesh__publicMeSHNote mesh__D045123 2004   
% 217.19/217.33  |- mesh__dateEstablished mesh__D045123 2004-01-01
% 217.19/217.33  |- skos__prefLabel mesh__D045123 Blood Physiologic Processes
% 217.19/217.33  |- skos__scopeNote mesh__D045123
% 217.19/217.33       Biological actions and events that support the functions of the BLOOD.%A%    
% 217.19/217.33  |- mesh__dateEstablished mesh__D031901 2003-01-01
% 217.19/217.33  |- mesh__publicMeSHNote mesh__D031901 2003   
% 217.19/217.33  |- rdf__type mesh__D031901sskos__Concept
% 217.19/217.33  |- skos__historyNote mesh__D031901
% 217.19/217.33       Trophoblastic Neoplasms %28%1980-2002%29%
% 217.19/217.33  |- skos__hiddenLabel mesh__D031901 Neoplasm, Gestational Trophoblastic
% 217.19/217.33  |- mesh__recordOriginator mesh__D031901 lkt
% 217.19/217.33  |- mesh__dateRevised mesh__D031901 2004-07-13
% 217.19/217.33  |- skos__scopeNote mesh__D031901
% 217.19/217.33       A group of interrelated trophoblastic diseases arising from pregnancy. They are commonly associated with  hyperplasia of trophoblasts %28%TROPHOBLAST%29% and markedly elevated human CHORIONIC GONADOTROPIN. They include HYDATIDIFORM MOLE, invasive mole %28%HYDATIDIFORM MOLE, INVASIVE%29%, placental-site trophoblastic tumor %28%TROPHOBLASTIC TUMOR, PLACENTAL SITE%29%, and CHORIOCARCINOMA. These neoplasms have varying propensities for invasion and spread.%A%    
% 217.19/217.33  |- mesh__dateCreated mesh__D031901 2002-07-03
% 217.19/217.33  |- mesh__recordAuthorizer mesh__D031901 sjn
% 217.19/217.33  |- mesh__historyNote mesh__D031901 2003   
% 217.19/217.33  |- skos__broader mesh__D031901smesh__D014328
% 217.19/217.33  |- skos__hiddenLabel mesh__D031901 Trophoblastic Neoplasm, Gestational
% 217.19/217.33  |- skos__hiddenLabel mesh__D031901 Gestational Trophoblastic Neoplasm
% 217.19/217.33  |- skos__hiddenLabel mesh__D031901 Neoplasms, Gestational Trophoblastic
% 217.19/217.33  |- skos__altLabel mesh__D031901 Trophoblastic Neoplasms, Gestational
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D031901 2006
% 217.19/217.33  |- skos__historyNote mesh__D031901 Choriocarcinoma %28%1980-2002%29%
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D031901 2005
% 217.19/217.33  |- skos__historyNote mesh__D031901 Hydatidiform Mole %28%1980-2002%29%
% 217.19/217.33  |- skos__prefLabel mesh__D031901 Gestational Trophoblastic Neoplasms
% 217.19/217.33  |- mesh__recordMaintainer mesh__D031901 sjn
% 217.19/217.33  |- skos__related mesh__D017432smesh__D009626
% 217.19/217.33  |- mesh__dateCreated mesh__D017432 1992-03-27
% 217.19/217.33  |- mesh__dateEstablished mesh__D017432 1993-01-01
% 217.19/217.33  |- skos__broader mesh__D017432smesh__D018875
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D017432 2003
% 217.19/217.33  |- rdf__type mesh__D017432sskos__Concept
% 217.19/217.33  |- mesh__historyNote mesh__D017432 92   
% 217.19/217.33  |- mesh__recordAuthorizer mesh__D017432 sjn
% 217.19/217.33  |- skos__annotation mesh__D017432 CATALOG: use NAF entry   
% 217.19/217.33  |- skos__scopeNote mesh__D017432
% 217.19/217.33       A research and development program initiated by the NATIONAL LIBRARY OF MEDICINE to build knowledge sources for the purpose of aiding the development of systems that help health professionals retrieve and integrate biomedical information. The knowledge sources can be used to link disparate information systems to overcome retrieval problems caused by differences in terminology and the scattering of relevant information across many databases.   The three knowledge sources are the Metathesaurus, the Semantic Network, and the Specialist Lexicon.%A%    
% 217.19/217.33  |- skos__related mesh__D017432smesh__D013358
% 217.19/217.33  |- skos__altLabel mesh__D017432 UMLS
% 217.19/217.33  |- mesh__recordOriginator mesh__D017432 PLS
% 217.19/217.33  |- mesh__recordMaintainer mesh__D017432 JLS
% 217.19/217.33  |- mesh__publicMeSHNote mesh__D017432 92   
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D017432 2006
% 217.19/217.33  |- skos__prefLabel mesh__D017432 Unified Medical Language System
% 217.19/217.33  |- mesh__dateRevised mesh__D017432 2002-07-03
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D017432 2005
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D017432 2004
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D031103 2003
% 217.19/217.33  |- skos__prefLabel mesh__D031103 Gymnema
% 217.19/217.33  |- mesh__dateEstablished mesh__D031103 2003-01-01
% 217.19/217.33  |- skos__scopeNote mesh__D031103
% 217.19/217.33       A plant genus of the family ASCLEPIADACEAE.     
% 217.19/217.33  |- mesh__historyNote mesh__D031103 2003   
% 217.19/217.33  |- skos__broader mesh__D031103smesh__D029067
% 217.19/217.33  |- skos__annotation mesh__D031103
% 217.19/217.33       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.19/217.33  |- mesh__publicMeSHNote mesh__D031103 2003   
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D031103 2006
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D031103 2004
% 217.19/217.33  |- rdf__type mesh__D031103sskos__Concept
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D031103 2005
% 217.19/217.33  |- mesh__dateCreated mesh__D031103 2002-07-03
% 217.19/217.33  |- rdf__type mesh__D050866sskos__Concept
% 217.19/217.33  |- skos__altLabel mesh__D050866 Mesomorphous Phase Materials
% 217.19/217.33  |- skos__prefLabel mesh__D050866 Liquid Crystals
% 217.19/217.33  |- skos__hiddenLabel mesh__D050866 Material, Mesomorphous Phase
% 217.19/217.33  |- mesh__historyNote mesh__D050866 2006   
% 217.19/217.33  |- skos__historyNote mesh__D050866 Crystallization %28%1966-2005%29%
% 217.19/217.33  |- skos__hiddenLabel mesh__D050866 Crystals, Liquid
% 217.19/217.33  |- skos__hiddenLabel mesh__D050866 Materials, Mesomorphous Phase
% 217.19/217.33  |- mesh__publicMeSHNote mesh__D050866 2006   
% 217.19/217.33  |- mesh__dateEstablished mesh__D050866 2006-01-01
% 217.19/217.33  |- skos__related mesh__D050866smesh__D003102
% 217.19/217.33  |- skos__broader mesh__D050866smesh__D008420
% 217.19/217.33  |- skos__scopeNote mesh__D050866
% 217.19/217.33       Materials in intermediate state between solid and liquid.%A%    
% 217.19/217.33  |- mesh__recordAuthorizer mesh__D050866 sjn
% 217.19/217.33  |- skos__hiddenLabel mesh__D050866 Mesomorphous Phase Material
% 217.19/217.33  |- skos__hiddenLabel mesh__D050866 Liquid Crystal
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D050866 2006
% 217.19/217.33  |- mesh__dateCreated mesh__D050866 2005-06-30
% 217.19/217.33  |- skos__hiddenLabel mesh__D050866 Crystal, Liquid
% 217.19/217.33  |- mesh__recordOriginator mesh__D050866 ssb
% 217.19/217.33  |- mesh__recordMaintainer mesh__D050866 ssb
% 217.19/217.33  |- mesh__dateEstablished mesh__D003412 1991-01-01
% 217.19/217.33  |- skos__broader mesh__D003412smesh__D006224
% 217.19/217.33  |- skos__annotation mesh__D003412
% 217.19/217.33       do not confuse with CRICETUS see CRICETINAE  or CRICETIDAE see ARVICOLINAE; NIM when exper animal: no qualif; when IM, qualif permitted; do not forget  to check tag%A%  
% 217.19/217.33  |- skos__hiddenLabel mesh__D003412 Chinese Hamster
% 217.19/217.33  |- mesh__recordMaintainer mesh__D003412 ags
% 217.19/217.33  |- mesh__dateCreated mesh__D003412 1977-05-05
% 217.19/217.33  |- skos__hiddenLabel mesh__D003412 Grey Hamster
% 217.19/217.33  |- mesh__recordOriginator mesh__D003412 EC
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D003412 2006
% 217.19/217.33  |- mesh__recordAuthorizer mesh__D003412 sjn
% 217.19/217.33  |- skos__scopeNote mesh__D003412
% 217.19/217.33       A genus of the family Muridae consisting of eleven species. C. migratorius, the grey or Armenian hamster, and C. griseus, the Chinese hamster, are the two species used in biomedical research.%A%    
% 217.19/217.33  |- skos__altLabel mesh__D003412 Hamsters, Grey
% 217.19/217.33  |- mesh__publicMeSHNote mesh__D003412 91; was see under HAMSTERS 1978-90   
% 217.19/217.33  |- mesh__dateRevised mesh__D003412 2005-07-01
% 217.19/217.33  |- skos__hiddenLabel mesh__D003412 Hamster, Chinese
% 217.19/217.33  |- skos__hiddenLabel mesh__D003412 Grey Hamsters
% 217.19/217.33  |- mesh__historyNote mesh__D003412
% 217.19/217.33       91%28%78%29%; was see under HAMSTERS 1978-90   
% 217.19/217.33  |- skos__hiddenLabel mesh__D003412 Hamster, Grey
% 217.19/217.33  |- skos__hiddenLabel mesh__D003412 Hamster, Armenian
% 217.19/217.33  |- skos__hiddenLabel mesh__D003412 Chinese Hamsters
% 217.19/217.33  |- skos__prefLabel mesh__D003412 Cricetulus
% 217.19/217.33  |- skos__hiddenLabel mesh__D003412 Armenian Hamsters
% 217.19/217.33  |- rdf__type mesh__D003412sskos__Concept
% 217.19/217.33  |- skos__hiddenLabel mesh__D003412 Armenian Hamster
% 217.19/217.33  |- skos__historyNote mesh__D003412 Hamsters %28%1966-1977%29%
% 217.19/217.33  |- mesh__dateRevised mesh__D027062 2005-06-30
% 217.19/217.33  |- skos__historyNote mesh__D027062 Amino Acids/metabolism %28%1976-2001%29%
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D027062 2006
% 217.19/217.33  |- rdf__type mesh__D027062sskos__Concept
% 217.19/217.33  |- skos__hiddenLabel mesh__D027062 Transporter, System L
% 217.19/217.33  |- mesh__recordMaintainer mesh__D027062 SYSTEM
% 217.19/217.33  |- mesh__dateEstablished mesh__D027062 2002-01-01
% 217.19/217.33  |- skos__altLabel mesh__D027062 System L Transporter
% 217.19/217.33  |- mesh__historyNote mesh__D027062
% 217.19/217.33       2002; for LARGE NEUTRAL AMINO ACID TRANSPORTER %28%LNAA%29% use AMINO ACID TRANSPORT SYSTEMS %28%NM%29% 1999-2001%A%  
% 217.19/217.33  |- mesh__publicMeSHNote mesh__D027062
% 217.19/217.33       2002; LARGE NEUTRAL AMINO ACID TRANSPORTER %28%LNAA%29% was indexed under CARRIER PROTEINS 1999-2001%A%  
% 217.19/217.33  |- skos__historyNote mesh__D027062 Carrier Proteins %28%1999-2001%29%
% 217.19/217.33  |- skos__altLabel mesh__D027062 Amino Acid Transport System L Proteins
% 217.19/217.33  |- mesh__recordOriginator mesh__D027062 jmp
% 217.19/217.33  |- skos__altLabel mesh__D027062 System L Transporter Proteins
% 217.19/217.33  |- mesh__recordAuthorizer mesh__D027062 sjn
% 217.19/217.33  |- skos__altLabel mesh__D027062 Large Amino Acid Transporter %28%LAT%29%
% 217.19/217.33  |- skos__altLabel mesh__D027062
% 217.19/217.33       Large Neutral Amino Acid Transporter %28%LNAA%29%
% 217.19/217.33  |- mesh__dateCreated mesh__D027062 2001-07-25
% 217.19/217.33  |- skos__prefLabel mesh__D027062 Amino Acid Transport System L
% 217.19/217.33  |- skos__scopeNote mesh__D027062
% 217.19/217.33       A sodium-independent neutral amino acid transporter system with specificity for large amino acids. One of the functions of the transporter system is to supply large neutral amino acids to the brain.%A%    
% 217.19/217.33  |- skos__broader mesh__D027062smesh__D026921
% 217.19/217.33  |- skos__hiddenLabel mesh__D013840 Sodium, Thiamylal
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D013840 2006
% 217.19/217.33  |- mesh__recordAuthorizer mesh__D013840 sjn
% 217.19/217.33  |- mesh__recordOriginator mesh__D013840 NLM
% 217.19/217.33  |- mesh__historyNote mesh__D013840 65   
% 217.19/217.33  |- skos__scopeNote mesh__D013840
% 217.19/217.33       A barbiturate that is administered intravenously for the production of complete anesthesia of short duration, for the induction of general anesthesia, or for inducing a hypnotic state. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p919%29%%A%    
% 217.19/217.33  |- mesh__dateCreated mesh__D013840 1999-01-01
% 217.19/217.33  |- mesh__publicMeSHNote mesh__D013840 65   
% 217.19/217.33  |- skos__prefLabel mesh__D013840 Thiamylal
% 217.19/217.33  |- rdf__type mesh__D013840sskos__Concept
% 217.19/217.33  |- skos__altLabel mesh__D013840 Parke Davis Brand of Thiamylal Sodium
% 217.19/217.33  |- mesh__dateEstablished mesh__D013840 1965-01-01
% 217.19/217.33  |- mesh__dateRevised mesh__D013840 2005-06-30
% 217.19/217.33  |- skos__broader mesh__D013840smesh__D013858
% 217.19/217.33  |- skos__altLabel mesh__D013840 Thioquinalbarbitone
% 217.19/217.33  |- mesh__recordMaintainer mesh__D013840 CCR
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D007803 2000
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D007803 1998
% 217.19/217.33  |- mesh__dateRevised mesh__D007803 1997-06-20
% 217.19/217.33  |- skos__prefLabel mesh__D007803 Language Arts
% 217.19/217.33  |- skos__hiddenLabel mesh__D007803 Art, Language
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D007803 2004
% 217.19/217.33  |- skos__historyNote mesh__D007803 Language %28%1966-1997%29%
% 217.19/217.33  |- mesh__publicMeSHNote mesh__D007803 98   
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D007803 2003
% 217.19/217.33  |- skos__hiddenLabel mesh__D007803 Language Art
% 217.19/217.33  |- skos__hiddenLabel mesh__D007803 Arts, Language
% 217.19/217.33  |- mesh__historyNote mesh__D007803 98; use explode 1975-97   
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D007803 2002
% 217.19/217.33  |- skos__historyNote mesh__D007803 Language Development %28%1968-1997%29%
% 217.19/217.33  |- skos__broader mesh__D007803smesh__D007802
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D007803 2006
% 217.19/217.33  |- mesh__recordOriginator mesh__D007803 NLM
% 217.19/217.33  |- mesh__recordAuthorizer mesh__D007803 SJN
% 217.19/217.33  |- mesh__dateCreated mesh__D007803 1999-01-01
% 217.19/217.33  |- mesh__dateEstablished mesh__D007803 1998-01-01
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D007803 2005
% 217.19/217.33  |- skos__scopeNote mesh__D007803
% 217.19/217.33       Skills in the use of language which lead to proficiency in written or spoken communication.%A%    
% 217.19/217.33  |- skos__annotation mesh__D007803
% 217.19/217.33       emphasis here is on skill %26% applic of language: differentiate from LANGUAGE itself: see note there; GEN or unspecified; prefer specifics%A%  
% 217.19/217.33  |- mesh__recordMaintainer mesh__D007803 TGC
% 217.19/217.33  |- rdf__type mesh__D007803sskos__Concept
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D007803 2001
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D007803 1999
% 217.19/217.33  |- rdf__type mesh__D007005sskos__Concept
% 217.19/217.33  |- skos__historyNote mesh__D007005 Cyclopropanes %28%1970-1976%29%
% 217.19/217.33  |- skos__historyNote mesh__D007005 Alanine %28%1973-1976%29%
% 217.19/217.33  |- mesh__dateRevised mesh__D007005 2005-06-30
% 217.19/217.33  |- skos__annotation mesh__D007005
% 217.19/217.33       Jamaican vomiting sickness : coordinate HYPOGLYCINS /pois %28%IM%29% with PLANT POISONING %28%IM%29%%A%  
% 217.19/217.33  |- mesh__recordMaintainer mesh__D007005 ssb
% 217.19/217.33  |- mesh__publicMeSHNote mesh__D007005
% 217.19/217.33       91; was see under CYCLOPROPANES 1977-90   
% 217.19/217.33  |- skos__broader mesh__D007005smesh__D014118
% 217.19/217.33  |- mesh__recordAuthorizer mesh__D007005 sjn
% 217.19/217.33  |- skos__broader mesh__D007005smesh__D003521
% 217.19/217.33  |- mesh__dateEstablished mesh__D007005 1991-01-01
% 217.19/217.33  |- skos__scopeNote mesh__D007005
% 217.19/217.33       Methylene cyclopropyl alanine and congeners isolated from the unripe edible fruit of the AKEE plant %28%BLIGHIA SAPIDA%29%. Hypoglycin B is the gamma-glutamyl congener of hypoglycin A. They are very toxic and teratogenic, causing a syndrome called Jamaican vomiting sickness that includes a fall in blood glucose due to the interference of FATTY ACIDS and LEUCINE metabolism which leads to VOMITING, liver damage, CONVULSIONS and DEATH.%A%    
% 217.19/217.33  |- mesh__recordOriginator mesh__D007005 SH
% 217.19/217.33  |- skos__prefLabel mesh__D007005 Hypoglycins
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D007005 2006
% 217.19/217.33  |- mesh__historyNote mesh__D007005
% 217.19/217.33       91%28%77%29%; was see under CYCLOPROPANES 1977-90   
% 217.19/217.33  |- mesh__dateCreated mesh__D007005 1976-04-16
% 217.19/217.33  |- skos__hiddenLabel mesh__D045124 Physiological Phenomena, Cardiovascular
% 217.19/217.33  |- skos__hiddenLabel mesh__D045124 Physiologic Phenomenon, Cardiovascular
% 217.19/217.33  |- skos__scopeNote mesh__D045124
% 217.19/217.33       Observable or measurable characteristics of CARDIOVASCULAR SYSTEM.%A%    
% 217.19/217.33  |- mesh__dateEstablished mesh__D045124 2004-01-01
% 217.19/217.33  |- skos__hiddenLabel mesh__D045124 Phenomenon, Cardiovascular Physiologic
% 217.19/217.33  |- skos__hiddenLabel mesh__D045124 Physiological Phenomenon, Cardiovascular
% 217.19/217.33  |- skos__altLabel mesh__D045124 Cardiovascular Physiological Phenomenon
% 217.19/217.33  |- skos__prefLabel mesh__D045124 Cardiovascular Physiologic Phenomena
% 217.19/217.33  |- skos__altLabel mesh__D045124 Cardiovascular Physiologic Phenomenon
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D045124 2004
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D045124 2005
% 217.19/217.33  |- mesh__dateCreated mesh__D045124 2003-07-09
% 217.19/217.33  |- rdf__type mesh__D045124sskos__Concept
% 217.19/217.33  |- skos__hiddenLabel mesh__D045124 Phenomena, Cardiovascular Physiological
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D045124 2006
% 217.19/217.33  |- skos__broader mesh__D045124smesh__D002320
% 217.19/217.33  |- mesh__publicMeSHNote mesh__D045124 2004   
% 217.19/217.33  |- mesh__historyNote mesh__D045124 2004   
% 217.19/217.33  |- skos__altLabel mesh__D045124 Cardiovascular Physiological Phenomena
% 217.19/217.33  |- skos__annotation mesh__D045124 not used for indexing or cataloging   
% 217.19/217.33  |- skos__hiddenLabel mesh__D045124 Physiologic Phenomena, Cardiovascular
% 217.19/217.33  |- skos__hiddenLabel mesh__D045124 Phenomenon, Cardiovascular Physiological
% 217.19/217.33  |- skos__hiddenLabel mesh__D045124 Phenomena, Cardiovascular Physiologic
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D017433 2005
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Conformation, alpha-Helical Protein
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 alpha-Helical Protein Conformations
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 beta Sheet Conformation, Protein
% 217.19/217.33  |- skos__historyNote mesh__D017433 Proteins %28%1966-1971%29%
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Structure, Secondary Protein
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Protein alpha-Helical Conformations
% 217.19/217.33  |- skos__annotation mesh__D017433
% 217.19/217.33       IM general; coord NIM with specific protein; DF: PROTEIN STRUCT SECOND%A%  
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Conformation, beta-Sheet Protein
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Protein Conformations, alpha-Helical
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Conformations, beta-Strand Protein
% 217.19/217.33  |- mesh__dateRevised mesh__D017433 2004-07-07
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Conformations, Protein beta-Strand
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 beta Strand Conformation, Protein
% 217.19/217.33  |- mesh__publicMeSHNote mesh__D017433 93   
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Conformation, Protein alpha-Helical
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Protein alpha-Helical Conformation
% 217.19/217.33  |- skos__altLabel mesh__D017433 Protein Conformation, alpha-Helical
% 217.19/217.33  |- mesh__recordAuthorizer mesh__D017433 sjn
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 beta-Strand Protein Conformations
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 alpha-Helical Protein Conformation
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Conformation, Protein beta-Strand
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Protein Conformation, alpha Helical
% 217.19/217.33  |- mesh__recordMaintainer mesh__D017433 nns
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Protein Conformations, beta-Strand
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Secondary Protein Structures
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Conformations, Protein beta-Sheet
% 217.19/217.33  |- skos__altLabel mesh__D017433 beta-Strand Conformation, Protein
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Structures, Secondary Protein
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Conformation, beta-Strand Protein
% 217.19/217.33  |- rdf__type mesh__D017433sskos__Concept
% 217.19/217.33  |- skos__historyNote mesh__D017433 Protein Conformation %28%1972-1992%29%
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Conformation, Protein beta-Sheet
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Protein beta-Strand Conformations
% 217.19/217.33  |- skos__broader mesh__D017433smesh__D011487
% 217.19/217.33  |- skos__prefLabel mesh__D017433 Protein Structure, Secondary
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 alpha Helical Conformation, Protein
% 217.19/217.33  |- skos__scopeNote mesh__D017433
% 217.19/217.33       The level of protein structure in which regular hydrogen-bond interactions within contiguous stretches of polypeptide chain give rise to alpha helices, beta strands %28%which align to form beta sheets%29% or other types of coils. This is the first folding level of protein conformation.%A%    
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Protein Conformation, beta Strand
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 beta-Sheet Conformations, Protein
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 beta-Strand Protein Conformation
% 217.19/217.33  |- mesh__dateCreated mesh__D017433 1992-05-22
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Protein Conformation, beta Sheet
% 217.19/217.33  |- skos__altLabel mesh__D017433 Secondary Protein Structure
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Protein beta-Strand Conformation
% 217.19/217.33  |- mesh__dateEstablished mesh__D017433 1993-01-01
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 beta-Sheet Protein Conformation
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Conformations, beta-Sheet Protein
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 beta-Strand Conformations, Protein
% 217.19/217.33  |- mesh__activeMeSHYear mesh__D017433 2006
% 217.19/217.33  |- mesh__historyNote mesh__D017433 93   
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Protein beta-Sheet Conformation
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 beta-Sheet Protein Conformations
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 alpha-Helical Conformations, Protein
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Protein Structures, Secondary
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Protein beta-Sheet Conformations
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Conformations, Protein alpha-Helical
% 217.19/217.33  |- skos__hiddenLabel mesh__D017433 Conformations, alpha-Helical Protein
% 217.19/217.34  |- mesh__recordOriginator mesh__D017433 PXP
% 217.19/217.34  |- skos__hiddenLabel mesh__D017433 Protein Conformations, beta-Sheet
% 217.19/217.34  |- skos__altLabel mesh__D017433 Protein Conformation, beta-Sheet
% 217.19/217.34  |- mesh__dateCreated mesh__D031104 2002-07-03
% 217.19/217.34  |- mesh__historyNote mesh__D031104
% 217.19/217.34       2003; for GURMAR use GURMAR %28%NM%29% 1984-2002   
% 217.19/217.34  |- mesh__recordMaintainer mesh__D031104 ssb
% 217.19/217.34  |- skos__altLabel mesh__D031104 Gurmar
% 217.19/217.34  |- mesh__recordOriginator mesh__D031104 ssb
% 217.19/217.34  |- mesh__publicMeSHNote mesh__D031104
% 217.19/217.34       2003; GURMAR was indexed under PLANT EXTRACTS 1984-2002   
% 217.19/217.34  |- mesh__dateEstablished mesh__D031104 2003-01-01
% 217.19/217.34  |- skos__annotation mesh__D031104
% 217.19/217.34       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.19/217.34  |- skos__scopeNote mesh__D031104
% 217.19/217.34       A plant species of the genus GYMNEMA that contains gymnemic acid %28%triterpene SAPONINS%29% which affects blood sugar level and gurmarin protein. The common name of Gurmar should not be confused with Guar %28%CYAMOPSIS%29%.%A%    
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D031104 2006
% 217.19/217.34  |- skos__prefLabel mesh__D031104 Gymnema sylvestre
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D031104 2004
% 217.19/217.34  |- rdf__type mesh__D031104sskos__Concept
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D031104 2005
% 217.19/217.34  |- skos__broader mesh__D031104smesh__D031103
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D031104 2003
% 217.19/217.34  |- mesh__recordAuthorizer mesh__D031104 sjn
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D003413 2006
% 217.19/217.34  |- skos__hiddenLabel mesh__D003413 Cricoid Cartilages
% 217.19/217.34  |- skos__scopeNote mesh__D003413
% 217.19/217.34       The small thick cartilage that forms the lower and posterior parts of the laryngeal wall.%A%    
% 217.19/217.34  |- skos__hiddenLabel mesh__D003413 Cartilages, Cricoid
% 217.19/217.34  |- mesh__recordAuthorizer mesh__D003413 sjn
% 217.19/217.34  |- rdf__type mesh__D003413sskos__Concept
% 217.19/217.34  |- skos__prefLabel mesh__D003413 Cricoid Cartilage
% 217.19/217.34  |- skos__broader mesh__D003413smesh__D007817
% 217.19/217.34  |- mesh__recordOriginator mesh__D003413 RC
% 217.19/217.34  |- skos__historyNote mesh__D003413 Laryngeal Cartilages %28%1966-1978%29%
% 217.19/217.34  |- mesh__dateEstablished mesh__D003413 1991-01-01
% 217.19/217.34  |- mesh__dateRevised mesh__D003413 2005-06-30
% 217.19/217.34  |- mesh__historyNote mesh__D003413
% 217.19/217.34       91%28%79%29%; was see under LARYNGEAL CARTILAGES 1979-90   
% 217.19/217.34  |- mesh__publicMeSHNote mesh__D003413
% 217.19/217.34       91; was see under LARYNGEAL CARTILAGES 1979-90   
% 217.19/217.34  |- mesh__dateCreated mesh__D003413 1978-05-19
% 217.19/217.34  |- skos__hiddenLabel mesh__D003413 Cartilage, Cricoid
% 217.19/217.34  |- mesh__recordMaintainer mesh__D003413 ags
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D027861 2003
% 217.19/217.34  |- skos__altLabel mesh__D027861 Peach Tree
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D027861 2005
% 217.19/217.34  |- skos__altLabel mesh__D027861 Apricots
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D027861 2004
% 217.19/217.34  |- skos__altLabel mesh__D027861 Plums
% 217.19/217.34  |- skos__altLabel mesh__D027861 Almonds
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D027861 2006
% 217.19/217.34  |- mesh__dateCreated mesh__D027861 2001-07-25
% 217.19/217.34  |- skos__historyNote mesh__D027861 Rosales %28%1998-2001%29%
% 217.19/217.34  |- skos__prefLabel mesh__D027861 Prunus
% 217.19/217.34  |- skos__scopeNote mesh__D027861
% 217.19/217.34       A plant genus in the family ROSACEAE, order Rosales, subclass Rosidae.  It is best known as a source of edible fruits such as apricot, plum, peach, cherry, and almond.%A%    
% 217.19/217.34  |- skos__annotation mesh__D027861
% 217.19/217.34       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.19/217.34  |- skos__altLabel mesh__D027861 Peaches
% 217.19/217.34  |- skos__altLabel mesh__D027861 Apricot Tree
% 217.19/217.34  |- skos__altLabel mesh__D027861 Cherries
% 217.19/217.34  |- skos__broader mesh__D027861smesh__D027824
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D027861 2002
% 217.19/217.34  |- mesh__historyNote mesh__D027861
% 217.19/217.34       2002; for APRICOT use ROSALES 1998-2001, use FRUIT 1963-1997;%A%  
% 217.19/217.34  |- mesh__dateEstablished mesh__D027861 2002-01-01
% 217.19/217.34  |- rdf__type mesh__D027861sskos__Concept
% 217.19/217.34  |- mesh__publicMeSHNote mesh__D027861
% 217.19/217.34       2002; for APRICOT see ROSALES 1998-2001, see FRUIT 1963-1997;%A%  
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D013841 2006
% 217.19/217.34  |- mesh__dateRevised mesh__D013841 2005-06-30
% 217.19/217.34  |- mesh__historyNote mesh__D013841 74%28%73%29%   
% 217.19/217.34  |- rdf__type mesh__D013841sskos__Concept
% 217.19/217.34  |- skos__historyNote mesh__D013841 Dibenzazepines %28%1968-1972%29%
% 217.19/217.34  |- mesh__recordAuthorizer mesh__D013841 sjn
% 217.19/217.34  |- mesh__publicMeSHNote mesh__D013841 74   
% 217.19/217.34  |- mesh__recordOriginator mesh__D013841 NLM
% 217.19/217.34  |- mesh__dateEstablished mesh__D013841 1974-01-01
% 217.19/217.34  |- skos__broader mesh__D013841smesh__D001381
% 217.19/217.34  |- mesh__recordMaintainer mesh__D013841 ssb
% 217.19/217.34  |- skos__historyNote mesh__D013841 Benzazepines %28%1968-1972%29%
% 217.19/217.34  |- skos__historyNote mesh__D013841 Azepines %28%1966-1972%29%
% 217.19/217.34  |- skos__broader mesh__D013841smesh__D013846
% 217.19/217.34  |- skos__prefLabel mesh__D013841 Thiazepines
% 217.19/217.34  |- mesh__dateCreated mesh__D013841 1999-01-01
% 217.19/217.34  |- mesh__historyNote mesh__D013043 80   
% 217.19/217.34  |- skos__historyNote mesh__D013043 Certification %28%1968-1977%29%
% 217.19/217.34  |- skos__broader mesh__D013043smesh__D008511
% 217.19/217.34  |- skos__annotation mesh__D013043
% 217.19/217.34       SPEC: SPEC qualif; coord IM with field or subject %28%IM%29%   
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D013043 2002
% 217.19/217.34  |- skos__altLabel mesh__D013043 Specialty, Surgical
% 217.19/217.34  |- mesh__dateRevised mesh__D013043 1999-11-03
% 217.19/217.34  |- rdf__type mesh__D013043sskos__Concept
% 217.19/217.34  |- mesh__dateCreated mesh__D013043 1979-05-29
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D013043 2005
% 217.19/217.34  |- skos__altLabel mesh__D013043 Surgical Specialties
% 217.19/217.34  |- mesh__dateEstablished mesh__D013043 1980-01-01
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D013043 2003
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D013043 2006
% 217.19/217.34  |- mesh__publicMeSHNote mesh__D013043 80   
% 217.19/217.34  |- skos__scopeNote mesh__D013043
% 217.19/217.34       Various branches of surgical practice limited to specialized areas.%A%    
% 217.19/217.34  |- skos__prefLabel mesh__D013043 Specialties, Surgical
% 217.19/217.34  |- mesh__recordOriginator mesh__D013043 EC
% 217.19/217.34  |- skos__historyNote mesh__D013043 Specialty Boards %28%1977-1979%29%
% 217.19/217.34  |- skos__altLabel mesh__D013043 Surgical Specialty
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D013043 2000
% 217.19/217.34  |- mesh__recordMaintainer mesh__D013043 kle
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D013043 2004
% 217.19/217.34  |- skos__historyNote mesh__D013043 Surgery %28%1966-1979%29%
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D013043 2001
% 217.19/217.34  |- mesh__recordAuthorizer mesh__D013043 sjn
% 217.19/217.34  |- skos__hiddenLabel mesh__D007804 Developments, Language
% 217.19/217.34  |- skos__related mesh__D007804smesh__D013060
% 217.19/217.34  |- skos__scopeNote mesh__D007804
% 217.19/217.34       The gradual expansion in complexity and meaning of symbols and sounds as perceived and interpreted by the individual through a maturational and learning process. Stages in development include babbling, cooing, word imitation with cognition, and use of short sentences.%A%    
% 217.19/217.34  |- mesh__dateRevised mesh__D007804 2003-07-09
% 217.19/217.34  |- mesh__historyNote mesh__D007804 68   
% 217.19/217.34  |- skos__historyNote mesh__D007804 Child Psychology %28%1966-1967%29%
% 217.19/217.34  |- skos__historyNote mesh__D007804 Speech %28%1966-1967%29%
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D007804 2006
% 217.19/217.34  |- mesh__recordMaintainer mesh__D007804 lkt
% 217.19/217.34  |- mesh__recordAuthorizer mesh__D007804 sjn
% 217.19/217.34  |- mesh__dateCreated mesh__D007804 1999-01-01
% 217.19/217.34  |- skos__historyNote mesh__D007804 Learning %28%1966-1967%29%
% 217.19/217.34  |- skos__hiddenLabel mesh__D007804 Development, Language
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D007804 2005
% 217.19/217.34  |- mesh__publicMeSHNote mesh__D007804 68   
% 217.19/217.34  |- rdf__type mesh__D007804sskos__Concept
% 217.19/217.34  |- skos__prefLabel mesh__D007804 Language Development
% 217.19/217.34  |- mesh__recordOriginator mesh__D007804 NLM
% 217.19/217.34  |- skos__broader mesh__D007804smesh__D002657
% 217.19/217.34  |- skos__historyNote mesh__D007804 Language %28%1966-1967%29%
% 217.19/217.34  |- mesh__dateEstablished mesh__D007804 1968-01-01
% 217.19/217.34  |- skos__annotation mesh__D007804 no qualif   
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D007804 2004
% 217.19/217.34  |- skos__hiddenLabel mesh__D007804 Language Developments
% 217.19/217.34  |- mesh__historyNote mesh__D051960 2006%28%1993%29%   
% 217.19/217.34  |- mesh__recordAuthorizer mesh__D051960 sjn
% 217.19/217.34  |- mesh__dateCreated mesh__D051960 2005-06-30
% 217.19/217.34  |- skos__broader mesh__D051960smesh__D019206
% 217.19/217.34  |- mesh__recordOriginator mesh__D051960 DRC
% 217.19/217.34  |- mesh__recordMaintainer mesh__D051960 DRC
% 217.19/217.34  |- skos__altLabel mesh__D051960 G Protein Subunit alpha I2
% 217.19/217.34  |- skos__scopeNote mesh__D051960
% 217.19/217.34       A PERTUSSIS TOXIN-sensitive GTP-binding protein alpha subunit. It couples with a variety of CELL SURFACE RECEPTORS, has been implicated in INTERLEUKIN-12 production, and may play a role in INFLAMMATORY BOWEL DISEASES.%A%    
% 217.19/217.34  |- mesh__dateEstablished mesh__D051960 2006-01-01
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D051960 2006
% 217.19/217.34  |- skos__altLabel mesh__D051960 Galpha%28%i2%29% Protein
% 217.19/217.34  |- rdf__type mesh__D051960sskos__Concept
% 217.19/217.34  |- skos__hiddenLabel mesh__D051960 GTP Binding Protein alpha Subunit, Gi2
% 217.19/217.34  |- mesh__publicMeSHNote mesh__D051960
% 217.19/217.34       2006; GTP-BINDING PROTEIN ALPHA SUBUNIT, GI2 was indexed under PROTO-ONCOGENE PROTEINS 1995-2005, %26% under GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO 2000-2005, %26% under GTP-BINDING PROTEINS 1994-1999, %26% under ONCOGENE PROTEINS 1993-1994%A%  
% 217.19/217.34  |- skos__altLabel mesh__D051960 Gi2-alpha Protein
% 217.19/217.34  |- skos__altLabel mesh__D051960 Galphai2 Protein
% 217.19/217.34  |- skos__hiddenLabel mesh__D051960 Gi2 alpha Protein
% 217.19/217.34  |- skos__prefLabel mesh__D051960 GTP-Binding Protein alpha Subunit, Gi2
% 217.19/217.34  |- rdf__type mesh__D007006sskos__Concept
% 217.19/217.34  |- mesh__recordOriginator mesh__D007006 NLM
% 217.19/217.34  |- mesh__dateCreated mesh__D007006 1999-01-01
% 217.19/217.34  |- skos__scopeNote mesh__D007006
% 217.19/217.34       Condition resulting from deficient gonadal functions, such as GAMETOGENESIS and the production of GONADAL STEROID HORMONES. It is characterized by delay in GROWTH, germ cell maturation, and development of secondary sex characteristics. Hypogonadism can be due to a deficiency of GONADOTROPINS %28%hypogonadotropic hypogonadism%29% or due to primary gonadal failure %28%hypergonadotropic hypogonadism%29%.%A%    
% 217.19/217.34  |- skos__annotation mesh__D007006
% 217.19/217.34       for male or female; do not routinely interpret hypogonadism in male as EUNUCHISM: use terminology of author%A%  
% 217.19/217.34  |- mesh__recordMaintainer mesh__D007006 lkt
% 217.19/217.34  |- mesh__dateRevised mesh__D007006 2005-06-30
% 217.19/217.34  |- skos__hiddenLabel mesh__D007006 Hypogonadism, Hypergonadotropic
% 217.19/217.34  |- skos__hiddenLabel mesh__D007006 Hypogonadism, Hypogonadotropic
% 217.19/217.34  |- mesh__historyNote mesh__D007006 1966   
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D007006 2006
% 217.19/217.34  |- mesh__recordAuthorizer mesh__D007006 sjn
% 217.19/217.34  |- skos__broader mesh__D007006smesh__D006058
% 217.19/217.34  |- mesh__publicMeSHNote mesh__D007006 1966   
% 217.19/217.34  |- skos__prefLabel mesh__D007006 Hypogonadism
% 217.19/217.34  |- skos__broader mesh__D013337Q000193smesh__D013337
% 217.19/217.34  |- mesh__preferredCombination mesh__D013337Q000193smesh__D004501
% 217.19/217.34  |- rdf__type mesh__D013337Q000193smesh__CompoundConcept
% 217.19/217.34  |- skos__hiddenLabel mesh__D012749 Disease, Venereal
% 217.19/217.34  |- mesh__recordOriginator mesh__D012749 NLM
% 217.19/217.34  |- mesh__dateCreated mesh__D012749 1999-01-01
% 217.19/217.34  |- mesh__historyNote mesh__D012749 87; was VENEREAL DISEASES 1963-86   
% 217.19/217.34  |- skos__hiddenLabel mesh__D012749 Diseases, Venereal
% 217.19/217.34  |- skos__annotation mesh__D012749
% 217.19/217.34       general or unspecified; prefer specifics; SEXUALLY TRANSMITTED DISEASES, BACTERIAL %26% SEXUALLY TRANSMITTED DISEASES, VIRAL are also available; not all genital diseases are venereal or sexually transm %26% not all sexually transm diseases are genital; contact tracing: index under CONTACT TRACING %28%IM%29% + SEXUALLY TRANSMITTED DISEASES /epidemiol or /transm %28%IM%29%%A%  
% 217.19/217.34  |- skos__hiddenLabel mesh__D012749 Sexually Transmitted Disease
% 217.19/217.34  |- skos__hiddenLabel mesh__D012749 Disease, Sexually Transmitted
% 217.19/217.34  |- mesh__dateRevised mesh__D012749 2005-06-30
% 217.19/217.34  |- skos__broader mesh__D012749smesh__D007239
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D012749 2006
% 217.19/217.34  |- mesh__recordAuthorizer mesh__D012749 sjn
% 217.19/217.34  |- skos__prefLabel mesh__D012749 Sexually Transmitted Diseases
% 217.19/217.34  |- mesh__onlineNote mesh__D012749
% 217.19/217.34       use SEXUALLY TRANSMITTED DISEASES to search VENEREAL DISEASES 1966-86%A%  
% 217.19/217.34  |- skos__hiddenLabel mesh__D012749 Diseases, Sexually Transmitted
% 217.19/217.34  |- rdf__type mesh__D012749sskos__Concept
% 217.19/217.34  |- skos__scopeNote mesh__D012749
% 217.19/217.34       Diseases due to or propagated by sexual contact.     
% 217.19/217.34  |- skos__altLabel mesh__D012749 STDs
% 217.19/217.34  |- skos__altLabel mesh__D012749 Venereal Diseases
% 217.19/217.34  |- skos__hiddenLabel mesh__D012749 Venereal Disease
% 217.19/217.34  |- skos__broader mesh__D012749smesh__D014777
% 217.19/217.34  |- mesh__publicMeSHNote mesh__D012749 87; was VENEREAL DISEASES 1963-86   
% 217.19/217.34  |- mesh__recordMaintainer mesh__D012749 ags
% 217.19/217.34  |- mesh__historyNote mesh__D045125 2004   
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D045125 2005
% 217.19/217.34  |- skos__altLabel mesh__D045125 Cardiovascular Physiological Process
% 217.19/217.34  |- mesh__dateCreated mesh__D045125 2003-07-09
% 217.19/217.34  |- skos__annotation mesh__D045125 not used for indexing or cataloging   
% 217.19/217.34  |- rdf__type mesh__D045125sskos__Concept
% 217.19/217.34  |- skos__hiddenLabel mesh__D045125 Processes, Cardiovascular Physiological
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D045125 2006
% 217.19/217.34  |- skos__broader mesh__D045125smesh__D002320
% 217.19/217.34  |- mesh__publicMeSHNote mesh__D045125 2004   
% 217.19/217.34  |- skos__prefLabel mesh__D045125 Cardiovascular Physiologic Processes
% 217.19/217.34  |- mesh__dateEstablished mesh__D045125 2004-01-01
% 217.19/217.34  |- skos__hiddenLabel mesh__D045125 Processes, Cardiovascular Physiologic
% 217.19/217.34  |- skos__hiddenLabel mesh__D045125 Process, Cardiovascular Physiological
% 217.19/217.34  |- skos__hiddenLabel mesh__D045125 Physiological Process, Cardiovascular
% 217.19/217.34  |- skos__hiddenLabel mesh__D045125 Physiologic Processes, Cardiovascular
% 217.19/217.34  |- skos__hiddenLabel mesh__D045125 Cardiovascular Physiological Processes
% 217.19/217.34  |- skos__hiddenLabel mesh__D045125 Physiological Processes, Cardiovascular
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D045125 2004
% 217.19/217.34  |- skos__scopeNote mesh__D045125
% 217.19/217.34       Biological actions and events that support the functions of the CARDIOVASCULAR SYSTEM.%A%    
% 217.19/217.34  |- skos__hiddenLabel mesh__D017434 Protein Structures, Tertiary
% 217.19/217.34  |- mesh__recordMaintainer mesh__D017434 nns
% 217.19/217.34  |- skos__scopeNote mesh__D017434
% 217.19/217.34       The level of protein structure in which combinations of secondary protein structures %28%alpha helices, beta sheets, loop regions, and motifs%29% pack together to form folded shapes called domains. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Small proteins usually consist of only one domain but larger proteins may contain a number of domains connected by segments of polypeptide chain which lack regular secondary structure.%A%    
% 217.19/217.34  |- skos__hiddenLabel mesh__D017434 Peptide Domains
% 217.19/217.34  |- skos__hiddenLabel mesh__D017434 Domains, Protein
% 217.19/217.34  |- mesh__publicMeSHNote mesh__D017434 93   
% 217.19/217.34  |- skos__altLabel mesh__D017434 Protein Domains
% 217.19/217.34  |- skos__historyNote mesh__D017434 Proteins %28%1966-1971%29%
% 217.19/217.34  |- skos__prefLabel mesh__D017434 Protein Structure, Tertiary
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D017434 2005
% 217.19/217.34  |- mesh__recordOriginator mesh__D017434 PXP
% 217.19/217.34  |- skos__altLabel mesh__D017434 Peptide Domain
% 217.19/217.34  |- skos__hiddenLabel mesh__D017434 Domain, Peptide
% 217.19/217.34  |- skos__historyNote mesh__D017434 Protein Conformation %28%1972-1992%29%
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D017434 2006
% 217.19/217.34  |- mesh__dateCreated mesh__D017434 1992-05-22
% 217.19/217.34  |- skos__hiddenLabel mesh__D017434 Domains, Peptide
% 217.19/217.34  |- mesh__historyNote mesh__D017434 93   
% 217.19/217.34  |- skos__annotation mesh__D017434
% 217.19/217.34       IM general; coord NIM with specific protein %28%IM%29%; PROTEIN MOTIFS see MOTIFS, AMINO ACID is available%A%  
% 217.19/217.34  |- skos__altLabel mesh__D017434 Tertiary Protein Structure
% 217.19/217.34  |- skos__broader mesh__D017434smesh__D011487
% 217.19/217.34  |- mesh__recordAuthorizer mesh__D017434 sjn
% 217.19/217.34  |- skos__hiddenLabel mesh__D017434 Tertiary Protein Structures
% 217.19/217.34  |- skos__hiddenLabel mesh__D017434 Domain, Protein
% 217.19/217.34  |- mesh__dateEstablished mesh__D017434 1993-01-01
% 217.19/217.34  |- mesh__dateRevised mesh__D017434 2004-07-07
% 217.19/217.34  |- skos__hiddenLabel mesh__D017434 Protein Domain
% 217.19/217.34  |- rdf__type mesh__D017434sskos__Concept
% 217.19/217.34  |- skos__broader mesh__D031105smesh__D029067
% 217.19/217.34  |- mesh__historyNote mesh__D031105 2003   
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D031105 2005
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D031105 2003
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D031105 2006
% 217.19/217.34  |- mesh__publicMeSHNote mesh__D031105 2003   
% 217.19/217.34  |- mesh__dateCreated mesh__D031105 2002-07-03
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D031105 2004
% 217.19/217.34  |- mesh__dateEstablished mesh__D031105 2003-01-01
% 217.19/217.34  |- rdf__type mesh__D031105sskos__Concept
% 217.19/217.34  |- skos__annotation mesh__D031105
% 217.19/217.34       CYNANCHUM INDICUM see TYLOPHORA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.19/217.34  |- skos__prefLabel mesh__D031105 Cynanchum
% 217.19/217.34  |- skos__scopeNote mesh__D031105
% 217.19/217.34       A plant genus of the family ASCLEPIADACEAE. Members contain steroidal glycosides and cytotoxic phenanthroindolizidine N-oxide alkaloids.%A%    
% 217.19/217.34  |- mesh__recordOriginator mesh__D003414 NLM
% 217.19/217.34  |- mesh__onlineNote mesh__D003414
% 217.19/217.34       use HYPERBILIRUBINEMIA, HEREDITARY to search CRIGLER-NAJJAR SYNDROME 1966-74%A%  
% 217.19/217.34  |- skos__hiddenLabel mesh__D003414 Crigler Najar Syndrome
% 217.19/217.34  |- mesh__dateRevised mesh__D003414 2001-07-25
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D003414 2006
% 217.19/217.34  |- mesh__publicMeSHNote mesh__D003414
% 217.19/217.34       91; was see under HYPERBILIRUBINEMIA, HEREDITARY 1975-90   
% 217.19/217.34  |- mesh__recordAuthorizer mesh__D003414 sjn
% 217.19/217.34  |- skos__hiddenLabel mesh__D003414 Crigler Najjar Syndrome
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D003414 2005
% 217.19/217.34  |- skos__altLabel mesh__D003414 Crigler-Najar Syndrome
% 217.19/217.34  |- rdf__type mesh__D003414sskos__Concept
% 217.19/217.34  |- mesh__recordMaintainer mesh__D003414 nns
% 217.19/217.34  |- skos__hiddenLabel mesh__D003414 Syndrome, Crigler-Najjar
% 217.19/217.34  |- skos__scopeNote mesh__D003414
% 217.19/217.34       A familial form of congenital hyperbilirubinemia transmitted as an autosomal recessive trait. It is characterized by icterus and brain damage caused by a glucuronyl transferase deficiency in the liver and faulty bilirubin conjugation.%A%    
% 217.19/217.34  |- skos__hiddenLabel mesh__D003414 Syndrome, Crigler-Najar
% 217.19/217.34  |- mesh__dateEstablished mesh__D003414 1991-01-01
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D003414 2002
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D003414 2004
% 217.19/217.34  |- skos__prefLabel mesh__D003414 Crigler-Najjar Syndrome
% 217.19/217.34  |- mesh__dateCreated mesh__D003414 1999-01-01
% 217.19/217.34  |- mesh__historyNote mesh__D003414
% 217.19/217.34       91%28%75%29%; was see under HYPERBILIRUBINEMIA, HEREDITARY 1975-90%A%  
% 217.19/217.34  |- skos__broader mesh__D003414smesh__D006933
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D003414 2003
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D013044 2000
% 217.19/217.34  |- skos__historyNote mesh__D013044 Certification %28%1968-Jul 1977%29%
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D013044 2001
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D013044 1996
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D013044 1999
% 217.19/217.34  |- mesh__publicMeSHNote mesh__D013044
% 217.19/217.34       91; was see under CERTIFICATION Aug 1977-90   
% 217.19/217.34  |- mesh__historyNote mesh__D013044
% 217.19/217.34       91%28%Aug 77%29%; was see under CERTIFICATION 1977-90   
% 217.19/217.34  |- rdf__type mesh__D013044sskos__Concept
% 217.19/217.34  |- skos__hiddenLabel mesh__D013044 Board, Specialty
% 217.19/217.34  |- skos__hiddenLabel mesh__D013044 Specialty Board
% 217.19/217.34  |- skos__scopeNote mesh__D013044
% 217.19/217.34       Organizations which certify physicians and dentists as specialists in various fields of medical and dental practice.%A%    
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D013044 2005
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D013044 1997
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D013044 2002
% 217.19/217.34  |- mesh__recordAuthorizer mesh__D013044 NLM
% 217.19/217.34  |- skos__prefLabel mesh__D013044 Specialty Boards
% 217.19/217.34  |- skos__broader mesh__D013044smesh__D002568
% 217.19/217.34  |- skos__annotation mesh__D013044 specify specialty %28%IM%29% + geog   
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D013044 2003
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D013044 2006
% 217.19/217.34  |- skos__historyNote mesh__D013044 specific specialty %28%1968-Jul 1977%29%
% 217.19/217.34  |- mesh__dateRevised mesh__D013044 1993-09-16
% 217.19/217.34  |- mesh__dateEstablished mesh__D013044 1991-01-01
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D013044 2004
% 217.19/217.34  |- skos__hiddenLabel mesh__D013044 Boards, Specialty
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D013044 1995
% 217.19/217.34  |- mesh__dateCreated mesh__D013044 1977-05-12
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D013044 1998
% 217.19/217.34  |- mesh__recordOriginator mesh__D013044 EC
% 217.19/217.34  |- mesh__recordMaintainer mesh__D013044 PLS
% 217.19/217.34  |- skos__broader mesh__D014465Q000176smesh__D014465
% 217.19/217.34  |- mesh__preferredCombination mesh__D014465Q000176smesh__D014463
% 217.19/217.34  |- rdf__type mesh__D014465Q000176smesh__CompoundConcept
% 217.19/217.34  |- skos__annotation mesh__D007805
% 217.19/217.34       do not confuse with LANGUAGE DISORDERS, disord of use or comprehension of language: LANGUAGE DEVELOPMENT DISORDERS is %22%failure to understand or speak the language at the expected age%22%; DF: LANGUAGE DEVELOPMENT DIS%A%  
% 217.19/217.34  |- skos__broader mesh__D007805smesh__D007806
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D007805 2002
% 217.19/217.34  |- skos__hiddenLabel mesh__D007805 Language Development Disorder
% 217.19/217.34  |- skos__hiddenLabel mesh__D007805 Semantic Pragmatic Disorder
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D007805 2005
% 217.19/217.34  |- skos__altLabel mesh__D007805 Speech or Language, Developmental Disorder
% 217.19/217.34  |- skos__prefLabel mesh__D007805 Language Development Disorders
% 217.19/217.34  |- mesh__recordMaintainer mesh__D007805 KEV
% 217.19/217.34  |- rdf__type mesh__D007805sskos__Concept
% 217.19/217.34  |- skos__historyNote mesh__D007805 Language Disorders %28%1967-1979%29%
% 217.19/217.34  |- skos__hiddenLabel mesh__D007805 Speech Delays
% 217.19/217.34  |- skos__hiddenLabel mesh__D007805 Delays, Speech
% 217.19/217.34  |- skos__altLabel mesh__D007805 Developmental Disorder, Speech or Language
% 217.19/217.34  |- skos__hiddenLabel mesh__D007805 Developmental Language Disorder
% 217.19/217.34  |- skos__hiddenLabel mesh__D007805 Language Disorder, Developmental
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D007805 2001
% 217.19/217.34  |- skos__hiddenLabel mesh__D007805 Delay, Speech
% 217.19/217.34  |- skos__hiddenLabel mesh__D007805 Development Disorder, Language
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D007805 2004
% 217.19/217.34  |- mesh__historyNote mesh__D007805 1986%28%1980%29%   
% 217.19/217.34  |- mesh__recordOriginator mesh__D007805 RC
% 217.19/217.34  |- mesh__dateRevised mesh__D007805 1999-11-08
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D007805 2000
% 217.19/217.34  |- mesh__dateCreated mesh__D007805 1979-02-21
% 217.19/217.34  |- skos__historyNote mesh__D007805 Language Development %28%1968-1979%29%
% 217.19/217.34  |- skos__altLabel mesh__D007805 Language Disorders, Developmental
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D007805 2003
% 217.19/217.34  |- mesh__dateEstablished mesh__D007805 1986-01-01
% 217.19/217.34  |- skos__hiddenLabel mesh__D007805 Language Delays
% 217.19/217.34  |- mesh__recordAuthorizer mesh__D007805 sjn
% 217.19/217.34  |- skos__altLabel mesh__D007805 Developmental Language Disorders
% 217.19/217.34  |- skos__hiddenLabel mesh__D007805 Semantic-Pragmatic Disorders
% 217.19/217.34  |- skos__altLabel mesh__D007805 Central Auditory Processing Disorder
% 217.19/217.34  |- skos__scopeNote mesh__D007805
% 217.19/217.34       Conditions characterized by language abilities %28%comprehension and expression of speech and writing%29% that are below the expected level for a given age, generally in the absence of an intellectual impairment. These conditions may be associated with DEAFNESS; BRAIN DISEASES; MENTAL DISORDERS; or environmental factors.%A%    
% 217.19/217.34  |- mesh__publicMeSHNote mesh__D007805
% 217.19/217.34       1986; see LANGUAGE DISORDERS 1980-1985   
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D007805 2006
% 217.19/217.34  |- mesh__recordAuthorizer mesh__D007007 sjn
% 217.19/217.34  |- mesh__recordOriginator mesh__D007007 SMH
% 217.19/217.34  |- skos__historyNote mesh__D007007 Sweating %28%1966-1974%29%
% 217.19/217.34  |- mesh__dateCreated mesh__D007007 1975-07-25
% 217.19/217.34  |- skos__prefLabel mesh__D007007 Hypohidrosis
% 217.19/217.34  |- skos__scopeNote mesh__D007007
% 217.19/217.34       Abnormally diminished or absent perspiration. Both generalized and segmented %28%reduced or absent sweating in circumscribed locations%29% forms of the disease are usually associated with other underlying conditions.%A%    
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D007007 2005
% 217.19/217.34  |- mesh__dateRevised mesh__D007007 2001-07-25
% 217.19/217.34  |- mesh__dateEstablished mesh__D007007 1976-01-01
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D007007 2002
% 217.19/217.34  |- mesh__historyNote mesh__D007007 76; was ANHIDROSIS 1975   
% 217.19/217.34  |- mesh__onlineNote mesh__D007007
% 217.19/217.34       use HYPOHIDROSIS to search ANHIDROSIS 1975   
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D007007 2006
% 217.19/217.34  |- skos__broader mesh__D007007smesh__D013543
% 217.19/217.34  |- mesh__publicMeSHNote mesh__D007007 76; was ANHIDROSIS 1975   
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D007007 2003
% 217.19/217.34  |- rdf__type mesh__D007007sskos__Concept
% 217.19/217.34  |- mesh__recordMaintainer mesh__D007007 lkt
% 217.19/217.34  |- skos__historyNote mesh__D007007 Ectodermal Dysplasia %28%1966-1974%29%
% 217.19/217.34  |- skos__annotation mesh__D007007
% 217.19/217.34       diminished sweating; do not confuse with HYPERHIDROSIS, excessive sweating%A%  
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D007007 2004
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D031106 2005
% 217.19/217.34  |- skos__annotation mesh__D031106
% 217.19/217.34       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.19/217.34  |- skos__broader mesh__D031106smesh__D029067
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D031106 2003
% 217.19/217.34  |- mesh__publicMeSHNote mesh__D031106 2003   
% 217.19/217.34  |- mesh__historyNote mesh__D031106 2003   
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D031106 2006
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D031106 2004
% 217.19/217.34  |- rdf__type mesh__D031106sskos__Concept
% 217.19/217.34  |- skos__scopeNote mesh__D031106
% 217.19/217.34       A plant genus of the family ASCLEPIADACEAE. Members contain the alkaloids quindoline, CSA-3, cryptolepine, and neocryptolepine.%A%    
% 217.19/217.34  |- skos__prefLabel mesh__D031106 Cryptolepis
% 217.19/217.34  |- mesh__dateCreated mesh__D031106 2002-07-03
% 217.19/217.34  |- mesh__dateEstablished mesh__D031106 2003-01-01
% 217.19/217.34  |- skos__altLabel mesh__D031106 Cryptolepsis
% 217.19/217.34  |- skos__scopeNote mesh__D003415
% 217.19/217.34       A violation of the criminal law, i.e., a breach of the conduct code specifically sanctioned by the state, which through its administrative agencies prosecutes offenders and imposes and administers punishments. The concept includes unacceptable actions whether prosecuted or going unpunished.%A%    
% 217.19/217.34  |- mesh__dateEstablished mesh__D003415 1968-01-01
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D003415 2006
% 217.19/217.34  |- skos__historyNote mesh__D003415 Criminology %28%1966-1967%29%
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D003415 2000
% 217.19/217.34  |- skos__broader mesh__D003415smesh__D012940
% 217.19/217.34  |- mesh__recordOriginator mesh__D003415 NLM
% 217.19/217.34  |- mesh__publicMeSHNote mesh__D003415 68   
% 217.19/217.34  |- rdf__type mesh__D003415sskos__Concept
% 217.19/217.34  |- mesh__dateCreated mesh__D003415 1999-01-01
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D003415 2001
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D003415 2003
% 217.19/217.34  |- skos__hiddenLabel mesh__D003415 Kidnappings
% 217.19/217.34  |- skos__broader mesh__D003415smesh__D003418
% 217.19/217.34  |- skos__annotation mesh__D003415 specify geog if pertinent   
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D003415 2002
% 217.19/217.34  |- mesh__recordAuthorizer mesh__D003415 sjn
% 217.19/217.34  |- skos__prefLabel mesh__D003415 Crime
% 217.19/217.34  |- skos__hiddenLabel mesh__D003415 Crimes
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D003415 2004
% 217.19/217.34  |- mesh__recordMaintainer mesh__D003415 kle
% 217.19/217.34  |- mesh__dateRevised mesh__D003415 1999-11-03
% 217.19/217.34  |- mesh__historyNote mesh__D003415 68   
% 217.19/217.34  |- mesh__activeMeSHYear mesh__D003415 2005
% 217.19/217.34  |- mesh__dateCreated mesh__D008100 1999-01-01
% 217.19/217.34  |- skos__altLabel mesh__D008100 Abscess, Hepatic
% 217.19/217.34  |- skos__broader mesh__D008100smesh__D008107
% 217.19/217.34  |- skos__annotation mesh__D008100
% 217.19/217.34       coordinate IM with specific organism infection term %28%IM%29%; LIVER ABSCESS, AMEBIC and LIVER ABSCESS, PYOGENIC are also available%A%  
% 217.19/217.34  |- skos__hiddenLabel mesh__D008100 Abscess, Liver
% 217.19/217.34  |- mesh__recordMaintainer mesh__D008100 lkt
% 217.19/217.34  |- skos__hiddenLabel mesh__D008100 Hepatic Abscesses
% 217.19/217.35  |- mesh__dateRevised mesh__D008100 2004-07-07
% 217.19/217.35  |- skos__hiddenLabel mesh__D008100 Abscesses, Hepatic
% 217.19/217.35  |- rdf__type mesh__D008100sskos__Concept
% 217.19/217.35  |- skos__hiddenLabel mesh__D008100 Hepatic Abscess
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D008100 2005
% 217.19/217.35  |- skos__broader mesh__D008100smesh__D018784
% 217.19/217.35  |- skos__scopeNote mesh__D008100
% 217.19/217.35       Solitary or multiple collections of PUS within the liver as a result of infection by bacteria, protozoa, or other agents.%A%    
% 217.19/217.35  |- mesh__recordAuthorizer mesh__D008100 sjn
% 217.19/217.35  |- skos__prefLabel mesh__D008100 Liver Abscess
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D008100 2006
% 217.19/217.35  |- skos__hiddenLabel mesh__D008100 Liver Abscesses
% 217.19/217.35  |- mesh__recordOriginator mesh__D008100 NLM
% 217.19/217.35  |- skos__hiddenLabel mesh__D008100 Abscesses, Liver
% 217.19/217.35  |- skos__broader mesh__D004625Q000254smesh__D004625
% 217.19/217.35  |- mesh__preferredCombination mesh__D004625Q000254smesh__D047108
% 217.19/217.35  |- rdf__type mesh__D004625Q000254smesh__CompoundConcept
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013843 2006
% 217.19/217.35  |- mesh__historyNote mesh__D013843
% 217.19/217.35       PYRIDOBENZOTHIAZINES was heading 1963-84   
% 217.19/217.35  |- rdf__type mesh__D013843sskos__Concept
% 217.19/217.35  |- skos__broader mesh__D013843smesh__D006573
% 217.19/217.35  |- mesh__dateRevised mesh__D013843 2005-06-30
% 217.19/217.35  |- mesh__onlineNote mesh__D013843
% 217.19/217.35       use THIAZINES to search PYRIDOBENZOTHIAZINES 1966-84   
% 217.19/217.35  |- skos__broader mesh__D013843smesh__D013457
% 217.19/217.35  |- mesh__recordAuthorizer mesh__D013843 sjn
% 217.19/217.35  |- mesh__recordOriginator mesh__D013843 NLM
% 217.19/217.35  |- mesh__dateCreated mesh__D013843 1999-01-01
% 217.19/217.35  |- mesh__publicMeSHNote mesh__D013843
% 217.19/217.35       PYRIDOBENZOTHIAZINES was heading 1963-84   
% 217.19/217.35  |- mesh__recordMaintainer mesh__D013843 ssb
% 217.19/217.35  |- skos__prefLabel mesh__D013843 Thiazines
% 217.19/217.35  |- skos__annotation mesh__D013045
% 217.19/217.35       NIM; no qualif; may refer to phylum, class, order, family, genus or strain as well as species: TN 176; do not limit to immunol specificity%A%  
% 217.19/217.35  |- skos__prefLabel mesh__D013045 Species Specificity
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013045 1990
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013045 2002
% 217.19/217.35  |- mesh__dateRevised mesh__D013045 1989-05-16
% 217.19/217.35  |- skos__hiddenLabel mesh__D013045 Specificity, Species
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013045 2001
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013045 1997
% 217.19/217.35  |- mesh__historyNote mesh__D013045 66%28%64%29%   
% 217.19/217.35  |- skos__broader mesh__D013045smesh__D000918
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013045 1999
% 217.19/217.35  |- rdf__type mesh__D013045sskos__Concept
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013045 1996
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013045 1993
% 217.19/217.35  |- skos__broader mesh__D013045smesh__D001687
% 217.19/217.35  |- skos__scopeNote mesh__D013045
% 217.19/217.35       Restriction of a characteristic or response to the members of one species; it usually refers to that property of the immune response which differentiates one species from another on the basis of antigen recognition, but the concept is not limited to immunology and is used loosely at levels higher than the species.%A%    
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013045 2000
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013045 1995
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013045 1998
% 217.19/217.35  |- mesh__recordOriginator mesh__D013045 NLM
% 217.19/217.35  |- mesh__publicMeSHNote mesh__D013045 66   
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013045 1992
% 217.19/217.35  |- mesh__recordAuthorizer mesh__D013045 PLS
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013045 2004
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013045 1994
% 217.19/217.35  |- mesh__dateCreated mesh__D013045 1999-01-01
% 217.19/217.35  |- skos__hiddenLabel mesh__D013045 Specificities, Species
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013045 2006
% 217.19/217.35  |- skos__hiddenLabel mesh__D013045 Species Specificities
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013045 2003
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013045 1991
% 217.19/217.35  |- mesh__recordMaintainer mesh__D013045 TGC
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013045 2005
% 217.19/217.35  |- mesh__dateEstablished mesh__D013045 1966-01-01
% 217.19/217.35  |- skos__scopeNote mesh__D007806
% 217.19/217.35       Conditions characterized by deficiencies of comprehension or expression of written and spoken forms of language. These include acquired and developmental disorders.%A%    
% 217.19/217.35  |- mesh__recordMaintainer mesh__D007806 KEV
% 217.19/217.35  |- rdf__type mesh__D007806sskos__Concept
% 217.19/217.35  |- skos__hiddenLabel mesh__D007806 Language Disorder, Acquired
% 217.19/217.35  |- skos__historyNote mesh__D007806 Language %28%1966%29%
% 217.19/217.35  |- skos__annotation mesh__D007806
% 217.19/217.35       /ther: consider also LANGUAGE THERAPY; do not confuse with SPEECH DISORDERS: read differentiation of LANGUAGE %26% SPEECH under LANGUAGE; do not confuse with LANGUAGE DEVELOPMENT DISORDERS: see note there%A%  
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007806 2002
% 217.19/217.35  |- skos__prefLabel mesh__D007806 Language Disorders
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007806 2004
% 217.19/217.35  |- mesh__recordOriginator mesh__D007806 NLM
% 217.19/217.35  |- skos__altLabel mesh__D007806 Language Disorders, Acquired
% 217.19/217.35  |- skos__broader mesh__D007806smesh__D003147
% 217.19/217.35  |- skos__hiddenLabel mesh__D007806 Acquired Language Disorder
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007806 2003
% 217.19/217.35  |- mesh__publicMeSHNote mesh__D007806 1967   
% 217.19/217.35  |- skos__hiddenLabel mesh__D007806 Language Disorder
% 217.19/217.35  |- skos__related mesh__D007806smesh__D013064
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007806 2001
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007806 2006
% 217.19/217.35  |- mesh__dateCreated mesh__D007806 1999-01-01
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007806 2000
% 217.19/217.35  |- mesh__dateRevised mesh__D007806 1999-11-03
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007806 2005
% 217.19/217.35  |- mesh__dateEstablished mesh__D007806 1967-01-01
% 217.19/217.35  |- mesh__recordAuthorizer mesh__D007806 sjn
% 217.19/217.35  |- mesh__historyNote mesh__D007806 1967   
% 217.19/217.35  |- skos__broader mesh__D007008smesh__D014883
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007008 2006
% 217.19/217.35  |- mesh__recordMaintainer mesh__D007008 TGC
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007008 1996
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007008 2000
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007008 1997
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007008 1994
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007008 2003
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007008 2001
% 217.19/217.35  |- rdf__type mesh__D007008sskos__Concept
% 217.19/217.35  |- mesh__dateCreated mesh__D007008 1999-01-01
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007008 1995
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007008 2004
% 217.19/217.35  |- skos__hiddenLabel mesh__D007008 Hypokalemias
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007008 1998
% 217.19/217.35  |- mesh__dateRevised mesh__D007008 1993-06-02
% 217.19/217.35  |- skos__scopeNote mesh__D007008
% 217.19/217.35       Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities %28%depression of the T wave and elevation of the U wave%29%, by renal disease, and by gastrointestinal disorders. %28%Dorland, 27th ed%29%%A%    
% 217.19/217.35  |- mesh__recordOriginator mesh__D007008 NLM
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007008 2002
% 217.19/217.35  |- mesh__recordAuthorizer mesh__D007008 PLS
% 217.19/217.35  |- skos__prefLabel mesh__D007008 Hypokalemia
% 217.19/217.35  |- skos__altLabel mesh__D007008 Hypopotassemia
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007008 1999
% 217.19/217.35  |- skos__annotation mesh__D007008
% 217.19/217.35       low blood potassium levels; do not confuse with HYPERKALEMIA%A%  
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007008 2005
% 217.19/217.35  |- skos__hiddenLabel mesh__D007008 Hypopotassemias
% 217.19/217.35  |- skos__hiddenLabel mesh__D017436 Syndrome, Kallmann%27%s
% 217.19/217.35  |- skos__altLabel mesh__D017436 Kallmann%27%s Syndrome
% 217.19/217.35  |- mesh__historyNote mesh__D017436 93   
% 217.19/217.35  |- skos__hiddenLabel mesh__D017436 Syndrome, Kallmann
% 217.19/217.35  |- mesh__recordMaintainer mesh__D017436 lkt
% 217.19/217.35  |- skos__scopeNote mesh__D017436
% 217.19/217.35       A genetically heterogeneous disorder caused by hypothalamic GNRH deficiency and OLFACTORY NERVE defects. It is characterized by congenital HYPOGONADOTROPIC HYPOGONADISM and ANOSMIA, possibly with additional midline defects. It can be transmitted as an X-linked %28%GENETIC DISEASES, X-LINKED%29%, an autosomal dominant, or an autosomal recessive trait.%A%    
% 217.19/217.35  |- mesh__dateEstablished mesh__D017436 1993-01-01
% 217.19/217.35  |- rdf__type mesh__D017436sskos__Concept
% 217.19/217.35  |- skos__prefLabel mesh__D017436 Kallmann Syndrome
% 217.19/217.35  |- mesh__recordAuthorizer mesh__D017436 sjn
% 217.19/217.35  |- skos__historyNote mesh__D017436 Hypogonadism %28%1966-1992%29%
% 217.19/217.35  |- mesh__dateRevised mesh__D017436 2005-06-30
% 217.19/217.35  |- mesh__publicMeSHNote mesh__D017436 93   
% 217.19/217.35  |- mesh__dateCreated mesh__D017436 1992-05-20
% 217.19/217.35  |- mesh__recordOriginator mesh__D017436 AGS
% 217.19/217.35  |- skos__broader mesh__D017436smesh__D007006
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D017436 2006
% 217.19/217.35  |- skos__broader mesh__D017436smesh__D012734
% 217.19/217.35  |- skos__broader mesh__D017436smesh__D030342
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D031107 2004
% 217.19/217.35  |- mesh__dateEstablished mesh__D031107 2003-01-01
% 217.19/217.35  |- rdf__type mesh__D031107sskos__Concept
% 217.19/217.35  |- mesh__dateCreated mesh__D031107 2002-07-03
% 217.19/217.35  |- skos__prefLabel mesh__D031107 Calotropis
% 217.19/217.35  |- skos__broader mesh__D031107smesh__D029067
% 217.19/217.35  |- skos__scopeNote mesh__D031107
% 217.19/217.35       A plant genus of the family ASCLEPIADACEAE. The downy akund floss fiber from the seeds is used like kapok.%A%    
% 217.19/217.35  |- mesh__historyNote mesh__D031107 2003   
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D031107 2005
% 217.19/217.35  |- skos__annotation mesh__D031107
% 217.19/217.35       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D031107 2003
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D031107 2006
% 217.19/217.35  |- mesh__publicMeSHNote mesh__D031107 2003   
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D003416 2006
% 217.19/217.35  |- mesh__historyNote mesh__D003416
% 217.19/217.35       91%28%78%29%; was see under JURISPRUDENCE 1978-90   
% 217.19/217.35  |- rdf__type mesh__D003416sskos__Concept
% 217.19/217.35  |- skos__related mesh__D003416smesh__D035846
% 217.19/217.35  |- mesh__publicMeSHNote mesh__D003416
% 217.19/217.35       91; was see under JURISPRUDENCE 1978-90   
% 217.19/217.35  |- skos__hiddenLabel mesh__D003416 Justice, Criminal
% 217.19/217.35  |- skos__hiddenLabel mesh__D003416 Law, Criminal
% 217.19/217.35  |- skos__broader mesh__D003416smesh__D007603
% 217.19/217.35  |- skos__scopeNote mesh__D003416
% 217.19/217.35       A branch of law that defines criminal offenses, regulates the apprehension, charging and trial of suspected persons, and fixes the penalties and modes of treatment applicable to convicted offenders.%A%    
% 217.19/217.35  |- skos__hiddenLabel mesh__D003416 Laws, Criminal
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D003416 2003
% 217.19/217.35  |- skos__prefLabel mesh__D003416 Criminal Law
% 217.19/217.35  |- mesh__dateRevised mesh__D003416 2002-07-03
% 217.19/217.35  |- skos__historyNote mesh__D003416 Jurisprudence %28%1966-1977%29%
% 217.19/217.35  |- mesh__dateCreated mesh__D003416 1977-04-22
% 217.19/217.35  |- mesh__recordMaintainer mesh__D003416 jrf
% 217.19/217.35  |- skos__annotation mesh__D003416
% 217.19/217.35       SPEC: SPEC qualif; specify state or country   
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D003416 2004
% 217.19/217.35  |- skos__hiddenLabel mesh__D003416 Criminal Laws
% 217.19/217.35  |- skos__broader mesh__D003416smesh__D003418
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D003416 2005
% 217.19/217.35  |- mesh__recordOriginator mesh__D003416 EC
% 217.19/217.35  |- mesh__dateEstablished mesh__D003416 1991-01-01
% 217.19/217.35  |- mesh__recordAuthorizer mesh__D003416 sjn
% 217.19/217.35  |- skos__broader mesh__D001808Q000530smesh__D001808
% 217.19/217.35  |- mesh__preferredCombination mesh__D001808Q000530smesh__D000792
% 217.19/217.35  |- rdf__type mesh__D001808Q000530smesh__CompoundConcept
% 217.19/217.35  |- skos__hiddenLabel mesh__D008101 Hepatic Abscesses, Amoebic
% 217.19/217.35  |- skos__altLabel mesh__D008101 Amoebiasis, Hepatic
% 217.19/217.35  |- skos__annotation mesh__D008101
% 217.19/217.35       coordinate IM with specific organism %28%IM%29%   
% 217.19/217.35  |- skos__hiddenLabel mesh__D008101 Liver Abscesses, Amebic
% 217.19/217.35  |- rdf__type mesh__D008101sskos__Concept
% 217.19/217.35  |- skos__altLabel mesh__D008101 Hepatic Abscess, Amoebic
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D008101 2005
% 217.19/217.35  |- skos__altLabel mesh__D008101 Liver Abscess, Amoebic
% 217.19/217.35  |- skos__hiddenLabel mesh__D008101 Liver Abscesses, Amoebic
% 217.19/217.35  |- skos__scopeNote mesh__D008101
% 217.19/217.35       Single or multiple areas of PUS due to infection by any ameboid protozoa %28%AMEBIASIS%29%. A common form is caused by the ingestion of ENTAMOEBA HISTOLYTICA.%A%    
% 217.19/217.35  |- mesh__dateRevised mesh__D008101 2004-07-07
% 217.19/217.35  |- skos__altLabel mesh__D008101 Abscess, Hepatic, Amebic
% 217.19/217.35  |- skos__hiddenLabel mesh__D008101 Entamoebiases, Hepatic
% 217.19/217.35  |- skos__hiddenLabel mesh__D008101 Abscesses, Amebic Liver
% 217.19/217.35  |- skos__altLabel mesh__D008101 Abscess, Liver, Amebic
% 217.19/217.35  |- skos__hiddenLabel mesh__D008101 Amoebic Liver Abscesses
% 217.19/217.35  |- skos__altLabel mesh__D008101 Hepatic Amebiasis
% 217.19/217.35  |- skos__hiddenLabel mesh__D008101 Abscess, Amebic Liver
% 217.19/217.35  |- skos__broader mesh__D008101smesh__D008109
% 217.19/217.35  |- skos__hiddenLabel mesh__D008101 Amoebic Hepatic Abscesses
% 217.19/217.35  |- mesh__recordMaintainer mesh__D008101 lkt
% 217.19/217.35  |- skos__altLabel mesh__D008101 Amebiasis, Hepatic
% 217.19/217.35  |- skos__hiddenLabel mesh__D008101 Abscess, Amoebic Liver
% 217.19/217.35  |- skos__hiddenLabel mesh__D008101 Abscesses, Amoebic Liver
% 217.19/217.35  |- skos__hiddenLabel mesh__D008101 Amoebic Hepatic Abscess
% 217.19/217.35  |- skos__broader mesh__D008101smesh__D008100
% 217.19/217.35  |- skos__hiddenLabel mesh__D008101 Abscess, Amoebic Hepatic
% 217.19/217.35  |- skos__altLabel mesh__D008101 Hepatic Entamoebiasis
% 217.19/217.35  |- skos__altLabel mesh__D008101 Abscess, Amebic, Hepatic
% 217.19/217.35  |- skos__hiddenLabel mesh__D008101 Abscesses, Amoebic Hepatic
% 217.19/217.35  |- skos__hiddenLabel mesh__D008101 Amebic Liver Abscess
% 217.19/217.35  |- skos__altLabel mesh__D008101 Hepatic Amoebiasis
% 217.19/217.35  |- skos__hiddenLabel mesh__D008101 Hepatic Entamoebiases
% 217.19/217.35  |- skos__hiddenLabel mesh__D008101 Amebic Liver Abscesses
% 217.19/217.35  |- mesh__dateCreated mesh__D008101 1999-01-01
% 217.19/217.35  |- skos__prefLabel mesh__D008101 Liver Abscess, Amebic
% 217.19/217.35  |- skos__hiddenLabel mesh__D008101 Amoebic Liver Abscess
% 217.19/217.35  |- mesh__recordAuthorizer mesh__D008101 sjn
% 217.19/217.35  |- mesh__recordOriginator mesh__D008101 NLM
% 217.19/217.35  |- skos__broader mesh__D008101smesh__D000562
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D008101 2006
% 217.19/217.35  |- mesh__recordMaintainer mesh__D013844 ssb
% 217.19/217.35  |- skos__broader mesh__D013844smesh__D001393
% 217.19/217.35  |- mesh__dateCreated mesh__D013844 1999-01-01
% 217.19/217.35  |- skos__prefLabel mesh__D013844 Thiazoles
% 217.19/217.35  |- skos__annotation mesh__D013844 includes thiazolines, thiazolidines   
% 217.19/217.35  |- mesh__publicMeSHNote mesh__D013844
% 217.19/217.35       ETHOXZOLAMIDE was see under CARBONIC ANHYDRASE INHIBITORS 1965-74%A%  
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013844 2006
% 217.19/217.35  |- mesh__dateRevised mesh__D013844 2005-06-30
% 217.19/217.35  |- rdf__type mesh__D013844sskos__Concept
% 217.19/217.35  |- skos__broader mesh__D013844smesh__D013457
% 217.19/217.35  |- mesh__recordOriginator mesh__D013844 NLM
% 217.19/217.35  |- mesh__recordAuthorizer mesh__D013844 sjn
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013046 1997
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013046 1999
% 217.19/217.35  |- rdf__type mesh__D013046sskos__Concept
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013046 1993
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013046 2002
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013046 1996
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013046 1995
% 217.19/217.35  |- skos__prefLabel mesh__D013046 Specific Gravity
% 217.19/217.35  |- mesh__dateEstablished mesh__D013046 1968-01-01
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013046 1998
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013046 2004
% 217.19/217.35  |- mesh__recordMaintainer mesh__D013046 TAP
% 217.19/217.35  |- mesh__dateCreated mesh__D013046 1999-01-01
% 217.19/217.35  |- skos__hiddenLabel mesh__D013046 Specific Gravities
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013046 2001
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013046 1994
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013046 2006
% 217.19/217.35  |- mesh__historyNote mesh__D013046 68   
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013046 2003
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013046 2000
% 217.19/217.35  |- skos__annotation mesh__D013046 NIM   
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D013046 2005
% 217.19/217.35  |- mesh__recordOriginator mesh__D013046 NLM
% 217.19/217.35  |- mesh__recordAuthorizer mesh__D013046 PLS
% 217.19/217.35  |- mesh__publicMeSHNote mesh__D013046 68   
% 217.19/217.35  |- skos__hiddenLabel mesh__D013046 Gravity, Specific
% 217.19/217.35  |- skos__hiddenLabel mesh__D013046 Gravities, Specific
% 217.19/217.35  |- skos__historyNote mesh__D013046 Chemistry, Physical %28%1966-1967%29%
% 217.19/217.35  |- skos__broader mesh__D013046smesh__D002627
% 217.19/217.35  |- mesh__dateRevised mesh__D013046 1992-05-18
% 217.19/217.35  |- skos__hiddenLabel mesh__D007807 Vocabulary Test
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007807 1993
% 217.19/217.35  |- skos__hiddenLabel mesh__D007807 Comprehension Tests, Language
% 217.19/217.35  |- mesh__recordOriginator mesh__D007807 RC
% 217.19/217.35  |- rdf__type mesh__D007807sskos__Concept
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007807 1999
% 217.19/217.35  |- skos__hiddenLabel mesh__D007807 Test, Language
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007807 2001
% 217.19/217.35  |- skos__hiddenLabel mesh__D007807 Comprehension Test, Language
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007807 2003
% 217.19/217.35  |- skos__hiddenLabel mesh__D007807 Test, Language Comprehension
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007807 1994
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007807 2002
% 217.19/217.35  |- skos__prefLabel mesh__D007807 Language Tests
% 217.19/217.35  |- skos__hiddenLabel mesh__D007807 Test, Vocabulary
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007807 2004
% 217.19/217.35  |- skos__broader mesh__D007807smesh__D011581
% 217.19/217.35  |- skos__hiddenLabel mesh__D007807 Tests, Language Comprehension
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007807 1995
% 217.19/217.35  |- skos__hiddenLabel mesh__D007807 Tests, Vocabulary
% 217.19/217.35  |- mesh__recordMaintainer mesh__D007807 TAP
% 217.19/217.35  |- skos__scopeNote mesh__D007807
% 217.19/217.35       Tests designed to assess language behavior and abilities. They include tests of vocabulary, comprehension, grammar and functional use of language, e.g., Development Sentence Scoring, Receptive-Expressive Emergent Language Scale, Parsons Language Sample, Utah Test of Language Development, Michigan Language Inventory and Verbal Language Development Scale, Illinois Test of Psycholinguistic Abilities, Northwestern Syntax Screening Test, Peabody Picture Vocabulary Test, Ammons Full-Range Picture Vocabulary Test, and Assessment of Children%27%s Language Comprehension.%A%    
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007807 1996
% 217.19/217.35  |- skos__hiddenLabel mesh__D007807 Language Comprehension Test
% 217.19/217.35  |- mesh__publicMeSHNote mesh__D007807 79   
% 217.19/217.35  |- mesh__dateRevised mesh__D007807 1992-03-25
% 217.19/217.35  |- skos__hiddenLabel mesh__D007807 Language Test
% 217.19/217.35  |- skos__historyNote mesh__D007807 Language %28%1966-1978%29%
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007807 2005
% 217.19/217.35  |- skos__historyNote mesh__D007807 Language Development %28%1968-1978%29%
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007807 1997
% 217.19/217.35  |- skos__hiddenLabel mesh__D007807 Tests, Language
% 217.19/217.35  |- mesh__dateCreated mesh__D007807 1978-05-22
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007807 2006
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007807 2000
% 217.19/217.35  |- mesh__recordAuthorizer mesh__D007807 PLS
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007807 1998
% 217.19/217.35  |- mesh__dateEstablished mesh__D007807 1979-01-01
% 217.19/217.35  |- mesh__historyNote mesh__D007807 79   
% 217.19/217.35  |- skos__historyNote mesh__D007009 Hypoproteinemia %28%1966-1977%29%
% 217.19/217.35  |- skos__historyNote mesh__D007009
% 217.19/217.35       Lipid Metabolism, Inborn Errors %28%1966-1977%29%
% 217.19/217.35  |- skos__historyNote mesh__D007009 Lipoproteins, HDL %28%1972-1977%29%
% 217.19/217.35  |- rdf__type mesh__D007009sskos__Concept
% 217.19/217.35  |- skos__annotation mesh__D007009
% 217.19/217.35       low blood lipoprotein levels; do not confuse with HYPERLIPOPROTEINEMIA; hypolipoproteinemia, VLDL %28%hypoprebetalipoproteinemia%29%: coord IM with LIPOPROTEINS, VLDL /blood %28%IM%29%; hypolipoproteinemia, HDL %28%hypoalphalipoproteinemia%29%: coord IM with LIPOPROTEINS, HDL/blood %28%IM%29%; hypolipoproteinemia, LDL = HYPOBETALIPOPROTEINEMIA; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; for near absence of apolipoprotein B, use ABETALIPOPROTEINEMIA%A%  
% 217.19/217.35  |- mesh__recordMaintainer mesh__D007009 lkt
% 217.19/217.35  |- mesh__historyNote mesh__D007009 80; was HYPOLIPOPROTEINEMIAS 1978-79   
% 217.19/217.35  |- skos__broader mesh__D007009smesh__D050171
% 217.19/217.35  |- mesh__publicMeSHNote mesh__D007009
% 217.19/217.35       80; was HYPOLIPOPROTEINEMIAS 1978-79   
% 217.19/217.35  |- mesh__dateRevised mesh__D007009 2005-06-30
% 217.19/217.35  |- skos__historyNote mesh__D007009 Lipoproteins %28%1966-1977%29%
% 217.19/217.35  |- skos__scopeNote mesh__D007009
% 217.19/217.35       The presence of abnormally low levels of lipoproteins in the serum.%A%    
% 217.19/217.35  |- mesh__recordAuthorizer mesh__D007009 sjn
% 217.19/217.35  |- mesh__recordOriginator mesh__D007009 VDK
% 217.19/217.35  |- skos__broader mesh__D007009smesh__D008052
% 217.19/217.35  |- skos__prefLabel mesh__D007009 Hypolipoproteinemia
% 217.19/217.35  |- mesh__dateEstablished mesh__D007009 1978-01-01
% 217.19/217.35  |- skos__hiddenLabel mesh__D007009 Hypolipoproteinemias
% 217.19/217.35  |- mesh__dateCreated mesh__D007009 1977-04-27
% 217.19/217.35  |- mesh__onlineNote mesh__D007009
% 217.19/217.35       use HYPOLIPOPROTEINEMIA to search HYPOLIPOPROTEINEMIAS 1978-79%A%  
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D007009 2006
% 217.19/217.35  |- skos__historyNote mesh__D007009
% 217.19/217.35       Blood Protein Disorders %28%1966-1977%29%
% 217.19/217.35  |- skos__prefLabel mesh__D017437 Skin and Connective Tissue Diseases
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D017437 2004
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D017437 2006
% 217.19/217.35  |- mesh__recordOriginator mesh__D017437 PLS
% 217.19/217.35  |- mesh__publicMeSHNote mesh__D017437 98   
% 217.19/217.35  |- mesh__dateRevised mesh__D017437 1998-06-11
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D017437 2003
% 217.19/217.35  |- mesh__recordMaintainer mesh__D017437 MSR
% 217.19/217.35  |- skos__scopeNote mesh__D017437
% 217.19/217.35       A collective term for diseases of the skin and its appendages and of connective tissue.%A%    
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D017437 2005
% 217.19/217.35  |- mesh__historyNote mesh__D017437 98; use explode 1993-97   
% 217.19/217.35  |- mesh__recordAuthorizer mesh__D017437 SJN
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D017437 2002
% 217.19/217.35  |- mesh__dateEstablished mesh__D017437 1998-01-01
% 217.19/217.35  |- rdf__type mesh__D017437sskos__Concept
% 217.19/217.35  |- skos__annotation mesh__D017437
% 217.19/217.35       not used for indexing; DF: SKIN CONNECTIVE TISSUE DIS      CATALOG: do not use%A%  
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D017437 2001
% 217.19/217.35  |- mesh__dateCreated mesh__D017437 1992-05-22
% 217.19/217.35  |- mesh__runningHead mesh__D017437
% 217.19/217.35       C17 - DISEASES - DERMATOLOGIC AND CONNECTIVE TISSUE   
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D017437 2000
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D017437 1999
% 217.19/217.35  |- mesh__dateEstablished mesh__D031108 2003-01-01
% 217.19/217.35  |- skos__annotation mesh__D031108
% 217.19/217.35       for ASCLEPIAS ASTHMATICA see TYLOPHORA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.19/217.35  |- skos__scopeNote mesh__D031108
% 217.19/217.35       A plant genus of the family ASCLEPIADACEAE. This is the true milkweed; APOCYNUM %26% EUPHORBIA hirta are rarely called milkweed. Asclepias asthmatica has been changed to TYLOPHORA.%A%    
% 217.19/217.35  |- skos__prefLabel mesh__D031108 Asclepias
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D031108 2005
% 217.19/217.35  |- skos__broader mesh__D031108smesh__D029067
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D031108 2003
% 217.19/217.35  |- mesh__publicMeSHNote mesh__D031108 2003   
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D031108 2006
% 217.19/217.35  |- mesh__dateCreated mesh__D031108 2002-07-02
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D031108 2004
% 217.19/217.35  |- rdf__type mesh__D031108sskos__Concept
% 217.19/217.35  |- skos__altLabel mesh__D031108 Milkweed, Common
% 217.19/217.35  |- mesh__historyNote mesh__D031108 2003   
% 217.19/217.35  |- skos__altLabel mesh__D003417 Psychology, Criminal
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D003417 2001
% 217.19/217.35  |- skos__prefLabel mesh__D003417 Criminal Psychology
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D003417 2004
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D003417 1997
% 217.19/217.35  |- skos__annotation mesh__D003417
% 217.19/217.35       as SPEC, SPEC qualif; as psychol of the criminal mind, no qualif; consider also PRISONERS /psychol; DF: CRIMINAL PSYCHOL%A%  
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D003417 2002
% 217.19/217.35  |- mesh__recordMaintainer mesh__D003417 JLS
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D003417 2005
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D003417 1998
% 217.19/217.35  |- mesh__recordAuthorizer mesh__D003417 PLS
% 217.19/217.35  |- skos__broader mesh__D003417smesh__D011585
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D003417 2006
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D003417 1999
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D003417 1994
% 217.19/217.35  |- rdf__type mesh__D003417sskos__Concept
% 217.19/217.35  |- mesh__dateCreated mesh__D003417 1999-01-01
% 217.19/217.35  |- skos__scopeNote mesh__D003417
% 217.19/217.35       The branch of psychology which investigates the psychology of crime with particular reference to the personality factors of the criminal.%A%    
% 217.19/217.35  |- mesh__dateRevised mesh__D003417 1993-06-04
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D003417 2000
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D003417 2003
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D003417 1995
% 217.19/217.35  |- mesh__recordOriginator mesh__D003417 NLM
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D003417 1996
% 217.19/217.35  |- skos__broader mesh__D001808Q000531smesh__D001808
% 217.19/217.35  |- mesh__preferredCombination mesh__D001808Q000531smesh__D011875
% 217.19/217.35  |- rdf__type mesh__D001808Q000531smesh__CompoundConcept
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D008900 2002
% 217.19/217.35  |- mesh__recordAuthorizer mesh__D008900 sjn
% 217.19/217.35  |- rdf__type mesh__D008900sskos__Concept
% 217.19/217.35  |- skos__hiddenLabel mesh__D008900 Water, Mineral
% 217.19/217.35  |- mesh__recordOriginator mesh__D008900 NLM
% 217.19/217.35  |- mesh__recordMaintainer mesh__D008900 kle
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D008900 2003
% 217.19/217.35  |- skos__annotation mesh__D008900
% 217.19/217.35       for drinking, with BALNEOLOGY probably better for bathing in mineral waters%A%  
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D008900 2000
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D008900 2005
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D008900 2004
% 217.19/217.35  |- skos__scopeNote mesh__D008900
% 217.19/217.35       Water naturally or artificially infused with mineral salts or gases %28%carbon dioxide%29%.%A%    
% 217.19/217.35  |- skos__broader mesh__D008900smesh__D001628
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D008900 2001
% 217.19/217.35  |- mesh__dateCreated mesh__D008900 1999-01-01
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D008900 2006
% 217.19/217.35  |- mesh__dateRevised mesh__D008900 1999-11-03
% 217.19/217.35  |- skos__hiddenLabel mesh__D008900 Waters, Mineral
% 217.19/217.35  |- skos__hiddenLabel mesh__D008900 Mineral Water
% 217.19/217.35  |- skos__prefLabel mesh__D008900 Mineral Waters
% 217.19/217.35  |- rdf__type mesh__D008102sskos__Concept
% 217.19/217.35  |- skos__prefLabel mesh__D008102 Liver Circulation
% 217.19/217.35  |- skos__annotation mesh__D008102
% 217.19/217.35       consider also LIVER /blood supply %26% ENTEROHEPATIC CIRCULATION %28%see note there%29%; DF: LIVER CIRC%A%  
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D008102 2005
% 217.19/217.35  |- skos__related mesh__D008102smesh__D004764
% 217.19/217.35  |- mesh__recordMaintainer mesh__D008102 nns
% 217.19/217.35  |- mesh__activeMeSHYear mesh__D008102 2006
% 217.19/217.35  |- skos__broader mesh__D008102smesh__D013152
% 217.19/217.35  |- skos__altLabel mesh__D008102 Circulation, Liver
% 217.19/217.35  |- mesh__recordAuthorizer mesh__D008102 sjn
% 217.19/217.36  |- mesh__dateCreated mesh__D008102 1999-01-01
% 217.19/217.36  |- mesh__recordOriginator mesh__D008102 NLM
% 217.19/217.36  |- skos__related mesh__D008102smesh__D011168
% 217.19/217.36  |- skos__scopeNote mesh__D008102
% 217.19/217.36       The circulation of BLOOD through the LIVER.     
% 217.19/217.36  |- skos__altLabel mesh__D008102 Hepatic Circulation
% 217.19/217.36  |- mesh__dateRevised mesh__D008102 2003-07-09
% 217.19/217.36  |- mesh__historyNote mesh__D008102 64   
% 217.19/217.36  |- mesh__publicMeSHNote mesh__D008102 64   
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D008102 2004
% 217.19/217.36  |- mesh__dateEstablished mesh__D008102 1964-01-01
% 217.19/217.36  |- skos__hiddenLabel mesh__D008102 Circulation, Hepatic
% 217.19/217.36  |- skos__historyNote mesh__D013845 Lactams %28%1974-1982%29%
% 217.19/217.36  |- mesh__dateEstablished mesh__D013845 1983-01-01
% 217.19/217.36  |- skos__historyNote mesh__D013845 Amides %28%1966-1973%29%
% 217.19/217.36  |- mesh__recordAuthorizer mesh__D013845 sjn
% 217.19/217.36  |- mesh__recordOriginator mesh__D013845 SH
% 217.19/217.36  |- skos__annotation mesh__D013845 /biosyn permitted if by living matter   
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013845 2005
% 217.19/217.36  |- skos__historyNote mesh__D013845 Antibiotics %28%1966-1982%29%
% 217.19/217.36  |- mesh__historyNote mesh__D013845 83   
% 217.19/217.36  |- mesh__recordMaintainer mesh__D013845 ssb
% 217.19/217.36  |- skos__broader mesh__D013845smesh__D015780
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013845 2006
% 217.19/217.36  |- rdf__type mesh__D013845sskos__Concept
% 217.19/217.36  |- mesh__publicMeSHNote mesh__D013845 83   
% 217.19/217.36  |- skos__altLabel mesh__D013845 Antibiotics, Thienamycin
% 217.19/217.36  |- skos__scopeNote mesh__D013845
% 217.19/217.36       Beta-lactam antibiotics that differ from PENICILLINS in having the thiazolidine sulfur atom replaced by carbon, the sulfur then becoming the first atom in the side chain. They are unstable chemically, but have a very broad antibacterial spectrum. Thienamycin and its more stable derivatives are proposed for use in combinations with enzyme inhibitors.%A%    
% 217.19/217.36  |- mesh__dateCreated mesh__D013845 1982-05-05
% 217.19/217.36  |- skos__prefLabel mesh__D013845 Thienamycins
% 217.19/217.36  |- skos__hiddenLabel mesh__D013845 Thienamycin Antibiotics
% 217.19/217.36  |- mesh__dateRevised mesh__D013845 2004-07-07
% 217.19/217.36  |- skos__broader mesh__D013047smesh__D005856
% 217.19/217.36  |- mesh__dateCreated mesh__D013047 1999-01-01
% 217.19/217.36  |- skos__hiddenLabel mesh__D013047 Pathogen Free Organisms
% 217.19/217.36  |- mesh__historyNote mesh__D013047
% 217.19/217.36       93; was SPECIFIC PATHOGEN FREE 1975-92 %28%see under GERM-FREE LIFE 1975-90%29%%A%  
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013047 2000
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013047 1994
% 217.19/217.36  |- skos__hiddenLabel mesh__D013047 Organisms, Specific Pathogen-Free
% 217.19/217.36  |- skos__altLabel mesh__D013047 Pathogen-Free Organisms
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013047 1993
% 217.19/217.36  |- mesh__publicMeSHNote mesh__D013047
% 217.19/217.36       93; was SPECIFIC PATHOGEN FREE 1975-92 %28%see under GERM-FREE LIFE 1975-90%29%%A%  
% 217.19/217.36  |- skos__hiddenLabel mesh__D013047 Organism, Specific Pathogen-Free
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013047 1998
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013047 2001
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013047 1995
% 217.19/217.36  |- skos__annotation mesh__D013047
% 217.19/217.36       organism may be human, animal or plant free of specific pathogens; usually NIM; when IM, coord IM with specific pathogenic microorganism discussed %28%IM%29%; do not confuse with GERM-FREE LIFE which refers to freedom from any microorganism, unspecified; DF: SPF ORGANISMS%A%  
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013047 2005
% 217.19/217.36  |- skos__hiddenLabel mesh__D013047 Pathogen-Free Organisms, Specific
% 217.19/217.36  |- mesh__recordAuthorizer mesh__D013047 PLS
% 217.19/217.36  |- skos__hiddenLabel mesh__D013047 Pathogen Frees, Specific
% 217.19/217.36  |- mesh__recordMaintainer mesh__D013047 PLS
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013047 1999
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013047 2002
% 217.19/217.36  |- skos__hiddenLabel mesh__D013047 Specific Pathogen Free Organisms
% 217.19/217.36  |- skos__hiddenLabel mesh__D013047 Organism, Pathogen-Free
% 217.19/217.36  |- skos__hiddenLabel mesh__D013047 Organisms, Pathogen-Free
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013047 1996
% 217.19/217.36  |- mesh__dateRevised mesh__D013047 1992-05-22
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013047 2006
% 217.19/217.36  |- skos__hiddenLabel mesh__D013047 Pathogen-Free Organism, Specific
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013047 2003
% 217.19/217.36  |- skos__hiddenLabel mesh__D013047 Pathogen Free, Specific
% 217.19/217.36  |- mesh__onlineNote mesh__D013047
% 217.19/217.36       use SPECIFIC PATHOGEN-FREE ORGANISMS to search SPECIFIC PATHOGEN FREE 1975-92; search GERM-FREE LIFE 1969-74%A%  
% 217.19/217.36  |- skos__scopeNote mesh__D013047
% 217.19/217.36       Animals or humans raised in the absence of a particular disease-causing virus or other microorganism. Less frequently plants are cultivated pathogen-free.%A%    
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013047 1997
% 217.19/217.36  |- skos__hiddenLabel mesh__D013047 Pathogen-Free Organism
% 217.19/217.36  |- skos__hiddenLabel mesh__D013047 Specific Pathogen-Free Organism
% 217.19/217.36  |- mesh__dateEstablished mesh__D013047 1991-01-01
% 217.19/217.36  |- skos__prefLabel mesh__D013047 Specific Pathogen-Free Organisms
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013047 2004
% 217.19/217.36  |- rdf__type mesh__D013047sskos__Concept
% 217.19/217.36  |- mesh__recordOriginator mesh__D013047 NLM
% 217.19/217.36  |- skos__annotation mesh__D007808
% 217.19/217.36       do not confuse with SPEECH THERAPY: LANGUAGE THERAPY is for LANGUAGE DISORDERS; SPEECH THERAPY is for SPEECH DISORDERS; coord IM with specific lang disord /ther %28%IM%29%, not /rehabil%A%  
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D007808 2004
% 217.19/217.36  |- mesh__publicMeSHNote mesh__D007808 80   
% 217.19/217.36  |- mesh__dateRevised mesh__D007808 2001-07-25
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D007808 2005
% 217.19/217.36  |- skos__broader mesh__D007808smesh__D012049
% 217.19/217.36  |- skos__historyNote mesh__D007808 Speech Therapy %28%1966-1979%29%
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D007808 2002
% 217.19/217.36  |- skos__hiddenLabel mesh__D007808 Training, Language
% 217.19/217.36  |- skos__historyNote mesh__D007808 Language Disorders %28%1967-1979%29%
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D007808 2006
% 217.19/217.36  |- skos__prefLabel mesh__D007808 Language Therapy
% 217.19/217.36  |- mesh__recordAuthorizer mesh__D007808 sjn
% 217.19/217.36  |- mesh__dateEstablished mesh__D007808 1980-01-01
% 217.19/217.36  |- skos__scopeNote mesh__D007808
% 217.19/217.36       Rehabilitation of persons with language disorders or training of children with language development disorders.%A%    
% 217.19/217.36  |- skos__hiddenLabel mesh__D007808 Therapies, Language
% 217.19/217.36  |- skos__altLabel mesh__D007808 Therapy, Language
% 217.19/217.36  |- skos__hiddenLabel mesh__D007808 Trainings, Language
% 217.19/217.36  |- skos__hiddenLabel mesh__D007808 Language Trainings
% 217.19/217.36  |- mesh__historyNote mesh__D007808 80   
% 217.19/217.36  |- mesh__recordOriginator mesh__D007808 RC
% 217.19/217.36  |- rdf__type mesh__D007808sskos__Concept
% 217.19/217.36  |- skos__hiddenLabel mesh__D007808 Language Therapies
% 217.19/217.36  |- mesh__dateCreated mesh__D007808 1979-02-21
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D007808 2003
% 217.19/217.36  |- mesh__recordMaintainer mesh__D007808 mdb
% 217.19/217.36  |- rdf__type mesh__D018530sskos__Concept
% 217.19/217.36  |- mesh__dateCreated mesh__D018530 1994-04-16
% 217.19/217.36  |- skos__hiddenLabel mesh__D018530 Gastric Stumps
% 217.19/217.36  |- skos__hiddenLabel mesh__D018530 Gastric Remnants
% 217.19/217.36  |- skos__hiddenLabel mesh__D018530 Residual Stomachs
% 217.19/217.36  |- skos__historyNote mesh__D018530 Stomach Neoplasms %28%1966-1994%29%
% 217.19/217.36  |- mesh__dateEstablished mesh__D018530 1995-01-01
% 217.19/217.36  |- mesh__historyNote mesh__D018530 95   
% 217.19/217.36  |- skos__hiddenLabel mesh__D018530 Remnants, Gastric
% 217.19/217.36  |- skos__historyNote mesh__D018530 Gastroenterostomy %28%1966-1994%29%
% 217.19/217.36  |- skos__hiddenLabel mesh__D018530 Stomachs, Remnant
% 217.19/217.36  |- skos__annotation mesh__D018530
% 217.19/217.36       stomach remnant after gastrectomy; a common site of neopl: coord IM with STOMACH NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 217.19/217.36  |- skos__historyNote mesh__D018530 Gastrectomy %28%1966-1994%29%
% 217.19/217.36  |- skos__prefLabel mesh__D018530 Gastric Stump
% 217.19/217.36  |- skos__hiddenLabel mesh__D018530 Remnant, Gastric
% 217.19/217.36  |- skos__altLabel mesh__D018530 Residual Stomach
% 217.19/217.36  |- skos__hiddenLabel mesh__D018530 Stump, Gastric
% 217.19/217.36  |- skos__broader mesh__D018530smesh__D013270
% 217.19/217.36  |- skos__hiddenLabel mesh__D018530 Remnant Stomachs
% 217.19/217.36  |- skos__hiddenLabel mesh__D018530 Stumps, Gastric
% 217.19/217.36  |- skos__altLabel mesh__D018530 Remnant Stomach
% 217.19/217.36  |- skos__hiddenLabel mesh__D018530 Stomach, Remnant
% 217.19/217.36  |- skos__altLabel mesh__D018530 Gastric Remnant
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D018530 2006
% 217.19/217.36  |- skos__hiddenLabel mesh__D018530 Stomachs, Residual
% 217.19/217.36  |- mesh__publicMeSHNote mesh__D018530 95   
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D018530 2004
% 217.19/217.36  |- skos__hiddenLabel mesh__D018530 Stomach, Residual
% 217.19/217.36  |- skos__scopeNote mesh__D018530
% 217.19/217.36       That portion of the stomach remaining after gastric surgery, usually gastrectomy or gastroenterostomy for cancer of the stomach or peptic ulcer. It is a common site of cancer referred to as stump cancer or carcinoma of the gastric stump.%A%    
% 217.19/217.36  |- mesh__dateRevised mesh__D018530 2003-07-09
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D018530 2005
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D032201 2006
% 217.19/217.36  |- skos__prefLabel mesh__D032201 Euphrasia
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D032201 2003
% 217.19/217.36  |- rdf__type mesh__D032201sskos__Concept
% 217.19/217.36  |- skos__altLabel mesh__D032201 Eyebright
% 217.19/217.36  |- mesh__dateCreated mesh__D032201 2002-07-03
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D032201 2004
% 217.19/217.36  |- mesh__dateEstablished mesh__D032201 2003-01-01
% 217.19/217.36  |- skos__broader mesh__D032201smesh__D028083
% 217.19/217.36  |- mesh__publicMeSHNote mesh__D032201 2003   
% 217.19/217.36  |- skos__annotation mesh__D032201
% 217.19/217.36       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D032201 2005
% 217.19/217.36  |- skos__scopeNote mesh__D032201
% 217.19/217.36       A plant genus of the family SCROPHULARIACEAE having a folk reputation for use with the eyes.%A%    
% 217.19/217.36  |- mesh__historyNote mesh__D032201 2003   
% 217.19/217.36  |- rdf__type mesh__D051964sskos__Concept
% 217.19/217.36  |- skos__hiddenLabel mesh__D051964 A Factor Receptor
% 217.19/217.36  |- mesh__recordMaintainer mesh__D051964 DRC
% 217.19/217.36  |- skos__scopeNote mesh__D051964
% 217.19/217.36       A family of pheromone receptors that were initially discovered in SACCHAROMYCES CEREVISIAE as proteins necessary for fungal conjugation. Each mating factor receptor is expressed in HAPLOID CELLS of a single mating type.%A%    
% 217.19/217.36  |- mesh__historyNote mesh__D051964 2006%28%1986%29%   
% 217.19/217.36  |- skos__altLabel mesh__D051964 Mating Factor Receptor alpha
% 217.19/217.36  |- mesh__recordAuthorizer mesh__D051964 sjn
% 217.19/217.36  |- mesh__recordOriginator mesh__D051964 DRC
% 217.19/217.36  |- skos__altLabel mesh__D051964 Mating Factor Receptor A
% 217.19/217.36  |- skos__hiddenLabel mesh__D051964 Receptor, alpha-Factor
% 217.19/217.36  |- skos__hiddenLabel mesh__D051964 Receptor, A-Factor
% 217.19/217.36  |- mesh__dateEstablished mesh__D051964 2006-01-01
% 217.19/217.36  |- skos__altLabel mesh__D051964 Mating Factor Receptors
% 217.19/217.36  |- skos__hiddenLabel mesh__D051964 alpha Factor Receptor
% 217.19/217.36  |- skos__broader mesh__D051964smesh__D043563
% 217.19/217.36  |- mesh__dateCreated mesh__D051964 2005-06-30
% 217.19/217.36  |- skos__altLabel mesh__D051964 alpha-Factor Receptor
% 217.19/217.36  |- mesh__publicMeSHNote mesh__D051964
% 217.19/217.36       2006; RECEPTORS, MATING FACTOR was indexed under TRANSCRIPTION FACTORS 1986-2005, %26% under RECEPTORS, PEPTIDE 1994-2005, %26% under RECEPTORS, ENDOGENOUS SUBSTANCES 1986-1993%A%  
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D051964 2006
% 217.19/217.36  |- skos__prefLabel mesh__D051964 Receptors, Mating Factor
% 217.19/217.36  |- skos__altLabel mesh__D051964 A-Factor Receptor
% 217.19/217.36  |- skos__altLabel mesh__D004510 Diploma Programs, Nursing
% 217.19/217.36  |- skos__scopeNote mesh__D004510
% 217.19/217.36       Programs usually offered in hospital schools of nursing leading to a registered nurse diploma %28%RN%29%. Graduates are eligible for state examination for licensure as RN %28%Registered Nurse%29%.%A%    
% 217.19/217.36  |- skos__annotation mesh__D004510
% 217.19/217.36       2-3-yr program in hosp school of nurs; DF: EDUC NURS DIPLOMA PROGRAMS%A%  
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D004510 2002
% 217.19/217.36  |- skos__hiddenLabel mesh__D004510 Programs, Nursing Diploma
% 217.19/217.36  |- mesh__historyNote mesh__D004510 67   
% 217.19/217.36  |- skos__hiddenLabel mesh__D004510 Nursing Diploma Program
% 217.19/217.36  |- mesh__dateEstablished mesh__D004510 1967-01-01
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D004510 2003
% 217.19/217.36  |- mesh__recordOriginator mesh__D004510 NLM
% 217.19/217.36  |- skos__hiddenLabel mesh__D004510 Program, Nursing Diploma
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D004510 2005
% 217.19/217.36  |- skos__prefLabel mesh__D004510 Education, Nursing, Diploma Programs
% 217.19/217.36  |- mesh__dateRevised mesh__D004510 1999-11-03
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D004510 2004
% 217.19/217.36  |- skos__broader mesh__D004510smesh__D004506
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D004510 2006
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D004510 2000
% 217.19/217.36  |- mesh__publicMeSHNote mesh__D004510 67   
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D004510 2001
% 217.19/217.36  |- skos__hiddenLabel mesh__D004510 Nursing Diploma Programs
% 217.19/217.36  |- skos__altLabel mesh__D004510 Nursing Education, Diploma Programs
% 217.19/217.36  |- skos__historyNote mesh__D004510 Education, Nursing %28%1966%29%
% 217.19/217.36  |- rdf__type mesh__D004510sskos__Concept
% 217.19/217.36  |- mesh__recordMaintainer mesh__D004510 kle
% 217.19/217.36  |- skos__hiddenLabel mesh__D004510 Diploma Program, Nursing
% 217.19/217.36  |- mesh__dateCreated mesh__D004510 1999-01-01
% 217.19/217.36  |- mesh__recordAuthorizer mesh__D004510 sjn
% 217.19/217.36  |- skos__hiddenLabel mesh__D017438
% 217.19/217.36       Bisphenol A Glycidyl Methacrylate Homopolymer
% 217.19/217.36  |- mesh__recordMaintainer mesh__D017438 jmp
% 217.19/217.36  |- skos__altLabel mesh__D017438 Concise Enamel Bond System
% 217.19/217.36  |- mesh__dateEstablished mesh__D017438 1993-01-01
% 217.19/217.36  |- skos__broader mesh__D017438smesh__D010636
% 217.19/217.36  |- skos__altLabel mesh__D017438
% 217.19/217.36       2-Propenoic acid, 2-methyl-, %28%1-methylethylidene%29%bis%28%4,1-phenyleneoxy%28%2-hydroxy-3,1-propanediyl%29%%29% ester, homopolymer
% 217.19/217.36  |- skos__altLabel mesh__D017438 Bisphenol A-Glycidyl Methacrylate Polymer
% 217.19/217.36  |- skos__broader mesh__D017438smesh__D008689
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D017438 2005
% 217.19/217.36  |- skos__hiddenLabel mesh__D017438 Resin, Bis-GMA
% 217.19/217.36  |- skos__historyNote mesh__D017438 Resins, Synthetic %28%1979-1980%29%
% 217.19/217.36  |- skos__historyNote mesh__D017438 Epoxy Resins %28%1979-1991%29%
% 217.19/217.36  |- skos__hiddenLabel mesh__D017438 Epoxylite 9075
% 217.19/217.36  |- skos__altLabel mesh__D017438 Bis%28%Phenol A-Glycidyl Methacrylate%29%
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D017438 2006
% 217.19/217.36  |- skos__hiddenLabel mesh__D017438 Methacrylate, Bisphenol A-Glycidyl
% 217.19/217.36  |- skos__hiddenLabel mesh__D017438 Bond, Concise Enamel
% 217.19/217.36  |- skos__hiddenLabel mesh__D017438 Epoxylite9075
% 217.19/217.36  |- skos__hiddenLabel mesh__D017438
% 217.19/217.36       Bisphenol A Glycidyl Methacrylate Polymer
% 217.19/217.36  |- skos__hiddenLabel mesh__D017438 Bis GMA
% 217.19/217.36  |- skos__altLabel mesh__D017438 Poly%28%Bis-GMA%29%
% 217.19/217.36  |- skos__hiddenLabel mesh__D017438 A-Glycidyl Methacrylate, Bisphenol
% 217.19/217.36  |- skos__historyNote mesh__D017438 Composite Resins %28%1980-1992%29%
% 217.19/217.36  |- skos__altLabel mesh__D017438 Bis%28%Phenol A-Glycydyl Methacrylate%29%
% 217.19/217.36  |- skos__hiddenLabel mesh__D017438 Nuva Seal
% 217.19/217.36  |- skos__historyNote mesh__D017438 Methacrylates %28%1987-1992%29%
% 217.19/217.36  |- mesh__recordAuthorizer mesh__D017438 sjn
% 217.19/217.36  |- skos__hiddenLabel mesh__D017438 Opaque, Panavia
% 217.19/217.36  |- mesh__dateRevised mesh__D017438 2004-07-07
% 217.19/217.36  |- skos__altLabel mesh__D017438 Bis-GMA Resin
% 217.19/217.36  |- mesh__recordOriginator mesh__D017438 TPW
% 217.19/217.36  |- skos__hiddenLabel mesh__D017438 Enamel Bond, Concise
% 217.19/217.36  |- skos__historyNote mesh__D017438 Polymethacrylic Acids %28%1980-1992%29%
% 217.19/217.36  |- skos__altLabel mesh__D017438 Bis-GMA
% 217.19/217.36  |- mesh__historyNote mesh__D017438
% 217.19/217.36       1993; use BIS%28%PHENOL A-GLYCYDYL METHACRYLATE%29% %28%NM%29% 1975-1992; for PANVIA OPAQUE use BIS%28%PHENOL A-GLYCYDYL METHACRYLATE%29% %28%NM%29% 1992-2000; for RETROPLAST use BIS%28%PHENOL A-GLYCYDYL METHACRYLATE%29% %28%NM%29% 1992; for SILUX use BIS%28%PHENOL A-GLYCYDYL METHACRYLATE%29% %28%NM%29% 1984-1992; for ADAPTIC, CONCISE %26% CONCISE WHITE SEALANT use BIS%28%PHENOL A-GLYCYDYL METHACRYLATE%29% %28%NM%29% 1981-1992; BIS%28%PHENOL A-GLYCIDYL METHACRYLATE%29%, HOMOPOLYMER use BIS%28%PHENOL A-GLYCYDYL METHACRYLATE%29% %28%NM%29% 1975-1992%A%  
% 217.19/217.36  |- skos__hiddenLabel mesh__D017438 NuvaSeal
% 217.19/217.36  |- skos__historyNote mesh__D017438 Acrylic Resins %28%1981-1992%29%
% 217.19/217.36  |- rdf__type mesh__D017438sskos__Concept
% 217.19/217.36  |- skos__altLabel mesh__D017438
% 217.19/217.36       Bis%28%Phenol A-Glycidyl Methacrylate%29%, Homopolymer
% 217.19/217.36  |- skos__hiddenLabel mesh__D017438 Bis GMA Resin
% 217.19/217.36  |- skos__hiddenLabel mesh__D017438 Bisphenol A Glycidyl Methacrylate
% 217.19/217.36  |- skos__altLabel mesh__D017438 Kerr Sealer
% 217.19/217.36  |- skos__prefLabel mesh__D017438 Bisphenol A-Glycidyl Methacrylate
% 217.19/217.36  |- skos__altLabel mesh__D017438 Bis-GMA Polymer
% 217.19/217.36  |- skos__historyNote mesh__D017438 Methacrylates %28%1975-1982%29%
% 217.19/217.36  |- skos__hiddenLabel mesh__D017438 Bis GMA Polymer
% 217.19/217.36  |- mesh__dateCreated mesh__D017438 1992-05-13
% 217.19/217.36  |- mesh__publicMeSHNote mesh__D017438
% 217.19/217.36       1993; BIS%28%PHENOL A-GLYCYDYL METHACRYLATE%29% was indexed under METHACRYLATES 1987-1992; PANVIA OPAQUE was indexed under DENTIN-BONDING AGENTS 1992-2000 %26% under ADHESIVES 1992; RETROPLAST was indexed under POLYMETHACRYLIC ACIDS 1992; SILUX was indexed under COMPOSITE RESINS 1984-1992; ADAPTIC was indexed under POLYMETHACRYLIC ACIDS 1981-1992; CONCISE was indexed under ACRYLIC RESINS 1981-1992; CONCISE WHITE SEALANT was indexed under COMPOSITE RESINS 1981-1992; BIS%28%PHENOL A-GLYCYDYL METHACRYLATE%29% HOMOPOLYMER was indexed under POLYMETHACRYLIC ACIDS 1984-1992, METHACRYLATES 1975-1983, EPOXY RESINS 1979-1982 %26% RESINS, SYNTHETIC 1979-1980%A%  
% 217.19/217.36  |- skos__hiddenLabel mesh__D017438 Polymer, Bis-GMA
% 217.19/217.36  |- skos__broader mesh__D017438smesh__D003188
% 217.19/217.36  |- skos__scopeNote mesh__D017438
% 217.19/217.36       The reaction product of bisphenol A and glycidyl methacrylate that undergoes polymerization when exposed to ultraviolet light or mixed with a catalyst. It is used as a bond implant material and as the resin component of dental sealants and composite restorative materials.%A%    
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D031109 2003
% 217.19/217.36  |- skos__annotation mesh__D031109
% 217.19/217.36       PERIPLOCA INDICA see HEMIDESMUS is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D031109 2005
% 217.19/217.36  |- rdf__type mesh__D031109sskos__Concept
% 217.19/217.36  |- mesh__dateCreated mesh__D031109 2002-07-03
% 217.19/217.36  |- skos__scopeNote mesh__D031109
% 217.19/217.36       A plant genus of the family ASCLEPIADACEAE. It is a source of periplocosides %28%pregnane steroid glycosides%29%.%A%    
% 217.19/217.36  |- mesh__dateEstablished mesh__D031109 2003-01-01
% 217.19/217.36  |- skos__prefLabel mesh__D031109 Periploca
% 217.19/217.36  |- mesh__historyNote mesh__D031109 2003   
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D031109 2004
% 217.19/217.36  |- skos__broader mesh__D031109smesh__D029067
% 217.19/217.36  |- mesh__publicMeSHNote mesh__D031109 2003   
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D031109 2006
% 217.19/217.36  |- skos__scopeNote mesh__D003418
% 217.19/217.36       The study of crime and criminals with special reference to the personality factors and social conditions leading toward, or away from crime.%A%    
% 217.19/217.36  |- mesh__dateRevised mesh__D003418 1993-06-04
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D003418 2000
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D003418 2005
% 217.19/217.36  |- mesh__recordOriginator mesh__D003418 NLM
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D003418 1998
% 217.19/217.36  |- skos__annotation mesh__D003418 SPEC: SPEC qualif; DF: CRIMINOL   
% 217.19/217.36  |- skos__prefLabel mesh__D003418 Criminology
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D003418 2001
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D003418 2006
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D003418 1999
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D003418 2002
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D003418 1994
% 217.19/217.36  |- mesh__recordMaintainer mesh__D003418 JLS
% 217.19/217.36  |- rdf__type mesh__D003418sskos__Concept
% 217.19/217.36  |- mesh__dateCreated mesh__D003418 1999-01-01
% 217.19/217.36  |- skos__broader mesh__D003418smesh__D012942
% 217.19/217.36  |- mesh__recordAuthorizer mesh__D003418 PLS
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D003418 1995
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D003418 2003
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D003418 1996
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D003418 2004
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D003418 1997
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D014140 2003
% 217.19/217.36  |- skos__broader mesh__D014140smesh__D019616
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D014140 1999
% 217.19/217.36  |- skos__broader mesh__D014140smesh__D013517
% 217.19/217.36  |- mesh__recordOriginator mesh__D014140 NLM
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D014140 2000
% 217.19/217.36  |- rdf__type mesh__D014140sskos__Concept
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D014140 1998
% 217.19/217.36  |- mesh__historyNote mesh__D014140 TRACHEOSTOMY was heading 1963-66   
% 217.19/217.36  |- mesh__recordMaintainer mesh__D014140 PXP
% 217.19/217.36  |- skos__annotation mesh__D014140
% 217.19/217.36       do not use /util except by MeSH definition; do not confuse with TRACHEOSTOMY%A%  
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D014140 2002
% 217.19/217.36  |- mesh__recordAuthorizer mesh__D014140 SJN
% 217.19/217.36  |- skos__hiddenLabel mesh__D014140 Tracheotomies
% 217.19/217.36  |- skos__prefLabel mesh__D014140 Tracheotomy
% 217.19/217.36  |- mesh__dateRevised mesh__D014140 1997-06-20
% 217.19/217.36  |- skos__scopeNote mesh__D014140 Surgical incision of the trachea.     
% 217.19/217.36  |- mesh__onlineNote mesh__D014140
% 217.19/217.36       use TRACHEOTOMY to search TRACHEOSTOMY 1966   
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D014140 2006
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D014140 2004
% 217.19/217.36  |- mesh__publicMeSHNote mesh__D014140 TRACHEOSTOMY was heading 1963-66   
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D014140 2005
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D014140 2001
% 217.19/217.36  |- mesh__dateCreated mesh__D014140 1999-01-01
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D008901 2005
% 217.19/217.36  |- mesh__historyNote mesh__D008901 67   
% 217.19/217.36  |- mesh__recordMaintainer mesh__D008901 ssb
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D008901 2004
% 217.19/217.36  |- mesh__dateCreated mesh__D008901 1999-01-01
% 217.19/217.36  |- skos__scopeNote mesh__D008901
% 217.19/217.36       A group of CORTICOSTEROIDS primarily associated with the water and electrolyte balance. This is accomplished through the effect on ION TRANSPORT in renal tubules, resulting in retention of sodium and loss of potassium. Mineralocorticoid secretion is itself regulated by PLASMA VOLUME, serum potassium, and ANGIOTENSIN II.%A%    
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D008901 2006
% 217.19/217.36  |- skos__broader mesh__D008901smesh__D006728
% 217.19/217.36  |- skos__prefLabel mesh__D008901 Mineralocorticoids
% 217.19/217.36  |- mesh__publicMeSHNote mesh__D008901 67   
% 217.19/217.36  |- mesh__recordAuthorizer mesh__D008901 sjn
% 217.19/217.36  |- mesh__recordOriginator mesh__D008901 NLM
% 217.19/217.36  |- mesh__dateRevised mesh__D008901 2003-07-09
% 217.19/217.36  |- skos__annotation mesh__D008901 GEN: avoid: prefer specifics;   
% 217.19/217.36  |- rdf__type mesh__D008901sskos__Concept
% 217.19/217.36  |- mesh__dateEstablished mesh__D008901 1967-01-01
% 217.19/217.36  |- skos__historyNote mesh__D008901 Adrenal Cortex Hormones %28%1966%29%
% 217.19/217.36  |- skos__hiddenLabel mesh__D008103 Cirrhoses, Liver
% 217.19/217.36  |- mesh__historyNote mesh__D008103
% 217.19/217.36       LIVER CIRRHOSIS, POSTNECROTIC was heading 1963-77   
% 217.19/217.36  |- skos__hiddenLabel mesh__D008103 Liver Cirrhoses
% 217.19/217.36  |- rdf__type mesh__D008103sskos__Concept
% 217.19/217.36  |- skos__altLabel mesh__D008103 Cirrhosis, Liver
% 217.19/217.36  |- mesh__dateCreated mesh__D008103 1999-01-01
% 217.19/217.36  |- skos__scopeNote mesh__D008103
% 217.19/217.36       Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.%A%    
% 217.19/217.36  |- skos__altLabel mesh__D008103 Liver Fibrosis
% 217.19/217.36  |- mesh__dateRevised mesh__D008103 2004-07-07
% 217.19/217.36  |- skos__broader mesh__D008103smesh__D008107
% 217.19/217.36  |- skos__altLabel mesh__D008103 Hepatic Cirrhosis
% 217.19/217.36  |- skos__prefLabel mesh__D008103 Liver Cirrhosis
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D008103 2006
% 217.19/217.36  |- mesh__onlineNote mesh__D008103
% 217.19/217.36       use LIVER CIRRHOSIS to search LIVER CIRRHOSIS, POSTNECROTIC 1966-77%A%  
% 217.19/217.36  |- mesh__recordMaintainer mesh__D008103 lkt
% 217.19/217.36  |- skos__hiddenLabel mesh__D008103 Fibroses, Liver
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D008103 2005
% 217.19/217.36  |- skos__hiddenLabel mesh__D008103 Liver Fibroses
% 217.19/217.36  |- mesh__publicMeSHNote mesh__D008103
% 217.19/217.36       LIVER CIRRHOSIS, POSTNECROTIC was heading 1963-77   
% 217.19/217.36  |- skos__hiddenLabel mesh__D008103 Hepatic Cirrhoses
% 217.19/217.36  |- skos__hiddenLabel mesh__D008103 Cirrhoses, Hepatic
% 217.19/217.36  |- mesh__recordAuthorizer mesh__D008103 sjn
% 217.19/217.36  |- mesh__recordOriginator mesh__D008103 NLM
% 217.19/217.36  |- skos__hiddenLabel mesh__D008103 Cirrhosis, Hepatic
% 217.19/217.36  |- mesh__historyNote mesh__D000120
% 217.19/217.36       96; was ACETYLPROCAINAMIDE 1980-95 %28%see under PROCAINAMIDE 1980-90%29%%A%  
% 217.19/217.36  |- mesh__dateEstablished mesh__D000120 1991-01-01
% 217.19/217.36  |- mesh__dateCreated mesh__D000120 1979-02-27
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D000120 2001
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D000120 2006
% 217.19/217.36  |- skos__altLabel mesh__D000120 Acecainide Monohydrochloride
% 217.19/217.36  |- skos__historyNote mesh__D000120
% 217.19/217.36       Procainamide %28%1966-1974%29% /analogs %26% derivatives %28%1975-1979%29%
% 217.19/217.36  |- mesh__recordMaintainer mesh__D000120 CCR
% 217.19/217.36  |- mesh__recordAuthorizer mesh__D000120 sjn
% 217.19/217.36  |- mesh__recordOriginator mesh__D000120 SH
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D000120 2005
% 217.19/217.36  |- skos__altLabel mesh__D000120 Acetylprocainamide
% 217.19/217.36  |- skos__hiddenLabel mesh__D000120 Monohydrochloride, Acecainide
% 217.19/217.36  |- skos__hiddenLabel mesh__D000120 N Acetylprocainamide
% 217.19/217.36  |- mesh__publicMeSHNote mesh__D000120
% 217.19/217.36       96; was ACETYLPROCAINAMIDE 1980-95 %28%see under PROCAINAMIDE 1980-90%29%%A%  
% 217.19/217.36  |- rdf__type mesh__D000120sskos__Concept
% 217.19/217.36  |- skos__broader mesh__D000120smesh__D010129
% 217.19/217.36  |- skos__altLabel mesh__D000120 N-Acetylprocainamide
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D000120 2002
% 217.19/217.36  |- skos__prefLabel mesh__D000120 Acecainide
% 217.19/217.36  |- skos__scopeNote mesh__D000120
% 217.19/217.36       A major metabolite of PROCAINAMIDE. Its anti-arrhythmic action may cause cardiac toxicity in kidney failure.%A%    
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D000120 2004
% 217.19/217.36  |- mesh__dateRevised mesh__D000120 2000-06-21
% 217.19/217.36  |- skos__hiddenLabel mesh__D000120 Hydrochloride, Acecainide
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D000120 2003
% 217.19/217.36  |- skos__broader mesh__D013846smesh__D013457
% 217.19/217.36  |- skos__prefLabel mesh__D013846 Thiepins
% 217.19/217.36  |- mesh__historyNote mesh__D013846 68   
% 217.19/217.36  |- mesh__dateEstablished mesh__D013846 1968-01-01
% 217.19/217.36  |- mesh__dateRevised mesh__D013846 2005-06-30
% 217.19/217.36  |- mesh__recordMaintainer mesh__D013846 ssb
% 217.19/217.36  |- mesh__dateCreated mesh__D013846 1999-01-01
% 217.19/217.36  |- mesh__publicMeSHNote mesh__D013846 68   
% 217.19/217.36  |- mesh__recordAuthorizer mesh__D013846 sjn
% 217.19/217.36  |- mesh__recordOriginator mesh__D013846 NLM
% 217.19/217.36  |- skos__broader mesh__D013846smesh__D006573
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013846 2006
% 217.19/217.36  |- rdf__type mesh__D013846sskos__Concept
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013048 2003
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013048 2001
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013048 2005
% 217.19/217.36  |- skos__annotation mesh__D013048 includes %22%collection%22%   
% 217.19/217.36  |- skos__hiddenLabel mesh__D013048 Specimen Handlings
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013048 2000
% 217.19/217.36  |- mesh__recordOriginator mesh__D013048 NLM
% 217.19/217.36  |- mesh__recordMaintainer mesh__D013048 PXP
% 217.19/217.36  |- mesh__dateRevised mesh__D013048 1997-06-20
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013048 1999
% 217.19/217.36  |- rdf__type mesh__D013048sskos__Concept
% 217.19/217.36  |- skos__hiddenLabel mesh__D013048 Handling, Specimen
% 217.19/217.36  |- skos__hiddenLabel mesh__D013048 Handlings, Specimen
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013048 1998
% 217.19/217.36  |- mesh__recordAuthorizer mesh__D013048 SJN
% 217.19/217.36  |- skos__scopeNote mesh__D013048
% 217.19/217.36       Procedures for collecting, preserving, and transporting of specimens sufficiently stable to provide accurate and precise results suitable for clinical interpretation.%A%    
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013048 2004
% 217.19/217.36  |- mesh__dateCreated mesh__D013048 1999-01-01
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013048 2002
% 217.19/217.36  |- skos__broader mesh__D013048smesh__D003942
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D013048 2006
% 217.19/217.36  |- skos__prefLabel mesh__D013048 Specimen Handling
% 217.19/217.36  |- mesh__dateRevised mesh__D007809 2003-07-09
% 217.19/217.36  |- mesh__activeMeSHYear mesh__D007809 2006
% 217.19/217.36  |- mesh__recordOriginator mesh__D007809 NLM
% 217.19/217.36  |- skos__scopeNote mesh__D007809
% 217.19/217.36       A yellow fat obtained from sheep%27%s wool. It is used as an emollient, cosmetic, and pharmaceutic aid.%A%    
% 217.19/217.36  |- rdf__type mesh__D007809sskos__Concept
% 217.19/217.37  |- skos__annotation mesh__D007809
% 217.19/217.37       an emollient %26% ointment base; D25-26 qualif   
% 217.19/217.37  |- skos__prefLabel mesh__D007809 Lanolin
% 217.19/217.37  |- mesh__recordMaintainer mesh__D007809 ssb
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D007809 2004
% 217.19/217.37  |- mesh__dateCreated mesh__D007809 1999-01-01
% 217.19/217.37  |- mesh__recordAuthorizer mesh__D007809 sjn
% 217.19/217.37  |- skos__broader mesh__D007809smesh__D014885
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D007809 2005
% 217.19/217.37  |- mesh__dateCreated mesh__D018531 1994-06-07
% 217.19/217.37  |- mesh__publicMeSHNote mesh__D018531 95   
% 217.19/217.37  |- mesh__recordMaintainer mesh__D018531 JLS
% 217.19/217.37  |- skos__hiddenLabel mesh__D018531 Space Crafts
% 217.19/217.37  |- skos__annotation mesh__D018531 manned or unmanned   
% 217.19/217.37  |- mesh__historyNote mesh__D018531 95   
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D018531 2000
% 217.19/217.37  |- mesh__recordOriginator mesh__D018531 JLS
% 217.19/217.37  |- skos__broader mesh__D018531smesh__D013026
% 217.19/217.37  |- skos__hiddenLabel mesh__D018531 Man-Made Satellites
% 217.19/217.37  |- skos__hiddenLabel mesh__D018531 Satellite, Man-Made
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D018531 2006
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D018531 2002
% 217.19/217.37  |- skos__scopeNote mesh__D018531
% 217.19/217.37       Devices, manned and unmanned, which are designed to be placed into an orbit about the Earth or into a trajectory to another celestial body. %28%NASA Thesaurus, 1988%29%%A%    
% 217.19/217.37  |- skos__prefLabel mesh__D018531 Spacecraft
% 217.19/217.37  |- skos__hiddenLabel mesh__D018531 Spacecrafts
% 217.19/217.37  |- skos__hiddenLabel mesh__D018531 Artificial Satellite
% 217.19/217.37  |- skos__altLabel mesh__D018531 Space Craft
% 217.19/217.37  |- skos__hiddenLabel mesh__D018531 Crafts, Space
% 217.19/217.37  |- skos__hiddenLabel mesh__D018531 Biosatellite
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D018531 2005
% 217.19/217.37  |- mesh__dateRevised mesh__D018531 1997-06-20
% 217.19/217.37  |- mesh__dateEstablished mesh__D018531 1995-01-01
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D018531 2004
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D018531 1999
% 217.19/217.37  |- skos__hiddenLabel mesh__D018531 Satellites, Man Made
% 217.19/217.37  |- skos__hiddenLabel mesh__D018531 Artificial Satellites
% 217.19/217.37  |- rdf__type mesh__D018531sskos__Concept
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D018531 2003
% 217.19/217.37  |- skos__historyNote mesh__D018531 Space Flight %28%1966-1994%29%
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D018531 1998
% 217.19/217.37  |- skos__hiddenLabel mesh__D018531 Man-Made Satellite
% 217.19/217.37  |- skos__hiddenLabel mesh__D018531 Craft, Space
% 217.19/217.37  |- skos__hiddenLabel mesh__D018531 Satellite, Artificial
% 217.19/217.37  |- skos__altLabel mesh__D018531 Satellites, Artificial
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D018531 2001
% 217.19/217.37  |- mesh__recordAuthorizer mesh__D018531 SJN
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D004511 2005
% 217.19/217.37  |- skos__scopeNote mesh__D004511
% 217.19/217.37       Those educational activities engaged in by holders of a bachelor%27%s degree in nursing, which are primarily designed to prepare them for entrance into a specific field of nursing, and may lead to board certification or a more advanced degree.%A%    
% 217.19/217.37  |- skos__hiddenLabel mesh__D004511 Education, Graduate Nursing
% 217.19/217.37  |- skos__broader mesh__D004511smesh__D004506
% 217.19/217.37  |- skos__broader mesh__D004511smesh__D004500
% 217.19/217.37  |- skos__altLabel mesh__D004511 Postgraduate Nursing Education
% 217.19/217.37  |- rdf__type mesh__D004511sskos__Concept
% 217.19/217.37  |- skos__hiddenLabel mesh__D004511 Education, Postgraduate Nursing
% 217.19/217.37  |- mesh__dateEstablished mesh__D004511 1966-01-01
% 217.19/217.37  |- skos__prefLabel mesh__D004511 Education, Nursing, Graduate
% 217.19/217.37  |- mesh__recordMaintainer mesh__D004511 kle
% 217.19/217.37  |- mesh__dateCreated mesh__D004511 1999-01-01
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D004511 2001
% 217.19/217.37  |- mesh__historyNote mesh__D004511 66   
% 217.19/217.37  |- mesh__recordAuthorizer mesh__D004511 sjn
% 217.19/217.37  |- skos__altLabel mesh__D004511 Nursing Education, Postgraduate
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D004511 2004
% 217.19/217.37  |- skos__altLabel mesh__D004511 Graduate Nursing Education
% 217.19/217.37  |- mesh__publicMeSHNote mesh__D004511 66   
% 217.19/217.37  |- mesh__dateRevised mesh__D004511 1999-11-05
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D004511 2000
% 217.19/217.37  |- skos__annotation mesh__D004511
% 217.19/217.37       differentiate from EDUCATION, NURSING, CONTINUING: see note on EDUCATION, CONTINUING; leads to MS or PhD; DF: EDUC NURS GRAD%A%  
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D004511 2003
% 217.19/217.37  |- skos__altLabel mesh__D004511 Education, Nursing, Postgraduate
% 217.19/217.37  |- mesh__recordOriginator mesh__D004511 NLM
% 217.19/217.37  |- skos__altLabel mesh__D004511 Nursing Education, Graduate
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D004511 2006
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D004511 2002
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D017439 2000
% 217.19/217.37  |- skos__hiddenLabel mesh__D017439 Scar, Hypertrophic
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D017439 1995
% 217.19/217.37  |- skos__hiddenLabel mesh__D017439 Hypertrophic Scar
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D017439 2003
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D017439 2006
% 217.19/217.37  |- skos__hiddenLabel mesh__D017439 Cicatrices, Hypertrophic
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D017439 1994
% 217.19/217.37  |- skos__hiddenLabel mesh__D017439 Hypertrophic Cicatrices
% 217.19/217.37  |- rdf__type mesh__D017439sskos__Concept
% 217.19/217.37  |- skos__scopeNote mesh__D017439
% 217.19/217.37       An elevated scar, resembling a KELOID, but which does not spread into surrounding tissues. It is formed by enlargement and overgrowth of cicatricial tissue and regresses spontaneously.%A%    
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D017439 2005
% 217.19/217.37  |- skos__altLabel mesh__D017439 Scars, Hypertrophic
% 217.19/217.37  |- mesh__publicMeSHNote mesh__D017439 93   
% 217.19/217.37  |- skos__hiddenLabel mesh__D017439 Hypertrophic Cicatrix
% 217.19/217.37  |- mesh__dateCreated mesh__D017439 1992-05-20
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D017439 1997
% 217.19/217.37  |- skos__broader mesh__D017439smesh__D002921
% 217.19/217.37  |- skos__related mesh__D017439smesh__D007627
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D017439 2002
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D017439 1996
% 217.19/217.37  |- skos__historyNote mesh__D017439 Cicatrix %28%1966-1992%29%
% 217.19/217.37  |- mesh__historyNote mesh__D017439 93   
% 217.19/217.37  |- skos__prefLabel mesh__D017439 Cicatrix, Hypertrophic
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D017439 1999
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D017439 2001
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D017439 1993
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D017439 1998
% 217.19/217.37  |- skos__annotation mesh__D017439
% 217.19/217.37       does not spread to surrounding tissue: do not confuse with KELOID which does; follow text of author%A%  
% 217.19/217.37  |- skos__hiddenLabel mesh__D017439 Hypertrophic Scars
% 217.19/217.37  |- mesh__dateEstablished mesh__D017439 1993-01-01
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D017439 2004
% 217.19/217.37  |- rdf__type mesh__D028161sskos__Concept
% 217.19/217.37  |- mesh__dateCreated mesh__D028161 2001-07-25
% 217.19/217.37  |- mesh__dateEstablished mesh__D028161 2002-01-01
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D028161 2006
% 217.19/217.37  |- mesh__recordOriginator mesh__D028161 ssb
% 217.19/217.37  |- mesh__recordAuthorizer mesh__D028161 sjn
% 217.19/217.37  |- mesh__recordMaintainer mesh__D028161 ssb
% 217.19/217.37  |- skos__annotation mesh__D028161
% 217.19/217.37       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.19/217.37  |- mesh__dateRevised mesh__D028161 2002-07-03
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D028161 2003
% 217.19/217.37  |- skos__broader mesh__D028161smesh__D019684
% 217.19/217.37  |- mesh__publicMeSHNote mesh__D028161 2002   
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D028161 2004
% 217.19/217.37  |- skos__prefLabel mesh__D028161 Valerianaceae
% 217.19/217.37  |- mesh__historyNote mesh__D028161 2002   
% 217.19/217.37  |- skos__scopeNote mesh__D028161
% 217.19/217.37       The Valerian plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida that is characterized by 3-5-lobed tubular flowers, often spurred at the base and clustered in tight heads.%A%    
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D028161 2005
% 217.19/217.37  |- skos__annotation mesh__D003419 a psychother technique   
% 217.19/217.37  |- mesh__historyNote mesh__D003419 70   
% 217.19/217.37  |- mesh__publicMeSHNote mesh__D003419 70   
% 217.19/217.37  |- skos__historyNote mesh__D003419
% 217.19/217.37       Community Health Services %28%1966-1969%29%
% 217.19/217.37  |- skos__historyNote mesh__D003419
% 217.19/217.37       Suicide/prevention %26% control %28%1966-1969%29%
% 217.19/217.37  |- skos__hiddenLabel mesh__D003419 Interventions, Crisis
% 217.19/217.37  |- skos__related mesh__D003419smesh__D015277
% 217.19/217.37  |- skos__hiddenLabel mesh__D003419 Crisis Interventions
% 217.19/217.37  |- skos__historyNote mesh__D003419
% 217.19/217.37       Community Mental Health Services %28%1967-1969%29%
% 217.19/217.37  |- skos__scopeNote mesh__D003419
% 217.19/217.37       Brief therapeutic approach which is ameliorative rather than curative of acute psychiatric emergencies. Used in contexts such as emergency rooms of psychiatric or general hospitals, or in the home or place of crisis occurrence, this treatment approach focuses on interpersonal and intrapsychic factors and environmental modification. %28%APA Thesaurus of Psychological Index Terms, 7th ed%29%%A%    
% 217.19/217.37  |- mesh__dateCreated mesh__D003419 1999-01-01
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D003419 2006
% 217.19/217.37  |- mesh__recordOriginator mesh__D003419 NLM
% 217.19/217.37  |- skos__historyNote mesh__D003419 Psychotherapy %28%1966-1969%29%
% 217.19/217.37  |- mesh__dateRevised mesh__D003419 2004-07-19
% 217.19/217.37  |- rdf__type mesh__D003419sskos__Concept
% 217.19/217.37  |- skos__historyNote mesh__D003419 Mental Health Services %28%1966-1969%29%
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D003419 2005
% 217.19/217.37  |- mesh__recordMaintainer mesh__D003419 jls
% 217.19/217.37  |- mesh__dateEstablished mesh__D003419 1970-01-01
% 217.19/217.37  |- skos__historyNote mesh__D003419
% 217.19/217.37       Mental Disorders/prevention %26% control %28%1966-1969%29%
% 217.19/217.37  |- mesh__recordAuthorizer mesh__D003419 sjn
% 217.19/217.37  |- skos__historyNote mesh__D003419
% 217.19/217.37       Emergency Medical Services %28%1968-1969%29%
% 217.19/217.37  |- skos__hiddenLabel mesh__D003419 Intervention, Crisis
% 217.19/217.37  |- skos__broader mesh__D003419smesh__D011613
% 217.19/217.37  |- skos__prefLabel mesh__D003419 Crisis Intervention
% 217.19/217.37  |- skos__annotation mesh__D014141
% 217.19/217.37       caused by Chlamydia trachomatis, a bacterium, not a virus %28%%22%trachoma virus%22%%29%%A%  
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014141 1998
% 217.19/217.37  |- skos__broader mesh__D014141smesh__D003234
% 217.19/217.37  |- skos__scopeNote mesh__D014141
% 217.19/217.37       A chronic infection of the conjunctiva and cornea caused by CHLAMYDIA TRACHOMATIS.%A%    
% 217.19/217.37  |- skos__hiddenLabel mesh__D014141 Trachomas
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014141 2001
% 217.19/217.37  |- skos__prefLabel mesh__D014141 Trachoma
% 217.19/217.37  |- mesh__recordOriginator mesh__D014141 NLM
% 217.19/217.37  |- skos__broader mesh__D014141smesh__D003316
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014141 2000
% 217.19/217.37  |- mesh__recordMaintainer mesh__D014141 PXP
% 217.19/217.37  |- skos__broader mesh__D014141smesh__D002690
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014141 2006
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014141 2004
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014141 2005
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014141 2002
% 217.19/217.37  |- mesh__recordAuthorizer mesh__D014141 SJN
% 217.19/217.37  |- mesh__dateRevised mesh__D014141 1997-06-20
% 217.19/217.37  |- mesh__dateCreated mesh__D014141 1999-01-01
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014141 2003
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014141 1999
% 217.19/217.37  |- rdf__type mesh__D014141sskos__Concept
% 217.19/217.37  |- skos__historyNote mesh__D008104 Liver Cirrhosis %28%1966-1977%29%
% 217.19/217.37  |- mesh__recordAuthorizer mesh__D008104 sjn
% 217.19/217.37  |- rdf__type mesh__D008104sskos__Concept
% 217.19/217.37  |- skos__scopeNote mesh__D008104
% 217.19/217.37       FIBROSIS of the hepatic parenchyma due to chronic excess ALCOHOL DRINKING.%A%    
% 217.19/217.37  |- skos__hiddenLabel mesh__D008104 Alcoholic Liver Cirrhosis
% 217.19/217.37  |- mesh__dateRevised mesh__D008104 2004-07-07
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D008104 2006
% 217.19/217.37  |- skos__prefLabel mesh__D008104 Liver Cirrhosis, Alcoholic
% 217.19/217.37  |- skos__historyNote mesh__D008104 Alcoholism %28%1966-1977%29%
% 217.19/217.37  |- mesh__dateCreated mesh__D008104 1977-03-29
% 217.19/217.37  |- mesh__publicMeSHNote mesh__D008104 78   
% 217.19/217.37  |- skos__broader mesh__D008104smesh__D008108
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D008104 2005
% 217.19/217.37  |- skos__altLabel mesh__D008104 Hepatic Cirrhosis, Alcoholic
% 217.19/217.37  |- skos__broader mesh__D008104smesh__D008103
% 217.19/217.37  |- mesh__recordOriginator mesh__D008104 SMH
% 217.19/217.37  |- mesh__historyNote mesh__D008104 78   
% 217.19/217.37  |- mesh__recordMaintainer mesh__D008104 lkt
% 217.19/217.37  |- skos__hiddenLabel mesh__D008104 Alcoholic Hepatic Cirrhosis
% 217.19/217.37  |- skos__altLabel mesh__D008104 Alcoholic Cirrhosis
% 217.19/217.37  |- mesh__dateEstablished mesh__D008104 1978-01-01
% 217.19/217.37  |- skos__hiddenLabel mesh__D000121 Oxyindol O Methyltransferase
% 217.19/217.37  |- skos__hiddenLabel mesh__D000121 Acetylserotonin N Methyltransferase
% 217.19/217.37  |- skos__scopeNote mesh__D000121
% 217.19/217.37       An enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine to N-acetylserotonin to form N-acetyl-5-methoxytryptamine %28%MELATONIN%29%. EC 2.1.1.4.%A%    
% 217.19/217.37  |- rdf__type mesh__D000121sskos__Concept
% 217.19/217.37  |- skos__altLabel mesh__D000121 Oxyindol-O-Methyltransferase
% 217.19/217.37  |- skos__annotation mesh__D000121 DF: HIOMT   
% 217.19/217.37  |- mesh__dateRevised mesh__D000121 2003-07-09
% 217.19/217.37  |- mesh__recordOriginator mesh__D000121 NLM
% 217.19/217.37  |- skos__broader mesh__D000121smesh__D008780
% 217.19/217.37  |- mesh__historyNote mesh__D000121 98%28%75%29%   
% 217.19/217.37  |- skos__historyNote mesh__D000121 Methyltransferases %28%1974%29%
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D000121 2004
% 217.19/217.37  |- skos__hiddenLabel mesh__D000121 Hydroxyindole O Methyltransferase
% 217.19/217.37  |- skos__hiddenLabel mesh__D000121 O-Methyltransferase, Hydroxyindole
% 217.19/217.37  |- mesh__recordAuthorizer mesh__D000121 sjn
% 217.19/217.37  |- mesh__dateCreated mesh__D000121 1974-11-11
% 217.19/217.37  |- mesh__publicMeSHNote mesh__D000121
% 217.19/217.37       98; see ACETYLSEROTONIN METHYLTRANSFERASE 1991-97; see METHYLTRANSFERASES 1975-90%A%  
% 217.19/217.37  |- skos__hiddenLabel mesh__D000121 N-Methyltransferase, Acetylserotonin
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D000121 2006
% 217.19/217.37  |- skos__altLabel mesh__D000121 Acetylserotonin Methyltransferase
% 217.19/217.37  |- skos__prefLabel mesh__D000121 Acetylserotonin N-Methyltransferase
% 217.19/217.37  |- mesh__dateEstablished mesh__D000121 1991-01-01
% 217.19/217.37  |- skos__altLabel mesh__D000121 Hydroxyindole O-Methyltransferase
% 217.19/217.37  |- skos__historyNote mesh__D000121 Serotonin %28%1974%29%
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D000121 2005
% 217.19/217.37  |- mesh__recordMaintainer mesh__D000121 ssb
% 217.19/217.37  |- skos__hiddenLabel mesh__D000121 Methyltransferase, Acetylserotonin
% 217.19/217.37  |- skos__scopeNote mesh__D013847
% 217.19/217.37       A dopamine antagonist that is particularly useful in treating the nausea and vomiting associated with anesthesia, mildly emetic cancer chemotherapy agents, radiation therapy, and toxins. This piperazine phenothiazine does not prevent vertigo or motion sickness. %28%From AMA Drug Evaluations Annual, 1994, p457%29%%A%    
% 217.19/217.37  |- skos__broader mesh__D013847smesh__D010640
% 217.19/217.37  |- mesh__dateCreated mesh__D013847 1999-01-01
% 217.19/217.37  |- skos__hiddenLabel mesh__D013847 Malate, Thiethylperazine
% 217.19/217.37  |- mesh__publicMeSHNote mesh__D013847 65   
% 217.19/217.37  |- skos__broader mesh__D013847smesh__D010879
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D013847 2006
% 217.19/217.37  |- mesh__dateEstablished mesh__D013847 1965-01-01
% 217.19/217.37  |- mesh__dateRevised mesh__D013847 2005-06-30
% 217.19/217.37  |- mesh__recordMaintainer mesh__D013847 ssb
% 217.19/217.37  |- rdf__type mesh__D013847sskos__Concept
% 217.19/217.37  |- mesh__historyNote mesh__D013847 65%28%63%29%   
% 217.19/217.37  |- skos__prefLabel mesh__D013847 Thiethylperazine
% 217.19/217.37  |- mesh__recordAuthorizer mesh__D013847 sjn
% 217.19/217.37  |- mesh__recordOriginator mesh__D013847 NLM
% 217.19/217.37  |- skos__broader mesh__D013049smesh__D008565
% 217.19/217.37  |- skos__hiddenLabel mesh__D013049 alpha Spectrin
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D013049 1996
% 217.19/217.37  |- mesh__recordOriginator mesh__D013049 RLS
% 217.19/217.37  |- skos__broader mesh__D013049smesh__D001798
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D013049 2000
% 217.19/217.37  |- skos__scopeNote mesh__D013049
% 217.19/217.37       A high molecular weight %28%220-250 kDa%29% water-soluble protein which can be extracted from erythrocyte ghosts in low ionic strength buffers. The protein contains no lipids or carbohydrates, is the predominant species of peripheral erythrocyte membrane proteins, and exists as a fibrous coating on the inner, cytoplasmic surface of the membrane.%A%    
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D013049 1998
% 217.19/217.37  |- mesh__recordAuthorizer mesh__D013049 PLS
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D013049 1997
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D013049 2001
% 217.19/217.37  |- mesh__dateCreated mesh__D013049 1976-04-16
% 217.19/217.37  |- mesh__historyNote mesh__D013049
% 217.19/217.37       84%28%77%29%; was see under MEMBRANE PROTEINS 1978-83, was see under BLOOD PROTEINS 1977%A%  
% 217.19/217.37  |- skos__broader mesh__D013049smesh__D003598
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D013049 1999
% 217.19/217.37  |- skos__annotation mesh__D013049
% 217.19/217.37       from erythrocytes; /biosyn /physiol permitted   
% 217.19/217.37  |- mesh__dateEstablished mesh__D013049 1984-01-01
% 217.19/217.37  |- rdf__type mesh__D013049sskos__Concept
% 217.19/217.37  |- mesh__dateRevised mesh__D013049 1995-06-08
% 217.19/217.37  |- mesh__publicMeSHNote mesh__D013049
% 217.19/217.37       84; was see under MEMBRANE PROTEINS 1978-83, was see under BLOOD PROTEINS 1977%A%  
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D013049 2003
% 217.19/217.37  |- skos__prefLabel mesh__D013049 Spectrin
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D013049 2005
% 217.19/217.37  |- skos__historyNote mesh__D013049 Erythrocytes %28%1966-1975%29%
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D013049 2004
% 217.19/217.37  |- mesh__recordMaintainer mesh__D013049 KEV
% 217.19/217.37  |- skos__hiddenLabel mesh__D013049 beta Spectrin
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D013049 2002
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D013049 2006
% 217.19/217.37  |- skos__historyNote mesh__D013049 Blood Proteins %28%1966-1976%29%
% 217.19/217.37  |- skos__historyNote mesh__D013049 Cell Membrane %28%1966-1975%29%
% 217.19/217.37  |- skos__hiddenLabel mesh__D018532 Pea
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D018532 2006
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D018532 2005
% 217.19/217.37  |- skos__prefLabel mesh__D018532 Peas
% 217.19/217.37  |- mesh__recordAuthorizer mesh__D018532 sjn
% 217.19/217.37  |- rdf__type mesh__D018532sskos__Concept
% 217.19/217.37  |- mesh__dateRevised mesh__D018532 2004-07-07
% 217.19/217.37  |- mesh__historyNote mesh__D018532 95; was see LEGUMES 1978-94   
% 217.19/217.37  |- mesh__onlineNote mesh__D018532 use LEGUMES to search PEAS 1978-94   
% 217.19/217.37  |- mesh__dateCreated mesh__D018532 1994-06-07
% 217.19/217.37  |- skos__broader mesh__D018532smesh__D007887
% 217.19/217.37  |- mesh__publicMeSHNote mesh__D018532 95; was see LEGUMES 1978-94   
% 217.19/217.37  |- mesh__recordOriginator mesh__D018532 JLS
% 217.19/217.37  |- skos__historyNote mesh__D018532 Legumes %28%1978-1994%29%
% 217.19/217.37  |- mesh__dateEstablished mesh__D018532 1995-01-01
% 217.19/217.37  |- skos__annotation mesh__D018532
% 217.19/217.37       as plant %26% food; selected qualif from Cat B6 %26% Cat J2   
% 217.19/217.37  |- mesh__recordMaintainer mesh__D018532 ssb
% 217.19/217.37  |- skos__scopeNote mesh__D018532
% 217.19/217.37       A variable annual leguminous vine %28%Pisum sativum%29% that is cultivated for its rounded smooth or wrinkled edible protein-rich seeds, the seed of the pea, and the immature pods with their included seeds. %28%From Webster%27%s New Collegiate Dictionary, 1973%29%%A%    
% 217.19/217.37  |- mesh__dateEstablished mesh__D051966 2006-01-01
% 217.19/217.37  |- skos__hiddenLabel mesh__D051966 PLC gamma
% 217.19/217.37  |- mesh__recordMaintainer mesh__D051966 AKE
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D051966 2006
% 217.19/217.37  |- mesh__dateCreated mesh__D051966 2005-06-30
% 217.19/217.37  |- skos__altLabel mesh__D051966 PLC-gamma D
% 217.19/217.37  |- skos__broader mesh__D051966smesh__D047908
% 217.19/217.37  |- skos__altLabel mesh__D051966 Phospholipase C gamma2
% 217.19/217.37  |- skos__scopeNote mesh__D051966
% 217.19/217.37       A phospholipase C that is activated in response to growth factor stimulation and TYROSINE phosphorylation. Isoforms of this enzyme are critical for the generation of CALCIUM signals in HEMATOPOIETIC SYSTEMS in response to the stimulation of immune receptors.%A%    
% 217.19/217.37  |- skos__altLabel mesh__D051966 Phospholipase C gamma1
% 217.19/217.37  |- rdf__type mesh__D051966sskos__Concept
% 217.19/217.37  |- skos__altLabel mesh__D051966 PLC-gamma 2
% 217.19/217.37  |- skos__altLabel mesh__D051966 PLCgamma2
% 217.19/217.37  |- mesh__recordOriginator mesh__D051966 AKE
% 217.19/217.37  |- skos__hiddenLabel mesh__D051966 PLC gamma 2
% 217.19/217.37  |- skos__hiddenLabel mesh__D051966 PLC gamma D
% 217.19/217.37  |- skos__altLabel mesh__D051966 PLC gamma1
% 217.19/217.37  |- skos__prefLabel mesh__D051966 Phospholipase C gamma
% 217.19/217.37  |- skos__altLabel mesh__D051966 PLC-gamma
% 217.19/217.37  |- skos__altLabel mesh__D051966 Phospholipase C gammaD
% 217.19/217.37  |- skos__broader mesh__D051966smesh__D010738
% 217.19/217.37  |- mesh__historyNote mesh__D051966 2006%28%1994%29%   
% 217.19/217.37  |- mesh__recordAuthorizer mesh__D051966 sjn
% 217.19/217.37  |- mesh__publicMeSHNote mesh__D051966
% 217.19/217.37       2006; PHOSPHOLIPASE C GAMMA was indexed under PHOSPHOLIPASE C 1994-2005%A%  
% 217.19/217.37  |- skos__altLabel mesh__D004512 Education, Pharmaceutical
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D004512 2002
% 217.19/217.37  |- mesh__dateCreated mesh__D004512 1999-01-01
% 217.19/217.37  |- mesh__dateRevised mesh__D004512 1999-11-03
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D004512 2004
% 217.19/217.37  |- skos__hiddenLabel mesh__D004512 Pharmaceutical Education
% 217.19/217.37  |- skos__hiddenLabel mesh__D004512 Pharmaceutic Education
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D004512 2003
% 217.19/217.37  |- mesh__recordMaintainer mesh__D004512 kle
% 217.19/217.37  |- skos__annotation mesh__D004512 DF: EDUC PHARM   
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D004512 2001
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D004512 2006
% 217.19/217.37  |- mesh__recordAuthorizer mesh__D004512 sjn
% 217.19/217.37  |- skos__scopeNote mesh__D004512
% 217.19/217.37       Formal instruction, learning, or training in the preparation, dispensing, and proper utilization of drugs in the field of medicine.%A%    
% 217.19/217.37  |- skos__altLabel mesh__D004512 Education, Pharmaceutic
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D004512 2000
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D004512 2005
% 217.19/217.37  |- skos__broader mesh__D004512smesh__D004517
% 217.19/217.37  |- rdf__type mesh__D004512sskos__Concept
% 217.19/217.37  |- mesh__recordOriginator mesh__D004512 NLM
% 217.19/217.37  |- skos__prefLabel mesh__D004512 Education, Pharmacy
% 217.19/217.37  |- skos__altLabel mesh__D004512 Pharmacy Education
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D028162 2006
% 217.19/217.37  |- mesh__recordOriginator mesh__D028162 ssb
% 217.19/217.37  |- mesh__historyNote mesh__D028162 2002   
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D028162 2002
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D028162 2003
% 217.19/217.37  |- skos__prefLabel mesh__D028162 Heliotropium
% 217.19/217.37  |- skos__historyNote mesh__D028162 Valerian %28%1986-2001%29%
% 217.19/217.37  |- mesh__recordMaintainer mesh__D028162 jls
% 217.19/217.37  |- skos__altLabel mesh__D028162 Heliotrope, True
% 217.19/217.37  |- mesh__publicMeSHNote mesh__D028162 2002   
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D028162 2004
% 217.19/217.37  |- skos__broader mesh__D028162smesh__D028082
% 217.19/217.37  |- mesh__dateCreated mesh__D028162 2001-08-03
% 217.19/217.37  |- mesh__recordAuthorizer mesh__D028162 sjn
% 217.19/217.37  |- skos__scopeNote mesh__D028162
% 217.19/217.37       A plant genus in the family Boraginaceae, order Lamiales, subclass Asteridae. This is the True Heliotrope that should not be confused with an unrelated plant sometimes called Garden Heliotrope %28%VALERIAN%29%.%A%    
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D028162 2005
% 217.19/217.37  |- rdf__type mesh__D028162sskos__Concept
% 217.19/217.37  |- skos__annotation mesh__D028162
% 217.19/217.37       distinguish from PHOTOTROPISM and VALERIAN; specify Plant Components; for /Chem coord with D tree compound and/or Preparation; for therap. coordinate with Diseases and PHYTOTHERAPY%A%  
% 217.19/217.37  |- mesh__dateEstablished mesh__D028162 2002-01-01
% 217.19/217.37  |- rdf__type mesh__D014940sskos__Concept
% 217.19/217.37  |- skos__historyNote mesh__D014940 Occupational Medicine %28%1966-1982%29%
% 217.19/217.37  |- mesh__recordAuthorizer mesh__D014940 sjn
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014940 2006
% 217.19/217.37  |- skos__prefLabel mesh__D014940 Work Schedule Tolerance
% 217.19/217.37  |- skos__hiddenLabel mesh__D014940 Tolerances, Work Schedule
% 217.19/217.37  |- skos__hiddenLabel mesh__D014940 Tolerance, Work Schedule
% 217.19/217.37  |- mesh__dateEstablished mesh__D014940 1991-01-01
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014940 2002
% 217.19/217.37  |- mesh__recordMaintainer mesh__D014940 KEV
% 217.19/217.37  |- mesh__dateCreated mesh__D014940 1982-04-28
% 217.19/217.37  |- skos__scopeNote mesh__D014940
% 217.19/217.37       Physiological or psychological effects of periods of work which may be fixed or flexible such as flexitime, work shifts, and rotating shifts.%A%    
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014940 2005
% 217.19/217.37  |- skos__broader mesh__D014940smesh__D014937
% 217.19/217.37  |- skos__hiddenLabel mesh__D014940 Schedule Tolerance, Work
% 217.19/217.37  |- skos__hiddenLabel mesh__D014940 Work Schedule Tolerances
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014940 2001
% 217.19/217.37  |- skos__annotation mesh__D014940 /physiol /psychol permitted   
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014940 2004
% 217.19/217.37  |- skos__hiddenLabel mesh__D014940 Schedule Tolerances, Work
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014940 2000
% 217.19/217.37  |- skos__historyNote mesh__D014940 Circadian Rhythm %28%1966-1982%29%
% 217.19/217.37  |- mesh__recordOriginator mesh__D014940 EC
% 217.19/217.37  |- mesh__publicMeSHNote mesh__D014940 91; was see under WORK 1983-90   
% 217.19/217.37  |- skos__historyNote mesh__D014940 Work %28%1966-1982%29%
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014940 2003
% 217.19/217.37  |- skos__related mesh__D014940smesh__D020178
% 217.19/217.37  |- mesh__dateRevised mesh__D014940 1999-11-09
% 217.19/217.37  |- mesh__historyNote mesh__D014940
% 217.19/217.37       91%28%83%29%; was see under WORK 1983-90   
% 217.19/217.37  |- skos__broader mesh__D000013Q000139smesh__D000013
% 217.19/217.37  |- mesh__preferredCombination mesh__D000013Q000139smesh__D000014
% 217.19/217.37  |- rdf__type mesh__D000013Q000139smesh__CompoundConcept
% 217.19/217.37  |- mesh__dateEstablished mesh__D014142 1976-01-01
% 217.19/217.37  |- rdf__type mesh__D014142sskos__Concept
% 217.19/217.37  |- skos__hiddenLabel mesh__D014142 Tracks
% 217.19/217.37  |- mesh__recordAuthorizer mesh__D014142 PLS
% 217.19/217.37  |- skos__prefLabel mesh__D014142 Track and Field
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014142 2005
% 217.19/217.37  |- mesh__dateRevised mesh__D014142 1996-06-10
% 217.19/217.37  |- skos__historyNote mesh__D014142 Sports %28%1966-1975%29%
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014142 2000
% 217.19/217.37  |- skos__hiddenLabel mesh__D014142 Field and Track
% 217.19/217.37  |- skos__scopeNote mesh__D014142
% 217.19/217.37       Sports performed on a track, field, or arena and including running events and other competitions, such as the pole vault, shot put, etc.%A%    
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014142 2003
% 217.19/217.37  |- skos__annotation mesh__D014142
% 217.19/217.37       /inj: coord IM with specific inj %28%IM%29%; /physiol permitted; DF: TRACK%A%  
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014142 2006
% 217.19/217.37  |- mesh__recordMaintainer mesh__D014142 TGC
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014142 2001
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014142 1998
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014142 2004
% 217.19/217.37  |- mesh__recordOriginator mesh__D014142 JW
% 217.19/217.37  |- skos__related mesh__D014142smesh__D012420
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014142 2002
% 217.19/217.37  |- mesh__publicMeSHNote mesh__D014142 76   
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014142 1999
% 217.19/217.37  |- mesh__historyNote mesh__D014142 76   
% 217.19/217.37  |- mesh__dateCreated mesh__D014142 1975-07-23
% 217.19/217.37  |- skos__broader mesh__D014142smesh__D013177
% 217.19/217.37  |- mesh__activeMeSHYear mesh__D014142 1997
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D008903 2005
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D008903 2004
% 217.19/217.38  |- skos__prefLabel mesh__D008903 Minerals
% 217.19/217.38  |- skos__broader mesh__D008903smesh__D007287
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D008903 2001
% 217.19/217.38  |- skos__annotation mesh__D008903
% 217.19/217.38       GEN: prefer specifics; trace minerals = TRACE ELEMENTS; %22%bone minerals%22% = MINERALS %28%IM%29% + BONE AND BONES %28%IM%29%%A%  
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D008903 2006
% 217.19/217.38  |- mesh__historyNote mesh__D008903
% 217.19/217.38       /metabolism was MINERAL METABOLISM 1963-65   
% 217.19/217.38  |- rdf__type mesh__D008903sskos__Concept
% 217.19/217.38  |- mesh__dateRevised mesh__D008903 1995-03-17
% 217.19/217.38  |- mesh__publicMeSHNote mesh__D008903
% 217.19/217.38       /metabolism was MINERAL METABOLISM 1963-65   
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D008903 1996
% 217.19/217.38  |- skos__scopeNote mesh__D008903
% 217.19/217.38       Native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions. They may occur as individual crystals or may be disseminated in some other mineral or rock. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D008903 2002
% 217.19/217.38  |- mesh__recordAuthorizer mesh__D008903 PLS
% 217.19/217.38  |- mesh__recordOriginator mesh__D008903 NLM
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D008903 1998
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D008903 1997
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D008903 2003
% 217.19/217.38  |- mesh__recordMaintainer mesh__D008903 TGC
% 217.19/217.38  |- mesh__dateCreated mesh__D008903 1999-01-01
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D008903 2000
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D008903 1999
% 217.19/217.38  |- skos__hiddenLabel mesh__D000920 Cytotoxicity, Antibody Dependent Cell
% 217.19/217.38  |- mesh__recordMaintainer mesh__D000920 sjn
% 217.19/217.38  |- mesh__dateEstablished mesh__D000920 1978-01-01
% 217.19/217.38  |- skos__altLabel mesh__D000920 ADCC
% 217.19/217.38  |- skos__hiddenLabel mesh__D000920 Cell Cytoxicity, Antibody Dependent
% 217.19/217.38  |- mesh__dateRevised mesh__D000920 2001-08-07
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D000920 2004
% 217.19/217.38  |- skos__historyNote mesh__D000920
% 217.19/217.38       Cytotoxicity Tests, Immunologic %28%1971-1977%29%
% 217.19/217.38  |- skos__annotation mesh__D000920 DF: note short X ref   
% 217.19/217.38  |- rdf__type mesh__D000920sskos__Concept
% 217.19/217.38  |- skos__altLabel mesh__D000920 Cytotoxicity, Antibody-Dependent Cell
% 217.19/217.38  |- skos__hiddenLabel mesh__D000920 Antibody-Dependent Cell Cytoxicity
% 217.19/217.38  |- skos__hiddenLabel mesh__D000920 Antibody Dependent Cell Cytotoxicity
% 217.19/217.38  |- mesh__dateCreated mesh__D000920 1977-05-13
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D000920 2003
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D000920 2006
% 217.19/217.38  |- mesh__recordAuthorizer mesh__D000920 sjn
% 217.19/217.38  |- skos__hiddenLabel mesh__D000920 Cell Cytotoxicity, Antibody-Dependent
% 217.19/217.38  |- mesh__publicMeSHNote mesh__D000920 78   
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D000920 2002
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D000920 2005
% 217.19/217.38  |- skos__hiddenLabel mesh__D000920 Antibody-Dependent Cell Cytotoxicities
% 217.19/217.38  |- skos__hiddenLabel mesh__D000920 Cell Cytoxicities, Antibody-Dependent
% 217.19/217.38  |- skos__hiddenLabel mesh__D000920 Cytoxicities, Antibody-Dependent Cell
% 217.19/217.38  |- skos__scopeNote mesh__D000920
% 217.19/217.38       The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a %22%killer%22% cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent.%A%    
% 217.19/217.38  |- skos__hiddenLabel mesh__D000920 Antibody-Dependent Cell Cytoxicities
% 217.19/217.38  |- skos__hiddenLabel mesh__D000920 Cytotoxicities, Antibody-Dependent Cell
% 217.19/217.38  |- skos__broader mesh__D000920smesh__D003602
% 217.19/217.38  |- skos__historyNote mesh__D000920 Lymphocytes %28%1966-1977%29%
% 217.19/217.38  |- mesh__recordOriginator mesh__D000920 AEP
% 217.19/217.38  |- skos__hiddenLabel mesh__D000920 Cytoxicity, Antibody-Dependent Cell
% 217.19/217.38  |- skos__hiddenLabel mesh__D000920 Cell Cytotoxicities, Antibody-Dependent
% 217.19/217.38  |- skos__altLabel mesh__D000920 Cell Cytoxicity, Antibody-Dependent
% 217.19/217.38  |- skos__prefLabel mesh__D000920 Antibody-Dependent Cell Cytotoxicity
% 217.19/217.38  |- mesh__historyNote mesh__D000920 78   
% 217.19/217.38  |- skos__historyNote mesh__D000920 Immunity, Cellular %28%1970-1977%29%
% 217.19/217.38  |- skos__hiddenLabel mesh__D008105 Obstructive Liver Cirrhosis
% 217.19/217.38  |- skos__altLabel mesh__D008105 Primary Biliary Cirrhosis
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D008105 2005
% 217.19/217.38  |- skos__altLabel mesh__D008105 Liver Cirrhosis, Obstructive
% 217.19/217.38  |- mesh__onlineNote mesh__D008105
% 217.19/217.38       use LIVER CIRRHOSIS, BILIARY to search LIVER CIRRHOSIS, OBSTRUCTIVE 1966-77%A%  
% 217.19/217.38  |- skos__altLabel mesh__D008105 Biliary Cirrhosis
% 217.19/217.38  |- skos__broader mesh__D008105smesh__D008103
% 217.19/217.38  |- mesh__publicMeSHNote mesh__D008105
% 217.19/217.38       78; was LIVER CIRRHOSIS, OBSTRUCTIVE 1963-77   
% 217.19/217.38  |- skos__altLabel mesh__D008105 Secondary Biliary Cirrhosis
% 217.19/217.38  |- mesh__recordOriginator mesh__D008105 NLM
% 217.19/217.38  |- mesh__recordAuthorizer mesh__D008105 sjn
% 217.19/217.38  |- skos__hiddenLabel mesh__D008105 Cirrhosis, Secondary Biliary
% 217.19/217.38  |- skos__altLabel mesh__D008105
% 217.19/217.38       Cholangitis, Chronic Nonsuppurative Destructive
% 217.19/217.38  |- skos__broader mesh__D008105smesh__D002780
% 217.19/217.38  |- rdf__type mesh__D008105sskos__Concept
% 217.19/217.38  |- skos__hiddenLabel mesh__D008105 Cirrhosis, Biliary
% 217.19/217.38  |- skos__prefLabel mesh__D008105 Liver Cirrhosis, Biliary
% 217.19/217.38  |- mesh__dateCreated mesh__D008105 1999-01-01
% 217.19/217.38  |- skos__scopeNote mesh__D008105
% 217.19/217.38       FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow %28%CHOLESTASIS%29% in the intrahepatic or extrahepatic bile ducts %28%BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC%29%. Primary biliary cirrhosis involves the destruction of small intra-hepatic bile ducts and bile secretion. Secondary biliary cirrhosis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes.%A%    
% 217.19/217.38  |- mesh__dateRevised mesh__D008105 2004-07-07
% 217.19/217.38  |- skos__hiddenLabel mesh__D008105 Liver Cirrhoses, Biliary
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D008105 2006
% 217.19/217.38  |- mesh__recordMaintainer mesh__D008105 lkt
% 217.19/217.38  |- mesh__historyNote mesh__D008105
% 217.19/217.38       78; was LIVER CIRRHOSIS, OBSTRUCTIVE 1963-77   
% 217.19/217.38  |- mesh__publicMeSHNote mesh__D000122 91; was see under CHOLINE 1975-90   
% 217.19/217.38  |- skos__scopeNote mesh__D000122
% 217.19/217.38       An agent used as a substrate in assays for cholinesterases, especially to discriminate among enzyme types.%A%    
% 217.19/217.38  |- mesh__dateCreated mesh__D000122 1974-11-19
% 217.19/217.38  |- mesh__recordMaintainer mesh__D000122 ssb
% 217.19/217.38  |- skos__historyNote mesh__D000122 Sulfhydryl Compounds %28%1973-1974%29%
% 217.19/217.38  |- mesh__dateRevised mesh__D000122 2005-06-30
% 217.19/217.38  |- skos__historyNote mesh__D000122 Acetylcholine %28%1972-1974%29%
% 217.19/217.38  |- skos__altLabel mesh__D000122
% 217.19/217.38       %28%2-Mercaptoethyl%29%trimethylammonium Acetate
% 217.19/217.38  |- skos__broader mesh__D000122smesh__D013860
% 217.19/217.38  |- mesh__recordOriginator mesh__D000122 NLM
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D000122 2006
% 217.19/217.38  |- mesh__dateEstablished mesh__D000122 1991-01-01
% 217.19/217.38  |- mesh__historyNote mesh__D000122
% 217.19/217.38       91%28%75%29%; was see under CHOLINE 1975-90   
% 217.19/217.38  |- skos__prefLabel mesh__D000122 Acetylthiocholine
% 217.19/217.38  |- mesh__recordAuthorizer mesh__D000122 sjn
% 217.19/217.38  |- rdf__type mesh__D000122sskos__Concept
% 217.19/217.38  |- skos__prefLabel mesh__D013848 Thigh
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D013848 2006
% 217.19/217.38  |- skos__broader mesh__D013848smesh__D035002
% 217.19/217.38  |- mesh__recordAuthorizer mesh__D013848 sjn
% 217.19/217.38  |- rdf__type mesh__D013848sskos__Concept
% 217.19/217.38  |- mesh__recordOriginator mesh__D013848 NLM
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D013848 2005
% 217.19/217.38  |- mesh__dateRevised mesh__D013848 2004-07-13
% 217.19/217.38  |- skos__related mesh__D013848smesh__D005269
% 217.19/217.38  |- skos__hiddenLabel mesh__D013848 Thighs
% 217.19/217.38  |- mesh__recordMaintainer mesh__D013848 sjn
% 217.19/217.38  |- mesh__dateCreated mesh__D013848 1999-01-01
% 217.19/217.38  |- skos__annotation mesh__D013848
% 217.19/217.38       for bone use FEMUR; NIM when merely locational as in skin dis %28%IM%29%; TN 117: use for human %26% other vertebrates%A%  
% 217.19/217.38  |- skos__broader mesh__D018533smesh__D017753
% 217.19/217.38  |- mesh__recordMaintainer mesh__D018533 nns
% 217.19/217.38  |- mesh__dateRevised mesh__D018533 2003-07-09
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D018533 2005
% 217.19/217.38  |- mesh__dateEstablished mesh__D018533 1995-01-01
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D018533 2004
% 217.19/217.38  |- rdf__type mesh__D018533sskos__Concept
% 217.19/217.38  |- skos__scopeNote mesh__D018533
% 217.19/217.38       Total mass of all the organisms of a given type and/or in a given area. %28%From Concise Dictionary of Biology, 1990%29% It includes the yield of vegetative mass produced from any given crop.%A%    
% 217.19/217.38  |- mesh__dateCreated mesh__D018533 1994-06-07
% 217.19/217.38  |- skos__hiddenLabel mesh__D018533 Biomasses
% 217.19/217.38  |- skos__prefLabel mesh__D018533 Biomass
% 217.19/217.38  |- mesh__onlineNote mesh__D018533 use ECOLOGY to search BIOMASS 1982-94   
% 217.19/217.38  |- mesh__publicMeSHNote mesh__D018533 95; was see ECOLOGY 1982-94   
% 217.19/217.38  |- mesh__historyNote mesh__D018533 95; was see ECOLOGY 1982-94   
% 217.19/217.38  |- mesh__recordOriginator mesh__D018533 JLS
% 217.19/217.38  |- mesh__recordAuthorizer mesh__D018533 sjn
% 217.19/217.38  |- skos__historyNote mesh__D018533 Ecology %28%1982-1994%29%
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D018533 2006
% 217.19/217.38  |- skos__hiddenLabel mesh__D010550 Spaces, Personal
% 217.19/217.38  |- mesh__recordAuthorizer mesh__D010550 sjn
% 217.19/217.38  |- mesh__dateCreated mesh__D010550 1999-01-01
% 217.19/217.38  |- skos__prefLabel mesh__D010550 Personal Space
% 217.19/217.38  |- mesh__recordOriginator mesh__D010550 NLM
% 217.19/217.38  |- skos__broader mesh__D010550smesh__D013037
% 217.19/217.38  |- rdf__type mesh__D010550sskos__Concept
% 217.19/217.38  |- skos__hiddenLabel mesh__D010550 Buffer Zone, Body
% 217.19/217.38  |- skos__hiddenLabel mesh__D010550 Buffer Zones, Body
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D010550 2005
% 217.19/217.38  |- skos__scopeNote mesh__D010550
% 217.19/217.38       Invisible boundaries surrounding the individual%27%s body which are maintained in relation to others.%A%    
% 217.19/217.38  |- mesh__onlineNote mesh__D010550
% 217.19/217.38       use SPATIAL BEHAVIOR to search PERSONAL SPACE 1974; use PERSONAL SPACE to search BODY BUFFER ZONE 1975-78, use SPATIAL BEHAVIOR 1974%A%  
% 217.19/217.38  |- skos__hiddenLabel mesh__D010550 Personal Spaces
% 217.19/217.38  |- mesh__recordMaintainer mesh__D010550 TGC
% 217.19/217.38  |- mesh__dateEstablished mesh__D010550 1991-01-01
% 217.19/217.38  |- skos__hiddenLabel mesh__D010550 Space Privacy
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D010550 2006
% 217.19/217.38  |- skos__hiddenLabel mesh__D010550 Zones, Body Buffer
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D010550 2003
% 217.19/217.38  |- mesh__publicMeSHNote mesh__D010550
% 217.19/217.38       91; was see under SPATIAL BEHAVIOR 1974-90; BODY BUFFER ZONE was see under SPATIAL BEHAVIOR 1974-78%A%  
% 217.19/217.38  |- skos__hiddenLabel mesh__D010550 Zone, Body Buffer
% 217.19/217.38  |- skos__altLabel mesh__D010550 Privacy of Space
% 217.19/217.38  |- skos__hiddenLabel mesh__D010550 Space, Personal
% 217.19/217.38  |- skos__hiddenLabel mesh__D010550 Body Buffer Zones
% 217.19/217.38  |- skos__altLabel mesh__D010550 Body Buffer Zone
% 217.19/217.38  |- skos__annotation mesh__D010550 no qualif   
% 217.19/217.38  |- mesh__dateRevised mesh__D010550 2002-07-02
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D010550 2004
% 217.19/217.38  |- mesh__historyNote mesh__D010550
% 217.19/217.38       91%28%75%29%; was see under SPATIAL BEHAVIOR 1974-90; BODY BUFFER ZONE was see under SPATIAL BEHAVIOR 1974-78%A%  
% 217.19/217.38  |- skos__altLabel mesh__D004513 Education, Pharmaceutical, Continuing
% 217.19/217.38  |- mesh__historyNote mesh__D004513 68   
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D004513 2003
% 217.19/217.38  |- skos__altLabel mesh__D004513 Pharmacy Education, Continuing
% 217.19/217.38  |- skos__altLabel mesh__D004513 Education, Continuing Pharmacy
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D004513 2000
% 217.19/217.38  |- skos__altLabel mesh__D004513 Pharmaceutic Education, Continuing
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D004513 2006
% 217.19/217.38  |- mesh__recordOriginator mesh__D004513 NLM
% 217.19/217.38  |- skos__historyNote mesh__D004513 Education, Pharmacy %28%1966-1967%29%
% 217.19/217.38  |- skos__altLabel mesh__D004513 Continuing Pharmacy Education
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D004513 2005
% 217.19/217.38  |- mesh__dateRevised mesh__D004513 1999-11-03
% 217.19/217.38  |- skos__broader mesh__D004513smesh__D004512
% 217.19/217.38  |- skos__broader mesh__D004513smesh__D004496
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D004513 2002
% 217.19/217.38  |- rdf__type mesh__D004513sskos__Concept
% 217.19/217.38  |- skos__annotation mesh__D004513
% 217.19/217.38       differentiate from EDUCATION, PHARMACY, GRADUATE: see note on EDUCATION, CONTINUING; DF: EDUC PHARM CONTINUING%A%  
% 217.19/217.38  |- skos__altLabel mesh__D004513 Pharmaceutical Education, Continuing
% 217.19/217.38  |- mesh__dateEstablished mesh__D004513 1968-01-01
% 217.19/217.38  |- skos__hiddenLabel mesh__D004513 Continuing Pharmaceutic Education
% 217.19/217.38  |- skos__hiddenLabel mesh__D004513 Education, Continuing Pharmaceutical
% 217.19/217.38  |- mesh__publicMeSHNote mesh__D004513 68   
% 217.19/217.38  |- skos__scopeNote mesh__D004513
% 217.19/217.38       Educational programs designed to inform graduate pharmacists of recent advances in their particular field.%A%    
% 217.19/217.38  |- skos__prefLabel mesh__D004513 Education, Pharmacy, Continuing
% 217.19/217.38  |- mesh__dateCreated mesh__D004513 1999-01-01
% 217.19/217.38  |- skos__hiddenLabel mesh__D004513 Continuing Pharmaceutical Education
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D004513 2004
% 217.19/217.38  |- mesh__recordMaintainer mesh__D004513 kle
% 217.19/217.38  |- skos__hiddenLabel mesh__D004513 Education, Continuing Pharmaceutic
% 217.19/217.38  |- skos__altLabel mesh__D004513 Education, Pharmaceutic, Continuing
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D004513 2001
% 217.19/217.38  |- mesh__recordAuthorizer mesh__D004513 sjn
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D028961 2006
% 217.19/217.38  |- skos__altLabel mesh__D028961 Karyopherin beta
% 217.19/217.38  |- mesh__dateCreated mesh__D028961 2001-07-25
% 217.19/217.38  |- skos__altLabel mesh__D028961 Importin-beta
% 217.19/217.38  |- skos__scopeNote mesh__D028961
% 217.19/217.38       Nucleocytoplasmic transport molecules that bind to ALPHA KARYOPHERINS in the CYTOSOL and are involved in transport of molecules through the NUCLEAR PORE COMPLEX. Once inside the CELL NUCLEUS beta karyopherins interact with RAN GTP-BINDING PROTEIN and dissociate from alpha karyopherins. Beta karyopherins bound to RAN GTP-BINDING PROTEIN are then re-transported to the cytoplasm where hydrolysis of the GTP of RAN GTP-BINDING PROTEIN causes release of karyopherin beta.%A%    
% 217.19/217.38  |- skos__broader mesh__D028961smesh__D028884
% 217.19/217.38  |- skos__altLabel mesh__D028961 p92 nuclear protein
% 217.19/217.38  |- mesh__publicMeSHNote mesh__D028961
% 217.19/217.38       2002; KARYOPHERIN BETA %26% IMPORTIN-BETA were indexed under NUCLEAR PROTEINS 1995-2001%A%  
% 217.19/217.38  |- rdf__type mesh__D028961sskos__Concept
% 217.19/217.38  |- skos__hiddenLabel mesh__D028961 Importin beta
% 217.19/217.38  |- skos__altLabel mesh__D028961 beta Importins
% 217.19/217.38  |- mesh__recordOriginator mesh__D028961 jmp
% 217.19/217.38  |- mesh__dateRevised mesh__D028961 2005-06-30
% 217.19/217.38  |- mesh__dateEstablished mesh__D028961 2002-01-01
% 217.19/217.38  |- skos__altLabel mesh__D028961 Kap95 protein
% 217.19/217.38  |- skos__prefLabel mesh__D028961 beta Karyopherins
% 217.19/217.38  |- skos__hiddenLabel mesh__D028961 Importins, beta
% 217.19/217.38  |- mesh__historyNote mesh__D028961
% 217.19/217.38       2002; use BETA KARYOPHERINS %28%NM%29% 1995-2001; for IMPORTIN-BETA use KARYOPHERINS %28%NM%29% 1995-2001%A%  
% 217.19/217.38  |- skos__hiddenLabel mesh__D028961 Karyopherin beta Subunit
% 217.19/217.38  |- skos__altLabel mesh__D028961 Karyopherin-beta Subunit
% 217.19/217.38  |- skos__hiddenLabel mesh__D028961 Karyopherins, beta
% 217.19/217.38  |- mesh__recordMaintainer mesh__D028961 jmp
% 217.19/217.38  |- skos__hiddenLabel mesh__D028961 nuclear protein, p92
% 217.19/217.38  |- skos__altLabel mesh__D028961 Karyopherin-beta
% 217.19/217.38  |- skos__historyNote mesh__D028961 Nuclear Proteins %28%1995-2001%29%
% 217.19/217.38  |- mesh__recordAuthorizer mesh__D028961 sjn
% 217.19/217.38  |- mesh__recordAuthorizer mesh__D028163 sjn
% 217.19/217.38  |- mesh__recordMaintainer mesh__D028163 ssb
% 217.19/217.38  |- skos__broader mesh__D028163smesh__D014784
% 217.19/217.38  |- mesh__publicMeSHNote mesh__D028163 2002   
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D028163 2004
% 217.19/217.38  |- skos__annotation mesh__D028163
% 217.19/217.38       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.19/217.38  |- skos__scopeNote mesh__D028163
% 217.19/217.38       The Christmas Mistletoe plant family of the order Santalales, subclass Rosidae, class Magnoliopsida. They are parasitic primarily on coniferous trees forming a drooping evergreen bush of leathery leaves on tree branches. The berries are sticky and toxic.%A%    
% 217.19/217.38  |- skos__prefLabel mesh__D028163 Viscaceae
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D028163 2005
% 217.19/217.38  |- mesh__historyNote mesh__D028163 2002   
% 217.19/217.38  |- rdf__type mesh__D028163sskos__Concept
% 217.19/217.38  |- mesh__dateRevised mesh__D028163 2002-07-02
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D028163 2006
% 217.19/217.38  |- mesh__dateEstablished mesh__D028163 2002-01-01
% 217.19/217.38  |- mesh__dateCreated mesh__D028163 2001-07-25
% 217.19/217.38  |- mesh__recordOriginator mesh__D028163 ssb
% 217.19/217.38  |- skos__historyNote mesh__D028163 Viscum %28%1965-2001%29%
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D028163 2003
% 217.19/217.38  |- skos__hiddenLabel mesh__D020180 Heteroduplex Analyses
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D020180 2001
% 217.19/217.38  |- mesh__publicMeSHNote mesh__D020180 99   
% 217.19/217.38  |- skos__broader mesh__D020180smesh__D009693
% 217.19/217.38  |- skos__historyNote mesh__D020180
% 217.19/217.38       Nucleic Acid Hybridization %28%1973-1979%29%
% 217.19/217.38  |- mesh__historyNote mesh__D020180 99   
% 217.19/217.38  |- skos__related mesh__D020180smesh__D020137
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D020180 1999
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D020180 2002
% 217.19/217.38  |- mesh__dateEstablished mesh__D020180 1999-01-01
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D020180 2003
% 217.19/217.38  |- skos__prefLabel mesh__D020180 Heteroduplex Analysis
% 217.19/217.38  |- skos__historyNote mesh__D020180
% 217.19/217.38       Nucleic Acid Heteroduplexes %28%1980-1998%29%
% 217.19/217.38  |- rdf__type mesh__D020180sskos__Concept
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D020180 2004
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D020180 2005
% 217.19/217.38  |- mesh__dateCreated mesh__D020180 1998-06-10
% 217.19/217.38  |- skos__scopeNote mesh__D020180
% 217.19/217.38       A method of detecting gene mutation by mixing PCR-amplified mutant and wild-type DNA followed by denaturation and reannealing. The resultant products are resolved by gel electrophoresis, with single base substitutions detectable under optimal electrophoretic conditions and gel formulations. Large base pair mismatches may also be analyzed by using electron microscopy to visualize heteroduplex regions.%A%    
% 217.19/217.38  |- skos__related mesh__D020180smesh__D009692
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D020180 2000
% 217.19/217.38  |- skos__hiddenLabel mesh__D020180 Analyses, Heteroduplex
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D020180 2006
% 217.19/217.38  |- skos__hiddenLabel mesh__D020180 Analysis, Heteroduplex
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D014941 1998
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D014941 2006
% 217.19/217.38  |- skos__annotation mesh__D014941 no qualif   
% 217.19/217.38  |- skos__historyNote mesh__D014941 Efficiency %28%1966-1974%29%
% 217.19/217.38  |- mesh__recordMaintainer mesh__D014941 JLS
% 217.19/217.38  |- skos__historyNote mesh__D014941
% 217.19/217.38       Task Performance and Analysis %28%1972-1974%29%
% 217.19/217.38  |- skos__hiddenLabel mesh__D014941 Work Simplifications
% 217.19/217.38  |- mesh__onlineNote mesh__D014941
% 217.19/217.38       search EFFICIENCY %26% TASK PERFORMANCE AND ANALYSIS 1974 %26% EFFICIENCY 1970-73%A%  
% 217.19/217.38  |- mesh__recordOriginator mesh__D014941 NLM
% 217.19/217.38  |- skos__hiddenLabel mesh__D014941 Simplifications, Work
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D014941 2005
% 217.19/217.38  |- skos__broader mesh__D014941smesh__D013647
% 217.19/217.38  |- skos__hiddenLabel mesh__D014941 Simplification, Work
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D014941 2004
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D014941 2002
% 217.19/217.38  |- mesh__dateCreated mesh__D014941 1999-01-01
% 217.19/217.38  |- mesh__recordAuthorizer mesh__D014941 SJN
% 217.19/217.38  |- skos__prefLabel mesh__D014941 Work Simplification
% 217.19/217.38  |- mesh__publicMeSHNote mesh__D014941
% 217.19/217.38       75; was see under EFFICIENCY 1970-73, was see under EFFICIENCY %26% TASK PERFORMANCE AND ANALYSIS 1974%A%  
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D014941 2003
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D014941 2001
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D014941 1999
% 217.19/217.38  |- rdf__type mesh__D014941sskos__Concept
% 217.19/217.38  |- mesh__dateRevised mesh__D014941 1997-06-20
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D014941 2000
% 217.19/217.38  |- mesh__dateEstablished mesh__D014941 1975-01-01
% 217.19/217.38  |- mesh__historyNote mesh__D014941
% 217.19/217.38       75; was see under EFFICIENCY 1970-73, was see under EFFICIENCY %26% TASK PERFORMANCE AND ANALYSIS 1974%A%  
% 217.19/217.38  |- skos__scopeNote mesh__D014941
% 217.19/217.38       The construction or arrangement of a task so that it may be done with the greatest possible efficiency.%A%    
% 217.19/217.38  |- mesh__recordAuthorizer mesh__D014143 SJN
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D014143 2005
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D014143 2003
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D014143 2006
% 217.19/217.38  |- mesh__dateCreated mesh__D014143 1999-01-01
% 217.19/217.38  |- skos__prefLabel mesh__D014143 Traction
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D014143 1998
% 217.19/217.38  |- skos__scopeNote mesh__D014143
% 217.19/217.38       The pull on a limb or a part thereof. Skin traction %28%indirect traction%29% is applied by using a bandage to pull on the skin and fascia where light traction is required. Skeletal traction %28%direct traction%29%, however, uses pins or wires inserted through bone and is attached to weights, pulleys, and ropes. %28%From Blauvelt %26% Nelson, A Manual of Orthopaedic Terminology, 5th ed%29%%A%    
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D014143 2004
% 217.19/217.38  |- skos__broader mesh__D014143smesh__D019637
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D014143 2000
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D014143 1999
% 217.19/217.38  |- skos__hiddenLabel mesh__D014143 Tractions
% 217.19/217.38  |- mesh__recordMaintainer mesh__D014143 PXP
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D014143 2001
% 217.19/217.38  |- rdf__type mesh__D014143sskos__Concept
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D014143 2002
% 217.19/217.38  |- mesh__recordOriginator mesh__D014143 NLM
% 217.19/217.38  |- mesh__dateRevised mesh__D014143 1997-06-20
% 217.19/217.38  |- skos__related mesh__D008904smesh__D008832
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D008904 2004
% 217.19/217.38  |- mesh__recordOriginator mesh__D008904 NLM
% 217.19/217.38  |- skos__hiddenLabel mesh__D008904 Miniaturizations
% 217.19/217.38  |- mesh__dateRevised mesh__D008904 2002-07-03
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D008904 2003
% 217.19/217.38  |- mesh__dateEstablished mesh__D008904 1991-01-01
% 217.19/217.38  |- mesh__dateCreated mesh__D008904 1999-01-01
% 217.19/217.38  |- mesh__publicMeSHNote mesh__D008904
% 217.19/217.38       91; was see under ELECTRONICS 1966-90   
% 217.19/217.38  |- mesh__historyNote mesh__D008904
% 217.19/217.38       91%28%66%29%; was see under ELECTRONICS 1966-90   
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D008904 2006
% 217.19/217.38  |- skos__broader mesh__D008904smesh__D013672
% 217.19/217.38  |- skos__altLabel mesh__D008904 Miniaturisation
% 217.19/217.38  |- rdf__type mesh__D008904sskos__Concept
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D008904 2005
% 217.19/217.38  |- skos__prefLabel mesh__D008904 Miniaturization
% 217.19/217.38  |- skos__scopeNote mesh__D008904
% 217.19/217.38       The design or construction of objects greatly reduced in scale.%A%    
% 217.19/217.38  |- skos__hiddenLabel mesh__D008904 Miniaturisations
% 217.19/217.38  |- mesh__recordMaintainer mesh__D008904 nns
% 217.19/217.38  |- mesh__recordAuthorizer mesh__D008904 sjn
% 217.19/217.38  |- skos__hiddenLabel mesh__D000921 Cells, Immunoglobulin-Secreting
% 217.19/217.38  |- rdf__type mesh__D000921sskos__Concept
% 217.19/217.38  |- skos__hiddenLabel mesh__D000921 Cell, Immunoglobulin-Producing
% 217.19/217.38  |- mesh__historyNote mesh__D000921 72%28%70%29%   
% 217.19/217.38  |- skos__hiddenLabel mesh__D000921 Antibody Producing Cells
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D000921 2006
% 217.19/217.38  |- mesh__publicMeSHNote mesh__D000921 72   
% 217.19/217.38  |- mesh__recordOriginator mesh__D000921 NLM
% 217.19/217.38  |- mesh__dateEstablished mesh__D000921 1972-01-01
% 217.19/217.38  |- skos__related mesh__D000921smesh__D006462
% 217.19/217.38  |- mesh__recordMaintainer mesh__D000921 jmp
% 217.19/217.38  |- skos__broader mesh__D000921smesh__D007107
% 217.19/217.38  |- mesh__dateRevised mesh__D000921 2003-07-09
% 217.19/217.38  |- skos__hiddenLabel mesh__D000921 Immunoglobulin-Secreting Cell
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D000921 2005
% 217.19/217.38  |- skos__hiddenLabel mesh__D000921 Immunoglobulin Secreting Cells
% 217.19/217.38  |- skos__hiddenLabel mesh__D000921 Cells, Immunoglobulin-Producing
% 217.19/217.38  |- skos__prefLabel mesh__D000921 Antibody-Producing Cells
% 217.19/217.38  |- skos__annotation mesh__D000921 A 11 qualif   
% 217.19/217.38  |- skos__historyNote mesh__D000921 Antibody Formation %28%1966-1969%29%
% 217.19/217.38  |- skos__hiddenLabel mesh__D000921 Cells, Antibody-Producing
% 217.19/217.38  |- skos__hiddenLabel mesh__D000921 Cell, Immunoglobulin-Secreting
% 217.19/217.38  |- mesh__recordAuthorizer mesh__D000921 sjn
% 217.19/217.38  |- skos__altLabel mesh__D000921 Immunoglobulin-Producing Cells
% 217.19/217.38  |- skos__hiddenLabel mesh__D000921 Antibody Secreting Cells
% 217.19/217.38  |- skos__scopeNote mesh__D000921
% 217.19/217.38       Cells of the lymphoid series that can react with antigen to produce specific cell products called antibodies. Various cell subpopulations, often B-lymphocytes, can be defined, based on the different classes of immunoglobulins that they synthesize.%A%    
% 217.19/217.38  |- skos__hiddenLabel mesh__D000921 Immunoglobulin Producing Cells
% 217.19/217.38  |- skos__altLabel mesh__D000921 Immunoglobulin-Secreting Cells
% 217.19/217.38  |- skos__hiddenLabel mesh__D000921 Cell, Antibody-Secreting
% 217.19/217.38  |- skos__hiddenLabel mesh__D000921 Cell, Antibody-Producing
% 217.19/217.38  |- skos__hiddenLabel mesh__D000921 Antibody-Producing Cell
% 217.19/217.38  |- mesh__dateCreated mesh__D000921 1999-01-01
% 217.19/217.38  |- skos__hiddenLabel mesh__D000921 Cells, Antibody-Secreting
% 217.19/217.38  |- skos__hiddenLabel mesh__D000921 Antibody-Secreting Cell
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D000921 2004
% 217.19/217.38  |- skos__broader mesh__D000921smesh__D002477
% 217.19/217.38  |- skos__hiddenLabel mesh__D000921 Immunoglobulin-Producing Cell
% 217.19/217.38  |- skos__altLabel mesh__D008106 Liver Cirrhoses, Experimental
% 217.19/217.38  |- skos__altLabel mesh__D008106 Hepatic Cirrhosis, Experimental
% 217.19/217.38  |- mesh__recordMaintainer mesh__D008106 lkt
% 217.19/217.38  |- skos__altLabel mesh__D008106 Experimental Liver Cirrhoses
% 217.19/217.38  |- skos__broader mesh__D008106smesh__D004195
% 217.19/217.38  |- skos__annotation mesh__D008106 DF: LIVER CIRRHOSIS EXPER   
% 217.19/217.38  |- rdf__type mesh__D008106sskos__Concept
% 217.19/217.38  |- mesh__dateCreated mesh__D008106 1999-01-01
% 217.19/217.38  |- skos__prefLabel mesh__D008106 Liver Cirrhosis, Experimental
% 217.19/217.38  |- mesh__dateRevised mesh__D008106 2004-07-07
% 217.19/217.38  |- mesh__recordOriginator mesh__D008106 NLM
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D008106 2006
% 217.19/217.38  |- mesh__recordAuthorizer mesh__D008106 sjn
% 217.19/217.38  |- skos__altLabel mesh__D008106 Cirrhoses, Experimental Liver
% 217.19/217.38  |- skos__scopeNote mesh__D008106
% 217.19/217.38       Experimentally induced chronic injuries to the parenchymal cells in the liver to achieve a model for LIVER CIRRHOSIS.%A%    
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D008106 2005
% 217.19/217.38  |- skos__altLabel mesh__D008106 Cirrhosis, Experimental Liver
% 217.19/217.38  |- skos__hiddenLabel mesh__D008106 Experimental Hepatic Cirrhosis
% 217.19/217.38  |- skos__altLabel mesh__D008106 Experimental Liver Cirrhosis
% 217.19/217.38  |- skos__broader mesh__D008106smesh__D008103
% 217.19/217.38  |- mesh__dateRevised mesh__D000123 2003-07-09
% 217.19/217.38  |- mesh__recordMaintainer mesh__D000123 ssb
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D000123 2004
% 217.19/217.38  |- mesh__recordAuthorizer mesh__D000123 sjn
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D000123 2005
% 217.19/217.38  |- skos__broader mesh__D000123smesh__D000217
% 217.19/217.38  |- mesh__activeMeSHYear mesh__D000123 2006
% 217.19/217.38  |- skos__historyNote mesh__D000123 Acyltransferases %28%1966-1972%29%
% 217.19/217.38  |- mesh__dateCreated mesh__D000123 1999-01-01
% 217.19/217.38  |- mesh__dateEstablished mesh__D000123 1973-01-01
% 217.19/217.38  |- skos__prefLabel mesh__D000123 Acetyltransferases
% 217.19/217.38  |- mesh__recordOriginator mesh__D000123 NLM
% 217.19/217.38  |- mesh__publicMeSHNote mesh__D000123 73   
% 217.19/217.38  |- skos__scopeNote mesh__D000123
% 217.19/217.38       Enzymes catalyzing the transfer of an acetyl group, usually from acetyl coenzyme A, to another compound. EC 2.3.1.%A%    
% 217.19/217.38  |- rdf__type mesh__D000123sskos__Concept
% 217.19/217.38  |- mesh__historyNote mesh__D000123 73   
% 217.19/217.38  |- skos__historyNote mesh__D013849 Benzoates %28%1974%29%
% 217.19/217.38  |- skos__altLabel mesh__D013849 Thiomersal
% 217.19/217.38  |- mesh__publicMeSHNote mesh__D013849
% 217.19/217.38       91; was see under ETHYLMERCURY COMPOUNDS 1980-90; was see under ETHYL MERCURY COMPOUNDS 1975-79%A%  
% 217.19/217.38  |- skos__altLabel mesh__D013849 Mercurothiolate
% 217.19/217.38  |- mesh__dateRevised mesh__D013849 2005-06-30
% 217.19/217.38  |- mesh__recordMaintainer mesh__D013849 CCR
% 217.19/217.38  |- skos__altLabel mesh__D013849 Novartis Brand of Thimerosal
% 217.19/217.39  |- skos__altLabel mesh__D013849 Thiomersalate
% 217.19/217.39  |- skos__historyNote mesh__D013849 Sulfides %28%1974%29%
% 217.19/217.39  |- skos__broader mesh__D013849smesh__D005035
% 217.19/217.39  |- mesh__recordAuthorizer mesh__D013849 sjn
% 217.19/217.39  |- skos__prefLabel mesh__D013849 Thimerosal
% 217.19/217.39  |- mesh__recordOriginator mesh__D013849 NLM
% 217.19/217.39  |- skos__scopeNote mesh__D013849
% 217.19/217.39       A topical antiseptic used on skin and mucous membranes. It is also used as a preservative in pharmaceuticals.%A%    
% 217.19/217.39  |- skos__historyNote mesh__D013849 Ethylmercury Compounds %28%1974%29%
% 217.19/217.39  |- mesh__dateCreated mesh__D013849 1974-11-11
% 217.19/217.39  |- mesh__dateEstablished mesh__D013849 1991-01-01
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D013849 2006
% 217.19/217.39  |- mesh__historyNote mesh__D013849
% 217.19/217.39       91%28%75%29%; was see under ETHYLMERCURY COMPOUNDS 1980-90; was see under ETHYL MERCURY COMPOUNDS 1975-79%A%  
% 217.19/217.39  |- rdf__type mesh__D013849sskos__Concept
% 217.19/217.39  |- mesh__publicMeSHNote mesh__D018534 95   
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018534 2004
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018534 1996
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018534 1999
% 217.19/217.39  |- skos__historyNote mesh__D018534 Planets %28%1991-1994%29%
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018534 2002
% 217.19/217.39  |- rdf__type mesh__D018534sskos__Concept
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018534 1997
% 217.19/217.39  |- skos__broader mesh__D018534smesh__D016083
% 217.19/217.39  |- mesh__dateCreated mesh__D018534 1994-06-07
% 217.19/217.39  |- mesh__historyNote mesh__D018534 95   
% 217.19/217.39  |- skos__prefLabel mesh__D018534 Earth %28%Planet%29%
% 217.19/217.39  |- mesh__dateEstablished mesh__D018534 1995-01-01
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018534 2005
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018534 1995
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018534 2000
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018534 2003
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018534 1998
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018534 2006
% 217.19/217.39  |- skos__scopeNote mesh__D018534
% 217.19/217.39       Planet that is the third in order from the sun. It is one of the four inner or terrestrial planets of the SOLAR SYSTEM.%A%    
% 217.19/217.39  |- skos__annotation mesh__D018534
% 217.19/217.39       3d planet from sun with 1 moon; no qualif; DF: EARTH   
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018534 2001
% 217.19/217.39  |- mesh__recordAuthorizer mesh__D010551 sjn
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D010551 2006
% 217.19/217.39  |- mesh__recordOriginator mesh__D010551 NLM
% 217.19/217.39  |- skos__hiddenLabel mesh__D010551 Personalities
% 217.19/217.39  |- skos__related mesh__D010551smesh__D040821
% 217.19/217.39  |- skos__scopeNote mesh__D010551
% 217.19/217.39       Behavior-response patterns that characterize the individual.%A%    
% 217.19/217.39  |- skos__broader mesh__D010551smesh__D001520
% 217.19/217.39  |- mesh__dateRevised mesh__D010551 2005-06-30
% 217.19/217.39  |- mesh__recordMaintainer mesh__D010551 jls
% 217.19/217.39  |- mesh__dateCreated mesh__D010551 1999-01-01
% 217.19/217.39  |- skos__prefLabel mesh__D010551 Personality
% 217.19/217.39  |- rdf__type mesh__D010551sskos__Concept
% 217.19/217.39  |- skos__altLabel mesh__D004514 Pharmacy Education, Graduate
% 217.19/217.39  |- skos__altLabel mesh__D004514 Pharmaceutic Education, Graduate
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D004514 2000
% 217.19/217.39  |- skos__altLabel mesh__D004514 Education, Graduate Pharmaceutical
% 217.19/217.39  |- skos__scopeNote mesh__D004514
% 217.19/217.39       Educational programs for pharmacists who have a bachelor%27%s degree or a Doctor of Pharmacy degree entering a specific field of pharmacy. They may lead to an advanced degree.%A%    
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D004514 2003
% 217.19/217.39  |- mesh__historyNote mesh__D004514 68   
% 217.19/217.39  |- mesh__recordOriginator mesh__D004514 NLM
% 217.19/217.39  |- skos__altLabel mesh__D004514 Pharmaceutical Education, Graduate
% 217.19/217.39  |- skos__annotation mesh__D004514
% 217.19/217.39       differentiate from EDUCATION, PHARMACY, CONTINUING: see note on EDUCATION, CONTINUING; DF: EDUC PHARM GRAD%A%  
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D004514 2006
% 217.19/217.39  |- rdf__type mesh__D004514sskos__Concept
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D004514 2002
% 217.19/217.39  |- skos__historyNote mesh__D004514 Education, Pharmacy %28%1966-1967%29%
% 217.19/217.39  |- skos__broader mesh__D004514smesh__D004512
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D004514 2005
% 217.19/217.39  |- mesh__dateRevised mesh__D004514 1999-11-03
% 217.19/217.39  |- skos__altLabel mesh__D004514 Graduate Pharmacy Education
% 217.19/217.39  |- mesh__dateCreated mesh__D004514 1999-01-01
% 217.19/217.39  |- skos__broader mesh__D004514smesh__D004500
% 217.19/217.39  |- skos__altLabel mesh__D004514 Education, Pharmaceutical, Graduate
% 217.19/217.39  |- mesh__publicMeSHNote mesh__D004514 68   
% 217.19/217.39  |- skos__hiddenLabel mesh__D004514 Education, Graduate Pharmacy
% 217.19/217.39  |- mesh__dateEstablished mesh__D004514 1968-01-01
% 217.19/217.39  |- skos__hiddenLabel mesh__D004514 Graduate Pharmaceutic Education
% 217.19/217.39  |- skos__hiddenLabel mesh__D004514 Graduate Pharmaceutical Education
% 217.19/217.39  |- mesh__recordAuthorizer mesh__D004514 sjn
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D004514 2001
% 217.19/217.39  |- mesh__recordMaintainer mesh__D004514 kle
% 217.19/217.39  |- skos__altLabel mesh__D004514 Education, Graduate Pharmaceutic
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D004514 2004
% 217.19/217.39  |- skos__prefLabel mesh__D004514 Education, Pharmacy, Graduate
% 217.19/217.39  |- skos__altLabel mesh__D004514 Education, Pharmaceutic, Graduate
% 217.19/217.39  |- skos__annotation mesh__D028962
% 217.19/217.39       infection: coord IM with CORONAVIRUS INFECTIONS %28%IM%29% + COMMON COLD %28%IM%29% if appropriate%A%  
% 217.19/217.39  |- mesh__historyNote mesh__D028962 2002   
% 217.19/217.39  |- rdf__type mesh__D028962sskos__Concept
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D028962 2002
% 217.19/217.39  |- mesh__dateEstablished mesh__D028962 2002-01-01
% 217.19/217.39  |- mesh__dateCreated mesh__D028962 2001-07-25
% 217.19/217.39  |- mesh__publicMeSHNote mesh__D028962 2002   
% 217.19/217.39  |- skos__altLabel mesh__D028962 Human coronavirus OC43
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D028962 2003
% 217.19/217.39  |- skos__broader mesh__D028962smesh__D017934
% 217.19/217.39  |- skos__scopeNote mesh__D028962
% 217.19/217.39       A species in the genus CORONAVIRUS causing the common cold and possibly nervous system infections in humans. It contains hemagglutinin-esterase.%A%    
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D028962 2005
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D028962 2004
% 217.19/217.39  |- skos__historyNote mesh__D028962 Coronavirus %28%1993-2001%29%
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D028962 2006
% 217.19/217.39  |- skos__prefLabel mesh__D028962 Coronavirus OC43, Human
% 217.19/217.39  |- skos__altLabel mesh__D020181
% 217.19/217.39       Syndrome, Upper Airway Resistance, Sleep Apnea
% 217.19/217.39  |- skos__altLabel mesh__D020181 Sleep Apnea Syndrome, Obstructive
% 217.19/217.39  |- rdf__type mesh__D020181sskos__Concept
% 217.19/217.39  |- mesh__publicMeSHNote mesh__D020181 2000   
% 217.19/217.39  |- skos__historyNote mesh__D020181 Sleep %28%1966-1979%29%
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D020181 2006
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D020181 2002
% 217.19/217.39  |- skos__hiddenLabel mesh__D020181 Obstructive Sleep Apneas
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D020181 2005
% 217.19/217.39  |- skos__historyNote mesh__D020181 Apnea %28%1966-1979%29%
% 217.19/217.39  |- skos__altLabel mesh__D020181 Syndrome, Obstructive Sleep Apnea
% 217.19/217.39  |- skos__altLabel mesh__D020181 Obstructive Sleep Apnea
% 217.19/217.39  |- skos__altLabel mesh__D020181 Obstructive Sleep Apnea Syndrome
% 217.19/217.39  |- skos__broader mesh__D020181smesh__D012891
% 217.19/217.39  |- mesh__historyNote mesh__D020181 2000   
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D020181 2001
% 217.19/217.39  |- mesh__dateCreated mesh__D020181 1999-11-09
% 217.19/217.39  |- skos__hiddenLabel mesh__D020181 Apneas, Obstructive Sleep
% 217.19/217.39  |- skos__scopeNote mesh__D020181
% 217.19/217.39       A disorder characterized by recurrent apneas during sleep despite persistent respiratory efforts. It is due to upper airway obstruction. The respiratory pauses may induce HYPERCAPNIA or HYPOXIA. Cardiac ARRHYTHMIA and elevation of systemic and pulmonary arterial pressures may occur. Frequent partial arousals occur throughout sleep, resulting in relative SLEEP DEPRIVATION and daytime tiredness. Associated conditions include OBESITY; ACROMEGALY; MYXEDEMA; micrognathia; MYOTONIC DYSTROPHY; adenotonsilar dystrophy; and NEUROMUSCULAR DISEASES. %28%From Adams et al., Principles of Neurology, 6th ed, p395%29%%A%    
% 217.19/217.39  |- skos__hiddenLabel mesh__D020181 Sleep Apneas, Obstructive
% 217.19/217.39  |- skos__prefLabel mesh__D020181 Sleep Apnea, Obstructive
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D020181 2004
% 217.19/217.39  |- skos__hiddenLabel mesh__D020181 Apnea, Obstructive Sleep
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D020181 2000
% 217.19/217.39  |- skos__altLabel mesh__D020181 Syndrome, Sleep Apnea, Obstructive
% 217.19/217.39  |- mesh__dateEstablished mesh__D020181 2000-01-01
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D020181 2003
% 217.19/217.39  |- skos__historyNote mesh__D020181 Sleep Apnea Syndromes %28%1980-1999%29%
% 217.19/217.39  |- mesh__onlineNote mesh__D014942
% 217.19/217.39       use WORKERS%27% COMPENSATION to search WORKMEN%27%S COMPENSATION 1966-92%A%  
% 217.19/217.39  |- mesh__historyNote mesh__D014942
% 217.19/217.39       93; was WORKMEN%27%S COMPENSATION 1963-92   
% 217.19/217.39  |- mesh__publicMeSHNote mesh__D014942
% 217.19/217.39       93; was WORKMEN%27%S COMPENSATION 1963-92   
% 217.19/217.39  |- skos__related mesh__D014942smesh__D035881
% 217.19/217.39  |- skos__annotation mesh__D014942 specify country or state   
% 217.19/217.39  |- mesh__recordMaintainer mesh__D014942 jrf
% 217.19/217.39  |- skos__hiddenLabel mesh__D014942 Workman Compensation
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D014942 2003
% 217.19/217.39  |- skos__hiddenLabel mesh__D014942 Compensations, Workman%27%s
% 217.19/217.39  |- skos__hiddenLabel mesh__D014942 Compensation, Workmen%27%s
% 217.19/217.39  |- skos__hiddenLabel mesh__D014942 Workmens Compensation
% 217.19/217.39  |- skos__hiddenLabel mesh__D014942 Compensations, Workmen%27%s
% 217.19/217.39  |- skos__broader mesh__D014942smesh__D005380
% 217.19/217.39  |- rdf__type mesh__D014942sskos__Concept
% 217.19/217.39  |- skos__hiddenLabel mesh__D014942 Compensations, Worker%27%s
% 217.19/217.39  |- skos__related mesh__D014942smesh__D004185
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D014942 2004
% 217.19/217.39  |- skos__hiddenLabel mesh__D014942 Compensations, Workers%27%
% 217.19/217.39  |- skos__hiddenLabel mesh__D014942 Compensation, Workers%27%
% 217.19/217.39  |- skos__hiddenLabel mesh__D014942 Workman%27%s Compensations
% 217.19/217.39  |- skos__hiddenLabel mesh__D014942 Worker Compensation
% 217.19/217.39  |- skos__hiddenLabel mesh__D014942 Compensation, Workman%27%s
% 217.19/217.39  |- skos__altLabel mesh__D014942 Worker%27%s Compensation
% 217.19/217.39  |- mesh__recordOriginator mesh__D014942 NLM
% 217.19/217.39  |- skos__altLabel mesh__D014942 Workman%27%s Compensation
% 217.19/217.39  |- mesh__dateRevised mesh__D014942 2002-07-03
% 217.19/217.39  |- mesh__dateCreated mesh__D014942 1999-01-01
% 217.19/217.39  |- skos__hiddenLabel mesh__D014942 Workmen Compensation
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D014942 2005
% 217.19/217.39  |- skos__hiddenLabel mesh__D014942 Compensation, Worker%27%s
% 217.19/217.39  |- skos__hiddenLabel mesh__D014942 Workmen%27%s Compensations
% 217.19/217.39  |- skos__hiddenLabel mesh__D014942 Workmans Compensation
% 217.19/217.39  |- skos__hiddenLabel mesh__D014942 Workers%27% Compensations
% 217.19/217.39  |- skos__scopeNote mesh__D014942
% 217.19/217.39       Insurance coverage providing compensation and medical benefits to individuals because of work-connected injuries or disease.%A%    
% 217.19/217.39  |- skos__altLabel mesh__D014942 Workmen%27%s Compensation
% 217.19/217.39  |- mesh__recordAuthorizer mesh__D014942 sjn
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D014942 2006
% 217.19/217.39  |- skos__hiddenLabel mesh__D014942 Worker%27%s Compensations
% 217.19/217.39  |- skos__hiddenLabel mesh__D014942 Workers Compensation
% 217.19/217.39  |- skos__prefLabel mesh__D014942 Workers%27% Compensation
% 217.19/217.39  |- skos__broader mesh__D014942smesh__D018868
% 217.19/217.39  |- mesh__dateCreated mesh__D014144 1977-03-01
% 217.19/217.39  |- skos__annotation mesh__D014144 /biosyn permitted if by plant   
% 217.19/217.39  |- skos__historyNote mesh__D014144 Pharmaceutic Aids %28%1968-1977%29%
% 217.19/217.39  |- mesh__dateRevised mesh__D014144 2005-06-30
% 217.19/217.39  |- mesh__dateEstablished mesh__D014144 1991-01-01
% 217.19/217.39  |- skos__historyNote mesh__D014144 Polysaccharides %28%1966-1977%29%
% 217.19/217.39  |- mesh__historyNote mesh__D014144
% 217.19/217.39       91%28%78%29%; was see under POLYSACCHARIDES 1978-90   
% 217.19/217.39  |- mesh__recordAuthorizer mesh__D014144 sjn
% 217.19/217.39  |- rdf__type mesh__D014144sskos__Concept
% 217.19/217.39  |- mesh__recordOriginator mesh__D014144 SH
% 217.19/217.39  |- skos__hiddenLabel mesh__D014144 Tragacanth, Gum
% 217.19/217.39  |- skos__scopeNote mesh__D014144
% 217.19/217.39       Powdered exudate from Astragalus gummifer and related plants. It forms gelatinous mass in water. Tragacanth is used as suspending agent, excipient or emulsifier in foods, cosmetics and pharmaceuticals. It has also been used as a bulk-forming laxative.%A%    
% 217.19/217.39  |- skos__historyNote mesh__D014144 Resins %28%1966-1977%29%
% 217.19/217.39  |- skos__prefLabel mesh__D014144 Tragacanth
% 217.19/217.39  |- skos__broader mesh__D014144smesh__D011134
% 217.19/217.39  |- skos__broader mesh__D014144smesh__D010936
% 217.19/217.39  |- skos__altLabel mesh__D014144 Gum Tragacanth
% 217.19/217.39  |- skos__historyNote mesh__D014144 Pharmacy %28%1966-1967%29%
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D014144 2006
% 217.19/217.39  |- mesh__recordMaintainer mesh__D014144 ssb
% 217.19/217.39  |- mesh__publicMeSHNote mesh__D014144
% 217.19/217.39       91; was see under POLYSACCHARIDES 1978-90   
% 217.19/217.39  |- skos__broader mesh__D014144smesh__D001704
% 217.19/217.39  |- skos__hiddenLabel mesh__D008905 Minicomputer
% 217.19/217.39  |- mesh__dateEstablished mesh__D008905 1991-01-01
% 217.19/217.39  |- mesh__publicMeSHNote mesh__D008905
% 217.19/217.39       91; was see under COMPUTERS 1980-90   
% 217.19/217.39  |- mesh__recordAuthorizer mesh__D008905 sjn
% 217.19/217.39  |- skos__scopeNote mesh__D008905
% 217.19/217.39       Small computers that lack the speed, memory capacity, and instructional capability of the full-size computer but usually retain its programmable flexibility. They are larger, faster, and more flexible, powerful, and expensive than microcomputers.%A%    
% 217.19/217.39  |- mesh__historyNote mesh__D008905
% 217.19/217.39       91%28%80%29%; was see under COMPUTERS 1980-90   
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D008905 2006
% 217.19/217.39  |- skos__annotation mesh__D008905
% 217.19/217.39       do not confuse with MICROCOMPUTERS; personal computers: index under MICROCOMPUTERS%A%  
% 217.19/217.39  |- mesh__dateRevised mesh__D008905 2004-07-07
% 217.19/217.39  |- skos__broader mesh__D008905smesh__D003201
% 217.19/217.39  |- rdf__type mesh__D008905sskos__Concept
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D008905 2005
% 217.19/217.39  |- mesh__recordMaintainer mesh__D008905 jls
% 217.19/217.39  |- skos__historyNote mesh__D008905 Computers %28%1966-1979%29%
% 217.19/217.39  |- skos__prefLabel mesh__D008905 Minicomputers
% 217.19/217.39  |- mesh__recordOriginator mesh__D008905 SMH
% 217.19/217.39  |- mesh__dateCreated mesh__D008905 1979-05-31
% 217.19/217.39  |- skos__hiddenLabel mesh__D000922 Conjugates, Antibody-Toxin
% 217.19/217.39  |- skos__altLabel mesh__D000922 Chimeric Toxins
% 217.19/217.39  |- skos__altLabel mesh__D000922 Toxin Carriers
% 217.19/217.39  |- skos__altLabel mesh__D000922 Toxin Carrier
% 217.19/217.39  |- skos__hiddenLabel mesh__D000922 Hybrids, Toxin-Antibody
% 217.19/217.39  |- skos__hiddenLabel mesh__D000922 Hybrids, Antibody-Toxin
% 217.19/217.39  |- mesh__dateCreated mesh__D000922 1986-03-25
% 217.19/217.39  |- skos__hiddenLabel mesh__D000922 Monoclonal Antibody Toxin Conjugates
% 217.19/217.39  |- skos__scopeNote mesh__D000922
% 217.19/217.39       Semisynthetic conjugates of various toxic molecules, including RADIOACTIVE ISOTOPES and bacterial or plant TOXINS, with specific immune substances such as IMMUNOGLOBULINS; MONOCLONAL ANTIBODIES; and ANTIGENS. The antitumor or antiviral immune substance carries the toxin to the tumor or infected cell where the toxin exerts its poisonous effect.%A%    
% 217.19/217.39  |- skos__historyNote mesh__D000922 Ricin %28%1978-1985%29%
% 217.19/217.39  |- skos__annotation mesh__D000922
% 217.19/217.39       coordinate IM with specific toxin %28%IM%29% + specific immune substance %28%NIM%29%%A%  
% 217.19/217.39  |- skos__hiddenLabel mesh__D000922 Carriers, Toxin
% 217.19/217.39  |- skos__altLabel mesh__D000922 Toxin-Antibody Conjugates
% 217.19/217.39  |- mesh__publicMeSHNote mesh__D000922
% 217.19/217.39       90; was ANTIBODY-TOXIN CONJUGATES 1987-89   
% 217.19/217.39  |- skos__historyNote mesh__D000922 Antigens, Surface %28%1979-1986%29%
% 217.19/217.39  |- skos__altLabel mesh__D000922 Monoclonal Antibody-Toxin Conjugates
% 217.19/217.39  |- skos__altLabel mesh__D000922 Cytotoxin-Antibody Conjugates
% 217.19/217.39  |- mesh__recordAuthorizer mesh__D000922 sjn
% 217.19/217.39  |- skos__hiddenLabel mesh__D000922 Cytotoxin Antibody Conjugates
% 217.19/217.39  |- skos__hiddenLabel mesh__D000922 Conjugates, Toxin
% 217.19/217.39  |- skos__altLabel mesh__D000922 Toxin-Antibody Hybrids
% 217.19/217.39  |- skos__altLabel mesh__D000922 Toxin Conjugates
% 217.19/217.39  |- mesh__recordOriginator mesh__D000922 SH
% 217.19/217.39  |- skos__historyNote mesh__D000922
% 217.19/217.39       Cytotoxicity, Immunologic %28%1978-1986%29%
% 217.19/217.39  |- skos__broader mesh__D000922smesh__D009676
% 217.19/217.39  |- skos__prefLabel mesh__D000922 Immunotoxins
% 217.19/217.39  |- skos__hiddenLabel mesh__D000922 Toxin, Chimeric
% 217.19/217.39  |- skos__historyNote mesh__D000922 Antibodies, Monoclonal %28%1982-1986%29%
% 217.19/217.39  |- mesh__recordMaintainer mesh__D000922 ssb
% 217.19/217.39  |- skos__altLabel mesh__D000922 Immunotoxin
% 217.19/217.39  |- skos__historyNote mesh__D000922 Antitoxins %28%1966-1986%29%
% 217.19/217.39  |- mesh__onlineNote mesh__D000922
% 217.19/217.39       use IMMUNOTOXINS to search ANTIBODY-TOXIN CONJUGATES 1987-89%A%  
% 217.19/217.39  |- skos__altLabel mesh__D000922 Chimeric Toxin
% 217.19/217.39  |- skos__broader mesh__D000922smesh__D018796
% 217.19/217.39  |- skos__hiddenLabel mesh__D000922 Carrier, Toxin
% 217.19/217.39  |- skos__hiddenLabel mesh__D000922 Conjugates, Monoclonal Antibody-Toxin
% 217.19/217.39  |- skos__altLabel mesh__D000922 Antibody-Toxin Conjugates
% 217.19/217.39  |- skos__hiddenLabel mesh__D000922 Conjugates, Toxin-Antibody
% 217.19/217.39  |- skos__altLabel mesh__D000922 Antibody-Toxin Hybrids
% 217.19/217.39  |- skos__hiddenLabel mesh__D000922 Toxin Antibody Conjugates
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D000922 2006
% 217.19/217.39  |- skos__hiddenLabel mesh__D000922 Antibody Toxin Conjugates
% 217.19/217.39  |- skos__hiddenLabel mesh__D000922 Toxin Antibody Hybrids
% 217.19/217.39  |- rdf__type mesh__D000922sskos__Concept
% 217.19/217.39  |- skos__altLabel mesh__D000922 Toxin Conjugate
% 217.19/217.39  |- mesh__historyNote mesh__D000922
% 217.19/217.39       90; was ANTIBODY-TOXIN CONJUGATES 1987-89   
% 217.19/217.39  |- skos__hiddenLabel mesh__D000922 Conjugate, Toxin
% 217.19/217.39  |- skos__hiddenLabel mesh__D000922 Antibody-Toxin Conjugates, Monoclonal
% 217.19/217.39  |- skos__hiddenLabel mesh__D000922 Antibody Toxin Hybrids
% 217.19/217.39  |- skos__altLabel mesh__D000922 Toxins, Targeted
% 217.19/217.39  |- skos__altLabel mesh__D000922 Affinotoxins
% 217.19/217.39  |- skos__hiddenLabel mesh__D000922 Conjugates, Cytotoxin-Antibody
% 217.19/217.39  |- mesh__dateEstablished mesh__D000922 1987-01-01
% 217.19/217.39  |- mesh__dateRevised mesh__D000922 2005-06-30
% 217.19/217.39  |- mesh__recordAuthorizer mesh__D008107 sjn
% 217.19/217.39  |- skos__hiddenLabel mesh__D008107 Dysfunction, Liver
% 217.19/217.39  |- skos__prefLabel mesh__D008107 Liver Diseases
% 217.19/217.39  |- mesh__dateCreated mesh__D008107 1999-01-01
% 217.19/217.39  |- mesh__recordOriginator mesh__D008107 NLM
% 217.19/217.39  |- mesh__historyNote mesh__D008107
% 217.19/217.39       ACUTE YELLOW ATROPHY was heading 1963-96   
% 217.19/217.39  |- skos__hiddenLabel mesh__D008107 Liver Disease
% 217.19/217.39  |- skos__hiddenLabel mesh__D008107 Dysfunctions, Liver
% 217.19/217.39  |- mesh__dateRevised mesh__D008107 2004-07-07
% 217.19/217.39  |- skos__hiddenLabel mesh__D008107 Liver Dysfunctions
% 217.19/217.39  |- skos__annotation mesh__D008107
% 217.19/217.39       GEN: prefer specifics; inflamm dis = HEPATITIS %26% its specifics; /chem ind permitted but consider also HEPATITIS, TOXIC; specialty is HEPATOLOGY see GASTROENTEROLOGY; be careful: do not confuse %22%hepatic dis%22% with %22%intrahepatic dis%22%: %22%intrahepatic dis%22% may refer to BILE DUCT DISEASES with regard to BILE DUCTS, INTRAHEPATIC, not LIVER DISEASES%A%  
% 217.19/217.39  |- rdf__type mesh__D008107sskos__Concept
% 217.19/217.39  |- skos__hiddenLabel mesh__D008107 Diseases, Liver
% 217.19/217.39  |- skos__scopeNote mesh__D008107 Pathological processes of the LIVER.     
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D008107 2005
% 217.19/217.39  |- skos__hiddenLabel mesh__D008107 Disease, Liver
% 217.19/217.39  |- skos__broader mesh__D008107smesh__D004066
% 217.19/217.39  |- mesh__publicMeSHNote mesh__D008107
% 217.19/217.39       ACUTE YELLOW ATROPHY was heading 1963-96   
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D008107 2006
% 217.19/217.39  |- mesh__recordMaintainer mesh__D008107 lkt
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D000124 1991
% 217.19/217.39  |- mesh__recordOriginator mesh__D000124 NLM
% 217.19/217.39  |- skos__broader mesh__D000124smesh__D009042
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D000124 2000
% 217.19/217.39  |- mesh__recordAuthorizer mesh__D000124 PLS
% 217.19/217.39  |- skos__hiddenLabel mesh__D000124 Achievements
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D000124 2005
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D000124 1996
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D000124 2001
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D000124 2006
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D000124 1992
% 217.19/217.39  |- mesh__dateEstablished mesh__D000124 1965-01-01
% 217.19/217.39  |- skos__annotation mesh__D000124 no qualif   
% 217.19/217.39  |- mesh__dateCreated mesh__D000124 1999-01-01
% 217.19/217.39  |- mesh__historyNote mesh__D000124 65%28%64%29%   
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D000124 1997
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D000124 2002
% 217.19/217.39  |- skos__broader mesh__D000124smesh__D011588
% 217.19/217.39  |- skos__scopeNote mesh__D000124
% 217.19/217.39       Success in bringing an effort to the desired end; the degree or level of success attained in some specified area %28%esp. scholastic%29% or in general.%A%    
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D000124 1993
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D000124 1998
% 217.19/217.39  |- skos__prefLabel mesh__D000124 Achievement
% 217.19/217.39  |- rdf__type mesh__D000124sskos__Concept
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D000124 1994
% 217.19/217.39  |- mesh__dateRevised mesh__D000124 1991-11-02
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D000124 1999
% 217.19/217.39  |- mesh__publicMeSHNote mesh__D000124 65   
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D000124 2003
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D000124 1990
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D000124 1995
% 217.19/217.39  |- mesh__recordMaintainer mesh__D000124 PLS
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D000124 2004
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018535 2000
% 217.19/217.39  |- rdf__type mesh__D018535sskos__Concept
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018535 1997
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018535 2001
% 217.19/217.39  |- mesh__dateCreated mesh__D018535 1994-06-07
% 217.19/217.39  |- mesh__publicMeSHNote mesh__D018535 95   
% 217.19/217.39  |- skos__historyNote mesh__D018535
% 217.19/217.39       Extraterrestrial Environment %28%1966-1990%29%
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018535 2002
% 217.19/217.39  |- mesh__historyNote mesh__D018535 95   
% 217.19/217.39  |- skos__prefLabel mesh__D018535 Mars
% 217.19/217.39  |- skos__annotation mesh__D018535
% 217.19/217.39       4th planet from sun with 2 moons; no qualif   
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018535 2005
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018535 1995
% 217.19/217.39  |- skos__broader mesh__D018535smesh__D016083
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018535 2006
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018535 2003
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018535 1998
% 217.19/217.39  |- skos__scopeNote mesh__D018535
% 217.19/217.39       The fourth planet in order from the sun. Its two natural satellites are Deimos and Phobos. It is one of the four inner or terrestrial planets of the solar system.%A%    
% 217.19/217.39  |- mesh__dateEstablished mesh__D018535 1995-01-01
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018535 2004
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018535 1999
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D018535 1996
% 217.19/217.39  |- skos__historyNote mesh__D018535 Planets %28%1991-1994%29%
% 217.19/217.39  |- skos__broader mesh__D010552smesh__D004191
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D010552 2000
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D010552 1996
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D010552 2003
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D010552 2001
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D010552 1997
% 217.19/217.39  |- skos__annotation mesh__D010552
% 217.19/217.39       by a professional; differentiate from PERSONALITY INVENTORY %28%by the person himself%29%; DF: PERSONALITY ASSESS%A%  
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D010552 2004
% 217.19/217.39  |- mesh__dateEstablished mesh__D010552 1968-01-01
% 217.19/217.39  |- skos__scopeNote mesh__D010552
% 217.19/217.39       The determination and evaluation of personality attributes by interviews, observations, tests, or scales. Articles concerning personality measurement are considered to be within scope of this term.%A%    
% 217.19/217.39  |- mesh__recordAuthorizer mesh__D010552 PLS
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D010552 1995
% 217.19/217.39  |- mesh__dateCreated mesh__D010552 1999-01-01
% 217.19/217.39  |- skos__hiddenLabel mesh__D010552 Assessments, Personality
% 217.19/217.39  |- rdf__type mesh__D010552sskos__Concept
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D010552 2002
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D010552 1998
% 217.19/217.39  |- skos__altLabel mesh__D010552 Assessment, Personality
% 217.19/217.39  |- mesh__dateRevised mesh__D010552 1994-02-08
% 217.19/217.39  |- mesh__historyNote mesh__D010552 68%28%66%29%   
% 217.19/217.39  |- mesh__recordOriginator mesh__D010552 NLM
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D010552 2005
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D010552 1999
% 217.19/217.39  |- mesh__publicMeSHNote mesh__D010552 68   
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D010552 2006
% 217.19/217.39  |- skos__hiddenLabel mesh__D010552 Personality Assessments
% 217.19/217.39  |- skos__prefLabel mesh__D010552 Personality Assessment
% 217.19/217.39  |- mesh__recordMaintainer mesh__D010552 TGC
% 217.19/217.39  |- mesh__recordAuthorizer mesh__D004515 sjn
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D004515 2001
% 217.19/217.39  |- mesh__recordMaintainer mesh__D004515 kle
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D004515 2006
% 217.19/217.39  |- rdf__type mesh__D004515sskos__Concept
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D004515 2000
% 217.19/217.39  |- skos__hiddenLabel mesh__D004515 Predental Educations
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D004515 2005
% 217.19/217.39  |- mesh__historyNote mesh__D004515 66   
% 217.19/217.39  |- mesh__recordOriginator mesh__D004515 NLM
% 217.19/217.39  |- mesh__dateCreated mesh__D004515 1999-01-01
% 217.19/217.39  |- skos__broader mesh__D004515smesh__D004493
% 217.19/217.39  |- skos__annotation mesh__D004515 DF: EDUC PREDENT   
% 217.19/217.39  |- skos__hiddenLabel mesh__D004515 Educations, Predental
% 217.19/217.39  |- mesh__dateEstablished mesh__D004515 1966-01-01
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D004515 2002
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D004515 2004
% 217.19/217.39  |- mesh__dateRevised mesh__D004515 1999-11-03
% 217.19/217.39  |- skos__scopeNote mesh__D004515
% 217.19/217.39       Preparatory education meeting the requirements for admission to dental school.%A%    
% 217.19/217.39  |- skos__altLabel mesh__D004515 Predental Education
% 217.19/217.39  |- skos__prefLabel mesh__D004515 Education, Predental
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D004515 2003
% 217.19/217.39  |- mesh__publicMeSHNote mesh__D004515 66   
% 217.19/217.39  |- mesh__dateRevised mesh__D009200 2003-07-09
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D009200 2006
% 217.19/217.39  |- skos__broader mesh__D009200smesh__D045125
% 217.19/217.39  |- mesh__publicMeSHNote mesh__D009200 75   
% 217.19/217.39  |- skos__historyNote mesh__D009200 Heart %28%1966-1974%29%
% 217.19/217.39  |- skos__hiddenLabel mesh__D009200 Contraction, Myocardial
% 217.19/217.39  |- skos__broader mesh__D009200smesh__D009119
% 217.19/217.39  |- mesh__dateCreated mesh__D009200 1974-11-11
% 217.19/217.39  |- skos__hiddenLabel mesh__D009200 Cardiac Inotropism
% 217.19/217.39  |- skos__hiddenLabel mesh__D009200 Heart Contractilities
% 217.19/217.39  |- mesh__recordAuthorizer mesh__D009200 sjn
% 217.19/217.39  |- skos__hiddenLabel mesh__D009200 Myocardial Contractions
% 217.19/217.39  |- skos__related mesh__D009200smesh__D017682
% 217.19/217.39  |- skos__scopeNote mesh__D009200
% 217.19/217.39       Contractile activity of the MYOCARDIUM.     
% 217.19/217.39  |- mesh__dateEstablished mesh__D009200 1975-09-01
% 217.19/217.39  |- skos__hiddenLabel mesh__D009200 Contractility, Heart
% 217.19/217.39  |- skos__hiddenLabel mesh__D009200 Inotropisms, Cardiac
% 217.19/217.39  |- mesh__historyNote mesh__D009200 75   
% 217.19/217.39  |- skos__hiddenLabel mesh__D009200 Contractilities, Heart
% 217.19/217.39  |- skos__related mesh__D009200smesh__D002316
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D009200 2004
% 217.19/217.39  |- skos__prefLabel mesh__D009200 Myocardial Contraction
% 217.19/217.39  |- skos__hiddenLabel mesh__D009200 Contractions, Myocardial
% 217.19/217.39  |- rdf__type mesh__D009200sskos__Concept
% 217.19/217.39  |- skos__annotation mesh__D009200
% 217.19/217.39       inotropic action of drugs = MYOCARDIAL CONTRACTION /drug eff %28%IM%29% + drug with /pharmacol %28%IM%29% + STIMULATION, CHEMICAL %28%NIM%29% for positive inotropic action %26% DEPRESSION, CHEMICAL %28%NIM%29% for negative but note that INOTROPIC AGENTS, POSITIVE CARDIAC see CARDIOTONIC AGENTS is available; for chronotropic action see note on HEART RATE; relaxation of cardiac muscle: DIASTOLE, do not add MUSCLE RELAXATION%A%  
% 217.19/217.39  |- mesh__activeMeSHYear mesh__D009200 2005
% 217.19/217.39  |- skos__hiddenLabel mesh__D009200 Cardiac Inotropisms
% 217.19/217.40  |- mesh__recordMaintainer mesh__D009200 nns
% 217.19/217.40  |- mesh__recordOriginator mesh__D009200 NLM
% 217.19/217.40  |- skos__hiddenLabel mesh__D020182 Central Alveolar Hypoventilation
% 217.19/217.40  |- skos__hiddenLabel mesh__D020182 Sleep-Disordered Breathings, Central
% 217.19/217.40  |- skos__historyNote mesh__D020182 Apnea %28%1966-1979%29%
% 217.19/217.40  |- skos__hiddenLabel mesh__D020182 Central Apnea
% 217.19/217.40  |- skos__altLabel mesh__D020182 Sleep-Disordered Breathing, Central
% 217.19/217.40  |- skos__historyNote mesh__D020182 Sleep %28%1966-1979%29%
% 217.19/217.40  |- skos__hiddenLabel mesh__D020182 Alveolar Hypoventilations, Central
% 217.19/217.40  |- skos__hiddenLabel mesh__D020182 Hypoventilations, Central Alveolar
% 217.19/217.40  |- skos__hiddenLabel mesh__D020182 Central Sleep-Disordered Breathing
% 217.19/217.40  |- skos__historyNote mesh__D020182 Sleep Apnea Syndromes %28%1980-1999%29%
% 217.19/217.40  |- skos__prefLabel mesh__D020182 Sleep Apnea, Central
% 217.19/217.40  |- skos__altLabel mesh__D020182 Newborn Primary Sleep Apneas
% 217.19/217.40  |- skos__hiddenLabel mesh__D020182 Breathing, Central Sleep-Disordered
% 217.19/217.40  |- mesh__dateEstablished mesh__D020182 2000-01-01
% 217.19/217.40  |- mesh__recordMaintainer mesh__D020182 lkt
% 217.19/217.40  |- skos__hiddenLabel mesh__D020182 Alveolar Hypoventilation, Central
% 217.19/217.40  |- mesh__dateCreated mesh__D020182 1999-11-08
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D020182 2006
% 217.19/217.40  |- skos__altLabel mesh__D020182 Central Sleep Apnea Syndrome
% 217.19/217.40  |- mesh__publicMeSHNote mesh__D020182 2000   
% 217.19/217.40  |- mesh__historyNote mesh__D020182 2000   
% 217.19/217.40  |- skos__hiddenLabel mesh__D020182 Central Sleep-Disordered Breathings
% 217.19/217.40  |- mesh__dateRevised mesh__D020182 2005-06-30
% 217.19/217.40  |- skos__hiddenLabel mesh__D020182 Breathings, Central Sleep-Disordered
% 217.19/217.40  |- mesh__recordAuthorizer mesh__D020182 sjn
% 217.19/217.40  |- mesh__recordOriginator mesh__D020182 KEV
% 217.19/217.40  |- rdf__type mesh__D020182sskos__Concept
% 217.19/217.40  |- skos__hiddenLabel mesh__D020182 Central Apneas
% 217.19/217.40  |- skos__hiddenLabel mesh__D020182 Apneas, Central Sleep
% 217.19/217.40  |- skos__hiddenLabel mesh__D020182 Central Sleep Apneas
% 217.19/217.40  |- skos__altLabel mesh__D020182 Central Sleep Disordered Breathing
% 217.19/217.40  |- skos__broader mesh__D020182smesh__D012891
% 217.19/217.40  |- skos__altLabel mesh__D020182 Apnea, Sleep, Central
% 217.19/217.40  |- skos__altLabel mesh__D020182 Ondine Syndrome
% 217.19/217.40  |- skos__altLabel mesh__D020182 Hypoventilation, Central Alveolar
% 217.19/217.40  |- skos__hiddenLabel mesh__D020182 Apneas, Central
% 217.19/217.40  |- skos__altLabel mesh__D020182 Primary Sleep Apneas of Newborn
% 217.19/217.40  |- skos__hiddenLabel mesh__D020182 Sleep Disordered Breathing, Central
% 217.19/217.40  |- skos__altLabel mesh__D020182 Secondary Central Sleep Apnea
% 217.19/217.40  |- skos__altLabel mesh__D020182 Primary Central Sleep Apnea
% 217.19/217.40  |- skos__scopeNote mesh__D020182
% 217.19/217.40       A condition associated with multiple episodes of sleep apnea which are distinguished from obstructive sleep apnea %28%SLEEP APNEA, OBSTRUCTIVE%29% by the complete cessation of efforts to breathe. This disorder is associated with dysfunction of central nervous system centers that regulate respiration. This condition may be idiopathic %28%primary%29% or associated with lower brain stem lesions; chronic obstructive pulmonary disease %28%LUNG DISEASES, OBSTRUCTIVE%29%; HEART FAILURE, CONGESTIVE; medication effect; and other conditions. Sleep maintenance is impaired, resulting in daytime hypersomnolence. Primary central sleep apnea is frequently associated with obstructive sleep apnea. When both forms are present the condition is referred to as mixed sleep apnea %28%see SLEEP APNEA SYNDROMES%29%. %28%Adams et al., Principles of Neurology, 6th ed, p395; Neurol Clin 1996;14%28%3%29%:611-28%29%%A%    
% 217.19/217.40  |- skos__altLabel mesh__D020182 Central Sleep Apnea
% 217.19/217.40  |- skos__hiddenLabel mesh__D020182 Apnea, Central Sleep
% 217.19/217.40  |- skos__hiddenLabel mesh__D020182 Sleep Apneas, Central
% 217.19/217.40  |- skos__altLabel mesh__D020182 Apnea, Central
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014943 2001
% 217.19/217.40  |- mesh__historyNote mesh__D014943 78   
% 217.19/217.40  |- mesh__recordOriginator mesh__D014943 EC
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014943 2006
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014943 2003
% 217.19/217.40  |- mesh__publicMeSHNote mesh__D014943 78   
% 217.19/217.40  |- skos__broader mesh__D014943smesh__D006262
% 217.19/217.40  |- mesh__recordAuthorizer mesh__D014943 SJN
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014943 2002
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014943 2004
% 217.19/217.40  |- skos__hiddenLabel mesh__D014943 International Health Problem
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014943 1998
% 217.19/217.40  |- mesh__dateEstablished mesh__D014943 1978-01-01
% 217.19/217.40  |- mesh__dateCreated mesh__D014943 1977-05-12
% 217.19/217.40  |- skos__hiddenLabel mesh__D014943 Health Problems, International
% 217.19/217.40  |- mesh__recordMaintainer mesh__D014943 PXP
% 217.19/217.40  |- rdf__type mesh__D014943sskos__Concept
% 217.19/217.40  |- skos__hiddenLabel mesh__D014943 Health, World
% 217.19/217.40  |- mesh__dateRevised mesh__D014943 1997-06-20
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014943 1999
% 217.19/217.40  |- skos__hiddenLabel mesh__D014943 Health Problem, International
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014943 2000
% 217.19/217.40  |- skos__annotation mesh__D014943 no qualif   
% 217.19/217.40  |- skos__prefLabel mesh__D014943 World Health
% 217.19/217.40  |- skos__hiddenLabel mesh__D014943 Problems, International Health
% 217.19/217.40  |- skos__hiddenLabel mesh__D014943 Problem, International Health
% 217.19/217.40  |- skos__scopeNote mesh__D014943
% 217.19/217.40       The concept pertaining to the health status of inhabitants of the world.%A%    
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014943 2005
% 217.19/217.40  |- mesh__recordAuthorizer mesh__D014145 PLS
% 217.19/217.40  |- mesh__publicMeSHNote mesh__D014145
% 217.19/217.40       91; was see under NEUROPSYCHOLOGICAL TESTS 1985-90; was see under PSYCHOLOGICAL TESTS 1971-84%A%  
% 217.19/217.40  |- mesh__recordMaintainer mesh__D014145 TAP
% 217.19/217.40  |- mesh__dateEstablished mesh__D014145 1991-01-01
% 217.19/217.40  |- skos__hiddenLabel mesh__D014145 Trail Making Tests
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014145 2000
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014145 1997
% 217.19/217.40  |- skos__scopeNote mesh__D014145
% 217.19/217.40       The subject%27%s ability to connect 25 numbered and lettered circles in sequence in a specific length of time. A score of 12 or below is suggestive of organic brain damage.%A%    
% 217.19/217.40  |- rdf__type mesh__D014145sskos__Concept
% 217.19/217.40  |- skos__hiddenLabel mesh__D014145 Tests, Trail Making
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014145 2001
% 217.19/217.40  |- mesh__historyNote mesh__D014145
% 217.19/217.40       91%28%71%29%; was see under NEUROPSYCHOLOGICAL TESTS 1985-90; was see under PSYCHOLOGICAL TESTS 1971-84%A%  
% 217.19/217.40  |- skos__hiddenLabel mesh__D014145 Making Tests, Trail
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014145 2005
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014145 1994
% 217.19/217.40  |- mesh__recordOriginator mesh__D014145 NLM
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014145 2002
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014145 2006
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014145 2003
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014145 1995
% 217.19/217.40  |- mesh__dateCreated mesh__D014145 1999-01-01
% 217.19/217.40  |- skos__prefLabel mesh__D014145 Trail Making Test
% 217.19/217.40  |- skos__historyNote mesh__D014145 Psychological Tests %28%1966-1970%29%
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014145 1998
% 217.19/217.40  |- skos__broader mesh__D014145smesh__D009483
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014145 2004
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014145 1993
% 217.19/217.40  |- skos__hiddenLabel mesh__D014145 Making Test, Trail
% 217.19/217.40  |- skos__hiddenLabel mesh__D014145 Test, Trail Making
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014145 1999
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014145 1996
% 217.19/217.40  |- mesh__dateRevised mesh__D014145 1992-05-18
% 217.19/217.40  |- rdf__type mesh__D008906sskos__Concept
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D008906 2005
% 217.19/217.40  |- skos__annotation mesh__D008906
% 217.19/217.40       SPEC: SPEC qualif; coord IM with substance being mined %28%IM or NIM%29%; COAL MINING is also available%A%  
% 217.19/217.40  |- skos__prefLabel mesh__D008906 Mining
% 217.19/217.40  |- skos__broader mesh__D008906smesh__D019652
% 217.19/217.40  |- skos__hiddenLabel mesh__D008906 Minings
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D008906 2001
% 217.19/217.40  |- mesh__recordMaintainer mesh__D008906 JLS
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D008906 2004
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D008906 2000
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D008906 1999
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D008906 2003
% 217.19/217.40  |- mesh__recordOriginator mesh__D008906 NLM
% 217.19/217.40  |- mesh__dateRevised mesh__D008906 1997-06-20
% 217.19/217.40  |- mesh__dateCreated mesh__D008906 1999-01-01
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D008906 1998
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D008906 2006
% 217.19/217.40  |- mesh__recordAuthorizer mesh__D008906 SJN
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D008906 2002
% 217.19/217.40  |- skos__annotation mesh__D000923
% 217.19/217.40       consider also CESTODA /drug eff %26% CESTODE INFECTIONS /drug ther or pertinent specifics%A%  
% 217.19/217.40  |- mesh__recordAuthorizer mesh__D000923 sjn
% 217.19/217.40  |- skos__prefLabel mesh__D000923 Anticestodal Agents
% 217.19/217.40  |- mesh__dateCreated mesh__D000923 1999-01-01
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D000923 2004
% 217.19/217.40  |- rdf__type mesh__D000923sskos__Concept
% 217.19/217.40  |- skos__historyNote mesh__D000923 Anthelmintics %28%1966-1974%29%
% 217.19/217.40  |- skos__broader mesh__D000923smesh__D000980
% 217.19/217.40  |- mesh__historyNote mesh__D000923 75   
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D000923 2006
% 217.19/217.40  |- mesh__recordMaintainer mesh__D000923 ssb
% 217.19/217.40  |- mesh__dateEstablished mesh__D000923 1975-09-01
% 217.19/217.40  |- mesh__dateRevised mesh__D000923 2003-07-09
% 217.19/217.40  |- skos__scopeNote mesh__D000923
% 217.19/217.40       Agents used to treat tapeworm infestations in man or animals.%A%    
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D000923 2005
% 217.19/217.40  |- mesh__publicMeSHNote mesh__D000923 75   
% 217.19/217.40  |- mesh__recordOriginator mesh__D000923 NLM
% 217.19/217.40  |- skos__hiddenLabel mesh__D000923 Agents, Anticestodal
% 217.19/217.40  |- mesh__dateRevised mesh__D008108 2004-07-07
% 217.19/217.40  |- mesh__dateCreated mesh__D008108 1978-01-26
% 217.19/217.40  |- skos__hiddenLabel mesh__D008108 Alcoholic Liver Disease
% 217.19/217.40  |- skos__hiddenLabel mesh__D008108 Liver Disease, Alcoholic
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D008108 2005
% 217.19/217.40  |- skos__prefLabel mesh__D008108 Liver Diseases, Alcoholic
% 217.19/217.40  |- mesh__recordAuthorizer mesh__D008108 sjn
% 217.19/217.40  |- skos__altLabel mesh__D008108 Alcoholic Liver Diseases
% 217.19/217.40  |- rdf__type mesh__D008108sskos__Concept
% 217.19/217.40  |- skos__broader mesh__D008108smesh__D008107
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D008108 2006
% 217.19/217.40  |- mesh__publicMeSHNote mesh__D008108 79   
% 217.19/217.40  |- skos__historyNote mesh__D008108 Liver Diseases %28%1966-1978%29%
% 217.19/217.40  |- skos__scopeNote mesh__D008108
% 217.19/217.40       Liver diseases associated with ALCOHOLISM. It usually refers to the coexistence of two or more subentities, i.e., ALCOHOLIC FATTY LIVER; ALCOHOLIC HEPATITIS; and ALCOHOLIC CIRRHOSIS.%A%    
% 217.19/217.40  |- mesh__dateEstablished mesh__D008108 1979-01-01
% 217.19/217.40  |- mesh__recordOriginator mesh__D008108 SMH
% 217.19/217.40  |- mesh__historyNote mesh__D008108 79   
% 217.19/217.40  |- skos__historyNote mesh__D008108 specific liver disease
% 217.19/217.40  |- skos__broader mesh__D008108smesh__D020751
% 217.19/217.40  |- mesh__recordMaintainer mesh__D008108 lkt
% 217.19/217.40  |- skos__historyNote mesh__D008108 Alcoholism %28%1966-1978%29%
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D000125 2004
% 217.19/217.40  |- skos__prefLabel mesh__D000125 Achilles Tendon
% 217.19/217.40  |- mesh__recordMaintainer mesh__D000125 nns
% 217.19/217.40  |- mesh__dateCreated mesh__D000125 1999-01-01
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D000125 2005
% 217.19/217.40  |- skos__annotation mesh__D000125
% 217.19/217.40       rupture = ACHILLES TENDON /inj %28%IM%29% + RUPTURE %28%NIM%29%   
% 217.19/217.40  |- mesh__recordAuthorizer mesh__D000125 sjn
% 217.19/217.40  |- mesh__dateRevised mesh__D000125 2001-07-25
% 217.19/217.40  |- skos__broader mesh__D000125smesh__D013710
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D000125 2002
% 217.19/217.40  |- skos__hiddenLabel mesh__D000125 Achilles Tendons
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D000125 2006
% 217.19/217.40  |- skos__hiddenLabel mesh__D000125 Tendon, Achilles
% 217.19/217.40  |- rdf__type mesh__D000125sskos__Concept
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D000125 2003
% 217.19/217.40  |- skos__hiddenLabel mesh__D000125 Tendons, Achilles
% 217.19/217.40  |- mesh__recordOriginator mesh__D000125 NLM
% 217.19/217.40  |- mesh__historyNote mesh__D018536 95   
% 217.19/217.40  |- mesh__dateEstablished mesh__D018536 1995-01-01
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D018536 2005
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D018536 1995
% 217.19/217.40  |- skos__annotation mesh__D018536
% 217.19/217.40       2d planet from sun with no moons; no qualif   
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D018536 2006
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D018536 2003
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D018536 1998
% 217.19/217.40  |- skos__historyNote mesh__D018536
% 217.19/217.40       Extraterrestrial Environment %28%1966-1990%29%
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D018536 2000
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D018536 2004
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D018536 1999
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D018536 1996
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D018536 2001
% 217.19/217.40  |- mesh__publicMeSHNote mesh__D018536 95   
% 217.19/217.40  |- skos__prefLabel mesh__D018536 Venus
% 217.19/217.40  |- rdf__type mesh__D018536sskos__Concept
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D018536 1997
% 217.19/217.40  |- skos__historyNote mesh__D018536 Planets %28%1991-1994%29%
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D018536 2002
% 217.19/217.40  |- skos__scopeNote mesh__D018536
% 217.19/217.40       The second planet in order from the sun. It has no known natural satellites. It is one of the four inner or terrestrial planets of the solar system.%A%    
% 217.19/217.40  |- skos__broader mesh__D018536smesh__D016083
% 217.19/217.40  |- mesh__dateCreated mesh__D018536 1994-06-07
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D010553 1997
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D010553 2006
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D010553 2001
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D010553 2003
% 217.19/217.40  |- mesh__recordAuthorizer mesh__D010553 PLS
% 217.19/217.40  |- mesh__dateCreated mesh__D010553 1999-01-01
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D010553 1994
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D010553 2004
% 217.19/217.40  |- skos__annotation mesh__D010553 no qualif   
% 217.19/217.40  |- skos__prefLabel mesh__D010553 Personality Development
% 217.19/217.40  |- rdf__type mesh__D010553sskos__Concept
% 217.19/217.40  |- skos__scopeNote mesh__D010553
% 217.19/217.40       Growth of habitual patterns of behavior in childhood and adolescence.%A%    
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D010553 1998
% 217.19/217.40  |- mesh__historyNote mesh__D010553 68   
% 217.19/217.40  |- mesh__dateEstablished mesh__D010553 1968-01-01
% 217.19/217.40  |- skos__hiddenLabel mesh__D010553 Development, Personality
% 217.19/217.40  |- mesh__recordOriginator mesh__D010553 NLM
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D010553 2002
% 217.19/217.40  |- skos__broader mesh__D010553smesh__D010551
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D010553 1995
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D010553 1999
% 217.19/217.40  |- mesh__dateRevised mesh__D010553 1993-06-03
% 217.19/217.40  |- mesh__publicMeSHNote mesh__D010553 68   
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D010553 1996
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D010553 2005
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D010553 2000
% 217.19/217.40  |- skos__historyNote mesh__D010553 Personality %28%1966-1967%29%
% 217.19/217.40  |- skos__related mesh__D010553smesh__D012951
% 217.19/217.40  |- mesh__recordMaintainer mesh__D010553 PLS
% 217.19/217.40  |- mesh__dateCreated mesh__D004516 1999-01-01
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D004516 2006
% 217.19/217.40  |- rdf__type mesh__D004516sskos__Concept
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D004516 2000
% 217.19/217.40  |- mesh__dateRevised mesh__D004516 1999-11-03
% 217.19/217.40  |- skos__altLabel mesh__D004516 Premedical Education
% 217.19/217.40  |- mesh__recordAuthorizer mesh__D004516 sjn
% 217.19/217.40  |- mesh__recordMaintainer mesh__D004516 kle
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D004516 2001
% 217.19/217.40  |- skos__prefLabel mesh__D004516 Education, Premedical
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D004516 2003
% 217.19/217.40  |- skos__broader mesh__D004516smesh__D004493
% 217.19/217.40  |- skos__scopeNote mesh__D004516
% 217.19/217.40       Preparatory education meeting the requirements for admission to medical school.%A%    
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D004516 2002
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D004516 2004
% 217.19/217.40  |- mesh__historyNote mesh__D004516 66   
% 217.19/217.40  |- mesh__recordOriginator mesh__D004516 NLM
% 217.19/217.40  |- skos__annotation mesh__D004516 DF: EDUC PREMED   
% 217.19/217.40  |- mesh__publicMeSHNote mesh__D004516 66   
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D004516 2005
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D009201 1997
% 217.19/217.40  |- mesh__dateRevised mesh__D009201 1992-05-22
% 217.19/217.40  |- mesh__dateEstablished mesh__D009201 1991-01-01
% 217.19/217.40  |- mesh__recordOriginator mesh__D009201 NLM
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D009201 1993
% 217.19/217.40  |- skos__scopeNote mesh__D009201
% 217.19/217.40       A low molecular weight peptide of about 800-1000 having a negative inotropic effect. It is released into the circulation during experimental hemorrhagic pancreatitis, severe ischemia, and postoligemic shock.%A%    
% 217.19/217.40  |- mesh__historyNote mesh__D009201
% 217.19/217.40       91%28%75%29%; was see under PEPTIDES 1975-90   
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D009201 2003
% 217.19/217.40  |- skos__hiddenLabel mesh__D009201 Factor, Myocardial Depressant
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D009201 1998
% 217.19/217.40  |- skos__annotation mesh__D009201
% 217.19/217.40       /biosyn /physiol permitted; do not confuse with MYOCARDIAL DEPRESSANTS %28%see ANTI-ARRHYTHMIA AGENTS%29%%A%  
% 217.19/217.40  |- skos__prefLabel mesh__D009201 Myocardial Depressant Factor
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D009201 2004
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D009201 1994
% 217.19/217.40  |- mesh__recordAuthorizer mesh__D009201 PLS
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D009201 1999
% 217.19/217.40  |- rdf__type mesh__D009201sskos__Concept
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D009201 2000
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D009201 1995
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D009201 2005
% 217.19/217.40  |- skos__hiddenLabel mesh__D009201 Depressant Factor, Myocardial
% 217.19/217.40  |- mesh__dateCreated mesh__D009201 1974-11-19
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D009201 2001
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D009201 2006
% 217.19/217.40  |- mesh__publicMeSHNote mesh__D009201 91; was see under PEPTIDES 1975-90   
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D009201 1996
% 217.19/217.40  |- skos__broader mesh__D009201smesh__D010455
% 217.19/217.40  |- skos__historyNote mesh__D009201 Peptides %28%1973-1974%29%
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D009201 2002
% 217.19/217.40  |- mesh__recordMaintainer mesh__D009201 TAP
% 217.19/217.40  |- mesh__historyNote mesh__D020183 2000   
% 217.19/217.40  |- skos__hiddenLabel mesh__D020183 Paroxysmal Dystonias, Hypnogenic
% 217.19/217.40  |- skos__historyNote mesh__D020183 Sleep Disorders %28%1981-1999%29%
% 217.19/217.40  |- skos__historyNote mesh__D020183 Dystonia %28%1981-1999%29%
% 217.19/217.40  |- skos__hiddenLabel mesh__D020183 Nocturnal Paroxysmal Dystonias
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D020183 2004
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D020183 2001
% 217.19/217.40  |- skos__hiddenLabel mesh__D020183 Hypnogenic Paroxysmal Dystonias
% 217.19/217.40  |- skos__broader mesh__D020183smesh__D020447
% 217.19/217.40  |- skos__altLabel mesh__D020183 Dystonia, Nocturnal, Paroxysmal
% 217.19/217.40  |- skos__hiddenLabel mesh__D020183 Paroxysmal Dystonia, Nocturnal
% 217.19/217.40  |- mesh__dateCreated mesh__D020183 1999-11-03
% 217.19/217.40  |- skos__hiddenLabel mesh__D020183 Sleep Related Dystonia
% 217.19/217.40  |- skos__altLabel mesh__D020183 Sleep-Related Dystonia
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D020183 2003
% 217.19/217.40  |- skos__hiddenLabel mesh__D020183 Dystonia, Sleep-Related
% 217.19/217.40  |- skos__hiddenLabel mesh__D020183 Dystonias, Nocturnal Paroxysmal
% 217.19/217.40  |- rdf__type mesh__D020183sskos__Concept
% 217.19/217.40  |- skos__prefLabel mesh__D020183 Nocturnal Paroxysmal Dystonia
% 217.19/217.40  |- skos__hiddenLabel mesh__D020183 Dystonias, Hypnogenic Paroxysmal
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D020183 2000
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D020183 2006
% 217.19/217.40  |- mesh__dateEstablished mesh__D020183 2000-01-01
% 217.19/217.40  |- skos__hiddenLabel mesh__D020183 Sleep-Related Dystonias
% 217.19/217.40  |- skos__hiddenLabel mesh__D020183 Dystonia, Hypnogenic Paroxysmal
% 217.19/217.40  |- skos__scopeNote mesh__D020183
% 217.19/217.40       A parasomnia characterized by paroxysmal episodes of choreoathetotic, ballistic, dystonic movements, and semipurposeful activity. The episodes occur during non-rapid eye movement sleep and typically recur several times per night. %28%Neurology 1992 Jul;42%28%7 Suppl 6%29%:61-67; Adams et al., Principles of Neurology, 6th ed, p391%29%%A%    
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D020183 2005
% 217.19/217.40  |- mesh__publicMeSHNote mesh__D020183 2000   
% 217.19/217.40  |- skos__hiddenLabel mesh__D020183 Dystonia, Nocturnal Paroxysmal
% 217.19/217.40  |- skos__hiddenLabel mesh__D020183 Dystonias, Sleep-Related
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D020183 2002
% 217.19/217.40  |- skos__altLabel mesh__D020183 Hypnogenic Paroxysmal Dystonia
% 217.19/217.40  |- skos__hiddenLabel mesh__D020183 Paroxysmal Dystonia, Hypnogenic
% 217.19/217.40  |- skos__hiddenLabel mesh__D020183 Paroxysmal Dystonias, Nocturnal
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014944 2000
% 217.19/217.40  |- mesh__dateEstablished mesh__D014944 1966-01-01
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014944 2003
% 217.19/217.40  |- skos__annotation mesh__D014944 DF: WHO      CATALOG: use NAF entry   
% 217.19/217.40  |- skos__scopeNote mesh__D014944
% 217.19/217.40       A specialized agency of the United Nations designed as a coordinating authority on international health work; its aim is to promote the attainment of the highest possible level of health by all peoples.%A%    
% 217.19/217.40  |- mesh__recordAuthorizer mesh__D014944 PLS
% 217.19/217.40  |- mesh__historyNote mesh__D014944 66%28%65%29%   
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014944 2001
% 217.19/217.40  |- mesh__publicMeSHNote mesh__D014944 66   
% 217.19/217.40  |- skos__broader mesh__D014944smesh__D014480
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014944 2004
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014944 1998
% 217.19/217.40  |- skos__prefLabel mesh__D014944 World Health Organization
% 217.19/217.40  |- rdf__type mesh__D014944sskos__Concept
% 217.19/217.40  |- skos__altLabel mesh__D014944 WHO
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014944 1999
% 217.19/217.40  |- mesh__recordOriginator mesh__D014944 NLM
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014944 1996
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014944 2002
% 217.19/217.40  |- mesh__dateRevised mesh__D014944 1995-05-23
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014944 2005
% 217.19/217.40  |- mesh__dateCreated mesh__D014944 1999-01-01
% 217.19/217.40  |- mesh__recordMaintainer mesh__D014944 KEV
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014944 1997
% 217.19/217.40  |- skos__altLabel mesh__D014944 Organization, World Health
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014944 2006
% 217.19/217.40  |- mesh__onlineNote mesh__D014146
% 217.19/217.40       use TRAINING SUPPORT to search STUDENT LOANS 1966-77   
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014146 2005
% 217.19/217.40  |- mesh__historyNote mesh__D014146
% 217.19/217.40       66; STUDENT LOANS was see under TRAINING SUPPORT 1966-77   
% 217.19/217.40  |- skos__hiddenLabel mesh__D014146 Supports, Training
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014146 2002
% 217.19/217.40  |- skos__broader mesh__D014146smesh__D012586
% 217.19/217.40  |- skos__hiddenLabel mesh__D014146 Traineeship
% 217.19/217.40  |- skos__hiddenLabel mesh__D014146 Student Loan
% 217.19/217.40  |- skos__altLabel mesh__D014146 Educational Grants and Subsidies
% 217.19/217.40  |- mesh__dateEstablished mesh__D014146 1966-01-01
% 217.19/217.40  |- skos__hiddenLabel mesh__D014146 Grant, Educational
% 217.19/217.40  |- mesh__dateRevised mesh__D014146 1999-11-03
% 217.19/217.40  |- mesh__publicMeSHNote mesh__D014146 66   
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014146 2001
% 217.19/217.40  |- mesh__dateCreated mesh__D014146 1999-01-01
% 217.19/217.40  |- skos__annotation mesh__D014146
% 217.19/217.40       SPEC qualif; specify agency or government %26% geog if possible%A%  
% 217.19/217.40  |- rdf__type mesh__D014146sskos__Concept
% 217.19/217.40  |- skos__altLabel mesh__D014146 Grants, Educational
% 217.19/217.40  |- skos__hiddenLabel mesh__D014146 Training Supports
% 217.19/217.40  |- skos__hiddenLabel mesh__D014146 Loan, Student
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014146 2000
% 217.19/217.40  |- skos__hiddenLabel mesh__D014146 Subsidy, Educational
% 217.19/217.40  |- skos__broader mesh__D014146smesh__D005378
% 217.19/217.40  |- skos__scopeNote mesh__D014146
% 217.19/217.40       Financial support for training including both student stipends and loans and training grants to institutions.%A%    
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014146 2004
% 217.19/217.40  |- mesh__recordMaintainer mesh__D014146 kle
% 217.19/217.40  |- skos__prefLabel mesh__D014146 Training Support
% 217.19/217.40  |- skos__hiddenLabel mesh__D014146 Loans, Student
% 217.19/217.40  |- mesh__recordOriginator mesh__D014146 NLM
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014146 2006
% 217.19/217.40  |- skos__altLabel mesh__D014146 Educational Subsidies
% 217.19/217.40  |- skos__hiddenLabel mesh__D014146 Support, Training
% 217.19/217.40  |- mesh__recordAuthorizer mesh__D014146 sjn
% 217.19/217.40  |- skos__hiddenLabel mesh__D014146 Educational Grant
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D014146 2003
% 217.19/217.40  |- skos__hiddenLabel mesh__D014146 Educational Subsidy
% 217.19/217.40  |- skos__hiddenLabel mesh__D008907 Mink, Sea
% 217.19/217.40  |- mesh__dateEstablished mesh__D008907 1968-01-01
% 217.19/217.40  |- mesh__historyNote mesh__D008907 68   
% 217.19/217.40  |- skos__altLabel mesh__D008907 European Mink
% 217.19/217.40  |- skos__altLabel mesh__D008907 American Mink
% 217.19/217.40  |- mesh__publicMeSHNote mesh__D008907 68   
% 217.19/217.40  |- skos__prefLabel mesh__D008907 Mink
% 217.19/217.40  |- skos__hiddenLabel mesh__D008907 Sea Minks
% 217.19/217.40  |- skos__hiddenLabel mesh__D008907 Mink, European
% 217.19/217.40  |- skos__altLabel mesh__D008907 Sea Mink
% 217.19/217.40  |- mesh__dateCreated mesh__D008907 1999-01-01
% 217.19/217.40  |- skos__broader mesh__D008907smesh__D045969
% 217.19/217.40  |- skos__scopeNote mesh__D008907
% 217.19/217.40       Carnivores of genus Mustela of the family MUSTELIDAE. The European mink, which has white upper and lower lips, was widely trapped for commercial purposes and is classified as endangered. The American mink, lacking a white upper lip, is farmed commercially.%A%    
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D008907 2006
% 217.19/217.40  |- mesh__dateRevised mesh__D008907 2004-07-07
% 217.19/217.40  |- mesh__recordAuthorizer mesh__D008907 sjn
% 217.19/217.40  |- skos__hiddenLabel mesh__D008907 Minks, Sea
% 217.19/217.40  |- skos__historyNote mesh__D008907 Carnivora %28%1966-1967%29%
% 217.19/217.40  |- rdf__type mesh__D008907sskos__Concept
% 217.19/217.40  |- skos__hiddenLabel mesh__D008907 Mink, American
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D008907 2005
% 217.19/217.40  |- mesh__recordMaintainer mesh__D008907 ags
% 217.19/217.40  |- mesh__recordOriginator mesh__D008907 NLM
% 217.19/217.40  |- skos__hiddenLabel mesh__D008907 Minks
% 217.19/217.40  |- mesh__dateEstablished mesh__D000924 1966-01-01
% 217.19/217.40  |- mesh__recordOriginator mesh__D000924 NLM
% 217.19/217.40  |- skos__altLabel mesh__D000924 Anticholesteremics
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D000924 2004
% 217.19/217.40  |- skos__altLabel mesh__D000924 Cholesterol Inhibitors
% 217.19/217.40  |- mesh__activeMeSHYear mesh__D000924 2005
% 217.19/217.40  |- rdf__type mesh__D000924sskos__Concept
% 217.19/217.40  |- skos__hiddenLabel mesh__D000924 Agents, Anticholesteremic
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D000924 2006
% 217.19/217.41  |- mesh__recordAuthorizer mesh__D000924 sjn
% 217.19/217.41  |- skos__altLabel mesh__D000924 Anticholesteremic Drugs
% 217.19/217.41  |- mesh__recordMaintainer mesh__D000924 ssb
% 217.19/217.41  |- mesh__dateRevised mesh__D000924 2003-07-09
% 217.19/217.41  |- skos__scopeNote mesh__D000924
% 217.19/217.41       Substances used to lower plasma cholesterol levels.     
% 217.19/217.41  |- mesh__publicMeSHNote mesh__D000924 66   
% 217.19/217.41  |- skos__broader mesh__D000924smesh__D000960
% 217.19/217.41  |- mesh__historyNote mesh__D000924 66%28%64%29%   
% 217.19/217.41  |- skos__hiddenLabel mesh__D000924 Drugs, Anticholesteremic
% 217.19/217.41  |- mesh__dateCreated mesh__D000924 1999-01-01
% 217.19/217.41  |- skos__prefLabel mesh__D000924 Anticholesteremic Agents
% 217.19/217.41  |- skos__altLabel mesh__D000924 Inhibitors, Cholesterol
% 217.19/217.41  |- skos__hiddenLabel mesh__D000924 Agents, Hypocholesteremic
% 217.19/217.41  |- skos__broader mesh__D008109smesh__D008107
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D008109 2006
% 217.19/217.41  |- skos__annotation mesh__D008109
% 217.19/217.41       coord IM with specific parasitic dis %28%IM%29% but note that also available are ECHINOCOCCOSIS, HEPATIC; FASCIOLIASIS %26% LIVER ABSCESS, AMEBIC%A%  
% 217.19/217.41  |- skos__scopeNote mesh__D008109
% 217.19/217.41       Liver diseases caused by infections with PARASITES, such as tapeworms %28%CESTODA%29% and flukes %28%TREMATODA%29%.%A%    
% 217.19/217.41  |- skos__altLabel mesh__D008109 Parasitic Liver Diseases
% 217.19/217.41  |- mesh__recordMaintainer mesh__D008109 lkt
% 217.19/217.41  |- skos__broader mesh__D008109smesh__D010272
% 217.19/217.41  |- skos__hiddenLabel mesh__D008109 Liver Disease, Parasitic
% 217.19/217.41  |- mesh__dateCreated mesh__D008109 1999-01-01
% 217.19/217.41  |- skos__hiddenLabel mesh__D008109 Parasitic Liver Disease
% 217.19/217.41  |- mesh__dateRevised mesh__D008109 2004-07-07
% 217.19/217.41  |- mesh__recordAuthorizer mesh__D008109 sjn
% 217.19/217.41  |- skos__hiddenLabel mesh__D008109 Disease, Parasitic Liver
% 217.19/217.41  |- mesh__recordOriginator mesh__D008109 NLM
% 217.19/217.41  |- skos__prefLabel mesh__D008109 Liver Diseases, Parasitic
% 217.19/217.41  |- rdf__type mesh__D008109sskos__Concept
% 217.19/217.41  |- skos__hiddenLabel mesh__D008109 Diseases, Parasitic Liver
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D008109 2005
% 217.19/217.41  |- skos__prefLabel mesh__D000126 Achlorhydria
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D000126 2006
% 217.19/217.41  |- skos__broader mesh__D000126smesh__D013272
% 217.19/217.41  |- rdf__type mesh__D000126sskos__Concept
% 217.19/217.41  |- mesh__recordOriginator mesh__D000126 NLM
% 217.19/217.41  |- mesh__onlineNote mesh__D000126
% 217.19/217.41       use ACHLORHYDRIA to search ACHYLIA GASTRICA 1966-78   
% 217.19/217.41  |- mesh__publicMeSHNote mesh__D000126
% 217.19/217.41       ACHYLIA GASTRICA was see under ACHLORHYDRIA 1963-78   
% 217.19/217.41  |- skos__broader mesh__D000126smesh__D000137
% 217.19/217.41  |- mesh__dateRevised mesh__D000126 2003-07-09
% 217.19/217.41  |- skos__related mesh__D000126smesh__D005750
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D000126 2004
% 217.19/217.41  |- skos__scopeNote mesh__D000126
% 217.19/217.41       A lack of HYDROCHLORIC ACID in GASTRIC JUICE despite stimulation of gastric secretion.%A%    
% 217.19/217.41  |- mesh__historyNote mesh__D000126
% 217.19/217.41       ACHYLIA GASTRICA was see under ACHLORHYDRIA 1963-78   
% 217.19/217.41  |- mesh__recordAuthorizer mesh__D000126 sjn
% 217.19/217.41  |- mesh__recordMaintainer mesh__D000126 lkt
% 217.19/217.41  |- mesh__dateCreated mesh__D000126 1999-01-01
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D000126 2005
% 217.19/217.41  |- skos__altLabel mesh__D000126 Achylia Gastrica
% 217.19/217.41  |- skos__broader mesh__D006454Q000652smesh__D006454
% 217.19/217.41  |- mesh__preferredCombination mesh__D006454Q000652smesh__D006456
% 217.19/217.41  |- rdf__type mesh__D006454Q000652smesh__CompoundConcept
% 217.19/217.41  |- mesh__recordMaintainer mesh__D046228 nns
% 217.19/217.41  |- skos__prefLabel mesh__D046228 Microarray Analysis
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D046228 2006
% 217.19/217.41  |- skos__hiddenLabel mesh__D046228 Microarray Microchip
% 217.19/217.41  |- skos__hiddenLabel mesh__D046228 Devices, Microarray Analytical
% 217.19/217.41  |- rdf__type mesh__D046228sskos__Concept
% 217.19/217.41  |- skos__broader mesh__D046228smesh__D046208
% 217.19/217.41  |- skos__hiddenLabel mesh__D046228 Device, Nanoarray Analytical
% 217.19/217.41  |- mesh__recordOriginator mesh__D046228 nns
% 217.19/217.41  |- skos__hiddenLabel mesh__D046228 Microchips, Microarray
% 217.19/217.41  |- skos__hiddenLabel mesh__D046228 Nanoarray Analytical Device
% 217.19/217.41  |- skos__hiddenLabel mesh__D046228 Analytical Devices, Nanoarray
% 217.19/217.41  |- skos__hiddenLabel mesh__D046228 Analysis, Microarray
% 217.19/217.41  |- skos__annotation mesh__D046228 general; prefer specifics   
% 217.19/217.41  |- skos__hiddenLabel mesh__D046228 Microarray Analytical Device
% 217.19/217.41  |- mesh__publicMeSHNote mesh__D046228 2005   
% 217.19/217.41  |- skos__hiddenLabel mesh__D046228 Analytical Device, Nanoarray
% 217.19/217.41  |- mesh__historyNote mesh__D046228 2005   
% 217.19/217.41  |- mesh__dateCreated mesh__D046228 2004-07-07
% 217.19/217.41  |- mesh__recordAuthorizer mesh__D046228 sjn
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D046228 2005
% 217.19/217.41  |- skos__hiddenLabel mesh__D046228 Microchip, Microarray
% 217.19/217.41  |- skos__hiddenLabel mesh__D046228 Device, Microarray Analytical
% 217.19/217.41  |- skos__hiddenLabel mesh__D046228 Analytical Device, Microarray
% 217.19/217.41  |- skos__hiddenLabel mesh__D046228 Analytical Devices, Microarray
% 217.19/217.41  |- skos__altLabel mesh__D046228 Microarray Microchips
% 217.19/217.41  |- skos__scopeNote mesh__D046228
% 217.19/217.41       The simultaneous analysis, on a microchip, of multiple samples or targets arranged in an array format.%A%    
% 217.19/217.41  |- skos__hiddenLabel mesh__D046228 Devices, Nanoarray Analytical
% 217.19/217.41  |- mesh__dateEstablished mesh__D046228 2005-01-01
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D018537 2006
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D018537 2003
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D018537 1998
% 217.19/217.41  |- skos__annotation mesh__D018537
% 217.19/217.41       1st planet from sun with no moons; no qualif   
% 217.19/217.41  |- mesh__dateEstablished mesh__D018537 1995-01-01
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D018537 2004
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D018537 1999
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D018537 1996
% 217.19/217.41  |- skos__prefLabel mesh__D018537 Mercury %28%Planet%29%
% 217.19/217.41  |- rdf__type mesh__D018537sskos__Concept
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D018537 1997
% 217.19/217.41  |- skos__historyNote mesh__D018537 Planets %28%1991-1994%29%
% 217.19/217.41  |- mesh__dateCreated mesh__D018537 1994-06-07
% 217.19/217.41  |- skos__historyNote mesh__D018537
% 217.19/217.41       Extraterrestrial Environment %28%1966-1990%29%
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D018537 2000
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D018537 2001
% 217.19/217.41  |- mesh__publicMeSHNote mesh__D018537 95   
% 217.19/217.41  |- mesh__historyNote mesh__D018537 95   
% 217.19/217.41  |- skos__scopeNote mesh__D018537
% 217.19/217.41       The first planet in order from the sun. It has no known natural satellites. It is one of the four inner or terrestrial planets of the solar system.%A%    
% 217.19/217.41  |- skos__broader mesh__D018537smesh__D016083
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D018537 2005
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D018537 2002
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D018537 1995
% 217.19/217.41  |- skos__hiddenLabel mesh__D010554 Impulse Ridden Personality
% 217.19/217.41  |- mesh__dateRevised mesh__D010554 1997-06-20
% 217.19/217.41  |- skos__historyNote mesh__D010554 Personality %28%1966-1967%29%
% 217.19/217.41  |- skos__hiddenLabel mesh__D010554 Personality Disorder
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D010554 2000
% 217.19/217.41  |- skos__scopeNote mesh__D010554
% 217.19/217.41       A major deviation from normal patterns of behavior.     
% 217.19/217.41  |- skos__hiddenLabel mesh__D010554 Personality Disorders, Avoidant
% 217.19/217.41  |- mesh__dateCreated mesh__D010554 1999-01-01
% 217.19/217.41  |- skos__hiddenLabel mesh__D010554 Personality Disorder, Narcissistic
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D010554 2004
% 217.19/217.41  |- skos__broader mesh__D010554smesh__D001523
% 217.19/217.41  |- rdf__type mesh__D010554sskos__Concept
% 217.19/217.41  |- mesh__historyNote mesh__D010554
% 217.19/217.41       68; AS IF PERSONALITY was see under PERSONALITY DISORDERS 1975-78; IMPULSE-RIDDEN PERSONALITY %26% INADEQUATE PERSONALITY were see under PERSONALITY DISORDERS 1968-78%A%  
% 217.19/217.41  |- skos__hiddenLabel mesh__D010554 Avoidant Personality Disorders
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D010554 2001
% 217.19/217.41  |- mesh__recordMaintainer mesh__D010554 JLS
% 217.19/217.41  |- mesh__recordAuthorizer mesh__D010554 SJN
% 217.19/217.41  |- mesh__dateEstablished mesh__D010554 1968-01-01
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D010554 1998
% 217.19/217.41  |- skos__hiddenLabel mesh__D010554 Personality, Impulse-Ridden
% 217.19/217.41  |- skos__hiddenLabel mesh__D010554 Personality Disorder, Avoidant
% 217.19/217.41  |- mesh__onlineNote mesh__D010554
% 217.19/217.41       use PERSONALITY DISORDERS to search AS IF PERSONALITY 1975-78 %26% IMPULSE-RIDDEN PERSONALITY %26% INADEQUATE PERSONALITY 1968-78%A%  
% 217.19/217.41  |- skos__hiddenLabel mesh__D010554 Personality, As If
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D010554 1999
% 217.19/217.41  |- mesh__publicMeSHNote mesh__D010554 68   
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D010554 2005
% 217.19/217.41  |- mesh__recordOriginator mesh__D010554 NLM
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D010554 2002
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D010554 2006
% 217.19/217.41  |- skos__prefLabel mesh__D010554 Personality Disorders
% 217.19/217.41  |- skos__historyNote mesh__D010554 Mental Disorders %28%1966-1967%29%
% 217.19/217.41  |- skos__hiddenLabel mesh__D010554 Personality, Inadequate
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D010554 2003
% 217.19/217.41  |- mesh__historyNote mesh__D004517 98; use explode 1975-97   
% 217.19/217.41  |- skos__altLabel mesh__D004517 Professional Education
% 217.19/217.41  |- mesh__publicMeSHNote mesh__D004517 98   
% 217.19/217.41  |- mesh__recordMaintainer mesh__D004517 TGC
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D004517 2003
% 217.19/217.41  |- mesh__recordAuthorizer mesh__D004517 SJN
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D004517 2000
% 217.19/217.41  |- mesh__dateEstablished mesh__D004517 1998-01-01
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D004517 2004
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D004517 1998
% 217.19/217.41  |- skos__prefLabel mesh__D004517 Education, Professional
% 217.19/217.41  |- mesh__dateRevised mesh__D004517 1997-06-20
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D004517 2001
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D004517 2005
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D004517 1999
% 217.19/217.41  |- skos__broader mesh__D004517smesh__D004493
% 217.19/217.41  |- skos__annotation mesh__D004517
% 217.19/217.41       GEN or unspecified; prefer specifics; DF: EDUC PROFESSIONAL%A%  
% 217.19/217.41  |- mesh__dateCreated mesh__D004517 1999-01-01
% 217.19/217.41  |- skos__scopeNote mesh__D004517
% 217.19/217.41       Formal education and training in preparation for the practice of a profession.%A%    
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D004517 2002
% 217.19/217.41  |- mesh__recordOriginator mesh__D004517 NLM
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D004517 2006
% 217.19/217.41  |- rdf__type mesh__D004517sskos__Concept
% 217.19/217.41  |- skos__hiddenLabel mesh__D009202 Diseases, Myocardial
% 217.19/217.41  |- skos__hiddenLabel mesh__D009202 Primary Cardiomyopathies
% 217.19/217.41  |- skos__prefLabel mesh__D009202 Cardiomyopathies
% 217.19/217.41  |- skos__hiddenLabel mesh__D009202 Diseases, Primary Myocardial
% 217.19/217.41  |- mesh__publicMeSHNote mesh__D009202
% 217.19/217.41       2005; see MYOCARDIAL DISEASES 1979-2004; MYOCARDIAL DISEASES, PRIMARY %26% MYOCARDIAL DISEASES, SECONDARY were headings 1966-1978%A%  
% 217.19/217.41  |- skos__hiddenLabel mesh__D009202 Disease, Secondary Myocardial
% 217.19/217.41  |- skos__altLabel mesh__D009202 Secondary Myocardial Diseases
% 217.19/217.41  |- skos__hiddenLabel mesh__D009202 Secondary Cardiomyopathies
% 217.19/217.41  |- skos__broader mesh__D009202smesh__D006331
% 217.19/217.41  |- rdf__type mesh__D009202sskos__Concept
% 217.19/217.41  |- skos__altLabel mesh__D009202 Myocardial Diseases
% 217.19/217.41  |- skos__hiddenLabel mesh__D009202 Secondary Cardiomyopathy
% 217.19/217.41  |- mesh__dateCreated mesh__D009202 1978-05-19
% 217.19/217.41  |- mesh__historyNote mesh__D009202 2005 %28%1979%29%   
% 217.19/217.41  |- mesh__dateRevised mesh__D009202 2004-07-19
% 217.19/217.41  |- skos__scopeNote mesh__D009202
% 217.19/217.41       A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features %28%DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY%29% or their etiological/pathological factors %28%CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS%29%.%A%    
% 217.19/217.41  |- skos__altLabel mesh__D009202 Myocardiopathies
% 217.19/217.41  |- skos__hiddenLabel mesh__D009202 Cardiomyopathy, Secondary
% 217.19/217.41  |- skos__hiddenLabel mesh__D009202 Primary Myocardial Disease
% 217.19/217.41  |- skos__hiddenLabel mesh__D009202 Disease, Myocardial
% 217.19/217.41  |- mesh__recordMaintainer mesh__D009202 lkt
% 217.19/217.41  |- skos__altLabel mesh__D009202 Primary Myocardial Diseases
% 217.19/217.41  |- skos__hiddenLabel mesh__D009202 Myocardial Disease, Secondary
% 217.19/217.41  |- skos__hiddenLabel mesh__D009202 Secondary Myocardial Disease
% 217.19/217.41  |- skos__hiddenLabel mesh__D009202 Diseases, Secondary Myocardial
% 217.19/217.41  |- skos__hiddenLabel mesh__D009202 Cardiomyopathy, Primary
% 217.19/217.41  |- skos__hiddenLabel mesh__D009202 Myocardiopathy
% 217.19/217.41  |- skos__hiddenLabel mesh__D009202 Cardiomyopathy
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D009202 2006
% 217.19/217.41  |- skos__altLabel mesh__D009202 Myocardial Diseases, Secondary
% 217.19/217.41  |- mesh__dateEstablished mesh__D009202 1979-01-01
% 217.19/217.41  |- skos__altLabel mesh__D009202 Myocardial Diseases, Primary
% 217.19/217.41  |- mesh__recordOriginator mesh__D009202 VDK
% 217.19/217.41  |- skos__hiddenLabel mesh__D009202 Myocardial Disease, Primary
% 217.19/217.41  |- mesh__recordAuthorizer mesh__D009202 sjn
% 217.19/217.41  |- skos__hiddenLabel mesh__D009202 Primary Cardiomyopathy
% 217.19/217.41  |- skos__hiddenLabel mesh__D009202 Disease, Primary Myocardial
% 217.19/217.41  |- skos__annotation mesh__D009202
% 217.19/217.41       GEN; prefer specifics; for infections of the myocardium, coord here %28%IM%29% with infection term %28%IM%29%, not with HEART DISEASES%A%  
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D009202 2005
% 217.19/217.41  |- skos__hiddenLabel mesh__D009202 Myocardial Disease
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Nocturnus, Childhood Pavor
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Adult Night Terror
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Terror, Sleep
% 217.19/217.41  |- skos__altLabel mesh__D020184 Pavor Nocturnus, Childhood
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Primary Night Terrors
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Night Terror, Childhood
% 217.19/217.41  |- skos__altLabel mesh__D020184 Pavor Nocturnus, Adult
% 217.19/217.41  |- mesh__dateEstablished mesh__D020184 2000-01-01
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D020184 2005
% 217.19/217.41  |- mesh__publicMeSHNote mesh__D020184
% 217.19/217.41       2000; see SLEEP DISORDERS 1981-1999; for SLEEP TERROR DISORDER see SLEEP DISORDERS 1981-1999%A%  
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Terrors, Primary Night
% 217.19/217.41  |- skos__altLabel mesh__D020184 Sleep Terrors
% 217.19/217.41  |- mesh__dateRevised mesh__D020184 2001-07-25
% 217.19/217.41  |- skos__prefLabel mesh__D020184 Night Terrors
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Childhood Night Terror
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Adult Pavor Nocturnus
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Nocturnus, Adult Pavor
% 217.19/217.41  |- mesh__recordAuthorizer mesh__D020184 sjn
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D020184 2006
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Childhood Pavor Nocturnus
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Terrors, Adult Night
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Primary Night Terror
% 217.19/217.41  |- skos__altLabel mesh__D020184 Sleep Terror Disorder
% 217.19/217.41  |- skos__altLabel mesh__D020184 Pavor Nocturnus
% 217.19/217.41  |- mesh__recordMaintainer mesh__D020184 nns
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Terror, Adult Night
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Secondary Night Terrors
% 217.19/217.41  |- mesh__recordOriginator mesh__D020184 KEV
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D020184 2002
% 217.19/217.41  |- rdf__type mesh__D020184sskos__Concept
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D020184 2003
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Night Terror, Secondary
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Terror, Primary Night
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Terror, Secondary Night
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Secondary Night Terror
% 217.19/217.41  |- mesh__dateCreated mesh__D020184 1999-11-03
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Terrors, Sleep
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Adult Night Terrors
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Terrors, Childhood Night
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D020184 2004
% 217.19/217.41  |- mesh__historyNote mesh__D020184
% 217.19/217.41       2000; use SLEEP DISORDERS 1981-1999; for SLEEP TERROR DISORDER use SLEEP DISORDERS 1981-1999%A%  
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Terrors, Secondary Night
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Childhood Night Terrors
% 217.19/217.41  |- skos__broader mesh__D020184smesh__D020921
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Night Terror, Adult
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Night Terror, Primary
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Terror, Childhood Night
% 217.19/217.41  |- skos__historyNote mesh__D020184 Sleep Disorders %28%1969-1999%29%
% 217.19/217.41  |- skos__hiddenLabel mesh__D020184 Sleep Terror
% 217.19/217.41  |- skos__scopeNote mesh__D020184
% 217.19/217.41       A disorder characterized by incomplete arousals from sleep associated with behavior suggesting extreme fright. This condition primarily affects children and young adults and the individual generally has no recall of the event. Episodes tend to occur during stage III or IV. SOMNAMBULISM is frequently associated with this condition. %28%Adams et al., Principles of Neurology, 6th ed, p391%29%%A%    
% 217.19/217.41  |- rdf__type mesh__D014945sskos__Concept
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D014945 2002
% 217.19/217.41  |- skos__prefLabel mesh__D014945 Wound Healing
% 217.19/217.41  |- mesh__recordAuthorizer mesh__D014945 sjn
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D014945 2005
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D014945 2000
% 217.19/217.41  |- mesh__dateRevised mesh__D014945 1999-11-03
% 217.19/217.41  |- mesh__dateCreated mesh__D014945 1999-01-01
% 217.19/217.41  |- skos__annotation mesh__D014945
% 217.19/217.41       also available is FRACTURE HEALING; not for invertebrates or plants%A%  
% 217.19/217.41  |- skos__related mesh__D014945smesh__D006097
% 217.19/217.41  |- skos__hiddenLabel mesh__D014945 Healing, Wound
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D014945 2006
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D014945 2001
% 217.19/217.41  |- skos__hiddenLabel mesh__D014945 Wound Healings
% 217.19/217.41  |- skos__related mesh__D014945smesh__D002921
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D014945 2003
% 217.19/217.41  |- mesh__recordMaintainer mesh__D014945 jmp
% 217.19/217.41  |- skos__hiddenLabel mesh__D014945 Healings, Wound
% 217.19/217.41  |- skos__broader mesh__D014945smesh__D012038
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D014945 2004
% 217.19/217.41  |- skos__scopeNote mesh__D014945
% 217.19/217.41       Restoration of integrity to traumatized tissue.     
% 217.19/217.41  |- mesh__recordOriginator mesh__D014945 NLM
% 217.19/217.41  |- skos__historyNote mesh__D014147 Anisoles %28%1974%29%
% 217.19/217.41  |- mesh__recordOriginator mesh__D014147 NLM
% 217.19/217.41  |- skos__hiddenLabel mesh__D014147 Hydrochloride, Tramadol
% 217.19/217.41  |- skos__scopeNote mesh__D014147
% 217.19/217.41       A narcotic analgesic proposed for severe pain. It may be habituating.%A%    
% 217.19/217.41  |- mesh__recordAuthorizer mesh__D014147 sjn
% 217.19/217.41  |- skos__hiddenLabel mesh__D014147 K 315
% 217.19/217.41  |- mesh__recordMaintainer mesh__D014147 ssb
% 217.19/217.41  |- mesh__publicMeSHNote mesh__D014147
% 217.19/217.41       91; was see under CYCLOHEXANOLS 1975-90   
% 217.19/217.41  |- rdf__type mesh__D014147sskos__Concept
% 217.19/217.41  |- mesh__dateEstablished mesh__D014147 1991-01-01
% 217.19/217.41  |- mesh__historyNote mesh__D014147
% 217.19/217.41       91%28%75%29%; was see under CYCLOHEXANOLS 1975-90   
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D014147 2002
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D014147 2004
% 217.19/217.41  |- mesh__dateRevised mesh__D014147 2001-07-25
% 217.19/217.41  |- skos__historyNote mesh__D014147 Dimethylamines %28%1974%29%
% 217.19/217.41  |- skos__broader mesh__D014147smesh__D003511
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D014147 2006
% 217.19/217.41  |- skos__prefLabel mesh__D014147 Tramadol
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D014147 2003
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D014147 2005
% 217.19/217.41  |- skos__historyNote mesh__D014147 Cyclohexanols %28%1974%29%
% 217.19/217.41  |- skos__hiddenLabel mesh__D014147 K315
% 217.19/217.41  |- mesh__dateCreated mesh__D014147 1974-11-19
% 217.19/217.41  |- mesh__historyNote mesh__D008908
% 217.19/217.41       91%28%86%29%; was see under MOUSE LEUKEMIA VIRUSES 1986-90   
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D008908 2003
% 217.19/217.41  |- mesh__dateEstablished mesh__D008908 1991-01-01
% 217.19/217.41  |- skos__historyNote mesh__D008908 Friend Virus %28%1966-1985%29%
% 217.19/217.41  |- skos__hiddenLabel mesh__D008908 MCF Virus
% 217.19/217.41  |- skos__hiddenLabel mesh__D008908 Viruses, MCF
% 217.19/217.41  |- mesh__recordAuthorizer mesh__D008908 sjn
% 217.19/217.41  |- skos__altLabel mesh__D008908 MCF Viruses
% 217.19/217.41  |- skos__prefLabel mesh__D008908 Mink Cell Focus-Inducing Viruses
% 217.19/217.41  |- skos__hiddenLabel mesh__D008908 Mink Cell Focus Inducing Viruses
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D008908 2004
% 217.19/217.41  |- mesh__dateRevised mesh__D008908 2002-07-03
% 217.19/217.41  |- skos__annotation mesh__D008908
% 217.19/217.41       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% + LEUKEMIA, EXPERIMENTAL %28%IM%29% or LEUKEMIA %28%IM%29% %28%for spontaneous leukemia%29%%A%  
% 217.19/217.41  |- mesh__dateCreated mesh__D008908 1985-05-09
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D008908 2005
% 217.19/217.41  |- skos__scopeNote mesh__D008908
% 217.19/217.41       Strains of Murine leukemia virus %28%LEUKEMIA VIRUS, MURINE%29% discovered in 1976 by Hartley, Wolford, Old, and Rowe and so named because the viruses originally isolated had the capacity to transform cell foci in mink cell cultures. MCF viruses are generated in a multi-step process by recombination with other viral types including AKR, Friend, Moloney, and Rauscher.%A%    
% 217.19/217.41  |- mesh__recordOriginator mesh__D008908 RC
% 217.19/217.41  |- skos__historyNote mesh__D008908 Mouse Leukemia Viruses %28%1966-1985%29%
% 217.19/217.41  |- skos__broader mesh__D008908smesh__D009052
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D008908 2006
% 217.19/217.41  |- mesh__publicMeSHNote mesh__D008908
% 217.19/217.41       91; was see under MOUSE LEUKEMIA VIRUSES 1986-90   
% 217.19/217.41  |- mesh__recordMaintainer mesh__D008908 ags
% 217.19/217.41  |- skos__historyNote mesh__D008908 Leukemia, Experimental %28%1966-1985%29%
% 217.19/217.41  |- rdf__type mesh__D008908sskos__Concept
% 217.19/217.41  |- skos__hiddenLabel mesh__D008908 Virus, MCF
% 217.19/217.41  |- skos__scopeNote mesh__D000925
% 217.19/217.41       Agents that prevent blood clotting. Naturally occurring agents in the blood are included only when they are used as drugs.%A%    
% 217.19/217.41  |- mesh__dateRevised mesh__D000925 2005-06-30
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D000925 2006
% 217.19/217.41  |- rdf__type mesh__D000925sskos__Concept
% 217.19/217.41  |- skos__broader mesh__D000925smesh__D006401
% 217.19/217.41  |- mesh__recordOriginator mesh__D000925 NLM
% 217.19/217.41  |- skos__annotation mesh__D000925
% 217.19/217.41       not for circulating natural anticoagulants; consider also BLOOD COAGULATION /drug eff %26% THROMBOSIS /drug ther or related dis with /drug ther; DF: ANTICOAG%A%  
% 217.19/217.41  |- skos__hiddenLabel mesh__D000925 Agents, Anticoagulant
% 217.19/217.41  |- mesh__dateCreated mesh__D000925 1999-01-01
% 217.19/217.41  |- mesh__recordAuthorizer mesh__D000925 sjn
% 217.19/217.41  |- skos__altLabel mesh__D000925 Anticoagulant Agents
% 217.19/217.41  |- mesh__recordMaintainer mesh__D000925 ssb
% 217.19/217.41  |- skos__hiddenLabel mesh__D000925 Drugs, Anticoagulant
% 217.19/217.41  |- skos__altLabel mesh__D000925 Anticoagulant Drugs
% 217.19/217.41  |- skos__prefLabel mesh__D000925 Anticoagulants
% 217.19/217.41  |- skos__prefLabel mesh__D033301 Deciduoma
% 217.19/217.41  |- skos__historyNote mesh__D033301 Decidua %28%1966-2001%29%
% 217.19/217.41  |- mesh__dateCreated mesh__D033301 2002-07-03
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D033301 2005
% 217.19/217.41  |- skos__historyNote mesh__D033301 Pregnancy %28%1967-2001%29%
% 217.19/217.41  |- mesh__publicMeSHNote mesh__D033301
% 217.19/217.41       2003; see  HYPERPLASIA 2002, see DECIDUA 1998-2001   
% 217.19/217.41  |- skos__broader mesh__D033301smesh__D003656
% 217.19/217.41  |- mesh__dateEstablished mesh__D033301 2003-01-01
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D033301 2006
% 217.19/217.41  |- rdf__type mesh__D033301sskos__Concept
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D033301 2003
% 217.19/217.41  |- skos__historyNote mesh__D033301 Pseudopregnancy %28%1966-2001%29%
% 217.19/217.41  |- skos__scopeNote mesh__D033301
% 217.19/217.41       An intrauterine mass containing decidual cells %28%DECIDUA%29% or with structures resembling the PLACENTA. Deciduomas usually are induced experimentally.%A%    
% 217.19/217.41  |- skos__hiddenLabel mesh__D033301 Deciduomas
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D033301 2004
% 217.19/217.41  |- mesh__historyNote mesh__D033301
% 217.19/217.41       2003; use HYPERPLASIA 2002, use DECIDUA 1998-2001   
% 217.19/217.41  |- skos__historyNote mesh__D033301 Hyperplasia %28%2002%29%
% 217.19/217.41  |- rdf__type mesh__D000127sskos__Concept
% 217.19/217.41  |- mesh__recordMaintainer mesh__D000127 SYSTEM
% 217.19/217.41  |- skos__historyNote mesh__D000127 Mycoplasma %28%1966-1975%29%
% 217.19/217.41  |- mesh__dateCreated mesh__D000127 1975-07-25
% 217.19/217.41  |- skos__prefLabel mesh__D000127 Acholeplasma
% 217.19/217.41  |- mesh__dateEstablished mesh__D000127 1976-01-01
% 217.19/217.41  |- skos__scopeNote mesh__D000127
% 217.19/217.41       A genus of gram-negative organisms including saprophytic and parasitic or pathogenic species.%A%    
% 217.19/217.41  |- mesh__dateRevised mesh__D000127 2005-06-30
% 217.19/217.41  |- mesh__historyNote mesh__D000127 76   
% 217.19/217.41  |- mesh__publicMeSHNote mesh__D000127 76   
% 217.19/217.41  |- mesh__recordOriginator mesh__D000127 JW
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D000127 2006
% 217.19/217.41  |- mesh__recordAuthorizer mesh__D000127 sjn
% 217.19/217.41  |- skos__broader mesh__D000127smesh__D000129
% 217.19/217.41  |- mesh__recordMaintainer mesh__D005610 jrf
% 217.19/217.41  |- mesh__historyNote mesh__D005610
% 217.19/217.41       91%28%78%29%; was see under HUMAN RIGHTS 1978-90   
% 217.19/217.41  |- mesh__publicMeSHNote mesh__D005610
% 217.19/217.41       91; was see under HUMAN RIGHTS 1978-90   
% 217.19/217.41  |- skos__broader mesh__D005610smesh__D006806
% 217.19/217.41  |- mesh__recordOriginator mesh__D005610 EC
% 217.19/217.41  |- skos__scopeNote mesh__D005610
% 217.19/217.41       The rights of individuals to act and make decisions without external constraints.%A%    
% 217.19/217.41  |- rdf__type mesh__D005610sskos__Concept
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D005610 2003
% 217.19/217.41  |- skos__historyNote mesh__D005610 Civil Rights %28%1968-1977%29%
% 217.19/217.41  |- mesh__dateCreated mesh__D005610 1977-04-22
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D005610 2005
% 217.19/217.41  |- skos__historyNote mesh__D005610 Human Rights %28%1973-1977%29%
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D005610 2004
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D005610 2006
% 217.19/217.41  |- skos__prefLabel mesh__D005610 Freedom
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D005610 2002
% 217.19/217.41  |- skos__altLabel mesh__D005610 Liberty
% 217.19/217.41  |- mesh__dateRevised mesh__D005610 2001-07-25
% 217.19/217.41  |- skos__hiddenLabel mesh__D005610 Freedoms
% 217.19/217.41  |- mesh__dateEstablished mesh__D005610 1991-01-01
% 217.19/217.41  |- skos__historyNote mesh__D005610 Philosophy %28%1966-1977%29%
% 217.19/217.41  |- mesh__recordAuthorizer mesh__D005610 sjn
% 217.19/217.41  |- mesh__dateCreated mesh__D018538 1994-06-07
% 217.19/217.41  |- skos__prefLabel mesh__D018538 Jupiter
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D018538 2000
% 217.19/217.41  |- mesh__publicMeSHNote mesh__D018538 95   
% 217.19/217.41  |- skos__historyNote mesh__D018538 Planets %28%1991-1994%29%
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D018538 2004
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D018538 2006
% 217.19/217.41  |- mesh__dateEstablished mesh__D018538 1995-01-01
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D018538 1997
% 217.19/217.41  |- mesh__activeMeSHYear mesh__D018538 2003
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D018538 2005
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D018538 1999
% 217.19/217.42  |- mesh__historyNote mesh__D018538 95   
% 217.19/217.42  |- skos__annotation mesh__D018538
% 217.19/217.42       5th planet from sun with 16 moons; no qualif   
% 217.19/217.42  |- skos__scopeNote mesh__D018538
% 217.19/217.42       The fifth planet in order from the sun. It is one of the five outer planets of the solar system. Its sixteen natural satellites include Callisto, Europa, Ganymede, and Io.%A%    
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D018538 1996
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D018538 1995
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D018538 2002
% 217.19/217.42  |- rdf__type mesh__D018538sskos__Concept
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D018538 1998
% 217.19/217.42  |- skos__broader mesh__D018538smesh__D016083
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D018538 2001
% 217.19/217.42  |- skos__historyNote mesh__D018538
% 217.19/217.42       Extraterrestrial Environment %28%1966-1990%29%
% 217.19/217.42  |- skos__hiddenLabel mesh__D010555 Indicator, Myers-Briggs Type
% 217.19/217.42  |- skos__scopeNote mesh__D010555
% 217.19/217.42       Check list, usually to be filled out by a person about himself, consisting of many statements about personal characteristics which the subject checks.%A%    
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010555 2006
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010555 2000
% 217.19/217.42  |- mesh__recordOriginator mesh__D010555 NLM
% 217.19/217.42  |- skos__prefLabel mesh__D010555 Personality Inventory
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010555 2004
% 217.19/217.42  |- skos__annotation mesh__D010555
% 217.19/217.42       by the person himself: differentiate from PERSONALITY ASSESSMENT %28%by professionals%29%%A%  
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010555 2005
% 217.19/217.42  |- skos__hiddenLabel mesh__D010555 Inventory, Personality
% 217.19/217.42  |- mesh__recordMaintainer mesh__D010555 PXP
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010555 2003
% 217.19/217.42  |- skos__hiddenLabel mesh__D010555 Inventories, Personality
% 217.19/217.42  |- mesh__recordAuthorizer mesh__D010555 PLS
% 217.19/217.42  |- rdf__type mesh__D010555sskos__Concept
% 217.19/217.42  |- mesh__dateCreated mesh__D010555 1999-01-01
% 217.19/217.42  |- skos__broader mesh__D010555smesh__D010556
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010555 2002
% 217.19/217.42  |- mesh__historyNote mesh__D010555
% 217.19/217.42       68%28%66%29%; EDWARDS PERSONAL PREFERENCE SCHEDULE was heading 1975-96 %28%see under PERSONALITY INVENTORY 1975-90%29%; MYERS-BRIGGS TYPE INDICATOR was see under PERSONALITY INVENTORY 1969-78%A%  
% 217.19/217.42  |- mesh__onlineNote mesh__D010555
% 217.19/217.42       use PERSONALITY INVENTORY to search EDWARDS PERSONAL PREFERENCE SCHEDULE 1975-96 %26% MYERS-BRIGGS TYPE INDICATOR 1969-78%A%  
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010555 1999
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010555 1997
% 217.19/217.42  |- mesh__publicMeSHNote mesh__D010555
% 217.19/217.42       68; EDWARDS PERSONAL PREFERENCE SCHEDULE was heading 1975-96 %28%see under PERSONALITY INVENTORY 1975-90%29%; MYERS-BRIGGS TYPE INDICATOR was see under PERSONALITY INVENTORY 1969-78%A%  
% 217.19/217.42  |- skos__hiddenLabel mesh__D010555 Myers Briggs Type Indicator
% 217.19/217.42  |- mesh__dateRevised mesh__D010555 1996-06-10
% 217.19/217.42  |- mesh__dateEstablished mesh__D010555 1968-01-01
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010555 1998
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010555 2001
% 217.19/217.42  |- skos__hiddenLabel mesh__D010555 Personality Inventories
% 217.19/217.42  |- mesh__recordAuthorizer mesh__D004518 sjn
% 217.19/217.42  |- mesh__dateCreated mesh__D004518 1978-05-08
% 217.19/217.42  |- mesh__recordMaintainer mesh__D004518 kle
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D004518 2001
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D004518 2004
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D004518 2002
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D004518 2005
% 217.19/217.42  |- mesh__recordOriginator mesh__D004518 EC
% 217.19/217.42  |- skos__hiddenLabel mesh__D004518 Professional Retrainings
% 217.19/217.42  |- mesh__publicMeSHNote mesh__D004518
% 217.19/217.42       91; was see under EDUCATION, CONTINUING 1979-90   
% 217.19/217.42  |- skos__prefLabel mesh__D004518 Education, Professional, Retraining
% 217.19/217.42  |- mesh__historyNote mesh__D004518
% 217.19/217.42       91%28%79%29%; was see under EDUCATION, CONTINUING 1979-90   
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D004518 2006
% 217.19/217.42  |- rdf__type mesh__D004518sskos__Concept
% 217.19/217.42  |- skos__altLabel mesh__D004518 Retraining, Professional
% 217.19/217.42  |- mesh__dateEstablished mesh__D004518 1991-01-01
% 217.19/217.42  |- skos__annotation mesh__D004518
% 217.19/217.42       coord NIM with specific type %28%medical, dental, etc.%29% of continuing educ %28%IM%29%%A%  
% 217.19/217.42  |- skos__broader mesh__D004518smesh__D004496
% 217.19/217.42  |- skos__hiddenLabel mesh__D004518 Professional Retraining
% 217.19/217.42  |- skos__scopeNote mesh__D004518
% 217.19/217.42       Educational programs for individuals who have been inactive in their profession, or who wish to regain unused skills.%A%    
% 217.19/217.42  |- skos__hiddenLabel mesh__D004518 Retrainings, Professional
% 217.19/217.42  |- mesh__dateRevised mesh__D004518 1999-11-03
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D004518 2000
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D004518 2003
% 217.19/217.42  |- mesh__recordOriginator mesh__D015240 RLS
% 217.19/217.42  |- skos__prefLabel mesh__D015240 Phorbol 12,13-Dibutyrate
% 217.19/217.42  |- skos__hiddenLabel mesh__D015240 Phorbol 12,13 Dibutyrate
% 217.19/217.42  |- mesh__publicMeSHNote mesh__D015240 89   
% 217.19/217.42  |- skos__scopeNote mesh__D015240
% 217.19/217.42       A phorbol ester found in CROTON OIL which, in addition to being a potent skin tumor promoter, is also an effective activator of calcium-activated, phospholipid-dependent protein kinase %28%protein kinase C%29%. Due to its activation of this enzyme, phorbol 12,13-dibutyrate profoundly affects many different biological systems.%A%    
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D015240 2006
% 217.19/217.42  |- mesh__recordAuthorizer mesh__D015240 jls
% 217.19/217.42  |- mesh__dateEstablished mesh__D015240 1989-01-01
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D015240 2002
% 217.19/217.42  |- skos__annotation mesh__D015240 D25-26 qualif; DF:PDBU   
% 217.19/217.42  |- skos__historyNote mesh__D015240 Phorbol Esters %28%1979-1988%29%
% 217.19/217.42  |- skos__hiddenLabel mesh__D015240 12,13-Dibutyrate, Phorbol
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D015240 2004
% 217.19/217.42  |- mesh__dateCreated mesh__D015240 1988-05-14
% 217.19/217.42  |- mesh__recordMaintainer mesh__D015240 jls
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D015240 2005A
% 217.19/217.42  |- mesh__historyNote mesh__D015240 89   
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D015240 2005
% 217.19/217.42  |- mesh__dateRevised mesh__D015240 2004-07-30
% 217.19/217.42  |- skos__altLabel mesh__D015240 Phorbol-12,13-Dibutyrate
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D015240 2003
% 217.19/217.42  |- rdf__type mesh__D015240sskos__Concept
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D015240 2001
% 217.19/217.42  |- skos__broader mesh__D015240smesh__D010703
% 217.19/217.42  |- rdf__type mesh__D009203sskos__Concept
% 217.19/217.42  |- mesh__recordMaintainer mesh__D009203 ssb
% 217.19/217.42  |- skos__broader mesh__D009203smesh__D017202
% 217.19/217.42  |- skos__hiddenLabel mesh__D009203 Myocardial Infarcts
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D009203 2006
% 217.19/217.42  |- mesh__recordAuthorizer mesh__D009203 sjn
% 217.19/217.42  |- skos__broader mesh__D009203smesh__D007238
% 217.19/217.42  |- skos__scopeNote mesh__D009203
% 217.19/217.42       Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area. %28%Dorland, 27th ed%29%%A%    
% 217.19/217.42  |- mesh__dateCreated mesh__D009203 1999-01-01
% 217.19/217.42  |- skos__altLabel mesh__D009203 Myocardial Infarct
% 217.19/217.42  |- skos__hiddenLabel mesh__D009203 Infarction, Myocardial
% 217.19/217.42  |- skos__prefLabel mesh__D009203 Myocardial Infarction
% 217.19/217.42  |- skos__hiddenLabel mesh__D009203 Infarctions, Myocardial
% 217.19/217.42  |- skos__hiddenLabel mesh__D009203 Myocardial Infarctions
% 217.19/217.42  |- skos__annotation mesh__D009203
% 217.19/217.42       do not coord with ACUTE DISEASE for %22%acute infarct%22%; DF: MYOCARDIAL INFARCT%A%  
% 217.19/217.42  |- mesh__recordOriginator mesh__D009203 NLM
% 217.19/217.42  |- mesh__historyNote mesh__D009203 79; was MYOCARDIAL INFARCT 1963-78   
% 217.19/217.42  |- mesh__dateRevised mesh__D009203 2005-06-30
% 217.19/217.42  |- skos__related mesh__D009203smesh__D006342
% 217.19/217.42  |- skos__hiddenLabel mesh__D009203 Infarct, Myocardial
% 217.19/217.42  |- mesh__publicMeSHNote mesh__D009203 79; was MYOCARDIAL INFARCT 1963-78   
% 217.19/217.42  |- mesh__onlineNote mesh__D009203
% 217.19/217.42       use MYOCARDIAL INFARCTION to search MYOCARDIAL INFARCT  1966-78%A%  
% 217.19/217.42  |- skos__hiddenLabel mesh__D009203 Infarcts, Myocardial
% 217.19/217.42  |- skos__altLabel mesh__D001220 Aspartase
% 217.19/217.42  |- mesh__recordMaintainer mesh__D001220 ssb
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D001220 2006
% 217.19/217.42  |- mesh__dateCreated mesh__D001220 1974-11-19
% 217.19/217.42  |- skos__hiddenLabel mesh__D001220 Ammonia-Lyase, Aspartate
% 217.19/217.42  |- skos__hiddenLabel mesh__D001220 Aminase, Fumaric
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D001220 2005
% 217.19/217.42  |- mesh__dateEstablished mesh__D001220 1991-01-01
% 217.19/217.42  |- rdf__type mesh__D001220sskos__Concept
% 217.19/217.42  |- skos__scopeNote mesh__D001220
% 217.19/217.42       An enzyme that catalyzes the conversion of aspartic acid to ammonia and fumaric acid in plants and some microorganisms. EC 4.3.1.1.%A%    
% 217.19/217.42  |- mesh__publicMeSHNote mesh__D001220
% 217.19/217.42       91; was see under AMMONIA-LYASES 1975-90   
% 217.19/217.42  |- skos__broader mesh__D001220smesh__D000642
% 217.19/217.42  |- mesh__recordOriginator mesh__D001220 NLM
% 217.19/217.42  |- skos__altLabel mesh__D001220 Fumaric Aminase
% 217.19/217.42  |- skos__hiddenLabel mesh__D001220 Aspartate Ammonia Lyase
% 217.19/217.42  |- mesh__historyNote mesh__D001220
% 217.19/217.42       91%28%75%29%; was see under AMMONIA-LYASES 1975-90   
% 217.19/217.42  |- skos__historyNote mesh__D001220 Aspartic Acid %28%1973-1974%29%
% 217.19/217.42  |- skos__historyNote mesh__D001220 Ammonia-Lyases %28%1973-1974%29%
% 217.19/217.42  |- mesh__recordAuthorizer mesh__D001220 sjn
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D001220 2004
% 217.19/217.42  |- skos__prefLabel mesh__D001220 Aspartate Ammonia-Lyase
% 217.19/217.42  |- mesh__dateRevised mesh__D001220 2003-07-09
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D020185 2002
% 217.19/217.42  |- skos__historyNote mesh__D020185 Benzoates %28%1961-1998%29%
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D020185 2005
% 217.19/217.42  |- rdf__type mesh__D020185sskos__Concept
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D020185 2006
% 217.19/217.42  |- mesh__dateEstablished mesh__D020185 1999-01-01
% 217.19/217.42  |- mesh__dateCreated mesh__D020185 1998-06-10
% 217.19/217.42  |- skos__prefLabel mesh__D020185 Benzoic Acids
% 217.19/217.42  |- mesh__publicMeSHNote mesh__D020185 99   
% 217.19/217.42  |- skos__scopeNote mesh__D020185
% 217.19/217.42       Acids, salts, and derivatives of BENZOIC ACID.     
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D020185 2000
% 217.19/217.42  |- skos__hiddenLabel mesh__D020185 Acids, Benzoic
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D020185 2003
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D020185 1999
% 217.19/217.42  |- mesh__historyNote mesh__D020185 99   
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D020185 2001
% 217.19/217.42  |- skos__annotation mesh__D020185 BENZOIC ACID is also available   
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D020185 2004
% 217.19/217.42  |- skos__broader mesh__D020185smesh__D000146
% 217.19/217.42  |- skos__hiddenLabel mesh__D014946 Infections, Wound
% 217.19/217.42  |- mesh__recordMaintainer mesh__D014946 PLS
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D014946 1993
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D014946 1996
% 217.19/217.42  |- mesh__dateCreated mesh__D014946 1999-01-01
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D014946 2005
% 217.19/217.42  |- skos__annotation mesh__D014946
% 217.19/217.42       IM; do not coord with BACTERIAL INFECTIONS unless particularly discussed but coord IM with specific bact infect %28%IM%29%%A%  
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D014946 2002
% 217.19/217.42  |- mesh__recordOriginator mesh__D014946 NLM
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D014946 1997
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D014946 2006
% 217.19/217.42  |- skos__altLabel mesh__D014946 Infection, Wound
% 217.19/217.42  |- mesh__dateRevised mesh__D014946 1991-06-19
% 217.19/217.42  |- skos__broader mesh__D014946smesh__D007239
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D014946 2003
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D014946 2000
% 217.19/217.42  |- skos__prefLabel mesh__D014946 Wound Infection
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D014946 1994
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D014946 2004
% 217.19/217.42  |- skos__broader mesh__D014946smesh__D014947
% 217.19/217.42  |- mesh__recordAuthorizer mesh__D014946 PLS
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D014946 1998
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D014946 1995
% 217.19/217.42  |- skos__hiddenLabel mesh__D014946 Wound Infections
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D014946 2001
% 217.19/217.42  |- rdf__type mesh__D014946sskos__Concept
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D014946 1992
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D014946 1999
% 217.19/217.42  |- skos__scopeNote mesh__D014946
% 217.19/217.42       Invasion of the site of trauma by pathogenic microorganisms.%A%    
% 217.19/217.42  |- mesh__recordMaintainer mesh__D014148 CCR
% 217.19/217.42  |- skos__scopeNote mesh__D014148
% 217.19/217.42       Antifibrinolytic hemostatic used in severe hemorrhage.     
% 217.19/217.42  |- skos__historyNote mesh__D014148 Methylamines %28%1973-1974%29%
% 217.19/217.42  |- skos__altLabel mesh__D014148
% 217.19/217.42       trans-4-%28%Aminomethyl%29%cyclohexanecarboxylic Acid
% 217.19/217.42  |- mesh__dateEstablished mesh__D014148 1991-01-01
% 217.19/217.42  |- skos__broader mesh__D014148smesh__D003509
% 217.19/217.42  |- skos__altLabel mesh__D014148 AMCA
% 217.19/217.42  |- mesh__dateCreated mesh__D014148 1974-11-19
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D014148 2006
% 217.19/217.42  |- skos__altLabel mesh__D014148 Abbott Brand of Tranexamic Acid
% 217.19/217.42  |- mesh__recordOriginator mesh__D014148 NLM
% 217.19/217.42  |- mesh__dateRevised mesh__D014148 2005-06-30
% 217.19/217.42  |- mesh__publicMeSHNote mesh__D014148
% 217.19/217.42       91; was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90   
% 217.19/217.42  |- mesh__recordAuthorizer mesh__D014148 sjn
% 217.19/217.42  |- skos__altLabel mesh__D014148 Fides Ecopharma Brand of Tranexamic Acid
% 217.19/217.42  |- skos__hiddenLabel mesh__D014148 Acid, Tranexamic
% 217.19/217.42  |- skos__altLabel mesh__D014148 Pharmygi%C3%%A8%ne Brand of Tranexamic Acid
% 217.19/217.42  |- skos__prefLabel mesh__D014148 Tranexamic Acid
% 217.19/217.42  |- skos__historyNote mesh__D014148 Amines %28%1966-1973%29%
% 217.19/217.42  |- skos__historyNote mesh__D014148
% 217.19/217.42       Cyclohexanecarboxylic Acids %28%1968-1974%29%
% 217.19/217.42  |- skos__altLabel mesh__D014148 Sanofi Synthelabo Brand of Tranexamic Acid
% 217.19/217.42  |- skos__altLabel mesh__D014148 AMCHA
% 217.19/217.42  |- mesh__historyNote mesh__D014148
% 217.19/217.42       91%28%75%29%; was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90%A%  
% 217.19/217.42  |- rdf__type mesh__D014148sskos__Concept
% 217.19/217.42  |- skos__altLabel mesh__D014148 Pharmacia Brand of Tranexamic Acid
% 217.19/217.42  |- skos__altLabel mesh__D014148 t-AMCHA
% 217.19/217.42  |- mesh__recordAuthorizer mesh__D000926 ags
% 217.19/217.42  |- skos__scopeNote mesh__D000926
% 217.19/217.42       The sequential set of three nucleotides in TRANSFER RNA that interacts with its complement in MESSENGER RNA, the CODON, during translation in the ribosome.%A%    
% 217.19/217.42  |- mesh__dateCreated mesh__D000926 1999-01-01
% 217.19/217.42  |- mesh__dateRevised mesh__D000926 2005-07-28
% 217.19/217.42  |- mesh__onlineNote mesh__D000926 search RNA, TRANSFER 1974   
% 217.19/217.42  |- skos__broader mesh__D000926smesh__D012343
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D000926 2003
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D000926 2005
% 217.19/217.42  |- mesh__publicMeSHNote mesh__D000926
% 217.19/217.42       91; was see under RNA, TRANSFER 1975-90   
% 217.19/217.42  |- mesh__recordOriginator mesh__D000926 NLM
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D000926 2004
% 217.19/217.42  |- skos__broader mesh__D000926smesh__D005815
% 217.19/217.42  |- mesh__historyNote mesh__D000926
% 217.19/217.42       91%28%75%29%; was see under RNA, TRANSFER 1975-90   
% 217.19/217.42  |- rdf__type mesh__D000926sskos__Concept
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D000926 2006
% 217.19/217.42  |- mesh__recordMaintainer mesh__D000926 ags
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D000926 2006A
% 217.19/217.42  |- mesh__dateEstablished mesh__D000926 1991-01-01
% 217.19/217.42  |- skos__hiddenLabel mesh__D000926 Anticodons
% 217.19/217.42  |- skos__prefLabel mesh__D000926 Anticodon
% 217.19/217.42  |- skos__broader mesh__D002241Q000378smesh__D002241
% 217.19/217.42  |- mesh__preferredCombination mesh__D002241Q000378smesh__D050260
% 217.19/217.42  |- rdf__type mesh__D002241Q000378smesh__CompoundConcept
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D033302 2005
% 217.19/217.42  |- skos__scopeNote mesh__D033302
% 217.19/217.42       A late 20th-century philosophical approach or style of cultural analysis that seeks to reveal the cultural or social construction of concepts conventionally assumed to be natural or universal. %28%from E.R. DuBose, The Illusion of Trust: Toward a Medical Theological Ethics in the Postmodern Age, Kluwer, 1995%29%%A%    
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D033302 2006
% 217.19/217.42  |- skos__historyNote mesh__D033302 Philosophy %28%1993-2002%29%
% 217.19/217.42  |- rdf__type mesh__D033302sskos__Concept
% 217.19/217.42  |- skos__prefLabel mesh__D033302 Postmodernism
% 217.19/217.42  |- skos__broader mesh__D033302smesh__D010684
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D033302 2003
% 217.19/217.42  |- mesh__dateCreated mesh__D033302 2002-07-03
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D033302 2004
% 217.19/217.42  |- mesh__dateEstablished mesh__D033302 2003-01-01
% 217.19/217.42  |- mesh__publicMeSHNote mesh__D033302 2003; see PHILOSOPHY 2002   
% 217.19/217.42  |- mesh__historyNote mesh__D033302 2003; use PHILOSOPHY 2002   
% 217.19/217.42  |- mesh__onlineNote mesh__D000128
% 217.19/217.42       use ACHOLEPLASMA LAIDLAWII to search MYCOPLASMA LAIDLAWII 1972-75%A%  
% 217.19/217.42  |- mesh__recordMaintainer mesh__D000128 SYSTEM
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D000128 2006
% 217.19/217.42  |- rdf__type mesh__D000128sskos__Concept
% 217.19/217.42  |- mesh__historyNote mesh__D000128 76; was MYCOPLASMA LAIDLAWII 1972-75   
% 217.19/217.42  |- mesh__recordAuthorizer mesh__D000128 sjn
% 217.19/217.42  |- skos__annotation mesh__D000128 in sewage, dung, soil %26% animals   
% 217.19/217.42  |- skos__altLabel mesh__D000128 Mycoplasma laidlawii
% 217.19/217.42  |- mesh__recordOriginator mesh__D000128 JW
% 217.19/217.42  |- skos__scopeNote mesh__D000128
% 217.19/217.42       An organism originally isolated from sewage, manure, humus, and soil, but recently found as a parasite in mammals and birds.%A%    
% 217.19/217.42  |- mesh__dateCreated mesh__D000128 1975-07-25
% 217.19/217.42  |- skos__broader mesh__D000128smesh__D000127
% 217.19/217.42  |- skos__prefLabel mesh__D000128 Acholeplasma laidlawii
% 217.19/217.42  |- mesh__dateEstablished mesh__D000128 1976-01-01
% 217.19/217.42  |- mesh__dateRevised mesh__D000128 2005-06-30
% 217.19/217.42  |- mesh__publicMeSHNote mesh__D000128
% 217.19/217.42       76; was MYCOPLASMA LAIDLAWII 1972-75   
% 217.19/217.42  |- skos__historyNote mesh__D000128 Mycoplasma %28%1966-1971%29%
% 217.19/217.42  |- skos__scopeNote mesh__D005611
% 217.19/217.42       A condition occurring in the female offspring of dizygotic twins %28%TWIN, DIZYGOTIC%29% in a mixed-sex pregnancy, usually in CATTLE. Freemartinism can occur in other mammals. When placental fusion between the male and the female FETUSES permits the exchange of fetal cells and fetal hormones, TESTICULAR HORMONES from the male fetus can androgenize the female fetus producing a sterile XX/XY chimeric %22%female%22%%28%CHIMERISM%29%.%A%    
% 217.19/217.42  |- mesh__dateCreated mesh__D005611 1999-01-01
% 217.19/217.42  |- rdf__type mesh__D005611sskos__Concept
% 217.19/217.42  |- mesh__recordAuthorizer mesh__D005611 sjn
% 217.19/217.42  |- mesh__dateEstablished mesh__D005611 1970-01-01
% 217.19/217.42  |- mesh__recordMaintainer mesh__D005611 lkt
% 217.19/217.42  |- skos__historyNote mesh__D005611 Cattle %28%1966-1969%29%
% 217.19/217.42  |- skos__prefLabel mesh__D005611 Freemartinism
% 217.19/217.42  |- mesh__recordOriginator mesh__D005611 NLM
% 217.19/217.42  |- skos__broader mesh__D005611smesh__D002418
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D005611 2006
% 217.19/217.42  |- mesh__dateRevised mesh__D005611 2005-06-30
% 217.19/217.42  |- skos__related mesh__D005611smesh__D002678
% 217.19/217.42  |- skos__historyNote mesh__D005611 Infertility, Female %28%1966-1969%29%
% 217.19/217.42  |- mesh__historyNote mesh__D005611 70   
% 217.19/217.42  |- mesh__publicMeSHNote mesh__D005611 70   
% 217.19/217.42  |- skos__broader mesh__D005611smesh__D012734
% 217.19/217.42  |- mesh__dateCreated mesh__D018539 1994-06-07
% 217.19/217.42  |- mesh__publicMeSHNote mesh__D018539 95   
% 217.19/217.42  |- skos__historyNote mesh__D018539 Planets %28%1991-1994%29%
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D018539 2004
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D018539 1997
% 217.19/217.42  |- skos__scopeNote mesh__D018539
% 217.19/217.42       The sixth planet in order from the sun. It is one of the five outer planets of the solar system. Its twelve natural satellites include Phoebe and Titan.%A%    
% 217.19/217.42  |- mesh__dateEstablished mesh__D018539 1995-01-01
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D018539 2003
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D018539 1996
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D018539 2006
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D018539 1999
% 217.19/217.42  |- mesh__historyNote mesh__D018539 95   
% 217.19/217.42  |- rdf__type mesh__D018539sskos__Concept
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D018539 2005
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D018539 2002
% 217.19/217.42  |- skos__prefLabel mesh__D018539 Saturn
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D018539 1998
% 217.19/217.42  |- skos__broader mesh__D018539smesh__D016083
% 217.19/217.42  |- skos__annotation mesh__D018539
% 217.19/217.42       6th planet from sun with 12 moons; no qualif   
% 217.19/217.42  |- skos__historyNote mesh__D018539
% 217.19/217.42       Extraterrestrial Environment %28%1966-1990%29%
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D018539 2001
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D018539 1995
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D018539 2000
% 217.19/217.42  |- mesh__dateRevised mesh__D010556 1992-05-15
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010556 2005
% 217.19/217.42  |- mesh__recordMaintainer mesh__D010556 TAP
% 217.19/217.42  |- skos__prefLabel mesh__D010556 Personality Tests
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010556 2001
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010556 2003
% 217.19/217.42  |- mesh__dateCreated mesh__D010556 1975-07-25
% 217.19/217.42  |- skos__hiddenLabel mesh__D010556 Test, Personality
% 217.19/217.42  |- rdf__type mesh__D010556sskos__Concept
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010556 2000
% 217.19/217.42  |- mesh__dateEstablished mesh__D010556 1976-01-01
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010556 1995
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010556 1993
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010556 1999
% 217.19/217.42  |- mesh__historyNote mesh__D010556
% 217.19/217.42       76; was NON MESH 1975, was see under PSYCHOLOGICAL TESTS 1963-74%A%  
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010556 1994
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010556 1997
% 217.19/217.42  |- mesh__publicMeSHNote mesh__D010556
% 217.19/217.42       76; was see under PSYCHOLOGICAL TESTS 1963-74   
% 217.19/217.42  |- mesh__recordAuthorizer mesh__D010556 PLS
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010556 1998
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010556 2002
% 217.19/217.42  |- skos__hiddenLabel mesh__D010556 Personality Test
% 217.19/217.42  |- mesh__recordOriginator mesh__D010556 EC
% 217.19/217.42  |- skos__scopeNote mesh__D010556
% 217.19/217.42       Standardized objective tests designed to facilitate the evaluation of personality.%A%    
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010556 1996
% 217.19/217.42  |- skos__hiddenLabel mesh__D010556 Tests, Personality
% 217.19/217.42  |- mesh__onlineNote mesh__D010556 search PSYCHOLOGICAL TESTS 1966-74   
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010556 2006
% 217.19/217.42  |- skos__broader mesh__D010556smesh__D011581
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D010556 2004
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D029261 2006
% 217.19/217.42  |- skos__altLabel mesh__D029261 Four Corners Virus
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D029261 2005
% 217.19/217.42  |- mesh__publicMeSHNote mesh__D029261 2002; see HANTAVIRUS 1995-2001   
% 217.19/217.42  |- skos__prefLabel mesh__D029261 Sin Nombre virus
% 217.19/217.42  |- skos__altLabel mesh__D029261 Muerto Canyon Virus
% 217.19/217.42  |- skos__historyNote mesh__D029261 Hantavirus %28%1994-2001%29%
% 217.19/217.42  |- skos__broader mesh__D029261smesh__D006476
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D029261 2004
% 217.19/217.42  |- mesh__dateCreated mesh__D029261 2001-07-25
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D029261 2002
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D029261 2003
% 217.19/217.42  |- mesh__historyNote mesh__D029261 2002; use HANTAVIRUS 1995-2001   
% 217.19/217.42  |- skos__scopeNote mesh__D029261
% 217.19/217.42       A species of HANTAVIRUS which emerged in the Four Corners area of the United States in 1993. It causes a serious, often fatal pulmonary illness %28%HANTAVIRUS PULMONARY SYNDROME%29% in humans. Transmission is by inhaling aerosolized rodent secretions that contain virus particles, carried especially by deer mice %28%PEROMYSCUS maniculatus%29% and pinyon mice %28%P. truei%29%.%A%    
% 217.19/217.42  |- mesh__dateEstablished mesh__D029261 2002-01-01
% 217.19/217.42  |- rdf__type mesh__D029261sskos__Concept
% 217.19/217.42  |- skos__annotation mesh__D029261
% 217.19/217.42       infection = HANTAVIRUS PULMONARY SYNDROME   
% 217.19/217.42  |- mesh__historyNote mesh__D004519 68%28%66%29%   
% 217.19/217.42  |- skos__hiddenLabel mesh__D004519 Educations, Special
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D004519 2000
% 217.19/217.42  |- skos__annotation mesh__D004519 IM   
% 217.19/217.42  |- skos__broader mesh__D004519smesh__D004505
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D004519 2005
% 217.19/217.42  |- mesh__dateCreated mesh__D004519 1999-01-01
% 217.19/217.42  |- mesh__recordAuthorizer mesh__D004519 sjn
% 217.19/217.42  |- mesh__recordMaintainer mesh__D004519 kle
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D004519 2001
% 217.19/217.42  |- mesh__dateEstablished mesh__D004519 1968-01-01
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D004519 2006
% 217.19/217.42  |- rdf__type mesh__D004519sskos__Concept
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D004519 2002
% 217.19/217.42  |- skos__hiddenLabel mesh__D004519 Special Educations
% 217.19/217.42  |- skos__prefLabel mesh__D004519 Education, Special
% 217.19/217.42  |- mesh__recordOriginator mesh__D004519 NLM
% 217.19/217.42  |- mesh__publicMeSHNote mesh__D004519 68   
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D004519 2003
% 217.19/217.42  |- skos__scopeNote mesh__D004519
% 217.19/217.42       Education of the individual who markedly deviates intellectually, physically, socially, or emotionally from those considered to be normal, thus requiring special instruction.%A%    
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D004519 2004
% 217.19/217.42  |- skos__altLabel mesh__D004519 Special Education
% 217.19/217.42  |- mesh__dateRevised mesh__D004519 1999-11-03
% 217.19/217.42  |- mesh__dateRevised mesh__D015241 2005-06-30
% 217.19/217.42  |- mesh__recordMaintainer mesh__D015241 ssb
% 217.19/217.42  |- mesh__recordOriginator mesh__D015241 RLS
% 217.19/217.42  |- skos__prefLabel mesh__D015241 Fibrinogens, Abnormal
% 217.19/217.42  |- rdf__type mesh__D015241sskos__Concept
% 217.19/217.42  |- mesh__dateCreated mesh__D015241 1988-05-16
% 217.19/217.42  |- skos__broader mesh__D015241smesh__D005340
% 217.19/217.42  |- skos__altLabel mesh__D015241 Abnormal Fibrinogens
% 217.19/217.42  |- mesh__recordAuthorizer mesh__D015241 sjn
% 217.19/217.42  |- skos__annotation mesh__D015241
% 217.19/217.42       %22%have a functional defect as the result of one or more amino acid substitutions in the amino acid seq of normal fibrinogen%22%; DF: FIBRINOGENS ABNORM%A%  
% 217.19/217.42  |- skos__scopeNote mesh__D015241
% 217.19/217.42       Fibrinogens which have a functional defect as the result of one or more amino acid substitutions in the amino acid sequence of normal fibrinogen. Abnormalities of the fibrinogen molecule may impair any of the major steps involved in the conversion of fibrinogen into stabilized fibrin, such as cleavage of the fibrinopeptides by thrombin, polymerization and cross-linking of fibrin. The resulting dysfibrinogenemias can be clinically silent or can be associated with bleeding, thrombosis or defective wound healing.%A%    
% 217.19/217.42  |- mesh__publicMeSHNote mesh__D015241 89   
% 217.19/217.42  |- mesh__historyNote mesh__D015241 89   
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D015241 2006
% 217.19/217.42  |- mesh__dateEstablished mesh__D015241 1989-01-01
% 217.19/217.42  |- skos__historyNote mesh__D015241 Fibrinogen %28%1966-1988%29%
% 217.19/217.42  |- mesh__activeMeSHYear mesh__D009204 2003
% 217.28/217.42  |- skos__annotation mesh__D009204
% 217.28/217.42       do not use /util except by MeSH definition   
% 217.28/217.42  |- mesh__activeMeSHYear mesh__D009204 1999
% 217.28/217.42  |- skos__hiddenLabel mesh__D009204 Revascularizations, Myocardial
% 217.28/217.42  |- mesh__recordMaintainer mesh__D009204 PXP
% 217.28/217.42  |- skos__historyNote mesh__D009204
% 217.28/217.42       Myocardial Infarct/surgery %28%1966-1971%29%
% 217.28/217.42  |- mesh__historyNote mesh__D009204
% 217.28/217.42       73; INTERNAL MAMMARY ARTERY IMPLANTATION was heading 1975-94 %28%see under MYOCARDIAL REVASCULARIZATION 1975-90%29%%A%  
% 217.28/217.42  |- mesh__recordOriginator mesh__D009204 NLM
% 217.28/217.42  |- mesh__dateCreated mesh__D009204 1999-01-01
% 217.28/217.42  |- rdf__type mesh__D009204sskos__Concept
% 217.28/217.42  |- mesh__activeMeSHYear mesh__D009204 1998
% 217.28/217.42  |- mesh__dateRevised mesh__D009204 1997-06-20
% 217.28/217.42  |- mesh__activeMeSHYear mesh__D009204 2002
% 217.28/217.42  |- mesh__activeMeSHYear mesh__D009204 2006
% 217.28/217.42  |- mesh__activeMeSHYear mesh__D009204 2001
% 217.28/217.42  |- skos__prefLabel mesh__D009204 Myocardial Revascularization
% 217.28/217.43  |- mesh__publicMeSHNote mesh__D009204
% 217.28/217.43       73; INTERNAL MAMMARY ARTERY IMPLANTATION was heading 1975-94 %28%see under MYOCARDIAL REVASCULARIZATION 1975-90%29%%A%  
% 217.28/217.43  |- skos__broader mesh__D009204smesh__D006348
% 217.28/217.43  |- skos__historyNote mesh__D009204
% 217.28/217.43       Coronary Disease/surgery %28%1966-1971%29%
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D009204 2005
% 217.28/217.43  |- skos__scopeNote mesh__D009204
% 217.28/217.43       The restoration of blood supply to the myocardium. %28%From Dorland, 28th ed%29%%A%    
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D009204 2000
% 217.28/217.43  |- mesh__recordAuthorizer mesh__D009204 SJN
% 217.28/217.43  |- mesh__onlineNote mesh__D009204
% 217.28/217.43       use MYOCARDIAL REVASCULARIZATION to search INTERNAL MAMMARY ARTERY IMPLANTATION 1975-94%A%  
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D009204 2004
% 217.28/217.43  |- mesh__dateEstablished mesh__D009204 1973-01-01
% 217.28/217.43  |- skos__historyNote mesh__D009204
% 217.28/217.43       Coronary Vessels/surgery %28%1966-1971%29%
% 217.28/217.43  |- skos__hiddenLabel mesh__D009204 Revascularization, Myocardial
% 217.28/217.43  |- skos__hiddenLabel mesh__D009204 Myocardial Revascularizations
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D001221 2005
% 217.28/217.43  |- mesh__dateCreated mesh__D001221 1999-01-01
% 217.28/217.43  |- rdf__type mesh__D001221sskos__Concept
% 217.28/217.43  |- mesh__recordMaintainer mesh__D001221 ssb
% 217.28/217.43  |- skos__broader mesh__D001221smesh__D009097
% 217.28/217.43  |- mesh__historyNote mesh__D001221 73   
% 217.28/217.43  |- skos__prefLabel mesh__D001221 Aspartate Carbamoyltransferase
% 217.28/217.43  |- skos__hiddenLabel mesh__D001221 Carbamoyltransferase, Aspartate
% 217.28/217.43  |- mesh__dateEstablished mesh__D001221 1973-01-01
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D001221 2004
% 217.28/217.43  |- mesh__publicMeSHNote mesh__D001221 73   
% 217.28/217.43  |- skos__broader mesh__D001221smesh__D019878
% 217.28/217.43  |- mesh__dateRevised mesh__D001221 2003-07-09
% 217.28/217.43  |- skos__hiddenLabel mesh__D001221 Transcarbamylase, Aspartate
% 217.28/217.43  |- skos__scopeNote mesh__D001221
% 217.28/217.43       An enzyme that catalyzes the conversion of carbamoyl phosphate and L-aspartate to yield orthophosphate and N-carbamoyl-L-aspartate. %28%From Enzyme Nomenclature, 1992%29% EC 2.1.3.2.%A%    
% 217.28/217.43  |- mesh__recordOriginator mesh__D001221 NLM
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D001221 2006
% 217.28/217.43  |- skos__altLabel mesh__D001221 Aspartate Transcarbamylase
% 217.28/217.43  |- mesh__recordAuthorizer mesh__D001221 sjn
% 217.28/217.43  |- rdf__type mesh__D020186sskos__Concept
% 217.28/217.43  |- skos__hiddenLabel mesh__D020186 Nocturnal Bruxism
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D020186 2001
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D020186 2006
% 217.28/217.43  |- mesh__publicMeSHNote mesh__D020186 2000   
% 217.28/217.43  |- skos__hiddenLabel mesh__D020186 Childhood Sleep Bruxisms
% 217.28/217.43  |- skos__altLabel mesh__D020186 Teeth Grinding Disorder, Nocturnal
% 217.28/217.43  |- skos__hiddenLabel mesh__D020186 Nocturnal Bruxisms
% 217.28/217.43  |- skos__broader mesh__D020186smesh__D020447
% 217.28/217.43  |- mesh__historyNote mesh__D020186 2000   
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D020186 2002
% 217.28/217.43  |- skos__prefLabel mesh__D020186 Sleep Bruxism
% 217.28/217.43  |- skos__scopeNote mesh__D020186
% 217.28/217.43       A sleep disorder characterized by grinding and clenching of the teeth and forceful lateral or protrusive jaw movements. Sleep bruxism may be associated with TOOTH INJURIES; TEMPOROMANDIBULAR JOINT DISORDERS; sleep disturbances; and other conditions.%A%    
% 217.28/217.43  |- skos__hiddenLabel mesh__D020186 Sleep-Related Bruxisms
% 217.28/217.43  |- mesh__dateCreated mesh__D020186 1999-11-03
% 217.28/217.43  |- skos__hiddenLabel mesh__D020186 Bruxisms, Sleep-Related
% 217.28/217.43  |- skos__hiddenLabel mesh__D020186 Adult Sleep Bruxism
% 217.28/217.43  |- skos__hiddenLabel mesh__D020186 Sleep Bruxisms, Childhood
% 217.28/217.43  |- mesh__dateEstablished mesh__D020186 2000-01-01
% 217.28/217.43  |- skos__hiddenLabel mesh__D020186 Sleep Related Bruxism
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D020186 2003
% 217.28/217.43  |- skos__historyNote mesh__D020186 Bruxism %28%1965-1999%29%
% 217.28/217.43  |- skos__hiddenLabel mesh__D020186 Childhood Sleep Bruxism
% 217.28/217.43  |- skos__hiddenLabel mesh__D020186 Sleep Bruxisms, Adult
% 217.28/217.43  |- skos__hiddenLabel mesh__D020186 Bruxism, Sleep-Related
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D020186 2004
% 217.28/217.43  |- skos__altLabel mesh__D020186 Nocturnal Teeth Grinding Disorder
% 217.28/217.43  |- skos__hiddenLabel mesh__D020186 Bruxisms, Sleep
% 217.28/217.43  |- skos__altLabel mesh__D020186 Bruxism, Nocturnal
% 217.28/217.43  |- skos__hiddenLabel mesh__D020186 Adult Sleep Bruxisms
% 217.28/217.43  |- skos__hiddenLabel mesh__D020186 Sleep Bruxisms
% 217.28/217.43  |- skos__broader mesh__D020186smesh__D002012
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D020186 2000
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D020186 2005
% 217.28/217.43  |- skos__hiddenLabel mesh__D020186 Bruxism, Sleep
% 217.28/217.43  |- skos__hiddenLabel mesh__D020186 Bruxisms, Nocturnal
% 217.28/217.43  |- skos__annotation mesh__D020186 BRUXISM is also available   
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D014947 2002
% 217.28/217.43  |- skos__altLabel mesh__D014947 Trauma
% 217.28/217.43  |- rdf__type mesh__D014947sskos__Concept
% 217.28/217.43  |- skos__scopeNote mesh__D014947
% 217.28/217.43       Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.%A%    
% 217.28/217.43  |- skos__hiddenLabel mesh__D014947 Wound
% 217.28/217.43  |- mesh__dateRevised mesh__D014947 1999-11-03
% 217.28/217.43  |- skos__prefLabel mesh__D014947 Wounds and Injuries
% 217.28/217.43  |- skos__altLabel mesh__D014947 Injuries and Wounds
% 217.28/217.43  |- skos__related mesh__D014947smesh__D005392
% 217.28/217.43  |- skos__hiddenLabel mesh__D014947 Injury
% 217.28/217.43  |- skos__altLabel mesh__D014947 Injuries, Wounds
% 217.28/217.43  |- skos__annotation mesh__D014947
% 217.28/217.43       GEN or unspecified; prefer /inj with organs %28%Manual 19.7+, 19.8.38%29% or specific organ /inj precoords; policy: Manual 23.23+; types of wounds are also available, as WOUNDS, PENETRATING, etc.; MULTIPLE TRAUMA is available; wound suction: coord wd %26% inj concept with DRAINAGE; DF: WOUNDS%A%  
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D014947 2001
% 217.28/217.43  |- mesh__dateCreated mesh__D014947 1999-01-01
% 217.28/217.43  |- mesh__recordMaintainer mesh__D014947 kle
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D014947 2006
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D014947 2000
% 217.28/217.43  |- skos__altLabel mesh__D014947 Wounds, Injury
% 217.28/217.43  |- mesh__recordOriginator mesh__D014947 NLM
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D014947 2004
% 217.28/217.43  |- mesh__recordAuthorizer mesh__D014947 sjn
% 217.28/217.43  |- skos__hiddenLabel mesh__D014947 Traumas
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D014947 2005
% 217.28/217.43  |- skos__broader mesh__D014947smesh__D007280
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D014947 2003
% 217.28/217.43  |- skos__hiddenLabel mesh__D014947 Injury and Wounds
% 217.28/217.43  |- mesh__onlineNote mesh__D014947
% 217.28/217.43       pre-explosion = WOUNDS A%23%D INJURIES %28%PX%29%   
% 217.28/217.43  |- skos__related mesh__D014947smesh__D014187
% 217.28/217.43  |- skos__altLabel mesh__D014947 Wounds and Injury
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D014149 2006
% 217.28/217.43  |- skos__altLabel mesh__D014149 Tranquillizing Agents
% 217.28/217.43  |- skos__hiddenLabel mesh__D014149 Drugs, Tranquilizing
% 217.28/217.43  |- skos__hiddenLabel mesh__D014149 Agents, Tranquilizing
% 217.28/217.43  |- skos__hiddenLabel mesh__D014149 Drugs, Tranquillizing
% 217.28/217.43  |- skos__altLabel mesh__D014149 Ataractics
% 217.28/217.43  |- skos__altLabel mesh__D014149 Tranquillizing Drugs
% 217.28/217.43  |- skos__scopeNote mesh__D014149
% 217.28/217.43       A traditional grouping of drugs said to have a soothing or calming effect on mood, thought, or behavior. Included here are the ANTI-ANXIETY AGENTS %28%minor tranquilizers%29%, ANTIMANIC AGENTS, and the ANTIPSYCHOTIC AGENTS %28%major tranquilizers%29%. These drugs act by different mechanisms and are used for different therapeutic purposes.%A%    
% 217.28/217.43  |- skos__altLabel mesh__D014149 Tranquilizing Drugs
% 217.28/217.43  |- mesh__recordOriginator mesh__D014149 NLM
% 217.28/217.43  |- mesh__dateRevised mesh__D014149 2005-06-30
% 217.28/217.43  |- mesh__dateCreated mesh__D014149 1999-01-01
% 217.28/217.43  |- rdf__type mesh__D014149sskos__Concept
% 217.28/217.43  |- mesh__recordAuthorizer mesh__D014149 sjn
% 217.28/217.43  |- skos__related mesh__D014149smesh__D006993
% 217.28/217.43  |- skos__prefLabel mesh__D014149 Tranquilizing Agents
% 217.28/217.43  |- skos__hiddenLabel mesh__D014149 Agents, Tranquillizing
% 217.28/217.43  |- skos__broader mesh__D014149smesh__D002492
% 217.28/217.43  |- mesh__recordMaintainer mesh__D014149 ssb
% 217.28/217.43  |- skos__annotation mesh__D014149
% 217.28/217.43       GEN or unspecified; prefer specific groups or specific drugs; available also are TRANQUILIZING AGENTS, MINOR see ANTI-ANXIETY AGENTS %26% TRANQUILIZING AGENTS, MAJOR see ANTIPSYCHOTIC AGENTS%A%  
% 217.28/217.43  |- skos__broader mesh__D014149smesh__D011619
% 217.28/217.43  |- skos__altLabel mesh__D000927 Anticonvulsant Drugs
% 217.28/217.43  |- skos__altLabel mesh__D000927 Anticonvulsive Drugs
% 217.28/217.43  |- skos__altLabel mesh__D000927 Antiepileptics
% 217.28/217.43  |- mesh__dateCreated mesh__D000927 1999-01-01
% 217.28/217.43  |- skos__hiddenLabel mesh__D000927 Drugs, Anticonvulsive
% 217.28/217.43  |- skos__altLabel mesh__D000927 Anticonvulsive Agents
% 217.28/217.43  |- skos__prefLabel mesh__D000927 Anticonvulsants
% 217.28/217.43  |- skos__related mesh__D000927smesh__D012640
% 217.28/217.43  |- mesh__recordAuthorizer mesh__D000927 sjn
% 217.28/217.43  |- mesh__recordMaintainer mesh__D000927 ssb
% 217.28/217.43  |- skos__hiddenLabel mesh__D000927 Agents, Antiepileptic
% 217.28/217.43  |- skos__altLabel mesh__D000927 Antiepileptic Drugs
% 217.28/217.43  |- skos__broader mesh__D000927smesh__D002491
% 217.28/217.43  |- rdf__type mesh__D000927sskos__Concept
% 217.28/217.43  |- skos__hiddenLabel mesh__D000927 Agents, Anticonvulsive
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D000927 2006
% 217.28/217.43  |- skos__hiddenLabel mesh__D000927 Drugs, Antiepileptic
% 217.28/217.43  |- mesh__dateRevised mesh__D000927 2005-06-30
% 217.28/217.43  |- skos__annotation mesh__D000927
% 217.28/217.43       GEN or unspecified; prefer specifics; consider also CONVULSIONS /drug ther%A%  
% 217.28/217.43  |- skos__hiddenLabel mesh__D000927 Drugs, Anticonvulsant
% 217.28/217.43  |- skos__scopeNote mesh__D000927
% 217.28/217.43       Drugs used to prevent SEIZURES or reduce their severity.%A%    
% 217.28/217.43  |- mesh__recordOriginator mesh__D000927 NLM
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Lutheran
% 217.28/217.43  |- mesh__recordAuthorizer mesh__D033303 sjn
% 217.28/217.43  |- skos__prefLabel mesh__D033303 Protestantism
% 217.28/217.43  |- mesh__recordMaintainer mesh__D033303 jrf
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Adventists, Seventh-Day
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Seventh-Day Adventist
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Protestant
% 217.28/217.43  |- mesh__dateCreated mesh__D033303 2002-07-02
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Friends Society
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Church, Anglican
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Church, Presbyterian
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Ethic, Protestant
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Church, Methodist
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D033303 2003
% 217.28/217.43  |- skos__altLabel mesh__D033303 Episcopalians
% 217.28/217.43  |- skos__altLabel mesh__D033303 Methodists
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Church, Baptist
% 217.28/217.43  |- skos__historyNote mesh__D033303 Christianity %28%1974-2002%29%
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Episcopalian
% 217.28/217.43  |- rdf__type mesh__D033303sskos__Concept
% 217.28/217.43  |- mesh__dateEstablished mesh__D033303 2003-01-01
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Anglican
% 217.28/217.43  |- skos__broader mesh__D033303smesh__D002835
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Protestant Ethic
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D033303 2004
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Seventh Day Adventists
% 217.28/217.43  |- skos__altLabel mesh__D033303 Anglicans
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Church, Lutheran
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Baptist
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D033303 2005
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Presbyterian
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Quaker
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Adventist, Seventh-Day
% 217.28/217.43  |- skos__altLabel mesh__D033303 Baptists
% 217.28/217.43  |- skos__altLabel mesh__D033303 Quakers
% 217.28/217.43  |- mesh__publicMeSHNote mesh__D033303
% 217.28/217.43       2003; see CHRISTIANITY 1978-2002;  for SEVENTH-DAY ADVENTISTS see CHRISTIANITY 1994-2002%A%  
% 217.28/217.43  |- skos__altLabel mesh__D033303 Presbyterians
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D033303 2006
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Methodist
% 217.28/217.43  |- mesh__historyNote mesh__D033303
% 217.28/217.43       2003; use CHRISTIANITY 1978-2002; for SEVENTH-DAY ADVENTISTS use CHRISTIANITY 1994-2002%A%  
% 217.28/217.43  |- skos__altLabel mesh__D033303 Lutherans
% 217.28/217.43  |- mesh__recordOriginator mesh__D033303 jrf
% 217.28/217.43  |- skos__scopeNote mesh__D033303
% 217.28/217.43       The name given to all Christian denominations, sects, or groups rising out of the Reformation.  Protestant churches generally agree that the principle of authority should be the Scriptures rather than the institutional church or the pope. %28%from W.L. Reese, Dictionary of Philosophy and Religion, 1999%29%%A%    
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Ethics, Protestant
% 217.28/217.43  |- skos__hiddenLabel mesh__D033303 Church, Episcopal
% 217.28/217.43  |- skos__annotation mesh__D033303 specify geog if pertinent   
% 217.28/217.43  |- rdf__type mesh__D000129sskos__Concept
% 217.28/217.43  |- mesh__dateEstablished mesh__D000129 1976-01-01
% 217.28/217.43  |- skos__annotation mesh__D000129
% 217.28/217.43       free-living saphrophytes %26% mammalian %26% avian parasites   
% 217.28/217.43  |- skos__prefLabel mesh__D000129 Acholeplasmataceae
% 217.28/217.43  |- mesh__dateCreated mesh__D000129 1975-07-25
% 217.28/217.43  |- mesh__publicMeSHNote mesh__D000129 76   
% 217.28/217.43  |- mesh__dateRevised mesh__D000129 2005-07-29
% 217.28/217.43  |- mesh__recordAuthorizer mesh__D000129 jls
% 217.28/217.43  |- skos__scopeNote mesh__D000129
% 217.28/217.43       Gram-negative organisms including apparently free-living saphrophytes as well as mammalian and avian parasites, and possibly pathogens.%A%    
% 217.28/217.43  |- mesh__recordOriginator mesh__D000129 JW
% 217.28/217.43  |- skos__broader mesh__D000129smesh__D008973
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D000129 2006A
% 217.28/217.43  |- skos__historyNote mesh__D000129 Mycoplasmataceae %28%1975%29%
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D000129 2006
% 217.28/217.43  |- mesh__historyNote mesh__D000129 76   
% 217.28/217.43  |- mesh__recordMaintainer mesh__D000129 jls
% 217.28/217.43  |- skos__historyNote mesh__D000129 Bacteria %28%1966-1974%29%
% 217.28/217.43  |- mesh__dateRevised mesh__D005612 2001-07-25
% 217.28/217.43  |- skos__altLabel mesh__D005612 Lyophilization
% 217.28/217.43  |- skos__hiddenLabel mesh__D005612 Freeze Dryings
% 217.28/217.43  |- skos__broader mesh__D005612smesh__D015925
% 217.28/217.43  |- mesh__recordMaintainer mesh__D005612 nns
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D005612 2004
% 217.28/217.43  |- rdf__type mesh__D005612sskos__Concept
% 217.28/217.43  |- mesh__dateCreated mesh__D005612 1999-01-01
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D005612 2003
% 217.28/217.43  |- mesh__recordAuthorizer mesh__D005612 sjn
% 217.28/217.43  |- skos__prefLabel mesh__D005612 Freeze Drying
% 217.28/217.43  |- skos__hiddenLabel mesh__D005612 Lyophilizations
% 217.28/217.43  |- skos__hiddenLabel mesh__D005612 Dryings, Freeze
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D005612 2006
% 217.28/217.43  |- mesh__recordOriginator mesh__D005612 NLM
% 217.28/217.43  |- skos__hiddenLabel mesh__D005612 Drying, Freeze
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D005612 2002
% 217.28/217.43  |- skos__annotation mesh__D005612 NIM   
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D005612 2005
% 217.28/217.43  |- skos__scopeNote mesh__D005612
% 217.28/217.43       Method of tissue preparation in which the tissue specimen is frozen and then dehydrated at low temperature in a high vacuum. This method is also used for dehydrating pharmaceutical and food products.%A%    
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D010557 2002
% 217.28/217.43  |- skos__altLabel mesh__D010557 Hospital Personnel Administration
% 217.28/217.43  |- skos__altLabel mesh__D010557 Hospital Personnel Management
% 217.28/217.43  |- skos__prefLabel mesh__D010557 Personnel Administration, Hospital
% 217.28/217.43  |- mesh__recordMaintainer mesh__D010557 KEV
% 217.28/217.43  |- mesh__dateRevised mesh__D010557 1999-11-08
% 217.28/217.43  |- skos__scopeNote mesh__D010557
% 217.28/217.43       Management activities concerned with hospital employees.%A%    
% 217.28/217.43  |- mesh__historyNote mesh__D010557
% 217.28/217.43       78; was HOSPITAL PERSONNEL ADMINISTRATION 1963-77   
% 217.28/217.43  |- skos__broader mesh__D010557smesh__D006748
% 217.28/217.43  |- skos__hiddenLabel mesh__D010557 Management, Hospital Personnel
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D010557 2006
% 217.28/217.43  |- skos__annotation mesh__D010557 DF: PERSONNEL ADMIN HOSP   
% 217.28/217.43  |- mesh__onlineNote mesh__D010557
% 217.28/217.43       use PERSONNEL ADMINISTRATION, HOSPITAL to search HOSPITAL PERSONNEL ADMINISTRATION 1966-77%A%  
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D010557 2004
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D010557 2001
% 217.28/217.43  |- mesh__publicMeSHNote mesh__D010557
% 217.28/217.43       78; was HOSPITAL PERSONNEL ADMINISTRATION 1963-77   
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D010557 2000
% 217.28/217.43  |- mesh__recordAuthorizer mesh__D010557 sjn
% 217.28/217.43  |- skos__altLabel mesh__D010557
% 217.28/217.43       Hospital Personnel Organization and Administration
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D010557 2005
% 217.28/217.43  |- mesh__recordOriginator mesh__D010557 NLM
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D010557 2003
% 217.28/217.43  |- skos__broader mesh__D010557smesh__D010559
% 217.28/217.43  |- skos__altLabel mesh__D010557 Administration, Hospital Personnel
% 217.28/217.43  |- mesh__dateCreated mesh__D010557 1999-01-01
% 217.28/217.43  |- rdf__type mesh__D010557sskos__Concept
% 217.28/217.43  |- skos__altLabel mesh__D010557 Personnel Management, Hospital
% 217.28/217.43  |- mesh__recordAuthorizer mesh__D029262 sjn
% 217.28/217.43  |- mesh__recordOriginator mesh__D029262 ags
% 217.28/217.43  |- skos__annotation mesh__D029262
% 217.28/217.43       infection: coord IM with HEMORRHAGIC FEVER WITH RENAL SYNDROME %28%IM%29%%A%  
% 217.28/217.43  |- mesh__dateEstablished mesh__D029262 2002-01-01
% 217.28/217.43  |- mesh__recordMaintainer mesh__D029262 ags
% 217.28/217.43  |- skos__prefLabel mesh__D029262 Puumala virus
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D029262 2003
% 217.28/217.43  |- skos__scopeNote mesh__D029262
% 217.28/217.43       A species of HANTAVIRUS causing nephropathia epidemica, a mild form of HEMORRHAGIC FEVER WITH RENAL SYNDROME. It is found in most of Europe and especially in Finland, along with its carrier rodent, the bank vole %28%Clethrionomys glareolus%29%.%A%    
% 217.28/217.43  |- skos__broader mesh__D029262smesh__D006476
% 217.28/217.43  |- mesh__publicMeSHNote mesh__D029262 2002; see HANTAVIRUS 1994-2001   
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D029262 2004
% 217.28/217.43  |- mesh__dateCreated mesh__D029262 2001-07-25
% 217.28/217.43  |- mesh__historyNote mesh__D029262 2002; use HANTAVIRUS 1994-2001   
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D029262 2005
% 217.28/217.43  |- rdf__type mesh__D029262sskos__Concept
% 217.28/217.43  |- mesh__dateRevised mesh__D029262 2002-07-03
% 217.28/217.43  |- skos__historyNote mesh__D029262 Hantavirus %28%1985-2001%29%
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D029262 2006
% 217.28/217.43  |- mesh__historyNote mesh__D015242 89   
% 217.28/217.43  |- skos__hiddenLabel mesh__D015242 DR3355
% 217.28/217.43  |- skos__hiddenLabel mesh__D015242 Ru43280
% 217.28/217.43  |- skos__historyNote mesh__D015242
% 217.28/217.43       Anti-Infective Agents, Urinary %28%1981-1988%29%
% 217.28/217.43  |- skos__historyNote mesh__D015242 Anti-Infective Agents %28%1981-1988%29%
% 217.28/217.43  |- skos__hiddenLabel mesh__D015242 Hoe280
% 217.28/217.43  |- rdf__type mesh__D015242sskos__Concept
% 217.28/217.43  |- skos__hiddenLabel mesh__D015242 DL 8280
% 217.28/217.43  |- mesh__dateCreated mesh__D015242 1988-05-16
% 217.28/217.43  |- skos__broader mesh__D015242smesh__D024841
% 217.28/217.43  |- skos__hiddenLabel mesh__D015242 DL8280
% 217.28/217.43  |- mesh__dateRevised mesh__D015242 2005-06-30
% 217.28/217.43  |- mesh__recordOriginator mesh__D015242 RLS
% 217.28/217.43  |- skos__historyNote mesh__D015242 Oxazines %28%1981-1988%29%
% 217.28/217.43  |- skos__hiddenLabel mesh__D015242 DR 3355
% 217.28/217.43  |- mesh__recordMaintainer mesh__D015242 ssb
% 217.28/217.43  |- skos__prefLabel mesh__D015242 Ofloxacin
% 217.28/217.43  |- skos__altLabel mesh__D015242 Ofloxacin, %28%S%29%-Isomer
% 217.28/217.43  |- mesh__publicMeSHNote mesh__D015242 89   
% 217.28/217.43  |- skos__hiddenLabel mesh__D015242 ORF 28489
% 217.28/217.43  |- skos__scopeNote mesh__D015242
% 217.28/217.43       A synthetic fluoroquinolone %28%FLUOROQUINOLONES%29% antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.%A%    
% 217.28/217.43  |- mesh__dateEstablished mesh__D015242 1989-01-01
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D015242 2006
% 217.28/217.43  |- mesh__recordAuthorizer mesh__D015242 sjn
% 217.28/217.43  |- skos__hiddenLabel mesh__D015242 Ru 43280
% 217.28/217.43  |- skos__hiddenLabel mesh__D015242 ORF28489
% 217.28/217.43  |- skos__hiddenLabel mesh__D015242 Hoe 280
% 217.28/217.43  |- skos__altLabel mesh__D015242 Ofloxacine
% 217.28/217.43  |- rdf__type mesh__D009205sskos__Concept
% 217.28/217.43  |- mesh__dateCreated mesh__D009205 1999-01-01
% 217.28/217.43  |- skos__broader mesh__D009205smesh__D009202
% 217.28/217.43  |- mesh__recordMaintainer mesh__D009205 lkt
% 217.28/217.43  |- skos__hiddenLabel mesh__D009205 Myocarditides
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D009205 2006
% 217.28/217.43  |- mesh__recordOriginator mesh__D009205 NLM
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D009205 2005
% 217.28/217.43  |- skos__prefLabel mesh__D009205 Myocarditis
% 217.28/217.43  |- skos__scopeNote mesh__D009205
% 217.28/217.43       Inflammatory processes of the muscular walls of the heart %28%MYOCARDIUM%29% which result in injury to the cardiac muscle cells %28%MYOCYTES, CARDIAC%29%. Manifestations range from subclinical to sudden death %28%DEATH, SUDDEN%29%. Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.%A%    
% 217.28/217.43  |- mesh__dateRevised mesh__D009205 2004-07-07
% 217.28/217.43  |- mesh__recordAuthorizer mesh__D009205 sjn
% 217.28/217.43  |- skos__hiddenLabel mesh__D001222 Kinase II, Aspartate
% 217.28/217.43  |- skos__hiddenLabel mesh__D001222 Kinase, Aspartyl
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D001222 2004
% 217.28/217.43  |- skos__historyNote mesh__D001222 Phosphotransferases, ATP %28%1974%29%
% 217.28/217.43  |- skos__broader mesh__D001222smesh__D017851
% 217.28/217.43  |- mesh__recordOriginator mesh__D001222 NLM
% 217.28/217.43  |- skos__scopeNote mesh__D001222
% 217.28/217.43       An enzyme that catalyzes the formation of beta-aspartyl phosphate from aspartic acid and ATP. Threonine serves as an allosteric regulator of this enzyme to control the biosynthetic pathway from aspartic acid to threonine. EC 2.7.2.4.%A%    
% 217.28/217.43  |- mesh__publicMeSHNote mesh__D001222
% 217.28/217.43       91; was see under PHOSPHOTRANSFERASES, ATP 1975-90   
% 217.28/217.43  |- mesh__dateRevised mesh__D001222 2003-07-09
% 217.28/217.43  |- mesh__recordAuthorizer mesh__D001222 sjn
% 217.28/217.43  |- skos__altLabel mesh__D001222 Aspartyl Kinase
% 217.28/217.43  |- skos__hiddenLabel mesh__D001222 Kinase, Aspartate
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D001222 2006
% 217.28/217.43  |- mesh__dateCreated mesh__D001222 1974-11-19
% 217.28/217.43  |- mesh__recordMaintainer mesh__D001222 ssb
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D001222 2005
% 217.28/217.43  |- skos__hiddenLabel mesh__D001222 Kinase III, Aspartate
% 217.28/217.43  |- rdf__type mesh__D001222sskos__Concept
% 217.28/217.43  |- skos__hiddenLabel mesh__D001222 Kinase I, Aspartate
% 217.28/217.43  |- skos__altLabel mesh__D001222 Aspartokinase
% 217.28/217.43  |- mesh__dateEstablished mesh__D001222 1991-01-01
% 217.28/217.43  |- skos__historyNote mesh__D001222 Aspartic Acid %28%1974%29%
% 217.28/217.43  |- mesh__historyNote mesh__D001222
% 217.28/217.43       91%28%75%29%; was see under PHOSPHOTRANSFERASES, ATP 1975-90   
% 217.28/217.43  |- skos__prefLabel mesh__D001222 Aspartate Kinase
% 217.28/217.43  |- skos__prefLabel mesh__D020187 REM Sleep Behavior Disorder
% 217.28/217.43  |- skos__historyNote mesh__D020187 Sleep Disorders %28%1987-1999%29%
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D020187 2003
% 217.28/217.43  |- skos__altLabel mesh__D020187 REM Behavior Disorder
% 217.28/217.43  |- skos__broader mesh__D020187smesh__D020923
% 217.28/217.43  |- skos__altLabel mesh__D020187 Rapid Eye Movement Sleep Behavior Disorder
% 217.28/217.43  |- skos__altLabel mesh__D020187 Behavior Disorder, Rapid Eye Movement Sleep
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D020187 2000
% 217.28/217.43  |- mesh__dateEstablished mesh__D020187 2000-01-01
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D020187 2004
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D020187 2001
% 217.28/217.43  |- mesh__publicMeSHNote mesh__D020187 2000   
% 217.28/217.43  |- skos__scopeNote mesh__D020187
% 217.28/217.43       A disorder characterized by episodes of vigorous and often violent motor activity during REM sleep %28%SLEEP, REM%29%. The affected individual may inflict self injury or harm others, and is difficult to awaken from this condition. Episodes are usually followed by a vivid recollection of a dream that is consistent with the aggressive behavior. This condition primarily affects adult males. %28%From Adams et al., Principles of Neurology, 6th ed, p393%29%%A%    
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D020187 2005
% 217.28/217.43  |- rdf__type mesh__D020187sskos__Concept
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D020187 2002
% 217.28/217.43  |- skos__hiddenLabel mesh__D020187 Behavior Disorders, REM
% 217.28/217.43  |- skos__altLabel mesh__D020187 Behavior Disorder, REM
% 217.28/217.43  |- mesh__dateCreated mesh__D020187 1999-11-08
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D020187 2006
% 217.28/217.43  |- mesh__historyNote mesh__D020187 2000   
% 217.28/217.43  |- skos__hiddenLabel mesh__D020187 REM Behavior Disorders
% 217.28/217.43  |- skos__historyNote mesh__D020187 Sleep, REM %28%1987-1999%29%
% 217.28/217.43  |- skos__hiddenLabel mesh__D014948 Gunshot Wound
% 217.28/217.43  |- skos__hiddenLabel mesh__D014948 Gunshot Wounds
% 217.28/217.43  |- skos__related mesh__D014948smesh__D044709
% 217.28/217.43  |- mesh__recordMaintainer mesh__D014948 lkt
% 217.28/217.43  |- skos__broader mesh__D014948smesh__D014950
% 217.28/217.43  |- skos__prefLabel mesh__D014948 Wounds, Gunshot
% 217.28/217.43  |- mesh__dateCreated mesh__D014948 1999-01-01
% 217.28/217.43  |- skos__scopeNote mesh__D014948
% 217.28/217.43       Disruption of structural continuity of the body as a result of the discharge of firearms.%A%    
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D014948 2006
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D014948 2004
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D014948 2005
% 217.28/217.43  |- skos__annotation mesh__D014948
% 217.28/217.43       coord IM with organ /inj %28%IM%29% or precoord inj term %28%IM%29%; FORENSIC BALLISTICS is also available%A%  
% 217.28/217.43  |- mesh__dateRevised mesh__D014948 2003-07-09
% 217.28/217.43  |- mesh__recordOriginator mesh__D014948 NLM
% 217.28/217.43  |- rdf__type mesh__D014948sskos__Concept
% 217.28/217.43  |- skos__hiddenLabel mesh__D014948 Wound, Gunshot
% 217.28/217.43  |- mesh__recordAuthorizer mesh__D014948 sjn
% 217.28/217.43  |- mesh__recordMaintainer mesh__D019633 SYSTEM
% 217.28/217.43  |- mesh__activeMeSHYear mesh__D019633 2006
% 217.28/217.43  |- mesh__historyNote mesh__D019633 98   
% 217.28/217.43  |- mesh__dateEstablished mesh__D019633 1998-01-01
% 217.28/217.43  |- skos__historyNote mesh__D019633 Halobacteriaceae %28%1993-1997%29%
% 217.28/217.43  |- skos__scopeNote mesh__D019633
% 217.28/217.43       A genus of rod-shaped, extremely halophilic HALOBACTERIACEAE which grows in alkaline conditions. They are strictly aerobic and some strains are motile. Natronobacterium is found in soda lakes, alkaline salterns, and soda soils.%A%    
% 217.28/217.44  |- rdf__type mesh__D019633sskos__Concept
% 217.28/217.44  |- mesh__dateCreated mesh__D019633 1997-06-20
% 217.28/217.44  |- mesh__recordAuthorizer mesh__D019633 sjn
% 217.28/217.44  |- skos__broader mesh__D019633smesh__D006216
% 217.28/217.44  |- mesh__publicMeSHNote mesh__D019633 98   
% 217.28/217.44  |- mesh__recordOriginator mesh__D019633 AGS
% 217.28/217.44  |- skos__prefLabel mesh__D019633 Natronobacterium
% 217.28/217.44  |- mesh__dateRevised mesh__D019633 2005-06-30
% 217.28/217.44  |- skos__annotation mesh__D019633
% 217.28/217.44       a genus of Halobacteriaceae; natrono- refers to its presence in soda lakes %26% soda soils; DF: NATRONOBACT%A%  
% 217.28/217.44  |- mesh__dateRevised mesh__D000928 2005-06-30
% 217.28/217.44  |- skos__broader mesh__D000928smesh__D011619
% 217.28/217.44  |- skos__related mesh__D000928smesh__D008996
% 217.28/217.44  |- mesh__recordOriginator mesh__D000928 NLM
% 217.28/217.44  |- mesh__publicMeSHNote mesh__D000928
% 217.28/217.44       66; PSYCHIC ENERGIZERS was see ANTIDEPRESSIVE AGENTS 1963-94; THYMOLEPTICS was see TRANQUILIZING AGENTS 1969-78%A%  
% 217.28/217.44  |- mesh__onlineNote mesh__D000928
% 217.28/217.44       use ANTIDEPRESSIVE AGENTS to search PSYCHIC ENERGIZERS 1966-94; use ANTIDEPRESSIVE AGENTS %26% TRANQUILIZING AGENTS to search THYMOLEPTICS 1969-78%A%  
% 217.28/217.44  |- mesh__historyNote mesh__D000928
% 217.28/217.44       66; PSYCHIC ENERGIZERS was see ANTIDEPRESSIVE AGENTS 1963-94; THYMOLEPTICS was see TRANQUILIZING AGENTS 1969-78%A%  
% 217.28/217.44  |- skos__altLabel mesh__D000928 Antidepressants
% 217.28/217.44  |- mesh__recordMaintainer mesh__D000928 ssb
% 217.28/217.44  |- mesh__dateCreated mesh__D000928 1999-01-01
% 217.28/217.44  |- skos__scopeNote mesh__D000928
% 217.28/217.44       Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents %28%ANTIDEPRESSIVE AGENTS, TRICYCLIC%29% also appear to act through brain catecholamine systems. A third group %28%ANTIDEPRESSIVE AGENTS, SECOND-GENERATION%29% is a diverse group of drugs including some that act specifically on serotonergic systems.%A%    
% 217.28/217.44  |- skos__annotation mesh__D000928
% 217.28/217.44       GEN or unspecified; prefer specific groups or specific antidepressive agents; consider also DEPRESSION /drug ther%A%  
% 217.28/217.44  |- skos__altLabel mesh__D000928 Antidepressant Drugs
% 217.28/217.44  |- skos__hiddenLabel mesh__D000928 Agents, Antidepressive
% 217.28/217.44  |- skos__prefLabel mesh__D000928 Antidepressive Agents
% 217.28/217.44  |- mesh__recordAuthorizer mesh__D000928 sjn
% 217.28/217.44  |- rdf__type mesh__D000928sskos__Concept
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D000928 2006
% 217.28/217.44  |- skos__hiddenLabel mesh__D000928 Drugs, Antidepressant
% 217.28/217.44  |- mesh__recordOriginator mesh__D011650 NLM
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011650 2004
% 217.28/217.44  |- skos__altLabel mesh__D011650 Pulmonary Alveolus
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011650 2002
% 217.28/217.44  |- mesh__recordAuthorizer mesh__D011650 PLS
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011650 1994
% 217.28/217.44  |- mesh__dateRevised mesh__D011650 1991-06-28
% 217.28/217.44  |- mesh__dateCreated mesh__D011650 1999-01-01
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011650 2003
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011650 1999
% 217.28/217.44  |- rdf__type mesh__D011650sskos__Concept
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011650 2001
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011650 1993
% 217.28/217.44  |- skos__broader mesh__D011650smesh__D008168
% 217.28/217.44  |- mesh__recordMaintainer mesh__D011650 TGC
% 217.28/217.44  |- skos__altLabel mesh__D011650 Alveoli, Pulmonary
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011650 1998
% 217.28/217.44  |- skos__scopeNote mesh__D011650
% 217.28/217.44       Small polyhedral outpouchings along the walls of the alveolar sacs, alveolar ducts and terminal bronchioles through the walls of which gas exchange between alveolar air and pulmonary capillary blood takes place.%A%    
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011650 2000
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011650 1992
% 217.28/217.44  |- skos__annotation mesh__D011650 DF: PULM ALVEOLI   
% 217.28/217.44  |- skos__altLabel mesh__D011650 Alveolus, Pulmonary
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011650 2006
% 217.28/217.44  |- mesh__publicMeSHNote mesh__D011650 66   
% 217.28/217.44  |- mesh__dateEstablished mesh__D011650 1966-01-01
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011650 1997
% 217.28/217.44  |- skos__prefLabel mesh__D011650 Pulmonary Alveoli
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011650 2005
% 217.28/217.44  |- mesh__historyNote mesh__D011650 66%28%64%29%   
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011650 1996
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011650 1995
% 217.28/217.44  |- skos__historyNote mesh__D033304 Crustacea %28%1965-2002%29%
% 217.28/217.44  |- skos__altLabel mesh__D033304 Amphipods
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D033304 2006
% 217.28/217.44  |- skos__scopeNote mesh__D033304
% 217.28/217.44       An order of mostly marine CRUSTACEA containing more than 5500 species in over 100 families. Like ISOPODA, the other large order in the superorder Peracarida, members are shrimp-like in appearance, have sessile compound eyes, and no carapace.  But unlike Isopoda, they possess thoracic gills and their bodies are laterally compressed.%A%    
% 217.28/217.44  |- rdf__type mesh__D033304sskos__Concept
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D033304 2004
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D033304 2005
% 217.28/217.44  |- skos__prefLabel mesh__D033304 Amphipoda
% 217.28/217.44  |- mesh__publicMeSHNote mesh__D033304 2003   
% 217.28/217.44  |- mesh__dateRevised mesh__D033304 2003-07-09
% 217.28/217.44  |- mesh__dateCreated mesh__D033304 2002-07-02
% 217.28/217.44  |- mesh__dateEstablished mesh__D033304 2003-01-01
% 217.28/217.44  |- mesh__historyNote mesh__D033304 2003   
% 217.28/217.44  |- skos__broader mesh__D033304smesh__D003445
% 217.28/217.44  |- skos__historyNote mesh__D005613 Freezing %28%1966-1968%29%
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D005613 2002
% 217.28/217.44  |- skos__hiddenLabel mesh__D005613 Etching, Freeze
% 217.28/217.44  |- skos__prefLabel mesh__D005613 Freeze Etching
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D005613 2004
% 217.28/217.44  |- rdf__type mesh__D005613sskos__Concept
% 217.28/217.44  |- mesh__dateCreated mesh__D005613 1999-01-01
% 217.28/217.44  |- skos__historyNote mesh__D005613
% 217.28/217.44       Histological Techniques %28%1966-1968%29%
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D005613 2003
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D005613 2001
% 217.28/217.44  |- skos__broader mesh__D005613smesh__D005614
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D005613 2006
% 217.28/217.44  |- mesh__recordMaintainer mesh__D005613 TAP
% 217.28/217.44  |- mesh__historyNote mesh__D005613 73%28%69%29%   
% 217.28/217.44  |- mesh__dateRevised mesh__D005613 2000-06-22
% 217.28/217.44  |- skos__scopeNote mesh__D005613
% 217.28/217.44       A replica technique in which cells are frozen to a very low temperature and cracked with a knife blade to expose the interior surfaces of the cells or cell membranes. The cracked cell surfaces are then freeze-dried to expose their constituents. The surfaces are now ready for shadowing to be viewed using an electron microscope. This method differs from freeze-fracturing in that no cryoprotectant is used and, thus, allows for the sublimation of water during the freeze-drying process to etch the surfaces.%A%    
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D005613 2005
% 217.28/217.44  |- skos__annotation mesh__D005613
% 217.28/217.44       do not confuse with FREEZE FRACTURING %28%wherein a cryoprotectant is used%29%%A%  
% 217.28/217.44  |- mesh__publicMeSHNote mesh__D005613 73   
% 217.28/217.44  |- mesh__recordAuthorizer mesh__D005613 sjn
% 217.28/217.44  |- skos__historyNote mesh__D005613 Microscopy, Electron %28%1966-1968%29%
% 217.28/217.44  |- mesh__recordOriginator mesh__D005613 NLM
% 217.28/217.44  |- mesh__dateEstablished mesh__D005613 1973-01-01
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010558 1994
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010558 1997
% 217.28/217.44  |- skos__hiddenLabel mesh__D010558 Loyalties, Personnel
% 217.28/217.44  |- skos__hiddenLabel mesh__D010558 Loyalty, Personnel
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010558 1992
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010558 1998
% 217.28/217.44  |- mesh__recordOriginator mesh__D010558 EC
% 217.28/217.44  |- mesh__dateRevised mesh__D010558 1990-04-13
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010558 1996
% 217.28/217.44  |- mesh__recordAuthorizer mesh__D010558 PLS
% 217.28/217.44  |- skos__prefLabel mesh__D010558 Personnel Loyalty
% 217.28/217.44  |- skos__hiddenLabel mesh__D010558 Personnel Loyalties
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010558 2006
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010558 2002
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010558 2004
% 217.28/217.44  |- mesh__recordMaintainer mesh__D010558 NLM
% 217.28/217.44  |- mesh__historyNote mesh__D010558
% 217.28/217.44       91%28%84%29%; was see under PERSONNEL MANAGEMENT 1984-90   
% 217.28/217.44  |- mesh__publicMeSHNote mesh__D010558
% 217.28/217.44       91; was see under PERSONNEL MANAGEMENT 1984-90   
% 217.28/217.44  |- mesh__dateEstablished mesh__D010558 1991-01-01
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010558 2005
% 217.28/217.44  |- skos__scopeNote mesh__D010558
% 217.28/217.44       Dedication or commitment shown by employees to organizations or institutions where they work.%A%    
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010558 2003
% 217.28/217.44  |- mesh__dateCreated mesh__D010558 1983-06-06
% 217.28/217.44  |- skos__annotation mesh__D010558 no qualif   
% 217.28/217.44  |- rdf__type mesh__D010558sskos__Concept
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010558 2001
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010558 1995
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010558 1991
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010558 2000
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010558 1993
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010558 1999
% 217.28/217.44  |- skos__broader mesh__D010558smesh__D010559
% 217.28/217.44  |- mesh__dateEstablished mesh__D029263 2002-01-01
% 217.28/217.44  |- skos__prefLabel mesh__D029263 Seoul virus
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D029263 2003
% 217.28/217.44  |- skos__scopeNote mesh__D029263
% 217.28/217.44       A species of HANTAVIRUS causing a less severe form of HEMORRHAGIC FEVER WITH RENAL SYNDROME in Asia %28%primarily Korea and Japan%29%. It is transmitted by rats, especially Rattus rattus and R. norvegicus.%A%    
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D029263 2004
% 217.28/217.44  |- skos__historyNote mesh__D029263 Bunyaviridae %28%1991-1992%29%
% 217.28/217.44  |- skos__broader mesh__D029263smesh__D006476
% 217.28/217.44  |- skos__annotation mesh__D029263
% 217.28/217.44       infection: coord IM with HEMORRHAGIC FEVER WITH RENAL SYNDROME %28%IM%29%%A%  
% 217.28/217.44  |- mesh__historyNote mesh__D029263 2002; use HANTAVIRUS 1992-2001   
% 217.28/217.44  |- skos__historyNote mesh__D029263 Hantavirus %28%1993-2001%29%
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D029263 2005
% 217.28/217.44  |- rdf__type mesh__D029263sskos__Concept
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D029263 2006
% 217.28/217.44  |- mesh__publicMeSHNote mesh__D029263 2002; see HANTAVIRUS 1992-2001   
% 217.28/217.44  |- mesh__dateCreated mesh__D029263 2001-07-25
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D029263 2002
% 217.28/217.44  |- skos__hiddenLabel mesh__D015243 Cholesterol Lipoprotein, VLDL
% 217.28/217.44  |- skos__broader mesh__D015243smesh__D008079
% 217.28/217.44  |- rdf__type mesh__D015243sskos__Concept
% 217.28/217.44  |- skos__hiddenLabel mesh__D015243 Cholesterol Lipoproteins, VLDL
% 217.28/217.44  |- skos__altLabel mesh__D015243 VLDL Cholesterol
% 217.28/217.44  |- mesh__recordAuthorizer mesh__D015243 sjn
% 217.28/217.44  |- skos__historyNote mesh__D015243 Cholesterol %28%1972-1988%29%
% 217.28/217.44  |- skos__prefLabel mesh__D015243 Lipoproteins, VLDL Cholesterol
% 217.28/217.44  |- skos__altLabel mesh__D015243 Cholesterol Very Low Density Lipoproteins
% 217.28/217.44  |- skos__scopeNote mesh__D015243
% 217.28/217.44       Cholesterol which is contained in or bound to very low density lipoproteins %28%VLDL%29%. High concentrations of VLDL cholesterol are found in Type IIB and Type V hyperlipoproteinemia. The end product of VLDL cholesterol catabolism is LDL %28%low density lipoproteins%29%.%A%    
% 217.28/217.44  |- skos__historyNote mesh__D015243 Lipoproteins, VLDL %28%1972-1988%29%
% 217.28/217.44  |- skos__altLabel mesh__D015243 Very Low Density Lipoprotein Cholesterol
% 217.28/217.44  |- mesh__historyNote mesh__D015243 89   
% 217.28/217.44  |- skos__hiddenLabel mesh__D015243 VLDL, Cholesterol
% 217.28/217.44  |- skos__broader mesh__D015243smesh__D002784
% 217.28/217.44  |- skos__altLabel mesh__D015243 Lipoprotein, VLDL Cholesterol
% 217.28/217.44  |- mesh__publicMeSHNote mesh__D015243 89   
% 217.28/217.44  |- skos__hiddenLabel mesh__D015243 Cholesterol, Prebetalipoprotein
% 217.28/217.44  |- mesh__dateEstablished mesh__D015243 1989-01-01
% 217.28/217.44  |- skos__altLabel mesh__D015243 Prebetalipoprotein Cholesterol
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D015243 2006
% 217.28/217.44  |- mesh__dateRevised mesh__D015243 2005-06-30
% 217.28/217.44  |- skos__hiddenLabel mesh__D015243 VLDL Cholesterol Lipoprotein
% 217.28/217.44  |- mesh__recordMaintainer mesh__D015243 SYSTEM
% 217.28/217.44  |- skos__hiddenLabel mesh__D015243 Cholesterol, VLDL
% 217.28/217.44  |- mesh__dateCreated mesh__D015243 1988-05-16
% 217.28/217.44  |- skos__hiddenLabel mesh__D015243 VLDL Cholesterol Lipoproteins
% 217.28/217.44  |- mesh__recordOriginator mesh__D015243 RLS
% 217.28/217.44  |- skos__altLabel mesh__D015243 Cholesterol VLDL
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D009206 2005
% 217.28/217.44  |- skos__broader mesh__D009206smesh__D009132
% 217.28/217.44  |- skos__altLabel mesh__D009206 Muscle, Heart
% 217.28/217.44  |- mesh__recordAuthorizer mesh__D009206 sjn
% 217.28/217.44  |- mesh__recordMaintainer mesh__D009206 lkt
% 217.28/217.44  |- skos__altLabel mesh__D009206 Myocardia
% 217.28/217.44  |- mesh__dateRevised mesh__D009206 2004-07-07
% 217.28/217.44  |- skos__hiddenLabel mesh__D009206 Heart Muscle
% 217.28/217.44  |- skos__scopeNote mesh__D009206
% 217.28/217.44       The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells %28%MYOCYTES, CARDIAC%29% connected to form the contractile pump to generate blood flow.%A%    
% 217.28/217.44  |- rdf__type mesh__D009206sskos__Concept
% 217.28/217.44  |- mesh__dateCreated mesh__D009206 1999-01-01
% 217.28/217.44  |- skos__broader mesh__D009206smesh__D006321
% 217.28/217.44  |- skos__annotation mesh__D009206
% 217.28/217.44       the heart as tissue, differentiated from the heart as a pump %28% = HEART%29%; Manual 21.48; ischemia = MYOCARDIAL ISCHEMIA; inflammation = MYOCARDITIS%A%  
% 217.28/217.44  |- skos__hiddenLabel mesh__D009206 Muscles, Cardiac
% 217.28/217.44  |- mesh__considerAlso mesh__D009206
% 217.28/217.44       consider also terms at CARDIAC and HEART   
% 217.28/217.44  |- skos__hiddenLabel mesh__D009206 Cardiac Muscles
% 217.28/217.44  |- mesh__recordOriginator mesh__D009206 NLM
% 217.28/217.44  |- skos__altLabel mesh__D009206 Cardiac Muscle
% 217.28/217.44  |- skos__hiddenLabel mesh__D009206 Muscles, Heart
% 217.28/217.44  |- skos__prefLabel mesh__D009206 Myocardium
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D009206 2006
% 217.28/217.44  |- skos__hiddenLabel mesh__D009206 Heart Muscles
% 217.28/217.44  |- skos__altLabel mesh__D009206 Muscle, Cardiac
% 217.28/217.44  |- mesh__publicMeSHNote mesh__D001223 65   
% 217.28/217.44  |- skos__hiddenLabel mesh__D001223 Dehydrogenase, Aspartate-Semialdehyde
% 217.28/217.44  |- skos__hiddenLabel mesh__D001223 Dehydrogenase, Semiaspartate Aldehyde
% 217.28/217.44  |- skos__hiddenLabel mesh__D001223 Aldehyde Dehydrogenase, Semiaspartate
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D001223 2006
% 217.28/217.44  |- skos__altLabel mesh__D001223 Semiaspartate Aldehyde Dehydrogenase
% 217.28/217.44  |- mesh__recordOriginator mesh__D001223 NLM
% 217.28/217.44  |- skos__prefLabel mesh__D001223 Aspartate-Semialdehyde Dehydrogenase
% 217.28/217.44  |- mesh__dateCreated mesh__D001223 1999-01-01
% 217.28/217.44  |- rdf__type mesh__D001223sskos__Concept
% 217.28/217.44  |- mesh__recordAuthorizer mesh__D001223 sjn
% 217.28/217.44  |- skos__broader mesh__D001223smesh__D000445
% 217.28/217.44  |- mesh__dateRevised mesh__D001223 2005-06-30
% 217.28/217.44  |- skos__hiddenLabel mesh__D001223 Aspartate Semialdehyde Dehydrogenase
% 217.28/217.44  |- mesh__historyNote mesh__D001223 65   
% 217.28/217.44  |- mesh__dateEstablished mesh__D001223 1965-01-01
% 217.28/217.44  |- skos__scopeNote mesh__D001223
% 217.28/217.44       An enzyme that catalyzes the conversion of L-aspartate 4-semialdehyde, orthophosphate, and NADP+ to yield L-4-aspartyl phosphate and NADPH. EC 1.2.1.11.%A%    
% 217.28/217.44  |- mesh__recordMaintainer mesh__D001223 jmp
% 217.28/217.44  |- skos__broader mesh__D020188smesh__D020923
% 217.28/217.44  |- mesh__recordOriginator mesh__D020188 KEV
% 217.28/217.44  |- skos__altLabel mesh__D020188 Paralysis, Sleep
% 217.28/217.44  |- mesh__dateEstablished mesh__D020188 2000-01-01
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D020188 2004
% 217.28/217.44  |- mesh__dateRevised mesh__D020188 2004-08-02
% 217.28/217.44  |- mesh__recordMaintainer mesh__D020188 jls
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D020188 2005
% 217.28/217.44  |- skos__prefLabel mesh__D020188 Sleep Paralysis
% 217.28/217.44  |- rdf__type mesh__D020188sskos__Concept
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D020188 2006
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D020188 2000
% 217.28/217.44  |- mesh__historyNote mesh__D020188 2000   
% 217.28/217.44  |- skos__scopeNote mesh__D020188
% 217.28/217.44       A common condition characterized by transient partial or total paralysis of skeletal muscles and areflexia that occurs upon awakening from sleep or less often while falling asleep. Stimuli such as touch or sound may terminate the episode, which usually has a duration of seconds to minutes. This condition may occur in normal subjects or be associated with NARCOLEPSY; CATAPLEXY; and hypnagogic HALLUCINATIONS. The pathophysiology of this condition is closely related to the normal hypotonia that occur during REM sleep. %28%From Adv Neurol 1995;67:245-271%29%%A%    
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D020188 2001
% 217.28/217.44  |- mesh__publicMeSHNote mesh__D020188 2000   
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D020188 2005A
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D020188 2002
% 217.28/217.44  |- mesh__dateCreated mesh__D020188 1999-11-08
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D020188 2003
% 217.28/217.44  |- mesh__recordAuthorizer mesh__D020188 jls
% 217.28/217.44  |- skos__historyNote mesh__D020188 Sleep Disorders %28%1965-1999%29%
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D014949 2000
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D014949 1993
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D014949 2005
% 217.28/217.44  |- mesh__dateEstablished mesh__D014949 1976-01-01
% 217.28/217.44  |- skos__prefLabel mesh__D014949 Wounds, Nonpenetrating
% 217.28/217.44  |- skos__hiddenLabel mesh__D014949 Wound, Nonpenetrating
% 217.28/217.44  |- mesh__publicMeSHNote mesh__D014949 76   
% 217.28/217.44  |- mesh__dateCreated mesh__D014949 1975-07-25
% 217.28/217.44  |- skos__broader mesh__D014949smesh__D014947
% 217.28/217.44  |- skos__hiddenLabel mesh__D014949 Blunt Injury
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D014949 2001
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D014949 2006
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D014949 1996
% 217.28/217.44  |- skos__hiddenLabel mesh__D014949 Injury, Blunt
% 217.28/217.44  |- skos__hiddenLabel mesh__D014949 Nonpenetrating Wound
% 217.28/217.44  |- mesh__recordAuthorizer mesh__D014949 PLS
% 217.28/217.44  |- skos__historyNote mesh__D014949 Abdominal Injuries %28%1966-1975%29%
% 217.28/217.44  |- skos__altLabel mesh__D014949 Injuries, Nonpenetrating
% 217.28/217.44  |- skos__altLabel mesh__D014949 Injuries, Blunt
% 217.28/217.44  |- skos__hiddenLabel mesh__D014949 Nonpenetrating Injury
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D014949 1997
% 217.28/217.44  |- skos__scopeNote mesh__D014949
% 217.28/217.44       Injuries caused by impact with a blunt object where there is no penetration of the skin.%A%    
% 217.28/217.44  |- skos__hiddenLabel mesh__D014949 Injury, Nonpenetrating
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D014949 1998
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D014949 2002
% 217.28/217.44  |- mesh__recordMaintainer mesh__D014949 PXP
% 217.28/217.44  |- mesh__recordOriginator mesh__D014949 SMH
% 217.28/217.44  |- skos__historyNote mesh__D014949 Thoracic Injuries %28%1966-1975%29%
% 217.28/217.44  |- skos__altLabel mesh__D014949 Blunt Injuries
% 217.28/217.44  |- rdf__type mesh__D014949sskos__Concept
% 217.28/217.44  |- mesh__historyNote mesh__D014949 76   
% 217.28/217.44  |- skos__altLabel mesh__D014949 Nonpenetrating Injuries
% 217.28/217.44  |- skos__hiddenLabel mesh__D014949 Nonpenetrating Wounds
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D014949 1994
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D014949 1999
% 217.28/217.44  |- skos__historyNote mesh__D014949 Heart Injuries %28%1966-1975%29%
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D014949 2003
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D014949 1992
% 217.28/217.44  |- mesh__dateRevised mesh__D014949 1990-11-10
% 217.28/217.44  |- skos__annotation mesh__D014949
% 217.28/217.44       IM; coord with organ /inj or precoord inj term %28%IM%29%   
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D014949 1995
% 217.28/217.44  |- skos__historyNote mesh__D014949 Head Injuries %28%1966-1975%29%
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D014949 2004
% 217.28/217.44  |- mesh__publicMeSHNote mesh__D019634 98   
% 217.28/217.44  |- mesh__recordOriginator mesh__D019634 AGS
% 217.28/217.44  |- skos__historyNote mesh__D019634 Archaea %28%1992-1997%29%
% 217.28/217.44  |- mesh__dateRevised mesh__D019634 2005-06-30
% 217.28/217.44  |- rdf__type mesh__D019634sskos__Concept
% 217.28/217.44  |- mesh__dateEstablished mesh__D019634 1998-01-01
% 217.28/217.44  |- skos__broader mesh__D019634smesh__D006216
% 217.28/217.44  |- skos__annotation mesh__D019634
% 217.28/217.44       a genus of Halobacteriaceae; natrono- refers to its presence in soda lakes %26% soda soils%A%  
% 217.28/217.44  |- skos__prefLabel mesh__D019634 Natronococcus
% 217.28/217.44  |- mesh__dateCreated mesh__D019634 1997-06-20
% 217.28/217.44  |- mesh__recordMaintainer mesh__D019634 SYSTEM
% 217.28/217.44  |- mesh__recordAuthorizer mesh__D019634 sjn
% 217.28/217.44  |- skos__scopeNote mesh__D019634
% 217.28/217.44       A genus of coccoid, extremely halophilic HALOBACTERIACEAE which grows in alkaline conditions. They are nonmotile and strictly aerobic and are found in soda lakes, alkaline salterns, and soda soils.%A%    
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D019634 2006
% 217.28/217.44  |- mesh__historyNote mesh__D019634 98   
% 217.28/217.44  |- skos__annotation mesh__D000929 GEN or unspecified; prefer specifics   
% 217.28/217.44  |- skos__altLabel mesh__D000929 Tricyclic Antidepressive Agents
% 217.28/217.44  |- mesh__dateRevised mesh__D000929 2005-06-30
% 217.28/217.44  |- skos__altLabel mesh__D000929 Antidepressants, Tricyclic
% 217.28/217.44  |- skos__historyNote mesh__D000929 Antidepressive Agents %28%1968-1974%29%
% 217.28/217.44  |- mesh__historyNote mesh__D000929 75   
% 217.28/217.44  |- skos__altLabel mesh__D000929 Antidepressant Drugs, Tricyclic
% 217.28/217.44  |- skos__hiddenLabel mesh__D000929 Tricyclic Antidepressants
% 217.28/217.44  |- mesh__recordOriginator mesh__D000929 NLM
% 217.28/217.44  |- mesh__dateEstablished mesh__D000929 1975-09-01
% 217.28/217.44  |- rdf__type mesh__D000929sskos__Concept
% 217.28/217.44  |- skos__hiddenLabel mesh__D000929 Tricyclic Antidepressant Drugs
% 217.28/217.44  |- skos__hiddenLabel mesh__D000929 Agents, Tricyclic Antidepressive
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D000929 2006
% 217.28/217.44  |- mesh__recordMaintainer mesh__D000929 ssb
% 217.28/217.44  |- skos__scopeNote mesh__D000929
% 217.28/217.44       Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system.%A%    
% 217.28/217.44  |- skos__broader mesh__D000929smesh__D000928
% 217.28/217.44  |- skos__hiddenLabel mesh__D000929 Drugs, Tricyclic Antidepressant
% 217.28/217.44  |- mesh__dateCreated mesh__D000929 1974-11-11
% 217.28/217.44  |- skos__prefLabel mesh__D000929 Antidepressive Agents, Tricyclic
% 217.28/217.44  |- mesh__publicMeSHNote mesh__D000929 75   
% 217.28/217.44  |- mesh__recordAuthorizer mesh__D000929 sjn
% 217.28/217.44  |- skos__altLabel mesh__D011651 Arteries, Pulmonary
% 217.28/217.44  |- mesh__recordMaintainer mesh__D011651 TAP
% 217.28/217.44  |- mesh__dateRevised mesh__D011651 1992-05-18
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011651 2004
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011651 2002
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011651 1998
% 217.28/217.44  |- mesh__recordAuthorizer mesh__D011651 PLS
% 217.28/217.44  |- rdf__type mesh__D011651sskos__Concept
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011651 1999
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011651 1993
% 217.28/217.44  |- mesh__recordOriginator mesh__D011651 NLM
% 217.28/217.44  |- skos__altLabel mesh__D011651 Pulmonary Arteries
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011651 2005
% 217.28/217.44  |- skos__broader mesh__D011651smesh__D001158
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011651 2000
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011651 1996
% 217.28/217.44  |- skos__prefLabel mesh__D011651 Pulmonary Artery
% 217.28/217.44  |- skos__scopeNote mesh__D011651
% 217.28/217.44       The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs.%A%    
% 217.28/217.44  |- skos__altLabel mesh__D011651 Artery, Pulmonary
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011651 2006
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011651 2001
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011651 1997
% 217.28/217.44  |- skos__annotation mesh__D011651 DF: PULM ARTERY   
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011651 1994
% 217.28/217.44  |- mesh__dateCreated mesh__D011651 1999-01-01
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011651 2003
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D011651 1995
% 217.28/217.44  |- rdf__type mesh__D005614sskos__Concept
% 217.28/217.44  |- mesh__publicMeSHNote mesh__D005614 75   
% 217.28/217.44  |- mesh__dateCreated mesh__D005614 1974-11-11
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D005614 2004
% 217.28/217.44  |- skos__annotation mesh__D005614
% 217.28/217.44       do not confuse with FREEZE ETCHING %28%wherein no cryoprotectant is used%29%%A%  
% 217.28/217.44  |- mesh__dateEstablished mesh__D005614 1975-09-01
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D005614 2001
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D005614 2003
% 217.28/217.44  |- skos__scopeNote mesh__D005614
% 217.28/217.44       Preparation for electron microscopy of minute replicas of exposed surfaces of the cell which have been ruptured in the frozen state. The specimen is frozen, then cleaved under high vacuum at the same temperature. The exposed surface is shadowed with carbon and platinum and coated with carbon to obtain a carbon replica.%A%    
% 217.28/217.44  |- mesh__recordMaintainer mesh__D005614 TAP
% 217.28/217.44  |- skos__hiddenLabel mesh__D005614 Fracturings, Freeze
% 217.28/217.44  |- skos__hiddenLabel mesh__D005614 Freeze Fracturings
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D005614 2006
% 217.28/217.44  |- mesh__dateRevised mesh__D005614 2000-06-22
% 217.28/217.44  |- mesh__recordAuthorizer mesh__D005614 sjn
% 217.28/217.44  |- skos__historyNote mesh__D005614 Freeze Etching %28%1969-1974%29%
% 217.28/217.44  |- mesh__recordOriginator mesh__D005614 NLM
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D005614 2005
% 217.28/217.44  |- skos__broader mesh__D005614smesh__D016628
% 217.28/217.44  |- skos__hiddenLabel mesh__D005614 Fracturing, Freeze
% 217.28/217.44  |- mesh__historyNote mesh__D005614 75   
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D005614 2002
% 217.28/217.44  |- skos__prefLabel mesh__D005614 Freeze Fracturing
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010559 1997
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010559 2005
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010559 2001
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010559 2003
% 217.28/217.44  |- mesh__recordMaintainer mesh__D010559 PLS
% 217.28/217.44  |- skos__scopeNote mesh__D010559
% 217.28/217.44       Planning, organizing, and administering all activities related to personnel.%A%    
% 217.28/217.44  |- skos__related mesh__D010559smesh__D010557
% 217.28/217.44  |- mesh__recordAuthorizer mesh__D010559 PLS
% 217.28/217.44  |- skos__hiddenLabel mesh__D010559 Client Staff Ratio
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010559 2006
% 217.28/217.44  |- mesh__dateCreated mesh__D010559 1999-01-01
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010559 2002
% 217.28/217.44  |- mesh__recordOriginator mesh__D010559 NLM
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010559 2004
% 217.28/217.44  |- skos__hiddenLabel mesh__D010559 Client-Staff Ratios
% 217.28/217.44  |- skos__prefLabel mesh__D010559 Personnel Management
% 217.28/217.44  |- skos__hiddenLabel mesh__D010559 Ratios, Client-Staff
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010559 1994
% 217.28/217.44  |- rdf__type mesh__D010559sskos__Concept
% 217.28/217.44  |- skos__hiddenLabel mesh__D010559 Ratio, Client-Staff
% 217.28/217.44  |- skos__hiddenLabel mesh__D010559 Management, Personnel
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010559 1998
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010559 1995
% 217.28/217.44  |- mesh__dateRevised mesh__D010559 1993-06-03
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010559 1996
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010559 2000
% 217.28/217.44  |- mesh__activeMeSHYear mesh__D010559 1999
% 217.28/217.44  |- skos__broader mesh__D010559smesh__D009934
% 217.28/217.44  |- skos__altLabel mesh__D021281 QSPR Modeling
% 217.28/217.44  |- rdf__type mesh__D021281sskos__Concept
% 217.28/217.44  |- mesh__dateEstablished mesh__D021281 2001-01-01
% 217.28/217.44  |- mesh__dateCreated mesh__D021281 2000-06-27
% 217.28/217.44  |- mesh__dateRevised mesh__D021281 2005-06-30
% 217.28/217.44  |- skos__altLabel mesh__D021281
% 217.28/217.44       Structure Activity Relationship, Quantitative
% 217.28/217.44  |- mesh__recordMaintainer mesh__D021281 ssb
% 217.28/217.44  |- skos__hiddenLabel mesh__D021281 3D-QSARs
% 217.28/217.45  |- skos__hiddenLabel mesh__D021281
% 217.28/217.45       Structure-Activity Relationship, Quantitative
% 217.28/217.45  |- skos__hiddenLabel mesh__D021281
% 217.28/217.45       Quantitative Structure-Activity Relationships
% 217.28/217.45  |- skos__hiddenLabel mesh__D021281
% 217.28/217.45       Quantitative Structure Activity Relationship
% 217.28/217.45  |- skos__historyNote mesh__D021281
% 217.28/217.45       Structure-Activity Relationship %28%1972-2000%29%
% 217.28/217.45  |- mesh__recordAuthorizer mesh__D021281 sjn
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D021281 2006
% 217.28/217.45  |- skos__altLabel mesh__D021281 QSAR
% 217.28/217.45  |- skos__hiddenLabel mesh__D021281
% 217.28/217.45       Relationship, Quantitative Structure-Activity
% 217.28/217.45  |- skos__hiddenLabel mesh__D021281 Modeling, QSPR
% 217.28/217.45  |- skos__prefLabel mesh__D021281
% 217.28/217.45       Quantitative Structure-Activity Relationship
% 217.28/217.45  |- skos__hiddenLabel mesh__D021281
% 217.28/217.45       Relationships, Quantitative Structure-Activity
% 217.28/217.45  |- skos__hiddenLabel mesh__D021281 3D QSAR
% 217.28/217.45  |- mesh__recordOriginator mesh__D021281 jmp
% 217.28/217.45  |- skos__scopeNote mesh__D021281
% 217.28/217.45       A quantitative prediction of the biological, ecotoxicological or pharmaceutical activity of a molecule. It is based upon structure and activity information gathered from a series of similar compounds.%A%    
% 217.28/217.45  |- skos__hiddenLabel mesh__D021281
% 217.28/217.45       Structure-Activity Relationships, Quantitative
% 217.28/217.45  |- mesh__publicMeSHNote mesh__D021281 2001   
% 217.28/217.45  |- mesh__historyNote mesh__D021281 2001   
% 217.28/217.45  |- skos__annotation mesh__D021281 DF:QSAR   
% 217.28/217.45  |- skos__broader mesh__D021281smesh__D013329
% 217.28/217.45  |- skos__broader mesh__D015244smesh__D000603
% 217.28/217.45  |- mesh__recordOriginator mesh__D015244 RLS
% 217.28/217.45  |- skos__altLabel mesh__D015244 Tiorphan
% 217.28/217.45  |- skos__broader mesh__D015244smesh__D034442
% 217.28/217.45  |- skos__historyNote mesh__D015244
% 217.28/217.45       Mercaptopropionylglycine/analogs %26% derivatives %28%1980-1988%29%
% 217.28/217.45  |- skos__prefLabel mesh__D015244 Thiorphan
% 217.28/217.45  |- skos__scopeNote mesh__D015244
% 217.28/217.45       A potent inhibitor of membrane metalloendopeptidase %28%ENKEPHALINASE%29%. Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.%A%    
% 217.28/217.45  |- mesh__publicMeSHNote mesh__D015244 89   
% 217.28/217.45  |- mesh__recordAuthorizer mesh__D015244 sjn
% 217.28/217.45  |- mesh__dateEstablished mesh__D015244 1989-01-01
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D015244 2006
% 217.28/217.45  |- mesh__historyNote mesh__D015244 89   
% 217.28/217.45  |- mesh__recordMaintainer mesh__D015244 ssb
% 217.28/217.45  |- mesh__dateCreated mesh__D015244 1988-05-16
% 217.28/217.45  |- skos__altLabel mesh__D015244 %28%3-Mercapto-2-benzylpropionyl%29%glycine
% 217.28/217.45  |- mesh__dateRevised mesh__D015244 2005-06-30
% 217.28/217.45  |- rdf__type mesh__D015244sskos__Concept
% 217.28/217.45  |- mesh__recordOriginator mesh__D009207 NLM
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D009207 2004
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D009207 2002
% 217.28/217.45  |- skos__hiddenLabel mesh__D009207 Jerks, Myoclonic
% 217.28/217.45  |- skos__hiddenLabel mesh__D009207 Sleep Myoclonus
% 217.28/217.45  |- skos__altLabel mesh__D009207 Myoclonic Jerking
% 217.28/217.45  |- skos__hiddenLabel mesh__D009207 Extremity Myoclonus, Upper
% 217.28/217.45  |- skos__hiddenLabel mesh__D009207 Eyelid Myoclonus
% 217.28/217.45  |- skos__scopeNote mesh__D009207
% 217.28/217.45       Involuntary shock-like contractions, irregular in rhythm and amplitude, followed by relaxation, of a muscle or a group of muscles. This condition may be a feature of some CENTRAL NERVOUS SYSTEMS DISEASES %28%e.g., EPILEPSY, MYOCLONIC%29%. Nocturnal myoclonus may represent a normal physiologic event or occur as the principal feature of the NOCTURNAL MYOCLONUS SYNDROME. %28%From Adams et al., Principles of Neurology, 6th ed, pp102-3%29%.%A%    
% 217.28/217.45  |- skos__hiddenLabel mesh__D009207 Palatal Myoclonus
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D009207 2003
% 217.28/217.45  |- skos__hiddenLabel mesh__D009207 Simplex, Myoclonus
% 217.28/217.45  |- skos__hiddenLabel mesh__D009207 Oculopalatal Myoclonus
% 217.28/217.45  |- skos__broader mesh__D009207smesh__D020820
% 217.28/217.45  |- skos__hiddenLabel mesh__D009207 Jerking, Myoclonic
% 217.28/217.45  |- mesh__recordAuthorizer mesh__D009207 sjn
% 217.28/217.45  |- mesh__dateCreated mesh__D009207 1999-01-01
% 217.28/217.45  |- rdf__type mesh__D009207sskos__Concept
% 217.28/217.45  |- skos__altLabel mesh__D009207 Myoclonic Jerk
% 217.28/217.45  |- skos__hiddenLabel mesh__D009207 Upper Extremity Myoclonus
% 217.28/217.45  |- skos__altLabel mesh__D009207 Myoclonus, Sleep
% 217.28/217.45  |- mesh__publicMeSHNote mesh__D009207
% 217.28/217.45       1963; for MYOCLONIC JERKING see EPILEPSY, MYOCLONIC 1992-1999; for MYOCLONIC JERKING, MASSIVE see SPASMS, INFANTILE 1977-1999%A%  
% 217.28/217.45  |- skos__hiddenLabel mesh__D009207 Segmental Myoclonus
% 217.28/217.45  |- skos__hiddenLabel mesh__D009207 Jerk, Myoclonic
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D009207 2006
% 217.28/217.45  |- skos__hiddenLabel mesh__D009207 Nocturnal Myoclonus
% 217.28/217.45  |- mesh__dateRevised mesh__D009207 2001-07-25
% 217.28/217.45  |- skos__hiddenLabel mesh__D009207 Lower Extremity Myoclonus
% 217.28/217.45  |- mesh__historyNote mesh__D009207
% 217.28/217.45       1963; for MYOCLONIC JERKING use EPILEPSY, MYOCLONIC 1992-1999; for MYOCLONIC JERKING, MASSIVE use SPASMS, INFANTILE 1977-1999%A%  
% 217.28/217.45  |- mesh__recordMaintainer mesh__D009207 ags
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D009207 2005
% 217.28/217.45  |- skos__hiddenLabel mesh__D009207 Intention Myoclonus
% 217.28/217.45  |- skos__hiddenLabel mesh__D009207 Myoclonic Jerks
% 217.28/217.45  |- skos__hiddenLabel mesh__D009207 Extremity Myoclonus, Lower
% 217.28/217.45  |- skos__annotation mesh__D009207
% 217.28/217.45       for %22%myoclonic seizure%22% consider MYOCLONUS or EPILEPSY, MYOCLONIC or SPASMS, INFANTILE; NOCTURNAL MYOCLONUS SYNDROME is also available%A%  
% 217.28/217.45  |- skos__prefLabel mesh__D009207 Myoclonus
% 217.28/217.45  |- skos__hiddenLabel mesh__D009207 Action Myoclonus
% 217.28/217.45  |- mesh__dateRevised mesh__D001224 2005-06-30
% 217.28/217.45  |- skos__hiddenLabel mesh__D001224 L Aspartic Acid
% 217.28/217.45  |- mesh__publicMeSHNote mesh__D001224
% 217.28/217.45       93; ISOASPARTIC ACID was indexed under ASPARTIC ACID 1990-92%A%  
% 217.28/217.45  |- skos__hiddenLabel mesh__D001224 L Aspartate
% 217.28/217.45  |- mesh__dateCreated mesh__D001224 1999-01-01
% 217.28/217.45  |- skos__altLabel mesh__D001224 Potassium Aspartate
% 217.28/217.45  |- skos__hiddenLabel mesh__D001224 Hydrochloride Aspartic Acid
% 217.28/217.45  |- mesh__historyNote mesh__D001224
% 217.28/217.45       93; ISOASPARTIC ACID was %28%NM%29% 1990-92   
% 217.28/217.45  |- skos__hiddenLabel mesh__D001224 Acid, Hydrochloride Aspartic
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D001224 2006
% 217.28/217.45  |- skos__hiddenLabel mesh__D001224 Aspartate, Magnesium
% 217.28/217.45  |- skos__altLabel mesh__D001224 L-Aspartic Acid
% 217.28/217.45  |- skos__hiddenLabel mesh__D001224 Aspartate, Sodium
% 217.28/217.45  |- skos__hiddenLabel mesh__D001224 Acid, L-Aspartic
% 217.28/217.45  |- skos__altLabel mesh__D001224 Magnesium Aspartate
% 217.28/217.45  |- skos__prefLabel mesh__D001224 Aspartic Acid
% 217.28/217.45  |- skos__scopeNote mesh__D001224
% 217.28/217.45       One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.%A%    
% 217.28/217.45  |- skos__altLabel mesh__D001224 L-Aspartate
% 217.28/217.45  |- rdf__type mesh__D001224sskos__Concept
% 217.28/217.45  |- skos__broader mesh__D001224smesh__D000600
% 217.28/217.45  |- skos__hiddenLabel mesh__D001224 Hydrobromide Aspartic Acid
% 217.28/217.45  |- skos__annotation mesh__D001224 D-ASPARTIC ACID is also available   
% 217.28/217.45  |- skos__hiddenLabel mesh__D001224 Acid, Hydrobromide Aspartic
% 217.28/217.45  |- skos__hiddenLabel mesh__D001224 Hydrochloride, Aspartate Magnesium
% 217.28/217.45  |- skos__hiddenLabel mesh__D001224 Mg 5 Longoral
% 217.28/217.45  |- skos__altLabel mesh__D001224 Sodium Aspartate
% 217.28/217.45  |- mesh__recordOriginator mesh__D001224 NLM
% 217.28/217.45  |- mesh__recordMaintainer mesh__D001224 ssb
% 217.28/217.45  |- skos__broader mesh__D001224smesh__D018846
% 217.28/217.45  |- mesh__onlineNote mesh__D001224
% 217.28/217.45       use ASPARTIC ACID %28%NM%29% to search ISOASPARTIC ACID 1990-92%A%  
% 217.28/217.45  |- skos__hiddenLabel mesh__D001224 Mg5Longoral
% 217.28/217.45  |- skos__broader mesh__D001224smesh__D024342
% 217.28/217.45  |- skos__hiddenLabel mesh__D001224 Acid, Aspartic
% 217.28/217.45  |- mesh__recordAuthorizer mesh__D001224 sjn
% 217.28/217.45  |- skos__hiddenLabel mesh__D001224 Aspartate, Potassium
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D020189 2003
% 217.28/217.45  |- skos__hiddenLabel mesh__D020189 Nocturnal Myoclonus Syndromes
% 217.28/217.45  |- skos__altLabel mesh__D020189 Periodic Movement Disorder, Sleep
% 217.28/217.45  |- skos__hiddenLabel mesh__D020189 Sleep Myoclonus Syndromes
% 217.28/217.45  |- skos__hiddenLabel mesh__D020189 Syndrome, Nocturnal Myoclonus
% 217.28/217.45  |- mesh__dateEstablished mesh__D020189 2000-01-01
% 217.28/217.45  |- skos__altLabel mesh__D020189 Periodic Limb Movement Disorder
% 217.28/217.45  |- mesh__dateRevised mesh__D020189 2001-07-25
% 217.28/217.45  |- mesh__recordOriginator mesh__D020189 KEV
% 217.28/217.45  |- skos__altLabel mesh__D020189 Sleep Disorder, Periodic Movements
% 217.28/217.45  |- skos__altLabel mesh__D020189
% 217.28/217.45       Periodic Leg Movements, Excessive, Sleep-Related
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D020189 2004
% 217.28/217.45  |- skos__hiddenLabel mesh__D020189 Myoclonus Syndromes, Sleep
% 217.28/217.45  |- rdf__type mesh__D020189sskos__Concept
% 217.28/217.45  |- skos__historyNote mesh__D020189 Myoclonus %28%1966-1999%29%
% 217.28/217.45  |- skos__scopeNote mesh__D020189
% 217.28/217.45       Excessive periodic leg movements during sleep that cause micro-arousals and interfere with the maintenance of sleep. This condition induces a state of relative sleep deprivation which manifests as excessive daytime hypersomnolence. The movements are characterized by repetitive contractions of the tibialis anterior muscle, extension of the toe, and intermittent flexion of the hip, knee and ankle. %28%Adams et al., Principles of Neurology, 6th ed, p387%29%%A%    
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D020189 2005
% 217.28/217.45  |- skos__historyNote mesh__D020189 Movement Disorders %28%1966-1999%29%
% 217.28/217.45  |- mesh__historyNote mesh__D020189 2000   
% 217.28/217.45  |- mesh__publicMeSHNote mesh__D020189 2000   
% 217.28/217.45  |- skos__hiddenLabel mesh__D020189 Syndromes, Sleep Myoclonus
% 217.28/217.45  |- skos__hiddenLabel mesh__D020189 Syndrome, Sleep Myoclonus
% 217.28/217.45  |- skos__altLabel mesh__D020189 Sleep Myoclonus Syndrome
% 217.28/217.45  |- skos__altLabel mesh__D020189
% 217.28/217.45       Excessive Periodic Sleep-Related Leg Movements
% 217.28/217.45  |- skos__hiddenLabel mesh__D020189
% 217.28/217.45       Excessive Periodic Sleep Related Leg Movements
% 217.28/217.45  |- skos__hiddenLabel mesh__D020189
% 217.28/217.45       Sleep Related Periodic Leg Movements, Excessive
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D020189 2006
% 217.28/217.45  |- skos__broader mesh__D020189smesh__D020919
% 217.28/217.45  |- mesh__recordAuthorizer mesh__D020189 sjn
% 217.28/217.45  |- mesh__dateCreated mesh__D020189 1999-11-08
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D020189 2002
% 217.28/217.45  |- skos__altLabel mesh__D020189
% 217.28/217.45       Sleep-Related Periodic Leg Movements, Excessive
% 217.28/217.45  |- mesh__recordMaintainer mesh__D020189 nns
% 217.28/217.45  |- skos__prefLabel mesh__D020189 Nocturnal Myoclonus Syndrome
% 217.28/217.45  |- skos__broader mesh__D020189smesh__D020447
% 217.28/217.45  |- skos__hiddenLabel mesh__D020189 Myoclonus Syndrome, Sleep
% 217.28/217.45  |- skos__hiddenLabel mesh__D020189 Myoclonus Syndrome, Nocturnal
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D019635 2004
% 217.28/217.45  |- skos__broader mesh__D019635smesh__D013514
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D019635 2002
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D019635 1999
% 217.28/217.45  |- rdf__type mesh__D019635sskos__Concept
% 217.28/217.45  |- skos__altLabel mesh__D019635 Procedures, Neurosurgical
% 217.28/217.45  |- skos__hiddenLabel mesh__D019635 Neurosurgical Procedure
% 217.28/217.45  |- skos__historyNote mesh__D019635 Neurosurgery %28%1966-1997%29%
% 217.28/217.45  |- skos__scopeNote mesh__D019635
% 217.28/217.45       Surgery performed on the nervous system or its parts.     
% 217.28/217.45  |- skos__prefLabel mesh__D019635 Neurosurgical Procedures
% 217.28/217.45  |- mesh__publicMeSHNote mesh__D019635 98   
% 217.28/217.45  |- skos__hiddenLabel mesh__D019635 Procedure, Neurosurgical
% 217.28/217.45  |- skos__related mesh__D019635smesh__D009493
% 217.28/217.45  |- mesh__dateEstablished mesh__D019635 1998-01-01
% 217.28/217.45  |- mesh__dateCreated mesh__D019635 1997-06-20
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D019635 2005
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D019635 2000
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D019635 2006
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D019635 2003
% 217.28/217.45  |- mesh__historyNote mesh__D019635 98   
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D019635 2001
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D019635 1998
% 217.28/217.45  |- mesh__publicMeSHNote mesh__D011652
% 217.28/217.45       1963; for RESPIRATORY CIRCULATION see RESPIRATORY CIRCULATION 1990-1999%A%  
% 217.28/217.45  |- rdf__type mesh__D011652sskos__Concept
% 217.28/217.45  |- skos__annotation mesh__D011652
% 217.28/217.45       consider also LUNG /blood supply; DF: PULM CIRC   
% 217.28/217.45  |- skos__related mesh__D011652smesh__D011669
% 217.28/217.45  |- skos__broader mesh__D011652smesh__D044703
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D011652 2005
% 217.28/217.45  |- skos__altLabel mesh__D011652 Respiratory Circulation
% 217.28/217.45  |- skos__altLabel mesh__D011652 Circulation, Respiratory
% 217.28/217.45  |- skos__altLabel mesh__D011652 Circulation, Pulmonary
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D011652 2006
% 217.28/217.45  |- skos__prefLabel mesh__D011652 Pulmonary Circulation
% 217.28/217.45  |- mesh__recordOriginator mesh__D011652 NLM
% 217.28/217.45  |- mesh__dateRevised mesh__D011652 2003-07-09
% 217.28/217.45  |- mesh__recordMaintainer mesh__D011652 nns
% 217.28/217.45  |- mesh__dateCreated mesh__D011652 1999-01-01
% 217.28/217.45  |- mesh__recordAuthorizer mesh__D011652 sjn
% 217.28/217.45  |- skos__broader mesh__D011652smesh__D001775
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D011652 2004
% 217.28/217.45  |- skos__scopeNote mesh__D011652
% 217.28/217.45       The circulation of  the BLOOD through the LUNGS.     
% 217.28/217.45  |- skos__related mesh__D011652smesh__D014692
% 217.28/217.45  |- mesh__historyNote mesh__D011652
% 217.28/217.45       1963; for RESPIRATORY CIRCULATION use PULMONARY CIRCULATION 1990-1999%A%  
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D005615 2003
% 217.28/217.45  |- skos__related mesh__D005615smesh__D003451
% 217.28/217.45  |- mesh__recordAuthorizer mesh__D005615 sjn
% 217.28/217.45  |- mesh__recordOriginator mesh__D005615 NLM
% 217.28/217.45  |- skos__annotation mesh__D005615
% 217.28/217.45       NIM; no qualif; note see related CRYOPRESERVATION   
% 217.28/217.45  |- skos__related mesh__D005615smesh__D012034
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D005615 2006
% 217.28/217.45  |- mesh__historyNote mesh__D005615 67%28%64%29%   
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D005615 2002
% 217.28/217.45  |- skos__related mesh__D005615smesh__D015925
% 217.28/217.45  |- mesh__publicMeSHNote mesh__D005615 67   
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D005615 2005
% 217.28/217.45  |- mesh__dateRevised mesh__D005615 2000-06-22
% 217.28/217.45  |- skos__related mesh__D005615smesh__D003452
% 217.28/217.45  |- skos__related mesh__D005615smesh__D007053
% 217.28/217.45  |- skos__hiddenLabel mesh__D005615 Freezings
% 217.28/217.45  |- skos__prefLabel mesh__D005615 Freezing
% 217.28/217.45  |- rdf__type mesh__D005615sskos__Concept
% 217.28/217.45  |- mesh__recordMaintainer mesh__D005615 jls
% 217.28/217.45  |- mesh__dateCreated mesh__D005615 1999-01-01
% 217.28/217.45  |- mesh__dateEstablished mesh__D005615 1967-01-01
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D005615 2001
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D005615 2004
% 217.28/217.45  |- skos__broader mesh__D005615smesh__D003080
% 217.28/217.45  |- skos__scopeNote mesh__D015245
% 217.28/217.45       One of the Type II site-specific deoxyribonucleases %28%EC 3.1.21.4%29%. It recognizes and cleaves the sequence G/GATCC at the slash. BamHI is from Bacillus amyloliquefaciens N. Numerous isoschizomers have been identified. EC 3.1.21.-.%A%    
% 217.28/217.45  |- skos__altLabel mesh__D015245 BamNI Endonuclease
% 217.28/217.45  |- mesh__recordOriginator mesh__D015245 RLS
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D015245 2004
% 217.28/217.45  |- mesh__recordMaintainer mesh__D015245 ssb
% 217.28/217.45  |- skos__altLabel mesh__D015245 BamHI Deoxyribonuclease
% 217.28/217.45  |- skos__altLabel mesh__D015245 Endonuclease GinI
% 217.28/217.45  |- skos__hiddenLabel mesh__D015245 Endonuclease, ApaCI
% 217.28/217.45  |- skos__altLabel mesh__D015245 BamKI Endonuclease
% 217.28/217.45  |- skos__altLabel mesh__D015245 Endonuclease MleI
% 217.28/217.45  |- skos__altLabel mesh__D015245 BstI Deoxyribonuclease
% 217.28/217.45  |- skos__altLabel mesh__D015245 Deoxyribonuclease BstI
% 217.28/217.45  |- skos__altLabel mesh__D015245 AliI Endonuclease
% 217.28/217.45  |- skos__altLabel mesh__D015245 BamFI Endonuclease
% 217.28/217.45  |- mesh__historyNote mesh__D015245 89   
% 217.28/217.45  |- skos__prefLabel mesh__D015245 Deoxyribonuclease BamHI
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D015245 2006
% 217.28/217.45  |- skos__broader mesh__D015245smesh__D015252
% 217.28/217.45  |- skos__altLabel mesh__D015245 BamHI Endonuclease
% 217.28/217.45  |- mesh__dateEstablished mesh__D015245 1989-01-01
% 217.28/217.45  |- skos__altLabel mesh__D015245 DdsI Endonuclease
% 217.28/217.45  |- skos__altLabel mesh__D015245 AacI Endonuclease
% 217.28/217.45  |- skos__hiddenLabel mesh__D015245 Endonuclease, SolI
% 217.28/217.45  |- skos__historyNote mesh__D015245
% 217.28/217.45       DNA Restriction Enzymes %28%1975-1988%29%
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D015245 2005
% 217.28/217.45  |- mesh__recordAuthorizer mesh__D015245 sjn
% 217.28/217.45  |- skos__altLabel mesh__D015245 Endonuclease GdoI
% 217.28/217.45  |- skos__altLabel mesh__D015245 DNA Restriction Enzyme BamHI
% 217.28/217.45  |- skos__hiddenLabel mesh__D015245 SolI, Endonuclease
% 217.28/217.45  |- skos__altLabel mesh__D015245 BstI Endonuclease
% 217.28/217.45  |- rdf__type mesh__D015245sskos__Concept
% 217.28/217.45  |- mesh__dateRevised mesh__D015245 2003-07-09
% 217.28/217.45  |- skos__altLabel mesh__D015245 BamI Endonuclease
% 217.28/217.45  |- skos__altLabel mesh__D015245 Endonuclease NasBI
% 217.28/217.45  |- mesh__publicMeSHNote mesh__D015245 89   
% 217.28/217.45  |- skos__annotation mesh__D015245
% 217.28/217.45       BamHI stands for Bacillus amyloliquefaciens + strain ident; DF: BAMHI%A%  
% 217.28/217.45  |- skos__altLabel mesh__D015245 AccEBI Endonuclease
% 217.28/217.45  |- skos__altLabel mesh__D015245 Endonuclease BamHI
% 217.28/217.45  |- skos__altLabel mesh__D015245 AaeI Endonuclease
% 217.28/217.45  |- skos__altLabel mesh__D015245 Endonuclease NspSAIV
% 217.28/217.45  |- skos__altLabel mesh__D015245 SolI Endonuclease
% 217.28/217.45  |- mesh__dateCreated mesh__D015245 1988-05-16
% 217.28/217.45  |- skos__altLabel mesh__D015245 Endonuclease RhsI
% 217.28/217.45  |- skos__altLabel mesh__D015245 BnaI Endonuclease
% 217.28/217.45  |- skos__altLabel mesh__D015245 Endonuclease GoxI
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D009208 2004
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D009208 2002
% 217.28/217.45  |- mesh__publicMeSHNote mesh__D009208
% 217.28/217.45       94; was MYOEPITHELIAL TUMOR 1963-93; MYOEPITHELIOMA was see MYOEPITHELIAL TUMOR 1984-93%A%  
% 217.28/217.45  |- mesh__recordMaintainer mesh__D009208 lkt
% 217.28/217.45  |- mesh__onlineNote mesh__D009208
% 217.28/217.45       use MYOEPITHELIOMA to search MYOEPITHELIAL TUMOR 1966-93   
% 217.28/217.45  |- skos__hiddenLabel mesh__D009208 Tumor, Myoepithelial
% 217.28/217.45  |- skos__broader mesh__D009208smesh__D018193
% 217.28/217.45  |- rdf__type mesh__D009208sskos__Concept
% 217.28/217.45  |- skos__hiddenLabel mesh__D009208 Myoepitheliomas
% 217.28/217.45  |- mesh__recordOriginator mesh__D009208 NLM
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D009208 2005
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D009208 2006
% 217.28/217.45  |- skos__annotation mesh__D009208
% 217.28/217.45       coord IM with precoord organ/neopl term %28%IM%29%   
% 217.28/217.45  |- skos__prefLabel mesh__D009208 Myoepithelioma
% 217.28/217.45  |- mesh__dateRevised mesh__D009208 2001-07-25
% 217.28/217.45  |- mesh__recordAuthorizer mesh__D009208 sjn
% 217.28/217.45  |- skos__scopeNote mesh__D009208
% 217.28/217.45       A usually benign tumor made up predominantly of myoepithelial cells.%A%    
% 217.28/217.45  |- mesh__historyNote mesh__D009208
% 217.28/217.45       94; was MYOEPITHELIAL TUMOR 1963-93; MYOEPITHELIOMA was see MYOEPITHELIAL TUMOR 1984-93%A%  
% 217.28/217.45  |- skos__altLabel mesh__D009208 Myoepithelial Tumor
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D009208 2003
% 217.28/217.45  |- skos__hiddenLabel mesh__D009208 Myoepithelial Tumors
% 217.28/217.45  |- skos__hiddenLabel mesh__D009208 Tumors, Myoepithelial
% 217.28/217.45  |- mesh__dateCreated mesh__D009208 1999-01-01
% 217.28/217.45  |- mesh__dateEstablished mesh__D001225 1991-01-01
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D001225 2004
% 217.28/217.45  |- mesh__dateCreated mesh__D001225 1975-07-23
% 217.28/217.45  |- skos__prefLabel mesh__D001225 Aspartokinase Homoserine Dehydrogenase
% 217.28/217.45  |- skos__broader mesh__D001225smesh__D006715
% 217.28/217.45  |- skos__historyNote mesh__D001225
% 217.28/217.45       Alcohol Oxidoreductases %28%1973-1975%29%
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D001225 2005
% 217.28/217.45  |- mesh__dateRevised mesh__D001225 2003-07-09
% 217.28/217.45  |- skos__broader mesh__D001225smesh__D001222
% 217.28/217.45  |- skos__scopeNote mesh__D001225
% 217.28/217.45       An enzyme complex consisting of aspartokinase, EC 2.7.2.4, and homoserine dehydrogenase, EC 1.1.1.3. The complex has been isolated from E. coli and consists of four identical subunits with a molecular weight of 85,000. The enzyme complex is involved in the biosynthesis of amino acids of the aspartate family.%A%    
% 217.28/217.45  |- skos__hiddenLabel mesh__D001225 Homoserine Dehydrogenase, Aspartokinase
% 217.28/217.45  |- mesh__publicMeSHNote mesh__D001225
% 217.28/217.45       91; was see under MULTIENZYME COMPLEXES 1976-90   
% 217.28/217.45  |- rdf__type mesh__D001225sskos__Concept
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D001225 2006
% 217.28/217.45  |- skos__historyNote mesh__D001225 Homoserine %28%1973-1975%29%
% 217.28/217.45  |- skos__hiddenLabel mesh__D001225 Dehydrogenase, Aspartokinase Homoserine
% 217.28/217.45  |- skos__historyNote mesh__D001225
% 217.28/217.45       Phosphotransferases, ATP %28%1974-1975%29%
% 217.28/217.45  |- skos__historyNote mesh__D001225 Multienzyme Complexes %28%1973-1975%29%
% 217.28/217.45  |- mesh__recordOriginator mesh__D001225 RLS
% 217.28/217.45  |- mesh__recordMaintainer mesh__D001225 ssb
% 217.28/217.45  |- mesh__recordAuthorizer mesh__D001225 sjn
% 217.28/217.45  |- skos__broader mesh__D001225smesh__D009097
% 217.28/217.45  |- mesh__historyNote mesh__D001225
% 217.28/217.45       91%28%76%29%; was see under MULTIENZYME COMPLEXES 1976-90   
% 217.28/217.45  |- skos__historyNote mesh__D001225 Aspartic Acid %28%1973-1975%29%
% 217.28/217.45  |- mesh__publicMeSHNote mesh__D019636 98   
% 217.28/217.45  |- skos__altLabel mesh__D019636 Degenerative Neurologic Disorders
% 217.28/217.45  |- skos__scopeNote mesh__D019636
% 217.28/217.45       Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.%A%    
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D019636 2004
% 217.28/217.45  |- skos__altLabel mesh__D019636 Neurologic Degenerative Conditions
% 217.28/217.45  |- mesh__historyNote mesh__D019636 98   
% 217.28/217.45  |- skos__hiddenLabel mesh__D019636 Neurologic Disorders, Degenerative
% 217.28/217.45  |- skos__hiddenLabel mesh__D019636 Neurodegenerative Disease
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D019636 2003
% 217.28/217.45  |- skos__hiddenLabel mesh__D019636 Degenerative Condition, Neurologic
% 217.28/217.45  |- mesh__dateRevised mesh__D019636 1999-11-03
% 217.28/217.45  |- skos__hiddenLabel mesh__D019636 Degenerative Neurologic Disease
% 217.28/217.45  |- skos__hiddenLabel mesh__D019636 Neurologic Disease, Degenerative
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D019636 2006
% 217.28/217.45  |- skos__altLabel mesh__D019636 Nervous System Degenerative Diseases
% 217.28/217.45  |- mesh__recordOriginator mesh__D019636 TGC
% 217.28/217.45  |- skos__altLabel mesh__D019636 Neurologic Diseases, Degenerative
% 217.28/217.45  |- rdf__type mesh__D019636sskos__Concept
% 217.28/217.45  |- skos__prefLabel mesh__D019636 Neurodegenerative Diseases
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D019636 2002
% 217.28/217.45  |- skos__hiddenLabel mesh__D019636 Neurologic Degenerative Disease
% 217.28/217.45  |- skos__hiddenLabel mesh__D019636 Neurologic Disorder, Degenerative
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D019636 2005
% 217.28/217.45  |- skos__hiddenLabel mesh__D019636 Neurologic Degenerative Condition
% 217.28/217.45  |- skos__annotation mesh__D019636
% 217.28/217.45       GEN or unspecified; prefer specifics; /genet: consider also HEREDODEGENERATIVE DISORDERS, NERVOUS SYSTEM%A%  
% 217.28/217.45  |- skos__altLabel mesh__D019636 Degenerative Neurologic Diseases
% 217.28/217.45  |- mesh__recordAuthorizer mesh__D019636 sjn
% 217.28/217.45  |- skos__hiddenLabel mesh__D019636 Degenerative Conditions, Neurologic
% 217.28/217.45  |- skos__altLabel mesh__D019636 Degenerative Diseases, Neurologic
% 217.28/217.45  |- skos__hiddenLabel mesh__D019636 Neurodegenerative Disorder
% 217.28/217.45  |- skos__altLabel mesh__D019636 Degenerative Diseases, Nervous System
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D019636 2001
% 217.28/217.45  |- mesh__recordMaintainer mesh__D019636 KEV
% 217.28/217.45  |- skos__broader mesh__D019636smesh__D009422
% 217.28/217.45  |- mesh__dateEstablished mesh__D019636 1998-01-01
% 217.28/217.45  |- mesh__dateCreated mesh__D019636 1997-06-20
% 217.28/217.45  |- skos__altLabel mesh__D019636 Neurodegenerative Disorders
% 217.28/217.45  |- skos__altLabel mesh__D019636 Neurologic Degenerative Diseases
% 217.28/217.45  |- skos__hiddenLabel mesh__D019636 Degenerative Neurologic Disorder
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D019636 2000
% 217.28/217.45  |- rdf__type mesh__D011653sskos__Concept
% 217.28/217.45  |- skos__annotation mesh__D011653 DF: PULM DIFFUSING CAPAC   
% 217.28/217.45  |- mesh__publicMeSHNote mesh__D011653 72   
% 217.28/217.45  |- skos__altLabel mesh__D011653 Diffusing Capacity, Pulmonary
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D011653 2005
% 217.28/217.45  |- mesh__recordOriginator mesh__D011653 NLM
% 217.28/217.45  |- skos__broader mesh__D011653smesh__D044702
% 217.28/217.45  |- skos__prefLabel mesh__D011653 Pulmonary Diffusing Capacity
% 217.28/217.45  |- skos__broader mesh__D011653smesh__D011659
% 217.28/217.45  |- skos__scopeNote mesh__D011653
% 217.28/217.45       The amount of a gas taken up, by the pulmonary capillary blood from the alveolar gas, per minute per unit of average pressure of the gradient of the gas across the BLOOD-AIR BARRIER.%A%    
% 217.28/217.45  |- skos__historyNote mesh__D011653
% 217.28/217.45       Respiratory Function Tests %28%1966-1970%29%
% 217.28/217.45  |- skos__historyNote mesh__D011653 Respiration %28%1966-1970%29%
% 217.28/217.45  |- mesh__dateCreated mesh__D011653 1999-01-01
% 217.28/217.45  |- mesh__recordMaintainer mesh__D011653 nns
% 217.28/217.45  |- mesh__recordAuthorizer mesh__D011653 sjn
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D011653 2006
% 217.28/217.45  |- skos__altLabel mesh__D011653 Capacity, Pulmonary Diffusing
% 217.28/217.45  |- skos__historyNote mesh__D011653 Diffusion %28%1968-1970%29%
% 217.28/217.45  |- mesh__dateRevised mesh__D011653 2003-07-09
% 217.28/217.45  |- mesh__dateEstablished mesh__D011653 1972-01-01
% 217.28/217.45  |- mesh__historyNote mesh__D011653 72%28%71%29%   
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D011653 2004
% 217.28/217.45  |- skos__broader mesh__D010447Q000037smesh__D010447
% 217.28/217.45  |- mesh__preferredCombination mesh__D010447Q000037smesh__D011480
% 217.28/217.45  |- rdf__type mesh__D010447Q000037smesh__CompoundConcept
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D005616 2006
% 217.28/217.45  |- skos__prefLabel mesh__D005616 French Guiana
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D005616 2000
% 217.28/217.45  |- skos__annotation mesh__D005616
% 217.28/217.45       in So. Amer; do not confuse with GUYANA %28% = British Guiana%29% nor with French Guinea %28% = GUINEA%29% in Africa%A%  
% 217.28/217.45  |- skos__scopeNote mesh__D005616
% 217.28/217.45       A French overseas department on the northeast coast of South America. Its capital is Cayenne. It was first settled by the French in 1604. Early development was hindered because of the presence of a penal colony. The name of the country and the capital are variants of Guyana, possibly from the native Indian Guarani guai %28%born%29% + ana %28%kin%29%, implying a united and interrelated race of people. %28%From Webster%27%s New Geographical Dictionary, 1988, p418 %26% Room, Brewer%27%s Dictionary of Names, 1992, p195%29%%A%    
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D005616 2005
% 217.28/217.45  |- mesh__recordAuthorizer mesh__D005616 PLS
% 217.28/217.45  |- mesh__recordOriginator mesh__D005616 NLM
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D005616 1997
% 217.28/217.45  |- mesh__recordMaintainer mesh__D005616 TGC
% 217.28/217.45  |- rdf__type mesh__D005616sskos__Concept
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D005616 1996
% 217.28/217.45  |- mesh__dateCreated mesh__D005616 1999-01-01
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D005616 2002
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D005616 2004
% 217.28/217.45  |- mesh__dateRevised mesh__D005616 1995-02-17
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D005616 2003
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D005616 1999
% 217.28/217.45  |- skos__broader mesh__D005616smesh__D013020
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D005616 1998
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D005616 2001
% 217.28/217.45  |- mesh__recordAuthorizer mesh__D015246 sjn
% 217.28/217.45  |- mesh__dateCreated mesh__D015246 1988-05-16
% 217.28/217.45  |- mesh__activeMeSHYear mesh__D015246 2004
% 217.28/217.45  |- mesh__recordMaintainer mesh__D015246 ssb
% 217.28/217.45  |- mesh__historyNote mesh__D015246 89   
% 217.28/217.45  |- skos__scopeNote mesh__D015246
% 217.28/217.45       One of the Type II site-specific deoxyribonucleases %28%EC 3.1.21.4%29%. It recognizes and cleaves the sequence G/AATTC at the slash. EcoRI is from E coliRY13. Several isoschizomers have been identified. EC 3.1.21.-.%A%    
% 217.28/217.45  |- skos__altLabel mesh__D015246 Endonuclease SsoI
% 217.28/217.45  |- rdf__type mesh__D015246sskos__Concept
% 217.28/217.45  |- skos__altLabel mesh__D015246 EcoRI Endonuclease
% 217.28/217.45  |- skos__altLabel mesh__D015246 Eco RI
% 217.28/217.45  |- skos__altLabel mesh__D015246 Endodeoxyribonuclease ECoRI
% 217.28/217.45  |- skos__altLabel mesh__D015246 Eco-RI
% 217.28/217.45  |- skos__altLabel mesh__D015246 Endodeoxyribonuclease HsaI
% 217.28/217.45  |- skos__altLabel mesh__D015246 Endonuclease EcoRI
% 217.28/217.45  |- skos__annotation mesh__D015246
% 217.28/217.45       a DNA restriction enzyme; EcoRI stands for E. coli + strain ident; DF: ECORI%A%  
% 217.28/217.45  |- mesh__recordOriginator mesh__D015246 RLS
% 217.28/217.46  |- skos__prefLabel mesh__D015246 Deoxyribonuclease EcoRI
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D015246 2005
% 217.28/217.46  |- mesh__publicMeSHNote mesh__D015246 89   
% 217.28/217.46  |- skos__historyNote mesh__D015246
% 217.28/217.46       DNA Restriction Enzymes %28%1975-1988%29%
% 217.28/217.46  |- skos__altLabel mesh__D015246 DNA Restriction Enzyme EcoRI
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D015246 2006
% 217.28/217.46  |- mesh__dateEstablished mesh__D015246 1989-01-01
% 217.28/217.46  |- skos__broader mesh__D015246smesh__D015252
% 217.28/217.46  |- mesh__dateRevised mesh__D015246 2003-07-09
% 217.28/217.46  |- skos__scopeNote mesh__D009209
% 217.28/217.46       Muscular pain in numerous body regions that can be reproduced by pressure on trigger points, localized hardenings in skeletal muscle tissue. Pain is referred to a location distant from the trigger points. A prime example is the TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME.%A%    
% 217.28/217.46  |- skos__prefLabel mesh__D009209 Myofascial Pain Syndromes
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D009209 1999
% 217.28/217.46  |- skos__annotation mesh__D009209
% 217.28/217.46       do not confuse with MYOFASCIAL PAIN DYSFUNCTION SYNDROME, TEMPOROMANDIBULAR JOINT see TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME%A%  
% 217.28/217.46  |- mesh__recordMaintainer mesh__D009209 TGC
% 217.28/217.46  |- skos__hiddenLabel mesh__D009209 Trigger Point, Myofascial
% 217.28/217.46  |- skos__hiddenLabel mesh__D009209 Syndrome, Myofascial Pain
% 217.28/217.46  |- mesh__publicMeSHNote mesh__D009209 82   
% 217.28/217.46  |- rdf__type mesh__D009209sskos__Concept
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D009209 2005
% 217.28/217.46  |- mesh__dateRevised mesh__D009209 1997-06-20
% 217.28/217.46  |- skos__hiddenLabel mesh__D009209 Myofascial Trigger Points
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D009209 2002
% 217.28/217.46  |- skos__hiddenLabel mesh__D009209 Pain Syndrome, Myofascial
% 217.28/217.46  |- mesh__recordOriginator mesh__D009209 RC
% 217.28/217.46  |- skos__hiddenLabel mesh__D009209 Myofascial Trigger Point
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D009209 2006
% 217.28/217.46  |- skos__hiddenLabel mesh__D009209 Myofascial Pain Syndrome
% 217.28/217.46  |- skos__broader mesh__D009209smesh__D009135
% 217.28/217.46  |- skos__hiddenLabel mesh__D009209 Pain Syndromes, Myofascial
% 217.28/217.46  |- mesh__dateEstablished mesh__D009209 1982-01-01
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D009209 2003
% 217.28/217.46  |- skos__hiddenLabel mesh__D009209 Syndromes, Myofascial Pain
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D009209 2000
% 217.28/217.46  |- mesh__recordAuthorizer mesh__D009209 SJN
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D009209 2004
% 217.28/217.46  |- mesh__historyNote mesh__D009209 82   
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D009209 1998
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D009209 2001
% 217.28/217.46  |- mesh__dateCreated mesh__D009209 1981-02-24
% 217.28/217.46  |- skos__broader mesh__D001226smesh__D000604
% 217.28/217.46  |- skos__hiddenLabel mesh__D001226 Asp tRNA Ligase
% 217.28/217.46  |- mesh__recordAuthorizer mesh__D001226 sjn
% 217.28/217.46  |- mesh__dateRevised mesh__D001226 2003-07-09
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D001226 2005
% 217.28/217.46  |- mesh__dateCreated mesh__D001226 1974-11-19
% 217.28/217.46  |- skos__hiddenLabel mesh__D001226 Ligase, Asp-tRNA
% 217.28/217.46  |- rdf__type mesh__D001226sskos__Concept
% 217.28/217.46  |- skos__prefLabel mesh__D001226 Aspartate-tRNA Ligase
% 217.28/217.46  |- skos__historyNote mesh__D001226
% 217.28/217.46       Amino Acyl T RNA Synthetases %28%1973-1974%29%
% 217.28/217.46  |- skos__hiddenLabel mesh__D001226 Synthetase, Aspartyl-tRNA
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D001226 2006
% 217.28/217.46  |- skos__hiddenLabel mesh__D001226 Ligase, Aspartate-tRNA
% 217.28/217.46  |- skos__altLabel mesh__D001226 Aspartyl T RNA Synthetase
% 217.28/217.46  |- skos__altLabel mesh__D001226 Asp-tRNA Ligase
% 217.28/217.46  |- skos__hiddenLabel mesh__D001226 Aspartate tRNA Ligase
% 217.28/217.46  |- skos__hiddenLabel mesh__D001226 Aspartyl tRNA Synthetase
% 217.28/217.46  |- mesh__publicMeSHNote mesh__D001226
% 217.28/217.46       98; see ASPARTYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A%  
% 217.28/217.46  |- skos__altLabel mesh__D001226 Aspartyl-tRNA Synthetase
% 217.28/217.46  |- skos__scopeNote mesh__D001226
% 217.28/217.46       An enzyme that activates aspartic acid with its specific transfer RNA. EC 6.1.1.12.%A%    
% 217.28/217.46  |- mesh__dateEstablished mesh__D001226 1991-01-01
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D001226 2004
% 217.28/217.46  |- skos__historyNote mesh__D001226 Aspartic Acid %28%1973-1974%29%
% 217.28/217.46  |- mesh__recordOriginator mesh__D001226 NLM
% 217.28/217.46  |- mesh__historyNote mesh__D001226 98%28%75%29%   
% 217.28/217.46  |- mesh__recordMaintainer mesh__D001226 ssb
% 217.28/217.46  |- rdf__type mesh__D047328sskos__Concept
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D047328 2006
% 217.28/217.46  |- mesh__recordMaintainer mesh__D047328 ags
% 217.28/217.46  |- skos__historyNote mesh__D047328 Sea Urchins %28%1971-2004%29%
% 217.28/217.46  |- mesh__dateCreated mesh__D047328 2004-07-07
% 217.28/217.46  |- skos__prefLabel mesh__D047328 Paracentrotus
% 217.28/217.46  |- mesh__dateEstablished mesh__D047328 2005-01-01
% 217.28/217.46  |- mesh__recordOriginator mesh__D047328 ags
% 217.28/217.46  |- mesh__publicMeSHNote mesh__D047328 2005   
% 217.28/217.46  |- mesh__recordAuthorizer mesh__D047328 sjn
% 217.28/217.46  |- mesh__historyNote mesh__D047328 2005   
% 217.28/217.46  |- skos__historyNote mesh__D047328 Echinodermata %28%1965-1971%29%
% 217.28/217.46  |- skos__scopeNote mesh__D047328
% 217.28/217.46       A genus of SEA URCHINS in the family Echinidae found primarily on the western coasts of Ireland.%A%    
% 217.28/217.46  |- skos__broader mesh__D047328smesh__D012617
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D047328 2005
% 217.28/217.46  |- skos__hiddenLabel mesh__D019637 Procedure, Orthopedic
% 217.28/217.46  |- skos__prefLabel mesh__D019637 Orthopedic Procedures
% 217.28/217.46  |- skos__hiddenLabel mesh__D019637 Procedures, Orthopedic Surgical
% 217.28/217.46  |- mesh__publicMeSHNote mesh__D019637 98   
% 217.28/217.46  |- mesh__recordMaintainer mesh__D019637 lkt
% 217.28/217.46  |- mesh__dateEstablished mesh__D019637 1998-01-01
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D019637 2005
% 217.28/217.46  |- skos__hiddenLabel mesh__D019637 Surgical Procedures, Orthopedic
% 217.28/217.46  |- skos__hiddenLabel mesh__D019637 Surgical Procedure, Orthopedic
% 217.28/217.46  |- skos__scopeNote mesh__D019637
% 217.28/217.46       Procedures used to treat and correct deformities, diseases, and injuries to the MUSCULOSKELETAL SYSTEM, its articulations, and associated structures.%A%    
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D019637 2006
% 217.28/217.46  |- mesh__dateCreated mesh__D019637 1997-06-20
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D019637 2003
% 217.28/217.46  |- mesh__historyNote mesh__D019637 98   
% 217.28/217.46  |- skos__hiddenLabel mesh__D019637 Procedures, Orthopedic
% 217.28/217.46  |- mesh__recordOriginator mesh__D019637 PXP
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D019637 2004
% 217.28/217.46  |- rdf__type mesh__D019637sskos__Concept
% 217.28/217.46  |- skos__related mesh__D019637smesh__D009985
% 217.28/217.46  |- skos__hiddenLabel mesh__D019637 Orthopedic Procedure
% 217.28/217.46  |- skos__broader mesh__D019637smesh__D013812
% 217.28/217.46  |- skos__broader mesh__D019637smesh__D013514
% 217.28/217.46  |- mesh__dateRevised mesh__D019637 2002-07-03
% 217.28/217.46  |- mesh__recordAuthorizer mesh__D019637 sjn
% 217.28/217.46  |- skos__historyNote mesh__D019637 Orthopedics %28%1966-1997%29%
% 217.28/217.46  |- skos__hiddenLabel mesh__D019637 Procedure, Orthopedic Surgical
% 217.28/217.46  |- skos__hiddenLabel mesh__D019637 Orthopedic Surgical Procedure
% 217.28/217.46  |- mesh__recordMaintainer mesh__D011654 TGC
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D011654 2005
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D011654 1997
% 217.28/217.46  |- mesh__publicMeSHNote mesh__D011654
% 217.28/217.46       WET LUNG was see RESPIRATORY DISTRESS SYNDROME, ADULT 1977-91; was WET LUNG SYNDROME see PULMONARY EDEMA 1975-76%A%  
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D011654 2000
% 217.28/217.46  |- skos__altLabel mesh__D011654 Edema, Pulmonary
% 217.28/217.46  |- mesh__dateCreated mesh__D011654 1999-01-01
% 217.28/217.46  |- skos__annotation mesh__D011654
% 217.28/217.46       includes congestion; X ref WET LUNG: in shock, consider also SHOCK LUNG see RESPIRATORY DISTRESS SYNDROME, ADULT; DF: PULM EDEMA%A%  
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D011654 2006
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D011654 2001
% 217.28/217.46  |- mesh__dateRevised mesh__D011654 1991-02-11
% 217.28/217.46  |- skos__broader mesh__D011654smesh__D008171
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D011654 1994
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D011654 2003
% 217.28/217.46  |- mesh__onlineNote mesh__D011654
% 217.28/217.46       use RESPIRATORY DISTRESS SYNDROME, ADULT to search WET LUNG 1977-91; use PULMONARY EDEMA to search WET LUNG SYNDROME 1975-76%A%  
% 217.28/217.46  |- skos__altLabel mesh__D011654 Wet Lung
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D011654 1998
% 217.28/217.46  |- skos__prefLabel mesh__D011654 Pulmonary Edema
% 217.28/217.46  |- skos__hiddenLabel mesh__D011654 Wet Lungs
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D011654 1995
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D011654 2004
% 217.28/217.46  |- rdf__type mesh__D011654sskos__Concept
% 217.28/217.46  |- skos__hiddenLabel mesh__D011654 Lungs, Wet
% 217.28/217.46  |- skos__altLabel mesh__D011654 Edemas, Pulmonary
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D011654 1992
% 217.28/217.46  |- mesh__recordAuthorizer mesh__D011654 PLS
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D011654 1999
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D011654 2002
% 217.28/217.46  |- mesh__historyNote mesh__D011654
% 217.28/217.46       WET LUNG was see RESPIRATORY DISTRESS SYNDROME, ADULT 1977-91; was WET LUNG SYNDROME see PULMONARY EDEMA 1975-76%A%  
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D011654 1996
% 217.28/217.46  |- mesh__recordOriginator mesh__D011654 NLM
% 217.28/217.46  |- skos__hiddenLabel mesh__D011654 Lung, Wet
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D011654 1993
% 217.28/217.46  |- skos__altLabel mesh__D011654 Pulmonary Edemas
% 217.28/217.46  |- skos__altLabel mesh__D005617 Freon
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D005617 2006
% 217.28/217.46  |- mesh__historyNote mesh__D005617 2001%28%1973%29%   
% 217.28/217.46  |- mesh__dateEstablished mesh__D005617 1977-01-01
% 217.28/217.46  |- mesh__dateCreated mesh__D005617 1999-01-01
% 217.28/217.46  |- skos__scopeNote mesh__D005617
% 217.28/217.46       A group of methane-based halogenated hydrocarbons containing one or more fluorine and chlorine atoms.%A%    
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D005617 2001
% 217.28/217.46  |- mesh__publicMeSHNote mesh__D005617
% 217.28/217.46       2001; see FREONS 1977-2000, see HYDROCARBONS, HALOGENATED 1973-1976%A%  
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D005617 2003
% 217.28/217.46  |- rdf__type mesh__D005617sskos__Concept
% 217.28/217.46  |- skos__prefLabel mesh__D005617 Chlorofluorocarbons, Methane
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D005617 2002
% 217.28/217.46  |- skos__hiddenLabel mesh__D005617 Propellants, Fluorocarbon
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D005617 2004
% 217.28/217.46  |- mesh__recordAuthorizer mesh__D005617 sjn
% 217.28/217.46  |- skos__broader mesh__D005617smesh__D017402
% 217.28/217.46  |- skos__annotation mesh__D005617
% 217.28/217.46       do not confuse X refs here with FLUOROCARBONS %28%for perfluorinated cpds%29%%A%  
% 217.28/217.46  |- mesh__recordOriginator mesh__D005617 NLM
% 217.28/217.46  |- skos__altLabel mesh__D005617 Fluorocarbon Aerosols
% 217.28/217.46  |- skos__hiddenLabel mesh__D005617 Aerosols, Fluorocarbon
% 217.28/217.46  |- mesh__recordMaintainer mesh__D005617 adp
% 217.28/217.46  |- mesh__dateRevised mesh__D005617 2000-06-21
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D005617 2005
% 217.28/217.46  |- skos__hiddenLabel mesh__D005617 Methane Chlorofluorocarbons
% 217.28/217.46  |- skos__altLabel mesh__D005617 Fluorocarbon Propellants
% 217.28/217.46  |- skos__annotation mesh__D030010
% 217.28/217.46       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.28/217.46  |- mesh__recordAuthorizer mesh__D030010 sjn
% 217.28/217.46  |- skos__scopeNote mesh__D030010
% 217.28/217.46       A plant genus of the family APOCYNACEAE. It is rarely called Milkweed, but should not be confused with true Milkweed %28%ASCLEPIAS%29%.%A%    
% 217.28/217.46  |- rdf__type mesh__D030010sskos__Concept
% 217.28/217.46  |- mesh__dateEstablished mesh__D030010 2002-01-01
% 217.28/217.46  |- mesh__publicMeSHNote mesh__D030010 2002   
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D030010 2005
% 217.28/217.46  |- skos__broader mesh__D030010smesh__D029062
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D030010 2006
% 217.28/217.46  |- mesh__recordMaintainer mesh__D030010 ssb
% 217.28/217.46  |- mesh__dateRevised mesh__D030010 2002-07-02
% 217.28/217.46  |- skos__prefLabel mesh__D030010 Apocynum
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D030010 2003
% 217.28/217.46  |- mesh__dateCreated mesh__D030010 2001-07-25
% 217.28/217.46  |- mesh__recordOriginator mesh__D030010 ssb
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D030010 2004
% 217.28/217.46  |- mesh__historyNote mesh__D030010 2002   
% 217.28/217.46  |- skos__altLabel mesh__D030010 Dogbane
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D015247 2004
% 217.28/217.46  |- skos__altLabel mesh__D015247 Endonuclease BstFI
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D015247 2006
% 217.28/217.46  |- skos__altLabel mesh__D015247 DNA Restriction Enzyme HindIII
% 217.28/217.46  |- skos__scopeNote mesh__D015247
% 217.28/217.46       One of the Type II site-specific deoxyribonucleases %28%EC 3.1.21.4%29%. It recognizes and cleaves the sequence A/AGCTT at the slash. HindIII is from Haemophilus influenzae R%28%d%29%. Numerous isoschizomers have been identified. EC 3.1.21.-.%A%    
% 217.28/217.46  |- mesh__recordMaintainer mesh__D015247 ssb
% 217.28/217.46  |- mesh__publicMeSHNote mesh__D015247 89   
% 217.28/217.46  |- skos__broader mesh__D015247smesh__D015252
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D015247 2005
% 217.28/217.46  |- mesh__dateCreated mesh__D015247 1988-05-16
% 217.28/217.46  |- skos__altLabel mesh__D015247 Endonuclease EcoVIII
% 217.28/217.46  |- mesh__recordAuthorizer mesh__D015247 sjn
% 217.28/217.46  |- skos__annotation mesh__D015247
% 217.28/217.46       HindIII stands for Haemophilus influenzae + strain ident; DF: HINDIII%A%  
% 217.28/217.46  |- mesh__dateRevised mesh__D015247 2003-07-09
% 217.28/217.46  |- skos__altLabel mesh__D015247 BpeI Endonuclease
% 217.28/217.46  |- skos__hiddenLabel mesh__D015247 LlaCI, Endonuclease
% 217.28/217.46  |- skos__altLabel mesh__D015247 B Pertussis Restriction Enzyme I
% 217.28/217.46  |- rdf__type mesh__D015247sskos__Concept
% 217.28/217.46  |- skos__altLabel mesh__D015247 Endonuclease HindIII
% 217.28/217.46  |- skos__historyNote mesh__D015247
% 217.28/217.46       DNA Restriction Enzymes %28%1975-1988%29%
% 217.28/217.46  |- mesh__dateEstablished mesh__D015247 1989-01-01
% 217.28/217.46  |- skos__prefLabel mesh__D015247 Deoxyribonuclease HindIII
% 217.28/217.46  |- mesh__historyNote mesh__D015247 89   
% 217.28/217.46  |- mesh__recordOriginator mesh__D015247 RLS
% 217.28/217.46  |- skos__prefLabel mesh__D034401 Ulmaceae
% 217.28/217.46  |- skos__altLabel mesh__D034401 Hackberry
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D034401 2003
% 217.28/217.46  |- skos__scopeNote mesh__D034401
% 217.28/217.46       A plant family of the order Urticales, subclass Hamamelidae, class Magnoliopsida. Members are trees and shrubs of temperate regions that have watery sap and alternate leaves which are lopsided at the base. The flowers lack petals.%A%    
% 217.28/217.46  |- skos__annotation mesh__D034401
% 217.28/217.46       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D034401 2004
% 217.28/217.46  |- skos__broader mesh__D034401smesh__D019684
% 217.28/217.46  |- mesh__historyNote mesh__D034401 2003   
% 217.28/217.46  |- rdf__type mesh__D034401sskos__Concept
% 217.28/217.46  |- mesh__publicMeSHNote mesh__D034401 2003   
% 217.28/217.46  |- mesh__dateCreated mesh__D034401 2002-07-03
% 217.28/217.46  |- mesh__dateEstablished mesh__D034401 2003-01-01
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D034401 2005
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D034401 2006
% 217.28/217.46  |- skos__altLabel mesh__D001227 Aspartylglucosaminidase
% 217.28/217.46  |- mesh__historyNote mesh__D001227
% 217.28/217.46       91%28%75%29%; was see under AMIDOHYDROLASES 1975-90   
% 217.28/217.46  |- skos__historyNote mesh__D001227 Aspartic Acid %28%1970-1974%29%
% 217.28/217.46  |- mesh__recordOriginator mesh__D001227 NLM
% 217.28/217.46  |- skos__hiddenLabel mesh__D001227 Deaspartylase, Aspartylglucosylamine
% 217.28/217.46  |- mesh__recordMaintainer mesh__D001227 ssb
% 217.28/217.46  |- mesh__dateCreated mesh__D001227 1974-11-19
% 217.28/217.46  |- skos__historyNote mesh__D001227 Amidohydrolases %28%1970-1974%29%
% 217.28/217.46  |- skos__hiddenLabel mesh__D001227 Amidohydrolase, Aspartylglucosamine
% 217.28/217.46  |- skos__altLabel mesh__D001227 Glycosylasparaginase
% 217.28/217.46  |- skos__altLabel mesh__D001227 Aspartylglucosylamine Deaspartylase
% 217.28/217.46  |- mesh__recordAuthorizer mesh__D001227 sjn
% 217.28/217.46  |- skos__altLabel mesh__D001227 Aspartylglycosamine Amidohydrolase
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D001227 2004
% 217.28/217.46  |- mesh__publicMeSHNote mesh__D001227
% 217.28/217.46       91; was see under AMIDOHYDROLASES 1975-90   
% 217.28/217.46  |- skos__prefLabel mesh__D001227 Aspartylglucosylaminase
% 217.28/217.46  |- skos__hiddenLabel mesh__D001227 Amidohydrolase, Aspartylglycosamine
% 217.28/217.46  |- skos__historyNote mesh__D001227 Glucosamine %28%1970-1974%29%
% 217.28/217.46  |- skos__scopeNote mesh__D001227
% 217.28/217.46       An enzyme that catalyzes the conversion of N%28%4%29%-%28%beta-N-acetyl-D-glucosaminyl%29%-L-asparagine and water to N-acetyl-beta-D-glucosaminylamine and L-aspartate. It acts only on asparagine oligosaccharides containing one amino acid, i.e. the asparagine has free alpha-amino and alpha-carboxyl groups. %28%From Enzyme Nomenclature, 1992%29% EC 3.5.1.26.%A%    
% 217.28/217.46  |- mesh__dateEstablished mesh__D001227 1991-01-01
% 217.28/217.46  |- skos__altLabel mesh__D001227 Aspartylglucosamine Amidohydrolase
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D001227 2005
% 217.28/217.46  |- mesh__dateRevised mesh__D001227 2003-07-09
% 217.28/217.46  |- skos__broader mesh__D001227smesh__D000581
% 217.28/217.46  |- rdf__type mesh__D001227sskos__Concept
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D001227 2006
% 217.28/217.46  |- skos__scopeNote mesh__D006710
% 217.28/217.46       A thiol-containing amino acid formed by a demethylation of METHIONINE.%A%    
% 217.28/217.46  |- skos__altLabel mesh__D006710 2-amino-4-mercaptobutyric acid
% 217.28/217.46  |- mesh__dateRevised mesh__D006710 2005-06-30
% 217.28/217.46  |- rdf__type mesh__D006710sskos__Concept
% 217.28/217.46  |- skos__annotation mesh__D006710 do not confuse with HOMOCYSTINE   
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D006710 2006
% 217.28/217.46  |- skos__prefLabel mesh__D006710 Homocysteine
% 217.28/217.46  |- mesh__recordOriginator mesh__D006710 NLM
% 217.28/217.46  |- skos__hiddenLabel mesh__D006710 2 amino 4 mercaptobutyric acid
% 217.28/217.46  |- skos__hiddenLabel mesh__D006710 L-Isomer Homocysteine
% 217.28/217.46  |- skos__hiddenLabel mesh__D006710 Homocysteine, L Isomer
% 217.28/217.46  |- skos__altLabel mesh__D006710 Homocysteine, L-Isomer
% 217.28/217.46  |- mesh__dateCreated mesh__D006710 1999-01-01
% 217.28/217.46  |- mesh__recordAuthorizer mesh__D006710 sjn
% 217.28/217.46  |- mesh__recordMaintainer mesh__D006710 ssb
% 217.28/217.46  |- skos__broader mesh__D006710smesh__D000603
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D047329 2006
% 217.28/217.46  |- mesh__historyNote mesh__D047329 2005   
% 217.28/217.46  |- skos__broader mesh__D047329smesh__D012617
% 217.28/217.46  |- mesh__recordMaintainer mesh__D047329 ags
% 217.28/217.46  |- skos__historyNote mesh__D047329 Sea Urchins %28%1974-2004%29%
% 217.28/217.46  |- mesh__dateCreated mesh__D047329 2004-07-07
% 217.28/217.46  |- skos__scopeNote mesh__D047329
% 217.28/217.46       A genus of SEA URCHINS in the family Echinometridae. They are closely related to and some say indistinguishable from the genus Heliocidaris.%A%    
% 217.28/217.46  |- mesh__publicMeSHNote mesh__D047329 2005   
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D047329 2005
% 217.28/217.46  |- mesh__dateEstablished mesh__D047329 2005-01-01
% 217.28/217.46  |- mesh__recordOriginator mesh__D047329 ags
% 217.28/217.46  |- skos__prefLabel mesh__D047329 Anthocidaris
% 217.28/217.46  |- mesh__recordAuthorizer mesh__D047329 sjn
% 217.28/217.46  |- rdf__type mesh__D047329sskos__Concept
% 217.28/217.46  |- mesh__recordAuthorizer mesh__D019638 sjn
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D019638 2006
% 217.28/217.46  |- mesh__historyNote mesh__D019638 98   
% 217.28/217.46  |- skos__broader mesh__D019638smesh__D017018
% 217.28/217.46  |- mesh__publicMeSHNote mesh__D019638 98   
% 217.28/217.46  |- mesh__dateEstablished mesh__D019638 1998-01-01
% 217.28/217.46  |- mesh__dateRevised mesh__D019638 2005-06-30
% 217.28/217.46  |- rdf__type mesh__D019638sskos__Concept
% 217.28/217.46  |- mesh__dateCreated mesh__D019638 1997-06-20
% 217.28/217.46  |- mesh__recordMaintainer mesh__D019638 SYSTEM
% 217.28/217.46  |- skos__scopeNote mesh__D019638
% 217.28/217.46       A family of anaerobic METHANOMICROBIALES whose cells are coccoid to straight or slightly curved rods. There are six genera.%A%    
% 217.28/217.46  |- mesh__recordOriginator mesh__D019638 AGS
% 217.28/217.46  |- skos__prefLabel mesh__D019638 Methanomicrobiaceae
% 217.28/217.46  |- mesh__recordOriginator mesh__D011655 NLM
% 217.28/217.46  |- mesh__dateRevised mesh__D011655 2005-06-30
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D011655 2006
% 217.28/217.46  |- skos__scopeNote mesh__D011655
% 217.28/217.46       Embolism in the pulmonary artery or one of its branches.%A%    
% 217.28/217.46  |- skos__broader mesh__D011655smesh__D008171
% 217.28/217.46  |- skos__broader mesh__D011655smesh__D004617
% 217.28/217.46  |- skos__prefLabel mesh__D011655 Pulmonary Embolism
% 217.28/217.46  |- skos__hiddenLabel mesh__D011655 Infarctions, Pulmonary
% 217.28/217.46  |- skos__altLabel mesh__D011655 Pulmonary Embolisms
% 217.28/217.46  |- mesh__recordAuthorizer mesh__D011655 sjn
% 217.28/217.46  |- skos__broader mesh__D011655smesh__D007238
% 217.28/217.46  |- skos__altLabel mesh__D011655 Thromboembolism, Pulmonary
% 217.28/217.46  |- skos__altLabel mesh__D011655 Embolisms, Pulmonary
% 217.28/217.46  |- rdf__type mesh__D011655sskos__Concept
% 217.28/217.46  |- skos__altLabel mesh__D011655 Pulmonary Thromboembolism
% 217.28/217.46  |- skos__altLabel mesh__D011655 Embolism, Pulmonary
% 217.28/217.46  |- skos__hiddenLabel mesh__D011655 Pulmonary Infarctions
% 217.28/217.46  |- skos__altLabel mesh__D011655 Infarction, Pulmonary
% 217.28/217.46  |- mesh__recordMaintainer mesh__D011655 ssb
% 217.28/217.46  |- skos__altLabel mesh__D011655 Thromboembolisms, Pulmonary
% 217.28/217.46  |- skos__annotation mesh__D011655 DF: PULM EMBOLISM   
% 217.28/217.46  |- mesh__dateCreated mesh__D011655 1999-01-01
% 217.28/217.46  |- mesh__recordOriginator mesh__D005618 NLM
% 217.28/217.46  |- skos__altLabel mesh__D005618 Freshwater
% 217.28/217.46  |- mesh__publicMeSHNote mesh__D005618 91; was see under WATER 1972-90   
% 217.28/217.46  |- skos__broader mesh__D005618smesh__D014867
% 217.28/217.46  |- rdf__type mesh__D005618sskos__Concept
% 217.28/217.46  |- skos__hiddenLabel mesh__D005618 Water, Fresh
% 217.28/217.46  |- skos__hiddenLabel mesh__D005618 Waters, Fresh
% 217.28/217.46  |- skos__hiddenLabel mesh__D005618 Fresh Waters
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D005618 2004
% 217.28/217.46  |- mesh__recordMaintainer mesh__D005618 ssb
% 217.28/217.46  |- skos__hiddenLabel mesh__D005618 Freshwaters
% 217.28/217.46  |- mesh__dateRevised mesh__D005618 2003-07-09
% 217.28/217.46  |- mesh__dateEstablished mesh__D005618 1991-01-01
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D005618 2005
% 217.28/217.46  |- mesh__historyNote mesh__D005618
% 217.28/217.46       91%28%72%29%; was see under WATER 1972-90   
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D005618 2006
% 217.28/217.46  |- mesh__recordAuthorizer mesh__D005618 sjn
% 217.28/217.46  |- skos__scopeNote mesh__D005618
% 217.28/217.46       Water containing no significant amounts of salts, such as water from RIVERS and lakes.%A%    
% 217.28/217.46  |- mesh__dateCreated mesh__D005618 1999-01-01
% 217.28/217.46  |- skos__historyNote mesh__D005618 Water %28%1966-1971%29%
% 217.28/217.46  |- skos__prefLabel mesh__D005618 Fresh Water
% 217.28/217.46  |- rdf__type mesh__D016340sskos__Concept
% 217.28/217.46  |- mesh__dateCreated mesh__D016340 1990-06-19
% 217.28/217.46  |- mesh__publicMeSHNote mesh__D016340 91   
% 217.28/217.46  |- skos__broader mesh__D016340smesh__D014763
% 217.28/217.46  |- mesh__dateRevised mesh__D016340 2005-07-01
% 217.28/217.46  |- mesh__recordMaintainer mesh__D016340 sjn
% 217.28/217.46  |- skos__scopeNote mesh__D016340
% 217.28/217.46       Non-glycosylated, membrane-associated, 16 kDa proteins which are expressed in large amounts in cells infected with HIV-1. The proteins are required for efficient virion maturation and release. They are not present in HIV-2 nor in SIMIAN IMMUNODEFICIENCY VIRUS. vpu is short for viral protein U, with U undefined.%A%    
% 217.28/217.46  |- mesh__recordAuthorizer mesh__D016340 sjn
% 217.28/217.46  |- skos__altLabel mesh__D016340 Gene Product, vpu
% 217.28/217.46  |- mesh__dateEstablished mesh__D016340 1991-01-01
% 217.28/217.46  |- skos__hiddenLabel mesh__D016340 Viral Protein U, HIV 1
% 217.28/217.46  |- skos__broader mesh__D016340smesh__D015520
% 217.28/217.46  |- skos__annotation mesh__D016340
% 217.28/217.46       Vpu stands for %22%viral protein U%22%; /drug eff /ultrastruct permitted%A%  
% 217.28/217.46  |- skos__hiddenLabel mesh__D016340 vpu Gene Product
% 217.28/217.46  |- skos__altLabel mesh__D016340 vpu Gene Products
% 217.28/217.46  |- skos__altLabel mesh__D016340 HIV-1 vpu Gene Products
% 217.28/217.46  |- skos__prefLabel mesh__D016340 Gene Products, vpu
% 217.28/217.46  |- mesh__historyNote mesh__D016340 91   
% 217.28/217.46  |- skos__hiddenLabel mesh__D016340 Protein, vpu
% 217.28/217.46  |- skos__historyNote mesh__D016340 Retroviridae Proteins %28%1988-1990%29%
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D016340 2006
% 217.28/217.46  |- skos__altLabel mesh__D016340 Viral Protein U, HIV-1
% 217.28/217.46  |- mesh__recordOriginator mesh__D016340 AGS
% 217.28/217.46  |- mesh__recordOriginator mesh__D030011 ssb
% 217.28/217.46  |- skos__prefLabel mesh__D030011 Ochrosia
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D030011 2003
% 217.28/217.46  |- skos__annotation mesh__D030011
% 217.28/217.46       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.28/217.46  |- skos__broader mesh__D030011smesh__D029062
% 217.28/217.46  |- skos__scopeNote mesh__D030011
% 217.28/217.46       A plant genus of the family Apocynaceae. Species of this genus contain 9-methoxyellipticine %28%ELLIPTICINES%29% which is the basis of one of the classes of ANTINEOPLASTIC AGENTS.%A%    
% 217.28/217.46  |- mesh__historyNote mesh__D030011 2002   
% 217.28/217.46  |- rdf__type mesh__D030011sskos__Concept
% 217.28/217.46  |- mesh__recordAuthorizer mesh__D030011 sjn
% 217.28/217.46  |- mesh__recordMaintainer mesh__D030011 ssb
% 217.28/217.46  |- mesh__publicMeSHNote mesh__D030011 2002   
% 217.28/217.46  |- mesh__dateEstablished mesh__D030011 2002-01-01
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D030011 2006
% 217.28/217.46  |- mesh__dateRevised mesh__D030011 2002-07-03
% 217.28/217.46  |- mesh__dateCreated mesh__D030011 2001-07-25
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D030011 2004
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D030011 2005
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D002320 2005
% 217.28/217.46  |- skos__scopeNote mesh__D002320
% 217.28/217.46       Functions and activities of the CARDIOVASCULAR SYSTEM as a whole or of any of its parts.%A%    
% 217.28/217.46  |- skos__hiddenLabel mesh__D002320 Cardiovascular Physiologies
% 217.28/217.46  |- skos__prefLabel mesh__D002320 Cardiovascular Physiology
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D002320 2004
% 217.28/217.46  |- skos__hiddenLabel mesh__D002320 Physiologies, Cardiovascular
% 217.28/217.46  |- mesh__activeMeSHYear mesh__D002320 2006
% 217.28/217.46  |- skos__annotation mesh__D002320
% 217.28/217.46       GEN or unspecified; prefer specifics; DF: CARDIOVASC PHYSIOL%A%  
% 217.28/217.46  |- mesh__historyNote mesh__D002320 98; use explode 1970-97   
% 217.28/217.46  |- mesh__recordMaintainer mesh__D002320 nns
% 217.28/217.46  |- mesh__publicMeSHNote mesh__D002320 98   
% 217.28/217.46  |- mesh__dateCreated mesh__D002320 1999-01-01
% 217.28/217.46  |- mesh__recordAuthorizer mesh__D002320 sjn
% 217.28/217.46  |- mesh__dateRevised mesh__D002320 2003-07-09
% 217.28/217.46  |- skos__broader mesh__D002320smesh__D002943
% 217.28/217.46  |- rdf__type mesh__D002320sskos__Concept
% 217.28/217.46  |- skos__altLabel mesh__D002320 Physiology, Cardiovascular
% 217.28/217.46  |- skos__historyNote mesh__D002320
% 217.28/217.46       Cardiovascular System/physiology %28%1966-1997%29%
% 217.28/217.46  |- mesh__dateEstablished mesh__D002320 1998-01-01
% 217.28/217.46  |- mesh__recordOriginator mesh__D002320 NLM
% 217.28/217.46  |- skos__hiddenLabel mesh__D015248 Gemfibrozil, GenRX
% 217.28/217.46  |- skos__scopeNote mesh__D015248
% 217.28/217.46       A lipid-regulating agent that lowers elevated serum lipids primarily by decreasing serum triglycerides with a variable reduction in total cholesterol. These decreases occur primarily in the VLDL fraction and less frequently in the LDL fraction. Gemfibrozil increases HDL subfractions HDL2 and HDL3 as well as apolipoproteins A-I and A-II. Its mechanism of action has not been definitely established.%A%    
% 217.28/217.46  |- skos__altLabel mesh__D015248 Apotex Brand of Gemfibrozil
% 217.28/217.46  |- mesh__recordOriginator mesh__D015248 RLS
% 217.28/217.46  |- skos__historyNote mesh__D015248 Valerates %28%1966-1974%29%
% 217.28/217.46  |- skos__hiddenLabel mesh__D015248 NuGemfibrozil
% 217.28/217.46  |- skos__broader mesh__D015248smesh__D002995
% 217.28/217.46  |- skos__altLabel mesh__D015248 Pharmascience Brand of Gemfibrozil
% 217.28/217.46  |- skos__altLabel mesh__D015248 Lopid R
% 217.28/217.46  |- skos__altLabel mesh__D015248 Warner-Lambert Brand of Gemfibrozil
% 217.28/217.46  |- skos__altLabel mesh__D015248 Parke Davis Brand of Gemfibrozil
% 217.28/217.46  |- skos__altLabel mesh__D015248 Genpharm Brand of Gemfibrozil
% 217.28/217.46  |- skos__altLabel mesh__D015248 Lipur
% 217.28/217.46  |- skos__altLabel mesh__D015248 Bull Brand of Gemfibrozil
% 217.28/217.46  |- skos__altLabel mesh__D015248 Farmasierra Brand of Gemfibrozil
% 217.28/217.47  |- skos__hiddenLabel mesh__D015248 Bexal, Gemfibrozilo
% 217.28/217.47  |- skos__hiddenLabel mesh__D015248 Apo Gemfibrozil
% 217.28/217.47  |- skos__altLabel mesh__D015248 Biochemie Brand of Gemfibrozil
% 217.28/217.47  |- skos__altLabel mesh__D015248 TAD Brand of Gemfibrozil
% 217.28/217.47  |- mesh__recordMaintainer mesh__D015248 CCR
% 217.28/217.47  |- skos__altLabel mesh__D015248 Faulding Brand of Gemfibrozil
% 217.28/217.47  |- skos__altLabel mesh__D015248 Ipsen Brand of Gemfibrozil
% 217.28/217.47  |- skos__hiddenLabel mesh__D015248 Nu Pharm Brand of Gemfibrozil
% 217.28/217.47  |- skos__altLabel mesh__D015248 Chem mart Brand of Gemfibrozil
% 217.28/217.47  |- skos__hiddenLabel mesh__D015248 CI 719
% 217.28/217.47  |- skos__altLabel mesh__D015248 Nu-Pharm Brand of Gemfibrozil
% 217.28/217.47  |- skos__altLabel mesh__D015248 Healthsense Brand of Gemfibrozil
% 217.28/217.47  |- mesh__dateCreated mesh__D015248 1988-05-16
% 217.28/217.47  |- mesh__dateEstablished mesh__D015248 1989-01-01
% 217.28/217.47  |- mesh__dateRevised mesh__D015248 2005-06-30
% 217.28/217.47  |- skos__altLabel mesh__D015248 Ferrer Brand of Gemfibrozil
% 217.28/217.47  |- skos__altLabel mesh__D015248 Cantabria Brand of Gemfibrozil
% 217.28/217.47  |- skos__altLabel mesh__D015248 Douglas Brand of Gemfibrozil
% 217.28/217.47  |- skos__hiddenLabel mesh__D015248 Novo Gemfibrozil
% 217.28/217.47  |- skos__altLabel mesh__D015248 1A Brand of Gemfibrozil
% 217.28/217.47  |- skos__altLabel mesh__D015248 Alphapharm Brand of Gemfibrozil
% 217.28/217.47  |- skos__hiddenLabel mesh__D015248 PMS Gemfibrozil
% 217.28/217.47  |- skos__altLabel mesh__D015248 Gemfibrosil
% 217.28/217.47  |- skos__altLabel mesh__D015248 Pfizer Brand of Gemfibrozil
% 217.28/217.47  |- skos__hiddenLabel mesh__D015248 GenGemfibrozil
% 217.28/217.47  |- skos__hiddenLabel mesh__D015248 Gemfibrozil, Healthsense
% 217.28/217.47  |- skos__altLabel mesh__D015248 Quimifar Brand of Gemfibrozil
% 217.28/217.47  |- skos__hiddenLabel mesh__D015248 Gen Gemfibrozil
% 217.28/217.47  |- skos__altLabel mesh__D015248 Hexal Brand of Gemfibrozil
% 217.28/217.47  |- skos__hiddenLabel mesh__D015248 ApoGemfibrozil
% 217.28/217.47  |- skos__altLabel mesh__D015248 Menarini Brand of Gemfibrozil
% 217.28/217.47  |- skos__hiddenLabel mesh__D015248 Gemfibrozil, SBPA
% 217.28/217.47  |- skos__hiddenLabel mesh__D015248 Nu Gemfibrozil
% 217.28/217.47  |- mesh__publicMeSHNote mesh__D015248 89   
% 217.28/217.47  |- mesh__historyNote mesh__D015248 89   
% 217.28/217.47  |- skos__historyNote mesh__D015248 Pentanoic Acids %28%1975-1988%29%
% 217.28/217.47  |- skos__hiddenLabel mesh__D015248 Bayvit, Gemfibrozilo
% 217.28/217.47  |- skos__hiddenLabel mesh__D015248 Warner Lambert Brand of Gemfibrozil
% 217.28/217.47  |- skos__broader mesh__D015248smesh__D010421
% 217.28/217.47  |- skos__altLabel mesh__D015248 Terry White Chemists Brand of Gemfibrozil
% 217.28/217.47  |- skos__hiddenLabel mesh__D015248 CI719
% 217.28/217.47  |- skos__altLabel mesh__D015248 Bayvit Brand of Gemfibrozil
% 217.28/217.47  |- skos__prefLabel mesh__D015248 Gemfibrozil
% 217.28/217.47  |- rdf__type mesh__D015248sskos__Concept
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D015248 2006
% 217.28/217.47  |- skos__altLabel mesh__D015248 United Drug Brand of Gemfibrozil
% 217.28/217.47  |- skos__altLabel mesh__D015248 Novopharm Brand of Gemfibrozil
% 217.28/217.47  |- mesh__recordAuthorizer mesh__D015248 sjn
% 217.28/217.47  |- skos__altLabel mesh__D015248 Bexal Brand of Gemfibrozil
% 217.28/217.47  |- skos__altLabel mesh__D015248 Sigma Brand of Gemfibrozil
% 217.28/217.47  |- rdf__type mesh__D034402sskos__Concept
% 217.28/217.47  |- mesh__publicMeSHNote mesh__D034402 2003   
% 217.28/217.47  |- skos__prefLabel mesh__D034402 Trema
% 217.28/217.47  |- skos__broader mesh__D034402smesh__D034401
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D034402 2005
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D034402 2006
% 217.28/217.47  |- skos__scopeNote mesh__D034402
% 217.28/217.47       A plant genus of the family ULMACEAE. Members contain PHENANTHRENES and COUMARINS.%A%    
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D034402 2003
% 217.28/217.47  |- skos__annotation mesh__D034402
% 217.28/217.47       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.28/217.47  |- mesh__historyNote mesh__D034402 2003   
% 217.28/217.47  |- mesh__dateEstablished mesh__D034402 2003-01-01
% 217.28/217.47  |- mesh__dateCreated mesh__D034402 2002-07-03
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D034402 2004
% 217.28/217.47  |- skos__broader mesh__D001228smesh__D009181
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D001228 2003
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D001228 1998
% 217.28/217.47  |- skos__annotation mesh__D001228
% 217.28/217.47       fungus dis; specify species %28%IM%29% if pertinent; coord IM with precoord organ/dis term %28%IM%29%; of lung = ASPERGILLOSIS %28%IM%29% + LUNG DISEASES, FUNGAL %28%IM%29% for non-allergic pulm aspergillosis but ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY for allergic pulm aspergillosis%A%  
% 217.28/217.47  |- mesh__dateCreated mesh__D001228 1999-01-01
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D001228 2004
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D001228 1999
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D001228 2000
% 217.28/217.47  |- skos__scopeNote mesh__D001228
% 217.28/217.47       Infections with fungi of the genus ASPERGILLUS.     
% 217.28/217.47  |- mesh__recordOriginator mesh__D001228 NLM
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D001228 2005
% 217.28/217.47  |- skos__prefLabel mesh__D001228 Aspergillosis
% 217.28/217.47  |- mesh__recordAuthorizer mesh__D001228 PLS
% 217.28/217.47  |- mesh__recordMaintainer mesh__D001228 TGC
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D001228 2001
% 217.28/217.47  |- rdf__type mesh__D001228sskos__Concept
% 217.28/217.47  |- skos__hiddenLabel mesh__D001228 Aspergilloses
% 217.28/217.47  |- mesh__dateRevised mesh__D001228 1996-06-10
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D001228 2006
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D001228 2002
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D001228 1997
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D006711 2006
% 217.28/217.47  |- skos__broader mesh__D006711smesh__D000600
% 217.28/217.47  |- skos__annotation mesh__D006711
% 217.28/217.47       /urine: consider also HOMOCYSTINURIA; do not confuse with HOMOCYSTEINE%A%  
% 217.28/217.47  |- mesh__recordAuthorizer mesh__D006711 sjn
% 217.28/217.47  |- mesh__recordMaintainer mesh__D006711 ssb
% 217.28/217.47  |- skos__broader mesh__D006711smesh__D000603
% 217.28/217.47  |- skos__broader mesh__D006711smesh__D000599
% 217.28/217.47  |- mesh__dateCreated mesh__D006711 1999-01-01
% 217.28/217.47  |- mesh__historyNote mesh__D006711 73%28%67%29%   
% 217.28/217.47  |- mesh__dateEstablished mesh__D006711 1973-01-01
% 217.28/217.47  |- skos__historyNote mesh__D006711 Aminobutyric Acids %28%1966%29%
% 217.28/217.47  |- mesh__dateRevised mesh__D006711 2005-06-30
% 217.28/217.47  |- skos__prefLabel mesh__D006711 Homocystine
% 217.28/217.47  |- mesh__publicMeSHNote mesh__D006711 73   
% 217.28/217.47  |- rdf__type mesh__D006711sskos__Concept
% 217.28/217.47  |- mesh__recordOriginator mesh__D006711 NLM
% 217.28/217.47  |- mesh__publicMeSHNote mesh__D019639 98   
% 217.28/217.47  |- mesh__dateEstablished mesh__D019639 1998-01-01
% 217.28/217.47  |- mesh__dateRevised mesh__D019639 2005-07-20
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D019639 2006
% 217.28/217.47  |- rdf__type mesh__D019639sskos__Concept
% 217.28/217.47  |- skos__broader mesh__D019639smesh__D017018
% 217.28/217.47  |- skos__historyNote mesh__D019639 Methanogens %28%1976-1997%29%
% 217.28/217.47  |- skos__prefLabel mesh__D019639 Methanospirillum
% 217.28/217.47  |- mesh__dateCreated mesh__D019639 1997-06-20
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D019639 2006A
% 217.28/217.47  |- mesh__recordMaintainer mesh__D019639 ags
% 217.28/217.47  |- mesh__recordAuthorizer mesh__D019639 ags
% 217.28/217.47  |- mesh__recordOriginator mesh__D019639 AGS
% 217.28/217.47  |- skos__scopeNote mesh__D019639
% 217.28/217.47       The sole genus in the family Methanospirillaceae whose organisms are progressively motile by means of polar, tufted flagella. They have been isolated from sewage-sludge and pear waste digesters as well as marine and non-marine habitats.%A%    
% 217.28/217.47  |- mesh__historyNote mesh__D019639 98   
% 217.28/217.47  |- skos__altLabel mesh__D011656 Pulmonary Emphysemas
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D011656 2006
% 217.28/217.47  |- mesh__dateCreated mesh__D011656 1999-01-01
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D011656 2004
% 217.28/217.47  |- mesh__recordOriginator mesh__D011656 NLM
% 217.28/217.47  |- skos__altLabel mesh__D011656 Emphysemas, Pulmonary
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D011656 2005
% 217.28/217.47  |- mesh__dateRevised mesh__D011656 2001-07-25
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D011656 2003
% 217.28/217.47  |- skos__broader mesh__D011656smesh__D029424
% 217.28/217.47  |- rdf__type mesh__D011656sskos__Concept
% 217.28/217.47  |- mesh__recordAuthorizer mesh__D011656 sjn
% 217.28/217.47  |- skos__prefLabel mesh__D011656 Pulmonary Emphysema
% 217.28/217.47  |- skos__annotation mesh__D011656
% 217.28/217.47       in cattle is probably EMPHYSEMA, ACUTE BOVINE PULMONARY see PNEUMONIA, ATYPICAL INTERSTITIAL, OF CATTLE; DF: PULM EMPHYSEMA%A%  
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D011656 2002
% 217.28/217.47  |- mesh__recordMaintainer mesh__D011656 lkt
% 217.28/217.47  |- skos__scopeNote mesh__D011656
% 217.28/217.47       A subcategory of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. The disease is characterized by anatomic alterations of the lungs, such as the enlargement of airspaces and destruction of alveolar walls.%A%    
% 217.28/217.47  |- skos__altLabel mesh__D011656 Emphysema, Pulmonary
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D005619 1998
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D005619 1993
% 217.28/217.47  |- mesh__recordMaintainer mesh__D005619 TAP
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D005619 2002
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D005619 1999
% 217.28/217.47  |- mesh__historyNote mesh__D005619
% 217.28/217.47       91%28%75%29%; was see under PSYCHOANALYTIC THEORY 1975-90   
% 217.28/217.47  |- mesh__onlineNote mesh__D005619 search PSYCHOANALYTIC THEORY 1969-74   
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D005619 2005
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D005619 1994
% 217.28/217.47  |- mesh__recordOriginator mesh__D005619 NLM
% 217.28/217.47  |- mesh__dateEstablished mesh__D005619 1991-01-01
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D005619 2006
% 217.28/217.47  |- skos__prefLabel mesh__D005619 Freudian Theory
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D005619 1995
% 217.28/217.47  |- mesh__dateCreated mesh__D005619 1999-01-01
% 217.28/217.47  |- skos__broader mesh__D005619smesh__D011574
% 217.28/217.47  |- skos__annotation mesh__D005619 IM   
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D005619 1996
% 217.28/217.47  |- mesh__dateRevised mesh__D005619 1992-05-15
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D005619 2000
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D005619 1997
% 217.28/217.47  |- rdf__type mesh__D005619sskos__Concept
% 217.28/217.47  |- mesh__publicMeSHNote mesh__D005619
% 217.28/217.47       91; was see under PSYCHOANALYTIC THEORY 1975-90   
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D005619 2003
% 217.28/217.47  |- skos__scopeNote mesh__D005619
% 217.28/217.47       Philosophic formulations which are basic to psychoanalysis. Some of the conceptual theories developed were of the libido, repression, regression, transference, id, ego, superego, Oedipus Complex, etc.%A%    
% 217.28/217.47  |- mesh__recordAuthorizer mesh__D005619 PLS
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D005619 2004
% 217.28/217.47  |- skos__hiddenLabel mesh__D005619 Theory, Freudian
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D005619 2001
% 217.28/217.47  |- skos__hiddenLabel mesh__D016341 A Gene
% 217.28/217.47  |- mesh__recordOriginator mesh__D016341 AGS
% 217.28/217.47  |- skos__altLabel mesh__D016341 sor Genes
% 217.28/217.47  |- skos__scopeNote mesh__D016341
% 217.28/217.47       DNA sequences that form the coding region for the vif %28%virion infectivity factor%29% protein that is important for the generation of infectious virions in human immunodeficiency virus %28%HIV%29%. The former name of this gene was sor %28%short open reading frame%29%.%A%    
% 217.28/217.47  |- skos__hiddenLabel mesh__D016341 vif Gene
% 217.28/217.47  |- skos__hiddenLabel mesh__D016341 Gene, vif
% 217.28/217.47  |- skos__hiddenLabel mesh__D016341 A Genes
% 217.28/217.47  |- skos__annotation mesh__D016341
% 217.28/217.47       vif stands for %22%Virion Infectivity Factor%22%; in X ref GENES, SOR, sor stands for %22%Short Open Reading frame%22%%A%  
% 217.28/217.47  |- skos__hiddenLabel mesh__D016341 Gene, Q
% 217.28/217.47  |- skos__hiddenLabel mesh__D016341 sor Gene
% 217.28/217.47  |- mesh__publicMeSHNote mesh__D016341 91   
% 217.28/217.47  |- mesh__recordMaintainer mesh__D016341 nns
% 217.28/217.47  |- mesh__dateEstablished mesh__D016341 1991-01-01
% 217.28/217.47  |- skos__prefLabel mesh__D016341 Genes, vif
% 217.28/217.47  |- skos__altLabel mesh__D016341 Genes, Q
% 217.28/217.47  |- skos__hiddenLabel mesh__D016341 Gene, A
% 217.28/217.47  |- mesh__dateRevised mesh__D016341 2005-06-30
% 217.28/217.47  |- mesh__historyNote mesh__D016341 91   
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D016341 2006
% 217.28/217.47  |- skos__hiddenLabel mesh__D016341 Q Genes
% 217.28/217.47  |- skos__hiddenLabel mesh__D016341 Gene, sor
% 217.28/217.47  |- mesh__recordAuthorizer mesh__D016341 sjn
% 217.28/217.47  |- mesh__dateCreated mesh__D016341 1990-05-29
% 217.28/217.47  |- skos__altLabel mesh__D016341 Genes, A
% 217.28/217.47  |- rdf__type mesh__D016341sskos__Concept
% 217.28/217.47  |- skos__broader mesh__D016341smesh__D005809
% 217.28/217.47  |- skos__altLabel mesh__D016341 vif Genes
% 217.28/217.47  |- skos__altLabel mesh__D016341 Genes, sor
% 217.28/217.47  |- skos__historyNote mesh__D016341 Genes, Viral %28%1986-1990%29%
% 217.28/217.47  |- skos__hiddenLabel mesh__D016341 Q Gene
% 217.28/217.47  |- skos__broader mesh__D016341smesh__D005814
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D030012 2004
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D030012 2005
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D030012 2003
% 217.28/217.47  |- skos__scopeNote mesh__D030012
% 217.28/217.47       A plant genus of the family GENTIANACEAE. Members contain secoiridoids.%A%    
% 217.28/217.47  |- rdf__type mesh__D030012sskos__Concept
% 217.28/217.47  |- mesh__recordOriginator mesh__D030012 ssb
% 217.28/217.47  |- mesh__publicMeSHNote mesh__D030012
% 217.28/217.47       2003; see GENTIAN 2002, see RAUWOLFIA 1998-2001   
% 217.28/217.47  |- mesh__historyNote mesh__D030012
% 217.28/217.47       2003 %28%2002%29%; use RAUWOLFIA 1998-2001   
% 217.28/217.47  |- mesh__recordAuthorizer mesh__D030012 sjn
% 217.28/217.47  |- mesh__recordMaintainer mesh__D030012 ssb
% 217.28/217.47  |- skos__prefLabel mesh__D030012 Gentiana
% 217.28/217.47  |- mesh__dateEstablished mesh__D030012 2002-01-01
% 217.28/217.47  |- skos__annotation mesh__D030012
% 217.28/217.47       do not confuse with GENTIAN VIOLET; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.28/217.47  |- skos__altLabel mesh__D030012 Gentian
% 217.28/217.47  |- skos__broader mesh__D030012smesh__D029965
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D030012 2006
% 217.28/217.47  |- mesh__dateCreated mesh__D030012 2001-07-25
% 217.28/217.47  |- mesh__dateRevised mesh__D030012 2002-07-03
% 217.28/217.47  |- rdf__type mesh__D002321sskos__Concept
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D002321 1993
% 217.28/217.47  |- skos__annotation mesh__D002321 no qualif   
% 217.28/217.47  |- skos__hiddenLabel mesh__D002321 Choice, Career
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D002321 2004
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D002321 1996
% 217.28/217.47  |- skos__hiddenLabel mesh__D002321 Career Choices
% 217.28/217.47  |- skos__broader mesh__D002321smesh__D002755
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D002321 2000
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D002321 1999
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D002321 1992
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D002321 2003
% 217.28/217.47  |- skos__prefLabel mesh__D002321 Career Choice
% 217.28/217.47  |- mesh__dateEstablished mesh__D002321 1983-01-01
% 217.28/217.47  |- mesh__publicMeSHNote mesh__D002321
% 217.28/217.47       83; was see under CHOICE BEHAVIOR 1981-82 %26% DECISION MAKING 1975-80%A%  
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D002321 1995
% 217.28/217.47  |- skos__hiddenLabel mesh__D002321 Choices, Career
% 217.28/217.47  |- mesh__recordOriginator mesh__D002321 NLM
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D002321 2006
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D002321 1998
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D002321 1991
% 217.28/217.47  |- skos__scopeNote mesh__D002321
% 217.28/217.47       Selection of a type of occupation or profession.     
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D002321 2002
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D002321 1994
% 217.28/217.47  |- mesh__dateRevised mesh__D002321 1989-04-28
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D002321 2005
% 217.28/217.47  |- mesh__recordAuthorizer mesh__D002321 PLS
% 217.28/217.47  |- mesh__dateCreated mesh__D002321 1974-11-11
% 217.28/217.47  |- mesh__historyNote mesh__D002321
% 217.28/217.47       83%28%75%29%; was see under CHOICE BEHAVIOR 1981-82 %26% DECISION MAKING 1975-80%A%  
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D002321 1997
% 217.28/217.47  |- mesh__recordMaintainer mesh__D002321 TGC
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D002321 1990
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D002321 2001
% 217.28/217.47  |- mesh__historyNote mesh__D034403 2003   
% 217.28/217.47  |- skos__scopeNote mesh__D034403
% 217.28/217.47       A plant genus of the family ULMACEAE that is susceptible to Dutch elm disease which is caused by the ASCOMYCOTA fungus, Ophiostoma.%A%    
% 217.28/217.47  |- mesh__dateEstablished mesh__D034403 2003-01-01
% 217.28/217.47  |- mesh__dateCreated mesh__D034403 2002-07-03
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D034403 2005
% 217.28/217.47  |- skos__broader mesh__D034403smesh__D034401
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D034403 2006
% 217.28/217.47  |- skos__annotation mesh__D034403
% 217.28/217.47       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D034403 2003
% 217.28/217.47  |- skos__prefLabel mesh__D034403 Ulmus
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D034403 2004
% 217.28/217.47  |- rdf__type mesh__D034403sskos__Concept
% 217.28/217.47  |- mesh__publicMeSHNote mesh__D034403 2003   
% 217.28/217.47  |- skos__altLabel mesh__D034403 Elm Tree
% 217.28/217.47  |- skos__broader mesh__D005502Q000600smesh__D005502
% 217.28/217.47  |- mesh__preferredCombination mesh__D005502Q000600smesh__D005523
% 217.28/217.47  |- rdf__type mesh__D005502Q000600smesh__CompoundConcept
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D001229 2000
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D001229 2006
% 217.28/217.47  |- skos__broader mesh__D001229smesh__D001228
% 217.28/217.47  |- skos__altLabel mesh__D001229 Aspergilloses, Allergic Bronchopulmonary
% 217.28/217.47  |- skos__altLabel mesh__D001229 Bronchopulmonary Aspergillosis
% 217.28/217.47  |- skos__altLabel mesh__D001229 Aspergilloses, Bronchopulmonary
% 217.28/217.47  |- skos__historyNote mesh__D001229 Lung Diseases, Fungal %28%1966-1978%29%
% 217.28/217.47  |- skos__altLabel mesh__D001229 Aspergillosis, Bronchopulmonary Allergic
% 217.28/217.47  |- mesh__dateRevised mesh__D001229 1996-06-10
% 217.28/217.47  |- skos__hiddenLabel mesh__D001229 Allergic Aspergillosis, Bronchopulmonary
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D001229 2001
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D001229 1997
% 217.28/217.47  |- skos__prefLabel mesh__D001229 Aspergillosis, Allergic Bronchopulmonary
% 217.28/217.47  |- skos__hiddenLabel mesh__D001229 Allergic Aspergilloses, Bronchopulmonary
% 217.28/217.47  |- skos__altLabel mesh__D001229 Allergic Bronchopulmonary Aspergillosis
% 217.28/217.47  |- skos__broader mesh__D001229smesh__D012130
% 217.28/217.47  |- skos__hiddenLabel mesh__D001229 Bronchopulmonary Allergic Aspergilloses
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D001229 2003
% 217.28/217.47  |- mesh__historyNote mesh__D001229 79   
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D001229 2002
% 217.28/217.47  |- skos__altLabel mesh__D001229 Bronchopulmonary Aspergilloses
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D001229 1998
% 217.28/217.47  |- skos__altLabel mesh__D001229 Allergic Bronchopulmonary Aspergilloses
% 217.28/217.47  |- mesh__publicMeSHNote mesh__D001229 79   
% 217.28/217.47  |- mesh__recordAuthorizer mesh__D001229 PLS
% 217.28/217.47  |- skos__altLabel mesh__D001229 Aspergillosis, Bronchopulmonary
% 217.28/217.47  |- skos__hiddenLabel mesh__D001229 Bronchopulmonary Allergic Aspergillosis
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D001229 2004
% 217.28/217.47  |- skos__scopeNote mesh__D001229
% 217.28/217.47       Aspergillosis of the lung occurring in an individual with long-standing bronchial asthma. It is characterized by pulmonary infiltrates, eosinophilia, elevated serum IgE and immediate type skin reactivity to aspergillus antigen.%A%    
% 217.28/217.47  |- skos__historyNote mesh__D001229 Aspergillosis %28%1966-1978%29%
% 217.28/217.47  |- skos__historyNote mesh__D001229
% 217.28/217.47       Respiratory Hypersensitivity %28%1966-1978%29%
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D001229 1999
% 217.28/217.47  |- skos__annotation mesh__D001229
% 217.28/217.47       fungus dis; do not coord with BRONCHIAL DISEASES nor with LUNG DISEASES, FUNGAL; note %22%allergic%22%: non-allergic pulm aspergillosis = ASPERGILLOSIS %28%IM%29% + LUNG DISEASES, FUNGAL %28%IM%29%; DF: ABPA or BRONCHOPULM ASPERG%A%  
% 217.28/217.47  |- skos__hiddenLabel mesh__D001229 Aspergilloses, Bronchopulmonary Allergic
% 217.28/217.47  |- mesh__dateEstablished mesh__D001229 1979-01-01
% 217.28/217.47  |- rdf__type mesh__D001229sskos__Concept
% 217.28/217.47  |- mesh__recordMaintainer mesh__D001229 TGC
% 217.28/217.47  |- mesh__recordOriginator mesh__D001229 VDK
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D001229 2005
% 217.28/217.47  |- skos__altLabel mesh__D001229 Bronchopulmonary Aspergillosis, Allergic
% 217.28/217.47  |- skos__broader mesh__D001229smesh__D008172
% 217.28/217.47  |- mesh__dateCreated mesh__D001229 1978-05-19
% 217.28/217.47  |- skos__altLabel mesh__D001229 Bronchopulmonary Aspergilloses, Allergic
% 217.28/217.47  |- skos__prefLabel mesh__D006712 Homocystinuria
% 217.28/217.47  |- skos__broader mesh__D006712smesh__D003240
% 217.28/217.47  |- skos__hiddenLabel mesh__D006712
% 217.28/217.47       Cystathionine beta Synthase Deficiency Disease
% 217.28/217.47  |- mesh__recordOriginator mesh__D006712 NLM
% 217.28/217.47  |- skos__hiddenLabel mesh__D006712
% 217.28/217.47       Deficiency Disease, Cystathionine beta Synthase
% 217.28/217.47  |- mesh__historyNote mesh__D006712 1969%28%1967%29%   
% 217.28/217.47  |- skos__broader mesh__D006712smesh__D000592
% 217.28/217.47  |- skos__related mesh__D006712smesh__D020138
% 217.28/217.47  |- mesh__dateCreated mesh__D006712 1999-01-01
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D006712 2002
% 217.28/217.47  |- mesh__recordAuthorizer mesh__D006712 sjn
% 217.28/217.47  |- skos__historyNote mesh__D006712
% 217.28/217.47       Amino Acid Metabolism, Inborn Errors %28%1966%29%
% 217.28/217.47  |- mesh__publicMeSHNote mesh__D006712 1969   
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D006712 2003
% 217.28/217.47  |- skos__related mesh__D006712smesh__D003541
% 217.28/217.47  |- mesh__dateEstablished mesh__D006712 1969-01-01
% 217.28/217.47  |- rdf__type mesh__D006712sskos__Concept
% 217.28/217.47  |- skos__scopeNote mesh__D006712
% 217.28/217.47       An autosomal recessive inborn error of methionine metabolism usually caused by a deficiency of CYSTATHIONINE BETA-SYNTHASE and associated with elevations of homocysteine in plasma and urine. Clinical features include a tall, slender habitus, SCOLIOSIS, arachnodactyly, MUSCLE WEAKNESS, genu varis, thin blond hair, malar flush, lens dislocations, an increased incidence of MENTAL RETARDATION, and a tendency to develop fibrosis of arteries, frequently complicated by CEREBROVASCULAR ACCIDENTS and MYOCARDIAL INFARCTION. %28%From Adams et al., Principles of Neurology, 6th ed, p979%29%%A%    
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D006712 2005
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D006712 2004
% 217.28/217.47  |- skos__altLabel mesh__D006712
% 217.28/217.47       Deficiency Disease, Cystathionine beta-Synthase
% 217.28/217.47  |- mesh__dateRevised mesh__D006712 2001-07-25
% 217.28/217.47  |- skos__historyNote mesh__D006712 Mental Retardation %28%1966%29%
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D006712 2006
% 217.28/217.47  |- skos__broader mesh__D006712smesh__D020739
% 217.28/217.47  |- mesh__recordMaintainer mesh__D006712 nns
% 217.28/217.47  |- skos__historyNote mesh__D011657 Lung Diseases %28%1966-1981%29%
% 217.28/217.47  |- skos__hiddenLabel mesh__D011657 Eosinophilic Pneumonias
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D011657 2006
% 217.28/217.47  |- mesh__recordAuthorizer mesh__D011657 PLS
% 217.28/217.47  |- mesh__historyNote mesh__D011657
% 217.28/217.47       82; LOEFFLER SYNDROME was heading LOEFFLER%27%S SYNDROME 1963-81%A%  
% 217.28/217.47  |- skos__hiddenLabel mesh__D011657 Tropical Eosinophilia
% 217.28/217.47  |- skos__altLabel mesh__D011657 Eosinophilic Pneumonia
% 217.28/217.47  |- skos__historyNote mesh__D011657 Eosinophilia %28%1966-1981%29%
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D011657 2004
% 217.28/217.47  |- skos__broader mesh__D011657smesh__D017681
% 217.28/217.47  |- skos__altLabel mesh__D011657 Eosinophilia, Pulmonary
% 217.28/217.47  |- skos__hiddenLabel mesh__D011657 Syndrome, Loeffler
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D011657 2005
% 217.28/217.47  |- skos__hiddenLabel mesh__D011657 Tropical Eosinophilias
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D011657 2001
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D011657 2003
% 217.28/217.47  |- skos__hiddenLabel mesh__D011657 Eosinophilias, Tropical
% 217.28/217.47  |- rdf__type mesh__D011657sskos__Concept
% 217.28/217.47  |- mesh__dateRevised mesh__D011657 1995-06-08
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D011657 2000
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D011657 1999
% 217.28/217.47  |- skos__scopeNote mesh__D011657
% 217.28/217.47       A disease characterized by pulmonary infiltrations of eosinophils and blood eosinophilia.%A%    
% 217.28/217.47  |- skos__altLabel mesh__D011657 Pulmonary Eosinophilias
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D011657 1997
% 217.28/217.47  |- mesh__recordOriginator mesh__D011657 VDK
% 217.28/217.47  |- skos__broader mesh__D011657smesh__D008171
% 217.28/217.47  |- mesh__onlineNote mesh__D011657
% 217.28/217.47       use PULMONARY EOSINOPHILIA to search LOEFFLER%27%S SYNDROME 1966-81%A%  
% 217.28/217.47  |- skos__prefLabel mesh__D011657 Pulmonary Eosinophilia
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D011657 1998
% 217.28/217.47  |- mesh__dateCreated mesh__D011657 1981-05-19
% 217.28/217.47  |- mesh__recordMaintainer mesh__D011657 RAZ
% 217.28/217.47  |- skos__hiddenLabel mesh__D011657 Pneumonias, Eosinophilic
% 217.28/217.47  |- skos__annotation mesh__D011657
% 217.28/217.47       pulm infiltrations of eosinophils; do not confuse X ref LOEFFLER SYNDROME with LOEFFLER%27%S ENDOCARDITIS see HYPEREOSINOPHILIC SYNDROME; DF: PULM EOSINOPHILIA%A%  
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D011657 1996
% 217.28/217.47  |- skos__altLabel mesh__D011657 Eosinophilias, Pulmonary
% 217.28/217.47  |- mesh__publicMeSHNote mesh__D011657
% 217.28/217.47       82; LOEFFLER SYNDROME was heading LOEFFLER%27%S SYNDROME 1963-81%A%  
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D011657 2002
% 217.28/217.47  |- mesh__dateEstablished mesh__D011657 1982-01-01
% 217.28/217.47  |- skos__historyNote mesh__D016342 Lasers %28%1982-1986%29%
% 217.28/217.47  |- skos__historyNote mesh__D016342 Laser Surgery %28%1987-1990%29%
% 217.28/217.47  |- mesh__historyNote mesh__D016342 91   
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D016342 2006
% 217.28/217.47  |- mesh__dateRevised mesh__D016342 1997-06-20
% 217.28/217.47  |- mesh__dateCreated mesh__D016342 1990-05-25
% 217.28/217.47  |- mesh__dateEstablished mesh__D016342 1991-01-01
% 217.28/217.47  |- skos__historyNote mesh__D016342
% 217.28/217.47       Angioplasty, Transluminal %28%1982-1990%29%
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D016342 2005
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D016342 2004
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D016342 2001
% 217.28/217.47  |- mesh__recordOriginator mesh__D016342 PXP
% 217.28/217.47  |- skos__broader mesh__D016342smesh__D007833
% 217.28/217.47  |- skos__broader mesh__D016342smesh__D017130
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D016342 2003
% 217.28/217.47  |- rdf__type mesh__D016342sskos__Concept
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D016342 2000
% 217.28/217.47  |- mesh__recordAuthorizer mesh__D016342 SJN
% 217.28/217.47  |- mesh__publicMeSHNote mesh__D016342 91   
% 217.28/217.47  |- skos__scopeNote mesh__D016342
% 217.28/217.47       A technique utilizing a laser coupled to a catheter which is used in the dilatation of occluded blood vessels. This includes laser thermal angioplasty where the laser energy heats up a metal tip, and direct laser angioplasty where the laser energy directly ablates the occlusion. One form of the latter approach uses an excimer laser which creates microscopically precise cuts without thermal injury. When laser angioplasty is performed in combination with balloon angioplasty it is called laser-assisted balloon angioplasty %28%ANGIOPLASTY, BALLOON, LASER-ASSISTED%29%.%A%    
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D016342 1999
% 217.28/217.47  |- skos__prefLabel mesh__D016342 Angioplasty, Laser
% 217.28/217.47  |- skos__altLabel mesh__D016342 Laser Angioplasty
% 217.28/217.47  |- skos__annotation mesh__D016342
% 217.28/217.47       coord IM with disease /surg %28%IM%29%; using balloon = ANGIOPLASTY, BALLOON, LASER-ASSISTED; do not use /util except by MeSH definition%A%  
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D016342 1998
% 217.28/217.47  |- skos__hiddenLabel mesh__D016342 Laser Angioplasties
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D016342 2002
% 217.28/217.47  |- skos__hiddenLabel mesh__D016342 Angioplasties, Laser
% 217.28/217.47  |- mesh__recordMaintainer mesh__D016342 PXP
% 217.28/217.47  |- rdf__type mesh__D030013sskos__Concept
% 217.28/217.47  |- mesh__dateCreated mesh__D030013 2001-07-25
% 217.28/217.47  |- mesh__dateRevised mesh__D030013 2002-07-03
% 217.28/217.47  |- skos__scopeNote mesh__D030013
% 217.28/217.47       A plant genus of the family APOCYNACEAE that contains OUABAIN cardiac glycosides.%A%    
% 217.28/217.47  |- skos__annotation mesh__D030013
% 217.28/217.47       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.28/217.47  |- mesh__dateEstablished mesh__D030013 2002-01-01
% 217.28/217.47  |- skos__broader mesh__D030013smesh__D029062
% 217.28/217.47  |- skos__prefLabel mesh__D030013 Strophanthus
% 217.28/217.47  |- mesh__publicMeSHNote mesh__D030013 2002   
% 217.28/217.47  |- mesh__historyNote mesh__D030013 2002   
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D030013 2006
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D030013 2004
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D030013 2005
% 217.28/217.47  |- mesh__activeMeSHYear mesh__D030013 2003
% 217.28/217.47  |- mesh__publicMeSHNote mesh__D002322 74   
% 217.28/217.48  |- mesh__dateRevised mesh__D002322 1999-11-03
% 217.28/217.48  |- skos__broader mesh__D002322smesh__D009790
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D002322 2003
% 217.28/217.48  |- mesh__recordAuthorizer mesh__D002322 sjn
% 217.28/217.48  |- skos__hiddenLabel mesh__D002322 Mobilities, Career
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D002322 2001
% 217.28/217.48  |- skos__hiddenLabel mesh__D002322 Ladder, Job
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D002322 2006
% 217.28/217.48  |- skos__altLabel mesh__D002322 Ladders, Clinical
% 217.28/217.48  |- skos__hiddenLabel mesh__D002322 Career Mobilities
% 217.28/217.48  |- skos__scopeNote mesh__D002322
% 217.28/217.48       The upward or downward mobility in an occupation or the change from one occupation to another.%A%    
% 217.28/217.48  |- skos__historyNote mesh__D002322 Health Occupations %28%1966-1971%29%
% 217.28/217.48  |- skos__hiddenLabel mesh__D002322 Ladders, Job
% 217.28/217.48  |- skos__hiddenLabel mesh__D002322 Career Ladder
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D002322 2000
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D002322 2005
% 217.28/217.48  |- mesh__historyNote mesh__D002322 74%28%72%29%   
% 217.28/217.48  |- skos__hiddenLabel mesh__D002322 Ladders, Career
% 217.28/217.48  |- skos__hiddenLabel mesh__D002322 Mobility, Career
% 217.28/217.48  |- skos__altLabel mesh__D002322 Ladder, Clinical
% 217.28/217.48  |- skos__broader mesh__D002322smesh__D012959
% 217.28/217.48  |- mesh__recordOriginator mesh__D002322 NLM
% 217.28/217.48  |- skos__prefLabel mesh__D002322 Career Mobility
% 217.28/217.48  |- mesh__dateCreated mesh__D002322 1999-01-01
% 217.28/217.48  |- skos__historyNote mesh__D002322 Occupations %28%1966-1971%29%
% 217.28/217.48  |- skos__altLabel mesh__D002322 Clinical Ladder
% 217.28/217.48  |- mesh__dateEstablished mesh__D002322 1974-01-01
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D002322 2002
% 217.28/217.48  |- skos__hiddenLabel mesh__D002322 Job Ladder
% 217.28/217.48  |- skos__broader mesh__D002322smesh__D010559
% 217.28/217.48  |- mesh__recordMaintainer mesh__D002322 kle
% 217.28/217.48  |- rdf__type mesh__D002322sskos__Concept
% 217.28/217.48  |- skos__hiddenLabel mesh__D002322 Ladder, Career
% 217.28/217.48  |- skos__annotation mesh__D002322 no qualif   
% 217.28/217.48  |- skos__historyNote mesh__D002322 specific occupation %28%1966-1971%29%
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D002322 2004
% 217.28/217.48  |- skos__broader mesh__D018634Q000193smesh__D018634
% 217.28/217.48  |- mesh__preferredCombination mesh__D018634Q000193smesh__D004520
% 217.28/217.48  |- rdf__type mesh__D018634Q000193smesh__CompoundConcept
% 217.28/217.48  |- skos__prefLabel mesh__D040441 Health Educators
% 217.28/217.48  |- mesh__historyNote mesh__D040441 2003   
% 217.28/217.48  |- mesh__dateEstablished mesh__D040441 2003-01-01
% 217.28/217.48  |- skos__hiddenLabel mesh__D040441 Health Educator
% 217.28/217.48  |- rdf__type mesh__D040441sskos__Concept
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D040441 2004
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D040441 2003
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D040441 2006
% 217.28/217.48  |- skos__scopeNote mesh__D040441
% 217.28/217.48       Professionals who plan, organize and direct health education programs for the individual, groups and the community.%A%    
% 217.28/217.48  |- skos__broader mesh__D040441smesh__D006282
% 217.28/217.48  |- skos__hiddenLabel mesh__D040441 Educators, Health
% 217.28/217.48  |- mesh__publicMeSHNote mesh__D040441 2003   
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D040441 2005
% 217.28/217.48  |- mesh__dateCreated mesh__D040441 2002-07-03
% 217.28/217.48  |- skos__hiddenLabel mesh__D040441 Educator, Health
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012750 2003
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012750 1999
% 217.28/217.48  |- mesh__dateCreated mesh__D012750 1974-11-11
% 217.28/217.48  |- skos__annotation mesh__D012750
% 217.28/217.48       a group of Indian Ocean Islands east of Tanzania   
% 217.28/217.48  |- mesh__dateRevised mesh__D012750 1995-02-21
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012750 1998
% 217.28/217.48  |- skos__scopeNote mesh__D012750
% 217.28/217.48       A group of Indian Ocean Islands, east of Tanzania. Their capital is Victoria. They were first claimed by the French in 1744 but taken by the English in 1794 and made a dependency of MAURITIUS in 1810. They became a crown colony in 1903 and a republic within the Commonwealth in 1976. They were named for the French finance minister, Jean Moreau de Sechelles, but respelled by the English in 1794. %28%From Webster%27%s New Geographical Dictionary, 1988, p1102 %26% Room, Brewer%27%s Dictionary of Names, 1992, p496%29%%A%    
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012750 2006
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012750 2002
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012750 1997
% 217.28/217.48  |- skos__broader mesh__D012750smesh__D007195
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012750 2005
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012750 2001
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012750 1996
% 217.28/217.48  |- mesh__recordOriginator mesh__D012750 NLM
% 217.28/217.48  |- mesh__dateEstablished mesh__D012750 1975-01-01
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012750 2004
% 217.28/217.48  |- skos__prefLabel mesh__D012750 Seychelles
% 217.28/217.48  |- mesh__recordAuthorizer mesh__D012750 PLS
% 217.28/217.48  |- rdf__type mesh__D012750sskos__Concept
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012750 2000
% 217.28/217.48  |- mesh__recordMaintainer mesh__D012750 TGC
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D006713 1999
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D006713 2006
% 217.28/217.48  |- mesh__recordAuthorizer mesh__D006713 PLS
% 217.28/217.48  |- mesh__historyNote mesh__D006713 73%28%71%29%   
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D006713 2002
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D006713 1995
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D006713 1998
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D006713 2005
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D006713 1994
% 217.28/217.48  |- skos__prefLabel mesh__D006713 Homogentisic Acid
% 217.28/217.48  |- skos__hiddenLabel mesh__D006713 Acid, Homogentisic
% 217.28/217.48  |- mesh__recordOriginator mesh__D006713 NLM
% 217.28/217.48  |- mesh__dateRevised mesh__D006713 1992-05-19
% 217.28/217.48  |- mesh__dateEstablished mesh__D006713 1973-01-01
% 217.28/217.48  |- skos__broader mesh__D006713smesh__D010648
% 217.28/217.48  |- mesh__dateCreated mesh__D006713 1999-01-01
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D006713 2001
% 217.28/217.48  |- mesh__publicMeSHNote mesh__D006713 73   
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D006713 1997
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D006713 2004
% 217.28/217.48  |- skos__historyNote mesh__D006713 Phenylacetates %28%1966-1970%29%
% 217.28/217.48  |- mesh__recordMaintainer mesh__D006713 TGC
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D006713 2000
% 217.28/217.48  |- rdf__type mesh__D006713sskos__Concept
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D006713 1993
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D006713 1996
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D006713 2003
% 217.28/217.48  |- skos__related mesh__D050071smesh__D050723
% 217.28/217.48  |- mesh__dateCreated mesh__D050071 2005-06-30
% 217.28/217.48  |- mesh__recordMaintainer mesh__D050071 ssb
% 217.28/217.48  |- mesh__recordAuthorizer mesh__D050071 sjn
% 217.28/217.48  |- skos__related mesh__D050071smesh__D001861
% 217.28/217.48  |- rdf__type mesh__D050071sskos__Concept
% 217.28/217.48  |- skos__related mesh__D050071smesh__D010024
% 217.28/217.48  |- skos__prefLabel mesh__D050071 Bone Density Conservation Agents
% 217.28/217.48  |- mesh__publicMeSHNote mesh__D050071 2006   
% 217.28/217.48  |- mesh__dateEstablished mesh__D050071 2006-01-01
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D050071 2006
% 217.28/217.48  |- skos__related mesh__D050071smesh__D020845
% 217.28/217.48  |- skos__broader mesh__D050071smesh__D045505
% 217.28/217.48  |- mesh__recordOriginator mesh__D050071 ssb
% 217.28/217.48  |- skos__scopeNote mesh__D050071
% 217.28/217.48       Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES.%A%    
% 217.28/217.48  |- mesh__historyNote mesh__D050071 2006   
% 217.28/217.48  |- rdf__type mesh__D011658sskos__Concept
% 217.28/217.48  |- skos__altLabel mesh__D011658 Hamman-Rich Syndrome
% 217.28/217.48  |- mesh__recordOriginator mesh__D011658 NLM
% 217.28/217.48  |- skos__hiddenLabel mesh__D011658 Syndrome, Hamman-Rich
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D011658 1999
% 217.28/217.48  |- mesh__recordMaintainer mesh__D011658 TGC
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D011658 1994
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D011658 1997
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D011658 2002
% 217.28/217.48  |- skos__broader mesh__D011658smesh__D017563
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D011658 1998
% 217.28/217.48  |- skos__hiddenLabel mesh__D011658 Hamman Rich Syndrome
% 217.28/217.48  |- skos__altLabel mesh__D011658 Pulmonary Fibroses
% 217.28/217.48  |- skos__hiddenLabel mesh__D011658 Fibrosing Alveolitides
% 217.28/217.48  |- skos__annotation mesh__D011658
% 217.28/217.48       an interstitial lung dis; usually chronic so do not coord with CHRONIC DISEASE; DF: PULM FIBROSIS%A%  
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D011658 1996
% 217.28/217.48  |- mesh__recordAuthorizer mesh__D011658 PLS
% 217.28/217.48  |- skos__altLabel mesh__D011658 Fibroses, Pulmonary
% 217.28/217.48  |- mesh__dateRevised mesh__D011658 1993-02-16
% 217.28/217.48  |- skos__hiddenLabel mesh__D011658 Fibrosing Alveolitis
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D011658 2006
% 217.28/217.48  |- skos__scopeNote mesh__D011658
% 217.28/217.48       Chronic inflammation and progressive fibrosis of the pulmonary alveolar walls, with steadily progressive dyspnea, resulting finally in death from oxygen lack or right heart failure.%A%    
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D011658 2001
% 217.28/217.48  |- mesh__dateCreated mesh__D011658 1999-01-01
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D011658 2004
% 217.28/217.48  |- skos__hiddenLabel mesh__D011658 Alveolitides, Fibrosing
% 217.28/217.48  |- skos__altLabel mesh__D011658 Fibrosis, Pulmonary
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D011658 2000
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D011658 2005
% 217.28/217.48  |- skos__prefLabel mesh__D011658 Pulmonary Fibrosis
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D011658 2003
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D011658 1995
% 217.28/217.48  |- skos__scopeNote mesh__D016343
% 217.28/217.48       The constant checking on the state or condition of a patient during the course of a surgical operation %28%e.g., checking of vital signs%29%.%A%    
% 217.28/217.48  |- skos__prefLabel mesh__D016343 Monitoring, Intraoperative
% 217.28/217.48  |- mesh__dateEstablished mesh__D016343 1991-01-01
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D016343 2005
% 217.28/217.48  |- mesh__dateCreated mesh__D016343 1990-05-29
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D016343 2004
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D016343 2002
% 217.28/217.48  |- skos__altLabel mesh__D016343 Intraoperative Monitoring
% 217.28/217.48  |- mesh__recordMaintainer mesh__D016343 PXP
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D016343 2003
% 217.28/217.48  |- mesh__dateRevised mesh__D016343 1997-06-20
% 217.28/217.48  |- rdf__type mesh__D016343sskos__Concept
% 217.28/217.48  |- mesh__publicMeSHNote mesh__D016343
% 217.28/217.48       98; see INTRAOPERATIVE MONITORING 1991-97, for MONITORING, INTRAOPERATIVE see INTRAOPERATIVE MONITORING 1991-97%A%  
% 217.28/217.48  |- skos__broader mesh__D016343smesh__D008991
% 217.28/217.48  |- skos__historyNote mesh__D016343
% 217.28/217.48       Monitoring, Physiologic %28%1978-1990%29%
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D016343 1999
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D016343 2001
% 217.28/217.48  |- skos__broader mesh__D016343smesh__D013514
% 217.28/217.48  |- mesh__historyNote mesh__D016343 98%28%91%29%   
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D016343 1998
% 217.28/217.48  |- skos__annotation mesh__D016343 DF: MONITORING INTRAOP   
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D016343 2000
% 217.28/217.48  |- mesh__recordAuthorizer mesh__D016343 SJN
% 217.28/217.48  |- mesh__recordOriginator mesh__D016343 MXR
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D016343 2006
% 217.28/217.48  |- mesh__historyNote mesh__D030014 2002   
% 217.28/217.48  |- mesh__publicMeSHNote mesh__D030014 2002   
% 217.28/217.48  |- mesh__dateEstablished mesh__D030014 2002-01-01
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D030014 2006
% 217.28/217.48  |- skos__altLabel mesh__D030014 Iboga
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D030014 2004
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D030014 2005
% 217.28/217.48  |- mesh__dateCreated mesh__D030014 2001-07-25
% 217.28/217.48  |- skos__annotation mesh__D030014
% 217.28/217.48       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.28/217.48  |- mesh__dateRevised mesh__D030014 2002-07-03
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D030014 2003
% 217.28/217.48  |- skos__broader mesh__D030014smesh__D029062
% 217.28/217.48  |- rdf__type mesh__D030014sskos__Concept
% 217.28/217.48  |- skos__scopeNote mesh__D030014
% 217.28/217.48       A plant genus of the family APOCYNACEAE that contains bisindole alkaloids and IBOGAINE.%A%    
% 217.28/217.48  |- skos__prefLabel mesh__D030014 Tabernaemontana
% 217.28/217.48  |- skos__broader mesh__D002323smesh__D002228
% 217.28/217.48  |- skos__scopeNote mesh__D002323
% 217.28/217.48       The phenyl ester of CARBENICILLIN that, upon oral administration, is broken down in the intestinal mucosa to the active antibacterial. It is used for urinary tract infections.%A%    
% 217.28/217.48  |- skos__hiddenLabel mesh__D002323 BRL3475
% 217.28/217.48  |- mesh__recordOriginator mesh__D002323 SH
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D002323 2005
% 217.28/217.48  |- skos__historyNote mesh__D002323 Carbenicillin %28%1973-1977%29%
% 217.28/217.48  |- skos__prefLabel mesh__D002323 Carfecillin
% 217.28/217.48  |- skos__hiddenLabel mesh__D002323 Salt, Carfecillin Sodium
% 217.28/217.48  |- mesh__historyNote mesh__D002323
% 217.28/217.48       91%28%78%29%; was see under CARBENICILLIN 1978-90   
% 217.28/217.48  |- rdf__type mesh__D002323sskos__Concept
% 217.28/217.48  |- mesh__publicMeSHNote mesh__D002323
% 217.28/217.48       91; was see under CARBENICILLIN 1978-90   
% 217.28/217.48  |- mesh__recordAuthorizer mesh__D002323 sjn
% 217.28/217.48  |- skos__altLabel mesh__D002323 Carfecillin Sodium Salt
% 217.28/217.48  |- skos__historyNote mesh__D002323 Penicillins %28%1966-1972%29%
% 217.28/217.48  |- mesh__dateCreated mesh__D002323 1977-04-22
% 217.28/217.48  |- mesh__recordMaintainer mesh__D002323 ssb
% 217.28/217.48  |- mesh__dateEstablished mesh__D002323 1991-01-01
% 217.28/217.48  |- skos__altLabel mesh__D002323 Carphecillin
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D002323 2006
% 217.28/217.48  |- mesh__dateRevised mesh__D002323 2004-07-07
% 217.28/217.48  |- skos__hiddenLabel mesh__D002323 Sodium Salt, Carfecillin
% 217.28/217.48  |- skos__hiddenLabel mesh__D002323 BRL 3475
% 217.28/217.48  |- skos__broader mesh__D006311Q000534smesh__D006311
% 217.28/217.48  |- mesh__preferredCombination mesh__D006311Q000534smesh__D012048
% 217.28/217.48  |- rdf__type mesh__D006311Q000534smesh__CompoundConcept
% 217.28/217.48  |- skos__scopeNote mesh__D040442
% 217.28/217.48       The systematic application of information and computer sciences to public health practice, research, and learning. It is the discipline that integrates public health with information technology. The development of this field and dissemination of informatics knowledge and expertise to public health professionals is the key to unlocking the potential of information systems to improve the health of the nation. %28%www.nlm.nih.gov/pubs/cbm/phi2001.html%29%%A%    
% 217.28/217.48  |- mesh__dateCreated mesh__D040442 2002-07-03
% 217.28/217.48  |- mesh__recordMaintainer mesh__D040442 jls
% 217.28/217.48  |- rdf__type mesh__D040442sskos__Concept
% 217.28/217.48  |- skos__prefLabel mesh__D040442 Public Health Informatics
% 217.28/217.48  |- mesh__recordOriginator mesh__D040442 jls
% 217.28/217.48  |- mesh__historyNote mesh__D040442 2003   
% 217.28/217.48  |- mesh__dateEstablished mesh__D040442 2003-01-01
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D040442 2006
% 217.28/217.48  |- skos__broader mesh__D040442smesh__D048088
% 217.28/217.48  |- mesh__publicMeSHNote mesh__D040442 2003   
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D040442 2005
% 217.28/217.48  |- mesh__recordAuthorizer mesh__D040442 sjn
% 217.28/217.48  |- mesh__dateRevised mesh__D040442 2004-07-07
% 217.28/217.48  |- skos__hiddenLabel mesh__D040442 Informatics, Public Health
% 217.28/217.48  |- mesh__dateRevised mesh__D012751 2001-08-13
% 217.28/217.48  |- mesh__recordOriginator mesh__D012751 VDK
% 217.28/217.48  |- mesh__publicMeSHNote mesh__D012751 79   
% 217.28/217.48  |- mesh__dateEstablished mesh__D012751 1979-01-01
% 217.28/217.48  |- skos__scopeNote mesh__D012751
% 217.28/217.48       A form of cutaneous T-cell lymphoma manifested by generalized exfoliative erythroderma, intense pruritus, peripheral lymphadenopathy, and abnormal hyperchromatic mononuclear cells in the skin, lymph nodes, and peripheral blood %28%Sezary cells%29%. %28%Dorland, 27th ed%29%%A%    
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012751 2006
% 217.28/217.48  |- mesh__recordMaintainer mesh__D012751 jls
% 217.28/217.48  |- skos__historyNote mesh__D012751
% 217.28/217.48       Keratosis Palmaris et Plantaris %28%1974-1978%29%
% 217.28/217.48  |- skos__broader mesh__D012751smesh__D008232
% 217.28/217.48  |- skos__prefLabel mesh__D012751 Sezary Syndrome
% 217.28/217.48  |- mesh__recordAuthorizer mesh__D012751 sjn
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012751 2005
% 217.28/217.48  |- skos__annotation mesh__D012751
% 217.28/217.48       a form of T-cell lymphoma of the skin; coord IM with SKIN NEOPLASMS %28%IM%29%; spell in titles %26% translations with accent: S%C3%%A9%zary%A%  
% 217.28/217.48  |- skos__altLabel mesh__D012751 Erythroderma, Sezary
% 217.28/217.48  |- skos__hiddenLabel mesh__D012751 Sezary Erythroderma
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012751 2004
% 217.28/217.48  |- rdf__type mesh__D012751sskos__Concept
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012751 2002
% 217.28/217.48  |- mesh__dateCreated mesh__D012751 1978-05-19
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012751 2003
% 217.28/217.48  |- mesh__historyNote mesh__D012751 79   
% 217.28/217.48  |- skos__historyNote mesh__D012751 Reticuloendotheliosis %28%1966-1978%29%
% 217.28/217.48  |- skos__hiddenLabel mesh__D012751 Syndrome, Sezary
% 217.28/217.48  |- skos__broader mesh__D012751smesh__D016410
% 217.28/217.48  |- skos__historyNote mesh__D012751 Dermatitis Exfoliativa %28%1966-1978%29%
% 217.28/217.48  |- skos__broader mesh__D013909Q000293smesh__D013909
% 217.28/217.48  |- mesh__preferredCombination mesh__D013909Q000293smesh__D013898
% 217.28/217.48  |- rdf__type mesh__D013909Q000293smesh__CompoundConcept
% 217.28/217.48  |- skos__historyNote mesh__D006714 Amino Acids %28%1966-1970%29%
% 217.28/217.48  |- skos__prefLabel mesh__D006714 Homoserine
% 217.28/217.48  |- mesh__historyNote mesh__D006714 73%28%71%29%   
% 217.28/217.48  |- skos__annotation mesh__D006714 an amino acid   
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D006714 2006
% 217.28/217.48  |- skos__historyNote mesh__D006714 Hydroxybutyrates %28%1966-1970%29%
% 217.28/217.48  |- mesh__recordOriginator mesh__D006714 NLM
% 217.28/217.48  |- mesh__recordMaintainer mesh__D006714 sjn
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D006714 2005
% 217.28/217.48  |- mesh__dateRevised mesh__D006714 2003-07-25
% 217.28/217.48  |- mesh__dateCreated mesh__D006714 1999-01-01
% 217.28/217.48  |- skos__hiddenLabel mesh__D006714 Homoserine L-isomer
% 217.28/217.48  |- mesh__publicMeSHNote mesh__D006714 73   
% 217.28/217.48  |- mesh__dateEstablished mesh__D006714 1973-01-01
% 217.28/217.48  |- mesh__recordAuthorizer mesh__D006714 sjn
% 217.28/217.48  |- skos__broader mesh__D006714smesh__D000596
% 217.28/217.48  |- rdf__type mesh__D006714sskos__Concept
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D006714 2004
% 217.28/217.48  |- skos__hiddenLabel mesh__D006714 L isomer of Homoserine
% 217.28/217.48  |- skos__prefLabel mesh__D050072 White Heifer Disease
% 217.28/217.48  |- mesh__recordMaintainer mesh__D050072 lkt
% 217.28/217.48  |- rdf__type mesh__D050072sskos__Concept
% 217.28/217.48  |- skos__annotation mesh__D050072 check tags CATTLE, FEMALE and ANIMAL   
% 217.28/217.48  |- skos__scopeNote mesh__D050072
% 217.28/217.48       A congenital reproductive abnormality in white female offspring %28%heifers%29% in certain breeds of CATTLE, such as Belgian Blue and Shorthorn. The white color is inherited as a recessive trait which is associated with defects in the female reproductive tract %28%Muellerian system%29%. These heifers are usually sterile.%A%    
% 217.28/217.48  |- mesh__dateCreated mesh__D050072 2005-06-30
% 217.28/217.48  |- skos__hiddenLabel mesh__D050072 Disease, White Heifer
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D050072 2006
% 217.28/217.48  |- mesh__recordAuthorizer mesh__D050072 sjn
% 217.28/217.48  |- mesh__historyNote mesh__D050072 2006; use FREEMARTINISM 1975-2005   
% 217.28/217.48  |- mesh__dateEstablished mesh__D050072 2006-01-01
% 217.28/217.48  |- mesh__publicMeSHNote mesh__D050072 2006; see FREEMARTINISM 1975-2005   
% 217.28/217.48  |- mesh__recordOriginator mesh__D050072 lkt
% 217.28/217.48  |- skos__broader mesh__D050072smesh__D002418
% 217.28/217.48  |- mesh__recordOriginator mesh__D011659 VDK
% 217.28/217.48  |- mesh__dateEstablished mesh__D011659 1983-01-01
% 217.28/217.48  |- mesh__dateCreated mesh__D011659 1982-04-26
% 217.28/217.48  |- mesh__publicMeSHNote mesh__D011659 83   
% 217.28/217.48  |- skos__broader mesh__D011659smesh__D015657
% 217.28/217.48  |- skos__related mesh__D011659smesh__D015824
% 217.28/217.48  |- mesh__recordAuthorizer mesh__D011659 sjn
% 217.28/217.48  |- mesh__dateRevised mesh__D011659 2003-07-09
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D011659 2006
% 217.28/217.48  |- skos__scopeNote mesh__D011659
% 217.28/217.48       The exchange of OXYGEN and CARBON DIOXIDE between alveolar air and pulmonary capillary blood that occurs across the BLOOD-AIR BARRIER.%A%    
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D011659 2004
% 217.28/217.48  |- skos__altLabel mesh__D011659 Exchange, Pulmonary Gas
% 217.28/217.48  |- mesh__historyNote mesh__D011659 83   
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D011659 2005
% 217.28/217.48  |- skos__prefLabel mesh__D011659 Pulmonary Gas Exchange
% 217.28/217.48  |- rdf__type mesh__D011659sskos__Concept
% 217.28/217.48  |- mesh__recordMaintainer mesh__D011659 nns
% 217.28/217.48  |- skos__broader mesh__D011659smesh__D012129
% 217.28/217.48  |- skos__altLabel mesh__D011659 Gas Exchange, Pulmonary
% 217.28/217.48  |- skos__annotation mesh__D011659
% 217.28/217.48       do not coord with OXYGEN or CARBON DIOXIDE unless particularly discussed; DF: PULM GAS EXCHANGE%A%  
% 217.28/217.48  |- mesh__dateCreated mesh__D016344 1990-05-29
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D016344 2004
% 217.28/217.48  |- skos__historyNote mesh__D016344 Hospitalization %28%1979-1990%29%
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D016344 2002
% 217.28/217.48  |- skos__hiddenLabel mesh__D016344 Part A, Medicare
% 217.28/217.48  |- mesh__publicMeSHNote mesh__D016344 91   
% 217.28/217.48  |- rdf__type mesh__D016344sskos__Concept
% 217.28/217.48  |- skos__historyNote mesh__D016344 Medicare %28%1966-1990%29%
% 217.28/217.48  |- mesh__dateEstablished mesh__D016344 1991-01-01
% 217.28/217.48  |- mesh__dateRevised mesh__D016344 1999-11-03
% 217.28/217.48  |- skos__prefLabel mesh__D016344 Medicare Part A
% 217.28/217.48  |- skos__altLabel mesh__D016344 Medicare Hospital Insurance Program
% 217.28/217.48  |- skos__broader mesh__D016344smesh__D006278
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D016344 2005
% 217.28/217.48  |- mesh__recordAuthorizer mesh__D016344 sjn
% 217.28/217.48  |- skos__scopeNote mesh__D016344
% 217.28/217.48       The compulsory portion of Medicare that is known as the Hospital Insurance Program. All persons 65 years and older who are entitled to benefits under the Old Age, Survivors, Disability and Health Insurance Program or railroad retirement, persons under the age of 65 who have been eligible for disability for more than two years, and insured workers %28%and their dependents%29% requiring renal dialysis or kidney transplantation are automatically enrolled in Medicare Part A.%A%    
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D016344 2000
% 217.28/217.48  |- skos__altLabel mesh__D016344 Hospital Insurance Program, Medicare
% 217.28/217.48  |- mesh__historyNote mesh__D016344 91   
% 217.28/217.48  |- mesh__recordOriginator mesh__D016344 JHM
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D016344 2003
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D016344 2006
% 217.28/217.48  |- mesh__recordMaintainer mesh__D016344 kle
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D016344 2001
% 217.28/217.48  |- skos__annotation mesh__D016344 specify state if given; DF: MEDICARE A   
% 217.28/217.48  |- mesh__dateEstablished mesh__D030015 2002-01-01
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D030015 2006
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D030015 2002
% 217.28/217.48  |- skos__hiddenLabel mesh__D030015 A24, Human coxsackievirus
% 217.28/217.48  |- skos__annotation mesh__D030015
% 217.28/217.48       infection: coord IM with ENTEROVIRUS INFECTIONS %28%IM%29% or COXSACKIEVIRUS INFECTIONS %28%IM%29%, follow text%A%  
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D030015 2004
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D030015 2005
% 217.28/217.48  |- skos__scopeNote mesh__D030015
% 217.28/217.48       A species of ENTEROVIRUS infecting humans and containing 11 serotypes, all coxsackieviruses.%A%    
% 217.28/217.48  |- skos__altLabel mesh__D030015 Coxsackievirus A24 Variant
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D030015 2003
% 217.28/217.48  |- skos__altLabel mesh__D030015 Human enterovirus C
% 217.28/217.48  |- skos__altLabel mesh__D030015 Human coxsackievirus A24
% 217.28/217.48  |- skos__altLabel mesh__D030015 Coxsackievirus A24, Human
% 217.28/217.48  |- rdf__type mesh__D030015sskos__Concept
% 217.28/217.48  |- skos__prefLabel mesh__D030015 Enterovirus C, Human
% 217.28/217.48  |- mesh__historyNote mesh__D030015
% 217.28/217.48       2002; for COXSACKIE A24 VARIANT VIRUS use ENTEROVIRUS 1992-2001%A%  
% 217.28/217.48  |- mesh__publicMeSHNote mesh__D030015
% 217.28/217.48       2002; for COXSACKIE A24 VARIANT VIRUS see COXSACKIEVIRUSES A 1992-2001%A%  
% 217.28/217.48  |- mesh__dateCreated mesh__D030015 2001-07-25
% 217.28/217.48  |- skos__broader mesh__D030015smesh__D004770
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D040443 2003
% 217.28/217.48  |- skos__altLabel mesh__D040443 Public Health Students
% 217.28/217.48  |- skos__hiddenLabel mesh__D040443 Health Students, Public
% 217.28/217.48  |- skos__broader mesh__D040443smesh__D013336
% 217.28/217.48  |- skos__scopeNote mesh__D040443
% 217.28/217.48       Individuals enrolled in a school of PUBLIC HEALTH or a formal educational program in public health.%A%    
% 217.28/217.48  |- skos__hiddenLabel mesh__D040443 Public Health Student
% 217.28/217.48  |- rdf__type mesh__D040443sskos__Concept
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D040443 2005
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D040443 2004
% 217.28/217.48  |- skos__hiddenLabel mesh__D040443 Health Student, Public
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D040443 2006
% 217.28/217.48  |- mesh__dateCreated mesh__D040443 2002-07-03
% 217.28/217.48  |- mesh__publicMeSHNote mesh__D040443 2003   
% 217.28/217.48  |- mesh__dateEstablished mesh__D040443 2003-01-01
% 217.28/217.48  |- mesh__historyNote mesh__D040443 2003   
% 217.28/217.48  |- skos__prefLabel mesh__D040443 Students, Public Health
% 217.28/217.48  |- skos__hiddenLabel mesh__D040443 Student, Public Health
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012752 2005
% 217.28/217.48  |- mesh__recordAuthorizer mesh__D012752 PLS
% 217.28/217.48  |- mesh__onlineNote mesh__D012752 search GUILT 1966-74   
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012752 2000
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012752 1996
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012752 2006
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012752 2001
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012752 1997
% 217.28/217.48  |- skos__hiddenLabel mesh__D012752 Shames
% 217.28/217.48  |- mesh__dateCreated mesh__D012752 1999-01-01
% 217.28/217.48  |- mesh__recordOriginator mesh__D012752 NLM
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012752 1994
% 217.28/217.48  |- mesh__publicMeSHNote mesh__D012752 91; was see under GUILT 1975-90   
% 217.28/217.48  |- mesh__recordMaintainer mesh__D012752 NLM
% 217.28/217.48  |- skos__prefLabel mesh__D012752 Shame
% 217.28/217.48  |- mesh__dateRevised mesh__D012752 1990-04-13
% 217.28/217.48  |- skos__broader mesh__D012752smesh__D006167
% 217.28/217.48  |- mesh__dateEstablished mesh__D012752 1991-01-01
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012752 2003
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012752 1995
% 217.28/217.48  |- skos__annotation mesh__D012752 no qualif   
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012752 2004
% 217.28/217.48  |- skos__scopeNote mesh__D012752
% 217.28/217.48       An emotional attitude excited by realization of a shortcoming or impropriety.%A%    
% 217.28/217.48  |- rdf__type mesh__D012752sskos__Concept
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012752 2002
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012752 1998
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012752 1992
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012752 1999
% 217.28/217.48  |- mesh__historyNote mesh__D012752
% 217.28/217.48       91%28%75%29%; was see under GUILT 1975-90   
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012752 1993
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D012752 1991
% 217.28/217.48  |- skos__historyNote mesh__D006715 Homoserine %28%1973-1974%29%
% 217.28/217.48  |- skos__hiddenLabel mesh__D006715 Dehydrogenase, Homoserine
% 217.28/217.48  |- mesh__activeMeSHYear mesh__D006715 2006
% 217.28/217.49  |- skos__prefLabel mesh__D006715 Homoserine Dehydrogenase
% 217.28/217.49  |- skos__scopeNote mesh__D006715
% 217.28/217.49       An enzyme that catalyzes the reduction of aspartic beta-semialdehyde to homoserine, which is the branch point in biosynthesis of methionine, lysine, threonine and leucine from aspartic acid. EC 1.1.1.3.%A%    
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D006715 2005
% 217.28/217.49  |- mesh__dateEstablished mesh__D006715 1991-01-01
% 217.28/217.49  |- mesh__recordOriginator mesh__D006715 NLM
% 217.28/217.49  |- mesh__recordMaintainer mesh__D006715 ssb
% 217.28/217.49  |- rdf__type mesh__D006715sskos__Concept
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D006715 2004
% 217.28/217.49  |- skos__historyNote mesh__D006715
% 217.28/217.49       Alcohol Oxidoreductases %28%1973-1974%29%
% 217.28/217.49  |- mesh__dateCreated mesh__D006715 1974-11-19
% 217.28/217.49  |- mesh__dateRevised mesh__D006715 2003-07-09
% 217.28/217.49  |- mesh__publicMeSHNote mesh__D006715
% 217.28/217.49       91; was see under ALCOHOL OXIDOREDUCTASES 1975-90   
% 217.28/217.49  |- mesh__historyNote mesh__D006715
% 217.28/217.49       91%28%75%29%; was see under ALCOHOL OXIDOREDUCTASES 1975-90   
% 217.28/217.49  |- mesh__recordAuthorizer mesh__D006715 sjn
% 217.28/217.49  |- skos__broader mesh__D006715smesh__D000429
% 217.28/217.49  |- skos__hiddenLabel mesh__D016345 Part B, Medicare
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D016345 2000
% 217.28/217.49  |- mesh__recordOriginator mesh__D016345 JHM
% 217.28/217.49  |- rdf__type mesh__D016345sskos__Concept
% 217.28/217.49  |- skos__scopeNote mesh__D016345
% 217.28/217.49       The voluntary portion of Medicare, known as the Supplementary Medical Insurance %28%SMI%29% Program, that includes physician%27%s services, home health care, medical services, outpatient hospital services, and laboratory, pathology, and radiology services. All persons entitled to Medicare Part A may enroll in Medicare Part B on a monthly premium basis.%A%    
% 217.28/217.49  |- mesh__recordMaintainer mesh__D016345 kle
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D016345 2001
% 217.28/217.49  |- mesh__dateEstablished mesh__D016345 1991-01-01
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D016345 2002
% 217.28/217.49  |- skos__historyNote mesh__D016345 Medicare %28%1979-1990%29%
% 217.28/217.49  |- skos__broader mesh__D016345smesh__D006278
% 217.28/217.49  |- skos__annotation mesh__D016345 specify state if given; DF: MEDICARE B   
% 217.28/217.49  |- mesh__publicMeSHNote mesh__D016345 91   
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D016345 2005
% 217.28/217.49  |- skos__altLabel mesh__D016345
% 217.28/217.49       Medicare Supplementary Medical Insurance Program
% 217.28/217.49  |- skos__prefLabel mesh__D016345 Medicare Part B
% 217.28/217.49  |- skos__hiddenLabel mesh__D016345 Program, SMI
% 217.28/217.49  |- mesh__historyNote mesh__D016345 91   
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D016345 2003
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D016345 2006
% 217.28/217.49  |- mesh__dateRevised mesh__D016345 1999-11-03
% 217.28/217.49  |- skos__hiddenLabel mesh__D016345 Programs, SMI
% 217.28/217.49  |- skos__altLabel mesh__D016345 SMI Program
% 217.28/217.49  |- mesh__dateCreated mesh__D016345 1990-05-29
% 217.28/217.49  |- skos__historyNote mesh__D016345 Fees, Medical %28%1972-1977%29%
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D016345 2004
% 217.28/217.49  |- skos__hiddenLabel mesh__D016345 SMI Programs
% 217.28/217.49  |- skos__altLabel mesh__D016345
% 217.28/217.49       Supplementary Medical Insurance Program, Medicare
% 217.28/217.49  |- mesh__recordAuthorizer mesh__D016345 sjn
% 217.28/217.49  |- mesh__recordOriginator mesh__D030016 ags
% 217.28/217.49  |- mesh__recordMaintainer mesh__D030016 sjn
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D030016 2006
% 217.28/217.49  |- skos__altLabel mesh__D030016 Human enterovirus 70
% 217.28/217.49  |- skos__annotation mesh__D030016
% 217.28/217.49       infection: coord IM with ENTEROVIRUS INFECTIONS %28%IM%29%   
% 217.28/217.49  |- skos__altLabel mesh__D030016 Enterovirus Type 70
% 217.28/217.49  |- skos__altLabel mesh__D030016 Enterovirus 70
% 217.28/217.49  |- skos__broader mesh__D030016smesh__D004770
% 217.28/217.49  |- mesh__dateEstablished mesh__D030016 2002-01-01
% 217.28/217.49  |- mesh__historyNote mesh__D030016
% 217.28/217.49       2002; for ENTEROVIRUS-70 use ENTEROVIRUS 1992-2001   
% 217.28/217.49  |- rdf__type mesh__D030016sskos__Concept
% 217.28/217.49  |- skos__altLabel mesh__D030016 Human enterovirus D
% 217.28/217.49  |- mesh__recordAuthorizer mesh__D030016 sjn
% 217.28/217.49  |- skos__prefLabel mesh__D030016 Enterovirus D, Human
% 217.28/217.49  |- mesh__publicMeSHNote mesh__D030016
% 217.28/217.49       2002; for ENTEROVIRUS-70 see ENTEROVIRUS 1992-2001   
% 217.28/217.49  |- mesh__dateCreated mesh__D030016 2001-07-25
% 217.28/217.49  |- mesh__dateRevised mesh__D030016 2004-07-13
% 217.28/217.49  |- skos__altLabel mesh__D030016 Enterovirus-70
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D030016 2005
% 217.28/217.49  |- skos__scopeNote mesh__D030016
% 217.28/217.49       A species of ENTEROVIRUS infecting humans and consisting of 2 serotypes: Human enterovirus 68 and Human enterovirus 70.%A%    
% 217.28/217.49  |- mesh__recordOriginator mesh__D002325 NLM
% 217.28/217.49  |- rdf__type mesh__D002325sskos__Concept
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D002325 2002
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D002325 2004
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D002325 1999
% 217.28/217.49  |- skos__prefLabel mesh__D002325 Caricatures
% 217.28/217.49  |- mesh__recordAuthorizer mesh__D002325 PLS
% 217.28/217.49  |- skos__hiddenLabel mesh__D002325 Caricature
% 217.28/217.49  |- mesh__recordMaintainer mesh__D002325 TGC
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D002325 2003
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D002325 1998
% 217.28/217.49  |- skos__scopeNote mesh__D002325
% 217.28/217.49       Works portraying in a critical or facetious way a real individual or group, or a figure representing a social, political, ethnic, or racial type. The effect is usually achieved through distortion or exaggeration of characteristics. %28%Genre Terms: A Thesaurus for Use in Rare Book and Special Collections Cataloguing, 2d ed%29%%A%    
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D002325 2001
% 217.28/217.49  |- mesh__dateRevised mesh__D002325 1996-06-10
% 217.28/217.49  |- skos__broader mesh__D002325smesh__D001154
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D002325 2006
% 217.28/217.49  |- skos__annotation mesh__D002325
% 217.28/217.49       IM; coord with subject %28%IM%29% or person with required biog and hist headings %26% check tags; do not confuse with Publication Type CARICATURES; CARTOONS is also available%A%  
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D002325 2000
% 217.28/217.49  |- mesh__dateCreated mesh__D002325 1999-01-01
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D002325 2005
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D002325 1997
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D007010 2003
% 217.28/217.49  |- mesh__recordAuthorizer mesh__D007010 PLS
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D007010 2004
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D007010 2001
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D007010 1998
% 217.28/217.49  |- skos__scopeNote mesh__D007010
% 217.28/217.49       Deficiency of sodium in the blood; salt depletion. %28%Dorland, 27th ed%29%%A%    
% 217.28/217.49  |- mesh__recordOriginator mesh__D007010 NLM
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D007010 2002
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D007010 1994
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D007010 1999
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D007010 2005
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D007010 1995
% 217.28/217.49  |- skos__broader mesh__D007010smesh__D014883
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D007010 2006
% 217.28/217.49  |- mesh__dateRevised mesh__D007010 1993-06-02
% 217.28/217.49  |- mesh__dateCreated mesh__D007010 1999-01-01
% 217.28/217.49  |- mesh__recordMaintainer mesh__D007010 TGC
% 217.28/217.49  |- skos__annotation mesh__D007010
% 217.28/217.49       low blood sodium levels; do not confuse with HYPERNATREMIA%A%  
% 217.28/217.49  |- skos__hiddenLabel mesh__D007010 Hyponatremias
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D007010 1996
% 217.28/217.49  |- skos__prefLabel mesh__D007010 Hyponatremia
% 217.28/217.49  |- rdf__type mesh__D007010sskos__Concept
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D007010 2000
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D007010 1997
% 217.28/217.49  |- mesh__dateRevised mesh__D012753 2001-08-13
% 217.28/217.49  |- skos__prefLabel mesh__D012753 Shared Paranoid Disorder
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D012753 2005
% 217.28/217.49  |- mesh__recordOriginator mesh__D012753 NLM
% 217.28/217.49  |- mesh__dateCreated mesh__D012753 1999-01-01
% 217.28/217.49  |- skos__annotation mesh__D012753
% 217.28/217.49       spell FOLIE A DEUX as folie %C3%%A1% deux %28%with accent%29% in translations%A%  
% 217.28/217.49  |- skos__hiddenLabel mesh__D012753 Disorders, Shared Paranoid
% 217.28/217.49  |- mesh__recordMaintainer mesh__D012753 jls
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D012753 2006
% 217.28/217.49  |- mesh__dateEstablished mesh__D012753 1968-01-01
% 217.28/217.49  |- skos__historyNote mesh__D012753 Psychotic Disorders %28%1966-1967%29%
% 217.28/217.49  |- skos__altLabel mesh__D012753 Shared Psychotic Disorder
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D012753 2003
% 217.28/217.49  |- skos__hiddenLabel mesh__D012753 Shared Psychotic Disorders
% 217.28/217.49  |- skos__hiddenLabel mesh__D012753 Psychotic Disorder, Shared
% 217.28/217.49  |- rdf__type mesh__D012753sskos__Concept
% 217.28/217.49  |- skos__broader mesh__D012753smesh__D012559
% 217.28/217.49  |- mesh__onlineNote mesh__D012753
% 217.28/217.49       use SHARED PARANOID DISORDER to search FOLIE A DEUX 1968-80%A%  
% 217.28/217.49  |- skos__altLabel mesh__D012753 Paranoid Disorder, Shared
% 217.28/217.49  |- skos__hiddenLabel mesh__D012753 Shared Paranoid Disorders
% 217.28/217.49  |- mesh__recordAuthorizer mesh__D012753 sjn
% 217.28/217.49  |- skos__hiddenLabel mesh__D012753 Disorder, Shared Paranoid
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D012753 2002
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D012753 2004
% 217.28/217.49  |- skos__hiddenLabel mesh__D012753 Disorders, Shared Psychotic
% 217.28/217.49  |- mesh__publicMeSHNote mesh__D012753 81; was FOLIE A DEUX 1968-80   
% 217.28/217.49  |- skos__scopeNote mesh__D012753
% 217.28/217.49       A condition in which two closely related persons, usually in the same family, share the same delusions.%A%    
% 217.28/217.49  |- skos__hiddenLabel mesh__D012753 Paranoid Disorders, Shared
% 217.28/217.49  |- skos__hiddenLabel mesh__D012753 Disorder, Shared Psychotic
% 217.28/217.49  |- mesh__historyNote mesh__D012753 81; was FOLIE A DEUX 1968-80   
% 217.28/217.49  |- skos__hiddenLabel mesh__D012753 Psychotic Disorders, Shared
% 217.28/217.49  |- skos__annotation mesh__D006716
% 217.28/217.49       general; prefer HOMOSEXUALITY, MALE or HOMOSEXUALITY, FEMALE%A%  
% 217.28/217.49  |- mesh__recordMaintainer mesh__D006716 lkt
% 217.28/217.49  |- skos__hiddenLabel mesh__D006716 Ego-Dystonic Homosexuality
% 217.28/217.49  |- skos__scopeNote mesh__D006716
% 217.28/217.49       The sexual attraction or relationship between members of the same SEX.%A%    
% 217.28/217.49  |- rdf__type mesh__D006716sskos__Concept
% 217.28/217.49  |- mesh__dateRevised mesh__D006716 2004-07-07
% 217.28/217.49  |- skos__broader mesh__D006716smesh__D019529
% 217.28/217.49  |- skos__hiddenLabel mesh__D006716 Homosexual
% 217.28/217.49  |- skos__hiddenLabel mesh__D006716 Homosexualities, Ego-Dystonic
% 217.28/217.49  |- skos__prefLabel mesh__D006716 Homosexuality
% 217.28/217.49  |- mesh__recordAuthorizer mesh__D006716 sjn
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D006716 2006
% 217.28/217.49  |- skos__hiddenLabel mesh__D006716 Homosexuality, Ego Dystonic
% 217.28/217.49  |- skos__hiddenLabel mesh__D006716 Ego-Dystonic Homosexualities
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D006716 2005
% 217.28/217.49  |- mesh__dateCreated mesh__D006716 1999-01-01
% 217.28/217.49  |- mesh__recordOriginator mesh__D006716 NLM
% 217.28/217.49  |- mesh__dateEstablished mesh__D016346 1991-01-01
% 217.28/217.49  |- skos__altLabel mesh__D016346 vif Gene Products
% 217.28/217.49  |- skos__scopeNote mesh__D016346
% 217.28/217.49       A 23-kDa regulatory protein important for virion infectivity in HIV. The protein is found in the cytoplasm of HIV-infected cells and is not absolutely required for virion formation.%A%    
% 217.28/217.49  |- skos__historyNote mesh__D016346 Retroviridae Proteins %28%1986%29%
% 217.28/217.49  |- mesh__dateRevised mesh__D016346 2005-06-30
% 217.28/217.49  |- skos__hiddenLabel mesh__D016346 sor Gene Product
% 217.28/217.49  |- mesh__recordOriginator mesh__D016346 AGS
% 217.28/217.49  |- skos__altLabel mesh__D016346 vif Protein
% 217.28/217.49  |- mesh__historyNote mesh__D016346 91   
% 217.28/217.49  |- mesh__recordMaintainer mesh__D016346 SYSTEM
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D016346 2006
% 217.28/217.49  |- mesh__recordAuthorizer mesh__D016346 sjn
% 217.28/217.49  |- skos__broader mesh__D016346smesh__D015520
% 217.28/217.49  |- skos__hiddenLabel mesh__D016346 Q Gene Product
% 217.28/217.49  |- skos__hiddenLabel mesh__D016346 Protein, vif
% 217.28/217.49  |- skos__hiddenLabel mesh__D016346 vif Gene Product
% 217.28/217.49  |- skos__hiddenLabel mesh__D016346 HIV 1 vif Gene Products
% 217.28/217.49  |- skos__historyNote mesh__D016346 Viral Proteins %28%1987-1990%29%
% 217.28/217.49  |- skos__altLabel mesh__D016346 Gene Products, sor
% 217.28/217.49  |- mesh__dateCreated mesh__D016346 1990-06-19
% 217.28/217.49  |- skos__prefLabel mesh__D016346 Gene Products, vif
% 217.28/217.49  |- skos__hiddenLabel mesh__D016346 A Gene Product
% 217.28/217.49  |- rdf__type mesh__D016346sskos__Concept
% 217.28/217.49  |- mesh__publicMeSHNote mesh__D016346 91   
% 217.28/217.49  |- skos__altLabel mesh__D016346 Gene Product, sor
% 217.28/217.49  |- skos__altLabel mesh__D016346 sor Gene Products
% 217.28/217.49  |- skos__altLabel mesh__D016346 Gene Product, vif
% 217.28/217.49  |- skos__annotation mesh__D016346
% 217.28/217.49       Vif stands for %22%virion infectivity factor%22%; /drug eff /ultrastruct permitted%A%  
% 217.28/217.49  |- skos__altLabel mesh__D030017 Alder, Black
% 217.28/217.49  |- mesh__dateEstablished mesh__D030017 2002-01-01
% 217.28/217.49  |- rdf__type mesh__D030017sskos__Concept
% 217.28/217.49  |- skos__scopeNote mesh__D030017
% 217.28/217.49       A plant genus of the family AQUIFOLIACEAE.  The common name of %27%holly%27% usually refers to this genus but may sometimes refer to similar looking plants of the MAHONIA or QUERCUS genus.%A%    
% 217.28/217.49  |- skos__broader mesh__D030017smesh__D029063
% 217.28/217.49  |- mesh__recordMaintainer mesh__D030017 ssb
% 217.28/217.49  |- skos__prefLabel mesh__D030017 Ilex
% 217.28/217.49  |- mesh__publicMeSHNote mesh__D030017 2002   
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D030017 2005
% 217.28/217.49  |- mesh__recordAuthorizer mesh__D030017 sjn
% 217.28/217.49  |- mesh__dateRevised mesh__D030017 2002-07-02
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D030017 2003
% 217.28/217.49  |- mesh__recordOriginator mesh__D030017 ssb
% 217.28/217.49  |- mesh__historyNote mesh__D030017 2002   
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D030017 2006
% 217.28/217.49  |- skos__annotation mesh__D030017
% 217.28/217.49       X ref HOLLY: restrict to ILEX; SEA HOLLY see ERYNGIUM is also available; X ref ALDER, BLACK: ALDER see ALNUS is also available;  prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.28/217.49  |- mesh__dateCreated mesh__D030017 2001-07-25
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D030017 2004
% 217.28/217.49  |- mesh__recordAuthorizer mesh__D002326 sjn
% 217.28/217.49  |- rdf__type mesh__D002326sskos__Concept
% 217.28/217.49  |- skos__hiddenLabel mesh__D002326 Agents, Cariogenic
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D002326 2001
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D002326 2003
% 217.28/217.49  |- skos__scopeNote mesh__D002326
% 217.28/217.49       Substances that promote DENTAL CARIES.     
% 217.28/217.49  |- mesh__publicMeSHNote mesh__D002326 65   
% 217.28/217.49  |- skos__related mesh__D002326smesh__D004037
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D002326 2002
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D002326 2004
% 217.28/217.49  |- mesh__recordOriginator mesh__D002326 NLM
% 217.28/217.49  |- mesh__dateCreated mesh__D002326 1999-01-01
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D002326 2005
% 217.28/217.49  |- mesh__historyNote mesh__D002326 65   
% 217.28/217.49  |- mesh__dateEstablished mesh__D002326 1965-01-01
% 217.28/217.49  |- mesh__dateRevised mesh__D002326 2000-06-21
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D002326 2006
% 217.28/217.49  |- mesh__recordMaintainer mesh__D002326 adp
% 217.28/217.49  |- skos__prefLabel mesh__D002326 Cariogenic Agents
% 217.28/217.49  |- skos__broader mesh__D002326smesh__D001697
% 217.28/217.49  |- mesh__recordAuthorizer mesh__D007011 sjn
% 217.28/217.49  |- skos__scopeNote mesh__D007011
% 217.28/217.49       A condition caused by a deficiency of PARATHYROID HORMONE %28%or PTH%29%. It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1 %28%DIGEORGE SYNDROME%29%; CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone.%A%    
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D007011 2006
% 217.28/217.49  |- mesh__recordOriginator mesh__D007011 NLM
% 217.28/217.49  |- mesh__dateCreated mesh__D007011 1999-01-01
% 217.28/217.49  |- skos__broader mesh__D007011smesh__D010279
% 217.28/217.49  |- rdf__type mesh__D007011sskos__Concept
% 217.28/217.49  |- skos__prefLabel mesh__D007011 Hypoparathyroidism
% 217.28/217.49  |- mesh__recordMaintainer mesh__D007011 lkt
% 217.28/217.49  |- skos__hiddenLabel mesh__D007011 Hypoparathyroidism, Idiopathic
% 217.28/217.49  |- mesh__dateRevised mesh__D007011 2005-06-30
% 217.28/217.49  |- skos__historyNote mesh__D048428 Fishes %28%1965-1989%29%
% 217.28/217.49  |- skos__hiddenLabel mesh__D048428 Lampreys, Sea
% 217.28/217.49  |- skos__altLabel mesh__D048428 Sea Lamprey
% 217.28/217.49  |- skos__hiddenLabel mesh__D048428 Lamprey, Sea
% 217.28/217.49  |- mesh__historyNote mesh__D048428 2005   
% 217.28/217.49  |- mesh__publicMeSHNote mesh__D048428 2005   
% 217.28/217.49  |- skos__scopeNote mesh__D048428
% 217.28/217.49       A genus of primitive fish in the family Petromyzontidae. The sole species is Petromyzon marinus, known as the sea lamprey. The adult form feeds parasitically on other fish species.%A%    
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D048428 2005
% 217.28/217.49  |- skos__prefLabel mesh__D048428 Petromyzon
% 217.28/217.49  |- mesh__recordMaintainer mesh__D048428 ags
% 217.28/217.49  |- skos__hiddenLabel mesh__D048428 Sea Lampreys
% 217.28/217.49  |- rdf__type mesh__D048428sskos__Concept
% 217.28/217.49  |- mesh__recordOriginator mesh__D048428 ags
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D048428 2006
% 217.28/217.49  |- skos__broader mesh__D048428smesh__D007798
% 217.28/217.49  |- mesh__dateCreated mesh__D048428 2004-07-07
% 217.28/217.49  |- mesh__recordAuthorizer mesh__D048428 sjn
% 217.28/217.49  |- skos__historyNote mesh__D048428 Lampreys %28%1974-2004%29%
% 217.28/217.49  |- mesh__dateEstablished mesh__D048428 2005-01-01
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D012754 2006
% 217.28/217.49  |- rdf__type mesh__D012754sskos__Concept
% 217.28/217.49  |- mesh__recordOriginator mesh__D012754 NLM
% 217.28/217.49  |- mesh__dateRevised mesh__D012754 2003-07-09
% 217.28/217.49  |- skos__scopeNote mesh__D012754
% 217.28/217.49       A group of elongate elasmobranchs. Sharks are mostly marine fish, with certain species large and voracious.%A%    
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D012754 2004
% 217.28/217.49  |- mesh__recordMaintainer mesh__D012754 ags
% 217.28/217.49  |- skos__hiddenLabel mesh__D012754 Shark
% 217.28/217.49  |- skos__broader mesh__D012754smesh__D018940
% 217.28/217.49  |- skos__annotation mesh__D012754
% 217.28/217.49       elasmobranch fish; IM; qualif permitted; DOGFISH is also available%A%  
% 217.28/217.49  |- mesh__recordAuthorizer mesh__D012754 sjn
% 217.28/217.49  |- skos__prefLabel mesh__D012754 Sharks
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D012754 2005
% 217.28/217.49  |- mesh__dateCreated mesh__D012754 1999-01-01
% 217.28/217.49  |- mesh__dateEstablished mesh__D031110 2003-01-01
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D031110 2004
% 217.28/217.49  |- rdf__type mesh__D031110sskos__Concept
% 217.28/217.49  |- skos__altLabel mesh__D031110 Asclepias asthmatica
% 217.28/217.49  |- skos__prefLabel mesh__D031110 Tylophora
% 217.28/217.49  |- skos__broader mesh__D031110smesh__D029067
% 217.28/217.49  |- skos__scopeNote mesh__D031110
% 217.28/217.49       A plant genus of the family ASCLEPIADACEAE. Members contain phenanthro-indolizidine alkaloids.%A%    
% 217.28/217.49  |- mesh__dateCreated mesh__D031110 2002-07-02
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D031110 2005
% 217.28/217.49  |- skos__altLabel mesh__D031110 Cynanchum indicum
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D031110 2006
% 217.28/217.49  |- mesh__publicMeSHNote mesh__D031110 2003   
% 217.28/217.49  |- mesh__historyNote mesh__D031110 2003   
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D031110 2003
% 217.28/217.49  |- skos__annotation mesh__D031110
% 217.28/217.49       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.28/217.49  |- skos__annotation mesh__D016347 DF: AUTOMATED MED RECORDS   
% 217.28/217.49  |- skos__altLabel mesh__D016347 Medical Record Systems, Automated
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D016347 2004
% 217.28/217.49  |- skos__hiddenLabel mesh__D016347 Record, Computerized Patient
% 217.28/217.49  |- skos__prefLabel mesh__D016347 Medical Records Systems, Computerized
% 217.28/217.49  |- skos__altLabel mesh__D016347 Computerized Medical Record System
% 217.28/217.49  |- skos__altLabel mesh__D016347 Automated Medical Records Systems
% 217.28/217.49  |- skos__altLabel mesh__D016347 Computerized Medical Records
% 217.28/217.49  |- mesh__recordMaintainer mesh__D016347 ags
% 217.28/217.49  |- skos__broader mesh__D016347smesh__D008499
% 217.28/217.49  |- mesh__dateCreated mesh__D016347 1990-05-29
% 217.28/217.49  |- skos__altLabel mesh__D016347 Computerized Medical Record Systems
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D016347 2006
% 217.28/217.49  |- skos__altLabel mesh__D016347 Medical Records System, Computerized
% 217.28/217.49  |- skos__altLabel mesh__D016347 Medical Record, Computerized
% 217.28/217.49  |- skos__broader mesh__D016347smesh__D007256
% 217.28/217.49  |- mesh__dateRevised mesh__D016347 2003-07-22
% 217.28/217.49  |- skos__altLabel mesh__D016347 Computerized Medical Records Systems
% 217.28/217.49  |- skos__scopeNote mesh__D016347
% 217.28/217.49       Computer-based systems for input, storage, display, retrieval, and printing of information contained in a patient%27%s medical record.%A%    
% 217.28/217.49  |- skos__altLabel mesh__D016347 Medical Records Systems, Automated
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D016347 2005
% 217.28/217.49  |- skos__altLabel mesh__D016347 Medical Records System, Automated
% 217.28/217.49  |- mesh__historyNote mesh__D016347 91   
% 217.28/217.49  |- skos__hiddenLabel mesh__D016347 Patient Record, Computerized
% 217.28/217.49  |- mesh__dateEstablished mesh__D016347 1991-01-01
% 217.28/217.49  |- mesh__publicMeSHNote mesh__D016347 91   
% 217.28/217.49  |- skos__altLabel mesh__D016347 Automated Medical Record Systems
% 217.28/217.49  |- mesh__recordAuthorizer mesh__D016347 sjn
% 217.28/217.49  |- skos__altLabel mesh__D016347 Automated Medical Records System
% 217.28/217.49  |- rdf__type mesh__D016347sskos__Concept
% 217.28/217.49  |- skos__altLabel mesh__D016347 Computerized Patient Medical Records
% 217.28/217.49  |- skos__altLabel mesh__D016347 Computerized Medical Record
% 217.28/217.49  |- skos__altLabel mesh__D016347 Automated Medical Record System
% 217.28/217.49  |- skos__altLabel mesh__D016347 Medical Record System, Automated
% 217.28/217.49  |- skos__hiddenLabel mesh__D016347 Computerized Patient Record
% 217.28/217.49  |- skos__altLabel mesh__D016347 Medical Record System, Computerized
% 217.28/217.49  |- skos__altLabel mesh__D016347 Computerized Medical Records System
% 217.28/217.49  |- skos__altLabel mesh__D016347 Medical Record Systems, Computerized
% 217.28/217.49  |- skos__altLabel mesh__D016347 Patient Records, Computerized
% 217.28/217.49  |- skos__hiddenLabel mesh__D016347 Record, Computerized Medical
% 217.28/217.49  |- skos__hiddenLabel mesh__D016347 Records, Computerized Medical
% 217.28/217.49  |- mesh__recordOriginator mesh__D016347 JHM
% 217.28/217.49  |- skos__hiddenLabel mesh__D016347 Records, Computerized Patient
% 217.28/217.49  |- mesh__dateEstablished mesh__D030018 2002-01-01
% 217.28/217.49  |- skos__altLabel mesh__D030018 Guayusa
% 217.28/217.49  |- skos__broader mesh__D030018smesh__D030017
% 217.28/217.49  |- mesh__historyNote mesh__D030018 2002   
% 217.28/217.49  |- mesh__publicMeSHNote mesh__D030018 2002   
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D030018 2005
% 217.28/217.49  |- mesh__dateCreated mesh__D030018 2001-07-25
% 217.28/217.49  |- skos__scopeNote mesh__D030018
% 217.28/217.49       A plant species of the family AQUIFOLIACEAE known for ritual use by Amazonian Jivaro Indians.%A%    
% 217.28/217.49  |- skos__annotation mesh__D030018
% 217.28/217.49       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D030018 2003
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D030018 2006
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D030018 2004
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D030018 2002
% 217.28/217.49  |- skos__prefLabel mesh__D030018 Ilex guayusa
% 217.28/217.49  |- rdf__type mesh__D030018sskos__Concept
% 217.28/217.49  |- skos__broader mesh__D035501smesh__D011336
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D035501 2003
% 217.28/217.49  |- skos__scopeNote mesh__D035501
% 217.28/217.49       The condition in which reasonable knowledge regarding risks, benefits, or the future is not available.%A%    
% 217.28/217.49  |- rdf__type mesh__D035501sskos__Concept
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D035501 2004
% 217.28/217.49  |- mesh__dateCreated mesh__D035501 2002-07-03
% 217.28/217.49  |- skos__prefLabel mesh__D035501 Uncertainty
% 217.28/217.49  |- skos__broader mesh__D035501smesh__D003657
% 217.28/217.49  |- mesh__publicMeSHNote mesh__D035501 2003   
% 217.28/217.49  |- mesh__dateEstablished mesh__D035501 2003-01-01
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D035501 2005
% 217.28/217.49  |- mesh__historyNote mesh__D035501 2003   
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D035501 2006
% 217.28/217.49  |- skos__related mesh__D002327smesh__D005457
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D002327 2004
% 217.28/217.49  |- mesh__recordAuthorizer mesh__D002327 sjn
% 217.28/217.49  |- mesh__dateCreated mesh__D002327 1999-01-01
% 217.28/217.49  |- skos__scopeNote mesh__D002327
% 217.28/217.49       Substances that inhibit or arrest DENTAL CARIES formation. %28%Boucher%27%s Clinical Dental Terminology, 4th ed%29%%A%    
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D002327 2005
% 217.28/217.49  |- mesh__historyNote mesh__D002327 65   
% 217.28/217.49  |- skos__annotation mesh__D002327
% 217.28/217.49       D25-26 qualif; consider also DENTAL CARIES /prev or /drug ther%A%  
% 217.28/217.49  |- mesh__publicMeSHNote mesh__D002327 65   
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D002327 2006
% 217.28/217.49  |- mesh__recordOriginator mesh__D002327 NLM
% 217.28/217.49  |- skos__hiddenLabel mesh__D002327 Agents, Cariostatic
% 217.28/217.49  |- skos__broader mesh__D002327smesh__D001697
% 217.28/217.49  |- mesh__dateRevised mesh__D002327 2003-07-09
% 217.28/217.49  |- skos__broader mesh__D002327smesh__D020011
% 217.28/217.49  |- rdf__type mesh__D002327sskos__Concept
% 217.28/217.49  |- skos__prefLabel mesh__D002327 Cariostatic Agents
% 217.28/217.49  |- mesh__dateEstablished mesh__D002327 1965-01-01
% 217.28/217.49  |- mesh__recordMaintainer mesh__D002327 ssb
% 217.28/217.49  |- mesh__historyNote mesh__D007810 74%28%72%29%   
% 217.28/217.49  |- mesh__recordOriginator mesh__D007810 NLM
% 217.28/217.49  |- mesh__dateEstablished mesh__D007810 1974-01-01
% 217.28/217.49  |- mesh__recordMaintainer mesh__D007810 ssb
% 217.28/217.49  |- rdf__type mesh__D007810sskos__Concept
% 217.28/217.49  |- skos__broader mesh__D007810smesh__D002775
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D007810 2005
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D007810 2004
% 217.28/217.49  |- skos__historyNote mesh__D007810 Sterols %28%1966-1971%29%
% 217.28/217.49  |- skos__broader mesh__D007810smesh__D013261
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D007810 2006
% 217.28/217.49  |- skos__annotation mesh__D007810 /biosyn permitted   
% 217.28/217.49  |- skos__prefLabel mesh__D007810 Lanosterol
% 217.28/217.49  |- mesh__recordAuthorizer mesh__D007810 sjn
% 217.28/217.49  |- mesh__dateCreated mesh__D007810 1999-01-01
% 217.28/217.49  |- mesh__dateRevised mesh__D007810 2003-07-09
% 217.28/217.49  |- mesh__publicMeSHNote mesh__D007810 74   
% 217.28/217.49  |- skos__altLabel mesh__D007810 Kryptosterol
% 217.28/217.49  |- skos__altLabel mesh__D007810
% 217.28/217.49       4,4,14 alpha-trimethyl-5 alpha-cholesta-8,24-dien-3 beta-ol
% 217.28/217.49  |- skos__annotation mesh__D007012
% 217.28/217.49       coord IM with histol type of neopl %28%IM%29%   
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D007012 2006
% 217.28/217.49  |- mesh__dateCreated mesh__D007012 1984-05-29
% 217.28/217.49  |- skos__broader mesh__D007012smesh__D010610
% 217.28/217.49  |- rdf__type mesh__D007012sskos__Concept
% 217.28/217.49  |- mesh__dateEstablished mesh__D007012 1991-01-01
% 217.28/217.49  |- skos__scopeNote mesh__D007012 Tumors or cancer of the HYPOPHARYNX.     
% 217.28/217.49  |- skos__historyNote mesh__D007012 Pharyngeal Neoplasms %28%1966-1984%29%
% 217.28/217.49  |- mesh__recordOriginator mesh__D007012 VDK
% 217.28/217.49  |- skos__hiddenLabel mesh__D007012 Hypopharyngeal Cancers
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D007012 2003
% 217.28/217.49  |- mesh__recordAuthorizer mesh__D007012 sjn
% 217.28/217.49  |- mesh__dateRevised mesh__D007012 1999-11-03
% 217.28/217.49  |- mesh__activeMeSHYear mesh__D007012 2000
% 217.28/217.49  |- skos__hiddenLabel mesh__D007012 Hypopharyngeal Neoplasm
% 217.28/217.49  |- skos__hiddenLabel mesh__D007012 Cancer, Hypopharyngeal
% 217.28/217.49  |- mesh__historyNote mesh__D007012
% 217.28/217.49       91%28%85%29%; was see under PHARYNGEAL NEOPLASMS 1985-90   
% 217.28/217.50  |- skos__hiddenLabel mesh__D007012 Neoplasm, Hypopharyngeal
% 217.28/217.50  |- mesh__activeMeSHYear mesh__D007012 2004
% 217.28/217.50  |- skos__prefLabel mesh__D007012 Hypopharyngeal Neoplasms
% 217.28/217.50  |- mesh__publicMeSHNote mesh__D007012
% 217.28/217.50       91; was see under PHARYNGEAL NEOPLASMS 1985-90   
% 217.28/217.50  |- skos__hiddenLabel mesh__D007012 Cancers, Hypopharyngeal
% 217.28/217.50  |- mesh__recordMaintainer mesh__D007012 nns
% 217.28/217.50  |- mesh__activeMeSHYear mesh__D007012 2001
% 217.28/217.50  |- mesh__activeMeSHYear mesh__D007012 2005
% 217.28/217.50  |- skos__altLabel mesh__D007012 Neoplasms, Hypopharyngeal
% 217.28/217.50  |- skos__historyNote mesh__D007012 Hypopharynx %28%1979-1984%29%
% 217.28/217.50  |- mesh__activeMeSHYear mesh__D007012 2002
% 217.28/217.50  |- mesh__activeMeSHYear mesh__D048429 2005A
% 217.28/217.50  |- skos__hiddenLabel mesh__D048429 Cell Sizes
% 217.28/217.50  |- mesh__dateEstablished mesh__D048429 2005-01-01
% 217.28/217.50  |- skos__hiddenLabel mesh__D048429 Sizes, Cell
% 217.28/217.50  |- mesh__activeMeSHYear mesh__D048429 2005
% 217.28/217.50  |- skos__prefLabel mesh__D048429 Cell Size
% 217.28/217.50  |- mesh__recordOriginator mesh__D048429 nns
% 217.28/217.50  |- mesh__dateRevised mesh__D048429 2004-08-06
% 217.28/217.50  |- skos__historyNote mesh__D048429 Cell Size %28%1993-2004%29%
% 217.28/217.50  |- rdf__type mesh__D048429sskos__Concept
% 217.28/217.50  |- mesh__activeMeSHYear mesh__D048429 2006
% 217.28/217.50  |- skos__historyNote mesh__D048429 specific cell/cytology %28%1966-1992%29%
% 217.28/217.50  |- skos__hiddenLabel mesh__D048429 Volume, Cell
% 217.28/217.50  |- mesh__dateCreated mesh__D048429 2004-07-07
% 217.28/217.50  |- skos__broader mesh__D048429smesh__D002468
% 217.28/217.50  |- mesh__historyNote mesh__D048429 2005%28%1993%29%   
% 217.28/217.50  |- mesh__recordMaintainer mesh__D048429 jls
% 217.28/217.50  |- mesh__publicMeSHNote mesh__D048429 2005%28%1993%29%   
% 217.28/217.50  |- skos__scopeNote mesh__D048429
% 217.28/217.50       The quantity of volume or surface area of CELLS.     
% 217.28/217.50  |- skos__hiddenLabel mesh__D048429 Cell Volumes
% 217.28/217.50  |- skos__hiddenLabel mesh__D048429 Size, Cell
% 217.35/217.50  |- skos__annotation mesh__D048429
% 217.35/217.50       not for microorganisms; coordinate with organ /cytol or /pathol or specific cell /cytol or /pathol%A%  
% 217.35/217.50  |- skos__historyNote mesh__D048429
% 217.35/217.50       specific organ/cytology %28%1966-1992%29%
% 217.35/217.50  |- skos__hiddenLabel mesh__D048429 Volumes, Cell
% 217.35/217.50  |- mesh__recordAuthorizer mesh__D048429 jls
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006718 2004
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006718 1998
% 217.35/217.50  |- mesh__publicMeSHNote mesh__D006718 68   
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006718 1999
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006718 2005
% 217.35/217.50  |- mesh__dateCreated mesh__D006718 1999-01-01
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006718 1994
% 217.35/217.50  |- skos__broader mesh__D006718smesh__D013256
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006718 2006
% 217.35/217.50  |- mesh__recordMaintainer mesh__D006718 PLS
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006718 2000
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006718 1995
% 217.35/217.50  |- mesh__recordOriginator mesh__D006718 NLM
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006718 1996
% 217.35/217.50  |- skos__prefLabel mesh__D006718 Homosteroids
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006718 1997
% 217.35/217.50  |- mesh__recordAuthorizer mesh__D006718 PLS
% 217.35/217.50  |- skos__scopeNote mesh__D006718
% 217.35/217.50       Steroids whose structure has been expanded by the addition of one or more carbon atoms to the ring skeleton in any of the four rings.%A%    
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006718 2001
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006718 2003
% 217.35/217.50  |- mesh__dateEstablished mesh__D006718 1968-01-01
% 217.35/217.50  |- mesh__dateRevised mesh__D006718 1993-06-03
% 217.35/217.50  |- mesh__historyNote mesh__D006718 68   
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006718 2002
% 217.35/217.50  |- rdf__type mesh__D006718sskos__Concept
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017440 2003
% 217.35/217.50  |- skos__hiddenLabel mesh__D017440 Photoperiods
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017440 1994
% 217.35/217.50  |- skos__annotation mesh__D017440
% 217.35/217.50       %22%photo-%22% refers to natural or artificial light; no qualif%A%  
% 217.35/217.50  |- mesh__dateEstablished mesh__D017440 1993-01-01
% 217.35/217.50  |- rdf__type mesh__D017440sskos__Concept
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017440 2004
% 217.35/217.50  |- skos__historyNote mesh__D017440 Light %28%1966-1992%29%
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017440 2000
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017440 1995
% 217.35/217.50  |- skos__prefLabel mesh__D017440 Photoperiod
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017440 1998
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017440 2001
% 217.35/217.50  |- skos__broader mesh__D017440smesh__D013995
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017440 1993
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017440 1999
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017440 2005
% 217.35/217.50  |- skos__historyNote mesh__D017440 Periodicity %28%1966-1992%29%
% 217.35/217.50  |- mesh__publicMeSHNote mesh__D017440 93   
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017440 1996
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017440 2006
% 217.35/217.50  |- skos__scopeNote mesh__D017440
% 217.35/217.50       The time period of daily exposure that an organism receives from daylight or artificial light. It is believed that photoperiodic responses may affect the control of energy balance and thermoregulation.%A%    
% 217.35/217.50  |- mesh__historyNote mesh__D017440 93   
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017440 2002
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017440 1997
% 217.35/217.50  |- mesh__dateCreated mesh__D017440 1992-05-22
% 217.35/217.50  |- mesh__recordOriginator mesh__D031111 ssb
% 217.35/217.50  |- mesh__recordMaintainer mesh__D031111 ssb
% 217.35/217.50  |- mesh__dateEstablished mesh__D031111 2003-01-01
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D031111 2005
% 217.35/217.50  |- mesh__recordAuthorizer mesh__D031111 sjn
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D031111 2006
% 217.35/217.50  |- mesh__publicMeSHNote mesh__D031111 2003   
% 217.35/217.50  |- skos__scopeNote mesh__D031111
% 217.35/217.50       A plant family of the order Santalales, subclass Rosidae, class Magnoliopsida. They are root parasites lacking CHLOROPHYLL.%A%    
% 217.35/217.50  |- skos__broader mesh__D031111smesh__D019684
% 217.35/217.50  |- skos__prefLabel mesh__D031111 Balanophoraceae
% 217.35/217.50  |- mesh__dateCreated mesh__D031111 2002-07-02
% 217.35/217.50  |- mesh__dateRevised mesh__D031111 2003-07-09
% 217.35/217.50  |- skos__annotation mesh__D031111
% 217.35/217.50       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D031111 2004
% 217.35/217.50  |- mesh__historyNote mesh__D031111 2003   
% 217.35/217.50  |- rdf__type mesh__D031111sskos__Concept
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D003420 2003
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D003420 2001
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D003420 2005
% 217.35/217.50  |- skos__scopeNote mesh__D003420
% 217.35/217.50       Cardiac malformation characterized by an atrioventricular spatial relation that places or appears to place each ventricle in a contralateral position relative to its associated atrium.%A%    
% 217.35/217.50  |- mesh__publicMeSHNote mesh__D003420
% 217.35/217.50       91; was see under HEART DEFECTS, CONGENITAL 1987-90   
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D003420 2004
% 217.35/217.50  |- skos__prefLabel mesh__D003420 Crisscross Heart
% 217.35/217.50  |- mesh__dateRevised mesh__D003420 1999-11-03
% 217.35/217.50  |- skos__broader mesh__D003420smesh__D006330
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D003420 2006
% 217.35/217.50  |- skos__hiddenLabel mesh__D003420 Hearts, Crisscross
% 217.35/217.50  |- skos__annotation mesh__D003420
% 217.35/217.50       a congen atrioventric defect; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 217.35/217.50  |- skos__historyNote mesh__D003420
% 217.35/217.50       Heart Defects, Congenital %28%1966-1986%29%
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D003420 2002
% 217.35/217.50  |- mesh__recordMaintainer mesh__D003420 kle
% 217.35/217.50  |- mesh__recordAuthorizer mesh__D003420 sjn
% 217.35/217.50  |- skos__hiddenLabel mesh__D003420 Heart, Crisscross
% 217.35/217.50  |- mesh__historyNote mesh__D003420
% 217.35/217.50       91%28%87%29%; was see under HEART DEFECTS, CONGENITAL 1987-90   
% 217.35/217.50  |- mesh__recordOriginator mesh__D003420 VDK
% 217.35/217.50  |- mesh__dateEstablished mesh__D003420 1991-01-01
% 217.35/217.50  |- mesh__dateCreated mesh__D003420 1986-06-23
% 217.35/217.50  |- rdf__type mesh__D003420sskos__Concept
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D003420 2000
% 217.35/217.50  |- skos__hiddenLabel mesh__D003420 Crisscross Hearts
% 217.35/217.50  |- skos__prefLabel mesh__D016348 Osseointegration
% 217.35/217.50  |- skos__related mesh__D016348smesh__D006622
% 217.35/217.50  |- skos__broader mesh__D016348smesh__D001861
% 217.35/217.50  |- mesh__recordMaintainer mesh__D016348 nns
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D016348 2004
% 217.35/217.50  |- skos__annotation mesh__D016348
% 217.35/217.50       note category %26% MeSH definition: must involve bone growth in relation to surg implanted material; do not confuse with OSSIFICATION, HETEROTOPIC, a Cat C term%A%  
% 217.35/217.50  |- mesh__publicMeSHNote mesh__D016348 91   
% 217.35/217.50  |- skos__related mesh__D016348smesh__D018786
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D016348 2006
% 217.35/217.50  |- mesh__dateEstablished mesh__D016348 1991-01-01
% 217.35/217.50  |- mesh__dateCreated mesh__D016348 1990-05-29
% 217.35/217.50  |- skos__related mesh__D016348smesh__D003758
% 217.35/217.50  |- mesh__recordOriginator mesh__D016348 MXR
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D016348 2005
% 217.35/217.50  |- rdf__type mesh__D016348sskos__Concept
% 217.35/217.50  |- skos__related mesh__D016348smesh__D001178
% 217.35/217.50  |- skos__scopeNote mesh__D016348
% 217.35/217.50       The growth action of bone tissue, as it assimilates surgically implanted devices or prostheses to be used as either replacement parts %28%e.g., hip%29% or as anchors %28%e.g., endosseous dental implants%29%.%A%    
% 217.35/217.50  |- mesh__dateRevised mesh__D016348 2003-07-09
% 217.35/217.50  |- mesh__historyNote mesh__D016348 91   
% 217.35/217.50  |- mesh__recordAuthorizer mesh__D016348 sjn
% 217.35/217.50  |- skos__altLabel mesh__D030019 Yerba Mate
% 217.35/217.50  |- mesh__publicMeSHNote mesh__D030019 2002   
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D030019 2005
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D030019 2003
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D030019 2006
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D030019 2004
% 217.35/217.50  |- skos__broader mesh__D030019smesh__D030017
% 217.35/217.50  |- mesh__historyNote mesh__D030019 2002   
% 217.35/217.50  |- mesh__dateCreated mesh__D030019 2001-07-25
% 217.35/217.50  |- skos__annotation mesh__D030019
% 217.35/217.50       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.35/217.50  |- rdf__type mesh__D030019sskos__Concept
% 217.35/217.50  |- skos__prefLabel mesh__D030019 Ilex paraguariensis
% 217.35/217.50  |- mesh__dateEstablished mesh__D030019 2002-01-01
% 217.35/217.50  |- skos__scopeNote mesh__D030019
% 217.35/217.50       A plant species of the family AQUIFOLIACEAE.  An infusion of the leaves is commonly drunk in South America for stimulating effect in much the same manner as coffee is in other cultures.%A%    
% 217.35/217.50  |- skos__altLabel mesh__D030019 Mate, Yerba
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D030019 2002
% 217.35/217.50  |- rdf__type mesh__D035502sskos__Concept
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D035502 2004
% 217.35/217.50  |- mesh__historyNote mesh__D035502 2003   
% 217.35/217.50  |- mesh__publicMeSHNote mesh__D035502 2003   
% 217.35/217.50  |- skos__scopeNote mesh__D035502
% 217.35/217.50       Confidence in or reliance on a person or thing.     
% 217.35/217.50  |- mesh__dateCreated mesh__D035502 2002-07-03
% 217.35/217.50  |- skos__broader mesh__D035502smesh__D007398
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D035502 2005
% 217.35/217.50  |- skos__prefLabel mesh__D035502 Trust
% 217.35/217.50  |- skos__historyNote mesh__D035502
% 217.35/217.50       Professional-Patient Relations %28%1967-2002%29%
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D035502 2006
% 217.35/217.50  |- skos__historyNote mesh__D035502
% 217.35/217.50       Interpersonal Relations %28%1967-2002%29%
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D035502 2003
% 217.35/217.50  |- mesh__dateEstablished mesh__D035502 2003-01-01
% 217.35/217.50  |- mesh__recordOriginator mesh__D002328 NLM
% 217.35/217.50  |- skos__scopeNote mesh__D002328
% 217.35/217.50       A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1202%29%%A%    
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D002328 2006
% 217.35/217.50  |- skos__broader mesh__D002328smesh__D002219
% 217.35/217.50  |- skos__prefLabel mesh__D002328 Carisoprodol
% 217.35/217.50  |- skos__altLabel mesh__D002328 Carter Horner Brand of Carisoprodol
% 217.35/217.50  |- skos__altLabel mesh__D002328 Wallace Brand 3 of Carisoprodol
% 217.35/217.50  |- skos__altLabel mesh__D002328 GM Pharmaceuticals Brand of Carisoprodol
% 217.35/217.50  |- skos__altLabel mesh__D002328 Belmac Brand of Carisoprodol
% 217.35/217.50  |- rdf__type mesh__D002328sskos__Concept
% 217.35/217.50  |- skos__altLabel mesh__D002328 Forest Brand of Carisoprodol
% 217.35/217.50  |- skos__altLabel mesh__D002328 Isomeprobamate
% 217.35/217.50  |- skos__altLabel mesh__D002328 Isopropylmeprobamate
% 217.35/217.50  |- mesh__recordMaintainer mesh__D002328 lkw
% 217.35/217.50  |- mesh__recordAuthorizer mesh__D002328 sjn
% 217.35/217.50  |- skos__altLabel mesh__D002328 Wallace Brand 2 of Carisoprodol
% 217.35/217.50  |- skos__altLabel mesh__D002328 Schein Brand of Carisoprodol
% 217.35/217.50  |- skos__altLabel mesh__D002328 Carisoprodate
% 217.35/217.50  |- skos__altLabel mesh__D002328 Isobamate
% 217.35/217.50  |- skos__altLabel mesh__D002328 Wallace Brand 1 of Carisoprodol
% 217.35/217.50  |- mesh__dateRevised mesh__D002328 2005-06-30
% 217.35/217.50  |- mesh__dateCreated mesh__D002328 1999-01-01
% 217.35/217.50  |- skos__altLabel mesh__D013050 Spectrofluorometry
% 217.35/217.50  |- skos__hiddenLabel mesh__D013050 Spectroscopy, Fluorescence
% 217.35/217.50  |- skos__annotation mesh__D013050
% 217.35/217.50       a type of spectrum anal; NIM; do not confuse with SPECTROMETRY, X-RAY FLUORESCENCE see SPECTROMETRY, X-RAY EMISSION%A%  
% 217.35/217.50  |- mesh__historyNote mesh__D013050
% 217.35/217.50       74; was FLUORESCENCE SPECTROPHOTOMETRY %28%Prov 1972-73%29%   
% 217.35/217.50  |- mesh__dateEstablished mesh__D013050 1974-01-01
% 217.35/217.50  |- skos__broader mesh__D013050smesh__D005470
% 217.35/217.50  |- mesh__onlineNote mesh__D013050
% 217.35/217.50       use SPECTROMETRY, FLUORESCENCE to search FLUORESCENCE SPECTROPHOTOMETRY 1972-73 %28%as Prov 1972-73%29%%A%  
% 217.35/217.50  |- skos__hiddenLabel mesh__D013050 Spectrophotometry, Fluorescence
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D013050 2006
% 217.35/217.50  |- mesh__publicMeSHNote mesh__D013050 74   
% 217.35/217.50  |- skos__historyNote mesh__D013050 Fluorescence %28%1966-1971%29%
% 217.35/217.50  |- skos__scopeNote mesh__D013050
% 217.35/217.50       Measurement of the intensity and quality of fluorescence.%A%    
% 217.35/217.50  |- skos__prefLabel mesh__D013050 Spectrometry, Fluorescence
% 217.35/217.50  |- skos__broader mesh__D013050smesh__D013057
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D013050 2005
% 217.35/217.50  |- skos__hiddenLabel mesh__D013050 Fluorescence Spectrometry
% 217.35/217.50  |- mesh__recordAuthorizer mesh__D013050 sjn
% 217.35/217.50  |- mesh__recordMaintainer mesh__D013050 ssb
% 217.35/217.50  |- mesh__recordOriginator mesh__D013050 NLM
% 217.35/217.50  |- mesh__dateRevised mesh__D013050 2004-07-07
% 217.35/217.50  |- rdf__type mesh__D013050sskos__Concept
% 217.35/217.50  |- mesh__dateCreated mesh__D013050 1999-01-01
% 217.35/217.50  |- skos__historyNote mesh__D013050 Spectrum Analysis %28%1966-1971%29%
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D007811 2005
% 217.35/217.50  |- skos__scopeNote mesh__D007811
% 217.35/217.50       Lanthanum. The prototypical element in the rare earth family of metals. It has the atomic symbol La, atomic number 57, and atomic weight 138.91. Lanthanide ion is used in experimental biology as a calcium antagonist; lanthanum oxide improves the optical properties of glass.%A%    
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D007811 2004
% 217.35/217.50  |- mesh__recordMaintainer mesh__D007811 jmp
% 217.35/217.50  |- mesh__recordOriginator mesh__D007811 NLM
% 217.35/217.50  |- skos__prefLabel mesh__D007811 Lanthanum
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D007811 2006
% 217.35/217.50  |- mesh__dateCreated mesh__D007811 1999-01-01
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D007811 2002
% 217.35/217.50  |- skos__annotation mesh__D007811
% 217.35/217.50       a rare earth metal; La-139; La-138 = LANTHANUM %28%IM%29% + ISOTOPES %28%NIM%29%; La-126-137, 140-144 = LANTHANUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 217.35/217.50  |- mesh__recordAuthorizer mesh__D007811 sjn
% 217.35/217.50  |- skos__broader mesh__D007811smesh__D028581
% 217.35/217.50  |- rdf__type mesh__D007811sskos__Concept
% 217.35/217.50  |- mesh__dateRevised mesh__D007811 2001-07-25
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D007811 2003
% 217.35/217.50  |- skos__prefLabel mesh__D007013 Hypopharynx
% 217.35/217.50  |- rdf__type mesh__D007013sskos__Concept
% 217.35/217.50  |- skos__altLabel mesh__D007013 Laryngopharynges
% 217.35/217.50  |- skos__annotation mesh__D007013
% 217.35/217.50       inflammation: coord IM with PHARYNGITIS %28%IM%29%   
% 217.35/217.50  |- skos__scopeNote mesh__D007013
% 217.35/217.50       The portion of the pharynx between the inferior portion of the oropharynx and the larynx.%A%    
% 217.35/217.50  |- mesh__recordMaintainer mesh__D007013 lkt
% 217.35/217.50  |- skos__altLabel mesh__D007013 Hypopharynxes
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D007013 2004
% 217.35/217.50  |- skos__broader mesh__D007013smesh__D010614
% 217.35/217.50  |- mesh__recordOriginator mesh__D007013 RC
% 217.35/217.50  |- skos__historyNote mesh__D007013 Pharynx %28%1966-1978%29%
% 217.35/217.50  |- mesh__dateEstablished mesh__D007013 1979-01-01
% 217.35/217.50  |- mesh__publicMeSHNote mesh__D007013 79   
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D007013 2005
% 217.35/217.50  |- mesh__historyNote mesh__D007013 79   
% 217.35/217.50  |- mesh__recordAuthorizer mesh__D007013 sjn
% 217.35/217.50  |- mesh__dateCreated mesh__D007013 1978-05-19
% 217.35/217.50  |- skos__altLabel mesh__D007013 Laryngopharynxes
% 217.35/217.50  |- skos__altLabel mesh__D007013 Laryngopharynx
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D007013 2006
% 217.35/217.50  |- skos__altLabel mesh__D007013 Hypopharynges
% 217.35/217.50  |- mesh__dateRevised mesh__D007013 2003-07-09
% 217.35/217.50  |- skos__scopeNote mesh__D045930
% 217.35/217.50       These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power.%A%    
% 217.35/217.50  |- skos__hiddenLabel mesh__D045930 Agents, Anabolic
% 217.35/217.50  |- mesh__dateEstablished mesh__D045930 2004-01-01
% 217.35/217.50  |- mesh__historyNote mesh__D045930 2004   
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D045930 2005
% 217.35/217.50  |- skos__prefLabel mesh__D045930 Anabolic Agents
% 217.35/217.50  |- skos__broader mesh__D045930smesh__D006728
% 217.35/217.50  |- rdf__type mesh__D045930sskos__Concept
% 217.35/217.50  |- mesh__dateCreated mesh__D045930 2003-07-09
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D045930 2006
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D045930 2004
% 217.35/217.50  |- mesh__publicMeSHNote mesh__D045930 2004   
% 217.35/217.50  |- skos__altLabel mesh__D012756 Ovis
% 217.35/217.50  |- skos__altLabel mesh__D012756 Ovis dalli
% 217.35/217.50  |- skos__prefLabel mesh__D012756 Sheep
% 217.35/217.50  |- mesh__recordMaintainer mesh__D012756 ags
% 217.35/217.50  |- skos__scopeNote mesh__D012756
% 217.35/217.50       Any of the ruminant mammals with curved horns in the genus Ovis, family Bovidae. They possess lachrymal grooves and interdigital glands, which are absent in GOATS.%A%    
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D012756 2005
% 217.35/217.50  |- mesh__dateCreated mesh__D012756 1999-01-01
% 217.35/217.50  |- mesh__recordAuthorizer mesh__D012756 sjn
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D012756 2006
% 217.35/217.50  |- skos__altLabel mesh__D012756 Sheep, Dall
% 217.35/217.50  |- skos__annotation mesh__D012756
% 217.35/217.50       SHEEP, DOMESTIC and SHEEP, BIGHORN are also available; SHEEP unspecified goes here%A%  
% 217.35/217.50  |- skos__broader mesh__D012756smesh__D012418
% 217.35/217.50  |- rdf__type mesh__D012756sskos__Concept
% 217.35/217.50  |- mesh__dateRevised mesh__D012756 2003-07-09
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D012756 2004
% 217.35/217.50  |- mesh__recordOriginator mesh__D012756 NLM
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006719 1999
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006719 2005
% 217.35/217.50  |- mesh__dateCreated mesh__D006719 1999-01-01
% 217.35/217.50  |- skos__broader mesh__D006719smesh__D010648
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006719 2002
% 217.35/217.50  |- skos__prefLabel mesh__D006719 Homovanillic Acid
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006719 1994
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006719 2006
% 217.35/217.50  |- mesh__dateEstablished mesh__D006719 1986-01-01
% 217.35/217.50  |- skos__hiddenLabel mesh__D006719 Acid, 4-Hydroxy-3-Methoxyphenylacetic
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006719 1995
% 217.35/217.50  |- skos__hiddenLabel mesh__D006719 Acid, Homovanillic
% 217.35/217.50  |- mesh__publicMeSHNote mesh__D006719
% 217.35/217.50       86; was see under PHENYLACETATES 1975-85   
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006719 1996
% 217.35/217.50  |- skos__hiddenLabel mesh__D006719 Acid, 3-Methoxy-4-Hydroxyphenylacetic
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006719 1997
% 217.35/217.50  |- skos__hiddenLabel mesh__D006719 4 Hydroxy 3 Methoxyphenylacetic Acid
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006719 2003
% 217.35/217.50  |- mesh__dateRevised mesh__D006719 1992-05-19
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006719 2000
% 217.35/217.50  |- mesh__recordOriginator mesh__D006719 NLM
% 217.35/217.50  |- rdf__type mesh__D006719sskos__Concept
% 217.35/217.50  |- skos__hiddenLabel mesh__D006719 3 Methoxy 4 Hydroxyphenylacetic Acid
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006719 2004
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006719 1998
% 217.35/217.50  |- skos__altLabel mesh__D006719 4-Hydroxy-3-Methoxyphenylacetic Acid
% 217.35/217.50  |- mesh__historyNote mesh__D006719
% 217.35/217.50       86%28%73%29%; was see under PHENYLACETATES 1975-85, was Prov 1973-74%A%  
% 217.35/217.50  |- skos__altLabel mesh__D006719 3-Methoxy-4-Hydroxyphenylacetic Acid
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006719 1993
% 217.35/217.50  |- mesh__recordMaintainer mesh__D006719 TGC
% 217.35/217.50  |- mesh__recordAuthorizer mesh__D006719 PLS
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D006719 2001
% 217.35/217.50  |- mesh__dateRevised mesh__D017441 1997-06-20
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017441 2006
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017441 1998
% 217.35/217.50  |- skos__annotation mesh__D017441
% 217.35/217.50       a group of collagen dis affecting the %22%collagen bundles in the dermis%22%; NECROBIOSIS LIPOIDICA with or without diabetes mellitus is also available%A%  
% 217.35/217.50  |- skos__hiddenLabel mesh__D017441 Disorder, Necrobiotic
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017441 2004
% 217.35/217.50  |- mesh__recordMaintainer mesh__D017441 TPW
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017441 2001
% 217.35/217.50  |- mesh__historyNote mesh__D017441 93   
% 217.35/217.50  |- mesh__publicMeSHNote mesh__D017441 93   
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017441 2005
% 217.35/217.50  |- mesh__recordAuthorizer mesh__D017441 SJN
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017441 2000
% 217.35/217.50  |- skos__prefLabel mesh__D017441 Necrobiotic Disorders
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017441 2003
% 217.35/217.50  |- rdf__type mesh__D017441sskos__Concept
% 217.35/217.50  |- skos__altLabel mesh__D017441 Necrobiosis
% 217.35/217.50  |- skos__hiddenLabel mesh__D017441 Necrobioses
% 217.35/217.50  |- skos__hiddenLabel mesh__D017441 Necrobiotic Disorder
% 217.35/217.50  |- mesh__dateCreated mesh__D017441 1992-05-22
% 217.35/217.50  |- skos__scopeNote mesh__D017441
% 217.35/217.50       A group of disorders characterized by swelling, basophilia, and distortion of collagen bundles in the dermis.%A%    
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017441 2002
% 217.35/217.50  |- mesh__recordOriginator mesh__D017441 PLS
% 217.35/217.50  |- skos__broader mesh__D017441smesh__D012871
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D017441 1999
% 217.35/217.50  |- skos__broader mesh__D017441smesh__D003095
% 217.35/217.50  |- skos__hiddenLabel mesh__D017441 Disorders, Necrobiotic
% 217.35/217.50  |- mesh__dateEstablished mesh__D017441 1993-01-01
% 217.35/217.50  |- mesh__historyNote mesh__D031112 2003   
% 217.35/217.50  |- skos__scopeNote mesh__D031112
% 217.35/217.50       A plant family of the order Violales %28%by some in Begoniales%29%, subclass Dilleniidae, class Magnoliopsida. Members are found throughout tropical and warm temperate habitats. Most are perennial herbs with monoecious flowers %28%both sexes on the same plant%29%. Fruits are usually capsules containing many tiny seeds.%A%    
% 217.35/217.50  |- mesh__dateEstablished mesh__D031112 2003-01-01
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D031112 2005
% 217.35/217.50  |- skos__broader mesh__D031112smesh__D019684
% 217.35/217.50  |- mesh__publicMeSHNote mesh__D031112 2003   
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D031112 2006
% 217.35/217.50  |- mesh__dateCreated mesh__D031112 2002-07-02
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D031112 2003
% 217.35/217.50  |- skos__annotation mesh__D031112
% 217.35/217.50       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.35/217.50  |- rdf__type mesh__D031112sskos__Concept
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D031112 2004
% 217.35/217.50  |- skos__prefLabel mesh__D031112 Begoniaceae
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D003421 2004
% 217.35/217.50  |- skos__broader mesh__D003421smesh__D014351
% 217.35/217.50  |- mesh__recordMaintainer mesh__D003421 ags
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D003421 2006
% 217.35/217.50  |- mesh__dateCreated mesh__D003421 1977-12-05
% 217.35/217.50  |- mesh__publicMeSHNote mesh__D003421 79   
% 217.35/217.50  |- mesh__dateRevised mesh__D003421 2003-07-09
% 217.35/217.50  |- skos__historyNote mesh__D003421 Mastigophora %28%1966-1978%29%
% 217.35/217.50  |- mesh__recordOriginator mesh__D003421 AEP
% 217.35/217.50  |- mesh__historyNote mesh__D003421 79   
% 217.35/217.50  |- skos__historyNote mesh__D003421 Trypanosoma %28%1966-1978%29%
% 217.35/217.50  |- mesh__dateEstablished mesh__D003421 1979-01-01
% 217.35/217.50  |- rdf__type mesh__D003421sskos__Concept
% 217.35/217.50  |- skos__scopeNote mesh__D003421
% 217.35/217.50       A genus of parasitic protozoans found in the digestive tract of invertebrates, especially insects. Organisms of this genus have an amastigote and choanomastigote stage in their life cycle.%A%    
% 217.35/217.50  |- mesh__recordAuthorizer mesh__D003421 sjn
% 217.35/217.50  |- skos__annotation mesh__D003421
% 217.35/217.50       mastigophoran used as source organism in immunol %26% other exper; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D003421 2005
% 217.35/217.50  |- skos__prefLabel mesh__D003421 Crithidia
% 217.35/217.50  |- skos__related mesh__D035503smesh__D005824
% 217.35/217.50  |- mesh__dateEstablished mesh__D035503 2003-01-01
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D035503 2005
% 217.35/217.50  |- skos__broader mesh__D035503smesh__D001695
% 217.35/217.50  |- skos__scopeNote mesh__D035503
% 217.35/217.50       The comparative study of social organization in animals including humans, especially with regard to its genetic basis and evolutionary history. %28%Merriam-Webster%27%s Collegiate Dictionary, 10th ed%29%%A%    
% 217.35/217.50  |- skos__related mesh__D035503smesh__D005075
% 217.35/217.50  |- mesh__activeMeSHYear mesh__D035503 2006
% 217.35/217.51  |- mesh__historyNote mesh__D035503 2003   
% 217.35/217.51  |- mesh__dateRevised mesh__D035503 2003-07-09
% 217.35/217.51  |- mesh__recordAuthorizer mesh__D035503 sjn
% 217.35/217.51  |- rdf__type mesh__D035503sskos__Concept
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D035503 2004
% 217.35/217.51  |- skos__broader mesh__D035503smesh__D001525
% 217.35/217.51  |- skos__prefLabel mesh__D035503 Sociobiology
% 217.35/217.51  |- mesh__recordOriginator mesh__D035503 hjn
% 217.35/217.51  |- mesh__recordMaintainer mesh__D035503 jls
% 217.35/217.51  |- mesh__publicMeSHNote mesh__D035503 2003   
% 217.35/217.51  |- mesh__dateCreated mesh__D035503 2002-07-03
% 217.35/217.51  |- mesh__recordOriginator mesh__D002329 SH
% 217.35/217.51  |- skos__annotation mesh__D002329 D25-26 qualif   
% 217.35/217.51  |- mesh__dateEstablished mesh__D002329 1991-01-01
% 217.35/217.51  |- skos__historyNote mesh__D002329 Calcium %28%1972-1975%29%
% 217.35/217.51  |- mesh__dateCreated mesh__D002329 1975-07-23
% 217.35/217.51  |- rdf__type mesh__D002329sskos__Concept
% 217.35/217.51  |- skos__prefLabel mesh__D002329 Carmine
% 217.35/217.51  |- skos__scopeNote mesh__D002329
% 217.35/217.51       Coloring matter from the insect Coccus cacti L. It is used in foods, pharmaceuticals, toiletries, etc., as a dye, and also has use as a microscopic stain and biological marker.%A%    
% 217.35/217.51  |- mesh__publicMeSHNote mesh__D002329
% 217.35/217.51       91; was see under ANTHRAQUINONES 1976-90   
% 217.35/217.51  |- skos__altLabel mesh__D002329 Natural Red 4
% 217.35/217.51  |- skos__broader mesh__D002329smesh__D000880
% 217.35/217.51  |- mesh__recordMaintainer mesh__D002329 NLM
% 217.35/217.51  |- mesh__historyNote mesh__D002329
% 217.35/217.51       91%28%76%29%; was see under ANTHRAQUINONES 1976-90   
% 217.35/217.51  |- mesh__dateRevised mesh__D002329 2005-07-06
% 217.35/217.51  |- skos__historyNote mesh__D002329 Aluminum %28%1972-1975%29%
% 217.35/217.51  |- skos__historyNote mesh__D002329 Anthraquinones %28%1972-1975%29%
% 217.35/217.51  |- mesh__recordAuthorizer mesh__D002329 NLM
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D002329 2006
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D013051 2006
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D013051 2004
% 217.35/217.51  |- mesh__recordAuthorizer mesh__D013051 sjn
% 217.35/217.51  |- skos__broader mesh__D013051smesh__D013057
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D013051 2005
% 217.35/217.51  |- mesh__recordOriginator mesh__D013051 NLM
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D013051 2003
% 217.35/217.51  |- mesh__dateRevised mesh__D013051 2002-07-03
% 217.35/217.51  |- skos__hiddenLabel mesh__D013051 Gamma Spectrometry
% 217.35/217.51  |- mesh__historyNote mesh__D013051
% 217.35/217.51       74; was GAMMA SPECTROMETRY %28%Prov 1969-73%29%   
% 217.35/217.51  |- skos__prefLabel mesh__D013051 Spectrometry, Gamma
% 217.35/217.51  |- mesh__dateEstablished mesh__D013051 1974-01-01
% 217.35/217.51  |- rdf__type mesh__D013051sskos__Concept
% 217.35/217.51  |- skos__altLabel mesh__D013051 Gamma Spectrophotometry
% 217.35/217.51  |- mesh__dateCreated mesh__D013051 1999-01-01
% 217.35/217.51  |- skos__hiddenLabel mesh__D013051 Spectrophotometry, Gamma
% 217.35/217.51  |- skos__scopeNote mesh__D013051
% 217.35/217.51       Determination of the energy distribution of gamma rays emitted by nuclei. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 217.35/217.51  |- mesh__onlineNote mesh__D013051
% 217.35/217.51       use SPECTROMETRY, GAMMA to search GAMMA SPECTROMETRY 1969-73 %28%as Prov 1969-73%29%%A%  
% 217.35/217.51  |- skos__annotation mesh__D013051 a type of spectrum anal; NIM   
% 217.35/217.51  |- skos__historyNote mesh__D013051 Spectrum Analysis %28%1966-1968%29%
% 217.35/217.51  |- mesh__publicMeSHNote mesh__D013051 74   
% 217.35/217.51  |- mesh__recordMaintainer mesh__D013051 lkt
% 217.35/217.51  |- skos__historyNote mesh__D013051 Radiometry %28%1966-1968%29%
% 217.35/217.51  |- skos__broader mesh__D013051smesh__D011874
% 217.35/217.51  |- skos__prefLabel mesh__D007812 Laos
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007812 2002
% 217.35/217.51  |- mesh__dateCreated mesh__D007812 1999-01-01
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007812 1996
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007812 1998
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007812 1992
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007812 1990
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007812 1997
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007812 2000
% 217.35/217.51  |- mesh__dateRevised mesh__D007812 1991-11-26
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007812 1994
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007812 1999
% 217.35/217.51  |- mesh__recordAuthorizer mesh__D007812 PLS
% 217.35/217.51  |- rdf__type mesh__D007812sskos__Concept
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007812 1993
% 217.35/217.51  |- mesh__recordMaintainer mesh__D007812 PLS
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007812 2003
% 217.35/217.51  |- mesh__recordOriginator mesh__D007812 NLM
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007812 1995
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007812 2001
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007812 2005
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007812 2004
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007812 1991
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007812 2006
% 217.35/217.51  |- skos__broader mesh__D007812smesh__D001210
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007812 1989
% 217.35/217.51  |- mesh__publicMeSHNote mesh__D007014 72   
% 217.35/217.51  |- skos__prefLabel mesh__D007014 Hypophosphatasia
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007014 2006
% 217.35/217.51  |- skos__annotation mesh__D007014
% 217.35/217.51       defic of blood phosphatases; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 217.35/217.51  |- mesh__recordAuthorizer mesh__D007014 sjn
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007014 2005
% 217.35/217.51  |- mesh__dateEstablished mesh__D007014 1972-01-01
% 217.35/217.51  |- mesh__historyNote mesh__D007014 72%28%66%29%   
% 217.35/217.51  |- skos__hiddenLabel mesh__D007014 Hypophosphatasias
% 217.35/217.51  |- rdf__type mesh__D007014sskos__Concept
% 217.35/217.51  |- skos__scopeNote mesh__D007014
% 217.35/217.51       A genetic metabolic disorder resulting from serum and bone alkaline phosphatase deficiency leading to hypercalcemia, ethanolamine phosphatemia, and ethanolamine phosphaturia. Clinical manifestations include severe skeletal defects resembling vitamin D-resistant rickets, failure of the calvarium to calcify, dyspnea, cyanosis, vomiting, constipation, renal calcinosis, failure to thrive, disorders of movement, beading of the costochondral junction, and rachitic bone changes. %28%From Dorland, 27th ed%29%%A%    
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007014 2004
% 217.35/217.51  |- mesh__recordOriginator mesh__D007014 NLM
% 217.35/217.51  |- mesh__recordMaintainer mesh__D007014 nns
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007014 2003
% 217.35/217.51  |- skos__broader mesh__D007014smesh__D008664
% 217.35/217.51  |- mesh__dateRevised mesh__D007014 2001-07-25
% 217.35/217.51  |- mesh__dateCreated mesh__D007014 1999-01-01
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007014 2002
% 217.35/217.51  |- mesh__dateRevised mesh__D012757 2003-07-30
% 217.35/217.51  |- skos__hiddenLabel mesh__D012757 Disease, Ovine
% 217.35/217.51  |- skos__hiddenLabel mesh__D012757 Diseases, Sheep
% 217.35/217.51  |- mesh__recordMaintainer mesh__D012757 ags
% 217.35/217.51  |- skos__hiddenLabel mesh__D012757 Diseases, Ovine
% 217.35/217.51  |- mesh__recordOriginator mesh__D012757 NLM
% 217.35/217.51  |- skos__scopeNote mesh__D012757
% 217.35/217.51       Diseases of domestic and mountain sheep of the genus Ovis.%A%    
% 217.35/217.51  |- skos__annotation mesh__D012757
% 217.35/217.51       IM GEN or unspecified; coord IM with specific dis /vet %28%IM%29% or specific sheep dis %28%IM%29%; for abnormalities or injuries, index under SHEEP /abnorm or SHEEP /inj; don%27%t forget also SHEEP %28%NIM%29% %26% check tag ANIMALS; DF: SHEEP DIS%A%  
% 217.35/217.51  |- skos__broader mesh__D012757smesh__D000820
% 217.35/217.51  |- mesh__dateCreated mesh__D012757 1999-01-01
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D012757 2006
% 217.35/217.51  |- mesh__recordAuthorizer mesh__D012757 sjn
% 217.35/217.51  |- skos__hiddenLabel mesh__D012757 Disease, Sheep
% 217.35/217.51  |- skos__prefLabel mesh__D012757 Sheep Diseases
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D012757 2004
% 217.35/217.51  |- skos__hiddenLabel mesh__D012757 Ovine Disease
% 217.35/217.51  |- skos__altLabel mesh__D012757 Ovine Diseases
% 217.35/217.51  |- rdf__type mesh__D012757sskos__Concept
% 217.35/217.51  |- skos__hiddenLabel mesh__D012757 Sheep Disease
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D012757 2005
% 217.35/217.51  |- mesh__onlineNote mesh__D017442
% 217.35/217.51       use HISTAMINE AGONISTS to search HISTAMINE H1 RECEPTOR AGONISTS %26% HISTAMINE H2 RECEPTOR AGONISTS 1993-94%A%  
% 217.35/217.51  |- skos__altLabel mesh__D017442 H1 Agonists
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 Agonists, H1
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 Agonists, Histaminergic
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 Agonist, Histamine
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 Agonist, Histamine H1
% 217.35/217.51  |- mesh__recordMaintainer mesh__D017442 ssb
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 Agonist, Histamine H3
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 Agonist, H2
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 H1 Agonist, Histamine
% 217.35/217.51  |- mesh__recordAuthorizer mesh__D017442 sjn
% 217.35/217.51  |- skos__altLabel mesh__D017442 Histaminergic Agonists
% 217.35/217.51  |- skos__altLabel mesh__D017442 Histamine H1 Receptor Agonist
% 217.35/217.51  |- mesh__dateRevised mesh__D017442 2005-06-30
% 217.35/217.51  |- skos__altLabel mesh__D017442 H3 Agonists
% 217.35/217.51  |- skos__broader mesh__D017442smesh__D018494
% 217.35/217.51  |- skos__altLabel mesh__D017442 Histamine H1 Agonist
% 217.35/217.51  |- mesh__historyNote mesh__D017442
% 217.35/217.51       93; HISTAMINE H1 RECEPTOR AGONISTS %26% HISTAMINE H2 RECEPTOR AGONISTS were see HISTAMINE AGONISTS 1993-94%A%  
% 217.35/217.51  |- skos__altLabel mesh__D017442 Histamine H2 Agonist
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 Agonist, Histamine H2
% 217.35/217.51  |- skos__altLabel mesh__D017442 Histamine H3 Receptor Agonists
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 Agonist, H1
% 217.35/217.51  |- skos__altLabel mesh__D017442 H1 Agonist
% 217.35/217.51  |- skos__altLabel mesh__D017442 Histamine H2 Receptor Agonists
% 217.35/217.51  |- skos__altLabel mesh__D017442 Histamine H3 Agonist
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 Agonists, H3
% 217.35/217.51  |- skos__altLabel mesh__D017442 H2 Agonist
% 217.35/217.51  |- skos__annotation mesh__D017442
% 217.35/217.51       GEN or unspecified; prefer specifics; do not confuse with HISTAMINE ANTAGONISTS; DF: HISTAMINE AGON or HISTAMINE AG%A%  
% 217.35/217.51  |- skos__scopeNote mesh__D017442
% 217.35/217.51       Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically.%A%    
% 217.35/217.51  |- skos__altLabel mesh__D017442 Histamine H1 Receptor Agonists
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 Agonists, Histamine
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 Agonists, Histamine H3
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 Agonist, Histaminergic
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 Agonists, Histamine H2
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D017442 2006
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 H3 Agonists, Histamine
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 Agonists, H2
% 217.35/217.51  |- mesh__dateEstablished mesh__D017442 1993-01-01
% 217.35/217.51  |- skos__altLabel mesh__D017442 H3 Agonist
% 217.35/217.51  |- mesh__dateCreated mesh__D017442 1992-05-20
% 217.35/217.51  |- skos__altLabel mesh__D017442 Histamine Agonist
% 217.35/217.51  |- skos__altLabel mesh__D017442 H2 Agonists
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 H3 Agonist, Histamine
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 H2 Agonists, Histamine
% 217.35/217.51  |- skos__altLabel mesh__D017442 Histamine H2 Receptor Agonist
% 217.35/217.51  |- skos__prefLabel mesh__D017442 Histamine Agonists
% 217.35/217.51  |- skos__historyNote mesh__D017442
% 217.35/217.51       Receptors, Histamine/drug effects %28%1975-1992%29%
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 Agonist, H3
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 Agonists, Histamine H1
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 H1 Agonists, Histamine
% 217.35/217.51  |- skos__altLabel mesh__D017442 Histaminergic Agonist
% 217.35/217.51  |- mesh__recordOriginator mesh__D017442 TPW
% 217.35/217.51  |- skos__hiddenLabel mesh__D017442 H2 Agonist, Histamine
% 217.35/217.51  |- mesh__publicMeSHNote mesh__D017442
% 217.35/217.51       93; HISTAMINE H1 RECEPTOR AGONISTS %26% HISTAMINE H2 RECEPTOR AGONISTS were see HISTAMINE AGONISTS 1993-94%A%  
% 217.35/217.51  |- rdf__type mesh__D017442sskos__Concept
% 217.35/217.51  |- skos__hiddenLabel mesh__D050876 Oxidase, Sulfite
% 217.35/217.51  |- skos__scopeNote mesh__D050876
% 217.35/217.51       A MOLYBDENUM requiring enzyme that catalyzes the terminal reaction in the oxidative degradation of SULFUR AMINO ACIDS with the formation of a sulfate. A deficiency of sulfite oxidase results in sulfocysteinuria.%A%    
% 217.35/217.51  |- skos__broader mesh__D050876smesh__D050862
% 217.35/217.51  |- mesh__recordAuthorizer mesh__D050876 ags
% 217.35/217.51  |- mesh__dateEstablished mesh__D050876 2006-01-01
% 217.35/217.51  |- mesh__recordOriginator mesh__D050876 jmp
% 217.35/217.51  |- skos__altLabel mesh__D050876 Sulphite Oxidase
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D050876 2006
% 217.35/217.51  |- mesh__publicMeSHNote mesh__D050876
% 217.35/217.51       2006; for SULPHITE OXIDASE see SULFITE OXIDASES 1982-2005%A%  
% 217.35/217.51  |- mesh__historyNote mesh__D050876 2006%28%1982%29%   
% 217.35/217.51  |- mesh__dateRevised mesh__D050876 2005-08-01
% 217.35/217.51  |- mesh__recordMaintainer mesh__D050876 ags
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D050876 2006A
% 217.35/217.51  |- skos__historyNote mesh__D050876 Sulfite Oxidases %28%1983-2005%29%
% 217.35/217.51  |- mesh__dateCreated mesh__D050876 2005-06-30
% 217.35/217.51  |- skos__prefLabel mesh__D050876 Sulfite Oxidase
% 217.35/217.51  |- rdf__type mesh__D050876sskos__Concept
% 217.35/217.51  |- skos__historyNote mesh__D050876
% 217.35/217.51       Oxidoreductases Acting on Sulfur Group Donors %28%1977-1982%29%
% 217.35/217.51  |- skos__hiddenLabel mesh__D050876 Oxidase, Sulphite
% 217.35/217.51  |- mesh__historyNote mesh__D003422 75   
% 217.35/217.51  |- skos__historyNote mesh__D003422 Nursing Care %28%1966-1974%29%
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D003422 2000
% 217.35/217.51  |- skos__related mesh__D003422smesh__D017055
% 217.35/217.51  |- skos__prefLabel mesh__D003422 Critical Care
% 217.35/217.51  |- mesh__dateRevised mesh__D003422 1997-06-20
% 217.35/217.51  |- skos__historyNote mesh__D003422 Intensive Care Units %28%1966-1974%29%
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D003422 2003
% 217.35/217.51  |- mesh__dateEstablished mesh__D003422 1975-09-01
% 217.35/217.51  |- mesh__dateCreated mesh__D003422 1974-11-11
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D003422 2006
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D003422 2002
% 217.35/217.51  |- skos__broader mesh__D003422smesh__D005791
% 217.35/217.51  |- skos__scopeNote mesh__D003422
% 217.35/217.51       Health care provided to a critically ill patient during a medical emergency or crisis.%A%    
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D003422 2005
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D003422 1999
% 217.35/217.51  |- skos__hiddenLabel mesh__D003422 Care, Critical
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D003422 1998
% 217.35/217.51  |- mesh__recordAuthorizer mesh__D003422 SJN
% 217.35/217.51  |- mesh__recordMaintainer mesh__D003422 PXP
% 217.35/217.51  |- rdf__type mesh__D003422sskos__Concept
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D003422 2001
% 217.35/217.51  |- mesh__recordOriginator mesh__D003422 NLM
% 217.35/217.51  |- mesh__publicMeSHNote mesh__D003422 75   
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D003422 2004
% 217.35/217.51  |- skos__scopeNote mesh__D041541
% 217.35/217.51       A genus of facultatively anaerobic coccoid ARCHAEA, in the family SULFOLOBACEAE. Cells are highly irregular in shape and thermoacidophilic. Lithotrophic growth occurs aerobically via sulfur oxidation in some species. Distribution includes solfataric springs and fields, mudholes, and geothermically heated acidic marine environments.%A%    
% 217.35/217.51  |- mesh__dateCreated mesh__D041541 2003-07-09
% 217.35/217.51  |- rdf__type mesh__D041541sskos__Concept
% 217.35/217.51  |- skos__historyNote mesh__D041541 Archaea %28%1999-2000%29%
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D041541 2006
% 217.35/217.51  |- mesh__recordAuthorizer mesh__D041541 sjn
% 217.35/217.51  |- mesh__publicMeSHNote mesh__D041541 2004   
% 217.35/217.51  |- skos__historyNote mesh__D041541 Sulfolobaceae %28%1996-2003%29%
% 217.35/217.51  |- mesh__historyNote mesh__D041541 2004   
% 217.35/217.51  |- mesh__dateEstablished mesh__D041541 2004-01-01
% 217.35/217.51  |- mesh__recordMaintainer mesh__D041541 SYSTEM
% 217.35/217.51  |- skos__broader mesh__D041541smesh__D016943
% 217.35/217.51  |- mesh__dateRevised mesh__D041541 2005-06-30
% 217.35/217.51  |- skos__prefLabel mesh__D041541 Acidianus
% 217.35/217.51  |- mesh__recordOriginator mesh__D041541 ags
% 217.35/217.51  |- skos__scopeNote mesh__D013850
% 217.35/217.51       Mental activity, not predominantly perceptual, by which one apprehends some aspect of an object or situation based on past learning and experience.%A%    
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D013850 1999
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D013850 2006
% 217.35/217.51  |- mesh__recordOriginator mesh__D013850 NLM
% 217.35/217.51  |- mesh__recordMaintainer mesh__D013850 KEV
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D013850 1998
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D013850 2005
% 217.35/217.51  |- skos__annotation mesh__D013850
% 217.35/217.51       the thought process: do not confuse with MEDITATION, a relaxation technique; differentiate from COGNITION: see treeing %26% MeSH definition%A%  
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D013850 2002
% 217.35/217.51  |- rdf__type mesh__D013850sskos__Concept
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D013850 1997
% 217.35/217.51  |- mesh__dateCreated mesh__D013850 1999-01-01
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D013850 2004
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D013850 2001
% 217.35/217.51  |- mesh__dateRevised mesh__D013850 1995-05-23
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D013850 1996
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D013850 2003
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D013850 2000
% 217.35/217.51  |- skos__broader mesh__D013850smesh__D008606
% 217.35/217.51  |- mesh__recordAuthorizer mesh__D013850 PLS
% 217.35/217.51  |- skos__prefLabel mesh__D013850 Thinking
% 217.35/217.51  |- skos__altLabel mesh__D013052 Xray Emission Spectroscopy
% 217.35/217.51  |- skos__hiddenLabel mesh__D013052 Spectroscopy, X-Ray Emission
% 217.35/217.51  |- skos__hiddenLabel mesh__D013052 Spectrometry, X Ray Fluorescence
% 217.35/217.51  |- skos__altLabel mesh__D013052 Proton-Induced X-Ray Emission Spectrometry
% 217.35/217.51  |- skos__historyNote mesh__D013052 X-Rays %28%1975-1977%29%
% 217.35/217.51  |- skos__altLabel mesh__D013052 X-Ray Emission Spectrometry
% 217.35/217.51  |- skos__altLabel mesh__D013052
% 217.35/217.51       Spectrometry, Particle-Induced X-Ray Emission
% 217.35/217.51  |- rdf__type mesh__D013052sskos__Concept
% 217.35/217.51  |- skos__broader mesh__D013052smesh__D011874
% 217.35/217.51  |- skos__altLabel mesh__D013052 X-Ray Fluorescence Spectrometry
% 217.35/217.51  |- skos__hiddenLabel mesh__D013052 Emission Spectrometry, X-Ray
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D013052 2006A
% 217.35/217.51  |- skos__altLabel mesh__D013052
% 217.35/217.51       Particle-Induced X-Ray Emission Spectrometry
% 217.35/217.51  |- skos__historyNote mesh__D013052 Fluorescence %28%1966-1977%29%
% 217.35/217.51  |- mesh__recordMaintainer mesh__D013052 ags
% 217.35/217.51  |- mesh__recordOriginator mesh__D013052 SMH
% 217.35/217.51  |- skos__hiddenLabel mesh__D013052 Emission Spectroscopy, Xray
% 217.35/217.51  |- skos__scopeNote mesh__D013052
% 217.35/217.51       The analysis of the spectrum of fluorescent X-RAYS, i.e. X-rays emitted after bombarding matter with high energy particles such as PROTONS; ELECTRONS; or higher energy X-rays. The identification and quantitation of ELEMENTS by this technique is based on the fact that the wavelength and intensity of the fluorescent X-rays are characteristic of specific elements and the concentration of the elements in the matter being analyzed.%A%    
% 217.35/217.51  |- skos__hiddenLabel mesh__D013052 X Ray Emission Spectrometry
% 217.35/217.51  |- skos__altLabel mesh__D013052 Spectrometry, X-Ray Fluorescence
% 217.35/217.51  |- skos__annotation mesh__D013052
% 217.35/217.51       NIM; do not confuse with any of numerous X refs under ELECTRON PROBE MICROANALYSIS; do not confuse X ref SPECTROMETRY, X-RAY FLUORESCENCE  with SPECTROMETRY, FLUORESCENCE%A%  
% 217.35/217.51  |- mesh__dateEstablished mesh__D013052 1978-01-01
% 217.35/217.51  |- skos__altLabel mesh__D013052 Spectrometry, Proton Induced X Ray Emission
% 217.35/217.51  |- skos__historyNote mesh__D013052 Spectrum Analysis %28%1966-1977%29%
% 217.35/217.51  |- skos__historyNote mesh__D013052
% 217.35/217.51       Spectrometry, Fluorescence %28%1972-1977%29%
% 217.35/217.51  |- mesh__recordAuthorizer mesh__D013052 ags
% 217.35/217.51  |- skos__altLabel mesh__D013052 Spectrometry, Xray Emission
% 217.35/217.51  |- mesh__historyNote mesh__D013052 1978   
% 217.35/217.51  |- skos__altLabel mesh__D013052 Spectrometry, Proton-Induced X-Ray Emission
% 217.35/217.51  |- skos__hiddenLabel mesh__D013052 X Ray Fluorescence Spectrometry
% 217.35/217.51  |- skos__hiddenLabel mesh__D013052 Fluorescence Spectrometry, X-Ray
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D013052 2005
% 217.35/217.51  |- mesh__dateCreated mesh__D013052 1977-03-29
% 217.35/217.51  |- skos__hiddenLabel mesh__D013052 X Ray Emission Spectroscopy
% 217.35/217.51  |- skos__altLabel mesh__D013052
% 217.35/217.51       Spectrometry, Particle Induced X Ray Emission
% 217.35/217.51  |- mesh__dateRevised mesh__D013052 2005-07-27
% 217.35/217.51  |- skos__hiddenLabel mesh__D013052 Xray Emission Spectrometry
% 217.35/217.51  |- skos__broader mesh__D013052smesh__D013057
% 217.35/217.51  |- skos__hiddenLabel mesh__D013052 Spectrometry, X Ray Emission
% 217.35/217.51  |- skos__hiddenLabel mesh__D013052 Emission Spectroscopy, X-Ray
% 217.35/217.51  |- skos__prefLabel mesh__D013052 Spectrometry, X-Ray Emission
% 217.35/217.51  |- skos__hiddenLabel mesh__D013052 Emission Spectrometry, Xray
% 217.35/217.51  |- skos__altLabel mesh__D013052
% 217.35/217.51       Particle Induced X Ray Emission Spectrometry
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D013052 2006
% 217.35/217.51  |- skos__hiddenLabel mesh__D013052 Spectroscopy, Xray Emission
% 217.35/217.51  |- mesh__publicMeSHNote mesh__D013052 1978   
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007813 1996
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007813 1998
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007813 1992
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007813 1997
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007813 2002
% 217.35/217.51  |- mesh__dateRevised mesh__D007813 1991-11-26
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007813 1994
% 217.35/217.51  |- skos__annotation mesh__D007813
% 217.35/217.51       avoid: used too loosely in the literature; not a coord for operative surg on abdominal organs; restrict to technique of surg incision of abdom wall at any point; usually exploratory; prefer /surg with specific organs; do not use /util except by MeSH definition%A%  
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007813 1999
% 217.35/217.51  |- rdf__type mesh__D007813sskos__Concept
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007813 1993
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007813 2003
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007813 1995
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007813 2005
% 217.35/217.51  |- skos__hiddenLabel mesh__D007813 Minilaparotomies
% 217.35/217.51  |- skos__hiddenLabel mesh__D007813 Laparotomies
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007813 2004
% 217.35/217.51  |- skos__broader mesh__D007813smesh__D013514
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007813 2006
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007813 2000
% 217.35/217.51  |- mesh__recordAuthorizer mesh__D007813 PLS
% 217.35/217.51  |- mesh__recordMaintainer mesh__D007813 PLS
% 217.35/217.51  |- skos__prefLabel mesh__D007813 Laparotomy
% 217.35/217.51  |- mesh__recordOriginator mesh__D007813 NLM
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007813 2001
% 217.35/217.51  |- mesh__dateCreated mesh__D007813 1999-01-01
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007813 1991
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007015 2005
% 217.35/217.51  |- skos__hiddenLabel mesh__D007015 Hypophosphatemic Rickets, X-Linked
% 217.35/217.51  |- skos__hiddenLabel mesh__D007015 Rickets, X Linked Hypophosphatemic
% 217.35/217.51  |- skos__altLabel mesh__D007015 Rickets, Vitamin D-Resistant
% 217.35/217.51  |- skos__altLabel mesh__D007015 Rickets, Hypophosphatemic
% 217.35/217.51  |- rdf__type mesh__D007015sskos__Concept
% 217.35/217.51  |- mesh__onlineNote mesh__D007015
% 217.35/217.51       use HYPOPHOSPHATEMIA, FAMILIAL to search RICKETS, VITAMIN D-RESISTANT 1972-93%A%  
% 217.35/217.51  |- skos__hiddenLabel mesh__D007015 X-Linked Hypophosphatemic Rickets
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007015 2004
% 217.35/217.51  |- skos__prefLabel mesh__D007015 Hypophosphatemia, Familial
% 217.35/217.51  |- skos__annotation mesh__D007015
% 217.35/217.51       a clin entity: not for decreased blood phosphate levels %28% = PHOSPHATES /blood%29%; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 217.35/217.51  |- mesh__recordAuthorizer mesh__D007015 sjn
% 217.35/217.51  |- skos__broader mesh__D007015smesh__D008664
% 217.35/217.51  |- mesh__dateRevised mesh__D007015 2002-07-03
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007015 2003
% 217.35/217.51  |- skos__hiddenLabel mesh__D007015 Familial Hypophosphatemias
% 217.35/217.51  |- skos__hiddenLabel mesh__D007015 Hypophosphatemic Rickets
% 217.35/217.51  |- mesh__publicMeSHNote mesh__D007015
% 217.35/217.51       65; RICKETS, VITAMIN D-RESISTANT was heading 1972-93   
% 217.35/217.51  |- skos__broader mesh__D007015smesh__D015499
% 217.35/217.51  |- skos__hiddenLabel mesh__D007015 Vitamin D-Resistant Rickets
% 217.35/217.51  |- skos__hiddenLabel mesh__D007015 Familial Hypophosphatemia
% 217.35/217.51  |- mesh__dateEstablished mesh__D007015 1965-01-01
% 217.35/217.51  |- skos__hiddenLabel mesh__D007015 Hypophosphatemias, Familial
% 217.35/217.51  |- skos__scopeNote mesh__D007015
% 217.35/217.51       Familial disorder characterized by hypophosphatemia associated with decreased renal tubular reabsorption of inorganic phosphorus. It is sometimes associated with osteomalacia or rickets which do not respond to the usual doses of vitamin D.%A%    
% 217.35/217.51  |- skos__hiddenLabel mesh__D007015 Rickets, Vitamin D Resistant
% 217.35/217.51  |- mesh__dateCreated mesh__D007015 1999-01-01
% 217.35/217.51  |- mesh__recordOriginator mesh__D007015 NLM
% 217.35/217.51  |- mesh__historyNote mesh__D007015
% 217.35/217.51       65; RICKETS, VITAMIN D-RESISTANT was heading 1972-93   
% 217.35/217.51  |- skos__altLabel mesh__D007015 Phosphate Diabetes
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D007015 2006
% 217.35/217.51  |- mesh__recordMaintainer mesh__D007015 mdb
% 217.35/217.51  |- skos__related mesh__D012758smesh__D049851
% 217.35/217.51  |- mesh__recordMaintainer mesh__D012758 ags
% 217.35/217.51  |- skos__scopeNote mesh__D012758
% 217.35/217.51       Aquatic invertebrates belonging to the phylum MOLLUSCA or the subphylum CRUSTACEA, and used as food.%A%    
% 217.35/217.51  |- skos__related mesh__D012758smesh__D003386
% 217.35/217.51  |- skos__prefLabel mesh__D012758 Shellfish
% 217.35/217.51  |- skos__related mesh__D012758smesh__D049830
% 217.35/217.51  |- skos__broader mesh__D012758smesh__D017747
% 217.35/217.51  |- mesh__dateCreated mesh__D012758 1999-01-01
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D012758 2006
% 217.35/217.51  |- skos__related mesh__D012758smesh__D008121
% 217.35/217.51  |- mesh__recordOriginator mesh__D012758 NLM
% 217.35/217.51  |- rdf__type mesh__D012758sskos__Concept
% 217.35/217.51  |- skos__related mesh__D012758smesh__D003400
% 217.35/217.51  |- mesh__dateRevised mesh__D012758 2005-06-30
% 217.35/217.51  |- skos__annotation mesh__D012758
% 217.35/217.51       as food, coordinate IM with specific shellfish %28%IM%29%; shellfish as animal = CRUSTACEA or MOLLUSCA or specifics;  shellfish poisoning usually due to toxins from marine flora or fauna = MARINE TOXINS%A%  
% 217.35/217.51  |- skos__related mesh__D012758smesh__D049872
% 217.35/217.51  |- mesh__recordAuthorizer mesh__D012758 sjn
% 217.35/217.51  |- skos__altLabel mesh__D017443 Eczematous Disorders
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D017443 1993
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D017443 1994
% 217.35/217.51  |- skos__broader mesh__D017443smesh__D012871
% 217.35/217.51  |- skos__hiddenLabel mesh__D017443 Skin Disease, Eczematous
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D017443 1999
% 217.35/217.51  |- skos__hiddenLabel mesh__D017443 Eczematous Skin Disease
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D017443 2002
% 217.35/217.51  |- mesh__dateCreated mesh__D017443 1992-05-22
% 217.35/217.51  |- mesh__dateEstablished mesh__D017443 1993-01-01
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D017443 1998
% 217.35/217.51  |- skos__hiddenLabel mesh__D017443 Diseases, Eczematous Skin
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D017443 1997
% 217.35/217.51  |- skos__prefLabel mesh__D017443 Skin Diseases, Eczematous
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D017443 2006
% 217.35/217.51  |- skos__historyNote mesh__D017443 Eczema %28%1966-1992%29%
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D017443 1996
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D017443 2005
% 217.35/217.51  |- mesh__historyNote mesh__D017443 93   
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D017443 2004
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D017443 2001
% 217.35/217.51  |- skos__altLabel mesh__D017443 Eczematous Skin Diseases
% 217.35/217.51  |- skos__hiddenLabel mesh__D017443 Eczematous Disorder
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D017443 2003
% 217.35/217.51  |- mesh__publicMeSHNote mesh__D017443 93   
% 217.35/217.51  |- skos__historyNote mesh__D017443 Skin Diseases %28%1966-1992%29%
% 217.35/217.51  |- rdf__type mesh__D017443sskos__Concept
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D017443 1995
% 217.35/217.51  |- skos__scopeNote mesh__D017443
% 217.35/217.51       Any of a variety of eruptive skin disorders characterized by erythema, oozing, vesiculation, and scaling. Etiology is varied.%A%    
% 217.35/217.51  |- skos__hiddenLabel mesh__D017443 Disorders, Eczematous
% 217.35/217.51  |- skos__hiddenLabel mesh__D017443 Disorder, Eczematous
% 217.35/217.51  |- mesh__activeMeSHYear mesh__D017443 2000
% 217.35/217.52  |- skos__annotation mesh__D017443
% 217.35/217.52       GEN or unspecified; prefer ECZEMA or specific eczematous skin dis%A%  
% 217.35/217.52  |- skos__hiddenLabel mesh__D017443 Disease, Eczematous Skin
% 217.35/217.52  |- skos__hiddenLabel mesh__D003423 Period, Critical %28%Psychology%29%
% 217.35/217.52  |- skos__hiddenLabel mesh__D003423 Period, Critical
% 217.35/217.52  |- mesh__dateCreated mesh__D003423 1999-01-01
% 217.35/217.52  |- skos__hiddenLabel mesh__D003423 Periods, Critical %28%Psychology%29%
% 217.35/217.52  |- mesh__recordOriginator mesh__D003423 NLM
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D003423 2006
% 217.35/217.52  |- skos__hiddenLabel mesh__D003423 Periods, Critical
% 217.35/217.52  |- mesh__recordMaintainer mesh__D003423 sjn
% 217.35/217.52  |- skos__scopeNote mesh__D003423
% 217.35/217.52       A specific stage in animal and human development during which certain types of behavior normally are shaped and molded for life.%A%    
% 217.35/217.52  |- mesh__dateRevised mesh__D003423 2004-07-13
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D003423 2005
% 217.35/217.52  |- skos__prefLabel mesh__D003423 Critical Period %28%Psychology%29%
% 217.35/217.52  |- mesh__recordAuthorizer mesh__D003423 sjn
% 217.35/217.52  |- mesh__historyNote mesh__D003423 68   
% 217.35/217.52  |- mesh__publicMeSHNote mesh__D003423 68   
% 217.35/217.52  |- skos__annotation mesh__D003423
% 217.35/217.52       human %26% animal; no qualif; DF: CRITICAL PERIOD   
% 217.35/217.52  |- mesh__dateEstablished mesh__D003423 1968-01-01
% 217.35/217.52  |- skos__hiddenLabel mesh__D003423 Critical Periods %28%Psychology%29%
% 217.35/217.52  |- rdf__type mesh__D003423sskos__Concept
% 217.35/217.52  |- skos__altLabel mesh__D003423 Critical Period
% 217.35/217.52  |- skos__hiddenLabel mesh__D003423 Critical Periods
% 217.35/217.52  |- skos__broader mesh__D003423smesh__D007858
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D041542 2006
% 217.35/217.52  |- skos__historyNote mesh__D041542 Thermoproteaceae %28%1998-2003%29%
% 217.35/217.52  |- mesh__dateRevised mesh__D041542 2005-06-30
% 217.35/217.52  |- mesh__recordOriginator mesh__D041542 ags
% 217.35/217.52  |- skos__broader mesh__D041542smesh__D019624
% 217.35/217.52  |- mesh__historyNote mesh__D041542 2004; use THERMOPROTEACEAE 1998-2003   
% 217.35/217.52  |- mesh__recordMaintainer mesh__D041542 SYSTEM
% 217.35/217.52  |- skos__prefLabel mesh__D041542 Thermoproteus
% 217.35/217.52  |- skos__scopeNote mesh__D041542
% 217.35/217.52       A genus of obligately anaerobic ARCHAEA, in the family THERMOPROTEACEAE. They are found in acidic hot springs and water holes.%A%    
% 217.35/217.52  |- skos__historyNote mesh__D041542 Archaea %28%1985-1997%29%
% 217.35/217.52  |- mesh__dateEstablished mesh__D041542 2004-01-01
% 217.35/217.52  |- mesh__recordAuthorizer mesh__D041542 sjn
% 217.35/217.52  |- mesh__dateCreated mesh__D041542 2003-07-09
% 217.35/217.52  |- rdf__type mesh__D041542sskos__Concept
% 217.35/217.52  |- mesh__publicMeSHNote mesh__D041542
% 217.35/217.52       2004; see THERMOPROTEACEAE 1998-2003   
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D013851 2005
% 217.35/217.52  |- skos__altLabel mesh__D013851 Leanness
% 217.35/217.52  |- rdf__type mesh__D013851sskos__Concept
% 217.35/217.52  |- skos__prefLabel mesh__D013851 Thinness
% 217.35/217.52  |- mesh__dateCreated mesh__D013851 1999-01-01
% 217.35/217.52  |- skos__broader mesh__D013851smesh__D001835
% 217.35/217.52  |- skos__scopeNote mesh__D013851
% 217.35/217.52       A state of insufficient flesh on the body usually defined as having a body weight less than skeletal and physical standards. Depending on age, sex, and genetic background, a BODY MASS INDEX of less than 18.5 is considered as underweight.%A%    
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D013851 2006A
% 217.35/217.52  |- mesh__recordAuthorizer mesh__D013851 ags
% 217.35/217.52  |- mesh__dateRevised mesh__D013851 2005-07-11
% 217.35/217.52  |- mesh__recordOriginator mesh__D013851 NLM
% 217.35/217.52  |- skos__related mesh__D013851smesh__D004614
% 217.35/217.52  |- mesh__recordMaintainer mesh__D013851 ags
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D013851 2006
% 217.35/217.52  |- mesh__dateCreated mesh__D013053 1999-01-01
% 217.35/217.52  |- skos__annotation mesh__D013053 a type of spectrum anal; NIM   
% 217.35/217.52  |- skos__prefLabel mesh__D013053 Spectrophotometry
% 217.35/217.52  |- rdf__type mesh__D013053sskos__Concept
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D013053 2005
% 217.35/217.52  |- mesh__recordMaintainer mesh__D013053 lkt
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D013053 2003
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D013053 2006
% 217.35/217.52  |- skos__broader mesh__D013053smesh__D010783
% 217.35/217.52  |- skos__scopeNote mesh__D013053
% 217.35/217.52       The art or process of comparing photometrically the relative intensities of the light in different parts of the spectrum.%A%    
% 217.35/217.52  |- mesh__recordAuthorizer mesh__D013053 sjn
% 217.35/217.52  |- mesh__recordOriginator mesh__D013053 NLM
% 217.35/217.52  |- mesh__dateRevised mesh__D013053 2002-07-03
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D013053 2004
% 217.35/217.52  |- skos__broader mesh__D013053smesh__D013057
% 217.35/217.52  |- mesh__historyNote mesh__D007814 74%28%70%29%   
% 217.35/217.52  |- mesh__recordMaintainer mesh__D007814 lkt
% 217.35/217.52  |- mesh__dateRevised mesh__D007814 2004-07-07
% 217.35/217.52  |- rdf__type mesh__D007814sskos__Concept
% 217.35/217.52  |- mesh__recordAuthorizer mesh__D007814 sjn
% 217.35/217.52  |- skos__altLabel mesh__D007814 Maggot
% 217.35/217.52  |- mesh__publicMeSHNote mesh__D007814 74   
% 217.35/217.52  |- skos__broader mesh__D007814smesh__D008018
% 217.35/217.52  |- mesh__dateEstablished mesh__D007814 1974-01-01
% 217.35/217.52  |- skos__prefLabel mesh__D007814 Larva
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007814 2005
% 217.35/217.52  |- mesh__recordOriginator mesh__D007814 NLM
% 217.35/217.52  |- skos__historyNote mesh__D007814 Insects %28%1966-1969%29%
% 217.35/217.52  |- mesh__dateCreated mesh__D007814 1999-01-01
% 217.35/217.52  |- skos__scopeNote mesh__D007814
% 217.35/217.52       Wormlike or grublike stage, following the egg in the life cycle of insects, worms, and other metamorphosing animals.%A%    
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007814 2006
% 217.35/217.52  |- skos__altLabel mesh__D007814 Tadpoles
% 217.35/217.52  |- skos__historyNote mesh__D007814
% 217.35/217.52       Metamorphosis, Biological %28%1966-1969%29%
% 217.35/217.52  |- skos__annotation mesh__D007814
% 217.35/217.52       NIM; only for metamorphosing animals %28%so correct for tadpoles%29%; do not use /embryol with reference to larvae; maggot is the larval form of a fly%A%  
% 217.35/217.52  |- skos__altLabel mesh__D007814 Larvae
% 217.35/217.52  |- mesh__recordMaintainer mesh__D007016 PXP
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007016 2003
% 217.35/217.52  |- mesh__recordOriginator mesh__D007016 NLM
% 217.35/217.52  |- mesh__recordAuthorizer mesh__D007016 SJN
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007016 1999
% 217.35/217.52  |- mesh__dateCreated mesh__D007016 1999-01-01
% 217.35/217.52  |- mesh__dateRevised mesh__D007016 1997-06-20
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007016 1998
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007016 2006
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007016 2002
% 217.35/217.52  |- skos__broader mesh__D007016smesh__D019635
% 217.35/217.52  |- skos__broader mesh__D007016smesh__D013507
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007016 2005
% 217.35/217.52  |- skos__related mesh__D007016smesh__D010910
% 217.35/217.52  |- skos__hiddenLabel mesh__D007016 Hypophysectomies
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007016 2001
% 217.35/217.52  |- skos__scopeNote mesh__D007016
% 217.35/217.52       Surgical removal or destruction of the hypophysis, or pituitary gland. %28%Dorland, 28th ed%29%%A%    
% 217.35/217.52  |- skos__prefLabel mesh__D007016 Hypophysectomy
% 217.35/217.52  |- rdf__type mesh__D007016sskos__Concept
% 217.35/217.52  |- skos__annotation mesh__D007016
% 217.35/217.52       do not use /util except by MeSH definition   
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007016 2004
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007016 2000
% 217.35/217.52  |- skos__hiddenLabel mesh__D012759 Sheltered Workshop
% 217.35/217.52  |- skos__scopeNote mesh__D012759
% 217.35/217.52       Protective places of employment for disabled persons which provide training and employment on a temporary or permanent basis.%A%    
% 217.35/217.52  |- mesh__dateCreated mesh__D012759 1999-01-01
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D012759 2006
% 217.35/217.52  |- skos__broader mesh__D012759smesh__D012047
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D012759 2001
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D012759 2004
% 217.35/217.52  |- skos__prefLabel mesh__D012759 Sheltered Workshops
% 217.35/217.52  |- mesh__recordAuthorizer mesh__D012759 PLS
% 217.35/217.52  |- rdf__type mesh__D012759sskos__Concept
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D012759 2000
% 217.35/217.52  |- skos__related mesh__D012759smesh__D016832
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D012759 2005
% 217.35/217.52  |- skos__hiddenLabel mesh__D012759 Workshop, Sheltered
% 217.35/217.52  |- mesh__recordMaintainer mesh__D012759 PLS
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D012759 2003
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D012759 1995
% 217.35/217.52  |- skos__annotation mesh__D012759
% 217.35/217.52       do not confuse with EMPLOYMENT, SUPPORTED which takes place in normal or regular work setting: a sheltered workshop is work in a controlled working environment%A%  
% 217.35/217.52  |- mesh__dateRevised mesh__D012759 1992-05-22
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D012759 1993
% 217.35/217.52  |- skos__hiddenLabel mesh__D012759 Workshops, Sheltered
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D012759 1999
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D012759 1994
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D012759 1997
% 217.35/217.52  |- mesh__historyNote mesh__D012759 67%28%65%29%   
% 217.35/217.52  |- mesh__dateEstablished mesh__D012759 1967-01-01
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D012759 2002
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D012759 1998
% 217.35/217.52  |- mesh__publicMeSHNote mesh__D012759 67   
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D012759 1996
% 217.35/217.52  |- mesh__recordOriginator mesh__D012759 NLM
% 217.35/217.52  |- mesh__dateCreated mesh__D023481 2000-06-22
% 217.35/217.52  |- rdf__type mesh__D023481sskos__Concept
% 217.35/217.52  |- skos__prefLabel mesh__D023481 Terrorism
% 217.35/217.52  |- skos__historyNote mesh__D023481 Violence %28%1976-2000%29%
% 217.35/217.52  |- mesh__publicMeSHNote mesh__D023481 2001; see VIOLENCE 1981-2000   
% 217.35/217.52  |- skos__broader mesh__D023481smesh__D014754
% 217.35/217.52  |- mesh__recordMaintainer mesh__D023481 ags
% 217.35/217.52  |- mesh__dateRevised mesh__D023481 2005-06-30
% 217.35/217.52  |- mesh__dateEstablished mesh__D023481 2001-01-01
% 217.35/217.52  |- mesh__recordOriginator mesh__D023481 ags
% 217.35/217.52  |- skos__scopeNote mesh__D023481
% 217.35/217.52       The use or threatened use of force or violence against persons or property in violation of criminal laws for purposes of intimidation, coercion, or ransom, in support of political or social objectives.%A%    
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D023481 2006
% 217.35/217.52  |- mesh__historyNote mesh__D023481 2001; use VIOLENCE 1981-2000   
% 217.35/217.52  |- mesh__recordAuthorizer mesh__D023481 sjn
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017444 1999
% 217.35/217.52  |- mesh__publicMeSHNote mesh__D017444 93   
% 217.35/217.52  |- skos__historyNote mesh__D017444 Skin Diseases %28%1966-1992%29%
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017444 2000
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017444 1998
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017444 1997
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017444 2006
% 217.35/217.52  |- skos__scopeNote mesh__D017444
% 217.35/217.52       A group of dermatoses with distinct morphologic features. The primary lesion is most commonly a papule, usually erythematous, with a variable degree of scaling on the surface. Plaques form through the coalescing of primary lesions.%A%    
% 217.35/217.52  |- skos__hiddenLabel mesh__D017444 Diseases, Papulosquamous Skin
% 217.35/217.52  |- skos__prefLabel mesh__D017444 Skin Diseases, Papulosquamous
% 217.35/217.52  |- skos__hiddenLabel mesh__D017444 Skin Disease, Papulosquamous
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017444 1996
% 217.35/217.52  |- skos__hiddenLabel mesh__D017444 Papulosquamous Skin Disease
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017444 2005
% 217.35/217.52  |- mesh__historyNote mesh__D017444 93   
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017444 2004
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017444 2002
% 217.35/217.52  |- mesh__dateCreated mesh__D017444 1992-05-22
% 217.35/217.52  |- skos__altLabel mesh__D017444 Papulosquamous Disorders
% 217.35/217.52  |- mesh__dateEstablished mesh__D017444 1993-01-01
% 217.35/217.52  |- skos__hiddenLabel mesh__D017444 Papulosquamous Disorder
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017444 2003
% 217.35/217.52  |- rdf__type mesh__D017444sskos__Concept
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017444 1995
% 217.35/217.52  |- skos__hiddenLabel mesh__D017444 Disease, Papulosquamous Skin
% 217.35/217.52  |- skos__annotation mesh__D017444 GEN or unspecified; prefer specifics   
% 217.35/217.52  |- skos__broader mesh__D017444smesh__D012871
% 217.35/217.52  |- skos__hiddenLabel mesh__D017444 Disorders, Papulosquamous
% 217.35/217.52  |- skos__hiddenLabel mesh__D017444 Disorder, Papulosquamous
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017444 1993
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017444 1994
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017444 2001
% 217.35/217.52  |- skos__altLabel mesh__D017444 Papulosquamous Skin Diseases
% 217.35/217.52  |- skos__hiddenLabel mesh__D003424 Crohns Disease
% 217.35/217.52  |- skos__broader mesh__D003424smesh__D015212
% 217.35/217.52  |- rdf__type mesh__D003424sskos__Concept
% 217.35/217.52  |- mesh__historyNote mesh__D003424
% 217.35/217.52       80; was ENTERITIS, REGIONAL 1965-79, was ILEITIS, REGIONAL 1963-64%A%  
% 217.35/217.52  |- skos__annotation mesh__D003424
% 217.35/217.52       coord IM with ILEITIS %28%IM%29% or COLITIS %28%IM%29% only if site is particularly discussed; usually chronic so do not coord with CHRONIC DISEASE%A%  
% 217.35/217.52  |- mesh__recordMaintainer mesh__D003424 lkt
% 217.35/217.52  |- skos__altLabel mesh__D003424 Ileitis, Regional
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D003424 2004
% 217.35/217.52  |- mesh__recordOriginator mesh__D003424 NLM
% 217.35/217.52  |- skos__prefLabel mesh__D003424 Crohn Disease
% 217.35/217.52  |- mesh__publicMeSHNote mesh__D003424
% 217.35/217.52       80; was ENTERITIS, REGIONAL 1965-79, was ILEITIS, REGIONAL 1963-64%A%  
% 217.35/217.52  |- mesh__dateCreated mesh__D003424 1999-01-01
% 217.35/217.52  |- mesh__dateRevised mesh__D003424 2003-07-09
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D003424 2006
% 217.35/217.52  |- mesh__recordAuthorizer mesh__D003424 sjn
% 217.35/217.52  |- skos__altLabel mesh__D003424 Crohn%27%s Disease
% 217.35/217.52  |- mesh__onlineNote mesh__D003424
% 217.35/217.52       use CROHN DISEASE to search ENTERITIS, REGIONAL 1966-79   
% 217.35/217.52  |- mesh__dateEstablished mesh__D003424 1965-01-01
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D003424 2005
% 217.35/217.52  |- skos__scopeNote mesh__D003424
% 217.35/217.52       A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients.%A%    
% 217.35/217.52  |- skos__altLabel mesh__D003424 Enteritis, Regional
% 217.35/217.52  |- mesh__recordAuthorizer mesh__D041543 sjn
% 217.35/217.52  |- skos__broader mesh__D041543smesh__D019624
% 217.35/217.52  |- mesh__historyNote mesh__D041543 2004   
% 217.35/217.52  |- mesh__recordMaintainer mesh__D041543 SYSTEM
% 217.35/217.52  |- skos__scopeNote mesh__D041543
% 217.35/217.52       A genus of rod-shaped, almost rectangular ARCHAEA, in the family THERMOPROTEACEAE. Organisms are facultatively aerobic or strictly anaerobic, grow on various organic substrates, and are found in continental solfataras.%A%    
% 217.35/217.52  |- skos__historyNote mesh__D041543 Thermoproteaceae %28%1998-2003%29%
% 217.35/217.52  |- mesh__dateRevised mesh__D041543 2005-06-30
% 217.35/217.52  |- mesh__recordOriginator mesh__D041543 ags
% 217.35/217.52  |- skos__historyNote mesh__D041543 Archaea %28%1991-2001%29%
% 217.35/217.52  |- mesh__dateCreated mesh__D041543 2003-07-09
% 217.35/217.52  |- rdf__type mesh__D041543sskos__Concept
% 217.35/217.52  |- mesh__publicMeSHNote mesh__D041543 2004   
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D041543 2006
% 217.35/217.52  |- skos__prefLabel mesh__D041543 Pyrobaculum
% 217.35/217.52  |- mesh__dateEstablished mesh__D041543 2004-01-01
% 217.35/217.52  |- skos__broader mesh__D013852smesh__D013721
% 217.35/217.52  |- mesh__dateCreated mesh__D013852 1999-01-01
% 217.35/217.52  |- skos__scopeNote mesh__D013852
% 217.35/217.52       A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%, thiotepa may reasonably be anticipated to be a carcinogen %28%Merck Index, 11th ed%29%.%A%    
% 217.35/217.52  |- mesh__historyNote mesh__D013852
% 217.35/217.52       92; was THIO-TEPA 1963-91; THIOTEPA was see THIO-TEPA 1977-91%A%  
% 217.35/217.52  |- mesh__dateRevised mesh__D013852 2005-06-30
% 217.35/217.52  |- mesh__recordMaintainer mesh__D013852 ssb
% 217.35/217.52  |- skos__hiddenLabel mesh__D013852 NSC 6396
% 217.35/217.52  |- skos__prefLabel mesh__D013852 Thiotepa
% 217.35/217.52  |- skos__hiddenLabel mesh__D013852 AI3 24916
% 217.35/217.52  |- mesh__onlineNote mesh__D013852
% 217.35/217.52       use THIOTEPA to search THIO-TEPA 1966-91   
% 217.35/217.52  |- skos__altLabel mesh__D013852 Tris%28%1-aziridinyl%29%phosphine Sulfide
% 217.35/217.52  |- skos__broader mesh__D013852smesh__D009946
% 217.35/217.52  |- skos__hiddenLabel mesh__D013852 NSC6396
% 217.35/217.52  |- skos__hiddenLabel mesh__D013852 AI324916
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D013852 2006
% 217.35/217.52  |- mesh__recordAuthorizer mesh__D013852 sjn
% 217.35/217.52  |- mesh__recordOriginator mesh__D013852 NLM
% 217.35/217.52  |- skos__altLabel mesh__D013852 Thio-Tepa
% 217.35/217.52  |- skos__hiddenLabel mesh__D013852 Thio Tepa
% 217.35/217.52  |- skos__altLabel mesh__D013852 Triethylenethiophosphoramide
% 217.35/217.52  |- rdf__type mesh__D013852sskos__Concept
% 217.35/217.52  |- mesh__publicMeSHNote mesh__D013852
% 217.35/217.52       92; was THIO-TEPA 1963-91; THIOTEPA was see THIO-TEPA 1977-91%A%  
% 217.35/217.52  |- skos__altLabel mesh__D013852 Thiophosphamide
% 217.35/217.52  |- mesh__recordAuthorizer mesh__D013054 sjn
% 217.35/217.52  |- mesh__recordOriginator mesh__D013054 NLM
% 217.35/217.52  |- skos__hiddenLabel mesh__D013054 Spectrophotometry, AA
% 217.35/217.52  |- skos__broader mesh__D013054smesh__D013053
% 217.35/217.52  |- mesh__dateEstablished mesh__D013054 1973-01-01
% 217.35/217.52  |- skos__hiddenLabel mesh__D013054 Spectrophotometries, AE
% 217.35/217.52  |- skos__historyNote mesh__D013054 Spectrophotometry %28%1966-1971%29%
% 217.35/217.52  |- rdf__type mesh__D013054sskos__Concept
% 217.35/217.52  |- skos__hiddenLabel mesh__D013054 Spectrophotometries, AA
% 217.35/217.52  |- skos__hiddenLabel mesh__D013054 Emission Spectrophotometry, Atomic
% 217.35/217.52  |- skos__altLabel mesh__D013054 Atomic Emission Spectrophotometry
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D013054 2005
% 217.35/217.52  |- skos__altLabel mesh__D013054 AA Spectrophotometry
% 217.35/217.52  |- skos__hiddenLabel mesh__D013054 AE Spectrophotometries
% 217.35/217.52  |- skos__altLabel mesh__D013054 Atomic Spectrophotometry
% 217.35/217.52  |- skos__altLabel mesh__D013054 AE Spectrophotometry
% 217.35/217.52  |- mesh__publicMeSHNote mesh__D013054
% 217.35/217.52       2004; see SPECTROPHOTOMETRY, ATOMIC ABSORPTION 1972-2003   
% 217.35/217.52  |- skos__altLabel mesh__D013054 ICP-AES
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D013054 2006
% 217.35/217.52  |- mesh__historyNote mesh__D013054 2004 %28%1972%29%   
% 217.35/217.52  |- skos__prefLabel mesh__D013054 Spectrophotometry, Atomic
% 217.35/217.52  |- skos__altLabel mesh__D013054 Atomic Absorption Spectrophotometry
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D013054 2004
% 217.35/217.52  |- skos__scopeNote mesh__D013054
% 217.35/217.52       Spectrophotometric techniques in which the samples are examined in the form of atoms based on their unique energy levels for ELECTRONS. They are used to analyze TRACE ELEMENTS, such as ALUMINUM; ARSENIC; BERYLLIUM; CALCIUM; COPPER; IRON; LEAD; and LITHIUM.%A%    
% 217.35/217.52  |- mesh__dateRevised mesh__D013054 2003-07-09
% 217.35/217.52  |- mesh__dateCreated mesh__D013054 1999-01-01
% 217.35/217.52  |- mesh__recordMaintainer mesh__D013054 lkt
% 217.35/217.52  |- skos__hiddenLabel mesh__D013054 Absorption Spectrophotometry, Atomic
% 217.35/217.52  |- skos__hiddenLabel mesh__D013054 AA Spectrophotometries
% 217.35/217.52  |- skos__hiddenLabel mesh__D013054 Spectrophotometry, AE
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007815 1997
% 217.35/217.52  |- mesh__recordOriginator mesh__D007815 NLM
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007815 2006
% 217.35/217.52  |- mesh__dateCreated mesh__D007815 1999-01-01
% 217.35/217.52  |- skos__hiddenLabel mesh__D007815 Creeping Eruptions
% 217.35/217.52  |- skos__altLabel mesh__D007815 Larva Migrans, Cutaneous
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007815 1996
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007815 2005
% 217.35/217.52  |- skos__altLabel mesh__D007815 Creeping Eruption
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007815 2001
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007815 1993
% 217.35/217.52  |- skos__annotation mesh__D007815
% 217.35/217.52       note category: a disease; restrict this dis to nematode infections; Ancylostoma brasiliensis causes cutaneous larva migrans, Toxocara causes visceral%A%  
% 217.35/217.52  |- skos__scopeNote mesh__D007815
% 217.35/217.52       Infections caused by nematode larvae which never develop into the adult stage and migrate through various body tissues. They commonly infect the skin, eyes, and viscera in man. Ancylostoma brasiliensis causes cutaneous larva migrans. Toxocara causes visceral larva migrans.%A%    
% 217.35/217.52  |- rdf__type mesh__D007815sskos__Concept
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007815 1999
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007815 2000
% 217.35/217.52  |- mesh__recordAuthorizer mesh__D007815 PLS
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007815 2004
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007815 1998
% 217.35/217.52  |- skos__hiddenLabel mesh__D007815 Eruption, Creeping
% 217.35/217.52  |- skos__broader mesh__D007815smesh__D012876
% 217.35/217.52  |- mesh__recordMaintainer mesh__D007815 PLS
% 217.35/217.52  |- skos__prefLabel mesh__D007815 Larva Migrans
% 217.35/217.52  |- mesh__dateRevised mesh__D007815 1992-05-20
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007815 2003
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007815 1995
% 217.35/217.52  |- skos__hiddenLabel mesh__D007815 Eruptions, Creeping
% 217.35/217.52  |- skos__altLabel mesh__D007815 Larva Migrans, Ocular
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007815 2002
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007815 1994
% 217.35/217.52  |- skos__broader mesh__D007815smesh__D009349
% 217.35/217.52  |- mesh__dateEstablished mesh__D007017 1991-01-01
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007017 1999
% 217.35/217.52  |- skos__hiddenLabel mesh__D007017 Hypophysectomies, Chemical
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007017 2000
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007017 1998
% 217.35/217.52  |- skos__altLabel mesh__D007017 Chemical Hypophysectomy
% 217.35/217.52  |- mesh__recordMaintainer mesh__D007017 PXP
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007017 2006
% 217.35/217.52  |- skos__prefLabel mesh__D007017 Hypophysectomy, Chemical
% 217.35/217.52  |- skos__historyNote mesh__D007017 Pain, Intractable %28%1977-1981%29%
% 217.35/217.52  |- skos__hiddenLabel mesh__D007017 Chemical Hypophysectomies
% 217.35/217.52  |- mesh__recordAuthorizer mesh__D007017 SJN
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007017 2005
% 217.35/217.52  |- mesh__publicMeSHNote mesh__D007017
% 217.35/217.52       91; was see under HYPOPHYSECTOMY 1982-90   
% 217.35/217.52  |- skos__annotation mesh__D007017
% 217.35/217.52       coord IM with disease /ther %28%IM%29%, not /surg; usually performed with ethyl alcohol so do not index under ETHANOL unless particularly discussed%A%  
% 217.35/217.52  |- mesh__dateRevised mesh__D007017 1997-06-20
% 217.35/217.52  |- rdf__type mesh__D007017sskos__Concept
% 217.35/217.52  |- mesh__dateCreated mesh__D007017 1981-02-24
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007017 2004
% 217.35/217.52  |- skos__scopeNote mesh__D007017
% 217.35/217.52       Total or subtotal destruction of the pituitary gland by chemical injection. It is usually achieved by injection of ethyl alcohol via trans-sphenoidal cannulation under stereotaxic control. It is usually performed for the treatment of intractable pain.%A%    
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007017 2002
% 217.35/217.52  |- skos__historyNote mesh__D007017
% 217.35/217.52       Pituitary Gland/drug effects %28%1977-1981%29%
% 217.35/217.52  |- skos__historyNote mesh__D007017 Hypophysectomy %28%1977-1981%29%
% 217.35/217.52  |- skos__historyNote mesh__D007017 Alcohol, Ethyl %28%1977-1981%29%
% 217.35/217.52  |- mesh__historyNote mesh__D007017
% 217.35/217.52       91%28%82%29%; was see under HYPOPHYSECTOMY 1982-90   
% 217.35/217.52  |- skos__broader mesh__D007017smesh__D007016
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007017 2003
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D007017 2001
% 217.35/217.52  |- mesh__recordOriginator mesh__D007017 SMH
% 217.35/217.52  |- mesh__dateRevised mesh__D023482 2005-06-30
% 217.35/217.52  |- mesh__recordOriginator mesh__D023482 ags
% 217.35/217.52  |- skos__historyNote mesh__D023482 Biological Warfare %28%1996-2000%29%
% 217.35/217.52  |- skos__historyNote mesh__D023482 Violence %28%1996-2000%29%
% 217.35/217.52  |- skos__altLabel mesh__D023482 Biological Terrorism
% 217.35/217.52  |- mesh__recordMaintainer mesh__D023482 ags
% 217.35/217.52  |- mesh__recordAuthorizer mesh__D023482 sjn
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D023482 2006
% 217.35/217.52  |- skos__hiddenLabel mesh__D023482 Terrorism, Biological
% 217.35/217.52  |- mesh__dateEstablished mesh__D023482 2001-01-01
% 217.35/217.52  |- rdf__type mesh__D023482sskos__Concept
% 217.35/217.52  |- skos__broader mesh__D023482smesh__D023481
% 217.35/217.52  |- mesh__dateCreated mesh__D023482 2000-06-22
% 217.35/217.52  |- skos__scopeNote mesh__D023482
% 217.35/217.52       The use of biological agents in TERRORISM. This includes the malevolent use of BACTERIA; VIRUSES; or other BIOLOGICAL TOXINS against people, ANIMALS; or PLANTS.%A%    
% 217.35/217.52  |- skos__broader mesh__D023482smesh__D001694
% 217.35/217.52  |- mesh__publicMeSHNote mesh__D023482 2001   
% 217.35/217.52  |- skos__prefLabel mesh__D023482 Bioterrorism
% 217.35/217.52  |- mesh__historyNote mesh__D023482 2001   
% 217.35/217.52  |- skos__related mesh__D023482smesh__D001694
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017445 2005
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017445 1999
% 217.35/217.52  |- mesh__dateEstablished mesh__D017445 1993-01-01
% 217.35/217.52  |- mesh__recordAuthorizer mesh__D017445 SJN
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017445 2000
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017445 2003
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017445 2006
% 217.35/217.52  |- mesh__recordMaintainer mesh__D017445 TPW
% 217.35/217.52  |- skos__hiddenLabel mesh__D017445 Vascular Skin Disease
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017445 2001
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017445 2004
% 217.35/217.52  |- mesh__historyNote mesh__D017445 93   
% 217.35/217.52  |- mesh__publicMeSHNote mesh__D017445 93   
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017445 2002
% 217.35/217.52  |- skos__annotation mesh__D017445
% 217.35/217.52       note X ref: livedo reticularis + cerebrovasc disord = SNEDDON SYNDROME%A%  
% 217.35/217.52  |- skos__hiddenLabel mesh__D017445 Disease, Vascular Skin
% 217.35/217.52  |- skos__historyNote mesh__D017445 Skin Diseases %28%1966-1992%29%
% 217.35/217.52  |- rdf__type mesh__D017445sskos__Concept
% 217.35/217.52  |- skos__hiddenLabel mesh__D017445 Diseases, Vascular Skin
% 217.35/217.52  |- skos__scopeNote mesh__D017445
% 217.35/217.52       Skin diseases affecting or involving the cutaneous blood vessels and generally manifested as inflammation, swelling, erythema, or necrosis in the affected area.%A%    
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D017445 1998
% 217.35/217.52  |- skos__broader mesh__D017445smesh__D012871
% 217.35/217.52  |- mesh__dateCreated mesh__D017445 1992-05-22
% 217.35/217.52  |- skos__prefLabel mesh__D017445 Skin Diseases, Vascular
% 217.35/217.52  |- mesh__dateRevised mesh__D017445 1997-06-20
% 217.35/217.52  |- mesh__recordOriginator mesh__D017445 PLS
% 217.35/217.52  |- skos__altLabel mesh__D017445 Vascular Skin Diseases
% 217.35/217.52  |- skos__hiddenLabel mesh__D017445 Skin Disease, Vascular
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D050879 2006
% 217.35/217.52  |- skos__broader mesh__D050879smesh__D010089
% 217.35/217.52  |- mesh__publicMeSHNote mesh__D050879
% 217.35/217.52       2006; SARCOSINE OXIDASE was indexed under OXIDOREDUCTASES, N-DEMETHYLATING 1998-2005%A%  
% 217.35/217.52  |- mesh__historyNote mesh__D050879 2006%28%1998%29%   
% 217.35/217.52  |- skos__hiddenLabel mesh__D050879 Oxidase, L-Pipecolic Acid
% 217.35/217.52  |- skos__altLabel mesh__D050879 L-Pipecolic Acid Oxidase
% 217.35/217.52  |- rdf__type mesh__D050879sskos__Concept
% 217.35/217.52  |- mesh__dateEstablished mesh__D050879 2006-01-01
% 217.35/217.52  |- skos__prefLabel mesh__D050879 Sarcosine Oxidase
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D050879 2006A
% 217.35/217.52  |- skos__hiddenLabel mesh__D050879 Oxidase, Sarcosine
% 217.35/217.52  |- skos__scopeNote mesh__D050879
% 217.35/217.52       A FLAVOPROTEIN, this enzyme catalyzes the oxidation of SARCOSINE to GLYCINE; FORMALDEHYDE; and HYDROGEN PEROXIDE %28%H2O2%29%.%A%    
% 217.35/217.52  |- mesh__dateCreated mesh__D050879 2005-06-30
% 217.35/217.52  |- mesh__recordAuthorizer mesh__D050879 ags
% 217.35/217.52  |- mesh__recordOriginator mesh__D050879 AKE
% 217.35/217.52  |- skos__historyNote mesh__D050879
% 217.35/217.52       Oxidoreductases, N-Demethylating %28%1998-2005%29%
% 217.35/217.52  |- skos__broader mesh__D050879smesh__D005420
% 217.35/217.52  |- skos__hiddenLabel mesh__D050879 L Pipecolic Acid Oxidase
% 217.35/217.52  |- skos__altLabel mesh__D050879
% 217.35/217.52       Sarcosine-Oxygen Oxidoreductase %28%Demethylating%29%
% 217.35/217.52  |- skos__hiddenLabel mesh__D050879 Acid Oxidase, L-Pipecolic
% 217.35/217.52  |- mesh__activeMeSHYear mesh__D050879 2006B
% 217.35/217.52  |- mesh__recordMaintainer mesh__D050879 ags
% 217.35/217.52  |- mesh__dateRevised mesh__D050879 2005-07-29
% 217.35/217.53  |- mesh__publicMeSHNote mesh__D003425
% 217.35/217.53       96; was CRONOLONE 1965-95 %28%see under PREGNENEDIONES 1965-90%29%%A%  
% 217.35/217.53  |- skos__hiddenLabel mesh__D003425
% 217.35/217.53       beta-hydroxyprogesterone, 17 beta-Acetoxy-9-fluoro-11
% 217.35/217.53  |- rdf__type mesh__D003425sskos__Concept
% 217.35/217.53  |- mesh__dateRevised mesh__D003425 2005-06-30
% 217.35/217.53  |- skos__altLabel mesh__D003425 Fluorogestone Acetate
% 217.35/217.53  |- skos__altLabel mesh__D003425 Flugestone Acetate
% 217.35/217.53  |- mesh__recordMaintainer mesh__D003425 exl
% 217.35/217.53  |- mesh__recordOriginator mesh__D003425 NLM
% 217.35/217.53  |- mesh__dateEstablished mesh__D003425 1991-01-01
% 217.35/217.53  |- mesh__historyNote mesh__D003425
% 217.35/217.53       96; was CRONOLONE 1965-95 %28%see under PREGNENEDIONES 1965-90%29%%A%  
% 217.35/217.53  |- skos__broader mesh__D003425smesh__D011282
% 217.35/217.53  |- skos__altLabel mesh__D003425 Flurogestone
% 217.35/217.53  |- skos__hiddenLabel mesh__D003425
% 217.35/217.53       beta-Acetoxy-9-fluoro-11 beta-hydroxyprogesterone, 17
% 217.35/217.53  |- mesh__dateCreated mesh__D003425 1999-01-01
% 217.35/217.53  |- skos__hiddenLabel mesh__D003425 Acetate, Fluorogestone
% 217.35/217.53  |- skos__prefLabel mesh__D003425 Flurogestone Acetate
% 217.35/217.53  |- mesh__recordAuthorizer mesh__D003425 sjn
% 217.35/217.53  |- skos__hiddenLabel mesh__D003425
% 217.35/217.53       17 beta Acetoxy 9 fluoro 11 beta hydroxyprogesterone
% 217.35/217.53  |- skos__broader mesh__D003425smesh__D013259
% 217.35/217.53  |- skos__hiddenLabel mesh__D003425 Acetate, Flurogestone
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003425 2006
% 217.35/217.53  |- skos__scopeNote mesh__D003425
% 217.35/217.53       A synthetic fluorinated steroid that is used as a progestational hormone.%A%    
% 217.35/217.53  |- skos__hiddenLabel mesh__D003425 Acetate, Flugestone
% 217.35/217.53  |- skos__prefLabel mesh__D008110 Liver Extracts
% 217.35/217.53  |- rdf__type mesh__D008110sskos__Concept
% 217.35/217.53  |- skos__hiddenLabel mesh__D008110 Extracts, Liver
% 217.35/217.53  |- skos__scopeNote mesh__D008110
% 217.35/217.53       Extracts of liver tissue containing uncharacterized specific factors with specific activities; a soluble thermostable fraction of mammalian liver is used in the treatment of pernicious anemia.%A%    
% 217.35/217.53  |- mesh__recordMaintainer mesh__D008110 ssb
% 217.35/217.53  |- mesh__dateCreated mesh__D008110 1999-01-01
% 217.35/217.53  |- mesh__dateRevised mesh__D008110 2005-06-30
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D008110 2006
% 217.35/217.53  |- mesh__recordAuthorizer mesh__D008110 sjn
% 217.35/217.53  |- mesh__recordOriginator mesh__D008110 NLM
% 217.35/217.53  |- skos__annotation mesh__D008110
% 217.35/217.53       extracts of liver or liver fractions containing uncharacterized factors; do not confuse with chemical substances %22%extracted%22% from the liver, as %22%peptides extracted from the mouse liver%22% %28% = PEPTIDES /anal + LIVER /anal%29%%A%  
% 217.35/217.53  |- skos__broader mesh__D008110smesh__D014020
% 217.35/217.53  |- skos__scopeNote mesh__D013853
% 217.35/217.53       A crystalline compound used as a laboratory reagent in place of HYDROGEN SULFIDE. It is a potent hepatocarcinogen.%A%    
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013853 2002
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013853 2004
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013853 2001
% 217.35/217.53  |- mesh__dateRevised mesh__D013853 1999-11-03
% 217.35/217.53  |- mesh__recordMaintainer mesh__D013853 jmp
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013853 2003
% 217.35/217.53  |- mesh__publicMeSHNote mesh__D013853
% 217.35/217.53       91; was see under ACETAMIDES 1973-90   
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013853 2000
% 217.35/217.53  |- mesh__recordAuthorizer mesh__D013853 sjn
% 217.35/217.53  |- mesh__historyNote mesh__D013853
% 217.35/217.53       91%28%73%29%; was see under ACETAMIDES 1973-90   
% 217.35/217.53  |- skos__broader mesh__D013853smesh__D013854
% 217.35/217.53  |- skos__prefLabel mesh__D013853 Thioacetamide
% 217.35/217.53  |- mesh__recordOriginator mesh__D013853 NLM
% 217.35/217.53  |- skos__broader mesh__D013853smesh__D000081
% 217.35/217.53  |- skos__altLabel mesh__D013853 Thiacetamid
% 217.35/217.53  |- mesh__dateEstablished mesh__D013853 1991-01-01
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013853 2006
% 217.35/217.53  |- rdf__type mesh__D013853sskos__Concept
% 217.35/217.53  |- mesh__dateCreated mesh__D013853 1999-01-01
% 217.35/217.53  |- skos__altLabel mesh__D013853 Thioacetamid
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013853 2005
% 217.35/217.53  |- mesh__recordMaintainer mesh__D013055 lkt
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013055 2003
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013055 2006
% 217.35/217.53  |- skos__scopeNote mesh__D013055
% 217.35/217.53       Spectrophotometry in the infrared region, usually for the purpose of chemical analysis through measurement of absorption spectra associated with rotational and vibrational energy levels of molecules. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 217.35/217.53  |- skos__prefLabel mesh__D013055 Spectrophotometry, Infrared
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013055 2004
% 217.35/217.53  |- mesh__dateEstablished mesh__D013055 1973-01-01
% 217.35/217.53  |- mesh__recordAuthorizer mesh__D013055 sjn
% 217.35/217.53  |- mesh__recordOriginator mesh__D013055 NLM
% 217.35/217.53  |- mesh__dateCreated mesh__D013055 1999-01-01
% 217.35/217.53  |- mesh__dateRevised mesh__D013055 2002-07-03
% 217.35/217.53  |- skos__historyNote mesh__D013055 Spectrophotometry %28%1966-1972%29%
% 217.35/217.53  |- skos__annotation mesh__D013055
% 217.35/217.53       a type of spectrum anal; NIM; 770-1500 millimus   
% 217.35/217.53  |- mesh__publicMeSHNote mesh__D013055 73   
% 217.35/217.53  |- mesh__historyNote mesh__D013055 73   
% 217.35/217.53  |- skos__altLabel mesh__D013055 Infrared Spectrophotometry
% 217.35/217.53  |- skos__broader mesh__D013055smesh__D013053
% 217.35/217.53  |- rdf__type mesh__D013055sskos__Concept
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013055 2005
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D007816 2005
% 217.35/217.53  |- skos__hiddenLabel mesh__D007816 Migrans, Visceral Larva
% 217.35/217.53  |- mesh__publicMeSHNote mesh__D007816 68   
% 217.35/217.53  |- rdf__type mesh__D007816sskos__Concept
% 217.35/217.53  |- mesh__recordOriginator mesh__D007816 NLM
% 217.35/217.53  |- skos__hiddenLabel mesh__D007816 Visceral Larva Migrans
% 217.35/217.53  |- mesh__dateEstablished mesh__D007816 1968-01-01
% 217.35/217.53  |- skos__prefLabel mesh__D007816 Larva Migrans, Visceral
% 217.35/217.53  |- skos__historyNote mesh__D007816 Larva Migrans %28%1966-1967%29%
% 217.35/217.53  |- mesh__recordMaintainer mesh__D007816 sjn
% 217.35/217.53  |- skos__broader mesh__D007816smesh__D007815
% 217.35/217.53  |- skos__broader mesh__D007816smesh__D014120
% 217.35/217.53  |- mesh__dateRevised mesh__D007816 2004-07-13
% 217.35/217.53  |- skos__scopeNote mesh__D007816
% 217.35/217.53       A condition produced in man by the prolonged migration of animal nematode larvae in extraintestinal tissues other than skin; characterized by persistent hypereosinophilia, hepatomegaly, and frequently pneumonitis, commonly caused by Toxocara canis and Toxocara cati.%A%    
% 217.35/217.53  |- mesh__historyNote mesh__D007816 68   
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D007816 2006
% 217.35/217.53  |- mesh__recordAuthorizer mesh__D007816 sjn
% 217.35/217.53  |- mesh__dateCreated mesh__D007816 1999-01-01
% 217.35/217.53  |- skos__annotation mesh__D007816
% 217.35/217.53       note category: a disease; in human only, caused by Toxocara: coord IM with TOXOCARA CANIS %28%IM%29% if caused by T. canis but not with TOXOCARA if by T. cati; in animal probably = TOXOCARIASIS%A%  
% 217.35/217.53  |- skos__altLabel mesh__D007018 Sheehan%27%s Syndrome
% 217.35/217.53  |- skos__hiddenLabel mesh__D007018 Syndrome, Sheehan%27%s
% 217.35/217.53  |- mesh__historyNote mesh__D007018
% 217.35/217.53       1963; for SIMMONDS%27% DISEASE %26% SHEEHAN%27%S SYNDROME use  SIMMONDS%27% DISEASE 1963-1967%A%  
% 217.35/217.53  |- mesh__recordMaintainer mesh__D007018 lkt
% 217.35/217.53  |- mesh__dateRevised mesh__D007018 2005-06-30
% 217.35/217.53  |- skos__hiddenLabel mesh__D007018 Sheehans Syndrome
% 217.35/217.53  |- skos__hiddenLabel mesh__D007018 Panhypopituitarism, Postpartum
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D007018 2006
% 217.35/217.53  |- skos__scopeNote mesh__D007018
% 217.35/217.53       Diminution or cessation of secretion of one or more hormones from the anterior pituitary gland %28%including LH; FOLLICLE STIMULATING HORMONE; SOMATOTROPIN; and CORTICOTROPIN%29%. This may result from surgical or radiation ablation, non-secretory PITUITARY NEOPLASMS, metastatic tumors, infarction, PITUITARY APOPLEXY, infiltrative or granulomatous processes, and other conditions.%A%    
% 217.35/217.53  |- mesh__publicMeSHNote mesh__D007018
% 217.35/217.53       1963; for SIMMONDS%27% DISEASE %26% SHEEHAN%27%S SYNDROME see  SIMMONDS%27% DISEASE 1963-1967%A%  
% 217.35/217.53  |- skos__altLabel mesh__D007018 Adenohypophyseal Hyposecretion
% 217.35/217.53  |- skos__hiddenLabel mesh__D007018 Insufficiency, Pituitary
% 217.35/217.53  |- skos__altLabel mesh__D007018 Hyposecretion Syndrome, Anterior Pituitary
% 217.35/217.53  |- mesh__recordAuthorizer mesh__D007018 sjn
% 217.35/217.53  |- skos__hiddenLabel mesh__D007018 Disease, Simmonds
% 217.35/217.53  |- skos__hiddenLabel mesh__D007018 Pituitary Insufficiency, Postpartum
% 217.35/217.53  |- skos__altLabel mesh__D007018 Simmonds%27% Disease
% 217.35/217.53  |- skos__hiddenLabel mesh__D007018 Simmond%27%s Disease
% 217.35/217.53  |- rdf__type mesh__D007018sskos__Concept
% 217.35/217.53  |- skos__altLabel mesh__D007018 Anterior Pituitary Hyposecretion Syndrome
% 217.35/217.53  |- skos__altLabel mesh__D007018 Hyposecretion, Adenohypophyseal
% 217.35/217.53  |- skos__altLabel mesh__D007018 Postpartum Pituitary Insufficiency
% 217.35/217.53  |- mesh__dateCreated mesh__D007018 1999-01-01
% 217.35/217.53  |- skos__prefLabel mesh__D007018 Hypopituitarism
% 217.35/217.53  |- skos__altLabel mesh__D007018 Postpartum Panhypopituitarism
% 217.35/217.53  |- mesh__recordOriginator mesh__D007018 NLM
% 217.35/217.53  |- skos__altLabel mesh__D007018 Pituitary Insufficiency
% 217.35/217.53  |- skos__hiddenLabel mesh__D007018 Hypopituitarism, Postpartum
% 217.35/217.53  |- skos__hiddenLabel mesh__D007018 Syndrome, Sheehan
% 217.35/217.53  |- skos__altLabel mesh__D007018 Sheehan Syndrome
% 217.35/217.53  |- skos__altLabel mesh__D007018 Simmonds Disease
% 217.35/217.53  |- skos__broader mesh__D007018smesh__D010900
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D017446 2006
% 217.35/217.53  |- skos__hiddenLabel mesh__D017446 Trihydrochloride, Impromidine
% 217.35/217.53  |- skos__hiddenLabel mesh__D017446 SK%26%F92676
% 217.35/217.53  |- mesh__historyNote mesh__D017446
% 217.35/217.53       93; was IMPROMIDINE %28%NM%29% 1979-92   
% 217.35/217.53  |- skos__scopeNote mesh__D017446
% 217.35/217.53       A highly potent and specific histamine H2 receptor agonist. It has been used diagnostically as a gastric secretion indicator.%A%    
% 217.35/217.53  |- mesh__recordAuthorizer mesh__D017446 sjn
% 217.35/217.53  |- mesh__dateEstablished mesh__D017446 1993-01-01
% 217.35/217.53  |- skos__historyNote mesh__D017446 Imidazoles %28%1979-1992%29%
% 217.35/217.53  |- skos__hiddenLabel mesh__D017446 SKF 92676
% 217.35/217.53  |- mesh__recordMaintainer mesh__D017446 ssb
% 217.35/217.53  |- mesh__dateRevised mesh__D017446 2005-06-30
% 217.35/217.53  |- skos__hiddenLabel mesh__D017446 SK%26%F 92676
% 217.35/217.53  |- rdf__type mesh__D017446sskos__Concept
% 217.35/217.53  |- skos__broader mesh__D017446smesh__D007093
% 217.35/217.53  |- mesh__dateCreated mesh__D017446 1992-05-20
% 217.35/217.53  |- mesh__onlineNote mesh__D017446
% 217.35/217.53       use IMPROMIDINE %28%NM%29% to search IMPROMIDINE 1980-92   
% 217.35/217.53  |- mesh__publicMeSHNote mesh__D017446
% 217.35/217.53       93; IMPROMIDINE was indexed under GUANIDINES 1979-82 %26% 1989-92, %26% IMIDAZOLES 1979-92%A%  
% 217.35/217.53  |- skos__altLabel mesh__D017446 SKF-92676
% 217.35/217.53  |- skos__hiddenLabel mesh__D017446 SKF92676
% 217.35/217.53  |- mesh__recordOriginator mesh__D017446 TPW
% 217.35/217.53  |- skos__hiddenLabel mesh__D017446 Hydrochloride, Impromidine
% 217.35/217.53  |- skos__altLabel mesh__D017446 Impromidine Trihydrochloride
% 217.35/217.53  |- skos__broader mesh__D017446smesh__D006146
% 217.35/217.53  |- skos__prefLabel mesh__D017446 Impromidine
% 217.35/217.53  |- skos__historyNote mesh__D017446 Guanidines %28%1979-82,89-1992%29%
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003426 1990
% 217.35/217.53  |- mesh__dateRevised mesh__D003426 1978-11-07
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003426 1995
% 217.35/217.53  |- mesh__historyNote mesh__D003426 68   
% 217.35/217.53  |- skos__historyNote mesh__D003426 Birds %28%1966-1967%29%
% 217.35/217.53  |- mesh__dateEstablished mesh__D003426 1968-01-01
% 217.35/217.53  |- skos__hiddenLabel mesh__D003426 Avian Crop
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003426 2002
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003426 1994
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003426 1989
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003426 2004
% 217.35/217.53  |- mesh__recordMaintainer mesh__D003426 GJB
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003426 1997
% 217.35/217.53  |- mesh__dateCreated mesh__D003426 1999-01-01
% 217.35/217.53  |- skos__hiddenLabel mesh__D003426 Crops, Avian
% 217.35/217.53  |- skos__hiddenLabel mesh__D003426 Avian Crops
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003426 2003
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003426 1996
% 217.35/217.53  |- mesh__recordAuthorizer mesh__D003426 NLM
% 217.35/217.53  |- mesh__recordOriginator mesh__D003426 NLM
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003426 1991
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003426 2001
% 217.35/217.53  |- skos__broader mesh__D003426smesh__D000825
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003426 1993
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003426 2006
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003426 1999
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003426 2000
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003426 1992
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003426 2005
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003426 1998
% 217.35/217.53  |- skos__prefLabel mesh__D003426 Crop, Avian
% 217.35/217.53  |- mesh__publicMeSHNote mesh__D003426 68   
% 217.35/217.53  |- rdf__type mesh__D003426sskos__Concept
% 217.35/217.53  |- mesh__recordMaintainer mesh__D008111 PXP
% 217.35/217.53  |- skos__annotation mesh__D008111 NIM   
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D008111 1998
% 217.35/217.53  |- skos__hiddenLabel mesh__D008111 Liver Function Test
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D008111 2004
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D008111 2001
% 217.35/217.53  |- rdf__type mesh__D008111sskos__Concept
% 217.35/217.53  |- skos__hiddenLabel mesh__D008111 Function Tests, Liver
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D008111 1999
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D008111 2002
% 217.35/217.53  |- mesh__recordOriginator mesh__D008111 NLM
% 217.35/217.53  |- mesh__recordAuthorizer mesh__D008111 SJN
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D008111 2005
% 217.35/217.53  |- skos__broader mesh__D008111smesh__D003938
% 217.35/217.53  |- skos__hiddenLabel mesh__D008111 Function Test, Liver
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D008111 2006
% 217.35/217.53  |- skos__hiddenLabel mesh__D008111 Tests, Liver Function
% 217.35/217.53  |- skos__prefLabel mesh__D008111 Liver Function Tests
% 217.35/217.53  |- mesh__dateCreated mesh__D008111 1999-01-01
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D008111 2000
% 217.35/217.53  |- mesh__dateRevised mesh__D008111 1997-06-20
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D008111 2003
% 217.35/217.53  |- skos__hiddenLabel mesh__D008111 Test, Liver Function
% 217.35/217.53  |- mesh__dateCreated mesh__D049528 2004-07-07
% 217.35/217.53  |- skos__prefLabel mesh__D049528 Insulin, Long-Acting
% 217.35/217.53  |- skos__hiddenLabel mesh__D049528 Monotard, Insulin Novo
% 217.35/217.53  |- skos__altLabel mesh__D049528 Long-Acting Insulin
% 217.35/217.53  |- rdf__type mesh__D049528sskos__Concept
% 217.35/217.53  |- mesh__recordMaintainer mesh__D049528 jls
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D049528 2005
% 217.35/217.53  |- skos__hiddenLabel mesh__D049528 Novo Monotard, Insulin
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D049528 2005A
% 217.35/217.53  |- skos__hiddenLabel mesh__D049528 Long Acting Insulin
% 217.35/217.53  |- mesh__recordOriginator mesh__D049528 jls
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D049528 2006
% 217.35/217.53  |- skos__scopeNote mesh__D049528
% 217.35/217.53       Insulin formulation containing substance which delays or retards time period of the absorption of insulin.%A%    
% 217.35/217.53  |- skos__hiddenLabel mesh__D049528 Protamine Zinc Insulin
% 217.35/217.53  |- skos__hiddenLabel mesh__D049528 Insulin, Long Acting
% 217.35/217.53  |- skos__hiddenLabel mesh__D049528 Lente Insulin
% 217.35/217.53  |- mesh__recordAuthorizer mesh__D049528 jls
% 217.35/217.53  |- mesh__publicMeSHNote mesh__D049528 2005   
% 217.35/217.53  |- skos__hiddenLabel mesh__D049528 Insulin, Ultralente
% 217.35/217.53  |- mesh__historyNote mesh__D049528 2005   
% 217.35/217.53  |- skos__hiddenLabel mesh__D049528 Zinc Insulin, Protamine
% 217.35/217.53  |- mesh__dateEstablished mesh__D049528 2005-01-01
% 217.35/217.53  |- skos__broader mesh__D049528smesh__D007328
% 217.35/217.53  |- skos__historyNote mesh__D049528 Insulin %28%1977-2004%29%
% 217.35/217.53  |- mesh__dateRevised mesh__D049528 2004-07-28
% 217.35/217.53  |- skos__hiddenLabel mesh__D049528 Monotard Insulin
% 217.35/217.53  |- skos__hiddenLabel mesh__D049528 Semilente Insulin
% 217.35/217.53  |- mesh__dateRevised mesh__D013854 1992-05-20
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013854 2002
% 217.35/217.53  |- mesh__dateEstablished mesh__D013854 1991-01-01
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013854 2004
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013854 1994
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013854 1998
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013854 1995
% 217.35/217.53  |- skos__scopeNote mesh__D013854
% 217.35/217.53       Organic compounds containing the radical -CSNH2.     
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013854 2000
% 217.35/217.53  |- mesh__dateCreated mesh__D013854 1974-11-11
% 217.35/217.53  |- mesh__recordAuthorizer mesh__D013854 PLS
% 217.35/217.53  |- skos__prefLabel mesh__D013854 Thioamides
% 217.35/217.53  |- mesh__publicMeSHNote mesh__D013854 91; was see under AMIDES 1975-90   
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013854 1999
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013854 2005
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013854 2001
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013854 1996
% 217.35/217.53  |- mesh__recordMaintainer mesh__D013854 TGC
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013854 1993
% 217.35/217.53  |- skos__broader mesh__D013854smesh__D013457
% 217.35/217.53  |- skos__historyNote mesh__D013854 Amides %28%1966-1974%29%
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013854 2006
% 217.35/217.53  |- rdf__type mesh__D013854sskos__Concept
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013854 1997
% 217.35/217.53  |- skos__broader mesh__D013854smesh__D000577
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013854 2003
% 217.35/217.53  |- mesh__historyNote mesh__D013854
% 217.35/217.53       91%28%75%29%; was see under AMIDES 1975-90   
% 217.35/217.53  |- mesh__recordOriginator mesh__D013854 NLM
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013056 2004
% 217.35/217.53  |- mesh__recordMaintainer mesh__D013056 lkt
% 217.35/217.53  |- mesh__dateCreated mesh__D013056 1999-01-01
% 217.35/217.53  |- skos__historyNote mesh__D013056 Spectrophotometry %28%1966-1972%29%
% 217.35/217.53  |- mesh__historyNote mesh__D013056 73   
% 217.35/217.53  |- skos__broader mesh__D013056smesh__D013053
% 217.35/217.53  |- skos__scopeNote mesh__D013056
% 217.35/217.53       Determination of the spectra of ultraviolet absorption by specific molecules in gases or liquids, for example Cl2, SO2, NO2, CS2, ozone, mercury vapor, and various unsaturated compounds. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 217.35/217.53  |- mesh__dateEstablished mesh__D013056 1973-01-01
% 217.35/217.53  |- skos__annotation mesh__D013056
% 217.35/217.53       a type of spectrum anal; NIM; 180-390 millimus   
% 217.35/217.53  |- mesh__recordAuthorizer mesh__D013056 sjn
% 217.35/217.53  |- mesh__recordOriginator mesh__D013056 NLM
% 217.35/217.53  |- rdf__type mesh__D013056sskos__Concept
% 217.35/217.53  |- mesh__dateRevised mesh__D013056 2002-07-03
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013056 2005
% 217.35/217.53  |- mesh__publicMeSHNote mesh__D013056 73   
% 217.35/217.53  |- skos__altLabel mesh__D013056 Ultraviolet Spectrophotometry
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013056 2003
% 217.35/217.53  |- skos__prefLabel mesh__D013056 Spectrophotometry, Ultraviolet
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D013056 2006
% 217.35/217.53  |- skos__prefLabel mesh__D007817 Laryngeal Cartilages
% 217.35/217.53  |- skos__broader mesh__D007817smesh__D007830
% 217.35/217.53  |- mesh__recordMaintainer mesh__D007817 ags
% 217.35/217.53  |- mesh__dateRevised mesh__D007817 2005-06-30
% 217.35/217.53  |- mesh__recordAuthorizer mesh__D007817 sjn
% 217.35/217.53  |- skos__hiddenLabel mesh__D007817 Cartilage, Laryngeal
% 217.35/217.53  |- skos__broader mesh__D007817smesh__D051457
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D007817 2006
% 217.35/217.53  |- mesh__dateCreated mesh__D007817 1999-01-01
% 217.35/217.53  |- skos__scopeNote mesh__D007817
% 217.35/217.53       The nine cartilages of the larynx, including the cricoid, thyroid and epiglottic, and two each of arytenoid, corniculate and cuneiform.%A%    
% 217.35/217.53  |- mesh__recordOriginator mesh__D007817 NLM
% 217.35/217.53  |- skos__broader mesh__D007817smesh__D051472
% 217.35/217.53  |- skos__hiddenLabel mesh__D007817 Cartilages, Laryngeal
% 217.35/217.53  |- rdf__type mesh__D007817sskos__Concept
% 217.35/217.53  |- skos__hiddenLabel mesh__D007817 Laryngeal Cartilage
% 217.35/217.53  |- skos__annotation mesh__D007817 GEN or unspecified; prefer specifics   
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D007019 2006
% 217.35/217.53  |- skos__related mesh__D007019smesh__D011504
% 217.35/217.53  |- mesh__publicMeSHNote mesh__D007019 65   
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D007019 2003
% 217.35/217.53  |- mesh__recordMaintainer mesh__D007019 lkt
% 217.35/217.53  |- rdf__type mesh__D007019sskos__Concept
% 217.35/217.53  |- mesh__dateCreated mesh__D007019 1999-01-01
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D007019 2004
% 217.35/217.53  |- mesh__recordAuthorizer mesh__D007019 sjn
% 217.35/217.53  |- skos__hiddenLabel mesh__D007019 Hypoproteinemias
% 217.35/217.53  |- mesh__dateRevised mesh__D007019 2002-07-03
% 217.35/217.53  |- skos__broader mesh__D007019smesh__D001796
% 217.35/217.53  |- skos__scopeNote mesh__D007019
% 217.35/217.53       A condition in which total serum protein level is below the normal range. Hypoproteinemia can be caused by protein malabsorption in the gastrointestinal tract, EDEMA, or PROTEINURIA.%A%    
% 217.35/217.53  |- mesh__dateEstablished mesh__D007019 1965-01-01
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D007019 2005
% 217.35/217.53  |- skos__prefLabel mesh__D007019 Hypoproteinemia
% 217.35/217.53  |- mesh__recordOriginator mesh__D007019 NLM
% 217.35/217.53  |- mesh__historyNote mesh__D007019 65%28%63%29%   
% 217.35/217.53  |- skos__prefLabel mesh__D017447 Receptors, Dopamine D1
% 217.35/217.53  |- rdf__type mesh__D017447sskos__Concept
% 217.35/217.53  |- skos__scopeNote mesh__D017447
% 217.35/217.53       A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D1-class receptor genes lack INTRONS, and the receptors stimulate ADENYLATE CYCLASE.%A%    
% 217.35/217.53  |- mesh__publicMeSHNote mesh__D017447
% 217.35/217.53       93; DOPAMINE-D1 RECEPTOR was indexed under RECEPTORS, DOPAMINE 1982-92%A%  
% 217.35/217.53  |- skos__broader mesh__D017447smesh__D011954
% 217.35/217.53  |- skos__annotation mesh__D017447 DF: RECEPT DOPAMINE D1   
% 217.35/217.53  |- mesh__historyNote mesh__D017447
% 217.35/217.53       93; was DOPAMINE-D1 RECEPTOR %28%NM%29% 1982-92   
% 217.35/217.53  |- skos__altLabel mesh__D017447 Dopamine D1 Receptors
% 217.35/217.53  |- mesh__dateCreated mesh__D017447 1992-05-22
% 217.35/217.53  |- skos__hiddenLabel mesh__D017447 Receptor, Dopamine-D1
% 217.35/217.53  |- mesh__dateEstablished mesh__D017447 1993-01-01
% 217.35/217.53  |- skos__hiddenLabel mesh__D017447 D1 Receptors, Dopamine
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D017447 2006
% 217.35/217.53  |- mesh__recordAuthorizer mesh__D017447 sjn
% 217.35/217.53  |- skos__historyNote mesh__D017447 Receptors, Dopamine %28%1982-1992%29%
% 217.35/217.53  |- mesh__recordOriginator mesh__D017447 PXP
% 217.35/217.53  |- mesh__dateRevised mesh__D017447 2005-06-30
% 217.35/217.53  |- mesh__onlineNote mesh__D017447
% 217.35/217.53       use RECEPTORS, DOPAMINE D1 %28%NM%29% to search DOPAMINE-D1 RECEPTOR 1982-92%A%  
% 217.35/217.53  |- skos__altLabel mesh__D017447 Dopamine-D1 Receptor
% 217.35/217.53  |- skos__hiddenLabel mesh__D017447 Dopamine D1 Receptor
% 217.35/217.53  |- mesh__recordMaintainer mesh__D017447 DRC
% 217.35/217.53  |- skos__annotation mesh__D036601
% 217.35/217.53       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.35/217.53  |- mesh__publicMeSHNote mesh__D036601 2003   
% 217.35/217.53  |- mesh__dateEstablished mesh__D036601 2003-01-01
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D036601 2005
% 217.35/217.53  |- skos__scopeNote mesh__D036601
% 217.35/217.53       A plant genus of the family ASTERACEAE. Members contain wedelolactone.%A%    
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D036601 2004
% 217.35/217.53  |- skos__broader mesh__D036601smesh__D019659
% 217.35/217.53  |- rdf__type mesh__D036601sskos__Concept
% 217.35/217.53  |- mesh__dateCreated mesh__D036601 2002-07-03
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D036601 2003
% 217.35/217.53  |- skos__prefLabel mesh__D036601 Eclipta
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D036601 2006
% 217.35/217.53  |- mesh__historyNote mesh__D036601 2003   
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003427 2001
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003427 2003
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003427 1995
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003427 1996
% 217.35/217.53  |- mesh__recordMaintainer mesh__D003427 TGC
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003427 2002
% 217.35/217.53  |- mesh__publicMeSHNote mesh__D003427
% 217.35/217.53       91; was see under PARABIOSIS 1975-90; was in Cat G only 1975-78%A%  
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003427 2004
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003427 1997
% 217.35/217.53  |- skos__hiddenLabel mesh__D003427 Circulations, Cross
% 217.35/217.53  |- mesh__onlineNote mesh__D003427 search PARABIOSIS 1970-74   
% 217.35/217.53  |- skos__hiddenLabel mesh__D003427 Cross Circulations
% 217.35/217.53  |- mesh__recordAuthorizer mesh__D003427 PLS
% 217.35/217.53  |- skos__broader mesh__D003427smesh__D010227
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003427 2005
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003427 1998
% 217.35/217.53  |- skos__scopeNote mesh__D003427
% 217.35/217.53       The circulation in a portion of the body of one individual of blood supplied from another individual.%A%    
% 217.35/217.53  |- skos__annotation mesh__D003427 a type of parabiosis; DF: CROSS CIRC   
% 217.35/217.53  |- mesh__dateEstablished mesh__D003427 1991-01-01
% 217.35/217.53  |- mesh__historyNote mesh__D003427
% 217.35/217.53       91%28%75%29%; was see under PARABIOSIS 1975-90; was in Cat G only 1975-78%A%  
% 217.35/217.53  |- skos__altLabel mesh__D003427 Circulation, Cross
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003427 2006
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003427 1999
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D003427 2000
% 217.35/217.53  |- mesh__recordOriginator mesh__D003427 NLM
% 217.35/217.53  |- rdf__type mesh__D003427sskos__Concept
% 217.35/217.53  |- skos__prefLabel mesh__D003427 Cross Circulation
% 217.35/217.53  |- mesh__dateCreated mesh__D003427 1999-01-01
% 217.35/217.53  |- mesh__dateRevised mesh__D003427 1994-06-03
% 217.35/217.53  |- mesh__recordOriginator mesh__D008910 NLM
% 217.35/217.53  |- mesh__recordAuthorizer mesh__D008910 SJN
% 217.35/217.53  |- mesh__recordMaintainer mesh__D008910 PXP
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D008910 2004
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D008910 1999
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D008910 2002
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D008910 2006
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D008910 2003
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D008910 1998
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D008910 2001
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D008910 2005
% 217.35/217.53  |- skos__broader mesh__D008910smesh__D006114
% 217.35/217.53  |- mesh__dateCreated mesh__D008910 1999-01-01
% 217.35/217.53  |- skos__prefLabel mesh__D008910 Minnesota
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D008910 2000
% 217.35/217.53  |- skos__broader mesh__D008910smesh__D015146
% 217.35/217.53  |- rdf__type mesh__D008910sskos__Concept
% 217.35/217.53  |- mesh__dateRevised mesh__D008910 1997-06-20
% 217.35/217.53  |- skos__hiddenLabel mesh__D008112 Glycogen, Liver
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D008112 2005
% 217.35/217.53  |- mesh__recordAuthorizer mesh__D008112 sjn
% 217.35/217.53  |- skos__altLabel mesh__D008112 Hepatic Glycogen
% 217.35/217.53  |- mesh__activeMeSHYear mesh__D008112 2006
% 217.35/217.53  |- skos__hiddenLabel mesh__D008112 Glycogen, Hepatic
% 217.35/217.53  |- skos__prefLabel mesh__D008112 Liver Glycogen
% 217.35/217.53  |- mesh__recordOriginator mesh__D008112 NLM
% 217.35/217.53  |- skos__scopeNote mesh__D008112
% 217.35/217.53       Glycogen stored in the liver. %28%Dorland, 28th ed%29%     
% 217.35/217.53  |- mesh__dateCreated mesh__D008112 1999-01-01
% 217.35/217.53  |- skos__broader mesh__D008112smesh__D006003
% 217.35/217.53  |- mesh__dateRevised mesh__D008112 2004-07-07
% 217.35/217.54  |- mesh__recordMaintainer mesh__D008112 jmp
% 217.35/217.54  |- rdf__type mesh__D008112sskos__Concept
% 217.35/217.54  |- mesh__recordAuthorizer mesh__D013855 sjn
% 217.35/217.54  |- skos__broader mesh__D013855smesh__D006091
% 217.35/217.54  |- mesh__recordOriginator mesh__D013855 NLM
% 217.35/217.54  |- mesh__dateCreated mesh__D013855 1999-01-01
% 217.35/217.54  |- skos__broader mesh__D013855smesh__D043363
% 217.35/217.54  |- skos__prefLabel mesh__D013855 Thiobacillus
% 217.35/217.54  |- rdf__type mesh__D013855sskos__Concept
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D013855 2006
% 217.35/217.54  |- mesh__dateRevised mesh__D013855 2005-06-30
% 217.35/217.54  |- mesh__recordMaintainer mesh__D013855 SYSTEM
% 217.35/217.54  |- skos__scopeNote mesh__D013855
% 217.35/217.54       A genus of gram-negative, rod-shaped bacteria that derives energy from the oxidation of one or more reduced sulfur compounds. Many former species have been reclassified to other classes of PROTEOBACTERIA.%A%    
% 217.35/217.54  |- mesh__recordMaintainer mesh__D013057 lkt
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D013057 2004
% 217.35/217.54  |- skos__scopeNote mesh__D013057
% 217.35/217.54       The measurement of the amplitude of the components of a complex waveform throughout the frequency range of the waveform. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 217.35/217.54  |- skos__broader mesh__D013057smesh__D002623
% 217.35/217.54  |- mesh__recordOriginator mesh__D013057 NLM
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D013057 2006
% 217.35/217.54  |- mesh__dateCreated mesh__D013057 1999-01-01
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D013057 2003
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D013057 2005
% 217.35/217.54  |- skos__hiddenLabel mesh__D013057 Spectrum Analyses
% 217.35/217.54  |- skos__altLabel mesh__D013057 Spectroscopy
% 217.35/217.54  |- rdf__type mesh__D013057sskos__Concept
% 217.35/217.54  |- skos__prefLabel mesh__D013057 Spectrum Analysis
% 217.35/217.54  |- mesh__dateRevised mesh__D013057 2002-07-02
% 217.35/217.54  |- skos__annotation mesh__D013057
% 217.35/217.54       an anal chem technique; GEN or unspecified; prefer specifics; NIM; x-ray absorption spectroscopy goes here + X-RAYS %28%NIM%29%%A%  
% 217.35/217.54  |- skos__hiddenLabel mesh__D013057 Spectroscopies
% 217.35/217.54  |- skos__hiddenLabel mesh__D013057 Analyses, Spectrum
% 217.35/217.54  |- mesh__recordAuthorizer mesh__D013057 sjn
% 217.35/217.54  |- skos__altLabel mesh__D013057 Analysis, Spectrum
% 217.35/217.54  |- skos__hiddenLabel mesh__D007818 Laryngeal Disease
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D007818 2003
% 217.35/217.54  |- skos__hiddenLabel mesh__D007818 Perichondritides, Laryngeal
% 217.35/217.54  |- skos__hiddenLabel mesh__D007818 Perichondritis, Laryngeal
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D007818 2001
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D007818 1997
% 217.35/217.54  |- skos__altLabel mesh__D007818 Larynx Diseases
% 217.35/217.54  |- skos__hiddenLabel mesh__D007818 Larynx Disease
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D007818 2006
% 217.35/217.54  |- mesh__dateCreated mesh__D007818 1999-01-01
% 217.35/217.54  |- skos__broader mesh__D007818smesh__D012140
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D007818 2000
% 217.35/217.54  |- mesh__recordAuthorizer mesh__D007818 PLS
% 217.35/217.54  |- mesh__dateEstablished mesh__D007818 1966-01-01
% 217.35/217.54  |- skos__prefLabel mesh__D007818 Laryngeal Diseases
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D007818 2005
% 217.35/217.54  |- skos__broader mesh__D007818smesh__D010038
% 217.35/217.54  |- skos__hiddenLabel mesh__D007818 Diseases, Laryngeal
% 217.35/217.54  |- mesh__dateRevised mesh__D007818 1996-06-10
% 217.35/217.54  |- skos__hiddenLabel mesh__D007818 Disease, Larynx
% 217.35/217.54  |- skos__hiddenLabel mesh__D007818 Disease, Laryngeal
% 217.35/217.54  |- mesh__publicMeSHNote mesh__D007818
% 217.35/217.54       66; LARYNGEAL PERICHONDRITIS was heading 1963-96   
% 217.35/217.54  |- rdf__type mesh__D007818sskos__Concept
% 217.35/217.54  |- skos__annotation mesh__D007818
% 217.35/217.54       inflamm dis = LARYNGITIS; laryngocele: index under LARYNX /abnorm%A%  
% 217.35/217.54  |- skos__hiddenLabel mesh__D007818 Diseases, Larynx
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D007818 1999
% 217.35/217.54  |- skos__scopeNote mesh__D007818
% 217.35/217.54       Disorders of the larynx, general or unspecified.     
% 217.35/217.54  |- mesh__historyNote mesh__D007818
% 217.35/217.54       66; LARYNGEAL PERICHONDRITIS was heading 1963-96   
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D007818 2002
% 217.35/217.54  |- mesh__recordMaintainer mesh__D007818 PXP
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D007818 2004
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D007818 1998
% 217.35/217.54  |- mesh__recordOriginator mesh__D007818 NLM
% 217.35/217.54  |- skos__hiddenLabel mesh__D007818 Laryngeal Perichondritides
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D018540 2005
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D018540 1995
% 217.35/217.54  |- mesh__dateEstablished mesh__D018540 1995-01-01
% 217.35/217.54  |- skos__historyNote mesh__D018540
% 217.35/217.54       Extraterrestrial Environment %28%1966-1990%29%
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D018540 2006
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D018540 2000
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D018540 1998
% 217.35/217.54  |- skos__annotation mesh__D018540
% 217.35/217.54       7th planet from sun with 5 moons; no qualif   
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D018540 2003
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D018540 1999
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D018540 2001
% 217.35/217.54  |- rdf__type mesh__D018540sskos__Concept
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D018540 2004
% 217.35/217.54  |- skos__broader mesh__D018540smesh__D016083
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D018540 1996
% 217.35/217.54  |- skos__scopeNote mesh__D018540
% 217.35/217.54       The seventh planet in order from the sun. It is one of the five outer planets of the solar system. It has five known natural satellites.%A%    
% 217.35/217.54  |- skos__prefLabel mesh__D018540 Uranus
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D018540 1997
% 217.35/217.54  |- mesh__publicMeSHNote mesh__D018540 95   
% 217.35/217.54  |- skos__historyNote mesh__D018540 Planets %28%1991-1994%29%
% 217.35/217.54  |- mesh__dateCreated mesh__D018540 1994-06-07
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D018540 2002
% 217.35/217.54  |- mesh__historyNote mesh__D018540 95   
% 217.35/217.54  |- rdf__type mesh__D004520sskos__Concept
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D004520 2002
% 217.35/217.54  |- mesh__dateCreated mesh__D004520 1999-01-01
% 217.35/217.54  |- skos__scopeNote mesh__D004520
% 217.35/217.54       Use for general articles concerning veterinary medical education.%A%    
% 217.35/217.54  |- mesh__recordOriginator mesh__D004520 NLM
% 217.35/217.54  |- mesh__publicMeSHNote mesh__D004520 74   
% 217.35/217.54  |- mesh__dateEstablished mesh__D004520 1974-01-01
% 217.35/217.54  |- mesh__historyNote mesh__D004520 74   
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D004520 2003
% 217.35/217.54  |- skos__hiddenLabel mesh__D004520 Educations, Veterinary
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D004520 2005
% 217.35/217.54  |- mesh__dateRevised mesh__D004520 1999-11-03
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D004520 2000
% 217.35/217.54  |- skos__hiddenLabel mesh__D004520 Veterinary Educations
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D004520 2004
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D004520 2001
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D004520 2006
% 217.35/217.54  |- skos__broader mesh__D004520smesh__D004517
% 217.35/217.54  |- skos__prefLabel mesh__D004520 Education, Veterinary
% 217.35/217.54  |- skos__annotation mesh__D004520 DF: EDUC VET   
% 217.35/217.54  |- mesh__recordMaintainer mesh__D004520 kle
% 217.35/217.54  |- mesh__recordAuthorizer mesh__D004520 sjn
% 217.35/217.54  |- skos__altLabel mesh__D004520 Veterinary Education
% 217.35/217.54  |- skos__prefLabel mesh__D051176 beta Catenin
% 217.35/217.54  |- mesh__publicMeSHNote mesh__D051176
% 217.35/217.54       2006; BETA CATENIN was indexed under CYTOSKELETAL PROTEINS %26% TRANS-ACTIVATORS 1993-2005, %26% under CADHERINS 1992%A%  
% 217.35/217.54  |- mesh__historyNote mesh__D051176 2006%28%1992%29%   
% 217.35/217.54  |- mesh__dateEstablished mesh__D051176 2006-01-01
% 217.35/217.54  |- mesh__recordAuthorizer mesh__D051176 sjn
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D051176 2006
% 217.35/217.54  |- skos__scopeNote mesh__D051176
% 217.35/217.54       A multi-functional catenin that participates in CELL ADHESION and nuclear signaling. Beta catenin binds CADHERINS and helps link their cytoplasmic tails to the ACTIN in the CYTOSKELETON via ALPHA CATENIN. It also serves as a transcriptional co-activator and downstream component of WNT PROTEIN-mediated SIGNAL TRANSDUCTION PATHWAYS.%A%    
% 217.35/217.54  |- skos__broader mesh__D051176smesh__D014157
% 217.35/217.54  |- skos__hiddenLabel mesh__D051176 Catenin, beta
% 217.35/217.54  |- mesh__recordOriginator mesh__D051176 DRC
% 217.35/217.54  |- skos__broader mesh__D051176smesh__D051186
% 217.35/217.54  |- rdf__type mesh__D051176sskos__Concept
% 217.35/217.54  |- skos__broader mesh__D051176smesh__D051177
% 217.35/217.54  |- mesh__dateCreated mesh__D051176 2005-06-30
% 217.35/217.54  |- mesh__recordMaintainer mesh__D051176 DRC
% 217.35/217.54  |- skos__altLabel mesh__D051176 beta-Catenin
% 217.35/217.54  |- skos__prefLabel mesh__D017448 Receptors, Dopamine D2
% 217.35/217.54  |- mesh__dateRevised mesh__D017448 2005-06-30
% 217.35/217.54  |- mesh__publicMeSHNote mesh__D017448
% 217.35/217.54       93; DOPAMINE-D2 RECEPTOR was indexed under RECEPTORS, DOPAMINE 1982-92%A%  
% 217.35/217.54  |- mesh__recordMaintainer mesh__D017448 DRC
% 217.35/217.54  |- skos__hiddenLabel mesh__D017448 Dopamine D2 Receptor
% 217.35/217.54  |- skos__scopeNote mesh__D017448
% 217.35/217.54       A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects.  D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLATE CYCLASE.%A%    
% 217.35/217.54  |- mesh__historyNote mesh__D017448
% 217.35/217.54       93; was DOPAMINE-D2 RECEPTOR %28%NM%29% 1982-92   
% 217.35/217.54  |- skos__broader mesh__D017448smesh__D011954
% 217.35/217.54  |- skos__altLabel mesh__D017448 Dopamine D2 Receptors
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D017448 2006
% 217.35/217.54  |- skos__historyNote mesh__D017448 Receptors, Dopamine %28%1982-1992%29%
% 217.35/217.54  |- mesh__recordOriginator mesh__D017448 PXP
% 217.35/217.54  |- mesh__onlineNote mesh__D017448
% 217.35/217.54       use RECEPTORS, DOPAMINE D2 %28%NM%29% to search DOPAMINE-D2 RECEPTOR 1982-92%A%  
% 217.35/217.54  |- skos__hiddenLabel mesh__D017448 Receptor, Dopamine-D2
% 217.35/217.54  |- mesh__dateCreated mesh__D017448 1992-05-22
% 217.35/217.54  |- skos__annotation mesh__D017448 DF: RECEPT DOPAMINE D2   
% 217.35/217.54  |- mesh__dateEstablished mesh__D017448 1993-01-01
% 217.35/217.54  |- skos__altLabel mesh__D017448 Dopamine-D2 Receptor
% 217.35/217.54  |- skos__hiddenLabel mesh__D017448 D2 Receptors, Dopamine
% 217.35/217.54  |- mesh__recordAuthorizer mesh__D017448 sjn
% 217.35/217.54  |- rdf__type mesh__D017448sskos__Concept
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D036602 2003
% 217.35/217.54  |- mesh__publicMeSHNote mesh__D036602 2003   
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D036602 2004
% 217.35/217.54  |- skos__broader mesh__D036602smesh__D019659
% 217.35/217.54  |- mesh__dateEstablished mesh__D036602 2003-01-01
% 217.35/217.54  |- rdf__type mesh__D036602sskos__Concept
% 217.35/217.54  |- skos__annotation mesh__D036602
% 217.35/217.54       EUPATORIUM REBAUDIANUM see STEVIA; EUPATORIUM ODORATUM see CHROMOLAENA and EUPATORIUM ADENOPHORUM see AGERATINA are also available; for other species check plant taxonomy reference: Manual 22.37; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.35/217.54  |- mesh__historyNote mesh__D036602 2003   
% 217.35/217.54  |- skos__prefLabel mesh__D036602 Eupatorium
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D036602 2005
% 217.35/217.54  |- mesh__dateCreated mesh__D036602 2002-07-03
% 217.35/217.54  |- skos__scopeNote mesh__D036602
% 217.35/217.54       A plant genus of the family ASTERACEAE. Ingestion has been associated with MILK SICKNESS. The common name of thoroughwort is also used for other plants including CHROMOLAENA; Hebeclinium, and Koanophyllon.%A%    
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D036602 2006
% 217.35/217.54  |- skos__altLabel mesh__D003428 Nosocomial Infections
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D003428 2000
% 217.35/217.54  |- mesh__dateRevised mesh__D003428 1993-06-21
% 217.35/217.54  |- skos__annotation mesh__D003428
% 217.35/217.54       restricted to any infect from one patient to another or from health care worker to patient %22%in a health-care institution%22%; also available for dis from patient to health care worker is DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL and for health care worker to patient is DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT%A%  
% 217.35/217.54  |- skos__altLabel mesh__D003428 Infection, Cross
% 217.35/217.54  |- skos__broader mesh__D003428smesh__D007239
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D003428 2005
% 217.35/217.54  |- skos__prefLabel mesh__D003428 Cross Infection
% 217.35/217.54  |- rdf__type mesh__D003428sskos__Concept
% 217.35/217.54  |- skos__related mesh__D003428smesh__D010356
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D003428 1998
% 217.35/217.54  |- mesh__historyNote mesh__D003428
% 217.35/217.54       HOSPITAL INFECTIONS was see under CROSS INFECTION 1971-78, was see CROSS INFECTIONS 1963-70%A%  
% 217.35/217.54  |- skos__related mesh__D003428smesh__D017053
% 217.35/217.54  |- skos__related mesh__D003428smesh__D017714
% 217.35/217.54  |- skos__hiddenLabel mesh__D003428 Cross Infections
% 217.35/217.54  |- skos__related mesh__D003428smesh__D017757
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D003428 2004
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D003428 1997
% 217.35/217.54  |- skos__related mesh__D003428smesh__D010357
% 217.35/217.54  |- skos__hiddenLabel mesh__D003428 Hospital Infection
% 217.35/217.54  |- skos__altLabel mesh__D003428 Hospital Infections
% 217.35/217.54  |- mesh__recordOriginator mesh__D003428 NLM
% 217.35/217.54  |- skos__related mesh__D003428smesh__D017758
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D003428 2003
% 217.35/217.54  |- skos__hiddenLabel mesh__D003428 Infection, Hospital
% 217.35/217.54  |- skos__hiddenLabel mesh__D003428 Infection, Nosocomial
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D003428 1996
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D003428 2002
% 217.35/217.54  |- skos__hiddenLabel mesh__D003428 Infections, Cross
% 217.35/217.54  |- mesh__onlineNote mesh__D003428
% 217.35/217.54       use CROSS INFECTION to search HOSPITAL INFECTIONS 1966-78%A%  
% 217.35/217.54  |- skos__hiddenLabel mesh__D003428 Nosocomial Infection
% 217.35/217.54  |- skos__scopeNote mesh__D003428
% 217.35/217.54       Any infection which a patient contracts in a health-care institution.%A%    
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D003428 1995
% 217.35/217.54  |- mesh__recordMaintainer mesh__D003428 RAZ
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D003428 2001
% 217.35/217.54  |- mesh__recordAuthorizer mesh__D003428 PLS
% 217.35/217.54  |- mesh__dateCreated mesh__D003428 1999-01-01
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D003428 2006
% 217.35/217.54  |- skos__altLabel mesh__D003428 Infections, Nosocomial
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D003428 1999
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D003428 1994
% 217.35/217.54  |- skos__broader mesh__D014150smesh__D014149
% 217.35/217.54  |- mesh__recordAuthorizer mesh__D014150 sjn
% 217.35/217.54  |- mesh__dateCreated mesh__D014150 1999-01-01
% 217.35/217.54  |- skos__hiddenLabel mesh__D014150 Agents, Major Tranquilizing
% 217.35/217.54  |- skos__prefLabel mesh__D014150 Antipsychotic Agents
% 217.35/217.54  |- skos__annotation mesh__D014150
% 217.35/217.54       GEN or unspecified; prefer specific groups or specific drugs; consider also PSYCHOSES /drug ther%A%  
% 217.35/217.54  |- mesh__onlineNote mesh__D014150
% 217.35/217.54       use ANTIPSYCHOTIC AGENTS to search TRANQUILIZING AGENTS, MAJOR 1975-94; use TRANQUILIZING AGENTS to search NEUROLEPTICS 1969-94%A%  
% 217.35/217.54  |- rdf__type mesh__D014150sskos__Concept
% 217.35/217.54  |- skos__related mesh__D014150smesh__D018492
% 217.35/217.54  |- skos__hiddenLabel mesh__D014150 Major Tranquilizing Agents
% 217.35/217.54  |- skos__altLabel mesh__D014150 Tranquilizing Agents, Major
% 217.35/217.54  |- skos__hiddenLabel mesh__D014150 Major Tranquillizing Agents
% 217.35/217.54  |- skos__altLabel mesh__D014150 Antipsychotics
% 217.35/217.54  |- skos__altLabel mesh__D014150 Major Tranquilizers
% 217.35/217.54  |- skos__altLabel mesh__D014150 Neuroleptics
% 217.35/217.54  |- skos__hiddenLabel mesh__D014150 Drugs, Antipsychotic
% 217.35/217.54  |- skos__hiddenLabel mesh__D014150 Agents, Major Tranquillizing
% 217.35/217.54  |- skos__altLabel mesh__D014150 Neuroleptic Agents
% 217.35/217.54  |- skos__altLabel mesh__D014150 Antipsychotic Drugs
% 217.35/217.54  |- mesh__historyNote mesh__D014150
% 217.35/217.54       95; was TRANQUILIZING AGENTS, MAJOR 1975-94; ANTIPSYCHOTIC AGENTS was see TRANQUILIZING AGENTS, MAJOR 1975-94; NEUROLEPTICS was see TRANQUILIZING AGENTS 1975-78, was see under TRANQUILIZING AGENTS 1969-74%A%  
% 217.35/217.54  |- skos__historyNote mesh__D014150 Tranquilizing Agents %28%1966-1974%29%
% 217.35/217.54  |- skos__scopeNote mesh__D014150
% 217.35/217.54       Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in schizophrenia, senile dementia, transient psychosis following surgery or myocardial infarction, etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.%A%    
% 217.35/217.54  |- skos__altLabel mesh__D014150 Tranquillizing Agents, Major
% 217.35/217.54  |- mesh__dateEstablished mesh__D014150 1975-09-01
% 217.35/217.54  |- mesh__publicMeSHNote mesh__D014150
% 217.35/217.54       95; was TRANQUILIZING AGENTS, MAJOR 1975-94; ANTIPSYCHOTIC AGENTS was see TRANQUILIZING AGENTS, MAJOR 1975-94; NEUROLEPTICS was see TRANQUILIZING AGENTS 1975-78, was see under TRANQUILIZING AGENTS 1969-74%A%  
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D014150 2006
% 217.35/217.54  |- skos__hiddenLabel mesh__D014150 Tranquilizers, Major
% 217.35/217.54  |- skos__hiddenLabel mesh__D014150 Drugs, Neuroleptic
% 217.35/217.54  |- skos__altLabel mesh__D014150 Neuroleptic Drugs
% 217.35/217.54  |- mesh__recordMaintainer mesh__D014150 ssb
% 217.35/217.54  |- mesh__dateRevised mesh__D014150 2005-06-30
% 217.35/217.54  |- skos__hiddenLabel mesh__D014150 Agents, Neuroleptic
% 217.35/217.54  |- mesh__recordOriginator mesh__D014150 NLM
% 217.35/217.54  |- skos__hiddenLabel mesh__D014150 Agents, Antipsychotic
% 217.35/217.54  |- skos__altLabel mesh__D008911 Ichthyol Brand of Minocycline Hydrochloride
% 217.35/217.54  |- skos__hiddenLabel mesh__D008911 Mino Wolff
% 217.35/217.54  |- skos__altLabel mesh__D008911 Apotex Brand of Minocycline Hydrochloride
% 217.35/217.54  |- skos__altLabel mesh__D008911 Mestacine
% 217.35/217.54  |- skos__hiddenLabel mesh__D008911 Aknin Mino
% 217.35/217.54  |- skos__altLabel mesh__D008911
% 217.35/217.54       Alphapharm Brand of Minocycline Hydrochloride
% 217.35/217.54  |- rdf__type mesh__D008911sskos__Concept
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D008911 2006
% 217.35/217.54  |- skos__altLabel mesh__D008911
% 217.35/217.54       Sanofi Synthelabo Brand of Minocycline Hydrochloride
% 217.35/217.54  |- mesh__dateCreated mesh__D008911 1999-01-01
% 217.35/217.54  |- skos__altLabel mesh__D008911
% 217.35/217.54       Lederle Brand 2 of Minocycline Hydrochloride
% 217.35/217.54  |- skos__hiddenLabel mesh__D008911 Icht Oral
% 217.35/217.54  |- skos__historyNote mesh__D008911 Tetracycline %28%1966-1972%29%
% 217.35/217.54  |- skos__altLabel mesh__D008911 APS Brand of Minocycline Hydrochloride
% 217.35/217.54  |- skos__altLabel mesh__D008911 Minotab
% 217.35/217.54  |- skos__altLabel mesh__D008911 Minocycline Monohydrochloride
% 217.35/217.54  |- skos__altLabel mesh__D008911 Rowa Brand of Minocycline
% 217.35/217.54  |- skos__altLabel mesh__D008911 Wyeth Brand of Minocycline Hydrochloride
% 217.35/217.54  |- mesh__dateRevised mesh__D008911 2005-06-30
% 217.35/217.54  |- skos__hiddenLabel mesh__D008911 Akne Puren
% 217.35/217.54  |- skos__altLabel mesh__D008911 Mynocine
% 217.35/217.54  |- skos__altLabel mesh__D008911 Crookes Brand of Minocycline Hydrochloride
% 217.35/217.54  |- skos__altLabel mesh__D008911 AHP Brand of Minocycline Hydrochloride
% 217.35/217.54  |- skos__altLabel mesh__D008911 Faulding Brand of Minocycline Hydrochloride
% 217.35/217.54  |- skos__altLabel mesh__D008911
% 217.35/217.54       Blackwell Brand of Minocycline Hydrochloride
% 217.35/217.54  |- skos__altLabel mesh__D008911
% 217.35/217.54       Jenapharm Brand of Minocycline Hydrochloride
% 217.35/217.54  |- mesh__publicMeSHNote mesh__D008911
% 217.35/217.54       91; was see under TETRACYCLINES 1973-90   
% 217.35/217.54  |- mesh__recordMaintainer mesh__D008911 CCR
% 217.35/217.54  |- skos__altLabel mesh__D008911 Minocin MR
% 217.35/217.54  |- skos__altLabel mesh__D008911 Merck Brand of Minocycline Hydrochloride
% 217.35/217.54  |- mesh__dateEstablished mesh__D008911 1991-01-01
% 217.35/217.54  |- skos__altLabel mesh__D008911
% 217.35/217.54       OraPharma Brand of Minocycline Hydrochloride
% 217.35/217.54  |- skos__altLabel mesh__D008911 Wolff Brand of Minocycline Hydrochloride
% 217.35/217.54  |- mesh__historyNote mesh__D008911
% 217.35/217.54       91%28%73%29%; was see under TETRACYCLINES 1973-90   
% 217.35/217.54  |- skos__altLabel mesh__D008911
% 217.35/217.54       Ashbourne Brand of Minocycline Hydrochloride
% 217.35/217.54  |- mesh__recordAuthorizer mesh__D008911 sjn
% 217.35/217.54  |- skos__altLabel mesh__D008911 ICN Brand of Minocycline Hydrochloride
% 217.35/217.54  |- skos__altLabel mesh__D008911 Bioglan Brand of Minocycline Hydrochloride
% 217.35/217.54  |- skos__altLabel mesh__D008911 Alpharma Brand of Minocycline Hydrochloride
% 217.35/217.54  |- skos__altLabel mesh__D008911 Rosen Brand of Minocycline Hydrochloride
% 217.35/217.54  |- skos__broader mesh__D008911smesh__D013754
% 217.35/217.54  |- skos__altLabel mesh__D008911
% 217.35/217.54       Expanscience Brand of Minocycline Hydrochloride
% 217.35/217.54  |- skos__hiddenLabel mesh__D008911 Monohydrochloride, Minocycline
% 217.35/217.54  |- skos__altLabel mesh__D008911 Medicis Brand of Minocycline Hydrochloride
% 217.35/217.54  |- mesh__recordOriginator mesh__D008911 NLM
% 217.35/217.54  |- skos__altLabel mesh__D008911 Hermal Brand of Minocycline Hydrochloride
% 217.35/217.54  |- skos__altLabel mesh__D008911
% 217.35/217.54       Lederle Brand 1 of Minocycline Hydrochloride
% 217.35/217.54  |- skos__hiddenLabel mesh__D008911 Hydrochloride, Minocycline
% 217.35/217.54  |- skos__altLabel mesh__D008911 Minomycin
% 217.35/217.54  |- skos__prefLabel mesh__D008911 Minocycline
% 217.35/217.54  |- skos__hiddenLabel mesh__D008911 Apo Minocycline
% 217.35/217.54  |- skos__scopeNote mesh__D008911
% 217.35/217.54       A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections.%A%    
% 217.35/217.54  |- skos__altLabel mesh__D008113 Hepatic Cancer
% 217.35/217.54  |- skos__hiddenLabel mesh__D008113 Neoplasm, Liver
% 217.35/217.54  |- skos__annotation mesh__D008113
% 217.35/217.54       coord IM with histol type of neopl %28%IM%29%, including HEPATOMA %28%IM%29%; LIVER NEOPLASMS, EXPERIMENTAL is available; be careful: do not confuse %22%hepatic neopl%22% with %22%intrahepatic neopl%22%: %22%intrahepatic neopl%22% may refer to BILE DUCT NEOPLASMS with regard to BILE DUCTS, INTRAHEPATIC, not LIVER NEOPLASMS%A%  
% 217.35/217.54  |- skos__broader mesh__D008113smesh__D008107
% 217.35/217.54  |- skos__altLabel mesh__D008113 Neoplasms, Hepatic
% 217.35/217.54  |- skos__hiddenLabel mesh__D008113 Hepatic Neoplasm
% 217.35/217.54  |- mesh__dateCreated mesh__D008113 1999-01-01
% 217.35/217.54  |- skos__altLabel mesh__D008113 Neoplasms, Liver
% 217.35/217.54  |- skos__hiddenLabel mesh__D008113 Liver Cancers
% 217.35/217.54  |- mesh__recordMaintainer mesh__D008113 lkt
% 217.35/217.54  |- skos__hiddenLabel mesh__D008113 Liver Neoplasm
% 217.35/217.54  |- skos__hiddenLabel mesh__D008113 Hepatic Cancers
% 217.35/217.54  |- skos__altLabel mesh__D008113 Liver Cancer
% 217.35/217.54  |- skos__altLabel mesh__D008113 Cancer of the Liver
% 217.35/217.54  |- skos__hiddenLabel mesh__D008113 Cancer, Liver
% 217.35/217.54  |- mesh__dateRevised mesh__D008113 2003-07-09
% 217.35/217.54  |- skos__prefLabel mesh__D008113 Liver Neoplasms
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D008113 2004
% 217.35/217.54  |- rdf__type mesh__D008113sskos__Concept
% 217.35/217.54  |- skos__hiddenLabel mesh__D008113 Neoplasm, Hepatic
% 217.35/217.54  |- skos__hiddenLabel mesh__D008113 Cancers, Hepatic
% 217.35/217.54  |- skos__altLabel mesh__D008113 Hepatic Neoplasms
% 217.35/217.54  |- mesh__recordAuthorizer mesh__D008113 sjn
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D008113 2005
% 217.35/217.54  |- skos__hiddenLabel mesh__D008113 Cancers, Liver
% 217.35/217.54  |- mesh__recordOriginator mesh__D008113 NLM
% 217.35/217.54  |- skos__broader mesh__D008113smesh__D004067
% 217.35/217.54  |- skos__hiddenLabel mesh__D008113 Cancer, Hepatic
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D008113 2006
% 217.35/217.54  |- skos__scopeNote mesh__D008113 Tumors or cancer of the LIVER.     
% 217.35/217.54  |- mesh__recordMaintainer mesh__D000130 lkt
% 217.35/217.54  |- rdf__type mesh__D000130sskos__Concept
% 217.35/217.54  |- mesh__recordAuthorizer mesh__D000130 sjn
% 217.35/217.54  |- skos__scopeNote mesh__D000130
% 217.35/217.54       An autosomal dominant disorder that is the most frequent form of short-limb dwarfism. Affected individuals exhibit short stature caused by rhizomelic shortening of the limbs, characteristic facies with frontal bossing and mid-face hypoplasia, exaggerated lumbar lordosis, limitation of elbow extension, genu varum, and trident hand. %28%Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim, MIM%23%100800, April 20, 2001%29%%A%    
% 217.35/217.54  |- skos__prefLabel mesh__D000130 Achondroplasia
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D000130 2006
% 217.35/217.54  |- mesh__dateRevised mesh__D000130 2005-06-30
% 217.35/217.54  |- mesh__recordOriginator mesh__D000130 NLM
% 217.35/217.54  |- skos__broader mesh__D000130smesh__D010009
% 217.35/217.54  |- skos__hiddenLabel mesh__D000130 Achondroplasias
% 217.35/217.54  |- skos__broader mesh__D000130smesh__D004392
% 217.35/217.54  |- mesh__dateCreated mesh__D000130 1999-01-01
% 217.35/217.54  |- mesh__historyNote mesh__D013856 2004 %28%1972%29%   
% 217.35/217.54  |- rdf__type mesh__D013856sskos__Concept
% 217.35/217.54  |- mesh__dateRevised mesh__D013856 2005-06-30
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D013856 2006
% 217.35/217.54  |- skos__scopeNote mesh__D013856
% 217.35/217.54       A strictly autotrophic species of bacteria that oxidizes sulfur and thiosulfate to sulfuric acid. It was formerly called Thiobacillus thiooxidans.%A%    
% 217.35/217.54  |- skos__altLabel mesh__D013856 Thiobacillus thiooxidans
% 217.35/217.54  |- skos__annotation mesh__D013856 THIOBACILLUS is also available   
% 217.35/217.54  |- mesh__publicMeSHNote mesh__D013856
% 217.35/217.54       2004; see THIOBACILLUS THIOOXIDANS 1991-2003,  see THIOBACILLUS 1972-1990%A%  
% 217.35/217.54  |- skos__historyNote mesh__D013856 Thiobacillus %28%1966-1971%29%
% 217.35/217.54  |- mesh__recordAuthorizer mesh__D013856 sjn
% 217.35/217.54  |- skos__broader mesh__D013856smesh__D042763
% 217.35/217.54  |- mesh__recordOriginator mesh__D013856 NLM
% 217.35/217.54  |- mesh__recordMaintainer mesh__D013856 SYSTEM
% 217.35/217.54  |- mesh__dateEstablished mesh__D013856 1991-01-01
% 217.35/217.54  |- mesh__dateCreated mesh__D013856 1999-01-01
% 217.35/217.54  |- skos__prefLabel mesh__D013856 Acidithiobacillus thiooxidans
% 217.35/217.54  |- skos__hiddenLabel mesh__D013058 Analyses, Mass Spectrum
% 217.35/217.54  |- mesh__dateCreated mesh__D013058 1999-01-01
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D013058 2003
% 217.35/217.54  |- skos__altLabel mesh__D013058 Spectroscopy, Mass
% 217.35/217.54  |- mesh__recordAuthorizer mesh__D013058 sjn
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D013058 2005
% 217.35/217.54  |- skos__historyNote mesh__D013058 Spectrum Analysis %28%1966-1970%29%
% 217.35/217.54  |- mesh__recordMaintainer mesh__D013058 lkt
% 217.35/217.54  |- skos__prefLabel mesh__D013058 Spectrum Analysis, Mass
% 217.35/217.54  |- skos__altLabel mesh__D013058 Analysis, Mass Spectrum
% 217.35/217.54  |- skos__broader mesh__D013058smesh__D013057
% 217.35/217.54  |- mesh__dateEstablished mesh__D013058 1974-01-01
% 217.35/217.54  |- skos__altLabel mesh__D013058 Mass Spectrometry
% 217.35/217.54  |- mesh__recordOriginator mesh__D013058 NLM
% 217.35/217.54  |- skos__annotation mesh__D013058
% 217.35/217.54       mass refers to the mass of the object being analyzed; NIM%A%  
% 217.35/217.54  |- rdf__type mesh__D013058sskos__Concept
% 217.35/217.54  |- skos__altLabel mesh__D013058 Mass Spectrum Analysis
% 217.35/217.54  |- skos__scopeNote mesh__D013058
% 217.35/217.54       Analysis of the mass of an object through means of determining the wave length%28%s%29% at which electromagnetic energy is absorbed by that object.%A%    
% 217.35/217.54  |- skos__altLabel mesh__D013058 Mass Spectroscopy
% 217.35/217.54  |- skos__hiddenLabel mesh__D013058 Spectrum Analyses, Mass
% 217.35/217.54  |- skos__hiddenLabel mesh__D013058 Mass Spectrum Analyses
% 217.35/217.54  |- mesh__historyNote mesh__D013058
% 217.35/217.54       74; was MASS SPECTRUM ANALYSIS 1971-73 %28%Prov%29%   
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D013058 2004
% 217.35/217.54  |- skos__altLabel mesh__D013058 Spectrometry, Mass
% 217.35/217.54  |- mesh__onlineNote mesh__D013058
% 217.35/217.54       use SPECTRUM ANALYSIS, MASS to search MASS SPECTRUM ANALYSIS 1971-73 %28%as Prov 1971-73%29%%A%  
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D013058 2006
% 217.35/217.54  |- mesh__publicMeSHNote mesh__D013058 74   
% 217.35/217.54  |- mesh__dateRevised mesh__D013058 2002-07-02
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D007819 1996
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D007819 2005
% 217.35/217.54  |- skos__broader mesh__D007819smesh__D007818
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D007819 1997
% 217.35/217.54  |- skos__hiddenLabel mesh__D007819 Laryngeal Edemas
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D007819 2006
% 217.35/217.54  |- mesh__recordOriginator mesh__D007819 NLM
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D007819 2000
% 217.35/217.54  |- mesh__recordAuthorizer mesh__D007819 PLS
% 217.35/217.54  |- mesh__dateRevised mesh__D007819 1995-06-08
% 217.35/217.54  |- skos__hiddenLabel mesh__D007819 Edema, Laryngeal
% 217.35/217.54  |- skos__scopeNote mesh__D007819
% 217.35/217.54       Edema of any region of the larynx from a variety of causes. In the earliest stages it may be difficult to differentiate from infection, although mucosal injection and erythema are found more often in the latter. Allergic edema may result as a response from provocation induced by foods, inhalants, and drugs. The entire respiratory tract or only an isolated portion of the larynx may be affected. Laryngeal edema may also be hereditary. Other possible causes of laryngeal edema include increased capillary pressure due to superior vena cava syndrome, internal jugular vein ligation, lowered plasma osmotic failure induced by renal failure, impaired lymphatic flow, and increased capillary permeability to proteins. %28%From Paparella et al., Otolaryngology, 3d ed, p2253%29%%A%    
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D007819 1998
% 217.35/217.54  |- skos__hiddenLabel mesh__D007819 Edemas, Laryngeal
% 217.35/217.54  |- skos__prefLabel mesh__D007819 Laryngeal Edema
% 217.35/217.54  |- rdf__type mesh__D007819sskos__Concept
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D007819 2001
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D007819 2003
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D007819 1999
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D007819 2002
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D007819 2004
% 217.35/217.54  |- mesh__dateCreated mesh__D007819 1999-01-01
% 217.35/217.54  |- mesh__recordMaintainer mesh__D007819 TAP
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D018541 2006
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D018541 1998
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D018541 2002
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D018541 2003
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D018541 1999
% 217.35/217.54  |- rdf__type mesh__D018541sskos__Concept
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D018541 2004
% 217.35/217.54  |- mesh__dateEstablished mesh__D018541 1995-01-01
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D018541 1996
% 217.35/217.54  |- skos__historyNote mesh__D018541
% 217.35/217.54       Extraterrestrial Environment %28%1966-1990%29%
% 217.35/217.54  |- mesh__activeMeSHYear mesh__D018541 2000
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D018541 1997
% 217.35/217.55  |- skos__historyNote mesh__D018541 Planets %28%1991-1994%29%
% 217.35/217.55  |- mesh__dateCreated mesh__D018541 1994-06-07
% 217.35/217.55  |- skos__scopeNote mesh__D018541
% 217.35/217.55       The eighth planet in order from the sun. It is one of the five outer planets of the solar system. Its two natural satellites are Nereid and Triton.%A%    
% 217.35/217.55  |- skos__annotation mesh__D018541
% 217.35/217.55       8th planet from sun with 2 moons; no qualif   
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D018541 2001
% 217.35/217.55  |- mesh__historyNote mesh__D018541 95   
% 217.35/217.55  |- skos__broader mesh__D018541smesh__D016083
% 217.35/217.55  |- skos__prefLabel mesh__D018541 Neptune
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D018541 2005
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D018541 1995
% 217.35/217.55  |- mesh__publicMeSHNote mesh__D018541 95   
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004521 2001
% 217.35/217.55  |- mesh__onlineNote mesh__D004521
% 217.35/217.55       use EDUCATIONAL MEASUREMENT to search GRADUATE RECORDS EXAMINATION 1966-82%A%  
% 217.35/217.55  |- mesh__recordMaintainer mesh__D004521 TGC
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004521 1996
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004521 2005
% 217.35/217.55  |- skos__hiddenLabel mesh__D004521 Educational Assessments
% 217.35/217.55  |- skos__prefLabel mesh__D004521 Educational Measurement
% 217.35/217.55  |- skos__altLabel mesh__D004521 Examination, Graduate Records
% 217.35/217.55  |- skos__altLabel mesh__D004521 Measurement, Educational
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004521 2004
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004521 1998
% 217.35/217.55  |- skos__related mesh__D004521smesh__D001077
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004521 1997
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004521 2006
% 217.35/217.55  |- mesh__publicMeSHNote mesh__D004521
% 217.35/217.55       66; GRADUATE RECORDS EXAMINATION was see under EDUCATIONAL MEASUREMENT 1966-82%A%  
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004521 1999
% 217.35/217.55  |- skos__hiddenLabel mesh__D004521 Examinations, Graduate Records
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004521 2002
% 217.35/217.55  |- skos__hiddenLabel mesh__D004521 Measurements, Educational
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004521 1995
% 217.35/217.55  |- mesh__dateRevised mesh__D004521 1994-01-25
% 217.35/217.55  |- skos__annotation mesh__D004521 DF: EDUC MEASUREMENT   
% 217.35/217.55  |- mesh__dateEstablished mesh__D004521 1966-01-01
% 217.35/217.55  |- skos__hiddenLabel mesh__D004521 Graduate Records Examinations
% 217.35/217.55  |- mesh__recordOriginator mesh__D004521 NLM
% 217.35/217.55  |- rdf__type mesh__D004521sskos__Concept
% 217.35/217.55  |- mesh__dateCreated mesh__D004521 1999-01-01
% 217.35/217.55  |- skos__altLabel mesh__D004521 Assessment, Educational
% 217.35/217.55  |- skos__hiddenLabel mesh__D004521 Assessments, Educational
% 217.35/217.55  |- mesh__recordAuthorizer mesh__D004521 PLS
% 217.35/217.55  |- skos__broader mesh__D004521smesh__D004493
% 217.35/217.55  |- skos__scopeNote mesh__D004521
% 217.35/217.55       The assessing of academic or educational achievement. It includes all aspects of testing and test construction.%A%    
% 217.35/217.55  |- mesh__historyNote mesh__D004521
% 217.35/217.55       66; GRADUATE RECORDS EXAMINATION was see under EDUCATIONAL MEASUREMENT 1966-82%A%  
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004521 2000
% 217.35/217.55  |- skos__hiddenLabel mesh__D004521 Educational Measurements
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004521 2003
% 217.35/217.55  |- mesh__dateCreated mesh__D051177 2005-06-30
% 217.35/217.55  |- mesh__recordOriginator mesh__D051177 DRC
% 217.35/217.55  |- rdf__type mesh__D051177sskos__Concept
% 217.35/217.55  |- skos__scopeNote mesh__D051177
% 217.35/217.55       A family of cytoskeletal proteins that play essential roles in CELL ADHESION at ADHERENS JUNCTIONS by linking CADHERINS to the ACTIN FILAMENTS of the CYTOSKELETON.%A%    
% 217.35/217.55  |- mesh__historyNote mesh__D051177 2006   
% 217.35/217.55  |- mesh__dateEstablished mesh__D051177 2006-01-01
% 217.35/217.55  |- skos__prefLabel mesh__D051177 Catenins
% 217.35/217.55  |- skos__altLabel mesh__D051177 Catenin Proteins
% 217.35/217.55  |- mesh__recordAuthorizer mesh__D051177 sjn
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D051177 2006
% 217.35/217.55  |- mesh__publicMeSHNote mesh__D051177 2006   
% 217.35/217.55  |- mesh__recordMaintainer mesh__D051177 DRC
% 217.35/217.55  |- skos__broader mesh__D051177smesh__D003598
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D017449 2002
% 217.35/217.55  |- mesh__dateEstablished mesh__D017449 1993-01-01
% 217.35/217.55  |- skos__broader mesh__D017449smesh__D006968
% 217.35/217.55  |- rdf__type mesh__D017449sskos__Concept
% 217.35/217.55  |- skos__altLabel mesh__D017449 Dermatitis, Contact, Allergic
% 217.35/217.55  |- skos__scopeNote mesh__D017449
% 217.35/217.55       A contact dermatitis due to allergic sensitization to various substances. These substances subsequently produce inflammatory reactions in the skin of those who have acquired hypersensitivity to them as a result of prior exposure.%A%    
% 217.35/217.55  |- mesh__dateRevised mesh__D017449 2001-08-14
% 217.35/217.55  |- skos__related mesh__D017449smesh__D020315
% 217.35/217.55  |- skos__altLabel mesh__D017449 Allergic Contact Dermatitis
% 217.35/217.55  |- skos__hiddenLabel mesh__D017449 Contact Dermatitides, Allergic
% 217.35/217.55  |- mesh__historyNote mesh__D017449 93   
% 217.35/217.55  |- skos__altLabel mesh__D017449 Dermatitis, Allergic Eczematous
% 217.35/217.55  |- skos__broader mesh__D017449smesh__D003877
% 217.35/217.55  |- skos__hiddenLabel mesh__D017449 Dermatitides, Allergic Contact
% 217.35/217.55  |- skos__prefLabel mesh__D017449 Dermatitis, Allergic Contact
% 217.35/217.55  |- skos__hiddenLabel mesh__D017449 Eczematous Dermatitis, Allergic
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D017449 2004
% 217.35/217.55  |- mesh__publicMeSHNote mesh__D017449 93   
% 217.35/217.55  |- skos__hiddenLabel mesh__D017449 Dermatitides, Allergic Eczematous
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D017449 2006
% 217.35/217.55  |- mesh__dateCreated mesh__D017449 1992-05-20
% 217.35/217.55  |- mesh__recordOriginator mesh__D017449 PLS
% 217.35/217.55  |- mesh__recordMaintainer mesh__D017449 NLM
% 217.35/217.55  |- skos__hiddenLabel mesh__D017449 Eczematous Dermatitides, Allergic
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D017449 2003
% 217.35/217.55  |- skos__hiddenLabel mesh__D017449 Allergic Eczematous Dermatitis
% 217.35/217.55  |- skos__hiddenLabel mesh__D017449 Contact Dermatitis, Allergic
% 217.35/217.55  |- skos__historyNote mesh__D017449 Dermatitis, Contact %28%1966-1992%29%
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D017449 2005
% 217.35/217.55  |- skos__hiddenLabel mesh__D017449 Allergic Contact Dermatitides
% 217.35/217.55  |- skos__hiddenLabel mesh__D017449 Allergic Eczematous Dermatitides
% 217.35/217.55  |- mesh__recordAuthorizer mesh__D017449 NLM
% 217.35/217.55  |- skos__broader mesh__D036603smesh__D019659
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D036603 2004
% 217.35/217.55  |- rdf__type mesh__D036603sskos__Concept
% 217.35/217.55  |- mesh__dateCreated mesh__D036603 2002-07-02
% 217.35/217.55  |- skos__scopeNote mesh__D036603
% 217.35/217.55       A plant genus of the family ASTERACEAE. The common name of snakeroot is also used for POLYGALA; SANICULA; ARISTOLOCHIA and others.%A%    
% 217.35/217.55  |- mesh__dateEstablished mesh__D036603 2003-01-01
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D036603 2005
% 217.35/217.55  |- mesh__historyNote mesh__D036603 2003   
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D036603 2006
% 217.35/217.55  |- skos__prefLabel mesh__D036603 Ageratina
% 217.35/217.55  |- skos__annotation mesh__D036603
% 217.35/217.55       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D036603 2003
% 217.35/217.55  |- mesh__publicMeSHNote mesh__D036603 2003   
% 217.35/217.55  |- skos__altLabel mesh__D036603 Eupatorium adenophorum
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D003429 1993
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D003429 2006
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D003429 1999
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D003429 1994
% 217.35/217.55  |- mesh__dateCreated mesh__D003429 1999-01-01
% 217.35/217.55  |- mesh__recordMaintainer mesh__D003429 TAP
% 217.35/217.55  |- rdf__type mesh__D003429sskos__Concept
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D003429 2000
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D003429 1995
% 217.35/217.55  |- skos__prefLabel mesh__D003429 Cross Reactions
% 217.35/217.55  |- mesh__dateRevised mesh__D003429 1992-05-14
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D003429 2003
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D003429 1996
% 217.35/217.55  |- skos__broader mesh__D003429smesh__D000937
% 217.35/217.55  |- mesh__publicMeSHNote mesh__D003429 72   
% 217.35/217.55  |- mesh__recordOriginator mesh__D003429 NLM
% 217.35/217.55  |- skos__hiddenLabel mesh__D003429 Reactions, Cross
% 217.35/217.55  |- skos__historyNote mesh__D003429
% 217.35/217.55       Antigen-Antibody Reactions %28%1966-1968%29%
% 217.35/217.55  |- skos__hiddenLabel mesh__D003429 Cross Reaction
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D003429 2001
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D003429 2004
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D003429 1997
% 217.35/217.55  |- mesh__dateEstablished mesh__D003429 1972-01-01
% 217.35/217.55  |- skos__annotation mesh__D003429
% 217.35/217.55       IM GEN only; NIM with specific antigen or antibody %28%IM%29%   
% 217.35/217.55  |- skos__scopeNote mesh__D003429
% 217.35/217.55       Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen.%A%    
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D003429 2002
% 217.35/217.55  |- skos__hiddenLabel mesh__D003429 Reaction, Cross
% 217.35/217.55  |- mesh__historyNote mesh__D003429 72%28%69%29%   
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D003429 2005
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D003429 1998
% 217.35/217.55  |- mesh__recordAuthorizer mesh__D003429 PLS
% 217.35/217.55  |- skos__prefLabel mesh__D014151 Anti-Anxiety Agents
% 217.35/217.55  |- rdf__type mesh__D014151sskos__Concept
% 217.35/217.55  |- mesh__recordMaintainer mesh__D014151 ssb
% 217.35/217.55  |- mesh__recordOriginator mesh__D014151 NLM
% 217.35/217.55  |- mesh__dateRevised mesh__D014151 2005-06-30
% 217.35/217.55  |- skos__altLabel mesh__D014151 Tranquilizing Agents, Minor
% 217.35/217.55  |- skos__hiddenLabel mesh__D014151 Minor Tranquilizing Agents
% 217.35/217.55  |- skos__hiddenLabel mesh__D014151 Anti Anxiety Drugs
% 217.35/217.55  |- mesh__recordAuthorizer mesh__D014151 sjn
% 217.35/217.55  |- skos__altLabel mesh__D014151 Anti-Anxiety Drugs
% 217.35/217.55  |- skos__hiddenLabel mesh__D014151 Agents, Anxiolytic
% 217.35/217.55  |- skos__altLabel mesh__D014151 Anxiolytic Agents
% 217.35/217.55  |- mesh__publicMeSHNote mesh__D014151
% 217.35/217.55       95; was TRANQUILIZING AGENTS, MINOR 1975-94; ANTI-ANXIETY AGENTS was see TRANQUILIZING AGENTS, MINOR 1975-94%A%  
% 217.35/217.55  |- skos__hiddenLabel mesh__D014151 Anti Anxiety Agents
% 217.35/217.55  |- skos__hiddenLabel mesh__D014151 Agents, Minor Tranquilizing
% 217.35/217.55  |- skos__altLabel mesh__D014151 Tranquillizing Agents, Minor
% 217.35/217.55  |- mesh__dateEstablished mesh__D014151 1975-09-01
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014151 2006
% 217.35/217.55  |- skos__related mesh__D014151smesh__D000319
% 217.35/217.55  |- skos__hiddenLabel mesh__D014151 Agents, Anti-Anxiety
% 217.35/217.55  |- skos__hiddenLabel mesh__D014151 Agents, Minor Tranquillizing
% 217.35/217.55  |- skos__hiddenLabel mesh__D014151 Drugs, Anti-Anxiety
% 217.35/217.55  |- skos__broader mesh__D014151smesh__D014149
% 217.35/217.55  |- skos__scopeNote mesh__D014151
% 217.35/217.55       Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. Some are also effective as anticonvulsants, muscle relaxants, or anesthesia adjuvants. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.%A%    
% 217.35/217.55  |- mesh__historyNote mesh__D014151
% 217.35/217.55       95; was TRANQUILIZING AGENTS, MINOR 1975-94; ANTI-ANXIETY AGENTS was see TRANQUILIZING AGENTS, MINOR 1975-94%A%  
% 217.35/217.55  |- mesh__dateCreated mesh__D014151 1999-01-01
% 217.35/217.55  |- skos__historyNote mesh__D014151 Tranquilizing Agents %28%1966-1974%29%
% 217.35/217.55  |- skos__hiddenLabel mesh__D014151 Minor Tranquillizing Agents
% 217.35/217.55  |- mesh__onlineNote mesh__D014151
% 217.35/217.55       use ANTI-ANXIETY AGENTS to search TRANQUILIZING AGENTS, MINOR 1975-94%A%  
% 217.35/217.55  |- skos__altLabel mesh__D014151 Anxiolytics
% 217.35/217.55  |- skos__historyNote mesh__D008912 T Lymphocytes %28%1973-1982%29%
% 217.35/217.55  |- mesh__dateRevised mesh__D008912 2005-06-30
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D008912 2006
% 217.35/217.55  |- skos__broader mesh__D008912smesh__D005796
% 217.35/217.55  |- skos__scopeNote mesh__D008912
% 217.35/217.55       Genetic loci responsible for the encoding of histocompatibility antigens other than those encoded by the MAJOR HISTOCOMPATIBILITY COMPLEX. The antigens encoded by these genes are often responsible for graft rejection in cases where histocompatibility has been established by standard tests. The location of some of these loci on the X and Y chromosomes explains why grafts from males to females may be rejected while grafts from females to males are accepted. In the mouse roughly 30 minor histocompatibility loci have been recognized, comprising more than 500 genes.%A%    
% 217.35/217.55  |- mesh__dateCreated mesh__D008912 1982-04-19
% 217.35/217.55  |- skos__hiddenLabel mesh__D008912 Loci, Minor Histocompatibility
% 217.35/217.55  |- mesh__publicMeSHNote mesh__D008912 83   
% 217.35/217.55  |- skos__hiddenLabel mesh__D008912 Histocompatibility Locus, Minor
% 217.35/217.55  |- skos__altLabel mesh__D008912 Histocompatibility Loci, Minor
% 217.35/217.55  |- skos__broader mesh__D008912smesh__D007125
% 217.35/217.55  |- skos__historyNote mesh__D008912 H-2 Antigens %28%1978-1982%29%
% 217.35/217.55  |- mesh__dateEstablished mesh__D008912 1983-01-01
% 217.35/217.55  |- mesh__recordOriginator mesh__D008912 AEP
% 217.35/217.55  |- skos__hiddenLabel mesh__D008912 Locus, Minor Histocompatibility
% 217.35/217.55  |- mesh__recordAuthorizer mesh__D008912 sjn
% 217.35/217.55  |- skos__annotation mesh__D008912 DF: MHL   
% 217.35/217.55  |- rdf__type mesh__D008912sskos__Concept
% 217.35/217.55  |- skos__prefLabel mesh__D008912 Minor Histocompatibility Loci
% 217.35/217.55  |- skos__historyNote mesh__D008912
% 217.35/217.55       Histocompatibility Antigens %28%1973-1982%29%
% 217.35/217.55  |- mesh__recordMaintainer mesh__D008912 nns
% 217.35/217.55  |- skos__hiddenLabel mesh__D008912 Minor Histocompatibility Locus
% 217.35/217.55  |- mesh__historyNote mesh__D008912 83   
% 217.35/217.55  |- skos__broader mesh__D004194Q000235smesh__D004194
% 217.35/217.55  |- mesh__preferredCombination mesh__D004194Q000235smesh__D030342
% 217.35/217.55  |- rdf__type mesh__D004194Q000235smesh__CompoundConcept
% 217.35/217.55  |- mesh__publicMeSHNote mesh__D008114
% 217.35/217.55       85; was HEPATOMA, EXPERIMENTAL 1979-84   
% 217.35/217.55  |- skos__altLabel mesh__D008114 Hepatomas, Experimental
% 217.35/217.55  |- skos__annotation mesh__D008114
% 217.35/217.55       animal only; don%27%t forget check tag ANIMALS; DF: LIVER NEOPL EXPER%A%  
% 217.35/217.55  |- skos__broader mesh__D008114smesh__D008113
% 217.35/217.55  |- skos__historyNote mesh__D008114
% 217.35/217.55       Neoplasms, Experimental %28%1966-1978%29%
% 217.35/217.55  |- skos__scopeNote mesh__D008114
% 217.35/217.55       Experimentally induced tumors of the LIVER.     
% 217.35/217.55  |- skos__altLabel mesh__D008114 Neoplasms, Experimental Liver
% 217.35/217.55  |- mesh__onlineNote mesh__D008114
% 217.35/217.55       use LIVER NEOPLASMS, EXPERIMENTAL to search HEPATOMA, EXPERIMENTAL 1979-84%A%  
% 217.35/217.55  |- mesh__dateEstablished mesh__D008114 1979-01-01
% 217.35/217.55  |- skos__altLabel mesh__D008114 Experimental Liver Neoplasms
% 217.35/217.55  |- mesh__recordOriginator mesh__D008114 VDK
% 217.35/217.55  |- skos__broader mesh__D008114smesh__D009374
% 217.35/217.55  |- skos__historyNote mesh__D008114 Hepatoma %28%1966-1978%29%
% 217.35/217.55  |- mesh__dateRevised mesh__D008114 2004-07-07
% 217.35/217.55  |- rdf__type mesh__D008114sskos__Concept
% 217.35/217.55  |- skos__prefLabel mesh__D008114 Liver Neoplasms, Experimental
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D008114 2005
% 217.35/217.55  |- skos__hiddenLabel mesh__D008114 Novikoff Hepatoma
% 217.35/217.55  |- skos__hiddenLabel mesh__D008114 Morris Hepatoma
% 217.35/217.55  |- mesh__recordMaintainer mesh__D008114 lkt
% 217.35/217.55  |- skos__historyNote mesh__D008114 Liver Neoplasms %28%1966-1978%29%
% 217.35/217.55  |- skos__altLabel mesh__D008114 Hepatoma, Experimental
% 217.35/217.55  |- skos__altLabel mesh__D008114 Experimental Hepatomas
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D008114 2006
% 217.35/217.55  |- skos__hiddenLabel mesh__D008114 Liver Neoplasm, Experimental
% 217.35/217.55  |- skos__hiddenLabel mesh__D008114 Experimental Liver Neoplasm
% 217.35/217.55  |- mesh__historyNote mesh__D008114
% 217.35/217.55       85; was HEPATOMA, EXPERIMENTAL 1979-84   
% 217.35/217.55  |- mesh__dateCreated mesh__D008114 1977-12-06
% 217.35/217.55  |- mesh__recordAuthorizer mesh__D008114 sjn
% 217.35/217.55  |- skos__altLabel mesh__D013059 Raman Spectrum Analysis
% 217.35/217.55  |- rdf__type mesh__D013059sskos__Concept
% 217.35/217.55  |- skos__prefLabel mesh__D013059 Spectrum Analysis, Raman
% 217.35/217.55  |- mesh__dateRevised mesh__D013059 2003-07-09
% 217.35/217.55  |- skos__scopeNote mesh__D013059
% 217.35/217.55       Analysis of the intensity of Raman scattering of monochromatic light as a function of frequency of the scattered light.%A%    
% 217.35/217.55  |- mesh__publicMeSHNote mesh__D013059 77   
% 217.35/217.55  |- skos__altLabel mesh__D013059 Raman Spectroscopy
% 217.35/217.55  |- skos__hiddenLabel mesh__D013059 Spectroscopy, Raman
% 217.35/217.55  |- mesh__dateEstablished mesh__D013059 1977-01-01
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D013059 2004
% 217.35/217.55  |- mesh__recordAuthorizer mesh__D013059 sjn
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D013059 2006
% 217.35/217.55  |- mesh__dateCreated mesh__D013059 1976-04-16
% 217.35/217.55  |- mesh__historyNote mesh__D013059 77   
% 217.35/217.55  |- skos__altLabel mesh__D013059 Analysis, Raman Spectrum
% 217.35/217.55  |- mesh__recordOriginator mesh__D013059 VDK
% 217.35/217.55  |- mesh__recordMaintainer mesh__D013059 ssb
% 217.35/217.55  |- skos__broader mesh__D013059smesh__D012542
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D013059 2005
% 217.35/217.55  |- skos__historyNote mesh__D013059 Spectrum Analysis %28%1966-1976%29%
% 217.35/217.55  |- skos__broader mesh__D013059smesh__D013057
% 217.35/217.55  |- skos__historyNote mesh__D013059 Scattering, Radiation %28%1971-1976%29%
% 217.35/217.55  |- mesh__dateEstablished mesh__D018542 1995-01-01
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D018542 1995
% 217.35/217.55  |- skos__scopeNote mesh__D018542
% 217.35/217.55       The ninth planet in order from the sun. It is one of the five outer planets of the solar system. Its only natural satellite is Charon.%A%    
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D018542 2006
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D018542 2001
% 217.35/217.55  |- skos__annotation mesh__D018542
% 217.35/217.55       9th %28%farthest%29% planet from sun with 1 moon; no qualif   
% 217.35/217.55  |- skos__prefLabel mesh__D018542 Pluto
% 217.35/217.55  |- skos__historyNote mesh__D018542
% 217.35/217.55       Extraterrestrial Environment %28%1966-1990%29%
% 217.35/217.55  |- mesh__publicMeSHNote mesh__D018542 95   
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D018542 2005
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D018542 2004
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D018542 1999
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D018542 2000
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D018542 2003
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D018542 1998
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D018542 1997
% 217.35/217.55  |- rdf__type mesh__D018542sskos__Concept
% 217.35/217.55  |- skos__broader mesh__D018542smesh__D016083
% 217.35/217.55  |- mesh__dateCreated mesh__D018542 1994-06-07
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D018542 1996
% 217.35/217.55  |- skos__historyNote mesh__D018542 Planets %28%1991-1994%29%
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D018542 2002
% 217.35/217.55  |- mesh__historyNote mesh__D018542 95   
% 217.35/217.55  |- skos__broader mesh__D004522smesh__D012959
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004522 2006
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004522 1997
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004522 2000
% 217.35/217.55  |- skos__altLabel mesh__D004522 Achievement, Educational
% 217.35/217.55  |- skos__historyNote mesh__D004522 Students %28%1966-1967%29%
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004522 1999
% 217.35/217.55  |- mesh__dateRevised mesh__D004522 1995-06-08
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004522 2001
% 217.35/217.55  |- skos__annotation mesh__D004522 NIM; no qualif   
% 217.35/217.55  |- rdf__type mesh__D004522sskos__Concept
% 217.35/217.55  |- mesh__dateCreated mesh__D004522 1999-01-01
% 217.35/217.55  |- skos__hiddenLabel mesh__D004522 Achievements, Educational
% 217.35/217.55  |- mesh__publicMeSHNote mesh__D004522 68   
% 217.35/217.55  |- skos__hiddenLabel mesh__D004522 Educational Achievements
% 217.35/217.55  |- skos__altLabel mesh__D004522 Status, Educational
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004522 2002
% 217.35/217.55  |- mesh__historyNote mesh__D004522 68   
% 217.35/217.55  |- mesh__recordMaintainer mesh__D004522 PLS
% 217.35/217.55  |- skos__altLabel mesh__D004522 Educational Achievement
% 217.35/217.55  |- skos__scopeNote mesh__D004522
% 217.35/217.55       Educational attainment or level of education of individuals.%A%    
% 217.35/217.55  |- skos__prefLabel mesh__D004522 Educational Status
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004522 2003
% 217.35/217.55  |- mesh__recordOriginator mesh__D004522 NLM
% 217.35/217.55  |- skos__altLabel mesh__D004522 Maternal Educational Status
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004522 1996
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004522 2005
% 217.35/217.55  |- skos__hiddenLabel mesh__D004522 Status, Maternal Educational
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004522 2004
% 217.35/217.55  |- mesh__recordAuthorizer mesh__D004522 PLS
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D004522 1998
% 217.35/217.55  |- skos__historyNote mesh__D004522 Sociology %28%1966-1967%29%
% 217.35/217.55  |- mesh__dateEstablished mesh__D004522 1968-01-01
% 217.35/217.55  |- skos__hiddenLabel mesh__D051178 E-Catenin, alpha
% 217.35/217.55  |- skos__hiddenLabel mesh__D051178 Cadherin Associated Protein 102 kDa
% 217.35/217.55  |- mesh__recordMaintainer mesh__D051178 DRC
% 217.35/217.55  |- skos__broader mesh__D051178smesh__D051177
% 217.35/217.55  |- skos__hiddenLabel mesh__D051178 Catenin, alphaE
% 217.35/217.55  |- mesh__dateCreated mesh__D051178 2005-06-30
% 217.35/217.55  |- skos__hiddenLabel mesh__D051178 alpha Catulin
% 217.35/217.55  |- skos__hiddenLabel mesh__D051178 alpha 1 Catenin
% 217.35/217.55  |- skos__altLabel mesh__D051178 Cadherin-Associated Protein 102 kDa
% 217.35/217.55  |- skos__hiddenLabel mesh__D051178 Catenin, alpha-1
% 217.35/217.55  |- skos__hiddenLabel mesh__D051178 alpha E Catenin
% 217.35/217.55  |- skos__altLabel mesh__D051178 CAP102 Protein
% 217.35/217.55  |- skos__altLabel mesh__D051178 alpha E-Catenin
% 217.35/217.55  |- mesh__dateEstablished mesh__D051178 2006-01-01
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D051178 2006
% 217.35/217.55  |- skos__hiddenLabel mesh__D051178 Catenin, alpha
% 217.35/217.55  |- skos__altLabel mesh__D051178 alphaE Catenin
% 217.35/217.55  |- skos__altLabel mesh__D051178 alpha-1 Catenin
% 217.35/217.55  |- mesh__recordAuthorizer mesh__D051178 sjn
% 217.35/217.55  |- mesh__publicMeSHNote mesh__D051178
% 217.35/217.55       2006; ALPHA CATENIN was indexed under CYTOSKELETAL PROTEINS 1994-2000; %26% under CADHERINS 1991-1993%A%  
% 217.35/217.55  |- skos__prefLabel mesh__D051178 alpha Catenin
% 217.35/217.55  |- mesh__historyNote mesh__D051178 2006%28%1991%29%   
% 217.35/217.55  |- skos__scopeNote mesh__D051178
% 217.35/217.55       A catenin that binds F-ACTIN and links the CYTOSKELETON with BETA CATENIN and GAMMA CATENIN.%A%    
% 217.35/217.55  |- mesh__recordOriginator mesh__D051178 DRC
% 217.35/217.55  |- skos__altLabel mesh__D051178 alpha-Catenin
% 217.35/217.55  |- rdf__type mesh__D051178sskos__Concept
% 217.35/217.55  |- skos__broader mesh__D014950smesh__D014947
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014950 1999
% 217.35/217.55  |- rdf__type mesh__D014950sskos__Concept
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014950 1993
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014950 2002
% 217.35/217.55  |- mesh__recordOriginator mesh__D014950 SMH
% 217.35/217.55  |- skos__prefLabel mesh__D014950 Wounds, Penetrating
% 217.35/217.55  |- skos__hiddenLabel mesh__D014950 Wound, Penetrating
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014950 2006
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014950 1998
% 217.35/217.55  |- skos__historyNote mesh__D014950
% 217.35/217.55       specific heading/injuries %28%1966-1975%29%
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014950 1992
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014950 2001
% 217.35/217.55  |- mesh__dateRevised mesh__D014950 1991-02-21
% 217.35/217.55  |- mesh__publicMeSHNote mesh__D014950 76   
% 217.35/217.55  |- skos__hiddenLabel mesh__D014950 Penetrating Wounds
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014950 1997
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014950 2005
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014950 2000
% 217.35/217.55  |- mesh__recordMaintainer mesh__D014950 PLS
% 217.35/217.55  |- skos__scopeNote mesh__D014950
% 217.35/217.55       Wounds caused by objects penetrating the skin.     
% 217.35/217.55  |- mesh__historyNote mesh__D014950 76   
% 217.35/217.55  |- skos__hiddenLabel mesh__D014950 Penetrating Wound
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014950 2004
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014950 1996
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014950 1995
% 217.35/217.55  |- mesh__recordAuthorizer mesh__D014950 PLS
% 217.35/217.55  |- mesh__dateEstablished mesh__D014950 1976-01-01
% 217.35/217.55  |- mesh__dateCreated mesh__D014950 1975-07-25
% 217.35/217.55  |- skos__annotation mesh__D014950
% 217.35/217.55       note WOUNDS, GUNSHOT %26% WOUNDS, STAB; IM; coord with organ /inj or precoord inj term %28%IM%29%%A%  
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014950 2003
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014950 1994
% 217.35/217.55  |- skos__altLabel mesh__D036604 Eupatorium odoratum
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D036604 2005
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D036604 2006
% 217.35/217.55  |- mesh__dateCreated mesh__D036604 2002-07-03
% 217.35/217.55  |- skos__prefLabel mesh__D036604 Chromolaena
% 217.35/217.55  |- skos__annotation mesh__D036604
% 217.35/217.55       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D036604 2003
% 217.35/217.55  |- mesh__publicMeSHNote mesh__D036604 2003   
% 217.35/217.55  |- skos__scopeNote mesh__D036604
% 217.35/217.55       A plant genus of the family ASTERACEAE. The common name of thoroughwort is also used for other plants including EUPATORIUM; CHROMOLAENA, Hebeclinium and Koanophyllon. Eupolin is the aqueous extract of the leaves.%A%    
% 217.35/217.55  |- skos__broader mesh__D036604smesh__D019659
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D036604 2004
% 217.35/217.55  |- mesh__dateEstablished mesh__D036604 2003-01-01
% 217.35/217.55  |- rdf__type mesh__D036604sskos__Concept
% 217.35/217.55  |- mesh__historyNote mesh__D036604 2003   
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014152 2002
% 217.35/217.55  |- skos__annotation mesh__D014152
% 217.35/217.55       a psychoanal technique; DF: TRANSACTIONAL ANAL   
% 217.35/217.55  |- skos__broader mesh__D014152smesh__D011575
% 217.35/217.55  |- skos__prefLabel mesh__D014152 Transactional Analysis
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014152 2006
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014152 2004
% 217.35/217.55  |- mesh__dateEstablished mesh__D014152 1979-01-01
% 217.35/217.55  |- mesh__publicMeSHNote mesh__D014152
% 217.35/217.55       79; was see under PSYCHOANALYTIC THERAPY 1975-78   
% 217.35/217.55  |- skos__hiddenLabel mesh__D014152 Analyses, Transactional
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014152 2005
% 217.35/217.55  |- mesh__recordAuthorizer mesh__D014152 PLS
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014152 2001
% 217.35/217.55  |- mesh__dateRevised mesh__D014152 1995-05-31
% 217.35/217.55  |- mesh__recordMaintainer mesh__D014152 TGC
% 217.35/217.55  |- mesh__dateCreated mesh__D014152 1999-01-01
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014152 2003
% 217.35/217.55  |- skos__altLabel mesh__D014152 Analysis, Transactional
% 217.35/217.55  |- mesh__recordOriginator mesh__D014152 NLM
% 217.35/217.55  |- mesh__historyNote mesh__D014152
% 217.35/217.55       79%28%73%29%; was see under PSYCHOANALYTIC THERAPY 1975-78   
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014152 2000
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014152 1999
% 217.35/217.55  |- skos__scopeNote mesh__D014152
% 217.35/217.55       A psychoanalytic therapy wherein each social transaction is analyzed to determine the involved ego state %28%whether parent-like, child-like, or adult-like%29% as a basis for understanding behavior.%A%    
% 217.35/217.55  |- skos__historyNote mesh__D014152 Psychoanalytic Therapy %28%1973-1978%29%
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014152 1997
% 217.35/217.55  |- rdf__type mesh__D014152sskos__Concept
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014152 1998
% 217.35/217.55  |- skos__hiddenLabel mesh__D014152 Transactional Analyses
% 217.35/217.55  |- mesh__activeMeSHYear mesh__D014152 1996
% 217.35/217.55  |- mesh__recordOriginator mesh__D008913 NLM
% 217.35/217.55  |- mesh__historyNote mesh__D008913 68   
% 217.35/217.55  |- rdf__type mesh__D008913sskos__Concept
% 217.35/217.55  |- skos__historyNote mesh__D008913 Jews %28%1966-1967%29%
% 217.35/217.56  |- skos__hiddenLabel mesh__D008913 Minority Group
% 217.35/217.56  |- skos__historyNote mesh__D008913 Blacks %28%1966-1967%29%
% 217.35/217.56  |- skos__annotation mesh__D008913
% 217.35/217.56       IM; coord with specific minority group %28%IM%29% %26% geog   
% 217.35/217.56  |- mesh__publicMeSHNote mesh__D008913 68   
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008913 2003
% 217.35/217.56  |- skos__hiddenLabel mesh__D008913 Groups, Minority
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008913 2005
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008913 2004
% 217.35/217.56  |- skos__historyNote mesh__D008913 Attitude %28%1966-1967%29%
% 217.35/217.56  |- skos__prefLabel mesh__D008913 Minority Groups
% 217.35/217.56  |- mesh__dateCreated mesh__D008913 1999-01-01
% 217.35/217.56  |- skos__hiddenLabel mesh__D008913 Group, Minority
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008913 2006
% 217.35/217.56  |- mesh__recordMaintainer mesh__D008913 KEV
% 217.35/217.56  |- mesh__dateEstablished mesh__D008913 1968-01-01
% 217.35/217.56  |- mesh__dateRevised mesh__D008913 2002-07-03
% 217.35/217.56  |- skos__broader mesh__D008913smesh__D012961
% 217.35/217.56  |- skos__historyNote mesh__D008913 Prejudice %28%1966-1967%29%
% 217.35/217.56  |- mesh__recordAuthorizer mesh__D008913 sjn
% 217.35/217.56  |- skos__scopeNote mesh__D008913
% 217.35/217.56       A subgroup having special characteristics within a larger group, often bound together by special ties which distinguish it from the larger group.%A%    
% 217.35/217.56  |- mesh__dateEstablished mesh__D000930 1975-09-01
% 217.35/217.56  |- mesh__recordMaintainer mesh__D000930 ssb
% 217.35/217.56  |- mesh__recordAuthorizer mesh__D000930 sjn
% 217.35/217.56  |- skos__scopeNote mesh__D000930
% 217.35/217.56       Miscellaneous agents found useful in the symptomatic treatment of diarrhea. They have no effect on the agent%28%s%29% that cause diarrhea, but merely alleviate the condition.%A%    
% 217.35/217.56  |- skos__prefLabel mesh__D000930 Antidiarrheals
% 217.35/217.56  |- skos__hiddenLabel mesh__D000930 Agents, Antiperistaltic
% 217.35/217.56  |- skos__hiddenLabel mesh__D000930 Drugs, Antiperistaltic
% 217.35/217.56  |- skos__altLabel mesh__D000930 Antiperistaltics
% 217.35/217.56  |- skos__altLabel mesh__D000930 Antidiarrheal Drugs
% 217.35/217.56  |- mesh__historyNote mesh__D000930
% 217.35/217.56       75; was see under GASTROINTESTINAL AGENTS 1969-74   
% 217.35/217.56  |- skos__altLabel mesh__D000930 Antiperistaltic Drugs
% 217.35/217.56  |- mesh__dateRevised mesh__D000930 2005-06-30
% 217.35/217.56  |- skos__historyNote mesh__D000930
% 217.35/217.56       Gastrointestinal Agents %28%1967-1974%29%
% 217.35/217.56  |- skos__hiddenLabel mesh__D000930 Drugs, Antidiarrheal
% 217.35/217.56  |- skos__annotation mesh__D000930 consider also DIARRHEA /drug ther   
% 217.35/217.56  |- rdf__type mesh__D000930sskos__Concept
% 217.35/217.56  |- skos__hiddenLabel mesh__D000930 Agents, Antidiarrheal
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D000930 2006
% 217.35/217.56  |- mesh__recordOriginator mesh__D000930 NLM
% 217.35/217.56  |- mesh__onlineNote mesh__D000930 search GASTROINTESTINAL AGENTS 1969-74   
% 217.35/217.56  |- skos__altLabel mesh__D000930 Antidiarrheal Agents
% 217.35/217.56  |- skos__broader mesh__D000930smesh__D005765
% 217.35/217.56  |- mesh__publicMeSHNote mesh__D000930
% 217.35/217.56       75; was see under GASTROINTESTINAL AGENTS 1969-74   
% 217.35/217.56  |- mesh__dateCreated mesh__D000930 1999-01-01
% 217.35/217.56  |- skos__hiddenLabel mesh__D008115 Regenerations, Liver
% 217.35/217.56  |- skos__hiddenLabel mesh__D008115 Regeneration, Liver
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008115 1997
% 217.35/217.56  |- mesh__dateEstablished mesh__D008115 1964-01-01
% 217.35/217.56  |- mesh__recordAuthorizer mesh__D008115 PLS
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008115 2005
% 217.35/217.56  |- mesh__recordMaintainer mesh__D008115 TAP
% 217.35/217.56  |- skos__broader mesh__D008115smesh__D004068
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008115 1996
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008115 2000
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008115 1995
% 217.35/217.56  |- skos__prefLabel mesh__D008115 Liver Regeneration
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008115 2004
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008115 1994
% 217.35/217.56  |- mesh__recordOriginator mesh__D008115 NLM
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008115 2003
% 217.35/217.56  |- skos__broader mesh__D008115smesh__D012038
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008115 1999
% 217.35/217.56  |- mesh__historyNote mesh__D008115 64   
% 217.35/217.56  |- mesh__dateRevised mesh__D008115 1992-03-25
% 217.35/217.56  |- skos__annotation mesh__D008115 IM   
% 217.35/217.56  |- rdf__type mesh__D008115sskos__Concept
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008115 1993
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008115 1998
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008115 2002
% 217.35/217.56  |- skos__hiddenLabel mesh__D008115 Liver Regenerations
% 217.35/217.56  |- mesh__publicMeSHNote mesh__D008115 64   
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008115 2006
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008115 2001
% 217.35/217.56  |- mesh__dateCreated mesh__D008115 1999-01-01
% 217.35/217.56  |- skos__scopeNote mesh__D008115 Repair or renewal of hepatic tissue.     
% 217.35/217.56  |- skos__scopeNote mesh__D013858
% 217.35/217.56       Compounds in which one or more of the ketone groups on the pyrimidine ring of barbituric acid are replaced by thione groups.%A%    
% 217.35/217.56  |- mesh__dateEstablished mesh__D013858 1975-09-01
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013858 2001
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013858 1998
% 217.35/217.56  |- rdf__type mesh__D013858sskos__Concept
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013858 2006
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013858 2000
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013858 1996
% 217.35/217.56  |- mesh__dateRevised mesh__D013858 1992-05-20
% 217.35/217.56  |- skos__historyNote mesh__D013858 Barbiturates %28%1966-1974%29%
% 217.35/217.56  |- mesh__recordAuthorizer mesh__D013858 PLS
% 217.35/217.56  |- mesh__recordOriginator mesh__D013858 NLM
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013858 2004
% 217.35/217.56  |- skos__prefLabel mesh__D013858 Thiobarbiturates
% 217.35/217.56  |- mesh__historyNote mesh__D013858 75   
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013858 2005
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013858 2003
% 217.35/217.56  |- mesh__recordMaintainer mesh__D013858 TAP
% 217.35/217.56  |- mesh__publicMeSHNote mesh__D013858 75   
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013858 2002
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013858 1995
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013858 1993
% 217.35/217.56  |- skos__broader mesh__D013858smesh__D001463
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013858 1999
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013858 1994
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013858 1997
% 217.35/217.56  |- mesh__dateCreated mesh__D013858 1974-11-11
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018543 2006
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018543 2002
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018543 2005
% 217.35/217.56  |- skos__altLabel mesh__D018543 Asteroids
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018543 2004
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018543 1999
% 217.35/217.56  |- mesh__dateEstablished mesh__D018543 1995-01-01
% 217.35/217.56  |- skos__broader mesh__D018543smesh__D016082
% 217.35/217.56  |- skos__hiddenLabel mesh__D018543 Minor Planet
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018543 2003
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018543 1998
% 217.35/217.56  |- skos__altLabel mesh__D018543 Planetoids
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018543 1997
% 217.35/217.56  |- rdf__type mesh__D018543sskos__Concept
% 217.35/217.56  |- skos__annotation mesh__D018543 no qualif   
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018543 2001
% 217.35/217.56  |- skos__hiddenLabel mesh__D018543 Planetoid
% 217.35/217.56  |- skos__historyNote mesh__D018543 Solar System %28%1991-1994%29%
% 217.35/217.56  |- mesh__dateCreated mesh__D018543 1994-06-07
% 217.35/217.56  |- skos__historyNote mesh__D018543
% 217.35/217.56       Extraterrestrial Environment %28%1966-1990%29%
% 217.35/217.56  |- mesh__publicMeSHNote mesh__D018543 95   
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018543 1996
% 217.35/217.56  |- skos__scopeNote mesh__D018543
% 217.35/217.56       Small solar system planetary bodies including asteroids. Most asteroids are found within the gap lying between the orbits of Mars and Jupiter.%A%    
% 217.35/217.56  |- skos__prefLabel mesh__D018543 Minor Planets
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018543 2000
% 217.35/217.56  |- mesh__historyNote mesh__D018543 95   
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018543 1995
% 217.35/217.56  |- skos__hiddenLabel mesh__D018543 Asteroid
% 217.35/217.56  |- skos__altLabel mesh__D018543 Planets, Minor
% 217.35/217.56  |- skos__hiddenLabel mesh__D018543 Planet, Minor
% 217.35/217.56  |- skos__hiddenLabel mesh__D010560 Activity, Recruitment
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D010560 1999
% 217.35/217.56  |- skos__prefLabel mesh__D010560 Personnel Selection
% 217.35/217.56  |- mesh__dateCreated mesh__D010560 1977-05-12
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D010560 2006
% 217.35/217.56  |- mesh__recordAuthorizer mesh__D010560 PLS
% 217.35/217.56  |- skos__hiddenLabel mesh__D010560 Recruitment, Personnel
% 217.35/217.56  |- skos__hiddenLabel mesh__D010560 Personnel Selections
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D010560 2002
% 217.35/217.56  |- mesh__recordOriginator mesh__D010560 EC
% 217.35/217.56  |- skos__hiddenLabel mesh__D010560 Selections, Personnel
% 217.35/217.56  |- mesh__publicMeSHNote mesh__D010560
% 217.35/217.56       91; was see under PERSONNEL MANAGEMENT Aug 1977-90   
% 217.35/217.56  |- mesh__dateRevised mesh__D010560 1994-03-17
% 217.35/217.56  |- mesh__recordMaintainer mesh__D010560 NLM
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D010560 1998
% 217.35/217.56  |- skos__hiddenLabel mesh__D010560 Selection, Personnel
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D010560 2005
% 217.35/217.56  |- skos__hiddenLabel mesh__D010560 Activities, Recruitment
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D010560 2001
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D010560 1997
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D010560 2004
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D010560 2000
% 217.35/217.56  |- rdf__type mesh__D010560sskos__Concept
% 217.35/217.56  |- skos__hiddenLabel mesh__D010560 Recruitment Activity
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D010560 1996
% 217.35/217.56  |- mesh__dateEstablished mesh__D010560 1991-01-01
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D010560 1995
% 217.35/217.56  |- skos__hiddenLabel mesh__D010560 Recruitments, Personnel
% 217.35/217.56  |- skos__hiddenLabel mesh__D010560 Personnel Recruitments
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D010560 2003
% 217.35/217.56  |- skos__scopeNote mesh__D010560
% 217.35/217.56       The process of choosing employees for specific types of employment. The concept includes recruitment.%A%    
% 217.35/217.56  |- skos__broader mesh__D010560smesh__D010559
% 217.35/217.56  |- mesh__historyNote mesh__D010560
% 217.35/217.56       91%28%Aug 77%29%; was see under PERSONNEL MANAGEMENT 1977-90   
% 217.35/217.56  |- skos__altLabel mesh__D051179 Cytolinker Proteins
% 217.35/217.56  |- skos__altLabel mesh__D051179 Cytoskeletal Linker Proteins
% 217.35/217.56  |- mesh__dateEstablished mesh__D051179 2006-01-01
% 217.35/217.56  |- mesh__recordAuthorizer mesh__D051179 sjn
% 217.35/217.56  |- mesh__recordMaintainer mesh__D051179 DRC
% 217.35/217.56  |- skos__broader mesh__D051179smesh__D003598
% 217.35/217.56  |- skos__altLabel mesh__D051179 Cytoskeletal Adaptor Proteins
% 217.35/217.56  |- mesh__recordOriginator mesh__D051179 DRC
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D051179 2006
% 217.35/217.56  |- skos__prefLabel mesh__D051179 Plakins
% 217.35/217.56  |- mesh__dateCreated mesh__D051179 2005-06-30
% 217.35/217.56  |- mesh__publicMeSHNote mesh__D051179 2006   
% 217.35/217.56  |- skos__scopeNote mesh__D051179
% 217.35/217.56       A family of related proteins that associate with cytoskeletal elements and junctional complexes at INTERCELLULAR JUNCTIONS. Plakins share a common plakin domain or a plakin repeat domain.%A%    
% 217.35/217.56  |- mesh__historyNote mesh__D051179 2006   
% 217.35/217.56  |- rdf__type mesh__D051179sskos__Concept
% 217.35/217.56  |- skos__hiddenLabel mesh__D051179 Adaptor Proteins, Cytoskeletal
% 217.35/217.56  |- skos__historyNote mesh__D020190 Epilepsies, Myoclonic %28%1977-1999%29%
% 217.35/217.56  |- skos__hiddenLabel mesh__D020190 Epilepsies, Adolescent Myoclonic
% 217.35/217.56  |- mesh__dateCreated mesh__D020190 1999-11-03
% 217.35/217.56  |- rdf__type mesh__D020190sskos__Concept
% 217.35/217.56  |- skos__altLabel mesh__D020190 Janz Impulsive Petit Mal
% 217.35/217.56  |- mesh__dateEstablished mesh__D020190 2000-01-01
% 217.35/217.56  |- skos__hiddenLabel mesh__D020190 Myoclonic Epilepsies, Juvenile
% 217.35/217.56  |- skos__hiddenLabel mesh__D020190 Epilepsy, Juvenile Myoclonic
% 217.35/217.56  |- skos__hiddenLabel mesh__D020190 Juvenile Myoclonic Epilepsies
% 217.35/217.56  |- skos__altLabel mesh__D020190 Petit Mal, Impulsive, Janz
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D020190 2006
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D020190 2001
% 217.35/217.56  |- skos__scopeNote mesh__D020190
% 217.35/217.56       A disorder characterized by the onset of myoclonus in adolescence, a marked increase in the incidence of absence seizures %28%see EPILEPSY, ABSENCE%29%, and generalized major motor seizures %28%see EPILEPSY, TONIC-CLONIC%29%. The myoclonic episodes tend to occur shortly after awakening. Seizures tend to be aggravated by sleep deprivation and alcohol consumption. Hereditary and sporadic forms have been identified. %28%From Adams et al., Principles of Neurology, 6th ed, p323%29%%A%    
% 217.35/217.56  |- skos__altLabel mesh__D020190 Myoclonic Epilepsy, Adolescent
% 217.35/217.56  |- skos__hiddenLabel mesh__D020190 Adolescent Myoclonic Epilepsies
% 217.35/217.56  |- skos__hiddenLabel mesh__D020190 JMEs %28%Juvenile Myoclonic Epilepsy%29%
% 217.35/217.56  |- skos__altLabel mesh__D020190 JME %28%Juvenile Myoclonic Epilepsy%29%
% 217.35/217.56  |- skos__historyNote mesh__D020190 Myoclonus %28%1975-1999%29%
% 217.35/217.56  |- skos__historyNote mesh__D020190 Epilepsy, Absence %28%1975-1999%29%
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D020190 2000
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D020190 2005
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D020190 2004
% 217.35/217.56  |- skos__hiddenLabel mesh__D020190 Adolescent Myoclonic Epilepsy
% 217.35/217.56  |- skos__altLabel mesh__D020190 Epilepsy, Myoclonic, Juvenile
% 217.35/217.56  |- skos__prefLabel mesh__D020190 Myoclonic Epilepsy, Juvenile
% 217.35/217.56  |- mesh__historyNote mesh__D020190 2000   
% 217.35/217.56  |- skos__hiddenLabel mesh__D020190 Syndrome, Janz
% 217.35/217.56  |- skos__hiddenLabel mesh__D020190 Epilepsy, Adolescent Myoclonic
% 217.35/217.56  |- skos__altLabel mesh__D020190 Impulsive Petit Mal, Janz
% 217.35/217.56  |- mesh__publicMeSHNote mesh__D020190 2000   
% 217.35/217.56  |- skos__altLabel mesh__D020190 Janz Juvenile Myoclonic Epilepsy
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D020190 2003
% 217.35/217.56  |- skos__hiddenLabel mesh__D020190 Myoclonic Epilepsies, Adolescent
% 217.35/217.56  |- skos__altLabel mesh__D020190 Impulsive Petit Mal Epilepsy
% 217.35/217.56  |- skos__altLabel mesh__D020190 Janz Syndrome
% 217.35/217.56  |- skos__altLabel mesh__D020190 Juvenile Myoclonic Epilepsy of Janz
% 217.35/217.56  |- skos__broader mesh__D020190smesh__D004831
% 217.35/217.56  |- skos__hiddenLabel mesh__D020190 Epilepsies, Juvenile Myoclonic
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D020190 2002
% 217.35/217.56  |- skos__altLabel mesh__D020190 Juvenile Myoclonic Epilepsy
% 217.35/217.56  |- skos__annotation mesh__D014951
% 217.35/217.56       IM; coord with organ /inj or precoord inj term %28%IM%29%   
% 217.35/217.56  |- skos__hiddenLabel mesh__D014951 Stab Wounds
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D014951 1998
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D014951 2006
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D014951 1992
% 217.35/217.56  |- skos__broader mesh__D014951smesh__D014950
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D014951 1997
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D014951 2005
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D014951 2002
% 217.35/217.56  |- mesh__recordOriginator mesh__D014951 SMH
% 217.35/217.56  |- mesh__historyNote mesh__D014951 76   
% 217.35/217.56  |- skos__prefLabel mesh__D014951 Wounds, Stab
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D014951 2004
% 217.35/217.56  |- skos__historyNote mesh__D014951
% 217.35/217.56       specific heading/injuries %28%1966-1975%29%
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D014951 1996
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D014951 1995
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D014951 2001
% 217.35/217.56  |- mesh__dateCreated mesh__D014951 1975-07-25
% 217.35/217.56  |- skos__scopeNote mesh__D014951
% 217.35/217.56       Penetrating wounds caused by a pointed object.     
% 217.35/217.56  |- mesh__dateRevised mesh__D014951 1991-02-21
% 217.35/217.56  |- skos__hiddenLabel mesh__D014951 Stab Wound
% 217.35/217.56  |- mesh__publicMeSHNote mesh__D014951 76   
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D014951 2003
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D014951 1994
% 217.35/217.56  |- mesh__recordMaintainer mesh__D014951 PLS
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D014951 2000
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D014951 1999
% 217.35/217.56  |- rdf__type mesh__D014951sskos__Concept
% 217.35/217.56  |- skos__hiddenLabel mesh__D014951 Wound, Stab
% 217.35/217.56  |- mesh__recordAuthorizer mesh__D014951 PLS
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D014951 1993
% 217.35/217.56  |- mesh__dateEstablished mesh__D014951 1976-01-01
% 217.35/217.56  |- skos__broader mesh__D014153smesh__D019880
% 217.35/217.56  |- skos__historyNote mesh__D014153 Transferases %28%1966-1971%29%
% 217.35/217.56  |- skos__prefLabel mesh__D014153 Transaldolase
% 217.35/217.56  |- mesh__dateCreated mesh__D014153 1999-01-01
% 217.35/217.56  |- skos__scopeNote mesh__D014153
% 217.35/217.56       An enzyme of the transferase class that catalyzes the reaction sedoheptulose 7-phosphate and D-glyceraldehyde 3-phosphate to yield D-erythrose 4-phosphate and D-fructose phosphate in the PENTOSE PHOSPHATE PATHWAY. %28%Dorland, 27th ed%29% EC 2.2.1.2.%A%    
% 217.35/217.56  |- mesh__recordMaintainer mesh__D014153 sjn
% 217.35/217.56  |- mesh__publicMeSHNote mesh__D014153
% 217.35/217.56       91; was see under TRANSFERASES 1972-90   
% 217.35/217.56  |- rdf__type mesh__D014153sskos__Concept
% 217.35/217.56  |- mesh__recordOriginator mesh__D014153 NLM
% 217.35/217.56  |- mesh__historyNote mesh__D014153
% 217.35/217.56       91%28%72%29%; was see under TRANSFERASES 1972-90   
% 217.35/217.56  |- mesh__dateEstablished mesh__D014153 1991-01-01
% 217.35/217.56  |- mesh__dateRevised mesh__D014153 2005-07-01
% 217.35/217.56  |- mesh__recordAuthorizer mesh__D014153 sjn
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D014153 2006
% 217.35/217.56  |- skos__altLabel mesh__D008914 Regaine
% 217.35/217.56  |- skos__historyNote mesh__D008914
% 217.35/217.56       Antihypertensive Agents %28%1966-1971%29%
% 217.35/217.56  |- skos__scopeNote mesh__D008914
% 217.35/217.56       A potent direct-acting peripheral vasodilator %28%VASODILATOR AGENTS%29% that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p371%29%%A%    
% 217.35/217.56  |- skos__historyNote mesh__D008914 Piperidines %28%1966-1971%29%
% 217.35/217.56  |- skos__hiddenLabel mesh__D008914 Minoxidil Pfizer Brand
% 217.35/217.56  |- rdf__type mesh__D008914sskos__Concept
% 217.35/217.56  |- skos__altLabel mesh__D008914 Pfizer Brand of Minoxidil
% 217.35/217.56  |- skos__prefLabel mesh__D008914 Minoxidil
% 217.35/217.56  |- skos__broader mesh__D008914smesh__D011743
% 217.35/217.56  |- mesh__recordMaintainer mesh__D008914 jmp
% 217.35/217.56  |- skos__historyNote mesh__D008914 Pyrimidines %28%1966-1971%29%
% 217.35/217.56  |- mesh__historyNote mesh__D008914
% 217.35/217.56       86%28%72%29%; was see under PYRIMIDINES 1975-85, was Prov 1972-74%A%  
% 217.35/217.56  |- mesh__publicMeSHNote mesh__D008914
% 217.35/217.56       86; was see under PYRIMIDINES 1975-85   
% 217.35/217.56  |- mesh__dateCreated mesh__D008914 1999-01-01
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008914 2005
% 217.35/217.56  |- mesh__recordAuthorizer mesh__D008914 sjn
% 217.35/217.56  |- mesh__dateEstablished mesh__D008914 1986-01-01
% 217.35/217.56  |- skos__broader mesh__D008914smesh__D010880
% 217.35/217.56  |- mesh__dateRevised mesh__D008914 2004-07-07
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008914 2006
% 217.35/217.56  |- mesh__recordOriginator mesh__D008914 NLM
% 217.35/217.56  |- skos__related mesh__D000931smesh__D000997
% 217.35/217.56  |- mesh__recordOriginator mesh__D000931 NLM
% 217.35/217.56  |- skos__related mesh__D000931smesh__D002614
% 217.35/217.56  |- mesh__historyNote mesh__D000931 66%28%64%29%   
% 217.35/217.56  |- skos__prefLabel mesh__D000931 Antidotes
% 217.35/217.56  |- mesh__recordMaintainer mesh__D000931 ssb
% 217.35/217.56  |- mesh__publicMeSHNote mesh__D000931 66   
% 217.35/217.56  |- mesh__dateEstablished mesh__D000931 1966-01-01
% 217.35/217.56  |- mesh__recordAuthorizer mesh__D000931 sjn
% 217.35/217.56  |- rdf__type mesh__D000931sskos__Concept
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D000931 2006
% 217.35/217.56  |- skos__related mesh__D000931smesh__D002801
% 217.35/217.56  |- skos__scopeNote mesh__D000931
% 217.35/217.56       Agents counteracting or neutralizing the action of POISONS.%A%    
% 217.35/217.56  |- mesh__dateCreated mesh__D000931 1999-01-01
% 217.35/217.56  |- mesh__dateRevised mesh__D000931 2005-06-30
% 217.35/217.56  |- skos__broader mesh__D000931smesh__D020011
% 217.35/217.56  |- skos__altLabel mesh__D000931 Theriacs
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008116 2004
% 217.35/217.56  |- mesh__historyNote mesh__D008116 68   
% 217.35/217.56  |- mesh__dateEstablished mesh__D008116 1968-01-01
% 217.35/217.56  |- mesh__dateRevised mesh__D008116 2003-07-09
% 217.35/217.56  |- skos__historyNote mesh__D008116 Reptiles %28%1966-1967%29%
% 217.35/217.56  |- skos__annotation mesh__D008116
% 217.35/217.56       includes IGUANAS, geckos, chameleons, Gila monsters; IM; qualif permitted%A%  
% 217.35/217.56  |- rdf__type mesh__D008116sskos__Concept
% 217.35/217.56  |- mesh__recordAuthorizer mesh__D008116 sjn
% 217.35/217.56  |- mesh__recordMaintainer mesh__D008116 ags
% 217.35/217.56  |- mesh__recordOriginator mesh__D008116 NLM
% 217.35/217.56  |- skos__broader mesh__D008116smesh__D012104
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008116 2006
% 217.35/217.56  |- mesh__dateCreated mesh__D008116 1999-01-01
% 217.35/217.56  |- mesh__publicMeSHNote mesh__D008116 68   
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D008116 2005
% 217.35/217.56  |- skos__prefLabel mesh__D008116 Lizards
% 217.35/217.56  |- skos__hiddenLabel mesh__D008116 Lizard
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013859 2004
% 217.35/217.56  |- mesh__dateRevised mesh__D013859 1993-06-04
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013859 2005
% 217.35/217.56  |- mesh__historyNote mesh__D013859 66   
% 217.35/217.56  |- mesh__dateEstablished mesh__D013859 1966-01-01
% 217.35/217.56  |- mesh__publicMeSHNote mesh__D013859 66   
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013859 2001
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013859 2003
% 217.35/217.56  |- skos__prefLabel mesh__D013859 Thiocarbamates
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013859 2000
% 217.35/217.56  |- mesh__recordOriginator mesh__D013859 NLM
% 217.35/217.56  |- mesh__recordAuthorizer mesh__D013859 PLS
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013859 1995
% 217.35/217.56  |- skos__broader mesh__D013859smesh__D013457
% 217.35/217.56  |- skos__scopeNote mesh__D013859
% 217.35/217.56       Carbamates in which the -CO- group has been replaced by a -CS- group.%A%    
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013859 1999
% 217.35/217.56  |- skos__broader mesh__D013859smesh__D002219
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013859 1994
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013859 1997
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013859 2002
% 217.35/217.56  |- mesh__dateCreated mesh__D013859 1999-01-01
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013859 1998
% 217.35/217.56  |- mesh__recordMaintainer mesh__D013859 TPW
% 217.35/217.56  |- rdf__type mesh__D013859sskos__Concept
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013859 2006
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D013859 1996
% 217.35/217.56  |- rdf__type mesh__D024581sskos__Concept
% 217.35/217.56  |- mesh__dateCreated mesh__D024581 2001-07-25
% 217.35/217.56  |- skos__altLabel mesh__D024581
% 217.35/217.56       Glyceraldehyde-3-Phosphate Dehydrogenases %28%Phosphorylating%29%
% 217.35/217.56  |- skos__altLabel mesh__D024581 GAPD %28%Phosphorylating%29%
% 217.35/217.56  |- skos__hiddenLabel mesh__D024581
% 217.35/217.56       Glyceraldehyde-3-Phosphate Dehydrogenase, Phosphorylating
% 217.35/217.56  |- skos__hiddenLabel mesh__D024581
% 217.35/217.56       Phosphorylating Glyceraldehyde 3 Phosphate Dehydrogenase
% 217.35/217.56  |- skos__altLabel mesh__D024581
% 217.35/217.56       Glyceraldehyde-3-Phosphate Dehydrogenase %28%NAD+%29% %28%Phosphorylating%29%
% 217.35/217.56  |- mesh__dateEstablished mesh__D024581 2002-01-01
% 217.35/217.56  |- skos__altLabel mesh__D024581
% 217.35/217.56       Phosphorylating Glyceraldehyde-3-Phosphate Dehydrogenase
% 217.35/217.56  |- skos__broader mesh__D024581smesh__D005987
% 217.35/217.56  |- skos__historyNote mesh__D024581
% 217.35/217.56       Glyceraldehyde-3-Phosphate Dehydrogenases %28%1972-2001%29%
% 217.35/217.56  |- skos__hiddenLabel mesh__D024581
% 217.35/217.56       Dehydrogenase, Phosphorylating Glyceraldehyde-3-Phosphate
% 217.35/217.56  |- skos__hiddenLabel mesh__D024581
% 217.35/217.56       NAD Dependent Glyceraldehyde 3 phosphate Dehydrogenase
% 217.35/217.56  |- skos__scopeNote mesh__D024581
% 217.35/217.56       An NAD-dependent glyceraldehyde-3-phosphate dehydrogenase found in the cytosol of eucaryotes. It catalyses the dehydrogenation and phosphorylation of GLYCERALDEHYDE 3-PHOSPHATE to 3-phospho-D-glyceroyl phosphate, which is an important step in the GLYCOLYSIS pathway.%A%    
% 217.35/217.56  |- mesh__recordMaintainer mesh__D024581 jmp
% 217.35/217.56  |- mesh__historyNote mesh__D024581
% 217.35/217.56       2002; use GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES 1999-2001%A%  
% 217.35/217.56  |- skos__hiddenLabel mesh__D024581
% 217.35/217.56       Dehydrogenase, NAD-Dependent Glyceraldehyde-3-phosphate
% 217.35/217.56  |- mesh__recordOriginator mesh__D024581 jmp
% 217.35/217.56  |- skos__annotation mesh__D024581
% 217.35/217.56       do not confuse with Glyceraldehyde 3 Phosphate-Dehydrogenase %28%NADP+%29%%28%Phosphorylating%29%%A%  
% 217.35/217.56  |- skos__prefLabel mesh__D024581
% 217.35/217.56       Glyceraldehyde-3-Phosphate Dehydrogenase %28%Phosphorylating%29%
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D024581 2006
% 217.35/217.56  |- mesh__publicMeSHNote mesh__D024581
% 217.35/217.56       2002; see GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES 1999-2001%A%  
% 217.35/217.56  |- skos__hiddenLabel mesh__D024581
% 217.35/217.56       Glyceraldehyde-3-phosphate Dehydrogenase, NAD-Dependent
% 217.35/217.56  |- mesh__dateRevised mesh__D024581 2005-06-30
% 217.35/217.56  |- mesh__recordAuthorizer mesh__D024581 sjn
% 217.35/217.56  |- skos__altLabel mesh__D024581
% 217.35/217.56       NAD-Dependent Glyceraldehyde-3-phosphate Dehydrogenase
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018544 1998
% 217.35/217.56  |- skos__hiddenLabel mesh__D018544 Weightlessness Countermeasure
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018544 1997
% 217.35/217.56  |- skos__broader mesh__D018544smesh__D008919
% 217.35/217.56  |- mesh__recordAuthorizer mesh__D018544 PLS
% 217.35/217.56  |- mesh__dateCreated mesh__D018544 1994-06-07
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018544 2000
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018544 1996
% 217.35/217.56  |- skos__scopeNote mesh__D018544
% 217.35/217.56       Techniques and routines designed to prevent or reverse unwanted effects of weightlessness experienced during actual and simulated space flight, including physiologic changes related to removal of gravitational loading. Specific measures include creation of artificial gravity, exercise, low-level lower body negative pressure, and use of anti-deconditioning devices. %28%From Nicogossian, Space Physiology and Medicine, 2d ed, pp294-297%29%%A%    
% 217.35/217.56  |- mesh__recordOriginator mesh__D018544 JLS
% 217.35/217.56  |- mesh__historyNote mesh__D018544 95   
% 217.35/217.56  |- mesh__recordMaintainer mesh__D018544 TAP
% 217.35/217.56  |- mesh__dateRevised mesh__D018544 1995-06-09
% 217.35/217.56  |- mesh__dateEstablished mesh__D018544 1995-01-01
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018544 2002
% 217.35/217.56  |- skos__annotation mesh__D018544
% 217.35/217.56       in actual or simulated space flight; no qualif   
% 217.35/217.56  |- skos__related mesh__D018544smesh__D018493
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018544 2006
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018544 2005
% 217.35/217.56  |- skos__historyNote mesh__D018544 Space Flight %28%1966-1994%29%
% 217.35/217.56  |- skos__altLabel mesh__D018544 Countermeasures, Weightlessness
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018544 2004
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018544 1999
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018544 2001
% 217.35/217.56  |- rdf__type mesh__D018544sskos__Concept
% 217.35/217.56  |- mesh__publicMeSHNote mesh__D018544 95   
% 217.35/217.56  |- skos__hiddenLabel mesh__D018544 Countermeasure, Weightlessness
% 217.35/217.56  |- skos__prefLabel mesh__D018544 Weightlessness Countermeasures
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D018544 2003
% 217.35/217.56  |- mesh__recordMaintainer mesh__D010561 TGC
% 217.35/217.56  |- mesh__activeMeSHYear mesh__D010561 1998
% 217.35/217.56  |- skos__scopeNote mesh__D010561
% 217.35/217.56       The selection, appointing, and scheduling of personnel.%A%    
% 217.35/217.57  |- mesh__publicMeSHNote mesh__D010561
% 217.35/217.57       91; was see under PERSONNEL MANAGEMENT 1975-90   
% 217.35/217.57  |- skos__broader mesh__D010561smesh__D010559
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010561 2005
% 217.35/217.57  |- mesh__dateRevised mesh__D010561 1994-05-05
% 217.35/217.57  |- skos__hiddenLabel mesh__D010561 Staffing, Personnel
% 217.35/217.57  |- mesh__recordOriginator mesh__D010561 NLM
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010561 1997
% 217.35/217.57  |- mesh__recordAuthorizer mesh__D010561 PLS
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010561 2004
% 217.35/217.57  |- skos__hiddenLabel mesh__D010561 Scheduling and Staffing
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010561 2002
% 217.35/217.57  |- rdf__type mesh__D010561sskos__Concept
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010561 1996
% 217.35/217.57  |- mesh__dateEstablished mesh__D010561 1991-01-01
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010561 1995
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010561 2003
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010561 2001
% 217.35/217.57  |- mesh__dateCreated mesh__D010561 1974-11-11
% 217.35/217.57  |- mesh__historyNote mesh__D010561
% 217.35/217.57       91%28%75%29%; was see under PERSONNEL MANAGEMENT 1975-90   
% 217.35/217.57  |- skos__prefLabel mesh__D010561 Personnel Staffing and Scheduling
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010561 2000
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010561 1999
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010561 2006
% 217.35/217.57  |- skos__annotation mesh__D010561
% 217.35/217.57       med or non-med personnel; DF: PERSONNEL STAFFING   
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D004524 2006
% 217.35/217.57  |- mesh__recordAuthorizer mesh__D004524 sjn
% 217.35/217.57  |- skos__broader mesh__D004524smesh__D005399
% 217.35/217.57  |- mesh__recordMaintainer mesh__D004524 ags
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D004524 2005
% 217.35/217.57  |- skos__hiddenLabel mesh__D004524 Eel
% 217.35/217.57  |- skos__prefLabel mesh__D004524 Eels
% 217.35/217.57  |- mesh__recordOriginator mesh__D004524 NLM
% 217.35/217.57  |- rdf__type mesh__D004524sskos__Concept
% 217.35/217.57  |- mesh__dateRevised mesh__D004524 2003-07-09
% 217.35/217.57  |- skos__altLabel mesh__D004524 Anguilliformes
% 217.35/217.57  |- skos__annotation mesh__D004524
% 217.35/217.57       EELS, SWAMP see SMEGMAMORPHA and EEL, ELECTRIC see ELECTROPHORUS are also available%A%  
% 217.35/217.57  |- mesh__dateCreated mesh__D004524 1999-01-01
% 217.35/217.57  |- skos__scopeNote mesh__D004524
% 217.35/217.57       Common name for an order %28%Anguilliformes%29% of voracious, elongate, snakelike teleost fishes.%A%    
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D004524 2004
% 217.35/217.57  |- skos__hiddenLabel mesh__D042643 c fos induced growth factor
% 217.35/217.57  |- skos__altLabel mesh__D042643 FIGF protein
% 217.35/217.57  |- mesh__dateCreated mesh__D042643 2003-07-09
% 217.35/217.57  |- mesh__publicMeSHNote mesh__D042643
% 217.35/217.57       2004; VASCULAR ENDOTHELIAL GROWTH FACTOR D was indexed under ENDOTHELIAL GROWTH FACTORS 1997-2003%A%  
% 217.35/217.57  |- skos__broader mesh__D042643smesh__D042442
% 217.35/217.57  |- skos__annotation mesh__D042643 see SCR for organism-specific terms   
% 217.35/217.57  |- skos__historyNote mesh__D042643
% 217.35/217.57       Endothelial Growth Factor %28%1997-2003%29%
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D042643 2006
% 217.35/217.57  |- mesh__recordOriginator mesh__D042643 jmp
% 217.35/217.57  |- skos__altLabel mesh__D042643 VEGF-D
% 217.35/217.57  |- mesh__recordAuthorizer mesh__D042643 sjn
% 217.35/217.57  |- skos__altLabel mesh__D042643 c-fos-induced growth factor
% 217.35/217.57  |- skos__altLabel mesh__D042643 Vascular Endothelial Growth Factor-D
% 217.35/217.57  |- skos__prefLabel mesh__D042643 Vascular Endothelial Growth Factor D
% 217.35/217.57  |- mesh__dateRevised mesh__D042643 2005-06-30
% 217.35/217.57  |- mesh__dateEstablished mesh__D042643 2004-01-01
% 217.35/217.57  |- mesh__recordMaintainer mesh__D042643 ssb
% 217.35/217.57  |- rdf__type mesh__D042643sskos__Concept
% 217.35/217.57  |- mesh__historyNote mesh__D042643
% 217.35/217.57       2004; use VASCULAR ENDOTHELIAL GROWTH FACTOR D %28%NM%29% 1997-2003%A%  
% 217.35/217.57  |- skos__scopeNote mesh__D042643
% 217.35/217.57       A vascular endothelial growth factor that specifically binds to VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 and VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3. In addition to being an angiogenic factor it can act on LYMPHATIC VESSELS to stimulate LYMPHANGIOGENESIS. It is similar in structure to VASCULAR ENDOTHELIAL GROWTH FACTOR C in that they both contain N- and C-terminal extensions that were not found in other VEGF family members.%A%    
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Inclusion-Body Disease, Atypical
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Biotin Responsive Encephalopathy
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Myoclonic Epilepsy, Progressive
% 217.35/217.57  |- skos__broader mesh__D020191smesh__D004831
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Inclusion-Body Diseases, Atypical
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Epilepsy, Progressive Myoclonic
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Encephalopathies, Biotin-Responsive
% 217.35/217.57  |- skos__historyNote mesh__D020191 Epilepsy %28%1965-1999%29%
% 217.35/217.57  |- mesh__recordAuthorizer mesh__D020191 sjn
% 217.35/217.57  |- mesh__dateEstablished mesh__D020191 2000-01-01
% 217.35/217.57  |- skos__historyNote mesh__D020191 Myoclonus %28%1968-1999%29%
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Epilepsy, Progressive Myoclonus
% 217.35/217.57  |- mesh__recordOriginator mesh__D020191 KEV
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Disease, Atypical Inclusion-Body
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Atypical Inclusion Body Disease
% 217.35/217.57  |- rdf__type mesh__D020191sskos__Concept
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Epilepsies, Progressive Myoclonic
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Syndromes, May-White
% 217.35/217.57  |- mesh__historyNote mesh__D020191
% 217.35/217.57       2000; use Epilepsy, Myoclonic 1977-1999   
% 217.35/217.57  |- mesh__dateCreated mesh__D020191 1999-11-04
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Diseases, Atypical Inclusion-Body
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Syndrome, May-White
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D020191 2006
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Action Myoclonus Renal Failure Syndrome
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Dentatorubral Pallidoluysian Atrophy
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Dentatorubral-Pallidoluysian Atrophies
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 May-White Syndromes
% 217.35/217.57  |- skos__altLabel mesh__D020191 Progressive Myoclonic Epilepsy
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Atrophies, Dentatorubral-Pallidoluysian
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Epilepsies, Progressive Myoclonus
% 217.35/217.57  |- mesh__publicMeSHNote mesh__D020191
% 217.35/217.57       2000; see Epilepsy, Myoclonic 1977-1999   
% 217.35/217.57  |- skos__altLabel mesh__D020191 Progressive Myoclonus Epilepsies
% 217.35/217.57  |- skos__prefLabel mesh__D020191 Myoclonic Epilepsies, Progressive
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Biotin-Responsive Encephalopathies
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 May White Syndrome
% 217.35/217.57  |- mesh__dateRevised mesh__D020191 2001-07-25
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D020191 2005
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D020191 2004
% 217.35/217.57  |- skos__scopeNote mesh__D020191
% 217.35/217.57       A heterogeneous group of primarily familial disorders characterized by myoclonic seizures, tonic-clonic seizures, ataxia, progressive intellectual deterioration, and neuronal degeneration. These include LAFORA DISEASE; MERRF SYNDROME; NEURONAL CEROID-LIPOFUSCINOSIS; sialidosis %28%see MUCOLIPIDOSES%29%, and UNVERRICHT-LUNDBORG SYNDROME.%A%    
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Progressive Myoclonus Epilepsy
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Atypical Inclusion-Body Diseases
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Encephalopathy, Biotin-Responsive
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Myoclonus Epilepsy, Progressive
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D020191 2002
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Progressive Myoclonic Epilepsies
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Atrophy, Dentatorubral-Pallidoluysian
% 217.35/217.57  |- skos__historyNote mesh__D020191 Epilepsies, Myoclonic %28%1977-1999%29%
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D020191 2003
% 217.35/217.57  |- mesh__recordMaintainer mesh__D020191 nns
% 217.35/217.57  |- skos__hiddenLabel mesh__D020191 Myoclonus Epilepsies, Progressive
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D014952 2004
% 217.35/217.57  |- mesh__recordOriginator mesh__D014952 JW
% 217.35/217.57  |- mesh__dateRevised mesh__D014952 1997-06-20
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D014952 2000
% 217.35/217.57  |- mesh__publicMeSHNote mesh__D014952 90; was see under SPORTS 1976-89   
% 217.35/217.57  |- skos__prefLabel mesh__D014952 Wrestling
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D014952 2003
% 217.35/217.57  |- skos__hiddenLabel mesh__D014952 Wrestlings
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D014952 1999
% 217.35/217.57  |- rdf__type mesh__D014952sskos__Concept
% 217.35/217.57  |- mesh__historyNote mesh__D014952
% 217.35/217.57       90%28%76%29%; was see under SPORTS 1976-89   
% 217.35/217.57  |- mesh__dateCreated mesh__D014952 1975-07-23
% 217.35/217.57  |- skos__related mesh__D014952smesh__D016139
% 217.35/217.57  |- mesh__dateEstablished mesh__D014952 1990-01-01
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D014952 2006
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D014952 1998
% 217.35/217.57  |- mesh__recordMaintainer mesh__D014952 TGC
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D014952 2002
% 217.35/217.57  |- skos__historyNote mesh__D014952 Sports %28%1966-1975%29%
% 217.35/217.57  |- skos__annotation mesh__D014952
% 217.35/217.57       /inj: coord IM with specific inj %28%IM%29%; /physiol permitted%A%  
% 217.35/217.57  |- mesh__recordAuthorizer mesh__D014952 SJN
% 217.35/217.57  |- skos__scopeNote mesh__D014952
% 217.35/217.57       A sport consisting of hand-to-hand combat between two unarmed contestants seeking to pin or press each other%27%s shoulders to the ground.%A%    
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D014952 2005
% 217.35/217.57  |- skos__broader mesh__D014952smesh__D013177
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D014952 2001
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D014154 2004
% 217.35/217.57  |- mesh__historyNote mesh__D014154 82   
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D014154 2002
% 217.35/217.57  |- mesh__recordOriginator mesh__D014154 SMH
% 217.35/217.57  |- mesh__dateCreated mesh__D014154 1981-02-27
% 217.35/217.57  |- mesh__recordAuthorizer mesh__D014154 sjn
% 217.35/217.57  |- skos__prefLabel mesh__D014154 Transcaucasia
% 217.35/217.57  |- mesh__dateEstablished mesh__D014154 1982-01-01
% 217.35/217.57  |- mesh__dateRevised mesh__D014154 2001-07-25
% 217.35/217.57  |- rdf__type mesh__D014154sskos__Concept
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D014154 2005
% 217.35/217.57  |- mesh__recordMaintainer mesh__D014154 mdb
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D014154 2003
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D014154 2006
% 217.35/217.57  |- skos__scopeNote mesh__D014154
% 217.35/217.57       Area of Europe that includes ARMENIA,; AZERBAIJAN; and the Republic of GEORGIA.%A%    
% 217.35/217.57  |- skos__broader mesh__D014154smesh__D005060
% 217.35/217.57  |- skos__hiddenLabel mesh__D008915 Minute Virus, Mice
% 217.35/217.57  |- skos__hiddenLabel mesh__D008915 Mice Minute Viruses
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D008915 2002
% 217.35/217.57  |- mesh__recordAuthorizer mesh__D008915 PLS
% 217.35/217.57  |- mesh__recordOriginator mesh__D008915 NLM
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D008915 1998
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D008915 1997
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D008915 2003
% 217.35/217.57  |- mesh__dateEstablished mesh__D008915 1991-01-01
% 217.35/217.57  |- mesh__recordMaintainer mesh__D008915 AGS
% 217.35/217.57  |- skos__prefLabel mesh__D008915 Mice Minute Virus
% 217.35/217.57  |- skos__hiddenLabel mesh__D008915 Minute Viruses, Mice
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D008915 2000
% 217.35/217.57  |- skos__altLabel mesh__D008915 Minute Virus of Mice
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D008915 1999
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D008915 2005
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D008915 2004
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D008915 2001
% 217.35/217.57  |- skos__annotation mesh__D008915
% 217.35/217.57       a mouse parvovirus; infection: coord IM with PARVOVIRIDAE INFECTIONS %28%IM%29%%A%  
% 217.35/217.57  |- skos__broader mesh__D008915smesh__D017992
% 217.35/217.57  |- mesh__dateRevised mesh__D008915 1996-06-10
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D008915 2006
% 217.35/217.57  |- mesh__dateCreated mesh__D008915 1974-12-12
% 217.35/217.57  |- skos__scopeNote mesh__D008915
% 217.35/217.57       The type species of PARVOVIRUS prevalent in mouse colonies and found as a contaminant of many transplanted tumors or leukemias.%A%    
% 217.35/217.57  |- mesh__publicMeSHNote mesh__D008915
% 217.35/217.57       97; was MINUTE VIRUS OF MICE 1975-96 %28%see under PARVOVIRIDAE 1981-90, see under PARVOVIRUSES 1975-80%29%%A%  
% 217.35/217.57  |- rdf__type mesh__D008915sskos__Concept
% 217.35/217.57  |- mesh__historyNote mesh__D008915
% 217.35/217.57       97; was MINUTE VIRUS OF MICE 1975-96 %28%see under PARVOVIRIDAE 1981-90, see under PARVOVIRUSES 1975-80%29%%A%  
% 217.35/217.57  |- skos__scopeNote mesh__D000932
% 217.35/217.57       Drugs used to prevent NAUSEA or VOMITING. Antiemetics act by a wide range of mechanisms. Some act on the medullary control centers %28%the vomiting center and the chemoreceptive trigger zone%29% while others affect the peripheral receptors.%A%    
% 217.35/217.57  |- skos__hiddenLabel mesh__D000932 Drugs, Antiemetic
% 217.35/217.57  |- mesh__recordMaintainer mesh__D000932 ssb
% 217.35/217.57  |- mesh__dateRevised mesh__D000932 2005-06-30
% 217.35/217.57  |- mesh__dateCreated mesh__D000932 1999-01-01
% 217.35/217.57  |- skos__broader mesh__D000932smesh__D002491
% 217.35/217.57  |- skos__broader mesh__D000932smesh__D005765
% 217.35/217.57  |- mesh__recordOriginator mesh__D000932 NLM
% 217.35/217.57  |- skos__hiddenLabel mesh__D000932 Anti emetics
% 217.35/217.57  |- skos__altLabel mesh__D000932 Anti-emetics
% 217.35/217.57  |- rdf__type mesh__D000932sskos__Concept
% 217.35/217.57  |- skos__broader mesh__D000932smesh__D001337
% 217.35/217.57  |- skos__hiddenLabel mesh__D000932 Agents, Antiemetic
% 217.35/217.57  |- mesh__recordAuthorizer mesh__D000932 sjn
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D000932 2006
% 217.35/217.57  |- skos__prefLabel mesh__D000932 Antiemetics
% 217.35/217.57  |- skos__altLabel mesh__D000932 Antiemetic Drugs
% 217.35/217.57  |- skos__altLabel mesh__D000932 Antiemetic Agents
% 217.35/217.57  |- skos__annotation mesh__D000932 GEN or unspecified; prefer specifics;   
% 217.35/217.57  |- mesh__dateRevised mesh__D008117 2003-07-09
% 217.35/217.57  |- rdf__type mesh__D008117sskos__Concept
% 217.35/217.57  |- mesh__recordOriginator mesh__D008117 NLM
% 217.35/217.57  |- mesh__publicMeSHNote mesh__D008117 LOA LOA was see under LOA 1979-85   
% 217.35/217.57  |- skos__prefLabel mesh__D008117 Loa
% 217.35/217.57  |- mesh__historyNote mesh__D008117 LOA LOA was see under LOA 1979-85   
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D008117 2006
% 217.35/217.57  |- mesh__dateCreated mesh__D008117 1999-01-01
% 217.35/217.57  |- mesh__recordMaintainer mesh__D008117 ags
% 217.35/217.57  |- skos__annotation mesh__D008117
% 217.35/217.57       infection = LOIASIS; coord with specific helminth term %28%ANTIGENS, HELMINTH, etc.%29% if pertinent; /drug eff: consider FILARICIDES%A%  
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D008117 2005
% 217.35/217.57  |- mesh__onlineNote mesh__D008117 use LOA to search LOA LOA 1979-85   
% 217.35/217.57  |- skos__scopeNote mesh__D008117
% 217.35/217.57       A genus of parasitic nematodes found throughout the rain-forest areas of the Sudan and the basin of the Congo. L. loa inhabits the subcutaneous tissues, which it traverses freely.%A%    
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D008117 2004
% 217.35/217.57  |- skos__broader mesh__D008117smesh__D005370
% 217.35/217.57  |- mesh__recordAuthorizer mesh__D008117 sjn
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D000134 2006
% 217.35/217.57  |- skos__broader mesh__D000134smesh__D045662
% 217.35/217.57  |- mesh__dateEstablished mesh__D000134 1991-01-01
% 217.35/217.57  |- skos__annotation mesh__D000134
% 217.35/217.57       etching of tooth surface to increase adhesion of resins; do not use for etching of metal appliances for better adhesion %28% = specific appliance %28%IM%29% + METALLURGY %28%NIM%29% %29%; do not use for etching of veneers or resins %28% = specific dent restoration%29%; DF: ACID ETCHING DENT%A%  
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D000134 2005
% 217.35/217.57  |- skos__altLabel mesh__D000134 Etching, Dental Acid
% 217.35/217.57  |- mesh__recordAuthorizer mesh__D000134 sjn
% 217.35/217.57  |- skos__historyNote mesh__D000134 Bonding, Dental %28%1971-1976%29%
% 217.35/217.57  |- mesh__recordOriginator mesh__D000134 SMH
% 217.35/217.57  |- skos__altLabel mesh__D000134 Dental Acid Etching
% 217.35/217.57  |- mesh__dateCreated mesh__D000134 1976-04-13
% 217.35/217.57  |- rdf__type mesh__D000134sskos__Concept
% 217.35/217.57  |- mesh__dateRevised mesh__D000134 2003-07-09
% 217.35/217.57  |- skos__historyNote mesh__D000134 Dental Enamel %28%1966-1976%29%
% 217.35/217.57  |- mesh__historyNote mesh__D000134
% 217.35/217.57       91%28%77%29%; was see under BONDING, DENTAL 1977-90   
% 217.35/217.57  |- mesh__recordMaintainer mesh__D000134 ssb
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D000134 2004
% 217.35/217.57  |- skos__prefLabel mesh__D000134 Acid Etching, Dental
% 217.35/217.57  |- skos__historyNote mesh__D000134 Phosphoric Acids %28%1968-1976%29%
% 217.35/217.57  |- skos__scopeNote mesh__D000134
% 217.35/217.57       Preparation of TOOTH surfaces and DENTAL MATERIALS with etching agents, usually phosphoric acid, to roughen the surface to increase adhesion or osteointegration.%A%    
% 217.35/217.57  |- mesh__publicMeSHNote mesh__D000134
% 217.35/217.57       91; was see under BONDING, DENTAL 1977-90   
% 217.35/217.57  |- mesh__publicMeSHNote mesh__D018545 95   
% 217.35/217.57  |- mesh__recordOriginator mesh__D018545 JLS
% 217.35/217.57  |- mesh__historyNote mesh__D018545 95   
% 217.35/217.57  |- mesh__recordAuthorizer mesh__D018545 sjn
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D018545 2006
% 217.35/217.57  |- skos__broader mesh__D018545smesh__D019659
% 217.35/217.57  |- skos__annotation mesh__D018545
% 217.35/217.57       as plant %26% food; selected qualif from Cat B6 %26% Cat J2   
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D018545 2005
% 217.35/217.57  |- skos__broader mesh__D018545smesh__D014675
% 217.35/217.57  |- mesh__dateEstablished mesh__D018545 1995-01-01
% 217.35/217.57  |- mesh__recordMaintainer mesh__D018545 ssb
% 217.35/217.57  |- rdf__type mesh__D018545sskos__Concept
% 217.35/217.57  |- mesh__dateRevised mesh__D018545 2004-07-07
% 217.35/217.57  |- skos__prefLabel mesh__D018545 Lettuce
% 217.35/217.57  |- mesh__dateCreated mesh__D018545 1994-06-07
% 217.35/217.57  |- skos__scopeNote mesh__D018545
% 217.35/217.57       Any of the various plants of the genus Lactuca, especially L. sativa, cultivated for its edible leaves. %28%From American Heritage Dictionary, 2d ed%29%%A%    
% 217.35/217.57  |- skos__historyNote mesh__D018545 Plants, Edible %28%1966-1994%29%
% 217.35/217.57  |- mesh__dateCreated mesh__D010562 1986-06-17
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010562 2001
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010562 1996
% 217.35/217.57  |- skos__annotation mesh__D010562 IM   
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010562 2003
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010562 1997
% 217.35/217.57  |- mesh__dateRevised mesh__D010562 1995-06-16
% 217.35/217.57  |- mesh__recordMaintainer mesh__D010562 RAZ
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010562 2004
% 217.35/217.57  |- mesh__recordAuthorizer mesh__D010562 PLS
% 217.35/217.57  |- mesh__publicMeSHNote mesh__D010562
% 217.35/217.57       91; was see under MANAGEMENT INFORMATION SYSTEMS 1987-90   
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010562 2002
% 217.35/217.57  |- rdf__type mesh__D010562sskos__Concept
% 217.35/217.57  |- skos__altLabel mesh__D010562
% 217.35/217.57       Personnel Staffing Scheduling Information Systems
% 217.35/217.57  |- skos__prefLabel mesh__D010562
% 217.35/217.57       Personnel Staffing and Scheduling Information Systems
% 217.35/217.57  |- skos__broader mesh__D010562smesh__D008331
% 217.35/217.57  |- mesh__recordOriginator mesh__D010562 EC
% 217.35/217.57  |- mesh__historyNote mesh__D010562
% 217.35/217.57       91%28%87%29%; was see under MANAGEMENT INFORMATION SYSTEMS 1987-90%A%  
% 217.35/217.57  |- skos__scopeNote mesh__D010562
% 217.35/217.57       Computer-based systems for use in personnel management in a facility, e.g., distribution of caregivers with relation to patient needs.%A%    
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010562 1998
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010562 2005
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010562 2000
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010562 1999
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D010562 2006
% 217.35/217.57  |- mesh__dateEstablished mesh__D010562 1991-01-01
% 217.35/217.57  |- skos__prefLabel mesh__D004525 Efferent Pathways
% 217.35/217.57  |- mesh__recordMaintainer mesh__D004525 ags
% 217.35/217.57  |- skos__hiddenLabel mesh__D004525 Pathway, Efferent
% 217.35/217.57  |- skos__historyNote mesh__D004525 specific central nervous system heading
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D004525 2006
% 217.35/217.57  |- mesh__dateCreated mesh__D004525 1975-07-25
% 217.35/217.57  |- skos__annotation mesh__D004525
% 217.35/217.57       coord NIM with origin %28%IM%29% + termination %28%IM%29%   
% 217.35/217.57  |- rdf__type mesh__D004525sskos__Concept
% 217.35/217.57  |- mesh__dateRevised mesh__D004525 2005-07-21
% 217.35/217.57  |- skos__broader mesh__D004525smesh__D009434
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D004525 2005
% 217.35/217.57  |- skos__hiddenLabel mesh__D004525 Efferent Pathway
% 217.35/217.57  |- mesh__dateEstablished mesh__D004525 1976-01-01
% 217.35/217.57  |- mesh__historyNote mesh__D004525 76; was NON MESH before 1976   
% 217.35/217.57  |- skos__scopeNote mesh__D004525
% 217.35/217.57       Nerve structures through which impulses are conducted from a nerve center toward a peripheral site. Such impulses are conducted via efferent neurons %28%NEURONS, EFFERENT%29%, such as MOTOR NEURONS, autonomic neurons, and hypophyseal neurons.%A%    
% 217.35/217.57  |- skos__historyNote mesh__D004525 Neurons, Efferent %28%1969-1975%29%
% 217.35/217.57  |- mesh__recordOriginator mesh__D004525 SMH
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D004525 2006A
% 217.35/217.57  |- mesh__recordAuthorizer mesh__D004525 ags
% 217.35/217.57  |- mesh__publicMeSHNote mesh__D004525 76   
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D004525 2004
% 217.35/217.57  |- skos__hiddenLabel mesh__D004525 Pathways, Efferent
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D004525 2003
% 217.35/217.57  |- mesh__recordMaintainer mesh__D009210 nns
% 217.35/217.57  |- mesh__dateCreated mesh__D009210 1999-01-01
% 217.35/217.57  |- mesh__recordAuthorizer mesh__D009210 sjn
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D009210 2004
% 217.35/217.57  |- skos__scopeNote mesh__D009210
% 217.35/217.57       Highly organized bundles of actin %28%=ACTINS%29%, MYOSINS, and other proteins in the cytoplasm of skeletal and cardiac muscle cells that contract by a sliding filament mechanism.%A%    
% 217.35/217.57  |- rdf__type mesh__D009210sskos__Concept
% 217.35/217.57  |- mesh__dateEstablished mesh__D009210 1965-01-01
% 217.35/217.57  |- skos__annotation mesh__D009210
% 217.35/217.57       does not include muscle fibers %28% = MUSCLE FIBERS or specific%29%%A%  
% 217.35/217.57  |- skos__broader mesh__D009210smesh__D003599
% 217.35/217.57  |- mesh__dateRevised mesh__D009210 2003-07-09
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D009210 2006
% 217.35/217.57  |- skos__prefLabel mesh__D009210 Myofibrils
% 217.35/217.57  |- mesh__publicMeSHNote mesh__D009210 65   
% 217.35/217.57  |- skos__broader mesh__D009210smesh__D018485
% 217.35/217.57  |- mesh__historyNote mesh__D009210 65   
% 217.35/217.57  |- skos__related mesh__D009210smesh__D009119
% 217.35/217.57  |- mesh__recordOriginator mesh__D009210 NLM
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D009210 2005
% 217.35/217.57  |- skos__hiddenLabel mesh__D009210 Myofibril
% 217.35/217.57  |- skos__broader mesh__D038781Q000295smesh__D038781
% 217.35/217.57  |- mesh__preferredCombination mesh__D038781Q000295smesh__D019720
% 217.35/217.57  |- rdf__type mesh__D038781Q000295smesh__CompoundConcept
% 217.35/217.57  |- mesh__recordOriginator mesh__D020192 KEV
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D020192 2003
% 217.35/217.57  |- skos__altLabel mesh__D020192 Late Onset Lafora Body Disease
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D020192 2005
% 217.35/217.57  |- skos__altLabel mesh__D020192 Epilepsy, Progressive Myoclonic, Lafora
% 217.35/217.57  |- skos__altLabel mesh__D020192 Lafora Progressive Myoclonic Epilepsy
% 217.35/217.57  |- skos__hiddenLabel mesh__D020192 Disease, Lafora Body
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D020192 2004
% 217.35/217.57  |- mesh__dateEstablished mesh__D020192 2000-01-01
% 217.35/217.57  |- rdf__type mesh__D020192sskos__Concept
% 217.35/217.57  |- skos__altLabel mesh__D020192 Lafora-Body Disease, Late Onset
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D020192 2006
% 217.35/217.57  |- skos__historyNote mesh__D020192 Epilepsies, Myoclonic %28%1977-1999%29%
% 217.35/217.57  |- skos__altLabel mesh__D020192 Progressive Myoclonic Epilepsy, Lafora
% 217.35/217.57  |- mesh__historyNote mesh__D020192
% 217.35/217.57       2000; use Epilepsy, Myoclonic 1977-1999   
% 217.35/217.57  |- skos__altLabel mesh__D020192 Progressive Myoclonic Epilepsy, Lafora Type
% 217.35/217.57  |- skos__altLabel mesh__D020192 Lafora Type Progressive Myoclonic Epilepsy
% 217.35/217.57  |- skos__scopeNote mesh__D020192
% 217.35/217.57       A form of stimulus sensitive myoclonic epilepsy inherited as an autosomal recessive condition. The most common presenting feature is a single seizure in the second decade of life. This is followed by progressive myoclonus, myoclonic seizures, tonic-clonic seizures, focal occipital seizures, intellectual decline, and severe motor and coordination impairments. Most affected individuals do not live past the age of 25 years. Concentric amyloid %28%Lafora%29% bodies are found in neurons, liver, skin, bone, and muscle %28%From Menkes, Textbook of Childhood Neurology, 5th ed, pp111-110%29%%A%    
% 217.35/217.57  |- skos__historyNote mesh__D020192 Epilepsy %28%1966-1976%29%
% 217.35/217.57  |- skos__hiddenLabel mesh__D020192 Disease, Lafora
% 217.35/217.57  |- mesh__recordMaintainer mesh__D020192 nns
% 217.35/217.57  |- skos__altLabel mesh__D020192 Lafora Body Disease
% 217.35/217.57  |- mesh__dateCreated mesh__D020192 1999-11-03
% 217.35/217.57  |- skos__broader mesh__D020192smesh__D020271
% 217.35/217.57  |- mesh__dateRevised mesh__D020192 2001-07-25
% 217.35/217.57  |- skos__broader mesh__D020192smesh__D020191
% 217.35/217.57  |- skos__prefLabel mesh__D020192 Lafora Disease
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D020192 2002
% 217.35/217.57  |- mesh__recordAuthorizer mesh__D020192 sjn
% 217.35/217.57  |- mesh__publicMeSHNote mesh__D020192
% 217.35/217.57       2000; see Epilepsy, Myoclonic 1977-1999   
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D014953 2005
% 217.35/217.57  |- mesh__dateCreated mesh__D014953 1999-01-01
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D014953 2004
% 217.35/217.57  |- skos__broader mesh__D014953smesh__D006225
% 217.35/217.57  |- mesh__recordOriginator mesh__D014953 NLM
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D014953 2003
% 217.35/217.57  |- skos__prefLabel mesh__D014953 Wrist
% 217.35/217.57  |- rdf__type mesh__D014953sskos__Concept
% 217.35/217.57  |- mesh__recordAuthorizer mesh__D014953 sjn
% 217.35/217.57  |- skos__annotation mesh__D014953
% 217.35/217.57       primates only; for non-primate vertebrates: Manual 21.58; wrist ganglion is indexed under WRIST %28%IM%29% + SYNOVIAL CYST %28%IM%29%; differentiate from WRIST JOINT; wrist bone = CARPAL BONES or specifics%A%  
% 217.35/217.57  |- skos__scopeNote mesh__D014953
% 217.35/217.57       The region of the upper limb between the metacarpus and the FOREARM.%A%    
% 217.35/217.57  |- skos__hiddenLabel mesh__D014953 Wrists
% 217.35/217.57  |- mesh__dateRevised mesh__D014953 2002-07-03
% 217.35/217.57  |- mesh__activeMeSHYear mesh__D014953 2006
% 217.35/217.57  |- mesh__recordMaintainer mesh__D014953 TPW
% 217.35/217.57  |- skos__hiddenLabel mesh__D014155 Vitamin B12 Binding Proteins
% 217.35/217.57  |- skos__hiddenLabel mesh__D014155 Vitamin B 12 Binding Proteins
% 217.35/217.57  |- skos__altLabel mesh__D014155 Transcobalamin %28%I%29%
% 217.35/217.57  |- skos__broader mesh__D014155smesh__D012712
% 217.35/217.57  |- skos__hiddenLabel mesh__D014155 R Binder
% 217.35/217.57  |- skos__hiddenLabel mesh__D014155 Holo Transcobalamin II
% 217.35/217.57  |- mesh__recordOriginator mesh__D014155 NLM
% 217.35/217.57  |- rdf__type mesh__D014155sskos__Concept
% 217.35/217.57  |- mesh__dateRevised mesh__D014155 2005-06-30
% 217.35/217.57  |- skos__hiddenLabel mesh__D014155 Cobalamin Binding Proteins
% 217.35/217.57  |- mesh__dateCreated mesh__D014155 1974-11-19
% 217.35/217.58  |- mesh__recordAuthorizer mesh__D014155 sjn
% 217.35/217.58  |- skos__altLabel mesh__D014155 Vitamin B12-Binding Proteins
% 217.35/217.58  |- skos__historyNote mesh__D014155 Vitamin B 12 %28%1973-1974%29%
% 217.35/217.58  |- skos__altLabel mesh__D014155 Cobalamin-Binding Proteins
% 217.35/217.58  |- skos__scopeNote mesh__D014155
% 217.35/217.58       A group of carrier proteins which bind with VITAMIN B12 in the BLOOD and aid in its transport. Transcobalamin I migrates electrophoretically as a beta-globulin, while transcobalamins II and III migrate as alpha-globulins.%A%    
% 217.35/217.58  |- skos__hiddenLabel mesh__D014155 Proteins, Vitamin B12-Binding
% 217.35/217.58  |- skos__historyNote mesh__D014155 Carrier Proteins %28%1973-1974%29%
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014155 2006
% 217.35/217.58  |- skos__hiddenLabel mesh__D014155 Proteins, Cobalamin-Binding
% 217.35/217.58  |- skos__historyNote mesh__D014155 Blood Proteins %28%1973-1974%29%
% 217.35/217.58  |- skos__prefLabel mesh__D014155 Transcobalamins
% 217.35/217.58  |- mesh__dateEstablished mesh__D014155 1984-01-01
% 217.35/217.58  |- skos__broader mesh__D014155smesh__D002352
% 217.35/217.58  |- mesh__publicMeSHNote mesh__D014155
% 217.35/217.58       84; was see under BLOOD PROTEINS 1975-83   
% 217.35/217.58  |- mesh__historyNote mesh__D014155
% 217.35/217.58       84%28%75%29%; was see under BLOOD PROTEINS 1975-83   
% 217.35/217.58  |- mesh__recordMaintainer mesh__D014155 ssb
% 217.35/217.58  |- skos__altLabel mesh__D014155 Vitamin B 12-Binding Proteins
% 217.35/217.58  |- skos__annotation mesh__D008916
% 217.35/217.58       do not confuse with %22%mitotic%22%; GEN or unspecified; prefer specifics; consider also PUPIL /drug eff%A%  
% 217.35/217.58  |- rdf__type mesh__D008916sskos__Concept
% 217.35/217.58  |- mesh__dateRevised mesh__D008916 2005-06-30
% 217.35/217.58  |- skos__related mesh__D008916smesh__D002800
% 217.35/217.58  |- skos__broader mesh__D008916smesh__D001337
% 217.35/217.58  |- skos__related mesh__D008916smesh__D018674
% 217.35/217.58  |- mesh__recordAuthorizer mesh__D008916 sjn
% 217.35/217.58  |- skos__related mesh__D008916smesh__D018721
% 217.35/217.58  |- mesh__recordOriginator mesh__D008916 NLM
% 217.35/217.58  |- skos__related mesh__D008916smesh__D010277
% 217.35/217.58  |- skos__related mesh__D008916smesh__D013565
% 217.35/217.58  |- skos__scopeNote mesh__D008916
% 217.35/217.58       Agents causing contraction of the pupil of the eye. Because the size of the pupil is under the antagonistic control of the sympathetic and parasympathetic systems, drugs affecting either system can cause miosis. Drugs that mimic or potentiate the parasympathetic input to the circular constrictor muscle and drugs that inhibit sympathetic input to the radial dilator muscle tend to contract the pupils. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here.%A%    
% 217.35/217.58  |- mesh__recordMaintainer mesh__D008916 ssb
% 217.35/217.58  |- mesh__dateCreated mesh__D008916 1999-01-01
% 217.35/217.58  |- skos__prefLabel mesh__D008916 Miotics
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008916 2006
% 217.35/217.58  |- mesh__recordAuthorizer mesh__D000933 sjn
% 217.35/217.58  |- skos__hiddenLabel mesh__D000933 Inhibitor, Plasmin
% 217.35/217.58  |- skos__prefLabel mesh__D000933 Antifibrinolytic Agents
% 217.35/217.58  |- mesh__dateCreated mesh__D000933 1999-01-01
% 217.35/217.58  |- skos__altLabel mesh__D000933 Antifibrinolytics
% 217.35/217.58  |- skos__scopeNote mesh__D000933
% 217.35/217.58       Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders.%A%    
% 217.35/217.58  |- skos__broader mesh__D000933smesh__D050299
% 217.35/217.58  |- rdf__type mesh__D000933sskos__Concept
% 217.35/217.58  |- mesh__recordMaintainer mesh__D000933 ssb
% 217.35/217.58  |- mesh__dateRevised mesh__D000933 2005-06-30
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D000933 2006
% 217.35/217.58  |- skos__hiddenLabel mesh__D000933 Agents, Antifibrinolytic
% 217.35/217.58  |- mesh__recordOriginator mesh__D000933 NLM
% 217.35/217.58  |- skos__altLabel mesh__D000933 Antifibrinolysins
% 217.35/217.58  |- mesh__publicMeSHNote mesh__D000933 66   
% 217.35/217.58  |- mesh__dateEstablished mesh__D000933 1966-01-01
% 217.35/217.58  |- skos__altLabel mesh__D000933 Antiplasmins
% 217.35/217.58  |- mesh__historyNote mesh__D000933 66   
% 217.35/217.58  |- skos__broader mesh__D000933smesh__D006490
% 217.35/217.58  |- mesh__recordAuthorizer mesh__D008118 SJN
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008118 2000
% 217.35/217.58  |- skos__scopeNote mesh__D008118
% 217.35/217.58       A parasitic infection caused by the nematode Loa loa. The vector in the transmission of this infection is the horsefly %28%Tabanus%29% or the deerfly or mango fly %28%Chrysops%29%. The larvae may be seen just beneath the skin or passing through the conjunctiva. Eye lesions are not uncommon. The disease is generally mild and painless.%A%    
% 217.35/217.58  |- mesh__dateRevised mesh__D008118 1998-06-10
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008118 2006
% 217.35/217.58  |- mesh__dateCreated mesh__D008118 1999-01-01
% 217.35/217.58  |- mesh__publicMeSHNote mesh__D008118
% 217.35/217.58       91; was see under FILARIASIS 1989-90; was LOAIASIS see under FILARIASIS 1975-88%A%  
% 217.35/217.58  |- mesh__recordOriginator mesh__D008118 NLM
% 217.35/217.58  |- mesh__onlineNote mesh__D008118
% 217.35/217.58       %28%75%29%; use LOIASIS to search LOAIASIS 1975-88; search FILARIASIS 1967-74%A%  
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008118 2005
% 217.35/217.58  |- skos__prefLabel mesh__D008118 Loiasis
% 217.35/217.58  |- mesh__recordMaintainer mesh__D008118 NDW
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008118 2004
% 217.35/217.58  |- mesh__historyNote mesh__D008118
% 217.35/217.58       91%28%75%29%; was see under FILARIASIS 1989-90; was LOAIASIS see under FILARIASIS 1975-88%A%  
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008118 2002
% 217.35/217.58  |- skos__annotation mesh__D008118 /drug ther: consider FILARICIDES   
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008118 2003
% 217.35/217.58  |- mesh__dateEstablished mesh__D008118 1991-01-01
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008118 2001
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008118 1999
% 217.35/217.58  |- rdf__type mesh__D008118sskos__Concept
% 217.35/217.58  |- skos__hiddenLabel mesh__D008118 Loiases
% 217.35/217.58  |- skos__altLabel mesh__D008118 Loaiasis
% 217.35/217.58  |- skos__broader mesh__D008118smesh__D005368
% 217.35/217.58  |- skos__hiddenLabel mesh__D008118 Loaiases
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D000135 2006
% 217.35/217.58  |- skos__hiddenLabel mesh__D000135 Acid beta Glycerophosphatase
% 217.35/217.58  |- mesh__dateCreated mesh__D000135 1999-01-01
% 217.35/217.58  |- skos__annotation mesh__D000135
% 217.35/217.58       /defic permitted: TN 222; prostate-specific acid phosphatase %28%PROSTATE + ACID PHOSPHATASE%29%: do not confuse with PROSTATE-SPECIFIC ANTIGEN, a serine proteinase%A%  
% 217.35/217.58  |- skos__scopeNote mesh__D000135
% 217.35/217.58       An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.2.%A%    
% 217.35/217.58  |- mesh__onlineNote mesh__D000135
% 217.35/217.58       use ACID PHOSPHATASE to search BLOOD ACID PHOSPHATASE 1966-67%A%  
% 217.35/217.58  |- mesh__recordOriginator mesh__D000135 NLM
% 217.35/217.58  |- skos__broader mesh__D000135smesh__D010744
% 217.35/217.58  |- rdf__type mesh__D000135sskos__Concept
% 217.35/217.58  |- mesh__dateRevised mesh__D000135 2003-07-09
% 217.35/217.58  |- skos__prefLabel mesh__D000135 Acid Phosphatase
% 217.35/217.58  |- mesh__historyNote mesh__D000135
% 217.35/217.58       /blood was BLOOD ACID PHOSPHATASE 1963-67   
% 217.35/217.58  |- mesh__recordMaintainer mesh__D000135 ssb
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D000135 2004
% 217.35/217.58  |- mesh__recordAuthorizer mesh__D000135 sjn
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D000135 2005
% 217.35/217.58  |- mesh__publicMeSHNote mesh__D000135
% 217.35/217.58       /blood was BLOOD ACID PHOSPHATASE 1963-67   
% 217.35/217.58  |- skos__broader mesh__D006262Q000193smesh__D006262
% 217.35/217.58  |- mesh__preferredCombination mesh__D006262Q000193smesh__D006266
% 217.35/217.58  |- rdf__type mesh__D006262Q000193smesh__CompoundConcept
% 217.35/217.58  |- skos__broader mesh__D018546smesh__D018520
% 217.35/217.58  |- mesh__historyNote mesh__D018546 95   
% 217.35/217.58  |- mesh__recordMaintainer mesh__D018546 PXP
% 217.35/217.58  |- mesh__recordOriginator mesh__D018546 JLS
% 217.35/217.58  |- mesh__dateEstablished mesh__D018546 1995-01-01
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D018546 2005
% 217.35/217.58  |- skos__altLabel mesh__D018546 Hypocotyls
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D018546 2006
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D018546 2003
% 217.35/217.58  |- skos__broader mesh__D018546smesh__D018547
% 217.35/217.58  |- skos__prefLabel mesh__D018546 Hypocotyl
% 217.35/217.58  |- mesh__publicMeSHNote mesh__D018546 95   
% 217.35/217.58  |- mesh__recordAuthorizer mesh__D018546 sjn
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D018546 2004
% 217.35/217.58  |- mesh__dateRevised mesh__D018546 2002-07-03
% 217.35/217.58  |- skos__annotation mesh__D018546
% 217.35/217.58       part of plant stem below the seed leaf; IM GEN or unspecified; coord probably IM in genetics %26% space physiol, NIM in pharmacognosy, with specific plant %28%IM or NIM%29%%A%  
% 217.35/217.58  |- rdf__type mesh__D018546sskos__Concept
% 217.35/217.58  |- skos__historyNote mesh__D018546 Plants %28%1966-1994%29%
% 217.35/217.58  |- skos__scopeNote mesh__D018546
% 217.35/217.58       The region of the stem beneath the stalks of the seed leaves %28%cotyledons%29% and directly above the young root of the embryo plant. It grows rapidly in seedlings showing epigeal germination and lifts the cotyledons above the soil surface. In this region %28%the transition zone%29% the arrangement of vascular bundles in the root changes to that of the stem. %28%From Concise Dictionary of Biology, 1990%29%%A%    
% 217.35/217.58  |- mesh__dateCreated mesh__D018546 1994-06-07
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D010563 2003
% 217.35/217.58  |- skos__hiddenLabel mesh__D010563 Turnovers, Employee
% 217.35/217.58  |- skos__hiddenLabel mesh__D010563 Turnover, Personnel
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D010563 2000
% 217.35/217.58  |- skos__hiddenLabel mesh__D010563 Personnel Turnovers
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D010563 1997
% 217.35/217.58  |- skos__hiddenLabel mesh__D010563 Employee Turnovers
% 217.35/217.58  |- mesh__dateCreated mesh__D010563 1982-04-28
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D010563 2004
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D010563 1994
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D010563 2001
% 217.35/217.58  |- rdf__type mesh__D010563sskos__Concept
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D010563 1995
% 217.35/217.58  |- skos__prefLabel mesh__D010563 Personnel Turnover
% 217.35/217.58  |- mesh__historyNote mesh__D010563
% 217.35/217.58       91%28%83%29%; was see under PERSONNEL MANAGEMENT 1983-90   
% 217.35/217.58  |- mesh__recordMaintainer mesh__D010563 TAP
% 217.35/217.58  |- mesh__publicMeSHNote mesh__D010563
% 217.35/217.58       91; was see under PERSONNEL MANAGEMENT 1983-90   
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D010563 1998
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D010563 2005
% 217.35/217.58  |- mesh__recordAuthorizer mesh__D010563 PLS
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D010563 2002
% 217.35/217.58  |- skos__scopeNote mesh__D010563
% 217.35/217.58       A change or shift in personnel due to reorganization, resignation, or discharge.%A%    
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D010563 1999
% 217.35/217.58  |- mesh__dateRevised mesh__D010563 1992-05-15
% 217.35/217.58  |- skos__hiddenLabel mesh__D010563 Turnover, Employee
% 217.35/217.58  |- skos__broader mesh__D010563smesh__D010559
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D010563 1993
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D010563 2006
% 217.35/217.58  |- mesh__dateEstablished mesh__D010563 1991-01-01
% 217.35/217.58  |- skos__altLabel mesh__D010563 Employee Turnover
% 217.35/217.58  |- mesh__recordOriginator mesh__D010563 EC
% 217.35/217.58  |- skos__hiddenLabel mesh__D010563 Turnovers, Personnel
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D010563 1996
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D004526 2005
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D004526 1995
% 217.35/217.58  |- mesh__dateCreated mesh__D004526 1999-01-01
% 217.35/217.58  |- skos__broader mesh__D004526smesh__D011590
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D004526 1994
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D004526 1997
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D004526 2001
% 217.35/217.58  |- mesh__dateRevised mesh__D004526 1992-12-28
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D004526 2004
% 217.35/217.58  |- mesh__recordAuthorizer mesh__D004526 PLS
% 217.35/217.58  |- mesh__recordMaintainer mesh__D004526 TGC
% 217.35/217.58  |- skos__prefLabel mesh__D004526 Efficiency
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D004526 1996
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D004526 2000
% 217.35/217.58  |- mesh__historyNote mesh__D004526
% 217.35/217.58       was in Cat F only 1963-81; was in Cat F %26% N 1982-91   
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D004526 2003
% 217.35/217.58  |- mesh__recordOriginator mesh__D004526 NLM
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D004526 1999
% 217.35/217.58  |- skos__annotation mesh__D004526
% 217.35/217.58       note category: do not confuse with PHYSICAL FITNESS nor with metabolic efficiency; EFFICIENCY, ORGANIZATIONAL is available%A%  
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D004526 2006
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D004526 1998
% 217.35/217.58  |- skos__scopeNote mesh__D004526
% 217.35/217.58       Ratio of output to effort, or the ratio of effort produced to energy expended.%A%    
% 217.35/217.58  |- rdf__type mesh__D004526sskos__Concept
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D004526 2002
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D009211 2004
% 217.35/217.58  |- mesh__recordOriginator mesh__D009211 NLM
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D009211 1999
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D009211 2002
% 217.35/217.58  |- skos__broader mesh__D009211smesh__D006420
% 217.35/217.58  |- rdf__type mesh__D009211sskos__Concept
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D009211 2003
% 217.35/217.58  |- skos__prefLabel mesh__D009211 Myoglobin
% 217.35/217.58  |- skos__annotation mesh__D009211
% 217.35/217.58       a hemeprotein %26% muscle protein; /biosyn /physiol permitted%A%  
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D009211 1998
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D009211 2006
% 217.35/217.58  |- skos__scopeNote mesh__D009211
% 217.35/217.58       A conjugated protein which is the oxygen-transporting pigment of muscle. It is made up of one globin polypeptide chain and one heme group.%A%    
% 217.35/217.58  |- skos__broader mesh__D009211smesh__D009124
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D009211 2001
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D009211 2005
% 217.35/217.58  |- mesh__recordAuthorizer mesh__D009211 PLS
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D009211 1997
% 217.35/217.58  |- mesh__recordMaintainer mesh__D009211 KEV
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D009211 2000
% 217.35/217.58  |- mesh__dateRevised mesh__D009211 1995-05-22
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D009211 1996
% 217.35/217.58  |- mesh__dateCreated mesh__D009211 1999-01-01
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014954 2001
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014954 1995
% 217.35/217.58  |- mesh__recordMaintainer mesh__D014954 PXP
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014954 2003
% 217.35/217.58  |- skos__broader mesh__D014954smesh__D001134
% 217.35/217.58  |- rdf__type mesh__D014954sskos__Concept
% 217.35/217.58  |- skos__scopeNote mesh__D014954
% 217.35/217.58       Injuries to the wrist or the wrist joint.     
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014954 1999
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014954 2000
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014954 1994
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014954 1998
% 217.35/217.58  |- mesh__recordAuthorizer mesh__D014954 PLS
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014954 1993
% 217.35/217.58  |- skos__annotation mesh__D014954 consider also CARPAL BONES /inj   
% 217.35/217.58  |- skos__hiddenLabel mesh__D014954 Injury, Wrist
% 217.35/217.58  |- mesh__recordOriginator mesh__D014954 NLM
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014954 1997
% 217.35/217.58  |- skos__altLabel mesh__D014954 Injuries, Wrist
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014954 1992
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014954 2006
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014954 1996
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014954 2005
% 217.35/217.58  |- skos__prefLabel mesh__D014954 Wrist Injuries
% 217.35/217.58  |- mesh__dateCreated mesh__D014954 1999-01-01
% 217.35/217.58  |- skos__hiddenLabel mesh__D014954 Wrist Injury
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014954 2002
% 217.35/217.58  |- mesh__dateRevised mesh__D014954 1990-11-10
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014954 2004
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D047330 2005
% 217.35/217.58  |- mesh__dateEstablished mesh__D047330 2005-01-01
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D047330 2006
% 217.35/217.58  |- mesh__recordMaintainer mesh__D047330 ags
% 217.35/217.58  |- mesh__recordOriginator mesh__D047330 ags
% 217.35/217.58  |- mesh__historyNote mesh__D047330 2005   
% 217.35/217.58  |- skos__broader mesh__D047330smesh__D012617
% 217.35/217.58  |- skos__prefLabel mesh__D047330 Hemicentrotus
% 217.35/217.58  |- mesh__recordAuthorizer mesh__D047330 sjn
% 217.35/217.58  |- rdf__type mesh__D047330sskos__Concept
% 217.35/217.58  |- skos__historyNote mesh__D047330 Sea Urchins %28%1969-2004%29%
% 217.35/217.58  |- mesh__dateCreated mesh__D047330 2004-07-07
% 217.35/217.58  |- mesh__publicMeSHNote mesh__D047330 2005   
% 217.35/217.58  |- skos__scopeNote mesh__D047330
% 217.35/217.58       A genus of SEA URCHINS in the family Strongylocentrotidae with a hemicyclic apical disk and short spines.%A%    
% 217.35/217.58  |- mesh__publicMeSHNote mesh__D014156 65   
% 217.35/217.58  |- mesh__historyNote mesh__D014156 65%28%64%29%   
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014156 2005
% 217.35/217.58  |- skos__prefLabel mesh__D014156 Transcortin
% 217.35/217.58  |- skos__hiddenLabel mesh__D014156 Corticosteroid Anionbinder IIIA
% 217.35/217.58  |- skos__broader mesh__D014156smesh__D000510
% 217.35/217.58  |- mesh__recordAuthorizer mesh__D014156 PLS
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014156 2003
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014156 2006
% 217.35/217.58  |- mesh__dateCreated mesh__D014156 1999-01-01
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014156 2000
% 217.35/217.58  |- mesh__dateRevised mesh__D014156 1995-05-25
% 217.35/217.58  |- skos__broader mesh__D014156smesh__D002352
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014156 2004
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014156 1998
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014156 2001
% 217.35/217.58  |- skos__hiddenLabel mesh__D014156 Globulin, Corticosteroid-Binding
% 217.35/217.58  |- skos__altLabel mesh__D014156 Corticosteroid-Binding Globulin
% 217.35/217.58  |- skos__hiddenLabel mesh__D014156 Corticosteroid Binding Globulin
% 217.35/217.58  |- mesh__recordOriginator mesh__D014156 NLM
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014156 1996
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014156 1999
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014156 2002
% 217.35/217.58  |- mesh__recordMaintainer mesh__D014156 PLS
% 217.35/217.58  |- skos__annotation mesh__D014156 an alpha-globulin   
% 217.35/217.58  |- mesh__dateEstablished mesh__D014156 1965-01-01
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D014156 1997
% 217.35/217.58  |- skos__broader mesh__D014156smesh__D006023
% 217.35/217.58  |- rdf__type mesh__D014156sskos__Concept
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008917 2002
% 217.35/217.58  |- mesh__publicMeSHNote mesh__D008917
% 217.35/217.58       91; was see under INSECTICIDES, ORGANOCHLORINE 1972-90   
% 217.35/217.58  |- skos__prefLabel mesh__D008917 Mirex
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008917 2004
% 217.35/217.58  |- skos__broader mesh__D008917smesh__D006843
% 217.35/217.58  |- mesh__historyNote mesh__D008917
% 217.35/217.58       91%28%72%29%; was see under INSECTICIDES, ORGANOCHLORINE 1972-90%A%  
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008917 2001
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008917 2003
% 217.35/217.58  |- mesh__dateEstablished mesh__D008917 1991-01-01
% 217.35/217.58  |- skos__annotation mesh__D008917 TN 111 for eff on insects   
% 217.35/217.58  |- mesh__dateRevised mesh__D008917 1999-11-03
% 217.35/217.58  |- mesh__dateCreated mesh__D008917 1999-01-01
% 217.35/217.58  |- mesh__recordAuthorizer mesh__D008917 sjn
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008917 2000
% 217.35/217.58  |- mesh__recordMaintainer mesh__D008917 adp
% 217.35/217.58  |- skos__scopeNote mesh__D008917
% 217.35/217.58       An organochlorine insecticide that is carcinogenic.     
% 217.35/217.58  |- mesh__recordOriginator mesh__D008917 NLM
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008917 2006
% 217.35/217.58  |- skos__historyNote mesh__D008917 Insecticides %28%1966-1972%29%
% 217.35/217.58  |- rdf__type mesh__D008917sskos__Concept
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008917 2005
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D000934 2004
% 217.35/217.58  |- skos__hiddenLabel mesh__D000934 Agents, Defoaming
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D000934 2006
% 217.35/217.58  |- mesh__dateEstablished mesh__D000934 1991-01-01
% 217.35/217.58  |- skos__scopeNote mesh__D000934
% 217.35/217.58       Agents used to prevent the formation of foam or to treat flatulence or bloat.%A%    
% 217.35/217.58  |- mesh__recordAuthorizer mesh__D000934 sjn
% 217.35/217.58  |- skos__historyNote mesh__D000934 Surface-Active Agents %28%1966-1976%29%
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D000934 2005
% 217.35/217.58  |- mesh__dateRevised mesh__D000934 2003-07-09
% 217.35/217.58  |- skos__prefLabel mesh__D000934 Antifoaming Agents
% 217.35/217.58  |- skos__hiddenLabel mesh__D000934 Agents, Antifoaming
% 217.35/217.58  |- skos__broader mesh__D000934smesh__D013501
% 217.35/217.58  |- mesh__publicMeSHNote mesh__D000934
% 217.35/217.58       91; was see under SURFACE-ACTIVE AGENTS 1977-90   
% 217.35/217.58  |- skos__annotation mesh__D000934
% 217.35/217.58       D25-26 qualif; consider also FLATULENCE /drug ther   
% 217.35/217.58  |- mesh__historyNote mesh__D000934
% 217.35/217.58       91%28%77%29%; was see under SURFACE-ACTIVE AGENTS 1977-90   
% 217.35/217.58  |- mesh__recordOriginator mesh__D000934 SH
% 217.35/217.58  |- skos__hiddenLabel mesh__D000934 Retardants, Foam
% 217.35/217.58  |- mesh__dateCreated mesh__D000934 1976-04-13
% 217.35/217.58  |- mesh__recordMaintainer mesh__D000934 ssb
% 217.35/217.58  |- skos__historyNote mesh__D000934 Silicones %28%1966-1976%29%
% 217.35/217.58  |- rdf__type mesh__D000934sskos__Concept
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008119 2000
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008119 1996
% 217.35/217.58  |- skos__annotation mesh__D008119 no qualif   
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008119 2006
% 217.35/217.58  |- skos__historyNote mesh__D008119 Politics %28%1968-1981%29%
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008119 2001
% 217.35/217.58  |- mesh__historyNote mesh__D008119
% 217.35/217.58       91%28%82%29%; was see under POLITICS 1982-90   
% 217.35/217.58  |- mesh__dateEstablished mesh__D008119 1991-01-01
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008119 1997
% 217.35/217.58  |- mesh__recordMaintainer mesh__D008119 NLM
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008119 1994
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008119 2003
% 217.35/217.58  |- skos__hiddenLabel mesh__D008119 Lobbyings
% 217.35/217.58  |- mesh__dateCreated mesh__D008119 1981-02-26
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008119 1995
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008119 2004
% 217.35/217.58  |- skos__prefLabel mesh__D008119 Lobbying
% 217.35/217.58  |- mesh__recordOriginator mesh__D008119 EC
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008119 2002
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008119 1998
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008119 1992
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008119 1999
% 217.35/217.58  |- skos__broader mesh__D008119smesh__D011057
% 217.35/217.58  |- rdf__type mesh__D008119sskos__Concept
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008119 1993
% 217.35/217.58  |- mesh__recordAuthorizer mesh__D008119 PLS
% 217.35/217.58  |- mesh__dateRevised mesh__D008119 1990-04-13
% 217.35/217.58  |- mesh__publicMeSHNote mesh__D008119 91; was see under POLITICS 1982-90   
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008119 1991
% 217.35/217.58  |- skos__scopeNote mesh__D008119
% 217.35/217.58       A process whereby representatives of a particular interest group attempt to influence governmental decision makers to accept the policy desires of the lobbying organization.%A%    
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D008119 2005
% 217.35/217.58  |- skos__hiddenLabel mesh__D000136 Gap, Anion
% 217.35/217.58  |- skos__hiddenLabel mesh__D000136 Equilibrium, Acid-Base
% 217.35/217.58  |- skos__hiddenLabel mesh__D000136 Acid Base Balance
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D000136 2006
% 217.35/217.58  |- skos__broader mesh__D000136smesh__D001669
% 217.35/217.58  |- skos__related mesh__D000136smesh__D002021
% 217.35/217.58  |- mesh__recordOriginator mesh__D000136 NLM
% 217.35/217.58  |- skos__hiddenLabel mesh__D000136 Balance, Acid-Base
% 217.35/217.58  |- skos__related mesh__D000136smesh__D006863
% 217.35/217.58  |- skos__hiddenLabel mesh__D000136 Acid Base Equilibrium
% 217.35/217.58  |- rdf__type mesh__D000136sskos__Concept
% 217.35/217.58  |- skos__scopeNote mesh__D000136
% 217.35/217.58       The balance between acids and bases in the BODY FLUIDS. The pH %28%HYDROGEN-ION CONCENTRATION%29% of the arterial BLOOD provides an index for the total body acid-base balance.%A%    
% 217.35/217.58  |- skos__broader mesh__D000136smesh__D045122
% 217.35/217.58  |- skos__hiddenLabel mesh__D000136 Gaps, Anion
% 217.35/217.58  |- mesh__recordMaintainer mesh__D000136 nns
% 217.35/217.58  |- skos__related mesh__D000136smesh__D000138
% 217.35/217.58  |- skos__hiddenLabel mesh__D000136 Anion Gaps
% 217.35/217.58  |- mesh__recordAuthorizer mesh__D000136 sjn
% 217.35/217.58  |- mesh__dateRevised mesh__D000136 2003-07-09
% 217.35/217.58  |- skos__broader mesh__D000136smesh__D006706
% 217.35/217.58  |- skos__annotation mesh__D000136 consider also ACID-BASE IMBALANCE   
% 217.35/217.58  |- skos__broader mesh__D000136smesh__D006863
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D000136 2004
% 217.35/217.58  |- skos__related mesh__D000136smesh__D000471
% 217.35/217.58  |- skos__prefLabel mesh__D000136 Acid-Base Equilibrium
% 217.35/217.58  |- skos__altLabel mesh__D000136 Acid-Base Balance
% 217.35/217.58  |- mesh__dateCreated mesh__D000136 1999-01-01
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D000136 2005
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D018547 2005
% 217.35/217.58  |- mesh__activeMeSHYear mesh__D018547 2003A
% 217.35/217.58  |- skos__historyNote mesh__D018547 Plants %28%1966-1994%29%
% 217.35/217.58  |- mesh__recordMaintainer mesh__D018547 sjn
% 217.35/217.59  |- skos__annotation mesh__D018547
% 217.35/217.59       coord with specific plant; PLANT BARK is also available   
% 217.35/217.59  |- mesh__activeMeSHYear mesh__D018547 2006
% 217.35/217.59  |- mesh__activeMeSHYear mesh__D018547 2003
% 217.35/217.59  |- mesh__dateRevised mesh__D018547 2002-09-19
% 217.35/217.59  |- skos__altLabel mesh__D018547 Plant Stem
% 217.35/217.59  |- skos__broader mesh__D018547smesh__D035261
% 217.35/217.59  |- skos__scopeNote mesh__D018547
% 217.35/217.59       Parts of plants that usually grow vertically upwards towards the light and support the leaves, buds, and reproductive structures. %28%From Concise Dictionary of Biology, 1990%29%%A%    
% 217.35/217.59  |- mesh__activeMeSHYear mesh__D018547 2004
% 217.35/217.59  |- mesh__dateEstablished mesh__D018547 1995-01-01
% 217.35/217.59  |- rdf__type mesh__D018547sskos__Concept
% 217.35/217.59  |- mesh__dateCreated mesh__D018547 1994-06-07
% 217.35/217.59  |- mesh__publicMeSHNote mesh__D018547 95   
% 217.44/217.59  |- mesh__recordAuthorizer mesh__D018547 sjn
% 217.44/217.59  |- skos__prefLabel mesh__D018547 Plant Stems
% 217.44/217.59  |- mesh__historyNote mesh__D018547 95   
% 217.44/217.59  |- mesh__recordOriginator mesh__D018547 JLS
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D010564 1997
% 217.44/217.59  |- skos__broader mesh__D010564smesh__D006282
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D010564 2003
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D010564 2001
% 217.44/217.59  |- rdf__type mesh__D010564sskos__Concept
% 217.44/217.59  |- mesh__historyNote mesh__D010564 78; was HOSPITAL PERSONNEL 1968-77   
% 217.44/217.59  |- skos__annotation mesh__D010564
% 217.44/217.59       /organ = PERSONNEL ADMINISTRATION, HOSPITAL but consider also other terms under ADMINISTRATIVE PERSONNEL %26% ALLIED HEALTH PERSONNEL, etc.; %22%orderlies%22% %26% %22%ward attendants%22% unspecified go here except for PSYCHIATRIC AIDES %28%see note there%29%%A%  
% 217.44/217.59  |- skos__prefLabel mesh__D010564 Personnel, Hospital
% 217.44/217.59  |- skos__scopeNote mesh__D010564
% 217.44/217.59       The individuals employed by the hospital.     
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D010564 2004
% 217.44/217.59  |- skos__historyNote mesh__D010564
% 217.44/217.59       Personnel Administration, Hospital %28%1966-1967%29%
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D010564 1994
% 217.44/217.59  |- mesh__recordMaintainer mesh__D010564 PLS
% 217.44/217.59  |- mesh__dateCreated mesh__D010564 1999-01-01
% 217.44/217.59  |- mesh__onlineNote mesh__D010564
% 217.44/217.59       use PERSONNEL, HOSPITAL to search HOSPITAL PERSONNEL 1968-77%A%  
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D010564 1998
% 217.44/217.59  |- mesh__recordAuthorizer mesh__D010564 PLS
% 217.44/217.59  |- skos__altLabel mesh__D010564 Hospital Personnel
% 217.44/217.59  |- mesh__dateEstablished mesh__D010564 1968-01-01
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D010564 1995
% 217.44/217.59  |- mesh__publicMeSHNote mesh__D010564 78; was HOSPITAL PERSONNEL 1968-77   
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D010564 2002
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D010564 1999
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D010564 2005
% 217.44/217.59  |- mesh__recordOriginator mesh__D010564 NLM
% 217.44/217.59  |- mesh__dateRevised mesh__D010564 1993-06-03
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D010564 1996
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D010564 2006
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D010564 2000
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D037701 2006
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D037701 2006A
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D037701 2005
% 217.44/217.59  |- skos__altLabel mesh__D037701
% 217.44/217.59       Pulmonary Surfactant-Associated Protein SP-B
% 217.44/217.59  |- skos__scopeNote mesh__D037701
% 217.44/217.59       A pulmonary surfactant associated-protein that plays an essential role in alveolar stability by lowering the surface tension at the air-liquid interface. Inherited deficiency of pulmonary surfactant-associated protein B is one cause of RESPIRATORY DISTRESS SYNDROME, NEWBORN.%A%    
% 217.44/217.59  |- mesh__recordOriginator mesh__D037701 jmp
% 217.44/217.59  |- rdf__type mesh__D037701sskos__Concept
% 217.44/217.59  |- mesh__dateEstablished mesh__D037701 2003-01-01
% 217.44/217.59  |- skos__altLabel mesh__D037701 Surfactant Protein SP-B
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D037701 2004
% 217.44/217.59  |- mesh__historyNote mesh__D037701
% 217.44/217.59       2003; use PULMONARY SURFACTANT-ASSOCIATED PROTEIN B %28%NM%29% 1989-2002%A%  
% 217.44/217.59  |- skos__broader mesh__D037701smesh__D008565
% 217.44/217.59  |- skos__prefLabel mesh__D037701 Pulmonary Surfactant-Associated Protein B
% 217.44/217.59  |- mesh__publicMeSHNote mesh__D037701
% 217.44/217.59       2003; PULMONARY SURFACTANT ASSOCIATED PROTEIN SP-B %28%now PULMONARY SURFACTANT-ASSOCIATED PROTEIN B%29% was indexed under PROTEOLIPIDS %26% PULMONARY SURFACTANTS 1989-2002%A%  
% 217.44/217.59  |- skos__hiddenLabel mesh__D037701
% 217.44/217.59       Pulmonary Surfactant Associated Protein SP B
% 217.44/217.59  |- skos__hiddenLabel mesh__D037701
% 217.44/217.59       Pulmonary Surfactant Associated Protein B
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D037701 2003
% 217.44/217.59  |- skos__hiddenLabel mesh__D037701
% 217.44/217.59       SP B Pulmonary Surfactant Associated Protein
% 217.44/217.59  |- skos__broader mesh__D037701smesh__D037661
% 217.44/217.59  |- skos__altLabel mesh__D037701
% 217.44/217.59       SP-B Pulmonary Surfactant-Associated Protein
% 217.44/217.59  |- skos__historyNote mesh__D037701 Proteolipids %28%1989-2002%29%
% 217.44/217.59  |- mesh__dateRevised mesh__D037701 2005-07-28
% 217.44/217.59  |- skos__historyNote mesh__D037701 Pulmonary Surfactants %28%1989-2002%29%
% 217.44/217.59  |- mesh__recordAuthorizer mesh__D037701 ags
% 217.44/217.59  |- skos__hiddenLabel mesh__D037701 SP B Protein
% 217.44/217.59  |- skos__altLabel mesh__D037701 SP-B Protein
% 217.44/217.59  |- mesh__dateCreated mesh__D037701 2002-07-03
% 217.44/217.59  |- skos__hiddenLabel mesh__D037701 Surfactant Protein SP B
% 217.44/217.59  |- mesh__recordMaintainer mesh__D037701 ags
% 217.44/217.59  |- mesh__dateEstablished mesh__D004527 1973-01-01
% 217.44/217.59  |- skos__hiddenLabel mesh__D004527 Proteins, Egg Yolk
% 217.44/217.59  |- mesh__historyNote mesh__D004527 73   
% 217.44/217.59  |- skos__hiddenLabel mesh__D004527 Proteins, Yolk
% 217.44/217.59  |- skos__hiddenLabel mesh__D004527 White Proteins, Egg
% 217.44/217.59  |- skos__historyNote mesh__D004527 Proteins %28%1966-1972%29%
% 217.44/217.59  |- mesh__dateRevised mesh__D004527 2005-06-30
% 217.44/217.59  |- skos__hiddenLabel mesh__D004527 Proteins, Egg
% 217.44/217.59  |- skos__historyNote mesh__D004527 Egg White %28%1966-1972%29%
% 217.44/217.59  |- skos__hiddenLabel mesh__D004527 Proteins, Ovum
% 217.44/217.59  |- mesh__recordAuthorizer mesh__D004527 sjn
% 217.44/217.59  |- skos__altLabel mesh__D004527 Ovum Proteins
% 217.44/217.59  |- skos__scopeNote mesh__D004527
% 217.44/217.59       Proteins which are found in eggs %28%OVA%29% from any species.%A%    
% 217.44/217.59  |- skos__hiddenLabel mesh__D004527 Yolk Proteins, Egg
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D004527 2006
% 217.44/217.59  |- skos__hiddenLabel mesh__D004527 Shell Proteins, Egg
% 217.44/217.59  |- skos__broader mesh__D004527smesh__D011506
% 217.44/217.59  |- rdf__type mesh__D004527sskos__Concept
% 217.44/217.59  |- skos__annotation mesh__D004527
% 217.44/217.59       GEN or unspecified: prefer specifics %26% note EGG PROTEINS, DIETARY%A%  
% 217.44/217.59  |- mesh__publicMeSHNote mesh__D004527 73   
% 217.44/217.59  |- skos__hiddenLabel mesh__D004527 Proteins, Egg White
% 217.44/217.59  |- mesh__recordMaintainer mesh__D004527 SYSTEM
% 217.44/217.59  |- mesh__recordOriginator mesh__D004527 NLM
% 217.44/217.59  |- mesh__dateCreated mesh__D004527 1999-01-01
% 217.44/217.59  |- skos__altLabel mesh__D004527 Egg Yolk Proteins
% 217.44/217.59  |- skos__prefLabel mesh__D004527 Egg Proteins
% 217.44/217.59  |- skos__historyNote mesh__D004527 Egg Yolk %28%1966-1972%29%
% 217.44/217.59  |- skos__hiddenLabel mesh__D004527 Proteins, Egg Shell
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D009212 2004
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D009212 1991
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D009212 2001
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D009212 1994
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D009212 1999
% 217.44/217.59  |- skos__hiddenLabel mesh__D009212 Myoglobinurias
% 217.44/217.59  |- rdf__type mesh__D009212sskos__Concept
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D009212 2002
% 217.44/217.59  |- mesh__historyNote mesh__D009212
% 217.44/217.59       91%28%84%29%65%28%63%29%; was see under RHABDOMYOLYSIS 1984-90; was heading 1965-83; was Prov 1963-64%A%  
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D009212 1995
% 217.44/217.59  |- mesh__dateEstablished mesh__D009212 1965-01-01
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D009212 2005
% 217.44/217.59  |- skos__prefLabel mesh__D009212 Myoglobinuria
% 217.44/217.59  |- mesh__recordOriginator mesh__D009212 NLM
% 217.44/217.59  |- skos__annotation mesh__D009212
% 217.44/217.59       myoglobinuria in rhabdomyolysis: index under RHABDOMYOLYSIS %28%IM%29% + MYOGLOBINURIA %28%NIM%29% only if myoglobinuria is particularly discussed%A%  
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D009212 2006
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D009212 1996
% 217.44/217.59  |- mesh__recordMaintainer mesh__D009212 NLM
% 217.44/217.59  |- mesh__dateCreated mesh__D009212 1999-01-01
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D009212 1997
% 217.44/217.59  |- mesh__recordAuthorizer mesh__D009212 PLS
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D009212 1992
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D009212 2000
% 217.44/217.59  |- skos__broader mesh__D009212smesh__D012206
% 217.44/217.59  |- mesh__dateRevised mesh__D009212 1990-06-01
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D009212 1993
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D009212 2003
% 217.44/217.59  |- mesh__publicMeSHNote mesh__D009212
% 217.44/217.59       91,65-83; was see under RHABDOMYOLYSIS 1984-90; was heading 1965-83%A%  
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D009212 1998
% 217.44/217.59  |- mesh__dateRevised mesh__D020194 2001-07-25
% 217.44/217.59  |- skos__broader mesh__D020194smesh__D020191
% 217.44/217.59  |- skos__hiddenLabel mesh__D020194 Myoclonus Epilepsy, Baltic
% 217.44/217.59  |- mesh__recordMaintainer mesh__D020194 nns
% 217.44/217.59  |- skos__hiddenLabel mesh__D020194 Disease, Unverricht
% 217.44/217.59  |- mesh__recordAuthorizer mesh__D020194 sjn
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D020194 2003
% 217.44/217.59  |- skos__scopeNote mesh__D020194
% 217.44/217.59       An autosomal recessive condition characterized by recurrent myoclonic and generalized seizures, ATAXIA, slowly progressive intellectual deterioration, dysarthria, and intention tremor. Myoclonic seizures are severe and continuous, and tend to be triggered by movement, stress, and sensory stimuli. The age of onset is between 8 and 13 years, and the condition is relatively frequent in the Baltic region, especially Finland. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp109-110%29%%A%    
% 217.44/217.59  |- skos__historyNote mesh__D020194 Epilepsies, Myoclonic %28%1977-1999%29%
% 217.44/217.59  |- skos__altLabel mesh__D020194 Mediterranean Myoclonic Epilepsy
% 217.44/217.59  |- skos__broader mesh__D020194smesh__D020271
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D020194 2002
% 217.44/217.59  |- skos__altLabel mesh__D020194 Unverricht Disease
% 217.44/217.59  |- skos__hiddenLabel mesh__D020194 Lundborg Unverricht Syndrome
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D020194 2004
% 217.44/217.59  |- skos__historyNote mesh__D020194 Myoclonus %28%1965-1976%29%
% 217.44/217.59  |- skos__hiddenLabel mesh__D020194 Epilepsy, Mediterranean Myoclonic
% 217.44/217.59  |- skos__hiddenLabel mesh__D020194 Baltic Myoclonus Epilepsies
% 217.44/217.59  |- skos__historyNote mesh__D020194 Epilepsy %28%1965-1976%29%
% 217.44/217.59  |- skos__hiddenLabel mesh__D020194 Syndrome, Unverricht-Lundborg
% 217.44/217.59  |- skos__hiddenLabel mesh__D020194 Epilepsies, Baltic Myoclonus
% 217.44/217.59  |- skos__hiddenLabel mesh__D020194 Myoclonus, Baltic
% 217.44/217.59  |- skos__altLabel mesh__D020194 Baltic Myoclonus
% 217.44/217.59  |- skos__altLabel mesh__D020194 Lundborg-Unverricht Syndrome
% 217.44/217.59  |- skos__hiddenLabel mesh__D020194 Myoclonic Epilepsy, Mediterranean
% 217.44/217.59  |- mesh__dateEstablished mesh__D020194 2000-01-01
% 217.44/217.59  |- skos__hiddenLabel mesh__D020194 Syndrome, Lundborg-Unverricht
% 217.44/217.59  |- skos__hiddenLabel mesh__D020194 Myoclonus Epilepsies, Baltic
% 217.44/217.59  |- skos__altLabel mesh__D020194 Baltic Myoclonus Epilepsy
% 217.44/217.59  |- skos__prefLabel mesh__D020194 Unverricht-Lundborg Syndrome
% 217.44/217.59  |- skos__hiddenLabel mesh__D020194 Unverricht Diseases
% 217.44/217.59  |- skos__hiddenLabel mesh__D020194 Diseases, Unverricht
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D020194 2005
% 217.44/217.59  |- mesh__recordOriginator mesh__D020194 KEV
% 217.44/217.59  |- rdf__type mesh__D020194sskos__Concept
% 217.44/217.59  |- skos__hiddenLabel mesh__D020194 Epilepsy, Baltic Myoclonus
% 217.44/217.59  |- mesh__historyNote mesh__D020194
% 217.44/217.59       2000; for LUNDBORG-UNVERRICHT SYNDROME use EPILEPSY, MYOCLONIC 1977-1999%A%  
% 217.44/217.59  |- mesh__publicMeSHNote mesh__D020194
% 217.44/217.59       2000; for LUNDBORG-UNVERRICHT SYNDROME see EPILEPSY, MYOCLONIC 1977-1999%A%  
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D020194 2006
% 217.44/217.59  |- mesh__dateCreated mesh__D020194 1999-11-03
% 217.44/217.59  |- skos__hiddenLabel mesh__D020194 Unverricht Lundborg Syndrome
% 217.44/217.59  |- mesh__dateEstablished mesh__D014955 1965-01-01
% 217.44/217.59  |- mesh__recordAuthorizer mesh__D014955 sjn
% 217.44/217.59  |- skos__hiddenLabel mesh__D014955 Joints, Wrist
% 217.44/217.59  |- skos__hiddenLabel mesh__D014955 Wrist Joints
% 217.44/217.59  |- rdf__type mesh__D014955sskos__Concept
% 217.44/217.59  |- mesh__recordMaintainer mesh__D014955 ags
% 217.44/217.59  |- skos__prefLabel mesh__D014955 Wrist Joint
% 217.44/217.59  |- skos__scopeNote mesh__D014955
% 217.44/217.59       The joint that is formed by the distal end of the RADIUS, the articular disc of the distal radioulnar joint, and the proximal row of CARPAL BONES; %28%SCAPHOID BONE; LUNATE BONE; triquetral bone%29%.%A%    
% 217.44/217.59  |- skos__hiddenLabel mesh__D014955 Joint, Wrist
% 217.44/217.59  |- mesh__dateCreated mesh__D014955 1999-01-01
% 217.44/217.59  |- mesh__dateRevised mesh__D014955 2005-06-30
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D014955 2006
% 217.44/217.59  |- skos__broader mesh__D014955smesh__D050823
% 217.44/217.59  |- mesh__historyNote mesh__D014955 65   
% 217.44/217.59  |- mesh__recordOriginator mesh__D014955 NLM
% 217.44/217.59  |- mesh__publicMeSHNote mesh__D014955 65   
% 217.44/217.59  |- skos__annotation mesh__D014955
% 217.44/217.59       primates only; use CARPUS, ANIMAL for non-primate vertebrates; differentiate from wrist; wrist ganglion is indexed under WRIST %28%IM%29% + SYNOVIAL CYST %28%IM%29%%A%  
% 217.44/217.59  |- mesh__recordAuthorizer mesh__D047331 sjn
% 217.44/217.59  |- mesh__recordMaintainer mesh__D047331 ags
% 217.44/217.59  |- skos__scopeNote mesh__D047331
% 217.44/217.59       A genus of SEA URCHINS in the family Toxopneustidae possessing trigeminate ambulacral plating.%A%    
% 217.44/217.59  |- rdf__type mesh__D047331sskos__Concept
% 217.44/217.59  |- skos__prefLabel mesh__D047331 Lytechnius
% 217.44/217.59  |- mesh__dateEstablished mesh__D047331 2005-01-01
% 217.44/217.59  |- mesh__publicMeSHNote mesh__D047331 2005   
% 217.44/217.59  |- mesh__dateCreated mesh__D047331 2004-07-07
% 217.44/217.59  |- skos__historyNote mesh__D047331 Sea Urchins %28%1971-2004%29%
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D047331 2005
% 217.44/217.59  |- mesh__recordOriginator mesh__D047331 ags
% 217.44/217.59  |- skos__historyNote mesh__D047331 Echinodermata %28%1966-1971%29%
% 217.44/217.59  |- mesh__historyNote mesh__D047331 2005   
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D047331 2006
% 217.44/217.59  |- skos__broader mesh__D047331smesh__D012617
% 217.44/217.59  |- skos__scopeNote mesh__D014157
% 217.44/217.59       Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.%A%    
% 217.44/217.59  |- mesh__recordMaintainer mesh__D014157 SYSTEM
% 217.44/217.59  |- mesh__recordOriginator mesh__D014157 RLS
% 217.44/217.59  |- skos__historyNote mesh__D014157 Bacterial Proteins %28%1973-1976%29%
% 217.44/217.59  |- mesh__recordAuthorizer mesh__D014157 sjn
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D014157 2006
% 217.44/217.59  |- mesh__publicMeSHNote mesh__D014157 77   
% 217.44/217.59  |- skos__historyNote mesh__D014157 Transcription, Genetic %28%1973-1976%29%
% 217.44/217.59  |- skos__hiddenLabel mesh__D014157 Factor, Transcription
% 217.44/217.59  |- skos__hiddenLabel mesh__D014157 Factors, Transcription
% 217.44/217.59  |- skos__altLabel mesh__D014157 Transcription Factor
% 217.44/217.59  |- mesh__dateCreated mesh__D014157 1976-04-16
% 217.44/217.59  |- skos__historyNote mesh__D014157 Proteins %28%1966-1976%29%
% 217.44/217.59  |- skos__annotation mesh__D014157
% 217.44/217.59       in genetic transcription; /biosyn /physiol permitted; regulatory proteins go here or under REPRESSOR PROTEINS or VIRAL REGULATORY PROTEINS%A%  
% 217.44/217.59  |- skos__related mesh__D014157smesh__D015534
% 217.44/217.59  |- skos__broader mesh__D014157smesh__D011506
% 217.44/217.59  |- rdf__type mesh__D014157sskos__Concept
% 217.44/217.59  |- mesh__dateEstablished mesh__D014157 1977-01-01
% 217.44/217.59  |- skos__prefLabel mesh__D014157 Transcription Factors
% 217.44/217.59  |- mesh__dateRevised mesh__D014157 2005-06-30
% 217.44/217.59  |- mesh__historyNote mesh__D014157 77   
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D000935 2006
% 217.44/217.59  |- mesh__recordMaintainer mesh__D000935 ssb
% 217.44/217.59  |- skos__annotation mesh__D000935
% 217.44/217.59       used in therapy: differentiate from FUNGICIDES, INDUSTRIAL;  for resistance to antifungal agents, DRUG RESISTANCE, FUNGAL and DRUG RESISTANCE, MULTIPLE, FUNGAL are available%A%  
% 217.44/217.59  |- skos__related mesh__D000935smesh__D005659
% 217.44/217.59  |- mesh__dateRevised mesh__D000935 2005-06-30
% 217.44/217.59  |- skos__altLabel mesh__D000935 Fungicides, Therapeutic
% 217.44/217.59  |- skos__altLabel mesh__D000935 Therapeutic Fungicides
% 217.44/217.59  |- mesh__recordOriginator mesh__D000935 NLM
% 217.44/217.59  |- skos__broader mesh__D000935smesh__D000890
% 217.44/217.59  |- skos__hiddenLabel mesh__D000935 Agents, Antifungal
% 217.44/217.59  |- skos__prefLabel mesh__D000935 Antifungal Agents
% 217.44/217.59  |- mesh__historyNote mesh__D000935
% 217.44/217.59       67; FUNGICIDES was included in ANTIFUNGAL AGENTS 1967-71, was heading 1963-66%A%  
% 217.44/217.59  |- mesh__dateCreated mesh__D000935 1999-01-01
% 217.44/217.59  |- mesh__recordAuthorizer mesh__D000935 sjn
% 217.44/217.59  |- skos__scopeNote mesh__D000935
% 217.44/217.59       Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.%A%    
% 217.44/217.59  |- mesh__publicMeSHNote mesh__D000935
% 217.44/217.59       67; FUNGICIDES was included in ANTIFUNGAL AGENTS 1967-71, was heading 1963-66%A%  
% 217.44/217.59  |- mesh__onlineNote mesh__D000935
% 217.44/217.59       use ANTIFUNGAL AGENTS to search FUNGICIDES 1966-71   
% 217.44/217.59  |- rdf__type mesh__D000935sskos__Concept
% 217.44/217.59  |- mesh__dateEstablished mesh__D000935 1967-01-01
% 217.44/217.59  |- mesh__recordMaintainer mesh__D019640 SYSTEM
% 217.44/217.59  |- mesh__recordAuthorizer mesh__D019640 sjn
% 217.44/217.59  |- mesh__recordOriginator mesh__D019640 AGS
% 217.44/217.59  |- mesh__historyNote mesh__D019640 98   
% 217.44/217.59  |- skos__broader mesh__D019640smesh__D019605
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D019640 2006
% 217.44/217.59  |- rdf__type mesh__D019640sskos__Concept
% 217.44/217.59  |- mesh__dateRevised mesh__D019640 2005-06-30
% 217.44/217.59  |- mesh__dateCreated mesh__D019640 1997-06-20
% 217.44/217.59  |- mesh__dateEstablished mesh__D019640 1998-01-01
% 217.44/217.59  |- mesh__publicMeSHNote mesh__D019640 98   
% 217.44/217.59  |- skos__prefLabel mesh__D019640 Methanosarcinales
% 217.44/217.59  |- skos__scopeNote mesh__D019640
% 217.44/217.59       An order of anaerobic methanogens in the kingdom EURYARCHAEOTA. There are two families: METHANOSARCINACEAE and Methanosaetaceae.%A%    
% 217.44/217.59  |- skos__scopeNote mesh__D000137
% 217.44/217.59       Disturbances in the ACID-BASE EQUILIBRIUM of the body.     
% 217.44/217.59  |- skos__hiddenLabel mesh__D000137 Imbalances, Acid-Base
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D000137 1993
% 217.44/217.59  |- rdf__type mesh__D000137sskos__Concept
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D000137 1999
% 217.44/217.59  |- mesh__dateRevised mesh__D000137 1991-06-17
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D000137 2003
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D000137 1994
% 217.44/217.59  |- mesh__dateCreated mesh__D000137 1975-07-25
% 217.44/217.59  |- skos__hiddenLabel mesh__D000137 Acid Base Imbalance
% 217.44/217.59  |- skos__hiddenLabel mesh__D000137 Acid-Base Imbalances
% 217.44/217.59  |- skos__broader mesh__D000137smesh__D008659
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D000137 2000
% 217.44/217.59  |- mesh__recordAuthorizer mesh__D000137 PLS
% 217.44/217.59  |- mesh__dateEstablished mesh__D000137 1976-01-01
% 217.44/217.59  |- mesh__recordMaintainer mesh__D000137 PLS
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D000137 2004
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D000137 1995
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D000137 1996
% 217.44/217.59  |- skos__prefLabel mesh__D000137 Acid-Base Imbalance
% 217.44/217.59  |- skos__historyNote mesh__D000137 Acid-Base Equilibrium %28%1966-1975%29%
% 217.44/217.59  |- mesh__publicMeSHNote mesh__D000137 76   
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D000137 2001
% 217.44/217.59  |- mesh__historyNote mesh__D000137 76; was NON MESH before 1976   
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D000137 2005
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D000137 1997
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D000137 2002
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D000137 1992
% 217.44/217.59  |- skos__hiddenLabel mesh__D000137 Imbalance, Acid-Base
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D000137 2006
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D000137 1998
% 217.44/217.59  |- mesh__recordOriginator mesh__D000137 SMH
% 217.44/217.59  |- mesh__recordOriginator mesh__D005620 NLM
% 217.44/217.59  |- skos__hiddenLabel mesh__D005620 Freunds Adjuvant
% 217.44/217.59  |- skos__altLabel mesh__D005620 Freund Adjuvant
% 217.44/217.59  |- mesh__historyNote mesh__D005620 64%28%63%29%   
% 217.44/217.59  |- skos__hiddenLabel mesh__D005620 Adjuvant, Freund
% 217.44/217.59  |- skos__broader mesh__D005620smesh__D045424
% 217.44/217.59  |- mesh__recordMaintainer mesh__D005620 ssb
% 217.44/217.59  |- mesh__dateRevised mesh__D005620 2005-06-30
% 217.44/217.59  |- mesh__dateCreated mesh__D005620 1999-01-01
% 217.44/217.59  |- rdf__type mesh__D005620sskos__Concept
% 217.44/217.59  |- skos__hiddenLabel mesh__D005620 Adjuvant, Freund%27%s
% 217.44/217.59  |- skos__scopeNote mesh__D005620
% 217.44/217.59       An antigen solution emulsified in mineral oil. The complete form is made up of killed, dried mycobacteria, usually M. tuberculosis, suspended in the oil phase. It is effective in stimulating cell-mediated immunity %28%IMMUNITY, CELLULAR%29% and potentiates the production of certain IMMUNOGLOBULINS in some animals. The incomplete form does not contain mycobacteria.%A%    
% 217.44/217.59  |- mesh__publicMeSHNote mesh__D005620 64   
% 217.44/217.59  |- skos__prefLabel mesh__D005620 Freund%27%s Adjuvant
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D005620 2006
% 217.44/217.59  |- mesh__dateEstablished mesh__D005620 1964-01-01
% 217.44/217.59  |- mesh__recordAuthorizer mesh__D005620 sjn
% 217.44/217.59  |- mesh__recordMaintainer mesh__D052276 jmp
% 217.44/217.59  |- skos__altLabel mesh__D052276 Brain Creatine Kinase
% 217.44/217.59  |- mesh__publicMeSHNote mesh__D052276
% 217.44/217.59       2006; CREATINE KINASE, BB FORM was indexed under CREATINE KINASE 2000-2005%A%  
% 217.44/217.59  |- mesh__recordAuthorizer mesh__D052276 sjn
% 217.44/217.59  |- skos__altLabel mesh__D052276 BB Creatine Kinase
% 217.44/217.59  |- skos__hiddenLabel mesh__D052276 Kinase, Brain Creatine
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D052276 2006
% 217.44/217.59  |- mesh__dateEstablished mesh__D052276 2006-01-01
% 217.44/217.59  |- mesh__dateCreated mesh__D052276 2005-06-30
% 217.44/217.59  |- skos__hiddenLabel mesh__D052276 Creatine Kinase, BB
% 217.44/217.59  |- skos__broader mesh__D052276smesh__D003402
% 217.44/217.59  |- skos__prefLabel mesh__D052276 Creatine Kinase, BB Form
% 217.44/217.59  |- mesh__historyNote mesh__D052276 2006%28%2000%29%   
% 217.44/217.59  |- rdf__type mesh__D052276sskos__Concept
% 217.44/217.59  |- mesh__recordOriginator mesh__D052276 jmp
% 217.44/217.59  |- skos__hiddenLabel mesh__D052276 Kinase, BB Creatine
% 217.44/217.59  |- skos__hiddenLabel mesh__D052276 Creatine Kinase, Brain
% 217.44/217.59  |- skos__scopeNote mesh__D052276
% 217.44/217.59       A form of creatine kinase found in the BRAIN.     
% 217.44/217.59  |- mesh__recordMaintainer mesh__D018548 JLS
% 217.44/217.59  |- mesh__publicMeSHNote mesh__D018548 95   
% 217.44/217.59  |- mesh__recordAuthorizer mesh__D018548 sjn
% 217.44/217.59  |- rdf__type mesh__D018548sskos__Concept
% 217.44/217.59  |- mesh__dateRevised mesh__D018548 2002-07-03
% 217.44/217.59  |- skos__altLabel mesh__D018548 Coleoptiles
% 217.44/217.59  |- mesh__dateCreated mesh__D018548 1994-06-07
% 217.44/217.59  |- skos__annotation mesh__D018548
% 217.44/217.59       IM GEN or unspecified; coord probably IM in genetics %26% space physiol, NIM in pharmacognosy, with specific plant %28%IM or NIM%29%%A%  
% 217.44/217.59  |- skos__historyNote mesh__D018548 Plants %28%1966-1994%29%
% 217.44/217.59  |- skos__prefLabel mesh__D018548 Cotyledon
% 217.44/217.59  |- skos__broader mesh__D018548smesh__D018520
% 217.44/217.59  |- mesh__historyNote mesh__D018548 95   
% 217.44/217.59  |- mesh__recordOriginator mesh__D018548 JLS
% 217.44/217.59  |- mesh__dateEstablished mesh__D018548 1995-01-01
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D018548 2005
% 217.44/217.59  |- skos__altLabel mesh__D018548 Seed Leaf
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D018548 2006
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D018548 2003
% 217.44/217.59  |- skos__scopeNote mesh__D018548
% 217.44/217.59       A part of the embryo in a seed plant. The number of cotyledons is an important feature in classifying plants. In seeds without an endosperm, they store food which is used in germination. In some plants, they emerge above the soil surface and become the first photosynthetic leaves. %28%From Concise Dictionary of Biology, 1990%29%%A%    
% 217.44/217.59  |- skos__altLabel mesh__D018548 Cotyledons
% 217.44/217.59  |- skos__altLabel mesh__D018548 Seed Leaves
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D018548 2004
% 217.44/217.59  |- skos__annotation mesh__D010565 no qualif   
% 217.44/217.59  |- skos__scopeNote mesh__D010565
% 217.44/217.59       A mode of communication concerned with inducing or urging the adoption of certain beliefs, theories, or lines of action by others.%A%    
% 217.44/217.59  |- mesh__recordOriginator mesh__D010565 NLM
% 217.44/217.59  |- skos__related mesh__D010565smesh__D013404
% 217.44/217.59  |- mesh__dateEstablished mesh__D010565 1969-01-01
% 217.44/217.59  |- mesh__dateRevised mesh__D010565 2002-07-02
% 217.44/217.59  |- skos__prefLabel mesh__D010565 Persuasive Communication
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D010565 2005
% 217.44/217.59  |- skos__related mesh__D010565smesh__D011583
% 217.44/217.59  |- skos__hiddenLabel mesh__D010565 Communication, Persuasive
% 217.44/217.59  |- skos__altLabel mesh__D010565 Persuasion
% 217.44/217.59  |- mesh__recordMaintainer mesh__D010565 jrf
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D010565 2006
% 217.44/217.59  |- skos__related mesh__D010565smesh__D011406
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D010565 2003
% 217.44/217.59  |- skos__historyNote mesh__D010565 Suggestion %28%1966-1968%29%
% 217.44/217.59  |- rdf__type mesh__D010565sskos__Concept
% 217.44/217.59  |- mesh__historyNote mesh__D010565 69   
% 217.44/217.59  |- skos__related mesh__D010565smesh__D032763
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D010565 2004
% 217.44/217.59  |- skos__broader mesh__D010565smesh__D003142
% 217.44/217.59  |- mesh__dateCreated mesh__D010565 1999-01-01
% 217.44/217.59  |- mesh__publicMeSHNote mesh__D010565 69   
% 217.44/217.59  |- mesh__recordAuthorizer mesh__D010565 sjn
% 217.44/217.59  |- mesh__recordMaintainer mesh__D004528 TGC
% 217.44/217.59  |- mesh__dateRevised mesh__D004528 1989-04-28
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D004528 1997
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D004528 2002
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D004528 1990
% 217.44/217.59  |- mesh__recordOriginator mesh__D004528 NLM
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D004528 2004
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D004528 1992
% 217.44/217.59  |- skos__broader mesh__D004528smesh__D000825
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D004528 1998
% 217.44/217.59  |- skos__annotation mesh__D004528
% 217.44/217.59       IM avian only if pertinent; NIM reptilian; do not use for lower animals%A%  
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D004528 1991
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D004528 2005
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D004528 1993
% 217.44/217.59  |- mesh__dateCreated mesh__D004528 1999-01-01
% 217.44/217.59  |- mesh__activeMeSHYear mesh__D004528 1999
% 217.44/217.59  |- mesh__publicMeSHNote mesh__D004528 74   
% 217.44/217.59  |- skos__hiddenLabel mesh__D004528 Egg Shells
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D004528 2006
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D004528 1994
% 217.44/217.60  |- mesh__recordAuthorizer mesh__D004528 PLS
% 217.44/217.60  |- mesh__dateEstablished mesh__D004528 1974-01-01
% 217.44/217.60  |- rdf__type mesh__D004528sskos__Concept
% 217.44/217.60  |- skos__hiddenLabel mesh__D004528 Shell, Egg
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D004528 2000
% 217.44/217.60  |- skos__hiddenLabel mesh__D004528 Shells, Egg
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D004528 1996
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D004528 1995
% 217.44/217.60  |- mesh__historyNote mesh__D004528 74   
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D004528 2001
% 217.44/217.60  |- skos__prefLabel mesh__D004528 Egg Shell
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D004528 2003
% 217.44/217.60  |- mesh__publicMeSHNote mesh__D015250 89   
% 217.44/217.60  |- skos__altLabel mesh__D015250 Aclacinomycin A
% 217.44/217.60  |- skos__hiddenLabel mesh__D015250 MA 144A1
% 217.44/217.60  |- mesh__recordAuthorizer mesh__D015250 sjn
% 217.44/217.60  |- mesh__dateEstablished mesh__D015250 1989-01-01
% 217.44/217.60  |- mesh__recordMaintainer mesh__D015250 ssb
% 217.44/217.60  |- mesh__dateCreated mesh__D015250 1988-05-16
% 217.44/217.60  |- skos__historyNote mesh__D015250 Naphthacenes %28%1966-1988%29%
% 217.44/217.60  |- rdf__type mesh__D015250sskos__Concept
% 217.44/217.60  |- mesh__historyNote mesh__D015250 89   
% 217.44/217.60  |- skos__altLabel mesh__D015250 Medac Brand of Aclarubicin Hydrochloride
% 217.44/217.60  |- skos__broader mesh__D015250smesh__D018943
% 217.44/217.60  |- skos__altLabel mesh__D015250 Lundbeck Brand of Aclarubicin Hydrochloride
% 217.44/217.60  |- skos__scopeNote mesh__D015250
% 217.44/217.60       An anthracycline produced by Streptomyces galilaeus. It has potent antineoplastic activity.%A%    
% 217.44/217.60  |- mesh__recordOriginator mesh__D015250 RLS
% 217.44/217.60  |- skos__hiddenLabel mesh__D015250 NSC 208734
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D015250 2005
% 217.44/217.60  |- skos__hiddenLabel mesh__D015250 NSC208734
% 217.44/217.60  |- skos__hiddenLabel mesh__D015250 MA144A1
% 217.44/217.60  |- skos__prefLabel mesh__D015250 Aclarubicin
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D015250 2006
% 217.44/217.60  |- mesh__dateRevised mesh__D015250 2004-07-07
% 217.44/217.60  |- skos__historyNote mesh__D015250
% 217.44/217.60       Antibiotics, Antineoplastic %28%1967-1988%29%
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D009213 2000
% 217.44/217.60  |- rdf__type mesh__D009213sskos__Concept
% 217.44/217.60  |- mesh__dateRevised mesh__D009213 1997-06-20
% 217.44/217.60  |- skos__broader mesh__D009213smesh__D019937
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D009213 2005
% 217.44/217.60  |- skos__annotation mesh__D009213
% 217.44/217.60       NIM; do not use /util except by MeSH definition; DF: MYOGR%A%  
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D009213 2001
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D009213 2006
% 217.44/217.60  |- mesh__dateCreated mesh__D009213 1999-01-01
% 217.44/217.60  |- skos__scopeNote mesh__D009213
% 217.44/217.60       The recording of muscular movements. The apparatus is called a myograph, the record or tracing, a myogram. %28%From Stedman, 25th ed%29%%A%    
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D009213 2002
% 217.44/217.60  |- mesh__recordMaintainer mesh__D009213 PXP
% 217.44/217.60  |- skos__prefLabel mesh__D009213 Myography
% 217.44/217.60  |- mesh__recordAuthorizer mesh__D009213 SJN
% 217.44/217.60  |- skos__hiddenLabel mesh__D009213 Myographies
% 217.44/217.60  |- mesh__recordOriginator mesh__D009213 NLM
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D009213 2003
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D009213 1998
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D009213 2004
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D009213 1999
% 217.44/217.60  |- skos__annotation mesh__D001230
% 217.44/217.60       GEN or unspecified; prefer specific genera; infection = ASPERGILLOSIS%A%  
% 217.44/217.60  |- skos__prefLabel mesh__D001230 Aspergillus
% 217.44/217.60  |- mesh__recordMaintainer mesh__D001230 SYSTEM
% 217.44/217.60  |- mesh__recordOriginator mesh__D001230 NLM
% 217.44/217.60  |- skos__broader mesh__D001230smesh__D003904
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D001230 2006
% 217.44/217.60  |- mesh__recordAuthorizer mesh__D001230 sjn
% 217.44/217.60  |- mesh__dateCreated mesh__D001230 1999-01-01
% 217.44/217.60  |- skos__scopeNote mesh__D001230
% 217.44/217.60       A genus of mitosporic fungi containing about 100 species and eleven different teleomorphs in the family Trichocomaceae.%A%    
% 217.44/217.60  |- mesh__dateRevised mesh__D001230 2005-06-30
% 217.44/217.60  |- rdf__type mesh__D001230sskos__Concept
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Photosensitive Reflex Epilepsies
% 217.44/217.60  |- mesh__dateCreated mesh__D020195 1999-11-03
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Reading Reflex Epilepsies
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsies, Eating-Induced Reflex
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Reflex Epilepsies, Tactile
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195
% 217.44/217.60       Cursive Reflex Epilepsies %28%Running%29%
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Tactile Reflex Epilepsies
% 217.44/217.60  |- skos__altLabel mesh__D020195 Visual Pattern Reflex Epilepsy
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Reflex Epilepsies, Eating-Induced
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsy, Immersion Related
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsies, Audiogenic Reflex
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Writing Induced Reflex Epilepsy
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsies, Musicogenic
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D020195 2006
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsy, Photosensitive
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Audiogenic Reflex Epilepsies
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsy, Writing-Induced Reflex
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D020195 2002
% 217.44/217.60  |- mesh__historyNote mesh__D020195 2000   
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Eating-Induced Epilepsies
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsy, Audiogenic Reflex
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Reflex Epilepsy, Tactile
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Reflex Epilepsy, Eating Induced
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Reflex Epilepsies
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsy, Reading
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Immersion Related Epilepsies
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Eating-Induced Reflex Epilepsies
% 217.44/217.60  |- skos__scopeNote mesh__D020195
% 217.44/217.60       A subtype of epilepsy characterized by seizures that are consistently provoked by a certain specific stimulus. Auditory, visual, and somatosensory stimuli as well as the acts of writing, reading, eating, and decision making are examples of events or activities that may induce seizure activity in affected individuals. %28%From Neurol Clin 1994 Feb;12%28%1%29%:57-8%29%%A%    
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsies, Photosensitive Reflex
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D020195 2003
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Reading Epilepsies
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsy, Eating-Induced
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Eating Induced Epilepsy
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Cursive Reflex Epilepsy %28%Running%29%
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Musicogenic Reflex Epilepsies
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Writing-Induced Reflex Epilepsies
% 217.44/217.60  |- skos__altLabel mesh__D020195 Cursive Epilepsy
% 217.44/217.60  |- skos__altLabel mesh__D020195 Audiogenic Epilepsy
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsies, Reading Reflex
% 217.44/217.60  |- skos__altLabel mesh__D020195 Musicogenic Epilepsy
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsies, Reflex
% 217.44/217.60  |- skos__broader mesh__D020195smesh__D004827
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Audiogenic Epilepsies
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Reflex Epilepsies, Musicogenic
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Reflex Epilepsy, Writing-Induced
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsies, Writing-Induced Reflex
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Photosensitive Reflex Epilepsy
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Reflex Epilepsies, Photosensitive
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D020195 2004
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsies, Photosensitive
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsies, Reading
% 217.44/217.60  |- mesh__dateEstablished mesh__D020195 2000-01-01
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsy, Photosensitive Reflex
% 217.44/217.60  |- skos__altLabel mesh__D020195 Reading Epilepsy
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsy, Cursive Reflex %28%Running%29%
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D020195 2000
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsy, Musicogenic
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Eating-Induced Reflex Epilepsy
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Reflex Epilepsies, Reading
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195
% 217.44/217.60       Reflex Epilepsies, Cursive %28%Running%29%
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Photosensitive Epilepsies
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsy, Eating-Induced Reflex
% 217.44/217.60  |- skos__altLabel mesh__D020195 Reflex Epilepsy
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsy, Audiogenic
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsy, Cursive
% 217.44/217.60  |- skos__prefLabel mesh__D020195 Epilepsy, Reflex
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsies, Tactile Reflex
% 217.44/217.60  |- skos__historyNote mesh__D020195 Epilepsy %28%1965-1999%29%
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsies, Cursive
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsies, Immersion Related
% 217.44/217.60  |- skos__annotation mesh__D020195
% 217.44/217.60       coord with stimulus which precipitates the seizures/adv eff  if permitted%A%  
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D020195 2001
% 217.44/217.60  |- mesh__publicMeSHNote mesh__D020195 2000   
% 217.44/217.60  |- skos__altLabel mesh__D020195 Eating-Induced Epilepsy
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsies, Eating-Induced
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Musicogenic Epilepsies
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Musicogenic Reflex Epilepsy
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D020195 2005
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Reflex Epilepsies, Writing-Induced
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsies, Musicogenic Reflex
% 217.44/217.60  |- skos__altLabel mesh__D020195 Photosensitive Epilepsy
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Reading Reflex Epilepsy
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsy, Tactile Reflex
% 217.44/217.60  |- rdf__type mesh__D020195sskos__Concept
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Audiogenic Reflex Epilepsy
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsy, Reading Reflex
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Epilepsy, Musicogenic Reflex
% 217.44/217.60  |- skos__hiddenLabel mesh__D020195 Reflex Epilepsies, Audiogenic
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D014956 1999
% 217.44/217.60  |- mesh__recordMaintainer mesh__D014956 PLS
% 217.44/217.60  |- mesh__recordOriginator mesh__D014956 NLM
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D014956 1996
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D014956 2002
% 217.44/217.60  |- skos__broader mesh__D014956smesh__D007803
% 217.44/217.60  |- skos__prefLabel mesh__D014956 Writing
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D014956 2005
% 217.44/217.60  |- mesh__dateCreated mesh__D014956 1999-01-01
% 217.44/217.60  |- skos__scopeNote mesh__D014956
% 217.44/217.60       The act or practice of literary composition, the occupation of writer, or producing or engaging in literary work as a profession.%A%    
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D014956 1997
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D014956 2006
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D014956 2000
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D014956 2003
% 217.44/217.60  |- skos__annotation mesh__D014956
% 217.44/217.60       the act or profession of writing or its product, i.e., being a writer or creating text for books, articles, speeches, etc.: do not confuse with PUBLISHING %28%the industry %26% dissemination of knowledge %26% research%29% or LITERATURE %28%literary production%29% or AUTHORSHIP %28%identity as author%29% or JOURNALISM %28%writing for publication in the media%29%; %22%medical writing%22% can go here but consider JOURNALISM; style of writing goes here; editing for publication goes under PUBLISHING; writing for periodicals goes under PERIODICALS; HANDWRITING is also available; includes typewriting; letters %26% correspondence of biographees %26% famous persons are indexed as CORRESPONDENCE %28%IM%29% + required biog terms %26% hist tags%A%  
% 217.44/217.60  |- mesh__recordAuthorizer mesh__D014956 PLS
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D014956 2001
% 217.44/217.60  |- mesh__dateRevised mesh__D014956 1994-03-14
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D014956 2004
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D014956 1998
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D014956 1995
% 217.44/217.60  |- rdf__type mesh__D014956sskos__Concept
% 217.44/217.60  |- mesh__recordOriginator mesh__D047332 ags
% 217.44/217.60  |- rdf__type mesh__D047332sskos__Concept
% 217.44/217.60  |- mesh__historyNote mesh__D047332 2005   
% 217.44/217.60  |- mesh__recordAuthorizer mesh__D047332 sjn
% 217.44/217.60  |- skos__historyNote mesh__D047332 Echinodermata %28%1968-1988%29%
% 217.44/217.60  |- mesh__dateCreated mesh__D047332 2004-07-07
% 217.44/217.60  |- mesh__publicMeSHNote mesh__D047332 2005   
% 217.44/217.60  |- skos__broader mesh__D047332smesh__D012616
% 217.44/217.60  |- skos__prefLabel mesh__D047332 Holothuria
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D047332 2005
% 217.44/217.60  |- mesh__dateEstablished mesh__D047332 2005-01-01
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D047332 2006
% 217.44/217.60  |- skos__scopeNote mesh__D047332
% 217.44/217.60       A genus of large SEA CUCUMBERS in the family Holothuriidae possessing thick body walls, a warty body surface, and microscopic ossicles.%A%    
% 217.44/217.60  |- skos__historyNote mesh__D047332 Sea Cucumbers %28%1989-2004%29%
% 217.44/217.60  |- mesh__recordMaintainer mesh__D047332 ags
% 217.44/217.60  |- skos__related mesh__D014158smesh__D015534
% 217.44/217.60  |- skos__related mesh__D014158smesh__D015696
% 217.44/217.60  |- rdf__type mesh__D014158sskos__Concept
% 217.44/217.60  |- skos__hiddenLabel mesh__D014158 Gene Transcription, Early
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D014158 2006A
% 217.44/217.60  |- mesh__historyNote mesh__D014158 1973   
% 217.44/217.60  |- mesh__dateEstablished mesh__D014158 1973-01-01
% 217.44/217.60  |- skos__related mesh__D014158smesh__D016355
% 217.44/217.60  |- skos__altLabel mesh__D014158 Genetic Transcription
% 217.44/217.60  |- skos__related mesh__D014158smesh__D015756
% 217.44/217.60  |- skos__hiddenLabel mesh__D014158 Gene Transcription, Late
% 217.44/217.60  |- skos__related mesh__D014158smesh__D014157
% 217.44/217.60  |- skos__hiddenLabel mesh__D014158 Transcription, Late Gene
% 217.44/217.60  |- mesh__dateRevised mesh__D014158 2005-08-03
% 217.44/217.60  |- mesh__publicMeSHNote mesh__D014158 1973   
% 217.44/217.60  |- skos__related mesh__D014158smesh__D015694
% 217.44/217.60  |- skos__scopeNote mesh__D014158
% 217.44/217.60       The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION.%A%    
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D014158 2006
% 217.44/217.60  |- mesh__recordOriginator mesh__D014158 NLM
% 217.44/217.60  |- skos__broader mesh__D014158smesh__D015870
% 217.44/217.60  |- skos__prefLabel mesh__D014158 Transcription, Genetic
% 217.44/217.60  |- mesh__recordAuthorizer mesh__D014158 ags
% 217.44/217.60  |- skos__historyNote mesh__D014158 RNA, Messenger %28%1966-1972%29%
% 217.44/217.60  |- skos__related mesh__D014158smesh__D016356
% 217.44/217.60  |- skos__related mesh__D014158smesh__D015757
% 217.44/217.60  |- mesh__recordMaintainer mesh__D014158 ags
% 217.44/217.60  |- mesh__dateCreated mesh__D014158 1999-01-01
% 217.44/217.60  |- skos__hiddenLabel mesh__D014158 Transcription, Early Gene
% 217.44/217.60  |- skos__hiddenLabel mesh__D008919 Techniques, Investigative
% 217.44/217.60  |- skos__scopeNote mesh__D008919
% 217.44/217.60       Investigative techniques used in pre-clinical and clinical research, epidemiology, chemistry, immunology, genetics, etc. They do not include techniques specifically applied to DIAGNOSIS; THERAPEUTICS; anesthesia and analgesia; SURGICAL PROCEDURES, OPERATIVE; and DENTISTRY.%A%    
% 217.44/217.60  |- mesh__onlineNote mesh__D008919
% 217.44/217.60       pre-explosion = INVESTIGATIVE TECHNIQUES %28%PX%29%   
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D008919 1998
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D008919 2001
% 217.44/217.60  |- skos__hiddenLabel mesh__D008919 Technique, Investigative
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D008919 2006
% 217.44/217.60  |- mesh__recordAuthorizer mesh__D008919 ags
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D008919 2000
% 217.44/217.60  |- skos__altLabel mesh__D008919 Investigative Technics
% 217.44/217.60  |- rdf__type mesh__D008919sskos__Concept
% 217.44/217.60  |- skos__hiddenLabel mesh__D008919 Technics, Investigative
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D008919 2005
% 217.44/217.60  |- mesh__recordMaintainer mesh__D008919 ags
% 217.44/217.60  |- mesh__recordOriginator mesh__D008919 NLM
% 217.44/217.60  |- skos__prefLabel mesh__D008919 Investigative Techniques
% 217.44/217.60  |- skos__hiddenLabel mesh__D008919 Investigative Technique
% 217.44/217.60  |- mesh__publicMeSHNote mesh__D008919 98   
% 217.44/217.60  |- mesh__dateRevised mesh__D008919 2005-08-01
% 217.44/217.60  |- skos__hiddenLabel mesh__D008919 Investigative Technic
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D008919 2002
% 217.44/217.60  |- mesh__dateEstablished mesh__D008919 1998-01-01
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D008919 2006A
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D008919 2004
% 217.44/217.60  |- mesh__historyNote mesh__D008919 98; use pre-explosion   
% 217.44/217.60  |- mesh__runningHead mesh__D008919
% 217.44/217.60       E5 - PROCEDURES AND TECHNIQUES- INVESTIGATIVE   
% 217.44/217.60  |- skos__hiddenLabel mesh__D008919 Technic, Investigative
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D008919 1999
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D008919 2003
% 217.44/217.60  |- mesh__dateCreated mesh__D008919 1999-01-01
% 217.44/217.60  |- skos__annotation mesh__D008919
% 217.44/217.60       not used for indexing      CATALOG: do not use   
% 217.44/217.60  |- mesh__dateEstablished mesh__D000936 1972-01-01
% 217.44/217.60  |- skos__hiddenLabel mesh__D000936 Complex, Antigen-Antibody
% 217.44/217.60  |- mesh__recordAuthorizer mesh__D000936 sjn
% 217.44/217.60  |- mesh__recordMaintainer mesh__D000936 ssb
% 217.44/217.60  |- mesh__dateCreated mesh__D000936 1999-01-01
% 217.44/217.60  |- mesh__historyNote mesh__D000936 72%28%70%29%   
% 217.44/217.60  |- skos__hiddenLabel mesh__D000936 Complexes, Antigen-Antibody
% 217.44/217.60  |- skos__scopeNote mesh__D000936
% 217.44/217.60       The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES.%A%    
% 217.44/217.60  |- skos__hiddenLabel mesh__D000936 Antigen Antibody Complex
% 217.44/217.60  |- skos__broader mesh__D000936smesh__D000906
% 217.44/217.60  |- skos__hiddenLabel mesh__D000936 Complex, Immune
% 217.44/217.60  |- skos__hiddenLabel mesh__D000936 Antigen Antibody Complexes
% 217.44/217.60  |- mesh__dateRevised mesh__D000936 2005-06-30
% 217.44/217.60  |- skos__related mesh__D000936smesh__D007105
% 217.44/217.60  |- skos__prefLabel mesh__D000936 Antigen-Antibody Complex
% 217.44/217.60  |- skos__hiddenLabel mesh__D000936 Complexes, Immune
% 217.44/217.60  |- skos__altLabel mesh__D000936 Immune Complex
% 217.44/217.60  |- mesh__recordOriginator mesh__D000936 NLM
% 217.44/217.60  |- skos__broader mesh__D000936smesh__D000941
% 217.44/217.60  |- skos__historyNote mesh__D000936 Antigens %28%1966-1969%29%
% 217.44/217.60  |- rdf__type mesh__D000936sskos__Concept
% 217.44/217.60  |- skos__altLabel mesh__D000936 Immune Complexes
% 217.44/217.60  |- mesh__publicMeSHNote mesh__D000936 72   
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D000936 2006
% 217.44/217.60  |- skos__historyNote mesh__D000936 Antibodies %28%1966-1969%29%
% 217.44/217.60  |- skos__altLabel mesh__D000936 Antigen-Antibody Complexes
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D019641 2005
% 217.44/217.60  |- mesh__dateCreated mesh__D019641 1997-06-20
% 217.44/217.60  |- mesh__historyNote mesh__D019641 98   
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D019641 2006
% 217.44/217.60  |- mesh__publicMeSHNote mesh__D019641 98   
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D019641 2000
% 217.44/217.60  |- skos__broader mesh__D019641smesh__D004247
% 217.44/217.60  |- rdf__type mesh__D019641sskos__Concept
% 217.44/217.60  |- skos__annotation mesh__D019641
% 217.44/217.60       IM; coord with specific archaeon %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D019641 2003
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D019641 1998
% 217.44/217.60  |- skos__scopeNote mesh__D019641
% 217.44/217.60       Deoxyribonucleic acid that makes up the genetic material of archaea.%A%    
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D019641 2001
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D019641 2004
% 217.44/217.60  |- skos__altLabel mesh__D019641 Archaeal DNA
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D019641 1999
% 217.44/217.60  |- skos__prefLabel mesh__D019641 DNA, Archaeal
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D019641 2002
% 217.44/217.60  |- mesh__dateEstablished mesh__D019641 1998-01-01
% 217.44/217.60  |- skos__historyNote mesh__D019641 DNA, Bacterial %28%1979-1997%29%
% 217.44/217.60  |- skos__annotation mesh__D000138
% 217.44/217.60       an acid-base imbalance; GEN %26% unspecified; prefer specifics%A%  
% 217.44/217.60  |- skos__prefLabel mesh__D000138 Acidosis
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D000138 2001
% 217.44/217.60  |- mesh__recordMaintainer mesh__D000138 TGC
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D000138 2004
% 217.44/217.60  |- mesh__recordAuthorizer mesh__D000138 SJN
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D000138 2002
% 217.44/217.60  |- mesh__dateRevised mesh__D000138 1997-06-20
% 217.44/217.60  |- skos__scopeNote mesh__D000138
% 217.44/217.60       A pathologic condition resulting from accumulation of acid or depletion of the alkaline reserve %28%bicarbonate%29% content of the blood and body tissues, and characterized by an increase in hydrogen ion concentration %28%decrease in pH%29%. %28%Dorland, 27th ed%29%%A%    
% 217.44/217.60  |- mesh__dateCreated mesh__D000138 1999-01-01
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D000138 2005
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D000138 2006
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D000138 1998
% 217.44/217.60  |- skos__hiddenLabel mesh__D000138 Acidoses
% 217.44/217.60  |- rdf__type mesh__D000138sskos__Concept
% 217.44/217.60  |- mesh__recordOriginator mesh__D000138 NLM
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D000138 1999
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D000138 2000
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D000138 2003
% 217.44/217.60  |- skos__broader mesh__D000138smesh__D000137
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Hereditary Ataxia, Friedreich%27%s
% 217.44/217.60  |- skos__altLabel mesh__D005621 Friedreich Hereditary Spinal Ataxia
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Disease, Friedreich
% 217.44/217.60  |- skos__altLabel mesh__D005621 Friedreich Hereditary Ataxia
% 217.44/217.60  |- rdf__type mesh__D005621sskos__Concept
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Spinocerebellar Ataxia, Friedreich
% 217.44/217.60  |- mesh__recordOriginator mesh__D005621 NLM
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Familial Ataxia, Friedreich
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Ataxia, Friedreich%27%s Hereditary
% 217.44/217.60  |- skos__altLabel mesh__D005621 Friedreich%27%s Disease
% 217.44/217.60  |- skos__altLabel mesh__D005621 Sclerosis, Hereditary Spinal
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Ataxia, Freidreich%27%s
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Hereditary Spinal Scleroses
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Friedreich Ataxias
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D005621 2006
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Disease, Friedreich%27%s
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Ataxias, Friedreich
% 217.44/217.60  |- skos__broader mesh__D005621smesh__D028361
% 217.44/217.60  |- skos__prefLabel mesh__D005621 Friedreich Ataxia
% 217.44/217.60  |- skos__altLabel mesh__D005621 Friedreich Disease
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Hereditary Ataxia, Friedreich
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Spinal Scleroses, Hereditary
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Ataxia, Friedreich Spinocerebellar
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Familial Ataxia, Friedreich%27%s
% 217.44/217.60  |- skos__altLabel mesh__D005621 Hereditary Spinal Ataxia, Friedreich
% 217.44/217.60  |- skos__broader mesh__D005621smesh__D013132
% 217.44/217.60  |- skos__altLabel mesh__D005621 Friedreich%27%s Ataxia
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Ataxia, Friedreich
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D005621 2005
% 217.44/217.60  |- mesh__dateRevised mesh__D005621 2001-07-25
% 217.44/217.60  |- skos__altLabel mesh__D005621 Friedreich%27%s Familial Ataxia
% 217.44/217.60  |- mesh__recordAuthorizer mesh__D005621 sjn
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Spinal Sclerosis, Hereditary
% 217.44/217.60  |- skos__altLabel mesh__D005621 Friedreich Familial Ataxia
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Ataxias, Friedreich%27%s Hereditary
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D005621 2004
% 217.44/217.60  |- mesh__dateCreated mesh__D005621 1999-01-01
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Ataxia, Friedreich Hereditary
% 217.44/217.60  |- mesh__historyNote mesh__D005621
% 217.44/217.60       2000%28%1966%29%; for FRIEDREICH%27%S DISEASE use MYOCLONUS 1997-1999%A%  
% 217.44/217.60  |- skos__scopeNote mesh__D005621
% 217.44/217.60       An autosomal recessive disease, usually of childhood onset, characterized pathologically by degeneration of the spinocerebellar tracts, posterior columns, and to a lesser extent the corticospinal tracts. Clinical manifestations include GAIT ATAXIA, pes cavus, speech impairment, lateral curvature of spine, rhythmic head tremor, kyphoscoliosis, congestive heart failure %28%secondary to a cardiomyopathy%29%, and lower extremity weakness.  Most forms of this condition are associated with a mutation in a gene on chromosome 9, at band q13, which codes for the mitochondrial protein frataxin. %28%From Adams et al., Principles of Neurology, 6th ed, p1081; N Engl J Med 1996 Oct 17;335%28%16%29%:1169-75%29% The severity of Friedreich ataxia associated with expansion of GAA repeats in the first intron of the frataxin gene correlates with the number of trinucleotide repeats. %28%From Durr et al, N Engl J Med 1996 Oct 17;335%28%16%29%:1169-75%29%%A%    
% 217.44/217.60  |- mesh__recordMaintainer mesh__D005621 nns
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Hereditary Ataxias, Friedreich%27%s
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Ataxia, Friedreich%27%s
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Scleroses, Hereditary Spinal
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D005621 2003
% 217.44/217.60  |- skos__altLabel mesh__D005621 Friedreich%27%s Hereditary Spinal Ataxia
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Friedreich%27%s Hereditary Ataxias
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Ataxia, Friedreich%27%s Familial
% 217.44/217.60  |- mesh__publicMeSHNote mesh__D005621
% 217.44/217.60       2000; see FRIEDREICH%27%S ATAXIA 1966-1999; for FRIEDREICH%27%S DISEASE see MYOCLONUS 1997-1999%A%  
% 217.44/217.60  |- skos__altLabel mesh__D005621 Friedreich%27%s Hereditary Ataxia
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D005621 2002
% 217.44/217.60  |- skos__altLabel mesh__D005621 Freidreich%27%s Ataxia
% 217.44/217.60  |- skos__altLabel mesh__D005621 Hereditary Spinal Ataxia, Friedreich%27%s
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Friedreichs Familial Ataxia
% 217.44/217.60  |- skos__altLabel mesh__D005621 Hereditary Spinal Sclerosis
% 217.44/217.60  |- skos__altLabel mesh__D005621 Friedreich Spinocerebellar Ataxia
% 217.44/217.60  |- skos__hiddenLabel mesh__D005621 Ataxia, Friedreich Familial
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D018549 2000
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D018549 2001
% 217.44/217.60  |- mesh__publicMeSHNote mesh__D018549 95   
% 217.44/217.60  |- mesh__historyNote mesh__D018549 95   
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D018549 2005
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D018549 2002
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D018549 1995
% 217.44/217.60  |- skos__historyNote mesh__D018549 Pneumonia %28%1985-1993%29%
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D018549 2006
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D018549 2003
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D018549 1998
% 217.44/217.60  |- mesh__dateCreated mesh__D018549 1994-01-25
% 217.44/217.60  |- skos__historyNote mesh__D018549
% 217.44/217.60       Bronchiolitis Obliterans %28%1988-1994%29%
% 217.44/217.60  |- skos__annotation mesh__D018549 DF: note short X ref   
% 217.44/217.60  |- skos__broader mesh__D018549smesh__D001989
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D018549 2004
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D018549 1999
% 217.44/217.60  |- skos__prefLabel mesh__D018549
% 217.44/217.60       Bronchiolitis Obliterans Organizing Pneumonia
% 217.44/217.60  |- mesh__dateEstablished mesh__D018549 1995-01-01
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D018549 1996
% 217.44/217.60  |- skos__altLabel mesh__D018549 BOOP
% 217.44/217.60  |- skos__scopeNote mesh__D018549
% 217.44/217.60       A disease formerly considered a form of interstitial pneumonia. Its etiology is obscure but it may be associated with toxic fumes, infection, and connective tissue disease. Clinical symptoms include cough, dyspnea and influenza-like symptoms with the development of the usual interstitial pneumonia in many cases. Obstructive symptoms are limited to smokers. There are patchy polypoid masses of intra-alveolar granulation tissue in small airway lumina and alveolar ducts. %22%Organizing%22% refers to unresolved pneumonia %28%in which the alveolar exudate persists and eventually undergoes fibrosis%29% in which fibrous tissue forms in the alveoli. %28%From Segen, Dictionary of Modern Medicine, 1992; Stedman, 25th ed%29%%A%    
% 217.44/217.60  |- rdf__type mesh__D018549sskos__Concept
% 217.44/217.60  |- mesh__activeMeSHYear mesh__D018549 1997
% 217.44/217.60  |- mesh__dateRevised mesh__D010566 2005-07-01
% 217.44/217.60  |- mesh__recordAuthorizer mesh__D010566 sjn
% 217.44/217.60  |- mesh__dateEstablished mesh__D010566 1986-01-01
% 217.44/217.60  |- skos__altLabel mesh__D010566 LFP-Hemagglutinin
% 217.44/217.60  |- skos__altLabel mesh__D010566 Bordetella Virulence Factors
% 217.44/217.61  |- skos__hiddenLabel mesh__D010566
% 217.44/217.61       Lymphocytosis Promoting Factor Hemagglutinin
% 217.44/217.61  |- mesh__dateCreated mesh__D010566 1985-06-17
% 217.44/217.61  |- skos__hiddenLabel mesh__D010566 Factors, Bordetella Virulence
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D010566 2006
% 217.44/217.61  |- skos__altLabel mesh__D010566 LP-HA
% 217.44/217.61  |- mesh__recordMaintainer mesh__D010566 sjn
% 217.44/217.61  |- skos__hiddenLabel mesh__D010566 LFP Hemagglutinin
% 217.44/217.61  |- skos__hiddenLabel mesh__D010566
% 217.44/217.61       Leukocytosis Promoting Factor Hemagglutinin
% 217.44/217.61  |- skos__prefLabel mesh__D010566 Virulence Factors, Bordetella
% 217.44/217.61  |- mesh__publicMeSHNote mesh__D010566
% 217.44/217.61       2003 see PERTUSSIS TOXINS 1986-2002   
% 217.44/217.61  |- skos__altLabel mesh__D010566 Leukocytosis-Promoting Factor Hemagglutinin
% 217.44/217.61  |- skos__hiddenLabel mesh__D010566 Agglutinins, Pertussis
% 217.44/217.61  |- skos__hiddenLabel mesh__D010566
% 217.44/217.61       Factor-Hemagglutinin, Lymphocytosis-Promoting
% 217.44/217.61  |- skos__hiddenLabel mesh__D010566 Determinant, Bordetella Virulence
% 217.44/217.61  |- rdf__type mesh__D010566sskos__Concept
% 217.44/217.61  |- skos__hiddenLabel mesh__D010566 Virulence Determinant, Bordetella
% 217.44/217.61  |- skos__broader mesh__D010566smesh__D037521
% 217.44/217.61  |- mesh__recordOriginator mesh__D010566 SH
% 217.44/217.61  |- skos__historyNote mesh__D010566 Bacterial Toxins %28%1977-1985%29%
% 217.44/217.61  |- skos__hiddenLabel mesh__D010566
% 217.44/217.61       Hemagglutinin, Leukocytosis-Promoting Factor
% 217.44/217.61  |- skos__broader mesh__D010566smesh__D001427
% 217.44/217.61  |- skos__altLabel mesh__D010566 Bordetella Virulence Determinant
% 217.44/217.61  |- skos__scopeNote mesh__D010566
% 217.44/217.61       A set of ADHESINS and TOXINS, BIOLOGICAL produced by BORDETELLA organisms that determine the pathogenesis of  BORDETELLA INFECTIONS, such as WHOOPING COUGH. They include filamentous hemagglutinin; FIMBRIAE PROTEINS; pertactin; PERTUSSIS TOXIN; ADENYLATE CYCLASE TOXIN; dermonecrotic toxin; tracheal cytotoxin; Bordetella LIPOPOLYSACCHARIDES; and tracheal colonization factor.%A%    
% 217.44/217.61  |- skos__historyNote mesh__D010566 Bacterial Proteins %28%1966-1985%29%
% 217.44/217.61  |- skos__hiddenLabel mesh__D010566 LP HA
% 217.44/217.61  |- skos__historyNote mesh__D010566 Toxins %28%1966-1976%29%
% 217.44/217.61  |- skos__historyNote mesh__D010566 Bordetella Pertussis %28%1966-1985%29%
% 217.44/217.61  |- skos__hiddenLabel mesh__D010566
% 217.44/217.61       Factor Hemagglutinin, Leukocytosis-Promoting
% 217.44/217.61  |- mesh__historyNote mesh__D010566 2003 %28%1986%29%   
% 217.44/217.61  |- mesh__recordMaintainer mesh__D004529 JLS
% 217.44/217.61  |- skos__annotation mesh__D004529
% 217.44/217.61       white of egg as food or as distinct from EGG YOLK, or egg white from dietary, food technol or econ viewpoint; differentiate from OVALBUMIN, the chemical albumin in egg white; egg-white edema: coord EDEMA %28%IM%29% + OVALBUMIN %28%NIM if indexed at all%29%%A%  
% 217.44/217.61  |- mesh__dateRevised mesh__D004529 1997-06-20
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D004529 1998
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D004529 2001
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D004529 2005
% 217.44/217.61  |- mesh__dateCreated mesh__D004529 1999-01-01
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D004529 1999
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D004529 2002
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D004529 2006
% 217.44/217.61  |- mesh__recordOriginator mesh__D004529 NLM
% 217.44/217.61  |- rdf__type mesh__D004529sskos__Concept
% 217.44/217.61  |- skos__related mesh__D004529smesh__D010047
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D004529 2003
% 217.44/217.61  |- skos__prefLabel mesh__D004529 Egg White
% 217.44/217.61  |- skos__hiddenLabel mesh__D004529 Egg Whites
% 217.44/217.61  |- skos__scopeNote mesh__D004529
% 217.44/217.61       The white of an egg, especially a chicken%27%s egg, used in cooking. It contains albumin. %28%Random House Unabridged Dictionary, 2d ed%29%%A%    
% 217.44/217.61  |- mesh__recordAuthorizer mesh__D004529 SJN
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D004529 2000
% 217.44/217.61  |- skos__broader mesh__D004529smesh__D004531
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D004529 2004
% 217.44/217.61  |- mesh__dateRevised mesh__D015251 2005-06-30
% 217.44/217.61  |- skos__altLabel mesh__D015251 Lemery Brand of Epirubicin Hydrochloride
% 217.44/217.61  |- mesh__dateEstablished mesh__D015251 1989-01-01
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D015251 2006
% 217.44/217.61  |- skos__historyNote mesh__D015251 Doxorubicin %28%1973-1988%29%
% 217.44/217.61  |- skos__hiddenLabel mesh__D015251 NSC 256942
% 217.44/217.61  |- skos__hiddenLabel mesh__D015251 Hydrochloride, Epirubicin
% 217.44/217.61  |- skos__hiddenLabel mesh__D015251 IMI 28
% 217.44/217.61  |- skos__altLabel mesh__D015251 4%27%-Epi-DXR
% 217.44/217.61  |- skos__hiddenLabel mesh__D015251 4%27% Epi Doxorubicin
% 217.44/217.61  |- skos__altLabel mesh__D015251 4%27%-Epiadriamycin
% 217.44/217.61  |- skos__altLabel mesh__D015251 cell pharm Brand of Epirubicin
% 217.44/217.61  |- skos__altLabel mesh__D015251 Kenfarma Brand of Epirubicin Hydrochloride
% 217.44/217.61  |- mesh__recordOriginator mesh__D015251 RLS
% 217.44/217.61  |- skos__altLabel mesh__D015251 4%27%-Epidoxorubicin
% 217.44/217.61  |- rdf__type mesh__D015251sskos__Concept
% 217.44/217.61  |- skos__hiddenLabel mesh__D015251 4%27% Epi DXR
% 217.44/217.61  |- skos__hiddenLabel mesh__D015251 4%27% Epidoxorubicin
% 217.44/217.61  |- skos__altLabel mesh__D015251 Pharmorubicin
% 217.44/217.61  |- mesh__dateCreated mesh__D015251 1988-05-16
% 217.44/217.61  |- skos__altLabel mesh__D015251 Farmorubicin
% 217.44/217.61  |- mesh__recordAuthorizer mesh__D015251 sjn
% 217.44/217.61  |- skos__scopeNote mesh__D015251
% 217.44/217.61       An anthracycline which is the 4%27%-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.%A%    
% 217.44/217.61  |- skos__broader mesh__D015251smesh__D004317
% 217.44/217.61  |- skos__hiddenLabel mesh__D015251 4%27% Epi Adriamycin
% 217.44/217.61  |- skos__hiddenLabel mesh__D015251 4%27% Epiadriamycin
% 217.44/217.61  |- skos__altLabel mesh__D015251 4%27%-Epi-Adriamycin
% 217.44/217.61  |- skos__prefLabel mesh__D015251 Epirubicin
% 217.44/217.61  |- skos__altLabel mesh__D015251 Pharmacia Brand of Epirubicin Hydrochloride
% 217.44/217.61  |- skos__altLabel mesh__D015251 4%27%-Epi-Doxorubicin
% 217.44/217.61  |- mesh__historyNote mesh__D015251 89   
% 217.44/217.61  |- skos__altLabel mesh__D015251 Farmorubicine
% 217.44/217.61  |- skos__hiddenLabel mesh__D015251 IMI28
% 217.44/217.61  |- skos__hiddenLabel mesh__D015251 NSC256942
% 217.44/217.61  |- mesh__publicMeSHNote mesh__D015251 89   
% 217.44/217.61  |- mesh__recordMaintainer mesh__D015251 exl
% 217.44/217.61  |- skos__hiddenLabel mesh__D009214 Myomas
% 217.44/217.61  |- mesh__dateCreated mesh__D009214 1999-01-01
% 217.44/217.61  |- mesh__recordMaintainer mesh__D009214 KEV
% 217.44/217.61  |- mesh__recordOriginator mesh__D009214 NLM
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D009214 1997
% 217.44/217.61  |- skos__broader mesh__D009214smesh__D009379
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D009214 1998
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D009214 2003
% 217.44/217.61  |- mesh__recordAuthorizer mesh__D009214 PLS
% 217.44/217.61  |- skos__annotation mesh__D009214
% 217.44/217.61       uterine = LEIOMYOMA + UTERINE NEOPLASMS; /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D009214 2000
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D009214 1999
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D009214 2004
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D009214 2001
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D009214 2005
% 217.44/217.61  |- skos__prefLabel mesh__D009214 Myoma
% 217.44/217.61  |- skos__scopeNote mesh__D009214
% 217.44/217.61       A benign neoplasm of muscular tissue. %28%Stedman, 25th ed%29%%A%    
% 217.44/217.61  |- rdf__type mesh__D009214sskos__Concept
% 217.44/217.61  |- mesh__dateRevised mesh__D009214 1995-06-08
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D009214 2002
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D009214 2006
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D009214 1996
% 217.44/217.61  |- mesh__dateRevised mesh__D001231 2005-06-30
% 217.44/217.61  |- skos__historyNote mesh__D001231 Aspergillus %28%1966-1971%29%
% 217.44/217.61  |- mesh__publicMeSHNote mesh__D001231 74   
% 217.44/217.61  |- skos__prefLabel mesh__D001231 Aspergillus flavus
% 217.44/217.61  |- mesh__recordMaintainer mesh__D001231 SYSTEM
% 217.44/217.61  |- skos__broader mesh__D001231smesh__D001230
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D001231 2006
% 217.44/217.61  |- mesh__dateCreated mesh__D001231 1999-01-01
% 217.44/217.61  |- skos__scopeNote mesh__D001231
% 217.44/217.61       A species of imperfect fungi which grows on peanuts and other plants and produces the carcinogenic substance aflatoxin. It is also used in the production of the antibiotic flavicin.%A%    
% 217.44/217.61  |- skos__annotation mesh__D001231
% 217.44/217.61       infection: coord IM with ASPERGILLOSIS %28%IM%29%   
% 217.44/217.61  |- mesh__recordOriginator mesh__D001231 NLM
% 217.44/217.61  |- rdf__type mesh__D001231sskos__Concept
% 217.44/217.61  |- skos__related mesh__D001231smesh__D000348
% 217.44/217.61  |- mesh__recordAuthorizer mesh__D001231 sjn
% 217.44/217.61  |- mesh__dateEstablished mesh__D001231 1974-01-01
% 217.44/217.61  |- mesh__historyNote mesh__D001231 74%28%72%29%   
% 217.44/217.61  |- skos__broader mesh__D001779Q000172smesh__D001779
% 217.44/217.61  |- mesh__preferredCombination mesh__D001779Q000172smesh__D020147
% 217.44/217.61  |- rdf__type mesh__D001779Q000172smesh__CompoundConcept
% 217.44/217.61  |- skos__scopeNote mesh__D020196
% 217.44/217.61       Traumatic injuries to the brain, cranial nerves, spinal cord, autonomic nervous system, or neuromuscular system, including iatrogenic injuries induced by surgical procedures.%A%    
% 217.44/217.61  |- skos__hiddenLabel mesh__D020196 Injuries, Craniocervical
% 217.44/217.61  |- mesh__recordMaintainer mesh__D020196 sjn
% 217.44/217.61  |- skos__hiddenLabel mesh__D020196 Injury, Craniocervical
% 217.44/217.61  |- mesh__recordAuthorizer mesh__D020196 sjn
% 217.44/217.61  |- skos__altLabel mesh__D020196 Nervous System Injuries
% 217.44/217.61  |- skos__hiddenLabel mesh__D020196 Nervous System Trauma
% 217.44/217.61  |- skos__annotation mesh__D020196
% 217.44/217.61       GEN: prefer specific precoord organ/injuries term or organ/inj; DF: NERVOUS SYSTEM INJ%A%  
% 217.44/217.61  |- mesh__historyNote mesh__D020196 2000   
% 217.44/217.61  |- skos__hiddenLabel mesh__D020196 Craniocervical Injury
% 217.44/217.61  |- mesh__publicMeSHNote mesh__D020196 2000   
% 217.44/217.61  |- skos__hiddenLabel mesh__D020196 Nervous System Injury
% 217.44/217.61  |- mesh__dateRevised mesh__D020196 2003-07-22
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D020196 2004
% 217.44/217.61  |- mesh__recordOriginator mesh__D020196 KEV
% 217.44/217.61  |- skos__broader mesh__D020196smesh__D009422
% 217.44/217.61  |- skos__historyNote mesh__D020196 Spinal Cord Injuries %28%1996-1999%29%
% 217.44/217.61  |- skos__altLabel mesh__D020196 Injuries, Nervous System
% 217.44/217.61  |- mesh__dateCreated mesh__D020196 1999-11-08
% 217.44/217.61  |- skos__hiddenLabel mesh__D020196 Injury, Nervous System
% 217.44/217.61  |- skos__hiddenLabel mesh__D020196 Nervous System Traumas
% 217.44/217.61  |- skos__historyNote mesh__D020196 Craniocerebral Trauma %28%1996-1999%29%
% 217.44/217.61  |- rdf__type mesh__D020196sskos__Concept
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D020196 2006
% 217.44/217.61  |- skos__prefLabel mesh__D020196 Trauma, Nervous System
% 217.44/217.61  |- mesh__dateEstablished mesh__D020196 2000-01-01
% 217.44/217.61  |- skos__broader mesh__D020196smesh__D014947
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D020196 2005
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D014957 2006
% 217.44/217.61  |- skos__prefLabel mesh__D014957 Wuchereria
% 217.44/217.61  |- skos__scopeNote mesh__D014957 A genus of filarial nematodes.     
% 217.44/217.61  |- skos__broader mesh__D014957smesh__D005370
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D014957 2004
% 217.44/217.61  |- mesh__recordOriginator mesh__D014957 NLM
% 217.44/217.61  |- rdf__type mesh__D014957sskos__Concept
% 217.44/217.61  |- skos__annotation mesh__D014957
% 217.44/217.61       infection: coord IM with FILARIASIS %28%IM%29%; coord with specific helminth term %28%ANTIGENS, HELMINTH, etc%29% if pertinent; /drug eff: consider FILARICIDES%A%  
% 217.44/217.61  |- mesh__dateRevised mesh__D014957 2003-07-09
% 217.44/217.61  |- mesh__recordAuthorizer mesh__D014957 sjn
% 217.44/217.61  |- mesh__dateCreated mesh__D014957 1999-01-01
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D014957 2005
% 217.44/217.61  |- mesh__recordMaintainer mesh__D014957 ags
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D014159 2004
% 217.44/217.61  |- mesh__onlineNote mesh__D014159
% 217.44/217.61       use TRANSDUCERS to search TRANSDUCER 1966-72 %28%as Prov 1966-67%29%%A%  
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D014159 2001
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D014159 2006
% 217.44/217.61  |- skos__annotation mesh__D014159 NIM   
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D014159 2005B
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D014159 2003
% 217.44/217.61  |- mesh__dateRevised mesh__D014159 2004-08-02
% 217.44/217.61  |- skos__hiddenLabel mesh__D014159 Transducer
% 217.44/217.61  |- mesh__recordAuthorizer mesh__D014159 jls
% 217.44/217.61  |- skos__scopeNote mesh__D014159
% 217.44/217.61       Any device or element which converts an input signal into an output signal of a different form. Examples include the microphone, phonographic pickup, loudspeaker, barometer, photoelectric cell, automobile horn, doorbell, and underwater sound transducer. %28%McGraw Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 217.44/217.61  |- mesh__dateEstablished mesh__D014159 1973-01-01
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D014159 2000
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D014159 2005
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D014159 1997
% 217.44/217.61  |- skos__broader mesh__D014159smesh__D004864
% 217.44/217.61  |- mesh__recordOriginator mesh__D014159 NLM
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D014159 1999
% 217.44/217.61  |- skos__broader mesh__D014159smesh__D004581
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D014159 1996
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D014159 1998
% 217.44/217.61  |- mesh__dateCreated mesh__D014159 1999-01-01
% 217.44/217.61  |- mesh__recordMaintainer mesh__D014159 jls
% 217.44/217.61  |- rdf__type mesh__D014159sskos__Concept
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D014159 2005A
% 217.44/217.61  |- mesh__historyNote mesh__D014159
% 217.44/217.61       73; was TRANSDUCER 1966-72 %28%Prov 1966-67%29%   
% 217.44/217.61  |- mesh__publicMeSHNote mesh__D014159 73; was TRANSDUCER 1968-72   
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D014159 2002
% 217.44/217.61  |- skos__prefLabel mesh__D014159 Transducers
% 217.44/217.61  |- skos__hiddenLabel mesh__D000937 Antigen Antibody Reactions
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D000937 1993
% 217.44/217.61  |- mesh__dateCreated mesh__D000937 1999-01-01
% 217.44/217.61  |- mesh__recordMaintainer mesh__D000937 PLS
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D000937 1995
% 217.44/217.61  |- skos__related mesh__D000937smesh__D006969
% 217.44/217.61  |- skos__hiddenLabel mesh__D000937 Reaction, Antigen-Antibody
% 217.44/217.61  |- skos__hiddenLabel mesh__D000937 Antigen-Antibody Reaction
% 217.44/217.61  |- skos__related mesh__D000937smesh__D001666
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D000937 2000
% 217.44/217.61  |- skos__broader mesh__D000937smesh__D007109
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D000937 2003
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D000937 1996
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D000937 2001
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D000937 2005
% 217.44/217.61  |- skos__prefLabel mesh__D000937 Antigen-Antibody Reactions
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D000937 1998
% 217.44/217.61  |- mesh__recordAuthorizer mesh__D000937 PLS
% 217.44/217.61  |- rdf__type mesh__D000937sskos__Concept
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D000937 2004
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D000937 1997
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D000937 2006
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D000937 1999
% 217.44/217.61  |- skos__hiddenLabel mesh__D000937 Reactions, Antigen-Antibody
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D000937 1994
% 217.44/217.61  |- mesh__dateRevised mesh__D000937 1992-03-25
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D000937 2002
% 217.44/217.61  |- mesh__recordOriginator mesh__D000937 NLM
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D019642 2002
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D019642 1998
% 217.44/217.61  |- mesh__dateEstablished mesh__D019642 1998-01-01
% 217.44/217.61  |- skos__scopeNote mesh__D019642
% 217.44/217.61       Ribonucleic acid in archaea having regulatory and catalytic roles as well as involvement in protein synthesis.%A%    
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D019642 2003
% 217.44/217.61  |- rdf__type mesh__D019642sskos__Concept
% 217.44/217.61  |- skos__annotation mesh__D019642
% 217.44/217.61       IM; coord with specific archaeon %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 217.44/217.61  |- mesh__dateCreated mesh__D019642 1997-06-20
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D019642 1999
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D019642 2004
% 217.44/217.61  |- mesh__publicMeSHNote mesh__D019642 98   
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D019642 2000
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D019642 2001
% 217.44/217.61  |- skos__historyNote mesh__D019642 RNA, Bacterial %28%1983-1997%29%
% 217.44/217.61  |- skos__altLabel mesh__D019642 Archaeal RNA
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D019642 2005
% 217.44/217.61  |- skos__broader mesh__D019642smesh__D012313
% 217.44/217.61  |- skos__prefLabel mesh__D019642 RNA, Archaeal
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D019642 2006
% 217.44/217.61  |- mesh__historyNote mesh__D019642 98   
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D005622 2004
% 217.44/217.61  |- mesh__publicMeSHNote mesh__D005622 2002; see FRIEND VIRUS 1966-2001   
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D005622 2006
% 217.44/217.61  |- skos__prefLabel mesh__D005622 Friend murine leukemia virus
% 217.44/217.61  |- skos__broader mesh__D005622smesh__D009052
% 217.44/217.61  |- skos__scopeNote mesh__D005622
% 217.44/217.61       A strain of Murine leukemia virus %28%LEUKEMIA VIRUS, MURINE%29% producing leukemia of the reticulum-cell type with massive infiltration of liver, spleen, and bone marrow. It infects DBA/2 and Swiss mice.%A%    
% 217.44/217.61  |- mesh__dateEstablished mesh__D005622 1966-01-01
% 217.44/217.61  |- mesh__recordMaintainer mesh__D005622 ags
% 217.44/217.61  |- mesh__historyNote mesh__D005622 2002 %28%1966%29%   
% 217.44/217.61  |- skos__altLabel mesh__D005622 Rowson-Parr Virus
% 217.44/217.61  |- mesh__recordAuthorizer mesh__D005622 sjn
% 217.44/217.61  |- skos__annotation mesh__D005622
% 217.44/217.61       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% + LEUKEMIA, EXPERIMENTAL %28%IM%29% or LEUKEMIA %28%IM%29%; Friend erythroleukemia cells: coord IM with LEUKEMIA, ERYTHROBLASTIC, ACUTE + TUMOR CELLS, CULTURED%A%  
% 217.44/217.61  |- skos__hiddenLabel mesh__D005622 Virus, Rowson-Parr
% 217.44/217.61  |- skos__hiddenLabel mesh__D005622 Virus, Friend
% 217.44/217.61  |- mesh__recordOriginator mesh__D005622 NLM
% 217.44/217.61  |- skos__altLabel mesh__D005622 Friend Virus
% 217.44/217.61  |- mesh__dateCreated mesh__D005622 1999-01-01
% 217.44/217.61  |- skos__hiddenLabel mesh__D005622 Rowson Parr Virus
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D005622 2003
% 217.44/217.61  |- rdf__type mesh__D005622sskos__Concept
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D005622 2005
% 217.44/217.61  |- mesh__dateRevised mesh__D005622 2002-07-03
% 217.44/217.61  |- skos__hiddenLabel mesh__D010567 Vaccine, Pertussis
% 217.44/217.61  |- mesh__dateRevised mesh__D010567 2005-06-30
% 217.44/217.61  |- mesh__dateCreated mesh__D010567 1999-01-01
% 217.44/217.61  |- skos__broader mesh__D010567smesh__D001428
% 217.44/217.61  |- skos__scopeNote mesh__D010567
% 217.44/217.61       A suspension of killed Bordetella pertussis organisms, used for immunization against pertussis %28%WHOOPING COUGH%29%. It is generally used in a mixture with diphtheria and tetanus toxoids %28%DTP%29%. There is an acellular pertussis vaccine prepared from the purified antigenic components of Bordetella pertussis, which causes fewer adverse reactions than whole-cell vaccine and, like the whole-cell vaccine, is generally used in a mixture with diphtheria and tetanus toxoids. %28%From Dorland, 28th ed%29%%A%    
% 217.44/217.61  |- skos__prefLabel mesh__D010567 Pertussis Vaccine
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D010567 2006
% 217.44/217.61  |- mesh__recordAuthorizer mesh__D010567 sjn
% 217.44/217.61  |- mesh__recordOriginator mesh__D010567 NLM
% 217.44/217.61  |- skos__annotation mesh__D010567
% 217.44/217.61       DIPHTHERIA-TETANUS-PERTUSSIS VACCINE is also available   
% 217.44/217.61  |- rdf__type mesh__D010567sskos__Concept
% 217.44/217.61  |- mesh__recordMaintainer mesh__D010567 ssb
% 217.44/217.61  |- skos__altLabel mesh__D015252 DNase, Site Specific, Type II
% 217.44/217.61  |- skos__altLabel mesh__D015252 Type II Site Specific DNase
% 217.44/217.61  |- skos__historyNote mesh__D015252
% 217.44/217.61       DNA Restriction Enzymes %28%1978-1988%29%
% 217.44/217.61  |- mesh__historyNote mesh__D015252 89   
% 217.44/217.61  |- skos__altLabel mesh__D015252 DNA Restriction Enzymes, Type II
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D015252 2005
% 217.44/217.61  |- skos__altLabel mesh__D015252 Type II Site Specific Deoxyribonucleases
% 217.44/217.61  |- skos__prefLabel mesh__D015252 Deoxyribonucleases, Type II Site-Specific
% 217.44/217.61  |- rdf__type mesh__D015252sskos__Concept
% 217.44/217.61  |- skos__altLabel mesh__D015252 Site-Specific DNase, Type II
% 217.44/217.61  |- mesh__recordMaintainer mesh__D015252 ssb
% 217.44/217.61  |- skos__altLabel mesh__D015252 Deoxyribonucleases, Type II, Site-Specific
% 217.44/217.61  |- skos__broader mesh__D015252smesh__D004262
% 217.44/217.61  |- skos__scopeNote mesh__D015252
% 217.44/217.61       Enzyme systems containing a single subunit and requiring only magnesium for endonucleolytic activity. The corresponding modification methylases are separate enzymes. The systems recognize specific short DNA sequences and cleave either within, or at a short specific distance from, the recognition sequence to give specific double-stranded fragments with terminal 5%27%-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.4.%A%    
% 217.44/217.61  |- mesh__recordOriginator mesh__D015252 RLS
% 217.44/217.61  |- skos__altLabel mesh__D015252 Type II Site-Specific Deoxyribonucleases
% 217.44/217.61  |- skos__altLabel mesh__D015252 DNase, Site-Specific, Type II
% 217.44/217.61  |- skos__altLabel mesh__D015252 Deoxyribonucleases, Type II, Site Specific
% 217.44/217.61  |- mesh__dateCreated mesh__D015252 1988-05-17
% 217.44/217.61  |- skos__altLabel mesh__D015252 Restriction Endonucleases, Type II
% 217.44/217.61  |- mesh__recordAuthorizer mesh__D015252 sjn
% 217.44/217.61  |- mesh__publicMeSHNote mesh__D015252 89   
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D015252 2006
% 217.44/217.61  |- mesh__dateEstablished mesh__D015252 1989-01-01
% 217.44/217.61  |- skos__annotation mesh__D015252
% 217.44/217.61       a DNA restriction enzyme; DF: DNASE SS II   
% 217.44/217.61  |- skos__altLabel mesh__D015252 Type II Site-Specific DNase
% 217.44/217.61  |- skos__altLabel mesh__D015252 Type II Restriction Enzymes
% 217.44/217.61  |- mesh__dateRevised mesh__D015252 2003-07-09
% 217.44/217.61  |- skos__hiddenLabel mesh__D015252 Site Specific DNase, Type II
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D015252 2004
% 217.44/217.61  |- skos__hiddenLabel mesh__D015252
% 217.44/217.61       Deoxyribonucleases, Type II Site Specific
% 217.44/217.61  |- skos__hiddenLabel mesh__D009215 Muscle, Uterine
% 217.44/217.61  |- skos__prefLabel mesh__D009215 Myometrium
% 217.44/217.61  |- mesh__dateRevised mesh__D009215 2004-07-07
% 217.44/217.61  |- skos__hiddenLabel mesh__D009215 Uterine Muscles
% 217.44/217.61  |- mesh__dateEstablished mesh__D009215 1984-01-01
% 217.44/217.61  |- mesh__historyNote mesh__D009215
% 217.44/217.61       84%28%75%29%; was see under UTERUS 1975-83   
% 217.44/217.61  |- mesh__recordOriginator mesh__D009215 NLM
% 217.44/217.61  |- mesh__recordMaintainer mesh__D009215 ags
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D009215 2005
% 217.44/217.61  |- skos__historyNote mesh__D009215 Uterus %28%1966-1974%29%
% 217.44/217.61  |- rdf__type mesh__D009215sskos__Concept
% 217.44/217.61  |- skos__scopeNote mesh__D009215
% 217.44/217.61       The smooth muscle coat of the uterus, which forms the main mass of the organ.%A%    
% 217.44/217.61  |- skos__broader mesh__D009215smesh__D009130
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D009215 2006
% 217.44/217.61  |- mesh__recordAuthorizer mesh__D009215 sjn
% 217.44/217.61  |- skos__broader mesh__D009215smesh__D014599
% 217.44/217.61  |- skos__altLabel mesh__D009215 Uterine Muscle
% 217.44/217.61  |- mesh__publicMeSHNote mesh__D009215 84; was see under UTERUS 1975-83   
% 217.44/217.61  |- skos__annotation mesh__D009215
% 217.44/217.61       /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 217.44/217.61  |- mesh__dateCreated mesh__D009215 1974-11-11
% 217.44/217.61  |- skos__hiddenLabel mesh__D009215 Muscles, Uterine
% 217.44/217.61  |- mesh__recordOriginator mesh__D001232 NLM
% 217.44/217.61  |- mesh__dateEstablished mesh__D001232 1974-01-01
% 217.44/217.61  |- mesh__recordAuthorizer mesh__D001232 sjn
% 217.44/217.61  |- mesh__dateRevised mesh__D001232 2005-06-30
% 217.44/217.61  |- skos__annotation mesh__D001232
% 217.44/217.61       infection: coord IM with ASPERGILLOSIS %28%IM%29%   
% 217.44/217.61  |- skos__broader mesh__D001232smesh__D001230
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D001232 2006
% 217.44/217.61  |- mesh__recordMaintainer mesh__D001232 SYSTEM
% 217.44/217.61  |- mesh__publicMeSHNote mesh__D001232 74   
% 217.44/217.61  |- skos__scopeNote mesh__D001232
% 217.44/217.61       A species of imperfect fungi from which the antibiotic fumigatin is obtained. Its spores may cause respiratory infection in birds and mammals.%A%    
% 217.44/217.61  |- mesh__dateCreated mesh__D001232 1999-01-01
% 217.44/217.61  |- rdf__type mesh__D001232sskos__Concept
% 217.44/217.61  |- skos__prefLabel mesh__D001232 Aspergillus fumigatus
% 217.44/217.61  |- mesh__historyNote mesh__D001232 74%28%72%29%   
% 217.44/217.61  |- skos__historyNote mesh__D001232 Aspergillus %28%1966-1971%29%
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D020197 2005
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Penetrating Cranial Trauma
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Penetrating Head Injury
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Injury, Penetrating Head
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Penetrating Head Injuries
% 217.44/217.61  |- mesh__publicMeSHNote mesh__D020197 2000   
% 217.44/217.61  |- skos__prefLabel mesh__D020197 Head Injuries, Penetrating
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D020197 2004
% 217.44/217.61  |- skos__altLabel mesh__D020197 Penetrating Missile Injuries, Head
% 217.44/217.61  |- skos__broader mesh__D020197smesh__D014950
% 217.44/217.61  |- skos__altLabel mesh__D020197 Craniocerebral Trauma, Penetrating
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Penetrating Head Trauma
% 217.44/217.61  |- mesh__historyNote mesh__D020197 2000   
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Head Traumas, Penetrating
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Trauma, Penetrating Cranial
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Penetrating Craniocerebral Traumas
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Craniocerebral Traumas, Penetrating
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Penetrating Head Traumas
% 217.44/217.61  |- skos__altLabel mesh__D020197 Head Trauma, Penetrating
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Penetrating Brain Injury
% 217.44/217.61  |- mesh__recordOriginator mesh__D020197 KEV
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Penetrating Brain Injuries
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Traumas, Penetrating Cranial
% 217.44/217.61  |- skos__broader mesh__D020197smesh__D006259
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Injuries, Penetrating Head
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Trauma, Penetrating Head
% 217.44/217.61  |- rdf__type mesh__D020197sskos__Concept
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Traumas, Penetrating Head
% 217.44/217.61  |- skos__altLabel mesh__D020197 Cranial Trauma, Penetrating
% 217.44/217.61  |- mesh__recordMaintainer mesh__D020197 sjn
% 217.44/217.61  |- mesh__dateCreated mesh__D020197 1999-11-08
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Brain Injury, Penetrating
% 217.44/217.61  |- skos__altLabel mesh__D020197 Head Injury, Penetrating
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D020197 2006
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Penetrating Cranial Traumas
% 217.44/217.61  |- skos__altLabel mesh__D020197 Head Injuries, Penetrating, Missile
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Cranial Traumas, Penetrating
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Penetrating Craniocerebral Trauma
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Trauma, Penetrating Craniocerebral
% 217.44/217.61  |- mesh__dateEstablished mesh__D020197 2000-01-01
% 217.44/217.61  |- mesh__recordAuthorizer mesh__D020197 sjn
% 217.44/217.61  |- skos__scopeNote mesh__D020197
% 217.44/217.61       Head injuries which feature compromise of the skull and dura mater. These may result from gunshot wounds %28%WOUNDS, GUNSHOT%29%, stab wounds %28%WOUNDS, STAB%29%, and other forms of trauma.%A%    
% 217.44/217.61  |- skos__historyNote mesh__D020197 Wounds, Penetrating %28%1971-1999%29%
% 217.44/217.61  |- skos__historyNote mesh__D020197 Craniocerebral Trauma %28%1971-1999%29%
% 217.44/217.61  |- skos__hiddenLabel mesh__D020197 Traumas, Penetrating Craniocerebral
% 217.44/217.61  |- mesh__dateRevised mesh__D020197 2003-07-22
% 217.44/217.61  |- mesh__historyNote mesh__D014958
% 217.44/217.61       91%28%79%29%; was see under WUCHERERIA 1979-90; was FILARIA BANCROFTI see under WUCHERERIA 1963-78; FILARIA SANGUINIS HOMINIS was see under WUCHERERIA 1963-78%A%  
% 217.44/217.61  |- skos__prefLabel mesh__D014958 Wuchereria bancrofti
% 217.44/217.61  |- skos__altLabel mesh__D014958 Filaria bancrofti
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D014958 2004
% 217.44/217.61  |- mesh__dateEstablished mesh__D014958 1991-01-01
% 217.44/217.61  |- skos__annotation mesh__D014958
% 217.44/217.61       infection: coord IM with probably ELEPHANTIASIS, FILARIAL %28%IM%29% but if elephantiasis is not present, coord with FILARIASIS %28%IM%29% instead; coord with specific helminth term %28%ANTIGENS, HELMINTH, etc%29% if pertinent; /drug eff: consider FILARICIDES%A%  
% 217.44/217.61  |- rdf__type mesh__D014958sskos__Concept
% 217.44/217.61  |- mesh__dateRevised mesh__D014958 2003-07-09
% 217.44/217.61  |- mesh__publicMeSHNote mesh__D014958
% 217.44/217.61       91; was see under WUCHERERIA 1979-90; was FILARIA BANCROFTI see under WUCHERERIA 1963-78; FILARIA SANGUINIS HOMINIS was see under WUCHERERIA 1963-78%A%  
% 217.44/217.61  |- mesh__dateCreated mesh__D014958 1999-01-01
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D014958 2005
% 217.44/217.61  |- mesh__recordMaintainer mesh__D014958 ags
% 217.44/217.61  |- skos__scopeNote mesh__D014958
% 217.44/217.61       A white threadlike worm which causes elephantiasis, lymphangitis, and chyluria by interfering with the lymphatic circulation. The microfilaria are found in the circulating blood and are carried by mosquitoes.%A%    
% 217.44/217.61  |- mesh__recordOriginator mesh__D014958 NLM
% 217.44/217.61  |- mesh__onlineNote mesh__D014958
% 217.44/217.61       use WUCHERERIA BANCROFTI to search FILARIA BANCROFTI %26% FILARIA SANGUINIS HOMINIS 1975-78; use WUCHERERIA 1966-74%A%  
% 217.44/217.61  |- mesh__activeMeSHYear mesh__D014958 2006
% 217.44/217.61  |- mesh__recordAuthorizer mesh__D014958 sjn
% 217.44/217.61  |- skos__broader mesh__D014958smesh__D014957
% 217.44/217.61  |- skos__altLabel mesh__D014958 Filaria sanguinis hominis
% 217.44/217.61  |- mesh__publicMeSHNote mesh__D019643 98; see JOINT PROSTHESIS 1979-97   
% 217.44/217.61  |- skos__prefLabel mesh__D019643 Arthroplasty, Replacement
% 217.44/217.62  |- skos__related mesh__D019643smesh__D007595
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D019643 2006
% 217.44/217.62  |- skos__scopeNote mesh__D019643
% 217.44/217.62       Partial or total replacement of a joint.     
% 217.44/217.62  |- skos__hiddenLabel mesh__D019643 Joint Prosthesis Implantations
% 217.44/217.62  |- skos__hiddenLabel mesh__D019643 Prosthesis Implantation, Joint
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D019643 2001
% 217.44/217.62  |- mesh__dateCreated mesh__D019643 1997-06-20
% 217.44/217.62  |- skos__historyNote mesh__D019643 Joint Prosthesis %28%1971-1997%29%
% 217.44/217.62  |- mesh__dateEstablished mesh__D019643 1998-01-01
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D019643 2005
% 217.44/217.62  |- skos__broader mesh__D019643smesh__D019919
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D019643 2004
% 217.44/217.62  |- skos__historyNote mesh__D019643 specific joint %28%1966-1970%29%
% 217.44/217.62  |- rdf__type mesh__D019643sskos__Concept
% 217.44/217.62  |- skos__altLabel mesh__D019643 Replacement Arthroplasty
% 217.44/217.62  |- skos__broader mesh__D019643smesh__D001178
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D019643 2000
% 217.44/217.62  |- skos__hiddenLabel mesh__D019643 Implantations, Joint Prosthesis
% 217.44/217.62  |- mesh__historyNote mesh__D019643 98; use JOINT PROSTHESIS 1979-97   
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D019643 2003
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D019643 1999
% 217.44/217.62  |- skos__altLabel mesh__D019643 Joint Prosthesis Implantation
% 217.44/217.62  |- skos__altLabel mesh__D019643 Replacement Arthroplasties
% 217.44/217.62  |- skos__altLabel mesh__D019643 Arthroplasties, Replacement
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D019643 1998
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D019643 2002
% 217.44/217.62  |- skos__annotation mesh__D019643
% 217.44/217.62       ARTHROPLASTY, REPLACEMENT, HIP %26% ARTHROPLASTY, REPLACEMENT, KNEE are also available; do not use /util except by MeSH definition; DF: ARTHROPLASTY REPLACE%A%  
% 217.44/217.62  |- skos__historyNote mesh__D019643
% 217.44/217.62       Prostheses and Implants %28%1966-1970%29%
% 217.44/217.62  |- skos__hiddenLabel mesh__D019643 Prosthesis Implantations, Joint
% 217.44/217.62  |- skos__hiddenLabel mesh__D019643 Implantation, Joint Prosthesis
% 217.44/217.62  |- skos__altLabel mesh__D000938 Immunologic Accessory Cell
% 217.44/217.62  |- skos__related mesh__D000938smesh__D017951
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D000938 2003
% 217.44/217.62  |- skos__historyNote mesh__D000938
% 217.44/217.62       Antigens, Immune Response %28%1981-1984%29%
% 217.44/217.62  |- skos__related mesh__D000938smesh__D000949
% 217.44/217.62  |- skos__hiddenLabel mesh__D000938 Cell, Antigen-Presenting
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D000938 2005
% 217.44/217.62  |- skos__prefLabel mesh__D000938 Antigen-Presenting Cells
% 217.44/217.62  |- rdf__type mesh__D000938sskos__Concept
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D000938 2004
% 217.44/217.62  |- mesh__recordOriginator mesh__D000938 AEP
% 217.44/217.62  |- mesh__publicMeSHNote mesh__D000938 85   
% 217.44/217.62  |- skos__altLabel mesh__D000938 Accessory Cells, Immunologic
% 217.44/217.62  |- skos__historyNote mesh__D000938 T Lymphocytes %28%1973-1984%29%
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D000938 2006
% 217.44/217.62  |- skos__historyNote mesh__D000938 Antigenic Determinants %28%1970-1984%29%
% 217.44/217.62  |- skos__annotation mesh__D000938 A 11 qualif   
% 217.44/217.62  |- skos__historyNote mesh__D000938
% 217.44/217.62       Lymphocyte Transformation %28%1969-1984%29%
% 217.44/217.62  |- skos__broader mesh__D000938smesh__D007107
% 217.44/217.62  |- skos__altLabel mesh__D000938 Accessory Cell, Immunologic
% 217.44/217.62  |- skos__hiddenLabel mesh__D000938 Cells, Antigen-Presenting
% 217.44/217.62  |- skos__hiddenLabel mesh__D000938 Antigen-Presenting Cell
% 217.44/217.62  |- mesh__dateCreated mesh__D000938 1984-05-30
% 217.44/217.62  |- skos__altLabel mesh__D000938 Cell, Immunologic Accessory
% 217.44/217.62  |- mesh__dateEstablished mesh__D000938 1985-01-01
% 217.44/217.62  |- mesh__recordMaintainer mesh__D000938 NLM
% 217.44/217.62  |- skos__related mesh__D000938smesh__D008213
% 217.44/217.62  |- mesh__dateRevised mesh__D000938 2002-08-01
% 217.44/217.62  |- mesh__historyNote mesh__D000938 85   
% 217.44/217.62  |- skos__hiddenLabel mesh__D000938 Antigen Presenting Cells
% 217.44/217.62  |- skos__broader mesh__D000938smesh__D002477
% 217.44/217.62  |- mesh__recordAuthorizer mesh__D000938 NLM
% 217.44/217.62  |- skos__scopeNote mesh__D000938
% 217.44/217.62       Heterogeneous group of immunocompetent cells that mediates the cellular immune response by processing and presenting antigens to the T-cell receptor. Traditional antigen-presenting cells include MACROPHAGES; DENDRITIC CELLS; LANGERHANS CELLS; and B-LYMPHOCYTES. Follicular dendritic cells %28%DENDRITIC CELLS, FOLLICULAR%29% are also considered to be antigen-presenting cells by some authors.%A%    
% 217.44/217.62  |- skos__altLabel mesh__D000938 Cells, Immunologic Accessory
% 217.44/217.62  |- skos__altLabel mesh__D000938 Immunologic Accessory Cells
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011660 2002
% 217.44/217.62  |- mesh__recordAuthorizer mesh__D011660 PLS
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011660 1996
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011660 1995
% 217.44/217.62  |- skos__broader mesh__D011660smesh__D006331
% 217.44/217.62  |- skos__prefLabel mesh__D011660 Pulmonary Heart Disease
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011660 2004
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011660 2001
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011660 1994
% 217.44/217.62  |- mesh__dateCreated mesh__D011660 1999-01-01
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011660 2003
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011660 1999
% 217.44/217.62  |- skos__annotation mesh__D011660 DF: PULM HEART DIS   
% 217.44/217.62  |- rdf__type mesh__D011660sskos__Concept
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011660 2000
% 217.44/217.62  |- skos__altLabel mesh__D011660 Heart Diseases, Pulmonary
% 217.44/217.62  |- skos__altLabel mesh__D011660 Diseases, Pulmonary Heart
% 217.44/217.62  |- mesh__dateRevised mesh__D011660 1993-06-02
% 217.44/217.62  |- mesh__recordMaintainer mesh__D011660 TAP
% 217.44/217.62  |- skos__altLabel mesh__D011660 Disease, Pulmonary Heart
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011660 1998
% 217.44/217.62  |- skos__altLabel mesh__D011660 Pulmonary Heart Diseases
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011660 2006
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011660 1997
% 217.44/217.62  |- skos__altLabel mesh__D011660 Heart Disease, Pulmonary
% 217.44/217.62  |- mesh__recordOriginator mesh__D011660 NLM
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011660 2005
% 217.44/217.62  |- skos__altLabel mesh__D011660 Cor Pulmonale
% 217.44/217.62  |- mesh__dateCreated mesh__D052279 2005-06-30
% 217.44/217.62  |- skos__altLabel mesh__D052279 Isoenzyme CPK-MB
% 217.44/217.62  |- skos__altLabel mesh__D052279 MB Creatine Kinase
% 217.44/217.62  |- skos__hiddenLabel mesh__D052279 Isoenzyme CPK MB
% 217.44/217.62  |- skos__hiddenLabel mesh__D052279 Creatine Kinase, Myocardial
% 217.44/217.62  |- skos__prefLabel mesh__D052279 Creatine Kinase, MB Form
% 217.44/217.62  |- mesh__historyNote mesh__D052279 2006%28%2000%29%   
% 217.44/217.62  |- mesh__recordOriginator mesh__D052279 jmp
% 217.44/217.62  |- skos__altLabel mesh__D052279 Myocardial Creatine Kinase
% 217.44/217.62  |- mesh__recordMaintainer mesh__D052279 jmp
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D052279 2006
% 217.44/217.62  |- skos__hiddenLabel mesh__D052279 Creatine Kinase, MB
% 217.44/217.62  |- skos__scopeNote mesh__D052279
% 217.44/217.62       An isoenzyme of creatine kinase found in the CARDIAC MUSCLE.%A%    
% 217.44/217.62  |- skos__hiddenLabel mesh__D052279 Kinase, Myocardial Creatine
% 217.44/217.62  |- skos__broader mesh__D052279smesh__D003402
% 217.44/217.62  |- skos__hiddenLabel mesh__D052279 CPK-MB, Isoenzyme
% 217.44/217.62  |- rdf__type mesh__D052279sskos__Concept
% 217.44/217.62  |- mesh__publicMeSHNote mesh__D052279
% 217.44/217.62       2006; CREATINE KINASE, MB FORM was indexed under CREATINE KINASE 2000-2005%A%  
% 217.44/217.62  |- mesh__dateEstablished mesh__D052279 2006-01-01
% 217.44/217.62  |- skos__hiddenLabel mesh__D052279 Kinase, MB Creatine
% 217.44/217.62  |- mesh__recordAuthorizer mesh__D052279 sjn
% 217.44/217.62  |- skos__broader mesh__D010568smesh__D013020
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D010568 1999
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D010568 1994
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D010568 1997
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D010568 2002
% 217.44/217.62  |- mesh__dateRevised mesh__D010568 1993-06-03
% 217.44/217.62  |- mesh__recordAuthorizer mesh__D010568 PLS
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D010568 1998
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D010568 2006
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D010568 1996
% 217.44/217.62  |- skos__prefLabel mesh__D010568 Peru
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D010568 2004
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D010568 2005
% 217.44/217.62  |- rdf__type mesh__D010568sskos__Concept
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D010568 2001
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D010568 2003
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D010568 2000
% 217.44/217.62  |- mesh__recordMaintainer mesh__D010568 PLS
% 217.44/217.62  |- mesh__dateCreated mesh__D010568 1999-01-01
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D010568 1995
% 217.44/217.62  |- mesh__recordOriginator mesh__D010568 NLM
% 217.44/217.62  |- skos__altLabel mesh__D015253 Deoxyribonucleases, Type I, Site Specific
% 217.44/217.62  |- skos__altLabel mesh__D015253 DNA Restriction Enzymes, Type I
% 217.44/217.62  |- skos__altLabel mesh__D015253 Type I Site-Specific DNase
% 217.44/217.62  |- skos__prefLabel mesh__D015253 Deoxyribonucleases, Type I Site-Specific
% 217.44/217.62  |- mesh__recordAuthorizer mesh__D015253 sjn
% 217.44/217.62  |- skos__hiddenLabel mesh__D015253 Deoxyribonucleases, Type I Site Specific
% 217.44/217.62  |- skos__scopeNote mesh__D015253
% 217.44/217.62       Enzyme systems containing three different subunits and requiring ATP, S-adenosylmethionine, and magnesium for endonucleolytic activity to give random double-stranded fragments with terminal 5%27%-phosphates. They function also as DNA-dependent ATPases and modification methylases, catalyzing the reactions of EC 2.1.1.72 and EC 2.1.1.73 with similar site-specificity. The systems recognize specific short DNA sequences and cleave at sites remote from the recognition sequence. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.3.%A%    
% 217.44/217.62  |- skos__altLabel mesh__D015253 Deoxyribonucleases, Type I, Site-Specific
% 217.44/217.62  |- skos__altLabel mesh__D015253 Restriction Endonucleases, Type I
% 217.44/217.62  |- mesh__publicMeSHNote mesh__D015253 89   
% 217.44/217.62  |- mesh__historyNote mesh__D015253 89   
% 217.44/217.62  |- skos__altLabel mesh__D015253 Type I Site-Specific Deoxyribonucleases
% 217.44/217.62  |- mesh__dateEstablished mesh__D015253 1989-01-01
% 217.44/217.62  |- skos__hiddenLabel mesh__D015253 Site Specific DNase, Type I
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D015253 2006
% 217.44/217.62  |- mesh__dateRevised mesh__D015253 2003-07-09
% 217.44/217.62  |- skos__altLabel mesh__D015253 Type I Site Specific Deoxyribonucleases
% 217.44/217.62  |- skos__annotation mesh__D015253 DF: DNASE SS I   
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D015253 2005
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D015253 2004
% 217.44/217.62  |- mesh__recordOriginator mesh__D015253 RLS
% 217.44/217.62  |- skos__altLabel mesh__D015253 Site-Specific DNase, Type I
% 217.44/217.62  |- mesh__dateCreated mesh__D015253 1988-05-17
% 217.44/217.62  |- skos__altLabel mesh__D015253 DNase, Site-Specific, Type I
% 217.44/217.62  |- mesh__recordMaintainer mesh__D015253 ssb
% 217.44/217.62  |- skos__broader mesh__D015253smesh__D004262
% 217.44/217.62  |- skos__altLabel mesh__D015253 Type I Restriction Enzymes
% 217.44/217.62  |- skos__historyNote mesh__D015253
% 217.44/217.62       DNA Restriction Enzymes %28%1978-1988%29%
% 217.44/217.62  |- rdf__type mesh__D015253sskos__Concept
% 217.44/217.62  |- skos__altLabel mesh__D015253 Type I Site Specific DNase
% 217.44/217.62  |- skos__altLabel mesh__D015253 DNase, Site Specific, Type I
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D009216 2005
% 217.44/217.62  |- skos__prefLabel mesh__D009216 Myopia
% 217.44/217.62  |- mesh__recordAuthorizer mesh__D009216 sjn
% 217.44/217.62  |- skos__scopeNote mesh__D009216
% 217.44/217.62       A refractive error in which rays of light entering the EYE parallel to the optic axis are brought to a focus in front of the RETINA when accommodation %28%ACCOMMODATION, OCULAR%29% is relaxed. This results from an overly curved CORNEA or from the eyeball being too long from front to back. It is also called nearsightedness.%A%    
% 217.44/217.62  |- skos__hiddenLabel mesh__D009216 Nearsightednesses
% 217.44/217.62  |- skos__annotation mesh__D009216 MYOPIA, DEGENERATIVE is also available   
% 217.44/217.62  |- skos__altLabel mesh__D009216 Nearsightedness
% 217.44/217.62  |- skos__broader mesh__D009216smesh__D012030
% 217.44/217.62  |- mesh__dateRevised mesh__D009216 2004-07-07
% 217.44/217.62  |- skos__hiddenLabel mesh__D009216 Myopias
% 217.44/217.62  |- mesh__recordOriginator mesh__D009216 NLM
% 217.44/217.62  |- mesh__dateCreated mesh__D009216 1999-01-01
% 217.44/217.62  |- rdf__type mesh__D009216sskos__Concept
% 217.44/217.62  |- mesh__recordMaintainer mesh__D009216 ags
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D009216 2006
% 217.44/217.62  |- mesh__historyNote mesh__D001233 74%28%72%29%   
% 217.44/217.62  |- skos__historyNote mesh__D001233 Aspergillus %28%1966-1971%29%
% 217.44/217.62  |- mesh__recordOriginator mesh__D001233 NLM
% 217.44/217.62  |- mesh__dateEstablished mesh__D001233 1974-01-01
% 217.44/217.62  |- skos__broader mesh__D001233smesh__D001230
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D001233 2006
% 217.44/217.62  |- mesh__recordAuthorizer mesh__D001233 sjn
% 217.44/217.62  |- skos__prefLabel mesh__D001233 Aspergillus nidulans
% 217.44/217.62  |- mesh__recordMaintainer mesh__D001233 SYSTEM
% 217.44/217.62  |- mesh__dateRevised mesh__D001233 2005-06-30
% 217.44/217.62  |- mesh__dateCreated mesh__D001233 1999-01-01
% 217.44/217.62  |- skos__annotation mesh__D001233
% 217.44/217.62       infection: coord IM with ASPERGILLOSIS %28%IM%29%   
% 217.44/217.62  |- rdf__type mesh__D001233sskos__Concept
% 217.44/217.62  |- skos__scopeNote mesh__D001233
% 217.44/217.62       A species of imperfect fungi from which the antibiotic nidulin is obtained. Its teleomorph is Emericella nidulans.%A%    
% 217.44/217.62  |- mesh__publicMeSHNote mesh__D001233 74   
% 217.44/217.62  |- skos__altLabel mesh__D020198 Traumatic Intracranial Hemorrhage
% 217.44/217.62  |- skos__annotation mesh__D020198
% 217.44/217.62       BRAIN HEMORRHAGE, TRAUMATIC and specifics are available   
% 217.44/217.62  |- mesh__dateEstablished mesh__D020198 2000-01-01
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D020198 2003
% 217.44/217.62  |- skos__hiddenLabel mesh__D020198 Hemorrhages, Traumatic Intracranial
% 217.44/217.62  |- skos__hiddenLabel mesh__D020198 Intracranial Hemorrhages, Traumatic
% 217.44/217.62  |- skos__broader mesh__D020198smesh__D006259
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D020198 2004
% 217.44/217.62  |- skos__hiddenLabel mesh__D020198 Hematomas, Traumatic Intracranial
% 217.44/217.62  |- skos__historyNote mesh__D020198 Cerebral Hemorrhage %28%1966-1999%29%
% 217.44/217.62  |- skos__hiddenLabel mesh__D020198 Traumatic Intracranial Hemorrhages
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D020198 2000
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D020198 2005
% 217.44/217.62  |- skos__hiddenLabel mesh__D020198 Hematoma, Traumatic Intracranial
% 217.44/217.62  |- skos__hiddenLabel mesh__D020198 Hemorrhage, Traumatic Intracranial
% 217.44/217.62  |- skos__hiddenLabel mesh__D020198 Intracranial Hematomas, Traumatic
% 217.44/217.62  |- rdf__type mesh__D020198sskos__Concept
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D020198 2001
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D020198 2006
% 217.44/217.62  |- mesh__publicMeSHNote mesh__D020198 2000   
% 217.44/217.62  |- skos__broader mesh__D020198smesh__D020300
% 217.44/217.62  |- mesh__historyNote mesh__D020198 2000   
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D020198 2002
% 217.44/217.62  |- skos__prefLabel mesh__D020198 Intracranial Hemorrhage, Traumatic
% 217.44/217.62  |- skos__hiddenLabel mesh__D020198 Traumatic Intracranial Hematomas
% 217.44/217.62  |- skos__hiddenLabel mesh__D020198 Traumatic Intracranial Hematoma
% 217.44/217.62  |- mesh__dateCreated mesh__D020198 1999-11-03
% 217.44/217.62  |- skos__scopeNote mesh__D020198
% 217.44/217.62       Bleeding within the cranial vault induced by penetrating and nonpenetrating traumatic injuries, including hemorrhages into the epidural, subdural and subarachnoid spaces, cerebral hemispheres, DIENCEPHALON; BRAIN STEM; and CEREBELLUM.%A%    
% 217.44/217.62  |- skos__altLabel mesh__D020198 Hemorrhage, Intracranial, Traumatic
% 217.44/217.62  |- mesh__dateRevised mesh__D014959 1997-06-20
% 217.44/217.62  |- mesh__dateCreated mesh__D014959 1999-01-01
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D014959 2006
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D014959 2000
% 217.44/217.62  |- mesh__recordOriginator mesh__D014959 NLM
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D014959 2004
% 217.44/217.62  |- skos__prefLabel mesh__D014959 Wyoming
% 217.44/217.62  |- skos__broader mesh__D014959smesh__D015205
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D014959 2005
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D014959 2003
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D014959 2002
% 217.44/217.62  |- rdf__type mesh__D014959sskos__Concept
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D014959 1999
% 217.44/217.62  |- mesh__recordAuthorizer mesh__D014959 SJN
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D014959 1998
% 217.44/217.62  |- mesh__recordMaintainer mesh__D014959 PXP
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D014959 2001
% 217.44/217.62  |- skos__hiddenLabel mesh__D025681 Adenovirus 1, Fowl
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D025681 2004
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D025681 2002
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D025681 2006
% 217.44/217.62  |- rdf__type mesh__D025681sskos__Concept
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D025681 2003
% 217.44/217.62  |- skos__hiddenLabel mesh__D025681 Virus, CELO
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D025681 2005
% 217.44/217.62  |- skos__altLabel mesh__D025681 CELO Virus
% 217.44/217.62  |- mesh__recordAuthorizer mesh__D025681 jls
% 217.44/217.62  |- skos__broader mesh__D025681smesh__D000259
% 217.44/217.62  |- mesh__historyNote mesh__D025681
% 217.44/217.62       2002; for FOWL ADENOVIRUS 1 use AVIADENOVIRUS 1994-2001; for CELO VIRUS use AVIADENOVIRUS 1978-2001, use ADENOVIRUSES 1975-1976%A%  
% 217.44/217.62  |- skos__prefLabel mesh__D025681 Fowl adenovirus A
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D025681 2005A
% 217.44/217.62  |- skos__hiddenLabel mesh__D025681 CELO Viruses
% 217.44/217.62  |- mesh__dateEstablished mesh__D025681 2002-01-01
% 217.44/217.62  |- mesh__recordOriginator mesh__D025681 ags
% 217.44/217.62  |- skos__hiddenLabel mesh__D025681 Viruses, CELO
% 217.44/217.62  |- mesh__publicMeSHNote mesh__D025681
% 217.44/217.62       2002; for FOWL ADENOVIRUS 1 see AVIADENOVIRUS 1994-2001; for CELO VIRUS see AVIADENOVIRUS 1978-2001, see ADENOVIRUSES 1975-1976%A%  
% 217.44/217.62  |- mesh__dateRevised mesh__D025681 2004-07-27
% 217.44/217.62  |- mesh__dateCreated mesh__D025681 2001-07-25
% 217.44/217.62  |- mesh__recordMaintainer mesh__D025681 jls
% 217.44/217.62  |- skos__scopeNote mesh__D025681
% 217.44/217.62       The type species of the genus AVIADENOVIRUS, family ADENOVIRIDAE, an oncogenic virus of birds. This is also called CELO virus for chick embryo lethal orphan virus.%A%    
% 217.44/217.62  |- skos__annotation mesh__D025681
% 217.44/217.62       infection: coord IM with ADENOVIRIDAE INFECTIONS %28%IM%29%   
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D019644 2002
% 217.44/217.62  |- mesh__recordMaintainer mesh__D019644 SJN
% 217.44/217.62  |- mesh__recordAuthorizer mesh__D019644 SJN
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D019644 2004
% 217.44/217.62  |- skos__hiddenLabel mesh__D019644 Hip Replacements, Total
% 217.44/217.62  |- skos__historyNote mesh__D019644 Arthroplasty %28%1966-1979%29%
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D019644 2005
% 217.44/217.62  |- skos__related mesh__D019644smesh__D006622
% 217.44/217.62  |- skos__altLabel mesh__D019644 Arthroplasties, Hip Replacement
% 217.44/217.62  |- skos__altLabel mesh__D019644 Total Hip Replacement
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D019644 1999
% 217.44/217.62  |- skos__altLabel mesh__D019644 Replacement, Total Hip
% 217.44/217.62  |- skos__altLabel mesh__D019644 Replacement Arthroplasties, Hip
% 217.44/217.62  |- skos__historyNote mesh__D019644 Hip %28%1966-1979%29%
% 217.44/217.62  |- skos__hiddenLabel mesh__D019644 Hip Prosthesis Implantations
% 217.44/217.62  |- skos__hiddenLabel mesh__D019644 Implantations, Hip Prosthesis
% 217.44/217.62  |- skos__historyNote mesh__D019644 Hip Joint %28%1966-1979%29%
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D019644 2006
% 217.44/217.62  |- skos__hiddenLabel mesh__D019644 Prosthesis Implantation, Hip
% 217.44/217.62  |- mesh__dateEstablished mesh__D019644 1998-01-01
% 217.44/217.62  |- mesh__dateCreated mesh__D019644 1997-06-20
% 217.44/217.62  |- skos__hiddenLabel mesh__D019644 Prosthesis Implantations, Hip
% 217.44/217.62  |- rdf__type mesh__D019644sskos__Concept
% 217.44/217.62  |- skos__scopeNote mesh__D019644 Replacement of the hip joint.     
% 217.44/217.62  |- skos__altLabel mesh__D019644 Replacement Arthroplasty, Hip
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D019644 2000
% 217.44/217.62  |- mesh__recordOriginator mesh__D019644 PXP
% 217.44/217.62  |- skos__altLabel mesh__D019644 Hip Replacement Arthroplasty
% 217.44/217.62  |- skos__altLabel mesh__D019644 Arthroplasty, Hip Replacement
% 217.44/217.62  |- mesh__dateRevised mesh__D019644 1998-06-10
% 217.44/217.62  |- mesh__historyNote mesh__D019644 98; use HIP PROSTHESIS 1980-97   
% 217.44/217.62  |- skos__broader mesh__D019644smesh__D019643
% 217.44/217.62  |- skos__hiddenLabel mesh__D019644 Implantation, Hip Prosthesis
% 217.44/217.62  |- skos__altLabel mesh__D019644 Hip Replacement Arthroplasties
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D019644 2001
% 217.44/217.62  |- skos__hiddenLabel mesh__D019644 Replacements, Total Hip
% 217.44/217.62  |- mesh__publicMeSHNote mesh__D019644 98; see HIP PROSTHESIS 1980-97   
% 217.44/217.62  |- skos__historyNote mesh__D019644
% 217.44/217.62       Prostheses and Implants %28%1966-1970%29%
% 217.44/217.62  |- skos__annotation mesh__D019644
% 217.44/217.62       do not use /util except by MeSH definition; DF: ARTHROPLASTY REPLACE HIP%A%  
% 217.44/217.62  |- skos__hiddenLabel mesh__D019644 Total Hip Replacements
% 217.44/217.62  |- skos__altLabel mesh__D019644 Hip Prosthesis Implantation
% 217.44/217.62  |- skos__historyNote mesh__D019644 Joint Prosthesis %28%1971-1979%29%
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D019644 2003
% 217.44/217.62  |- skos__prefLabel mesh__D019644 Arthroplasty, Replacement, Hip
% 217.44/217.62  |- skos__historyNote mesh__D019644 Hip Prosthesis %28%1980-1997%29%
% 217.44/217.62  |- skos__altLabel mesh__D019644 Arthroplasties, Replacement, Hip
% 217.44/217.62  |- skos__altLabel mesh__D000939 Antigenic Determinants
% 217.44/217.62  |- rdf__type mesh__D000939sskos__Concept
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D000939 2006
% 217.44/217.62  |- skos__annotation mesh__D000939
% 217.44/217.62       X ref ANTIGENIC DETERMINANTS: do not confuse with genetic determinants %28% = GENES or specific%29%%A%  
% 217.44/217.62  |- skos__related mesh__D000939smesh__D018604
% 217.44/217.62  |- skos__related mesh__D000939smesh__D000888
% 217.44/217.62  |- skos__related mesh__D000939smesh__D000915
% 217.44/217.62  |- mesh__dateRevised mesh__D000939 2005-06-30
% 217.44/217.62  |- mesh__historyNote mesh__D000939
% 217.44/217.62       96; was ANTIGENIC DETERMINANTS 1970-95 %28%as Prov 1970-71%29%   
% 217.44/217.62  |- skos__historyNote mesh__D000939 Antigens %28%1966-1969%29%
% 217.44/217.62  |- mesh__dateCreated mesh__D000939 1999-01-01
% 217.44/217.62  |- skos__prefLabel mesh__D000939 Epitopes
% 217.44/217.62  |- mesh__recordOriginator mesh__D000939 NLM
% 217.44/217.62  |- skos__broader mesh__D000939smesh__D000941
% 217.44/217.62  |- mesh__publicMeSHNote mesh__D000939
% 217.44/217.62       96; was ANTIGENIC DETERMINANTS 1972-95   
% 217.44/217.62  |- skos__hiddenLabel mesh__D000939 Determinants, Antigenic
% 217.44/217.62  |- mesh__dateEstablished mesh__D000939 1972-01-01
% 217.44/217.62  |- skos__hiddenLabel mesh__D000939 Specificity, Antigenic
% 217.44/217.62  |- skos__scopeNote mesh__D000939
% 217.44/217.62       Sites on an antigen that interact with specific antibodies.%A%    
% 217.44/217.62  |- mesh__recordAuthorizer mesh__D000939 sjn
% 217.44/217.62  |- mesh__recordMaintainer mesh__D000939 ssb
% 217.44/217.62  |- skos__related mesh__D000939smesh__D018716
% 217.44/217.62  |- skos__altLabel mesh__D011661 Lung Stretch Receptors
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011661 2004
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011661 1995
% 217.44/217.62  |- skos__hiddenLabel mesh__D011661 Pulmonary Stretch Receptor
% 217.44/217.62  |- mesh__publicMeSHNote mesh__D011661
% 217.44/217.62       91; was see under MECHANORECEPTORS 1971-90   
% 217.44/217.62  |- skos__broader mesh__D011661smesh__D008465
% 217.44/217.62  |- skos__hiddenLabel mesh__D011661 Stretch Receptor, Lung
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011661 2005
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011661 2000
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011661 1996
% 217.44/217.62  |- mesh__recordMaintainer mesh__D011661 RAZ
% 217.44/217.62  |- skos__hiddenLabel mesh__D011661 Lung Stretch Receptor
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011661 2006
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011661 2001
% 217.44/217.62  |- skos__annotation mesh__D011661
% 217.44/217.62       mechanoreceptors in bronchi %26% bronchioles; DF: PULM STRETCH RECEPT%A%  
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011661 1997
% 217.44/217.62  |- mesh__recordAuthorizer mesh__D011661 PLS
% 217.44/217.62  |- mesh__dateEstablished mesh__D011661 1991-01-01
% 217.44/217.62  |- skos__altLabel mesh__D011661 Receptors, Stretch, Lung
% 217.44/217.62  |- skos__hiddenLabel mesh__D011661 Stretch Receptor, Pulmonary
% 217.44/217.62  |- skos__altLabel mesh__D011661 Stretch Receptors, Pulmonary
% 217.44/217.62  |- skos__hiddenLabel mesh__D011661 Receptor, Lung Stretch
% 217.44/217.62  |- skos__altLabel mesh__D011661 Stretch Receptors, Lung
% 217.44/217.62  |- skos__prefLabel mesh__D011661 Pulmonary Stretch Receptors
% 217.44/217.62  |- mesh__dateCreated mesh__D011661 1999-01-01
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011661 2002
% 217.44/217.62  |- rdf__type mesh__D011661sskos__Concept
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011661 1998
% 217.44/217.62  |- skos__scopeNote mesh__D011661
% 217.44/217.62       Stretch receptors found in the bronchi and bronchioles. Pulmonary stretch receptors are sensors for a reflex which stops inspiration. In humans, the reflex is protective and is probably not activated during normal respiration.%A%    
% 217.44/217.62  |- skos__hiddenLabel mesh__D011661 Receptors, Lung Stretch
% 217.44/217.62  |- mesh__historyNote mesh__D011661
% 217.44/217.62       91%28%71%29%; was see under MECHANORECEPTORS 1971-90   
% 217.44/217.62  |- skos__historyNote mesh__D011661 Lung/innervation %28%1966-1970%29%
% 217.44/217.62  |- mesh__dateRevised mesh__D011661 1993-06-18
% 217.44/217.62  |- skos__altLabel mesh__D011661 Receptors, Stretch, Pulmonary
% 217.44/217.62  |- mesh__recordOriginator mesh__D011661 NLM
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011661 2003
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011661 1994
% 217.44/217.62  |- skos__hiddenLabel mesh__D011661 Receptor, Pulmonary Stretch
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D011661 1999
% 217.44/217.62  |- skos__altLabel mesh__D011661 Receptors, Pulmonary Stretch
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D005624 1996
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D005624 2003
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D005624 1999
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D005624 2006
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D005624 1992
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D005624 1989
% 217.44/217.62  |- skos__hiddenLabel mesh__D005624 Frontal Bones
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D005624 1995
% 217.44/217.62  |- mesh__recordOriginator mesh__D005624 NLM
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D005624 2002
% 217.44/217.62  |- skos__prefLabel mesh__D005624 Frontal Bone
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D005624 1998
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D005624 2005
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D005624 1991
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D005624 1994
% 217.44/217.62  |- mesh__recordMaintainer mesh__D005624 GJB
% 217.44/217.62  |- skos__hiddenLabel mesh__D005624 Bone, Frontal
% 217.44/217.62  |- skos__annotation mesh__D005624
% 217.44/217.62       fractures: coord FRONTAL BONE /inj %28%IM%29% + SKULL FRACTURES %28%IM%29%; neopl: coord IM with SKULL NEOPLASMS %28%IM%29%%A%  
% 217.44/217.62  |- skos__hiddenLabel mesh__D005624 Bones, Frontal
% 217.44/217.62  |- mesh__dateRevised mesh__D005624 1979-01-10
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D005624 2001
% 217.44/217.62  |- mesh__recordAuthorizer mesh__D005624 MED
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D005624 1997
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D005624 2004
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D005624 1990
% 217.44/217.62  |- skos__broader mesh__D005624smesh__D012886
% 217.44/217.62  |- rdf__type mesh__D005624sskos__Concept
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D005624 2000
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D005624 1993
% 217.44/217.62  |- mesh__dateCreated mesh__D005624 1999-01-01
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D043743 2004
% 217.44/217.62  |- skos__hiddenLabel mesh__D043743 Ligase Complexes, Ubiquitin-Protein
% 217.44/217.62  |- mesh__activeMeSHYear mesh__D043743 2006
% 217.44/217.62  |- skos__scopeNote mesh__D043743
% 217.44/217.62       Complexes of enzymes that catalyze the covalent attachment of UBIQUITIN to other proteins by forming a peptide bond between the C-terminal GLYCINE of UBIQUITIN and the alpha-amino groups of LYSINE residues in the protein. The complexes play an important role in mediating the selective-degradation of short-lived and abnormal proteins. The complex of enzymes can be broken down into three components that involve activation of ubiquitin %28%UBIQUITIN-ACTIVATING ENZYMES%29%, conjugation of ubiquitin to the ligase complex %28%UBIQUITIN-CONJUGATING ENZYMES%29%, and ligation of ubiquitin to the substrate protein %28%UBIQUITIN-PROTEIN LIGASES%29%.%A%    
% 217.44/217.62  |- mesh__recordAuthorizer mesh__D043743 sjn
% 217.44/217.62  |- mesh__dateCreated mesh__D043743 2003-07-09
% 217.44/217.62  |- rdf__type mesh__D043743sskos__Concept
% 217.44/217.62  |- skos__annotation mesh__D043743
% 217.44/217.62       UBIQUITIN-PROTEIN LIGASES is also available   
% 217.44/217.63  |- mesh__historyNote mesh__D043743 2004   
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D043743 2005
% 217.44/217.63  |- skos__historyNote mesh__D043743 Ligases %28%1983-2003%29%
% 217.44/217.63  |- skos__broader mesh__D043743smesh__D008025
% 217.44/217.63  |- skos__hiddenLabel mesh__D043743 Ubiquitin Protein Ligase Complexes
% 217.44/217.63  |- skos__prefLabel mesh__D043743 Ubiquitin-Protein Ligase Complexes
% 217.44/217.63  |- mesh__recordOriginator mesh__D043743 AKE
% 217.44/217.63  |- mesh__recordMaintainer mesh__D043743 jmp
% 217.44/217.63  |- mesh__publicMeSHNote mesh__D043743 2004   
% 217.44/217.63  |- skos__hiddenLabel mesh__D043743 Complexes, Ubiquitin-Protein Ligase
% 217.44/217.63  |- mesh__dateEstablished mesh__D043743 2004-01-01
% 217.44/217.63  |- mesh__recordAuthorizer mesh__D010569 sjn
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D010569 2005
% 217.44/217.63  |- mesh__dateEstablished mesh__D010569 1991-01-01
% 217.44/217.63  |- rdf__type mesh__D010569sskos__Concept
% 217.44/217.63  |- mesh__publicMeSHNote mesh__D010569
% 217.44/217.63       91; was see under BENZANTHRACENES 1979-90   
% 217.44/217.63  |- mesh__recordOriginator mesh__D010569 SH
% 217.44/217.63  |- skos__broader mesh__D010569smesh__D001551
% 217.44/217.63  |- skos__altLabel mesh__D010569 Perilene
% 217.44/217.63  |- skos__hiddenLabel mesh__D010569 Peri Dinaphthalene
% 217.44/217.63  |- skos__prefLabel mesh__D010569 Perylene
% 217.44/217.63  |- skos__historyNote mesh__D010569
% 217.44/217.63       Polycyclic Hydrocarbons %28%1974-1978%29%
% 217.44/217.63  |- mesh__dateRevised mesh__D010569 2004-07-07
% 217.44/217.63  |- mesh__recordMaintainer mesh__D010569 ssb
% 217.44/217.63  |- skos__broader mesh__D010569smesh__D043803
% 217.44/217.63  |- skos__altLabel mesh__D010569 Peri-Dinaphthalene
% 217.44/217.63  |- skos__scopeNote mesh__D010569
% 217.44/217.63       A 20-carbon dibenz%28%de,kl%29%anthracene that can be viewed as a naphthalene fused to a phenalene or as dinaphthalene. It is used as fluorescent lipid probe in the cytochemistry of membranes and is a polycyclic hydrocarbon pollutant in soil and water. Derivatives may be carcinogenic.%A%    
% 217.44/217.63  |- mesh__dateCreated mesh__D010569 1978-05-03
% 217.44/217.63  |- skos__historyNote mesh__D010569 Benzanthracenes %28%1966-1978%29%
% 217.44/217.63  |- mesh__historyNote mesh__D010569
% 217.44/217.63       91%28%79%29%; was see under BENZANTHRACENES 1979-90   
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D010569 2006
% 217.44/217.63  |- skos__hiddenLabel mesh__D015254 Methyltransferases, DNA Modification
% 217.44/217.63  |- mesh__dateEstablished mesh__D015254 1989-01-01
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D015254 2006
% 217.44/217.63  |- mesh__dateRevised mesh__D015254 2003-07-09
% 217.44/217.63  |- skos__hiddenLabel mesh__D015254 Methylases, Modification
% 217.44/217.63  |- skos__hiddenLabel mesh__D015254 Modification Methylases, DNA
% 217.44/217.63  |- mesh__recordAuthorizer mesh__D015254 sjn
% 217.44/217.63  |- skos__hiddenLabel mesh__D015254 Methylases, DNA Modification
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D015254 2005
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D015254 2004
% 217.44/217.63  |- skos__historyNote mesh__D015254
% 217.44/217.63       DNA %28%Cytosine-5-%29%-Methyltransferase %28%1975-1988%29%
% 217.44/217.63  |- mesh__historyNote mesh__D015254 1989   
% 217.44/217.63  |- skos__prefLabel mesh__D015254 DNA Modification Methylases
% 217.44/217.63  |- skos__altLabel mesh__D015254 DNA Modification Methyltransferases
% 217.44/217.63  |- skos__historyNote mesh__D015254 Methyltransferases %28%1971-1988%29%
% 217.44/217.63  |- skos__hiddenLabel mesh__D015254 Modification Methyltransferases, DNA
% 217.44/217.63  |- skos__broader mesh__D015254smesh__D015280
% 217.44/217.63  |- skos__altLabel mesh__D015254 Modification Methylases
% 217.44/217.63  |- rdf__type mesh__D015254sskos__Concept
% 217.44/217.63  |- skos__broader mesh__D015254smesh__D008780
% 217.44/217.63  |- mesh__recordOriginator mesh__D015254 RLS
% 217.44/217.63  |- mesh__dateCreated mesh__D015254 1988-05-17
% 217.44/217.63  |- skos__scopeNote mesh__D015254
% 217.44/217.63       Enzymes that are part of the restriction-modification systems. They are responsible for producing a species-characteristic methylation pattern, on either adenine or cytosine residues, in a specific short base sequence in the host cell%27%s own DNA. This methylated sequence will occur many times in the host-cell DNA and remain intact for the lifetime of the cell. Any DNA from another species which gains entry into a living cell and lacks the characteristic methylation pattern will be recognized by the restriction endonucleases of similar specificity and destroyed by cleavage. Most have been studied in bacterial systems, but a few have been found in eukaryotic organisms.%A%    
% 217.44/217.63  |- mesh__recordMaintainer mesh__D015254 ssb
% 217.44/217.63  |- mesh__publicMeSHNote mesh__D015254 1989   
% 217.44/217.63  |- skos__broader mesh__D009217smesh__D009379
% 217.44/217.63  |- skos__broader mesh__D009217smesh__D012509
% 217.44/217.63  |- mesh__publicMeSHNote mesh__D009217
% 217.44/217.63       91,63-85; was see under SARCOMA 1986-90; was heading 1963-85%A%  
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D009217 2004
% 217.44/217.63  |- mesh__recordMaintainer mesh__D009217 KEV
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D009217 2001
% 217.44/217.63  |- skos__prefLabel mesh__D009217 Myosarcoma
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D009217 2003
% 217.44/217.63  |- mesh__dateRevised mesh__D009217 1995-06-08
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D009217 1999
% 217.44/217.63  |- skos__hiddenLabel mesh__D009217 Myosarcomas
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D009217 2000
% 217.44/217.63  |- mesh__dateEstablished mesh__D009217 1991-01-01
% 217.44/217.63  |- mesh__dateCreated mesh__D009217 1999-01-01
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D009217 1998
% 217.44/217.63  |- rdf__type mesh__D009217sskos__Concept
% 217.44/217.63  |- skos__annotation mesh__D009217
% 217.44/217.63       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 217.44/217.63  |- skos__scopeNote mesh__D009217
% 217.44/217.63       A general term for a malignant neoplasm derived from muscular tissue. %28%Stedman, 25th ed%29%%A%    
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D009217 2006
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D009217 1997
% 217.44/217.63  |- mesh__recordAuthorizer mesh__D009217 PLS
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D009217 2005
% 217.44/217.63  |- mesh__recordOriginator mesh__D009217 NLM
% 217.44/217.63  |- mesh__historyNote mesh__D009217
% 217.44/217.63       91%28%86%29%63; was see under SARCOMA 1986-90; was heading 1963-85%A%  
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D009217 1996
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D009217 2002
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D001234 2006
% 217.44/217.63  |- skos__annotation mesh__D001234
% 217.44/217.63       infection: coord IM with ASPERGILLOSIS %28%IM%29%   
% 217.44/217.63  |- skos__scopeNote mesh__D001234
% 217.44/217.63       An imperfect fungus causing smut or black mold of several fruits, vegetables, etc.%A%    
% 217.44/217.63  |- rdf__type mesh__D001234sskos__Concept
% 217.44/217.63  |- mesh__recordMaintainer mesh__D001234 SYSTEM
% 217.44/217.63  |- skos__prefLabel mesh__D001234 Aspergillus niger
% 217.44/217.63  |- mesh__recordOriginator mesh__D001234 NLM
% 217.44/217.63  |- mesh__publicMeSHNote mesh__D001234 78; see ASPERGILLUS 1975-77   
% 217.44/217.63  |- mesh__historyNote mesh__D001234 78%28%75%29%   
% 217.44/217.63  |- mesh__recordAuthorizer mesh__D001234 sjn
% 217.44/217.63  |- mesh__dateCreated mesh__D001234 1974-12-12
% 217.44/217.63  |- mesh__dateEstablished mesh__D001234 1978-01-01
% 217.44/217.63  |- mesh__dateRevised mesh__D001234 2005-06-30
% 217.44/217.63  |- skos__broader mesh__D001234smesh__D001230
% 217.44/217.63  |- skos__historyNote mesh__D001234 Aspergillus %28%1966-1974%29%
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D020199 2005
% 217.44/217.63  |- mesh__dateCreated mesh__D020199 1999-11-03
% 217.44/217.63  |- mesh__recordAuthorizer mesh__D020199 sjn
% 217.44/217.63  |- rdf__type mesh__D020199sskos__Concept
% 217.44/217.63  |- skos__altLabel mesh__D020199 Subdural Hematoma, Acute
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D020199 2006
% 217.44/217.63  |- mesh__dateRevised mesh__D020199 2004-07-07
% 217.44/217.63  |- mesh__historyNote mesh__D020199 2000   
% 217.44/217.63  |- skos__prefLabel mesh__D020199 Hematoma, Subdural, Acute
% 217.44/217.63  |- skos__hiddenLabel mesh__D020199 Hematomas, Acute Subdural
% 217.44/217.63  |- mesh__recordOriginator mesh__D020199 KEV
% 217.44/217.63  |- skos__historyNote mesh__D020199 Hematoma, Subdural %28%1965-1999%29%
% 217.44/217.63  |- skos__hiddenLabel mesh__D020199 Subdural Hematomas, Acute
% 217.44/217.63  |- skos__hiddenLabel mesh__D020199 Acute Subdural Hematomas
% 217.44/217.63  |- skos__hiddenLabel mesh__D020199 Acute Subdural Hematoma
% 217.44/217.63  |- skos__hiddenLabel mesh__D020199 Hematoma, Acute Subdural
% 217.44/217.63  |- skos__scopeNote mesh__D020199
% 217.44/217.63       Hemorrhage and accumulation of blood in the subdural space associated with the acute onset of neurologic deficits, usually following CRANIOCEREBRAL TRAUMA. Hematoma formation occurs most frequently over the lateral and superior aspects of a cerebral hemisphere, but may also occur in the posterior fossa and spinal canal. Clinical manifestations may include hemiparesis, SEIZURES, third nerve palsy %28%see OCULOMOTOR NERVE DISEASES%29%, mental status changes, and COMA. %28%From Adams et al., Principles of Neurology, 6th ed, p886%29%%A%    
% 217.44/217.63  |- skos__altLabel mesh__D020199 Hemorrhage, Subdural, Acute
% 217.44/217.63  |- mesh__recordMaintainer mesh__D020199 ags
% 217.44/217.63  |- mesh__dateEstablished mesh__D020199 2000-01-01
% 217.44/217.63  |- skos__broader mesh__D020199smesh__D006408
% 217.44/217.63  |- mesh__publicMeSHNote mesh__D020199 2000   
% 217.44/217.63  |- mesh__dateEstablished mesh__D025682 2002-01-01
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D025682 2002
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D025682 2006
% 217.44/217.63  |- rdf__type mesh__D025682sskos__Concept
% 217.44/217.63  |- skos__broader mesh__D025682smesh__D004267
% 217.44/217.63  |- skos__hiddenLabel mesh__D025682 Nanoviruses
% 217.44/217.63  |- skos__annotation mesh__D025682
% 217.44/217.63       coord IM with specific plant /virol %28%IM%29% if pertinent   
% 217.44/217.63  |- skos__broader mesh__D025682smesh__D010942
% 217.44/217.63  |- mesh__publicMeSHNote mesh__D025682 2002   
% 217.44/217.63  |- skos__broader mesh__D025682smesh__D014713
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D025682 2003
% 217.44/217.63  |- skos__scopeNote mesh__D025682
% 217.44/217.63       Unassigned genus of plant-infecting viruses containing multiple circular single-stranded DNA molecules. The type species is Subterranean clover stunt virus.%A%    
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D025682 2005
% 217.44/217.63  |- mesh__dateCreated mesh__D025682 2001-07-25
% 217.44/217.63  |- skos__historyNote mesh__D025682 Plant Viruses %28%1999-2001%29%
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D025682 2004
% 217.44/217.63  |- skos__prefLabel mesh__D025682 Nanovirus
% 217.44/217.63  |- mesh__historyNote mesh__D025682 2002   
% 217.44/217.63  |- skos__altLabel mesh__D019645 Arthroplasty, Knee Replacement
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D019645 2000
% 217.44/217.63  |- skos__historyNote mesh__D019645 Knee Prosthesis %28%1980-1997%29%
% 217.44/217.63  |- skos__altLabel mesh__D019645 Arthroplasties, Replacement, Knee
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D019645 1998
% 217.44/217.63  |- skos__altLabel mesh__D019645 Knee Replacement, Total
% 217.44/217.63  |- skos__prefLabel mesh__D019645 Arthroplasty, Replacement, Knee
% 217.44/217.63  |- skos__historyNote mesh__D019645
% 217.44/217.63       Prostheses and Implants %28%1966-1970%29%
% 217.44/217.63  |- skos__scopeNote mesh__D019645 Replacement of the knee joint.     
% 217.44/217.63  |- skos__altLabel mesh__D019645 Knee Replacement Arthroplasty
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D019645 2002
% 217.44/217.63  |- skos__hiddenLabel mesh__D019645 Total Knee Replacements
% 217.44/217.63  |- skos__historyNote mesh__D019645 Arthroplasty %28%1966-1979%29%
% 217.44/217.63  |- mesh__historyNote mesh__D019645
% 217.44/217.63       98; use KNEE PROSTHESIS 1980-97; for KNEE REPLACEMENT, TOTAL use KNEE PROSTHESIS 1992-97%A%  
% 217.44/217.63  |- skos__historyNote mesh__D019645 Knee %28%1966-1979%29%
% 217.44/217.63  |- skos__hiddenLabel mesh__D019645 Knee Replacements, Total
% 217.44/217.63  |- skos__historyNote mesh__D019645 Knee Joint %28%1966-1979%29%
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D019645 2006
% 217.44/217.63  |- skos__hiddenLabel mesh__D019645 Replacements, Total Knee
% 217.44/217.63  |- skos__historyNote mesh__D019645 Joint Prosthesis %28%1971-1979%29%
% 217.44/217.63  |- skos__altLabel mesh__D019645 Arthroplasties, Knee Replacement
% 217.44/217.63  |- mesh__dateEstablished mesh__D019645 1998-01-01
% 217.44/217.63  |- skos__altLabel mesh__D019645 Total Knee Replacement
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D019645 2005
% 217.44/217.63  |- skos__altLabel mesh__D019645 Replacement Arthroplasty, Knee
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D019645 2004
% 217.44/217.63  |- rdf__type mesh__D019645sskos__Concept
% 217.44/217.63  |- skos__altLabel mesh__D019645 Replacement, Total Knee
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D019645 2001
% 217.44/217.63  |- skos__broader mesh__D019645smesh__D019643
% 217.44/217.63  |- mesh__dateCreated mesh__D019645 1997-06-20
% 217.44/217.63  |- skos__altLabel mesh__D019645 Knee Replacement Arthroplasties
% 217.44/217.63  |- skos__related mesh__D019645smesh__D007720
% 217.44/217.63  |- skos__annotation mesh__D019645
% 217.44/217.63       do not use /util except by MeSH definition; DF: ARTHROPLASTY REPLACE KNEE%A%  
% 217.44/217.63  |- mesh__publicMeSHNote mesh__D019645
% 217.44/217.63       98; see KNEE PROSTHESIS 1980-97; for KNEE REPLACEMENT, TOTAL see KNEE PROSTHESIS 1992-97%A%  
% 217.44/217.63  |- skos__altLabel mesh__D019645 Replacement Arthroplasties, Knee
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D019645 2003
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D019645 1999
% 217.44/217.63  |- mesh__publicMeSHNote mesh__D011662
% 217.44/217.63       91; was see under CARDIOMYOPATHY, HYPERTROPHIC 1986-90; was see under IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1967-85%A%  
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D011662 2004
% 217.44/217.63  |- skos__altLabel mesh__D011662 Stenosis, Pulmonary Infundibular
% 217.44/217.63  |- skos__altLabel mesh__D011662 Stenosis, Pulmonary Subvalvular
% 217.44/217.63  |- skos__altLabel mesh__D011662 Pulmonary Stenoses, Subvalvular
% 217.44/217.63  |- skos__altLabel mesh__D011662 Subvalvular Pulmonary Stenosis
% 217.44/217.63  |- skos__altLabel mesh__D011662 Stenoses, Subvalvular Pulmonary
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D011662 2005
% 217.44/217.63  |- skos__altLabel mesh__D011662 Pulmonary Stenosis, Subvalvular
% 217.44/217.63  |- skos__altLabel mesh__D011662 Obstructive Subaortic Conus
% 217.44/217.63  |- skos__altLabel mesh__D011662 Pulmonary Infundibular Stenoses
% 217.44/217.63  |- skos__altLabel mesh__D011662 Infundibular Stenoses, Pulmonary
% 217.44/217.63  |- mesh__dateRevised mesh__D011662 2000-06-22
% 217.44/217.63  |- skos__annotation mesh__D011662
% 217.44/217.63       do not confuse with PULMONARY VALVE STENOSIS; if secondary to idiopathic hypertrophic subaortic stenosis, coordinate with CARDIOMYOPATHY, HYPERTROPHIC; DF: PULM SUBVALV STENOSIS%A%  
% 217.44/217.63  |- skos__altLabel mesh__D011662 Infundibular Stenosis, Pulmonary
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D011662 2006
% 217.44/217.63  |- skos__broader mesh__D011662smesh__D011666
% 217.44/217.63  |- skos__altLabel mesh__D011662 Subvalvular Pulmonary Stenoses
% 217.44/217.63  |- skos__altLabel mesh__D011662 Pulmonary Infundibular Stenosis
% 217.44/217.63  |- skos__hiddenLabel mesh__D011662 Subaortic Conus, Obstructive
% 217.44/217.63  |- mesh__historyNote mesh__D011662
% 217.44/217.63       91%28%75%29%; was see under CARDIOMYOPATHY, HYPERTROPHIC 1986-90; was see under IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1967-85%A%  
% 217.44/217.63  |- skos__hiddenLabel mesh__D011662 Conus, Obstructive Subaortic
% 217.44/217.63  |- skos__altLabel mesh__D011662 Stenoses, Pulmonary Infundibular
% 217.44/217.63  |- skos__altLabel mesh__D011662 Stenosis, Subvalvular Pulmonary
% 217.44/217.63  |- mesh__dateEstablished mesh__D011662 1991-01-01
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D011662 2001
% 217.44/217.63  |- mesh__dateCreated mesh__D011662 1999-01-01
% 217.44/217.63  |- skos__altLabel mesh__D011662 Subvalvular Stenosis, Pulmonary
% 217.44/217.63  |- rdf__type mesh__D011662sskos__Concept
% 217.44/217.63  |- mesh__recordMaintainer mesh__D011662 nns
% 217.44/217.63  |- skos__altLabel mesh__D011662 Stenoses, Pulmonary Subvalvular
% 217.44/217.63  |- skos__scopeNote mesh__D011662
% 217.44/217.63       Stenosis of the conus arteriosus %28%infundibulum%29% with or without involvement of the pulmonary valve. It is usually associated with a defect in the interventricular septum.%A%    
% 217.44/217.63  |- skos__prefLabel mesh__D011662 Pulmonary Subvalvular Stenosis
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D011662 2002
% 217.44/217.63  |- skos__altLabel mesh__D011662 Pulmonary Subvalvular Stenoses
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D011662 2003
% 217.44/217.63  |- mesh__recordAuthorizer mesh__D011662 sjn
% 217.44/217.63  |- skos__altLabel mesh__D011662 Subvalvular Stenoses, Pulmonary
% 217.44/217.63  |- mesh__recordOriginator mesh__D011662 NLM
% 217.44/217.63  |- mesh__onlineNote mesh__D011662
% 217.44/217.63       search CARDIOMYOPATHY, HYPERTROPHIC 1967-74   
% 217.44/217.63  |- skos__broader mesh__D005625smesh__D002540
% 217.44/217.63  |- skos__annotation mesh__D005625
% 217.44/217.63       dis: coord IM with BRAIN DISEASES %28%IM%29%; neopl: coord IM with BRAIN NEOPLASMS %28%IM%29%%A%  
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D005625 2003
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D005625 1999
% 217.44/217.63  |- skos__hiddenLabel mesh__D005625 Frontal Lobes
% 217.44/217.63  |- mesh__recordOriginator mesh__D005625 NLM
% 217.44/217.63  |- skos__hiddenLabel mesh__D005625 Area, Broca
% 217.44/217.63  |- skos__hiddenLabel mesh__D005625 Lobes, Frontal
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D005625 2002
% 217.44/217.63  |- skos__hiddenLabel mesh__D005625 Lobe, Frontal
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D005625 2006
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D005625 2005
% 217.44/217.63  |- mesh__recordAuthorizer mesh__D005625 SJN
% 217.44/217.63  |- skos__scopeNote mesh__D005625
% 217.44/217.63       The anterior part of the cerebral hemisphere.     
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D005625 2001
% 217.44/217.63  |- rdf__type mesh__D005625sskos__Concept
% 217.44/217.63  |- mesh__recordMaintainer mesh__D005625 MSR
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D005625 2000
% 217.44/217.63  |- skos__prefLabel mesh__D005625 Frontal Lobe
% 217.44/217.63  |- mesh__dateCreated mesh__D005625 1999-01-01
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D005625 2004
% 217.44/217.63  |- mesh__dateRevised mesh__D005625 1998-06-10
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D015255 2005
% 217.44/217.63  |- skos__hiddenLabel mesh__D015255 Hydrochloride, Idarubicin
% 217.44/217.63  |- skos__hiddenLabel mesh__D015255 NSC256439
% 217.44/217.63  |- skos__prefLabel mesh__D015255 Idarubicin
% 217.44/217.63  |- mesh__publicMeSHNote mesh__D015255 89   
% 217.44/217.63  |- mesh__dateEstablished mesh__D015255 1989-01-01
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D015255 2006
% 217.44/217.63  |- mesh__dateRevised mesh__D015255 2004-07-07
% 217.44/217.63  |- skos__hiddenLabel mesh__D015255 IMI 30
% 217.44/217.63  |- skos__historyNote mesh__D015255
% 217.44/217.63       Antibiotics, Antineoplastic %28%1967-1988%29%
% 217.44/217.63  |- skos__hiddenLabel mesh__D015255 4 Desmethoxydaunorubicin
% 217.44/217.63  |- skos__altLabel mesh__D015255 4-Demethoxydaunorubicin
% 217.44/217.63  |- skos__hiddenLabel mesh__D015255 NSC 256439
% 217.44/217.63  |- mesh__recordOriginator mesh__D015255 RLS
% 217.44/217.63  |- mesh__dateCreated mesh__D015255 1988-05-17
% 217.44/217.63  |- skos__hiddenLabel mesh__D015255 4 Demethoxydaunorubicin
% 217.44/217.63  |- skos__broader mesh__D015255smesh__D003630
% 217.44/217.63  |- rdf__type mesh__D015255sskos__Concept
% 217.44/217.63  |- skos__altLabel mesh__D015255 4-Desmethoxydaunorubicin
% 217.44/217.63  |- mesh__recordAuthorizer mesh__D015255 sjn
% 217.44/217.63  |- skos__historyNote mesh__D015255
% 217.44/217.63       Daunorubicin/analogs %26% derivatives %28%1975-1988%29%
% 217.44/217.63  |- skos__hiddenLabel mesh__D015255 IMI30
% 217.44/217.63  |- skos__scopeNote mesh__D015255
% 217.44/217.63       An orally administered anthracycline antineoplastic. The compound has shown activity against breast cancer, lymphomas and leukemias, together with the potential for reduced cardiac toxicity.%A%    
% 217.44/217.63  |- mesh__historyNote mesh__D015255 89   
% 217.44/217.63  |- mesh__recordMaintainer mesh__D015255 ssb
% 217.44/217.63  |- skos__altLabel mesh__D009218 Adenosine Triphosphatase, Myosin
% 217.44/217.63  |- skos__broader mesh__D009218smesh__D000251
% 217.44/217.63  |- skos__hiddenLabel mesh__D009218 Actin Activated ATPase
% 217.44/217.63  |- mesh__dateCreated mesh__D009218 1999-01-01
% 217.44/217.63  |- skos__historyNote mesh__D009218
% 217.44/217.63       Adenosine Triphosphatase %28%1966-1968%29%
% 217.44/217.63  |- skos__altLabel mesh__D009218 Adenosinetriphosphatase, Myosin
% 217.44/217.63  |- skos__altLabel mesh__D009218 Myosin ATPase
% 217.44/217.63  |- rdf__type mesh__D009218sskos__Concept
% 217.44/217.63  |- skos__altLabel mesh__D009218 Actomyosin ATPase
% 217.44/217.63  |- skos__historyNote mesh__D009218 Muscle Proteins %28%1966-1970%29%
% 217.44/217.63  |- mesh__publicMeSHNote mesh__D009218
% 217.44/217.63       2002; see MYOSIN 1973-2001, see MUSCLE PROTEINS 1969-1972; see ADENOSINE TRIPHOSPHATASE 1963-1968; for MYOSIN ATPASE see MYOSIN ATPASE 1993-2001, see ADENOSINE TRIPHOSPHATASE, MYOSIN 1989-1992, see ADENOSINE TRIPHOSPHATASE 1984-1988; for  ADENOSINE TRIPHOSPHATASE, MYOSIN %26% MYOSIN ADENOSINETRIPHOSPHATASE see MYOSIN ATPASE 1993-2001; for ACTOMYOSIN ADENOSINETRIPHOSPHATASE %26% ADENOSINETRIPHOSPHATASE, ACTOMYOSIN see MYOSIN ATPASE 1993-2001, see ADENOSINE TRIPHOSPHATASE, MYOSIN 1989-92; for ACTOMYOSIN ATPASE see MYOSIN ATPASE 1993-2001, see ADENOSINE TRIPHOSPHATASE, MYOSIN 1989-1992, see ADENOSINE TRIPHOSPHATASE 1985-1988%A%  
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D009218 2006
% 217.44/217.63  |- skos__altLabel mesh__D009218 Adenosinetriphosphatase, Actomyosin
% 217.44/217.63  |- mesh__dateRevised mesh__D009218 2005-06-30
% 217.44/217.63  |- mesh__recordOriginator mesh__D009218 NLM
% 217.44/217.63  |- mesh__historyNote mesh__D009218
% 217.44/217.63       2002%28%1971%29%; use ADENOSINE TRIPHOSPHATASE 1963-1968; for MYOSIN ATPASE use ADENOSINETRIPHOSPHATASE 1984-1988; for ACTOMYOSIN ATPASE use ADENOSINETRIPHOSPHATASE 1985-1988%A%  
% 217.44/217.63  |- skos__hiddenLabel mesh__D009218 ATPase, Actin Activated
% 217.44/217.63  |- skos__altLabel mesh__D009218 ATPase, Actin-Activated
% 217.44/217.63  |- skos__broader mesh__D009218smesh__D009124
% 217.44/217.63  |- skos__hiddenLabel mesh__D009218 Myosin Adenosine Triphosphatase
% 217.44/217.63  |- skos__altLabel mesh__D009218 Actin-Activated ATPase
% 217.44/217.63  |- skos__altLabel mesh__D009218 ATPase, Myosin
% 217.44/217.63  |- mesh__recordAuthorizer mesh__D009218 sjn
% 217.44/217.63  |- skos__altLabel mesh__D009218 Myosin Adenosinetriphosphatase
% 217.44/217.63  |- mesh__dateEstablished mesh__D009218 1973-01-01
% 217.44/217.63  |- skos__altLabel mesh__D009218 ATPase, Actomyosin
% 217.44/217.63  |- skos__annotation mesh__D009218 GEN or unspecified; prefer specifics   
% 217.44/217.63  |- skos__altLabel mesh__D009218 Myosin
% 217.44/217.63  |- skos__broader mesh__D009218smesh__D008840
% 217.44/217.63  |- skos__scopeNote mesh__D009218
% 217.44/217.63       A diverse superfamily of proteins that function as translocating proteins. They share the common characteristics of being able to bind ACTINS and hydrolyse MgATP. Myosins generally consist of heavy chains which are involved in locomotion, and light chains which are involved in regulation. Within the structure of myosin heavy chain are three domains: the head, the neck and the tail.  The head region of the heavy chain contains the actin binding domain and MgATPase domain which provides energy for locomotion. The neck region is involved in binding the light-chains. The tail region provides the anchoring point that maintains the position of the heavy chain. The superfamily of myosins is organized into structural classes based upon the type and arrangement of the subunits they contain.%A%    
% 217.44/217.63  |- mesh__recordMaintainer mesh__D009218 DRC
% 217.44/217.63  |- skos__prefLabel mesh__D009218 Myosins
% 217.44/217.63  |- skos__prefLabel mesh__D001235 Aspergillus ochraceus
% 217.44/217.63  |- mesh__recordAuthorizer mesh__D001235 sjn
% 217.44/217.63  |- rdf__type mesh__D001235sskos__Concept
% 217.44/217.63  |- mesh__recordMaintainer mesh__D001235 SYSTEM
% 217.44/217.63  |- mesh__dateRevised mesh__D001235 2005-06-30
% 217.44/217.63  |- mesh__dateEstablished mesh__D001235 1991-01-01
% 217.44/217.63  |- skos__scopeNote mesh__D001235
% 217.44/217.63       An imperfect fungus that produces ochratoxins and contaminates cereals and coffee beans.%A%    
% 217.44/217.63  |- mesh__historyNote mesh__D001235
% 217.44/217.63       91%28%86%29%; was see under ASPERGILLUS 1986-90   
% 217.44/217.63  |- mesh__publicMeSHNote mesh__D001235
% 217.44/217.63       91; was see under ASPERGILLUS 1986-90   
% 217.44/217.63  |- mesh__dateCreated mesh__D001235 1985-02-11
% 217.44/217.63  |- mesh__recordOriginator mesh__D001235 RC
% 217.44/217.63  |- skos__historyNote mesh__D001235 Aspergillus %28%1966-1985%29%
% 217.44/217.63  |- skos__broader mesh__D001235smesh__D001230
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D001235 2006
% 217.44/217.63  |- skos__historyNote mesh__D019646 Atmospheric Pressure %28%1966-1980%29%
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D019646 2001
% 217.44/217.63  |- mesh__dateCreated mesh__D019646 1997-06-20
% 217.44/217.63  |- skos__hiddenLabel mesh__D019646 Explosive Decompression
% 217.44/217.63  |- skos__broader mesh__D019646smesh__D003664
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D019646 2000
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D019646 2006
% 217.44/217.63  |- skos__scopeNote mesh__D019646
% 217.44/217.63       A sudden loss of pressure in a pressurized cabin, cockpit, or the like, so rapid as to be explosive. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%    
% 217.44/217.63  |- skos__historyNote mesh__D019646 Decompression %28%1981-1997%29%
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D019646 2004
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D019646 2005
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D019646 2002
% 217.44/217.63  |- rdf__type mesh__D019646sskos__Concept
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D019646 1999
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D019646 2003
% 217.44/217.63  |- mesh__historyNote mesh__D019646
% 217.44/217.63       98; use DECOMPRESSION 1981-97, use ATMOSPHERIC PRESSURE 1975-80; use DECOMPRESSION 1964-74%A%  
% 217.44/217.63  |- skos__prefLabel mesh__D019646 Decompression, Explosive
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D019646 1998
% 217.44/217.63  |- mesh__dateEstablished mesh__D019646 1998-01-01
% 217.44/217.63  |- mesh__publicMeSHNote mesh__D019646
% 217.44/217.63       98; see DECOMPRESSION 1981-97, see ATMOSPHERIC PRESSURE 1975-80%A%  
% 217.44/217.63  |- mesh__dateEstablished mesh__D011663 1973-01-01
% 217.44/217.63  |- mesh__recordAuthorizer mesh__D011663 sjn
% 217.44/217.63  |- skos__scopeNote mesh__D011663
% 217.44/217.63       Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI.%A%    
% 217.44/217.63  |- skos__prefLabel mesh__D011663 Pulmonary Surfactants
% 217.44/217.63  |- skos__broader mesh__D011663smesh__D019141
% 217.44/217.63  |- mesh__onlineNote mesh__D011663
% 217.44/217.63       use PULMONARY SURFACTANTS to search PULMONARY SURFACTANT 1971-86 %28%as Prov 1971-72%29%%A%  
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D011663 2006
% 217.44/217.63  |- mesh__dateCreated mesh__D011663 1999-01-01
% 217.44/217.63  |- mesh__historyNote mesh__D011663
% 217.44/217.63       87; was PULMONARY SURFACTANT 1971-86 %28%Prov 1971-72%29%   
% 217.44/217.63  |- skos__historyNote mesh__D011663 Pulmonary Alveoli %28%1966-1970%29%
% 217.44/217.63  |- skos__altLabel mesh__D011663 Surfactants, Pulmonary
% 217.44/217.63  |- mesh__publicMeSHNote mesh__D011663
% 217.44/217.63       87; was PULMONARY SURFACTANT 1973-86   
% 217.44/217.63  |- mesh__dateRevised mesh__D011663 2005-06-30
% 217.44/217.63  |- mesh__recordMaintainer mesh__D011663 ssb
% 217.44/217.63  |- skos__annotation mesh__D011663 DF: PULM SURFACTANTS   
% 217.44/217.63  |- skos__altLabel mesh__D011663 Pulmonary Surfactant
% 217.44/217.63  |- rdf__type mesh__D011663sskos__Concept
% 217.44/217.63  |- skos__historyNote mesh__D011663 Surface-Active Agents %28%1966-1970%29%
% 217.44/217.63  |- skos__altLabel mesh__D011663 Surfactant, Pulmonary
% 217.44/217.63  |- mesh__recordOriginator mesh__D011663 NLM
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D005626 2000
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D005626 1998
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D005626 2006
% 217.44/217.63  |- mesh__recordAuthorizer mesh__D005626 PLS
% 217.44/217.63  |- mesh__dateRevised mesh__D005626 1994-05-12
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D005626 1995
% 217.44/217.63  |- mesh__recordMaintainer mesh__D005626 PXP
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D005626 2005
% 217.44/217.63  |- mesh__recordOriginator mesh__D005626 NLM
% 217.44/217.63  |- skos__hiddenLabel mesh__D005626 Sinus, Frontal
% 217.44/217.63  |- skos__broader mesh__D005626smesh__D010256
% 217.44/217.63  |- skos__annotation mesh__D005626
% 217.44/217.63       inflammation or sinusitis = FRONTAL SINUSITIS; fractures: coord FRONTAL SINUS /inj %28%IM%29% + SKULL FRACTURES %28%IM%29%; neopl: coord IM with PARANASAL SINUS NEOPLASMS %28%IM%29%%A%  
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D005626 1997
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D005626 2002
% 217.44/217.63  |- rdf__type mesh__D005626sskos__Concept
% 217.44/217.63  |- skos__prefLabel mesh__D005626 Frontal Sinus
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D005626 1996
% 217.44/217.63  |- mesh__dateCreated mesh__D005626 1999-01-01
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D005626 2004
% 217.44/217.63  |- skos__scopeNote mesh__D005626
% 217.44/217.63       One of the paired, but seldom symmetrical, air spaces located between the inner and outer compact layers of the frontal bone.%A%    
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D005626 2003
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D005626 2001
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D005626 1999
% 217.44/217.63  |- mesh__dateCreated mesh__D048430 2004-07-07
% 217.44/217.63  |- skos__prefLabel mesh__D048430 Cell Shape
% 217.44/217.63  |- mesh__recordAuthorizer mesh__D048430 jls
% 217.44/217.63  |- mesh__recordMaintainer mesh__D048430 jls
% 217.44/217.63  |- skos__broader mesh__D048430smesh__D002468
% 217.44/217.63  |- skos__hiddenLabel mesh__D048430 Shape, Cell
% 217.44/217.63  |- skos__hiddenLabel mesh__D048430 Shapes, Cell
% 217.44/217.63  |- mesh__publicMeSHNote mesh__D048430 2005; see CELL SIZE 1993-2004   
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D048430 2005
% 217.44/217.63  |- mesh__dateEstablished mesh__D048430 2005-01-01
% 217.44/217.63  |- mesh__historyNote mesh__D048430 2005; use CELL SIZE 1993-2004   
% 217.44/217.63  |- skos__annotation mesh__D048430
% 217.44/217.63       not for microorganisms; coordinate with organ /cytol or /pathol or specific cell /cytol or /pathol%A%  
% 217.44/217.63  |- skos__scopeNote mesh__D048430
% 217.44/217.63       The quality of surface form or outline of CELLS.     
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D048430 2005A
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D048430 2006
% 217.44/217.63  |- mesh__recordOriginator mesh__D048430 nns
% 217.44/217.63  |- skos__historyNote mesh__D048430 Cell Size %28%1992-2004%29%
% 217.44/217.63  |- mesh__dateRevised mesh__D048430 2004-08-06
% 217.44/217.63  |- skos__hiddenLabel mesh__D048430 Cell Shapes
% 217.44/217.63  |- rdf__type mesh__D048430sskos__Concept
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D015256 2006
% 217.44/217.63  |- mesh__dateRevised mesh__D015256 2003-07-09
% 217.44/217.63  |- skos__altLabel mesh__D015256 Acyl-CoA-Transferases
% 217.44/217.63  |- mesh__historyNote mesh__D015256 89   
% 217.44/217.63  |- mesh__recordMaintainer mesh__D015256 ssb
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D015256 2004
% 217.44/217.63  |- skos__altLabel mesh__D015256 CoA-Transferases
% 217.44/217.63  |- skos__hiddenLabel mesh__D015256 Transferases, Coenzyme A
% 217.44/217.63  |- skos__hiddenLabel mesh__D015256 Acyl CoA Transferases
% 217.44/217.63  |- skos__altLabel mesh__D015256 Coenzyme A Transferases
% 217.44/217.63  |- rdf__type mesh__D015256sskos__Concept
% 217.44/217.63  |- skos__hiddenLabel mesh__D015256 A-Transferases, Coenzyme
% 217.44/217.63  |- skos__hiddenLabel mesh__D015256 Transferases, CoA
% 217.44/217.63  |- mesh__recordOriginator mesh__D015256 RLS
% 217.44/217.63  |- mesh__dateCreated mesh__D015256 1988-05-17
% 217.44/217.63  |- skos__historyNote mesh__D015256 Sulfurtransferases %28%1972-1988%29%
% 217.44/217.63  |- mesh__activeMeSHYear mesh__D015256 2005
% 217.44/217.63  |- skos__prefLabel mesh__D015256 Coenzyme A-Transferases
% 217.44/217.64  |- skos__altLabel mesh__D015256 CoA Transferases
% 217.44/217.64  |- skos__hiddenLabel mesh__D015256 A Transferases, Coenzyme
% 217.44/217.64  |- mesh__publicMeSHNote mesh__D015256 89   
% 217.44/217.64  |- skos__broader mesh__D015256smesh__D019885
% 217.44/217.64  |- mesh__recordAuthorizer mesh__D015256 sjn
% 217.44/217.64  |- mesh__dateEstablished mesh__D015256 1989-01-01
% 217.44/217.64  |- skos__scopeNote mesh__D015256
% 217.44/217.64       Enzymes which transfer coenzyme A moieties from acyl- or acetyl-CoA to various carboxylic acceptors forming a thiol ester. Enzymes in this group are instrumental in ketone body metabolism and utilization of acetoacetate in mitochondria. EC 2.8.3.%A%    
% 217.44/217.64  |- skos__historyNote mesh__D015256 Transferases %28%1966-1971%29%
% 217.44/217.64  |- mesh__recordMaintainer mesh__D009219 jmp
% 217.44/217.64  |- skos__prefLabel mesh__D009219 Myosin-Light-Chain Kinase
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D009219 2006
% 217.44/217.64  |- skos__hiddenLabel mesh__D009219 Myosin Regulatory Light Chain Kinase
% 217.44/217.64  |- mesh__historyNote mesh__D009219 87   
% 217.44/217.64  |- skos__altLabel mesh__D009219 Myosin Kinase
% 217.44/217.64  |- skos__annotation mesh__D009219 DF: MLCK   
% 217.44/217.64  |- skos__scopeNote mesh__D009219
% 217.44/217.64       An enzyme that phosphorylates myosin light chains in the presence of ATP to yield myosin-light chain phosphate and ADP, and requires calcium and calmodulin. The 20-kDa light chain is phosphorylated more rapidly than any other acceptor, but light chains from other myosins and myosin itself can act as acceptors. The enzyme plays a central role in the regulation of smooth muscle contraction.%A%    
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D009219 2005
% 217.44/217.64  |- skos__altLabel mesh__D009219 Myosin Regulatory Light-Chain Kinase
% 217.44/217.64  |- mesh__recordOriginator mesh__D009219 RLS
% 217.44/217.64  |- skos__hiddenLabel mesh__D009219 Kinase, Myosin-Light-Chain
% 217.44/217.64  |- mesh__dateCreated mesh__D009219 1986-06-16
% 217.44/217.64  |- mesh__dateEstablished mesh__D009219 1987-01-01
% 217.44/217.64  |- mesh__dateRevised mesh__D009219 2004-07-07
% 217.44/217.64  |- skos__altLabel mesh__D009219 Myosin LCK
% 217.44/217.64  |- mesh__publicMeSHNote mesh__D009219 87   
% 217.44/217.64  |- skos__hiddenLabel mesh__D009219 Myosin Light Chain Kinase
% 217.44/217.64  |- skos__historyNote mesh__D009219 Protein Kinases %28%1973-1986%29%
% 217.44/217.64  |- skos__historyNote mesh__D009219
% 217.44/217.64       Phosphotransferases, ATP %28%1966-1972%29%
% 217.44/217.64  |- skos__hiddenLabel mesh__D009219 LCK, Myosin
% 217.44/217.64  |- mesh__recordAuthorizer mesh__D009219 sjn
% 217.44/217.64  |- skos__hiddenLabel mesh__D009219 Kinase, Myosin
% 217.44/217.64  |- rdf__type mesh__D009219sskos__Concept
% 217.44/217.64  |- skos__broader mesh__D009219smesh__D017871
% 217.44/217.64  |- mesh__dateEstablished mesh__D001236 1991-01-01
% 217.44/217.64  |- mesh__recordMaintainer mesh__D001236 SYSTEM
% 217.44/217.64  |- mesh__dateRevised mesh__D001236 2005-06-30
% 217.44/217.64  |- skos__scopeNote mesh__D001236
% 217.44/217.64       An imperfect fungus present on most agricultural seeds and often responsible for the spoilage of seeds in bulk storage. It is also used in the production of fermented food or drink, especially in Japan.%A%    
% 217.44/217.64  |- skos__prefLabel mesh__D001236 Aspergillus oryzae
% 217.44/217.64  |- mesh__dateCreated mesh__D001236 1974-12-12
% 217.44/217.64  |- skos__broader mesh__D001236smesh__D001230
% 217.44/217.64  |- mesh__recordOriginator mesh__D001236 NLM
% 217.44/217.64  |- mesh__historyNote mesh__D001236 91%28%75%29%   
% 217.44/217.64  |- mesh__publicMeSHNote mesh__D001236 91; see ASPERGILLUS 1975-90   
% 217.44/217.64  |- mesh__recordAuthorizer mesh__D001236 sjn
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D001236 2006
% 217.44/217.64  |- rdf__type mesh__D001236sskos__Concept
% 217.44/217.64  |- mesh__publicMeSHNote mesh__D019647 98   
% 217.44/217.64  |- mesh__dateCreated mesh__D019647 1997-06-20
% 217.44/217.64  |- skos__altLabel mesh__D019647 Oral Surgical Procedure
% 217.44/217.64  |- mesh__dateEstablished mesh__D019647 1998-01-01
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D019647 2005
% 217.44/217.64  |- skos__scopeNote mesh__D019647
% 217.44/217.64       Procedures used to treat disease, injuries, and defects of the oral and maxillofacial region.%A%    
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D019647 2000
% 217.44/217.64  |- skos__hiddenLabel mesh__D019647 Procedure, Maxillofacial
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D019647 2006
% 217.44/217.64  |- skos__historyNote mesh__D019647 Surgery, Oral %28%1966-1997%29%
% 217.44/217.64  |- skos__altLabel mesh__D019647 Procedure, Oral Surgical
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D019647 2003
% 217.44/217.64  |- mesh__historyNote mesh__D019647 98   
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D019647 2001
% 217.44/217.64  |- skos__altLabel mesh__D019647 Surgical Procedures, Oral
% 217.44/217.64  |- skos__altLabel mesh__D019647 Surgical Procedure, Oral
% 217.44/217.64  |- skos__broader mesh__D019647smesh__D003813
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D019647 2004
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D019647 1998
% 217.44/217.64  |- skos__hiddenLabel mesh__D019647 Maxillofacial Procedure
% 217.44/217.64  |- rdf__type mesh__D019647sskos__Concept
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D019647 2002
% 217.44/217.64  |- skos__related mesh__D019647smesh__D013515
% 217.44/217.64  |- skos__altLabel mesh__D019647 Procedures, Oral Surgical
% 217.44/217.64  |- skos__broader mesh__D019647smesh__D013514
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D019647 1999
% 217.44/217.64  |- skos__hiddenLabel mesh__D019647 Procedures, Maxillofacial
% 217.44/217.64  |- skos__prefLabel mesh__D019647 Oral Surgical Procedures
% 217.44/217.64  |- skos__annotation mesh__D011664
% 217.44/217.64       dis: coord IM with HEART VALVE DISEASES %28%NIM%29% but note specific pulm valve dis; DF: PULM VALVE%A%  
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011664 2005
% 217.44/217.64  |- skos__altLabel mesh__D011664 Valves, Pulmonary
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011664 2001
% 217.44/217.64  |- mesh__dateCreated mesh__D011664 1999-01-01
% 217.44/217.64  |- skos__broader mesh__D011664smesh__D006351
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011664 2006
% 217.44/217.64  |- skos__altLabel mesh__D011664 Valve, Pulmonary
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011664 2003
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011664 1998
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011664 2002
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011664 2004
% 217.44/217.64  |- mesh__recordAuthorizer mesh__D011664 SJN
% 217.44/217.64  |- mesh__dateRevised mesh__D011664 1997-06-20
% 217.44/217.64  |- rdf__type mesh__D011664sskos__Concept
% 217.44/217.64  |- skos__prefLabel mesh__D011664 Pulmonary Valve
% 217.44/217.64  |- mesh__recordOriginator mesh__D011664 NLM
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011664 1999
% 217.44/217.64  |- skos__altLabel mesh__D011664 Pulmonary Valves
% 217.44/217.64  |- skos__scopeNote mesh__D011664
% 217.44/217.64       A valve situated at the entrance to the pulmonary trunk from the right ventricle.%A%    
% 217.44/217.64  |- mesh__recordMaintainer mesh__D011664 TGC
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011664 2000
% 217.44/217.64  |- skos__hiddenLabel mesh__D038801 Code, ICD
% 217.44/217.64  |- skos__altLabel mesh__D038801
% 217.44/217.64       International Statistical Classification of Diseases and Related Health Problems
% 217.44/217.64  |- mesh__publicMeSHNote mesh__D038801 2003   
% 217.44/217.64  |- skos__hiddenLabel mesh__D038801 Codes, ICD
% 217.44/217.64  |- skos__prefLabel mesh__D038801 International Classification of Diseases
% 217.44/217.64  |- mesh__dateCreated mesh__D038801 2002-07-03
% 217.44/217.64  |- mesh__recordMaintainer mesh__D038801 sjn
% 217.44/217.64  |- skos__scopeNote mesh__D038801
% 217.44/217.64       A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization %28%From ICD-10, p1%29%. The Clinical Modifications, produced by the UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S.%A%    
% 217.44/217.64  |- mesh__recordAuthorizer mesh__D038801 sjn
% 217.44/217.64  |- skos__altLabel mesh__D038801
% 217.44/217.64       International Classification of Disease Codes
% 217.44/217.64  |- skos__annotation mesh__D038801
% 217.44/217.64       CATALOG: use NAF entry for specific work   
% 217.44/217.64  |- skos__hiddenLabel mesh__D038801 ICD Code
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D038801 2006
% 217.44/217.64  |- mesh__recordOriginator mesh__D038801 ags
% 217.44/217.64  |- rdf__type mesh__D038801sskos__Concept
% 217.44/217.64  |- skos__broader mesh__D038801smesh__D018875
% 217.44/217.64  |- mesh__historyNote mesh__D038801 2003   
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D038801 2005
% 217.44/217.64  |- mesh__dateRevised mesh__D038801 2004-07-13
% 217.44/217.64  |- mesh__dateEstablished mesh__D038801 2003-01-01
% 217.44/217.64  |- skos__hiddenLabel mesh__D005627 Frostbites
% 217.44/217.64  |- mesh__recordMaintainer mesh__D005627 nns
% 217.44/217.64  |- rdf__type mesh__D005627sskos__Concept
% 217.44/217.64  |- mesh__dateCreated mesh__D005627 1999-01-01
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D005627 2004
% 217.44/217.64  |- skos__prefLabel mesh__D005627 Frostbite
% 217.44/217.64  |- mesh__dateRevised mesh__D005627 2002-07-03
% 217.44/217.64  |- skos__broader mesh__D005627smesh__D014947
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D005627 2003
% 217.44/217.64  |- mesh__recordAuthorizer mesh__D005627 sjn
% 217.44/217.64  |- skos__scopeNote mesh__D005627
% 217.44/217.64       Damage to tissues as the result of low environmental temperatures.%A%    
% 217.44/217.64  |- mesh__recordOriginator mesh__D005627 NLM
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D005627 2006
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D005627 2005
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D030020 2004
% 217.44/217.64  |- skos__annotation mesh__D030020
% 217.44/217.64       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.44/217.64  |- mesh__dateEstablished mesh__D030020 2002-01-01
% 217.44/217.64  |- skos__scopeNote mesh__D030020
% 217.44/217.64       A plant species of the family AQUIFOLIACEAE.  It has been used to induce vomiting in purification rites.%A%    
% 217.44/217.64  |- rdf__type mesh__D030020sskos__Concept
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D030020 2005
% 217.44/217.64  |- skos__altLabel mesh__D030020 Yaupon
% 217.44/217.64  |- mesh__publicMeSHNote mesh__D030020 2002   
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D030020 2002
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D030020 2006
% 217.44/217.64  |- mesh__dateCreated mesh__D030020 2001-07-25
% 217.44/217.64  |- skos__broader mesh__D030020smesh__D030017
% 217.44/217.64  |- mesh__historyNote mesh__D030020 2002   
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D030020 2003
% 217.44/217.64  |- skos__prefLabel mesh__D030020 Ilex vomitoria
% 217.44/217.64  |- skos__altLabel mesh__D015257
% 217.44/217.64       DNA Modification Methylases %28%Cytosine-Specific%29%
% 217.44/217.64  |- skos__altLabel mesh__D015257 DNA-Cytosine Methylases
% 217.44/217.64  |- rdf__type mesh__D015257sskos__Concept
% 217.44/217.64  |- skos__broader mesh__D015257smesh__D015254
% 217.44/217.64  |- skos__hiddenLabel mesh__D015257 Methylases, DNA Cytosine
% 217.44/217.64  |- skos__altLabel mesh__D015257 DNA Cytosine Methylases
% 217.44/217.64  |- skos__hiddenLabel mesh__D015257 Cytosine Methylases, DNA
% 217.44/217.64  |- skos__altLabel mesh__D015257
% 217.44/217.64       Site-Specific Methyltransferases %28%Cytosine-Specific%29%
% 217.44/217.64  |- skos__altLabel mesh__D015257
% 217.44/217.64       Modification Methylases %28%Cytosine Specific%29%
% 217.44/217.64  |- mesh__recordAuthorizer mesh__D015257 sjn
% 217.44/217.64  |- skos__altLabel mesh__D015257
% 217.44/217.64       Site Specific Methyltransferases %28%Cytosine Specific%29%
% 217.44/217.64  |- skos__historyNote mesh__D015257
% 217.44/217.64       DNA %28%Cytosine-5-%29%-Methyltransferase %28%1975-88%29%
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D015257 2005
% 217.44/217.64  |- skos__annotation mesh__D015257
% 217.44/217.64       do not confuse with DNA %28%CYTOSINE-5-%29%-METHYLTRANSFERASE   
% 217.44/217.64  |- skos__altLabel mesh__D015257
% 217.44/217.64       DNA Modification Methylases Cytosine Specific
% 217.44/217.64  |- mesh__recordMaintainer mesh__D015257 ssb
% 217.44/217.64  |- skos__altLabel mesh__D015257
% 217.44/217.64       Modification Methylases %28%Cytosine-Specific%29%
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D015257 2006
% 217.44/217.64  |- mesh__dateEstablished mesh__D015257 1989-01-01
% 217.44/217.64  |- skos__historyNote mesh__D015257 Methyltransferases %28%1971-1988%29%
% 217.44/217.64  |- skos__scopeNote mesh__D015257
% 217.44/217.64       An enzyme responsible for producing a species-characteristic methylation pattern on cytosine residues in a specific short base sequence in the host cell%27%s DNA. The enzyme catalyzes the methylation of DNA cytosine in the presence of S-adenosyl-L-methionine to form S-adenosyl-L-homocysteine and DNA containing 5-methylcytosine. EC 2.1.1.73.%A%    
% 217.44/217.64  |- mesh__dateRevised mesh__D015257 2003-07-09
% 217.44/217.64  |- skos__prefLabel mesh__D015257
% 217.44/217.64       Site-Specific DNA Methyltransferase %28%Cytosine-Specific%29%
% 217.44/217.64  |- skos__hiddenLabel mesh__D015257 Methylases, DNA-Cytosine
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D015257 2004
% 217.44/217.64  |- mesh__historyNote mesh__D015257 98%28%89%29%   
% 217.44/217.64  |- mesh__recordOriginator mesh__D015257 RLS
% 217.44/217.64  |- mesh__publicMeSHNote mesh__D015257
% 217.44/217.64       98; see DNA MODIFICATION METHYLASES %28%CYTOSINE-SPECIFIC%29% 1989-97%A%  
% 217.44/217.64  |- mesh__dateCreated mesh__D015257 1988-05-17
% 217.44/217.64  |- skos__scopeNote mesh__D001237
% 217.44/217.64       A pathological condition caused by lack of oxygen, manifested in impending or actual cessation of life.%A%    
% 217.44/217.64  |- skos__altLabel mesh__D001237 Suffocation
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D001237 2000
% 217.44/217.64  |- mesh__recordOriginator mesh__D001237 NLM
% 217.44/217.64  |- mesh__recordMaintainer mesh__D001237 KEV
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D001237 2001
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D001237 2003
% 217.44/217.64  |- mesh__recordAuthorizer mesh__D001237 sjn
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D001237 2002
% 217.44/217.64  |- mesh__dateCreated mesh__D001237 1999-01-01
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D001237 2004
% 217.44/217.64  |- skos__hiddenLabel mesh__D001237 Asphyxias
% 217.44/217.64  |- skos__broader mesh__D001237smesh__D014947
% 217.44/217.64  |- skos__hiddenLabel mesh__D001237 Suffocations
% 217.44/217.64  |- skos__annotation mesh__D001237
% 217.44/217.64       in newborn inf = ASPHYXIA NEONATORUM + tag INFANT, NEWBORN; choking: use AIRWAY OBSTRUCTION%A%  
% 217.44/217.64  |- mesh__dateRevised mesh__D001237 1999-11-08
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D001237 2005
% 217.44/217.64  |- skos__broader mesh__D001237smesh__D003643
% 217.44/217.64  |- skos__prefLabel mesh__D001237 Asphyxia
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D001237 2006
% 217.44/217.64  |- rdf__type mesh__D001237sskos__Concept
% 217.44/217.64  |- skos__broader mesh__D006720smesh__D005838
% 217.44/217.64  |- skos__scopeNote mesh__D006720
% 217.44/217.64       An individual in which both alleles at a given locus are identical.%A%    
% 217.44/217.64  |- skos__historyNote mesh__D006720 Genetics %28%1966-1967%29%
% 217.44/217.64  |- mesh__dateRevised mesh__D006720 2002-07-03
% 217.44/217.64  |- mesh__dateEstablished mesh__D006720 1968-01-01
% 217.44/217.64  |- skos__prefLabel mesh__D006720 Homozygote
% 217.44/217.64  |- mesh__publicMeSHNote mesh__D006720 68   
% 217.44/217.64  |- rdf__type mesh__D006720sskos__Concept
% 217.44/217.64  |- skos__hiddenLabel mesh__D006720 Homozygotes
% 217.44/217.64  |- mesh__historyNote mesh__D006720 68   
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D006720 2004
% 217.44/217.64  |- mesh__recordAuthorizer mesh__D006720 sjn
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D006720 2006
% 217.44/217.64  |- mesh__dateCreated mesh__D006720 1999-01-01
% 217.44/217.64  |- mesh__recordMaintainer mesh__D006720 TGC
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D006720 2003
% 217.44/217.64  |- mesh__recordOriginator mesh__D006720 NLM
% 217.44/217.64  |- skos__annotation mesh__D006720 no qualif   
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D006720 2005
% 217.44/217.64  |- skos__historyNote mesh__D006720 Genes %28%1966-1967%29%
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D019648 2006
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D019648 2003
% 217.44/217.64  |- skos__annotation mesh__D019648
% 217.44/217.64       GEN or unspecified; prefer specific groups   
% 217.44/217.64  |- mesh__historyNote mesh__D019648 98   
% 217.44/217.64  |- mesh__publicMeSHNote mesh__D019648 98   
% 217.44/217.64  |- mesh__dateCreated mesh__D019648 1997-06-20
% 217.44/217.64  |- skos__hiddenLabel mesh__D019648 Specialized Foods
% 217.44/217.64  |- rdf__type mesh__D019648sskos__Concept
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D019648 2004
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D019648 1998
% 217.44/217.64  |- mesh__dateEstablished mesh__D019648 1998-01-01
% 217.44/217.64  |- skos__broader mesh__D019648smesh__D005502
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D019648 2000
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D019648 1999
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D019648 2001
% 217.44/217.64  |- skos__prefLabel mesh__D019648 Foods, Specialized
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D019648 2002
% 217.44/217.64  |- skos__hiddenLabel mesh__D019648 Food, Specialized
% 217.44/217.64  |- skos__hiddenLabel mesh__D019648 Specialized Food
% 217.44/217.64  |- skos__scopeNote mesh__D019648
% 217.44/217.64       Foods and beverages prepared for use to meet specific needs such as infant foods.%A%    
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D019648 2005
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011665 1994
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011665 2002
% 217.44/217.64  |- mesh__dateEstablished mesh__D011665 1967-01-01
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011665 1997
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011665 2006
% 217.44/217.64  |- skos__altLabel mesh__D011665 Pulmonary Insufficiency
% 217.44/217.64  |- skos__altLabel mesh__D011665 Valve Regurgitation, Pulmonary
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011665 1993
% 217.44/217.64  |- rdf__type mesh__D011665sskos__Concept
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011665 1996
% 217.44/217.64  |- skos__altLabel mesh__D011665 Valve Insufficiency, Pulmonary
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011665 2005
% 217.44/217.64  |- skos__altLabel mesh__D011665 Insufficiency, Pulmonary Valve
% 217.44/217.64  |- skos__altLabel mesh__D011665 Valve Incompetence, Pulmonary
% 217.44/217.64  |- skos__altLabel mesh__D011665 Incompetence, Pulmonary Valve
% 217.44/217.64  |- skos__scopeNote mesh__D011665
% 217.44/217.64       Backflow of blood from the pulmonary artery into the right ventricle, owing to imperfect functioning of the pulmonary valve.%A%    
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011665 2001
% 217.44/217.64  |- skos__altLabel mesh__D011665 Pulmonary Valve Incompetence
% 217.44/217.64  |- skos__altLabel mesh__D011665 Pulmonary Regurgitation
% 217.44/217.64  |- skos__annotation mesh__D011665
% 217.44/217.64       imperfect closing of valve; DF: PULM VALVE INSUFFICIENCY   
% 217.44/217.64  |- skos__altLabel mesh__D011665 Pulmonary Incompetence
% 217.44/217.64  |- skos__altLabel mesh__D011665 Insufficiency, Pulmonary
% 217.44/217.64  |- mesh__historyNote mesh__D011665 67   
% 217.44/217.64  |- skos__altLabel mesh__D011665 Regurgitation, Pulmonary Valve
% 217.44/217.64  |- skos__altLabel mesh__D011665 Regurgitation, Pulmonary
% 217.44/217.64  |- mesh__dateRevised mesh__D011665 1992-05-22
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011665 1999
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011665 2000
% 217.44/217.64  |- skos__altLabel mesh__D011665 Pulmonary Valve Regurgitation
% 217.44/217.64  |- skos__broader mesh__D011665smesh__D006349
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011665 2004
% 217.44/217.64  |- mesh__dateCreated mesh__D011665 1999-01-01
% 217.44/217.64  |- skos__historyNote mesh__D011665 Heart Diseases %28%1966%29%
% 217.44/217.64  |- mesh__recordOriginator mesh__D011665 NLM
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011665 1995
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011665 1998
% 217.44/217.64  |- skos__historyNote mesh__D011665 Pulmonary Valve %28%1966%29%
% 217.44/217.64  |- skos__prefLabel mesh__D011665 Pulmonary Valve Insufficiency
% 217.44/217.64  |- mesh__publicMeSHNote mesh__D011665 67   
% 217.44/217.64  |- mesh__recordAuthorizer mesh__D011665 PLS
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D011665 2003
% 217.44/217.64  |- skos__altLabel mesh__D011665 Incompetence, Pulmonary
% 217.44/217.64  |- mesh__recordMaintainer mesh__D011665 PLS
% 217.44/217.64  |- mesh__dateRevised mesh__D005628 1997-06-20
% 217.44/217.64  |- mesh__dateCreated mesh__D005628 1999-01-01
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D005628 2002
% 217.44/217.64  |- mesh__recordMaintainer mesh__D005628 JLS
% 217.44/217.64  |- skos__hiddenLabel mesh__D005628 Foods, Frozen
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D005628 2004
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D005628 2003
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D005628 1999
% 217.44/217.64  |- mesh__historyNote mesh__D005628
% 217.44/217.64       91%28%64%29%; was see under FOOD PRESERVATION 1964-90 %28%Prov 1964-67%29%%A%  
% 217.44/217.64  |- mesh__recordAuthorizer mesh__D005628 SJN
% 217.44/217.64  |- skos__prefLabel mesh__D005628 Frozen Foods
% 217.44/217.64  |- mesh__onlineNote mesh__D005628
% 217.44/217.64       use FOOD PRESERVATION to search FROZEN FOODS 1966-74   
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D005628 2001
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D005628 1998
% 217.44/217.64  |- mesh__publicMeSHNote mesh__D005628
% 217.44/217.64       91; was see under FOOD PRESERVATION 1968-90   
% 217.44/217.64  |- skos__altLabel mesh__D005628 Food, Frozen
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D005628 2006
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D005628 2000
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D005628 2005
% 217.44/217.64  |- skos__broader mesh__D005628smesh__D005519
% 217.44/217.64  |- skos__hiddenLabel mesh__D005628 Frozen Food
% 217.44/217.64  |- mesh__recordOriginator mesh__D005628 NLM
% 217.44/217.64  |- mesh__dateEstablished mesh__D005628 1991-01-01
% 217.44/217.64  |- rdf__type mesh__D005628sskos__Concept
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D016350 2005
% 217.44/217.64  |- skos__historyNote mesh__D016350 Amino Acid Sequence %28%1989-1990%29%
% 217.44/217.64  |- skos__broader mesh__D016350smesh__D020816
% 217.44/217.64  |- skos__hiddenLabel mesh__D016350 Leucine Zipper
% 217.44/217.64  |- skos__prefLabel mesh__D016350 Leucine Zippers
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D016350 2006
% 217.44/217.64  |- mesh__recordOriginator mesh__D016350 PXP
% 217.44/217.64  |- mesh__recordMaintainer mesh__D016350 nns
% 217.44/217.64  |- mesh__historyNote mesh__D016350 91   
% 217.44/217.64  |- skos__scopeNote mesh__D016350
% 217.44/217.64       DNA-binding motifs formed from two alpha-helixes which intertwine for about eight turns into a coiled coil and then bifurcate to form Y shaped structures. Leucines occurring in heptad repeats end up on the same sides of the helixes and are adjacent to each other in the stem of the Y %28%the %22%zipper%22% region%29%. The DNA-binding residues are located in the bifurcated region of the Y.%A%    
% 217.44/217.64  |- mesh__dateCreated mesh__D016350 1990-05-29
% 217.44/217.64  |- skos__historyNote mesh__D016350
% 217.44/217.64       Molecular Sequence Data %28%1989-1990%29%
% 217.44/217.64  |- mesh__recordAuthorizer mesh__D016350 sjn
% 217.44/217.64  |- rdf__type mesh__D016350sskos__Concept
% 217.44/217.64  |- skos__hiddenLabel mesh__D016350 Zipper, Leucine
% 217.44/217.64  |- mesh__dateRevised mesh__D016350 2004-07-07
% 217.44/217.64  |- skos__historyNote mesh__D016350 DNA-Binding Proteins %28%1989-1990%29%
% 217.44/217.64  |- skos__hiddenLabel mesh__D016350 Zippers, Leucine
% 217.44/217.64  |- mesh__publicMeSHNote mesh__D016350 91   
% 217.44/217.64  |- mesh__dateEstablished mesh__D016350 1991-01-01
% 217.44/217.64  |- skos__altLabel mesh__D030021 Ban Xia
% 217.44/217.64  |- mesh__dateEstablished mesh__D030021 2002-01-01
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D030021 2005
% 217.44/217.64  |- mesh__publicMeSHNote mesh__D030021 2002   
% 217.44/217.64  |- skos__scopeNote mesh__D030021
% 217.44/217.64       A plant genus of the family ARACEAE that contains pinellian %28%an acidic polysaccharide%29%.  The plant is an ingredient of some traditional Asian medicinal mixtures including sho-saiko-to, saiko-keishi-to, and banxia houpu decoction.%A%    
% 217.44/217.64  |- mesh__dateCreated mesh__D030021 2001-07-25
% 217.44/217.64  |- skos__broader mesh__D030021smesh__D029064
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D030021 2006
% 217.44/217.64  |- mesh__historyNote mesh__D030021 2002   
% 217.44/217.64  |- mesh__recordAuthorizer mesh__D030021 sjn
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D030021 2003
% 217.44/217.64  |- mesh__recordOriginator mesh__D030021 ssb
% 217.44/217.64  |- skos__altLabel mesh__D030021 Banha
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D030021 2004
% 217.44/217.64  |- mesh__recordMaintainer mesh__D030021 ssb
% 217.44/217.64  |- rdf__type mesh__D030021sskos__Concept
% 217.44/217.64  |- skos__prefLabel mesh__D030021 Pinellia
% 217.44/217.64  |- mesh__dateRevised mesh__D030021 2002-07-02
% 217.44/217.64  |- skos__annotation mesh__D030021
% 217.44/217.64       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.44/217.64  |- skos__historyNote mesh__D002330 Nitroso Compounds %28%1966-1971%29%
% 217.44/217.64  |- skos__altLabel mesh__D002330
% 217.44/217.64       N,N%27%-Bis%28%2-Chloroethyl%29%-N-Nitrosourea
% 217.44/217.64  |- skos__altLabel mesh__D002330 FIVB
% 217.44/217.64  |- mesh__dateEstablished mesh__D002330 1973-01-01
% 217.44/217.64  |- skos__broader mesh__D002330smesh__D009607
% 217.44/217.64  |- mesh__recordMaintainer mesh__D002330 jmp
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D002330 2006
% 217.44/217.64  |- skos__scopeNote mesh__D002330
% 217.44/217.64       A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p462%29% This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%. %28%From Merck Index, 11th ed%29%%A%    
% 217.44/217.64  |- mesh__recordAuthorizer mesh__D002330 sjn
% 217.44/217.64  |- mesh__dateRevised mesh__D002330 2005-06-30
% 217.44/217.64  |- mesh__dateCreated mesh__D002330 1999-01-01
% 217.44/217.64  |- skos__altLabel mesh__D002330 1,3-Bis%28%2-Chloroethyl%29%-1-Nitrosourea
% 217.44/217.64  |- skos__prefLabel mesh__D002330 Carmustine
% 217.44/217.64  |- mesh__historyNote mesh__D002330 73%28%72%29%   
% 217.44/217.64  |- mesh__publicMeSHNote mesh__D002330 73   
% 217.44/217.64  |- skos__historyNote mesh__D002330 Alkylating Agents %28%1966-1971%29%
% 217.44/217.64  |- skos__historyNote mesh__D002330 Urea %28%1966-1971%29%
% 217.44/217.64  |- skos__altLabel mesh__D002330 BCNU
% 217.44/217.64  |- mesh__recordOriginator mesh__D002330 NLM
% 217.44/217.64  |- rdf__type mesh__D002330sskos__Concept
% 217.44/217.64  |- skos__annotation mesh__D015258 specify geog if pertinent   
% 217.44/217.64  |- mesh__dateRevised mesh__D015258 2005-06-30
% 217.44/217.64  |- mesh__recordOriginator mesh__D015258 RLS
% 217.44/217.64  |- skos__prefLabel mesh__D015258 Acid Rain
% 217.44/217.64  |- mesh__dateCreated mesh__D015258 1988-05-17
% 217.44/217.64  |- skos__hiddenLabel mesh__D015258 Acid Rains
% 217.44/217.64  |- mesh__publicMeSHNote mesh__D015258 89   
% 217.44/217.64  |- mesh__dateEstablished mesh__D015258 1989-01-01
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D015258 2006
% 217.44/217.64  |- skos__historyNote mesh__D015258
% 217.44/217.64       Water Pollutants, Chemical %28%1975-1988%29%
% 217.44/217.64  |- skos__historyNote mesh__D015258 Weather %28%1975-1988%29%
% 217.44/217.64  |- mesh__recordAuthorizer mesh__D015258 sjn
% 217.44/217.64  |- skos__altLabel mesh__D015258 Rain, Acid
% 217.44/217.64  |- skos__hiddenLabel mesh__D015258 Rains, Acid
% 217.44/217.64  |- skos__broader mesh__D015258smesh__D011891
% 217.44/217.64  |- skos__broader mesh__D015258smesh__D045424
% 217.44/217.64  |- mesh__historyNote mesh__D015258 89   
% 217.44/217.64  |- mesh__recordMaintainer mesh__D015258 ags
% 217.44/217.64  |- skos__historyNote mesh__D015258
% 217.44/217.64       Air Pollutants, Environmental %28%1975-1988%29%
% 217.44/217.64  |- skos__scopeNote mesh__D015258
% 217.44/217.64       Acidic water usually pH 2.5 to 4.5, which poisons the ecosystem and adversely affects plants, fishes, and mammals. It is caused by industrial pollutants, mainly sulfur oxides and nitrogen oxides, emitted into the atmosphere and returning to earth in the form of acidic rain water.%A%    
% 217.44/217.64  |- skos__historyNote mesh__D015258 Soil Pollutants %28%1975-1988%29%
% 217.44/217.64  |- skos__broader mesh__D015258smesh__D014877
% 217.44/217.64  |- rdf__type mesh__D015258sskos__Concept
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D001238 2003
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D001238 2000
% 217.44/217.64  |- mesh__dateCreated mesh__D001238 1999-01-01
% 217.44/217.64  |- mesh__recordOriginator mesh__D001238 NLM
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D001238 2004
% 217.44/217.64  |- skos__broader mesh__D001238smesh__D007232
% 217.44/217.64  |- mesh__dateRevised mesh__D001238 1999-11-03
% 217.44/217.64  |- mesh__activeMeSHYear mesh__D001238 2001
% 217.44/217.64  |- skos__prefLabel mesh__D001238 Asphyxia Neonatorum
% 217.44/217.64  |- mesh__recordAuthorizer mesh__D001238 sjn
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D001238 2005
% 217.44/217.65  |- skos__annotation mesh__D001238
% 217.44/217.65       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; tag INFANT, NEWBORN%A%  
% 217.44/217.65  |- mesh__recordMaintainer mesh__D001238 kle
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D001238 2002
% 217.44/217.65  |- rdf__type mesh__D001238sskos__Concept
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D001238 2006
% 217.44/217.65  |- skos__scopeNote mesh__D001238
% 217.44/217.65       Respiratory failure in the newborn. %28%Dorland, 27th ed%29%     
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006721 2000
% 217.44/217.65  |- skos__prefLabel mesh__D006721 Honduras
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006721 1990
% 217.44/217.65  |- mesh__dateRevised mesh__D006721 1991-11-12
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006721 1996
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006721 2001
% 217.44/217.65  |- mesh__recordOriginator mesh__D006721 NLM
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006721 1998
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006721 1992
% 217.44/217.65  |- mesh__dateCreated mesh__D006721 1999-01-01
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006721 1997
% 217.44/217.65  |- rdf__type mesh__D006721sskos__Concept
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006721 1994
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006721 2003
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006721 1999
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006721 1993
% 217.44/217.65  |- skos__broader mesh__D006721smesh__D002489
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006721 2005
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006721 1991
% 217.44/217.65  |- mesh__recordMaintainer mesh__D006721 PLS
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006721 1995
% 217.44/217.65  |- mesh__recordAuthorizer mesh__D006721 PLS
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006721 2004
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006721 2002
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006721 2006
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006721 1989
% 217.44/217.65  |- skos__broader mesh__D019804Q000031smesh__D019804
% 217.44/217.65  |- mesh__preferredCombination mesh__D019804Q000031smesh__D000636
% 217.44/217.65  |- rdf__type mesh__D019804Q000031smesh__CompoundConcept
% 217.44/217.65  |- mesh__recordOriginator mesh__D019649 JLS
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D019649 2001
% 217.44/217.65  |- skos__hiddenLabel mesh__D019649 Industry, Food
% 217.44/217.65  |- skos__broader mesh__D019649smesh__D007221
% 217.44/217.65  |- skos__hiddenLabel mesh__D019649 Industries, Food
% 217.44/217.65  |- skos__scopeNote mesh__D019649
% 217.44/217.65       The industry concerned with processing, preparing, preserving, distributing, and serving of foods and beverages.%A%    
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D019649 2002
% 217.44/217.65  |- skos__hiddenLabel mesh__D019649 Food Industries
% 217.44/217.65  |- mesh__recordAuthorizer mesh__D019649 sjn
% 217.44/217.65  |- skos__annotation mesh__D019649
% 217.44/217.65       GEN or unspecified; prefer specific activities; DF: FOOD INDUST%A%  
% 217.44/217.65  |- mesh__dateEstablished mesh__D019649 1998-01-01
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D019649 2005
% 217.44/217.65  |- mesh__publicMeSHNote mesh__D019649 98   
% 217.44/217.65  |- mesh__dateCreated mesh__D019649 1997-06-20
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D019649 2006
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D019649 2003
% 217.44/217.65  |- mesh__historyNote mesh__D019649 98   
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D019649 2000
% 217.44/217.65  |- mesh__recordMaintainer mesh__D019649 kle
% 217.44/217.65  |- rdf__type mesh__D019649sskos__Concept
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D019649 2004
% 217.44/217.65  |- mesh__dateRevised mesh__D019649 1999-11-03
% 217.44/217.65  |- skos__prefLabel mesh__D019649 Food Industry
% 217.44/217.65  |- mesh__onlineNote mesh__D011666
% 217.44/217.65       use PULMONARY VALVE STENOSIS to search PULMONARY STENOSIS 1966%A%  
% 217.44/217.65  |- skos__altLabel mesh__D011666 Stenosis, Pulmonary Valve
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011666 1995
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011666 2004
% 217.44/217.65  |- skos__altLabel mesh__D011666 Pulmonary Stenosis
% 217.44/217.65  |- rdf__type mesh__D011666sskos__Concept
% 217.44/217.65  |- mesh__recordAuthorizer mesh__D011666 PLS
% 217.44/217.65  |- mesh__dateRevised mesh__D011666 1994-04-16
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011666 1999
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011666 2002
% 217.44/217.65  |- skos__altLabel mesh__D011666 Stenoses, Pulmonary Valve
% 217.44/217.65  |- mesh__publicMeSHNote mesh__D011666 67; was PULMONARY STENOSIS 1963-66   
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011666 1996
% 217.44/217.65  |- mesh__recordOriginator mesh__D011666 NLM
% 217.44/217.65  |- skos__altLabel mesh__D011666 Stenoses, Pulmonary
% 217.44/217.65  |- mesh__recordMaintainer mesh__D011666 TGC
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011666 2005
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011666 1997
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011666 2000
% 217.44/217.65  |- skos__altLabel mesh__D011666 Pulmonary Stenoses
% 217.44/217.65  |- skos__annotation mesh__D011666
% 217.44/217.65       do not confuse with PULMONARY SUBVALVULAR STENOSIS; atresia = PULMONARY ATRESIA; DF: PULM VALVE STENOSIS%A%  
% 217.44/217.65  |- skos__altLabel mesh__D011666 Stenosis, Pulmonary
% 217.44/217.65  |- mesh__historyNote mesh__D011666 67; was PULMONARY STENOSIS 1963-66   
% 217.44/217.65  |- skos__altLabel mesh__D011666 Pulmonary Valve Stenoses
% 217.44/217.65  |- mesh__dateCreated mesh__D011666 1999-01-01
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011666 2006
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011666 2001
% 217.44/217.65  |- skos__prefLabel mesh__D011666 Pulmonary Valve Stenosis
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011666 2003
% 217.44/217.65  |- mesh__dateEstablished mesh__D011666 1967-01-01
% 217.44/217.65  |- skos__broader mesh__D011666smesh__D006349
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011666 1998
% 217.44/217.65  |- skos__hiddenLabel mesh__D044042 Receptor, Chemoattractant
% 217.44/217.65  |- skos__hiddenLabel mesh__D044042 Formyl Peptide Receptors
% 217.44/217.65  |- skos__hiddenLabel mesh__D044042 Receptor, FMLP
% 217.44/217.65  |- skos__altLabel mesh__D044042 F-Chemotactic Peptide Receptor
% 217.44/217.65  |- skos__hiddenLabel mesh__D044042 Receptor, Formyl Peptide
% 217.44/217.65  |- skos__historyNote mesh__D044042 Receptors, Peptide %28%1980-2003%29%
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D044042 2006
% 217.44/217.65  |- skos__altLabel mesh__D044042 N-formyl Hexapeptide Receptor
% 217.44/217.65  |- mesh__recordOriginator mesh__D044042 jmp
% 217.44/217.65  |- skos__altLabel mesh__D044042 N-Formylmethionyl Peptide Receptor
% 217.44/217.65  |- skos__broader mesh__D044042smesh__D043562
% 217.44/217.65  |- skos__broader mesh__D044042smesh__D018000
% 217.44/217.65  |- skos__hiddenLabel mesh__D044042 fMet Leu Phe Receptor
% 217.44/217.65  |- skos__altLabel mesh__D044042 Chemoattractant Receptor
% 217.44/217.65  |- skos__altLabel mesh__D044042 Chemotactic Peptide Receptor
% 217.44/217.65  |- rdf__type mesh__D044042sskos__Concept
% 217.44/217.65  |- skos__hiddenLabel mesh__D044042 Receptor, N-formyl Hexapeptide
% 217.44/217.65  |- skos__historyNote mesh__D044042 Receptors, Immunologic %28%1980-2003%29%
% 217.44/217.65  |- skos__altLabel mesh__D044042 Formyl Peptide Receptor
% 217.44/217.65  |- skos__hiddenLabel mesh__D044042 Receptor, fMet-Leu-Phe
% 217.44/217.65  |- skos__altLabel mesh__D044042 fMet-Leu-Phe Receptor
% 217.44/217.65  |- mesh__recordAuthorizer mesh__D044042 sjn
% 217.44/217.65  |- skos__altLabel mesh__D044042 Receptor, Chemotactic Peptide
% 217.44/217.65  |- skos__hiddenLabel mesh__D044042 Hexapeptide Receptor, N-formyl
% 217.44/217.65  |- skos__scopeNote mesh__D044042
% 217.44/217.65       A family of G-protein-coupled receptors that was originally identified by its ability to bind N-formyl peptides such as N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE. Since N-formyl peptides are found in MITOCHONDRIA and BACTERIA, this class of receptors is believed to play a role in mediating cellular responses to cellular damage and bacterial invasion. However, non-formylated peptide ligands have also been found for this receptor class.%A%    
% 217.44/217.65  |- skos__hiddenLabel mesh__D044042 N Formylmethionyl Peptide Receptor
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D044042 2004
% 217.44/217.65  |- mesh__recordMaintainer mesh__D044042 jmp
% 217.44/217.65  |- skos__prefLabel mesh__D044042 Receptors, Formyl Peptide
% 217.44/217.65  |- skos__hiddenLabel mesh__D044042 N formyl Hexapeptide Receptor
% 217.44/217.65  |- skos__hiddenLabel mesh__D044042 Peptide Receptor, N-Formylmethionyl
% 217.44/217.65  |- skos__broader mesh__D044042smesh__D011971
% 217.44/217.65  |- skos__hiddenLabel mesh__D044042 F Chemotactic Peptide Receptor
% 217.44/217.65  |- skos__hiddenLabel mesh__D044042 Peptide Receptors, Formyl
% 217.44/217.65  |- skos__hiddenLabel mesh__D044042 Peptide Receptor, Chemotactic
% 217.44/217.65  |- skos__hiddenLabel mesh__D044042 Receptor, F-Chemotactic Peptide
% 217.44/217.65  |- skos__altLabel mesh__D044042 FMLP Receptor
% 217.44/217.65  |- mesh__publicMeSHNote mesh__D044042
% 217.44/217.65       2004; CHEMOTACTIC PEPTIDE RECEPTOR %28%now RECEPTORS, FORMYL PEPTIDE%29% was indexed under RECEPTORS, IMMUNOLOGIC %26% RECEPTORS, PEPTIDE 1980-2003%A%  
% 217.44/217.65  |- mesh__historyNote mesh__D044042
% 217.44/217.65       2004; use RECEPTORS, FORMYL PEPTIDE %28%NM%29% 1980-2003   
% 217.44/217.65  |- mesh__dateCreated mesh__D044042 2003-07-09
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D044042 2005
% 217.44/217.65  |- mesh__dateEstablished mesh__D044042 2004-01-01
% 217.44/217.65  |- skos__hiddenLabel mesh__D044042 Receptor, N-Formylmethionyl Peptide
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D005629 2002
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D005629 2004
% 217.44/217.65  |- mesh__recordAuthorizer mesh__D005629 sjn
% 217.44/217.65  |- mesh__dateRevised mesh__D005629 2000-06-22
% 217.44/217.65  |- skos__hiddenLabel mesh__D005629 Section, Frozen
% 217.44/217.65  |- skos__scopeNote mesh__D005629
% 217.44/217.65       Thinly cut sections of frozen tissue specimens prepared with a cryostat or freezing microtome.%A%    
% 217.44/217.65  |- skos__broader mesh__D005629smesh__D016616
% 217.44/217.65  |- mesh__dateEstablished mesh__D005629 1991-01-01
% 217.44/217.65  |- mesh__recordOriginator mesh__D005629 NLM
% 217.44/217.65  |- mesh__onlineNote mesh__D005629 search MICROTOMY 1966-74   
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D005629 2005
% 217.44/217.65  |- mesh__historyNote mesh__D005629
% 217.44/217.65       91%28%75%29%; was see under MICROTOMY 1975-90   
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D005629 2006
% 217.44/217.65  |- mesh__dateCreated mesh__D005629 1999-01-01
% 217.44/217.65  |- skos__prefLabel mesh__D005629 Frozen Sections
% 217.44/217.65  |- mesh__recordMaintainer mesh__D005629 PXP
% 217.44/217.65  |- mesh__publicMeSHNote mesh__D005629
% 217.44/217.65       91; was see under MICROTOMY 1975-90   
% 217.44/217.65  |- skos__hiddenLabel mesh__D005629 Frozen Section
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D005629 2001
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D005629 2003
% 217.44/217.65  |- skos__hiddenLabel mesh__D005629 Sections, Frozen
% 217.44/217.65  |- rdf__type mesh__D005629sskos__Concept
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D030022 2006
% 217.44/217.65  |- skos__broader mesh__D030022smesh__D029065
% 217.44/217.65  |- mesh__dateRevised mesh__D030022 2002-07-02
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D030022 2003
% 217.44/217.65  |- mesh__dateCreated mesh__D030022 2001-07-25
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D030022 2004
% 217.44/217.65  |- mesh__historyNote mesh__D030022 2002   
% 217.44/217.65  |- skos__scopeNote mesh__D030022
% 217.44/217.65       A plant genus of the family ARISTOLOCHIACEAE.  Species of this genus have been used in traditional medicine but they contain aristolochic acid which is associated with nephropathy.  These are sometimes called %27%snakeroot%27% but that name is also used with a number of other plants such as POLYGALA; SANICULA; ASARUM; ARISTOLOCHIA; AGERATINA; and others.%A%    
% 217.44/217.65  |- rdf__type mesh__D030022sskos__Concept
% 217.44/217.65  |- skos__prefLabel mesh__D030022 Aristolochia
% 217.44/217.65  |- skos__annotation mesh__D030022
% 217.44/217.65       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.44/217.65  |- mesh__dateEstablished mesh__D030022 2002-01-01
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D030022 2005
% 217.44/217.65  |- mesh__publicMeSHNote mesh__D030022 2002   
% 217.44/217.65  |- skos__altLabel mesh__D030022 Birthwort
% 217.44/217.65  |- mesh__historyNote mesh__D002331
% 217.44/217.65       66%28%64%29%; was see under VITAMIN B COMPLEX 1963-65   
% 217.44/217.65  |- skos__annotation mesh__D002331
% 217.44/217.65       deficiency: coordinate CARNITINE /defic %28%IM%29% with VITAMIN B DEFICIENCY %28%IM%29%%A%  
% 217.44/217.65  |- mesh__dateCreated mesh__D002331 1999-01-01
% 217.44/217.65  |- skos__hiddenLabel mesh__D002331 L Carnitine
% 217.44/217.65  |- mesh__recordOriginator mesh__D002331 NLM
% 217.44/217.65  |- skos__broader mesh__D002331smesh__D050337
% 217.44/217.65  |- skos__scopeNote mesh__D002331
% 217.44/217.65       Constituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias.%A%    
% 217.44/217.65  |- mesh__recordMaintainer mesh__D002331 ssb
% 217.44/217.65  |- mesh__publicMeSHNote mesh__D002331
% 217.44/217.65       66; was see under VITAMIN B COMPLEX 1963-65   
% 217.44/217.65  |- skos__prefLabel mesh__D002331 Carnitine
% 217.44/217.65  |- rdf__type mesh__D002331sskos__Concept
% 217.44/217.65  |- skos__altLabel mesh__D002331 Vitamin B T
% 217.44/217.65  |- mesh__recordAuthorizer mesh__D002331 sjn
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D002331 2006
% 217.44/217.65  |- mesh__dateRevised mesh__D002331 2005-06-30
% 217.44/217.65  |- mesh__dateEstablished mesh__D002331 1966-01-01
% 217.44/217.65  |- mesh__dateCreated mesh__D015259 1988-05-17
% 217.44/217.65  |- rdf__type mesh__D015259sskos__Concept
% 217.44/217.65  |- skos__prefLabel mesh__D015259 Dopamine Agents
% 217.44/217.65  |- skos__broader mesh__D015259smesh__D018377
% 217.44/217.65  |- skos__hiddenLabel mesh__D015259 Agents, Dopamine
% 217.44/217.65  |- skos__altLabel mesh__D015259 Dopamine Drugs
% 217.44/217.65  |- skos__scopeNote mesh__D015259
% 217.44/217.65       Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.%A%    
% 217.44/217.65  |- skos__historyNote mesh__D015259 Receptors, Dopamine %28%1977-1988%29%
% 217.44/217.65  |- mesh__dateEstablished mesh__D015259 1989-01-01
% 217.44/217.65  |- mesh__dateRevised mesh__D015259 2005-06-30
% 217.44/217.65  |- mesh__recordOriginator mesh__D015259 RLS
% 217.44/217.65  |- skos__altLabel mesh__D015259 Dopaminergic Drugs
% 217.44/217.65  |- mesh__historyNote mesh__D015259
% 217.44/217.65       95; was DOPAMINERGIC AGENTS 1989-94; DOPAMINE NEURON AGENTS %28%NON MESH%29% was heading 1995%A%  
% 217.44/217.65  |- mesh__onlineNote mesh__D015259
% 217.44/217.65       use DOPAMINE AGENTS to search DOPAMINERGIC AGENTS 1989-94%A%  
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D015259 2006
% 217.44/217.65  |- skos__hiddenLabel mesh__D015259 Agents, Dopaminergic
% 217.44/217.65  |- skos__altLabel mesh__D015259 Dopaminergic Agents
% 217.44/217.65  |- skos__hiddenLabel mesh__D015259 Drugs, Dopamine
% 217.44/217.65  |- mesh__recordMaintainer mesh__D015259 ssb
% 217.44/217.65  |- skos__historyNote mesh__D015259 Dopamine/metabolism %28%1966-1988%29%
% 217.44/217.65  |- skos__annotation mesh__D015259
% 217.44/217.65       GEN or unspecified; prefer specific groups or specific drugs%A%  
% 217.44/217.65  |- mesh__recordAuthorizer mesh__D015259 sjn
% 217.44/217.65  |- mesh__publicMeSHNote mesh__D015259
% 217.44/217.65       95; was DOPAMINERGIC AGENTS 1989-94   
% 217.44/217.65  |- skos__hiddenLabel mesh__D015259 Drugs, Dopaminergic
% 217.44/217.65  |- skos__hiddenLabel mesh__D001239 Respiratory Inspirations
% 217.44/217.65  |- skos__hiddenLabel mesh__D001239 Respiratory Inspiration
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D001239 2005
% 217.44/217.65  |- skos__hiddenLabel mesh__D001239 Aspirations, Respiratory
% 217.44/217.65  |- skos__altLabel mesh__D001239 Aspiration, Respiratory
% 217.44/217.65  |- mesh__dateEstablished mesh__D001239 1991-01-01
% 217.44/217.65  |- mesh__dateRevised mesh__D001239 2003-07-09
% 217.44/217.65  |- mesh__recordMaintainer mesh__D001239 nns
% 217.44/217.65  |- rdf__type mesh__D001239sskos__Concept
% 217.44/217.65  |- skos__altLabel mesh__D001239 Inhaling
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D001239 2006
% 217.44/217.65  |- mesh__historyNote mesh__D001239
% 217.44/217.65       2004%28%1966%29%; was see under RESPIRATION 1966-1990   
% 217.44/217.65  |- skos__hiddenLabel mesh__D001239 Respiratory Aspiration
% 217.44/217.65  |- skos__hiddenLabel mesh__D001239 Inhalings
% 217.44/217.65  |- skos__hiddenLabel mesh__D001239 Inspirations, Respiratory
% 217.44/217.65  |- skos__hiddenLabel mesh__D001239 Respiratory Aspirations
% 217.44/217.65  |- skos__annotation mesh__D001239
% 217.44/217.65       differentiate from ASPIRATION, MECHANICAL   
% 217.44/217.65  |- skos__scopeNote mesh__D001239 The act of BREATHING in.     
% 217.44/217.65  |- mesh__recordOriginator mesh__D001239 NLM
% 217.44/217.65  |- skos__altLabel mesh__D001239 Inspiration, Respiratory
% 217.44/217.65  |- skos__hiddenLabel mesh__D001239 Inhalations
% 217.44/217.65  |- mesh__publicMeSHNote mesh__D001239
% 217.44/217.65       2004; see ASPIRATION 1991-2003; was see under RESPIRATION 1966-1990%A%  
% 217.44/217.65  |- mesh__recordAuthorizer mesh__D001239 sjn
% 217.44/217.65  |- mesh__dateCreated mesh__D001239 1999-01-01
% 217.44/217.65  |- skos__broader mesh__D001239smesh__D015656
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D001239 2004
% 217.44/217.65  |- skos__prefLabel mesh__D001239 Inhalation
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006722 1998
% 217.44/217.65  |- skos__broader mesh__D006722smesh__D005502
% 217.44/217.65  |- mesh__dateCreated mesh__D006722 1999-01-01
% 217.44/217.65  |- rdf__type mesh__D006722sskos__Concept
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006722 2003
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006722 1999
% 217.44/217.65  |- mesh__recordAuthorizer mesh__D006722 SJN
% 217.44/217.65  |- skos__hiddenLabel mesh__D006722 Honeys
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006722 2000
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006722 2005
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006722 2004
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006722 2001
% 217.44/217.65  |- mesh__recordOriginator mesh__D006722 NLM
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006722 2006
% 217.44/217.65  |- mesh__dateRevised mesh__D006722 1997-06-20
% 217.44/217.65  |- mesh__recordMaintainer mesh__D006722 JLS
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D006722 2002
% 217.44/217.65  |- skos__scopeNote mesh__D006722
% 217.44/217.65       A sweet viscous liquid food, produced in the honey sacs of various bees from nectar collected from flowers. The nectar is ripened into honey by inversion of its sucrose sugar into fructose and glucose. It is somewhat acidic and has mild antiseptic properties, being sometimes used in the treatment of burns and lacerations.%A%    
% 217.44/217.65  |- skos__prefLabel mesh__D006722 Honey
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011667 1996
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011667 1993
% 217.44/217.65  |- skos__prefLabel mesh__D011667 Pulmonary Veins
% 217.44/217.65  |- mesh__recordMaintainer mesh__D011667 TAP
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011667 2005
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011667 1997
% 217.44/217.65  |- mesh__recordAuthorizer mesh__D011667 PLS
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011667 2002
% 217.44/217.65  |- mesh__dateCreated mesh__D011667 1999-01-01
% 217.44/217.65  |- skos__broader mesh__D011667smesh__D014680
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011667 2006
% 217.44/217.65  |- mesh__recordOriginator mesh__D011667 NLM
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011667 1994
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011667 2003
% 217.44/217.65  |- skos__scopeNote mesh__D011667
% 217.44/217.65       The veins that return the oxygenated blood from the lungs to the left atrium of the heart.%A%    
% 217.44/217.65  |- skos__altLabel mesh__D011667 Pulmonary Vein
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011667 2000
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011667 1998
% 217.44/217.65  |- skos__annotation mesh__D011667 DF: PULM VEINS   
% 217.44/217.65  |- skos__altLabel mesh__D011667 Veins, Pulmonary
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011667 1995
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011667 2004
% 217.44/217.65  |- mesh__dateRevised mesh__D011667 1992-05-18
% 217.44/217.65  |- rdf__type mesh__D011667sskos__Concept
% 217.44/217.65  |- skos__altLabel mesh__D011667 Vein, Pulmonary
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011667 2001
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D011667 1999
% 217.44/217.65  |- skos__annotation mesh__D044043 GEN; prefer specifics   
% 217.44/217.65  |- mesh__recordOriginator mesh__D044043 ags
% 217.44/217.65  |- skos__scopeNote mesh__D044043
% 217.44/217.65       A genus of gram-negative bacteria in the family ENTEROBACTERIACEAE consisting of species that profusely produce pectinolytic enzymes in plant pathogenesis.%A%    
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D044043 2006
% 217.44/217.65  |- mesh__dateEstablished mesh__D044043 2004-01-01
% 217.44/217.65  |- mesh__dateRevised mesh__D044043 2005-06-30
% 217.44/217.65  |- mesh__historyNote mesh__D044043 2004   
% 217.44/217.65  |- rdf__type mesh__D044043sskos__Concept
% 217.44/217.65  |- mesh__dateCreated mesh__D044043 2003-07-09
% 217.44/217.65  |- mesh__publicMeSHNote mesh__D044043 2004   
% 217.44/217.65  |- mesh__recordAuthorizer mesh__D044043 sjn
% 217.44/217.65  |- mesh__recordMaintainer mesh__D044043 SYSTEM
% 217.44/217.65  |- skos__prefLabel mesh__D044043 Pectobacterium
% 217.44/217.65  |- skos__broader mesh__D044043smesh__D004755
% 217.44/217.65  |- skos__related mesh__D030821smesh__D046549
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D030821 2006
% 217.44/217.65  |- skos__related mesh__D030821smesh__D005818
% 217.44/217.65  |- skos__annotation mesh__D030821 coord with specific plant /genet   
% 217.44/217.65  |- mesh__dateEstablished mesh__D030821 2002-01-01
% 217.44/217.65  |- mesh__publicMeSHNote mesh__D030821
% 217.44/217.65       2002; PLANTS, TRANSGENIC as heading 1992-2001   
% 217.44/217.65  |- mesh__recordMaintainer mesh__D030821 jls
% 217.44/217.65  |- skos__related mesh__D030821smesh__D030841
% 217.44/217.65  |- mesh__dateCreated mesh__D030821 2001-07-25
% 217.44/217.65  |- skos__altLabel mesh__D030821 Genetically Engineered Plants
% 217.44/217.65  |- mesh__recordAuthorizer mesh__D030821 sjn
% 217.44/217.65  |- skos__altLabel mesh__D030821 GMO Plants
% 217.44/217.65  |- skos__prefLabel mesh__D030821 Plants, Genetically Modified
% 217.44/217.65  |- mesh__dateRevised mesh__D030821 2005-06-30
% 217.44/217.65  |- skos__altLabel mesh__D030821 Transgenic Plants
% 217.44/217.65  |- skos__scopeNote mesh__D030821
% 217.44/217.65       PLANTS, or their progeny, whose GENOME has been altered by GENETIC ENGINEERING.%A%    
% 217.44/217.65  |- skos__related mesh__D030821smesh__D019076
% 217.44/217.65  |- skos__broader mesh__D030821smesh__D030781
% 217.44/217.65  |- skos__altLabel mesh__D030821 Genetically Modified Plants
% 217.44/217.65  |- skos__historyNote mesh__D030821 Plants, Transgenic %28%1992-2001%29%
% 217.44/217.65  |- mesh__historyNote mesh__D030821 2002   
% 217.44/217.65  |- mesh__recordOriginator mesh__D030821 nns
% 217.44/217.65  |- skos__historyNote mesh__D030821 Genetic Engineering %28%1990-2001%29%
% 217.44/217.65  |- rdf__type mesh__D030821sskos__Concept
% 217.44/217.65  |- skos__scopeNote mesh__D016352
% 217.44/217.65       Housing for groups of patients, children, or others who need or desire emotional or physical support. They are usually established as planned, single housekeeping units in residential dwellings that provide care and supervision for small groups of residents, who, although unrelated, live together as a family.%A%    
% 217.44/217.65  |- mesh__dateEstablished mesh__D016352 1991-01-01
% 217.44/217.65  |- mesh__onlineNote mesh__D016352
% 217.44/217.65       use RESIDENTIAL FACILITIES to search GROUP HOMES 1990   
% 217.44/217.65  |- mesh__historyNote mesh__D016352
% 217.44/217.65       91; was see RESIDENTIAL FACILITIES 1990   
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D016352 2006
% 217.44/217.65  |- mesh__recordOriginator mesh__D016352 JHM
% 217.44/217.65  |- skos__annotation mesh__D016352 in med %26% non-med contexts   
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D016352 2004
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D016352 2001
% 217.44/217.65  |- mesh__recordMaintainer mesh__D016352 kle
% 217.44/217.65  |- mesh__dateCreated mesh__D016352 1990-05-29
% 217.44/217.65  |- rdf__type mesh__D016352sskos__Concept
% 217.44/217.65  |- skos__historyNote mesh__D016352 Residential Facilities %28%1970-1990%29%
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D016352 2000
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D016352 2005
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D016352 2003
% 217.44/217.65  |- skos__prefLabel mesh__D016352 Group Homes
% 217.44/217.65  |- skos__historyNote mesh__D016352 Halfway Houses %28%1970-1990%29%
% 217.44/217.65  |- skos__hiddenLabel mesh__D016352 Group Home
% 217.44/217.65  |- skos__hiddenLabel mesh__D016352 Homes, Group
% 217.44/217.65  |- skos__hiddenLabel mesh__D016352 Home, Group
% 217.44/217.65  |- mesh__dateRevised mesh__D016352 1999-11-03
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D016352 2002
% 217.44/217.65  |- skos__broader mesh__D016352smesh__D012112
% 217.44/217.65  |- mesh__publicMeSHNote mesh__D016352
% 217.44/217.65       91; was see RESIDENTIAL FACILITIES 1990   
% 217.44/217.65  |- mesh__recordAuthorizer mesh__D016352 sjn
% 217.44/217.65  |- mesh__publicMeSHNote mesh__D030023 2002   
% 217.44/217.65  |- skos__scopeNote mesh__D030023
% 217.44/217.65       A plant genus of the family ARISTOLOCHIACEAE which was used medicinally by North American Indians.  The common name of %27%snakeroot%27% is also used for many other plants, including SANICULA; or ARISTOLOCHIA; or Polygala.%A%    
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D030023 2006
% 217.44/217.65  |- skos__altLabel mesh__D030023 Canada Snakeroot
% 217.44/217.65  |- skos__broader mesh__D030023smesh__D029065
% 217.44/217.65  |- mesh__dateRevised mesh__D030023 2002-07-02
% 217.44/217.65  |- skos__altLabel mesh__D030023 Wild Ginger
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D030023 2003
% 217.44/217.65  |- skos__altLabel mesh__D030023 Snakeroot, Canada
% 217.44/217.65  |- skos__prefLabel mesh__D030023 Asarum
% 217.44/217.65  |- skos__annotation mesh__D030023
% 217.44/217.65       snakeroot may or may not go here, check text; note X ref WILD GINGER: GINGER is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.44/217.65  |- mesh__dateCreated mesh__D030023 2001-07-25
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D030023 2004
% 217.44/217.65  |- rdf__type mesh__D030023sskos__Concept
% 217.44/217.65  |- mesh__historyNote mesh__D030023 2002   
% 217.44/217.65  |- mesh__dateEstablished mesh__D030023 2002-01-01
% 217.44/217.65  |- skos__altLabel mesh__D030023 Ginger, Wild
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D030023 2005
% 217.44/217.65  |- mesh__recordAuthorizer mesh__D002332 sjn
% 217.44/217.65  |- skos__broader mesh__D002332smesh__D000123
% 217.44/217.65  |- skos__scopeNote mesh__D002332
% 217.44/217.65       An enzyme that catalyzes the formation of O-acetylcarnitine from acetyl-CoA plus carnitine. EC 2.3.1.7.%A%    
% 217.44/217.65  |- mesh__dateRevised mesh__D002332 2003-07-09
% 217.44/217.65  |- skos__hiddenLabel mesh__D002332 O-Acetyltransferase, Carnitine
% 217.44/217.65  |- mesh__dateEstablished mesh__D002332 1991-01-01
% 217.44/217.65  |- skos__altLabel mesh__D002332 Carnitine Acetyltransferase
% 217.44/217.65  |- rdf__type mesh__D002332sskos__Concept
% 217.44/217.65  |- skos__hiddenLabel mesh__D002332 Carnitine O Acetyltransferase
% 217.44/217.65  |- skos__historyNote mesh__D002332 Carnitine %28%1973-1974%29%
% 217.44/217.65  |- skos__hiddenLabel mesh__D002332 Acetyltransferase, Carnitine
% 217.44/217.65  |- skos__annotation mesh__D002332
% 217.44/217.65       do not confuse with CARNITINE ACYLTRANSFERASES   
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D002332 2005
% 217.44/217.65  |- skos__prefLabel mesh__D002332 Carnitine O-Acetyltransferase
% 217.44/217.65  |- mesh__historyNote mesh__D002332 98%28%75%29%   
% 217.44/217.65  |- mesh__recordOriginator mesh__D002332 NLM
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D002332 2004
% 217.44/217.65  |- mesh__recordMaintainer mesh__D002332 ssb
% 217.44/217.65  |- skos__historyNote mesh__D002332 Acetyltransferases %28%1973-1974%29%
% 217.44/217.65  |- mesh__activeMeSHYear mesh__D002332 2006
% 217.44/217.65  |- mesh__dateCreated mesh__D002332 1974-11-19
% 217.44/217.65  |- mesh__publicMeSHNote mesh__D002332
% 217.44/217.65       98; see CARNITINE ACETYLTRANSFERASE 1991-97; see ACETYLTRANSFERASES 1975-90%A%  
% 217.44/217.65  |- skos__hiddenLabel mesh__D002332 Carnitine Acetyl CoA Transferase
% 217.44/217.66  |- skos__altLabel mesh__D002332 Carnitine-Acetyl-CoA-Transferase
% 217.44/217.66  |- skos__broader mesh__D002332smesh__D002333
% 217.44/217.66  |- mesh__recordAuthorizer mesh__D012760 sjn
% 217.44/217.66  |- skos__scopeNote mesh__D012760
% 217.44/217.66       A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that ferments sugar without gas production. Its organisms are intestinal pathogens of man and other primates and cause bacillary dysentery %28%DYSENTERY, BACILLARY%29%.%A%    
% 217.44/217.66  |- skos__prefLabel mesh__D012760 Shigella
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D012760 2006
% 217.44/217.66  |- mesh__recordOriginator mesh__D012760 NLM
% 217.44/217.66  |- skos__annotation mesh__D012760
% 217.44/217.66       GEN; prefer specifics; infection = DYSENTERY, BACILLARY %26% specify species if pertinent %28%IM%29%%A%  
% 217.44/217.66  |- mesh__dateRevised mesh__D012760 2005-06-30
% 217.44/217.66  |- skos__broader mesh__D012760smesh__D004755
% 217.44/217.66  |- mesh__recordMaintainer mesh__D012760 SYSTEM
% 217.44/217.66  |- skos__related mesh__D012760smesh__D004405
% 217.44/217.66  |- mesh__dateCreated mesh__D012760 1999-01-01
% 217.44/217.66  |- rdf__type mesh__D012760sskos__Concept
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D006723 2005
% 217.44/217.66  |- skos__broader mesh__D006723smesh__D002681
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D006723 2004
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D006723 2006
% 217.44/217.66  |- mesh__recordMaintainer mesh__D006723 TGC
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D006723 2002
% 217.44/217.66  |- skos__scopeNote mesh__D006723
% 217.44/217.66       The former British crown colony located off the southeast coast of China, comprised of Hong Kong Island, Kowloon Peninsula, and New Territories. The three sites were ceded to the British by the Chinese respectively in 1841, 1860, and 1898. Hong Kong reverted to China in July 1997. The name represents the Cantonese pronunciation of the Chinese xianggang, fragrant port, from xiang, perfume and gang, port or harbor, with reference to its currents sweetened by fresh water from a river west of it.%A%    
% 217.44/217.66  |- skos__prefLabel mesh__D006723 Hong Kong
% 217.44/217.66  |- mesh__recordAuthorizer mesh__D006723 SJN
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D006723 1998
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D006723 2000
% 217.44/217.66  |- mesh__dateCreated mesh__D006723 1999-01-01
% 217.44/217.66  |- skos__altLabel mesh__D006723 Hongkong
% 217.44/217.66  |- rdf__type mesh__D006723sskos__Concept
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D006723 2003
% 217.44/217.66  |- mesh__recordOriginator mesh__D006723 NLM
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D006723 1999
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D006723 2001
% 217.44/217.66  |- mesh__dateRevised mesh__D006723 1997-06-20
% 217.44/217.66  |- skos__altLabel mesh__D044842 Cullin Domain Protein
% 217.44/217.66  |- skos__altLabel mesh__D044842 Cullin Protein
% 217.44/217.66  |- mesh__dateRevised mesh__D044842 2005-07-13
% 217.44/217.66  |- skos__prefLabel mesh__D044842 Cullin Proteins
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D044842 2006A
% 217.44/217.66  |- skos__altLabel mesh__D044842 Cullin Domain Proteins
% 217.44/217.66  |- mesh__recordAuthorizer mesh__D044842 ags
% 217.44/217.66  |- skos__broader mesh__D044842smesh__D044843
% 217.44/217.66  |- mesh__publicMeSHNote mesh__D044842 2004   
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D044842 2006
% 217.44/217.66  |- rdf__type mesh__D044842sskos__Concept
% 217.44/217.66  |- mesh__recordMaintainer mesh__D044842 ags
% 217.44/217.66  |- skos__broader mesh__D044842smesh__D018797
% 217.44/217.66  |- mesh__recordOriginator mesh__D044842 jmp
% 217.44/217.66  |- mesh__historyNote mesh__D044842 2004   
% 217.44/217.66  |- mesh__dateCreated mesh__D044842 2003-07-09
% 217.44/217.66  |- skos__scopeNote mesh__D044842
% 217.44/217.66       A family of structurally related proteins that were originally discovered for their role in cell-cycle regulation in CAENORHABDITIS ELEGANS. They play important roles in regulation of the CELL CYCLE and as components of UBIQUITIN-PROTEIN LIGASES.%A%    
% 217.44/217.66  |- skos__altLabel mesh__D044842 Cullins
% 217.44/217.66  |- mesh__dateEstablished mesh__D044842 2004-01-01
% 217.44/217.66  |- skos__altLabel mesh__D011668 Pulmonary Veno Occlusive Disease
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D011668 2003
% 217.44/217.66  |- mesh__dateRevised mesh__D011668 1992-12-28
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D011668 1995
% 217.44/217.66  |- mesh__recordMaintainer mesh__D011668 TGC
% 217.44/217.66  |- rdf__type mesh__D011668sskos__Concept
% 217.44/217.66  |- skos__historyNote mesh__D011668 Vascular Diseases %28%1966-1986%29%
% 217.44/217.66  |- skos__hiddenLabel mesh__D011668 Diseases, Pulmonary Veno-Occlusive
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D011668 2002
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D011668 1999
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D011668 1994
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D011668 1997
% 217.44/217.66  |- skos__broader mesh__D011668smesh__D014652
% 217.44/217.66  |- skos__historyNote mesh__D011668 Pulmonary Veins %28%1966-1986%29%
% 217.44/217.66  |- mesh__recordAuthorizer mesh__D011668 PLS
% 217.44/217.66  |- mesh__dateCreated mesh__D011668 1986-06-24
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D011668 1998
% 217.44/217.66  |- mesh__publicMeSHNote mesh__D011668 87   
% 217.44/217.66  |- mesh__historyNote mesh__D011668 87   
% 217.44/217.66  |- skos__broader mesh__D011668smesh__D008171
% 217.44/217.66  |- skos__altLabel mesh__D011668 Veno-Occlusive Disease, Pulmonary
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D011668 1996
% 217.44/217.66  |- skos__hiddenLabel mesh__D011668 Veno Occlusive Disease, Pulmonary
% 217.44/217.66  |- skos__scopeNote mesh__D011668
% 217.44/217.66       Obstruction of the small- and medium-sized pulmonary veins by fibrous proliferation of the intima and media or by thrombosis or a combination of both.%A%    
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D011668 2001
% 217.44/217.66  |- skos__annotation mesh__D011668 pulm vein blockage; DF: PVOD   
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D011668 2006
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D011668 2000
% 217.44/217.66  |- skos__hiddenLabel mesh__D011668 Veno-Occlusive Diseases, Pulmonary
% 217.44/217.66  |- skos__hiddenLabel mesh__D011668 Disease, Pulmonary Veno-Occlusive
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D011668 2004
% 217.44/217.66  |- skos__hiddenLabel mesh__D011668 Pulmonary Veno-Occlusive Diseases
% 217.44/217.66  |- mesh__recordOriginator mesh__D011668 VDK
% 217.44/217.66  |- skos__prefLabel mesh__D011668 Pulmonary Veno-Occlusive Disease
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D011668 2005
% 217.44/217.66  |- mesh__dateEstablished mesh__D011668 1987-01-01
% 217.44/217.66  |- skos__broader mesh__D044044smesh__D006092
% 217.44/217.66  |- mesh__recordAuthorizer mesh__D044044 sjn
% 217.44/217.66  |- skos__annotation mesh__D044044
% 217.44/217.66       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 217.44/217.66  |- mesh__publicMeSHNote mesh__D044044 2004   
% 217.44/217.66  |- mesh__dateEstablished mesh__D044044 2004-01-01
% 217.44/217.66  |- mesh__recordOriginator mesh__D044044 ags
% 217.44/217.66  |- mesh__dateRevised mesh__D044044 2005-06-30
% 217.44/217.66  |- mesh__historyNote mesh__D044044 2004   
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D044044 2006
% 217.44/217.66  |- mesh__recordMaintainer mesh__D044044 SYSTEM
% 217.44/217.66  |- skos__broader mesh__D044044smesh__D020563
% 217.44/217.66  |- skos__prefLabel mesh__D044044 Aeromonadaceae
% 217.44/217.66  |- rdf__type mesh__D044044sskos__Concept
% 217.44/217.66  |- skos__scopeNote mesh__D044044
% 217.44/217.66       A family of gram-negative facultatively anaerobic bacteria, ubiquitous in fresh and brackish water, and associated with GASTROINTESTINAL DISEASES.%A%    
% 217.44/217.66  |- mesh__dateCreated mesh__D044044 2003-07-09
% 217.44/217.66  |- skos__hiddenLabel mesh__D016353 Examinations, Self
% 217.44/217.66  |- mesh__dateCreated mesh__D016353 1990-05-29
% 217.44/217.66  |- mesh__historyNote mesh__D016353 91   
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D016353 2005
% 217.44/217.66  |- skos__historyNote mesh__D016353 Palpation %28%1969-1990%29%
% 217.44/217.66  |- mesh__activeMeSHYear mesh__D016353 2004
% 217.44/217.66  |- mesh__recordAuthorizer mesh__D016353 sjn
% 217.54/217.71  |- skos__scopeNote mesh__D016353
% 217.54/217.71       The inspection of one%27%s own body, usually for signs of disease %28%e.g., BREAST SELF-EXAMINATION, testicular self-examination%29%.%A%    
% 217.57/217.71  |- rdf__type mesh__D016353sskos__Concept
% 217.57/217.71  |- skos__broader mesh__D016353smesh__D015438
% 217.57/217.71  |- skos__annotation mesh__D016353
% 217.57/217.71       coord IM with organ with no qualif %28%IM%29% + disease term /diag %28%IM%29% if discussed; BREAST SELF-EXAMINATION is also available; DF: SELF EXAM%A%  
% 217.57/217.71  |- mesh__activeMeSHYear mesh__D016353 2003
% 217.57/217.71  |- skos__prefLabel mesh__D016353 Self-Examination
% 217.57/217.71  |- skos__hiddenLabel mesh__D016353 Self Examinations
% 217.57/217.71  |- mesh__dateRevised mesh__D016353 2002-07-03
% 217.57/217.71  |- mesh__recordOriginator mesh__D016353 JHM
% 217.57/217.71  |- skos__altLabel mesh__D016353 Examination, Self
% 217.57/217.71  |- mesh__publicMeSHNote mesh__D016353 91   
% 217.57/217.71  |- skos__broader mesh__D016353smesh__D010808
% 217.57/217.71  |- skos__hiddenLabel mesh__D016353 Self Examination
% 217.57/217.71  |- skos__hiddenLabel mesh__D016353 Self-Examinations
% 217.57/217.71  |- mesh__activeMeSHYear mesh__D016353 2006
% 217.57/217.71  |- mesh__recordMaintainer mesh__D016353 PXP
% 217.57/217.71  |- mesh__dateEstablished mesh__D016353 1991-01-01
% 217.57/217.71  |- skos__altLabel mesh__D030024 Turmeric
% 217.57/217.71  |- mesh__historyNote mesh__D030024 2002   
% 217.57/217.71  |- mesh__dateEstablished mesh__D030024 2002-01-01
% 217.57/217.71  |- mesh__publicMeSHNote mesh__D030024 2002   
% 217.57/217.71  |- skos__scopeNote mesh__D030024
% 217.57/217.71       A plant genus of the family ZINGIBERACEAE that contains CURCUMIN and curcuminoids.%A%    
% 217.57/217.71  |- skos__annotation mesh__D030024
% 217.57/217.71       X ref TUMERIC: TURMERIC YELLOW see CURCUMIN is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.57/217.71  |- mesh__activeMeSHYear mesh__D030024 2006
% 217.57/217.71  |- mesh__dateCreated mesh__D030024 2001-07-25
% 217.57/217.71  |- mesh__activeMeSHYear mesh__D030024 2004
% 217.57/217.71  |- mesh__dateRevised mesh__D030024 2002-07-03
% 217.57/217.71  |- skos__broader mesh__D030024smesh__D030521
% 217.57/217.71  |- mesh__activeMeSHYear mesh__D030024 2005
% 217.57/217.71  |- mesh__activeMeSHYear mesh__D030024 2003
% 217.57/217.71  |- mesh__recordOriginator mesh__D030024 ssb
% 217.57/217.71  |- rdf__type mesh__D030024sskos__Concept
% 217.57/217.71  |- mesh__recordAuthorizer mesh__D030024 sjn
% 217.57/217.71  |- skos__prefLabel mesh__D030024 Curcuma
% 217.57/217.71  |- skos__altLabel mesh__D030024 Zedoary zedoaria
% 217.57/217.71  |- mesh__recordMaintainer mesh__D030024 ssb
% 217.57/217.71  |- skos__altLabel mesh__D002333 Carnitine-Acylcarnitine Translocase
% 217.57/217.71  |- skos__prefLabel mesh__D002333 Carnitine Acyltransferases
% 217.57/217.71  |- skos__hiddenLabel mesh__D002333 Acyltransferases, Carnitine
% 217.57/217.71  |- skos__historyNote mesh__D002333 Acyltransferases %28%1972-1974%29%
% 217.57/217.71  |- mesh__activeMeSHYear mesh__D002333 2005
% 217.57/217.71  |- mesh__dateRevised mesh__D002333 2003-07-09
% 217.57/217.71  |- skos__altLabel mesh__D002333 Carnitine Translocase
% 217.57/217.72  |- skos__hiddenLabel mesh__D002333 Carnitine Acetylcarnitine Translocase
% 217.57/217.72  |- skos__broader mesh__D002333smesh__D000217
% 217.57/217.72  |- skos__hiddenLabel mesh__D002333 Translocase, Carnitine
% 217.57/217.72  |- mesh__dateCreated mesh__D002333 1974-11-11
% 217.57/217.72  |- mesh__recordAuthorizer mesh__D002333 sjn
% 217.57/217.72  |- skos__hiddenLabel mesh__D002333 Translocase, Carnitine-Acylcarnitine
% 217.57/217.72  |- mesh__publicMeSHNote mesh__D002333
% 217.57/217.72       91; was see under ACYLTRANSFERASES 1975-90   
% 217.57/217.72  |- rdf__type mesh__D002333sskos__Concept
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D002333 2004
% 217.57/217.72  |- mesh__dateEstablished mesh__D002333 1991-01-01
% 217.57/217.72  |- skos__hiddenLabel mesh__D002333 Translocase, Carnitine-Acetylcarnitine
% 217.57/217.72  |- mesh__recordMaintainer mesh__D002333 ssb
% 217.57/217.72  |- skos__hiddenLabel mesh__D002333 Carnitine Acylcarnitine Translocase
% 217.57/217.72  |- skos__scopeNote mesh__D002333
% 217.57/217.72       Acyltransferases in the inner mitochondrial membrane that catalyze the reversible transfer of acyl groups from acyl-CoA to L-carnitine and thereby mediate the transport of activated fatty acids through that membrane. EC 2.3.1.%A%    
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D002333 2006
% 217.57/217.72  |- mesh__recordOriginator mesh__D002333 NLM
% 217.57/217.72  |- mesh__historyNote mesh__D002333
% 217.57/217.72       91%28%75%29%; was see under ACYLTRANSFERASES 1975-90   
% 217.57/217.72  |- skos__annotation mesh__D002333
% 217.57/217.72       do not confuse with CARNITINE ACETYLTRANSFERASE see CARNITINE O-ACETYLTRANSFERASE%A%  
% 217.57/217.72  |- skos__altLabel mesh__D002333 Acylcarnitine Translocase
% 217.57/217.72  |- skos__hiddenLabel mesh__D002333 Translocase, Acylcarnitine
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D026781 2005
% 217.57/217.72  |- skos__prefLabel mesh__D026781 Mandragora
% 217.57/217.72  |- skos__broader mesh__D026781smesh__D019657
% 217.57/217.72  |- mesh__publicMeSHNote mesh__D026781
% 217.57/217.72       2002, 1963-1991; see PLANTS, TOXIC 1986-1990; for MANDRAKE, EUROPEAN see PLANTS, TOXIC 1997-2001; see MANDRAGORA 1986-96%A%  
% 217.57/217.72  |- mesh__dateCreated mesh__D026781 2001-08-03
% 217.57/217.72  |- mesh__dateRevised mesh__D026781 2002-07-02
% 217.57/217.72  |- mesh__historyNote mesh__D026781
% 217.57/217.72       2002, 1963-1996; use PLANTS, TOXIC 1997-2001; for MANDRAKE, EUROPEAN use PLANTS, TOXIC 1986-2001%A%  
% 217.57/217.72  |- skos__annotation mesh__D026781
% 217.57/217.72       do not confuse X ref MANDRAKE, EUROPEAN with MANDRAKE, AMERICAN see PODOPHYLLUM; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.57/217.72  |- mesh__recordMaintainer mesh__D026781 ssb
% 217.57/217.72  |- skos__scopeNote mesh__D026781
% 217.57/217.72       Plants of the Mandragora genus in the SOLANACEAE family, including Mandragora officinarum L. and Mandragora vernalis Bertol %28%sometimes called Atropa mandragora%29%. They contain TROPANES that are anticholinergic %28%CHOLINERGIC ANTAGONISTS%29%.  Mandrake may also refer to PODOPHYLLUM.%A%    
% 217.57/217.72  |- skos__altLabel mesh__D026781 Atropa mandragora
% 217.57/217.72  |- skos__altLabel mesh__D026781 Mandrake, European
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D026781 2004
% 217.57/217.72  |- mesh__recordOriginator mesh__D026781 ssb
% 217.57/217.72  |- mesh__recordAuthorizer mesh__D026781 sjn
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D026781 2006
% 217.57/217.72  |- mesh__dateEstablished mesh__D026781 2002-01-01
% 217.57/217.72  |- skos__historyNote mesh__D026781 Plants, Toxic %28%1997-2001%29%
% 217.57/217.72  |- rdf__type mesh__D026781sskos__Concept
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D026781 2003
% 217.57/217.72  |- skos__historyNote mesh__D012761 Shigella %28%1966-1971%29%
% 217.57/217.72  |- mesh__publicMeSHNote mesh__D012761 91; was see under SHIGELLA 1972-90   
% 217.57/217.72  |- skos__prefLabel mesh__D012761 Shigella boydii
% 217.57/217.72  |- skos__scopeNote mesh__D012761
% 217.57/217.72       One of the SHIGELLA species that produces bacillary dysentery %28%DYSENTERY, BACILLARY%29%.%A%    
% 217.57/217.72  |- mesh__recordAuthorizer mesh__D012761 sjn
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D012761 2006
% 217.57/217.72  |- mesh__recordMaintainer mesh__D012761 SYSTEM
% 217.57/217.72  |- mesh__historyNote mesh__D012761
% 217.57/217.72       91%28%72%29%; was see under SHIGELLA 1972-90   
% 217.57/217.72  |- mesh__dateCreated mesh__D012761 1999-01-01
% 217.57/217.72  |- rdf__type mesh__D012761sskos__Concept
% 217.57/217.72  |- mesh__recordOriginator mesh__D012761 NLM
% 217.57/217.72  |- skos__broader mesh__D012761smesh__D012760
% 217.57/217.72  |- mesh__dateRevised mesh__D012761 2005-06-30
% 217.57/217.72  |- skos__annotation mesh__D012761
% 217.57/217.72       infection: coord IM with DYSENTERY, BACILLARY %28%IM%29%   
% 217.57/217.72  |- mesh__dateEstablished mesh__D012761 1991-01-01
% 217.57/217.72  |- mesh__recordOriginator mesh__D006724 NLM
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006724 2001
% 217.57/217.72  |- mesh__recordMaintainer mesh__D006724 MSR
% 217.57/217.72  |- mesh__dateRevised mesh__D006724 1998-06-10
% 217.57/217.72  |- mesh__dateEstablished mesh__D006724 1968-01-01
% 217.57/217.72  |- skos__altLabel mesh__D006724 Hoof
% 217.57/217.72  |- skos__historyNote mesh__D006724 specific animal
% 217.57/217.72  |- skos__altLabel mesh__D006724 Hooves and Claws
% 217.57/217.72  |- skos__altLabel mesh__D006724 Claw and Hoof
% 217.57/217.72  |- skos__prefLabel mesh__D006724 Hoof and Claw
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006724 2002
% 217.57/217.72  |- skos__annotation mesh__D006724
% 217.57/217.72       for cat %26% dog claws %28%nails%29%: not for chicken claws %28%whole foot%29%; diseases: coord IM with FOOT DISEASES /vet %28%IM%29%; DF: HOOF%A%  
% 217.57/217.72  |- mesh__dateCreated mesh__D006724 1999-01-01
% 217.57/217.72  |- mesh__publicMeSHNote mesh__D006724 68   
% 217.57/217.72  |- rdf__type mesh__D006724sskos__Concept
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006724 2003
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006724 1999
% 217.57/217.72  |- mesh__historyNote mesh__D006724 68   
% 217.57/217.72  |- skos__broader mesh__D006724smesh__D000825
% 217.57/217.72  |- skos__historyNote mesh__D006724 Foot %28%1966-1967%29%
% 217.57/217.72  |- skos__hiddenLabel mesh__D006724 Claws
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006724 2005
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006724 2004
% 217.57/217.72  |- skos__altLabel mesh__D006724 Claws and Hooves
% 217.57/217.72  |- mesh__recordAuthorizer mesh__D006724 SJN
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006724 2006
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006724 2000
% 217.57/217.72  |- skos__hiddenLabel mesh__D050880 p300 CBP Protein
% 217.57/217.72  |- skos__hiddenLabel mesh__D050880 Transcription Factors, p300-CBP
% 217.57/217.72  |- mesh__publicMeSHNote mesh__D050880
% 217.57/217.72       2006; P300/CBP PROTEINS was indexed under NUCLEAR PROTEINS %26% TRANS-ACTIVATORS 1999-2005%A%  
% 217.57/217.72  |- skos__hiddenLabel mesh__D050880 p300 CBP Transcription Factors
% 217.57/217.72  |- skos__hiddenLabel mesh__D050880 Coactivator, p300-CBP
% 217.57/217.72  |- skos__altLabel mesh__D050880 p300-CBP Protein
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D050880 2006
% 217.57/217.72  |- mesh__dateEstablished mesh__D050880 2006-01-01
% 217.57/217.72  |- mesh__dateCreated mesh__D050880 2005-06-30
% 217.57/217.72  |- mesh__recordMaintainer mesh__D050880 DRC
% 217.57/217.72  |- mesh__recordOriginator mesh__D050880 DRC
% 217.57/217.72  |- skos__altLabel mesh__D050880 p300-CBP Coactivator
% 217.57/217.72  |- rdf__type mesh__D050880sskos__Concept
% 217.57/217.72  |- skos__altLabel mesh__D050880 p300/CBP Protein
% 217.57/217.72  |- mesh__recordAuthorizer mesh__D050880 sjn
% 217.57/217.72  |- skos__scopeNote mesh__D050880
% 217.57/217.72       A family of histone acetyltransferases that is structurally-related to CREB-BINDING PROTEIN and to E1A-ASSOCIATED P300 PROTEIN. They function as transcriptional coactivators by bridging between DNA-binding TRANSCRIPTION FACTORS and the basal transcription machinery. They also modify transcription factors and CHROMATIN through ACETYLATION.%A%    
% 217.57/217.72  |- skos__broader mesh__D050880smesh__D014157
% 217.57/217.72  |- mesh__historyNote mesh__D050880 2006%28%1994%29%   
% 217.57/217.72  |- skos__prefLabel mesh__D050880 p300-CBP Transcription Factors
% 217.57/217.72  |- skos__broader mesh__D050880smesh__D000123
% 217.57/217.72  |- skos__hiddenLabel mesh__D050880 p300 CBP Coactivator
% 217.57/217.72  |- mesh__recordAuthorizer mesh__D044843 sjn
% 217.57/217.72  |- skos__hiddenLabel mesh__D044843 Ubiquitin Ligase, Skp1-Cullin-1-F-box
% 217.57/217.72  |- mesh__historyNote mesh__D044843
% 217.57/217.72       2004; use SKP CULLIN F-BOX LIGASES %28%NM%29% 1999-2003   
% 217.57/217.72  |- skos__hiddenLabel mesh__D044843 SKP1 Cullin Ubiquitin Ligases
% 217.57/217.72  |- skos__hiddenLabel mesh__D044843 Ligase, SCF Ubiquitin
% 217.57/217.72  |- skos__prefLabel mesh__D044843 SKP Cullin F-Box Protein Ligases
% 217.57/217.72  |- skos__altLabel mesh__D044843 Skp1-Cullin-1-F-box Ubiquitin Ligase
% 217.57/217.72  |- skos__hiddenLabel mesh__D044843 Ligase, Skp1-Cullin-1-F-box Ubiquitin
% 217.57/217.72  |- skos__historyNote mesh__D044843 Peptide Synthases %28%1999-2003%29%
% 217.57/217.72  |- skos__historyNote mesh__D044843 Ligases %28%1997-2003%29%
% 217.57/217.72  |- skos__hiddenLabel mesh__D044843 Skp1 Cullin F Box Proteins
% 217.57/217.72  |- skos__hiddenLabel mesh__D044843 Skp1 Cullin 1 F box Ubiquitin Ligase
% 217.57/217.72  |- skos__hiddenLabel mesh__D044843 Ligases, SKP1-Cullin Ubiquitin
% 217.57/217.72  |- skos__related mesh__D044843smesh__D044783
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D044843 2004
% 217.57/217.72  |- skos__hiddenLabel mesh__D044843 Ubiquitin Ligases, SKP1-Cullin
% 217.57/217.72  |- skos__hiddenLabel mesh__D044843 Ubiquitin Ligase, SCF
% 217.57/217.72  |- skos__related mesh__D044843smesh__D044786
% 217.57/217.72  |- rdf__type mesh__D044843sskos__Concept
% 217.57/217.72  |- mesh__recordOriginator mesh__D044843 jmp
% 217.57/217.72  |- skos__altLabel mesh__D044843 SCF Ubiquitin Ligase
% 217.57/217.72  |- mesh__publicMeSHNote mesh__D044843
% 217.57/217.72       2004; SCF UBIQUITIN LIGASE %28%now SKP CULLIN F-BOX LIGASES%29% was indexed under PEPTIDE SYNTHASES 1999-2003%A%  
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D044843 2006
% 217.57/217.72  |- mesh__dateCreated mesh__D044843 2003-07-09
% 217.57/217.72  |- skos__hiddenLabel mesh__D044843 SKP Cullin F Box Protein Ligases
% 217.57/217.72  |- skos__scopeNote mesh__D044843
% 217.57/217.72       A subset of ubiquitin protein ligases that are formed by the association of a SKP DOMAIN PROTEIN, a CULLIN DOMAIN PROTEIN and a F-BOX DOMAIN PROTEIN.%A%    
% 217.57/217.72  |- mesh__dateEstablished mesh__D044843 2004-01-01
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D044843 2005
% 217.57/217.72  |- skos__broader mesh__D044843smesh__D044767
% 217.57/217.72  |- mesh__recordMaintainer mesh__D044843 jmp
% 217.57/217.72  |- skos__related mesh__D044843smesh__D044842
% 217.57/217.72  |- skos__altLabel mesh__D044843 Skp1-Cullin-F-Box Proteins
% 217.57/217.72  |- skos__altLabel mesh__D011669 Wedge Pressure, Pulmonary
% 217.57/217.72  |- skos__prefLabel mesh__D011669 Pulmonary Wedge Pressure
% 217.57/217.72  |- mesh__recordOriginator mesh__D011669 VDK
% 217.57/217.72  |- mesh__dateEstablished mesh__D011669 1981-01-01
% 217.57/217.72  |- skos__scopeNote mesh__D011669
% 217.57/217.72       The blood pressure as recorded after wedging a CATHETER in a small PULMONARY ARTERY; believed to reflect the PRESSURE in the pulmonary CAPILLARIES.%A%    
% 217.57/217.72  |- skos__altLabel mesh__D011669 Pulmonary Artery Wedge Pressure
% 217.57/217.72  |- skos__annotation mesh__D011669 DF: PULM WEDGE PRESSURE   
% 217.57/217.72  |- mesh__recordAuthorizer mesh__D011669 sjn
% 217.57/217.72  |- mesh__dateCreated mesh__D011669 1980-05-09
% 217.57/217.72  |- skos__hiddenLabel mesh__D011669 Pressure, Wedge
% 217.57/217.72  |- skos__historyNote mesh__D011669 Blood Pressure %28%1966-1980%29%
% 217.57/217.72  |- skos__hiddenLabel mesh__D011669 Pressures, Wedge
% 217.57/217.72  |- skos__altLabel mesh__D011669 Wedge Pressures, Pulmonary
% 217.57/217.72  |- mesh__dateRevised mesh__D011669 2003-07-09
% 217.57/217.72  |- mesh__publicMeSHNote mesh__D011669 81   
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D011669 2006
% 217.57/217.72  |- skos__hiddenLabel mesh__D011669 Wedge Pressures
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D011669 2004
% 217.57/217.72  |- skos__altLabel mesh__D011669 Pressure, Pulmonary Wedge
% 217.57/217.72  |- skos__historyNote mesh__D011669 Pulmonary Circulation %28%1966-1980%29%
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D011669 2005
% 217.57/217.72  |- skos__broader mesh__D011669smesh__D001794
% 217.57/217.72  |- mesh__historyNote mesh__D011669 81   
% 217.57/217.72  |- skos__related mesh__D011669smesh__D011652
% 217.57/217.72  |- skos__altLabel mesh__D011669 Pressures, Pulmonary Wedge
% 217.57/217.72  |- skos__altLabel mesh__D011669 Pulmonary Wedge Pressures
% 217.57/217.72  |- mesh__recordMaintainer mesh__D011669 nns
% 217.57/217.72  |- rdf__type mesh__D011669sskos__Concept
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D044045 2004
% 217.57/217.72  |- skos__historyNote mesh__D044045
% 217.57/217.72       Hydroxyeicosatetraenoic Acids %28%1984-2003%29%
% 217.57/217.72  |- skos__prefLabel mesh__D044045 Lipoxins
% 217.57/217.72  |- mesh__recordMaintainer mesh__D044045 jls
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D044045 2006
% 217.57/217.72  |- mesh__dateEstablished mesh__D044045 2004-01-01
% 217.57/217.72  |- skos__altLabel mesh__D044045 Lipoxin
% 217.57/217.72  |- rdf__type mesh__D044045sskos__Concept
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D044045 2005
% 217.57/217.72  |- mesh__recordOriginator mesh__D044045 jmp
% 217.57/217.72  |- mesh__dateCreated mesh__D044045 2003-07-09
% 217.57/217.72  |- mesh__historyNote mesh__D044045 2004   
% 217.57/217.72  |- mesh__recordAuthorizer mesh__D044045 jls
% 217.57/217.72  |- skos__scopeNote mesh__D044045
% 217.57/217.72       Trihydroxy derivatives of eicosanoic acids. They are primarily derived from arachidonic acid, however eicosapentaenoic acid derivatives also exist. Many of them are naturally occurring mediators of immune regulation.%A%    
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D044045 2005A
% 217.57/217.72  |- mesh__dateRevised mesh__D044045 2004-07-28
% 217.57/217.72  |- mesh__publicMeSHNote mesh__D044045 2004   
% 217.57/217.72  |- skos__broader mesh__D044045smesh__D015777
% 217.57/217.72  |- mesh__publicMeSHNote mesh__D016354 91   
% 217.57/217.72  |- mesh__recordMaintainer mesh__D016354 SYSTEM
% 217.57/217.72  |- skos__altLabel mesh__D016354 Rhodopseudomonas capsulatus
% 217.57/217.72  |- skos__scopeNote mesh__D016354
% 217.57/217.72       Non-pathogenic ovoid to rod-shaped bacteria that are widely distributed and found in fresh water as well as marine and hypersaline habitats.%A%    
% 217.57/217.72  |- mesh__dateRevised mesh__D016354 2005-06-30
% 217.57/217.72  |- skos__historyNote mesh__D016354 Rhodopseudomonas %28%1968-1990%29%
% 217.57/217.72  |- skos__prefLabel mesh__D016354 Rhodobacter capsulatus
% 217.57/217.72  |- skos__broader mesh__D016354smesh__D016992
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D016354 2006
% 217.57/217.72  |- mesh__recordAuthorizer mesh__D016354 sjn
% 217.57/217.72  |- mesh__dateCreated mesh__D016354 1990-05-29
% 217.57/217.72  |- mesh__historyNote mesh__D016354 91   
% 217.57/217.72  |- skos__annotation mesh__D016354 in fresh %26% marine water   
% 217.57/217.72  |- skos__altLabel mesh__D016354 Rhodopseudomonas capsulata
% 217.57/217.72  |- mesh__dateEstablished mesh__D016354 1991-01-01
% 217.57/217.72  |- mesh__recordOriginator mesh__D016354 PXP
% 217.57/217.72  |- rdf__type mesh__D016354sskos__Concept
% 217.57/217.72  |- skos__historyNote mesh__D002334 Acyltransferases %28%1973-1974%29%
% 217.57/217.72  |- mesh__recordOriginator mesh__D002334 NLM
% 217.57/217.72  |- skos__hiddenLabel mesh__D002334 Palmitoyltransferase I, Carnitine
% 217.57/217.72  |- mesh__dateCreated mesh__D002334 1974-11-11
% 217.57/217.72  |- skos__historyNote mesh__D002334 Palmitic Acids %28%1973-1974%29%
% 217.57/217.72  |- skos__hiddenLabel mesh__D002334 II, Carnitine Palmitoyltransferase
% 217.57/217.72  |- skos__hiddenLabel mesh__D002334 Carnitine O Palmitoyltransferase
% 217.57/217.72  |- skos__scopeNote mesh__D002334
% 217.57/217.72       An enzyme that catalyzes reversibly the conversion of palmitoyl-CoA to palmitoylcarnitine in the inner mitochondrial membrane. EC 2.3.1.21.%A%    
% 217.57/217.72  |- skos__hiddenLabel mesh__D002334 Acyltransferase I, Carnitine
% 217.57/217.72  |- mesh__publicMeSHNote mesh__D002334
% 217.57/217.72       98; see CARNITINE PALMITOYLTRANSFERASE 1991-97; see ACYLTRANSFERASES 1975-90%A%  
% 217.57/217.72  |- skos__historyNote mesh__D002334 Carnitine %28%1973-1974%29%
% 217.57/217.72  |- skos__hiddenLabel mesh__D002334 O-Palmitoyltransferase, Carnitine
% 217.57/217.72  |- skos__hiddenLabel mesh__D002334 Acyltransferase, Palmitylcarnitine
% 217.57/217.72  |- rdf__type mesh__D002334sskos__Concept
% 217.57/217.72  |- skos__prefLabel mesh__D002334 Carnitine O-Palmitoyltransferase
% 217.57/217.72  |- mesh__historyNote mesh__D002334 98%28%75%29%   
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D002334 2004
% 217.57/217.72  |- skos__hiddenLabel mesh__D002334 Palmitoyltransferase II, Carnitine
% 217.57/217.72  |- mesh__dateEstablished mesh__D002334 1991-01-01
% 217.57/217.72  |- skos__altLabel mesh__D002334 Carnitine Acyltransferase I
% 217.57/217.72  |- skos__altLabel mesh__D002334 Palmitoylcarnitine Transferase
% 217.57/217.72  |- mesh__recordAuthorizer mesh__D002334 sjn
% 217.57/217.72  |- skos__altLabel mesh__D002334 Carnitine Palmitoyltransferase
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D002334 2006
% 217.57/217.72  |- skos__broader mesh__D002334smesh__D002333
% 217.57/217.72  |- skos__altLabel mesh__D002334 CPT II
% 217.57/217.72  |- mesh__recordMaintainer mesh__D002334 ssb
% 217.57/217.72  |- skos__hiddenLabel mesh__D002334 Palmitoyltransferase, Carnitine
% 217.57/217.72  |- skos__hiddenLabel mesh__D002334 Transferase, Palmitoylcarnitine
% 217.57/217.72  |- skos__altLabel mesh__D002334 Palmitylcarnitine Acyltransferase
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D002334 2005
% 217.57/217.72  |- mesh__dateRevised mesh__D002334 2003-07-09
% 217.57/217.72  |- skos__broader mesh__D008706Q000097smesh__D008706
% 217.57/217.72  |- mesh__preferredCombination mesh__D008706Q000097smesh__D008708
% 217.57/217.72  |- rdf__type mesh__D008706Q000097smesh__CompoundConcept
% 217.57/217.72  |- skos__related mesh__D012762smesh__D022281
% 217.57/217.72  |- mesh__recordOriginator mesh__D012762 NLM
% 217.57/217.72  |- mesh__dateRevised mesh__D012762 2005-06-30
% 217.57/217.72  |- rdf__type mesh__D012762sskos__Concept
% 217.57/217.72  |- mesh__dateCreated mesh__D012762 1999-01-01
% 217.57/217.72  |- skos__broader mesh__D012762smesh__D012760
% 217.57/217.72  |- mesh__recordMaintainer mesh__D012762 SYSTEM
% 217.57/217.72  |- skos__scopeNote mesh__D012762
% 217.57/217.72       A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that is extremely pathogenic and causes severe dysentery. Infection with this organism often leads to ulceration of the intestinal epithelium.%A%    
% 217.57/217.72  |- mesh__recordAuthorizer mesh__D012762 sjn
% 217.57/217.72  |- skos__annotation mesh__D012762
% 217.57/217.72       infection: coord IM with DYSENTERY, BACILLARY %28%IM%29%   
% 217.57/217.72  |- skos__prefLabel mesh__D012762 Shigella dysenteriae
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D012762 2006
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006725 1995
% 217.57/217.72  |- skos__scopeNote mesh__D006725
% 217.57/217.72       Infection of humans or animals with hookworms other than those caused by the genus Ancylostoma or Necator, for which the specific terms ANCYLOSTOMIASIS and NECATORIASIS are available.%A%    
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006725 2001
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006725 2006
% 217.57/217.72  |- skos__prefLabel mesh__D006725 Hookworm Infections
% 217.57/217.72  |- mesh__recordMaintainer mesh__D006725 PXP
% 217.57/217.72  |- skos__altLabel mesh__D006725 Infections, Hookworm
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006725 1996
% 217.57/217.72  |- mesh__recordAuthorizer mesh__D006725 PLS
% 217.57/217.72  |- mesh__onlineNote mesh__D006725
% 217.57/217.72       use HOOKWORM INFECTIONS to search HOOKWORM INFECTION 1966-72 %26% BUNOSTOMIASIS 1968-92%A%  
% 217.57/217.72  |- skos__hiddenLabel mesh__D006725 Bunostomiases
% 217.57/217.72  |- skos__hiddenLabel mesh__D006725 Hookworm Infection
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006725 1998
% 217.57/217.72  |- mesh__dateCreated mesh__D006725 1999-01-01
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006725 1997
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006725 2002
% 217.57/217.72  |- mesh__publicMeSHNote mesh__D006725
% 217.57/217.72       73; was HOOKWORM INFECTION 1963-72; BUNOSTOMIASIS was heading 1968-92%A%  
% 217.57/217.72  |- skos__annotation mesh__D006725
% 217.57/217.72       GEN: prefer specifics; New World hookworm infection = NECATORIASIS, Old World hookworm infection = ANCYLOSTOMIASIS%A%  
% 217.57/217.72  |- rdf__type mesh__D006725sskos__Concept
% 217.57/217.72  |- skos__broader mesh__D006725smesh__D017206
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006725 1999
% 217.57/217.72  |- skos__hiddenLabel mesh__D006725 Infection, Hookworm
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006725 2003
% 217.57/217.72  |- mesh__historyNote mesh__D006725
% 217.57/217.72       73; was HOOKWORM INFECTION 1963-72; BUNOSTOMIASIS was heading 1968-92%A%  
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006725 1994
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006725 2000
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006725 1993
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006725 2005
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D006725 2004
% 217.57/217.72  |- mesh__dateRevised mesh__D006725 1992-05-20
% 217.57/217.72  |- mesh__dateEstablished mesh__D006725 1973-01-01
% 217.57/217.72  |- mesh__recordOriginator mesh__D006725 NLM
% 217.57/217.72  |- mesh__historyNote mesh__D050881 2006%28%1994%29%   
% 217.57/217.72  |- skos__altLabel mesh__D050881 p300 E1A-Associated Coactivator
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D050881 2006
% 217.57/217.72  |- skos__hiddenLabel mesh__D050881 E1A-Associated Coactivator, p300
% 217.57/217.72  |- skos__prefLabel mesh__D050881 E1A-Associated p300 Protein
% 217.57/217.72  |- mesh__recordOriginator mesh__D050881 DRC
% 217.57/217.72  |- rdf__type mesh__D050881sskos__Concept
% 217.57/217.72  |- skos__hiddenLabel mesh__D050881 E1A Associated p300 Protein
% 217.57/217.72  |- skos__hiddenLabel mesh__D050881 p300 Protein, E1A-Associated
% 217.57/217.72  |- skos__scopeNote mesh__D050881
% 217.57/217.72       A member of the p300-CBP transcription factors that was originally identified as a binding partner for ADENOVIRUS E1A PROTEINS.%A%    
% 217.57/217.72  |- mesh__publicMeSHNote mesh__D050881
% 217.57/217.72       2006; E1A-ASSOCIATED P300 PROTEIN was indexed under NUCLEAR PROTEINS %26% TRANS-ACTIVATORS 1999-2005 %26% under TRANSCRIPTION FACTORS 1994-1998%A%  
% 217.57/217.72  |- skos__hiddenLabel mesh__D050881 p300 E1A Associated Coactivator
% 217.57/217.72  |- mesh__dateEstablished mesh__D050881 2006-01-01
% 217.57/217.72  |- mesh__dateCreated mesh__D050881 2005-06-30
% 217.57/217.72  |- mesh__recordMaintainer mesh__D050881 DRC
% 217.57/217.72  |- mesh__recordAuthorizer mesh__D050881 sjn
% 217.57/217.72  |- skos__broader mesh__D050881smesh__D050880
% 217.57/217.72  |- skos__annotation mesh__D044844 see SCR for organism specific terms   
% 217.57/217.72  |- mesh__recordAuthorizer mesh__D044844 sjn
% 217.57/217.72  |- skos__scopeNote mesh__D044844
% 217.57/217.72       A family of F-box domain proteins that contain sequences that are homologous to the beta subunit of transducin %28%BETA-TRANSDUCIN%29%. They play an important role in the protein degradation pathway by becoming components of SKP CULLIN F-BOX PROTEIN LIGASES, which selectively act on a subset of proteins including beta-catenin and IkappaBbeta.%A%    
% 217.57/217.72  |- skos__hiddenLabel mesh__D044844
% 217.57/217.72       beta Transducin Repeat Containing Protein
% 217.57/217.72  |- rdf__type mesh__D044844sskos__Concept
% 217.57/217.72  |- skos__hiddenLabel mesh__D044844
% 217.57/217.72       Repeat-Containing Proteins, beta-Transducin
% 217.57/217.72  |- mesh__dateRevised mesh__D044844 2005-06-30
% 217.57/217.72  |- mesh__recordMaintainer mesh__D044844 SYSTEM
% 217.57/217.72  |- skos__hiddenLabel mesh__D044844
% 217.57/217.72       beta Transducin Repeat Containing Proteins
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D044844 2006
% 217.57/217.72  |- mesh__historyNote mesh__D044844 2004   
% 217.57/217.72  |- skos__hiddenLabel mesh__D044844 beta TrCP
% 217.57/217.72  |- mesh__dateCreated mesh__D044844 2003-07-09
% 217.57/217.72  |- skos__altLabel mesh__D044844 beta-TrCP
% 217.57/217.72  |- skos__altLabel mesh__D044844 beta-Transducin Repeat-Containing Protein
% 217.57/217.72  |- skos__altLabel mesh__D044844 betaTrCP
% 217.57/217.72  |- mesh__publicMeSHNote mesh__D044844 2004   
% 217.57/217.72  |- mesh__recordOriginator mesh__D044844 jmp
% 217.57/217.72  |- skos__prefLabel mesh__D044844 beta-Transducin Repeat-Containing Proteins
% 217.57/217.72  |- skos__hiddenLabel mesh__D044844
% 217.57/217.72       Repeat-Containing Protein, beta-Transducin
% 217.57/217.72  |- skos__broader mesh__D044844smesh__D044783
% 217.57/217.72  |- skos__hiddenLabel mesh__D044844
% 217.57/217.72       Protein, beta-Transducin Repeat-Containing
% 217.57/217.72  |- mesh__dateEstablished mesh__D044844 2004-01-01
% 217.57/217.72  |- skos__altLabel mesh__D016355 Genes, rex
% 217.57/217.72  |- skos__hiddenLabel mesh__D016355 Gene, lor
% 217.57/217.72  |- skos__hiddenLabel mesh__D016355 tax Genes, HTLV-I
% 217.57/217.72  |- skos__altLabel mesh__D016355 Genes, lor
% 217.57/217.72  |- skos__hiddenLabel mesh__D016355 Genes, HTLV-I tax
% 217.57/217.72  |- skos__hiddenLabel mesh__D016355 HTLV II tax Genes
% 217.57/217.72  |- skos__hiddenLabel mesh__D016355 HTLV-I tax Gene
% 217.57/217.72  |- skos__hiddenLabel mesh__D016355 Genes, HTLV-II tax
% 217.57/217.72  |- skos__hiddenLabel mesh__D016355 rex Gene, HTLV-I
% 217.57/217.72  |- skos__hiddenLabel mesh__D016355 Gene, HTLV-II rex
% 217.57/217.72  |- skos__hiddenLabel mesh__D016355 tax Gene
% 217.57/217.72  |- skos__altLabel mesh__D016355 Genes, tax
% 217.57/217.72  |- mesh__activeMeSHYear mesh__D016355 2006
% 217.57/217.72  |- mesh__historyNote mesh__D016355
% 217.57/217.72       91; LOR PROTEINS %26% PX PROTEINS were see TRANS-ACTIVATORS 1990%A%  
% 217.57/217.72  |- mesh__dateEstablished mesh__D016355 1991-01-01
% 217.57/217.72  |- skos__hiddenLabel mesh__D016355 pX Gene
% 217.57/217.72  |- skos__hiddenLabel mesh__D016355 tax Genes, HTLV-II
% 217.57/217.72  |- skos__historyNote mesh__D016355 Genes, Regulator %28%1984-1990%29%
% 217.57/217.72  |- skos__hiddenLabel mesh__D016355 Gene, pX
% 217.57/217.72  |- skos__prefLabel mesh__D016355 Genes, pX
% 217.57/217.72  |- skos__hiddenLabel mesh__D016355 Gene, rex
% 217.57/217.72  |- skos__hiddenLabel mesh__D016355 rex Gene, HTLV-II
% 217.57/217.72  |- skos__broader mesh__D016355smesh__D005814
% 217.57/217.72  |- mesh__recordAuthorizer mesh__D016355 sjn
% 217.57/217.72  |- mesh__recordOriginator mesh__D016355 AGS
% 217.57/217.72  |- rdf__type mesh__D016355sskos__Concept
% 217.57/217.72  |- skos__hiddenLabel mesh__D016355 tax Gene, HTLV-II
% 217.57/217.72  |- skos__hiddenLabel mesh__D016355 rex Genes, HTLV-II
% 217.57/217.72  |- skos__scopeNote mesh__D016355
% 217.57/217.72       DNA sequences that form the coding region for at least three proteins which regulate the expression of HUMAN T-LYMPHOTROPIC VIRUS 1 and HUMAN T-LYMPHOTROPIC VIRUS 2. The proteins are p21%28%x%29%, p27%28%rex%29%, and p40%28%tax%29%. The tax %28%trans-activator x%29% and rex %28%regulator x%29% genes are part of pX but are in overlapping reading frames. X was the original designation for the sequences or region %28%at that time of unknown function%29% in the long open reading frame %28%lor%29% which is now called pX.%A%    
% 217.57/217.72  |- skos__hiddenLabel mesh__D016355 HTLV-I rex Gene
% 217.57/217.72  |- skos__hiddenLabel mesh__D016355 Gene, HTLV-II tax
% 217.57/217.72  |- mesh__dateRevised mesh__D016355 2005-06-30
% 217.57/217.72  |- skos__broader mesh__D016355smesh__D005809
% 217.57/217.72  |- skos__hiddenLabel mesh__D016355 HTLV II rex Genes
% 217.57/217.72  |- skos__hiddenLabel mesh__D016355 rex Genes, HTLV-I
% 217.59/217.72  |- skos__hiddenLabel mesh__D016355 Gene, tax
% 217.59/217.72  |- skos__hiddenLabel mesh__D016355 Gene, HTLV-I rex
% 217.59/217.72  |- skos__hiddenLabel mesh__D016355 Genes, HTLV-I rex
% 217.59/217.72  |- skos__hiddenLabel mesh__D016355 rex Gene
% 217.59/217.72  |- skos__hiddenLabel mesh__D016355 HTLV-II tax Gene
% 217.59/217.72  |- skos__hiddenLabel mesh__D016355 HTLV I rex Genes
% 217.59/217.72  |- skos__hiddenLabel mesh__D016355 HTLV I tax Genes
% 217.59/217.72  |- mesh__publicMeSHNote mesh__D016355
% 217.59/217.72       91; LOR PROTEINS %26% PX PROTEINS were see TRANS-ACTIVATORS 1990%A%  
% 217.59/217.72  |- skos__altLabel mesh__D016355 pX Genes
% 217.59/217.72  |- skos__hiddenLabel mesh__D016355 tax Gene, HTLV-I
% 217.59/217.72  |- skos__hiddenLabel mesh__D016355 HTLV-II rex Gene
% 217.59/217.72  |- skos__hiddenLabel mesh__D016355 lor Genes
% 217.59/217.72  |- skos__hiddenLabel mesh__D016355 Genes, HTLV-II rex
% 217.59/217.72  |- mesh__recordMaintainer mesh__D016355 nns
% 217.59/217.72  |- skos__hiddenLabel mesh__D016355 lor Gene
% 217.59/217.72  |- skos__hiddenLabel mesh__D016355 Gene, HTLV-I tax
% 217.59/217.72  |- skos__historyNote mesh__D016355 Genes, Viral %28%1984-1990%29%
% 217.59/217.72  |- mesh__dateCreated mesh__D016355 1990-06-07
% 217.59/217.72  |- mesh__recordAuthorizer mesh__D002335 sjn
% 217.59/217.72  |- skos__broader mesh__D002335smesh__D008322
% 217.59/217.72  |- skos__annotation mesh__D002335 GEN or unspecified; prefer specifics   
% 217.59/217.72  |- mesh__activeMeSHYear mesh__D002335 2006
% 217.59/217.72  |- mesh__dateRevised mesh__D002335 2004-07-07
% 217.59/217.72  |- mesh__recordOriginator mesh__D002335 NLM
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D002335 2005
% 217.59/217.73  |- mesh__recordMaintainer mesh__D002335 ags
% 217.59/217.73  |- skos__scopeNote mesh__D002335
% 217.59/217.73       An order of MAMMALS, usually flesh eaters with appropriate dentition. Suborders include the terrestrial carnivores Fissipedia, and the aquatic carnivores PINNIPEDIA.%A%    
% 217.59/217.73  |- mesh__dateCreated mesh__D002335 1999-01-01
% 217.59/217.73  |- skos__prefLabel mesh__D002335 Carnivora
% 217.59/217.73  |- rdf__type mesh__D002335sskos__Concept
% 217.59/217.73  |- skos__altLabel mesh__D007020 Deficiency, Factor II
% 217.59/217.73  |- mesh__recordOriginator mesh__D007020 NLM
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D007020 2003
% 217.59/217.73  |- skos__hiddenLabel mesh__D007020 Prothrombin Deficiencies
% 217.59/217.73  |- skos__broader mesh__D007020smesh__D025861
% 217.59/217.73  |- skos__broader mesh__D007020smesh__D020147
% 217.59/217.73  |- skos__hiddenLabel mesh__D007020 Deficiencies, Prothrombin
% 217.59/217.73  |- skos__scopeNote mesh__D007020
% 217.59/217.73       Absence or reduced levels of prothrombin in the blood.     
% 217.59/217.73  |- skos__hiddenLabel mesh__D007020 Hypoprothrombinemia
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D007020 2006
% 217.59/217.73  |- mesh__recordMaintainer mesh__D007020 nns
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D007020 2005
% 217.59/217.73  |- skos__hiddenLabel mesh__D007020 Factor II Deficiencies
% 217.59/217.73  |- skos__hiddenLabel mesh__D007020 Deficiency, Prothrombin
% 217.59/217.73  |- rdf__type mesh__D007020sskos__Concept
% 217.59/217.73  |- skos__prefLabel mesh__D007020 Hypoprothrombinemias
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D007020 2002
% 217.59/217.73  |- skos__broader mesh__D007020smesh__D006474
% 217.59/217.73  |- skos__altLabel mesh__D007020 Prothrombin Deficiency
% 217.59/217.73  |- mesh__dateCreated mesh__D007020 1999-01-01
% 217.59/217.73  |- mesh__recordAuthorizer mesh__D007020 sjn
% 217.59/217.73  |- mesh__dateRevised mesh__D007020 2001-07-25
% 217.59/217.73  |- skos__altLabel mesh__D007020 Factor II Deficiency
% 217.59/217.73  |- skos__hiddenLabel mesh__D007020 Deficiencies, Factor II
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D007020 2004
% 217.59/217.73  |- rdf__type mesh__D012763sskos__Concept
% 217.59/217.73  |- mesh__dateCreated mesh__D012763 1999-01-01
% 217.59/217.73  |- skos__broader mesh__D012763smesh__D012760
% 217.59/217.73  |- mesh__historyNote mesh__D012763 74%28%72%29%   
% 217.59/217.73  |- mesh__recordMaintainer mesh__D012763 SYSTEM
% 217.59/217.73  |- mesh__dateEstablished mesh__D012763 1974-01-01
% 217.59/217.73  |- mesh__recordOriginator mesh__D012763 NLM
% 217.59/217.73  |- skos__prefLabel mesh__D012763 Shigella flexneri
% 217.59/217.73  |- mesh__dateRevised mesh__D012763 2005-06-30
% 217.59/217.73  |- skos__annotation mesh__D012763
% 217.59/217.73       infection: coord IM with DYSENTERY, BACILLARY %28%IM%29%   
% 217.59/217.73  |- skos__historyNote mesh__D012763 Shigella %28%1966-1971%29%
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D012763 2006
% 217.59/217.73  |- skos__scopeNote mesh__D012763
% 217.59/217.73       A bacterium which is one of the etiologic agents of bacillary dysentery %28%DYSENTERY, BACILLARY%29% and sometimes of infantile gastroenteritis.%A%    
% 217.59/217.73  |- mesh__recordAuthorizer mesh__D012763 sjn
% 217.59/217.73  |- mesh__publicMeSHNote mesh__D012763 74   
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D006726 1998
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D006726 2003
% 217.59/217.73  |- mesh__recordMaintainer mesh__D006726 TAP
% 217.59/217.73  |- skos__broader mesh__D006726smesh__D015818
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D006726 1995
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D006726 2002
% 217.59/217.73  |- skos__altLabel mesh__D006726 Stye
% 217.59/217.73  |- mesh__recordAuthorizer mesh__D006726 PLS
% 217.59/217.73  |- mesh__recordOriginator mesh__D006726 NLM
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D006726 2006
% 217.59/217.73  |- skos__broader mesh__D006726smesh__D005141
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D006726 1994
% 217.59/217.73  |- skos__scopeNote mesh__D006726
% 217.59/217.73       Purulent infection of one of the sebaceous glands of Zeis along the eyelid margin %28%external%29% or of the meibomian gland on the conjunctival side of the eyelid %28%internal%29%.%A%    
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D006726 1997
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D006726 2005
% 217.59/217.73  |- skos__hiddenLabel mesh__D006726 Styes
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D006726 1996
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D006726 2001
% 217.59/217.73  |- skos__prefLabel mesh__D006726 Hordeolum
% 217.59/217.73  |- rdf__type mesh__D006726sskos__Concept
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D006726 2000
% 217.59/217.73  |- mesh__dateCreated mesh__D006726 1999-01-01
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D006726 1999
% 217.59/217.73  |- skos__annotation mesh__D006726 bact eye infect   
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D006726 2004
% 217.59/217.73  |- mesh__dateRevised mesh__D006726 1993-06-02
% 217.59/217.73  |- rdf__type mesh__D039102sskos__Concept
% 217.59/217.73  |- skos__altLabel mesh__D039102 Poly A-Binding Proteins
% 217.59/217.73  |- skos__prefLabel mesh__D039102 Poly%28%A%29%-Binding Proteins
% 217.59/217.73  |- skos__hiddenLabel mesh__D039102 Poly A Binding Protein
% 217.59/217.73  |- skos__hiddenLabel mesh__D039102 Poly A Binding Proteins
% 217.59/217.73  |- skos__broader mesh__D039102smesh__D016601
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D039102 2006
% 217.59/217.73  |- skos__historyNote mesh__D039102 RNA-Binding Proteins %28%1994-2002%29%
% 217.59/217.73  |- skos__altLabel mesh__D039102 Poly%28%A%29%-Binding Protein
% 217.59/217.73  |- skos__annotation mesh__D039102
% 217.59/217.73       GEN; prefer specifics; note species-specific terms in SCR%A%  
% 217.59/217.73  |- mesh__recordOriginator mesh__D039102 jmp
% 217.59/217.73  |- skos__scopeNote mesh__D039102
% 217.59/217.73       Proteins that bind to the 3%27% polyadenylated region of MRNA. When complexed with RNA the proteins serve an array of functions such as stabilizing the 3%27% end of RNA, promoting poly%28%A%29% synthesis and stimulating mRNA translation.%A%    
% 217.59/217.73  |- mesh__dateCreated mesh__D039102 2002-07-03
% 217.59/217.73  |- mesh__dateEstablished mesh__D039102 2003-01-01
% 217.59/217.73  |- skos__altLabel mesh__D039102 Poly A-Binding Protein
% 217.59/217.73  |- skos__historyNote mesh__D039102 Carrier Proteins %28%1982-2002%29%
% 217.59/217.73  |- mesh__publicMeSHNote mesh__D039102
% 217.59/217.73       2003; POLY%28%A%29%-BINDING PROTEINS was indexed under RNA-BINDING PROTEINS 1994-2002 %26% under CARRIER PROTEINS 1982-1993%A%  
% 217.59/217.73  |- mesh__historyNote mesh__D039102
% 217.59/217.73       2003; use POLY%28%A%29%-BINDING PROTEINS %28%NM%29% 1982-2002   
% 217.59/217.73  |- mesh__recordMaintainer mesh__D039102 SYSTEM
% 217.59/217.73  |- skos__altLabel mesh__D039102 Poly%28%A%29%+ mRNA Binding Protein
% 217.59/217.73  |- mesh__recordAuthorizer mesh__D039102 sjn
% 217.59/217.73  |- mesh__dateRevised mesh__D039102 2005-06-30
% 217.59/217.73  |- mesh__dateCreated mesh__D050882 2005-06-30
% 217.59/217.73  |- mesh__historyNote mesh__D050882 2006%28%1994%29%   
% 217.59/217.73  |- skos__hiddenLabel mesh__D050882 Phospho CREB Binding Protein
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D050882 2006
% 217.59/217.73  |- mesh__dateEstablished mesh__D050882 2006-01-01
% 217.59/217.73  |- skos__altLabel mesh__D050882 Nuclear Protein CBP
% 217.59/217.73  |- mesh__recordAuthorizer mesh__D050882 sjn
% 217.59/217.73  |- skos__broader mesh__D050882smesh__D050880
% 217.59/217.73  |- rdf__type mesh__D050882sskos__Concept
% 217.59/217.73  |- mesh__publicMeSHNote mesh__D050882
% 217.59/217.73       2006; CREB-BINDING PROTEIN was indexed under TRANS-ACTIVATORS %26% NUCLEAR PROTEINS 1999-2005, %26% under TRANSCRIPTION FACTORS 1994-1998%A%  
% 217.59/217.73  |- skos__scopeNote mesh__D050882
% 217.59/217.73       A member of the p300-CBP transcription factor family that was initially identified as a binding partner for CAMP RESPONSE ELEMENT-BINDING PROTEIN. Mutations in CREB-binding protein are associated with RUBINSTEIN-TAYBI SYNDROME.%A%    
% 217.59/217.73  |- skos__altLabel mesh__D050882 Phospho-CREB-Binding Protein
% 217.59/217.73  |- skos__hiddenLabel mesh__D050882 CREB Binding Protein
% 217.59/217.73  |- skos__hiddenLabel mesh__D050882 CBP, Nuclear Protein
% 217.59/217.73  |- mesh__recordMaintainer mesh__D050882 DRC
% 217.59/217.73  |- skos__prefLabel mesh__D050882 CREB-Binding Protein
% 217.59/217.73  |- mesh__recordOriginator mesh__D050882 DRC
% 217.59/217.73  |- skos__altLabel mesh__D016356 p40%28%tax%29%
% 217.59/217.73  |- skos__altLabel mesh__D016356 Trans-Activator Protein pX
% 217.59/217.73  |- skos__historyNote mesh__D016356 Transcription Factors %28%1986-1989%29%
% 217.59/217.73  |- skos__altLabel mesh__D016356 Transactivator Protein p40%28%x%29%
% 217.59/217.73  |- skos__altLabel mesh__D016356 Trans-Activator Protein p40%28%lor%29%
% 217.59/217.73  |- skos__altLabel mesh__D016356 HTLV-I tax Protein
% 217.59/217.73  |- skos__hiddenLabel mesh__D016356 Protein, HTLV-II Trans-Activator
% 217.59/217.73  |- skos__hiddenLabel mesh__D016356 Protein, HTLV-I tax
% 217.59/217.73  |- skos__hiddenLabel mesh__D016356 Trans Activator Protein p40x
% 217.59/217.73  |- skos__hiddenLabel mesh__D016356 HTLV I tax Protein
% 217.59/217.73  |- skos__broader mesh__D016356smesh__D015682
% 217.59/217.73  |- skos__altLabel mesh__D016356
% 217.59/217.73       Human T-Cell Leukemia Virus Type II tax Gene Product
% 217.59/217.73  |- skos__hiddenLabel mesh__D016356 HTLV II tax Protein
% 217.59/217.73  |- mesh__onlineNote mesh__D016356
% 217.59/217.73       use TRANS-ACTIVATORS to search HTLV-I TRANS-ACTIVATOR PROTEIN, TRANS-ACTIVATOR PROTEIN P40%28%X%29%, %26% TAX PROTEIN 1990%A%  
% 217.59/217.73  |- skos__altLabel mesh__D016356 p40 tax
% 217.59/217.73  |- skos__altLabel mesh__D016356 HTLV-II tax Protein
% 217.59/217.73  |- skos__hiddenLabel mesh__D016356 tax Protein, HTLV-II
% 217.59/217.73  |- skos__hiddenLabel mesh__D016356 Protein pX, Trans-Activator
% 217.59/217.73  |- skos__hiddenLabel mesh__D016356 tax Gene Product
% 217.59/217.73  |- skos__altLabel mesh__D016356 HTLV-I tax Gene Product
% 217.59/217.73  |- rdf__type mesh__D016356sskos__Concept
% 217.59/217.73  |- mesh__recordAuthorizer mesh__D016356 sjn
% 217.59/217.73  |- skos__prefLabel mesh__D016356 Gene Products, tax
% 217.59/217.73  |- mesh__historyNote mesh__D016356
% 217.59/217.73       91; HTLV-I TRANS-ACTIVATOR PROTEIN, TRANS-ACTIVATOR PROTEIN P40%28%X%29%, %26% TAX PROTEIN were see TRANS-ACTIVATORS 1990%A%  
% 217.59/217.73  |- skos__hiddenLabel mesh__D016356 tax, p40
% 217.59/217.73  |- skos__hiddenLabel mesh__D016356 Protein p40x, Trans-Activator
% 217.59/217.73  |- skos__hiddenLabel mesh__D016356 p40x, Transforming Antigen
% 217.59/217.73  |- skos__hiddenLabel mesh__D016356 p40x, Trans-Activator Protein
% 217.59/217.73  |- mesh__dateRevised mesh__D016356 2005-06-30
% 217.59/217.73  |- skos__altLabel mesh__D016356 Trans-Activator Protein p40x
% 217.59/217.73  |- skos__hiddenLabel mesh__D016356 Trans-Activator Protein, HTLV-II
% 217.59/217.73  |- skos__altLabel mesh__D016356 Trans-Activator Protein p40%28%x%29%
% 217.59/217.73  |- skos__hiddenLabel mesh__D016356 Trans Activator Protein pX
% 217.59/217.73  |- skos__hiddenLabel mesh__D016356 HTLV I Trans Activator Protein
% 217.59/217.73  |- skos__altLabel mesh__D016356 Gene Product, tax
% 217.59/217.73  |- skos__annotation mesh__D016356
% 217.59/217.73       Tax stands for %22%trans-activator x%22%; /drug eff /ultrastruct permitted%A%  
% 217.59/217.73  |- skos__altLabel mesh__D016356 HTLV-II tax Gene Product
% 217.59/217.73  |- skos__hiddenLabel mesh__D016356 tax Protein, HTLV-I
% 217.59/217.73  |- skos__hiddenLabel mesh__D016356 HTLV II Trans Activator Protein
% 217.59/217.73  |- mesh__dateCreated mesh__D016356 1990-06-19
% 217.59/217.73  |- skos__hiddenLabel mesh__D016356 pX, Trans-Activator Protein
% 217.59/217.73  |- skos__altLabel mesh__D016356
% 217.59/217.73       Human T-Cell Leukemia Virus Type I tax Gene Product
% 217.59/217.73  |- skos__hiddenLabel mesh__D016356 Protein, HTLV-II tax
% 217.59/217.73  |- mesh__recordMaintainer mesh__D016356 DRC
% 217.59/217.73  |- skos__altLabel mesh__D016356 Transforming Antigen p40x
% 217.59/217.73  |- skos__hiddenLabel mesh__D016356 Antigen p40x, Transforming
% 217.59/217.73  |- skos__altLabel mesh__D016356 Transactivator p40%28%tax%29%
% 217.59/217.73  |- skos__altLabel mesh__D016356 tax Protein
% 217.59/217.73  |- mesh__dateEstablished mesh__D016356 1991-01-01
% 217.59/217.73  |- mesh__recordOriginator mesh__D016356 AGS
% 217.59/217.73  |- mesh__publicMeSHNote mesh__D016356
% 217.59/217.73       91; HTLV-I TRANS-ACTIVATOR PROTEIN, TRANS-ACTIVATOR PROTEIN P40%28%X%29%, %26% TAX PROTEIN were see TRANS-ACTIVATORS 1990%A%  
% 217.59/217.73  |- skos__historyNote mesh__D016356 Trans-Activators %28%1990%29%
% 217.59/217.73  |- skos__broader mesh__D016356smesh__D015534
% 217.59/217.73  |- skos__scopeNote mesh__D016356
% 217.59/217.73       Transcriptional trans-acting proteins of the promoter elements found in the long terminal repeats %28%LTR%29% of HUMAN T-LYMPHOTROPIC VIRUS 1 and HUMAN T-LYMPHOTROPIC VIRUS 2. The tax %28%trans-activator x; x is undefined%29% proteins act by binding to enhancer elements in the LTR.%A%    
% 217.59/217.73  |- skos__altLabel mesh__D016356
% 217.59/217.73       Human T-Cell Leukemia Virus Type I tax Protein
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D016356 2006
% 217.59/217.73  |- skos__altLabel mesh__D016356 Trans-Activator Protein p40%28%tax%29%
% 217.59/217.73  |- skos__hiddenLabel mesh__D016356 Trans-Activator Protein, HTLV-I
% 217.59/217.73  |- skos__altLabel mesh__D016356 tax Gene Products
% 217.59/217.73  |- mesh__onlineNote mesh__D002336
% 217.59/217.73       search DIPEPTIDES 1967-74 %26% PEPTIDES 1966   
% 217.59/217.73  |- skos__altLabel mesh__D002336 beta-Alanylhistidine
% 217.59/217.73  |- mesh__dateEstablished mesh__D002336 1991-01-01
% 217.59/217.73  |- mesh__recordMaintainer mesh__D002336 ssb
% 217.59/217.73  |- skos__scopeNote mesh__D002336
% 217.59/217.73       A naturally occurring dipeptide neuropeptide found in muscles.%A%    
% 217.59/217.73  |- mesh__publicMeSHNote mesh__D002336
% 217.59/217.73       91; was see under DIPEPTIDES 1967-90; was see under PEPTIDES 1963-66%A%  
% 217.59/217.73  |- mesh__dateRevised mesh__D002336 2005-06-30
% 217.59/217.73  |- mesh__historyNote mesh__D002336
% 217.59/217.73       91%28%75%29%; was see under DIPEPTIDES 1967-90; was see under PEPTIDES 1963-66%A%  
% 217.59/217.73  |- mesh__recordOriginator mesh__D002336 NLM
% 217.59/217.73  |- skos__broader mesh__D002336smesh__D004151
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D002336 2006
% 217.59/217.73  |- skos__prefLabel mesh__D002336 Carnosine
% 217.59/217.73  |- mesh__dateCreated mesh__D002336 1999-01-01
% 217.59/217.73  |- skos__broader mesh__D002336smesh__D009479
% 217.59/217.73  |- rdf__type mesh__D002336sskos__Concept
% 217.59/217.73  |- mesh__recordAuthorizer mesh__D002336 sjn
% 217.59/217.73  |- skos__hiddenLabel mesh__D002336 beta Alanylhistidine
% 217.59/217.73  |- skos__broader mesh__D007021smesh__D010409
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D007021 2006
% 217.59/217.73  |- skos__scopeNote mesh__D007021
% 217.59/217.73       A birth defect due to malformation of the URETHRA in which the urethral opening is below its normal location. In the male, the malformed urethra generally opens on the ventral surface of the PENIS or on the PERINEUM. In the female, the malformed urethral opening is in the VAGINA.%A%    
% 217.59/217.73  |- mesh__recordOriginator mesh__D007021 NLM
% 217.59/217.73  |- skos__broader mesh__D007021smesh__D014564
% 217.59/217.73  |- rdf__type mesh__D007021sskos__Concept
% 217.59/217.73  |- mesh__dateCreated mesh__D007021 1999-01-01
% 217.59/217.73  |- mesh__recordMaintainer mesh__D007021 lkt
% 217.59/217.73  |- skos__hiddenLabel mesh__D007021 Hypospadia
% 217.59/217.73  |- skos__prefLabel mesh__D007021 Hypospadias
% 217.59/217.73  |- mesh__dateRevised mesh__D007021 2005-06-30
% 217.59/217.73  |- mesh__recordAuthorizer mesh__D007021 sjn
% 217.59/217.73  |- skos__prefLabel mesh__D012764 Shigella sonnei
% 217.59/217.73  |- mesh__dateCreated mesh__D012764 1999-01-01
% 217.59/217.73  |- rdf__type mesh__D012764sskos__Concept
% 217.59/217.73  |- mesh__recordOriginator mesh__D012764 NLM
% 217.59/217.73  |- mesh__historyNote mesh__D012764 66%28%63%29%   
% 217.59/217.73  |- mesh__publicMeSHNote mesh__D012764 66   
% 217.59/217.73  |- mesh__recordMaintainer mesh__D012764 SYSTEM
% 217.59/217.73  |- skos__broader mesh__D012764smesh__D012760
% 217.59/217.73  |- skos__annotation mesh__D012764
% 217.59/217.73       infection: coord IM with DYSENTERY, BACILLARY %28%IM%29%   
% 217.59/217.73  |- mesh__dateEstablished mesh__D012764 1966-01-01
% 217.59/217.73  |- mesh__dateRevised mesh__D012764 2005-06-30
% 217.59/217.73  |- mesh__recordAuthorizer mesh__D012764 sjn
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D012764 2006
% 217.59/217.73  |- skos__scopeNote mesh__D012764
% 217.59/217.73       A lactose-fermenting bacterium causing dysentery.     
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D039901 2006
% 217.59/217.73  |- skos__hiddenLabel mesh__D039901 Cell, Totipotent Stem
% 217.59/217.73  |- skos__prefLabel mesh__D039901 Totipotent Stem Cells
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D039901 2005
% 217.59/217.73  |- skos__hiddenLabel mesh__D039901 Cells, Totipotent Stem
% 217.59/217.73  |- skos__altLabel mesh__D039901 Stem Cells, Totipotent
% 217.59/217.73  |- skos__broader mesh__D039901smesh__D013234
% 217.59/217.73  |- skos__annotation mesh__D039901
% 217.59/217.73       MULTIPOTENT STEM CELLS and PLURIPOTENT STEM CELLS are also available%A%  
% 217.59/217.73  |- mesh__historyNote mesh__D039901 2003   
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D039901 2004
% 217.59/217.73  |- rdf__type mesh__D039901sskos__Concept
% 217.59/217.73  |- mesh__dateEstablished mesh__D039901 2003-01-01
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D039901 2003
% 217.59/217.73  |- skos__scopeNote mesh__D039901
% 217.59/217.73       Single cells that have the potential to form an entire organism. They have the capacity to specialize into extraembryonic membranes and tissues, the embryo, and all postembryonic tissues and organs. %28%Stem Cells: A Primer %5B%Internet%5D%. Bethesda %28%MD%29%: National Institutes of Health %28%US%29%;  2000 May %5B%cited 2002 Apr 5%5D%. Available from: http://www.nih.gov/news/stemcell/primer.htm%29%%A%    
% 217.59/217.73  |- mesh__publicMeSHNote mesh__D039901 2003   
% 217.59/217.73  |- skos__hiddenLabel mesh__D039901 Stem Cell, Totipotent
% 217.59/217.73  |- mesh__dateCreated mesh__D039901 2002-07-03
% 217.59/217.73  |- skos__hiddenLabel mesh__D039901 Totipotent Stem Cell
% 217.59/217.73  |- mesh__historyNote mesh__D006727 75   
% 217.59/217.73  |- skos__historyNote mesh__D006727
% 217.59/217.73       Hormones/antagonists %26% inhibitors %28%1968-1974%29%
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D006727 2006
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D006727 2005
% 217.59/217.73  |- mesh__dateRevised mesh__D006727 2003-07-09
% 217.59/217.73  |- skos__prefLabel mesh__D006727 Hormone Antagonists
% 217.59/217.73  |- skos__hiddenLabel mesh__D006727 Antagonists, Hormone
% 217.59/217.73  |- mesh__recordAuthorizer mesh__D006727 sjn
% 217.59/217.73  |- skos__scopeNote mesh__D006727
% 217.59/217.73       Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites.%A%    
% 217.59/217.73  |- mesh__recordOriginator mesh__D006727 NLM
% 217.59/217.73  |- rdf__type mesh__D006727sskos__Concept
% 217.59/217.73  |- mesh__recordMaintainer mesh__D006727 ssb
% 217.59/217.73  |- skos__annotation mesh__D006727 DF: HORMONE ANTAG   
% 217.59/217.73  |- mesh__dateCreated mesh__D006727 1999-01-01
% 217.59/217.73  |- mesh__publicMeSHNote mesh__D006727 75   
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D006727 2004
% 217.59/217.73  |- mesh__dateEstablished mesh__D006727 1975-09-01
% 217.59/217.73  |- skos__broader mesh__D006727smesh__D006730
% 217.59/217.73  |- skos__altLabel mesh__D039103 Pabp2 Protein
% 217.59/217.73  |- skos__broader mesh__D039103smesh__D039102
% 217.59/217.73  |- skos__scopeNote mesh__D039103
% 217.59/217.73       A poly%28%A%29% binding protein that is involved in promoting the extension of the poly A tails of MRNA. The protein requires a minimum of ten ADENOSINE nucleotides in order for binding to mRNA. Once bound it works in conjunction with CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR to stimulate the rate of poly A synthesis by POLY A POLYMERASE. Once poly-A tails reach around 250 nucleotides in length poly%28%A%29% binding protein II no longer stimulates POLYADENYLATION. Mutations within a GCG repeat region in the gene for poly%28%A%29% binding protein II have been shown to cause the disease MUSCULAR DYSTROPHY, OCULOPHARYNGEAL.%A%    
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D039103 2006
% 217.59/217.73  |- mesh__recordAuthorizer mesh__D039103 sjn
% 217.59/217.73  |- skos__altLabel mesh__D039103 PAB II
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D039103 2005
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D039103 2004
% 217.59/217.73  |- skos__altLabel mesh__D039103 Pabp2 Gene Product
% 217.59/217.73  |- skos__prefLabel mesh__D039103 Poly%28%A%29%-Binding Protein II
% 217.59/217.73  |- mesh__publicMeSHNote mesh__D039103
% 217.59/217.73       2003; PAB II was indexed under RNA-BINDING PROTEINS 1995-2002; PABP2 GENE PRODUCT %26% PABP2 PROTEIN were indexed under RNA-BINDING PROTEINS 1999-2002; PABP2 was indexed under RNA-BINDING PROTEINS 2000-2002%A%  
% 217.59/217.73  |- skos__altLabel mesh__D039103 Poly%28%A%29% Binding Protein, Nuclear 1
% 217.59/217.73  |- skos__altLabel mesh__D039103 Poly%28%A%29% Binding Protein II
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D039103 2003
% 217.59/217.73  |- mesh__recordMaintainer mesh__D039103 jmp
% 217.59/217.73  |- mesh__historyNote mesh__D039103
% 217.59/217.73       2003; for PAB II use POLY%28%A%29%-BINDING PROTEINS %28%NM%29% 1995-2002; for PABP2 GENE PRODUCT %26% PABP2 PROTEIN use POLY%28%A%29%-BINDING PROTEINS %28%NM%29% 1999-2002; for PABP2 use POLY%28%A%29%-BINDING PROTEINS %28%NM%29% 2000-2002%A%  
% 217.59/217.73  |- mesh__recordOriginator mesh__D039103 jmp
% 217.59/217.73  |- mesh__dateCreated mesh__D039103 2002-07-03
% 217.59/217.73  |- skos__related mesh__D039103smesh__D039141
% 217.59/217.73  |- rdf__type mesh__D039103sskos__Concept
% 217.59/217.73  |- mesh__dateEstablished mesh__D039103 2003-01-01
% 217.59/217.73  |- skos__historyNote mesh__D039103 RNA-Binding Proteins %28%1995-2002%29%
% 217.59/217.73  |- skos__altLabel mesh__D039103 PABP2
% 217.59/217.73  |- skos__altLabel mesh__D039103 PAB2 Poly%28%A%29% Binding Protein
% 217.59/217.73  |- skos__hiddenLabel mesh__D050883 HSC70 Heat Shock Proteins
% 217.59/217.73  |- skos__altLabel mesh__D050883 Heat-Shock Cognate 70 Protein
% 217.59/217.73  |- mesh__recordMaintainer mesh__D050883 DRC
% 217.59/217.73  |- rdf__type mesh__D050883sskos__Concept
% 217.59/217.73  |- mesh__historyNote mesh__D050883 2006%28%2001%29%   
% 217.59/217.73  |- mesh__dateCreated mesh__D050883 2005-06-30
% 217.59/217.73  |- skos__prefLabel mesh__D050883 HSC70 Heat-Shock Proteins
% 217.59/217.73  |- mesh__dateEstablished mesh__D050883 2006-01-01
% 217.59/217.73  |- mesh__publicMeSHNote mesh__D050883
% 217.59/217.73       2006; HSC70 PROTEIN, was indexed under HEAT SHOCK PROTEINS 70 2001-2005%A%  
% 217.59/217.73  |- mesh__recordAuthorizer mesh__D050883 sjn
% 217.59/217.73  |- skos__hiddenLabel mesh__D050883 Uncoating Protein, Clathrin
% 217.59/217.73  |- skos__altLabel mesh__D050883 Hsc70 Protein
% 217.59/217.73  |- skos__hiddenLabel mesh__D050883 Heat-Shock Proteins, HSC70
% 217.59/217.73  |- skos__scopeNote mesh__D050883
% 217.59/217.73       A constitutively expressed subfamily of the HSP70 heat-shock proteins. They preferentially bind and release hydrophobic peptides by an ATP-dependent process and are involved in post-translational PROTEIN TRANSLOCATION.%A%    
% 217.59/217.73  |- skos__broader mesh__D050883smesh__D018840
% 217.59/217.73  |- skos__altLabel mesh__D050883 70 kDa Heat-Shock Cognate Protein
% 217.59/217.73  |- mesh__recordOriginator mesh__D050883 DRC
% 217.59/217.73  |- skos__hiddenLabel mesh__D050883 70 kDa Heat Shock Cognate Protein
% 217.59/217.73  |- skos__altLabel mesh__D050883 Clathrin Uncoating Protein
% 217.59/217.73  |- skos__hiddenLabel mesh__D050883 Heat Shock Cognate 70 Protein
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D050883 2006
% 217.59/217.73  |- skos__broader mesh__D012256Q000172smesh__D012256
% 217.59/217.73  |- mesh__preferredCombination mesh__D012256Q000172smesh__D012257
% 217.59/217.73  |- rdf__type mesh__D012256Q000172smesh__CompoundConcept
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D016357 1997
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D016357 2006
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D016357 2003
% 217.59/217.73  |- skos__altLabel mesh__D016357 Practitioner, Infection Control
% 217.59/217.73  |- mesh__recordAuthorizer mesh__D016357 PLS
% 217.59/217.73  |- mesh__historyNote mesh__D016357 91   
% 217.59/217.73  |- mesh__dateCreated mesh__D016357 1990-05-29
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D016357 2004
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D016357 1994
% 217.59/217.73  |- rdf__type mesh__D016357sskos__Concept
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D016357 2000
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D016357 1995
% 217.59/217.73  |- mesh__dateRevised mesh__D016357 1992-05-14
% 217.59/217.73  |- skos__scopeNote mesh__D016357
% 217.59/217.73       Physicians or other qualified individuals responsible for implementing and overseeing the policies and procedures followed by a health care facility to reduce the risk of infection to patients and staff.%A%    
% 217.59/217.73  |- skos__prefLabel mesh__D016357 Infection Control Practitioners
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D016357 2001
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D016357 1993
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D016357 1998
% 217.59/217.73  |- mesh__recordOriginator mesh__D016357 JHM
% 217.59/217.73  |- skos__annotation mesh__D016357 DF: INFECT CONTROL PRACTITIONERS   
% 217.59/217.73  |- mesh__dateEstablished mesh__D016357 1991-01-01
% 217.59/217.73  |- mesh__publicMeSHNote mesh__D016357 91   
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D016357 2002
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D016357 1999
% 217.59/217.73  |- skos__broader mesh__D016357smesh__D006282
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D016357 1996
% 217.59/217.73  |- skos__altLabel mesh__D016357 Practitioners, Infection Control
% 217.59/217.73  |- skos__altLabel mesh__D016357 Infection Control Practitioner
% 217.59/217.73  |- mesh__recordMaintainer mesh__D016357 TGC
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D016357 2005
% 217.59/217.73  |- mesh__recordMaintainer mesh__D007820 lkt
% 217.59/217.73  |- mesh__publicMeSHNote mesh__D007820 91; was see under LARYNX 1979-90   
% 217.59/217.73  |- skos__prefLabel mesh__D007820 Laryngeal Mucosa
% 217.59/217.73  |- mesh__dateEstablished mesh__D007820 1991-01-01
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D007820 2006
% 217.59/217.73  |- skos__hiddenLabel mesh__D007820 Epithelium, Laryngeal
% 217.59/217.73  |- mesh__dateCreated mesh__D007820 1978-05-19
% 217.59/217.73  |- mesh__dateRevised mesh__D007820 2005-06-30
% 217.59/217.73  |- skos__broader mesh__D007820smesh__D020545
% 217.59/217.73  |- mesh__recordAuthorizer mesh__D007820 sjn
% 217.59/217.73  |- skos__broader mesh__D007820smesh__D007830
% 217.59/217.73  |- skos__hiddenLabel mesh__D007820 Mucosa, Laryngeal
% 217.59/217.73  |- skos__historyNote mesh__D007820 Mucous Membrane %28%1966-1978%29%
% 217.59/217.73  |- mesh__recordOriginator mesh__D007820 RC
% 217.59/217.73  |- mesh__historyNote mesh__D007820
% 217.59/217.73       91%28%79%29%; was see under LARYNX 1979-90   
% 217.59/217.73  |- skos__historyNote mesh__D007820 Larynx %28%1966-1978%29%
% 217.59/217.73  |- rdf__type mesh__D007820sskos__Concept
% 217.59/217.73  |- skos__scopeNote mesh__D007820
% 217.59/217.73       The mucous lining of the LARYNX, consisting of various types of epithelial cells ranging from stratified squamous EPITHELIUM in the upper larynx to ciliated columnar epithelium in the rest of the larynx, mucous GOBLET CELLS, and glands containing both mucous and serous cells.%A%    
% 217.59/217.73  |- skos__related mesh__D007022smesh__D019462
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D007022 2006
% 217.59/217.73  |- mesh__recordAuthorizer mesh__D007022 SJN
% 217.59/217.73  |- mesh__dateCreated mesh__D007022 1999-01-01
% 217.59/217.73  |- mesh__recordMaintainer mesh__D007022 TGC
% 217.59/217.73  |- skos__hiddenLabel mesh__D007022 Low Blood Pressure
% 217.59/217.73  |- skos__scopeNote mesh__D007022
% 217.59/217.73       Abnormally low blood pressure seen in shock but not necessarily indicative of it. %28%Dorland, 28th ed%29%%A%    
% 217.59/217.73  |- mesh__dateRevised mesh__D007022 1997-06-20
% 217.59/217.73  |- rdf__type mesh__D007022sskos__Concept
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D007022 2000
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D007022 2003
% 217.59/217.73  |- skos__hiddenLabel mesh__D007022 Low Blood Pressures
% 217.59/217.73  |- skos__hiddenLabel mesh__D007022 Hypotensions
% 217.59/217.73  |- skos__broader mesh__D007022smesh__D014652
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D007022 2004
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D007022 2001
% 217.59/217.73  |- mesh__recordOriginator mesh__D007022 NLM
% 217.59/217.73  |- skos__prefLabel mesh__D007022 Hypotension
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D007022 1998
% 217.59/217.73  |- skos__hiddenLabel mesh__D007022 Blood Pressures, Low
% 217.59/217.73  |- skos__altLabel mesh__D007022 Blood Pressure, Low
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D007022 2002
% 217.59/217.73  |- skos__annotation mesh__D007022
% 217.59/217.73       only blood pressure; not for intracranial pressure; relation to BLOOD PRESSURE: Manual 23.27+%A%  
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D007022 2005
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D007022 1999
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D012765 1994
% 217.59/217.73  |- rdf__type mesh__D012765sskos__Concept
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D012765 2002
% 217.59/217.73  |- mesh__activeMeSHYear mesh__D012765 1998
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D012765 2004
% 217.59/217.74  |- skos__prefLabel mesh__D012765 Shikimic Acid
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D012765 1995
% 217.59/217.74  |- skos__broader mesh__D012765smesh__D006880
% 217.59/217.74  |- mesh__dateRevised mesh__D012765 1992-05-20
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D012765 1999
% 217.59/217.74  |- mesh__recordAuthorizer mesh__D012765 PLS
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D012765 2000
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D012765 1996
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D012765 1993
% 217.59/217.74  |- skos__broader mesh__D012765smesh__D003509
% 217.59/217.74  |- mesh__recordOriginator mesh__D012765 NLM
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D012765 2005
% 217.59/217.74  |- mesh__recordMaintainer mesh__D012765 TAP
% 217.59/217.74  |- mesh__dateCreated mesh__D012765 1999-01-01
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D012765 2001
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D012765 1997
% 217.59/217.74  |- skos__hiddenLabel mesh__D012765 Acid, Shikimic
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D012765 2006
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D012765 2003
% 217.59/217.74  |- skos__broader mesh__D039902smesh__D013234
% 217.59/217.74  |- skos__annotation mesh__D039902
% 217.59/217.74       TOTIPOTENT STEM CELLS and PLURIPOTENT STEM CELLS are also available%A%  
% 217.59/217.74  |- skos__altLabel mesh__D039902 Stem Cells, Multipotent
% 217.59/217.74  |- mesh__dateCreated mesh__D039902 2002-07-03
% 217.59/217.74  |- skos__prefLabel mesh__D039902 Multipotent Stem Cells
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D039902 2004
% 217.59/217.74  |- rdf__type mesh__D039902sskos__Concept
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D039902 2003
% 217.59/217.74  |- skos__scopeNote mesh__D039902
% 217.59/217.74       Specialized stem cells that are committed to give rise to cells that have a particular function; examples are MYOBLASTS; MYELOID PROGENITOR CELLS; and skin stem cells. %28%Stem Cells: A Primer %5B%Internet%5D%. Bethesda %28%MD%29%: National Institutes of Health %28%US%29%; 2000 May %5B%cited 2002 Apr 5%5D%. Available from: http://www.nih.gov/news/stemcell/primer.htm%29%%A%    
% 217.59/217.74  |- mesh__publicMeSHNote mesh__D039902 2003   
% 217.59/217.74  |- mesh__historyNote mesh__D039902 2003   
% 217.59/217.74  |- skos__historyNote mesh__D039902
% 217.59/217.74       Stem Cells or specifics %28%1982-2002%29%
% 217.59/217.74  |- mesh__dateEstablished mesh__D039902 2003-01-01
% 217.59/217.74  |- skos__hiddenLabel mesh__D039902 Stem Cell, Multipotent
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D039902 2006
% 217.59/217.74  |- skos__hiddenLabel mesh__D039902 Multipotent Stem Cell
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D039902 2005
% 217.59/217.74  |- skos__broader mesh__D039104smesh__D038621
% 217.59/217.74  |- mesh__recordOriginator mesh__D039104 jmp
% 217.59/217.74  |- mesh__dateEstablished mesh__D039104 2003-01-01
% 217.59/217.74  |- skos__broader mesh__D039104smesh__D040461
% 217.59/217.74  |- skos__hiddenLabel mesh__D039104 Sequence, AAUAAA RNA
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D039104 2006
% 217.59/217.74  |- skos__hiddenLabel mesh__D039104 RNA Sequence, AAUAAA
% 217.59/217.74  |- mesh__publicMeSHNote mesh__D039104 2003   
% 217.59/217.74  |- skos__altLabel mesh__D039104 3%27% Polyadenylation Signal
% 217.59/217.74  |- skos__hiddenLabel mesh__D039104 Sequences, AAUAAA RNA
% 217.59/217.74  |- skos__prefLabel mesh__D039104 RNA 3%27% Polyadenylation Signals
% 217.59/217.74  |- skos__hiddenLabel mesh__D039104 3%27% Polyadenylation Signals
% 217.59/217.74  |- skos__hiddenLabel mesh__D039104 Polyadenylation Signal, 3%27%
% 217.59/217.74  |- mesh__recordMaintainer mesh__D039104 nns
% 217.59/217.74  |- mesh__dateCreated mesh__D039104 2002-07-02
% 217.59/217.74  |- mesh__recordAuthorizer mesh__D039104 sjn
% 217.59/217.74  |- mesh__dateRevised mesh__D039104 2005-06-30
% 217.59/217.74  |- skos__hiddenLabel mesh__D039104 Signals, 3%27% Polyadenylation
% 217.59/217.74  |- skos__scopeNote mesh__D039104
% 217.59/217.74       Sequences found near the 3%27% end of MESSENGER RNA that direct the cleavage and addition of multiple ADENINE NUCLEOTIDES to the 3%27% end of mRNA.%A%    
% 217.59/217.74  |- skos__altLabel mesh__D039104 RNA 3%27% Polyadenylation Signal
% 217.59/217.74  |- rdf__type mesh__D039104sskos__Concept
% 217.59/217.74  |- skos__hiddenLabel mesh__D039104 AAUAAA RNA Sequences
% 217.59/217.74  |- mesh__historyNote mesh__D039104 2003   
% 217.59/217.74  |- mesh__recordMaintainer mesh__D006728 ssb
% 217.59/217.74  |- skos__scopeNote mesh__D006728
% 217.59/217.74       Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.%A%    
% 217.59/217.74  |- rdf__type mesh__D006728sskos__Concept
% 217.59/217.74  |- skos__related mesh__D006728smesh__D011956
% 217.59/217.74  |- mesh__dateCreated mesh__D006728 1999-01-01
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D006728 2004
% 217.59/217.74  |- skos__broader mesh__D006728smesh__D006730
% 217.59/217.74  |- skos__prefLabel mesh__D006728 Hormones
% 217.59/217.74  |- mesh__onlineNote mesh__D006728 pre-explosion = HORMONES %28%PX%29%   
% 217.59/217.74  |- skos__annotation mesh__D006728
% 217.59/217.74       GEN; prefer specifics; for hormone receptors, see note at RECEPTORS, CELL SURFACE%A%  
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D006728 2006
% 217.59/217.74  |- mesh__recordAuthorizer mesh__D006728 sjn
% 217.59/217.74  |- skos__altLabel mesh__D006728 Hormone
% 217.59/217.74  |- mesh__recordOriginator mesh__D006728 NLM
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D006728 2005
% 217.59/217.74  |- mesh__dateRevised mesh__D006728 2003-07-09
% 217.59/217.74  |- skos__related mesh__D006728smesh__D006727
% 217.59/217.74  |- mesh__dateRevised mesh__D017450 2003-07-09
% 217.59/217.74  |- skos__altLabel mesh__D017450 mu Receptor
% 217.59/217.74  |- skos__hiddenLabel mesh__D017450 Receptor, mu Opioid
% 217.59/217.74  |- skos__altLabel mesh__D017450 Receptors, mu
% 217.59/217.74  |- skos__altLabel mesh__D017450 Receptors, Morphine
% 217.59/217.74  |- skos__altLabel mesh__D017450 Receptors, mu Opioid
% 217.59/217.74  |- mesh__publicMeSHNote mesh__D017450
% 217.59/217.74       94; was RECEPTORS, MU 1993; MU RECEPTOR was indexed under RECEPTORS, ENDORPHIN 1981-92; MORPHINE RECEPTORS %26% RECEPTORS, MORPHINE were see RECEPTORS, OPIOID 1977-94%A%  
% 217.59/217.74  |- mesh__dateEstablished mesh__D017450 1993-01-01
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D017450 2004
% 217.59/217.74  |- skos__hiddenLabel mesh__D017450 Opioid Receptor, mu
% 217.59/217.74  |- mesh__recordAuthorizer mesh__D017450 sjn
% 217.59/217.74  |- skos__altLabel mesh__D017450 Opioid Receptors, mu
% 217.59/217.74  |- rdf__type mesh__D017450sskos__Concept
% 217.59/217.74  |- skos__hiddenLabel mesh__D017450 Receptor, mu
% 217.59/217.74  |- skos__annotation mesh__D017450
% 217.59/217.74       opioid receptors found in the hypothalamus; DF: RECEPT MU%A%  
% 217.59/217.74  |- skos__hiddenLabel mesh__D017450 Receptor, Morphine
% 217.59/217.74  |- skos__scopeNote mesh__D017450
% 217.59/217.74       A class of opioid receptors recognized by its pharmacological profile. Mu opioid receptors bind, in decreasing order of affinity, endorphins, dynorphins, met-enkephalin, and leu-enkephalin. They have also been shown to be molecular receptors for morphine.%A%    
% 217.59/217.74  |- skos__altLabel mesh__D017450 mu Receptors
% 217.59/217.74  |- skos__altLabel mesh__D017450 mu Opioid Receptor
% 217.59/217.74  |- mesh__onlineNote mesh__D017450
% 217.59/217.74       use RECEPTORS, OPIOID, MU to search RECEPTORS, MU 1993; use RECEPTORS, OPIOID, MU %28%NM%29% to search MU RECEPTOR 1981-92; use RECEPTORS, OPIOID to search MORPHINE RECEPTORS %26% RECEPTORS, MORPHINE 1977-94%A%  
% 217.59/217.74  |- skos__hiddenLabel mesh__D017450 mu Opioid Receptors
% 217.59/217.74  |- skos__broader mesh__D017450smesh__D011957
% 217.59/217.74  |- skos__altLabel mesh__D017450 Morphine Receptors
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D017450 2005
% 217.59/217.74  |- skos__historyNote mesh__D017450 Receptors, Endorphin %28%1981-1992%29%
% 217.59/217.74  |- mesh__historyNote mesh__D017450
% 217.59/217.74       94; was RECEPTORS, MU 1993; was MU RECEPTOR %28%NM%29% 1981-92; MORPHINE RECEPTORS %26% RECEPTORS, MORPHINE were see RECEPTORS, OPIOID 1977-94%A%  
% 217.59/217.74  |- mesh__recordMaintainer mesh__D017450 jmp
% 217.59/217.74  |- mesh__dateCreated mesh__D017450 1992-05-22
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D017450 2006
% 217.59/217.74  |- skos__prefLabel mesh__D017450 Receptors, Opioid, mu
% 217.59/217.74  |- mesh__recordOriginator mesh__D017450 PXP
% 217.59/217.74  |- rdf__type mesh__D031121sskos__Concept
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D031121 2006A
% 217.59/217.74  |- mesh__recordAuthorizer mesh__D031121 ags
% 217.59/217.74  |- mesh__dateCreated mesh__D031121 2002-07-03
% 217.59/217.74  |- skos__prefLabel mesh__D031121 Mannheimia
% 217.59/217.74  |- mesh__dateRevised mesh__D031121 2005-07-22
% 217.59/217.74  |- mesh__dateEstablished mesh__D031121 2003-01-01
% 217.59/217.74  |- skos__broader mesh__D031121smesh__D015661
% 217.59/217.74  |- skos__altLabel mesh__D031121 Pasteurella granulomatis
% 217.59/217.74  |- skos__scopeNote mesh__D031121
% 217.59/217.74       Genus of bacteria in the family PASTEURELLACEAE, comprising multiple species that do not ferment trehalose. Species include MANNHEIMIA HAEMOLYTICA; M. glucosida, M. granulomatis, M. ruminalis, and M. varigena.%A%    
% 217.59/217.74  |- mesh__recordOriginator mesh__D031121 ags
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D031121 2006
% 217.59/217.74  |- mesh__publicMeSHNote mesh__D031121 2003   
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D031121 2006B
% 217.59/217.74  |- skos__annotation mesh__D031121
% 217.59/217.74       infection: coord IM with PASTEURELLACEAE INFECTIONS %28%IM%29%   
% 217.59/217.74  |- mesh__historyNote mesh__D031121 2003   
% 217.59/217.74  |- mesh__recordMaintainer mesh__D031121 ags
% 217.59/217.74  |- skos__hiddenLabel mesh__D050884 Heat Shock Protein p72
% 217.59/217.74  |- skos__hiddenLabel mesh__D050884 HSP 72 Protein
% 217.59/217.74  |- mesh__publicMeSHNote mesh__D050884
% 217.59/217.74       2006; HSP72 PROTEIN was indexed under HEAT SHOCK PROTEINS 1994-2005%A%  
% 217.59/217.74  |- skos__scopeNote mesh__D050884
% 217.59/217.74       Stress-inducible members of the heat-shock proteins 70 family.  HSP72 heat shock proteins function with other MOLECULAR CHAPERONES to mediate PROTEIN FOLDING and to stabilize pre-existent proteins against aggregation.%A%    
% 217.59/217.74  |- skos__broader mesh__D050884smesh__D018840
% 217.59/217.74  |- mesh__recordMaintainer mesh__D050884 DRC
% 217.59/217.74  |- skos__altLabel mesh__D050884 Heat-Shock Protein p72
% 217.59/217.74  |- mesh__recordOriginator mesh__D050884 DRC
% 217.59/217.74  |- skos__hiddenLabel mesh__D050884 HSP70 1 Heat Shock Proteins
% 217.59/217.74  |- skos__altLabel mesh__D050884 Heat Shock Proteins 72
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D050884 2006
% 217.59/217.74  |- mesh__dateEstablished mesh__D050884 2006-01-01
% 217.59/217.74  |- mesh__dateCreated mesh__D050884 2005-06-30
% 217.59/217.74  |- mesh__historyNote mesh__D050884 2006%28%1994%29%   
% 217.59/217.74  |- skos__hiddenLabel mesh__D050884 Heat-Shock Proteins, HSP72
% 217.59/217.74  |- skos__altLabel mesh__D050884 HSP-72 Protein
% 217.59/217.74  |- skos__prefLabel mesh__D050884 HSP72 Heat-Shock Proteins
% 217.59/217.74  |- rdf__type mesh__D050884sskos__Concept
% 217.59/217.74  |- skos__hiddenLabel mesh__D050884 p72, Heat-Shock Protein
% 217.59/217.74  |- skos__altLabel mesh__D050884 Heat Shock Protein 72
% 217.59/217.74  |- mesh__recordAuthorizer mesh__D050884 sjn
% 217.59/217.74  |- skos__hiddenLabel mesh__D050884 HSP72 Heat Shock Proteins
% 217.59/217.74  |- skos__altLabel mesh__D050884 HSP70-1 Heat Shock Proteins
% 217.59/217.74  |- skos__altLabel mesh__D050884 Hsp72 Protein
% 217.59/217.74  |- skos__hiddenLabel mesh__D003430 Analyses, Cross-Sectional
% 217.59/217.74  |- skos__hiddenLabel mesh__D003430 Prevalence Study
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D003430 2006
% 217.59/217.74  |- mesh__dateEstablished mesh__D003430 1990-01-01
% 217.59/217.74  |- skos__hiddenLabel mesh__D003430 Survey, Cross-Sectional
% 217.59/217.74  |- skos__altLabel mesh__D003430 Disease Frequency Surveys
% 217.59/217.74  |- skos__altLabel mesh__D003430 Cross-Sectional Survey
% 217.59/217.74  |- mesh__recordMaintainer mesh__D003430 ags
% 217.59/217.74  |- skos__hiddenLabel mesh__D003430 Study, Prevalence
% 217.59/217.74  |- mesh__onlineNote mesh__D003430
% 217.59/217.74       use CROSS-SECTIONAL STUDIES to search PREVALENCE STUDIES 1989%A%  
% 217.59/217.74  |- mesh__publicMeSHNote mesh__D003430
% 217.59/217.74       90; was see under EPIDEMIOLOGIC METHODS 1975-89; PREVALENCE STUDIES was heading 1989%A%  
% 217.59/217.74  |- skos__hiddenLabel mesh__D003430 Cross Sectional Survey
% 217.59/217.74  |- skos__annotation mesh__D003430
% 217.59/217.74       IM GEN only; coord NIM with specific disease %28%IM%29%; no qualif; specify geog if pertinent%A%  
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D003430 2005
% 217.59/217.74  |- skos__hiddenLabel mesh__D003430 Cross Sectional Analyses
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D003430 2004
% 217.59/217.74  |- rdf__type mesh__D003430sskos__Concept
% 217.59/217.74  |- skos__scopeNote mesh__D003430
% 217.59/217.74       Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time.%A%    
% 217.59/217.74  |- mesh__recordOriginator mesh__D003430 NLM
% 217.59/217.74  |- skos__prefLabel mesh__D003430 Cross-Sectional Studies
% 217.59/217.74  |- skos__hiddenLabel mesh__D003430 Study, Cross-Sectional
% 217.59/217.74  |- skos__hiddenLabel mesh__D003430 Cross-Sectional Surveys
% 217.59/217.74  |- skos__hiddenLabel mesh__D003430 Surveys, Cross-Sectional
% 217.59/217.74  |- skos__hiddenLabel mesh__D003430 Cross Sectional Studies
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D003430 2003
% 217.59/217.74  |- mesh__historyNote mesh__D003430
% 217.59/217.74       90%28%75%29%; was see under EPIDEMIOLOGIC METHODS 1975-89; PREVALENCE STUDIES was heading 1989%A%  
% 217.59/217.74  |- mesh__dateRevised mesh__D003430 2001-07-25
% 217.59/217.74  |- skos__hiddenLabel mesh__D003430 Cross-Sectional Analyses
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D003430 2002
% 217.59/217.74  |- skos__hiddenLabel mesh__D003430 Analysis, Cross Sectional
% 217.59/217.74  |- skos__hiddenLabel mesh__D003430 Studies, Prevalence
% 217.59/217.74  |- skos__hiddenLabel mesh__D003430 Analyses, Cross Sectional
% 217.59/217.74  |- skos__altLabel mesh__D003430 Analysis, Cross-Sectional
% 217.59/217.74  |- mesh__recordAuthorizer mesh__D003430 sjn
% 217.59/217.74  |- skos__hiddenLabel mesh__D003430 Studies, Cross-Sectional
% 217.59/217.74  |- skos__altLabel mesh__D003430 Cross Sectional Analysis
% 217.59/217.74  |- skos__hiddenLabel mesh__D003430 Survey, Disease Frequency
% 217.59/217.74  |- skos__hiddenLabel mesh__D003430 Disease Frequency Survey
% 217.59/217.74  |- mesh__dateCreated mesh__D003430 1974-11-19
% 217.59/217.74  |- skos__hiddenLabel mesh__D003430 Cross-Sectional Study
% 217.59/217.74  |- skos__altLabel mesh__D003430 Surveys, Disease Frequency
% 217.59/217.74  |- skos__broader mesh__D003430smesh__D016021
% 217.59/217.74  |- skos__hiddenLabel mesh__D003430 Cross-Sectional Analysis
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D016358 2001
% 217.59/217.74  |- rdf__type mesh__D016358sskos__Concept
% 217.59/217.74  |- skos__broader mesh__D016358smesh__D003140
% 217.59/217.74  |- mesh__recordAuthorizer mesh__D016358 jls
% 217.59/217.74  |- mesh__publicMeSHNote mesh__D016358 91   
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D016358 2002
% 217.59/217.74  |- skos__annotation mesh__D016358
% 217.59/217.74       IM; coord with disease /epidemiol or /transm %28%IM%29%   
% 217.59/217.74  |- skos__scopeNote mesh__D016358
% 217.59/217.74       Identification of those persons %28%or animals%29% who have had such an association with an infected person, animal, or contaminated environment as to have had the opportunity to acquire the infection. Contact tracing is a generally accepted method for the control of sexually transmitted diseases.%A%    
% 217.59/217.74  |- skos__prefLabel mesh__D016358 Contact Tracing
% 217.59/217.74  |- skos__altLabel mesh__D016358 Infectious Disease Contact Tracing
% 217.59/217.74  |- skos__historyNote mesh__D016358
% 217.59/217.74       specific disease/prevention %26% control %28%1972-1990%29%
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D016358 1999
% 217.59/217.74  |- mesh__dateCreated mesh__D016358 1990-08-02
% 217.59/217.74  |- mesh__dateEstablished mesh__D016358 1991-01-01
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D016358 2005
% 217.59/217.74  |- skos__hiddenLabel mesh__D016358 Partner Notifications
% 217.59/217.74  |- skos__historyNote mesh__D016358
% 217.59/217.74       Sexually Transmitted Diseases/prevention %26% control %28%1966-1990%29%
% 217.59/217.74  |- skos__hiddenLabel mesh__D016358 Notifications, Partner
% 217.59/217.74  |- skos__altLabel mesh__D016358 Communicable Disease Contact Tracing
% 217.59/217.74  |- skos__hiddenLabel mesh__D016358 Tracing, Contact
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D016358 2006
% 217.59/217.74  |- mesh__recordOriginator mesh__D016358 AGS
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D016358 2003
% 217.59/217.74  |- skos__broader mesh__D016358smesh__D004812
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D016358 2003A
% 217.59/217.74  |- skos__historyNote mesh__D016358
% 217.59/217.74       specific infection/prevention %26% control %28%1986-1990%29%
% 217.59/217.74  |- mesh__historyNote mesh__D016358 91   
% 217.59/217.74  |- skos__altLabel mesh__D016358 Partner Notification
% 217.59/217.74  |- mesh__recordMaintainer mesh__D016358 jls
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D016358 2000
% 217.59/217.74  |- mesh__dateRevised mesh__D016358 2002-10-31
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D016358 2004
% 217.59/217.74  |- mesh__dateCreated mesh__D002338 1999-01-01
% 217.59/217.74  |- skos__prefLabel mesh__D002338 Carotenoids
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D002338 2006
% 217.59/217.74  |- mesh__recordMaintainer mesh__D002338 ssb
% 217.59/217.74  |- skos__broader mesh__D002338smesh__D013729
% 217.59/217.74  |- skos__altLabel mesh__D002338 Carotene
% 217.59/217.74  |- mesh__recordAuthorizer mesh__D002338 sjn
% 217.59/217.74  |- rdf__type mesh__D002338sskos__Concept
% 217.59/217.74  |- mesh__historyNote mesh__D002338 1966   
% 217.59/217.74  |- mesh__dateRevised mesh__D002338 2005-06-30
% 217.59/217.74  |- skos__broader mesh__D002338smesh__D010860
% 217.59/217.74  |- mesh__publicMeSHNote mesh__D002338
% 217.59/217.74       1966; for CAROTENE see CAROTENE 1966-2001   
% 217.59/217.74  |- mesh__recordOriginator mesh__D002338 NLM
% 217.59/217.74  |- skos__scopeNote mesh__D002338
% 217.59/217.74       The general name for a group of fat-soluble pigments found in green, yellow, and leafy vegetables, and yellow fruits. They are aliphatic hydrocarbons consisting of a polyisoprene backbone.%A%    
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D013060 2003
% 217.59/217.74  |- skos__hiddenLabel mesh__D013060 Speaking, Public
% 217.59/217.74  |- skos__annotation mesh__D013060
% 217.59/217.74       = LANGUAGE as it comes out of the mouth; VERBAL BEHAVIOR is how it comes out; PHONETICS is the sounds making up SPEECH; AMERICAN SPEECH-LANGUAGE-HEARING ASSOCIATION is also available%A%  
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D013060 2003A
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D013060 2004
% 217.59/217.74  |- skos__broader mesh__D013060smesh__D014705
% 217.59/217.74  |- skos__related mesh__D013060smesh__D014705
% 217.59/217.74  |- rdf__type mesh__D013060sskos__Concept
% 217.59/217.74  |- mesh__dateCreated mesh__D013060 1999-01-01
% 217.59/217.74  |- mesh__dateRevised mesh__D013060 2002-10-23
% 217.59/217.74  |- mesh__recordAuthorizer mesh__D013060 sjn
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D013060 2005
% 217.59/217.74  |- mesh__recordMaintainer mesh__D013060 sjn
% 217.59/217.74  |- skos__scopeNote mesh__D013060
% 217.59/217.74       Communication through a system of conventional vocal symbols.%A%    
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D013060 2006
% 217.59/217.74  |- mesh__recordOriginator mesh__D013060 NLM
% 217.59/217.74  |- skos__broader mesh__D013060smesh__D007803
% 217.59/217.74  |- skos__broader mesh__D013060smesh__D009424
% 217.59/217.74  |- skos__prefLabel mesh__D013060 Speech
% 217.59/217.74  |- mesh__recordMaintainer mesh__D007821 nns
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D007821 2003
% 217.59/217.74  |- mesh__historyNote mesh__D007821
% 217.59/217.74       91%28%79%29%; was see under MUSCLES 1979-90   
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D007821 2005
% 217.59/217.74  |- skos__broader mesh__D007821smesh__D018482
% 217.59/217.74  |- mesh__dateRevised mesh__D007821 2001-07-25
% 217.59/217.74  |- skos__hiddenLabel mesh__D007821 Muscle, Laryngeal
% 217.59/217.74  |- skos__broader mesh__D007821smesh__D007830
% 217.59/217.74  |- mesh__dateCreated mesh__D007821 1978-05-19
% 217.59/217.74  |- skos__hiddenLabel mesh__D007821 Laryngeal Muscle
% 217.59/217.74  |- mesh__publicMeSHNote mesh__D007821 91; was see under MUSCLES 1979-90   
% 217.59/217.74  |- skos__historyNote mesh__D007821 Larynx %28%1966-1978%29%
% 217.59/217.74  |- mesh__recordOriginator mesh__D007821 RC
% 217.59/217.74  |- rdf__type mesh__D007821sskos__Concept
% 217.59/217.74  |- mesh__recordAuthorizer mesh__D007821 sjn
% 217.59/217.74  |- skos__annotation mesh__D007821
% 217.59/217.74       /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 217.59/217.74  |- skos__historyNote mesh__D007821 Muscles %28%1966-1978%29%
% 217.59/217.74  |- skos__prefLabel mesh__D007821 Laryngeal Muscles
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D007821 2004
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D007821 2002
% 217.59/217.74  |- skos__scopeNote mesh__D007821
% 217.59/217.74       The intrinsic muscles of the larynx are the aryepiglottic%28%us%29%, arytenoid%28%eus%29%, cricoarytenoid%28%eus%29%, cricothyroid%28%eus%29%, thyroarytenoid%28%eus%29%, thyroepiglottic%28%us%29% and vocal%28%is%29%.%A%    
% 217.59/217.74  |- mesh__dateEstablished mesh__D007821 1991-01-01
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D007821 2006
% 217.59/217.74  |- skos__hiddenLabel mesh__D007821 Muscles, Laryngeal
% 217.59/217.74  |- mesh__dateCreated mesh__D007023 1999-01-01
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D007023 1991
% 217.59/217.74  |- skos__hiddenLabel mesh__D007023 Controlled Hypotension
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D007023 2002
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D007023 1996
% 217.59/217.74  |- rdf__type mesh__D007023sskos__Concept
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D007023 2003
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D007023 1997
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D007023 1992
% 217.59/217.74  |- skos__prefLabel mesh__D007023 Hypotension, Controlled
% 217.59/217.74  |- mesh__dateRevised mesh__D007023 1991-11-14
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D007023 1993
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D007023 2004
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D007023 1998
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D007023 2000
% 217.59/217.74  |- mesh__recordMaintainer mesh__D007023 PLS
% 217.59/217.74  |- skos__broader mesh__D007023smesh__D000760
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D007023 2005
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D007023 1994
% 217.59/217.74  |- mesh__recordAuthorizer mesh__D007023 PLS
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D007023 1999
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D007023 2001
% 217.59/217.74  |- mesh__recordOriginator mesh__D007023 NLM
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D007023 1995
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D007023 2006
% 217.59/217.74  |- skos__annotation mesh__D007023
% 217.59/217.74       note category: a technique; do not use /util except by MeSH definition%A%  
% 217.59/217.74  |- skos__hiddenLabel mesh__D012766 Pneumonic Pasteurellosis
% 217.59/217.74  |- skos__broader mesh__D012766smesh__D048090
% 217.59/217.74  |- skos__prefLabel mesh__D012766 Pasteurellosis, Pneumonic
% 217.59/217.74  |- mesh__publicMeSHNote mesh__D012766
% 217.59/217.74       91; was SHIPPING FEVER see under PASTEURELLA INFECTIONS 1963-90%A%  
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D012766 2005
% 217.59/217.74  |- mesh__dateCreated mesh__D012766 1999-01-01
% 217.59/217.74  |- mesh__dateRevised mesh__D012766 2004-07-30
% 217.59/217.74  |- mesh__recordAuthorizer mesh__D012766 jls
% 217.59/217.74  |- skos__broader mesh__D012766smesh__D016871
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D012766 2006
% 217.59/217.74  |- mesh__onlineNote mesh__D012766
% 217.59/217.74       Use PASTEURELLOSIS, PNEUMONIC to search SHIPPING FEVER 1975-90; use PASTEURELLA INFECTIONS 1966-74%A%  
% 217.59/217.74  |- mesh__dateEstablished mesh__D012766 1991-01-01
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D012766 2005A
% 217.59/217.74  |- skos__altLabel mesh__D012766 Shipping Fever
% 217.59/217.74  |- skos__annotation mesh__D012766
% 217.59/217.74       infection: coordinate with PASTEURELLA MULTOCIDA %28%IM%29%,  MANNHEIMIA HAEMOLYTICA %28%IM%29% or HAEMOPHILUS SOMNUS %28%IM%29% only if particularly discussed; if in cows, check the tag CATTLE; if in other animas, coordinate with precoordinated animal/disease term %28%IM%29% + specific animal %28%NIM%29% or specific animal %28%IM%29% if there is no precoordinated animal/disease term%A%  
% 217.59/217.74  |- mesh__recordOriginator mesh__D012766 NLM
% 217.59/217.74  |- rdf__type mesh__D012766sskos__Concept
% 217.59/217.74  |- skos__scopeNote mesh__D012766
% 217.59/217.74       Bovine respiratory disease found in animals that have been shipped or exposed to CATTLE recently transported. The major agent responsible for the disease is MANNHEIMIA HAEMOLYTICA and less commonly, PASTEURELLA MULTOCIDA or HAEMOPHILUS SOMNUS. All three agents are normal inhabitants of the bovine nasal pharyngeal mucosa but not the LUNG. They are considered opportunistic pathogens following STRESS and/or a viral infection. The resulting bacterial fibrinous BRONCHOPNEUMONIA is often fatal.%A%    
% 217.59/217.74  |- mesh__recordMaintainer mesh__D012766 jls
% 217.59/217.74  |- skos__hiddenLabel mesh__D012766 Fever, Shipping
% 217.59/217.74  |- skos__broader mesh__D012766smesh__D010253
% 217.59/217.74  |- mesh__historyNote mesh__D012766
% 217.59/217.74       91; was SHIPPING FEVER see under PASTEURELLA INFECTIONS 1963-90%A%  
% 217.59/217.74  |- skos__annotation mesh__D045142
% 217.59/217.74       note category, an immunologic process; do not confuse with cross-modality priming %28%= probably ASSOCIATION LEARNING or other psychol terms%29%%A%  
% 217.59/217.74  |- skos__broader mesh__D045142smesh__D007109
% 217.59/217.74  |- skos__hiddenLabel mesh__D045142 Cross Priming
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D045142 2005
% 217.59/217.74  |- skos__hiddenLabel mesh__D045142 Cross Presentation
% 217.59/217.74  |- mesh__recordOriginator mesh__D045142 ags
% 217.59/217.74  |- mesh__recordMaintainer mesh__D045142 ags
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D045142 2006
% 217.59/217.74  |- rdf__type mesh__D045142sskos__Concept
% 217.59/217.74  |- mesh__publicMeSHNote mesh__D045142 2004   
% 217.59/217.74  |- mesh__dateCreated mesh__D045142 2003-07-09
% 217.59/217.74  |- skos__broader mesh__D045142smesh__D008213
% 217.59/217.74  |- skos__scopeNote mesh__D045142
% 217.59/217.74       Class I-restricted activation of CD8-POSITIVE LYMPHOCYTES resulting from ANTIGEN PRESENTATION of exogenous ANTIGENS %28%cross-presentation%29%. This is in contrast to normal activation of these lymphocytes %28%direct-priming%29% which results from presentation of endogenous antigens.%A%    
% 217.59/217.74  |- skos__prefLabel mesh__D045142 Cross-Priming
% 217.59/217.74  |- mesh__dateRevised mesh__D045142 2004-07-07
% 217.59/217.74  |- mesh__recordAuthorizer mesh__D045142 sjn
% 217.59/217.74  |- mesh__historyNote mesh__D045142 2004   
% 217.59/217.74  |- skos__related mesh__D045142smesh__D017951
% 217.59/217.74  |- mesh__dateEstablished mesh__D045142 2004-01-01
% 217.59/217.74  |- mesh__dateCreated mesh__D039903 2002-07-02
% 217.59/217.74  |- skos__broader mesh__D039903smesh__D006094
% 217.59/217.74  |- mesh__historyNote mesh__D039903
% 217.59/217.74       2003; for ACTINOMYCETES use ACTINOMYCETALES 1997-2002 %26% 1963-1966%A%  
% 217.59/217.74  |- skos__altLabel mesh__D039903 Actinomycetes
% 217.59/217.74  |- skos__altLabel mesh__D039903 High G+C Gram-Positive Bacteria
% 217.59/217.74  |- skos__prefLabel mesh__D039903 Actinobacteria
% 217.59/217.74  |- mesh__publicMeSHNote mesh__D039903
% 217.59/217.74       2003; for ACTINOMYCETES see ACTINOMYCETALES 1997-2002, see ACTINOMYCETES 1963-1966%A%  
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D039903 2006
% 217.59/217.74  |- skos__scopeNote mesh__D039903
% 217.59/217.74       Class of BACTERIA with diverse morphological properties. Strains of Actinobacteria show greater than 80%25% 16S rDNA/rRNA sequence similarity among each other and also the presence of certain signature nucleotides. %28%Stackebrandt E. et al, Int. J. Syst. Bacteriol. %28%1997%29% 47:479-491%29%%A%    
% 217.59/217.74  |- skos__broader mesh__D039903smesh__D016988
% 217.59/217.74  |- mesh__recordAuthorizer mesh__D039903 sjn
% 217.59/217.74  |- mesh__recordOriginator mesh__D039903 ags
% 217.59/217.74  |- rdf__type mesh__D039903sskos__Concept
% 217.59/217.74  |- mesh__dateEstablished mesh__D039903 2003-01-01
% 217.59/217.74  |- mesh__dateRevised mesh__D039903 2005-06-30
% 217.59/217.74  |- skos__altLabel mesh__D039903 Gram-Positive Bacteria, High G+C
% 217.59/217.74  |- mesh__recordMaintainer mesh__D039903 SYSTEM
% 217.59/217.74  |- skos__scopeNote mesh__D006729
% 217.59/217.74       Hormones released from neoplasms or from other cells that are not the usual sources of hormones.%A%    
% 217.59/217.74  |- mesh__dateCreated mesh__D006729 1999-01-01
% 217.59/217.74  |- skos__related mesh__D006729smesh__D009384
% 217.59/217.74  |- mesh__publicMeSHNote mesh__D006729 68   
% 217.59/217.74  |- mesh__dateRevised mesh__D006729 2005-06-30
% 217.59/217.74  |- skos__broader mesh__D006729smesh__D006728
% 217.59/217.74  |- skos__hiddenLabel mesh__D006729 Ectopic Hormones
% 217.59/217.74  |- mesh__dateEstablished mesh__D006729 1968-01-01
% 217.59/217.74  |- mesh__recordOriginator mesh__D006729 NLM
% 217.59/217.74  |- mesh__recordMaintainer mesh__D006729 ssb
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D006729 2006
% 217.59/217.74  |- skos__broader mesh__D006729smesh__D014408
% 217.59/217.74  |- skos__prefLabel mesh__D006729 Hormones, Ectopic
% 217.59/217.74  |- skos__annotation mesh__D006729
% 217.59/217.74       coord IM with specific hormone %28%IM%29% + ectopic site %28%IM%29% or neopl term %28%IM%29% if applicable%A%  
% 217.59/217.74  |- rdf__type mesh__D006729sskos__Concept
% 217.59/217.74  |- mesh__historyNote mesh__D006729 68   
% 217.59/217.74  |- mesh__recordAuthorizer mesh__D006729 sjn
% 217.59/217.74  |- skos__altLabel mesh__D017451 Somatomedin Receptors
% 217.59/217.74  |- skos__altLabel mesh__D017451 Insulin-Like Growth Factor Receptor
% 217.59/217.74  |- skos__scopeNote mesh__D017451
% 217.59/217.74       Cell surface receptors that bind somatomedins and trigger intracellular changes which influence the behavior of cells. Studies have disclosed two types of receptors for this family of peptide hormones. The type I receptor is homologous to the insulin receptor and has tyrosine kinase activity. The type II receptor is identical to the mannose-6-phosphate receptor which is important in trafficking of lysosomal enzymes.%A%    
% 217.59/217.74  |- skos__broader mesh__D017451smesh__D017978
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D017451 1998
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D017451 2002
% 217.59/217.74  |- mesh__dateCreated mesh__D017451 1992-05-22
% 217.59/217.74  |- skos__hiddenLabel mesh__D017451 Receptors, Insulin Like Growth Factors
% 217.59/217.74  |- skos__hiddenLabel mesh__D017451 Receptor, Somatomedin
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D017451 1999
% 217.59/217.74  |- mesh__dateRevised mesh__D017451 1997-06-20
% 217.59/217.74  |- skos__annotation mesh__D017451
% 217.59/217.74       specifics are also available; DF: RECEPT SOMATOMEDIN   
% 217.59/217.74  |- mesh__activeMeSHYear mesh__D017451 2005
% 217.59/217.75  |- mesh__dateEstablished mesh__D017451 1993-01-01
% 217.59/217.75  |- mesh__recordMaintainer mesh__D017451 NDW
% 217.59/217.75  |- skos__historyNote mesh__D017451
% 217.59/217.75       Receptors, Endogenous Substances %28%1980-1992%29%
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D017451 2006
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D017451 2000
% 217.59/217.75  |- mesh__recordAuthorizer mesh__D017451 SJN
% 217.59/217.75  |- skos__hiddenLabel mesh__D017451 Insulin Like Growth Factor Receptor
% 217.59/217.75  |- skos__altLabel mesh__D017451 Insulin-Like Growth Factor Receptors
% 217.59/217.75  |- mesh__onlineNote mesh__D017451
% 217.59/217.75       use RECEPTORS, SOMATOMEDIN %28%NM%29% to search INSULIN-LIKE GROWTH FACTOR RECEPTOR 1980-92; use RECEPTORS, SOMATOMEDIN to search INSULIN-LIKE GROWTH FACTORS RECEPTOR 1993%A%  
% 217.59/217.75  |- skos__prefLabel mesh__D017451 Receptors, Somatomedin
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D017451 2003
% 217.59/217.75  |- mesh__recordOriginator mesh__D017451 PXP
% 217.59/217.75  |- mesh__publicMeSHNote mesh__D017451
% 217.59/217.75       93; INSULIN-LIKE GROWTH FACTOR RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1980-92 %26% RECEPTORS, INSULIN 1980-89; INSULIN-LIKE GROWTH FACTORS RECEPTORS was see RECEPTORS, SOMATOMEDIN 1993%A%  
% 217.59/217.75  |- skos__hiddenLabel mesh__D017451 Insulin Like Growth Factor Receptors
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D017451 2001
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D017451 2004
% 217.59/217.75  |- skos__altLabel mesh__D017451 Somatomedin Receptor
% 217.59/217.75  |- rdf__type mesh__D017451sskos__Concept
% 217.59/217.75  |- mesh__historyNote mesh__D017451
% 217.59/217.75       93; was INSULIN-LIKE GROWTH FACTOR RECEPTOR %28%NM%29% 1980-92; INSULIN-LIKE GROWTH FACTORS RECEPTORS was see RECEPTORS, SOMATOMEDIN 1993%A%  
% 217.59/217.75  |- skos__altLabel mesh__D017451 Receptors, Insulin-Like Growth Factors
% 217.59/217.75  |- skos__historyNote mesh__D017451 Receptors, Insulin %28%1980-1989%29%
% 217.59/217.75  |- skos__broader mesh__D039105smesh__D019684
% 217.59/217.75  |- skos__scopeNote mesh__D039105
% 217.59/217.75       A plant family of the order Proteales, subclass Rosidae class Magnoliopsida. Cluster roots, bottlebrush-like clusters of rootlets which form in response to poor soil, are common in this family.%A%    
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D039105 2004
% 217.59/217.75  |- mesh__publicMeSHNote mesh__D039105 2003   
% 217.59/217.75  |- mesh__historyNote mesh__D039105 2003   
% 217.59/217.75  |- mesh__dateEstablished mesh__D039105 2003-01-01
% 217.59/217.75  |- mesh__dateCreated mesh__D039105 2002-07-03
% 217.59/217.75  |- skos__prefLabel mesh__D039105 Proteaceae
% 217.59/217.75  |- rdf__type mesh__D039105sskos__Concept
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D039105 2005
% 217.59/217.75  |- skos__annotation mesh__D039105
% 217.59/217.75       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D039105 2006
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D039105 2003
% 217.59/217.75  |- mesh__recordAuthorizer mesh__D050885 sjn
% 217.59/217.75  |- skos__hiddenLabel mesh__D050885 Reductases, Bisulfite
% 217.59/217.75  |- skos__broader mesh__D050885smesh__D050862
% 217.59/217.75  |- skos__scopeNote mesh__D050885
% 217.59/217.75       An enzyme found primarily in SULFUR-REDUCING BACTERIA where it plays an important role in the anaerobic carbon oxidation pathway.%A%    
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D050885 2006
% 217.59/217.75  |- mesh__recordMaintainer mesh__D050885 jmp
% 217.59/217.75  |- skos__altLabel mesh__D050885 Desulfoviridins
% 217.59/217.75  |- skos__hiddenLabel mesh__D050885 Reductase, Bisulfite
% 217.59/217.75  |- skos__altLabel mesh__D050885 Bisulfite Reductase
% 217.59/217.75  |- mesh__recordOriginator mesh__D050885 jmp
% 217.59/217.75  |- skos__historyNote mesh__D050885
% 217.59/217.75       Oxidoreductases Acting on Sulfur Group Donors %28%1978-2005%29%
% 217.59/217.75  |- skos__altLabel mesh__D050885 Dissimilatory Sulfite Reductase
% 217.59/217.75  |- rdf__type mesh__D050885sskos__Concept
% 217.59/217.75  |- skos__hiddenLabel mesh__D050885 Reductase, Dissimilatory Sulfite
% 217.59/217.75  |- skos__hiddenLabel mesh__D050885 Sulfite Reductase, Dissimilatory
% 217.59/217.75  |- skos__prefLabel mesh__D050885 Hydrogensulfite Reductase
% 217.59/217.75  |- skos__hiddenLabel mesh__D050885 Reductase, Hydrogensulfite
% 217.59/217.75  |- skos__altLabel mesh__D050885 Bisulfite Reductases
% 217.59/217.75  |- mesh__publicMeSHNote mesh__D050885
% 217.59/217.75       2006; HYROGENSULFITE REDUCTASE was indexed under SULFITE REDUCTASES 1995-2005; for DESULFOVIRIDINS and BISULFITE REDUCTASES see SULFITE REDUCTASES 1978-2005; for SIROHAEM SULFITE REDUCTASE see SULFITE REDUCTASES 1997-2005%A%  
% 217.59/217.75  |- mesh__dateEstablished mesh__D050885 2006-01-01
% 217.59/217.75  |- mesh__historyNote mesh__D050885 2006%28%1995%29%   
% 217.59/217.75  |- mesh__dateCreated mesh__D050885 2005-06-30
% 217.59/217.75  |- skos__hiddenLabel mesh__D050885 Reductase, Sirohaem Sulfite
% 217.59/217.75  |- skos__hiddenLabel mesh__D050885 Sulfite Reductase, Sirohaem
% 217.59/217.75  |- skos__historyNote mesh__D003431 Culture %28%1966-1967%29%
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D003431 2000
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D003431 1992
% 217.59/217.75  |- mesh__dateEstablished mesh__D003431 1968-01-01
% 217.59/217.75  |- skos__historyNote mesh__D003431 Anthropology %28%1966-1967%29%
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D003431 2004
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D003431 1997
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D003431 1994
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D003431 2001
% 217.59/217.75  |- mesh__recordMaintainer mesh__D003431 PLS
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D003431 1999
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D003431 2006
% 217.59/217.75  |- skos__hiddenLabel mesh__D003431 Studies, Transcultural
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D003431 1993
% 217.59/217.75  |- skos__historyNote mesh__D003431 Sociology %28%1966-1967%29%
% 217.59/217.75  |- skos__broader mesh__D003431smesh__D003469
% 217.59/217.75  |- skos__hiddenLabel mesh__D003431 Transcultural Study
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D003431 1995
% 217.59/217.75  |- skos__prefLabel mesh__D003431 Cross-Cultural Comparison
% 217.59/217.75  |- skos__annotation mesh__D003431 no qualif   
% 217.59/217.75  |- mesh__recordOriginator mesh__D003431 NLM
% 217.59/217.75  |- mesh__recordAuthorizer mesh__D003431 PLS
% 217.59/217.75  |- skos__hiddenLabel mesh__D003431 Cross Cultural Comparison
% 217.59/217.75  |- skos__hiddenLabel mesh__D003431 Comparisons, Cross-Cultural
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D003431 2002
% 217.59/217.75  |- rdf__type mesh__D003431sskos__Concept
% 217.59/217.75  |- mesh__historyNote mesh__D003431 68   
% 217.59/217.75  |- mesh__publicMeSHNote mesh__D003431 68   
% 217.59/217.75  |- skos__hiddenLabel mesh__D003431 Study, Transcultural
% 217.59/217.75  |- skos__hiddenLabel mesh__D003431 Comparison, Cross-Cultural
% 217.59/217.75  |- skos__hiddenLabel mesh__D003431 Cross-Cultural Comparisons
% 217.59/217.75  |- mesh__dateRevised mesh__D003431 1991-11-05
% 217.59/217.75  |- skos__scopeNote mesh__D003431
% 217.59/217.75       Comparison of various psychological, sociological, or cultural factors in order to assess the similarities or diversities occurring in two or more different cultures or societies.%A%    
% 217.59/217.75  |- mesh__dateCreated mesh__D003431 1999-01-01
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D003431 1996
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D003431 2003
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D003431 1998
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D003431 2005
% 217.59/217.75  |- mesh__recordMaintainer mesh__D027081 ssb
% 217.59/217.75  |- skos__historyNote mesh__D027081 DNA, Circular %28%1976-1977%29%
% 217.59/217.75  |- mesh__recordAuthorizer mesh__D027081 sjn
% 217.59/217.75  |- mesh__historyNote mesh__D027081
% 217.59/217.75       2002; use DNA TOPOISOMERASE %28%ATP-HYDROLYZING%29% 1994-2001, use DNA GYRASE 1980-1993; for GYRA PROTEIN use DNA TOPOISOMERASE %28%ATP-HYDROLYZING%29% %28%NM%29% 1992-2001; GYRB PROTEIN use DNA TOPOISOMERASE %28%ATP-HYDROLYZING%29% %28%NM%29% 1991-2001%A%  
% 217.59/217.75  |- skos__historyNote mesh__D027081 DNA Topoisomerases %28%1977-1978%29%
% 217.59/217.75  |- skos__altLabel mesh__D027081 gyrA Gene product
% 217.59/217.75  |- skos__prefLabel mesh__D027081 DNA Gyrase
% 217.59/217.75  |- rdf__type mesh__D027081sskos__Concept
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D027081 2006
% 217.59/217.75  |- mesh__publicMeSHNote mesh__D027081
% 217.59/217.75       2002; see DNA TOPOISOMERASE %28%ATP-HYDROLYZING%29% 1994-2001, see DNA GYRASE 1980-1993; GYRA PROTEIN was indexed under DNA TOPOISOMERASE %28%ATP-HYDROLYZING%29% %28%NM%29% 1992-2001; GYRB PROTEIN was indexed under DNA TOPOISOMERASE %28%ATP-HYDROLYZING%29% %28%NM%29% 1991-2001%A%  
% 217.59/217.75  |- mesh__dateRevised mesh__D027081 2003-07-09
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D027081 2005
% 217.59/217.75  |- skos__altLabel mesh__D027081 gyrB Gene Product
% 217.59/217.75  |- mesh__dateCreated mesh__D027081 2001-07-25
% 217.59/217.75  |- skos__historyNote mesh__D027081
% 217.59/217.75       DNA Topoisomerases, Type II %28%1979-2001%29%
% 217.59/217.75  |- mesh__dateEstablished mesh__D027081 2002-01-01
% 217.59/217.75  |- skos__altLabel mesh__D027081 gyrB Protein
% 217.59/217.75  |- skos__broader mesh__D027081smesh__D027061
% 217.59/217.75  |- mesh__recordOriginator mesh__D027081 lkt
% 217.59/217.75  |- skos__scopeNote mesh__D027081
% 217.59/217.75       A bacterial DNA topoisomerase II that catalyzes ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. Gyrase binds to DNA as a heterotetramer consisting two A and two B subunits. In the presence of ATP, gyrase is able to convert relaxed circular DNA duplex into a superhelix. In the absence of ATP, supercoiled DNA is relaxed by DNA gyrase.%A%    
% 217.59/217.75  |- skos__altLabel mesh__D027081 DNA-Gyrase
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D027081 2004
% 217.59/217.75  |- skos__altLabel mesh__D027081 gyrA Protein
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D002339 2002
% 217.59/217.75  |- skos__broader mesh__D002339smesh__D001158
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D002339 2006
% 217.59/217.75  |- mesh__recordOriginator mesh__D002339 NLM
% 217.59/217.75  |- skos__annotation mesh__D002339
% 217.59/217.75       inj = CAROTID ARTERY INJURIES or specifics   
% 217.59/217.75  |- skos__hiddenLabel mesh__D002339 Arteries, Carotid
% 217.59/217.75  |- skos__hiddenLabel mesh__D002339 Carotid Artery
% 217.59/217.75  |- skos__scopeNote mesh__D002339
% 217.59/217.75       Either of the two principal arteries on both sides of the neck that supply blood to the head and neck; each divides into two branches, the internal carotid artery and the external carotid artery.%A%    
% 217.59/217.75  |- rdf__type mesh__D002339sskos__Concept
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D002339 2003
% 217.59/217.75  |- skos__prefLabel mesh__D002339 Carotid Arteries
% 217.59/217.75  |- skos__hiddenLabel mesh__D002339 Artery, Carotid
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D002339 2000
% 217.59/217.75  |- mesh__recordMaintainer mesh__D002339 KEV
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D002339 2004
% 217.59/217.75  |- mesh__recordAuthorizer mesh__D002339 sjn
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D002339 2001
% 217.59/217.75  |- mesh__dateCreated mesh__D002339 1999-01-01
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D002339 2005
% 217.59/217.75  |- mesh__dateRevised mesh__D002339 1999-11-03
% 217.59/217.75  |- mesh__historyNote mesh__D013061
% 217.59/217.75       91%28%80%29%; was see under SPEECH 1980-90   
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D013061 2006
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D013061 1996
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D013061 2004
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D013061 2001
% 217.59/217.75  |- skos__historyNote mesh__D013061 Speech %28%1966-1979%29%
% 217.59/217.75  |- skos__hiddenLabel mesh__D013061 Speech Acoustic
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D013061 2000
% 217.59/217.75  |- mesh__dateCreated mesh__D013061 1979-02-21
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D013061 2005
% 217.59/217.75  |- mesh__dateEstablished mesh__D013061 1991-01-01
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D013061 2003
% 217.59/217.75  |- skos__historyNote mesh__D013061 Voice %28%1966-1979%29%
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D013061 1995
% 217.59/217.75  |- mesh__recordMaintainer mesh__D013061 TGC
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D013061 1993
% 217.59/217.75  |- skos__hiddenLabel mesh__D013061 Acoustic, Speech
% 217.59/217.75  |- skos__broader mesh__D013061smesh__D013060
% 217.59/217.75  |- rdf__type mesh__D013061sskos__Concept
% 217.59/217.75  |- skos__historyNote mesh__D013061 Phonetics %28%1966-1979%29%
% 217.59/217.75  |- skos__altLabel mesh__D013061 Acoustics, Speech
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D013061 1994
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D013061 1992
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D013061 2002
% 217.59/217.75  |- skos__historyNote mesh__D013061 Acoustics %28%1966-1979%29%
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D013061 1999
% 217.59/217.75  |- skos__scopeNote mesh__D013061
% 217.59/217.75       The acoustic aspects of speech in terms of frequency, intensity, and time.%A%    
% 217.59/217.75  |- mesh__dateRevised mesh__D013061 1991-05-28
% 217.59/217.75  |- skos__prefLabel mesh__D013061 Speech Acoustics
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D013061 1997
% 217.59/217.75  |- mesh__recordOriginator mesh__D013061 RC
% 217.59/217.75  |- skos__annotation mesh__D013061 no qualif   
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D013061 1998
% 217.59/217.75  |- mesh__publicMeSHNote mesh__D013061 91; was see under SPEECH 1980-90   
% 217.59/217.75  |- mesh__recordAuthorizer mesh__D013061 PLS
% 217.59/217.75  |- skos__hiddenLabel mesh__D007822 Neoplasms, Larynx
% 217.59/217.75  |- skos__hiddenLabel mesh__D007822 Cancer, Larynx
% 217.59/217.75  |- mesh__dateCreated mesh__D007822 1999-01-01
% 217.59/217.75  |- skos__hiddenLabel mesh__D007822 Neoplasm, Laryngeal
% 217.59/217.75  |- skos__altLabel mesh__D007822 Cancer of the Larynx
% 217.59/217.75  |- skos__broader mesh__D007822smesh__D012142
% 217.59/217.75  |- skos__hiddenLabel mesh__D007822 Cancers, Laryngeal
% 217.59/217.75  |- mesh__dateRevised mesh__D007822 2005-07-15
% 217.59/217.75  |- skos__prefLabel mesh__D007822 Laryngeal Neoplasms
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D007822 2000
% 217.59/217.75  |- skos__hiddenLabel mesh__D007822 Larynx Neoplasm
% 217.59/217.75  |- skos__altLabel mesh__D007822 Larynx Cancer
% 217.59/217.75  |- skos__altLabel mesh__D007822 Larynx Neoplasms
% 217.59/217.75  |- skos__hiddenLabel mesh__D007822 Laryngeal Cancers
% 217.59/217.75  |- mesh__recordAuthorizer mesh__D007822 ags
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D007822 2001
% 217.59/217.75  |- skos__hiddenLabel mesh__D007822 Neoplasm, Larynx
% 217.59/217.75  |- mesh__recordOriginator mesh__D007822 NLM
% 217.59/217.75  |- rdf__type mesh__D007822sskos__Concept
% 217.59/217.75  |- skos__hiddenLabel mesh__D007822 Cancers, Larynx
% 217.59/217.75  |- skos__altLabel mesh__D007822 Laryngeal Cancer
% 217.59/217.75  |- skos__altLabel mesh__D007822 Neoplasms, Laryngeal
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D007822 2003
% 217.59/217.75  |- mesh__recordMaintainer mesh__D007822 ags
% 217.59/217.75  |- skos__scopeNote mesh__D007822
% 217.59/217.75       Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.%A%    
% 217.59/217.75  |- skos__hiddenLabel mesh__D007822 Cancer, Laryngeal
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D007822 2005
% 217.59/217.75  |- skos__hiddenLabel mesh__D007822 Laryngeal Neoplasm
% 217.59/217.75  |- skos__annotation mesh__D007822
% 217.59/217.75       coord IM with histol type of neopl %28%IM%29%; laryngeal polyps = LARYNGEAL NEOPLASMS %28%IM%29% + POLYPS %28%IM%29%%A%  
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D007822 2004
% 217.59/217.75  |- skos__broader mesh__D007822smesh__D007818
% 217.59/217.75  |- skos__hiddenLabel mesh__D007822 Larynx Cancers
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D007822 2002
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D007822 2006
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D007822 2006A
% 217.59/217.75  |- skos__broader mesh__D007822smesh__D010039
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D007024 2000
% 217.59/217.75  |- skos__hiddenLabel mesh__D007024 Postural Hypotension
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D007024 2004
% 217.59/217.75  |- mesh__recordMaintainer mesh__D007024 KEV
% 217.59/217.75  |- skos__hiddenLabel mesh__D007024 Orthostatic Hypotension
% 217.59/217.75  |- skos__altLabel mesh__D007024 Hypotension, Postural
% 217.59/217.75  |- mesh__recordOriginator mesh__D007024 NLM
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D007024 2001
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D007024 2005
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D007024 2002
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D007024 2006
% 217.59/217.75  |- mesh__dateCreated mesh__D007024 1999-01-01
% 217.59/217.75  |- rdf__type mesh__D007024sskos__Concept
% 217.59/217.75  |- skos__prefLabel mesh__D007024 Hypotension, Orthostatic
% 217.59/217.75  |- skos__scopeNote mesh__D007024
% 217.59/217.75       A drop in blood pressure upon standing or after standing motionless in a static position.%A%    
% 217.59/217.75  |- skos__broader mesh__D007024smesh__D007022
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D007024 2003
% 217.59/217.75  |- mesh__dateRevised mesh__D007024 1999-11-03
% 217.59/217.75  |- mesh__recordAuthorizer mesh__D007024 sjn
% 217.59/217.75  |- rdf__type mesh__D051180sskos__Concept
% 217.59/217.75  |- skos__altLabel mesh__D051180 Desmoplakin
% 217.59/217.75  |- mesh__recordOriginator mesh__D051180 DRC
% 217.59/217.75  |- skos__broader mesh__D051180smesh__D051179
% 217.59/217.75  |- skos__scopeNote mesh__D051180
% 217.59/217.75       Desmoplakins are cytoskeletal linker proteins that anchor INTERMEDIATE FILAMENTS to the PLASMA MEMBRANE at DESMOSOMES.%A%    
% 217.59/217.75  |- skos__altLabel mesh__D051180 Desmoplakin I
% 217.59/217.75  |- mesh__dateEstablished mesh__D051180 2006-01-01
% 217.59/217.75  |- skos__prefLabel mesh__D051180 Desmoplakins
% 217.59/217.75  |- mesh__recordMaintainer mesh__D051180 DRC
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D051180 2006
% 217.59/217.75  |- mesh__publicMeSHNote mesh__D051180
% 217.59/217.75       2006; DESMOPLAKINS was indexed under CYTOSKELETAL PROTEINS 1990-2005, %26% under MEMBRANE GLYCOPROTEINS 1988-1989, %26% under MEMBRANE PROTEINS 1983-1987%A%  
% 217.59/217.75  |- mesh__dateCreated mesh__D051180 2005-06-30
% 217.59/217.75  |- skos__altLabel mesh__D051180 Desmoplakin II
% 217.59/217.75  |- mesh__recordAuthorizer mesh__D051180 sjn
% 217.59/217.75  |- mesh__historyNote mesh__D051180 2006%28%1983%29%   
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D012767 2005
% 217.59/217.75  |- skos__prefLabel mesh__D012767 Ships
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D012767 2000
% 217.59/217.75  |- mesh__dateCreated mesh__D012767 1999-01-01
% 217.59/217.75  |- skos__annotation mesh__D012767
% 217.59/217.75       sailors goes here if non-med; if med index under NAVAL MEDICINE but see note there%A%  
% 217.59/217.75  |- skos__scopeNote mesh__D012767
% 217.59/217.75       Large vessels propelled by power or sail used for transportation on rivers, seas, oceans, or other navigable waters. Boats are smaller vessels propelled by oars, paddles, sail, or power; they may or may not have a deck.%A%    
% 217.59/217.75  |- mesh__recordOriginator mesh__D012767 NLM
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D012767 2006
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D012767 2001
% 217.59/217.75  |- mesh__dateRevised mesh__D012767 1999-11-03
% 217.59/217.75  |- mesh__recordMaintainer mesh__D012767 kle
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D012767 2003
% 217.59/217.75  |- skos__hiddenLabel mesh__D012767 Boat
% 217.59/217.75  |- rdf__type mesh__D012767sskos__Concept
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D012767 2004
% 217.59/217.75  |- skos__hiddenLabel mesh__D012767 Ship
% 217.59/217.75  |- mesh__recordAuthorizer mesh__D012767 sjn
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D012767 2002
% 217.59/217.75  |- skos__broader mesh__D012767smesh__D014186
% 217.59/217.75  |- mesh__dateEstablished mesh__D039904 2003-01-01
% 217.59/217.75  |- skos__historyNote mesh__D039904
% 217.59/217.75       Stem Cells or specifics %28%1972-2002%29%
% 217.59/217.75  |- mesh__historyNote mesh__D039904 2003   
% 217.59/217.75  |- skos__prefLabel mesh__D039904 Pluripotent Stem Cells
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D039904 2006
% 217.59/217.75  |- skos__hiddenLabel mesh__D039904 Pluripotent Stem Cell
% 217.59/217.75  |- skos__scopeNote mesh__D039904
% 217.59/217.75       Cells that can give rise to most types of cells but not all types of cells necessary for fetal development. %28%Stem Cells: A Primer %5B%Internet%5D%. Bethesda %28%MD%29%: National Institutes of Health %28%US%29%; 2000 May %5B%cited 2002 Apr 5%5D%. Available from: http://www.nih.gov/news/stemcell/primer.htm%29%%A%    
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D039904 2005
% 217.59/217.75  |- skos__broader mesh__D039904smesh__D013234
% 217.59/217.75  |- skos__altLabel mesh__D039904 Stem Cells, Pluripotent
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D039904 2004
% 217.59/217.75  |- rdf__type mesh__D039904sskos__Concept
% 217.59/217.75  |- mesh__dateCreated mesh__D039904 2002-07-03
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D039904 2003
% 217.59/217.75  |- skos__hiddenLabel mesh__D039904 Stem Cell, Pluripotent
% 217.59/217.75  |- mesh__publicMeSHNote mesh__D039904 2003   
% 217.59/217.75  |- skos__annotation mesh__D039904
% 217.59/217.75       TOTIPOTENT STEM CELLS and MULTIPOTENT STEM CELLS are also available%A%  
% 217.59/217.75  |- skos__historyNote mesh__D017452 Receptors, Immunologic %28%1981-1987%29%
% 217.59/217.75  |- skos__hiddenLabel mesh__D017452 gamma Receptors, Fc
% 217.59/217.75  |- skos__altLabel mesh__D017452 Fc gamma Receptors
% 217.59/217.75  |- skos__scopeNote mesh__D017452
% 217.59/217.75       Specific molecular sites on the surface of various cells, including B-lymphocytes and macrophages, that combine with IMMUNOGLOBULIN Gs. Three subclasses exist: Fc gamma RI %28%the CD64 antigen, a low affinity receptor%29%, Fc gamma RII %28%the CD32 antigen, a high affinity receptor%29%, and Fc gamma RIII %28%the CD16 antigen, a low affinity receptor%29%.%A%    
% 217.59/217.75  |- skos__hiddenLabel mesh__D017452 gamma RI, Fc
% 217.59/217.75  |- skos__broader mesh__D017452smesh__D011961
% 217.59/217.75  |- skos__hiddenLabel mesh__D017452 Antigens, CD 64
% 217.59/217.75  |- skos__altLabel mesh__D017452 IgG Receptors
% 217.59/217.75  |- skos__hiddenLabel mesh__D017452 Antigens, Leu-11
% 217.59/217.75  |- skos__altLabel mesh__D017452 CD 32 Antigens
% 217.59/217.75  |- mesh__recordMaintainer mesh__D017452 ssb
% 217.59/217.75  |- skos__broader mesh__D017452smesh__D015703
% 217.59/217.75  |- mesh__historyNote mesh__D017452
% 217.59/217.75       93; was IMMUNOGLOBULIN G RECEPTOR %28%NM%29% 1981-92; CD32 ANTIGEN was NM 1988-92%A%  
% 217.59/217.75  |- skos__altLabel mesh__D017452 Receptors, Fc gamma
% 217.59/217.75  |- skos__altLabel mesh__D017452 Immunoglobulin G Receptor
% 217.59/217.75  |- skos__hiddenLabel mesh__D017452 Leu 11 Antigens
% 217.59/217.75  |- skos__altLabel mesh__D017452 CD 16 Antigens
% 217.59/217.75  |- skos__altLabel mesh__D017452 Fc gamma RIII
% 217.59/217.75  |- skos__hiddenLabel mesh__D017452 gamma RII, Fc
% 217.59/217.75  |- skos__hiddenLabel mesh__D017452 Antigens, CDw32
% 217.59/217.75  |- skos__altLabel mesh__D017452 Antigens, CD64
% 217.59/217.75  |- skos__hiddenLabel mesh__D017452 Receptor, Immunoglobulin G
% 217.59/217.75  |- skos__altLabel mesh__D017452 Fc Receptors, gamma
% 217.59/217.75  |- skos__historyNote mesh__D017452 Receptors, Fc %28%1981-1992%29%
% 217.59/217.75  |- skos__hiddenLabel mesh__D017452 gamma RIII, Fc
% 217.59/217.75  |- skos__prefLabel mesh__D017452 Receptors, IgG
% 217.59/217.75  |- skos__altLabel mesh__D017452 Fc gamma RII
% 217.59/217.75  |- skos__altLabel mesh__D017452 Fc gamma RI
% 217.59/217.75  |- skos__altLabel mesh__D017452 Antigens, CD32
% 217.59/217.75  |- skos__altLabel mesh__D017452 CD16 Antigens
% 217.59/217.75  |- mesh__dateCreated mesh__D017452 1992-05-22
% 217.59/217.75  |- skos__altLabel mesh__D017452 CD 64 Antigens
% 217.59/217.75  |- mesh__onlineNote mesh__D017452
% 217.59/217.75       use RECEPTORS, IGG %28%NM%29% to search IMMUNOGLOBULIN G RECEPTOR 1981-92 %26% CD32 ANTIGEN 1988-92%A%  
% 217.59/217.75  |- mesh__dateRevised mesh__D017452 2005-06-30
% 217.59/217.75  |- skos__annotation mesh__D017452 DF: RECEPT IGG   
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D017452 2006
% 217.59/217.75  |- rdf__type mesh__D017452sskos__Concept
% 217.59/217.75  |- skos__hiddenLabel mesh__D017452 Receptors, gamma Fc
% 217.59/217.75  |- skos__altLabel mesh__D017452 gamma Fc Receptors
% 217.59/217.75  |- mesh__dateEstablished mesh__D017452 1993-01-01
% 217.59/217.75  |- skos__historyNote mesh__D017452
% 217.59/217.75       Antigens, Differentiation %28%1988-1992%29%
% 217.59/217.75  |- mesh__recordOriginator mesh__D017452 PXP
% 217.59/217.75  |- skos__hiddenLabel mesh__D017452 Antigens, CD 16
% 217.59/217.75  |- skos__hiddenLabel mesh__D017452 Antigens, CD 32
% 217.59/217.75  |- mesh__publicMeSHNote mesh__D017452
% 217.59/217.75       93; IMMUNOGLOBULIN G RECEPTOR was indexed under ANTIGENS, DIFFERENTIATION 1988-92, RECEPTORS, FC 1981-92 %26% RECEPTORS, IMMUNOLOGIC 1981-87; CD32 ANTIGEN was indexed under ANTIGENS, CD 1990-92 %26% ANTIGENS, DIFFERENTIATION 1988-91%A%  
% 217.59/217.75  |- mesh__recordAuthorizer mesh__D017452 sjn
% 217.59/217.75  |- rdf__type mesh__D039106sskos__Concept
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D039106 2005
% 217.59/217.75  |- skos__broader mesh__D039106smesh__D039105
% 217.59/217.75  |- mesh__dateEstablished mesh__D039106 2003-01-01
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D039106 2006
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D039106 2003
% 217.59/217.75  |- mesh__historyNote mesh__D039106 2003   
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D039106 2004
% 217.59/217.75  |- mesh__publicMeSHNote mesh__D039106 2003   
% 217.59/217.75  |- mesh__dateCreated mesh__D039106 2002-07-03
% 217.59/217.75  |- skos__annotation mesh__D039106
% 217.59/217.75       coord with FOOD if pertinent; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.59/217.75  |- skos__prefLabel mesh__D039106 Macadamia
% 217.59/217.75  |- skos__scopeNote mesh__D039106
% 217.59/217.75       A plant genus of the family PROTEACEAE that is the source of edible NUTS.%A%    
% 217.59/217.75  |- skos__hiddenLabel mesh__D050886 HSP20 Heat Shock Protein
% 217.59/217.75  |- mesh__recordOriginator mesh__D050886 DRC
% 217.59/217.75  |- skos__altLabel mesh__D050886 Heat-Shock Proteins 20
% 217.59/217.75  |- skos__prefLabel mesh__D050886 HSP20 Heat-Shock Proteins
% 217.59/217.75  |- skos__hiddenLabel mesh__D050886 Heat-Shock Proteins, HSP20
% 217.59/217.75  |- mesh__dateEstablished mesh__D050886 2006-01-01
% 217.59/217.75  |- mesh__historyNote mesh__D050886 2006%28%1997%29%   
% 217.59/217.75  |- skos__broader mesh__D050886smesh__D050888
% 217.59/217.75  |- skos__hiddenLabel mesh__D050886 pp3, Heat-Shock Protein
% 217.59/217.75  |- mesh__recordAuthorizer mesh__D050886 sjn
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D050886 2006
% 217.59/217.75  |- skos__hiddenLabel mesh__D050886 Heat Shock Proteins 20
% 217.59/217.75  |- skos__altLabel mesh__D050886 HSP20 Heat-Shock Protein
% 217.59/217.75  |- mesh__dateCreated mesh__D050886 2005-06-30
% 217.59/217.75  |- skos__hiddenLabel mesh__D050886 Heat Shock Protein pp3
% 217.59/217.75  |- mesh__recordMaintainer mesh__D050886 DRC
% 217.59/217.75  |- rdf__type mesh__D050886sskos__Concept
% 217.59/217.75  |- skos__hiddenLabel mesh__D050886 Heat-Shock Protein, HSP20
% 217.59/217.75  |- skos__scopeNote mesh__D050886
% 217.59/217.75       A subfamily of small heat-shock proteins that are closely related to ALPHA B-CRYSTALLIN. Hsp20 heat-shock proteins can undergo PHOSPHORYLATION by CYCLIC GMP-DEPENDENT PROTEIN KINASES.%A%    
% 217.59/217.75  |- skos__hiddenLabel mesh__D050886 HSP20 Heat Shock Proteins
% 217.59/217.75  |- mesh__publicMeSHNote mesh__D050886
% 217.59/217.75       2006; HEAT-SHOCK PROTEINS 20 was indexed under HEAT-SHOCK PROTEINS %26% PHOSPHOPROTEINS 1997-2005%A%  
% 217.59/217.75  |- skos__historyNote mesh__D003432
% 217.59/217.75       Indicators and Reagents %28%1966-1979%29%
% 217.59/217.75  |- mesh__recordAuthorizer mesh__D003432 sjn
% 217.59/217.75  |- mesh__dateEstablished mesh__D003432 1980-01-01
% 217.59/217.75  |- mesh__dateRevised mesh__D003432 2003-07-09
% 217.59/217.75  |- skos__broader mesh__D003432smesh__D007202
% 217.59/217.75  |- mesh__recordOriginator mesh__D003432 SH
% 217.59/217.75  |- skos__altLabel mesh__D003432 Bifunctional Reagents
% 217.59/217.75  |- mesh__dateCreated mesh__D003432 1979-03-01
% 217.59/217.75  |- rdf__type mesh__D003432sskos__Concept
% 217.59/217.75  |- mesh__historyNote mesh__D003432 80   
% 217.59/217.75  |- skos__hiddenLabel mesh__D003432 Reagents, Cross Linking
% 217.59/217.75  |- skos__historyNote mesh__D003432 Protein Binding %28%1966-1979%29%
% 217.59/217.75  |- skos__altLabel mesh__D003432 Cross Linking Reagents
% 217.59/217.75  |- skos__prefLabel mesh__D003432 Cross-Linking Reagents
% 217.59/217.75  |- skos__altLabel mesh__D003432 Crosslinking Reagents
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D003432 2005
% 217.59/217.75  |- skos__hiddenLabel mesh__D003432 Linking Reagents, Cross
% 217.59/217.75  |- skos__hiddenLabel mesh__D003432 Reagents, Cross-Linking
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D003432 2004
% 217.59/217.75  |- skos__annotation mesh__D003432 D25-26 qualif   
% 217.59/217.75  |- mesh__activeMeSHYear mesh__D003432 2006
% 217.59/217.75  |- mesh__publicMeSHNote mesh__D003432 80   
% 217.59/217.75  |- skos__scopeNote mesh__D003432
% 217.59/217.75       Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other.%A%    
% 217.59/217.75  |- mesh__recordMaintainer mesh__D003432 ssb
% 217.59/217.75  |- skos__hiddenLabel mesh__D003432 Reagents, Crosslinking
% 217.59/217.75  |- skos__hiddenLabel mesh__D003432 Reagents, Bifunctional
% 217.59/217.75  |- mesh__recordOriginator mesh__D013860 NLM
% 217.59/217.75  |- mesh__dateCreated mesh__D013860 1974-11-11
% 217.59/217.75  |- skos__broader mesh__D013860smesh__D002794
% 217.59/217.75  |- mesh__dateRevised mesh__D013860 2005-06-30
% 217.59/217.75  |- skos__prefLabel mesh__D013860 Thiocholine
% 217.59/217.75  |- skos__historyNote mesh__D013860 Sulfhydryl Compounds %28%1966-1974%29%
% 217.59/217.75  |- mesh__dateEstablished mesh__D013860 1991-01-01
% 217.59/217.76  |- mesh__publicMeSHNote mesh__D013860 91; was see under CHOLINE 1975-90   
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013860 2006
% 217.59/217.76  |- skos__scopeNote mesh__D013860
% 217.59/217.76       %28%2-Mercaptoethyl%29%trimethylammonium. A reagent for the determination of cholinesterases; acts also as a highly selective nerve stain.%A%    
% 217.59/217.76  |- skos__historyNote mesh__D013860 Choline %28%1966-1974%29%
% 217.59/217.76  |- skos__annotation mesh__D013860 a reagent; D25-26 qualif   
% 217.59/217.76  |- mesh__recordMaintainer mesh__D013860 ssb
% 217.59/217.76  |- mesh__recordAuthorizer mesh__D013860 sjn
% 217.59/217.76  |- mesh__historyNote mesh__D013860
% 217.59/217.76       91%28%75%29%; was see under CHOLINE 1975-90   
% 217.59/217.76  |- rdf__type mesh__D013860sskos__Concept
% 217.59/217.76  |- skos__hiddenLabel mesh__D013062 Articulation Test, Speech
% 217.59/217.76  |- skos__broader mesh__D013062smesh__D013068
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013062 2005
% 217.59/217.76  |- skos__hiddenLabel mesh__D013062 Articulation Tests, Speech
% 217.59/217.76  |- mesh__dateEstablished mesh__D013062 1991-01-01
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013062 2003
% 217.59/217.76  |- skos__hiddenLabel mesh__D013062 Test, Speech Articulation
% 217.59/217.76  |- mesh__dateRevised mesh__D013062 1997-06-20
% 217.59/217.76  |- rdf__type mesh__D013062sskos__Concept
% 217.59/217.76  |- mesh__recordAuthorizer mesh__D013062 SJN
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013062 2001
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013062 2000
% 217.59/217.76  |- skos__prefLabel mesh__D013062 Speech Articulation Tests
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013062 1999
% 217.59/217.76  |- mesh__recordOriginator mesh__D013062 RC
% 217.59/217.76  |- mesh__recordMaintainer mesh__D013062 PXP
% 217.59/217.76  |- mesh__historyNote mesh__D013062
% 217.59/217.76       91%28%79%29%; was see under SPEECH PRODUCTION MEASUREMENT 1979-90%A%  
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013062 1998
% 217.59/217.76  |- skos__scopeNote mesh__D013062
% 217.59/217.76       Tests of accuracy in pronouncing speech sounds, e.g., Iowa Pressure Articulation Test, Deep Test of Articulation, Templin-Darley Tests of Articulation, Goldman-Fristoe Test of Articulation, Screening Speech Articulation Test, Arizona Articulation Proficiency Scale.%A%    
% 217.59/217.76  |- mesh__dateCreated mesh__D013062 1978-05-22
% 217.59/217.76  |- skos__hiddenLabel mesh__D013062 Tests, Speech Articulation
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013062 2006
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013062 2002
% 217.59/217.76  |- mesh__publicMeSHNote mesh__D013062
% 217.59/217.76       91; was see under SPEECH PRODUCTION MEASUREMENT 1979-90   
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013062 2004
% 217.59/217.76  |- skos__hiddenLabel mesh__D013062 Speech Articulation Test
% 217.59/217.76  |- skos__hiddenLabel mesh__D007823 Nerve, Laryngeal
% 217.59/217.76  |- skos__scopeNote mesh__D007823
% 217.59/217.76       Branches of the VAGUS NERVE %28%the tenth cranial nerve%29%. The superior laryngeal nerves originate near the nodose ganglion and separate into external branches, which supply motor fibers to the cricothyroid muscles, and internal branches, which carry sensory fibers. The RECURRENT %28%inferior%29% LARYNGEAL NERVE originates more caudally and carries efferents to all muscles of the larynx except the cricothyroid. The laryngeal nerves and their various branches also carry sensory and autonomic fibers to the laryngeal, pharyngeal, tracheal, and cardiac regions.%A%    
% 217.59/217.76  |- skos__hiddenLabel mesh__D007823 Laryngeal Nerve
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D007823 2002
% 217.59/217.76  |- mesh__recordAuthorizer mesh__D007823 SJN
% 217.59/217.76  |- mesh__historyNote mesh__D007823 65   
% 217.59/217.76  |- skos__broader mesh__D007823smesh__D014630
% 217.59/217.76  |- skos__prefLabel mesh__D007823 Laryngeal Nerves
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D007823 1999
% 217.59/217.76  |- mesh__publicMeSHNote mesh__D007823 65   
% 217.59/217.76  |- rdf__type mesh__D007823sskos__Concept
% 217.59/217.76  |- skos__hiddenLabel mesh__D007823 Nerve, Superior Laryngeal
% 217.59/217.76  |- mesh__recordMaintainer mesh__D007823 MSR
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D007823 2003
% 217.59/217.76  |- mesh__dateEstablished mesh__D007823 1965-01-01
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D007823 2000
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D007823 2005
% 217.59/217.76  |- skos__hiddenLabel mesh__D007823 Superior Laryngeal Nerves
% 217.59/217.76  |- mesh__dateRevised mesh__D007823 1998-06-10
% 217.59/217.76  |- skos__hiddenLabel mesh__D007823 Nerves, Superior Laryngeal
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D007823 2004
% 217.59/217.76  |- skos__hiddenLabel mesh__D007823 Superior Laryngeal Nerve
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D007823 2001
% 217.59/217.76  |- mesh__recordOriginator mesh__D007823 NLM
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D007823 2006
% 217.59/217.76  |- skos__annotation mesh__D007823
% 217.59/217.76       branches of the vagus %28%10th cranial%29% nerve; dis: coord IM with CRANIAL NERVE DISEASES %28%IM%29%; neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 217.59/217.76  |- skos__hiddenLabel mesh__D007823 Laryngeal Nerves, Superior
% 217.59/217.76  |- skos__hiddenLabel mesh__D007823 Nerves, Laryngeal
% 217.59/217.76  |- mesh__dateCreated mesh__D007823 1999-01-01
% 217.59/217.76  |- skos__hiddenLabel mesh__D007025 Hypothalamic Areas, Anterior
% 217.59/217.76  |- mesh__historyNote mesh__D007025 2000%28%1983%29%   
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D007025 2005
% 217.59/217.76  |- skos__hiddenLabel mesh__D007025 Hypothalamic Nucleus, Anterior
% 217.59/217.76  |- mesh__recordAuthorizer mesh__D007025 sjn
% 217.59/217.76  |- skos__hiddenLabel mesh__D007025 Nucleus, Anterior Hypothalamic
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D007025 2006
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D007025 2000
% 217.59/217.76  |- skos__broader mesh__D007025smesh__D007032
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D007025 2001
% 217.59/217.76  |- mesh__publicMeSHNote mesh__D007025
% 217.59/217.76       2000; see HYPOTHALAMIC AREA, ANTERIOR 1983-1999; for ANTERIOR HYPOTHALAMIC NUCLEUS see HYPOTHALAMIC AREA, ANTERIOR 1983-1999%A%  
% 217.59/217.76  |- skos__altLabel mesh__D007025 Hypothalamic Area, Anterior
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D007025 2002
% 217.59/217.76  |- skos__historyNote mesh__D007025 Hypothalamus, Anterior %28%1975-1982%29%
% 217.59/217.76  |- mesh__dateCreated mesh__D007025 1982-04-28
% 217.59/217.76  |- skos__prefLabel mesh__D007025 Anterior Hypothalamic Nucleus
% 217.59/217.76  |- rdf__type mesh__D007025sskos__Concept
% 217.59/217.76  |- skos__hiddenLabel mesh__D007025 Area, Anterior Hypothalamic
% 217.59/217.76  |- skos__hiddenLabel mesh__D007025 Areas, Anterior Hypothalamic
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D007025 2003
% 217.59/217.76  |- mesh__dateRevised mesh__D007025 1999-11-08
% 217.59/217.76  |- skos__hiddenLabel mesh__D007025 Anterior Hypothalamic Areas
% 217.59/217.76  |- skos__scopeNote mesh__D007025
% 217.59/217.76       Loose heterogeneous collection of cells in the anterior hypothalamus, continuous rostrally with the medial and lateral preoptic areas and caudally with the tuber cinereum.%A%    
% 217.59/217.76  |- skos__annotation mesh__D007025
% 217.59/217.76       do not confuse with HYPOTHALAMUS, ANTERIOR; diseases: coord IM with HYPOTHALAMIC DISEASES %28%IM%29%%A%  
% 217.59/217.76  |- skos__altLabel mesh__D007025 Anterior Hypothalamic Area
% 217.59/217.76  |- mesh__dateEstablished mesh__D007025 1983-01-01
% 217.59/217.76  |- mesh__recordOriginator mesh__D007025 RC
% 217.59/217.76  |- skos__historyNote mesh__D007025 Hypothalamus %28%1966-1982%29%
% 217.59/217.76  |- mesh__recordMaintainer mesh__D007025 adp
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D007025 2004
% 217.59/217.76  |- mesh__recordAuthorizer mesh__D051181 sjn
% 217.59/217.76  |- skos__hiddenLabel mesh__D051181 Cadherins, Desmosomal
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D051181 2006
% 217.59/217.76  |- mesh__historyNote mesh__D051181 2006   
% 217.59/217.76  |- skos__prefLabel mesh__D051181 Desmosomal Cadherins
% 217.59/217.76  |- skos__scopeNote mesh__D051181
% 217.59/217.76       A single-pass transmembrane glycoproteins that mediate CALCIUM-dependent CELL ADHESION and are core components of DESMOSOMES.%A%    
% 217.59/217.76  |- skos__broader mesh__D051181smesh__D015820
% 217.59/217.76  |- mesh__dateEstablished mesh__D051181 2006-01-01
% 217.59/217.76  |- mesh__recordMaintainer mesh__D051181 DRC
% 217.59/217.76  |- mesh__publicMeSHNote mesh__D051181 2006   
% 217.59/217.76  |- rdf__type mesh__D051181sskos__Concept
% 217.59/217.76  |- mesh__dateCreated mesh__D051181 2005-06-30
% 217.59/217.76  |- mesh__recordOriginator mesh__D051181 DRC
% 217.59/217.76  |- skos__prefLabel mesh__D012768 Shivering
% 217.59/217.76  |- skos__broader mesh__D012768smesh__D022722
% 217.59/217.76  |- skos__scopeNote mesh__D012768
% 217.59/217.76       Involuntary contraction or twitching of the muscles. It is a physiologic method of heat production in man and other mammals.%A%    
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D012768 2003
% 217.59/217.76  |- mesh__recordMaintainer mesh__D012768 jmp
% 217.59/217.76  |- mesh__dateEstablished mesh__D012768 1970-01-01
% 217.59/217.76  |- rdf__type mesh__D012768sskos__Concept
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D012768 2004
% 217.59/217.76  |- mesh__historyNote mesh__D012768 70%28%64%29%   
% 217.59/217.76  |- mesh__recordOriginator mesh__D012768 NLM
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D012768 2001
% 217.59/217.76  |- mesh__publicMeSHNote mesh__D012768 70   
% 217.59/217.76  |- skos__hiddenLabel mesh__D012768 Shiverings
% 217.59/217.76  |- mesh__dateRevised mesh__D012768 2000-06-22
% 217.59/217.76  |- mesh__dateCreated mesh__D012768 1999-01-01
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D012768 2005
% 217.59/217.76  |- mesh__recordAuthorizer mesh__D012768 sjn
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D012768 2002
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D012768 2006
% 217.59/217.76  |- rdf__type mesh__D017453sskos__Concept
% 217.59/217.76  |- skos__scopeNote mesh__D017453
% 217.59/217.76       A non-allergic contact dermatitis caused by prolonged exposure to irritants and not explained by delayed hypersensitivity mechanisms.%A%    
% 217.59/217.76  |- skos__hiddenLabel mesh__D017453 Primary Irritant Dermatitis
% 217.59/217.76  |- skos__hiddenLabel mesh__D017453 Irritant Dermatitis, Primary
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017453 1994
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017453 2002
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017453 1993
% 217.59/217.76  |- skos__hiddenLabel mesh__D017453 Primary Irritant Dermatitides
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017453 1999
% 217.59/217.76  |- skos__hiddenLabel mesh__D017453 Irritant Dermatitides
% 217.59/217.76  |- mesh__dateEstablished mesh__D017453 1993-01-01
% 217.59/217.76  |- skos__altLabel mesh__D017453 Dermatitis, Primary Irritant
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017453 1998
% 217.59/217.76  |- skos__historyNote mesh__D017453 Dermatitis, Contact %28%1966-1992%29%
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017453 1997
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017453 2006
% 217.59/217.76  |- skos__altLabel mesh__D017453 Irritant Dermatitis
% 217.59/217.76  |- skos__hiddenLabel mesh__D017453 Irritant Dermatitides, Primary
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017453 2001
% 217.59/217.76  |- skos__hiddenLabel mesh__D017453 Dermatitides, Irritant
% 217.59/217.76  |- skos__annotation mesh__D017453
% 217.59/217.76       %22%a non-allergic contact dermatitis caused by prolonged exposure to irritants%22%%A%  
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017453 1996
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017453 2005
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017453 2004
% 217.59/217.76  |- mesh__historyNote mesh__D017453 93   
% 217.59/217.76  |- mesh__publicMeSHNote mesh__D017453 93   
% 217.59/217.76  |- skos__broader mesh__D017453smesh__D003877
% 217.59/217.76  |- mesh__dateCreated mesh__D017453 1992-05-20
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017453 2000
% 217.59/217.76  |- skos__prefLabel mesh__D017453 Dermatitis, Irritant
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017453 2003
% 217.59/217.76  |- skos__hiddenLabel mesh__D017453 Dermatitides, Primary Irritant
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017453 1995
% 217.59/217.76  |- rdf__type mesh__D003433sskos__Concept
% 217.59/217.76  |- skos__related mesh__D003433smesh__D003227
% 217.59/217.76  |- mesh__publicMeSHNote mesh__D003433 68   
% 217.59/217.76  |- skos__altLabel mesh__D003433 Genetic Cross
% 217.59/217.76  |- mesh__recordOriginator mesh__D003433 NLM
% 217.59/217.76  |- skos__related mesh__D003433smesh__D014161
% 217.59/217.76  |- skos__prefLabel mesh__D003433 Crosses, Genetic
% 217.59/217.76  |- mesh__historyNote mesh__D003433 68   
% 217.59/217.76  |- mesh__dateCreated mesh__D003433 1999-01-01
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D003433 2003
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D003433 2005
% 217.59/217.76  |- mesh__dateEstablished mesh__D003433 1968-01-01
% 217.59/217.76  |- skos__related mesh__D003433smesh__D006824
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D003433 2004
% 217.59/217.76  |- skos__historyNote mesh__D003433 Genetics %28%1966-1967%29%
% 217.59/217.76  |- mesh__recordAuthorizer mesh__D003433 NLM
% 217.59/217.76  |- skos__related mesh__D003433smesh__D014170
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D003433 2006
% 217.59/217.76  |- skos__altLabel mesh__D003433 Cross, Genetic
% 217.59/217.76  |- skos__broader mesh__D003433smesh__D005821
% 217.59/217.76  |- skos__annotation mesh__D003433
% 217.59/217.76       no qualif; the result of breeding of 2 varieties of same species; do not confuse with CROSSING OVER, interchange of genes between homologous chromosomes%A%  
% 217.59/217.76  |- mesh__recordMaintainer mesh__D003433 NLM
% 217.59/217.76  |- skos__altLabel mesh__D003433 Genetic Crosses
% 217.59/217.76  |- mesh__dateRevised mesh__D003433 2002-08-01
% 217.59/217.76  |- mesh__dateEstablished mesh__D027881 2002-01-01
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D027881 2004
% 217.59/217.76  |- skos__prefLabel mesh__D027881 Agavaceae
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D027881 2006
% 217.59/217.76  |- skos__broader mesh__D027881smesh__D019684
% 217.59/217.76  |- mesh__recordOriginator mesh__D027881 ssb
% 217.59/217.76  |- mesh__recordMaintainer mesh__D027881 ssb
% 217.59/217.76  |- skos__altLabel mesh__D027881 Flax, New Zealand
% 217.59/217.76  |- mesh__historyNote mesh__D027881 2002   
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D027881 2005
% 217.59/217.76  |- skos__scopeNote mesh__D027881
% 217.59/217.76       A plant family of the order Liliales, subclass Liliidae, class Liliopsida. Members of the family have narrow, lance-shaped, sometimes fleshy or toothed leaves that are clustered at the base of each plant. Most species have large flower clusters containing many flowers. The fruit is a capsule or berry.%A%    
% 217.59/217.76  |- mesh__dateRevised mesh__D027881 2003-07-09
% 217.59/217.76  |- rdf__type mesh__D027881sskos__Concept
% 217.59/217.76  |- mesh__recordAuthorizer mesh__D027881 sjn
% 217.59/217.76  |- mesh__publicMeSHNote mesh__D027881 2002   
% 217.59/217.76  |- mesh__dateCreated mesh__D027881 2001-07-25
% 217.59/217.76  |- skos__annotation mesh__D027881
% 217.59/217.76       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.59/217.76  |- skos__historyNote mesh__D027881 Plants, Medicinal %28%1969-2001%29%
% 217.59/217.76  |- mesh__recordMaintainer mesh__D013861 TPW
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013861 2005
% 217.59/217.76  |- skos__prefLabel mesh__D013861 Thiocyanates
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013861 2000
% 217.59/217.76  |- rdf__type mesh__D013861sskos__Concept
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013861 1997
% 217.59/217.76  |- mesh__recordAuthorizer mesh__D013861 PLS
% 217.59/217.76  |- mesh__dateCreated mesh__D013861 1999-01-01
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013861 2004
% 217.59/217.76  |- skos__broader mesh__D013861smesh__D013457
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013861 1996
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013861 1995
% 217.59/217.76  |- skos__broader mesh__D013861smesh__D003485
% 217.59/217.76  |- mesh__recordOriginator mesh__D013861 NLM
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013861 2003
% 217.59/217.76  |- mesh__dateRevised mesh__D013861 1993-02-16
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013861 1994
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013861 2002
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013861 1999
% 217.59/217.76  |- skos__altLabel mesh__D013861 Rhodanates
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013861 2006
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013861 2001
% 217.59/217.76  |- skos__scopeNote mesh__D013861
% 217.59/217.76       Organic derivatives of thiocyanic acid which contain the general formula R-SCN.%A%    
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013861 1998
% 217.59/217.76  |- skos__hiddenLabel mesh__D013063 Speech Discrimination Test
% 217.59/217.76  |- skos__hiddenLabel mesh__D013063 Discrimination Tests, Speech
% 217.59/217.76  |- skos__hiddenLabel mesh__D013063 Discrimination Test, Speech
% 217.59/217.76  |- skos__historyNote mesh__D013063 Audiometry %28%1966-1978%29%
% 217.59/217.76  |- skos__annotation mesh__D013063
% 217.59/217.76       the examinee hears %26% understands the examiner%27%s speech; do not confuse with SPEECH INTELLIGIBILITY %28%the speaker speaks in such a way that the hearer understands him%29%%A%  
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013063 1999
% 217.59/217.76  |- mesh__recordOriginator mesh__D013063 RC
% 217.59/217.76  |- skos__historyNote mesh__D013063 Speech %28%1966-1978%29%
% 217.59/217.76  |- skos__prefLabel mesh__D013063 Speech Discrimination Tests
% 217.59/217.76  |- mesh__recordAuthorizer mesh__D013063 ags
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013063 2002
% 217.59/217.76  |- mesh__dateEstablished mesh__D013063 1979-01-01
% 217.59/217.76  |- mesh__publicMeSHNote mesh__D013063 1979   
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013063 1998
% 217.59/217.76  |- mesh__dateCreated mesh__D013063 1978-05-22
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013063 2006
% 217.59/217.76  |- mesh__recordMaintainer mesh__D013063 ags
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013063 2004
% 217.59/217.76  |- skos__historyNote mesh__D013063
% 217.59/217.76       Discrimination %28%Psychology%29% %28%1966-1978%29%
% 217.59/217.76  |- skos__hiddenLabel mesh__D013063 Test, Speech Discrimination
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013063 2005
% 217.59/217.76  |- skos__scopeNote mesh__D013063
% 217.59/217.76       Tests of the ability to hear and understand speech as determined by scoring the number of words in a word list repeated correctly.%A%    
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013063 2001
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013063 2000A
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013063 2003
% 217.59/217.76  |- mesh__dateRevised mesh__D013063 1999-12-16
% 217.59/217.76  |- skos__broader mesh__D013063smesh__D001302
% 217.59/217.76  |- skos__hiddenLabel mesh__D013063 Tests, Speech Discrimination
% 217.59/217.76  |- mesh__historyNote mesh__D013063 1979   
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D013063 2000
% 217.59/217.76  |- rdf__type mesh__D013063sskos__Concept
% 217.59/217.76  |- mesh__recordOriginator mesh__D007026 RC
% 217.59/217.76  |- mesh__dateRevised mesh__D007026 2004-07-13
% 217.59/217.76  |- skos__prefLabel mesh__D007026 Hypothalamic Area, Lateral
% 217.59/217.76  |- skos__broader mesh__D007026smesh__D007031
% 217.59/217.76  |- skos__annotation mesh__D007026
% 217.59/217.76       diseases: coord IM with HYPOTHALAMIC DISEASES %28%IM%29%   
% 217.59/217.76  |- skos__hiddenLabel mesh__D007026 Areas, Lateral Hypothalamic
% 217.59/217.76  |- mesh__dateEstablished mesh__D007026 1983-01-01
% 217.59/217.76  |- mesh__dateCreated mesh__D007026 1982-04-28
% 217.59/217.76  |- mesh__historyNote mesh__D007026 83   
% 217.59/217.76  |- skos__hiddenLabel mesh__D007026 Nucleus, Lateral Hypothalamic
% 217.59/217.76  |- skos__historyNote mesh__D007026 Hypothalamus %28%1966-1982%29%
% 217.59/217.76  |- mesh__recordMaintainer mesh__D007026 sjn
% 217.59/217.76  |- mesh__publicMeSHNote mesh__D007026 83   
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D007026 2006
% 217.59/217.76  |- skos__hiddenLabel mesh__D007026 Area, Lateral Hypothalamic
% 217.59/217.76  |- mesh__recordAuthorizer mesh__D007026 sjn
% 217.59/217.76  |- skos__scopeNote mesh__D007026
% 217.59/217.76       This area is bounded medially by the mammillothalamic tract and the anterior column of fornix. The medial edge of the internal capsule and the subthalamic region form its lateral boundary. It contains the lateral hypothalamic nucleus, tuberomammillary nucleus, lateral tuberal nuclei, and fibers of the MEDIAL FOREBRAIN BUNDLE. %28%Parent, Carpenter%27%s Human Neuroanatomy, 9th ed, p710%29%%A%    
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D007026 2005
% 217.59/217.76  |- skos__altLabel mesh__D007026 Lateral Hypothalamic Area
% 217.59/217.76  |- skos__hiddenLabel mesh__D007026 Nucleus, Tuberomammillary
% 217.59/217.76  |- skos__hiddenLabel mesh__D007026 Lateral Hypothalamic Areas
% 217.59/217.76  |- skos__hiddenLabel mesh__D007026 Hypothalamic Nucleus, Lateral
% 217.59/217.76  |- rdf__type mesh__D007026sskos__Concept
% 217.59/217.76  |- skos__hiddenLabel mesh__D007026 Hypothalamic Areas, Lateral
% 217.59/217.76  |- skos__broader mesh__D051182smesh__D051181
% 217.59/217.76  |- skos__altLabel mesh__D051182 Desmoglein
% 217.59/217.76  |- skos__prefLabel mesh__D051182 Desmogleins
% 217.59/217.76  |- mesh__dateEstablished mesh__D051182 2006-01-01
% 217.59/217.76  |- skos__scopeNote mesh__D051182
% 217.59/217.76       A group of desmosomal cadherins with cytoplasmic tails that resemble those of classical CADHERINS.%A%    
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D051182 2006
% 217.59/217.76  |- mesh__dateCreated mesh__D051182 2005-06-30
% 217.59/217.76  |- mesh__publicMeSHNote mesh__D051182
% 217.59/217.76       2006; DESMOGLEINS was indexed under CYTOSKELETAL PROTEINS 1990-2005, %26% under MEMBRANE GLYCOPROTEINS 1988-1989, %26% under MEMBRANE PROTEINS 1983-1987%A%  
% 217.59/217.76  |- mesh__recordAuthorizer mesh__D051182 sjn
% 217.59/217.76  |- mesh__historyNote mesh__D051182 2006%28%1983%29%   
% 217.59/217.76  |- mesh__recordOriginator mesh__D051182 DRC
% 217.59/217.76  |- rdf__type mesh__D051182sskos__Concept
% 217.59/217.76  |- mesh__recordMaintainer mesh__D051182 DRC
% 217.59/217.76  |- mesh__dateRevised mesh__D012769 1999-11-03
% 217.59/217.76  |- skos__altLabel mesh__D012769 Circulatory Collapse
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D012769 2001
% 217.59/217.76  |- mesh__dateCreated mesh__D012769 1999-01-01
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D012769 2006
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D012769 2000
% 217.59/217.76  |- mesh__recordAuthorizer mesh__D012769 sjn
% 217.59/217.76  |- skos__scopeNote mesh__D012769
% 217.59/217.76       A pathological condition that can suddenly affect the hemodynamic equilibrium, usually manifested by failure to perfuse or oxygenate vital organs.%A%    
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D012769 2004
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D012769 2005
% 217.59/217.76  |- rdf__type mesh__D012769sskos__Concept
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D012769 2003
% 217.59/217.76  |- skos__annotation mesh__D012769
% 217.59/217.76       therapy of shock = SHOCK /ther, not SHOCK THERAPY %28%see ELECTROCONVULSIVE THERAPY%29%, a psychother technique; note TOXIC SHOCK SYNDROME see SHOCK, SEPTIC is available%A%  
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D012769 2002
% 217.59/217.76  |- skos__hiddenLabel mesh__D012769 Shock, Hypovolemic
% 217.59/217.76  |- skos__broader mesh__D012769smesh__D009102
% 217.59/217.76  |- skos__hiddenLabel mesh__D012769 Collapse, Circulatory
% 217.59/217.76  |- mesh__recordOriginator mesh__D012769 NLM
% 217.59/217.76  |- skos__prefLabel mesh__D012769 Shock
% 217.59/217.76  |- mesh__recordMaintainer mesh__D012769 KEV
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017454 2002
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017454 2004
% 217.59/217.76  |- mesh__dateCreated mesh__D017454 1992-05-20
% 217.59/217.76  |- skos__hiddenLabel mesh__D017454 Photocontact Dermatitides
% 217.59/217.76  |- skos__hiddenLabel mesh__D017454 Photoallergies
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017454 2005
% 217.59/217.76  |- mesh__dateRevised mesh__D017454 1993-06-02
% 217.59/217.76  |- skos__hiddenLabel mesh__D017454 Photoallergic Contact Dermatitides
% 217.59/217.76  |- skos__hiddenLabel mesh__D017454 Photoallergic Dermatitides
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017454 2006
% 217.59/217.76  |- skos__hiddenLabel mesh__D017454 Photosensitive Contact Dermatitides
% 217.59/217.76  |- rdf__type mesh__D017454sskos__Concept
% 217.59/217.76  |- skos__altLabel mesh__D017454 Dermatitis, Contact, Photosensitive
% 217.59/217.76  |- mesh__recordMaintainer mesh__D017454 TAP
% 217.59/217.76  |- skos__hiddenLabel mesh__D017454 Contact Dermatitis, Photosensitive
% 217.59/217.76  |- mesh__dateEstablished mesh__D017454 1993-01-01
% 217.59/217.76  |- mesh__publicMeSHNote mesh__D017454
% 217.59/217.76       93; DERMATITIS, CONTACT, PHOTOSENSITIVE; DERMATITIS, PHOTOCONTACT; %26% PHOTOALLERGY were see PHOTOSENSITIVITY DISORDERS 1979-92%A%  
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017454 1996
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017454 2000
% 217.59/217.76  |- skos__prefLabel mesh__D017454 Dermatitis, Photoallergic
% 217.59/217.76  |- skos__broader mesh__D017454smesh__D017449
% 217.59/217.76  |- skos__historyNote mesh__D017454
% 217.59/217.76       Photosensitivity Disorders %28%1966-1992%29%
% 217.59/217.76  |- skos__annotation mesh__D017454 a delayed hypersensitivity   
% 217.59/217.76  |- skos__hiddenLabel mesh__D017454 Contact Dermatitis, Photoallergic
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017454 1997
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017454 2001
% 217.59/217.76  |- skos__hiddenLabel mesh__D017454 Photocontact Dermatitis
% 217.59/217.76  |- skos__hiddenLabel mesh__D017454 Dermatitides, Photoallergic
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017454 1998
% 217.59/217.76  |- skos__altLabel mesh__D017454 Dermatitis, Photocontact
% 217.59/217.76  |- skos__hiddenLabel mesh__D017454 Photoallergic Dermatitis
% 217.59/217.76  |- skos__altLabel mesh__D017454 Photoallergic Contact Dermatitis
% 217.59/217.76  |- skos__hiddenLabel mesh__D017454 Dermatitides, Photosensitive Contact
% 217.59/217.76  |- skos__hiddenLabel mesh__D017454 Contact Dermatitides, Photosensitive
% 217.59/217.76  |- skos__hiddenLabel mesh__D017454 Dermatitides, Photocontact
% 217.59/217.76  |- skos__hiddenLabel mesh__D017454 Contact Dermatitides, Photoallergic
% 217.59/217.76  |- mesh__recordAuthorizer mesh__D017454 PLS
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017454 1994
% 217.59/217.76  |- skos__hiddenLabel mesh__D017454 Dermatitis, Photosensitive Contact
% 217.59/217.76  |- mesh__historyNote mesh__D017454
% 217.59/217.76       93; DERMATITIS, CONTACT, PHOTOSENSITIVE; DERMATITIS, PHOTOCONTACT; %26% PHOTOALLERGY were see PHOTOSENSITIVITY DISORDERS 1979-92%A%  
% 217.59/217.76  |- skos__altLabel mesh__D017454 Dermatitis, Contact, Photoallergic
% 217.59/217.76  |- skos__hiddenLabel mesh__D017454 Dermatitis, Photoallergic Contact
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017454 2003
% 217.59/217.76  |- skos__altLabel mesh__D017454 Photosensitive Contact Dermatitis
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017454 1999
% 217.59/217.76  |- mesh__onlineNote mesh__D017454
% 217.59/217.76       use PHOTOSENSITIVITY DISORDERS to search DERMATITIS, CONTACT, PHOTOSENSITIVE; DERMATITIS, PHOTOCONTACT; %26% PHOTOALLERGY 1979-92%A%  
% 217.59/217.76  |- skos__broader mesh__D017454smesh__D010787
% 217.59/217.76  |- mesh__recordOriginator mesh__D017454 PLS
% 217.59/217.76  |- skos__hiddenLabel mesh__D017454 Dermatitides, Photoallergic Contact
% 217.59/217.76  |- skos__scopeNote mesh__D017454
% 217.59/217.76       A delayed hypersensitivity involving the reaction between sunlight or other radiant energy source and a chemical substance to which the individual has been previously exposed and sensitized. It manifests as a papulovesicular, eczematous, or exudative dermatitis occurring chiefly on the light-exposed areas of the skin.%A%    
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D017454 1995
% 217.59/217.76  |- skos__prefLabel mesh__D050888 Heat-Shock Proteins, Small
% 217.59/217.76  |- mesh__recordAuthorizer mesh__D050888 sjn
% 217.59/217.76  |- mesh__recordMaintainer mesh__D050888 DRC
% 217.59/217.76  |- mesh__dateCreated mesh__D050888 2005-06-30
% 217.59/217.76  |- skos__hiddenLabel mesh__D050888 Small Heat Shock Proteins
% 217.59/217.76  |- rdf__type mesh__D050888sskos__Concept
% 217.59/217.76  |- skos__scopeNote mesh__D050888
% 217.59/217.76       A family of low molecular weight heat-shock proteins that can serve as MOLECULAR CHAPERONES.%A%    
% 217.59/217.76  |- mesh__recordOriginator mesh__D050888 DRC
% 217.59/217.76  |- skos__broader mesh__D050888smesh__D018832
% 217.59/217.76  |- skos__broader mesh__D050888smesh__D006360
% 217.59/217.76  |- skos__annotation mesh__D050888 index only when used by author   
% 217.59/217.76  |- skos__hiddenLabel mesh__D050888 Heat Shock Proteins, Small
% 217.59/217.76  |- skos__altLabel mesh__D050888 Small Heat-Shock Proteins
% 217.59/217.76  |- mesh__historyNote mesh__D050888 2006   
% 217.59/217.76  |- skos__hiddenLabel mesh__D050888 HSP Proteins, Small
% 217.59/217.76  |- mesh__dateEstablished mesh__D050888 2006-01-01
% 217.59/217.76  |- skos__altLabel mesh__D050888 Small HSP Proteins
% 217.59/217.76  |- mesh__publicMeSHNote mesh__D050888 2006   
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D050888 2006
% 217.59/217.76  |- mesh__activeMeSHYear mesh__D003434 2005
% 217.59/217.76  |- mesh__dateEstablished mesh__D003434 1968-01-01
% 217.59/217.76  |- skos__altLabel mesh__D003434 Crossing-Over, Genetic
% 217.59/217.76  |- rdf__type mesh__D003434sskos__Concept
% 217.59/217.76  |- mesh__dateRevised mesh__D003434 2004-07-19
% 217.59/217.76  |- mesh__recordMaintainer mesh__D003434 nns
% 217.59/217.76  |- skos__historyNote mesh__D003434 Cytogenetics %28%1967%29%
% 217.59/217.76  |- skos__related mesh__D003434smesh__D012854
% 217.59/217.76  |- mesh__publicMeSHNote mesh__D003434
% 217.59/217.76       2005; see CROSSING OVER %28%GENETICS%29% 1968-2004   
% 217.59/217.76  |- skos__hiddenLabel mesh__D003434 Genetic Crossing Over
% 217.59/217.76  |- mesh__historyNote mesh__D003434 2005%28%1968%29%   
% 217.59/217.77  |- mesh__recordOriginator mesh__D003434 NLM
% 217.59/217.77  |- skos__scopeNote mesh__D003434
% 217.59/217.77       The reciprocal exchange of segments at corresponding positions along pairs of homologous CHROMOSOMES by symmetrical breakage and crosswise rejoining forming cross-over sites %28%HOLLIDAY JUNCTIONS%29% that are resolved during CHROMOSOME SEGREGATION. Crossing-over typically occurs during MEIOSIS but it may also occur in the absence of meiosis, for example, with bacterial chromosomes, organelle chromosomes, or somatic cell nuclear chromosomes.%A%    
% 217.59/217.77  |- skos__annotation mesh__D003434
% 217.59/217.77       do not confuse with CROSSES, GENETIC, the result of breeding 2 varieties of the same species; DF: CROSSING OVER%A%  
% 217.59/217.77  |- mesh__dateCreated mesh__D003434 1999-01-01
% 217.59/217.77  |- skos__hiddenLabel mesh__D003434 Crossing Overs
% 217.59/217.77  |- mesh__recordAuthorizer mesh__D003434 sjn
% 217.59/217.77  |- skos__broader mesh__D003434smesh__D011995
% 217.59/217.77  |- skos__prefLabel mesh__D003434 Crossing Over, Genetic
% 217.59/217.77  |- skos__altLabel mesh__D003434 Crossing Over
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D003434 2006
% 217.59/217.77  |- skos__hiddenLabel mesh__D003434 Genetic Crossing-Over
% 217.59/217.77  |- skos__related mesh__D003434smesh__D023902
% 217.59/217.77  |- skos__related mesh__D003434smesh__D049471
% 217.59/217.77  |- skos__historyNote mesh__D003434 Genetics %28%1966-1967%29%
% 217.59/217.77  |- rdf__type mesh__D027882sskos__Concept
% 217.59/217.77  |- mesh__dateCreated mesh__D027882 2001-08-03
% 217.59/217.77  |- mesh__publicMeSHNote mesh__D027882 2002   
% 217.59/217.77  |- skos__scopeNote mesh__D027882
% 217.59/217.77       A genus known for fibers obtained from their leaves:  sisal from A. sisalana, henequen from A. fourcroyoides and A. cantala, or Manila-Maguey fiber from A. cantala. Some species provide a sap that is fermented to an intoxicating drink, called pulque in Mexico. Some contain agavesides.%A%    
% 217.59/217.77  |- skos__broader mesh__D027882smesh__D027881
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D027882 2004
% 217.59/217.77  |- mesh__historyNote mesh__D027882 2002   
% 217.59/217.77  |- skos__historyNote mesh__D027882 Plants, Medicinal %28%1966-2001%29%
% 217.59/217.77  |- mesh__dateRevised mesh__D027882 2005-07-12
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D027882 2006
% 217.59/217.77  |- skos__prefLabel mesh__D027882 Agave
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D027882 2003
% 217.59/217.77  |- mesh__recordMaintainer mesh__D027882 ags
% 217.59/217.77  |- mesh__dateEstablished mesh__D027882 2002-01-01
% 217.59/217.77  |- skos__annotation mesh__D027882
% 217.59/217.77       X ref CENTURY PLANT: CENTAURIUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D027882 2006A
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D027882 2005
% 217.59/217.77  |- mesh__recordAuthorizer mesh__D027882 ags
% 217.59/217.77  |- mesh__recordOriginator mesh__D027882 ssb
% 217.59/217.77  |- rdf__type mesh__D013862sskos__Concept
% 217.59/217.77  |- mesh__dateRevised mesh__D013862 2005-06-30
% 217.59/217.77  |- mesh__recordMaintainer mesh__D013862 ssb
% 217.59/217.77  |- skos__historyNote mesh__D013862 Galactose %28%1974%29%
% 217.59/217.77  |- skos__historyNote mesh__D013862 Thioglycosides %28%1974%29%
% 217.59/217.77  |- skos__prefLabel mesh__D013862 Thiogalactosides
% 217.59/217.77  |- skos__broader mesh__D013862smesh__D005697
% 217.59/217.77  |- skos__scopeNote mesh__D013862
% 217.59/217.77       Galactosides in which the oxygen atom linking the sugar and aglycone is replaced by a sulfur atom.%A%    
% 217.59/217.77  |- skos__broader mesh__D013862smesh__D013865
% 217.59/217.77  |- skos__altLabel mesh__D013862 Thiogalactopyranosides
% 217.59/217.77  |- mesh__recordAuthorizer mesh__D013862 sjn
% 217.59/217.77  |- mesh__historyNote mesh__D013862
% 217.59/217.77       91%28%75%29%; was see under THIOGLYCOSIDES 1975-90   
% 217.59/217.77  |- mesh__dateCreated mesh__D013862 1974-11-19
% 217.59/217.77  |- mesh__dateEstablished mesh__D013862 1991-01-01
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D013862 2006
% 217.59/217.77  |- mesh__recordOriginator mesh__D013862 NLM
% 217.59/217.77  |- mesh__publicMeSHNote mesh__D013862
% 217.59/217.77       91; was see under THIOGLYCOSIDES 1975-90   
% 217.59/217.77  |- skos__altLabel mesh__D013064 Aprosodic Speech
% 217.59/217.77  |- mesh__recordMaintainer mesh__D013064 KEV
% 217.59/217.77  |- mesh__recordOriginator mesh__D013064 NLM
% 217.59/217.77  |- skos__hiddenLabel mesh__D013064 Clutterings
% 217.59/217.77  |- mesh__dateCreated mesh__D013064 1999-01-01
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D013064 2000
% 217.59/217.77  |- skos__annotation mesh__D013064
% 217.59/217.77       /ther: consider also SPEECH THERAPY; do not confuse with LANGUAGE DISORDERS: read differentiation of SPEECH %26% LANGUAGE under SPEECH%A%  
% 217.59/217.77  |- mesh__dateRevised mesh__D013064 1999-11-03
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D013064 2006
% 217.59/217.77  |- skos__hiddenLabel mesh__D013064 Speech, Aprosodic
% 217.59/217.77  |- skos__prefLabel mesh__D013064 Speech Disorders
% 217.59/217.77  |- skos__hiddenLabel mesh__D013064 Aprosodias
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D013064 2005
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D013064 2004
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D013064 2002
% 217.59/217.77  |- skos__hiddenLabel mesh__D013064 Dysglossias
% 217.59/217.77  |- skos__hiddenLabel mesh__D013064 Rhinolalias
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D013064 2003
% 217.59/217.77  |- skos__hiddenLabel mesh__D013064 Dyslalias
% 217.59/217.77  |- skos__related mesh__D013064smesh__D007806
% 217.59/217.77  |- rdf__type mesh__D013064sskos__Concept
% 217.59/217.77  |- skos__scopeNote mesh__D013064
% 217.59/217.77       Acquired or developmental conditions marked by an impaired ability to comprehend or generate spoken forms of language.%A%    
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D013064 2001
% 217.59/217.77  |- mesh__recordAuthorizer mesh__D013064 sjn
% 217.59/217.77  |- skos__broader mesh__D013064smesh__D007806
% 217.59/217.77  |- skos__hiddenLabel mesh__D013064 Verbal Fluency Disorder
% 217.59/217.77  |- skos__related mesh__D007825smesh__D007831
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007825 2001
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007825 2003
% 217.59/217.77  |- skos__hiddenLabel mesh__D007825 Laryngectomies
% 217.59/217.77  |- skos__scopeNote mesh__D007825
% 217.59/217.77       Total or partial excision of the larynx.     
% 217.59/217.77  |- mesh__recordMaintainer mesh__D007825 PXP
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007825 2005
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007825 2004
% 217.59/217.77  |- skos__annotation mesh__D007825
% 217.59/217.77       do not use /util except by MeSH definition   
% 217.59/217.77  |- mesh__dateCreated mesh__D007825 1999-01-01
% 217.59/217.77  |- mesh__recordAuthorizer mesh__D007825 SJN
% 217.59/217.77  |- skos__broader mesh__D007825smesh__D013517
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007825 2002
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007825 2006
% 217.59/217.77  |- skos__related mesh__D007825smesh__D013071
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007825 1998
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007825 2000
% 217.59/217.77  |- skos__prefLabel mesh__D007825 Laryngectomy
% 217.59/217.77  |- rdf__type mesh__D007825sskos__Concept
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007825 1999
% 217.59/217.77  |- mesh__dateRevised mesh__D007825 1997-06-20
% 217.59/217.77  |- mesh__recordOriginator mesh__D007825 NLM
% 217.59/217.77  |- skos__altLabel mesh__D051981 Uracil-DNA Glycosylase
% 217.59/217.77  |- mesh__publicMeSHNote mesh__D051981
% 217.59/217.77       2006; URACIL-DNA GLYCOSIDASE was indexd under DNA Glycosylases 1981-2005, under DEOXYURACIL NUCLEOTIDES 1978-1980, %26% under DNA 1976-1980%A%  
% 217.59/217.77  |- skos__hiddenLabel mesh__D051981 Glycosylase, Uracil-DNA
% 217.59/217.77  |- skos__hiddenLabel mesh__D051981 Glycosidase, Ura-DNA
% 217.59/217.77  |- mesh__recordAuthorizer mesh__D051981 sjn
% 217.59/217.77  |- skos__hiddenLabel mesh__D051981 Uracil N Glycosylase
% 217.59/217.77  |- skos__hiddenLabel mesh__D051981 Glycosylase, Uracil DNA
% 217.59/217.77  |- skos__altLabel mesh__D051981 Uracil N-Glycosylase
% 217.59/217.77  |- skos__prefLabel mesh__D051981 Uracil-DNA Glycosidase
% 217.59/217.77  |- skos__scopeNote mesh__D051981
% 217.59/217.77       An enzyme that catalyzes the HYDROLYSIS of the N-glycosidic bond between sugar phosphate backbone and URACIL residue during DNA synthesis.%A%    
% 217.59/217.77  |- skos__hiddenLabel mesh__D051981 Glycosidase, Uracil-DNA
% 217.59/217.77  |- skos__altLabel mesh__D051981 Ura-DNA Glycosidase
% 217.59/217.77  |- skos__hiddenLabel mesh__D051981 Uracil N Glycosidase
% 217.59/217.77  |- skos__altLabel mesh__D051981 Ung DNA Glycosylase
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D051981 2006
% 217.59/217.77  |- skos__altLabel mesh__D051981 Uracil N-Glycosidase
% 217.59/217.77  |- rdf__type mesh__D051981sskos__Concept
% 217.59/217.77  |- mesh__dateEstablished mesh__D051981 2006-01-01
% 217.59/217.77  |- skos__hiddenLabel mesh__D051981 Uracil DNA Glycosidase
% 217.59/217.77  |- skos__hiddenLabel mesh__D051981 Ura DNA Glycosylase
% 217.59/217.77  |- skos__hiddenLabel mesh__D051981 N-Glycosylase, Uracil
% 217.59/217.77  |- skos__hiddenLabel mesh__D051981 DNA Glycosylase, Uracil
% 217.59/217.77  |- skos__altLabel mesh__D051981 Uracil DNA Glycosylase
% 217.59/217.77  |- skos__broader mesh__D051981smesh__D045647
% 217.59/217.77  |- mesh__historyNote mesh__D051981
% 217.59/217.77       2006%28%1980%29% use DNA 1976-1979 %26% DEOXYURACIL NUCLEOTIDES 1978-1979%A%  
% 217.59/217.77  |- skos__hiddenLabel mesh__D051981 Ura DNA Glycosidase
% 217.59/217.77  |- skos__altLabel mesh__D051981 Ura-DNA Glycosylase
% 217.59/217.77  |- mesh__dateCreated mesh__D051981 2005-06-30
% 217.59/217.77  |- skos__hiddenLabel mesh__D051981 Glycosylase, Ura-DNA
% 217.59/217.77  |- mesh__recordOriginator mesh__D051981 AKE
% 217.59/217.77  |- skos__hiddenLabel mesh__D051981 Glycosylase, Ung DNA
% 217.59/217.77  |- skos__hiddenLabel mesh__D051981 N-Glycosidase, Uracil
% 217.59/217.77  |- mesh__recordMaintainer mesh__D051981 AKE
% 217.59/217.77  |- skos__hiddenLabel mesh__D051981 DNA Glycosylase, Ung
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Syndromes, Hypothalamic Dysfunction
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Disorder, Hypothalamic-Adenohypophyseal
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Diseases, Hypothalamic
% 217.59/217.77  |- skos__prefLabel mesh__D007027 Hypothalamic Diseases
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Syndrome, Hypothalamic Dysfunction
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Disorders, Hypothalamic-Adenohypophyseal
% 217.59/217.77  |- mesh__dateEstablished mesh__D007027 1981-01-01
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007027 2001
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Dysinhibition Syndromes, Hypothalamic
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007027 2003
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Froehlich Syndrome
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Disorders, Hypothalamic-Neurohypophyseal
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Hypothalamic Pseudopuberties
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007027 2002
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Hypothalamic-Neurohypophyseal Disorder
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007027 2004
% 217.59/217.77  |- mesh__recordAuthorizer mesh__D007027 ags
% 217.59/217.77  |- mesh__publicMeSHNote mesh__D007027
% 217.59/217.77       1981; FROEHLICH%27%S SYNDROME was heading 1963-1984   
% 217.59/217.77  |- skos__annotation mesh__D007027
% 217.59/217.77       GEN: prefer specifics; coord IM with specific part of hypothalamus %28%IM%29%%A%  
% 217.59/217.77  |- skos__scopeNote mesh__D007027
% 217.59/217.77       Neoplastic, inflammatory, infectious, and other diseases of the hypothalamus. Clinical manifestations include appetite disorders; AUTONOMIC NERVOUS SYSTEM DISEASES; SLEEP DISORDERS; behavioral symptoms related to dysfunction of the LIMBIC SYSTEM; and neuroendocrine disorders.%A%    
% 217.59/217.77  |- skos__historyNote mesh__D007027 Brain Diseases %28%1966-1980%29%
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Syndrome, Froehlich%27%s
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Syndrome, Hypothalamic Dysinhibition
% 217.59/217.77  |- rdf__type mesh__D007027sskos__Concept
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Hypothalamic Neurohypophyseal Disorders
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Dysfunction Syndrome, Hypothalamic
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Froehlichs Syndrome
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Overactivity Syndromes, Hypothalamic
% 217.59/217.77  |- skos__broader mesh__D007027smesh__D001927
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Disease, Hypothalamic
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007027 2005
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Syndromes, Hypothalamic Dysinhibition
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Syndrome, Hypothalamic Overactivity
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Pseudopuberties, Hypothalamic
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Syndromes, Hypothalamic Overactivity
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Diencephalic Syndromes, Pituitary
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Diencephalic Syndrome, Pituitary
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Disorder, Hypothalamic-Neurohypophyseal
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Syndromes, Pituitary Diencephalic
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007027 2000A
% 217.59/217.77  |- mesh__dateRevised mesh__D007027 1999-12-03
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Hypothalamic Adenohypophyseal Disorders
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Hypothalamic Dysinhibition Syndromes
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007027 2006
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Pituitary Diencephalic Syndromes
% 217.59/217.77  |- mesh__historyNote mesh__D007027 1981   
% 217.59/217.77  |- mesh__recordMaintainer mesh__D007027 ags
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Hypothalamic Disease
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Dysinhibition Syndrome, Hypothalamic
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Hypothalamic Overactivity Syndromes
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Overactivity Syndrome, Hypothalamic
% 217.59/217.77  |- mesh__dateCreated mesh__D007027 1980-04-04
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Pseudopuberty, Hypothalamic
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Hypothalamic-Adenohypophyseal Disorder
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007027 2000
% 217.59/217.77  |- skos__historyNote mesh__D007027 Hypothalamus %28%1966-1980%29%
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Dysfunction Syndromes, Hypothalamic
% 217.59/217.77  |- mesh__recordOriginator mesh__D007027 RC
% 217.59/217.77  |- skos__hiddenLabel mesh__D007027 Hypothalamic Dysfunction Syndrome
% 217.59/217.77  |- skos__altLabel mesh__D051183 Dsg1 Antigen
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D051183 2006
% 217.59/217.77  |- mesh__historyNote mesh__D051183 2006%28%1994%29%   
% 217.59/217.77  |- mesh__recordMaintainer mesh__D051183 DRC
% 217.59/217.77  |- skos__scopeNote mesh__D051183
% 217.59/217.77       A desmosomal cadherin that is an autoantigen in the acquired skin disorder PEMPHIGUS FOLIACEUS.%A%    
% 217.59/217.77  |- skos__altLabel mesh__D051183 PFAN Protein
% 217.59/217.77  |- mesh__dateEstablished mesh__D051183 2006-01-01
% 217.59/217.77  |- mesh__recordOriginator mesh__D051183 DRC
% 217.59/217.77  |- mesh__publicMeSHNote mesh__D051183
% 217.59/217.77       2006; DESMOGLEIN 1 was indexed under CADHERINS 1994-2005   
% 217.59/217.77  |- skos__broader mesh__D051183smesh__D051182
% 217.59/217.77  |- mesh__dateCreated mesh__D051183 2005-06-30
% 217.59/217.77  |- skos__altLabel mesh__D051183 Pemphigus Foliaceus Antigen
% 217.59/217.77  |- skos__altLabel mesh__D051183 Desmosomal Glycoprotein 1
% 217.59/217.77  |- mesh__recordAuthorizer mesh__D051183 sjn
% 217.59/217.77  |- rdf__type mesh__D051183sskos__Concept
% 217.59/217.77  |- skos__altLabel mesh__D051183 Desmoglein I
% 217.59/217.77  |- skos__broader mesh__D051183smesh__D001324
% 217.59/217.77  |- skos__prefLabel mesh__D051183 Desmoglein 1
% 217.59/217.77  |- skos__scopeNote mesh__D017455
% 217.59/217.77       Specific molecular sites on the surface of B- and T-lymphocytes which combine with IgEs. Two subclasses exist: low affinity receptors %28%Fc epsilon RII%29% and high affinity receptors %28%Fc epsilon RI%29%.%A%    
% 217.59/217.77  |- skos__altLabel mesh__D017455 CD 23 Antigens
% 217.59/217.77  |- skos__broader mesh__D017455smesh__D011961
% 217.59/217.77  |- skos__hiddenLabel mesh__D017455 Receptors, epsilon Fc
% 217.59/217.77  |- skos__hiddenLabel mesh__D017455 epsilon RII, Fc
% 217.59/217.77  |- skos__altLabel mesh__D017455 IgE Receptors
% 217.59/217.77  |- skos__altLabel mesh__D017455 Receptors, Fc epsilon
% 217.59/217.77  |- skos__prefLabel mesh__D017455 Receptors, IgE
% 217.59/217.77  |- skos__altLabel mesh__D017455 Fc epsilon Receptors
% 217.59/217.77  |- mesh__dateRevised mesh__D017455 2005-06-30
% 217.59/217.77  |- skos__altLabel mesh__D017455 Antigens, CD23
% 217.59/217.77  |- mesh__onlineNote mesh__D017455
% 217.59/217.77       use RECEPTORS, IGE %28%NM%29% to search IMMUNOGLOBULIN E RECEPTOR 1981-92%A%  
% 217.59/217.77  |- skos__altLabel mesh__D017455 Immunoglobulin E Receptor
% 217.59/217.77  |- rdf__type mesh__D017455sskos__Concept
% 217.59/217.77  |- skos__altLabel mesh__D017455 CD23 Antigen
% 217.59/217.77  |- skos__annotation mesh__D017455 DF: RECEPT IGE   
% 217.59/217.77  |- skos__hiddenLabel mesh__D017455 Receptor, Immunoglobulin E
% 217.59/217.77  |- skos__altLabel mesh__D017455 epsilon Fc Receptors
% 217.59/217.77  |- mesh__recordOriginator mesh__D017455 PXP
% 217.59/217.77  |- skos__hiddenLabel mesh__D017455 Antigens, CD 23
% 217.59/217.77  |- skos__hiddenLabel mesh__D017455 epsilon Receptors, Fc
% 217.59/217.77  |- skos__broader mesh__D017455smesh__D015703
% 217.59/217.77  |- skos__altLabel mesh__D017455 CD23 Antigens
% 217.59/217.77  |- mesh__recordMaintainer mesh__D017455 ssb
% 217.59/217.77  |- skos__historyNote mesh__D017455
% 217.59/217.77       Antigens, Differentiation, B-Lymphocyte %28%1988-1992%29%
% 217.59/217.77  |- skos__hiddenLabel mesh__D017455 Antigen, CD23
% 217.59/217.77  |- skos__hiddenLabel mesh__D017455 epsilon RI, Fc
% 217.59/217.77  |- skos__altLabel mesh__D017455 Fc Receptors, epsilon
% 217.59/217.77  |- mesh__dateCreated mesh__D017455 1992-05-22
% 217.59/217.77  |- skos__historyNote mesh__D017455 Receptors, Fc %28%1981-1992%29%
% 217.59/217.77  |- mesh__dateEstablished mesh__D017455 1993-01-01
% 217.59/217.77  |- mesh__publicMeSHNote mesh__D017455
% 217.59/217.77       93; IMMUNOGLOBULIN E RECEPTOR was indexed under RECEPTORS, FC 1981-92, ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1988-92 %26% RECEPTORS, IMMUNOLOGIC 1981-87%A%  
% 217.59/217.77  |- mesh__historyNote mesh__D017455
% 217.59/217.77       93; was IMMUNOGLOBULIN E RECEPTOR %28%NM%29% 1981-92   
% 217.59/217.77  |- skos__historyNote mesh__D017455 Receptors, Immunologic %28%1981-1987%29%
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D017455 2006
% 217.59/217.77  |- mesh__recordAuthorizer mesh__D017455 sjn
% 217.59/217.77  |- mesh__dateEstablished mesh__D050889 2006-01-01
% 217.59/217.77  |- rdf__type mesh__D050889sskos__Concept
% 217.59/217.77  |- mesh__recordOriginator mesh__D050889 jmp
% 217.59/217.77  |- mesh__historyNote mesh__D050889 2006%28%1982%29%   
% 217.59/217.77  |- mesh__recordAuthorizer mesh__D050889 sjn
% 217.59/217.77  |- skos__prefLabel mesh__D050889 Sulfite Reductase %28%Ferredoxin%29%
% 217.59/217.77  |- mesh__dateCreated mesh__D050889 2005-06-30
% 217.59/217.77  |- mesh__publicMeSHNote mesh__D050889
% 217.59/217.77       2006; FERREDOXIN SULFITE REDUCTASE was indexed under SULFITE REDUCTASES 1982-2005%A%  
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D050889 2006
% 217.59/217.77  |- skos__broader mesh__D050889smesh__D050862
% 217.59/217.77  |- mesh__recordMaintainer mesh__D050889 jmp
% 217.59/217.77  |- skos__altLabel mesh__D050889 Ferredoxin Sulfite Reductase
% 217.59/217.77  |- skos__hiddenLabel mesh__D050889 Reductase, Ferredoxin Sulfite
% 217.59/217.77  |- skos__scopeNote mesh__D050889
% 217.59/217.77       A FERREDOXIN-dependent oxidoreductase that is primarily found in PLANTS where it plays an important role in the assimilation of SULFUR atoms for the production of CYSTEINE and METHIONINE.%A%    
% 217.59/217.77  |- skos__hiddenLabel mesh__D050889 Sulfite Reductase, Ferredoxin
% 217.59/217.77  |- skos__historyNote mesh__D050889
% 217.59/217.77       Oxidoreductases Acting on Sulfur Group Donors %28%1982-2005%29%
% 217.59/217.77  |- rdf__type mesh__D003435sskos__Concept
% 217.59/217.77  |- skos__prefLabel mesh__D003435 Crotalid Venoms
% 217.59/217.77  |- skos__hiddenLabel mesh__D003435 Venoms, Crotalid
% 217.59/217.77  |- skos__historyNote mesh__D003435 Snake Venoms %28%1975-1977%29%
% 217.59/217.77  |- skos__altLabel mesh__D003435 Pit Viper Venom
% 217.59/217.77  |- mesh__dateCreated mesh__D003435 1977-04-22
% 217.59/217.77  |- skos__annotation mesh__D003435
% 217.59/217.77       from pit vipers %28%rattlesnake, cottonmouth, etc.%29%; /antag permitted but consider also ANTIVENINS; /enzymology permitted; TN 241: common %26% scientific names of various crotalids%A%  
% 217.59/217.77  |- skos__hiddenLabel mesh__D003435 Venom, Rattlesnake
% 217.59/217.77  |- skos__hiddenLabel mesh__D003435 Venom, Pit Viper
% 217.59/217.77  |- mesh__recordMaintainer mesh__D003435 ssb
% 217.59/217.77  |- mesh__dateRevised mesh__D003435 2005-06-30
% 217.59/217.77  |- skos__hiddenLabel mesh__D003435 Viper Venom, Pit
% 217.59/217.77  |- skos__altLabel mesh__D003435 Rattlesnake Venom
% 217.59/217.77  |- skos__historyNote mesh__D003435 Snakes %28%1966-1974%29%
% 217.59/217.77  |- skos__hiddenLabel mesh__D003435 Venom, Crotaline Snake
% 217.59/217.77  |- mesh__publicMeSHNote mesh__D003435 78   
% 217.59/217.77  |- skos__altLabel mesh__D003435 Pit Viper Venoms
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D003435 2006
% 217.59/217.77  |- skos__broader mesh__D003435smesh__D014757
% 217.59/217.77  |- skos__historyNote mesh__D003435 Venoms %28%1966-1974%29%
% 217.59/217.77  |- skos__hiddenLabel mesh__D003435 Venoms, Rattlesnake
% 217.59/217.77  |- mesh__historyNote mesh__D003435 78   
% 217.59/217.77  |- mesh__recordAuthorizer mesh__D003435 sjn
% 217.59/217.77  |- skos__hiddenLabel mesh__D003435 Venoms, Pit Viper
% 217.59/217.77  |- skos__scopeNote mesh__D003435
% 217.59/217.77       Venoms from snakes of the subfamily Crotalinae or pit vipers, found mostly in the Americas. They include the rattlesnake, cottonmouth, fer-de-lance, bushmaster, and American copperhead. Their venoms contain nontoxic proteins, cardio-, hemo-, cyto-, and neurotoxins, and many enzymes, especially phospholipases A. Many of the toxins have been characterized.%A%    
% 217.59/217.77  |- skos__hiddenLabel mesh__D003435 Venom, Crotalid
% 217.59/217.77  |- skos__hiddenLabel mesh__D003435 Snake Venom, Crotaline
% 217.59/217.77  |- skos__altLabel mesh__D003435 Crotalid Venom
% 217.59/217.77  |- mesh__recordOriginator mesh__D003435 SH
% 217.59/217.77  |- mesh__dateEstablished mesh__D003435 1978-01-01
% 217.59/217.77  |- skos__altLabel mesh__D008120 Inibsa Brand of Lobelin Sulfate
% 217.59/217.77  |- skos__broader mesh__D008120smesh__D010880
% 217.59/217.77  |- mesh__recordMaintainer mesh__D008120 CCR
% 217.59/217.77  |- rdf__type mesh__D008120sskos__Concept
% 217.59/217.77  |- mesh__dateCreated mesh__D008120 1999-01-01
% 217.59/217.77  |- skos__prefLabel mesh__D008120 Lobeline
% 217.59/217.77  |- skos__broader mesh__D008120smesh__D000470
% 217.59/217.77  |- skos__hiddenLabel mesh__D008120 Sulfate, Lobeline
% 217.59/217.77  |- mesh__recordAuthorizer mesh__D008120 sjn
% 217.59/217.77  |- skos__annotation mesh__D008120 /biosyn permitted if by plant   
% 217.59/217.77  |- skos__scopeNote mesh__D008120
% 217.59/217.77       An alkaloid that has actions similar to NICOTINE on nicotinic cholinergic receptors but is less potent. It has been proposed for a variety of therapeutic uses including in respiratory disorders, peripheral vascular disorders, insomnia, and smoking cessation.%A%    
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D008120 2006
% 217.59/217.77  |- mesh__dateRevised mesh__D008120 2004-07-07
% 217.59/217.77  |- mesh__recordOriginator mesh__D008120 NLM
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D008120 2005
% 217.59/217.77  |- mesh__publicMeSHNote mesh__D027883 2002   
% 217.59/217.77  |- skos__broader mesh__D027883smesh__D007887
% 217.59/217.77  |- mesh__recordAuthorizer mesh__D027883 sjn
% 217.59/217.77  |- skos__scopeNote mesh__D027883
% 217.59/217.77       A plant genus in the family FABACEAE, subfamily Papilionaceae, order Fabales, subclass Rosidae. Many of the species are associated with poisoning of grazing animals. Some of the species are used medicinally.%A%    
% 217.59/217.77  |- skos__annotation mesh__D027883
% 217.59/217.77       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.59/217.77  |- mesh__dateCreated mesh__D027883 2001-07-25
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D027883 2004
% 217.59/217.77  |- skos__prefLabel mesh__D027883 Astragalus Plant
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D027883 2006
% 217.59/217.77  |- mesh__dateEstablished mesh__D027883 2002-01-01
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D027883 2003
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D027883 2005
% 217.59/217.77  |- mesh__dateRevised mesh__D027883 2002-07-02
% 217.59/217.77  |- mesh__recordOriginator mesh__D027883 ssb
% 217.59/217.77  |- mesh__recordMaintainer mesh__D027883 ssb
% 217.59/217.77  |- mesh__historyNote mesh__D027883 2002   
% 217.59/217.77  |- rdf__type mesh__D027883sskos__Concept
% 217.59/217.77  |- skos__broader mesh__D013863smesh__D005960
% 217.59/217.77  |- mesh__recordOriginator mesh__D013863 NLM
% 217.59/217.77  |- skos__prefLabel mesh__D013863 Thioglucosides
% 217.59/217.77  |- mesh__publicMeSHNote mesh__D013863
% 217.59/217.77       91; was see under THIOGLYCOSIDES 1975-90   
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D013863 2006
% 217.59/217.77  |- mesh__onlineNote mesh__D013863 search THIOGLYCOSIDES 1974   
% 217.59/217.77  |- mesh__dateRevised mesh__D013863 2005-06-30
% 217.59/217.77  |- mesh__recordMaintainer mesh__D013863 ssb
% 217.59/217.77  |- mesh__dateEstablished mesh__D013863 1991-01-01
% 217.59/217.77  |- skos__altLabel mesh__D013863 Thioglucopyranosides
% 217.59/217.77  |- rdf__type mesh__D013863sskos__Concept
% 217.59/217.77  |- skos__annotation mesh__D013863 do not confuse with THIOGLYCOSIDES   
% 217.59/217.77  |- mesh__dateCreated mesh__D013863 1999-01-01
% 217.59/217.77  |- skos__broader mesh__D013863smesh__D013865
% 217.59/217.77  |- mesh__recordAuthorizer mesh__D013863 sjn
% 217.59/217.77  |- mesh__historyNote mesh__D013863
% 217.59/217.77       91%28%75%29%; was see under THIOGLYCOSIDES 1975-90   
% 217.59/217.77  |- skos__historyNote mesh__D013065 Speech %28%1966-1978%29%
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D013065 2005
% 217.59/217.77  |- skos__hiddenLabel mesh__D013065 Intelligibilities, Speech
% 217.59/217.77  |- skos__related mesh__D013065smesh__D013068
% 217.59/217.77  |- mesh__historyNote mesh__D013065 79   
% 217.59/217.77  |- mesh__dateEstablished mesh__D013065 1979-01-01
% 217.59/217.77  |- mesh__publicMeSHNote mesh__D013065 79   
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D013065 2003
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D013065 2006
% 217.59/217.77  |- mesh__recordAuthorizer mesh__D013065 sjn
% 217.59/217.77  |- skos__broader mesh__D013065smesh__D013060
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D013065 2004
% 217.59/217.77  |- skos__prefLabel mesh__D013065 Speech Intelligibility
% 217.59/217.77  |- skos__historyNote mesh__D013065 Auditory Perception %28%1967-1978%29%
% 217.59/217.77  |- mesh__dateRevised mesh__D013065 2002-07-03
% 217.59/217.77  |- mesh__recordOriginator mesh__D013065 RC
% 217.59/217.77  |- skos__annotation mesh__D013065
% 217.59/217.77       the speaker%27%s speech is understood or not understood by the hearer; do not confuse with SPEECH DISCRIMINATION TESTS %28%the examinee hears %26% understands the examiner%27%s speech%29%%A%  
% 217.59/217.77  |- mesh__recordMaintainer mesh__D013065 TGC
% 217.59/217.77  |- skos__scopeNote mesh__D013065
% 217.59/217.77       Ability to make speech sounds that are recognizable.     
% 217.59/217.77  |- skos__hiddenLabel mesh__D013065 Speech Intelligibilities
% 217.59/217.77  |- rdf__type mesh__D013065sskos__Concept
% 217.59/217.77  |- skos__hiddenLabel mesh__D013065 Intelligibility, Speech
% 217.59/217.77  |- mesh__dateCreated mesh__D013065 1978-05-22
% 217.59/217.77  |- skos__prefLabel mesh__D007826 Laryngismus
% 217.59/217.77  |- mesh__recordAuthorizer mesh__D007826 PLS
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007826 1995
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007826 2005
% 217.59/217.77  |- skos__annotation mesh__D007826
% 217.59/217.77       %22%spasm of the larynx%22%: note X ref   
% 217.59/217.77  |- mesh__recordMaintainer mesh__D007826 TGC
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007826 2004
% 217.59/217.77  |- mesh__recordOriginator mesh__D007826 NLM
% 217.59/217.77  |- mesh__dateCreated mesh__D007826 1999-01-01
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007826 2001
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007826 2006
% 217.59/217.77  |- skos__scopeNote mesh__D007826 Spasm of the larynx.     
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007826 1996
% 217.59/217.77  |- skos__altLabel mesh__D007826 Laryngospasm
% 217.59/217.77  |- skos__broader mesh__D007826smesh__D012120
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007826 1998
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007826 1997
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007826 2002
% 217.59/217.77  |- rdf__type mesh__D007826sskos__Concept
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007826 1999
% 217.59/217.77  |- skos__hiddenLabel mesh__D007826 Laryngospasms
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007826 1994
% 217.59/217.77  |- skos__broader mesh__D007826smesh__D007818
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007826 2003
% 217.59/217.77  |- mesh__dateRevised mesh__D007826 1993-06-02
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007826 2000
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007028 2002
% 217.59/217.77  |- mesh__recordAuthorizer mesh__D007028 PLS
% 217.59/217.77  |- mesh__recordOriginator mesh__D007028 RLS
% 217.59/217.77  |- skos__historyNote mesh__D007028 Hormones %28%1966-1978%29%
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007028 2005
% 217.59/217.77  |- skos__historyNote mesh__D007028 specific hormone %28%1966-1978%29%
% 217.59/217.77  |- skos__historyNote mesh__D007028 Pituitary Hormones %28%1972-1978%29%
% 217.59/217.77  |- mesh__activeMeSHYear mesh__D007028 2001
% 217.59/217.78  |- skos__hiddenLabel mesh__D007028 Hormones, Hypothalamic
% 217.59/217.78  |- mesh__dateCreated mesh__D007028 1978-05-16
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007028 1997
% 217.59/217.78  |- rdf__type mesh__D007028sskos__Concept
% 217.59/217.78  |- skos__annotation mesh__D007028
% 217.59/217.78       GEN or unspecified; prefer specifics; /biosyn /physiol permitted; consider also PITUITARY HORMONE-RELEASING HORMONES %26% PITUITARY HORMONE RELEASE INHIBITING HORMONES %26% their specifics%A%  
% 217.59/217.78  |- skos__prefLabel mesh__D007028 Hypothalamic Hormones
% 217.59/217.78  |- mesh__dateEstablished mesh__D007028 1979-01-01
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007028 2004
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007028 1996
% 217.59/217.78  |- skos__historyNote mesh__D007028 Hypothalamus %28%1966-1978%29%
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007028 2000
% 217.59/217.78  |- mesh__historyNote mesh__D007028 79   
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007028 2003
% 217.59/217.78  |- skos__related mesh__D007028smesh__D010909
% 217.59/217.78  |- skos__scopeNote mesh__D007028
% 217.59/217.78       Hormones isolated from the hypothalamus which exercise control over other organs, primarily the pituitary gland. Well-known members include certain pituitary hormone-releasing hormones and pituitary hormone release inhibiting hormones. Vasopressin and oxytocin which are found in the posterior pituitary may also be secreted by the hypothalamus but are not grouped here %28%PITUITARY HORMONES, POSTERIOR%29%.%A%    
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007028 1999
% 217.59/217.78  |- mesh__dateRevised mesh__D007028 1995-06-08
% 217.59/217.78  |- skos__broader mesh__D007028smesh__D006728
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007028 2006
% 217.59/217.78  |- mesh__recordMaintainer mesh__D007028 JRT
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007028 1998
% 217.59/217.78  |- mesh__publicMeSHNote mesh__D007028 79   
% 217.59/217.78  |- skos__broader mesh__D007515Q000637smesh__D007515
% 217.59/217.78  |- mesh__preferredCombination mesh__D007515Q000637smesh__D016381
% 217.59/217.78  |- rdf__type mesh__D007515Q000637smesh__CompoundConcept
% 217.59/217.78  |- skos__broader mesh__D051184smesh__D051182
% 217.59/217.78  |- skos__broader mesh__D051184smesh__D001324
% 217.59/217.78  |- rdf__type mesh__D051184sskos__Concept
% 217.59/217.78  |- mesh__publicMeSHNote mesh__D051184
% 217.59/217.78       2006; DESMOGLEIN 3 was indexed under CYTOSKELETAL PROTEINS %28%2005%29%%A%  
% 217.59/217.78  |- mesh__recordMaintainer mesh__D051184 DRC
% 217.59/217.78  |- skos__altLabel mesh__D051184 Desmoglein III
% 217.59/217.78  |- skos__prefLabel mesh__D051184 Desmoglein 3
% 217.59/217.78  |- mesh__historyNote mesh__D051184 2006%28%2005%29%   
% 217.59/217.78  |- mesh__dateEstablished mesh__D051184 2006-01-01
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D051184 2006
% 217.59/217.78  |- skos__scopeNote mesh__D051184
% 217.59/217.78       A desmosomal cadherin that is an autoantigen in the acquired skin disorder PEMPHIGUS VULGARIS.%A%    
% 217.59/217.78  |- skos__altLabel mesh__D051184 Desmosomal Glycoprotein 3
% 217.59/217.78  |- mesh__dateCreated mesh__D051184 2005-06-30
% 217.59/217.78  |- mesh__recordAuthorizer mesh__D051184 sjn
% 217.59/217.78  |- mesh__recordOriginator mesh__D051184 DRC
% 217.59/217.78  |- skos__broader mesh__D017456smesh__D009856
% 217.59/217.78  |- mesh__recordOriginator mesh__D017456 AGS
% 217.59/217.78  |- mesh__dateEstablished mesh__D017456 1993-01-01
% 217.59/217.78  |- skos__annotation mesh__D017456
% 217.59/217.78       viral oncogene proteins; GEN or unspecified; prefer specifics; /drug eff /ultrastruct permitted%A%  
% 217.59/217.78  |- skos__hiddenLabel mesh__D017456 Protein, Adenovirus E19
% 217.59/217.78  |- skos__historyNote mesh__D017456
% 217.59/217.78       Oncogene Proteins, Viral %28%1985-1992%29%
% 217.59/217.78  |- mesh__recordAuthorizer mesh__D017456 sjn
% 217.59/217.78  |- skos__scopeNote mesh__D017456
% 217.59/217.78       Proteins encoded by adenoviruses that are synthesized prior to, and in the absence of, viral DNA replication. The proteins are involved in both positive and negative regulation of expression in viral and cellular genes, and also affect the stability of viral mRNA. Some are also involved in oncogenic transformation.%A%    
% 217.59/217.78  |- rdf__type mesh__D017456sskos__Concept
% 217.59/217.78  |- skos__hiddenLabel mesh__D017456 Proteins, Adenovirus E19
% 217.59/217.78  |- skos__hiddenLabel mesh__D017456 Protein, Adenovirus E29
% 217.59/217.78  |- skos__altLabel mesh__D017456 Adenovirus E19 Protein
% 217.59/217.78  |- skos__prefLabel mesh__D017456 Adenovirus Early Proteins
% 217.59/217.78  |- mesh__dateRevised mesh__D017456 2005-06-30
% 217.59/217.78  |- skos__hiddenLabel mesh__D017456 E29 Proteins, Adenovirus
% 217.59/217.78  |- skos__hiddenLabel mesh__D017456 E19 Protein, Adenovirus
% 217.59/217.78  |- mesh__onlineNote mesh__D017456
% 217.59/217.78       use ADENOVIRUS EARLY PROTEINS %28%NM%29% to search ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS 1985-92%A%  
% 217.59/217.78  |- skos__hiddenLabel mesh__D017456 E29 Protein, Adenovirus
% 217.59/217.78  |- skos__hiddenLabel mesh__D017456 Proteins, Adenovirus E29
% 217.59/217.78  |- mesh__dateCreated mesh__D017456 1992-05-13
% 217.59/217.78  |- mesh__recordMaintainer mesh__D017456 ssb
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D017456 2006
% 217.59/217.78  |- skos__altLabel mesh__D017456 Adenovirus E29 Proteins
% 217.59/217.78  |- skos__historyNote mesh__D017456 Antigens, Viral, Tumor %28%1985%29%
% 217.59/217.78  |- skos__hiddenLabel mesh__D017456 Early Proteins, Adenovirus
% 217.59/217.78  |- mesh__publicMeSHNote mesh__D017456
% 217.59/217.78       93; ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS was indexed under ONCOGENE PROTEINS, VIRAL 1985-92 %26% ANTIGENS, VIRAL, TUMOR 1985%A%  
% 217.59/217.78  |- mesh__historyNote mesh__D017456
% 217.59/217.78       93; was ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS %28%NM%29% 1985-92%A%  
% 217.59/217.78  |- skos__broader mesh__D017456smesh__D000956
% 217.59/217.78  |- skos__hiddenLabel mesh__D017456 E19 Proteins, Adenovirus
% 217.59/217.78  |- skos__altLabel mesh__D017456
% 217.59/217.78       Adenovirus Early Region Transforming Proteins
% 217.59/217.78  |- skos__prefLabel mesh__D003436 Croton Oil
% 217.59/217.78  |- mesh__recordMaintainer mesh__D003436 ssb
% 217.59/217.78  |- skos__broader mesh__D003436smesh__D005224
% 217.59/217.78  |- mesh__dateCreated mesh__D003436 1999-01-01
% 217.59/217.78  |- skos__hiddenLabel mesh__D003436 Oil, Croton
% 217.59/217.78  |- skos__related mesh__D003436smesh__D010703
% 217.59/217.78  |- mesh__dateRevised mesh__D003436 2005-06-30
% 217.59/217.78  |- mesh__recordOriginator mesh__D003436 NLM
% 217.59/217.78  |- mesh__recordAuthorizer mesh__D003436 sjn
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D003436 2006
% 217.59/217.78  |- skos__scopeNote mesh__D003436
% 217.59/217.78       Viscous, nauseating oil obtained from the shrub Croton tiglium %28%Euphorbaceae%29%. It is a vesicant and skin irritant used as pharmacologic standard for skin inflammation and allergy and causes skin cancer. It was formerly used as an emetic and cathartic with frequent mortality.%A%    
% 217.59/217.78  |- skos__broader mesh__D003436smesh__D010938
% 217.59/217.78  |- rdf__type mesh__D003436sskos__Concept
% 217.59/217.78  |- skos__annotation mesh__D003436 a dermatol agent %26% carcinogen   
% 217.59/217.78  |- mesh__historyNote mesh__D008121 2003 %28%1972%29%   
% 217.59/217.78  |- skos__historyNote mesh__D008121 Crustacea %28%1966-1971%29%
% 217.59/217.78  |- mesh__recordOriginator mesh__D008121 NLM
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D008121 2006
% 217.59/217.78  |- skos__broader mesh__D008121smesh__D033364
% 217.59/217.78  |- skos__prefLabel mesh__D008121 Nephropidae
% 217.59/217.78  |- skos__altLabel mesh__D008121 Lobsters, Clawed
% 217.59/217.78  |- skos__altLabel mesh__D008121 Clawed Lobsters
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D008121 2005
% 217.59/217.78  |- skos__altLabel mesh__D008121 Homaridae
% 217.59/217.78  |- mesh__dateRevised mesh__D008121 2003-07-09
% 217.59/217.78  |- mesh__dateEstablished mesh__D008121 1972-01-01
% 217.59/217.78  |- skos__scopeNote mesh__D008121
% 217.59/217.78       Family of large marine CRUSTACEA, in the order DECAPODA. These are called clawed lobsters because they bear pincers on the first three pairs of legs. The American lobster and Cape lobster in the genus Homarus are commonly used for food.%A%    
% 217.59/217.78  |- skos__annotation mesh__D008121
% 217.59/217.78       as animal %26% food; unspecified lobster as food probably goes here and is coord IM with SHELLFISH %28%IM%29%%A%  
% 217.59/217.78  |- mesh__publicMeSHNote mesh__D008121 2003; see LOBSTERS 1972-2002   
% 217.59/217.78  |- mesh__recordMaintainer mesh__D008121 ags
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D008121 2004
% 217.59/217.78  |- rdf__type mesh__D008121sskos__Concept
% 217.59/217.78  |- mesh__dateCreated mesh__D008121 1999-01-01
% 217.59/217.78  |- mesh__recordAuthorizer mesh__D008121 sjn
% 217.59/217.78  |- mesh__publicMeSHNote mesh__D027884 2002   
% 217.59/217.78  |- mesh__dateEstablished mesh__D027884 2002-01-01
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D027884 2003
% 217.59/217.78  |- mesh__historyNote mesh__D027884 2002   
% 217.59/217.78  |- mesh__dateCreated mesh__D027884 2001-07-25
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D027884 2005
% 217.59/217.78  |- skos__broader mesh__D027884smesh__D027883
% 217.59/217.78  |- skos__annotation mesh__D027884
% 217.59/217.78       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D027884 2004
% 217.59/217.78  |- skos__prefLabel mesh__D027884 Astragalus gummifer
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D027884 2002
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D027884 2006
% 217.59/217.78  |- rdf__type mesh__D027884sskos__Concept
% 217.59/217.78  |- skos__scopeNote mesh__D027884
% 217.59/217.78       Astragalus gummifer Labill. is the source of gum TRAGACANTH.%A%    
% 217.59/217.78  |- skos__broader mesh__D013864smesh__D013438
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D013864 1999
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D013864 2002
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D013864 2006
% 217.59/217.78  |- mesh__recordAuthorizer mesh__D013864 SJN
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D013864 2001
% 217.59/217.78  |- rdf__type mesh__D013864sskos__Concept
% 217.59/217.78  |- mesh__dateRevised mesh__D013864 1998-06-11
% 217.59/217.78  |- skos__prefLabel mesh__D013864 Thioglycolates
% 217.59/217.78  |- mesh__publicMeSHNote mesh__D013864 70   
% 217.59/217.78  |- mesh__dateCreated mesh__D013864 1999-01-01
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D013864 2005
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D013864 2000
% 217.59/217.78  |- skos__altLabel mesh__D013864 Thioglycollates
% 217.59/217.78  |- mesh__historyNote mesh__D013864 70%28%64%29%   
% 217.59/217.78  |- mesh__dateEstablished mesh__D013864 1970-01-01
% 217.59/217.78  |- skos__broader mesh__D013864smesh__D000085
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D013864 2004
% 217.59/217.78  |- skos__scopeNote mesh__D013864
% 217.59/217.78       Organic esters of thioglycolic acid %28%HS-CH2COOH%29%.     
% 217.59/217.78  |- mesh__recordMaintainer mesh__D013864 ADP
% 217.59/217.78  |- mesh__recordOriginator mesh__D013864 NLM
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D013864 2003
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D013066 2003
% 217.59/217.78  |- skos__altLabel mesh__D013066 Pathology, Language
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D013066 2006
% 217.59/217.78  |- mesh__dateCreated mesh__D013066 1978-12-14
% 217.59/217.78  |- mesh__recordAuthorizer mesh__D013066 PLS
% 217.59/217.78  |- skos__hiddenLabel mesh__D013066 Pathology, Speech Language
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D013066 1994
% 217.59/217.78  |- skos__altLabel mesh__D013066 Pathology, Speech-Language
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D013066 2004
% 217.59/217.78  |- mesh__recordMaintainer mesh__D013066 JLS
% 217.59/217.78  |- skos__scopeNote mesh__D013066
% 217.59/217.78       The study of speech or language disorders and their diagnosis and correction.%A%    
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D013066 2000
% 217.59/217.78  |- mesh__recordOriginator mesh__D013066 RC
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D013066 1995
% 217.59/217.78  |- skos__historyNote mesh__D013066 Speech Therapy %28%1966-1979%29%
% 217.59/217.78  |- skos__prefLabel mesh__D013066 Speech-Language Pathology
% 217.59/217.78  |- skos__altLabel mesh__D013066 Speech Pathology
% 217.59/217.78  |- mesh__historyNote mesh__D013066
% 217.59/217.78       91; was SPEECH PATHOLOGY 1980-90; was included in SPEECH THERAPY 1964-79 %28%Prov 1964-65%29%%A%  
% 217.59/217.78  |- skos__hiddenLabel mesh__D013066 Speech Language Pathology
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D013066 2001
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D013066 1998
% 217.59/217.78  |- skos__annotation mesh__D013066
% 217.59/217.78       SPEC: SPEC qualif; the specialty devoted to study of speech %26% language disord, their diag %26% ther; do not confuse with the patient or dis %28% = SPEECH DISORDERS or LANGUAGE DISORDERS%29%; AMERICAN SPEECH-LANGUAGE-HEARING ASSOCIATION is also available; DF: SPEECH LANGUAGE PATHOL or SPEECH PATHOL%A%  
% 217.59/217.78  |- skos__broader mesh__D013066smesh__D016390
% 217.59/217.78  |- rdf__type mesh__D013066sskos__Concept
% 217.59/217.78  |- mesh__dateRevised mesh__D013066 1993-06-04
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D013066 2002
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D013066 1996
% 217.59/217.78  |- mesh__dateEstablished mesh__D013066 1980-01-01
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D013066 1999
% 217.59/217.78  |- mesh__publicMeSHNote mesh__D013066
% 217.59/217.78       91; was SPEECH PATHOLOGY 1980-90; was included in SPEECH THERAPY 1966-79%A%  
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D013066 2005
% 217.59/217.78  |- mesh__onlineNote mesh__D013066
% 217.59/217.78       use SPEECH-LANGUAGE PATHOLOGY to search SPEECH PATHOLOGY 1980-90; search SPEECH THERAPY 1966-79%A%  
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D013066 1997
% 217.59/217.78  |- mesh__dateRevised mesh__D007827 1990-05-29
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007827 2000
% 217.59/217.78  |- skos__hiddenLabel mesh__D007827 Laryngitides
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007827 1992
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007827 2004
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007827 1998
% 217.59/217.78  |- mesh__recordMaintainer mesh__D007827 PLS
% 217.59/217.78  |- mesh__recordAuthorizer mesh__D007827 NLM
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007827 1991
% 217.59/217.78  |- skos__scopeNote mesh__D007827
% 217.59/217.78       Inflammation of the larynx. This condition presents itself with dryness and soreness of the throat, difficulty in swallowing, cough, and hoarseness.%A%    
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007827 2003
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007827 1995
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007827 2002
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007827 1994
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007827 1997
% 217.59/217.78  |- mesh__recordOriginator mesh__D007827 NLM
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007827 2006
% 217.59/217.78  |- mesh__dateCreated mesh__D007827 1999-01-01
% 217.59/217.78  |- skos__prefLabel mesh__D007827 Laryngitis
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007827 1996
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007827 2005
% 217.59/217.78  |- skos__broader mesh__D007827smesh__D012141
% 217.59/217.78  |- skos__broader mesh__D007827smesh__D007818
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007827 2001
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007827 1993
% 217.59/217.78  |- rdf__type mesh__D007827sskos__Concept
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007827 1999
% 217.59/217.78  |- skos__broader mesh__D007029smesh__D007027
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007029 2001
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Hypothalamic Neoplasm
% 217.59/217.78  |- skos__historyNote mesh__D007029 Hypothalamus %28%1966-1980%29%
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Hypothalamus Tumor
% 217.59/217.78  |- skos__altLabel mesh__D007029 Neoplasms, Hypothalamic, Benign
% 217.59/217.78  |- skos__altLabel mesh__D007029 Neoplasms, Hypothalamus
% 217.59/217.78  |- mesh__recordOriginator mesh__D007029 RC
% 217.59/217.78  |- skos__altLabel mesh__D007029
% 217.59/217.78       Hypothalamo-Neurohypophysial Region Neoplasms
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029
% 217.59/217.78       Neoplasm, Hypothalamo-Neurohypophysial Region
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Neoplasm, Benign Hypothalamic
% 217.59/217.78  |- mesh__publicMeSHNote mesh__D007029 1981   
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Neoplasm, Malignant Hypothalamic
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Tumor, Hypothalamic
% 217.59/217.78  |- mesh__recordMaintainer mesh__D007029 jls
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Hypothalamus Tumors
% 217.59/217.78  |- mesh__dateEstablished mesh__D007029 1981-01-01
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007029 2002
% 217.59/217.78  |- skos__altLabel mesh__D007029 Hypothalamus Neoplasms
% 217.59/217.78  |- mesh__recordAuthorizer mesh__D007029 jls
% 217.59/217.78  |- skos__prefLabel mesh__D007029 Hypothalamic Neoplasms
% 217.59/217.78  |- skos__altLabel mesh__D007029 Neoplasms, Hypothalamic-Pituitary
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Neoplasm, Hypothalamic
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007029 2003
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029
% 217.59/217.78       Hypothalamo-Neurohypophysial Region Neoplasm
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Benign Hypothalamic Neoplasm
% 217.59/217.78  |- skos__altLabel mesh__D007029
% 217.59/217.78       Neoplasms, Hypothalamo-Neurohypophysial Region
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Teratoma, Hypothalamic
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029
% 217.59/217.78       Neoplasms, Hypothalamo Neurohypophysial Region
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029
% 217.59/217.78       Hypothalamo Neurohypophysial Region Neoplasms
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Cancers, Hypothalamic
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Neoplasms, Hypothalamic Pituitary
% 217.59/217.78  |- skos__altLabel mesh__D007029 Hypothalamic Tumors
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Malignant Hypothalamic Neoplasm
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Neoplasm, Hypothalamic-Pituitary
% 217.59/217.78  |- skos__altLabel mesh__D007029 Hypothalamic Neoplasms, Benign
% 217.59/217.78  |- skos__altLabel mesh__D007029 Hypothalamic Neoplasms, Malignant
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007029 2004
% 217.59/217.78  |- mesh__dateRevised mesh__D007029 2004-07-28
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Neoplasms, Hypothalamic Chiasmatic
% 217.59/217.78  |- skos__annotation mesh__D007029
% 217.59/217.78       coord IM with site in hypothalamus %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Neoplasms, Malignant Hypothalamic
% 217.59/217.78  |- skos__altLabel mesh__D007029 Neoplasms, Hypothalamic, Malignant
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Cancer, Hypothalamic
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Hypothalamic Pituitary Neoplasms
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Neoplasm, Hypothalamic-Chiasmatic
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Hypothalamic Chiasmatic Neoplasms
% 217.59/217.78  |- rdf__type mesh__D007029sskos__Concept
% 217.59/217.78  |- skos__broader mesh__D007029smesh__D015173
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Hypothalamic Tumor
% 217.59/217.78  |- skos__scopeNote mesh__D007029
% 217.59/217.78       Benign and malignant tumors of the HYPOTHALAMUS. Pilocytic astrocytomas and hamartomas are relatively frequent histologic types. Neoplasms of the hypothalamus frequently originate from adjacent structures, including the OPTIC CHIASM, optic nerve %28%see OPTIC NERVE NEOPLASMS%29%, and pituitary gland %28%see PITUITARY NEOPLASMS%29%. Relatively frequent clinical manifestations include visual loss, developmental delay, macrocephaly, and precocious puberty. %28%From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2051%29%%A%    
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007029 2005
% 217.59/217.78  |- mesh__historyNote mesh__D007029 1981   
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Hypothalamic-Chiasmatic Neoplasm
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Hypothalamus Neoplasm
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007029 2000A
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Teratomas, Hypothalamic
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Tumor, Hypothalamus
% 217.59/217.78  |- mesh__dateCreated mesh__D007029 1980-04-04
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Hypothalamic Teratoma
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007029 2000
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Hypothalamic-Pituitary Neoplasm
% 217.59/217.78  |- skos__altLabel mesh__D007029 Tumors, Hypothalamus
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007029 2005A
% 217.59/217.78  |- skos__altLabel mesh__D007029 Neoplasms, Hypothalamic
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D007029 2006
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Tumors, Hypothalamic
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Neoplasm, Hypothalamus
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Hypothalamic Cancers
% 217.59/217.78  |- skos__hiddenLabel mesh__D007029 Hypothalamic Neoplasm, Malignant
% 217.59/217.78  |- skos__altLabel mesh__D007029 Neoplasms, Hypothalamic-Chiasmatic
% 217.59/217.78  |- skos__altLabel mesh__D007029 Malignant Hypothalamic Neoplasms
% 217.59/217.78  |- skos__historyNote mesh__D007029 Brain Neoplasms %28%1966-1980%29%
% 217.59/217.78  |- rdf__type mesh__D051185sskos__Concept
% 217.59/217.78  |- skos__altLabel mesh__D051185 gamma-Catenin
% 217.59/217.78  |- mesh__publicMeSHNote mesh__D051185
% 217.59/217.78       2006; GAMMA CATENIN was indexed under CYTOSKELETAL PROTEINS 1990-2005, %26% under MEMBRANE GLYCOPROTEINS 1988-1989, %26% under MEMBRANE PROTEINS 1983-1987%A%  
% 217.59/217.78  |- mesh__dateCreated mesh__D051185 2005-06-30
% 217.59/217.78  |- mesh__recordAuthorizer mesh__D051185 sjn
% 217.59/217.78  |- skos__broader mesh__D051185smesh__D051177
% 217.59/217.78  |- skos__scopeNote mesh__D051185
% 217.59/217.78       A multi-functional catenin that is highly homologous to BETA CATENIN.  Gamma catenin binds CADHERINS and helps link their cytoplasmic tails to ACTIN in the CYTOSKELETON via ALPHA CATENIN. It is also found in DESMOSOMES where it mediates the link between DESMOSOMAL CADHERINS and DESMOPLAKIN.%A%    
% 217.59/217.78  |- skos__altLabel mesh__D051185 Plakoglobin
% 217.59/217.78  |- mesh__historyNote mesh__D051185 2006%28%1983%29%   
% 217.59/217.78  |- skos__prefLabel mesh__D051185 gamma Catenin
% 217.59/217.78  |- skos__hiddenLabel mesh__D051185 Catenin, gamma
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D051185 2006
% 217.59/217.78  |- skos__broader mesh__D051185smesh__D051186
% 217.59/217.78  |- mesh__recordMaintainer mesh__D051185 DRC
% 217.59/217.78  |- mesh__recordOriginator mesh__D051185 DRC
% 217.59/217.78  |- mesh__dateEstablished mesh__D051185 2006-01-01
% 217.59/217.78  |- rdf__type mesh__D017457sskos__Concept
% 217.59/217.78  |- mesh__dateCreated mesh__D017457 1992-05-26
% 217.59/217.78  |- skos__scopeNote mesh__D017457
% 217.59/217.78       Cell surface proteins that bind albumin with high affinity and trigger intracellular changes influencing the behavior of cells.%A%    
% 217.59/217.78  |- skos__broader mesh__D017457smesh__D018000
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D017457 1998
% 217.59/217.78  |- skos__annotation mesh__D017457
% 217.59/217.78       coord IM with specific albumin %28%IM%29%; DF; RECEPT ALBUMIN   
% 217.59/217.78  |- mesh__dateRevised mesh__D017457 1997-06-20
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D017457 1999
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D017457 2005
% 217.59/217.78  |- mesh__recordOriginator mesh__D017457 PXP
% 217.59/217.78  |- mesh__recordMaintainer mesh__D017457 NDW
% 217.59/217.78  |- mesh__dateEstablished mesh__D017457 1993-01-01
% 217.59/217.78  |- skos__hiddenLabel mesh__D017457 Receptor, Albumin
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D017457 2000
% 217.59/217.78  |- mesh__recordAuthorizer mesh__D017457 SJN
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D017457 2006
% 217.59/217.78  |- skos__altLabel mesh__D017457 Albumin Receptor
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D017457 2003
% 217.59/217.78  |- skos__historyNote mesh__D017457
% 217.59/217.78       Receptors, Endogenous Substances %28%1981-1992%29%
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D017457 2001
% 217.59/217.78  |- mesh__publicMeSHNote mesh__D017457
% 217.59/217.78       93; ALBUMIN RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-92 %26% RECEPTORS, HORMONE 1981-82%A%  
% 217.59/217.78  |- skos__prefLabel mesh__D017457 Receptors, Albumin
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D017457 2004
% 217.59/217.78  |- mesh__historyNote mesh__D017457
% 217.59/217.78       93; was ALBUMIN RECEPTOR %28%NM%29% 1981-92   
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D017457 2002
% 217.59/217.78  |- mesh__onlineNote mesh__D017457
% 217.59/217.78       use RECEPTORS, ALBUMIN %28%NM%29% to search ALBUMIN RECEPTOR 1981-92%A%  
% 217.59/217.78  |- skos__altLabel mesh__D017457 Albumin Receptors
% 217.59/217.78  |- skos__prefLabel mesh__D003437 Crotonates
% 217.59/217.78  |- mesh__recordAuthorizer mesh__D003437 sjn
% 217.59/217.78  |- mesh__historyNote mesh__D003437
% 217.59/217.78       91%28%73%29%; was see under FATTY ACIDS, MONOUNSATURATED 1973-90%A%  
% 217.59/217.78  |- mesh__dateRevised mesh__D003437 2003-07-09
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D003437 2006
% 217.59/217.78  |- rdf__type mesh__D003437sskos__Concept
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D003437 2005
% 217.59/217.78  |- mesh__publicMeSHNote mesh__D003437
% 217.59/217.78       91; was see under FATTY ACIDS, MONOUNSATURATED 1973-90   
% 217.59/217.78  |- mesh__dateEstablished mesh__D003437 1991-01-01
% 217.59/217.78  |- mesh__recordMaintainer mesh__D003437 ssb
% 217.59/217.78  |- skos__scopeNote mesh__D003437 Salts and esters of crotonic acid.     
% 217.59/217.78  |- skos__broader mesh__D003437smesh__D003438
% 217.59/217.78  |- mesh__dateCreated mesh__D003437 1999-01-01
% 217.59/217.78  |- mesh__recordOriginator mesh__D003437 NLM
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D003437 2004
% 217.59/217.78  |- skos__historyNote mesh__D003437 Butyrates %28%1966-1972%29%
% 217.59/217.78  |- skos__scopeNote mesh__D008920
% 217.59/217.78       A nitroimidazole that sensitizes normally radio-resistant hypoxic cells to radiation. It may also be directly cytotoxic to hypoxic cells and has been proposed as an antineoplastic.%A%    
% 217.59/217.78  |- skos__altLabel mesh__D008920
% 217.59/217.78       alpha-%28%Methoxymethyl%29%-2-nitro-1H-imidazole-1-ethanol
% 217.59/217.78  |- skos__historyNote mesh__D008920 Imidazoles %28%1966-1973%29%
% 217.59/217.78  |- skos__hiddenLabel mesh__D008920 Ro 7 0582
% 217.59/217.78  |- skos__prefLabel mesh__D008920 Misonidazole
% 217.59/217.78  |- mesh__dateCreated mesh__D008920 1978-05-03
% 217.59/217.78  |- mesh__dateEstablished mesh__D008920 1986-01-01
% 217.59/217.78  |- skos__broader mesh__D008920smesh__D009593
% 217.59/217.78  |- mesh__dateRevised mesh__D008920 2005-06-30
% 217.59/217.78  |- skos__altLabel mesh__D008920 Ro 7-0582
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D008920 2006
% 217.59/217.78  |- mesh__historyNote mesh__D008920
% 217.59/217.78       86%28%79%29%; was see under NITROIMIDAZOLES 1979-85   
% 217.59/217.78  |- mesh__recordOriginator mesh__D008920 SH
% 217.59/217.78  |- mesh__publicMeSHNote mesh__D008920
% 217.59/217.78       86; was see under NITROIMIDAZOLES 1979-85   
% 217.59/217.78  |- skos__hiddenLabel mesh__D008920 Ro 70582
% 217.59/217.78  |- skos__historyNote mesh__D008920 Nitroimidazoles %28%1974-1978%29%
% 217.59/217.78  |- skos__hiddenLabel mesh__D008920 Ro 070582
% 217.59/217.78  |- mesh__recordAuthorizer mesh__D008920 sjn
% 217.59/217.78  |- mesh__recordMaintainer mesh__D008920 ssb
% 217.59/217.78  |- rdf__type mesh__D008920sskos__Concept
% 217.59/217.78  |- skos__hiddenLabel mesh__D008920 Ro 07 0582
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D008122 2006
% 217.59/217.78  |- skos__annotation mesh__D008122 IM   
% 217.59/217.78  |- mesh__dateRevised mesh__D008122 2004-07-07
% 217.59/217.78  |- skos__hiddenLabel mesh__D008122 Area Networks, Local
% 217.59/217.78  |- mesh__recordOriginator mesh__D008122 EC
% 217.59/217.78  |- skos__broader mesh__D008122smesh__D003195
% 217.59/217.78  |- skos__hiddenLabel mesh__D008122 Networks, Local Area
% 217.59/217.78  |- mesh__recordAuthorizer mesh__D008122 sjn
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D008122 2005
% 217.59/217.78  |- skos__altLabel mesh__D008122 LAN
% 217.59/217.78  |- skos__prefLabel mesh__D008122 Local Area Networks
% 217.59/217.78  |- mesh__dateCreated mesh__D008122 1986-06-18
% 217.59/217.78  |- mesh__dateEstablished mesh__D008122 1991-01-01
% 217.59/217.78  |- skos__hiddenLabel mesh__D008122 Area Network, Local
% 217.59/217.78  |- mesh__historyNote mesh__D008122
% 217.59/217.78       91%28%87%29%; was see under COMPUTER SYSTEMS 1987-90   
% 217.59/217.78  |- rdf__type mesh__D008122sskos__Concept
% 217.59/217.78  |- skos__hiddenLabel mesh__D008122 Local Area Network
% 217.59/217.78  |- skos__hiddenLabel mesh__D008122 Network, Local Area
% 217.59/217.78  |- skos__scopeNote mesh__D008122
% 217.59/217.78       Communications networks connecting various hardware devices together within or between buildings by means of a continuous cable or voice data telephone system.%A%    
% 217.59/217.78  |- mesh__recordMaintainer mesh__D008122 jls
% 217.59/217.78  |- mesh__publicMeSHNote mesh__D008122
% 217.59/217.78       91; was see under COMPUTER SYSTEMS 1987-90   
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D027885 2003
% 217.59/217.78  |- skos__broader mesh__D027885smesh__D027883
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D027885 2005
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D027885 2004
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D027885 2006
% 217.59/217.78  |- skos__prefLabel mesh__D027885 Astragalus membranaceus
% 217.59/217.78  |- mesh__historyNote mesh__D027885 2002   
% 217.59/217.78  |- skos__historyNote mesh__D027885 Plants, Medicinal %28%1979-2001%29%
% 217.59/217.78  |- mesh__dateCreated mesh__D027885 2001-07-25
% 217.59/217.78  |- skos__annotation mesh__D027885
% 217.59/217.78       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.59/217.78  |- skos__scopeNote mesh__D027885
% 217.59/217.78       A plant species of the Astragalus genus which is source of Huang qi preparation used in TRADITIONAL CHINESE MEDICINE.%A%    
% 217.59/217.78  |- mesh__activeMeSHYear mesh__D027885 2002
% 217.59/217.78  |- rdf__type mesh__D027885sskos__Concept
% 217.59/217.78  |- mesh__publicMeSHNote mesh__D027885 2002   
% 217.59/217.78  |- mesh__dateEstablished mesh__D027885 2002-01-01
% 217.59/217.78  |- skos__historyNote mesh__D027885
% 217.59/217.78       Medicine, Chinese Traditional %28%1983-2001%29%
% 217.59/217.78  |- skos__broader mesh__D013865smesh__D006027
% 217.59/217.79  |- mesh__publicMeSHNote mesh__D013865 74   
% 217.59/217.79  |- skos__broader mesh__D013865smesh__D013457
% 217.59/217.79  |- mesh__recordOriginator mesh__D013865 NLM
% 217.59/217.79  |- skos__prefLabel mesh__D013865 Thioglycosides
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D013865 2006
% 217.59/217.79  |- rdf__type mesh__D013865sskos__Concept
% 217.59/217.79  |- mesh__dateEstablished mesh__D013865 1974-01-01
% 217.59/217.79  |- mesh__dateCreated mesh__D013865 1999-01-01
% 217.59/217.79  |- mesh__recordMaintainer mesh__D013865 ssb
% 217.59/217.79  |- mesh__dateRevised mesh__D013865 2005-06-30
% 217.59/217.79  |- skos__annotation mesh__D013865 do not confuse with THIOGLUCOSIDES   
% 217.59/217.79  |- mesh__historyNote mesh__D013865 74   
% 217.59/217.79  |- mesh__recordAuthorizer mesh__D013865 sjn
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D013067 2002
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D013067 1998
% 217.59/217.79  |- mesh__recordMaintainer mesh__D013067 TGC
% 217.59/217.79  |- rdf__type mesh__D013067sskos__Concept
% 217.59/217.79  |- skos__historyNote mesh__D013067 Hearing %28%1966-1967%29%
% 217.59/217.79  |- mesh__dateCreated mesh__D013067 1978-05-22
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D013067 1999
% 217.59/217.79  |- skos__broader mesh__D013067smesh__D001307
% 217.59/217.79  |- skos__historyNote mesh__D013067 Perception %28%1966-1967%29%
% 217.59/217.79  |- skos__hiddenLabel mesh__D013067 Discrimination, Speech
% 217.59/217.79  |- skos__historyNote mesh__D013067 Speech %28%1966-1978%29%
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D013067 2005
% 217.59/217.79  |- mesh__dateEstablished mesh__D013067 1979-01-01
% 217.59/217.79  |- mesh__dateRevised mesh__D013067 1997-06-20
% 217.59/217.79  |- mesh__publicMeSHNote mesh__D013067 79   
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D013067 2003
% 217.59/217.79  |- mesh__recordAuthorizer mesh__D013067 SJN
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D013067 2006
% 217.59/217.79  |- mesh__historyNote mesh__D013067 79   
% 217.59/217.79  |- skos__scopeNote mesh__D013067
% 217.59/217.79       The process whereby an utterance is decoded into a representation in terms of linguistic units %28%sequences of phonetic segments which combine to form lexical and grammatical morphemes%29%.%A%    
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D013067 2000
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D013067 2004
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D013067 2001
% 217.59/217.79  |- skos__historyNote mesh__D013067 Auditory Perception %28%1967-1978%29%
% 217.59/217.79  |- skos__hiddenLabel mesh__D013067 Perception, Speech
% 217.59/217.79  |- mesh__recordOriginator mesh__D013067 RC
% 217.59/217.79  |- skos__prefLabel mesh__D013067 Speech Perception
% 217.59/217.79  |- skos__broader mesh__D007828smesh__D004724
% 217.59/217.79  |- skos__scopeNote mesh__D007828
% 217.59/217.79       Examination, therapy or surgery of the interior of the larynx performed with a specially designed endoscope.%A%    
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007828 2001
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007828 2003
% 217.59/217.79  |- mesh__recordMaintainer mesh__D007828 nns
% 217.59/217.79  |- skos__altLabel mesh__D007828 Surgery, Laryngoscopic
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007828 2000
% 217.59/217.79  |- skos__hiddenLabel mesh__D007828 Laryngoscopic Surgeries
% 217.59/217.79  |- skos__hiddenLabel mesh__D007828 Laryngoscopic Surgical Procedure
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007828 2006
% 217.59/217.79  |- mesh__recordAuthorizer mesh__D007828 sjn
% 217.59/217.79  |- mesh__dateCreated mesh__D007828 1999-01-01
% 217.59/217.79  |- skos__hiddenLabel mesh__D007828 Procedure, Laryngoscopic Surgical
% 217.59/217.79  |- skos__altLabel mesh__D007828 Laryngoscopic Surgery
% 217.59/217.79  |- skos__broader mesh__D007828smesh__D013517
% 217.59/217.79  |- mesh__dateRevised mesh__D007828 1999-11-03
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007828 2005
% 217.59/217.79  |- skos__broader mesh__D007828smesh__D003948
% 217.59/217.79  |- skos__hiddenLabel mesh__D007828 Surgical Procedure, Laryngoscopic
% 217.59/217.79  |- skos__hiddenLabel mesh__D007828 Laryngoscopies
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007828 2002
% 217.59/217.79  |- rdf__type mesh__D007828sskos__Concept
% 217.59/217.79  |- skos__altLabel mesh__D007828 Surgical Procedures, Laryngoscopic
% 217.59/217.79  |- mesh__recordOriginator mesh__D007828 NLM
% 217.59/217.79  |- skos__prefLabel mesh__D007828 Laryngoscopy
% 217.59/217.79  |- skos__hiddenLabel mesh__D007828 Surgeries, Laryngoscopic
% 217.59/217.79  |- skos__hiddenLabel mesh__D007828 Procedures, Laryngoscopic Surgical
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007828 2004
% 217.59/217.79  |- skos__historyNote mesh__D018550
% 217.59/217.79       Cephalosporins/pharmacology %28%1966-1994%29%
% 217.59/217.79  |- skos__hiddenLabel mesh__D018550 Resistance, Cephalosporin
% 217.59/217.79  |- mesh__historyNote mesh__D018550 95   
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D018550 2005
% 217.59/217.79  |- mesh__dateEstablished mesh__D018550 1995-01-01
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D018550 2006
% 217.59/217.79  |- mesh__dateCreated mesh__D018550 1994-01-25
% 217.59/217.79  |- skos__historyNote mesh__D018550
% 217.59/217.79       Drug Resistance, Microbial %28%1977-1994%29%
% 217.59/217.79  |- skos__annotation mesh__D018550
% 217.59/217.79       coord IM with specific cephalosporin %28%IM%29%   
% 217.59/217.79  |- mesh__recordMaintainer mesh__D018550 ssb
% 217.59/217.79  |- skos__hiddenLabel mesh__D018550 Resistances, Cephalosporin
% 217.59/217.79  |- skos__scopeNote mesh__D018550
% 217.59/217.79       Non-susceptibility of an organism to the action of the cephalosporins.%A%    
% 217.59/217.79  |- mesh__recordAuthorizer mesh__D018550 sjn
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D018550 2004
% 217.59/217.79  |- mesh__publicMeSHNote mesh__D018550 95   
% 217.59/217.79  |- rdf__type mesh__D018550sskos__Concept
% 217.59/217.79  |- mesh__dateRevised mesh__D018550 2003-07-09
% 217.59/217.79  |- skos__broader mesh__D018550smesh__D018440
% 217.59/217.79  |- skos__hiddenLabel mesh__D018550 Cephalosporin Resistances
% 217.59/217.79  |- skos__prefLabel mesh__D018550 Cephalosporin Resistance
% 217.59/217.79  |- mesh__recordOriginator mesh__D018550 AGS
% 217.59/217.79  |- skos__prefLabel mesh__D032221 Linaria
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D032221 2004
% 217.59/217.79  |- skos__scopeNote mesh__D032221
% 217.59/217.79       A plant genus of the family SCROPHULARIACEAE. Members contain linarin %28%also called acaciin%29%.%A%    
% 217.59/217.79  |- rdf__type mesh__D032221sskos__Concept
% 217.59/217.79  |- mesh__historyNote mesh__D032221 2003   
% 217.59/217.79  |- mesh__publicMeSHNote mesh__D032221 2003   
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D032221 2005
% 217.59/217.79  |- mesh__dateCreated mesh__D032221 2002-07-03
% 217.59/217.79  |- skos__annotation mesh__D032221
% 217.59/217.79       X ref TOADFLAX: TOADFLAX, BASTARD see SANTALACEAE is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D032221 2006
% 217.59/217.79  |- skos__altLabel mesh__D032221 Toadflax
% 217.59/217.79  |- mesh__dateEstablished mesh__D032221 2003-01-01
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D032221 2003
% 217.59/217.79  |- skos__broader mesh__D032221smesh__D028083
% 217.59/217.79  |- skos__hiddenLabel mesh__D004530 Egg Yolks
% 217.59/217.79  |- mesh__historyNote mesh__D004530 was in Cat J only 1963-76   
% 217.59/217.79  |- mesh__recordOriginator mesh__D004530 NLM
% 217.59/217.79  |- mesh__dateCreated mesh__D004530 1999-01-01
% 217.59/217.79  |- skos__broader mesh__D004530smesh__D010063
% 217.59/217.79  |- mesh__dateRevised mesh__D004530 1999-11-03
% 217.59/217.79  |- skos__scopeNote mesh__D004530
% 217.59/217.79       Cytoplasm stored in an egg that contains nutritional reserves for the developing embryo. It is rich in polysaccharides, lipids, and proteins.%A%    
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D004530 2004
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D004530 2002
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D004530 2006
% 217.59/217.79  |- skos__broader mesh__D004530smesh__D004531
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D004530 2003
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D004530 2001
% 217.59/217.79  |- mesh__recordMaintainer mesh__D004530 KEV
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D004530 2005
% 217.59/217.79  |- skos__prefLabel mesh__D004530 Egg Yolk
% 217.59/217.79  |- skos__hiddenLabel mesh__D004530 Yolks, Egg
% 217.59/217.79  |- skos__hiddenLabel mesh__D004530 Yolk, Egg
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D004530 2000
% 217.59/217.79  |- rdf__type mesh__D004530sskos__Concept
% 217.59/217.79  |- skos__annotation mesh__D004530
% 217.59/217.79       for both ovum nutrient %26% dietary portion of eggs   
% 217.59/217.79  |- mesh__recordAuthorizer mesh__D004530 sjn
% 217.59/217.79  |- skos__prefLabel mesh__D051186 Armadillo Domain Proteins
% 217.59/217.79  |- mesh__recordOriginator mesh__D051186 DRC
% 217.59/217.79  |- rdf__type mesh__D051186sskos__Concept
% 217.59/217.79  |- skos__annotation mesh__D051186
% 217.59/217.79       don%27%t confuse with proteins from Armadillos   
% 217.59/217.79  |- mesh__publicMeSHNote mesh__D051186
% 217.59/217.79       2006; ARMADILLO PROTEINS was indexed under TRANS-ACTIVATORS %26% DROSOPHILA PROTEINS 2005%A%  
% 217.59/217.79  |- skos__scopeNote mesh__D051186
% 217.59/217.79       A family of proteins that contain several 42-amino acid repeat domains and are homologous to the Drosophila armadillo protein. They bind to other proteins through their armadillo domains and play a variety of roles in the CELL including SIGNAL TRANSDUCTION, regulation of DESMOSOME assembly, and CELL ADHESION.%A%    
% 217.59/217.79  |- mesh__dateEstablished mesh__D051186 2006-01-01
% 217.59/217.79  |- skos__altLabel mesh__D051186 Armadillo Protein Family
% 217.59/217.79  |- skos__altLabel mesh__D051186 Armadillo Motif Proteins
% 217.59/217.79  |- mesh__dateCreated mesh__D051186 2005-06-30
% 217.59/217.79  |- skos__altLabel mesh__D051186 Armadillo Proteins
% 217.59/217.79  |- mesh__recordAuthorizer mesh__D051186 sjn
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D051186 2006
% 217.59/217.79  |- mesh__recordMaintainer mesh__D051186 DRC
% 217.59/217.79  |- mesh__historyNote mesh__D051186 2006%28%2005%29%   
% 217.59/217.79  |- skos__altLabel mesh__D051186 Arm Motif Proteins
% 217.59/217.79  |- skos__broader mesh__D051186smesh__D011506
% 217.59/217.79  |- skos__altLabel mesh__D017458 Aldosterone Receptors
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D017458 1998
% 217.59/217.79  |- mesh__onlineNote mesh__D017458
% 217.59/217.79       use RECEPTORS, ALDOSTERONE %28%NM%29% to search ALDOSTERONE RECEPTOR 1981-92%A%  
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D017458 2002
% 217.59/217.79  |- skos__annotation mesh__D017458 DF: RECEPT ALDOSTERONE   
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D017458 1999
% 217.59/217.79  |- skos__altLabel mesh__D017458 Aldosterone Receptor
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D017458 2005
% 217.59/217.79  |- mesh__recordOriginator mesh__D017458 PXP
% 217.59/217.79  |- mesh__historyNote mesh__D017458
% 217.59/217.79       93; was ALDOSTERONE RECEPTOR %28%NM%29% 1981-92   
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D017458 2006
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D017458 2003
% 217.59/217.79  |- mesh__dateCreated mesh__D017458 1992-05-22
% 217.59/217.79  |- mesh__publicMeSHNote mesh__D017458
% 217.59/217.79       93; ALDOSTERONE RECEPTOR was indexed under RECEPTORS, GLUCOCORTICOID 1981-92%A%  
% 217.59/217.79  |- skos__scopeNote mesh__D017458
% 217.59/217.79       Cytoplasmic proteins that specifically bind aldosterone and mediate its cellular effects. The aldosterone-bound receptor acts in the nucleus to regulate the transcription of specific segments of DNA.%A%    
% 217.59/217.79  |- mesh__dateRevised mesh__D017458 1997-06-20
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D017458 2004
% 217.59/217.79  |- skos__hiddenLabel mesh__D017458 Receptor, Aldosterone
% 217.59/217.79  |- skos__historyNote mesh__D017458
% 217.59/217.79       Receptors, Glucocorticoid %28%1981-1992%29%
% 217.59/217.79  |- skos__broader mesh__D017458smesh__D018161
% 217.59/217.79  |- mesh__recordMaintainer mesh__D017458 NDW
% 217.59/217.79  |- mesh__dateEstablished mesh__D017458 1993-01-01
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D017458 2000
% 217.59/217.79  |- skos__prefLabel mesh__D017458 Receptors, Aldosterone
% 217.59/217.79  |- mesh__recordAuthorizer mesh__D017458 SJN
% 217.59/217.79  |- rdf__type mesh__D017458sskos__Concept
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D017458 2001
% 217.59/217.79  |- skos__prefLabel mesh__D003438 Crotonic Acids
% 217.59/217.79  |- skos__hiddenLabel mesh__D003438 2 Butenoic Acids
% 217.59/217.79  |- mesh__recordOriginator mesh__D003438 NLM
% 217.59/217.79  |- mesh__dateRevised mesh__D003438 2003-07-09
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D003438 2006
% 217.59/217.79  |- mesh__recordAuthorizer mesh__D003438 sjn
% 217.59/217.79  |- rdf__type mesh__D003438sskos__Concept
% 217.59/217.79  |- skos__hiddenLabel mesh__D003438 Acids, Crotonic
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D003438 2005
% 217.59/217.79  |- skos__broader mesh__D003438smesh__D002088
% 217.59/217.79  |- mesh__dateEstablished mesh__D003438 1991-01-01
% 217.59/217.79  |- mesh__historyNote mesh__D003438
% 217.59/217.79       91%28%75%29%; was see under FATTY ACIDS, MONOUNSATURATED 1975-90%A%  
% 217.59/217.79  |- skos__scopeNote mesh__D003438
% 217.59/217.79       4-Carbon monounsaturated monocarboxylic acids with the unsaturation in the 2 position.%A%    
% 217.59/217.79  |- skos__historyNote mesh__D003438 Crotonates %28%1973-1974%29%
% 217.59/217.79  |- skos__broader mesh__D003438smesh__D005229
% 217.59/217.79  |- mesh__dateCreated mesh__D003438 1974-11-11
% 217.59/217.79  |- mesh__publicMeSHNote mesh__D003438
% 217.59/217.79       91; was see under FATTY ACIDS, MONOUNSATURATED 1975-90   
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D003438 2004
% 217.59/217.79  |- mesh__recordMaintainer mesh__D003438 ssb
% 217.59/217.79  |- skos__altLabel mesh__D003438 2-Butenoic Acids
% 217.59/217.79  |- skos__hiddenLabel mesh__D003438 Acids, 2-Butenoic
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D014160 2005
% 217.59/217.79  |- skos__historyNote mesh__D014160 Transducers %28%1966-1979%29%
% 217.59/217.79  |- skos__hiddenLabel mesh__D014160 Transducer, Pressure
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D014160 2006
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D014160 2000
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D014160 2003
% 217.59/217.79  |- skos__annotation mesh__D014160 NIM   
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D014160 1998
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D014160 2001
% 217.59/217.79  |- mesh__recordMaintainer mesh__D014160 PXP
% 217.59/217.79  |- skos__prefLabel mesh__D014160 Transducers, Pressure
% 217.59/217.79  |- skos__hiddenLabel mesh__D014160 Pressure Transducers
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D014160 2004
% 217.59/217.79  |- skos__historyNote mesh__D014160 Manometry %28%1966-1979%29%
% 217.59/217.79  |- mesh__dateEstablished mesh__D014160 1991-01-01
% 217.59/217.79  |- skos__hiddenLabel mesh__D014160 Pressure Transducer
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D014160 1999
% 217.59/217.79  |- skos__scopeNote mesh__D014160
% 217.59/217.79       Transducers that are activated by pressure changes, e.g., blood pressure.%A%    
% 217.59/217.79  |- mesh__recordAuthorizer mesh__D014160 SJN
% 217.59/217.79  |- mesh__dateRevised mesh__D014160 1997-06-20
% 217.59/217.79  |- mesh__publicMeSHNote mesh__D014160
% 217.59/217.79       91; was see under TRANSDUCERS 1980-90   
% 217.59/217.79  |- mesh__recordOriginator mesh__D014160 RC
% 217.59/217.79  |- mesh__historyNote mesh__D014160
% 217.59/217.79       91%28%80%29%; was see under TRANSDUCERS 1980-90   
% 217.59/217.79  |- skos__broader mesh__D014160smesh__D014159
% 217.59/217.79  |- rdf__type mesh__D014160sskos__Concept
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D014160 2002
% 217.59/217.79  |- mesh__dateCreated mesh__D014160 1978-12-14
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008921 2000
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008921 1999
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008921 2006
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008921 1993
% 217.59/217.79  |- skos__broader mesh__D008921smesh__D005159
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008921 2003
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008921 1996
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008921 1995
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008921 1998
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008921 2005
% 217.59/217.79  |- skos__hiddenLabel mesh__D008921 Missionaries and Missions
% 217.59/217.79  |- skos__hiddenLabel mesh__D008921 Mission
% 217.59/217.79  |- mesh__dateRevised mesh__D008921 1992-05-15
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008921 1994
% 217.59/217.79  |- mesh__recordOriginator mesh__D008921 NLM
% 217.59/217.79  |- mesh__dateCreated mesh__D008921 1999-01-01
% 217.59/217.79  |- skos__hiddenLabel mesh__D008921 Missionary
% 217.59/217.79  |- rdf__type mesh__D008921sskos__Concept
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008921 2002
% 217.59/217.79  |- skos__annotation mesh__D008921
% 217.59/217.79       do not confuse with MEDICAL MISSIONS, OFFICIAL; DF: MISSIONS%A%  
% 217.59/217.79  |- skos__scopeNote mesh__D008921
% 217.59/217.79       To be used for articles pertaining to medical activities carried out by personnel in institutions which are administered by a religious organization.%A%    
% 217.59/217.79  |- mesh__recordAuthorizer mesh__D008921 PLS
% 217.59/217.79  |- mesh__recordMaintainer mesh__D008921 TAP
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008921 2001
% 217.59/217.79  |- skos__broader mesh__D008921smesh__D009274
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008921 1997
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008921 2004
% 217.59/217.79  |- skos__prefLabel mesh__D008921 Missions and Missionaries
% 217.59/217.79  |- skos__hiddenLabel mesh__D008123 Location Directory
% 217.59/217.79  |- mesh__recordMaintainer mesh__D008123 TGC
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008123 2006
% 217.59/217.79  |- mesh__dateEstablished mesh__D008123 1991-01-01
% 217.59/217.79  |- mesh__historyNote mesh__D008123
% 217.59/217.79       91%28%82%29%; was see under FACILITY DESIGN AND CONSTRUCTION 1982-90; was LOCATION DIRECTORIES see under FACILITY DESIGN AND CONSTRUCTION Aug 1977-81%A%  
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008123 1996
% 217.59/217.79  |- skos__hiddenLabel mesh__D008123 Directories, Location
% 217.59/217.79  |- mesh__recordOriginator mesh__D008123 EC
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008123 1997
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008123 2000
% 217.59/217.79  |- skos__altLabel mesh__D008123 Signs and Location Directories
% 217.59/217.79  |- skos__prefLabel mesh__D008123 Location Directories and Signs
% 217.59/217.79  |- mesh__publicMeSHNote mesh__D008123
% 217.59/217.79       91; was see under FACILITY DESIGN AND CONSTRUCTION 1982-90; was LOCATION DIRECTORIES see under FACILITY DESIGN AND CONSTRUCTION Aug 1977-81%A%  
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008123 2003
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008123 1993
% 217.59/217.79  |- skos__broader mesh__D008123smesh__D005160
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008123 1998
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008123 2004
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008123 2001
% 217.59/217.79  |- mesh__dateCreated mesh__D008123 1977-05-11
% 217.59/217.79  |- rdf__type mesh__D008123sskos__Concept
% 217.59/217.79  |- mesh__recordAuthorizer mesh__D008123 PLS
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008123 1994
% 217.59/217.79  |- skos__hiddenLabel mesh__D008123 Sign, Location
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008123 1999
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008123 2002
% 217.59/217.79  |- mesh__onlineNote mesh__D008123
% 217.59/217.79       use LOCATION DIRECTORIES AND SIGNS to search LOCATION DIRECTORIES Aug 1977-81%A%  
% 217.59/217.79  |- skos__hiddenLabel mesh__D008123 Signs, Location
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008123 2005
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D008123 1995
% 217.59/217.79  |- skos__hiddenLabel mesh__D008123 Directory, Location
% 217.59/217.79  |- skos__hiddenLabel mesh__D008123 Location Sign
% 217.59/217.79  |- mesh__dateRevised mesh__D008123 1992-03-25
% 217.59/217.79  |- skos__scopeNote mesh__D008123
% 217.59/217.79       Directory signs or listings of designated areas within or without a facility.%A%    
% 217.59/217.79  |- mesh__recordOriginator mesh__D000140 VDK
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D000140 1998
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D000140 2005
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D000140 2000
% 217.59/217.79  |- mesh__dateCreated mesh__D000140 1986-04-18
% 217.59/217.79  |- skos__historyNote mesh__D000140 Acidosis %28%1966-1986%29%
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D000140 2004
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D000140 1997
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D000140 1994
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D000140 2001
% 217.59/217.79  |- skos__historyNote mesh__D000140 Lactates %28%1966-1986%29%
% 217.59/217.79  |- mesh__dateRevised mesh__D000140 1993-05-24
% 217.59/217.79  |- mesh__dateEstablished mesh__D000140 1987-01-01
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D000140 1999
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D000140 2006
% 217.59/217.79  |- skos__prefLabel mesh__D000140 Acidosis, Lactic
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D000140 1995
% 217.59/217.79  |- skos__annotation mesh__D000140 accumulation of lactic acid   
% 217.59/217.79  |- skos__broader mesh__D000140smesh__D000138
% 217.59/217.79  |- mesh__recordMaintainer mesh__D000140 TGC
% 217.59/217.79  |- rdf__type mesh__D000140sskos__Concept
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D000140 2002
% 217.59/217.79  |- skos__altLabel mesh__D000140 Lactic Acidosis
% 217.59/217.79  |- mesh__recordAuthorizer mesh__D000140 PLS
% 217.59/217.79  |- skos__scopeNote mesh__D000140
% 217.59/217.79       Acidosis caused by accumulation of lactic acid more rapidly than it can be metabolized. It may occur spontaneously or in association with diseases such as diabetes mellitus, leukemia, or liver failure.%A%    
% 217.59/217.79  |- mesh__historyNote mesh__D000140 87   
% 217.59/217.79  |- mesh__publicMeSHNote mesh__D000140 87   
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D000140 1996
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D000140 2003
% 217.59/217.79  |- skos__altLabel mesh__D013866 Wellcome Brand of Thioguanine
% 217.59/217.79  |- skos__scopeNote mesh__D013866
% 217.59/217.79       An antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia.%A%    
% 217.59/217.79  |- mesh__dateRevised mesh__D013866 2005-06-30
% 217.59/217.79  |- skos__hiddenLabel mesh__D013866 6 Thioguanine
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D013866 2006
% 217.59/217.79  |- rdf__type mesh__D013866sskos__Concept
% 217.59/217.79  |- skos__altLabel mesh__D013866 6-Thioguanine
% 217.59/217.79  |- skos__broader mesh__D013866smesh__D011687
% 217.59/217.79  |- skos__altLabel mesh__D013866 Tioguanine
% 217.59/217.79  |- skos__altLabel mesh__D013866 Lanvis
% 217.59/217.79  |- mesh__recordAuthorizer mesh__D013866 sjn
% 217.59/217.79  |- mesh__recordMaintainer mesh__D013866 CCR
% 217.59/217.79  |- skos__altLabel mesh__D013866 Thioguanin Glaxo Wellcome
% 217.59/217.79  |- skos__altLabel mesh__D013866 GlaxoSmithKline Brand of Thioguanine
% 217.59/217.79  |- mesh__recordOriginator mesh__D013866 NLM
% 217.59/217.79  |- mesh__publicMeSHNote mesh__D013866 66   
% 217.59/217.79  |- skos__hiddenLabel mesh__D013866 Hemihydrate, Thioguanine
% 217.59/217.79  |- skos__hiddenLabel mesh__D013866 Thioguanin GSK
% 217.59/217.79  |- skos__altLabel mesh__D013866 Thioguanin-GSK
% 217.59/217.79  |- skos__prefLabel mesh__D013866 Thioguanine
% 217.59/217.79  |- skos__altLabel mesh__D013866 Glaxo Wellcome Brand of Thioguanine
% 217.59/217.79  |- mesh__historyNote mesh__D013866 66%28%64%29%   
% 217.59/217.79  |- mesh__dateEstablished mesh__D013866 1966-01-01
% 217.59/217.79  |- mesh__dateCreated mesh__D013866 1999-01-01
% 217.59/217.79  |- rdf__type mesh__D013068sskos__Concept
% 217.59/217.79  |- mesh__recordMaintainer mesh__D013068 PXP
% 217.59/217.79  |- skos__scopeNote mesh__D013068
% 217.59/217.79       Measurement of parameters of the speech product such as vocal tone, loudness, pitch, voice quality, articulation, resonance, phonation, phonetic structure and prosody.%A%    
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D013068 2001
% 217.59/217.79  |- mesh__dateCreated mesh__D013068 1978-05-22
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D013068 1999
% 217.59/217.79  |- skos__prefLabel mesh__D013068 Speech Production Measurement
% 217.59/217.79  |- skos__broader mesh__D013068smesh__D019937
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D013068 2005
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D013068 2002
% 217.59/217.79  |- mesh__dateEstablished mesh__D013068 1979-01-01
% 217.59/217.79  |- skos__hiddenLabel mesh__D013068 Measurement, Speech Production
% 217.59/217.79  |- skos__hiddenLabel mesh__D013068 Measurements, Speech Production
% 217.59/217.79  |- mesh__publicMeSHNote mesh__D013068 79   
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D013068 2006
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D013068 2003
% 217.59/217.79  |- skos__hiddenLabel mesh__D013068 Production Measurement, Speech
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D013068 2004
% 217.59/217.79  |- skos__historyNote mesh__D013068 Speech %28%1966-1978%29%
% 217.59/217.79  |- mesh__dateRevised mesh__D013068 1997-06-20
% 217.59/217.79  |- skos__hiddenLabel mesh__D013068 Production Measurements, Speech
% 217.59/217.79  |- skos__hiddenLabel mesh__D013068 Speech Production Measurements
% 217.59/217.79  |- mesh__recordAuthorizer mesh__D013068 SJN
% 217.59/217.79  |- mesh__recordOriginator mesh__D013068 RC
% 217.59/217.79  |- mesh__historyNote mesh__D013068 79   
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D013068 2000
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D013068 1998
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007829 2002
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007829 1996
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007829 2005
% 217.59/217.79  |- skos__scopeNote mesh__D007829
% 217.59/217.79       Stricture or narrowing of the larynx. This condition may be developmental or acquired; with progressive respiratory difficulty as a symptom.%A%    
% 217.59/217.79  |- mesh__recordOriginator mesh__D007829 NLM
% 217.59/217.79  |- skos__hiddenLabel mesh__D007829 Laryngostenoses
% 217.59/217.79  |- skos__prefLabel mesh__D007829 Laryngostenosis
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007829 1993
% 217.59/217.79  |- rdf__type mesh__D007829sskos__Concept
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007829 1999
% 217.59/217.79  |- skos__broader mesh__D007829smesh__D007818
% 217.59/217.79  |- mesh__dateRevised mesh__D007829 1990-05-29
% 217.59/217.79  |- skos__altLabel mesh__D007829 Laryngeal Stenosis
% 217.59/217.79  |- skos__hiddenLabel mesh__D007829 Laryngeal Stenoses
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007829 2004
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007829 2001
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007829 1992
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007829 1998
% 217.59/217.79  |- mesh__recordAuthorizer mesh__D007829 NLM
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007829 2000
% 217.59/217.79  |- skos__hiddenLabel mesh__D007829 Stenoses, Laryngeal
% 217.59/217.79  |- mesh__recordMaintainer mesh__D007829 PLS
% 217.59/217.79  |- skos__annotation mesh__D007829
% 217.59/217.79       narrowing or stricture of larynx; do not confuse with spasmodic closure %28% = LARYNGOSPASM or LARYNGISMUS%29%%A%  
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007829 1995
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007829 2003
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007829 1991
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007829 1994
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007829 1997
% 217.59/217.79  |- skos__hiddenLabel mesh__D007829 Stenosis, Laryngeal
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D007829 2006
% 217.59/217.79  |- mesh__dateCreated mesh__D007829 1999-01-01
% 217.59/217.79  |- skos__altLabel mesh__D018551 Tomato
% 217.59/217.79  |- skos__altLabel mesh__D018551 Solanum lycopersicum
% 217.59/217.79  |- skos__historyNote mesh__D018551 Plants, Edible %28%1966-1994%29%
% 217.59/217.79  |- skos__prefLabel mesh__D018551 Lycopersicon esculentum
% 217.59/217.79  |- mesh__activeMeSHYear mesh__D018551 2006
% 217.59/217.80  |- skos__historyNote mesh__D018551 Plants %28%1966-1994%29%
% 217.59/217.80  |- skos__historyNote mesh__D018551 Vegetables %28%1966-1994%29%
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D018551 2003
% 217.59/217.80  |- mesh__historyNote mesh__D018551 2003%28%1995%29%   
% 217.59/217.80  |- rdf__type mesh__D018551sskos__Concept
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D018551 2004
% 217.59/217.80  |- mesh__publicMeSHNote mesh__D018551 2003; see TOMATOES 1995-2002   
% 217.59/217.80  |- mesh__dateEstablished mesh__D018551 1995-01-01
% 217.59/217.80  |- skos__hiddenLabel mesh__D018551 lycopersicum, Solanum
% 217.59/217.80  |- mesh__recordMaintainer mesh__D018551 ssb
% 217.59/217.80  |- skos__broader mesh__D018551smesh__D014675
% 217.59/217.80  |- skos__annotation mesh__D018551
% 217.59/217.80       X ref SOLANUM LYCOPERSICUM: SOLANUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.59/217.80  |- mesh__recordAuthorizer mesh__D018551 sjn
% 217.59/217.80  |- mesh__dateCreated mesh__D018551 1994-06-07
% 217.59/217.80  |- skos__scopeNote mesh__D018551
% 217.59/217.80       A plant species of the family SOLANACEAE, native of South America, widely cultivated for their edible, fleshy, usually red fruit.%A%    
% 217.59/217.80  |- mesh__recordOriginator mesh__D018551 JLS
% 217.59/217.80  |- skos__broader mesh__D018551smesh__D019657
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D018551 2005
% 217.59/217.80  |- mesh__dateRevised mesh__D018551 2002-07-03
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D004531 2003
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D004531 2005
% 217.59/217.80  |- mesh__recordAuthorizer mesh__D004531 sjn
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D004531 2004
% 217.59/217.80  |- skos__prefLabel mesh__D004531 Eggs
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D004531 2002
% 217.59/217.80  |- skos__annotation mesh__D004531
% 217.59/217.80       differentiate from OVUM; eggs as food %28%chicken, duck, quail, etc. eggs%29%; fish roe %26% reptile eggs as food go here but if physiol or anat, use OVUM; /adv eff consider also EGG HYPERSENSITIVITY%A%  
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D004531 2006
% 217.59/217.80  |- skos__broader mesh__D004531smesh__D005502
% 217.59/217.80  |- mesh__dateRevised mesh__D004531 2001-07-25
% 217.59/217.80  |- mesh__recordOriginator mesh__D004531 NLM
% 217.59/217.80  |- rdf__type mesh__D004531sskos__Concept
% 217.59/217.80  |- mesh__dateCreated mesh__D004531 1999-01-01
% 217.59/217.80  |- skos__scopeNote mesh__D004531
% 217.59/217.80       Animal reproductive bodies, or the contents thereof, used as food. The concept is differentiated from OVUM, the anatomic or physiologic entity.%A%    
% 217.59/217.80  |- mesh__recordMaintainer mesh__D004531 tpw
% 217.59/217.80  |- mesh__recordOriginator mesh__D051187 DRC
% 217.59/217.80  |- rdf__type mesh__D051187sskos__Concept
% 217.59/217.80  |- skos__prefLabel mesh__D051187 Desmocollins
% 217.59/217.80  |- mesh__dateEstablished mesh__D051187 2006-01-01
% 217.59/217.80  |- mesh__dateRevised mesh__D051187 2005-07-27
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D051187 2006A
% 217.59/217.80  |- mesh__publicMeSHNote mesh__D051187
% 217.59/217.80       2006; DESMOCOLLINS was indexed under CYTOSKELETAL PROTEINS 1990-2005, %26% under MEMBRANE GLYCOPROTEINS 1988-1989, %26% under MEMBRANE PROTEINS 1983-1987%A%  
% 217.59/217.80  |- mesh__recordMaintainer mesh__D051187 ags
% 217.59/217.80  |- mesh__dateCreated mesh__D051187 2005-06-30
% 217.59/217.80  |- skos__broader mesh__D051187smesh__D051181
% 217.59/217.80  |- skos__scopeNote mesh__D051187
% 217.59/217.80       A group of desmosomal cadherins with cytoplasmic tails that are divergent from those of classical CADHERINS. Their intracytoplasmic domains bind PLAKOGLOBIN; PLAKOPHILINS; and DESMOPLAKINS.%A%    
% 217.59/217.80  |- mesh__recordAuthorizer mesh__D051187 ags
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D051187 2006
% 217.59/217.80  |- mesh__historyNote mesh__D051187 2006%28%1983%29%   
% 217.59/217.80  |- mesh__dateEstablished mesh__D017459 1993-01-01
% 217.59/217.80  |- skos__hiddenLabel mesh__D017459 Amino Acids Receptors
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D017459 2006
% 217.59/217.80  |- mesh__recordAuthorizer mesh__D017459 sjn
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D017459 2003
% 217.59/217.80  |- skos__historyNote mesh__D017459
% 217.59/217.80       Receptors, Endogenous Substances %28%1981-1992%29%
% 217.59/217.80  |- skos__annotation mesh__D017459
% 217.59/217.80       coord IM with specific amino acid %28%IM%29%; DF: RECEPT AA   
% 217.59/217.80  |- mesh__recordOriginator mesh__D017459 PXP
% 217.59/217.80  |- mesh__recordMaintainer mesh__D017459 sjn
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D017459 2004
% 217.59/217.80  |- mesh__dateRevised mesh__D017459 2001-08-03
% 217.59/217.80  |- skos__prefLabel mesh__D017459 Receptors, Amino Acid
% 217.59/217.80  |- skos__altLabel mesh__D017459 Amino Acid Receptors
% 217.59/217.80  |- skos__scopeNote mesh__D017459
% 217.59/217.80       Cell surface proteins that bind amino acids and trigger changes which influence the behavior of cells. Glutamate receptors are the most common receptors for fast excitatory synaptic transmission in the vertebrate central nervous system, and GAMMA-AMINOBUTYRIC ACID and glycine receptors are the most common receptors for fast inhibition.%A%    
% 217.59/217.80  |- skos__altLabel mesh__D017459 Receptor, Amino Acid
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D017459 2002
% 217.59/217.80  |- rdf__type mesh__D017459sskos__Concept
% 217.59/217.80  |- mesh__publicMeSHNote mesh__D017459
% 217.59/217.80       93; AMINO ACID RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-92%A%  
% 217.59/217.80  |- mesh__historyNote mesh__D017459
% 217.59/217.80       93; was AMINO ACID RECEPTOR %28%NM%29% 1981-92   
% 217.59/217.80  |- skos__hiddenLabel mesh__D017459 Amino Acid Receptor
% 217.59/217.80  |- skos__altLabel mesh__D017459 Receptors, Amino Acids
% 217.59/217.80  |- skos__broader mesh__D017459smesh__D017981
% 217.59/217.80  |- mesh__onlineNote mesh__D017459
% 217.59/217.80       use RECEPTORS, AMINO ACID %28%NM%29% to search AMINO ACID RECEPTOR 1981-92%A%  
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D017459 2005
% 217.59/217.80  |- mesh__dateCreated mesh__D017459 1992-05-22
% 217.59/217.80  |- skos__prefLabel mesh__D028181 Viscum
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D028181 2005
% 217.59/217.80  |- mesh__dateCreated mesh__D028181 2001-07-25
% 217.59/217.80  |- mesh__dateRevised mesh__D028181 2002-07-03
% 217.59/217.80  |- mesh__dateEstablished mesh__D028181 2002-01-01
% 217.59/217.80  |- skos__annotation mesh__D028181
% 217.59/217.80       VISCUM LEUCARPUM see PHORADENDRON is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.59/217.80  |- mesh__publicMeSHNote mesh__D028181 2002; see MISTLETOE 1963-2001   
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D028181 2004
% 217.59/217.80  |- skos__broader mesh__D028181smesh__D028163
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D028181 2003
% 217.59/217.80  |- skos__scopeNote mesh__D028181
% 217.59/217.80       A plant genus in the family VISCACEAE, order Santalales, subclass Rosidae, class Magnoliopsida. Species of this genus contain cytotoxic LECTINS. The common name of MISTLETOE is used for many species of this and the LORANTHACEAE families.%A%    
% 217.59/217.80  |- mesh__historyNote mesh__D028181 2002; use MISTLETOE 1963-2001   
% 217.59/217.80  |- skos__historyNote mesh__D028181 Mistletoe %28%1963-2001%29%
% 217.59/217.80  |- rdf__type mesh__D028181sskos__Concept
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D028181 2006
% 217.59/217.80  |- skos__broader mesh__D003439smesh__D003435
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D003439 2006
% 217.59/217.80  |- mesh__recordOriginator mesh__D003439 SH
% 217.59/217.80  |- rdf__type mesh__D003439sskos__Concept
% 217.59/217.80  |- mesh__publicMeSHNote mesh__D003439
% 217.59/217.80       91; was see under CROTALID VENOMS 1978-90   
% 217.59/217.80  |- mesh__dateRevised mesh__D003439 2005-06-30
% 217.59/217.80  |- mesh__dateCreated mesh__D003439 1977-04-27
% 217.59/217.80  |- skos__historyNote mesh__D003439 Snakes %28%1966-1974%29%
% 217.59/217.80  |- skos__prefLabel mesh__D003439 Crotoxin
% 217.59/217.80  |- mesh__recordAuthorizer mesh__D003439 sjn
% 217.59/217.80  |- skos__historyNote mesh__D003439 Venoms %28%1966-1974%29%
% 217.59/217.80  |- skos__annotation mesh__D003439
% 217.59/217.80       from a So. Amer. rattlesnake; /antag permitted but consider also ANTIVENINS%A%  
% 217.59/217.80  |- mesh__recordMaintainer mesh__D003439 ssb
% 217.59/217.80  |- mesh__dateEstablished mesh__D003439 1991-01-01
% 217.59/217.80  |- mesh__historyNote mesh__D003439
% 217.59/217.80       91%28%78%29%; was see under CROTALID VENOMS 1978-90   
% 217.59/217.80  |- skos__scopeNote mesh__D003439
% 217.59/217.80       A specific complex of toxic proteins from the venom of Crotalus durissus terrificus %28%South American rattlesnake%29%. It can be separated into a phospholipase A and crotapotin fragment; the latter consists of three different amino acid chains, potentiates the enzyme, and is specifically neurotoxic.%A%    
% 217.59/217.80  |- skos__historyNote mesh__D003439 Snake Venoms %28%1975-1977%29%
% 217.59/217.80  |- skos__related mesh__D014161smesh__D014170
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D014161 2006
% 217.59/217.80  |- mesh__recordOriginator mesh__D014161 NLM
% 217.59/217.80  |- skos__hiddenLabel mesh__D014161 Transductions, Genetic
% 217.59/217.80  |- mesh__dateCreated mesh__D014161 1999-01-01
% 217.59/217.80  |- skos__broader mesh__D014161smesh__D018014
% 217.59/217.80  |- mesh__historyNote mesh__D014161 68   
% 217.59/217.80  |- skos__prefLabel mesh__D014161 Transduction, Genetic
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D014161 2004
% 217.59/217.80  |- mesh__dateRevised mesh__D014161 2004-08-02
% 217.59/217.80  |- mesh__dateEstablished mesh__D014161 1968-01-01
% 217.59/217.80  |- skos__altLabel mesh__D014161 Genetic Transduction
% 217.59/217.80  |- skos__broader mesh__D014161smesh__D011995
% 217.59/217.80  |- skos__hiddenLabel mesh__D014161 Genetic Transductions
% 217.59/217.80  |- skos__scopeNote mesh__D014161
% 217.59/217.80       The transfer of bacterial DNA by phages from an infected bacterium to another bacterium. This also refers to the transfer of genes into eukaryotic cells by viruses. This naturally occurring process is routinely employed as a GENE TRANSFER TECHNIQUE.%A%    
% 217.59/217.80  |- rdf__type mesh__D014161sskos__Concept
% 217.59/217.80  |- mesh__recordMaintainer mesh__D014161 jls
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D014161 2005A
% 217.59/217.80  |- mesh__publicMeSHNote mesh__D014161 68   
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D014161 2005
% 217.59/217.80  |- mesh__recordAuthorizer mesh__D014161 jls
% 217.59/217.80  |- skos__historyNote mesh__D014161 Genetics %28%1966-1967%29%
% 217.59/217.80  |- skos__prefLabel mesh__D008922 Mississippi
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D008922 1998
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D008922 2005
% 217.59/217.80  |- mesh__dateCreated mesh__D008922 1999-01-01
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D008922 2000
% 217.59/217.80  |- skos__broader mesh__D008922smesh__D015144
% 217.59/217.80  |- rdf__type mesh__D008922sskos__Concept
% 217.59/217.80  |- mesh__dateRevised mesh__D008922 1997-06-20
% 217.59/217.80  |- mesh__recordOriginator mesh__D008922 NLM
% 217.59/217.80  |- mesh__recordAuthorizer mesh__D008922 SJN
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D008922 2004
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D008922 2002
% 217.59/217.80  |- mesh__recordMaintainer mesh__D008922 PXP
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D008922 1999
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D008922 2006
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D008922 2003
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D008922 2001
% 217.59/217.80  |- skos__annotation mesh__D008124
% 217.59/217.80       differentiate LOCOMOTION %28%getting from one point to another%29% from GAIT %28%how a man or major animal gets there%29%, MOVEMENT %28%without necessarily locomoting%29%, MOTOR ACTIVITY %28%movement assoc with behavior%29%, WALKING %28%purposeful locomotion to get somewhere or for recreation, fitness or competition%29%; CELL MOVEMENT is available%A%  
% 217.59/217.80  |- skos__broader mesh__D008124smesh__D009068
% 217.59/217.80  |- mesh__dateCreated mesh__D008124 1999-01-01
% 217.59/217.80  |- mesh__dateRevised mesh__D008124 2003-07-09
% 217.59/217.80  |- skos__hiddenLabel mesh__D008124 Locomotions
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D008124 2004
% 217.59/217.80  |- rdf__type mesh__D008124sskos__Concept
% 217.59/217.80  |- skos__scopeNote mesh__D008124
% 217.59/217.80       Movement or the ability to move from one place or another. It can refer to humans, vertebrate or invertebrate animals, and microorganisms.%A%    
% 217.59/217.80  |- skos__prefLabel mesh__D008124 Locomotion
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D008124 2005
% 217.59/217.80  |- mesh__recordAuthorizer mesh__D008124 sjn
% 217.59/217.80  |- mesh__recordMaintainer mesh__D008124 nns
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D008124 2006
% 217.59/217.80  |- skos__related mesh__D008124smesh__D005684
% 217.59/217.80  |- mesh__recordOriginator mesh__D008124 NLM
% 217.59/217.80  |- skos__scopeNote mesh__D000141
% 217.59/217.80       A rare sometimes familial disorder of the renal tubule characterized by the inability to excrete urine of normal acidity. This leads to a hyperchloremic acidosis which is often associated with one or more secondary complications such as hypercalcinuria with nephrolithiasis and nephrocalcinosis, rickets, or osteomalacia and severe potassium depletion.%A%    
% 217.59/217.80  |- skos__prefLabel mesh__D000141 Acidosis, Renal Tubular
% 217.59/217.80  |- mesh__publicMeSHNote mesh__D000141 65   
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D000141 2002
% 217.59/217.80  |- skos__broader mesh__D000141smesh__D015499
% 217.59/217.80  |- mesh__recordMaintainer mesh__D000141 nns
% 217.59/217.80  |- skos__hiddenLabel mesh__D000141 Tubular Acidoses, Renal
% 217.59/217.80  |- skos__annotation mesh__D000141
% 217.59/217.80       does not include TYPE IV RENAL TUBULAR ACIDOSIS   
% 217.59/217.80  |- mesh__recordAuthorizer mesh__D000141 sjn
% 217.59/217.80  |- rdf__type mesh__D000141sskos__Concept
% 217.59/217.80  |- mesh__dateEstablished mesh__D000141 1965-01-01
% 217.59/217.80  |- skos__altLabel mesh__D000141 Acidosis, Renal Tubular, Type I
% 217.59/217.80  |- skos__hiddenLabel mesh__D000141 Tubular Acidosis, Renal
% 217.59/217.80  |- mesh__dateRevised mesh__D000141 2001-07-25
% 217.59/217.80  |- mesh__dateCreated mesh__D000141 1999-01-01
% 217.59/217.80  |- skos__altLabel mesh__D000141 Acidosis, Renal Tubular, Type II
% 217.59/217.80  |- mesh__historyNote mesh__D000141 65   
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D000141 2003
% 217.59/217.80  |- skos__altLabel mesh__D000141 Proximal Renal Tubular Acidosis
% 217.59/217.80  |- skos__hiddenLabel mesh__D000141 Renal Tubular Acidoses
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D000141 2005
% 217.59/217.80  |- skos__hiddenLabel mesh__D000141 Renal Tubular Acidosis
% 217.59/217.80  |- mesh__recordOriginator mesh__D000141 NLM
% 217.59/217.80  |- skos__altLabel mesh__D000141 Distal Renal Tubular Acidosis
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D000141 2004
% 217.59/217.80  |- skos__hiddenLabel mesh__D000141 Acidoses, Renal Tubular
% 217.59/217.80  |- skos__altLabel mesh__D000141 Classic Distal Renal Tubular Acidosis
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D000141 2006
% 217.59/217.80  |- skos__broader mesh__D000141smesh__D000138
% 217.59/217.80  |- skos__scopeNote mesh__D052280
% 217.59/217.80       Attachment of orthodontic devices and materials to the MOUTH area for support and to provide a counterforce to orthodontic forces.%A%    
% 217.59/217.80  |- skos__hiddenLabel mesh__D052280 Anchorage Techniques, Orthodontic
% 217.59/217.80  |- skos__hiddenLabel mesh__D052280 Procedure, Orthodontic Anchorage
% 217.59/217.80  |- mesh__publicMeSHNote mesh__D052280 2006   
% 217.59/217.80  |- rdf__type mesh__D052280sskos__Concept
% 217.59/217.80  |- skos__prefLabel mesh__D052280 Orthodontic Anchorage Procedures
% 217.59/217.80  |- mesh__historyNote mesh__D052280 2006   
% 217.59/217.80  |- skos__hiddenLabel mesh__D052280 Technique, Orthodontic Anchorage
% 217.59/217.80  |- mesh__dateCreated mesh__D052280 2005-06-30
% 217.59/217.80  |- mesh__dateEstablished mesh__D052280 2006-01-01
% 217.59/217.80  |- skos__hiddenLabel mesh__D052280 Techniques, Orthodontic Anchorage
% 217.59/217.80  |- skos__hiddenLabel mesh__D052280 Anchorage Procedures, Orthodontic
% 217.59/217.80  |- skos__hiddenLabel mesh__D052280 Orthodontic Anchorage Procedure
% 217.59/217.80  |- mesh__recordAuthorizer mesh__D052280 sjn
% 217.59/217.80  |- skos__hiddenLabel mesh__D052280 Orthodontic Anchorage Technique
% 217.59/217.80  |- skos__altLabel mesh__D052280 Orthodontic Anchorage Techniques
% 217.59/217.80  |- mesh__recordOriginator mesh__D052280 ssb
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D052280 2006
% 217.59/217.80  |- skos__hiddenLabel mesh__D052280 Procedures, Orthodontic Anchorage
% 217.59/217.80  |- skos__historyNote mesh__D052280 Orthodontics %28%1965-2005%29%
% 217.59/217.80  |- skos__annotation mesh__D052280 consider also DENTAL IMPLANTS   
% 217.59/217.80  |- skos__broader mesh__D052280smesh__D009970
% 217.59/217.80  |- skos__hiddenLabel mesh__D052280 Anchorage Technique, Orthodontic
% 217.59/217.80  |- mesh__recordMaintainer mesh__D052280 ssb
% 217.59/217.80  |- skos__hiddenLabel mesh__D052280 Anchorage Procedure, Orthodontic
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D013867 2006
% 217.59/217.80  |- rdf__type mesh__D013867sskos__Concept
% 217.59/217.80  |- mesh__publicMeSHNote mesh__D013867
% 217.59/217.80       91; was see under HYDANTOINS 1973-90   
% 217.59/217.80  |- skos__broader mesh__D013867smesh__D006827
% 217.59/217.80  |- mesh__dateRevised mesh__D013867 2005-06-30
% 217.59/217.80  |- mesh__dateEstablished mesh__D013867 1991-01-01
% 217.59/217.80  |- mesh__historyNote mesh__D013867
% 217.59/217.80       91%28%73%29%; was see under HYDANTOINS 1973-90   
% 217.59/217.80  |- mesh__recordAuthorizer mesh__D013867 sjn
% 217.59/217.80  |- mesh__recordOriginator mesh__D013867 NLM
% 217.59/217.80  |- mesh__recordMaintainer mesh__D013867 ssb
% 217.59/217.80  |- mesh__dateCreated mesh__D013867 1999-01-01
% 217.59/217.80  |- skos__prefLabel mesh__D013867 Thiohydantoins
% 217.59/217.80  |- skos__historyNote mesh__D013069 Auditory Threshold %28%1968-1978%29%
% 217.59/217.80  |- mesh__dateEstablished mesh__D013069 1991-01-01
% 217.59/217.80  |- skos__broader mesh__D013069smesh__D001302
% 217.59/217.80  |- skos__historyNote mesh__D013069 Speech %28%1966-1978%29%
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D013069 2001
% 217.59/217.80  |- rdf__type mesh__D013069sskos__Concept
% 217.59/217.80  |- skos__annotation mesh__D013069 DF: SRT TEST   
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D013069 1999
% 217.59/217.80  |- mesh__publicMeSHNote mesh__D013069
% 217.59/217.80       91; was see under SPEECH DISCRIMINATION TESTS 1979-90   
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D013069 2000
% 217.59/217.80  |- skos__scopeNote mesh__D013069
% 217.59/217.80       A test to determine the lowest sound intensity level at which fifty percent or more of the spondaic test words %28%words of two syllables having equal stress%29% are repeated correctly.%A%    
% 217.59/217.80  |- skos__historyNote mesh__D013069 Hearing %28%1966-1967%29%
% 217.59/217.80  |- skos__prefLabel mesh__D013069 Speech Reception Threshold Test
% 217.59/217.80  |- mesh__recordMaintainer mesh__D013069 PXP
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D013069 2004
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D013069 1998
% 217.59/217.80  |- skos__altLabel mesh__D013069 Test, Speech Reception Threshold
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D013069 2006
% 217.59/217.80  |- mesh__dateRevised mesh__D013069 1997-06-20
% 217.59/217.80  |- mesh__dateCreated mesh__D013069 1978-05-22
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D013069 2003
% 217.59/217.80  |- skos__historyNote mesh__D013069 Audiometry %28%1966-1978%29%
% 217.59/217.80  |- mesh__recordAuthorizer mesh__D013069 SJN
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D013069 2005
% 217.59/217.80  |- mesh__recordOriginator mesh__D013069 RC
% 217.59/217.80  |- mesh__historyNote mesh__D013069
% 217.59/217.80       91%28%79%29%; was see under SPEECH DISCRIMINATION TESTS 1979-90%A%  
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D013069 2002
% 217.59/217.80  |- mesh__recordMaintainer mesh__D018552 JLS
% 217.59/217.80  |- rdf__type mesh__D018552sskos__Concept
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D018552 2004
% 217.59/217.80  |- skos__historyNote mesh__D018552 Vegetables %28%1966-1994%29%
% 217.59/217.80  |- skos__scopeNote mesh__D018552
% 217.59/217.80       A plant species of the family APIACEAE that is widely cultivated for the edible yellow-orange root. The plant has finely divided leaves and flat clusters of small white flowers.%A%    
% 217.59/217.80  |- mesh__recordAuthorizer mesh__D018552 sjn
% 217.59/217.80  |- skos__broader mesh__D018552smesh__D014675
% 217.59/217.80  |- mesh__dateRevised mesh__D018552 2002-07-03
% 217.59/217.80  |- mesh__dateCreated mesh__D018552 1994-06-07
% 217.59/217.80  |- skos__historyNote mesh__D018552 Plants, Edible %28%1966-1979%29%
% 217.59/217.80  |- mesh__recordOriginator mesh__D018552 JLS
% 217.59/217.80  |- skos__prefLabel mesh__D018552 Daucus carota
% 217.59/217.80  |- skos__historyNote mesh__D018552 Plants %28%1966-1994%29%
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D018552 2005
% 217.59/217.80  |- skos__hiddenLabel mesh__D018552 Carrot
% 217.59/217.80  |- skos__annotation mesh__D018552
% 217.59/217.80       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.59/217.80  |- mesh__publicMeSHNote mesh__D018552 2003; see CARROTS 1995-2002   
% 217.59/217.80  |- mesh__dateEstablished mesh__D018552 1995-01-01
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D018552 2006
% 217.59/217.80  |- skos__historyNote mesh__D018552 Carrots %28%1995-2002%29%
% 217.59/217.80  |- skos__broader mesh__D018552smesh__D019661
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D018552 2003
% 217.59/217.80  |- mesh__historyNote mesh__D018552 2003%28%1995%29%   
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D004532 2004
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D004532 1998
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D004532 2001
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D004532 1997
% 217.59/217.80  |- mesh__dateEstablished mesh__D004532 1968-01-01
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D004532 2006
% 217.59/217.80  |- mesh__dateRevised mesh__D004532 1996-06-13
% 217.59/217.80  |- skos__historyNote mesh__D004532 Defense Mechanisms %28%1966-1967%29%
% 217.59/217.80  |- mesh__historyNote mesh__D004532
% 217.59/217.80       68; SELF was heading 1965-68, was see under PERSONALITY 1963-64%A%  
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D004532 1999
% 217.59/217.80  |- skos__historyNote mesh__D004532 Personality %28%1966-1967%29%
% 217.59/217.80  |- skos__historyNote mesh__D004532 Psychoanalytic Theory %28%1966-1967%29%
% 217.59/217.80  |- mesh__recordMaintainer mesh__D004532 JLS
% 217.59/217.80  |- skos__broader mesh__D004532smesh__D011574
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D004532 2002
% 217.59/217.80  |- mesh__dateCreated mesh__D004532 1999-01-01
% 217.59/217.80  |- rdf__type mesh__D004532sskos__Concept
% 217.59/217.80  |- skos__hiddenLabel mesh__D004532 Egos
% 217.59/217.80  |- skos__broader mesh__D004532smesh__D010553
% 217.59/217.80  |- mesh__recordOriginator mesh__D004532 NLM
% 217.59/217.80  |- mesh__onlineNote mesh__D004532
% 217.59/217.80       use EGO to search SELF 1969-75 %26% SELF CONCEPT 1966-68   
% 217.59/217.80  |- mesh__publicMeSHNote mesh__D004532
% 217.59/217.80       68; SELF was heading 1965-68, was see under PERSONALITY 1963-64%A%  
% 217.59/217.80  |- skos__related mesh__D004532smesh__D019455
% 217.59/217.80  |- mesh__recordAuthorizer mesh__D004532 PLS
% 217.59/217.80  |- skos__prefLabel mesh__D004532 Ego
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D004532 2003
% 217.59/217.80  |- skos__annotation mesh__D004532
% 217.59/217.80       no qualif; egocentrism: index DEFENSE MECHANISMS   
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D004532 2000
% 217.59/217.80  |- skos__scopeNote mesh__D004532
% 217.59/217.80       The conscious portion of the personality structure which serves to mediate between the demands of the primitive instinctual drives, %28%the id%29%, of internalized parental and social prohibitions or the conscience, %28%the superego%29%, and of reality.%A%    
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D004532 2005
% 217.59/217.80  |- skos__broader mesh__D051188smesh__D001185
% 217.59/217.80  |- skos__altLabel mesh__D051188 Knowledgebases
% 217.59/217.80  |- skos__broader mesh__D051188smesh__D007256
% 217.59/217.80  |- skos__hiddenLabel mesh__D051188 Knowledge Base %28%Computer%29%
% 217.59/217.80  |- skos__hiddenLabel mesh__D051188 Base, Knowledge
% 217.59/217.80  |- mesh__publicMeSHNote mesh__D051188
% 217.59/217.80       2006; see ARTIFICIAL INTELLIGENCE %28%1987-2005%29%   
% 217.59/217.80  |- skos__hiddenLabel mesh__D051188 Knowledge Base
% 217.59/217.80  |- mesh__recordMaintainer mesh__D051188 ags
% 217.59/217.80  |- skos__prefLabel mesh__D051188 Knowledge Bases
% 217.59/217.80  |- skos__altLabel mesh__D051188 Knowledge Bases %28%Computer%29%
% 217.59/217.80  |- skos__hiddenLabel mesh__D051188 Bases, Knowledge
% 217.59/217.80  |- mesh__dateEstablished mesh__D051188 2006-01-01
% 217.59/217.80  |- mesh__recordAuthorizer mesh__D051188 sjn
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D051188 2006
% 217.59/217.80  |- skos__hiddenLabel mesh__D051188 Knowledgebase
% 217.59/217.80  |- skos__hiddenLabel mesh__D051188 Bases, Knowledge %28%Computer%29%
% 217.59/217.80  |- mesh__historyNote mesh__D051188
% 217.59/217.80       2006; use ARTIFICIAL INTELLIGENCE %28%1987-2005%29%   
% 217.59/217.80  |- skos__hiddenLabel mesh__D051188 Base, Knowledge %28%Computer%29%
% 217.59/217.80  |- skos__scopeNote mesh__D051188
% 217.59/217.80       Collections of facts, assumptions, beliefs, and heuristics that are used in combination with DATABASES to achieve desired results, such as a diagnosis, an interpretation, or a solution to a problem %28%From McGraw Hill Dictionary of Scientific and Technical Terms, 6th ed%29%.%A%    
% 217.59/217.80  |- mesh__dateCreated mesh__D051188 2005-06-30
% 217.59/217.80  |- mesh__recordOriginator mesh__D051188 ags
% 217.59/217.80  |- rdf__type mesh__D051188sskos__Concept
% 217.59/217.80  |- rdf__type mesh__D045949sskos__Concept
% 217.59/217.80  |- mesh__historyNote mesh__D045949
% 217.59/217.80       2005; use CARNIVORA 1998-2004; for CIVET CATS use CARNIVORA 2004%A%  
% 217.59/217.80  |- skos__altLabel mesh__D045949 Civets
% 217.59/217.80  |- mesh__dateEstablished mesh__D045949 2005-01-01
% 217.59/217.80  |- mesh__recordMaintainer mesh__D045949 ags
% 217.59/217.80  |- skos__prefLabel mesh__D045949 Viverridae
% 217.59/217.80  |- skos__scopeNote mesh__D045949
% 217.59/217.80       The family of civets which are small and medium-sized Old World carnivores, often stripped or spotted.%A%    
% 217.59/217.80  |- skos__altLabel mesh__D045949 Civet Cats
% 217.59/217.80  |- mesh__recordOriginator mesh__D045949 ags
% 217.59/217.80  |- skos__hiddenLabel mesh__D045949 Civet
% 217.59/217.80  |- mesh__recordAuthorizer mesh__D045949 sjn
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D045949 2005
% 217.59/217.80  |- skos__hiddenLabel mesh__D045949 Cats, Civet
% 217.59/217.80  |- mesh__dateCreated mesh__D045949 2004-07-07
% 217.59/217.80  |- skos__hiddenLabel mesh__D045949 Civet Cat
% 217.59/217.80  |- mesh__publicMeSHNote mesh__D045949
% 217.59/217.80       2005; see CARNIVORA 1998-2004; for CIVET CATS see CARNIVORA 2004%A%  
% 217.59/217.80  |- skos__hiddenLabel mesh__D045949 Cat, Civet
% 217.59/217.80  |- skos__historyNote mesh__D045949 Carnivora %28%1967-2004%29%
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D045949 2006
% 217.59/217.80  |- skos__broader mesh__D045949smesh__D002335
% 217.59/217.80  |- mesh__dateEstablished mesh__D028182 2002-01-01
% 217.59/217.80  |- skos__prefLabel mesh__D028182 Viscum album
% 217.59/217.80  |- mesh__publicMeSHNote mesh__D028182 2002   
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D028182 2004
% 217.59/217.80  |- skos__annotation mesh__D028182
% 217.59/217.80       X ref MISTLETOE, EUROPEAN: several mistletoe terms are available, check text and MeSH; Christmas mistletoe goes here; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.59/217.80  |- mesh__dateCreated mesh__D028182 2001-07-25
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D028182 2003
% 217.59/217.80  |- mesh__dateRevised mesh__D028182 2002-07-03
% 217.59/217.80  |- skos__historyNote mesh__D028182 Viscum %28%1963-2001%29%
% 217.59/217.80  |- rdf__type mesh__D028182sskos__Concept
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D028182 2006
% 217.59/217.80  |- skos__broader mesh__D028182smesh__D028181
% 217.59/217.80  |- skos__scopeNote mesh__D028182
% 217.59/217.80       A plant species of the family VISCACEAE, order Santalales, subclass Rosidae. This is the traditional mistletoe of literature and Christmas. Members contain viscotoxin %28%5 kDa basic polypeptides related to thionins%29%, beta-galactoside- and N-acetyl-D-galactosamine-specific lectin II %28%60 kDa%29%, and polysaccharides. Mistletoe lectin I is a type 2 ribosome-inactivating protein. Commercial extracts include Plenosol, Eurixor, Helixor Isorel, Iscador, and NSC 635089 %28%ANTINEOPLASTIC AGENTS, PHYTOGENIC%29%.%A%    
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D028182 2005
% 217.59/217.80  |- mesh__historyNote mesh__D028182 2002   
% 217.59/217.80  |- skos__altLabel mesh__D028182 Mistletoe, European
% 217.59/217.80  |- skos__broader mesh__D014960smesh__D012730
% 217.59/217.80  |- skos__annotation mesh__D014960
% 217.59/217.80       abnormalities: coordinate IM with SEX CHROMOSOME ABERRATIONS %28%IM%29% or specific diseases %28%IM%29% +  SEX CHROMOSOME ABERRATIONS %28%NIM%29%; X-lined disease = GENETIC DISEASES, X-LINKED or specifics; X CHROMOSOME, HUMAN is also available%A%  
% 217.59/217.80  |- mesh__dateCreated mesh__D014960 1977-04-29
% 217.59/217.80  |- skos__prefLabel mesh__D014960 X Chromosome
% 217.59/217.80  |- skos__historyNote mesh__D014960 Chromosomes %28%1966-1967%29%
% 217.59/217.80  |- rdf__type mesh__D014960sskos__Concept
% 217.59/217.80  |- mesh__dateRevised mesh__D014960 2005-06-30
% 217.59/217.80  |- mesh__recordMaintainer mesh__D014960 lkt
% 217.59/217.80  |- mesh__historyNote mesh__D014960
% 217.59/217.80       84%28%78%29%; was see under SEX CHROMOSOMES 1968-83   
% 217.59/217.80  |- skos__scopeNote mesh__D014960
% 217.59/217.80       The female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in human and other male-heterogametic species.%A%    
% 217.59/217.80  |- skos__historyNote mesh__D014960 Sex Chromosomes %28%1968-1977%29%
% 217.59/217.80  |- mesh__publicMeSHNote mesh__D014960
% 217.59/217.80       84; was see under SEX CHROMOSOMES 1968-83   
% 217.59/217.80  |- skos__hiddenLabel mesh__D014960 Chromosome, X
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D014960 2006
% 217.59/217.80  |- mesh__recordOriginator mesh__D014960 VDK
% 217.59/217.80  |- mesh__dateEstablished mesh__D014960 1984-01-01
% 217.59/217.80  |- mesh__recordAuthorizer mesh__D014960 sjn
% 217.59/217.80  |- skos__historyNote mesh__D014960 Karyotyping %28%1967%29%
% 217.59/217.80  |- skos__hiddenLabel mesh__D014960 Chromosomes, X
% 217.59/217.80  |- mesh__onlineNote mesh__D014960 search SEX CHROMOSOMES 1968-77   
% 217.59/217.80  |- skos__hiddenLabel mesh__D014960 X Chromosomes
% 217.59/217.80  |- mesh__publicMeSHNote mesh__D014162
% 217.59/217.80       78; was see under TRANSFORMATION, GENETIC 1975-77   
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D014162 2006
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D014162 2004
% 217.59/217.80  |- skos__related mesh__D014162smesh__D014169
% 217.59/217.80  |- mesh__activeMeSHYear mesh__D014162 2005
% 217.59/217.80  |- skos__related mesh__D014162smesh__D018274
% 217.59/217.80  |- mesh__recordAuthorizer mesh__D014162 sjn
% 217.59/217.80  |- skos__related mesh__D014162smesh__D014170
% 217.59/217.80  |- mesh__recordOriginator mesh__D014162 AEP
% 217.59/217.81  |- skos__broader mesh__D014162smesh__D018014
% 217.59/217.81  |- skos__annotation mesh__D014162
% 217.59/217.81       coord with recipient/genet if permitted + specific donor/genet; do not confuse with genetic transvection %28%index under PHENOTYPE%29%, an epigenetic phenomenon%A%  
% 217.59/217.81  |- skos__prefLabel mesh__D014162 Transfection
% 217.59/217.81  |- mesh__recordMaintainer mesh__D014162 nns
% 217.59/217.81  |- rdf__type mesh__D014162sskos__Concept
% 217.59/217.81  |- skos__scopeNote mesh__D014162
% 217.59/217.81       The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation %28%TRANSFORMATION, BACTERIAL%29% and both are routinely employed in GENE TRANSFER TECHNIQUES.%A%    
% 217.59/217.81  |- mesh__historyNote mesh__D014162
% 217.59/217.81       78%28%75%29%; was see under TRANSFORMATION, GENETIC 1975-77   
% 217.59/217.81  |- mesh__dateEstablished mesh__D014162 1978-01-01
% 217.59/217.81  |- mesh__dateCreated mesh__D014162 1977-05-04
% 217.59/217.81  |- skos__historyNote mesh__D014162
% 217.59/217.81       Transformation, Genetic %28%1968-1974%29%
% 217.59/217.81  |- skos__broader mesh__D014162smesh__D011995
% 217.59/217.81  |- mesh__dateRevised mesh__D014162 2003-07-09
% 217.59/217.81  |- skos__hiddenLabel mesh__D014162 Transfections
% 217.59/217.81  |- skos__broader mesh__D008923smesh__D015146
% 217.59/217.81  |- mesh__activeMeSHYear mesh__D008923 2000
% 217.59/217.81  |- skos__prefLabel mesh__D008923 Missouri
% 217.59/217.81  |- rdf__type mesh__D008923sskos__Concept
% 217.59/217.81  |- mesh__activeMeSHYear mesh__D008923 2001
% 217.59/217.81  |- mesh__dateRevised mesh__D008923 1997-06-20
% 217.59/217.81  |- mesh__activeMeSHYear mesh__D008923 2003
% 217.59/217.81  |- mesh__activeMeSHYear mesh__D008923 1998
% 217.59/217.81  |- mesh__activeMeSHYear mesh__D008923 2005
% 217.59/217.81  |- mesh__recordAuthorizer mesh__D008923 SJN
% 217.59/217.81  |- mesh__activeMeSHYear mesh__D008923 2004
% 217.59/217.81  |- mesh__recordMaintainer mesh__D008923 PXP
% 217.59/217.81  |- mesh__activeMeSHYear mesh__D008923 2002
% 217.59/217.81  |- mesh__dateCreated mesh__D008923 1999-01-01
% 217.59/217.81  |- mesh__activeMeSHYear mesh__D008923 1999
% 217.59/217.81  |- mesh__activeMeSHYear mesh__D008923 2006
% 217.59/217.81  |- mesh__recordOriginator mesh__D008923 NLM
% 217.59/217.81  |- mesh__recordOriginator mesh__D000940 SCD
% 217.59/217.81  |- mesh__dateCreated mesh__D000940 1987-05-11
% 217.59/217.81  |- mesh__publicMeSHNote mesh__D000940 1988   
% 217.59/217.81  |- skos__broader mesh__D000940smesh__D014644
% 217.59/217.81  |- skos__scopeNote mesh__D000940
% 217.59/217.81       Change in the surface ANTIGEN of a microorganism. There are two different types. One is a phenomenon, especially associated with INFLUENZA VIRUSES, where they undergo spontaneous variation both as slow antigenic drift and sudden emergence of new strains %28%antigenic shift%29%. The second type is when certain PARASITES, especially trypanosomes, PLASMODIUM, and BORRELIA, survive the immune response of the host by changing the surface coat %28%antigen switching%29%. %28%From Herbert et al., The Dictionary of Immunology, 4th ed%29%%A%    
% 217.59/217.81  |- mesh__recordAuthorizer mesh__D000940 sjn
% 217.59/217.81  |- skos__altLabel mesh__D000940 Antigen Variation
% 217.59/217.81  |- skos__historyNote mesh__D000940
% 217.59/217.81       Variation %28%Genetics%29% %28%1966-1987%29%
% 217.59/217.81  |- mesh__historyNote mesh__D000940 1988   
% 217.59/217.81  |- skos__annotation mesh__D000940
% 217.59/217.81       microbes only; ANTIBODY DIVERSITY is also available   
% 217.59/217.81  |- mesh__recordMaintainer mesh__D000940 ags
% 217.59/217.81  |- skos__historyNote mesh__D000940 Antigenic Determinants %28%1975-1987%29%
% 217.66/217.81  |- skos__altLabel mesh__D000940 Switching, Antigenic
% 217.66/217.81  |- skos__hiddenLabel mesh__D000940 Diversity, Antigenic
% 217.66/217.81  |- skos__prefLabel mesh__D000940 Antigenic Variation
% 217.66/217.81  |- skos__altLabel mesh__D000940 Antigenic Switching
% 217.66/217.81  |- mesh__dateRevised mesh__D000940 2002-07-02
% 217.66/217.81  |- skos__altLabel mesh__D000940 Variation, Antigenic
% 217.66/217.81  |- skos__historyNote mesh__D000940 Genetics, Microbial %28%1973-1987%29%
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D000940 2005
% 217.66/217.81  |- mesh__dateEstablished mesh__D000940 1988-01-01
% 217.66/217.81  |- rdf__type mesh__D000940sskos__Concept
% 217.66/217.81  |- skos__broader mesh__D000940smesh__D007125
% 217.66/217.81  |- skos__hiddenLabel mesh__D000940 Variation, Antigen
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D000940 2003
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D000940 2006
% 217.66/217.81  |- skos__altLabel mesh__D000940 Antigenic Variability
% 217.66/217.81  |- skos__hiddenLabel mesh__D000940 Variability, Antigenic
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D000940 2004
% 217.66/217.81  |- skos__hiddenLabel mesh__D000940 Switching, Antigen
% 217.66/217.81  |- mesh__recordMaintainer mesh__D008125 ags
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D008125 2004
% 217.66/217.81  |- skos__hiddenLabel mesh__D008125 Pontis, Nucleus Pigmentosus
% 217.66/217.81  |- skos__broader mesh__D008125smesh__D011149
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D008125 2001
% 217.66/217.81  |- rdf__type mesh__D008125sskos__Concept
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D008125 2005
% 217.66/217.81  |- mesh__historyNote mesh__D008125 78   
% 217.66/217.81  |- mesh__recordAuthorizer mesh__D008125 sjn
% 217.66/217.81  |- skos__altLabel mesh__D008125 Nucleus Pigmentosus Pontis
% 217.66/217.81  |- mesh__recordOriginator mesh__D008125 RC
% 217.66/217.81  |- skos__altLabel mesh__D008125 Locus Caeruleus
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D008125 2002
% 217.66/217.81  |- skos__historyNote mesh__D008125 Cerebral Ventricles %28%1966-1977%29%
% 217.66/217.81  |- skos__historyNote mesh__D008125 Pons %28%1966-1977%29%
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D008125 2006
% 217.66/217.81  |- skos__historyNote mesh__D008125 Mesencephalon %28%1966-1977%29%
% 217.66/217.81  |- skos__altLabel mesh__D008125 Locus Ceruleus
% 217.66/217.81  |- skos__broader mesh__D008125smesh__D008636
% 217.66/217.81  |- mesh__dateRevised mesh__D008125 1999-11-03
% 217.66/217.81  |- mesh__dateEstablished mesh__D008125 1978-01-01
% 217.66/217.81  |- skos__scopeNote mesh__D008125
% 217.66/217.81       Bluish region in the superior angle of the fourth ventricle floor, corresponding to melanin-like pigmented nerve cells which lie lateral to the ponto-mesencephalic central gray %28%griseum centrale%29%. It is also known as nucleus pigmentosus pontis.%A%    
% 217.66/217.81  |- mesh__dateCreated mesh__D008125 1977-04-11
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D008125 2003
% 217.66/217.81  |- mesh__publicMeSHNote mesh__D008125 78   
% 217.66/217.81  |- skos__prefLabel mesh__D008125 Locus Coeruleus
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D008125 2000
% 217.66/217.81  |- rdf__type mesh__D000142sskos__Concept
% 217.66/217.81  |- skos__hiddenLabel mesh__D000142 Respiratory Acidoses
% 217.66/217.81  |- mesh__historyNote mesh__D000142 67   
% 217.66/217.81  |- skos__broader mesh__D000142smesh__D000138
% 217.66/217.81  |- skos__broader mesh__D000142smesh__D012131
% 217.66/217.81  |- mesh__dateCreated mesh__D000142 1999-01-01
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D000142 2002
% 217.66/217.81  |- skos__historyNote mesh__D000142 Acidosis %28%1966%29%
% 217.66/217.81  |- mesh__dateEstablished mesh__D000142 1967-01-01
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D000142 2003
% 217.66/217.81  |- mesh__recordAuthorizer mesh__D000142 sjn
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D000142 2005
% 217.66/217.81  |- mesh__dateRevised mesh__D000142 1999-11-08
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D000142 2004
% 217.66/217.81  |- skos__scopeNote mesh__D000142
% 217.66/217.81       Respiratory retention of carbon dioxide. It may be chronic or acute.%A%    
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D000142 2006
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D000142 2000
% 217.66/217.81  |- skos__hiddenLabel mesh__D000142 Acidoses, Respiratory
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D000142 2001
% 217.66/217.81  |- skos__prefLabel mesh__D000142 Acidosis, Respiratory
% 217.66/217.81  |- mesh__recordMaintainer mesh__D000142 adp
% 217.66/217.81  |- skos__altLabel mesh__D000142 Respiratory Acidosis
% 217.66/217.81  |- mesh__publicMeSHNote mesh__D000142 67   
% 217.66/217.81  |- mesh__recordOriginator mesh__D000142 NLM
% 217.66/217.81  |- mesh__recordAuthorizer mesh__D052281 sjn
% 217.66/217.81  |- mesh__publicMeSHNote mesh__D052281
% 217.66/217.81       2006; CREATINE KINASE, MITOCHONDRIAL FORM was indexed under CREATINE KINASE 2000-2005%A%  
% 217.66/217.81  |- skos__hiddenLabel mesh__D052281 Kinase, Mitochondrial Creatine
% 217.66/217.81  |- mesh__recordOriginator mesh__D052281 jmp
% 217.66/217.81  |- mesh__historyNote mesh__D052281 2006%28%2000%29%   
% 217.66/217.81  |- skos__altLabel mesh__D052281 Mitochondrial Creatine Kinase
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D052281 2006
% 217.66/217.81  |- mesh__recordMaintainer mesh__D052281 jmp
% 217.66/217.81  |- skos__prefLabel mesh__D052281 Creatine Kinase, Mitochondrial Form
% 217.66/217.81  |- mesh__dateEstablished mesh__D052281 2006-01-01
% 217.66/217.81  |- skos__broader mesh__D052281smesh__D003402
% 217.66/217.81  |- mesh__dateCreated mesh__D052281 2005-06-30
% 217.66/217.81  |- rdf__type mesh__D052281sskos__Concept
% 217.66/217.81  |- skos__scopeNote mesh__D052281
% 217.66/217.81       A form of creatine kinase found in the MITOCHONDRIA.     
% 217.66/217.81  |- skos__altLabel mesh__D052281 Creatine Kinase, Mitochondrial
% 217.66/217.81  |- mesh__recordMaintainer mesh__D013868 ssb
% 217.66/217.81  |- mesh__dateEstablished mesh__D013868 1991-01-01
% 217.66/217.81  |- mesh__recordOriginator mesh__D013868 NLM
% 217.66/217.81  |- mesh__historyNote mesh__D013868
% 217.66/217.81       91%28%75%29%; was see under INOSINE 1975-90   
% 217.66/217.81  |- skos__broader mesh__D013868smesh__D013872
% 217.66/217.81  |- skos__historyNote mesh__D013868 Inosine %28%1973-1974%29%
% 217.66/217.81  |- skos__altLabel mesh__D013868 Ribosyl-6-mercaptopurine
% 217.66/217.81  |- skos__altLabel mesh__D013868 6-Mercaptopurine Riboside
% 217.66/217.81  |- mesh__dateCreated mesh__D013868 1974-11-19
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D013868 2006
% 217.66/217.81  |- mesh__dateRevised mesh__D013868 2005-06-30
% 217.66/217.81  |- rdf__type mesh__D013868sskos__Concept
% 217.66/217.81  |- skos__hiddenLabel mesh__D013868 Riboside, 6-Mercaptopurine
% 217.66/217.81  |- skos__scopeNote mesh__D013868
% 217.66/217.81       Sulfhydryl analog of INOSINE that inhibits nucleoside transport across erythrocyte plasma membranes, and has immunosuppressive properties. It has been used similarly to MERCAPTOPURINE in the treatment of leukemia. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p503%29%%A%    
% 217.66/217.81  |- skos__broader mesh__D013868smesh__D007288
% 217.66/217.81  |- skos__historyNote mesh__D013868 Mercaptopurine %28%1973-1974%29%
% 217.66/217.81  |- mesh__publicMeSHNote mesh__D013868 91; was see under INOSINE 1975-90   
% 217.66/217.81  |- skos__hiddenLabel mesh__D013868 6 Mercaptopurine Riboside
% 217.66/217.81  |- mesh__recordAuthorizer mesh__D013868 sjn
% 217.66/217.81  |- skos__hiddenLabel mesh__D013868 Ribosyl 6 mercaptopurine
% 217.66/217.81  |- skos__prefLabel mesh__D013868 Thioinosine
% 217.66/217.81  |- skos__broader mesh__D018553smesh__D014675
% 217.66/217.81  |- skos__broader mesh__D018553smesh__D028462
% 217.66/217.81  |- skos__scopeNote mesh__D018553
% 217.66/217.81       A creeping annual plant species of the CUCURBITACEAE family. It has a rough succulent, trailing stem and hairy leaves with three to five pointed lobes.%A%    
% 217.66/217.81  |- mesh__recordOriginator mesh__D018553 JLS
% 217.66/217.81  |- mesh__publicMeSHNote mesh__D018553 2002; see CUCUMBERS 1995-2001   
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D018553 2005
% 217.66/217.81  |- mesh__dateCreated mesh__D018553 1994-06-07
% 217.66/217.81  |- mesh__recordMaintainer mesh__D018553 ssb
% 217.66/217.81  |- mesh__historyNote mesh__D018553 2002%28%1995%29%   
% 217.66/217.81  |- skos__prefLabel mesh__D018553 Cucumis sativus
% 217.66/217.81  |- mesh__recordAuthorizer mesh__D018553 sjn
% 217.66/217.81  |- skos__annotation mesh__D018553
% 217.66/217.81       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D018553 2006
% 217.66/217.81  |- skos__historyNote mesh__D018553 Plants, Edible %28%1966-1994%29%
% 217.66/217.81  |- skos__historyNote mesh__D018553 Plants %28%1966-1994%29%
% 217.66/217.81  |- mesh__dateRevised mesh__D018553 2004-07-07
% 217.66/217.81  |- skos__historyNote mesh__D018553 Vegetables %28%1966-1994%29%
% 217.66/217.81  |- rdf__type mesh__D018553sskos__Concept
% 217.66/217.81  |- mesh__dateEstablished mesh__D018553 1995-01-01
% 217.66/217.81  |- mesh__recordOriginator mesh__D010570 NLM
% 217.66/217.81  |- skos__scopeNote mesh__D010570
% 217.66/217.81       Devices worn in the vagina to provide support to displaced uterus or rectum. Pessaries are used in conditions such as UTERINE PROLAPSE; CYSTOCELE; or RECTOCELE.%A%    
% 217.66/217.81  |- skos__hiddenLabel mesh__D010570 Pessary
% 217.66/217.81  |- mesh__recordMaintainer mesh__D010570 lkt
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D010570 2006
% 217.66/217.81  |- mesh__dateCreated mesh__D010570 1999-01-01
% 217.66/217.81  |- skos__broader mesh__D010570smesh__D013523
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D010570 2005
% 217.66/217.81  |- skos__prefLabel mesh__D010570 Pessaries
% 217.66/217.81  |- mesh__dateRevised mesh__D010570 2002-07-03
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D010570 2004
% 217.66/217.81  |- mesh__recordAuthorizer mesh__D010570 sjn
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D010570 2003
% 217.66/217.81  |- rdf__type mesh__D010570sskos__Concept
% 217.66/217.81  |- mesh__recordMaintainer mesh__D004533 ags
% 217.66/217.81  |- mesh__recordAuthorizer mesh__D004533 ags
% 217.66/217.81  |- mesh__publicMeSHNote mesh__D004533
% 217.66/217.81       92; was EGTA 1975-91 %28%see under ETHYLENE GLYCOLS 1975-86%29%%A%  
% 217.66/217.81  |- mesh__recordOriginator mesh__D004533 NLM
% 217.66/217.81  |- rdf__type mesh__D004533sskos__Concept
% 217.66/217.81  |- skos__altLabel mesh__D004533 EGTA
% 217.66/217.81  |- mesh__dateRevised mesh__D004533 2005-07-13
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D004533 2006A
% 217.66/217.81  |- skos__altLabel mesh__D004533 Ethylene Glycol Tetraacetic Acid
% 217.66/217.81  |- skos__hiddenLabel mesh__D004533 EGTA, Tetrasodium
% 217.66/217.81  |- skos__altLabel mesh__D004533
% 217.66/217.81       Glycoletherdiamine-N,N,N%27%,N%27%-tetraacetic Acid
% 217.66/217.81  |- skos__broader mesh__D004533smesh__D000088
% 217.66/217.81  |- skos__prefLabel mesh__D004533 Egtazic Acid
% 217.66/217.81  |- mesh__dateEstablished mesh__D004533 1987-01-01
% 217.66/217.81  |- mesh__onlineNote mesh__D004533
% 217.66/217.81       use EGTAZIC ACID to search EGTA 1975-91   
% 217.66/217.81  |- skos__hiddenLabel mesh__D004533 Magnesium EGTA
% 217.66/217.81  |- skos__altLabel mesh__D004533 GEDTA
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D004533 2005
% 217.66/217.81  |- skos__historyNote mesh__D004533 Acetic Acids %28%1969-1974%29%
% 217.66/217.81  |- skos__historyNote mesh__D004533 Glycols %28%1969-1974%29%
% 217.66/217.81  |- skos__altLabel mesh__D004533
% 217.66/217.81       Ethylenebis%28%oxyethylenenitrile%29%tetraacetic Acid
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D004533 2004
% 217.66/217.81  |- skos__altLabel mesh__D004533 EGATA
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D004533 2006
% 217.66/217.81  |- skos__hiddenLabel mesh__D004533 Acid, Egtazic
% 217.66/217.81  |- mesh__dateCreated mesh__D004533 1974-11-11
% 217.66/217.81  |- skos__broader mesh__D004533smesh__D005029
% 217.66/217.81  |- skos__scopeNote mesh__D004533
% 217.66/217.81       A chelating agent relatively more specific for calcium and less toxic than EDETIC ACID.%A%    
% 217.66/217.81  |- mesh__historyNote mesh__D004533
% 217.66/217.81       92; was EGTA 1975-91 %28%see under ETHYLENE GLYCOLS 1975-86%29%%A%  
% 217.66/217.81  |- skos__altLabel mesh__D004533
% 217.66/217.81       Ethylene Glycol Bis%28%2-aminoethyl ether%29%tetraacetic Acid
% 217.66/217.81  |- mesh__recordAuthorizer mesh__D051189 sjn
% 217.66/217.81  |- skos__annotation mesh__D051189
% 217.66/217.81       do not check tags MICE or RATS for MURINAE or its entry terms such as RATS, BANDICOOT; do not confuse BANDICOOT RATS with bandicoot %28%= MARSUPIALIA%29%%A%  
% 217.66/217.81  |- skos__scopeNote mesh__D051189
% 217.66/217.81       A subfamily in the family MURIDAE, comprising the Old World MICE and RATS.%A%    
% 217.66/217.81  |- mesh__recordMaintainer mesh__D051189 ags
% 217.66/217.81  |- mesh__publicMeSHNote mesh__D051189
% 217.66/217.81       2006; for ACOMYS, APODEMUS, BANDICOTA, MASTOMYS, PRAOMYS, and RATS, BANDICOTT see MURIDAE 1982-2005%A%  
% 217.66/217.81  |- mesh__historyNote mesh__D051189
% 217.66/217.81       2006; for ACOMYS, APODEMUS, BANDICOTA, MASTOMYS, PRAOMYS, and RATS, BANDICOTT use MURIDAE 1982-2005%A%  
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D051189 2006
% 217.66/217.81  |- mesh__dateCreated mesh__D051189 2005-06-30
% 217.66/217.81  |- mesh__recordOriginator mesh__D051189 ags
% 217.66/217.81  |- skos__altLabel mesh__D051189 Bandicoot Rats
% 217.66/217.81  |- skos__hiddenLabel mesh__D051189 Rat, Bandicoot
% 217.66/217.81  |- skos__prefLabel mesh__D051189 Murinae
% 217.66/217.81  |- rdf__type mesh__D051189sskos__Concept
% 217.66/217.81  |- skos__hiddenLabel mesh__D051189 Bandicotas
% 217.66/217.81  |- skos__broader mesh__D051189smesh__D009115
% 217.66/217.81  |- skos__hiddenLabel mesh__D051189 Bandicoot Rat
% 217.66/217.81  |- mesh__dateEstablished mesh__D051189 2006-01-01
% 217.66/217.81  |- skos__historyNote mesh__D051189 Muridae %28%1987-2005%29%
% 217.66/217.81  |- rdf__type mesh__D028981sskos__Concept
% 217.66/217.81  |- mesh__dateCreated mesh__D028981 2001-07-25
% 217.66/217.81  |- skos__annotation mesh__D028981
% 217.66/217.81       infection: coord IM with MONONEGAVIRALES INFECTIONS %28%IM%29%   
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D028981 2002
% 217.66/217.81  |- skos__hiddenLabel mesh__D028981 Bornaviruses
% 217.66/217.81  |- mesh__dateEstablished mesh__D028981 2002-01-01
% 217.66/217.81  |- skos__scopeNote mesh__D028981
% 217.66/217.81       A family in the order MONONEGAVIRALES comprising one genus Bornavirus. This family has a unique form of mRNA processing: replication and transcription takes place in the nucleus.%A%    
% 217.66/217.81  |- mesh__publicMeSHNote mesh__D028981 2002   
% 217.66/217.81  |- mesh__historyNote mesh__D028981 2002   
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D028981 2004
% 217.66/217.81  |- skos__broader mesh__D028981smesh__D018096
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D028981 2006
% 217.66/217.81  |- skos__prefLabel mesh__D028981 Bornaviridae
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D028981 2003
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D028981 2005
% 217.66/217.81  |- mesh__recordMaintainer mesh__D028183 ssb
% 217.66/217.81  |- skos__annotation mesh__D028183
% 217.66/217.81       X ref MISTLETOE, ARGENTINE: several mistletoe terms are available, check text and MeSH; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.66/217.81  |- rdf__type mesh__D028183sskos__Concept
% 217.66/217.81  |- mesh__historyNote mesh__D028183 2002   
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D028183 2006
% 217.66/217.81  |- mesh__dateRevised mesh__D028183 2003-07-09
% 217.66/217.81  |- skos__historyNote mesh__D028183 Mistletoe %28%1963-2001%29%
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D028183 2005
% 217.66/217.81  |- skos__altLabel mesh__D028183 Mistletoe, Argentine
% 217.66/217.81  |- skos__scopeNote mesh__D028183
% 217.66/217.81       The showy mistletoe plant family of the order Santalales, subclass Rosidae, class Magnoliopsida. This includes parasitic tropical plants with haustoria connecting to the hosts. The leaves are opposite and thick. The flowers %28%4-7%29% have both calyx and corolla. The fruit is a berry with one seed.%A%    
% 217.66/217.81  |- mesh__recordAuthorizer mesh__D028183 sjn
% 217.66/217.81  |- skos__altLabel mesh__D028183 Mistletoe, African
% 217.66/217.81  |- mesh__dateCreated mesh__D028183 2001-07-25
% 217.66/217.81  |- skos__broader mesh__D028183smesh__D014784
% 217.66/217.81  |- skos__related mesh__D028183smesh__D028184
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D028183 2004
% 217.66/217.81  |- mesh__publicMeSHNote mesh__D028183 2002   
% 217.66/217.81  |- skos__prefLabel mesh__D028183 Loranthaceae
% 217.66/217.81  |- mesh__dateEstablished mesh__D028183 2002-01-01
% 217.66/217.81  |- mesh__recordOriginator mesh__D028183 ssb
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D014961 2003
% 217.66/217.81  |- mesh__historyNote mesh__D014961 65%28%63%29%   
% 217.66/217.81  |- mesh__recordAuthorizer mesh__D014961 sjn
% 217.66/217.81  |- mesh__recordOriginator mesh__D014961 NLM
% 217.66/217.81  |- skos__broader mesh__D014961smesh__D003461
% 217.66/217.81  |- mesh__dateRevised mesh__D014961 2002-07-03
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D014961 2004
% 217.66/217.81  |- skos__prefLabel mesh__D014961 X-Ray Diffraction
% 217.66/217.81  |- skos__scopeNote mesh__D014961
% 217.66/217.81       The scattering of x-rays by matter, especially crystals, with accompanying variation in intensity due to interference effects. Analysis of the crystal structure of materials is performed by passing x-rays through them and registering the diffraction image of the rays %28%CRYSTALLOGRAPHY, X-RAY%29%. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 217.66/217.81  |- rdf__type mesh__D014961sskos__Concept
% 217.66/217.81  |- mesh__dateCreated mesh__D014961 1999-01-01
% 217.66/217.81  |- skos__annotation mesh__D014961
% 217.66/217.81       an anal chem technique; application to study of crystal structure = CRYSTALLOGRAPHY, X-RAY; NIM%A%  
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D014961 2005
% 217.66/217.81  |- skos__hiddenLabel mesh__D014961 Diffraction, Xray
% 217.66/217.81  |- mesh__publicMeSHNote mesh__D014961 65   
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D014961 2006
% 217.66/217.81  |- mesh__dateEstablished mesh__D014961 1965-01-01
% 217.66/217.81  |- skos__hiddenLabel mesh__D014961 Xray Diffractions
% 217.66/217.81  |- mesh__recordMaintainer mesh__D014961 lkt
% 217.66/217.81  |- skos__altLabel mesh__D014961 Xray Diffraction
% 217.66/217.81  |- skos__hiddenLabel mesh__D014961 X Ray Diffraction
% 217.66/217.81  |- skos__hiddenLabel mesh__D014961 X-Ray Diffractions
% 217.66/217.81  |- skos__hiddenLabel mesh__D014961 Diffractions, Xray
% 217.66/217.81  |- skos__hiddenLabel mesh__D014961 Diffraction, X-Ray
% 217.66/217.81  |- skos__hiddenLabel mesh__D014961 Diffractions, X-Ray
% 217.66/217.81  |- mesh__dateEstablished mesh__D014163 1965-01-01
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D014163 2006
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D014163 2002
% 217.66/217.81  |- mesh__recordMaintainer mesh__D014163 TGC
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D014163 2004
% 217.66/217.81  |- mesh__recordAuthorizer mesh__D014163 SJN
% 217.66/217.81  |- mesh__dateRevised mesh__D014163 1997-06-20
% 217.66/217.81  |- mesh__publicMeSHNote mesh__D014163 65   
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D014163 2005
% 217.66/217.81  |- mesh__dateCreated mesh__D014163 1999-01-01
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D014163 2003
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D014163 1999
% 217.66/217.81  |- skos__annotation mesh__D014163 human %26% animal; DF: TRANSFER   
% 217.66/217.81  |- skos__prefLabel mesh__D014163 Transfer %28%Psychology%29%
% 217.66/217.81  |- skos__hiddenLabel mesh__D014163 Training Transfer
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D014163 2001
% 217.66/217.81  |- rdf__type mesh__D014163sskos__Concept
% 217.66/217.81  |- mesh__recordOriginator mesh__D014163 NLM
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D014163 2000
% 217.66/217.81  |- skos__scopeNote mesh__D014163
% 217.66/217.81       Change in learning in one situation due to prior learning in another situation. The transfer can be positive %28%with second learning improved by first%29% or negative %28%where the reverse holds%29%.%A%    
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D014163 1998
% 217.66/217.81  |- skos__hiddenLabel mesh__D014163 Learning Transfer
% 217.66/217.81  |- skos__altLabel mesh__D014163 Transfer
% 217.66/217.81  |- skos__hiddenLabel mesh__D014163 Transfers %28%Psychology%29%
% 217.66/217.81  |- skos__altLabel mesh__D014163 Transfer of Training
% 217.66/217.81  |- skos__altLabel mesh__D014163 Transfer of Learning
% 217.66/217.81  |- skos__broader mesh__D014163smesh__D007858
% 217.66/217.81  |- mesh__historyNote mesh__D014163 65%28%64%29%   
% 217.66/217.81  |- mesh__recordAuthorizer mesh__D008924 sjn
% 217.66/217.81  |- rdf__type mesh__D008924sskos__Concept
% 217.66/217.81  |- mesh__recordOriginator mesh__D008924 NLM
% 217.66/217.81  |- mesh__publicMeSHNote mesh__D008924 1968; see ACARIASIS 1963-1967   
% 217.66/217.81  |- skos__prefLabel mesh__D008924 Mite Infestations
% 217.66/217.81  |- skos__broader mesh__D008924smesh__D004478
% 217.66/217.81  |- skos__hiddenLabel mesh__D008924 Mite Infestation
% 217.66/217.81  |- skos__hiddenLabel mesh__D008924 Infestations, Mite
% 217.66/217.81  |- mesh__dateCreated mesh__D008924 1999-01-01
% 217.66/217.81  |- mesh__dateRevised mesh__D008924 2005-06-30
% 217.66/217.81  |- mesh__dateEstablished mesh__D008924 1968-01-01
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D008924 2006
% 217.66/217.81  |- skos__scopeNote mesh__D008924
% 217.66/217.81       Infestations with arthropods of the subclass ACARI, superorder Acariformes.%A%    
% 217.66/217.81  |- skos__hiddenLabel mesh__D008924 Infestation, Mite
% 217.66/217.81  |- mesh__recordMaintainer mesh__D008924 ags
% 217.66/217.81  |- skos__altLabel mesh__D008924 Acariasis
% 217.66/217.81  |- mesh__historyNote mesh__D008924 1968   
% 217.66/217.81  |- skos__annotation mesh__D000941 GEN or unspecified: prefer specifics   
% 217.66/217.81  |- mesh__recordOriginator mesh__D000941 NLM
% 217.66/217.81  |- mesh__recordMaintainer mesh__D000941 ssb
% 217.66/217.81  |- mesh__recordAuthorizer mesh__D000941 sjn
% 217.66/217.81  |- skos__related mesh__D000941smesh__D000937
% 217.66/217.81  |- rdf__type mesh__D000941sskos__Concept
% 217.66/217.81  |- skos__broader mesh__D000941smesh__D001685
% 217.66/217.81  |- mesh__dateCreated mesh__D000941 1999-01-01
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D000941 2006
% 217.66/217.81  |- skos__scopeNote mesh__D000941
% 217.66/217.81       Substances that are recognized by the immune system and induce an immune reaction.%A%    
% 217.66/217.81  |- skos__altLabel mesh__D000941 Antigen
% 217.66/217.81  |- mesh__dateRevised mesh__D000941 2005-06-30
% 217.66/217.81  |- skos__related mesh__D000941smesh__D011946
% 217.66/217.81  |- skos__prefLabel mesh__D000941 Antigens
% 217.66/217.81  |- skos__broader mesh__D008126smesh__D008040
% 217.66/217.81  |- mesh__dateCreated mesh__D008126 1980-05-14
% 217.66/217.81  |- skos__historyNote mesh__D008126
% 217.66/217.81       Linkage %28%Genetics%29% %28%1970-1980%29%
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D008126 2006
% 217.66/217.81  |- skos__historyNote mesh__D008126 Genetics %28%1970-1972%29%
% 217.66/217.81  |- skos__hiddenLabel mesh__D008126 Scores, Lod
% 217.66/217.81  |- mesh__historyNote mesh__D008126
% 217.66/217.81       91%28%81%29%; was see under LINKAGE %28%GENETICS%29% 1981-90   
% 217.66/217.81  |- mesh__dateRevised mesh__D008126 2002-07-03
% 217.66/217.81  |- mesh__recordAuthorizer mesh__D008126 sjn
% 217.66/217.81  |- skos__scopeNote mesh__D008126
% 217.66/217.81       The total relative probability, expressed on a logarithmic scale, that a linkage relationship exists among selected loci. Lod is an acronym for %22%logarithmic odds.%22%%A%    
% 217.66/217.81  |- mesh__dateEstablished mesh__D008126 1991-01-01
% 217.66/217.81  |- skos__hiddenLabel mesh__D008126 Lod Scores
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D008126 2003
% 217.66/217.81  |- mesh__recordOriginator mesh__D008126 AEP
% 217.66/217.81  |- skos__hiddenLabel mesh__D008126 Score, Lod
% 217.66/217.81  |- mesh__publicMeSHNote mesh__D008126
% 217.66/217.81       91; was see under LINKAGE %28%GENETICS%29% 1981-90   
% 217.66/217.81  |- mesh__recordMaintainer mesh__D008126 ags
% 217.66/217.81  |- skos__annotation mesh__D008126
% 217.66/217.81       for Logarithmic ODds: in genet a linkage relat among loci; no qualif%A%  
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D008126 2004
% 217.66/217.81  |- skos__prefLabel mesh__D008126 Lod Score
% 217.66/217.81  |- rdf__type mesh__D008126sskos__Concept
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D008126 2005
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D000143 2002
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D000143 1998
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D000143 2005
% 217.66/217.81  |- rdf__type mesh__D000143sskos__Concept
% 217.66/217.81  |- skos__scopeNote mesh__D000143
% 217.66/217.81       Chemical compounds which yield hydrogen ions or protons when dissolved in water, whose hydrogen can be replaced by metals or basic radicals, or which react with bases to form salts and water %28%neutralization%29%. An extension of the term includes substances dissolved in media other than water. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 217.66/217.81  |- skos__annotation mesh__D000143
% 217.66/217.81       GEN; avoid; do not use for specific acids, acid-fast bacteria, acid reactions, etc.%A%  
% 217.66/217.81  |- mesh__recordAuthorizer mesh__D000143 SJN
% 217.66/217.81  |- mesh__recordOriginator mesh__D000143 NLM
% 217.66/217.81  |- mesh__activeMeSHYear mesh__D000143 2001
% 217.66/217.81  |- skos__prefLabel mesh__D000143 Acids
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D000143 2004
% 217.66/217.82  |- mesh__dateCreated mesh__D000143 1999-01-01
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D000143 2000
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D000143 2003
% 217.66/217.82  |- skos__broader mesh__D000143smesh__D007287
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D000143 1999
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D000143 2006
% 217.66/217.82  |- mesh__recordMaintainer mesh__D000143 TPW
% 217.66/217.82  |- mesh__dateRevised mesh__D000143 1997-06-20
% 217.66/217.82  |- mesh__recordAuthorizer mesh__D013869 sjn
% 217.66/217.82  |- skos__broader mesh__D013869smesh__D004950
% 217.66/217.82  |- mesh__dateCreated mesh__D013869 1999-01-01
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D013869 2005
% 217.66/217.82  |- mesh__recordMaintainer mesh__D013869 ssb
% 217.66/217.82  |- mesh__recordOriginator mesh__D013869 NLM
% 217.66/217.82  |- skos__hiddenLabel mesh__D013869 Hydrolases, Thiolester
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D013869 2006
% 217.66/217.82  |- rdf__type mesh__D013869sskos__Concept
% 217.66/217.82  |- skos__historyNote mesh__D013869 Esterases %28%1966-1972%29%
% 217.66/217.82  |- mesh__historyNote mesh__D013869 73   
% 217.66/217.82  |- mesh__dateRevised mesh__D013869 2003-07-09
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D013869 2004
% 217.66/217.82  |- skos__prefLabel mesh__D013869 Thiolester Hydrolases
% 217.66/217.82  |- mesh__publicMeSHNote mesh__D013869 73   
% 217.66/217.82  |- mesh__dateEstablished mesh__D013869 1973-01-01
% 217.66/217.82  |- skos__prefLabel mesh__D018554 Avena sativa
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D018554 2003
% 217.66/217.82  |- skos__broader mesh__D018554smesh__D002523
% 217.66/217.82  |- skos__broader mesh__D018554smesh__D000821
% 217.66/217.82  |- rdf__type mesh__D018554sskos__Concept
% 217.66/217.82  |- mesh__historyNote mesh__D018554 2003%28%1995%29%   
% 217.66/217.82  |- mesh__dateCreated mesh__D018554 1994-06-07
% 217.66/217.82  |- mesh__recordMaintainer mesh__D018554 ssb
% 217.66/217.82  |- skos__annotation mesh__D018554
% 217.66/217.82       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.66/217.82  |- skos__broader mesh__D018554smesh__D006109
% 217.66/217.82  |- mesh__recordOriginator mesh__D018554 JLS
% 217.66/217.82  |- mesh__publicMeSHNote mesh__D018554
% 217.66/217.82       2003; see OATS 1994-2002, see CEREALS 1985-1994; see GRAIN 1963-1984%A%  
% 217.66/217.82  |- mesh__dateEstablished mesh__D018554 1995-01-01
% 217.66/217.82  |- skos__historyNote mesh__D018554 Cereals %28%1966-1994%29%
% 217.66/217.82  |- skos__hiddenLabel mesh__D018554 Oat
% 217.66/217.82  |- mesh__dateRevised mesh__D018554 2002-07-02
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D018554 2006
% 217.66/217.82  |- skos__scopeNote mesh__D018554
% 217.66/217.82       A plant species of the family POACEAE that is widely cultivated for its edible seeds.%A%    
% 217.66/217.82  |- mesh__recordAuthorizer mesh__D018554 sjn
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D018554 2005
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D018554 2004
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010571 2006
% 217.66/217.82  |- mesh__historyNote mesh__D010571 76; was NON MESH before 1976   
% 217.66/217.82  |- mesh__dateCreated mesh__D010571 1975-07-23
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010571 1993
% 217.66/217.82  |- mesh__dateEstablished mesh__D010571 1976-01-01
% 217.66/217.82  |- skos__hiddenLabel mesh__D010571 Controls, Pest
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010571 1998
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010571 2005
% 217.66/217.82  |- mesh__recordAuthorizer mesh__D010571 PLS
% 217.66/217.82  |- mesh__publicMeSHNote mesh__D010571 76   
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010571 2002
% 217.66/217.82  |- mesh__dateRevised mesh__D010571 1992-05-15
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010571 1997
% 217.66/217.82  |- skos__prefLabel mesh__D010571 Pest Control
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010571 2004
% 217.66/217.82  |- skos__annotation mesh__D010571
% 217.66/217.82       IM; coord with specific pest but note that INSECT CONTROL %26% MOSQUITO CONTROL are available%A%  
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010571 2001
% 217.66/217.82  |- skos__hiddenLabel mesh__D010571 Pest Controls
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010571 1996
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010571 1995
% 217.66/217.82  |- rdf__type mesh__D010571sskos__Concept
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010571 2003
% 217.66/217.82  |- skos__hiddenLabel mesh__D010571 Control, Pest
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010571 2000
% 217.66/217.82  |- mesh__recordMaintainer mesh__D010571 TAP
% 217.66/217.82  |- skos__broader mesh__D010571smesh__D003140
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010571 1994
% 217.66/217.82  |- mesh__recordOriginator mesh__D010571 JW
% 217.66/217.82  |- skos__scopeNote mesh__D010571
% 217.66/217.82       The reduction or regulation of the population of noxious, destructive, or dangerous insects or other animals.%A%    
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010571 1999
% 217.66/217.82  |- skos__scopeNote mesh__D004534
% 217.66/217.82       A republic in northwest Africa. Its capital is Cairo. It was a very ancient kingdom which, by ca. 3000 B.C., was one of the early civilizations of the ancient world. It was the center of Hellenistic culture 330-323 B.C. and part of the Roman Empire from 30 B.C. until 640 A.D.%A%    
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D004534 2002
% 217.66/217.82  |- skos__broader mesh__D004534smesh__D000352
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D004534 2003
% 217.66/217.82  |- mesh__recordOriginator mesh__D004534 NLM
% 217.66/217.82  |- skos__altLabel mesh__D004534 Arab Republic of Egypt
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D004534 2005
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D004534 2004
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D004534 2006
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D004534 2000
% 217.66/217.82  |- skos__prefLabel mesh__D004534 Egypt
% 217.66/217.82  |- mesh__recordAuthorizer mesh__D004534 SJN
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D004534 1999
% 217.66/217.82  |- mesh__dateRevised mesh__D004534 1998-06-10
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D004534 2001
% 217.66/217.82  |- mesh__recordMaintainer mesh__D004534 JLS
% 217.66/217.82  |- skos__annotation mesh__D004534 ancient or modern Egypt   
% 217.66/217.82  |- skos__broader mesh__D004534smesh__D018436
% 217.66/217.82  |- skos__broader mesh__D004534smesh__D008877
% 217.66/217.82  |- rdf__type mesh__D004534sskos__Concept
% 217.66/217.82  |- mesh__dateCreated mesh__D004534 1999-01-01
% 217.66/217.82  |- mesh__dateCreated mesh__D028184 2001-07-25
% 217.66/217.82  |- skos__historyNote mesh__D028184 Viscum %28%1963-2001%29%
% 217.66/217.82  |- mesh__dateRevised mesh__D028184 2002-07-03
% 217.66/217.82  |- rdf__type mesh__D028184sskos__Concept
% 217.66/217.82  |- skos__broader mesh__D028184smesh__D028163
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D028184 2006
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D028184 2005
% 217.66/217.82  |- skos__prefLabel mesh__D028184 Phoradendron
% 217.66/217.82  |- skos__altLabel mesh__D028184 Viscum leucarpum
% 217.66/217.82  |- mesh__historyNote mesh__D028184 2002   
% 217.66/217.82  |- skos__annotation mesh__D028184
% 217.66/217.82       X ref MISTLETOE, AMERICAN: several mistletoe terms are available, check text and MeSH; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.66/217.82  |- skos__scopeNote mesh__D028184
% 217.66/217.82       A plant genus in the family VISCACEAE, order Santalales, subclass Rosidae. Members contain phoratoxin and oleanane TRITERPENES.%A%    
% 217.66/217.82  |- mesh__publicMeSHNote mesh__D028184 2002   
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D028184 2004
% 217.66/217.82  |- mesh__dateEstablished mesh__D028184 2002-01-01
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D028184 2003
% 217.66/217.82  |- skos__related mesh__D028184smesh__D028183
% 217.66/217.82  |- skos__altLabel mesh__D028184 Mistletoe, American
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014962 1996
% 217.66/217.82  |- skos__hiddenLabel mesh__D014962 Xray Films
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014962 2006
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014962 2000
% 217.66/217.82  |- skos__prefLabel mesh__D014962 X-Ray Film
% 217.66/217.82  |- mesh__recordOriginator mesh__D014962 SMH
% 217.66/217.82  |- skos__scopeNote mesh__D014962
% 217.66/217.82       A film base coated with an emulsion designed for use with x-rays.%A%    
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014962 1997
% 217.66/217.82  |- skos__historyNote mesh__D014962 Radiography %28%1966-1981%29%
% 217.66/217.82  |- rdf__type mesh__D014962sskos__Concept
% 217.66/217.82  |- skos__hiddenLabel mesh__D014962 Films, Radiographic
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014962 2001
% 217.66/217.82  |- skos__altLabel mesh__D014962 Film, Radiographic
% 217.66/217.82  |- skos__annotation mesh__D014962
% 217.66/217.82       the film itself: do not confuse with x-ray technique %28% = /radiogr or RADIOGRAPHY%29%; /hist: index under RADIOGRAPHY /hist or TECHNOLOGY, RADIOLOGIC /hist%A%  
% 217.66/217.82  |- skos__hiddenLabel mesh__D014962 Films, Xray
% 217.66/217.82  |- skos__altLabel mesh__D014962 Radiographic Film
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014962 1998
% 217.66/217.82  |- mesh__historyNote mesh__D014962 82   
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014962 2003
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014962 2002
% 217.66/217.82  |- skos__altLabel mesh__D014962 Film, X-Ray
% 217.66/217.82  |- skos__altLabel mesh__D014962 Xray Film
% 217.66/217.82  |- skos__hiddenLabel mesh__D014962 X Ray Film
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014962 1994
% 217.66/217.82  |- skos__hiddenLabel mesh__D014962 Films, X-Ray
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014962 1999
% 217.66/217.82  |- mesh__recordMaintainer mesh__D014962 TAP
% 217.66/217.82  |- skos__hiddenLabel mesh__D014962 Radiographic Films
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014962 2004
% 217.66/217.82  |- skos__hiddenLabel mesh__D014962 Film, Xray
% 217.66/217.82  |- skos__historyNote mesh__D014962 Technology, Radiologic %28%1966-1981%29%
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014962 1993
% 217.66/217.82  |- mesh__dateRevised mesh__D014962 1992-05-18
% 217.66/217.82  |- mesh__dateCreated mesh__D014962 1981-05-18
% 217.66/217.82  |- mesh__dateEstablished mesh__D014962 1982-01-01
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014962 1995
% 217.66/217.82  |- mesh__publicMeSHNote mesh__D014962 82   
% 217.66/217.82  |- mesh__recordAuthorizer mesh__D014962 PLS
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014962 2005
% 217.66/217.82  |- skos__broader mesh__D014962smesh__D004864
% 217.66/217.82  |- skos__hiddenLabel mesh__D014962 Film, X Ray
% 217.66/217.82  |- skos__hiddenLabel mesh__D014962 X-Ray Films
% 217.66/217.82  |- skos__historyNote mesh__D014962
% 217.66/217.82       specific radiography heading %28%1966-1981%29%
% 217.66/217.82  |- mesh__dateCreated mesh__D014164 1999-01-01
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014164 1999
% 217.66/217.82  |- skos__historyNote mesh__D014164 specific organization
% 217.66/217.82  |- mesh__recordOriginator mesh__D014164 NLM
% 217.66/217.82  |- skos__hiddenLabel mesh__D014164 Transfer Agreements
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014164 2000
% 217.66/217.82  |- skos__scopeNote mesh__D014164
% 217.66/217.82       A written agreement for the transfer of patients and their medical records from one health care institution to another.%A%    
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014164 1998
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014164 1997
% 217.66/217.82  |- skos__broader mesh__D014164smesh__D009935
% 217.66/217.82  |- rdf__type mesh__D014164sskos__Concept
% 217.66/217.82  |- skos__hiddenLabel mesh__D014164 Agreements, Transfer
% 217.66/217.82  |- mesh__historyNote mesh__D014164 68   
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014164 1996
% 217.66/217.82  |- skos__hiddenLabel mesh__D014164 Agreement, Transfer
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014164 2002
% 217.66/217.82  |- mesh__dateEstablished mesh__D014164 1968-01-01
% 217.66/217.82  |- mesh__publicMeSHNote mesh__D014164 68   
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014164 2006
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014164 1995
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014164 2005
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014164 2004
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014164 2001
% 217.66/217.82  |- skos__annotation mesh__D014164
% 217.66/217.82       %22%transfer of patients %26% their med records from onehealth care institution to another%22%%A%  
% 217.66/217.82  |- mesh__recordMaintainer mesh__D014164 TGC
% 217.66/217.82  |- mesh__recordAuthorizer mesh__D014164 PLS
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014164 2003
% 217.66/217.82  |- skos__prefLabel mesh__D014164 Transfer Agreement
% 217.66/217.82  |- mesh__dateRevised mesh__D014164 1994-05-05
% 217.66/217.82  |- mesh__recordOriginator mesh__D008925 NLM
% 217.66/217.82  |- rdf__type mesh__D008925sskos__Concept
% 217.66/217.82  |- skos__broader mesh__D008925smesh__D000053
% 217.66/217.82  |- skos__scopeNote mesh__D008925
% 217.66/217.82       Any arthropod of the subclass ACARI except the TICKS. They are minute animals related to the spiders, usually having transparent or semitransparent bodies. They may be parasitic on humans and domestic animals, producing various irritations of the skin %28%MITE INFESTATIONS%29%. Many mite species are important to human and veterinary medicine as both parasite and vector. Mites also infest plants.%A%    
% 217.66/217.82  |- mesh__recordMaintainer mesh__D008925 sjn
% 217.66/217.82  |- skos__prefLabel mesh__D008925 Mites
% 217.66/217.82  |- mesh__dateCreated mesh__D008925 1999-01-01
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D008925 2005
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D008925 2006
% 217.66/217.82  |- mesh__dateRevised mesh__D008925 2004-07-13
% 217.66/217.82  |- mesh__recordAuthorizer mesh__D008925 sjn
% 217.66/217.82  |- skos__annotation mesh__D008925
% 217.66/217.82       /microbiol /parasitol /virol permitted; infection = MITE INFESTATIONS; for miticides %28%chemicals killing or controlling mites%29% index under INSECTICIDES even though mites are not insects; mite vectors = ARACHNID VECTORS %28%IM%29% + MITES %28%IM%29%; mite control: coord IM with TICK CONTROL %28%IM%29%%A%  
% 217.66/217.82  |- mesh__historyNote mesh__D000942
% 217.66/217.82       73; was BACTERIAL ANTIGENS 1971-72 %28%Prov%29%   
% 217.66/217.82  |- rdf__type mesh__D000942sskos__Concept
% 217.66/217.82  |- mesh__dateEstablished mesh__D000942 1973-01-01
% 217.66/217.82  |- mesh__onlineNote mesh__D000942
% 217.66/217.82       use ANTIGENS, BACTERIAL to search BACTERIAL ANTIGENS 1971-72 %28%as Prov%29%%A%  
% 217.66/217.82  |- mesh__dateCreated mesh__D000942 1999-01-01
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D000942 2006
% 217.66/217.82  |- mesh__dateRevised mesh__D000942 2005-06-30
% 217.66/217.82  |- skos__altLabel mesh__D000942 Bacterial Antigens
% 217.66/217.82  |- mesh__recordOriginator mesh__D000942 NLM
% 217.66/217.82  |- skos__broader mesh__D000942smesh__D000941
% 217.66/217.82  |- skos__scopeNote mesh__D000942
% 217.66/217.82       Substances elaborated by bacteria that have antigenic activity.%A%    
% 217.66/217.82  |- mesh__recordMaintainer mesh__D000942 ssb
% 217.66/217.82  |- skos__annotation mesh__D000942
% 217.66/217.82       coord IM with specific bacterium /immunol %28%IM%29%; DF: ANTIGENS BACT%A%  
% 217.66/217.82  |- skos__historyNote mesh__D000942
% 217.66/217.82       Polysaccharides, Bacterial %28%1966-1970%29%
% 217.66/217.82  |- mesh__recordAuthorizer mesh__D000942 sjn
% 217.66/217.82  |- skos__historyNote mesh__D000942 Antigens %28%1966-1970%29%
% 217.66/217.82  |- skos__prefLabel mesh__D000942 Antigens, Bacterial
% 217.66/217.82  |- mesh__publicMeSHNote mesh__D000942 73   
% 217.66/217.82  |- skos__altLabel mesh__D008127 Merck Brand of Lofepramine Hydrochloride
% 217.66/217.82  |- mesh__recordMaintainer mesh__D008127 CCR
% 217.66/217.82  |- skos__historyNote mesh__D008127 Dibenzazepines %28%1969-1978%29%
% 217.66/217.82  |- skos__altLabel mesh__D008127 Rosemont Brand of Lofepramine Hydrochloride
% 217.66/217.82  |- skos__broader mesh__D008127smesh__D003984
% 217.66/217.82  |- rdf__type mesh__D008127sskos__Concept
% 217.66/217.82  |- skos__altLabel mesh__D008127 Deftan
% 217.66/217.82  |- skos__prefLabel mesh__D008127 Lofepramine
% 217.66/217.82  |- skos__hiddenLabel mesh__D008127 Hydrochloride, Lofepramine
% 217.66/217.82  |- mesh__dateRevised mesh__D008127 2004-07-07
% 217.66/217.82  |- skos__altLabel mesh__D008127 Lopramine
% 217.66/217.82  |- skos__altLabel mesh__D008127 Gamonil
% 217.66/217.82  |- skos__altLabel mesh__D008127
% 217.66/217.82       Ashbourne Brand of Lofepramine Hydrochloride
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D008127 2006
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D008127 2005
% 217.66/217.82  |- mesh__historyNote mesh__D008127
% 217.66/217.82       91%28%79%29%; was see under DIBENZAZEPINES 1979-90   
% 217.66/217.82  |- mesh__recordOriginator mesh__D008127 SH
% 217.66/217.82  |- mesh__dateCreated mesh__D008127 1978-03-20
% 217.66/217.82  |- skos__scopeNote mesh__D008127
% 217.66/217.82       A psychotropic IMIPRAMINE derivative that acts as a tricyclic antidepressant and possesses few anticholinergic properties. It is metabolized to DESIPRAMINE.%A%    
% 217.66/217.82  |- mesh__recordAuthorizer mesh__D008127 sjn
% 217.66/217.82  |- mesh__dateEstablished mesh__D008127 1991-01-01
% 217.66/217.82  |- mesh__publicMeSHNote mesh__D008127
% 217.66/217.82       91; was see under DIBENZAZEPINES 1979-90   
% 217.66/217.82  |- rdf__type mesh__D000144sskos__Concept
% 217.66/217.82  |- mesh__dateRevised mesh__D000144 1997-06-20
% 217.66/217.82  |- skos__annotation mesh__D000144
% 217.66/217.82       GEN; prefer specifics; used for mapping supplementary chemicals%A%  
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D000144 2002
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D000144 2004
% 217.66/217.82  |- mesh__recordMaintainer mesh__D000144 ADP
% 217.66/217.82  |- mesh__dateCreated mesh__D000144 1999-01-01
% 217.66/217.82  |- mesh__publicMeSHNote mesh__D000144 98   
% 217.66/217.82  |- mesh__dateEstablished mesh__D000144 1998-01-01
% 217.66/217.82  |- mesh__recordAuthorizer mesh__D000144 SJN
% 217.66/217.82  |- skos__altLabel mesh__D000144 Acyclic Acids
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D000144 2003
% 217.66/217.82  |- skos__broader mesh__D000144smesh__D002264
% 217.66/217.82  |- mesh__recordOriginator mesh__D000144 NLM
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D000144 2001
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D000144 1999
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D000144 2006
% 217.66/217.82  |- mesh__historyNote mesh__D000144 98; use explode 1967-97   
% 217.66/217.82  |- skos__prefLabel mesh__D000144 Acids, Acyclic
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D000144 2000
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D000144 1998
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D000144 2005
% 217.66/217.82  |- skos__scopeNote mesh__D000144
% 217.66/217.82       Carboxylic acids that have open-chain molecular structures as opposed to ring-shaped structures.%A%    
% 217.66/217.82  |- skos__hiddenLabel mesh__D052283 Creatine Kinase, MM
% 217.66/217.82  |- mesh__recordMaintainer mesh__D052283 jmp
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D052283 2006
% 217.66/217.82  |- skos__altLabel mesh__D052283 MM Creatine Kinase
% 217.66/217.82  |- skos__hiddenLabel mesh__D052283 Creatine Kinase, Muscle
% 217.66/217.82  |- skos__altLabel mesh__D052283 Muscle Creatine Kinase
% 217.66/217.82  |- mesh__publicMeSHNote mesh__D052283
% 217.66/217.82       2006; CRATINE KINASE, MM FORM was indexed under CREATINE KINASE 2000-2005%A%  
% 217.66/217.82  |- skos__hiddenLabel mesh__D052283 Kinase, Muscle Creatine
% 217.66/217.82  |- mesh__dateCreated mesh__D052283 2005-06-30
% 217.66/217.82  |- skos__hiddenLabel mesh__D052283 Kinase, MM Creatine
% 217.66/217.82  |- mesh__dateEstablished mesh__D052283 2006-01-01
% 217.66/217.82  |- mesh__recordAuthorizer mesh__D052283 sjn
% 217.66/217.82  |- skos__broader mesh__D052283smesh__D003402
% 217.66/217.82  |- skos__prefLabel mesh__D052283 Creatine Kinase, MM Form
% 217.66/217.82  |- rdf__type mesh__D052283sskos__Concept
% 217.66/217.82  |- skos__scopeNote mesh__D052283
% 217.66/217.82       An isoenzyme of creatine kinase found in the MUSCLE.     
% 217.66/217.82  |- skos__hiddenLabel mesh__D052283 Creatine Kinase, M
% 217.66/217.82  |- skos__hiddenLabel mesh__D052283 Kinase, M Creatine
% 217.66/217.82  |- skos__altLabel mesh__D052283 M Creatine Kinase
% 217.66/217.82  |- mesh__recordOriginator mesh__D052283 jmp
% 217.66/217.82  |- mesh__historyNote mesh__D052283 2006%28%2000%29%   
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010572 1997
% 217.66/217.82  |- mesh__recordMaintainer mesh__D010572 JLS
% 217.66/217.82  |- skos__altLabel mesh__D010572 Biological Pest Control
% 217.66/217.82  |- skos__hiddenLabel mesh__D010572 Biocontrols
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010572 2004
% 217.66/217.82  |- skos__prefLabel mesh__D010572 Pest Control, Biological
% 217.66/217.82  |- skos__hiddenLabel mesh__D010572 Pest Controls, Biological
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010572 2000
% 217.66/217.82  |- rdf__type mesh__D010572sskos__Concept
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010572 1996
% 217.66/217.82  |- skos__historyNote mesh__D010572 Insect Control %28%1966-1972%29%
% 217.66/217.82  |- skos__hiddenLabel mesh__D010572 Biological Pest Controls
% 217.66/217.82  |- skos__altLabel mesh__D010572 Biologic Pest Control
% 217.66/217.82  |- mesh__historyNote mesh__D010572 73   
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010572 2003
% 217.66/217.82  |- skos__hiddenLabel mesh__D010572 Pest Controls, Biologic
% 217.66/217.82  |- mesh__dateEstablished mesh__D010572 1973-01-01
% 217.66/217.82  |- skos__related mesh__D010572smesh__D002629
% 217.66/217.82  |- skos__hiddenLabel mesh__D010572 Biologic Pest Controls
% 217.66/217.82  |- mesh__dateRevised mesh__D010572 1995-06-05
% 217.66/217.82  |- mesh__publicMeSHNote mesh__D010572 73   
% 217.66/217.82  |- skos__altLabel mesh__D010572 Pest Control, Biologic
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010572 1999
% 217.66/217.82  |- skos__scopeNote mesh__D010572
% 217.66/217.82       The use of biological mechanisms, usually involving living organisms such as bacteria, for the reduction or regulation of the population of noxious, destructive, or dangerous pests. Environmental concerns have focused attention on natural forms of disease control as potentially safe and effective alternatives to chemical pesticides. This has led to increased efforts to develop control strategies that rely on natural predators and parasites or that involve genetically engineered microbial pest control agents.%A%    
% 217.66/217.82  |- mesh__recordOriginator mesh__D010572 NLM
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010572 2006
% 217.66/217.82  |- mesh__recordAuthorizer mesh__D010572 PLS
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010572 2002
% 217.66/217.82  |- mesh__dateCreated mesh__D010572 1999-01-01
% 217.66/217.82  |- skos__historyNote mesh__D010572 Rodent Control %28%1966-1972%29%
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010572 1998
% 217.66/217.82  |- skos__broader mesh__D010572smesh__D010571
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010572 2005
% 217.66/217.82  |- skos__historyNote mesh__D010572 Mosquito Control %28%1966-1972%29%
% 217.66/217.82  |- skos__annotation mesh__D010572
% 217.66/217.82       IM; coord with specific insect or other pest %28%IM%29% but not the precoords INSECT CONTROL %26% MOSQUITO CONTROL%A%  
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D010572 2001
% 217.66/217.82  |- skos__hiddenLabel mesh__D004535 Ehlers Danlos Disease
% 217.66/217.82  |- skos__hiddenLabel mesh__D004535 Disease, Ehlers-Danlos
% 217.66/217.82  |- rdf__type mesh__D004535sskos__Concept
% 217.66/217.82  |- mesh__recordMaintainer mesh__D004535 sjn
% 217.66/217.82  |- skos__scopeNote mesh__D004535
% 217.66/217.82       A heterogeneous group of inherited COLLAGEN DISEASES. The most common manifestations of Ehlers-Danlos Syndrome are hyperextensible skin and joints, skin fragility and reduced wound healing capability.%A%    
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D004535 2002A
% 217.66/217.82  |- skos__broader mesh__D004535smesh__D020141
% 217.66/217.82  |- skos__broader mesh__D004535smesh__D003095
% 217.66/217.82  |- skos__related mesh__D004535smesh__D012155
% 217.66/217.82  |- skos__altLabel mesh__D004535 Cutis Elastica
% 217.66/217.82  |- skos__broader mesh__D004535smesh__D012868
% 217.66/217.82  |- mesh__dateCreated mesh__D004535 1999-01-01
% 217.66/217.82  |- mesh__recordAuthorizer mesh__D004535 sjn
% 217.66/217.82  |- skos__altLabel mesh__D004535 Ehlers-Danlos Disease
% 217.66/217.82  |- mesh__dateRevised mesh__D004535 2001-09-07
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D004535 2004
% 217.66/217.82  |- skos__hiddenLabel mesh__D004535 Syndrome, Ehlers-Danlos
% 217.66/217.82  |- skos__hiddenLabel mesh__D004535 Ehlers Danlos Syndrome
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D004535 2003
% 217.66/217.82  |- mesh__recordOriginator mesh__D004535 NLM
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D004535 2006
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D004535 2002
% 217.66/217.82  |- skos__prefLabel mesh__D004535 Ehlers-Danlos Syndrome
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D004535 2005
% 217.66/217.82  |- skos__broader mesh__D004535smesh__D012873
% 217.66/217.82  |- rdf__type mesh__D009220sskos__Concept
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D009220 2003
% 217.66/217.82  |- skos__hiddenLabel mesh__D009220 Myopathies, Inflammatory
% 217.66/217.82  |- skos__altLabel mesh__D009220 Infectious Myositis
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D009220 2002
% 217.66/217.82  |- skos__prefLabel mesh__D009220 Myositis
% 217.66/217.82  |- skos__altLabel mesh__D009220 Inflammatory Muscle Diseases
% 217.66/217.82  |- skos__hiddenLabel mesh__D009220 Muscle Disease, Inflammatory
% 217.66/217.82  |- mesh__historyNote mesh__D009220
% 217.66/217.82       MYOSITIS, EOSINOPHILIC was heading 1970-80   
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D009220 2004
% 217.66/217.82  |- skos__hiddenLabel mesh__D009220 Myositides, Infectious
% 217.66/217.82  |- skos__hiddenLabel mesh__D009220 Idiopathic Inflammatory Myopathy
% 217.66/217.82  |- mesh__publicMeSHNote mesh__D009220
% 217.66/217.82       MYOSITIS, EOSINOPHILIC was heading 1970-80   
% 217.66/217.82  |- skos__hiddenLabel mesh__D009220 Inflammatory Myopathies
% 217.66/217.82  |- skos__hiddenLabel mesh__D009220 Proliferative Myositides
% 217.66/217.82  |- mesh__onlineNote mesh__D009220
% 217.66/217.82       use MYOSITIS to search MYOSITIS, EOSINOPHILIC 1972-80   
% 217.66/217.82  |- skos__scopeNote mesh__D009220
% 217.66/217.82       Inflammation of skeletal muscle %28%MUSCLE, SKELETAL%29%. Infectious, autoimmune, and paraneoplastic processes represent some of the more common conditions that may be associated with myositis. %28%From Adams et al., Principles of Neurology, 6th ed., pp 1402-13%29%%A%    
% 217.66/217.82  |- skos__hiddenLabel mesh__D009220 Inflammatory Myopathy, Idiopathic
% 217.66/217.82  |- mesh__recordOriginator mesh__D009220 NLM
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D009220 2000
% 217.66/217.82  |- skos__annotation mesh__D009220
% 217.66/217.82       DERMATOMYOSITIS %26% POLYMYOSITIS are also available   
% 217.66/217.82  |- mesh__recordAuthorizer mesh__D009220 sjn
% 217.66/217.82  |- skos__hiddenLabel mesh__D009220 Focal Myositides
% 217.66/217.82  |- skos__hiddenLabel mesh__D009220 Myositides
% 217.66/217.82  |- skos__hiddenLabel mesh__D009220 Myositides, Focal
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D009220 2005
% 217.66/217.82  |- skos__altLabel mesh__D009220 Inflammatory Myopathies, Idiopathic
% 217.66/217.82  |- mesh__recordMaintainer mesh__D009220 jls
% 217.66/217.82  |- skos__broader mesh__D009220smesh__D009135
% 217.66/217.82  |- mesh__dateRevised mesh__D009220 1999-11-09
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D009220 2001
% 217.66/217.82  |- skos__hiddenLabel mesh__D009220 Proliferative Myositis
% 217.66/217.82  |- skos__altLabel mesh__D009220 Myopathy, Inflammatory
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D009220 2006
% 217.66/217.82  |- skos__hiddenLabel mesh__D009220 Myositides, Proliferative
% 217.66/217.82  |- skos__hiddenLabel mesh__D009220 Focal Myositis
% 217.66/217.82  |- skos__altLabel mesh__D009220 Inflammatory Myopathy
% 217.66/217.82  |- skos__hiddenLabel mesh__D009220 Inflammatory Muscle Disease
% 217.66/217.82  |- mesh__dateCreated mesh__D009220 1999-01-01
% 217.66/217.82  |- skos__hiddenLabel mesh__D009220 Myopathy, Idiopathic Inflammatory
% 217.66/217.82  |- skos__altLabel mesh__D009220 Myopathies, Idiopathic Inflammatory
% 217.66/217.82  |- skos__hiddenLabel mesh__D009220 Infectious Myositides
% 217.66/217.82  |- skos__altLabel mesh__D009220 Muscle Diseases, Inflammatory
% 217.66/217.82  |- skos__hiddenLabel mesh__D014963 X-Ray Intensifying Screen
% 217.66/217.82  |- skos__hiddenLabel mesh__D014963 Screen, Radiographic Intensifying
% 217.66/217.82  |- skos__hiddenLabel mesh__D014963 Screen, X-Ray Intensifying
% 217.66/217.82  |- skos__altLabel mesh__D014963 X-Ray Film-Screen Systems
% 217.66/217.82  |- skos__hiddenLabel mesh__D014963 Intensifying Screen, X-Ray
% 217.66/217.82  |- skos__historyNote mesh__D014963 Radiography %28%1977-1981%29%
% 217.66/217.82  |- skos__hiddenLabel mesh__D014963 Screen-Film System, X-Ray
% 217.66/217.82  |- mesh__activeMeSHYear mesh__D014963 2000
% 217.66/217.82  |- skos__hiddenLabel mesh__D014963 X-Ray Screen-Film Systems
% 217.66/217.82  |- mesh__publicMeSHNote mesh__D014963
% 217.66/217.82       89; was see under RADIOGRAPHIC IMAGE ENHANCEMENT 1982-88   
% 217.66/217.83  |- rdf__type mesh__D014963sskos__Concept
% 217.66/217.83  |- skos__hiddenLabel mesh__D014963 X-Ray Film-Screen System
% 217.66/217.83  |- skos__hiddenLabel mesh__D014963 Intensifying Screens, Xray
% 217.66/217.83  |- mesh__dateEstablished mesh__D014963 1989-01-01
% 217.66/217.83  |- mesh__recordOriginator mesh__D014963 SMH
% 217.66/217.83  |- skos__hiddenLabel mesh__D014963 X Ray Film Screen Systems
% 217.66/217.83  |- skos__altLabel mesh__D014963 Screens, Radiographic Intensifying
% 217.66/217.83  |- skos__hiddenLabel mesh__D014963 Screens, Xray Intensifying
% 217.66/217.83  |- skos__hiddenLabel mesh__D014963 Intensifying Screens, Radiographic
% 217.66/217.83  |- skos__hiddenLabel mesh__D014963 System, X-Ray Screen-Film
% 217.66/217.83  |- skos__historyNote mesh__D014963 Angiography %28%1977-1981%29%
% 217.66/217.83  |- skos__hiddenLabel mesh__D014963 Screen Film Systems, X Ray
% 217.66/217.83  |- skos__altLabel mesh__D014963 Screen-Film Systems, X-Ray
% 217.66/217.83  |- mesh__recordMaintainer mesh__D014963 PXP
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D014963 2001
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D014963 1998
% 217.66/217.83  |- skos__hiddenLabel mesh__D014963 Screens, X-Ray Intensifying
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D014963 2003
% 217.66/217.83  |- mesh__dateCreated mesh__D014963 1981-05-19
% 217.66/217.83  |- skos__altLabel mesh__D014963 Film-Screen Systems, X-Ray
% 217.66/217.83  |- skos__hiddenLabel mesh__D014963 Film Screen Systems, X Ray
% 217.66/217.83  |- skos__altLabel mesh__D014963 Radiographic Intensifying Screens
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D014963 2002
% 217.66/217.83  |- skos__historyNote mesh__D014963 Mammography %28%1977-1981%29%
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D014963 1999
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D014963 2004
% 217.66/217.83  |- skos__hiddenLabel mesh__D014963 Xray Intensifying Screen
% 217.66/217.83  |- skos__hiddenLabel mesh__D014963 Radiographic Intensifying Screen
% 217.66/217.83  |- skos__hiddenLabel mesh__D014963 Systems, X-Ray Film-Screen
% 217.66/217.83  |- skos__historyNote mesh__D014963
% 217.66/217.83       Radiographic Image Enhancement %28%1977-1981%29%
% 217.66/217.83  |- skos__hiddenLabel mesh__D014963 X-Ray Screen-Film System
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D014963 2005
% 217.66/217.83  |- skos__altLabel mesh__D014963 Xray Intensifying Screens
% 217.66/217.83  |- skos__broader mesh__D014963smesh__D004864
% 217.66/217.83  |- skos__historyNote mesh__D014963 Technology, Radiologic %28%1977-1981%29%
% 217.66/217.83  |- skos__hiddenLabel mesh__D014963 Intensifying Screen, Radiographic
% 217.66/217.83  |- skos__hiddenLabel mesh__D014963 Intensifying Screen, Xray
% 217.66/217.83  |- skos__scopeNote mesh__D014963
% 217.66/217.83       Screens which absorb the energy in the x-ray beam that has penetrated the patient and convert this energy into a light pattern which has as nearly as possible the same information as the original x-ray beam. The more light a screen produces for a given input of x-radiation, the less x-ray exposure and thus shorter exposure time are needed to expose the film. In most film-screen systems, the film is sandwiched between two screens in a cassette so that the emulsion on each side is exposed to the light from its contiguous screen.%A%    
% 217.66/217.83  |- skos__hiddenLabel mesh__D014963 Intensifying Screens, X-Ray
% 217.66/217.83  |- skos__hiddenLabel mesh__D014963 Film-Screen System, X-Ray
% 217.66/217.83  |- skos__hiddenLabel mesh__D014963 System, X-Ray Film-Screen
% 217.66/217.83  |- mesh__recordAuthorizer mesh__D014963 SJN
% 217.66/217.83  |- mesh__historyNote mesh__D014963
% 217.66/217.83       89%28%82%29%; was see under RADIOGRAPHIC IMAGE ENHANCEMENT 1982-88%A%  
% 217.66/217.83  |- skos__hiddenLabel mesh__D014963 Screen, Xray Intensifying
% 217.66/217.83  |- mesh__dateRevised mesh__D014963 1997-06-20
% 217.66/217.83  |- skos__prefLabel mesh__D014963 X-Ray Intensifying Screens
% 217.66/217.83  |- skos__hiddenLabel mesh__D014963 X Ray Intensifying Screens
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D014963 2006
% 217.66/217.83  |- skos__hiddenLabel mesh__D014963 Systems, X-Ray Screen-Film
% 217.66/217.83  |- rdf__type mesh__D014165sskos__Concept
% 217.66/217.83  |- skos__prefLabel mesh__D014165 Transfer Factor
% 217.66/217.83  |- skos__annotation mesh__D014165
% 217.66/217.83       derived from leukocytes; /biosyn /drug eff /physiol /ultrastruct permitted%A%  
% 217.66/217.83  |- skos__historyNote mesh__D014165 Immunization, Passive %28%1970-1974%29%
% 217.66/217.83  |- skos__historyNote mesh__D014165 Lymphokines %28%1974%29%
% 217.66/217.83  |- mesh__recordOriginator mesh__D014165 NLM
% 217.66/217.83  |- mesh__recordMaintainer mesh__D014165 ssb
% 217.66/217.83  |- mesh__dateRevised mesh__D014165 2005-06-30
% 217.66/217.83  |- mesh__publicMeSHNote mesh__D014165 75   
% 217.66/217.83  |- mesh__recordAuthorizer mesh__D014165 sjn
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D014165 2006
% 217.66/217.83  |- skos__broader mesh__D014165smesh__D008222
% 217.66/217.83  |- skos__historyNote mesh__D014165
% 217.66/217.83       Immunity, Maternally-Acquired %28%1966-1974%29%
% 217.66/217.83  |- mesh__historyNote mesh__D014165 75   
% 217.66/217.83  |- skos__hiddenLabel mesh__D014165 Factor, Transfer
% 217.66/217.83  |- mesh__dateEstablished mesh__D014165 1975-09-01
% 217.66/217.83  |- skos__hiddenLabel mesh__D014165 Leukocyte Extract, Dialyzable
% 217.66/217.83  |- mesh__dateCreated mesh__D014165 1974-11-11
% 217.66/217.83  |- skos__hiddenLabel mesh__D014165 Extract, Dialyzable Leukocyte
% 217.66/217.83  |- skos__scopeNote mesh__D014165
% 217.66/217.83       Factor derived from leukocyte lysates of immune donors which can transfer both local and systemic cellular immunity to nonimmune recipients.%A%    
% 217.66/217.83  |- mesh__recordMaintainer mesh__D008926 ssb
% 217.66/217.83  |- mesh__publicMeSHNote mesh__D008926 93; was MITHRAMYCIN 1973-92   
% 217.66/217.83  |- mesh__dateCreated mesh__D008926 1999-01-01
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D008926 2005
% 217.66/217.83  |- skos__altLabel mesh__D008926 Aureolic Acid
% 217.66/217.83  |- mesh__recordAuthorizer mesh__D008926 sjn
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D008926 2006
% 217.66/217.83  |- mesh__recordOriginator mesh__D008926 NLM
% 217.66/217.83  |- mesh__dateRevised mesh__D008926 2004-07-07
% 217.66/217.83  |- mesh__historyNote mesh__D008926
% 217.66/217.83       93; was MITHRAMYCIN 1971-92 %28%Prov 1971-72%29%   
% 217.66/217.83  |- mesh__onlineNote mesh__D008926
% 217.66/217.83       use PLICAMYCIN to search MITHRAMYCIN 1971-92 %28%as Prov 1971-72%29%%A%  
% 217.66/217.83  |- skos__broader mesh__D008926smesh__D018943
% 217.66/217.83  |- skos__hiddenLabel mesh__D008926 Acid, Aureolic
% 217.66/217.83  |- rdf__type mesh__D008926sskos__Concept
% 217.66/217.83  |- skos__scopeNote mesh__D008926
% 217.66/217.83       A tricyclic pentaglycosidic antibiotic from Streptomyces strains that inhibits RNA and protein synthesis by adhering to DNA. It is used as a fluorescent dye and as an antineoplastic agent, especially in bone and testicular tumors. Plicamycin is also used to reduce hypercalcemia, especially that due to malignancies.%A%    
% 217.66/217.83  |- skos__historyNote mesh__D008926
% 217.66/217.83       Antibiotics, Antineoplastic %28%1967-1970%29%
% 217.66/217.83  |- skos__altLabel mesh__D008926 Mitramycin
% 217.66/217.83  |- skos__altLabel mesh__D008926 Mithramycin
% 217.66/217.83  |- mesh__dateEstablished mesh__D008926 1973-01-01
% 217.66/217.83  |- skos__prefLabel mesh__D008926 Plicamycin
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D000943 2006
% 217.66/217.83  |- mesh__onlineNote mesh__D000943
% 217.66/217.83       use ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE to search DIFFERENTIATION ANTIGENS, HAIRY CELL LEUKEMIA 1988-91; use ANTIGENS, DIFFERENTIATION to search LEU ANTIGENS 1989 to present; use ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988%A%  
% 217.66/217.83  |- mesh__dateCreated mesh__D000943 1987-03-13
% 217.66/217.83  |- skos__historyNote mesh__D000943
% 217.66/217.83       specific cell or tissue %28%1966-1987%29%
% 217.66/217.83  |- skos__broader mesh__D000943smesh__D015415
% 217.66/217.83  |- skos__prefLabel mesh__D000943 Antigens, Differentiation
% 217.66/217.83  |- mesh__recordOriginator mesh__D000943 SCD
% 217.66/217.83  |- mesh__dateEstablished mesh__D000943 1988-01-01
% 217.66/217.83  |- skos__altLabel mesh__D000943 Differentiation Antigens
% 217.66/217.83  |- skos__historyNote mesh__D000943 Antigens, Surface %28%1979-1987%29%
% 217.66/217.83  |- mesh__recordMaintainer mesh__D000943 jls
% 217.66/217.83  |- skos__historyNote mesh__D000943 Antigens %28%1966-1977%29%
% 217.66/217.83  |- skos__hiddenLabel mesh__D000943 Antigens, Leu
% 217.66/217.83  |- mesh__dateRevised mesh__D000943 2005-07-29
% 217.66/217.83  |- skos__broader mesh__D000943smesh__D000954
% 217.66/217.83  |- skos__historyNote mesh__D000943
% 217.66/217.83       Cell Transformation, Neoplastic %28%1970-1987%29%
% 217.66/217.83  |- skos__altLabel mesh__D000943 Differentiation Markers
% 217.66/217.83  |- mesh__recordAuthorizer mesh__D000943 jls
% 217.66/217.83  |- mesh__publicMeSHNote mesh__D000943
% 217.66/217.83       88; DIFFERENTIATION ANTIGENS, HAIRY CELL LEUKEMIA was see ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1988-91; LEU ANTIGENS was see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988%A%  
% 217.66/217.83  |- skos__historyNote mesh__D000943 Cell Differentiation %28%1966-1987%29%
% 217.66/217.83  |- skos__altLabel mesh__D000943 Marker Antigens
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D000943 2006A
% 217.66/217.83  |- skos__altLabel mesh__D000943 Markers, Differentiation
% 217.66/217.83  |- rdf__type mesh__D000943sskos__Concept
% 217.66/217.83  |- skos__annotation mesh__D000943
% 217.66/217.83       GEN: prefer specific groups %26% specific differentiation antigens; note X ref LEU ANTIGENS but several specific Leu antigens are also available; DF: ANTIGENS DIFFER%A%  
% 217.66/217.83  |- skos__scopeNote mesh__D000943
% 217.66/217.83       Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation.%A%    
% 217.66/217.83  |- skos__historyNote mesh__D000943 Antigens, Neoplasm %28%1973-1987%29%
% 217.66/217.83  |- mesh__historyNote mesh__D000943
% 217.66/217.83       88; DIFFERENTIATION ANTIGENS, HAIRY CELL LEUKEMIA was see ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1988-91; LEU ANTIGENS was see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988%A%  
% 217.66/217.83  |- skos__hiddenLabel mesh__D000943 Antigens, Marker
% 217.66/217.83  |- skos__hiddenLabel mesh__D008128 Logics
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D008128 1998
% 217.66/217.83  |- skos__annotation mesh__D008128 no qualif   
% 217.66/217.83  |- mesh__recordOriginator mesh__D008128 NLM
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D008128 2006
% 217.66/217.83  |- mesh__dateCreated mesh__D008128 1999-01-01
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D008128 1997
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D008128 2005
% 217.66/217.83  |- skos__prefLabel mesh__D008128 Logic
% 217.66/217.83  |- skos__scopeNote mesh__D008128
% 217.66/217.83       The science that investigates the principles governing correct or reliable inference and deals with the canons and criteria of validity in thought and demonstration. This system of reasoning is applicable to any branch of knowledge or study. %28%Random House Unabridged Dictionary, 2d ed %26% Sippl, Computer Dictionary, 4th ed%29%%A%    
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D008128 2002
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D008128 1996
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D008128 2004
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D008128 2001
% 217.66/217.83  |- skos__broader mesh__D008128smesh__D010684
% 217.66/217.83  |- mesh__dateRevised mesh__D008128 1995-05-18
% 217.66/217.83  |- mesh__recordAuthorizer mesh__D008128 PLS
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D008128 2003
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D008128 1999
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D008128 2000
% 217.66/217.83  |- mesh__recordMaintainer mesh__D008128 TGC
% 217.66/217.83  |- rdf__type mesh__D008128sskos__Concept
% 217.66/217.83  |- mesh__dateCreated mesh__D000145 1999-01-01
% 217.66/217.83  |- skos__scopeNote mesh__D000145
% 217.66/217.83       Dicarboxylic acids in which one of the carboxyl groups %28%-COOH%29% has been replaced by an aldehyde group %28%-CHO%29%.%A%    
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D000145 2001
% 217.66/217.83  |- mesh__historyNote mesh__D000145 98; use explode 1967-97   
% 217.66/217.83  |- mesh__recordMaintainer mesh__D000145 ADP
% 217.66/217.83  |- skos__broader mesh__D000145smesh__D002264
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D000145 2003
% 217.66/217.83  |- skos__prefLabel mesh__D000145 Acids, Aldehydic
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D000145 2000
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D000145 1999
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D000145 2006
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D000145 1998
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D000145 2005
% 217.66/217.83  |- mesh__dateRevised mesh__D000145 1997-06-20
% 217.66/217.83  |- skos__annotation mesh__D000145
% 217.66/217.83       GEN; prefer specifics; used for mapping supplementary chemicals%A%  
% 217.66/217.83  |- skos__altLabel mesh__D000145 Aldehydic Acids
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D000145 2002
% 217.66/217.83  |- mesh__dateEstablished mesh__D000145 1998-01-01
% 217.66/217.83  |- rdf__type mesh__D000145sskos__Concept
% 217.66/217.83  |- mesh__publicMeSHNote mesh__D000145 98   
% 217.66/217.83  |- mesh__recordAuthorizer mesh__D000145 SJN
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D000145 2004
% 217.66/217.83  |- mesh__recordOriginator mesh__D000145 NLM
% 217.66/217.83  |- skos__related mesh__D052284smesh__D010058
% 217.66/217.83  |- skos__annotation mesh__D052284
% 217.66/217.83       oviparous or ovoviviparous animals only; for viviparous animals use LITTER SIZE%A%  
% 217.66/217.83  |- skos__hiddenLabel mesh__D052284 Size, Clutch
% 217.66/217.83  |- skos__related mesh__D052284smesh__D052287
% 217.66/217.83  |- mesh__recordMaintainer mesh__D052284 ags
% 217.66/217.83  |- skos__scopeNote mesh__D052284
% 217.66/217.83       The number of offspring produced at one birth by an oviparous or ovoviviparous animal.%A%    
% 217.66/217.83  |- mesh__publicMeSHNote mesh__D052284 2006   
% 217.66/217.83  |- rdf__type mesh__D052284sskos__Concept
% 217.66/217.83  |- mesh__historyNote mesh__D052284 2006   
% 217.66/217.83  |- skos__hiddenLabel mesh__D052284 Clutch Sizes
% 217.66/217.83  |- skos__hiddenLabel mesh__D052284 Sizes, Clutch
% 217.66/217.83  |- mesh__dateCreated mesh__D052284 2005-06-30
% 217.66/217.83  |- mesh__dateEstablished mesh__D052284 2006-01-01
% 217.66/217.83  |- mesh__recordOriginator mesh__D052284 ags
% 217.66/217.83  |- mesh__recordAuthorizer mesh__D052284 sjn
% 217.66/217.83  |- skos__broader mesh__D052284smesh__D012098
% 217.66/217.83  |- skos__prefLabel mesh__D052284 Clutch Size
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D052284 2006
% 217.66/217.83  |- skos__related mesh__D052284smesh__D052285
% 217.66/217.83  |- skos__broader mesh__D018556smesh__D005502
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D018556 2006
% 217.66/217.83  |- skos__hiddenLabel mesh__D018556 Agricultural Crop
% 217.66/217.83  |- mesh__dateRevised mesh__D018556 1997-06-20
% 217.66/217.83  |- mesh__recordMaintainer mesh__D018556 JLS
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D018556 2005
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D018556 2004
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D018556 2001
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D018556 1999
% 217.66/217.83  |- mesh__publicMeSHNote mesh__D018556 95   
% 217.66/217.83  |- mesh__recordAuthorizer mesh__D018556 SJN
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D018556 2003
% 217.66/217.83  |- skos__altLabel mesh__D018556 Agricultural Crops
% 217.66/217.83  |- rdf__type mesh__D018556sskos__Concept
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D018556 1998
% 217.66/217.83  |- skos__scopeNote mesh__D018556
% 217.66/217.83       Cultivated plants or agricultural produce such as grain, vegetables, or fruit. %28%From American Heritage Dictionary, 1982%29%%A%    
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D018556 2000
% 217.66/217.83  |- mesh__dateCreated mesh__D018556 1994-06-07
% 217.66/217.83  |- skos__broader mesh__D018556smesh__D010945
% 217.66/217.83  |- mesh__recordOriginator mesh__D018556 JLS
% 217.66/217.83  |- skos__annotation mesh__D018556
% 217.66/217.83       cultivated edible plants; selected qualif from Cat B6 %26% Cat J2%A%  
% 217.66/217.83  |- mesh__historyNote mesh__D018556 95   
% 217.66/217.83  |- skos__prefLabel mesh__D018556 Crops, Agricultural
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D018556 2002
% 217.66/217.83  |- mesh__dateEstablished mesh__D018556 1995-01-01
% 217.66/217.83  |- skos__hiddenLabel mesh__D010573 Pesticide Residue
% 217.66/217.83  |- skos__hiddenLabel mesh__D010573 Residue, Pesticide
% 217.66/217.83  |- skos__broader mesh__D010573smesh__D010575
% 217.66/217.83  |- rdf__type mesh__D010573sskos__Concept
% 217.66/217.83  |- skos__scopeNote mesh__D010573
% 217.66/217.83       Pesticides or their breakdown products remaining in the environment following their normal use or accidental contamination.%A%    
% 217.66/217.83  |- mesh__historyNote mesh__D010573 73   
% 217.66/217.83  |- skos__hiddenLabel mesh__D010573 Residues, Pesticide
% 217.66/217.83  |- skos__annotation mesh__D010573
% 217.66/217.83       IM; coord with specific pesticide or pesticide group %28%IM%29%%A%  
% 217.66/217.83  |- mesh__dateRevised mesh__D010573 2003-07-09
% 217.66/217.83  |- skos__broader mesh__D010573smesh__D001822
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D010573 2006
% 217.66/217.83  |- skos__historyNote mesh__D010573 Pesticides %28%1966-1972%29%
% 217.66/217.83  |- mesh__dateEstablished mesh__D010573 1973-01-01
% 217.66/217.83  |- mesh__dateCreated mesh__D010573 1999-01-01
% 217.66/217.83  |- mesh__recordAuthorizer mesh__D010573 sjn
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D010573 2005
% 217.66/217.83  |- mesh__recordMaintainer mesh__D010573 ssb
% 217.66/217.83  |- mesh__publicMeSHNote mesh__D010573 73   
% 217.66/217.83  |- mesh__recordOriginator mesh__D010573 NLM
% 217.66/217.83  |- skos__prefLabel mesh__D010573 Pesticide Residues
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D010573 2004
% 217.66/217.83  |- rdf__type mesh__D004536sskos__Concept
% 217.66/217.83  |- mesh__publicMeSHNote mesh__D004536
% 217.66/217.83       91,63-65; was see under RICKETTSIACEAE 1975-90; was heading 1963-65%A%  
% 217.66/217.83  |- mesh__dateCreated mesh__D004536 1999-01-01
% 217.66/217.83  |- mesh__dateEstablished mesh__D004536 1991-01-01
% 217.66/217.83  |- skos__scopeNote mesh__D004536
% 217.66/217.83       Small, often pleomorphic, coccoid to ellipsoidal organisms occurring intracytoplasmically in circulating LYMPHOCYTES. They are the etiologic agents of tick-borne diseases of humans; DOGS; CATTLE; SHEEP; GOATS; and HORSES.%A%    
% 217.66/217.83  |- mesh__dateRevised mesh__D004536 2005-07-13
% 217.66/217.83  |- mesh__recordAuthorizer mesh__D004536 ags
% 217.66/217.83  |- skos__prefLabel mesh__D004536 Ehrlichia
% 217.66/217.83  |- skos__annotation mesh__D004536 infection = EHRLICHIOSIS   
% 217.66/217.83  |- mesh__recordOriginator mesh__D004536 NLM
% 217.66/217.83  |- skos__altLabel mesh__D004536 Cowdria
% 217.66/217.83  |- mesh__recordMaintainer mesh__D004536 ags
% 217.66/217.83  |- skos__broader mesh__D004536smesh__D000710
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D004536 2006
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D004536 2006A
% 217.66/217.83  |- mesh__historyNote mesh__D004536
% 217.66/217.83       91%28%73%29%63-65; was see under RICKETTSIACEAE 1973-90 %28%Prov 1973-75%29%; was heading 1963-65%A%  
% 217.66/217.83  |- mesh__recordMaintainer mesh__D009221 TGC
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D009221 2001
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D009221 2006
% 217.66/217.83  |- mesh__dateRevised mesh__D009221 1999-11-03
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D009221 2000
% 217.66/217.83  |- mesh__recordAuthorizer mesh__D009221 sjn
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D009221 2005
% 217.66/217.83  |- mesh__recordOriginator mesh__D009221 NLM
% 217.66/217.83  |- skos__prefLabel mesh__D009221 Myositis Ossificans
% 217.66/217.83  |- skos__scopeNote mesh__D009221
% 217.66/217.83       A disease characterized by bony deposits or the ossification of muscle tissue.%A%    
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D009221 2002
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D009221 2004
% 217.66/217.83  |- rdf__type mesh__D009221sskos__Concept
% 217.66/217.83  |- skos__broader mesh__D009221smesh__D009220
% 217.66/217.83  |- mesh__dateCreated mesh__D009221 1999-01-01
% 217.66/217.83  |- skos__annotation mesh__D009221
% 217.66/217.83       myositis with bony deposits or muscle ossification   
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D009221 2003
% 217.66/217.83  |- skos__altLabel mesh__D014964 Therapy, X Ray
% 217.66/217.83  |- skos__hiddenLabel mesh__D014964 Therapies, X-Ray
% 217.66/217.83  |- mesh__dateEstablished mesh__D014964 1991-01-01
% 217.66/217.83  |- skos__annotation mesh__D014964
% 217.66/217.83       see note on RADIOTHERAPY when tempted to use for IM; do not index as IM or NIM coord when using /radiother: assume all /radiother is X-RAY THERAPY unless otherwise specified %28%as /radiother + RADIUM /ther use or /radiother + ULTRAVIOLET THERAPY, etc.%29%: Manual 19.8.63; DF: X RAY THER%A%  
% 217.66/217.83  |- skos__altLabel mesh__D014964 Xray Therapy
% 217.66/217.83  |- rdf__type mesh__D014964sskos__Concept
% 217.66/217.83  |- skos__broader mesh__D014964smesh__D011878
% 217.66/217.83  |- skos__prefLabel mesh__D014964 X-Ray Therapy
% 217.66/217.83  |- skos__altLabel mesh__D014964 Roentgenotherapy
% 217.66/217.83  |- mesh__dateRevised mesh__D014964 2005-06-30
% 217.66/217.83  |- skos__hiddenLabel mesh__D014964 X Ray Therapy
% 217.66/217.83  |- mesh__historyNote mesh__D014964
% 217.66/217.83       91%28%75%29%; was see under RADIOTHERAPY 1975-90   
% 217.66/217.83  |- mesh__recordMaintainer mesh__D014964 lkt
% 217.66/217.83  |- mesh__recordOriginator mesh__D014964 NLM
% 217.66/217.83  |- mesh__recordAuthorizer mesh__D014964 sjn
% 217.66/217.83  |- mesh__onlineNote mesh__D014964 search RADIOTHERAPY 1966-74   
% 217.66/217.83  |- skos__hiddenLabel mesh__D014964 Therapies, X Ray
% 217.66/217.83  |- skos__hiddenLabel mesh__D014964 Therapies, Xray
% 217.66/217.83  |- skos__hiddenLabel mesh__D014964 Xray Therapies
% 217.66/217.83  |- skos__hiddenLabel mesh__D014964 X Ray Therapies
% 217.66/217.83  |- skos__hiddenLabel mesh__D014964 X-Ray Therapies
% 217.66/217.83  |- skos__altLabel mesh__D014964 Therapy, Xray
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D014964 2006
% 217.66/217.83  |- skos__hiddenLabel mesh__D014964 Therapy, X-Ray
% 217.66/217.83  |- mesh__dateCreated mesh__D014964 1999-01-01
% 217.66/217.83  |- skos__hiddenLabel mesh__D014964 Roentgenotherapies
% 217.66/217.83  |- mesh__publicMeSHNote mesh__D014964
% 217.66/217.83       91; was see under RADIOTHERAPY 1975-90   
% 217.66/217.83  |- skos__prefLabel mesh__D014166 Transferases
% 217.66/217.83  |- mesh__dateRevised mesh__D014166 2003-07-09
% 217.66/217.83  |- rdf__type mesh__D014166sskos__Concept
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D014166 2005
% 217.66/217.83  |- mesh__recordMaintainer mesh__D014166 ssb
% 217.66/217.83  |- skos__broader mesh__D014166smesh__D004798
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D014166 2006
% 217.66/217.83  |- mesh__dateCreated mesh__D014166 1999-01-01
% 217.66/217.83  |- skos__altLabel mesh__D014166 Transferase
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D014166 2004
% 217.66/217.83  |- mesh__recordOriginator mesh__D014166 NLM
% 217.66/217.83  |- skos__scopeNote mesh__D014166
% 217.66/217.83       Transferases are enzymes transferring a group, for example, the methyl group or a glycosyl group, from one compound %28%generally regarded as donor%29% to another compound %28%generally regarded as acceptor%29%. The classification is based on the scheme %22%donor:acceptor group transferase%22%. %28%Enzyme Nomenclature, 1992%29% EC 2.%A%    
% 217.66/217.83  |- mesh__recordAuthorizer mesh__D014166 sjn
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D008927 2005
% 217.66/217.83  |- skos__hiddenLabel mesh__D008927 NSC 94100
% 217.66/217.83  |- skos__hiddenLabel mesh__D008927 NSC 94,100
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D008927 2006
% 217.66/217.83  |- mesh__recordMaintainer mesh__D008927 ssb
% 217.66/217.83  |- mesh__dateRevised mesh__D008927 2004-07-07
% 217.66/217.83  |- skos__historyNote mesh__D008927 Mannitol %28%1971-1974%29%
% 217.66/217.83  |- rdf__type mesh__D008927sskos__Concept
% 217.66/217.83  |- mesh__publicMeSHNote mesh__D008927 91; was see under MANNITOL 1975-90   
% 217.66/217.83  |- mesh__recordAuthorizer mesh__D008927 sjn
% 217.66/217.83  |- skos__altLabel mesh__D008927 Dibromomannitol
% 217.66/217.83  |- mesh__recordOriginator mesh__D008927 NLM
% 217.66/217.83  |- skos__altLabel mesh__D008927 NSC-94100
% 217.66/217.83  |- skos__hiddenLabel mesh__D008927 NSC94100
% 217.66/217.83  |- skos__broader mesh__D008927smesh__D008353
% 217.66/217.83  |- skos__scopeNote mesh__D008927
% 217.66/217.83       Brominated analog of MANNITOL which is an antineoplastic agent appearing to act as an alkylating agent.%A%    
% 217.66/217.83  |- mesh__historyNote mesh__D008927
% 217.66/217.83       91%28%75%29%; was see under MANNITOL 1975-90   
% 217.66/217.83  |- mesh__dateCreated mesh__D008927 1974-11-19
% 217.66/217.83  |- skos__prefLabel mesh__D008927 Mitobronitol
% 217.66/217.83  |- mesh__dateEstablished mesh__D008927 1991-01-01
% 217.66/217.83  |- skos__historyNote mesh__D008927 Bromine %28%1971-1974%29%
% 217.66/217.83  |- skos__hiddenLabel mesh__D008927 NSC94,100
% 217.66/217.83  |- skos__altLabel mesh__D000944 B-Lymphocyte Differentiation Antigens
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D000944 2006
% 217.66/217.83  |- skos__hiddenLabel mesh__D000944 Differentiation Antigens, B Lymphocyte
% 217.66/217.83  |- skos__historyNote mesh__D000944 B-Lymphocytes %28%1973-1987%29%
% 217.66/217.83  |- skos__altLabel mesh__D000944 Antigens, Plasma Cell, PC-1
% 217.66/217.83  |- skos__hiddenLabel mesh__D000944 B-Lymphocyte Leu Antigens
% 217.66/217.83  |- skos__altLabel mesh__D000944 Leu Antigens, B-Lymphocyte
% 217.66/217.83  |- skos__historyNote mesh__D000944 Cell Differentiation %28%1966-1987%29%
% 217.66/217.83  |- skos__hiddenLabel mesh__D000944 Antigens, B-Cell Differentiation
% 217.66/217.83  |- skos__annotation mesh__D000944 DF: B CELL DIFFER ANTIGENS   
% 217.66/217.83  |- mesh__dateEstablished mesh__D000944 1988-01-01
% 217.66/217.83  |- skos__altLabel mesh__D000944 Antigens, Differentiation, B Lymphocyte
% 217.66/217.83  |- mesh__dateCreated mesh__D000944 1987-04-13
% 217.66/217.83  |- skos__prefLabel mesh__D000944 Antigens, Differentiation, B-Lymphocyte
% 217.66/217.83  |- skos__hiddenLabel mesh__D000944 B Lymphocyte Differentiation Antigens
% 217.66/217.83  |- skos__altLabel mesh__D000944 Antigens, Differentiation, B-Cell
% 217.66/217.83  |- mesh__dateRevised mesh__D000944 2005-06-30
% 217.66/217.83  |- skos__broader mesh__D000944smesh__D000943
% 217.66/217.83  |- skos__hiddenLabel mesh__D000944 Antigen, B-Cell Blast-2
% 217.66/217.83  |- skos__hiddenLabel mesh__D000944 Plasma Cell Antigens PC 1
% 217.66/217.83  |- skos__hiddenLabel mesh__D000944 Antigens, B-Lymphocyte Leu
% 217.66/217.83  |- skos__hiddenLabel mesh__D000944 B Cell Differentiation Antigens
% 217.66/217.83  |- skos__altLabel mesh__D000944 Differentiation Antigens, B-Lymphocyte
% 217.66/217.83  |- skos__historyNote mesh__D000944 Antigens, Surface %28%1979-1987%29%
% 217.66/217.83  |- skos__hiddenLabel mesh__D000944 Leu Antigens, B Lymphocyte
% 217.66/217.83  |- skos__hiddenLabel mesh__D000944 Differentiation Antigens, B Cell
% 217.66/217.83  |- mesh__onlineNote mesh__D000944
% 217.66/217.83       use ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE to search ANTIGENS, DIFFERENTIATION B LYMPHOCYTE 1988-89%A%  
% 217.66/217.83  |- skos__scopeNote mesh__D000944
% 217.66/217.83       Membrane antigens associated with maturation stages of B-lymphocytes, often expressed in tumors of B-cell origin.%A%    
% 217.66/217.83  |- mesh__recordAuthorizer mesh__D000944 sjn
% 217.66/217.83  |- mesh__publicMeSHNote mesh__D000944
% 217.66/217.83       90; was ANTIGENS, DIFFERENTIATION, B LYMPHOCYTE 1988-89   
% 217.66/217.83  |- rdf__type mesh__D000944sskos__Concept
% 217.66/217.83  |- mesh__recordOriginator mesh__D000944 SCD
% 217.66/217.83  |- skos__altLabel mesh__D000944 Blast-2 Antigen, B-Cell
% 217.66/217.83  |- skos__altLabel mesh__D000944 B-Cell Differentiation Antigens
% 217.66/217.83  |- skos__hiddenLabel mesh__D000944 Blast 2 Antigen, B Cell
% 217.66/217.83  |- skos__altLabel mesh__D000944 Differentiation Antigens, B-Cell
% 217.66/217.83  |- skos__hiddenLabel mesh__D000944 Antigens, B-Lymphocyte Differentiation
% 217.66/217.83  |- mesh__historyNote mesh__D000944
% 217.66/217.83       90; was ANTIGENS, DIFFERENTIATION, B LYMPHOCYTE 1988-89   
% 217.66/217.83  |- skos__hiddenLabel mesh__D000944 B Cell Blast 2 Antigen
% 217.66/217.83  |- mesh__recordMaintainer mesh__D000944 ssb
% 217.66/217.83  |- mesh__dateCreated mesh__D008129 1985-05-03
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D008129 2005
% 217.66/217.83  |- mesh__recordOriginator mesh__D008129 SH
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D008129 2004
% 217.66/217.83  |- skos__altLabel mesh__D008129 Ryegrass
% 217.66/217.83  |- mesh__publicMeSHNote mesh__D008129 91; was see under GRASSES 1986-90   
% 217.66/217.83  |- skos__broader mesh__D008129smesh__D006109
% 217.66/217.83  |- mesh__dateRevised mesh__D008129 2002-07-03
% 217.66/217.83  |- mesh__recordAuthorizer mesh__D008129 sjn
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D008129 2003
% 217.66/217.83  |- mesh__dateEstablished mesh__D008129 1991-01-01
% 217.66/217.83  |- mesh__historyNote mesh__D008129
% 217.66/217.83       91%28%86%29%; was see under GRASSES 1986-90   
% 217.66/217.83  |- rdf__type mesh__D008129sskos__Concept
% 217.66/217.83  |- skos__prefLabel mesh__D008129 Lolium
% 217.66/217.83  |- mesh__recordMaintainer mesh__D008129 sjn
% 217.66/217.83  |- skos__historyNote mesh__D008129 Rye %28%1966-1985%29%
% 217.66/217.83  |- skos__annotation mesh__D008129
% 217.66/217.83       used as cattle fodder; do not confuse X ref RYE GRASS with rye  %28%SECALE CEREALE%29%%A%  
% 217.66/217.83  |- skos__broader mesh__D008129smesh__D000821
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D008129 2006
% 217.66/217.83  |- skos__historyNote mesh__D008129 Grasses %28%1966-1985%29%
% 217.66/217.83  |- skos__hiddenLabel mesh__D008129 Grass, Rye
% 217.66/217.83  |- skos__scopeNote mesh__D008129
% 217.66/217.83       Common member of the Gramineae family used as cattle fodder. It harbors several fungi and other parasites toxic to livestock and people and produces allergenic compounds, especially in its pollen. The most commonly seen varieties are L. perenne, L. multiflorum, and L. rigidum.%A%    
% 217.66/217.83  |- skos__altLabel mesh__D008129 Rye Grass
% 217.66/217.83  |- mesh__publicMeSHNote mesh__D000146 98   
% 217.66/217.83  |- skos__altLabel mesh__D000146 Carbocyclic Acids
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D000146 1999
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D000146 2006
% 217.66/217.83  |- mesh__recordAuthorizer mesh__D000146 PLS
% 217.66/217.83  |- skos__scopeNote mesh__D000146
% 217.66/217.83       Carboxylic acids that have a homocyclic ring structure in which all the ring atoms are carbon.%A%    
% 217.66/217.83  |- mesh__recordOriginator mesh__D000146 NLM
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D000146 2001
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D000146 1998
% 217.66/217.83  |- mesh__historyNote mesh__D000146 98; use explode 1967-97   
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D000146 2005
% 217.66/217.83  |- rdf__type mesh__D000146sskos__Concept
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D000146 2000
% 217.66/217.83  |- mesh__recordMaintainer mesh__D000146 SJN
% 217.66/217.83  |- mesh__activeMeSHYear mesh__D000146 2004
% 217.66/217.84  |- mesh__dateCreated mesh__D000146 1999-01-01
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D000146 2002
% 217.66/217.84  |- mesh__dateEstablished mesh__D000146 1998-01-01
% 217.66/217.84  |- mesh__dateRevised mesh__D000146 1998-09-09
% 217.66/217.84  |- skos__broader mesh__D000146smesh__D002264
% 217.66/217.84  |- skos__annotation mesh__D000146
% 217.66/217.84       GEN; prefer specifics; used for mapping supplementary chemicals; do not confuse with CARBOXYLIC ACIDS%A%  
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D000146 2003
% 217.66/217.84  |- skos__prefLabel mesh__D000146 Acids, Carbocyclic
% 217.66/217.84  |- skos__related mesh__D052285smesh__D052284
% 217.66/217.84  |- mesh__dateCreated mesh__D052285 2005-06-30
% 217.66/217.84  |- rdf__type mesh__D052285sskos__Concept
% 217.66/217.84  |- mesh__recordOriginator mesh__D052285 ags
% 217.66/217.84  |- mesh__publicMeSHNote mesh__D052285 2006   
% 217.66/217.84  |- skos__scopeNote mesh__D052285
% 217.66/217.84       The capability of producing yolk-filled eggs that hatch within the body, so that the young are born alive, but without placental attachment. This applies to certain species of REPTILES and FISHES.%A%    
% 217.66/217.84  |- mesh__recordAuthorizer mesh__D052285 sjn
% 217.66/217.84  |- mesh__recordMaintainer mesh__D052285 ags
% 217.66/217.84  |- skos__prefLabel mesh__D052285 Ovoviviparity
% 217.66/217.84  |- skos__broader mesh__D052285smesh__D012098
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D052285 2006
% 217.66/217.84  |- skos__altLabel mesh__D052285 Ovoviviparous
% 217.66/217.84  |- mesh__dateEstablished mesh__D052285 2006-01-01
% 217.66/217.84  |- mesh__historyNote mesh__D052285 2006   
% 217.66/217.84  |- skos__altLabel mesh__D046248 Stenosis, Hypertrophic Pyloric
% 217.66/217.84  |- skos__scopeNote mesh__D046248
% 217.66/217.84       Narrowing of the pyloric canal due to HYPERTROPHY of the surrounding circular muscle. It is usually seen in infants or young children.%A%    
% 217.66/217.84  |- mesh__dateEstablished mesh__D046248 2005-01-01
% 217.66/217.84  |- mesh__recordMaintainer mesh__D046248 lkt
% 217.66/217.84  |- mesh__publicMeSHNote mesh__D046248 2005   
% 217.66/217.84  |- mesh__recordOriginator mesh__D046248 lkt
% 217.66/217.84  |- mesh__recordAuthorizer mesh__D046248 sjn
% 217.66/217.84  |- mesh__historyNote mesh__D046248 2005   
% 217.66/217.84  |- skos__historyNote mesh__D046248 Pyloric Stenosis %28%1965-2004%29%
% 217.66/217.84  |- mesh__dateCreated mesh__D046248 2004-07-07
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D046248 2006
% 217.66/217.84  |- skos__prefLabel mesh__D046248 Pyloric Stenosis, Hypertrophic
% 217.66/217.84  |- skos__broader mesh__D046248smesh__D011707
% 217.66/217.84  |- rdf__type mesh__D046248sskos__Concept
% 217.66/217.84  |- skos__altLabel mesh__D046248 Hypertrophic Pyloric Stenosis
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D046248 2005
% 217.66/217.84  |- skos__broader mesh__D018557smesh__D006077
% 217.66/217.84  |- skos__annotation mesh__D018557
% 217.66/217.84       add UNITED STATES %28%NIM%29%; research support by this agency is checked as OTHER GOVT SUP; DF: note short X ref      CATALOG: use NAF entry%A%  
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D018557 2004
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D018557 2005
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D018557 2002
% 217.66/217.84  |- mesh__dateEstablished mesh__D018557 1995-01-01
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D018557 1999
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D018557 2003
% 217.66/217.84  |- mesh__dateRevised mesh__D018557 1997-06-20
% 217.66/217.84  |- rdf__type mesh__D018557sskos__Concept
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D018557 1998
% 217.66/217.84  |- skos__scopeNote mesh__D018557
% 217.66/217.84       An independent Federal agency established in 1958. It conducts research for the solution of problems of flight within and outside the Earth%27%s atmosphere and develops, constructs, tests, and operates aeronautical and space vehicles. %28%From U.S. Government Manual, 1993%29%%A%    
% 217.66/217.84  |- mesh__dateCreated mesh__D018557 1994-06-07
% 217.66/217.84  |- skos__altLabel mesh__D018557
% 217.66/217.84       National Aeronautics and Space Administration
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D018557 2001
% 217.66/217.84  |- mesh__publicMeSHNote mesh__D018557 95   
% 217.66/217.84  |- mesh__recordAuthorizer mesh__D018557 SJN
% 217.66/217.84  |- skos__altLabel mesh__D018557 NASA
% 217.66/217.84  |- mesh__historyNote mesh__D018557 95   
% 217.66/217.84  |- skos__prefLabel mesh__D018557
% 217.66/217.84       United States National Aeronautics and Space Administration
% 217.66/217.84  |- mesh__recordOriginator mesh__D018557 JLS
% 217.66/217.84  |- mesh__recordMaintainer mesh__D018557 PXP
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D018557 2000
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D018557 2006
% 217.66/217.84  |- mesh__recordAuthorizer mesh__D010574 sjn
% 217.66/217.84  |- rdf__type mesh__D010574sskos__Concept
% 217.66/217.84  |- mesh__historyNote mesh__D010574 73%28%72%29%   
% 217.66/217.84  |- mesh__dateEstablished mesh__D010574 1973-01-01
% 217.66/217.84  |- mesh__dateCreated mesh__D010574 1999-01-01
% 217.66/217.84  |- mesh__publicMeSHNote mesh__D010574 73   
% 217.66/217.84  |- mesh__recordOriginator mesh__D010574 NLM
% 217.66/217.84  |- skos__prefLabel mesh__D010574 Pesticide Synergists
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D010574 2005
% 217.66/217.84  |- mesh__dateRevised mesh__D010574 2003-07-09
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D010574 2006
% 217.66/217.84  |- skos__broader mesh__D010574smesh__D010575
% 217.66/217.84  |- skos__scopeNote mesh__D010574
% 217.66/217.84       Chemicals that, while not possessing inherent pesticidal activity, nonetheless promote or enhance the effectiveness of other pesticides when combined.%A%    
% 217.66/217.84  |- skos__hiddenLabel mesh__D010574 Synergists, Pesticide
% 217.66/217.84  |- mesh__recordMaintainer mesh__D010574 ssb
% 217.66/217.84  |- skos__historyNote mesh__D010574 Pesticides %28%1966-1971%29%
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D010574 2004
% 217.66/217.84  |- skos__broader mesh__D004537smesh__D005227
% 217.66/217.84  |- mesh__publicMeSHNote mesh__D004537 75   
% 217.66/217.84  |- skos__historyNote mesh__D004537 Fatty Acids %28%1966-1974%29%
% 217.66/217.84  |- skos__prefLabel mesh__D004537 Eicosanoic Acids
% 217.66/217.84  |- skos__scopeNote mesh__D004537
% 217.66/217.84       20-carbon saturated monocarboxylic acids.     
% 217.66/217.84  |- mesh__dateRevised mesh__D004537 2003-07-09
% 217.66/217.84  |- skos__altLabel mesh__D004537 Arachidic Acids
% 217.66/217.84  |- skos__annotation mesh__D004537 fatty acids   
% 217.66/217.84  |- skos__hiddenLabel mesh__D004537 Acids, Arachidic
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D004537 2004
% 217.66/217.84  |- skos__hiddenLabel mesh__D004537 Acids, Eicosanoic
% 217.66/217.84  |- skos__historyNote mesh__D004537
% 217.66/217.84       Fatty Acids, Nonesterified %28%1968-1974%29%
% 217.66/217.84  |- mesh__recordAuthorizer mesh__D004537 sjn
% 217.66/217.84  |- mesh__recordMaintainer mesh__D004537 ssb
% 217.66/217.84  |- mesh__dateEstablished mesh__D004537 1975-09-01
% 217.66/217.84  |- mesh__dateCreated mesh__D004537 1974-11-11
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D004537 2006
% 217.66/217.84  |- mesh__recordOriginator mesh__D004537 NLM
% 217.66/217.84  |- rdf__type mesh__D004537sskos__Concept
% 217.66/217.84  |- mesh__historyNote mesh__D004537 75   
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D004537 2005
% 217.66/217.84  |- skos__hiddenLabel mesh__D009222 Phenomenon, Myotonic
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D009222 2005
% 217.66/217.84  |- skos__scopeNote mesh__D009222
% 217.66/217.84       Prolonged failure of muscle relaxation after contraction. This may occur after voluntary contractions, muscle percussion, or electrical stimulation of the muscle. Myotonia is a characteristic feature of MYOTONIC DISORDERS.%A%    
% 217.66/217.84  |- skos__prefLabel mesh__D009222 Myotonia
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D009222 2002
% 217.66/217.84  |- skos__hiddenLabel mesh__D009222 Myotonias, Percussion
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D009222 2004
% 217.66/217.84  |- skos__hiddenLabel mesh__D009222 Myotonias
% 217.66/217.84  |- rdf__type mesh__D009222sskos__Concept
% 217.66/217.84  |- mesh__dateRevised mesh__D009222 1999-11-03
% 217.66/217.84  |- mesh__dateCreated mesh__D009222 1999-01-01
% 217.66/217.84  |- skos__hiddenLabel mesh__D009222 Percussion Myotonias
% 217.66/217.84  |- skos__hiddenLabel mesh__D009222 Myotonic Phenomenons
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D009222 2001
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D009222 2003
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D009222 2000
% 217.66/217.84  |- mesh__recordAuthorizer mesh__D009222 sjn
% 217.66/217.84  |- skos__hiddenLabel mesh__D009222 Myotonia, Percussion
% 217.66/217.84  |- mesh__recordMaintainer mesh__D009222 KEV
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D009222 2006
% 217.66/217.84  |- skos__broader mesh__D009222smesh__D020879
% 217.66/217.84  |- mesh__recordOriginator mesh__D009222 NLM
% 217.66/217.84  |- skos__hiddenLabel mesh__D009222 Phenomenons, Myotonic
% 217.66/217.84  |- skos__broader mesh__D003315Q000637smesh__D003315
% 217.66/217.84  |- mesh__preferredCombination mesh__D003315Q000637smesh__D016039
% 217.66/217.84  |- rdf__type mesh__D003315Q000637smesh__CompoundConcept
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D014965 1997
% 217.66/217.84  |- skos__altLabel mesh__D014965 X-Radiation
% 217.66/217.84  |- skos__altLabel mesh__D014965 Radiation, X
% 217.66/217.84  |- skos__broader mesh__D014965smesh__D011839
% 217.66/217.84  |- skos__hiddenLabel mesh__D014965 X Radiations
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D014965 2002
% 217.66/217.84  |- skos__altLabel mesh__D014965 Roentgen Rays
% 217.66/217.84  |- skos__hiddenLabel mesh__D014965 X Rays
% 217.66/217.84  |- skos__hiddenLabel mesh__D014965 Xray
% 217.66/217.84  |- mesh__onlineNote mesh__D014965 search RADIATION 1966-74   
% 217.66/217.84  |- mesh__recordMaintainer mesh__D014965 TGC
% 217.66/217.84  |- skos__hiddenLabel mesh__D014965 Radiations, X
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D014965 2006
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D014965 2001
% 217.66/217.84  |- skos__hiddenLabel mesh__D014965 X-Radiations
% 217.66/217.84  |- mesh__dateCreated mesh__D014965 1999-01-01
% 217.66/217.84  |- skos__hiddenLabel mesh__D014965 X Radiation
% 217.66/217.84  |- mesh__dateRevised mesh__D014965 1996-06-10
% 217.66/217.84  |- skos__annotation mesh__D014965
% 217.66/217.84       almost never IM; /diag use = RADIOGRAPHY %28%general%29% or /radiogr with diseases; /ther use = X-RAY THERAPY or /radiother with diseases %28%see note on X-RAY THERAPY%29%; do not index as IM or NIM coord when using /rad eff: assume all /rad eff is X-RAYS unless otherwise specified %28%as /rad eff + GAMMA RAYS%29%; TN 158: how to index IM or NIM, also Manual 19.8.60, 19.8.61, 19.8.63, 28.11.2; X-ray or x-ray in translations: follow text%A%  
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D014965 2005
% 217.66/217.84  |- mesh__recordAuthorizer mesh__D014965 PLS
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D014965 2000
% 217.66/217.84  |- mesh__historyNote mesh__D014965
% 217.66/217.84       91%28%75%29%; was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1965-75%A%  
% 217.66/217.84  |- skos__hiddenLabel mesh__D014965 X-Ray
% 217.66/217.84  |- skos__hiddenLabel mesh__D014965 Rays, Grenz
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D014965 2004
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D014965 1999
% 217.66/217.84  |- skos__altLabel mesh__D014965 Xrays
% 217.66/217.84  |- rdf__type mesh__D014965sskos__Concept
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D014965 2003
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D014965 1998
% 217.66/217.84  |- skos__prefLabel mesh__D014965 X-Rays
% 217.66/217.84  |- mesh__dateEstablished mesh__D014965 1991-01-01
% 217.66/217.84  |- skos__hiddenLabel mesh__D014965 Rays, Roentgen
% 217.66/217.84  |- mesh__publicMeSHNote mesh__D014965
% 217.66/217.84       91; was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1965-75%A%  
% 217.66/217.84  |- mesh__recordOriginator mesh__D014965 NLM
% 217.66/217.84  |- skos__scopeNote mesh__D014965
% 217.66/217.84       Penetrating electromagnetic radiation emitted when the inner orbital electrons of an atom are excited and release energy - in the same energy range as gamma rays %28%0.010-10 Mev%29%, but of non-nuclear origin, of shorter wavelength than ultraviolet; soft x-rays or Grenz rays are less penetrating and longer in wavelength than hard x-rays.%A%    
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D014167 2005
% 217.66/217.84  |- mesh__dateRevised mesh__D014167 1997-06-20
% 217.66/217.84  |- mesh__recordAuthorizer mesh__D014167 SJN
% 217.66/217.84  |- mesh__publicMeSHNote mesh__D014167 65   
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D014167 2006
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D014167 2003
% 217.66/217.84  |- mesh__dateCreated mesh__D014167 1999-01-01
% 217.66/217.84  |- mesh__dateEstablished mesh__D014167 1965-01-01
% 217.66/217.84  |- skos__scopeNote mesh__D014167
% 217.66/217.84       The unconscious transfer to others %28%including psychotherapists%29% of feelings and attitudes which were originally associated with important figures %28%parents, siblings, etc.%29% in one%27%s early life.%A%    
% 217.66/217.84  |- skos__altLabel mesh__D014167 Transference
% 217.66/217.84  |- skos__hiddenLabel mesh__D014167 Transferences %28%Psychology%29%
% 217.66/217.84  |- skos__prefLabel mesh__D014167 Transference %28%Psychology%29%
% 217.66/217.84  |- skos__broader mesh__D014167smesh__D013811
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D014167 2004
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D014167 1998
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D014167 2000
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D014167 1999
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D014167 2001
% 217.66/217.84  |- mesh__recordMaintainer mesh__D014167 PXP
% 217.66/217.84  |- skos__annotation mesh__D014167
% 217.66/217.84       human only; no qualif; DF: TRANSFERENCE   
% 217.66/217.84  |- mesh__historyNote mesh__D014167 65%28%63%29%   
% 217.66/217.84  |- mesh__recordOriginator mesh__D014167 NLM
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D014167 2002
% 217.66/217.84  |- rdf__type mesh__D014167sskos__Concept
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D008928 2004
% 217.66/217.84  |- skos__annotation mesh__D008928
% 217.66/217.84       A 11 qualif except /cytol; /genet permitted; coord with organ /metab %28%IM%29% but not also organ /ultrastruct for metab studies, coord with organ /ultrastruct %28%IM%29% for morphol studies: TN 126; mitochondria of vasc or smooth musc tissue goes under MITOCHONDRIA, MUSCLE %26% do not coord with MUSCLE, SMOOTH or MUSCLE, SMOOTH, VASCULAR unless particularly discussed %26% then probably only NIM%A%  
% 217.66/217.84  |- skos__broader mesh__D008928smesh__D015388
% 217.66/217.84  |- mesh__dateCreated mesh__D008928 1999-01-01
% 217.66/217.84  |- skos__prefLabel mesh__D008928 Mitochondria
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D008928 2006
% 217.66/217.84  |- skos__hiddenLabel mesh__D008928 Mitochondrial Contractions
% 217.66/217.84  |- mesh__dateRevised mesh__D008928 2003-07-09
% 217.66/217.84  |- mesh__historyNote mesh__D008928
% 217.66/217.84       MITOCHONDRIAL CONTRACTION was heading 1969-96 %28%was see under MITOCHONDRIA 1975, was Prov 1969-74%29%%A%  
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D008928 2005
% 217.66/217.84  |- rdf__type mesh__D008928sskos__Concept
% 217.66/217.84  |- skos__scopeNote mesh__D008928
% 217.66/217.84       Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs %28%RNA, TRANSFER%29%; AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs %28%RNA, MESSENGER%29%. Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. %28%King %26% Stansfield, A Dictionary of Genetics, 4th ed%29%%A%    
% 217.66/217.84  |- mesh__publicMeSHNote mesh__D008928
% 217.66/217.84       MITOCHONDRIAL CONTRACTION was heading 1975-96 %28%see under MITOCHONDRIA 1975%29%%A%  
% 217.66/217.84  |- skos__hiddenLabel mesh__D008928 Contractions, Mitochondrial
% 217.66/217.84  |- skos__altLabel mesh__D008928 Mitochondrion
% 217.66/217.84  |- mesh__recordMaintainer mesh__D008928 nns
% 217.66/217.84  |- mesh__recordAuthorizer mesh__D008928 sjn
% 217.66/217.84  |- skos__hiddenLabel mesh__D008928 Contraction, Mitochondrial
% 217.66/217.84  |- skos__broader mesh__D008928smesh__D013347
% 217.66/217.84  |- mesh__recordOriginator mesh__D008928 NLM
% 217.66/217.84  |- skos__hiddenLabel mesh__D000945 T Lymphocyte Differentiation Antigens
% 217.66/217.84  |- mesh__dateCreated mesh__D000945 1987-03-13
% 217.66/217.84  |- skos__altLabel mesh__D000945 Antigens, Differentiation, T Lymphocyte
% 217.66/217.84  |- skos__broader mesh__D000945smesh__D000943
% 217.66/217.84  |- mesh__dateRevised mesh__D000945 2005-06-30
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D000945 2006
% 217.66/217.84  |- skos__hiddenLabel mesh__D000945 Leu Antigens, T Lymphocyte
% 217.66/217.84  |- skos__altLabel mesh__D000945 Leu Antigens, T-Lymphocyte
% 217.66/217.84  |- skos__prefLabel mesh__D000945 Antigens, Differentiation, T-Lymphocyte
% 217.66/217.84  |- skos__annotation mesh__D000945 DF: T CELL DIFFER ANTIGENS   
% 217.66/217.84  |- skos__hiddenLabel mesh__D000945 Antigens, T-Lymphocyte Leu
% 217.66/217.84  |- mesh__publicMeSHNote mesh__D000945
% 217.66/217.84       90; was ANTIGENS, DIFFERENTIATION, T LYMPHOCYTE 1988-89; T8 ANTIGENS was see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-92%A%  
% 217.66/217.84  |- skos__hiddenLabel mesh__D000945 Differentiation Antigens, T Cell
% 217.66/217.84  |- skos__hiddenLabel mesh__D000945 Differentiation Antigens, T-Lymphocyte
% 217.66/217.84  |- skos__historyNote mesh__D000945 T-Lymphocytes %28%1973-1987%29%
% 217.66/217.84  |- skos__hiddenLabel mesh__D000945 Antigens, L3T4
% 217.66/217.84  |- mesh__recordAuthorizer mesh__D000945 sjn
% 217.66/217.84  |- skos__hiddenLabel mesh__D000945 Antigens, T-Lymphocyte Differentiation
% 217.66/217.84  |- mesh__onlineNote mesh__D000945
% 217.66/217.84       use ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE to search T8 ANTIGENS 1988-92 %26% ANTIGENS, DIFFERENTIATION T LYMPHOCYTE 1988-89%A%  
% 217.66/217.84  |- skos__hiddenLabel mesh__D000945 Antigens, T-Cell Differentiation
% 217.66/217.84  |- skos__altLabel mesh__D000945 T-Lymphocyte Differentiation Antigens
% 217.66/217.84  |- mesh__dateEstablished mesh__D000945 1988-01-01
% 217.66/217.84  |- skos__altLabel mesh__D000945 Differentiation Antigens, T-Cell
% 217.66/217.84  |- skos__altLabel mesh__D000945 T-Cell Differentiation Antigens
% 217.66/217.84  |- skos__hiddenLabel mesh__D000945 Antigens, T6
% 217.66/217.84  |- skos__hiddenLabel mesh__D000945 T Cell Differentiation Antigens
% 217.66/217.84  |- skos__historyNote mesh__D000945 Antigens, Surface %28%1979-1987%29%
% 217.66/217.84  |- rdf__type mesh__D000945sskos__Concept
% 217.66/217.84  |- skos__scopeNote mesh__D000945
% 217.66/217.84       Antigens expressed on the cell membrane of T-lymphocytes during differentiation, activation, and normal and neoplastic transformation. Their phenotypic characterization is important in differential diagnosis and studies of thymic ontogeny and T-cell function.%A%    
% 217.66/217.84  |- mesh__historyNote mesh__D000945
% 217.66/217.84       90; was ANTIGENS, DIFFERENTIATION, T LYMPHOCYTE 1988-89; T8 ANTIGENS was see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-92%A%  
% 217.66/217.84  |- skos__historyNote mesh__D000945 Cell Differentiation %28%1966-1987%29%
% 217.66/217.84  |- skos__historyNote mesh__D000945 Antigens %28%1971-1978%29%
% 217.66/217.84  |- skos__altLabel mesh__D000945 Differentiation Antigens, T Lymphocyte
% 217.66/217.84  |- skos__altLabel mesh__D000945 Antigens, Differentiation, T-Cell
% 217.66/217.84  |- mesh__recordOriginator mesh__D000945 SCD
% 217.66/217.84  |- mesh__recordMaintainer mesh__D000945 ssb
% 217.66/217.84  |- skos__hiddenLabel mesh__D000945 T-Lymphocyte Leu Antigens
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D019650 2000
% 217.66/217.84  |- skos__related mesh__D019650smesh__D001781
% 217.66/217.84  |- skos__hiddenLabel mesh__D019650 Mobilization, Stem Cell
% 217.66/217.84  |- skos__annotation mesh__D019650
% 217.66/217.84       note category; %22%release of stem cells from bone marrow into peripheral blood circ%22% prior to stem cell transpl%A%  
% 217.66/217.84  |- skos__historyNote mesh__D019650
% 217.66/217.84       Hematopoietic Stem Cells %28%1990-1997%29%
% 217.66/217.84  |- mesh__historyNote mesh__D019650 98   
% 217.66/217.84  |- skos__broader mesh__D019650smesh__D001691
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D019650 2006
% 217.66/217.84  |- mesh__recordAuthorizer mesh__D019650 jls
% 217.66/217.84  |- skos__altLabel mesh__D019650 Stem Cell Mobilization
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D019650 2005A
% 217.66/217.84  |- skos__prefLabel mesh__D019650 Hematopoietic Stem Cell Mobilization
% 217.66/217.84  |- rdf__type mesh__D019650sskos__Concept
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D019650 2005
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D019650 2004
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D019650 1999
% 217.66/217.84  |- mesh__recordMaintainer mesh__D019650 jls
% 217.66/217.84  |- mesh__publicMeSHNote mesh__D019650 98   
% 217.66/217.84  |- skos__scopeNote mesh__D019650
% 217.66/217.84       The release of stem cells from the bone marrow into the peripheral blood circulation for the purpose of leukapheresis, prior to stem cell transplantation. Hematopoietic growth factors or chemotherapeutic agents often are used to stimulate the mobilization.%A%    
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D019650 2002
% 217.66/217.84  |- mesh__dateEstablished mesh__D019650 1998-01-01
% 217.66/217.84  |- mesh__recordOriginator mesh__D019650 AGS
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D019650 2003
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D019650 1998
% 217.66/217.84  |- mesh__dateRevised mesh__D019650 2004-07-27
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D019650 2001
% 217.66/217.84  |- mesh__dateCreated mesh__D019650 1997-06-20
% 217.66/217.84  |- skos__related mesh__D019650smesh__D018380
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D033321 2005
% 217.66/217.84  |- mesh__dateCreated mesh__D033321 2002-07-03
% 217.66/217.84  |- skos__historyNote mesh__D033321 Crustacea %28%1966-2002%29%
% 217.66/217.84  |- rdf__type mesh__D033321sskos__Concept
% 217.66/217.84  |- mesh__publicMeSHNote mesh__D033321 2003   
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D033321 2004
% 217.66/217.84  |- skos__prefLabel mesh__D033321 Isopoda
% 217.66/217.84  |- mesh__dateRevised mesh__D033321 2003-07-09
% 217.66/217.84  |- mesh__dateEstablished mesh__D033321 2003-01-01
% 217.66/217.84  |- skos__broader mesh__D033321smesh__D003445
% 217.66/217.84  |- skos__altLabel mesh__D033321 Isopods
% 217.66/217.84  |- mesh__historyNote mesh__D033321 2003   
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D033321 2006
% 217.66/217.84  |- skos__scopeNote mesh__D033321
% 217.66/217.84       One of the largest orders of mostly marine CRUSTACEA, containing over 10,000 species. Like AMPHIPODA, the other large order in the superorder Peracarida, members are shrimp-like in appearance, have sessile compound eyes, and no carapace. But unlike Amphipoda, they possess abdominal pleopods %28%modified as gills%29% and their bodies are dorsoventrally flattened.%A%    
% 217.66/217.84  |- skos__scopeNote mesh__D000147
% 217.66/217.84       A class of acids containing a ring structure in which at least one atom other than CARBON is incorporated.%A%    
% 217.66/217.84  |- mesh__recordOriginator mesh__D000147 NLM
% 217.66/217.84  |- mesh__recordMaintainer mesh__D000147 jls
% 217.66/217.84  |- mesh__dateRevised mesh__D000147 2004-07-19
% 217.66/217.84  |- mesh__historyNote mesh__D000147 98; use explode 1967-97   
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D000147 2006
% 217.66/217.84  |- rdf__type mesh__D000147sskos__Concept
% 217.66/217.84  |- skos__prefLabel mesh__D000147 Acids, Heterocyclic
% 217.66/217.84  |- skos__altLabel mesh__D000147 Heterocyclic Acids
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D000147 2005
% 217.66/217.84  |- mesh__recordAuthorizer mesh__D000147 sjn
% 217.66/217.84  |- mesh__dateEstablished mesh__D000147 1998-01-01
% 217.66/217.84  |- mesh__dateCreated mesh__D000147 1999-01-01
% 217.66/217.84  |- skos__annotation mesh__D000147
% 217.66/217.84       GEN; prefer specifics; used for mapping supplementary chemicals%A%  
% 217.66/217.84  |- mesh__publicMeSHNote mesh__D000147 98   
% 217.66/217.84  |- skos__broader mesh__D000147smesh__D006571
% 217.66/217.84  |- mesh__dateRevised mesh__D005630 2004-07-07
% 217.66/217.84  |- mesh__historyNote mesh__D005630
% 217.66/217.84       91%28%75%29%; was see under POLYSACCHARIDES 1975-90   
% 217.66/217.84  |- skos__historyNote mesh__D005630 Polysaccharides %28%1973-1974%29%
% 217.66/217.84  |- mesh__dateEstablished mesh__D005630 1991-01-01
% 217.66/217.84  |- rdf__type mesh__D005630sskos__Concept
% 217.66/217.84  |- skos__scopeNote mesh__D005630
% 217.66/217.84       Polysaccharides composed of D-fructose units.     
% 217.66/217.84  |- skos__historyNote mesh__D005630 Fructose %28%1973-1974%29%
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D005630 2006
% 217.66/217.84  |- mesh__recordMaintainer mesh__D005630 ssb
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D005630 2005
% 217.66/217.84  |- mesh__publicMeSHNote mesh__D005630
% 217.66/217.84       91; was see under POLYSACCHARIDES 1975-90   
% 217.66/217.84  |- mesh__dateCreated mesh__D005630 1974-11-19
% 217.66/217.84  |- mesh__recordAuthorizer mesh__D005630 sjn
% 217.66/217.84  |- skos__broader mesh__D005630smesh__D011134
% 217.66/217.84  |- mesh__recordOriginator mesh__D005630 NLM
% 217.66/217.84  |- skos__altLabel mesh__D005630 Levans
% 217.66/217.84  |- skos__annotation mesh__D005630 polysaccharides   
% 217.66/217.84  |- skos__prefLabel mesh__D005630 Fructans
% 217.66/217.84  |- mesh__dateEstablished mesh__D052286 2006-01-01
% 217.66/217.84  |- skos__hiddenLabel mesh__D052286 Nonmammalian Viviparity
% 217.66/217.84  |- mesh__historyNote mesh__D052286 2006   
% 217.66/217.84  |- mesh__dateCreated mesh__D052286 2005-06-30
% 217.66/217.84  |- skos__broader mesh__D052286smesh__D012098
% 217.66/217.84  |- mesh__recordOriginator mesh__D052286 ags
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D052286 2006
% 217.66/217.84  |- mesh__recordAuthorizer mesh__D052286 sjn
% 217.66/217.84  |- skos__prefLabel mesh__D052286 Viviparity, Nonmammalian
% 217.66/217.84  |- skos__related mesh__D052286smesh__D008098
% 217.66/217.84  |- skos__scopeNote mesh__D052286
% 217.66/217.84       The capability of bearing live young %28%rather than eggs%29% in nonmammalian species. Some species of REPTILES and FISHES exhibit this.%A%    
% 217.66/217.84  |- rdf__type mesh__D052286sskos__Concept
% 217.66/217.84  |- mesh__publicMeSHNote mesh__D052286 2006   
% 217.66/217.84  |- mesh__recordMaintainer mesh__D052286 ags
% 217.66/217.84  |- mesh__historyNote mesh__D046249 2005   
% 217.66/217.84  |- skos__altLabel mesh__D046249 Transfer RNA Acylation
% 217.66/217.84  |- skos__broader mesh__D046249smesh__D049148
% 217.66/217.84  |- skos__related mesh__D046249smesh__D000604
% 217.66/217.84  |- skos__altLabel mesh__D046249 tRNA Charging
% 217.66/217.84  |- mesh__recordOriginator mesh__D046249 nns
% 217.66/217.84  |- skos__broader mesh__D046249smesh__D014176
% 217.66/217.84  |- skos__hiddenLabel mesh__D046249 tRNA Chargings
% 217.66/217.84  |- mesh__dateCreated mesh__D046249 2004-07-07
% 217.66/217.84  |- skos__hiddenLabel mesh__D046249 Aminoacylations, tRNA
% 217.66/217.84  |- mesh__publicMeSHNote mesh__D046249 2005   
% 217.66/217.84  |- skos__hiddenLabel mesh__D046249 Transfer RNA Chargings
% 217.66/217.84  |- skos__hiddenLabel mesh__D046249 Amino Acylation, tRNA
% 217.66/217.84  |- skos__hiddenLabel mesh__D046249 tRNA Acylations
% 217.66/217.84  |- skos__hiddenLabel mesh__D046249 Acylations, Transfer RNA
% 217.66/217.84  |- skos__hiddenLabel mesh__D046249 Acylation, Transfer RNA
% 217.66/217.84  |- skos__altLabel mesh__D046249 tRNA Amino Acylation
% 217.66/217.84  |- skos__prefLabel mesh__D046249 Transfer RNA Aminoacylation
% 217.66/217.84  |- skos__hiddenLabel mesh__D046249 tRNA Aminoacylations
% 217.66/217.84  |- mesh__dateEstablished mesh__D046249 2005-01-01
% 217.66/217.84  |- skos__altLabel mesh__D046249 Aminoacylation, Transfer RNA
% 217.66/217.84  |- skos__hiddenLabel mesh__D046249 Aminoacylation, tRNA
% 217.66/217.84  |- skos__scopeNote mesh__D046249
% 217.66/217.84       The conversion of uncharged TRANSFER RNA  to AMINO ACYL TRNA.%A%    
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D046249 2005
% 217.66/217.84  |- skos__altLabel mesh__D046249 tRNA Acylation
% 217.66/217.84  |- skos__hiddenLabel mesh__D046249 Acylations, tRNA
% 217.66/217.84  |- skos__altLabel mesh__D046249 Transfer RNA Amino Acylation
% 217.66/217.84  |- skos__hiddenLabel mesh__D046249 Transfer RNA Acylations
% 217.66/217.84  |- mesh__recordMaintainer mesh__D046249 nns
% 217.66/217.84  |- skos__hiddenLabel mesh__D046249 RNA Charging, Transfer
% 217.66/217.84  |- skos__altLabel mesh__D046249 tRNA Aminoacylation
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D046249 2006
% 217.66/217.84  |- skos__altLabel mesh__D046249 Transfer RNA Charging
% 217.66/217.84  |- rdf__type mesh__D046249sskos__Concept
% 217.66/217.84  |- skos__hiddenLabel mesh__D046249 Transfer RNA Aminoacylations
% 217.66/217.84  |- skos__hiddenLabel mesh__D046249 Aminoacylations, Transfer RNA
% 217.66/217.84  |- skos__hiddenLabel mesh__D046249 RNA Aminoacylations, Transfer
% 217.66/217.84  |- mesh__recordAuthorizer mesh__D046249 sjn
% 217.66/217.84  |- skos__hiddenLabel mesh__D046249 Acylation, tRNA
% 217.66/217.84  |- skos__scopeNote mesh__D010575
% 217.66/217.84       Chemicals used to destroy pests of any sort. The concept includes fungicides %28%FUNGICIDES, INDUSTRIAL%29%; INSECTICIDES; RODENTICIDES; etc.%A%    
% 217.66/217.84  |- mesh__dateCreated mesh__D010575 1999-01-01
% 217.66/217.84  |- mesh__recordOriginator mesh__D010575 NLM
% 217.66/217.84  |- skos__prefLabel mesh__D010575 Pesticides
% 217.66/217.84  |- skos__annotation mesh__D010575
% 217.66/217.84       very general: prefer specifics or specific types   
% 217.66/217.84  |- skos__broader mesh__D010575smesh__D020313
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D010575 2005
% 217.66/217.84  |- mesh__dateRevised mesh__D010575 2003-07-09
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D010575 2006
% 217.66/217.84  |- mesh__recordMaintainer mesh__D010575 ssb
% 217.66/217.84  |- mesh__recordAuthorizer mesh__D010575 sjn
% 217.66/217.84  |- rdf__type mesh__D010575sskos__Concept
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D010575 2004
% 217.66/217.84  |- skos__broader mesh__D010575smesh__D004786
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D004538 2000
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D004538 2003
% 217.66/217.84  |- skos__hiddenLabel mesh__D004538 Imagery, Eidetic
% 217.66/217.84  |- mesh__recordOriginator mesh__D004538 NLM
% 217.66/217.84  |- skos__altLabel mesh__D004538 Memory, Photographic
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D004538 1999
% 217.66/217.84  |- skos__hiddenLabel mesh__D004538 Photographic Memories
% 217.66/217.84  |- skos__hiddenLabel mesh__D004538 Memories, Photographic
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D004538 2006
% 217.66/217.84  |- mesh__activeMeSHYear mesh__D004538 1998
% 217.66/217.84  |- rdf__type mesh__D004538sskos__Concept
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D004538 2002
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D004538 2005
% 217.66/217.85  |- skos__scopeNote mesh__D004538
% 217.66/217.85       A visual image which is recalled in accurate detail. It is a sort of projection of an image on a mental screen.%A%    
% 217.66/217.85  |- skos__prefLabel mesh__D004538 Eidetic Imagery
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D004538 1995
% 217.66/217.85  |- skos__broader mesh__D004538smesh__D010465
% 217.66/217.85  |- mesh__dateCreated mesh__D004538 1999-01-01
% 217.66/217.85  |- skos__annotation mesh__D004538 a form of perception   
% 217.66/217.85  |- skos__hiddenLabel mesh__D004538 Imageries, Eidetic
% 217.66/217.85  |- mesh__onlineNote mesh__D004538
% 217.66/217.85       use EIDETIC IMAGERY to search PHOTOGRAPHIC MEMORY 1969-78%A%  
% 217.66/217.85  |- skos__hiddenLabel mesh__D004538 Eidetic Imageries
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D004538 1997
% 217.66/217.85  |- mesh__historyNote mesh__D004538
% 217.66/217.85       PHOTOGRAPHIC MEMORY was see under EIDETIC IMAGERY 1969-78%A%  
% 217.66/217.85  |- skos__altLabel mesh__D004538 Photographic Memory
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D004538 2001
% 217.66/217.85  |- mesh__recordMaintainer mesh__D004538 TGC
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D004538 2004
% 217.66/217.85  |- mesh__recordAuthorizer mesh__D004538 PLS
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D004538 1996
% 217.66/217.85  |- mesh__dateRevised mesh__D004538 1994-04-21
% 217.66/217.85  |- skos__broader mesh__D015260smesh__D008666
% 217.66/217.85  |- skos__hiddenLabel mesh__D015260 Endopeptidase 24.11, Neutral
% 217.66/217.85  |- skos__broader mesh__D015260smesh__D014408
% 217.66/217.85  |- skos__altLabel mesh__D015260 Enkephalinase-24.11
% 217.66/217.85  |- skos__altLabel mesh__D015260 CD10 Antigens
% 217.66/217.85  |- skos__hiddenLabel mesh__D015260 YGG Forming Enzyme
% 217.66/217.85  |- skos__hiddenLabel mesh__D015260 Antigen, CD10
% 217.66/217.85  |- skos__altLabel mesh__D015260 Endopeptidase-24.11
% 217.66/217.85  |- skos__hiddenLabel mesh__D015260 Metalloendopeptidase, Thermolysin-Like
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D015260 2006
% 217.66/217.85  |- skos__altLabel mesh__D015260 Atriopeptidase
% 217.66/217.85  |- skos__altLabel mesh__D015260 Enkephalin Dipeptidyl Carboxypeptidase
% 217.66/217.85  |- skos__hiddenLabel mesh__D015260 Neutral Proteinase, Kidney-Brush-Border
% 217.66/217.85  |- skos__altLabel mesh__D015260 Thermolysin-Like Metalloendopeptidase
% 217.66/217.85  |- skos__hiddenLabel mesh__D015260 Thermolysin Like Metalloendopeptidase
% 217.66/217.85  |- mesh__recordMaintainer mesh__D015260 ssb
% 217.66/217.85  |- skos__altLabel mesh__D015260
% 217.66/217.85       Antigens, Leukemia, Common Acute Lymphoblastic
% 217.66/217.85  |- skos__hiddenLabel mesh__D015260 Kidney Brush Border Neutral Proteinase
% 217.66/217.85  |- skos__altLabel mesh__D015260 Neutral Endopeptidase 24.11
% 217.66/217.85  |- skos__altLabel mesh__D015260 Membrane Metallo-Endopeptidase
% 217.66/217.85  |- mesh__recordOriginator mesh__D015260 RLS
% 217.66/217.85  |- skos__hiddenLabel mesh__D015260 Membrane Metallo Endopeptidase
% 217.66/217.85  |- skos__broader mesh__D015260smesh__D015703
% 217.66/217.85  |- mesh__dateEstablished mesh__D015260 1989-01-01
% 217.66/217.85  |- skos__hiddenLabel mesh__D015260 Carboxypeptidase, Enkephalin Dipeptidyl
% 217.66/217.85  |- skos__hiddenLabel mesh__D015260 Dipeptidyl Carboxypeptidase, Enkephalin
% 217.66/217.85  |- skos__hiddenLabel mesh__D015260 Metallo-Endopeptidase, Membrane
% 217.66/217.85  |- skos__altLabel mesh__D015260 CD10 Antigen
% 217.66/217.85  |- skos__scopeNote mesh__D015260
% 217.66/217.85       Enzyme that is a major constituent of kidney brush-border membranes and is also present to a lesser degree in the brain and other tissues. It preferentially catalyzes cleavage at the amino group of hydrophobic residues of the B-chain of insulin as well as opioid peptides and other biologically active peptides. The enzyme is inhibited primarily by EDTA, phosphoramidon, and thiorphan and is reactivated by zinc. Neprilysin is identical to common acute lymphoblastic leukemia antigen %28%CALLA Antigen%29%, an important marker in the diagnosis of human acute lymphocytic leukemia. There is no relationship with CALLA PLANT.%A%    
% 217.66/217.85  |- mesh__recordAuthorizer mesh__D015260 sjn
% 217.66/217.85  |- skos__related mesh__D015260smesh__D015453
% 217.66/217.85  |- skos__hiddenLabel mesh__D015260 Enzyme, YGG-Forming
% 217.66/217.85  |- skos__hiddenLabel mesh__D015260 Endopeptidase 24.11
% 217.66/217.85  |- mesh__publicMeSHNote mesh__D015260
% 217.66/217.85       97; was MEMBRANE METALLO-ENDOPEPTIDASE 1989-96; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGENS was indexed under ANTIGENS, NEOPLASM %26% ANTIGENS, DIFFERENTIATION 1983-92; for CALLA ANTIGEN see CALLA 1993-2002%A%  
% 217.66/217.85  |- mesh__onlineNote mesh__D015260
% 217.66/217.85       use NEPRILYSIN %28%NM%29% to search COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGENS 1983-92%A%  
% 217.66/217.85  |- skos__hiddenLabel mesh__D015260 Enkephalinase 24.11
% 217.66/217.85  |- skos__altLabel mesh__D015260 Enkephalinase
% 217.66/217.85  |- skos__altLabel mesh__D015260 Neutral Endopeptidase
% 217.66/217.85  |- skos__altLabel mesh__D015260 Kidney-Brush-Border Neutral Proteinase
% 217.66/217.85  |- skos__altLabel mesh__D015260 YGG-Forming Enzyme
% 217.66/217.85  |- mesh__dateRevised mesh__D015260 2005-06-30
% 217.66/217.85  |- skos__hiddenLabel mesh__D015260 Endopeptidase, Neutral
% 217.66/217.85  |- skos__prefLabel mesh__D015260 Neprilysin
% 217.66/217.85  |- rdf__type mesh__D015260sskos__Concept
% 217.66/217.85  |- skos__altLabel mesh__D015260 CALLA Antigen
% 217.66/217.85  |- mesh__historyNote mesh__D015260
% 217.66/217.85       97; was MEMBRANE METALLO-ENDOPEPTIDASE 1989-96; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGENS was COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGENS %28%NM%29% 1983-92%A%  
% 217.66/217.85  |- skos__altLabel mesh__D015260 Antigens, CD10
% 217.66/217.85  |- skos__broader mesh__D015260smesh__D000951
% 217.66/217.85  |- skos__historyNote mesh__D015260
% 217.66/217.85       Peptide Peptidohydrolases %28%1966-1987%29%
% 217.66/217.85  |- skos__altLabel mesh__D015260
% 217.66/217.85       Common Acute Lymphoblastic Leukemia Antigens
% 217.66/217.85  |- skos__historyNote mesh__D015260 Metalloproteinases %28%1987-1988%29%
% 217.66/217.85  |- mesh__dateCreated mesh__D015260 1988-05-18
% 217.66/217.85  |- skos__annotation mesh__D009223
% 217.66/217.85       do not confuse with MUSCULAR DYSTROPHIES   
% 217.66/217.85  |- skos__hiddenLabel mesh__D009223 Dystrophies, Myotonic
% 217.66/217.85  |- mesh__recordOriginator mesh__D009223 NLM
% 217.66/217.85  |- skos__altLabel mesh__D009223 Steinert%27%s Disease
% 217.66/217.85  |- skos__altLabel mesh__D009223 Dystrophia Myotonica
% 217.66/217.85  |- skos__broader mesh__D009223smesh__D009136
% 217.66/217.85  |- rdf__type mesh__D009223sskos__Concept
% 217.66/217.85  |- mesh__dateCreated mesh__D009223 1999-11-08
% 217.66/217.85  |- skos__hiddenLabel mesh__D009223 Dystrophy, Myotonic
% 217.66/217.85  |- skos__prefLabel mesh__D009223 Myotonic Dystrophy
% 217.66/217.85  |- skos__altLabel mesh__D009223 Myotonia Atrophica
% 217.66/217.85  |- mesh__dateRevised mesh__D009223 2004-07-07
% 217.66/217.85  |- mesh__publicMeSHNote mesh__D009223
% 217.66/217.85       2000; see MYOTONIA ATROPHICA 1966-1999; for MYOTONIC DYSTROPHY see MYOTONIC ATROPHICA 1993-1999%A%  
% 217.66/217.85  |- skos__scopeNote mesh__D009223
% 217.66/217.85       An autosomal dominant neuromuscular disorder which usually presents in early adulthood, characterized by progressive muscular atrophy %28%most frequently involving the hands, forearms, and face%29%, myotonia, frontal baldness, lenticular opacities, and testicular atrophy. Cardiac conduction abnormalities, diaphragmatic weakness, and mild mental retardation may also occur. Congenital myotonic dystrophy is a severe form of this disorder, characterized by neonatal MUSCLE HYPOTONIA, feeding difficulties, respiratory muscle weakness, and an increased incidence of MENTAL RETARDATION. %28%From Adams et al., Principles of Neurology, 6th ed, pp1423-5; Joynt, Clinical Neurology, 1997, Ch16, pp16-7%29%%A%    
% 217.66/217.85  |- skos__related mesh__D009223smesh__D019680
% 217.66/217.85  |- skos__hiddenLabel mesh__D009223 Dystrophy, Congenital Myotonic
% 217.66/217.85  |- skos__altLabel mesh__D009223 Congenital Myotonic Dystrophy
% 217.66/217.85  |- skos__hiddenLabel mesh__D009223 Myotonic Dystrophies, Congenital
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D009223 2006
% 217.66/217.85  |- skos__broader mesh__D009223smesh__D020967
% 217.66/217.85  |- skos__hiddenLabel mesh__D009223 Myotonic Dystrophies
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D009223 2005
% 217.66/217.85  |- skos__hiddenLabel mesh__D009223 Dystrophies, Congenital Myotonic
% 217.66/217.85  |- mesh__historyNote mesh__D009223 2000%28%1966%29%   
% 217.66/217.85  |- skos__altLabel mesh__D009223 Steinert Disease
% 217.66/217.85  |- skos__altLabel mesh__D009223 Myotonia Dystrophica
% 217.66/217.85  |- mesh__recordAuthorizer mesh__D009223 sjn
% 217.66/217.85  |- skos__broader mesh__D009223smesh__D020271
% 217.66/217.85  |- mesh__recordMaintainer mesh__D009223 lkt
% 217.66/217.85  |- skos__hiddenLabel mesh__D009223 Congenital Myotonic Dystrophies
% 217.66/217.85  |- rdf__type mesh__D001240sskos__Concept
% 217.66/217.85  |- skos__historyNote mesh__D001240 Motivation %28%1966-1974%29%
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D001240 2000
% 217.66/217.85  |- skos__prefLabel mesh__D001240 Aspirations %28%Psychology%29%
% 217.66/217.85  |- mesh__dateEstablished mesh__D001240 1975-09-01
% 217.66/217.85  |- mesh__dateRevised mesh__D001240 1993-06-04
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D001240 2001
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D001240 1996
% 217.66/217.85  |- mesh__recordAuthorizer mesh__D001240 PLS
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D001240 1998
% 217.66/217.85  |- mesh__dateCreated mesh__D001240 1974-11-11
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D001240 2003
% 217.66/217.85  |- skos__altLabel mesh__D001240 Aspiration %28%Psychology%29%
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D001240 2005
% 217.66/217.85  |- mesh__recordOriginator mesh__D001240 NLM
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D001240 1997
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D001240 1994
% 217.66/217.85  |- skos__annotation mesh__D001240 no qualif; DF: ASPIRATIONS   
% 217.66/217.85  |- skos__altLabel mesh__D001240 Aspirations
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D001240 1999
% 217.66/217.85  |- skos__scopeNote mesh__D001240
% 217.66/217.85       Strong desires to accomplish something. This usually pertains to greater values or high ideals.%A%    
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D001240 2004
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D001240 2002
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D001240 1995
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D001240 2006
% 217.66/217.85  |- mesh__historyNote mesh__D001240 75   
% 217.66/217.85  |- mesh__publicMeSHNote mesh__D001240 75   
% 217.66/217.85  |- mesh__recordMaintainer mesh__D001240 JLS
% 217.66/217.85  |- skos__broader mesh__D001240smesh__D009042
% 217.66/217.85  |- skos__broader mesh__D001240smesh__D011588
% 217.66/217.85  |- mesh__recordOriginator mesh__D014966 NLM
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D014966 2006
% 217.66/217.85  |- mesh__recordAuthorizer mesh__D014966 sjn
% 217.66/217.85  |- mesh__dateCreated mesh__D014966 1999-01-01
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D014966 2005
% 217.66/217.85  |- skos__broader mesh__D014966smesh__D006575
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D014966 2004
% 217.66/217.85  |- rdf__type mesh__D014966sskos__Concept
% 217.66/217.85  |- mesh__recordMaintainer mesh__D014966 ssb
% 217.66/217.85  |- skos__prefLabel mesh__D014966 Xanthenes
% 217.66/217.85  |- skos__annotation mesh__D014966 do not confuse with XANTHINES   
% 217.66/217.85  |- mesh__dateRevised mesh__D014966 2003-07-09
% 217.66/217.85  |- skos__scopeNote mesh__D014966
% 217.66/217.85       Compounds with three aromatic rings in linear arrangement with an OXYGEN in the center ring.%A%    
% 217.66/217.85  |- skos__hiddenLabel mesh__D014168 2-Transferrin, beta
% 217.66/217.85  |- skos__hiddenLabel mesh__D014168 In Transferrin
% 217.66/217.85  |- skos__annotation mesh__D014168 a beta-globulin   
% 217.66/217.85  |- skos__hiddenLabel mesh__D014168 tau Transferrin
% 217.66/217.85  |- mesh__recordOriginator mesh__D014168 NLM
% 217.66/217.85  |- skos__related mesh__D014168smesh__D011990
% 217.66/217.85  |- skos__broader mesh__D014168smesh__D033862
% 217.66/217.85  |- mesh__recordAuthorizer mesh__D014168 sjn
% 217.66/217.85  |- skos__hiddenLabel mesh__D014168 C, Tf
% 217.66/217.85  |- mesh__dateRevised mesh__D014168 2002-07-02
% 217.66/217.85  |- skos__prefLabel mesh__D014168 Transferrin
% 217.66/217.85  |- skos__altLabel mesh__D014168 Tf C
% 217.66/217.85  |- skos__altLabel mesh__D014168 Siderophilin
% 217.66/217.85  |- rdf__type mesh__D014168sskos__Concept
% 217.66/217.85  |- skos__hiddenLabel mesh__D014168 beta 2 Transferrin
% 217.66/217.85  |- mesh__recordMaintainer mesh__D014168 KEV
% 217.66/217.85  |- skos__hiddenLabel mesh__D014168 B, Transferrin
% 217.66/217.85  |- skos__broader mesh__D014168smesh__D001609
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D014168 2005
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D014168 2006
% 217.66/217.85  |- mesh__dateCreated mesh__D014168 1999-01-01
% 217.66/217.85  |- skos__hiddenLabel mesh__D014168 Transferrins, Monoferric
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D014168 2003
% 217.66/217.85  |- skos__broader mesh__D014168smesh__D000209
% 217.66/217.85  |- skos__scopeNote mesh__D014168
% 217.66/217.85       Serum beta-globulin that binds and transports iron. %28%From Dorland, 28th ed%29%%A%    
% 217.66/217.85  |- skos__hiddenLabel mesh__D014168 C, Transferrin
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D014168 2004
% 217.66/217.85  |- mesh__recordOriginator mesh__D008929 VDK
% 217.66/217.85  |- mesh__recordAuthorizer mesh__D008929 sjn
% 217.66/217.85  |- skos__annotation mesh__D008929
% 217.66/217.85       A 11 qualif except /cytol; /genet permitted   
% 217.66/217.85  |- mesh__recordMaintainer mesh__D008929 nns
% 217.66/217.85  |- skos__historyNote mesh__D008929 Mitochondria %28%1966-1977%29%
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D008929 2006
% 217.66/217.85  |- skos__altLabel mesh__D008929 Myocardial Mitochondria
% 217.66/217.85  |- skos__altLabel mesh__D008929 Mitochondrion, Heart
% 217.66/217.85  |- skos__scopeNote mesh__D008929 The mitochondria of the myocardium.     
% 217.66/217.85  |- skos__broader mesh__D008929smesh__D008931
% 217.66/217.85  |- skos__historyNote mesh__D008929 Heart %28%1966-1977%29%
% 217.66/217.85  |- mesh__dateRevised mesh__D008929 2003-07-09
% 217.66/217.85  |- mesh__dateCreated mesh__D008929 1977-04-27
% 217.66/217.85  |- rdf__type mesh__D008929sskos__Concept
% 217.66/217.85  |- skos__historyNote mesh__D008929 Mitochondria, Muscle %28%1968-1977%29%
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D008929 2005
% 217.66/217.85  |- skos__hiddenLabel mesh__D008929 Heart Mitochondrion
% 217.66/217.85  |- skos__hiddenLabel mesh__D008929 Mitochondria, Myocardial
% 217.66/217.85  |- mesh__historyNote mesh__D008929 78   
% 217.66/217.85  |- mesh__publicMeSHNote mesh__D008929 78   
% 217.66/217.85  |- skos__altLabel mesh__D008929 Heart Mitochondria
% 217.66/217.85  |- skos__historyNote mesh__D008929 Myocardium %28%1966-1977%29%
% 217.66/217.85  |- mesh__dateEstablished mesh__D008929 1978-01-01
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D008929 2004
% 217.66/217.85  |- skos__prefLabel mesh__D008929 Mitochondria, Heart
% 217.66/217.85  |- skos__scopeNote mesh__D000946
% 217.66/217.85       Substances of fungal origin that have antigenic activity.%A%    
% 217.66/217.85  |- mesh__dateEstablished mesh__D000946 1973-01-01
% 217.66/217.85  |- skos__altLabel mesh__D000946 Fungal Antigens
% 217.66/217.85  |- mesh__dateCreated mesh__D000946 1999-01-01
% 217.66/217.85  |- mesh__recordMaintainer mesh__D000946 ssb
% 217.66/217.85  |- mesh__dateRevised mesh__D000946 2005-06-30
% 217.66/217.85  |- rdf__type mesh__D000946sskos__Concept
% 217.66/217.85  |- mesh__recordOriginator mesh__D000946 NLM
% 217.66/217.85  |- skos__historyNote mesh__D000946 Antigens %28%1966-1972%29%
% 217.66/217.85  |- mesh__historyNote mesh__D000946 73   
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D000946 2006
% 217.66/217.85  |- mesh__publicMeSHNote mesh__D000946 73   
% 217.66/217.85  |- skos__prefLabel mesh__D000946 Antigens, Fungal
% 217.66/217.85  |- mesh__recordAuthorizer mesh__D000946 sjn
% 217.66/217.85  |- skos__broader mesh__D000946smesh__D000941
% 217.66/217.85  |- skos__annotation mesh__D000946
% 217.66/217.85       coord IM with specific fungus /immunol %28%IM%29%   
% 217.66/217.85  |- mesh__dateCreated mesh__D019651 1997-06-20
% 217.66/217.85  |- skos__related mesh__D019651smesh__D013518
% 217.66/217.85  |- mesh__publicMeSHNote mesh__D019651 98   
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D019651 2000
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D019651 2005
% 217.66/217.85  |- skos__altLabel mesh__D019651 Reconstructive Surgical Procedure
% 217.66/217.85  |- mesh__historyNote mesh__D019651 98   
% 217.66/217.85  |- skos__altLabel mesh__D019651 Procedure, Reconstructive Surgical
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D019651 2006
% 217.66/217.85  |- skos__annotation mesh__D019651
% 217.66/217.85       not for -plasty in internal surgery: Manual 26.18+; do not confuse with SURGERY, PLASTIC, the specialty%A%  
% 217.66/217.85  |- mesh__recordMaintainer mesh__D019651 ndw
% 217.66/217.85  |- skos__prefLabel mesh__D019651 Reconstructive Surgical Procedures
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D019651 2001
% 217.66/217.85  |- rdf__type mesh__D019651sskos__Concept
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D019651 2003
% 217.66/217.85  |- mesh__recordOriginator mesh__D019651 PXP
% 217.66/217.85  |- skos__broader mesh__D019651smesh__D013514
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D019651 2004
% 217.66/217.85  |- skos__historyNote mesh__D019651 Surgery, Plastic %28%1966-1997%29%
% 217.66/217.85  |- skos__altLabel mesh__D019651
% 217.66/217.85       Reconstructive Surgical Procedures, Cosmetic
% 217.66/217.85  |- mesh__dateRevised mesh__D019651 1999-11-03
% 217.66/217.85  |- mesh__recordAuthorizer mesh__D019651 sjn
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D019651 2002
% 217.66/217.85  |- skos__altLabel mesh__D019651 Surgical Procedures, Reconstructive
% 217.66/217.85  |- skos__altLabel mesh__D019651
% 217.66/217.85       Reconstructive Surgical Procedures, Esthetic
% 217.66/217.85  |- skos__altLabel mesh__D019651 Procedures, Reconstructive Surgical
% 217.66/217.85  |- skos__altLabel mesh__D019651 Surgical Procedure, Reconstructive
% 217.66/217.85  |- mesh__dateEstablished mesh__D019651 1998-01-01
% 217.66/217.85  |- skos__scopeNote mesh__D019651
% 217.66/217.85       Procedures used to reconstruct, restore, or improve defective, damaged, or missing structures.%A%    
% 217.66/217.85  |- mesh__recordAuthorizer mesh__D000148 SJN
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D000148 2005
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D000148 1999
% 217.66/217.85  |- skos__broader mesh__D000148smesh__D000143
% 217.66/217.85  |- mesh__publicMeSHNote mesh__D000148 98   
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D000148 2006
% 217.66/217.85  |- mesh__dateCreated mesh__D000148 1999-01-01
% 217.66/217.85  |- rdf__type mesh__D000148sskos__Concept
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D000148 2000
% 217.66/217.85  |- skos__altLabel mesh__D000148 Noncarboxylic Acids
% 217.66/217.85  |- mesh__recordOriginator mesh__D000148 NLM
% 217.66/217.85  |- mesh__historyNote mesh__D000148 98; use explode 1968-97   
% 217.66/217.85  |- skos__scopeNote mesh__D000148
% 217.66/217.85       Inorganic acids with a non metal, other than carbon, attached to hydrogen, or an acid radical containing no carbon.%A%    
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D000148 2001
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D000148 2003
% 217.66/217.85  |- mesh__dateRevised mesh__D000148 1997-06-20
% 217.66/217.85  |- mesh__recordMaintainer mesh__D000148 ADP
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D000148 2002
% 217.66/217.85  |- skos__annotation mesh__D000148
% 217.66/217.85       GEN; prefer specifics; used for mapping supplementary chemicals%A%  
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D000148 2004
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D000148 1998
% 217.66/217.85  |- skos__prefLabel mesh__D000148 Acids, Noncarboxylic
% 217.66/217.85  |- mesh__dateEstablished mesh__D000148 1998-01-01
% 217.66/217.85  |- mesh__recordAuthorizer mesh__D005631 sjn
% 217.66/217.85  |- mesh__dateEstablished mesh__D005631 1991-01-01
% 217.66/217.85  |- rdf__type mesh__D005631sskos__Concept
% 217.66/217.85  |- skos__historyNote mesh__D005631
% 217.66/217.85       Phosphotransferases, ATP %28%1974-1978%29%
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D005631 2004
% 217.66/217.85  |- mesh__dateRevised mesh__D005631 2003-07-09
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D005631 2006
% 217.66/217.85  |- skos__broader mesh__D005631smesh__D017853
% 217.66/217.85  |- skos__prefLabel mesh__D005631 Fructokinases
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D005631 2005
% 217.66/217.85  |- mesh__dateCreated mesh__D005631 1978-05-18
% 217.66/217.85  |- mesh__publicMeSHNote mesh__D005631
% 217.66/217.85       91; was see under PHOSPHOTRANSFERASES, ATP 1979-90   
% 217.66/217.85  |- skos__scopeNote mesh__D005631
% 217.66/217.85       A class of enzymes that catalyzes the phosphorylation of fructose in the presence of ATP. EC 2.7.1.-.%A%    
% 217.66/217.85  |- mesh__historyNote mesh__D005631
% 217.66/217.85       91%28%79%29%; was see under PHOSPHOTRANSFERASES, ATP 1979-90   
% 217.66/217.85  |- mesh__recordMaintainer mesh__D005631 ssb
% 217.66/217.85  |- mesh__recordOriginator mesh__D005631 RLS
% 217.66/217.85  |- skos__historyNote mesh__D005631 Phosphotransferases %28%1966-1973%29%
% 217.66/217.85  |- skos__altLabel mesh__D005631 Ketohexokinases
% 217.66/217.85  |- mesh__recordMaintainer mesh__D052287 ags
% 217.66/217.85  |- skos__altLabel mesh__D052287 Oviparous
% 217.66/217.85  |- mesh__historyNote mesh__D052287 2006   
% 217.66/217.85  |- mesh__dateEstablished mesh__D052287 2006-01-01
% 217.66/217.85  |- skos__broader mesh__D052287smesh__D012098
% 217.66/217.85  |- mesh__recordAuthorizer mesh__D052287 sjn
% 217.66/217.85  |- mesh__recordOriginator mesh__D052287 ags
% 217.66/217.85  |- skos__prefLabel mesh__D052287 Oviparity
% 217.66/217.85  |- mesh__dateCreated mesh__D052287 2005-06-30
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D052287 2006
% 217.66/217.85  |- skos__scopeNote mesh__D052287
% 217.66/217.85       The capability of producing eggs %28%OVA%29% from which young are hatched outside the body. While mostly referring to nonmammalian species, this does include MAMMALS of the order MONOTREMATA.%A%    
% 217.66/217.85  |- skos__related mesh__D052287smesh__D010058
% 217.66/217.85  |- skos__related mesh__D052287smesh__D052284
% 217.66/217.85  |- rdf__type mesh__D052287sskos__Concept
% 217.66/217.85  |- mesh__publicMeSHNote mesh__D052287 2006   
% 217.66/217.85  |- rdf__type mesh__D018559sskos__Concept
% 217.66/217.85  |- skos__prefLabel mesh__D018559 Exobiology
% 217.66/217.85  |- mesh__publicMeSHNote mesh__D018559 95   
% 217.66/217.85  |- mesh__recordAuthorizer mesh__D018559 sjn
% 217.66/217.85  |- mesh__dateCreated mesh__D018559 1994-06-07
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D018559 2002
% 217.66/217.85  |- mesh__recordOriginator mesh__D018559 JLS
% 217.66/217.85  |- mesh__historyNote mesh__D018559 95   
% 217.66/217.85  |- skos__annotation mesh__D018559
% 217.66/217.85       exo- %28%from Greek exo, outside%29% refers to extraterrestrial environ; IM: SPEC with SPEC qualif; for %22%exobiological aspects of%22%, NIM with no qualif; DF: EXOBIOL%A%  
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D018559 2005
% 217.66/217.85  |- mesh__recordMaintainer mesh__D018559 jls
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D018559 2006
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D018559 2003
% 217.66/217.85  |- skos__scopeNote mesh__D018559
% 217.66/217.85       The interdisciplinary science that studies evolutionary biology, including the origin and evolution of the major elements required for life, their processing in the interstellar medium and in protostellar systems. This field also includes the study of chemical evolution and the subsequent interactions between evolving biota and planetary evolution as well as the field of biology that deals with the study of extraterrestrial life.%A%    
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D018559 2004
% 217.66/217.85  |- mesh__dateRevised mesh__D018559 2001-07-25
% 217.66/217.85  |- mesh__dateEstablished mesh__D018559 1995-01-01
% 217.66/217.85  |- skos__broader mesh__D018559smesh__D001695
% 217.66/217.85  |- mesh__recordOriginator mesh__D010576 RC
% 217.66/217.85  |- mesh__recordAuthorizer mesh__D010576 sjn
% 217.66/217.85  |- mesh__dateEstablished mesh__D010576 1981-01-01
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D010576 2002
% 217.66/217.85  |- mesh__historyNote mesh__D010576 94; was PESTIVIRUSES 1981-93   
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D010576 2005
% 217.66/217.85  |- mesh__dateCreated mesh__D010576 1980-05-22
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D010576 2006
% 217.66/217.85  |- skos__hiddenLabel mesh__D010576 Pestiviruses
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D010576 2003
% 217.66/217.85  |- mesh__recordMaintainer mesh__D010576 sjn
% 217.66/217.85  |- skos__broader mesh__D010576smesh__D018067
% 217.66/217.85  |- rdf__type mesh__D010576sskos__Concept
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D010576 2004
% 217.66/217.85  |- skos__annotation mesh__D010576
% 217.66/217.85       a genus of the family Flaviviridae; infection = PESTIVIRUS INFECTIONS%A%  
% 217.66/217.85  |- mesh__onlineNote mesh__D010576
% 217.66/217.85       use PESTIVIRUS to search PESTIVIRUSES 1981-93   
% 217.66/217.85  |- skos__prefLabel mesh__D010576 Pestivirus
% 217.66/217.85  |- mesh__dateRevised mesh__D010576 2001-08-03
% 217.66/217.85  |- skos__scopeNote mesh__D010576
% 217.66/217.85       A genus of FLAVIVIRIDAE, also known as mucosal disease virus group, which is not arthropod-borne. Transmission is by direct and indirect contact, and by transplacental and congenital transmission. Species include BORDER DISEASE VIRUS, bovine viral diarrhea virus %28%DIARRHEA VIRUS, BOVINE VIRAL%29%, and CLASSICAL SWINE FEVER VIRUS.%A%    
% 217.66/217.85  |- mesh__publicMeSHNote mesh__D010576 94; was PESTIVIRUSES 1981-93   
% 217.66/217.85  |- mesh__dateEstablished mesh__D029281 2002-01-01
% 217.66/217.85  |- skos__historyNote mesh__D029281 Arboviruses %28%1965-1981%29%
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D029281 2002
% 217.66/217.85  |- skos__scopeNote mesh__D029281
% 217.66/217.85       A species of NAIROVIRUS, transmitted by the ixodid ticks and producing a lethal gastroenteritis in sheep and goats. Though a major veterinary pathogen, its effect on humans has not been firmly established.%A%    
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D029281 2003
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D029281 2005
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D029281 2004
% 217.66/217.85  |- skos__annotation mesh__D029281 infection = NAIROBI SHEEP DISEASE   
% 217.66/217.85  |- skos__broader mesh__D029281smesh__D016855
% 217.66/217.85  |- rdf__type mesh__D029281sskos__Concept
% 217.66/217.85  |- skos__historyNote mesh__D029281 Nairovirus %28%1996-2001%29%
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D029281 2006
% 217.66/217.85  |- mesh__historyNote mesh__D029281 2002   
% 217.66/217.85  |- mesh__publicMeSHNote mesh__D029281 2002   
% 217.66/217.85  |- skos__historyNote mesh__D029281 Bunyaviridae %28%1982-1995%29%
% 217.66/217.85  |- mesh__dateCreated mesh__D029281 2001-07-25
% 217.66/217.85  |- skos__prefLabel mesh__D029281 Nairobi sheep disease virus
% 217.66/217.85  |- mesh__recordAuthorizer mesh__D004539 sjn
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D004539 2006
% 217.66/217.85  |- rdf__type mesh__D004539sskos__Concept
% 217.66/217.85  |- mesh__recordMaintainer mesh__D004539 ags
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D004539 2005
% 217.66/217.85  |- mesh__recordOriginator mesh__D004539 NLM
% 217.66/217.85  |- mesh__dateCreated mesh__D004539 1999-01-01
% 217.66/217.85  |- skos__scopeNote mesh__D004539
% 217.66/217.85       A genus of protozoan parasites of the subclass COCCIDIA. Various species are parasitic in the epithelial cells of the liver and intestines of man and other animals.%A%    
% 217.66/217.85  |- skos__prefLabel mesh__D004539 Eimeria
% 217.66/217.85  |- mesh__dateRevised mesh__D004539 2003-07-09
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D004539 2004
% 217.66/217.85  |- skos__annotation mesh__D004539
% 217.66/217.85       infection: coord IM with COCCIDIOSIS %28%IM%29%; drug eff: consider also COCCIDIOSTATS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 217.66/217.85  |- skos__broader mesh__D004539smesh__D021743
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D009224 2003
% 217.66/217.85  |- skos__altLabel mesh__D009224 Thomsen%27%s Disease
% 217.66/217.85  |- skos__hiddenLabel mesh__D009224 Myotonias, Generalized
% 217.66/217.85  |- skos__altLabel mesh__D009224 Myotonia, Generalized, Becker
% 217.66/217.85  |- skos__altLabel mesh__D009224 Generalized Myotonia of Thomsen
% 217.66/217.85  |- skos__hiddenLabel mesh__D009224 Generalized Myotonia
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D009224 2004
% 217.66/217.85  |- rdf__type mesh__D009224sskos__Concept
% 217.66/217.85  |- mesh__recordMaintainer mesh__D009224 nns
% 217.66/217.85  |- skos__hiddenLabel mesh__D009224 Generalized Myotonias
% 217.66/217.85  |- skos__broader mesh__D009224smesh__D020967
% 217.66/217.85  |- mesh__dateRevised mesh__D009224 2001-07-25
% 217.66/217.85  |- skos__hiddenLabel mesh__D009224 Thomsen Generalized Myotonia
% 217.66/217.85  |- mesh__recordAuthorizer mesh__D009224 sjn
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D009224 2002
% 217.66/217.85  |- skos__hiddenLabel mesh__D009224 Thomsen Generalized Myotonias
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D009224 2005
% 217.66/217.85  |- skos__hiddenLabel mesh__D009224 Myotonia, Becker Generalized
% 217.66/217.85  |- mesh__recordOriginator mesh__D009224 NLM
% 217.66/217.85  |- skos__scopeNote mesh__D009224
% 217.66/217.85       A dominantly inherited muscle disease that begins in early childhood and is characterized by severe myotonia %28%delayed relaxation of a muscle%29% after forceful voluntary contractions. Muscular hypertrophy is common and myotonia may impair ambulation and other movements. Myotonia typically becomes less severe with repetitive voluntary contractions of the affected muscles. Generalized myotonia %28%of Becker%29% is an autosomal recessive variant of myotonia congenita that may feature more severe myotonia and muscle wasting. %28%From Adams et al., Principles of Neurology, 6th ed, pp1476-7; Joynt, Clinical Neurology, 1997, Ch53, p18%29%%A%    
% 217.66/217.85  |- skos__hiddenLabel mesh__D009224 Generalized Myotonia, Becker
% 217.66/217.85  |- skos__altLabel mesh__D009224 Generalized Myotonia of Becker
% 217.66/217.85  |- skos__broader mesh__D009224smesh__D020271
% 217.66/217.85  |- mesh__activeMeSHYear mesh__D009224 2006
% 217.66/217.85  |- skos__altLabel mesh__D009224 Thomsen Disease
% 217.66/217.85  |- skos__altLabel mesh__D009224 Myotonia, Generalized
% 217.66/217.85  |- skos__altLabel mesh__D009224 Thomsens Disease
% 217.66/217.85  |- mesh__dateCreated mesh__D009224 1999-01-01
% 217.66/217.85  |- skos__prefLabel mesh__D009224 Myotonia Congenita
% 217.66/217.86  |- mesh__publicMeSHNote mesh__D001241
% 217.66/217.86       65; was ACETYLSALICYLIC ACID 1963-64   
% 217.66/217.86  |- mesh__dateEstablished mesh__D001241 1965-01-01
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D001241 2003
% 217.66/217.86  |- skos__prefLabel mesh__D001241 Aspirin
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D001241 2005
% 217.66/217.86  |- mesh__dateRevised mesh__D001241 2000-06-21
% 217.66/217.86  |- skos__altLabel mesh__D001241 2-%28%Acetyloxy%29%benzoic Acid
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D001241 2004
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D001241 2001
% 217.66/217.86  |- skos__hiddenLabel mesh__D001241 Acid, Acetylsalicylic
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D001241 2006
% 217.66/217.86  |- mesh__dateCreated mesh__D001241 1999-01-01
% 217.66/217.86  |- mesh__recordMaintainer mesh__D001241 CCR
% 217.66/217.86  |- mesh__recordOriginator mesh__D001241 NLM
% 217.66/217.86  |- skos__broader mesh__D001241smesh__D012461
% 217.66/217.86  |- skos__altLabel mesh__D001241 Acetylsalicylic Acid
% 217.66/217.86  |- mesh__historyNote mesh__D001241 65; was ACETYLSALICYLIC ACID 1963-64   
% 217.66/217.86  |- mesh__recordAuthorizer mesh__D001241 sjn
% 217.66/217.86  |- rdf__type mesh__D001241sskos__Concept
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D001241 2002
% 217.66/217.86  |- skos__scopeNote mesh__D001241
% 217.66/217.86       The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p5%29%%A%    
% 217.66/217.86  |- skos__historyNote mesh__D014169
% 217.66/217.86       Transformation, Genetic %28%1968-1977%29%
% 217.66/217.86  |- skos__altLabel mesh__D014169 Bacterial Transformation
% 217.66/217.86  |- mesh__recordMaintainer mesh__D014169 nns
% 217.66/217.86  |- mesh__dateCreated mesh__D014169 1977-05-13
% 217.66/217.86  |- skos__broader mesh__D014169smesh__D014170
% 217.66/217.86  |- rdf__type mesh__D014169sskos__Concept
% 217.66/217.86  |- mesh__dateRevised mesh__D014169 2003-07-09
% 217.66/217.86  |- skos__prefLabel mesh__D014169 Transformation, Bacterial
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D014169 2005
% 217.66/217.86  |- skos__related mesh__D014169smesh__D014162
% 217.66/217.86  |- skos__historyNote mesh__D014169 Genetics %28%1966-1967%29%
% 217.66/217.86  |- mesh__recordAuthorizer mesh__D014169 sjn
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D014169 2006
% 217.66/217.86  |- mesh__recordOriginator mesh__D014169 AEP
% 217.66/217.86  |- skos__scopeNote mesh__D014169
% 217.66/217.86       The heritable modification of the properties of a competent bacterium by naked DNA from another source. The uptake of naked DNA is a naturally occuring phenomenon in some bacteria. It is often used as a GENE TRANSFER TECHNIQUE.%A%    
% 217.66/217.86  |- mesh__publicMeSHNote mesh__D014169 78   
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D014169 2004
% 217.66/217.86  |- skos__annotation mesh__D014169
% 217.66/217.86       coord with specific bact transformed/genet; DF: TRANSFORM BACT%A%  
% 217.66/217.86  |- mesh__dateEstablished mesh__D014169 1978-01-01
% 217.66/217.86  |- skos__broader mesh__D014169smesh__D014162
% 217.66/217.86  |- skos__broader mesh__D014169smesh__D008827
% 217.66/217.86  |- mesh__historyNote mesh__D014169 78   
% 217.66/217.86  |- skos__altLabel mesh__D000947 Helminth Antigens
% 217.66/217.86  |- skos__historyNote mesh__D000947 Antigens, Surface %28%1979-1984%29%
% 217.66/217.86  |- mesh__dateCreated mesh__D000947 1984-05-02
% 217.66/217.86  |- mesh__recordAuthorizer mesh__D000947 sjn
% 217.66/217.86  |- mesh__publicMeSHNote mesh__D000947 85   
% 217.66/217.86  |- mesh__dateEstablished mesh__D000947 1985-01-01
% 217.66/217.86  |- skos__broader mesh__D000947smesh__D000941
% 217.66/217.86  |- mesh__historyNote mesh__D000947 85   
% 217.66/217.86  |- rdf__type mesh__D000947sskos__Concept
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D000947 2006
% 217.66/217.86  |- mesh__recordMaintainer mesh__D000947 ssb
% 217.66/217.86  |- mesh__dateRevised mesh__D000947 2005-06-30
% 217.66/217.86  |- skos__scopeNote mesh__D000947
% 217.66/217.86       Any part or derivative of a helminth that elicits an immune reaction. The most commonly seen helminth antigens are those of the schistosomes.%A%    
% 217.66/217.86  |- skos__annotation mesh__D000947
% 217.66/217.86       coord IM with specific helminth /immunol %28%IM%29%   
% 217.66/217.86  |- skos__prefLabel mesh__D000947 Antigens, Helminth
% 217.66/217.86  |- mesh__recordOriginator mesh__D000947 SH
% 217.66/217.86  |- skos__historyNote mesh__D000947 Antigens %28%1966-1984%29%
% 217.66/217.86  |- mesh__historyNote mesh__D019652 98   
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D019652 2006
% 217.66/217.86  |- skos__annotation mesh__D019652
% 217.66/217.86       indust removal of raw materials from the earth %26% conversion into refined products%A%  
% 217.66/217.86  |- mesh__dateEstablished mesh__D019652 1998-01-01
% 217.66/217.86  |- rdf__type mesh__D019652sskos__Concept
% 217.66/217.86  |- mesh__dateCreated mesh__D019652 1997-06-20
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D019652 2003
% 217.66/217.86  |- mesh__recordMaintainer mesh__D019652 ags
% 217.66/217.86  |- mesh__publicMeSHNote mesh__D019652 98   
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D019652 2000
% 217.66/217.86  |- mesh__recordOriginator mesh__D019652 JLS
% 217.66/217.86  |- mesh__dateRevised mesh__D019652 1999-12-28
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D019652 2004
% 217.66/217.86  |- skos__prefLabel mesh__D019652 Extraction and Processing Industry
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D019652 2000A
% 217.66/217.86  |- skos__scopeNote mesh__D019652
% 217.66/217.86       The industry concerned with the removal of raw materials from the Earth%27%s crust and with their conversion into refined products.%A%    
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D019652 2001
% 217.66/217.86  |- mesh__recordAuthorizer mesh__D019652 ags
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D019652 2005
% 217.66/217.86  |- skos__broader mesh__D019652smesh__D007221
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D019652 2002
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D000149 2002
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D000149 2006
% 217.66/217.86  |- mesh__recordAuthorizer mesh__D000149 sjn
% 217.66/217.86  |- rdf__type mesh__D000149sskos__Concept
% 217.66/217.86  |- skos__hiddenLabel mesh__D000149 Fluoride, Acid Phosphate
% 217.66/217.86  |- skos__historyNote mesh__D000149 Phosphates %28%1966-1976%29%
% 217.66/217.86  |- skos__historyNote mesh__D000149 Fluorides, Topical %28%1966-1976%29%
% 217.66/217.86  |- mesh__dateRevised mesh__D000149 2000-06-21
% 217.66/217.86  |- skos__historyNote mesh__D000149 Fluorides %28%1966-1976%29%
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D000149 2003
% 217.66/217.86  |- skos__broader mesh__D000149smesh__D010710
% 217.66/217.86  |- skos__broader mesh__D000149smesh__D002327
% 217.66/217.86  |- skos__broader mesh__D000149smesh__D012969
% 217.66/217.86  |- mesh__historyNote mesh__D000149
% 217.66/217.86       91%28%77%29%; was see under SODIUM FLUORIDE 1984-90; was see under FLUORIDES 1977-83%A%  
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D000149 2004
% 217.66/217.86  |- mesh__publicMeSHNote mesh__D000149
% 217.66/217.86       91; was see under SODIUM FLUORIDE 1984-90; was see under FLUORIDES 1977-83%A%  
% 217.66/217.86  |- skos__prefLabel mesh__D000149 Acidulated Phosphate Fluoride
% 217.66/217.86  |- mesh__recordMaintainer mesh__D000149 adp
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D000149 2001
% 217.66/217.86  |- skos__altLabel mesh__D000149 Acid Phosphate Fluoride
% 217.66/217.86  |- mesh__dateEstablished mesh__D000149 1991-01-01
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D000149 2005
% 217.66/217.86  |- skos__altLabel mesh__D000149 Phosphate Fluoride, Acidulated
% 217.66/217.86  |- mesh__recordOriginator mesh__D000149 RLS
% 217.66/217.86  |- skos__scopeNote mesh__D000149
% 217.66/217.86       A sodium fluoride solution, paste or powder, which has been acidulated to pH 3 to 4 and buffered with a phosphate. It is used in the prevention of dental caries.%A%    
% 217.66/217.86  |- mesh__dateCreated mesh__D000149 1976-04-16
% 217.66/217.86  |- skos__hiddenLabel mesh__D000149 Fluoride, Acidulated Phosphate
% 217.66/217.86  |- rdf__type mesh__D005632sskos__Concept
% 217.66/217.86  |- skos__hiddenLabel mesh__D005632 Levulosa, Apir
% 217.66/217.86  |- skos__altLabel mesh__D005632 Fresenius Kabi Brand of Fructose
% 217.66/217.86  |- skos__altLabel mesh__D005632 Ern Brand of Fructose
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D005632 2006
% 217.66/217.86  |- mesh__recordMaintainer mesh__D005632 CCR
% 217.66/217.86  |- skos__altLabel mesh__D005632 Plast Apyr Levulosa Mein
% 217.66/217.86  |- skos__altLabel mesh__D005632 Levulose
% 217.66/217.86  |- skos__altLabel mesh__D005632 Instituto Farmacologico Brand of Fructose
% 217.66/217.86  |- mesh__recordAuthorizer mesh__D005632 sjn
% 217.66/217.86  |- skos__altLabel mesh__D005632 Bieffe Brand of Fructose
% 217.66/217.86  |- skos__altLabel mesh__D005632 Grifols Brand of Fructose
% 217.66/217.86  |- skos__scopeNote mesh__D005632
% 217.66/217.86       A monosaccharide in sweet fruits and honey that is soluble in water, alcohol, or ether. It is used as a preservative and an intravenous infusion in parenteral feeding.%A%    
% 217.66/217.86  |- skos__altLabel mesh__D005632 Levulosado Braun
% 217.66/217.86  |- skos__altLabel mesh__D005632 Levulosa Grifols
% 217.66/217.86  |- mesh__recordOriginator mesh__D005632 NLM
% 217.66/217.86  |- skos__altLabel mesh__D005632 Levulosa Mein
% 217.66/217.86  |- skos__hiddenLabel mesh__D005632 Levulosa, Fleboplast
% 217.66/217.86  |- skos__altLabel mesh__D005632 Baxter Brand of Fructose
% 217.66/217.86  |- skos__broader mesh__D005632smesh__D007661
% 217.66/217.86  |- skos__prefLabel mesh__D005632 Fructose
% 217.66/217.86  |- skos__altLabel mesh__D005632 Levulosa
% 217.66/217.86  |- mesh__dateRevised mesh__D005632 2005-06-30
% 217.66/217.86  |- skos__altLabel mesh__D005632 Levulosa Ibys
% 217.66/217.86  |- skos__altLabel mesh__D005632 Braun Brand of Fructose
% 217.66/217.86  |- skos__broader mesh__D005632smesh__D006601
% 217.66/217.86  |- mesh__dateCreated mesh__D005632 1999-01-01
% 217.66/217.86  |- rdf__type mesh__D052288sskos__Concept
% 217.66/217.86  |- skos__prefLabel mesh__D052288 Support of Research
% 217.66/217.86  |- skos__annotation mesh__D052288 not used for indexing or cataloging   
% 217.66/217.86  |- mesh__historyNote mesh__D052288 2006   
% 217.66/217.86  |- skos__scopeNote mesh__D052288
% 217.66/217.86       Organizational source for funding of research activity.%A%    
% 217.66/217.86  |- mesh__recordAuthorizer mesh__D052288 sjn
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D052288 2006
% 217.66/217.86  |- mesh__dateEstablished mesh__D052288 2006-01-01
% 217.66/217.86  |- mesh__recordOriginator mesh__D052288 jls
% 217.66/217.86  |- mesh__dateCreated mesh__D052288 2005-06-30
% 217.66/217.86  |- mesh__recordMaintainer mesh__D052288 jls
% 217.66/217.86  |- mesh__runningHead mesh__D052288 V4 - SUPPORT OF RESEARCH   
% 217.66/217.86  |- skos__scopeNote mesh__D010577
% 217.66/217.86       A colloidal system of semisolid hydrocarbons obtained from PETROLEUM. It is used as an ointment base, topical protectant, and lubricant.%A%    
% 217.66/217.86  |- skos__hiddenLabel mesh__D010577 Jelly, Petroleum
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D010577 2006
% 217.66/217.86  |- skos__altLabel mesh__D010577 Paraffin Jelly
% 217.66/217.86  |- mesh__historyNote mesh__D010577 was in Cat D only 1963-82   
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D010577 2003
% 217.66/217.86  |- skos__broader mesh__D010577smesh__D006838
% 217.66/217.86  |- rdf__type mesh__D010577sskos__Concept
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D010577 2004
% 217.66/217.86  |- mesh__dateCreated mesh__D010577 1999-01-01
% 217.66/217.86  |- skos__hiddenLabel mesh__D010577 Hydrophilic Petrolatum
% 217.66/217.86  |- mesh__recordAuthorizer mesh__D010577 sjn
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D010577 2002
% 217.66/217.86  |- mesh__recordMaintainer mesh__D010577 CCR
% 217.66/217.86  |- skos__hiddenLabel mesh__D010577 Jelly, Paraffin
% 217.66/217.86  |- mesh__recordOriginator mesh__D010577 NLM
% 217.66/217.86  |- skos__prefLabel mesh__D010577 Petrolatum
% 217.66/217.86  |- skos__annotation mesh__D010577 D25-26 qualif   
% 217.66/217.86  |- mesh__dateRevised mesh__D010577 2001-07-25
% 217.66/217.86  |- skos__hiddenLabel mesh__D010577 White Petrolatum
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D010577 2005
% 217.66/217.86  |- skos__altLabel mesh__D010577 Petroleum Jelly
% 217.66/217.86  |- skos__altLabel mesh__D029282
% 217.66/217.86       Consumer Information Handout %28%Pub Type%29%
% 217.66/217.86  |- skos__altLabel mesh__D029282 Consumer Handout %28%Pub Type%29%
% 217.66/217.86  |- skos__prefLabel mesh__D029282
% 217.66/217.86       Patient Education Handout %5B%Publication Type%5D%
% 217.66/217.86  |- skos__altLabel mesh__D029282 Patient Handout %28%Pub Type%29%
% 217.66/217.86  |- skos__altLabel mesh__D029282 Consumer Information Handout %28%PT%29%
% 217.66/217.86  |- skos__altLabel mesh__D029282 Patient Handout %28%PT%29%
% 217.66/217.86  |- mesh__recordMaintainer mesh__D029282 jls
% 217.66/217.86  |- skos__broader mesh__D029282smesh__D020496
% 217.66/217.86  |- skos__altLabel mesh__D029282 Patient Education Handout %28%PT%29%
% 217.66/217.86  |- skos__altLabel mesh__D029282 Consumer Handout %28%PT%29%
% 217.66/217.86  |- skos__scopeNote mesh__D029282
% 217.66/217.86       Works consisting of a handout or self-contained informative material used to explain a procedure or a condition or the contents of a specific article in a biomedical journal and written in non-technical language for the patient or consumer.%A%    
% 217.66/217.86  |- mesh__dateEstablished mesh__D029282 2002-01-01
% 217.66/217.86  |- mesh__recordOriginator mesh__D029282 jls
% 217.66/217.86  |- skos__altLabel mesh__D029282 Patient Education Handout %28%Pub Type%29%
% 217.66/217.86  |- rdf__type mesh__D029282sskos__Concept
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D029282 2006
% 217.66/217.86  |- mesh__dateRevised mesh__D029282 2005-06-30
% 217.66/217.86  |- mesh__dateCreated mesh__D029282 2001-07-25
% 217.66/217.86  |- skos__broader mesh__D029282smesh__D052181
% 217.66/217.86  |- mesh__recordAuthorizer mesh__D029282 sjn
% 217.66/217.86  |- mesh__historyNote mesh__D029282 2002   
% 217.66/217.86  |- mesh__recordOriginator mesh__D015262 RLS
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D015262 2005
% 217.66/217.86  |- skos__annotation mesh__D015262
% 217.66/217.86       GEN only; do not interpret: use the term if used by the author%A%  
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D015262 2006
% 217.66/217.86  |- skos__scopeNote mesh__D015262
% 217.66/217.86       Chemical substances that are foreign to the biological system. They include naturally occurring compounds, drugs, environmental agents, carcinogens, insecticides, etc.%A%    
% 217.66/217.86  |- mesh__recordMaintainer mesh__D015262 ssb
% 217.66/217.86  |- mesh__publicMeSHNote mesh__D015262 89   
% 217.66/217.86  |- mesh__recordAuthorizer mesh__D015262 sjn
% 217.66/217.86  |- mesh__dateEstablished mesh__D015262 1989-01-01
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D015262 2004
% 217.66/217.86  |- mesh__historyNote mesh__D015262 89   
% 217.66/217.86  |- skos__broader mesh__D015262smesh__D004364
% 217.66/217.86  |- mesh__dateRevised mesh__D015262 2003-07-09
% 217.66/217.86  |- rdf__type mesh__D015262sskos__Concept
% 217.66/217.86  |- mesh__dateCreated mesh__D015262 1988-05-18
% 217.66/217.86  |- skos__prefLabel mesh__D015262 Xenobiotics
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D009225 2004
% 217.66/217.86  |- mesh__dateRevised mesh__D009225 1997-06-20
% 217.66/217.86  |- rdf__type mesh__D009225sskos__Concept
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D009225 2005
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D009225 2000
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D009225 2001
% 217.66/217.86  |- skos__broader mesh__D009225smesh__D013506
% 217.66/217.86  |- mesh__publicMeSHNote mesh__D009225 66   
% 217.66/217.86  |- mesh__recordAuthorizer mesh__D009225 SJN
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D009225 2006
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D009225 2002
% 217.66/217.86  |- skos__annotation mesh__D009225
% 217.66/217.86       for repair of tympanic membrane perf; do not use /util except by MeSH definition%A%  
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D009225 1998
% 217.66/217.86  |- mesh__recordOriginator mesh__D009225 NLM
% 217.66/217.86  |- skos__hiddenLabel mesh__D009225 Myringoplasties
% 217.66/217.86  |- mesh__historyNote mesh__D009225 66%28%64%29%   
% 217.66/217.86  |- skos__scopeNote mesh__D009225
% 217.66/217.86       Surgical restoration of a perforated tympanic membrane by grafting. %28%Dorland, 28th ed.%29%%A%    
% 217.66/217.86  |- mesh__dateCreated mesh__D009225 1999-01-01
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D009225 1999
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D009225 2003
% 217.66/217.86  |- skos__prefLabel mesh__D009225 Myringoplasty
% 217.66/217.86  |- mesh__dateEstablished mesh__D009225 1966-01-01
% 217.66/217.86  |- mesh__recordMaintainer mesh__D009225 PXP
% 217.66/217.86  |- skos__related mesh__D009225smesh__D014433
% 217.66/217.86  |- skos__broader mesh__D001242smesh__D010551
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D001242 2006
% 217.66/217.86  |- mesh__recordMaintainer mesh__D001242 JLS
% 217.66/217.86  |- mesh__recordOriginator mesh__D001242 EC
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D001242 2002
% 217.66/217.86  |- skos__scopeNote mesh__D001242
% 217.66/217.86       Strongly insistent, self-assured, and demanding behavior.%A%    
% 217.66/217.86  |- rdf__type mesh__D001242sskos__Concept
% 217.66/217.86  |- skos__prefLabel mesh__D001242 Assertiveness
% 217.66/217.86  |- skos__historyNote mesh__D001242 Aggression %28%1966-1979%29%
% 217.66/217.86  |- mesh__dateEstablished mesh__D001242 1980-01-01
% 217.66/217.86  |- mesh__dateCreated mesh__D001242 1979-04-11
% 217.66/217.86  |- mesh__historyNote mesh__D001242 80   
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D001242 2000
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D001242 1998
% 217.66/217.86  |- skos__annotation mesh__D001242
% 217.66/217.86       no qualif; assertiveness training: coord IM with BEHAVIOR THERAPY %28%IM%29%%A%  
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D001242 2003
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D001242 2001
% 217.66/217.86  |- skos__hiddenLabel mesh__D001242 Assertivenesses
% 217.66/217.86  |- mesh__dateRevised mesh__D001242 1997-06-20
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D001242 2005
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D001242 1999
% 217.66/217.86  |- mesh__publicMeSHNote mesh__D001242 80   
% 217.66/217.86  |- mesh__recordAuthorizer mesh__D001242 SJN
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D001242 2004
% 217.66/217.86  |- skos__altLabel mesh__D014968 Purine Hydroxylase I
% 217.66/217.86  |- rdf__type mesh__D014968sskos__Concept
% 217.66/217.86  |- skos__broader mesh__D014968smesh__D000429
% 217.66/217.86  |- skos__historyNote mesh__D014968 Ketone Oxidoreductases %28%1973-1974%29%
% 217.66/217.86  |- mesh__publicMeSHNote mesh__D014968
% 217.66/217.86       91; was see under KETONE OXIDOREDUCTASES 1975-90   
% 217.66/217.86  |- mesh__dateRevised mesh__D014968 2005-06-30
% 217.66/217.86  |- skos__hiddenLabel mesh__D014968 I, Purine Hydroxylase
% 217.66/217.86  |- skos__hiddenLabel mesh__D014968 Dehydrogenase, Xanthine
% 217.66/217.86  |- skos__scopeNote mesh__D014968
% 217.66/217.86       An enzyme that catalyzes the oxidation of xanthine in the presence of NAD+ to form urate and NADH. It acts also on a variety of other purines and aldehydes. EC 1.1.1.204.%A%    
% 217.66/217.86  |- skos__hiddenLabel mesh__D014968 Hydroxylase I, Purine
% 217.66/217.86  |- skos__prefLabel mesh__D014968 Xanthine Dehydrogenase
% 217.66/217.86  |- mesh__recordAuthorizer mesh__D014968 sjn
% 217.66/217.86  |- mesh__recordOriginator mesh__D014968 NLM
% 217.66/217.86  |- mesh__recordMaintainer mesh__D014968 jmp
% 217.66/217.86  |- skos__historyNote mesh__D014968 Xanthines %28%1973-1974%29%
% 217.66/217.86  |- mesh__dateCreated mesh__D014968 1974-11-11
% 217.66/217.86  |- mesh__dateEstablished mesh__D014968 1991-01-01
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D014968 2006
% 217.66/217.86  |- mesh__historyNote mesh__D014968
% 217.66/217.86       91%28%75%29%; was see under KETONE OXIDOREDUCTASES 1975-90   
% 217.66/217.86  |- skos__hiddenLabel mesh__D019653 Agonists, Myeloablative
% 217.66/217.86  |- skos__scopeNote mesh__D019653
% 217.66/217.86       Agents that destroy bone marrow activity. They are used to prepare patients for BONE MARROW TRANSPLANTATION or STEM CELL TRANSPLANTATION.%A%    
% 217.66/217.86  |- skos__annotation mesh__D019653 DF: MYELOABLATIVE AG   
% 217.66/217.86  |- skos__broader mesh__D019653smesh__D007166
% 217.66/217.86  |- skos__hiddenLabel mesh__D019653 Agonist, Myeloablative
% 217.66/217.86  |- mesh__recordOriginator mesh__D019653 AGS
% 217.66/217.86  |- mesh__dateEstablished mesh__D019653 1998-01-01
% 217.66/217.86  |- mesh__recordAuthorizer mesh__D019653 sjn
% 217.66/217.86  |- skos__altLabel mesh__D019653 Myeloablative Agonist
% 217.66/217.86  |- skos__broader mesh__D019653smesh__D000970
% 217.66/217.86  |- mesh__dateCreated mesh__D019653 1997-06-20
% 217.66/217.86  |- mesh__dateRevised mesh__D019653 2005-06-30
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D019653 2006
% 217.66/217.86  |- mesh__historyNote mesh__D019653 98   
% 217.66/217.86  |- mesh__publicMeSHNote mesh__D019653 98   
% 217.66/217.86  |- skos__prefLabel mesh__D019653 Myeloablative Agonists
% 217.66/217.86  |- rdf__type mesh__D019653sskos__Concept
% 217.66/217.86  |- mesh__recordMaintainer mesh__D019653 ssb
% 217.66/217.86  |- mesh__dateRevised mesh__D011670 1990-03-22
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D011670 1998
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D011670 1993
% 217.66/217.86  |- mesh__dateCreated mesh__D011670 1999-01-01
% 217.66/217.86  |- mesh__publicMeSHNote mesh__D011670 65   
% 217.66/217.86  |- skos__broader mesh__D011670smesh__D004708
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D011670 2002
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D011670 1994
% 217.66/217.86  |- mesh__recordAuthorizer mesh__D011670 PLS
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D011670 1999
% 217.66/217.86  |- mesh__recordOriginator mesh__D011670 NLM
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D011670 2003
% 217.66/217.86  |- mesh__historyNote mesh__D011670 65   
% 217.66/217.86  |- rdf__type mesh__D011670sskos__Concept
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D011670 1995
% 217.66/217.86  |- mesh__recordMaintainer mesh__D011670 TAP
% 217.66/217.86  |- skos__hiddenLabel mesh__D011670 Pulpectomies
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D011670 2004
% 217.66/217.86  |- mesh__dateEstablished mesh__D011670 1965-01-01
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D011670 2005
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D011670 1996
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D011670 1991
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D011670 2006
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D011670 2000
% 217.66/217.86  |- skos__prefLabel mesh__D011670 Pulpectomy
% 217.66/217.86  |- skos__annotation mesh__D011670
% 217.66/217.86       removal of pulp from pulp chamber %26% root canal: differentiate from PULPOTOMY; do not use /util except by MeSH definition%A%  
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D011670 1992
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D011670 1997
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D011670 2001
% 217.66/217.86  |- skos__scopeNote mesh__D005633
% 217.66/217.86       An autosomal recessive fructose metabolism disorder due to deficient fructose-1-phosphate aldolase %28%EC 2.1.2.13%29% activity, resulting in accumulation of fructose-1-phosphate. The accumulated fructose-1-phosphate inhibits glycogenolysis and gluconeogenesis, causing severe hypoglycemia following ingestion of fructose. Prolonged fructose ingestion in infants leads ultimately to hepatic failure and death. Patients develop a strong distaste for sweet food, and avoid a chronic course of the disease by remaining on a fructose- and sucrose-free diet.%A%    
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D005633 2006
% 217.66/217.86  |- skos__hiddenLabel mesh__D005633 Fructose Intolerances
% 217.66/217.86  |- skos__hiddenLabel mesh__D005633 Intolerance, Fructose
% 217.66/217.86  |- mesh__dateEstablished mesh__D005633 1991-01-01
% 217.66/217.86  |- skos__hiddenLabel mesh__D005633 Intolerances, Fructose
% 217.66/217.86  |- skos__prefLabel mesh__D005633 Fructose Intolerance
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D005633 2002
% 217.66/217.86  |- mesh__dateRevised mesh__D005633 2001-07-25
% 217.66/217.86  |- mesh__historyNote mesh__D005633
% 217.66/217.86       91%28%75%29%%28%64-66%29%; was see under FRUCTOSE METABOLISM, INBORN ERRORS 1989-90; was see under CARBOHYDRATE METABOLISM, INBORN ERRORS 1964-88 %28%Prov 1964-66%29%%A%  
% 217.66/217.86  |- skos__broader mesh__D005633smesh__D015318
% 217.66/217.86  |- skos__related mesh__D005633smesh__D005634
% 217.66/217.86  |- mesh__recordAuthorizer mesh__D005633 sjn
% 217.66/217.86  |- skos__annotation mesh__D005633
% 217.66/217.86       an inborn error of fructose metab; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 217.66/217.86  |- mesh__onlineNote mesh__D005633
% 217.66/217.86       use CARBOHYDRATE METABOLISM, INBORN ERRORS to search FRUCTOSE INTOLERANCE 1966-74 %28%as Prov 1966%29%%A%  
% 217.66/217.86  |- mesh__dateCreated mesh__D005633 1999-01-01
% 217.66/217.86  |- mesh__recordMaintainer mesh__D005633 nns
% 217.66/217.86  |- mesh__recordOriginator mesh__D005633 NLM
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D005633 2003
% 217.66/217.86  |- mesh__publicMeSHNote mesh__D005633
% 217.66/217.86       91; was see under FRUCTOSE METABOLISM, INBORN ERRORS 1989-90; was see under CARBOHYDRATE METABOLISM, INBORN ERRORS 1967-88%A%  
% 217.66/217.86  |- rdf__type mesh__D005633sskos__Concept
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D005633 2005
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D005633 2004
% 217.66/217.86  |- skos__broader mesh__D004364Q000037smesh__D004364
% 217.66/217.86  |- mesh__preferredCombination mesh__D004364Q000037smesh__D004336
% 217.66/217.86  |- rdf__type mesh__D004364Q000037smesh__CompoundConcept
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D010578 2000
% 217.66/217.86  |- mesh__dateRevised mesh__D010578 1997-06-20
% 217.66/217.86  |- skos__hiddenLabel mesh__D010578 Petroleums
% 217.66/217.86  |- rdf__type mesh__D010578sskos__Concept
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D010578 2004
% 217.66/217.86  |- skos__prefLabel mesh__D010578 Petroleum
% 217.66/217.86  |- mesh__recordAuthorizer mesh__D010578 SJN
% 217.66/217.86  |- mesh__dateCreated mesh__D010578 1999-01-01
% 217.66/217.86  |- mesh__recordMaintainer mesh__D010578 JLS
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D010578 2001
% 217.66/217.86  |- skos__hiddenLabel mesh__D010578 Crude Oils
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D010578 1998
% 217.66/217.86  |- skos__altLabel mesh__D010578 Crude Oil
% 217.66/217.86  |- mesh__historyNote mesh__D010578
% 217.66/217.86       was in Cat J only 1975-81, was in Cat D %26% J 1968-74, was in Cat D only 1963-67%A%  
% 217.66/217.86  |- skos__broader mesh__D010578smesh__D005579
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D010578 1999
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D010578 2005
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D010578 2002
% 217.66/217.86  |- skos__scopeNote mesh__D010578
% 217.66/217.86       Naturally occurring complex liquid hydrocarbons which, after distillation, yield combustible fuels, petrochemicals, and lubricants.%A%    
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D010578 2006
% 217.66/217.86  |- mesh__recordOriginator mesh__D010578 NLM
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D010578 2003
% 217.66/217.86  |- skos__hiddenLabel mesh__D010578 Oil, Crude
% 217.66/217.86  |- skos__hiddenLabel mesh__D010578 Oils, Crude
% 217.66/217.86  |- skos__altLabel mesh__D015263 Restriction Endonucleases, Type III
% 217.66/217.86  |- skos__prefLabel mesh__D015263 Deoxyribonucleases, Type III Site-Specific
% 217.66/217.86  |- skos__altLabel mesh__D015263 Deoxyribonucleases, Type III, Site-Specific
% 217.66/217.86  |- skos__hiddenLabel mesh__D015263 Site Specific DNase, Type III
% 217.66/217.86  |- mesh__dateCreated mesh__D015263 1988-05-18
% 217.66/217.86  |- skos__historyNote mesh__D015263
% 217.66/217.86       DNA Restriction Enzymes %28%1975-1988%29%
% 217.66/217.86  |- skos__altLabel mesh__D015263 Deoxyribonucleases, Type III, Site Specific
% 217.66/217.86  |- skos__altLabel mesh__D015263 Type III Site Specific Deoxyribonucleases
% 217.66/217.86  |- skos__altLabel mesh__D015263 Type III Site-Specific Deoxyribonucleases
% 217.66/217.86  |- mesh__historyNote mesh__D015263 89   
% 217.66/217.86  |- skos__hiddenLabel mesh__D015263
% 217.66/217.86       Deoxyribonucleases, Type III Site Specific
% 217.66/217.86  |- skos__altLabel mesh__D015263 DNA Restriction Enzymes, Type III
% 217.66/217.86  |- skos__altLabel mesh__D015263 Type III Site-Specific DNase
% 217.66/217.86  |- skos__altLabel mesh__D015263 Type III Restriction Enzymes
% 217.66/217.86  |- mesh__publicMeSHNote mesh__D015263 89   
% 217.66/217.86  |- mesh__recordMaintainer mesh__D015263 ssb
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D015263 2006
% 217.66/217.86  |- skos__altLabel mesh__D015263 DNase, Site Specific, Type III
% 217.66/217.86  |- mesh__dateEstablished mesh__D015263 1989-01-01
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D015263 2004
% 217.66/217.86  |- skos__altLabel mesh__D015263 Site-Specific DNase, Type III
% 217.66/217.86  |- skos__altLabel mesh__D015263 DNase, Site-Specific, Type III
% 217.66/217.86  |- mesh__dateRevised mesh__D015263 2003-07-09
% 217.66/217.86  |- skos__broader mesh__D015263smesh__D004262
% 217.66/217.86  |- mesh__activeMeSHYear mesh__D015263 2005
% 217.66/217.86  |- skos__annotation mesh__D015263 DF: DNASE SS III   
% 217.66/217.86  |- skos__scopeNote mesh__D015263
% 217.66/217.86       Enzyme systems composed of two subunits and requiring ATP and magnesium for endonucleolytic activity; they do not function as ATPases. They exist as complexes with modification methylases of similar specificity listed under EC 2.1.1.72 or EC 2.1.1.73. The systems recognize specific short DNA sequences and cleave a short distance, about 24 to 27 bases, away from the recognition sequence to give specific double-stranded fragments with terminal 5%27%-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.5.%A%    
% 217.66/217.87  |- mesh__recordOriginator mesh__D015263 RLS
% 217.66/217.87  |- rdf__type mesh__D015263sskos__Concept
% 217.66/217.87  |- mesh__recordAuthorizer mesh__D015263 sjn
% 217.66/217.87  |- skos__altLabel mesh__D015263 Type III Site Specific DNase
% 217.66/217.87  |- mesh__historyNote mesh__D009226
% 217.66/217.87       91%28%75%29%; was see under MYRISTIC ACIDS 1975-90   
% 217.66/217.87  |- mesh__recordOriginator mesh__D009226 NLM
% 217.66/217.87  |- skos__broader mesh__D009226smesh__D009227
% 217.66/217.87  |- skos__historyNote mesh__D009226 Fatty Acids %28%1966-1974%29%
% 217.66/217.87  |- mesh__publicMeSHNote mesh__D009226
% 217.66/217.87       91; was see under MYRISTIC ACIDS 1975-90   
% 217.66/217.87  |- mesh__dateRevised mesh__D009226 2003-07-09
% 217.66/217.87  |- mesh__recordMaintainer mesh__D009226 ssb
% 217.66/217.87  |- skos__scopeNote mesh__D009226
% 217.66/217.87       Salts and esters of the 14-carbon saturated monocarboxylic acid--myristic acid.%A%    
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D009226 2004
% 217.66/217.87  |- rdf__type mesh__D009226sskos__Concept
% 217.66/217.87  |- mesh__dateEstablished mesh__D009226 1991-01-01
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D009226 2005
% 217.66/217.87  |- skos__prefLabel mesh__D009226 Myristates
% 217.66/217.87  |- skos__altLabel mesh__D009226 Tetradecanoates
% 217.66/217.87  |- mesh__dateCreated mesh__D009226 1974-11-14
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D009226 2006
% 217.66/217.87  |- mesh__recordAuthorizer mesh__D009226 sjn
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001243 2001
% 217.66/217.87  |- mesh__publicMeSHNote mesh__D001243 67   
% 217.66/217.87  |- skos__annotation mesh__D001243
% 217.66/217.87       do not use /util except by MeSH definition; do not confuse with EXTRACORPOREAL CIRCULATION or its specifics; DF: ASSISTED CIRC%A%  
% 217.66/217.87  |- rdf__type mesh__D001243sskos__Concept
% 217.66/217.87  |- mesh__recordOriginator mesh__D001243 NLM
% 217.66/217.87  |- mesh__recordMaintainer mesh__D001243 ndw
% 217.66/217.87  |- mesh__dateEstablished mesh__D001243 1967-01-01
% 217.66/217.87  |- mesh__recordAuthorizer mesh__D001243 sjn
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001243 2002
% 217.66/217.87  |- skos__scopeNote mesh__D001243
% 217.66/217.87       Pumping that aids the natural activity of the heart. %28%Dorland, 27th ed%29%%A%    
% 217.66/217.87  |- skos__prefLabel mesh__D001243 Assisted Circulation
% 217.66/217.87  |- skos__related mesh__D001243smesh__D006353
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001243 2003
% 217.66/217.87  |- skos__historyNote mesh__D001243 Heart-Lung Machine %28%1966%29%
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001243 2005
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001243 2004
% 217.66/217.87  |- skos__altLabel mesh__D001243 Circulation, Assisted
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001243 2006
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001243 2000
% 217.66/217.87  |- mesh__dateRevised mesh__D001243 1999-11-03
% 217.66/217.87  |- mesh__dateCreated mesh__D001243 1999-01-01
% 217.66/217.87  |- skos__broader mesh__D001243smesh__D013514
% 217.66/217.87  |- mesh__historyNote mesh__D001243 67   
% 217.66/217.87  |- skos__scopeNote mesh__D014969
% 217.66/217.87       An iron-molybdenum flavoprotein containing FLAVIN-ADENINE DINUCLEOTIDE that oxidizes hypoxanthine, some other purines and pterins, and aldehydes. Deficiency of the enzyme, an autosomal recessive trait, causes xanthinuria. EC 1.1.3.22.%A%    
% 217.66/217.87  |- mesh__historyNote mesh__D014969 65   
% 217.66/217.87  |- skos__prefLabel mesh__D014969 Xanthine Oxidase
% 217.66/217.87  |- mesh__dateEstablished mesh__D014969 1965-01-01
% 217.66/217.87  |- skos__altLabel mesh__D014969 Purine-Xanthine Oxidase
% 217.66/217.87  |- mesh__recordAuthorizer mesh__D014969 sjn
% 217.66/217.87  |- skos__hiddenLabel mesh__D014969 Oxidase, Hypoxanthine-Xanthine
% 217.66/217.87  |- mesh__recordOriginator mesh__D014969 NLM
% 217.66/217.87  |- skos__hiddenLabel mesh__D014969 Oxidase, Hypoxanthine
% 217.66/217.87  |- mesh__dateCreated mesh__D014969 1999-01-01
% 217.66/217.87  |- skos__annotation mesh__D014969
% 217.66/217.87       /defic: consider also XANTHINES /urine %28%IM%29% + PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS %28%IM%29%%A%  
% 217.66/217.87  |- skos__hiddenLabel mesh__D014969 Purine Xanthine Oxidase
% 217.66/217.87  |- skos__hiddenLabel mesh__D014969 Hypoxanthine Xanthine Oxidase
% 217.66/217.87  |- skos__altLabel mesh__D014969 Hypoxanthine Dehydrogenase
% 217.66/217.87  |- skos__altLabel mesh__D014969 Hypoxanthine-Xanthine Oxidase
% 217.66/217.87  |- skos__hiddenLabel mesh__D014969 Oxidase, Purine-Xanthine
% 217.66/217.87  |- skos__altLabel mesh__D014969 Hypoxanthine Oxidase
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D014969 2006
% 217.66/217.87  |- mesh__recordMaintainer mesh__D014969 jmp
% 217.66/217.87  |- skos__hiddenLabel mesh__D014969 Oxidase, Xanthine
% 217.66/217.87  |- skos__hiddenLabel mesh__D014969 Dehydrogenase, Hypoxanthine
% 217.66/217.87  |- skos__broader mesh__D014969smesh__D000429
% 217.66/217.87  |- mesh__publicMeSHNote mesh__D014969 65   
% 217.66/217.87  |- mesh__dateRevised mesh__D014969 2005-06-30
% 217.66/217.87  |- rdf__type mesh__D014969sskos__Concept
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D019654 2001
% 217.66/217.87  |- skos__historyNote mesh__D019654 Lenses %28%1966-1978%29%
% 217.66/217.87  |- skos__hiddenLabel mesh__D019654 Intraocular Lens Implantations
% 217.66/217.87  |- skos__related mesh__D019654smesh__D019591
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D019654 2005
% 217.66/217.87  |- mesh__publicMeSHNote mesh__D019654
% 217.66/217.87       98; was see LENSES, INTRAOCULAR 1979-97   
% 217.66/217.87  |- skos__broader mesh__D019654smesh__D013508
% 217.66/217.87  |- mesh__historyNote mesh__D019654
% 217.66/217.87       98; was see LENSES, INTRAOCULAR 1979-97   
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D019654 2006
% 217.66/217.87  |- skos__hiddenLabel mesh__D019654 Implantations, Intraocular Lens
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D019654 2002
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D019654 1998
% 217.66/217.87  |- mesh__dateEstablished mesh__D019654 1998-01-01
% 217.66/217.87  |- skos__hiddenLabel mesh__D019654 Implantation, Intraocular Lens
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D019654 2003
% 217.66/217.87  |- rdf__type mesh__D019654sskos__Concept
% 217.66/217.87  |- skos__hiddenLabel mesh__D019654 Lens Implantations, Intraocular
% 217.66/217.87  |- mesh__dateCreated mesh__D019654 1997-06-20
% 217.66/217.87  |- skos__hiddenLabel mesh__D019654 Intraocular Lens Implantation
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D019654 1999
% 217.66/217.87  |- skos__scopeNote mesh__D019654
% 217.66/217.87       Insertion of an artificial lens following removal of the crystalline lens, usually after cataract extraction.%A%    
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D019654 2004
% 217.66/217.87  |- skos__prefLabel mesh__D019654 Lens Implantation, Intraocular
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D019654 2000
% 217.66/217.87  |- skos__historyNote mesh__D019654 Lenses, Intraocular %28%1979-1997%29%
% 217.66/217.87  |- skos__hiddenLabel mesh__D000949 Antigens, Class II
% 217.66/217.87  |- skos__hiddenLabel mesh__D000949 Ia Like Antigens
% 217.66/217.87  |- skos__altLabel mesh__D000949 Antigens, Immune Response
% 217.66/217.87  |- skos__altLabel mesh__D000949 Immune Response Antigens
% 217.66/217.87  |- skos__hiddenLabel mesh__D000949 Antigen, IA
% 217.66/217.87  |- skos__hiddenLabel mesh__D000949 Antigens, Immune-Associated
% 217.66/217.87  |- skos__historyNote mesh__D000949 HLA Antigens %28%1975-1980%29%
% 217.66/217.87  |- mesh__onlineNote mesh__D000949
% 217.66/217.87       use HISTOCOMPATIBILITY ANTIGENS CLASS II to search ANTIGENS, IMMUNE RESPONSE 1981-88 %26% I-A-ANTIGEN 1987-93%A%  
% 217.66/217.87  |- skos__altLabel mesh__D000949 I-A-Antigen
% 217.66/217.87  |- skos__annotation mesh__D000949
% 217.66/217.87       human %26% animal; GEN: prefer specifics; see also HLA ANTIGENS %26% specifics for human; X ref IA ANTIGENS refers to any class II histocompatibility antigen%A%  
% 217.66/217.87  |- mesh__publicMeSHNote mesh__D000949
% 217.66/217.87       89; was ANTIGENS, IMMUNE RESPONSE 1981-88; I-A-ANTIGEN was indexed under HISTOCOMPATIBILITY ANTIGENS CLASS II 1987-93%A%  
% 217.66/217.87  |- skos__altLabel mesh__D000949 Class II Antigen
% 217.66/217.87  |- skos__prefLabel mesh__D000949 Histocompatibility Antigens Class II
% 217.66/217.87  |- skos__altLabel mesh__D000949 I-A Antigen
% 217.66/217.87  |- mesh__historyNote mesh__D000949
% 217.66/217.87       89; was ANTIGENS, IMMUNE RESPONSE 1981-88; I-A-ANTIGEN was NM 1987-93%A%  
% 217.66/217.87  |- mesh__recordMaintainer mesh__D000949 ssb
% 217.66/217.87  |- mesh__dateRevised mesh__D000949 2005-06-30
% 217.66/217.87  |- skos__scopeNote mesh__D000949
% 217.66/217.87       Large, transmembrane, non-covalently linked glycoproteins %28%alpha and beta%29%. Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen.%A%    
% 217.66/217.87  |- mesh__recordOriginator mesh__D000949 SH
% 217.66/217.87  |- skos__altLabel mesh__D000949 Class II Major Histocompatibility Antigens
% 217.66/217.87  |- skos__broader mesh__D000949smesh__D006649
% 217.66/217.87  |- skos__historyNote mesh__D000949
% 217.66/217.87       Histocompatibility Antigens %28%1973-1980%29%
% 217.66/217.87  |- skos__altLabel mesh__D000949 IA Antigen
% 217.66/217.87  |- mesh__dateEstablished mesh__D000949 1981-01-01
% 217.66/217.87  |- rdf__type mesh__D000949sskos__Concept
% 217.66/217.87  |- skos__altLabel mesh__D000949 Class II Histocompatibility Antigens
% 217.66/217.87  |- mesh__recordAuthorizer mesh__D000949 sjn
% 217.66/217.87  |- skos__altLabel mesh__D000949 Ia Antigens
% 217.66/217.87  |- skos__hiddenLabel mesh__D000949 Immune Associated Antigens
% 217.66/217.87  |- skos__hiddenLabel mesh__D000949 Immune Response Associated Antigens
% 217.66/217.87  |- skos__altLabel mesh__D000949 Immune-Response-Associated Antigens
% 217.66/217.87  |- mesh__dateCreated mesh__D000949 1980-05-13
% 217.66/217.87  |- skos__hiddenLabel mesh__D000949 Antigen, I-A
% 217.66/217.87  |- skos__altLabel mesh__D000949 Class II Antigens
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D000949 2006
% 217.66/217.87  |- skos__hiddenLabel mesh__D000949 Antigens, Immune-Response-Associated
% 217.66/217.87  |- skos__hiddenLabel mesh__D000949 Antigens, Ia-Like
% 217.66/217.87  |- skos__hiddenLabel mesh__D000949 I A Antigen
% 217.66/217.87  |- skos__hiddenLabel mesh__D000949 Antigens, Ia
% 217.66/217.87  |- skos__historyNote mesh__D000949 Isoantigens %28%1973-1980%29%
% 217.66/217.87  |- skos__altLabel mesh__D000949 Ia-Like Antigens
% 217.66/217.87  |- skos__hiddenLabel mesh__D000949 Antigen, Class II
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D011671 2006
% 217.66/217.87  |- skos__hiddenLabel mesh__D011671 Pulpitides
% 217.66/217.87  |- mesh__publicMeSHNote mesh__D011671 65   
% 217.66/217.87  |- skos__hiddenLabel mesh__D011671 Inflammations, Endodontic
% 217.66/217.87  |- skos__broader mesh__D011671smesh__D003788
% 217.66/217.87  |- skos__hiddenLabel mesh__D011671 Endodontic Inflammations
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D011671 2005
% 217.66/217.87  |- mesh__recordAuthorizer mesh__D011671 sjn
% 217.66/217.87  |- skos__prefLabel mesh__D011671 Pulpitis
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D011671 2004
% 217.66/217.87  |- rdf__type mesh__D011671sskos__Concept
% 217.66/217.87  |- skos__hiddenLabel mesh__D011671 Endodontic Inflammation
% 217.66/217.87  |- skos__scopeNote mesh__D011671
% 217.66/217.87       Inflammation of the DENTAL PULP, usually due to bacterial infection in dental caries, tooth fracture, or other conditions causing exposure of the pulp to bacterial invasion. Chemical irritants, thermal factors, hyperemic changes, and other factors may also cause pulpitis.%A%    
% 217.66/217.87  |- mesh__dateRevised mesh__D011671 2003-07-09
% 217.66/217.87  |- mesh__dateEstablished mesh__D011671 1965-01-01
% 217.66/217.87  |- skos__altLabel mesh__D011671 Inflammation, Endodontic
% 217.66/217.87  |- mesh__recordOriginator mesh__D011671 NLM
% 217.66/217.87  |- mesh__historyNote mesh__D011671 65%28%63%29%   
% 217.66/217.87  |- skos__related mesh__D011671smesh__D010485
% 217.66/217.87  |- mesh__dateCreated mesh__D011671 1999-01-01
% 217.66/217.87  |- mesh__recordMaintainer mesh__D011671 ssb
% 217.66/217.87  |- mesh__dateEstablished mesh__D005634 1974-01-01
% 217.66/217.87  |- mesh__recordOriginator mesh__D005634 NLM
% 217.66/217.87  |- skos__hiddenLabel mesh__D005634 Fructose 1 Phosphate Aldolase
% 217.66/217.87  |- skos__hiddenLabel mesh__D005634 1,6-Bisphosphate Aldolase, Fructose
% 217.66/217.87  |- skos__hiddenLabel mesh__D005634 Aldolase, Fructosemonophosphate
% 217.66/217.87  |- skos__altLabel mesh__D005634 Fructosediphosphate Aldolase
% 217.66/217.87  |- mesh__recordMaintainer mesh__D005634 ssb
% 217.66/217.87  |- mesh__dateCreated mesh__D005634 1999-01-01
% 217.66/217.87  |- skos__annotation mesh__D005634
% 217.66/217.87       /defic: consider also FRUCTOSE INTOLERANCE   
% 217.66/217.87  |- rdf__type mesh__D005634sskos__Concept
% 217.66/217.87  |- skos__hiddenLabel mesh__D005634 Fructose 1,6 Bisphosphate Aldolase
% 217.66/217.87  |- skos__hiddenLabel mesh__D005634 Aldolase, Fructosediphosphate
% 217.66/217.87  |- skos__hiddenLabel mesh__D005634 Aldolase, Fructose Biphosphate
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D005634 2005
% 217.66/217.87  |- skos__broader mesh__D005634smesh__D000446
% 217.66/217.87  |- mesh__historyNote mesh__D005634 98%28%63%29%   
% 217.66/217.87  |- skos__altLabel mesh__D005634 Fructose Biphosphate Aldolase
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D005634 2004
% 217.66/217.87  |- skos__related mesh__D005634smesh__D005633
% 217.66/217.87  |- skos__hiddenLabel mesh__D005634 Aldolase, Fructose-Bisphosphate
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D005634 2006
% 217.66/217.87  |- mesh__dateRevised mesh__D005634 2003-07-09
% 217.66/217.87  |- mesh__publicMeSHNote mesh__D005634
% 217.66/217.87       98; see FRUCTOSEDIPHOSPHATE ALDOLASE 1974-97, see ALDOLASE 1963-73%A%  
% 217.66/217.87  |- skos__altLabel mesh__D005634
% 217.66/217.87       Fructose 1,6-Bisphosphate Aldolase, Class II
% 217.66/217.87  |- skos__prefLabel mesh__D005634 Fructose-Bisphosphate Aldolase
% 217.66/217.87  |- skos__scopeNote mesh__D005634
% 217.66/217.87       An enzyme of the lyase class that catalyzes the cleavage of fructose 1,6-biphosphate to form dihydroxyacetone phosphate and glyceraldehyde 3-phosphate. The enzyme also acts on %28%3S,4R%29%-ketose 1-phosphates. The yeast and bacterial enzymes are zinc proteins. %28%Enzyme Nomenclature, 1992%29% E.C. 4.1.2.13.%A%    
% 217.66/217.87  |- skos__hiddenLabel mesh__D005634 Aldolase, Fructose 1,6-Bisphosphate
% 217.66/217.87  |- skos__hiddenLabel mesh__D005634 Fructose Bisphosphate Aldolase
% 217.66/217.87  |- skos__altLabel mesh__D005634 Fructose 1,6-Bisphosphate Aldolase
% 217.66/217.87  |- skos__hiddenLabel mesh__D005634 Aldolase, Fructose 1-Phosphate
% 217.66/217.87  |- skos__altLabel mesh__D005634 Aldolase
% 217.66/217.87  |- mesh__recordAuthorizer mesh__D005634 sjn
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D010579 2006
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D010579 2000
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D010579 1996
% 217.66/217.87  |- skos__broader mesh__D010579smesh__D013701
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D010579 2004
% 217.66/217.87  |- skos__hiddenLabel mesh__D010579 Pyramid, Petrous
% 217.66/217.87  |- skos__hiddenLabel mesh__D010579 Bones, Petrous
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D010579 2005
% 217.66/217.87  |- mesh__recordOriginator mesh__D010579 NLM
% 217.66/217.87  |- skos__hiddenLabel mesh__D010579 Petrous Bones
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D010579 2003
% 217.66/217.87  |- rdf__type mesh__D010579sskos__Concept
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D010579 2002
% 217.66/217.87  |- skos__hiddenLabel mesh__D010579 Bone, Petrous
% 217.66/217.87  |- mesh__recordAuthorizer mesh__D010579 PLS
% 217.66/217.87  |- mesh__dateCreated mesh__D010579 1999-01-01
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D010579 1995
% 217.66/217.87  |- mesh__recordMaintainer mesh__D010579 TGC
% 217.66/217.87  |- mesh__dateRevised mesh__D010579 1991-01-08
% 217.66/217.87  |- skos__annotation mesh__D010579
% 217.66/217.87       fractures: coord PETROUS BONE /inj %28%IM%29% + SKULL FRACTURES %28%IM%29%; neopl: coord IM with SKULL NEOPLASMS %28%IM%29%%A%  
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D010579 1993
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D010579 1999
% 217.66/217.87  |- skos__hiddenLabel mesh__D010579 Pyramids, Petrous
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D010579 1994
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D010579 1997
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D010579 2001
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D010579 1992
% 217.66/217.87  |- skos__prefLabel mesh__D010579 Petrous Bone
% 217.66/217.87  |- skos__hiddenLabel mesh__D010579 Petrous Pyramids
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D010579 1998
% 217.66/217.87  |- mesh__publicMeSHNote mesh__D009227 75   
% 217.66/217.87  |- skos__historyNote mesh__D009227 Fatty Acids %28%1966-1974%29%
% 217.66/217.87  |- mesh__dateCreated mesh__D009227 1974-11-11
% 217.66/217.87  |- mesh__dateRevised mesh__D009227 2003-07-09
% 217.66/217.87  |- mesh__recordAuthorizer mesh__D009227 sjn
% 217.66/217.87  |- skos__prefLabel mesh__D009227 Myristic Acids
% 217.66/217.87  |- skos__hiddenLabel mesh__D009227 Acids, Myristic
% 217.66/217.87  |- skos__altLabel mesh__D009227 Tetradecanoic Acids
% 217.66/217.87  |- mesh__recordOriginator mesh__D009227 NLM
% 217.66/217.87  |- mesh__historyNote mesh__D009227 75   
% 217.66/217.87  |- mesh__dateEstablished mesh__D009227 1975-09-01
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D009227 2004
% 217.66/217.87  |- rdf__type mesh__D009227sskos__Concept
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D009227 2005
% 217.66/217.87  |- mesh__recordMaintainer mesh__D009227 ssb
% 217.66/217.87  |- skos__scopeNote mesh__D009227
% 217.66/217.87       14-carbon saturated monocarboxylic acids.     
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D009227 2006
% 217.66/217.87  |- skos__hiddenLabel mesh__D009227 Acids, Tetradecanoic
% 217.66/217.87  |- skos__broader mesh__D009227smesh__D005227
% 217.66/217.87  |- mesh__dateRevised mesh__D001244 1997-06-20
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001244 2006
% 217.66/217.87  |- mesh__historyNote mesh__D001244 66%28%65%29%   
% 217.66/217.87  |- skos__prefLabel mesh__D001244 Association
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001244 1998
% 217.66/217.87  |- mesh__recordAuthorizer mesh__D001244 SJN
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001244 2002
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001244 2005
% 217.66/217.87  |- skos__hiddenLabel mesh__D001244 Associations
% 217.66/217.87  |- mesh__dateCreated mesh__D001244 1999-01-01
% 217.66/217.87  |- rdf__type mesh__D001244sskos__Concept
% 217.66/217.87  |- mesh__publicMeSHNote mesh__D001244 66   
% 217.66/217.87  |- mesh__recordOriginator mesh__D001244 NLM
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001244 2001
% 217.66/217.87  |- skos__annotation mesh__D001244
% 217.66/217.87       a psychol or learning context; no qualif; DF: ASSOC   
% 217.66/217.87  |- skos__broader mesh__D001244smesh__D007858
% 217.66/217.87  |- skos__related mesh__D001244smesh__D014936
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001244 2004
% 217.66/217.87  |- skos__broader mesh__D001244smesh__D013811
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001244 2000
% 217.66/217.87  |- mesh__recordMaintainer mesh__D001244 PXP
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001244 1999
% 217.66/217.87  |- skos__scopeNote mesh__D001244
% 217.66/217.87       A functional relationship between psychological phenomena of such nature that the presence of one tends to evoke the other; also, the process by which such a relationship is established.%A%    
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001244 2003
% 217.66/217.87  |- mesh__dateEstablished mesh__D001244 1966-01-01
% 217.66/217.87  |- mesh__recordOriginator mesh__D019655 NDW
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D019655 2003
% 217.66/217.87  |- skos__hiddenLabel mesh__D019655 Quantitative Traits, Heritable
% 217.66/217.87  |- mesh__dateRevised mesh__D019655 2002-07-03
% 217.66/217.87  |- skos__broader mesh__D019655smesh__D040582
% 217.66/217.87  |- skos__related mesh__D019655smesh__D040641
% 217.66/217.87  |- mesh__recordMaintainer mesh__D019655 NNS
% 217.66/217.87  |- skos__scopeNote mesh__D019655
% 217.66/217.87       A characteristic showing quantitative inheritance such as SKIN PIGMENTATION in humans. %28%From A Dictionary of Genetics, 4th ed%29%%A%    
% 217.66/217.87  |- skos__related mesh__D019655smesh__D020412
% 217.66/217.87  |- mesh__historyNote mesh__D019655 1998   
% 217.66/217.87  |- skos__prefLabel mesh__D019655 Quantitative Trait, Heritable
% 217.66/217.87  |- skos__hiddenLabel mesh__D019655 Trait, Heritable Quantitative
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D019655 2006
% 217.66/217.87  |- skos__historyNote mesh__D019655 Phenotype %28%1968-1997%29%
% 217.66/217.87  |- skos__hiddenLabel mesh__D019655 Heritable Quantitative Traits
% 217.66/217.87  |- mesh__dateCreated mesh__D019655 1997-06-20
% 217.66/217.87  |- mesh__dateEstablished mesh__D019655 1998-01-01
% 217.66/217.87  |- skos__hiddenLabel mesh__D019655 Heritable Quantitative Trait
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D019655 2005
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D019655 2004
% 217.66/217.87  |- rdf__type mesh__D019655sskos__Concept
% 217.66/217.87  |- skos__hiddenLabel mesh__D019655 Traits, Heritable Quantitative
% 217.66/217.87  |- mesh__publicMeSHNote mesh__D019655
% 217.66/217.87       1998; see QUANTITATIVE TRAIT 1998-2002   
% 217.66/217.87  |- mesh__recordAuthorizer mesh__D019655 sjn
% 217.66/217.87  |- mesh__historyNote mesh__D011672 65   
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D011672 2005
% 217.66/217.87  |- mesh__recordMaintainer mesh__D011672 TAP
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D011672 2002
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D011672 1994
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D011672 1991
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D011672 2004
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D011672 1999
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D011672 1993
% 217.66/217.87  |- mesh__publicMeSHNote mesh__D011672 65   
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D011672 2001
% 217.66/217.87  |- mesh__recordAuthorizer mesh__D011672 PLS
% 217.66/217.87  |- rdf__type mesh__D011672sskos__Concept
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D011672 2003
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D011672 1998
% 217.66/217.87  |- skos__broader mesh__D011672smesh__D004708
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D011672 1992
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D011672 2000
% 217.66/217.87  |- mesh__dateRevised mesh__D011672 1990-03-22
% 217.66/217.87  |- skos__hiddenLabel mesh__D011672 Pulpotomies
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D011672 1997
% 217.66/217.87  |- mesh__dateCreated mesh__D011672 1999-01-01
% 217.66/217.87  |- skos__annotation mesh__D011672
% 217.66/217.87       removal of coronal portion of pulp: differentiate from PULPECTOMY; do not use /util except by MeSH definition%A%  
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D011672 2006
% 217.66/217.87  |- skos__prefLabel mesh__D011672 Pulpotomy
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D011672 1996
% 217.66/217.87  |- mesh__dateEstablished mesh__D011672 1965-01-01
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D011672 1995
% 217.66/217.87  |- mesh__recordOriginator mesh__D011672 NLM
% 217.66/217.87  |- skos__broader mesh__D005635smesh__D006598
% 217.66/217.87  |- skos__historyNote mesh__D005635 Hexosediphosphates %28%1973-1977%29%
% 217.66/217.87  |- mesh__recordOriginator mesh__D005635 RLS
% 217.66/217.87  |- mesh__recordAuthorizer mesh__D005635 sjn
% 217.66/217.87  |- rdf__type mesh__D005635sskos__Concept
% 217.66/217.87  |- mesh__historyNote mesh__D005635
% 217.66/217.87       91%28%78%29%; was see under HEXOSEDIPHOSPHATES 1978-90   
% 217.66/217.87  |- mesh__dateCreated mesh__D005635 1977-04-15
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D005635 2005
% 217.66/217.87  |- skos__historyNote mesh__D005635 Fructosephosphates %28%1971-1977%29%
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D005635 2006
% 217.66/217.87  |- mesh__recordMaintainer mesh__D005635 ssb
% 217.66/217.87  |- mesh__publicMeSHNote mesh__D005635
% 217.66/217.87       91; was see under HEXOSEDIPHOSPHATES 1978-90   
% 217.66/217.87  |- skos__broader mesh__D005635smesh__D005636
% 217.66/217.87  |- skos__scopeNote mesh__D005635
% 217.66/217.87       Diphosphoric acid esters of fructose. The fructose-1,6- diphosphate isomer is most prevalent. It is an important intermediate in the glycolysis process.%A%    
% 217.66/217.87  |- skos__prefLabel mesh__D005635 Fructosediphosphates
% 217.66/217.87  |- mesh__dateRevised mesh__D005635 2004-07-07
% 217.66/217.87  |- mesh__dateEstablished mesh__D005635 1991-01-01
% 217.66/217.87  |- skos__hiddenLabel mesh__D015265 Methylases, DNA-Adenine
% 217.66/217.87  |- skos__altLabel mesh__D015265
% 217.66/217.87       Modification Methylases %28%Adenine Specific%29%
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D015265 2005
% 217.66/217.87  |- skos__prefLabel mesh__D015265
% 217.66/217.87       Site-Specific DNA-Methyltransferase %28%Adenine-Specific%29%
% 217.66/217.87  |- skos__altLabel mesh__D015265
% 217.66/217.87       Site Specific Methyltransferases %28%Adenine Specific%29%
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D015265 2004
% 217.66/217.87  |- skos__altLabel mesh__D015265
% 217.66/217.87       Modification Methylases %28%Adenine-Specific%29%
% 217.66/217.87  |- mesh__recordMaintainer mesh__D015265 ssb
% 217.66/217.87  |- mesh__recordOriginator mesh__D015265 RLS
% 217.66/217.87  |- skos__hiddenLabel mesh__D015265 DNA Adenine Methylases
% 217.66/217.87  |- skos__altLabel mesh__D015265 DNA-Adenine Methylases
% 217.66/217.87  |- rdf__type mesh__D015265sskos__Concept
% 217.66/217.87  |- mesh__dateCreated mesh__D015265 1988-05-18
% 217.66/217.87  |- skos__scopeNote mesh__D015265
% 217.66/217.87       An enzyme responsible for producing a species-characteristic methylation pattern on adenine residues in a specific short base sequence in the host cell DNA. The enzyme catalyzes the methylation of DNA adenine in the presence of S-adenosyl-L-methionine to form DNA containing 6-methylaminopurine and S-adenosyl-L-homocysteine. EC 2.1.1.72.%A%    
% 217.66/217.87  |- mesh__historyNote mesh__D015265 98%28%89%29%   
% 217.66/217.87  |- skos__altLabel mesh__D015265
% 217.66/217.87       DNA Modification Methylases Adenine Specific
% 217.66/217.87  |- skos__altLabel mesh__D015265
% 217.66/217.87       DNA Modification Methylases %28%Adenine-Specific%29%
% 217.66/217.87  |- skos__altLabel mesh__D015265
% 217.66/217.87       Site-Specific Methyltransferases %28%Adenine-Specific%29%
% 217.66/217.87  |- mesh__recordAuthorizer mesh__D015265 sjn
% 217.66/217.87  |- skos__broader mesh__D015265smesh__D015254
% 217.66/217.87  |- mesh__publicMeSHNote mesh__D015265
% 217.66/217.87       98; see DNA MODIFICATION METHYLASES %28%ADENINE-SPECIFIC%29% 1989-97%A%  
% 217.66/217.87  |- skos__historyNote mesh__D015265 Methyltransferases %28%1971-1988%29%
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D015265 2006
% 217.66/217.87  |- mesh__dateEstablished mesh__D015265 1989-01-01
% 217.66/217.87  |- mesh__dateRevised mesh__D015265 2003-07-09
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D009228 2006
% 217.66/217.87  |- mesh__dateCreated mesh__D009228 1999-01-01
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D009228 2001
% 217.66/217.87  |- skos__scopeNote mesh__D009228
% 217.66/217.87       A philosophy based upon spiritual intuition that is believed to transcend ordinary sensory experiences or understanding.%A%    
% 217.66/217.87  |- mesh__recordMaintainer mesh__D009228 kle
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D009228 2005
% 217.66/217.87  |- skos__hiddenLabel mesh__D009228 Mysticisms
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D009228 2000
% 217.66/217.87  |- mesh__dateRevised mesh__D009228 1999-11-03
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D009228 2004
% 217.66/217.87  |- mesh__recordAuthorizer mesh__D009228 sjn
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D009228 2003
% 217.66/217.87  |- mesh__recordOriginator mesh__D009228 NLM
% 217.66/217.87  |- rdf__type mesh__D009228sskos__Concept
% 217.66/217.87  |- skos__prefLabel mesh__D009228 Mysticism
% 217.66/217.87  |- skos__broader mesh__D009228smesh__D012072
% 217.66/217.87  |- skos__annotation mesh__D009228 IM; specify geog if pertinent   
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D009228 2002
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001245 2000
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001245 2005
% 217.66/217.87  |- mesh__dateCreated mesh__D001245 1999-01-01
% 217.66/217.87  |- skos__annotation mesh__D001245 a form of learning; DF: ASSOC LEARNING   
% 217.66/217.87  |- mesh__dateEstablished mesh__D001245 1991-01-01
% 217.66/217.87  |- rdf__type mesh__D001245sskos__Concept
% 217.66/217.87  |- mesh__recordAuthorizer mesh__D001245 PLS
% 217.66/217.87  |- skos__broader mesh__D001245smesh__D001244
% 217.66/217.87  |- mesh__publicMeSHNote mesh__D001245 91; was see under LEARNING 1975-90   
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001245 2002
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001245 1997
% 217.66/217.87  |- skos__hiddenLabel mesh__D001245 Learnings, Association
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001245 2004
% 217.66/217.87  |- skos__prefLabel mesh__D001245 Association Learning
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001245 1996
% 217.66/217.87  |- skos__scopeNote mesh__D001245
% 217.66/217.87       The principle that items experienced together enter into a connection, so that one tends to reinstate the other.%A%    
% 217.66/217.87  |- mesh__historyNote mesh__D001245
% 217.66/217.87       91%28%75%29%; was see under LEARNING 1975-90   
% 217.66/217.87  |- mesh__dateRevised mesh__D001245 1994-05-12
% 217.66/217.87  |- mesh__recordMaintainer mesh__D001245 TGC
% 217.66/217.87  |- skos__hiddenLabel mesh__D001245 Association Learnings
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001245 1999
% 217.66/217.87  |- mesh__activeMeSHYear mesh__D001245 2003
% 217.66/217.87  |- mesh__recordOriginator mesh__D001245 NLM
% 217.66/217.88  |- skos__hiddenLabel mesh__D001245 Learning, Association
% 217.66/217.88  |- mesh__activeMeSHYear mesh__D001245 2001
% 217.66/217.88  |- mesh__activeMeSHYear mesh__D001245 1995
% 217.66/217.88  |- mesh__activeMeSHYear mesh__D001245 2006
% 217.66/217.88  |- mesh__onlineNote mesh__D001245 search LEARNING 1966-74   
% 217.66/217.88  |- mesh__activeMeSHYear mesh__D001245 1998
% 217.66/217.88  |- mesh__dateEstablished mesh__D019656 1998-01-01
% 217.66/217.88  |- skos__broader mesh__D019656smesh__D022981
% 217.66/217.88  |- skos__scopeNote mesh__D019656
% 217.66/217.88       The loss of one allele at a specific locus, caused by a deletion mutation; or loss of a chromosome from a chromosome pair, resulting in abnormal hemizygosity. It is detected when heterozygous markers for a locus appear monomorphic because one of the ALLELES was deleted. When this occurs at a tumor suppressor gene locus where one of the alleles is already abnormal, it can result in neoplastic transformation %28%CELL TRANSFORMATION, NEOPLASTIC%29%.%A%    
% 217.66/217.88  |- mesh__dateRevised mesh__D019656 2002-07-02
% 217.66/217.88  |- skos__altLabel mesh__D019656 Heterozygosity, Loss of
% 217.66/217.88  |- skos__altLabel mesh__D019656 LOH
% 217.66/217.88  |- mesh__recordAuthorizer mesh__D019656 sjn
% 217.66/217.88  |- skos__historyNote mesh__D019656 Heterozygote %28%1983-1997%29%
% 217.66/217.88  |- mesh__activeMeSHYear mesh__D019656 2006
% 217.66/217.88  |- mesh__publicMeSHNote mesh__D019656 98   
% 217.66/217.88  |- mesh__historyNote mesh__D019656 98   
% 217.66/217.88  |- mesh__recordOriginator mesh__D019656 AGS
% 217.66/217.88  |- skos__annotation mesh__D019656
% 217.66/217.88       do not confuse X ref ALLELIC LOSS with ALLELIC IMBALANCE   
% 217.66/217.88  |- skos__hiddenLabel mesh__D019656 Allelic Losses
% 217.66/217.88  |- mesh__activeMeSHYear mesh__D019656 2005
% 217.66/217.88  |- mesh__activeMeSHYear mesh__D019656 2004
% 217.66/217.88  |- skos__prefLabel mesh__D019656 Loss of Heterozygosity
% 217.66/217.88  |- mesh__dateCreated mesh__D019656 1997-07-14
% 217.66/217.88  |- rdf__type mesh__D019656sskos__Concept
% 217.66/217.88  |- skos__altLabel mesh__D019656 Allelic Loss
% 217.66/217.88  |- skos__historyNote mesh__D019656 Chromosome Deletion %28%1987-1997%29%
% 217.66/217.88  |- skos__hiddenLabel mesh__D019656 Heterozygosity Loss
% 217.66/217.88  |- mesh__activeMeSHYear mesh__D019656 2003
% 217.66/217.88  |- mesh__recordMaintainer mesh__D019656 nns
% 217.66/217.88  |- skos__historyNote mesh__D011673 Blood Flow Velocity %28%1966-1986%29%
% 217.66/217.88  |- skos__prefLabel mesh__D011673 Pulsatile Flow
% 217.66/217.88  |- mesh__historyNote mesh__D011673
% 217.66/217.88       91%28%87%29%; was see under RHEOLOGY 1987-90   
% 217.66/217.88  |- skos__hiddenLabel mesh__D011673 Flow, Pulsatile
% 217.66/217.88  |- mesh__dateRevised mesh__D011673 2003-07-09
% 217.66/217.88  |- skos__hiddenLabel mesh__D011673 Flows, Pulsating
% 217.66/217.88  |- mesh__dateCreated mesh__D011673 1986-06-20
% 217.66/217.88  |- skos__historyNote mesh__D011673 Models, Cardiovascular %28%1980-1986%29%
% 217.66/217.88  |- mesh__recordOriginator mesh__D011673 SH
% 217.66/217.88  |- skos__hiddenLabel mesh__D011673 Perfusions, Pulsatile
% 217.66/217.88  |- skos__related mesh__D011673smesh__D001775
% 217.66/217.88  |- skos__broader mesh__D011673smesh__D012212
% 217.66/217.88  |- mesh__recordMaintainer mesh__D011673 nns
% 217.66/217.88  |- skos__hiddenLabel mesh__D011673 Pulsatile Flows
% 217.66/217.88  |- skos__hiddenLabel mesh__D011673 Flows, Pulsatile
% 217.66/217.88  |- skos__hiddenLabel mesh__D011673 Pulsating Flow
% 217.66/217.88  |- skos__hiddenLabel mesh__D011673 Pulsatile Perfusions
% 217.66/217.88  |- mesh__activeMeSHYear mesh__D011673 2006
% 217.66/217.88  |- skos__annotation mesh__D011673 hematol or non-hematol application   
% 217.66/217.88  |- mesh__dateEstablished mesh__D011673 1991-01-01
% 217.66/217.88  |- skos__historyNote mesh__D011673 Rheology %28%1966-1986%29%
% 217.66/217.88  |- skos__hiddenLabel mesh__D011673 Pulsating Flows
% 217.66/217.88  |- mesh__activeMeSHYear mesh__D011673 2005
% 217.66/217.88  |- mesh__publicMeSHNote mesh__D011673 91; was see under RHEOLOGY 1987-90   
% 217.66/217.88  |- skos__hiddenLabel mesh__D011673 Pulsatile Perfusion
% 217.66/217.88  |- skos__altLabel mesh__D011673 Perfusion, Pulsatile
% 217.66/217.88  |- mesh__activeMeSHYear mesh__D011673 2004
% 217.66/217.88  |- mesh__recordAuthorizer mesh__D011673 sjn
% 217.66/217.88  |- skos__altLabel mesh__D011673 Flow, Pulsating
% 217.66/217.88  |- rdf__type mesh__D011673sskos__Concept
% 217.66/217.88  |- skos__historyNote mesh__D011673 Models, Biological %28%1966-1979%29%
% 217.66/217.88  |- skos__scopeNote mesh__D011673
% 217.66/217.88       Rhythmic, intermittent propagation of a fluid through a BLOOD VESSEL or piping system, in contrast to constant, smooth propagation, which produces laminar flow.%A%    
% 217.66/217.88  |- skos__prefLabel mesh__D005636 Fructosephosphates
% 217.66/217.88  |- mesh__recordAuthorizer mesh__D005636 sjn
% 217.66/217.88  |- mesh__dateEstablished mesh__D005636 1973-01-01
% 217.66/217.88  |- rdf__type mesh__D005636sskos__Concept
% 217.66/217.88  |- mesh__recordOriginator mesh__D005636 NLM
% 217.66/217.88  |- mesh__recordMaintainer mesh__D005636 ssb
% 217.66/217.88  |- skos__broader mesh__D005636smesh__D006600
% 217.66/217.88  |- mesh__activeMeSHYear mesh__D005636 2005
% 217.66/217.88  |- skos__historyNote mesh__D005636 Fructose %28%1966-1970%29%
% 217.66/217.88  |- mesh__activeMeSHYear mesh__D005636 2006
% 217.66/217.88  |- skos__historyNote mesh__D005636 Hexosephosphates %28%1966-1970%29%
% 217.66/217.88  |- mesh__dateRevised mesh__D005636 2004-07-07
% 217.66/217.88  |- mesh__publicMeSHNote mesh__D005636 73   
% 217.66/217.88  |- mesh__dateCreated mesh__D005636 1999-01-01
% 217.66/217.88  |- mesh__historyNote mesh__D005636 73%28%71%29%   
% 217.66/217.88  |- skos__prefLabel mesh__D015266 Carcinoma, Merkel Cell
% 217.66/217.88  |- mesh__activeMeSHYear mesh__D015266 2003
% 217.66/217.88  |- skos__historyNote mesh__D015266 Skin Neoplasms %28%1966-1988%29%
% 217.66/217.88  |- rdf__type mesh__D015266sskos__Concept
% 217.66/217.88  |- mesh__recordAuthorizer mesh__D015266 PLS
% 217.66/217.88  |- skos__hiddenLabel mesh__D015266 Tumor, Merkel Cell
% 217.66/217.88  |- mesh__activeMeSHYear mesh__D015266 2001
% 217.66/217.88  |- mesh__onlineNote mesh__D015266
% 217.66/217.88       use CARCINOMA, MERKEL CELL to search CARCINOMA, TRABECULAR 1992-93%A%  
% 217.66/217.88  |- mesh__activeMeSHYear mesh__D015266 1999
% 217.66/217.88  |- mesh__activeMeSHYear mesh__D015266 2000
% 217.66/217.88  |- skos__broader mesh__D015266smesh__D018278
% 217.66/217.88  |- skos__altLabel mesh__D015266 Merkel Cell Tumor
% 217.66/217.88  |- skos__scopeNote mesh__D015266
% 217.66/217.88       A carcinoma arising from MERKEL CELLS located in the basal layer of the epidermis and occurring most commonly as a primary neuroendocrine carcinoma of the skin. Merkel cells are tactile cells of neuroectodermal origin and histologically show neurosecretory granules. The skin of the head and neck are a common site of Merkel cell carcinoma, occurring generally in elderly patients. %28%Holland et al., Cancer Medicine, 3d ed, p1245%29%%A%    
% 217.66/217.88  |- mesh__activeMeSHYear mesh__D015266 2006
% 217.74/217.88  |- mesh__dateCreated mesh__D015266 1988-05-18
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D015266 1998
% 217.74/217.88  |- mesh__dateRevised mesh__D015266 1995-06-08
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D015266 1997
% 217.74/217.88  |- mesh__dateEstablished mesh__D015266 1989-01-01
% 217.74/217.88  |- mesh__recordMaintainer mesh__D015266 KEV
% 217.74/217.88  |- skos__hiddenLabel mesh__D015266 Merkel Cell Carcinoma
% 217.74/217.88  |- mesh__publicMeSHNote mesh__D015266
% 217.74/217.88       89; CARCINOMA, TRABECULAR was see CARCINOMA, MERKEL CELL 1992-93%A%  
% 217.74/217.88  |- mesh__historyNote mesh__D015266
% 217.74/217.88       89; CARCINOMA, TRABECULAR was see CARCINOMA, MERKEL CELL 1992-93%A%  
% 217.74/217.88  |- skos__annotation mesh__D015266
% 217.74/217.88       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with SKIN NEOPLASMS %28%IM%29%%A%  
% 217.74/217.88  |- mesh__recordOriginator mesh__D015266 EC
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D015266 2005
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D015266 2004
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D015266 1996
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D015266 2002
% 217.74/217.88  |- skos__annotation mesh__D009229
% 217.74/217.88       classical or modern; includes legends %26% folk tales; med mythology: do not coord with MEDICINE; DF: MYTHOL%A%  
% 217.74/217.88  |- skos__scopeNote mesh__D009229
% 217.74/217.88       A body of stories, the origins of which may be unknown or forgotten, that serve to explain practices, beliefs, institutions or natural phenomena. Mythology includes legends and folk tales. It may refer to classical mythology or to a body of modern thought and modern life. %28%From Webster%27%s 1st ed%29%%A%    
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D009229 2002
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D009229 1994
% 217.74/217.88  |- mesh__recordAuthorizer mesh__D009229 PLS
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D009229 1999
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D009229 2004
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D009229 2001
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D009229 1998
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D009229 2003
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D009229 2000
% 217.74/217.88  |- rdf__type mesh__D009229sskos__Concept
% 217.74/217.88  |- skos__broader mesh__D009229smesh__D008091
% 217.74/217.88  |- mesh__dateRevised mesh__D009229 1993-06-04
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D009229 1997
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D009229 2006
% 217.74/217.88  |- mesh__dateCreated mesh__D009229 1999-01-01
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D009229 1996
% 217.74/217.88  |- skos__prefLabel mesh__D009229 Mythology
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D009229 1995
% 217.74/217.88  |- mesh__recordMaintainer mesh__D009229 JLS
% 217.74/217.88  |- mesh__recordOriginator mesh__D009229 NLM
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D009229 2005
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D001246 1997
% 217.74/217.88  |- skos__prefLabel mesh__D001246 Astatine
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D001246 2004
% 217.74/217.88  |- mesh__recordOriginator mesh__D001246 NLM
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D001246 1996
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D001246 2001
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D001246 1999
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D001246 2003
% 217.74/217.88  |- mesh__recordMaintainer mesh__D001246 TPW
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D001246 2000
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D001246 1995
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D001246 2006
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D001246 1998
% 217.74/217.88  |- mesh__dateRevised mesh__D001246 1993-06-04
% 217.74/217.88  |- skos__broader mesh__D001246smesh__D006219
% 217.74/217.88  |- mesh__recordAuthorizer mesh__D001246 PLS
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D001246 2005
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D001246 1994
% 217.74/217.88  |- skos__annotation mesh__D001246 naturally radioactive; IM   
% 217.74/217.88  |- mesh__dateCreated mesh__D001246 1999-01-01
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D001246 2002
% 217.74/217.88  |- rdf__type mesh__D001246sskos__Concept
% 217.74/217.88  |- skos__scopeNote mesh__D001246
% 217.74/217.88       Astatine. A radioactive halogen with the atomic symbol At, atomic number 85, and atomic weight 210. Its isotopes range in mass number from 200 to 219 and all have an extremely short half-life. Astatine may be of use in the treatment of hyperthyroidism.%A%    
% 217.74/217.88  |- skos__broader mesh__D001246smesh__D004603
% 217.74/217.88  |- mesh__historyNote mesh__D020400 99   
% 217.74/217.88  |- rdf__type mesh__D020400sskos__Concept
% 217.74/217.88  |- skos__hiddenLabel mesh__D020400 Provider Sponsored Organizations
% 217.74/217.88  |- mesh__publicMeSHNote mesh__D020400 99   
% 217.74/217.88  |- skos__broader mesh__D020400smesh__D008329
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D020400 2005
% 217.74/217.88  |- skos__prefLabel mesh__D020400 Provider-Sponsored Organizations
% 217.74/217.88  |- skos__hiddenLabel mesh__D020400 Organization, Provider-Sponsored
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D020400 2003
% 217.74/217.88  |- mesh__recordMaintainer mesh__D020400 kle
% 217.74/217.88  |- skos__scopeNote mesh__D020400
% 217.74/217.88       Entities sponsored by local hospitals, physician groups, and other licensed providers which are affiliated through common ownership or control and share financial risk whose purpose is to deliver health care services.%A%    
% 217.74/217.88  |- mesh__recordOriginator mesh__D020400 JLS
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D020400 2006
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D020400 2004
% 217.74/217.88  |- mesh__recordAuthorizer mesh__D020400 sjn
% 217.74/217.88  |- skos__hiddenLabel mesh__D020400 Provider-Sponsored Organization
% 217.74/217.88  |- mesh__dateCreated mesh__D020400 1998-06-10
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D020400 2000
% 217.74/217.88  |- skos__broader mesh__D020400smesh__D019033
% 217.74/217.88  |- mesh__dateEstablished mesh__D020400 1999-01-01
% 217.74/217.88  |- mesh__dateRevised mesh__D020400 1999-11-03
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D020400 2001
% 217.74/217.88  |- skos__hiddenLabel mesh__D020400 Organizations, Provider-Sponsored
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D020400 2002
% 217.74/217.88  |- skos__hiddenLabel mesh__D047348 Tannins, Pyrogallol
% 217.74/217.88  |- skos__broader mesh__D047348smesh__D013634
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D047348 2005
% 217.74/217.88  |- skos__hiddenLabel mesh__D047348 Gallo Tannins
% 217.74/217.88  |- mesh__recordOriginator mesh__D047348 ssb
% 217.74/217.88  |- skos__altLabel mesh__D047348 Gallo-Tannins
% 217.74/217.88  |- skos__altLabel mesh__D047348 Ellagi-Tannins
% 217.74/217.88  |- mesh__publicMeSHNote mesh__D047348 2005   
% 217.74/217.88  |- skos__scopeNote mesh__D047348
% 217.74/217.88       Polymeric derivatives of GALLIC ACID that are esters of a sugar.%A%    
% 217.74/217.88  |- mesh__recordAuthorizer mesh__D047348 sjn
% 217.74/217.88  |- skos__historyNote mesh__D047348 Tannins %28%1963-2004%29%
% 217.74/217.88  |- skos__prefLabel mesh__D047348 Hydrolyzable Tannins
% 217.74/217.88  |- mesh__recordMaintainer mesh__D047348 ssb
% 217.74/217.88  |- skos__broader mesh__D047348smesh__D005707
% 217.74/217.88  |- skos__hiddenLabel mesh__D047348 Ellagi Tannins
% 217.74/217.88  |- mesh__historyNote mesh__D047348 2005   
% 217.74/217.88  |- mesh__dateCreated mesh__D047348 2004-07-07
% 217.74/217.88  |- rdf__type mesh__D047348sskos__Concept
% 217.74/217.88  |- skos__hiddenLabel mesh__D047348 Tannins, Hydrolyzable
% 217.74/217.88  |- mesh__dateEstablished mesh__D047348 2005-01-01
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D047348 2006
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D019657 2006
% 217.74/217.88  |- mesh__historyNote mesh__D019657 98   
% 217.74/217.88  |- skos__broader mesh__D019657smesh__D019684
% 217.74/217.88  |- mesh__dateEstablished mesh__D019657 1998-01-01
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D019657 2004
% 217.74/217.88  |- mesh__dateRevised mesh__D019657 2003-07-09
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D019657 2005
% 217.74/217.88  |- skos__annotation mesh__D019657
% 217.74/217.88       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.74/217.88  |- rdf__type mesh__D019657sskos__Concept
% 217.74/217.88  |- mesh__recordOriginator mesh__D019657 JLS
% 217.74/217.88  |- mesh__dateCreated mesh__D019657 1997-06-20
% 217.74/217.88  |- skos__prefLabel mesh__D019657 Solanaceae
% 217.74/217.88  |- mesh__recordAuthorizer mesh__D019657 sjn
% 217.74/217.88  |- skos__scopeNote mesh__D019657
% 217.74/217.88       A plant family of the order Solanales, subclass Asteridae. Among the most important are POTATOES; TOMATOES; CAPSICUM %28%green and red peppers%29%; TOBACCO; and BELLADONNA.%A%    
% 217.74/217.88  |- mesh__recordMaintainer mesh__D019657 ssb
% 217.74/217.88  |- mesh__publicMeSHNote mesh__D019657 98   
% 217.74/217.88  |- skos__scopeNote mesh__D011674
% 217.74/217.88       The rhythmical expansion and contraction of an ARTERY produced by waves of pressure caused by the ejection of BLOOD from the left ventricle of the HEART as it contracts.%A%    
% 217.74/217.88  |- mesh__recordAuthorizer mesh__D011674 sjn
% 217.74/217.88  |- mesh__dateCreated mesh__D011674 1999-01-01
% 217.74/217.88  |- skos__hiddenLabel mesh__D011674 Pulses
% 217.74/217.88  |- skos__broader mesh__D011674smesh__D045472
% 217.74/217.88  |- skos__related mesh__D011674smesh__D006339
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D011674 2006
% 217.74/217.88  |- skos__annotation mesh__D011674
% 217.74/217.88       do not add PULSE %28%NIM%29% for PULSE PRESSURE see BLOOD PRESSURE unless particularly discussed; Oriental taking of pulses = PULSE + appropriate acupuncture or Oriental medicine terms%A%  
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D011674 2005
% 217.74/217.88  |- mesh__recordOriginator mesh__D011674 NLM
% 217.74/217.88  |- mesh__recordMaintainer mesh__D011674 nns
% 217.74/217.88  |- skos__prefLabel mesh__D011674 Pulse
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D011674 2004
% 217.74/217.88  |- skos__broader mesh__D011674smesh__D006334
% 217.74/217.88  |- rdf__type mesh__D011674sskos__Concept
% 217.74/217.88  |- mesh__dateRevised mesh__D011674 2003-07-09
% 217.74/217.88  |- skos__broader mesh__D011674smesh__D010808
% 217.74/217.88  |- skos__broader mesh__D009294Q000037smesh__D009294
% 217.74/217.88  |- mesh__preferredCombination mesh__D009294Q000037smesh__D009292
% 217.74/217.88  |- rdf__type mesh__D009294Q000037smesh__CompoundConcept
% 217.74/217.88  |- skos__historyNote mesh__D005637 Uronic Acids %28%1974%29%
% 217.74/217.88  |- mesh__dateEstablished mesh__D005637 1991-01-01
% 217.74/217.88  |- skos__hiddenLabel mesh__D005637 Reductase, Fructuronate
% 217.74/217.88  |- skos__altLabel mesh__D005637 Mannonate Oxidoreductase
% 217.74/217.88  |- skos__scopeNote mesh__D005637
% 217.74/217.88       An enzyme that catalyzes the reversible oxidation of mannonate to fructuronate in the presence of NAD. Also reduces D-tagaturonate to D-altronate. EC 1.1.1.57.%A%    
% 217.74/217.88  |- skos__broader mesh__D005637smesh__D002237
% 217.74/217.88  |- rdf__type mesh__D005637sskos__Concept
% 217.74/217.88  |- skos__hiddenLabel mesh__D005637 Dehydrogenase, D-Mannonate-NAD
% 217.74/217.88  |- mesh__recordMaintainer mesh__D005637 ssb
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D005637 2004
% 217.74/217.88  |- mesh__recordAuthorizer mesh__D005637 sjn
% 217.74/217.88  |- mesh__recordOriginator mesh__D005637 NLM
% 217.74/217.88  |- mesh__dateRevised mesh__D005637 2003-07-09
% 217.74/217.88  |- skos__altLabel mesh__D005637 D-Mannonate-NAD Dehydrogenase
% 217.74/217.88  |- mesh__dateCreated mesh__D005637 1974-11-19
% 217.74/217.88  |- skos__prefLabel mesh__D005637 Fructuronate Reductase
% 217.74/217.88  |- mesh__publicMeSHNote mesh__D005637
% 217.74/217.88       91; was see under CARBOHYDRATE DEHYDROGENASES 1978-90; was see under ALCOHOL OXIDOREDUCTASES 1975-77%A%  
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D005637 2006
% 217.74/217.88  |- skos__hiddenLabel mesh__D005637 D Mannonate NAD Dehydrogenase
% 217.74/217.88  |- skos__hiddenLabel mesh__D005637 Oxidoreductase, Mannonate
% 217.74/217.88  |- mesh__historyNote mesh__D005637
% 217.74/217.88       91%28%75%29%; was see under CARBOHYDRATE DEHYDROGENASES 1978-90; was see under ALCOHOL OXIDOREDUCTASES 1975-77%A%  
% 217.74/217.88  |- skos__historyNote mesh__D005637 Alcohol Oxidoreductases %28%1974%29%
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D005637 2005
% 217.74/217.88  |- skos__altLabel mesh__D015267 Allergic Granulomatous Angiitis
% 217.74/217.88  |- skos__hiddenLabel mesh__D015267 Angiitides, Allergic Granulomatous
% 217.74/217.88  |- skos__hiddenLabel mesh__D015267 Allergic Granulomatous Angiitides
% 217.74/217.88  |- mesh__dateRevised mesh__D015267 1999-11-03
% 217.74/217.88  |- mesh__recordOriginator mesh__D015267 EC
% 217.74/217.88  |- skos__historyNote mesh__D015267 Granuloma %28%1966-1988%29%
% 217.74/217.88  |- skos__hiddenLabel mesh__D015267 Allergic Angiitides
% 217.74/217.88  |- rdf__type mesh__D015267sskos__Concept
% 217.74/217.88  |- skos__scopeNote mesh__D015267
% 217.74/217.88       Widespread necrotizing angiitis with granulomas. Pulmonary involvement is frequent. Asthma or other respiratory infection may precede evidence of vasculitis. Eosinophilia and lung involvement differentiate this disease from POLYARTERITIS NODOSA.%A%    
% 217.74/217.88  |- skos__hiddenLabel mesh__D015267 Vasculitis, Churg Strauss
% 217.74/217.88  |- skos__hiddenLabel mesh__D015267 Churg-Strauss Vasculitis
% 217.74/217.88  |- mesh__recordAuthorizer mesh__D015267 sjn
% 217.74/217.88  |- skos__prefLabel mesh__D015267 Churg-Strauss Syndrome
% 217.74/217.88  |- skos__broader mesh__D015267smesh__D014657
% 217.74/217.88  |- mesh__historyNote mesh__D015267 89   
% 217.74/217.88  |- skos__altLabel mesh__D015267 Angiitis, Allergic Granulomatous
% 217.74/217.88  |- skos__hiddenLabel mesh__D015267 Granulomatous Angiitides, Allergic
% 217.74/217.88  |- skos__historyNote mesh__D015267 Vasculitis %28%1966-1988%29%
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D015267 2005
% 217.74/217.88  |- skos__hiddenLabel mesh__D015267 Granulomatous Angiitis, Allergic
% 217.74/217.88  |- skos__altLabel mesh__D015267 Allergic Angiitis
% 217.74/217.88  |- skos__altLabel mesh__D015267 Vasculitis, Churg-Strauss
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D015267 2000
% 217.74/217.88  |- mesh__publicMeSHNote mesh__D015267 89   
% 217.74/217.88  |- skos__broader mesh__D015267smesh__D006099
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D015267 2003
% 217.74/217.88  |- skos__hiddenLabel mesh__D015267 Angiitis, Allergic
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D015267 2006
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D015267 2001
% 217.74/217.88  |- mesh__dateEstablished mesh__D015267 1989-01-01
% 217.74/217.88  |- mesh__recordMaintainer mesh__D015267 KEV
% 217.74/217.88  |- skos__hiddenLabel mesh__D015267 Syndrome, Churg-Strauss
% 217.74/217.88  |- skos__hiddenLabel mesh__D015267 Angiitides, Allergic
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D015267 2004
% 217.74/217.88  |- mesh__dateCreated mesh__D015267 1988-05-18
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D015267 2002
% 217.74/217.88  |- skos__hiddenLabel mesh__D015267 Churg Strauss Syndrome
% 217.74/217.88  |- mesh__dateEstablished mesh__D034421 2003-01-01
% 217.74/217.88  |- rdf__type mesh__D034421sskos__Concept
% 217.74/217.88  |- skos__hiddenLabel mesh__D034421 Pigs, Domestic
% 217.74/217.88  |- skos__altLabel mesh__D034421 Wild Boar
% 217.74/217.88  |- mesh__recordAuthorizer mesh__D034421 jls
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D034421 2006
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D034421 2005A
% 217.74/217.88  |- mesh__dateCreated mesh__D034421 2002-07-02
% 217.74/217.88  |- mesh__recordOriginator mesh__D034421 ags
% 217.74/217.88  |- mesh__recordMaintainer mesh__D034421 jls
% 217.74/217.88  |- skos__hiddenLabel mesh__D034421 Boars, Wild
% 217.74/217.88  |- skos__hiddenLabel mesh__D034421 Boar, Wild
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D034421 2005
% 217.74/217.88  |- skos__hiddenLabel mesh__D034421 Domestic Pig
% 217.74/217.88  |- skos__prefLabel mesh__D034421 Sus scrofa
% 217.74/217.88  |- skos__annotation mesh__D034421
% 217.74/217.88       only Sus scrofa; index other species or unspecified swine or pigs under SWINE%A%  
% 217.74/217.88  |- mesh__historyNote mesh__D034421 2003   
% 217.74/217.88  |- skos__altLabel mesh__D034421 Pig, Domestic
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D034421 2004
% 217.74/217.88  |- mesh__publicMeSHNote mesh__D034421 2003   
% 217.74/217.88  |- skos__hiddenLabel mesh__D034421 Wild Boars
% 217.74/217.88  |- skos__scopeNote mesh__D034421
% 217.74/217.88       A species of SWINE, in the family Suidae, comprising a number of subspecies including the domestic pig Sus scrofa domestica.%A%    
% 217.74/217.88  |- skos__broader mesh__D034421smesh__D013552
% 217.74/217.88  |- skos__hiddenLabel mesh__D034421 Domestic Pigs
% 217.74/217.88  |- mesh__dateRevised mesh__D034421 2004-08-02
% 217.74/217.88  |- skos__broader mesh__D001247smesh__D012816
% 217.74/217.88  |- mesh__recordOriginator mesh__D001247 NLM
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D001247 2001
% 217.74/217.88  |- mesh__recordAuthorizer mesh__D001247 sjn
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D001247 2004
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D001247 2000
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D001247 2003
% 217.74/217.88  |- skos__annotation mesh__D001247
% 217.74/217.88       NEUROCIRCULATORY ASTHENIA is also available   
% 217.74/217.88  |- skos__scopeNote mesh__D001247
% 217.74/217.88       Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.%A%    
% 217.74/217.88  |- skos__hiddenLabel mesh__D001247 Asthenias
% 217.74/217.88  |- mesh__dateCreated mesh__D001247 1999-01-01
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D001247 2006
% 217.74/217.88  |- rdf__type mesh__D001247sskos__Concept
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D001247 2002
% 217.74/217.88  |- skos__related mesh__D001247smesh__D018908
% 217.74/217.88  |- skos__related mesh__D001247smesh__D005221
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D001247 2005
% 217.74/217.88  |- mesh__recordMaintainer mesh__D001247 KEV
% 217.74/217.88  |- mesh__dateRevised mesh__D001247 1999-11-03
% 217.74/217.88  |- skos__prefLabel mesh__D001247 Asthenia
% 217.74/217.88  |- skos__related mesh__D001247smesh__D009440
% 217.74/217.88  |- mesh__recordMaintainer mesh__D006730 nns
% 217.74/217.88  |- skos__scopeNote mesh__D006730
% 217.74/217.88       A collective grouping for both naturally occurring and synthetic hormones, substitutes, and antagonists.%A%    
% 217.74/217.88  |- mesh__dateEstablished mesh__D006730 1998-01-01
% 217.74/217.88  |- mesh__historyNote mesh__D006730 98; use explode   
% 217.74/217.88  |- skos__annotation mesh__D006730
% 217.74/217.88       not used for indexing      CATALOG: do not use   
% 217.74/217.88  |- mesh__runningHead mesh__D006730
% 217.74/217.88       D6 - HORMONES, HORMONE SUBSTITUTES, AND HORMONE ANTAGONISTS%A%  
% 217.74/217.88  |- rdf__type mesh__D006730sskos__Concept
% 217.74/217.88  |- skos__prefLabel mesh__D006730
% 217.74/217.88       Hormones, Hormone Substitutes, and Hormone Antagonists
% 217.74/217.88  |- mesh__dateRevised mesh__D006730 2005-06-30
% 217.74/217.88  |- mesh__recordAuthorizer mesh__D006730 sjn
% 217.74/217.88  |- mesh__publicMeSHNote mesh__D006730 98   
% 217.74/217.88  |- mesh__recordOriginator mesh__D006730 NLM
% 217.74/217.88  |- skos__related mesh__D006730smesh__D052244
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D006730 2006
% 217.74/217.88  |- skos__altLabel mesh__D006730 Hormones, Substitutes, Antagonists
% 217.74/217.88  |- mesh__dateCreated mesh__D006730 1999-01-01
% 217.74/217.88  |- mesh__dateCreated mesh__D020401 1998-06-10
% 217.74/217.88  |- skos__broader mesh__D020401smesh__D016133
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D020401 2003
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D020401 2006
% 217.74/217.88  |- skos__historyNote mesh__D020401
% 217.74/217.88       In Situ Hybridization, Fluorescence %28%1993-1998%29%
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D020401 2005
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D020401 2002
% 217.74/217.88  |- mesh__dateEstablished mesh__D020401 1999-01-01
% 217.74/217.88  |- skos__prefLabel mesh__D020401 Primed In Situ Labeling
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D020401 2001
% 217.74/217.88  |- skos__broader mesh__D020401smesh__D017403
% 217.74/217.88  |- skos__scopeNote mesh__D020401
% 217.74/217.88       A technique that labels specific sequences in whole chromosomes by in situ DNA chain elongation or PCR %28%polymerase chain reaction%29%.%A%    
% 217.74/217.88  |- skos__altLabel mesh__D020401 DISC-PCR
% 217.74/217.88  |- mesh__publicMeSHNote mesh__D020401 99   
% 217.74/217.88  |- skos__altLabel mesh__D020401 In Situ Labeling, Primed
% 217.74/217.88  |- skos__altLabel mesh__D020401 Direct In Situ Copy PCR
% 217.74/217.88  |- skos__historyNote mesh__D020401 In Situ Hybridization %28%1993-1998%29%
% 217.74/217.88  |- skos__altLabel mesh__D020401 PRINS
% 217.74/217.88  |- rdf__type mesh__D020401sskos__Concept
% 217.74/217.88  |- mesh__dateRevised mesh__D020401 2000-06-22
% 217.74/217.88  |- mesh__historyNote mesh__D020401 99   
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D020401 2004
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D019658 2004
% 217.74/217.88  |- skos__scopeNote mesh__D019658
% 217.74/217.88       A plant family in the order Linales. These plants have simple leaves and regular flowers housing a compound ovary. Stamens are usually fused by their filaments.%A%    
% 217.74/217.88  |- mesh__activeMeSHYear mesh__D019658 2005
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D019658 2002
% 217.74/217.89  |- rdf__type mesh__D019658sskos__Concept
% 217.74/217.89  |- mesh__publicMeSHNote mesh__D019658 98   
% 217.74/217.89  |- mesh__recordOriginator mesh__D019658 JLS
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D019658 2003
% 217.74/217.89  |- skos__broader mesh__D019658smesh__D019684
% 217.74/217.89  |- mesh__dateEstablished mesh__D019658 1998-01-01
% 217.74/217.89  |- skos__prefLabel mesh__D019658 Linaceae
% 217.74/217.89  |- mesh__dateCreated mesh__D019658 1997-06-20
% 217.74/217.89  |- mesh__recordAuthorizer mesh__D019658 sjn
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D019658 2006
% 217.74/217.89  |- mesh__historyNote mesh__D019658 98   
% 217.74/217.89  |- mesh__recordMaintainer mesh__D019658 ssb
% 217.74/217.89  |- mesh__dateRevised mesh__D019658 2001-07-25
% 217.74/217.89  |- skos__annotation mesh__D019658
% 217.74/217.89       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.74/217.89  |- mesh__dateEstablished mesh__D011675 1991-01-01
% 217.74/217.89  |- skos__scopeNote mesh__D011675
% 217.74/217.89       Use of a pulse of X-rays or fast electrons to generate free radicals for spectroscopic examination.%A%    
% 217.74/217.89  |- skos__prefLabel mesh__D011675 Pulse Radiolysis
% 217.74/217.89  |- skos__annotation mesh__D011675 a type of spectrum anal; NIM   
% 217.74/217.89  |- mesh__recordOriginator mesh__D011675 NLM
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D011675 2006
% 217.74/217.89  |- mesh__dateCreated mesh__D011675 1974-11-11
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D011675 2005
% 217.74/217.89  |- mesh__publicMeSHNote mesh__D011675
% 217.74/217.89       91; was see under SPECTRUM ANALYSIS 1975-90   
% 217.74/217.89  |- mesh__historyNote mesh__D011675
% 217.74/217.89       91%28%75%29%; was see under SPECTRUM ANALYSIS 1975-90   
% 217.74/217.89  |- rdf__type mesh__D011675sskos__Concept
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D011675 2004
% 217.74/217.89  |- skos__broader mesh__D011675smesh__D013057
% 217.74/217.89  |- mesh__recordMaintainer mesh__D011675 lkt
% 217.74/217.89  |- skos__hiddenLabel mesh__D011675 Radiolysis, Pulse
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D011675 2003
% 217.74/217.89  |- mesh__dateRevised mesh__D011675 2002-07-03
% 217.74/217.89  |- mesh__recordAuthorizer mesh__D011675 sjn
% 217.74/217.89  |- skos__hiddenLabel mesh__D005638 Legume Pods
% 217.74/217.89  |- skos__annotation mesh__D005638
% 217.74/217.89       as plant %26% food; fruit as plant tissue: Manual 31.9   
% 217.74/217.89  |- rdf__type mesh__D005638sskos__Concept
% 217.74/217.89  |- mesh__dateCreated mesh__D005638 1999-01-01
% 217.74/217.89  |- mesh__recordMaintainer mesh__D005638 JLS
% 217.74/217.89  |- skos__hiddenLabel mesh__D005638 Plant Arils
% 217.74/217.89  |- skos__hiddenLabel mesh__D005638 Capsules, Plant
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D005638 2004
% 217.74/217.89  |- mesh__dateRevised mesh__D005638 2002-07-02
% 217.74/217.89  |- skos__scopeNote mesh__D005638
% 217.74/217.89       The fleshy or dry ripened ovary of a plant, enclosing the seed or seeds.%A%    
% 217.74/217.89  |- skos__hiddenLabel mesh__D005638 Fruits
% 217.74/217.89  |- skos__hiddenLabel mesh__D005638 Pod, Legume
% 217.74/217.89  |- skos__broader mesh__D005638smesh__D035261
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D005638 2003
% 217.74/217.89  |- skos__hiddenLabel mesh__D005638 Capsule, Plant
% 217.74/217.89  |- skos__hiddenLabel mesh__D005638 Berry
% 217.74/217.89  |- mesh__publicMeSHNote mesh__D005638 66   
% 217.74/217.89  |- mesh__historyNote mesh__D005638 66   
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D005638 2006
% 217.74/217.89  |- mesh__recordAuthorizer mesh__D005638 sjn
% 217.74/217.89  |- skos__broader mesh__D005638smesh__D005502
% 217.74/217.89  |- skos__hiddenLabel mesh__D005638 Plant Capsules
% 217.74/217.89  |- mesh__recordOriginator mesh__D005638 NLM
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D005638 2005
% 217.74/217.89  |- skos__hiddenLabel mesh__D005638 Aril, Plant
% 217.74/217.89  |- skos__prefLabel mesh__D005638 Fruit
% 217.74/217.89  |- skos__hiddenLabel mesh__D005638 Arils, Plant
% 217.74/217.89  |- skos__hiddenLabel mesh__D005638 Pods, Legume
% 217.74/217.89  |- mesh__recordOriginator mesh__D016360 PXP
% 217.74/217.89  |- skos__related mesh__D016360smesh__D004761
% 217.74/217.89  |- mesh__recordMaintainer mesh__D016360 SYSTEM
% 217.74/217.89  |- mesh__recordAuthorizer mesh__D016360 sjn
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D016360 2006
% 217.74/217.89  |- skos__prefLabel mesh__D016360 Clostridium difficile
% 217.74/217.89  |- skos__historyNote mesh__D016360 Clostridium %28%1976-1990%29%
% 217.74/217.89  |- mesh__historyNote mesh__D016360 91   
% 217.74/217.89  |- rdf__type mesh__D016360sskos__Concept
% 217.74/217.89  |- skos__broader mesh__D016360smesh__D003013
% 217.74/217.89  |- mesh__dateCreated mesh__D016360 1990-05-25
% 217.74/217.89  |- mesh__dateEstablished mesh__D016360 1991-01-01
% 217.74/217.89  |- mesh__publicMeSHNote mesh__D016360 91   
% 217.74/217.89  |- skos__annotation mesh__D016360
% 217.74/217.89       infection = probably ENTEROCOLITIS, PSEUDOMEMBRANOUS   
% 217.74/217.89  |- skos__scopeNote mesh__D016360
% 217.74/217.89       A common inhabitant of the colon flora in human infants and sometimes in adults. It produces a toxin that causes pseudomembranous enterocolitis %28%ENTEROCOLITIS, PSEUDOMEMBRANOUS%29% in patients receiving antibiotic therapy.%A%    
% 217.74/217.89  |- mesh__dateRevised mesh__D016360 2005-06-30
% 217.74/217.89  |- skos__altLabel mesh__D002340 Arterial Diseases, Carotid
% 217.74/217.89  |- skos__hiddenLabel mesh__D002340 Atherosclerotic Diseases, Carotid
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D002340 2003
% 217.74/217.89  |- mesh__recordMaintainer mesh__D002340 mdb
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D002340 2005
% 217.74/217.89  |- skos__hiddenLabel mesh__D002340 Carotid Arterial Diseases
% 217.74/217.89  |- skos__hiddenLabel mesh__D002340 Carotid Atherosclerotic Diseases
% 217.74/217.89  |- skos__altLabel mesh__D002340 Arterial Diseases, External Carotid
% 217.74/217.89  |- skos__altLabel mesh__D002340 Common Carotid Artery Diseases
% 217.74/217.89  |- skos__altLabel mesh__D002340 Atherosclerotic Disease, Carotid
% 217.74/217.89  |- skos__hiddenLabel mesh__D002340 Artery Diseases, Carotid
% 217.74/217.89  |- skos__prefLabel mesh__D002340 Carotid Artery Diseases
% 217.74/217.89  |- mesh__recordAuthorizer mesh__D002340 sjn
% 217.74/217.89  |- skos__annotation mesh__D002340
% 217.74/217.89       GEN or unspecified; coord IM with CAROTID ARTERY, COMMON; CAROTID ARTERY, INTERNAL or CAROTID ARTERY, EXTERNAL %28%IM%29% if pertinent%A%  
% 217.74/217.89  |- skos__altLabel mesh__D002340 Carotid Atherosclerotic Disease
% 217.74/217.89  |- skos__hiddenLabel mesh__D002340 Carotid Arterial Disease
% 217.74/217.89  |- skos__hiddenLabel mesh__D002340 Disorders, Carotid Artery
% 217.74/217.89  |- skos__altLabel mesh__D002340 Arterial Diseases, Internal Carotid
% 217.74/217.89  |- mesh__dateCreated mesh__D002340 1999-01-01
% 217.74/217.89  |- rdf__type mesh__D002340sskos__Concept
% 217.74/217.89  |- skos__hiddenLabel mesh__D002340 Carotid Artery Disorder
% 217.74/217.89  |- skos__hiddenLabel mesh__D002340 Artery Disorders, Carotid
% 217.74/217.89  |- skos__hiddenLabel mesh__D002340 Artery Disorder, Carotid
% 217.74/217.89  |- skos__hiddenLabel mesh__D002340 Arterial Disease, Carotid
% 217.74/217.89  |- skos__scopeNote mesh__D002340
% 217.74/217.89       Diseases of the common, internal, and external carotid arteries. ATHEROSCLEROSIS and trauma are relatively frequent causes of carotid artery pathology.%A%    
% 217.74/217.89  |- skos__hiddenLabel mesh__D002340 Carotid Artery Disease
% 217.74/217.89  |- mesh__recordOriginator mesh__D002340 NLM
% 217.74/217.89  |- skos__hiddenLabel mesh__D002340 Artery Disease, Carotid
% 217.74/217.89  |- skos__broader mesh__D002340smesh__D002561
% 217.74/217.89  |- skos__hiddenLabel mesh__D002340 Carotid Atheroscleroses
% 217.74/217.89  |- skos__altLabel mesh__D002340 Carotid Artery Disorders
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D002340 2004
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D002340 2002
% 217.74/217.89  |- mesh__dateRevised mesh__D002340 2001-07-25
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D002340 2006
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D001248 2004
% 217.74/217.89  |- skos__broader mesh__D001248smesh__D005128
% 217.74/217.89  |- skos__prefLabel mesh__D001248 Asthenopia
% 217.74/217.89  |- mesh__onlineNote mesh__D001248
% 217.74/217.89       use ASTHENOPIA to search EYESTRAIN 1966-67   
% 217.74/217.89  |- mesh__historyNote mesh__D001248 EYESTRAIN was heading 1963-67   
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D001248 1999
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D001248 2003
% 217.74/217.89  |- skos__altLabel mesh__D001248 Eyestrain
% 217.74/217.89  |- mesh__recordOriginator mesh__D001248 NLM
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D001248 1998
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D001248 2001
% 217.74/217.89  |- mesh__dateCreated mesh__D001248 1999-01-01
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D001248 2006
% 217.74/217.89  |- mesh__recordMaintainer mesh__D001248 TGC
% 217.74/217.89  |- skos__annotation mesh__D001248 ocular fatigue   
% 217.74/217.89  |- rdf__type mesh__D001248sskos__Concept
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D001248 2000
% 217.74/217.89  |- skos__altLabel mesh__D001248 Fatigue, Visual
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D001248 2005
% 217.74/217.89  |- skos__scopeNote mesh__D001248
% 217.74/217.89       Term generally used to describe complaints related to refractive error, ocular muscle imbalance, including pain or aching around the eyes, burning and itchiness of the eyelids, ocular fatigue, and headaches.%A%    
% 217.74/217.89  |- mesh__publicMeSHNote mesh__D001248 EYESTRAIN was heading 1963-67   
% 217.74/217.89  |- mesh__dateRevised mesh__D001248 1997-06-20
% 217.74/217.89  |- skos__altLabel mesh__D001248 Eye Fatigue
% 217.74/217.89  |- mesh__recordAuthorizer mesh__D001248 SJN
% 217.74/217.89  |- skos__hiddenLabel mesh__D001248 Fatigue, Eye
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D001248 2002
% 217.74/217.89  |- skos__altLabel mesh__D001248 Visual Fatigue
% 217.74/217.89  |- mesh__historyNote mesh__D020402 99   
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D020402 2005
% 217.74/217.89  |- mesh__dateCreated mesh__D020402 1998-06-10
% 217.74/217.89  |- skos__hiddenLabel mesh__D020402 Account, Medical Savings
% 217.74/217.89  |- skos__prefLabel mesh__D020402 Medical Savings Accounts
% 217.74/217.89  |- mesh__publicMeSHNote mesh__D020402 99   
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D020402 1999
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D020402 2002
% 217.74/217.89  |- mesh__dateEstablished mesh__D020402 1999-01-01
% 217.74/217.89  |- skos__altLabel mesh__D020402 Savings Accounts, Medical
% 217.74/217.89  |- skos__broader mesh__D020402smesh__D017047
% 217.74/217.89  |- skos__broader mesh__D020402smesh__D005382
% 217.74/217.89  |- rdf__type mesh__D020402sskos__Concept
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D020402 2001
% 217.74/217.89  |- skos__hiddenLabel mesh__D020402 Savings Account, Medical
% 217.74/217.89  |- skos__scopeNote mesh__D020402
% 217.74/217.89       Tax-exempt trusts or custodial accounts established by individuals with financial institutions for saving money for future medical expenses.%A%    
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D020402 2004
% 217.74/217.89  |- skos__altLabel mesh__D020402 Accounts, Medical Savings
% 217.74/217.89  |- skos__hiddenLabel mesh__D020402 Medical Savings Account
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D020402 2000
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D020402 2006
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D020402 2003
% 217.74/217.89  |- skos__broader mesh__D020402smesh__D007348
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D019659 2004
% 217.74/217.89  |- rdf__type mesh__D019659sskos__Concept
% 217.74/217.89  |- mesh__recordOriginator mesh__D019659 JLS
% 217.74/217.89  |- mesh__recordMaintainer mesh__D019659 ags
% 217.74/217.89  |- skos__scopeNote mesh__D019659
% 217.74/217.89       A large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes.  The common name of %22%daisy%22% refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.%A%    
% 217.74/217.89  |- mesh__publicMeSHNote mesh__D019659
% 217.74/217.89       1998; for DORONICUM see ARNICA 1996-2002   
% 217.74/217.89  |- mesh__historyNote mesh__D019659
% 217.74/217.89       1998; for DORONICUM use ARNICA 1996-2002   
% 217.74/217.89  |- skos__annotation mesh__D019659
% 217.74/217.89       X ref ENHYDRA FLUCTUANS: do not confuse with the sea otter ENHYDRA LUTRIS see OTTERS; prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.74/217.89  |- skos__altLabel mesh__D019659 Leopard%27%s Bane, False
% 217.74/217.89  |- mesh__dateRevised mesh__D019659 2005-07-08
% 217.74/217.89  |- mesh__recordAuthorizer mesh__D019659 ags
% 217.74/217.89  |- skos__broader mesh__D019659smesh__D019684
% 217.74/217.89  |- mesh__dateCreated mesh__D019659 1997-06-20
% 217.74/217.89  |- skos__prefLabel mesh__D019659 Asteraceae
% 217.74/217.89  |- mesh__dateEstablished mesh__D019659 1998-01-01
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D019659 2005
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D019659 2006
% 217.74/217.89  |- skos__altLabel mesh__D019659 Compositae
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D019659 2006A
% 217.74/217.89  |- mesh__recordMaintainer mesh__D011676 jls
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D011676 2005
% 217.74/217.89  |- mesh__recordAuthorizer mesh__D011676 sjn
% 217.74/217.89  |- mesh__dateRevised mesh__D011676 2004-07-07
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D011676 2006
% 217.74/217.89  |- skos__hiddenLabel mesh__D011676 Punched Card Systems
% 217.74/217.89  |- mesh__dateCreated mesh__D011676 1999-01-01
% 217.74/217.89  |- skos__broader mesh__D011676smesh__D001330
% 217.74/217.89  |- skos__hiddenLabel mesh__D011676 Systems, Punched-Card
% 217.74/217.89  |- skos__hiddenLabel mesh__D011676 Punched-Card System
% 217.74/217.89  |- rdf__type mesh__D011676sskos__Concept
% 217.74/217.89  |- mesh__recordOriginator mesh__D011676 NLM
% 217.74/217.89  |- skos__prefLabel mesh__D011676 Punched-Card Systems
% 217.74/217.89  |- skos__hiddenLabel mesh__D011676 System, Punched-Card
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D005639 1999
% 217.74/217.89  |- mesh__recordAuthorizer mesh__D005639 PLS
% 217.74/217.89  |- skos__hiddenLabel mesh__D005639 Frustrations
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D005639 1992
% 217.74/217.89  |- mesh__recordOriginator mesh__D005639 NLM
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D005639 1998
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D005639 2006
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D005639 2002
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D005639 1995
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D005639 2005
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D005639 1991
% 217.74/217.89  |- skos__annotation mesh__D005639 human %26% animal; no qualif   
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D005639 1994
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D005639 1997
% 217.74/217.89  |- rdf__type mesh__D005639sskos__Concept
% 217.74/217.89  |- mesh__dateRevised mesh__D005639 1989-04-28
% 217.74/217.89  |- mesh__recordMaintainer mesh__D005639 TGC
% 217.74/217.89  |- mesh__dateCreated mesh__D005639 1999-01-01
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D005639 2001
% 217.74/217.89  |- skos__broader mesh__D005639smesh__D004644
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D005639 1996
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D005639 2004
% 217.74/217.89  |- skos__prefLabel mesh__D005639 Frustration
% 217.74/217.89  |- skos__scopeNote mesh__D005639
% 217.74/217.89       The motivational and/or affective state resulting from being blocked, thwarted, disappointed or defeated.%A%    
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D005639 1990
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D005639 2000
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D005639 1993
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D005639 2003
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D016361 2006
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D016361 1997
% 217.74/217.89  |- mesh__historyNote mesh__D016361 91   
% 217.74/217.89  |- skos__scopeNote mesh__D016361
% 217.74/217.89       The state of legal insolvency with assets taken over by judicial process so that they may be distributed among creditors.%A%    
% 217.74/217.89  |- skos__hiddenLabel mesh__D016361 Insolvencies, Financial
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D016361 2003
% 217.74/217.89  |- mesh__dateRevised mesh__D016361 1993-09-16
% 217.74/217.89  |- skos__altLabel mesh__D016361 Financial Insolvency
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D016361 2000
% 217.74/217.89  |- skos__broader mesh__D016361smesh__D005376
% 217.74/217.89  |- rdf__type mesh__D016361sskos__Concept
% 217.74/217.89  |- skos__hiddenLabel mesh__D016361 Bankruptcies
% 217.74/217.89  |- mesh__recordAuthorizer mesh__D016361 NLM
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D016361 2004
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D016361 1995
% 217.74/217.89  |- skos__prefLabel mesh__D016361 Bankruptcy
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D016361 2001
% 217.74/217.89  |- mesh__dateEstablished mesh__D016361 1991-01-01
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D016361 1998
% 217.74/217.89  |- skos__hiddenLabel mesh__D016361 Insolvency, Financial
% 217.74/217.89  |- mesh__recordMaintainer mesh__D016361 PLS
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D016361 1999
% 217.74/217.89  |- mesh__recordOriginator mesh__D016361 JHM
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D016361 2005
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D016361 1996
% 217.74/217.89  |- skos__hiddenLabel mesh__D016361 Financial Insolvencies
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D016361 2002
% 217.74/217.89  |- mesh__dateCreated mesh__D016361 1990-05-25
% 217.74/217.89  |- mesh__publicMeSHNote mesh__D016361 91   
% 217.74/217.89  |- mesh__recordMaintainer mesh__D002341 KEV
% 217.74/217.89  |- skos__broader mesh__D002341smesh__D002340
% 217.74/217.89  |- mesh__recordOriginator mesh__D002341 NLM
% 217.74/217.89  |- mesh__dateCreated mesh__D002341 1999-01-01
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D002341 2000
% 217.74/217.89  |- mesh__dateRevised mesh__D002341 1999-11-04
% 217.74/217.89  |- mesh__dateEstablished mesh__D002341 1964-01-01
% 217.74/217.89  |- skos__altLabel mesh__D002341 Thrombosis, External Carotid Artery
% 217.74/217.89  |- skos__altLabel mesh__D002341 Carotid Thrombosis
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D002341 2001
% 217.74/217.89  |- skos__broader mesh__D002341smesh__D002542
% 217.74/217.89  |- skos__altLabel mesh__D002341 Thrombosis, Common Carotid Artery
% 217.74/217.89  |- skos__altLabel mesh__D002341 Thrombosis, Carotid
% 217.74/217.89  |- skos__hiddenLabel mesh__D002341 Carotid Artery Thromboses
% 217.74/217.89  |- rdf__type mesh__D002341sskos__Concept
% 217.74/217.89  |- skos__altLabel mesh__D002341 Thrombosis, Carotid Artery
% 217.74/217.89  |- skos__prefLabel mesh__D002341 Carotid Artery Thrombosis
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D002341 2003
% 217.74/217.89  |- skos__annotation mesh__D002341
% 217.74/217.89       coord IM with specific carotid artery %28%IM%29% if pertinent   
% 217.74/217.89  |- skos__scopeNote mesh__D002341
% 217.74/217.89       Blood clot formation in the common, internal, or external carotid artery which may produce stenosis or occlusion of the vessel, leading to ischemia or infarction of tissue supplied by these arteries. Thrombosis of the common and internal carotid arteries may result in ISCHEMIC ATTACKS, TRANSIENT; CEREBRAL INFARCTION; or AMAUROSIS FUGAX.%A%    
% 217.74/217.89  |- mesh__recordAuthorizer mesh__D002341 sjn
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D002341 2005
% 217.74/217.89  |- mesh__historyNote mesh__D002341 1964   
% 217.74/217.89  |- skos__altLabel mesh__D002341 Thrombosis, Internal Carotid Artery
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D002341 2004
% 217.74/217.89  |- mesh__publicMeSHNote mesh__D002341 1964   
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D002341 2002
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D002341 2006
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D015269 2006
% 217.74/217.89  |- mesh__dateEstablished mesh__D015269 1989-01-01
% 217.74/217.89  |- skos__scopeNote mesh__D015269
% 217.74/217.89       A complex that includes several strains of M. avium. M. intracellulare is not easily distinguished from M. avium and therefore is included in the complex. These organisms are most frequently found in pulmonary secretions from persons with a tuberculous-like mycobacteriosis. Strains of this complex have also been associated with childhood lymphadenitis and AIDS; M. avium alone causes tuberculosis in a variety of birds and other animals, including pigs.%A%    
% 217.74/217.89  |- skos__altLabel mesh__D015269 Mycobacterium intracellulare
% 217.74/217.89  |- mesh__dateRevised mesh__D015269 2005-06-30
% 217.74/217.89  |- skos__altLabel mesh__D015269 Mycobacterium avium-intracellulare Complex
% 217.74/217.89  |- mesh__recordMaintainer mesh__D015269 SYSTEM
% 217.74/217.89  |- skos__altLabel mesh__D015269 MAIC
% 217.74/217.89  |- mesh__recordOriginator mesh__D015269 EC
% 217.74/217.89  |- skos__annotation mesh__D015269
% 217.74/217.89       infection = MYCOBACTERIUM AVIUM INTRACELLULARE INFECTION; index also appropriate TUBERCULOSIS term for tuberculosis in animals caused by this organism; DF: MYCOBACT AVIUM COMPLEX or short X ref%A%  
% 217.74/217.89  |- skos__related mesh__D015269smesh__D009162
% 217.74/217.89  |- mesh__historyNote mesh__D015269
% 217.74/217.89       89; MAIC, MYCOBACTERIUM AVIUM-INTRACELLULARE %26% MYCOBACTERIUM INTRACELLULARE were see MYCOBACTERIUM AVIUM 1987-88%A%  
% 217.74/217.89  |- skos__broader mesh__D015269smesh__D009170
% 217.74/217.89  |- rdf__type mesh__D015269sskos__Concept
% 217.74/217.89  |- mesh__publicMeSHNote mesh__D015269
% 217.74/217.89       89; MAIC, MYCOBACTERIUM AVIUM-INTRACELLULARE %26% MYCOBACTERIUM INTRACELLULARE were see MYCOBACTERIUM AVIUM 1987-88%A%  
% 217.74/217.89  |- skos__prefLabel mesh__D015269 Mycobacterium avium Complex
% 217.74/217.89  |- skos__altLabel mesh__D015269 Mycobacterium avium-intracellulare
% 217.74/217.89  |- skos__historyNote mesh__D015269 Mycobacterium avium %28%1975-1988%29%
% 217.74/217.89  |- mesh__recordAuthorizer mesh__D015269 sjn
% 217.74/217.89  |- mesh__dateCreated mesh__D015269 1988-05-19
% 217.74/217.89  |- mesh__onlineNote mesh__D015269
% 217.74/217.89       use MYCOBACTERIUM AVIUM to search MAIC, MYCOBACTERIUM AVIUM-INTRACELLULARE %26% MYCOBACTERIUM INTRACELLULARE 1987-88%A%  
% 217.74/217.89  |- skos__altLabel mesh__D001249 Asthma, Bronchial
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D001249 2004
% 217.74/217.89  |- skos__annotation mesh__D001249
% 217.74/217.89       do not coord with BRONCHIAL DIS for X ref ASTHMA, BRONCHIAL; /drug ther: consider also ANTI-ASTHMATIC AGENTS; ASTHMA, CARDIAC see DYSPNEA, PAROXYSMAL is available%A%  
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D001249 2005
% 217.74/217.89  |- skos__broader mesh__D001249smesh__D008173
% 217.74/217.89  |- skos__scopeNote mesh__D001249
% 217.74/217.89       A form of bronchial disorder associated with airway obstruction, marked by recurrent attacks of paroxysmal dyspnea, with wheezing due to spasmodic contraction of the bronchi.%A%    
% 217.74/217.89  |- skos__broader mesh__D001249smesh__D001982
% 217.74/217.89  |- skos__hiddenLabel mesh__D001249 Bronchial Asthmas
% 217.74/217.89  |- skos__prefLabel mesh__D001249 Asthma
% 217.74/217.89  |- skos__hiddenLabel mesh__D001249 Asthmas, Bronchial
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D001249 2006
% 217.74/217.89  |- rdf__type mesh__D001249sskos__Concept
% 217.74/217.89  |- skos__hiddenLabel mesh__D001249 Asthmas
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D001249 2000
% 217.74/217.89  |- skos__related mesh__D001249smesh__D018927
% 217.74/217.89  |- mesh__recordOriginator mesh__D001249 NLM
% 217.74/217.89  |- skos__broader mesh__D001249smesh__D012130
% 217.74/217.89  |- mesh__recordMaintainer mesh__D001249 KEV
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D001249 2001
% 217.74/217.89  |- mesh__dateRevised mesh__D001249 1999-11-03
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D001249 2003
% 217.74/217.89  |- mesh__recordAuthorizer mesh__D001249 sjn
% 217.74/217.89  |- skos__altLabel mesh__D001249 Bronchial Asthma
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D001249 2002
% 217.74/217.89  |- mesh__dateCreated mesh__D001249 1999-01-01
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Bernards Syndrome
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Claude Bernard Horner Syndrome
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D006732 2004
% 217.74/217.89  |- mesh__recordMaintainer mesh__D006732 ags
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Ocular Ophthalmoplegias, Sympathetic
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Central Horner Syndrome
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Syndromes, Oculosympathetic
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Syndrome, Pupil Horner%27%s
% 217.74/217.89  |- skos__altLabel mesh__D006732 Horner%27%s Syndrome
% 217.74/217.89  |- skos__altLabel mesh__D006732 Sympathetic Ocular-Ophthalmoplegia
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Ophthalmoplegias, Sympathetic Ocular
% 217.74/217.89  |- skos__scopeNote mesh__D006732
% 217.74/217.89       A syndrome associated with defective sympathetic innervation to one side of the face, including the eye. Clinical features include MIOSIS; mild BLEPHAROPTOSIS; and hemifacial ANHIDROSIS %28%decreased sweating%29%%28%see HYPOHIDROSIS%29%. Lesions of the BRAIN STEM; cervical SPINAL CORD; first thoracic nerve root; apex of the LUNG; CAROTID ARTERY; CAVERNOUS SINUS; and apex of the ORBIT may cause this condition. %28%From Miller et al., Clinical Neuro-Ophthalmology, 4th ed, pp500-11%29%%A%    
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Pupil Horner%27%s Syndrome
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Bernard Syndromes
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Oculosympathetic Syndromes
% 217.74/217.89  |- skos__altLabel mesh__D006732 Bernard Syndrome
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D006732 2000A
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Sympathetic Ocular-Ophthalmoplegias
% 217.74/217.89  |- skos__altLabel mesh__D006732 Bernard%27%s Syndrome
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Syndrome, Bernard
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D006732 2000
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Sympathetic Ocular Ophthalmoplegia
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Syndrome, Bernard%27%s
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Ocular Ophthalmoplegia, Sympathetic
% 217.74/217.89  |- mesh__recordAuthorizer mesh__D006732 ags
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Syndrome, Horner
% 217.74/217.89  |- skos__altLabel mesh__D006732 Ophthalmoplegia, Sympathetic Ocular
% 217.74/217.89  |- skos__prefLabel mesh__D006732 Horner Syndrome
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Syndromes, Bernard
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Horners Syndrome, Pupil
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Horners Syndrome
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Syndrome, Central Horner
% 217.74/217.89  |- mesh__recordOriginator mesh__D006732 NLM
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Ocular-Ophthalmoplegias, Sympathetic
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D006732 2005
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D006732 2001
% 217.74/217.89  |- skos__broader mesh__D006732smesh__D015877
% 217.74/217.89  |- skos__altLabel mesh__D006732 Claude Bernard-Horner Syndrome
% 217.74/217.89  |- mesh__publicMeSHNote mesh__D006732
% 217.74/217.89       2000; see HORNER%27%S SYNDROME 1966-1999   
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Ocular-Ophthalmoplegia, Sympathetic
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Syndrome, Oculosympathetic
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Syndrome, Horner%27%s
% 217.74/217.89  |- rdf__type mesh__D006732sskos__Concept
% 217.74/217.89  |- mesh__dateCreated mesh__D006732 1999-01-01
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Syndrome, Claude Bernard-Horner
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Syndrome, Acquired Horner
% 217.74/217.89  |- skos__altLabel mesh__D006732 Oculosympathetic Syndrome
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D006732 2006
% 217.74/217.89  |- mesh__dateRevised mesh__D006732 1999-11-30
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D006732 2002
% 217.74/217.89  |- mesh__historyNote mesh__D006732 2000%28%1966%29%   
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D006732 2003
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Horner Syndrome, Pupil
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Sympathetic Ocular Ophthalmoplegias
% 217.74/217.89  |- skos__broader mesh__D006732smesh__D001342
% 217.74/217.89  |- skos__hiddenLabel mesh__D006732 Acquired Horner Syndrome
% 217.74/217.89  |- skos__hiddenLabel mesh__D020403 Selective Provider Restriction
% 217.74/217.89  |- mesh__recordOriginator mesh__D020403 JLS
% 217.74/217.89  |- skos__altLabel mesh__D020403 AWS-FOC Laws
% 217.74/217.89  |- mesh__recordMaintainer mesh__D020403 ags
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D020403 2001
% 217.74/217.89  |- skos__scopeNote mesh__D020403
% 217.74/217.89       Laws requiring patients under managed care programs to receive services from the physician or other provider of their choice. Any willing provider laws take many different forms, but they typically prohibit managed-care organizations from having a closed panel of physicians, hospitals, or other providers.%A%    
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D020403 2000
% 217.74/217.89  |- skos__altLabel mesh__D020403 Choice of Healthcare Provider Laws
% 217.74/217.89  |- rdf__type mesh__D020403sskos__Concept
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D020403 2004
% 217.74/217.89  |- skos__prefLabel mesh__D020403 Patient Freedom of Choice Laws
% 217.74/217.89  |- skos__altLabel mesh__D020403 Selective Provider Restrictions
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D020403 2000A
% 217.74/217.89  |- skos__broader mesh__D020403smesh__D008329
% 217.74/217.89  |- skos__broader mesh__D020403smesh__D007878
% 217.74/217.89  |- mesh__historyNote mesh__D020403 99   
% 217.74/217.89  |- mesh__activeMeSHYear mesh__D020403 2006
% 217.74/217.89  |- skos__hiddenLabel mesh__D020403 Restriction, Selective Provider
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D020403 2003
% 217.74/217.90  |- skos__hiddenLabel mesh__D020403 Provider Restriction, Selective
% 217.74/217.90  |- mesh__dateCreated mesh__D020403 1998-06-10
% 217.74/217.90  |- skos__altLabel mesh__D020403 Choice of Health Care Provider Laws
% 217.74/217.90  |- mesh__dateEstablished mesh__D020403 1999-01-01
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D020403 2005
% 217.74/217.90  |- mesh__dateRevised mesh__D020403 1999-12-28
% 217.74/217.90  |- skos__hiddenLabel mesh__D020403 Restrictions, Selective Provider
% 217.74/217.90  |- mesh__recordAuthorizer mesh__D020403 ags
% 217.74/217.90  |- skos__hiddenLabel mesh__D020403 Provider Restrictions, Selective
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D020403 2002
% 217.74/217.90  |- skos__hiddenLabel mesh__D020403 Any-Willing-Provider-Law
% 217.74/217.90  |- skos__altLabel mesh__D020403 Any-Willing-Provider-Laws
% 217.74/217.90  |- mesh__publicMeSHNote mesh__D020403 99   
% 217.74/217.90  |- skos__altLabel mesh__D050090 True Hermaphroditism
% 217.74/217.90  |- skos__broader mesh__D050090smesh__D006546
% 217.74/217.90  |- mesh__dateEstablished mesh__D050090 2006-01-01
% 217.74/217.90  |- skos__historyNote mesh__D050090 Hermaphroditism %28%1964-2005%29%
% 217.74/217.90  |- mesh__recordOriginator mesh__D050090 lkt
% 217.74/217.90  |- skos__prefLabel mesh__D050090 Hermaphroditism, True
% 217.74/217.90  |- mesh__historyNote mesh__D050090 2006   
% 217.74/217.90  |- skos__scopeNote mesh__D050090
% 217.74/217.90       A rare condition of sexual ambiguity in which the individual possesses gonadal tissues of both SEXES, tissues from the OVARY and the TESTIS. There can be a testis on one side and an ovary on the other %28%lateral%29%, or there may be combined ovarian and testicular tissue %28%ovotestes%29% on each side %28%bilateral%29%. Most common karyotype is 46,XX. Others include 46,XY and 45,X/XY.%A%    
% 217.74/217.90  |- mesh__recordMaintainer mesh__D050090 lkt
% 217.74/217.90  |- mesh__dateCreated mesh__D050090 2005-06-30
% 217.74/217.90  |- rdf__type mesh__D050090sskos__Concept
% 217.74/217.90  |- mesh__recordAuthorizer mesh__D050090 sjn
% 217.74/217.90  |- mesh__publicMeSHNote mesh__D050090 2006   
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D050090 2006
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011677 2005
% 217.74/217.90  |- skos__related mesh__D011677smesh__D019152
% 217.74/217.90  |- skos__broader mesh__D011677smesh__D013812
% 217.74/217.90  |- skos__prefLabel mesh__D011677 Punctures
% 217.74/217.90  |- skos__hiddenLabel mesh__D011677 Micropuncture
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011677 2006
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011677 1998
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011677 2000
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011677 2003
% 217.74/217.90  |- mesh__dateCreated mesh__D011677 1999-01-01
% 217.74/217.90  |- skos__scopeNote mesh__D011677
% 217.74/217.90       Incision of tissues for injection of medication or for other diagnostic or therapeutic procedures. Punctures of the skin, for example may be used for diagnostic drainage; of blood vessels for diagnostic imaging procedures.%A%    
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011677 1999
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011677 2001
% 217.74/217.90  |- skos__broader mesh__D011677smesh__D013048
% 217.74/217.90  |- rdf__type mesh__D011677sskos__Concept
% 217.74/217.90  |- skos__hiddenLabel mesh__D011677 Puncture
% 217.74/217.90  |- skos__annotation mesh__D011677
% 217.74/217.90       restrict to penetration procedures for diag or ther: do not confuse with traumatic punctures %28% = WOUNDS, PENETRATING or specific%29%; do not use /util except by MeSH definition%A%  
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011677 2004
% 217.74/217.90  |- mesh__recordAuthorizer mesh__D011677 SJN
% 217.74/217.90  |- mesh__recordMaintainer mesh__D011677 PXP
% 217.74/217.90  |- mesh__dateRevised mesh__D011677 1997-06-20
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011677 2002
% 217.74/217.90  |- mesh__recordOriginator mesh__D011677 NLM
% 217.74/217.90  |- skos__altLabel mesh__D016362 Obstetrical Analgesia
% 217.74/217.90  |- mesh__recordMaintainer mesh__D016362 lkt
% 217.74/217.90  |- mesh__dateRevised mesh__D016362 2004-07-07
% 217.74/217.90  |- skos__annotation mesh__D016362
% 217.74/217.90       do not confuse with ANESTHESIA, OBSTETRICAL; coordinate IM with specific type of analgesia %28%IM%29% or analgesic %28%IM%29%%A%  
% 217.74/217.90  |- mesh__dateCreated mesh__D016362 1990-05-25
% 217.74/217.90  |- mesh__dateEstablished mesh__D016362 1991-01-01
% 217.74/217.90  |- mesh__publicMeSHNote mesh__D016362 91   
% 217.74/217.90  |- mesh__recordOriginator mesh__D016362 MXR
% 217.74/217.90  |- skos__altLabel mesh__D016362 Analgesia, Obstetric
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D016362 2005
% 217.74/217.90  |- skos__historyNote mesh__D016362 Anesthesia, Epidural %28%1976-1990%29%
% 217.74/217.90  |- skos__historyNote mesh__D016362
% 217.74/217.90       Anesthesia, Obstetrical %28%1976-1990%29%
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D016362 2006
% 217.74/217.90  |- mesh__historyNote mesh__D016362 91   
% 217.74/217.90  |- skos__prefLabel mesh__D016362 Analgesia, Obstetrical
% 217.74/217.90  |- mesh__recordAuthorizer mesh__D016362 sjn
% 217.74/217.90  |- skos__historyNote mesh__D016362 Analgesia %28%1966-1990%29%
% 217.74/217.90  |- skos__broader mesh__D016362smesh__D000698
% 217.74/217.90  |- rdf__type mesh__D016362sskos__Concept
% 217.74/217.90  |- skos__hiddenLabel mesh__D016362 Obstetric Analgesia
% 217.74/217.90  |- skos__scopeNote mesh__D016362
% 217.74/217.90       The elimination of PAIN, without the loss of CONSCIOUSNESS, during OBSTETRIC LABOR; OBSTETRIC DELIVERY; or the POSTPARTUM PERIOD, usually through the administration of ANALGESICS.%A%    
% 217.74/217.90  |- skos__scopeNote mesh__D002342
% 217.74/217.90       Branch of the common carotid artery which supplies the exterior of the head, the face, and the greater part of the neck.%A%    
% 217.74/217.90  |- mesh__dateCreated mesh__D002342 1999-01-01
% 217.74/217.90  |- skos__hiddenLabel mesh__D002342 External Carotid Arteries
% 217.74/217.90  |- skos__prefLabel mesh__D002342 Carotid Artery, External
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D002342 2002
% 217.74/217.90  |- skos__historyNote mesh__D002342 Carotid Arteries %28%1966-1971%29%
% 217.74/217.90  |- skos__hiddenLabel mesh__D002342 External Carotid Artery
% 217.74/217.90  |- skos__hiddenLabel mesh__D002342 Carotid Arteries, External
% 217.74/217.90  |- mesh__recordOriginator mesh__D002342 NLM
% 217.74/217.90  |- skos__hiddenLabel mesh__D002342 Arteries, External Carotid
% 217.74/217.90  |- skos__annotation mesh__D002342
% 217.74/217.90       dis: coord IM with CAROTID ARTERY DISEASES %28%IM%29%; inj: coord IM with CAROTID ARTERY INJURIES %28%IM%29% or specifics %28%IM%29%%A%  
% 217.74/217.90  |- rdf__type mesh__D002342sskos__Concept
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D002342 2003
% 217.74/217.90  |- skos__hiddenLabel mesh__D002342 Artery, External Carotid
% 217.74/217.90  |- mesh__publicMeSHNote mesh__D002342 74   
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D002342 2005
% 217.74/217.90  |- mesh__historyNote mesh__D002342 74%28%72%29%   
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D002342 2000
% 217.74/217.90  |- skos__broader mesh__D002342smesh__D017536
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D002342 2004
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D002342 2001
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D002342 2006
% 217.74/217.90  |- mesh__dateRevised mesh__D002342 1999-11-03
% 217.74/217.90  |- mesh__dateEstablished mesh__D002342 1974-01-01
% 217.74/217.90  |- mesh__recordMaintainer mesh__D002342 KEV
% 217.74/217.90  |- mesh__recordAuthorizer mesh__D002342 sjn
% 217.74/217.90  |- skos__annotation mesh__D040461
% 217.74/217.90       general; prefer specifics; do not confuse with GENOME COMPONENTS%A%  
% 217.74/217.90  |- skos__hiddenLabel mesh__D040461 Components, Gene
% 217.74/217.90  |- mesh__dateEstablished mesh__D040461 2003-01-01
% 217.74/217.90  |- mesh__recordOriginator mesh__D040461 nns
% 217.74/217.90  |- skos__hiddenLabel mesh__D040461 Component, Gene
% 217.74/217.90  |- skos__prefLabel mesh__D040461 Gene Components
% 217.74/217.90  |- mesh__dateCreated mesh__D040461 2002-07-03
% 217.74/217.90  |- skos__hiddenLabel mesh__D040461 Gene Component
% 217.74/217.90  |- mesh__historyNote mesh__D040461 2003   
% 217.74/217.90  |- skos__scopeNote mesh__D040461
% 217.74/217.90       The parts of the gene sequence that carry out the different functions of the GENES.%A%    
% 217.74/217.90  |- mesh__recordAuthorizer mesh__D040461 sjn
% 217.74/217.90  |- mesh__recordMaintainer mesh__D040461 nns
% 217.74/217.90  |- skos__broader mesh__D040461smesh__D005796
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D040461 2006
% 217.74/217.90  |- mesh__dateRevised mesh__D040461 2005-06-30
% 217.74/217.90  |- rdf__type mesh__D040461sskos__Concept
% 217.74/217.90  |- mesh__publicMeSHNote mesh__D040461 2003   
% 217.74/217.90  |- skos__historyNote mesh__D012770 Shock %28%1966-1970%29%
% 217.74/217.90  |- skos__broader mesh__D012770smesh__D012769
% 217.74/217.90  |- mesh__publicMeSHNote mesh__D012770 71   
% 217.74/217.90  |- mesh__recordMaintainer mesh__D012770 ssb
% 217.74/217.90  |- mesh__recordOriginator mesh__D012770 NLM
% 217.74/217.90  |- skos__broader mesh__D012770smesh__D009203
% 217.74/217.90  |- rdf__type mesh__D012770sskos__Concept
% 217.74/217.90  |- skos__prefLabel mesh__D012770 Shock, Cardiogenic
% 217.74/217.90  |- skos__historyNote mesh__D012770 Myocardial Infarction %28%1966-1970%29%
% 217.74/217.90  |- mesh__dateRevised mesh__D012770 2005-06-30
% 217.74/217.90  |- mesh__dateEstablished mesh__D012770 1971-01-01
% 217.74/217.90  |- skos__scopeNote mesh__D012770
% 217.74/217.90       Shock resulting from diminution of cardiac output in heart disease.%A%    
% 217.74/217.90  |- mesh__dateCreated mesh__D012770 1999-01-01
% 217.74/217.90  |- mesh__historyNote mesh__D012770 71   
% 217.74/217.90  |- skos__hiddenLabel mesh__D012770 Cardiogenic Shock
% 217.74/217.90  |- mesh__recordAuthorizer mesh__D012770 sjn
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D012770 2006
% 217.74/217.90  |- rdf__type mesh__D006733sskos__Concept
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D006733 2005
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D006733 1993
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D006733 1995
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D006733 1991
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D006733 2004
% 217.74/217.90  |- skos__annotation mesh__D006733
% 217.74/217.90       animal anat only: not for cutaneous horn %28% = SKIN DISEASES or SKIN /abnorm%29%; horn cancer: coord IM with NEOPLASMS /vet %28%IM%29% + histol type of neopl /vet %28%IM%29%%A%  
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D006733 2006
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D006733 2002
% 217.74/217.90  |- mesh__recordAuthorizer mesh__D006733 NLM
% 217.74/217.90  |- skos__historyNote mesh__D006733 specific animal %28%1966-1967%29%
% 217.74/217.90  |- mesh__dateRevised mesh__D006733 1984-06-05
% 217.74/217.90  |- mesh__historyNote mesh__D006733 68   
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D006733 1989
% 217.74/217.90  |- mesh__dateEstablished mesh__D006733 1968-01-01
% 217.74/217.90  |- skos__broader mesh__D006733smesh__D000825
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D006733 2000
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D006733 1996
% 217.74/217.90  |- mesh__recordMaintainer mesh__D006733 RRC
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D006733 1990
% 217.74/217.90  |- skos__hiddenLabel mesh__D006733 Horn
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D006733 2001
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D006733 1998
% 217.74/217.90  |- mesh__recordOriginator mesh__D006733 NLM
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D006733 1997
% 217.74/217.90  |- mesh__dateCreated mesh__D006733 1999-01-01
% 217.74/217.90  |- mesh__publicMeSHNote mesh__D006733 68   
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D006733 1992
% 217.74/217.90  |- skos__prefLabel mesh__D006733 Horns
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D006733 1994
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D006733 2003
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D006733 1999
% 217.74/217.90  |- rdf__type mesh__D020404sskos__Concept
% 217.74/217.90  |- mesh__historyNote mesh__D020404
% 217.74/217.90       99; for PHOSPHOGLYCERIDES use GLYCEROPHOSPHATES 1977-98   
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D020404 2004
% 217.74/217.90  |- skos__altLabel mesh__D020404 Phosphoglycerides
% 217.74/217.90  |- skos__historyNote mesh__D020404 Phosphatidic Acids %28%1977-1998%29%
% 217.74/217.90  |- skos__scopeNote mesh__D020404
% 217.74/217.90       Derivatives of phosphatidic acid in which the hydrophobic regions are composed of two fatty acids and a polar alcohol is joined to the C-3 position of glycerol through a phosphodiester bond. They are named according to their polar head groups, such as phosphatidylcholine and phosphatidylethanolamine.%A%    
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D020404 2006
% 217.74/217.90  |- mesh__dateRevised mesh__D020404 2003-07-09
% 217.74/217.90  |- skos__broader mesh__D020404smesh__D010712
% 217.74/217.90  |- skos__prefLabel mesh__D020404 Glycerophospholipids
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D020404 2005
% 217.74/217.90  |- mesh__publicMeSHNote mesh__D020404
% 217.74/217.90       99; for PHOSPHOGLYCERIDES see GLYCEROPHOSPHATES 1977-98   
% 217.74/217.90  |- mesh__dateCreated mesh__D020404 1998-06-10
% 217.74/217.90  |- mesh__dateEstablished mesh__D020404 1999-01-01
% 217.74/217.90  |- mesh__dateCreated mesh__D050091 2005-06-30
% 217.74/217.90  |- skos__altLabel mesh__D050091 Dendritic Compounds
% 217.74/217.90  |- mesh__recordOriginator mesh__D050091 ssb
% 217.74/217.90  |- mesh__recordAuthorizer mesh__D050091 sjn
% 217.74/217.90  |- skos__altLabel mesh__D050091 Dendrons
% 217.74/217.90  |- rdf__type mesh__D050091sskos__Concept
% 217.74/217.90  |- mesh__dateEstablished mesh__D050091 2006-01-01
% 217.74/217.90  |- mesh__publicMeSHNote mesh__D050091 2006   
% 217.74/217.90  |- skos__historyNote mesh__D050091 Polymers %28%1990-2005%29%
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D050091 2006
% 217.74/217.90  |- mesh__recordMaintainer mesh__D050091 ssb
% 217.74/217.90  |- skos__prefLabel mesh__D050091 Dendrimers
% 217.74/217.90  |- mesh__historyNote mesh__D050091 2006   
% 217.74/217.90  |- skos__scopeNote mesh__D050091
% 217.74/217.90       Compounds comprising branches from an inner core. The overall globular shape and presence of cavities gives potential as DRUG CARRIERS.%A%    
% 217.74/217.90  |- skos__annotation mesh__D050091
% 217.74/217.90       coordinate with compounds comprising the dendrimers   
% 217.74/217.90  |- skos__broader mesh__D050091smesh__D046911
% 217.74/217.90  |- mesh__dateCreated mesh__D011678 1999-01-01
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011678 1999
% 217.74/217.90  |- rdf__type mesh__D011678sskos__Concept
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011678 2004
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011678 1996
% 217.74/217.90  |- skos__broader mesh__D011678smesh__D012054
% 217.74/217.90  |- skos__scopeNote mesh__D011678
% 217.74/217.90       The application of an unpleasant stimulus or penalty for the purpose of eliminating or correcting undesirable behavior.%A%    
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011678 2002
% 217.74/217.90  |- mesh__recordOriginator mesh__D011678 NLM
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011678 1997
% 217.74/217.90  |- skos__prefLabel mesh__D011678 Punishment
% 217.74/217.90  |- skos__broader mesh__D011678smesh__D012927
% 217.74/217.90  |- mesh__recordAuthorizer mesh__D011678 PLS
% 217.74/217.90  |- skos__hiddenLabel mesh__D011678 Punishments
% 217.74/217.90  |- mesh__recordMaintainer mesh__D011678 KEV
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011678 2005
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011678 2000
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011678 2006
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011678 1998
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011678 2001
% 217.74/217.90  |- mesh__dateRevised mesh__D011678 1995-05-23
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011678 2003
% 217.74/217.90  |- skos__annotation mesh__D011678 human %26% animal   
% 217.74/217.90  |- mesh__recordAuthorizer mesh__D016363 sjn
% 217.74/217.90  |- skos__hiddenLabel mesh__D016363 Antitrust Act, Sherman
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D016363 2001
% 217.74/217.90  |- mesh__dateEstablished mesh__D016363 1991-01-01
% 217.74/217.90  |- skos__hiddenLabel mesh__D016363 Liabilities, Antitrust
% 217.74/217.90  |- skos__annotation mesh__D016363 specify geog   
% 217.74/217.90  |- skos__hiddenLabel mesh__D016363 Antitrust Law
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D016363 2005
% 217.74/217.90  |- skos__broader mesh__D016363smesh__D007878
% 217.74/217.90  |- skos__historyNote mesh__D016363
% 217.74/217.90       Economics/legislation %26% jurisprudence %28%1982-1990%29%
% 217.74/217.90  |- mesh__recordOriginator mesh__D016363 JHM
% 217.74/217.90  |- skos__hiddenLabel mesh__D016363 Act, Sherman Antitrust
% 217.74/217.90  |- mesh__recordMaintainer mesh__D016363 kle
% 217.74/217.90  |- skos__historyNote mesh__D016363
% 217.74/217.90       Economic Competition/legislation %26% jurisprudence %28%1982-1990%29%
% 217.74/217.90  |- skos__hiddenLabel mesh__D016363 Law, Antitrust
% 217.74/217.90  |- skos__hiddenLabel mesh__D016363 Liability, Antitrust
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D016363 2006
% 217.74/217.90  |- skos__hiddenLabel mesh__D016363 Antitrust Liabilities
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D016363 2002
% 217.74/217.90  |- mesh__dateCreated mesh__D016363 1990-05-25
% 217.74/217.90  |- mesh__historyNote mesh__D016363 91   
% 217.74/217.90  |- mesh__publicMeSHNote mesh__D016363 91   
% 217.74/217.90  |- skos__scopeNote mesh__D016363
% 217.74/217.90       Those federal and state laws, and their enforcement, that protect trade and commerce from unlawful restraints and monopolies or unfair business practices.%A%    
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D016363 2003
% 217.74/217.90  |- skos__prefLabel mesh__D016363 Antitrust Laws
% 217.74/217.90  |- rdf__type mesh__D016363sskos__Concept
% 217.74/217.90  |- mesh__dateRevised mesh__D016363 1999-11-03
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D016363 2004
% 217.74/217.90  |- skos__hiddenLabel mesh__D016363 Laws, Antitrust
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D016363 2000
% 217.74/217.90  |- mesh__dateRevised mesh__D002343 1999-11-03
% 217.74/217.90  |- skos__hiddenLabel mesh__D002343 Artery, Internal Carotid
% 217.74/217.90  |- rdf__type mesh__D002343sskos__Concept
% 217.74/217.90  |- mesh__dateEstablished mesh__D002343 1974-01-01
% 217.74/217.90  |- skos__prefLabel mesh__D002343 Carotid Artery, Internal
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D002343 2003
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D002343 2001
% 217.74/217.90  |- skos__hiddenLabel mesh__D002343 Arteries, Internal Carotid
% 217.74/217.90  |- skos__hiddenLabel mesh__D002343 Carotid Arteries, Internal
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D002343 2005
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D002343 2004
% 217.74/217.90  |- skos__broader mesh__D002343smesh__D017536
% 217.74/217.90  |- mesh__recordAuthorizer mesh__D002343 sjn
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D002343 2006
% 217.74/217.90  |- skos__hiddenLabel mesh__D002343 Internal Carotid Arteries
% 217.74/217.90  |- mesh__recordMaintainer mesh__D002343 KEV
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D002343 2002
% 217.74/217.90  |- skos__scopeNote mesh__D002343
% 217.74/217.90       Branch of the common carotid artery which supplies the anterior part of the brain, the eye and its appendages, the forehead and nose.%A%    
% 217.74/217.90  |- mesh__dateCreated mesh__D002343 1999-01-01
% 217.74/217.90  |- skos__hiddenLabel mesh__D002343 Internal Carotid Artery
% 217.74/217.90  |- mesh__recordOriginator mesh__D002343 NLM
% 217.74/217.90  |- skos__annotation mesh__D002343
% 217.74/217.90       dis: coord IM with CAROTID ARTERY DISEASES %28%IM%29%; inj: coord IM with CAROTID ARTERY INJURIES %28%IM%29% or specifics %28%IM%29%%A%  
% 217.74/217.90  |- mesh__publicMeSHNote mesh__D002343 74   
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D002343 2000
% 217.74/217.90  |- skos__historyNote mesh__D002343 Carotid Arteries %28%1966-1971%29%
% 217.74/217.90  |- mesh__historyNote mesh__D002343 74%28%72%29%   
% 217.74/217.90  |- skos__scopeNote mesh__D012771
% 217.74/217.90       Acute hemorrhage or excessive fluid loss resulting in HYPOVOLEMIA.%A%    
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D012771 2002
% 217.74/217.90  |- mesh__recordAuthorizer mesh__D012771 sjn
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D012771 2003
% 217.74/217.90  |- mesh__dateRevised mesh__D012771 1999-11-04
% 217.74/217.90  |- rdf__type mesh__D012771sskos__Concept
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D012771 2004
% 217.74/217.90  |- skos__prefLabel mesh__D012771 Shock, Hemorrhagic
% 217.74/217.90  |- skos__broader mesh__D012771smesh__D012769
% 217.74/217.90  |- skos__broader mesh__D012771smesh__D006470
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D012771 2005
% 217.74/217.90  |- mesh__dateCreated mesh__D012771 1999-01-01
% 217.74/217.90  |- mesh__recordMaintainer mesh__D012771 KEV
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D012771 2006
% 217.74/217.90  |- mesh__recordOriginator mesh__D012771 NLM
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D012771 2000
% 217.74/217.90  |- skos__altLabel mesh__D012771 Hemorrhagic Shock
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D012771 2001
% 217.74/217.90  |- skos__annotation mesh__D012771
% 217.74/217.90       HYPOVOLEMIC SHOCK does not go here: it is a see ref to SHOCK%A%  
% 217.74/217.90  |- mesh__recordOriginator mesh__D006734 NLM
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D006734 2006
% 217.74/217.90  |- skos__hiddenLabel mesh__D006734 Disease, Equine
% 217.74/217.90  |- skos__hiddenLabel mesh__D006734 Diseases, Horse
% 217.74/217.90  |- skos__annotation mesh__D006734
% 217.74/217.90       IM GEN or unspecified; coord IM with specific dis /vet %28%IM%29% or specific horse dis %28%IM%29%; for abnormalities or injuries index under HORSES /abnorm or HORSES /inj; don%27%t forget also HORSES %28%NIM%29% %26% check tag ANIMALS; DF: HORSE DIS%A%  
% 217.74/217.90  |- mesh__dateRevised mesh__D006734 2003-07-30
% 217.74/217.90  |- skos__altLabel mesh__D006734 Equine Diseases
% 217.74/217.90  |- skos__hiddenLabel mesh__D006734 Disease, Horse
% 217.74/217.90  |- skos__hiddenLabel mesh__D006734 Diseases, Equine
% 217.74/217.90  |- mesh__dateCreated mesh__D006734 1999-01-01
% 217.74/217.90  |- skos__prefLabel mesh__D006734 Horse Diseases
% 217.74/217.90  |- skos__hiddenLabel mesh__D006734 Horse Disease
% 217.74/217.90  |- mesh__recordMaintainer mesh__D006734 ags
% 217.74/217.90  |- skos__broader mesh__D006734smesh__D000820
% 217.74/217.90  |- skos__scopeNote mesh__D006734
% 217.74/217.90       Diseases of domestic and wild horses of the species Equus caballus.%A%    
% 217.74/217.90  |- skos__hiddenLabel mesh__D006734 Equine Disease
% 217.74/217.90  |- rdf__type mesh__D006734sskos__Concept
% 217.74/217.90  |- mesh__recordAuthorizer mesh__D006734 sjn
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D006734 2005
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D006734 2004
% 217.74/217.90  |- rdf__type mesh__D020405sskos__Concept
% 217.74/217.90  |- skos__historyNote mesh__D020405 Skin %28%1966-1998%29%
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D020405 2004
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D020405 2005
% 217.74/217.90  |- mesh__recordMaintainer mesh__D020405 nns
% 217.74/217.90  |- mesh__dateCreated mesh__D020405 1998-06-10
% 217.74/217.90  |- skos__prefLabel mesh__D020405 Dermis
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D020405 2006
% 217.74/217.90  |- mesh__publicMeSHNote mesh__D020405 99   
% 217.74/217.90  |- mesh__dateRevised mesh__D020405 2002-07-03
% 217.74/217.90  |- mesh__dateEstablished mesh__D020405 1999-01-01
% 217.74/217.90  |- skos__scopeNote mesh__D020405
% 217.74/217.90       A layer of vascularized connective tissue underneath the EPIDERMIS. The surface of the dermis contains innervated papillae. Embedded in or beneath the dermis are SWEAT GLANDS; HAIR FOLLICLES; and SEBACEOUS GLANDS.%A%    
% 217.74/217.90  |- skos__altLabel mesh__D020405 Corium
% 217.74/217.90  |- mesh__recordOriginator mesh__D020405 NNS
% 217.74/217.90  |- mesh__historyNote mesh__D020405 99   
% 217.74/217.90  |- mesh__recordAuthorizer mesh__D020405 sjn
% 217.74/217.90  |- skos__broader mesh__D020405smesh__D012867
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D020405 2003
% 217.74/217.90  |- skos__prefLabel mesh__D050890 HSP30 Heat-Shock Proteins
% 217.74/217.90  |- mesh__publicMeSHNote mesh__D050890
% 217.74/217.90       2006; HEAT-SHOCK PROTEINS 30 was indexed under HEAT-SHOCK PROTEINS 1993-2005%A%  
% 217.74/217.90  |- skos__hiddenLabel mesh__D050890 HSP30 Heat Shock Proteins
% 217.74/217.90  |- skos__broader mesh__D050890smesh__D050888
% 217.74/217.90  |- mesh__dateCreated mesh__D050890 2005-06-30
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D050890 2006
% 217.74/217.90  |- skos__altLabel mesh__D050890 HSP30 Proteins
% 217.74/217.90  |- mesh__dateEstablished mesh__D050890 2006-01-01
% 217.74/217.90  |- mesh__historyNote mesh__D050890 2006%28%1993%29%   
% 217.74/217.90  |- mesh__recordMaintainer mesh__D050890 DRC
% 217.74/217.90  |- mesh__recordAuthorizer mesh__D050890 sjn
% 217.74/217.90  |- skos__altLabel mesh__D050890 Heat-Shock Proteins 30
% 217.74/217.90  |- mesh__recordOriginator mesh__D050890 DRC
% 217.74/217.90  |- rdf__type mesh__D050890sskos__Concept
% 217.74/217.90  |- skos__scopeNote mesh__D050890
% 217.74/217.90       A subfamily of small heat-shock proteins found in a wide variety of organisms.%A%    
% 217.74/217.90  |- skos__hiddenLabel mesh__D050890 Heat-Shock Proteins, HSP30
% 217.74/217.90  |- skos__hiddenLabel mesh__D050890 Heat Shock Proteins 30
% 217.74/217.90  |- mesh__recordMaintainer mesh__D011679 lkt
% 217.74/217.90  |- mesh__recordAuthorizer mesh__D011679 sjn
% 217.74/217.90  |- skos__historyNote mesh__D011679
% 217.74/217.90       Metamorphosis, Biological %28%1966-1969%29%
% 217.74/217.90  |- skos__prefLabel mesh__D011679 Pupa
% 217.74/217.90  |- skos__historyNote mesh__D011679 Insects %28%1966-1969%29%
% 217.74/217.90  |- skos__broader mesh__D011679smesh__D008018
% 217.74/217.90  |- skos__annotation mesh__D011679
% 217.74/217.90       NIM; for metamorphosing insects only: do not use /embryol with ref to pupae%A%  
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011679 2005
% 217.74/217.90  |- mesh__publicMeSHNote mesh__D011679 74   
% 217.74/217.90  |- skos__scopeNote mesh__D011679
% 217.74/217.90       An inactive stage between the larval and adult stages in the life cycle of insects.%A%    
% 217.74/217.90  |- mesh__dateRevised mesh__D011679 2004-07-07
% 217.74/217.90  |- mesh__historyNote mesh__D011679 74%28%70%29%   
% 217.74/217.90  |- mesh__recordOriginator mesh__D011679 NLM
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D011679 2006
% 217.74/217.90  |- mesh__dateCreated mesh__D011679 1999-01-01
% 217.74/217.90  |- rdf__type mesh__D011679sskos__Concept
% 217.74/217.90  |- mesh__dateEstablished mesh__D011679 1974-01-01
% 217.74/217.90  |- skos__altLabel mesh__D011679 Pupae
% 217.74/217.90  |- skos__historyNote mesh__D011679 specific insect%28%1966-1969%29%
% 217.74/217.90  |- rdf__type mesh__D016364sskos__Concept
% 217.74/217.90  |- mesh__recordMaintainer mesh__D016364 nns
% 217.74/217.90  |- skos__prefLabel mesh__D016364 Reading Frames
% 217.74/217.90  |- skos__hiddenLabel mesh__D016364 Frame, Reading
% 217.74/217.90  |- skos__hiddenLabel mesh__D016364 Frames, Reading
% 217.74/217.90  |- mesh__dateRevised mesh__D016364 2004-07-07
% 217.74/217.90  |- skos__scopeNote mesh__D016364
% 217.74/217.90       The three possible sequences of CODONS by which GENETIC TRANSLATION may occur from one nucleotide sequence. A segment of mRNA 5%27%AUCCGA3%27% could be translated as 5%27%AUC.. or 5%27%UCC.. or 5%27%CCG.., depending on the location of the START CODON.%A%    
% 217.74/217.90  |- mesh__recordAuthorizer mesh__D016364 sjn
% 217.74/217.90  |- skos__historyNote mesh__D016364 Base Sequence %28%1980-1990%29%
% 217.74/217.90  |- skos__hiddenLabel mesh__D016364 Reading Frame
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D016364 2006
% 217.74/217.90  |- mesh__dateEstablished mesh__D016364 1991-01-01
% 217.74/217.90  |- skos__broader mesh__D016364smesh__D005815
% 217.74/217.90  |- skos__related mesh__D016364smesh__D003062
% 217.74/217.90  |- mesh__dateCreated mesh__D016364 1990-05-29
% 217.74/217.90  |- skos__historyNote mesh__D016364 Amino Acid Sequence %28%1980-1990%29%
% 217.74/217.90  |- mesh__historyNote mesh__D016364 91   
% 217.74/217.90  |- mesh__recordOriginator mesh__D016364 PXP
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D016364 2005
% 217.74/217.90  |- mesh__publicMeSHNote mesh__D016364 91   
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D002344 2004
% 217.74/217.90  |- skos__prefLabel mesh__D002344 Carotid Body
% 217.74/217.90  |- skos__hiddenLabel mesh__D002344 Body, Carotid
% 217.74/217.90  |- mesh__activeMeSHYear mesh__D002344 2006
% 217.74/217.90  |- skos__related mesh__D002344smesh__D002345
% 217.74/217.90  |- skos__annotation mesh__D002344 a nonchromaffin paraganglion   
% 217.74/217.90  |- mesh__recordMaintainer mesh__D002344 jmp
% 217.74/217.90  |- skos__altLabel mesh__D002344 Glomus Caroticum
% 217.74/217.90  |- mesh__dateCreated mesh__D002344 1999-01-01
% 217.74/217.90  |- mesh__recordAuthorizer mesh__D002344 sjn
% 217.74/217.90  |- skos__hiddenLabel mesh__D002344 Carotid Bodies
% 217.74/217.90  |- skos__hiddenLabel mesh__D002344 Caroticum, Glomus
% 217.74/217.90  |- mesh__dateRevised mesh__D002344 2003-07-09
% 217.74/217.90  |- skos__scopeNote mesh__D002344
% 217.74/217.90       A small cluster of chemoreceptive and supporting cells located near the bifurcation of the internal carotid artery. The carotid body, which is richly supplied with fenestrated capillaries, senses the pH, carbon dioxide, and oxygen concentrations in the blood and plays a crucial role in their homeostatic control.%A%    
% 217.74/217.91  |- rdf__type mesh__D002344sskos__Concept
% 217.74/217.91  |- skos__hiddenLabel mesh__D002344 Bodies, Carotid
% 217.74/217.91  |- skos__broader mesh__D002344smesh__D010234
% 217.74/217.91  |- mesh__recordOriginator mesh__D002344 NLM
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002344 2005
% 217.74/217.91  |- skos__hiddenLabel mesh__D012772 Shock Syndromes, Toxic
% 217.74/217.91  |- skos__hiddenLabel mesh__D012772 Toxic Shock Syndromes
% 217.74/217.91  |- mesh__historyNote mesh__D012772
% 217.74/217.91       77; was SHOCK, TOXIC 1963-76; SHOCK, ENDOTOXIC was heading 1968-76%A%  
% 217.74/217.91  |- mesh__recordOriginator mesh__D012772 MM
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D012772 2005
% 217.74/217.91  |- skos__broader mesh__D012772smesh__D012769
% 217.74/217.91  |- mesh__dateEstablished mesh__D012772 1977-01-01
% 217.74/217.91  |- skos__scopeNote mesh__D012772
% 217.74/217.91       Shock due to circulatory insufficiency caused most commonly by gram-negative BACTEREMIA. It is less often the result of the persistent presence of other micro-organisms in the blood %28%FUNGEMIA; VIREMIA%29%; in rare instances, it is caused by gram-positive organisms, but with different symptomatology.%A%    
% 217.74/217.91  |- mesh__publicMeSHNote mesh__D012772
% 217.74/217.91       77; was SHOCK, TOXIC 1963-76; SHOCK, ENDOTOXIC was heading 1968-76%A%  
% 217.74/217.91  |- mesh__onlineNote mesh__D012772
% 217.74/217.91       use SHOCK, SEPTIC to search SHOCK, TOXIC 1966-76 %26% SHOCK, ENDOTOXIC 1968-76%A%  
% 217.74/217.91  |- skos__hiddenLabel mesh__D012772 Endotoxic Shock
% 217.74/217.91  |- mesh__dateRevised mesh__D012772 2001-07-25
% 217.74/217.91  |- mesh__recordMaintainer mesh__D012772 mdb
% 217.74/217.91  |- skos__hiddenLabel mesh__D012772 Syndromes, Toxic Shock
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D012772 2004
% 217.74/217.91  |- skos__hiddenLabel mesh__D012772 Toxic Shock
% 217.74/217.91  |- skos__hiddenLabel mesh__D012772 Shock Syndrome, Toxic
% 217.74/217.91  |- skos__hiddenLabel mesh__D012772 Septic Shock
% 217.74/217.91  |- mesh__recordAuthorizer mesh__D012772 sjn
% 217.74/217.91  |- rdf__type mesh__D012772sskos__Concept
% 217.74/217.91  |- skos__broader mesh__D012772smesh__D012687
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D012772 2003
% 217.74/217.91  |- mesh__dateCreated mesh__D012772 1976-04-16
% 217.74/217.91  |- skos__altLabel mesh__D012772 Toxic Shock Syndrome
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D012772 2002
% 217.74/217.91  |- skos__hiddenLabel mesh__D012772 Syndrome, Toxic Shock
% 217.74/217.91  |- skos__annotation mesh__D012772
% 217.74/217.91       coord %28%IM%29% with specific infect %28%IM%29%   
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D012772 2006
% 217.74/217.91  |- skos__prefLabel mesh__D012772 Shock, Septic
% 217.74/217.91  |- skos__hiddenLabel mesh__D006735 Peroxidase, Horseradish
% 217.74/217.91  |- skos__scopeNote mesh__D006735
% 217.74/217.91       An enzyme isolated from horseradish which is able to act as an antigen. It is frequently used as a histochemical tracer for light and electron microscopy. Its antigenicity has permitted its use as a combined antigen and marker in experimental immunology.%A%    
% 217.74/217.91  |- skos__historyNote mesh__D006735 Peroxidases %28%1972-1975%29%
% 217.74/217.91  |- skos__hiddenLabel mesh__D006735 Peroxidase, Ferrihorseradish
% 217.74/217.91  |- mesh__dateRevised mesh__D006735 2003-07-09
% 217.74/217.91  |- mesh__historyNote mesh__D006735
% 217.74/217.91       91%28%76%29%; was see under PEROXIDASES 1976-90   
% 217.74/217.91  |- skos__hiddenLabel mesh__D006735 Alpha Peroxidase
% 217.74/217.91  |- skos__broader mesh__D006735smesh__D010544
% 217.74/217.91  |- mesh__recordAuthorizer mesh__D006735 sjn
% 217.74/217.91  |- skos__hiddenLabel mesh__D006735 II, Horseradish Peroxidase
% 217.74/217.91  |- skos__hiddenLabel mesh__D006735 Peroxidase III, Horseradish
% 217.74/217.91  |- rdf__type mesh__D006735sskos__Concept
% 217.74/217.91  |- mesh__dateEstablished mesh__D006735 1991-01-01
% 217.74/217.91  |- skos__hiddenLabel mesh__D006735 III, Horseradish Peroxidase
% 217.74/217.91  |- mesh__dateCreated mesh__D006735 1975-07-25
% 217.74/217.91  |- skos__historyNote mesh__D006735 Plants %28%1972-1975%29%
% 217.74/217.91  |- skos__hiddenLabel mesh__D006735 Peroxidase II, Horseradish
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D006735 2005
% 217.74/217.91  |- skos__prefLabel mesh__D006735 Horseradish Peroxidase
% 217.74/217.91  |- mesh__recordOriginator mesh__D006735 RLS
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D006735 2004
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D006735 2006
% 217.74/217.91  |- mesh__recordMaintainer mesh__D006735 ssb
% 217.74/217.91  |- mesh__publicMeSHNote mesh__D006735
% 217.74/217.91       91; was see under PEROXIDASES 1976-90   
% 217.74/217.91  |- skos__annotation mesh__D006735 NIM   
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D020406 2004
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D020406 2006
% 217.74/217.91  |- skos__prefLabel mesh__D020406 Medicare Payment Advisory Commission
% 217.74/217.91  |- mesh__publicMeSHNote mesh__D020406 99   
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D020406 2002
% 217.74/217.91  |- skos__annotation mesh__D020406 CATALOG: use NAF entry   
% 217.74/217.91  |- mesh__dateCreated mesh__D020406 1998-06-10
% 217.74/217.91  |- skos__related mesh__D020406smesh__D011444
% 217.74/217.91  |- skos__related mesh__D020406smesh__D015284
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D020406 1999
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D020406 2000
% 217.74/217.91  |- mesh__dateEstablished mesh__D020406 1999-01-01
% 217.74/217.91  |- skos__scopeNote mesh__D020406
% 217.74/217.91       The Commission was created by the Balanced Budget Act of 1997 under Title XVIII. It is specifically charged to review the effect of Medicare+Choice under Medicare Part C and to review payment policies under Parts A and B. It is also generally charged to evaluate the effect of prospective payment policies and their impact on health care delivery in the US. The former Prospective Payment Assessment Commission %28%ProPAC%29% and the Physician Payment Review Commission %28%PPRC%29% were merged to form MEDPAC.%A%    
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D020406 2003
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D020406 2001
% 217.74/217.91  |- skos__altLabel mesh__D020406 MEDPAC
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D020406 2005
% 217.74/217.91  |- mesh__historyNote mesh__D020406 99   
% 217.74/217.91  |- skos__broader mesh__D020406smesh__D011445
% 217.74/217.91  |- rdf__type mesh__D020406sskos__Concept
% 217.74/217.91  |- skos__hiddenLabel mesh__D050891
% 217.74/217.91       Oxidoreductases Acting on CH NH2 Group Donors
% 217.74/217.91  |- mesh__recordMaintainer mesh__D050891 jmp
% 217.74/217.91  |- mesh__recordOriginator mesh__D050891 jmp
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D050891 2006
% 217.74/217.91  |- mesh__historyNote mesh__D050891 2006   
% 217.74/217.91  |- rdf__type mesh__D050891sskos__Concept
% 217.74/217.91  |- skos__historyNote mesh__D050891
% 217.74/217.91       Oxidoreductases Acting on CH-NH Group Donors %28%1975-2005%29%
% 217.74/217.91  |- mesh__dateCreated mesh__D050891 2005-06-30
% 217.74/217.91  |- skos__prefLabel mesh__D050891
% 217.74/217.91       Oxidoreductases Acting on CH-NH2 Group Donors
% 217.74/217.91  |- skos__broader mesh__D050891smesh__D010088
% 217.74/217.91  |- mesh__dateEstablished mesh__D050891 2006-01-01
% 217.74/217.91  |- skos__annotation mesh__D050891
% 217.74/217.91       general: prefer specifics; do not confuse with OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS%A%  
% 217.74/217.91  |- mesh__publicMeSHNote mesh__D050891 2006   
% 217.74/217.91  |- skos__hiddenLabel mesh__D050891 Amine Oxidoreductases, Primary
% 217.74/217.91  |- skos__altLabel mesh__D050891 Oxidoreductases, Primary Amine
% 217.74/217.91  |- mesh__recordAuthorizer mesh__D050891 sjn
% 217.74/217.91  |- skos__altLabel mesh__D050891 Primary Amine Oxidoreductases
% 217.74/217.91  |- skos__scopeNote mesh__D050891
% 217.74/217.91       Enzymes catalyzing the dehydrogenation of or oxidation of compounds containing primary amines.%A%    
% 217.74/217.91  |- mesh__recordOriginator mesh__D016365 JHM
% 217.74/217.91  |- mesh__dateRevised mesh__D016365 2002-07-03
% 217.74/217.91  |- skos__historyNote mesh__D016365 Jurisprudence %28%1966-1990%29%
% 217.74/217.91  |- skos__hiddenLabel mesh__D016365 Liability, Professional
% 217.74/217.91  |- mesh__publicMeSHNote mesh__D016365 91   
% 217.74/217.91  |- skos__hiddenLabel mesh__D016365 Liabilities, Legal
% 217.74/217.91  |- skos__broader mesh__D016365smesh__D007603
% 217.74/217.91  |- skos__hiddenLabel mesh__D016365 Liabilities, Personal
% 217.74/217.91  |- skos__hiddenLabel mesh__D016365 Institutional Liabilities
% 217.74/217.91  |- skos__related mesh__D016365smesh__D008318
% 217.74/217.91  |- skos__hiddenLabel mesh__D016365 Liability, Institutional
% 217.74/217.91  |- skos__hiddenLabel mesh__D016365 Medical Liabilities
% 217.74/217.91  |- skos__hiddenLabel mesh__D016365 Liability, Medical
% 217.74/217.91  |- mesh__dateCreated mesh__D016365 1990-08-02
% 217.74/217.91  |- skos__scopeNote mesh__D016365
% 217.74/217.91       Accountability and responsibility to another, enforceable by civil or criminal sanctions.%A%    
% 217.74/217.91  |- skos__hiddenLabel mesh__D016365 Liabilities, Medical
% 217.74/217.91  |- skos__hiddenLabel mesh__D016365 Professional Liabilities
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D016365 2006
% 217.74/217.91  |- mesh__dateEstablished mesh__D016365 1991-01-01
% 217.74/217.91  |- skos__hiddenLabel mesh__D016365 Legal Liabilities
% 217.74/217.91  |- skos__hiddenLabel mesh__D016365 Tort
% 217.74/217.91  |- mesh__historyNote mesh__D016365 91   
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D016365 2005
% 217.74/217.91  |- skos__hiddenLabel mesh__D016365 Personal Liabilities
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D016365 2004
% 217.74/217.91  |- mesh__recordMaintainer mesh__D016365 hjn
% 217.74/217.91  |- mesh__recordAuthorizer mesh__D016365 sjn
% 217.74/217.91  |- skos__hiddenLabel mesh__D016365 Liabilities, Professional
% 217.74/217.91  |- skos__hiddenLabel mesh__D016365 Liabilities, Institutional
% 217.74/217.91  |- rdf__type mesh__D016365sskos__Concept
% 217.74/217.91  |- skos__hiddenLabel mesh__D016365 Liability, Personal
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D016365 2003
% 217.74/217.91  |- skos__prefLabel mesh__D016365 Liability, Legal
% 217.74/217.91  |- skos__altLabel mesh__D016365 Legal Liability
% 217.74/217.91  |- skos__historyNote mesh__D016365 Malpractice %28%1968-1990%29%
% 217.74/217.91  |- skos__annotation mesh__D016365
% 217.74/217.91       statement of responsibility: do not confuse with MALPRACTICE, the commission of a harmful act; coord IM with specialty %28%IM%29% if relevant or area of responsibility %28%IM%29% if relevant%A%  
% 217.74/217.91  |- skos__historyNote mesh__D016365
% 217.74/217.91       Malpractice/legislation %26% jurisprudence %28%1981-1990%29%
% 217.74/217.91  |- rdf__type mesh__D002345sskos__Concept
% 217.74/217.91  |- skos__hiddenLabel mesh__D002345 Carotid Body Paragangliomas
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002345 2004
% 217.74/217.91  |- skos__scopeNote mesh__D002345
% 217.74/217.91       An invariably benign, encapsulated, firm round mass at the bifurcation of the common carotid artery, with nests of large polyhedral cells in alveolar or organoid arrangement. It is usually asymptomatic but large masses may encroach upon the parapharyngeal space and produce dysphagia, pain, and cranial nerve palsies. %28%Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, pp570-71%29%%A%    
% 217.74/217.91  |- mesh__dateRevised mesh__D002345 1995-06-08
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002345 1996
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002345 2000
% 217.74/217.91  |- skos__altLabel mesh__D002345 Paraganglioma, Carotid Body
% 217.74/217.91  |- skos__broader mesh__D002345smesh__D010236
% 217.74/217.91  |- mesh__recordMaintainer mesh__D002345 KEV
% 217.74/217.91  |- skos__annotation mesh__D002345
% 217.74/217.91       /blood supply /chem /second /secret /ultrastruct permitted; organ/neopl %26% histol coords not necessary%A%  
% 217.74/217.91  |- skos__hiddenLabel mesh__D002345 Carotid Body Paraganglioma
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002345 1999
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002345 2003
% 217.74/217.91  |- skos__hiddenLabel mesh__D002345 Carotid Body Tumors
% 217.74/217.91  |- mesh__recordOriginator mesh__D002345 NLM
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002345 2006
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002345 1998
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002345 2002
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002345 2005
% 217.74/217.91  |- skos__hiddenLabel mesh__D002345 Tumors, Carotid Body
% 217.74/217.91  |- mesh__recordAuthorizer mesh__D002345 PLS
% 217.74/217.91  |- mesh__dateCreated mesh__D002345 1999-01-01
% 217.74/217.91  |- skos__hiddenLabel mesh__D002345 Tumor, Carotid Body
% 217.74/217.91  |- skos__hiddenLabel mesh__D002345 Paragangliomas, Carotid Body
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002345 1997
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002345 2001
% 217.74/217.91  |- skos__prefLabel mesh__D002345 Carotid Body Tumor
% 217.74/217.91  |- mesh__recordOriginator mesh__D007030 NLM
% 217.74/217.91  |- mesh__historyNote mesh__D007030 65   
% 217.74/217.91  |- skos__prefLabel mesh__D007030 Hypothalamo-Hypophyseal System
% 217.74/217.91  |- skos__broader mesh__D007030smesh__D007033
% 217.74/217.91  |- skos__annotation mesh__D007030
% 217.74/217.91       hypothalamo-pituitary-adrenal axis: coordinate HYPOTHALAMO-HYPOPHYSEAL SYSTEM + PITUITARY-ADRENAL SYSTEM; emphasis here is on interrelation between hypothalamus %26% pituitary: do not use as a substitute for HYPOTHALAMUS %26% PITUITARY GLAND as entities; diseases: coordinate IM with HYPOTHALAMIC DISEASES %28%IM%29%%A%  
% 217.74/217.91  |- skos__hiddenLabel mesh__D007030 Hypothalamo Hypophyseal System
% 217.74/217.91  |- mesh__dateEstablished mesh__D007030 1965-01-01
% 217.74/217.91  |- mesh__recordMaintainer mesh__D007030 lkt
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D007030 2006
% 217.74/217.91  |- skos__altLabel mesh__D007030 Hypothalamic-Pituitary Unit
% 217.74/217.91  |- skos__scopeNote mesh__D007030
% 217.74/217.91       A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine %28%HYPOTHALAMIC HORMONES%29% regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS.%A%    
% 217.74/217.91  |- mesh__publicMeSHNote mesh__D007030 65   
% 217.74/217.91  |- mesh__dateRevised mesh__D007030 2005-06-30
% 217.74/217.91  |- skos__broader mesh__D007030smesh__D009490
% 217.74/217.91  |- mesh__recordAuthorizer mesh__D007030 sjn
% 217.74/217.91  |- rdf__type mesh__D007030sskos__Concept
% 217.74/217.91  |- skos__hiddenLabel mesh__D007030 Hypothalamic Pituitary Unit
% 217.74/217.91  |- skos__related mesh__D007030smesh__D010906
% 217.74/217.91  |- mesh__dateCreated mesh__D007030 1999-01-01
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D012773 2002
% 217.74/217.91  |- skos__prefLabel mesh__D012773 Shock, Surgical
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D012773 2004
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D012773 2001
% 217.74/217.91  |- mesh__dateCreated mesh__D012773 1999-01-01
% 217.74/217.91  |- rdf__type mesh__D012773sskos__Concept
% 217.74/217.91  |- mesh__dateRevised mesh__D012773 1999-11-03
% 217.74/217.91  |- mesh__recordOriginator mesh__D012773 NLM
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D012773 2003
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D012773 2000
% 217.74/217.91  |- skos__broader mesh__D012773smesh__D012769
% 217.74/217.91  |- skos__hiddenLabel mesh__D012773 Surgical Shocks
% 217.74/217.91  |- skos__broader mesh__D012773smesh__D011183
% 217.74/217.91  |- skos__altLabel mesh__D012773 Surgical Shock
% 217.74/217.91  |- mesh__recordAuthorizer mesh__D012773 sjn
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D012773 2006
% 217.74/217.91  |- skos__scopeNote mesh__D012773
% 217.74/217.91       A type of shock that occurs as a result of a surgical procedure.%A%    
% 217.74/217.91  |- mesh__recordMaintainer mesh__D012773 KEV
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D012773 2005
% 217.74/217.91  |- skos__hiddenLabel mesh__D006736 Domestic Horses
% 217.74/217.91  |- skos__altLabel mesh__D006736 Equus caballus
% 217.74/217.91  |- mesh__recordAuthorizer mesh__D006736 sjn
% 217.74/217.91  |- mesh__dateCreated mesh__D006736 1999-01-01
% 217.74/217.91  |- mesh__dateRevised mesh__D006736 2003-07-09
% 217.74/217.91  |- mesh__recordOriginator mesh__D006736 NLM
% 217.74/217.91  |- rdf__type mesh__D006736sskos__Concept
% 217.74/217.91  |- mesh__considerAlso mesh__D006736 consider also terms at EQUINE   
% 217.74/217.91  |- skos__altLabel mesh__D006736 Horse, Domestic
% 217.74/217.91  |- skos__broader mesh__D006736smesh__D018397
% 217.74/217.91  |- mesh__recordMaintainer mesh__D006736 ags
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D006736 2005
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D006736 2004
% 217.74/217.91  |- skos__scopeNote mesh__D006736
% 217.74/217.91       Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest.%A%    
% 217.74/217.91  |- skos__annotation mesh__D006736 see X refs at EQUIDAE   
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D006736 2006
% 217.74/217.91  |- skos__hiddenLabel mesh__D006736 Horse
% 217.74/217.91  |- skos__prefLabel mesh__D006736 Horses
% 217.74/217.91  |- skos__hiddenLabel mesh__D006736 Domestic Horse
% 217.74/217.91  |- skos__hiddenLabel mesh__D006736 Horses, Domestic
% 217.74/217.91  |- mesh__recordOriginator mesh__D020407 JLS
% 217.74/217.91  |- skos__hiddenLabel mesh__D020407 Wide Web, World
% 217.74/217.91  |- skos__hiddenLabel mesh__D020407 Web, World Wide
% 217.74/217.91  |- skos__broader mesh__D020407smesh__D003195
% 217.74/217.91  |- skos__scopeNote mesh__D020407
% 217.74/217.91       A loose confederation of computer communication networks around the world. The networks that make up the Internet are connected through several backbone networks. The Internet grew out of the US Government ARPAnet project and was designed to facilitate information exchange.%A%    
% 217.74/217.91  |- skos__altLabel mesh__D020407 World Wide Web
% 217.74/217.91  |- skos__prefLabel mesh__D020407 Internet
% 217.74/217.91  |- mesh__recordAuthorizer mesh__D020407 sjn
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D020407 2005
% 217.74/217.91  |- rdf__type mesh__D020407sskos__Concept
% 217.74/217.91  |- mesh__recordMaintainer mesh__D020407 jls
% 217.74/217.91  |- skos__hiddenLabel mesh__D020407 Internets
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D020407 2006
% 217.74/217.91  |- mesh__dateRevised mesh__D020407 2004-07-07
% 217.74/217.91  |- mesh__publicMeSHNote mesh__D020407
% 217.74/217.91       99; use COMPUTER COMMUNICATION NETWORKS 1996-98   
% 217.74/217.91  |- mesh__dateCreated mesh__D020407 1998-06-10
% 217.74/217.91  |- mesh__historyNote mesh__D020407
% 217.74/217.91       99; see COMPUTER COMMUNICATION NETWORKS 1996-98   
% 217.74/217.91  |- mesh__dateEstablished mesh__D020407 1999-01-01
% 217.74/217.91  |- skos__historyNote mesh__D020407
% 217.74/217.91       Computer Communication Networks %28%1996-1998%29%
% 217.74/217.91  |- skos__prefLabel mesh__D050892 Sarcosine Dehydrogenase
% 217.74/217.91  |- mesh__publicMeSHNote mesh__D050892
% 217.74/217.91       2006; SARCOSINE DEHYDROGENASE was indexed under OXIDOREDUCTASES, N-DEMETHYLATING 1976-2004, %26% under SARCOSINE 1976-1982%A%  
% 217.74/217.91  |- mesh__historyNote mesh__D050892
% 217.74/217.91       2006%28%1976%29%; use OXIDOREDUCTASES, N-DEMETHYLATING, %26% SARCOSINE 1976-1979%A%  
% 217.74/217.91  |- rdf__type mesh__D050892sskos__Concept
% 217.74/217.91  |- skos__scopeNote mesh__D050892
% 217.74/217.91       A LIVER mitochondrial matrix flavoenzyme that catalyzes the oxidation of SARCOSINE to GLYCINE and FORMALDEHYDE. Mutation in the enzyme causes sarcosinemia, a rare autosomal metabolic defect characterized by elevated levels of SARCOSINE in BLOOD and URINE.%A%    
% 217.74/217.91  |- skos__altLabel mesh__D050892 Sarcosine N-Demethylase
% 217.74/217.91  |- mesh__recordAuthorizer mesh__D050892 sjn
% 217.74/217.91  |- skos__hiddenLabel mesh__D050892 N-Demethylase, Sarcosine
% 217.74/217.91  |- mesh__recordMaintainer mesh__D050892 AKE
% 217.74/217.91  |- mesh__recordOriginator mesh__D050892 AKE
% 217.74/217.91  |- skos__broader mesh__D050892smesh__D010089
% 217.74/217.91  |- skos__hiddenLabel mesh__D050892 Dehydrogenase, Monomethylglycine
% 217.74/217.91  |- skos__hiddenLabel mesh__D050892 Sarcosine N Demethylase
% 217.74/217.91  |- skos__altLabel mesh__D050892 Monomethylglycine Dehydrogenase
% 217.74/217.91  |- skos__hiddenLabel mesh__D050892 Dehydrogenase, Sarcosine
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D050892 2006
% 217.74/217.91  |- mesh__dateEstablished mesh__D050892 2006-01-01
% 217.74/217.91  |- mesh__dateCreated mesh__D050892 2005-06-30
% 217.74/217.91  |- skos__altLabel mesh__D016366 ORFs
% 217.74/217.91  |- skos__hiddenLabel mesh__D016366 Reading Frames, Open
% 217.74/217.91  |- skos__hiddenLabel mesh__D016366 Reading Frames, Unidentified
% 217.74/217.91  |- skos__hiddenLabel mesh__D016366 Frame, Unassigned Reading
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D016366 2006
% 217.74/217.91  |- skos__hiddenLabel mesh__D016366 Frames, Unidentified Reading
% 217.74/217.91  |- skos__hiddenLabel mesh__D016366 Frame, Unidentified Reading
% 217.74/217.91  |- mesh__recordAuthorizer mesh__D016366 sjn
% 217.74/217.91  |- skos__hiddenLabel mesh__D016366 Coding Region, Protein
% 217.74/217.91  |- skos__hiddenLabel mesh__D016366 Regions, Protein Coding
% 217.74/217.91  |- mesh__dateCreated mesh__D016366 1990-05-29
% 217.74/217.91  |- skos__broader mesh__D016366smesh__D016364
% 217.74/217.91  |- skos__altLabel mesh__D016366 Unidentified Reading Frame
% 217.74/217.91  |- skos__historyNote mesh__D016366 Amino Acid Sequence %28%1981-1990%29%
% 217.74/217.91  |- skos__altLabel mesh__D016366 Unassigned Reading Frame
% 217.74/217.91  |- mesh__dateEstablished mesh__D016366 1991-01-01
% 217.74/217.91  |- skos__altLabel mesh__D016366 Protein Coding Region
% 217.74/217.91  |- skos__historyNote mesh__D016366 Base Sequence %28%1977-1990%29%
% 217.74/217.91  |- mesh__recordOriginator mesh__D016366 PXP
% 217.74/217.91  |- rdf__type mesh__D016366sskos__Concept
% 217.74/217.91  |- skos__hiddenLabel mesh__D016366 Reading Frame, Unidentified
% 217.74/217.91  |- skos__scopeNote mesh__D016366
% 217.74/217.91       A sequence of successive nucleotide triplets that are read as CODONS specifying AMINO ACIDS and begin with an INITIATOR CODON and end with a stop codon %28%CODON, TERMINATOR%29%.%A%    
% 217.74/217.91  |- skos__hiddenLabel mesh__D016366 Frame, Open Reading
% 217.74/217.91  |- mesh__recordMaintainer mesh__D016366 nns
% 217.74/217.91  |- skos__hiddenLabel mesh__D016366 Unidentified Reading Frames
% 217.74/217.91  |- skos__broader mesh__D016366smesh__D040461
% 217.74/217.91  |- skos__hiddenLabel mesh__D016366 Region, Protein Coding
% 217.74/217.91  |- skos__hiddenLabel mesh__D016366 Coding Regions, Protein
% 217.74/217.91  |- mesh__publicMeSHNote mesh__D016366
% 217.74/217.91       1991; for UNIDENTIFIED READING FRAME and UNASSIGNED READING FRAMES see READING FRAMES 1991-2004%A%  
% 217.74/217.91  |- skos__prefLabel mesh__D016366 Open Reading Frames
% 217.74/217.91  |- skos__hiddenLabel mesh__D016366 Reading Frames, Unassigned
% 217.74/217.91  |- skos__hiddenLabel mesh__D016366 Protein Coding Regions
% 217.74/217.91  |- mesh__historyNote mesh__D016366
% 217.74/217.91       1991; for UNIDENTIFIED READING FRAME and UNASSIGNED READING FRAMES use READING FRAMES 1991-2004%A%  
% 217.74/217.91  |- mesh__dateRevised mesh__D016366 2005-06-30
% 217.74/217.91  |- skos__hiddenLabel mesh__D016366 Reading Frame, Open
% 217.74/217.91  |- skos__hiddenLabel mesh__D016366 Reading Frame, Unassigned
% 217.74/217.91  |- skos__hiddenLabel mesh__D016366 Open Reading Frame
% 217.74/217.91  |- skos__hiddenLabel mesh__D016366 Frames, Unassigned Reading
% 217.74/217.91  |- skos__hiddenLabel mesh__D016366 Frames, Open Reading
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002346 1999
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002346 2003
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002346 2001
% 217.74/217.91  |- skos__scopeNote mesh__D002346
% 217.74/217.91       The dilated portion of the common carotid artery at its bifurcation into external and internal carotids. It contains baroreceptors which, when stimulated, cause slowing of the heart, vasodilatation, and a fall in blood pressure.%A%    
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002346 2006
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002346 1995
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002346 1998
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002346 2000
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002346 2005
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002346 1994
% 217.74/217.91  |- skos__broader mesh__D002346smesh__D002339
% 217.74/217.91  |- skos__prefLabel mesh__D002346 Carotid Sinus
% 217.74/217.91  |- mesh__recordOriginator mesh__D002346 NLM
% 217.74/217.91  |- skos__related mesh__D002346smesh__D011311
% 217.74/217.91  |- mesh__dateCreated mesh__D002346 1999-01-01
% 217.74/217.91  |- mesh__recordMaintainer mesh__D002346 TAP
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002346 2002
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002346 1997
% 217.74/217.91  |- rdf__type mesh__D002346sskos__Concept
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002346 2004
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002346 1993
% 217.74/217.91  |- mesh__recordAuthorizer mesh__D002346 PLS
% 217.74/217.91  |- skos__hiddenLabel mesh__D002346 Sinus, Carotid
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D002346 1996
% 217.74/217.91  |- mesh__dateRevised mesh__D002346 1992-05-07
% 217.74/217.91  |- skos__prefLabel mesh__D007031 Hypothalamus
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D007031 2001
% 217.74/217.91  |- mesh__recordOriginator mesh__D007031 NLM
% 217.74/217.91  |- skos__annotation mesh__D007031
% 217.74/217.91       GEN or unspecified; prefer specific structures %26% areas in the hypothalamus; HYPOTHALAMO-HYPOPHYSEAL SYSTEM is available for the hypothalamus-pituitary relationship%A%  
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D007031 2006
% 217.74/217.91  |- skos__broader mesh__D007031smesh__D004027
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D007031 2005
% 217.74/217.91  |- skos__broader mesh__D007031smesh__D008032
% 217.74/217.91  |- rdf__type mesh__D007031sskos__Concept
% 217.74/217.91  |- mesh__recordMaintainer mesh__D007031 ags
% 217.74/217.91  |- mesh__dateCreated mesh__D007031 1999-01-01
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D007031 2002
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D007031 2004
% 217.74/217.91  |- skos__scopeNote mesh__D007031
% 217.74/217.91       Ventral part of the diencephalon extending from the region of the optic chiasm to the caudal border of the mammillary bodies and forming the inferior and lateral walls of the third ventricle.%A%    
% 217.74/217.91  |- mesh__dateRevised mesh__D007031 2000-06-22
% 217.74/217.91  |- mesh__recordAuthorizer mesh__D007031 sjn
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D007031 2003
% 217.74/217.91  |- mesh__dateEstablished mesh__D048448 2005-01-01
% 217.74/217.91  |- mesh__dateCreated mesh__D048448 2004-07-07
% 217.74/217.91  |- skos__prefLabel mesh__D048448 Phenylcarbamates
% 217.74/217.91  |- skos__hiddenLabel mesh__D048448 Phenyl Carbamates
% 217.74/217.91  |- mesh__publicMeSHNote mesh__D048448 2005   
% 217.74/217.91  |- skos__altLabel mesh__D048448 Phenyl-Carbamates
% 217.74/217.91  |- skos__historyNote mesh__D048448 Carbamates %28%1963-2004%29%
% 217.74/217.91  |- skos__scopeNote mesh__D048448
% 217.74/217.91       Phenyl esters of carbamic acid or of N-substituted carbamic acids. Structures are similar to PHENYLUREA COMPOUNDS with a carbamate in place of the urea.%A%    
% 217.74/217.91  |- skos__broader mesh__D048448smesh__D002219
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D048448 2006
% 217.74/217.91  |- mesh__recordOriginator mesh__D048448 ssb
% 217.74/217.91  |- rdf__type mesh__D048448sskos__Concept
% 217.74/217.91  |- mesh__recordAuthorizer mesh__D048448 sjn
% 217.74/217.91  |- mesh__recordMaintainer mesh__D048448 ssb
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D048448 2005
% 217.74/217.91  |- mesh__historyNote mesh__D048448 2005   
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D012774 2003
% 217.74/217.91  |- mesh__recordAuthorizer mesh__D012774 sjn
% 217.74/217.91  |- skos__hiddenLabel mesh__D012774 Traumatic Shock
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D012774 2006
% 217.74/217.91  |- skos__broader mesh__D012774smesh__D014947
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D012774 2002
% 217.74/217.91  |- mesh__dateRevised mesh__D012774 1999-11-03
% 217.74/217.91  |- mesh__recordMaintainer mesh__D012774 KEV
% 217.74/217.91  |- skos__scopeNote mesh__D012774 Shock produced as a result of trauma.     
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D012774 2005
% 217.74/217.91  |- skos__prefLabel mesh__D012774 Shock, Traumatic
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D012774 2001
% 217.74/217.91  |- mesh__recordOriginator mesh__D012774 NLM
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D012774 2004
% 217.74/217.91  |- skos__broader mesh__D012774smesh__D012769
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D012774 2000
% 217.74/217.91  |- mesh__dateCreated mesh__D012774 1999-01-01
% 217.74/217.91  |- rdf__type mesh__D012774sskos__Concept
% 217.74/217.91  |- mesh__dateRevised mesh__D006737 2004-07-07
% 217.74/217.91  |- skos__broader mesh__D006737smesh__D001181
% 217.74/217.91  |- skos__related mesh__D006737smesh__D008033
% 217.74/217.91  |- rdf__type mesh__D006737sskos__Concept
% 217.74/217.91  |- skos__prefLabel mesh__D006737 Horseshoe Crabs
% 217.74/217.91  |- mesh__recordAuthorizer mesh__D006737 sjn
% 217.74/217.91  |- mesh__onlineNote mesh__D006737
% 217.74/217.91       use HORSESHOE CRABS to search LIMULUS 1977   
% 217.74/217.91  |- mesh__recordMaintainer mesh__D006737 ags
% 217.74/217.91  |- skos__historyNote mesh__D006737 Arachnida %28%1966-1976%29%
% 217.74/217.91  |- mesh__recordOriginator mesh__D006737 FPG
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D006737 2005
% 217.74/217.91  |- skos__altLabel mesh__D006737 Crabs, Horseshoe
% 217.74/217.91  |- mesh__dateCreated mesh__D006737 1976-04-16
% 217.74/217.91  |- skos__historyNote mesh__D006737 Arthropods %28%1966-1976%29%
% 217.74/217.91  |- mesh__activeMeSHYear mesh__D006737 2006
% 217.74/217.91  |- skos__altLabel mesh__D006737 Xiphosura
% 217.74/217.91  |- skos__historyNote mesh__D006737 Crustacea %28%1966-1976%29%
% 217.74/217.91  |- mesh__publicMeSHNote mesh__D006737
% 217.74/217.91       78; was LIMULUS see under ARTHROPODS 1977   
% 217.74/217.91  |- skos__scopeNote mesh__D006737
% 217.74/217.91       An arthropod subclass %28%Xiphosura%29% comprising the North American %28%Limulus%29% and Asiatic %28%Tachypleus%29% genera of horseshoe crabs.%A%    
% 217.74/217.91  |- mesh__dateEstablished mesh__D006737 1978-01-01
% 217.74/217.91  |- mesh__historyNote mesh__D006737
% 217.74/217.91       78; was LIMULUS see under ARTHROPODS 1977   
% 217.74/217.91  |- mesh__dateCreated mesh__D020408 1998-06-10
% 217.74/217.91  |- skos__broader mesh__D020408smesh__D007348
% 217.74/217.91  |- skos__altLabel mesh__D020408 PL 104-191
% 217.74/217.92  |- skos__altLabel mesh__D020408 Kennedy Kassebaum Act
% 217.74/217.92  |- mesh__dateEstablished mesh__D020408 1999-01-01
% 217.74/217.92  |- skos__annotation mesh__D020408
% 217.74/217.92       add UNITED STATES %28%NIM%29%      CATALOG: use NAF entry   
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D020408 2003
% 217.74/217.92  |- skos__prefLabel mesh__D020408
% 217.74/217.92       Health Insurance Portability and Accountability Act
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D020408 2005
% 217.74/217.92  |- skos__altLabel mesh__D020408 PL104-191
% 217.74/217.92  |- rdf__type mesh__D020408sskos__Concept
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D020408 2004
% 217.74/217.92  |- mesh__historyNote mesh__D020408 99   
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D020408 2006
% 217.74/217.92  |- skos__hiddenLabel mesh__D020408 PL104 191
% 217.74/217.92  |- mesh__publicMeSHNote mesh__D020408 99   
% 217.74/217.92  |- skos__altLabel mesh__D020408 Public Law 104-191
% 217.74/217.92  |- mesh__dateRevised mesh__D020408 2001-07-25
% 217.74/217.92  |- mesh__recordAuthorizer mesh__D020408 sjn
% 217.74/217.92  |- skos__hiddenLabel mesh__D020408 Public Law 104 191
% 217.74/217.92  |- skos__altLabel mesh__D020408 Kassebaum Kennedy Act
% 217.74/217.92  |- skos__altLabel mesh__D020408
% 217.74/217.92       United States Health Insurance Portability and Accountability Act
% 217.74/217.92  |- mesh__recordMaintainer mesh__D020408 jls
% 217.74/217.92  |- skos__altLabel mesh__D020408 HIPAA
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D020408 2002
% 217.74/217.92  |- mesh__recordOriginator mesh__D020408 JLS
% 217.74/217.92  |- skos__scopeNote mesh__D020408
% 217.74/217.92       Public Law 104-91, enacted in 1996, is designed to protect health insurance coverage for workers and their families when they change or lose their jobs. HIPAA has separate provisions for the large and small group markets, and the individual market. HIPAA amends the Employee Retirement Income Security Act %28%ERISA%29%, the Public Health Service Act, and the Internal Revenue Code to provide improved portability and continuity of health insurance coverage, extending earlier provisions under the Consolidated Omnibus Budget Reconciliation Act of 1985 %28%%22%COBRA%22%%29%.%A%    
% 217.74/217.92  |- mesh__dateEstablished mesh__D050893 2006-01-01
% 217.74/217.92  |- skos__historyNote mesh__D050893 Methylglycine %28%1979-1982%29%
% 217.74/217.92  |- mesh__dateCreated mesh__D050893 2005-06-30
% 217.74/217.92  |- mesh__historyNote mesh__D050893 2006%28%1979%29%   
% 217.74/217.92  |- skos__scopeNote mesh__D050893
% 217.74/217.92       A FLAVOPROTEIN enzyme that catalyzes the oxidative demethylation of DIMETHYLGLYCINE to SARCOSINE and FORMALDEHYDE.%A%    
% 217.74/217.92  |- mesh__recordMaintainer mesh__D050893 AKE
% 217.74/217.92  |- mesh__recordAuthorizer mesh__D050893 sjn
% 217.74/217.92  |- skos__prefLabel mesh__D050893 Dimethylglycine Dehydrogenase
% 217.74/217.92  |- skos__broader mesh__D050893smesh__D010089
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D050893 2006
% 217.74/217.92  |- mesh__publicMeSHNote mesh__D050893
% 217.74/217.92       2006; DIMETHYLGLYCINE DEHYDROGENASE was indexed under OXIDOREDUCTASES, N-DEMETHYLATING 1979-2005 %26% under METHYLGLYCINE 1979-1982%A%  
% 217.74/217.92  |- skos__hiddenLabel mesh__D050893 Dehydrogenase, Dimethylglycine
% 217.74/217.92  |- mesh__recordOriginator mesh__D050893 AKE
% 217.74/217.92  |- skos__historyNote mesh__D050893
% 217.74/217.92       Oxidoreductases, N-Demethylating %28%1979-2005%29%
% 217.74/217.92  |- rdf__type mesh__D050893sskos__Concept
% 217.74/217.92  |- mesh__historyNote mesh__D016367 91   
% 217.74/217.92  |- skos__broader mesh__D016367smesh__D007304
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D016367 2005
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D016367 2004
% 217.74/217.92  |- mesh__dateEstablished mesh__D016367 1991-01-01
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D016367 2002
% 217.74/217.92  |- skos__annotation mesh__D016367 coord IM with specific insect /virol   
% 217.74/217.92  |- rdf__type mesh__D016367sskos__Concept
% 217.74/217.92  |- skos__hiddenLabel mesh__D016367 Oryctes Virus
% 217.74/217.92  |- mesh__recordMaintainer mesh__D016367 ags
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D016367 2003
% 217.74/217.92  |- mesh__dateCreated mesh__D016367 1990-05-25
% 217.74/217.92  |- mesh__recordAuthorizer mesh__D016367 sjn
% 217.74/217.92  |- mesh__dateRevised mesh__D016367 2001-07-25
% 217.74/217.92  |- skos__historyNote mesh__D016367 Polyhedrosis Viruses %28%1973-1990%29%
% 217.74/217.92  |- mesh__recordOriginator mesh__D016367 AGS
% 217.74/217.92  |- skos__hiddenLabel mesh__D016367 Baculoviruses
% 217.74/217.92  |- skos__scopeNote mesh__D016367
% 217.74/217.92       Family of INSECT VIRUSES containing two subfamilies: Eubaculovirinae %28%occluded baculoviruses%29% and Nudibaculovirinae %28%nonoccluded baculoviruses%29%. The Eubaculovirinae, which contain polyhedron-shaped inclusion bodies, have two genera: NUCLEOPOLYHEDROVIRUS and GRANULOVIRUS. Baculovirus vectors are used for expression of foreign genes in insects.%A%    
% 217.74/217.92  |- mesh__publicMeSHNote mesh__D016367 91   
% 217.74/217.92  |- skos__broader mesh__D016367smesh__D004267
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D016367 2006
% 217.74/217.92  |- skos__prefLabel mesh__D016367 Baculoviridae
% 217.74/217.92  |- rdf__type mesh__D035521sskos__Concept
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D035521 2003
% 217.74/217.92  |- skos__historyNote mesh__D035521 Jurisprudence %28%1974-2002%29%
% 217.74/217.92  |- mesh__recordMaintainer mesh__D035521 hjn
% 217.74/217.92  |- mesh__recordAuthorizer mesh__D035521 sjn
% 217.74/217.92  |- mesh__recordOriginator mesh__D035521 hjn
% 217.74/217.92  |- skos__broader mesh__D035521smesh__D007603
% 217.74/217.92  |- skos__hiddenLabel mesh__D035521 Supreme Court Decision
% 217.74/217.92  |- mesh__dateCreated mesh__D035521 2002-07-03
% 217.74/217.92  |- skos__hiddenLabel mesh__D035521 Decisions, Supreme Court
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D035521 2006
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D035521 2005
% 217.74/217.92  |- skos__prefLabel mesh__D035521 Supreme Court Decisions
% 217.74/217.92  |- skos__annotation mesh__D035521
% 217.74/217.92       US only; for supreme courts of other nations use JURISPRUDENCE%A%  
% 217.74/217.92  |- skos__altLabel mesh__D035521 United States Supreme Court Decisions
% 217.74/217.92  |- skos__hiddenLabel mesh__D035521 Decision, Supreme Court
% 217.74/217.92  |- skos__scopeNote mesh__D035521
% 217.74/217.92       Decisions made by the United States Supreme Court.     
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D035521 2004
% 217.74/217.92  |- mesh__publicMeSHNote mesh__D035521 2003   
% 217.74/217.92  |- mesh__historyNote mesh__D035521 2003   
% 217.74/217.92  |- mesh__dateEstablished mesh__D035521 2003-01-01
% 217.74/217.92  |- skos__altLabel mesh__D002347 Hypophthalmichthys molitrix
% 217.74/217.92  |- skos__altLabel mesh__D002347 Cyprinus carpio
% 217.74/217.92  |- skos__broader mesh__D002347smesh__D003530
% 217.74/217.92  |- skos__scopeNote mesh__D002347
% 217.74/217.92       Common name for a number of different species of fish in the family Cyprinidae. This includes, among others, the common carp, crucian carp, grass carp, and silver carp.%A%    
% 217.74/217.92  |- mesh__recordMaintainer mesh__D002347 jls
% 217.74/217.92  |- mesh__historyNote mesh__D002347 2002 %28%1975%29%   
% 217.74/217.92  |- skos__hiddenLabel mesh__D002347 Grass Carps
% 217.74/217.92  |- skos__hiddenLabel mesh__D002347 Carp, Koi
% 217.74/217.92  |- skos__hiddenLabel mesh__D002347 Carp, Grass
% 217.74/217.92  |- skos__hiddenLabel mesh__D002347 Silver Carps
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D002347 2006
% 217.74/217.92  |- mesh__publicMeSHNote mesh__D002347
% 217.74/217.92       2002;  see CARP 1991-2001, see CYPRINIDAE 1975-90   
% 217.74/217.92  |- skos__prefLabel mesh__D002347 Carps
% 217.74/217.92  |- mesh__recordOriginator mesh__D002347 NLM
% 217.74/217.92  |- skos__hiddenLabel mesh__D002347 Carp, Crucian
% 217.74/217.92  |- skos__hiddenLabel mesh__D002347 Carp, Silver
% 217.74/217.92  |- mesh__dateCreated mesh__D002347 1999-01-01
% 217.74/217.92  |- skos__altLabel mesh__D002347 Crucian Carp
% 217.74/217.92  |- mesh__dateRevised mesh__D002347 2004-07-19
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D002347 2005
% 217.74/217.92  |- rdf__type mesh__D002347sskos__Concept
% 217.74/217.92  |- skos__hiddenLabel mesh__D002347 Carps, Crucian
% 217.74/217.92  |- skos__hiddenLabel mesh__D002347 Carps, Silver
% 217.74/217.92  |- mesh__dateEstablished mesh__D002347 1991-01-01
% 217.74/217.92  |- skos__altLabel mesh__D002347 Ctenopharyngodon idellus
% 217.74/217.92  |- skos__hiddenLabel mesh__D002347 Crucian Carps
% 217.74/217.92  |- skos__hiddenLabel mesh__D002347 Carps, Grass
% 217.74/217.92  |- mesh__recordAuthorizer mesh__D002347 sjn
% 217.74/217.92  |- skos__broader mesh__D007830smesh__D012137
% 217.74/217.92  |- mesh__dateRevised mesh__D007830 2002-07-03
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007830 2004
% 217.74/217.92  |- skos__scopeNote mesh__D007830
% 217.74/217.92       An irregularly shaped, musculocartilaginous tubular structure, lined with mucous membrane, located at the top of the trachea and below the root of the tongue and the hyoid bone. It is the essential sphincter guarding the entrance into the trachea and functioning secondarily as the organ of voice.%A%    
% 217.74/217.92  |- skos__prefLabel mesh__D007830 Larynx
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007830 2006
% 217.74/217.92  |- skos__annotation mesh__D007830
% 217.74/217.92       LARYNGEAL CARTILAGES is available; /surg: probably LARYNGECTOMY; inflammation = LARYNGITIS; laryngocele: index under LARYNX /abnorm%A%  
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007830 2003
% 217.74/217.92  |- mesh__recordMaintainer mesh__D007830 mdb
% 217.74/217.92  |- mesh__recordAuthorizer mesh__D007830 sjn
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007830 2005
% 217.74/217.92  |- skos__related mesh__D007830smesh__D007828
% 217.74/217.92  |- skos__related mesh__D007830smesh__D007825
% 217.74/217.92  |- mesh__considerAlso mesh__D007830
% 217.74/217.92       consider also terms at VOCAL and VOICE   
% 217.74/217.92  |- rdf__type mesh__D007830sskos__Concept
% 217.74/217.92  |- mesh__recordOriginator mesh__D007830 NLM
% 217.74/217.92  |- mesh__dateCreated mesh__D007830 1999-01-01
% 217.74/217.92  |- mesh__publicMeSHNote mesh__D021501 2001   
% 217.74/217.92  |- mesh__dateCreated mesh__D021501 2000-06-22
% 217.74/217.92  |- skos__hiddenLabel mesh__D021501 Flank Pains, Left
% 217.74/217.92  |- skos__hiddenLabel mesh__D021501 Left Flank Pains
% 217.74/217.92  |- skos__hiddenLabel mesh__D021501 Pains, Flank
% 217.74/217.92  |- skos__scopeNote mesh__D021501
% 217.74/217.92       Pain emanating from below the RIBS and above the ILIUM.%A%    
% 217.74/217.92  |- mesh__historyNote mesh__D021501 2001   
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D021501 2001
% 217.74/217.92  |- skos__hiddenLabel mesh__D021501 Pain, Left Flank
% 217.74/217.92  |- skos__hiddenLabel mesh__D021501 Pain, Flank
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D021501 2002
% 217.74/217.92  |- skos__prefLabel mesh__D021501 Flank Pain
% 217.74/217.92  |- skos__hiddenLabel mesh__D021501 Right Flank Pains
% 217.74/217.92  |- rdf__type mesh__D021501sskos__Concept
% 217.74/217.92  |- skos__hiddenLabel mesh__D021501 Pains, Right Flank
% 217.74/217.92  |- skos__historyNote mesh__D021501 Pain %28%1966-2000%29%
% 217.74/217.92  |- skos__hiddenLabel mesh__D021501 Flank Pains
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D021501 2005
% 217.74/217.92  |- skos__hiddenLabel mesh__D021501 Flank Pains, Right
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D021501 2003
% 217.74/217.92  |- skos__hiddenLabel mesh__D021501 Pains, Left Flank
% 217.74/217.92  |- mesh__dateEstablished mesh__D021501 2001-01-01
% 217.74/217.92  |- skos__hiddenLabel mesh__D021501 Pain, Right Flank
% 217.74/217.92  |- skos__broader mesh__D021501smesh__D010146
% 217.74/217.92  |- skos__hiddenLabel mesh__D021501 Flank Pain, Right
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D021501 2006
% 217.74/217.92  |- skos__hiddenLabel mesh__D021501 Flank Pain, Left
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D021501 2004
% 217.74/217.92  |- mesh__dateEstablished mesh__D007032 1983-01-01
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007032 2005
% 217.74/217.92  |- mesh__dateRevised mesh__D007032 1999-11-09
% 217.74/217.92  |- skos__broader mesh__D007032smesh__D007031
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007032 2002
% 217.74/217.92  |- skos__hiddenLabel mesh__D007032 Anterior Hypothalamus
% 217.74/217.92  |- rdf__type mesh__D007032sskos__Concept
% 217.74/217.92  |- mesh__publicMeSHNote mesh__D007032
% 217.74/217.92       83; was see under HYPOTHALAMUS 1975-82   
% 217.74/217.92  |- mesh__recordAuthorizer mesh__D007032 sjn
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007032 2004
% 217.74/217.92  |- mesh__dateCreated mesh__D007032 1974-11-11
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007032 2001
% 217.74/217.92  |- skos__annotation mesh__D007032
% 217.74/217.92       diseases: coord IM with HYPOTHALAMIC DISEASES %28%IM%29%; do not confuse with ANTERIOR HYPOTHALAMIC NUCLEUS%A%  
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007032 2003
% 217.74/217.92  |- mesh__recordOriginator mesh__D007032 NLM
% 217.74/217.92  |- mesh__recordMaintainer mesh__D007032 jls
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007032 2000
% 217.74/217.92  |- mesh__historyNote mesh__D007032
% 217.74/217.92       83%28%75%29%; was see under HYPOTHALAMUS 1975-82   
% 217.74/217.92  |- skos__prefLabel mesh__D007032 Hypothalamus, Anterior
% 217.74/217.92  |- skos__hiddenLabel mesh__D007032 Supraoptic Hypothalamus
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007032 2006
% 217.74/217.92  |- skos__scopeNote mesh__D007032
% 217.74/217.92       The front portion of the HYPOTHALAMUS separated into the preoptic region and the supraoptic region. The preoptic region is made up of the periventricular gray matter of the rostral portion of the third ventricle and contains the preoptic ventricular nucleus and the medial preoptic nucleus. The supraoptic region contains the PARAVENTRICULAR HYPOTHALAMIC NUCLEUS, the SUPRAOPTIC NUCLEUS, the ANTERIOR HYPOTHALAMIC NUCLEUS, and the SUPRACHIASMATIC NUCLEUS.%A%    
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D012775 2003
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D012775 1999
% 217.74/217.92  |- mesh__recordAuthorizer mesh__D012775 SJN
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D012775 1998
% 217.74/217.92  |- mesh__recordMaintainer mesh__D012775 JLS
% 217.74/217.92  |- mesh__dateRevised mesh__D012775 1997-06-20
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D012775 2002
% 217.74/217.92  |- skos__annotation mesh__D012775
% 217.74/217.92       horseshoes may be indexed here but only as NIM   
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D012775 2006
% 217.74/217.92  |- mesh__recordOriginator mesh__D012775 NLM
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D012775 2001
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D012775 2005
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D012775 2000
% 217.74/217.92  |- mesh__dateCreated mesh__D012775 1999-01-01
% 217.74/217.92  |- rdf__type mesh__D012775sskos__Concept
% 217.74/217.92  |- skos__prefLabel mesh__D012775 Shoes
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D012775 2004
% 217.74/217.92  |- skos__hiddenLabel mesh__D012775 Shoe
% 217.74/217.92  |- skos__broader mesh__D012775smesh__D003020
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D006738 2005
% 217.74/217.92  |- skos__hiddenLabel mesh__D006738 Hospice
% 217.74/217.92  |- mesh__publicMeSHNote mesh__D006738
% 217.74/217.92       80; was see under HOSPITALS, SPECIAL 1978-79   
% 217.74/217.92  |- mesh__dateEstablished mesh__D006738 1980-01-01
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D006738 2001
% 217.74/217.92  |- skos__broader mesh__D006738smesh__D006782
% 217.74/217.92  |- rdf__type mesh__D006738sskos__Concept
% 217.74/217.92  |- mesh__recordMaintainer mesh__D006738 kle
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D006738 2000
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D006738 2004
% 217.74/217.92  |- skos__scopeNote mesh__D006738
% 217.74/217.92       Facilities or services which are especially devoted to providing palliative and supportive care to the patient with a terminal illness and to the patient%27%s family.%A%    
% 217.74/217.92  |- mesh__recordOriginator mesh__D006738 EC
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D006738 2003
% 217.74/217.92  |- mesh__historyNote mesh__D006738
% 217.74/217.92       80%28%Aug 77%29%; was see under HOSPITALS, SPECIAL Aug 77-79   
% 217.74/217.92  |- mesh__recordAuthorizer mesh__D006738 sjn
% 217.74/217.92  |- skos__broader mesh__D006738smesh__D003153
% 217.74/217.92  |- skos__historyNote mesh__D006738 Hospitals, Special %28%1968-Jul 1977%29%
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D006738 2002
% 217.74/217.92  |- mesh__dateRevised mesh__D006738 1999-11-03
% 217.74/217.92  |- skos__prefLabel mesh__D006738 Hospices
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D006738 2006
% 217.74/217.92  |- skos__annotation mesh__D006738
% 217.74/217.92       %22%palliative %26% supportive care to the dying patient %26% his family%22%; specify geog%A%  
% 217.74/217.92  |- mesh__dateCreated mesh__D006738 1977-05-12
% 217.74/217.92  |- mesh__recordAuthorizer mesh__D020409 sjn
% 217.74/217.92  |- mesh__recordOriginator mesh__D020409 NNS
% 217.74/217.92  |- skos__scopeNote mesh__D020409
% 217.74/217.92       Protein based machines that are involved in or cause movement such as the rotary devices %28%flagellar motor%29% or the devices whose movement is directed along cytoskeletal filaments %28%MYOSIN; KINESIN; and DYNEIN motor families%29%.%A%    
% 217.74/217.92  |- mesh__publicMeSHNote mesh__D020409 99   
% 217.74/217.92  |- mesh__recordMaintainer mesh__D020409 jmp
% 217.74/217.92  |- mesh__historyNote mesh__D020409 99   
% 217.74/217.92  |- skos__hiddenLabel mesh__D020409 Motors, Molecular
% 217.74/217.92  |- mesh__dateCreated mesh__D020409 1998-06-10
% 217.74/217.92  |- skos__broader mesh__D020409smesh__D046912
% 217.74/217.92  |- rdf__type mesh__D020409sskos__Concept
% 217.74/217.92  |- skos__prefLabel mesh__D020409 Molecular Motors
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D020409 2006
% 217.74/217.92  |- mesh__dateEstablished mesh__D020409 1999-01-01
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D020409 2005
% 217.74/217.92  |- mesh__dateRevised mesh__D020409 2004-07-07
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D003440 2004
% 217.74/217.92  |- skos__prefLabel mesh__D003440 Croup
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D003440 2000
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D003440 1999
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D003440 2006
% 217.74/217.92  |- mesh__dateCreated mesh__D003440 1999-01-01
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D003440 2003
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D003440 1996
% 217.74/217.92  |- mesh__publicMeSHNote mesh__D003440
% 217.74/217.92       91; was see under LARYNGITIS 1975-90   
% 217.74/217.92  |- mesh__recordOriginator mesh__D003440 NLM
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D003440 1995
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D003440 1998
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D003440 2005
% 217.74/217.92  |- mesh__historyNote mesh__D003440
% 217.74/217.92       91%28%75%29%; was see under LARYNGITIS 1975-90   
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D003440 1994
% 217.74/217.92  |- mesh__recordAuthorizer mesh__D003440 PLS
% 217.74/217.92  |- mesh__onlineNote mesh__D003440 search LARYNGITIS 1966-74   
% 217.74/217.92  |- rdf__type mesh__D003440sskos__Concept
% 217.74/217.92  |- mesh__dateEstablished mesh__D003440 1991-01-01
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D003440 2002
% 217.74/217.92  |- mesh__dateRevised mesh__D003440 1993-05-26
% 217.74/217.92  |- mesh__recordMaintainer mesh__D003440 PLS
% 217.74/217.92  |- skos__scopeNote mesh__D003440
% 217.74/217.92       A condition characterized by resonant barking cough, hoarseness and persistant stridor and caused by allergy, foreign body, infection, or neoplasm. It occurs chiefly in infants and children.%A%    
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D003440 2001
% 217.74/217.92  |- skos__broader mesh__D003440smesh__D007827
% 217.74/217.92  |- skos__annotation mesh__D003440 a form of laryngitis in inf %26% child   
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D003440 1997
% 217.74/217.92  |- skos__scopeNote mesh__D016368
% 217.74/217.92       A type of mutation in which a number of NUCLEOTIDES not divisible by three is deleted from or inserted into a protein coding sequence, thereby causing an alteration in the READING FRAMES of the entire coding sequence downstream of the mutation. These mutations may be induced by certain types of MUTAGENS or may occur spontaneously.%A%    
% 217.74/217.92  |- skos__hiddenLabel mesh__D016368 Mutation, Out-of-Frame
% 217.74/217.92  |- mesh__publicMeSHNote mesh__D016368 91   
% 217.74/217.92  |- skos__hiddenLabel mesh__D016368 Frame Shift Mutations
% 217.74/217.92  |- skos__hiddenLabel mesh__D016368 Deletion, Out-of-Frame
% 217.74/217.92  |- skos__hiddenLabel mesh__D016368 Out-of-Frame Mutations
% 217.74/217.92  |- skos__hiddenLabel mesh__D016368 Mutations, Out-of-Frame
% 217.74/217.92  |- rdf__type mesh__D016368sskos__Concept
% 217.74/217.92  |- skos__hiddenLabel mesh__D016368 Frameshift Mutations
% 217.74/217.92  |- mesh__dateCreated mesh__D016368 1990-05-25
% 217.74/217.92  |- skos__hiddenLabel mesh__D016368 Out of Frame Mutation
% 217.74/217.92  |- mesh__dateRevised mesh__D016368 2005-06-30
% 217.74/217.92  |- mesh__dateEstablished mesh__D016368 1991-01-01
% 217.74/217.92  |- skos__hiddenLabel mesh__D016368 Mutation, Frame Shift
% 217.74/217.92  |- skos__altLabel mesh__D016368 Frame Shift Mutation
% 217.74/217.92  |- skos__hiddenLabel mesh__D016368 Out-of-Frame Deletions
% 217.74/217.92  |- skos__altLabel mesh__D016368 Out-of-Frame Mutation
% 217.74/217.92  |- mesh__recordOriginator mesh__D016368 PXP
% 217.74/217.92  |- skos__annotation mesh__D016368
% 217.74/217.92       do not confuse with FRAMESHIFTING, RIBOSOMAL, physiology process %26% form of genetic translation; do not confuse effects of drug %26% radiation on frameshift mutation with drug- %26% radiation-induced frame mutation%A%  
% 217.74/217.92  |- mesh__recordAuthorizer mesh__D016368 sjn
% 217.74/217.92  |- skos__broader mesh__D016368smesh__D009154
% 217.74/217.92  |- skos__altLabel mesh__D016368 Mutation, Frameshift
% 217.74/217.92  |- skos__hiddenLabel mesh__D016368 Mutations, Frameshift
% 217.74/217.92  |- skos__hiddenLabel mesh__D016368 Deletions, Out-of-Frame
% 217.74/217.92  |- skos__historyNote mesh__D016368 Mutation %28%1968-1990%29%
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D016368 2006
% 217.74/217.92  |- skos__hiddenLabel mesh__D016368 Out of Frame Deletion
% 217.74/217.92  |- mesh__recordMaintainer mesh__D016368 nns
% 217.74/217.92  |- skos__hiddenLabel mesh__D016368 Mutations, Frame Shift
% 217.74/217.92  |- skos__prefLabel mesh__D016368 Frameshift Mutation
% 217.74/217.92  |- mesh__historyNote mesh__D016368 91   
% 217.74/217.92  |- mesh__dateCreated mesh__D002348 1999-01-01
% 217.74/217.92  |- skos__hiddenLabel mesh__D002348 Carpal Bone
% 217.74/217.92  |- mesh__recordMaintainer mesh__D002348 ags
% 217.74/217.92  |- rdf__type mesh__D002348sskos__Concept
% 217.74/217.92  |- mesh__historyNote mesh__D002348 72   
% 217.74/217.92  |- mesh__recordAuthorizer mesh__D002348 sjn
% 217.74/217.92  |- mesh__publicMeSHNote mesh__D002348 72   
% 217.74/217.92  |- skos__hiddenLabel mesh__D002348 Bones, Carpal
% 217.74/217.92  |- skos__historyNote mesh__D002348 Wrist Joint %28%1966-1971%29%
% 217.74/217.92  |- skos__prefLabel mesh__D002348 Carpal Bones
% 217.74/217.92  |- skos__broader mesh__D002348smesh__D050276
% 217.74/217.92  |- mesh__dateRevised mesh__D002348 2005-06-30
% 217.74/217.92  |- skos__historyNote mesh__D002348 Wrist %28%1966-1971%29%
% 217.74/217.92  |- skos__hiddenLabel mesh__D002348 Bone, Carpal
% 217.74/217.92  |- mesh__recordOriginator mesh__D002348 NLM
% 217.74/217.92  |- skos__annotation mesh__D002348
% 217.74/217.92       do not confuse with WRIST %28%the area%29% or WRIST JOINT; see note on CARPUS, ANIMAL; /inj permitted: not necessarily WRIST INJURIES%A%  
% 217.74/217.92  |- skos__scopeNote mesh__D002348
% 217.74/217.92       The eight bones of the wrist: SCAPHOID BONE; LUNATE BONE; TRIQUETRUM BONE; PISIFORM BONE; TRAPEZIUM BONE; TRAPEZOID BONE; CAPITATE BONE; and HAMATE BONE.%A%    
% 217.74/217.92  |- mesh__dateEstablished mesh__D002348 1972-01-01
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D002348 2006
% 217.74/217.92  |- mesh__historyNote mesh__D013070
% 217.74/217.92       66%28%64%29%; was in Cat E %26% G 1973-79, was in Cat G only 1968-72, was in Cat E only 1964-67%A%  
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D013070 2003
% 217.74/217.92  |- mesh__dateEstablished mesh__D013070 1966-01-01
% 217.74/217.92  |- skos__related mesh__D013070smesh__D014834
% 217.74/217.92  |- skos__hiddenLabel mesh__D013070 Therapies, Speech
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D013070 2004
% 217.74/217.92  |- mesh__publicMeSHNote mesh__D013070 66   
% 217.74/217.92  |- skos__hiddenLabel mesh__D013070 Speech Therapies
% 217.74/217.92  |- rdf__type mesh__D013070sskos__Concept
% 217.74/217.92  |- skos__broader mesh__D013070smesh__D012049
% 217.74/217.92  |- mesh__recordAuthorizer mesh__D013070 sjn
% 217.74/217.92  |- mesh__dateCreated mesh__D013070 1999-01-01
% 217.74/217.92  |- mesh__recordMaintainer mesh__D013070 mdb
% 217.74/217.92  |- mesh__dateRevised mesh__D013070 2001-07-25
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D013070 2005
% 217.74/217.92  |- mesh__recordOriginator mesh__D013070 NLM
% 217.74/217.92  |- skos__prefLabel mesh__D013070 Speech Therapy
% 217.74/217.92  |- skos__altLabel mesh__D013070 Therapy, Speech
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D013070 2002
% 217.74/217.92  |- skos__annotation mesh__D013070
% 217.74/217.92       do not confuse with LANGUAGE THERAPY: SPEECH THERAPY is for SPEECH DISORDERS; LANGUAGE THERAPY is for LANGUAGE DISORDERS; coord IM with specific speech disord /ther %28%IM%29%, not /rehabil%A%  
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D013070 2006
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007831 2006
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007831 2003
% 217.74/217.92  |- skos__scopeNote mesh__D007831
% 217.74/217.92       A device, activated electronically or by expired pulmonary air, which simulates laryngeal activity and enables a laryngectomized person to speak. Examples of the pneumatic mechanical device are the Tokyo and Van Hunen artificial larynges. Electronic devices include the Western Electric electrolarynx, Tait oral vibrator, Cooper-Rand electrolarynx and the Ticchioni pipe.%A%    
% 217.74/217.92  |- skos__broader mesh__D007831smesh__D001187
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007831 2005
% 217.74/217.92  |- skos__prefLabel mesh__D007831 Larynx, Artificial
% 217.74/217.92  |- mesh__publicMeSHNote mesh__D007831 80   
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007831 2000
% 217.74/217.92  |- mesh__recordMaintainer mesh__D007831 PXP
% 217.74/217.92  |- skos__historyNote mesh__D007831 Prosthesis %28%1966-1979%29%
% 217.74/217.92  |- skos__hiddenLabel mesh__D007831 Larynges, Artificial
% 217.74/217.92  |- mesh__dateEstablished mesh__D007831 1980-01-01
% 217.74/217.92  |- mesh__dateRevised mesh__D007831 1997-06-20
% 217.74/217.92  |- skos__hiddenLabel mesh__D007831 Laryngeal Prostheses
% 217.74/217.92  |- skos__hiddenLabel mesh__D007831 Voice Prostheses
% 217.74/217.92  |- rdf__type mesh__D007831sskos__Concept
% 217.74/217.92  |- skos__hiddenLabel mesh__D007831 Prostheses, Voice
% 217.74/217.92  |- skos__altLabel mesh__D007831 Laryngeal Prosthesis
% 217.74/217.92  |- skos__hiddenLabel mesh__D007831 Prosthesis, Voice
% 217.74/217.92  |- mesh__recordAuthorizer mesh__D007831 SJN
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007831 1999
% 217.74/217.92  |- mesh__dateCreated mesh__D007831 1978-12-21
% 217.74/217.92  |- skos__altLabel mesh__D007831 Artificial Larynx
% 217.74/217.92  |- mesh__recordOriginator mesh__D007831 RC
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007831 2002
% 217.74/217.92  |- skos__altLabel mesh__D007831 Artificial Larynges
% 217.74/217.92  |- mesh__historyNote mesh__D007831 80   
% 217.74/217.92  |- skos__hiddenLabel mesh__D007831 Prostheses, Laryngeal
% 217.74/217.92  |- skos__related mesh__D007831smesh__D013071
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007831 1998
% 217.74/217.92  |- skos__hiddenLabel mesh__D007831 Prosthesis, Laryngeal
% 217.74/217.92  |- skos__historyNote mesh__D007831 Speech, Alaryngeal %28%1968-1979%29%
% 217.74/217.92  |- skos__broader mesh__D007831smesh__D019736
% 217.74/217.92  |- skos__historyNote mesh__D007831 Larynx %28%1966-1979%29%
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007831 2004
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007831 2001
% 217.74/217.92  |- skos__hiddenLabel mesh__D007033 Hypothalamic Region, Intermediate
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007033 2004
% 217.74/217.92  |- mesh__dateEstablished mesh__D007033 1983-01-01
% 217.74/217.92  |- mesh__onlineNote mesh__D007033
% 217.74/217.92       use HYPOTHALAMUS, MIDDLE to search HYPOTHALAMUS, MEDIAL 1975-82%A%  
% 217.74/217.92  |- skos__hiddenLabel mesh__D007033 Region, Intermediate Hypothalamic
% 217.74/217.92  |- mesh__dateCreated mesh__D007033 1974-11-11
% 217.74/217.92  |- skos__broader mesh__D007033smesh__D007031
% 217.74/217.92  |- mesh__publicMeSHNote mesh__D007033
% 217.74/217.92       83; was HYPOTHALAMUS, MEDIAL see under HYPOTHALAMUS 1975-82%A%  
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007033 2002
% 217.74/217.92  |- skos__hiddenLabel mesh__D007033 Regions, Intermediate Hypothalamic
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007033 2003
% 217.74/217.92  |- skos__annotation mesh__D007033
% 217.74/217.92       diseases: coord IM with HYPOTHALAMIC DISEASES %28%IM%29%; HYPOTHALAMIC AREA, LATERAL is also available%A%  
% 217.74/217.92  |- skos__hiddenLabel mesh__D007033 Medial Hypothalamus
% 217.74/217.92  |- mesh__recordAuthorizer mesh__D007033 sjn
% 217.74/217.92  |- mesh__dateRevised mesh__D007033 1999-11-08
% 217.74/217.92  |- skos__altLabel mesh__D007033 Intermediate Hypothalamic Region
% 217.74/217.92  |- skos__hiddenLabel mesh__D007033 Hypothalamic Regions, Intermediate
% 217.74/217.92  |- mesh__activeMeSHYear mesh__D007033 2006
% 217.74/217.93  |- mesh__recordMaintainer mesh__D007033 adp
% 217.74/217.93  |- skos__prefLabel mesh__D007033 Hypothalamus, Middle
% 217.74/217.93  |- skos__hiddenLabel mesh__D007033 Middle Hypothalamus
% 217.74/217.93  |- skos__scopeNote mesh__D007033
% 217.74/217.93       That middle portion of the hypothalamus containing the arcuate, dorsomedial, and ventromedial nuclei, and the tuber cinereum. The pituitary gland can also be considered part of the middle hypothalamic region.%A%    
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D007033 2001
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D007033 2005
% 217.74/217.93  |- mesh__recordOriginator mesh__D007033 NLM
% 217.74/217.93  |- skos__hiddenLabel mesh__D007033 Intermediate Hypothalamic Regions
% 217.74/217.93  |- skos__altLabel mesh__D007033 Hypothalamus, Medial
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D007033 2000
% 217.74/217.93  |- mesh__historyNote mesh__D007033
% 217.74/217.93       83; was HYPOTHALAMUS, MEDIAL see under HYPOTHALAMUS 1975-82%A%  
% 217.74/217.93  |- rdf__type mesh__D007033sskos__Concept
% 217.74/217.93  |- skos__altLabel mesh__D012776 Shope Fibroma Virus
% 217.74/217.93  |- skos__broader mesh__D012776smesh__D018152
% 217.74/217.93  |- mesh__publicMeSHNote mesh__D012776
% 217.74/217.93       94; was SHOPE FIBROMA VIRUS 1975-93 %28%see under POXVIRIDAE 1981-90, see under POXVIRUSES 1975-80%29%%A%  
% 217.74/217.93  |- mesh__historyNote mesh__D012776
% 217.74/217.93       94; was SHOPE FIBROMA VIRUS 1975-93 %28%see under POXVIRIDAE 1981-90, see under POXVIRUSES 1975-80%29%%A%  
% 217.74/217.93  |- mesh__recordMaintainer mesh__D012776 ags
% 217.74/217.93  |- skos__hiddenLabel mesh__D012776 Rabbits Fibromatosis Viruses
% 217.74/217.93  |- mesh__recordAuthorizer mesh__D012776 sjn
% 217.74/217.93  |- mesh__dateRevised mesh__D012776 2001-07-25
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D012776 2006
% 217.74/217.93  |- skos__hiddenLabel mesh__D012776 Rabbits Fibromatosis Virus
% 217.74/217.93  |- mesh__dateCreated mesh__D012776 1974-12-12
% 217.74/217.93  |- skos__prefLabel mesh__D012776 Fibroma Virus, Rabbit
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D012776 2005
% 217.74/217.93  |- mesh__onlineNote mesh__D012776
% 217.74/217.93       use FIBROMA VIRUS, RABBIT to search SHOPE FIBROMA VIRUS 1975-93%A%  
% 217.74/217.93  |- skos__altLabel mesh__D012776 Fibromatosis Virus of Rabbits
% 217.74/217.93  |- skos__hiddenLabel mesh__D012776 Fibroma Viruses, Rabbit
% 217.74/217.93  |- rdf__type mesh__D012776sskos__Concept
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D012776 2002
% 217.74/217.93  |- skos__altLabel mesh__D012776 Rabbit Fibromatosis Virus
% 217.74/217.93  |- skos__annotation mesh__D012776
% 217.74/217.93       X ref SHOPE FIBROMA VIRUS, described by Shope in 1932: do not confuse with SHOPE PAPILLOMA VIRUS; infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%%A%  
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D012776 2004
% 217.74/217.93  |- skos__scopeNote mesh__D012776
% 217.74/217.93       A species of LEPORIPOXVIRUS causing subcutaneous localized swellings in rabbits, usually on the feet.%A%    
% 217.74/217.93  |- skos__hiddenLabel mesh__D012776 Fibromatosis Viruses, Rabbit
% 217.74/217.93  |- mesh__recordOriginator mesh__D012776 NLM
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D012776 2003
% 217.74/217.93  |- skos__hiddenLabel mesh__D012776 Rabbit Fibromatosis Viruses
% 217.74/217.93  |- skos__hiddenLabel mesh__D012776 Fibroma Virus, Shope
% 217.74/217.93  |- skos__altLabel mesh__D012776 Rabbit fibroma virus
% 217.74/217.93  |- skos__hiddenLabel mesh__D012776 Fibromatosis Virus, Rabbit
% 217.74/217.93  |- mesh__dateEstablished mesh__D012776 1991-01-01
% 217.74/217.93  |- skos__hiddenLabel mesh__D012776 Rabbit Fibroma Viruses
% 217.74/217.93  |- mesh__dateRevised mesh__D006739 1999-11-03
% 217.74/217.93  |- mesh__recordOriginator mesh__D006739 NLM
% 217.74/217.93  |- rdf__type mesh__D006739sskos__Concept
% 217.74/217.93  |- skos__scopeNote mesh__D006739
% 217.74/217.93       Management of the internal organization of the hospital.%A%    
% 217.74/217.93  |- mesh__dateCreated mesh__D006739 1999-01-01
% 217.74/217.93  |- skos__broader mesh__D006739smesh__D006268
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D006739 2004
% 217.74/217.93  |- skos__hiddenLabel mesh__D006739 Administrations, Hospital
% 217.74/217.93  |- skos__broader mesh__D006739smesh__D009934
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D006739 2001
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D006739 2003
% 217.74/217.93  |- skos__altLabel mesh__D006739 Administration, Hospital
% 217.74/217.93  |- skos__prefLabel mesh__D006739 Hospital Administration
% 217.74/217.93  |- skos__related mesh__D006739smesh__D011367
% 217.74/217.93  |- mesh__recordMaintainer mesh__D006739 kle
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D006739 2000
% 217.74/217.93  |- skos__annotation mesh__D006739 SPEC: SPEC qualif; DF: HOSP ADMIN   
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D006739 2006
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D006739 2005
% 217.74/217.93  |- skos__altLabel mesh__D006739 Organization and Administration, Hospital
% 217.74/217.93  |- mesh__recordAuthorizer mesh__D006739 sjn
% 217.74/217.93  |- skos__hiddenLabel mesh__D006739 Hospital Administrations
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D006739 2002
% 217.74/217.93  |- skos__broader mesh__D006739smesh__D006281
% 217.74/217.93  |- skos__broader mesh__D017461smesh__D050705
% 217.74/217.93  |- skos__scopeNote mesh__D017461
% 217.74/217.93       Cell surface proteins that bind ATRIAL NATRIURETIC FACTOR with high affinity and trigger intracellular changes influencing the behavior of cells. They contain intrinsic guanylyl cyclase activity.%A%    
% 217.74/217.93  |- skos__altLabel mesh__D017461 ANP Receptors
% 217.74/217.93  |- skos__altLabel mesh__D017461 ANF Receptors
% 217.74/217.93  |- mesh__publicMeSHNote mesh__D017461
% 217.74/217.93       93; ATRIAL NATRIURETIC FACTOR RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1984-92 %26% MUSCLE PROTEINS 1984-85%A%  
% 217.74/217.93  |- skos__historyNote mesh__D017461
% 217.74/217.93       Receptors, Endogenous Substances %28%1984-1992%29%
% 217.74/217.93  |- mesh__historyNote mesh__D017461
% 217.74/217.93       93; was ATRIAL NATRIURETIC FACTOR RECEPTOR %28%NM%29% 1984-92   
% 217.74/217.93  |- skos__historyNote mesh__D017461 Muscle Proteins %28%1984-1985%29%
% 217.74/217.93  |- skos__altLabel mesh__D017461 Receptors, ANF
% 217.74/217.93  |- skos__altLabel mesh__D017461 Atrial Natriuretic Peptides Receptor
% 217.74/217.93  |- skos__prefLabel mesh__D017461 Receptors, Atrial Natriuretic Factor
% 217.74/217.93  |- mesh__recordMaintainer mesh__D017461 jmp
% 217.74/217.93  |- mesh__recordOriginator mesh__D017461 PXP
% 217.74/217.93  |- skos__altLabel mesh__D017461 Receptors, Atrial Natriuretic Peptides
% 217.74/217.93  |- skos__broader mesh__D017461smesh__D018000
% 217.74/217.93  |- mesh__dateCreated mesh__D017461 1992-05-22
% 217.74/217.93  |- skos__altLabel mesh__D017461 Atrial Natriuretic Factor Receptor
% 217.74/217.93  |- mesh__recordAuthorizer mesh__D017461 sjn
% 217.74/217.93  |- mesh__onlineNote mesh__D017461
% 217.74/217.93       use RECEPTORS, ATRIAL NATRIURETIC FACTOR %28%NM%29% to search ATRIAL NATRIURETIC FACTOR RECEPTOR 1984-92%A%  
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D017461 2006
% 217.74/217.93  |- skos__altLabel mesh__D017461 Receptors, ANP
% 217.74/217.93  |- skos__altLabel mesh__D017461 Atriopeptin Receptors
% 217.74/217.93  |- skos__altLabel mesh__D017461 Atrial Natriuretic Factor Receptors
% 217.74/217.93  |- skos__altLabel mesh__D017461 Atrial Natriuretic Peptides Receptors
% 217.74/217.93  |- mesh__dateEstablished mesh__D017461 1993-01-01
% 217.74/217.93  |- skos__broader mesh__D017461smesh__D018013
% 217.74/217.93  |- rdf__type mesh__D017461sskos__Concept
% 217.74/217.93  |- skos__altLabel mesh__D017461 Receptors, Atriopeptin
% 217.74/217.93  |- mesh__dateRevised mesh__D017461 2005-06-30
% 217.74/217.93  |- skos__altLabel mesh__D050895
% 217.74/217.93       Assimilatory Nitrate Reductase, NADH-Dependent
% 217.74/217.93  |- skos__annotation mesh__D050895
% 217.74/217.93       do not confuse with NITRATE REDUCTASE %28%NAD%28%P%29%H%29% or NITRATE REDUCTASE %28%NADPH%29%%A%  
% 217.74/217.93  |- skos__hiddenLabel mesh__D050895 NADH Nitrate Reductase
% 217.74/217.93  |- skos__hiddenLabel mesh__D050895 NADH Dependent Nitrate Reductase
% 217.74/217.93  |- skos__altLabel mesh__D050895 Nitrite:NAD+ Oxidoreductase
% 217.74/217.93  |- skos__prefLabel mesh__D050895 Nitrate Reductase %28%NADH%29%
% 217.74/217.93  |- mesh__recordAuthorizer mesh__D050895 ags
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D050895 2006
% 217.74/217.93  |- skos__hiddenLabel mesh__D050895 Reductase, NADH-Dependent Nitrate
% 217.74/217.93  |- skos__hiddenLabel mesh__D050895 Nitrate Reductase, NADH-Dependent
% 217.74/217.93  |- skos__broader mesh__D050895smesh__D005420
% 217.74/217.93  |- skos__hiddenLabel mesh__D050895 Reductase, NADH-Nitrate
% 217.74/217.93  |- skos__hiddenLabel mesh__D050895 Oxidoreductase, Nitrite:NAD+
% 217.74/217.93  |- mesh__historyNote mesh__D050895 2006%28%1981%29%   
% 217.74/217.93  |- skos__altLabel mesh__D050895 Nitrate Reductase %28%NADH%29%2
% 217.74/217.93  |- mesh__recordOriginator mesh__D050895 AKE
% 217.74/217.93  |- skos__broader mesh__D050895smesh__D009565
% 217.74/217.93  |- rdf__type mesh__D050895sskos__Concept
% 217.74/217.93  |- mesh__publicMeSHNote mesh__D050895
% 217.74/217.93       2006; NITRATE REDUCTASE %28%NADH%29% was indexed under NITRATE REDUCTASES 1981-2004%A%  
% 217.74/217.93  |- skos__hiddenLabel mesh__D050895
% 217.74/217.93       Assimilatory Nitrate Reductase, NADH Dependent
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D050895 2006A
% 217.74/217.93  |- mesh__dateCreated mesh__D050895 2005-06-30
% 217.74/217.93  |- skos__altLabel mesh__D050895 NADH-Nitrate Reductase
% 217.74/217.93  |- skos__altLabel mesh__D050895 NADH-Dependent Nitrate Reductase
% 217.74/217.93  |- mesh__recordMaintainer mesh__D050895 ags
% 217.74/217.93  |- mesh__dateRevised mesh__D050895 2005-07-21
% 217.74/217.93  |- mesh__dateEstablished mesh__D050895 2006-01-01
% 217.74/217.93  |- skos__scopeNote mesh__D050895
% 217.74/217.93       An NAD-dependent enzyme that catalyzes the oxidation of nitrite to nitrate. It is a FLAVOPROTEIN that contains IRON and MOLYBDENUM and is involved in the first step of nitrate assimilation in PLANTS; FUNGI; and BACTERIA. It was formerly classified as EC 1.6.6.1.%A%    
% 217.74/217.93  |- mesh__recordMaintainer mesh__D003441 sjn
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D003441 2005
% 217.74/217.93  |- mesh__dateEstablished mesh__D003441 1968-01-01
% 217.74/217.93  |- skos__prefLabel mesh__D003441 Crowding
% 217.74/217.93  |- skos__annotation mesh__D003441 human %26% animal   
% 217.74/217.93  |- mesh__publicMeSHNote mesh__D003441 68   
% 217.74/217.93  |- rdf__type mesh__D003441sskos__Concept
% 217.74/217.93  |- mesh__recordOriginator mesh__D003441 NLM
% 217.74/217.93  |- skos__broader mesh__D003441smesh__D013037
% 217.74/217.93  |- mesh__historyNote mesh__D003441 68   
% 217.74/217.93  |- mesh__dateRevised mesh__D003441 2004-07-13
% 217.74/217.93  |- mesh__recordAuthorizer mesh__D003441 sjn
% 217.74/217.93  |- skos__scopeNote mesh__D003441
% 217.74/217.93       Behavior with respect to an excessive number of individuals, human or animal, in relation to available space.%A%    
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D003441 2006
% 217.74/217.93  |- mesh__dateCreated mesh__D003441 1999-01-01
% 217.74/217.93  |- skos__broader mesh__D013255Q000172smesh__D013255
% 217.74/217.93  |- mesh__preferredCombination mesh__D013255Q000172smesh__D000312
% 217.74/217.93  |- rdf__type mesh__D013255Q000172smesh__CompoundConcept
% 217.74/217.93  |- mesh__dateCreated mesh__D016369 1991-01-03
% 217.74/217.93  |- skos__annotation mesh__D016369
% 217.74/217.93       note category: in dent cavity prep; no qualif   
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D016369 2001
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D016369 1998
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D016369 2002
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D016369 1999
% 217.74/217.93  |- mesh__recordOriginator mesh__D016369 MXR
% 217.74/217.93  |- mesh__historyNote mesh__D016369 92   
% 217.74/217.93  |- skos__prefLabel mesh__D016369 Smear Layer
% 217.74/217.93  |- skos__historyNote mesh__D016369 Dental Pulp Cavity %28%1981-1991%29%
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D016369 2005
% 217.74/217.93  |- mesh__dateEstablished mesh__D016369 1992-01-01
% 217.74/217.93  |- skos__hiddenLabel mesh__D016369 Layer, Smear
% 217.74/217.93  |- mesh__dateRevised mesh__D016369 1997-06-20
% 217.74/217.93  |- mesh__publicMeSHNote mesh__D016369 92   
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D016369 2006
% 217.74/217.93  |- skos__broader mesh__D016369smesh__D003741
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D016369 2003
% 217.74/217.93  |- skos__historyNote mesh__D016369 Dentin %28%1981-1991%29%
% 217.74/217.93  |- mesh__recordMaintainer mesh__D016369 JLS
% 217.74/217.93  |- skos__scopeNote mesh__D016369
% 217.74/217.93       Adherent debris produced when cutting the enamel or dentin in cavity preparation. It is about 1 micron thick and its composition reflects the underlying dentin, although different quantities and qualities of smear layer can be produced by the various instrumentation techniques. Its function is presumed to be protective, as it lowers dentin permeability. However, it masks the underlying dentin and interferes with attempts to bond dental material to the dentin.%A%    
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D016369 2004
% 217.74/217.93  |- skos__historyNote mesh__D016369
% 217.74/217.93       Dental Cavity Preparation %28%1981-1991%29%
% 217.74/217.93  |- mesh__recordAuthorizer mesh__D016369 SJN
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D016369 2000
% 217.74/217.93  |- rdf__type mesh__D016369sskos__Concept
% 217.74/217.93  |- skos__altLabel mesh__D002349 Compression Neuropathy, Carpal Tunnel
% 217.74/217.93  |- skos__broader mesh__D002349smesh__D012090
% 217.74/217.93  |- mesh__dateEstablished mesh__D002349 1965-01-01
% 217.74/217.93  |- skos__broader mesh__D002349smesh__D020423
% 217.74/217.93  |- rdf__type mesh__D002349sskos__Concept
% 217.74/217.93  |- mesh__historyNote mesh__D002349 1965%28%1963%29%   
% 217.74/217.93  |- skos__broader mesh__D002349smesh__D009408
% 217.74/217.93  |- skos__prefLabel mesh__D002349 Carpal Tunnel Syndrome
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D002349 2002
% 217.74/217.93  |- skos__hiddenLabel mesh__D002349 Syndromes, Carpal Tunnel
% 217.74/217.93  |- skos__hiddenLabel mesh__D002349 Syndrome, Carpal Tunnel
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D002349 2004
% 217.74/217.93  |- mesh__recordMaintainer mesh__D002349 KEV
% 217.74/217.93  |- skos__hiddenLabel mesh__D002349 Carpal Tunnel Syndromes
% 217.74/217.93  |- skos__altLabel mesh__D002349 Entrapment Neuropathy, Carpal Tunnel
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D002349 2003
% 217.74/217.93  |- mesh__recordAuthorizer mesh__D002349 sjn
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D002349 2001
% 217.74/217.93  |- mesh__dateRevised mesh__D002349 1999-11-04
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D002349 2006
% 217.74/217.93  |- skos__altLabel mesh__D002349 Median Neuropathy, Carpal Tunnel
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D002349 2000
% 217.74/217.93  |- mesh__dateCreated mesh__D002349 1999-01-01
% 217.74/217.93  |- mesh__publicMeSHNote mesh__D002349 1965   
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D002349 2005
% 217.74/217.93  |- skos__scopeNote mesh__D002349
% 217.74/217.93       Entrapment of the MEDIAN NERVE in the carpal tunnel, which is formed by the flexor retinaculum and the CARPAL BONES. This syndrome may be associated with repetitive occupational trauma %28%CUMULATIVE TRAUMA DISORDERS%29%; wrist injuries; AMYLOID NEUROPATHIES; rheumatoid arthritis %28%see ARTHRITIS, RHEUMATOID%29%; ACROMEGALY; PREGNANCY; and other conditions. Symptoms include burning pain and paresthesias involving the ventral surface of the hand and fingers which may radiate proximally. Impairment of sensation in the distribution of the median nerve and thenar muscle atrophy may occur. %28%Joynt, Clinical Neurology, 1995, Ch51, p45%29%%A%    
% 217.74/217.93  |- mesh__recordOriginator mesh__D002349 NLM
% 217.74/217.93  |- rdf__type mesh__D013071sskos__Concept
% 217.74/217.93  |- mesh__publicMeSHNote mesh__D013071
% 217.74/217.93       80; was VOICE PRODUCTION, ALARYNGEAL 1968-79   
% 217.74/217.93  |- mesh__dateCreated mesh__D013071 1999-01-01
% 217.74/217.93  |- mesh__recordOriginator mesh__D013071 NLM
% 217.74/217.93  |- skos__hiddenLabel mesh__D013071 Voice Productions, Alaryngeal
% 217.74/217.93  |- skos__hiddenLabel mesh__D013071 Alaryngeal Speech
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D013071 2005
% 217.74/217.93  |- skos__hiddenLabel mesh__D013071 Productions, Alaryngeal Voice
% 217.74/217.93  |- skos__scopeNote mesh__D013071
% 217.74/217.93       Methods of enabling a patient without a larynx or with a non-functional larynx to produce voice or speech. The methods may be pneumatic or electronic.%A%    
% 217.74/217.93  |- mesh__recordMaintainer mesh__D013071 mdb
% 217.74/217.93  |- mesh__dateRevised mesh__D013071 2002-07-02
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D013071 2006
% 217.74/217.93  |- mesh__historyNote mesh__D013071
% 217.74/217.93       80; was VOICE PRODUCTION, ALARYNGEAL 1968-79   
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D013071 2003
% 217.74/217.93  |- mesh__onlineNote mesh__D013071
% 217.74/217.93       use SPEECH, ALARYNGEAL to search VOICE PRODUCTION, ALARYNGEAL 1968-79%A%  
% 217.74/217.93  |- skos__hiddenLabel mesh__D013071 Production, Alaryngeal Voice
% 217.74/217.93  |- skos__hiddenLabel mesh__D013071 Alaryngeal Voice Productions
% 217.74/217.93  |- skos__related mesh__D013071smesh__D007831
% 217.74/217.93  |- skos__hiddenLabel mesh__D013071 Alaryngeal Voice Production
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D013071 2004
% 217.74/217.93  |- skos__broader mesh__D013071smesh__D012049
% 217.74/217.93  |- skos__altLabel mesh__D013071 Voice Production, Alaryngeal
% 217.74/217.93  |- mesh__recordAuthorizer mesh__D013071 sjn
% 217.74/217.93  |- skos__prefLabel mesh__D013071 Speech, Alaryngeal
% 217.74/217.93  |- mesh__dateEstablished mesh__D007832 1980-01-01
% 217.74/217.93  |- rdf__type mesh__D007832sskos__Concept
% 217.74/217.93  |- skos__historyNote mesh__D007832 Benzoates %28%1973-1974%29%
% 217.74/217.93  |- skos__historyNote mesh__D007832 Antibiotics %28%1973-1974%29%
% 217.74/217.93  |- mesh__dateRevised mesh__D007832 2004-07-07
% 217.74/217.93  |- mesh__publicMeSHNote mesh__D007832
% 217.74/217.93       80; was indexed under ANTIBIOTICS 1975-79   
% 217.74/217.93  |- skos__scopeNote mesh__D007832
% 217.74/217.93       Cationic ionophore antibiotic obtained from Streptomyces lasaliensis that, among other effects, dissociates the calcium fluxes in muscle fibers. It is used as a coccidiostat, especially in poultry.%A%    
% 217.74/217.93  |- skos__hiddenLabel mesh__D007832 Ro 22985
% 217.74/217.93  |- mesh__dateCreated mesh__D007832 1974-11-19
% 217.74/217.93  |- mesh__recordOriginator mesh__D007832 NLM
% 217.74/217.93  |- skos__altLabel mesh__D007832 Lasalocid A
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D007832 2006
% 217.74/217.93  |- mesh__historyNote mesh__D007832
% 217.74/217.93       80%28%78%29%; was see under ANTIBIOTICS 1978-79; was X 537A see under ANTIBIOTICS 1975-77%A%  
% 217.74/217.93  |- mesh__onlineNote mesh__D007832 use LASALOCID to search X 537A 1975-77   
% 217.74/217.93  |- skos__broader mesh__D007832smesh__D005663
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D007832 2005
% 217.74/217.93  |- skos__prefLabel mesh__D007832 Lasalocid
% 217.74/217.93  |- mesh__recordMaintainer mesh__D007832 jmp
% 217.74/217.93  |- skos__hiddenLabel mesh__D007832 Ro 2 2985
% 217.74/217.93  |- mesh__recordAuthorizer mesh__D007832 sjn
% 217.74/217.93  |- skos__hiddenLabel mesh__D007034 Regions, Posterior Hypothalamic
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D007034 2003
% 217.74/217.93  |- skos__annotation mesh__D007034
% 217.74/217.93       diseases: coord IM with HYPOTHALAMIC DISEASES %28%IM%29%   
% 217.74/217.93  |- skos__altLabel mesh__D007034 Hypothalamic Region, Posterior
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D007034 2004
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D007034 2001
% 217.74/217.93  |- mesh__recordOriginator mesh__D007034 NLM
% 217.74/217.93  |- mesh__recordMaintainer mesh__D007034 KEV
% 217.74/217.93  |- skos__altLabel mesh__D007034 Posterior Hypothalamic Region
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D007034 2002
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D007034 2005
% 217.74/217.93  |- skos__hiddenLabel mesh__D007034 Posterior Hypothalamus
% 217.74/217.93  |- skos__broader mesh__D007034smesh__D007031
% 217.74/217.93  |- mesh__dateRevised mesh__D007034 1999-11-05
% 217.74/217.93  |- skos__hiddenLabel mesh__D007034 Hypothalamic Regions, Posterior
% 217.74/217.93  |- skos__prefLabel mesh__D007034 Hypothalamus, Posterior
% 217.74/217.93  |- skos__scopeNote mesh__D007034
% 217.74/217.93       The part of the hypothalamus posterior to the middle region consisting of several nuclei including the medial mamillary nucleus, lateral mamillary nucleus, and posterior hypothalamic nucleus %28%posterior hypothalamic area%29%. The posterior hypothalamic area is concerned with control of sympathetic responses and is sensitive to conditions of decreasing temperature and controls the mechanisms for the conservation and increased production of heat.%A%    
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D007034 2006
% 217.74/217.93  |- skos__hiddenLabel mesh__D007034 Region, Posterior Hypothalamic
% 217.74/217.93  |- mesh__dateEstablished mesh__D007034 1991-01-01
% 217.74/217.93  |- mesh__publicMeSHNote mesh__D007034
% 217.74/217.93       91; was see under HYPOTHALAMUS 1975-90   
% 217.74/217.93  |- mesh__historyNote mesh__D007034
% 217.74/217.93       91%28%75%29%; was see under HYPOTHALAMUS 1975-90   
% 217.74/217.93  |- mesh__recordAuthorizer mesh__D007034 sjn
% 217.74/217.93  |- mesh__dateCreated mesh__D007034 1974-11-11
% 217.74/217.93  |- rdf__type mesh__D007034sskos__Concept
% 217.74/217.93  |- skos__hiddenLabel mesh__D007034 Posterior Hypothalamic Regions
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D007034 2000
% 217.74/217.93  |- skos__hiddenLabel mesh__D051190 500 kDa HD1 Protein
% 217.74/217.93  |- skos__hiddenLabel mesh__D051190 HD1 Protein, 500-kDa
% 217.74/217.93  |- skos__broader mesh__D051190smesh__D051179
% 217.74/217.93  |- skos__altLabel mesh__D051190 500-kDa HD1 Protein
% 217.74/217.93  |- mesh__publicMeSHNote mesh__D051190
% 217.74/217.93       2006; PLECTIN was indexed under INTERMEDIATE FILAMENT PROTEINS 1992-2005, %26% under PROTEINS 1982-1991%A%  
% 217.74/217.93  |- rdf__type mesh__D051190sskos__Concept
% 217.74/217.93  |- skos__scopeNote mesh__D051190
% 217.74/217.93       A cytoskeletal linker protein with a molecular weight of greater than 500 kDa. It binds INTERMEDIATE FILAMENTS; MICROTUBULES; and MICROFILAMENTS and plays a central role in the organization and stability of the CYTOSKELETON. Plectin is phosphorylated by CALMODULIN KINASE; PROTEIN KINASE A; and PROTEIN KINASE C.%A%    
% 217.74/217.93  |- skos__altLabel mesh__D051190 Hemidesmosomal Protein HD1
% 217.74/217.93  |- mesh__recordOriginator mesh__D051190 DRC
% 217.74/217.93  |- skos__hiddenLabel mesh__D051190 HD1, Hemidesmosomal Protein
% 217.74/217.93  |- mesh__historyNote mesh__D051190 2006%28%1982%29%   
% 217.74/217.93  |- mesh__dateEstablished mesh__D051190 2006-01-01
% 217.74/217.93  |- mesh__recordMaintainer mesh__D051190 DRC
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D051190 2006
% 217.74/217.93  |- skos__prefLabel mesh__D051190 Plectin
% 217.74/217.93  |- mesh__dateCreated mesh__D051190 2005-06-30
% 217.74/217.93  |- mesh__recordAuthorizer mesh__D051190 sjn
% 217.74/217.93  |- skos__broader mesh__D051190smesh__D010750
% 217.74/217.93  |- skos__broader mesh__D015907Q000295smesh__D015907
% 217.74/217.93  |- mesh__preferredCombination mesh__D015907Q000295smesh__D020702
% 217.74/217.93  |- rdf__type mesh__D015907Q000295smesh__CompoundConcept
% 217.74/217.93  |- skos__altLabel mesh__D012777 Papillomavirus sylvilagi
% 217.74/217.93  |- skos__altLabel mesh__D012777 Papillomavirus, Rabbit
% 217.74/217.93  |- mesh__recordOriginator mesh__D012777 NLM
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D012777 2005
% 217.74/217.93  |- skos__prefLabel mesh__D012777 Papillomavirus, Cottontail Rabbit
% 217.74/217.93  |- skos__hiddenLabel mesh__D012777 Papillomaviruses, Rabbit
% 217.74/217.93  |- skos__altLabel mesh__D012777 Rabbit Papilloma Virus
% 217.74/217.93  |- skos__broader mesh__D012777smesh__D010213
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D012777 2006
% 217.74/217.93  |- mesh__publicMeSHNote mesh__D012777
% 217.74/217.93       97; was PAPILLOMAVIRUS SYLVILAGI 1994-96; was SHOPE PAPILLOMA VIRUS 1975-93 %28%see under PAPILLOMAVIRUSES 1978-90, see under PAPILLOMA VIRUSES 1975-77%29%%A%  
% 217.74/217.93  |- mesh__dateEstablished mesh__D012777 1991-01-01
% 217.74/217.93  |- skos__hiddenLabel mesh__D012777 Rabbit Papillomavirus
% 217.74/217.93  |- mesh__historyNote mesh__D012777
% 217.74/217.93       97; was PAPILLOMAVIRUS SYLVILAGI 1994-96; was SHOPE PAPILLOMA VIRUS 1975-93 %28%see under PAPILLOMAVIRUSES 1978-90, see under PAPILLOMA VIRUSES 1975-77%29%%A%  
% 217.74/217.93  |- skos__altLabel mesh__D012777 Shope Papilloma Virus
% 217.74/217.93  |- mesh__dateCreated mesh__D012777 1974-12-12
% 217.74/217.93  |- skos__altLabel mesh__D012777 Papilloma Virus, Rabbit
% 217.74/217.93  |- skos__annotation mesh__D012777
% 217.74/217.93       do not confuse X ref SHOPE PAPILLOMA VIRUS with SHOPE FIBROMA VIRUS; infection: coord IM with PAPILLOMAVIRUS INFECTIONS %28%IM%29%%A%  
% 217.74/217.93  |- rdf__type mesh__D012777sskos__Concept
% 217.74/217.93  |- skos__hiddenLabel mesh__D012777 Rabbit Papillomaviruses
% 217.74/217.93  |- skos__altLabel mesh__D012777 Cottontail rabbit papillomavirus
% 217.74/217.93  |- mesh__recordAuthorizer mesh__D012777 sjn
% 217.74/217.93  |- skos__hiddenLabel mesh__D012777 Papillomaviruses, Cottontail Rabbit
% 217.74/217.93  |- skos__hiddenLabel mesh__D012777 Papilloma Viruses, Rabbit
% 217.74/217.93  |- skos__hiddenLabel mesh__D012777 Cottontail Rabbit Papillomaviruses
% 217.74/217.93  |- mesh__dateRevised mesh__D012777 2003-07-09
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D012777 2004
% 217.74/217.93  |- skos__altLabel mesh__D012777 Papilloma Virus, Shope
% 217.74/217.93  |- skos__hiddenLabel mesh__D012777 Rabbit Papilloma Viruses
% 217.74/217.93  |- mesh__onlineNote mesh__D012777
% 217.74/217.93       use PAPILLOMAVIRUS, COTTONTAIL RABBIT to search PAPILLOMAVIRUS SYLVILAGI 1994-96 %26% SHOPE PAPILLOMA VIRUS 1975-93%A%  
% 217.74/217.93  |- mesh__recordMaintainer mesh__D012777 ags
% 217.74/217.93  |- skos__scopeNote mesh__D012777
% 217.74/217.93       The type species of PAPILLOMAVIRUS. It is reported to occur naturally in cottontail rabbits in North America.%A%    
% 217.74/217.93  |- skos__annotation mesh__D050896
% 217.74/217.93       do not confuse with NITRATE REDUCTASE %28%NADPH%29% or NITRATE REDUCTASE %28%NADH%29% or NITRITE REDUCTASE %28%NAD%28%P%29%H%29%%A%  
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D050896 2006
% 217.74/217.93  |- skos__altLabel mesh__D050896 Bi-Specific NAD%28%P%29%H Nitrate Reductase
% 217.74/217.93  |- mesh__dateEstablished mesh__D050896 2006-01-01
% 217.74/217.93  |- mesh__historyNote mesh__D050896 2006   
% 217.74/217.93  |- mesh__dateCreated mesh__D050896 2005-06-30
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D050896 2006A
% 217.74/217.93  |- mesh__dateRevised mesh__D050896 2005-07-27
% 217.74/217.93  |- skos__broader mesh__D050896smesh__D005420
% 217.74/217.93  |- skos__altLabel mesh__D050896 Nitrite:NAD%28%P%29%+ Oxidoreductase
% 217.74/217.93  |- rdf__type mesh__D050896sskos__Concept
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D050896 2006B
% 217.74/217.93  |- skos__altLabel mesh__D050896 Nitrate Reductase NAD%28%P%29%H
% 217.74/217.93  |- skos__altLabel mesh__D050896 NAD%28%P%29%H Nitrate Reductase
% 217.74/217.93  |- skos__altLabel mesh__D050896
% 217.74/217.93       Nitrate Reductase %28%Reduced Nicotinamide Adenine Dinucleotide %28%Phosphate%29%%29%
% 217.74/217.93  |- skos__broader mesh__D050896smesh__D007506
% 217.74/217.93  |- skos__prefLabel mesh__D050896 Nitrate Reductase %28%NAD%28%P%29%H%29%
% 217.74/217.93  |- skos__altLabel mesh__D050896 NAD%28%P%29%H Bispecific Nitrate Reductase
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D050896 2006C
% 217.74/217.93  |- skos__altLabel mesh__D050896 NAD%28%P%29%H-Nitrate Reductase
% 217.74/217.93  |- mesh__recordMaintainer mesh__D050896 ags
% 217.74/217.93  |- skos__scopeNote mesh__D050896
% 217.74/217.93       An iron-sulfur and MOLYBDENUM containing FLAVOPROTEIN that catalyzes the oxidation of nitrite to nitrate. This enzyme can use either NAD or NADP as cofactors. It is a key enzyme that is involved in the first step of nitrate assimilation in PLANTS; FUNGI; and BACTERIA. This enzyme was formerly classified as EC 1.6.6.2.%A%    
% 217.74/217.93  |- skos__altLabel mesh__D050896
% 217.74/217.93       Assimilatory NAD%28%P%29%H Nitrate Reductase
% 217.74/217.93  |- mesh__publicMeSHNote mesh__D050896
% 217.74/217.93       2006; NITRATE REDUCTASE %28%NAD%28%P%29%H%29% was indexed under NITRATE REDUCTASES 1981-2004%A%  
% 217.74/217.93  |- mesh__recordOriginator mesh__D050896 AKE
% 217.74/217.93  |- skos__broader mesh__D050896smesh__D009565
% 217.74/217.93  |- mesh__recordAuthorizer mesh__D050896 ags
% 217.74/217.93  |- skos__broader mesh__D003442smesh__D003793
% 217.74/217.93  |- skos__scopeNote mesh__D003442
% 217.74/217.93       A prosthetic restoration that reproduces the entire surface anatomy of the visible natural crown of a tooth. It may be partial %28%covering three or more surfaces of a tooth%29% or complete %28%covering all surfaces%29%. It is made of gold or other metal, porcelain, or resin.%A%    
% 217.74/217.93  |- mesh__historyNote mesh__D003442
% 217.74/217.93       65; CROWN AND BRIDGEWORK was heading 1963-64   
% 217.74/217.93  |- mesh__recordAuthorizer mesh__D003442 SJN
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D003442 2000
% 217.74/217.93  |- skos__hiddenLabel mesh__D003442 Crown
% 217.74/217.93  |- mesh__dateEstablished mesh__D003442 1965-01-01
% 217.74/217.93  |- rdf__type mesh__D003442sskos__Concept
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D003442 2001
% 217.74/217.93  |- mesh__dateRevised mesh__D003442 1997-06-20
% 217.74/217.93  |- skos__altLabel mesh__D003442 Dental Crown
% 217.74/217.93  |- skos__altLabel mesh__D003442 Crown, Dental
% 217.74/217.93  |- mesh__dateCreated mesh__D003442 1999-01-01
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D003442 2003
% 217.74/217.93  |- skos__related mesh__D003442smesh__D003776
% 217.74/217.93  |- skos__prefLabel mesh__D003442 Crowns
% 217.74/217.93  |- skos__broader mesh__D003442smesh__D017266
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D003442 1998
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D003442 2005
% 217.74/217.93  |- skos__altLabel mesh__D003442 Crowns, Dental
% 217.74/217.93  |- mesh__recordOriginator mesh__D003442 NLM
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D003442 2004
% 217.74/217.93  |- skos__altLabel mesh__D003442 Dental Crowns
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D003442 2002
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D003442 1999
% 217.74/217.93  |- mesh__publicMeSHNote mesh__D003442
% 217.74/217.93       65; CROWN AND BRIDGEWORK was heading 1963-64   
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D003442 2006
% 217.74/217.93  |- mesh__recordMaintainer mesh__D003442 PXP
% 217.74/217.93  |- skos__broader mesh__D003442smesh__D003794
% 217.74/217.93  |- skos__annotation mesh__D003442
% 217.74/217.93       note category: anatomical crown of tooth = TOOTH CROWN; do not confuse X ref DENTAL CROWNS with TOOTH CROWN%A%  
% 217.74/217.93  |- mesh__recordMaintainer mesh__D041561 SYSTEM
% 217.74/217.93  |- mesh__recordOriginator mesh__D041561 ags
% 217.74/217.93  |- mesh__dateEstablished mesh__D041561 2004-01-01
% 217.74/217.93  |- skos__broader mesh__D041561smesh__D019619
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D041561 2006
% 217.74/217.93  |- mesh__historyNote mesh__D041561
% 217.74/217.93       2004; for THERMOFILUM use THERMOPROTEALES 1998-2003   
% 217.74/217.93  |- rdf__type mesh__D041561sskos__Concept
% 217.74/217.93  |- mesh__publicMeSHNote mesh__D041561
% 217.74/217.93       2004; for THERMOFILUM see THERMOPROTEALES 1998-2003   
% 217.74/217.93  |- mesh__dateCreated mesh__D041561 2003-07-09
% 217.74/217.93  |- skos__prefLabel mesh__D041561 Thermofilaceae
% 217.74/217.93  |- mesh__recordAuthorizer mesh__D041561 sjn
% 217.74/217.93  |- mesh__dateRevised mesh__D041561 2005-06-30
% 217.74/217.93  |- skos__scopeNote mesh__D041561
% 217.74/217.93       A family of THERMOPROTEALES consisting of anaerobic, thermoacidophilic thin rods found in solfataric hot springs.%A%    
% 217.74/217.93  |- rdf__type mesh__D013870sskos__Concept
% 217.74/217.93  |- mesh__recordAuthorizer mesh__D013870 PLS
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D013870 1996
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D013870 2003
% 217.74/217.93  |- mesh__dateRevised mesh__D013870 1992-05-20
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D013870 1997
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D013870 2004
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D013870 2005
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D013870 1998
% 217.74/217.93  |- mesh__activeMeSHYear mesh__D013870 1993
% 217.74/217.93  |- mesh__dateCreated mesh__D013870 1999-01-01
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013870 2000
% 217.74/217.94  |- skos__broader mesh__D013870smesh__D013438
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013870 1994
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013870 2001
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013870 1999
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013870 2006
% 217.74/217.94  |- skos__prefLabel mesh__D013870 Thiomalates
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013870 1995
% 217.74/217.94  |- mesh__recordMaintainer mesh__D013870 TGC
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013870 2002
% 217.74/217.94  |- skos__broader mesh__D013870smesh__D008293
% 217.74/217.94  |- mesh__recordOriginator mesh__D013870 NLM
% 217.74/217.94  |- skos__annotation mesh__D013072 post-laryngectomy speech   
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013072 1999
% 217.74/217.94  |- mesh__historyNote mesh__D013072
% 217.74/217.94       91%28%75%29%%28%65-67%29%; was see under SPEECH, ALARYNGEAL 1979-90; was see under VOICE PRODUCTION, ALARYNGEAL 1965-79 %28%Prov 1965-67%29%%A%  
% 217.74/217.94  |- mesh__recordMaintainer mesh__D013072 TGC
% 217.74/217.94  |- skos__broader mesh__D013072smesh__D013071
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013072 2005
% 217.74/217.94  |- mesh__publicMeSHNote mesh__D013072
% 217.74/217.94       91; was see under SPEECH, ALARYNGEAL 1979-90; was see under VOICE PRODUCTION, ALARYNGEAL 1968-79%A%  
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013072 1996
% 217.74/217.94  |- skos__prefLabel mesh__D013072 Speech, Esophageal
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013072 2006
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013072 1997
% 217.74/217.94  |- mesh__recordOriginator mesh__D013072 NLM
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013072 2002
% 217.74/217.94  |- mesh__dateEstablished mesh__D013072 1991-01-01
% 217.74/217.94  |- mesh__recordAuthorizer mesh__D013072 PLS
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013072 2003
% 217.74/217.94  |- skos__hiddenLabel mesh__D013072 Esophageal Speech
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013072 2004
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013072 2000
% 217.74/217.94  |- skos__hiddenLabel mesh__D013072 Esophageal Speechs
% 217.74/217.94  |- skos__scopeNote mesh__D013072
% 217.74/217.94       A method of speech used after laryngectomy, with sound produced by vibration of the column of air in the esophagus against the contracting cricopharyngeal sphincter. %28%Dorland, 27th ed%29%%A%    
% 217.74/217.94  |- rdf__type mesh__D013072sskos__Concept
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013072 1998
% 217.74/217.94  |- mesh__onlineNote mesh__D013072
% 217.74/217.94       use SPEECH, ALARYNGEAL to search SPEECH, ESOPHAGEAL 1966-74 %28%as Prov 1966-67%29%%A%  
% 217.74/217.94  |- mesh__dateCreated mesh__D013072 1999-01-01
% 217.74/217.94  |- skos__hiddenLabel mesh__D013072 Speechs, Esophageal
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013072 2001
% 217.74/217.94  |- mesh__dateRevised mesh__D013072 1995-03-13
% 217.74/217.94  |- rdf__type mesh__D007833sskos__Concept
% 217.74/217.94  |- mesh__historyNote mesh__D007833 87   
% 217.74/217.94  |- mesh__dateEstablished mesh__D007833 1987-01-01
% 217.74/217.94  |- skos__hiddenLabel mesh__D007833 Knife, Laser
% 217.74/217.94  |- skos__altLabel mesh__D007833 Laser Knife
% 217.74/217.94  |- skos__altLabel mesh__D007833 Laser Knives
% 217.74/217.94  |- mesh__recordAuthorizer mesh__D007833 sjn
% 217.74/217.94  |- skos__hiddenLabel mesh__D007833 Scalpel, Laser
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D007833 2004
% 217.74/217.94  |- skos__hiddenLabel mesh__D007833 Laser Vaporizations
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D007833 2006
% 217.74/217.94  |- skos__historyNote mesh__D007833 Lasers/therapeutic use %28%1966-1986%29%
% 217.74/217.94  |- mesh__recordMaintainer mesh__D007833 nns
% 217.74/217.94  |- mesh__dateCreated mesh__D007833 1986-06-20
% 217.74/217.94  |- skos__hiddenLabel mesh__D007833 Knives, Laser
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D007833 2005
% 217.74/217.94  |- mesh__recordOriginator mesh__D007833 SH
% 217.74/217.94  |- skos__hiddenLabel mesh__D007833 Laser Vaporization
% 217.74/217.94  |- mesh__dateRevised mesh__D007833 2003-07-09
% 217.74/217.94  |- skos__prefLabel mesh__D007833 Laser Surgery
% 217.74/217.94  |- skos__altLabel mesh__D007833 Surgery, Laser
% 217.74/217.94  |- skos__hiddenLabel mesh__D007833 Vaporizations, Laser
% 217.74/217.94  |- skos__hiddenLabel mesh__D007833 Scalpels, Laser
% 217.74/217.94  |- skos__annotation mesh__D007833
% 217.74/217.94       do not confuse with LASER COAGULATION; coord IM with Cat A or Cat C term with /surg %28%IM%29%; laser surg of cataract = LASER SURGERY %28%IM%29% + CATARACT EXTRACTION %28%IM%29% but note LASER COAGULATION also used in ophthalmol surg; laser microsurgery coord with MICROSURGERY%A%  
% 217.74/217.94  |- skos__hiddenLabel mesh__D007833 Laser Scalpels
% 217.74/217.94  |- skos__scopeNote mesh__D007833
% 217.74/217.94       The use of a laser either to vaporize surface lesions or to make bloodless cuts in tissue. It does not include the coagulation of tissue by laser %28%LASER COAGULATION%29%.%A%    
% 217.74/217.94  |- mesh__publicMeSHNote mesh__D007833 87   
% 217.74/217.94  |- skos__broader mesh__D007833smesh__D013514
% 217.74/217.94  |- mesh__recordAuthorizer mesh__D007035 sjn
% 217.74/217.94  |- skos__annotation mesh__D007035
% 217.74/217.94       do not confuse with HYPOTHERMIA, INDUCED for cooling of organs during surgery or for therapy; relation to BODY TEMPERATURE: see Manual 23.27+%A%  
% 217.74/217.94  |- skos__hiddenLabel mesh__D007035 Hypothermias
% 217.74/217.94  |- skos__hiddenLabel mesh__D007035 Accidental Hypothermias
% 217.74/217.94  |- mesh__recordOriginator mesh__D007035 NLM
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D007035 2006
% 217.74/217.94  |- skos__prefLabel mesh__D007035 Hypothermia
% 217.74/217.94  |- skos__hiddenLabel mesh__D007035 Accidental Hypothermia
% 217.74/217.94  |- skos__hiddenLabel mesh__D007035 Hypothermias, Accidental
% 217.74/217.94  |- mesh__dateCreated mesh__D007035 1999-01-01
% 217.74/217.94  |- skos__scopeNote mesh__D007035
% 217.74/217.94       Lower than normal body temperature, especially in warm-blooded animals; in man usually accidental or unintentional.%A%    
% 217.74/217.94  |- rdf__type mesh__D007035sskos__Concept
% 217.74/217.94  |- skos__related mesh__D007035smesh__D017694
% 217.74/217.94  |- skos__broader mesh__D007035smesh__D001832
% 217.74/217.94  |- mesh__recordMaintainer mesh__D007035 lkt
% 217.74/217.94  |- mesh__dateRevised mesh__D007035 2005-06-30
% 217.74/217.94  |- mesh__historyNote mesh__D051191 2006%28%1995%29%   
% 217.74/217.94  |- mesh__recordOriginator mesh__D051191 DRC
% 217.74/217.94  |- mesh__publicMeSHNote mesh__D051191
% 217.74/217.94       2006; PLAKOPHILINS was indexed under PROTEINS 1995-2005   
% 217.74/217.94  |- skos__altLabel mesh__D051191 Desmosome Band 6 Protein
% 217.74/217.94  |- mesh__recordMaintainer mesh__D051191 ags
% 217.74/217.94  |- skos__broader mesh__D051191smesh__D003598
% 217.74/217.94  |- skos__altLabel mesh__D051191 Band 6 Protein, Desmosomal
% 217.74/217.94  |- skos__altLabel mesh__D051191 Plakophilin-3
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D051191 2006
% 217.74/217.94  |- skos__broader mesh__D051191smesh__D051186
% 217.74/217.94  |- mesh__recordAuthorizer mesh__D051191 ags
% 217.74/217.94  |- skos__altLabel mesh__D051191 Desmosome Band 6 Polypeptide
% 217.74/217.94  |- mesh__dateEstablished mesh__D051191 2006-01-01
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D051191 2006A
% 217.74/217.94  |- mesh__dateRevised mesh__D051191 2005-07-13
% 217.74/217.94  |- skos__scopeNote mesh__D051191
% 217.74/217.94       Members of the armadillo family of proteins that are found in DESMOSOMES and interact with various proteins including desmocadherins; DESMOPLAKIN; ACTIN FILAMENTS; and KERATIN.%A%    
% 217.74/217.94  |- mesh__dateCreated mesh__D051191 2005-06-30
% 217.74/217.94  |- skos__prefLabel mesh__D051191 Plakophilins
% 217.74/217.94  |- rdf__type mesh__D051191sskos__Concept
% 217.74/217.94  |- skos__hiddenLabel mesh__D012778 Bowel Syndromes, Short
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D012778 2006
% 217.74/217.94  |- mesh__dateEstablished mesh__D012778 1991-01-01
% 217.74/217.94  |- skos__historyNote mesh__D012778 Syndrome %28%1972-1980%29%
% 217.74/217.94  |- skos__prefLabel mesh__D012778 Short Bowel Syndrome
% 217.74/217.94  |- mesh__recordAuthorizer mesh__D012778 ags
% 217.74/217.94  |- mesh__dateCreated mesh__D012778 1980-04-09
% 217.74/217.94  |- mesh__historyNote mesh__D012778
% 217.74/217.94       91%28%81%29%; was see under MALABSORPTION SYNDROMES 1981-90   
% 217.74/217.94  |- skos__historyNote mesh__D012778
% 217.74/217.94       Malabsorption Syndromes %28%1966-1980%29%
% 217.74/217.94  |- rdf__type mesh__D012778sskos__Concept
% 217.74/217.94  |- skos__broader mesh__D012778smesh__D011183
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D012778 2004
% 217.74/217.94  |- mesh__dateRevised mesh__D012778 2005-07-14
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D012778 2006A
% 217.74/217.94  |- skos__hiddenLabel mesh__D012778 Short Bowel Syndromes
% 217.74/217.94  |- mesh__recordMaintainer mesh__D012778 ags
% 217.74/217.94  |- skos__scopeNote mesh__D012778
% 217.74/217.94       A malabsorption syndrome resulting from extensive operative resection of the SMALL INTESTINE, the absorptive region of the GASTROINTESTINAL TRACT.%A%    
% 217.74/217.94  |- skos__hiddenLabel mesh__D012778 Syndrome, Short Bowel
% 217.74/217.94  |- skos__hiddenLabel mesh__D012778 Syndromes, Short Bowel
% 217.74/217.94  |- mesh__recordOriginator mesh__D012778 RC
% 217.74/217.94  |- skos__historyNote mesh__D012778
% 217.74/217.94       Postoperative Complications %28%1966-1980%29%
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D012778 2005
% 217.74/217.94  |- mesh__publicMeSHNote mesh__D012778
% 217.74/217.94       91; was see under MALABSORPTION SYNDROMES 1981-90   
% 217.74/217.94  |- skos__broader mesh__D012778smesh__D008286
% 217.74/217.94  |- skos__hiddenLabel mesh__D012778 Bowel Syndrome, Short
% 217.74/217.94  |- skos__altLabel mesh__D017463 CD 35 Antigens
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D017463 2006
% 217.74/217.94  |- mesh__dateCreated mesh__D017463 1992-05-22
% 217.74/217.94  |- skos__hiddenLabel mesh__D017463 35 Antigens, CD
% 217.74/217.94  |- mesh__recordAuthorizer mesh__D017463 sjn
% 217.74/217.94  |- skos__prefLabel mesh__D017463 Receptors, Complement 3b
% 217.74/217.94  |- mesh__dateEstablished mesh__D017463 1993-01-01
% 217.74/217.94  |- skos__annotation mesh__D017463 DF: RECEPT C 3B   
% 217.74/217.94  |- skos__historyNote mesh__D017463 Receptors, Complement %28%1982-1992%29%
% 217.74/217.94  |- skos__hiddenLabel mesh__D017463 Antigens, CD 35
% 217.74/217.94  |- rdf__type mesh__D017463sskos__Concept
% 217.74/217.94  |- mesh__recordMaintainer mesh__D017463 sjn
% 217.74/217.94  |- skos__altLabel mesh__D017463 Receptors, CR1
% 217.74/217.94  |- skos__scopeNote mesh__D017463
% 217.74/217.94       Molecular sites on or in some B-lymphocytes and macrophages that recognize and combine with COMPLEMENT C3B. The primary structure of these receptors reveal that they contain transmembrane and cytoplasmic domains, with their extracellular portion composed entirely of thirty short consensus repeats each having 60 to 70 amino acids.%A%    
% 217.74/217.94  |- skos__altLabel mesh__D017463 Receptors, C3b
% 217.74/217.94  |- skos__broader mesh__D017463smesh__D015703
% 217.74/217.94  |- skos__altLabel mesh__D017463 Antigens, CD35
% 217.74/217.94  |- skos__hiddenLabel mesh__D017463 Receptor, Complement 3b
% 217.74/217.94  |- skos__broader mesh__D017463smesh__D011951
% 217.74/217.94  |- skos__altLabel mesh__D017463 CR1 Receptors
% 217.74/217.94  |- skos__altLabel mesh__D017463 CD35 Antigens
% 217.74/217.94  |- skos__altLabel mesh__D017463 Complement 3b Receptor
% 217.74/217.94  |- skos__hiddenLabel mesh__D017463 Antigen, CD35
% 217.74/217.94  |- mesh__onlineNote mesh__D017463
% 217.74/217.94       use RECEPTORS, COMPLEMENT 3B %28%NM%29% to search COMPLEMENT 3B RECEPTOR 1982-92%A%  
% 217.74/217.94  |- mesh__dateRevised mesh__D017463 2005-07-01
% 217.74/217.94  |- skos__altLabel mesh__D017463 Complement 3b Receptors
% 217.74/217.94  |- mesh__historyNote mesh__D017463
% 217.74/217.94       93; was COMPLEMENT 3B RECEPTOR %28%NM%29% 1982-92   
% 217.74/217.94  |- mesh__publicMeSHNote mesh__D017463
% 217.74/217.94       93; COMPLEMENT 3B RECEPTOR was indexed under RECEPTORS, COMPLEMENT 1982-92%A%  
% 217.74/217.94  |- skos__altLabel mesh__D017463 CD35 Antigen
% 217.74/217.94  |- mesh__recordOriginator mesh__D017463 PXP
% 217.74/217.94  |- skos__altLabel mesh__D017463 C3b Receptors
% 217.74/217.94  |- mesh__recordOriginator mesh__D050897 AKE
% 217.74/217.94  |- rdf__type mesh__D050897sskos__Concept
% 217.74/217.94  |- skos__broader mesh__D050897smesh__D009565
% 217.74/217.94  |- skos__annotation mesh__D050897
% 217.74/217.94       do not confuse with NITRATE REDUCTASE %28%NAD%28%P%29%H%29% or NITRATE REDUCTASE %28%NADH%29%%A%  
% 217.74/217.94  |- skos__hiddenLabel mesh__D050897 NADPH Nitrate Reductase
% 217.74/217.94  |- skos__hiddenLabel mesh__D050897
% 217.74/217.94       Triphosphopyridine Nucleotide Nitrate Reductase
% 217.74/217.94  |- skos__hiddenLabel mesh__D050897
% 217.74/217.94       Assimilatory Reduced Nicotinamide Adenine Dinucleotide Phosphate Nitrate Reductase
% 217.74/217.94  |- mesh__dateEstablished mesh__D050897 2006-01-01
% 217.74/217.94  |- skos__altLabel mesh__D050897 Nitrite:NADP+ Oxidoreductase
% 217.74/217.94  |- skos__altLabel mesh__D050897 NADPH-Nitrate Reductase
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D050897 2006A
% 217.74/217.94  |- mesh__dateCreated mesh__D050897 2005-06-30
% 217.74/217.94  |- skos__scopeNote mesh__D050897
% 217.74/217.94       An enzyme that catalyzes the oxidation of nitrite to nitrate in the presence of NADP+. It is a FLAVOPROTEIN that contains IRON and MOLYBDENUM. This enzyme was formerly classified as EC 1.6.6.3 and should not be confused with the enzyme NITRATE REDUCTASE %28%NAD%28%P%29%H%29%.%A%    
% 217.74/217.94  |- mesh__recordMaintainer mesh__D050897 ags
% 217.74/217.94  |- mesh__dateRevised mesh__D050897 2005-07-21
% 217.74/217.94  |- skos__hiddenLabel mesh__D050897 Reductase, NADPH:Nitrate
% 217.74/217.94  |- skos__hiddenLabel mesh__D050897 NADPH-Nitrate Reductase, Assimilatory
% 217.74/217.94  |- skos__hiddenLabel mesh__D050897
% 217.74/217.94       Assimilatory Nitrate Reductase, NADPH Dependent
% 217.74/217.94  |- skos__altLabel mesh__D050897
% 217.74/217.94       Triphosphopyridine Nucleotide-Nitrate Reductase
% 217.74/217.94  |- skos__broader mesh__D050897smesh__D007506
% 217.74/217.94  |- skos__hiddenLabel mesh__D050897 Oxidoreductase, Nitrite:NADP+
% 217.74/217.94  |- skos__altLabel mesh__D050897
% 217.74/217.94       Assimilatory Nitrate Reductase, NADPH-Dependent
% 217.74/217.94  |- skos__hiddenLabel mesh__D050897
% 217.74/217.94       Reductase, Triphosphopyridine Nucleotide-Nitrate
% 217.74/217.94  |- skos__altLabel mesh__D050897
% 217.74/217.94       Assimilatory Reduced Nicotinamide Adenine Dinucleotide Phosphate-Nitrate Reductase
% 217.74/217.94  |- skos__hiddenLabel mesh__D050897
% 217.74/217.94       Nucleotide-Nitrate Reductase, Triphosphopyridine
% 217.74/217.94  |- mesh__recordAuthorizer mesh__D050897 ags
% 217.74/217.94  |- skos__hiddenLabel mesh__D050897 Reductase, NADPH-Nitrate
% 217.74/217.94  |- skos__altLabel mesh__D050897 Assimilatory NADPH-Nitrate Reductase
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D050897 2006
% 217.74/217.94  |- skos__prefLabel mesh__D050897 Nitrate Reductase %28%NADPH%29%
% 217.74/217.94  |- skos__altLabel mesh__D050897 NADPH:Nitrate Reductase
% 217.74/217.94  |- mesh__publicMeSHNote mesh__D050897
% 217.74/217.94       2006; NITRATE REDUCTASE %28%NADPH%29% was indexed under NITRATE REDUCTASES 1984-2004%A%  
% 217.74/217.94  |- skos__broader mesh__D050897smesh__D005420
% 217.74/217.94  |- skos__hiddenLabel mesh__D050897 Reductase, Assimilatory NADPH-Nitrate
% 217.74/217.94  |- mesh__historyNote mesh__D050897 2006%28%2004%29%   
% 217.74/217.94  |- skos__hiddenLabel mesh__D050897 Assimilatory NADPH Nitrate Reductase
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013871 2001
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013871 1993
% 217.74/217.94  |- mesh__dateCreated mesh__D013871 1999-01-01
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013871 1998
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013871 2005
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013871 2002
% 217.74/217.94  |- skos__prefLabel mesh__D013871 Thiones
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013871 1994
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013871 1999
% 217.74/217.94  |- mesh__dateEstablished mesh__D013871 1974-01-01
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013871 2006
% 217.74/217.94  |- mesh__recordOriginator mesh__D013871 NLM
% 217.74/217.94  |- skos__annotation mesh__D013871 also %22%thions%22%   
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013871 1995
% 217.74/217.94  |- mesh__recordAuthorizer mesh__D013871 PLS
% 217.74/217.94  |- skos__broader mesh__D013871smesh__D013457
% 217.74/217.94  |- mesh__recordMaintainer mesh__D013871 TGC
% 217.74/217.94  |- mesh__dateRevised mesh__D013871 1992-05-20
% 217.74/217.94  |- rdf__type mesh__D013871sskos__Concept
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013871 1996
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013871 2003
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013871 2000
% 217.74/217.94  |- mesh__publicMeSHNote mesh__D013871 74   
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013871 1997
% 217.74/217.94  |- mesh__historyNote mesh__D013871 74   
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013871 2004
% 217.74/217.94  |- skos__hiddenLabel mesh__D013073 Sperm Agglutinations
% 217.74/217.94  |- rdf__type mesh__D013073sskos__Concept
% 217.74/217.94  |- skos__historyNote mesh__D013073 Spermatozoa %28%1966-1974%29%
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013073 2002
% 217.74/217.94  |- mesh__dateRevised mesh__D013073 1999-11-03
% 217.74/217.94  |- mesh__historyNote mesh__D013073 75   
% 217.74/217.94  |- skos__hiddenLabel mesh__D013073 Agglutinations, Sperm
% 217.74/217.94  |- mesh__recordMaintainer mesh__D013073 ags
% 217.74/217.94  |- mesh__dateEstablished mesh__D013073 1975-09-01
% 217.74/217.94  |- mesh__dateCreated mesh__D013073 1974-11-11
% 217.74/217.94  |- mesh__recordAuthorizer mesh__D013073 sjn
% 217.74/217.94  |- mesh__publicMeSHNote mesh__D013073 75   
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013073 2006
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013073 2004
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013073 2001
% 217.74/217.94  |- skos__prefLabel mesh__D013073 Sperm Agglutination
% 217.74/217.94  |- mesh__recordOriginator mesh__D013073 NLM
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013073 2000
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013073 2005
% 217.74/217.94  |- skos__scopeNote mesh__D013073
% 217.74/217.94       Agglutination of spermatozoa by antibodies or autoantibodies.%A%    
% 217.74/217.94  |- skos__hiddenLabel mesh__D013073 Agglutination, Sperm
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D013073 2003
% 217.74/217.94  |- skos__broader mesh__D013073smesh__D000371
% 217.74/217.94  |- skos__broader mesh__D007834smesh__D004864
% 217.74/217.94  |- mesh__recordMaintainer mesh__D007834 ssb
% 217.74/217.94  |- mesh__recordOriginator mesh__D007834 NLM
% 217.74/217.94  |- skos__prefLabel mesh__D007834 Lasers
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D007834 2005
% 217.74/217.94  |- skos__scopeNote mesh__D007834
% 217.74/217.94       Light Amplification by Stimulated Emission of Radiation. This phenomenon is brought about using devices that transform light of varying frequencies into a single intense, nearly nondivergent beam of monochromatic radiation. Lasers operate in the visible, infrared, or ultraviolet regions of the spectrum. They are capable of producing immense heat and power when focused at close range and are used in surgical procedures, in diagnosis, and in physiologic studies. Lasers used at low power, transmitting light not heat, have been used in wound healing and pain control %28%LASER THERAPY, LOW-LEVEL%29%.%A%    
% 217.74/217.94  |- skos__broader mesh__D007834smesh__D008027
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D007834 2006
% 217.74/217.94  |- mesh__historyNote mesh__D007834 65%28%63%29%   
% 217.74/217.94  |- mesh__recordAuthorizer mesh__D007834 sjn
% 217.74/217.94  |- skos__annotation mesh__D007834
% 217.74/217.94       lasers as surg = LASER SURGERY + disease /surg, not /radiother; low-intensity lasers = LASER THERAPY, LOW-LEVEL; multiple doses over time in ther = LASERS /ther use + disease /radiother; laser inj = LASERS /adv eff + organ /inj but do not coord with RADIATION INJURIES or any BURNS term; eff of laser as radiation: coord IM with Cat A, B or D term /rad eff %28%IM%29%; do not index under source of light %28%ARGON; XENON; etc.%29% unless the point of the article %26% then probably NIM only, without qualif; laser surg of cataract = LASER SURGERY %28%IM%29% + CATARACT EXTRACTION %28%IM%29% but note LASER COAGULATION which is also used in eye surg%A%  
% 217.74/217.94  |- skos__related mesh__D007834smesh__D006696
% 217.74/217.94  |- mesh__publicMeSHNote mesh__D007834 65   
% 217.74/217.94  |- mesh__dateRevised mesh__D007834 2004-07-07
% 217.74/217.94  |- mesh__dateCreated mesh__D007834 1999-01-01
% 217.74/217.94  |- mesh__dateEstablished mesh__D007834 1965-01-01
% 217.74/217.94  |- rdf__type mesh__D007834sskos__Concept
% 217.74/217.94  |- mesh__recordMaintainer mesh__D007036 lkt
% 217.74/217.94  |- mesh__dateCreated mesh__D007036 1999-01-01
% 217.74/217.94  |- skos__scopeNote mesh__D007036
% 217.74/217.94       Abnormally low BODY TEMPERATURE intentionally induced in warm-blooded animals by artificial means.%A%    
% 217.74/217.94  |- skos__altLabel mesh__D007036 Hibernation, Artificial
% 217.74/217.94  |- rdf__type mesh__D007036sskos__Concept
% 217.74/217.94  |- mesh__onlineNote mesh__D007036
% 217.74/217.94       use HYPOTHERMIA, INDUCED to search ANESTHESIA, REFRIGERATION %26% HIBERNATION, ARTIFICIAL 1966-83; use HYPOTHERMIA, INDUCED + STOMACH %28%NIM%29% to search GASTRIC HYPOTHERMIA 1966-83%A%  
% 217.74/217.94  |- skos__related mesh__D007036smesh__D017679
% 217.74/217.94  |- mesh__dateRevised mesh__D007036 2005-06-30
% 217.74/217.94  |- skos__altLabel mesh__D007036 Induced Hypothermia
% 217.74/217.94  |- mesh__recordAuthorizer mesh__D007036 sjn
% 217.74/217.94  |- skos__prefLabel mesh__D007036 Hypothermia, Induced
% 217.74/217.94  |- skos__hiddenLabel mesh__D007036 Artificial Hibernation
% 217.74/217.94  |- mesh__publicMeSHNote mesh__D007036
% 217.74/217.94       ANESTHESIA, REFRIGERATION %26% HIBERNATION, ARTIFICIAL were headings 1963-83; GASTRIC HYPOTHERMIA was heading 1966-83%A%  
% 217.74/217.94  |- mesh__historyNote mesh__D007036
% 217.74/217.94       ANESTHESIA, REFRIGERATION %26% HIBERNATION, ARTIFICIAL were headings 1963-83; GASTRIC HYPOTHERMIA was heading 1964-83 %28%Prov 1964-65%29%%A%  
% 217.74/217.94  |- mesh__recordOriginator mesh__D007036 NLM
% 217.74/217.94  |- skos__related mesh__D007036smesh__D017694
% 217.74/217.94  |- skos__broader mesh__D007036smesh__D017679
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D007036 2006
% 217.74/217.94  |- skos__prefLabel mesh__D051192 Receptors, Pattern Recognition
% 217.74/217.94  |- mesh__dateCreated mesh__D051192 2005-06-30
% 217.74/217.94  |- mesh__recordAuthorizer mesh__D051192 sjn
% 217.74/217.94  |- mesh__publicMeSHNote mesh__D051192 2006   
% 217.74/217.94  |- skos__broader mesh__D051192smesh__D011971
% 217.74/217.94  |- rdf__type mesh__D051192sskos__Concept
% 217.74/217.94  |- mesh__recordOriginator mesh__D051192 DRC
% 217.74/217.94  |- mesh__historyNote mesh__D051192 2006   
% 217.74/217.94  |- skos__annotation mesh__D051192 general; prefer specifics   
% 217.74/217.94  |- skos__altLabel mesh__D051192 Pattern Recognition Receptors
% 217.74/217.94  |- skos__scopeNote mesh__D051192
% 217.74/217.94       A large family of cell surface receptors that bind conserved molecular structures present in pathogens. They play important roles in host defense by mediating cellular responses to pathogens.%A%    
% 217.74/217.94  |- mesh__dateEstablished mesh__D051192 2006-01-01
% 217.74/217.94  |- mesh__recordMaintainer mesh__D051192 DRC
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D051192 2006
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D012779 2004
% 217.74/217.94  |- skos__scopeNote mesh__D012779
% 217.74/217.94       A syndrome inherited as an autosomal recessive trait and incompatible with life. The main features are narrow thorax, short ribs, scapular and pelvic dysplasia, and polydactyly.%A%    
% 217.74/217.94  |- skos__hiddenLabel mesh__D012779 Syndrome, Majewski
% 217.74/217.94  |- mesh__recordAuthorizer mesh__D012779 sjn
% 217.74/217.94  |- skos__hiddenLabel mesh__D012779 Syndrome, Saldino-Noonan
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D012779 2002
% 217.74/217.94  |- skos__hiddenLabel mesh__D012779 Short Rib Polydactyly Syndrome
% 217.74/217.94  |- skos__annotation mesh__D012779
% 217.74/217.94       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; do not confuse X ref with NOONAN SYNDROME, the male Turner syndrome%A%  
% 217.74/217.94  |- skos__hiddenLabel mesh__D012779 Saldino Noonan Syndrome
% 217.74/217.94  |- skos__historyNote mesh__D012779 Fingers %28%1966-1984%29%
% 217.74/217.94  |- mesh__dateCreated mesh__D012779 1984-04-06
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D012779 2000
% 217.74/217.94  |- mesh__recordOriginator mesh__D012779 RC
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D012779 2005
% 217.74/217.94  |- skos__broader mesh__D012779smesh__D000015
% 217.74/217.94  |- skos__hiddenLabel mesh__D012779 Short Rib-Polydactyly Syndromes
% 217.74/217.94  |- skos__broader mesh__D012779smesh__D017689
% 217.74/217.94  |- mesh__publicMeSHNote mesh__D012779
% 217.74/217.94       91; was see under OSTEOCHONDRODYSPLASIAS 1985-90   
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D012779 2006
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D012779 2001
% 217.74/217.94  |- mesh__recordMaintainer mesh__D012779 kle
% 217.74/217.94  |- skos__historyNote mesh__D012779
% 217.74/217.94       Abnormalities, Multiple %28%1968-1984%29%
% 217.74/217.94  |- skos__historyNote mesh__D012779 Ribs %28%1966-1984%29%
% 217.74/217.94  |- mesh__dateRevised mesh__D012779 1999-11-03
% 217.74/217.94  |- skos__hiddenLabel mesh__D012779 Syndrome, Short Rib-Polydactyly
% 217.74/217.94  |- mesh__historyNote mesh__D012779
% 217.74/217.94       91%28%85%29%; was see under OSTEOCHONDRODYSPLASIAS 1985-90   
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D012779 2003
% 217.74/217.94  |- skos__prefLabel mesh__D012779 Short Rib-Polydactyly Syndrome
% 217.74/217.94  |- mesh__dateEstablished mesh__D012779 1991-01-01
% 217.74/217.94  |- skos__broader mesh__D012779smesh__D010009
% 217.74/217.94  |- rdf__type mesh__D012779sskos__Concept
% 217.74/217.94  |- skos__altLabel mesh__D017464 C3d Receptors
% 217.74/217.94  |- mesh__historyNote mesh__D017464
% 217.74/217.94       93; use RECEPTORS, COMPLEMENT 3D %28%NM%29% 1981-92; for EPSTEIN-BARR VIRUS RECEPTOR use RECEPTORS, COMPLEMENT 3D %28%NM%29% 1981-98%A%  
% 217.74/217.94  |- mesh__onlineNote mesh__D017464
% 217.74/217.94       use RECEPTORS, COMPLEMENT 3D %28%NM%29% to search COMPLEMENT 3D RECEPTOR 1981-92%A%  
% 217.74/217.94  |- skos__altLabel mesh__D017464 CD 21 Antigens
% 217.74/217.94  |- skos__altLabel mesh__D017464 Antigens, CD21
% 217.74/217.94  |- skos__altLabel mesh__D017464 Receptors, CR2
% 217.74/217.94  |- skos__historyNote mesh__D017464 Receptors, Complement %28%1981-1992%29%
% 217.74/217.94  |- skos__broader mesh__D017464smesh__D015703
% 217.74/217.94  |- skos__prefLabel mesh__D017464 Receptors, Complement 3d
% 217.74/217.94  |- skos__hiddenLabel mesh__D017464 Antigen, CD21
% 217.74/217.94  |- skos__hiddenLabel mesh__D017464 2, Complement Receptor
% 217.74/217.94  |- mesh__recordMaintainer mesh__D017464 sjn
% 217.74/217.94  |- skos__scopeNote mesh__D017464
% 217.74/217.94       Molecular sites on or in B-lymphocytes, follicular dendritic cells, lymphoid cells, and epithelial cells that recognize and combine with COMPLEMENT C3D. Human complement receptor 2 %28%CR2%29% serves as a receptor for both C3dg and the gp350/220 glycoprotein of HERPESVIRUS 4, HUMAN, and binds the monoclonal antibody OKB7, which blocks binding of both ligands to the receptor.%A%    
% 217.74/217.94  |- skos__altLabel mesh__D017464 Herpesvirus 4 Receptors, Human
% 217.74/217.94  |- skos__altLabel mesh__D017464 Epstein-Barr Virus Receptors
% 217.74/217.94  |- skos__altLabel mesh__D017464 Complement 3d Receptors
% 217.74/217.94  |- skos__altLabel mesh__D017464 CD21 Antigens
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D017464 2006
% 217.74/217.94  |- skos__altLabel mesh__D017464 CD21 Antigen
% 217.74/217.94  |- rdf__type mesh__D017464sskos__Concept
% 217.74/217.94  |- skos__altLabel mesh__D017464 Complement Receptors 2
% 217.74/217.94  |- mesh__dateCreated mesh__D017464 1992-06-03
% 217.74/217.94  |- skos__annotation mesh__D017464 DF: RECEPT C 3D   
% 217.74/217.94  |- skos__altLabel mesh__D017464 Epstein-Barr Virus Receptor
% 217.74/217.94  |- skos__broader mesh__D017464smesh__D011991
% 217.74/217.94  |- mesh__dateRevised mesh__D017464 2005-07-01
% 217.74/217.94  |- skos__hiddenLabel mesh__D017464 Receptor, Epstein-Barr Virus
% 217.74/217.94  |- skos__broader mesh__D017464smesh__D011951
% 217.74/217.94  |- skos__altLabel mesh__D017464 Receptors, Epstein-Barr Virus
% 217.74/217.94  |- skos__altLabel mesh__D017464 Complement Receptor 2
% 217.74/217.94  |- skos__altLabel mesh__D017464 CR2 Receptors
% 217.74/217.94  |- skos__hiddenLabel mesh__D017464 Epstein Barr Virus Receptor
% 217.74/217.94  |- mesh__recordAuthorizer mesh__D017464 sjn
% 217.74/217.94  |- skos__altLabel mesh__D017464 Complement 3d Receptor
% 217.74/217.94  |- skos__hiddenLabel mesh__D017464 2, Complement Receptors
% 217.74/217.94  |- skos__historyNote mesh__D017464
% 217.74/217.94       Antigens, Differentiation, B-Lymphocyte %28%1988-1992%29%
% 217.74/217.94  |- skos__altLabel mesh__D017464 Receptors, C3d
% 217.74/217.94  |- skos__hiddenLabel mesh__D017464 Epstein Barr Virus Receptors
% 217.74/217.94  |- mesh__publicMeSHNote mesh__D017464
% 217.74/217.94       93; EPSTEIN-BARR VIRUS RECEPTOR was indexed under RECEPTORS, VIRUS 1981-98; COMPLEMENT 3D RECEPTOR was indexed under RECEPTORS, COMPLEMENT %26% ANTIGENS 1981-92 %26% DIFFERENTIATION, B-LYMPHOCYTE 1988-92%A%  
% 217.74/217.94  |- skos__hiddenLabel mesh__D017464 Receptors 2, Complement
% 217.74/217.94  |- skos__hiddenLabel mesh__D017464 Receptor 2, Complement
% 217.74/217.94  |- skos__hiddenLabel mesh__D017464 Receptors, Epstein Barr Virus
% 217.74/217.94  |- skos__hiddenLabel mesh__D017464 Virus Receptors, Epstein-Barr
% 217.74/217.94  |- skos__hiddenLabel mesh__D017464 Antigens, CD 21
% 217.74/217.94  |- mesh__dateEstablished mesh__D017464 1993-01-01
% 217.74/217.94  |- skos__hiddenLabel mesh__D017464 Virus Receptor, Epstein-Barr
% 217.74/217.94  |- mesh__recordOriginator mesh__D017464 PXP
% 217.74/217.94  |- skos__hiddenLabel mesh__D017464 Receptor, Complement 3d
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D050898 2006
% 217.74/217.94  |- mesh__publicMeSHNote mesh__D050898
% 217.74/217.94       2006; NITRITE REDUCTASE %28%NAD%28%P%29%H%29% was indexed under NITRITE REDUCTASES 1981-2004%A%  
% 217.74/217.94  |- mesh__recordOriginator mesh__D050898 AKE
% 217.74/217.94  |- skos__hiddenLabel mesh__D050898 NADH Nitrite Oxidoreductase
% 217.74/217.94  |- mesh__dateCreated mesh__D050898 2005-06-30
% 217.74/217.94  |- skos__hiddenLabel mesh__D050898 NADPH Nitrite Reductase
% 217.74/217.94  |- skos__altLabel mesh__D050898
% 217.74/217.94       Nitrite Reductase %28%NAD%28%P%29%H%28%2%29%%29%
% 217.74/217.94  |- skos__altLabel mesh__D050898
% 217.74/217.94       Nitrite Reductase %28%Reduced Nicotinamide Adenine Dinucleotide %28%Phosphate%29%%29%
% 217.74/217.94  |- skos__prefLabel mesh__D050898 Nitrite Reductase %28%NAD%28%P%29%H%29%
% 217.74/217.94  |- skos__altLabel mesh__D050898 NAD%28%P%29%H-Nitrite Reductase
% 217.74/217.94  |- rdf__type mesh__D050898sskos__Concept
% 217.74/217.94  |- mesh__historyNote mesh__D050898 2006%28%1981%29%   
% 217.74/217.94  |- skos__scopeNote mesh__D050898
% 217.74/217.94       An enzyme found primarily in BACTERIA and FUNGI that catalyzes the oxidation of AMMONIUM HYDROXIDE to nitrite. It is an iron-sulfur HEME; FLAVOPROTEIN containing SIROHEME and can utilize both NAD and NADP as cofactors. This enzyme was formerly classified as EC 1.6.6.4.%A%    
% 217.74/217.94  |- skos__altLabel mesh__D050898 Assimilatory Nitrite Reductase
% 217.74/217.94  |- skos__hiddenLabel mesh__D050898 Nitrite Reductase, NADH-Dependent
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D050898 2006B
% 217.74/217.94  |- skos__broader mesh__D050898smesh__D009572
% 217.74/217.94  |- skos__hiddenLabel mesh__D050898 NADH Dependent Nitrite Reductase
% 217.74/217.94  |- skos__altLabel mesh__D050898 NADH-Nitrite Oxidoreductase
% 217.74/217.94  |- mesh__dateRevised mesh__D050898 2005-07-21
% 217.74/217.94  |- mesh__recordAuthorizer mesh__D050898 ags
% 217.74/217.94  |- skos__altLabel mesh__D050898 NADH-Dependent Nitrite Reductase
% 217.74/217.94  |- skos__annotation mesh__D050898
% 217.74/217.94       do not confuse with NITRATE REDUCTASE %28%NAD%28%P%29%H%29%   
% 217.74/217.94  |- mesh__dateEstablished mesh__D050898 2006-01-01
% 217.74/217.94  |- mesh__activeMeSHYear mesh__D050898 2006A
% 217.74/217.94  |- skos__altLabel mesh__D050898 NADPH-Nitrite Reductase
% 217.74/217.95  |- mesh__recordMaintainer mesh__D050898 ags
% 217.74/217.95  |- skos__prefLabel mesh__D003444 Crush Syndrome
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D003444 2001
% 217.74/217.95  |- mesh__historyNote mesh__D003444
% 217.74/217.95       91%28%75%29%; was see under SHOCK, TRAUMATIC 1979-90; was see under KIDNEY FAILURE, ACUTE 1967-78; was see under ACUTE RENAL FAILURE 1963-66%A%  
% 217.74/217.95  |- mesh__publicMeSHNote mesh__D003444
% 217.74/217.95       91; was see under SHOCK, TRAUMATIC 1979-90; was see under KIDNEY FAILURE, ACUTE 1967-78; was see under ACUTE KIDNEY FAILURE 1963-66%A%  
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D003444 2005
% 217.74/217.95  |- mesh__recordMaintainer mesh__D003444 KEV
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D003444 2004
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D003444 2006
% 217.74/217.95  |- mesh__dateRevised mesh__D003444 1999-11-03
% 217.74/217.95  |- skos__broader mesh__D003444smesh__D012774
% 217.74/217.95  |- mesh__onlineNote mesh__D003444
% 217.74/217.95       use KIDNEY FAILURE, ACUTE to search CRUSH SYNDROME 1966-74%A%  
% 217.74/217.95  |- mesh__dateEstablished mesh__D003444 1991-01-01
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D003444 2002
% 217.74/217.95  |- mesh__recordOriginator mesh__D003444 NLM
% 217.74/217.95  |- mesh__recordAuthorizer mesh__D003444 sjn
% 217.74/217.95  |- skos__hiddenLabel mesh__D003444 Syndrome, Crush
% 217.74/217.95  |- skos__hiddenLabel mesh__D003444 Crush Syndromes
% 217.74/217.95  |- rdf__type mesh__D003444sskos__Concept
% 217.74/217.95  |- skos__related mesh__D003444smesh__D003161
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D003444 2000
% 217.74/217.95  |- mesh__dateCreated mesh__D003444 1999-01-01
% 217.74/217.95  |- skos__scopeNote mesh__D003444
% 217.74/217.95       Severe systemic manifestation of trauma and ischemia involving soft tissues, principally skeletal muscle, due to prolonged severe crushing. It leads to increased permeability of the cell membrane and to the release of potassium, enzymes, and myoglobin from within cells. Ischemic renal dysfunction secondary to hypotension and diminished renal perfusion results in acute tubular necrosis and uremia.%A%    
% 217.74/217.95  |- skos__hiddenLabel mesh__D003444 Syndromes, Crush
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D003444 2003
% 217.74/217.95  |- skos__historyNote mesh__D013872 Nucleosides %28%1966-1976%29%
% 217.74/217.95  |- mesh__publicMeSHNote mesh__D013872 77   
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D013872 2006
% 217.74/217.95  |- mesh__recordMaintainer mesh__D013872 ssb
% 217.74/217.95  |- mesh__recordAuthorizer mesh__D013872 sjn
% 217.74/217.95  |- mesh__dateEstablished mesh__D013872 1977-01-01
% 217.74/217.95  |- rdf__type mesh__D013872sskos__Concept
% 217.74/217.95  |- mesh__historyNote mesh__D013872 77   
% 217.74/217.95  |- skos__broader mesh__D013872smesh__D009705
% 217.74/217.95  |- mesh__dateCreated mesh__D013872 1976-04-16
% 217.74/217.95  |- mesh__recordOriginator mesh__D013872 RLS
% 217.74/217.95  |- skos__prefLabel mesh__D013872 Thionucleosides
% 217.74/217.95  |- skos__historyNote mesh__D013872 specific nucleoside %28%1966-1976%29%
% 217.74/217.95  |- skos__broader mesh__D013872smesh__D013457
% 217.74/217.95  |- skos__scopeNote mesh__D013872
% 217.74/217.95       Nucleosides in which the base moiety is substituted with one or more sulfur atoms.%A%    
% 217.74/217.95  |- mesh__dateRevised mesh__D013872 2005-06-30
% 217.74/217.95  |- mesh__dateCreated mesh__D013074 1981-03-02
% 217.74/217.95  |- skos__hiddenLabel mesh__D013074 Banks, Sperm
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D013074 1999
% 217.74/217.95  |- skos__hiddenLabel mesh__D013074 Bank, Sperm
% 217.74/217.95  |- mesh__recordMaintainer mesh__D013074 KEV
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D013074 1997
% 217.74/217.95  |- mesh__dateRevised mesh__D013074 1995-05-23
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D013074 1998
% 217.74/217.95  |- skos__historyNote mesh__D013074 Semen Preservation %28%1978-1981%29%
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D013074 2006
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D013074 1996
% 217.74/217.95  |- mesh__recordOriginator mesh__D013074 EC
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D013074 2002
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D013074 2004
% 217.74/217.95  |- skos__historyNote mesh__D013074 Tissue Banks %28%1978-1981%29%
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D013074 2005
% 217.74/217.95  |- skos__broader mesh__D013074smesh__D018070
% 217.74/217.95  |- mesh__dateEstablished mesh__D013074 1991-01-01
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D013074 2003
% 217.74/217.95  |- mesh__recordAuthorizer mesh__D013074 PLS
% 217.74/217.95  |- skos__historyNote mesh__D013074 Spermatozoa %28%1978-1981%29%
% 217.74/217.95  |- skos__historyNote mesh__D013074
% 217.74/217.95       Insemination, Artificial %28%1978-1981%29%
% 217.74/217.95  |- mesh__historyNote mesh__D013074
% 217.74/217.95       91%28%82%29%; was see under TISSUE BANKS 1982-90   
% 217.74/217.95  |- mesh__publicMeSHNote mesh__D013074
% 217.74/217.95       91; was see under TISSUE BANKS 1982-90   
% 217.74/217.95  |- rdf__type mesh__D013074sskos__Concept
% 217.74/217.95  |- skos__hiddenLabel mesh__D013074 Sperm Bank
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D013074 2001
% 217.74/217.95  |- skos__prefLabel mesh__D013074 Sperm Banks
% 217.74/217.95  |- skos__scopeNote mesh__D013074
% 217.74/217.95       Centers for acquiring and storing semen.     
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D013074 2000
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D007835 2005
% 217.74/217.95  |- skos__scopeNote mesh__D007835
% 217.74/217.95       An acute febrile human disease caused by the LASSA VIRUS.%A%    
% 217.74/217.95  |- skos__hiddenLabel mesh__D007835 Lassa Fevers
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D007835 2006
% 217.74/217.95  |- skos__broader mesh__D007835smesh__D001117
% 217.74/217.95  |- mesh__dateEstablished mesh__D007835 1977-01-01
% 217.74/217.95  |- skos__broader mesh__D007835smesh__D006482
% 217.74/217.95  |- skos__hiddenLabel mesh__D007835 Fever, Lassa
% 217.74/217.95  |- mesh__recordMaintainer mesh__D007835 sjn
% 217.74/217.95  |- mesh__recordAuthorizer mesh__D007835 sjn
% 217.74/217.95  |- rdf__type mesh__D007835sskos__Concept
% 217.74/217.95  |- mesh__dateRevised mesh__D007835 2004-07-13
% 217.74/217.95  |- skos__prefLabel mesh__D007835 Lassa Fever
% 217.74/217.95  |- mesh__recordOriginator mesh__D007835 FPG
% 217.74/217.95  |- mesh__dateCreated mesh__D007835 1976-05-19
% 217.74/217.95  |- mesh__historyNote mesh__D007835 77   
% 217.74/217.95  |- mesh__publicMeSHNote mesh__D007835 77   
% 217.74/217.95  |- skos__historyNote mesh__D007835
% 217.74/217.95       Hemorrhagic Fevers, Viral %28%1966-1976%29%
% 217.74/217.95  |- skos__hiddenLabel mesh__D007835 Fevers, Lassa
% 217.74/217.95  |- skos__annotation mesh__D007835
% 217.74/217.95       a hemorrhagic fever caused by an arenavirus   
% 217.74/217.95  |- skos__prefLabel mesh__D007037 Hypothyroidism
% 217.74/217.95  |- mesh__recordOriginator mesh__D007037 NLM
% 217.74/217.95  |- skos__related mesh__D007037smesh__D003409
% 217.74/217.95  |- rdf__type mesh__D007037sskos__Concept
% 217.74/217.95  |- mesh__recordMaintainer mesh__D007037 lkt
% 217.74/217.95  |- skos__broader mesh__D007037smesh__D013959
% 217.74/217.95  |- skos__hiddenLabel mesh__D007037 Hypothyroidisms
% 217.74/217.95  |- mesh__dateRevised mesh__D007037 2005-06-30
% 217.74/217.95  |- skos__related mesh__D007037smesh__D009230
% 217.74/217.95  |- mesh__recordAuthorizer mesh__D007037 sjn
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D007037 2006
% 217.74/217.95  |- skos__scopeNote mesh__D007037
% 217.74/217.95       A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA.%A%    
% 217.74/217.95  |- mesh__dateCreated mesh__D007037 1999-01-01
% 217.74/217.95  |- mesh__dateEstablished mesh__D051193 2006-01-01
% 217.74/217.95  |- mesh__recordMaintainer mesh__D051193 DRC
% 217.74/217.95  |- mesh__historyNote mesh__D051193 2006%28%1998%29%   
% 217.74/217.95  |- skos__hiddenLabel mesh__D051193 Toll Like Receptors
% 217.74/217.95  |- skos__altLabel mesh__D051193 Toll-Like Receptor
% 217.74/217.95  |- rdf__type mesh__D051193sskos__Concept
% 217.74/217.95  |- mesh__dateCreated mesh__D051193 2005-06-30
% 217.74/217.95  |- mesh__recordOriginator mesh__D051193 DRC
% 217.74/217.95  |- skos__prefLabel mesh__D051193 Toll-Like Receptors
% 217.74/217.95  |- mesh__recordAuthorizer mesh__D051193 sjn
% 217.74/217.95  |- skos__annotation mesh__D051193 general; prefer specifics   
% 217.74/217.95  |- skos__hiddenLabel mesh__D051193 Toll Like Receptor
% 217.74/217.95  |- skos__broader mesh__D051193smesh__D051192
% 217.74/217.95  |- skos__scopeNote mesh__D051193
% 217.74/217.95       A family of pattern recognition receptors characterized by an extracellular leucine-rich domain and a cytoplasmic domain that share homology with the INTERLEUKIN 1 RECEPTOR and the DROSOPHILA toll protein. Following pathogen recognition, toll-like receptors recruit and activate a variety of SIGNAL TRANSDUCING ADAPTOR PROTEINS.%A%    
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D051193 2006
% 217.74/217.95  |- skos__altLabel mesh__D051193 Receptors, Toll-Like
% 217.74/217.95  |- skos__hiddenLabel mesh__D051193 Receptors, Toll Like
% 217.74/217.95  |- skos__hiddenLabel mesh__D051193 Receptor, Toll-Like
% 217.74/217.95  |- mesh__publicMeSHNote mesh__D051193
% 217.74/217.95       2006; TOLL-LIKE RECEPTOR was indexed under MEMBRANE GLYCOPROTEINS %26% RECEPTORS, CELL SURFACE 1998-2005%A%  
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D017465 2006
% 217.74/217.95  |- mesh__recordOriginator mesh__D017465 PXP
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D017465 2005
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D017465 2004
% 217.74/217.95  |- mesh__dateEstablished mesh__D017465 1993-01-01
% 217.74/217.95  |- mesh__onlineNote mesh__D017465
% 217.74/217.95       use RECEPTORS, OPIOID, DELTA to search RECEPTORS, DELTA 1993; use RECEPTORS, OPIOID, DELTA %28%NM%29% to search DELTA RECEPTOR 1982-92%A%  
% 217.74/217.95  |- skos__broader mesh__D017465smesh__D011957
% 217.74/217.95  |- rdf__type mesh__D017465sskos__Concept
% 217.74/217.95  |- skos__altLabel mesh__D017465 delta Receptors
% 217.74/217.95  |- skos__scopeNote mesh__D017465
% 217.74/217.95       A class of opioid receptors recognized by its pharmacological profile. Delta opioid receptors bind endorphins and enkephalins with approximately equal affinity and have less affinity for dynorphins.%A%    
% 217.74/217.95  |- skos__hiddenLabel mesh__D017465 Opioid Receptor, delta
% 217.74/217.95  |- skos__prefLabel mesh__D017465 Receptors, Opioid, delta
% 217.74/217.95  |- skos__historyNote mesh__D017465 Receptors, Endorphin %28%1982-1992%29%
% 217.74/217.95  |- skos__altLabel mesh__D017465 delta Opioid Receptor
% 217.74/217.95  |- skos__altLabel mesh__D017465 Receptors, delta
% 217.74/217.95  |- mesh__publicMeSHNote mesh__D017465
% 217.74/217.95       94; was RECEPTORS, DELTA 1993; DELTA RECEPTOR was indexed under RECEPTORS, ENDORPHIN 1982-92%A%  
% 217.74/217.95  |- skos__altLabel mesh__D017465 Receptors, delta Opioid
% 217.74/217.95  |- skos__annotation mesh__D017465 opioid receptors; DF: RECEPT DELTA   
% 217.74/217.95  |- skos__altLabel mesh__D017465 Opioid Receptors, delta
% 217.74/217.95  |- mesh__historyNote mesh__D017465
% 217.74/217.95       94; was RECEPTORS, DELTA 1993; was DELTA RECEPTOR %28%NM%29% 1982-92%A%  
% 217.74/217.95  |- skos__hiddenLabel mesh__D017465 delta Opioid Receptors
% 217.74/217.95  |- skos__hiddenLabel mesh__D017465 Receptor, delta
% 217.74/217.95  |- skos__altLabel mesh__D017465 delta Receptor
% 217.74/217.95  |- mesh__recordMaintainer mesh__D017465 jmp
% 217.74/217.95  |- mesh__recordAuthorizer mesh__D017465 sjn
% 217.74/217.95  |- mesh__dateRevised mesh__D017465 2003-07-09
% 217.74/217.95  |- skos__hiddenLabel mesh__D017465 Receptor, delta Opioid
% 217.74/217.95  |- mesh__dateCreated mesh__D017465 1992-05-22
% 217.74/217.95  |- mesh__dateEstablished mesh__D050899 2006-01-01
% 217.74/217.95  |- skos__prefLabel mesh__D050899 GMP Reductase
% 217.74/217.95  |- skos__altLabel mesh__D050899 Guanosine 5%27%-Phosphate Reductase
% 217.74/217.95  |- mesh__publicMeSHNote mesh__D050899
% 217.74/217.95       2006; GMP REDUCTASE was indexed under as NADH, NADPH OXIDOREDUCTASES 1983-2004, GUANOSINE MONOPHOSPHATE 1976-1982, %26% GUANINE NUCLEOTIDES 1976-1978%A%  
% 217.74/217.95  |- skos__altLabel mesh__D050899 Guanosine 5%27%-Monophosphate Reductase
% 217.74/217.95  |- rdf__type mesh__D050899sskos__Concept
% 217.74/217.95  |- mesh__recordAuthorizer mesh__D050899 sjn
% 217.74/217.95  |- skos__hiddenLabel mesh__D050899 Reductase, Guanosine Monophosphate
% 217.74/217.95  |- mesh__recordOriginator mesh__D050899 AKE
% 217.74/217.95  |- mesh__dateCreated mesh__D050899 2005-06-30
% 217.74/217.95  |- skos__broader mesh__D050899smesh__D009601
% 217.74/217.95  |- skos__hiddenLabel mesh__D050899 Reductase, GMP
% 217.74/217.95  |- skos__hiddenLabel mesh__D050899 Reductase, Guanosine 5%27%-Phosphate
% 217.74/217.95  |- skos__hiddenLabel mesh__D050899
% 217.74/217.95       Oxidoreductase, Guanosine 5%27%-Monophosphate
% 217.74/217.95  |- mesh__recordMaintainer mesh__D050899 AKE
% 217.74/217.95  |- skos__altLabel mesh__D050899 Guanosine Monophosphate Reductase
% 217.74/217.95  |- skos__altLabel mesh__D050899
% 217.74/217.95       NADPH:Guanosine-5%27%-Phosphate Oxidoreductase %28%Deaminating%29%
% 217.74/217.95  |- skos__hiddenLabel mesh__D050899 Reductase, Guanosine 5%27%-Monophosphate
% 217.74/217.95  |- skos__hiddenLabel mesh__D050899 Guanosine 5%27% Monophosphate Reductase
% 217.74/217.95  |- skos__hiddenLabel mesh__D050899 Reductase, Guanylate
% 217.74/217.95  |- skos__hiddenLabel mesh__D050899 5%27%-Phosphate Reductase, Guanosine
% 217.74/217.95  |- skos__hiddenLabel mesh__D050899 5%27%-Monophosphate Reductase, Guanosine
% 217.74/217.95  |- skos__hiddenLabel mesh__D050899
% 217.74/217.95       Guanosine 5%27% Monophosphate Oxidoreductase
% 217.74/217.95  |- skos__altLabel mesh__D050899
% 217.74/217.95       NADPH:GMP Oxidoreductase %28%Deaminating%29%
% 217.74/217.95  |- skos__altLabel mesh__D050899
% 217.74/217.95       Guanosine 5%27%-Monophosphate Oxidoreductase
% 217.74/217.95  |- skos__hiddenLabel mesh__D050899
% 217.74/217.95       5%27%-Monophosphate Oxidoreductase, Guanosine
% 217.74/217.95  |- skos__altLabel mesh__D050899 Guanylate Reductase
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D050899 2006
% 217.74/217.95  |- mesh__historyNote mesh__D050899
% 217.74/217.95       2006%28%1980%29% use GUANOSINE MONOPHOSPHATE 1976-1979 %26% GUANINE NUCLEOTIDES 1976-1978%A%  
% 217.74/217.95  |- skos__hiddenLabel mesh__D050899 Guanosine 5%27% Phosphate Reductase
% 217.74/217.95  |- skos__hiddenLabel mesh__D050899 Monophosphate Reductase, Guanosine
% 217.74/217.95  |- skos__scopeNote mesh__D050899
% 217.74/217.95       An enzyme that catalyzes the reversible oxidation of inosine 5%27%-phosphate %28%IMP%29% to guanosine 5%27%-phosphate %28%GMP%29% in the presence of AMMONIA and NADP+. This enzyme was formerly classified as EC 1.6.6.8.%A%    
% 217.74/217.95  |- skos__related mesh__D003445smesh__D012758
% 217.74/217.95  |- skos__altLabel mesh__D003445 Ostracods
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D003445 2006
% 217.74/217.95  |- mesh__recordMaintainer mesh__D003445 jls
% 217.74/217.95  |- skos__annotation mesh__D003445
% 217.74/217.95       as animal %26% food; IM; GEN or unspecified; prefer specifics; as food, coord IM with SHELLFISH %28%IM%29%%A%  
% 217.74/217.95  |- mesh__dateRevised mesh__D003445 2004-07-19
% 217.74/217.95  |- skos__broader mesh__D003445smesh__D001181
% 217.74/217.95  |- rdf__type mesh__D003445sskos__Concept
% 217.74/217.95  |- skos__scopeNote mesh__D003445
% 217.74/217.95       A large subphylum of mostly marine ARTHROPODS containing over 42,000 species. They include familiar arthropods such as lobsters %28%NEPHROPIDAE%29%,  crabs %28%BRACHYURA%29%, shrimp %28%PENAEIDAE%29%, and  barnacles %28%THORACICA%29%.%A%    
% 217.74/217.95  |- mesh__recordOriginator mesh__D003445 NLM
% 217.74/217.95  |- mesh__dateCreated mesh__D003445 1999-01-01
% 217.74/217.95  |- mesh__recordAuthorizer mesh__D003445 sjn
% 217.74/217.95  |- skos__prefLabel mesh__D003445 Crustacea
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D003445 2005
% 217.74/217.95  |- mesh__dateRevised mesh__D008130 2004-07-07
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D008130 2006
% 217.74/217.95  |- mesh__dateCreated mesh__D008130 1974-11-11
% 217.74/217.95  |- mesh__dateEstablished mesh__D008130 1984-01-01
% 217.74/217.95  |- skos__hiddenLabel mesh__D008130 NSC79037
% 217.74/217.95  |- skos__hiddenLabel mesh__D008130
% 217.74/217.95       Rh%C3%%B4%ne Poulenc Rorer Brand of Lomustine
% 217.74/217.95  |- skos__hiddenLabel mesh__D008130 Bristol Myers Squibb Brand of Lomustine
% 217.74/217.95  |- mesh__historyNote mesh__D008130
% 217.74/217.95       84%28%75%29%; was see under NITROSOUREA COMPOUNDS 1975-83   
% 217.74/217.95  |- skos__prefLabel mesh__D008130 Lomustine
% 217.74/217.95  |- skos__altLabel mesh__D008130 Bristol-Myers Squibb Brand of Lomustine
% 217.74/217.95  |- skos__scopeNote mesh__D008130
% 217.74/217.95       An alkylating agent of value against both hematologic malignancies and solid tumors.%A%    
% 217.74/217.95  |- skos__broader mesh__D008130smesh__D009607
% 217.74/217.95  |- skos__historyNote mesh__D008130 Nitrosourea Compounds %28%1972-1974%29%
% 217.74/217.95  |- skos__hiddenLabel mesh__D008130 NSC 79037
% 217.74/217.95  |- mesh__recordAuthorizer mesh__D008130 sjn
% 217.74/217.95  |- mesh__publicMeSHNote mesh__D008130
% 217.74/217.95       84; was see under NITROSOUREA COMPOUNDS 1975-83   
% 217.74/217.95  |- mesh__recordOriginator mesh__D008130 NLM
% 217.74/217.95  |- skos__altLabel mesh__D008130
% 217.74/217.95       Rh%C3%%B4%ne-Poulenc Rorer Brand of Lomustine
% 217.74/217.95  |- skos__altLabel mesh__D008130 medac Brand of Lomustine
% 217.74/217.95  |- rdf__type mesh__D008130sskos__Concept
% 217.74/217.95  |- skos__historyNote mesh__D008130 Cyclohexanes %28%1972-1974%29%
% 217.74/217.95  |- skos__hiddenLabel mesh__D008130 Lomustine medac Brand
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D008130 2005
% 217.74/217.95  |- mesh__recordMaintainer mesh__D008130 CCR
% 217.74/217.95  |- skos__broader mesh__D013873smesh__D009711
% 217.74/217.95  |- skos__historyNote mesh__D013873 specific nucleotide %28%1966-1976%29%
% 217.74/217.95  |- mesh__recordOriginator mesh__D013873 RLS
% 217.74/217.95  |- mesh__historyNote mesh__D013873 77   
% 217.74/217.95  |- mesh__dateEstablished mesh__D013873 1977-01-01
% 217.74/217.95  |- mesh__recordMaintainer mesh__D013873 ssb
% 217.74/217.95  |- mesh__dateRevised mesh__D013873 2005-06-30
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D013873 2006
% 217.74/217.95  |- mesh__publicMeSHNote mesh__D013873 77   
% 217.74/217.95  |- skos__prefLabel mesh__D013873 Thionucleotides
% 217.74/217.95  |- skos__scopeNote mesh__D013873
% 217.74/217.95       Nucleotides in which the base moiety is substituted with one or more sulfur atoms.%A%    
% 217.74/217.95  |- rdf__type mesh__D013873sskos__Concept
% 217.74/217.95  |- mesh__recordAuthorizer mesh__D013873 sjn
% 217.74/217.95  |- mesh__dateCreated mesh__D013873 1976-04-16
% 217.74/217.95  |- skos__historyNote mesh__D013873 Nucleotides %28%1966-1976%29%
% 217.74/217.95  |- skos__broader mesh__D013873smesh__D013457
% 217.74/217.95  |- mesh__recordMaintainer mesh__D013075 lkt
% 217.74/217.95  |- mesh__dateEstablished mesh__D013075 1973-01-01
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D013075 2005
% 217.74/217.95  |- mesh__historyNote mesh__D013075 73%28%72%29%   
% 217.74/217.95  |- skos__scopeNote mesh__D013075
% 217.74/217.95       The structural and functional changes by which SPERMATOZOA become capable of oocyte FERTILIZATION. It normally requires exposing the sperm to the female genital tract for a period of time to bring about increased SPERM MOTILITY and the ACROSOME REACTION before fertilization in the FALLOPIAN TUBES can take place.%A%    
% 217.74/217.95  |- mesh__recordAuthorizer mesh__D013075 sjn
% 217.74/217.95  |- skos__historyNote mesh__D013075 Spermatozoa %28%1966-1971%29%
% 217.74/217.95  |- skos__prefLabel mesh__D013075 Sperm Capacitation
% 217.74/217.95  |- mesh__recordOriginator mesh__D013075 NLM
% 217.74/217.95  |- mesh__publicMeSHNote mesh__D013075 73   
% 217.74/217.95  |- mesh__dateRevised mesh__D013075 2004-07-07
% 217.74/217.95  |- skos__hiddenLabel mesh__D013075 Capacitation, Sperm
% 217.74/217.95  |- skos__altLabel mesh__D013075 Capacitation of Spermatozoa
% 217.74/217.95  |- rdf__type mesh__D013075sskos__Concept
% 217.74/217.95  |- mesh__dateCreated mesh__D013075 1999-01-01
% 217.74/217.95  |- skos__broader mesh__D013075smesh__D005306
% 217.74/217.95  |- skos__hiddenLabel mesh__D013075 Spermatozoa Capacitation
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D013075 2006
% 217.74/217.95  |- mesh__dateRevised mesh__D007836 2001-08-03
% 217.74/217.95  |- skos__scopeNote mesh__D007836
% 217.74/217.95       A species of ARENAVIRUS, part of the Old World Arenaviruses %28%ARENAVIRUSES, OLD WORLD%29%, and the etiologic agent of LASSA FEVER. LASSA VIRUS is a common infective agent in humans in West Africa. Its natural host is the multimammate mouse Mastomys natalensis.%A%    
% 217.74/217.95  |- mesh__recordOriginator mesh__D007836 NLM
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D007836 2005
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D007836 2004
% 217.74/217.95  |- skos__broader mesh__D007836smesh__D018049
% 217.74/217.95  |- mesh__historyNote mesh__D007836
% 217.74/217.95       91%28%72%29%; was see under ARENAVIRIDAE 1981-90; was see under ARENAVIRUSES 1978-80; was see under RNA VIRUSES 1972-77%A%  
% 217.74/217.95  |- mesh__publicMeSHNote mesh__D007836
% 217.74/217.95       91; was see under ARENAVIRIDAE 1981-90; was see under ARENAVIRUSES 1978-80; was see under RNA VIRUSES 1972-77%A%  
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D007836 2006
% 217.74/217.95  |- mesh__dateCreated mesh__D007836 1999-01-01
% 217.74/217.95  |- skos__prefLabel mesh__D007836 Lassa virus
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D007836 2002
% 217.74/217.95  |- mesh__dateEstablished mesh__D007836 1991-01-01
% 217.74/217.95  |- mesh__recordAuthorizer mesh__D007836 sjn
% 217.74/217.95  |- skos__annotation mesh__D007836 infection = LASSA FEVER   
% 217.74/217.95  |- rdf__type mesh__D007836sskos__Concept
% 217.74/217.95  |- mesh__recordMaintainer mesh__D007836 sjn
% 217.74/217.95  |- skos__historyNote mesh__D007836 RNA Viruses %28%1966-1971%29%
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D007836 2003
% 217.74/217.95  |- mesh__recordMaintainer mesh__D007038 ssb
% 217.74/217.95  |- skos__broader mesh__D007038smesh__D012996
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D007038 2006
% 217.74/217.95  |- skos__scopeNote mesh__D007038
% 217.74/217.95       Solutions that have a lesser osmotic pressure than a reference solution such as blood, plasma, or interstitial fluid.%A%    
% 217.74/217.95  |- mesh__recordAuthorizer mesh__D007038 sjn
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D007038 2005
% 217.74/217.95  |- skos__hiddenLabel mesh__D007038 Solutions, Hypotonic
% 217.74/217.95  |- mesh__publicMeSHNote mesh__D007038 66   
% 217.74/217.95  |- mesh__dateRevised mesh__D007038 2003-07-09
% 217.74/217.95  |- rdf__type mesh__D007038sskos__Concept
% 217.74/217.95  |- mesh__recordOriginator mesh__D007038 NLM
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D007038 2004
% 217.74/217.95  |- mesh__dateEstablished mesh__D007038 1966-01-01
% 217.74/217.95  |- mesh__dateCreated mesh__D007038 1999-01-01
% 217.74/217.95  |- skos__annotation mesh__D007038
% 217.74/217.95       GEN; NIM; no qualif when NIM coord; SALINE SOLUTION, HYPERTONIC %26% GLUCOSE SOLUTION, HYPERTONIC are available; DF: HYPOTONIC SOL%A%  
% 217.74/217.95  |- skos__prefLabel mesh__D007038 Hypotonic Solutions
% 217.74/217.95  |- mesh__historyNote mesh__D007038 66%28%65%29%   
% 217.74/217.95  |- mesh__recordOriginator mesh__D051194 DRC
% 217.74/217.95  |- skos__hiddenLabel mesh__D051194 Receptor, TLR1
% 217.74/217.95  |- skos__altLabel mesh__D051194 TLR1 Receptor
% 217.74/217.95  |- rdf__type mesh__D051194sskos__Concept
% 217.74/217.95  |- mesh__publicMeSHNote mesh__D051194
% 217.74/217.95       2006; TOLL-LIKE RECEPTOR 1 was indexed under MEMBRANE GLYCOPROTEINS %26% RECEPTORS, CELL SURFACE 2003-2005%A%  
% 217.74/217.95  |- mesh__recordMaintainer mesh__D051194 DRC
% 217.74/217.95  |- skos__scopeNote mesh__D051194
% 217.74/217.95       A pattern recognition receptor that forms heterodimers with TOLL-LIKE RECEPTOR 2.%A%    
% 217.74/217.95  |- skos__broader mesh__D051194smesh__D051193
% 217.74/217.95  |- skos__prefLabel mesh__D051194 Toll-Like Receptor 1
% 217.74/217.95  |- skos__hiddenLabel mesh__D051194 Toll Like Receptor 1
% 217.74/217.95  |- mesh__historyNote mesh__D051194 2006%28%2003%29%   
% 217.74/217.95  |- mesh__dateEstablished mesh__D051194 2006-01-01
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D051194 2006
% 217.74/217.95  |- mesh__dateCreated mesh__D051194 2005-06-30
% 217.74/217.95  |- mesh__recordAuthorizer mesh__D051194 sjn
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D017466 2004
% 217.74/217.95  |- mesh__recordAuthorizer mesh__D017466 sjn
% 217.74/217.95  |- rdf__type mesh__D017466sskos__Concept
% 217.74/217.95  |- mesh__dateCreated mesh__D017466 1992-05-22
% 217.74/217.95  |- skos__broader mesh__D017466smesh__D018000
% 217.74/217.95  |- skos__altLabel mesh__D017466
% 217.74/217.95       Endothelium Derived Vasoconstrictor Factor Receptors
% 217.74/217.95  |- mesh__dateEstablished mesh__D017466 1993-01-01
% 217.74/217.95  |- mesh__publicMeSHNote mesh__D017466
% 217.74/217.95       93; ENDOTHELIN RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1988-92; ENDOTHELIN DERIVED  VASOCONSTRICTOR FACTORS RECEPTORS %26% RECEPTORS, ENDOTHELIUM DERIVED VASOCONSTRICTOR FACTORS were see RECEPTORS, ENDOTHELIN 1993%A%  
% 217.74/217.95  |- skos__historyNote mesh__D017466
% 217.74/217.95       Receptors, Endogenous Substances %28%1988-1992%29%
% 217.74/217.95  |- skos__altLabel mesh__D017466 Endothelin Receptors
% 217.74/217.95  |- skos__hiddenLabel mesh__D017466
% 217.74/217.95       Receptors, Endothelium Derived Vasoconstrictor Factor
% 217.74/217.95  |- mesh__recordMaintainer mesh__D017466 jmp
% 217.74/217.95  |- skos__altLabel mesh__D017466 Endothelin Receptor
% 217.74/217.95  |- mesh__onlineNote mesh__D017466
% 217.74/217.95       use RECEPTORS, ENDOTHELIN to search  ENDOTHELIN DERIVED VASOCONSTRICTOR FACTORS RECEPTORS %26% RECEPTORS, ENDOTHELIUM DERIVED VASOCONSTRICTOR FACTORS 1993; use RECEPTORS, ENDOTHELIN %28%NM%29% to search ENDOTHELIN RECEPTOR 1988-92%A%  
% 217.74/217.95  |- skos__scopeNote mesh__D017466
% 217.74/217.95       Cell surface proteins that bind ENDOTHELINS with high affinity and trigger intracellular changes which influence the behavior of cells.%A%    
% 217.74/217.95  |- mesh__dateRevised mesh__D017466 2003-07-09
% 217.74/217.95  |- skos__hiddenLabel mesh__D017466 Receptor, Endothelin
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D017466 2006
% 217.74/217.95  |- mesh__recordOriginator mesh__D017466 PXP
% 217.74/217.95  |- skos__altLabel mesh__D017466 Receptors, Endothelins
% 217.74/217.95  |- skos__broader mesh__D017466smesh__D043562
% 217.74/217.95  |- skos__altLabel mesh__D017466
% 217.74/217.95       Receptors, Endothelium-Derived Vasoconstrictor Factor
% 217.74/217.95  |- skos__annotation mesh__D017466 DF: RECEPT ENDOTHELIN   
% 217.74/217.95  |- skos__prefLabel mesh__D017466 Receptors, Endothelin
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D017466 2005
% 217.74/217.95  |- mesh__historyNote mesh__D017466
% 217.74/217.95       93; was ENDOTHELIN RECEPTOR %28%NM%29% 1988-92; ENDOTHELIN DERIVED VASOCONSTRICTOR FACTORS RECEPTORS %26% RECEPTORS, ENDOTHELIUM-DERIVED VASOCONSTRICTOR FACTORS were see RECEPTORS, ENDOTHELIN 1993%A%  
% 217.74/217.95  |- mesh__recordOriginator mesh__D003446 NLM
% 217.74/217.95  |- mesh__dateCreated mesh__D003446 1999-01-01
% 217.74/217.95  |- mesh__recordAuthorizer mesh__D003446 sjn
% 217.74/217.95  |- skos__scopeNote mesh__D003446
% 217.74/217.95       Wooden or metal staffs designed to aid a person in walking. %28%UMDNS,1999%29%%A%    
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D003446 2003
% 217.74/217.95  |- mesh__recordMaintainer mesh__D003446 mdb
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D003446 2006
% 217.74/217.95  |- mesh__dateRevised mesh__D003446 2002-07-03
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D003446 2005
% 217.74/217.95  |- skos__broader mesh__D003446smesh__D009983
% 217.74/217.95  |- rdf__type mesh__D003446sskos__Concept
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D003446 2004
% 217.74/217.95  |- skos__prefLabel mesh__D003446 Crutches
% 217.74/217.95  |- rdf__type mesh__D008131sskos__Concept
% 217.74/217.95  |- mesh__recordOriginator mesh__D008131 NLM
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D008131 2000
% 217.74/217.95  |- mesh__dateCreated mesh__D008131 1999-01-01
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D008131 2003
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D008131 1999
% 217.74/217.95  |- mesh__dateRevised mesh__D008131 1996-06-10
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D008131 1998
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D008131 2006
% 217.74/217.95  |- mesh__recordAuthorizer mesh__D008131 PLS
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D008131 2002
% 217.74/217.95  |- skos__broader mesh__D008131smesh__D004739
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D008131 2005
% 217.74/217.95  |- skos__broader mesh__D008131smesh__D002947
% 217.74/217.95  |- skos__annotation mesh__D008131
% 217.74/217.95       early %26% modern LONDON: Manual 32.15.5, 36.14   
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D008131 1997
% 217.74/217.95  |- mesh__recordMaintainer mesh__D008131 TAP
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D008131 2001
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D008131 2004
% 217.74/217.95  |- skos__prefLabel mesh__D008131 London
% 217.74/217.95  |- skos__altLabel mesh__D013874 Penthiobarbital
% 217.74/217.95  |- skos__altLabel mesh__D013874 Thiopentone
% 217.74/217.95  |- skos__altLabel mesh__D013874 Altana Pharma Brand of Thiopental Sodium
% 217.74/217.95  |- mesh__recordOriginator mesh__D013874 NLM
% 217.74/217.95  |- mesh__activeMeSHYear mesh__D013874 2006
% 217.74/217.95  |- skos__prefLabel mesh__D013874 Thiopental
% 217.74/217.95  |- rdf__type mesh__D013874sskos__Concept
% 217.74/217.95  |- mesh__dateRevised mesh__D013874 2005-06-30
% 217.74/217.95  |- mesh__dateCreated mesh__D013874 1999-01-01
% 217.74/217.95  |- skos__altLabel mesh__D013874 Thiomebumal
% 217.74/217.95  |- skos__broader mesh__D013874smesh__D013858
% 217.74/217.95  |- skos__altLabel mesh__D013874 Nycomed Brand of Thiopental Sodium
% 217.74/217.95  |- skos__scopeNote mesh__D013874
% 217.74/217.95       A barbiturate that is administered intravenously for the induction of general anesthesia or for the production of complete anesthesia of short duration. It is also used for hypnosis and for the control of convulsive states. It has been used in neurosurgical patients to reduce increased intracranial pressure. It does not produce any excitation but has poor analgesic and muscle relaxant properties. Small doses have been shown to be anti-analgesic and lower the pain threshold. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p920%29%%A%    
% 217.74/217.95  |- skos__altLabel mesh__D013874 Pisa Brand of Thiopental Sodium
% 217.74/217.95  |- skos__altLabel mesh__D013874 Abbott Brand of Thiopental Sodium
% 217.74/217.95  |- skos__altLabel mesh__D013874 Thiopentobarbital
% 217.74/217.95  |- mesh__recordMaintainer mesh__D013874 CCR
% 217.74/217.95  |- skos__altLabel mesh__D013874 Pentothal Sodico
% 217.74/217.95  |- mesh__recordAuthorizer mesh__D013874 sjn
% 217.74/217.95  |- skos__altLabel mesh__D013874 Braun Brand of Thiopental Sodium
% 217.74/217.95  |- mesh__dateRevised mesh__D013076 2003-07-09
% 217.74/217.95  |- mesh__dateCreated mesh__D013076 1979-03-12
% 217.74/217.95  |- skos__scopeNote mesh__D013076
% 217.74/217.95       A count of SPERM in the ejaculum, expressed as number per milliliter.%A%    
% 217.74/217.95  |- mesh__recordMaintainer mesh__D013076 lkt
% 217.74/217.95  |- skos__related mesh__D013076smesh__D009845
% 217.74/217.95  |- skos__historyNote mesh__D013076 Cell Count %28%1969-1979%29%
% 217.74/217.95  |- skos__hiddenLabel mesh__D013076 Number, Sperm
% 217.74/217.95  |- skos__hiddenLabel mesh__D013076 Count, Sperm
% 217.74/217.95  |- rdf__type mesh__D013076sskos__Concept
% 217.74/217.95  |- mesh__recordAuthorizer mesh__D013076 sjn
% 217.74/217.95  |- skos__hiddenLabel mesh__D013076 Sperm Numbers
% 217.74/217.95  |- skos__historyNote mesh__D013076 Spermatozoa %28%1966-1979%29%
% 217.74/217.96  |- mesh__publicMeSHNote mesh__D013076 80   
% 217.74/217.96  |- skos__hiddenLabel mesh__D013076 Sperm Counts
% 217.74/217.96  |- skos__broader mesh__D013076smesh__D002452
% 217.74/217.96  |- mesh__dateEstablished mesh__D013076 1980-01-01
% 217.74/217.96  |- mesh__historyNote mesh__D013076 80   
% 217.74/217.96  |- skos__broader mesh__D013076smesh__D003942
% 217.74/217.96  |- skos__historyNote mesh__D013076 Oligospermia %28%1975-1979%29%
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D013076 2006
% 217.74/217.96  |- skos__prefLabel mesh__D013076 Sperm Count
% 217.74/217.96  |- skos__hiddenLabel mesh__D013076 Counts, Sperm
% 217.74/217.96  |- skos__hiddenLabel mesh__D013076 Numbers, Sperm
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D013076 2005
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D013076 2004
% 217.74/217.96  |- mesh__recordOriginator mesh__D013076 SMH
% 217.74/217.96  |- mesh__dateCreated mesh__D007837 1999-01-01
% 217.74/217.96  |- skos__hiddenLabel mesh__D007837 Period, Latency
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D007837 1996
% 217.74/217.96  |- mesh__publicMeSHNote mesh__D007837
% 217.74/217.96       91; was see under PSYCHOSEXUAL DEVELOPMENT 1975-90   
% 217.74/217.96  |- skos__altLabel mesh__D007837 Latency Period
% 217.74/217.96  |- rdf__type mesh__D007837sskos__Concept
% 217.74/217.96  |- skos__hiddenLabel mesh__D007837 Period, Latency %28%Psychology%29%
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D007837 1998
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D007837 2000
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D007837 1997
% 217.74/217.96  |- skos__prefLabel mesh__D007837 Latency Period %28%Psychology%29%
% 217.74/217.96  |- mesh__dateEstablished mesh__D007837 1991-01-01
% 217.74/217.96  |- skos__annotation mesh__D007837 no qualif; DF: LATENCY PERIOD   
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D007837 1992
% 217.74/217.96  |- skos__scopeNote mesh__D007837
% 217.74/217.96       The period from about 5 to 7 years to adolescence when there is an apparent cessation of psychosexual development.%A%    
% 217.74/217.96  |- mesh__recordAuthorizer mesh__D007837 PLS
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D007837 1999
% 217.74/217.96  |- skos__hiddenLabel mesh__D007837 Latency Periods %28%Psychology%29%
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D007837 2001
% 217.74/217.96  |- mesh__historyNote mesh__D007837
% 217.74/217.96       91%28%75%29%; was see under PSYCHOSEXUAL DEVELOPMENT 1975-90   
% 217.74/217.96  |- skos__broader mesh__D007837smesh__D011606
% 217.74/217.96  |- mesh__recordOriginator mesh__D007837 NLM
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D007837 2003
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D007837 1994
% 217.74/217.96  |- skos__hiddenLabel mesh__D007837 Latency Periods
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D007837 1993
% 217.74/217.96  |- mesh__onlineNote mesh__D007837
% 217.74/217.96       search PSYCHOSEXUAL DEVELOPMENT 1968-74   
% 217.74/217.96  |- mesh__recordMaintainer mesh__D007837 TGC
% 217.74/217.96  |- skos__hiddenLabel mesh__D007837 Periods, Latency %28%Psychology%29%
% 217.74/217.96  |- mesh__dateRevised mesh__D007837 1991-06-11
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D007837 2005
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D007837 2004
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D007837 1995
% 217.74/217.96  |- skos__hiddenLabel mesh__D007837 Periods, Latency
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D007837 2002
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D007837 2006
% 217.74/217.96  |- mesh__dateRevised mesh__D007039 2001-07-25
% 217.74/217.96  |- mesh__onlineNote mesh__D007039 search ALOPECIA 1966-74   
% 217.74/217.96  |- mesh__recordMaintainer mesh__D007039 lkt
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D007039 2002
% 217.74/217.96  |- skos__scopeNote mesh__D007039
% 217.74/217.96       Presence of less than the normal amount of hair. %28%Dorland, 27th ed%29%%A%    
% 217.74/217.96  |- rdf__type mesh__D007039sskos__Concept
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D007039 2004
% 217.74/217.96  |- mesh__historyNote mesh__D007039
% 217.74/217.96       91%28%75%29%; was see under ALOPECIA 1975-90   
% 217.74/217.96  |- mesh__recordAuthorizer mesh__D007039 sjn
% 217.74/217.96  |- skos__hiddenLabel mesh__D007039 Hypotrichoses
% 217.74/217.96  |- mesh__publicMeSHNote mesh__D007039 91; was see under ALOPECIA 1975-90   
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D007039 2003
% 217.74/217.96  |- mesh__dateEstablished mesh__D007039 1991-01-01
% 217.74/217.96  |- mesh__dateCreated mesh__D007039 1999-01-01
% 217.74/217.96  |- mesh__recordOriginator mesh__D007039 NLM
% 217.74/217.96  |- skos__annotation mesh__D007039
% 217.74/217.96       less than normal amt of hair; do not confuse with HYPERTRICHOSIS, localized or generalized excess hair%A%  
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D007039 2006
% 217.74/217.96  |- skos__prefLabel mesh__D007039 Hypotrichosis
% 217.74/217.96  |- skos__broader mesh__D007039smesh__D006201
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D007039 2005
% 217.74/217.96  |- mesh__dateCreated mesh__D051195 2005-06-30
% 217.74/217.96  |- mesh__recordAuthorizer mesh__D051195 sjn
% 217.74/217.96  |- rdf__type mesh__D051195sskos__Concept
% 217.74/217.96  |- skos__broader mesh__D051195smesh__D051193
% 217.74/217.96  |- mesh__publicMeSHNote mesh__D051195
% 217.74/217.96       2006; TOLL-LIKE RECEPTOR 2 was indexed under MEMBRANE GLYCOPROTEINS %26% RECEPTORS, CELL SURFACE 1998-2005%A%  
% 217.74/217.96  |- skos__hiddenLabel mesh__D051195 Toll Like Receptor 2
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D051195 2006
% 217.74/217.96  |- mesh__recordMaintainer mesh__D051195 DRC
% 217.74/217.96  |- skos__prefLabel mesh__D051195 Toll-Like Receptor 2
% 217.74/217.96  |- skos__altLabel mesh__D051195 TLR2 Receptor
% 217.74/217.96  |- mesh__dateEstablished mesh__D051195 2006-01-01
% 217.74/217.96  |- mesh__recordOriginator mesh__D051195 DRC
% 217.74/217.96  |- skos__scopeNote mesh__D051195
% 217.74/217.96       A pattern recognition receptor that forms heterodimers with other TOLL-LIKE RECEPTORS. It interacts with multiple ligands including PEPTIDOGLYCAN, bacterial LIPOPROTEINS, lipoarabinomannan, and a variety of PORINS.%A%    
% 217.74/217.96  |- skos__hiddenLabel mesh__D051195 Receptor, TLR2
% 217.74/217.96  |- mesh__historyNote mesh__D051195 2006%28%1998%29%   
% 217.74/217.96  |- skos__hiddenLabel mesh__D017467 Receptor, Erythropoietin
% 217.74/217.96  |- skos__annotation mesh__D017467 DF: RECEPT ERYTHROPOIETIN   
% 217.74/217.96  |- mesh__dateRevised mesh__D017467 2003-07-09
% 217.74/217.96  |- mesh__recordMaintainer mesh__D017467 jmp
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D017467 2006
% 217.74/217.96  |- mesh__recordAuthorizer mesh__D017467 sjn
% 217.74/217.96  |- mesh__publicMeSHNote mesh__D017467
% 217.74/217.96       93; ERYTHROPOIETIN RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1985-92%A%  
% 217.74/217.96  |- skos__altLabel mesh__D017467 Erythropoietin Receptor
% 217.74/217.96  |- mesh__dateCreated mesh__D017467 1992-05-22
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D017467 2005
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D017467 2004
% 217.74/217.96  |- mesh__recordOriginator mesh__D017467 PXP
% 217.74/217.96  |- mesh__dateEstablished mesh__D017467 1993-01-01
% 217.74/217.96  |- skos__altLabel mesh__D017467 Erythropoietin Receptors
% 217.74/217.96  |- rdf__type mesh__D017467sskos__Concept
% 217.74/217.96  |- mesh__historyNote mesh__D017467
% 217.74/217.96       93; was ERYTHROPOIETIN RECEPTOR %28%NM%29% 1985-92   
% 217.74/217.96  |- skos__scopeNote mesh__D017467
% 217.74/217.96       Cell surface proteins that bind erythropoietin with high affinity and trigger intracellular changes influencing the behavior of cells.%A%    
% 217.74/217.96  |- mesh__onlineNote mesh__D017467
% 217.74/217.96       use RECEPTORS, ERYTHROPOIETIN %28%NM%29% to search ERYTHROPOIETIN RECEPTOR 1985-92%A%  
% 217.74/217.96  |- skos__broader mesh__D017467smesh__D016184
% 217.74/217.96  |- skos__historyNote mesh__D017467
% 217.74/217.96       Receptors, Endogenous Substances %28%1985-1992%29%
% 217.74/217.96  |- skos__prefLabel mesh__D017467 Receptors, Erythropoietin
% 217.74/217.96  |- skos__prefLabel mesh__D036621 Geigeria
% 217.74/217.96  |- skos__broader mesh__D036621smesh__D019659
% 217.74/217.96  |- rdf__type mesh__D036621sskos__Concept
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D036621 2003
% 217.74/217.96  |- mesh__dateEstablished mesh__D036621 2003-01-01
% 217.74/217.96  |- mesh__dateCreated mesh__D036621 2002-07-03
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D036621 2006
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D036621 2005
% 217.74/217.96  |- skos__annotation mesh__D036621
% 217.74/217.96       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.74/217.96  |- mesh__publicMeSHNote mesh__D036621 2003   
% 217.74/217.96  |- skos__scopeNote mesh__D036621
% 217.74/217.96       A plant genus of the family ASTERACEAE that causes vermeersiekte poisoning of sheep in South Africa. Members contain dihydrogriesenin and ivalin %28%sesquiterpene lactones%29%.%A%    
% 217.74/217.96  |- mesh__historyNote mesh__D036621 2003   
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D036621 2004
% 217.74/217.96  |- skos__altLabel mesh__D008930 Mitochondrion, Liver
% 217.74/217.96  |- mesh__dateRevised mesh__D008930 2003-07-09
% 217.74/217.96  |- mesh__historyNote mesh__D008930 68   
% 217.74/217.96  |- mesh__recordMaintainer mesh__D008930 nns
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D008930 2004
% 217.74/217.96  |- mesh__publicMeSHNote mesh__D008930 68   
% 217.74/217.96  |- skos__prefLabel mesh__D008930 Mitochondria, Liver
% 217.74/217.96  |- skos__annotation mesh__D008930
% 217.74/217.96       A 11 qualif except /cytol; /genet permitted   
% 217.74/217.96  |- skos__scopeNote mesh__D008930
% 217.74/217.96       Mitochondria in hepatocytes. As in all mitochondria, there are an outer membrane and an inner membrane, together creating two separate mitochondrial compartments: the internal matrix space and a much narrower intermembrane space. In the liver mitochondrion, an estimated 67%25% of the total mitochondrial proteins is located in the matrix. %28%From Alberts et al., Molecular Biology of the Cell, 2d ed, p343-4%29%%A%    
% 217.74/217.96  |- skos__altLabel mesh__D008930 Liver Mitochondrion
% 217.74/217.96  |- skos__historyNote mesh__D008930 Mitochondria %28%1966-1967%29%
% 217.74/217.96  |- rdf__type mesh__D008930sskos__Concept
% 217.74/217.96  |- skos__altLabel mesh__D008930 Liver Mitochondria
% 217.74/217.96  |- skos__broader mesh__D008930smesh__D008928
% 217.74/217.96  |- mesh__dateCreated mesh__D008930 1999-01-01
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D008930 2005
% 217.74/217.96  |- mesh__recordAuthorizer mesh__D008930 sjn
% 217.74/217.96  |- mesh__recordOriginator mesh__D008930 NLM
% 217.74/217.96  |- mesh__dateEstablished mesh__D008930 1968-01-01
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D008930 2006
% 217.74/217.96  |- mesh__publicMeSHNote mesh__D008132
% 217.74/217.96       91; was see under SOCIAL ISOLATION 1973-90; for HOMESICKNESS see ANXIETY, SEPARATION 1975-97; see EMOTIONS 1963-74%A%  
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D008132 2001
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D008132 2006
% 217.74/217.96  |- mesh__recordMaintainer mesh__D008132 NNS
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D008132 2000
% 217.74/217.96  |- skos__broader mesh__D008132smesh__D012934
% 217.74/217.96  |- mesh__recordOriginator mesh__D008132 NLM
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D008132 2005
% 217.74/217.96  |- mesh__dateEstablished mesh__D008132 1991-01-01
% 217.74/217.96  |- mesh__historyNote mesh__D008132
% 217.74/217.96       91%28%73%29%; see SOCIAL ISOLATION 1973-90; HOMESICKNESS see ANXIETY, SEPARATION 1975-78; see EMOTIONS 1963-74%A%  
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D008132 2002
% 217.74/217.96  |- skos__scopeNote mesh__D008132
% 217.74/217.96       The state of feeling sad or dejected as a result of lack of companionship or being separated from others.%A%    
% 217.74/217.96  |- mesh__dateRevised mesh__D008132 1998-06-10
% 217.74/217.96  |- skos__broader mesh__D008132smesh__D004644
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D008132 2004
% 217.74/217.96  |- mesh__recordAuthorizer mesh__D008132 SJN
% 217.74/217.96  |- mesh__dateCreated mesh__D008132 1999-01-01
% 217.74/217.96  |- rdf__type mesh__D008132sskos__Concept
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D008132 1999
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D008132 2003
% 217.74/217.96  |- skos__prefLabel mesh__D008132 Loneliness
% 217.74/217.96  |- skos__historyNote mesh__D013875 Phenylthiourea %28%1966-1974%29%
% 217.74/217.96  |- skos__hiddenLabel mesh__D013875 Bis-Thioallophanate, Dimethylphenylene
% 217.74/217.96  |- mesh__publicMeSHNote mesh__D013875
% 217.74/217.96       91; was see under CARBAMATES 1979-90; was THIOPHANATE-METHYL see under CARBAMATES 1975-78%A%  
% 217.74/217.96  |- mesh__historyNote mesh__D013875
% 217.74/217.96       91%28%79%29%; was see under CARBAMATES 1979-90; was THIOPHANATE-METHYL see under CARBAMATES 1975-78%A%  
% 217.74/217.96  |- mesh__dateCreated mesh__D013875 1974-11-19
% 217.74/217.96  |- mesh__dateEstablished mesh__D013875 1991-01-01
% 217.74/217.96  |- skos__scopeNote mesh__D013875
% 217.74/217.96       Nematocide used in livestock; also has fungicidal properties.%A%    
% 217.74/217.96  |- skos__broader mesh__D013875smesh__D002219
% 217.74/217.96  |- skos__hiddenLabel mesh__D013875 Cercobin M70
% 217.74/217.96  |- skos__hiddenLabel mesh__D013875 Dimethylphenylene Bis Thioallophanate
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D013875 2006
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D013875 2002
% 217.74/217.96  |- rdf__type mesh__D013875sskos__Concept
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D013875 2005
% 217.74/217.96  |- skos__broader mesh__D013875smesh__D010670
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D013875 2001
% 217.74/217.96  |- skos__historyNote mesh__D013875 Carbamates %28%1966-1974%29%
% 217.74/217.96  |- skos__hiddenLabel mesh__D013875 Cercobin M 70
% 217.74/217.96  |- mesh__onlineNote mesh__D013875
% 217.74/217.96       use THIOPHANATE to search THIOPHANATE-METHYL 1975-78   
% 217.74/217.96  |- mesh__dateRevised mesh__D013875 2000-06-22
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D013875 2004
% 217.74/217.96  |- skos__prefLabel mesh__D013875 Thiophanate
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D013875 2003
% 217.74/217.96  |- skos__altLabel mesh__D013875 Thiophanate-Methyl
% 217.74/217.96  |- mesh__recordAuthorizer mesh__D013875 sjn
% 217.74/217.96  |- mesh__recordMaintainer mesh__D013875 CCR
% 217.74/217.96  |- skos__hiddenLabel mesh__D013875 Thiophanate Methyl
% 217.74/217.96  |- mesh__recordOriginator mesh__D013875 NLM
% 217.74/217.96  |- skos__hiddenLabel mesh__D013077 Heads, Sperm
% 217.74/217.96  |- mesh__dateRevised mesh__D013077 2002-07-03
% 217.74/217.96  |- skos__broader mesh__D013077smesh__D013094
% 217.74/217.96  |- skos__hiddenLabel mesh__D013077 Sperm Heads
% 217.74/217.96  |- mesh__dateCreated mesh__D013077 1974-11-11
% 217.74/217.96  |- rdf__type mesh__D013077sskos__Concept
% 217.74/217.96  |- mesh__publicMeSHNote mesh__D013077
% 217.74/217.96       91; was see under SPERMATOZOA 1975-90   
% 217.74/217.96  |- skos__scopeNote mesh__D013077
% 217.74/217.96       The anterior portion of the spermatozoon %28%SPERMATOZOA%29% that contains mainly the nucleus with highly compact CHROMATIN material.%A%    
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D013077 2005
% 217.74/217.96  |- skos__prefLabel mesh__D013077 Sperm Head
% 217.74/217.96  |- mesh__historyNote mesh__D013077
% 217.74/217.96       91%28%75%29%; was see under SPERMATOZOA 1975-90   
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D013077 2003
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D013077 2006
% 217.74/217.96  |- mesh__dateEstablished mesh__D013077 1991-01-01
% 217.74/217.96  |- mesh__recordMaintainer mesh__D013077 lkt
% 217.74/217.96  |- mesh__recordAuthorizer mesh__D013077 sjn
% 217.74/217.96  |- skos__hiddenLabel mesh__D013077 Head, Sperm
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D013077 2004
% 217.74/217.96  |- mesh__recordOriginator mesh__D013077 NLM
% 217.74/217.96  |- mesh__recordOriginator mesh__D004540 NLM
% 217.74/217.96  |- skos__annotation mesh__D004540 man-made radioactive element; IM   
% 217.74/217.96  |- mesh__dateRevised mesh__D004540 2005-06-30
% 217.74/217.96  |- skos__prefLabel mesh__D004540 Einsteinium
% 217.74/217.96  |- mesh__dateCreated mesh__D004540 1999-01-01
% 217.74/217.96  |- skos__scopeNote mesh__D004540
% 217.74/217.96       Einsteinium. A man-made radioactive actinide with atomic symbol Es, atomic number 99, and atomic weight 252. Its known isotopes range in mass number from 243-246. Its valence can be +2 or +3. Einsteinium was originally discovered in the debris from a thermonuclear explosion in 1952.%A%    
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D004540 2006
% 217.74/217.96  |- skos__broader mesh__D004540smesh__D019216
% 217.74/217.96  |- mesh__recordAuthorizer mesh__D004540 sjn
% 217.74/217.96  |- mesh__recordMaintainer mesh__D004540 jmp
% 217.74/217.96  |- rdf__type mesh__D004540sskos__Concept
% 217.74/217.96  |- skos__broader mesh__D004540smesh__D008671
% 217.74/217.96  |- mesh__dateEstablished mesh__D051196 2006-01-01
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D051196 2006
% 217.74/217.96  |- skos__hiddenLabel mesh__D051196 Receptor, TLR3
% 217.74/217.96  |- mesh__dateCreated mesh__D051196 2005-06-30
% 217.74/217.96  |- mesh__recordAuthorizer mesh__D051196 sjn
% 217.74/217.96  |- mesh__recordOriginator mesh__D051196 DRC
% 217.74/217.96  |- skos__hiddenLabel mesh__D051196 Toll Like Receptor 3
% 217.74/217.96  |- skos__scopeNote mesh__D051196
% 217.74/217.96       A pattern recognition receptor that binds DOUBLE-STRANDED RNA. It mediates cellular responses to certain viral pathogens.%A%    
% 217.74/217.96  |- skos__altLabel mesh__D051196 TLR3 Receptor
% 217.74/217.96  |- mesh__publicMeSHNote mesh__D051196
% 217.74/217.96       2006; TOLL-LIKE RECEPTOR 3 was indexed under MEMBRANE GLYCOPROTEINS %26% RECEPTORS, CELL SURFACE 2005%A%  
% 217.74/217.96  |- skos__prefLabel mesh__D051196 Toll-Like Receptor 3
% 217.74/217.96  |- rdf__type mesh__D051196sskos__Concept
% 217.74/217.96  |- mesh__recordMaintainer mesh__D051196 DRC
% 217.74/217.96  |- skos__broader mesh__D051196smesh__D051193
% 217.74/217.96  |- mesh__historyNote mesh__D051196 2006%28%2005%29%   
% 217.74/217.96  |- mesh__dateRevised mesh__D017468 2003-07-09
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D017468 2006
% 217.74/217.96  |- skos__historyNote mesh__D017468 Receptors, Growth %28%1985-2004%29%
% 217.74/217.96  |- mesh__recordMaintainer mesh__D017468 jmp
% 217.74/217.96  |- skos__broader mesh__D017468smesh__D017978
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D017468 2004
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D017468 2005
% 217.74/217.96  |- mesh__recordOriginator mesh__D017468 PXP
% 217.74/217.96  |- skos__hiddenLabel mesh__D017468 Heparin Binding Growth Factor Receptor
% 217.74/217.96  |- mesh__publicMeSHNote mesh__D017468
% 217.74/217.96       2004; FIBROBLAST GROWTH FACTOR RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1985-1992; HEPARIN-BINDING GROWTH FACTOR RECEPTOR was indexed under RECEPTORS, MITOGEN %26% RECEPTORS, GROWTH FACTOR 1985-2003%A%  
% 217.74/217.96  |- rdf__type mesh__D017468sskos__Concept
% 217.74/217.96  |- skos__altLabel mesh__D017468 FGF Receptor
% 217.74/217.96  |- skos__altLabel mesh__D017468 FGF Receptors
% 217.74/217.96  |- skos__scopeNote mesh__D017468
% 217.74/217.96       Specific molecular sites or structures on cell membranes that react with FIBROBLAST GROWTH FACTORS %28%both the basic and acidic forms%29%, their analogs, or their antagonists to elicit or to inhibit the specific response of the cell to these factors. These receptors frequently possess tyrosine kinase activity.%A%    
% 217.74/217.96  |- mesh__recordAuthorizer mesh__D017468 sjn
% 217.74/217.96  |- skos__annotation mesh__D017468
% 217.74/217.96       coord IM with specific FIBROBLAST GROWTH FACTORS %28%IM%29%; DF: note short X ref%A%  
% 217.74/217.96  |- skos__altLabel mesh__D017468 Fibroblast Growth Factor Receptor
% 217.74/217.96  |- skos__altLabel mesh__D017468 Receptors, FGF
% 217.74/217.96  |- skos__historyNote mesh__D017468
% 217.74/217.96       Receptors, Endogenous Substances %28%1985-1992%29%
% 217.74/217.96  |- skos__hiddenLabel mesh__D017468 Receptor, FGF
% 217.74/217.96  |- mesh__dateCreated mesh__D017468 1992-05-22
% 217.74/217.96  |- mesh__historyNote mesh__D017468
% 217.74/217.96       2004; use FIBROBLAST GROWTH FACTOR RECEPTOR %28%NM%29% 1985-1992%A%  
% 217.74/217.96  |- skos__historyNote mesh__D017468 Receptors, Mitogen %28%1985-2004%29%
% 217.74/217.96  |- mesh__dateEstablished mesh__D017468 1993-01-01
% 217.74/217.96  |- skos__prefLabel mesh__D017468 Receptors, Fibroblast Growth Factor
% 217.74/217.96  |- skos__altLabel mesh__D017468 Fibroblast Growth Factor Receptors
% 217.74/217.96  |- mesh__historyNote mesh__D036622 2003   
% 217.74/217.96  |- skos__prefLabel mesh__D036622 Gnaphalium
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D036622 2006
% 217.74/217.96  |- mesh__dateEstablished mesh__D036622 2003-01-01
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D036622 2005
% 217.74/217.96  |- skos__annotation mesh__D036622
% 217.74/217.96       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.74/217.96  |- mesh__dateCreated mesh__D036622 2002-07-03
% 217.74/217.96  |- mesh__publicMeSHNote mesh__D036622 2003   
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D036622 2004
% 217.74/217.96  |- skos__broader mesh__D036622smesh__D019659
% 217.74/217.96  |- rdf__type mesh__D036622sskos__Concept
% 217.74/217.96  |- skos__scopeNote mesh__D036622
% 217.74/217.96       A plant genus of the family ASTERACEAE. The common name of cudweed is also used for other plants including Evax, Hesperevax,  Pseudognaphalium, and Omalotheca. The common name of everlasting is also used for other plants including Anaphalis, Antennaria, HELICHRYSUM,  Gamochaeta, and Pseudognaphalium.%A%    
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D036622 2003
% 217.74/217.96  |- skos__broader mesh__D003448smesh__D007804
% 217.74/217.96  |- mesh__recordMaintainer mesh__D003448 lkt
% 217.74/217.96  |- mesh__dateEstablished mesh__D003448 1970-01-01
% 217.74/217.96  |- mesh__recordOriginator mesh__D003448 NLM
% 217.74/217.96  |- skos__historyNote mesh__D003448 Infant, Newborn %28%1966-1969%29%
% 217.74/217.96  |- mesh__recordAuthorizer mesh__D003448 sjn
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D003448 2006
% 217.74/217.96  |- mesh__dateRevised mesh__D003448 2003-07-09
% 217.74/217.96  |- mesh__historyNote mesh__D003448 70   
% 217.74/217.96  |- mesh__publicMeSHNote mesh__D003448 70   
% 217.74/217.96  |- skos__historyNote mesh__D003448 Child Behavior %28%1966-1969%29%
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D003448 2005
% 217.74/217.96  |- rdf__type mesh__D003448sskos__Concept
% 217.74/217.96  |- skos__hiddenLabel mesh__D003448 Cryings
% 217.74/217.96  |- skos__scopeNote mesh__D003448
% 217.74/217.96       To utter an inarticulate, characteristic sound in order to communicate or express a feeling, or desire for attention.%A%    
% 217.74/217.96  |- skos__prefLabel mesh__D003448 Crying
% 217.74/217.96  |- mesh__dateCreated mesh__D003448 1999-01-01
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D003448 2004
% 217.74/217.96  |- skos__historyNote mesh__D003448 Voice %28%1966-1969%29%
% 217.74/217.96  |- skos__broader mesh__D003448smesh__D009633
% 217.74/217.96  |- skos__hiddenLabel mesh__D014170 Transformations, Genetic
% 217.74/217.96  |- mesh__recordOriginator mesh__D014170 NLM
% 217.74/217.96  |- mesh__dateEstablished mesh__D014170 1968-01-01
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D014170 2004
% 217.74/217.96  |- mesh__dateRevised mesh__D014170 2003-07-09
% 217.74/217.96  |- mesh__dateCreated mesh__D014170 1999-01-01
% 217.74/217.96  |- rdf__type mesh__D014170sskos__Concept
% 217.74/217.96  |- skos__related mesh__D014170smesh__D014162
% 217.74/217.96  |- mesh__publicMeSHNote mesh__D014170 68   
% 217.74/217.96  |- mesh__recordMaintainer mesh__D014170 nns
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D014170 2005
% 217.74/217.96  |- skos__historyNote mesh__D014170 Genetics %28%1966-1967%29%
% 217.74/217.96  |- skos__annotation mesh__D014170
% 217.74/217.96       GEN: prefer specifics; DF: TRANSFORM GENET   
% 217.74/217.96  |- skos__broader mesh__D014170smesh__D011995
% 217.74/217.96  |- skos__related mesh__D014170smesh__D003227
% 217.74/217.96  |- skos__altLabel mesh__D014170 Genetic Transformation
% 217.74/217.96  |- mesh__recordAuthorizer mesh__D014170 sjn
% 217.74/217.96  |- skos__prefLabel mesh__D014170 Transformation, Genetic
% 217.74/217.96  |- mesh__historyNote mesh__D014170 68   
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D014170 2006
% 217.74/217.96  |- skos__scopeNote mesh__D014170
% 217.74/217.96       Change brought about to an organisms genetic composition by unidirectional transfer %28%TRANSFECTION; TRANSDUCTION, GENETIC; CONJUGATION, GENETIC, etc.%29% and incorporation of foreign DNA into prokaryotic or eukaryotic cells by recombination of part or all of that DNA into the cell%27%s genome.%A%    
% 217.74/217.96  |- skos__hiddenLabel mesh__D014170 Genetic Transformations
% 217.74/217.96  |- skos__related mesh__D014170smesh__D014161
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D008931 2004
% 217.74/217.96  |- skos__altLabel mesh__D008931 Sarcosomes
% 217.74/217.96  |- skos__historyNote mesh__D008931 Muscle Contraction %28%1966-1967%29%
% 217.74/217.96  |- skos__related mesh__D008931smesh__D017240
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D008931 2006
% 217.74/217.96  |- mesh__recordAuthorizer mesh__D008931 sjn
% 217.74/217.96  |- skos__historyNote mesh__D008931 Mitochondria %28%1966-1967%29%
% 217.74/217.96  |- skos__prefLabel mesh__D008931 Mitochondria, Muscle
% 217.74/217.96  |- mesh__recordOriginator mesh__D008931 NLM
% 217.74/217.96  |- skos__annotation mesh__D008931
% 217.74/217.96       A 11 qualif except /cytol; /genet permitted; for skeletal %26% smooth musc mitochondria; for vasc %26% smooth musc mitochondria see note on MITOCHONDRIA%A%  
% 217.74/217.96  |- skos__hiddenLabel mesh__D008931 Muscle Mitochondria
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D008931 2005
% 217.74/217.96  |- skos__historyNote mesh__D008931 Muscles %28%1966-1967%29%
% 217.74/217.96  |- mesh__historyNote mesh__D008931 68   
% 217.74/217.96  |- skos__hiddenLabel mesh__D008931 Sarcosome
% 217.74/217.96  |- skos__hiddenLabel mesh__D008931 Muscle Mitochondrion
% 217.74/217.96  |- skos__broader mesh__D008931smesh__D008928
% 217.74/217.96  |- mesh__dateCreated mesh__D008931 1999-01-01
% 217.74/217.96  |- mesh__dateRevised mesh__D008931 2003-07-09
% 217.74/217.96  |- mesh__dateEstablished mesh__D008931 1968-01-01
% 217.74/217.96  |- skos__historyNote mesh__D008931 Myocardium %28%1966-1967%29%
% 217.74/217.96  |- rdf__type mesh__D008931sskos__Concept
% 217.74/217.96  |- mesh__recordMaintainer mesh__D008931 nns
% 217.74/217.96  |- skos__related mesh__D008931smesh__D017237
% 217.74/217.96  |- mesh__publicMeSHNote mesh__D008931 68   
% 217.74/217.96  |- skos__altLabel mesh__D008931 Mitochondrion, Muscle
% 217.74/217.96  |- skos__scopeNote mesh__D008931
% 217.74/217.96       Mitochondria of skeletal and smooth muscle. It does not include myocardial mitochondria for which MITOCHONDRIA, HEART is available.%A%    
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D008133 2002
% 217.74/217.96  |- skos__historyNote mesh__D008133 Tachycardia %28%1966-1985%29%
% 217.74/217.96  |- skos__scopeNote mesh__D008133
% 217.74/217.96       A syndrome characterized by history of syncopal episodes and a long QT interval, sometimes leading to sudden death %28%DEATH, SUDDEN, CARDIAC%29% due to paroxysmal ventricular arrhythmia. A form associated with autosomal recessive inheritance and congenital deafness is called the JERVELL-LANGE NIELSEN SYNDROME. An autosomal dominant form without deafness is called the ROMANO-WARD SYNDROME.%A%    
% 217.74/217.96  |- mesh__dateRevised mesh__D008133 2001-07-25
% 217.74/217.96  |- mesh__recordOriginator mesh__D008133 VDK
% 217.74/217.96  |- skos__hiddenLabel mesh__D008133 Long QT Syndromes
% 217.74/217.96  |- mesh__historyNote mesh__D008133
% 217.74/217.96       91%28%86%29%; was see under ARRHYTHMIA 1986-90   
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D008133 2004
% 217.74/217.96  |- mesh__dateEstablished mesh__D008133 1991-01-01
% 217.74/217.96  |- rdf__type mesh__D008133sskos__Concept
% 217.74/217.96  |- mesh__recordAuthorizer mesh__D008133 sjn
% 217.74/217.96  |- skos__hiddenLabel mesh__D008133 QT Syndromes, Long
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D008133 2003
% 217.74/217.96  |- skos__broader mesh__D008133smesh__D001145
% 217.74/217.96  |- skos__hiddenLabel mesh__D008133 Syndrome, Long QT
% 217.74/217.96  |- mesh__publicMeSHNote mesh__D008133
% 217.74/217.96       91; was see under ARRHYTHMIA 1986-90   
% 217.74/217.96  |- mesh__dateCreated mesh__D008133 1985-03-11
% 217.74/217.96  |- mesh__recordMaintainer mesh__D008133 nns
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D008133 2006
% 217.74/217.96  |- skos__hiddenLabel mesh__D008133 QT Syndrome, Long
% 217.74/217.96  |- skos__prefLabel mesh__D008133 Long QT Syndrome
% 217.74/217.96  |- skos__historyNote mesh__D008133 Arrhythmia %28%1966-1985%29%
% 217.74/217.96  |- skos__hiddenLabel mesh__D008133 Syndromes, Long QT
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D008133 2005
% 217.74/217.96  |- mesh__dateRevised mesh__D000150 2005-06-30
% 217.74/217.96  |- skos__historyNote mesh__D000150 Alcaligenes %28%1974%29%
% 217.74/217.96  |- skos__prefLabel mesh__D000150 Acinetobacter
% 217.74/217.96  |- mesh__dateEstablished mesh__D000150 1976-01-01
% 217.74/217.96  |- mesh__recordOriginator mesh__D000150 NLM
% 217.74/217.96  |- rdf__type mesh__D000150sskos__Concept
% 217.74/217.96  |- mesh__onlineNote mesh__D000150
% 217.74/217.96       search ALCALIGENES 1974; use ACINETOBACTER to search MIMAE 1966-91, HERELLA 1976-91, %26% COLLOIDES 1976-91%A%  
% 217.74/217.96  |- mesh__publicMeSHNote mesh__D000150
% 217.74/217.96       76; was see under ACHROMOBACTER 1974-75; HERELLEA was HERELLA see ACINETOBACTER 1976-91; MIMA was MIMAE see ACINETOBACTER 1976-91; MIMAE was heading 1963-75; COLLOIDES was see ACINETOBACTER 1976-91%A%  
% 217.74/217.96  |- skos__annotation mesh__D000150 infection = ACINETOBACTER INFECTIONS   
% 217.74/217.96  |- mesh__recordMaintainer mesh__D000150 SYSTEM
% 217.74/217.96  |- mesh__recordAuthorizer mesh__D000150 sjn
% 217.74/217.96  |- skos__scopeNote mesh__D000150
% 217.74/217.96       A genus of gram-negative bacteria of the family MORAXELLACEAE, found in soil and water and of uncertain pathogenicity.%A%    
% 217.74/217.96  |- mesh__historyNote mesh__D000150
% 217.74/217.96       76%28%75%29%; was see under ACHROMOBACTER 1974-75; HERELLEA was HERELLA see ACINETOBACTER 1976-91; MIMA was MIMAE see ACINETOBACTER 1976-91; MIMAE was heading 1963-75; COLLOIDES was see ACINETOBACTER 1976-91%A%  
% 217.74/217.96  |- mesh__dateCreated mesh__D000150 1999-01-01
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D000150 2006
% 217.74/217.96  |- skos__broader mesh__D000150smesh__D044007
% 217.74/217.96  |- rdf__type mesh__D013876sskos__Concept
% 217.74/217.96  |- mesh__dateCreated mesh__D013876 1999-01-01
% 217.74/217.96  |- skos__prefLabel mesh__D013876 Thiophenes
% 217.74/217.96  |- mesh__recordAuthorizer mesh__D013876 sjn
% 217.74/217.96  |- mesh__recordOriginator mesh__D013876 NLM
% 217.74/217.96  |- skos__broader mesh__D013876smesh__D013457
% 217.74/217.96  |- mesh__recordMaintainer mesh__D013876 ssb
% 217.74/217.96  |- skos__broader mesh__D013876smesh__D006573
% 217.74/217.96  |- mesh__activeMeSHYear mesh__D013876 2006
% 217.74/217.96  |- mesh__dateRevised mesh__D013876 2005-06-30
% 217.74/217.96  |- mesh__publicMeSHNote mesh__D013078 75   
% 217.74/217.97  |- skos__historyNote mesh__D013078 Contraceptive Agents %28%1967-1974%29%
% 217.74/217.97  |- rdf__type mesh__D013078sskos__Concept
% 217.74/217.97  |- mesh__recordOriginator mesh__D013078 NLM
% 217.74/217.97  |- skos__hiddenLabel mesh__D013078 Agents, Sperm-Immobilizing
% 217.74/217.97  |- skos__altLabel mesh__D013078 Sperm-Immobilizing Agents
% 217.74/217.97  |- mesh__dateEstablished mesh__D013078 1975-01-01
% 217.74/217.97  |- mesh__historyNote mesh__D013078 75   
% 217.74/217.97  |- mesh__activeMeSHYear mesh__D013078 2006
% 217.74/217.97  |- skos__annotation mesh__D013078
% 217.74/217.97       consider also SPERM MOTILITY /drug eff, etc.   
% 217.74/217.97  |- skos__broader mesh__D013078smesh__D003271
% 217.74/217.97  |- mesh__recordMaintainer mesh__D013078 ssb
% 217.74/217.97  |- mesh__dateRevised mesh__D013078 2005-06-30
% 217.74/217.97  |- skos__prefLabel mesh__D013078 Sperm Immobilizing Agents
% 217.74/217.97  |- skos__scopeNote mesh__D013078
% 217.74/217.97       Chemical substances with sperm immobilizing activity used as topically administered vaginal contraceptives.%A%    
% 217.74/217.97  |- skos__historyNote mesh__D013078
% 217.74/217.97       Spermatozoa/drug effects %28%1966-1974%29%
% 217.74/217.97  |- skos__hiddenLabel mesh__D013078 Agents, Sperm Immobilizing
% 217.74/217.97  |- skos__broader mesh__D013078smesh__D000988
% 217.74/217.97  |- mesh__recordAuthorizer mesh__D013078 sjn
% 217.74/217.97  |- mesh__dateCreated mesh__D013078 1999-01-01
% 217.74/217.97  |- skos__hiddenLabel mesh__D007839 Ambidexterities
% 217.74/217.97  |- mesh__activeMeSHYear mesh__D007839 2006
% 217.74/217.97  |- skos__hiddenLabel mesh__D007839 Lateralities
% 217.74/217.97  |- mesh__onlineNote mesh__D007839
% 217.74/217.97       use LATERALITY to search AMBIDEXTERITY 1966-85   
% 217.74/217.97  |- mesh__recordOriginator mesh__D007839 NLM
% 217.74/217.97  |- skos__hiddenLabel mesh__D007839 Handednesses
% 217.74/217.97  |- mesh__dateCreated mesh__D007839 1999-01-01
% 217.74/217.97  |- rdf__type mesh__D007839sskos__Concept
% 217.74/217.97  |- skos__prefLabel mesh__D007839 Laterality
% 217.74/217.97  |- skos__annotation mesh__D007839
% 217.74/217.97       restrict to neurological %26% psychological sense; sidedness or laterality of disease, index the disease with /pathol or /physiopathol; for unilateral or bilateral surgery, index the surgical technique with /methods if pertinent%A%  
% 217.74/217.97  |- skos__scopeNote mesh__D007839
% 217.74/217.97       Behavioral manifestations of cerebral dominance in which there is preferential use and superior functioning of either the left or the right side, as in the preferred use of the right hand or right foot.%A%    
% 217.74/217.97  |- skos__related mesh__D007839smesh__D050812
% 217.74/217.97  |- mesh__recordMaintainer mesh__D007839 ags
% 217.74/217.97  |- mesh__dateRevised mesh__D007839 2005-06-30
% 217.74/217.97  |- skos__altLabel mesh__D007839 Handedness
% 217.74/217.97  |- mesh__recordAuthorizer mesh__D007839 sjn
% 217.74/217.97  |- mesh__publicMeSHNote mesh__D007839
% 217.74/217.97       AMBIDEXTERITY was see under LATERALITY 1975-85, was see LATERALITY 1966-74%A%  
% 217.74/217.97  |- skos__broader mesh__D007839smesh__D004292
% 217.74/217.97  |- mesh__historyNote mesh__D007839
% 217.74/217.97       AMBIDEXTERITY was see under LATERALITY 1975-85, was see LATERALITY 1966-74%A%  
% 217.74/217.97  |- mesh__activeMeSHYear mesh__D018561 2005
% 217.74/217.97  |- mesh__activeMeSHYear mesh__D018561 1999
% 217.74/217.97  |- mesh__activeMeSHYear mesh__D018561 2004
% 217.74/217.97  |- rdf__type mesh__D018561sskos__Concept
% 217.74/217.97  |- skos__hiddenLabel mesh__D018561 Space Models
% 217.74/217.97  |- mesh__dateEstablished mesh__D018561 1995-01-01
% 217.74/217.97  |- mesh__activeMeSHYear mesh__D018561 2002
% 217.74/217.97  |- mesh__activeMeSHYear mesh__D018561 1998
% 217.74/217.97  |- mesh__activeMeSHYear mesh__D018561 2003
% 217.74/217.97  |- skos__hiddenLabel mesh__D018561 Simulation, Space
% 217.74/217.97  |- mesh__activeMeSHYear mesh__D018561 1997
% 217.74/217.97  |- skos__hiddenLabel mesh__D018561 Space Model
% 217.74/217.97  |- mesh__activeMeSHYear mesh__D018561 2001
% 217.74/217.97  |- mesh__dateCreated mesh__D018561 1994-06-07
% 217.74/217.97  |- skos__hiddenLabel mesh__D018561 Space Simulations
% 217.74/217.97  |- mesh__activeMeSHYear mesh__D018561 2000
% 217.74/217.97  |- mesh__dateRevised mesh__D018561 1995-06-05
% 217.74/217.97  |- mesh__recordMaintainer mesh__D018561 JLS
% 217.74/217.97  |- mesh__recordAuthorizer mesh__D018561 PLS
% 217.74/217.97  |- mesh__recordOriginator mesh__D018561 JLS
% 217.74/217.97  |- mesh__historyNote mesh__D018561 95   
% 217.74/217.97  |- skos__prefLabel mesh__D018561 Space Simulation
% 217.74/217.97  |- mesh__activeMeSHYear mesh__D018561 1996
% 217.74/217.97  |- skos__broader mesh__D018561smesh__D004780
% 217.74/217.97  |- skos__hiddenLabel mesh__D018561 Simulations, Space
% 217.74/217.97  |- skos__scopeNote mesh__D018561
% 217.74/217.97       An environment simulating one or more parameters of the space environment, applied in testing space systems or components. Often, a closed chamber is used, capable of approximating the vacuum and normal environments of space. %28%From NASA Thesaurus, 1988%29% This also includes simulated EXTRAVEHICULAR ACTIVITY studies in atmosphere exposure chambers or water tanks.%A%    
% 217.74/217.97  |- mesh__publicMeSHNote mesh__D018561 95   
% 217.74/217.97  |- mesh__activeMeSHYear mesh__D018561 2006
% 217.74/217.97  |- skos__hiddenLabel mesh__D018561 Model, Space
% 217.74/217.97  |- skos__annotation mesh__D018561
% 217.74/217.97       to test space systems or components by approximating the space environment%A%  
% 217.74/217.97  |- skos__hiddenLabel mesh__D018561 Simulations, Orbital
% 217.83/217.97  |- skos__related mesh__D018561smesh__D018474
% 217.83/217.97  |- skos__hiddenLabel mesh__D018561 Simulation, Orbital
% 217.83/217.97  |- skos__hiddenLabel mesh__D018561 Orbital Simulations
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D004541 2000
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D004541 2006
% 217.83/217.97  |- mesh__recordAuthorizer mesh__D004541 sjn
% 217.83/217.97  |- skos__hiddenLabel mesh__D004541 Eisenmengers Complex
% 217.83/217.97  |- skos__annotation mesh__D004541
% 217.83/217.97       a congen heart defect; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 217.83/217.97  |- skos__hiddenLabel mesh__D004541 Syndrome, Eisenmenger%27%s
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D004541 2003
% 217.83/217.97  |- mesh__recordMaintainer mesh__D004541 kle
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D004541 2005
% 217.83/217.97  |- skos__altLabel mesh__D004541 Eisenmenger%27%s Syndrome
% 217.83/217.97  |- rdf__type mesh__D004541sskos__Concept
% 217.83/217.97  |- skos__hiddenLabel mesh__D004541 Syndrome, Eisenmenger
% 217.83/217.97  |- mesh__dateRevised mesh__D004541 1999-11-03
% 217.83/217.97  |- skos__broader mesh__D004541smesh__D006330
% 217.83/217.97  |- skos__scopeNote mesh__D004541
% 217.83/217.97       Defect of the interventricular septum with severe pulmonary hypertension, hypertrophy of the right ventricle, and latent or overt cyanosis.%A%    
% 217.83/217.97  |- mesh__recordOriginator mesh__D004541 NLM
% 217.83/217.97  |- skos__altLabel mesh__D004541 Eisenmenger Syndrome
% 217.83/217.97  |- skos__hiddenLabel mesh__D004541 Complex, Eisenmenger%27%s
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D004541 2002
% 217.83/217.97  |- skos__hiddenLabel mesh__D004541 Eisenmengers Syndrome
% 217.83/217.97  |- skos__prefLabel mesh__D004541 Eisenmenger Complex
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D004541 2001
% 217.83/217.97  |- skos__altLabel mesh__D004541 Eisenmenger%27%s Complex
% 217.83/217.97  |- skos__hiddenLabel mesh__D004541 Complex, Eisenmenger
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D004541 2004
% 217.83/217.97  |- mesh__dateCreated mesh__D004541 1999-01-01
% 217.83/217.97  |- skos__altLabel mesh__D051197 Toll-4 Receptor
% 217.83/217.97  |- skos__scopeNote mesh__D051197
% 217.83/217.97       A pattern recognition receptor that interacts with LYMPHOCYTE ANTIGEN 96 and LIPOPOLYSACCHARIDES. It mediates cellular responses to GRAM-NEGATIVE BACTERIA.%A%    
% 217.83/217.97  |- mesh__publicMeSHNote mesh__D051197
% 217.83/217.97       2006; TOLL-LIKE RECEPTOR 4 was indexed under MEMBRANE GLYCOPROTEINS %26% RECEPTORS, CELL SURFACE 2001-2005%A%  
% 217.83/217.97  |- mesh__dateEstablished mesh__D051197 2006-01-01
% 217.83/217.97  |- mesh__recordOriginator mesh__D051197 DRC
% 217.83/217.97  |- skos__hiddenLabel mesh__D051197 Toll Like Receptor 4
% 217.83/217.97  |- skos__hiddenLabel mesh__D051197 Toll 4 Receptor
% 217.83/217.97  |- skos__prefLabel mesh__D051197 Toll-Like Receptor 4
% 217.83/217.97  |- skos__hiddenLabel mesh__D051197 Receptor, TLR4
% 217.83/217.97  |- rdf__type mesh__D051197sskos__Concept
% 217.83/217.97  |- mesh__historyNote mesh__D051197 2006%28%2001%29%   
% 217.83/217.97  |- mesh__dateCreated mesh__D051197 2005-06-30
% 217.83/217.97  |- mesh__recordAuthorizer mesh__D051197 sjn
% 217.83/217.97  |- skos__broader mesh__D051197smesh__D051193
% 217.83/217.97  |- skos__altLabel mesh__D051197 TLR4 Receptor
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D051197 2006
% 217.83/217.97  |- mesh__recordMaintainer mesh__D051197 DRC
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D017469 2005
% 217.83/217.97  |- mesh__recordMaintainer mesh__D017469 jmp
% 217.83/217.97  |- skos__altLabel mesh__D017469 Fibronectin Receptors
% 217.83/217.97  |- mesh__dateCreated mesh__D017469 1992-05-22
% 217.83/217.97  |- mesh__dateRevised mesh__D017469 2003-07-09
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D017469 2006
% 217.83/217.97  |- skos__annotation mesh__D017469
% 217.83/217.97       dp not confuse with FIBRONECTIN RECEPTOR see INTEGRIN ALPHA5BETA1, DF: RECEPT FIBRONECTIN%A%  
% 217.83/217.97  |- skos__broader mesh__D017469smesh__D016023
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D017469 2004
% 217.83/217.97  |- mesh__dateEstablished mesh__D017469 1993-01-01
% 217.83/217.97  |- skos__historyNote mesh__D017469
% 217.83/217.97       Receptors, Endogenous Substances %28%1981-1984%29%
% 217.83/217.97  |- skos__historyNote mesh__D017469 Receptors, Immunologic %28%1984-1992%29%
% 217.83/217.97  |- rdf__type mesh__D017469sskos__Concept
% 217.83/217.97  |- mesh__historyNote mesh__D017469
% 217.83/217.97       1993; use FIBRONECTIN RECEPTOR %28%NM%29% 1981-1992   
% 217.83/217.97  |- skos__scopeNote mesh__D017469
% 217.83/217.97       Specific cell surface receptors which bind to FIBRONECTINS. Studies have shown that these receptors function in certain types of adhesive contact as well as playing a major role in matrix assembly. These receptors include the traditional fibronectin receptor, also called INTEGRIN ALPHA5BETA1 and several other integrins.%A%    
% 217.83/217.97  |- mesh__recordOriginator mesh__D017469 PXP
% 217.83/217.97  |- mesh__publicMeSHNote mesh__D017469
% 217.83/217.97       1993; FIBRONECTIN RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1984-1992 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1981-84%A%  
% 217.83/217.97  |- skos__prefLabel mesh__D017469 Receptors, Fibronectin
% 217.83/217.97  |- mesh__recordAuthorizer mesh__D017469 sjn
% 217.83/217.97  |- skos__prefLabel mesh__D036623 Grindelia
% 217.83/217.97  |- mesh__historyNote mesh__D036623 2003   
% 217.83/217.97  |- skos__altLabel mesh__D036623 Gumweed
% 217.83/217.97  |- skos__scopeNote mesh__D036623
% 217.83/217.97       A plant genus of the family ASTERACEAE. Members contain triterpenoid sapogenins.%A%    
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D036623 2006
% 217.83/217.97  |- mesh__dateEstablished mesh__D036623 2003-01-01
% 217.83/217.97  |- skos__annotation mesh__D036623
% 217.83/217.97       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D036623 2005
% 217.83/217.97  |- mesh__dateCreated mesh__D036623 2002-07-03
% 217.83/217.97  |- skos__altLabel mesh__D036623 Gumplant
% 217.83/217.97  |- mesh__publicMeSHNote mesh__D036623 2003   
% 217.83/217.97  |- rdf__type mesh__D036623sskos__Concept
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D036623 2004
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D036623 2003
% 217.83/217.97  |- skos__broader mesh__D036623smesh__D019659
% 217.83/217.97  |- rdf__type mesh__D003449sskos__Concept
% 217.83/217.97  |- mesh__dateRevised mesh__D003449 1998-06-10
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D003449 2005
% 217.83/217.97  |- skos__broader mesh__D003449smesh__D020141
% 217.83/217.97  |- mesh__publicMeSHNote mesh__D003449
% 217.83/217.97       85; was see under PARAPROTEINEMIAS 1982-84   
% 217.83/217.97  |- mesh__historyNote mesh__D003449
% 217.83/217.97       85%28%82%29%; was see under PARAPROTEINEMIAS 1982-84   
% 217.83/217.97  |- skos__hiddenLabel mesh__D003449 Cryoglobulinemias
% 217.83/217.97  |- skos__historyNote mesh__D003449 Paraproteinemias %28%1976-1981%29%
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D003449 2001
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D003449 2004
% 217.83/217.97  |- mesh__recordAuthorizer mesh__D003449 SJN
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D003449 2000
% 217.83/217.97  |- mesh__recordMaintainer mesh__D003449 NNS
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D003449 2003
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D003449 1999
% 217.83/217.97  |- mesh__recordOriginator mesh__D003449 VDK
% 217.83/217.97  |- skos__historyNote mesh__D003449 Cryoglobulins %28%1966-1981%29%
% 217.83/217.97  |- skos__annotation mesh__D003449 a blood protein disord   
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D003449 2006
% 217.83/217.97  |- mesh__dateEstablished mesh__D003449 1985-01-01
% 217.83/217.97  |- skos__broader mesh__D003449smesh__D010265
% 217.83/217.97  |- skos__historyNote mesh__D003449
% 217.83/217.97       Blood Protein Disorders %28%1966-1975%29%
% 217.83/217.97  |- skos__prefLabel mesh__D003449 Cryoglobulinemia
% 217.83/217.97  |- skos__scopeNote mesh__D003449
% 217.83/217.97       A condition characterized by the presence of abnormal or abnormal quantities of cryoglobulins in the blood. They are precipitated into the microvasculature on exposure to cold and cause restricted blood flow in exposed areas.%A%    
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D003449 2002
% 217.83/217.97  |- mesh__dateCreated mesh__D003449 1981-05-19
% 217.83/217.97  |- mesh__recordAuthorizer mesh__D014171 sjn
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D014171 2004
% 217.83/217.97  |- mesh__dateCreated mesh__D014171 1999-01-01
% 217.83/217.97  |- skos__altLabel mesh__D014171 Nomads
% 217.83/217.97  |- skos__hiddenLabel mesh__D014171 Migrant
% 217.83/217.97  |- skos__scopeNote mesh__D014171
% 217.83/217.97       Mobile, short-term residents who move usually to find work.%A%    
% 217.83/217.97  |- skos__related mesh__D014171smesh__D006703
% 217.83/217.97  |- rdf__type mesh__D014171sskos__Concept
% 217.83/217.97  |- skos__hiddenLabel mesh__D014171 Migration, Labor
% 217.83/217.97  |- mesh__dateRevised mesh__D014171 1999-11-03
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D014171 2001
% 217.83/217.97  |- skos__annotation mesh__D014171
% 217.83/217.97       specify geog if possible; DF: TRANSIENTS   
% 217.83/217.97  |- skos__hiddenLabel mesh__D014171 Nomad
% 217.83/217.97  |- skos__hiddenLabel mesh__D014171 Migrants and Transients
% 217.83/217.97  |- skos__hiddenLabel mesh__D014171 Nonmigrant
% 217.83/217.97  |- mesh__recordOriginator mesh__D014171 NLM
% 217.83/217.97  |- skos__hiddenLabel mesh__D014171 Migrant, Illegal
% 217.83/217.97  |- skos__hiddenLabel mesh__D014171 Migrant Worker
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D014171 2005
% 217.83/217.97  |- skos__prefLabel mesh__D014171 Transients and Migrants
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D014171 2002
% 217.83/217.97  |- skos__hiddenLabel mesh__D014171 Transient
% 217.83/217.97  |- skos__hiddenLabel mesh__D014171 Workers, Migrant
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D014171 2006
% 217.83/217.97  |- skos__hiddenLabel mesh__D014171 Migrations, Labor
% 217.83/217.97  |- skos__hiddenLabel mesh__D014171 Migrants, Illegal
% 217.83/217.97  |- skos__hiddenLabel mesh__D014171 Labor Migrations
% 217.83/217.97  |- mesh__recordMaintainer mesh__D014171 kle
% 217.83/217.97  |- skos__altLabel mesh__D014171 Illegal Migrants
% 217.83/217.97  |- skos__hiddenLabel mesh__D014171 Illegal Migrant
% 217.83/217.97  |- skos__hiddenLabel mesh__D014171 Squatter
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D014171 2003
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D014171 2000
% 217.83/217.97  |- skos__broader mesh__D014171smesh__D009272
% 217.83/217.97  |- skos__hiddenLabel mesh__D014171 Worker, Migrant
% 217.83/217.97  |- skos__hiddenLabel mesh__D022603 Toxins, Vero
% 217.83/217.97  |- skos__hiddenLabel mesh__D022603 Toxin, Vero
% 217.83/217.97  |- mesh__dateEstablished mesh__D022603 2001-01-01
% 217.83/217.97  |- skos__hiddenLabel mesh__D022603 Toxins, Shiga-Like
% 217.83/217.97  |- mesh__recordMaintainer mesh__D022603 ssb
% 217.83/217.97  |- skos__altLabel mesh__D022603 Shiga-Like Toxins
% 217.83/217.97  |- skos__annotation mesh__D022603 SHIGA TOXIN is also available   
% 217.83/217.97  |- rdf__type mesh__D022603sskos__Concept
% 217.83/217.97  |- skos__hiddenLabel mesh__D022603 Cytotoxin, Vero Cell
% 217.83/217.97  |- mesh__publicMeSHNote mesh__D022603
% 217.83/217.97       2001; VERO CYTOTOXIN, VERO CELL CYTOTOXIN, VERO TOXIN %26% VERO TOXIN were indexed under BACTERIAL TOXINS 1980-2000%A%  
% 217.83/217.97  |- skos__altLabel mesh__D022603 Vero Toxins
% 217.83/217.97  |- mesh__dateCreated mesh__D022603 2000-06-22
% 217.83/217.97  |- skos__broader mesh__D022603smesh__D004768
% 217.83/217.97  |- mesh__historyNote mesh__D022603
% 217.83/217.97       2001; for VERO CYTOTOXIN, VERO CELL CYTOTOXIN, VERO TOXIN %26% VERO TOXIN use SHIGA-LIKE TOXIN I %28%NM%29% 1980-2000%A%  
% 217.83/217.97  |- skos__hiddenLabel mesh__D022603 Cytoxins, Vero
% 217.83/217.97  |- skos__hiddenLabel mesh__D022603 Cell Cytotoxins, Vero
% 217.83/217.97  |- mesh__dateRevised mesh__D022603 2005-06-30
% 217.83/217.97  |- mesh__recordAuthorizer mesh__D022603 sjn
% 217.83/217.97  |- skos__altLabel mesh__D022603 Verotoxin
% 217.83/217.97  |- skos__altLabel mesh__D022603 Vero Cell Cytotoxins
% 217.83/217.97  |- skos__altLabel mesh__D022603 Vero Cell Cytotoxin
% 217.83/217.97  |- skos__hiddenLabel mesh__D022603 Toxins, Shiga
% 217.83/217.97  |- skos__altLabel mesh__D022603 Vero Cytotoxin
% 217.83/217.97  |- skos__hiddenLabel mesh__D022603 Cytotoxins, Vero Cell
% 217.83/217.97  |- skos__altLabel mesh__D022603 Vero Toxin
% 217.83/217.97  |- skos__scopeNote mesh__D022603
% 217.83/217.97       A class of toxins that inhibit protein synthesis by blocking the interaction of ribosomal RNA; %28%RNA, RIBOSOMAL%29% with PEPTIDE ELONGATION FACTORS. They include SHIGA TOXIN which is produced by SHIGELLA DYSENTERIAE and a variety of shiga-like toxins that are produced by pathologic strains of ESCHERICHIA COLI such as ESCHERICHIA COLI O157.%A%    
% 217.83/217.97  |- skos__altLabel mesh__D022603 Verotoxins
% 217.83/217.97  |- skos__broader mesh__D022603smesh__D001427
% 217.83/217.97  |- skos__altLabel mesh__D022603 Vero Cytoxins
% 217.83/217.97  |- skos__related mesh__D022603smesh__D004403
% 217.83/217.97  |- skos__hiddenLabel mesh__D022603 Shiga Like Toxins
% 217.83/217.97  |- mesh__recordOriginator mesh__D022603 jmp
% 217.83/217.97  |- skos__hiddenLabel mesh__D022603 Cytotoxin, Vero
% 217.83/217.97  |- skos__prefLabel mesh__D022603 Shiga Toxins
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D022603 2006
% 217.83/217.97  |- skos__historyNote mesh__D022603 Bacterial Toxins %28%1980-2000%29%
% 217.83/217.97  |- mesh__onlineNote mesh__D008134
% 217.83/217.97       use LONG-TERM CARE to search LONG TERM CARE 1968-91   
% 217.83/217.97  |- skos__historyNote mesh__D008134 Chronic Disease %28%1966-1967%29%
% 217.83/217.97  |- mesh__recordMaintainer mesh__D008134 JLS
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D008134 2004
% 217.83/217.97  |- mesh__dateEstablished mesh__D008134 1968-01-01
% 217.83/217.97  |- rdf__type mesh__D008134sskos__Concept
% 217.83/217.97  |- mesh__dateCreated mesh__D008134 1999-01-01
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D008134 2002
% 217.83/217.97  |- mesh__dateRevised mesh__D008134 1998-06-10
% 217.83/217.97  |- mesh__historyNote mesh__D008134 92; was LONG TERM CARE 1968-91   
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D008134 1999
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D008134 2003
% 217.83/217.97  |- skos__prefLabel mesh__D008134 Long-Term Care
% 217.83/217.97  |- mesh__recordAuthorizer mesh__D008134 SJN
% 217.83/217.97  |- skos__annotation mesh__D008134 NIM   
% 217.83/217.97  |- mesh__publicMeSHNote mesh__D008134 92; was LONG TERM CARE 1968-91   
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D008134 2006
% 217.83/217.97  |- skos__scopeNote mesh__D008134
% 217.83/217.97       Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care.%A%    
% 217.83/217.97  |- skos__hiddenLabel mesh__D008134 Care, Long-Term
% 217.83/217.97  |- skos__broader mesh__D008134smesh__D005791
% 217.83/217.97  |- skos__related mesh__D008134smesh__D007353
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D008134 2001
% 217.83/217.97  |- skos__hiddenLabel mesh__D008134 Long Term Care
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D008134 2005
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D008134 2000
% 217.83/217.97  |- mesh__recordOriginator mesh__D008134 NLM
% 217.83/217.97  |- skos__broader mesh__D000151smesh__D045828
% 217.83/217.97  |- mesh__onlineNote mesh__D000151
% 217.83/217.97       use ACINETOBACTER INFECTIONS to search MIMAE INFECTIONS 1968-76%A%  
% 217.83/217.97  |- mesh__recordOriginator mesh__D000151 FPG
% 217.83/217.97  |- mesh__recordAuthorizer mesh__D000151 sjn
% 217.83/217.97  |- mesh__historyNote mesh__D000151 77; was MIMAE INFECTIONS 1968-76   
% 217.83/217.97  |- mesh__dateCreated mesh__D000151 1976-04-16
% 217.83/217.97  |- mesh__publicMeSHNote mesh__D000151 77; was MIMAE INFECTIONS 1968-76   
% 217.83/217.97  |- skos__hiddenLabel mesh__D000151 Acinetobacter Infection
% 217.83/217.97  |- skos__prefLabel mesh__D000151 Acinetobacter Infections
% 217.83/217.97  |- mesh__dateRevised mesh__D000151 2003-07-09
% 217.83/217.97  |- skos__annotation mesh__D000151 gram-neg bact infect   
% 217.83/217.97  |- skos__hiddenLabel mesh__D000151 Infection, Acinetobacter
% 217.83/217.97  |- rdf__type mesh__D000151sskos__Concept
% 217.83/217.97  |- mesh__dateEstablished mesh__D000151 1977-01-01
% 217.83/217.97  |- skos__hiddenLabel mesh__D000151 Mimae Infection
% 217.83/217.97  |- skos__scopeNote mesh__D000151
% 217.83/217.97       Infections with bacteria of the genus ACINETOBACTER.     
% 217.83/217.97  |- skos__historyNote mesh__D000151 Acinetobacter %28%1966-1967%29%
% 217.83/217.97  |- skos__hiddenLabel mesh__D000151 Infection, Mimae
% 217.83/217.97  |- mesh__recordMaintainer mesh__D000151 ags
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D000151 2005
% 217.83/217.97  |- skos__altLabel mesh__D000151 Mimae Infections
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D000151 2004
% 217.83/217.97  |- skos__altLabel mesh__D000151 Infections, Acinetobacter
% 217.83/217.97  |- skos__altLabel mesh__D000151 Infections, Mimae
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D000151 2006
% 217.83/217.97  |- mesh__dateRevised mesh__D013877 2005-06-30
% 217.83/217.97  |- skos__prefLabel mesh__D013877 Thiophosphoric Acid Esters
% 217.83/217.97  |- skos__hiddenLabel mesh__D013877 Acid Esters, Thiophosphoric
% 217.83/217.97  |- mesh__recordAuthorizer mesh__D013877 sjn
% 217.83/217.97  |- skos__broader mesh__D013877smesh__D009946
% 217.83/217.97  |- mesh__recordOriginator mesh__D013877 NLM
% 217.83/217.97  |- mesh__dateEstablished mesh__D013877 1991-01-01
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D013877 2006
% 217.83/217.97  |- mesh__onlineNote mesh__D013877
% 217.83/217.97       search ORGANOTHIOPHOSPHORUS COMPOUNDS 1972-74   
% 217.83/217.97  |- rdf__type mesh__D013877sskos__Concept
% 217.83/217.97  |- mesh__historyNote mesh__D013877
% 217.83/217.97       91%28%75%29%; was see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1975-90%A%  
% 217.83/217.97  |- mesh__dateCreated mesh__D013877 1999-01-01
% 217.83/217.97  |- skos__hiddenLabel mesh__D013877 Esters, Thiophosphoric Acid
% 217.83/217.97  |- mesh__publicMeSHNote mesh__D013877
% 217.83/217.97       91; was see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1975-90   
% 217.83/217.97  |- mesh__recordMaintainer mesh__D013877 ssb
% 217.83/217.97  |- skos__hiddenLabel mesh__D013079 Spermatozoa Maturation
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D013079 2006
% 217.83/217.97  |- skos__altLabel mesh__D013079 Maturation of Spermatozoa
% 217.83/217.97  |- mesh__dateRevised mesh__D013079 2004-08-02
% 217.83/217.97  |- skos__hiddenLabel mesh__D013079 Maturation, Sperm
% 217.83/217.97  |- skos__related mesh__D013079smesh__D000988
% 217.83/217.97  |- mesh__publicMeSHNote mesh__D013079 76; was see under SPERMATOZOA 1975   
% 217.83/217.97  |- skos__scopeNote mesh__D013079
% 217.83/217.97       The maturing process of SPERMATOZOA after leaving the testicular SEMINIFEROUS TUBULES. Maturation in SPERM MOTILITY and FERTILITY takes place in the EPIDIDYMIS as the sperm migrate from caput epididymis to cauda epididymis.%A%    
% 217.83/217.97  |- mesh__dateEstablished mesh__D013079 1976-01-01
% 217.83/217.97  |- skos__prefLabel mesh__D013079 Sperm Maturation
% 217.83/217.97  |- mesh__recordOriginator mesh__D013079 NLM
% 217.83/217.97  |- mesh__dateCreated mesh__D013079 1974-11-11
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D013079 2005A
% 217.83/217.97  |- rdf__type mesh__D013079sskos__Concept
% 217.83/217.97  |- skos__broader mesh__D013079smesh__D013091
% 217.83/217.97  |- skos__historyNote mesh__D013079 Spermatozoa %28%1966-1974%29%
% 217.83/217.97  |- mesh__recordAuthorizer mesh__D013079 jls
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D013079 2005
% 217.83/217.97  |- mesh__historyNote mesh__D013079
% 217.83/217.97       76%28%75%29%; was see under SPERMATOZOA 1975   
% 217.83/217.97  |- mesh__recordMaintainer mesh__D013079 jls
% 217.83/217.97  |- skos__related mesh__D018562smesh__D050456
% 217.83/217.97  |- mesh__recordMaintainer mesh__D018562 ags
% 217.83/217.97  |- skos__broader mesh__D018562smesh__D011634
% 217.83/217.97  |- mesh__recordAuthorizer mesh__D018562 sjn
% 217.83/217.97  |- skos__prefLabel mesh__D018562 Disease Transmission
% 217.83/217.97  |- skos__related mesh__D018562smesh__D003141
% 217.83/217.97  |- rdf__type mesh__D018562sskos__Concept
% 217.83/217.97  |- mesh__publicMeSHNote mesh__D018562 95   
% 217.83/217.97  |- skos__annotation mesh__D018562
% 217.83/217.97       general or unspecified; prefer /transm with specific diseases; DF: DIS TRANSM%A%  
% 217.83/217.97  |- skos__altLabel mesh__D018562 Transmission, Disease
% 217.83/217.97  |- mesh__recordOriginator mesh__D018562 AGS
% 217.83/217.97  |- mesh__historyNote mesh__D018562 95   
% 217.83/217.97  |- skos__hiddenLabel mesh__D018562 Transmissions, Disease
% 217.83/217.97  |- skos__hiddenLabel mesh__D018562 Disease Transmissions
% 217.83/217.97  |- skos__historyNote mesh__D018562
% 217.83/217.97       Communicable Diseases/transmission %28%1974-1994%29%
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D018562 2006
% 217.83/217.97  |- skos__altLabel mesh__D018562 Transmission of Disease
% 217.83/217.97  |- mesh__dateEstablished mesh__D018562 1995-01-01
% 217.83/217.97  |- mesh__dateRevised mesh__D018562 2005-06-30
% 217.83/217.97  |- mesh__dateCreated mesh__D018562 1994-01-25
% 217.83/217.97  |- skos__scopeNote mesh__D018562
% 217.83/217.97       The transmission of infectious disease or pathogens. When transmission is within the same species, the mode can be horizontal %28%DISEASE TRANSMISSION, HORIZONTAL%29% or vertical %28%DISEASE TRANSMISSION, VERTICAL%29%.%A%    
% 217.83/217.97  |- skos__altLabel mesh__D051996 Transcription Factor p65
% 217.83/217.97  |- skos__broader mesh__D051996smesh__D016328
% 217.83/217.97  |- mesh__dateCreated mesh__D051996 2005-06-30
% 217.83/217.97  |- skos__hiddenLabel mesh__D051996 p65, NF-kappa B
% 217.83/217.97  |- skos__hiddenLabel mesh__D051996 NF kappaB 65 kDa
% 217.83/217.97  |- mesh__recordMaintainer mesh__D051996 DRC
% 217.83/217.97  |- skos__altLabel mesh__D051996 NF-kappa B p65 Subunit
% 217.83/217.97  |- mesh__recordAuthorizer mesh__D051996 sjn
% 217.83/217.97  |- skos__hiddenLabel mesh__D051996 p65, Transcription Factor
% 217.83/217.97  |- skos__prefLabel mesh__D051996 Transcription Factor RelA
% 217.83/217.97  |- skos__scopeNote mesh__D051996
% 217.83/217.97       A subunit of NF-kappa B that is primarily responsible for its transactivation function. It contains a C-terminal transactivation domain and an N-terminal domain with homology to PROTO-ONCOGENE PROTEINS C-REL.%A%    
% 217.83/217.97  |- mesh__publicMeSHNote mesh__D051996
% 217.83/217.97       2006; TRANSCRIPTION FACTOR RELA was indexed under NF-KAPPA B 1993-2005%A%  
% 217.83/217.97  |- mesh__recordOriginator mesh__D051996 DRC
% 217.83/217.97  |- mesh__activeMeSHYear mesh__D051996 2006
% 217.83/217.97  |- skos__hiddenLabel mesh__D051996 NF kappa B p65 Subunit
% 217.83/217.97  |- skos__altLabel mesh__D051996 p65 Transcription Factor
% 217.83/217.97  |- mesh__historyNote mesh__D051996 2006%28%1993%29%   
% 217.83/217.97  |- rdf__type mesh__D051996sskos__Concept
% 217.83/217.97  |- skos__altLabel mesh__D051996 NF-kappaB 65-kDa
% 217.83/217.97  |- skos__altLabel mesh__D051996
% 217.83/217.97       v-Rel Reticuloendotheliosis Viral Oncogene Homolog A
% 217.83/217.97  |- skos__hiddenLabel mesh__D051996 Transcription Factor, p65
% 217.83/217.97  |- skos__hiddenLabel mesh__D051996
% 217.83/217.97       v Rel Reticuloendotheliosis Viral Oncogene Homolog A
% 217.83/217.97  |- skos__altLabel mesh__D051996 NF-kappa B p65
% 217.83/217.97  |- skos__hiddenLabel mesh__D051996 RelA, Transcription Factor
% 217.83/217.97  |- mesh__dateEstablished mesh__D051996 2006-01-01
% 217.83/217.97  |- skos__hiddenLabel mesh__D051996 NF kappa B p65
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D004542 2005
% 217.83/217.98  |- skos__broader mesh__D004542smesh__D012098
% 217.83/217.98  |- rdf__type mesh__D004542sskos__Concept
% 217.83/217.98  |- mesh__dateRevised mesh__D004542 2004-07-07
% 217.83/217.98  |- skos__prefLabel mesh__D004542 Ejaculation
% 217.83/217.98  |- mesh__recordAuthorizer mesh__D004542 sjn
% 217.83/217.98  |- mesh__recordMaintainer mesh__D004542 lkt
% 217.83/217.98  |- mesh__recordOriginator mesh__D004542 NLM
% 217.83/217.98  |- skos__scopeNote mesh__D004542
% 217.83/217.98       The emission of SEMEN to the exterior, resulting from the contraction of muscles surrounding the male internal urogenital ducts.%A%    
% 217.83/217.98  |- mesh__dateCreated mesh__D004542 1999-01-01
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D004542 2006
% 217.83/217.98  |- skos__hiddenLabel mesh__D004542 Ejaculations
% 217.83/217.98  |- mesh__recordMaintainer mesh__D051198 DRC
% 217.83/217.98  |- skos__hiddenLabel mesh__D051198 Toll Like Receptor 5
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D051198 2006
% 217.83/217.98  |- mesh__recordOriginator mesh__D051198 DRC
% 217.83/217.98  |- mesh__historyNote mesh__D051198 2006%28%2005%29%   
% 217.83/217.98  |- mesh__publicMeSHNote mesh__D051198
% 217.83/217.98       2006; TOLL-LIKE RECEPTOR 5 was indexed under MEMBRANE GLYCOPROTEINS %26% RECEPTORS, CELL SURFACE 2005%A%  
% 217.83/217.98  |- mesh__dateEstablished mesh__D051198 2006-01-01
% 217.83/217.98  |- skos__prefLabel mesh__D051198 Toll-Like Receptor 5
% 217.83/217.98  |- rdf__type mesh__D051198sskos__Concept
% 217.83/217.98  |- skos__hiddenLabel mesh__D051198 Receptor, TLR5
% 217.83/217.98  |- mesh__recordAuthorizer mesh__D051198 sjn
% 217.83/217.98  |- skos__broader mesh__D051198smesh__D051193
% 217.83/217.98  |- mesh__dateCreated mesh__D051198 2005-06-30
% 217.83/217.98  |- skos__altLabel mesh__D051198 TLR5 Receptor
% 217.83/217.98  |- skos__scopeNote mesh__D051198
% 217.83/217.98       A pattern recognition receptor that binds FLAGELLIN. It mediates cellular responses to certain bacterial pathogens.%A%    
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D014970 2000
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D014970 2003
% 217.83/217.98  |- skos__scopeNote mesh__D014970
% 217.83/217.98       Purine bases found in body tissues and fluids and in some plants.%A%    
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D014970 2001
% 217.83/217.98  |- mesh__recordMaintainer mesh__D014970 adp
% 217.83/217.98  |- skos__broader mesh__D014970smesh__D011688
% 217.83/217.98  |- skos__annotation mesh__D014970
% 217.83/217.98       do not confuse with XANTHENES; XANTHINE is also available%A%  
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D014970 2004
% 217.83/217.98  |- mesh__dateCreated mesh__D014970 1999-01-01
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D014970 2002
% 217.83/217.98  |- rdf__type mesh__D014970sskos__Concept
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D014970 2005
% 217.83/217.98  |- mesh__recordOriginator mesh__D014970 NLM
% 217.83/217.98  |- mesh__recordAuthorizer mesh__D014970 sjn
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D014970 2006
% 217.83/217.98  |- skos__prefLabel mesh__D014970 Xanthines
% 217.83/217.98  |- mesh__dateRevised mesh__D014970 1999-11-03
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D036624 2006
% 217.83/217.98  |- mesh__dateCreated mesh__D036624 2002-07-03
% 217.83/217.98  |- skos__annotation mesh__D036624
% 217.83/217.98       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.83/217.98  |- skos__altLabel mesh__D036624 Golden Rod
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D036624 2005
% 217.83/217.98  |- rdf__type mesh__D036624sskos__Concept
% 217.83/217.98  |- mesh__publicMeSHNote mesh__D036624 2003   
% 217.83/217.98  |- skos__scopeNote mesh__D036624
% 217.83/217.98       A plant genus of the family ASTERACEAE known for allergenic pollen %28%ALLERGENS%29%.%A%    
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D036624 2004
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D036624 2003
% 217.83/217.98  |- skos__broader mesh__D036624smesh__D019659
% 217.83/217.98  |- mesh__historyNote mesh__D036624 2003   
% 217.83/217.98  |- skos__prefLabel mesh__D036624 Solidago
% 217.83/217.98  |- mesh__dateEstablished mesh__D036624 2003-01-01
% 217.83/217.98  |- skos__altLabel mesh__D036624 Goldenrod
% 217.83/217.98  |- skos__hiddenLabel mesh__D014172 Transilluminations
% 217.83/217.98  |- skos__hiddenLabel mesh__D014172 Diaphanographies
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D014172 2005
% 217.83/217.98  |- skos__annotation mesh__D014172
% 217.83/217.98       do not use /util except by MeSH definition   
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D014172 2006
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D014172 2000
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D014172 1998
% 217.83/217.98  |- skos__hiddenLabel mesh__D014172 Diaphanoscopies
% 217.83/217.98  |- mesh__recordAuthorizer mesh__D014172 SJN
% 217.83/217.98  |- skos__altLabel mesh__D014172 Diaphanoscopy
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D014172 2003
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D014172 1999
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D014172 2001
% 217.83/217.98  |- skos__prefLabel mesh__D014172 Transillumination
% 217.83/217.98  |- skos__broader mesh__D014172smesh__D003952
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D014172 2004
% 217.83/217.98  |- mesh__dateRevised mesh__D014172 1997-06-20
% 217.83/217.98  |- mesh__dateCreated mesh__D014172 1999-01-01
% 217.83/217.98  |- rdf__type mesh__D014172sskos__Concept
% 217.83/217.98  |- mesh__recordOriginator mesh__D014172 NLM
% 217.83/217.98  |- mesh__recordMaintainer mesh__D014172 PXP
% 217.83/217.98  |- skos__scopeNote mesh__D014172
% 217.83/217.98       Passage of light through body tissues or cavities for examination of internal structures.%A%    
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D014172 2002
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D008933 2002
% 217.83/217.98  |- rdf__type mesh__D008933sskos__Concept
% 217.83/217.98  |- mesh__publicMeSHNote mesh__D008933
% 217.83/217.98       76; was see under MITOCHONDRIA 1975   
% 217.83/217.98  |- mesh__recordAuthorizer mesh__D008933 PLS
% 217.83/217.98  |- mesh__recordMaintainer mesh__D008933 TAP
% 217.83/217.98  |- skos__hiddenLabel mesh__D008933 Swelling, Mitochondrial
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D008933 2001
% 217.83/217.98  |- skos__historyNote mesh__D008933 Mitochondria, Liver %28%1968%29%
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D008933 1997
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D008933 2004
% 217.83/217.98  |- skos__historyNote mesh__D008933 Mitochondria %28%1966-1968%29%
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D008933 2000
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D008933 1999
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D008933 2006
% 217.83/217.98  |- skos__scopeNote mesh__D008933
% 217.83/217.98       Increase in volume of mitochondria due to an influx of fluid; it occurs in hypotonic solutions due to osmotic pressure and in isotonic solutions as a result of altered permeability of the membranes of respiring mitochondria.%A%    
% 217.83/217.98  |- skos__hiddenLabel mesh__D008933 Swellings, Mitochondrial
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D008933 1993
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D008933 2003
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D008933 1996
% 217.83/217.98  |- mesh__historyNote mesh__D008933
% 217.83/217.98       76%28%69%29%; was see under MITOCHONDRIA 1975   
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D008933 1995
% 217.83/217.98  |- skos__broader mesh__D008933smesh__D002468
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D008933 1998
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D008933 2005
% 217.83/217.98  |- mesh__dateEstablished mesh__D008933 1976-01-01
% 217.83/217.98  |- skos__historyNote mesh__D008933 Mitochondria, Muscle %28%1968%29%
% 217.83/217.98  |- skos__prefLabel mesh__D008933 Mitochondrial Swelling
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D008933 1994
% 217.83/217.98  |- mesh__dateRevised mesh__D008933 1992-05-15
% 217.83/217.98  |- mesh__dateCreated mesh__D008933 1999-01-01
% 217.83/217.98  |- skos__hiddenLabel mesh__D008933 Mitochondrial Swellings
% 217.83/217.98  |- mesh__recordOriginator mesh__D008933 NLM
% 217.83/217.98  |- skos__prefLabel mesh__D000950 Antigens, Ly
% 217.83/217.98  |- mesh__recordAuthorizer mesh__D000950 sjn
% 217.83/217.98  |- skos__hiddenLabel mesh__D000950 Lyt 3 Antigen
% 217.83/217.98  |- mesh__publicMeSHNote mesh__D000950 82   
% 217.83/217.98  |- skos__hiddenLabel mesh__D000950 Antigen, Lyt-3.2
% 217.83/217.98  |- skos__hiddenLabel mesh__D000950 Lyt 2 Antigen
% 217.83/217.98  |- skos__hiddenLabel mesh__D000950 Ly 33
% 217.83/217.98  |- skos__hiddenLabel mesh__D000950 Antigen, Lyt-3
% 217.83/217.98  |- skos__scopeNote mesh__D000950
% 217.83/217.98       A group of lymphocyte surface antigens differentially located on subpopulations of mouse lymphocytes. This localization has been useful in distinguishing different functional subpopulations of lymphocytes. For example, cytotoxic T-cells bear primarily Lyt-23 on their surface and not Lyt-1, whereas helper cells bear Lyt-1 and not Lyt-23.%A%    
% 217.83/217.98  |- mesh__recordMaintainer mesh__D000950 ssb
% 217.83/217.98  |- skos__hiddenLabel mesh__D000950 Lyt 3.2 Antigen
% 217.83/217.98  |- skos__hiddenLabel mesh__D000950 Lyt 1.2 Antigen
% 217.83/217.98  |- skos__hiddenLabel mesh__D000950 Ly 6 Antigen
% 217.83/217.98  |- skos__hiddenLabel mesh__D000950 Antigen, Ly-5
% 217.83/217.98  |- rdf__type mesh__D000950sskos__Concept
% 217.83/217.98  |- skos__altLabel mesh__D000950 Lyt-1 Antigen
% 217.83/217.98  |- mesh__dateCreated mesh__D000950 1981-05-20
% 217.83/217.98  |- skos__altLabel mesh__D000950 Ly Antigens
% 217.83/217.98  |- mesh__dateEstablished mesh__D000950 1982-01-01
% 217.83/217.98  |- skos__hiddenLabel mesh__D000950 Antigen, Ly-6
% 217.83/217.98  |- skos__hiddenLabel mesh__D000950 Ly 27.2
% 217.83/217.98  |- skos__hiddenLabel mesh__D000950 Ly 5 Antigen
% 217.83/217.98  |- skos__altLabel mesh__D000950 Antigen, Lyt-1
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D000950 2006
% 217.83/217.98  |- skos__hiddenLabel mesh__D000950 Antigen, Lyt-1.2
% 217.83/217.98  |- mesh__dateRevised mesh__D000950 2005-06-30
% 217.83/217.98  |- skos__hiddenLabel mesh__D000950 Antigen, Lyt 1
% 217.83/217.98  |- skos__historyNote mesh__D000950 T Lymphocytes %28%1975-1981%29%
% 217.83/217.98  |- skos__historyNote mesh__D000950 Lymphocytes %28%1966-1981%29%
% 217.83/217.98  |- skos__hiddenLabel mesh__D000950 Ly 7 Antigen
% 217.83/217.98  |- skos__hiddenLabel mesh__D000950 Antigen, Lyt-2
% 217.83/217.98  |- skos__hiddenLabel mesh__D000950 Ly 2 Antigen
% 217.83/217.98  |- skos__hiddenLabel mesh__D000950 Antigen, Ly-7
% 217.83/217.98  |- skos__hiddenLabel mesh__D000950 Antigen, Ly-2
% 217.83/217.98  |- skos__broader mesh__D000950smesh__D000943
% 217.83/217.98  |- skos__hiddenLabel mesh__D000950 Ly 17
% 217.83/217.98  |- mesh__historyNote mesh__D000950 82   
% 217.83/217.98  |- mesh__recordOriginator mesh__D000950 SAG
% 217.83/217.98  |- mesh__publicMeSHNote mesh__D008135 68   
% 217.83/217.98  |- skos__altLabel mesh__D008135 LATS
% 217.83/217.98  |- skos__broader mesh__D008135smesh__D007074
% 217.83/217.98  |- mesh__recordAuthorizer mesh__D008135 sjn
% 217.83/217.98  |- mesh__recordMaintainer mesh__D008135 ssb
% 217.83/217.98  |- skos__hiddenLabel mesh__D008135 Long Acting Thyroid Stimulator
% 217.83/217.98  |- rdf__type mesh__D008135sskos__Concept
% 217.83/217.98  |- mesh__recordOriginator mesh__D008135 NLM
% 217.83/217.98  |- skos__scopeNote mesh__D008135
% 217.83/217.98       An immunoglobulin G, often found in the blood of hyperthyroid individuals. It stimulates the thyroid for a longer duration than does thyrotoxin and may cause hyperthyroidism in newborns due to placental transmission.%A%    
% 217.83/217.98  |- skos__related mesh__D008135smesh__D011988
% 217.83/217.98  |- skos__broader mesh__D008135smesh__D018828
% 217.83/217.98  |- mesh__historyNote mesh__D008135 68%28%65%29%   
% 217.83/217.98  |- skos__prefLabel mesh__D008135 Long-Acting Thyroid Stimulator
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D008135 2006
% 217.83/217.98  |- skos__hiddenLabel mesh__D008135 Thyroid Stimulator, Long Acting
% 217.83/217.98  |- mesh__dateRevised mesh__D008135 2005-06-30
% 217.83/217.98  |- mesh__dateEstablished mesh__D008135 1968-01-01
% 217.83/217.98  |- skos__hiddenLabel mesh__D008135 Stimulator, Long-Acting Thyroid
% 217.83/217.98  |- mesh__dateCreated mesh__D008135 1999-01-01
% 217.83/217.98  |- skos__altLabel mesh__D008135 Thyroid Stimulator, Long-Acting
% 217.83/217.98  |- rdf__type mesh__D000152sskos__Concept
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D000152 2002
% 217.83/217.98  |- mesh__publicMeSHNote mesh__D000152 93; was ACNE 1963-92   
% 217.83/217.98  |- mesh__dateCreated mesh__D000152 1999-01-01
% 217.83/217.98  |- mesh__recordAuthorizer mesh__D000152 sjn
% 217.83/217.98  |- skos__annotation mesh__D000152 an acneiform eruption   
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D000152 2003
% 217.83/217.98  |- mesh__onlineNote mesh__D000152
% 217.83/217.98       use ACNE VULGARIS to search ACNE 1966-92   
% 217.83/217.98  |- mesh__dateRevised mesh__D000152 2001-07-25
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D000152 2005
% 217.83/217.98  |- skos__broader mesh__D000152smesh__D012625
% 217.83/217.98  |- mesh__recordMaintainer mesh__D000152 lkt
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D000152 2004
% 217.83/217.98  |- skos__prefLabel mesh__D000152 Acne Vulgaris
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D000152 2006
% 217.83/217.98  |- mesh__historyNote mesh__D000152 93; was ACNE 1963-92   
% 217.83/217.98  |- skos__scopeNote mesh__D000152
% 217.83/217.98       A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones %28%blackheads%29%, closed comedones %28%whiteheads%29%, and pustular nodules. The cause is unknown, but heredity and age are predisposing factors.%A%    
% 217.83/217.98  |- skos__broader mesh__D000152smesh__D017486
% 217.83/217.98  |- mesh__recordOriginator mesh__D000152 NLM
% 217.83/217.98  |- skos__altLabel mesh__D000152 Acne
% 217.83/217.98  |- skos__broader mesh__D000433Q000031smesh__D000433
% 217.83/217.98  |- mesh__preferredCombination mesh__D000433Q000031smesh__D020005
% 217.83/217.98  |- rdf__type mesh__D000433Q000031smesh__CompoundConcept
% 217.83/217.98  |- skos__hiddenLabel mesh__D018563 Infectious Disease Reportings
% 217.83/217.98  |- mesh__dateEstablished mesh__D018563 1995-01-01
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D018563 2001
% 217.83/217.98  |- skos__altLabel mesh__D018563 Infectious Disease Reporting
% 217.83/217.98  |- skos__hiddenLabel mesh__D018563 Disease Reportings, Infectious
% 217.83/217.98  |- skos__hiddenLabel mesh__D018563 Notifications, Exposure
% 217.83/217.98  |- mesh__recordOriginator mesh__D018563 JLS
% 217.83/217.98  |- mesh__publicMeSHNote mesh__D018563 95   
% 217.83/217.98  |- mesh__historyNote mesh__D018563 95   
% 217.83/217.98  |- mesh__dateRevised mesh__D018563 1997-06-20
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D018563 2005
% 217.83/217.98  |- skos__related mesh__D018563smesh__D019221
% 217.83/217.98  |- skos__hiddenLabel mesh__D018563 Reporting, Infectious Disease
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D018563 2002
% 217.83/217.98  |- skos__hiddenLabel mesh__D018563 Notifications, Disease
% 217.83/217.98  |- skos__hiddenLabel mesh__D018563 Exposure Notifications
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D018563 2006
% 217.83/217.98  |- skos__hiddenLabel mesh__D018563 Notification, Exposure
% 217.83/217.98  |- skos__hiddenLabel mesh__D018563 Reportings, Infectious Disease
% 217.83/217.98  |- skos__altLabel mesh__D018563 Notification, Disease
% 217.83/217.98  |- mesh__recordAuthorizer mesh__D018563 SJN
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D018563 1998
% 217.83/217.98  |- skos__broader mesh__D018563smesh__D003140
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D018563 2003
% 217.83/217.98  |- skos__hiddenLabel mesh__D018563 Disease Notifications
% 217.83/217.98  |- skos__broader mesh__D018563smesh__D004812
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D018563 2000
% 217.83/217.98  |- mesh__recordMaintainer mesh__D018563 TGC
% 217.83/217.98  |- skos__hiddenLabel mesh__D018563 Disease Reporting, Infectious
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D018563 1999
% 217.83/217.98  |- mesh__dateCreated mesh__D018563 1994-04-19
% 217.83/217.98  |- skos__prefLabel mesh__D018563 Disease Notification
% 217.83/217.98  |- skos__historyNote mesh__D018563
% 217.83/217.98       Communicable Disease Control %28%1966-1994%29%
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D018563 2004
% 217.83/217.98  |- skos__scopeNote mesh__D018563
% 217.83/217.98       Notification or reporting by a physician or other health care provider of the occurrence of specified contagious diseases such as tuberculosis and HIV infections to designated public health agencies. The United States system of reporting notifiable diseases evolved from the Quarantine Act of 1878, which authorized the US Public Health Service to collect morbidity data on cholera, smallpox, and yellow fever; each state in the US has its own list of notifiable diseases and depends largely on reporting by the individual health care provider. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 217.83/217.98  |- rdf__type mesh__D018563sskos__Concept
% 217.83/217.98  |- skos__annotation mesh__D018563
% 217.83/217.98       for reporting occur of contagious dis: do not confuse with MANDATORY REPORTING, reporting of %22%suspected incidence of abuse %26% neglect%22%; IM GEN only; NIM with specific dis IM; DF: DIS NOTIF%A%  
% 217.83/217.98  |- skos__hiddenLabel mesh__D010580 Polyps-and-Spots Syndromes
% 217.83/217.98  |- skos__hiddenLabel mesh__D010580 Polyps and Spots Syndrome
% 217.83/217.98  |- skos__hiddenLabel mesh__D010580 Syndrome, Peutz-Jeghers
% 217.83/217.98  |- skos__hiddenLabel mesh__D010580 Intestinal Polyposes, Hamartomatous
% 217.83/217.98  |- skos__hiddenLabel mesh__D010580 Intestinal Polyposis, Hamartomatous
% 217.83/217.98  |- mesh__historyNote mesh__D010580
% 217.83/217.98       65; was see under POLYPI %28%now POLYPS%29% 1963-64   
% 217.83/217.98  |- mesh__dateCreated mesh__D010580 1999-01-01
% 217.83/217.98  |- skos__hiddenLabel mesh__D010580 Perioral Lentiginoses
% 217.83/217.98  |- skos__hiddenLabel mesh__D010580 Syndromes, Polyps-and-Spots
% 217.83/217.98  |- rdf__type mesh__D010580sskos__Concept
% 217.83/217.98  |- skos__hiddenLabel mesh__D010580 Hamartomatous Intestinal Polyposes
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D010580 2004
% 217.83/217.98  |- mesh__dateRevised mesh__D010580 2003-07-09
% 217.83/217.98  |- skos__hiddenLabel mesh__D010580 Perioral Lentiginosis
% 217.83/217.98  |- skos__broader mesh__D010580smesh__D044483
% 217.83/217.98  |- skos__hiddenLabel mesh__D010580 Peutz Jeghers Syndrome
% 217.83/217.98  |- skos__hiddenLabel mesh__D010580 Hamartomatous Intestinal Polyposis
% 217.83/217.98  |- skos__hiddenLabel mesh__D010580 Syndrome, Peutz-Jegher%27%s
% 217.83/217.98  |- skos__altLabel mesh__D010580 Peutz-Jegher%27%s Syndrome
% 217.83/217.98  |- skos__hiddenLabel mesh__D010580 Polyposes, Hamartomatous Intestinal
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D010580 2005
% 217.83/217.98  |- mesh__dateEstablished mesh__D010580 1965-01-01
% 217.83/217.98  |- skos__hiddenLabel mesh__D010580 Peutz-Jegher Syndrome
% 217.83/217.98  |- skos__altLabel mesh__D010580 Lentiginosis, Perioral
% 217.83/217.98  |- mesh__publicMeSHNote mesh__D010580
% 217.83/217.98       65; was see under POLYPI %28%now POLYPS%29% 1963-64   
% 217.83/217.98  |- skos__altLabel mesh__D010580 Polyps-and-Spots Syndrome
% 217.83/217.98  |- skos__broader mesh__D010580smesh__D007911
% 217.83/217.98  |- mesh__recordAuthorizer mesh__D010580 sjn
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D010580 2006
% 217.83/217.98  |- skos__prefLabel mesh__D010580 Peutz-Jeghers Syndrome
% 217.83/217.98  |- skos__scopeNote mesh__D010580
% 217.83/217.98       A hereditary disease caused by autosomal dominant mutations involving CHROMOSOME 19. It is characterized by the presence of INTESTINAL POLYPS, consistently in the JEJUNUM, and mucocutaneous pigmentation with MELANIN spots of the lips, buccal MUCOSA, and digits.%A%    
% 217.83/217.98  |- skos__hiddenLabel mesh__D010580 Lentiginoses, Perioral
% 217.83/217.98  |- skos__hiddenLabel mesh__D010580 Syndrome, Polyps-and-Spots
% 217.83/217.98  |- mesh__recordOriginator mesh__D010580 NLM
% 217.83/217.98  |- skos__altLabel mesh__D010580 Polyposis, Hamartomatous Intestinal
% 217.83/217.98  |- mesh__recordMaintainer mesh__D010580 lkt
% 217.83/217.98  |- skos__broader mesh__D010580smesh__D009386
% 217.83/217.98  |- skos__hiddenLabel mesh__D010580 Peutz Jegher%27%s Syndrome
% 217.83/217.98  |- skos__altLabel mesh__D051997 CD38 Antigens
% 217.83/217.98  |- skos__altLabel mesh__D051997
% 217.83/217.98       Acute Lymphoblastic Leukemia Cells Antigen CD38
% 217.83/217.98  |- skos__altLabel mesh__D051997 ADPR Cyclase CD38
% 217.83/217.98  |- skos__hiddenLabel mesh__D051997 Antigen, T10
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D051997 2006
% 217.83/217.98  |- skos__altLabel mesh__D051997 NIM-R5 Antigen
% 217.83/217.98  |- mesh__dateEstablished mesh__D051997 2006-01-01
% 217.83/217.98  |- rdf__type mesh__D051997sskos__Concept
% 217.83/217.98  |- skos__altLabel mesh__D051997 Lymphocyte Differentiation Antigen CD38
% 217.83/217.98  |- skos__prefLabel mesh__D051997 Antigens, CD38
% 217.83/217.98  |- mesh__publicMeSHNote mesh__D051997
% 217.83/217.98       2006; ANTIGENS, CD38 was indexed under ANTIGENS, CD %26% ADP-RIBOSYL CYCLASE 2003-2005, %26% under NAD+ NUCLEOSIDASE 1998-2002, %26% under ANTIGENS, DIFFERENTIATION 1988-2002, %26% under NUCLEOSIDASES 1988-1997%A%  
% 217.83/217.98  |- skos__altLabel mesh__D051997 CD38 Antigen
% 217.83/217.98  |- skos__hiddenLabel mesh__D051997 Cyclase CD38, ADPR
% 217.83/217.98  |- skos__altLabel mesh__D051997 ADPR Cyclase T10
% 217.83/217.98  |- skos__broader mesh__D051997smesh__D015703
% 217.83/217.98  |- mesh__dateCreated mesh__D051997 2005-06-30
% 217.83/217.98  |- skos__hiddenLabel mesh__D051997 CD38, ADPR Cyclase
% 217.83/217.98  |- mesh__historyNote mesh__D051997 2006%28%1988%29%   
% 217.83/217.98  |- mesh__recordOriginator mesh__D051997 AKE
% 217.83/217.98  |- mesh__recordMaintainer mesh__D051997 AKE
% 217.83/217.98  |- mesh__recordAuthorizer mesh__D051997 sjn
% 217.83/217.98  |- skos__broader mesh__D051997smesh__D036541
% 217.83/217.98  |- skos__hiddenLabel mesh__D051997 Cyclase T10, ADPR
% 217.83/217.98  |- skos__altLabel mesh__D051997 T10 Antigen
% 217.83/217.98  |- skos__hiddenLabel mesh__D051997 NIM R5 Antigen
% 217.83/217.98  |- skos__scopeNote mesh__D051997
% 217.83/217.98       A bifunctional enzyme that catalyzes the synthesis and HYDROLYSIS of CYCLIC ADP-RIBOSE %28%cADPR%29% from NAD+ to ADP-RIBOSE. It is a cell surface molecule which is predominantly expressed on LYMPHOID CELLS and MYELOID CELLS.%A%    
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D004543 1993
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D004543 1991
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D004543 1995
% 217.83/217.98  |- rdf__type mesh__D004543sskos__Concept
% 217.83/217.98  |- skos__hiddenLabel mesh__D004543 Ducts, Ejaculatory
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D004543 2000
% 217.83/217.98  |- skos__hiddenLabel mesh__D004543 Duct, Ejaculatory
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D004543 1989
% 217.83/217.98  |- skos__prefLabel mesh__D004543 Ejaculatory Ducts
% 217.83/217.98  |- mesh__dateCreated mesh__D004543 1999-01-01
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D004543 2001
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D004543 2003
% 217.83/217.98  |- skos__hiddenLabel mesh__D004543 Ejaculatory Duct
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D004543 2005
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D004543 1990
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D004543 1996
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D004543 2004
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D004543 2002
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D004543 1998
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D004543 2006
% 217.83/217.98  |- skos__broader mesh__D004543smesh__D005837
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D004543 1992
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D004543 1997
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D004543 1994
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D004543 1999
% 217.83/217.98  |- skos__broader mesh__D051199smesh__D051193
% 217.83/217.98  |- mesh__dateCreated mesh__D051199 2005-06-30
% 217.83/217.98  |- mesh__recordMaintainer mesh__D051199 DRC
% 217.83/217.98  |- skos__altLabel mesh__D051199 TLR7 Receptor
% 217.83/217.98  |- mesh__historyNote mesh__D051199 2006%28%2005%29%   
% 217.83/217.98  |- mesh__publicMeSHNote mesh__D051199
% 217.83/217.98       2006; TOLL-LIKE RECEPTOR 7 was indexed under MEMBRANE GLYCOPROTEINS %26% RECEPTORS, CELL SURFACE 2005%A%  
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D051199 2006
% 217.83/217.98  |- skos__prefLabel mesh__D051199 Toll-Like Receptor 7
% 217.83/217.98  |- skos__hiddenLabel mesh__D051199 Toll Like Receptor 7
% 217.83/217.98  |- skos__scopeNote mesh__D051199
% 217.83/217.98       A pattern recognition receptor that binds several forms of imidazo-quinoline including the antiviral compound Imiquimod.%A%    
% 217.83/217.98  |- mesh__recordOriginator mesh__D051199 DRC
% 217.83/217.98  |- rdf__type mesh__D051199sskos__Concept
% 217.83/217.98  |- mesh__dateEstablished mesh__D051199 2006-01-01
% 217.83/217.98  |- mesh__recordAuthorizer mesh__D051199 sjn
% 217.83/217.98  |- skos__hiddenLabel mesh__D051199 Receptor, TLR7
% 217.83/217.98  |- skos__altLabel mesh__D042662
% 217.83/217.98       Endocrine-Gland-Derived Vascular Endothelial Growth Factor
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D042662 2006
% 217.83/217.98  |- mesh__recordAuthorizer mesh__D042662 sjn
% 217.83/217.98  |- mesh__recordOriginator mesh__D042662 jmp
% 217.83/217.98  |- mesh__dateEstablished mesh__D042662 2004-01-01
% 217.83/217.98  |- mesh__dateCreated mesh__D042662 2003-07-09
% 217.83/217.98  |- mesh__dateRevised mesh__D042662 2005-06-30
% 217.83/217.98  |- skos__altLabel mesh__D042662 EG-VEGF
% 217.83/217.98  |- mesh__historyNote mesh__D042662
% 217.83/217.98       2004; use VASCULAR ENDOTHELIAL GROWTH FACTOR, ENDOCRINE-GLAND-DERIVED %28%NM%29% 2001-2002%A%  
% 217.83/217.98  |- skos__historyNote mesh__D042662 Mitogens %28%2001-2002%29%
% 217.83/217.98  |- mesh__recordMaintainer mesh__D042662 ssb
% 217.83/217.98  |- skos__scopeNote mesh__D042662
% 217.83/217.98       A vascular endothelial growth factor whose expression is found largely restricted to the GONADS; ADRENAL CORTEX; and PLACENTA. It has similar biological activity to VASCULAR ENDOTHELIAL GROWTH FACTOR-A.%A%    
% 217.83/217.98  |- skos__historyNote mesh__D042662 Gastrointestinal Hormones %28%2003%29%
% 217.83/217.98  |- mesh__publicMeSHNote mesh__D042662
% 217.83/217.98       2004; ENDOCRINE-GLAND-DERIVED ENDOTHELIAL GROWTH FACTOR %28%now VASCULAR ENDOTHELIAL GROWTH FACTOR, ENDOCRINE-GLAND-DERIVED%29% was indexed under ANGIOGENESIS FACTOR %26% GASTROINTESTINAL HORMONES %28%2003%29%, under MITOGENS 2001-2002%A%  
% 217.83/217.98  |- rdf__type mesh__D042662sskos__Concept
% 217.83/217.98  |- skos__hiddenLabel mesh__D042662
% 217.83/217.98       Vascular Endothelial Growth Factor, Endocrine Gland Derived
% 217.83/217.98  |- skos__hiddenLabel mesh__D042662
% 217.83/217.98       Endocrine Gland Derived Vascular Endothelial Growth Factor
% 217.83/217.98  |- skos__prefLabel mesh__D042662
% 217.83/217.98       Vascular Endothelial Growth Factor, Endocrine-Gland-Derived
% 217.83/217.98  |- skos__historyNote mesh__D042662 Angiogenesis Factor %28%2003%29%
% 217.83/217.98  |- skos__broader mesh__D042662smesh__D042442
% 217.83/217.98  |- skos__altLabel mesh__D042662 Prokineticin 1
% 217.83/217.98  |- mesh__recordOriginator mesh__D014971 NLM
% 217.83/217.98  |- skos__historyNote mesh__D014971 Amino Alcohols %28%1974%29%
% 217.83/217.98  |- skos__altLabel mesh__D014971 ratiopharm Brand of Xanthinol Niacinate
% 217.83/217.98  |- skos__scopeNote mesh__D014971
% 217.83/217.98       A vasodilator used in peripheral vascular disorders and insufficiency. It may cause gastric discomfort and hypotension.%A%    
% 217.83/217.98  |- skos__historyNote mesh__D014971 Nicotinic Acid %28%1969-1974%29%
% 217.83/217.98  |- mesh__dateCreated mesh__D014971 1974-11-19
% 217.83/217.98  |- skos__altLabel mesh__D014971 Sadamine
% 217.83/217.98  |- skos__broader mesh__D014971smesh__D013806
% 217.83/217.98  |- rdf__type mesh__D014971sskos__Concept
% 217.83/217.98  |- skos__hiddenLabel mesh__D014971 Niacinate, Xanthinol
% 217.83/217.98  |- skos__altLabel mesh__D014971 Riemser Brand of Xanthinol Niacinate
% 217.83/217.98  |- skos__altLabel mesh__D014971 Complamine
% 217.83/217.98  |- mesh__publicMeSHNote mesh__D014971
% 217.83/217.98       91; was see under THEOPHYLLINE 1975-90   
% 217.83/217.98  |- skos__hiddenLabel mesh__D014971 Nicotinate, Xanthinol
% 217.83/217.98  |- skos__altLabel mesh__D014971 Xanthinol Nicotinate
% 217.83/217.98  |- mesh__recordMaintainer mesh__D014971 lkw
% 217.83/217.98  |- mesh__dateRevised mesh__D014971 2005-06-30
% 217.83/217.98  |- skos__broader mesh__D014971smesh__D009539
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D014971 2006
% 217.83/217.98  |- mesh__historyNote mesh__D014971
% 217.83/217.98       91%28%75%29%; was see under THEOPHYLLINE 1975-90   
% 217.83/217.98  |- skos__historyNote mesh__D014971 Theophylline %28%1969-1974%29%
% 217.83/217.98  |- skos__altLabel mesh__D014971 Xantinol Nicotinate
% 217.83/217.98  |- skos__altLabel mesh__D014971
% 217.83/217.98       SmithKline Beecham Brand of Xanthinol Niacinate
% 217.83/217.98  |- skos__hiddenLabel mesh__D014971 Nicotinate, Xantinol
% 217.83/217.98  |- mesh__dateEstablished mesh__D014971 1991-01-01
% 217.83/217.98  |- mesh__recordAuthorizer mesh__D014971 sjn
% 217.83/217.98  |- skos__prefLabel mesh__D014971 Xanthinol Niacinate
% 217.83/217.98  |- skos__altLabel mesh__D014971 Komplamin
% 217.83/217.98  |- mesh__recordOriginator mesh__D036625 ssb
% 217.83/217.98  |- mesh__activeMeSHYear mesh__D036625 2005
% 217.83/217.98  |- skos__prefLabel mesh__D036625 Stevia
% 217.83/217.98  |- rdf__type mesh__D036625sskos__Concept
% 217.83/217.98  |- mesh__publicMeSHNote mesh__D036625 2003   
% 217.83/217.98  |- mesh__dateRevised mesh__D036625 2004-07-07
% 217.83/217.98  |- mesh__dateCreated mesh__D036625 2002-07-03
% 217.83/217.98  |- mesh__recordAuthorizer mesh__D036625 sjn
% 217.83/217.98  |- skos__altLabel mesh__D036625 Eupatorium rebaudianum
% 217.83/217.98  |- skos__broader mesh__D036625smesh__D019659
% 217.83/217.98  |- skos__altLabel mesh__D036625 Sweetleaf
% 217.83/217.98  |- skos__scopeNote mesh__D036625
% 217.83/217.98       A plant genus of the family ASTERACEAE. Members contain stevioside and other sweet diterpene glycosides. The leaf is used for sweetening %28%SWEETENING AGENTS%29%.%A%    
% 217.83/217.99  |- mesh__recordMaintainer mesh__D036625 ssb
% 217.84/217.99  |- mesh__historyNote mesh__D036625 2003   
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D036625 2006
% 217.84/217.99  |- mesh__dateEstablished mesh__D036625 2003-01-01
% 217.84/217.99  |- skos__annotation mesh__D036625
% 217.84/217.99       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014173 1991
% 217.84/217.99  |- mesh__recordOriginator mesh__D014173 NLM
% 217.84/217.99  |- skos__broader mesh__D014173smesh__D012666
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014173 1992
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014173 2006
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014173 1998
% 217.84/217.99  |- mesh__onlineNote mesh__D014173 search SEMICONDUCTORS 1973-74   
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014173 2002
% 217.84/217.99  |- skos__hiddenLabel mesh__D014173 Transistor
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014173 1993
% 217.84/217.99  |- skos__annotation mesh__D014173
% 217.84/217.99       NIM; do not use /util except by MeSH definition   
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014173 2003
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014173 1999
% 217.84/217.99  |- mesh__dateRevised mesh__D014173 1990-04-13
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014173 2004
% 217.84/217.99  |- mesh__historyNote mesh__D014173
% 217.84/217.99       91%28%75%29%; was see under SEMICONDUCTORS 1975-90; was in Cat H %26% J 1975-82%A%  
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014173 1996
% 217.84/217.99  |- mesh__dateCreated mesh__D014173 1999-01-01
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014173 2000
% 217.84/217.99  |- rdf__type mesh__D014173sskos__Concept
% 217.84/217.99  |- mesh__recordAuthorizer mesh__D014173 PLS
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014173 1997
% 217.84/217.99  |- mesh__dateEstablished mesh__D014173 1991-01-01
% 217.84/217.99  |- skos__prefLabel mesh__D014173 Transistors
% 217.84/217.99  |- mesh__recordMaintainer mesh__D014173 NLM
% 217.84/217.99  |- mesh__publicMeSHNote mesh__D014173
% 217.84/217.99       91; was see under SEMICONDUCTORS 1975-90; was in Cat H %26% J 1975-82%A%  
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014173 2001
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014173 1994
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014173 2005
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014173 1995
% 217.84/217.99  |- mesh__recordMaintainer mesh__D008934 ssb
% 217.84/217.99  |- skos__historyNote mesh__D008934 Mitosis/drug effects %28%1966-1971%29%
% 217.84/217.99  |- mesh__recordOriginator mesh__D008934 NLM
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D008934 2006
% 217.84/217.99  |- mesh__dateEstablished mesh__D008934 1973-01-01
% 217.84/217.99  |- mesh__dateRevised mesh__D008934 2005-06-30
% 217.84/217.99  |- mesh__dateCreated mesh__D008934 1999-01-01
% 217.84/217.99  |- skos__scopeNote mesh__D008934
% 217.84/217.99       Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci %28%associated with streptolysin S%29% and from strains of alpha-toxin-producing staphylococci. %28%Stedman, 25th ed%29%%A%    
% 217.84/217.99  |- skos__broader mesh__D008934smesh__D050258
% 217.84/217.99  |- rdf__type mesh__D008934sskos__Concept
% 217.84/217.99  |- skos__related mesh__D008934smesh__D011975
% 217.84/217.99  |- mesh__historyNote mesh__D008934
% 217.84/217.99       1973%28%1972%29%; for PHYTOMITOGENS use PLANT LECTINS 1978-2002%A%  
% 217.84/217.99  |- mesh__publicMeSHNote mesh__D008934
% 217.84/217.99       1973; for PHYTOMITOGENS see PLANT LECTINS 1978-2002   
% 217.84/217.99  |- skos__prefLabel mesh__D008934 Mitogens
% 217.84/217.99  |- mesh__recordAuthorizer mesh__D008934 sjn
% 217.84/217.99  |- rdf__type mesh__D000951sskos__Concept
% 217.84/217.99  |- mesh__recordAuthorizer mesh__D000951 sjn
% 217.84/217.99  |- skos__annotation mesh__D000951
% 217.84/217.99       coord IM with required neopl coords with /immunol %28%IM%29%; Manual 24.4.4.1+%A%  
% 217.84/217.99  |- skos__broader mesh__D000951smesh__D000941
% 217.84/217.99  |- skos__hiddenLabel mesh__D000951 Antigens, Tumor
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D000951 2006
% 217.84/217.99  |- mesh__publicMeSHNote mesh__D000951 73   
% 217.84/217.99  |- skos__historyNote mesh__D000951 Neoplasms/immunology %28%1966-1972%29%
% 217.84/217.99  |- mesh__recordMaintainer mesh__D000951 ssb
% 217.84/217.99  |- mesh__dateEstablished mesh__D000951 1973-01-01
% 217.84/217.99  |- mesh__historyNote mesh__D000951 73   
% 217.84/217.99  |- skos__prefLabel mesh__D000951 Antigens, Neoplasm
% 217.84/217.99  |- mesh__dateCreated mesh__D000951 1999-01-01
% 217.84/217.99  |- skos__historyNote mesh__D000951 Antigens %28%1966-1972%29%
% 217.84/217.99  |- mesh__dateRevised mesh__D000951 2005-06-30
% 217.84/217.99  |- skos__altLabel mesh__D000951 Neoplasm Antigens
% 217.84/217.99  |- skos__scopeNote mesh__D000951
% 217.84/217.99       Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.%A%    
% 217.84/217.99  |- skos__historyNote mesh__D000951
% 217.84/217.99       specific neoplasm/immunology %28%1966-1972%29%
% 217.84/217.99  |- mesh__recordOriginator mesh__D000951 NLM
% 217.84/217.99  |- mesh__dateRevised mesh__D008136 2004-07-07
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D008136 2005
% 217.84/217.99  |- rdf__type mesh__D008136sskos__Concept
% 217.84/217.99  |- skos__broader mesh__D008136smesh__D000375
% 217.84/217.99  |- mesh__recordMaintainer mesh__D008136 nns
% 217.84/217.99  |- skos__prefLabel mesh__D008136 Longevity
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D008136 2006
% 217.84/217.99  |- mesh__recordAuthorizer mesh__D008136 sjn
% 217.84/217.99  |- mesh__recordOriginator mesh__D008136 NLM
% 217.84/217.99  |- skos__related mesh__D008136smesh__D000369
% 217.84/217.99  |- skos__altLabel mesh__D008136 Length of Life
% 217.84/217.99  |- mesh__dateCreated mesh__D008136 1999-01-01
% 217.84/217.99  |- skos__related mesh__D008136smesh__D000368
% 217.84/217.99  |- skos__related mesh__D008136smesh__D008017
% 217.84/217.99  |- skos__annotation mesh__D008136
% 217.84/217.99       human %26% animal; consider also LIFE EXPECTANCY   
% 217.84/217.99  |- skos__hiddenLabel mesh__D000153 Acne Keloids
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D000153 2003
% 217.84/217.99  |- skos__broader mesh__D000153smesh__D007627
% 217.84/217.99  |- skos__scopeNote mesh__D000153
% 217.84/217.99       A type of acneiform disorder in which secondary pyogenic infection in and around pilosebaceous structures ends in keloidal scarring. It manifests as persistent folliculitis of the back of the neck associated with occlusion of the follicular orifices. It is most often encountered in black or Asian men.%A%    
% 217.84/217.99  |- skos__hiddenLabel mesh__D000153 Acne, Keloidal
% 217.84/217.99  |- skos__altLabel mesh__D000153 Acne Keloidalis
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D000153 2005
% 217.84/217.99  |- skos__prefLabel mesh__D000153 Acne Keloid
% 217.84/217.99  |- mesh__onlineNote mesh__D000153 search FOLLICULITIS 1966-74   
% 217.84/217.99  |- mesh__historyNote mesh__D000153
% 217.84/217.99       91%28%75%29%; was see under FOLLICULITIS 1975-90   
% 217.84/217.99  |- skos__annotation mesh__D000153
% 217.84/217.99       acneiform eruption with keloid scarring   
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D000153 2004
% 217.84/217.99  |- mesh__recordOriginator mesh__D000153 NLM
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D000153 2006
% 217.84/217.99  |- skos__broader mesh__D000153smesh__D005499
% 217.84/217.99  |- skos__broader mesh__D000153smesh__D017486
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D000153 2002
% 217.84/217.99  |- skos__altLabel mesh__D000153 Keloidal Acne
% 217.84/217.99  |- mesh__dateEstablished mesh__D000153 1991-01-01
% 217.84/217.99  |- mesh__recordAuthorizer mesh__D000153 sjn
% 217.84/217.99  |- rdf__type mesh__D000153sskos__Concept
% 217.84/217.99  |- skos__hiddenLabel mesh__D000153 Keloids, Acne
% 217.84/217.99  |- mesh__publicMeSHNote mesh__D000153
% 217.84/217.99       91; was see under FOLLICULITIS 1975-90   
% 217.84/217.99  |- skos__altLabel mesh__D000153 Folliculitis Keloidalis
% 217.84/217.99  |- skos__hiddenLabel mesh__D000153 Keloid, Acne
% 217.84/217.99  |- mesh__recordMaintainer mesh__D000153 lkt
% 217.84/217.99  |- skos__hiddenLabel mesh__D000153 Keloidal Acnes
% 217.84/217.99  |- mesh__dateRevised mesh__D000153 2001-07-25
% 217.84/217.99  |- mesh__dateCreated mesh__D000153 1999-01-01
% 217.84/217.99  |- mesh__recordAuthorizer mesh__D013879 sjn
% 217.84/217.99  |- skos__historyNote mesh__D013879 Bacterial Proteins %28%1968-1974%29%
% 217.84/217.99  |- skos__annotation mesh__D013879
% 217.84/217.99       a protein; /drug eff /ultrastruct permitted   
% 217.84/217.99  |- skos__prefLabel mesh__D013879 Thioredoxin
% 217.84/217.99  |- mesh__recordOriginator mesh__D013879 NLM
% 217.84/217.99  |- skos__broader mesh__D013879smesh__D011506
% 217.84/217.99  |- mesh__historyNote mesh__D013879
% 217.84/217.99       91%28%75%29%; was see under BACTERIAL PROTEINS 1975-90   
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D013879 2006
% 217.84/217.99  |- rdf__type mesh__D013879sskos__Concept
% 217.84/217.99  |- skos__scopeNote mesh__D013879
% 217.84/217.99       A hydrogen-carrying protein that participates in a variety of biochemical reactions including ribonucleotide reduction. Thioredoxin is oxidized from a dithiol to a disulfide during ribonucleotide reduction. The disulfide form is then reduced by NADPH in a reaction catalyzed by THIOREDOXIN REDUCTASE.%A%    
% 217.84/217.99  |- mesh__publicMeSHNote mesh__D013879
% 217.84/217.99       91; was see under BACTERIAL PROTEINS 1975-90   
% 217.84/217.99  |- mesh__dateRevised mesh__D013879 2005-06-30
% 217.84/217.99  |- mesh__recordMaintainer mesh__D013879 SYSTEM
% 217.84/217.99  |- mesh__dateEstablished mesh__D013879 1991-01-01
% 217.84/217.99  |- mesh__dateCreated mesh__D013879 1974-11-19
% 217.84/217.99  |- mesh__dateCreated mesh__D010581 1999-01-01
% 217.84/217.99  |- mesh__recordOriginator mesh__D010581 NLM
% 217.84/217.99  |- skos__scopeNote mesh__D010581
% 217.84/217.99       Lymphoid tissue on the mucosa of the small intestine.     
% 217.84/217.99  |- skos__annotation mesh__D010581
% 217.84/217.99       an area of lymphoid tissue on small intestine mucosa   
% 217.84/217.99  |- skos__hiddenLabel mesh__D010581 Peyers Patches
% 217.84/217.99  |- rdf__type mesh__D010581sskos__Concept
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D010581 2004
% 217.84/217.99  |- mesh__dateRevised mesh__D010581 2003-07-09
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D010581 2005
% 217.84/217.99  |- skos__prefLabel mesh__D010581 Peyer%27%s Patches
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D010581 2006
% 217.84/217.99  |- skos__broader mesh__D010581smesh__D008221
% 217.84/217.99  |- skos__historyNote mesh__D010581 Lymphoid Tissue %28%1966-1971%29%
% 217.84/217.99  |- mesh__recordMaintainer mesh__D010581 jmp
% 217.84/217.99  |- mesh__dateEstablished mesh__D010581 1985-01-01
% 217.84/217.99  |- skos__hiddenLabel mesh__D010581 Patches, Peyer%27%s
% 217.84/217.99  |- mesh__publicMeSHNote mesh__D010581
% 217.84/217.99       85; was see under LYMPHOID TISSUE 1975-84   
% 217.84/217.99  |- skos__hiddenLabel mesh__D010581 Peyer Patches
% 217.84/217.99  |- mesh__recordAuthorizer mesh__D010581 sjn
% 217.84/217.99  |- mesh__historyNote mesh__D010581
% 217.84/217.99       85%28%72%29%; was see under LYMPHOID TISSUE 1975-84   
% 217.84/217.99  |- mesh__dateCreated mesh__D004544 1999-01-01
% 217.84/217.99  |- mesh__recordMaintainer mesh__D004544 PLS
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D004544 1991
% 217.84/217.99  |- mesh__recordOriginator mesh__D004544 NLM
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D004544 2003
% 217.84/217.99  |- mesh__dateRevised mesh__D004544 1991-11-07
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D004544 2000
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D004544 2005
% 217.84/217.99  |- mesh__recordAuthorizer mesh__D004544 PLS
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D004544 1989
% 217.84/217.99  |- skos__broader mesh__D004544smesh__D002489
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D004544 1996
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D004544 2004
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D004544 2001
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D004544 1998
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D004544 2006
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D004544 1992
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D004544 1997
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D004544 1994
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D004544 1999
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D004544 1993
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D004544 1990
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D004544 1995
% 217.84/217.99  |- skos__prefLabel mesh__D004544 El Salvador
% 217.84/217.99  |- rdf__type mesh__D004544sskos__Concept
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D004544 2002
% 217.84/217.99  |- skos__broader mesh__D003553Q000652smesh__D003553
% 217.84/217.99  |- mesh__preferredCombination mesh__D003553Q000652smesh__D003555
% 217.84/217.99  |- rdf__type mesh__D003553Q000652smesh__CompoundConcept
% 217.84/217.99  |- skos__scopeNote mesh__D014972
% 217.84/217.99       Benign disorder of infants and children characterized by multiple nodules with lipid-laden, non-Langerhans-cell histiocytes.%A%    
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014972 2005
% 217.84/217.99  |- mesh__historyNote mesh__D014972
% 217.84/217.99       92; was XANTHOMA, JUVENILE 1963-91 %28%Prov 1963-66%29%; XANTHOGRANULOMA, JUVENILE was see XANTHOMA, JUVENILE 1979-91%A%  
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014972 2002
% 217.84/217.99  |- skos__hiddenLabel mesh__D014972 Juvenile Xanthoma
% 217.84/217.99  |- skos__hiddenLabel mesh__D014972 Xanthomas, Juvenile
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014972 2006
% 217.84/217.99  |- mesh__dateEstablished mesh__D014972 1967-01-01
% 217.84/217.99  |- mesh__recordAuthorizer mesh__D014972 sjn
% 217.84/217.99  |- mesh__recordOriginator mesh__D014972 NLM
% 217.84/217.99  |- skos__hiddenLabel mesh__D014972 Xanthogranulomas, Juvenile
% 217.84/217.99  |- mesh__dateRevised mesh__D014972 2001-07-25
% 217.84/217.99  |- skos__broader mesh__D014972smesh__D015616
% 217.84/217.99  |- mesh__onlineNote mesh__D014972
% 217.84/217.99       use XANTHOGRANULOMA, JUVENILE to search XANTHOMA, JUVENILE 1966-91%A%  
% 217.84/217.99  |- skos__altLabel mesh__D014972 Xanthoma, Juvenile
% 217.84/217.99  |- skos__hiddenLabel mesh__D014972 Juvenile Xanthomas
% 217.84/217.99  |- skos__altLabel mesh__D014972 Nevoxanthoendothelioma
% 217.84/217.99  |- skos__annotation mesh__D014972
% 217.84/217.99       non-neoplastic; a non-Langerhans cell histiocytosis   
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014972 2003
% 217.84/217.99  |- skos__hiddenLabel mesh__D014972 Nevoxanthoendotheliomas
% 217.84/217.99  |- skos__hiddenLabel mesh__D014972 Juvenile Xanthogranulomas
% 217.84/217.99  |- mesh__recordMaintainer mesh__D014972 nns
% 217.84/217.99  |- skos__prefLabel mesh__D014972 Xanthogranuloma, Juvenile
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014972 2004
% 217.84/217.99  |- mesh__publicMeSHNote mesh__D014972
% 217.84/217.99       92; was XANTHOMA, JUVENILE 1967-91; XANTHOGRANULOMA, JUVENILE was see XANTHOMA, JUVENILE 1979-91%A%  
% 217.84/217.99  |- skos__hiddenLabel mesh__D014972 Juvenile Xanthogranuloma
% 217.84/217.99  |- skos__broader mesh__D014972smesh__D012875
% 217.84/217.99  |- mesh__dateCreated mesh__D014972 1999-01-01
% 217.84/217.99  |- rdf__type mesh__D014972sskos__Concept
% 217.84/217.99  |- mesh__recordAuthorizer mesh__D014174 sjn
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D014174 2006
% 217.84/217.99  |- skos__prefLabel mesh__D014174 Transketolase
% 217.84/217.99  |- skos__broader mesh__D014174smesh__D019880
% 217.84/217.99  |- mesh__historyNote mesh__D014174 73%28%72%29%   
% 217.84/217.99  |- mesh__recordMaintainer mesh__D014174 sjn
% 217.84/217.99  |- mesh__recordOriginator mesh__D014174 NLM
% 217.84/217.99  |- mesh__publicMeSHNote mesh__D014174 73   
% 217.84/217.99  |- skos__scopeNote mesh__D014174
% 217.84/217.99       An enzyme of the transferase class that catalyzes the conversion of sedoheptulose 7-phosphate and D-glyceraldehyde 3-phosphate to D-ribose 5-phosphate and D-xylulose 5-phosphate in the PENTOSE PHOSPHATE PATHWAY. %28%Dorland, 27th ed%29% EC 2.2.1.1.%A%    
% 217.84/217.99  |- mesh__dateEstablished mesh__D014174 1973-01-01
% 217.84/217.99  |- skos__altLabel mesh__D014174 Glycolaldehydetransferase
% 217.84/217.99  |- skos__historyNote mesh__D014174 Transferases %28%1966-1971%29%
% 217.84/217.99  |- mesh__dateRevised mesh__D014174 2005-07-01
% 217.84/217.99  |- rdf__type mesh__D014174sskos__Concept
% 217.84/217.99  |- mesh__dateCreated mesh__D014174 1999-01-01
% 217.84/217.99  |- skos__altLabel mesh__D008935 MGBG
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D008935 2003
% 217.84/217.99  |- skos__hiddenLabel mesh__D008935 Methyl gag
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D008935 2005
% 217.84/217.99  |- skos__broader mesh__D008935smesh__D006146
% 217.84/217.99  |- skos__hiddenLabel mesh__D008935 NSC32946
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D008935 2004
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D008935 2002
% 217.84/217.99  |- skos__hiddenLabel mesh__D008935 NSC 32946
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D008935 2006
% 217.84/217.99  |- mesh__recordAuthorizer mesh__D008935 sjn
% 217.84/217.99  |- skos__altLabel mesh__D008935 Methylglyoxal Bis%28%guanylhydrazone%29%
% 217.84/217.99  |- skos__historyNote mesh__D008935 Amidines %28%1973-1974%29%
% 217.84/217.99  |- mesh__dateEstablished mesh__D008935 1986-01-01
% 217.84/217.99  |- skos__scopeNote mesh__D008935
% 217.84/217.99       Antineoplastic agent effective against myelogenous leukemia in experimental animals. Also acts as an inhibitor of animal S-adenosylmethionine decarboxylase.%A%    
% 217.84/217.99  |- mesh__recordOriginator mesh__D008935 NLM
% 217.84/217.99  |- skos__hiddenLabel mesh__D008935 Methylgag
% 217.84/217.99  |- mesh__historyNote mesh__D008935
% 217.84/217.99       86%28%75%29%; was see under GUANIDINES 1975-85   
% 217.84/217.99  |- skos__historyNote mesh__D008935 Glyoxal %28%1973-1974%29%
% 217.84/217.99  |- mesh__publicMeSHNote mesh__D008935
% 217.84/217.99       86; was see under GUANIDINES 1975-85   
% 217.84/217.99  |- mesh__dateCreated mesh__D008935 1974-11-19
% 217.84/217.99  |- rdf__type mesh__D008935sskos__Concept
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D008935 2001
% 217.84/217.99  |- skos__historyNote mesh__D008935 Hydrazones %28%1973-1974%29%
% 217.84/217.99  |- skos__prefLabel mesh__D008935 Mitoguazone
% 217.84/217.99  |- mesh__dateRevised mesh__D008935 2000-06-22
% 217.84/217.99  |- mesh__recordMaintainer mesh__D008935 CCR
% 217.84/217.99  |- skos__hiddenLabel mesh__D000952 T Proteins, Polyomavirus
% 217.84/217.99  |- skos__altLabel mesh__D000952 Polyomaviruses Small T Proteins
% 217.84/217.99  |- skos__hiddenLabel mesh__D000952 Antigens, SV40 T
% 217.84/217.99  |- skos__scopeNote mesh__D000952
% 217.84/217.99       Polyomavirus antigens which cause infection and cellular transformation. The large T antigen is necessary for the initiation of viral DNA synthesis, repression of transcription of the early region and is responsible in conjunction with the middle T antigen for the transformation of primary cells. Small T antigen is necessary for the completion of the productive infection cycle.%A%    
% 217.84/217.99  |- skos__annotation mesh__D000952
% 217.84/217.99       coord IM with specific polyoma virus /immunol %28%IM%29%; DF: PVTA%A%  
% 217.84/217.99  |- skos__hiddenLabel mesh__D000952 Proteins, SV40 T
% 217.84/217.99  |- skos__historyNote mesh__D000952 Antigens, Viral %28%1973-1983%29%
% 217.84/217.99  |- rdf__type mesh__D000952sskos__Concept
% 217.84/217.99  |- mesh__dateEstablished mesh__D000952 1988-01-01
% 217.84/217.99  |- skos__hiddenLabel mesh__D000952 T Antigens, SV40
% 217.84/217.99  |- mesh__dateRevised mesh__D000952 2005-06-30
% 217.84/217.99  |- skos__hiddenLabel mesh__D000952 Tumor Antigens, Polyomavirus
% 217.84/217.99  |- skos__hiddenLabel mesh__D000952 Proteins, Polyomavirus T
% 217.84/217.99  |- skos__broader mesh__D000952smesh__D009856
% 217.84/217.99  |- skos__historyNote mesh__D000952 Viral Proteins %28%1966-1985%29%
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D000952 2006
% 217.84/217.99  |- skos__altLabel mesh__D000952 SV40 T Antigens
% 217.84/217.99  |- mesh__recordMaintainer mesh__D000952 ssb
% 217.84/217.99  |- skos__hiddenLabel mesh__D000952 T Proteins, SV40
% 217.84/217.99  |- mesh__historyNote mesh__D000952 88   
% 217.84/217.99  |- skos__altLabel mesh__D000952 Polyomaviruses Large T Proteins
% 217.84/217.99  |- skos__altLabel mesh__D000952 Polyomaviruses Middle T Proteins
% 217.84/217.99  |- mesh__publicMeSHNote mesh__D000952 88   
% 217.84/217.99  |- skos__altLabel mesh__D000952 Polyomavirus Transforming Antigens
% 217.84/217.99  |- skos__historyNote mesh__D000952
% 217.84/217.99       Oncogene Proteins, Viral %28%1986-1987%29%
% 217.84/217.99  |- mesh__recordAuthorizer mesh__D000952 sjn
% 217.84/217.99  |- skos__historyNote mesh__D000952 Antigens, Viral, Tumor %28%1984-1987%29%
% 217.84/217.99  |- skos__prefLabel mesh__D000952 Antigens, Polyomavirus Transforming
% 217.84/217.99  |- skos__altLabel mesh__D000952 Polyomavirus Tumor Antigens
% 217.84/217.99  |- skos__hiddenLabel mesh__D000952 Antigens, Polyomavirus Tumor
% 217.84/217.99  |- mesh__dateCreated mesh__D000952 1987-05-07
% 217.84/217.99  |- skos__hiddenLabel mesh__D000952 Transforming Antigens, Polyomavirus
% 217.84/217.99  |- mesh__recordOriginator mesh__D000952 RLS
% 217.84/217.99  |- skos__broader mesh__D000952smesh__D000957
% 217.84/217.99  |- skos__hiddenLabel mesh__D008137 Studies, Longitudinal
% 217.84/217.99  |- skos__hiddenLabel mesh__D008137 Longitudinal Surveys
% 217.84/217.99  |- skos__hiddenLabel mesh__D008137 Survey, Longitudinal
% 217.84/217.99  |- skos__scopeNote mesh__D008137
% 217.84/217.99       Studies in which variables relating to an individual or group of individuals are assessed over a period of time.%A%    
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D008137 2003
% 217.84/217.99  |- mesh__dateEstablished mesh__D008137 1979-01-01
% 217.84/217.99  |- skos__broader mesh__D008137smesh__D015331
% 217.84/217.99  |- mesh__recordMaintainer mesh__D008137 ags
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D008137 2004
% 217.84/217.99  |- skos__hiddenLabel mesh__D008137 Surveys, Longitudinal
% 217.84/217.99  |- mesh__publicMeSHNote mesh__D008137
% 217.84/217.99       79; was see under EPIDEMIOLOGIC METHODS 1975-78   
% 217.84/217.99  |- skos__prefLabel mesh__D008137 Longitudinal Studies
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D008137 2005
% 217.84/217.99  |- skos__hiddenLabel mesh__D008137 Study, Longitudinal
% 217.84/217.99  |- rdf__type mesh__D008137sskos__Concept
% 217.84/217.99  |- skos__hiddenLabel mesh__D008137 Longitudinal Study
% 217.84/217.99  |- mesh__recordAuthorizer mesh__D008137 sjn
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D008137 2002
% 217.84/217.99  |- mesh__dateRevised mesh__D008137 2001-07-25
% 217.84/217.99  |- mesh__historyNote mesh__D008137
% 217.84/217.99       79%28%75%29%; was see under EPIDEMIOLOGIC METHODS 1975-78   
% 217.84/217.99  |- mesh__recordOriginator mesh__D008137 NLM
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D008137 2006
% 217.84/217.99  |- skos__annotation mesh__D008137
% 217.84/217.99       IM GEN only; coord NIM with specific disease %28%IM%29%; no qualif; specify geog if pertinent%A%  
% 217.84/217.99  |- mesh__dateCreated mesh__D008137 1974-11-19
% 217.84/217.99  |- skos__historyNote mesh__D008137 Epidemiologic Methods %28%1966-1974%29%
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D000154 2004
% 217.84/217.99  |- skos__hiddenLabel mesh__D000154 Citrate Hydro Lyase
% 217.84/217.99  |- mesh__publicMeSHNote mesh__D000154
% 217.84/217.99       78; was see under HYDRO-LYASES 1975-77   
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D000154 2006
% 217.84/217.99  |- skos__hiddenLabel mesh__D000154 Hydratase, Aconitate
% 217.84/217.99  |- skos__hiddenLabel mesh__D000154 Hydro-Lyase, Citrate
% 217.84/217.99  |- skos__scopeNote mesh__D000154
% 217.84/217.99       An enzyme that catalyzes the reversible hydration of cis-aconitate to yield citrate or isocitrate. It is one of the citric acid cycle enzymes. EC 4.2.1.3.%A%    
% 217.84/217.99  |- skos__hiddenLabel mesh__D000154 Isocitrate Hydro Lyase
% 217.84/217.99  |- skos__altLabel mesh__D000154 Citrate Hydrolyase
% 217.84/217.99  |- skos__prefLabel mesh__D000154 Aconitate Hydratase
% 217.84/217.99  |- skos__historyNote mesh__D000154 Hydro-Lyases %28%1966-1972%29%
% 217.84/217.99  |- mesh__recordOriginator mesh__D000154 NLM
% 217.84/217.99  |- rdf__type mesh__D000154sskos__Concept
% 217.84/217.99  |- skos__hiddenLabel mesh__D000154 Hydro-Lyase, Isocitrate
% 217.84/217.99  |- mesh__dateRevised mesh__D000154 2003-07-09
% 217.84/217.99  |- skos__altLabel mesh__D000154 Aconitase
% 217.84/217.99  |- mesh__recordMaintainer mesh__D000154 ssb
% 217.84/217.99  |- skos__altLabel mesh__D000154 Isocitrate Hydro-Lyase
% 217.84/217.99  |- mesh__dateCreated mesh__D000154 1999-01-01
% 217.84/217.99  |- mesh__dateEstablished mesh__D000154 1978-01-01
% 217.84/217.99  |- skos__altLabel mesh__D000154 Citrate Hydro-Lyase
% 217.84/217.99  |- mesh__historyNote mesh__D000154
% 217.84/217.99       78%28%73%29%; was see under HYDRO-LYASES 1975-77   
% 217.84/217.99  |- mesh__recordAuthorizer mesh__D000154 sjn
% 217.84/217.99  |- skos__hiddenLabel mesh__D000154 Hydrolyase, Citrate
% 217.84/217.99  |- skos__broader mesh__D000154smesh__D006836
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D000154 2005
% 217.84/217.99  |- skos__hiddenLabel mesh__D018565 Drug Food Interactions
% 217.84/217.99  |- skos__prefLabel mesh__D018565 Food-Drug Interactions
% 217.84/217.99  |- skos__historyNote mesh__D018565 Drug Interactions %28%1972-1994%29%
% 217.84/217.99  |- skos__hiddenLabel mesh__D018565 Drug-Food Interaction
% 217.84/217.99  |- skos__hiddenLabel mesh__D018565 Interaction, Food-Drug
% 217.84/217.99  |- skos__hiddenLabel mesh__D018565 Interactions, Food
% 217.84/217.99  |- skos__hiddenLabel mesh__D018565 Interactions, Drug-Food
% 217.84/217.99  |- mesh__dateCreated mesh__D018565 1994-04-19
% 217.84/217.99  |- skos__hiddenLabel mesh__D018565 Interaction, Food
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D018565 2004
% 217.84/217.99  |- mesh__dateRevised mesh__D018565 2003-07-09
% 217.84/217.99  |- skos__hiddenLabel mesh__D018565 Food-Drug Interaction
% 217.84/217.99  |- rdf__type mesh__D018565sskos__Concept
% 217.84/217.99  |- skos__scopeNote mesh__D018565
% 217.84/217.99       The pharmacological result, either desirable or undesirable, of drugs interacting with components of the diet. %28%From Stedman, 25th ed%29%%A%    
% 217.84/217.99  |- skos__hiddenLabel mesh__D018565 Food Interaction
% 217.84/217.99  |- mesh__dateEstablished mesh__D018565 1995-01-01
% 217.84/217.99  |- skos__broader mesh__D018565smesh__D004347
% 217.84/217.99  |- skos__hiddenLabel mesh__D018565 Food Drug Interactions
% 217.84/217.99  |- skos__annotation mesh__D018565
% 217.84/217.99       IM; coord with specific food %28%IM%29% + specific drug %28%IM%29% with pertinent qualif%A%  
% 217.84/217.99  |- skos__hiddenLabel mesh__D018565 Interaction, Drug-Food
% 217.84/217.99  |- skos__altLabel mesh__D018565 Drug-Food Interactions
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D018565 2005
% 217.84/217.99  |- mesh__historyNote mesh__D018565 95   
% 217.84/217.99  |- mesh__publicMeSHNote mesh__D018565 95   
% 217.84/217.99  |- skos__hiddenLabel mesh__D018565 Interactions, Food-Drug
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D018565 2006
% 217.84/217.99  |- skos__altLabel mesh__D010582 lambda Phage
% 217.84/217.99  |- mesh__dateEstablished mesh__D010582 1980-01-01
% 217.84/217.99  |- skos__scopeNote mesh__D010582
% 217.84/217.99       A temperate inducible phage and type species of the genus lambda-like Viruses, in the family SIPHOVIRIDAE. Its natural host is E. coli K12. Its virion contains linear double-stranded DNA with single-stranded 12-base 5%27% sticky ends. The DNA circularizes on infection.%A%    
% 217.84/217.99  |- skos__historyNote mesh__D010582 Coliphages %28%1966-1979%29%
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D010582 2004
% 217.84/217.99  |- skos__altLabel mesh__D010582 Phage lambda
% 217.84/217.99  |- mesh__recordOriginator mesh__D010582 AEP
% 217.84/217.99  |- mesh__recordAuthorizer mesh__D010582 sjn
% 217.84/217.99  |- mesh__recordMaintainer mesh__D010582 ags
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D010582 2003
% 217.84/217.99  |- rdf__type mesh__D010582sskos__Concept
% 217.84/217.99  |- mesh__publicMeSHNote mesh__D010582
% 217.84/217.99       93; was PHAGE LAMBDA 1980-92; BACTERIOPHAGE LAMBDA was see PHAGE LAMBDA 1980-92, was see COLIPHAGES 1975-79; LAMBDA PHAGE was see COLIPHAGES 1975-79%A%  
% 217.84/217.99  |- mesh__historyNote mesh__D010582
% 217.84/217.99       93; was PHAGE LAMBDA 1980-92; BACTERIOPHAGE LAMBDA was see PHAGE LAMBDA 1980-92, was see COLIPHAGES 1975-79; LAMBDA PHAGE was see COLIPHAGES 1975-79%A%  
% 217.84/217.99  |- mesh__onlineNote mesh__D010582
% 217.84/217.99       use BACTERIOPHAGE LAMBDA to search PHAGE LAMBDA 1980-92; use COLIPHAGES to search BACTERIOPHAGE LAMBDA %26% LAMBDA PHAGE 1975-79%A%  
% 217.84/217.99  |- skos__altLabel mesh__D010582 Coliphage lambda
% 217.84/217.99  |- mesh__activeMeSHYear mesh__D010582 2002
% 217.84/217.99  |- mesh__dateCreated mesh__D010582 1979-04-12
% 217.84/217.99  |- skos__annotation mesh__D010582
% 217.84/217.99       LAMBDA-LIKE PHAGES see SIPHOVIRIDAE is also available   
% 217.84/217.99  |- skos__altLabel mesh__D010582 Enterobacteria phage lambda
% 217.84/217.99  |- mesh__dateRevised mesh__D010582 2001-07-25
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D010582 2006
% 217.84/218.00  |- skos__broader mesh__D010582smesh__D017906
% 217.84/218.00  |- skos__broader mesh__D010582smesh__D003090
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D010582 2005
% 217.84/218.00  |- skos__prefLabel mesh__D010582 Bacteriophage lambda
% 217.84/218.00  |- mesh__recordMaintainer mesh__D009230 lkt
% 217.84/218.00  |- mesh__recordAuthorizer mesh__D009230 sjn
% 217.84/218.00  |- mesh__recordOriginator mesh__D009230 NLM
% 217.84/218.00  |- skos__hiddenLabel mesh__D009230 Myxedemas
% 217.84/218.00  |- mesh__dateRevised mesh__D009230 2005-06-30
% 217.84/218.00  |- skos__annotation mesh__D009230
% 217.84/218.00       pretibial myxedema = MYXEDEMA %28%IM%29% + LEG DERMATOSES %28%IM%29%   
% 217.84/218.00  |- skos__prefLabel mesh__D009230 Myxedema
% 217.84/218.00  |- mesh__dateCreated mesh__D009230 1999-01-01
% 217.84/218.00  |- skos__broader mesh__D009230smesh__D007037
% 217.84/218.00  |- rdf__type mesh__D009230sskos__Concept
% 217.84/218.00  |- skos__broader mesh__D009230smesh__D017520
% 217.84/218.00  |- skos__scopeNote mesh__D009230
% 217.84/218.00       A condition characterized by a dry, waxy type of swelling %28%EDEMA%29% with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips.%A%    
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D009230 2006
% 217.84/218.00  |- mesh__recordMaintainer mesh__D014973 nns
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014973 2006
% 217.84/218.00  |- skos__broader mesh__D014973smesh__D012875
% 217.84/218.00  |- skos__hiddenLabel mesh__D014973 Xanthomas
% 217.84/218.00  |- skos__hiddenLabel mesh__D014973 Xanthomatoses
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014973 2002
% 217.84/218.00  |- skos__prefLabel mesh__D014973 Xanthomatosis
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014973 2003
% 217.84/218.00  |- mesh__recordAuthorizer mesh__D014973 sjn
% 217.84/218.00  |- mesh__recordOriginator mesh__D014973 NLM
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014973 2004
% 217.84/218.00  |- mesh__dateRevised mesh__D014973 2001-07-25
% 217.84/218.00  |- mesh__dateCreated mesh__D014973 1999-01-01
% 217.84/218.00  |- rdf__type mesh__D014973sskos__Concept
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014973 2005
% 217.84/218.00  |- skos__scopeNote mesh__D014973
% 217.84/218.00       A condition of morphologic change in which there is accumulation of lipids in the large foam cells of tissues. It is the cutaneous manifestation of lipidosis in which plasma fatty acids and lipoproteins are quantitatively changed. The xanthomatous eruptions have several different distinct morphologies dependent upon the specific form taken by the disease.%A%    
% 217.84/218.00  |- skos__annotation mesh__D014973
% 217.84/218.00       non-neoplastic; a metab skin dis manifest of lipidosis; coord with organ/disease term %28%IM%29%; xanthogranuloma goes here %28%IM%29% + GRANULOMA %28%IM%29% but note XANTHOGRANULOMA, JUVENILE is available%A%  
% 217.84/218.00  |- skos__broader mesh__D014175smesh__D007803
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014175 2006
% 217.84/218.00  |- skos__hiddenLabel mesh__D014175 Translatings
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014175 1993
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014175 1994
% 217.84/218.00  |- mesh__recordMaintainer mesh__D014175 TGC
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014175 2002
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014175 2005
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014175 2004
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014175 1992
% 217.84/218.00  |- skos__prefLabel mesh__D014175 Translating
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014175 1999
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014175 1990
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014175 2003
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014175 1998
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014175 1997
% 217.84/218.00  |- skos__scopeNote mesh__D014175
% 217.84/218.00       Conversion from one language to another language.     
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014175 2001
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014175 1996
% 217.84/218.00  |- mesh__recordOriginator mesh__D014175 NLM
% 217.84/218.00  |- rdf__type mesh__D014175sskos__Concept
% 217.84/218.00  |- skos__annotation mesh__D014175 a cataloging term; no qualif   
% 217.84/218.00  |- mesh__dateRevised mesh__D014175 1989-05-16
% 217.84/218.00  |- mesh__dateCreated mesh__D014175 1999-01-01
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014175 2000
% 217.84/218.00  |- mesh__recordAuthorizer mesh__D014175 PLS
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014175 1995
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014175 1991
% 217.84/218.00  |- mesh__dateEstablished mesh__D008936 1974-01-01
% 217.84/218.00  |- mesh__dateCreated mesh__D008936 1999-01-01
% 217.84/218.00  |- mesh__recordAuthorizer mesh__D008936 sjn
% 217.84/218.00  |- skos__hiddenLabel mesh__D008936 NSC104800
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D008936 2005
% 217.84/218.00  |- mesh__publicMeSHNote mesh__D008936 81; was DIBROMODULCITOL 1974-80   
% 217.84/218.00  |- mesh__recordOriginator mesh__D008936 NLM
% 217.84/218.00  |- skos__broader mesh__D008936smesh__D004376
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D008936 2006
% 217.84/218.00  |- mesh__dateRevised mesh__D008936 2004-07-07
% 217.84/218.00  |- skos__historyNote mesh__D008936 Bromine %28%1966-1973%29%
% 217.84/218.00  |- skos__altLabel mesh__D008936 Dibromodulcitol
% 217.84/218.00  |- skos__hiddenLabel mesh__D008936 NSC 104800
% 217.84/218.00  |- mesh__onlineNote mesh__D008936
% 217.84/218.00       use MITOLACTOL to search DIBROMODULCITOL 1974-80   
% 217.84/218.00  |- rdf__type mesh__D008936sskos__Concept
% 217.84/218.00  |- skos__prefLabel mesh__D008936 Mitolactol
% 217.84/218.00  |- mesh__historyNote mesh__D008936 81; was DIBROMODULCITOL 1974-80   
% 217.84/218.00  |- skos__scopeNote mesh__D008936
% 217.84/218.00       Alkylating antineoplastic toxic to bone marrow; used in breast cancer, also in combination with other drugs.%A%    
% 217.84/218.00  |- mesh__recordMaintainer mesh__D008936 ssb
% 217.84/218.00  |- skos__historyNote mesh__D008936 Antineoplastic Agents %28%1966-1973%29%
% 217.84/218.00  |- skos__prefLabel mesh__D000953 Antigens, Protozoan
% 217.84/218.00  |- skos__historyNote mesh__D000953 Antigens, Surface %28%1979-1984%29%
% 217.84/218.00  |- mesh__publicMeSHNote mesh__D000953 85   
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D000953 2006
% 217.84/218.00  |- skos__scopeNote mesh__D000953
% 217.84/218.00       Any part or derivative of any protozoan that elicits immunity; malaria %28%Plasmodium%29% and trypanosome antigens are presently the most frequently encountered.%A%    
% 217.84/218.00  |- mesh__dateRevised mesh__D000953 2005-06-30
% 217.84/218.00  |- mesh__dateCreated mesh__D000953 1984-05-02
% 217.84/218.00  |- skos__broader mesh__D000953smesh__D000941
% 217.84/218.00  |- mesh__historyNote mesh__D000953 85   
% 217.84/218.00  |- mesh__recordOriginator mesh__D000953 SH
% 217.84/218.00  |- mesh__recordMaintainer mesh__D000953 ssb
% 217.84/218.00  |- mesh__dateEstablished mesh__D000953 1985-01-01
% 217.84/218.00  |- skos__annotation mesh__D000953
% 217.84/218.00       coord IM with specific protozoan /immunol %28%IM%29%   
% 217.84/218.00  |- skos__historyNote mesh__D000953 Antigens %28%1966-1984%29%
% 217.84/218.00  |- mesh__recordAuthorizer mesh__D000953 sjn
% 217.84/218.00  |- rdf__type mesh__D000953sskos__Concept
% 217.84/218.00  |- skos__altLabel mesh__D000953 Protozoan Antigens
% 217.84/218.00  |- mesh__recordOriginator mesh__D008138 NLM
% 217.84/218.00  |- mesh__dateEstablished mesh__D008138 1991-01-01
% 217.84/218.00  |- mesh__dateCreated mesh__D008138 1999-01-01
% 217.84/218.00  |- skos__prefLabel mesh__D008138 Loop of Henle
% 217.84/218.00  |- mesh__historyNote mesh__D008138
% 217.84/218.00       91%28%73%29%; was see under KIDNEY TUBULES 1973-90   
% 217.84/218.00  |- skos__broader mesh__D008138smesh__D007684
% 217.84/218.00  |- rdf__type mesh__D008138sskos__Concept
% 217.84/218.00  |- mesh__recordMaintainer mesh__D008138 lkt
% 217.84/218.00  |- skos__scopeNote mesh__D008138
% 217.84/218.00       The U-shaped portion of the renal tubule in the KIDNEY MEDULLA, consisting of a descending limb and an ascending limb. It is situated between the PROXIMAL KIDNEY TUBULE and the DISTAL KIDNEY TUBULE.%A%    
% 217.84/218.00  |- mesh__dateRevised mesh__D008138 2005-06-30
% 217.84/218.00  |- skos__hiddenLabel mesh__D008138 Henle Loop
% 217.84/218.00  |- skos__historyNote mesh__D008138 Kidney Tubules %28%1966-1972%29%
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D008138 2006
% 217.84/218.00  |- mesh__publicMeSHNote mesh__D008138
% 217.84/218.00       91; was see under KIDNEY TUBULES 1973-90   
% 217.84/218.00  |- mesh__recordAuthorizer mesh__D008138 sjn
% 217.84/218.00  |- mesh__historyNote mesh__D018566 95   
% 217.84/218.00  |- skos__prefLabel mesh__D018566 Pregnancy, High-Risk
% 217.84/218.00  |- mesh__dateEstablished mesh__D018566 1995-01-01
% 217.84/218.00  |- skos__hiddenLabel mesh__D018566 Pregnancies, High-Risk
% 217.84/218.00  |- skos__related mesh__D018566smesh__D011248
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D018566 2006
% 217.84/218.00  |- skos__annotation mesh__D018566
% 217.84/218.00       check tags FEMALE %26% PREGNANCY; DF: PREGN HIGH RISK   
% 217.84/218.00  |- mesh__dateCreated mesh__D018566 1994-04-19
% 217.84/218.00  |- mesh__publicMeSHNote mesh__D018566 95   
% 217.84/218.00  |- mesh__recordAuthorizer mesh__D018566 sjn
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D018566 2005
% 217.84/218.00  |- skos__scopeNote mesh__D018566
% 217.84/218.00       Pregnancy in which the mother and/or FETUS are at greater than normal risk of MORBIDITY or MORTALITY. Causes include inadequate PRENATAL CARE, previous obstetrical history %28%ABORTION, SPONTANEOUS%29%, pre-existing maternal disease, pregnancy-induced disease %28%GESTATIONAL HYPERTENSION%29%, and MULTIPLE PREGNANCY, as well as advanced maternal age above 35.%A%    
% 217.84/218.00  |- skos__hiddenLabel mesh__D018566 Pregnancy, High Risk
% 217.84/218.00  |- mesh__recordMaintainer mesh__D018566 lkt
% 217.84/218.00  |- skos__altLabel mesh__D018566 High-Risk Pregnancy
% 217.84/218.00  |- skos__hiddenLabel mesh__D018566 High Risk Pregnancy
% 217.84/218.00  |- skos__historyNote mesh__D018566
% 217.84/218.00       Pregnancy Complications %28%1966-1994%29%
% 217.84/218.00  |- rdf__type mesh__D018566sskos__Concept
% 217.84/218.00  |- mesh__dateRevised mesh__D018566 2004-07-07
% 217.84/218.00  |- skos__broader mesh__D018566smesh__D011247
% 217.84/218.00  |- mesh__recordOriginator mesh__D018566 JLS
% 217.84/218.00  |- skos__hiddenLabel mesh__D018566 High-Risk Pregnancies
% 217.84/218.00  |- mesh__onlineNote mesh__D010583
% 217.84/218.00       use BACTERIOPHAGE MU to search PHAGE MU 1990-92 %26% PHAGE MU 1 1980-89%A%  
% 217.84/218.00  |- skos__broader mesh__D010583smesh__D003090
% 217.84/218.00  |- skos__altLabel mesh__D010583 mu Phage
% 217.84/218.00  |- mesh__recordMaintainer mesh__D010583 ags
% 217.84/218.00  |- skos__hiddenLabel mesh__D010583 mu Phages
% 217.84/218.00  |- skos__altLabel mesh__D010583 Coliphage mu
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D010583 2003
% 217.84/218.00  |- rdf__type mesh__D010583sskos__Concept
% 217.84/218.00  |- skos__scopeNote mesh__D010583
% 217.84/218.00       A temperate coliphage, in the genus Mu-like Viruses, family MYOVIRIDAE, composed of a linear, double-stranded molecule of DNA, which is able to insert itself randomly at any point on the host chromosome. It frequently causes a mutation by interrupting the continuity of the bacterial operon at the site of insertion.%A%    
% 217.84/218.00  |- mesh__dateCreated mesh__D010583 1979-04-16
% 217.84/218.00  |- skos__historyNote mesh__D010583 Coliphages %28%1966-1979%29%
% 217.84/218.00  |- mesh__recordOriginator mesh__D010583 AEP
% 217.84/218.00  |- mesh__recordAuthorizer mesh__D010583 sjn
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D010583 2006
% 217.84/218.00  |- skos__broader mesh__D010583smesh__D017900
% 217.84/218.00  |- skos__prefLabel mesh__D010583 Bacteriophage mu
% 217.84/218.00  |- skos__altLabel mesh__D010583 Phage mu
% 217.84/218.00  |- mesh__historyNote mesh__D010583
% 217.84/218.00       93; was PHAGE MU 1990-92; BACTERIOPHAGE MU was see PHAGE MU 1990-92, was see PHAGE MU 1 1980-89%A%  
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D010583 2005
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D010583 2002
% 217.84/218.00  |- mesh__dateEstablished mesh__D010583 1980-01-01
% 217.84/218.00  |- mesh__dateRevised mesh__D010583 2001-07-25
% 217.84/218.00  |- mesh__publicMeSHNote mesh__D010583
% 217.84/218.00       93; was PHAGE MU 1990-92; BACTERIOPHAGE MU was see PHAGE MU 1990-92, was see PHAGE MU 1 1980-89%A%  
% 217.84/218.00  |- skos__altLabel mesh__D010583 Enterobacteria phage Mu
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D010583 2004
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D004546 2006
% 217.84/218.00  |- skos__historyNote mesh__D004546 Snake Venoms %28%1975-1977%29%
% 217.84/218.00  |- skos__historyNote mesh__D004546 Venoms %28%1966-1974%29%
% 217.84/218.00  |- mesh__historyNote mesh__D004546 78   
% 217.84/218.00  |- skos__hiddenLabel mesh__D004546 Venoms, Elapid
% 217.84/218.00  |- rdf__type mesh__D004546sskos__Concept
% 217.84/218.00  |- mesh__recordOriginator mesh__D004546 SH
% 217.84/218.00  |- skos__prefLabel mesh__D004546 Elapid Venoms
% 217.84/218.00  |- mesh__recordAuthorizer mesh__D004546 sjn
% 217.84/218.00  |- skos__broader mesh__D004546smesh__D012910
% 217.84/218.00  |- skos__altLabel mesh__D004546 Elapid Venom
% 217.84/218.00  |- skos__historyNote mesh__D004546 Snakes %28%1966-1974%29%
% 217.84/218.00  |- skos__hiddenLabel mesh__D004546 Venom, Elapid
% 217.84/218.00  |- mesh__publicMeSHNote mesh__D004546 78   
% 217.84/218.00  |- skos__scopeNote mesh__D004546
% 217.84/218.00       Venoms from snakes of the family Elapidae, including cobras, kraits, mambas, coral, tiger, and Australian snakes. The venoms contain polypeptide toxins of various kinds, cytolytic, hemolytic, and neurotoxic factors, but fewer enzymes than viper or crotalid venoms. Many of the toxins have been characterized.%A%    
% 217.84/218.00  |- mesh__dateCreated mesh__D004546 1977-04-22
% 217.84/218.00  |- skos__annotation mesh__D004546
% 217.84/218.00       /antag permitted but consider also ANTIVENINS; /enzymol permitted; note that BUNGAROTOXINS; COBRA NEUROTOXINS; COBRA VENOMS %26% other specifics are available; TN 241: common %26% scientific names of various elapids%A%  
% 217.84/218.00  |- mesh__recordMaintainer mesh__D004546 ssb
% 217.84/218.00  |- mesh__dateEstablished mesh__D004546 1978-01-01
% 217.84/218.00  |- mesh__dateRevised mesh__D004546 2005-06-30
% 217.84/218.00  |- mesh__recordMaintainer mesh__D009231 SYSTEM
% 217.84/218.00  |- mesh__historyNote mesh__D009231 1992 %28%1974%29%   
% 217.84/218.00  |- mesh__dateCreated mesh__D009231 1999-01-01
% 217.84/218.00  |- mesh__recordAuthorizer mesh__D009231 sjn
% 217.84/218.00  |- skos__altLabel mesh__D009231 Myxobacterales
% 217.84/218.00  |- rdf__type mesh__D009231sskos__Concept
% 217.84/218.00  |- mesh__recordOriginator mesh__D009231 NLM
% 217.84/218.00  |- skos__altLabel mesh__D009231 Myxobacteria
% 217.84/218.00  |- skos__altLabel mesh__D009231 Slime Bacteria
% 217.84/218.00  |- skos__prefLabel mesh__D009231 Myxococcales
% 217.84/218.00  |- mesh__dateRevised mesh__D009231 2005-06-30
% 217.84/218.00  |- mesh__publicMeSHNote mesh__D009231
% 217.84/218.00       1992; see MYXOBACTERALES 1974-1991; for POLYANGIACEAE see POLYANGIACEAE 1975-1981; for POLYANGIUM see POLYANGIUM 1963-1981; for SLIME BACTERIA see MYXOBACTERALES 1974-1978%A%  
% 217.84/218.00  |- skos__broader mesh__D009231smesh__D020564
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D009231 2006
% 217.84/218.00  |- mesh__dateEstablished mesh__D009231 1974-01-01
% 217.84/218.00  |- skos__scopeNote mesh__D009231
% 217.84/218.00       An order of rod-shaped, gram-negative fruiting gliding bacteria found in SOIL; WATER; and HUMUS.%A%    
% 217.84/218.00  |- rdf__type mesh__D014974sskos__Concept
% 217.84/218.00  |- mesh__recordOriginator mesh__D014974 NLM
% 217.84/218.00  |- mesh__recordMaintainer mesh__D014974 SYSTEM
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014974 2006
% 217.84/218.00  |- skos__prefLabel mesh__D014974 Xanthomonas
% 217.84/218.00  |- skos__broader mesh__D014974smesh__D044166
% 217.84/218.00  |- mesh__dateRevised mesh__D014974 2005-06-30
% 217.84/218.00  |- mesh__dateCreated mesh__D014974 1999-01-01
% 217.84/218.00  |- skos__scopeNote mesh__D014974
% 217.84/218.00       A genus of PSEUDOMONADACEAE whose cells produce a yellow pigment %28%Gr. xanthos - yellow%29%. It is pathogenic to plants.%A%    
% 217.84/218.00  |- mesh__recordAuthorizer mesh__D014974 sjn
% 217.84/218.00  |- mesh__dateEstablished mesh__D014176 1973-01-01
% 217.84/218.00  |- skos__altLabel mesh__D014176 Protein Biosynthesis, Ribosomal
% 217.84/218.00  |- mesh__recordOriginator mesh__D014176 NLM
% 217.84/218.00  |- skos__hiddenLabel mesh__D014176 Biosynthesis, Ribosomal Protein
% 217.84/218.00  |- mesh__publicMeSHNote mesh__D014176
% 217.84/218.00       2005%28%1973%29%; see TRANSLATION,  GENETIC 1973-2004   
% 217.84/218.00  |- skos__hiddenLabel mesh__D014176 Biosynthesis, Protein
% 217.84/218.00  |- skos__hiddenLabel mesh__D014176 Genetic Translations
% 217.84/218.00  |- skos__prefLabel mesh__D014176 Protein Biosynthesis
% 217.84/218.00  |- skos__broader mesh__D014176smesh__D015870
% 217.84/218.00  |- rdf__type mesh__D014176sskos__Concept
% 217.84/218.00  |- skos__related mesh__D014176smesh__D005815
% 217.84/218.00  |- mesh__dateCreated mesh__D014176 1999-01-01
% 217.84/218.00  |- skos__hiddenLabel mesh__D014176 Ribosomal Protein Biosynthesis
% 217.84/218.00  |- skos__altLabel mesh__D014176 Protein Synthesis, Ribosomal
% 217.84/218.00  |- skos__annotation mesh__D014176
% 217.84/218.00       do not confuse the ribosome translocation step of  PROTEIN BIOSYNTHESIS with TRANSLOCATION, GENETIC a chromosome aberration; coordinate with the specific protein/biosyn only when genetic translation is discussed; PEPTIDE BIOSYNTHESIS and PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT%A%  
% 217.84/218.00  |- skos__hiddenLabel mesh__D014176 Translation, mRNA
% 217.84/218.00  |- mesh__recordMaintainer mesh__D014176 ags
% 217.84/218.00  |- mesh__recordAuthorizer mesh__D014176 ags
% 217.84/218.00  |- skos__historyNote mesh__D014176 Ribosomes %28%1966-1972%29%
% 217.84/218.00  |- skos__hiddenLabel mesh__D014176 Ribosomal Protein Synthesis
% 217.84/218.00  |- skos__altLabel mesh__D014176 Genetic Translation
% 217.84/218.00  |- skos__broader mesh__D014176smesh__D010452
% 217.84/218.00  |- skos__hiddenLabel mesh__D014176 mRNA Translations
% 217.84/218.00  |- skos__altLabel mesh__D014176 Ribosomal Peptide Biosynthesis
% 217.84/218.00  |- skos__altLabel mesh__D014176 Peptide Biosynthesis, Ribosomal
% 217.84/218.00  |- mesh__dateRevised mesh__D014176 2005-08-02
% 217.84/218.00  |- mesh__historyNote mesh__D014176 2005%28%1973%29%   
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014176 2006A
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014176 2006
% 217.84/218.00  |- skos__hiddenLabel mesh__D014176 Biosynthesis, Ribosomal Peptide
% 217.84/218.00  |- skos__scopeNote mesh__D014176
% 217.84/218.00       The biosynthesis of PEPTIDES and PROTEINS on RIBOSOMES, directed by MESSENGER RNA, via TRANSFER RNA that is charged with standard proteinogenic AMINO ACIDS.%A%    
% 217.84/218.00  |- skos__altLabel mesh__D014176 mRNA Translation
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D014176 2005
% 217.84/218.00  |- skos__hiddenLabel mesh__D014176 Synthesis, Ribosomal Protein
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D008937 2005
% 217.84/218.00  |- mesh__recordMaintainer mesh__D008937 ssb
% 217.84/218.00  |- skos__annotation mesh__D008937 MITOMYCIN is also available   
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D008937 2006
% 217.84/218.00  |- mesh__dateRevised mesh__D008937 2004-07-07
% 217.84/218.00  |- skos__broader mesh__D008937smesh__D001389
% 217.84/218.00  |- skos__scopeNote mesh__D008937
% 217.84/218.00       A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.%A%    
% 217.84/218.00  |- mesh__historyNote mesh__D008937 82; was MITOMYCIN 1963-81   
% 217.84/218.00  |- mesh__recordAuthorizer mesh__D008937 sjn
% 217.84/218.00  |- mesh__publicMeSHNote mesh__D008937 82; was MITOMYCIN 1963-81   
% 217.84/218.00  |- mesh__recordOriginator mesh__D008937 NLM
% 217.84/218.00  |- mesh__onlineNote mesh__D008937
% 217.84/218.00       use MITOMYCINS to search MITOMYCIN 1966-81   
% 217.84/218.00  |- rdf__type mesh__D008937sskos__Concept
% 217.84/218.00  |- skos__broader mesh__D008937smesh__D045563
% 217.84/218.00  |- skos__prefLabel mesh__D008937 Mitomycins
% 217.84/218.00  |- mesh__dateCreated mesh__D008937 1999-01-01
% 217.84/218.00  |- skos__hiddenLabel mesh__D000954 Immunological Surface Markers
% 217.84/218.00  |- skos__hiddenLabel mesh__D000954 Antigen, Cell Surface
% 217.84/218.00  |- mesh__recordMaintainer mesh__D000954 ssb
% 217.84/218.00  |- skos__altLabel mesh__D000954 Surface Markers, Immunologic
% 217.84/218.00  |- skos__hiddenLabel mesh__D000954 Antigens, Cell Surface
% 217.84/218.00  |- skos__hiddenLabel mesh__D000954 Markers, Immunologic Surface
% 217.84/218.00  |- mesh__historyNote mesh__D000954 79   
% 217.84/218.00  |- mesh__recordAuthorizer mesh__D000954 sjn
% 217.84/218.00  |- skos__hiddenLabel mesh__D000954 Antigen, Surface
% 217.84/218.00  |- skos__altLabel mesh__D000954 Cell Surface Antigens
% 217.84/218.00  |- mesh__recordOriginator mesh__D000954 SH
% 217.84/218.00  |- mesh__publicMeSHNote mesh__D000954 79   
% 217.84/218.00  |- skos__prefLabel mesh__D000954 Antigens, Surface
% 217.84/218.00  |- mesh__dateCreated mesh__D000954 1978-05-01
% 217.84/218.00  |- skos__altLabel mesh__D000954 Cell Surface Antigen
% 217.84/218.00  |- skos__historyNote mesh__D000954 Antigens %28%1966-1978%29%
% 217.84/218.00  |- mesh__dateEstablished mesh__D000954 1979-01-01
% 217.84/218.00  |- skos__hiddenLabel mesh__D000954 Surface Antigen, Cell
% 217.84/218.00  |- skos__altLabel mesh__D000954 Surface Antigens
% 217.84/218.00  |- skos__annotation mesh__D000954
% 217.84/218.00       coord NIM with specific antigen/organism heading %28%IM%29%   
% 217.84/218.00  |- skos__scopeNote mesh__D000954
% 217.84/218.00       Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated.%A%    
% 217.84/218.00  |- rdf__type mesh__D000954sskos__Concept
% 217.84/218.00  |- skos__altLabel mesh__D000954 Surface Antigen
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D000954 2006
% 217.84/218.00  |- skos__hiddenLabel mesh__D000954 Surface Antigens, Cell
% 217.84/218.00  |- skos__altLabel mesh__D000954 Immunologic Surface Markers
% 217.84/218.00  |- mesh__dateRevised mesh__D000954 2005-06-30
% 217.84/218.00  |- skos__altLabel mesh__D000954 Markers, Immunological Surface
% 217.84/218.00  |- skos__altLabel mesh__D000954 Surface Markers, Immunological
% 217.84/218.00  |- skos__broader mesh__D000954smesh__D000941
% 217.84/218.00  |- skos__broader mesh__D008139smesh__D010880
% 217.84/218.00  |- skos__hiddenLabel mesh__D008139 R 18553
% 217.84/218.00  |- skos__hiddenLabel mesh__D008139 R18553
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D008139 2005
% 217.84/218.00  |- mesh__historyNote mesh__D008139
% 217.84/218.00       91%28%76%29%; was see under PIPERIDINES 1976-90   
% 217.84/218.00  |- mesh__dateCreated mesh__D008139 1975-07-23
% 217.84/218.00  |- mesh__recordOriginator mesh__D008139 SH
% 217.84/218.00  |- skos__prefLabel mesh__D008139 Loperamide
% 217.84/218.00  |- mesh__recordAuthorizer mesh__D008139 sjn
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D008139 2004
% 217.84/218.00  |- skos__altLabel mesh__D008139 Loperamide Monohydrochloride
% 217.84/218.00  |- skos__hiddenLabel mesh__D008139 Hydrochloride, Loperamide
% 217.84/218.00  |- skos__scopeNote mesh__D008139
% 217.84/218.00       One of the long-acting synthetic ANTIDIARRHEALS; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally.%A%    
% 217.84/218.00  |- mesh__dateEstablished mesh__D008139 1991-01-01
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D008139 2003
% 217.84/218.00  |- mesh__recordMaintainer mesh__D008139 jmp
% 217.84/218.00  |- mesh__dateRevised mesh__D008139 2001-07-25
% 217.84/218.00  |- mesh__publicMeSHNote mesh__D008139
% 217.84/218.00       91; was see under PIPERIDINES 1976-90   
% 217.84/218.00  |- skos__historyNote mesh__D008139 Chlorobenzenes %28%1974-1975%29%
% 217.84/218.00  |- rdf__type mesh__D008139sskos__Concept
% 217.84/218.00  |- skos__historyNote mesh__D008139 Amides %28%1974-1975%29%
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D008139 2002
% 217.84/218.00  |- skos__hiddenLabel mesh__D008139 Monohydrochloride, Loperamide
% 217.84/218.00  |- skos__historyNote mesh__D008139 Piperidines %28%1974-1975%29%
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D008139 2006
% 217.84/218.00  |- skos__altLabel mesh__D000156 Aconitate
% 217.84/218.00  |- skos__hiddenLabel mesh__D000156 Acid, Pyrocitric
% 217.84/218.00  |- mesh__dateEstablished mesh__D000156 1991-01-01
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D000156 1997
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D000156 2002
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D000156 2004
% 217.84/218.00  |- skos__altLabel mesh__D000156 Carboxyglutaconic Acid
% 217.84/218.00  |- mesh__recordAuthorizer mesh__D000156 PLS
% 217.84/218.00  |- mesh__dateCreated mesh__D000156 1999-01-01
% 217.84/218.00  |- mesh__recordOriginator mesh__D000156 NLM
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D000156 1994
% 217.84/218.00  |- skos__altLabel mesh__D000156 Adonic Acid
% 217.84/218.00  |- skos__hiddenLabel mesh__D000156 Acid, Achilleic
% 217.84/218.00  |- rdf__type mesh__D000156sskos__Concept
% 217.84/218.00  |- skos__altLabel mesh__D000156 Citridinic Acid
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D000156 1998
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D000156 1995
% 217.84/218.00  |- skos__hiddenLabel mesh__D000156 Acid, Acontic
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D000156 2005
% 217.84/218.00  |- mesh__recordMaintainer mesh__D000156 TAP
% 217.84/218.00  |- skos__altLabel mesh__D000156 Pyrocitric Acid
% 217.84/218.00  |- skos__altLabel mesh__D000156 Achilleic Acid
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D000156 2000
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D000156 1993
% 217.84/218.00  |- skos__hiddenLabel mesh__D000156 Acid, Carboxyglutaconic
% 217.84/218.00  |- skos__hiddenLabel mesh__D000156 Acid, Citridic
% 217.84/218.00  |- skos__altLabel mesh__D000156 Acontic Acid
% 217.84/218.00  |- skos__altLabel mesh__D000156 Citridic Acid
% 217.84/218.00  |- skos__broader mesh__D000156smesh__D014233
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D000156 1999
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D000156 2006
% 217.84/218.00  |- mesh__dateRevised mesh__D000156 1992-05-07
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D000156 2001
% 217.84/218.00  |- skos__hiddenLabel mesh__D000156 Acid, Aconitic
% 217.84/218.00  |- skos__altLabel mesh__D000156 Equisetic Acid
% 217.84/218.00  |- mesh__publicMeSHNote mesh__D000156
% 217.84/218.00       91; was see under TRICARBOXYLIC ACIDS 1973-90   
% 217.84/218.00  |- skos__hiddenLabel mesh__D000156 Acid, Equisetic
% 217.84/218.00  |- mesh__historyNote mesh__D000156
% 217.84/218.00       91%28%73%29%; was see under TRICARBOXYLIC ACIDS 1973-90   
% 217.84/218.00  |- skos__prefLabel mesh__D000156 Aconitic Acid
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D000156 1996
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D000156 2003
% 217.84/218.00  |- skos__hiddenLabel mesh__D000156 Acid, Citridinic
% 217.84/218.00  |- skos__hiddenLabel mesh__D000156 Acid, Adonic
% 217.84/218.00  |- skos__broader mesh__D005363Q000031smesh__D005363
% 217.84/218.00  |- mesh__preferredCombination mesh__D005363Q000031smesh__D011564
% 217.84/218.00  |- rdf__type mesh__D005363Q000031smesh__CompoundConcept
% 217.84/218.00  |- skos__hiddenLabel mesh__D018567 Breast Tumor, Male
% 217.84/218.00  |- skos__hiddenLabel mesh__D018567 Carcinoma, Male Breast
% 217.84/218.00  |- skos__altLabel mesh__D018567 Breast Carcinoma, Male
% 217.84/218.00  |- skos__altLabel mesh__D018567 Male Breast Neoplasms
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D018567 2005
% 217.84/218.00  |- mesh__dateCreated mesh__D018567 1994-06-01
% 217.84/218.00  |- skos__hiddenLabel mesh__D018567 Tumor, Male Breast
% 217.84/218.00  |- skos__scopeNote mesh__D018567
% 217.84/218.00       Any neoplasms of the male breast. These occur infrequently in males in developed countries, the incidence being about 1%25% of that in females.%A%    
% 217.84/218.00  |- mesh__recordMaintainer mesh__D018567 sjn
% 217.84/218.00  |- mesh__dateEstablished mesh__D018567 1995-01-01
% 217.84/218.00  |- rdf__type mesh__D018567sskos__Concept
% 217.84/218.00  |- skos__hiddenLabel mesh__D018567 Male Breast Tumor
% 217.84/218.00  |- skos__hiddenLabel mesh__D018567 Male Breast Tumors
% 217.84/218.00  |- mesh__publicMeSHNote mesh__D018567 95   
% 217.84/218.00  |- mesh__recordAuthorizer mesh__D018567 sjn
% 217.84/218.00  |- skos__hiddenLabel mesh__D018567 Breast Neoplasm, Male
% 217.84/218.00  |- mesh__dateRevised mesh__D018567 2004-07-13
% 217.84/218.00  |- skos__altLabel mesh__D018567 Tumors, Breast, Male
% 217.84/218.00  |- mesh__recordOriginator mesh__D018567 JLS
% 217.84/218.00  |- skos__broader mesh__D018567smesh__D001943
% 217.84/218.00  |- skos__hiddenLabel mesh__D018567 Tumors, Male Breast
% 217.84/218.00  |- skos__hiddenLabel mesh__D018567 Male Breast Neoplasm
% 217.84/218.00  |- mesh__historyNote mesh__D018567 95   
% 217.84/218.00  |- skos__altLabel mesh__D018567 Breast Tumors, Male
% 217.84/218.00  |- skos__hiddenLabel mesh__D018567 Cancer, Male Breast
% 217.84/218.00  |- skos__altLabel mesh__D018567 Breast Cancer, Male
% 217.84/218.00  |- skos__altLabel mesh__D018567 Neoplasms, Breast, Male
% 217.84/218.00  |- skos__hiddenLabel mesh__D018567 Neoplasm, Male Breast
% 217.84/218.00  |- skos__altLabel mesh__D018567 Neoplasms, Male Breast
% 217.84/218.00  |- skos__historyNote mesh__D018567 Breast Neoplasms %28%1966-1994%29%
% 217.84/218.00  |- skos__annotation mesh__D018567
% 217.84/218.00        human only; for animal, see note at BREAST NEOPLASMS; coordinate IM with histological type of neoplasm %28%IM%29%; check tags HUMANS %26% MALE%A%  
% 217.84/218.00  |- skos__prefLabel mesh__D018567 Breast Neoplasms, Male
% 217.84/218.00  |- skos__hiddenLabel mesh__D018567 Male Breast Carcinoma
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D018567 2006
% 217.84/218.00  |- skos__hiddenLabel mesh__D010584 phi X174, Phage
% 217.84/218.00  |- skos__broader mesh__D010584smesh__D017915
% 217.84/218.00  |- mesh__activeMeSHYear mesh__D010584 2006
% 217.84/218.00  |- skos__prefLabel mesh__D010584 Bacteriophage phi X 174
% 217.84/218.01  |- skos__altLabel mesh__D010584 Phage phi X 174
% 217.84/218.01  |- mesh__onlineNote mesh__D010584
% 217.84/218.01       use BACTERIOPHAGE PHI X 174 to search PHI X 174 1980-93 %26% PHAGE PHI X 174 1980-92%A%  
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D010584 2002
% 217.84/218.01  |- skos__broader mesh__D010584smesh__D003090
% 217.84/218.01  |- mesh__dateRevised mesh__D010584 2001-07-25
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D010584 2005
% 217.84/218.01  |- mesh__dateCreated mesh__D010584 1979-04-16
% 217.84/218.01  |- skos__altLabel mesh__D010584 Coliphage phi X 174
% 217.84/218.01  |- mesh__historyNote mesh__D010584
% 217.84/218.01       93; was PHAGE PHI X 174 1980-92; PHI X 174 was see BACTERIOPHAGE PHI X 174 1980-93; BACTERIOPHAGE PHI X 174 was see PHAGE PHI X 174 1980-92%A%  
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D010584 2004
% 217.84/218.01  |- mesh__publicMeSHNote mesh__D010584
% 217.84/218.01       93; was PHAGE PHI X 174 1980-92; PHI X 174 was see BACTERIOPHAGE PHI X 174 1980-93; BACTERIOPHAGE PHI X 174 was see PHAGE PHI X 174 1980-92%A%  
% 217.84/218.01  |- mesh__dateEstablished mesh__D010584 1980-01-01
% 217.84/218.01  |- skos__scopeNote mesh__D010584
% 217.84/218.01       The type species of the genus MICROVIRUS. A prototype of the small virulent DNA coliphages, it is composed of a single strand of supercoiled circular DNA, which on infection, is converted to a double-stranded replicative form by a host enzyme.%A%    
% 217.84/218.01  |- skos__historyNote mesh__D010584 Coliphages %28%1966-1979%29%
% 217.84/218.01  |- skos__altLabel mesh__D010584 Enterobacteria phage phi X 174
% 217.84/218.01  |- rdf__type mesh__D010584sskos__Concept
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D010584 2003
% 217.84/218.01  |- mesh__recordOriginator mesh__D010584 AEP
% 217.84/218.01  |- skos__altLabel mesh__D010584 phi X 174 Phage
% 217.84/218.01  |- mesh__recordAuthorizer mesh__D010584 sjn
% 217.84/218.01  |- mesh__recordMaintainer mesh__D010584 ags
% 217.84/218.01  |- skos__altLabel mesh__D010584 Phage phi X174
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D037721 2005
% 217.84/218.01  |- skos__broader mesh__D037721smesh__D037661
% 217.84/218.01  |- skos__historyNote mesh__D037721 Pulmonary Surfactants %28%1990-2002%29%
% 217.84/218.01  |- skos__hiddenLabel mesh__D037721
% 217.84/218.01       Pulmonary Surfactant Associated Protein SP C
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D037721 2006
% 217.84/218.01  |- mesh__historyNote mesh__D037721
% 217.84/218.01       2003; use PULMONARY SURFACTANT-ASSOCIATED PROTEIN C %28%NM%29% 1990-2002%A%  
% 217.84/218.01  |- mesh__dateCreated mesh__D037721 2002-07-03
% 217.84/218.01  |- skos__annotation mesh__D037721 DF: SP-C PROTEIN   
% 217.84/218.01  |- skos__altLabel mesh__D037721 Surfactant Polypeptide SP-C
% 217.84/218.01  |- skos__altLabel mesh__D037721 SP-C protein
% 217.84/218.01  |- skos__prefLabel mesh__D037721 Pulmonary Surfactant-Associated Protein C
% 217.84/218.01  |- skos__hiddenLabel mesh__D037721 Surfactant Polypeptide SP C
% 217.84/218.01  |- mesh__dateEstablished mesh__D037721 2003-01-01
% 217.84/218.01  |- skos__hiddenLabel mesh__D037721 SP-C, Surfactant Polypeptide
% 217.84/218.01  |- skos__hiddenLabel mesh__D037721 SP C protein
% 217.84/218.01  |- rdf__type mesh__D037721sskos__Concept
% 217.84/218.01  |- skos__hiddenLabel mesh__D037721
% 217.84/218.01       Pulmonary Surfactant Associated Protein C
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D037721 2003
% 217.84/218.01  |- skos__broader mesh__D037721smesh__D011510
% 217.84/218.01  |- skos__altLabel mesh__D037721 Pulmonary Surfactant Protein C
% 217.84/218.01  |- skos__altLabel mesh__D037721
% 217.84/218.01       Pulmonary Surfactant-Associated Protein SP-C
% 217.84/218.01  |- skos__scopeNote mesh__D037721
% 217.84/218.01       A pulmonary surfactant associated protein that plays a role in alveolar stability by lowering the surface tension at the air-liquid interface. It is a membrane-bound protein that constitutes 1-2%25% of the pulmonary surfactant mass. Pulmonary surfactant-associated protein C is one of the most hydrophobic peptides yet isolated and contains an alpha-helical domain with a central poly-valine segment that binds to phospholipid bilayers.%A%    
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D037721 2004
% 217.84/218.01  |- skos__broader mesh__D037721smesh__D008565
% 217.84/218.01  |- skos__historyNote mesh__D037721 Proteolipids %28%1990-2002%29%
% 217.84/218.01  |- mesh__publicMeSHNote mesh__D037721
% 217.84/218.01       2003; PULMONARY SURFACTANT ASSOCIATED-PROTEIN SP-C %28%now PULMONARY SURFACTANT-ASSOCIATED PROTEIN C%29% was indexed under PROTEOLIPIDS %26% PULMONARY SURFACTANTS 1990-2002%A%  
% 217.84/218.01  |- mesh__dateRevised mesh__D004547 2005-06-30
% 217.84/218.01  |- skos__hiddenLabel mesh__D004547 Tissues, Elastic
% 217.84/218.01  |- skos__hiddenLabel mesh__D004547 Fibers, Elastic
% 217.84/218.01  |- rdf__type mesh__D004547sskos__Concept
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D004547 2006
% 217.84/218.01  |- mesh__recordMaintainer mesh__D004547 ags
% 217.84/218.01  |- skos__prefLabel mesh__D004547 Elastic Tissue
% 217.84/218.01  |- mesh__recordAuthorizer mesh__D004547 sjn
% 217.84/218.01  |- mesh__dateCreated mesh__D004547 1999-01-01
% 217.84/218.01  |- skos__hiddenLabel mesh__D004547 Tissue, Elastic
% 217.84/218.01  |- skos__broader mesh__D004547smesh__D003238
% 217.84/218.01  |- skos__scopeNote mesh__D004547
% 217.84/218.01       Connective tissue comprised chiefly of elastic fibers. Elastic fibers have two components: ELASTIN and MICROFIBRILS.%A%    
% 217.84/218.01  |- skos__annotation mesh__D004547 ELASTIC CARTILAGE is also available   
% 217.84/218.01  |- mesh__recordOriginator mesh__D004547 NLM
% 217.84/218.01  |- skos__hiddenLabel mesh__D004547 Fiber, Elastic
% 217.84/218.01  |- skos__hiddenLabel mesh__D004547 Elastic Tissues
% 217.84/218.01  |- skos__hiddenLabel mesh__D004547 Elastic Fiber
% 217.84/218.01  |- mesh__dateEstablished mesh__D023701 2002-01-01
% 217.84/218.01  |- skos__prefLabel mesh__D023701 Smegmamorpha
% 217.84/218.01  |- skos__hiddenLabel mesh__D023701 Stickleback
% 217.84/218.01  |- skos__altLabel mesh__D023701 Gasterosteidae
% 217.84/218.01  |- skos__broader mesh__D023701smesh__D005399
% 217.84/218.01  |- skos__altLabel mesh__D023701 Synbranchidae
% 217.84/218.01  |- mesh__publicMeSHNote mesh__D023701
% 217.84/218.01       2002; for STICKLEBACKS see FISHES 1975-2001; for MULLETS see PERCIFORMES 1987-2001%A%  
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D023701 2005A
% 217.84/218.01  |- skos__hiddenLabel mesh__D023701 Swamp Eel
% 217.84/218.01  |- skos__hiddenLabel mesh__D023701 Eel, Swamp
% 217.84/218.01  |- mesh__historyNote mesh__D023701
% 217.84/218.01       2002; for STICKLEBACKS use FISHES 1975-2001; for MULLETS use PERCIFORMES 1987-2001%A%  
% 217.84/218.01  |- skos__annotation mesh__D023701
% 217.84/218.01       note X ref SWAMP EELS; EELS is also available   
% 217.84/218.01  |- skos__altLabel mesh__D023701 Eels, Swamp
% 217.84/218.01  |- mesh__recordMaintainer mesh__D023701 jls
% 217.84/218.01  |- skos__scopeNote mesh__D023701
% 217.84/218.01       Group of fish under the superorder Acanthopterygii, separate from the PERCIFORMES, which includes swamp eels, mullets, sticklebacks, seahorses, spiny eels, rainbowfishes, and KILLIFISHES. The name is derived from the six taxa which comprise the group. %28%From http://www.nanfa.org/articles/Elassoma/elassoma.htm, 8/4/2000%29%%A%    
% 217.84/218.01  |- mesh__recordOriginator mesh__D023701 ags
% 217.84/218.01  |- skos__hiddenLabel mesh__D023701 Mullet
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D023701 2005
% 217.84/218.01  |- rdf__type mesh__D023701sskos__Concept
% 217.84/218.01  |- mesh__dateRevised mesh__D023701 2004-08-02
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D023701 2006
% 217.84/218.01  |- mesh__dateCreated mesh__D023701 2001-07-25
% 217.84/218.01  |- mesh__recordAuthorizer mesh__D023701 jls
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D023701 2004
% 217.84/218.01  |- skos__hiddenLabel mesh__D023701 Seahorse
% 217.84/218.01  |- skos__altLabel mesh__D009232 Angiomyxoma
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D009232 1996
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D009232 2005
% 217.84/218.01  |- skos__broader mesh__D009232smesh__D009372
% 217.84/218.01  |- skos__hiddenLabel mesh__D009232 Myxomas
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D009232 1999
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D009232 2004
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D009232 2001
% 217.84/218.01  |- skos__hiddenLabel mesh__D009232 Angiomyxomas
% 217.84/218.01  |- mesh__dateRevised mesh__D009232 1995-06-08
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D009232 1998
% 217.84/218.01  |- rdf__type mesh__D009232sskos__Concept
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D009232 2000
% 217.84/218.01  |- mesh__dateCreated mesh__D009232 1999-01-01
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D009232 2003
% 217.84/218.01  |- mesh__recordAuthorizer mesh__D009232 PLS
% 217.84/218.01  |- skos__annotation mesh__D009232
% 217.84/218.01       /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 217.84/218.01  |- mesh__recordOriginator mesh__D009232 NLM
% 217.84/218.01  |- mesh__recordMaintainer mesh__D009232 KEV
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D009232 1997
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D009232 2006
% 217.84/218.01  |- skos__scopeNote mesh__D009232
% 217.84/218.01       A benign neoplasm derived from connective tissue, consisting chiefly of polyhedral and stellate cells that are loosely embedded in a soft mucoid matrix, thereby resembling primitive mesenchymal tissue. It occurs frequently intramuscularly where it may be mistaken for a sarcoma. It appears also in the jaws and the skin. %28%From Stedman, 25th ed%29%%A%    
% 217.84/218.01  |- skos__prefLabel mesh__D009232 Myxoma
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D009232 2002
% 217.84/218.01  |- skos__altLabel mesh__D014975
% 217.84/218.01       beta,epsilon-Carotene-3,3%27%-diol, %28%3S,3%27%R,6%27%S%29%-
% 217.84/218.01  |- mesh__historyNote mesh__D014975 2002%28%1966%29%   
% 217.84/218.01  |- skos__broader mesh__D014975smesh__D024341
% 217.84/218.01  |- skos__hiddenLabel mesh__D014975 Lutein, gamma
% 217.84/218.01  |- mesh__recordMaintainer mesh__D014975 ssb
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D014975 2006
% 217.84/218.01  |- mesh__dateCreated mesh__D014975 1999-01-01
% 217.84/218.01  |- skos__scopeNote mesh__D014975
% 217.84/218.01       A carotenoid alcohol widespread in nature. It is present in egg yolk, algae, and petals of yellow flowers, among other sources.%A%    
% 217.84/218.01  |- mesh__dateRevised mesh__D014975 2005-06-30
% 217.84/218.01  |- mesh__publicMeSHNote mesh__D014975 2002; see XANTHOPHYLL 1966-2001   
% 217.84/218.01  |- skos__prefLabel mesh__D014975 Lutein
% 217.84/218.01  |- skos__altLabel mesh__D014975 gamma Lutein
% 217.84/218.01  |- skos__altLabel mesh__D014975
% 217.84/218.01       beta,epsilon-Carotene-3, 3%27%-Diol, %28%3R,3%27%R,6%27%S%29%-
% 217.84/218.01  |- mesh__recordAuthorizer mesh__D014975 sjn
% 217.84/218.01  |- mesh__recordOriginator mesh__D014975 NLM
% 217.84/218.01  |- rdf__type mesh__D014975sskos__Concept
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D014177 1996
% 217.84/218.01  |- rdf__type mesh__D014177sskos__Concept
% 217.84/218.01  |- mesh__dateCreated mesh__D014177 1999-01-01
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D014177 2001
% 217.84/218.01  |- mesh__recordOriginator mesh__D014177 NLM
% 217.84/218.01  |- skos__annotation mesh__D014177 a cataloging term; no qualif   
% 217.84/218.01  |- mesh__dateRevised mesh__D014177 1990-03-23
% 217.84/218.01  |- skos__scopeNote mesh__D014177
% 217.84/218.01       Products resulting from the conversion of one language to another.%A%    
% 217.84/218.01  |- skos__prefLabel mesh__D014177 Translations
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D014177 1995
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D014177 2000
% 217.84/218.01  |- skos__broader mesh__D014177smesh__D011642
% 217.84/218.01  |- mesh__recordAuthorizer mesh__D014177 PLS
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D014177 2006
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D014177 1993
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D014177 1994
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D014177 1991
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D014177 2005
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D014177 2004
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D014177 1992
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D014177 1999
% 217.84/218.01  |- mesh__recordMaintainer mesh__D014177 TGC
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D014177 2002
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D014177 2003
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D014177 1998
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D014177 1997
% 217.84/218.01  |- skos__broader mesh__D008938smesh__D048750
% 217.84/218.01  |- skos__related mesh__D008938smesh__D016200
% 217.84/218.01  |- rdf__type mesh__D008938sskos__Concept
% 217.84/218.01  |- skos__hiddenLabel mesh__D008938 Mitoses
% 217.84/218.01  |- skos__hiddenLabel mesh__D008938 M Phases, Mitotic
% 217.84/218.01  |- mesh__recordMaintainer mesh__D008938 ssb
% 217.84/218.01  |- mesh__dateCreated mesh__D008938 1999-01-01
% 217.84/218.01  |- mesh__historyNote mesh__D008938
% 217.84/218.01       68; was see under CELL DIVISION 1963-67; KARYOKINESIS was see under CELL DIVISION 1963-80%A%  
% 217.84/218.01  |- mesh__dateRevised mesh__D008938 2005-06-30
% 217.84/218.01  |- skos__related mesh__D008938smesh__D008934
% 217.84/218.01  |- skos__altLabel mesh__D008938 Mitotic M Phase
% 217.84/218.01  |- mesh__publicMeSHNote mesh__D008938
% 217.84/218.01       68; was see under CELL DIVISION 1963-67; KARYOKINESIS was see under CELL DIVISION 1963-80%A%  
% 217.84/218.01  |- skos__hiddenLabel mesh__D008938 Phases, Mitotic M
% 217.84/218.01  |- skos__hiddenLabel mesh__D008938 Phase, Mitotic M
% 217.84/218.01  |- skos__hiddenLabel mesh__D008938 Mitotic M Phases
% 217.84/218.01  |- mesh__recordAuthorizer mesh__D008938 sjn
% 217.84/218.01  |- skos__scopeNote mesh__D008938
% 217.84/218.01       A type of CELL NUCLEUS division by means of which the two daughter nuclei normally receive identical complements of the number of CHROMOSOMES of the somatic cells of the species.%A%    
% 217.84/218.01  |- skos__prefLabel mesh__D008938 Mitosis
% 217.84/218.01  |- skos__related mesh__D008938smesh__D050256
% 217.84/218.01  |- skos__historyNote mesh__D008938 Cell Division %28%1966-1967%29%
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D008938 2006
% 217.84/218.01  |- mesh__recordOriginator mesh__D008938 NLM
% 217.84/218.01  |- mesh__dateEstablished mesh__D008938 1968-01-01
% 217.84/218.01  |- mesh__onlineNote mesh__D008938
% 217.84/218.01       search CELL DIVISION 1966-67; use CELL DIVISION to search KARYOKINESIS 1966-80%A%  
% 217.84/218.01  |- skos__related mesh__D008938smesh__D008940
% 217.84/218.01  |- skos__historyNote mesh__D000955 T Lymphocytes %28%1973-1981%29%
% 217.84/218.01  |- mesh__recordOriginator mesh__D000955 SAG
% 217.84/218.01  |- mesh__publicMeSHNote mesh__D000955 82   
% 217.84/218.01  |- skos__broader mesh__D000955smesh__D000941
% 217.84/218.01  |- mesh__recordMaintainer mesh__D000955 ssb
% 217.84/218.01  |- skos__altLabel mesh__D000955 Thymus-Independent Antigens
% 217.84/218.01  |- skos__historyNote mesh__D000955 B Lymphocytes %28%1973-1981%29%
% 217.84/218.01  |- skos__hiddenLabel mesh__D000955 TI 2 Antigens
% 217.84/218.01  |- rdf__type mesh__D000955sskos__Concept
% 217.84/218.01  |- mesh__recordAuthorizer mesh__D000955 sjn
% 217.84/218.01  |- mesh__dateCreated mesh__D000955 1981-05-20
% 217.84/218.01  |- mesh__dateEstablished mesh__D000955 1982-01-01
% 217.84/218.01  |- skos__historyNote mesh__D000955 Lymphocytes %28%1969-1972%29%
% 217.84/218.01  |- skos__hiddenLabel mesh__D000955 Thymus Independent Antigens
% 217.84/218.01  |- skos__hiddenLabel mesh__D000955 Antigens, Thymus-Independent
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D000955 2006
% 217.84/218.01  |- mesh__historyNote mesh__D000955 82   
% 217.84/218.01  |- skos__altLabel mesh__D000955 T-Independent Antigens
% 217.84/218.01  |- skos__historyNote mesh__D000955 Antibody Formation %28%1969-1971%29%
% 217.84/218.01  |- skos__altLabel mesh__D000955 Antigens, T Independent
% 217.84/218.01  |- skos__hiddenLabel mesh__D000955 T Independent Antigens
% 217.84/218.01  |- skos__hiddenLabel mesh__D000955 Antigens, TI-2
% 217.84/218.01  |- skos__scopeNote mesh__D000955
% 217.84/218.01       Antigens which may directly stimulate B lymphocytes without the cooperation of T lymphocytes.%A%    
% 217.84/218.01  |- skos__prefLabel mesh__D000955 Antigens, T-Independent
% 217.84/218.01  |- skos__hiddenLabel mesh__D000955 Independent Antigens, T
% 217.84/218.01  |- mesh__dateRevised mesh__D000955 2005-06-30
% 217.84/218.01  |- skos__prefLabel mesh__D019660 Malvaceae
% 217.84/218.01  |- mesh__historyNote mesh__D019660 98   
% 217.84/218.01  |- mesh__recordAuthorizer mesh__D019660 ags
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D019660 2006
% 217.84/218.01  |- mesh__dateRevised mesh__D019660 2005-07-12
% 217.84/218.01  |- rdf__type mesh__D019660sskos__Concept
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D019660 2005
% 217.84/218.01  |- mesh__recordMaintainer mesh__D019660 ags
% 217.84/218.01  |- mesh__recordOriginator mesh__D019660 JLS
% 217.84/218.01  |- mesh__publicMeSHNote mesh__D019660 98   
% 217.84/218.01  |- skos__annotation mesh__D019660
% 217.84/218.01       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D019660 2004
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D019660 2006A
% 217.84/218.01  |- skos__scopeNote mesh__D019660
% 217.84/218.01       The mallow family of the order Malvales, subclass Dilleniidae, class Magnoliopsida.  Members include GOSSYPIUM, okra %28%ABELMOSCHUS%29%, HIBISCUS, and CACAO.  The common names of hollyhock and mallow are used for several genera of Malvaceae.%A%    
% 217.84/218.01  |- mesh__dateEstablished mesh__D019660 1998-01-01
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D019660 2003
% 217.84/218.01  |- mesh__dateCreated mesh__D019660 1997-06-20
% 217.84/218.01  |- skos__broader mesh__D019660smesh__D019684
% 217.84/218.01  |- mesh__dateCreated mesh__D000157 1974-11-19
% 217.84/218.01  |- skos__altLabel mesh__D000157 Acetylbenzoyl-aconine
% 217.84/218.01  |- rdf__type mesh__D000157sskos__Concept
% 217.84/218.01  |- skos__broader mesh__D000157smesh__D000470
% 217.84/218.01  |- skos__scopeNote mesh__D000157
% 217.84/218.01       A C19 norditerpenoid alkaloid %28%DITERPENES%29% from the root of ACONITUM plants. It activates voltage-gated SODIUM CHANNELS. It has been used to induce ARRHYTHMIA in experimental animals and it has antiinflammatory and antineuralgic properties.%A%    
% 217.84/218.01  |- mesh__recordMaintainer mesh__D000157 ssb
% 217.84/218.01  |- mesh__publicMeSHNote mesh__D000157 91; was see under ACONITE 1975-90   
% 217.84/218.01  |- skos__altLabel mesh__D000157 Acetylbenzoylaconine
% 217.84/218.01  |- mesh__dateEstablished mesh__D000157 1991-01-01
% 217.84/218.01  |- mesh__recordOriginator mesh__D000157 NLM
% 217.84/218.01  |- skos__historyNote mesh__D000157 Aconite %28%1972-1974%29%
% 217.84/218.01  |- skos__prefLabel mesh__D000157 Aconitine
% 217.84/218.01  |- mesh__historyNote mesh__D000157
% 217.84/218.01       91%28%75%29%; was see under ACONITE 1975-90   
% 217.84/218.01  |- skos__broader mesh__D000157smesh__D004224
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D000157 2006
% 217.84/218.01  |- mesh__dateRevised mesh__D000157 2004-07-07
% 217.84/218.01  |- skos__annotation mesh__D000157
% 217.84/218.01       ACONITE %28%see ACONITUM%29% is also available   
% 217.84/218.01  |- mesh__recordAuthorizer mesh__D000157 sjn
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D000157 2005
% 217.84/218.01  |- skos__hiddenLabel mesh__D000157 Acetylbenzoyl aconine
% 217.84/218.01  |- skos__related mesh__D005640smesh__D011962
% 217.84/218.01  |- mesh__publicMeSHNote mesh__D005640
% 217.84/218.01       2002; see FSH 1963-2001; for FOLLICLE STIMULATING HORMONE see FSH 1963-2001%A%  
% 217.84/218.01  |- mesh__recordMaintainer mesh__D005640 sjn
% 217.84/218.01  |- mesh__historyNote mesh__D005640 2002%28%1963%29%   
% 217.84/218.01  |- rdf__type mesh__D005640sskos__Concept
% 217.84/218.01  |- skos__annotation mesh__D005640
% 217.84/218.01       for alpha subunit, coord with GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT is also available; FOLLICLE STIMULATING HORMONE, HUMAN is also available%A%  
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D005640 2006
% 217.84/218.01  |- mesh__dateCreated mesh__D005640 1999-01-01
% 217.84/218.01  |- skos__altLabel mesh__D005640 FSH %28%Follicle Stimulating Hormone%29%
% 217.84/218.01  |- mesh__dateRevised mesh__D005640 2004-07-13
% 217.84/218.01  |- skos__prefLabel mesh__D005640 Follicle Stimulating Hormone
% 217.84/218.01  |- mesh__recordAuthorizer mesh__D005640 sjn
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D005640 2005
% 217.84/218.01  |- skos__altLabel mesh__D005640 Follitropin
% 217.84/218.01  |- skos__scopeNote mesh__D005640
% 217.84/218.01       A major gonadotropin secreted by the adenohypophysis %28%PITUITARY GLAND, ANTERIOR%29%. Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones %28%TSH, LH, and FSH%29%, but the beta subunit is unique and confers its biological specificity.%A%    
% 217.84/218.01  |- mesh__recordOriginator mesh__D005640 NLM
% 217.84/218.01  |- skos__broader mesh__D005640smesh__D006065
% 217.84/218.01  |- skos__altLabel mesh__D005640 Follicle-Stimulating Hormone
% 217.84/218.01  |- skos__broader mesh__D018568smesh__D000886
% 217.84/218.01  |- rdf__type mesh__D018568sskos__Concept
% 217.84/218.01  |- mesh__dateRevised mesh__D018568 2004-07-07
% 217.84/218.01  |- skos__hiddenLabel mesh__D018568 Crown Rump Length
% 217.84/218.01  |- skos__prefLabel mesh__D018568 Crown-Rump Length
% 217.84/218.01  |- mesh__recordMaintainer mesh__D018568 nns
% 217.84/218.01  |- skos__hiddenLabel mesh__D018568 Crown-Rump Lengths
% 217.84/218.01  |- mesh__recordOriginator mesh__D018568 JLS
% 217.84/218.01  |- mesh__historyNote mesh__D018568 95   
% 217.84/218.01  |- mesh__dateEstablished mesh__D018568 1995-01-01
% 217.84/218.01  |- skos__hiddenLabel mesh__D018568 Length, Crown-Rump
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D018568 2006
% 217.84/218.01  |- skos__scopeNote mesh__D018568
% 217.84/218.01       In utero measurement corresponding to the sitting height %28%crown to rump%29% of the fetus. Length is considered a more accurate criterion of the age of the fetus than is the weight. The average crown-rump length of the fetus at term is 36 cm. %28%From Williams Obstetrics, 18th ed, p91%29%%A%    
% 217.84/218.01  |- mesh__dateCreated mesh__D018568 1994-04-19
% 217.84/218.01  |- skos__broader mesh__D018568smesh__D001837
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D018568 2005
% 217.84/218.01  |- skos__hiddenLabel mesh__D018568 Lengths, Crown-Rump
% 217.84/218.01  |- mesh__publicMeSHNote mesh__D018568 95   
% 217.84/218.01  |- mesh__recordAuthorizer mesh__D018568 sjn
% 217.84/218.01  |- skos__annotation mesh__D018568 measurement in utero; no qualif   
% 217.84/218.01  |- skos__hiddenLabel mesh__D010585 Dysfunction, Phagocyte Bactericidal
% 217.84/218.01  |- mesh__dateEstablished mesh__D010585 1972-01-01
% 217.84/218.01  |- mesh__recordMaintainer mesh__D010585 TGC
% 217.84/218.01  |- mesh__dateCreated mesh__D010585 1999-01-01
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D010585 2005
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D010585 1998
% 217.84/218.01  |- mesh__recordOriginator mesh__D010585 NLM
% 217.84/218.01  |- skos__historyNote mesh__D010585 Granuloma %28%1966-1971%29%
% 217.84/218.01  |- mesh__publicMeSHNote mesh__D010585 72   
% 217.84/218.01  |- mesh__recordAuthorizer mesh__D010585 PLS
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D010585 2004
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D010585 1997
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D010585 2002
% 217.84/218.01  |- skos__hiddenLabel mesh__D010585 Bactericidal Dysfunctions, Phagocyte
% 217.84/218.01  |- rdf__type mesh__D010585sskos__Concept
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D010585 2003
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D010585 1996
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D010585 1995
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D010585 2001
% 217.84/218.01  |- skos__scopeNote mesh__D010585
% 217.84/218.01       Disorders in which phagocytic cells cannot kill ingested bacteria; characterized by frequent recurring infection with formulation of granulomas.%A%    
% 217.84/218.01  |- skos__historyNote mesh__D010585
% 217.84/218.01       Immunologic Deficiency Syndromes %28%1968-1971%29%
% 217.84/218.01  |- skos__broader mesh__D010585smesh__D007960
% 217.84/218.01  |- skos__broader mesh__D010585smesh__D007153
% 217.84/218.01  |- skos__historyNote mesh__D010585 Phagocytosis %28%1966-1971%29%
% 217.84/218.01  |- skos__hiddenLabel mesh__D010585 Phagocyte Bactericidal Dysfunctions
% 217.84/218.01  |- skos__annotation mesh__D010585
% 217.84/218.01       immunodefic syndrome where phagocytes cannot kill bacteria%A%  
% 217.84/218.01  |- skos__prefLabel mesh__D010585 Phagocyte Bactericidal Dysfunction
% 217.84/218.01  |- skos__hiddenLabel mesh__D010585 Bactericidal Dysfunction, Phagocyte
% 217.84/218.01  |- mesh__dateRevised mesh__D010585 1993-06-02
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D010585 1994
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D010585 2000
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D010585 2006
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D010585 1999
% 217.84/218.01  |- mesh__historyNote mesh__D010585 72   
% 217.84/218.01  |- skos__hiddenLabel mesh__D010585 Dysfunctions, Phagocyte Bactericidal
% 217.84/218.01  |- mesh__recordOriginator mesh__D004548 NLM
% 217.84/218.01  |- mesh__dateEstablished mesh__D004548 1967-01-01
% 217.84/218.01  |- mesh__historyNote mesh__D004548 67%28%64%29%   
% 217.84/218.01  |- skos__prefLabel mesh__D004548 Elasticity
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D004548 2006
% 217.84/218.01  |- rdf__type mesh__D004548sskos__Concept
% 217.84/218.01  |- skos__broader mesh__D004548smesh__D001696
% 217.84/218.01  |- mesh__publicMeSHNote mesh__D004548 67   
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D004548 2005
% 217.84/218.01  |- mesh__recordAuthorizer mesh__D004548 sjn
% 217.84/218.01  |- skos__annotation mesh__D004548 of inanimate or living structures; NIM   
% 217.84/218.01  |- mesh__dateCreated mesh__D004548 1999-01-01
% 217.84/218.01  |- skos__scopeNote mesh__D004548
% 217.84/218.01       Resistance and recovery from distortion of shape.     
% 217.84/218.01  |- mesh__dateRevised mesh__D004548 2003-07-09
% 217.84/218.01  |- skos__broader mesh__D004548smesh__D019563
% 217.84/218.01  |- mesh__recordMaintainer mesh__D004548 nns
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D004548 2004
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D015270 2000A
% 217.84/218.01  |- skos__hiddenLabel mesh__D015270 Mycobacterium intracellulare Infections
% 217.84/218.01  |- mesh__recordOriginator mesh__D015270 EC
% 217.84/218.01  |- rdf__type mesh__D015270sskos__Concept
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D015270 2002
% 217.84/218.01  |- skos__historyNote mesh__D015270
% 217.84/218.01       Mycobacterium Infections %28%1966-1988%29%
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D015270 2003
% 217.84/218.01  |- mesh__historyNote mesh__D015270 1989   
% 217.84/218.01  |- skos__hiddenLabel mesh__D015270
% 217.84/218.01       Mycobacterium avium-intracellulare Infections
% 217.84/218.01  |- skos__prefLabel mesh__D015270
% 217.84/218.01       Mycobacterium avium-intracellulare Infection
% 217.84/218.01  |- skos__historyNote mesh__D015270 Mycobacterium avium %28%1975-1988%29%
% 217.84/218.01  |- mesh__activeMeSHYear mesh__D015270 2001
% 217.84/218.01  |- skos__scopeNote mesh__D015270
% 217.84/218.01       A nontuberculous infection when occurring in humans. It is characterized by pulmonary disease, lymphadenitis in children, and systemic disease in AIDS patients. Mycobacterium avium-intracellulare infection of birds and swine results in tuberculosis.%A%    
% 217.84/218.01  |- skos__annotation mesh__D015270 DF: MAI INFECT   
% 217.87/218.01  |- skos__altLabel mesh__D015270 Mycobacterium intracellulare Infection
% 217.87/218.01  |- mesh__activeMeSHYear mesh__D015270 2000
% 217.87/218.01  |- skos__broader mesh__D015270smesh__D009165
% 217.87/218.01  |- skos__altLabel mesh__D015270
% 217.87/218.01       Mycobacterium avium intracellulare Infection
% 217.87/218.01  |- mesh__activeMeSHYear mesh__D015270 1999
% 217.87/218.01  |- mesh__publicMeSHNote mesh__D015270 1989   
% 217.87/218.01  |- skos__hiddenLabel mesh__D015270 Infections, Mycobacterium intracellulare
% 217.87/218.01  |- skos__altLabel mesh__D015270
% 217.87/218.01       Infection, Mycobacterium avium-intracellulare
% 217.87/218.01  |- skos__altLabel mesh__D015270 Infection, Mycobacterium intracellulare
% 217.87/218.01  |- mesh__activeMeSHYear mesh__D015270 2006
% 217.87/218.01  |- mesh__activeMeSHYear mesh__D015270 2005
% 217.87/218.01  |- mesh__dateRevised mesh__D015270 1999-12-16
% 217.87/218.01  |- skos__hiddenLabel mesh__D015270
% 217.87/218.01       Infection, Mycobacterium avium intracellulare
% 217.87/218.01  |- mesh__dateEstablished mesh__D015270 1989-01-01
% 217.87/218.01  |- mesh__recordMaintainer mesh__D015270 ags
% 217.87/218.01  |- mesh__activeMeSHYear mesh__D015270 2004
% 217.87/218.01  |- skos__hiddenLabel mesh__D015270
% 217.87/218.01       Infections, Mycobacterium avium-intracellulare
% 217.87/218.01  |- mesh__recordAuthorizer mesh__D015270 ags
% 217.87/218.01  |- mesh__dateCreated mesh__D015270 1988-05-19
% 217.87/218.01  |- mesh__recordOriginator mesh__D023702 ags
% 217.87/218.01  |- mesh__publicMeSHNote mesh__D023702
% 217.87/218.01       2002; for GYMNOTID see ELECTRIC FISH 1987-2001   
% 217.87/218.01  |- skos__broader mesh__D023702smesh__D004555
% 217.87/218.01  |- skos__scopeNote mesh__D023702
% 217.87/218.01       An order of neotropical electric fish found chiefly in the waters of South America. They continually emit weak electric discharges, which they use in object location and communication. A most popular species of research interest is the electric eel, ELECTROPHORUS electricus.%A%    
% 217.87/218.01  |- mesh__activeMeSHYear mesh__D023702 2005
% 217.87/218.01  |- mesh__dateCreated mesh__D023702 2001-07-25
% 217.87/218.01  |- mesh__historyNote mesh__D023702
% 217.87/218.01       2002; for GYMNOTID use ELECTRIC FISH 1987-2001   
% 217.87/218.01  |- mesh__dateRevised mesh__D023702 2003-07-09
% 217.87/218.01  |- skos__altLabel mesh__D023702 Gymnotidae
% 217.87/218.01  |- rdf__type mesh__D023702sskos__Concept
% 217.87/218.01  |- mesh__activeMeSHYear mesh__D023702 2006
% 217.87/218.01  |- mesh__activeMeSHYear mesh__D023702 2004
% 217.87/218.01  |- mesh__recordAuthorizer mesh__D023702 sjn
% 217.87/218.01  |- skos__hiddenLabel mesh__D023702 Eigenmannias
% 217.87/218.01  |- skos__hiddenLabel mesh__D023702 Gymnotids
% 217.87/218.01  |- mesh__recordMaintainer mesh__D023702 ags
% 217.87/218.01  |- mesh__dateEstablished mesh__D023702 2002-01-01
% 217.87/218.01  |- skos__prefLabel mesh__D023702 Gymnotiformes
% 217.87/218.01  |- mesh__recordOriginator mesh__D009233 NLM
% 217.87/218.01  |- skos__altLabel mesh__D009233 Myxomatosis Virus
% 217.87/218.01  |- mesh__dateRevised mesh__D009233 2001-07-25
% 217.87/218.01  |- skos__hiddenLabel mesh__D009233 Myxomatosis Viruses
% 217.87/218.01  |- mesh__activeMeSHYear mesh__D009233 2002
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D009233 2004
% 217.87/218.02  |- rdf__type mesh__D009233sskos__Concept
% 217.87/218.02  |- mesh__dateCreated mesh__D009233 1999-01-01
% 217.87/218.02  |- skos__hiddenLabel mesh__D009233 Myxoma viruses
% 217.87/218.02  |- skos__annotation mesh__D009233
% 217.87/218.02       infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% or index if pertinent under MYXOMATOSIS, INFECTIOUS instead%A%  
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D009233 2003
% 217.87/218.02  |- skos__broader mesh__D009233smesh__D018152
% 217.87/218.02  |- skos__prefLabel mesh__D009233 Myxoma virus
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D009233 2006
% 217.87/218.02  |- mesh__recordMaintainer mesh__D009233 ags
% 217.87/218.02  |- mesh__recordAuthorizer mesh__D009233 sjn
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D009233 2005
% 217.87/218.02  |- skos__altLabel mesh__D009233 Poxvirus Myxomatis
% 217.87/218.02  |- skos__scopeNote mesh__D009233
% 217.87/218.02       The type species of LEPORIPOXVIRUS causing infectious myxomatosis, a severe generalized disease, in rabbits. Tumors are not always present.%A%    
% 217.87/218.02  |- mesh__publicMeSHNote mesh__D001250 91; was see under ASTHMA 1979-90   
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001250 2001
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001250 2005
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001250 2002
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001250 1994
% 217.87/218.02  |- skos__scopeNote mesh__D001250
% 217.87/218.02       Asthma attacks following a period of exercise. Usually the induced attack is short-lived and regresses spontaneously. The magnitude of postexertional airway obstruction is strongly influenced by the environment in which exercise is performed %28%i.e. inhalation of cold air during physical exertion markedly augments the severity of the airway obstruction; conversely, warm humid air blunts or abolishes it%29%.%A%    
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001250 2006
% 217.87/218.02  |- mesh__recordAuthorizer mesh__D001250 PLS
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001250 2003
% 217.87/218.02  |- skos__hiddenLabel mesh__D001250 Exercise Induced Bronchospasm
% 217.87/218.02  |- rdf__type mesh__D001250sskos__Concept
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001250 1998
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001250 1995
% 217.87/218.02  |- skos__historyNote mesh__D001250 Exertion %28%1966-1978%29%
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001250 1992
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001250 2004
% 217.87/218.02  |- skos__historyNote mesh__D001250 Bronchial Spasm %28%1966-1978%29%
% 217.87/218.02  |- mesh__recordMaintainer mesh__D001250 PXP
% 217.87/218.02  |- skos__hiddenLabel mesh__D001250 Asthma, Exercise Induced
% 217.87/218.02  |- skos__prefLabel mesh__D001250 Asthma, Exercise-Induced
% 217.87/218.02  |- skos__hiddenLabel mesh__D001250 Bronchospasm, Exercise Induced
% 217.87/218.02  |- skos__altLabel mesh__D001250 Exercise-Induced Bronchospasm
% 217.87/218.02  |- skos__hiddenLabel mesh__D001250 Asthmas, Exercise-Induced
% 217.87/218.02  |- skos__hiddenLabel mesh__D001250 Bronchospasms, Exercise-Induced
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001250 1999
% 217.87/218.02  |- skos__altLabel mesh__D001250 Exercise-Induced Asthma
% 217.87/218.02  |- skos__hiddenLabel mesh__D001250 Exercise Induced Asthma
% 217.87/218.02  |- mesh__historyNote mesh__D001250
% 217.87/218.02       91%28%79%29%; was see under ASTHMA 1979-90   
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001250 1996
% 217.87/218.02  |- mesh__dateCreated mesh__D001250 1978-05-12
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001250 1993
% 217.87/218.02  |- mesh__recordOriginator mesh__D001250 VDK
% 217.87/218.02  |- skos__broader mesh__D001250smesh__D001249
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001250 2000
% 217.87/218.02  |- mesh__dateEstablished mesh__D001250 1991-01-01
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001250 1997
% 217.87/218.02  |- skos__hiddenLabel mesh__D001250 Exercise-Induced Asthmas
% 217.87/218.02  |- mesh__dateRevised mesh__D001250 1991-01-02
% 217.87/218.02  |- skos__historyNote mesh__D001250 Asthma %28%1966-1978%29%
% 217.87/218.02  |- skos__hiddenLabel mesh__D001250 Exercise-Induced Bronchospasms
% 217.87/218.02  |- mesh__recordAuthorizer mesh__D014976 sjn
% 217.87/218.02  |- mesh__recordOriginator mesh__D014976 NLM
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D014976 2006
% 217.87/218.02  |- skos__broader mesh__D014976smesh__D011622
% 217.87/218.02  |- mesh__dateCreated mesh__D014976 1999-01-01
% 217.87/218.02  |- skos__scopeNote mesh__D014976
% 217.87/218.02       2-Amino-1,5-dihydro-4,6-pteridinedione. Pigment first discovered in butterfly wings and widely distributed in plants and animals.%A%    
% 217.87/218.02  |- mesh__recordMaintainer mesh__D014976 ssb
% 217.87/218.02  |- skos__annotation mesh__D014976 a pigment   
% 217.87/218.02  |- rdf__type mesh__D014976sskos__Concept
% 217.87/218.02  |- mesh__dateRevised mesh__D014976 2005-06-30
% 217.87/218.02  |- skos__prefLabel mesh__D014976 Xanthopterin
% 217.87/218.02  |- skos__hiddenLabel mesh__D014178 Translocations, Genetic
% 217.87/218.02  |- skos__broader mesh__D014178smesh__D016296
% 217.87/218.02  |- rdf__type mesh__D014178sskos__Concept
% 217.87/218.02  |- mesh__publicMeSHNote mesh__D014178
% 217.87/218.02       2005; see TRANSLOCATION %28%GENETICS%29% 1978-2005; see CHROMOSOME ABERRATIONS 1968-1977%A%  
% 217.87/218.02  |- skos__historyNote mesh__D014178
% 217.87/218.02       Chromosome Abnormalities %28%1966-1967%29%
% 217.87/218.02  |- skos__prefLabel mesh__D014178 Translocation, Genetic
% 217.87/218.02  |- skos__historyNote mesh__D014178 Chromosome Aberrations %28%1968-1974%29%
% 217.87/218.02  |- mesh__historyNote mesh__D014178 2005%28%1968%29%   
% 217.87/218.02  |- mesh__recordMaintainer mesh__D014178 sjn
% 217.87/218.02  |- skos__hiddenLabel mesh__D014178 Genetic Translocation
% 217.87/218.02  |- mesh__dateRevised mesh__D014178 2004-07-13
% 217.87/218.02  |- mesh__recordAuthorizer mesh__D014178 sjn
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D014178 2005
% 217.87/218.02  |- skos__hiddenLabel mesh__D014178 Chromosomal Translocations
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D014178 2006
% 217.87/218.02  |- skos__broader mesh__D014178smesh__D002869
% 217.87/218.02  |- skos__altLabel mesh__D014178 Chromosomal Translocation
% 217.87/218.02  |- skos__hiddenLabel mesh__D014178 Translocations, Chromosomal
% 217.87/218.02  |- mesh__recordOriginator mesh__D014178 NLM
% 217.87/218.02  |- skos__scopeNote mesh__D014178
% 217.87/218.02       A type of chromosome aberration characterized by CHROMOSOME BREAKAGE and transfer of the broken-off portion to another location, often to a different chromosome.%A%    
% 217.87/218.02  |- mesh__dateEstablished mesh__D014178 1978-01-01
% 217.87/218.02  |- mesh__dateCreated mesh__D014178 1999-01-01
% 217.87/218.02  |- skos__hiddenLabel mesh__D014178 Genetic Translocations
% 217.87/218.02  |- skos__altLabel mesh__D014178 Translocation, Chromosomal
% 217.87/218.02  |- skos__annotation mesh__D014178
% 217.87/218.02        do not confuse with  PROTEIN BIOSYNTHESIS %28%RNA-directed formation of peptides%29%%A%  
% 217.87/218.02  |- mesh__recordAuthorizer mesh__D008939 sjn
% 217.87/218.02  |- mesh__recordOriginator mesh__D008939 NLM
% 217.87/218.02  |- skos__prefLabel mesh__D008939 Mitotane
% 217.87/218.02  |- skos__broader mesh__D008939smesh__D006843
% 217.87/218.02  |- mesh__publicMeSHNote mesh__D008939 73   
% 217.87/218.02  |- mesh__dateCreated mesh__D008939 1999-01-01
% 217.87/218.02  |- skos__altLabel mesh__D008939 ortho,para-DDD
% 217.87/218.02  |- skos__altLabel mesh__D008939 o,p-DDD
% 217.87/218.02  |- mesh__recordMaintainer mesh__D008939 CCR
% 217.87/218.02  |- skos__hiddenLabel mesh__D008939 Bristol Myers Squibb Brand of Mitotane
% 217.87/218.02  |- skos__annotation mesh__D008939 TN 111 for eff on insects   
% 217.87/218.02  |- mesh__historyNote mesh__D008939 73   
% 217.87/218.02  |- skos__scopeNote mesh__D008939
% 217.87/218.02        A derivative of the insecticide  DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.%A%    
% 217.87/218.02  |- skos__altLabel mesh__D008939 Mytotan
% 217.87/218.02  |- skos__altLabel mesh__D008939 Khloditan
% 217.87/218.02  |- skos__altLabel mesh__D008939 Bristol-Myers Squibb Brand of Mitotane
% 217.87/218.02  |- mesh__dateEstablished mesh__D008939 1973-01-01
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D008939 2006
% 217.87/218.02  |- skos__hiddenLabel mesh__D008939 ortho,para DDD
% 217.87/218.02  |- mesh__dateRevised mesh__D008939 2005-06-30
% 217.87/218.02  |- rdf__type mesh__D008939sskos__Concept
% 217.87/218.02  |- skos__historyNote mesh__D008939 DDD/PD %28%1966-1972%29%
% 217.87/218.02  |- mesh__recordMaintainer mesh__D000956 ssb
% 217.87/218.02  |- mesh__dateEstablished mesh__D000956 1973-01-01
% 217.87/218.02  |- skos__annotation mesh__D000956
% 217.87/218.02       coord IM with specific virus /immunol %28%IM%29%   
% 217.87/218.02  |- mesh__dateCreated mesh__D000956 1999-01-01
% 217.87/218.02  |- mesh__dateRevised mesh__D000956 2005-06-30
% 217.87/218.02  |- mesh__recordOriginator mesh__D000956 NLM
% 217.87/218.02  |- skos__historyNote mesh__D000956 Viruses/immunology %28%1966-1972%29%
% 217.87/218.02  |- rdf__type mesh__D000956sskos__Concept
% 217.87/218.02  |- mesh__publicMeSHNote mesh__D000956 73   
% 217.87/218.02  |- skos__historyNote mesh__D000956 Antigens %28%1966-1972%29%
% 217.87/218.02  |- mesh__recordAuthorizer mesh__D000956 sjn
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D000956 2006
% 217.87/218.02  |- skos__scopeNote mesh__D000956
% 217.87/218.02       Substances elaborated by viruses that have antigenic activity.%A%    
% 217.87/218.02  |- mesh__historyNote mesh__D000956 73   
% 217.87/218.02  |- skos__broader mesh__D000956smesh__D000941
% 217.87/218.02  |- skos__prefLabel mesh__D000956 Antigens, Viral
% 217.87/218.02  |- skos__altLabel mesh__D000956 Viral Antigens
% 217.87/218.02  |- skos__annotation mesh__D019661
% 217.87/218.02       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.87/218.02  |- mesh__publicMeSHNote mesh__D019661 98   
% 217.87/218.02  |- mesh__dateEstablished mesh__D019661 1998-01-01
% 217.87/218.02  |- rdf__type mesh__D019661sskos__Concept
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D019661 2005
% 217.87/218.02  |- skos__broader mesh__D019661smesh__D019684
% 217.87/218.02  |- mesh__recordOriginator mesh__D019661 JLS
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D019661 2004
% 217.87/218.02  |- mesh__dateCreated mesh__D019661 1997-06-20
% 217.87/218.02  |- skos__altLabel mesh__D019661 Fangfeng
% 217.87/218.02  |- mesh__dateRevised mesh__D019661 2003-07-09
% 217.87/218.02  |- mesh__recordMaintainer mesh__D019661 ssb
% 217.87/218.02  |- mesh__recordAuthorizer mesh__D019661 sjn
% 217.87/218.02  |- skos__scopeNote mesh__D019661
% 217.87/218.02       A large plant family in the order Apiales, also known as Umbelliferae.  Most are aromatic herbs with alternate, feather-divided leaves that are sheathed at the base. The flowers often form a conspicuous flat-topped umbel. Each small individual flower is usually bisexual, with five sepals, five petals, and an enlarged disk at the base of the style. The fruits are ridged and are composed of two parts that split open at maturity.%A%    
% 217.87/218.02  |- skos__prefLabel mesh__D019661 Apiaceae
% 217.87/218.02  |- skos__altLabel mesh__D019661 Umbelliferae
% 217.87/218.02  |- mesh__historyNote mesh__D019661 98   
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D019661 2006
% 217.87/218.02  |- skos__altLabel mesh__D000158 Impedance Tests, Acoustic
% 217.87/218.02  |- mesh__historyNote mesh__D000158 78   
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D000158 2002
% 217.87/218.02  |- rdf__type mesh__D000158sskos__Concept
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D000158 2005
% 217.87/218.02  |- skos__hiddenLabel mesh__D000158 Tests, Electroacoustic Impedance
% 217.87/218.02  |- skos__hiddenLabel mesh__D000158 Electroacoustic Impedance Test
% 217.87/218.02  |- skos__hiddenLabel mesh__D000158 Impedance Test, Electroacoustic
% 217.87/218.02  |- skos__scopeNote mesh__D000158
% 217.87/218.02       Objective tests of middle ear function based on the difficulty %28%impedance%29% or ease %28%admittance%29% of sound flow through the middle ear. These include static impedance and dynamic impedance %28%i.e., tympanometry and impedance tests in conjunction with intra-aural muscle reflex elicitation%29%. This term is used also for various components of impedance and admittance %28%e.g., compliance, conductance, reactance, resistance, susceptance%29%.%A%    
% 217.87/218.02  |- skos__hiddenLabel mesh__D000158 Impedance Tests, Electroacoustic
% 217.87/218.02  |- mesh__dateCreated mesh__D000158 1977-04-22
% 217.87/218.02  |- skos__historyNote mesh__D000158 Tympanic Membrane %28%1966-1977%29%
% 217.87/218.02  |- skos__hiddenLabel mesh__D000158 Impedance Audiometry
% 217.87/218.02  |- mesh__recordAuthorizer mesh__D000158 SJN
% 217.87/218.02  |- skos__hiddenLabel mesh__D000158 Tests, Acoustic Impedance
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D000158 2001
% 217.87/218.02  |- mesh__recordOriginator mesh__D000158 SMH
% 217.87/218.02  |- skos__hiddenLabel mesh__D000158 Test, Acoustic Impedance
% 217.87/218.02  |- skos__historyNote mesh__D000158 Ear, Middle %28%1966-1977%29%
% 217.87/218.02  |- skos__prefLabel mesh__D000158 Acoustic Impedance Tests
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D000158 2004
% 217.87/218.02  |- mesh__publicMeSHNote mesh__D000158 78   
% 217.87/218.02  |- skos__hiddenLabel mesh__D000158 Test, Electroacoustic Impedance
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D000158 2000
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D000158 2003
% 217.87/218.02  |- skos__annotation mesh__D000158
% 217.87/218.02       do not use /util except by MeSH definition   
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D000158 1999
% 217.87/218.02  |- skos__hiddenLabel mesh__D000158 Impedance Test, Acoustic
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D000158 1998
% 217.87/218.02  |- mesh__dateEstablished mesh__D000158 1978-01-01
% 217.87/218.02  |- mesh__recordMaintainer mesh__D000158 PXP
% 217.87/218.02  |- mesh__dateRevised mesh__D000158 1997-06-20
% 217.87/218.02  |- skos__hiddenLabel mesh__D000158 Acoustic Impedance Test
% 217.87/218.02  |- skos__historyNote mesh__D000158 Audiometry %28%1966-1977%29%
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D000158 2006
% 217.87/218.02  |- skos__broader mesh__D000158smesh__D006320
% 217.87/218.02  |- skos__scopeNote mesh__D005641
% 217.87/218.02       Congener of FLUOROURACIL with comparable antineoplastic action. It has been suggested especially for the treatment of breast neoplasms.%A%    
% 217.87/218.02  |- rdf__type mesh__D005641sskos__Concept
% 217.87/218.02  |- skos__altLabel mesh__D005641
% 217.87/218.02       5-Fluoro-1-%28%tetrahydro-2-furanyl%29%-2,4-pyrimidinedione
% 217.87/218.02  |- skos__prefLabel mesh__D005641 Tegafur
% 217.87/218.02  |- mesh__dateCreated mesh__D005641 1976-04-16
% 217.87/218.02  |- skos__hiddenLabel mesh__D005641 FT 207
% 217.87/218.02  |- skos__altLabel mesh__D005641 Bristol-Myers Squibb Brand of Tegafur
% 217.87/218.02  |- mesh__dateRevised mesh__D005641 2005-06-30
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D005641 2006
% 217.87/218.02  |- skos__altLabel mesh__D005641 Prasfarma Brand of Tegafur
% 217.87/218.02  |- skos__altLabel mesh__D005641 FT207
% 217.87/218.02  |- skos__broader mesh__D005641smesh__D005472
% 217.87/218.02  |- mesh__publicMeSHNote mesh__D005641
% 217.87/218.02       91; was FTORAFUR 1986-90 %26% FTORAFUR see under FLUOROURACIL 1977-85%A%  
% 217.87/218.02  |- skos__altLabel mesh__D005641 1-%28%2-Tetrahydrofuryl%29%-5-fluorouracil
% 217.87/218.02  |- mesh__onlineNote mesh__D005641 use TEGAFUR to search FTORAFUR 1977-91   
% 217.87/218.02  |- mesh__historyNote mesh__D005641
% 217.87/218.02       91%28%77%29%; was FTORAFUR 1986-90 %26% FTORAFUR see under FLUOROURACIL 1977-85%A%  
% 217.87/218.02  |- skos__historyNote mesh__D005641 Fluorouracil %28%1972-1976%29%
% 217.87/218.02  |- mesh__dateEstablished mesh__D005641 1986-01-01
% 217.87/218.02  |- mesh__recordMaintainer mesh__D005641 CCR
% 217.87/218.02  |- skos__hiddenLabel mesh__D005641 Bristol Myers Squibb Brand of Tegafur
% 217.87/218.02  |- skos__altLabel mesh__D005641
% 217.87/218.02       N1-%28%2%27%-Tetrahydrofuryl%29%-5-fluorouracil
% 217.87/218.02  |- skos__altLabel mesh__D005641 Fluorofur
% 217.87/218.02  |- mesh__recordAuthorizer mesh__D005641 sjn
% 217.87/218.02  |- skos__historyNote mesh__D005641 Furans %28%1972-1976%29%
% 217.87/218.02  |- skos__altLabel mesh__D005641
% 217.87/218.02       1-%28%Tetrahydro-2-furanyl%29%-5-fluorouracil
% 217.87/218.02  |- mesh__recordOriginator mesh__D005641 SH
% 217.87/218.02  |- skos__altLabel mesh__D005641 Almirall Brand of Tegafur
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D010586 1991
% 217.87/218.02  |- skos__broader mesh__D010586smesh__D002477
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D010586 1998
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D010586 1993
% 217.87/218.02  |- skos__historyNote mesh__D010586 Phagocytosis %28%1966-1972%29%
% 217.87/218.02  |- mesh__recordOriginator mesh__D010586 NLM
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D010586 2006
% 217.87/218.02  |- skos__annotation mesh__D010586 A 11 qualif   
% 217.87/218.02  |- mesh__dateEstablished mesh__D010586 1973-01-01
% 217.87/218.02  |- skos__hiddenLabel mesh__D010586 Phagocyte
% 217.87/218.02  |- mesh__publicMeSHNote mesh__D010586 73   
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D010586 1992
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D010586 1997
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D010586 2005
% 217.87/218.02  |- skos__prefLabel mesh__D010586 Phagocytes
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D010586 2002
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D010586 1996
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D010586 2004
% 217.87/218.02  |- rdf__type mesh__D010586sskos__Concept
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D010586 2001
% 217.87/218.02  |- mesh__recordMaintainer mesh__D010586 PLS
% 217.87/218.02  |- mesh__historyNote mesh__D010586 73   
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D010586 2003
% 217.87/218.02  |- mesh__dateRevised mesh__D010586 1990-05-26
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D010586 2000
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D010586 1995
% 217.87/218.02  |- mesh__recordAuthorizer mesh__D010586 NLM
% 217.87/218.02  |- skos__broader mesh__D010586smesh__D007107
% 217.87/218.02  |- mesh__dateCreated mesh__D010586 1999-01-01
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D010586 1999
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D010586 1994
% 217.87/218.02  |- mesh__publicMeSHNote mesh__D004549 66   
% 217.87/218.02  |- skos__hiddenLabel mesh__D004549 kappa Elastin
% 217.87/218.02  |- rdf__type mesh__D004549sskos__Concept
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D004549 2006
% 217.87/218.02  |- skos__prefLabel mesh__D004549 Elastin
% 217.87/218.02  |- mesh__dateRevised mesh__D004549 2004-07-07
% 217.87/218.02  |- mesh__recordOriginator mesh__D004549 NLM
% 217.87/218.02  |- mesh__recordMaintainer mesh__D004549 jmp
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D004549 2005
% 217.87/218.02  |- skos__annotation mesh__D004549 /biosyn /physiol permitted   
% 217.87/218.02  |- mesh__dateCreated mesh__D004549 1999-01-01
% 217.87/218.02  |- skos__related mesh__D004549smesh__D018980
% 217.87/218.02  |- mesh__dateEstablished mesh__D004549 1966-01-01
% 217.87/218.02  |- skos__broader mesh__D004549smesh__D001704
% 217.87/218.02  |- mesh__historyNote mesh__D004549 66%28%63%29%   
% 217.87/218.02  |- skos__hiddenLabel mesh__D004549 alpha Elastin
% 217.87/218.02  |- mesh__recordAuthorizer mesh__D004549 sjn
% 217.87/218.02  |- skos__broader mesh__D004549smesh__D016326
% 217.87/218.02  |- rdf__type mesh__D015271sskos__Concept
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D015271 2002
% 217.87/218.02  |- skos__hiddenLabel mesh__D015271 Pools, Insurance
% 217.87/218.02  |- skos__historyNote mesh__D015271 Insurance, Health %28%1971-1988%29%
% 217.87/218.02  |- skos__broader mesh__D015271smesh__D007341
% 217.87/218.02  |- mesh__recordOriginator mesh__D015271 EC
% 217.87/218.02  |- mesh__recordAuthorizer mesh__D015271 sjn
% 217.87/218.02  |- mesh__dateRevised mesh__D015271 1999-11-03
% 217.87/218.02  |- skos__historyNote mesh__D015271 Insurance, Liability %28%1971-1988%29%
% 217.87/218.02  |- mesh__recordMaintainer mesh__D015271 kle
% 217.87/218.02  |- mesh__historyNote mesh__D015271 89   
% 217.87/218.02  |- skos__hiddenLabel mesh__D015271 Pool, Insurance
% 217.87/218.02  |- skos__annotation mesh__D015271 specify geog if possible   
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D015271 2000
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D015271 2005
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D015271 2006
% 217.87/218.02  |- mesh__dateCreated mesh__D015271 1988-05-19
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D015271 2001
% 217.87/218.02  |- skos__hiddenLabel mesh__D015271 Alliances, Health
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D015271 2003
% 217.87/218.02  |- mesh__publicMeSHNote mesh__D015271 89   
% 217.87/218.02  |- skos__hiddenLabel mesh__D015271 Insurance Pool
% 217.87/218.02  |- mesh__dateEstablished mesh__D015271 1989-01-01
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D015271 2004
% 217.87/218.02  |- skos__scopeNote mesh__D015271
% 217.87/218.02       An organization of insurers or reinsurers through which particular types of risk are shared or pooled. The risk of high loss by a particular insurance company is transferred to the group as a whole %28%the insurance pool%29% with premiums, losses, and expenses shared in agreed amounts.%A%    
% 217.87/218.02  |- skos__prefLabel mesh__D015271 Insurance Pools
% 217.87/218.02  |- skos__hiddenLabel mesh__D015271 Alliance, Health
% 217.87/218.02  |- skos__hiddenLabel mesh__D015271 Health Alliance
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D009234 2001
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D009234 1994
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D009234 2003
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D009234 2000
% 217.87/218.02  |- skos__prefLabel mesh__D009234 Myxomatosis, Infectious
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D009234 1997
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D009234 2006
% 217.87/218.02  |- mesh__recordAuthorizer mesh__D009234 PLS
% 217.87/218.02  |- mesh__recordMaintainer mesh__D009234 TGC
% 217.87/218.02  |- skos__broader mesh__D009234smesh__D011213
% 217.87/218.02  |- mesh__recordOriginator mesh__D009234 NLM
% 217.87/218.02  |- skos__broader mesh__D009234smesh__D000820
% 217.87/218.02  |- skos__hiddenLabel mesh__D009234 Infectious Myxomatosis
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D009234 1996
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D009234 2005
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D009234 2002
% 217.87/218.02  |- skos__annotation mesh__D009234
% 217.87/218.02       caused by a poxvirus; usually animal; check tag ANIMAL   
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D009234 1999
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D009234 1995
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D009234 2004
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D009234 1998
% 217.87/218.02  |- rdf__type mesh__D009234sskos__Concept
% 217.87/218.02  |- skos__hiddenLabel mesh__D009234 Infectious Myxomatoses
% 217.87/218.02  |- mesh__dateCreated mesh__D009234 1999-01-01
% 217.87/218.02  |- mesh__dateRevised mesh__D009234 1993-06-02
% 217.87/218.02  |- skos__hiddenLabel mesh__D009234 Myxomatoses, Infectious
% 217.87/218.02  |- skos__broader mesh__D001251smesh__D012030
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001251 2004
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001251 1999
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001251 2002
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001251 2006
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001251 1996
% 217.87/218.02  |- skos__scopeNote mesh__D001251
% 217.87/218.02       Unequal curvature of the refractive surfaces of the eye. Thus a point source of light cannot be brought to a point focus on the retina but is spread over a more or less diffuse area. This results from the radius of curvature in one plane being longer or shorter than the radius at right angles to it. %28%Dorland, 27th ed%29%%A%    
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001251 2003
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001251 1995
% 217.87/218.02  |- skos__annotation mesh__D001251 refractive error   
% 217.87/218.02  |- mesh__dateRevised mesh__D001251 1993-05-24
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001251 1998
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001251 2001
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001251 2005
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001251 1994
% 217.87/218.02  |- rdf__type mesh__D001251sskos__Concept
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001251 2000
% 217.87/218.02  |- mesh__recordOriginator mesh__D001251 NLM
% 217.87/218.02  |- mesh__recordMaintainer mesh__D001251 PLS
% 217.87/218.02  |- skos__prefLabel mesh__D001251 Astigmatism
% 217.87/218.02  |- mesh__dateCreated mesh__D001251 1999-01-01
% 217.87/218.02  |- mesh__recordAuthorizer mesh__D001251 PLS
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D001251 1997
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D014977 2005
% 217.87/218.02  |- mesh__recordAuthorizer mesh__D014977 PLS
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D014977 2000
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D014977 1995
% 217.87/218.02  |- mesh__dateRevised mesh__D014977 1992-05-20
% 217.87/218.02  |- skos__broader mesh__D014977smesh__D000147
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D014977 2004
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D014977 1999
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D014977 1994
% 217.87/218.02  |- rdf__type mesh__D014977sskos__Concept
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D014977 2003
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D014977 1998
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D014977 1993
% 217.87/218.02  |- mesh__recordOriginator mesh__D014977 NLM
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D014977 1997
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D014977 1996
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D014977 2002
% 217.87/218.02  |- mesh__activeMeSHYear mesh__D014977 2006
% 217.87/218.02  |- skos__prefLabel mesh__D014977 Xanthurenates
% 217.87/218.02  |- mesh__recordMaintainer mesh__D014977 TAP
% 217.88/218.02  |- mesh__activeMeSHYear mesh__D014977 2001
% 217.88/218.02  |- mesh__dateCreated mesh__D014977 1999-01-01
% 217.88/218.02  |- skos__altLabel mesh__D014179 Transmitter Uptake Inhibitors, Neuronal
% 217.88/218.02  |- mesh__onlineNote mesh__D014179
% 217.88/218.02       use NEUROTRANSMITTER UPTAKE INHIBITORS to search TRANSMITTER UPTAKE INHIBITORS, NEURONAL; INHIBITORS OF NEUROTRANSMITTER UPTAKE %26% UPTAKE INHIBITORS, NEUROTRANSMITTER 1985-92%A%  
% 217.88/218.02  |- skos__broader mesh__D014179smesh__D018377
% 217.88/218.02  |- skos__altLabel mesh__D014179 Reuptake Inhibitors, Neurotransmitter
% 217.88/218.02  |- mesh__historyNote mesh__D014179
% 217.88/218.02       93; WAS TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92; NEUROTRANSMITTER UPTAKE INHIBITORS, INHIBITORS OF NEUROTRANSMITTER UPTAKE %26% UPTAKE INHIBITORS, NEUROTRANSMITTER were see TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92%A%  
% 217.88/218.02  |- skos__altLabel mesh__D014179 Inhibitors, Neurotransmitter Uptake
% 217.88/218.02  |- mesh__dateCreated mesh__D014179 1984-05-01
% 217.88/218.02  |- skos__historyNote mesh__D014179 Synapses %28%1966-1971%29%
% 217.88/218.02  |- mesh__activeMeSHYear mesh__D014179 2006
% 217.88/218.02  |- skos__historyNote mesh__D014179 Synaptosomes %28%1974-1984%29%
% 217.88/218.02  |- skos__hiddenLabel mesh__D014179 Inhibitors, Neurotransmitter Reuptake
% 217.88/218.02  |- mesh__recordAuthorizer mesh__D014179 sjn
% 217.88/218.02  |- mesh__publicMeSHNote mesh__D014179
% 217.88/218.02       93; was TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92; NEUROTRANSMITTER UPTAKE INHIBITORS, INHIBITORS OF NEUROTRANSMITTER UPTAKE %26% UPTAKE INHIBITORS, NEUROTRANSMITTER were see TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92%A%  
% 217.88/218.02  |- skos__hiddenLabel mesh__D014179 Neurotransmitter Reuptake Inhibitors
% 217.88/218.02  |- mesh__dateEstablished mesh__D014179 1985-01-01
% 217.88/218.02  |- skos__prefLabel mesh__D014179 Neurotransmitter Uptake Inhibitors
% 217.88/218.02  |- mesh__recordMaintainer mesh__D014179 ssb
% 217.88/218.02  |- skos__scopeNote mesh__D014179
% 217.88/218.02       Drugs that inhibit the transport of neurotransmitters into axon terminals or into storage vesicles within terminals. For many transmitters, uptake determines the time course of transmitter action so inhibiting uptake prolongs the activity of the transmitter. Blocking uptake may also deplete available transmitter stores. Many clinically important drugs are uptake inhibitors although the indirect reactions of the brain rather than the acute block of uptake itself is often responsible for the therapeutic effects.%A%    
% 217.88/218.02  |- skos__altLabel mesh__D014179 Uptake Inhibitors, Neurotransmitter
% 217.88/218.02  |- skos__historyNote mesh__D014179 Synaptic Vesicles %28%1972-1973%29%
% 217.88/218.03  |- skos__historyNote mesh__D014179 Cytoplasmic Granules %28%1966-1977%29%
% 217.88/218.03  |- skos__annotation mesh__D014179
% 217.88/218.03       GEN or unspecified; prefer specific groups or specific drugs; coord IM with specific neurotransmitters /physiol %28%IM%29%; DF: NEUROTRANSM UPTAKE INHIB%A%  
% 217.88/218.03  |- mesh__recordOriginator mesh__D014179 SH
% 217.88/218.03  |- skos__historyNote mesh__D014179 Nerve Endings %28%1966-1973%29%
% 217.88/218.03  |- skos__historyNote mesh__D014179 Kinetics %28%1966-1984%29%
% 217.88/218.03  |- rdf__type mesh__D014179sskos__Concept
% 217.88/218.03  |- mesh__dateRevised mesh__D014179 2005-06-30
% 217.88/218.03  |- skos__broader mesh__D000957smesh__D000951
% 217.88/218.03  |- rdf__type mesh__D000957sskos__Concept
% 217.88/218.03  |- mesh__recordMaintainer mesh__D000957 ssb
% 217.88/218.03  |- skos__altLabel mesh__D000957 Viral Tumor Antigens
% 217.88/218.03  |- skos__hiddenLabel mesh__D000957 T Antigen, Small
% 217.88/218.03  |- skos__hiddenLabel mesh__D000957 Antigens, T
% 217.88/218.03  |- skos__hiddenLabel mesh__D000957 Antigens, Viral Tumor
% 217.88/218.03  |- skos__scopeNote mesh__D000957
% 217.88/218.03       Those proteins recognized by antibodies from serum of animals bearing tumors induced by viruses; these proteins are presumably coded for by the nucleic acids of the same viruses that caused the neoplastic transformation.%A%    
% 217.88/218.03  |- skos__hiddenLabel mesh__D000957 Antigen, T
% 217.88/218.03  |- skos__altLabel mesh__D000957 T-Antigen
% 217.88/218.03  |- skos__hiddenLabel mesh__D000957 Transforming Antigens, Virus
% 217.88/218.03  |- skos__altLabel mesh__D000957 Virus Transforming Antigens
% 217.88/218.03  |- skos__altLabel mesh__D000957 Neoplasm Antigens, Viral
% 217.88/218.03  |- skos__historyNote mesh__D000957 Antigens %28%1966-1972%29%
% 217.88/218.03  |- skos__annotation mesh__D000957
% 217.88/218.03       coord IM with specific virus /immunol %28%IM%29%   
% 217.88/218.03  |- skos__hiddenLabel mesh__D000957 Antigen, Small T
% 217.88/218.03  |- mesh__historyNote mesh__D000957 84   
% 217.88/218.03  |- skos__hiddenLabel mesh__D000957 T Antigen, Large
% 217.88/218.03  |- skos__altLabel mesh__D000957 Tumor Antigens, Viral
% 217.88/218.03  |- skos__prefLabel mesh__D000957 Antigens, Viral, Tumor
% 217.88/218.03  |- mesh__dateEstablished mesh__D000957 1984-01-01
% 217.88/218.03  |- mesh__recordAuthorizer mesh__D000957 sjn
% 217.88/218.03  |- skos__altLabel mesh__D000957 Small T Antigen
% 217.88/218.03  |- mesh__dateCreated mesh__D000957 1983-06-10
% 217.88/218.03  |- mesh__recordOriginator mesh__D000957 SH
% 217.88/218.03  |- mesh__publicMeSHNote mesh__D000957 84   
% 217.88/218.03  |- skos__hiddenLabel mesh__D000957 Antigens, Viral Neoplasm
% 217.88/218.03  |- skos__hiddenLabel mesh__D000957 Antigen, Large T
% 217.88/218.03  |- skos__altLabel mesh__D000957 Viral T Antigens
% 217.88/218.03  |- skos__hiddenLabel mesh__D000957 T-Antigen, Large
% 217.88/218.03  |- skos__hiddenLabel mesh__D000957 T Antigens, Viral
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D000957 2006
% 217.88/218.03  |- skos__broader mesh__D000957smesh__D000956
% 217.88/218.03  |- skos__historyNote mesh__D000957 Antigens, Neoplasm %28%1973-1983%29%
% 217.88/218.03  |- skos__altLabel mesh__D000957 Large T Antigen
% 217.88/218.03  |- skos__hiddenLabel mesh__D000957 Viral Neoplasm Antigens
% 217.88/218.03  |- skos__historyNote mesh__D000957 Antigens, Viral %28%1973-1983%29%
% 217.88/218.03  |- skos__altLabel mesh__D000957 T Antigen
% 217.88/218.03  |- mesh__dateRevised mesh__D000957 2005-06-30
% 217.88/218.03  |- skos__hiddenLabel mesh__D000957 Antigens, Virus Transforming
% 217.88/218.03  |- skos__hiddenLabel mesh__D000957 Antigens, Viral T
% 217.88/218.03  |- skos__altLabel mesh__D000957 T Antigens
% 217.88/218.03  |- skos__hiddenLabel mesh__D000957 T-Antigen, Small
% 217.88/218.03  |- mesh__recordOriginator mesh__D019662 JLS
% 217.88/218.03  |- skos__scopeNote mesh__D019662
% 217.88/218.03       The gourd plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida. It is sometimes placed in its own order, Cucurbitales. %27%Melon%27% generally refers to CUCUMIS; CITRULLUS; or MOMORDICA.%A%    
% 217.88/218.03  |- skos__prefLabel mesh__D019662 Cucurbitaceae
% 217.88/218.03  |- mesh__recordMaintainer mesh__D019662 ags
% 217.88/218.03  |- skos__annotation mesh__D019662
% 217.88/218.03       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.88/218.03  |- mesh__dateEstablished mesh__D019662 1998-01-01
% 217.88/218.03  |- mesh__historyNote mesh__D019662
% 217.88/218.03       1998; for MELONS use CUCUMIS 2002-2004   
% 217.88/218.03  |- mesh__dateRevised mesh__D019662 2005-07-13
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D019662 2006A
% 217.88/218.03  |- skos__broader mesh__D019662smesh__D019684
% 217.88/218.03  |- mesh__dateCreated mesh__D019662 1997-06-20
% 217.88/218.03  |- mesh__recordAuthorizer mesh__D019662 ags
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D019662 2006
% 217.88/218.03  |- skos__altLabel mesh__D019662 Gourd, Ivy
% 217.88/218.03  |- skos__altLabel mesh__D019662 Ivy Gourd
% 217.88/218.03  |- rdf__type mesh__D019662sskos__Concept
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D019662 2005
% 217.88/218.03  |- mesh__publicMeSHNote mesh__D019662
% 217.88/218.03       1998; for MELONS see CUCUMIS 2002-2004   
% 217.88/218.03  |- skos__altLabel mesh__D000159 Eighth Cranial Nerve
% 217.88/218.03  |- skos__hiddenLabel mesh__D000159 Cranial Nerve VIIIs
% 217.88/218.03  |- mesh__dateCreated mesh__D000159 1999-01-01
% 217.88/218.03  |- skos__broader mesh__D000159smesh__D003391
% 217.88/218.03  |- skos__hiddenLabel mesh__D000159 Nerve, Vestibulocochlear
% 217.88/218.03  |- skos__annotation mesh__D000159
% 217.88/218.03       neopl: coord VESTIBULOCOCHLEAR NERVE DISEASES %28%IM%29% with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29% but note that NEUROMA, ACOUSTIC is also available%A%  
% 217.88/218.03  |- skos__hiddenLabel mesh__D000159 Vestibulocochlear Nerves
% 217.88/218.03  |- mesh__publicMeSHNote mesh__D000159
% 217.88/218.03       2000; see ACOUSTIC NERVE 1963-1999; for VESTIBULOCOCHLEAR NERVE see ACOUSTIC NERVE 1963-1999%A%  
% 217.88/218.03  |- skos__hiddenLabel mesh__D000159 Cranial Nerves, Eighth
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D000159 2002
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D000159 2004
% 217.88/218.03  |- skos__hiddenLabel mesh__D000159 Cranial Nerve, Eighth
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D000159 2003
% 217.88/218.03  |- mesh__recordOriginator mesh__D000159 NLM
% 217.88/218.03  |- skos__scopeNote mesh__D000159
% 217.88/218.03       The 8th cranial nerve. The vestibulocochlear nerve has a cochlear part %28%COCHLEAR NERVE%29% which is concerned with hearing and a vestibular part %28%VESTIBULAR NERVE%29% which mediates the sense of balance and head position. The fibers of the cochlear nerve originate from neurons of the SPIRAL GANGLION and project to the cochlear nuclei %28%COCHLEAR NUCLEUS%29%. The fibers of the vestibular nerve arise from neurons of Scarpa%27%s ganglion and project to the VESTIBULAR NUCLEI.%A%    
% 217.88/218.03  |- mesh__recordMaintainer mesh__D000159 ags
% 217.88/218.03  |- mesh__historyNote mesh__D000159 2000%28%1963%29%   
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D000159 2001
% 217.88/218.03  |- skos__hiddenLabel mesh__D000159 Nerves, Vestibulocochlear
% 217.88/218.03  |- mesh__dateRevised mesh__D000159 1999-11-03
% 217.88/218.03  |- skos__hiddenLabel mesh__D000159 Nerve, Eighth Cranial
% 217.88/218.03  |- skos__hiddenLabel mesh__D000159 Eighth Cranial Nerves
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D000159 2006
% 217.88/218.03  |- skos__prefLabel mesh__D000159 Vestibulocochlear Nerve
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D000159 2000
% 217.88/218.03  |- rdf__type mesh__D000159sskos__Concept
% 217.88/218.03  |- skos__hiddenLabel mesh__D000159 VIIIs, Cranial Nerve
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D000159 2005
% 217.88/218.03  |- mesh__recordAuthorizer mesh__D000159 sjn
% 217.88/218.03  |- skos__altLabel mesh__D000159 Cranial Nerve VIII
% 217.88/218.03  |- skos__hiddenLabel mesh__D000159 Nerve VIIIs, Cranial
% 217.88/218.03  |- skos__hiddenLabel mesh__D000159 Nerves, Eighth Cranial
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D005642 2003
% 217.88/218.03  |- skos__annotation mesh__D005642 a corneal dystrophy   
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D005642 2005
% 217.88/218.03  |- skos__hiddenLabel mesh__D005642 Endothelial Dystrophy, Fuchs%27%
% 217.88/218.03  |- skos__hiddenLabel mesh__D005642 Fuch Endothelial Dystrophy
% 217.88/218.03  |- mesh__publicMeSHNote mesh__D005642
% 217.88/218.03       91; was see under CORNEAL DYSTROPHIES, HEREDITARY 1990; was see under CORNEAL DYSTROPHIES 1975-89%A%  
% 217.88/218.03  |- mesh__recordAuthorizer mesh__D005642 sjn
% 217.88/218.03  |- skos__hiddenLabel mesh__D005642 Dystrophy, Fuch%27%s Endothelial
% 217.88/218.03  |- skos__hiddenLabel mesh__D005642 Endothelial Dystrophy, Fuch%27%s
% 217.88/218.03  |- mesh__recordOriginator mesh__D005642 NLM
% 217.88/218.03  |- skos__hiddenLabel mesh__D005642 Dystrophy, Fuchs%27% Endothelial
% 217.88/218.03  |- skos__hiddenLabel mesh__D005642 Fuchs Endothelial Dystrophy
% 217.88/218.03  |- skos__prefLabel mesh__D005642 Fuchs%27% Endothelial Dystrophy
% 217.88/218.03  |- skos__scopeNote mesh__D005642
% 217.88/218.03       Disorder caused by loss of endothelium of the central cornea. It is characterized by hyaline endothelial outgrowths on Descemet%27%s membrane, epithelial blisters, reduced vision, and pain.%A%    
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D005642 2002
% 217.88/218.03  |- mesh__dateRevised mesh__D005642 2001-07-25
% 217.88/218.03  |- mesh__recordMaintainer mesh__D005642 nns
% 217.88/218.03  |- skos__broader mesh__D005642smesh__D003317
% 217.88/218.03  |- mesh__dateEstablished mesh__D005642 1991-01-01
% 217.88/218.03  |- mesh__historyNote mesh__D005642
% 217.88/218.03       91%28%75%29%; was see under CORNEAL DYSTROPHIES, HEREDITARY 1990; was see under CORNEAL DYSTROPHIES 1975-89%A%  
% 217.88/218.03  |- rdf__type mesh__D005642sskos__Concept
% 217.88/218.03  |- skos__altLabel mesh__D005642 Fuch%27%s Endothelial Dystrophy
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D005642 2004
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D005642 2006
% 217.88/218.03  |- mesh__dateCreated mesh__D005642 1999-01-01
% 217.88/218.03  |- mesh__dateRevised mesh__D010587 2003-07-09
% 217.88/218.03  |- skos__hiddenLabel mesh__D010587 Phagocytoses
% 217.88/218.03  |- skos__prefLabel mesh__D010587 Phagocytosis
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D010587 2006
% 217.88/218.03  |- skos__scopeNote mesh__D010587
% 217.88/218.03       The engulfing of microorganisms, other cells, and foreign particles by phagocytic cells %28%PHAGOCYTES%29%.%A%    
% 217.88/218.03  |- mesh__recordAuthorizer mesh__D010587 sjn
% 217.88/218.03  |- skos__broader mesh__D010587smesh__D007113
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D010587 2004
% 217.88/218.03  |- rdf__type mesh__D010587sskos__Concept
% 217.88/218.03  |- mesh__recordOriginator mesh__D010587 NLM
% 217.88/218.03  |- mesh__dateCreated mesh__D010587 1999-01-01
% 217.88/218.03  |- skos__related mesh__D010587smesh__D008264
% 217.88/218.03  |- mesh__recordMaintainer mesh__D010587 nns
% 217.88/218.03  |- skos__broader mesh__D010587smesh__D045123
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D010587 2005
% 217.88/218.03  |- skos__broader mesh__D010587smesh__D004705
% 217.88/218.03  |- mesh__recordAuthorizer mesh__D015272 SJN
% 217.88/218.03  |- skos__broader mesh__D015272smesh__D007388
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D015272 2005
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D015272 1999
% 217.88/218.03  |- skos__altLabel mesh__D015272 Pneumology
% 217.88/218.03  |- skos__prefLabel mesh__D015272 Pulmonary Disease %28%Specialty%29%
% 217.88/218.03  |- skos__hiddenLabel mesh__D015272 Pulmonary Diseases %28%Specialty%29%
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D015272 2002
% 217.88/218.03  |- mesh__recordMaintainer mesh__D015272 AGS
% 217.88/218.03  |- skos__historyNote mesh__D015272 Lung Diseases %28%1966-1988%29%
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D015272 2006
% 217.88/218.03  |- skos__altLabel mesh__D015272 Pulmonology
% 217.88/218.03  |- skos__altLabel mesh__D015272 Pulmonary Medicine
% 217.88/218.03  |- skos__hiddenLabel mesh__D015272 Disease, Pulmonary %28%Specialty%29%
% 217.88/218.03  |- skos__altLabel mesh__D015272 Medicine, Pulmonary
% 217.88/218.03  |- mesh__dateRevised mesh__D015272 1998-06-10
% 217.88/218.03  |- mesh__recordOriginator mesh__D015272 EC
% 217.88/218.03  |- skos__historyNote mesh__D015272 Internal Medicine %28%1966-1988%29%
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D015272 2003
% 217.88/218.03  |- mesh__historyNote mesh__D015272 89   
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D015272 2000
% 217.88/218.03  |- mesh__publicMeSHNote mesh__D015272 89   
% 217.88/218.03  |- skos__hiddenLabel mesh__D015272 Diseases, Pulmonary %28%Specialty%29%
% 217.88/218.03  |- mesh__dateEstablished mesh__D015272 1989-01-01
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D015272 2004
% 217.88/218.03  |- skos__scopeNote mesh__D015272
% 217.88/218.03       A subspecialty of internal medicine concerned with the study of the respiratory system. It is especially concerned with diagnosis and treatment of diseases and defects of the lungs and bronchial tree.%A%    
% 217.88/218.03  |- mesh__dateCreated mesh__D015272 1988-05-19
% 217.88/218.03  |- skos__annotation mesh__D015272
% 217.88/218.03       SPEC: SPEC qualif; do not confuse with LUNG DISEASES %28%Cat C%29%; DF: PULM DIS SPEC%A%  
% 217.88/218.03  |- rdf__type mesh__D015272sskos__Concept
% 217.88/218.03  |- skos__altLabel mesh__D015272 Pneumonology
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D015272 2001
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D009235 2006
% 217.88/218.03  |- mesh__historyNote mesh__D009235 99%28%63%29%   
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D009235 2005
% 217.88/218.03  |- mesh__recordMaintainer mesh__D009235 ags
% 217.88/218.03  |- skos__scopeNote mesh__D009235
% 217.88/218.03       A division of organisms that exist vegetatively as complex mobile plasmodia, reproduce by means of spores, and have complex life cycles. They are now classed as protozoa but formerly were considered fungi.%A%    
% 217.88/218.03  |- mesh__recordAuthorizer mesh__D009235 sjn
% 217.88/218.03  |- mesh__dateRevised mesh__D009235 2003-07-09
% 217.88/218.03  |- mesh__publicMeSHNote mesh__D009235
% 217.88/218.03       99; see MYXOMYCOTA 1986-98, see MYXOMYCETES 1963-85   
% 217.88/218.03  |- mesh__recordOriginator mesh__D009235 NLM
% 217.88/218.03  |- skos__broader mesh__D009235smesh__D011527
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D009235 2004
% 217.88/218.03  |- rdf__type mesh__D009235sskos__Concept
% 217.88/218.03  |- skos__annotation mesh__D009235 protozoa, formerly considered fungi   
% 217.88/218.03  |- mesh__dateCreated mesh__D009235 1999-01-01
% 217.88/218.03  |- skos__altLabel mesh__D009235 Slime Molds, Plasmodial
% 217.88/218.03  |- skos__prefLabel mesh__D009235 Myxomycetes
% 217.88/218.03  |- skos__altLabel mesh__D009235 Slime Molds, True
% 217.88/218.03  |- skos__altLabel mesh__D009235 Myxomycota
% 217.88/218.03  |- skos__scopeNote mesh__D001252
% 217.88/218.03       Agents, usually topical, that cause the contraction of tissues for the control of bleeding or secretions.%A%    
% 217.88/218.03  |- mesh__publicMeSHNote mesh__D001252
% 217.88/218.03       ANTIPERSPIRANTS was see ASTRINGENTS 1985-94   
% 217.88/218.03  |- mesh__recordAuthorizer mesh__D001252 sjn
% 217.88/218.03  |- mesh__dateRevised mesh__D001252 2005-06-30
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D001252 2006
% 217.88/218.03  |- rdf__type mesh__D001252sskos__Concept
% 217.88/218.03  |- mesh__dateCreated mesh__D001252 1999-01-01
% 217.88/218.03  |- skos__broader mesh__D001252smesh__D003879
% 217.88/218.03  |- mesh__onlineNote mesh__D001252
% 217.88/218.03       use ASTRINGENTS to search ANTIPERSPIRANTS 1985-94   
% 217.88/218.03  |- mesh__historyNote mesh__D001252
% 217.88/218.03       ANTIPERSPIRANTS was see ASTRINGENTS 1985-94   
% 217.88/218.03  |- mesh__recordMaintainer mesh__D001252 ssb
% 217.88/218.03  |- skos__broader mesh__D001252smesh__D045505
% 217.88/218.03  |- skos__prefLabel mesh__D001252 Astringents
% 217.88/218.03  |- mesh__recordOriginator mesh__D001252 NLM
% 217.88/218.03  |- skos__prefLabel mesh__D014978 Xenon
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D014978 2001
% 217.88/218.03  |- rdf__type mesh__D014978sskos__Concept
% 217.88/218.03  |- skos__scopeNote mesh__D014978
% 217.88/218.03       A noble gas with the atomic symbol Xe, atomic number 54, and atomic weight 131.30. It is found in the earth%27%s atmosphere and has been used as an anesthetic.%A%    
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D014978 2003
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D014978 1998
% 217.88/218.03  |- mesh__recordAuthorizer mesh__D014978 SJN
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D014978 2000
% 217.88/218.03  |- mesh__dateRevised mesh__D014978 1997-06-20
% 217.88/218.03  |- skos__annotation mesh__D014978
% 217.88/218.03       a rare gas; Xe-132; sometimes used as an inhalation anesthetic%A%  
% 217.88/218.03  |- skos__broader mesh__D014978smesh__D005741
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D014978 2006
% 217.88/218.03  |- mesh__recordOriginator mesh__D014978 NLM
% 217.88/218.03  |- mesh__dateCreated mesh__D014978 1999-01-01
% 217.88/218.03  |- skos__related mesh__D014978smesh__D014979
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D014978 2005
% 217.88/218.03  |- mesh__recordMaintainer mesh__D014978 ADP
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D014978 2002
% 217.88/218.03  |- skos__related mesh__D014978smesh__D014980
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D014978 2004
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D014978 1999
% 217.88/218.03  |- skos__broader mesh__D009230Q000151smesh__D009230
% 217.88/218.03  |- mesh__preferredCombination mesh__D009230Q000151smesh__D003409
% 217.88/218.03  |- rdf__type mesh__D009230Q000151smesh__CompoundConcept
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D019663 2004
% 217.88/218.03  |- skos__scopeNote mesh__D019663
% 217.88/218.03       The goosefoot plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. It includes beets and chard %28%BETA VULGARIS%29%, as well as SPINACH, and salt tolerant plants.%A%    
% 217.88/218.03  |- mesh__recordAuthorizer mesh__D019663 sjn
% 217.88/218.03  |- skos__prefLabel mesh__D019663 Chenopodiaceae
% 217.88/218.03  |- mesh__dateRevised mesh__D019663 2002-07-03
% 217.88/218.03  |- mesh__dateEstablished mesh__D019663 1998-01-01
% 217.88/218.03  |- mesh__dateCreated mesh__D019663 1997-06-20
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D019663 2005
% 217.88/218.03  |- skos__broader mesh__D019663smesh__D019684
% 217.88/218.03  |- skos__annotation mesh__D019663
% 217.88/218.03       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.88/218.03  |- mesh__publicMeSHNote mesh__D019663 98   
% 217.88/218.03  |- mesh__historyNote mesh__D019663 98   
% 217.88/218.03  |- mesh__recordMaintainer mesh__D019663 ssb
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D019663 2006
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D019663 2003
% 217.88/218.03  |- rdf__type mesh__D019663sskos__Concept
% 217.88/218.03  |- mesh__recordOriginator mesh__D019663 JLS
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D000958 2004
% 217.88/218.03  |- mesh__recordAuthorizer mesh__D000958 PLS
% 217.88/218.03  |- rdf__type mesh__D000958sskos__Concept
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D000958 2006
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D000958 1997
% 217.88/218.03  |- mesh__recordOriginator mesh__D000958 NLM
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D000958 2003
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D000958 1999
% 217.88/218.03  |- mesh__historyNote mesh__D000958 75   
% 217.88/218.03  |- skos__altLabel mesh__D000958 Antigua and Barbuda
% 217.88/218.03  |- mesh__dateCreated mesh__D000958 1974-11-11
% 217.88/218.03  |- skos__broader mesh__D000958smesh__D014900
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D000958 2005
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D000958 1996
% 217.88/218.03  |- mesh__dateEstablished mesh__D000958 1975-01-01
% 217.88/218.03  |- skos__prefLabel mesh__D000958 Antigua
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D000958 1998
% 217.88/218.03  |- skos__annotation mesh__D000958
% 217.88/218.03       an island in the Lesser Antilles in the West Indies   
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D000958 2002
% 217.88/218.03  |- mesh__dateRevised mesh__D000958 1995-02-22
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D000958 2001
% 217.88/218.03  |- skos__scopeNote mesh__D000958
% 217.88/218.03       An island in the Lesser Antilles, one of the Leeward Islands. With Barbuda and Redonda, an uninhabited island, it constitutes the independent state of Antigua and Barbuda. Its capital is St. Johns. It was discovered by Columbus in 1493, settled by the English in 1632, occupied by the French in 1666, returned to the British in 1667, became self-governing in 1967 and independent in 1981. It was named by Columbus after the church of Santa Maria la Antigua %28%St. Mary the Ancient%29% in Seville. %28%From Webster%27%s New Geographical Dictionary, 1988, p56; Antigua and Barbuda Embassy %28%telephone 202-362-5122%29%; Room, Brewer%27%s Dictionary of Names, 1992, p24%29%%A%    
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D000958 2000
% 217.88/218.03  |- mesh__recordMaintainer mesh__D000958 TGC
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D011680 1997
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D011680 2002
% 217.88/218.03  |- mesh__recordAuthorizer mesh__D011680 PLS
% 217.88/218.03  |- skos__related mesh__D011680smesh__D012025
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D011680 1998
% 217.88/218.03  |- mesh__dateCreated mesh__D011680 1999-01-01
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D011680 1993
% 217.88/218.03  |- mesh__recordOriginator mesh__D011680 NLM
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D011680 1994
% 217.88/218.03  |- skos__broader mesh__D011680smesh__D007498
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D011680 1999
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D011680 2003
% 217.88/218.03  |- skos__prefLabel mesh__D011680 Pupil
% 217.88/218.03  |- skos__related mesh__D011680smesh__D009184
% 217.88/218.03  |- skos__related mesh__D011680smesh__D008916
% 217.88/218.03  |- mesh__dateRevised mesh__D011680 1992-05-18
% 217.88/218.03  |- skos__hiddenLabel mesh__D011680 Pupils
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D011680 1995
% 217.88/218.03  |- rdf__type mesh__D011680sskos__Concept
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D011680 2004
% 217.88/218.03  |- mesh__recordMaintainer mesh__D011680 TGC
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D011680 2005
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D011680 2000
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D011680 1996
% 217.88/218.03  |- skos__scopeNote mesh__D011680
% 217.88/218.03       The aperture in the iris through which light passes.     
% 217.88/218.03  |- skos__annotation mesh__D011680
% 217.88/218.03       of eye: do not use for STUDENTS; only contraction %26% dilation of pupil go here: everything else is probably IRIS; /drug eff: consider also MIOTICS %26% MYDRIATICS; /physiol: consider also MIOSIS %28%contraction of pupil%29% %26% MYDRIASIS %28%dilation of pupil%29%%A%  
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D011680 2001
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D011680 2006
% 217.88/218.03  |- skos__altLabel mesh__D005643 Deoxygalactose
% 217.88/218.03  |- skos__altLabel mesh__D005643 alpha-Fucose
% 217.88/218.03  |- mesh__recordMaintainer mesh__D005643 ssb
% 217.88/218.03  |- mesh__dateRevised mesh__D005643 2004-07-07
% 217.88/218.03  |- mesh__historyNote mesh__D005643 66%28%63%29%   
% 217.88/218.03  |- mesh__recordAuthorizer mesh__D005643 sjn
% 217.88/218.03  |- rdf__type mesh__D005643sskos__Concept
% 217.88/218.03  |- mesh__publicMeSHNote mesh__D005643 66   
% 217.88/218.03  |- mesh__recordOriginator mesh__D005643 NLM
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D005643 2006
% 217.88/218.03  |- skos__prefLabel mesh__D005643 Fucose
% 217.88/218.03  |- skos__broader mesh__D005643smesh__D006601
% 217.88/218.03  |- mesh__dateCreated mesh__D005643 1999-01-01
% 217.88/218.03  |- mesh__dateEstablished mesh__D005643 1966-01-01
% 217.88/218.03  |- skos__broader mesh__D005643smesh__D003837
% 217.88/218.03  |- skos__hiddenLabel mesh__D005643 alpha Fucose
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D005643 2005
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D043762 2004
% 217.88/218.03  |- skos__annotation mesh__D043762
% 217.88/218.03       human only; for animals use SEX BEHAVIOR, ANIMAL or REPRODUCTION%A%  
% 217.88/218.03  |- rdf__type mesh__D043762sskos__Concept
% 217.88/218.03  |- skos__historyNote mesh__D043762 Reproduction %28%1965-2003%29%
% 217.88/218.03  |- skos__hiddenLabel mesh__D043762 Childbearing, Delayed
% 217.88/218.03  |- skos__related mesh__D043762smesh__D012725
% 217.88/218.03  |- mesh__dateEstablished mesh__D043762 2004-01-01
% 217.88/218.03  |- skos__prefLabel mesh__D043762 Reproductive Behavior
% 217.88/218.03  |- skos__broader mesh__D043762smesh__D001519
% 217.88/218.03  |- skos__broader mesh__D043762smesh__D012098
% 217.88/218.03  |- mesh__dateCreated mesh__D043762 2003-07-09
% 217.88/218.03  |- mesh__recordOriginator mesh__D043762 lkt
% 217.88/218.03  |- mesh__historyNote mesh__D043762 2004; use SEX BEHAVIOR 1980-2003   
% 217.88/218.03  |- mesh__recordMaintainer mesh__D043762 lkt
% 217.88/218.03  |- skos__historyNote mesh__D043762 Sex Behavior %28%1980-2003%29%
% 217.88/218.03  |- skos__hiddenLabel mesh__D043762 Childlessness, Voluntary
% 217.88/218.03  |- skos__hiddenLabel mesh__D043762 Behavior, Reproductive
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D043762 2005
% 217.88/218.03  |- mesh__publicMeSHNote mesh__D043762 2004; see SEX BEHAVIOR 1980-2003   
% 217.88/218.03  |- mesh__recordAuthorizer mesh__D043762 sjn
% 217.88/218.03  |- skos__scopeNote mesh__D043762
% 217.88/218.03       Human behavior or decision related to REPRODUCTION.     
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D043762 2006
% 217.88/218.03  |- skos__related mesh__D010588smesh__D010587
% 217.88/218.03  |- skos__historyNote mesh__D010588 Phagocytosis %28%1966-1985%29%
% 217.88/218.03  |- mesh__publicMeSHNote mesh__D010588 86   
% 217.88/218.03  |- skos__scopeNote mesh__D010588
% 217.88/218.03       Membrane-bound cytoplasmic vesicles formed by invagination of phagocytized material. They fuse with lysosomes to form phagolysosomes in which the hydrolytic enzymes of the lysosome digest the phagocytized material.%A%    
% 217.88/218.03  |- skos__broader mesh__D010588smesh__D022162
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D010588 2004
% 217.88/218.03  |- rdf__type mesh__D010588sskos__Concept
% 217.88/218.03  |- skos__annotation mesh__D010588
% 217.88/218.03       A 11 qualif except /cytol; /genet permitted   
% 217.88/218.03  |- skos__prefLabel mesh__D010588 Phagosomes
% 217.88/218.03  |- mesh__recordAuthorizer mesh__D010588 sjn
% 217.88/218.03  |- skos__hiddenLabel mesh__D010588 Phagosome
% 217.88/218.03  |- mesh__recordOriginator mesh__D010588 AEP
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D010588 2005
% 217.88/218.03  |- skos__historyNote mesh__D010588 Lysosomes %28%1966-1985%29%
% 217.88/218.03  |- mesh__dateEstablished mesh__D010588 1986-01-01
% 217.88/218.03  |- skos__hiddenLabel mesh__D010588 Phagolysosome
% 217.88/218.03  |- mesh__dateRevised mesh__D010588 2003-07-09
% 217.88/218.03  |- mesh__historyNote mesh__D010588 86   
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D010588 2006
% 217.88/218.03  |- mesh__dateCreated mesh__D010588 1985-03-11
% 217.88/218.03  |- mesh__recordMaintainer mesh__D010588 nns
% 217.88/218.03  |- mesh__dateCreated mesh__D015273 1988-05-19
% 217.88/218.03  |- skos__annotation mesh__D015273 no qualif   
% 217.88/218.03  |- skos__hiddenLabel mesh__D015273 Selection Bias, Insurance
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D015273 2003
% 217.88/218.03  |- skos__hiddenLabel mesh__D015273 Bias, Insurance Selection
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D015273 2004
% 217.88/218.03  |- mesh__dateEstablished mesh__D015273 1991-01-01
% 217.88/218.03  |- rdf__type mesh__D015273sskos__Concept
% 217.88/218.03  |- skos__historyNote mesh__D015273
% 217.88/218.03       Consumer Participation/economics %28%1974-1988%29%
% 217.88/218.03  |- mesh__publicMeSHNote mesh__D015273
% 217.88/218.03       91; was see under INSURANCE 1989-90   
% 217.88/218.03  |- skos__broader mesh__D015273smesh__D007341
% 217.88/218.03  |- skos__scopeNote mesh__D015273
% 217.88/218.03       Adverse of favorable selection bias exhibited by insurers or enrollees resulting in disproportionate enrollment of certain groups of people.%A%    
% 217.88/218.03  |- mesh__recordOriginator mesh__D015273 EC
% 217.88/218.03  |- skos__prefLabel mesh__D015273 Insurance Selection Bias
% 217.88/218.03  |- skos__historyNote mesh__D015273
% 217.88/218.03       Insurance, Health/utilization %28%1976-1988%29%
% 217.88/218.03  |- mesh__recordMaintainer mesh__D015273 mdb
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D015273 2005
% 217.88/218.03  |- mesh__dateRevised mesh__D015273 2002-07-02
% 217.88/218.03  |- mesh__recordAuthorizer mesh__D015273 sjn
% 217.88/218.03  |- mesh__historyNote mesh__D015273
% 217.88/218.03       91%28%89%29%; was see under INSURANCE 1989-90   
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D015273 2006
% 217.88/218.03  |- mesh__recordMaintainer mesh__D009236 KEV
% 217.88/218.03  |- mesh__recordOriginator mesh__D009236 NLM
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D009236 2006
% 217.88/218.03  |- mesh__activeMeSHYear mesh__D009236 1997
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D009236 1998
% 217.88/218.04  |- skos__broader mesh__D009236smesh__D012509
% 217.88/218.04  |- mesh__historyNote mesh__D009236
% 217.88/218.04       91%28%86%29%63; was see under SARCOMA 1986-90; was heading 1963-85%A%  
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D009236 2000
% 217.88/218.04  |- mesh__dateCreated mesh__D009236 1999-01-01
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D009236 1999
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D009236 2003
% 217.88/218.04  |- skos__hiddenLabel mesh__D009236 Myxosarcomas
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D009236 2001
% 217.88/218.04  |- mesh__recordAuthorizer mesh__D009236 PLS
% 217.88/218.04  |- mesh__dateEstablished mesh__D009236 1991-01-01
% 217.88/218.04  |- mesh__publicMeSHNote mesh__D009236
% 217.88/218.04       91,63-85; was see under SARCOMA 1986-90; was heading 1963-85%A%  
% 217.88/218.04  |- skos__annotation mesh__D009236
% 217.88/218.04       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; myxosarcoma of breast = PHYLLODES TUMOR%A%  
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D009236 2004
% 217.88/218.04  |- mesh__dateRevised mesh__D009236 1995-06-08
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D009236 2002
% 217.88/218.04  |- rdf__type mesh__D009236sskos__Concept
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D009236 2005
% 217.88/218.04  |- skos__broader mesh__D009236smesh__D009372
% 217.88/218.04  |- skos__prefLabel mesh__D009236 Myxosarcoma
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D009236 1996
% 217.88/218.04  |- skos__scopeNote mesh__D009236
% 217.88/218.04       A sarcoma, usually a liposarcoma or malignant fibrous histiocytoma, with an abundant component of myxoid tissue resembling primitive mesenchyme containing connective tissue mucin. %28%Stedman, 25th ed%29%%A%    
% 217.88/218.04  |- mesh__onlineNote mesh__D001253 search NEUROGLIA 1966-74   
% 217.88/218.04  |- skos__prefLabel mesh__D001253 Astrocytes
% 217.88/218.04  |- rdf__type mesh__D001253sskos__Concept
% 217.88/218.04  |- mesh__publicMeSHNote mesh__D001253
% 217.88/218.04       79; was see under NEUROGLIA 1963-78   
% 217.88/218.04  |- mesh__dateCreated mesh__D001253 1999-01-01
% 217.88/218.04  |- mesh__recordOriginator mesh__D001253 NLM
% 217.88/218.04  |- mesh__recordAuthorizer mesh__D001253 sjn
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D001253 2002
% 217.88/218.04  |- skos__hiddenLabel mesh__D001253 Astrocyte
% 217.88/218.04  |- skos__altLabel mesh__D001253 Astroglia
% 217.88/218.04  |- mesh__recordMaintainer mesh__D001253 nns
% 217.88/218.04  |- skos__scopeNote mesh__D001253
% 217.88/218.04       A class of large neuroglial %28%macroglial%29% cells in the central nervous system - the largest and most numerous neuroglial cells in the brain and spinal cord. Astrocytes %28%from %22%star%22% cells%29% are irregularly shaped with many long processes, including those with %22%end feet%22% which form the glial %28%limiting%29% membrane and directly and indirectly contribute to the BLOOD-BRAIN BARRIER. They regulate the extracellular ionic and chemical environment, and %22%reactive astrocytes%22% %28%along with MICROGLIA%29% respond to injury.%A%    
% 217.88/218.04  |- mesh__dateRevised mesh__D001253 2001-07-25
% 217.88/218.04  |- skos__historyNote mesh__D001253 Neuroglia %28%1966-1974%29%
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D001253 2003
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D001253 2005
% 217.88/218.04  |- skos__related mesh__D001253smesh__D001812
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D001253 2004
% 217.88/218.04  |- mesh__historyNote mesh__D001253
% 217.88/218.04       79%28%75%29%; was see under NEUROGLIA 1963-78   
% 217.88/218.04  |- mesh__dateEstablished mesh__D001253 1979-01-01
% 217.88/218.04  |- skos__hiddenLabel mesh__D001253 Astroglias
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D001253 2006
% 217.88/218.04  |- skos__broader mesh__D001253smesh__D009457
% 217.88/218.04  |- mesh__recordAuthorizer mesh__D014979 sjn
% 217.88/218.04  |- rdf__type mesh__D014979sskos__Concept
% 217.88/218.04  |- mesh__recordOriginator mesh__D014979 NLM
% 217.88/218.04  |- skos__historyNote mesh__D014979 Xenon %28%1966-1974%29%
% 217.88/218.04  |- skos__hiddenLabel mesh__D014979 Isotopes, Xenon
% 217.88/218.04  |- mesh__historyNote mesh__D014979 75   
% 217.88/218.04  |- mesh__publicMeSHNote mesh__D014979 75   
% 217.88/218.04  |- skos__prefLabel mesh__D014979 Xenon Isotopes
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D014979 2005
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D014979 2001
% 217.88/218.04  |- mesh__recordMaintainer mesh__D014979 nns
% 217.88/218.04  |- skos__scopeNote mesh__D014979
% 217.88/218.04       Stable xenon atoms that have the same atomic number as the element xenon, but differ in atomic weight. Xe-124, 126, 128-131, 134, and 136 are stable xenon isotopes.%A%    
% 217.88/218.04  |- mesh__dateCreated mesh__D014979 1974-11-11
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D014979 2006
% 217.88/218.04  |- mesh__dateRevised mesh__D014979 2000-06-22
% 217.88/218.04  |- skos__historyNote mesh__D014979 Isotopes %28%1966-1974%29%
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D014979 2003
% 217.88/218.04  |- skos__broader mesh__D014979smesh__D007554
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D014979 2002
% 217.88/218.04  |- mesh__dateEstablished mesh__D014979 1975-09-01
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D014979 2004
% 217.88/218.04  |- skos__annotation mesh__D014979 Xe-124,126,128-131,134,136; NIM   
% 217.88/218.04  |- skos__prefLabel mesh__D019664 Polygonaceae
% 217.88/218.04  |- mesh__publicMeSHNote mesh__D019664 1998   
% 217.88/218.04  |- skos__scopeNote mesh__D019664
% 217.88/218.04       The only family of the buckwheat order %28%Polygonales%29% of dicotyledonous flowering plants. It has 40 genera of herbs, shrubs, and trees.%A%    
% 217.88/218.04  |- mesh__dateRevised mesh__D019664 2005-07-01
% 217.88/218.04  |- skos__annotation mesh__D019664
% 217.88/218.04       FAGOPYRUM %26% RHEUM are also available; prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.88/218.04  |- mesh__recordAuthorizer mesh__D019664 sjn
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D019664 2006
% 217.88/218.04  |- mesh__dateEstablished mesh__D019664 1998-01-01
% 217.88/218.04  |- mesh__dateCreated mesh__D019664 1997-06-20
% 217.88/218.04  |- mesh__recordOriginator mesh__D019664 JLS
% 217.88/218.04  |- rdf__type mesh__D019664sskos__Concept
% 217.88/218.04  |- skos__broader mesh__D019664smesh__D019684
% 217.88/218.04  |- mesh__recordMaintainer mesh__D019664 sjn
% 217.88/218.04  |- mesh__historyNote mesh__D019664 1998   
% 217.88/218.04  |- skos__altLabel mesh__D000959 Anti-Hypertensive Drugs
% 217.88/218.04  |- mesh__dateRevised mesh__D000959 2005-07-13
% 217.88/218.04  |- skos__altLabel mesh__D000959 Antihypertensive Drugs
% 217.88/218.04  |- skos__prefLabel mesh__D000959 Antihypertensive Agents
% 217.88/218.04  |- skos__scopeNote mesh__D000959
% 217.88/218.04       Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; %28%especially DIURETICS, THIAZIDE%29%; ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.%A%    
% 217.88/218.04  |- skos__related mesh__D000959smesh__D004232
% 217.88/218.04  |- mesh__recordMaintainer mesh__D000959 ags
% 217.88/218.04  |- skos__hiddenLabel mesh__D000959 Agents, Anti-Hypertensive
% 217.88/218.04  |- mesh__recordOriginator mesh__D000959 NLM
% 217.88/218.04  |- skos__annotation mesh__D000959 not for ocular hypertension   
% 217.88/218.04  |- skos__related mesh__D000959smesh__D014665
% 217.88/218.04  |- skos__altLabel mesh__D000959 Anti-Hypertensives
% 217.88/218.04  |- skos__related mesh__D000959smesh__D005730
% 217.88/218.04  |- skos__hiddenLabel mesh__D000959 Agents, Antihypertensive
% 217.88/218.04  |- skos__hiddenLabel mesh__D000959 Drugs, Antihypertensive
% 217.88/218.04  |- skos__hiddenLabel mesh__D000959 Anti Hypertensives
% 217.88/218.04  |- skos__hiddenLabel mesh__D000959 Anti Hypertensive Agents
% 217.88/218.04  |- mesh__dateCreated mesh__D000959 1999-01-01
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D000959 2006A
% 217.88/218.04  |- skos__related mesh__D000959smesh__D000319
% 217.88/218.04  |- skos__altLabel mesh__D000959 Anti-Hypertensive Agents
% 217.88/218.04  |- skos__broader mesh__D000959smesh__D002317
% 217.88/218.04  |- skos__hiddenLabel mesh__D000959 Anti Hypertensive Drugs
% 217.88/218.04  |- skos__altLabel mesh__D000959 Antihypertensives
% 217.88/218.04  |- mesh__recordAuthorizer mesh__D000959 ags
% 217.88/218.04  |- rdf__type mesh__D000959sskos__Concept
% 217.88/218.04  |- skos__related mesh__D000959smesh__D000317
% 217.88/218.04  |- skos__related mesh__D000959smesh__D000806
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D000959 2006
% 217.88/218.04  |- skos__hiddenLabel mesh__D000959 Drugs, Anti-Hypertensive
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupils, Keyhole
% 217.88/218.04  |- skos__broader mesh__D011681smesh__D009461
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Paralyses, Pupillary
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupillary Sector Paralyses
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Wernickes Hemianopic Pupil
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupil, Occluded
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D011681 2005
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Marcus Gunn Pupil
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Reaction Absent, Pupil
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupil Malformation
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D011681 2006A
% 217.88/218.04  |- skos__altLabel mesh__D011681 Pupillary Disorders
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Anomalies, Pupillary
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Paralysis, Pupillary Sector
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Sphincter Ruptures, Pupillary
% 217.88/218.04  |- skos__prefLabel mesh__D011681 Pupil Disorders
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Afferent Pupillary Defects
% 217.88/218.04  |- mesh__recordMaintainer mesh__D011681 ags
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Sector Paralysis, Pupillary
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Hemianopic Pupil, Wernicke%27%s
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupils, Occluded
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupils, Fixed
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Fixed Pupil
% 217.88/218.04  |- skos__altLabel mesh__D011681 Pupillary Anomaly
% 217.88/218.04  |- mesh__publicMeSHNote mesh__D011681
% 217.88/218.04       2000; see PUPILLARY FUNCTIONS, ABNORMAL 1990-1999   
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Malformation, Pupil
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D011681 2004
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Paralyses, Pupillary Sector
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupillary Sphincter Ruptures
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupillary Function, Abnormal
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupil, Deformed
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D011681 2002
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Rupture, Pupillary Sphincter
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupillary Disorder
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupillary Defect, Afferent
% 217.88/218.04  |- mesh__dateCreated mesh__D011681 1999-01-01
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupillary Defects, Afferent
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupil, Wernicke%27%s Hemianopic
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupil, Wernicke Hemianopic
% 217.88/218.04  |- skos__altLabel mesh__D011681 Marcus-Gunn Pupil
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupil, Keyhole
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Abnormal Pupillary Functions
% 217.88/218.04  |- mesh__recordOriginator mesh__D011681 NLM
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupillary Defect, Efferent
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupils, Deformed
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Sphincter Rupture, Pupillary
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Ruptures, Pupillary Sphincter
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D011681 2003
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Argyll-Robertson Pupil, Non-Syphilitic
% 217.88/218.04  |- mesh__dateEstablished mesh__D011681 1990-01-01
% 217.88/218.04  |- skos__altLabel mesh__D011681 Pupillary Occlusion
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Non Syphilitic Argyll Robertson Pupil
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Deformed Pupils
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Abnormal Pupillary Function
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupil, Non-Syphilitic Argyll-Robertson
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Occluded Pupil
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D011681 2001
% 217.88/218.04  |- skos__historyNote mesh__D011681 Pupil %28%1967-1989%29%
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupil, Marcus-Gunn
% 217.88/218.04  |- skos__altLabel mesh__D011681 Sector Pupil Palsy
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Hemianopic Pupil, Wernicke
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Efferent Pupillary Defects
% 217.88/218.04  |- mesh__historyNote mesh__D011681 2000%28%1974%29%   
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupillary Defects, Efferent
% 217.88/218.04  |- skos__broader mesh__D011681smesh__D005128
% 217.88/218.04  |- mesh__dateRevised mesh__D011681 2005-07-18
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Malformations, Pupil
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Sector Paralyses, Pupillary
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Ectopic Pupils
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Occlusions, Pupillary
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupil, Fixed
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D011681 2000
% 217.88/218.04  |- rdf__type mesh__D011681sskos__Concept
% 217.88/218.04  |- skos__historyNote mesh__D011681 specific eye disease %28%1969-1989%29%
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Occlusion, Pupillary
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Paralysis, Pupillary
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Reaction Absents, Pupil
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Anomaly, Pupillary
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupillary Paralyses
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupil, Ectopic
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D011681 2006
% 217.88/218.04  |- skos__annotation mesh__D011681 see also IRIS DISEASES   
% 217.88/218.04  |- mesh__recordAuthorizer mesh__D011681 ags
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupil Disorder
% 217.88/218.04  |- skos__altLabel mesh__D011681 Wernicke%27%s Hemianopic Pupil
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupils, Ectopic
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupillary Occlusions
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Keyhole Pupils
% 217.88/218.04  |- skos__hiddenLabel mesh__D011681 Pupillary Anomalies
% 217.88/218.04  |- skos__scopeNote mesh__D011681
% 217.88/218.04       Conditions which affect the structure or function of the pupil of the eye, including disorders of innervation to the pupillary constrictor or dilator muscles, and disorders of pupillary reflexes.%A%    
% 217.88/218.04  |- mesh__publicMeSHNote mesh__D005644
% 217.88/218.04       1978; see DISACCHARIDASES 1975-1977, see FUCOSIDASE 1975-1999%A%  
% 217.88/218.04  |- skos__altLabel mesh__D005644 Fucosidase
% 217.88/218.04  |- mesh__dateEstablished mesh__D005644 1978-01-01
% 217.88/218.04  |- mesh__recordOriginator mesh__D005644 NLM
% 217.88/218.04  |- skos__scopeNote mesh__D005644
% 217.88/218.04       An enzyme that catalyzes the hydrolysis of an alpha L-fucoside to yield an alcohol and L-fucose. Deficiency of this enzyme can cause FUCOSIDOSIS. EC 3.2.1.51.%A%    
% 217.88/218.04  |- skos__annotation mesh__D005644 /defic: consider also FUCOSIDOSIS   
% 217.88/218.04  |- skos__historyNote mesh__D005644 Fucose %28%1966-1974%29%
% 217.88/218.04  |- mesh__recordMaintainer mesh__D005644 ssb
% 217.88/218.04  |- skos__altLabel mesh__D005644 alpha-Fucosidase
% 217.88/218.04  |- skos__hiddenLabel mesh__D005644 alpha L Fucosidase
% 217.88/218.04  |- skos__prefLabel mesh__D005644 alpha-L-Fucosidase
% 217.88/218.04  |- skos__historyNote mesh__D005644 Glycoside Hydrolases %28%1966-1974%29%
% 217.88/218.04  |- mesh__historyNote mesh__D005644 1978%28%1975%29%   
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D005644 2005
% 217.88/218.04  |- rdf__type mesh__D005644sskos__Concept
% 217.88/218.04  |- skos__related mesh__D005644smesh__D005645
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D005644 2004
% 217.88/218.04  |- mesh__dateCreated mesh__D005644 1974-11-19
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D005644 2006
% 217.88/218.04  |- mesh__dateRevised mesh__D005644 2003-07-09
% 217.88/218.04  |- skos__hiddenLabel mesh__D005644 alpha Fucosidase
% 217.88/218.04  |- mesh__recordAuthorizer mesh__D005644 sjn
% 217.88/218.04  |- skos__broader mesh__D005644smesh__D006026
% 217.88/218.04  |- skos__annotation mesh__D015274 no qualif; DF: INTERDEP RELAT   
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D015274 2004
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D015274 2000
% 217.88/218.04  |- mesh__dateEstablished mesh__D015274 1991-01-01
% 217.88/218.04  |- mesh__dateCreated mesh__D015274 1988-05-19
% 217.88/218.04  |- rdf__type mesh__D015274sskos__Concept
% 217.88/218.04  |- mesh__recordMaintainer mesh__D015274 JLS
% 217.88/218.04  |- mesh__publicMeSHNote mesh__D015274
% 217.88/218.04       91; was see under PUBLIC RELATIONS 1989-90   
% 217.88/218.04  |- skos__hiddenLabel mesh__D015274 Relation, Interdepartmental
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D015274 1998
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D015274 2001
% 217.88/218.04  |- skos__broader mesh__D015274smesh__D011641
% 217.88/218.04  |- skos__hiddenLabel mesh__D015274 Interdepartmental Relation
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D015274 2005
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D015274 1999
% 217.88/218.04  |- mesh__recordAuthorizer mesh__D015274 SJN
% 217.88/218.04  |- skos__historyNote mesh__D015274
% 217.88/218.04       Interprofessional Relations %28%1966-1988%29%
% 217.88/218.04  |- mesh__historyNote mesh__D015274
% 217.88/218.04       91%28%89%29%; was see under PUBLIC RELATIONS 1989-90   
% 217.88/218.04  |- skos__prefLabel mesh__D015274 Interdepartmental Relations
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D015274 2006
% 217.88/218.04  |- skos__hiddenLabel mesh__D015274 Relations, Interdepartmental
% 217.88/218.04  |- mesh__recordOriginator mesh__D015274 EC
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D015274 2002
% 217.88/218.04  |- mesh__dateRevised mesh__D015274 1997-06-20
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D015274 2003
% 217.88/218.04  |- skos__scopeNote mesh__D015274
% 217.88/218.04       The interactions between representatives of institutional departments.%A%    
% 217.88/218.04  |- skos__hiddenLabel mesh__D009237 beta 1,4 Galactosyltransferase
% 217.88/218.04  |- skos__hiddenLabel mesh__D009237
% 217.88/218.04       beta-D-Galactosyltransferase, N-Acetylglucosamine
% 217.88/218.04  |- skos__hiddenLabel mesh__D009237 N Acetyllactosamine Synthase
% 217.88/218.04  |- skos__prefLabel mesh__D009237 N-Acetyllactosamine Synthase
% 217.88/218.04  |- mesh__recordAuthorizer mesh__D009237 sjn
% 217.88/218.04  |- skos__hiddenLabel mesh__D009237 N Acetyllactosamine Synthetase
% 217.88/218.04  |- skos__historyNote mesh__D009237 Lactose Synthase %28%1973-1974%29%
% 217.88/218.04  |- mesh__onlineNote mesh__D009237
% 217.88/218.04       use N-ACETYLLACTOSAMINE SYNTHASE to search N-ACETYLLACTOSAMINE SYNTHETASE 1975-91%A%  
% 217.88/218.04  |- skos__altLabel mesh__D009237
% 217.88/218.04       UDP Galactose-N-Acetylglucosamine Galactosyltransferase
% 217.88/218.04  |- mesh__recordOriginator mesh__D009237 NLM
% 217.88/218.04  |- mesh__dateRevised mesh__D009237 2003-07-09
% 217.88/218.04  |- skos__altLabel mesh__D009237
% 217.88/218.04       UDP Galactose Acetylglucosamine Galactosyltransferase
% 217.88/218.04  |- mesh__dateEstablished mesh__D009237 1991-01-01
% 217.88/218.04  |- skos__scopeNote mesh__D009237
% 217.88/218.04       The A protein of the lactose synthase complex. In the presence of the B protein %28%LACTALBUMIN%29% specificity is changed from N-acetylglucosamine to glucose. EC 2.4.1.90.%A%    
% 217.88/218.04  |- skos__hiddenLabel mesh__D009237 Synthetase, N-Acetyllactosamine
% 217.88/218.04  |- skos__historyNote mesh__D009237 Glucosamine %28%1973-1974%29%
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D009237 2004
% 217.88/218.04  |- mesh__recordMaintainer mesh__D009237 ssb
% 217.88/218.04  |- skos__hiddenLabel mesh__D009237
% 217.88/218.04       N Acetylglucosamine beta D Galactosyltransferase
% 217.88/218.04  |- skos__hiddenLabel mesh__D009237
% 217.88/218.04       Galactosyltransferase, UDP Galactose-N-Acetylglucosamine
% 217.88/218.04  |- rdf__type mesh__D009237sskos__Concept
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D009237 2005
% 217.88/218.04  |- skos__broader mesh__D009237smesh__D007788
% 217.88/218.04  |- skos__altLabel mesh__D009237 N-Acetyllactosamine Synthetase
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D009237 2006
% 217.88/218.04  |- skos__hiddenLabel mesh__D009237
% 217.88/218.04       UDP Galactose N Acetylglucosamine Galactosyltransferase
% 217.88/218.04  |- mesh__publicMeSHNote mesh__D009237
% 217.88/218.04       92; was N-ACETYLLACTOSAMINE SYNTHETASE 1975-91 %28%see under LACTOSE SYNTHASE 1975-90%29%%A%  
% 217.88/218.04  |- mesh__historyNote mesh__D009237
% 217.88/218.04       92; was N-ACETYLLACTOSAMINE SYNTHETASE 1975-91 %28%see under LACTOSE SYNTHASE 1975-90%29%%A%  
% 217.88/218.04  |- skos__hiddenLabel mesh__D009237 Synthase, N-Acetyllactosamine
% 217.88/218.04  |- mesh__dateCreated mesh__D009237 1974-11-19
% 217.88/218.04  |- skos__altLabel mesh__D009237 beta-1,4-Galactosyltransferase
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Intracranial Astrocytomas
% 217.88/218.04  |- skos__altLabel mesh__D001254 Astroglioma
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Pilocytic Astrocytomas
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytoma, Juvenile Pilocytic
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D001254 2006
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytomas
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytoma, Fibrillary
% 217.88/218.04  |- skos__prefLabel mesh__D001254 Astrocytoma
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Grade II Astrocytoma
% 217.88/218.04  |- mesh__recordOriginator mesh__D001254 NLM
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Grade I Astrocytomas
% 217.88/218.04  |- rdf__type mesh__D001254sskos__Concept
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Juvenile Pilocytic Astrocytomas
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Anaplastic Astrocytomas
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytomas, Grade I
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytoma, Anaplastic
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Cerebral Astrocytoma, Childhood
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytoma, Gemistocytic
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytoma, Intracranial
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytoma, Pilocytic
% 217.88/218.04  |- skos__altLabel mesh__D001254 Astrocytoma, Grade III
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D001254 2005
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Pilocytic Astrocytoma, Juvenile
% 217.88/218.04  |- skos__scopeNote mesh__D001254
% 217.88/218.04       Neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy %28%grades I through IV%29%. In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. %28%From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082%29%%A%    
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Childhood Cerebral Astrocytomas
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Mixed Oligoastrocytoma
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D001254 2004
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytic Gliomas
% 217.88/218.04  |- mesh__publicMeSHNote mesh__D001254
% 217.88/218.04       1963; for ASTROCYTOMA, SUBEPENDYMAL GIANT CELL see GLIOMA 1994-1999%A%  
% 217.88/218.04  |- mesh__historyNote mesh__D001254
% 217.88/218.04       1963; for ASTROCYTOMA, SUBEPENDYMAL GIANT CELL use GLIOMA 1994-1999%A%  
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytomas, Pilocytic
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Cerebral Astrocytomas
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D001254 2002
% 217.88/218.04  |- skos__broader mesh__D001254smesh__D005910
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Grade I Astrocytoma
% 217.88/218.04  |- skos__altLabel mesh__D001254 Glioma, Astrocytic
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Grade II Astrocytomas
% 217.88/218.04  |- mesh__recordAuthorizer mesh__D001254 sjn
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytomas, Juvenile Pilocytic
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Protoplasmic Astrocytoma
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytoma, Childhood Cerebral
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Oligoastrocytomas, Mixed
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D001254 2003
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Protoplasmic Astrocytomas
% 217.88/218.04  |- skos__altLabel mesh__D001254 Subependymal Giant Cell Astrocytoma
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrogliomas
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Grade III Astrocytomas
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytomas, Childhood Cerebral
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Fibrillary Astrocytomas
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Gemistocytic Astrocytomas
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytomas, Grade II
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytomas, Fibrillary
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Cerebral Astrocytomas, Childhood
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Gliomas, Astrocytic
% 217.88/218.04  |- mesh__dateCreated mesh__D001254 1999-01-01
% 217.88/218.04  |- mesh__recordMaintainer mesh__D001254 ags
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytomas, Grade III
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytomas, Intracranial
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytomas, Anaplastic
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Pilocytic Astrocytomas, Juvenile
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytomas, Protoplasmic
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytomas, Cerebral
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytic Glioma
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytoma, Cerebral
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Grade III Astrocytoma
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Astrocytomas, Gemistocytic
% 217.88/218.04  |- skos__annotation mesh__D001254
% 217.88/218.04       coord IM with precoord CNS/neopl term %28%IM%29% + site %28%IM%29%; Grades I-III go here, with pathol; for ASTROCYTOMA, GRADE IV see GLIOBLASTOMA; for SUBEPENDYMAL ASTROCYTOMA see GLIOMA, SUBEPENDYMAL; for MIXED OLIGODENDROGLIOMA-ASTROCYTOMA see OLIGODENDROGLIOMA%A%  
% 217.88/218.04  |- mesh__dateRevised mesh__D001254 2001-07-25
% 217.88/218.04  |- skos__hiddenLabel mesh__D001254 Mixed Oligoastrocytomas
% 217.88/218.04  |- skos__broader mesh__D019665smesh__D019684
% 217.88/218.04  |- skos__scopeNote mesh__D019665
% 217.88/218.04       The spurge family of flowering plants, in the order Euphorbiales, contains some 7,500 species in 275 genera. The family consists of annual and perennial herbs and woody shrubs or trees.%A%    
% 217.88/218.04  |- mesh__dateRevised mesh__D019665 2002-07-02
% 217.88/218.04  |- mesh__dateCreated mesh__D019665 1997-06-20
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D019665 2006
% 217.88/218.04  |- mesh__historyNote mesh__D019665 98   
% 217.88/218.04  |- skos__prefLabel mesh__D019665 Euphorbiaceae
% 217.88/218.04  |- mesh__publicMeSHNote mesh__D019665 98   
% 217.88/218.04  |- skos__annotation mesh__D019665
% 217.88/218.04       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D019665 2003
% 217.88/218.04  |- mesh__recordOriginator mesh__D019665 JLS
% 217.88/218.04  |- mesh__recordMaintainer mesh__D019665 ssb
% 217.88/218.04  |- rdf__type mesh__D019665sskos__Concept
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D019665 2004
% 217.88/218.04  |- mesh__dateEstablished mesh__D019665 1998-01-01
% 217.88/218.04  |- mesh__recordAuthorizer mesh__D019665 sjn
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D019665 2005
% 217.88/218.04  |- mesh__onlineNote mesh__D011682
% 217.88/218.04       use PURCHASING, HOSPITAL to search HOSPITAL PURCHASING 1966-77%A%  
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D011682 2005
% 217.88/218.04  |- skos__prefLabel mesh__D011682 Purchasing, Hospital
% 217.88/218.04  |- mesh__recordAuthorizer mesh__D011682 SJN
% 217.88/218.04  |- skos__related mesh__D011682smesh__D004865
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D011682 2006
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D011682 2000
% 217.88/218.04  |- skos__altLabel mesh__D011682 Hospital Purchasing
% 217.88/218.04  |- skos__altLabel mesh__D011682 Purchasings, Hospital
% 217.88/218.04  |- mesh__dateRevised mesh__D011682 1997-06-20
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D011682 2001
% 217.88/218.04  |- mesh__dateCreated mesh__D011682 1999-01-01
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D011682 1998
% 217.88/218.04  |- mesh__recordMaintainer mesh__D011682 PXP
% 217.88/218.04  |- skos__altLabel mesh__D011682 Hospital Purchasings
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D011682 2002
% 217.88/218.04  |- skos__scopeNote mesh__D011682
% 217.88/218.04       Hospital department responsible for the purchasing of supplies and equipment.%A%    
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D011682 1999
% 217.88/218.04  |- mesh__publicMeSHNote mesh__D011682
% 217.88/218.04       78; was HOSPITAL PURCHASING 1963-77   
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D011682 2003
% 217.88/218.04  |- mesh__recordOriginator mesh__D011682 NLM
% 217.88/218.04  |- mesh__historyNote mesh__D011682 78; was HOSPITAL PURCHASING 1963-77   
% 217.88/218.04  |- rdf__type mesh__D011682sskos__Concept
% 217.88/218.04  |- skos__broader mesh__D011682smesh__D006748
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D011682 2004
% 217.88/218.04  |- mesh__historyNote mesh__D005645 1985   
% 217.88/218.04  |- skos__hiddenLabel mesh__D005645 Diseases, Fucosidase Deficiency
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D005645 2006A
% 217.88/218.04  |- mesh__activeMeSHYear mesh__D005645 2002
% 217.88/218.05  |- skos__hiddenLabel mesh__D005645 Deficiency Disease, Fucosidase
% 217.88/218.05  |- skos__hiddenLabel mesh__D005645 Diseases, alpha-Fucosidase Deficiency
% 217.88/218.05  |- skos__historyNote mesh__D005645
% 217.88/218.05       Carbohydrate Metabolism, Inborn Errors %28%1966-1984%29%
% 217.88/218.05  |- skos__altLabel mesh__D005645 alpha-L-Fucosidase Deficiency Disease
% 217.88/218.05  |- skos__altLabel mesh__D005645 Deficiency Disease, alpha-Fucosidase
% 217.88/218.05  |- skos__hiddenLabel mesh__D005645 Disease, Fucosidase Deficiency
% 217.88/218.05  |- skos__historyNote mesh__D005645 Fucosidase %28%1975-1984%29%
% 217.88/218.05  |- mesh__dateEstablished mesh__D005645 1985-01-01
% 217.88/218.05  |- skos__hiddenLabel mesh__D005645 Deficiency Diseases, alpha-L-Fucosidase
% 217.88/218.05  |- skos__altLabel mesh__D005645 Fucosidosis, Juvenile
% 217.88/218.05  |- skos__altLabel mesh__D005645 Fucosidase Deficiency Disease
% 217.88/218.05  |- skos__broader mesh__D005645smesh__D002239
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D005645 2006
% 217.88/218.05  |- skos__hiddenLabel mesh__D005645 Fucosidase Deficiency Diseases
% 217.88/218.05  |- skos__hiddenLabel mesh__D005645 Juvenile Fucosidosis
% 217.88/218.05  |- skos__hiddenLabel mesh__D005645 Deficiency Diseases, Fucosidase
% 217.88/218.05  |- skos__hiddenLabel mesh__D005645 alpha Fucosidase Deficiency Disease
% 217.88/218.05  |- skos__related mesh__D005645smesh__D005644
% 217.88/218.05  |- skos__hiddenLabel mesh__D005645 Infantile Fucosidosis
% 217.88/218.05  |- mesh__recordMaintainer mesh__D005645 ags
% 217.88/218.05  |- mesh__publicMeSHNote mesh__D005645 1985   
% 217.88/218.05  |- skos__altLabel mesh__D005645 Fucosidosis, Infantile
% 217.88/218.05  |- skos__hiddenLabel mesh__D005645 Disease, alpha-Fucosidase Deficiency
% 217.88/218.05  |- skos__broader mesh__D005645smesh__D020140
% 217.88/218.05  |- rdf__type mesh__D005645sskos__Concept
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D005645 2005
% 217.88/218.05  |- skos__altLabel mesh__D005645 Deficiency Disease, alpha-L-Fucosidase
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D005645 2004
% 217.88/218.05  |- skos__broader mesh__D005645smesh__D020739
% 217.88/218.05  |- skos__hiddenLabel mesh__D005645 Deficiency Diseases, alpha-Fucosidase
% 217.88/218.05  |- skos__altLabel mesh__D005645 alpha-Fucosidase Deficiency Disease
% 217.88/218.05  |- skos__hiddenLabel mesh__D005645 alpha-L-Fucosidase Deficiency Diseases
% 217.88/218.05  |- skos__hiddenLabel mesh__D005645 Disease, alpha-L-Fucosidase Deficiency
% 217.88/218.05  |- skos__historyNote mesh__D005645 Fucose %28%1966-1984%29%
% 217.88/218.05  |- mesh__recordOriginator mesh__D005645 VDK
% 217.88/218.05  |- mesh__dateRevised mesh__D005645 2005-08-01
% 217.88/218.05  |- skos__prefLabel mesh__D005645 Fucosidosis
% 217.88/218.05  |- skos__hiddenLabel mesh__D005645 Deficiency Disease, alpha L Fucosidase
% 217.88/218.05  |- mesh__dateCreated mesh__D005645 1984-05-29
% 217.88/218.05  |- skos__hiddenLabel mesh__D005645 Deficiency Disease, alpha Fucosidase
% 217.88/218.05  |- mesh__recordAuthorizer mesh__D005645 ags
% 217.88/218.05  |- skos__hiddenLabel mesh__D005645 alpha L Fucosidase Deficiency Disease
% 217.88/218.05  |- skos__scopeNote mesh__D005645
% 217.88/218.05       An autosomal recessive lysosomal storage disease caused by a deficiency of ALPHA-L-FUCOSIDASE activity resulting in an accumulation of fucose containing SPHINGOLIPIDS; GLYCOPROTEINS, and mucopolysaccharides %28%GLYCOSAMINOGLYCANS%29% in lysosomes. The infantile form %28%type I%29% features psychomotor deterioration, MUSCLE SPASTICITY, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, SEIZURES, recurrent infections, and MACROGLOSSIA, with death occurring in the first decade of life. Juvenile fucosidosis %28%type II%29% is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type II survival may be through the fourth decade of life. %28%From Menkes, Textbook of Child Neurology, 5th ed, p87; Am J Med Genet 1991 Jan;38%28%1%29%:111-31%29%%A%    
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D005645 2003
% 217.88/218.05  |- skos__hiddenLabel mesh__D005645 Diseases, alpha-L-Fucosidase Deficiency
% 217.88/218.05  |- skos__hiddenLabel mesh__D005645 alpha-Fucosidase Deficiency Diseases
% 217.88/218.05  |- skos__altLabel mesh__D024001 HMGN Family Proteins
% 217.88/218.05  |- skos__altLabel mesh__D024001 Nucleosomal Binding Proteins
% 217.88/218.05  |- skos__scopeNote mesh__D024001
% 217.88/218.05       A family of HIGH MOBILITY GROUP PROTEINS that bind to NUCLEOSOMES.%A%    
% 217.88/218.05  |- skos__hiddenLabel mesh__D024001 Binding Proteins, Nucleosomal
% 217.88/218.05  |- skos__historyNote mesh__D024001 Nucleoproteins %28%1966-1981%29%
% 217.88/218.05  |- mesh__recordMaintainer mesh__D024001 SYSTEM
% 217.88/218.05  |- mesh__dateRevised mesh__D024001 2005-06-30
% 217.88/218.05  |- skos__historyNote mesh__D024001
% 217.88/218.05       Chromosomal Proteins, Non-Histone %28%1977-1984%29%
% 217.88/218.05  |- skos__altLabel mesh__D024001 HMGN
% 217.88/218.05  |- skos__prefLabel mesh__D024001 HMGN Proteins
% 217.88/218.05  |- mesh__historyNote mesh__D024001 2002   
% 217.88/218.05  |- mesh__recordOriginator mesh__D024001 jmp
% 217.88/218.05  |- mesh__recordAuthorizer mesh__D024001 sjn
% 217.88/218.05  |- mesh__dateCreated mesh__D024001 2001-07-25
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D024001 2006
% 217.88/218.05  |- skos__altLabel mesh__D024001
% 217.88/218.05       High Mobility Group Nucleosomal Binding Proteins
% 217.88/218.05  |- mesh__publicMeSHNote mesh__D024001 2002   
% 217.88/218.05  |- rdf__type mesh__D024001sskos__Concept
% 217.88/218.05  |- skos__related mesh__D024001smesh__D009707
% 217.88/218.05  |- skos__broader mesh__D024001smesh__D006609
% 217.88/218.05  |- skos__historyNote mesh__D024001
% 217.88/218.05       High Mobility Group Proteins %28%1985-2001%29%
% 217.88/218.05  |- mesh__dateEstablished mesh__D024001 2002-01-01
% 217.88/218.05  |- mesh__dateEstablished mesh__D015275 1989-01-01
% 217.88/218.05  |- skos__broader mesh__D015275smesh__D008232
% 217.88/218.05  |- skos__historyNote mesh__D015275
% 217.88/218.05       Burkitt%27%s Lymphoma/complications %28%1980-1988%29%
% 217.88/218.05  |- skos__related mesh__D015275smesh__D014409
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D015275 2005
% 217.88/218.05  |- skos__hiddenLabel mesh__D015275 Syndromes, Tumour Lysis
% 217.88/218.05  |- skos__historyNote mesh__D015275
% 217.88/218.05       Antineoplastic Agents, Combined/adverse effects/therapeutic use %28%1980-1988%29%
% 217.88/218.05  |- skos__hiddenLabel mesh__D015275 Tumour Lysis Syndromes
% 217.88/218.05  |- rdf__type mesh__D015275sskos__Concept
% 217.88/218.05  |- skos__annotation mesh__D015275
% 217.88/218.05       lymphoproliferative disord caused by anticancer drugs; coord IM with /etiol %28%not /chem ind%29% + anticancer drug /adv eff %28%IM%29% + required neopl coords /drug ther %28%IM or NIM%29% if pertinent%A%  
% 217.88/218.05  |- skos__hiddenLabel mesh__D015275 Syndromes, Tumor Lysis
% 217.88/218.05  |- mesh__recordMaintainer mesh__D015275 NLM
% 217.88/218.05  |- mesh__historyNote mesh__D015275 89   
% 217.88/218.05  |- skos__scopeNote mesh__D015275
% 217.88/218.05       A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.%A%    
% 217.88/218.05  |- skos__historyNote mesh__D015275
% 217.88/218.05       Antineoplastic Agents/therapeutic use %28%1984-1988%29%
% 217.88/218.05  |- skos__hiddenLabel mesh__D015275 Syndrome, Tumour Lysis
% 217.88/218.05  |- skos__prefLabel mesh__D015275 Tumor Lysis Syndrome
% 217.88/218.05  |- mesh__recordOriginator mesh__D015275 EC
% 217.88/218.05  |- mesh__dateCreated mesh__D015275 1988-05-19
% 217.88/218.05  |- skos__hiddenLabel mesh__D015275 Syndrome, Tumor Lysis
% 217.88/218.05  |- mesh__recordAuthorizer mesh__D015275 NLM
% 217.88/218.05  |- mesh__dateRevised mesh__D015275 2004-07-20
% 217.88/218.05  |- skos__altLabel mesh__D015275 Tumour Lysis Syndrome
% 217.88/218.05  |- mesh__publicMeSHNote mesh__D015275 89   
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D015275 2006
% 217.88/218.05  |- skos__hiddenLabel mesh__D015275 Tumor Lysis Syndromes
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D009238 2004
% 217.88/218.05  |- skos__hiddenLabel mesh__D009238 Lysozyme, T7
% 217.88/218.05  |- rdf__type mesh__D009238sskos__Concept
% 217.88/218.05  |- mesh__dateEstablished mesh__D009238 1991-01-01
% 217.88/218.05  |- skos__historyNote mesh__D009238 Muramic Acids %28%1973-1978%29%
% 217.88/218.05  |- skos__altLabel mesh__D009238 LE-Enzyme
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D009238 2005
% 217.88/218.05  |- skos__hiddenLabel mesh__D009238 Amidase, N-Acetylmuramoyl-L-alanine
% 217.88/218.05  |- skos__scopeNote mesh__D009238
% 217.88/218.05       An autolytic enzyme bound to the surface of bacterial cell walls. It catalyzes the hydrolysis of the link between N-acetylmuramoyl residues and L-amino acid residues in certain cell wall glycopeptides, particularly peptidoglycan. EC 3.5.1.28.%A%    
% 217.88/218.05  |- skos__hiddenLabel mesh__D009238 Hydrolase, Peptidoglycan
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D009238 2006
% 217.88/218.05  |- mesh__dateCreated mesh__D009238 1978-05-16
% 217.88/218.05  |- mesh__recordAuthorizer mesh__D009238 sjn
% 217.88/218.05  |- mesh__recordOriginator mesh__D009238 RLS
% 217.88/218.05  |- skos__broader mesh__D009238smesh__D000581
% 217.88/218.05  |- skos__hiddenLabel mesh__D009238 Amidohydrolase, Mucopeptide
% 217.88/218.05  |- skos__hiddenLabel mesh__D009238 LE Enzyme
% 217.88/218.05  |- skos__altLabel mesh__D009238 Mucopeptide Amidohydrolase
% 217.88/218.05  |- skos__historyNote mesh__D009238 Alanine %28%1966-1978%29%
% 217.88/218.05  |- skos__hiddenLabel mesh__D009238 Hydrolase, Murein
% 217.88/218.05  |- mesh__historyNote mesh__D009238
% 217.88/218.05       91%28%79%29%; was see under AMIDOHYDROLASES 1979-90   
% 217.88/218.05  |- skos__hiddenLabel mesh__D009238 Endolysin, T7
% 217.88/218.05  |- skos__altLabel mesh__D009238 Murein Hydrolase
% 217.88/218.05  |- skos__prefLabel mesh__D009238 N-Acetylmuramoyl-L-alanine Amidase
% 217.88/218.05  |- skos__altLabel mesh__D009238 Peptidoglycan Hydrolase
% 217.88/218.05  |- mesh__publicMeSHNote mesh__D009238
% 217.88/218.05       91; was see under AMIDOHYDROLASES 1979-90   
% 217.88/218.05  |- mesh__dateRevised mesh__D009238 2003-07-09
% 217.88/218.05  |- mesh__recordMaintainer mesh__D009238 ssb
% 217.88/218.05  |- skos__hiddenLabel mesh__D009238 N Acetylmuramoyl L alanine Amidase
% 217.88/218.05  |- skos__historyNote mesh__D009238 Amidohydrolases %28%1966-1978%29%
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D001255 2003
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D001255 2005
% 217.88/218.05  |- skos__prefLabel mesh__D001255 Astrology
% 217.88/218.05  |- mesh__dateRevised mesh__D001255 2001-07-25
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D001255 2004
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D001255 2006
% 217.88/218.05  |- mesh__recordMaintainer mesh__D001255 ssb
% 217.88/218.05  |- rdf__type mesh__D001255sskos__Concept
% 217.88/218.05  |- mesh__dateCreated mesh__D001255 1999-01-01
% 217.88/218.05  |- skos__annotation mesh__D001255 a form of occultism; DF: ASTROL   
% 217.88/218.05  |- skos__broader mesh__D001255smesh__D009781
% 217.88/218.05  |- mesh__recordAuthorizer mesh__D001255 sjn
% 217.88/218.05  |- mesh__recordOriginator mesh__D001255 NLM
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D001255 2002
% 217.88/218.05  |- mesh__dateEstablished mesh__D019666 1998-01-01
% 217.88/218.05  |- mesh__recordAuthorizer mesh__D019666 sjn
% 217.88/218.05  |- mesh__recordOriginator mesh__D019666 JLS
% 217.88/218.05  |- rdf__type mesh__D019666sskos__Concept
% 217.88/218.05  |- skos__broader mesh__D019666smesh__D019684
% 217.88/218.05  |- mesh__dateCreated mesh__D019666 1997-06-20
% 217.88/218.05  |- skos__annotation mesh__D019666
% 217.88/218.05       do not confuse X ref CRUCIATA with crucifers %28%CRUCIFERAE%29%; prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D019666 2004
% 217.88/218.05  |- skos__scopeNote mesh__D019666
% 217.88/218.05       The Madder plant family of the order Rubiales, subclass Asteridae, class Magnoliopsida includes important medicinal plants that provide QUININE;  IPECAC; and COFFEE. They have opposite leaves and interpetiolar stipules.%A%    
% 217.88/218.05  |- mesh__dateRevised mesh__D019666 2003-07-09
% 217.88/218.05  |- mesh__publicMeSHNote mesh__D019666 1998   
% 217.88/218.05  |- mesh__historyNote mesh__D019666 1998   
% 217.88/218.05  |- skos__prefLabel mesh__D019666 Rubiaceae
% 217.88/218.05  |- mesh__recordMaintainer mesh__D019666 ssb
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D019666 2005
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D019666 2006
% 217.88/218.05  |- skos__hiddenLabel mesh__D011683 Phosphorylases, Purine Nucleoside
% 217.88/218.05  |- skos__hiddenLabel mesh__D011683 Phosphorylase, Purine-Nucleoside
% 217.88/218.05  |- skos__altLabel mesh__D011683 Inosine Phosphorylase
% 217.88/218.05  |- mesh__onlineNote mesh__D011683
% 217.88/218.05       use PURINE-NUCLEOSIDE PHOSPHORYLASE to search PURINE NUCLEOSIDE PHOSPHORYLASES 1975-91%A%  
% 217.88/218.05  |- rdf__type mesh__D011683sskos__Concept
% 217.88/218.05  |- skos__hiddenLabel mesh__D011683 Purine Nucleoside Phosphorylase
% 217.88/218.05  |- mesh__dateRevised mesh__D011683 2003-07-09
% 217.88/218.05  |- mesh__publicMeSHNote mesh__D011683
% 217.88/218.05       92; was PURINE NUCLEOSIDE PHOSPHORYLASES 1975-91 %28%see under PENTOSYLTRANSFERASES 1975-90%29%%A%  
% 217.88/218.05  |- skos__historyNote mesh__D011683 Pentosyltransferases %28%1973-1974%29%
% 217.88/218.05  |- mesh__dateCreated mesh__D011683 1974-11-19
% 217.88/218.05  |- mesh__recordOriginator mesh__D011683 NLM
% 217.88/218.05  |- skos__historyNote mesh__D011683 Phosphates %28%1973-1974%29%
% 217.88/218.05  |- mesh__dateEstablished mesh__D011683 1991-01-01
% 217.88/218.05  |- skos__historyNote mesh__D011683 Purine Nucleosides %28%1973-1974%29%
% 217.88/218.05  |- skos__scopeNote mesh__D011683
% 217.88/218.05       An enzyme that catalyzes the reaction between a purine nucleoside and orthophosphate to form a free purine plus ribose-5-phosphate. EC 2.4.2.1.%A%    
% 217.88/218.05  |- mesh__historyNote mesh__D011683
% 217.88/218.05       92; was PURINE NUCLEOSIDE PHOSPHORYLASES 1975-91 %28%see under PENTOSYLTRANSFERASES 1975-90%29%%A%  
% 217.88/218.05  |- mesh__recordMaintainer mesh__D011683 ssb
% 217.88/218.05  |- skos__altLabel mesh__D011683 Purine Nucleoside Phosphorylases
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D011683 2006
% 217.88/218.05  |- skos__broader mesh__D011683smesh__D010430
% 217.88/218.05  |- skos__hiddenLabel mesh__D011683 Nucleoside Phosphorylases, Purine
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D011683 2005
% 217.88/218.05  |- skos__prefLabel mesh__D011683 Purine-Nucleoside Phosphorylase
% 217.88/218.05  |- mesh__recordAuthorizer mesh__D011683 sjn
% 217.88/218.05  |- skos__hiddenLabel mesh__D011683 Riboside Phosphorylase, Nicotinamide
% 217.88/218.05  |- skos__hiddenLabel mesh__D011683 Phosphorylase, Nicotinamide Riboside
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D011683 2004
% 217.88/218.05  |- skos__hiddenLabel mesh__D011683 Phosphorylase, Inosine
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D005646 2004
% 217.88/218.05  |- mesh__dateCreated mesh__D005646 1974-11-19
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D005646 2006
% 217.88/218.05  |- mesh__dateRevised mesh__D005646 2003-07-09
% 217.88/218.05  |- skos__hiddenLabel mesh__D005646
% 217.88/218.05       Galactose alpha-N-Acetylgalactosaminyltransferase, Fucosyl
% 217.88/218.05  |- mesh__onlineNote mesh__D005646
% 217.88/218.05       use FUCOSYL GALACTOSE ALPHA-N-ACETYLGALACTOSAMINYLTRANSFERASE to search FUCOSYL GALACTOSE ACETYLGALACTOSAMINYLTRANSFERASE 1975-91%A%  
% 217.88/218.05  |- skos__hiddenLabel mesh__D005646
% 217.88/218.05       Fucosyl Galactose alpha N Acetylgalactosaminyltransferase
% 217.88/218.05  |- skos__broader mesh__D005646smesh__D017350
% 217.88/218.05  |- skos__hiddenLabel mesh__D005646
% 217.88/218.05       Galactose Acetylgalactosaminyltransferase, Fucosyl
% 217.88/218.05  |- mesh__recordAuthorizer mesh__D005646 sjn
% 217.88/218.05  |- mesh__dateEstablished mesh__D005646 1991-01-01
% 217.88/218.05  |- skos__historyNote mesh__D005646 Hexosyltransferases %28%1973-1974%29%
% 217.88/218.05  |- mesh__recordOriginator mesh__D005646 NLM
% 217.88/218.05  |- skos__historyNote mesh__D005646 Galactosamine %28%1971-1974%29%
% 217.88/218.05  |- skos__prefLabel mesh__D005646
% 217.88/218.05       Fucosyl Galactose alpha-N-Acetylgalactosaminyltransferase
% 217.88/218.05  |- skos__scopeNote mesh__D005646
% 217.88/218.05       An enzyme that catalyzes the transfer of acetylgalactosamine from UDP N-acetylgalactosamine to various 2-fucosylgalactosides as acceptors. EC 2.4.1.40.%A%    
% 217.88/218.05  |- skos__hiddenLabel mesh__D005646
% 217.88/218.05       alpha-N-Acetylgalactosaminyltransferase, Fucosyl Galactose
% 217.88/218.05  |- skos__historyNote mesh__D005646 Oligosaccharides %28%1970-1974%29%
% 217.88/218.05  |- mesh__recordMaintainer mesh__D005646 ssb
% 217.88/218.05  |- rdf__type mesh__D005646sskos__Concept
% 217.88/218.05  |- skos__hiddenLabel mesh__D005646
% 217.88/218.05       Acetylgalactosaminyltransferase, Fucosyl Galactose
% 217.88/218.05  |- mesh__publicMeSHNote mesh__D005646
% 217.88/218.05       92; was FUCOSYL GALACTOSE ACETYLGALACTOSAMINYLTRANSFERASE 1975-91 %28%see under GALACTOSYLTRANSFERASES 1979-90, see under HEXOSYLTRANSFERASES 1975-78%29%%A%  
% 217.88/218.05  |- skos__annotation mesh__D005646 DF: FUG TRANSFERASE   
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D005646 2005
% 217.88/218.05  |- skos__altLabel mesh__D005646
% 217.88/218.05       Fucosyl Galactose Acetylgalactosaminyltransferase
% 217.88/218.05  |- mesh__historyNote mesh__D005646
% 217.88/218.05       92%28%75%29%; was FUCOSYL GALACTOSE ACETYLGALACTOSAMINYLTRANSFERASE 1975-91 %28%see under GALACTOSYLTRANSFERASES 1979-90, see under HEXOSYLTRANSFERASES 1975-78%29%%A%  
% 217.88/218.05  |- skos__broader mesh__D004878Q000031smesh__D004878
% 217.88/218.05  |- mesh__preferredCombination mesh__D004878Q000031smesh__D004879
% 217.88/218.05  |- rdf__type mesh__D004878Q000031smesh__CompoundConcept
% 217.88/218.05  |- mesh__recordMaintainer mesh__D024002 SYSTEM
% 217.88/218.05  |- mesh__dateCreated mesh__D024002 2001-07-25
% 217.88/218.05  |- skos__prefLabel mesh__D024002 HMGB Proteins
% 217.88/218.05  |- skos__altLabel mesh__D024002 HMG-B
% 217.88/218.05  |- skos__historyNote mesh__D024002
% 217.88/218.05       Chromosomal Proteins, Non-Histone %28%1977-1984%29%
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D024002 2006
% 217.88/218.05  |- mesh__publicMeSHNote mesh__D024002 2002   
% 217.88/218.05  |- skos__broader mesh__D024002smesh__D006609
% 217.88/218.05  |- rdf__type mesh__D024002sskos__Concept
% 217.88/218.05  |- skos__historyNote mesh__D024002
% 217.88/218.05       High Mobility Group Proteins %28%1985-2001%29%
% 217.88/218.05  |- skos__altLabel mesh__D024002 HMG-Box Proteins
% 217.88/218.05  |- skos__scopeNote mesh__D024002
% 217.88/218.05       A family of sequence-related proteins similar to HMGB1 PROTEIN that contains specific HMG-BOX DOMAINS.%A%    
% 217.88/218.05  |- skos__hiddenLabel mesh__D024002 HMG Box Proteins
% 217.88/218.05  |- skos__historyNote mesh__D024002 Nucleoproteins %28%1966-1981%29%
% 217.88/218.05  |- skos__related mesh__D024002smesh__D024742
% 217.88/218.05  |- mesh__dateEstablished mesh__D024002 2002-01-01
% 217.88/218.05  |- skos__altLabel mesh__D024002 High Mobility Group Box Proteins
% 217.88/218.05  |- mesh__dateRevised mesh__D024002 2005-06-30
% 217.88/218.05  |- mesh__historyNote mesh__D024002 2002   
% 217.88/218.05  |- skos__broader mesh__D024002smesh__D004268
% 217.88/218.05  |- skos__altLabel mesh__D024002 HMGB
% 217.88/218.05  |- mesh__recordAuthorizer mesh__D024002 sjn
% 217.88/218.05  |- mesh__recordOriginator mesh__D024002 jmp
% 217.88/218.05  |- mesh__dateCreated mesh__D015276 1988-05-19
% 217.88/218.05  |- skos__broader mesh__D015276smesh__D040841
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D015276 2003
% 217.88/218.05  |- skos__altLabel mesh__D015276 Healthcare Rationing
% 217.88/218.05  |- skos__prefLabel mesh__D015276 Health Care Rationing
% 217.88/218.05  |- skos__hiddenLabel mesh__D015276 Rationing, Healthcare
% 217.88/218.05  |- rdf__type mesh__D015276sskos__Concept
% 217.88/218.05  |- mesh__dateRevised mesh__D015276 2002-07-03
% 217.88/218.05  |- mesh__recordMaintainer mesh__D015276 hjn
% 217.88/218.05  |- skos__altLabel mesh__D015276 Rationing, Health Care
% 217.88/218.05  |- mesh__recordAuthorizer mesh__D015276 sjn
% 217.88/218.05  |- mesh__publicMeSHNote mesh__D015276 89   
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D015276 2006
% 217.88/218.05  |- skos__historyNote mesh__D015276
% 217.88/218.05       Health Resources/supply %26% distribution %28%1978-1988%29%
% 217.88/218.05  |- mesh__dateEstablished mesh__D015276 1989-01-01
% 217.88/218.05  |- skos__historyNote mesh__D015276
% 217.88/218.05       Health Services/supply %26% distribution %28%1974-1988%29%
% 217.88/218.05  |- skos__scopeNote mesh__D015276
% 217.88/218.05       Planning for the equitable allocation, apportionment, or distribution of available health resources.%A%    
% 217.88/218.05  |- skos__related mesh__D015276smesh__D018579
% 217.88/218.05  |- mesh__historyNote mesh__D015276 89   
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D015276 2005
% 217.88/218.05  |- skos__broader mesh__D015276smesh__D006297
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D015276 2004
% 217.88/218.05  |- skos__broader mesh__D015276smesh__D006285
% 217.88/218.05  |- mesh__recordOriginator mesh__D015276 EC
% 217.88/218.05  |- mesh__dateEstablished mesh__D009239 1991-01-01
% 217.88/218.05  |- mesh__recordMaintainer mesh__D009239 ssb
% 217.88/218.05  |- skos__broader mesh__D009239smesh__D008715
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D009239 2006
% 217.88/218.05  |- skos__prefLabel mesh__D009239 N-Formylmethionine
% 217.88/218.05  |- skos__scopeNote mesh__D009239
% 217.88/218.05       Effective in the initiation of protein synthesis. The initiating methionine residue enters the ribosome as N-formylmethionyl tRNA. This process occurs in Escherichia coli and other bacteria as well as in the mitochondria of eucaryotic cells.%A%    
% 217.88/218.05  |- mesh__dateCreated mesh__D009239 1974-11-19
% 217.88/218.05  |- mesh__publicMeSHNote mesh__D009239
% 217.88/218.05       91; was see under METHIONINE 1975-90   
% 217.88/218.05  |- mesh__historyNote mesh__D009239
% 217.88/218.05       91%28%75%29%; was see under METHIONINE 1975-90   
% 217.88/218.05  |- skos__hiddenLabel mesh__D009239 Formylmethionine, N
% 217.88/218.05  |- skos__historyNote mesh__D009239 Formic Acids %28%1974%29%
% 217.88/218.05  |- mesh__recordAuthorizer mesh__D009239 sjn
% 217.88/218.05  |- mesh__recordOriginator mesh__D009239 NLM
% 217.88/218.05  |- skos__altLabel mesh__D009239 N Formylmethionine
% 217.88/218.05  |- skos__historyNote mesh__D009239 Methionine %28%1974%29%
% 217.88/218.05  |- mesh__dateRevised mesh__D009239 2005-06-30
% 217.88/218.05  |- rdf__type mesh__D009239sskos__Concept
% 217.88/218.05  |- skos__hiddenLabel mesh__D001256 Star %28%Astronomy%29%
% 217.88/218.05  |- skos__scopeNote mesh__D001256
% 217.88/218.05       The science concerned with celestial bodies and the observation and interpretation of the radiation received in the vicinity of the earth from the component parts of the universe %28%McGraw Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%    
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D001256 2001
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D001256 1997
% 217.88/218.05  |- skos__broader mesh__D001256smesh__D010811
% 217.88/218.05  |- mesh__recordOriginator mesh__D001256 NLM
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D001256 2004
% 217.88/218.05  |- mesh__dateRevised mesh__D001256 1995-06-05
% 217.88/218.05  |- skos__prefLabel mesh__D001256 Astronomy
% 217.88/218.05  |- skos__hiddenLabel mesh__D001256 Galaxy
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D001256 2000
% 217.88/218.05  |- mesh__recordMaintainer mesh__D001256 JLS
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D001256 1996
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D001256 2003
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D001256 1999
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D001256 2006
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D001256 2002
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D001256 1998
% 217.88/218.05  |- mesh__recordAuthorizer mesh__D001256 PLS
% 217.88/218.05  |- rdf__type mesh__D001256sskos__Concept
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D001256 2005
% 217.88/218.05  |- skos__annotation mesh__D001256 SPEC: SPEC qualif   
% 217.88/218.05  |- mesh__dateCreated mesh__D001256 1999-01-01
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D020410 2006
% 217.88/218.05  |- mesh__recordAuthorizer mesh__D020410 sjn
% 217.88/218.05  |- mesh__dateRevised mesh__D020410 2005-06-30
% 217.88/218.05  |- skos__broader mesh__D020410smesh__D016326
% 217.88/218.05  |- skos__hiddenLabel mesh__D020410 Zebrafish Alcam protein
% 217.88/218.05  |- skos__altLabel mesh__D020410 KG-CAM
% 217.88/218.05  |- skos__altLabel mesh__D020410 CD166 Antigens
% 217.88/218.05  |- skos__broader mesh__D020410smesh__D019062
% 217.88/218.05  |- mesh__publicMeSHNote mesh__D020410
% 217.88/218.05       99; CD6 LIGAND was indexed under GLYCOPROTEINS 1995-98; KG-CAM was indexed under CELL ADHESION MOLECULES, NEURON-GLIA 1996-98 %26% CELL ADHESION MOLECULES 1994-95; NEUROLIN was indexed under CELL ADHESION MOLECULES, NEURONAL 1992-98; all are now ACTIVATED-LEUKOCYTE CELL ADHESION MOLECULE%A%  
% 217.88/218.05  |- mesh__historyNote mesh__D020410
% 217.88/218.05       99; use ACTIVATED-LEUKOCYTE CELL ADHESION MOLECULE %28%NM%29% 1990-98%A%  
% 217.88/218.05  |- skos__altLabel mesh__D020410 CD6 Ligand
% 217.88/218.05  |- skos__altLabel mesh__D020410 Activated Leukocyte Cell Adhesion Molecule
% 217.88/218.05  |- skos__altLabel mesh__D020410 Alcam protein, Zebrafish
% 217.88/218.05  |- mesh__recordOriginator mesh__D020410 AGS
% 217.88/218.05  |- mesh__dateCreated mesh__D020410 1998-06-10
% 217.88/218.05  |- skos__scopeNote mesh__D020410
% 217.88/218.05       Cell adhesion molecule expressed on activated leukocytes, fibroblasts, and neurons. It is a ligand for CD6. ALCAM-CD6 interactions may play a role in the binding of T and B cells to activated leukocytes.%A%    
% 217.88/218.05  |- mesh__recordMaintainer mesh__D020410 ssb
% 217.88/218.05  |- skos__prefLabel mesh__D020410 Activated-Leukocyte Cell Adhesion Molecule
% 217.88/218.05  |- skos__historyNote mesh__D020410
% 217.88/218.05       Extracellular Matrix Proteins %28%1991-1998%29%
% 217.88/218.05  |- skos__altLabel mesh__D020410 Antigens, CD166
% 217.88/218.05  |- rdf__type mesh__D020410sskos__Concept
% 217.88/218.05  |- mesh__dateEstablished mesh__D020410 1999-01-01
% 217.88/218.05  |- skos__broader mesh__D020410smesh__D015703
% 217.88/218.05  |- skos__historyNote mesh__D020410 Nerve Tissue Proteins %28%1991-1998%29%
% 217.88/218.05  |- skos__altLabel mesh__D020410 ALCAM
% 217.88/218.05  |- skos__historyNote mesh__D020410 Glycoproteins %28%1995-1998%29%
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D011684 2000
% 217.88/218.05  |- mesh__historyNote mesh__D011684 74   
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D011684 1997
% 217.88/218.05  |- mesh__dateCreated mesh__D011684 1999-01-01
% 217.88/218.05  |- mesh__publicMeSHNote mesh__D011684 74   
% 217.88/218.05  |- mesh__dateEstablished mesh__D011684 1974-01-01
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D011684 2006
% 217.88/218.05  |- mesh__dateRevised mesh__D011684 1992-05-20
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D011684 1996
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D011684 1995
% 217.88/218.05  |- mesh__recordOriginator mesh__D011684 NLM
% 217.88/218.05  |- skos__prefLabel mesh__D011684 Purine Nucleosides
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D011684 2005
% 217.88/218.05  |- skos__broader mesh__D011684smesh__D009705
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D011684 2002
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D011684 1994
% 217.88/218.05  |- skos__hiddenLabel mesh__D011684 Nucleosides, Purine
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D011684 2004
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D011684 1999
% 217.88/218.05  |- mesh__recordMaintainer mesh__D011684 TGC
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D011684 2001
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D011684 1993
% 217.88/218.05  |- mesh__recordAuthorizer mesh__D011684 PLS
% 217.88/218.05  |- rdf__type mesh__D011684sskos__Concept
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D011684 2003
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D011684 1998
% 217.88/218.05  |- mesh__publicMeSHNote mesh__D038821 2003   
% 217.88/218.05  |- skos__annotation mesh__D038821
% 217.88/218.05       coord with specific plant and specific fungus if pertinent%A%  
% 217.88/218.05  |- skos__altLabel mesh__D038821 Arbuscular Mycorrhizae
% 217.88/218.05  |- mesh__dateCreated mesh__D038821 2002-07-02
% 217.88/218.05  |- skos__broader mesh__D038821smesh__D005658
% 217.88/218.05  |- mesh__dateRevised mesh__D038821 2005-06-30
% 217.88/218.05  |- skos__altLabel mesh__D038821 Mycorrhiza
% 217.88/218.05  |- mesh__historyNote mesh__D038821 2003   
% 217.88/218.05  |- skos__related mesh__D038821smesh__D013559
% 217.88/218.05  |- skos__scopeNote mesh__D038821
% 217.88/218.05       Symbiotic combination %28%dual organism%29% of the MYCELIUM of FUNGI with the roots of plants %28%PLANT ROOTS%29%. The roots of almost all higher plants exhibit this mutually beneficial relationship, whereby the fungus supplies water and mineral salts to the plant, and the plant supplies CARBOHYDRATES to the fungus. There are two major types of mycorrhizae: ectomycorrhizae and endomycorrhizae.%A%    
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D038821 2006
% 217.88/218.05  |- skos__altLabel mesh__D038821 Mycorrhizae, Vesicular-Arbuscular
% 217.88/218.05  |- skos__broader mesh__D038821smesh__D018517
% 217.88/218.05  |- mesh__recordAuthorizer mesh__D038821 sjn
% 217.88/218.05  |- mesh__recordMaintainer mesh__D038821 SYSTEM
% 217.88/218.05  |- skos__altLabel mesh__D038821 Mycorrhizae, Arbuscular
% 217.88/218.05  |- skos__prefLabel mesh__D038821 Mycorrhizae
% 217.88/218.05  |- mesh__recordOriginator mesh__D038821 ags
% 217.88/218.05  |- skos__altLabel mesh__D038821 Vesicular-Arbuscular Mycorrhizae
% 217.88/218.05  |- mesh__dateEstablished mesh__D038821 2003-01-01
% 217.88/218.05  |- rdf__type mesh__D038821sskos__Concept
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D005647 2005
% 217.88/218.05  |- skos__historyNote mesh__D005647 Transferases %28%1966-1971%29%
% 217.88/218.05  |- mesh__dateRevised mesh__D005647 2004-07-13
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D005647 2006
% 217.88/218.05  |- mesh__recordAuthorizer mesh__D005647 sjn
% 217.88/218.05  |- skos__prefLabel mesh__D005647 Fucosyltransferases
% 217.88/218.05  |- mesh__dateEstablished mesh__D005647 1991-01-01
% 217.88/218.05  |- skos__broader mesh__D005647smesh__D006602
% 217.88/218.05  |- skos__historyNote mesh__D005647 Hexosyltransferases %28%1972-1978%29%
% 217.88/218.05  |- skos__scopeNote mesh__D005647
% 217.88/218.05       Enzymes catalyzing the transfer of fucose from a nucleoside diphosphate fucose to an acceptor molecule which is frequently another carbohydrate, a glycoprotein, or a glycolipid molecule. Elevated activity of some fucosyltransferases in human serum may serve as an indicator of malignancy. The class includes EC 2.4.1.65; EC 2.4.1.68; EC 2.4.1.69; EC 2.4.1.89.%A%    
% 217.88/218.05  |- mesh__historyNote mesh__D005647
% 217.88/218.05       91%28%79%29%; was see under HEXOSYLTRANSFERASES 1979-90   
% 217.88/218.05  |- mesh__recordOriginator mesh__D005647 RLS
% 217.88/218.05  |- mesh__recordMaintainer mesh__D005647 sjn
% 217.88/218.05  |- mesh__dateCreated mesh__D005647 1978-03-09
% 217.88/218.05  |- mesh__publicMeSHNote mesh__D005647
% 217.88/218.05       91; was see under HEXOSYLTRANSFERASES 1979-90   
% 217.88/218.05  |- rdf__type mesh__D005647sskos__Concept
% 217.88/218.05  |- skos__related mesh__D024801smesh__D003704
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D024801 2005
% 217.88/218.05  |- skos__broader mesh__D024801smesh__D019636
% 217.88/218.05  |- mesh__recordAuthorizer mesh__D024801 ags
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D024801 2003
% 217.88/218.05  |- skos__altLabel mesh__D024801 Tauopathy
% 217.88/218.05  |- skos__prefLabel mesh__D024801 Tauopathies
% 217.88/218.05  |- mesh__activeMeSHYear mesh__D024801 2006
% 217.88/218.05  |- rdf__type mesh__D024801sskos__Concept
% 217.88/218.05  |- skos__related mesh__D024801smesh__D016875
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D024801 2002
% 217.88/218.06  |- mesh__historyNote mesh__D024801 2002   
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D024801 2004
% 217.88/218.06  |- mesh__dateCreated mesh__D024801 2001-07-25
% 217.88/218.06  |- mesh__recordMaintainer mesh__D024801 ags
% 217.88/218.06  |- skos__related mesh__D024801smesh__D016874
% 217.88/218.06  |- mesh__dateRevised mesh__D024801 2005-07-07
% 217.88/218.06  |- skos__historyNote mesh__D024801 tau Proteins %28%1997-2001%29%
% 217.88/218.06  |- mesh__dateEstablished mesh__D024801 2002-01-01
% 217.88/218.06  |- mesh__recordOriginator mesh__D024801 lkt
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D024801 2006A
% 217.88/218.06  |- skos__scopeNote mesh__D024801
% 217.88/218.06       Neurodegenerative disorders involving deposition of abnormal tau protein isoforms %28%TAU PROTEINS%29% in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy %28%SUPRANUCLEAR PALSY, PROGRESSIVE%29%; and corticobasal degeneration.%A%    
% 217.88/218.06  |- mesh__publicMeSHNote mesh__D024801 2002   
% 217.88/218.06  |- skos__historyNote mesh__D024003
% 217.88/218.06       Chromosomal Proteins, Non-Histone %28%1977-1984%29%
% 217.88/218.06  |- mesh__historyNote mesh__D024003 2002   
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D024003 2006
% 217.88/218.06  |- mesh__publicMeSHNote mesh__D024003 2002   
% 217.88/218.06  |- skos__hiddenLabel mesh__D024003 HMG AT Proteins
% 217.88/218.06  |- rdf__type mesh__D024003sskos__Concept
% 217.88/218.06  |- skos__altLabel mesh__D024003 HMG-AT-Hook Proteins
% 217.88/218.06  |- mesh__recordAuthorizer mesh__D024003 sjn
% 217.88/218.06  |- mesh__recordOriginator mesh__D024003 jmp
% 217.88/218.06  |- skos__altLabel mesh__D024003 HMG-AT Proteins
% 217.88/218.06  |- mesh__dateCreated mesh__D024003 2001-07-25
% 217.88/218.06  |- skos__altLabel mesh__D024003 HMG-AT
% 217.88/218.06  |- skos__broader mesh__D024003smesh__D006609
% 217.88/218.06  |- mesh__dateEstablished mesh__D024003 2002-01-01
% 217.88/218.06  |- skos__historyNote mesh__D024003
% 217.88/218.06       High Mobility Group Proteins %28%1985-2001%29%
% 217.88/218.06  |- skos__altLabel mesh__D024003 HMGA
% 217.88/218.06  |- skos__prefLabel mesh__D024003 HMGA Proteins
% 217.88/218.06  |- skos__scopeNote mesh__D024003
% 217.88/218.06       Proteins containing AT-HOOK MOTIFS that are rich in arginine and glycine residues. They bind to the minor grove of AT-rich regions of DNA.%A%    
% 217.88/218.06  |- skos__hiddenLabel mesh__D024003 HMG AT Hook Proteins
% 217.88/218.06  |- skos__broader mesh__D024003smesh__D004268
% 217.88/218.06  |- skos__historyNote mesh__D024003 Nucleoproteins %28%1966-1981%29%
% 217.88/218.06  |- mesh__recordMaintainer mesh__D024003 SYSTEM
% 217.88/218.06  |- mesh__dateRevised mesh__D024003 2005-06-30
% 217.88/218.06  |- skos__related mesh__D024003smesh__D024761
% 217.88/218.06  |- mesh__dateRevised mesh__D015277 1992-05-15
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D015277 1994
% 217.88/218.06  |- skos__hiddenLabel mesh__D015277 Hotline
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D015277 1993
% 217.88/218.06  |- mesh__recordOriginator mesh__D015277 EC
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D015277 2002
% 217.88/218.06  |- mesh__dateCreated mesh__D015277 1988-05-19
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D015277 1999
% 217.88/218.06  |- skos__hiddenLabel mesh__D015277 Telephone Hotline
% 217.88/218.06  |- mesh__historyNote mesh__D015277 89   
% 217.88/218.06  |- skos__scopeNote mesh__D015277
% 217.88/218.06       A direct communication system, usually telephone, established for instant contact. It is designed to provide special information and assistance through trained personnel and is used for counseling, referrals, and emergencies such as poisonings and threatened suicides.%A%    
% 217.88/218.06  |- skos__broader mesh__D015277smesh__D003142
% 217.88/218.06  |- mesh__recordMaintainer mesh__D015277 TAP
% 217.88/218.06  |- mesh__publicMeSHNote mesh__D015277 89   
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D015277 2006
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D015277 1998
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D015277 1997
% 217.88/218.06  |- mesh__dateEstablished mesh__D015277 1989-01-01
% 217.88/218.06  |- mesh__recordAuthorizer mesh__D015277 PLS
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D015277 2005
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D015277 2004
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D015277 1996
% 217.88/218.06  |- skos__hiddenLabel mesh__D015277 Hotlines, Telephone
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D015277 2001
% 217.88/218.06  |- skos__hiddenLabel mesh__D015277 Hotline, Telephone
% 217.88/218.06  |- skos__prefLabel mesh__D015277 Hotlines
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D015277 2003
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D015277 2000
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D015277 1995
% 217.88/218.06  |- skos__altLabel mesh__D015277 Telephone Hotlines
% 217.88/218.06  |- rdf__type mesh__D015277sskos__Concept
% 217.88/218.06  |- skos__prefLabel mesh__D001257 Astrovirus
% 217.88/218.06  |- mesh__dateRevised mesh__D001257 2004-07-13
% 217.88/218.06  |- mesh__historyNote mesh__D001257
% 217.88/218.06       97; was ASTROVIRUSES 1979-96 %28%see under VERTEBRATE VIRUSES, UNCLASSIFIED 1979-90%29%%A%  
% 217.88/218.06  |- mesh__recordOriginator mesh__D001257 AEP
% 217.88/218.06  |- skos__broader mesh__D001257smesh__D019200
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D001257 2006
% 217.88/218.06  |- skos__historyNote mesh__D001257 Vertebrate Viruses %28%1975-1978%29%
% 217.88/218.06  |- mesh__recordAuthorizer mesh__D001257 sjn
% 217.88/218.06  |- mesh__onlineNote mesh__D001257
% 217.88/218.06       use ASTROVIRUS to search ASTROVIRUSES 1979-96   
% 217.88/218.06  |- mesh__dateCreated mesh__D001257 1978-03-20
% 217.88/218.06  |- rdf__type mesh__D001257sskos__Concept
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D001257 2005
% 217.88/218.06  |- skos__annotation mesh__D001257 infection = ASTROVIRIDAE INFECTIONS   
% 217.88/218.06  |- skos__historyNote mesh__D001257 Diarrhea, Infantile %28%1975-1978%29%
% 217.88/218.06  |- skos__historyNote mesh__D001257
% 217.88/218.06       Vertebrate Viruses, Unclassified %28%1975-1978%29%
% 217.88/218.06  |- mesh__dateEstablished mesh__D001257 1991-01-01
% 217.88/218.06  |- mesh__recordMaintainer mesh__D001257 sjn
% 217.88/218.06  |- mesh__publicMeSHNote mesh__D001257
% 217.88/218.06       97; was ASTROVIRUSES 1979-96 %28%see under VERTEBRATE VIRUSES, UNCLASSIFIED 1979-90%29%%A%  
% 217.88/218.06  |- skos__scopeNote mesh__D001257
% 217.88/218.06       A genus of small, circular RNA viruses in the family ASTROVIRIDAE. They cause gastroenteritis and are found in the stools of several vertebrates including humans. Transmission is by the fecal-oral route. There are at least eight human serotypes and the type species is Human astrovirus 1.%A%    
% 217.88/218.06  |- skos__broader mesh__D006740smesh__D006270
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006740 1996
% 217.88/218.06  |- skos__altLabel mesh__D006740 Hospital Administrator
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006740 1999
% 217.88/218.06  |- mesh__dateRevised mesh__D006740 1992-05-15
% 217.88/218.06  |- rdf__type mesh__D006740sskos__Concept
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006740 2005
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006740 2002
% 217.88/218.06  |- skos__altLabel mesh__D006740 Administrators, Hospital
% 217.88/218.06  |- mesh__recordOriginator mesh__D006740 EC
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006740 1997
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006740 2003
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006740 2006
% 217.88/218.06  |- skos__scopeNote mesh__D006740
% 217.88/218.06       Managerial personnel responsible for implementing policy and directing the activities of hospitals.%A%    
% 217.88/218.06  |- skos__prefLabel mesh__D006740 Hospital Administrators
% 217.88/218.06  |- skos__historyNote mesh__D006740
% 217.88/218.06       Hospital Administration %28%1966-1977%29%
% 217.88/218.06  |- mesh__publicMeSHNote mesh__D006740
% 217.88/218.06       90; was see under HEALTH FACILITY ADMINISTRATORS 1978-89   
% 217.88/218.06  |- mesh__recordMaintainer mesh__D006740 TAP
% 217.88/218.06  |- skos__broader mesh__D006740smesh__D010564
% 217.88/218.06  |- mesh__historyNote mesh__D006740
% 217.88/218.06       90%28%78%29%; was see under HEALTH FACILITY ADMINISTRATORS 1978-89%A%  
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006740 2004
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006740 1994
% 217.88/218.06  |- skos__altLabel mesh__D006740 Administrator, Hospital
% 217.88/218.06  |- mesh__dateCreated mesh__D006740 1977-05-05
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006740 1995
% 217.88/218.06  |- mesh__dateEstablished mesh__D006740 1990-01-01
% 217.88/218.06  |- mesh__recordAuthorizer mesh__D006740 PLS
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006740 2000
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006740 1998
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006740 1993
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006740 2001
% 217.88/218.06  |- skos__altLabel mesh__D020411 Oligonucleotide Microarrays
% 217.88/218.06  |- skos__altLabel mesh__D020411 DNA Chips
% 217.88/218.06  |- skos__broader mesh__D020411smesh__D017421
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Array, cDNA
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Chips, DNA
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Chip, Gene Expression
% 217.88/218.06  |- skos__altLabel mesh__D020411 Gene Expression Microarray Analysis
% 217.88/218.06  |- skos__historyNote mesh__D020411
% 217.88/218.06       Nucleic Acid Hybridization %28%1993-1998%29%
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Oligonucleotide Array
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Microarray, Oligonucleotide
% 217.88/218.06  |- skos__related mesh__D020411smesh__D020869
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Microarrays, DNA
% 217.88/218.06  |- skos__altLabel mesh__D020411 Gene Chips
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Arrays, Oligonucleotide
% 217.88/218.06  |- skos__annotation mesh__D020411
% 217.88/218.06       coord with GENE EXPRESSION PROFILING if pertinent   
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Chips, Gene Expression
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Microarrays, cDNA
% 217.88/218.06  |- skos__broader mesh__D020411smesh__D015336
% 217.88/218.06  |- mesh__recordAuthorizer mesh__D020411 sjn
% 217.88/218.06  |- skos__broader mesh__D020411smesh__D046228
% 217.88/218.06  |- mesh__recordMaintainer mesh__D020411 ssb
% 217.88/218.06  |- skos__altLabel mesh__D020411 DNA Microchips
% 217.88/218.06  |- skos__altLabel mesh__D020411 Sequence Analysis, Oligonucleotide Array
% 217.88/218.06  |- skos__altLabel mesh__D020411 cDNA Arrays
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 DNA Chip
% 217.88/218.06  |- skos__altLabel mesh__D020411 DNA Arrays
% 217.88/218.06  |- skos__altLabel mesh__D020411
% 217.88/218.06       Oligodeoxyribonucleotide Array Sequence Analysis
% 217.88/218.06  |- mesh__dateCreated mesh__D020411 1998-06-10
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Microarray, DNA
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Microarray, cDNA
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Gene Expression Chip
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Expression Chip, Gene
% 217.88/218.06  |- skos__related mesh__D020411smesh__D015345
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Microarrays, Oligonucleotide
% 217.88/218.06  |- mesh__recordOriginator mesh__D020411 NNS
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Chip, Gene
% 217.88/218.06  |- mesh__dateRevised mesh__D020411 2005-06-30
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Chips, Gene
% 217.88/218.06  |- mesh__dateEstablished mesh__D020411 1999-01-01
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 DNA Array
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 DNA Microarray
% 217.88/218.06  |- mesh__historyNote mesh__D020411 99   
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Gene Chip
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D020411 2006
% 217.88/218.06  |- skos__related mesh__D020411smesh__D020650
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Microchips, DNA
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Expression Chips, Gene
% 217.88/218.06  |- rdf__type mesh__D020411sskos__Concept
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Microchip, DNA
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Array, DNA
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 cDNA Microarray
% 217.88/218.06  |- skos__scopeNote mesh__D020411
% 217.88/218.06       Hybridization of a nucleic acid sample to a very large set of oligonucleotide probes, which are attached to a solid support, to determine sequence or to detect variations in a gene sequence or expression or for gene mapping.%A%    
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Arrays, DNA
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Oligonucleotide Microarray
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Sequencing By Hybridizations
% 217.88/218.06  |- mesh__publicMeSHNote mesh__D020411 99   
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 cDNA Array
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 DNA Microchip
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Array, Oligonucleotide
% 217.88/218.06  |- skos__prefLabel mesh__D020411 Oligonucleotide Array Sequence Analysis
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Chip, DNA
% 217.88/218.06  |- skos__hiddenLabel mesh__D020411 Arrays, cDNA
% 217.88/218.06  |- skos__broader mesh__D020411smesh__D009693
% 217.88/218.06  |- skos__prefLabel mesh__D019668 Liliaceae
% 217.88/218.06  |- mesh__publicMeSHNote mesh__D019668 98   
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D019668 2005
% 217.88/218.06  |- mesh__recordOriginator mesh__D019668 JLS
% 217.88/218.06  |- rdf__type mesh__D019668sskos__Concept
% 217.88/218.06  |- skos__annotation mesh__D019668
% 217.88/218.06       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.88/218.06  |- skos__broader mesh__D019668smesh__D019684
% 217.88/218.06  |- mesh__dateCreated mesh__D019668 1997-06-20
% 217.88/218.06  |- mesh__dateRevised mesh__D019668 2004-07-07
% 217.88/218.06  |- mesh__dateEstablished mesh__D019668 1998-01-01
% 217.88/218.06  |- mesh__recordAuthorizer mesh__D019668 sjn
% 217.88/218.06  |- skos__scopeNote mesh__D019668
% 217.88/218.06       A monocot family within the order Liliales. This family is divided by some botanists into other families such as Convallariaceae, Hyacinthaceae and Amaryllidaceae. Amaryllidaceae, which have inferior ovaries, includes CRINUM; GALANTHUS; LYCORIS; and NARCISSUS and are known for AMARYLLIDACEAE ALKALOIDS.%A%    
% 217.88/218.06  |- mesh__recordMaintainer mesh__D019668 ssb
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D019668 2006
% 217.88/218.06  |- mesh__historyNote mesh__D019668 98   
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D011685 2002
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D011685 1996
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D011685 1995
% 217.88/218.06  |- skos__broader mesh__D011685smesh__D009711
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D011685 2005
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D011685 2001
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D011685 1994
% 217.88/218.06  |- skos__prefLabel mesh__D011685 Purine Nucleotides
% 217.88/218.06  |- mesh__historyNote mesh__D011685 74%28%72%29%   
% 217.88/218.06  |- mesh__recordAuthorizer mesh__D011685 PLS
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D011685 2004
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D011685 1999
% 217.88/218.06  |- skos__historyNote mesh__D011685 Nucleotides %28%1966-1971%29%
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D011685 2000
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D011685 1993
% 217.88/218.06  |- mesh__dateEstablished mesh__D011685 1974-01-01
% 217.88/218.06  |- rdf__type mesh__D011685sskos__Concept
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D011685 2003
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D011685 1998
% 217.88/218.06  |- mesh__recordMaintainer mesh__D011685 TGC
% 217.88/218.06  |- skos__hiddenLabel mesh__D011685 Nucleotides, Purine
% 217.88/218.06  |- mesh__publicMeSHNote mesh__D011685 74   
% 217.88/218.06  |- mesh__dateRevised mesh__D011685 1992-05-20
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D011685 1997
% 217.88/218.06  |- mesh__dateCreated mesh__D011685 1999-01-01
% 217.88/218.06  |- mesh__recordOriginator mesh__D011685 NLM
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D011685 2006
% 217.88/218.06  |- skos__broader mesh__D005648smesh__D010578
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D005648 2006
% 217.88/218.06  |- skos__hiddenLabel mesh__D005648 Oil, Fuel
% 217.88/218.06  |- skos__hiddenLabel mesh__D005648 Fuel Oil
% 217.88/218.06  |- mesh__dateEstablished mesh__D005648 1991-01-01
% 217.88/218.06  |- skos__hiddenLabel mesh__D005648 Oils, Fuel
% 217.88/218.06  |- mesh__dateRevised mesh__D005648 1997-06-20
% 217.88/218.06  |- mesh__publicMeSHNote mesh__D005648
% 217.88/218.06       91; was see under PETROLEUM 1975-90; was in Cat J only 1975-81%A%  
% 217.88/218.06  |- mesh__dateCreated mesh__D005648 1999-01-01
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D005648 2002
% 217.88/218.06  |- mesh__recordAuthorizer mesh__D005648 SJN
% 217.88/218.06  |- rdf__type mesh__D005648sskos__Concept
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D005648 2003
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D005648 1998
% 217.88/218.06  |- mesh__recordOriginator mesh__D005648 NLM
% 217.88/218.06  |- skos__scopeNote mesh__D005648
% 217.88/218.06       Complex petroleum hydrocarbons consisting mainly of residues from crude oil distillation. These liquid products include heating oils, stove oils, and furnace oils and are burned to generate energy.%A%    
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D005648 2000
% 217.88/218.06  |- skos__prefLabel mesh__D005648 Fuel Oils
% 217.88/218.06  |- mesh__historyNote mesh__D005648
% 217.88/218.06       91%28%75%29%; was see under PETROLEUM 1975-90; was in Cat J only 1975-81%A%  
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D005648 2005
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D005648 2004
% 217.88/218.06  |- mesh__onlineNote mesh__D005648
% 217.88/218.06       use PETROLEUM to search FOSSIL FUELS 1968-74   
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D005648 1999
% 217.88/218.06  |- mesh__recordMaintainer mesh__D005648 JLS
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D005648 2001
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D016370 2006
% 217.88/218.06  |- mesh__historyNote mesh__D016370 91   
% 217.88/218.06  |- skos__altLabel mesh__D016370 HTLV-II rex Protein
% 217.88/218.06  |- skos__altLabel mesh__D016370
% 217.88/218.06       Human T-Cell Leukemia Virus Type I rex Protein
% 217.88/218.06  |- mesh__dateEstablished mesh__D016370 1991-01-01
% 217.88/218.06  |- mesh__recordAuthorizer mesh__D016370 sjn
% 217.88/218.06  |- skos__hiddenLabel mesh__D016370 HTLV II rex Protein
% 217.88/218.06  |- skos__annotation mesh__D016370
% 217.88/218.06       Rex stands for %22%regulator x%22%; /drug eff /ultrastruct permitted%A%  
% 217.88/218.06  |- skos__hiddenLabel mesh__D016370 rex Gene Product
% 217.88/218.06  |- rdf__type mesh__D016370sskos__Concept
% 217.88/218.06  |- skos__hiddenLabel mesh__D016370 rex Protein, HTLV-II
% 217.88/218.06  |- skos__hiddenLabel mesh__D016370 rex Protein, HTLV-I
% 217.88/218.06  |- skos__altLabel mesh__D016370 HTLV-I rex Protein
% 217.88/218.06  |- skos__broader mesh__D016370smesh__D015682
% 217.88/218.06  |- skos__altLabel mesh__D016370 p27%28%rex%29%
% 217.88/218.06  |- skos__altLabel mesh__D016370 Gene Product, rex
% 217.88/218.06  |- skos__altLabel mesh__D016370
% 217.88/218.06       Human T-Cell Leukemia Virus Type I rex Gene Product
% 217.88/218.06  |- mesh__recordMaintainer mesh__D016370 SYSTEM
% 217.88/218.06  |- skos__scopeNote mesh__D016370
% 217.88/218.06       Post-transcriptional regulatory proteins required for the accumulation of mRNAs that encode the gag and env gene products in HUMAN T-LYMPHOTROPIC VIRUS 1 and HUMAN T-LYMPHOTROPIC VIRUS 2. The rex %28%regulator x; x is undefined%29% products act by binding to elements in the LTR.%A%    
% 217.88/218.06  |- skos__altLabel mesh__D016370 HTLV-I rex Gene Product
% 217.88/218.06  |- skos__hiddenLabel mesh__D016370 HTLV I rex Protein
% 217.88/218.06  |- skos__altLabel mesh__D016370 p27 rex
% 217.88/218.06  |- mesh__recordOriginator mesh__D016370 AGS
% 217.88/218.06  |- mesh__dateCreated mesh__D016370 1990-06-19
% 217.88/218.06  |- mesh__publicMeSHNote mesh__D016370 91   
% 217.88/218.06  |- skos__historyNote mesh__D016370 Viral Regulatory Proteins %28%1990%29%
% 217.88/218.06  |- skos__altLabel mesh__D016370 rex Gene Products
% 217.88/218.06  |- skos__hiddenLabel mesh__D016370 rex, p27
% 217.88/218.06  |- skos__prefLabel mesh__D016370 Gene Products, rex
% 217.88/218.06  |- skos__broader mesh__D016370smesh__D015520
% 217.88/218.06  |- skos__altLabel mesh__D016370 rex Protein
% 217.88/218.06  |- mesh__dateRevised mesh__D016370 2005-06-30
% 217.88/218.06  |- skos__altLabel mesh__D016370 HTLV-II rex Gene Product
% 217.88/218.06  |- mesh__publicMeSHNote mesh__D030041
% 217.88/218.06       2002, 1977-1993; see HEPATOVIRUS 1994-2001   
% 217.88/218.06  |- skos__scopeNote mesh__D030041
% 217.88/218.06       A species in the genus HEPATOVIRUS containing one serotype and two strains: HUMAN HEPATITIS A VIRUS and Simian hepatitis A virus causing hepatitis in humans %28%HEPATITIS A%29% and primates, respectively.%A%    
% 217.88/218.06  |- mesh__recordAuthorizer mesh__D030041 sjn
% 217.88/218.06  |- skos__hiddenLabel mesh__D030041 Hepatitis A viruses
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D030041 2005
% 217.88/218.06  |- skos__historyNote mesh__D030041 Hepatovirus %28%1964-2001%29%
% 217.88/218.06  |- mesh__dateEstablished mesh__D030041 2002-01-01
% 217.88/218.06  |- mesh__recordMaintainer mesh__D030041 sjn
% 217.88/218.06  |- mesh__dateCreated mesh__D030041 2001-07-25
% 217.88/218.06  |- skos__annotation mesh__D030041
% 217.88/218.06       infection = HEPATITIS A; HEPATITIS A VIRUS, HUMAN is also available%A%  
% 217.88/218.06  |- mesh__dateRevised mesh__D030041 2004-07-13
% 217.88/218.06  |- mesh__historyNote mesh__D030041
% 217.88/218.06       2002, 1977-1993; use HEPATOVIRUS 1994-2001   
% 217.88/218.06  |- rdf__type mesh__D030041sskos__Concept
% 217.88/218.06  |- mesh__recordOriginator mesh__D030041 ags
% 217.88/218.06  |- skos__prefLabel mesh__D030041 Hepatitis A virus
% 217.88/218.06  |- skos__broader mesh__D030041smesh__D006507
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D030041 2006
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D024802 2006
% 217.88/218.06  |- rdf__type mesh__D024802sskos__Concept
% 217.88/218.06  |- skos__hiddenLabel mesh__D024802 Roles, Nurse%27%s
% 217.88/218.06  |- skos__hiddenLabel mesh__D024802 Role, Nurse%27%s
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D024802 2004
% 217.88/218.06  |- skos__scopeNote mesh__D024802
% 217.88/218.06       The expected function  of a member of the nursing profession.%A%    
% 217.88/218.06  |- skos__broader mesh__D024802smesh__D024382
% 217.88/218.06  |- skos__hiddenLabel mesh__D024802 Nurse Role
% 217.88/218.06  |- skos__hiddenLabel mesh__D024802 Nurses Role
% 217.88/218.06  |- mesh__dateEstablished mesh__D024802 2002-01-01
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D024802 2002
% 217.88/218.06  |- mesh__historyNote mesh__D024802 2002   
% 217.88/218.06  |- skos__prefLabel mesh__D024802 Nurse%27%s Role
% 217.88/218.06  |- mesh__dateCreated mesh__D024802 2001-07-25
% 217.88/218.06  |- skos__broader mesh__D024802smesh__D001291
% 217.88/218.06  |- mesh__publicMeSHNote mesh__D024802 2002   
% 217.88/218.06  |- skos__hiddenLabel mesh__D024802 Nurse%27%s Roles
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D024802 2005
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D024802 2003
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D002350 2006
% 217.88/218.06  |- skos__annotation mesh__D002350 TN 117 %26% table: animal extremities   
% 217.88/218.06  |- mesh__recordAuthorizer mesh__D002350 sjn
% 217.88/218.06  |- mesh__recordMaintainer mesh__D002350 ags
% 217.88/218.06  |- mesh__dateRevised mesh__D002350 2005-06-30
% 217.88/218.06  |- mesh__historyNote mesh__D002350
% 217.88/218.06       91%28%75%29%; was see under FORELIMB 1975-90   
% 217.88/218.06  |- mesh__onlineNote mesh__D002350 search FORELIMB 1968-74   
% 217.88/218.06  |- skos__scopeNote mesh__D002350
% 217.88/218.06       The region corresponding to the human WRIST in non-human ANIMALS.%A%    
% 217.88/218.06  |- skos__prefLabel mesh__D002350 Carpus, Animal
% 217.88/218.06  |- mesh__publicMeSHNote mesh__D002350 91; was see under FORELIMB 1975-90   
% 217.88/218.06  |- mesh__recordOriginator mesh__D002350 NLM
% 217.88/218.06  |- skos__hiddenLabel mesh__D002350 Animal Carpus
% 217.88/218.06  |- mesh__dateCreated mesh__D002350 1999-01-01
% 217.88/218.06  |- rdf__type mesh__D002350sskos__Concept
% 217.88/218.06  |- mesh__dateEstablished mesh__D002350 1991-01-01
% 217.88/218.06  |- skos__broader mesh__D002350smesh__D005552
% 217.88/218.06  |- skos__broader mesh__D001940Q000530smesh__D001940
% 217.88/218.06  |- mesh__preferredCombination mesh__D001940Q000530smesh__D008327
% 217.88/218.06  |- rdf__type mesh__D001940Q000530smesh__CompoundConcept
% 217.88/218.06  |- skos__prefLabel mesh__D015278 Intensive Care Units, Pediatric
% 217.88/218.06  |- skos__annotation mesh__D015278
% 217.88/218.06        check also tags  HUMANS %26% CHILD; DF: ICU PEDIATRIC   
% 217.88/218.06  |- skos__scopeNote mesh__D015278
% 217.88/218.06       Hospital units providing continuous surveillance and care to acutely ill infants and children. Neonates are excluded since INTENSIVE CARE UNITS, NEONATAL is available.%A%    
% 217.88/218.06  |- skos__historyNote mesh__D015278 Infant %28%1966-1988%29%
% 217.88/218.06  |- mesh__publicMeSHNote mesh__D015278 89   
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D015278 2006
% 217.88/218.06  |- mesh__dateEstablished mesh__D015278 1989-01-01
% 217.88/218.06  |- mesh__recordAuthorizer mesh__D015278 sjn
% 217.88/218.06  |- skos__historyNote mesh__D015278 Intensive Care Units %28%1966-1988%29%
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D015278 2005
% 217.88/218.06  |- mesh__recordOriginator mesh__D015278 EC
% 217.88/218.06  |- skos__historyNote mesh__D015278 Child %28%1966-1988%29%
% 217.88/218.06  |- mesh__dateCreated mesh__D015278 1988-05-19
% 217.88/218.06  |- mesh__recordMaintainer mesh__D015278 sjn
% 217.88/218.06  |- mesh__historyNote mesh__D015278 89   
% 217.88/218.06  |- skos__broader mesh__D015278smesh__D007362
% 217.88/218.06  |- skos__altLabel mesh__D015278 Pediatric Intensive Care Units
% 217.88/218.06  |- rdf__type mesh__D015278sskos__Concept
% 217.88/218.06  |- mesh__dateRevised mesh__D015278 2004-07-13
% 217.88/218.06  |- skos__altLabel mesh__D006741 Auxiliaries, Hospital
% 217.88/218.06  |- skos__prefLabel mesh__D006741 Hospital Auxiliaries
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006741 2001
% 217.88/218.06  |- mesh__dateRevised mesh__D006741 1992-05-15
% 217.88/218.06  |- mesh__historyNote mesh__D006741
% 217.88/218.06       91%28%Aug 77%29%; was see under HOSPITAL VOLUNTEERS 1977-90   
% 217.88/218.06  |- skos__broader mesh__D006741smesh__D006758
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006741 1997
% 217.88/218.06  |- mesh__dateCreated mesh__D006741 1977-05-05
% 217.88/218.06  |- rdf__type mesh__D006741sskos__Concept
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006741 2000
% 217.88/218.06  |- skos__altLabel mesh__D006741 Auxiliary, Hospital
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006741 1999
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006741 1993
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006741 1996
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006741 2004
% 217.88/218.06  |- skos__annotation mesh__D006741
% 217.88/218.06       organizations: do not confuse with HOSPITAL VOLUNTEERS, people%A%  
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006741 1995
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006741 1998
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006741 2006
% 217.88/218.06  |- mesh__dateEstablished mesh__D006741 1991-01-01
% 217.88/218.06  |- mesh__recordOriginator mesh__D006741 EC
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006741 2003
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006741 1994
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006741 2005
% 217.88/218.06  |- skos__scopeNote mesh__D006741
% 217.88/218.06       Volunteer organizations whose members perform work for the hospital without compensation.%A%    
% 217.88/218.06  |- mesh__recordMaintainer mesh__D006741 TAP
% 217.88/218.06  |- mesh__recordAuthorizer mesh__D006741 PLS
% 217.88/218.06  |- mesh__publicMeSHNote mesh__D006741
% 217.88/218.06       91; was see under HOSPITAL VOLUNTEERS Aug 1977-90   
% 217.88/218.06  |- skos__altLabel mesh__D006741 Hospital Auxiliary
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D006741 2002
% 217.88/218.06  |- skos__hiddenLabel mesh__D020412 Traits, Oligogenic
% 217.88/218.06  |- skos__altLabel mesh__D020412 Polygenic Traits
% 217.88/218.06  |- skos__hiddenLabel mesh__D020412 Polygenic Trait
% 217.88/218.06  |- skos__hiddenLabel mesh__D020412 Inheritances, Polygenic
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D020412 2004
% 217.88/218.06  |- skos__hiddenLabel mesh__D020412 Oligogenic Inheritances
% 217.88/218.06  |- skos__hiddenLabel mesh__D020412 Trait, Polygenic
% 217.88/218.06  |- skos__hiddenLabel mesh__D020412 Oligogenic Trait
% 217.88/218.06  |- skos__hiddenLabel mesh__D020412 Polygenic Character
% 217.88/218.06  |- mesh__dateCreated mesh__D020412 1998-06-10
% 217.88/218.06  |- skos__prefLabel mesh__D020412 Multifactorial Inheritance
% 217.88/218.06  |- skos__hiddenLabel mesh__D020412 Inheritance, Polygenic
% 217.88/218.06  |- mesh__dateRevised mesh__D020412 2004-07-29
% 217.88/218.06  |- mesh__activeMeSHYear mesh__D020412 2003
% 217.88/218.06  |- skos__altLabel mesh__D020412 Oligogenic Traits
% 217.88/218.06  |- mesh__recordOriginator mesh__D020412 NNS
% 217.88/218.07  |- skos__altLabel mesh__D020412 Polygenic Characters
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D020412 2005A
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D020412 2006
% 217.88/218.07  |- skos__hiddenLabel mesh__D020412 Polygenic Inheritances
% 217.88/218.07  |- skos__hiddenLabel mesh__D020412 Trait, Oligogenic
% 217.88/218.07  |- skos__related mesh__D020412smesh__D019655
% 217.88/218.07  |- skos__hiddenLabel mesh__D020412 Inheritance, Oligogenic
% 217.88/218.07  |- rdf__type mesh__D020412sskos__Concept
% 217.88/218.07  |- mesh__dateEstablished mesh__D020412 1999-01-01
% 217.88/218.07  |- skos__hiddenLabel mesh__D020412 Traits, Polygenic
% 217.88/218.07  |- mesh__historyNote mesh__D020412 99   
% 217.88/218.07  |- skos__hiddenLabel mesh__D020412 Inheritances, Multifactorial
% 217.88/218.07  |- skos__historyNote mesh__D020412
% 217.88/218.07       specific disease /genetics %28%1967-1998%29%
% 217.88/218.07  |- skos__hiddenLabel mesh__D020412 Multifactorial Inheritances
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D020412 2005
% 217.88/218.07  |- mesh__publicMeSHNote mesh__D020412 99   
% 217.88/218.07  |- skos__hiddenLabel mesh__D020412 Characters, Polygenic
% 217.88/218.07  |- mesh__recordMaintainer mesh__D020412 jls
% 217.88/218.07  |- skos__hiddenLabel mesh__D020412 Inheritances, Oligogenic
% 217.88/218.07  |- skos__broader mesh__D020412smesh__D040582
% 217.88/218.07  |- skos__hiddenLabel mesh__D020412 Character, Polygenic
% 217.88/218.07  |- skos__hiddenLabel mesh__D020412 Inheritance, Multifactorial
% 217.88/218.07  |- skos__scopeNote mesh__D020412
% 217.88/218.07       A phenotypic outcome %28%physical characteristic or disease predisposition%29% that is determined by more than one gene. Polygenic refers to those determined by many genes, while oligogenic refers to those determined by a few genes.%A%    
% 217.88/218.07  |- mesh__recordAuthorizer mesh__D020412 jls
% 217.88/218.07  |- skos__broader mesh__D006321Q000378smesh__D006321
% 217.88/218.07  |- mesh__preferredCombination mesh__D006321Q000378smesh__D009206Q000378
% 217.88/218.07  |- rdf__type mesh__D006321Q000378smesh__CompoundConcept
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D019669 2000
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D019669 1998
% 217.88/218.07  |- skos__prefLabel mesh__D019669 Plant Families and Groups
% 217.88/218.07  |- skos__scopeNote mesh__D019669
% 217.88/218.07       Groupings that include specific plants within larger families or divisions.%A%    
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D019669 2002
% 217.88/218.07  |- mesh__publicMeSHNote mesh__D019669 98   
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D019669 2006
% 217.88/218.07  |- mesh__historyNote mesh__D019669 98   
% 217.88/218.07  |- skos__broader mesh__D019669smesh__D010944
% 217.88/218.07  |- skos__annotation mesh__D019669
% 217.88/218.07       not used for indexing      CATALOG: do not use   
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D019669 2004
% 217.88/218.07  |- mesh__dateEstablished mesh__D019669 1998-01-01
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D019669 2005
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D019669 2001
% 217.88/218.07  |- rdf__type mesh__D019669sskos__Concept
% 217.88/218.07  |- mesh__dateCreated mesh__D019669 1997-06-20
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D019669 2003
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D019669 1999
% 217.88/218.07  |- mesh__publicMeSHNote mesh__D011686 65   
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D011686 2006
% 217.88/218.07  |- mesh__recordAuthorizer mesh__D011686 sjn
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D011686 2005
% 217.88/218.07  |- skos__prefLabel mesh__D011686
% 217.88/218.07       Purine-Pyrimidine Metabolism, Inborn Errors
% 217.88/218.07  |- mesh__dateEstablished mesh__D011686 1965-01-01
% 217.88/218.07  |- rdf__type mesh__D011686sskos__Concept
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D011686 2004
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D011686 2003
% 217.88/218.07  |- mesh__dateRevised mesh__D011686 2001-07-25
% 217.88/218.07  |- mesh__recordOriginator mesh__D011686 NLM
% 217.88/218.07  |- mesh__dateCreated mesh__D011686 1999-01-01
% 217.88/218.07  |- skos__altLabel mesh__D011686 Purine Pyrimidine Metabolism, Inborn Errors
% 217.88/218.07  |- mesh__recordMaintainer mesh__D011686 nns
% 217.88/218.07  |- skos__annotation mesh__D011686
% 217.88/218.07       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific purine /metab %28%IM%29% or pyrimidine /metab %28%IM%29%; DF: PP METAB INBORN ERR%A%  
% 217.88/218.07  |- skos__broader mesh__D011686smesh__D008661
% 217.88/218.07  |- mesh__historyNote mesh__D011686 65   
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D011686 2002
% 217.88/218.07  |- skos__broader mesh__D044062smesh__D011453
% 217.88/218.07  |- mesh__historyNote mesh__D044062 2004; use EPOPROSTENOL 1979-2003   
% 217.88/218.07  |- skos__altLabel mesh__D044062 Prostaglandin I
% 217.88/218.07  |- mesh__dateCreated mesh__D044062 2003-07-09
% 217.88/218.07  |- skos__prefLabel mesh__D044062 Prostaglandins I
% 217.88/218.07  |- skos__annotation mesh__D044062 DF: PGI   
% 217.88/218.07  |- mesh__recordAuthorizer mesh__D044062 sjn
% 217.88/218.07  |- mesh__dateEstablished mesh__D044062 2004-01-01
% 217.88/218.07  |- mesh__recordOriginator mesh__D044062 jmp
% 217.88/218.07  |- mesh__dateRevised mesh__D044062 2005-06-30
% 217.88/218.07  |- skos__altLabel mesh__D044062 Prostacyclins
% 217.88/218.07  |- skos__historyNote mesh__D044062 Epoprostenol %28%1977-2003%29%
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D044062 2006
% 217.88/218.07  |- skos__scopeNote mesh__D044062
% 217.88/218.07       A class of cyclic prostaglandins that contain the 6,9-epoxy bond. Endogenous members of this family are biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES.%A%    
% 217.88/218.07  |- mesh__recordMaintainer mesh__D044062 ssb
% 217.88/218.07  |- mesh__publicMeSHNote mesh__D044062
% 217.88/218.07       2004; see EPOPROSTENOL 1991-2003, see PROSTGLANDINS X 1984-1990, see PROSTAGLANDINS 1979-1983%A%  
% 217.88/218.07  |- rdf__type mesh__D044062sskos__Concept
% 217.88/218.07  |- mesh__dateEstablished mesh__D005649 1978-01-01
% 217.88/218.07  |- mesh__dateRevised mesh__D005649 2003-07-09
% 217.88/218.07  |- mesh__recordOriginator mesh__D005649 NLM
% 217.88/218.07  |- skos__altLabel mesh__D005649 Fumarase
% 217.88/218.07  |- mesh__historyNote mesh__D005649
% 217.88/218.07       78%28%73%29%; was see under HYDRO-LYASES 1975-77   
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D005649 2006
% 217.88/218.07  |- skos__prefLabel mesh__D005649 Fumarate Hydratase
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D005649 2005
% 217.88/218.07  |- skos__historyNote mesh__D005649 Hydro-Lyases %28%1966-1972%29%
% 217.88/218.07  |- mesh__publicMeSHNote mesh__D005649
% 217.88/218.07       78; was see under HYDRO-LYASES 1975-77   
% 217.88/218.07  |- skos__hiddenLabel mesh__D005649 Hydratase, Fumarate
% 217.88/218.07  |- mesh__dateCreated mesh__D005649 1999-01-01
% 217.88/218.07  |- rdf__type mesh__D005649sskos__Concept
% 217.88/218.07  |- skos__broader mesh__D005649smesh__D006836
% 217.88/218.07  |- mesh__recordMaintainer mesh__D005649 ssb
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D005649 2004
% 217.88/218.07  |- mesh__recordAuthorizer mesh__D005649 sjn
% 217.88/218.07  |- skos__scopeNote mesh__D005649
% 217.88/218.07       An enzyme that catalyzes the reversible hydration of fumaric acid to yield L-malic acid. It is one of the citric acid cycle enzymes. EC 4.2.1.2.%A%    
% 217.88/218.07  |- rdf__type mesh__D016371sskos__Concept
% 217.88/218.07  |- skos__prefLabel mesh__D016371 Cranial Irradiation
% 217.88/218.07  |- mesh__dateRevised mesh__D016371 2005-06-30
% 217.88/218.07  |- skos__hiddenLabel mesh__D016371 Cranial Irradiations
% 217.88/218.07  |- mesh__dateCreated mesh__D016371 1990-05-25
% 217.88/218.07  |- mesh__recordAuthorizer mesh__D016371 sjn
% 217.88/218.07  |- skos__hiddenLabel mesh__D016371 Irradiations, Cranial
% 217.88/218.07  |- skos__broader mesh__D016371smesh__D011878
% 217.88/218.07  |- mesh__recordOriginator mesh__D016371 MXR
% 217.88/218.07  |- mesh__recordMaintainer mesh__D016371 lkt
% 217.88/218.07  |- skos__related mesh__D016371smesh__D010910
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D016371 2006
% 217.88/218.07  |- mesh__historyNote mesh__D016371 91   
% 217.88/218.07  |- skos__scopeNote mesh__D016371
% 217.88/218.07       The exposure of the head to roentgen rays or other forms of radioactivity for therapeutic or preventive purposes.%A%    
% 217.88/218.07  |- mesh__publicMeSHNote mesh__D016371 91   
% 217.88/218.07  |- mesh__dateEstablished mesh__D016371 1991-01-01
% 217.88/218.07  |- skos__hiddenLabel mesh__D016371 Irradiation, Cranial
% 217.88/218.07  |- mesh__dateCreated mesh__D024803 2001-07-25
% 217.88/218.07  |- skos__scopeNote mesh__D024803
% 217.88/218.07       The use of technology-based interventions to improve functional capacities rather than to treat disease.%A%    
% 217.88/218.07  |- skos__broader mesh__D024803smesh__D020811
% 217.88/218.07  |- skos__hiddenLabel mesh__D024803 Technology, Enhancement
% 217.88/218.07  |- mesh__recordAuthorizer mesh__D024803 jls
% 217.88/218.07  |- mesh__dateEstablished mesh__D024803 2002-01-01
% 217.88/218.07  |- mesh__publicMeSHNote mesh__D024803 2002   
% 217.88/218.07  |- skos__hiddenLabel mesh__D024803 Enhancements, Biomedical
% 217.88/218.07  |- mesh__recordOriginator mesh__D024803 jrf
% 217.88/218.07  |- skos__hiddenLabel mesh__D024803 Technologies, Enhancement
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D024803 2005
% 217.88/218.07  |- mesh__recordMaintainer mesh__D024803 jls
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D024803 2003
% 217.88/218.07  |- skos__hiddenLabel mesh__D024803 Enhancement Technology
% 217.88/218.07  |- skos__hiddenLabel mesh__D024803 Biomedical Enhancements
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D024803 2006
% 217.88/218.07  |- rdf__type mesh__D024803sskos__Concept
% 217.88/218.07  |- skos__prefLabel mesh__D024803 Biomedical Enhancement
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D024803 2004
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D024803 2002
% 217.88/218.07  |- mesh__historyNote mesh__D024803 2002   
% 217.88/218.07  |- skos__altLabel mesh__D024803 Enhancement, Biomedical
% 217.88/218.07  |- skos__broader mesh__D024803smesh__D008919
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D024803 2003A
% 217.88/218.07  |- mesh__dateRevised mesh__D024803 2002-10-31
% 217.88/218.07  |- skos__hiddenLabel mesh__D002351 kappa Carrageenan
% 217.88/218.07  |- mesh__recordOriginator mesh__D002351 NLM
% 217.88/218.07  |- mesh__dateRevised mesh__D002351 2004-07-07
% 217.88/218.07  |- mesh__dateEstablished mesh__D002351 1966-01-01
% 217.88/218.07  |- skos__related mesh__D002351smesh__D044723
% 217.88/218.07  |- skos__scopeNote mesh__D002351
% 217.88/218.07       A water-soluble extractive mixture of sulfated polysaccharides from RED ALGAE. Chief sources are the Irish moss CHONDRUS CRISPUS %28%Carrageen%29%, and Gigartina stellata. It is used as a stabilizer, for suspending COCOA in chocolate manufacture, and to clarify BEVERAGES.%A%    
% 217.88/218.07  |- mesh__dateCreated mesh__D002351 1999-01-01
% 217.88/218.07  |- skos__prefLabel mesh__D002351 Carrageenan
% 217.88/218.07  |- mesh__historyNote mesh__D002351 66%28%64%29%   
% 217.88/218.07  |- rdf__type mesh__D002351sskos__Concept
% 217.88/218.07  |- skos__broader mesh__D002351smesh__D011134
% 217.88/218.07  |- mesh__recordMaintainer mesh__D002351 ssb
% 217.88/218.07  |- skos__hiddenLabel mesh__D002351 lambda Carrageenan
% 217.88/218.07  |- mesh__recordAuthorizer mesh__D002351 sjn
% 217.88/218.07  |- skos__altLabel mesh__D002351 Carrageenin
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D002351 2006
% 217.88/218.07  |- skos__hiddenLabel mesh__D002351 iota Carrageenan
% 217.88/218.07  |- mesh__publicMeSHNote mesh__D002351 66   
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D002351 2005
% 217.88/218.07  |- skos__broader mesh__D014953Q000293smesh__D014953
% 217.88/218.07  |- mesh__preferredCombination mesh__D014953Q000293smesh__D014954
% 217.88/218.07  |- rdf__type mesh__D014953Q000293smesh__CompoundConcept
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D015279 1996
% 217.88/218.07  |- skos__hiddenLabel mesh__D015279 Corporate Cultures
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D015279 2000
% 217.88/218.07  |- skos__altLabel mesh__D015279 Corporate Culture
% 217.88/218.07  |- skos__broader mesh__D015279smesh__D009934
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D015279 2006
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D015279 2003
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D015279 1997
% 217.88/218.07  |- skos__scopeNote mesh__D015279
% 217.88/218.07       Beliefs and values shared by all members of the organization. These shared values are reflected in the day to day operations of the organization.%A%    
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D015279 2001
% 217.88/218.07  |- skos__historyNote mesh__D015279
% 217.88/218.07       Organization and Administration %28%1968-1988%29%
% 217.88/218.07  |- mesh__publicMeSHNote mesh__D015279
% 217.88/218.07       91; was see under ORGANIZATION AND ADMINISTRATION 1989-90%A%  
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D015279 2004
% 217.88/218.07  |- skos__historyNote mesh__D015279 Culture %28%1966-1988%29%
% 217.88/218.07  |- skos__hiddenLabel mesh__D015279 Culture, Organizational
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D015279 2002
% 217.88/218.07  |- skos__prefLabel mesh__D015279 Organizational Culture
% 217.88/218.07  |- mesh__recordMaintainer mesh__D015279 TGC
% 217.88/218.07  |- skos__hiddenLabel mesh__D015279 Organizational Cultures
% 217.88/218.07  |- skos__hiddenLabel mesh__D015279 Culture, Corporate
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D015279 1994
% 217.88/218.07  |- mesh__dateEstablished mesh__D015279 1991-01-01
% 217.88/218.07  |- skos__hiddenLabel mesh__D015279 Cultures, Corporate
% 217.88/218.07  |- skos__hiddenLabel mesh__D015279 Cultures, Organizational
% 217.88/218.07  |- mesh__recordOriginator mesh__D015279 EC
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D015279 1995
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D015279 1992
% 217.88/218.07  |- mesh__recordAuthorizer mesh__D015279 PLS
% 217.88/218.07  |- mesh__dateCreated mesh__D015279 1988-05-20
% 217.88/218.07  |- rdf__type mesh__D015279sskos__Concept
% 217.88/218.07  |- skos__annotation mesh__D015279
% 217.88/218.07       %22%beliefs %26% values shared by all members of the organization%22%; NIM; coord with specific organization %28%IM%29%; no qualif%A%  
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D015279 1998
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D015279 1993
% 217.88/218.07  |- mesh__historyNote mesh__D015279
% 217.88/218.07       91%28%89%29%; was see under ORGANIZATION AND ADMINISTRATION 1989-90%A%  
% 217.88/218.07  |- mesh__dateRevised mesh__D015279 1991-06-10
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D015279 2005
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D015279 1999
% 217.88/218.07  |- skos__scopeNote mesh__D001259
% 217.88/218.07       Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.%A%    
% 217.88/218.07  |- skos__altLabel mesh__D001259 Dyssynergia
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Motor Ataxias
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Motor Ataxia
% 217.88/218.07  |- mesh__recordMaintainer mesh__D001259 sjn
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Rubral Tremor
% 217.88/218.07  |- mesh__dateCreated mesh__D001259 1999-01-01
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Incoordinations
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Ataxias, Appendicular
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D001259 2004
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D001259 2000
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Rubral Tremors
% 217.88/218.07  |- skos__broader mesh__D001259smesh__D020820
% 217.88/218.07  |- skos__altLabel mesh__D001259 Ataxy
% 217.88/218.07  |- skos__prefLabel mesh__D001259 Ataxia
% 217.88/218.07  |- mesh__recordAuthorizer mesh__D001259 sjn
% 217.88/218.07  |- skos__altLabel mesh__D001259 Lack of Coordination
% 217.88/218.07  |- skos__altLabel mesh__D001259 Incoordination
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Appendicular Ataxia
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Impairments, Coordination
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Coordination Lack
% 217.88/218.07  |- skos__annotation mesh__D001259
% 217.88/218.07       note specifics; coord other ataxias with organ/diseases term; enzootic = SWAYBACK; familial: consider also SPINOCEREBELLAR DEGENERATIONS%A%  
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D001259 2001
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Limb Ataxias
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Ataxias
% 217.88/218.07  |- skos__altLabel mesh__D001259 Coordination Impairment
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Ataxias, Limb
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D001259 2005
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Ataxias, Sensory
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Limb Ataxia
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Sensory Ataxias
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Coordination Impairments
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Ataxias, Motor
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D001259 2003A
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Truncal Ataxias
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Tremors, Rubral
% 217.88/218.07  |- mesh__dateRevised mesh__D001259 2002-11-14
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D001259 2006
% 217.88/218.07  |- rdf__type mesh__D001259sskos__Concept
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D001259 2002
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Sensory Ataxia
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Truncal Ataxia
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Impairment, Coordination
% 217.88/218.07  |- mesh__recordOriginator mesh__D001259 NLM
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Ataxias, Truncal
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D001259 2003
% 217.88/218.07  |- skos__hiddenLabel mesh__D001259 Appendicular Ataxias
% 217.88/218.07  |- skos__altLabel mesh__D001259 Ataxia, Limb
% 217.88/218.07  |- skos__historyNote mesh__D006742 Health Facility Size %28%1968-1974%29%
% 217.88/218.07  |- skos__hiddenLabel mesh__D006742 Hospital Bed Capacities
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D006742 2002
% 217.88/218.07  |- mesh__dateEstablished mesh__D006742 1978-01-01
% 217.88/218.07  |- rdf__type mesh__D006742sskos__Concept
% 217.88/218.07  |- mesh__recordAuthorizer mesh__D006742 sjn
% 217.88/218.07  |- skos__scopeNote mesh__D006742
% 217.88/218.07       The number of beds which a hospital has been designed and constructed to contain. It may also refer to the number of beds set up and staffed for use.%A%    
% 217.88/218.07  |- skos__broader mesh__D006742smesh__D006276
% 217.88/218.07  |- skos__annotation mesh__D006742
% 217.88/218.07       GEN or unspecified; prefer specific capacity; specify geog; do not confuse with BED OCCUPANCY which is for actual no. of beds occupied; DF: HOSP BED CAPAC%A%  
% 217.88/218.07  |- skos__altLabel mesh__D006742 Sizes, Bed
% 217.88/218.07  |- mesh__recordOriginator mesh__D006742 NLM
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D006742 2004
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D006742 2001
% 217.88/218.07  |- skos__altLabel mesh__D006742 Bed Capacities, Hospital
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D006742 2006
% 217.88/218.07  |- mesh__dateCreated mesh__D006742 1999-01-01
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D006742 2003
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D006742 2005
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D006742 2000
% 217.88/218.07  |- skos__altLabel mesh__D006742 Bed Size, Hospital
% 217.88/218.07  |- skos__altLabel mesh__D006742 Hospital Bed Sizes
% 217.88/218.07  |- mesh__publicMeSHNote mesh__D006742
% 217.88/218.07       78; was see under HEALTH FACILITY SIZE 1968-77   
% 217.88/218.07  |- skos__altLabel mesh__D006742 Size, Bed
% 217.88/218.07  |- skos__altLabel mesh__D006742 Bed Capacity, Hospital
% 217.88/218.07  |- skos__altLabel mesh__D006742 Bed Sizes, Hospital
% 217.88/218.07  |- skos__altLabel mesh__D006742 Size, Hospital Bed
% 217.88/218.07  |- skos__altLabel mesh__D006742 Capacities, Hospital Bed
% 217.88/218.07  |- mesh__recordMaintainer mesh__D006742 kle
% 217.88/218.07  |- skos__related mesh__D006742smesh__D001509
% 217.88/218.07  |- mesh__onlineNote mesh__D006742 search HEALTH FACILITY SIZE 1968-74   
% 217.88/218.07  |- skos__altLabel mesh__D006742 Sizes, Hospital Bed
% 217.88/218.07  |- skos__altLabel mesh__D006742 Hospital Bed Size
% 217.88/218.07  |- skos__altLabel mesh__D006742 Bed Sizes
% 217.88/218.07  |- mesh__historyNote mesh__D006742
% 217.88/218.07       78%28%75%29%; was see under HEALTH FACILITY SIZE 1968-77   
% 217.88/218.07  |- mesh__dateRevised mesh__D006742 1999-11-03
% 217.88/218.07  |- skos__prefLabel mesh__D006742 Hospital Bed Capacity
% 217.88/218.07  |- skos__altLabel mesh__D006742 Capacity, Hospital Bed
% 217.88/218.07  |- mesh__publicMeSHNote mesh__D020413 99   
% 217.88/218.07  |- mesh__recordAuthorizer mesh__D020413 sjn
% 217.88/218.07  |- mesh__dateRevised mesh__D020413 2005-06-30
% 217.88/218.07  |- skos__altLabel mesh__D020413 3%27% UTR
% 217.88/218.07  |- skos__hiddenLabel mesh__D020413 Untranslated Regions, 3%27%
% 217.88/218.07  |- skos__altLabel mesh__D020413 3%27%UTR
% 217.88/218.07  |- rdf__type mesh__D020413sskos__Concept
% 217.88/218.07  |- mesh__historyNote mesh__D020413 99   
% 217.88/218.07  |- skos__scopeNote mesh__D020413
% 217.88/218.07       The sequence at the 3%27% end of messenger RNA that does not code for product. This region contains transcription and translation regulating sequences.%A%    
% 217.88/218.07  |- skos__related mesh__D020413smesh__D024509
% 217.88/218.07  |- skos__hiddenLabel mesh__D020413 Untranslated Region, 3%27%
% 217.88/218.07  |- skos__hiddenLabel mesh__D020413 UTRs, 3%27%
% 217.88/218.07  |- mesh__dateCreated mesh__D020413 1998-06-11
% 217.88/218.07  |- skos__hiddenLabel mesh__D020413 UTR, 3%27%
% 217.88/218.07  |- skos__altLabel mesh__D020413 3%27% Untranslated Region
% 217.88/218.07  |- skos__historyNote mesh__D020413 RNA, Messenger %28%1975-1998%29%
% 217.88/218.07  |- skos__annotation mesh__D020413
% 217.88/218.07       do not confuse with 3%27% FLANKING REGION   
% 217.88/218.07  |- skos__hiddenLabel mesh__D020413 3%27% UTRs
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D020413 2006
% 217.88/218.07  |- skos__hiddenLabel mesh__D020413 Regions, 3%27% Untranslated
% 217.88/218.07  |- skos__hiddenLabel mesh__D020413 Region, 3%27% Untranslated
% 217.88/218.07  |- mesh__dateEstablished mesh__D020413 1999-01-01
% 217.88/218.07  |- skos__broader mesh__D020413smesh__D020506
% 217.88/218.07  |- mesh__recordMaintainer mesh__D020413 nns
% 217.88/218.07  |- skos__hiddenLabel mesh__D020413 3%27%UTRs
% 217.88/218.07  |- skos__prefLabel mesh__D020413 3%27% Untranslated Regions
% 217.88/218.07  |- mesh__recordOriginator mesh__D020413 NNS
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D011687 2005
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D011687 1999
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D011687 2002
% 217.88/218.07  |- rdf__type mesh__D011687sskos__Concept
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D011687 2004
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D011687 1998
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D011687 2001
% 217.88/218.07  |- mesh__recordMaintainer mesh__D011687 PLS
% 217.88/218.07  |- mesh__recordAuthorizer mesh__D011687 PLS
% 217.88/218.07  |- skos__prefLabel mesh__D011687 Purines
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D011687 2003
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D011687 1997
% 217.88/218.07  |- mesh__dateCreated mesh__D011687 1999-01-01
% 217.88/218.07  |- skos__broader mesh__D011687smesh__D006574
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D011687 2000
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D011687 1996
% 217.88/218.07  |- skos__scopeNote mesh__D011687
% 217.88/218.07       A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.%A%    
% 217.88/218.07  |- mesh__dateRevised mesh__D011687 1994-07-05
% 217.88/218.07  |- mesh__recordOriginator mesh__D011687 NLM
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D011687 2006
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D011687 1995
% 217.88/218.07  |- mesh__dateCreated mesh__D044063 2003-07-09
% 217.88/218.07  |- mesh__publicMeSHNote mesh__D044063 2004   
% 217.88/218.07  |- mesh__historyNote mesh__D044063 2004   
% 217.88/218.07  |- mesh__recordMaintainer mesh__D044063 SYSTEM
% 217.88/218.07  |- skos__annotation mesh__D044063
% 217.88/218.07       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 217.88/218.07  |- mesh__recordAuthorizer mesh__D044063 sjn
% 217.88/218.07  |- skos__scopeNote mesh__D044063
% 217.88/218.07       A family of gram-negative, rod-shaped bacteria isolated from the RUMEN of SHEEP and CATTLE and from human FECES. They are chemoorganotrophic and strictly anaerobic.%A%    
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D044063 2006
% 217.88/218.07  |- skos__historyNote mesh__D044063
% 217.88/218.07       Gram-Negative Anaerobic Bacteria %28%1999-2003%29%
% 217.88/218.07  |- skos__broader mesh__D044063smesh__D020563
% 217.88/218.07  |- skos__prefLabel mesh__D044063 Succinivibrionaceae
% 217.88/218.07  |- mesh__dateEstablished mesh__D044063 2004-01-01
% 217.88/218.07  |- rdf__type mesh__D044063sskos__Concept
% 217.88/218.07  |- mesh__dateRevised mesh__D044063 2005-06-30
% 217.88/218.07  |- mesh__recordOriginator mesh__D044063 ags
% 217.88/218.07  |- skos__broader mesh__D044063smesh__D016965
% 217.88/218.07  |- skos__related mesh__D030841smesh__D030781
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D030841 2002
% 217.88/218.07  |- skos__related mesh__D030841smesh__D030821
% 217.88/218.07  |- skos__hiddenLabel mesh__D030841 Food, GMO
% 217.88/218.07  |- skos__hiddenLabel mesh__D030841 Genetically Modified Foods
% 217.88/218.07  |- skos__prefLabel mesh__D030841 Food, Genetically Modified
% 217.88/218.07  |- skos__related mesh__D030841smesh__D030801
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D030841 2004
% 217.88/218.07  |- skos__scopeNote mesh__D030841
% 217.88/218.07       Food derived from genetically modified organisms %28%ORGANISMS, GENETICALLY MODIFIED%29%.%A%    
% 217.88/218.07  |- skos__altLabel mesh__D030841 Genetically Modified Food
% 217.88/218.07  |- skos__altLabel mesh__D030841 GMO Food
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D030841 2003
% 217.88/218.07  |- mesh__dateEstablished mesh__D030841 2002-01-01
% 217.88/218.07  |- mesh__dateCreated mesh__D030841 2001-07-25
% 217.88/218.07  |- skos__hiddenLabel mesh__D030841 Foods, Genetically Modified
% 217.88/218.07  |- skos__annotation mesh__D030841 coord with specific food   
% 217.88/218.07  |- skos__hiddenLabel mesh__D030841 Foods, GMO
% 217.88/218.07  |- mesh__publicMeSHNote mesh__D030841 2002   
% 217.88/218.07  |- skos__broader mesh__D030841smesh__D005502
% 217.88/218.07  |- skos__hiddenLabel mesh__D030841 GMO Foods
% 217.88/218.07  |- mesh__historyNote mesh__D030841 2002   
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D030841 2006
% 217.88/218.07  |- rdf__type mesh__D030841sskos__Concept
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D030841 2005
% 217.88/218.07  |- rdf__type mesh__D016372sskos__Concept
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D016372 2004
% 217.88/218.07  |- skos__prefLabel mesh__D016372 RNA, Antisense
% 217.88/218.07  |- skos__historyNote mesh__D016372 RNA %28%1985-1990%29%
% 217.88/218.07  |- mesh__publicMeSHNote mesh__D016372 91   
% 217.88/218.07  |- mesh__dateRevised mesh__D016372 2003-07-09
% 217.88/218.07  |- mesh__dateEstablished mesh__D016372 1991-01-01
% 217.88/218.07  |- mesh__recordMaintainer mesh__D016372 ssb
% 217.88/218.07  |- skos__hiddenLabel mesh__D016372 Anti Sense RNA
% 217.88/218.07  |- skos__altLabel mesh__D016372 Anti-Sense RNA
% 217.88/218.07  |- skos__broader mesh__D016372smesh__D012313
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D016372 2005
% 217.88/218.07  |- skos__broader mesh__D016372smesh__D016375
% 217.88/218.07  |- skos__scopeNote mesh__D016372
% 217.88/218.07       RNA molecules which hybridize to complementary sequences in either RNA or DNA altering the function of the latter. Endogenous antisense RNAs function as regulators of gene expression by a variety of mechanisms. Synthetic antisense RNAs are used to effect the functioning of specific genes for investigative or therapeutic purposes.%A%    
% 217.88/218.07  |- skos__altLabel mesh__D016372 Antisense RNA
% 217.88/218.07  |- mesh__recordOriginator mesh__D016372 PXP
% 217.88/218.07  |- mesh__recordAuthorizer mesh__D016372 sjn
% 217.88/218.07  |- mesh__activeMeSHYear mesh__D016372 2006
% 217.88/218.07  |- skos__hiddenLabel mesh__D016372 RNA, Anti-Sense
% 217.88/218.07  |- mesh__historyNote mesh__D016372 91   
% 217.88/218.07  |- mesh__dateCreated mesh__D016372 1990-05-29
% 217.88/218.07  |- skos__altLabel mesh__D002352 Transport Proteins
% 217.88/218.07  |- mesh__dateRevised mesh__D002352 2005-07-28
% 217.88/218.07  |- skos__annotation mesh__D002352
% 217.88/218.07       do not confuse BINDING PROTEINS %28%X ref%29% with PROTEIN BINDING; do not use CARRIER PROTEINS if the protein functions as a receptor: use instead the pertinent receptors term; not for antigenic carriers %28% = ANTIGENS%29%%A%  
% 217.88/218.07  |- skos__historyNote mesh__D002352 Proteins %28%1966-1970%29%
% 217.88/218.07  |- mesh__publicMeSHNote mesh__D002352 73   
% 217.88/218.07  |- mesh__dateCreated mesh__D002352 1999-01-01
% 217.88/218.07  |- rdf__type mesh__D002352sskos__Concept
% 217.88/218.07  |- skos__prefLabel mesh__D002352 Carrier Proteins
% 217.88/218.07  |- skos__hiddenLabel mesh__D002352 Proteins, Binding
% 217.88/218.07  |- mesh__recordOriginator mesh__D002352 NLM
% 217.88/218.07  |- skos__scopeNote mesh__D002352
% 217.88/218.07       Transport proteins that carry specific substances in the blood or across cell membranes.%A%    
% 217.88/218.08  |- mesh__dateEstablished mesh__D002352 1973-01-01
% 217.88/218.08  |- skos__historyNote mesh__D002352 Protein Binding %28%1966-1970%29%
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D002352 2006
% 217.88/218.08  |- skos__hiddenLabel mesh__D002352 Proteins, Transport
% 217.88/218.08  |- skos__altLabel mesh__D002352 Binding Proteins
% 217.88/218.08  |- skos__broader mesh__D002352smesh__D011506
% 217.88/218.08  |- mesh__recordAuthorizer mesh__D002352 ags
% 217.88/218.08  |- skos__hiddenLabel mesh__D002352 Proteins, Carrier
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D002352 2006A
% 217.88/218.08  |- mesh__historyNote mesh__D002352 73%28%71%29%   
% 217.88/218.08  |- mesh__recordMaintainer mesh__D002352 ags
% 217.88/218.08  |- skos__hiddenLabel mesh__D002352 Protein, Binding
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D012780 2006
% 217.88/218.08  |- mesh__dateCreated mesh__D012780 1999-01-01
% 217.88/218.08  |- mesh__publicMeSHNote mesh__D012780
% 217.88/218.08       91; was see under DIATHERMY 1975-90   
% 217.88/218.08  |- skos__hiddenLabel mesh__D012780 Short-Wave Therapies
% 217.88/218.08  |- skos__hiddenLabel mesh__D012780 Wave Therapy, Short
% 217.88/218.08  |- mesh__historyNote mesh__D012780
% 217.88/218.08       91%28%75%29%; was see under DIATHERMY 1975-90   
% 217.88/218.08  |- mesh__onlineNote mesh__D012780 search DIATHERMY 1966-74   
% 217.88/218.08  |- skos__broader mesh__D012780smesh__D003972
% 217.88/218.08  |- mesh__recordMaintainer mesh__D012780 lkt
% 217.88/218.08  |- skos__altLabel mesh__D012780 Short Wave Therapy
% 217.88/218.08  |- skos__hiddenLabel mesh__D012780 Therapies, Shortwave
% 217.88/218.08  |- skos__scopeNote mesh__D012780
% 217.88/218.08       The use of focused short radio waves to produce local hyperthermia in an injured person or diseased body area.%A%    
% 217.88/218.08  |- skos__annotation mesh__D012780
% 217.88/218.08       do not use /util except by MeSH definition   
% 217.88/218.08  |- skos__hiddenLabel mesh__D012780 Therapies, Short Wave
% 217.88/218.08  |- skos__hiddenLabel mesh__D012780 Therapies, Short-Wave
% 217.88/218.08  |- mesh__dateRevised mesh__D012780 2005-06-30
% 217.88/218.08  |- mesh__dateEstablished mesh__D012780 1991-01-01
% 217.88/218.08  |- rdf__type mesh__D012780sskos__Concept
% 217.88/218.08  |- mesh__recordOriginator mesh__D012780 NLM
% 217.88/218.08  |- skos__prefLabel mesh__D012780 Short-Wave Therapy
% 217.88/218.08  |- skos__altLabel mesh__D012780 Therapy, Shortwave
% 217.88/218.08  |- skos__altLabel mesh__D012780 Shortwave Therapy
% 217.88/218.08  |- mesh__recordAuthorizer mesh__D012780 sjn
% 217.88/218.08  |- skos__altLabel mesh__D012780 Therapy, Short-Wave
% 217.88/218.08  |- skos__hiddenLabel mesh__D012780 Therapy, Short Wave
% 217.88/218.08  |- skos__hiddenLabel mesh__D012780 Wave Therapies, Short
% 217.88/218.08  |- skos__hiddenLabel mesh__D012780 Shortwave Therapies
% 217.88/218.08  |- skos__hiddenLabel mesh__D012780 Short Wave Therapies
% 217.88/218.08  |- skos__prefLabel mesh__D006743 Hospital Bed Capacity, under 100
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D006743 2003
% 217.88/218.08  |- mesh__dateRevised mesh__D006743 1999-11-03
% 217.88/218.08  |- mesh__recordMaintainer mesh__D006743 kle
% 217.88/218.08  |- mesh__dateEstablished mesh__D006743 1991-01-01
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D006743 2005
% 217.88/218.08  |- skos__annotation mesh__D006743
% 217.88/218.08       NIM; specify geog; DF: HOSP BED CAPAC UNDER 100   
% 217.88/218.08  |- mesh__publicMeSHNote mesh__D006743
% 217.88/218.08       91; was see under HOSPITAL BED CAPACITY 1980-90   
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D006743 2002
% 217.88/218.08  |- mesh__recordAuthorizer mesh__D006743 sjn
% 217.88/218.08  |- skos__broader mesh__D006743smesh__D006742
% 217.88/218.08  |- mesh__historyNote mesh__D006743
% 217.88/218.08       91%28%80%29%; was see under HOSPITAL BED CAPACITY 1980-90   
% 217.88/218.08  |- skos__historyNote mesh__D006743 Hospital Bed Capacity %28%1975-1977%29%
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D006743 2001
% 217.88/218.08  |- rdf__type mesh__D006743sskos__Concept
% 217.88/218.08  |- skos__historyNote mesh__D006743
% 217.88/218.08       Hospital Bed Capacity, 100 to 299 %28%1978-1979%29%
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D006743 2004
% 217.88/218.08  |- mesh__dateCreated mesh__D006743 1979-04-11
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D006743 2000
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D006743 2006
% 217.88/218.08  |- mesh__recordOriginator mesh__D006743 EC
% 217.88/218.08  |- mesh__dateEstablished mesh__D020414 1999-01-01
% 217.88/218.08  |- skos__scopeNote mesh__D020414
% 217.88/218.08       Any system which allows payors to share some of the financial risk associated with a particular patient population with providers. Providers agree to adhere to fixed fee schedules in exchange for an increase in their payor base and a chance to benefit from cost containment measures. Common risk-sharing methods are prospective payment schedules %28%PROSPECTIVE PAYMENT SYSTEM%29%, capitation %28%CAPITATION FEES%29%, diagnosis-related fees %28%DIAGNOSIS-RELATED GROUPS%29%, and pre-negotiated fees.%A%    
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D020414 2001
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D020414 2004
% 217.88/218.08  |- rdf__type mesh__D020414sskos__Concept
% 217.88/218.08  |- mesh__dateCreated mesh__D020414 1998-06-11
% 217.88/218.08  |- skos__broader mesh__D020414smesh__D012308
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D020414 2000
% 217.88/218.08  |- skos__prefLabel mesh__D020414 Risk Sharing, Financial
% 217.88/218.08  |- skos__related mesh__D020414smesh__D008329
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D020414 2006
% 217.88/218.08  |- skos__hiddenLabel mesh__D020414 Sharing, Financial Risk
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D020414 2003
% 217.88/218.08  |- skos__historyNote mesh__D020414 Risk Management %28%1995-1998%29%
% 217.88/218.08  |- skos__hiddenLabel mesh__D020414 Sharings, Financial Risk
% 217.88/218.08  |- mesh__historyNote mesh__D020414 99   
% 217.88/218.08  |- skos__hiddenLabel mesh__D020414 Financial Risk Sharings
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D020414 2005
% 217.88/218.08  |- skos__altLabel mesh__D020414 Financial Risk Sharing
% 217.88/218.08  |- mesh__publicMeSHNote mesh__D020414 99   
% 217.88/218.08  |- skos__hiddenLabel mesh__D020414 Risk Sharings, Financial
% 217.88/218.08  |- skos__historyNote mesh__D020414 Managed Care Programs %28%1995-1998%29%
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D020414 1999
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D020414 2002
% 217.88/218.08  |- rdf__type mesh__D044862sskos__Concept
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D044862 2006
% 217.88/218.08  |- skos__annotation mesh__D044862
% 217.88/218.08       infection: coord IM with CAMPYLOBACTER INFECTIONS %28%IM%29%   
% 217.88/218.08  |- skos__broader mesh__D044862smesh__D002167
% 217.88/218.08  |- mesh__recordAuthorizer mesh__D044862 sjn
% 217.88/218.08  |- mesh__publicMeSHNote mesh__D044862
% 217.88/218.08       2005; see CAMPYLOBACTER HYOINTESTINAL 2004   
% 217.88/218.08  |- mesh__recordMaintainer mesh__D044862 sjn
% 217.88/218.08  |- mesh__dateRevised mesh__D044862 2005-07-01
% 217.88/218.08  |- mesh__dateCreated mesh__D044862 2003-07-09
% 217.88/218.08  |- mesh__recordOriginator mesh__D044862 ags
% 217.88/218.08  |- mesh__historyNote mesh__D044862 2005 %28%2004%29%   
% 217.88/218.08  |- mesh__dateEstablished mesh__D044862 2004-01-01
% 217.88/218.08  |- skos__historyNote mesh__D044862 Campylobacter %28%1983-2003%29%
% 217.88/218.08  |- skos__scopeNote mesh__D044862
% 217.88/218.08       A species of CAMPYLOBACTER isolated from the INTESTINES of PIGS with proliferative ENTERITIS. It is also found in CATTLE and in CRICETINAE and can cause enteritis in humans.%A%    
% 217.88/218.08  |- skos__prefLabel mesh__D044862 Campylobacter hyointestinalis
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D011688 2003
% 217.88/218.08  |- mesh__dateCreated mesh__D011688 1999-01-01
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D011688 1999
% 217.88/218.08  |- mesh__historyNote mesh__D011688 68   
% 217.88/218.08  |- rdf__type mesh__D011688sskos__Concept
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D011688 2002
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D011688 2004
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D011688 1996
% 217.88/218.08  |- mesh__dateEstablished mesh__D011688 1968-01-01
% 217.88/218.08  |- mesh__recordOriginator mesh__D011688 NLM
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D011688 1993
% 217.88/218.08  |- skos__altLabel mesh__D011688 Oxopurines
% 217.88/218.08  |- mesh__recordAuthorizer mesh__D011688 PLS
% 217.88/218.08  |- mesh__dateRevised mesh__D011688 1992-05-20
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D011688 1997
% 217.88/218.08  |- mesh__recordMaintainer mesh__D011688 TAP
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D011688 2000
% 217.88/218.08  |- skos__historyNote mesh__D011688 Purines %28%1966-1967%29%
% 217.88/218.08  |- mesh__publicMeSHNote mesh__D011688 68   
% 217.88/218.08  |- skos__prefLabel mesh__D011688 Purinones
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D011688 2005
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D011688 2001
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D011688 1994
% 217.88/218.08  |- skos__broader mesh__D011688smesh__D011687
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D011688 2006
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D011688 1998
% 217.88/218.08  |- skos__historyNote mesh__D011688 Ketones %28%1966-1967%29%
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D011688 1995
% 217.88/218.08  |- skos__prefLabel mesh__D044064 Anaerobiospirillum
% 217.88/218.08  |- skos__scopeNote mesh__D044064
% 217.88/218.08       A genus of gram-negative, spiral-shaped bacteria in the family SUCCINIVIBRIONACEAE. It has been isolated from the THROAT and COLON of beagle dogs and from human FECES.%A%    
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D044064 2006
% 217.88/218.08  |- mesh__dateRevised mesh__D044064 2005-06-30
% 217.88/218.08  |- mesh__recordOriginator mesh__D044064 ags
% 217.88/218.08  |- rdf__type mesh__D044064sskos__Concept
% 217.88/218.08  |- skos__annotation mesh__D044064
% 217.88/218.08       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 217.88/218.08  |- mesh__historyNote mesh__D044064 2004   
% 217.88/218.08  |- skos__broader mesh__D044064smesh__D016965
% 217.88/218.08  |- mesh__dateCreated mesh__D044064 2003-07-09
% 217.88/218.08  |- mesh__publicMeSHNote mesh__D044064 2004   
% 217.88/218.08  |- skos__broader mesh__D044064smesh__D044063
% 217.88/218.08  |- mesh__dateEstablished mesh__D044064 2004-01-01
% 217.88/218.08  |- mesh__recordMaintainer mesh__D044064 SYSTEM
% 217.88/218.08  |- mesh__recordAuthorizer mesh__D044064 sjn
% 217.88/218.08  |- skos__hiddenLabel mesh__D016373 DNA, Anti-Sense
% 217.88/218.08  |- mesh__dateRevised mesh__D016373 2003-07-09
% 217.88/218.08  |- mesh__dateEstablished mesh__D016373 1991-01-01
% 217.88/218.08  |- skos__scopeNote mesh__D016373
% 217.88/218.08       DNA that is complementary to the sense strand. %28%The sense strand has the same sequence as the mRNA transcript. The antisense strand is the template for mRNA synthesis.%29% Synthetic antisense DNAs are used to hybridize to complementary sequences in target RNAs or DNAs to effect the functioning of specific genes for investigative or therapeutic purposes.%A%    
% 217.88/218.08  |- skos__hiddenLabel mesh__D016373 Anti Sense DNA
% 217.88/218.08  |- skos__prefLabel mesh__D016373 DNA, Antisense
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D016373 2005
% 217.88/218.08  |- skos__broader mesh__D016373smesh__D016375
% 217.88/218.08  |- mesh__recordOriginator mesh__D016373 PXP
% 217.88/218.08  |- mesh__publicMeSHNote mesh__D016373 91   
% 217.88/218.08  |- mesh__dateCreated mesh__D016373 1990-05-25
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D016373 2006
% 217.88/218.08  |- skos__altLabel mesh__D016373 Antisense DNA
% 217.88/218.08  |- mesh__historyNote mesh__D016373 91   
% 217.88/218.08  |- mesh__recordMaintainer mesh__D016373 ssb
% 217.88/218.08  |- skos__broader mesh__D016373smesh__D004247
% 217.88/218.08  |- skos__altLabel mesh__D016373 Anti-Sense DNA
% 217.88/218.08  |- skos__historyNote mesh__D016373 DNA %28%1988-1990%29%
% 217.88/218.08  |- rdf__type mesh__D016373sskos__Concept
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D016373 2004
% 217.88/218.08  |- mesh__recordAuthorizer mesh__D016373 sjn
% 217.88/218.08  |- skos__prefLabel mesh__D002353 Carrier State
% 217.88/218.08  |- skos__hiddenLabel mesh__D002353 States, Carrier
% 217.88/218.08  |- rdf__type mesh__D002353sskos__Concept
% 217.88/218.08  |- skos__scopeNote mesh__D002353
% 217.88/218.08       The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host.%A%    
% 217.88/218.08  |- mesh__recordAuthorizer mesh__D002353 sjn
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D002353 2005
% 217.88/218.08  |- mesh__publicMeSHNote mesh__D002353 65   
% 217.88/218.08  |- skos__broader mesh__D002353smesh__D011634
% 217.88/218.08  |- skos__annotation mesh__D002353
% 217.88/218.08       disease carriers, not genetic carriers %28% = CARRIERS, GENETIC see HETEROZYGOTE%29%; coord with disease, not organism%A%  
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D002353 2006
% 217.88/218.08  |- mesh__dateRevised mesh__D002353 2004-07-19
% 217.88/218.08  |- skos__hiddenLabel mesh__D002353 Carrier States
% 217.88/218.08  |- mesh__recordOriginator mesh__D002353 NLM
% 217.88/218.08  |- mesh__historyNote mesh__D002353 65%28%63%29%   
% 217.88/218.08  |- skos__hiddenLabel mesh__D002353 State, Carrier
% 217.88/218.08  |- mesh__dateCreated mesh__D002353 1999-01-01
% 217.88/218.08  |- mesh__recordMaintainer mesh__D002353 jls
% 217.88/218.08  |- mesh__dateEstablished mesh__D002353 1965-01-01
% 217.88/218.08  |- skos__broader mesh__D003165Q000037smesh__D003165
% 217.88/218.08  |- mesh__preferredCombination mesh__D003165Q000037smesh__D003169
% 217.88/218.08  |- rdf__type mesh__D003165Q000037smesh__CompoundConcept
% 217.88/218.08  |- skos__hiddenLabel mesh__D012781 Shorthands
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D012781 1996
% 217.88/218.08  |- skos__broader mesh__D012781smesh__D006236
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D012781 1992
% 217.88/218.08  |- mesh__recordAuthorizer mesh__D012781 PLS
% 217.88/218.08  |- rdf__type mesh__D012781sskos__Concept
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D012781 2003
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D012781 1997
% 217.88/218.08  |- skos__annotation mesh__D012781 no qualif   
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D012781 1998
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D012781 1993
% 217.88/218.08  |- mesh__recordMaintainer mesh__D012781 TGC
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D012781 2004
% 217.88/218.08  |- mesh__dateRevised mesh__D012781 1989-05-16
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D012781 1994
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D012781 2005
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D012781 2000
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D012781 1999
% 217.88/218.08  |- mesh__recordOriginator mesh__D012781 NLM
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D012781 1990
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D012781 2001
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D012781 1995
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D012781 2006
% 217.88/218.08  |- skos__prefLabel mesh__D012781 Shorthand
% 217.88/218.08  |- mesh__dateCreated mesh__D012781 1999-01-01
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D012781 1991
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D012781 2002
% 217.88/218.08  |- skos__prefLabel mesh__D006744 Hospital Bed Capacity, 100 to 299
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D006744 2000
% 217.88/218.08  |- mesh__recordOriginator mesh__D006744 EC
% 217.88/218.08  |- skos__broader mesh__D006744smesh__D006742
% 217.88/218.08  |- mesh__dateRevised mesh__D006744 1999-11-03
% 217.88/218.08  |- mesh__recordMaintainer mesh__D006744 kle
% 217.88/218.08  |- skos__annotation mesh__D006744
% 217.88/218.08       NIM; specify geog; DF: HOSP BED CAPAC 100   
% 217.88/218.08  |- mesh__publicMeSHNote mesh__D006744
% 217.88/218.08       91; was see under HOSPITAL BED CAPACITY 1980-90; was HOSPITAL BED CAPACITY, UNDER 200 see under HOSPITAL BED CAPACITY 1978-79%A%  
% 217.88/218.08  |- rdf__type mesh__D006744sskos__Concept
% 217.88/218.08  |- mesh__dateCreated mesh__D006744 1977-05-11
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D006744 2004
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D006744 2002
% 217.88/218.08  |- mesh__onlineNote mesh__D006744
% 217.88/218.08       use HOSPITAL BED CAPACITY, 100 TO 299 to search HOSPITAL BED CAPACITY, UNDER 200 1978-79%A%  
% 217.88/218.08  |- mesh__recordAuthorizer mesh__D006744 sjn
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D006744 2006
% 217.88/218.08  |- skos__historyNote mesh__D006744 Hospital Bed Capacity %28%1975-1977%29%
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D006744 2003
% 217.88/218.08  |- mesh__historyNote mesh__D006744
% 217.88/218.08       91%28%80%29%; was see under HOSPITAL BED CAPACITY 1980-90; was HOSPITAL BED CAPACITY, UNDER 200 see under HOSPITAL BED CAPACITY 1978-79%A%  
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D006744 2001
% 217.88/218.08  |- mesh__dateEstablished mesh__D006744 1991-01-01
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D006744 2005
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D020415 2006
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D020415 2003
% 217.88/218.08  |- mesh__dateCreated mesh__D020415 1998-06-10
% 217.88/218.08  |- skos__scopeNote mesh__D020415
% 217.88/218.08       Reducing staff to cut costs or to achieve greater efficiency.%A%    
% 217.88/218.08  |- skos__historyNote mesh__D020415 Hospital Restructuring %28%1990-1998%29%
% 217.88/218.08  |- skos__prefLabel mesh__D020415 Personnel Downsizing
% 217.88/218.08  |- mesh__dateEstablished mesh__D020415 1999-01-01
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D020415 2005
% 217.88/218.08  |- skos__altLabel mesh__D020415 Staff Downsizing
% 217.88/218.08  |- skos__broader mesh__D020415smesh__D010559
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D020415 2002
% 217.88/218.08  |- mesh__publicMeSHNote mesh__D020415 99   
% 217.88/218.08  |- skos__altLabel mesh__D020415 Downsizing, Staff
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D020415 1999
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D020415 2001
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D020415 2000
% 217.88/218.08  |- skos__broader mesh__D020415smesh__D004651
% 217.88/218.08  |- skos__historyNote mesh__D020415 Personnel Management %28%1990-1998%29%
% 217.88/218.08  |- rdf__type mesh__D020415sskos__Concept
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D020415 2004
% 217.88/218.08  |- skos__hiddenLabel mesh__D020415 Downsizing, Personnel
% 217.88/218.08  |- mesh__historyNote mesh__D020415 99   
% 217.88/218.08  |- mesh__dateRevised mesh__D044863 2005-06-30
% 217.88/218.08  |- mesh__publicMeSHNote mesh__D044863 2004   
% 217.88/218.08  |- mesh__historyNote mesh__D044863 2004   
% 217.88/218.08  |- rdf__type mesh__D044863sskos__Concept
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D044863 2006
% 217.88/218.08  |- mesh__recordMaintainer mesh__D044863 SYSTEM
% 217.88/218.08  |- mesh__dateEstablished mesh__D044863 2004-01-01
% 217.88/218.08  |- skos__historyNote mesh__D044863 Campylobacter %28%1984-2003%29%
% 217.88/218.08  |- skos__broader mesh__D044863smesh__D002167
% 217.88/218.08  |- skos__prefLabel mesh__D044863 Campylobacter lari
% 217.88/218.08  |- mesh__dateCreated mesh__D044863 2003-07-09
% 217.88/218.08  |- skos__annotation mesh__D044863
% 217.88/218.08       infection: coord IM with CAMPYLOBACTER INFECTIONS %28%IM%29%   
% 217.88/218.08  |- skos__scopeNote mesh__D044863
% 217.88/218.08       A species of thermophilic CAMPYLOBACTER found in healthy seagulls and causing ENTERITIS in humans.%A%    
% 217.88/218.08  |- mesh__recordAuthorizer mesh__D044863 sjn
% 217.88/218.08  |- mesh__recordOriginator mesh__D044863 ags
% 217.88/218.08  |- rdf__type mesh__D011689sskos__Concept
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D011689 2004
% 217.88/218.08  |- mesh__recordAuthorizer mesh__D011689 sjn
% 217.88/218.08  |- mesh__historyNote mesh__D011689 65%28%64%29%   
% 217.88/218.08  |- skos__prefLabel mesh__D011689 Purkinje Cells
% 217.88/218.08  |- skos__scopeNote mesh__D011689
% 217.88/218.08       The output neurons of the cerebellar cortex.     
% 217.88/218.08  |- skos__broader mesh__D011689smesh__D002525
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D011689 2002
% 217.88/218.08  |- skos__hiddenLabel mesh__D011689 Cells, Purkinje
% 217.88/218.08  |- mesh__dateEstablished mesh__D011689 1965-01-01
% 217.88/218.08  |- mesh__recordOriginator mesh__D011689 NLM
% 217.88/218.08  |- mesh__publicMeSHNote mesh__D011689 65   
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D011689 2005
% 217.88/218.08  |- skos__broader mesh__D011689smesh__D009474
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D011689 2006
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D011689 2000
% 217.88/218.08  |- mesh__recordMaintainer mesh__D011689 ags
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D011689 2003
% 217.88/218.08  |- mesh__dateCreated mesh__D011689 1999-01-01
% 217.88/218.08  |- skos__annotation mesh__D011689
% 217.88/218.08       in cerebellum: do not confuse with PURKINJE FIBERS %28%heart%29%%A%  
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D011689 2001
% 217.88/218.08  |- mesh__dateRevised mesh__D011689 1999-11-03
% 217.88/218.08  |- skos__prefLabel mesh__D044065 Cardiobacteriaceae
% 217.88/218.08  |- rdf__type mesh__D044065sskos__Concept
% 217.88/218.08  |- mesh__dateEstablished mesh__D044065 2004-01-01
% 217.88/218.08  |- mesh__recordAuthorizer mesh__D044065 sjn
% 217.88/218.08  |- skos__broader mesh__D044065smesh__D020563
% 217.88/218.08  |- skos__broader mesh__D044065smesh__D006092
% 217.88/218.08  |- mesh__dateCreated mesh__D044065 2003-07-09
% 217.88/218.08  |- mesh__publicMeSHNote mesh__D044065 2004   
% 217.88/218.08  |- mesh__dateRevised mesh__D044065 2005-06-30
% 217.88/218.08  |- mesh__recordOriginator mesh__D044065 ags
% 217.88/218.08  |- skos__annotation mesh__D044065
% 217.88/218.08       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 217.88/218.08  |- mesh__historyNote mesh__D044065 2004   
% 217.88/218.08  |- mesh__recordMaintainer mesh__D044065 SYSTEM
% 217.88/218.08  |- skos__scopeNote mesh__D044065
% 217.88/218.08       A family of gram-negative, mostly aerobic bacteria, in the order Cardiobacteriales. There are three genera: CARDIOBACTERIUM; DICHELOBACTER; and Suttonella.%A%    
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D044065 2006
% 217.88/218.08  |- skos__hiddenLabel mesh__D016374 Proteins v-abl, Oncogene
% 217.88/218.08  |- skos__historyNote mesh__D016374 Viral Proteins %28%1984-1986%29%
% 217.88/218.08  |- skos__historyNote mesh__D016374 Retroviridae Proteins %28%1987-1990%29%
% 217.88/218.08  |- mesh__dateRevised mesh__D016374 2005-06-30
% 217.88/218.08  |- skos__broader mesh__D016374smesh__D015682
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D016374 2006
% 217.88/218.08  |- skos__hiddenLabel mesh__D016374 v-abl, Oncogene Proteins
% 217.88/218.08  |- skos__hiddenLabel mesh__D016374 v abl Proteins
% 217.88/218.08  |- mesh__historyNote mesh__D016374 91   
% 217.88/218.08  |- mesh__recordMaintainer mesh__D016374 SYSTEM
% 217.88/218.08  |- skos__altLabel mesh__D016374 Oncogene Products v-abl
% 217.88/218.08  |- skos__hiddenLabel mesh__D016374 Oncogene Proteins, abl
% 217.88/218.08  |- skos__hiddenLabel mesh__D016374 Oncogene Products v abl
% 217.88/218.08  |- mesh__recordAuthorizer mesh__D016374 sjn
% 217.88/218.08  |- skos__scopeNote mesh__D016374
% 217.88/218.08       Transforming proteins encoded by the abl oncogenes. Oncogenic transformation of c-abl to v-abl occurs by insertional activation that results in deletions of specific N-terminal amino acids.%A%    
% 217.88/218.08  |- rdf__type mesh__D016374sskos__Concept
% 217.88/218.08  |- mesh__recordOriginator mesh__D016374 AGS
% 217.88/218.08  |- skos__annotation mesh__D016374
% 217.88/218.08       IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 217.88/218.08  |- skos__prefLabel mesh__D016374 Oncogene Proteins v-abl
% 217.88/218.08  |- skos__altLabel mesh__D016374 v-abl Proteins
% 217.88/218.08  |- skos__hiddenLabel mesh__D016374 Products v-abl, Oncogene
% 217.88/218.08  |- skos__hiddenLabel mesh__D016374 v-abl, Oncogene Products
% 217.88/218.08  |- mesh__dateCreated mesh__D016374 1990-06-19
% 217.88/218.08  |- mesh__publicMeSHNote mesh__D016374 91   
% 217.88/218.08  |- mesh__dateEstablished mesh__D016374 1991-01-01
% 217.88/218.08  |- skos__hiddenLabel mesh__D016374 Oncogene Proteins v abl
% 217.88/218.08  |- skos__altLabel mesh__D016374 abl Oncogene Proteins
% 217.88/218.08  |- skos__hiddenLabel mesh__D002354 Hydrochloride, Carteolol
% 217.88/218.08  |- skos__scopeNote mesh__D002354
% 217.88/218.08       A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.%A%    
% 217.88/218.08  |- mesh__historyNote mesh__D002354
% 217.88/218.08       91%28%79%29%; was see under PROPANOLAMINES 1979-90   
% 217.88/218.08  |- mesh__publicMeSHNote mesh__D002354
% 217.88/218.08       91; was see under PROPANOLAMINES 1979-90   
% 217.88/218.08  |- skos__historyNote mesh__D002354 Quinolines %28%1966-1978%29%
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D002354 2006
% 217.88/218.08  |- mesh__recordAuthorizer mesh__D002354 sjn
% 217.88/218.08  |- skos__altLabel mesh__D002354 Carteolol Monohydrochloride
% 217.88/218.08  |- mesh__dateRevised mesh__D002354 2005-06-30
% 217.88/218.08  |- mesh__recordOriginator mesh__D002354 SH
% 217.88/218.08  |- skos__hiddenLabel mesh__D002354 Monohydrochloride, Carteolol
% 217.88/218.08  |- mesh__dateEstablished mesh__D002354 1991-01-01
% 217.88/218.08  |- skos__broader mesh__D002354smesh__D015363
% 217.88/218.08  |- skos__broader mesh__D002354smesh__D050198
% 217.88/218.08  |- skos__hiddenLabel mesh__D002354 OPC1085
% 217.88/218.08  |- skos__historyNote mesh__D002354 Amino Alcohols %28%1966-1972%29%
% 217.88/218.08  |- skos__hiddenLabel mesh__D002354 OPC 1085
% 217.88/218.08  |- skos__historyNote mesh__D002354 Bunolol %28%1973-1978%29%
% 217.88/218.08  |- skos__broader mesh__D002354smesh__D011412
% 217.88/218.08  |- skos__prefLabel mesh__D002354 Carteolol
% 217.88/218.08  |- mesh__dateCreated mesh__D002354 1978-05-01
% 217.88/218.08  |- rdf__type mesh__D002354sskos__Concept
% 217.88/218.08  |- mesh__recordMaintainer mesh__D002354 ssb
% 217.88/218.08  |- mesh__historyNote mesh__D012782
% 217.88/218.08       SHOULDER ARTHROSES was heading 1963-64   
% 217.88/218.08  |- mesh__recordOriginator mesh__D012782 NLM
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D012782 2005
% 217.88/218.08  |- mesh__recordMaintainer mesh__D012782 sjn
% 217.88/218.08  |- mesh__recordAuthorizer mesh__D012782 sjn
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D012782 2006
% 217.88/218.08  |- mesh__dateCreated mesh__D012782 1999-01-01
% 217.88/218.08  |- skos__broader mesh__D012782smesh__D034941
% 217.88/218.08  |- skos__hiddenLabel mesh__D012782 Shoulders
% 217.88/218.08  |- skos__annotation mesh__D012782
% 217.88/218.08       TN 117: use for human %26% other vertebrates; TN 238: differentiation from SHOULDER JOINT %26% indexing instructions%A%  
% 217.88/218.08  |- mesh__publicMeSHNote mesh__D012782
% 217.88/218.08       SHOULDER ARTHROSES was heading 1963-64   
% 217.88/218.08  |- rdf__type mesh__D012782sskos__Concept
% 217.88/218.08  |- mesh__dateRevised mesh__D012782 2004-07-13
% 217.88/218.08  |- skos__prefLabel mesh__D012782 Shoulder
% 217.88/218.08  |- mesh__recordAuthorizer mesh__D006745 sjn
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D006745 2000
% 217.88/218.08  |- skos__annotation mesh__D006745
% 217.88/218.08       NIM; specify geog; DF: HOSP BED CAPAC 300   
% 217.88/218.08  |- mesh__dateCreated mesh__D006745 1977-05-11
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D006745 2001
% 217.88/218.08  |- mesh__dateEstablished mesh__D006745 1991-01-01
% 217.88/218.08  |- mesh__recordOriginator mesh__D006745 EC
% 217.88/218.08  |- skos__historyNote mesh__D006745 Hospital Bed Capacity %28%1975-1977%29%
% 217.88/218.08  |- mesh__historyNote mesh__D006745
% 217.88/218.08       91%28%80%29%; was see under HOSPITAL BED CAPACITY 1980-90; was HOSPITAL BED CAPACITY, 200 TO 499 see under HOSPITAL BED CAPACITY 1978-79%A%  
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D006745 2003
% 217.88/218.08  |- rdf__type mesh__D006745sskos__Concept
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D006745 2005
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D006745 2004
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D006745 2002
% 217.88/218.08  |- mesh__recordMaintainer mesh__D006745 kle
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D006745 2006
% 217.88/218.08  |- mesh__publicMeSHNote mesh__D006745
% 217.88/218.08       91; was see under HOSPITAL BED CAPACITY 1980-90; was HOSPITAL BED CAPACITY, 200 TO 499 see under HOSPITAL BED CAPACITY 1978-79%A%  
% 217.88/218.08  |- mesh__onlineNote mesh__D006745
% 217.88/218.08       use HOSPITAL BED CAPACITY, 300 TO 499 to search HOSPITAL BED CAPACITY, 200 TO 499 1978-79%A%  
% 217.88/218.08  |- skos__broader mesh__D006745smesh__D006742
% 217.88/218.08  |- mesh__dateRevised mesh__D006745 1999-11-03
% 217.88/218.08  |- skos__prefLabel mesh__D006745 Hospital Bed Capacity, 300 to 499
% 217.88/218.08  |- mesh__activeMeSHYear mesh__D020416 2005
% 217.88/218.08  |- mesh__historyNote mesh__D020416 99   
% 217.88/218.08  |- mesh__dateRevised mesh__D020416 1999-11-03
% 217.88/218.08  |- skos__hiddenLabel mesh__D020416 Outsourced Service
% 217.88/218.08  |- mesh__publicMeSHNote mesh__D020416 99   
% 217.88/218.08  |- mesh__dateCreated mesh__D020416 1998-06-10
% 217.88/218.08  |- mesh__recordOriginator mesh__D020416 JLS
% 217.88/218.08  |- mesh__dateEstablished mesh__D020416 1999-01-01
% 217.88/218.09  |- mesh__recordMaintainer mesh__D020416 kle
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D020416 2002
% 217.88/218.09  |- rdf__type mesh__D020416sskos__Concept
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D020416 2004
% 217.88/218.09  |- skos__broader mesh__D020416smesh__D003284
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D020416 2001
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D020416 2006
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D020416 2003
% 217.88/218.09  |- skos__historyNote mesh__D020416 Contract Services %28%1996-1998%29%
% 217.88/218.09  |- mesh__recordAuthorizer mesh__D020416 sjn
% 217.88/218.09  |- skos__altLabel mesh__D020416 Services, Outsourced
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D020416 2000
% 217.88/218.09  |- skos__prefLabel mesh__D020416 Outsourced Services
% 217.88/218.09  |- skos__scopeNote mesh__D020416
% 217.88/218.09       Organizational activities previously performed internally that are provided by external agents.%A%    
% 217.88/218.09  |- skos__broader mesh__D039121smesh__D017474
% 217.88/218.09  |- skos__hiddenLabel mesh__D039121 alpha6Abeta1, Integrin
% 217.88/218.09  |- mesh__dateCreated mesh__D039121 2002-07-02
% 217.88/218.09  |- skos__scopeNote mesh__D039121
% 217.88/218.09       A cell surface receptor mediating cell adhesion to the EXTRACELLULAR MATRIX and to other cells via binding to LAMININ. It is involved in cell migration, embryonic development, leukocyte activation and tumor cell invasiveness. Integrin alpha6beta1 is the major laminin receptor on PLATELETS; LEUKOCYTES; and many EPITHELIAL CELLS, and ligand binding may activate a number of signal transduction pathways.  Alternative splicing of the cytoplasmic domain of the alpha6 subunit %28%INTEGRIN ALPHA6%29% results in the formation of  A and B isoforms of the heterodimer, which are expressed in a tissue-specific manner.%A%    
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D039121 2005
% 217.88/218.09  |- skos__altLabel mesh__D039121 alpha6beta1 Integrin
% 217.88/218.09  |- mesh__recordOriginator mesh__D039121 MDJ
% 217.88/218.09  |- skos__hiddenLabel mesh__D039121 I%27%c-IIa, Platelet Glycoprotein
% 217.88/218.09  |- skos__altLabel mesh__D039121 alpha 6 beta 1 Integrin
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D039121 2006
% 217.88/218.09  |- mesh__historyNote mesh__D039121
% 217.88/218.09       2003; use INTEGRIN ALPHA6BETA1 %28%NM%29% 1992-2002   
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D039121 2006A
% 217.88/218.09  |- skos__altLabel mesh__D039121 CD49f-CD29
% 217.88/218.09  |- skos__prefLabel mesh__D039121 Integrin alpha6beta1
% 217.88/218.09  |- skos__broader mesh__D039121smesh__D016029
% 217.88/218.09  |- skos__hiddenLabel mesh__D039121 alpha6Bbeta1, Integrin
% 217.88/218.09  |- skos__hiddenLabel mesh__D039121 Platelet Glycoprotein I%27%c IIa
% 217.88/218.09  |- skos__hiddenLabel mesh__D039121 Integrin, alpha6beta1
% 217.88/218.09  |- skos__historyNote mesh__D039121 Integrins %28%1992-2002%29%
% 217.88/218.09  |- mesh__dateRevised mesh__D039121 2005-07-27
% 217.88/218.09  |- mesh__publicMeSHNote mesh__D039121
% 217.88/218.09       2003; INTEGRIN ALPHA5BETA1 was indexed under INTEGRINS 1992-2002%A%  
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D039121 2004
% 217.88/218.09  |- skos__altLabel mesh__D039121 Platelet Glycoprotein I%27%c-IIa
% 217.88/218.09  |- skos__hiddenLabel mesh__D039121 Glycoprotein I%27%c-IIa, Platelet
% 217.88/218.09  |- rdf__type mesh__D039121sskos__Concept
% 217.88/218.09  |- skos__hiddenLabel mesh__D039121 CD49f CD29
% 217.88/218.09  |- mesh__dateEstablished mesh__D039121 2003-01-01
% 217.88/218.09  |- skos__hiddenLabel mesh__D039121 VLA 6
% 217.88/218.09  |- skos__broader mesh__D039121smesh__D010980
% 217.88/218.09  |- skos__altLabel mesh__D039121 VLA-6
% 217.88/218.09  |- mesh__recordMaintainer mesh__D039121 ags
% 217.88/218.09  |- mesh__recordAuthorizer mesh__D039121 ags
% 217.88/218.09  |- skos__hiddenLabel mesh__D039121 alpha6beta1, Integrin
% 217.88/218.09  |- skos__altLabel mesh__D039121 Integrin alpha%28%6%29%beta%28%1%29%
% 217.88/218.09  |- mesh__publicMeSHNote mesh__D025101 2002; see PYRIDOXINE 1963-2001   
% 217.88/218.09  |- mesh__dateRevised mesh__D025101 2005-06-30
% 217.88/218.09  |- skos__prefLabel mesh__D025101 Vitamin B 6
% 217.88/218.09  |- mesh__recordAuthorizer mesh__D025101 sjn
% 217.88/218.09  |- mesh__recordOriginator mesh__D025101 ssb
% 217.88/218.09  |- rdf__type mesh__D025101sskos__Concept
% 217.88/218.09  |- skos__broader mesh__D025101smesh__D010847
% 217.88/218.09  |- mesh__historyNote mesh__D025101 2002; use PYRIDOXINE 1963-2001   
% 217.88/218.09  |- skos__altLabel mesh__D025101 Vitamin B6
% 217.88/218.09  |- skos__scopeNote mesh__D025101
% 217.88/218.09       VITAMIN B 6 refers to several PICOLINES %28%especially PYRIDOXINE; PYRIDOXAL; %26% PYRIDOXAMINE%29% that are efficiently converted by the body to PYRIDOXAL PHOSPHATE which is a coenzyme for synthesis of amino acids, neurotransmitters %28%serotonin, norepinephrine%29%, sphingolipids, and aminolevulinic acid.  During transamination of amino acids, pyridoxal phosphate is transiently converted into PYRIDOXAMINE phosphate. Although pyridoxine and Vitamin B 6 are still frequently used as synonyms, especially by medical researchers, this practice is erroneous and sometimes misleading %28%EE Snell; Ann NY Acad Sci, vol 585 pg 1, 1990%29%. Most of vitamin B6 is eventually degraded to PYRIDOXIC ACID and excreted in the urine.%A%    
% 217.88/218.09  |- mesh__dateCreated mesh__D025101 2001-07-25
% 217.88/218.09  |- skos__annotation mesh__D025101
% 217.88/218.09       /ther use: coordinate with disease /drug ther, not /diet ther%A%  
% 217.88/218.09  |- skos__historyNote mesh__D025101 Pyridoxine %28%1965-2001%29%
% 217.88/218.09  |- mesh__dateEstablished mesh__D025101 2002-01-01
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D025101 2006
% 217.88/218.09  |- mesh__recordMaintainer mesh__D025101 ssb
% 217.88/218.09  |- mesh__historyNote mesh__D044066 2004   
% 217.88/218.09  |- skos__prefLabel mesh__D044066 Cardiobacterium
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D044066 2006
% 217.88/218.09  |- mesh__recordMaintainer mesh__D044066 SYSTEM
% 217.88/218.09  |- rdf__type mesh__D044066sskos__Concept
% 217.88/218.09  |- mesh__dateCreated mesh__D044066 2003-07-09
% 217.88/218.09  |- skos__annotation mesh__D044066
% 217.88/218.09       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29% + ENDOCARDITIS, BACTERIAL if pertinent%A%  
% 217.88/218.09  |- mesh__recordAuthorizer mesh__D044066 sjn
% 217.88/218.09  |- mesh__publicMeSHNote mesh__D044066 2004   
% 217.88/218.09  |- skos__broader mesh__D044066smesh__D044065
% 217.88/218.09  |- skos__historyNote mesh__D044066
% 217.88/218.09       Gram-Negative Facultatively Anaerobic Rods %28%1976-2003%29%
% 217.88/218.09  |- mesh__dateRevised mesh__D044066 2005-06-30
% 217.88/218.09  |- mesh__recordOriginator mesh__D044066 ags
% 217.88/218.09  |- mesh__dateEstablished mesh__D044066 2004-01-01
% 217.88/218.09  |- skos__scopeNote mesh__D044066
% 217.88/218.09       A genus of gram-negative, facultatively anaerobic bacteria in the family CARDIOBACTERIACEAE. It is found in the nasal flora of humans and causes ENDOCARDITIS.%A%    
% 217.88/218.09  |- mesh__historyNote mesh__D016375 91   
% 217.88/218.09  |- mesh__dateCreated mesh__D016375 1990-05-25
% 217.88/218.09  |- mesh__publicMeSHNote mesh__D016375 91   
% 217.88/218.09  |- skos__annotation mesh__D016375 DF: ANTISENSE ELEMENTS   
% 217.88/218.09  |- mesh__recordOriginator mesh__D016375 PXP
% 217.88/218.09  |- skos__broader mesh__D016375smesh__D015341
% 217.88/218.09  |- skos__altLabel mesh__D016375 Anti-Sense Elements
% 217.88/218.09  |- skos__hiddenLabel mesh__D016375 Anti Sense Elements
% 217.88/218.09  |- rdf__type mesh__D016375sskos__Concept
% 217.88/218.09  |- skos__hiddenLabel mesh__D016375 Probes, Antisense
% 217.88/218.09  |- mesh__recordMaintainer mesh__D016375 ssb
% 217.88/218.09  |- skos__altLabel mesh__D016375 Anti-Sense Probes
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D016375 2004
% 217.88/218.09  |- skos__hiddenLabel mesh__D016375 Probes, Anti-Sense
% 217.88/218.09  |- skos__hiddenLabel mesh__D016375 Elements, Anti-Sense
% 217.88/218.09  |- mesh__dateRevised mesh__D016375 2003-07-09
% 217.88/218.09  |- skos__related mesh__D016375smesh__D014158
% 217.88/218.09  |- mesh__recordAuthorizer mesh__D016375 sjn
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D016375 2005
% 217.88/218.09  |- skos__hiddenLabel mesh__D016375 Anti Sense Probes
% 217.88/218.09  |- skos__broader mesh__D016375smesh__D009706
% 217.88/218.09  |- mesh__dateEstablished mesh__D016375 1991-01-01
% 217.88/218.09  |- skos__prefLabel mesh__D016375 Antisense Elements %28%Genetics%29%
% 217.88/218.09  |- skos__scopeNote mesh__D016375
% 217.88/218.09       Nucleic acids which hybridize to complementary sequences in other target nucleic acids causing the function of the latter to be affected.%A%    
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D016375 2006
% 217.88/218.09  |- skos__hiddenLabel mesh__D002355 Hoe045
% 217.88/218.09  |- skos__altLabel mesh__D002355 Carticain
% 217.88/218.09  |- mesh__dateCreated mesh__D002355 1978-03-17
% 217.88/218.09  |- mesh__recordOriginator mesh__D002355 SH
% 217.88/218.09  |- skos__altLabel mesh__D002355 Articain
% 217.88/218.09  |- skos__hiddenLabel mesh__D002355 Hoe 045
% 217.88/218.09  |- skos__historyNote mesh__D002355 Thiophenes %28%1966-1978%29%
% 217.88/218.09  |- skos__altLabel mesh__D002355 Articaine
% 217.88/218.09  |- skos__altLabel mesh__D002355 Hoechst Brand of Artiaine Hydrochloride
% 217.88/218.09  |- mesh__recordMaintainer mesh__D002355 ssb
% 217.88/218.09  |- skos__altLabel mesh__D002355 Hoe-045
% 217.88/218.09  |- mesh__dateEstablished mesh__D002355 1991-01-01
% 217.88/218.09  |- skos__broader mesh__D002355smesh__D013876
% 217.88/218.09  |- rdf__type mesh__D002355sskos__Concept
% 217.88/218.09  |- skos__scopeNote mesh__D002355
% 217.88/218.09       A thiophene-containing local anesthetic pharmacologically similar to MEPIVACAINE.%A%    
% 217.88/218.09  |- mesh__historyNote mesh__D002355
% 217.88/218.09       91%28%79%29%; was see under THIOPHENES 1979-90   
% 217.88/218.09  |- mesh__publicMeSHNote mesh__D002355
% 217.88/218.09       91; was see under THIOPHENES 1979-90   
% 217.88/218.09  |- mesh__recordAuthorizer mesh__D002355 sjn
% 217.88/218.09  |- skos__prefLabel mesh__D002355 Carticaine
% 217.88/218.09  |- skos__hiddenLabel mesh__D002355 Hoe 40045
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D002355 2006
% 217.88/218.09  |- skos__hiddenLabel mesh__D002355 Hoe40045
% 217.88/218.09  |- mesh__dateRevised mesh__D002355 2005-06-30
% 217.88/218.09  |- skos__scopeNote mesh__D007040
% 217.88/218.09       A reduction in the amount of air entering the pulmonary alveoli.%A%    
% 217.88/218.09  |- mesh__recordOriginator mesh__D007040 NLM
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D007040 2002
% 217.88/218.09  |- rdf__type mesh__D007040sskos__Concept
% 217.88/218.09  |- skos__prefLabel mesh__D007040 Hypoventilation
% 217.88/218.09  |- skos__broader mesh__D007040smesh__D012131
% 217.88/218.09  |- mesh__dateCreated mesh__D007040 1999-01-01
% 217.88/218.09  |- skos__broader mesh__D007040smesh__D012818
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D007040 2000
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D007040 2003
% 217.88/218.09  |- mesh__dateRevised mesh__D007040 1999-11-03
% 217.88/218.09  |- mesh__historyNote mesh__D007040 70%28%66%29%   
% 217.88/218.09  |- mesh__recordAuthorizer mesh__D007040 sjn
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D007040 2001
% 217.88/218.09  |- mesh__dateEstablished mesh__D007040 1970-01-01
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D007040 2005
% 217.88/218.09  |- skos__annotation mesh__D007040 respiratory, not environmental   
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D007040 2004
% 217.88/218.09  |- mesh__publicMeSHNote mesh__D007040 70   
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D007040 2006
% 217.88/218.09  |- mesh__recordMaintainer mesh__D007040 KEV
% 217.88/218.09  |- skos__hiddenLabel mesh__D007040 Hypoventilations
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D012783 1999
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D012783 2005
% 217.88/218.09  |- skos__hiddenLabel mesh__D012783 Dislocation, Shoulder
% 217.88/218.09  |- mesh__recordMaintainer mesh__D012783 PLS
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D012783 1995
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D012783 2006
% 217.88/218.09  |- skos__prefLabel mesh__D012783 Shoulder Dislocation
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D012783 2000
% 217.88/218.09  |- mesh__dateCreated mesh__D012783 1999-01-01
% 217.88/218.09  |- mesh__recordOriginator mesh__D012783 NLM
% 217.88/218.09  |- skos__annotation mesh__D012783
% 217.88/218.09       disloc of humerus from shoulder joint; acromioclavicular disloc = ACROMIOCLAVICULAR JOINT + DISLOCATIONS%A%  
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D012783 2001
% 217.88/218.09  |- mesh__recordAuthorizer mesh__D012783 NLM
% 217.88/218.09  |- skos__broader mesh__D012783smesh__D001134
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D012783 1991
% 217.88/218.09  |- skos__broader mesh__D012783smesh__D004204
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D012783 1996
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D012783 2002
% 217.88/218.09  |- mesh__dateRevised mesh__D012783 1990-05-29
% 217.88/218.09  |- rdf__type mesh__D012783sskos__Concept
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D012783 1992
% 217.88/218.09  |- skos__hiddenLabel mesh__D012783 Dislocations, Shoulder
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D012783 1997
% 217.88/218.09  |- skos__hiddenLabel mesh__D012783 Shoulder Dislocations
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D012783 2003
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D012783 1993
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D012783 1998
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D012783 2004
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D012783 1994
% 217.88/218.09  |- mesh__dateCreated mesh__D006746 1977-05-11
% 217.88/218.09  |- mesh__dateRevised mesh__D006746 1999-11-03
% 217.88/218.09  |- skos__altLabel mesh__D006746 Hospital Bed Capacity 500 Over
% 217.88/218.09  |- mesh__dateEstablished mesh__D006746 1991-01-01
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D006746 2003
% 217.88/218.09  |- rdf__type mesh__D006746sskos__Concept
% 217.88/218.09  |- mesh__recordAuthorizer mesh__D006746 sjn
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D006746 2000
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D006746 2005
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D006746 2004
% 217.88/218.09  |- skos__prefLabel mesh__D006746 Hospital Bed Capacity, 500 and over
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D006746 2001
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D006746 2006
% 217.88/218.09  |- mesh__recordOriginator mesh__D006746 EC
% 217.88/218.09  |- skos__historyNote mesh__D006746 Hospital Bed Capacity %28%1975-1977%29%
% 217.88/218.09  |- skos__annotation mesh__D006746
% 217.88/218.09       IM; specify geog; DF: HOSP BED CAPAC 500   
% 217.88/218.09  |- skos__broader mesh__D006746smesh__D006742
% 217.88/218.09  |- mesh__publicMeSHNote mesh__D006746
% 217.88/218.09       91; was see under HOSPITAL BED CAPACITY 1978-90   
% 217.88/218.09  |- mesh__historyNote mesh__D006746
% 217.88/218.09       91%28%78%29%; was see under HOSPITAL BED CAPACITY 1978-90   
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D006746 2002
% 217.88/218.09  |- mesh__recordMaintainer mesh__D006746 kle
% 217.88/218.09  |- skos__broader mesh__D020417smesh__D007232
% 217.88/218.09  |- mesh__historyNote mesh__D020417 2000   
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D020417 2001
% 217.88/218.09  |- mesh__dateEstablished mesh__D020417 2000-01-01
% 217.88/218.09  |- skos__prefLabel mesh__D020417 Nystagmus, Congenital
% 217.88/218.09  |- skos__historyNote mesh__D020417 Nystagmus, Pathologic %28%1966-1999%29%
% 217.88/218.09  |- skos__altLabel mesh__D020417 Congenital Nystagmus
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D020417 2003
% 217.88/218.09  |- mesh__publicMeSHNote mesh__D020417 2000   
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D020417 2002
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D020417 2005
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D020417 2004
% 217.88/218.09  |- rdf__type mesh__D020417sskos__Concept
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D020417 2006
% 217.88/218.09  |- skos__broader mesh__D020417smesh__D009759
% 217.88/218.09  |- skos__scopeNote mesh__D020417
% 217.88/218.09       Nystagmus present at birth or caused by lesions sustained in utero or at the time of birth. It is usually pendular, and is associated with ALBINISM and conditions characterized by early loss of central vision. Inheritance patterns may be X-linked, autosomal dominant, or recessive. %28%Adams et al., Principles of Neurology, 6th ed, p275%29%%A%    
% 217.88/218.09  |- skos__annotation mesh__D020417
% 217.88/218.09       do not use /congen; do not coord with INFANT, NEWBORN, DISEASES%A%  
% 217.88/218.09  |- mesh__dateCreated mesh__D020417 1999-11-08
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D020417 2000
% 217.88/218.09  |- skos__broader mesh__D039122smesh__D039102
% 217.88/218.09  |- mesh__dateEstablished mesh__D039122 2003-01-01
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D039122 2003
% 217.88/218.09  |- skos__historyNote mesh__D039122 RNA-Binding Proteins %28%1993-2002%29%
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D039122 2004
% 217.88/218.09  |- mesh__dateCreated mesh__D039122 2002-07-03
% 217.88/218.09  |- mesh__publicMeSHNote mesh__D039122
% 217.88/218.09       2003; P70 POLY%28%A%29% BINDING PROTEIN was indexed under RNA-BINDING PROTEINS 1999-2002%A%  
% 217.88/218.09  |- mesh__recordOriginator mesh__D039122 jmp
% 217.88/218.09  |- mesh__historyNote mesh__D039122
% 217.88/218.09       2003; for P70 POLY%28%A%29% BINDING PROTEIN use POLY%28%A%29%-BINDING PROTEINS %28%NM%29% 1999-2002%A%  
% 217.88/218.09  |- rdf__type mesh__D039122sskos__Concept
% 217.88/218.09  |- skos__altLabel mesh__D039122 PAB1 Poly%28%A%29% Binding Protein
% 217.88/218.09  |- mesh__dateRevised mesh__D039122 2005-07-21
% 217.88/218.09  |- mesh__recordAuthorizer mesh__D039122 ags
% 217.88/218.09  |- skos__scopeNote mesh__D039122
% 217.88/218.09       A poly%28%A%29% binding protein that has a variety of functions such as mRNA stabilization and protection of RNA from nuclease activity. Although poly%28%A%29% binding protein I is considered a major cytoplasmic RNA-binding protein it is also found in the CELL NUCLEUS and may be involved in transport of mRNP particles.%A%    
% 217.88/218.09  |- skos__altLabel mesh__D039122 PABP1 Protein
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D039122 2006A
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D039122 2005
% 217.88/218.09  |- mesh__recordMaintainer mesh__D039122 ags
% 217.88/218.09  |- skos__altLabel mesh__D039122
% 217.88/218.09       Poly%28%A%29%-Binding Protein, Cytoplasmic 1
% 217.88/218.09  |- skos__altLabel mesh__D039122 PABPC1 Protein
% 217.88/218.09  |- skos__altLabel mesh__D039122 p70 Poly%28%A%29% Binding Protein
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D039122 2006
% 217.88/218.09  |- skos__prefLabel mesh__D039122 Poly%28%A%29%-Binding Protein I
% 217.88/218.09  |- mesh__recordOriginator mesh__D025102 jmp
% 217.88/218.09  |- mesh__dateEstablished mesh__D025102 2002-01-01
% 217.88/218.09  |- mesh__dateRevised mesh__D025102 2005-06-30
% 217.88/218.09  |- mesh__recordAuthorizer mesh__D025102 sjn
% 217.88/218.09  |- skos__scopeNote mesh__D025102
% 217.88/218.09       A subclass of myosins originally found in the photoreceptor of DROSOPHILA. The heavy chains can occur as two alternatively spliced isoforms of 132 and 174 KDa. The amino terminal of myosin type III is highly unusual in that it contains a protein kinase domain which may be an important component of the visual process.%A%    
% 217.88/218.09  |- skos__broader mesh__D025102smesh__D010770
% 217.88/218.09  |- mesh__publicMeSHNote mesh__D025102 2002   
% 217.88/218.09  |- mesh__dateCreated mesh__D025102 2001-07-25
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D025102 2006
% 217.88/218.09  |- skos__altLabel mesh__D025102 Myosin III
% 217.88/218.09  |- mesh__recordMaintainer mesh__D025102 DRC
% 217.88/218.09  |- mesh__historyNote mesh__D025102 2002   
% 217.88/218.09  |- skos__prefLabel mesh__D025102 Myosin Type III
% 217.88/218.09  |- skos__broader mesh__D025102smesh__D009218
% 217.88/218.09  |- skos__historyNote mesh__D025102 Myosins %28%1998-2001%29%
% 217.88/218.09  |- rdf__type mesh__D025102sskos__Concept
% 217.88/218.09  |- mesh__dateEstablished mesh__D044067 2004-01-01
% 217.88/218.09  |- rdf__type mesh__D044067sskos__Concept
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D044067 2005
% 217.88/218.09  |- mesh__dateCreated mesh__D044067 2003-07-09
% 217.88/218.09  |- mesh__historyNote mesh__D044067 2004   
% 217.88/218.09  |- mesh__publicMeSHNote mesh__D044067 2004   
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D044067 2004
% 217.88/218.09  |- skos__scopeNote mesh__D044067
% 217.88/218.09       Cell surface proteins that bind LIPOXINS with high affinity and trigger intracellular changes influencing the behavior of cells.%A%    
% 217.88/218.09  |- skos__prefLabel mesh__D044067 Receptors, Lipoxin
% 217.88/218.09  |- skos__broader mesh__D044067smesh__D018055
% 217.88/218.09  |- skos__altLabel mesh__D044067 Lipoxin Receptors
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D044067 2006
% 217.88/218.09  |- mesh__recordAuthorizer mesh__D016376 sjn
% 217.88/218.09  |- skos__prefLabel mesh__D016376 Oligonucleotides, Antisense
% 217.88/218.09  |- skos__broader mesh__D016376smesh__D009841
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D016376 2006
% 217.88/218.09  |- skos__historyNote mesh__D016376 Oligonucleotides %28%1987-1990%29%
% 217.88/218.09  |- mesh__historyNote mesh__D016376 91   
% 217.88/218.09  |- mesh__dateEstablished mesh__D016376 1991-01-01
% 217.88/218.09  |- mesh__dateCreated mesh__D016376 1990-05-29
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D016376 2005
% 217.88/218.09  |- mesh__recordOriginator mesh__D016376 PXP
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D016376 2004
% 217.88/218.09  |- mesh__recordMaintainer mesh__D016376 ssb
% 217.88/218.09  |- skos__hiddenLabel mesh__D016376 Anti Sense Oligonucleotides
% 217.88/218.09  |- skos__broader mesh__D016376smesh__D016375
% 217.88/218.09  |- skos__altLabel mesh__D016376 Antisense Oligonucleotides
% 217.88/218.09  |- mesh__dateRevised mesh__D016376 2003-07-09
% 217.88/218.09  |- mesh__publicMeSHNote mesh__D016376 91   
% 217.88/218.09  |- rdf__type mesh__D016376sskos__Concept
% 217.88/218.09  |- skos__annotation mesh__D016376
% 217.88/218.09       coord IM with THIONUCLEOTIDES %28%IM or NIM if pertinent%29%   
% 217.88/218.09  |- skos__hiddenLabel mesh__D016376 Oligonucleotides, Anti-Sense
% 217.88/218.09  |- skos__altLabel mesh__D016376 Anti-Sense Oligonucleotides
% 217.88/218.09  |- skos__scopeNote mesh__D016376
% 217.88/218.09       Short fragments of DNA or RNA that are used to alter the function of target RNAs or DNAs to which they hybridize.%A%    
% 217.88/218.09  |- mesh__recordAuthorizer mesh__D002356 sjn
% 217.88/218.09  |- mesh__recordMaintainer mesh__D002356 ags
% 217.88/218.09  |- mesh__dateRevised mesh__D002356 2005-06-30
% 217.88/218.09  |- mesh__considerAlso mesh__D002356 consider also terms at CHONDRO-   
% 217.88/218.09  |- skos__prefLabel mesh__D002356 Cartilage
% 217.88/218.09  |- skos__broader mesh__D002356smesh__D009141
% 217.88/218.09  |- skos__broader mesh__D002356smesh__D003238
% 217.88/218.09  |- rdf__type mesh__D002356sskos__Concept
% 217.88/218.09  |- skos__scopeNote mesh__D002356
% 217.88/218.09       A non-vascular form of connective tissue composed of CHONDROCYTES embedded in a matrix that includes CHONDROITIN SULFATE and various types of FIBRILLAR COLLAGEN. There are three major types: HYALINE CARTILAGE; FIBROCARTILAGE; and ELASTIC CARTILAGE.%A%    
% 217.88/218.09  |- mesh__recordOriginator mesh__D002356 NLM
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D002356 2006
% 217.88/218.09  |- skos__related mesh__D002356smesh__D002807
% 217.88/218.09  |- skos__annotation mesh__D002356
% 217.88/218.09       general: prefer specifics; inflammation %28%chondritis%29% is likely to be OSTEOCHONDRITIS%A%  
% 217.88/218.09  |- skos__hiddenLabel mesh__D002356 Cartilages
% 217.88/218.09  |- mesh__dateCreated mesh__D002356 1999-01-01
% 217.88/218.09  |- skos__hiddenLabel mesh__D007041
% 217.88/218.09       Phosphoribosyltransferase, Hypoxanthine-Guanine
% 217.88/218.09  |- skos__hiddenLabel mesh__D007041 Phosphoribosyltransferase, Hypoxanthine
% 217.88/218.09  |- mesh__dateRevised mesh__D007041 2003-07-09
% 217.88/218.09  |- mesh__dateEstablished mesh__D007041 1975-09-01
% 217.88/218.09  |- skos__related mesh__D007041smesh__D006073
% 217.88/218.09  |- mesh__recordOriginator mesh__D007041 NLM
% 217.88/218.09  |- skos__historyNote mesh__D007041 Pentosephosphates %28%1972-1974%29%
% 217.88/218.09  |- skos__altLabel mesh__D007041 HPRT
% 217.88/218.09  |- mesh__dateCreated mesh__D007041 1974-11-11
% 217.88/218.09  |- skos__altLabel mesh__D007041 HGPRT
% 217.88/218.09  |- skos__broader mesh__D007041smesh__D010430
% 217.88/218.09  |- mesh__onlineNote mesh__D007041
% 217.88/218.09       use HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE %28%NM%29% to search GUANINE PHOSPHORIBOSYLTRANSFERASE %28%NM%29% 1980-91%A%  
% 217.88/218.09  |- skos__historyNote mesh__D007041 Pentosyltransferases %28%1972-1974%29%
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D007041 2005
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D007041 2004
% 217.88/218.09  |- skos__prefLabel mesh__D007041 Hypoxanthine Phosphoribosyltransferase
% 217.88/218.09  |- skos__scopeNote mesh__D007041
% 217.88/218.09       An enzyme that catalyzes the conversion of 5-phosphoribosyl-1-pyrophosphate and hypoxanthine, guanine, or 6-mercaptopurine to the corresponding 5%27%-mononucleotides and pyrophosphate. The enzyme is important in purine biosynthesis as well as central nervous system functions. Complete lack of enzyme activity is associated with the LESCH-NYHAN SYNDROME, while partial deficiency results in overproduction of uric acid. EC 2.4.2.8.%A%    
% 217.88/218.09  |- skos__hiddenLabel mesh__D007041 Phosphoribosyltransferase, Guanine
% 217.88/218.09  |- skos__annotation mesh__D007041
% 217.88/218.09       /defic: consider also LESCH-NYHAN SYNDROME or GOUT; DF: note short X ref%A%  
% 217.88/218.09  |- skos__related mesh__D007041smesh__D007926
% 217.88/218.09  |- skos__hiddenLabel mesh__D007041 Pyrophosphorylase, IMP
% 217.88/218.09  |- mesh__historyNote mesh__D007041
% 217.88/218.09       75; GUANINE PHOSPHORIBOSYLTRANSFERASE was GUANINE PHOSPHORIBOSYLTRANSFERASE %28%NM%29% 1978-91%A%  
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D007041 2006
% 217.88/218.09  |- mesh__publicMeSHNote mesh__D007041
% 217.88/218.09       75; GUANINE PHOSPHORIBOSYLTRANSFERASE was indexed under PENTOSYLTRANSFERASES 1978-91%A%  
% 217.88/218.09  |- mesh__recordMaintainer mesh__D007041 ssb
% 217.88/218.09  |- skos__altLabel mesh__D007041
% 217.88/218.09       Hypoxanthine-Guanine Phosphoribosyltransferase
% 217.88/218.09  |- skos__altLabel mesh__D007041 IMP Pyrophosphorylase
% 217.88/218.09  |- mesh__recordAuthorizer mesh__D007041 sjn
% 217.88/218.09  |- rdf__type mesh__D007041sskos__Concept
% 217.88/218.09  |- skos__altLabel mesh__D007041 HPRTase
% 217.88/218.09  |- skos__hiddenLabel mesh__D007041
% 217.88/218.09       Hypoxanthine Guanine Phosphoribosyltransferase
% 217.88/218.09  |- skos__altLabel mesh__D007041 Guanine Phosphoribosyltransferase
% 217.88/218.09  |- skos__hiddenLabel mesh__D012784 Shoulder Fracture
% 217.88/218.09  |- skos__hiddenLabel mesh__D012784 Fracture, Proximal Humeral
% 217.88/218.09  |- mesh__dateCreated mesh__D012784 1999-01-01
% 217.88/218.09  |- skos__hiddenLabel mesh__D012784 Humeral Fracture, Proximal
% 217.88/218.09  |- skos__broader mesh__D012784smesh__D050723
% 217.88/218.09  |- skos__altLabel mesh__D012784 Humeral Fractures, Proximal
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D012784 2006
% 217.88/218.09  |- skos__annotation mesh__D012784
% 217.88/218.09       refers to SHOULDER, not SHOULDER JOINT; restricted to fract of proximal humerus %28%head, neck, tuberosities%29%: do not confuse with HUMERAL FRACTURES %28%non-head, etc.%29%%A%  
% 217.88/218.09  |- skos__broader mesh__D012784smesh__D001134
% 217.88/218.09  |- mesh__dateRevised mesh__D012784 2005-06-30
% 217.88/218.09  |- skos__hiddenLabel mesh__D012784 Fractures, Shoulder
% 217.88/218.09  |- mesh__recordOriginator mesh__D012784 NLM
% 217.88/218.09  |- skos__hiddenLabel mesh__D012784 Proximal Humeral Fracture
% 217.88/218.09  |- skos__hiddenLabel mesh__D012784 Fractures, Proximal Humeral
% 217.88/218.09  |- skos__scopeNote mesh__D012784
% 217.88/218.09       Fractures of the proximal humerus, including the head, anatomic and surgical necks, and tuberosities.%A%    
% 217.88/218.09  |- skos__hiddenLabel mesh__D012784 Proximal Humeral Fractures
% 217.88/218.09  |- rdf__type mesh__D012784sskos__Concept
% 217.88/218.09  |- skos__hiddenLabel mesh__D012784 Fracture, Shoulder
% 217.88/218.09  |- skos__prefLabel mesh__D012784 Shoulder Fractures
% 217.88/218.09  |- mesh__recordMaintainer mesh__D012784 ssb
% 217.88/218.09  |- mesh__recordAuthorizer mesh__D012784 sjn
% 217.88/218.09  |- skos__broader mesh__D039921smesh__D011956
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D039921 2006
% 217.88/218.09  |- mesh__recordOriginator mesh__D039921 MDJ
% 217.88/218.09  |- skos__altLabel mesh__D039921 Neuropilin
% 217.88/218.09  |- mesh__recordAuthorizer mesh__D039921 sjn
% 217.88/218.09  |- mesh__dateCreated mesh__D039921 2002-07-03
% 217.88/218.09  |- mesh__dateRevised mesh__D039921 2005-06-30
% 217.88/218.09  |- skos__historyNote mesh__D039921 Nerve Tissue Proteins %28%1998-2002%29%
% 217.88/218.09  |- mesh__publicMeSHNote mesh__D039921
% 217.88/218.09       2003; NEUROPILIN was indexed under NERVE TISSUE PROTEINS 1998-2002%A%  
% 217.88/218.09  |- mesh__historyNote mesh__D039921
% 217.88/218.09       2003; for NEUROPILIN use NEUROPILIN-1 %28%NM%29% 1998-2002   
% 217.88/218.09  |- mesh__dateEstablished mesh__D039921 2003-01-01
% 217.88/218.09  |- skos__prefLabel mesh__D039921 Neuropilins
% 217.88/218.09  |- rdf__type mesh__D039921sskos__Concept
% 217.88/218.09  |- mesh__recordMaintainer mesh__D039921 jmp
% 217.88/218.09  |- skos__scopeNote mesh__D039921
% 217.88/218.09       Neuropilins are 140-kDa vertebrate cell surface receptors that bind neuronal guidance molecules during neural development and axonal outgrowth, and modulate VEGF-mediated angiogenesis.  NEUROPILIN-1 and NEUROPILIN-2 differ in their binding specificities, and are distributed complementarily in regions of the developing nervous system.  Neuropilins are receptors for secreted CLASS 3 SEMAPHORINS as well as for vascular endothelial growth factors, and may form hetero- or homodimers. They may also interact synergistically with plexins and with VEGF RECEPTORS to form receptor complexes with distinct affinities and specificities.  Neuropilin binding specificity is determined by CUB and coagulation-factor-like domains in the extracellular portion of the molecule, while a MAM domain is essential for SIGNAL TRANSDUCTION.%A%    
% 217.88/218.09  |- mesh__dateCreated mesh__D006747 1999-01-01
% 217.88/218.09  |- skos__annotation mesh__D006747 communication with staff or patients   
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D006747 1998
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D006747 1997
% 217.88/218.09  |- rdf__type mesh__D006747sskos__Concept
% 217.88/218.09  |- skos__hiddenLabel mesh__D006747 Communication Hospital Systems
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D006747 2000
% 217.88/218.09  |- skos__altLabel mesh__D006747 Communication Systems, Hospital
% 217.88/218.09  |- skos__hiddenLabel mesh__D006747 System, Communication Hospital
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D006747 2003
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D006747 1999
% 217.88/218.09  |- mesh__recordOriginator mesh__D006747 NLM
% 217.88/218.09  |- skos__altLabel mesh__D006747 System, Hospital Communication
% 217.88/218.09  |- skos__altLabel mesh__D006747 Systems, Communication Hospital
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D006747 2001
% 217.88/218.09  |- mesh__publicMeSHNote mesh__D006747 73   
% 217.88/218.09  |- skos__broader mesh__D006747smesh__D006739
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D006747 2005
% 217.88/218.09  |- skos__hiddenLabel mesh__D006747 Systems, Hospital Communication
% 217.88/218.09  |- mesh__activeMeSHYear mesh__D006747 2004
% 217.88/218.09  |- mesh__recordMaintainer mesh__D006747 KEV
% 217.88/218.09  |- mesh__dateEstablished mesh__D006747 1973-01-01
% 217.88/218.09  |- skos__hiddenLabel mesh__D006747 Communication Hospital System
% 217.88/218.10  |- skos__prefLabel mesh__D006747 Hospital Communication Systems
% 217.88/218.10  |- mesh__historyNote mesh__D006747 73%28%64%29%   
% 217.88/218.10  |- mesh__recordAuthorizer mesh__D006747 PLS
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D006747 2006
% 217.88/218.10  |- skos__scopeNote mesh__D006747
% 217.88/218.10       The transmission of messages to staff and patients within a hospital.%A%    
% 217.88/218.10  |- skos__altLabel mesh__D006747 Hospital Communication System
% 217.88/218.10  |- skos__hiddenLabel mesh__D006747 Hospital System, Communication
% 217.88/218.10  |- skos__hiddenLabel mesh__D006747 Hospital Systems, Communication
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D006747 2002
% 217.88/218.10  |- skos__altLabel mesh__D006747 Communication System, Hospital
% 217.88/218.10  |- mesh__dateRevised mesh__D006747 1996-06-10
% 217.88/218.10  |- skos__annotation mesh__D020418
% 217.88/218.10       coord IM with specific protein %28%IM%29% + specific alga %28%IM%29%   
% 217.88/218.10  |- skos__hiddenLabel mesh__D020418 Gene Proteins, Algal
% 217.88/218.10  |- mesh__dateEstablished mesh__D020418 1999-01-01
% 217.88/218.10  |- mesh__historyNote mesh__D020418 99   
% 217.88/218.10  |- skos__prefLabel mesh__D020418 Algal Proteins
% 217.88/218.10  |- rdf__type mesh__D020418sskos__Concept
% 217.88/218.10  |- mesh__recordAuthorizer mesh__D020418 sjn
% 217.88/218.10  |- mesh__dateRevised mesh__D020418 2005-06-30
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D020418 2006
% 217.88/218.10  |- skos__altLabel mesh__D020418 Gene Products, Algal
% 217.88/218.10  |- mesh__publicMeSHNote mesh__D020418 99   
% 217.88/218.10  |- mesh__recordMaintainer mesh__D020418 SYSTEM
% 217.88/218.10  |- skos__hiddenLabel mesh__D020418 Proteins, Algal
% 217.88/218.10  |- skos__historyNote mesh__D020418 Fungi %28%1963-1998%29%
% 217.88/218.10  |- skos__broader mesh__D020418smesh__D011506
% 217.88/218.10  |- skos__historyNote mesh__D020418 Algae %28%1963-1998%29%
% 217.88/218.10  |- skos__altLabel mesh__D020418 Algal Gene Products
% 217.88/218.10  |- skos__altLabel mesh__D020418 Algal Gene Proteins
% 217.88/218.10  |- mesh__recordOriginator mesh__D020418 AGS
% 217.88/218.10  |- skos__hiddenLabel mesh__D020418 Peptides, Algal
% 217.88/218.10  |- skos__scopeNote mesh__D020418
% 217.88/218.10       Proteins found in any species of algae.     
% 217.88/218.10  |- mesh__dateCreated mesh__D020418 1998-06-10
% 217.88/218.10  |- rdf__type mesh__D025901sskos__Concept
% 217.88/218.10  |- skos__broader mesh__D025901smesh__D002268
% 217.88/218.10  |- skos__altLabel mesh__D025901 Arginine Carboxypeptidase
% 217.88/218.10  |- skos__altLabel mesh__D025901 Thrombin-Activatable Fibrinolysis Inhibitor
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D025901 2006
% 217.88/218.10  |- skos__altLabel mesh__D025901 Plasma Procarboxypeptidase B
% 217.88/218.10  |- mesh__dateEstablished mesh__D025901 2002-01-01
% 217.88/218.10  |- skos__broader mesh__D025901smesh__D043484
% 217.88/218.10  |- mesh__recordAuthorizer mesh__D025901 sjn
% 217.88/218.10  |- skos__scopeNote mesh__D025901
% 217.88/218.10       A metallocarboxypeptidase that removes C-terminal lysine and arginine from biologically active peptides and proteins thereby regulating their activity. It is a zinc enzyme with no preference shown for lysine over arginine. Pro-carboxypeptidase U in human plasma is activated by thrombin or plasmin during clotting to form the unstable carboxypeptidase U.%A%    
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D025901 2005
% 217.88/218.10  |- mesh__recordOriginator mesh__D025901 lkt
% 217.88/218.10  |- skos__historyNote mesh__D025901
% 217.88/218.10       Lysine Carboxypeptidase %28%1994-2001%29%
% 217.88/218.10  |- mesh__dateRevised mesh__D025901 2004-07-13
% 217.88/218.10  |- mesh__publicMeSHNote mesh__D025901
% 217.88/218.10       2002; CARBOXYPEPTIDASE U %28%NM%29% was indexed under CARBOXYPEPTIDASES 1994-2001; for ARGININE CARBOXYPEPTIDASE see LYSINE CARBOXYPEPTIDASE 1997-2001%A%  
% 217.88/218.10  |- skos__broader mesh__D025901smesh__D045727
% 217.88/218.10  |- skos__altLabel mesh__D025901 Carboxypeptidase R
% 217.88/218.10  |- skos__hiddenLabel mesh__D025901
% 217.88/218.10       Thrombin Activatable Fibrinolysis Inhibitor
% 217.88/218.10  |- mesh__historyNote mesh__D025901
% 217.88/218.10       2002; use CARBOXYPEPTIDASE U %28%NM%29% 1994-2001 and LYSINE CARBOXYPEPTIDASE 1997-2001%A%  
% 217.88/218.10  |- mesh__dateCreated mesh__D025901 2001-07-25
% 217.88/218.10  |- skos__prefLabel mesh__D025901 Carboxypeptidase U
% 217.88/218.10  |- skos__historyNote mesh__D025901 Carboxypeptidases %28%1979-2001%29%
% 217.88/218.10  |- mesh__recordMaintainer mesh__D025901 sjn
% 217.88/218.10  |- skos__altLabel mesh__D025901 TAFI
% 217.88/218.10  |- skos__hiddenLabel mesh__D016377 Transplantations, Organ
% 217.88/218.10  |- skos__altLabel mesh__D016377 Grafting, Organ
% 217.88/218.10  |- mesh__dateEstablished mesh__D016377 1991-01-01
% 217.88/218.10  |- mesh__historyNote mesh__D016377 91   
% 217.88/218.10  |- skos__historyNote mesh__D016377 Transplantation %28%1966-1990%29%
% 217.88/218.10  |- skos__broader mesh__D016377smesh__D014180
% 217.88/218.10  |- mesh__dateCreated mesh__D016377 1990-05-29
% 217.88/218.10  |- mesh__recordOriginator mesh__D016377 PXP
% 217.88/218.10  |- skos__annotation mesh__D016377
% 217.88/218.10       GEN %26% unspecified only: prefer /transpl with organs %28%Manual 19.7+, 19.8.75%29% but many specific precoord organ/transpl terms are available; available also are several types of technical transpl terms %28%e.g., TRANSPLANTATION, HETEROLOGOUS%29%; immunol of organ transpl = TRANSPLANTATION IMMUNOLOGY; DF: ORGAN TRANSPL%A%  
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D016377 2005
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D016377 2004
% 217.88/218.10  |- skos__hiddenLabel mesh__D016377 Organ Grafting
% 217.88/218.10  |- mesh__recordAuthorizer mesh__D016377 sjn
% 217.88/218.10  |- skos__related mesh__D016377smesh__D014181
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D016377 2003
% 217.88/218.10  |- rdf__type mesh__D016377sskos__Concept
% 217.88/218.10  |- mesh__dateRevised mesh__D016377 2002-07-03
% 217.88/218.10  |- mesh__recordMaintainer mesh__D016377 lkt
% 217.88/218.10  |- skos__hiddenLabel mesh__D016377 Organ Graftings
% 217.88/218.10  |- mesh__publicMeSHNote mesh__D016377 91   
% 217.88/218.10  |- skos__prefLabel mesh__D016377 Organ Transplantation
% 217.88/218.10  |- skos__scopeNote mesh__D016377
% 217.88/218.10       Transference of an organ between individuals of the same species or between individuals of different species.%A%    
% 217.88/218.10  |- skos__historyNote mesh__D016377
% 217.88/218.10       specific organ/transplantation %28%1966-1990%29%
% 217.88/218.10  |- skos__hiddenLabel mesh__D016377 Organ Transplantations
% 217.88/218.10  |- skos__altLabel mesh__D016377 Transplantation, Organ
% 217.88/218.10  |- skos__hiddenLabel mesh__D016377 Graftings, Organ
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D016377 2006
% 217.88/218.10  |- skos__hiddenLabel mesh__D002357 Disease, Cartilage
% 217.88/218.10  |- skos__hiddenLabel mesh__D002357 Cartilage Disease
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D002357 2005
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D002357 1994
% 217.88/218.10  |- mesh__publicMeSHNote mesh__D002357 68   
% 217.88/218.10  |- mesh__recordAuthorizer mesh__D002357 PLS
% 217.88/218.10  |- mesh__historyNote mesh__D002357 68   
% 217.88/218.10  |- mesh__dateCreated mesh__D002357 1999-01-01
% 217.88/218.10  |- skos__historyNote mesh__D002357 Cartilage, Articular %28%1966-1967%29%
% 217.88/218.10  |- mesh__recordMaintainer mesh__D002357 PLS
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D002357 1997
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D002357 2001
% 217.88/218.10  |- skos__hiddenLabel mesh__D002357 Diseases, Cartilage
% 217.88/218.10  |- skos__related mesh__D002357smesh__D004839
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D002357 2004
% 217.88/218.10  |- rdf__type mesh__D002357sskos__Concept
% 217.88/218.10  |- skos__annotation mesh__D002357
% 217.88/218.10       GEN; inflamm dis %28%chondritis%29% is likely to be OSTEOCHONDRITIS%A%  
% 217.88/218.10  |- skos__related mesh__D002357smesh__D004613
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D002357 1993
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D002357 1996
% 217.88/218.10  |- skos__broader mesh__D002357smesh__D009140
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D002357 2000
% 217.88/218.10  |- mesh__dateEstablished mesh__D002357 1968-01-01
% 217.88/218.10  |- mesh__dateRevised mesh__D002357 1992-05-07
% 217.88/218.10  |- skos__related mesh__D002357smesh__D010007
% 217.88/218.10  |- skos__historyNote mesh__D002357 Cartilage %28%1966-1967%29%
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D002357 1999
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D002357 2003
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D002357 2006
% 217.88/218.10  |- mesh__recordOriginator mesh__D002357 NLM
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D002357 1995
% 217.88/218.10  |- skos__broader mesh__D002357smesh__D003240
% 217.88/218.10  |- skos__prefLabel mesh__D002357 Cartilage Diseases
% 217.88/218.10  |- skos__historyNote mesh__D002357 Osteochondritis %28%1966-1967%29%
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D002357 1998
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D002357 2002
% 217.88/218.10  |- skos__scopeNote mesh__D007840
% 217.88/218.10       A milky, product excreted from the latex canals of a variety of plant species that contain cauotchouc. Latex is composed of 25-35%25% caoutchouc, 60-75%25% water, 2%25% protein, 2%25% resin, 1.5%25% sugar %26% 1%25% ash. RUBBER is made by the removal of water from latex.%28%From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed%29% However, the term latex has been broadened in scope to include RUBBER and other synthetic polymers. Latexes are used as inert vehicles to carry antibodies or antigens in LATEX FIXATION TESTS.%A%    
% 217.88/218.10  |- mesh__dateRevised mesh__D007840 2004-07-28
% 217.88/218.10  |- skos__broader mesh__D007840smesh__D011108
% 217.88/218.10  |- skos__related mesh__D007840smesh__D020315
% 217.88/218.10  |- skos__altLabel mesh__D007840 Latices
% 217.88/218.10  |- rdf__type mesh__D007840sskos__Concept
% 217.88/218.10  |- mesh__dateCreated mesh__D007840 1980-05-20
% 217.88/218.10  |- skos__broader mesh__D007840smesh__D001704
% 217.88/218.10  |- mesh__historyNote mesh__D007840
% 217.88/218.10       1981%28%1963-1967%29%; use LATEX RUBBER 1968-1980; for CAOUTCHOUC use LATEX 1980-1999%A%  
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007840 2005A
% 217.88/218.10  |- mesh__recordAuthorizer mesh__D007840 jls
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007840 2005
% 217.88/218.10  |- mesh__dateEstablished mesh__D007840 1981-01-01
% 217.88/218.10  |- skos__prefLabel mesh__D007840 Latex
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007840 2006
% 217.88/218.10  |- skos__historyNote mesh__D007840 Rubber %28%1966-1980%29%
% 217.88/218.10  |- mesh__recordMaintainer mesh__D007840 jls
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007840 2005B
% 217.88/218.10  |- mesh__recordOriginator mesh__D007840 SH
% 217.88/218.10  |- mesh__publicMeSHNote mesh__D007840
% 217.88/218.10       1981; see LATEX RUBBER 1968-1980, see RUBBER 1963-1967; LATEX PARTICLES was heading 1968-1980; for CAOUTCHOUC see LATEX 1980-1999; for LATICES see LATEX 1981-1995%A%  
% 217.88/218.10  |- skos__related mesh__D007840smesh__D012408
% 217.88/218.10  |- skos__annotation mesh__D007840
% 217.88/218.10       can be synthesized; do not confuse with RUBBER, processed or synthetic; D25-26 qualif; /biosyn permitted if by plant%A%  
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007042 1998
% 217.88/218.10  |- mesh__recordMaintainer mesh__D007042 TPW
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007042 2002
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007042 2005
% 217.88/218.10  |- rdf__type mesh__D007042sskos__Concept
% 217.88/218.10  |- mesh__historyNote mesh__D007042 66%28%64%29%   
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007042 1997
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007042 2001
% 217.88/218.10  |- skos__annotation mesh__D007042
% 217.88/218.10       do not confuse with the specific chem HYPOXANTHINE; hypoxanthine riboside, hypoxanthine ribonucleoside = INOSINE%A%  
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007042 2004
% 217.88/218.10  |- mesh__dateCreated mesh__D007042 1999-01-01
% 217.88/218.10  |- skos__scopeNote mesh__D007042
% 217.88/218.10       Purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.%A%    
% 217.88/218.10  |- skos__prefLabel mesh__D007042 Hypoxanthines
% 217.88/218.10  |- mesh__recordOriginator mesh__D007042 NLM
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007042 2000
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007042 2003
% 217.88/218.10  |- mesh__publicMeSHNote mesh__D007042 66   
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007042 1999
% 217.88/218.10  |- mesh__recordAuthorizer mesh__D007042 PLS
% 217.88/218.10  |- mesh__dateRevised mesh__D007042 1996-06-10
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007042 2006
% 217.88/218.10  |- skos__broader mesh__D007042smesh__D011688
% 217.88/218.10  |- mesh__dateEstablished mesh__D007042 1966-01-01
% 217.88/218.10  |- skos__hiddenLabel mesh__D012785 Joints, Shoulder
% 217.88/218.10  |- skos__broader mesh__D012785smesh__D007596
% 217.88/218.10  |- mesh__dateRevised mesh__D012785 2004-07-13
% 217.88/218.10  |- mesh__recordAuthorizer mesh__D012785 sjn
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D012785 2006
% 217.88/218.10  |- mesh__publicMeSHNote mesh__D012785
% 217.88/218.10       65; SHOULDER ARTHROSES was heading 1963-64   
% 217.88/218.10  |- mesh__dateEstablished mesh__D012785 1965-01-01
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D012785 2005
% 217.88/218.10  |- skos__hiddenLabel mesh__D012785 Joint, Shoulder
% 217.88/218.10  |- skos__prefLabel mesh__D012785 Shoulder Joint
% 217.88/218.10  |- mesh__historyNote mesh__D012785
% 217.88/218.10       65; SHOULDER ARTHROSES was heading 1963-64   
% 217.88/218.10  |- mesh__recordMaintainer mesh__D012785 sjn
% 217.88/218.10  |- rdf__type mesh__D012785sskos__Concept
% 217.88/218.10  |- skos__hiddenLabel mesh__D012785 Shoulder Joints
% 217.88/218.10  |- skos__annotation mesh__D012785
% 217.88/218.10       TN 117: use for human %26% other vertebrates; TN 238: differentiation from SHOULDER %26% indexing instructions%A%  
% 217.88/218.10  |- mesh__recordOriginator mesh__D012785 NLM
% 217.88/218.10  |- mesh__dateCreated mesh__D012785 1999-01-01
% 217.88/218.10  |- skos__hiddenLabel mesh__D020419 Photoreceptor, Vertebrate
% 217.88/218.10  |- rdf__type mesh__D020419sskos__Concept
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D020419 2004
% 217.88/218.10  |- skos__broader mesh__D020419smesh__D010786
% 217.88/218.10  |- mesh__publicMeSHNote mesh__D020419
% 217.88/218.10       99; see PHOTORECEPTORS 1997-98; for RODS AND CONES see PHOTORECEPTORS 1997-98, see RODS AND CONES 1966-96%A%  
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D020419 2002
% 217.88/218.10  |- skos__altLabel mesh__D020419 Vertebrate Photoreceptors
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D020419 2006
% 217.88/218.10  |- skos__related mesh__D020419smesh__D019174
% 217.88/218.10  |- mesh__dateCreated mesh__D020419 1998-06-10
% 217.88/218.10  |- skos__scopeNote mesh__D020419
% 217.88/218.10       Cells specialized to detect and transduce light. Rods and cones are the photoreceptors in the vertebrate retina.%A%    
% 217.88/218.10  |- mesh__historyNote mesh__D020419
% 217.88/218.10       99; use PHOTORECEPTORS 1997-98; for RODS AND CONES use PHOTORECEPTORS 1966-98%A%  
% 217.88/218.10  |- skos__historyNote mesh__D020419 Photoreceptors %28%1971-1998%29%
% 217.88/218.10  |- mesh__dateEstablished mesh__D020419 1999-01-01
% 217.88/218.10  |- skos__prefLabel mesh__D020419 Photoreceptors, Vertebrate
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D020419 2000
% 217.88/218.10  |- skos__hiddenLabel mesh__D020419 Vertebrate Photoreceptor
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D020419 2001
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D020419 1999
% 217.88/218.10  |- skos__altLabel mesh__D020419 Rods and Cones
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D020419 2003
% 217.88/218.10  |- skos__annotation mesh__D020419
% 217.88/218.10       note X ref RODS AND CONES: these are vertebrate only but RODS %28%RETINA%29% %26% CONES %28%RETINA%29% are also available%A%  
% 217.88/218.10  |- skos__hiddenLabel mesh__D020419 Cones and Rods
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D020419 2005
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D006748 2005
% 217.88/218.10  |- skos__hiddenLabel mesh__D006748 Department, Hospital
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D006748 2004
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D006748 2002
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D006748 2006
% 217.88/218.10  |- mesh__recordMaintainer mesh__D006748 TGC
% 217.88/218.10  |- skos__hiddenLabel mesh__D006748 Hospital Department
% 217.88/218.10  |- mesh__dateEstablished mesh__D006748 1968-01-01
% 217.88/218.10  |- skos__historyNote mesh__D006748
% 217.88/218.10       Hospital Administration %28%1966-1967%29%
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D006748 2000
% 217.88/218.10  |- mesh__recordAuthorizer mesh__D006748 SJN
% 217.88/218.10  |- mesh__historyNote mesh__D006748 68   
% 217.88/218.10  |- mesh__dateCreated mesh__D006748 1999-01-01
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D006748 1998
% 217.88/218.10  |- mesh__recordOriginator mesh__D006748 NLM
% 217.88/218.10  |- skos__prefLabel mesh__D006748 Hospital Departments
% 217.88/218.10  |- rdf__type mesh__D006748sskos__Concept
% 217.88/218.10  |- skos__annotation mesh__D006748
% 217.88/218.10       GEN or unspecified; prefer specifics; for those not precoord, coord IM with specialty or service %28%IM%29%; DF: HOSP DEP%A%  
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D006748 2001
% 217.88/218.10  |- skos__broader mesh__D006748smesh__D006739
% 217.88/218.10  |- skos__altLabel mesh__D006748 Departments, Hospital
% 217.88/218.10  |- mesh__publicMeSHNote mesh__D006748 68   
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D006748 2003
% 217.88/218.10  |- mesh__dateRevised mesh__D006748 1997-06-20
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D006748 1999
% 217.88/218.10  |- skos__scopeNote mesh__D006748
% 217.88/218.10       Major administrative divisions of the hospital.     
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D017470 2002
% 217.88/218.10  |- skos__altLabel mesh__D017470 Glutamate Receptor
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D017470 2004
% 217.88/218.10  |- mesh__onlineNote mesh__D017470
% 217.88/218.10       use RECEPTORS, GLUTAMATE %28%NM%29% to search GLUTAMATE RECEPTOR 1980-92; use RECEPTORS, AMINO ACID to search EXCITATORY AMINO ACID RECEPTORS %26% RECEPTORS, EXCITATORY AMINO ACID 1993%A%  
% 217.88/218.10  |- skos__historyNote mesh__D017470 Receptors, Drug %28%1980-1981%29%
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D017470 2001
% 217.88/218.10  |- skos__hiddenLabel mesh__D017470 Receptor, Glutamate
% 217.88/218.10  |- mesh__dateRevised mesh__D017470 1997-06-20
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D017470 2003
% 217.88/218.10  |- skos__altLabel mesh__D017470 Glutamate Receptors
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D017470 1999
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D017470 2000
% 217.88/218.10  |- mesh__dateEstablished mesh__D017470 1993-01-01
% 217.88/218.10  |- mesh__recordMaintainer mesh__D017470 NDW
% 217.88/218.10  |- skos__altLabel mesh__D017470 Excitatory Amino Acid Receptors
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D017470 1998
% 217.88/218.10  |- skos__historyNote mesh__D017470
% 217.88/218.10       Receptors, Endogenous Substances %28%1980-1984%29%
% 217.88/218.10  |- mesh__recordAuthorizer mesh__D017470 SJN
% 217.88/218.10  |- mesh__historyNote mesh__D017470
% 217.88/218.10       93; was GLUTAMATE RECEPTOR %28%NM%29% 1980-92; EXCITATORY AMINO ACID RECEPTORS %26% RECEPTORS, EXCITATORY AMINO ACID were see RECEPTORS, AMINO ACID 1993%A%  
% 217.88/218.10  |- mesh__publicMeSHNote mesh__D017470
% 217.88/218.10       93; GLUTAMATE RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1980-92, RECEPTORS, ENDOGENOUS SUBSTANCES 1980-84 %26% RECEPTORS, DRUG 1980-81; EXCITATORY AMINO ACID RECEPTORS %26% RECEPTORS, EXCITATORY AMINO ACID were see RECEPTORS, AMINO ACID 1993%A%  
% 217.88/218.10  |- skos__prefLabel mesh__D017470 Receptors, Glutamate
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D017470 2006
% 217.88/218.10  |- skos__annotation mesh__D017470
% 217.88/218.10       GEN; prefer specifics; DF: RECEPT GLUTAMATE   
% 217.88/218.10  |- skos__broader mesh__D017470smesh__D017459
% 217.88/218.10  |- skos__scopeNote mesh__D017470
% 217.88/218.10       Cell-surface proteins that bind glutamate and trigger changes which influence the behavior of cells. Glutamate receptors include ionotropic receptors %28%AMPA, kainate, and N-methyl-D-aspartate receptors%29%, which directly control ion channels, and metabotropic receptors which act through second messenger systems. Glutamate receptors are the most common mediators of fast excitatory synaptic transmission in the central nervous system. They have also been implicated in the mechanisms of memory and of many diseases.%A%    
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D017470 2005
% 217.88/218.10  |- mesh__recordOriginator mesh__D017470 PXP
% 217.88/218.10  |- skos__historyNote mesh__D017470 Receptors, Synaptic %28%1980-1992%29%
% 217.88/218.10  |- skos__altLabel mesh__D017470 Receptors, Excitatory Amino Acid
% 217.88/218.10  |- mesh__dateCreated mesh__D017470 1992-05-22
% 217.88/218.10  |- rdf__type mesh__D017470sskos__Concept
% 217.88/218.10  |- mesh__recordOriginator mesh__D003450 NLM
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D003450 2006
% 217.88/218.10  |- mesh__dateCreated mesh__D003450 1999-01-01
% 217.88/218.10  |- skos__prefLabel mesh__D003450 Cryoglobulins
% 217.88/218.10  |- mesh__recordAuthorizer mesh__D003450 sjn
% 217.88/218.10  |- mesh__recordMaintainer mesh__D003450 ssb
% 217.88/218.10  |- skos__broader mesh__D003450smesh__D010266
% 217.88/218.10  |- skos__scopeNote mesh__D003450
% 217.88/218.10       Abnormal immunoglobulins, especially IGG or IGM, that precipitate spontaneously when SERUM is cooled below 37 degrees Celsius. It is characteristic of CRYOGLOBULINEMIA.%A%    
% 217.88/218.10  |- rdf__type mesh__D003450sskos__Concept
% 217.88/218.10  |- mesh__dateRevised mesh__D003450 2005-06-30
% 217.88/218.10  |- mesh__publicMeSHNote mesh__D016378 91   
% 217.88/218.10  |- skos__prefLabel mesh__D016378 Tissue Transplantation
% 217.88/218.10  |- mesh__dateCreated mesh__D016378 1990-08-02
% 217.88/218.10  |- skos__broader mesh__D016378smesh__D014180
% 217.88/218.10  |- skos__hiddenLabel mesh__D016378 Tissue Grafting
% 217.88/218.10  |- skos__historyNote mesh__D016378
% 217.88/218.10       specific tissue/transplantation %28%1966-1990%29%
% 217.88/218.10  |- skos__altLabel mesh__D016378 Grafting, Tissue
% 217.88/218.10  |- skos__related mesh__D016378smesh__D014181
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D016378 2006
% 217.88/218.10  |- mesh__recordAuthorizer mesh__D016378 sjn
% 217.88/218.10  |- skos__annotation mesh__D016378
% 217.88/218.10       GEN %26% unspecified only: prefer /transpl with tissues %28%Manual 19.7+, 19.8.75%29% but many specific precoord tissue/transpl terms are available; available also are several types of technical transpl terms %28%e.g., TRANSPLANTATION, HETEROLOGOUS%29%; immunol of tissue transpl = TRANSPLANTATION IMMUNOLOGY; DF: TISSUE TRANSPL%A%  
% 217.88/218.10  |- mesh__historyNote mesh__D016378 91   
% 217.88/218.10  |- skos__related mesh__D016378smesh__D014021
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D016378 2005
% 217.88/218.10  |- skos__altLabel mesh__D016378 Transplantation, Tissue
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D016378 2004
% 217.88/218.10  |- skos__related mesh__D016378smesh__D014019
% 217.88/218.10  |- skos__scopeNote mesh__D016378
% 217.88/218.10       Transference of tissue within an individual, between individuals of the same species, or between individuals of different species.%A%    
% 217.88/218.10  |- skos__historyNote mesh__D016378 Transplantation %28%1966-1990%29%
% 217.88/218.10  |- mesh__dateEstablished mesh__D016378 1991-01-01
% 217.88/218.10  |- mesh__recordMaintainer mesh__D016378 lkt
% 217.88/218.10  |- mesh__dateRevised mesh__D016378 2002-07-03
% 217.88/218.10  |- mesh__recordOriginator mesh__D016378 PXP
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D016378 2003
% 217.88/218.10  |- rdf__type mesh__D016378sskos__Concept
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D002358 2006
% 217.88/218.10  |- skos__annotation mesh__D002358
% 217.88/218.10       inflammation %28%chondritis%29% is likely to be OSTEOCHONDRITIS%A%  
% 217.88/218.10  |- mesh__recordMaintainer mesh__D002358 ags
% 217.88/218.10  |- mesh__dateCreated mesh__D002358 1999-01-01
% 217.88/218.10  |- skos__hiddenLabel mesh__D002358 Cartilages, Articular
% 217.88/218.10  |- mesh__historyNote mesh__D002358 65   
% 217.88/218.10  |- mesh__recordAuthorizer mesh__D002358 sjn
% 217.88/218.10  |- skos__hiddenLabel mesh__D002358 Articular Cartilages
% 217.88/218.10  |- skos__broader mesh__D002358smesh__D007596
% 217.88/218.10  |- rdf__type mesh__D002358sskos__Concept
% 217.88/218.10  |- skos__hiddenLabel mesh__D002358 Articular Cartilage
% 217.88/218.10  |- mesh__dateRevised mesh__D002358 2005-06-30
% 217.88/218.10  |- mesh__recordOriginator mesh__D002358 NLM
% 217.88/218.10  |- skos__broader mesh__D002358smesh__D051457
% 217.88/218.10  |- skos__prefLabel mesh__D002358 Cartilage, Articular
% 217.88/218.10  |- mesh__dateEstablished mesh__D002358 1965-01-01
% 217.88/218.10  |- mesh__publicMeSHNote mesh__D002358 65   
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007841 2000
% 217.88/218.10  |- mesh__recordOriginator mesh__D007841 NLM
% 217.88/218.10  |- mesh__recordMaintainer mesh__D007841 PXP
% 217.88/218.10  |- rdf__type mesh__D007841sskos__Concept
% 217.88/218.10  |- skos__scopeNote mesh__D007841
% 217.88/218.10       Passive agglutination tests in which antigen is adsorbed onto latex particles which then clump in the presence of antibody specific for the adsorbed antigen. %28%From Stedman, 26th ed%29%%A%    
% 217.88/218.10  |- skos__hiddenLabel mesh__D007841 Test, Latex Fixation
% 217.88/218.10  |- mesh__dateEstablished mesh__D007841 1965-01-01
% 217.88/218.10  |- skos__hiddenLabel mesh__D007841 Tests, Latex Agglutination
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007841 2001
% 217.88/218.10  |- skos__broader mesh__D007841smesh__D000372
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007841 1999
% 217.88/218.10  |- skos__hiddenLabel mesh__D007841 Test, Latex Agglutination
% 217.88/218.10  |- skos__hiddenLabel mesh__D007841 Agglutination Test, Latex
% 217.88/218.10  |- skos__hiddenLabel mesh__D007841 Fixation Tests, Latex
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007841 2005
% 217.88/218.10  |- skos__hiddenLabel mesh__D007841 Latex Agglutination Test
% 217.88/218.10  |- skos__altLabel mesh__D007841 Latex Agglutination Tests
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007841 2002
% 217.88/218.10  |- skos__prefLabel mesh__D007841 Latex Fixation Tests
% 217.88/218.10  |- mesh__publicMeSHNote mesh__D007841 65   
% 217.88/218.10  |- skos__hiddenLabel mesh__D007841 Agglutination Tests, Latex
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007841 2003
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007841 2006
% 217.88/218.10  |- mesh__dateCreated mesh__D007841 1999-01-01
% 217.88/218.10  |- skos__annotation mesh__D007841 NIM   
% 217.88/218.10  |- mesh__dateRevised mesh__D007841 1997-06-20
% 217.88/218.10  |- skos__hiddenLabel mesh__D007841 Tests, Latex Fixation
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007841 2004
% 217.88/218.10  |- skos__hiddenLabel mesh__D007841 Fixation Test, Latex
% 217.88/218.10  |- mesh__historyNote mesh__D007841 65%28%64%29%   
% 217.88/218.10  |- skos__hiddenLabel mesh__D007841 Latex Fixation Test
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007841 1998
% 217.88/218.10  |- mesh__recordAuthorizer mesh__D007841 SJN
% 217.88/218.10  |- mesh__recordMaintainer mesh__D007043 ags
% 217.88/218.10  |- skos__broader mesh__D007043smesh__D008322
% 217.88/218.10  |- mesh__publicMeSHNote mesh__D007043 91; was see under MAMMALS 1975-90   
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007043 2004
% 217.88/218.10  |- mesh__dateCreated mesh__D007043 1974-12-12
% 217.88/218.10  |- mesh__dateEstablished mesh__D007043 1991-01-01
% 217.88/218.10  |- mesh__recordAuthorizer mesh__D007043 sjn
% 217.88/218.10  |- skos__scopeNote mesh__D007043
% 217.88/218.10       Any of certain small mammals of the order Hyracoidea.     
% 217.88/218.10  |- skos__altLabel mesh__D007043 Hyraces
% 217.88/218.10  |- skos__annotation mesh__D007043 IM; qualif permitted   
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007043 2006
% 217.88/218.10  |- skos__prefLabel mesh__D007043 Hyraxes
% 217.88/218.10  |- mesh__recordOriginator mesh__D007043 NLM
% 217.88/218.10  |- skos__altLabel mesh__D007043 Hyrax
% 217.88/218.10  |- mesh__historyNote mesh__D007043
% 217.88/218.10       91%28%75%29%; was see under MAMMALS 1975-90   
% 217.88/218.10  |- rdf__type mesh__D007043sskos__Concept
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D007043 2005
% 217.88/218.10  |- mesh__dateRevised mesh__D007043 2003-07-09
% 217.88/218.10  |- rdf__type mesh__D045162sskos__Concept
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D045162 2006
% 217.88/218.10  |- mesh__dateCreated mesh__D045162 2003-07-09
% 217.88/218.10  |- mesh__recordOriginator mesh__D045162 ssb
% 217.88/218.10  |- skos__scopeNote mesh__D045162
% 217.88/218.10       THIAZOLES with two keto oxygens. Members are insulin-sensitizing agents which overcome INSULIN RESISTANCE by activation of the peroxisome proliferator activated receptor gamma %28%PPAR-gamma%29%.%A%    
% 217.88/218.10  |- mesh__historyNote mesh__D045162 2004   
% 217.88/218.10  |- mesh__publicMeSHNote mesh__D045162 2004   
% 217.88/218.10  |- skos__prefLabel mesh__D045162 Thiazolidinediones
% 217.88/218.10  |- mesh__recordAuthorizer mesh__D045162 sjn
% 217.88/218.10  |- skos__altLabel mesh__D045162 Glitazones
% 217.88/218.10  |- skos__broader mesh__D045162smesh__D013844
% 217.88/218.10  |- mesh__dateRevised mesh__D045162 2005-06-30
% 217.88/218.10  |- mesh__dateEstablished mesh__D045162 2004-01-01
% 217.88/218.10  |- skos__historyNote mesh__D045162 Thiazoles %28%1968-2003%29%
% 217.88/218.10  |- mesh__recordMaintainer mesh__D045162 ssb
% 217.88/218.10  |- mesh__publicMeSHNote mesh__D006749
% 217.88/218.10       68; HOSPITAL PLANNING AND CONSTRUCTION was heading 1963-67%A%  
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D006749 2001
% 217.88/218.10  |- skos__altLabel mesh__D006749 Hospital Design
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D006749 2006
% 217.88/218.10  |- skos__hiddenLabel mesh__D006749 Renovations, Hospital
% 217.88/218.10  |- skos__altLabel mesh__D006749 Hospital Renovation
% 217.88/218.10  |- mesh__historyNote mesh__D006749
% 217.88/218.10       68; HOSPITAL PLANNING AND CONSTRUCTION was heading 1963-67%A%  
% 217.88/218.10  |- mesh__dateEstablished mesh__D006749 1968-01-01
% 217.88/218.10  |- skos__scopeNote mesh__D006749
% 217.88/218.10       The architecture, functional design, and construction of hospitals.%A%    
% 217.88/218.10  |- mesh__dateCreated mesh__D006749 1999-01-01
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D006749 2002
% 217.88/218.10  |- mesh__recordMaintainer mesh__D006749 kle
% 217.88/218.10  |- skos__hiddenLabel mesh__D006749 Renovation, Hospital
% 217.88/218.10  |- rdf__type mesh__D006749sskos__Concept
% 217.88/218.10  |- skos__hiddenLabel mesh__D006749 Designs, Hospital
% 217.88/218.10  |- skos__hiddenLabel mesh__D006749 Design, Hospital
% 217.88/218.10  |- skos__hiddenLabel mesh__D006749 Construction, Hospital
% 217.88/218.10  |- mesh__onlineNote mesh__D006749
% 217.88/218.10       use HOSPITAL DESIGN AND CONSTRUCTION to search HOSPITAL PLANNING AND CONSTRUCTION 1966-67%A%  
% 217.88/218.10  |- mesh__dateRevised mesh__D006749 1999-11-03
% 217.88/218.10  |- skos__prefLabel mesh__D006749 Hospital Design and Construction
% 217.88/218.10  |- mesh__activeMeSHYear mesh__D006749 2003
% 217.88/218.10  |- skos__broader mesh__D006749smesh__D005160
% 217.88/218.11  |- skos__altLabel mesh__D006749 Hospital Construction and Design
% 217.88/218.11  |- mesh__recordAuthorizer mesh__D006749 sjn
% 217.88/218.11  |- mesh__activeMeSHYear mesh__D006749 2000
% 217.88/218.11  |- mesh__activeMeSHYear mesh__D006749 2005
% 217.88/218.11  |- mesh__recordOriginator mesh__D006749 NLM
% 217.88/218.11  |- mesh__activeMeSHYear mesh__D006749 2004
% 217.88/218.11  |- skos__annotation mesh__D006749
% 217.88/218.11       differentiate from HOSPITAL PLANNING %28%develop of plans at a community, state, regional or natl level%29%: HOSPITAL DESIGN AND CONSTRUCTION refers to architecture %26% decor; DF: HOSP DESIGN%A%  
% 217.88/218.11  |- skos__prefLabel mesh__D017471 Receptors, Interferon
% 217.88/218.11  |- mesh__recordMaintainer mesh__D017471 jmp
% 217.88/218.11  |- mesh__activeMeSHYear mesh__D017471 2006
% 217.88/218.11  |- skos__historyNote mesh__D017471 Receptors, Immunologic %28%1984-1992%29%
% 217.88/218.11  |- mesh__dateCreated mesh__D017471 1992-05-22
% 217.88/218.11  |- skos__altLabel mesh__D017471 Interferon Receptor
% 217.88/218.11  |- skos__broader mesh__D017471smesh__D018121
% 217.88/218.11  |- mesh__recordAuthorizer mesh__D017471 sjn
% 217.88/218.11  |- mesh__dateEstablished mesh__D017471 1993-01-01
% 217.88/218.11  |- mesh__dateRevised mesh__D017471 2003-07-09
% 217.88/218.11  |- mesh__activeMeSHYear mesh__D017471 2005
% 217.88/218.11  |- rdf__type mesh__D017471sskos__Concept
% 217.88/218.11  |- skos__historyNote mesh__D017471
% 217.88/218.11       Receptors, Endogenous Substances %28%1980-1984%29%
% 217.88/218.11  |- mesh__activeMeSHYear mesh__D017471 2004
% 217.88/218.11  |- mesh__publicMeSHNote mesh__D017471
% 217.88/218.11       93; INTERFERON RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1984-92, RECEPTORS, ENDOGENOUS SUBSTANCES 1980-84 %26% RECEPTORS, DRUG 1980-81%A%  
% 217.88/218.11  |- mesh__recordOriginator mesh__D017471 PXP
% 217.88/218.11  |- skos__historyNote mesh__D017471 Receptors, Drug %28%1980-1981%29%
% 217.88/218.11  |- skos__scopeNote mesh__D017471
% 217.88/218.11       Specific molecular sites or structures on or in cells with which interferons react or to which they bind in order to modify the function of the cells. Interferons exert their pleiotropic effects through two different receptors. alpha- and beta-interferon crossreact with common receptors, while gamma-interferon initiates its biological effects through its own specific receptor system.%A%    
% 217.88/218.11  |- mesh__historyNote mesh__D017471
% 217.88/218.11       93; was INTERFERON RECEPTOR %28%NM%29% 1980-92   
% 217.88/218.11  |- skos__hiddenLabel mesh__D017471 Receptor, Interferon
% 217.88/218.11  |- skos__altLabel mesh__D017471 Interferon Receptors
% 217.88/218.11  |- skos__annotation mesh__D017471
% 217.88/218.11       coord IM with specific interferon %28%IM%29%; DF: RECEPT INTERFERON%A%  
% 217.88/218.11  |- mesh__onlineNote mesh__D017471
% 217.88/218.11       use RECEPTORS, INTERFERON %28%NM%29% to search INTERFERON RECEPTOR 1980-92%A%  
% 217.88/218.11  |- mesh__activeMeSHYear mesh__D003451 2005
% 217.88/218.11  |- skos__prefLabel mesh__D003451 Cryoprotective Agents
% 217.88/218.11  |- mesh__recordOriginator mesh__D003451 NLM
% 217.88/218.11  |- mesh__dateRevised mesh__D003451 2003-07-09
% 217.88/218.11  |- mesh__recordAuthorizer mesh__D003451 sjn
% 217.88/218.11  |- skos__hiddenLabel mesh__D003451 Agents, Cryoprotective
% 217.88/218.11  |- mesh__dateEstablished mesh__D003451 1972-01-01
% 217.88/218.11  |- rdf__type mesh__D003451sskos__Concept
% 217.88/218.11  |- skos__broader mesh__D003451smesh__D020011
% 217.88/218.11  |- skos__historyNote mesh__D003451 Freezing %28%1966%29%
% 217.88/218.11  |- skos__scopeNote mesh__D003451
% 217.88/218.11       Substances that provide protection against the harmful effects of freezing temperatures.%A%    
% 217.88/218.11  |- mesh__recordMaintainer mesh__D003451 ssb
% 217.88/218.11  |- mesh__activeMeSHYear mesh__D003451 2004
% 217.88/218.11  |- mesh__historyNote mesh__D003451 72%28%67%29%   
% 217.88/218.11  |- mesh__activeMeSHYear mesh__D003451 2006
% 217.88/218.11  |- mesh__publicMeSHNote mesh__D003451 72   
% 217.96/218.11  |- mesh__dateCreated mesh__D003451 1999-01-01
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D016379 2001
% 217.96/218.11  |- mesh__historyNote mesh__D016379 92   
% 217.96/218.11  |- skos__hiddenLabel mesh__D016379 Bridges, Resin-Bonded
% 217.96/218.11  |- skos__prefLabel mesh__D016379 Denture, Partial, Fixed, Resin-Bonded
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D016379 1999
% 217.96/218.11  |- skos__historyNote mesh__D016379
% 217.96/218.11       Denture, Partial, Fixed %28%1982-1991%29%
% 217.96/218.11  |- mesh__recordAuthorizer mesh__D016379 SJN
% 217.96/218.11  |- skos__historyNote mesh__D016379 Dental Bonding %28%1982-1991%29%
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D016379 2000
% 217.96/218.11  |- skos__historyNote mesh__D016379 Acid Etching, Dental %28%1982-1991%29%
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D016379 2006
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D016379 1998
% 217.96/218.11  |- mesh__recordOriginator mesh__D016379 MXR
% 217.96/218.11  |- skos__hiddenLabel mesh__D016379 Bridge, Resin-Bonded
% 217.96/218.11  |- skos__altLabel mesh__D016379 Resin-Bonded Fixed Partial Denture
% 217.96/218.11  |- skos__altLabel mesh__D016379 Maryland Bridge
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D016379 2005
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D016379 2004
% 217.96/218.11  |- mesh__dateEstablished mesh__D016379 1992-01-01
% 217.96/218.11  |- mesh__publicMeSHNote mesh__D016379 92   
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D016379 2002
% 217.96/218.11  |- mesh__recordMaintainer mesh__D016379 PXP
% 217.96/218.11  |- skos__scopeNote mesh__D016379
% 217.96/218.11       A commonly used prosthesis that results in a strong, permanent restoration. It consists of an electrolytically etched cast-metal retainer that is cemented %28%bonded%29%, using resins, to adjacent teeth whose enamel was previously acid-treated %28%acid-etched%29%. This type of bridgework is sometimes referred to as a Maryland bridge.%A%    
% 217.96/218.11  |- skos__hiddenLabel mesh__D016379 Resin-Bonded Bridges
% 217.96/218.11  |- rdf__type mesh__D016379sskos__Concept
% 217.96/218.11  |- skos__hiddenLabel mesh__D016379 Resin Bonded Bridge
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D016379 2003
% 217.96/218.11  |- skos__altLabel mesh__D016379 Resin-Bonded Bridge
% 217.96/218.11  |- skos__hiddenLabel mesh__D016379 Bridge, Maryland
% 217.96/218.11  |- skos__broader mesh__D016379smesh__D003830
% 217.96/218.11  |- skos__hiddenLabel mesh__D016379 Resin Bonded Fixed Partial Denture
% 217.96/218.11  |- skos__altLabel mesh__D016379
% 217.96/218.11       Resin-Bonded Acid-Etched Fixed Partial Denture
% 217.96/218.11  |- mesh__dateRevised mesh__D016379 1997-06-20
% 217.96/218.11  |- skos__annotation mesh__D016379 DF: note short X ref   
% 217.96/218.11  |- skos__hiddenLabel mesh__D016379
% 217.96/218.11       Resin Bonded Acid Etched Fixed Partial Denture
% 217.96/218.11  |- mesh__dateCreated mesh__D016379 1991-01-02
% 217.96/218.11  |- skos__prefLabel mesh__D002359 Cartoons
% 217.96/218.11  |- skos__annotation mesh__D002359
% 217.96/218.11       IM; do not confuse with Publication Type CARTOONS; CARICATURES is also available%A%  
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D002359 2002
% 217.96/218.11  |- skos__broader mesh__D002359smesh__D002325
% 217.96/218.11  |- rdf__type mesh__D002359sskos__Concept
% 217.96/218.11  |- skos__scopeNote mesh__D002359
% 217.96/218.11       Sketches or drawings, usually humorous, symbolizing, satirizing, or caricaturing some action, subject, or person of popular interest. %28%Random House Unabridged Dictionary, 2d ed%29%%A%    
% 217.96/218.11  |- mesh__onlineNote mesh__D002359 search CARICATURES 1966-74   
% 217.96/218.11  |- mesh__recordMaintainer mesh__D002359 kle
% 217.96/218.11  |- mesh__historyNote mesh__D002359
% 217.96/218.11       91%28%75%29%; was see under CARICATURES 1975-90   
% 217.96/218.11  |- mesh__dateEstablished mesh__D002359 1991-01-01
% 217.96/218.11  |- mesh__publicMeSHNote mesh__D002359
% 217.96/218.11       91; was see under CARICATURES 1975-90   
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D002359 2004
% 217.96/218.11  |- mesh__recordAuthorizer mesh__D002359 sjn
% 217.96/218.11  |- skos__hiddenLabel mesh__D002359 Cartoon
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D002359 2001
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D002359 2003
% 217.96/218.11  |- mesh__dateRevised mesh__D002359 1999-11-03
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D002359 2000
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D002359 2006
% 217.96/218.11  |- mesh__recordOriginator mesh__D002359 NLM
% 217.96/218.11  |- mesh__dateCreated mesh__D002359 1999-01-01
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D002359 2005
% 217.96/218.11  |- mesh__historyNote mesh__D013081
% 217.96/218.11       76%28%75%29%; was see under SPERMATOZOA 1975   
% 217.96/218.11  |- skos__hiddenLabel mesh__D013081 Sperm Motilities
% 217.96/218.11  |- rdf__type mesh__D013081sskos__Concept
% 217.96/218.11  |- mesh__dateEstablished mesh__D013081 1976-01-01
% 217.96/218.11  |- skos__prefLabel mesh__D013081 Sperm Motility
% 217.96/218.11  |- skos__broader mesh__D013081smesh__D002465
% 217.96/218.11  |- mesh__publicMeSHNote mesh__D013081 76; was see under SPERMATOZOA 1975   
% 217.96/218.11  |- skos__hiddenLabel mesh__D013081 Motilities, Sperm
% 217.96/218.11  |- skos__historyNote mesh__D013081 Spermatozoa %28%1966-1974%29%
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D013081 2005
% 217.96/218.11  |- mesh__dateCreated mesh__D013081 1974-11-11
% 217.96/218.11  |- skos__hiddenLabel mesh__D013081 Motility, Sperm
% 217.96/218.11  |- skos__broader mesh__D013081smesh__D005306
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D013081 2006
% 217.96/218.11  |- skos__related mesh__D013081smesh__D013083
% 217.96/218.11  |- skos__related mesh__D013081smesh__D013078
% 217.96/218.11  |- mesh__recordMaintainer mesh__D013081 lkt
% 217.96/218.11  |- mesh__recordAuthorizer mesh__D013081 sjn
% 217.96/218.11  |- skos__scopeNote mesh__D013081
% 217.96/218.11       Movement characteristics of SPERMATOZOA in a fresh specimen. It is measured as the percentage of sperms that are moving, and as the percentage of sperms with productive flagellar motion such as rapid, linear, and forward progression.%A%    
% 217.96/218.11  |- mesh__dateRevised mesh__D013081 2004-07-07
% 217.96/218.11  |- mesh__recordOriginator mesh__D013081 NLM
% 217.96/218.11  |- mesh__recordMaintainer mesh__D007842 sjn
% 217.96/218.11  |- skos__scopeNote mesh__D007842
% 217.96/218.11       A paralytic condition of the legs caused by ingestion of lathyrogens, especially beta-aminopropionitrile, found in the seeds of plants of the genus Lathyrus %28%see FABACEAE%29%.%A%    
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007842 2002
% 217.96/218.11  |- skos__annotation mesh__D007842
% 217.96/218.11       if nitrile-induced, index also under the nitrile, probably NIM%A%  
% 217.96/218.11  |- skos__prefLabel mesh__D007842 Lathyrism
% 217.96/218.11  |- rdf__type mesh__D007842sskos__Concept
% 217.96/218.11  |- mesh__dateRevised mesh__D007842 2001-08-07
% 217.96/218.11  |- mesh__recordOriginator mesh__D007842 NLM
% 217.96/218.11  |- skos__broader mesh__D007842smesh__D010939
% 217.96/218.11  |- mesh__dateCreated mesh__D007842 1999-01-01
% 217.96/218.11  |- skos__hiddenLabel mesh__D007842 Lathyrisms
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007842 2004
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007842 2006
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007842 2003
% 217.96/218.11  |- mesh__recordAuthorizer mesh__D007842 sjn
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007842 2005
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007044 2001
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007044 2003
% 217.96/218.11  |- skos__broader mesh__D007044smesh__D013509
% 217.96/218.11  |- skos__prefLabel mesh__D007044 Hysterectomy
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007044 2000
% 217.96/218.11  |- mesh__dateRevised mesh__D007044 1997-06-20
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007044 1999
% 217.96/218.11  |- mesh__recordOriginator mesh__D007044 NLM
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007044 2006
% 217.96/218.11  |- skos__annotation mesh__D007044
% 217.96/218.11       do not use /util except by MeSH definition; abdominal: do not coord with ABDOMEN%A%  
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007044 1998
% 217.96/218.11  |- rdf__type mesh__D007044sskos__Concept
% 217.96/218.11  |- skos__hiddenLabel mesh__D007044 Hysterectomies
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007044 2005
% 217.96/218.11  |- mesh__recordMaintainer mesh__D007044 TGC
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007044 2002
% 217.96/218.11  |- mesh__recordAuthorizer mesh__D007044 SJN
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007044 2004
% 217.96/218.11  |- mesh__dateCreated mesh__D007044 1999-01-01
% 217.96/218.11  |- skos__scopeNote mesh__D007044 Excision of the uterus.     
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D012787 2006
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D012787 2001
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D012787 1996
% 217.96/218.11  |- mesh__recordOriginator mesh__D012787 NLM
% 217.96/218.11  |- skos__broader mesh__D012787smesh__D012263
% 217.96/218.11  |- skos__prefLabel mesh__D012787 Showdomycin
% 217.96/218.11  |- rdf__type mesh__D012787sskos__Concept
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D012787 2005
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D012787 2000
% 217.96/218.11  |- mesh__recordMaintainer mesh__D012787 JRT
% 217.96/218.11  |- mesh__recordAuthorizer mesh__D012787 PLS
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D012787 2004
% 217.96/218.11  |- mesh__dateRevised mesh__D012787 1995-06-08
% 217.96/218.11  |- skos__scopeNote mesh__D012787
% 217.96/218.11       3-beta-D-Ribofuranosylmaleimide. Antineoplastic antibiotic isolated from Streptomyces showdoensis. It is possibly active also as a sulfhydryl reagent.%A%    
% 217.96/218.11  |- skos__historyNote mesh__D012787 Ribonucleosides %28%1973-1974%29%
% 217.96/218.11  |- mesh__historyNote mesh__D012787
% 217.96/218.11       91%28%75%29%; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90%A%  
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D012787 2003
% 217.96/218.11  |- skos__annotation mesh__D012787 an antineoplastic antibiotic   
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D012787 1999
% 217.96/218.11  |- mesh__publicMeSHNote mesh__D012787
% 217.96/218.11       91; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90   
% 217.96/218.11  |- mesh__dateEstablished mesh__D012787 1991-01-01
% 217.96/218.11  |- skos__historyNote mesh__D012787 Maleimides %28%1974%29%
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D012787 1998
% 217.96/218.11  |- skos__historyNote mesh__D012787
% 217.96/218.11       Antibiotics, Antineoplastic %28%1971-1974%29%
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D012787 2002
% 217.96/218.11  |- mesh__dateCreated mesh__D012787 1974-11-19
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D012787 1997
% 217.96/218.11  |- skos__hiddenLabel mesh__D045163 Phosphopeptide Specific Antibodies
% 217.96/218.11  |- skos__hiddenLabel mesh__D045163
% 217.96/218.11       State-Specific Antibodies, Phosphorylation
% 217.96/218.11  |- skos__hiddenLabel mesh__D045163 Antibody, Phosphospecific
% 217.96/218.11  |- rdf__type mesh__D045163sskos__Concept
% 217.96/218.11  |- mesh__dateRevised mesh__D045163 2005-06-30
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D045163 2006
% 217.96/218.11  |- mesh__dateCreated mesh__D045163 2003-07-09
% 217.96/218.11  |- skos__annotation mesh__D045163
% 217.96/218.11       do not confuse with ANTIBODIES, ANTIPHOSPHOLIPID   
% 217.96/218.11  |- skos__broader mesh__D045163smesh__D000906
% 217.96/218.11  |- skos__related mesh__D045163smesh__D017152
% 217.96/218.11  |- skos__prefLabel mesh__D045163 Antibodies, Phospho-Specific
% 217.96/218.11  |- skos__altLabel mesh__D045163 Phosphorylation State-Specific Antibodies
% 217.96/218.11  |- skos__altLabel mesh__D045163 Phosphopeptide-Specific Antibodies
% 217.96/218.11  |- mesh__dateEstablished mesh__D045163 2004-01-01
% 217.96/218.11  |- skos__hiddenLabel mesh__D045163 Antibodies, Phosphopeptide Specific
% 217.96/218.11  |- mesh__publicMeSHNote mesh__D045163 2004   
% 217.96/218.11  |- skos__altLabel mesh__D045163 Phosphospecific Antibody
% 217.96/218.11  |- mesh__recordOriginator mesh__D045163 ags
% 217.96/218.11  |- skos__altLabel mesh__D045163 Antibodies, Phosphopeptide-Specific
% 217.96/218.11  |- skos__hiddenLabel mesh__D045163 Antibodies, Phospho Specific
% 217.96/218.11  |- skos__hiddenLabel mesh__D045163
% 217.96/218.11       Phosphorylation State Specific Antibodies
% 217.96/218.11  |- skos__hiddenLabel mesh__D045163 Antibodies, Antiphosphopeptide Specific
% 217.96/218.11  |- skos__altLabel mesh__D045163 Antibodies, Antiphosphopeptide-Specific
% 217.96/218.11  |- skos__hiddenLabel mesh__D045163 Phospho Specific Antibodies
% 217.96/218.11  |- skos__scopeNote mesh__D045163
% 217.96/218.11       Antibodies directed against immunogen-coupled phosphorylated PEPTIDES corresponding to amino acids surrounding the PHOSPHORYLATION site. They are used to study proteins involved in SIGNAL TRANSDUCTION pathways. %28%From Methods Mol Biol 2000; 99:177-89%29%%A%    
% 217.96/218.11  |- mesh__historyNote mesh__D045163 2004   
% 217.96/218.11  |- skos__hiddenLabel mesh__D045163 Antiphosphopeptide-Specific Antibodies
% 217.96/218.11  |- mesh__recordAuthorizer mesh__D045163 sjn
% 217.96/218.11  |- skos__hiddenLabel mesh__D045163
% 217.96/218.11       Antibodies, Phosphorylation State-Specific
% 217.96/218.11  |- mesh__recordMaintainer mesh__D045163 ssb
% 217.96/218.11  |- skos__altLabel mesh__D045163 Phospho-Specific Antibodies
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D031941 2004
% 217.96/218.11  |- skos__related mesh__D031941smesh__D006483
% 217.96/218.11  |- skos__hiddenLabel mesh__D031941 Viral Hemorrhagic Septicemia
% 217.96/218.11  |- skos__hiddenLabel mesh__D031941 Viral Haemorrhagic Septicaemia
% 217.96/218.11  |- skos__broader mesh__D031941smesh__D005393
% 217.96/218.11  |- mesh__historyNote mesh__D031941 2003   
% 217.96/218.11  |- mesh__dateCreated mesh__D031941 2002-07-03
% 217.96/218.11  |- mesh__publicMeSHNote mesh__D031941 2003   
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D031941 2003
% 217.96/218.11  |- skos__historyNote mesh__D031941
% 217.96/218.11       Rhabdoviridae Infections %28%1994-2002%29%
% 217.96/218.11  |- skos__prefLabel mesh__D031941 Hemorrhagic Septicemia, Viral
% 217.96/218.11  |- mesh__dateEstablished mesh__D031941 2003-01-01
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D031941 2006
% 217.96/218.11  |- skos__scopeNote mesh__D031941
% 217.96/218.11       A systemic infection of various salmonid and a few nonsalmonid fishes caused by Viral hemorrhagic septicemia virus %28%see NOVIRHABDOVIRUS%29%,%A%    
% 217.96/218.11  |- skos__altLabel mesh__D031941 Haemorrhagic Septicaemia, Viral
% 217.96/218.11  |- skos__hiddenLabel mesh__D031941 Septicaemia, Viral Haemorrhagic
% 217.96/218.11  |- skos__hiddenLabel mesh__D031941 Septicemia, Viral Hemorrhagic
% 217.96/218.11  |- skos__historyNote mesh__D031941 Fish Diseases %28%1972-2003%29%
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D031941 2005
% 217.96/218.11  |- skos__broader mesh__D031941smesh__D018353
% 217.96/218.11  |- rdf__type mesh__D031941sskos__Concept
% 217.96/218.11  |- skos__broader mesh__D017472smesh__D015703
% 217.96/218.11  |- mesh__recordMaintainer mesh__D017472 ssb
% 217.96/218.11  |- skos__hiddenLabel mesh__D017472 CDw121a Antigens
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D017472 2006
% 217.96/218.11  |- mesh__dateRevised mesh__D017472 2005-06-30
% 217.96/218.11  |- skos__annotation mesh__D017472 DF: RECEPT IL 1 or RECEPT IL1   
% 217.96/218.11  |- skos__altLabel mesh__D017472 Interleukin 1 Receptor
% 217.96/218.11  |- skos__hiddenLabel mesh__D017472 Receptors, IL1
% 217.96/218.11  |- mesh__publicMeSHNote mesh__D017472
% 217.96/218.11       93; INTERLEUKIN 1 RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1985-92; CD121A was CD121WA 1996-1999%A%  
% 217.96/218.11  |- skos__hiddenLabel mesh__D017472 Receptor, Interleukin 1
% 217.96/218.11  |- skos__altLabel mesh__D017472 Antigens, CDw121a
% 217.96/218.11  |- rdf__type mesh__D017472sskos__Concept
% 217.96/218.11  |- mesh__recordOriginator mesh__D017472 PXP
% 217.96/218.11  |- skos__historyNote mesh__D017472 Receptors, Immunologic %28%1985-1992%29%
% 217.96/218.11  |- mesh__dateCreated mesh__D017472 1992-05-22
% 217.96/218.11  |- skos__hiddenLabel mesh__D017472 Receptors, Interleukin 1
% 217.96/218.11  |- skos__prefLabel mesh__D017472 Receptors, Interleukin-1
% 217.96/218.11  |- skos__hiddenLabel mesh__D017472 Interleukin 1 Receptors
% 217.96/218.11  |- skos__altLabel mesh__D017472 IL1 Receptors
% 217.96/218.11  |- mesh__historyNote mesh__D017472
% 217.96/218.11       93; use INTERLEUKIN 1 RECEPTOR %28%NM%29% 1985-92   
% 217.96/218.11  |- mesh__recordAuthorizer mesh__D017472 sjn
% 217.96/218.11  |- mesh__dateEstablished mesh__D017472 1993-01-01
% 217.96/218.11  |- skos__altLabel mesh__D017472 Interleukin-1 Receptors
% 217.96/218.11  |- skos__altLabel mesh__D017472 IL-1 Receptors
% 217.96/218.11  |- skos__hiddenLabel mesh__D017472 Receptors, IL 1
% 217.96/218.11  |- skos__scopeNote mesh__D017472
% 217.96/218.11       Specific molecular sites or structures on cells with which interleukin-1 reacts or to which it binds to modify the function of the cells. The IL-1 receptor on T-lymphocytes and fibroblasts is composed of a single polypeptide chain that binds both IL-1 alpha and IL-1 beta. The molecular weight of this high-affinity receptor is believed to be 80 kD.%A%    
% 217.96/218.11  |- skos__altLabel mesh__D017472 CDw121b Antigens
% 217.96/218.11  |- skos__altLabel mesh__D017472 Receptors, IL-1
% 217.96/218.11  |- skos__broader mesh__D017472smesh__D018123
% 217.96/218.11  |- skos__hiddenLabel mesh__D017472 IL 1 Receptors
% 217.96/218.11  |- skos__hiddenLabel mesh__D003452 Cryoablations
% 217.96/218.11  |- rdf__type mesh__D003452sskos__Concept
% 217.96/218.11  |- mesh__recordMaintainer mesh__D003452 ssb
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D003452 2002
% 217.96/218.11  |- skos__altLabel mesh__D003452 Cryoablation
% 217.96/218.11  |- skos__annotation mesh__D003452
% 217.96/218.11       destruction or excision of tissue by very low temp; do not use /util except by MeSH definition; coord IM with disease /surg %28%IM%29%; differentiate from HYPOTHERMIA, INDUCED for cooling of organs during surgery%A%  
% 217.96/218.11  |- mesh__dateRevised mesh__D003452 2001-07-25
% 217.96/218.11  |- skos__broader mesh__D003452smesh__D013514
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D003452 2004
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D003452 2006
% 217.96/218.11  |- mesh__dateCreated mesh__D003452 1999-01-01
% 217.96/218.11  |- skos__hiddenLabel mesh__D003452 Cryosurgeries
% 217.96/218.11  |- mesh__recordOriginator mesh__D003452 NLM
% 217.96/218.11  |- skos__scopeNote mesh__D003452
% 217.96/218.11       The use of freezing as a special surgical technique to destroy or excise tissue.%A%    
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D003452 2003
% 217.96/218.11  |- mesh__publicMeSHNote mesh__D003452
% 217.96/218.11       84; was CRYOGENIC SURGERY 1963-83; CRYOTHERAPY was heading 1967-83%A%  
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D003452 2005
% 217.96/218.11  |- mesh__historyNote mesh__D003452
% 217.96/218.11       84; was CRYOGENIC SURGERY 1963-83; CRYOTHERAPY was heading 1964-83 %28%Prov 1964-66%29%%A%  
% 217.96/218.11  |- mesh__recordAuthorizer mesh__D003452 sjn
% 217.96/218.11  |- mesh__onlineNote mesh__D003452
% 217.96/218.11       use CRYOSURGERY to search CRYOGENIC SURGERY %26% CRYOTHERAPY 1966-83%A%  
% 217.96/218.11  |- skos__prefLabel mesh__D003452 Cryosurgery
% 217.96/218.11  |- skos__hiddenLabel mesh__D013880 Reductase, NADPH-Thioredoxin
% 217.96/218.11  |- mesh__dateCreated mesh__D013880 1974-11-19
% 217.96/218.11  |- mesh__dateRevised mesh__D013880 2005-06-30
% 217.96/218.11  |- skos__broader mesh__D013880smesh__D005420
% 217.96/218.11  |- skos__hiddenLabel mesh__D013880 Thioredoxin Disulfide Reductase
% 217.96/218.11  |- mesh__recordMaintainer mesh__D013880 AKE
% 217.96/218.11  |- skos__hiddenLabel mesh__D013880 Reductase, Thioredoxin-Disulfide
% 217.96/218.11  |- skos__altLabel mesh__D013880 NADP-Thioredoxin Reductase
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D013880 2006
% 217.96/218.11  |- skos__broader mesh__D013880smesh__D050862
% 217.96/218.11  |- mesh__publicMeSHNote mesh__D013880
% 217.96/218.11       91; was see under NADH, NADPH OXIDOREDUCTASES 1975-90   
% 217.96/218.11  |- skos__historyNote mesh__D013880 Bacterial Proteins %28%1972-1974%29%
% 217.96/218.11  |- skos__altLabel mesh__D013880 NADPH-Thioredoxin Reductase
% 217.96/218.11  |- mesh__recordAuthorizer mesh__D013880 sjn
% 217.96/218.11  |- mesh__dateEstablished mesh__D013880 1991-01-01
% 217.96/218.11  |- skos__hiddenLabel mesh__D013880 NADPH Thioredoxin Reductase
% 217.96/218.11  |- rdf__type mesh__D013880sskos__Concept
% 217.96/218.11  |- skos__historyNote mesh__D013880 Oxidoreductases %28%1972-1974%29%
% 217.96/218.11  |- skos__scopeNote mesh__D013880
% 217.96/218.11       A FLAVOPROTEIN enzyme that catalyzes the oxidation of THIOREDOXIN to thioredoxin disulfide in the presence of NADP+. It was formerly listed as EC 1.6.4.5%A%    
% 217.96/218.11  |- mesh__historyNote mesh__D013880
% 217.96/218.11       91%28%75%29%; was see under NADH, NADPH OXIDOREDUCTASES 1975-90%A%  
% 217.96/218.11  |- skos__historyNote mesh__D013880 NADH, NADPH Oxidoreductases %28%1974%29%
% 217.96/218.11  |- mesh__recordOriginator mesh__D013880 NLM
% 217.96/218.11  |- skos__altLabel mesh__D013880 Thioredoxin-Disulfide Reductase
% 217.96/218.11  |- skos__hiddenLabel mesh__D013880 NADP Thioredoxin Reductase
% 217.96/218.11  |- skos__prefLabel mesh__D013880 Thioredoxin Reductase %28%NADPH%29%
% 217.96/218.11  |- skos__annotation mesh__D013880 DF: THIOREDOXIN REDUCTASE   
% 217.96/218.11  |- skos__hiddenLabel mesh__D013880 Reductase, NADP-Thioredoxin
% 217.96/218.11  |- mesh__recordAuthorizer mesh__D013082 sjn
% 217.96/218.11  |- skos__hiddenLabel mesh__D013082 Tails, Sperm
% 217.96/218.11  |- mesh__recordMaintainer mesh__D013082 lkt
% 217.96/218.11  |- skos__hiddenLabel mesh__D013082 Flagellum, Sperm
% 217.96/218.11  |- skos__hiddenLabel mesh__D013082 Flagellums, Sperm
% 217.96/218.11  |- skos__hiddenLabel mesh__D013082 Sperm Flagellums
% 217.96/218.11  |- mesh__recordOriginator mesh__D013082 NLM
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D013082 2005
% 217.96/218.11  |- mesh__dateCreated mesh__D013082 1974-11-11
% 217.96/218.11  |- mesh__dateRevised mesh__D013082 2002-07-03
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D013082 2006
% 217.96/218.11  |- mesh__dateEstablished mesh__D013082 1991-01-01
% 217.96/218.11  |- mesh__publicMeSHNote mesh__D013082
% 217.96/218.11       91; was see under SPERMATOZOA 1975-90   
% 217.96/218.11  |- skos__broader mesh__D013082smesh__D005407
% 217.96/218.11  |- skos__broader mesh__D013082smesh__D013094
% 217.96/218.11  |- skos__altLabel mesh__D013082 Sperm Flagellum
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D013082 2003
% 217.96/218.11  |- mesh__historyNote mesh__D013082
% 217.96/218.11       91%28%75%29%; was see under SPERMATOZOA 1975-90   
% 217.96/218.11  |- skos__scopeNote mesh__D013082
% 217.96/218.11       The posterior filiform portion of the spermatozoon %28%SPERMATOZOA%29% that provides sperm motility.%A%    
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D013082 2004
% 217.96/218.11  |- skos__hiddenLabel mesh__D013082 Tail, Sperm
% 217.96/218.11  |- skos__hiddenLabel mesh__D013082 Sperm Tails
% 217.96/218.11  |- skos__prefLabel mesh__D013082 Sperm Tail
% 217.96/218.11  |- rdf__type mesh__D013082sskos__Concept
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007843 1997
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007843 1991
% 217.96/218.11  |- rdf__type mesh__D007843sskos__Concept
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007843 1999
% 217.96/218.11  |- mesh__dateCreated mesh__D007843 1999-01-01
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007843 2002
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007843 1993
% 217.96/218.11  |- skos__broader mesh__D007843smesh__D000569
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007843 1996
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007843 1995
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007843 1990
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007843 1998
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007843 2004
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007843 2006
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007843 2001
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007843 1992
% 217.96/218.11  |- skos__prefLabel mesh__D007843 Latin America
% 217.96/218.11  |- mesh__dateRevised mesh__D007843 1991-11-26
% 217.96/218.11  |- mesh__dateEstablished mesh__D007843 1975-01-01
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007843 1994
% 217.96/218.11  |- skos__scopeNote mesh__D007843
% 217.96/218.11       The geographic area of Latin America in general and when the specific country or countries are not indicated. It usually includes Central America, South America, Mexico, and the islands of the Caribbean.%A%    
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007843 2003
% 217.96/218.11  |- mesh__recordOriginator mesh__D007843 NLM
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007843 2000
% 217.96/218.11  |- mesh__recordMaintainer mesh__D007843 PLS
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007843 2005
% 217.96/218.11  |- mesh__historyNote mesh__D007843 75   
% 217.96/218.11  |- mesh__recordAuthorizer mesh__D007843 PLS
% 217.96/218.11  |- skos__annotation mesh__D007843 GEN: prefer specific country   
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007843 1989
% 217.96/218.11  |- skos__broader mesh__D007045smesh__D007044
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007045 1999
% 217.96/218.11  |- mesh__recordAuthorizer mesh__D007045 SJN
% 217.96/218.11  |- mesh__activeMeSHYear mesh__D007045 2006
% 217.96/218.11  |- skos__scopeNote mesh__D007045
% 217.96/218.11       Removal of the uterus through the vagina.     
% 217.96/218.11  |- skos__annotation mesh__D007045
% 217.96/218.11       do not use /util except by MeSH definition   
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007045 1998
% 217.96/218.12  |- skos__hiddenLabel mesh__D007045 Vaginal Hysterectomies
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007045 2001
% 217.96/218.12  |- rdf__type mesh__D007045sskos__Concept
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007045 2005
% 217.96/218.12  |- skos__hiddenLabel mesh__D007045 Vaginal Hysterectomy
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007045 2000
% 217.96/218.12  |- mesh__recordOriginator mesh__D007045 NLM
% 217.96/218.12  |- mesh__dateRevised mesh__D007045 1997-06-20
% 217.96/218.12  |- skos__hiddenLabel mesh__D007045 Colpohysterectomies
% 217.96/218.12  |- skos__altLabel mesh__D007045 Colpohysterectomy
% 217.96/218.12  |- mesh__dateCreated mesh__D007045 1974-11-19
% 217.96/218.12  |- mesh__recordMaintainer mesh__D007045 PXP
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007045 2004
% 217.96/218.12  |- mesh__historyNote mesh__D007045
% 217.96/218.12       91%28%75%29%; was see under HYSTERECTOMY 1975-90   
% 217.96/218.12  |- skos__prefLabel mesh__D007045 Hysterectomy, Vaginal
% 217.96/218.12  |- mesh__publicMeSHNote mesh__D007045
% 217.96/218.12       91; was see under HYSTERECTOMY 1975-90   
% 217.96/218.12  |- skos__hiddenLabel mesh__D007045 Hysterectomies, Vaginal
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007045 2002
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007045 2003
% 217.96/218.12  |- mesh__dateEstablished mesh__D007045 1991-01-01
% 217.96/218.12  |- skos__historyNote mesh__D012788 Insectivora %28%1966-1971%29%
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D012788 2004
% 217.96/218.12  |- skos__broader mesh__D012788smesh__D007312
% 217.96/218.12  |- mesh__dateCreated mesh__D012788 1999-01-01
% 217.96/218.12  |- skos__hiddenLabel mesh__D012788 Shrew
% 217.96/218.12  |- mesh__dateRevised mesh__D012788 2003-07-09
% 217.96/218.12  |- mesh__dateEstablished mesh__D012788 1972-01-01
% 217.96/218.12  |- mesh__publicMeSHNote mesh__D012788 72   
% 217.96/218.12  |- mesh__recordOriginator mesh__D012788 NLM
% 217.96/218.12  |- mesh__historyNote mesh__D012788 72   
% 217.96/218.12  |- skos__annotation mesh__D012788
% 217.96/218.12       IM; qualif permitted; do not confuse SHREWS %28%insectivore%29% with TREE SHREWS see TUPAIIDAE%A%  
% 217.96/218.12  |- mesh__recordMaintainer mesh__D012788 ags
% 217.96/218.12  |- skos__prefLabel mesh__D012788 Shrews
% 217.96/218.12  |- mesh__recordAuthorizer mesh__D012788 sjn
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D012788 2006
% 217.96/218.12  |- rdf__type mesh__D012788sskos__Concept
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D012788 2005
% 217.96/218.12  |- mesh__historyNote mesh__D045164 2004   
% 217.96/218.12  |- skos__broader mesh__D045164smesh__D033581
% 217.96/218.12  |- mesh__publicMeSHNote mesh__D045164 2004   
% 217.96/218.12  |- skos__scopeNote mesh__D045164
% 217.96/218.12       Transfer of MESENCHYMAL STEM CELLS between individuals within the same species %28%TRANSPLANTATION, HOMOLOGOUS%29% or transfer within the same individual %28%TRANSPLANTATION, AUTOLOGOUS%29%.%A%    
% 217.96/218.12  |- skos__altLabel mesh__D045164 Stem Cell Transplantation, Mesenchymal
% 217.96/218.12  |- mesh__dateEstablished mesh__D045164 2004-01-01
% 217.96/218.12  |- skos__prefLabel mesh__D045164 Mesenchymal Stem Cell Transplantation
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D045164 2005
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D045164 2004
% 217.96/218.12  |- rdf__type mesh__D045164sskos__Concept
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D045164 2006
% 217.96/218.12  |- skos__altLabel mesh__D045164 Transplantation, Mesenchymal Stem Cell
% 217.96/218.12  |- mesh__dateCreated mesh__D045164 2003-07-09
% 217.96/218.12  |- mesh__publicMeSHNote mesh__D031942 2003   
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D031942 2003
% 217.96/218.12  |- skos__prefLabel mesh__D031942 Cynara
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D031942 2006
% 217.96/218.12  |- skos__broader mesh__D031942smesh__D019659
% 217.96/218.12  |- mesh__historyNote mesh__D031942 2003   
% 217.96/218.12  |- mesh__dateCreated mesh__D031942 2002-07-03
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D031942 2005
% 217.96/218.12  |- skos__scopeNote mesh__D031942
% 217.96/218.12       A plant genus of the family ASTERACEAE.     
% 217.96/218.12  |- skos__annotation mesh__D031942
% 217.96/218.12       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.96/218.12  |- mesh__dateEstablished mesh__D031942 2003-01-01
% 217.96/218.12  |- rdf__type mesh__D031942sskos__Concept
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D031942 2004
% 217.96/218.12  |- skos__altLabel mesh__D031942 Cardoon
% 217.96/218.12  |- skos__scopeNote mesh__D017473
% 217.96/218.12       A class of opioid receptors recognized by its pharmacological profile. Kappa opioid receptors bind dynorphins with a higher affinity than endorphins which are themselves preferred to enkephalins.%A%    
% 217.96/218.12  |- skos__altLabel mesh__D017473 kappa Receptor
% 217.96/218.12  |- mesh__recordAuthorizer mesh__D017473 sjn
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D017473 2006
% 217.96/218.12  |- mesh__publicMeSHNote mesh__D017473
% 217.96/218.12       94; was RECEPTORS, KAPPA 1993; KAPPA RECEPTOR was indexed under RECEPTORS, ENDORPHIN 1980-92%A%  
% 217.96/218.12  |- skos__hiddenLabel mesh__D017473 Receptor, kappa Opioid
% 217.96/218.12  |- mesh__dateEstablished mesh__D017473 1993-01-01
% 217.96/218.12  |- mesh__dateRevised mesh__D017473 2003-07-09
% 217.96/218.12  |- skos__hiddenLabel mesh__D017473 Receptor, kappa
% 217.96/218.12  |- skos__broader mesh__D017473smesh__D011957
% 217.96/218.12  |- mesh__onlineNote mesh__D017473
% 217.96/218.12       use RECEPTORS, OPIOID, KAPPA to search RECEPTORS, KAPPA 1993; use RECEPTORS, OPIOID, KAPPA %28%NM%29% to search KAPPA RECEPTOR 1980-92%A%  
% 217.96/218.12  |- rdf__type mesh__D017473sskos__Concept
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D017473 2004
% 217.96/218.12  |- skos__altLabel mesh__D017473 Receptors, kappa Opioid
% 217.96/218.12  |- skos__altLabel mesh__D017473 kappa Receptors
% 217.96/218.12  |- skos__altLabel mesh__D017473 Receptors, kappa
% 217.96/218.12  |- skos__prefLabel mesh__D017473 Receptors, Opioid, kappa
% 217.96/218.12  |- skos__hiddenLabel mesh__D017473 kappa Opioid Receptors
% 217.96/218.12  |- skos__annotation mesh__D017473
% 217.96/218.12       opioid receptors found in the anterior pituitary %26% substantia nigra; DF: RECEPT KAPPA%A%  
% 217.96/218.12  |- mesh__recordMaintainer mesh__D017473 jmp
% 217.96/218.12  |- mesh__recordOriginator mesh__D017473 PXP
% 217.96/218.12  |- mesh__historyNote mesh__D017473
% 217.96/218.12       94; was RECEPTORS, KAPPA 1993; was KAPPA RECEPTOR %28%NM%29% 1980-92%A%  
% 217.96/218.12  |- skos__hiddenLabel mesh__D017473 Opioid Receptor, kappa
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D017473 2005
% 217.96/218.12  |- mesh__dateCreated mesh__D017473 1992-05-22
% 217.96/218.12  |- skos__historyNote mesh__D017473 Receptors, Endorphin %28%1980-1992%29%
% 217.96/218.12  |- skos__altLabel mesh__D017473 kappa Opioid Receptor
% 217.96/218.12  |- skos__altLabel mesh__D017473 Opioid Receptors, kappa
% 217.96/218.12  |- mesh__recordAuthorizer mesh__D003453 PLS
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D003453 2004
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D003453 2002
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D003453 1997
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D003453 2006
% 217.96/218.12  |- mesh__dateCreated mesh__D003453 1999-01-01
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D003453 1999
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D003453 2003
% 217.96/218.12  |- skos__broader mesh__D003453smesh__D009181
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D003453 2001
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D003453 1996
% 217.96/218.12  |- mesh__recordMaintainer mesh__D003453 TAP
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D003453 2005
% 217.96/218.12  |- skos__annotation mesh__D003453 fungus dis   
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D003453 1995
% 217.96/218.12  |- mesh__dateRevised mesh__D003453 1993-06-02
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D003453 1998
% 217.96/218.12  |- skos__prefLabel mesh__D003453 Cryptococcosis
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D003453 1994
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D003453 2000
% 217.96/218.12  |- skos__hiddenLabel mesh__D003453 Toruloses
% 217.96/218.12  |- skos__hiddenLabel mesh__D003453 Cryptococcoses
% 217.96/218.12  |- mesh__recordOriginator mesh__D003453 NLM
% 217.96/218.12  |- skos__altLabel mesh__D003453 Torulosis
% 217.96/218.12  |- rdf__type mesh__D003453sskos__Concept
% 217.96/218.12  |- skos__scopeNote mesh__D003453
% 217.96/218.12       Infection with a fungus of the species CRYPTOCOCCUS NEOFORMANS.%A%    
% 217.96/218.12  |- skos__altLabel mesh__D013881 Melleryl
% 217.96/218.12  |- mesh__recordMaintainer mesh__D013881 ssb
% 217.96/218.12  |- mesh__recordAuthorizer mesh__D013881 sjn
% 217.96/218.12  |- skos__altLabel mesh__D013881 Mellaril
% 217.96/218.12  |- mesh__recordOriginator mesh__D013881 NLM
% 217.96/218.12  |- mesh__dateCreated mesh__D013881 1999-01-01
% 217.96/218.12  |- skos__hiddenLabel mesh__D013881 Hydrochloride, Thioridazine
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D013881 2006
% 217.96/218.12  |- skos__altLabel mesh__D013881 Melleril
% 217.96/218.12  |- mesh__dateRevised mesh__D013881 2005-06-30
% 217.96/218.12  |- rdf__type mesh__D013881sskos__Concept
% 217.96/218.12  |- skos__scopeNote mesh__D013881
% 217.96/218.12       A phenothiazine antipsychotic used in the management of psychoses, including schizophrenia, and in the control of severely disturbed or agitated behavior. It has little antiemetic activity. Thioridazine has a higher incidence of antimuscarinic effects, but a lower incidence of extrapyramidal symptoms, than CHLORPROMAZINE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p618%29%%A%    
% 217.96/218.12  |- skos__broader mesh__D013881smesh__D010640
% 217.96/218.12  |- skos__prefLabel mesh__D013881 Thioridazine
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D013083 2006
% 217.96/218.12  |- skos__scopeNote mesh__D013083
% 217.96/218.12       Passive or active movement of SPERMATOZOA from the testicular SEMINIFEROUS TUBULES through the male reproductive tract as well as within the female reproductive tract.%A%    
% 217.96/218.12  |- skos__broader mesh__D013083smesh__D005306
% 217.96/218.12  |- mesh__recordMaintainer mesh__D013083 lkt
% 217.96/218.12  |- mesh__dateRevised mesh__D013083 2004-07-07
% 217.96/218.12  |- mesh__recordAuthorizer mesh__D013083 sjn
% 217.96/218.12  |- rdf__type mesh__D013083sskos__Concept
% 217.96/218.12  |- mesh__dateEstablished mesh__D013083 1976-01-01
% 217.96/218.12  |- mesh__recordOriginator mesh__D013083 NLM
% 217.96/218.12  |- skos__broader mesh__D013083smesh__D002465
% 217.96/218.12  |- mesh__publicMeSHNote mesh__D013083 76; was see under SPERMATOZOA 1975   
% 217.96/218.12  |- skos__related mesh__D013083smesh__D013081
% 217.96/218.12  |- mesh__historyNote mesh__D013083
% 217.96/218.12       76%28%75%29%; was see under SPERMATOZOA 1975   
% 217.96/218.12  |- skos__hiddenLabel mesh__D013083 Transport, Sperm
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D013083 2005
% 217.96/218.12  |- mesh__dateCreated mesh__D013083 1974-11-11
% 217.96/218.12  |- skos__prefLabel mesh__D013083 Sperm Transport
% 217.96/218.12  |- skos__historyNote mesh__D013083 Spermatozoa %28%1966-1974%29%
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007844 1998
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007844 2004
% 217.96/218.12  |- mesh__recordOriginator mesh__D007844 NLM
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007844 2000
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007844 2006
% 217.96/218.12  |- skos__prefLabel mesh__D007844 Latvia
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007844 2003
% 217.96/218.12  |- mesh__recordAuthorizer mesh__D007844 PLS
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007844 2005
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007844 2002
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007844 1997
% 217.96/218.12  |- rdf__type mesh__D007844sskos__Concept
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007844 1999
% 217.96/218.12  |- mesh__dateCreated mesh__D007844 1999-01-01
% 217.96/218.12  |- mesh__dateRevised mesh__D007844 1994-03-17
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007844 2001
% 217.96/218.12  |- skos__broader mesh__D007844smesh__D001454
% 217.96/218.12  |- mesh__recordMaintainer mesh__D007844 PLS
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007844 1996
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007844 1995
% 217.96/218.12  |- skos__broader mesh__D009206Q000201smesh__D009206
% 217.96/218.12  |- rdf__type mesh__D009206Q000201smesh__CompoundConcept
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007046 2006
% 217.96/218.12  |- skos__hiddenLabel mesh__D007046 Neuroses, Hysterical
% 217.96/218.12  |- mesh__onlineNote mesh__D007046
% 217.96/218.12       use HYSTERIA to search HYSTERICAL NEUROSES 1969-78   
% 217.96/218.12  |- skos__prefLabel mesh__D007046 Hysteria
% 217.96/218.12  |- rdf__type mesh__D007046sskos__Concept
% 217.96/218.12  |- mesh__dateCreated mesh__D007046 1999-01-01
% 217.96/218.12  |- mesh__recordAuthorizer mesh__D007046 sjn
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007046 2000
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007046 2003
% 217.96/218.12  |- mesh__dateRevised mesh__D007046 1999-11-03
% 217.96/218.12  |- skos__broader mesh__D007046smesh__D006677
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007046 2004
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007046 2001
% 217.96/218.12  |- mesh__historyNote mesh__D007046
% 217.96/218.12       HYSTERICAL NEUROSES was see under HYSTERIA 1969-78   
% 217.96/218.12  |- mesh__recordOriginator mesh__D007046 NLM
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007046 2002
% 217.96/218.12  |- mesh__recordMaintainer mesh__D007046 KEV
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007046 2005
% 217.96/218.12  |- skos__scopeNote mesh__D007046
% 217.96/218.12       Historical term for a chronic, but fluctuating, disorder beginning in early life and characterized by recurrent and multiple somatic complaints not apparently due to physical illness. This diagnosis is not used in contemporary practice.%A%    
% 217.96/218.12  |- skos__scopeNote mesh__D045165
% 217.96/218.12       Steroidal compounds related to TESTOSTERONE, the major mammalian male sex hormone. Testosterone congeners include important testosterone precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with androgenic activities.%A%    
% 217.96/218.12  |- skos__broader mesh__D045165smesh__D012739
% 217.96/218.12  |- skos__altLabel mesh__D045165 Androgen Analogues
% 217.96/218.12  |- mesh__recordOriginator mesh__D045165 lkt
% 217.96/218.12  |- skos__hiddenLabel mesh__D045165 Analogues, Androgen
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D045165 2005
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D045165 2004
% 217.96/218.12  |- mesh__historyNote mesh__D045165 2004   
% 217.96/218.12  |- rdf__type mesh__D045165sskos__Concept
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D045165 2006
% 217.96/218.12  |- skos__historyNote mesh__D045165 Androgens %28%1964-2003%29%
% 217.96/218.12  |- mesh__recordAuthorizer mesh__D045165 sjn
% 217.96/218.12  |- mesh__dateCreated mesh__D045165 2003-07-09
% 217.96/218.12  |- skos__altLabel mesh__D045165 Androgen Analogs
% 217.96/218.12  |- mesh__recordMaintainer mesh__D045165 lkt
% 217.96/218.12  |- mesh__publicMeSHNote mesh__D045165
% 217.96/218.12       2004; for ANDROGENS, SYNTHETIC see ANDROGENS, SYNTHETIC 1975-2003%A%  
% 217.96/218.12  |- skos__altLabel mesh__D045165 Synthetic Androgens
% 217.96/218.12  |- mesh__dateEstablished mesh__D045165 2004-01-01
% 217.96/218.12  |- skos__hiddenLabel mesh__D045165 Analogs, Androgen
% 217.96/218.12  |- skos__prefLabel mesh__D045165 Testosterone Congeners
% 217.96/218.12  |- skos__annotation mesh__D045165 GEN or unspecified; prefer specifics   
% 217.96/218.12  |- skos__scopeNote mesh__D031943
% 217.96/218.12       A plant species of the genus CYNARA, family ASTERACEAE. The flower bud is the familiar artichoke eaten as a vegetable.%A%    
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D031943 2005
% 217.96/218.12  |- skos__prefLabel mesh__D031943 Cynara scolymus
% 217.96/218.12  |- skos__broader mesh__D031943smesh__D031942
% 217.96/218.12  |- rdf__type mesh__D031943sskos__Concept
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D031943 2004
% 217.96/218.12  |- mesh__dateCreated mesh__D031943 2002-07-02
% 217.96/218.12  |- mesh__publicMeSHNote mesh__D031943 2003   
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D031943 2003
% 217.96/218.12  |- mesh__historyNote mesh__D031943 2003   
% 217.96/218.12  |- mesh__dateEstablished mesh__D031943 2003-01-01
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D031943 2006
% 217.96/218.12  |- skos__annotation mesh__D031943
% 217.96/218.12       SCOLYMUS genus is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.96/218.12  |- mesh__dateRevised mesh__D017474 2003-07-09
% 217.96/218.12  |- mesh__onlineNote mesh__D017474
% 217.96/218.12       use RECEPTORS, LAMININ %28%NM%29% to search LAMININ RECEPTOR 1983-92%A%  
% 217.96/218.12  |- mesh__dateCreated mesh__D017474 1992-05-22
% 217.96/218.12  |- skos__altLabel mesh__D017474 Laminin Receptor
% 217.96/218.12  |- rdf__type mesh__D017474sskos__Concept
% 217.96/218.12  |- skos__scopeNote mesh__D017474
% 217.96/218.12       Glycoprotein molecules on the surface of cells that react with or bind to laminin whose function allows the binding of epithelial cells to the basement membrane. The molecular weight of this high-affinity receptor is 67 kD.%A%    
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D017474 2004
% 217.96/218.12  |- skos__altLabel mesh__D017474 Laminin Receptors
% 217.96/218.12  |- mesh__recordAuthorizer mesh__D017474 sjn
% 217.96/218.12  |- skos__prefLabel mesh__D017474 Receptors, Laminin
% 217.96/218.12  |- mesh__dateEstablished mesh__D017474 1993-01-01
% 217.96/218.12  |- skos__historyNote mesh__D017474 Receptors, Immunologic %28%1984-1992%29%
% 217.96/218.12  |- mesh__historyNote mesh__D017474
% 217.96/218.12       93; was LAMININ RECEPTOR %28%NM%29% 1983-92   
% 217.96/218.12  |- mesh__recordMaintainer mesh__D017474 jmp
% 217.96/218.12  |- mesh__recordOriginator mesh__D017474 PXP
% 217.96/218.12  |- skos__hiddenLabel mesh__D017474 Receptor, Laminin
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D017474 2005
% 217.96/218.12  |- mesh__publicMeSHNote mesh__D017474
% 217.96/218.12       93; LAMININ RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1984-92 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1983-84%A%  
% 217.96/218.12  |- skos__broader mesh__D017474smesh__D011971
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D017474 2006
% 217.96/218.12  |- skos__historyNote mesh__D017474
% 217.96/218.12       Receptors, Endogenous Substances %28%1983-1984%29%
% 217.96/218.12  |- skos__annotation mesh__D017474 immunol receptors; DF: RECEPT LAMININ   
% 217.96/218.12  |- mesh__dateRevised mesh__D003454 2005-06-30
% 217.96/218.12  |- skos__annotation mesh__D003454 infection = CRYPTOCOCCOSIS   
% 217.96/218.12  |- mesh__recordOriginator mesh__D003454 NLM
% 217.96/218.12  |- mesh__recordMaintainer mesh__D003454 SYSTEM
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D003454 2006
% 217.96/218.12  |- skos__prefLabel mesh__D003454 Cryptococcus
% 217.96/218.12  |- mesh__recordAuthorizer mesh__D003454 sjn
% 217.96/218.12  |- skos__scopeNote mesh__D003454
% 217.96/218.12       A mitosporic Tremellales fungal genus whose species usually have a capsule and do not form pseudomycellium. Teleomorphs include Filobasidiella and Fidobasidium.%A%    
% 217.96/218.12  |- skos__broader mesh__D003454smesh__D003904
% 217.96/218.12  |- rdf__type mesh__D003454sskos__Concept
% 217.96/218.12  |- skos__broader mesh__D003454smesh__D015003
% 217.96/218.12  |- skos__altLabel mesh__D003454 Torula
% 217.96/218.12  |- mesh__dateCreated mesh__D003454 1999-01-01
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D013882 2000
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D013882 1998
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D013882 2005
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D013882 2001
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D013882 1999
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D013882 2006
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D013882 2002
% 217.96/218.12  |- mesh__recordMaintainer mesh__D013882 JRT
% 217.96/218.12  |- mesh__recordOriginator mesh__D013882 NLM
% 217.96/218.12  |- mesh__recordAuthorizer mesh__D013882 PLS
% 217.96/218.12  |- rdf__type mesh__D013882sskos__Concept
% 217.96/218.12  |- mesh__dateRevised mesh__D013882 1995-06-08
% 217.96/218.12  |- skos__prefLabel mesh__D013882 Thiosemicarbazones
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D013882 1996
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D013882 2003
% 217.96/218.12  |- skos__broader mesh__D013882smesh__D013457
% 217.96/218.12  |- skos__annotation mesh__D013882 antituberc agents   
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D013882 1997
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D013882 2004
% 217.96/218.12  |- skos__broader mesh__D013882smesh__D012664
% 217.96/218.12  |- mesh__dateCreated mesh__D013882 1999-01-01
% 217.96/218.12  |- skos__scopeNote mesh__D013084
% 217.96/218.12       Interactive processes between the oocyte %28%OVUM%29% and the sperm %28%SPERMATOZOA%29% including sperm adhesion, ACROSOME REACTION, sperm penetration of the ZONA PELLUCIDA, and events leading to FERTILIZATION.%A%    
% 217.96/218.12  |- skos__altLabel mesh__D013084 Oocyte-Sperm Interactions
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Sperm-Oocyte Penetrations
% 217.96/218.12  |- skos__altLabel mesh__D013084 Sperm-Ovum Penetration
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Sperm-Ovum Interaction
% 217.96/218.12  |- skos__altLabel mesh__D013084 Ovum-Sperm Interactions
% 217.96/218.12  |- skos__altLabel mesh__D013084 Gamete Interactions
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Sperm-Egg Interaction
% 217.96/218.12  |- skos__altLabel mesh__D013084 Sperm-Egg Interactions
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Sperm-Zona Pellucida Penetrations
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Sperm Oocyte Penetration
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Sperm-Oocyte Interaction
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D013084 2006
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Sperm Egg Interactions
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Ovum-Sperm Interaction
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Oocyte Sperm Interactions
% 217.96/218.12  |- skos__altLabel mesh__D013084 Egg-Sperm Interactions
% 217.96/218.12  |- mesh__historyNote mesh__D013084
% 217.96/218.12       85%28%75%29%; was see under FERTILIZATION 1975-84   
% 217.96/218.12  |- skos__altLabel mesh__D013084 Sperm-Egg Penetration
% 217.96/218.12  |- skos__altLabel mesh__D013084 Sperm-Oocyte Interactions
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Sperm-Egg Penetrations
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D013084 2005
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Ovum Sperm Interactions
% 217.96/218.12  |- mesh__dateCreated mesh__D013084 1974-11-11
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Oocyte-Sperm Interaction
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Sperm Ovum Interactions
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Egg Sperm Interactions
% 217.96/218.12  |- skos__altLabel mesh__D013084 Sperm-Oocyte Penetration
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Sperm Penetrations
% 217.96/218.12  |- mesh__dateRevised mesh__D013084 2004-08-02
% 217.96/218.12  |- mesh__dateEstablished mesh__D013084 1985-01-01
% 217.96/218.12  |- mesh__recordMaintainer mesh__D013084 jls
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D013084 2005A
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Sperm Ovum Penetration
% 217.96/218.12  |- mesh__recordAuthorizer mesh__D013084 jls
% 217.96/218.12  |- skos__altLabel mesh__D013084 Sperm Penetration
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Gamete Interaction
% 217.96/218.12  |- rdf__type mesh__D013084sskos__Concept
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Sperm Zona Pellucida Penetration
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Sperm Egg Penetration
% 217.96/218.12  |- skos__broader mesh__D013084smesh__D005306
% 217.96/218.12  |- skos__prefLabel mesh__D013084 Sperm-Ovum Interactions
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Sperm Oocyte Interactions
% 217.96/218.12  |- mesh__recordOriginator mesh__D013084 NLM
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Egg-Sperm Interaction
% 217.96/218.12  |- skos__hiddenLabel mesh__D013084 Sperm-Ovum Penetrations
% 217.96/218.12  |- mesh__publicMeSHNote mesh__D013084
% 217.96/218.12       85; was see under FERTILIZATION 1975-84   
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007845 2003
% 217.96/218.12  |- skos__related mesh__D007845smesh__D014925
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007845 2005
% 217.96/218.12  |- skos__broader mesh__D007845smesh__D009633
% 217.96/218.12  |- mesh__recordOriginator mesh__D007845 NLM
% 217.96/218.12  |- skos__scopeNote mesh__D007845
% 217.96/218.12       An involuntary expression of merriment and pleasure; it includes the patterned motor responses as well as the inarticulate vocalization.%A%    
% 217.96/218.12  |- mesh__dateRevised mesh__D007845 2002-07-03
% 217.96/218.12  |- rdf__type mesh__D007845sskos__Concept
% 217.96/218.12  |- mesh__recordMaintainer mesh__D007845 ssb
% 217.96/218.12  |- skos__related mesh__D007845smesh__D027641
% 217.96/218.12  |- mesh__dateCreated mesh__D007845 1999-01-01
% 217.96/218.12  |- mesh__recordAuthorizer mesh__D007845 sjn
% 217.96/218.12  |- skos__hiddenLabel mesh__D007845 Laughters
% 217.96/218.12  |- skos__broader mesh__D007845smesh__D004644
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007845 2004
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007845 2006
% 217.96/218.12  |- skos__prefLabel mesh__D007845 Laughter
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007047 2002
% 217.96/218.12  |- skos__hiddenLabel mesh__D007047 Salpingographies
% 217.96/218.12  |- mesh__recordOriginator mesh__D007047 NLM
% 217.96/218.12  |- skos__prefLabel mesh__D007047 Hysterosalpingography
% 217.96/218.12  |- rdf__type mesh__D007047sskos__Concept
% 217.96/218.12  |- mesh__dateCreated mesh__D007047 1999-01-01
% 217.96/218.12  |- skos__broader mesh__D007047smesh__D003944
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007047 2003
% 217.96/218.12  |- mesh__recordAuthorizer mesh__D007047 SJN
% 217.96/218.12  |- skos__hiddenLabel mesh__D007047 Hysterosalpingographies
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007047 2004
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007047 1998
% 217.96/218.12  |- skos__broader mesh__D007047smesh__D011859
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007047 2005
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007047 2000
% 217.96/218.12  |- mesh__dateRevised mesh__D007047 1997-06-20
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007047 1999
% 217.96/218.12  |- mesh__recordMaintainer mesh__D007047 PXP
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007047 2001
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D007047 2006
% 217.96/218.12  |- skos__annotation mesh__D007047
% 217.96/218.12       NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: HYSTEROSALPINGOGR%A%  
% 217.96/218.12  |- skos__scopeNote mesh__D007047
% 217.96/218.12       Radiography of the uterus and fallopian tubes after the injection of a contrast medium.%A%    
% 217.96/218.12  |- skos__broader mesh__D026201smesh__D026741
% 217.96/218.12  |- mesh__historyNote mesh__D026201 2002   
% 217.96/218.12  |- skos__annotation mesh__D026201
% 217.96/218.12       general or unspecified; prefer specifics   
% 217.96/218.12  |- skos__hiddenLabel mesh__D026201 Therapies, Manipulative
% 217.96/218.12  |- skos__scopeNote mesh__D026201
% 217.96/218.12       Various manipulations of body tissues, muscles and bones by hands or equipment to improve health and circulation, relieve fatigue, promote healing.%A%    
% 217.96/218.12  |- skos__hiddenLabel mesh__D026201 Manipulation Therapies
% 217.96/218.12  |- skos__altLabel mesh__D026201 Therapy, Manipulation
% 217.96/218.12  |- skos__hiddenLabel mesh__D026201 Manual Therapy
% 217.96/218.12  |- skos__altLabel mesh__D026201 Manipulations, Musculoskeletal
% 217.96/218.12  |- skos__hiddenLabel mesh__D026201 Therapies, Manual
% 217.96/218.12  |- mesh__recordOriginator mesh__D026201 ssb
% 217.96/218.12  |- skos__hiddenLabel mesh__D026201 Manipulative Therapy
% 217.96/218.12  |- mesh__dateRevised mesh__D026201 2005-06-30
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D026201 2006
% 217.96/218.12  |- skos__hiddenLabel mesh__D026201 Therapy, Manual
% 217.96/218.12  |- mesh__dateEstablished mesh__D026201 2002-01-01
% 217.96/218.12  |- skos__prefLabel mesh__D026201 Musculoskeletal Manipulations
% 217.96/218.12  |- mesh__recordMaintainer mesh__D026201 ssb
% 217.96/218.12  |- skos__broader mesh__D026201smesh__D013812
% 217.96/218.12  |- skos__hiddenLabel mesh__D026201 Therapy, Manipulative
% 217.96/218.12  |- mesh__dateCreated mesh__D026201 2001-07-25
% 217.96/218.12  |- skos__altLabel mesh__D026201 Manipulative Therapies
% 217.96/218.12  |- skos__hiddenLabel mesh__D026201 Therapies, Manipulation
% 217.96/218.12  |- mesh__recordAuthorizer mesh__D026201 sjn
% 217.96/218.12  |- mesh__publicMeSHNote mesh__D026201 2002   
% 217.96/218.12  |- skos__broader mesh__D026201smesh__D000529
% 217.96/218.12  |- rdf__type mesh__D026201sskos__Concept
% 217.96/218.12  |- mesh__recordMaintainer mesh__D045166 lkt
% 217.96/218.12  |- skos__hiddenLabel mesh__D045166 Analogues, Estrogen
% 217.96/218.12  |- mesh__recordOriginator mesh__D045166 lkt
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D045166 2005
% 217.96/218.12  |- skos__altLabel mesh__D045166 Synthetic Estrogens
% 217.96/218.12  |- mesh__activeMeSHYear mesh__D045166 2004
% 217.96/218.13  |- rdf__type mesh__D045166sskos__Concept
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D045166 2006
% 217.96/218.13  |- skos__historyNote mesh__D045166 Estrogens %28%1964-2003%29%
% 217.96/218.13  |- mesh__dateCreated mesh__D045166 2003-07-09
% 217.96/218.13  |- mesh__publicMeSHNote mesh__D045166
% 217.96/218.13       2004; for ESTROGENS, SYNTHETIC see ESTROGENS, SYNTHETIC 1975-2003%A%  
% 217.96/218.13  |- skos__annotation mesh__D045166
% 217.96/218.13       GEN or unspecified; prefer specifics; do not confuse with ESTROGENS, CONJUGATED %28%USP%29%%A%  
% 217.96/218.13  |- skos__prefLabel mesh__D045166 Estradiol Congeners
% 217.96/218.13  |- skos__scopeNote mesh__D045166
% 217.96/218.13       Steroidal compounds related to ESTRADIOL, the major mammalian female sex hormone. Estradiol congeners include important estradiol precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with estrogenic activities.%A%    
% 217.96/218.13  |- skos__altLabel mesh__D045166 Estrogen Analogues
% 217.96/218.13  |- mesh__historyNote mesh__D045166 2004   
% 217.96/218.13  |- mesh__recordAuthorizer mesh__D045166 sjn
% 217.96/218.13  |- skos__hiddenLabel mesh__D045166 Analogs, Estrogen
% 217.96/218.13  |- skos__altLabel mesh__D045166 Estrogen Analogs
% 217.96/218.13  |- skos__broader mesh__D045166smesh__D012739
% 217.96/218.13  |- mesh__dateEstablished mesh__D045166 2004-01-01
% 217.96/218.13  |- mesh__historyNote mesh__D031944 2003   
% 217.96/218.13  |- mesh__dateCreated mesh__D031944 2002-07-03
% 217.96/218.13  |- mesh__dateEstablished mesh__D031944 2003-01-01
% 217.96/218.13  |- skos__prefLabel mesh__D031944 Dahlia
% 217.96/218.13  |- rdf__type mesh__D031944sskos__Concept
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D031944 2004
% 217.96/218.13  |- mesh__publicMeSHNote mesh__D031944 2003   
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D031944 2003
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D031944 2006
% 217.96/218.13  |- skos__broader mesh__D031944smesh__D019659
% 217.96/218.13  |- skos__annotation mesh__D031944
% 217.96/218.13       DAHLIA, SEA see COREOPSIS is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.96/218.13  |- skos__scopeNote mesh__D031944
% 217.96/218.13       A plant genus of the family ASTERACEAE that contains antifungal plant defensin.%A%    
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D031944 2005
% 217.96/218.13  |- skos__broader mesh__D013762Q000037smesh__D013762
% 217.96/218.13  |- mesh__preferredCombination mesh__D013762Q000037smesh__D005493
% 217.96/218.13  |- rdf__type mesh__D013762Q000037smesh__CompoundConcept
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D017475 2006A
% 217.96/218.13  |- skos__prefLabel mesh__D017475 Receptors, Nerve Growth Factor
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D017475 2002
% 217.96/218.13  |- mesh__recordAuthorizer mesh__D017475 ags
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D017475 2005
% 217.96/218.13  |- skos__altLabel mesh__D017475 Neurotrophic Factor Receptor
% 217.96/218.13  |- skos__altLabel mesh__D017475 Neurotrophin Receptors
% 217.96/218.13  |- mesh__onlineNote mesh__D017475
% 217.96/218.13       use RECEPTORS, NERVE GROWTH FACTOR %28%NM%29% to search NERVE GROWTH FACTORS RECEPTOR 1980-92%A%  
% 217.96/218.13  |- skos__hiddenLabel mesh__D017475 Receptor, Neurotrophic Factor
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D017475 2006
% 217.96/218.13  |- skos__annotation mesh__D017475
% 217.96/218.13       coord IM with specific nerve growth factor %28%IM%29% but note RECEPTOR, NERVE GROWTH FACTOR and other specifics are available%A%  
% 217.96/218.13  |- skos__hiddenLabel mesh__D017475 Neurotrophic Factor Receptors
% 217.96/218.13  |- skos__altLabel mesh__D017475 Receptors, Neurotrophin
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D017475 2000
% 217.96/218.13  |- mesh__recordOriginator mesh__D017475 PXP
% 217.96/218.13  |- mesh__dateCreated mesh__D017475 1992-05-22
% 217.96/218.13  |- skos__altLabel mesh__D017475 NGF Receptors
% 217.96/218.13  |- mesh__publicMeSHNote mesh__D017475
% 217.96/218.13       93; NERVE GROWTH FACTORS RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1980-92%A%  
% 217.96/218.13  |- mesh__dateEstablished mesh__D017475 1993-01-01
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D017475 2003
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D017475 2001
% 217.96/218.13  |- skos__historyNote mesh__D017475
% 217.96/218.13       Receptors, Endogenous Substances %28%1980-1992%29%
% 217.96/218.13  |- mesh__dateRevised mesh__D017475 2005-07-21
% 217.96/218.13  |- skos__scopeNote mesh__D017475
% 217.96/218.13       Cell surface receptors that bind NERVE GROWTH FACTOR; %28%NGF%29% and a NGF-related family of neurotrophic factors that includes neurotrophins, BRAIN-DERIVED NEUROTROPHIC FACTOR and CILIARY NEUROTROPHIC FACTOR.%A%    
% 217.96/218.13  |- skos__altLabel mesh__D017475 Receptors, NGF
% 217.96/218.13  |- skos__broader mesh__D017475smesh__D017978
% 217.96/218.13  |- skos__altLabel mesh__D017475 Receptors, Neurotrophic Factor
% 217.96/218.13  |- skos__altLabel mesh__D017475 Nerve Growth Factor Receptors
% 217.96/218.13  |- rdf__type mesh__D017475sskos__Concept
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D017475 2004
% 217.96/218.13  |- mesh__recordMaintainer mesh__D017475 ags
% 217.96/218.13  |- mesh__historyNote mesh__D017475
% 217.96/218.13       93; was NERVE GROWTH FACTORS RECEPTOR %28%NM%29% 1980-92   
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D003455 2006
% 217.96/218.13  |- skos__annotation mesh__D003455
% 217.96/218.13       infection = CRYPTOCOCCOSIS %26% do not coord with CRYPTOCOCCUS NEOFORMANS unless particularly discussed%A%  
% 217.96/218.13  |- mesh__dateEstablished mesh__D003455 1991-01-01
% 217.96/218.13  |- mesh__recordMaintainer mesh__D003455 ags
% 217.96/218.13  |- skos__broader mesh__D003455smesh__D003454
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D003455 2006B
% 217.96/218.13  |- mesh__recordAuthorizer mesh__D003455 ags
% 217.96/218.13  |- mesh__recordOriginator mesh__D003455 NLM
% 217.96/218.13  |- mesh__publicMeSHNote mesh__D003455 91; see CRYPTOCOCCUS 1972-90   
% 217.96/218.13  |- mesh__historyNote mesh__D003455 91%28%72%29%   
% 217.96/218.13  |- skos__historyNote mesh__D003455 Cryptococcus %28%1966-1971%29%
% 217.96/218.13  |- rdf__type mesh__D003455sskos__Concept
% 217.96/218.13  |- skos__prefLabel mesh__D003455 Cryptococcus neoformans
% 217.96/218.13  |- skos__scopeNote mesh__D003455
% 217.96/218.13       A species of the fungus Cryptococcus, which causes CRYPTOCOCCOSIS. Its teleomorph is Filobasidiella neoformans.%A%    
% 217.96/218.13  |- mesh__dateCreated mesh__D003455 1999-01-01
% 217.96/218.13  |- mesh__dateRevised mesh__D003455 2005-07-21
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D003455 2006A
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Lorazepam ct-Arzneimittel Brand
% 217.96/218.13  |- skos__broader mesh__D008140smesh__D001570
% 217.96/218.13  |- skos__historyNote mesh__D008140 Benzodiazepinones %28%1974%29%
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D008140 2006
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Lorazepam Novartis Brand
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 ct Arzneimittel Brand of Lorazepam
% 217.96/218.13  |- skos__historyNote mesh__D008140 Chlorobenzenes %28%1974%29%
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Lorazepam neuraxpharm
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Lorazepam Wyeth Brand
% 217.96/218.13  |- mesh__recordAuthorizer mesh__D008140 sjn
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Nu Loraz
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Lorazepam Llorens Brand
% 217.96/218.13  |- skos__altLabel mesh__D008140 ratiopharm Brand of Lorazepam
% 217.96/218.13  |- mesh__dateRevised mesh__D008140 2004-07-07
% 217.96/218.13  |- skos__altLabel mesh__D008140 Dolorgiet Brand of Lorazepam
% 217.96/218.13  |- mesh__dateEstablished mesh__D008140 1984-01-01
% 217.96/218.13  |- rdf__type mesh__D008140sskos__Concept
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Lorazepam ratiopharm
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D008140 2005
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Lorazepam Medical Brand
% 217.96/218.13  |- skos__altLabel mesh__D008140 Wyeth Brand of Lorazepam
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Lorazepam Riemser Brand
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 WY4036
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Lorazepam ratiopharm Brand
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Medical, Lorazepam
% 217.96/218.13  |- mesh__historyNote mesh__D008140
% 217.96/218.13       84%28%75%29%; was see under BENZODIAZEPINE TRANQUILIZERS 1975-83%A%  
% 217.96/218.13  |- skos__altLabel mesh__D008140 Novartis Brand of Lorazepam
% 217.96/218.13  |- mesh__recordMaintainer mesh__D008140 CCR
% 217.96/218.13  |- skos__altLabel mesh__D008140 Apotex Brand of Lorazepam
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 ApoLorazepam
% 217.96/218.13  |- skos__altLabel mesh__D008140 Nu-Pharm Brand of Lorazepam
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Intensol, Lorazepam
% 217.96/218.13  |- skos__altLabel mesh__D008140 ct-Arzneimittel Brand of Lorazepam
% 217.96/218.13  |- skos__altLabel mesh__D008140 Merck dura Brand of Lorazepam
% 217.96/218.13  |- skos__altLabel mesh__D008140 Medical Brand of Lorazepam
% 217.96/218.13  |- skos__altLabel mesh__D008140 Llorens Brand of Lorazepam
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 WY 4036
% 217.96/218.13  |- skos__prefLabel mesh__D008140 Lorazepam
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 NovoLorazem
% 217.96/218.13  |- skos__altLabel mesh__D008140 AHP Brand of Lorazepam
% 217.96/218.13  |- skos__altLabel mesh__D008140 Desitin Brand of Lorazepam
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Lorazepam Desitin Brand
% 217.96/218.13  |- skos__altLabel mesh__D008140 Roxane Brand of Lorazepam
% 217.96/218.13  |- skos__altLabel mesh__D008140 Novopharm Brand of Lorazepam
% 217.96/218.13  |- skos__altLabel mesh__D008140 T%C3%%A9%mesta
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Lorazepam AHP Brand
% 217.96/218.13  |- skos__altLabel mesh__D008140 Baxter Brand of Lorazepam
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Lorazepam Novopharm Brand
% 217.96/218.13  |- skos__altLabel mesh__D008140 Orfidal Wyeth
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Lorazepam Apotex Brand
% 217.96/218.13  |- skos__altLabel mesh__D008140 Riemser Brand of Lorazepam
% 217.96/218.13  |- mesh__publicMeSHNote mesh__D008140
% 217.96/218.13       84; was see under BENZODIAZEPINE TRANQUILIZERS 1975-83   
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Lorazepam Nu-Pharm Brand
% 217.96/218.13  |- mesh__dateCreated mesh__D008140 1974-11-11
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Lorazepam neuraxpharm Brand
% 217.96/218.13  |- skos__altLabel mesh__D008140 Durazolam
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Nu Pharm Brand of Lorazepam
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Lorazepam Roxane Brand
% 217.96/218.13  |- mesh__recordOriginator mesh__D008140 NLM
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Novo Lorazem
% 217.96/218.13  |- skos__altLabel mesh__D008140 Serra Pamies Brand of Lorazepam
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 NuLoraz
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Wyeth, Orfidal
% 217.96/218.13  |- skos__scopeNote mesh__D008140
% 217.96/218.13       A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.%A%    
% 217.96/218.13  |- skos__altLabel mesh__D008140 Medix Brand of Lorazepam
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Lorazepam Medix Brand
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Apo Lorazepam
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Lorazepam Baxter Brand
% 217.96/218.13  |- skos__hiddenLabel mesh__D008140 Lorazepam Dolorgiet Brand
% 217.96/218.13  |- skos__altLabel mesh__D008140 neuraxpharm Brand of Lorazepam
% 217.96/218.13  |- skos__scopeNote mesh__D013883
% 217.96/218.13       One of the CYCLIC PEPTIDES from Streptomyces that is active against gram-positive bacteria. In veterinary medicine, it has been used in mastitis caused by gram-negative organisms and in dermatologic disorders.%A%    
% 217.96/218.13  |- skos__historyNote mesh__D013883 Peptides %28%1971-1974%29%
% 217.96/218.13  |- rdf__type mesh__D013883sskos__Concept
% 217.96/218.13  |- skos__historyNote mesh__D013883 Antibiotics %28%1971-1974%29%
% 217.96/218.13  |- skos__prefLabel mesh__D013883 Thiostrepton
% 217.96/218.13  |- skos__broader mesh__D013883smesh__D010456
% 217.96/218.13  |- mesh__dateRevised mesh__D013883 2004-07-07
% 217.96/218.13  |- mesh__recordMaintainer mesh__D013883 ssb
% 217.96/218.13  |- mesh__recordAuthorizer mesh__D013883 sjn
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D013883 2005
% 217.96/218.13  |- mesh__publicMeSHNote mesh__D013883
% 217.96/218.13       91; was see under ANTIBIOTICS 1975-90   
% 217.96/218.13  |- mesh__dateEstablished mesh__D013883 1991-01-01
% 217.96/218.13  |- mesh__historyNote mesh__D013883
% 217.96/218.13       91%28%75%29%; was see under ANTIBIOTICS 1975-90   
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D013883 2006
% 217.96/218.13  |- mesh__dateCreated mesh__D013883 1974-11-19
% 217.96/218.13  |- mesh__recordOriginator mesh__D013883 NLM
% 217.96/218.13  |- mesh__recordAuthorizer mesh__D013085 sjn
% 217.96/218.13  |- skos__broader mesh__D013085smesh__D005837
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D013085 2006
% 217.96/218.13  |- mesh__recordMaintainer mesh__D013085 lkt
% 217.96/218.13  |- skos__hiddenLabel mesh__D013085 Cord, Spermatic
% 217.96/218.13  |- skos__annotation mesh__D013085
% 217.96/218.13       diseases: coord IM with GENITAL DISEASES, MALE %28%IM%29%   
% 217.96/218.13  |- mesh__recordOriginator mesh__D013085 NLM
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D013085 2005
% 217.96/218.13  |- skos__prefLabel mesh__D013085 Spermatic Cord
% 217.96/218.13  |- mesh__dateRevised mesh__D013085 2004-07-07
% 217.96/218.13  |- skos__altLabel mesh__D013085 Funiculus Spermaticus
% 217.96/218.13  |- rdf__type mesh__D013085sskos__Concept
% 217.96/218.13  |- mesh__dateCreated mesh__D013085 1999-01-01
% 217.96/218.13  |- skos__hiddenLabel mesh__D013085 Cords, Spermatic
% 217.96/218.13  |- skos__hiddenLabel mesh__D013085 Spermatic Cords
% 217.96/218.13  |- skos__scopeNote mesh__D013085
% 217.96/218.13       Either of a pair of tubular structures formed by DUCTUS DEFERENS; ARTERIES; VEINS; LYMPHATIC VESSELS; and nerves. The spermatic cord extends from the deep inguinal ring through the INGUINAL CANAL to the TESTIS in the SCROTUM.%A%    
% 217.96/218.13  |- mesh__dateRevised mesh__D007846 1989-06-14
% 217.96/218.13  |- mesh__dateCreated mesh__D007846 1999-01-01
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D007846 2000
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D007846 1996
% 217.96/218.13  |- skos__prefLabel mesh__D007846 Laundering
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D007846 1990
% 217.96/218.13  |- mesh__recordMaintainer mesh__D007846 TGC
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D007846 1998
% 217.96/218.13  |- skos__hiddenLabel mesh__D007846 Launderings
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D007846 2001
% 217.96/218.13  |- mesh__recordAuthorizer mesh__D007846 PLS
% 217.96/218.13  |- rdf__type mesh__D007846sskos__Concept
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D007846 1997
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D007846 1992
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D007846 1994
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D007846 1999
% 217.96/218.13  |- mesh__recordOriginator mesh__D007846 NLM
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D007846 2003
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D007846 1993
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D007846 2005
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D007846 1995
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D007846 1991
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D007846 2004
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D007846 2002
% 217.96/218.13  |- skos__broader mesh__D007846smesh__D007221
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D007846 2006
% 217.96/218.13  |- skos__annotation mesh__D007846 SPEC: SPEC qualif   
% 217.96/218.13  |- mesh__recordAuthorizer mesh__D007048 sjn
% 217.96/218.13  |- skos__scopeNote mesh__D007048
% 217.96/218.13       A blood group related both to the ABO and P systems that includes several different antigens found in most people on erythrocytes, in milk, and in saliva. The antibodies react only at low temperatures.%A%    
% 217.96/218.13  |- skos__hiddenLabel mesh__D007048 Blood-Group Systems, I
% 217.96/218.13  |- skos__hiddenLabel mesh__D007048 I Blood Group System
% 217.96/218.13  |- mesh__publicMeSHNote mesh__D007048
% 217.96/218.13       91; was see under BLOOD GROUPS 1976-90   
% 217.96/218.13  |- skos__annotation mesh__D007048
% 217.96/218.13       IM; coord with disease /blood %28%IM%29%, not /immunol nor /genet; TN 230%A%  
% 217.96/218.13  |- mesh__recordMaintainer mesh__D007048 ssb
% 217.96/218.13  |- skos__hiddenLabel mesh__D007048 System, I Blood-Group
% 217.96/218.13  |- skos__hiddenLabel mesh__D007048 I Blood-Group Systems
% 217.96/218.13  |- skos__prefLabel mesh__D007048 I Blood-Group System
% 217.96/218.13  |- skos__broader mesh__D007048smesh__D001789
% 217.96/218.13  |- mesh__dateCreated mesh__D007048 1975-07-25
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D007048 2006
% 217.96/218.13  |- mesh__recordOriginator mesh__D007048 SH
% 217.96/218.13  |- skos__hiddenLabel mesh__D007048 Systems, I Blood-Group
% 217.96/218.13  |- skos__hiddenLabel mesh__D007048 Blood-Group System, I
% 217.96/218.13  |- mesh__historyNote mesh__D007048
% 217.96/218.13       91%28%76%29%; was see under BLOOD GROUPS 1976-90   
% 217.96/218.13  |- rdf__type mesh__D007048sskos__Concept
% 217.96/218.13  |- mesh__dateRevised mesh__D007048 2005-06-30
% 217.96/218.13  |- skos__historyNote mesh__D007048 Blood Groups %28%1966-1975%29%
% 217.96/218.13  |- mesh__dateEstablished mesh__D007048 1991-01-01
% 217.96/218.13  |- skos__altLabel mesh__D045167 Progestational Hormone Analogs
% 217.96/218.13  |- skos__altLabel mesh__D045167 Progestagens, Synthetic
% 217.96/218.13  |- skos__altLabel mesh__D045167 Synthetic Progestins
% 217.96/218.13  |- skos__altLabel mesh__D045167 Progestins, Synthetic
% 217.96/218.13  |- mesh__recordAuthorizer mesh__D045167 sjn
% 217.96/218.13  |- skos__altLabel mesh__D045167 Progestogens, Synthetic
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D045167 2004
% 217.96/218.13  |- skos__prefLabel mesh__D045167 Progesterone Congeners
% 217.96/218.13  |- skos__altLabel mesh__D045167 Progestational Hormone Analogues
% 217.96/218.13  |- mesh__recordOriginator mesh__D045167 lkt
% 217.96/218.13  |- mesh__dateCreated mesh__D045167 2003-07-09
% 217.96/218.13  |- rdf__type mesh__D045167sskos__Concept
% 217.96/218.13  |- skos__altLabel mesh__D045167 Progestin Analogs
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D045167 2006
% 217.96/218.13  |- skos__annotation mesh__D045167 GEN or unspecified; prefer specifics   
% 217.96/218.13  |- mesh__recordMaintainer mesh__D045167 lkt
% 217.96/218.13  |- skos__historyNote mesh__D045167
% 217.96/218.13       Progestational Hormones %28%1965-2003%29%
% 217.96/218.13  |- mesh__publicMeSHNote mesh__D045167
% 217.96/218.13       2004; for PROGESTATIONAL HORMONES, SYNTHETIC see PROGESTATIONAL HORMONES, SYNTHETIC 1975-2003%A%  
% 217.96/218.13  |- skos__hiddenLabel mesh__D045167 Synthetic Progestogens
% 217.96/218.13  |- skos__hiddenLabel mesh__D045167 Synthetic Progestagens
% 217.96/218.13  |- skos__scopeNote mesh__D045167
% 217.96/218.13       Steroidal compounds related to PROGESTERONE, the major mammalian progestational hormone. Progesterone congeners include important progesterone precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with progestational activities.%A%    
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D045167 2005
% 217.96/218.13  |- mesh__dateEstablished mesh__D045167 2004-01-01
% 217.96/218.13  |- skos__altLabel mesh__D045167 Progestin Analogues
% 217.96/218.13  |- skos__altLabel mesh__D045167 Synthetic Progestational Hormones
% 217.96/218.13  |- skos__broader mesh__D045167smesh__D012739
% 217.96/218.13  |- mesh__historyNote mesh__D045167 2004   
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D031945 2003
% 217.96/218.13  |- mesh__dateEstablished mesh__D031945 2003-01-01
% 217.96/218.13  |- rdf__type mesh__D031945sskos__Concept
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D031945 2004
% 217.96/218.13  |- mesh__historyNote mesh__D031945 2003   
% 217.96/218.13  |- mesh__publicMeSHNote mesh__D031945 2003   
% 217.96/218.13  |- skos__annotation mesh__D031945
% 217.96/218.13       X ref DAHLIA, SEA: DAHLIA also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D031945 2005
% 217.96/218.13  |- skos__altLabel mesh__D031945 Dahlia, Sea
% 217.96/218.13  |- mesh__dateCreated mesh__D031945 2002-07-03
% 217.96/218.13  |- skos__scopeNote mesh__D031945
% 217.96/218.13       A plant genus of the family ASTERACEAE that contains phenyl propanoids.%A%    
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D031945 2006
% 217.96/218.13  |- skos__broader mesh__D031945smesh__D019659
% 217.96/218.13  |- skos__prefLabel mesh__D031945 Coreopsis
% 217.96/218.13  |- skos__altLabel mesh__D031945 Tickseed
% 217.96/218.13  |- skos__broader mesh__D017476smesh__D018013
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D017476 2005
% 217.96/218.13  |- mesh__historyNote mesh__D017476
% 217.96/218.13       93; was NEUROPEPTIDE Y RECEPTOR %28%NM%29% 1985-92   
% 217.96/218.13  |- skos__annotation mesh__D017476 DF: RECEPT NEUROPEPTIDE Y   
% 217.96/218.13  |- skos__historyNote mesh__D017476 Receptors, Neurohumor %28%1986-1992%29%
% 217.96/218.13  |- mesh__onlineNote mesh__D017476
% 217.96/218.13       use RECEPTORS, NEUROPEPTIDE Y %28%NM%29% to search NEUROPEPTIDE Y RECEPTOR 1985-92%A%  
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D017476 2006
% 217.96/218.13  |- skos__hiddenLabel mesh__D017476 Receptor, Neuropeptide Y
% 217.96/218.13  |- mesh__recordMaintainer mesh__D017476 jmp
% 217.96/218.13  |- mesh__recordOriginator mesh__D017476 PXP
% 217.96/218.13  |- mesh__dateRevised mesh__D017476 2003-07-09
% 217.96/218.13  |- skos__historyNote mesh__D017476
% 217.96/218.13       Receptors, Endogenous Substances %28%1985-1986%29%
% 217.96/218.13  |- skos__altLabel mesh__D017476 Neuropeptide Y Receptors
% 217.96/218.13  |- skos__altLabel mesh__D017476 Neuropeptide Y Receptor
% 217.96/218.13  |- rdf__type mesh__D017476sskos__Concept
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D017476 2004
% 217.96/218.13  |- skos__prefLabel mesh__D017476 Receptors, Neuropeptide Y
% 217.96/218.13  |- mesh__publicMeSHNote mesh__D017476
% 217.96/218.13       93; NEUROPEPTIDE Y RECEPTOR was indexed under RECEPTORS, NEUROHUMOR 1986-92 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1985-86%A%  
% 217.96/218.13  |- mesh__dateCreated mesh__D017476 1992-05-22
% 217.96/218.13  |- mesh__dateEstablished mesh__D017476 1993-01-01
% 217.96/218.13  |- mesh__recordAuthorizer mesh__D017476 sjn
% 217.96/218.13  |- skos__scopeNote mesh__D017476
% 217.96/218.13       Cell surface proteins that bind neuropeptide Y with high affinity and trigger intracellular changes which influence the behavior of cells.%A%    
% 217.96/218.13  |- skos__broader mesh__D017476smesh__D043562
% 217.96/218.13  |- mesh__recordAuthorizer mesh__D003456 sjn
% 217.96/218.13  |- skos__broader mesh__D003456smesh__D014564
% 217.96/218.13  |- mesh__publicMeSHNote mesh__D003456 95; was CRYPTORCHISM 1963-94   
% 217.96/218.13  |- skos__hiddenLabel mesh__D003456 Cryptorchidism, Inguinal
% 217.96/218.13  |- rdf__type mesh__D003456sskos__Concept
% 217.96/218.13  |- skos__hiddenLabel mesh__D003456 Undescended Testes
% 217.96/218.13  |- mesh__dateCreated mesh__D003456 1999-01-01
% 217.96/218.13  |- skos__hiddenLabel mesh__D003456 Cryptorchidism, Bilateral
% 217.96/218.13  |- skos__scopeNote mesh__D003456
% 217.96/218.13       A developmental defect in which a TESTIS or both TESTES failed to descend from high in the ABDOMEN to the bottom of the SCROTUM. Testicular descent is essential to normal SPERMATOGENESIS which requires temperature lower than the BODY TEMPERATURE. Cryptorchidism can be subclassified by the location of the maldescended testis.%A%    
% 217.96/218.13  |- mesh__onlineNote mesh__D003456
% 217.96/218.13       95; use CRYPTORCHIDISM to search CRYPTORCHISM 1966-94   
% 217.96/218.13  |- mesh__recordMaintainer mesh__D003456 lkt
% 217.96/218.13  |- skos__altLabel mesh__D003456 Testes, Undescended
% 217.96/218.13  |- skos__hiddenLabel mesh__D003456 Undescended Testis
% 217.96/218.13  |- mesh__dateRevised mesh__D003456 2005-06-30
% 217.96/218.13  |- skos__prefLabel mesh__D003456 Cryptorchidism
% 217.96/218.13  |- skos__broader mesh__D003456smesh__D013733
% 217.96/218.13  |- mesh__historyNote mesh__D003456 95; was CRYPTORCHISM 1963-94   
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D003456 2006
% 217.96/218.13  |- skos__hiddenLabel mesh__D003456 Cryptorchidism, Abdominal
% 217.96/218.13  |- skos__altLabel mesh__D003456 Cryptorchism
% 217.96/218.13  |- skos__altLabel mesh__D003456 Testis, Undescended
% 217.96/218.13  |- mesh__recordOriginator mesh__D003456 NLM
% 217.96/218.13  |- skos__hiddenLabel mesh__D003456 Cryptorchidism, Unilateral
% 217.96/218.13  |- mesh__recordMaintainer mesh__D008141 PLS
% 217.96/218.13  |- skos__broader mesh__D008141smesh__D013121
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D008141 1996
% 217.96/218.13  |- skos__annotation mesh__D008141
% 217.96/218.13       a type of spinal curvature; disease only; for normal lordosis index under SPINE; for lordosis in animal sex exper use POSTURE + SEX BEHAVIOR, ANIMAL%A%  
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D008141 2000
% 217.96/218.13  |- skos__scopeNote mesh__D008141
% 217.96/218.13       The anterior concavity in the curvature of the lumbar and cervical spine as viewed from the side. The term usually refers to abnormally increased curvature %28%hollow back, saddle back, swayback%29%. It does not include lordosis as normal mating posture in certain animals %28% = POSTURE + SEX BEHAVIOR, ANIMAL%29%.%A%    
% 217.96/218.13  |- mesh__dateCreated mesh__D008141 1999-01-01
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D008141 1998
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D008141 1997
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D008141 2003
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D008141 2001
% 217.96/218.13  |- rdf__type mesh__D008141sskos__Concept
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D008141 2005
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D008141 1999
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D008141 2004
% 217.96/218.13  |- skos__prefLabel mesh__D008141 Lordosis
% 217.96/218.13  |- mesh__dateRevised mesh__D008141 1994-04-11
% 217.96/218.13  |- mesh__recordAuthorizer mesh__D008141 PLS
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D008141 1995
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D008141 2006
% 217.96/218.13  |- mesh__recordOriginator mesh__D008141 NLM
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D008141 2002
% 217.96/218.13  |- rdf__type mesh__D013884sskos__Concept
% 217.96/218.13  |- skos__scopeNote mesh__D013884
% 217.96/218.13       An enzyme that catalyzes the transfer of the planetary sulfur atom of thiosulfate ion to cyanide ion to form thiocyanate ion. EC 2.8.1.1.%A%    
% 217.96/218.13  |- mesh__recordOriginator mesh__D013884 NLM
% 217.96/218.13  |- mesh__publicMeSHNote mesh__D013884
% 217.96/218.13       91; was see under SULFURTRANSFERASES 1975-90   
% 217.96/218.13  |- mesh__dateCreated mesh__D013884 1974-11-19
% 217.96/218.13  |- skos__hiddenLabel mesh__D013884 Cyanide Transsulphurase, Thiosulfate
% 217.96/218.13  |- skos__altLabel mesh__D013884 Thiosulfate Cyanide Transsulphurase
% 217.96/218.13  |- skos__historyNote mesh__D013884 Sulfurtransferases %28%1972-1974%29%
% 217.96/218.13  |- mesh__historyNote mesh__D013884
% 217.96/218.13       91%28%75%29%; was see under SULFURTRANSFERASES 1975-90   
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D013884 2004
% 217.96/218.13  |- skos__altLabel mesh__D013884 Rhodanese
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D013884 2005
% 217.96/218.13  |- skos__altLabel mesh__D013884 Thiosulfate Sulphurtransferase
% 217.96/218.13  |- mesh__dateEstablished mesh__D013884 1991-01-01
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D013884 2006
% 217.96/218.13  |- skos__historyNote mesh__D013884 Cyanides %28%1973-1974%29%
% 217.96/218.13  |- skos__prefLabel mesh__D013884 Thiosulfate Sulfurtransferase
% 217.96/218.13  |- skos__hiddenLabel mesh__D013884 Transsulphurase, Thiosulfate Cyanide
% 217.96/218.13  |- mesh__dateRevised mesh__D013884 2003-07-09
% 217.96/218.13  |- mesh__recordMaintainer mesh__D013884 ssb
% 217.96/218.13  |- skos__hiddenLabel mesh__D013884 Sulphurtransferase, Thiosulfate
% 217.96/218.13  |- skos__hiddenLabel mesh__D013884 Sulfurtransferase, Thiosulfate
% 217.96/218.13  |- mesh__recordAuthorizer mesh__D013884 sjn
% 217.96/218.13  |- skos__broader mesh__D013884smesh__D013466
% 217.96/218.13  |- skos__historyNote mesh__D013884 Thiosulfates %28%1972-1974%29%
% 217.96/218.13  |- skos__hiddenLabel mesh__D013086 Torsions, Testicular
% 217.96/218.13  |- skos__hiddenLabel mesh__D013086 Torsion, Spermatic Cord
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D013086 2003
% 217.96/218.13  |- skos__hiddenLabel mesh__D013086 Spermatic Cord Torsions
% 217.96/218.13  |- mesh__dateRevised mesh__D013086 1994-05-24
% 217.96/218.13  |- mesh__recordAuthorizer mesh__D013086 PLS
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D013086 1995
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D013086 2001
% 217.96/218.13  |- mesh__recordMaintainer mesh__D013086 TGC
% 217.96/218.13  |- mesh__recordOriginator mesh__D013086 NLM
% 217.96/218.13  |- rdf__type mesh__D013086sskos__Concept
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D013086 2000
% 217.96/218.13  |- skos__hiddenLabel mesh__D013086 Torsions, Spermatic Cord
% 217.96/218.13  |- skos__hiddenLabel mesh__D013086 Torsion, Testicular
% 217.96/218.13  |- skos__hiddenLabel mesh__D013086 Testicular Torsions
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D013086 1999
% 217.96/218.13  |- skos__prefLabel mesh__D013086 Spermatic Cord Torsion
% 217.96/218.13  |- skos__altLabel mesh__D013086 Testicular Torsion
% 217.96/218.13  |- mesh__dateCreated mesh__D013086 1999-01-01
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D013086 1998
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D013086 1997
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D013086 2006
% 217.96/218.13  |- skos__broader mesh__D013086smesh__D005832
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D013086 2002
% 217.96/218.13  |- skos__scopeNote mesh__D013086
% 217.96/218.13       Torsion of the spermatic cord caused usually by incomplete attachment of the epididymis to the testis or by inclusion of the cord within the tunica vaginalis. Faulty development of various anatomical components of the testes is also a cause. It occurs most frequently in childhood and adolescence. %28%From Current Medical Information %26% Terminology, 5th ed%29%%A%    
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D013086 1996
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D013086 2005
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D013086 2004
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D007847 2006
% 217.96/218.13  |- skos__hiddenLabel mesh__D007847 Hospital Laundry Services
% 217.96/218.13  |- mesh__dateEstablished mesh__D007847 1980-01-01
% 217.96/218.13  |- mesh__dateRevised mesh__D007847 1995-05-22
% 217.96/218.13  |- skos__altLabel mesh__D007847 Service, Hospital Laundry
% 217.96/218.13  |- mesh__activeMeSHYear mesh__D007847 1996
% 217.96/218.13  |- skos__altLabel mesh__D007847 Hospital Laundry Service
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D007847 2000
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D007847 1998
% 217.96/218.14  |- mesh__dateCreated mesh__D007847 1979-04-11
% 217.96/218.14  |- mesh__recordAuthorizer mesh__D007847 PLS
% 217.96/218.14  |- skos__hiddenLabel mesh__D007847 Services, Hospital Laundry
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D007847 1997
% 217.96/218.14  |- skos__historyNote mesh__D007847 Laundering %28%1966-1979%29%
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D007847 2001
% 217.96/218.14  |- rdf__type mesh__D007847sskos__Concept
% 217.96/218.14  |- skos__annotation mesh__D007847 DF: LAUNDRY SERV HOSP   
% 217.96/218.14  |- skos__related mesh__D007847smesh__D001512
% 217.96/218.14  |- mesh__recordOriginator mesh__D007847 EC
% 217.96/218.14  |- mesh__publicMeSHNote mesh__D007847 80   
% 217.96/218.14  |- mesh__historyNote mesh__D007847 80   
% 217.96/218.14  |- skos__hiddenLabel mesh__D007847 Laundry Services, Hospital
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D007847 1999
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D007847 2003
% 217.96/218.14  |- skos__scopeNote mesh__D007847
% 217.96/218.14       Hospital department which administers all activities pertaining to the hospital laundry service.%A%    
% 217.96/218.14  |- skos__broader mesh__D007847smesh__D006748
% 217.96/218.14  |- mesh__recordMaintainer mesh__D007847 KEV
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D007847 2002
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D007847 2005
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D007847 2004
% 217.96/218.14  |- skos__prefLabel mesh__D007847 Laundry Service, Hospital
% 217.96/218.14  |- mesh__recordMaintainer mesh__D007049 KEV
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D007049 2005
% 217.96/218.14  |- skos__hiddenLabel mesh__D007049 Diseases, Iatrogenic
% 217.96/218.14  |- skos__hiddenLabel mesh__D007049 Disease, Iatrogenic
% 217.96/218.14  |- skos__prefLabel mesh__D007049 Iatrogenic Disease
% 217.96/218.14  |- mesh__recordAuthorizer mesh__D007049 sjn
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D007049 2006
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D007049 2000
% 217.96/218.14  |- skos__scopeNote mesh__D007049
% 217.96/218.14       Any adverse condition in a patient occurring as the result of treatment by a physician, surgeon, or other health professional, especially infections acquired by the patient during the course of treatment.%A%    
% 217.96/218.14  |- skos__related mesh__D007049smesh__D017757
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D007049 2001
% 217.96/218.14  |- skos__hiddenLabel mesh__D007049 Iatrogenic Diseases
% 217.96/218.14  |- rdf__type mesh__D007049sskos__Concept
% 217.96/218.14  |- mesh__dateCreated mesh__D007049 1999-01-01
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D007049 2002
% 217.96/218.14  |- mesh__recordOriginator mesh__D007049 NLM
% 217.96/218.14  |- skos__annotation mesh__D007049
% 217.96/218.14       IM for general or as coord with specific iatrogenic dis; article must discuss dis as iatrogenic: do not routinely index adv eff of drugs or procedures as iatrogenic%A%  
% 217.96/218.14  |- skos__related mesh__D007049smesh__D019300
% 217.96/218.14  |- mesh__dateRevised mesh__D007049 1999-11-08
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D007049 2003
% 217.96/218.14  |- skos__broader mesh__D007049smesh__D020969
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D007049 2004
% 217.96/218.14  |- rdf__type mesh__D031946sskos__Concept
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D031946 2004
% 217.96/218.14  |- mesh__publicMeSHNote mesh__D031946 2003   
% 217.96/218.14  |- skos__scopeNote mesh__D031946
% 217.96/218.14       A plant genus of the family RANUNCULACEAE. Members contain cernuosides and other oleanane and hederagenin saponins.%A%    
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D031946 2005
% 217.96/218.14  |- mesh__dateEstablished mesh__D031946 2003-01-01
% 217.96/218.14  |- skos__prefLabel mesh__D031946 Pulsatilla
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D031946 2006
% 217.96/218.14  |- skos__broader mesh__D031946smesh__D029626
% 217.96/218.14  |- mesh__historyNote mesh__D031946 2003   
% 217.96/218.14  |- skos__altLabel mesh__D031946 Pasqueflower
% 217.96/218.14  |- mesh__dateCreated mesh__D031946 2002-07-03
% 217.96/218.14  |- skos__annotation mesh__D031946
% 217.96/218.14       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D031946 2003
% 217.96/218.14  |- skos__scopeNote mesh__D003457
% 217.96/218.14       Intestinal infection with PROTOZOA of the genus CRYPTOSPORIDIUM. It occurs in both animals and humans. Symptoms include severe DIARRHEA.%A%    
% 217.96/218.14  |- skos__historyNote mesh__D003457 Coccidiosis %28%1966-1984%29%
% 217.96/218.14  |- rdf__type mesh__D003457sskos__Concept
% 217.96/218.14  |- mesh__recordAuthorizer mesh__D003457 sjn
% 217.96/218.14  |- skos__prefLabel mesh__D003457 Cryptosporidiosis
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D003457 2005
% 217.96/218.14  |- mesh__publicMeSHNote mesh__D003457 1985   
% 217.96/218.14  |- skos__broader mesh__D003457smesh__D007411
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D003457 2004
% 217.96/218.14  |- mesh__dateEstablished mesh__D003457 1985-01-01
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D003457 2006
% 217.96/218.14  |- mesh__recordMaintainer mesh__D003457 lkt
% 217.96/218.14  |- skos__broader mesh__D003457smesh__D011529
% 217.96/218.14  |- mesh__historyNote mesh__D003457 1985   
% 217.96/218.14  |- mesh__dateCreated mesh__D003457 1984-04-06
% 217.96/218.14  |- mesh__dateRevised mesh__D003457 2003-07-09
% 217.96/218.14  |- skos__broader mesh__D003457smesh__D003048
% 217.96/218.14  |- mesh__recordOriginator mesh__D003457 EC
% 217.96/218.14  |- skos__hiddenLabel mesh__D003457 Cryptosporidioses
% 217.96/218.14  |- skos__hiddenLabel mesh__D008940 Mitotic Indices
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D008940 2004
% 217.96/218.14  |- skos__broader mesh__D008940smesh__D020732
% 217.96/218.14  |- mesh__dateCreated mesh__D008940 1974-12-12
% 217.96/218.14  |- skos__prefLabel mesh__D008940 Mitotic Index
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D008940 2001
% 217.96/218.14  |- mesh__historyNote mesh__D008940
% 217.96/218.14       91%28%75%29%; was see under MITOSIS 1975-90   
% 217.96/218.14  |- rdf__type mesh__D008940sskos__Concept
% 217.96/218.14  |- skos__scopeNote mesh__D008940
% 217.96/218.14       An expression of the number of mitoses found in a stated number of cells.%A%    
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D008940 2002
% 217.96/218.14  |- mesh__recordAuthorizer mesh__D008940 sjn
% 217.96/218.14  |- skos__hiddenLabel mesh__D008940 Index, Mitotic
% 217.96/218.14  |- mesh__publicMeSHNote mesh__D008940 91; was see under MITOSIS 1975-90   
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D008940 2005
% 217.96/218.14  |- mesh__dateEstablished mesh__D008940 1991-01-01
% 217.96/218.14  |- mesh__recordOriginator mesh__D008940 NLM
% 217.96/218.14  |- mesh__recordMaintainer mesh__D008940 KEV
% 217.96/218.14  |- mesh__dateRevised mesh__D008940 2000-06-22
% 217.96/218.14  |- skos__hiddenLabel mesh__D008940 Indices, Mitotic
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D008940 2003
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D008940 2006
% 217.96/218.14  |- mesh__recordAuthorizer mesh__D008142 sjn
% 217.96/218.14  |- skos__hiddenLabel mesh__D008142 Perodicticus pottos
% 217.96/218.14  |- skos__broader mesh__D008142smesh__D011443
% 217.96/218.14  |- mesh__recordMaintainer mesh__D008142 ags
% 217.96/218.14  |- skos__historyNote mesh__D008142 Prosimii %28%1975-1980%29%
% 217.96/218.14  |- mesh__historyNote mesh__D008142 81; NYCTICEBUS was NYCETIBUS 1981-92   
% 217.96/218.14  |- rdf__type mesh__D008142sskos__Concept
% 217.96/218.14  |- mesh__dateRevised mesh__D008142 2003-07-09
% 217.96/218.14  |- skos__hiddenLabel mesh__D008142 Slow Loris
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D008142 2005
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D008142 2004
% 217.96/218.14  |- skos__scopeNote mesh__D008142
% 217.96/218.14       A family of Primates of the suborder Strepsirhini containing six genera. The family is distributed in parts of Africa, India, Asia, and the Philippines. The six genera are: Arctocebus %28%golden potto%29%, GALAGO %28%bush babies%29%, Loris %28%slender loris%29%, Nycticebus %28%slow loris%29%, and Perodicticus %28%potto%29%. Lorises and pottos are relatively common except for Arctocebus, the golden potto. All are arboreal and nocturnal.%A%    
% 217.96/218.14  |- mesh__recordOriginator mesh__D008142 EC
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D008142 2006
% 217.96/218.14  |- mesh__dateEstablished mesh__D008142 1981-01-01
% 217.96/218.14  |- skos__altLabel mesh__D008142 Perodicticus potto
% 217.96/218.14  |- mesh__publicMeSHNote mesh__D008142
% 217.96/218.14       81; NYCTICEBUS was NYCETIBUS 1981-92   
% 217.96/218.14  |- skos__annotation mesh__D008142 prosimians; IM; qualif permitted   
% 217.96/218.14  |- skos__prefLabel mesh__D008142 Lorisidae
% 217.96/218.14  |- mesh__dateCreated mesh__D008142 1980-05-07
% 217.96/218.14  |- skos__hiddenLabel mesh__D008142 Potto
% 217.96/218.14  |- mesh__recordMaintainer mesh__D013885 TPW
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D013885 1998
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D013885 2005
% 217.96/218.14  |- skos__broader mesh__D013885smesh__D013431
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D013885 2000
% 217.96/218.14  |- skos__scopeNote mesh__D013885
% 217.96/218.14       Inorganic salts of thiosulfuric acid possessing the general formula R2S2O3.%A%    
% 217.96/218.14  |- mesh__recordAuthorizer mesh__D013885 PLS
% 217.96/218.14  |- rdf__type mesh__D013885sskos__Concept
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D013885 1997
% 217.96/218.14  |- mesh__dateCreated mesh__D013885 1999-01-01
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D013885 2004
% 217.96/218.14  |- mesh__recordOriginator mesh__D013885 NLM
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D013885 2003
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D013885 1996
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D013885 1995
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D013885 1994
% 217.96/218.14  |- mesh__dateRevised mesh__D013885 1993-06-28
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D013885 2002
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D013885 1999
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D013885 2006
% 217.96/218.14  |- skos__prefLabel mesh__D013885 Thiosulfates
% 217.96/218.14  |- mesh__activeMeSHYear mesh__D013885 2001
% 217.96/218.14  |- mesh__historyNote mesh__D013087
% 217.96/218.14       85%28%75%29%; was see under SPERMATOZOA 1975-84   
% 217.96/218.14  |- rdf__type mesh__D013087sskos__Concept
% 218.05/218.19  |- skos__historyNote mesh__D013087 Spermatozoa %28%1966-1974%29%
% 218.05/218.19  |- skos__broader mesh__D013087smesh__D013094
% 218.05/218.19  |- mesh__dateEstablished mesh__D013087 1985-01-01
% 218.05/218.19  |- mesh__publicMeSHNote mesh__D013087
% 218.05/218.19       85; was see under SPERMATOZOA 1975-84   
% 218.05/218.19  |- skos__hiddenLabel mesh__D013087 Spermatoblast
% 218.05/218.19  |- mesh__dateCreated mesh__D013087 1974-11-11
% 218.05/218.19  |- skos__prefLabel mesh__D013087 Spermatids
% 218.05/218.19  |- mesh__activeMeSHYear mesh__D013087 2006
% 218.05/218.19  |- skos__altLabel mesh__D013087 Spermatoblasts
% 218.05/218.19  |- mesh__recordMaintainer mesh__D013087 lkt
% 218.05/218.19  |- mesh__activeMeSHYear mesh__D013087 2005
% 218.05/218.19  |- mesh__activeMeSHYear mesh__D013087 2004
% 218.05/218.19  |- mesh__recordAuthorizer mesh__D013087 sjn
% 218.05/218.19  |- mesh__activeMeSHYear mesh__D013087 2003
% 218.05/218.19  |- mesh__recordOriginator mesh__D013087 NLM
% 218.05/218.19  |- skos__scopeNote mesh__D013087
% 218.05/218.19       Male germ cells derived from the haploid secondary SPERMATOCYTES. Without further division, spermatids undergo structural changes and give rise to SPERMATOZOA.%A%    
% 218.05/218.20  |- skos__hiddenLabel mesh__D013087 Spermatid
% 218.05/218.20  |- mesh__dateRevised mesh__D013087 2002-07-03
% 218.05/218.20  |- mesh__dateEstablished mesh__D007848 1991-01-01
% 218.05/218.20  |- mesh__dateRevised mesh__D007848 2003-07-09
% 218.05/218.20  |- mesh__historyNote mesh__D007848
% 218.05/218.20       91%28%75%29%; was see under LAURIC ACIDS 1975-90   
% 218.05/218.20  |- mesh__recordAuthorizer mesh__D007848 sjn
% 218.05/218.20  |- rdf__type mesh__D007848sskos__Concept
% 218.05/218.20  |- mesh__dateCreated mesh__D007848 1974-11-14
% 218.05/218.20  |- skos__altLabel mesh__D007848 Dodecanoates
% 218.05/218.20  |- skos__scopeNote mesh__D007848
% 218.05/218.20       Salts and esters of the 12-carbon saturated monocarboxylic acid--lauric acid.%A%    
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D007848 2005
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D007848 2004
% 218.05/218.20  |- mesh__recordMaintainer mesh__D007848 ssb
% 218.05/218.20  |- skos__prefLabel mesh__D007848 Laurates
% 218.05/218.20  |- mesh__recordOriginator mesh__D007848 NLM
% 218.05/218.20  |- mesh__publicMeSHNote mesh__D007848
% 218.05/218.20       91; was see under LAURIC ACIDS 1975-90   
% 218.05/218.20  |- skos__broader mesh__D007848smesh__D007850
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D007848 2006
% 218.05/218.20  |- skos__historyNote mesh__D007848 Fatty Acids %28%1966-1974%29%
% 218.05/218.20  |- mesh__dateEstablished mesh__D018570 1995-01-01
% 218.05/218.20  |- skos__hiddenLabel mesh__D018570 Risk-Benefit Assessments
% 218.05/218.20  |- skos__broader mesh__D018570smesh__D012306
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D018570 2006
% 218.05/218.20  |- skos__historyNote mesh__D018570 Risk Factors %28%1992-1994%29%
% 218.05/218.20  |- skos__hiddenLabel mesh__D018570 Risk Benefit Assessment
% 218.05/218.20  |- skos__hiddenLabel mesh__D018570 Risk Assessments
% 218.05/218.20  |- skos__broader mesh__D018570smesh__D015991
% 218.05/218.20  |- skos__hiddenLabel mesh__D018570 Assessments, Benefit-Risk
% 218.05/218.20  |- mesh__dateRevised mesh__D018570 2002-07-02
% 218.05/218.20  |- mesh__recordMaintainer mesh__D018570 jrf
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D018570 2005
% 218.05/218.20  |- skos__prefLabel mesh__D018570 Risk Assessment
% 218.05/218.20  |- skos__hiddenLabel mesh__D018570 Benefits and Risks
% 218.05/218.20  |- rdf__type mesh__D018570sskos__Concept
% 218.05/218.20  |- skos__scopeNote mesh__D018570
% 218.05/218.20       The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. %28%Last, Dictionary of Epidemiology, 1988%29%%A%    
% 218.05/218.20  |- mesh__recordAuthorizer mesh__D018570 sjn
% 218.05/218.20  |- skos__hiddenLabel mesh__D018570 Assessments, Risk
% 218.05/218.20  |- skos__hiddenLabel mesh__D018570 Assessment, Benefit-Risk
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D018570 2004
% 218.05/218.20  |- mesh__publicMeSHNote mesh__D018570 95   
% 218.05/218.20  |- skos__broader mesh__D018570smesh__D012308
% 218.05/218.20  |- skos__hiddenLabel mesh__D018570 Assessment, Risk-Benefit
% 218.05/218.20  |- skos__hiddenLabel mesh__D018570 Benefit-Risk Assessments
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D018570 2003
% 218.05/218.20  |- skos__altLabel mesh__D018570 Assessment, Risk
% 218.05/218.20  |- skos__hiddenLabel mesh__D018570 Benefit Risk Assessment
% 218.05/218.20  |- mesh__dateCreated mesh__D018570 1994-06-01
% 218.05/218.20  |- skos__hiddenLabel mesh__D018570 Assessments, Risk-Benefit
% 218.05/218.20  |- mesh__historyNote mesh__D018570 95   
% 218.05/218.20  |- mesh__recordOriginator mesh__D018570 JLS
% 218.05/218.20  |- skos__altLabel mesh__D018570 Risk-Benefit Assessment
% 218.05/218.20  |- skos__annotation mesh__D018570
% 218.05/218.20       coord NIM with specific disease or other concept %28%IM%29%; DF: RISK ASSESS%A%  
% 218.05/218.20  |- rdf__type mesh__D032241sskos__Concept
% 218.05/218.20  |- mesh__historyNote mesh__D032241 2003   
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D032241 2003
% 218.05/218.20  |- mesh__dateEstablished mesh__D032241 2003-01-01
% 218.05/218.20  |- skos__broader mesh__D032241smesh__D028083
% 218.05/218.20  |- mesh__dateCreated mesh__D032241 2002-07-03
% 218.05/218.20  |- skos__altLabel mesh__D032241 Monkeyflower
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D032241 2006
% 218.05/218.20  |- skos__annotation mesh__D032241
% 218.05/218.20       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D032241 2005
% 218.05/218.20  |- skos__prefLabel mesh__D032241 Mimulus
% 218.05/218.20  |- skos__scopeNote mesh__D032241
% 218.05/218.20       A plant genus of the family SCROPHULARIACEAE. Members contain 6-geranylflavanones and mimulone.%A%    
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D032241 2004
% 218.05/218.20  |- mesh__publicMeSHNote mesh__D032241 2003   
% 218.05/218.20  |- mesh__recordOriginator mesh__D004550 NLM
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D004550 2004
% 218.05/218.20  |- skos__related mesh__D004550smesh__D013716
% 218.05/218.20  |- rdf__type mesh__D004550sskos__Concept
% 218.05/218.20  |- mesh__dateCreated mesh__D004550 1999-01-01
% 218.05/218.20  |- mesh__recordMaintainer mesh__D004550 TPW
% 218.05/218.20  |- skos__broader mesh__D004550smesh__D034941
% 218.05/218.20  |- mesh__dateRevised mesh__D004550 2002-07-03
% 218.05/218.20  |- skos__hiddenLabel mesh__D004550 Elbows
% 218.05/218.20  |- mesh__recordAuthorizer mesh__D004550 sjn
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D004550 2005
% 218.05/218.20  |- skos__prefLabel mesh__D004550 Elbow
% 218.05/218.20  |- skos__annotation mesh__D004550
% 218.05/218.20       primates only; TN 238: differentiation from ELBOW JOINT %26% indexing instructions; TN 117: use FORELIMB for non-primate vertebrates%A%  
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D004550 2003
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D004550 2006
% 218.05/218.20  |- skos__broader mesh__D045169smesh__D018352
% 218.05/218.20  |- mesh__dateCreated mesh__D045169 2003-03-24
% 218.05/218.20  |- mesh__recordMaintainer mesh__D045169 ags
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D045169 2005
% 218.05/218.20  |- mesh__historyNote mesh__D045169 2003   
% 218.05/218.20  |- skos__altLabel mesh__D045169 Respiratory Syndrome, Severe Acute
% 218.05/218.20  |- mesh__recordOriginator mesh__D045169 ags
% 218.05/218.20  |- mesh__dateEstablished mesh__D045169 2003-03-24
% 218.05/218.20  |- skos__altLabel mesh__D045169 Respiratory Syndrome, Acute, Severe
% 218.05/218.20  |- mesh__publicMeSHNote mesh__D045169 2003   
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D045169 2004
% 218.05/218.20  |- skos__annotation mesh__D045169
% 218.05/218.20       do not confuse with RESPIRATORY DISTRESS SYNDROME, NEWBORN or RESPIRATORY DISTRESS SYNDROME, ADULT; do not confuse abbreviation, SARS, with SAR used for STRUCTURE-ACTIVITY RELATIONSHIP or scaffold attachment regions %28%genetics%29% use BASE SEQUENCE.%A%  
% 218.05/218.20  |- mesh__dateRevised mesh__D045169 2003-07-09
% 218.05/218.20  |- mesh__recordAuthorizer mesh__D045169 sjn
% 218.05/218.20  |- skos__prefLabel mesh__D045169 Severe Acute Respiratory Syndrome
% 218.05/218.20  |- rdf__type mesh__D045169sskos__Concept
% 218.05/218.20  |- skos__broader mesh__D045169smesh__D012141
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D045169 2006
% 218.05/218.20  |- skos__scopeNote mesh__D045169
% 218.05/218.20       A viral disorder characterized by high FEVER, dry COUGH, shortness of breath %28%DYSPNEA%29% or breathing difficulties, and atypical PNEUMONIA. A virus in the genus CORONAVIRUS is the suspected agent.%A%    
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D031947 2006
% 218.05/218.20  |- mesh__dateCreated mesh__D031947 2002-07-03
% 218.05/218.20  |- skos__broader mesh__D031947smesh__D029626
% 218.05/218.20  |- mesh__recordMaintainer mesh__D031947 jls
% 218.05/218.20  |- mesh__recordAuthorizer mesh__D031947 jls
% 218.05/218.20  |- skos__scopeNote mesh__D031947
% 218.05/218.20       A plant genus of the family RANUNCULACEAE that contains protoanemonin, anemonin, and ranunculin.%A%    
% 218.05/218.20  |- mesh__recordOriginator mesh__D031947 ssb
% 218.05/218.20  |- skos__annotation mesh__D031947
% 218.05/218.20       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.05/218.20  |- skos__prefLabel mesh__D031947 Ranunculus
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D031947 2003
% 218.05/218.20  |- mesh__dateRevised mesh__D031947 2004-08-02
% 218.05/218.20  |- rdf__type mesh__D031947sskos__Concept
% 218.05/218.20  |- mesh__dateEstablished mesh__D031947 2003-01-01
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D031947 2004
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D031947 2005A
% 218.05/218.20  |- mesh__publicMeSHNote mesh__D031947 2003   
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D031947 2005
% 218.05/218.20  |- mesh__historyNote mesh__D031947 2003   
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D017478 2000
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D017478 1998
% 218.05/218.20  |- mesh__recordMaintainer mesh__D017478 NDW
% 218.05/218.20  |- skos__prefLabel mesh__D017478 Receptors, Phencyclidine
% 218.05/218.20  |- skos__scopeNote mesh__D017478
% 218.05/218.20       Specific sites or molecular structures on cell membranes or in cells with which phencyclidine reacts or to which it binds to elicit the specific response of the cell to phencyclidine. Studies have demonstrated the presence of multiple receptor sites for PCP. These are the PCP/sigma site, which binds both PCP and psychotomimetic opiates but not certain antipsychotics, and the PCP site, which selectively binds PCP analogs.%A%    
% 218.05/218.20  |- skos__altLabel mesh__D017478 PCP Receptors
% 218.05/218.20  |- skos__altLabel mesh__D017478 Receptors, PCP
% 218.05/218.20  |- mesh__recordAuthorizer mesh__D017478 SJN
% 218.05/218.20  |- skos__historyNote mesh__D017478 Receptors, Drug %28%1981-1983%29%
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D017478 2006
% 218.05/218.20  |- skos__annotation mesh__D017478 DF: RECEPT PCP   
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D017478 2002
% 218.05/218.20  |- mesh__recordOriginator mesh__D017478 PXP
% 218.05/218.20  |- skos__broader mesh__D017478smesh__D011955
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D017478 2005
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D017478 2004
% 218.05/218.20  |- skos__historyNote mesh__D017478 Receptors, Synaptic %28%1983-1992%29%
% 218.05/218.20  |- skos__altLabel mesh__D017478 Phencylidine Receptor
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D017478 2003
% 218.05/218.20  |- mesh__dateCreated mesh__D017478 1992-05-22
% 218.05/218.20  |- rdf__type mesh__D017478sskos__Concept
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D017478 2001
% 218.05/218.20  |- mesh__publicMeSHNote mesh__D017478
% 218.05/218.20       93; PHENCYCLIDINE RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1983-92 %26% RECEPTORS, DRUG 1981-83%A%  
% 218.05/218.20  |- mesh__onlineNote mesh__D017478
% 218.05/218.20       use RECEPTORS, PHENCYCLIDINE %28%NM%29% to search PHENCYCLIDINE RECEPTOR 1981-92%A%  
% 218.05/218.20  |- skos__altLabel mesh__D017478 PCP Receptor
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D017478 1999
% 218.05/218.20  |- mesh__dateRevised mesh__D017478 1997-06-20
% 218.05/218.20  |- mesh__historyNote mesh__D017478
% 218.05/218.20       93; was PHENCYCLIDINE RECEPTOR %28%NM%29% 1981-92   
% 218.05/218.20  |- skos__hiddenLabel mesh__D017478 Receptor, Phencylidine
% 218.05/218.20  |- skos__altLabel mesh__D017478 Phencyclidine Receptors
% 218.05/218.20  |- mesh__dateEstablished mesh__D017478 1993-01-01
% 218.05/218.20  |- skos__hiddenLabel mesh__D017478 Receptor, PCP
% 218.05/218.20  |- mesh__dateRevised mesh__D003458 2003-07-09
% 218.05/218.20  |- mesh__recordAuthorizer mesh__D003458 sjn
% 218.05/218.20  |- skos__annotation mesh__D003458
% 218.05/218.20       infection = CRYPTOSPORIDIOSIS; /drug eff: consider also COCCIDIOSTATS; coord with specific protozoan terms %28%ANTIGENS, PROTOZOAN, etc%29% if pertinent%A%  
% 218.05/218.20  |- skos__broader mesh__D003458smesh__D021742
% 218.05/218.20  |- skos__historyNote mesh__D003458 Coccidia %28%1975-1984%29%
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D003458 2005
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D003458 2004
% 218.05/218.20  |- mesh__dateEstablished mesh__D003458 1991-01-01
% 218.05/218.20  |- mesh__historyNote mesh__D003458 1991%28%1985%29%   
% 218.05/218.20  |- skos__scopeNote mesh__D003458
% 218.05/218.20       A genus of coccidian parasites of the family CRYPTOSPORIDIIDAE, found in the intestinal epithelium of many vertebrates including humans.%A%    
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D003458 2006
% 218.05/218.20  |- mesh__dateCreated mesh__D003458 1984-04-06
% 218.05/218.20  |- mesh__recordMaintainer mesh__D003458 ags
% 218.05/218.20  |- skos__prefLabel mesh__D003458 Cryptosporidium
% 218.05/218.20  |- mesh__publicMeSHNote mesh__D003458 1991; see COCCIDIA 1985-90   
% 218.05/218.20  |- rdf__type mesh__D003458sskos__Concept
% 218.05/218.20  |- mesh__recordOriginator mesh__D003458 EC
% 218.05/218.20  |- rdf__type mesh__D014180sskos__Concept
% 218.05/218.20  |- skos__related mesh__D014180smesh__D009368
% 218.05/218.20  |- skos__altLabel mesh__D014180 Transplant Recipients
% 218.05/218.20  |- mesh__recordOriginator mesh__D014180 NLM
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D014180 2003
% 218.05/218.20  |- skos__annotation mesh__D014180
% 218.05/218.20       the surg procedure: do not confuse with TRANSPLANTS, the organ, tissue or cell transplanted; GEN %26% unspecified only: prefer /transpl with Category A terms: Manual 19.7+, 19.8.75; available also are several types of technical transpl terms %28%e.g., TRANSPLANTATION, HETEROLOGOUS%29% %26% many organ/transpl %26% tissue/transpl precoords; Manual 26.20+; TN 243; ORGAN TRANSPLANTATION %26% TISSUE TRANSPLANTATION %26% indentions are also available; rejection of transplants is GRAFT REJECTION; DF: TRANSPL%A%  
% 218.05/218.20  |- skos__related mesh__D014180smesh__D019520
% 218.05/218.20  |- skos__related mesh__D014180smesh__D014019
% 218.05/218.20  |- skos__broader mesh__D014180smesh__D013514
% 218.05/218.20  |- skos__related mesh__D014180smesh__D019188
% 218.05/218.20  |- mesh__dateCreated mesh__D014180 1999-01-01
% 218.05/218.20  |- skos__related mesh__D014180smesh__D006650
% 218.05/218.20  |- skos__prefLabel mesh__D014180 Transplantation
% 218.05/218.20  |- skos__hiddenLabel mesh__D014180 Transplantations
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D014180 2006
% 218.05/218.20  |- skos__altLabel mesh__D014180 Transplant Recipient
% 218.05/218.20  |- skos__related mesh__D014180smesh__D016377
% 218.05/218.20  |- mesh__recordAuthorizer mesh__D014180 sjn
% 218.05/218.20  |- skos__scopeNote mesh__D014180
% 218.05/218.20       Transference of a tissue or organ, alive or dead, within an individual, between individuals of the same species, or between individuals of different species.%A%    
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D014180 2005
% 218.05/218.20  |- skos__related mesh__D014180smesh__D018183
% 218.05/218.20  |- skos__related mesh__D014180smesh__D016378
% 218.05/218.20  |- skos__altLabel mesh__D014180 Recipients, Transplant
% 218.05/218.20  |- mesh__recordMaintainer mesh__D014180 lkt
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D014180 2004
% 218.05/218.20  |- mesh__dateRevised mesh__D014180 2002-07-03
% 218.05/218.20  |- skos__related mesh__D008941smesh__D018385
% 218.05/218.20  |- skos__historyNote mesh__D008941 Cell Division %28%1966-1967%29%
% 218.05/218.20  |- mesh__recordAuthorizer mesh__D008941 sjn
% 218.05/218.20  |- mesh__historyNote mesh__D008941 84   
% 218.05/218.20  |- rdf__type mesh__D008941sskos__Concept
% 218.05/218.20  |- skos__altLabel mesh__D008941 Spindle Apparatus, Mitotic
% 218.05/218.20  |- mesh__publicMeSHNote mesh__D008941 84   
% 218.05/218.20  |- skos__hiddenLabel mesh__D008941 Apparatus, Mitotic
% 218.05/218.20  |- mesh__recordOriginator mesh__D008941 AEP
% 218.05/218.20  |- mesh__recordMaintainer mesh__D008941 nns
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D008941 2005
% 218.05/218.20  |- skos__broader mesh__D008941smesh__D003599
% 218.05/218.20  |- skos__scopeNote mesh__D008941
% 218.05/218.20       An organelle consisting of three components: %28%1%29% the astral microtubules, which form around each centrosome and extend to the periphery; %28%2%29% the polar microtubules which extend from one spindle pole to the equator; and %28%3%29% the kinetochore microtubules, which connect the centromeres of the various chromosomes to either centrosome.%A%    
% 218.05/218.20  |- skos__prefLabel mesh__D008941 Mitotic Spindle Apparatus
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D008941 2006
% 218.05/218.20  |- skos__hiddenLabel mesh__D008941 Apparatus, Mitotic Spindle
% 218.05/218.20  |- skos__altLabel mesh__D008941 Mitotic Apparatus
% 218.05/218.20  |- mesh__dateEstablished mesh__D008941 1984-01-01
% 218.05/218.20  |- mesh__dateRevised mesh__D008941 2003-07-09
% 218.05/218.20  |- skos__related mesh__D008941smesh__D018386
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D008941 2004
% 218.05/218.20  |- skos__related mesh__D008941smesh__D008870
% 218.05/218.20  |- mesh__dateCreated mesh__D008941 1983-02-24
% 218.05/218.20  |- skos__annotation mesh__D008941
% 218.05/218.20       A 11 qualif except /cytol; /genet permitted   
% 218.05/218.20  |- skos__historyNote mesh__D008941 Mitosis %28%1968-1983%29%
% 218.05/218.20  |- skos__related mesh__D008941smesh__D002503
% 218.05/218.20  |- skos__historyNote mesh__D000160 Acoustic Nerve %28%1966-1978%29%
% 218.05/218.20  |- skos__historyNote mesh__D000160 Vestibular Nerve %28%1966-1978%29%
% 218.05/218.20  |- skos__hiddenLabel mesh__D000160 Vestibular Nerve Disorder
% 218.05/218.20  |- skos__altLabel mesh__D000160 Vestibular Nerve Disorders
% 218.05/218.20  |- mesh__recordAuthorizer mesh__D000160 sjn
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D000160 2002
% 218.05/218.20  |- skos__broader mesh__D000160smesh__D003389
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D000160 2004
% 218.05/218.20  |- skos__hiddenLabel mesh__D000160 Acoustic Nerve Disease
% 218.05/218.20  |- skos__hiddenLabel mesh__D000160 Vestibulocochlear Nerve Disease
% 218.05/218.20  |- skos__hiddenLabel mesh__D000160 Cochlear Nerve Disorder
% 218.05/218.20  |- mesh__dateRevised mesh__D000160 2001-07-25
% 218.05/218.20  |- skos__scopeNote mesh__D000160
% 218.05/218.20       Diseases of the vestibular and/or cochlear %28%acoustic%29% nerves, which join to form the vestibulocochlear nerve. VESTIBULAR NEURITIS, cochlear neuritis, and acoustic neuromas %28%NEUROMA, ACOUSTIC%29% are relatively common conditions that affect these nerves. Clinical manifestations vary with which nerve is primarily affected, and include hearing loss, vertigo, and tinnitus.%A%    
% 218.05/218.20  |- rdf__type mesh__D000160sskos__Concept
% 218.05/218.20  |- skos__altLabel mesh__D000160 Eighth Cranial Nerve Diseases
% 218.05/218.20  |- skos__altLabel mesh__D000160 Cochlear Nerve Disorders
% 218.05/218.20  |- skos__hiddenLabel mesh__D000160 Cochlear Nerve Disease
% 218.05/218.20  |- mesh__recordOriginator mesh__D000160 RC
% 218.05/218.20  |- skos__related mesh__D000160smesh__D020209
% 218.05/218.20  |- skos__broader mesh__D000160smesh__D012181
% 218.05/218.20  |- skos__prefLabel mesh__D000160 Vestibulocochlear Nerve Diseases
% 218.05/218.20  |- skos__altLabel mesh__D000160 Cranial Nerve VIII Diseases
% 218.05/218.20  |- skos__annotation mesh__D000160
% 218.05/218.20       coord IM with COCHLEAR NERVE %28%IM%29% for cochlear nerve dis or with VESTIBULAR NERVE %28%IM%29% for vestibular nerve dis: neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%; DF: ACOUSTIC NERVE DIS%A%  
% 218.05/218.20  |- mesh__publicMeSHNote mesh__D000160
% 218.05/218.20       2000; see ACOUSTIC NERVE DISEASES 1980-1999, use PERIPHERAL NERVE DISEASES 1979%A%  
% 218.05/218.20  |- mesh__historyNote mesh__D000160 2000%28%1979%29%   
% 218.05/218.20  |- skos__hiddenLabel mesh__D000160 Neuritis, Cochlear
% 218.05/218.20  |- mesh__recordMaintainer mesh__D000160 nns
% 218.05/218.20  |- skos__historyNote mesh__D000160 Cochlear Nerve %28%1966-1978%29%
% 218.05/218.20  |- skos__hiddenLabel mesh__D000160 Cochlear Neuritides
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D000160 2005
% 218.05/218.20  |- skos__altLabel mesh__D000160 Acoustic Nerve Disorders
% 218.05/218.20  |- skos__hiddenLabel mesh__D000160 Acoustic Nerve Disorder
% 218.05/218.20  |- mesh__dateEstablished mesh__D000160 1980-01-01
% 218.05/218.20  |- skos__altLabel mesh__D000160 Cranial Nerve VIII Disorders
% 218.05/218.20  |- skos__hiddenLabel mesh__D000160 Vestibular Nerve Disease
% 218.05/218.20  |- skos__related mesh__D000160smesh__D006313
% 218.05/218.20  |- skos__historyNote mesh__D000160
% 218.05/218.20       Peripheral Nerve Diseases %28%1966-1978%29%
% 218.05/218.20  |- skos__altLabel mesh__D000160 Cochlear Nerve Diseases
% 218.05/218.20  |- mesh__dateCreated mesh__D000160 1978-05-22
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D000160 2006
% 218.05/218.20  |- skos__hiddenLabel mesh__D000160 Neuritides, Cochlear
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D000160 2003
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013886 2000
% 218.05/218.20  |- mesh__recordAuthorizer mesh__D013886 PLS
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013886 1997
% 218.05/218.20  |- mesh__dateCreated mesh__D013886 1999-01-01
% 218.05/218.20  |- rdf__type mesh__D013886sskos__Concept
% 218.05/218.20  |- skos__broader mesh__D013886smesh__D013451
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013886 2005
% 218.05/218.20  |- skos__prefLabel mesh__D013886 Thiosulfonic Acids
% 218.05/218.20  |- mesh__publicMeSHNote mesh__D013886
% 218.05/218.20       91; was see under SULFONIC ACIDS 1975-90   
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013886 1996
% 218.05/218.20  |- mesh__recordOriginator mesh__D013886 NLM
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013886 2004
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013886 2003
% 218.05/218.20  |- skos__hiddenLabel mesh__D013886 Acids, Thiosulfonic
% 218.05/218.20  |- mesh__historyNote mesh__D013886
% 218.05/218.20       91%28%75%29%; was see under SULFONIC ACIDS 1975-90   
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013886 1995
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013886 2002
% 218.05/218.20  |- skos__scopeNote mesh__D013886
% 218.05/218.20       Inorganic or organic oxy acids of sulfur which contain the general formula RS2O2H.%A%    
% 218.05/218.20  |- mesh__dateEstablished mesh__D013886 1991-01-01
% 218.05/218.20  |- mesh__dateRevised mesh__D013886 1993-06-04
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013886 1999
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013886 1994
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013886 2001
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013886 1998
% 218.05/218.20  |- mesh__recordMaintainer mesh__D013886 TPW
% 218.05/218.20  |- mesh__onlineNote mesh__D013886
% 218.05/218.20       use SULFONIC ACIDS to search THIOSULFONIC ACIDS 1968-74   
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013886 2006
% 218.05/218.20  |- mesh__recordOriginator mesh__D013088 NLM
% 218.05/218.20  |- mesh__dateCreated mesh__D013088 1999-01-01
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013088 2000
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013088 1998
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013088 1997
% 218.05/218.20  |- mesh__dateRevised mesh__D013088 1993-06-03
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013088 2006
% 218.05/218.20  |- skos__broader mesh__D013088smesh__D005832
% 218.05/218.20  |- skos__annotation mesh__D013088 epididymis cyst containing sperm   
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013088 1996
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013088 2005
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013088 2004
% 218.05/218.20  |- skos__hiddenLabel mesh__D013088 Spermatoceles
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013088 2002
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013088 2003
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013088 1995
% 218.05/218.20  |- mesh__recordMaintainer mesh__D013088 TAP
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013088 1994
% 218.05/218.20  |- mesh__recordAuthorizer mesh__D013088 PLS
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013088 2001
% 218.05/218.20  |- rdf__type mesh__D013088sskos__Concept
% 218.05/218.20  |- skos__scopeNote mesh__D013088
% 218.05/218.20       A cystic distention of the epididymis or the rete testis containing spermatozoa. %28%Dorland, 27th ed%29%%A%    
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D013088 1999
% 218.05/218.20  |- skos__prefLabel mesh__D013088 Spermatocele
% 218.05/218.20  |- mesh__recordOriginator mesh__D007849 NLM
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D007849 2003
% 218.05/218.20  |- mesh__recordMaintainer mesh__D007849 KEV
% 218.05/218.20  |- skos__broader mesh__D007849smesh__D000015
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D007849 2005
% 218.05/218.20  |- skos__broader mesh__D007849smesh__D007027
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D007849 2004
% 218.05/218.20  |- skos__annotation mesh__D007849
% 218.05/218.20       note X ref: do not confuse with LAURENCE-MOON-BARDET-BIEDL SYNDROME see BARDET-BIEDL SYNDROME%A%  
% 218.05/218.20  |- skos__prefLabel mesh__D007849 Laurence-Moon Syndrome
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D007849 2002
% 218.05/218.20  |- mesh__dateRevised mesh__D007849 1999-11-03
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D007849 2006
% 218.05/218.20  |- mesh__dateCreated mesh__D007849 1999-01-01
% 218.05/218.20  |- mesh__recordAuthorizer mesh__D007849 sjn
% 218.05/218.20  |- skos__altLabel mesh__D007849 Laurence-Moon-Biedl Syndrome
% 218.05/218.20  |- skos__scopeNote mesh__D007849
% 218.05/218.20       An autosomal recessive condition characterized by hypogonadism; spinocerebellar degeneration; MENTAL RETARDATION; RETINITIS PIGMENTOSA; and OBESITY. This syndrome was previously referred to as Laurence-Moon-Biedl syndrome until BARDET-BIEDL SYNDROME was identified as a distinct entity. %28%From N Engl J Med. 1989 Oct 12;321%28%15%29%:1002-9%29%%A%    
% 218.05/218.20  |- rdf__type mesh__D007849sskos__Concept
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D007849 2000
% 218.05/218.20  |- skos__hiddenLabel mesh__D007849 Laurence Moon Biedl Syndrome
% 218.05/218.20  |- mesh__historyNote mesh__D007849 2000 %28%1966%29%   
% 218.05/218.20  |- skos__hiddenLabel mesh__D007849 Syndrome, Laurence-Moon-Biedl
% 218.05/218.20  |- skos__hiddenLabel mesh__D007849 Syndrome, Laurence-Moon
% 218.05/218.20  |- mesh__publicMeSHNote mesh__D007849
% 218.05/218.20       2000; see LAURENCE-MOON-BIEDL SYNDROME 1966-1999   
% 218.05/218.20  |- skos__related mesh__D007849smesh__D008607
% 218.05/218.20  |- skos__hiddenLabel mesh__D007849 Laurence Moon Syndrome
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D007849 2001
% 218.05/218.20  |- mesh__dateCreated mesh__D018571 1994-06-01
% 218.05/218.20  |- skos__scopeNote mesh__D018571
% 218.05/218.20       Monitoring of rate of occurrence of specific conditions to assess the stability or change in health levels of a population. It is also the study of disease rates in a specific cohort, geographic area, population subgroup, etc. to estimate trends in larger population. %28%From Last, Dictionary of Epidemiology, 2d ed%29%%A%    
% 218.05/218.20  |- skos__hiddenLabel mesh__D018571 Sentinel Health Events
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D018571 2005
% 218.05/218.20  |- rdf__type mesh__D018571sskos__Concept
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D018571 2002
% 218.05/218.20  |- skos__hiddenLabel mesh__D018571 Event, Sentinel Health
% 218.05/218.20  |- mesh__dateEstablished mesh__D018571 1995-01-01
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D018571 2004
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D018571 1999
% 218.05/218.20  |- mesh__recordMaintainer mesh__D018571 TAP
% 218.05/218.20  |- skos__hiddenLabel mesh__D018571 Health Events, Sentinel
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D018571 2001
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D018571 2003
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D018571 1998
% 218.05/218.20  |- skos__annotation mesh__D018571 an epidemiol method   
% 218.05/218.20  |- skos__historyNote mesh__D018571
% 218.05/218.20       Population Surveillance %28%1983-1994%29%
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D018571 2000
% 218.05/218.20  |- skos__broader mesh__D018571smesh__D004812
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D018571 1997
% 218.05/218.20  |- skos__hiddenLabel mesh__D018571 Surveillance, Sentinel
% 218.05/218.20  |- mesh__publicMeSHNote mesh__D018571 95   
% 218.05/218.20  |- mesh__recordAuthorizer mesh__D018571 PLS
% 218.05/218.20  |- skos__hiddenLabel mesh__D018571 Surveillances, Sentinel
% 218.05/218.20  |- skos__broader mesh__D018571smesh__D011159
% 218.05/218.20  |- mesh__historyNote mesh__D018571 95   
% 218.05/218.20  |- skos__hiddenLabel mesh__D018571 Sentinel Surveillances
% 218.05/218.20  |- skos__hiddenLabel mesh__D018571 Health Event, Sentinel
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D018571 1996
% 218.05/218.20  |- skos__prefLabel mesh__D018571 Sentinel Surveillance
% 218.05/218.20  |- mesh__dateRevised mesh__D018571 1995-06-08
% 218.05/218.20  |- mesh__recordOriginator mesh__D018571 JLS
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D018571 2006
% 218.05/218.20  |- skos__hiddenLabel mesh__D018571 Events, Sentinel Health
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D004551 2004
% 218.05/218.20  |- mesh__dateCreated mesh__D004551 1999-01-01
% 218.05/218.20  |- skos__hiddenLabel mesh__D004551 Joint, Elbow
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D004551 2006
% 218.05/218.20  |- skos__hiddenLabel mesh__D004551 Elbow Joints
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D004551 2003
% 218.05/218.20  |- mesh__activeMeSHYear mesh__D004551 2005
% 218.05/218.20  |- mesh__dateRevised mesh__D004551 2000-06-22
% 218.05/218.21  |- mesh__publicMeSHNote mesh__D004551 65   
% 218.05/218.21  |- mesh__historyNote mesh__D004551 65   
% 218.05/218.21  |- mesh__recordMaintainer mesh__D004551 jmp
% 218.05/218.21  |- mesh__recordOriginator mesh__D004551 NLM
% 218.05/218.21  |- rdf__type mesh__D004551sskos__Concept
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D004551 2002
% 218.05/218.21  |- skos__scopeNote mesh__D004551
% 218.05/218.21       A hinge joint connecting the FOREARM to the ARM.     
% 218.05/218.21  |- skos__broader mesh__D004551smesh__D007596
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D004551 2001
% 218.05/218.21  |- skos__annotation mesh__D004551
% 218.05/218.21       primates only; TN 238: differentiation from ELBOW %26% indexing instruction; TN 117: use FORELIMB %28%probably IM%29% + JOINTS %28%NIM%29% for non-primate vertebrates%A%  
% 218.05/218.21  |- skos__hiddenLabel mesh__D004551 Joints, Elbow
% 218.05/218.21  |- mesh__dateEstablished mesh__D004551 1965-01-01
% 218.05/218.21  |- mesh__recordAuthorizer mesh__D004551 sjn
% 218.05/218.21  |- skos__prefLabel mesh__D004551 Elbow Joint
% 218.05/218.21  |- skos__broader mesh__D045968smesh__D002335
% 218.05/218.21  |- mesh__dateEstablished mesh__D045968 2005-01-01
% 218.05/218.21  |- mesh__recordOriginator mesh__D045968 ags
% 218.05/218.21  |- skos__prefLabel mesh__D045968 Hyaenidae
% 218.05/218.21  |- mesh__historyNote mesh__D045968 2005; use CARNIVORA 1998-2004   
% 218.05/218.21  |- skos__historyNote mesh__D045968 Carnivora %28%1971-2004%29%
% 218.05/218.21  |- mesh__recordAuthorizer mesh__D045968 sjn
% 218.05/218.21  |- rdf__type mesh__D045968sskos__Concept
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D045968 2006
% 218.05/218.21  |- mesh__recordMaintainer mesh__D045968 ags
% 218.05/218.21  |- skos__hiddenLabel mesh__D045968 Protele
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D045968 2005
% 218.05/218.21  |- skos__hiddenLabel mesh__D045968 Aardwolve
% 218.05/218.21  |- skos__altLabel mesh__D045968 Aardwolves
% 218.05/218.21  |- skos__scopeNote mesh__D045968
% 218.05/218.21       A family of large terrestrial carnivores possessing long legs, coarse guard hairs and a busy tail. It is comprised of hyenas and aardwolves.%A%    
% 218.05/218.21  |- mesh__publicMeSHNote mesh__D045968 2005; see CARNIVORA 1998-2004   
% 218.05/218.21  |- mesh__dateCreated mesh__D045968 2004-07-07
% 218.05/218.21  |- skos__hiddenLabel mesh__D045968 Hyena
% 218.05/218.21  |- mesh__historyNote mesh__D031948 2003   
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D031948 2003
% 218.05/218.21  |- skos__related mesh__D031948smesh__D031884
% 218.05/218.21  |- skos__prefLabel mesh__D031948 Semiaquilegia
% 218.05/218.21  |- rdf__type mesh__D031948sskos__Concept
% 218.05/218.21  |- skos__altLabel mesh__D031948 Tian kui
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D031948 2004
% 218.05/218.21  |- mesh__publicMeSHNote mesh__D031948 2003   
% 218.05/218.21  |- skos__annotation mesh__D031948
% 218.05/218.21       X ref AQUILEGIA ADOXOIDES: AQUILEGIA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D031948 2005
% 218.05/218.21  |- mesh__dateCreated mesh__D031948 2002-07-02
% 218.05/218.21  |- skos__scopeNote mesh__D031948
% 218.05/218.21       A plant genus of the family RANUNCULACEAE that contains griffonilide, lithospermoside, and magnoflorine.%A%    
% 218.05/218.21  |- mesh__dateEstablished mesh__D031948 2003-01-01
% 218.05/218.21  |- skos__altLabel mesh__D031948 Isopyrum adoxoides
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D031948 2006
% 218.05/218.21  |- skos__broader mesh__D031948smesh__D029626
% 218.05/218.21  |- skos__altLabel mesh__D031948 Aquilegia adoxoides
% 218.05/218.21  |- mesh__dateCreated mesh__D017479 1992-05-22
% 218.05/218.21  |- mesh__historyNote mesh__D017479
% 218.05/218.21       93; was PLATELET-DERIVED GROWTH FACTOR RECEPTOR %28%NM%29% 1982-92; PLATELET DERIVED GROWTH FACTOR RECEPTOR-KINASE was NM 1989-92%A%  
% 218.05/218.21  |- skos__hiddenLabel mesh__D017479
% 218.05/218.21       Receptors, Platelet Derived Growth Factor
% 218.05/218.21  |- mesh__dateEstablished mesh__D017479 1993-01-01
% 218.05/218.21  |- skos__historyNote mesh__D017479
% 218.05/218.21       Receptors, Endogenous Substances %28%1982-1992%29%
% 218.05/218.21  |- skos__altLabel mesh__D017479 PDGF Receptor
% 218.05/218.21  |- mesh__recordOriginator mesh__D017479 PXP
% 218.05/218.21  |- mesh__publicMeSHNote mesh__D017479
% 218.05/218.21       93; PLATELET-DERIVED GROWTH FACTOR RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1982-92; PLATELET DERIVED GROWTH FACTOR RECEPTOR-KINASE was indexed under PROTEIN KINASES 1989-92%A%  
% 218.05/218.21  |- skos__annotation mesh__D017479 DF: RECEPT PDGF   
% 218.05/218.21  |- rdf__type mesh__D017479sskos__Concept
% 218.05/218.21  |- skos__altLabel mesh__D017479 Receptors, PDGF
% 218.05/218.21  |- mesh__dateRevised mesh__D017479 2005-06-30
% 218.05/218.21  |- skos__prefLabel mesh__D017479 Receptors, Platelet-Derived Growth Factor
% 218.05/218.21  |- skos__altLabel mesh__D017479 PDGF Receptors
% 218.05/218.21  |- skos__related mesh__D017479smesh__D010982
% 218.05/218.21  |- skos__altLabel mesh__D017479 Platelet-Derived Growth Factor Receptors
% 218.05/218.21  |- skos__broader mesh__D017479smesh__D017978
% 218.05/218.21  |- skos__broader mesh__D017479smesh__D020794
% 218.05/218.21  |- skos__hiddenLabel mesh__D017479 Platelet Derived Growth Factor Receptors
% 218.05/218.21  |- skos__hiddenLabel mesh__D017479 Receptor, PDGF
% 218.05/218.21  |- skos__altLabel mesh__D017479 Platelet-Derived Growth Factor Receptor
% 218.05/218.21  |- skos__scopeNote mesh__D017479
% 218.05/218.21       Specific receptors on cell membranes that react with PLATELET-DERIVED GROWTH FACTOR, its analogs, or antagonists. The alpha PDGF receptor %28%RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA%29% and the beta PDGF receptor %28%RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA%29% are the two principle types of PDGF receptors. Activation of the protein-tyrosine kinase activity of the receptors occurs by ligand-induced dimerization or heterodimerization of PDGF receptor types.%A%    
% 218.05/218.21  |- skos__hiddenLabel mesh__D017479 Platelet Derived Growth Factor Receptor
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D017479 2006
% 218.05/218.21  |- mesh__recordAuthorizer mesh__D017479 sjn
% 218.05/218.21  |- mesh__recordMaintainer mesh__D017479 jmp
% 218.05/218.21  |- skos__altLabel mesh__D003459 Crystallin
% 218.05/218.21  |- mesh__dateEstablished mesh__D003459 1968-01-01
% 218.05/218.21  |- rdf__type mesh__D003459sskos__Concept
% 218.05/218.21  |- skos__hiddenLabel mesh__D003459 Lens Protein, Eye
% 218.05/218.21  |- mesh__recordMaintainer mesh__D003459 SYSTEM
% 218.05/218.21  |- mesh__dateRevised mesh__D003459 2005-06-30
% 218.05/218.21  |- mesh__recordOriginator mesh__D003459 NLM
% 218.05/218.21  |- mesh__publicMeSHNote mesh__D003459 68   
% 218.05/218.21  |- mesh__historyNote mesh__D003459 68%28%64%29%   
% 218.05/218.21  |- mesh__dateCreated mesh__D003459 1999-01-01
% 218.05/218.21  |- mesh__recordAuthorizer mesh__D003459 sjn
% 218.05/218.21  |- skos__broader mesh__D003459smesh__D005136
% 218.05/218.21  |- skos__scopeNote mesh__D003459
% 218.05/218.21       A heterogeneous family of water-soluble structural proteins found in cells of the vertebrate lens. The presence of these proteins accounts for the transparency of the lens. The family is composed of four major groups, alpha, beta, gamma, and delta, and several minor groups, which are classed on the basis of size, charge, immunological properties, and vertebrate source. Alpha, beta, and delta crystallins occur in avian and reptilian lenses, while alpha, beta, and gamma crystallins occur in all other lenses.%A%    
% 218.05/218.21  |- skos__hiddenLabel mesh__D003459 Proteins, Lens
% 218.05/218.21  |- skos__hiddenLabel mesh__D003459 Protein, Eye Lens
% 218.05/218.21  |- skos__prefLabel mesh__D003459 Crystallins
% 218.05/218.21  |- skos__altLabel mesh__D003459 Lens Proteins
% 218.05/218.21  |- skos__annotation mesh__D003459
% 218.05/218.21       not for crystalline lens %28% = LENS, CRYSTALLINE%29%   
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D003459 2006
% 218.05/218.21  |- mesh__recordMaintainer mesh__D014181 JLS
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014181 2001
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014181 1996
% 218.05/218.21  |- mesh__dateEstablished mesh__D014181 1965-01-01
% 218.05/218.21  |- mesh__dateRevised mesh__D014181 1993-06-04
% 218.05/218.21  |- mesh__dateCreated mesh__D014181 1999-01-01
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014181 2000
% 218.05/218.21  |- mesh__historyNote mesh__D014181 65   
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014181 1995
% 218.05/218.21  |- mesh__recordAuthorizer mesh__D014181 PLS
% 218.05/218.21  |- mesh__recordOriginator mesh__D014181 NLM
% 218.05/218.21  |- skos__broader mesh__D014181smesh__D007111
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014181 2006
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014181 1994
% 218.05/218.21  |- skos__altLabel mesh__D014181 Immunology, Transplantation
% 218.05/218.21  |- skos__annotation mesh__D014181 IM; DF: TRANSPL IMMUNOL   
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014181 2005
% 218.05/218.21  |- skos__related mesh__D014181smesh__D006650
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014181 1999
% 218.05/218.21  |- skos__related mesh__D014181smesh__D007165
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014181 2004
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014181 1998
% 218.05/218.21  |- skos__prefLabel mesh__D014181 Transplantation Immunology
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014181 2002
% 218.05/218.21  |- rdf__type mesh__D014181sskos__Concept
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014181 2003
% 218.05/218.21  |- mesh__publicMeSHNote mesh__D014181 65   
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014181 1997
% 218.05/218.21  |- skos__scopeNote mesh__D014181
% 218.05/218.21       A general term for the complex phenomena involved in allo- and xenograft rejection by a host and graft vs host reaction. Although the reactions involved in transplantation immunology are primarily thymus-dependent phenomena of cellular immunity, humoral factors also play a part in late rejection.%A%    
% 218.05/218.21  |- skos__altLabel mesh__D008942 DHAQ
% 218.05/218.21  |- skos__hiddenLabel mesh__D008942 CL232325
% 218.05/218.21  |- rdf__type mesh__D008942sskos__Concept
% 218.05/218.21  |- skos__hiddenLabel mesh__D008942 NSC 301739D
% 218.05/218.21  |- mesh__dateCreated mesh__D008942 1986-06-03
% 218.05/218.21  |- mesh__publicMeSHNote mesh__D008942 87   
% 218.05/218.21  |- skos__hiddenLabel mesh__D008942 Acetate, Mitoxantrone
% 218.05/218.21  |- skos__hiddenLabel mesh__D008942 NSC 301739
% 218.05/218.21  |- skos__hiddenLabel mesh__D008942 NSC287836
% 218.05/218.21  |- skos__prefLabel mesh__D008942 Mitoxantrone
% 218.05/218.21  |- skos__altLabel mesh__D008942 Wyeth Brand of Mitoxantrone Hydrochloride
% 218.05/218.21  |- mesh__dateEstablished mesh__D008942 1987-01-01
% 218.05/218.21  |- skos__broader mesh__D008942smesh__D000880
% 218.05/218.21  |- skos__altLabel mesh__D008942 AHP Brand of Mitoxantrone Hydrochloride
% 218.05/218.21  |- skos__hiddenLabel mesh__D008942 NSC301739
% 218.05/218.21  |- mesh__recordMaintainer mesh__D008942 CCR
% 218.05/218.21  |- skos__altLabel mesh__D008942 Ralenova
% 218.05/218.21  |- skos__hiddenLabel mesh__D008942 CL 232325
% 218.05/218.21  |- skos__hiddenLabel mesh__D008942 NSC279836
% 218.05/218.21  |- skos__altLabel mesh__D008942
% 218.05/218.21       ASTA Medica Brand of Mitoxantrone Hydrochloride
% 218.05/218.21  |- skos__hiddenLabel mesh__D008942 NSC 287836
% 218.05/218.21  |- skos__historyNote mesh__D008942 Anthraquinones %28%1966-1986%29%
% 218.05/218.21  |- skos__hiddenLabel mesh__D008942 Hydrochloride, Mitoxantrone
% 218.05/218.21  |- skos__hiddenLabel mesh__D008942 NSC 279836
% 218.05/218.21  |- mesh__recordAuthorizer mesh__D008942 sjn
% 218.05/218.21  |- skos__altLabel mesh__D008942
% 218.05/218.21       Columbia Brand of Mitoxantrone Hydrochloride
% 218.05/218.21  |- mesh__dateRevised mesh__D008942 2005-06-30
% 218.05/218.21  |- skos__altLabel mesh__D008942 Novantron
% 218.05/218.21  |- mesh__recordOriginator mesh__D008942 RLS
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D008942 2006
% 218.05/218.21  |- skos__altLabel mesh__D008942 Amgen Brand of Mitoxantrone Hydrochloride
% 218.05/218.21  |- skos__scopeNote mesh__D008942
% 218.05/218.21       An anthracenedione-derived antineoplastic agent.     
% 218.05/218.21  |- skos__hiddenLabel mesh__D008942 NSC301739D
% 218.05/218.21  |- skos__hiddenLabel mesh__D008942 NSC 299195
% 218.05/218.21  |- skos__altLabel mesh__D008942 Lederle Brand of Mitoxantrone Hydrochloride
% 218.05/218.21  |- skos__hiddenLabel mesh__D008942 NSC299195
% 218.05/218.21  |- skos__altLabel mesh__D008942 Mitozantrone
% 218.05/218.21  |- skos__altLabel mesh__D008942
% 218.05/218.21       Baxter Oncology Brand of Mitoxantrone Hydrochloride
% 218.05/218.21  |- skos__altLabel mesh__D008942 Inibsa Brand of Mitoxantrone Hydrochloride
% 218.05/218.21  |- mesh__historyNote mesh__D008942 87   
% 218.05/218.21  |- skos__scopeNote mesh__D008144
% 218.05/218.21       The perceived attribute of a sound which corresponds to the physical attribute of intensity.%A%    
% 218.05/218.21  |- mesh__recordAuthorizer mesh__D008144 PLS
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D008144 2002
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D008144 1993
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D008144 1996
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D008144 2004
% 218.05/218.21  |- mesh__dateEstablished mesh__D008144 1979-01-01
% 218.05/218.21  |- skos__hiddenLabel mesh__D008144 Loudness Perceptions
% 218.05/218.21  |- rdf__type mesh__D008144sskos__Concept
% 218.05/218.21  |- mesh__publicMeSHNote mesh__D008144 79   
% 218.05/218.21  |- skos__broader mesh__D008144smesh__D001307
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D008144 1999
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D008144 2003
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D008144 1995
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D008144 2001
% 218.05/218.21  |- mesh__recordMaintainer mesh__D008144 TAP
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D008144 1998
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D008144 2006
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D008144 2000
% 218.05/218.21  |- skos__historyNote mesh__D008144 Auditory Threshold %28%1968-1978%29%
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D008144 1994
% 218.05/218.21  |- skos__hiddenLabel mesh__D008144 Perception, Loudness
% 218.05/218.21  |- skos__prefLabel mesh__D008144 Loudness Perception
% 218.05/218.21  |- mesh__dateCreated mesh__D008144 1978-05-22
% 218.05/218.21  |- mesh__historyNote mesh__D008144 79   
% 218.05/218.21  |- skos__historyNote mesh__D008144 Auditory Perception %28%1967-1978%29%
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D008144 2005
% 218.05/218.21  |- mesh__dateRevised mesh__D008144 1992-05-22
% 218.05/218.21  |- skos__hiddenLabel mesh__D008144 Perceptions, Loudness
% 218.05/218.21  |- mesh__recordOriginator mesh__D008144 RC
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D008144 1997
% 218.05/218.21  |- skos__historyNote mesh__D000161 Sound %28%1966-1971%29%
% 218.05/218.21  |- skos__broader mesh__D000161smesh__D013812
% 218.05/218.21  |- rdf__type mesh__D000161sskos__Concept
% 218.05/218.21  |- skos__altLabel mesh__D000161 Auditory Stimulation
% 218.05/218.21  |- mesh__recordMaintainer mesh__D000161 lkt
% 218.05/218.21  |- mesh__publicMeSHNote mesh__D000161 73   
% 218.05/218.21  |- mesh__historyNote mesh__D000161 73%28%72%29%   
% 218.05/218.21  |- skos__broader mesh__D000161smesh__D010812
% 218.05/218.21  |- skos__related mesh__D000161smesh__D005072
% 218.05/218.21  |- mesh__dateRevised mesh__D000161 2005-06-30
% 218.05/218.21  |- mesh__dateEstablished mesh__D000161 1973-01-01
% 218.05/218.21  |- skos__altLabel mesh__D000161 Stimulation, Auditory
% 218.05/218.21  |- mesh__recordOriginator mesh__D000161 NLM
% 218.05/218.21  |- mesh__dateCreated mesh__D000161 1999-01-01
% 218.05/218.21  |- skos__scopeNote mesh__D000161
% 218.05/218.21       Use of sound to elicit a response in the nervous system.%A%    
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D000161 2006
% 218.05/218.21  |- skos__altLabel mesh__D000161 Stimulation, Acoustic
% 218.05/218.21  |- skos__broader mesh__D000161smesh__D026421
% 218.05/218.21  |- skos__prefLabel mesh__D000161 Acoustic Stimulation
% 218.05/218.21  |- skos__related mesh__D000161smesh__D009147
% 218.05/218.21  |- mesh__recordAuthorizer mesh__D000161 sjn
% 218.05/218.21  |- skos__hiddenLabel mesh__D013089 Agents, Spermicidal Contraceptive
% 218.05/218.21  |- skos__hiddenLabel mesh__D013089 Spermatocidal Contraceptive Agents
% 218.05/218.21  |- skos__historyNote mesh__D013089
% 218.05/218.21       Spermatozoa/drug effects %28%1966-1974%29%
% 218.05/218.21  |- skos__altLabel mesh__D013089 Spermatocidal Drugs
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D013089 2006
% 218.05/218.21  |- skos__broader mesh__D013089smesh__D000988
% 218.05/218.21  |- mesh__recordAuthorizer mesh__D013089 sjn
% 218.05/218.21  |- skos__hiddenLabel mesh__D013089 Contraceptive Agents, Spermicidal
% 218.05/218.21  |- skos__altLabel mesh__D013089 Spermicidal Agents
% 218.05/218.21  |- mesh__publicMeSHNote mesh__D013089 75   
% 218.05/218.21  |- mesh__recordOriginator mesh__D013089 NLM
% 218.05/218.21  |- skos__historyNote mesh__D013089 Contraceptive Agents %28%1967-1974%29%
% 218.05/218.21  |- mesh__dateEstablished mesh__D013089 1975-01-01
% 218.05/218.21  |- skos__altLabel mesh__D013089 Spermatocides
% 218.05/218.21  |- skos__hiddenLabel mesh__D013089 Spermicides, Vaginal
% 218.05/218.21  |- skos__hiddenLabel mesh__D013089 Agents, Spermicidal
% 218.05/218.21  |- mesh__dateCreated mesh__D013089 1999-01-01
% 218.05/218.21  |- skos__altLabel mesh__D013089 Contraceptive Agents, Spermatocidal
% 218.05/218.21  |- skos__hiddenLabel mesh__D013089 Drugs, Spermatocidal
% 218.05/218.21  |- skos__hiddenLabel mesh__D013089 Agents, Spermatocidal Contraceptive
% 218.05/218.21  |- skos__broader mesh__D013089smesh__D003271
% 218.05/218.21  |- skos__scopeNote mesh__D013089
% 218.05/218.21       Chemical substances that are destructive to spermatozoa used as topically administered vaginal contraceptives.%A%    
% 218.05/218.21  |- skos__hiddenLabel mesh__D013089 Agents, Spermatocidal
% 218.05/218.21  |- mesh__recordMaintainer mesh__D013089 ssb
% 218.05/218.21  |- rdf__type mesh__D013089sskos__Concept
% 218.05/218.21  |- skos__prefLabel mesh__D013089 Spermatocidal Agents
% 218.05/218.21  |- skos__annotation mesh__D013089 consider also SPERMATOZOA /drug eff   
% 218.05/218.21  |- skos__altLabel mesh__D013089 Spermicidal Contraceptive Agents
% 218.05/218.21  |- mesh__dateRevised mesh__D013089 2005-06-30
% 218.05/218.21  |- mesh__historyNote mesh__D013089 75   
% 218.05/218.21  |- skos__prefLabel mesh__D018572 Disease-Free Survival
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D018572 2003
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D018572 1998
% 218.05/218.21  |- skos__scopeNote mesh__D018572
% 218.05/218.21       Period after successful treatment in which there is no appearance of the symptoms or effects of the disease.%A%    
% 218.05/218.21  |- skos__hiddenLabel mesh__D018572 Progression-Free Survivals
% 218.05/218.21  |- skos__hiddenLabel mesh__D018572 Disease-Free Survivals
% 218.05/218.21  |- skos__hiddenLabel mesh__D018572 Survivals, Progression-Free
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D018572 1997
% 218.05/218.21  |- skos__hiddenLabel mesh__D018572 Survival, Progression-Free
% 218.05/218.21  |- skos__hiddenLabel mesh__D018572 Disease Free Survival
% 218.05/218.21  |- mesh__historyNote mesh__D018572 95   
% 218.05/218.21  |- skos__hiddenLabel mesh__D018572 Survivals, Event-Free
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D018572 1996
% 218.05/218.21  |- mesh__dateEstablished mesh__D018572 1995-01-01
% 218.05/218.21  |- skos__annotation mesh__D018572
% 218.05/218.21       after successful ther; never IM; coord NIM with specific dis /ther or more specific qualif %28%IM%29%; DF: DIS FREE SURVIVAL%A%  
% 218.05/218.21  |- skos__hiddenLabel mesh__D018572 Survivals, Disease-Free
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D018572 2006
% 218.05/218.21  |- skos__historyNote mesh__D018572 Prognosis %28%1980-1994%29%
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D018572 1995
% 218.05/218.21  |- skos__hiddenLabel mesh__D018572 Event-Free Survivals
% 218.05/218.21  |- skos__hiddenLabel mesh__D018572 Event Free Survival
% 218.05/218.21  |- skos__altLabel mesh__D018572 Event-Free Survival
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D018572 2002
% 218.05/218.21  |- skos__hiddenLabel mesh__D018572 Survival, Event-Free
% 218.05/218.21  |- mesh__dateCreated mesh__D018572 1994-04-19
% 218.05/218.21  |- skos__broader mesh__D018572smesh__D011379
% 218.05/218.21  |- skos__broader mesh__D018572smesh__D016019
% 218.05/218.21  |- skos__hiddenLabel mesh__D018572 Survival, Disease Free
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D018572 2005
% 218.05/218.21  |- skos__hiddenLabel mesh__D018572 Progression Free Survival
% 218.05/218.21  |- rdf__type mesh__D018572sskos__Concept
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D018572 2001
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D018572 2004
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D018572 1999
% 218.05/218.21  |- skos__altLabel mesh__D018572 Survival, Disease-Free
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D018572 2000
% 218.05/218.21  |- mesh__publicMeSHNote mesh__D018572 95   
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D004552 2003
% 218.05/218.21  |- mesh__recordAuthorizer mesh__D004552 SJN
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D004552 1999
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D004552 2005
% 218.05/218.21  |- skos__prefLabel mesh__D004552 Elder Abuse
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D004552 2000
% 218.05/218.21  |- mesh__recordOriginator mesh__D004552 EC
% 218.05/218.21  |- skos__broader mesh__D004552smesh__D017579
% 218.05/218.21  |- skos__historyNote mesh__D004552 Violence %28%1968-1983%29%
% 218.05/218.21  |- skos__hiddenLabel mesh__D004552 Abuse, Elder
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D004552 1998
% 218.05/218.21  |- rdf__type mesh__D004552sskos__Concept
% 218.05/218.21  |- skos__hiddenLabel mesh__D004552 Neglect, Elder
% 218.05/218.21  |- mesh__dateRevised mesh__D004552 1997-06-24
% 218.05/218.21  |- skos__scopeNote mesh__D004552
% 218.05/218.21       Emotional, nutritional, or physical maltreatment of the older person generally by family members or by institutional personnel.%A%    
% 218.05/218.21  |- mesh__historyNote mesh__D004552 84   
% 218.05/218.21  |- skos__historyNote mesh__D004552 Aged %28%1966-1983%29%
% 218.05/218.21  |- skos__altLabel mesh__D004552 Aged Abuse
% 218.05/218.21  |- skos__annotation mesh__D004552 check also tag AGED   
% 218.05/218.21  |- mesh__recordMaintainer mesh__D004552 TGC
% 218.05/218.21  |- skos__hiddenLabel mesh__D004552 Abuse, Aged
% 218.05/218.21  |- skos__historyNote mesh__D004552 Crime %28%1968-1983%29%
% 218.05/218.21  |- mesh__publicMeSHNote mesh__D004552 84   
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D004552 2002
% 218.05/218.21  |- mesh__dateCreated mesh__D004552 1983-06-06
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D004552 2004
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D004552 2001
% 218.05/218.21  |- skos__altLabel mesh__D004552 Elder Neglect
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D004552 2006
% 218.05/218.21  |- mesh__dateEstablished mesh__D004552 1984-01-01
% 218.05/218.21  |- skos__hiddenLabel mesh__D045969 Sable
% 218.05/218.21  |- mesh__publicMeSHNote mesh__D045969 2005; see CARNIVORA 1998-2004   
% 218.05/218.21  |- mesh__historyNote mesh__D045969 2005; use CARNIVORA 1998-2004   
% 218.05/218.21  |- skos__hiddenLabel mesh__D045969 Wolverine
% 218.05/218.21  |- rdf__type mesh__D045969sskos__Concept
% 218.05/218.21  |- skos__altLabel mesh__D045969 Wolverines
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D045969 2006
% 218.05/218.21  |- mesh__dateEstablished mesh__D045969 2005-01-01
% 218.05/218.21  |- mesh__recordOriginator mesh__D045969 ags
% 218.05/218.21  |- skos__altLabel mesh__D045969 Martes zibellina
% 218.05/218.21  |- mesh__recordMaintainer mesh__D045969 ags
% 218.05/218.21  |- skos__scopeNote mesh__D045969
% 218.05/218.21       A family of terrestrial carnivores with long, slender bodies, long tails, and anal scent glands. They include badgers, weasels, martens, FERRETS; MINKS; wolverines, polecats, and OTTERS.%A%    
% 218.05/218.21  |- skos__altLabel mesh__D045969 Martens
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D045969 2005
% 218.05/218.21  |- skos__hiddenLabel mesh__D045969 Gulos
% 218.05/218.21  |- mesh__recordAuthorizer mesh__D045969 sjn
% 218.05/218.21  |- skos__historyNote mesh__D045969 Carnivora %28%1967-2004%29%
% 218.05/218.21  |- skos__hiddenLabel mesh__D045969 Marten
% 218.05/218.21  |- mesh__dateCreated mesh__D045969 2004-07-07
% 218.05/218.21  |- skos__hiddenLabel mesh__D045969 Weasel
% 218.05/218.21  |- skos__broader mesh__D045969smesh__D002335
% 218.05/218.21  |- skos__hiddenLabel mesh__D045969 Badger
% 218.05/218.21  |- skos__prefLabel mesh__D045969 Mustelidae
% 218.05/218.21  |- mesh__historyNote mesh__D031949 2003   
% 218.05/218.21  |- skos__prefLabel mesh__D031949 Thalictrum
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D031949 2006
% 218.05/218.21  |- mesh__dateCreated mesh__D031949 2002-07-03
% 218.05/218.21  |- skos__scopeNote mesh__D031949
% 218.05/218.21       A plant genus of the family RANUNCULACEAE. Members contain isoquinoline alkaloids and triterpene glycosides.%A%    
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D031949 2005
% 218.05/218.21  |- mesh__dateEstablished mesh__D031949 2003-01-01
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D031949 2004
% 218.05/218.21  |- skos__altLabel mesh__D031949 Meadow Rue
% 218.05/218.21  |- rdf__type mesh__D031949sskos__Concept
% 218.05/218.21  |- skos__annotation mesh__D031949
% 218.05/218.21       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.05/218.21  |- skos__altLabel mesh__D031949 Rue, Meadow
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D031949 2003
% 218.05/218.21  |- mesh__publicMeSHNote mesh__D031949 2003   
% 218.05/218.21  |- skos__broader mesh__D031949smesh__D029626
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014980 1996
% 218.05/218.21  |- mesh__recordAuthorizer mesh__D014980 PLS
% 218.05/218.21  |- mesh__dateRevised mesh__D014980 1993-06-03
% 218.05/218.21  |- skos__scopeNote mesh__D014980
% 218.05/218.21       Unstable isotopes of xenon that decay or disintegrate emitting radiation. Xe atoms with atomic weights 121-123, 125, 127, 133, 135, 137-145 are radioactive xenon isotopes.%A%    
% 218.05/218.21  |- skos__broader mesh__D014980smesh__D014979
% 218.05/218.21  |- mesh__dateEstablished mesh__D014980 1975-09-01
% 218.05/218.21  |- skos__hiddenLabel mesh__D014980 Radioisotopes, Xenon
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014980 1999
% 218.05/218.21  |- skos__historyNote mesh__D014980 Radioisotopes %28%1966-1974%29%
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014980 2004
% 218.05/218.21  |- mesh__publicMeSHNote mesh__D014980 75   
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014980 2001
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014980 1995
% 218.05/218.21  |- rdf__type mesh__D014980sskos__Concept
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014980 1998
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014980 2003
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014980 1994
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014980 2000
% 218.05/218.21  |- skos__prefLabel mesh__D014980 Xenon Radioisotopes
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014980 2006
% 218.05/218.21  |- mesh__recordMaintainer mesh__D014980 TPW
% 218.05/218.21  |- mesh__recordOriginator mesh__D014980 NLM
% 218.05/218.21  |- mesh__historyNote mesh__D014980 75   
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014980 2005
% 218.05/218.21  |- skos__annotation mesh__D014980
% 218.05/218.21       Xe-118-123, 125, 127, 133, 135, 137-142; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 218.05/218.21  |- skos__broader mesh__D014980smesh__D011868
% 218.05/218.21  |- skos__historyNote mesh__D014980 Xenon %28%1966-1974%29%
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014980 1997
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014980 2002
% 218.05/218.21  |- mesh__dateCreated mesh__D014980 1974-11-11
% 218.05/218.21  |- skos__scopeNote mesh__D014182
% 218.05/218.21       Transplantation from another site in or on the body of the individual receiving it.%A%    
% 218.05/218.21  |- skos__altLabel mesh__D014182 Autotransplant
% 218.05/218.21  |- skos__annotation mesh__D014182
% 218.05/218.21       transpl in or on same body; NIM if at all: TN 243; no qualif when NIM coord; when IM, qualif permitted; Manual 19.8.75; for skin or musc flaps in plastic surg index under SKIN TRANSPLANTATION or SURGICAL FLAPS %26% not also here; DF: TRANSPL AUTOL%A%  
% 218.05/218.21  |- skos__altLabel mesh__D014182 Autologous Transplantation
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014182 2005
% 218.05/218.21  |- mesh__recordAuthorizer mesh__D014182 sjn
% 218.05/218.21  |- skos__hiddenLabel mesh__D014182 Autologous Transplantations
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014182 2006
% 218.05/218.21  |- skos__broader mesh__D014182smesh__D014180
% 218.05/218.21  |- skos__hiddenLabel mesh__D014182 Transplantations, Autologous
% 218.05/218.21  |- skos__hiddenLabel mesh__D014182 Autotransplants
% 218.05/218.21  |- skos__prefLabel mesh__D014182 Transplantation, Autologous
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014182 2003
% 218.05/218.21  |- mesh__activeMeSHYear mesh__D014182 2004
% 218.05/218.22  |- mesh__dateEstablished mesh__D014182 1965-01-01
% 218.05/218.22  |- mesh__dateRevised mesh__D014182 2002-07-02
% 218.05/218.22  |- mesh__recordOriginator mesh__D014182 NLM
% 218.05/218.22  |- mesh__dateCreated mesh__D014182 1999-01-01
% 218.05/218.22  |- mesh__recordMaintainer mesh__D014182 lkt
% 218.05/218.22  |- skos__hiddenLabel mesh__D014182 Autografts
% 218.05/218.22  |- mesh__historyNote mesh__D014182 65   
% 218.05/218.22  |- rdf__type mesh__D014182sskos__Concept
% 218.05/218.22  |- skos__altLabel mesh__D014182 Autograft
% 218.05/218.22  |- mesh__publicMeSHNote mesh__D014182 65   
% 218.05/218.22  |- rdf__type mesh__D008943sskos__Concept
% 218.05/218.22  |- mesh__recordMaintainer mesh__D008943 TGC
% 218.05/218.22  |- skos__hiddenLabel mesh__D008943 Valve, Mitral
% 218.05/218.22  |- mesh__recordAuthorizer mesh__D008943 SJN
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008943 2001
% 218.05/218.22  |- skos__altLabel mesh__D008943 Bicuspid Valve
% 218.05/218.22  |- skos__scopeNote mesh__D008943
% 218.05/218.22       The valve between the left atrium and left ventricle of the heart.%A%    
% 218.05/218.22  |- skos__hiddenLabel mesh__D008943 Valves, Bicuspid
% 218.05/218.22  |- skos__hiddenLabel mesh__D008943 Bicuspid Valves
% 218.05/218.22  |- skos__hiddenLabel mesh__D008943 Valve, Bicuspid
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008943 1999
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008943 2000
% 218.05/218.22  |- skos__hiddenLabel mesh__D008943 Valves, Mitral
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008943 2004
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008943 1998
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008943 2006
% 218.05/218.22  |- mesh__dateRevised mesh__D008943 1997-06-20
% 218.05/218.22  |- skos__hiddenLabel mesh__D008943 Mitral Valves
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008943 2003
% 218.05/218.22  |- skos__prefLabel mesh__D008943 Mitral Valve
% 218.05/218.22  |- skos__broader mesh__D008943smesh__D006351
% 218.05/218.22  |- mesh__dateCreated mesh__D008943 1999-01-01
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008943 2005
% 218.05/218.22  |- skos__annotation mesh__D008943 atresia: index MITRAL VALVE /abnorm   
% 218.05/218.22  |- mesh__recordOriginator mesh__D008943 NLM
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008943 2002
% 218.05/218.22  |- mesh__recordOriginator mesh__D000960 NLM
% 218.05/218.22  |- skos__broader mesh__D000960smesh__D000963
% 218.05/218.22  |- skos__broader mesh__D000960smesh__D045506
% 218.05/218.22  |- skos__hiddenLabel mesh__D000960 Agents, Antilipemic
% 218.05/218.22  |- mesh__recordAuthorizer mesh__D000960 sjn
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D000960 2006
% 218.05/218.22  |- skos__prefLabel mesh__D000960 Antilipemic Agents
% 218.05/218.22  |- mesh__dateRevised mesh__D000960 2003-07-09
% 218.05/218.22  |- skos__altLabel mesh__D000960 Antilipemics
% 218.05/218.22  |- mesh__recordMaintainer mesh__D000960 ssb
% 218.05/218.22  |- rdf__type mesh__D000960sskos__Concept
% 218.05/218.22  |- mesh__historyNote mesh__D000960 72%28%66%29%   
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D000960 2004
% 218.05/218.22  |- skos__hiddenLabel mesh__D000960 Agents, Hypolipidemic
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D000960 2005
% 218.05/218.22  |- mesh__dateEstablished mesh__D000960 1972-01-01
% 218.05/218.22  |- skos__altLabel mesh__D000960 Antilipemic Drugs
% 218.05/218.22  |- skos__altLabel mesh__D000960 Antihyperlipidemics
% 218.05/218.22  |- skos__hiddenLabel mesh__D000960 Drugs, Antilipemic
% 218.05/218.22  |- mesh__publicMeSHNote mesh__D000960 72   
% 218.05/218.22  |- skos__scopeNote mesh__D000960
% 218.05/218.22       Substances used to treat HYPERLIPIDEMIA.     
% 218.05/218.22  |- mesh__dateCreated mesh__D000960 1999-01-01
% 218.05/218.22  |- skos__altLabel mesh__D000960 Antihyperlipemics
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008145 2003
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008145 2000
% 218.05/218.22  |- mesh__recordOriginator mesh__D008145 NLM
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008145 1998
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008145 2006
% 218.05/218.22  |- mesh__dateRevised mesh__D008145 1997-06-20
% 218.05/218.22  |- mesh__recordMaintainer mesh__D008145 PXP
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008145 2005
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008145 2002
% 218.05/218.22  |- skos__broader mesh__D008145smesh__D015144
% 218.05/218.22  |- mesh__recordAuthorizer mesh__D008145 SJN
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008145 2004
% 218.05/218.22  |- mesh__dateCreated mesh__D008145 1999-01-01
% 218.05/218.22  |- rdf__type mesh__D008145sskos__Concept
% 218.05/218.22  |- skos__prefLabel mesh__D008145 Louisiana
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008145 2001
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008145 1999
% 218.05/218.22  |- skos__scopeNote mesh__D000162
% 218.05/218.22       The branch of physics that deals with sound and sound waves. In medicine it is often applied in procedures in speech and hearing studies. With regard to the environment, it refers to the characteristics of a room, auditorium, theatre, building, etc. that determines the audibility or fidelity of sounds in it. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 218.05/218.22  |- skos__related mesh__D000162smesh__D013061
% 218.05/218.22  |- mesh__recordMaintainer mesh__D000162 TGC
% 218.05/218.22  |- mesh__dateRevised mesh__D000162 1995-03-13
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D000162 2004
% 218.05/218.22  |- mesh__dateCreated mesh__D000162 1999-01-01
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D000162 2002
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D000162 1997
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D000162 2006
% 218.05/218.22  |- mesh__recordAuthorizer mesh__D000162 PLS
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D000162 1999
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D000162 2003
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D000162 2001
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D000162 1996
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D000162 2005
% 218.05/218.22  |- skos__annotation mesh__D000162
% 218.05/218.22       in speech %26% hearing research %26% for the environment %28%home, hospital, facilities, theater, etc.%29%%A%  
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D000162 1998
% 218.05/218.22  |- skos__prefLabel mesh__D000162 Acoustics
% 218.05/218.22  |- skos__broader mesh__D000162smesh__D010825
% 218.05/218.22  |- skos__related mesh__D000162smesh__D011571
% 218.05/218.22  |- mesh__recordOriginator mesh__D000162 NLM
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D000162 2000
% 218.05/218.22  |- skos__hiddenLabel mesh__D000162 Acoustic
% 218.05/218.22  |- rdf__type mesh__D000162sskos__Concept
% 218.05/218.22  |- skos__historyNote mesh__D013888 Tranquilizing Agents %28%1966-1969%29%
% 218.05/218.22  |- skos__scopeNote mesh__D013888
% 218.05/218.22       A thioxanthine used as an antipsychotic agent. Its effects are similar to the phenothiazine antipsychotics.%A%    
% 218.05/218.22  |- skos__altLabel mesh__D013888 Tiotixene
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D013888 2002
% 218.05/218.22  |- skos__historyNote mesh__D013888 Xanthenes %28%1966-1969%29%
% 218.05/218.22  |- mesh__recordMaintainer mesh__D013888 TWD
% 218.05/218.22  |- mesh__publicMeSHNote mesh__D013888 73   
% 218.05/218.22  |- skos__prefLabel mesh__D013888 Thiothixene
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D013888 2006
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D013888 2001
% 218.05/218.22  |- rdf__type mesh__D013888sskos__Concept
% 218.05/218.22  |- mesh__dateCreated mesh__D013888 1999-01-01
% 218.05/218.22  |- mesh__dateEstablished mesh__D013888 1973-01-01
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D013888 2005
% 218.05/218.22  |- mesh__historyNote mesh__D013888 73%28%70%29%   
% 218.05/218.22  |- mesh__recordAuthorizer mesh__D013888 sjn
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D013888 2004
% 218.05/218.22  |- mesh__recordOriginator mesh__D013888 NLM
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D013888 2003
% 218.05/218.22  |- mesh__dateRevised mesh__D013888 2000-06-22
% 218.05/218.22  |- skos__broader mesh__D013888smesh__D013892
% 218.05/218.22  |- mesh__dateRevised mesh__D010590 2005-06-30
% 218.05/218.22  |- skos__historyNote mesh__D010590 Peptides, Cyclic %28%1973-1974%29%
% 218.05/218.22  |- skos__historyNote mesh__D010590 Peptides %28%1966-1972%29%
% 218.05/218.22  |- mesh__recordMaintainer mesh__D010590 ssb
% 218.05/218.22  |- skos__altLabel mesh__D010590 Phalloidin
% 218.05/218.22  |- mesh__historyNote mesh__D010590
% 218.05/218.22       91%28%75%29%; was see under OLIGOPEPTIDES 1975-90   
% 218.05/218.22  |- mesh__dateCreated mesh__D010590 1974-11-19
% 218.05/218.22  |- skos__historyNote mesh__D010590 Mushrooms %28%1966-1967%29%
% 218.05/218.22  |- skos__broader mesh__D010590smesh__D009183
% 218.05/218.22  |- skos__historyNote mesh__D010590 Food Poisoning %28%1966-1967%29%
% 218.05/218.22  |- skos__historyNote mesh__D010590 Mushroom Poisoning %28%1968-1974%29%
% 218.05/218.22  |- skos__prefLabel mesh__D010590 Phalloidine
% 218.05/218.22  |- rdf__type mesh__D010590sskos__Concept
% 218.05/218.22  |- skos__broader mesh__D010590smesh__D009842
% 218.05/218.22  |- mesh__recordAuthorizer mesh__D010590 sjn
% 218.05/218.22  |- skos__scopeNote mesh__D010590
% 218.05/218.22       Very toxic polypeptide isolated mainly from AMANITA phalloides %28%Agaricaceae%29% or death cup; causes fatal liver, kidney and CNS damage in mushroom poisoning; used in the study of liver damage.%A%    
% 218.05/218.22  |- mesh__publicMeSHNote mesh__D010590
% 218.05/218.22       91; was see under OLIGOPEPTIDES 1975-90   
% 218.05/218.22  |- mesh__recordOriginator mesh__D010590 NLM
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D010590 2006
% 218.05/218.22  |- mesh__dateEstablished mesh__D010590 1991-01-01
% 218.05/218.22  |- skos__broader mesh__D010590smesh__D010456
% 218.05/218.22  |- mesh__recordOriginator mesh__D004553 NLM
% 218.05/218.22  |- mesh__dateEstablished mesh__D004553 1968-01-01
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D004553 2002
% 218.05/218.22  |- mesh__publicMeSHNote mesh__D004553 68   
% 218.05/218.22  |- skos__hiddenLabel mesh__D004553 Conductivity, Electric
% 218.05/218.22  |- skos__altLabel mesh__D004553 Electrical Conductivity
% 218.05/218.22  |- mesh__dateRevised mesh__D004553 2001-07-25
% 218.05/218.22  |- skos__historyNote mesh__D004553 Electricity %28%1966-1967%29%
% 218.05/218.22  |- mesh__recordMaintainer mesh__D004553 nns
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D004553 2004
% 218.05/218.22  |- mesh__dateCreated mesh__D004553 1999-01-01
% 218.05/218.22  |- skos__scopeNote mesh__D004553
% 218.05/218.22       The ability of a substrate to allow the passage of ELECTRONS.%A%    
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D004553 2006
% 218.05/218.22  |- mesh__recordAuthorizer mesh__D004553 sjn
% 218.05/218.22  |- skos__prefLabel mesh__D004553 Electric Conductivity
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D004553 2003
% 218.05/218.22  |- mesh__historyNote mesh__D004553 68   
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D004553 2005
% 218.05/218.22  |- skos__hiddenLabel mesh__D004553 Conductivity, Electrical
% 218.05/218.22  |- skos__broader mesh__D004553smesh__D004594
% 218.05/218.22  |- rdf__type mesh__D004553sskos__Concept
% 218.05/218.22  |- skos__historyNote mesh__D004553 Electrophysiology %28%1966-1967%29%
% 218.05/218.22  |- skos__broader mesh__D004553smesh__D004560
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D014981 2004
% 218.05/218.22  |- mesh__publicMeSHNote mesh__D014981 72   
% 218.05/218.22  |- rdf__type mesh__D014981sskos__Concept
% 218.05/218.22  |- mesh__historyNote mesh__D014981 72   
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D014981 2006
% 218.05/218.22  |- mesh__dateEstablished mesh__D014981 1972-01-01
% 218.05/218.22  |- mesh__dateCreated mesh__D014981 1999-01-01
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D014981 2005
% 218.05/218.22  |- skos__scopeNote mesh__D014981
% 218.05/218.22       An aquatic genus of the family, Pipidae, occurring in Africa and distinguished by having black horny claws on three inner hind toes.%A%    
% 218.05/218.22  |- skos__broader mesh__D014981smesh__D010884
% 218.05/218.22  |- skos__annotation mesh__D014981
% 218.05/218.22       NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 218.05/218.22  |- skos__prefLabel mesh__D014981 Xenopus
% 218.05/218.22  |- skos__related mesh__D014981smesh__D029867
% 218.05/218.22  |- mesh__dateRevised mesh__D014981 2003-07-09
% 218.05/218.22  |- skos__historyNote mesh__D014981 Anura %28%1966-1971%29%
% 218.05/218.22  |- mesh__recordOriginator mesh__D014981 NLM
% 218.05/218.22  |- mesh__recordAuthorizer mesh__D014981 sjn
% 218.05/218.22  |- mesh__recordMaintainer mesh__D014981 ags
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D014183 2005
% 218.05/218.22  |- skos__prefLabel mesh__D014183 Transplantation, Heterologous
% 218.05/218.22  |- skos__hiddenLabel mesh__D014183 Xenotransplantations
% 218.05/218.22  |- skos__hiddenLabel mesh__D014183 Xenografts
% 218.05/218.22  |- skos__hiddenLabel mesh__D014183 Heterografts
% 218.05/218.22  |- skos__altLabel mesh__D014183 Heterograft
% 218.05/218.22  |- mesh__publicMeSHNote mesh__D014183 65   
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D014183 2006
% 218.05/218.22  |- skos__annotation mesh__D014183
% 218.05/218.22       transpl between different species; IM: TN 243; no qualif when NIM coord; when IM, qualif permitted; do not coord here with BIOPROSTHESIS or BIOLOGICAL DRESSINGS: see notes there; do not confuse X ref HETEROGRAFT with %22%heterotopic transpl%22%: heterograft = transpl from one species to another, heterotopic = transpl from one site to another; TRANSPLANTATION, HETEROTOPIC is also available; Manual 19.8.75; DF: TRANSPL HETEROL%A%  
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D014183 2003
% 218.05/218.22  |- skos__scopeNote mesh__D014183
% 218.05/218.22       Transplantation between animals of different species.     
% 218.05/218.22  |- skos__altLabel mesh__D014183 Xenograft
% 218.05/218.22  |- mesh__recordAuthorizer mesh__D014183 sjn
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D014183 2004
% 218.05/218.22  |- mesh__dateCreated mesh__D014183 1999-01-01
% 218.05/218.22  |- skos__broader mesh__D014183smesh__D014180
% 218.05/218.22  |- skos__altLabel mesh__D014183 Heterologous Transplantation
% 218.05/218.22  |- mesh__historyNote mesh__D014183 65   
% 218.05/218.22  |- rdf__type mesh__D014183sskos__Concept
% 218.05/218.22  |- mesh__dateRevised mesh__D014183 2002-07-03
% 218.05/218.22  |- skos__hiddenLabel mesh__D014183 Heterologous Transplantations
% 218.05/218.22  |- skos__hiddenLabel mesh__D014183 Transplantations, Heterologous
% 218.05/218.22  |- mesh__dateEstablished mesh__D014183 1965-01-01
% 218.05/218.22  |- skos__altLabel mesh__D014183 Xenotransplantation
% 218.05/218.22  |- mesh__recordOriginator mesh__D014183 NLM
% 218.05/218.22  |- mesh__recordMaintainer mesh__D014183 lkt
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008944 2005
% 218.05/218.22  |- skos__hiddenLabel mesh__D008944 Incompetence, Mitral Valve
% 218.05/218.22  |- mesh__publicMeSHNote mesh__D008944
% 218.05/218.22       67; was MITRAL INSUFFICIENCY 1963-66   
% 218.05/218.22  |- mesh__recordAuthorizer mesh__D008944 PLS
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008944 2000
% 218.05/218.22  |- skos__altLabel mesh__D008944 Mitral Incompetence
% 218.05/218.22  |- skos__hiddenLabel mesh__D008944 Regurgitation, Mitral
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008944 1999
% 218.05/218.22  |- mesh__recordOriginator mesh__D008944 NLM
% 218.05/218.22  |- skos__altLabel mesh__D008944 Mitral Regurgitation
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008944 1996
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008944 1993
% 218.05/218.22  |- mesh__recordMaintainer mesh__D008944 PLS
% 218.05/218.22  |- skos__hiddenLabel mesh__D008944 Valve Regurgitation, Mitral
% 218.05/218.22  |- mesh__dateCreated mesh__D008944 1999-01-01
% 218.05/218.22  |- skos__hiddenLabel mesh__D008944 Insufficiency, Mitral Valve
% 218.05/218.22  |- skos__hiddenLabel mesh__D008944 Valve Insufficiency, Mitral
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008944 2006
% 218.05/218.22  |- skos__broader mesh__D008944smesh__D006349
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008944 2001
% 218.05/218.22  |- skos__hiddenLabel mesh__D008944 Insufficiency, Mitral
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008944 2003
% 218.05/218.22  |- skos__annotation mesh__D008944 imperfect closing of valve   
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008944 1997
% 218.05/218.22  |- skos__prefLabel mesh__D008944 Mitral Valve Insufficiency
% 218.05/218.22  |- skos__hiddenLabel mesh__D008944 Incompetence, Mitral
% 218.05/218.22  |- mesh__onlineNote mesh__D008944
% 218.05/218.22       use MITRAL VALVE INSUFFICIENCY to search MITRAL INSUFFICIENCY 1966%A%  
% 218.05/218.22  |- skos__scopeNote mesh__D008944
% 218.05/218.22       Backflow of blood from the left ventricle into the left atrium, owing to imperfect functioning of the mitral valve.%A%    
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008944 2002
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008944 2004
% 218.05/218.22  |- skos__hiddenLabel mesh__D008944 Regurgitation, Mitral Valve
% 218.05/218.22  |- rdf__type mesh__D008944sskos__Concept
% 218.05/218.22  |- skos__altLabel mesh__D008944 Mitral Valve Regurgitation
% 218.05/218.22  |- mesh__dateRevised mesh__D008944 1992-05-22
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008944 1994
% 218.05/218.22  |- mesh__dateEstablished mesh__D008944 1967-01-01
% 218.05/218.22  |- skos__altLabel mesh__D008944 Mitral Valve Incompetence
% 218.05/218.22  |- skos__altLabel mesh__D008944 Mitral Insufficiency
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008944 1998
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008944 1995
% 218.05/218.22  |- mesh__historyNote mesh__D008944 67; was MITRAL INSUFFICIENCY 1963-66   
% 218.05/218.22  |- skos__hiddenLabel mesh__D008944 Valve Incompetence, Mitral
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Antilymphocyte Immunoglobulins
% 218.05/218.22  |- skos__altLabel mesh__D000961
% 218.05/218.22       Lymphocyte Immune Globulin, Anti-Thymocyte Globulin
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Anti-Thymocyte Globulins
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Antibodies, Antilymphocyte
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Globulins, Antithymocyte
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Anti Thymocyte Globulin
% 218.05/218.22  |- skos__historyNote mesh__D000961 Immune Sera %28%1966-1967%29%
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Antilymphocyte Globulins
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Serum, Antilymphocyte
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Antithymocyte Globulins
% 218.05/218.22  |- mesh__recordAuthorizer mesh__D000961 jls
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Globulins, Antilymphocyte
% 218.05/218.22  |- skos__prefLabel mesh__D000961 Antilymphocyte Serum
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Antithymoglobulins
% 218.05/218.22  |- rdf__type mesh__D000961sskos__Concept
% 218.05/218.22  |- mesh__recordMaintainer mesh__D000961 jls
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Serums, Antilymphocyte
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Antilymphocyte Serums
% 218.05/218.22  |- skos__scopeNote mesh__D000961
% 218.05/218.22       Serum containing GAMMA-GLOBULINS which are antibodies for lymphocyte ANTIGENS. It is used both as a test for HISTOCOMPATIBILITY and therapeutically in TRANSPLANTATION.%A%    
% 218.05/218.22  |- mesh__recordOriginator mesh__D000961 NLM
% 218.05/218.22  |- mesh__onlineNote mesh__D000961
% 218.05/218.22       search LYMPHOCYTOTOXINS under LYMPHOTOXINS 1978   
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Globulin, Antithymocyte
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Antibodies, Lymphocytotoxic
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Globulin, Antilymphocyte
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Lymphocytotoxic Antibody
% 218.05/218.22  |- mesh__dateEstablished mesh__D000961 1970-01-01
% 218.05/218.22  |- mesh__historyNote mesh__D000961
% 218.05/218.22       70%28%68%29%; LYMPHOCYTOTOXINS was see LYMPHOTOXINS 1978   
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Antilymphocyte Antibody
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Antibody, Antilymphocyte
% 218.05/218.22  |- mesh__dateRevised mesh__D000961 2005-07-29
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Immunoglobulin, Antilymphocyte
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 ATGAMs
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Globulin, Anti-Thymocyte
% 218.05/218.22  |- mesh__publicMeSHNote mesh__D000961
% 218.05/218.22       70; LYMPHOCYTOTOXINS was see LYMPHOTOXINS 1978   
% 218.05/218.22  |- skos__broader mesh__D000961smesh__D007106
% 218.05/218.22  |- skos__altLabel mesh__D000961 Antithymocyte Globulin
% 218.05/218.22  |- skos__historyNote mesh__D000961 Lymphocytes %28%1966-1967%29%
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Globulins, Antilymphoblast
% 218.05/218.22  |- skos__altLabel mesh__D000961 Anti-Thymocyte Globulin
% 218.05/218.22  |- mesh__dateCreated mesh__D000961 1999-01-01
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Antilymphoblast Globulin
% 218.05/218.22  |- skos__annotation mesh__D000961
% 218.05/218.22       antithymocyte %26% anti-theta serum: index ANTILYMPHOCYTE SERUM + T LYMPHOCYTES /immunol; %22%lymphocytotoxin%22%: index CYTOTOXINS + LYMPHOCYTES but note X ref LYMPHOCYTOTOXIC ANTIBODIES for antibodies to lymphocytes%A%  
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Antibody, Lymphocytotoxic
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D000961 2006A
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D000961 2006
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Immunoglobulins, Antilymphocyte
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Globulin, Antilymphoblast
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961
% 218.05/218.22       Lymphocyte Immune Globulin, Anti Thymocyte Globulin
% 218.05/218.22  |- skos__hiddenLabel mesh__D000961 Globulins, Anti-Thymocyte
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008146 2006
% 218.05/218.22  |- mesh__historyNote mesh__D008146 71   
% 218.05/218.22  |- skos__historyNote mesh__D008146 Sheep Diseases %28%1966-1970%29%
% 218.05/218.22  |- skos__prefLabel mesh__D008146 Louping Ill
% 218.05/218.22  |- mesh__recordAuthorizer mesh__D008146 sjn
% 218.05/218.22  |- skos__hiddenLabel mesh__D008146 Ill, Louping
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008146 2005
% 218.05/218.22  |- mesh__recordOriginator mesh__D008146 NLM
% 218.05/218.22  |- skos__historyNote mesh__D008146
% 218.05/218.22       Encephalitis, Tick-Borne/veterinary %28%1966-1970%29%
% 218.05/218.22  |- mesh__dateRevised mesh__D008146 2003-07-30
% 218.05/218.22  |- mesh__dateEstablished mesh__D008146 1971-01-01
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D008146 2004
% 218.05/218.22  |- mesh__publicMeSHNote mesh__D008146 71   
% 218.05/218.22  |- mesh__recordMaintainer mesh__D008146 ags
% 218.05/218.22  |- mesh__dateCreated mesh__D008146 1999-01-01
% 218.05/218.22  |- rdf__type mesh__D008146sskos__Concept
% 218.05/218.22  |- skos__broader mesh__D008146smesh__D012757
% 218.05/218.22  |- skos__broader mesh__D008146smesh__D018177
% 218.05/218.22  |- skos__scopeNote mesh__D008146
% 218.05/218.22       An acute tick-borne arbovirus infection causing meningoencephalomyelitis of sheep.%A%    
% 218.05/218.22  |- skos__annotation mesh__D008146
% 218.05/218.22       caused by a tick-transm flavivirus; usually animal, generally sheep; %22%louping%22% is Scottish dialect for %22%leaping%22% with ref to musc manifest of infected animal; check tag ANIMALS; don%27%t forget also SHEEP %28%NIM%29% but do not index under SHEEP DISEASES%A%  
% 218.05/218.22  |- skos__hiddenLabel mesh__D000163 Syndrome, Acquired Immunodeficiency
% 218.05/218.22  |- skos__hiddenLabel mesh__D000163 Syndromes, Acquired Immunodeficiency
% 218.05/218.22  |- mesh__dateRevised mesh__D000163 2004-07-13
% 218.05/218.22  |- skos__related mesh__D000163smesh__D020943
% 218.05/218.22  |- skos__hiddenLabel mesh__D000163 Acquired Immunodeficiency Syndromes
% 218.05/218.22  |- skos__altLabel mesh__D000163 AIDS
% 218.05/218.22  |- skos__altLabel mesh__D000163 Immunologic Deficiency Syndrome, Acquired
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D000163 2005
% 218.05/218.22  |- mesh__historyNote mesh__D000163 83   
% 218.05/218.22  |- skos__related mesh__D000163smesh__D015492
% 218.05/218.22  |- skos__broader mesh__D000163smesh__D015658
% 218.05/218.22  |- skos__related mesh__D000163smesh__D015528
% 218.05/218.22  |- mesh__recordMaintainer mesh__D000163 sjn
% 218.05/218.22  |- skos__hiddenLabel mesh__D000163 Acquired Immuno-Deficiency Syndromes
% 218.05/218.22  |- skos__altLabel mesh__D000163 Acquired Immune Deficiency Syndrome
% 218.05/218.22  |- skos__altLabel mesh__D000163 Acquired Immuno-Deficiency Syndrome
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D000163 2006
% 218.05/218.22  |- skos__related mesh__D000163smesh__D015526
% 218.05/218.22  |- skos__prefLabel mesh__D000163 Acquired Immunodeficiency Syndrome
% 218.05/218.22  |- skos__annotation mesh__D000163
% 218.05/218.22       caused by HIV; coord IM with HIV-1 or HIV-2 %28%IM%29% if pertinent; /epidemiol: consider also HIV SEROPREVALENCE; AIDS-RELATED OPPORTUNISTIC INFECTIONS is available if particularly discussed: see note there; for lymphoma with AIDS, use LYMPHOMA, AIDS-RELATED%A%  
% 218.05/218.22  |- skos__hiddenLabel mesh__D000163 Immunodeficiency Syndromes, Acquired
% 218.05/218.22  |- skos__hiddenLabel mesh__D000163 Acquired Immuno Deficiency Syndrome
% 218.05/218.22  |- mesh__dateCreated mesh__D000163 1983-03-18
% 218.05/218.22  |- skos__hiddenLabel mesh__D000163 Syndrome, Acquired Immuno-Deficiency
% 218.05/218.22  |- mesh__recordAuthorizer mesh__D000163 sjn
% 218.05/218.22  |- skos__scopeNote mesh__D000163
% 218.05/218.22       An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus %28%HIV%29%, a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14%25% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation %28%wasting%29% and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.%A%    
% 218.05/218.22  |- skos__hiddenLabel mesh__D000163 Immuno-Deficiency Syndrome, Acquired
% 218.05/218.22  |- mesh__publicMeSHNote mesh__D000163 83   
% 218.05/218.22  |- skos__hiddenLabel mesh__D000163 Syndromes, Acquired Immuno-Deficiency
% 218.05/218.22  |- skos__hiddenLabel mesh__D000163 Immuno-Deficiency Syndromes, Acquired
% 218.05/218.22  |- skos__related mesh__D000163smesh__D016483
% 218.05/218.22  |- skos__historyNote mesh__D000163
% 218.05/218.22       Immunologic Deficiency Syndromes %28%1979-1982%29%
% 218.05/218.22  |- rdf__type mesh__D000163sskos__Concept
% 218.05/218.22  |- skos__altLabel mesh__D000163 Immunodeficiency Syndrome, Acquired
% 218.05/218.22  |- skos__broader mesh__D000163smesh__D012897
% 218.05/218.22  |- mesh__dateEstablished mesh__D000163 1983-01-01
% 218.05/218.22  |- mesh__recordOriginator mesh__D000163 AEP
% 218.05/218.22  |- skos__related mesh__D000163smesh__D006679
% 218.05/218.22  |- skos__annotation mesh__D013889 a thyroid antag   
% 218.05/218.22  |- mesh__recordOriginator mesh__D013889 NLM
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D013889 2006
% 218.05/218.22  |- rdf__type mesh__D013889sskos__Concept
% 218.05/218.22  |- mesh__dateCreated mesh__D013889 1999-01-01
% 218.05/218.22  |- skos__broader mesh__D013889smesh__D014498
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D013889 2005
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D013889 2002
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D013889 2004
% 218.05/218.22  |- skos__scopeNote mesh__D013889
% 218.05/218.22       Occurs in seeds of Brassica and Crucifera species. Thiouracil has been used as antithyroid, coronary vasodilator, and in congestive heart failure although its use has been largely supplanted by other drugs. It is known to cause blood dyscrasias and suspected of terato- and carcinogenesis.%A%    
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D013889 2001
% 218.05/218.22  |- mesh__dateRevised mesh__D013889 1999-11-03
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D013889 2003
% 218.05/218.22  |- mesh__recordMaintainer mesh__D013889 jmp
% 218.05/218.22  |- skos__prefLabel mesh__D013889 Thiouracil
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D013889 2000
% 218.05/218.22  |- mesh__recordAuthorizer mesh__D013889 sjn
% 218.05/218.22  |- skos__hiddenLabel mesh__D018574 Agencies, Home Health
% 218.05/218.22  |- mesh__historyNote mesh__D018574
% 218.05/218.22       95; HOME HEALTH AGENCIES was see HOME CARE SERVICES 1978-94%A%  
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D018574 2000
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D018574 2005
% 218.05/218.22  |- mesh__dateEstablished mesh__D018574 1995-01-01
% 218.05/218.22  |- skos__prefLabel mesh__D018574 Home Care Agencies
% 218.05/218.22  |- mesh__recordOriginator mesh__D018574 JLS
% 218.05/218.22  |- skos__hiddenLabel mesh__D018574 Care Agency, Home
% 218.05/218.22  |- skos__scopeNote mesh__D018574
% 218.05/218.22       Public or private organizations that provide, either directly or through arrangements with other organizations, home health services in the patient%27%s home. %28%Hospital Administration Terminology, 2d ed%29%%A%    
% 218.05/218.22  |- skos__hiddenLabel mesh__D018574 Agency, Home Health
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D018574 2006
% 218.05/218.22  |- skos__hiddenLabel mesh__D018574 Care Agencies, Home
% 218.05/218.22  |- skos__historyNote mesh__D018574 Home Care Services %28%1978-1994%29%
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D018574 2001
% 218.05/218.22  |- mesh__dateCreated mesh__D018574 1994-04-19
% 218.05/218.22  |- mesh__activeMeSHYear mesh__D018574 2003
% 218.05/218.22  |- mesh__recordMaintainer mesh__D018574 kle
% 218.05/218.23  |- rdf__type mesh__D018574sskos__Concept
% 218.05/218.23  |- mesh__recordAuthorizer mesh__D018574 sjn
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D018574 2004
% 218.05/218.23  |- mesh__dateRevised mesh__D018574 1999-11-03
% 218.05/218.23  |- skos__hiddenLabel mesh__D018574 Home Care Agency
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D018574 2002
% 218.05/218.23  |- skos__broader mesh__D018574smesh__D009938
% 218.05/218.23  |- mesh__onlineNote mesh__D018574
% 218.05/218.23       use HOME CARE SERVICES to search HOME HEALTH AGENCIES 1978-94%A%  
% 218.05/218.23  |- skos__hiddenLabel mesh__D018574 Agencies, Home Care
% 218.05/218.23  |- skos__hiddenLabel mesh__D018574 Home Health Agency
% 218.05/218.23  |- skos__hiddenLabel mesh__D018574 Agency, Home Care
% 218.05/218.23  |- skos__annotation mesh__D018574
% 218.05/218.23       public or private agencies; coord IM with specific home care %28%IM%29%%A%  
% 218.05/218.23  |- mesh__publicMeSHNote mesh__D018574
% 218.05/218.23       95; HOME HEALTH AGENCIES was see HOME CARE SERVICES 1978-94%A%  
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D010591 2003
% 218.05/218.23  |- mesh__dateCreated mesh__D010591 1999-01-01
% 218.05/218.23  |- skos__altLabel mesh__D010591 Pseudomelia
% 218.05/218.23  |- skos__broader mesh__D010591smesh__D010468
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D010591 2004
% 218.05/218.23  |- rdf__type mesh__D010591sskos__Concept
% 218.05/218.23  |- skos__scopeNote mesh__D010591
% 218.05/218.23       Perception of painful and nonpainful phantom sensations that occur following the complete or partial loss of a limb. The majority of individuals with an amputated extremity will experience the impression that the limb is still present, and in many cases, painful. %28%From Neurol Clin 1998 Nov;16%28%4%29%:919-36; Brain 1998 Sep;121%28%Pt 9%29%:1603-30%29%%A%    
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D010591 2005
% 218.05/218.23  |- skos__prefLabel mesh__D010591 Phantom Limb
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D010591 2000
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D010591 2001
% 218.05/218.23  |- mesh__dateRevised mesh__D010591 1999-11-08
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D010591 2006
% 218.05/218.23  |- mesh__recordMaintainer mesh__D010591 KEV
% 218.05/218.23  |- skos__hiddenLabel mesh__D010591 Limb, Phantom
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D010591 2002
% 218.05/218.23  |- mesh__recordAuthorizer mesh__D010591 sjn
% 218.05/218.23  |- skos__hiddenLabel mesh__D010591 Pseudomelias
% 218.05/218.23  |- skos__hiddenLabel mesh__D010591 Limbs, Phantom
% 218.05/218.23  |- skos__hiddenLabel mesh__D010591 Phantom Limbs
% 218.05/218.23  |- mesh__recordOriginator mesh__D010591 NLM
% 218.05/218.23  |- skos__hiddenLabel mesh__D004554 Electric Countershocks
% 218.05/218.23  |- mesh__publicMeSHNote mesh__D004554 65   
% 218.05/218.23  |- skos__altLabel mesh__D004554 Electroversion, Cardiac
% 218.05/218.23  |- mesh__dateCreated mesh__D004554 1999-01-01
% 218.05/218.23  |- mesh__recordOriginator mesh__D004554 NLM
% 218.05/218.23  |- skos__hiddenLabel mesh__D004554 Electroversions, Cardiac
% 218.05/218.23  |- skos__prefLabel mesh__D004554 Electric Countershock
% 218.05/218.23  |- skos__hiddenLabel mesh__D004554 Electric Defibrillations
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D004554 2006
% 218.05/218.23  |- mesh__dateRevised mesh__D004554 2005-06-30
% 218.05/218.23  |- mesh__historyNote mesh__D004554 65%28%63%29%   
% 218.05/218.23  |- skos__annotation mesh__D004554
% 218.05/218.23       /instrum: consider also DEFIBRILLATORS or DEFIBRILLATORS, IMPLANTABLE%A%  
% 218.05/218.23  |- skos__altLabel mesh__D004554 Therapy, Electroversion
% 218.05/218.23  |- skos__broader mesh__D004554smesh__D004599
% 218.05/218.23  |- skos__related mesh__D004554smesh__D047548
% 218.05/218.23  |- skos__hiddenLabel mesh__D004554 Countershock, Electric
% 218.05/218.23  |- skos__hiddenLabel mesh__D004554 Cardioversions
% 218.05/218.23  |- skos__hiddenLabel mesh__D004554 Countershocks, Electric
% 218.05/218.23  |- mesh__dateEstablished mesh__D004554 1965-01-01
% 218.05/218.23  |- skos__scopeNote mesh__D004554
% 218.05/218.23       An electrical current applied to the HEART to terminate a disturbance of its rhythm, ARRHYTHMIA. %28%Stedman, 25th ed%29%%A%    
% 218.05/218.23  |- skos__hiddenLabel mesh__D004554 Therapies, Electroversion
% 218.05/218.23  |- rdf__type mesh__D004554sskos__Concept
% 218.05/218.23  |- mesh__recordAuthorizer mesh__D004554 sjn
% 218.05/218.23  |- skos__hiddenLabel mesh__D004554 Electric Defibrillation
% 218.05/218.23  |- skos__hiddenLabel mesh__D004554 Cardiac Electroversions
% 218.05/218.23  |- skos__altLabel mesh__D004554 Defibrillation, Electric
% 218.05/218.23  |- skos__hiddenLabel mesh__D004554 Defibrillations, Electric
% 218.05/218.23  |- skos__hiddenLabel mesh__D004554 Electroversion Therapies
% 218.05/218.23  |- skos__altLabel mesh__D004554 Cardioversion
% 218.05/218.23  |- mesh__recordMaintainer mesh__D004554 lkt
% 218.05/218.23  |- skos__altLabel mesh__D004554 Cardiac Electroversion
% 218.05/218.23  |- skos__prefLabel mesh__D014982 Xenopus laevis
% 218.05/218.23  |- skos__altLabel mesh__D014982 Platanna
% 218.05/218.23  |- rdf__type mesh__D014982sskos__Concept
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D014982 2005
% 218.05/218.23  |- mesh__historyNote mesh__D014982 81   
% 218.05/218.23  |- skos__hiddenLabel mesh__D014982 laevis, Xenopus
% 218.05/218.23  |- skos__historyNote mesh__D014982 Xenopus %28%1972-1980%29%
% 218.05/218.23  |- mesh__recordAuthorizer mesh__D014982 sjn
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D014982 2006
% 218.05/218.23  |- skos__broader mesh__D014982smesh__D014981
% 218.05/218.23  |- skos__related mesh__D014982smesh__D029867
% 218.05/218.23  |- mesh__recordOriginator mesh__D014982 EC
% 218.05/218.23  |- mesh__dateCreated mesh__D014982 1980-05-13
% 218.05/218.23  |- skos__annotation mesh__D014982
% 218.05/218.23       NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 218.05/218.23  |- mesh__publicMeSHNote mesh__D014982 81   
% 218.05/218.23  |- mesh__dateRevised mesh__D014982 2003-07-09
% 218.05/218.23  |- mesh__recordMaintainer mesh__D014982 ags
% 218.05/218.23  |- mesh__dateEstablished mesh__D014982 1981-01-01
% 218.05/218.23  |- skos__hiddenLabel mesh__D014982 Platannas
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D014982 2004
% 218.05/218.23  |- skos__scopeNote mesh__D014982
% 218.05/218.23       The commonest and widest ranging species of the clawed %22%frog%22% %28%Xenopus%29% in Africa. This species is used extensively in research. There is now a significant population in California derived from escaped laboratory animals.%A%    
% 218.05/218.23  |- mesh__onlineNote mesh__D014184
% 218.05/218.23       use TRANSPLANTATION, HOMOLOGOUS to search TRANSPLANTATION, ALLOGENEIC 1975-79%A%  
% 218.05/218.23  |- skos__hiddenLabel mesh__D014184 Transplantations, Allogeneic
% 218.05/218.23  |- mesh__dateEstablished mesh__D014184 1965-01-01
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D014184 2004
% 218.05/218.23  |- skos__altLabel mesh__D014184 Homograft
% 218.05/218.23  |- mesh__recordMaintainer mesh__D014184 lkt
% 218.05/218.23  |- mesh__dateCreated mesh__D014184 1999-01-01
% 218.05/218.23  |- skos__altLabel mesh__D014184 Homologous Transplantation
% 218.05/218.23  |- skos__altLabel mesh__D014184 Allogeneic Transplantation
% 218.05/218.23  |- skos__altLabel mesh__D014184 Transplantation, Allogeneic
% 218.05/218.23  |- rdf__type mesh__D014184sskos__Concept
% 218.05/218.23  |- mesh__historyNote mesh__D014184
% 218.05/218.23       65; TRANSPLANTATION, ALLOGENEIC was see under TRANSPLANTATION, HOMOLOGOUS 1975-79%A%  
% 218.05/218.23  |- mesh__recordOriginator mesh__D014184 NLM
% 218.05/218.23  |- mesh__dateRevised mesh__D014184 2002-07-02
% 218.05/218.23  |- skos__annotation mesh__D014184
% 218.05/218.23       NIM if at all: TN 243; no qualif when NIM coord; when IM, qualif permitted; Manual 19.8.75; DF: TRANSPL HOMOL%A%  
% 218.05/218.23  |- skos__hiddenLabel mesh__D014184 Allogeneic Transplantations
% 218.05/218.23  |- skos__scopeNote mesh__D014184
% 218.05/218.23       Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals.%A%    
% 218.05/218.23  |- skos__hiddenLabel mesh__D014184 Homografts
% 218.05/218.23  |- skos__hiddenLabel mesh__D014184 Transplantations, Homologous
% 218.05/218.23  |- mesh__publicMeSHNote mesh__D014184 65   
% 218.05/218.23  |- skos__prefLabel mesh__D014184 Transplantation, Homologous
% 218.05/218.23  |- skos__hiddenLabel mesh__D014184 Allografts
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D014184 2005
% 218.05/218.23  |- skos__broader mesh__D014184smesh__D014180
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D014184 2006
% 218.05/218.23  |- mesh__recordAuthorizer mesh__D014184 sjn
% 218.05/218.23  |- skos__hiddenLabel mesh__D014184 Homologous Transplantations
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D014184 2003
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Click-Murmur Syndromes, Systolic
% 218.05/218.23  |- mesh__historyNote mesh__D008945 79   
% 218.05/218.23  |- skos__altLabel mesh__D008945 Mitral Click-Murmur Syndrome
% 218.05/218.23  |- skos__historyNote mesh__D008945 Heart Valve Diseases %28%1967-1978%29%
% 218.05/218.23  |- skos__broader mesh__D008945smesh__D016127
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Valve Prolapse, Mitral
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Systolic Click-Murmur Syndromes
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Floppy Mitral Valves
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D008945 2005
% 218.05/218.23  |- mesh__recordMaintainer mesh__D008945 lkt
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Mitral Valve, Floppy
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Syndrome, Systolic Click-Murmur
% 218.05/218.23  |- mesh__dateEstablished mesh__D008945 1979-01-01
% 218.05/218.23  |- skos__scopeNote mesh__D008945
% 218.05/218.23       Abnormal protrusion of one or both of the leaflets of the mitral valve into the left atrium during systole. This may be accompanied by mitral regurgitation, systolic murmur, nonejection click, or cardiac arrhythmia.%A%    
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Mitral Valve Prolapses
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Syndromes, Mitral Click-Murmur
% 218.05/218.23  |- mesh__publicMeSHNote mesh__D008945 79   
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D008945 2006
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Mitral Click-Murmur Syndromes
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Mitral Valves, Floppy
% 218.05/218.23  |- skos__altLabel mesh__D008945 Floppy Mitral Valve
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Prolapses, Mitral Valve
% 218.05/218.23  |- mesh__dateRevised mesh__D008945 2003-07-09
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Valve, Floppy Mitral
% 218.05/218.23  |- skos__historyNote mesh__D008945 Mitral Valve %28%1966-1978%29%
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Prolapse, Mitral Valve
% 218.05/218.23  |- skos__altLabel mesh__D008945 Systolic Click-Murmur Syndrome
% 218.05/218.23  |- skos__historyNote mesh__D008945
% 218.05/218.23       Mitral Valve Insufficiency %28%1966-1978%29%
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Syndromes, Systolic Click-Murmur
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D008945 2004
% 218.05/218.23  |- mesh__recordAuthorizer mesh__D008945 sjn
% 218.05/218.23  |- rdf__type mesh__D008945sskos__Concept
% 218.05/218.23  |- skos__prefLabel mesh__D008945 Mitral Valve Prolapse
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Click-Murmur Syndromes, Mitral
% 218.05/218.23  |- mesh__dateCreated mesh__D008945 1977-12-06
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Syndrome, Mitral Click-Murmur
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Click-Murmur Syndrome, Systolic
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Systolic Click Murmur Syndrome
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Valve Prolapses, Mitral
% 218.05/218.23  |- skos__historyNote mesh__D008945 Prolapse %28%1977-1978%29%
% 218.05/218.23  |- mesh__recordOriginator mesh__D008945 VDK
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Click-Murmur Syndrome, Mitral
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Mitral Click Murmur Syndrome
% 218.05/218.23  |- skos__hiddenLabel mesh__D008945 Valves, Floppy Mitral
% 218.05/218.23  |- skos__hiddenLabel mesh__D000962 Drugs, Antimalarial
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D000962 2006
% 218.05/218.23  |- mesh__dateRevised mesh__D000962 2003-07-09
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D000962 2004
% 218.05/218.23  |- skos__prefLabel mesh__D000962 Antimalarials
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D000962 2005
% 218.05/218.23  |- mesh__recordOriginator mesh__D000962 NLM
% 218.05/218.23  |- skos__scopeNote mesh__D000962
% 218.05/218.23       Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. %28%From AMA, Drug Evaluations Annual, 1992, p1585%29%%A%    
% 218.05/218.23  |- skos__altLabel mesh__D000962 Anti-Malarials
% 218.05/218.23  |- mesh__dateCreated mesh__D000962 1999-01-01
% 218.05/218.23  |- skos__hiddenLabel mesh__D000962 Anti Malarials
% 218.05/218.23  |- skos__altLabel mesh__D000962 Antimalarial Drugs
% 218.05/218.23  |- skos__altLabel mesh__D000962 Antimalarial Agents
% 218.05/218.23  |- mesh__recordAuthorizer mesh__D000962 sjn
% 218.05/218.23  |- mesh__recordMaintainer mesh__D000962 ssb
% 218.05/218.23  |- skos__hiddenLabel mesh__D000962 Agents, Antimalarial
% 218.05/218.23  |- rdf__type mesh__D000962sskos__Concept
% 218.05/218.23  |- skos__broader mesh__D000962smesh__D000981
% 218.05/218.23  |- skos__prefLabel mesh__D000164 Acremonium
% 218.05/218.23  |- mesh__dateRevised mesh__D000164 2005-06-30
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D000164 2006
% 218.05/218.23  |- mesh__recordMaintainer mesh__D000164 SYSTEM
% 218.05/218.23  |- mesh__historyNote mesh__D000164 86%28%63%29%   
% 218.05/218.23  |- mesh__recordOriginator mesh__D000164 NLM
% 218.05/218.23  |- skos__altLabel mesh__D000164 Cephalosporium
% 218.05/218.23  |- skos__broader mesh__D000164smesh__D003904
% 218.05/218.23  |- rdf__type mesh__D000164sskos__Concept
% 218.05/218.23  |- skos__scopeNote mesh__D000164
% 218.05/218.23       A mitosporic fungal genus with many reported ascomycetous teleomorphs. Cephalosporin antibiotics are derived from this genus.%A%    
% 218.05/218.23  |- mesh__publicMeSHNote mesh__D000164 86; see CEPHALOSPORIUM 1963-85   
% 218.05/218.23  |- mesh__dateCreated mesh__D000164 1999-01-01
% 218.05/218.23  |- mesh__recordAuthorizer mesh__D000164 sjn
% 218.05/218.23  |- skos__historyNote mesh__D027301 Antigens, Surface %28%1993-1995%29%
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D027301 2006
% 218.05/218.23  |- mesh__recordOriginator mesh__D027301 jmp
% 218.05/218.23  |- mesh__dateRevised mesh__D027301 2005-06-30
% 218.05/218.23  |- mesh__historyNote mesh__D027301 2002   
% 218.05/218.23  |- mesh__recordAuthorizer mesh__D027301 sjn
% 218.05/218.23  |- rdf__type mesh__D027301sskos__Concept
% 218.05/218.23  |- skos__altLabel mesh__D027301 CD98 Antigen Light Chain
% 218.05/218.23  |- mesh__dateEstablished mesh__D027301 2002-01-01
% 218.05/218.23  |- skos__historyNote mesh__D027301 Carrier Proteins %28%1996-2001%29%
% 218.05/218.23  |- skos__altLabel mesh__D027301 CD98 Antigens Light Chain
% 218.05/218.23  |- skos__historyNote mesh__D027301 Antigens, CD %28%1996-2001%29%
% 218.05/218.23  |- mesh__dateCreated mesh__D027301 2001-07-25
% 218.05/218.23  |- skos__altLabel mesh__D027301 4F2 Light Chains
% 218.05/218.23  |- skos__prefLabel mesh__D027301 Antigens, CD98 Light Chains
% 218.05/218.23  |- skos__broader mesh__D027301smesh__D027261
% 218.05/218.23  |- skos__altLabel mesh__D027301 4F2 Antigen, Light Chains
% 218.05/218.23  |- skos__scopeNote mesh__D027301
% 218.05/218.23       A family of light chains that bind to the CD98 heavy chain %28%ANTIGENS, CD98 HEAVY CHAIN%29% to form a heterodimer. They convey functional specificity to the protein.%A%    
% 218.05/218.23  |- mesh__publicMeSHNote mesh__D027301 2002   
% 218.05/218.23  |- mesh__recordMaintainer mesh__D027301 ssb
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D018575 2006
% 218.05/218.23  |- skos__altLabel mesh__D018575 Hospital-Based Home Care Services
% 218.05/218.23  |- skos__altLabel mesh__D018575 Hospital-Based Home Care
% 218.05/218.23  |- mesh__dateCreated mesh__D018575 1994-04-19
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D018575 2003
% 218.05/218.23  |- skos__hiddenLabel mesh__D018575 Hospital Based Home Care Services
% 218.05/218.23  |- skos__historyNote mesh__D018575 Home Care Services %28%1967-1994%29%
% 218.05/218.23  |- skos__altLabel mesh__D018575 Care, Hospital-Based Home
% 218.05/218.23  |- skos__altLabel mesh__D018575 Hospital Based Home Cares
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D018575 2000
% 218.05/218.23  |- skos__hiddenLabel mesh__D018575 Home Care, Hospital Based
% 218.05/218.23  |- skos__prefLabel mesh__D018575 Home Care Services, Hospital-Based
% 218.05/218.23  |- rdf__type mesh__D018575sskos__Concept
% 218.05/218.23  |- skos__hiddenLabel mesh__D018575 Hospital-Based Home Cares
% 218.05/218.23  |- skos__altLabel mesh__D018575 Hospital Home Care Services
% 218.05/218.23  |- mesh__dateEstablished mesh__D018575 1995-01-01
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D018575 2004
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D018575 2001
% 218.05/218.23  |- skos__hiddenLabel mesh__D018575 Cares, Hospital Based Home
% 218.05/218.23  |- skos__hiddenLabel mesh__D018575 Home Cares, Hospital Based
% 218.05/218.23  |- skos__annotation mesh__D018575 IM; DF: HOME CARE SERV HOSP BASED   
% 218.05/218.23  |- skos__scopeNote mesh__D018575
% 218.05/218.23       Hospital-sponsored provision of health services, such as nursing, therapy, and health-related homemaker or social services, in the patient%27%s home. %28%Hospital Administration Terminology, 2d ed%29%%A%    
% 218.05/218.23  |- mesh__recordMaintainer mesh__D018575 kle
% 218.05/218.23  |- skos__altLabel mesh__D018575 Home Care, Hospital-Based
% 218.05/218.23  |- skos__hiddenLabel mesh__D018575 Hospital Based Home Care
% 218.05/218.23  |- skos__altLabel mesh__D018575 Cares, Hospital-Based Home
% 218.05/218.23  |- skos__broader mesh__D018575smesh__D006699
% 218.05/218.23  |- mesh__publicMeSHNote mesh__D018575 95   
% 218.05/218.23  |- skos__altLabel mesh__D018575 Home Care Services, Hospital Based
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D018575 2005
% 218.05/218.23  |- mesh__recordAuthorizer mesh__D018575 sjn
% 218.05/218.23  |- mesh__dateRevised mesh__D018575 1999-11-03
% 218.05/218.23  |- skos__altLabel mesh__D018575 Home Cares, Hospital-Based
% 218.05/218.23  |- mesh__historyNote mesh__D018575 95   
% 218.05/218.23  |- skos__hiddenLabel mesh__D018575 Care, Hospital Based Home
% 218.05/218.23  |- mesh__recordOriginator mesh__D018575 JLS
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D018575 2002
% 218.05/218.23  |- skos__prefLabel mesh__D010592 Pharmaceutic Aids
% 218.05/218.23  |- skos__broader mesh__D010592smesh__D004364
% 218.05/218.23  |- mesh__historyNote mesh__D010592 68   
% 218.05/218.23  |- mesh__recordAuthorizer mesh__D010592 sjn
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D010592 2006
% 218.05/218.23  |- mesh__recordMaintainer mesh__D010592 sjn
% 218.05/218.23  |- mesh__dateRevised mesh__D010592 2005-07-05
% 218.05/218.23  |- mesh__recordOriginator mesh__D010592 NLM
% 218.05/218.23  |- skos__annotation mesh__D010592 D25-26 qualif; DF: PHARM AIDS   
% 218.05/218.23  |- skos__altLabel mesh__D010592 Aids, Pharmaceutic
% 218.05/218.23  |- skos__altLabel mesh__D010592 Aids, Pharmaceutical
% 218.05/218.23  |- skos__broader mesh__D010592smesh__D020313
% 218.05/218.23  |- mesh__dateCreated mesh__D010592 1999-01-01
% 218.05/218.23  |- skos__historyNote mesh__D010592 specific aid %28%1966-1967%29%
% 218.05/218.23  |- mesh__publicMeSHNote mesh__D010592 68   
% 218.05/218.23  |- mesh__dateEstablished mesh__D010592 1968-01-01
% 218.05/218.23  |- skos__historyNote mesh__D010592 Pharmacy %28%1966-1967%29%
% 218.05/218.23  |- rdf__type mesh__D010592sskos__Concept
% 218.05/218.23  |- skos__altLabel mesh__D010592 Pharmaceutical Aids
% 218.05/218.23  |- skos__scopeNote mesh__D010592
% 218.05/218.23       Substances which are of little or no therapeutic value, but are necessary in the manufacture, compounding, storage, etc., of pharmaceutical preparations or drug dosage forms. They include SOLVENTS, diluting agents, and suspending agents, and emulsifying agents. Also, ANTIOXIDANTS; PRESERVATIVES, PHARMACEUTICAL; COLORING AGENTS; FLAVORING AGENTS; VEHICLES; EXCIPIENTS; OINTMENT BASES.%A%    
% 218.05/218.23  |- skos__prefLabel mesh__D051400 Aquaporin 3
% 218.05/218.23  |- mesh__publicMeSHNote mesh__D051400
% 218.05/218.23       2006; AQUAPORIN 3 was indexed under AQUAPORINS 1999-2005, %26% under ION CHANNELS 1995-1998, %26% under MEMBRANE PROTEINS 1994%A%  
% 218.05/218.23  |- skos__scopeNote mesh__D051400
% 218.05/218.23       Aquaporin 3 is an aquaglyceroporin that is expressed in the KIDNEY COLLECTING DUCTS and is constitutively localized at the basolateral MEMBRANE.%A%    
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D051400 2006
% 218.05/218.23  |- mesh__dateCreated mesh__D051400 2005-06-30
% 218.05/218.23  |- skos__broader mesh__D051400smesh__D051397
% 218.05/218.23  |- mesh__recordMaintainer mesh__D051400 DRC
% 218.05/218.23  |- mesh__historyNote mesh__D051400 2006%28%1994%29%   
% 218.05/218.23  |- mesh__recordOriginator mesh__D051400 DRC
% 218.05/218.23  |- rdf__type mesh__D051400sskos__Concept
% 218.05/218.23  |- mesh__recordAuthorizer mesh__D051400 sjn
% 218.05/218.23  |- skos__altLabel mesh__D051400 Aquaporin 3 Protein
% 218.05/218.23  |- mesh__dateEstablished mesh__D051400 2006-01-01
% 218.05/218.23  |- skos__altLabel mesh__D051400 AQP3 Protein
% 218.05/218.23  |- mesh__dateRevised mesh__D004555 2003-07-09
% 218.05/218.23  |- skos__altLabel mesh__D004555 Elephantfish
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D004555 2005
% 218.05/218.23  |- mesh__recordAuthorizer mesh__D004555 sjn
% 218.05/218.23  |- skos__hiddenLabel mesh__D004555 Fish, Electric
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D004555 2004
% 218.05/218.23  |- skos__scopeNote mesh__D004555
% 218.05/218.23       Fishes which generate an electric discharge. The voltage of the discharge varies from weak to strong in various groups of fish. The ELECTRIC ORGAN and electroplax are of prime interest in this group. They occur in more than one family.%A%    
% 218.05/218.23  |- mesh__dateEstablished mesh__D004555 1987-01-01
% 218.05/218.23  |- skos__prefLabel mesh__D004555 Electric Fish
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D004555 2006
% 218.05/218.23  |- mesh__recordMaintainer mesh__D004555 ags
% 218.05/218.23  |- skos__broader mesh__D004555smesh__D005399
% 218.05/218.23  |- skos__hiddenLabel mesh__D004555 Mormyrids
% 218.05/218.23  |- skos__altLabel mesh__D004555 Elephantfishes
% 218.05/218.23  |- mesh__historyNote mesh__D004555 87   
% 218.05/218.23  |- rdf__type mesh__D004555sskos__Concept
% 218.05/218.23  |- mesh__dateCreated mesh__D004555 1986-04-15
% 218.05/218.23  |- mesh__recordOriginator mesh__D004555 EC
% 218.05/218.23  |- skos__altLabel mesh__D004555 Mormyridae
% 218.05/218.23  |- skos__annotation mesh__D004555
% 218.05/218.23       do not confuse with EEL, ELECTRIC see ELECTROPHORUS   
% 218.05/218.23  |- mesh__publicMeSHNote mesh__D004555 87   
% 218.05/218.23  |- skos__hiddenLabel mesh__D009240 Leucyl-Phenylalanine, N-Formylmethionine
% 218.05/218.23  |- rdf__type mesh__D009240sskos__Concept
% 218.05/218.23  |- mesh__recordAuthorizer mesh__D009240 sjn
% 218.05/218.23  |- skos__altLabel mesh__D009240 Formylmet-Leu-Phe
% 218.05/218.23  |- skos__prefLabel mesh__D009240 N-Formylmethionine Leucyl-Phenylalanine
% 218.05/218.23  |- skos__broader mesh__D009240smesh__D009842
% 218.05/218.23  |- skos__broader mesh__D009240smesh__D002631
% 218.05/218.23  |- skos__hiddenLabel mesh__D009240 Formylmethionyl Leucyl Phenylalanine
% 218.05/218.23  |- skos__broader mesh__D009240smesh__D009239
% 218.05/218.23  |- skos__hiddenLabel mesh__D009240 N Formyl Methionyl Leucyl Phenylalanine
% 218.05/218.23  |- mesh__publicMeSHNote mesh__D009240
% 218.05/218.23       85; was N-FORMYL-METHIONYL-LEUCYL-PHENYLALANINE 1984; CHEMOTACTIC PEPTIDE was see N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE 1984-90%A%  
% 218.05/218.23  |- skos__altLabel mesh__D009240 N-Formyl-Methionyl-Leucyl-Phenylalanine
% 218.05/218.23  |- skos__historyNote mesh__D009240 N-Formylmethionine %28%1975-1983%29%
% 218.05/218.23  |- skos__hiddenLabel mesh__D009240 N Formylmethionine Leucyl Phenylalanine
% 218.05/218.23  |- skos__hiddenLabel mesh__D009240 Peptide, Formylmethionyl
% 218.05/218.23  |- skos__historyNote mesh__D009240 Peptides %28%1966-1972%29%
% 218.05/218.23  |- mesh__dateRevised mesh__D009240 2005-06-30
% 218.05/218.23  |- mesh__historyNote mesh__D009240
% 218.05/218.23       85; was N-FORMYL-METHIONYL-LEUCYL-PHENYLALANINE 1984; CHEMOTACTIC PEPTIDE was see N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE 1984-90%A%  
% 218.05/218.23  |- mesh__recordOriginator mesh__D009240 SH
% 218.05/218.23  |- skos__historyNote mesh__D009240 Chemotaxis, Leukocyte %28%1977-1983%29%
% 218.05/218.23  |- skos__scopeNote mesh__D009240
% 218.05/218.23       N-Formylmethionyl-leucyl-phenylalanine. A formylated tripeptide originally isolated from bacterial filtrates that is positively chemotactic to polymorphonuclear leucocytes, and causes them to release lysosomal enzymes and become metabolically activated.%A%    
% 218.05/218.23  |- skos__annotation mesh__D009240 DF: FMLP   
% 218.05/218.23  |- mesh__dateEstablished mesh__D009240 1984-01-01
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D009240 2006
% 218.05/218.23  |- skos__historyNote mesh__D009240 Methionine %28%1966-1974%29%
% 218.05/218.23  |- skos__historyNote mesh__D009240 Oligopeptides %28%1973-1983%29%
% 218.05/218.23  |- mesh__recordMaintainer mesh__D009240 ssb
% 218.05/218.23  |- skos__altLabel mesh__D009240 F-Met-Leu-Phe
% 218.05/218.23  |- skos__altLabel mesh__D009240 N-Formylated Peptide
% 218.05/218.23  |- skos__hiddenLabel mesh__D009240 N Formylated Peptide
% 218.05/218.23  |- skos__hiddenLabel mesh__D009240 Formylmet Leu Phe
% 218.05/218.23  |- skos__hiddenLabel mesh__D009240 Peptide, N-Formylated
% 218.05/218.23  |- mesh__onlineNote mesh__D009240
% 218.05/218.23       use N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE to search N-FORMYL-METHIONYL-LEUCYL-PHENYLALANINE 1984%A%  
% 218.05/218.23  |- skos__altLabel mesh__D009240 Formylmethionyl-Leucyl-Phenylalanine
% 218.05/218.23  |- mesh__dateCreated mesh__D009240 1983-06-13
% 218.05/218.23  |- skos__altLabel mesh__D009240 Formylmethionylleucylphenylalanine
% 218.05/218.23  |- skos__hiddenLabel mesh__D009240 F Met Leu Phe
% 218.05/218.23  |- skos__broader mesh__D009240smesh__D002630
% 218.05/218.23  |- skos__historyNote mesh__D009240 Chemotaxis %28%1970-1979%29%
% 218.05/218.23  |- skos__historyNote mesh__D009240 Cytology %28%1966-1969%29%
% 218.05/218.23  |- skos__historyNote mesh__D009240 Chemotactic Factors %28%1980-1983%29%
% 218.05/218.23  |- skos__altLabel mesh__D014983 Kaposi Disease
% 218.05/218.23  |- skos__broader mesh__D014983smesh__D010787
% 218.05/218.23  |- mesh__recordMaintainer mesh__D014983 nns
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D014983 2006
% 218.05/218.23  |- mesh__dateRevised mesh__D014983 2005-06-30
% 218.05/218.23  |- skos__broader mesh__D014983smesh__D011230
% 218.05/218.23  |- skos__altLabel mesh__D014983 Kaposi%27%s Disease
% 218.05/218.23  |- mesh__historyNote mesh__D014983
% 218.05/218.23       63; KAPOSI DISEASE was KAPOSI%27%S DISEASE 1963-97   
% 218.05/218.23  |- mesh__publicMeSHNote mesh__D014983
% 218.05/218.23       63; KAPOSI DISEASE was KAPOSI%27%S DISEASE 1963-97   
% 218.05/218.23  |- skos__prefLabel mesh__D014983 Xeroderma Pigmentosum
% 218.05/218.23  |- mesh__recordAuthorizer mesh__D014983 sjn
% 218.05/218.23  |- mesh__recordOriginator mesh__D014983 NLM
% 218.05/218.23  |- skos__broader mesh__D014983smesh__D012873
% 218.05/218.23  |- skos__broader mesh__D014983smesh__D010859
% 218.05/218.23  |- skos__broader mesh__D014983smesh__D012868
% 218.05/218.23  |- skos__annotation mesh__D014983
% 218.05/218.23       if non-neoplastic, coordinate IM with precoordinated organ/disease term %28%IM%29%; if neoplastic, coordinate IM with organ/neoplasm term %28%IM%29%; do not confuse KAPOSI DISEASE with SARCOMA, KAPOSI%A%  
% 218.05/218.23  |- skos__hiddenLabel mesh__D014983 Kaposis Disease
% 218.05/218.23  |- mesh__dateCreated mesh__D014983 1999-01-01
% 218.05/218.23  |- rdf__type mesh__D014983sskos__Concept
% 218.05/218.23  |- skos__broader mesh__D014983smesh__D049914
% 218.05/218.23  |- skos__scopeNote mesh__D014983
% 218.05/218.23       A rare, pigmentary, and atrophic autosomal recessive disease. It is manifested as an extreme photosensitivity to ULTRAVIOLET RAYS as the result of a deficiency in the enzyme that permits excisional repair of ultraviolet-damaged DNA.%A%    
% 218.05/218.23  |- mesh__dateCreated mesh__D014185 1975-02-04
% 218.05/218.23  |- skos__hiddenLabel mesh__D014185 Isogeneic Homograft
% 218.05/218.23  |- rdf__type mesh__D014185sskos__Concept
% 218.05/218.23  |- skos__altLabel mesh__D014185 Transplantations, Syngeneic
% 218.05/218.23  |- mesh__recordAuthorizer mesh__D014185 sjn
% 218.05/218.23  |- skos__hiddenLabel mesh__D014185 Isografts
% 218.05/218.23  |- skos__altLabel mesh__D014185 Homograft, Isogeneic
% 218.05/218.23  |- skos__hiddenLabel mesh__D014185 Homografts, Isogeneic
% 218.05/218.23  |- skos__scopeNote mesh__D014185
% 218.05/218.23       Transplantation between genetically identical individuals, i.e., members of the same species with identical histocompatibility antigens, such as monozygotic twins, members of the same inbred strain, or members of a hybrid population produced by crossing certain inbred strains.%A%    
% 218.05/218.23  |- skos__annotation mesh__D014185
% 218.05/218.23       NIM: TN 243; no qualif when NIM coord; when IM, qualif permitted; Manual 19.8.75; DF: TRANSPL ISOGEN%A%  
% 218.05/218.23  |- mesh__dateRevised mesh__D014185 2002-07-03
% 218.05/218.23  |- mesh__recordMaintainer mesh__D014185 lkt
% 218.05/218.23  |- skos__hiddenLabel mesh__D014185 Homografts, Syngeneic
% 218.05/218.23  |- skos__prefLabel mesh__D014185 Transplantation, Isogeneic
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D014185 2005
% 218.05/218.23  |- skos__altLabel mesh__D014185 Transplantations, Isogeneic
% 218.05/218.23  |- mesh__publicMeSHNote mesh__D014185
% 218.05/218.23       80; was see under TRANSPLANTATION, HOMOLOGOUS 1975-79   
% 218.05/218.23  |- mesh__recordOriginator mesh__D014185 NLM
% 218.05/218.23  |- skos__altLabel mesh__D014185 Homograft, Syngeneic
% 218.05/218.23  |- mesh__historyNote mesh__D014185
% 218.05/218.23       80%28%75%29%; was see under TRANSPLANTATION, HOMOLOGOUS 1975-79%A%  
% 218.05/218.23  |- mesh__activeMeSHYear mesh__D014185 2006
% 218.05/218.23  |- skos__altLabel mesh__D014185 Isograft
% 218.05/218.23  |- skos__hiddenLabel mesh__D014185 Syngeneic Homograft
% 218.05/218.23  |- mesh__dateEstablished mesh__D014185 1980-01-01
% 218.05/218.23  |- skos__broader mesh__D014185smesh__D014184
% 218.05/218.23  |- skos__altLabel mesh__D014185 Syngeneic Transplantation
% 218.05/218.24  |- skos__altLabel mesh__D014185 Isogeneic Transplantations
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D014185 2003
% 218.05/218.24  |- skos__altLabel mesh__D014185 Transplantation, Syngeneic
% 218.05/218.24  |- skos__hiddenLabel mesh__D014185 Syngeneic Homografts
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D014185 2004
% 218.05/218.24  |- skos__hiddenLabel mesh__D014185 Isogeneic Homografts
% 218.05/218.24  |- skos__altLabel mesh__D014185 Syngeneic Transplantations
% 218.05/218.24  |- skos__historyNote mesh__D014185
% 218.05/218.24       Transplantation, Homologous %28%1966-1974%29%
% 218.05/218.24  |- skos__altLabel mesh__D014185 Isogeneic Transplantation
% 218.05/218.24  |- mesh__dateCreated mesh__D008946 1999-01-01
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008946 2005
% 218.05/218.24  |- skos__hiddenLabel mesh__D008946 Valve Stenosis, Mitral
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008946 2000
% 218.05/218.24  |- skos__prefLabel mesh__D008946 Mitral Valve Stenosis
% 218.05/218.24  |- rdf__type mesh__D008946sskos__Concept
% 218.05/218.24  |- mesh__dateEstablished mesh__D008946 1967-01-01
% 218.05/218.24  |- mesh__publicMeSHNote mesh__D008946 67; was MITRAL STENOSIS 1963-66   
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008946 2005A
% 218.05/218.24  |- skos__hiddenLabel mesh__D008946 Stenosis, Mitral Valve
% 218.05/218.24  |- mesh__recordMaintainer mesh__D008946 jls
% 218.05/218.24  |- skos__hiddenLabel mesh__D008946 Stenoses, Mitral
% 218.05/218.24  |- skos__hiddenLabel mesh__D008946 Valve Stenoses, Mitral
% 218.05/218.24  |- mesh__recordAuthorizer mesh__D008946 jls
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008946 1999
% 218.05/218.24  |- mesh__dateRevised mesh__D008946 2004-07-28
% 218.05/218.24  |- skos__broader mesh__D008946smesh__D006349
% 218.05/218.24  |- skos__hiddenLabel mesh__D008946 Stenosis, Mitral
% 218.05/218.24  |- skos__hiddenLabel mesh__D008946 Stenoses, Mitral Valve
% 218.05/218.24  |- mesh__onlineNote mesh__D008946
% 218.05/218.24       use MITRAL VALVE STENOSIS to search MITRAL STENOSIS 1966   
% 218.05/218.24  |- skos__hiddenLabel mesh__D008946 Mitral Valve Stenoses
% 218.05/218.24  |- skos__altLabel mesh__D008946 Mitral Stenosis
% 218.05/218.24  |- mesh__recordOriginator mesh__D008946 NLM
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008946 2004
% 218.05/218.24  |- skos__annotation mesh__D008946 atresia = MITRAL VALVE /abnorm   
% 218.05/218.24  |- skos__scopeNote mesh__D008946
% 218.05/218.24       A rheumatic disease causing diffuse thickening of the mitral valve leaflets by fibrous tissue or calcific deposits. %28%Harrison%27%s Principles of Internal Medicine, 13th ed, p1052%29%%A%    
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008946 2002
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008946 1998
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008946 2006
% 218.05/218.24  |- skos__hiddenLabel mesh__D008946 Mitral Stenoses
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008946 2003
% 218.05/218.24  |- mesh__historyNote mesh__D008946 67; was MITRAL STENOSIS 1963-66   
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008946 2001
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D000963 2005
% 218.05/218.24  |- skos__prefLabel mesh__D000963 Antimetabolites
% 218.05/218.24  |- mesh__dateCreated mesh__D000963 1999-01-01
% 218.05/218.24  |- skos__broader mesh__D000963smesh__D045504
% 218.05/218.24  |- mesh__recordOriginator mesh__D000963 NLM
% 218.05/218.24  |- rdf__type mesh__D000963sskos__Concept
% 218.05/218.24  |- mesh__recordAuthorizer mesh__D000963 sjn
% 218.05/218.24  |- skos__broader mesh__D000963smesh__D009676
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D000963 2006
% 218.05/218.24  |- mesh__recordMaintainer mesh__D000963 ssb
% 218.05/218.24  |- mesh__dateRevised mesh__D000963 2003-07-09
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D000963 2004
% 218.05/218.24  |- skos__scopeNote mesh__D000963
% 218.05/218.24       Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. %28%From AMA Drug Evaluations Annual, 1994, p2033%29%%A%    
% 218.05/218.24  |- skos__altLabel mesh__D008148 Mevinolin
% 218.05/218.24  |- skos__historyNote mesh__D008148
% 218.05/218.24       Hydroxymethylglutaryl CoA Reductases/antagonists %26% inhibitors %28%1977-1987%29%
% 218.05/218.24  |- skos__hiddenLabel mesh__D008148 6 Methylcompactin
% 218.05/218.24  |- skos__annotation mesh__D008148 /biosyn permitted if by fungus   
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008148 2003
% 218.05/218.24  |- skos__hiddenLabel mesh__D008148 MK803
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008148 2004
% 218.05/218.24  |- mesh__recordMaintainer mesh__D008148 CCR
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008148 2005
% 218.05/218.24  |- skos__prefLabel mesh__D008148 Lovastatin
% 218.05/218.24  |- skos__broader mesh__D008148smesh__D009281
% 218.05/218.24  |- rdf__type mesh__D008148sskos__Concept
% 218.05/218.24  |- skos__hiddenLabel mesh__D008148 MK 803
% 218.05/218.24  |- mesh__historyNote mesh__D008148
% 218.05/218.24       88; for MONACOLIN K use LOVASTATIN %28%NM%29% 1980-98   
% 218.05/218.24  |- mesh__dateCreated mesh__D008148 1987-05-04
% 218.05/218.24  |- skos__altLabel mesh__D008148 Monacolin K
% 218.05/218.24  |- skos__historyNote mesh__D008148
% 218.05/218.24       Anticholesteremic Agents %28%1966-1987%29%
% 218.05/218.24  |- mesh__dateEstablished mesh__D008148 1988-01-01
% 218.05/218.24  |- skos__altLabel mesh__D008148 6-Methylcompactin
% 218.05/218.24  |- mesh__recordOriginator mesh__D008148 RLS
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008148 2006
% 218.05/218.24  |- mesh__publicMeSHNote mesh__D008148
% 218.05/218.24       88; MONACOLIN K was indexed under NAPHTHALENES 1981-98 %26% ANTIBIOTICS 1980%A%  
% 218.05/218.24  |- skos__historyNote mesh__D008148 Naphthalenes %28%1966-1987%29%
% 218.05/218.24  |- mesh__recordAuthorizer mesh__D008148 sjn
% 218.05/218.24  |- skos__scopeNote mesh__D008148
% 218.05/218.24       A fungal metabolite isolated from cultures of Aspergillus terreus. The compound is a potent anticholesteremic agent. It inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase %28%HYDROXYMETHYLGLUTARYL COA REDUCTASES%29%, which is the rate-limiting enzyme in cholesterol biosynthesis. It also stimulates the production of low-density lipoprotein receptors in the liver.%A%    
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008148 2002
% 218.05/218.24  |- mesh__dateRevised mesh__D008148 2001-07-25
% 218.05/218.24  |- skos__hiddenLabel mesh__D000165 Acridine Diamine, Tetramethyl
% 218.05/218.24  |- mesh__dateEstablished mesh__D000165 1979-01-01
% 218.05/218.24  |- mesh__dateCreated mesh__D000165 1978-02-01
% 218.05/218.24  |- mesh__publicMeSHNote mesh__D000165 79   
% 218.05/218.24  |- mesh__recordAuthorizer mesh__D000165 sjn
% 218.05/218.24  |- rdf__type mesh__D000165sskos__Concept
% 218.05/218.24  |- skos__hiddenLabel mesh__D000165 Orange, Acridine
% 218.05/218.24  |- skos__hiddenLabel mesh__D000165 Orange, Rhoduline
% 218.05/218.24  |- skos__hiddenLabel mesh__D000165 Diamine, Tetramethyl Acridine
% 218.05/218.24  |- mesh__dateRevised mesh__D000165 2001-07-25
% 218.05/218.24  |- skos__hiddenLabel mesh__D000165 Base, Acridine Orange
% 218.05/218.24  |- skos__altLabel mesh__D000165 3,6-Bis%28%dimethylamino%29%acridine
% 218.05/218.24  |- mesh__recordOriginator mesh__D000165 SH
% 218.05/218.24  |- skos__annotation mesh__D000165 D25-26 qualif   
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D000165 2003
% 218.05/218.24  |- skos__hiddenLabel mesh__D000165 Orange 3RN, Basic
% 218.05/218.24  |- skos__hiddenLabel mesh__D000165 Orange Base, Acridine
% 218.05/218.24  |- skos__altLabel mesh__D000165 Rhoduline Orange
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D000165 2005
% 218.05/218.24  |- skos__historyNote mesh__D000165 Dimethylamines %28%1974%29%
% 218.05/218.24  |- skos__broader mesh__D000165smesh__D000609
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D000165 2004
% 218.05/218.24  |- mesh__recordMaintainer mesh__D000165 jmp
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D000165 2006
% 218.05/218.24  |- skos__historyNote mesh__D000165 Acridines %28%1966-1978%29%
% 218.05/218.24  |- skos__scopeNote mesh__D000165
% 218.05/218.24       A cationic cytochemical stain specific for cell nuclei, especially DNA. It is used as a supravital stain and in fluorescence cytochemistry. It may cause mutations in microorganisms.%A%    
% 218.05/218.24  |- skos__prefLabel mesh__D000165 Acridine Orange
% 218.05/218.24  |- skos__altLabel mesh__D000165 Acridine Orange Base
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D000165 2002
% 218.05/218.24  |- mesh__historyNote mesh__D000165 79   
% 218.05/218.24  |- skos__altLabel mesh__D018576 Homemaker-Home Health Aides
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D018576 2006
% 218.05/218.24  |- skos__scopeNote mesh__D018576
% 218.05/218.24       Persons who assist ill, elderly, or disabled persons in the home, carrying out personal care and housekeeping tasks. %28%From Slee %26% Slee, Health Care Terms. 2d ed, p202%29%%A%    
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D018576 2001
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D018576 1999
% 218.05/218.24  |- rdf__type mesh__D018576sskos__Concept
% 218.05/218.24  |- skos__hiddenLabel mesh__D018576 Aides, Home Care
% 218.05/218.24  |- skos__hiddenLabel mesh__D018576 Health Aide, Homemaker-Home
% 218.05/218.24  |- skos__hiddenLabel mesh__D018576 Care Aide, Home
% 218.05/218.24  |- skos__hiddenLabel mesh__D018576 Aide, Homemaker-Home Health
% 218.05/218.24  |- skos__hiddenLabel mesh__D018576 Health Aides, Homemaker-Home
% 218.05/218.24  |- skos__hiddenLabel mesh__D018576 Aides, Home Health
% 218.05/218.24  |- skos__hiddenLabel mesh__D018576 Home Health Aide
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D018576 2005
% 218.05/218.24  |- skos__hiddenLabel mesh__D018576 Aide, Home Care
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D018576 1998
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D018576 2000
% 218.05/218.24  |- mesh__dateEstablished mesh__D018576 1995-01-01
% 218.05/218.24  |- skos__broader mesh__D018576smesh__D000488
% 218.05/218.24  |- skos__hiddenLabel mesh__D018576 Care Aides, Home
% 218.05/218.24  |- mesh__recordAuthorizer mesh__D018576 PLS
% 218.05/218.24  |- mesh__dateCreated mesh__D018576 1994-04-19
% 218.05/218.24  |- skos__hiddenLabel mesh__D018576 Home Care Aide
% 218.05/218.24  |- skos__annotation mesh__D018576
% 218.05/218.24       coord IM with specific home health care %28%IM%29%   
% 218.05/218.24  |- skos__hiddenLabel mesh__D018576 Health Aide, Home
% 218.05/218.24  |- skos__historyNote mesh__D018576 Nurses%27% Aides %28%1966-1994%29%
% 218.05/218.24  |- skos__hiddenLabel mesh__D018576 Aide, Home Health
% 218.05/218.24  |- skos__historyNote mesh__D018576 Home Care Services %28%1967-1994%29%
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D018576 2004
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D018576 1997
% 218.05/218.24  |- skos__prefLabel mesh__D018576 Home Health Aides
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D018576 2002
% 218.05/218.24  |- skos__altLabel mesh__D018576 Home Care Aides
% 218.05/218.24  |- skos__hiddenLabel mesh__D018576 Homemaker Home Health Aides
% 218.05/218.24  |- skos__hiddenLabel mesh__D018576 Aides, Homemaker-Home Health
% 218.05/218.24  |- mesh__dateRevised mesh__D018576 1995-06-08
% 218.05/218.24  |- skos__hiddenLabel mesh__D018576 Homemaker-Home Health Aide
% 218.05/218.24  |- mesh__historyNote mesh__D018576 95   
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D018576 2003
% 218.05/218.24  |- mesh__recordOriginator mesh__D018576 JLS
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D018576 1996
% 218.05/218.24  |- skos__hiddenLabel mesh__D018576 Health Aides, Home
% 218.05/218.24  |- mesh__publicMeSHNote mesh__D018576 95   
% 218.05/218.24  |- mesh__recordMaintainer mesh__D018576 TAP
% 218.05/218.24  |- skos__broader mesh__D010593smesh__D006296
% 218.05/218.24  |- skos__hiddenLabel mesh__D010593 Care, Pharmaceutical
% 218.05/218.24  |- skos__historyNote mesh__D010593 Pharmacy %28%1966-1967%29%
% 218.05/218.24  |- skos__altLabel mesh__D010593 Services, Pharmacy
% 218.05/218.24  |- skos__hiddenLabel mesh__D010593 Pharmaceutical Service
% 218.05/218.24  |- skos__altLabel mesh__D010593 Services, Pharmaceutical
% 218.05/218.24  |- mesh__historyNote mesh__D010593 68   
% 218.05/218.24  |- skos__historyNote mesh__D010593 Prescriptions %28%1966-1967%29%
% 218.05/218.24  |- skos__hiddenLabel mesh__D010593 Cares, Pharmaceutical
% 218.05/218.24  |- skos__scopeNote mesh__D010593
% 218.05/218.24       Total pharmaceutical services provided by qualified PHARMACISTS. In addition to the preparation and distribution of medical products, they may include consultative services provided to agencies and institutions which do not have a qualified pharmacist.%A%    
% 218.05/218.24  |- mesh__recordAuthorizer mesh__D010593 sjn
% 218.05/218.24  |- skos__hiddenLabel mesh__D010593 Pharmacy Service
% 218.05/218.24  |- skos__altLabel mesh__D010593 Services, Pharmaceutic
% 218.05/218.24  |- mesh__dateCreated mesh__D010593 1999-01-01
% 218.05/218.24  |- skos__hiddenLabel mesh__D010593 Pharmaceutic Service
% 218.05/218.24  |- mesh__publicMeSHNote mesh__D010593 68   
% 218.05/218.24  |- skos__hiddenLabel mesh__D010593 Pharmaceutical Cares
% 218.05/218.24  |- mesh__dateEstablished mesh__D010593 1968-01-01
% 218.05/218.24  |- mesh__recordOriginator mesh__D010593 NLM
% 218.05/218.24  |- mesh__recordMaintainer mesh__D010593 lkt
% 218.05/218.24  |- rdf__type mesh__D010593sskos__Concept
% 218.05/218.24  |- skos__hiddenLabel mesh__D010593 Service, Pharmaceutical
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D010593 2005
% 218.05/218.24  |- skos__hiddenLabel mesh__D010593 Service, Pharmaceutic
% 218.05/218.24  |- mesh__dateRevised mesh__D010593 2004-07-07
% 218.05/218.24  |- skos__hiddenLabel mesh__D010593 Service, Pharmacy
% 218.05/218.24  |- skos__altLabel mesh__D010593 Pharmacy Services
% 218.05/218.24  |- skos__altLabel mesh__D010593 Pharmaceutic Services
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D010593 2006
% 218.05/218.24  |- skos__prefLabel mesh__D010593 Pharmaceutical Services
% 218.05/218.24  |- skos__annotation mesh__D010593 DF: PHARM SERV   
% 218.05/218.24  |- mesh__historyNote mesh__D051401 2006%28%1995%29%   
% 218.05/218.24  |- mesh__recordAuthorizer mesh__D051401 sjn
% 218.05/218.24  |- mesh__dateEstablished mesh__D051401 2006-01-01
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D051401 2006
% 218.05/218.24  |- skos__altLabel mesh__D051401 Aquaporin 4 Protein
% 218.05/218.24  |- mesh__recordOriginator mesh__D051401 DRC
% 218.05/218.24  |- mesh__publicMeSHNote mesh__D051401
% 218.05/218.24       2006; AQUAPORIN 4 was indexed under AQUAPORINS 1999-2005, %26% under ION CHANNELS 1995-1998%A%  
% 218.05/218.24  |- rdf__type mesh__D051401sskos__Concept
% 218.05/218.24  |- mesh__dateCreated mesh__D051401 2005-06-30
% 218.05/218.24  |- mesh__recordMaintainer mesh__D051401 DRC
% 218.05/218.24  |- skos__prefLabel mesh__D051401 Aquaporin 4
% 218.05/218.24  |- skos__altLabel mesh__D051401 AQP4 Protein
% 218.05/218.24  |- skos__broader mesh__D051401smesh__D020346
% 218.05/218.24  |- skos__scopeNote mesh__D051401
% 218.05/218.24       Aquaporin 4 is the major water-selective channel in the CENTRAL NERVOUS SYSTEM of mammals.%A%    
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D004556 2004
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D004556 2001
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D004556 1998
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D004556 2006
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D004556 1997
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D004556 1994
% 218.05/218.24  |- skos__annotation mesh__D004556
% 218.05/218.24       consider also BURNS, ELECTRIC; accidental shock by electricity is ELECTRIC INJURIES, not ELECTROSHOCK %28%for exper shock by electricity usually in psychol lit%29%%A%  
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D004556 1999
% 218.05/218.24  |- skos__hiddenLabel mesh__D004556 Injury, Electric
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D004556 1993
% 218.05/218.24  |- mesh__historyNote mesh__D004556 73; was ELECTRIC INJURY 1963-72   
% 218.05/218.24  |- mesh__onlineNote mesh__D004556
% 218.05/218.24       use ELECTRIC INJURIES to search ELECTRIC INJURY 1966-72   
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D004556 1995
% 218.05/218.24  |- skos__broader mesh__D004556smesh__D014947
% 218.05/218.24  |- rdf__type mesh__D004556sskos__Concept
% 218.05/218.24  |- skos__hiddenLabel mesh__D004556 Electrocutions, Accidental
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D004556 2002
% 218.05/218.24  |- mesh__dateEstablished mesh__D004556 1973-01-01
% 218.05/218.24  |- mesh__recordMaintainer mesh__D004556 TGC
% 218.05/218.24  |- mesh__dateCreated mesh__D004556 1999-01-01
% 218.05/218.24  |- skos__hiddenLabel mesh__D004556 Accidental Electrocutions
% 218.05/218.24  |- mesh__publicMeSHNote mesh__D004556 73; was ELECTRIC INJURY 1963-72   
% 218.05/218.24  |- skos__altLabel mesh__D004556 Injuries, Electric
% 218.05/218.24  |- skos__hiddenLabel mesh__D004556 Accidental Electrocution
% 218.05/218.24  |- mesh__dateRevised mesh__D004556 1992-05-15
% 218.05/218.24  |- skos__prefLabel mesh__D004556 Electric Injuries
% 218.05/218.24  |- mesh__recordOriginator mesh__D004556 NLM
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D004556 2003
% 218.05/218.24  |- skos__hiddenLabel mesh__D004556 Electric Injury
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D004556 2000
% 218.05/218.24  |- skos__scopeNote mesh__D004556
% 218.05/218.24       Injuries caused by electric currents. The concept excludes electric burns %28%BURNS, ELECTRIC%29%, but includes accidental electrocution and electric shock.%A%    
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D004556 2005
% 218.05/218.24  |- mesh__recordAuthorizer mesh__D004556 PLS
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D004556 1996
% 218.05/218.24  |- skos__broader mesh__D009241smesh__D001286
% 218.05/218.24  |- skos__historyNote mesh__D009241 Propane %28%1973-1974%29%
% 218.05/218.24  |- mesh__dateCreated mesh__D009241 1974-11-19
% 218.05/218.24  |- mesh__recordAuthorizer mesh__D009241 sjn
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D009241 2002
% 218.05/218.24  |- skos__hiddenLabel mesh__D009241 N Isopropylatropine
% 218.05/218.24  |- mesh__recordOriginator mesh__D009241 NLM
% 218.05/218.24  |- skos__historyNote mesh__D009241 Atropine %28%1973-1974%29%
% 218.05/218.24  |- mesh__onlineNote mesh__D009241
% 218.05/218.24       use IPRATROPIUM to search N-ISOPROPYLATROPINE 1975-92 %26% IPRATROPIUM BROMIDE 1976-92%A%  
% 218.05/218.24  |- mesh__dateEstablished mesh__D009241 1991-01-01
% 218.05/218.24  |- skos__hiddenLabel mesh__D009241 Sch1000
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D009241 2003
% 218.05/218.24  |- skos__prefLabel mesh__D009241 Ipratropium
% 218.05/218.24  |- skos__hiddenLabel mesh__D009241 Sch1178
% 218.05/218.24  |- skos__altLabel mesh__D009241 N-Isopropylatropine
% 218.05/218.24  |- rdf__type mesh__D009241sskos__Concept
% 218.05/218.24  |- mesh__publicMeSHNote mesh__D009241
% 218.05/218.24       93; was N-ISOPROPYLATROPINE 1975-92 %28%see under ATROPINE DERIVATIVES 1978-90, see under ATROPINE 1975-77%29%; IPRATROPIUM BROMIDE was see N-ISOPROPYLATROPINE 1976-92%A%  
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D009241 2005
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D009241 2004
% 218.05/218.24  |- skos__altLabel mesh__D009241
% 218.05/218.24       %28%endo,syn%29%-%28%+-%29%-3-%28%3-Hydroxy-1-oxo-2-phenylpropoxy%29%-8-methyl-8-%28%1-methylethyl%29%-8-azoniabicyclo%28%3.2.1%29%octane
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D009241 2001
% 218.05/218.24  |- skos__hiddenLabel mesh__D009241 Sch 1178
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D009241 2006
% 218.05/218.24  |- skos__scopeNote mesh__D009241
% 218.05/218.24       A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic.%A%    
% 218.05/218.24  |- skos__hiddenLabel mesh__D009241 Sch 1000
% 218.05/218.24  |- mesh__recordMaintainer mesh__D009241 TWD
% 218.05/218.24  |- mesh__dateRevised mesh__D009241 2000-06-21
% 218.05/218.24  |- mesh__historyNote mesh__D009241
% 218.05/218.24       93; was N-ISOPROPYLATROPINE 1975-92 %28%see under ATROPINE DERIVATIVES 1978-90 %26% see under ATROPINE 1975-77%29%; IPRATROPIUM BROMIDE was see N-ISOPROPYLATROPINE 1976-92%A%  
% 218.05/218.24  |- mesh__recordOriginator mesh__D014984 SMH
% 218.05/218.24  |- skos__altLabel mesh__D014984 Xeroradiography, Breast
% 218.05/218.24  |- mesh__historyNote mesh__D014984
% 218.05/218.24       91%28%77%29%; was see under MAMMOGRAPHY 1977-90   
% 218.05/218.24  |- mesh__dateCreated mesh__D014984 1976-04-27
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D014984 1998
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D014984 2003
% 218.05/218.24  |- mesh__dateEstablished mesh__D014984 1991-01-01
% 218.05/218.24  |- skos__broader mesh__D014984smesh__D014986
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D014984 2000
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D014984 1999
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D014984 2004
% 218.05/218.24  |- skos__historyNote mesh__D014984 Xeroradiography %28%1968-1976%29%
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D014984 2001
% 218.05/218.24  |- rdf__type mesh__D014984sskos__Concept
% 218.05/218.24  |- skos__scopeNote mesh__D014984 Xeroradiography of the breast.     
% 218.05/218.24  |- skos__historyNote mesh__D014984 Mammography %28%1966-1976%29%
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D014984 2005
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D014984 2002
% 218.05/218.24  |- mesh__publicMeSHNote mesh__D014984
% 218.05/218.24       91; was see under MAMMOGRAPHY 1977-90   
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D014984 2006
% 218.05/218.24  |- skos__prefLabel mesh__D014984 Xeromammography
% 218.05/218.24  |- skos__altLabel mesh__D014984 Breast Xeroradiography
% 218.05/218.24  |- mesh__recordAuthorizer mesh__D014984 SJN
% 218.05/218.24  |- mesh__recordMaintainer mesh__D014984 PXP
% 218.05/218.24  |- skos__annotation mesh__D014984
% 218.05/218.24       do not use /util except by MeSH definition; DF: XEROMAMMOGR%A%  
% 218.05/218.24  |- mesh__dateRevised mesh__D014984 1997-06-20
% 218.05/218.24  |- skos__broader mesh__D014984smesh__D008327
% 218.05/218.24  |- skos__historyNote mesh__D014984
% 218.05/218.24       Breast Neoplasms/radiography %28%1966-1976%29%
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D014186 2000
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D014186 2003
% 218.05/218.24  |- mesh__dateEstablished mesh__D014186 1976-01-01
% 218.05/218.24  |- mesh__dateCreated mesh__D014186 1975-07-21
% 218.05/218.24  |- mesh__recordMaintainer mesh__D014186 kle
% 218.05/218.24  |- skos__scopeNote mesh__D014186
% 218.05/218.24       The means of moving persons, animals, goods, or materials from one place to another.%A%    
% 218.05/218.24  |- rdf__type mesh__D014186sskos__Concept
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D014186 2002
% 218.05/218.24  |- mesh__historyNote mesh__D014186 76; was NON MESH before 1976   
% 218.05/218.24  |- skos__broader mesh__D014186smesh__D013676
% 218.05/218.24  |- mesh__recordAuthorizer mesh__D014186 sjn
% 218.05/218.24  |- mesh__dateRevised mesh__D014186 1999-11-03
% 218.05/218.24  |- skos__annotation mesh__D014186 specify industry or geog if pertinent   
% 218.05/218.24  |- skos__prefLabel mesh__D014186 Transportation
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D014186 2006
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D014186 2001
% 218.05/218.24  |- mesh__recordOriginator mesh__D014186 JW
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D014186 2005
% 218.05/218.24  |- mesh__publicMeSHNote mesh__D014186 76   
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D014186 2004
% 218.05/218.24  |- mesh__dateEstablished mesh__D008947 1979-01-01
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008947 1994
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008947 2000
% 218.05/218.24  |- skos__broader mesh__D008947smesh__D003240
% 218.05/218.24  |- rdf__type mesh__D008947sskos__Concept
% 218.05/218.24  |- skos__altLabel mesh__D008947 MCTD
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008947 2005
% 218.05/218.24  |- skos__historyNote mesh__D008947
% 218.05/218.24       Lupus Erythematosus, Systemic  %28%1972-1978%29%
% 218.05/218.24  |- skos__hiddenLabel mesh__D008947 Syndrome, Sharp
% 218.05/218.24  |- skos__prefLabel mesh__D008947 Mixed Connective Tissue Disease
% 218.05/218.24  |- mesh__historyNote mesh__D008947 79   
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008947 1997
% 218.05/218.24  |- skos__historyNote mesh__D008947 Scleroderma, Systemic %28%1972-1978%29%
% 218.05/218.24  |- skos__altLabel mesh__D008947 Sharp Syndrome
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008947 1999
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008947 1996
% 218.05/218.24  |- mesh__dateCreated mesh__D008947 1978-05-15
% 218.05/218.24  |- mesh__publicMeSHNote mesh__D008947 79   
% 218.05/218.24  |- skos__annotation mesh__D008947
% 218.05/218.24       disease entity: read definition %26% do not confuse with CONNECTIVE TISSUE DISEASES; DF: MCTD%A%  
% 218.05/218.24  |- mesh__recordAuthorizer mesh__D008947 PLS
% 218.05/218.24  |- mesh__recordOriginator mesh__D008947 AEP
% 218.05/218.24  |- mesh__dateRevised mesh__D008947 1992-05-22
% 218.05/218.24  |- mesh__recordMaintainer mesh__D008947 PLS
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008947 1993
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008947 1998
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008947 2002
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008947 2004
% 218.05/218.24  |- skos__altLabel mesh__D008947 Connective Tissue Disease, Mixed
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008947 1995
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008947 2001
% 218.05/218.24  |- skos__scopeNote mesh__D008947
% 218.05/218.24       A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud%27%s phenomenon. The disease is differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable %28%saline soluble%29% nuclear antigen and a %22%speckled%22% epidermal nuclear staining pattern on direct immunofluorescence.%A%    
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008947 2003
% 218.05/218.24  |- skos__historyNote mesh__D008947 Collagen Diseases %28%1972-1978%29%
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008947 2006
% 218.05/218.24  |- mesh__historyNote mesh__D000964 75   
% 218.05/218.24  |- mesh__recordAuthorizer mesh__D000964 sjn
% 218.05/218.24  |- mesh__publicMeSHNote mesh__D000964 75   
% 218.05/218.24  |- skos__annotation mesh__D000964
% 218.05/218.24       TN 4: relation to ANTINEOPLASTIC AGENTS   
% 218.05/218.24  |- skos__scopeNote mesh__D000964
% 218.05/218.24       Antimetabolites that are useful in cancer chemotherapy.%A%    
% 218.05/218.24  |- skos__prefLabel mesh__D000964 Antimetabolites, Antineoplastic
% 218.05/218.24  |- skos__broader mesh__D000964smesh__D000963
% 218.05/218.24  |- skos__broader mesh__D000964smesh__D000970
% 218.05/218.24  |- rdf__type mesh__D000964sskos__Concept
% 218.05/218.24  |- skos__altLabel mesh__D000964 Antineoplastic Antimetabolites
% 218.05/218.24  |- mesh__dateRevised mesh__D000964 2005-06-30
% 218.05/218.24  |- skos__historyNote mesh__D000964 Antineoplastic Agents %28%1966-1974%29%
% 218.05/218.24  |- mesh__dateCreated mesh__D000964 1999-01-01
% 218.05/218.24  |- mesh__recordOriginator mesh__D000964 NLM
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D000964 2006
% 218.05/218.24  |- mesh__recordMaintainer mesh__D000964 ssb
% 218.05/218.24  |- mesh__dateEstablished mesh__D000964 1975-09-01
% 218.05/218.24  |- skos__broader mesh__D008149smesh__D004644
% 218.05/218.24  |- skos__scopeNote mesh__D008149
% 218.05/218.24       Affection; in psychiatry commonly refers to pleasure, particularly as it applies to gratifying experiences between individuals.%A%    
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008149 2005
% 218.05/218.24  |- mesh__dateRevised mesh__D008149 2004-07-07
% 218.05/218.24  |- rdf__type mesh__D008149sskos__Concept
% 218.05/218.24  |- mesh__recordAuthorizer mesh__D008149 sjn
% 218.05/218.24  |- mesh__recordOriginator mesh__D008149 NLM
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D008149 2006
% 218.05/218.24  |- skos__annotation mesh__D008149 no qualif   
% 218.05/218.24  |- skos__related mesh__D008149smesh__D003380
% 218.05/218.24  |- skos__hiddenLabel mesh__D008149 Loves
% 218.05/218.24  |- mesh__dateCreated mesh__D008149 1999-01-01
% 218.05/218.24  |- mesh__recordMaintainer mesh__D008149 lkt
% 218.05/218.24  |- skos__prefLabel mesh__D008149 Love
% 218.05/218.24  |- rdf__type mesh__D000166sskos__Concept
% 218.05/218.24  |- mesh__dateRevised mesh__D000166 1991-11-02
% 218.05/218.24  |- mesh__dateCreated mesh__D000166 1999-01-01
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D000166 2002
% 218.05/218.24  |- mesh__recordMaintainer mesh__D000166 PLS
% 218.05/218.24  |- mesh__recordAuthorizer mesh__D000166 PLS
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D000166 2003
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D000166 1996
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D000166 2005
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D000166 1998
% 218.05/218.24  |- skos__prefLabel mesh__D000166 Acridines
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D000166 2004
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D000166 1992
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D000166 1997
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D000166 2006
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D000166 2000
% 218.05/218.24  |- skos__broader mesh__D000166smesh__D006575
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D000166 1994
% 218.05/218.24  |- mesh__activeMeSHYear mesh__D000166 1999
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D000166 1993
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D000166 2001
% 218.05/218.25  |- skos__annotation mesh__D000166
% 218.05/218.25       D25-26 qualif; acridinamines %26% acridinylamines = AMINOACRIDINES%A%  
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D000166 1995
% 218.05/218.25  |- mesh__recordOriginator mesh__D000166 NLM
% 218.05/218.25  |- skos__hiddenLabel mesh__D018577 Home-Bound Person
% 218.05/218.25  |- skos__hiddenLabel mesh__D018577 Homebound Person
% 218.05/218.25  |- skos__hiddenLabel mesh__D018577 Person, Homebound
% 218.05/218.25  |- skos__altLabel mesh__D018577 House-Bound Persons
% 218.05/218.25  |- skos__hiddenLabel mesh__D018577 Shut-In
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D018577 2005
% 218.05/218.25  |- skos__prefLabel mesh__D018577 Homebound Persons
% 218.05/218.25  |- skos__hiddenLabel mesh__D018577 Person, Home-Bound
% 218.05/218.25  |- skos__hiddenLabel mesh__D018577 House-Bound Person
% 218.05/218.25  |- skos__hiddenLabel mesh__D018577 Persons, House-Bound
% 218.05/218.25  |- mesh__historyNote mesh__D018577 95   
% 218.05/218.25  |- mesh__recordOriginator mesh__D018577 JLS
% 218.05/218.25  |- mesh__publicMeSHNote mesh__D018577 95   
% 218.05/218.25  |- skos__altLabel mesh__D018577 Shut-Ins
% 218.05/218.25  |- mesh__recordAuthorizer mesh__D018577 sjn
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D018577 2006
% 218.05/218.25  |- mesh__dateCreated mesh__D018577 1994-06-06
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D018577 2002
% 218.05/218.25  |- skos__annotation mesh__D018577
% 218.05/218.25       IM; homebound elderly: coord IM with AGED; AGED, 80 AND OVER or FRAIL ELDERLY %28%IM%29% only when aged is point of article%A%  
% 218.05/218.25  |- skos__historyNote mesh__D018577 Disabled %28%1983-1994%29%
% 218.05/218.25  |- skos__hiddenLabel mesh__D018577 Home Bound Persons
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D018577 2003
% 218.05/218.25  |- skos__hiddenLabel mesh__D018577 Shut Ins
% 218.05/218.25  |- skos__broader mesh__D018577smesh__D009272
% 218.05/218.25  |- mesh__recordMaintainer mesh__D018577 mdb
% 218.05/218.25  |- mesh__dateRevised mesh__D018577 2001-07-25
% 218.05/218.25  |- rdf__type mesh__D018577sskos__Concept
% 218.05/218.25  |- skos__scopeNote mesh__D018577
% 218.05/218.25       Those unable to leave home without exceptional effort and support; patients %28%in this condition%29% who are provided with or are eligible for home health services, including medical treatment and personal care. Persons are considered homebound even if they may be infrequently and briefly absent from home if these absences do not indicate an ability to receive health care in a professional%27%s office or health care facility. %28%From Facts on File Dictionary of Health Care Management, 1988, p309%29%%A%    
% 218.05/218.25  |- skos__altLabel mesh__D018577 Home-Bound Persons
% 218.05/218.25  |- mesh__dateEstablished mesh__D018577 1995-01-01
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D018577 2004
% 218.05/218.25  |- skos__hiddenLabel mesh__D018577 House Bound Persons
% 218.05/218.25  |- skos__hiddenLabel mesh__D018577 Persons, Homebound
% 218.05/218.25  |- skos__hiddenLabel mesh__D018577 Persons, Home-Bound
% 218.05/218.25  |- skos__hiddenLabel mesh__D018577 Person, House-Bound
% 218.05/218.25  |- mesh__recordOriginator mesh__D010594 NLM
% 218.05/218.25  |- skos__hiddenLabel mesh__D010594 Pharmacy Distributions
% 218.05/218.25  |- skos__hiddenLabel mesh__D010594 Distributions, Pharmacy
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D010594 2002
% 218.05/218.25  |- skos__hiddenLabel mesh__D010594 Distribution, Pharmacy
% 218.05/218.25  |- skos__hiddenLabel mesh__D010594 Community Pharmacy
% 218.05/218.25  |- skos__annotation mesh__D010594
% 218.05/218.25       the place: do not confuse with PHARMACY, the field   
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D010594 2006
% 218.05/218.25  |- mesh__recordMaintainer mesh__D010594 kle
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D010594 2001
% 218.05/218.25  |- mesh__dateCreated mesh__D010594 1999-01-01
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D010594 2005
% 218.05/218.25  |- mesh__historyNote mesh__D010594
% 218.05/218.25       COMMUNITY PHARMACIES was see under PHARMACIES 1968-78   
% 218.05/218.25  |- skos__broader mesh__D010594smesh__D006268
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D010594 2000
% 218.05/218.25  |- skos__prefLabel mesh__D010594 Pharmacies
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D010594 2004
% 218.05/218.25  |- skos__scopeNote mesh__D010594
% 218.05/218.25       Facilities for the preparation and dispensing of drugs.%A%    
% 218.05/218.25  |- skos__hiddenLabel mesh__D010594 Pharmacy, Community
% 218.05/218.25  |- mesh__onlineNote mesh__D010594
% 218.05/218.25       use PHARMACIES to search COMMUNITY PHARMACIES 1968-78   
% 218.05/218.25  |- mesh__recordAuthorizer mesh__D010594 sjn
% 218.05/218.25  |- skos__hiddenLabel mesh__D010594 Pharmacies, Community
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D010594 2003
% 218.05/218.25  |- mesh__dateRevised mesh__D010594 1999-11-03
% 218.05/218.25  |- rdf__type mesh__D010594sskos__Concept
% 218.05/218.25  |- mesh__recordOriginator mesh__D051402 DRC
% 218.05/218.25  |- mesh__dateCreated mesh__D051402 2005-06-30
% 218.05/218.25  |- skos__altLabel mesh__D051402 Aquaporin-5
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D051402 2006
% 218.05/218.25  |- skos__broader mesh__D051402smesh__D020346
% 218.05/218.25  |- skos__altLabel mesh__D051402 Aquaporin 5 Protein
% 218.05/218.25  |- skos__scopeNote mesh__D051402
% 218.05/218.25       Aquaporin 5 is a water-specific channel protein that is expressed primarily in alveolar, tracheal, and upper bronchial EPITHELIUM. It plays an important role in maintaining water HOMEOSTASIS in the LUNGS and may also regulate release of SALIVA and TEARS in the SALIVARY GLANDS and the LACRIMAL GLAND.%A%    
% 218.05/218.25  |- skos__altLabel mesh__D051402 AQP5 Protein
% 218.05/218.25  |- mesh__publicMeSHNote mesh__D051402
% 218.05/218.25       2006; AQUAPORIN 5 was indexed under AQUAPORINS %26% MEMBRANE PROTEINS 1999-2005, %26% under ION CHANNELS 1996-1998%A%  
% 218.05/218.25  |- mesh__recordAuthorizer mesh__D051402 sjn
% 218.05/218.25  |- mesh__historyNote mesh__D051402 2006%28%1996%29%   
% 218.05/218.25  |- rdf__type mesh__D051402sskos__Concept
% 218.05/218.25  |- mesh__dateEstablished mesh__D051402 2006-01-01
% 218.05/218.25  |- skos__prefLabel mesh__D051402 Aquaporin 5
% 218.05/218.25  |- mesh__recordMaintainer mesh__D051402 DRC
% 218.05/218.25  |- skos__prefLabel mesh__D004557 Electric Organ
% 218.05/218.25  |- rdf__type mesh__D004557sskos__Concept
% 218.05/218.25  |- skos__annotation mesh__D004557 animal only; IM   
% 218.05/218.25  |- skos__hiddenLabel mesh__D004557 Organ, Electric
% 218.05/218.25  |- mesh__recordOriginator mesh__D004557 NLM
% 218.05/218.25  |- skos__hiddenLabel mesh__D004557 Electric Organs
% 218.05/218.25  |- mesh__dateCreated mesh__D004557 1999-01-01
% 218.05/218.25  |- mesh__publicMeSHNote mesh__D004557 68   
% 218.05/218.25  |- mesh__historyNote mesh__D004557 68%28%63%29%   
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D004557 2000
% 218.05/218.25  |- mesh__recordAuthorizer mesh__D004557 PLS
% 218.05/218.25  |- mesh__recordMaintainer mesh__D004557 TGC
% 218.05/218.25  |- skos__scopeNote mesh__D004557
% 218.05/218.25       In about 250 species of electric fishes, modified muscle fibers forming disklike multinucleate plates arranged in stacks like batteries in series and embedded in a gelatinous matrix. A large torpedo ray may have half a million plates. Muscles in different parts of the body may be modified, i.e., the trunk and tail in the electric eel, the hyobranchial apparatus in the electric ray, and extrinsic eye muscles in the stargazers. Powerful electric organs emit pulses in brief bursts several times a second. They serve to stun prey and ward off predators. A large torpedo ray can produce of shock of more than 200 volts, capable of stunning a human. %28%Storer et al., General Zoology, 6th ed, p672%29%%A%    
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D004557 2003
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D004557 2001
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D004557 2005
% 218.05/218.25  |- skos__broader mesh__D004557smesh__D000825
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D004557 1996
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D004557 2004
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D004557 2006
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D004557 1998
% 218.05/218.25  |- mesh__dateRevised mesh__D004557 1995-05-18
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D004557 1997
% 218.05/218.25  |- skos__hiddenLabel mesh__D004557 Organs, Electric
% 218.05/218.25  |- mesh__dateEstablished mesh__D004557 1968-01-01
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D004557 1999
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D004557 2002
% 218.05/218.25  |- skos__broader mesh__D009242smesh__D009602
% 218.05/218.25  |- mesh__publicMeSHNote mesh__D009242
% 218.05/218.25       91; was see under NITROSAMINES 1979-90   
% 218.05/218.25  |- rdf__type mesh__D009242sskos__Concept
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D009242 2001
% 218.05/218.25  |- mesh__historyNote mesh__D009242
% 218.05/218.25       91%28%79%29%; was see under NITROSAMINES 1979-90   
% 218.05/218.25  |- mesh__dateEstablished mesh__D009242 1991-01-01
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D009242 2005
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D009242 2004
% 218.05/218.25  |- skos__hiddenLabel mesh__D009242 N Nitrosopyrrolidine
% 218.05/218.25  |- skos__scopeNote mesh__D009242
% 218.05/218.25       Carcinogenic nitrosamine that may be formed from preservatives in meats during their preparation or in the liver during metabolism.%A%    
% 218.05/218.25  |- mesh__recordMaintainer mesh__D009242 CCR
% 218.05/218.25  |- mesh__dateCreated mesh__D009242 1978-05-03
% 218.05/218.25  |- skos__annotation mesh__D009242 D25-26 qualif   
% 218.05/218.25  |- skos__broader mesh__D009242smesh__D011759
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D009242 2006
% 218.05/218.25  |- mesh__recordOriginator mesh__D009242 SH
% 218.05/218.25  |- mesh__recordAuthorizer mesh__D009242 sjn
% 218.05/218.25  |- mesh__dateRevised mesh__D009242 2000-06-22
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D009242 2002
% 218.05/218.25  |- skos__prefLabel mesh__D009242 N-Nitrosopyrrolidine
% 218.05/218.25  |- skos__historyNote mesh__D009242 Nitrosamines %28%1966-1978%29%
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D009242 2003
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014985 2003
% 218.05/218.25  |- mesh__recordAuthorizer mesh__D014985 PLS
% 218.05/218.25  |- mesh__recordOriginator mesh__D014985 NLM
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014985 1994
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014985 1999
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014985 2004
% 218.05/218.25  |- mesh__dateRevised mesh__D014985 1991-02-21
% 218.05/218.25  |- mesh__dateCreated mesh__D014985 1999-01-01
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014985 1995
% 218.05/218.25  |- rdf__type mesh__D014985sskos__Concept
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014985 2005
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014985 2006
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014985 2000
% 218.05/218.25  |- skos__broader mesh__D014985smesh__D015352
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014985 1996
% 218.05/218.25  |- skos__annotation mesh__D014985
% 218.05/218.25       dryness of the eyes; do not restrict to the xerosis of vit A defic: use for any cause; do not confuse with DRY EYE SYNDROMES%A%  
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014985 2001
% 218.05/218.25  |- skos__hiddenLabel mesh__D014985 Xerophthalmias
% 218.05/218.25  |- skos__scopeNote mesh__D014985
% 218.05/218.25       Dryness of the eye surfaces caused by deficiency of tears or conjunctival secretions. It may be associated with vitamin A deficiency, trauma, or any condition in which the eyelids do not close completely.%A%    
% 218.05/218.25  |- mesh__recordMaintainer mesh__D014985 TGC
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014985 1992
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014985 1997
% 218.05/218.25  |- skos__broader mesh__D014985smesh__D003229
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014985 2002
% 218.05/218.25  |- skos__prefLabel mesh__D014985 Xerophthalmia
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014985 1993
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014985 1998
% 218.05/218.25  |- skos__prefLabel mesh__D014187 Transportation of Patients
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014187 2001
% 218.05/218.25  |- skos__hiddenLabel mesh__D014187 Patients Transportation
% 218.05/218.25  |- mesh__recordMaintainer mesh__D014187 jls
% 218.05/218.25  |- skos__hiddenLabel mesh__D014187 Patients Transportations
% 218.05/218.25  |- mesh__recordOriginator mesh__D014187 NLM
% 218.05/218.25  |- mesh__dateCreated mesh__D014187 1999-01-01
% 218.05/218.25  |- rdf__type mesh__D014187sskos__Concept
% 218.05/218.25  |- skos__broader mesh__D014187smesh__D004632
% 218.05/218.25  |- skos__altLabel mesh__D014187 Transport, Wounded and Sick
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014187 2000
% 218.05/218.25  |- skos__annotation mesh__D014187
% 218.05/218.25       includes transport inside %28%e.g., bed to bed%29% %26% outside the hosp or elsewhere but do not confuse with PATIENT TRANSFER %28%interfacility or intrahospital transfer for admin reasons with regard to special care or economics%29%%A%  
% 218.05/218.25  |- skos__altLabel mesh__D014187 Transport of Wounded and Sick
% 218.05/218.25  |- mesh__publicMeSHNote mesh__D014187
% 218.05/218.25       78; was TRANSPORT OF WOUNDED AND SICK 1964-77, was TRANSPORT OF WOUNDED 1963%A%  
% 218.05/218.25  |- skos__scopeNote mesh__D014187
% 218.05/218.25       Conveying ill or injured individuals from one place to another.%A%    
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014187 2006
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014187 2002
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014187 2005
% 218.05/218.25  |- mesh__recordAuthorizer mesh__D014187 sjn
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014187 2004
% 218.05/218.25  |- mesh__dateRevised mesh__D014187 1999-11-05
% 218.05/218.25  |- mesh__dateEstablished mesh__D014187 1964-01-01
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D014187 2003
% 218.05/218.25  |- skos__broader mesh__D014187smesh__D004638
% 218.05/218.25  |- mesh__onlineNote mesh__D014187
% 218.05/218.25       use TRANSPORTATION OF PATIENTS to search TRANSPORT OF WOUNDED AND SICK 1966-77%A%  
% 218.05/218.25  |- mesh__historyNote mesh__D014187
% 218.05/218.25       78; was TRANSPORT OF WOUNDED AND SICK 1964-77, was TRANSPORT OF WOUNDED 1963%A%  
% 218.05/218.25  |- skos__broader mesh__D000965smesh__D019216
% 218.05/218.25  |- mesh__recordOriginator mesh__D000965 NLM
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D000965 2002
% 218.05/218.25  |- skos__prefLabel mesh__D000965 Antimony
% 218.05/218.25  |- skos__scopeNote mesh__D000965
% 218.05/218.25       A metallic element that has the atomic symbol Sb, atomic number 51, and atomic weight 121.75. It is used as a metal alloy and as medicinal and poisonous salts. It is toxic and an irritant to the skin and the mucous membranes.%A%    
% 218.05/218.25  |- mesh__dateRevised mesh__D000965 2000-06-21
% 218.05/218.25  |- mesh__recordAuthorizer mesh__D000965 sjn
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D000965 2005
% 218.05/218.25  |- rdf__type mesh__D000965sskos__Concept
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D000965 2003
% 218.05/218.25  |- mesh__dateCreated mesh__D000965 1999-01-01
% 218.05/218.25  |- skos__annotation mesh__D000965
% 218.05/218.25       Sb-121; Sb-123 = ANTIMONY %28%IM%29% + ISOTOPES %28%NIM%29%; Sb-112-120, 122, 124-133 = ANTIMONY %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D000965 2006
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D000965 2004
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D000965 2001
% 218.05/218.25  |- mesh__recordMaintainer mesh__D000965 adp
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D033341 2004
% 218.05/218.25  |- mesh__historyNote mesh__D033341 2003   
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D033341 2005
% 218.05/218.25  |- skos__altLabel mesh__D033341 Fish Lice
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D033341 2006
% 218.05/218.25  |- skos__broader mesh__D033341smesh__D003445
% 218.05/218.25  |- skos__prefLabel mesh__D033341 Arguloida
% 218.05/218.25  |- mesh__dateEstablished mesh__D033341 2003-01-01
% 218.05/218.25  |- skos__scopeNote mesh__D033341
% 218.05/218.25       An order of CRUSTACEA that are parasitic on freshwater fish.%A%    
% 218.05/218.25  |- skos__annotation mesh__D033341
% 218.05/218.25       do not confuse Branchiura the subclass of CRUSTACEA, with Branchiura a genus of ANNELIDA.%A%  
% 218.05/218.25  |- rdf__type mesh__D033341sskos__Concept
% 218.05/218.25  |- mesh__publicMeSHNote mesh__D033341 2003   
% 218.05/218.25  |- mesh__dateCreated mesh__D033341 2002-07-02
% 218.05/218.25  |- mesh__dateRevised mesh__D033341 2003-07-09
% 218.05/218.25  |- skos__altLabel mesh__D000167 Euflavine
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D000167 2005
% 218.05/218.25  |- mesh__onlineNote mesh__D000167 search ACRIDINES 1966-74   
% 218.05/218.25  |- skos__altLabel mesh__D000167 Acriflavine Chloride
% 218.05/218.25  |- skos__prefLabel mesh__D000167 Acriflavine
% 218.05/218.25  |- skos__altLabel mesh__D000167 Euflavin
% 218.05/218.25  |- mesh__historyNote mesh__D000167
% 218.05/218.25       91%28%75%29%; was see under AMINOACRIDINES 1982-90; was see under ACRIDINES 1963-81%A%  
% 218.05/218.25  |- rdf__type mesh__D000167sskos__Concept
% 218.05/218.25  |- skos__broader mesh__D000167smesh__D000609
% 218.05/218.25  |- mesh__recordOriginator mesh__D000167 NLM
% 218.05/218.25  |- skos__hiddenLabel mesh__D000167 Trichydrochloride, Acriflavine
% 218.05/218.25  |- mesh__publicMeSHNote mesh__D000167
% 218.05/218.25       91; was see under AMINOACRIDINES 1982-90; was see under ACRIDINES 1963-81%A%  
% 218.05/218.25  |- mesh__dateEstablished mesh__D000167 1991-01-01
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D000167 2001
% 218.05/218.25  |- skos__annotation mesh__D000167 D25-26 qualif   
% 218.05/218.25  |- mesh__dateRevised mesh__D000167 2000-06-21
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D000167 2004
% 218.05/218.25  |- mesh__dateCreated mesh__D000167 1999-01-01
% 218.05/218.25  |- mesh__recordMaintainer mesh__D000167 jmp
% 218.05/218.25  |- skos__altLabel mesh__D000167 Xanthacridinum
% 218.05/218.25  |- skos__hiddenLabel mesh__D000167 Dihydrochloride, Acriflavine
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D000167 2003
% 218.05/218.25  |- mesh__recordAuthorizer mesh__D000167 sjn
% 218.05/218.25  |- skos__hiddenLabel mesh__D000167 Chloride, Acriflavine
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D000167 2006
% 218.05/218.25  |- skos__scopeNote mesh__D000167
% 218.05/218.25       3,6-Diamino-10-methylacridinium chloride mixt. with 3,6-acridinediamine. Fluorescent dye used as a local antiseptic and also as a biological stain. It intercalates into nucleic acids thereby inhibiting bacterial and viral replication.%A%    
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D000167 2002
% 218.05/218.25  |- mesh__recordMaintainer mesh__D005650 TGC
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D005650 2000
% 218.05/218.25  |- skos__broader mesh__D005650smesh__D003998
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D005650 2004
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D005650 1997
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D005650 2001
% 218.05/218.25  |- mesh__dateRevised mesh__D005650 1992-05-19
% 218.05/218.25  |- mesh__dateCreated mesh__D005650 1999-01-01
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D005650 2002
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D005650 1994
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D005650 1995
% 218.05/218.25  |- mesh__recordAuthorizer mesh__D005650 PLS
% 218.05/218.25  |- skos__prefLabel mesh__D005650 Fumarates
% 218.05/218.25  |- mesh__recordOriginator mesh__D005650 NLM
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D005650 2005
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D005650 1998
% 218.05/218.25  |- rdf__type mesh__D005650sskos__Concept
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D005650 1993
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D005650 2006
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D005650 2003
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D005650 1996
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D005650 1999
% 218.05/218.25  |- skos__historyNote mesh__D046269 Women%27%s Rights %28%1970-2004%29%
% 218.05/218.25  |- skos__scopeNote mesh__D046269
% 218.05/218.25       Reproductive rights rest on the recognition of the basic right of all couples and individuals to decide freely and responsibly the number, spacing and timing of their children and to have the information and means to do so, and the right to attain the highest standard of sexual and reproductive health. They also include the right of all to make decisions concerning reproduction free of discrimination, coercion and violence.%A%    
% 218.05/218.25  |- mesh__recordAuthorizer mesh__D046269 sjn
% 218.05/218.25  |- mesh__dateCreated mesh__D046269 2004-07-07
% 218.05/218.25  |- skos__prefLabel mesh__D046269 Reproductive Rights
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D046269 2006
% 218.05/218.25  |- skos__broader mesh__D046269smesh__D006806
% 218.05/218.25  |- skos__hiddenLabel mesh__D046269 Rights, Reproduction
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D046269 2005
% 218.05/218.25  |- mesh__recordOriginator mesh__D046269 jls
% 218.05/218.25  |- skos__hiddenLabel mesh__D046269 Right, Reproduction
% 218.05/218.25  |- rdf__type mesh__D046269sskos__Concept
% 218.05/218.25  |- skos__hiddenLabel mesh__D046269 Reproduction Right
% 218.05/218.25  |- skos__hiddenLabel mesh__D046269 Rights, Reproductive
% 218.05/218.25  |- mesh__dateEstablished mesh__D046269 2005-01-01
% 218.05/218.25  |- mesh__recordMaintainer mesh__D046269 jls
% 218.05/218.25  |- mesh__historyNote mesh__D046269 2005   
% 218.05/218.25  |- mesh__publicMeSHNote mesh__D046269 2005   
% 218.05/218.25  |- skos__hiddenLabel mesh__D018578 Relations, Hospital-Physician
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D018578 2003
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D018578 1999
% 218.05/218.25  |- skos__hiddenLabel mesh__D018578 Physician Hospital Relations
% 218.05/218.25  |- skos__hiddenLabel mesh__D018578 Physician-Hospital Relation
% 218.05/218.25  |- skos__scopeNote mesh__D018578
% 218.05/218.25       Includes relationships between hospitals, their governing boards, and administrators in regard to physicians, whether or not the physicians are members of the medical staff or have medical staff privileges.%A%    
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D018578 1998
% 218.05/218.25  |- skos__hiddenLabel mesh__D018578 Hospital-Physician Relation
% 218.05/218.25  |- skos__annotation mesh__D018578 no qualif; DF: HOSP PHYSICIAN RELAT   
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D018578 2002
% 218.05/218.25  |- mesh__dateEstablished mesh__D018578 1995-01-01
% 218.05/218.25  |- mesh__historyNote mesh__D018578 95   
% 218.05/218.25  |- mesh__recordOriginator mesh__D018578 JLS
% 218.05/218.25  |- skos__broader mesh__D018578smesh__D011364
% 218.05/218.25  |- mesh__dateRevised mesh__D018578 1997-06-20
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D018578 2006
% 218.05/218.25  |- skos__prefLabel mesh__D018578 Hospital-Physician Relations
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D018578 2001
% 218.05/218.25  |- mesh__recordAuthorizer mesh__D018578 SJN
% 218.05/218.25  |- skos__broader mesh__D018578smesh__D006739
% 218.05/218.25  |- mesh__publicMeSHNote mesh__D018578 95   
% 218.05/218.25  |- skos__hiddenLabel mesh__D018578 Relation, Hospital-Physician
% 218.05/218.25  |- mesh__recordMaintainer mesh__D018578 JLS
% 218.05/218.25  |- skos__hiddenLabel mesh__D018578 Relation, Physician-Hospital
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D018578 2005
% 218.05/218.25  |- skos__altLabel mesh__D018578 Physician-Hospital Relations
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D018578 2004
% 218.05/218.25  |- skos__hiddenLabel mesh__D018578 Hospital Physician Relations
% 218.05/218.25  |- mesh__dateCreated mesh__D018578 1994-05-27
% 218.05/218.25  |- skos__hiddenLabel mesh__D018578 Relations, Physician-Hospital
% 218.05/218.25  |- skos__broader mesh__D018578smesh__D011641
% 218.05/218.25  |- skos__historyNote mesh__D018578 Physicians %28%1966-1994%29%
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D018578 2000
% 218.05/218.25  |- rdf__type mesh__D018578sskos__Concept
% 218.05/218.25  |- mesh__dateEstablished mesh__D010595 1968-01-01
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D010595 2006
% 218.05/218.25  |- mesh__publicMeSHNote mesh__D010595 68   
% 218.05/218.25  |- mesh__dateRevised mesh__D010595 2004-07-07
% 218.05/218.25  |- mesh__dateCreated mesh__D010595 1999-01-01
% 218.05/218.25  |- skos__hiddenLabel mesh__D010595 Clinical Pharmacist
% 218.05/218.25  |- mesh__recordOriginator mesh__D010595 NLM
% 218.05/218.25  |- skos__scopeNote mesh__D010595
% 218.05/218.25       Those persons legally qualified by education and training to engage in the practice of pharmacy.%A%    
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D010595 2005
% 218.05/218.25  |- skos__hiddenLabel mesh__D010595 Pharmacist, Clinical
% 218.05/218.25  |- skos__historyNote mesh__D010595 Pharmacy %28%1966-1967%29%
% 218.05/218.25  |- mesh__recordMaintainer mesh__D010595 lkt
% 218.05/218.25  |- skos__broader mesh__D010595smesh__D006282
% 218.05/218.25  |- skos__hiddenLabel mesh__D010595 Pharmacists, Clinical
% 218.05/218.25  |- skos__hiddenLabel mesh__D010595 Pharmacist
% 218.05/218.25  |- rdf__type mesh__D010595sskos__Concept
% 218.05/218.25  |- mesh__historyNote mesh__D010595 68   
% 218.05/218.25  |- skos__annotation mesh__D010595 IM   
% 218.05/218.25  |- skos__prefLabel mesh__D010595 Pharmacists
% 218.05/218.25  |- mesh__recordAuthorizer mesh__D010595 sjn
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D051403 2006
% 218.05/218.25  |- mesh__recordMaintainer mesh__D051403 DRC
% 218.05/218.25  |- skos__broader mesh__D051403smesh__D051397
% 218.05/218.25  |- mesh__dateCreated mesh__D051403 2005-06-30
% 218.05/218.25  |- mesh__publicMeSHNote mesh__D051403
% 218.05/218.25       2006; AQUAPORIN 6 was indexed under AQUAPORINS 2004-2005   
% 218.05/218.25  |- skos__altLabel mesh__D051403 AQP6 Protein
% 218.05/218.25  |- skos__altLabel mesh__D051403 Aquaporin-6
% 218.05/218.25  |- skos__scopeNote mesh__D051403
% 218.05/218.25       Aquaporin 6 is an aquaglyceroporin that is found primarily in KIDNEY COLLECTING DUCTS. AQP6 protein functions as an anion-selective channel.%A%    
% 218.05/218.25  |- rdf__type mesh__D051403sskos__Concept
% 218.05/218.25  |- mesh__recordAuthorizer mesh__D051403 sjn
% 218.05/218.25  |- skos__prefLabel mesh__D051403 Aquaporin 6
% 218.05/218.25  |- mesh__recordOriginator mesh__D051403 DRC
% 218.05/218.25  |- mesh__historyNote mesh__D051403 2006%28%2004%29%   
% 218.05/218.25  |- skos__altLabel mesh__D051403 Aquaporin 6 Protein
% 218.05/218.25  |- mesh__dateEstablished mesh__D051403 2006-01-01
% 218.05/218.25  |- skos__prefLabel mesh__D004558 Electric Stimulation
% 218.05/218.25  |- mesh__recordOriginator mesh__D004558 NLM
% 218.05/218.25  |- skos__scopeNote mesh__D004558
% 218.05/218.25       Use of electric potential or currents to elicit biological responses.%A%    
% 218.05/218.25  |- mesh__dateCreated mesh__D004558 1999-01-01
% 218.05/218.25  |- skos__related mesh__D004558smesh__D004554
% 218.05/218.25  |- skos__related mesh__D004558smesh__D002304
% 218.05/218.25  |- skos__altLabel mesh__D004558 Stimulation, Electric
% 218.05/218.25  |- skos__related mesh__D004558smesh__D004597
% 218.05/218.25  |- skos__hiddenLabel mesh__D004558 Stimulations, Electric
% 218.05/218.25  |- mesh__dateEstablished mesh__D004558 1965-01-01
% 218.05/218.25  |- skos__hiddenLabel mesh__D004558 Electric Stimulations
% 218.05/218.25  |- mesh__historyNote mesh__D004558 65%28%64%29%   
% 218.05/218.25  |- skos__hiddenLabel mesh__D004558 Electrical Stimulations
% 218.05/218.25  |- skos__related mesh__D004558smesh__D046690
% 218.05/218.25  |- skos__hiddenLabel mesh__D004558 Stimulations, Electrical
% 218.05/218.25  |- skos__hiddenLabel mesh__D004558 Stimulation, Electrical
% 218.05/218.25  |- skos__altLabel mesh__D004558 Electrical Stimulation
% 218.05/218.25  |- mesh__recordAuthorizer mesh__D004558 sjn
% 218.05/218.25  |- mesh__publicMeSHNote mesh__D004558 65   
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D004558 2005
% 218.05/218.25  |- skos__annotation mesh__D004558
% 218.05/218.25       NIM; used therapeutically = ELECTRIC STIMULATION THERAPY   
% 218.05/218.25  |- mesh__dateRevised mesh__D004558 2004-07-07
% 218.05/218.25  |- skos__broader mesh__D004558smesh__D010812
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D004558 2006
% 218.05/218.25  |- rdf__type mesh__D004558sskos__Concept
% 218.05/218.25  |- mesh__recordMaintainer mesh__D004558 ags
% 218.05/218.25  |- skos__related mesh__D004558smesh__D002907
% 218.05/218.25  |- rdf__type mesh__D015280sskos__Concept
% 218.05/218.25  |- skos__altLabel mesh__D015280 Restriction-Modification Systems
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D015280 2004
% 218.05/218.25  |- mesh__dateEstablished mesh__D015280 1989-01-01
% 218.05/218.25  |- mesh__recordMaintainer mesh__D015280 ssb
% 218.05/218.25  |- mesh__dateRevised mesh__D015280 2003-07-09
% 218.05/218.25  |- skos__hiddenLabel mesh__D015280 Systems, Restriction Modification
% 218.05/218.25  |- skos__historyNote mesh__D015280 Methyltransferases %28%1971-1988%29%
% 218.05/218.25  |- skos__hiddenLabel mesh__D015280 Systems, Restriction-Modification
% 218.05/218.25  |- skos__hiddenLabel mesh__D015280 Enzymes, DNA Restriction-Modification
% 218.05/218.25  |- mesh__recordOriginator mesh__D015280 RLS
% 218.05/218.25  |- mesh__dateCreated mesh__D015280 1988-05-23
% 218.05/218.25  |- skos__altLabel mesh__D015280 Restriction Modification Systems
% 218.05/218.25  |- skos__scopeNote mesh__D015280
% 218.05/218.25       Systems consisting of two enzymes, a modification methylase and a restriction endonuclease. They are closely related in their specificity and protect the DNA of a given bacterial species. The methylase adds methyl groups to adenine or cytosine residues in the same target sequence that constitutes the restriction enzyme binding site. The methylation renders the target site resistant to restriction, thereby protecting DNA against cleavage.%A%    
% 218.05/218.25  |- skos__hiddenLabel mesh__D015280 Modification Systems, Restriction
% 218.05/218.25  |- skos__broader mesh__D015280smesh__D004798
% 218.05/218.25  |- mesh__activeMeSHYear mesh__D015280 2006
% 218.05/218.25  |- skos__hiddenLabel mesh__D015280 Restriction-Modification Enzymes, DNA
% 218.05/218.25  |- mesh__recordAuthorizer mesh__D015280 sjn
% 218.05/218.25  |- mesh__historyNote mesh__D015280 89   
% 218.05/218.26  |- skos__historyNote mesh__D015280
% 218.05/218.26       DNA Restriction Enzymes %28%1975-1988%29%
% 218.05/218.26  |- skos__annotation mesh__D015280 DF: RESTRICT MOD ENZYMES   
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D015280 2005
% 218.05/218.26  |- skos__prefLabel mesh__D015280 DNA Restriction-Modification Enzymes
% 218.05/218.26  |- mesh__publicMeSHNote mesh__D015280 89   
% 218.05/218.26  |- skos__altLabel mesh__D015280 DNA Restriction Modification Enzymes
% 218.05/218.26  |- skos__altLabel mesh__D009243 Nadide
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D009243 2006
% 218.05/218.26  |- skos__broader mesh__D009243smesh__D000227
% 218.05/218.26  |- skos__altLabel mesh__D009243 DPN
% 218.05/218.26  |- skos__hiddenLabel mesh__D009243 Nicotinamide Adenine Dinucleotide
% 218.05/218.26  |- skos__hiddenLabel mesh__D009243
% 218.05/218.26       Adenine Dinucleotide, Dihydronicotinamide
% 218.05/218.26  |- skos__altLabel mesh__D009243 Dihydronicotinamide Adenine Dinucleotide
% 218.05/218.26  |- skos__broader mesh__D009243smesh__D003067
% 218.05/218.26  |- skos__hiddenLabel mesh__D009243
% 218.05/218.26       Dinucleotide, Dihydronicotinamide Adenine
% 218.05/218.26  |- skos__prefLabel mesh__D009243 NAD
% 218.05/218.26  |- skos__altLabel mesh__D009243 Diphosphopyridine Nucleotide
% 218.05/218.26  |- mesh__dateCreated mesh__D009243 1999-01-01
% 218.05/218.26  |- mesh__recordAuthorizer mesh__D009243 sjn
% 218.05/218.26  |- skos__scopeNote mesh__D009243
% 218.05/218.26       A coenzyme composed of ribosylnicotinamide 5%27%-diphosphate coupled to adenosine 5%27%-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized %28%NAD+%29% and reduced %28%NADH%29%. %28%Dorland, 27th ed%29%%A%    
% 218.05/218.26  |- rdf__type mesh__D009243sskos__Concept
% 218.05/218.26  |- skos__annotation mesh__D009243
% 218.05/218.26       a coenzyme; NAD or NADP probably correct for indexing of pyridine nucleotides%A%  
% 218.05/218.26  |- skos__hiddenLabel mesh__D009243 Nucleotide, Diphosphopyridine
% 218.05/218.26  |- skos__hiddenLabel mesh__D009243 Dinucleotide, Nicotinamide-Adenine
% 218.05/218.26  |- mesh__recordOriginator mesh__D009243 NLM
% 218.05/218.26  |- mesh__recordMaintainer mesh__D009243 ssb
% 218.05/218.26  |- skos__altLabel mesh__D009243 Coenzyme I
% 218.05/218.26  |- mesh__dateRevised mesh__D009243 2003-07-09
% 218.05/218.26  |- skos__altLabel mesh__D009243 Nicotinamide-Adenine Dinucleotide
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D009243 2004
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D009243 2005
% 218.05/218.26  |- mesh__recordMaintainer mesh__D001260 nns
% 218.05/218.26  |- skos__hiddenLabel mesh__D001260 Syndrome, Ataxia Telangiectasia
% 218.05/218.26  |- skos__historyNote mesh__D001260 Ataxia %28%1966-1967%29%
% 218.05/218.26  |- skos__broader mesh__D001260smesh__D049914
% 218.05/218.26  |- skos__altLabel mesh__D001260 Ataxia-Telangiectasia
% 218.05/218.26  |- mesh__recordAuthorizer mesh__D001260 sjn
% 218.05/218.26  |- skos__broader mesh__D001260smesh__D013684
% 218.05/218.26  |- mesh__recordOriginator mesh__D001260 NLM
% 218.05/218.26  |- skos__broader mesh__D001260smesh__D020752
% 218.05/218.26  |- mesh__dateEstablished mesh__D001260 1968-01-01
% 218.05/218.26  |- mesh__dateRevised mesh__D001260 2005-06-30
% 218.05/218.26  |- skos__altLabel mesh__D001260 Louis-Bar Syndrome
% 218.05/218.26  |- skos__altLabel mesh__D001260 Ataxia Telangiectasia Syndrome
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D001260 2006
% 218.05/218.26  |- skos__broader mesh__D001260smesh__D007153
% 218.05/218.26  |- skos__broader mesh__D001260smesh__D030342
% 218.05/218.26  |- skos__scopeNote mesh__D001260
% 218.05/218.26       An autosomal recessive inherited disorder characterized by choreoathetosis beginning in childhood, progressive CEREBELLAR ATAXIA; TELANGIECTASIS of CONJUNCTIVA and SKIN; DYSARTHRIA; B- and T-cell immunodeficiency, and RADIOSENSITIVITY to IONIZING RADIATION. Affected individuals are prone to recurrent sinobronchopulmonary infections, lymphoreticular neoplasms, and other malignancies. Serum ALPHA-FETOPROTEINS are usually elevated. %28%Menkes, Textbook of Child Neurology, 5th ed, p688%29% The gene for this disorder %28%ATM%29% encodes a cell cycle checkpoint protein kinase and has been mapped to chromosome 11 %28%11q22-q23%29%.%A%    
% 218.05/218.26  |- rdf__type mesh__D001260sskos__Concept
% 218.05/218.26  |- skos__broader mesh__D001260smesh__D020754
% 218.05/218.26  |- skos__hiddenLabel mesh__D001260 Louis Bar Syndrome
% 218.05/218.26  |- skos__hiddenLabel mesh__D001260 Syndrome, Louis-Bar
% 218.05/218.26  |- mesh__historyNote mesh__D001260 1968   
% 218.05/218.26  |- mesh__publicMeSHNote mesh__D001260 1968   
% 218.05/218.26  |- skos__prefLabel mesh__D001260 Ataxia Telangiectasia
% 218.05/218.26  |- mesh__dateCreated mesh__D001260 1999-01-01
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D014986 2003
% 218.05/218.26  |- mesh__dateEstablished mesh__D014986 1973-01-01
% 218.05/218.26  |- skos__annotation mesh__D014986
% 218.05/218.26       do not use /util except by MeSH definition; DF: XERORADIOGR%A%  
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D014986 1999
% 218.05/218.26  |- mesh__dateCreated mesh__D014986 1999-01-01
% 218.05/218.26  |- rdf__type mesh__D014986sskos__Concept
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D014986 2004
% 218.05/218.26  |- mesh__recordMaintainer mesh__D014986 PXP
% 218.05/218.26  |- mesh__historyNote mesh__D014986 73%28%67%29%   
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D014986 2000
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D014986 2005
% 218.05/218.26  |- skos__broader mesh__D014986smesh__D011859
% 218.05/218.26  |- skos__historyNote mesh__D014986 Radiography %28%1966%29%
% 218.05/218.26  |- skos__scopeNote mesh__D014986
% 218.05/218.26       A photoelectric method of recording an X-ray image on a coated metal plate, using low-energy photon beams, long exposure time and dry chemical developers.%A%    
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D014986 2001
% 218.05/218.26  |- skos__hiddenLabel mesh__D014986 Xeroradiographies
% 218.05/218.26  |- mesh__publicMeSHNote mesh__D014986 73   
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D014986 2006
% 218.05/218.26  |- skos__prefLabel mesh__D014986 Xeroradiography
% 218.05/218.26  |- skos__historyNote mesh__D014986
% 218.05/218.26       specific heading/radiography %28%1966%29%
% 218.05/218.26  |- skos__historyNote mesh__D014986
% 218.05/218.26       specific radiography heading %28%1966%29%
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D014986 2002
% 218.05/218.26  |- mesh__recordAuthorizer mesh__D014986 SJN
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D014986 1998
% 218.05/218.26  |- mesh__recordOriginator mesh__D014986 NLM
% 218.05/218.26  |- mesh__dateRevised mesh__D014986 1997-06-20
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D014188 2002
% 218.05/218.26  |- mesh__dateRevised mesh__D014188 1999-11-03
% 218.05/218.26  |- skos__annotation mesh__D014188
% 218.05/218.26       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 218.05/218.26  |- skos__hiddenLabel mesh__D014188 Great Vessels Transpositions
% 218.05/218.26  |- skos__hiddenLabel mesh__D014188 Vessels Transposition, Great
% 218.05/218.26  |- mesh__recordAuthorizer mesh__D014188 sjn
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D014188 2006
% 218.05/218.26  |- mesh__dateEstablished mesh__D014188 1965-01-01
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D014188 2005
% 218.05/218.26  |- skos__broader mesh__D014188smesh__D006330
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D014188 2004
% 218.05/218.26  |- mesh__publicMeSHNote mesh__D014188 65   
% 218.05/218.26  |- skos__scopeNote mesh__D014188
% 218.05/218.26       A congenital cardiovascular malformation in which the aorta arises entirely from the right ventricle and the pulmonary artery from the left ventricle, so that the venous return from the peripheral circulation is recirculated by the right ventricle via the aorta to the systemic circulation without being oxygenated in the lungs.%A%    
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D014188 2001
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D014188 2003
% 218.05/218.26  |- mesh__recordOriginator mesh__D014188 NLM
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D014188 2000
% 218.05/218.26  |- rdf__type mesh__D014188sskos__Concept
% 218.05/218.26  |- skos__hiddenLabel mesh__D014188 Vessels Transpositions, Great
% 218.05/218.26  |- mesh__recordMaintainer mesh__D014188 kle
% 218.05/218.26  |- mesh__dateCreated mesh__D014188 1999-01-01
% 218.05/218.26  |- skos__hiddenLabel mesh__D014188 Great Vessels Transposition
% 218.05/218.26  |- skos__prefLabel mesh__D014188 Transposition of Great Vessels
% 218.05/218.26  |- mesh__historyNote mesh__D014188 65   
% 218.05/218.26  |- skos__hiddenLabel mesh__D008949 Pleomorphic Adenoma
% 218.05/218.26  |- skos__hiddenLabel mesh__D008949 Chondroid Syringoma
% 218.05/218.26  |- mesh__dateRevised mesh__D008949 1995-06-08
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D008949 1998
% 218.05/218.26  |- mesh__recordOriginator mesh__D008949 NLM
% 218.05/218.26  |- skos__hiddenLabel mesh__D008949 Syringomas, Chondroid
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D008949 1997
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D008949 2000
% 218.05/218.26  |- mesh__dateCreated mesh__D008949 1999-01-01
% 218.05/218.26  |- mesh__historyNote mesh__D008949
% 218.05/218.26       94; was MIXED SALIVARY GLAND TUMOR 1963-93; SYRINGOMA, CHONDROID was see HIDRADENOMA %28%now ADENOMA, SWEAT GLAND%29% 1985-93%A%  
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D008949 1999
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D008949 2003
% 218.05/218.26  |- skos__prefLabel mesh__D008949 Adenoma, Pleomorphic
% 218.05/218.26  |- mesh__recordMaintainer mesh__D008949 KEV
% 218.05/218.26  |- mesh__publicMeSHNote mesh__D008949
% 218.05/218.26       94; was MIXED SALIVARY GLAND TUMOR 1963-93; SYRINGOMA, CHONDROID was see HIDRADENOMA %28%now ADENOMA, SWEAT GLAND%29% 1985-93%A%  
% 218.05/218.26  |- skos__hiddenLabel mesh__D008949 Chondroid Syringomas
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D008949 2001
% 218.05/218.26  |- mesh__onlineNote mesh__D008949
% 218.05/218.26       use ADENOMA, PLEOMORPHIC to search MIXED SALIVARY GLAND TUMOR 1966-93; use ADENOMA, SWEAT GLAND to search SYRINGOMA, CHONDROID 1985-93%A%  
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D008949 2005
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D008949 2004
% 218.05/218.26  |- skos__hiddenLabel mesh__D008949 Pleomorphic Adenomas
% 218.05/218.26  |- skos__altLabel mesh__D008949 Mixed Salivary Gland Tumor
% 218.05/218.26  |- skos__broader mesh__D008949smesh__D018193
% 218.05/218.26  |- skos__hiddenLabel mesh__D008949 Adenomas, Pleomorphic
% 218.05/218.26  |- skos__broader mesh__D008949smesh__D000236
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D008949 2006
% 218.05/218.26  |- skos__altLabel mesh__D008949 Syringoma, Chondroid
% 218.05/218.26  |- mesh__recordAuthorizer mesh__D008949 PLS
% 218.05/218.26  |- skos__altLabel mesh__D008949 Salivary Gland Tumor, Mixed
% 218.05/218.26  |- skos__annotation mesh__D008949
% 218.05/218.26       /blood supply /chem /secret /ultrastruct permitted; coord IM with SALIVARY GLAND NEOPLASMS %28%IM%29% or specific salivary gland neopl precoord %28%IM%29%; if of a minor salivary gland, coord IM with SALIVARY GLAND NEOPLASMS %28%IM%29% + SALIVARY GLANDS, MINOR %28%IM%29%; for X ref SYRINGOMA, CHONDROID, coord IM with SWEAT GLAND NEOPLASMS %28%IM%29%%A%  
% 218.05/218.26  |- rdf__type mesh__D008949sskos__Concept
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D008949 1996
% 218.05/218.26  |- skos__scopeNote mesh__D008949
% 218.05/218.26       A benign, slow-growing tumor, most commonly of the salivary gland, occurring as a small, painless, firm nodule, usually of the parotid gland, but also found in any major or accessory salivary gland anywhere in the oral cavity. It is most often seen in women in the fifth decade. Histologically, the tumor presents a variety of cells: cuboidal, columnar, and squamous cells, showing all forms of epithelial growth. %28%Dorland, 27th ed%29%%A%    
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D008949 2002
% 218.05/218.26  |- skos__hiddenLabel mesh__D000966 Emetic, Tartar
% 218.05/218.26  |- mesh__publicMeSHNote mesh__D000966 91; was see under ANTIMONY 1976-90   
% 218.05/218.26  |- mesh__dateRevised mesh__D000966 2000-06-21
% 218.05/218.26  |- mesh__dateEstablished mesh__D000966 1991-01-01
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D000966 2005
% 218.05/218.26  |- rdf__type mesh__D000966sskos__Concept
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D000966 2003
% 218.05/218.26  |- mesh__dateCreated mesh__D000966 1975-07-23
% 218.05/218.26  |- skos__broader mesh__D000966smesh__D009942
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D000966 2006
% 218.05/218.26  |- mesh__recordMaintainer mesh__D000966 CCR
% 218.05/218.26  |- skos__historyNote mesh__D000966 Tartrates %28%1969-1975%29%
% 218.05/218.26  |- skos__altLabel mesh__D000966 Potassium Antimonyltartrate
% 218.05/218.26  |- skos__hiddenLabel mesh__D000966 Potassium Tartrate, Antimony
% 218.05/218.26  |- mesh__historyNote mesh__D000966
% 218.05/218.26       91%28%76%29%; was see under ANTIMONY 1976-90   
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D000966 2001
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D000966 2004
% 218.05/218.26  |- skos__altLabel mesh__D000966 Tartrated Antimony
% 218.05/218.26  |- skos__hiddenLabel mesh__D000966 Tartrate, Antimony Potassium
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D000966 2002
% 218.05/218.26  |- skos__historyNote mesh__D000966 Antimony %28%1969-1975%29%
% 218.05/218.26  |- mesh__recordAuthorizer mesh__D000966 sjn
% 218.05/218.26  |- skos__hiddenLabel mesh__D000966 Antimony, Tartrated
% 218.05/218.26  |- skos__hiddenLabel mesh__D000966 Antimonyltartrate, Potassium
% 218.05/218.26  |- skos__prefLabel mesh__D000966 Antimony Potassium Tartrate
% 218.05/218.26  |- mesh__recordOriginator mesh__D000966 SH
% 218.05/218.26  |- skos__altLabel mesh__D000966 Tartar Emetic
% 218.05/218.26  |- skos__scopeNote mesh__D000966
% 218.05/218.26       A schistosomicide possibly useful against other parasites. It has irritant emetic properties and may cause lethal cardiac toxicity among other adverse effects.%A%    
% 218.05/218.26  |- rdf__type mesh__D033342sskos__Concept
% 218.05/218.26  |- mesh__dateEstablished mesh__D033342 2003-01-01
% 218.05/218.26  |- mesh__historyNote mesh__D033342 2003   
% 218.05/218.26  |- skos__altLabel mesh__D033342 Salmon Louse
% 218.05/218.26  |- skos__prefLabel mesh__D033342 Copepoda
% 218.05/218.26  |- mesh__dateCreated mesh__D033342 2002-07-03
% 218.05/218.26  |- skos__scopeNote mesh__D033342
% 218.05/218.26       A huge subclass of mostly marine CRUSTACEA, containing over 14,000 species. The 10 orders comprise both planktonic and benthic organisms, and include both free-living and parasitic forms. Planktonic copepods form the principle link between PHYTOPLANKTON and the higher trophic levels of the marine food chains.%A%    
% 218.05/218.26  |- mesh__recordMaintainer mesh__D033342 ags
% 218.05/218.26  |- mesh__recordAuthorizer mesh__D033342 sjn
% 218.05/218.26  |- mesh__recordOriginator mesh__D033342 ags
% 218.05/218.26  |- skos__broader mesh__D033342smesh__D003445
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D033342 2006
% 218.05/218.26  |- mesh__dateRevised mesh__D033342 2005-06-30
% 218.05/218.26  |- skos__historyNote mesh__D033342 Crustacea %28%1965-2002%29%
% 218.05/218.26  |- skos__altLabel mesh__D033342 Copepods
% 218.05/218.26  |- mesh__publicMeSHNote mesh__D033342
% 218.05/218.26       2003; for Siphonostomatoida see Siphonostomatotoida 2003   
% 218.05/218.26  |- skos__hiddenLabel mesh__D000168 Acrocephalosyndactylias
% 218.05/218.26  |- rdf__type mesh__D000168sskos__Concept
% 218.05/218.26  |- skos__broader mesh__D000168smesh__D003398
% 218.05/218.26  |- skos__hiddenLabel mesh__D000168 Saethre Chotzen Syndrome
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D000168 2002
% 218.05/218.26  |- skos__prefLabel mesh__D000168 Acrocephalosyndactylia
% 218.05/218.26  |- mesh__recordMaintainer mesh__D000168 kle
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D000168 2004
% 218.05/218.26  |- mesh__dateCreated mesh__D000168 1999-01-01
% 218.05/218.26  |- skos__hiddenLabel mesh__D000168 Syndrome, Apert
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D000168 2003
% 218.05/218.26  |- mesh__recordOriginator mesh__D000168 NLM
% 218.05/218.26  |- mesh__dateRevised mesh__D000168 1999-11-03
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D000168 2001
% 218.05/218.26  |- skos__annotation mesh__D000168
% 218.05/218.26       congen deform of skull, fingers %26% toes; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D000168 2006
% 218.05/218.26  |- skos__broader mesh__D000168smesh__D013576
% 218.05/218.26  |- skos__hiddenLabel mesh__D000168 Syndrome, Saethre-Chotzen
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D000168 2000
% 218.05/218.26  |- skos__scopeNote mesh__D000168
% 218.05/218.26       Craniostenosis characterized by acrocephaly and syndactyly, probably occurring as an autosomal dominant trait and usually as a new mutation. %28%Dorland, 27th ed%29%%A%    
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D000168 2005
% 218.05/218.26  |- skos__hiddenLabel mesh__D000168 Syndrome, Pfeiffer
% 218.05/218.26  |- mesh__recordAuthorizer mesh__D000168 sjn
% 218.05/218.26  |- skos__broader mesh__D005651smesh__D003140
% 218.05/218.26  |- skos__scopeNote mesh__D005651
% 218.05/218.26       The application of smoke, vapor, or gas for the purpose of disinfecting or destroying pests or microorganisms.%A%    
% 218.05/218.26  |- skos__hiddenLabel mesh__D005651 Fumigations
% 218.05/218.26  |- mesh__dateCreated mesh__D005651 1999-01-01
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D005651 1994
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D005651 2000
% 218.05/218.26  |- skos__prefLabel mesh__D005651 Fumigation
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D005651 2001
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D005651 1995
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D005651 2005
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D005651 1998
% 218.05/218.26  |- rdf__type mesh__D005651sskos__Concept
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D005651 2002
% 218.05/218.26  |- mesh__dateRevised mesh__D005651 1992-05-15
% 218.05/218.26  |- mesh__recordMaintainer mesh__D005651 TAP
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D005651 1993
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D005651 2003
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D005651 1996
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D005651 2006
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D005651 1999
% 218.05/218.26  |- mesh__recordAuthorizer mesh__D005651 PLS
% 218.05/218.26  |- mesh__recordOriginator mesh__D005651 NLM
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D005651 2004
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D005651 1997
% 218.05/218.26  |- mesh__recordMaintainer mesh__D018579 jls
% 218.05/218.26  |- mesh__dateEstablished mesh__D018579 1995-01-01
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Recruitment, Patient
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D018579 2003
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Selections, Research Subject
% 218.05/218.26  |- skos__broader mesh__D018579smesh__D010346
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Subject Selection, Research
% 218.05/218.26  |- mesh__recordAuthorizer mesh__D018579 jls
% 218.05/218.26  |- skos__related mesh__D018579smesh__D015276
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Recruitments, Patient
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Recruitment, Research Subject
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D018579 2002
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D018579 2004
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Treatments, Selection for
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Criteria, Selection
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D018579 2005
% 218.05/218.26  |- mesh__recordOriginator mesh__D018579 JLS
% 218.05/218.26  |- mesh__dateRevised mesh__D018579 2002-10-31
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Subjects Selection
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Subject Recruitments, Research
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Recruitments, Research Subject
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Selections, Patient
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Treatment, Selection for
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D018579 2006
% 218.05/218.26  |- mesh__publicMeSHNote mesh__D018579
% 218.05/218.26       1995; for SELECTION FOR TREATMENT see HEALTH CARE RATIONING 1991-2000%A%  
% 218.05/218.26  |- rdf__type mesh__D018579sskos__Concept
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Subjects Selections
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Subject Selections, Research
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Selection for Treatments
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Selection, Research Subject
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Selection, Patient
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Research Subject Recruitments
% 218.05/218.26  |- skos__scopeNote mesh__D018579
% 218.05/218.26       Criteria and standards used for the determination of the appropriateness of the inclusion of patients with specific conditions in proposed treatment plans and the criteria used for the inclusion of subjects in various clinical trials and other research protocols.%A%    
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D018579 2003A
% 218.05/218.26  |- mesh__historyNote mesh__D018579
% 218.05/218.26       1995; for SELECTION FOR TREATMENT use HEALTH CARE RATIONING 1991-2000%A%  
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Patient Selections
% 218.05/218.26  |- skos__prefLabel mesh__D018579 Patient Selection
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Subject Recruitment, Research
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Patient Recruitments
% 218.05/218.26  |- skos__hiddenLabel mesh__D018579 Research Subject Selections
% 218.05/218.26  |- skos__broader mesh__D018579smesh__D012107
% 218.05/218.26  |- mesh__dateCreated mesh__D018579 1994-06-01
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D010596 2004
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D010596 1997
% 218.05/218.26  |- skos__historyNote mesh__D010596 Pharmacy %28%1968-1970%29%
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D010596 2000
% 218.05/218.26  |- skos__hiddenLabel mesh__D010596 Pharmacists%27% Aide
% 218.05/218.26  |- skos__hiddenLabel mesh__D010596 Aide, Pharmacists%27%
% 218.05/218.26  |- skos__historyNote mesh__D010596 Health Manpower %28%1968-1970%29%
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D010596 2003
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D010596 1996
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D010596 1995
% 218.05/218.26  |- mesh__historyNote mesh__D010596 71   
% 218.05/218.26  |- rdf__type mesh__D010596sskos__Concept
% 218.05/218.26  |- skos__scopeNote mesh__D010596
% 218.05/218.26       Persons who perform certain functions under the supervision of the pharmacist.%A%    
% 218.05/218.26  |- skos__broader mesh__D010596smesh__D000488
% 218.05/218.26  |- skos__hiddenLabel mesh__D010596 Aides, Pharmacists%27%
% 218.05/218.26  |- mesh__dateEstablished mesh__D010596 1971-01-01
% 218.05/218.26  |- skos__prefLabel mesh__D010596 Pharmacists%27% Aides
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D010596 1994
% 218.05/218.26  |- skos__hiddenLabel mesh__D010596 Pharmacist%27%s Aides
% 218.05/218.26  |- mesh__recordOriginator mesh__D010596 NLM
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D010596 2006
% 218.05/218.26  |- mesh__recordAuthorizer mesh__D010596 PLS
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D010596 1999
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D010596 2002
% 218.05/218.26  |- mesh__dateRevised mesh__D010596 1993-06-04
% 218.05/218.26  |- mesh__dateCreated mesh__D010596 1999-01-01
% 218.05/218.26  |- skos__hiddenLabel mesh__D010596 Pharmacists Aides
% 218.05/218.26  |- skos__hiddenLabel mesh__D010596 Pharmacist Aides
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D010596 2005
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D010596 1998
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D010596 2001
% 218.05/218.26  |- mesh__publicMeSHNote mesh__D010596 71   
% 218.05/218.26  |- mesh__recordMaintainer mesh__D010596 AGS
% 218.05/218.26  |- skos__broader mesh__D004559smesh__D004560
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D004559 2002
% 218.05/218.26  |- skos__scopeNote mesh__D004559
% 218.05/218.26       An arrangement of wires distributing electricity.     
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D004559 1996
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D004559 2003
% 218.05/218.26  |- mesh__recordOriginator mesh__D004559 EC
% 218.05/218.26  |- mesh__dateRevised mesh__D004559 1992-05-15
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D004559 2000
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D004559 1998
% 218.05/218.26  |- mesh__recordAuthorizer mesh__D004559 PLS
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D004559 1997
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D004559 2005
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D004559 2004
% 218.05/218.26  |- mesh__historyNote mesh__D004559
% 218.05/218.26       91%28%Aug 77%29%; was see under ELECTRICITY 1977-90   
% 218.05/218.26  |- skos__hiddenLabel mesh__D004559 Wiring, Electrical
% 218.05/218.26  |- skos__altLabel mesh__D004559 Electrical Wiring
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D004559 2001
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D004559 1999
% 218.05/218.26  |- skos__prefLabel mesh__D004559 Electric Wiring
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D004559 2006
% 218.05/218.26  |- mesh__publicMeSHNote mesh__D004559
% 218.05/218.26       91; was see under ELECTRICITY Aug 1977-90   
% 218.05/218.26  |- rdf__type mesh__D004559sskos__Concept
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D004559 1994
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D004559 1993
% 218.05/218.26  |- mesh__recordMaintainer mesh__D004559 TAP
% 218.05/218.26  |- skos__hiddenLabel mesh__D004559 Wiring, Electric
% 218.05/218.26  |- mesh__dateCreated mesh__D004559 1977-05-05
% 218.05/218.26  |- mesh__dateEstablished mesh__D004559 1991-01-01
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D004559 1995
% 218.05/218.26  |- skos__historyNote mesh__D015281 Cephalosporins %28%1979-1981%29%
% 218.05/218.26  |- skos__hiddenLabel mesh__D015281 SCE1365
% 218.05/218.26  |- skos__prefLabel mesh__D015281 Cefmenoxime
% 218.05/218.26  |- skos__historyNote mesh__D015281 Cefotaxime %28%1982-1988%29%
% 218.05/218.26  |- mesh__recordAuthorizer mesh__D015281 sjn
% 218.05/218.26  |- mesh__historyNote mesh__D015281 89   
% 218.05/218.26  |- skos__hiddenLabel mesh__D015281 Hydrochloride, Cefmenoxime
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D015281 2006
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D015281 2005
% 218.05/218.26  |- mesh__recordMaintainer mesh__D015281 ssb
% 218.05/218.26  |- skos__hiddenLabel mesh__D015281 Abbott 50192
% 218.05/218.26  |- mesh__recordOriginator mesh__D015281 RLS
% 218.05/218.26  |- mesh__publicMeSHNote mesh__D015281 89   
% 218.05/218.26  |- rdf__type mesh__D015281sskos__Concept
% 218.05/218.26  |- mesh__dateEstablished mesh__D015281 1989-01-01
% 218.05/218.26  |- skos__scopeNote mesh__D015281
% 218.05/218.26       A cephalosporin antibiotic that is administered intravenously or intramuscularly. It is active against most common gram-positive and gram-negative microorganisms, is a potent inhibitor of Enterobacteriaceae, and is highly resistant to hydrolysis by beta-lactamases. The drug has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.%A%    
% 218.05/218.26  |- skos__hiddenLabel mesh__D015281 Abbott50192
% 218.05/218.26  |- skos__hiddenLabel mesh__D015281 SCE 1365
% 218.05/218.26  |- skos__broader mesh__D015281smesh__D002439
% 218.05/218.26  |- skos__altLabel mesh__D015281 Cefmenoxime Hydrochloride %28%2:1%29%
% 218.05/218.26  |- mesh__dateRevised mesh__D015281 2004-07-07
% 218.05/218.26  |- mesh__dateCreated mesh__D015281 1988-05-23
% 218.05/218.26  |- skos__hiddenLabel mesh__D009244 NADP Glycohydrolase
% 218.05/218.26  |- skos__historyNote mesh__D009244 Nucleosidases %28%1973-1974%29%
% 218.05/218.26  |- skos__historyNote mesh__D009244 NAD %28%1973-1974%29%
% 218.05/218.26  |- mesh__publicMeSHNote mesh__D009244
% 218.05/218.26       1994; see NAD NUCLEOSIDASE 1975-1993; NAD%28%P%29% NUCLEOSIDASE was indexed under N-GLYCOSYL HYDROLASES 1982-2002, NAD 1973-1981%A%  
% 218.05/218.26  |- mesh__dateEstablished mesh__D009244 1977-01-01
% 218.05/218.26  |- skos__hiddenLabel mesh__D009244 Nucleosidases, NAD+
% 218.05/218.26  |- skos__scopeNote mesh__D009244
% 218.05/218.26       An enzyme that catalyzes the hydrolysis of nicotinamide adenine dinucleotide %28%NAD%29% to NICOTINAMIDE and ADENOSINE DIPHOSPHATE RIBOSE. Some are extracellular %28%ectoenzymes%29%.The enzyme from some sources also catalyses the hydrolysis of nicotinamide adenine dinucleotide phosphate %28%NADP%29%.%A%    
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D009244 2006
% 218.05/218.26  |- skos__altLabel mesh__D009244 NADP Nucleosidase
% 218.05/218.26  |- skos__altLabel mesh__D009244 NADP-Glycohydrolase
% 218.05/218.26  |- skos__prefLabel mesh__D009244 NAD+ Nucleosidase
% 218.05/218.26  |- skos__hiddenLabel mesh__D009244 Nucleotidases, Diphosphopyridine
% 218.05/218.26  |- skos__altLabel mesh__D009244 DPNase
% 218.05/218.26  |- mesh__historyNote mesh__D009244
% 218.05/218.26       1994 %28%1975%29%; use NAD NUCLEOSIDASE 1977-1993; for NAD%28%P%29% NUCLEOSIDASE use NAD+ NUCLEOSIDASE %28%NM%29% 1973-2002%A%  
% 218.05/218.26  |- skos__hiddenLabel mesh__D009244 Glycohydrolase, NAD+
% 218.05/218.26  |- skos__hiddenLabel mesh__D009244 Nucleotidase, Diphosphopyridine
% 218.05/218.26  |- skos__hiddenLabel mesh__D009244 Glycohydrolase, Ecto-NAD+
% 218.05/218.26  |- mesh__dateRevised mesh__D009244 2003-07-09
% 218.05/218.26  |- skos__altLabel mesh__D009244 Diphosphopyridine Nucleotidase
% 218.05/218.26  |- mesh__dateCreated mesh__D009244 1974-11-19
% 218.05/218.26  |- skos__broader mesh__D009244smesh__D009699
% 218.05/218.26  |- mesh__activeMeSHYear mesh__D009244 2004
% 218.05/218.26  |- skos__altLabel mesh__D009244 Diphosphopyridine Nucleotidases
% 218.05/218.26  |- skos__hiddenLabel mesh__D009244 Nucleosidase, NAD+
% 218.05/218.26  |- skos__hiddenLabel mesh__D009244 Ecto NAD+ Glycohydrolase
% 218.05/218.26  |- skos__altLabel mesh__D009244 NADases
% 218.05/218.26  |- skos__altLabel mesh__D009244 NAD+ Glycohydrolase
% 218.05/218.26  |- rdf__type mesh__D009244sskos__Concept
% 218.05/218.26  |- skos__hiddenLabel mesh__D009244 NAD Glycohydrolases
% 218.05/218.26  |- skos__broader mesh__D009244smesh__D036002
% 218.05/218.26  |- skos__altLabel mesh__D009244 NAD+ Nucleosidases
% 218.05/218.26  |- skos__hiddenLabel mesh__D009244 Nucleosidase, NADP
% 218.05/218.26  |- skos__altLabel mesh__D009244 NAD-Glycohydrolase
% 218.05/218.26  |- mesh__recordOriginator mesh__D009244 NLM
% 218.05/218.26  |- mesh__recordMaintainer mesh__D009244 ssb
% 218.05/218.26  |- mesh__recordAuthorizer mesh__D009244 sjn
% 218.05/218.26  |- skos__altLabel mesh__D009244 NAD-Glycohydrolases
% 218.05/218.26  |- skos__hiddenLabel mesh__D009244 NAD Glycohydrolase
% 218.05/218.27  |- skos__altLabel mesh__D009244 NADase
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D009244 2005
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D001261 1997
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D001261 1991
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D001261 2004
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D001261 2001
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D001261 1999
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D001261 2006
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D001261 1996
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D001261 1993
% 218.05/218.27  |- skos__hiddenLabel mesh__D001261 Atelectases
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D001261 1995
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D001261 2003
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D001261 1998
% 218.05/218.27  |- skos__broader mesh__D001261smesh__D008171
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D001261 2005
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D001261 1992
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D001261 2000
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D001261 1994
% 218.05/218.27  |- rdf__type mesh__D001261sskos__Concept
% 218.05/218.27  |- mesh__dateRevised mesh__D001261 1990-05-29
% 218.05/218.27  |- mesh__recordOriginator mesh__D001261 NLM
% 218.05/218.27  |- skos__annotation mesh__D001261 = lung collapse, any part of the lung   
% 218.05/218.27  |- mesh__recordMaintainer mesh__D001261 PLS
% 218.05/218.27  |- mesh__recordAuthorizer mesh__D001261 NLM
% 218.05/218.27  |- mesh__dateCreated mesh__D001261 1999-01-01
% 218.05/218.27  |- skos__prefLabel mesh__D001261 Atelectasis
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D001261 2002
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014987 2005
% 218.05/218.27  |- skos__annotation mesh__D014987 decreased saliva flow   
% 218.05/218.27  |- skos__broader mesh__D014987smesh__D012466
% 218.05/218.27  |- skos__altLabel mesh__D014987 Mouth Dryness
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014987 1995
% 218.05/218.27  |- skos__hiddenLabel mesh__D014987 Dryness, Mouth
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014987 2004
% 218.05/218.27  |- mesh__recordOriginator mesh__D014987 NLM
% 218.05/218.27  |- skos__hiddenLabel mesh__D014987 Asialias
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014987 1999
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014987 1994
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014987 2003
% 218.05/218.27  |- rdf__type mesh__D014987sskos__Concept
% 218.05/218.27  |- skos__hiddenLabel mesh__D014987 Xerostomias
% 218.05/218.27  |- skos__altLabel mesh__D014987 Hyposalivation
% 218.05/218.27  |- skos__prefLabel mesh__D014987 Xerostomia
% 218.05/218.27  |- skos__altLabel mesh__D014987 Asialia
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014987 1998
% 218.05/218.27  |- mesh__dateRevised mesh__D014987 1993-06-03
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014987 2002
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014987 1997
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014987 2001
% 218.05/218.27  |- mesh__recordMaintainer mesh__D014987 TGC
% 218.05/218.27  |- skos__scopeNote mesh__D014987 Decreased salivary flow.     
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014987 1996
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014987 2006
% 218.05/218.27  |- mesh__recordAuthorizer mesh__D014987 PLS
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014987 2000
% 218.05/218.27  |- skos__hiddenLabel mesh__D014987 Hyposalivations
% 218.05/218.27  |- mesh__dateCreated mesh__D014987 1999-01-01
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014189 2006
% 218.05/218.27  |- mesh__recordAuthorizer mesh__D014189 SJN
% 218.05/218.27  |- skos__broader mesh__D014189smesh__D020018
% 218.05/218.27  |- mesh__dateRevised mesh__D014189 1998-06-11
% 218.05/218.27  |- skos__historyNote mesh__D014189 Paraphilias %28%1966-1967%29%
% 218.05/218.27  |- skos__historyNote mesh__D014189 Transvestism %28%1966-1967%29%
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014189 2005
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014189 2004
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014189 1999
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014189 2002
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014189 2003
% 218.05/218.27  |- skos__scopeNote mesh__D014189
% 218.05/218.27       Severe gender dysphoria, coupled with a persistent desire for the physical characteristics and social roles that connote the opposite biological sex. %28%APA, DSM-IV, 1994%29%%A%    
% 218.05/218.27  |- mesh__historyNote mesh__D014189 68   
% 218.05/218.27  |- mesh__recordMaintainer mesh__D014189 JLS
% 218.05/218.27  |- rdf__type mesh__D014189sskos__Concept
% 218.05/218.27  |- skos__hiddenLabel mesh__D014189 Transsexualisms
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014189 2001
% 218.05/218.27  |- mesh__dateCreated mesh__D014189 1999-01-01
% 218.05/218.27  |- skos__prefLabel mesh__D014189 Transsexualism
% 218.05/218.27  |- mesh__dateEstablished mesh__D014189 1968-01-01
% 218.05/218.27  |- mesh__recordOriginator mesh__D014189 NLM
% 218.05/218.27  |- mesh__publicMeSHNote mesh__D014189 68   
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014189 2000
% 218.05/218.27  |- skos__annotation mesh__D014189 for check tag use genetic sex   
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D000967 2006
% 218.05/218.27  |- skos__hiddenLabel mesh__D000967 Sodium Gluconates, Antimony
% 218.05/218.27  |- skos__scopeNote mesh__D000967
% 218.05/218.27       Antimony complex where the metal may exist in either the pentavalent or trivalent states. The pentavalent gluconate is used in leishmaniasis. The trivalent gluconate is most frequently used in schistosomiasis.%A%    
% 218.05/218.27  |- skos__historyNote mesh__D000967 Antimony %28%1970-1975%29%
% 218.05/218.27  |- mesh__historyNote mesh__D000967
% 218.05/218.27       94; was ANTIMONY SODIUM GLUCONATES 1991-93 %28%see under GLUCONATES 1977-90%29%; SODIUM STIBOGLUCONATE was STIBOGLUCONATE SODIUM 1977-93%A%  
% 218.05/218.27  |- skos__altLabel mesh__D000967 Stibogluconate Sodium
% 218.05/218.27  |- skos__prefLabel mesh__D000967 Antimony Sodium Gluconate
% 218.05/218.27  |- skos__altLabel mesh__D000967
% 218.05/218.27       GlaxoSmithKline Brand of Sodium Stibogluconate
% 218.05/218.27  |- mesh__recordMaintainer mesh__D000967 CCR
% 218.05/218.27  |- mesh__dateRevised mesh__D000967 2005-06-30
% 218.05/218.27  |- mesh__dateCreated mesh__D000967 1976-04-16
% 218.05/218.27  |- mesh__publicMeSHNote mesh__D000967
% 218.05/218.27       94; was ANTIMONY SODIUM GLUCONATES 1991-93 %28%see under GLUCONATES 1977-90%29%; SODIUM STIBOGLUCONATE was STIBOGLUCONATE SODIUM 1977-93%A%  
% 218.05/218.27  |- skos__hiddenLabel mesh__D000967 Stibogluconate, Sodium
% 218.05/218.27  |- mesh__recordOriginator mesh__D000967 SH
% 218.05/218.27  |- mesh__onlineNote mesh__D000967
% 218.05/218.27       use ANTIMONY SODIUM GLUCONATE to search ANTIMONY SODIUM GLUCONATES 1977-93%A%  
% 218.05/218.27  |- skos__altLabel mesh__D000967 Antimony Gluconate Sodium
% 218.05/218.27  |- skos__hiddenLabel mesh__D000967 Sodium, Stibogluconate
% 218.05/218.27  |- mesh__dateEstablished mesh__D000967 1991-01-01
% 218.05/218.27  |- rdf__type mesh__D000967sskos__Concept
% 218.05/218.27  |- mesh__recordAuthorizer mesh__D000967 sjn
% 218.05/218.27  |- skos__historyNote mesh__D000967 Gluconates %28%1970-1976%29%
% 218.05/218.27  |- skos__broader mesh__D000967smesh__D009942
% 218.05/218.27  |- skos__broader mesh__D000967smesh__D005942
% 218.05/218.27  |- mesh__dateRevised mesh__D019672 2005-06-30
% 218.05/218.27  |- skos__broader mesh__D019672smesh__D005796
% 218.05/218.27  |- rdf__type mesh__D019672sskos__Concept
% 218.05/218.27  |- skos__prefLabel mesh__D019672 Genes, T-Cell Receptor
% 218.05/218.27  |- mesh__publicMeSHNote mesh__D019672 98   
% 218.05/218.27  |- skos__scopeNote mesh__D019672
% 218.05/218.27       DNA sequences, in cells of the T-lymphocyte lineage, that code for T-cell receptors. The TcR genes are formed by somatic rearrangement %28%see GENE REARRANGEMENT, T-LYMPHOCYTE and its children%29% of germline gene segments, and resemble Ig genes in their mechanisms of diversity generation and expression.%A%    
% 218.05/218.27  |- mesh__recordOriginator mesh__D019672 AGS
% 218.05/218.27  |- skos__hiddenLabel mesh__D019672 T-Cell Receptor Gene
% 218.05/218.27  |- skos__hiddenLabel mesh__D019672 Gene, TcR
% 218.05/218.27  |- skos__annotation mesh__D019672
% 218.05/218.27       GEN or unspecified; prefer specifics; DF: note short X ref%A%  
% 218.05/218.27  |- mesh__recordMaintainer mesh__D019672 nns
% 218.05/218.27  |- mesh__dateEstablished mesh__D019672 1998-01-01
% 218.05/218.27  |- skos__related mesh__D019672smesh__D011948
% 218.05/218.27  |- mesh__dateCreated mesh__D019672 1997-06-20
% 218.05/218.27  |- skos__hiddenLabel mesh__D019672 Genes, T Cell Receptor
% 218.05/218.27  |- mesh__recordAuthorizer mesh__D019672 sjn
% 218.05/218.27  |- skos__hiddenLabel mesh__D019672 Genes, TcR
% 218.05/218.27  |- skos__hiddenLabel mesh__D019672 Gene, T-Cell Receptor
% 218.05/218.27  |- mesh__historyNote mesh__D019672 98   
% 218.05/218.27  |- skos__related mesh__D019672smesh__D015329
% 218.05/218.27  |- skos__altLabel mesh__D019672 T-Cell Receptor Genes
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D019672 2006
% 218.05/218.27  |- skos__altLabel mesh__D019672 TcR Genes
% 218.05/218.27  |- skos__hiddenLabel mesh__D019672 T Cell Receptor Genes
% 218.05/218.27  |- skos__hiddenLabel mesh__D019672 TcR Gene
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D000169 2002
% 218.05/218.27  |- mesh__dateCreated mesh__D000169 1999-01-01
% 218.05/218.27  |- skos__hiddenLabel mesh__D000169 Infantile Papular Acrodermatitides
% 218.05/218.27  |- skos__hiddenLabel mesh__D000169 Acrodermatitides, Infantile Papular
% 218.05/218.27  |- skos__hiddenLabel mesh__D000169 Gianotti Crosti Syndrome
% 218.05/218.27  |- skos__annotation mesh__D000169
% 218.05/218.27       dermatitis of hands or feet so do not bother to coord with HAND DERMATOSES or FOOT DERMATOSES unless particularly discussed%A%  
% 218.05/218.27  |- mesh__recordOriginator mesh__D000169 NLM
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D000169 2004
% 218.05/218.27  |- skos__scopeNote mesh__D000169
% 218.05/218.27       Inflammation involving the skin of the extremities, especially the hands and feet. Several forms are known, some idiopathic and some hereditary. The infantile form is called Gianotti-Crosti syndrome.%A%    
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D000169 2003
% 218.05/218.27  |- mesh__recordMaintainer mesh__D000169 nns
% 218.05/218.27  |- skos__altLabel mesh__D000169 Infantile Papular Acrodermatitis
% 218.05/218.27  |- skos__hiddenLabel mesh__D000169 Syndrome, Gianotti-Crosti
% 218.05/218.27  |- skos__hiddenLabel mesh__D000169 Acrodermatitides
% 218.05/218.27  |- skos__hiddenLabel mesh__D000169 Acrodermatitis, Infantile Papular
% 218.05/218.27  |- skos__prefLabel mesh__D000169 Acrodermatitis
% 218.05/218.27  |- skos__broader mesh__D000169smesh__D012868
% 218.05/218.27  |- skos__hiddenLabel mesh__D000169 Papular Acrodermatitis, Infantile
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D000169 2006
% 218.05/218.27  |- mesh__recordAuthorizer mesh__D000169 sjn
% 218.05/218.27  |- skos__hiddenLabel mesh__D000169 Papular Acrodermatitides, Infantile
% 218.05/218.27  |- skos__broader mesh__D000169smesh__D003872
% 218.05/218.27  |- mesh__dateRevised mesh__D000169 2001-07-25
% 218.05/218.27  |- rdf__type mesh__D000169sskos__Concept
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D000169 2005
% 218.05/218.27  |- mesh__publicMeSHNote mesh__D005652
% 218.05/218.27       91; was see under LUNG VOLUME MEASUREMENTS 1975-90   
% 218.05/218.27  |- mesh__dateRevised mesh__D005652 2003-07-09
% 218.05/218.27  |- mesh__recordAuthorizer mesh__D005652 sjn
% 218.05/218.27  |- skos__hiddenLabel mesh__D005652 Capacities, Functional Residual
% 218.05/218.27  |- skos__annotation mesh__D005652 NIM; DF: FRC   
% 218.05/218.27  |- rdf__type mesh__D005652sskos__Concept
% 218.05/218.27  |- skos__hiddenLabel mesh__D005652 Residual Capacities, Functional
% 218.05/218.27  |- skos__hiddenLabel mesh__D005652 Capacity, Functional Residual
% 218.05/218.27  |- mesh__dateEstablished mesh__D005652 1991-01-01
% 218.05/218.27  |- skos__hiddenLabel mesh__D005652 Residual Capacity, Functional
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D005652 2004
% 218.05/218.27  |- skos__prefLabel mesh__D005652 Functional Residual Capacity
% 218.05/218.27  |- skos__broader mesh__D005652smesh__D014109
% 218.05/218.27  |- mesh__historyNote mesh__D005652
% 218.05/218.27       91%28%75%29%; was see under LUNG VOLUME MEASUREMENTS 1975-90   
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D005652 2006
% 218.05/218.27  |- skos__hiddenLabel mesh__D005652 Functional Residual Capacities
% 218.05/218.27  |- skos__scopeNote mesh__D005652
% 218.05/218.27       The volume of air remaining in the LUNGS at the end of a normal, quiet expiration. It is the sum of the RESIDUAL VOLUME and the EXPIRATORY RESERVE VOLUME. Common abbreviation is FRC.%A%    
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D005652 2005
% 218.05/218.27  |- mesh__recordOriginator mesh__D005652 NLM
% 218.05/218.27  |- mesh__recordMaintainer mesh__D005652 nns
% 218.05/218.27  |- mesh__dateCreated mesh__D005652 1974-12-12
% 218.05/218.27  |- skos__annotation mesh__D010597
% 218.05/218.27       SPEC or GEN; prefer specific drug %26% specific genetic aspect: Manual 28.22.5%A%  
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D010597 2004
% 218.05/218.27  |- skos__broader mesh__D010597smesh__D005823
% 218.05/218.27  |- rdf__type mesh__D010597sskos__Concept
% 218.05/218.27  |- mesh__recordAuthorizer mesh__D010597 sjn
% 218.05/218.27  |- skos__scopeNote mesh__D010597
% 218.05/218.27       A branch of genetics which deals with the genetic variability in individual responses to drugs and drug metabolism %28%BIOTRANSFORMATION%29%.%A%    
% 218.05/218.27  |- skos__related mesh__D010597smesh__D014116
% 218.05/218.27  |- skos__broader mesh__D010597smesh__D010600
% 218.05/218.27  |- mesh__recordOriginator mesh__D010597 NLM
% 218.05/218.27  |- skos__prefLabel mesh__D010597 Pharmacogenetics
% 218.05/218.27  |- mesh__dateEstablished mesh__D010597 1970-01-01
% 218.05/218.27  |- mesh__dateCreated mesh__D010597 1999-01-01
% 218.05/218.27  |- mesh__publicMeSHNote mesh__D010597 70   
% 218.05/218.27  |- mesh__historyNote mesh__D010597 70%28%66%29%   
% 218.05/218.27  |- mesh__dateRevised mesh__D010597 2003-07-09
% 218.05/218.27  |- skos__related mesh__D010597smesh__D004351
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D010597 2006
% 218.05/218.27  |- mesh__recordMaintainer mesh__D010597 nns
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D010597 2005
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D015282 2006
% 218.05/218.27  |- skos__hiddenLabel mesh__D015282 SM 201995
% 218.05/218.27  |- skos__broader mesh__D015282smesh__D010456
% 218.05/218.27  |- skos__altLabel mesh__D015282 Compound 201-995
% 218.05/218.27  |- skos__altLabel mesh__D015282 SM 201-995
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D015282 2005
% 218.05/218.27  |- skos__historyNote mesh__D015282
% 218.05/218.27       Somatostatin/analogs %26% derivatives %28%1982-1988%29%
% 218.05/218.27  |- skos__hiddenLabel mesh__D015282 Sandoz 201995
% 218.05/218.27  |- skos__hiddenLabel mesh__D015282 SAN 201 995
% 218.05/218.27  |- mesh__recordAuthorizer mesh__D015282 sjn
% 218.05/218.27  |- skos__altLabel mesh__D015282 Sandostatin
% 218.05/218.27  |- mesh__publicMeSHNote mesh__D015282 89   
% 218.05/218.27  |- skos__hiddenLabel mesh__D015282 SM 201 995
% 218.05/218.27  |- mesh__historyNote mesh__D015282 89   
% 218.05/218.27  |- rdf__type mesh__D015282sskos__Concept
% 218.05/218.27  |- mesh__dateEstablished mesh__D015282 1989-01-01
% 218.05/218.27  |- skos__hiddenLabel mesh__D015282 Compound 201995
% 218.05/218.27  |- skos__altLabel mesh__D015282 Octreotide Acetate Salt
% 218.05/218.27  |- mesh__dateRevised mesh__D015282 2004-07-07
% 218.05/218.27  |- skos__prefLabel mesh__D015282 Octreotide
% 218.05/218.27  |- skos__hiddenLabel mesh__D015282 SMS 201 995
% 218.05/218.27  |- skos__historyNote mesh__D015282 Antineoplastic Agents %28%1982-1988%29%
% 218.05/218.27  |- mesh__recordMaintainer mesh__D015282 ssb
% 218.05/218.27  |- mesh__dateCreated mesh__D015282 1988-05-23
% 218.05/218.27  |- mesh__recordOriginator mesh__D015282 RLS
% 218.05/218.27  |- skos__altLabel mesh__D015282 Sandoz 201-995
% 218.05/218.27  |- skos__hiddenLabel mesh__D015282 SAN 201995
% 218.05/218.27  |- skos__scopeNote mesh__D015282
% 218.05/218.27       A potent, long-acting synthetic SOMATOSTATIN octapeptide analog that inhibits secretion of GROWTH HORMONE and is used to treat hormone-secreting tumors; DIABETES MELLITUS; HYPOTENSION, ORTHOSTATIC;  HYPERINSULINISM; hypergastrinemia; and small bowel fistula.%A%    
% 218.05/218.27  |- skos__hiddenLabel mesh__D015282 SMS 201995
% 218.05/218.27  |- skos__altLabel mesh__D015282 SAN 201-995
% 218.05/218.27  |- skos__hiddenLabel mesh__D015282 Sandoz 201 995
% 218.05/218.27  |- skos__hiddenLabel mesh__D015282 Compound 201 995
% 218.05/218.27  |- skos__broader mesh__D009245smesh__D042967
% 218.05/218.27  |- mesh__dateEstablished mesh__D009245 1991-01-01
% 218.05/218.27  |- mesh__dateCreated mesh__D009245 1979-05-23
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D009245 2006
% 218.05/218.27  |- mesh__historyNote mesh__D009245
% 218.05/218.27       91%28%80%29%; was see under CYTOCHROME REDUCTASES 1980-90   
% 218.05/218.27  |- skos__hiddenLabel mesh__D009245 Dehydrogenase, NADH
% 218.05/218.27  |- mesh__dateRevised mesh__D009245 2003-07-25
% 218.05/218.27  |- skos__scopeNote mesh__D009245
% 218.05/218.27       A flavoprotein and iron sulfur-containing oxidoreductase that catalyzes the oxidation of NADH to NAD. In eukaryotes the enzyme can be found as a component of mitochondrial electron transport complex I. Under experimental conditions the enzyme can use CYTOCHROME C GROUP as the reducing cofactor. The enzyme was formerly listed as EC 1.6.2.1.%A%    
% 218.05/218.27  |- mesh__publicMeSHNote mesh__D009245
% 218.05/218.27       91; was see under CYTOCHROME REDUCTASES 1980-90   
% 218.05/218.27  |- skos__historyNote mesh__D009245 Cytochrome Reductases %28%1973-1979%29%
% 218.05/218.27  |- mesh__recordAuthorizer mesh__D009245 sjn
% 218.05/218.27  |- skos__historyNote mesh__D009245
% 218.05/218.27       NADH, NADPH Oxidoreductases %28%1973-1979%29%
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D009245 2005
% 218.05/218.27  |- skos__annotation mesh__D009245
% 218.05/218.27       do not confuse with NADPH DEHYDROGENASE; do not confuse X ref NADH CYTOCHROME C REDUCTASE with NADPH CYTOCHROME C REDUCTASE%A%  
% 218.05/218.27  |- mesh__recordMaintainer mesh__D009245 sjn
% 218.05/218.27  |- skos__prefLabel mesh__D009245 NADH Dehydrogenase
% 218.05/218.27  |- skos__altLabel mesh__D009245 NADH %28%Acceptor%29% Oxidoreductase
% 218.05/218.27  |- mesh__recordOriginator mesh__D009245 RLS
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D009245 2004
% 218.05/218.27  |- skos__altLabel mesh__D009245 Diaphorase %28%NADH Dehydrogenase%29%
% 218.05/218.27  |- skos__altLabel mesh__D009245 NADH Cytochrome c Reductase
% 218.05/218.27  |- rdf__type mesh__D009245sskos__Concept
% 218.05/218.27  |- skos__historyNote mesh__D009245 Cytochrome c %28%1973-1979%29%
% 218.05/218.27  |- skos__altLabel mesh__D009245 NADH Cytochrome c Oxidoreductase
% 218.05/218.27  |- skos__broader mesh__D009245smesh__D005420
% 218.05/218.27  |- skos__historyNote mesh__D009245 Oxidoreductases %28%1966-1972%29%
% 218.05/218.27  |- mesh__dateRevised mesh__D001262 2005-06-30
% 218.05/218.27  |- skos__broader mesh__D001262smesh__D050198
% 218.05/218.27  |- rdf__type mesh__D001262sskos__Concept
% 218.05/218.27  |- mesh__dateCreated mesh__D001262 1974-11-19
% 218.05/218.27  |- mesh__publicMeSHNote mesh__D001262
% 218.05/218.27       84; was see under PROPANOLAMINES 1978-83; was ICI 66082 see under PROPANOLAMINES 1975-77%A%  
% 218.05/218.27  |- skos__scopeNote mesh__D001262
% 218.05/218.27       A cardioselective beta-adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.%A%    
% 218.05/218.27  |- mesh__historyNote mesh__D001262
% 218.05/218.27       84%28%78%29%; was see under PROPANOLAMINES 1978-83; was ICI 66082 see under PROPANOLAMINES 1975-77%A%  
% 218.05/218.27  |- skos__historyNote mesh__D001262 Propanolamines %28%1974%29%
% 218.05/218.27  |- mesh__dateEstablished mesh__D001262 1984-01-01
% 218.05/218.27  |- skos__hiddenLabel mesh__D001262 ICI 66082
% 218.05/218.27  |- skos__historyNote mesh__D001262 Phenyl Ethers %28%1974%29%
% 218.05/218.27  |- skos__historyNote mesh__D001262 Acetamides %28%1974%29%
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D001262 2006
% 218.05/218.27  |- skos__broader mesh__D001262smesh__D011412
% 218.05/218.27  |- skos__hiddenLabel mesh__D001262 ICI66082
% 218.05/218.27  |- mesh__recordAuthorizer mesh__D001262 sjn
% 218.05/218.27  |- mesh__recordOriginator mesh__D001262 NLM
% 218.05/218.27  |- skos__prefLabel mesh__D001262 Atenolol
% 218.05/218.27  |- skos__altLabel mesh__D001262 Tenormin
% 218.05/218.27  |- mesh__recordMaintainer mesh__D001262 ssb
% 218.05/218.27  |- skos__broader mesh__D014988smesh__D013449
% 218.05/218.27  |- mesh__dateEstablished mesh__D014988 1991-01-01
% 218.05/218.27  |- skos__altLabel mesh__D014988 Xipamid
% 218.05/218.27  |- rdf__type mesh__D014988sskos__Concept
% 218.05/218.27  |- skos__prefLabel mesh__D014988 Xipamide
% 218.05/218.27  |- skos__historyNote mesh__D014988 Xylenes %28%1974-1975%29%
% 218.05/218.27  |- mesh__dateRevised mesh__D014988 2005-06-30
% 218.05/218.27  |- mesh__dateCreated mesh__D014988 1976-04-16
% 218.05/218.27  |- skos__historyNote mesh__D014988 Salicylamides %28%1973-1976%29%
% 218.05/218.27  |- mesh__recordAuthorizer mesh__D014988 sjn
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D014988 2006
% 218.05/218.27  |- mesh__recordOriginator mesh__D014988 SH
% 218.05/218.27  |- mesh__publicMeSHNote mesh__D014988
% 218.05/218.27       91; was see under DIURETICS, SULFAMYL 1977-90   
% 218.05/218.27  |- mesh__historyNote mesh__D014988
% 218.05/218.27       91%28%77%29%; was see under DIURETICS, SULFAMYL 1977-90   
% 218.05/218.27  |- skos__scopeNote mesh__D014988
% 218.05/218.27       A sulfamoylbenzamide analog of CLOPAMIDE. It is diuretic and saluretic with antihypertensive activity. It is bound to PLASMA PROTEINS, thus has a delayed onset and prolonged action.%A%    
% 218.05/218.27  |- skos__historyNote mesh__D014988 Diuretics, Sulfamyl %28%1974-1976%29%
% 218.05/218.27  |- mesh__recordMaintainer mesh__D014988 ssb
% 218.05/218.27  |- skos__broader mesh__D006321Q000382smesh__D006321
% 218.05/218.27  |- rdf__type mesh__D006321Q000382smesh__CompoundConcept
% 218.05/218.27  |- skos__historyNote mesh__D019673
% 218.05/218.27       Receptors, Antigen, T-Cell, alpha-beta/genetics %28%1992-1997%29%
% 218.05/218.27  |- skos__altLabel mesh__D019673 T-Cell Receptor alpha-Chain Genes
% 218.05/218.27  |- mesh__recordAuthorizer mesh__D019673 sjn
% 218.05/218.27  |- skos__related mesh__D019673smesh__D015332
% 218.05/218.27  |- skos__broader mesh__D019673smesh__D019672
% 218.05/218.27  |- skos__hiddenLabel mesh__D019673 Gene, TcR alpha
% 218.05/218.27  |- mesh__historyNote mesh__D019673 98   
% 218.05/218.27  |- mesh__dateRevised mesh__D019673 2005-06-30
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D019673 2006
% 218.05/218.27  |- mesh__recordMaintainer mesh__D019673 nns
% 218.05/218.27  |- skos__hiddenLabel mesh__D019673 TcR alpha Gene
% 218.05/218.27  |- mesh__publicMeSHNote mesh__D019673 98   
% 218.05/218.27  |- mesh__dateEstablished mesh__D019673 1998-01-01
% 218.05/218.27  |- skos__hiddenLabel mesh__D019673 Genes, T Cell Receptor alpha
% 218.05/218.27  |- mesh__recordOriginator mesh__D019673 AGS
% 218.05/218.27  |- skos__historyNote mesh__D019673
% 218.05/218.27       Receptors, Antigen, T-Cell/genetics %28%1985-1991%29%
% 218.05/218.27  |- skos__prefLabel mesh__D019673 Genes, T-Cell Receptor alpha
% 218.05/218.27  |- rdf__type mesh__D019673sskos__Concept
% 218.05/218.27  |- skos__altLabel mesh__D019673 TcR alpha Genes
% 218.05/218.27  |- skos__scopeNote mesh__D019673
% 218.05/218.27       DNA sequences encoding the alpha chain of the T-cell receptor. The genomic organization of the TcR alpha genes is essentially the same in all species and is similar to the organization of Ig genes.%A%    
% 218.05/218.27  |- skos__hiddenLabel mesh__D019673 T Cell Receptor alpha Chain Genes
% 218.05/218.27  |- mesh__dateCreated mesh__D019673 1997-06-20
% 218.05/218.27  |- skos__hiddenLabel mesh__D019673 T Cell Receptor alpha Genes
% 218.05/218.27  |- skos__hiddenLabel mesh__D019673 Genes, TcR alpha
% 218.05/218.27  |- skos__related mesh__D019673smesh__D016693
% 218.05/218.27  |- skos__altLabel mesh__D019673 T-Cell Receptor alpha Genes
% 218.05/218.27  |- mesh__recordOriginator mesh__D000968 NLM
% 218.05/218.27  |- skos__broader mesh__D000968smesh__D018942
% 218.05/218.27  |- rdf__type mesh__D000968sskos__Concept
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D000968 2006
% 218.05/218.27  |- mesh__dateEstablished mesh__D000968 1966-01-01
% 218.05/218.27  |- mesh__dateRevised mesh__D000968 2004-07-19
% 218.05/218.27  |- mesh__recordAuthorizer mesh__D000968 sjn
% 218.05/218.27  |- skos__scopeNote mesh__D000968
% 218.05/218.27       An antibiotic substance produced by Streptomyces species. It inhibits mitochondrial respiration and may deplete cellular levels of ATP. Antimycin A1 has been used as a fungicide, insecticide, and miticide. %28%From Merck Index, 12th ed%29%%A%    
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D000968 2005
% 218.05/218.27  |- skos__prefLabel mesh__D000968 Antimycin A
% 218.05/218.27  |- mesh__publicMeSHNote mesh__D000968 66   
% 218.05/218.27  |- mesh__recordMaintainer mesh__D000968 ssb
% 218.05/218.27  |- mesh__historyNote mesh__D000968 66%28%64%29%   
% 218.05/218.27  |- mesh__dateCreated mesh__D000968 1999-01-01
% 218.05/218.27  |- skos__annotation mesh__D011690
% 218.05/218.27       in heart: do not confuse with PURKINJE CELLS in cerebellum; false tendons %28%free-running Purkinje fibers%29% go here but not with /abnorm%A%  
% 218.05/218.27  |- mesh__recordOriginator mesh__D011690 NLM
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D011690 1999
% 218.05/218.27  |- skos__broader mesh__D011690smesh__D006329
% 218.05/218.27  |- mesh__dateCreated mesh__D011690 1999-01-01
% 218.05/218.27  |- rdf__type mesh__D011690sskos__Concept
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D011690 1995
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D011690 2004
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D011690 1998
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D011690 2002
% 218.05/218.27  |- mesh__historyNote mesh__D011690
% 218.05/218.27       91%28%75%29%; was see under HEART CONDUCTION SYSTEM 1975-90   
% 218.05/218.27  |- mesh__recordMaintainer mesh__D011690 TAP
% 218.05/218.27  |- mesh__recordAuthorizer mesh__D011690 PLS
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D011690 1994
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D011690 2003
% 218.05/218.27  |- mesh__dateRevised mesh__D011690 1992-05-18
% 218.05/218.27  |- skos__scopeNote mesh__D011690
% 218.05/218.27       Modified cardiac muscle fibers composing the terminal portion of the heart conduction system.%A%    
% 218.05/218.27  |- skos__prefLabel mesh__D011690 Purkinje Fibers
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D011690 2006
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D011690 2001
% 218.05/218.27  |- mesh__dateEstablished mesh__D011690 1991-01-01
% 218.05/218.27  |- mesh__onlineNote mesh__D011690 search HEART CONDUCTION SYSTEM 1968-74   
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D011690 2005
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D011690 1997
% 218.05/218.27  |- mesh__publicMeSHNote mesh__D011690
% 218.05/218.27       91; was see under HEART CONDUCTION SYSTEM 1975-90   
% 218.05/218.27  |- skos__hiddenLabel mesh__D011690 Fibers, Purkinje
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D011690 1993
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D011690 1996
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D011690 2000
% 218.05/218.27  |- skos__related mesh__D005653smesh__D037921
% 218.05/218.27  |- mesh__recordMaintainer mesh__D005653 hjn
% 218.05/218.27  |- skos__prefLabel mesh__D005653 Fund Raising
% 218.05/218.27  |- rdf__type mesh__D005653sskos__Concept
% 218.05/218.27  |- mesh__historyNote mesh__D005653
% 218.05/218.27       91%28%78%29%; was see under FINANCIAL MANAGEMENT 1978-90   
% 218.05/218.27  |- mesh__dateEstablished mesh__D005653 1991-01-01
% 218.05/218.27  |- skos__broader mesh__D005653smesh__D005376
% 218.05/218.27  |- skos__hiddenLabel mesh__D005653 Philanthropic Fund
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D005653 2004
% 218.05/218.27  |- mesh__dateCreated mesh__D005653 1977-05-05
% 218.05/218.27  |- mesh__recordAuthorizer mesh__D005653 sjn
% 218.05/218.27  |- mesh__dateRevised mesh__D005653 2002-07-03
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D005653 2006
% 218.05/218.27  |- mesh__recordOriginator mesh__D005653 EC
% 218.05/218.27  |- skos__scopeNote mesh__D005653
% 218.05/218.27       Usually organized community efforts to raise money to promote financial programs of institutions. The funds may include individual gifts.%A%    
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D005653 2003
% 218.05/218.27  |- skos__hiddenLabel mesh__D005653 Funds, Philanthropic
% 218.05/218.27  |- skos__hiddenLabel mesh__D005653 Fund, Philanthropic
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D005653 2005
% 218.05/218.27  |- mesh__publicMeSHNote mesh__D005653
% 218.05/218.27       91; was see under FINANCIAL MANAGEMENT 1978-90   
% 218.05/218.27  |- skos__prefLabel mesh__D010598 Pharmacognosy
% 218.05/218.27  |- mesh__recordMaintainer mesh__D010598 sjn
% 218.05/218.27  |- skos__annotation mesh__D010598 SPEC   
% 218.05/218.27  |- skos__scopeNote mesh__D010598
% 218.05/218.27       The science of drugs prepared from natural-sources including preparations from PLANTS, animals, and other organisms as well as MINERALS and other substances included in MATERIA MEDICA. The therapeutic usage of plants is PHYTOTHERAPY.%A%    
% 218.05/218.27  |- skos__hiddenLabel mesh__D010598 Pharmacognosies
% 218.05/218.27  |- mesh__dateCreated mesh__D010598 1999-01-01
% 218.05/218.27  |- mesh__recordAuthorizer mesh__D010598 sjn
% 218.05/218.27  |- skos__broader mesh__D010598smesh__D001901
% 218.05/218.27  |- mesh__activeMeSHYear mesh__D010598 2006
% 218.05/218.27  |- mesh__dateRevised mesh__D010598 2003-07-25
% 218.05/218.27  |- skos__broader mesh__D010598smesh__D010600
% 218.05/218.27  |- mesh__recordOriginator mesh__D010598 NLM
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D010598 2005
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D010598 2004
% 218.05/218.28  |- rdf__type mesh__D010598sskos__Concept
% 218.05/218.28  |- skos__broader mesh__D010179Q000637smesh__D010179
% 218.05/218.28  |- mesh__preferredCombination mesh__D010179Q000637smesh__D016035
% 218.05/218.28  |- rdf__type mesh__D010179Q000637smesh__CompoundConcept
% 218.05/218.28  |- mesh__publicMeSHNote mesh__D015283
% 218.05/218.28       1989; for ESCITALOPRAM was indexed under CITALOPRAM 2001-2002%A%  
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D015283 2006
% 218.05/218.28  |- skos__historyNote mesh__D015283 Serotonin Antagonists %28%1978-1988%29%
% 218.05/218.28  |- skos__broader mesh__D015283smesh__D001572
% 218.05/218.28  |- skos__altLabel mesh__D015283 Cytalopram
% 218.05/218.28  |- mesh__dateRevised mesh__D015283 2005-06-30
% 218.05/218.28  |- skos__scopeNote mesh__D015283
% 218.05/218.28       A furancarbonitrile that is one of the SEROTONIN UPTAKE INHIBITORS used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from tardive dyskinesia in preference to tricyclic antidepressants, which aggravate this condition.%A%    
% 218.05/218.28  |- mesh__recordOriginator mesh__D015283 RLS
% 218.05/218.28  |- rdf__type mesh__D015283sskos__Concept
% 218.05/218.28  |- skos__broader mesh__D015283smesh__D009570
% 218.05/218.28  |- mesh__dateEstablished mesh__D015283 1989-01-01
% 218.05/218.28  |- skos__prefLabel mesh__D015283 Citalopram
% 218.05/218.28  |- skos__historyNote mesh__D015283 Antidepressive Agents %28%1977-1988%29%
% 218.05/218.28  |- mesh__recordMaintainer mesh__D015283 ssb
% 218.05/218.28  |- mesh__dateCreated mesh__D015283 1988-05-23
% 218.05/218.28  |- mesh__recordAuthorizer mesh__D015283 sjn
% 218.05/218.28  |- skos__hiddenLabel mesh__D015283 Lu10171
% 218.05/218.28  |- skos__historyNote mesh__D015283 Propylamines %28%1977-1988%29%
% 218.05/218.28  |- mesh__historyNote mesh__D015283
% 218.05/218.28       1989; for ESCITALOPRAM use CITALOPRAM %28%NM%29% 2001-2002   
% 218.05/218.28  |- skos__broader mesh__D015283smesh__D011437
% 218.05/218.28  |- skos__hiddenLabel mesh__D009246 Tetrazolium Reductase, NADH2
% 218.05/218.28  |- skos__broader mesh__D009246smesh__D009247
% 218.05/218.28  |- skos__historyNote mesh__D009246 NADH, NADPH Oxidoreductases %28%1974%29%
% 218.05/218.28  |- skos__altLabel mesh__D009246 NADH2 Tetrazolium Reductase
% 218.05/218.28  |- mesh__dateRevised mesh__D009246 2003-07-09
% 218.05/218.28  |- mesh__publicMeSHNote mesh__D009246
% 218.05/218.28       91; was see under NADH, NADPH OXIDOREDUCTASES 1975-90   
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D009246 2004
% 218.05/218.28  |- skos__scopeNote mesh__D009246
% 218.05/218.28       Catalyzes the reduction of tetrazolium compounds in the presence of NADH.%A%    
% 218.05/218.28  |- mesh__recordMaintainer mesh__D009246 ssb
% 218.05/218.28  |- rdf__type mesh__D009246sskos__Concept
% 218.05/218.28  |- mesh__historyNote mesh__D009246
% 218.05/218.28       91%28%75%29%; was see under NADH, NADPH OXIDOREDUCTASES 1975-90%A%  
% 218.05/218.28  |- mesh__recordAuthorizer mesh__D009246 sjn
% 218.05/218.28  |- skos__historyNote mesh__D009246 Oxidoreductases %28%1973%29%
% 218.05/218.28  |- skos__prefLabel mesh__D009246 NADH Tetrazolium Reductase
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D009246 2006
% 218.05/218.28  |- skos__hiddenLabel mesh__D009246 Reductase, NADH2 Tetrazolium
% 218.05/218.28  |- mesh__recordOriginator mesh__D009246 NLM
% 218.05/218.28  |- skos__historyNote mesh__D009246 Tetrazolium Salts %28%1973-1974%29%
% 218.05/218.28  |- skos__hiddenLabel mesh__D009246 Tetrazolium Reductase, NADH
% 218.05/218.28  |- mesh__dateEstablished mesh__D009246 1991-01-01
% 218.05/218.28  |- mesh__dateCreated mesh__D009246 1974-11-19
% 218.05/218.28  |- skos__hiddenLabel mesh__D009246 Reductase, NADH Tetrazolium
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D009246 2005
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D014989 1992
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D014989 1997
% 218.05/218.28  |- mesh__publicMeSHNote mesh__D014989 91; was see under STERNUM 1975-90   
% 218.05/218.28  |- mesh__onlineNote mesh__D014989 search STERNUM 1966-74   
% 218.05/218.28  |- skos__hiddenLabel mesh__D014989 Bones, Xiphoid
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D014989 2002
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D014989 1996
% 218.05/218.28  |- skos__hiddenLabel mesh__D014989 Bone, Xiphoid
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D014989 2006
% 218.05/218.28  |- skos__hiddenLabel mesh__D014989 Xiphoid Bones
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D014989 2001
% 218.05/218.28  |- mesh__historyNote mesh__D014989
% 218.05/218.28       91%28%75%29%; was see under STERNUM 1975-90   
% 218.05/218.28  |- mesh__dateCreated mesh__D014989 1999-01-01
% 218.05/218.28  |- mesh__dateRevised mesh__D014989 1990-04-13
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D014989 1991
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D014989 2005
% 218.05/218.28  |- mesh__recordAuthorizer mesh__D014989 PLS
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D014989 2000
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D014989 1995
% 218.05/218.28  |- skos__prefLabel mesh__D014989 Xiphoid Bone
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D014989 2004
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D014989 1999
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D014989 1994
% 218.05/218.28  |- rdf__type mesh__D014989sskos__Concept
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D014989 2003
% 218.05/218.28  |- mesh__recordOriginator mesh__D014989 NLM
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D014989 1993
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D014989 1998
% 218.05/218.28  |- mesh__dateEstablished mesh__D014989 1991-01-01
% 218.05/218.28  |- skos__broader mesh__D014989smesh__D013249
% 218.05/218.28  |- mesh__recordMaintainer mesh__D014989 NLM
% 218.05/218.28  |- skos__scopeNote mesh__D019674
% 218.05/218.28       DNA sequences encoding the beta chain of the T-cell receptor. The genomic organization of the TcR beta genes is essentially the same in all species and is similar to the organization of Ig genes.%A%    
% 218.05/218.28  |- mesh__dateCreated mesh__D019674 1997-06-20
% 218.05/218.28  |- skos__related mesh__D019674smesh__D016693
% 218.05/218.28  |- mesh__historyNote mesh__D019674 98   
% 218.05/218.28  |- skos__related mesh__D019674smesh__D015333
% 218.05/218.28  |- skos__historyNote mesh__D019674
% 218.05/218.28       Receptors, Antigen, T-Cell, alpha-beta/genetics %28%1992-1997%29%
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D019674 2006
% 218.05/218.28  |- skos__hiddenLabel mesh__D019674 Genes, TcR beta
% 218.05/218.28  |- mesh__recordAuthorizer mesh__D019674 sjn
% 218.05/218.28  |- skos__historyNote mesh__D019674
% 218.05/218.28       Receptors, Antigen, T-Cell/genetics %28%1984-1991%29%
% 218.05/218.28  |- skos__hiddenLabel mesh__D019674 Genes, T Cell Receptor beta
% 218.05/218.28  |- skos__hiddenLabel mesh__D019674 T Cell Receptor beta Genes
% 218.05/218.28  |- skos__altLabel mesh__D019674 TcR beta Genes
% 218.05/218.28  |- rdf__type mesh__D019674sskos__Concept
% 218.05/218.28  |- skos__broader mesh__D019674smesh__D019672
% 218.05/218.28  |- skos__hiddenLabel mesh__D019674 T Cell Receptor beta Chain Genes
% 218.05/218.28  |- skos__altLabel mesh__D019674 T-Cell Receptor beta Genes
% 218.05/218.28  |- mesh__dateRevised mesh__D019674 2005-06-30
% 218.05/218.28  |- mesh__recordMaintainer mesh__D019674 nns
% 218.05/218.28  |- mesh__publicMeSHNote mesh__D019674 98   
% 218.05/218.28  |- mesh__dateEstablished mesh__D019674 1998-01-01
% 218.05/218.28  |- mesh__recordOriginator mesh__D019674 AGS
% 218.05/218.28  |- skos__hiddenLabel mesh__D019674 Gene, TcR beta
% 218.05/218.28  |- skos__hiddenLabel mesh__D019674 TcR beta Gene
% 218.05/218.28  |- skos__prefLabel mesh__D019674 Genes, T-Cell Receptor beta
% 218.05/218.28  |- skos__altLabel mesh__D019674 T-Cell Receptor beta-Chain Genes
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D000969 2006
% 218.05/218.28  |- mesh__recordMaintainer mesh__D000969 ssb
% 218.05/218.28  |- skos__annotation mesh__D000969
% 218.05/218.28       consider also NEMATODA /drug eff %26% NEMATODE INFECTIONS /drug ther or pertinent specifics%A%  
% 218.05/218.28  |- mesh__publicMeSHNote mesh__D000969
% 218.05/218.28       76; was see under ANTHELMINTICS 1975; NEMATOCIDES was heading 1974-75%A%  
% 218.05/218.28  |- mesh__onlineNote mesh__D000969
% 218.05/218.28       use ANTINEMATODAL AGENTS to search NEMATOCIDES 1974-75   
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D000969 2005
% 218.05/218.28  |- skos__hiddenLabel mesh__D000969 Agents, Antinematodal
% 218.05/218.28  |- mesh__recordOriginator mesh__D000969 NLM
% 218.05/218.28  |- mesh__dateRevised mesh__D000969 2003-07-09
% 218.05/218.28  |- skos__altLabel mesh__D000969 Antinematodal Drugs
% 218.05/218.28  |- mesh__recordAuthorizer mesh__D000969 sjn
% 218.05/218.28  |- skos__prefLabel mesh__D000969 Antinematodal Agents
% 218.05/218.28  |- skos__altLabel mesh__D000969 Nematocides
% 218.05/218.28  |- skos__altLabel mesh__D000969 Antinematodals
% 218.05/218.28  |- mesh__dateEstablished mesh__D000969 1976-01-01
% 218.05/218.28  |- skos__scopeNote mesh__D000969
% 218.05/218.28       Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice.%A%    
% 218.05/218.28  |- mesh__dateCreated mesh__D000969 1999-01-01
% 218.05/218.28  |- skos__broader mesh__D000969smesh__D000871
% 218.05/218.28  |- mesh__historyNote mesh__D000969
% 218.05/218.28       76%28%75%29%; was see under ANTHELMINTICS 1975; NEMATOCIDES was heading 1974-75%A%  
% 218.05/218.28  |- skos__hiddenLabel mesh__D000969 Drugs, Antinematodal
% 218.05/218.28  |- skos__historyNote mesh__D000969 Anthelmintics %28%1966-1973%29%
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D000969 2004
% 218.05/218.28  |- rdf__type mesh__D000969sskos__Concept
% 218.05/218.28  |- skos__hiddenLabel mesh__D011691 CL13900
% 218.05/218.28  |- mesh__recordAuthorizer mesh__D011691 sjn
% 218.05/218.28  |- mesh__recordMaintainer mesh__D011691 ssb
% 218.05/218.28  |- skos__broader mesh__D011691smesh__D000241
% 218.05/218.28  |- rdf__type mesh__D011691sskos__Concept
% 218.05/218.28  |- mesh__historyNote mesh__D011691 65%28%63%29%   
% 218.05/218.28  |- skos__broader mesh__D011691smesh__D002934
% 218.05/218.28  |- mesh__publicMeSHNote mesh__D011691 65   
% 218.05/218.28  |- skos__prefLabel mesh__D011691 Puromycin
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D011691 2005
% 218.05/218.28  |- skos__hiddenLabel mesh__D011691 P638
% 218.05/218.28  |- mesh__recordOriginator mesh__D011691 NLM
% 218.05/218.28  |- skos__broader mesh__D011691smesh__D000617
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D011691 2006
% 218.05/218.28  |- skos__hiddenLabel mesh__D011691 P 638
% 218.05/218.28  |- skos__scopeNote mesh__D011691
% 218.05/218.28       A cinnamamido ADENOSINE found in STREPTOMYCES alboniger. It inhibits protein synthesis by binding to RNA. It is an antineoplastic and antitrypanosomal agent and is used in research as an inhibitor of protein synthesis.%A%    
% 218.05/218.28  |- mesh__dateCreated mesh__D011691 1999-01-01
% 218.05/218.28  |- skos__hiddenLabel mesh__D011691 CL 13900
% 218.05/218.28  |- mesh__dateEstablished mesh__D011691 1965-01-01
% 218.05/218.28  |- mesh__dateRevised mesh__D011691 2004-07-07
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D005654 1998
% 218.05/218.28  |- skos__prefLabel mesh__D005654 Fundus Oculi
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D005654 2003
% 218.05/218.28  |- skos__annotation mesh__D005654
% 218.05/218.28       no qualif; what is seen through an ophthalmoscope: do not confuse with RETINA %26% RETINAL VESSELS, the correct terms with subheadings, not FUNDUS OCULI; early coord for fundus fluorescent angiography: see hist notes under FLUORESCEIN ANGIOGRAPHY%A%  
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D005654 2005
% 218.05/218.28  |- mesh__dateCreated mesh__D005654 1999-01-01
% 218.05/218.28  |- mesh__recordAuthorizer mesh__D005654 PLS
% 218.05/218.28  |- mesh__recordOriginator mesh__D005654 NLM
% 218.05/218.28  |- skos__broader mesh__D005654smesh__D012160
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D005654 2002
% 218.05/218.28  |- mesh__recordMaintainer mesh__D005654 TGC
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D005654 1997
% 218.05/218.28  |- rdf__type mesh__D005654sskos__Concept
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D005654 2001
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D005654 1999
% 218.05/218.28  |- skos__related mesh__D005654smesh__D009887
% 218.05/218.28  |- skos__scopeNote mesh__D005654
% 218.05/218.28       The concave interior of the eye, consisting of the retina, the choroid, the sclera, the optic disk, and blood vessels, seen by means of the ophthalmoscope. %28%Cline et al., Dictionary of Visual Science, 4th ed%29%%A%    
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D005654 2004
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D005654 1996
% 218.05/218.28  |- mesh__dateRevised mesh__D005654 1995-05-18
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D005654 2000
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D005654 2006
% 218.05/218.28  |- skos__broader mesh__D010599smesh__D001702
% 218.05/218.28  |- skos__annotation mesh__D010599
% 218.05/218.28       general or unspecified; prefer /pharmacokin with drugs: Manual 19.7+, 19.8.53, 19.10+; DF: PHARMACOKIN%A%  
% 218.05/218.28  |- mesh__publicMeSHNote mesh__D010599 88   
% 218.05/218.28  |- mesh__dateCreated mesh__D010599 1987-04-18
% 218.05/218.28  |- skos__altLabel mesh__D010599 Drug Kinetics
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D010599 2005A
% 218.05/218.28  |- mesh__recordMaintainer mesh__D010599 jls
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D010599 2005
% 218.05/218.28  |- mesh__recordOriginator mesh__D010599 SCD
% 218.05/218.28  |- mesh__recordAuthorizer mesh__D010599 jls
% 218.05/218.28  |- skos__historyNote mesh__D010599 Kinetics %28%1966-1987%29%
% 218.05/218.28  |- mesh__dateEstablished mesh__D010599 1988-01-01
% 218.05/218.28  |- mesh__dateRevised mesh__D010599 2004-07-30
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D010599 2006
% 218.05/218.28  |- skos__historyNote mesh__D010599
% 218.05/218.28       specific Category D heading/metabolism %28%1966-1987%29%
% 218.05/218.28  |- skos__prefLabel mesh__D010599 Pharmacokinetics
% 218.05/218.28  |- skos__scopeNote mesh__D010599
% 218.05/218.28       Dynamic and kinetic mechanisms of exogenous chemical and drug ABSORPTION; BIOLOGICAL TRANSPORT; TISSUE DISTRIBUTION; BIOTRANSFORMATION; elimination; and TOXICOLOGY as a function of dosage, and rate of METABOLISM. It includes toxicokinetics, the pharmacokinetic mechanism of the toxic effects of a substance. ADME and ADMET are short-hand abbreviations for absorption, distribution, metabolism, elimination and toxicology.%A%    
% 218.05/218.28  |- skos__broader mesh__D010599smesh__D008660
% 218.05/218.28  |- mesh__historyNote mesh__D010599 88   
% 218.05/218.28  |- skos__altLabel mesh__D010599 Kinetics, Drug
% 218.05/218.28  |- rdf__type mesh__D010599sskos__Concept
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D015284 2003
% 218.05/218.28  |- mesh__recordOriginator mesh__D015284 EC
% 218.05/218.28  |- skos__broader mesh__D015284smesh__D012051
% 218.05/218.28  |- mesh__dateRevised mesh__D015284 1998-06-10
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D015284 2000
% 218.05/218.28  |- mesh__dateEstablished mesh__D015284 1991-01-01
% 218.05/218.28  |- rdf__type mesh__D015284sskos__Concept
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D015284 2004
% 218.05/218.28  |- skos__scopeNote mesh__D015284
% 218.05/218.28       A commission created by the Consolidated Omnibus Reconciliation Act of 1985, enacted in 1986, and given the mandate to advise Congress on Medicare-physician payment. The commission members are appointed by the U.S. Office of Technology Assessment.%A%    
% 218.05/218.28  |- mesh__recordMaintainer mesh__D015284 JLS
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D015284 2001
% 218.05/218.28  |- mesh__recordAuthorizer mesh__D015284 SJN
% 218.05/218.28  |- skos__altLabel mesh__D015284 Physician Payment Review Commissions
% 218.05/218.28  |- mesh__dateCreated mesh__D015284 1988-05-23
% 218.05/218.28  |- skos__related mesh__D015284smesh__D020406
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D015284 2005
% 218.05/218.28  |- skos__annotation mesh__D015284
% 218.05/218.28       specify geog if pertinent; DF: PPRC      CATALOG: use NAF entry: United States. Physician Payment Review Commission%A%  
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D015284 2002
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D015284 1999
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D015284 2006
% 218.05/218.28  |- skos__prefLabel mesh__D015284 Physician Payment Review Commission
% 218.05/218.28  |- mesh__historyNote mesh__D015284
% 218.05/218.28       91%28%89%29%; was see under REIMBURSEMENT MECHANISMS 1989-90   
% 218.05/218.28  |- mesh__publicMeSHNote mesh__D015284
% 218.05/218.28       91; was see under REIMBURSEMENT MECHANISMS 1989-90   
% 218.05/218.28  |- mesh__dateRevised mesh__D009247 2003-07-09
% 218.05/218.28  |- mesh__publicMeSHNote mesh__D009247 74   
% 218.05/218.28  |- mesh__recordOriginator mesh__D009247 NLM
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D009247 2004
% 218.05/218.28  |- skos__prefLabel mesh__D009247 NADH, NADPH Oxidoreductases
% 218.05/218.28  |- skos__scopeNote mesh__D009247
% 218.05/218.28       A group of oxidoreductases that act on NADH or NADPH. In general, enzymes using NADH or NADPH to reduce a substrate are classified according to the reverse reaction, in which NAD+ or NADP+ is formally regarded as an acceptor. This subclass includes only those enzymes in which some other redox carrier is the acceptor. %28%Enzyme Nomenclature, 1992, p100%29% EC 1.6.%A%    
% 218.05/218.28  |- skos__historyNote mesh__D009247 Oxidoreductases %28%1966-1972%29%
% 218.05/218.28  |- mesh__dateCreated mesh__D009247 1999-01-01
% 218.05/218.28  |- rdf__type mesh__D009247sskos__Concept
% 218.05/218.28  |- skos__hiddenLabel mesh__D009247 NADPH Oxidoreductases NADH
% 218.05/218.28  |- skos__broader mesh__D009247smesh__D010088
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D009247 2006
% 218.05/218.28  |- skos__hiddenLabel mesh__D009247 Oxidoreductases NADH, NADPH
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D009247 2005
% 218.05/218.28  |- mesh__recordMaintainer mesh__D009247 ssb
% 218.05/218.28  |- skos__altLabel mesh__D009247 Oxidoreductases, NADH, NADPH
% 218.05/218.28  |- mesh__recordAuthorizer mesh__D009247 sjn
% 218.05/218.28  |- mesh__dateEstablished mesh__D009247 1974-01-01
% 218.05/218.28  |- mesh__historyNote mesh__D009247 74%28%73%29%   
% 218.05/218.28  |- skos__altLabel mesh__D001264 Hammond Disease
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D001264 2000
% 218.05/218.28  |- skos__hiddenLabel mesh__D001264 Hammond%27%s Diseases
% 218.05/218.28  |- skos__hiddenLabel mesh__D001264 Hammond Diseases
% 218.05/218.28  |- skos__prefLabel mesh__D001264 Athetosis
% 218.05/218.28  |- skos__hiddenLabel mesh__D001264 Hammonds Disease
% 218.05/218.28  |- skos__altLabel mesh__D001264 Hammond%27%s Disease
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D001264 2001
% 218.05/218.28  |- mesh__recordAuthorizer mesh__D001264 ags
% 218.05/218.28  |- skos__broader mesh__D001264smesh__D020820
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D001264 2006A
% 218.05/218.28  |- skos__hiddenLabel mesh__D001264 Athetoid Movement
% 218.05/218.28  |- skos__hiddenLabel mesh__D001264 Movement, Athetoid
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D001264 2003
% 218.05/218.28  |- mesh__recordMaintainer mesh__D001264 ags
% 218.05/218.28  |- skos__hiddenLabel mesh__D001264 Movements, Athetoid
% 218.05/218.28  |- skos__altLabel mesh__D001264 Athetoid Movements
% 218.05/218.28  |- skos__hiddenLabel mesh__D001264 Disease, Hammond
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D001264 2005
% 218.05/218.28  |- mesh__recordOriginator mesh__D001264 NLM
% 218.05/218.28  |- skos__hiddenLabel mesh__D001264 Disease, Hammond%27%s
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D001264 2004
% 218.05/218.28  |- skos__hiddenLabel mesh__D001264 Diseases, Hammond%27%s
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D001264 2002
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D001264 2006
% 218.05/218.28  |- skos__hiddenLabel mesh__D001264 Athetoses
% 218.05/218.28  |- mesh__dateRevised mesh__D001264 2005-07-13
% 218.05/218.28  |- mesh__dateCreated mesh__D001264 1999-01-01
% 218.05/218.28  |- rdf__type mesh__D001264sskos__Concept
% 218.05/218.28  |- skos__annotation mesh__D001264
% 218.05/218.28       choreoathetosis = CHOREA %28%IM%29% + ATHETOSIS %28%IM%29%   
% 218.05/218.28  |- skos__hiddenLabel mesh__D001264 Diseases, Hammond
% 218.05/218.28  |- skos__scopeNote mesh__D001264
% 218.05/218.28       A dyskinesia characterized by an inability to maintain the fingers, toes, tongue, or other body parts in a stable position, resulting in continuous slow, sinusoidal, and flowing involuntary movements. This condition is frequently accompanied by CHOREA, where it is referred to as choreoathetosis. Athetosis may occur as a manifestation of BASAL GANGLIA DISEASES or DRUG TOXICITY. %28%From Adams et al., Principles of Neurology, 6th ed, p76%29%%A%    
% 218.05/218.28  |- mesh__dateCreated mesh__D019675 1997-06-20
% 218.05/218.28  |- skos__related mesh__D019675smesh__D016692
% 218.05/218.28  |- mesh__dateRevised mesh__D019675 2005-06-30
% 218.05/218.28  |- mesh__publicMeSHNote mesh__D019675 98   
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D019675 2006
% 218.05/218.28  |- mesh__historyNote mesh__D019675 98   
% 218.05/218.28  |- skos__hiddenLabel mesh__D019675 TcR gamma Gene
% 218.05/218.28  |- skos__hiddenLabel mesh__D019675 Genes, T Cell Receptor gamma
% 218.05/218.28  |- skos__related mesh__D019675smesh__D015334
% 218.05/218.28  |- rdf__type mesh__D019675sskos__Concept
% 218.05/218.28  |- skos__prefLabel mesh__D019675 Genes, T-Cell Receptor gamma
% 218.05/218.28  |- skos__altLabel mesh__D019675 TcR gamma Genes
% 218.05/218.28  |- skos__scopeNote mesh__D019675
% 218.05/218.28       DNA sequences encoding the gamma chain of the T-cell receptor. The human gamma-chain locus is organized similarly to the TcR beta-chain locus.%A%    
% 218.05/218.28  |- skos__broader mesh__D019675smesh__D019672
% 218.05/218.28  |- skos__altLabel mesh__D019675 T-Cell Receptor gamma Genes
% 218.05/218.28  |- skos__altLabel mesh__D019675 T-Cell Receptor gamma-Chain Genes
% 218.05/218.28  |- skos__hiddenLabel mesh__D019675 Genes, TcR gamma
% 218.05/218.28  |- mesh__recordOriginator mesh__D019675 AGS
% 218.05/218.28  |- mesh__recordAuthorizer mesh__D019675 sjn
% 218.05/218.28  |- skos__hiddenLabel mesh__D019675 T Cell Receptor gamma Genes
% 218.05/218.28  |- skos__hiddenLabel mesh__D019675 Gene, TcR gamma
% 218.05/218.28  |- mesh__recordMaintainer mesh__D019675 nns
% 218.05/218.28  |- skos__historyNote mesh__D019675
% 218.05/218.28       Receptors, Antigen, T-Cell/genetics %28%1985-1991%29%
% 218.05/218.28  |- skos__hiddenLabel mesh__D019675 T Cell Receptor gamma Chain Genes
% 218.05/218.28  |- mesh__dateEstablished mesh__D019675 1998-01-01
% 218.05/218.28  |- skos__historyNote mesh__D019675
% 218.05/218.28       Receptors, Antigen, T-Cell, gamma-delta/genetics %28%1992-1997%29%
% 218.05/218.28  |- skos__broader mesh__D011692smesh__D011691
% 218.05/218.28  |- mesh__publicMeSHNote mesh__D011692
% 218.05/218.28       91; was see under PUROMYCIN 1975-90   
% 218.05/218.28  |- skos__altLabel mesh__D011692
% 218.05/218.28       3%27%-Amino-3%27%-deoxy-N,N-dimethyladenosine
% 218.05/218.28  |- rdf__type mesh__D011692sskos__Concept
% 218.05/218.28  |- skos__historyNote mesh__D011692
% 218.05/218.28       Antibiotics, Antineoplastic %28%1972-1974%29%
% 218.05/218.28  |- skos__prefLabel mesh__D011692 Puromycin Aminonucleoside
% 218.05/218.28  |- mesh__historyNote mesh__D011692
% 218.05/218.28       91%28%75%29%; was see under PUROMYCIN 1975-90   
% 218.05/218.28  |- skos__broader mesh__D011692smesh__D003839
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D011692 2005
% 218.05/218.28  |- mesh__recordAuthorizer mesh__D011692 sjn
% 218.05/218.28  |- skos__scopeNote mesh__D011692
% 218.05/218.28       PUROMYCIN derivative that lacks the methoxyphenylalanyl group on the amine of the sugar ring. It is an antibiotic with antineoplastic properties and can cause nephrosis.%A%    
% 218.05/218.28  |- mesh__recordMaintainer mesh__D011692 ssb
% 218.05/218.28  |- skos__hiddenLabel mesh__D011692
% 218.05/218.28       3%27% Amino 3%27% deoxy N,N dimethyladenosine
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D011692 2006
% 218.05/218.28  |- skos__historyNote mesh__D011692 Deoxyadenosine %28%1972-1974%29%
% 218.05/218.28  |- skos__hiddenLabel mesh__D011692 Aminonucleoside, Puromycin
% 218.05/218.28  |- mesh__recordOriginator mesh__D011692 NLM
% 218.05/218.28  |- skos__historyNote mesh__D011692 Amino Sugars %28%1974%29%
% 218.05/218.28  |- mesh__dateRevised mesh__D011692 2004-07-07
% 218.05/218.28  |- mesh__dateCreated mesh__D011692 1974-11-19
% 218.05/218.28  |- mesh__dateEstablished mesh__D011692 1991-01-01
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D005655 2005
% 218.05/218.28  |- skos__prefLabel mesh__D005655 Funeral Rites
% 218.05/218.28  |- mesh__dateCreated mesh__D005655 1999-01-01
% 218.05/218.28  |- skos__scopeNote mesh__D005655
% 218.05/218.28       Those customs and ceremonies pertaining to the dead.     
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D005655 2000
% 218.05/218.28  |- skos__hiddenLabel mesh__D005655 Custom, Mortuary
% 218.05/218.28  |- mesh__recordMaintainer mesh__D005655 kle
% 218.05/218.28  |- skos__hiddenLabel mesh__D005655 Funeral Rite
% 218.05/218.28  |- mesh__dateRevised mesh__D005655 1999-11-03
% 218.05/218.28  |- mesh__historyNote mesh__D005655
% 218.05/218.28       83%28%75%29%; was see under MORTUARY CUSTOMS 1963-82; MORTUARY CUSTOMS was heading 1963-82%A%  
% 218.05/218.28  |- rdf__type mesh__D005655sskos__Concept
% 218.05/218.28  |- skos__hiddenLabel mesh__D005655 Rites, Funeral
% 218.05/218.28  |- mesh__onlineNote mesh__D005655
% 218.05/218.28       use FUNERAL RITES to search MORTUARY CUSTOMS 1966-82   
% 218.05/218.28  |- skos__hiddenLabel mesh__D005655 Mortuary Custom
% 218.05/218.28  |- mesh__recordOriginator mesh__D005655 NLM
% 218.05/218.28  |- mesh__dateEstablished mesh__D005655 1983-01-01
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D005655 2004
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D005655 2002
% 218.05/218.28  |- skos__broader mesh__D005655smesh__D003469
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D005655 2006
% 218.05/218.28  |- mesh__publicMeSHNote mesh__D005655
% 218.05/218.28       83; was see under MORTUARY CUSTOMS 1963-82; MORTUARY CUSTOMS was heading 1963-82%A%  
% 218.05/218.28  |- skos__hiddenLabel mesh__D005655 Customs, Mortuary
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D005655 2003
% 218.05/218.28  |- mesh__recordAuthorizer mesh__D005655 sjn
% 218.05/218.28  |- skos__hiddenLabel mesh__D005655 Rite, Funeral
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D005655 2001
% 218.05/218.28  |- skos__annotation mesh__D005655 specify geog if pertinent   
% 218.05/218.28  |- mesh__historyNote mesh__D015285
% 218.05/218.28       91%28%89%29%; was see under PUBLIC RELATIONS 1989-90   
% 218.05/218.28  |- mesh__dateCreated mesh__D015285 1988-05-23
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D015285 2002
% 218.05/218.28  |- skos__annotation mesh__D015285 no qualif; DF: HOSP PATIENT RELAT   
% 218.05/218.28  |- skos__broader mesh__D015285smesh__D006739
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D015285 1998
% 218.05/218.28  |- mesh__recordOriginator mesh__D015285 EC
% 218.05/218.28  |- mesh__dateRevised mesh__D015285 1997-06-20
% 218.05/218.28  |- mesh__activeMeSHYear mesh__D015285 2005
% 218.15/218.28  |- skos__historyNote mesh__D015285 Consumer Satisfaction %28%1983-1988%29%
% 218.15/218.28  |- mesh__activeMeSHYear mesh__D015285 1999
% 218.15/218.28  |- skos__broader mesh__D015285smesh__D011641
% 218.15/218.28  |- skos__scopeNote mesh__D015285
% 218.15/218.28       Interactions between hospital staff or administrators and patients. Includes guest relations programs designed to improve the image of the hospital and attract patients.%A%    
% 218.15/218.28  |- skos__hiddenLabel mesh__D015285 Relations, Guest
% 218.15/218.28  |- mesh__activeMeSHYear mesh__D015285 2006
% 218.15/218.28  |- mesh__activeMeSHYear mesh__D015285 2000
% 218.15/218.28  |- mesh__recordMaintainer mesh__D015285 JLS
% 218.15/218.28  |- skos__hiddenLabel mesh__D015285 Hospital-Patient Relation
% 218.15/218.28  |- mesh__activeMeSHYear mesh__D015285 2003
% 218.15/218.28  |- skos__hiddenLabel mesh__D015285 Relations, Hospital-Patient
% 218.15/218.28  |- mesh__activeMeSHYear mesh__D015285 2001
% 218.15/218.28  |- rdf__type mesh__D015285sskos__Concept
% 218.15/218.28  |- mesh__activeMeSHYear mesh__D015285 2004
% 218.15/218.28  |- mesh__recordAuthorizer mesh__D015285 SJN
% 218.15/218.28  |- skos__hiddenLabel mesh__D015285 Guest Relation
% 218.15/218.28  |- skos__hiddenLabel mesh__D015285 Hospital Patient Relations
% 218.15/218.28  |- mesh__publicMeSHNote mesh__D015285
% 218.15/218.28       91; was see under PUBLIC RELATIONS 1989-90   
% 218.15/218.28  |- skos__prefLabel mesh__D015285 Hospital-Patient Relations
% 218.15/218.28  |- mesh__dateEstablished mesh__D015285 1991-01-01
% 218.15/218.28  |- mesh__publicMeSHNote mesh__D009248 87   
% 218.15/218.28  |- skos__prefLabel mesh__D009248 Nadolol
% 218.15/218.28  |- skos__historyNote mesh__D009248
% 218.15/218.28       Adrenergic Beta Receptor Blockaders %28%1969-1986%29%
% 218.15/218.28  |- mesh__historyNote mesh__D009248 87   
% 218.15/218.28  |- rdf__type mesh__D009248sskos__Concept
% 218.15/218.28  |- mesh__recordAuthorizer mesh__D009248 sjn
% 218.15/218.28  |- skos__broader mesh__D009248smesh__D050198
% 218.15/218.28  |- skos__broader mesh__D009248smesh__D011412
% 218.15/218.28  |- skos__historyNote mesh__D009248 Propanolamines %28%1974-1986%29%
% 218.15/218.28  |- mesh__activeMeSHYear mesh__D009248 2006
% 218.15/218.28  |- mesh__recordOriginator mesh__D009248 SH
% 218.15/218.28  |- mesh__dateCreated mesh__D009248 1986-06-25
% 218.15/218.28  |- skos__scopeNote mesh__D009248
% 218.15/218.28       A non-selective beta-adrenergic antagonist with a long half-life, used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension. Nadolol is also used for MIGRAINE DISORDERS and for tremor.%A%    
% 218.15/218.28  |- skos__hiddenLabel mesh__D009248 SQ 11725
% 218.15/218.28  |- mesh__dateEstablished mesh__D009248 1987-01-01
% 218.15/218.28  |- skos__hiddenLabel mesh__D009248 SQ11725
% 218.15/218.29  |- mesh__recordMaintainer mesh__D009248 sjn
% 218.15/218.29  |- mesh__dateRevised mesh__D009248 2005-07-01
% 218.15/218.29  |- skos__altLabel mesh__D001265 Sports Injuries
% 218.15/218.29  |- skos__altLabel mesh__D001265 Injuries, Athletic
% 218.15/218.29  |- skos__scopeNote mesh__D001265
% 218.15/218.29       Injuries incurred during participation in competitive or non-competitive sports.%A%    
% 218.15/218.29  |- skos__hiddenLabel mesh__D001265 Sports Injury
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001265 2003
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001265 1998
% 218.15/218.29  |- skos__historyNote mesh__D001265 Sport Medicine %28%1966-1967%29%
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001265 2000
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001265 2005
% 218.15/218.29  |- skos__historyNote mesh__D001265 Sports %28%1966-1967%29%
% 218.15/218.29  |- skos__annotation mesh__D001265
% 218.15/218.29       GEN only: prefer specific sport /inj; when GEN, coord IM with specific inj %28%IM%29%; Manual 30.15.1: relation to SPORTS MEDICINE; consider also TENNIS ELBOW but see note there%A%  
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001265 2004
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001265 1999
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001265 2001
% 218.15/218.29  |- mesh__recordMaintainer mesh__D001265 TGC
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001265 2006
% 218.15/218.29  |- mesh__dateRevised mesh__D001265 1997-06-20
% 218.15/218.29  |- skos__prefLabel mesh__D001265 Athletic Injuries
% 218.15/218.29  |- mesh__recordAuthorizer mesh__D001265 SJN
% 218.15/218.29  |- mesh__publicMeSHNote mesh__D001265 68   
% 218.15/218.29  |- mesh__historyNote mesh__D001265 68   
% 218.15/218.29  |- skos__hiddenLabel mesh__D001265 Athletic Injury
% 218.15/218.29  |- skos__hiddenLabel mesh__D001265 Injury, Sports
% 218.15/218.29  |- mesh__dateCreated mesh__D001265 1999-01-01
% 218.15/218.29  |- rdf__type mesh__D001265sskos__Concept
% 218.15/218.29  |- mesh__recordOriginator mesh__D001265 NLM
% 218.15/218.29  |- skos__broader mesh__D001265smesh__D014947
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001265 2002
% 218.15/218.29  |- skos__hiddenLabel mesh__D001265 Injury, Athletic
% 218.15/218.29  |- mesh__dateEstablished mesh__D001265 1968-01-01
% 218.15/218.29  |- skos__altLabel mesh__D001265 Injuries, Sports
% 218.15/218.29  |- skos__altLabel mesh__D019676 TcR delta Genes
% 218.15/218.29  |- mesh__recordMaintainer mesh__D019676 nns
% 218.15/218.29  |- skos__hiddenLabel mesh__D019676 Genes, T Cell Receptor delta
% 218.15/218.29  |- skos__historyNote mesh__D019676
% 218.15/218.29       Receptors, Antigen, T-Cell/genetics %28%1987-1991%29%
% 218.15/218.29  |- skos__hiddenLabel mesh__D019676 Genes, TcR delta
% 218.15/218.29  |- skos__prefLabel mesh__D019676 Genes, T-Cell Receptor delta
% 218.15/218.29  |- mesh__dateEstablished mesh__D019676 1998-01-01
% 218.15/218.29  |- mesh__dateCreated mesh__D019676 1997-06-20
% 218.15/218.29  |- skos__related mesh__D019676smesh__D016692
% 218.15/218.29  |- skos__altLabel mesh__D019676 T-Cell Receptor delta Genes
% 218.15/218.29  |- mesh__dateRevised mesh__D019676 2005-06-30
% 218.15/218.29  |- mesh__publicMeSHNote mesh__D019676 98   
% 218.15/218.29  |- rdf__type mesh__D019676sskos__Concept
% 218.15/218.29  |- skos__related mesh__D019676smesh__D016694
% 218.15/218.29  |- skos__scopeNote mesh__D019676
% 218.15/218.29       DNA sequences encoding the delta chain of the T-cell receptor. The delta-chain locus is located entirely within the alpha-chain locus.%A%    
% 218.15/218.29  |- skos__hiddenLabel mesh__D019676 Gene, TcR delta
% 218.15/218.29  |- skos__historyNote mesh__D019676
% 218.15/218.29       Receptors, Antigen, T-Cell, gamma-delta/genetics %28%1992-1997%29%
% 218.15/218.29  |- skos__hiddenLabel mesh__D019676 TcR delta Gene
% 218.15/218.29  |- skos__broader mesh__D019676smesh__D019672
% 218.15/218.29  |- skos__hiddenLabel mesh__D019676 T Cell Receptor delta Chain Genes
% 218.15/218.29  |- skos__hiddenLabel mesh__D019676 T Cell Receptor delta Genes
% 218.15/218.29  |- skos__altLabel mesh__D019676 T-Cell Receptor delta-Chain Genes
% 218.15/218.29  |- mesh__recordOriginator mesh__D019676 AGS
% 218.15/218.29  |- mesh__recordAuthorizer mesh__D019676 sjn
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D019676 2006
% 218.15/218.29  |- mesh__historyNote mesh__D019676 98   
% 218.15/218.29  |- mesh__recordOriginator mesh__D011693 NLM
% 218.15/218.29  |- skos__scopeNote mesh__D011693
% 218.15/218.29       Purplish or brownish red discoloration, easily visible through the epidermis, caused by hemorrhage into the tissues.%A%    
% 218.15/218.29  |- mesh__dateCreated mesh__D011693 1999-01-01
% 218.15/218.29  |- skos__broader mesh__D011693smesh__D001778
% 218.15/218.29  |- skos__hiddenLabel mesh__D011693 Purpuras
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D011693 2003
% 218.15/218.29  |- skos__broader mesh__D011693smesh__D012877
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D011693 2000
% 218.15/218.29  |- rdf__type mesh__D011693sskos__Concept
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D011693 2004
% 218.15/218.29  |- mesh__recordAuthorizer mesh__D011693 sjn
% 218.15/218.29  |- mesh__dateRevised mesh__D011693 1999-11-08
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D011693 2001
% 218.15/218.29  |- mesh__recordMaintainer mesh__D011693 KEV
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D011693 2005
% 218.15/218.29  |- skos__annotation mesh__D011693 GEN or unspecified; prefer specifics   
% 218.15/218.29  |- skos__prefLabel mesh__D011693 Purpura
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D011693 2002
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D011693 2006
% 218.15/218.29  |- skos__broader mesh__D019989Q000193smesh__D019989
% 218.15/218.29  |- mesh__preferredCombination mesh__D019989Q000193smesh__D004495
% 218.15/218.29  |- rdf__type mesh__D019989Q000193smesh__CompoundConcept
% 218.15/218.29  |- skos__related mesh__D005656smesh__D005658
% 218.15/218.29  |- mesh__recordOriginator mesh__D005656 NLM
% 218.15/218.29  |- skos__altLabel mesh__D005656 Fungal Gene Proteins
% 218.15/218.29  |- skos__altLabel mesh__D005656 Gene Products, Fungal
% 218.15/218.29  |- skos__annotation mesh__D005656
% 218.15/218.29       /drug eff /ultrastruct permitted; /physiol permitted for function within the fungus; coord IM with specific protein %28%IM%29% + specific fungus %28%IM%29%%A%  
% 218.15/218.29  |- mesh__recordMaintainer mesh__D005656 DRC
% 218.15/218.29  |- mesh__recordAuthorizer mesh__D005656 sjn
% 218.15/218.29  |- mesh__dateRevised mesh__D005656 2005-06-30
% 218.15/218.29  |- skos__historyNote mesh__D005656 Proteins %28%1966-1972%29%
% 218.15/218.29  |- mesh__historyNote mesh__D005656 73   
% 218.15/218.29  |- skos__hiddenLabel mesh__D005656 Peptides, Fungal
% 218.15/218.29  |- skos__altLabel mesh__D005656 Fungal Gene Products
% 218.15/218.29  |- skos__broader mesh__D005656smesh__D011506
% 218.15/218.29  |- rdf__type mesh__D005656sskos__Concept
% 218.15/218.29  |- skos__related mesh__D005656smesh__D015003
% 218.15/218.29  |- skos__hiddenLabel mesh__D005656 Proteins, Fungal
% 218.15/218.29  |- mesh__publicMeSHNote mesh__D005656 73   
% 218.15/218.29  |- mesh__dateCreated mesh__D005656 1999-01-01
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D005656 2006
% 218.15/218.29  |- skos__scopeNote mesh__D005656
% 218.15/218.29       Proteins found in any species of fungus.     
% 218.15/218.29  |- skos__historyNote mesh__D005656 Fungi %28%1966-1972%29%
% 218.15/218.29  |- skos__hiddenLabel mesh__D005656 Gene Proteins, Fungal
% 218.15/218.29  |- mesh__dateEstablished mesh__D005656 1973-01-01
% 218.15/218.29  |- skos__prefLabel mesh__D005656 Fungal Proteins
% 218.15/218.29  |- mesh__dateCreated mesh__D015286 1988-05-23
% 218.15/218.29  |- skos__historyNote mesh__D015286 Kinins %28%1977-1988%29%
% 218.15/218.29  |- mesh__dateRevised mesh__D015286 2005-06-30
% 218.15/218.29  |- skos__broader mesh__D015286smesh__D015320
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D015286 2006
% 218.15/218.29  |- skos__historyNote mesh__D015286 Oligopeptides %28%1977-1988%29%
% 218.15/218.29  |- skos__prefLabel mesh__D015286 Kassinin
% 218.15/218.29  |- mesh__publicMeSHNote mesh__D015286 89   
% 218.15/218.29  |- mesh__historyNote mesh__D015286 89   
% 218.15/218.29  |- mesh__recordMaintainer mesh__D015286 ssb
% 218.15/218.29  |- mesh__dateEstablished mesh__D015286 1989-01-01
% 218.15/218.29  |- mesh__recordAuthorizer mesh__D015286 sjn
% 218.15/218.29  |- rdf__type mesh__D015286sskos__Concept
% 218.15/218.29  |- skos__scopeNote mesh__D015286
% 218.15/218.29       Dodecapeptide tachykinin found in the central nervous system of the amphibian Kassina senegalensis. It is similar in structure and action to other tachykinins, but is especially effective in contracting smooth muscle tissue and stimulating the micturition reflex.%A%    
% 218.15/218.29  |- mesh__recordOriginator mesh__D015286 RLS
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D009249 2004
% 218.15/218.29  |- skos__hiddenLabel mesh__D009249
% 218.15/218.29       Phosphate, Nicotinamide-Adenine Dinucleotide
% 218.15/218.29  |- rdf__type mesh__D009249sskos__Concept
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D009249 2005
% 218.15/218.29  |- skos__hiddenLabel mesh__D009249 Nucleotide, Triphosphopyridine
% 218.15/218.29  |- skos__prefLabel mesh__D009249 NADP
% 218.15/218.29  |- skos__broader mesh__D009249smesh__D000227
% 218.15/218.29  |- skos__altLabel mesh__D009249 Coenzyme II
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D009249 2006
% 218.15/218.29  |- skos__altLabel mesh__D009249 Triphosphopyridine Nucleotide
% 218.15/218.29  |- skos__broader mesh__D009249smesh__D003067
% 218.15/218.29  |- mesh__recordAuthorizer mesh__D009249 sjn
% 218.15/218.29  |- skos__hiddenLabel mesh__D009249
% 218.15/218.29       Dinucleotide Phosphate, Nicotinamide-Adenine
% 218.15/218.29  |- mesh__recordOriginator mesh__D009249 NLM
% 218.15/218.29  |- mesh__dateCreated mesh__D009249 1999-01-01
% 218.15/218.29  |- skos__scopeNote mesh__D009249
% 218.15/218.29       Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5%27%-phosphate %28%NMN%29% coupled by pyrophosphate linkage to the 5%27%-phosphate adenosine 2%27%,5%27%-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized %28%NADP+%29% and reduced %28%NADPH%29%. %28%Dorland, 27th ed%29%%A%    
% 218.15/218.29  |- mesh__dateRevised mesh__D009249 2003-07-09
% 218.15/218.29  |- skos__altLabel mesh__D009249 NADPH
% 218.15/218.29  |- skos__altLabel mesh__D009249 Nicotinamide-Adenine Dinucleotide Phosphate
% 218.15/218.29  |- skos__hiddenLabel mesh__D009249
% 218.15/218.29       Nicotinamide Adenine Dinucleotide Phosphate
% 218.15/218.29  |- mesh__recordMaintainer mesh__D009249 ssb
% 218.15/218.29  |- skos__annotation mesh__D009249
% 218.15/218.29       a coenzyme; NADP or NAD probably correct for indexing of pyridine nucleotides%A%  
% 218.15/218.29  |- mesh__dateRevised mesh__D001266 1996-06-10
% 218.15/218.29  |- skos__prefLabel mesh__D001266 Atlantic Islands
% 218.15/218.29  |- mesh__recordOriginator mesh__D001266 NLM
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001266 2002
% 218.15/218.29  |- mesh__recordMaintainer mesh__D001266 TGC
% 218.15/218.29  |- mesh__dateCreated mesh__D001266 1999-01-01
% 218.15/218.29  |- rdf__type mesh__D001266sskos__Concept
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001266 2000
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001266 2003
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001266 2001
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001266 1998
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001266 2005
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001266 1997
% 218.15/218.29  |- skos__annotation mesh__D001266
% 218.15/218.29       in addition to indentions here %26% under CARIBBEAN REGION, see MeSH definition for other specific islands; in titles %26% translations use accents on island names as in author%27%s text%A%  
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001266 2004
% 218.15/218.29  |- skos__altLabel mesh__D001266 Saint Helena
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001266 1999
% 218.15/218.29  |- mesh__recordAuthorizer mesh__D001266 PLS
% 218.15/218.29  |- skos__broader mesh__D001266smesh__D005842
% 218.15/218.29  |- skos__scopeNote mesh__D001266
% 218.15/218.29       Widely scattered islands in the Atlantic Ocean as far north as the AZORES and as far south as the South Sandwich Islands, with the greatest concentration found in the CARIBBEAN REGION. They include Annobon Island, Ascension, Canary Islands, Falkland Islands, Fernando Po %28%also called Isla de Bioko and Bioko%29%, Gough Island, Madeira, Sao Tome and Principe, Saint Helena, and Tristan da Cunha.%A%    
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001266 2006
% 218.15/218.29  |- mesh__recordAuthorizer mesh__D020420 sjn
% 218.15/218.29  |- skos__hiddenLabel mesh__D020420 Fluid, Cyst
% 218.15/218.29  |- mesh__publicMeSHNote mesh__D020420 99   
% 218.15/218.29  |- skos__prefLabel mesh__D020420 Cyst Fluid
% 218.15/218.29  |- skos__broader mesh__D020420smesh__D005122
% 218.15/218.29  |- skos__hiddenLabel mesh__D020420 Cyst Fluids
% 218.15/218.29  |- mesh__dateCreated mesh__D020420 1998-06-10
% 218.15/218.29  |- mesh__recordMaintainer mesh__D020420 sjn
% 218.15/218.29  |- mesh__dateRevised mesh__D020420 2004-07-13
% 218.15/218.29  |- rdf__type mesh__D020420sskos__Concept
% 218.15/218.29  |- skos__hiddenLabel mesh__D020420 Fluids, Cyst
% 218.15/218.29  |- mesh__dateEstablished mesh__D020420 1999-01-01
% 218.15/218.29  |- skos__historyNote mesh__D020420 Body Fluids %28%1971-1998%29%
% 218.15/218.29  |- skos__scopeNote mesh__D020420
% 218.15/218.29       Liquid material found in epithelial-lined closed cavities or sacs.%A%    
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D020420 2006
% 218.15/218.29  |- skos__annotation mesh__D020420
% 218.15/218.29        breast cyst fluid: coord NIM with  FIBROCYSTIC BREAST DISEASE %28%IM%29%%A%  
% 218.15/218.29  |- mesh__recordOriginator mesh__D020420 AGS
% 218.15/218.29  |- mesh__historyNote mesh__D020420 99   
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D020420 2005
% 218.15/218.29  |- skos__historyNote mesh__D020420
% 218.15/218.29       Exudates and Transudates %28%1969-1998%29%
% 218.15/218.29  |- skos__hiddenLabel mesh__D047368 Weight, Tumor
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D047368 2006
% 218.15/218.29  |- skos__scopeNote mesh__D047368
% 218.15/218.29       The total amount %28%cell number, weight, size or volume%29% of tumor cells or tissue in the body.%A%    
% 218.15/218.29  |- mesh__recordOriginator mesh__D047368 nns
% 218.15/218.29  |- skos__hiddenLabel mesh__D047368 Volume, Tumor
% 218.15/218.29  |- mesh__dateEstablished mesh__D047368 2005-01-01
% 218.15/218.29  |- skos__prefLabel mesh__D047368 Tumor Burden
% 218.15/218.29  |- skos__broader mesh__D047368smesh__D001837
% 218.15/218.29  |- skos__hiddenLabel mesh__D047368 Load, Tumor
% 218.15/218.29  |- skos__hiddenLabel mesh__D047368 Weights, Tumor
% 218.15/218.29  |- skos__annotation mesh__D047368 coordinate with neoplasm /pathol   
% 218.15/218.29  |- rdf__type mesh__D047368sskos__Concept
% 218.15/218.29  |- skos__hiddenLabel mesh__D047368 Tumor Weights
% 218.15/218.29  |- skos__hiddenLabel mesh__D047368 Burden, Tumor
% 218.15/218.29  |- skos__hiddenLabel mesh__D047368 Tumor Loads
% 218.15/218.29  |- mesh__recordAuthorizer mesh__D047368 sjn
% 218.15/218.29  |- skos__altLabel mesh__D047368 Tumor Load
% 218.15/218.29  |- mesh__historyNote mesh__D047368 2005   
% 218.15/218.29  |- skos__hiddenLabel mesh__D047368 Loads, Tumor
% 218.15/218.29  |- mesh__publicMeSHNote mesh__D047368 2005   
% 218.15/218.29  |- mesh__dateCreated mesh__D047368 2004-07-07
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D047368 2005
% 218.15/218.29  |- mesh__recordMaintainer mesh__D047368 nns
% 218.15/218.29  |- mesh__historyNote mesh__D019677 2006 %28%1998%29%   
% 218.15/218.29  |- skos__scopeNote mesh__D019677
% 218.15/218.29       The in vitro fusion of GENES by RECOMBINANT DNA techniques to analyze protein behavior or GENE EXPRESSION REGULATION, or to merge protein functions for specific medical or industrial uses.%A%    
% 218.15/218.29  |- skos__hiddenLabel mesh__D019677 Gene Fusions, Artificial
% 218.15/218.29  |- skos__hiddenLabel mesh__D019677 Artificial Gene Fusions
% 218.15/218.29  |- skos__historyNote mesh__D019677 Cloning, Molecular %28%1980-1997%29%
% 218.15/218.29  |- mesh__publicMeSHNote mesh__D019677
% 218.15/218.29       2006; see GENE FUSION 1998-2005; see CLONING, MOLECULAR 1988-1997%A%  
% 218.15/218.29  |- skos__altLabel mesh__D019677 In Vitro Gene Fusion Mutagenesis
% 218.15/218.29  |- skos__related mesh__D019677smesh__D050939
% 218.15/218.29  |- mesh__recordMaintainer mesh__D019677 nns
% 218.15/218.29  |- skos__related mesh__D019677smesh__D005818
% 218.15/218.29  |- mesh__dateEstablished mesh__D019677 1998-01-01
% 218.15/218.29  |- mesh__recordAuthorizer mesh__D019677 sjn
% 218.15/218.29  |- skos__broader mesh__D019677smesh__D003001
% 218.15/218.29  |- skos__hiddenLabel mesh__D019677 Gene Fusion, Artificial
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D019677 2006
% 218.15/218.29  |- mesh__dateCreated mesh__D019677 1997-06-20
% 218.15/218.29  |- mesh__dateRevised mesh__D019677 2005-06-30
% 218.15/218.29  |- skos__hiddenLabel mesh__D019677 Gene Fusion Technologies
% 218.15/218.29  |- skos__annotation mesh__D019677 GENE FUSION is also available   
% 218.15/218.29  |- skos__related mesh__D019677smesh__D011993
% 218.15/218.29  |- skos__related mesh__D019677smesh__D004274
% 218.15/218.29  |- skos__prefLabel mesh__D019677 Artificial Gene Fusion
% 218.15/218.29  |- rdf__type mesh__D019677sskos__Concept
% 218.15/218.29  |- mesh__recordOriginator mesh__D019677 NDW
% 218.15/218.29  |- mesh__dateCreated mesh__D011694 1999-01-01
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D011694 2002
% 218.15/218.29  |- skos__hiddenLabel mesh__D011694 Hyperglobulinemic Purpuras
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D011694 2003
% 218.15/218.29  |- mesh__recordOriginator mesh__D011694 NLM
% 218.15/218.29  |- skos__broader mesh__D011694smesh__D020141
% 218.15/218.29  |- rdf__type mesh__D011694sskos__Concept
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D011694 2004
% 218.15/218.29  |- skos__scopeNote mesh__D011694
% 218.15/218.29       Purpura seen in many hematological disorders, characterized by an increase in GAMMA-GLOBULINS.%A%    
% 218.15/218.29  |- skos__hiddenLabel mesh__D011694 Purpuras, Hyperglobulinemic
% 218.15/218.29  |- skos__prefLabel mesh__D011694 Purpura, Hyperglobulinemic
% 218.15/218.29  |- skos__hiddenLabel mesh__D011694 Hyperglobulinemic Purpura
% 218.15/218.29  |- mesh__recordMaintainer mesh__D011694 KEV
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D011694 2005
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D011694 2006
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D011694 2000
% 218.15/218.29  |- skos__broader mesh__D011694smesh__D011693
% 218.15/218.29  |- mesh__recordAuthorizer mesh__D011694 sjn
% 218.15/218.29  |- mesh__dateRevised mesh__D011694 1999-11-08
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D011694 2001
% 218.15/218.29  |- mesh__recordOriginator mesh__D005657 NLM
% 218.15/218.29  |- skos__broader mesh__D005657smesh__D014612
% 218.15/218.29  |- rdf__type mesh__D005657sskos__Concept
% 218.15/218.29  |- mesh__publicMeSHNote mesh__D005657 65   
% 218.15/218.29  |- skos__prefLabel mesh__D005657 Fungal Vaccines
% 218.15/218.29  |- mesh__historyNote mesh__D005657 65   
% 218.15/218.29  |- mesh__recordMaintainer mesh__D005657 ssb
% 218.15/218.29  |- mesh__dateCreated mesh__D005657 1999-01-01
% 218.15/218.29  |- skos__annotation mesh__D005657
% 218.15/218.29       coord IM with specific fungus /immunol %28%IM%29%   
% 218.15/218.29  |- mesh__recordAuthorizer mesh__D005657 sjn
% 218.15/218.29  |- mesh__dateRevised mesh__D005657 2005-06-30
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D005657 2006
% 218.15/218.29  |- skos__hiddenLabel mesh__D005657 Vaccines, Fungal
% 218.15/218.29  |- mesh__dateEstablished mesh__D005657 1965-01-01
% 218.15/218.29  |- skos__scopeNote mesh__D005657
% 218.15/218.29       Suspensions of attenuated or killed fungi administered for the prevention or treatment of infectious fungal disease.%A%    
% 218.15/218.29  |- mesh__publicMeSHNote mesh__D015287
% 218.15/218.29       2003: see NEUROKININ K %28%1989-2002%29%   
% 218.15/218.29  |- skos__prefLabel mesh__D015287 Neurokinin B
% 218.15/218.29  |- skos__broader mesh__D015287smesh__D015320
% 218.15/218.29  |- skos__historyNote mesh__D015287 Oligopeptides %28%1983-1986%29%
% 218.15/218.29  |- skos__related mesh__D015287smesh__D018042
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D015287 2006
% 218.15/218.29  |- mesh__dateRevised mesh__D015287 2005-06-30
% 218.15/218.29  |- mesh__dateEstablished mesh__D015287 1989-01-01
% 218.15/218.29  |- mesh__recordMaintainer mesh__D015287 ssb
% 218.15/218.29  |- skos__altLabel mesh__D015287 Neuromedin K
% 218.15/218.29  |- skos__scopeNote mesh__D015287
% 218.15/218.29       A mammalian neuropeptide of 10 amino acids that belongs to the tachykinin family. It is similar in structure and action to SUBSTANCE P and NEUROKININ A with the ability to excite neurons, dilate blood vessels, and contract smooth muscles, such as those in the BLADDER and UTERUS.%A%    
% 218.15/218.29  |- skos__historyNote mesh__D015287 Kinins %28%1983-1988%29%
% 218.15/218.29  |- skos__altLabel mesh__D015287 Neurokinin beta
% 218.15/218.29  |- mesh__recordOriginator mesh__D015287 RLS
% 218.15/218.29  |- skos__historyNote mesh__D015287 Neuropeptides %28%1987-1988%29%
% 218.15/218.29  |- mesh__historyNote mesh__D015287 2003 %28%1989%29%   
% 218.15/218.29  |- rdf__type mesh__D015287sskos__Concept
% 218.15/218.29  |- mesh__dateCreated mesh__D015287 1988-05-23
% 218.15/218.29  |- mesh__recordAuthorizer mesh__D015287 sjn
% 218.15/218.29  |- skos__broader mesh__D034441smesh__D012261
% 218.15/218.29  |- rdf__type mesh__D034441sskos__Concept
% 218.15/218.29  |- mesh__dateEstablished mesh__D034441 2003-01-01
% 218.15/218.29  |- skos__altLabel mesh__D034441 Informofer
% 218.15/218.29  |- skos__scopeNote mesh__D034441
% 218.15/218.29       A family of ribonucleoproteins that were originally found as proteins bound to nascent RNA transcripts in the form of ribonucleoprotein particles. Although considered ribonucleoproteins they are primarily classified by their protein component. They are involved in a variety of processes such as packaging of RNA and RNA TRANSPORT within the nucleus. A subset of heterogeneous-nuclear ribonucleoproteins are involved in additional functions such as nucleocytoplasmic transport %28%ACTIVE TRANSPORT, CELL NUCLEUS%29% of RNA and mRNA stability in the CYTOPLASM.%A%    
% 218.15/218.29  |- mesh__dateRevised mesh__D034441 2005-06-30
% 218.15/218.29  |- skos__hiddenLabel mesh__D034441
% 218.15/218.29       Ribonucleoproteins, Heterogeneous-Nuclear
% 218.15/218.29  |- mesh__historyNote mesh__D034441
% 218.15/218.29       2003; use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 1980-2002; for INFORMATIN use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 1980-2002%A%  
% 218.15/218.29  |- skos__altLabel mesh__D034441 Heterogeneous Nuclear Ribonucleoprotein
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D034441 2006
% 218.15/218.29  |- mesh__publicMeSHNote mesh__D034441
% 218.15/218.29       2003; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS was indexed under RIBONUCLEOPROTEINS 1980-2002; INFORMATIN was indexed under RIBONUCLEOPROTEINS 1978-2002%A%  
% 218.15/218.29  |- mesh__recordAuthorizer mesh__D034441 sjn
% 218.15/218.29  |- skos__hiddenLabel mesh__D034441 Particles, hnRNP
% 218.15/218.29  |- skos__hiddenLabel mesh__D034441 Heterogeneous Nuclear Ribonucleoproteins
% 218.15/218.29  |- skos__hiddenLabel mesh__D034441 Nuclear Ribonucleoprotein, Heterogeneous
% 218.15/218.29  |- skos__hiddenLabel mesh__D034441 Ribonucleoprotein, Heterogeneous Nuclear
% 218.15/218.29  |- skos__altLabel mesh__D034441 hnRNP
% 218.15/218.29  |- mesh__recordOriginator mesh__D034441 jmp
% 218.15/218.29  |- skos__prefLabel mesh__D034441 Heterogeneous-Nuclear Ribonucleoproteins
% 218.15/218.29  |- skos__hiddenLabel mesh__D034441 Complexes, hnRNP
% 218.15/218.29  |- mesh__dateCreated mesh__D034441 2002-07-03
% 218.15/218.29  |- skos__historyNote mesh__D034441 Ribonucleoproteins %28%1980-2002%29%
% 218.15/218.29  |- mesh__recordMaintainer mesh__D034441 SYSTEM
% 218.15/218.29  |- skos__altLabel mesh__D034441 Informatin
% 218.15/218.29  |- mesh__dateRevised mesh__D001267 1992-03-25
% 218.15/218.29  |- rdf__type mesh__D001267sskos__Concept
% 218.15/218.29  |- skos__annotation mesh__D001267 no qualif   
% 218.15/218.29  |- mesh__recordAuthorizer mesh__D001267 PLS
% 218.15/218.29  |- skos__prefLabel mesh__D001267 Atlantic Ocean
% 218.15/218.29  |- mesh__dateCreated mesh__D001267 1986-04-02
% 218.15/218.29  |- mesh__historyNote mesh__D001267 87   
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001267 2002
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001267 1996
% 218.15/218.29  |- mesh__recordOriginator mesh__D001267 RC
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001267 2003
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001267 1998
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001267 2005
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001267 1997
% 218.15/218.29  |- skos__broader mesh__D001267smesh__D009792
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001267 1994
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001267 2004
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001267 1999
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001267 2006
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001267 2000
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001267 1993
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001267 1995
% 218.15/218.29  |- mesh__dateEstablished mesh__D001267 1987-01-01
% 218.15/218.29  |- mesh__recordMaintainer mesh__D001267 TGC
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D001267 2001
% 218.15/218.29  |- skos__broader mesh__D000776Q000193smesh__D000776
% 218.15/218.29  |- rdf__type mesh__D000776Q000193smesh__CompoundConcept
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D006750 1998
% 218.15/218.29  |- skos__altLabel mesh__D006750 Distribution, Clinical
% 218.15/218.29  |- mesh__dateEstablished mesh__D006750 1991-01-01
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D006750 2002
% 218.15/218.29  |- mesh__dateRevised mesh__D006750 1994-05-05
% 218.15/218.29  |- skos__altLabel mesh__D006750 Clinical Distributions
% 218.15/218.29  |- rdf__type mesh__D006750sskos__Concept
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D006750 2005
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D006750 1996
% 218.15/218.29  |- skos__altLabel mesh__D006750 Clinical Distribution
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D006750 1999
% 218.15/218.29  |- skos__broader mesh__D006750smesh__D006739
% 218.15/218.29  |- skos__altLabel mesh__D006750 Hospital Distribution System
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D006750 2003
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D006750 2006
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D006750 1997
% 218.15/218.29  |- mesh__dateCreated mesh__D006750 1974-11-11
% 218.15/218.29  |- skos__scopeNote mesh__D006750
% 218.15/218.29       Systems for delivering hospital supplies, food, laundry, etc., to patient care areas.%A%    
% 218.15/218.29  |- skos__prefLabel mesh__D006750 Hospital Distribution Systems
% 218.15/218.29  |- skos__altLabel mesh__D006750 Distribution System, Hospital
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D006750 2004
% 218.15/218.29  |- mesh__recordOriginator mesh__D006750 NLM
% 218.15/218.29  |- mesh__publicMeSHNote mesh__D006750
% 218.15/218.29       91; was see under HOSPITAL ADMINISTRATION 1975-90   
% 218.15/218.29  |- mesh__recordMaintainer mesh__D006750 TGC
% 218.15/218.29  |- mesh__historyNote mesh__D006750
% 218.15/218.29       91%28%75%29%; was see under HOSPITAL ADMINISTRATION 1975-90   
% 218.15/218.29  |- skos__altLabel mesh__D006750 Distribution Systems, Hospital
% 218.15/218.29  |- mesh__recordAuthorizer mesh__D006750 PLS
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D006750 2000
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D006750 2001
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D006750 1995
% 218.15/218.29  |- skos__annotation mesh__D006750 within a hosp or between hosps   
% 218.15/218.29  |- skos__hiddenLabel mesh__D006750 Systems, Hospital Distribution
% 218.15/218.29  |- skos__hiddenLabel mesh__D006750 System, Hospital Distribution
% 218.15/218.29  |- skos__hiddenLabel mesh__D020421 Disorder, Pneumogastric Nerve
% 218.15/218.29  |- skos__altLabel mesh__D020421 Cranial Nerve X Diseases
% 218.15/218.29  |- skos__historyNote mesh__D020421
% 218.15/218.29       Vagus Nerve/physiopathology %28%1966-1999%29%
% 218.15/218.29  |- skos__hiddenLabel mesh__D020421 Neuropathies, Vagus
% 218.15/218.29  |- mesh__historyNote mesh__D020421 2000   
% 218.15/218.29  |- skos__broader mesh__D020421smesh__D003389
% 218.15/218.29  |- skos__annotation mesh__D020421
% 218.15/218.29       neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 218.15/218.29  |- skos__altLabel mesh__D020421 Tenth Cranial Nerve Diseases
% 218.15/218.29  |- skos__prefLabel mesh__D020421 Vagus Nerve Diseases
% 218.15/218.29  |- skos__hiddenLabel mesh__D020421 Pneumogastric Nerve Disorder
% 218.15/218.29  |- mesh__activeMeSHYear mesh__D020421 2000
% 218.15/218.30  |- skos__scopeNote mesh__D020421
% 218.15/218.30       Diseases of the tenth cranial nerve, including brain stem lesions involving its nuclei %28%solitary, ambiguus, and dorsal motor%29%, nerve fascicles, and intracranial and extracranial course. Clinical manifestations may include dysphagia, vocal cord weakness, and alterations of parasympathetic tone in the thorax and abdomen.%A%    
% 218.15/218.30  |- skos__altLabel mesh__D020421 Vagus Nerve Motor Disorder
% 218.15/218.30  |- skos__altLabel mesh__D020421 Vagus Nerve Disorders
% 218.15/218.30  |- skos__hiddenLabel mesh__D020421 Vagus Neuropathies
% 218.15/218.30  |- skos__hiddenLabel mesh__D020421 Vagus Nerve Disease
% 218.15/218.30  |- skos__altLabel mesh__D020421 Vagus Neuropathy
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D020421 2005
% 218.15/218.30  |- skos__historyNote mesh__D020421 Cranial Nerve Diseases %28%1981-1999%29%
% 218.15/218.30  |- mesh__dateEstablished mesh__D020421 2000-01-01
% 218.15/218.30  |- rdf__type mesh__D020421sskos__Concept
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D020421 2001
% 218.15/218.30  |- skos__altLabel mesh__D020421 Vagus Nerve Sensory Disorder
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D020421 2003
% 218.15/218.30  |- mesh__dateCreated mesh__D020421 1999-11-03
% 218.15/218.30  |- skos__altLabel mesh__D020421 Pneumogastric Nerve Disorders
% 218.15/218.30  |- skos__hiddenLabel mesh__D020421 Vagus Nerve Disorder
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D020421 2006
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D020421 2002
% 218.15/218.30  |- skos__hiddenLabel mesh__D020421 Disorders, Pneumogastric Nerve
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D020421 2004
% 218.15/218.30  |- skos__historyNote mesh__D020421 Vocal Cord Paralysis %28%1966-1999%29%
% 218.15/218.30  |- skos__hiddenLabel mesh__D020421 Neuropathy, Vagus
% 218.15/218.30  |- mesh__publicMeSHNote mesh__D020421 2000   
% 218.15/218.30  |- skos__related mesh__D020421smesh__D020209
% 218.15/218.30  |- mesh__publicMeSHNote mesh__D047369 2005   
% 218.15/218.30  |- mesh__recordAuthorizer mesh__D047369 sjn
% 218.15/218.30  |- mesh__historyNote mesh__D047369 2005   
% 218.15/218.30  |- mesh__recordMaintainer mesh__D047369 nns
% 218.15/218.30  |- mesh__dateCreated mesh__D047369 2004-07-19
% 218.15/218.30  |- skos__broader mesh__D047369smesh__D047468
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D047369 2006
% 218.15/218.30  |- skos__historyNote mesh__D047369 Precipitin Tests %28%2000-2004%29%
% 218.15/218.30  |- skos__broader mesh__D047369smesh__D005821
% 218.15/218.30  |- skos__prefLabel mesh__D047369 Chromatin Immunoprecipitation
% 218.15/218.30  |- mesh__dateEstablished mesh__D047369 2005-01-01
% 218.15/218.30  |- skos__scopeNote mesh__D047369
% 218.15/218.30       A technique for identifying specific DNA sequences that are bound, in vivo, to proteins of interest. It involves formaldehyde fixation of CHROMATIN to crosslink the DNA-BINDING PROTEINS to the DNA. After shearing the DNA into small fragments, specific DNA-protein complexes are isolated by immunoprecipitation with protein-specific ANTIBODIES. Then, the DNA isolated from the complex can be identified by PCR amplification and sequencing.%A%    
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D047369 2005
% 218.15/218.30  |- mesh__recordOriginator mesh__D047369 nns
% 218.15/218.30  |- rdf__type mesh__D047369sskos__Concept
% 218.15/218.30  |- skos__altLabel mesh__D047369 Immunoprecipitation, Chromatin
% 218.15/218.30  |- skos__hiddenLabel mesh__D011695 Purpura, Allergic
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D011695 2006
% 218.15/218.30  |- skos__hiddenLabel mesh__D011695 Hemorrhagica, Purpura
% 218.15/218.30  |- skos__hiddenLabel mesh__D011695 Schoenlein Henoch Purpura
% 218.15/218.30  |- mesh__historyNote mesh__D011695 75   
% 218.15/218.30  |- skos__hiddenLabel mesh__D011695 Nonthrombocytopenic Purpura
% 218.15/218.30  |- mesh__dateRevised mesh__D011695 2002-07-02
% 218.15/218.30  |- skos__altLabel mesh__D011695 Henoch-Schoenlein Purpura
% 218.15/218.30  |- skos__hiddenLabel mesh__D011695 Purpuras, Nonthrombopenic
% 218.15/218.30  |- skos__hiddenLabel mesh__D011695 Hemorrhagic Vasculitis
% 218.15/218.30  |- skos__historyNote mesh__D011695 Purpura %28%1966-1974%29%
% 218.15/218.30  |- mesh__recordOriginator mesh__D011695 NLM
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D011695 2003
% 218.15/218.30  |- skos__broader mesh__D011695smesh__D011693
% 218.15/218.30  |- skos__altLabel mesh__D011695 Allergic Purpura
% 218.15/218.30  |- mesh__publicMeSHNote mesh__D011695 75   
% 218.15/218.30  |- skos__scopeNote mesh__D011695
% 218.15/218.30       A form of nonthrombocytopenic purpura due to a hypersensitivity vasculitis associated with a variety of clinical symptoms including urticaria and erythema, arthropathy and arthritis, gastrointestinal symptoms, and renal involvement.%A%    
% 218.15/218.30  |- skos__hiddenLabel mesh__D011695 Nonthrombopenic Purpura
% 218.15/218.30  |- skos__broader mesh__D011695smesh__D020141
% 218.15/218.30  |- skos__prefLabel mesh__D011695 Purpura, Schoenlein-Henoch
% 218.15/218.30  |- skos__altLabel mesh__D011695 Anaphylactoid Purpura
% 218.15/218.30  |- rdf__type mesh__D011695sskos__Concept
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D011695 2004
% 218.15/218.30  |- skos__hiddenLabel mesh__D011695 Purpura, Henoch-Schoenlein
% 218.15/218.30  |- skos__hiddenLabel mesh__D011695 Purpura, Rheumatoid
% 218.15/218.30  |- skos__annotation mesh__D011695
% 218.15/218.30       nonthrombopenic: thrombopenic = PURPURA, THROMBOCYTOPENIC%A%  
% 218.15/218.30  |- skos__hiddenLabel mesh__D011695 Fulminans, Purpura
% 218.15/218.30  |- skos__hiddenLabel mesh__D011695 Henoch Schoenlein Purpura
% 218.15/218.30  |- skos__hiddenLabel mesh__D011695 Purpura, Anaphylactoid
% 218.15/218.30  |- skos__hiddenLabel mesh__D011695 Purpura, Henoch
% 218.15/218.30  |- mesh__dateEstablished mesh__D011695 1975-09-01
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D011695 2005
% 218.15/218.30  |- skos__hiddenLabel mesh__D011695 Nonthrombopenic Purpuras
% 218.15/218.30  |- skos__broader mesh__D011695smesh__D018366
% 218.15/218.30  |- skos__hiddenLabel mesh__D011695 Purpura, Schoenlein Henoch
% 218.15/218.30  |- mesh__recordMaintainer mesh__D011695 mdb
% 218.15/218.30  |- mesh__dateCreated mesh__D011695 1974-11-11
% 218.15/218.30  |- skos__altLabel mesh__D011695 Purpura, Nonthrombopenic
% 218.15/218.30  |- mesh__recordAuthorizer mesh__D011695 sjn
% 218.15/218.30  |- skos__altLabel mesh__D011695 Schoenlein-Henoch Purpura
% 218.15/218.30  |- skos__annotation mesh__D005658
% 218.15/218.30       GEN or unspecified; prefer specifics: Manual 22.32; fungal dis = MYCOSES, fungal dis of skin = DERMATOMYCOSES%A%  
% 218.15/218.30  |- mesh__recordOriginator mesh__D005658 NLM
% 218.15/218.30  |- mesh__considerAlso mesh__D005658 consider also terms at MYCO-   
% 218.15/218.30  |- rdf__type mesh__D005658sskos__Concept
% 218.15/218.30  |- mesh__dateCreated mesh__D005658 1999-01-01
% 218.15/218.30  |- mesh__recordMaintainer mesh__D005658 SYSTEM
% 218.15/218.30  |- mesh__recordAuthorizer mesh__D005658 sjn
% 218.15/218.30  |- skos__altLabel mesh__D005658 Molds
% 218.15/218.30  |- mesh__dateRevised mesh__D005658 2005-06-30
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D005658 2006
% 218.15/218.30  |- mesh__runningHead mesh__D005658 B5 - ORGANISMS-FUNGI   
% 218.15/218.30  |- skos__prefLabel mesh__D005658 Fungi
% 218.15/218.30  |- skos__related mesh__D005658smesh__D005656
% 218.15/218.30  |- skos__related mesh__D005658smesh__D005659
% 218.15/218.30  |- skos__related mesh__D005658smesh__D000935
% 218.15/218.30  |- skos__scopeNote mesh__D005658
% 218.15/218.30       A kingdom of eukaryotic, heterotrophic organisms that live parasitically as saprobes, including MUSHROOMS; YEASTS; smuts, molds, etc. They reproduce either sexually or asexually, and have life cycles that range from simple to complex. Filamentous fungi, commonly known as molds, refer to those that grow as multicellular colonies.%A%    
% 218.15/218.30  |- mesh__dateRevised mesh__D016380 2002-07-02
% 218.15/218.30  |- mesh__dateEstablished mesh__D016380 1991-01-01
% 218.15/218.30  |- mesh__recordAuthorizer mesh__D016380 sjn
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D016380 2006
% 218.15/218.30  |- skos__hiddenLabel mesh__D016380 Tissue Graftings, Brain
% 218.15/218.30  |- skos__hiddenLabel mesh__D016380 Graftings, Brain Tissue
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D016380 2005
% 218.15/218.30  |- skos__hiddenLabel mesh__D016380 Brain Tissue Graftings
% 218.15/218.30  |- mesh__publicMeSHNote mesh__D016380
% 218.15/218.30       91; was BRAIN/transplantation 1966-90   
% 218.15/218.30  |- skos__hiddenLabel mesh__D016380 Brain Tissue Grafting
% 218.15/218.30  |- mesh__historyNote mesh__D016380 91; was BRAIN/transplantation 1966-90   
% 218.15/218.30  |- rdf__type mesh__D016380sskos__Concept
% 218.15/218.30  |- mesh__recordOriginator mesh__D016380 PXP
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D016380 2004
% 218.15/218.30  |- skos__prefLabel mesh__D016380 Brain Tissue Transplantation
% 218.15/218.30  |- mesh__recordMaintainer mesh__D016380 lkt
% 218.15/218.30  |- skos__annotation mesh__D016380
% 218.15/218.30       coord IM with specific part of brain /transpl %28%IM or NIM%29%; do not use /util except by MeSH definition; do not coord with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; transpl of fetal or embryonic brain tissue: coord IM with FETAL TISSUE TRANSPLANTATION %28%IM%29% + specific tissue /transpl + /embryol if pertinent %28%IM or NIM%29%%A%  
% 218.15/218.30  |- skos__broader mesh__D016380smesh__D019635
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D016380 2003
% 218.15/218.30  |- skos__hiddenLabel mesh__D016380 Tissue Transplantations, Brain
% 218.15/218.30  |- skos__historyNote mesh__D016380 Brain/transplantation %28%1966-1990%29%
% 218.15/218.30  |- skos__altLabel mesh__D016380 Grafting, Brain Tissue
% 218.15/218.30  |- skos__hiddenLabel mesh__D016380 Tissue Grafting, Brain
% 218.15/218.30  |- skos__hiddenLabel mesh__D016380 Tissue Transplantation, Brain
% 218.15/218.30  |- skos__hiddenLabel mesh__D016380 Transplantations, Brain Tissue
% 218.15/218.30  |- skos__scopeNote mesh__D016380
% 218.15/218.30       Transference of brain tissue, either from a fetus or from a born individual, between individuals of the same species or between individuals of different species.%A%    
% 218.15/218.30  |- skos__broader mesh__D016380smesh__D016378
% 218.15/218.30  |- skos__hiddenLabel mesh__D016380 Brain Tissue Transplantations
% 218.15/218.30  |- skos__altLabel mesh__D016380 Transplantation, Brain Tissue
% 218.15/218.30  |- mesh__dateCreated mesh__D016380 1990-05-25
% 218.15/218.30  |- skos__hiddenLabel mesh__D002360 Hydrochloride, Carubicin
% 218.15/218.30  |- skos__altLabel mesh__D002360 Demethyldaunorubicin
% 218.15/218.30  |- mesh__dateEstablished mesh__D002360 1991-01-01
% 218.15/218.30  |- mesh__recordAuthorizer mesh__D002360 sjn
% 218.15/218.30  |- skos__altLabel mesh__D002360 Demethyldaunomycin
% 218.15/218.30  |- rdf__type mesh__D002360sskos__Concept
% 218.15/218.30  |- skos__altLabel mesh__D002360 Carminomycin I
% 218.15/218.30  |- mesh__historyNote mesh__D002360
% 218.15/218.30       91%28%84%29%; was see under DAUNORUBICIN/analogs %26% derivatives 1984-90; was CARMINOMYCIN see under DAUNORUBICIN 1980-83 %26% see under ANTIBIOTICS, ANTINEOPLASTIC 1975-79%A%  
% 218.15/218.30  |- skos__hiddenLabel mesh__D002360 NSC 180,024
% 218.15/218.30  |- mesh__publicMeSHNote mesh__D002360
% 218.15/218.30       91; was see under DAUNORUBICIN/analogs %26% derivatives 1984-90; was CARMINOMYCIN see under DAUNORUBICIN 1980-83 %26% see under ANTIBIOTICS, ANTINEOPLASTIC 1975-79%A%  
% 218.15/218.30  |- mesh__recordMaintainer mesh__D002360 ssb
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D002360 2005
% 218.15/218.30  |- mesh__dateCreated mesh__D002360 1974-11-19
% 218.15/218.30  |- skos__hiddenLabel mesh__D002360 NSC180024
% 218.15/218.30  |- skos__broader mesh__D002360smesh__D003630
% 218.15/218.30  |- skos__historyNote mesh__D002360 Aminoglycosides %28%1974%29%
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D002360 2006
% 218.15/218.30  |- mesh__recordOriginator mesh__D002360 NLM
% 218.15/218.30  |- skos__altLabel mesh__D002360 Karminomycin
% 218.15/218.30  |- skos__altLabel mesh__D002360 Karminomicin
% 218.15/218.30  |- skos__altLabel mesh__D002360 NSC-180024
% 218.15/218.30  |- mesh__dateRevised mesh__D002360 2004-07-07
% 218.15/218.30  |- skos__hiddenLabel mesh__D002360 NSC 180024
% 218.15/218.30  |- skos__scopeNote mesh__D002360
% 218.15/218.30       A very toxic anthracycline-type antineoplastic related to DAUNORUBICIN, obtained from Actinomadura carminata.%A%    
% 218.15/218.30  |- skos__hiddenLabel mesh__D002360 NSC180,024
% 218.15/218.30  |- skos__altLabel mesh__D002360 Carminomycin
% 218.15/218.30  |- skos__altLabel mesh__D002360 Carminomicin
% 218.15/218.30  |- skos__historyNote mesh__D002360 Naphthacenes %28%1966-1974%29%
% 218.15/218.30  |- mesh__onlineNote mesh__D002360
% 218.15/218.30       use CARUBICIN to search CARMINOMYCIN 1975-83   
% 218.15/218.30  |- skos__prefLabel mesh__D002360 Carubicin
% 218.15/218.30  |- skos__historyNote mesh__D002360
% 218.15/218.30       Antibiotics, Antineoplastic %28%1967-1974%29%
% 218.15/218.30  |- mesh__dateCreated mesh__D015288 1988-05-24
% 218.15/218.30  |- mesh__recordAuthorizer mesh__D015288 sjn
% 218.15/218.30  |- mesh__onlineNote mesh__D015288
% 218.15/218.30       use NEUROKININ A to search SUBSTANCE K 1989-93   
% 218.15/218.30  |- skos__historyNote mesh__D015288 Kinins %28%1980-1988%29%
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D015288 2006
% 218.15/218.30  |- mesh__publicMeSHNote mesh__D015288
% 218.15/218.30       94; was SUBSTANCE K 1989-93; NEUROKININ A was see SUBSTANCE K 1989-93%A%  
% 218.15/218.30  |- mesh__dateEstablished mesh__D015288 1989-01-01
% 218.15/218.30  |- skos__related mesh__D015288smesh__D018041
% 218.15/218.30  |- skos__prefLabel mesh__D015288 Neurokinin A
% 218.15/218.30  |- skos__historyNote mesh__D015288 Neuropeptides %28%1987-1988%29%
% 218.15/218.30  |- skos__scopeNote mesh__D015288
% 218.15/218.30       A mammalian neuropeptide of 10 amino acids that belongs to the tachykinin family. It is similar in structure and action to SUBSTANCE P and NEUROKININ B with the ability to excite neurons, dilate blood vessels, and contract smooth muscles, such as those in the BRONCHI.%A%    
% 218.15/218.30  |- skos__altLabel mesh__D015288 Neuromedin L
% 218.15/218.30  |- skos__altLabel mesh__D015288 Substance K
% 218.15/218.30  |- mesh__dateRevised mesh__D015288 2005-06-30
% 218.15/218.30  |- rdf__type mesh__D015288sskos__Concept
% 218.15/218.30  |- mesh__recordMaintainer mesh__D015288 ssb
% 218.15/218.30  |- mesh__historyNote mesh__D015288
% 218.15/218.30       94; was SUBSTANCE K 1989-93; NEUROKININ A was see SUBSTANCE K 1989-93%A%  
% 218.15/218.30  |- mesh__recordOriginator mesh__D015288 RLS
% 218.15/218.30  |- skos__historyNote mesh__D015288 Oligopeptides %28%1980-1986%29%
% 218.15/218.30  |- skos__altLabel mesh__D015288 Neurokinin alpha
% 218.15/218.30  |- skos__broader mesh__D015288smesh__D015320
% 218.15/218.30  |- mesh__publicMeSHNote mesh__D034442
% 218.15/218.30       2004; see N-SUBSTITUTED GLYCINE 2003   
% 218.15/218.30  |- skos__annotation mesh__D034442 GEN; prefer specifics   
% 218.15/218.30  |- mesh__dateCreated mesh__D034442 2002-07-03
% 218.15/218.30  |- skos__hiddenLabel mesh__D034442 N substituted Glycine
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D034442 2006
% 218.15/218.30  |- skos__prefLabel mesh__D034442 N-substituted Glycines
% 218.15/218.30  |- skos__historyNote mesh__D034442 Peptides %28%1992-2002%29%
% 218.15/218.30  |- mesh__recordMaintainer mesh__D034442 jmp
% 218.15/218.30  |- mesh__dateEstablished mesh__D034442 2003-01-01
% 218.15/218.30  |- mesh__recordOriginator mesh__D034442 ssb
% 218.15/218.30  |- skos__hiddenLabel mesh__D034442 N substituted Glycines
% 218.15/218.30  |- mesh__dateRevised mesh__D034442 2003-07-09
% 218.15/218.30  |- skos__scopeNote mesh__D034442
% 218.15/218.30       AMINO ACIDS composed of GLYCINE substituted at the nitrogen rather than the usual carbon position, resulting in the loss of HYDROGEN BONDING donors.  Polymers of these compounds are called PEPTOIDS.%A%    
% 218.15/218.30  |- mesh__recordAuthorizer mesh__D034442 sjn
% 218.15/218.30  |- skos__hiddenLabel mesh__D034442 Glycine, N-substituted
% 218.15/218.30  |- skos__altLabel mesh__D034442 N-substituted Glycine
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D034442 2004
% 218.15/218.30  |- skos__hiddenLabel mesh__D034442 Glycines, N-substituted
% 218.15/218.30  |- rdf__type mesh__D034442sskos__Concept
% 218.15/218.30  |- skos__broader mesh__D034442smesh__D034444
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D034442 2005
% 218.15/218.30  |- mesh__historyNote mesh__D034442 2004%28%2003%29%   
% 218.15/218.30  |- skos__broader mesh__D034442smesh__D005998
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D001268 2000
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D001268 1990
% 218.15/218.30  |- rdf__type mesh__D001268sskos__Concept
% 218.15/218.30  |- skos__hiddenLabel mesh__D001268 Atlanto-Axial Joints
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D001268 1997
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D001268 2005
% 218.15/218.30  |- skos__hiddenLabel mesh__D001268 Atlanto Axial Joints
% 218.15/218.30  |- skos__historyNote mesh__D001268 Atlas %28%1966-1982%29%
% 218.15/218.30  |- skos__broader mesh__D001268smesh__D007596
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D001268 2001
% 218.15/218.30  |- skos__hiddenLabel mesh__D001268 Joints, Atlanto-Axial
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D001268 1994
% 218.15/218.30  |- mesh__dateRevised mesh__D001268 1989-07-13
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D001268 2006
% 218.15/218.30  |- skos__altLabel mesh__D001268 Atlantoaxial Joint
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D001268 1992
% 218.15/218.30  |- mesh__recordOriginator mesh__D001268 RC
% 218.15/218.30  |- skos__hiddenLabel mesh__D001268 Joint, Atlantoaxial
% 218.15/218.30  |- skos__prefLabel mesh__D001268 Atlanto-Axial Joint
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D001268 1991
% 218.15/218.30  |- skos__hiddenLabel mesh__D001268 Joints, Atlantoaxial
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D001268 1998
% 218.15/218.30  |- mesh__recordMaintainer mesh__D001268 PLS
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D001268 1995
% 218.15/218.30  |- mesh__publicMeSHNote mesh__D001268 83   
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D001268 2003
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D001268 1993
% 218.15/218.30  |- mesh__recordAuthorizer mesh__D001268 PLS
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D001268 2002
% 218.15/218.30  |- skos__historyNote mesh__D001268 Axis %28%1966-1982%29%
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D001268 1999
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D001268 2004
% 218.15/218.30  |- mesh__historyNote mesh__D001268 83   
% 218.15/218.30  |- skos__hiddenLabel mesh__D001268 Atlantoaxial Joints
% 218.15/218.30  |- skos__hiddenLabel mesh__D001268 Joint, Atlanto Axial
% 218.15/218.30  |- skos__hiddenLabel mesh__D001268 Joint, Atlanto-Axial
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D001268 1996
% 218.15/218.30  |- mesh__dateEstablished mesh__D001268 1983-01-01
% 218.15/218.30  |- skos__altLabel mesh__D001268 Atlanto Axial Joint
% 218.15/218.30  |- skos__scopeNote mesh__D001268
% 218.15/218.30       The joint involving the atlas and axis bones.     
% 218.15/218.30  |- mesh__dateCreated mesh__D001268 1982-04-26
% 218.15/218.30  |- skos__hiddenLabel mesh__D001268 Joints, Atlanto Axial
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D006751 2006
% 218.15/218.30  |- skos__hiddenLabel mesh__D006751 Hospital Information System
% 218.15/218.30  |- skos__altLabel mesh__D006751 Information Systems, Hospital
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D006751 2000
% 218.15/218.30  |- skos__broader mesh__D006751smesh__D008331
% 218.15/218.30  |- mesh__dateEstablished mesh__D006751 1987-01-01
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D006751 2004
% 218.15/218.30  |- skos__hiddenLabel mesh__D006751 Multi-Hospital Information System
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D006751 2001
% 218.15/218.30  |- skos__hiddenLabel mesh__D006751 Information System, Multi-Hospital
% 218.15/218.30  |- skos__altLabel mesh__D006751 Information Systems, Multihospital
% 218.15/218.30  |- skos__altLabel mesh__D006751 Multihospital Information Systems
% 218.15/218.30  |- mesh__historyNote mesh__D006751 87   
% 218.15/218.30  |- skos__broader mesh__D006751smesh__D007256
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D006751 2002
% 218.15/218.30  |- mesh__recordOriginator mesh__D006751 EC
% 218.15/218.30  |- mesh__dateCreated mesh__D006751 1986-06-17
% 218.15/218.30  |- skos__altLabel mesh__D006751 Information System, Hospital
% 218.15/218.30  |- mesh__recordMaintainer mesh__D006751 TPW
% 218.15/218.30  |- skos__broader mesh__D006751smesh__D006739
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D006751 1998
% 218.15/218.30  |- mesh__publicMeSHNote mesh__D006751 87   
% 218.15/218.30  |- mesh__recordAuthorizer mesh__D006751 SJN
% 218.15/218.30  |- skos__altLabel mesh__D006751 Information System, Multihospital
% 218.15/218.30  |- skos__annotation mesh__D006751 DF: HOSP INFORMATION SYSTEMS   
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D006751 2005
% 218.15/218.30  |- rdf__type mesh__D006751sskos__Concept
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D006751 1999
% 218.15/218.30  |- skos__prefLabel mesh__D006751 Hospital Information Systems
% 218.15/218.30  |- skos__scopeNote mesh__D006751
% 218.15/218.30       Integrated, computer-assisted systems designed to store, manipulate, and retrieve information concerned with the administrative and clinical aspects of providing medical services within the hospital.%A%    
% 218.15/218.30  |- mesh__dateRevised mesh__D006751 1997-06-20
% 218.15/218.30  |- skos__hiddenLabel mesh__D006751 Multihospital Information System
% 218.15/218.30  |- skos__hiddenLabel mesh__D006751 Multi Hospital Information Systems
% 218.15/218.30  |- mesh__activeMeSHYear mesh__D006751 2003
% 218.15/218.30  |- skos__hiddenLabel mesh__D006751 Information Systems, Multi-Hospital
% 218.16/218.30  |- skos__hiddenLabel mesh__D020422 Syndromes, Mononeuropathy Multiplex
% 218.16/218.30  |- mesh__publicMeSHNote mesh__D020422 2000   
% 218.16/218.30  |- skos__broader mesh__D020422smesh__D010523
% 218.16/218.30  |- skos__historyNote mesh__D020422
% 218.16/218.30       Peripheral Nervous System Diseases %28%1968-1999%29%
% 218.16/218.30  |- mesh__activeMeSHYear mesh__D020422 2005
% 218.16/218.30  |- rdf__type mesh__D020422sskos__Concept
% 218.16/218.30  |- mesh__dateEstablished mesh__D020422 2000-01-01
% 218.16/218.30  |- skos__hiddenLabel mesh__D020422 Syndrome, Mononeuropathy Multiplex
% 218.16/218.30  |- mesh__activeMeSHYear mesh__D020422 2003
% 218.16/218.30  |- skos__prefLabel mesh__D020422 Mononeuropathies
% 218.16/218.30  |- skos__scopeNote mesh__D020422
% 218.16/218.30       Disease or trauma involving a single peripheral nerve in isolation, or out of proportion to evidence of diffuse peripheral nerve dysfunction. Mononeuropathy multiplex refers to a condition characterized by multiple isolated nerve injuries. Mononeuropathies may result from a wide variety of causes, including ISCHEMIA; traumatic injury; compression; CONNECTIVE TISSUE DISEASES; CUMULATIVE TRAUMA DISORDERS; and other conditions.%A%    
% 218.16/218.30  |- mesh__activeMeSHYear mesh__D020422 2006
% 218.16/218.30  |- skos__hiddenLabel mesh__D020422 Mononeuropathy
% 218.16/218.30  |- mesh__activeMeSHYear mesh__D020422 2000
% 218.16/218.30  |- skos__altLabel mesh__D020422 Mononeuropathy Multiplex Syndrome
% 218.16/218.30  |- mesh__activeMeSHYear mesh__D020422 2004
% 218.16/218.30  |- skos__annotation mesh__D020422 GEN: prefer specifics   
% 218.16/218.30  |- skos__hiddenLabel mesh__D020422 Mononeuropathy Multiplex Syndromes
% 218.16/218.30  |- mesh__activeMeSHYear mesh__D020422 2001
% 218.16/218.30  |- mesh__dateCreated mesh__D020422 1999-11-03
% 218.16/218.30  |- skos__hiddenLabel mesh__D020422 Mononeuritides
% 218.16/218.30  |- mesh__activeMeSHYear mesh__D020422 2002
% 218.16/218.30  |- mesh__historyNote mesh__D020422 2000   
% 218.16/218.30  |- skos__prefLabel mesh__D019679 Kininogen, High-Molecular-Weight
% 218.16/218.30  |- skos__scopeNote mesh__D019679
% 218.16/218.30       A plasma protein, molecular weight of 110 kD, that normally exists in plasma in a 1:1 complex with PREKALLIKREIN. HMWK is split by plasma kallikrein to produce BRADYKININ. The complex is a cofactor in the activation of coagulation factor XII. The product of this reaction, XIIa, in turn activates prekallikrein to KALLIKREINS. %28%From Stedman, 26th ed%29%%A%    
% 218.16/218.30  |- mesh__recordMaintainer mesh__D019679 ssb
% 218.16/218.30  |- skos__altLabel mesh__D019679 Kininogens, High Molecular Weight
% 218.16/218.30  |- skos__altLabel mesh__D019679 High Molecular Weight Kininogen
% 218.16/218.30  |- mesh__recordOriginator mesh__D019679 ADP
% 218.16/218.30  |- skos__hiddenLabel mesh__D019679 Kininogens, High-Molecular-Weight
% 218.16/218.30  |- skos__annotation mesh__D019679 DF: HMWK   
% 218.16/218.30  |- mesh__dateRevised mesh__D019679 2005-06-30
% 218.16/218.30  |- skos__historyNote mesh__D019679 Kininogens %28%1974-1997%29%
% 218.16/218.30  |- skos__altLabel mesh__D019679 HMWK
% 218.16/218.30  |- mesh__activeMeSHYear mesh__D019679 2006
% 218.16/218.30  |- mesh__publicMeSHNote mesh__D019679 98; see KININOGENS 1989-97   
% 218.16/218.30  |- skos__broader mesh__D019679smesh__D007704
% 218.16/218.30  |- skos__hiddenLabel mesh__D019679 Kininogen, High Molecular Weight
% 218.16/218.30  |- skos__altLabel mesh__D019679 Fitzgerald Factor
% 218.16/218.30  |- mesh__dateEstablished mesh__D019679 1998-01-01
% 218.16/218.30  |- mesh__dateCreated mesh__D019679 1997-06-20
% 218.16/218.30  |- skos__altLabel mesh__D019679 High Molecular Weight Kininogens
% 218.16/218.30  |- skos__altLabel mesh__D019679 High-Molecular-Weight Kininogen
% 218.16/218.30  |- mesh__historyNote mesh__D019679 98; use KININOGENS 1989-97   
% 218.16/218.30  |- mesh__recordAuthorizer mesh__D019679 sjn
% 218.16/218.30  |- rdf__type mesh__D019679sskos__Concept
% 218.16/218.30  |- skos__altLabel mesh__D019679 High-Molecular-Weight Kininogens
% 218.16/218.30  |- skos__scopeNote mesh__D011696
% 218.16/218.30       Any form of purpura in which the PLATELET COUNT is decreased. Many forms are thought to be caused by immunological mechanisms.%A%    
% 218.16/218.30  |- mesh__activeMeSHYear mesh__D011696 2005
% 218.16/218.30  |- skos__broader mesh__D011696smesh__D001778
% 218.16/218.30  |- skos__annotation mesh__D011696
% 218.16/218.30       PURPURA, THROMBOCYTOPENIC, IDIOPATHIC %26% PURPURA, THROMBOTIC THROMBOCYTOPENIC are also available; nonthrombocytopenic = PURPURA, SCHOENLEIN-HENOCH%A%  
% 218.16/218.30  |- mesh__activeMeSHYear mesh__D011696 2002
% 218.16/218.30  |- skos__hiddenLabel mesh__D011696 Thrombocytopenic Purpuras
% 218.16/218.30  |- skos__hiddenLabel mesh__D011696 Purpuras, Thrombocytopenic
% 218.16/218.30  |- skos__hiddenLabel mesh__D011696 Thrombopenic Purpuras
% 218.16/218.30  |- skos__hiddenLabel mesh__D011696 Thrombocytopenic Purpura
% 218.16/218.30  |- mesh__activeMeSHYear mesh__D011696 2004
% 218.16/218.30  |- skos__prefLabel mesh__D011696 Purpura, Thrombocytopenic
% 218.16/218.30  |- mesh__activeMeSHYear mesh__D011696 2001
% 218.16/218.30  |- skos__broader mesh__D011696smesh__D011693
% 218.16/218.30  |- rdf__type mesh__D011696sskos__Concept
% 218.16/218.30  |- mesh__activeMeSHYear mesh__D011696 2003
% 218.16/218.30  |- mesh__recordAuthorizer mesh__D011696 sjn
% 218.16/218.30  |- skos__broader mesh__D011696smesh__D007154
% 218.16/218.30  |- mesh__activeMeSHYear mesh__D011696 2000
% 218.16/218.30  |- skos__broader mesh__D011696smesh__D013921
% 218.16/218.30  |- skos__hiddenLabel mesh__D011696 Purpuras, Thrombopenic
% 218.16/218.30  |- mesh__dateRevised mesh__D011696 1999-11-08
% 218.16/218.30  |- mesh__historyNote mesh__D011696 86; was PURPURA, THROMBOPENIC 1963-85   
% 218.16/218.30  |- skos__hiddenLabel mesh__D011696 Thrombopenic Purpura
% 218.16/218.30  |- mesh__dateCreated mesh__D011696 1999-01-01
% 218.16/218.30  |- mesh__activeMeSHYear mesh__D011696 2006
% 218.16/218.30  |- mesh__recordMaintainer mesh__D011696 KEV
% 218.16/218.30  |- mesh__publicMeSHNote mesh__D011696
% 218.16/218.30       86; was PURPURA, THROMBOPENIC 1963-85   
% 218.16/218.30  |- mesh__recordOriginator mesh__D011696 NLM
% 218.16/218.30  |- mesh__onlineNote mesh__D011696
% 218.16/218.30       use PURPURA, THROMBOCYTOPENIC to search PURPURA, THROMBOPENIC 1966-85%A%  
% 218.16/218.30  |- skos__altLabel mesh__D011696 Purpura, Thrombopenic
% 218.16/218.30  |- skos__annotation mesh__D005659
% 218.16/218.30       differentiate from therapeutic fungicides %28% = ANTIFUNGAL AGENTS%29%; DF: FUNGICIDES INDUST%A%  
% 218.16/218.30  |- mesh__historyNote mesh__D005659
% 218.16/218.30       72; FUNGICIDES was included in ANTIFUNGAL AGENTS 1967-71, was heading 1963-66%A%  
% 218.16/218.30  |- mesh__activeMeSHYear mesh__D005659 2005
% 218.16/218.30  |- mesh__publicMeSHNote mesh__D005659
% 218.16/218.30       72; FUNGICIDES was included in ANTIFUNGAL AGENTS 1967-71, was heading 1963-66%A%  
% 218.16/218.30  |- mesh__activeMeSHYear mesh__D005659 2004
% 218.16/218.30  |- skos__broader mesh__D005659smesh__D010575
% 218.16/218.30  |- mesh__activeMeSHYear mesh__D005659 2006
% 218.16/218.30  |- skos__altLabel mesh__D005659 Industrial Fungicides
% 218.16/218.30  |- mesh__recordOriginator mesh__D005659 NLM
% 218.16/218.30  |- skos__prefLabel mesh__D005659 Fungicides, Industrial
% 218.16/218.30  |- mesh__dateEstablished mesh__D005659 1972-01-01
% 218.16/218.30  |- mesh__recordMaintainer mesh__D005659 ssb
% 218.16/218.30  |- rdf__type mesh__D005659sskos__Concept
% 218.16/218.30  |- mesh__recordAuthorizer mesh__D005659 sjn
% 218.16/218.30  |- mesh__dateRevised mesh__D005659 2003-07-09
% 218.16/218.30  |- mesh__onlineNote mesh__D005659
% 218.16/218.30       search FUNGICIDES under ANTIFUNGAL AGENTS 1966-71   
% 218.16/218.30  |- skos__historyNote mesh__D005659 Antifungal Agents %28%1966-1971%29%
% 218.16/218.30  |- skos__scopeNote mesh__D005659
% 218.16/218.30       Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc.%A%    
% 218.16/218.30  |- mesh__dateCreated mesh__D005659 1999-01-01
% 218.16/218.30  |- skos__altLabel mesh__D016381 Transplantation, Islet
% 218.16/218.30  |- mesh__activeMeSHYear mesh__D016381 2005
% 218.16/218.30  |- mesh__dateCreated mesh__D016381 1990-05-29
% 218.16/218.30  |- skos__altLabel mesh__D016381 Islet Transplantation
% 218.16/218.30  |- skos__altLabel mesh__D016381 Islands of Langerhans Transplantation
% 218.16/218.30  |- skos__broader mesh__D016381smesh__D013507
% 218.16/218.30  |- skos__annotation mesh__D016381
% 218.16/218.30       do not use /util except by MeSH definition; do not coord with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; in ther of diabetes mellitus, coord IM with dis /surg %28%IM%29%, not /ther; DF: ISLETS TRANSPL%A%  
% 218.16/218.31  |- rdf__type mesh__D016381sskos__Concept
% 218.16/218.31  |- mesh__recordOriginator mesh__D016381 PXP
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D016381 2004
% 218.16/218.31  |- mesh__recordAuthorizer mesh__D016381 sjn
% 218.16/218.31  |- skos__prefLabel mesh__D016381 Islets of Langerhans Transplantation
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D016381 2003
% 218.16/218.31  |- skos__altLabel mesh__D016381 Transplantation, Pancreatic Islets
% 218.16/218.31  |- skos__altLabel mesh__D016381 Transplantation, Islets of Langerhans
% 218.16/218.31  |- skos__altLabel mesh__D016381 Pancreatic Islets Transplantation
% 218.16/218.31  |- skos__altLabel mesh__D016381 Islands of Pancreas Transplantation
% 218.16/218.31  |- mesh__publicMeSHNote mesh__D016381
% 218.16/218.31       91; was ISLANDS OF LANGERHANS/transplantation 1966-90   
% 218.16/218.31  |- skos__altLabel mesh__D016381 Transplantation, Islands of Langerhans
% 218.16/218.31  |- skos__altLabel mesh__D016381 Grafting, Islets of Langerhans
% 218.16/218.31  |- skos__broader mesh__D016381smesh__D017690
% 218.16/218.31  |- skos__scopeNote mesh__D016381
% 218.16/218.31       The transference of pancreatic islets within an individual, between individuals of the same species, or between individuals of different species.%A%    
% 218.16/218.31  |- skos__hiddenLabel mesh__D016381 Islet Transplantations
% 218.16/218.31  |- skos__altLabel mesh__D016381 Transplantation, Islands of Pancreas
% 218.16/218.31  |- skos__historyNote mesh__D016381
% 218.16/218.31       Islets of Langerhans/transplantation %28%1966-1990%29%
% 218.16/218.31  |- mesh__dateRevised mesh__D016381 2002-07-03
% 218.16/218.31  |- mesh__recordMaintainer mesh__D016381 lkt
% 218.16/218.31  |- skos__hiddenLabel mesh__D016381 Islets Transplantation, Pancreatic
% 218.16/218.31  |- skos__hiddenLabel mesh__D016381 Transplantations, Islet
% 218.16/218.31  |- mesh__dateEstablished mesh__D016381 1991-01-01
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D016381 2006
% 218.16/218.31  |- mesh__historyNote mesh__D016381
% 218.16/218.31       91; was ISLANDS OF LANGERHANS/transplantation 1966-90   
% 218.16/218.31  |- skos__historyNote mesh__D015289 SRS-A %28%1979-1988%29%
% 218.16/218.31  |- mesh__dateRevised mesh__D015289 2005-06-30
% 218.16/218.31  |- mesh__recordOriginator mesh__D015289 RLS
% 218.16/218.31  |- skos__historyNote mesh__D015289 Arachidonic Acids %28%1979-1988%29%
% 218.16/218.31  |- mesh__recordMaintainer mesh__D015289 ssb
% 218.16/218.31  |- skos__historyNote mesh__D015289 Leukotrienes B %28%1983-1988%29%
% 218.16/218.31  |- skos__broader mesh__D015289smesh__D015777
% 218.16/218.31  |- rdf__type mesh__D015289sskos__Concept
% 218.16/218.31  |- skos__broader mesh__D015289smesh__D001095
% 218.16/218.31  |- mesh__recordAuthorizer mesh__D015289 sjn
% 218.16/218.31  |- skos__annotation mesh__D015289
% 218.16/218.31       eicosanoids; GEN or unspecified; prefer specifics; /biosyn /physiol permitted%A%  
% 218.16/218.31  |- mesh__dateCreated mesh__D015289 1988-05-24
% 218.16/218.31  |- skos__prefLabel mesh__D015289 Leukotrienes
% 218.16/218.31  |- mesh__historyNote mesh__D015289 89   
% 218.16/218.31  |- skos__scopeNote mesh__D015289
% 218.16/218.31       A family of biologically active compounds derived from arachidonic acid by oxidative metabolism through the 5-lipoxygenase pathway. They participate in host defense reactions and pathophysiological conditions such as immediate hypersensitivity and inflammation. They have potent actions on many essential organs and systems, including the cardiovascular, pulmonary, and central nervous system as well as the gastrointestinal tract and the immune system.%A%    
% 218.16/218.31  |- skos__related mesh__D015289smesh__D018077
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D015289 2006
% 218.16/218.31  |- mesh__publicMeSHNote mesh__D015289 89   
% 218.16/218.31  |- mesh__dateEstablished mesh__D015289 1989-01-01
% 218.16/218.31  |- skos__altLabel mesh__D034443 mRNA Localization Processes, Cellular
% 218.16/218.31  |- rdf__type mesh__D034443sskos__Concept
% 218.16/218.31  |- skos__hiddenLabel mesh__D034443 Transport, RNA
% 218.16/218.31  |- mesh__publicMeSHNote mesh__D034443 2003   
% 218.16/218.31  |- skos__altLabel mesh__D034443 Ribonucleic Acid Transport
% 218.16/218.31  |- skos__scopeNote mesh__D034443
% 218.16/218.31       The process of moving specific RNA molecules from one cellular compartment or region to another by various sorting and transport mechanisms.%A%    
% 218.16/218.31  |- skos__hiddenLabel mesh__D034443 RNA Sorting, Messenger
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D034443 2006
% 218.16/218.31  |- skos__hiddenLabel mesh__D034443 Sorting, RNA
% 218.16/218.31  |- skos__hiddenLabel mesh__D034443 Transport, Ribonucleic Acid
% 218.16/218.31  |- mesh__historyNote mesh__D034443 2003   
% 218.16/218.31  |- skos__altLabel mesh__D034443 mRNA Sorting
% 218.16/218.31  |- mesh__dateCreated mesh__D034443 2002-07-02
% 218.16/218.31  |- skos__broader mesh__D034443smesh__D001692
% 218.16/218.31  |- skos__altLabel mesh__D034443 RNA Sorting
% 218.16/218.31  |- skos__prefLabel mesh__D034443 RNA Transport
% 218.16/218.31  |- skos__hiddenLabel mesh__D034443 Sorting, Messenger RNA
% 218.16/218.31  |- mesh__recordOriginator mesh__D034443 jmp
% 218.16/218.31  |- mesh__recordMaintainer mesh__D034443 nns
% 218.16/218.31  |- mesh__dateEstablished mesh__D034443 2003-01-01
% 218.16/218.31  |- mesh__dateRevised mesh__D034443 2005-06-30
% 218.16/218.31  |- skos__hiddenLabel mesh__D034443 Acid Transport, Ribonucleic
% 218.16/218.31  |- skos__hiddenLabel mesh__D034443 Sorting, mRNA
% 218.16/218.31  |- mesh__recordAuthorizer mesh__D034443 sjn
% 218.16/218.31  |- skos__altLabel mesh__D034443 Messenger RNA Sorting
% 218.16/218.31  |- mesh__recordAuthorizer mesh__D001269 PLS
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D001269 1992
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D001269 1998
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D001269 2002
% 218.16/218.31  |- rdf__type mesh__D001269sskos__Concept
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D001269 2006
% 218.16/218.31  |- skos__prefLabel mesh__D001269 Atlanto-Occipital Joint
% 218.16/218.31  |- skos__hiddenLabel mesh__D001269 Atloido-Occipital Joints
% 218.16/218.31  |- skos__hiddenLabel mesh__D001269 Joint, Atlanto-Occipital
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D001269 1995
% 218.16/218.31  |- mesh__dateCreated mesh__D001269 1999-01-01
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D001269 2005
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D001269 1994
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D001269 1997
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D001269 2001
% 218.16/218.31  |- mesh__recordOriginator mesh__D001269 NLM
% 218.16/218.31  |- skos__broader mesh__D001269smesh__D007596
% 218.16/218.31  |- skos__hiddenLabel mesh__D001269 Joints, Atloido-Occipital
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D001269 1996
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D001269 2000
% 218.16/218.31  |- mesh__dateRevised mesh__D001269 1991-01-07
% 218.16/218.31  |- skos__hiddenLabel mesh__D001269 Atlanto Occipital Joint
% 218.16/218.31  |- skos__hiddenLabel mesh__D001269 Joints, Atlanto-Occipital
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D001269 2004
% 218.16/218.31  |- skos__hiddenLabel mesh__D001269 Atlanto-Occipital Joints
% 218.16/218.31  |- skos__altLabel mesh__D001269 Atloido-Occipital Joint
% 218.16/218.31  |- skos__hiddenLabel mesh__D001269 Atloido Occipital Joint
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D001269 1993
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D001269 2003
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D001269 1999
% 218.16/218.31  |- mesh__recordMaintainer mesh__D001269 TGC
% 218.16/218.31  |- skos__hiddenLabel mesh__D001269 Joint, Atloido-Occipital
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D006752 2004
% 218.16/218.31  |- mesh__dateEstablished mesh__D006752 1968-01-01
% 218.16/218.31  |- skos__altLabel mesh__D006752 Regional Hospital Plannings
% 218.16/218.31  |- mesh__recordAuthorizer mesh__D006752 sjn
% 218.16/218.31  |- mesh__recordMaintainer mesh__D006752 kle
% 218.16/218.31  |- skos__broader mesh__D006752smesh__D006275
% 218.16/218.31  |- mesh__recordOriginator mesh__D006752 NLM
% 218.16/218.31  |- mesh__dateCreated mesh__D006752 1999-01-01
% 218.16/218.31  |- skos__scopeNote mesh__D006752
% 218.16/218.31       Areawide planning for hospitals or planning of a particular hospital unit on the basis of projected consumer need. This does not include hospital design and construction or architectural plans.%A%    
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D006752 2000
% 218.16/218.31  |- skos__altLabel mesh__D006752 Planning, Hospital
% 218.16/218.31  |- skos__altLabel mesh__D006752 Regional Hospital Planning
% 218.16/218.31  |- skos__annotation mesh__D006752
% 218.16/218.31       differentiate from HOSPITAL DESIGN AND CONSTRUCTION %28%architecture %26% decor%29%: HOSPITAL PLANNING is for develop of plans at a community, state, regional or natl level%A%  
% 218.16/218.31  |- skos__prefLabel mesh__D006752 Hospital Planning
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D006752 2001
% 218.16/218.31  |- mesh__publicMeSHNote mesh__D006752
% 218.16/218.31       68; HOSPITAL PLANNING AND CONSTRUCTION was heading 1963-67%A%  
% 218.16/218.31  |- skos__altLabel mesh__D006752 Plannings, Hospital
% 218.16/218.31  |- skos__altLabel mesh__D006752 Hospital Plannings, Regional
% 218.16/218.31  |- rdf__type mesh__D006752sskos__Concept
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D006752 2005
% 218.16/218.31  |- mesh__dateRevised mesh__D006752 1999-11-03
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D006752 2002
% 218.16/218.31  |- skos__historyNote mesh__D006752
% 218.16/218.31       Hospital Design and Construction %28%1966-1967%29%
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D006752 2003
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D006752 2006
% 218.16/218.31  |- skos__hiddenLabel mesh__D006752 Planning, Regional Hospital
% 218.16/218.31  |- mesh__onlineNote mesh__D006752
% 218.16/218.31       search HOSPITAL PLANNING AND CONSTRUCTION under HOSPITAL DESIGN AND CONSTRUCTION 1966-67%A%  
% 218.16/218.31  |- mesh__historyNote mesh__D006752
% 218.16/218.31       68; HOSPITAL PLANNING AND CONSTRUCTION was heading 1963-67%A%  
% 218.16/218.31  |- skos__hiddenLabel mesh__D020423 Median Nerve Neuralgias
% 218.16/218.31  |- skos__hiddenLabel mesh__D020423 Neuralgias, Median Nerve
% 218.16/218.31  |- skos__hiddenLabel mesh__D020423 Nerve Diseases, Median
% 218.16/218.31  |- skos__prefLabel mesh__D020423 Median Neuropathy
% 218.16/218.31  |- skos__broader mesh__D020423smesh__D020422
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D020423 2006
% 218.16/218.31  |- mesh__dateEstablished mesh__D020423 2000-01-01
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D020423 2001
% 218.16/218.31  |- skos__hiddenLabel mesh__D020423 Neuralgia, Median Nerve
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D020423 2004
% 218.16/218.31  |- skos__hiddenLabel mesh__D020423 Neuropathy, Distal Medial
% 218.16/218.31  |- skos__hiddenLabel mesh__D020423 Distal Medial Neuropathies
% 218.16/218.31  |- skos__hiddenLabel mesh__D020423 Medial Neuropathies, Distal
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D020423 2002
% 218.16/218.31  |- skos__hiddenLabel mesh__D020423 Neuropathies, Distal Medial
% 218.16/218.31  |- skos__altLabel mesh__D020423 Median Nerve Diseases
% 218.16/218.31  |- skos__hiddenLabel mesh__D020423 Distal Medial Neuropathy
% 218.16/218.31  |- mesh__publicMeSHNote mesh__D020423 2000   
% 218.16/218.31  |- skos__hiddenLabel mesh__D020423 Proximal Median Neuropathies
% 218.16/218.31  |- mesh__historyNote mesh__D020423 2000   
% 218.16/218.31  |- skos__hiddenLabel mesh__D020423 Median Neuropathies
% 218.16/218.31  |- skos__altLabel mesh__D020423 Neuropathy, Median
% 218.16/218.31  |- skos__scopeNote mesh__D020423
% 218.16/218.31       Disease involving the median nerve, from its origin at the BRACHIAL PLEXUS to its termination in the hand. Clinical features include weakness of wrist and finger flexion, forearm pronation, thenar abduction, and loss of sensation over the lateral palm, first three fingers, and radial half of the ring finger. Common sites of injury include the elbow, where the nerve passes through the two heads of the pronator teres muscle %28%pronator syndrome%29% and in the carpal tunnel %28%CARPAL TUNNEL SYNDROME%29%.%A%    
% 218.16/218.31  |- skos__annotation mesh__D020423
% 218.16/218.31       pronator nerve syndrome: coord %28%IM%29% with NERVE COMPRESSION SYNDROMES%A%  
% 218.16/218.31  |- skos__hiddenLabel mesh__D020423 Median Neuropathies, Proximal
% 218.16/218.31  |- skos__hiddenLabel mesh__D020423 Median Nerve Disease
% 218.16/218.31  |- skos__hiddenLabel mesh__D020423 Neuropathy, Proximal Median
% 218.16/218.31  |- skos__hiddenLabel mesh__D020423 Nerve Disease, Median
% 218.16/218.31  |- rdf__type mesh__D020423sskos__Concept
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D020423 2005
% 218.16/218.31  |- skos__historyNote mesh__D020423 Median Nerve %28%1967-1999%29%
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D020423 2000
% 218.16/218.31  |- skos__hiddenLabel mesh__D020423 Proximal Median Neuropathy
% 218.16/218.31  |- skos__hiddenLabel mesh__D020423 Neuropathies, Proximal Median
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D020423 2003
% 218.16/218.31  |- mesh__dateCreated mesh__D020423 1999-11-03
% 218.16/218.31  |- skos__hiddenLabel mesh__D020423 Neuropathies, Median
% 218.16/218.31  |- skos__broader mesh__D011697smesh__D011696
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D011697 2002
% 218.16/218.31  |- skos__hiddenLabel mesh__D011697 Thrombotic Thrombopenic Purpura
% 218.16/218.31  |- skos__broader mesh__D011697smesh__D019851
% 218.16/218.31  |- mesh__historyNote mesh__D011697
% 218.16/218.31       86; was PURPURA, THROMBOTIC THROMBOPENIC 1965-85   
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D011697 2005
% 218.16/218.31  |- skos__prefLabel mesh__D011697 Purpura, Thrombotic Thrombocytopenic
% 218.16/218.31  |- mesh__dateRevised mesh__D011697 1999-11-03
% 218.16/218.31  |- skos__hiddenLabel mesh__D011697 Thrombopenic Purpura, Thrombotic
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D011697 2001
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D011697 2004
% 218.16/218.31  |- mesh__recordAuthorizer mesh__D011697 sjn
% 218.16/218.31  |- rdf__type mesh__D011697sskos__Concept
% 218.16/218.31  |- skos__broader mesh__D011697smesh__D013927
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D011697 2000
% 218.16/218.31  |- skos__altLabel mesh__D011697 Purpura, Thrombotic Thrombopenic
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D011697 2003
% 218.16/218.31  |- mesh__dateCreated mesh__D011697 1999-01-01
% 218.16/218.31  |- skos__hiddenLabel mesh__D011697 Disease, Moschkowitz
% 218.16/218.31  |- mesh__dateEstablished mesh__D011697 1965-01-01
% 218.16/218.31  |- mesh__recordOriginator mesh__D011697 NLM
% 218.16/218.31  |- skos__hiddenLabel mesh__D011697 Thrombocytopenic Purpura, Thrombotic
% 218.16/218.31  |- mesh__onlineNote mesh__D011697
% 218.16/218.31       use PURPURA, THROMBOTIC THROMBOCYTOPENIC to search PURPURA, THROMBOTIC THROMBOPENIC 1966-85%A%  
% 218.16/218.31  |- skos__scopeNote mesh__D011697
% 218.16/218.31       A disease characterized by thrombocytopenia, hemolytic anemia, bizarre neurological manifestations, azotemia, fever, and thromboses in terminal arterioles and capillaries.%A%    
% 218.16/218.31  |- mesh__recordMaintainer mesh__D011697 KEV
% 218.16/218.31  |- mesh__publicMeSHNote mesh__D011697
% 218.16/218.31       86; was PURPURA, THROMBOTIC THROMBOPENIC 1965-85   
% 218.16/218.31  |- skos__hiddenLabel mesh__D011697 Thrombotic Thrombocytopenic Purpura
% 218.16/218.31  |- skos__altLabel mesh__D011697 Moschkowitz Disease
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D011697 2006
% 218.16/218.31  |- mesh__dateRevised mesh__D016382 2002-07-18
% 218.16/218.31  |- mesh__historyNote mesh__D016382 92   
% 218.16/218.31  |- mesh__recordMaintainer mesh__D016382 sjn
% 218.16/218.31  |- skos__hiddenLabel mesh__D016382 Orthodontic Appliance Designs
% 218.16/218.31  |- skos__hiddenLabel mesh__D016382 Appliance Design, Orthodontic
% 218.16/218.31  |- skos__prefLabel mesh__D016382 Orthodontic Appliance Design
% 218.16/218.31  |- skos__historyNote mesh__D016382 Orthodontic Appliances %28%1972-1991%29%
% 218.16/218.31  |- mesh__dateCreated mesh__D016382 1991-01-03
% 218.16/218.31  |- skos__hiddenLabel mesh__D016382 Design, Orthodontic Appliance
% 218.16/218.31  |- mesh__recordOriginator mesh__D016382 MXR
% 218.16/218.31  |- skos__hiddenLabel mesh__D016382 Appliance Designs, Orthodontic
% 218.16/218.31  |- skos__annotation mesh__D016382
% 218.16/218.31       coord IM with specific appliance %28%IM or NIM%29% or orthodontic tech /instrum %28%IM or NIM%29%%A%  
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D016382 2006
% 218.16/218.31  |- mesh__dateEstablished mesh__D016382 1992-01-01
% 218.16/218.31  |- mesh__publicMeSHNote mesh__D016382 92   
% 218.16/218.31  |- skos__broader mesh__D016382smesh__D013674
% 218.16/218.31  |- mesh__recordAuthorizer mesh__D016382 sjn
% 218.16/218.31  |- skos__hiddenLabel mesh__D016382 Designs, Orthodontic Appliance
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D016382 2005
% 218.16/218.31  |- rdf__type mesh__D016382sskos__Concept
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D016382 2004
% 218.16/218.31  |- skos__broader mesh__D016382smesh__D009970
% 218.16/218.31  |- skos__scopeNote mesh__D016382
% 218.16/218.31       The planning, calculation, and creation of an apparatus for the purpose of correcting the placement or straightening of teeth.%A%    
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D016382 2003
% 218.16/218.31  |- skos__annotation mesh__D002362
% 218.16/218.31       coord with FRANGULA when appropriate; in translations use %22%cascara sagrada%22%, not %22%sacred bark%22%; use in therapy: coord with PHYTOTHERAPY%A%  
% 218.16/218.31  |- mesh__dateCreated mesh__D002362 1999-01-01
% 218.16/218.31  |- mesh__dateRevised mesh__D002362 2005-06-30
% 218.16/218.31  |- skos__broader mesh__D002362smesh__D010936
% 218.16/218.31  |- mesh__dateEstablished mesh__D002362 1991-01-01
% 218.16/218.31  |- skos__broader mesh__D002362smesh__D000880
% 218.16/218.31  |- rdf__type mesh__D002362sskos__Concept
% 218.16/218.31  |- mesh__recordOriginator mesh__D002362 NLM
% 218.16/218.31  |- skos__scopeNote mesh__D002362
% 218.16/218.31       Dried aged bark of a buckthorn, Frangula purshiana %28%FRANGULA%29%, that contains the anthraquinone EMODIN and cascarosides. It is used as a laxative %28%CATHARTICS%29%.%A%    
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D002362 2006
% 218.16/218.31  |- mesh__recordMaintainer mesh__D002362 ssb
% 218.16/218.31  |- mesh__historyNote mesh__D002362
% 218.16/218.31       91%28%75%29%; was see under CATHARTICS 1975-90   
% 218.16/218.31  |- mesh__recordAuthorizer mesh__D002362 sjn
% 218.16/218.31  |- mesh__publicMeSHNote mesh__D002362
% 218.16/218.31       91; was see under CATHARTICS 1975-90   
% 218.16/218.31  |- skos__prefLabel mesh__D002362 Cascara
% 218.16/218.31  |- skos__altLabel mesh__D002362 Sacred Bark
% 218.16/218.31  |- skos__altLabel mesh__D002362 Cascara Sagrada
% 218.16/218.31  |- mesh__onlineNote mesh__D002362 search CATHARTICS 1966-74   
% 218.16/218.31  |- mesh__dateCreated mesh__D040481 2002-07-03
% 218.16/218.31  |- skos__hiddenLabel mesh__D040481 Genome Component
% 218.16/218.31  |- skos__annotation mesh__D040481
% 218.16/218.31       general; prefer specifics; do not confuse with GENE COMPONENTS%A%  
% 218.16/218.31  |- skos__scopeNote mesh__D040481
% 218.16/218.31       The parts of a GENOME sequence that are involved with the different functions or properties of genomes as a whole as opposed to those of individual GENES.%A%    
% 218.16/218.31  |- mesh__historyNote mesh__D040481 2003   
% 218.16/218.31  |- mesh__dateEstablished mesh__D040481 2003-01-01
% 218.16/218.31  |- skos__hiddenLabel mesh__D040481 Component, Genome
% 218.16/218.31  |- mesh__recordOriginator mesh__D040481 nns
% 218.16/218.31  |- skos__hiddenLabel mesh__D040481 Components, Genome
% 218.16/218.31  |- mesh__recordAuthorizer mesh__D040481 sjn
% 218.16/218.31  |- skos__broader mesh__D040481smesh__D016678
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D040481 2006
% 218.16/218.31  |- mesh__dateRevised mesh__D040481 2005-06-30
% 218.16/218.31  |- rdf__type mesh__D040481sskos__Concept
% 218.16/218.31  |- mesh__publicMeSHNote mesh__D040481 2003   
% 218.16/218.31  |- skos__prefLabel mesh__D040481 Genome Components
% 218.16/218.31  |- mesh__recordMaintainer mesh__D040481 nns
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D012790 2002
% 218.16/218.31  |- mesh__dateCreated mesh__D012790 1999-01-01
% 218.16/218.31  |- skos__broader mesh__D012790smesh__D014657
% 218.16/218.31  |- rdf__type mesh__D012790sskos__Concept
% 218.16/218.31  |- mesh__recordMaintainer mesh__D012790 NNS
% 218.16/218.31  |- skos__hiddenLabel mesh__D012790 Reaction, Shwartzman
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D012790 2004
% 218.16/218.31  |- mesh__recordOriginator mesh__D012790 NLM
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D012790 2001
% 218.16/218.31  |- skos__altLabel mesh__D012790 Shwartzman Reaction
% 218.16/218.31  |- mesh__dateRevised mesh__D012790 1998-06-11
% 218.16/218.31  |- mesh__recordAuthorizer mesh__D012790 SJN
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D012790 1999
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D012790 2003
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D012790 2000
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D012790 2006
% 218.16/218.31  |- skos__scopeNote mesh__D012790
% 218.16/218.31       A vasculitis, local or systemic, caused by a two-stage reaction in which a first encounter with endotoxin produces intravascular fibrin thrombi whose clearance results in reticuloendothelial blockade which prevents the clearance of thrombi caused by a second encounter with endotoxin, %28%or a variety of polyanions, glycogen or antigen/antibody complexes%29% resulting in tissue necrosis and/or hemorrhage. In pregnancy gram-negative septicemia during delivery or abortion may serve as the first or provocative encounter.%A%    
% 218.16/218.31  |- skos__prefLabel mesh__D012790 Shwartzman Phenomenon
% 218.16/218.31  |- skos__broader mesh__D012790smesh__D020141
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D012790 2005
% 218.16/218.31  |- skos__hiddenLabel mesh__D012790 Phenomenon, Shwartzman
% 218.16/218.31  |- skos__scopeNote mesh__D034444
% 218.16/218.31       Polymers of N-SUBSTITUTED GLYCINES containing chiral centers at the a-position of their side chains. These oligomers lack HYDROGEN BONDING donors, preventing formation of the usual intrachain hydrogen bonds but can form helices driven by the steric influence of chiral side chains.%A%    
% 218.16/218.31  |- mesh__recordMaintainer mesh__D034444 sjn
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D034444 2006
% 218.16/218.31  |- mesh__recordAuthorizer mesh__D034444 sjn
% 218.16/218.31  |- mesh__dateCreated mesh__D034444 2002-07-03
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D034444 2005
% 218.16/218.31  |- mesh__dateRevised mesh__D034444 2003-07-25
% 218.16/218.31  |- skos__broader mesh__D034444smesh__D010455
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D034444 2004
% 218.16/218.31  |- skos__prefLabel mesh__D034444 Peptoids
% 218.16/218.31  |- skos__historyNote mesh__D034444 Peptides %28%1987-2002%29%
% 218.16/218.31  |- mesh__historyNote mesh__D034444 2003   
% 218.16/218.31  |- skos__altLabel mesh__D034444 Peptoid
% 218.16/218.31  |- mesh__recordOriginator mesh__D034444 ssb
% 218.16/218.31  |- rdf__type mesh__D034444sskos__Concept
% 218.16/218.31  |- mesh__publicMeSHNote mesh__D034444 2003   
% 218.16/218.31  |- mesh__dateEstablished mesh__D034444 2003-01-01
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D006753 1995
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D006753 1998
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D006753 2006
% 218.16/218.31  |- mesh__dateCreated mesh__D006753 1999-01-01
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D006753 2003
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D006753 1994
% 218.16/218.31  |- skos__annotation mesh__D006753
% 218.16/218.31       FORMS AND RECORDS CONTROL, also available, is probably NIM when coord; DF: HOSP RECORDS%A%  
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D006753 2005
% 218.16/218.31  |- mesh__recordAuthorizer mesh__D006753 PLS
% 218.16/218.31  |- skos__broader mesh__D006753smesh__D011996
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D006753 2002
% 218.16/218.31  |- skos__prefLabel mesh__D006753 Hospital Records
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D006753 2001
% 218.16/218.31  |- mesh__recordOriginator mesh__D006753 NLM
% 218.16/218.31  |- mesh__dateRevised mesh__D006753 1992-05-15
% 218.16/218.31  |- mesh__publicMeSHNote mesh__D006753
% 218.16/218.31       89; was see under RECORDS 1979-88; was see under MEDICAL RECORDS 1963-78%A%  
% 218.16/218.31  |- mesh__onlineNote mesh__D006753
% 218.16/218.31       use MEDICAL RECORDS to search HOSPITAL RECORDS 1966-74   
% 218.16/218.31  |- skos__scopeNote mesh__D006753
% 218.16/218.31       Compilations of data on hospital activities and programs; excludes patient medical records.%A%    
% 218.16/218.31  |- skos__hiddenLabel mesh__D006753 Record, Hospital
% 218.16/218.31  |- mesh__historyNote mesh__D006753
% 218.16/218.31       89%28%75%29%; was see under RECORDS 1979-88; was see under MEDICAL RECORDS 1963-78%A%  
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D006753 1997
% 218.16/218.31  |- skos__altLabel mesh__D006753 Records, Hospital
% 218.16/218.31  |- skos__related mesh__D006753smesh__D005568
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D006753 2000
% 218.16/218.31  |- rdf__type mesh__D006753sskos__Concept
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D006753 1999
% 218.16/218.31  |- mesh__dateEstablished mesh__D006753 1989-01-01
% 218.16/218.31  |- skos__hiddenLabel mesh__D006753 Hospital Record
% 218.16/218.31  |- mesh__recordMaintainer mesh__D006753 PLS
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D006753 2004
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D006753 1996
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D006753 1993
% 218.16/218.31  |- skos__historyNote mesh__D020424
% 218.16/218.31       Peripheral Nervous System Diseases %28%1966-1999%29%
% 218.16/218.31  |- skos__hiddenLabel mesh__D020424 Neuritis, Ulnar
% 218.16/218.31  |- skos__hiddenLabel mesh__D020424 Nerve Palsies, Ulnar
% 218.16/218.31  |- mesh__activeMeSHYear mesh__D020424 2000
% 218.18/218.31  |- skos__hiddenLabel mesh__D020424 Neuropathy, Ulnar
% 218.18/218.31  |- skos__hiddenLabel mesh__D020424 Nerve Palsy, Ulnar
% 218.18/218.31  |- mesh__dateCreated mesh__D020424 1999-11-03
% 218.18/218.31  |- skos__hiddenLabel mesh__D020424 Nerve Disease, Ulnar
% 218.18/218.31  |- skos__hiddenLabel mesh__D020424 Neuropathies, Ulnar
% 218.18/218.31  |- skos__broader mesh__D020424smesh__D020422
% 218.18/218.31  |- mesh__historyNote mesh__D020424 2000   
% 218.18/218.31  |- mesh__activeMeSHYear mesh__D020424 2001
% 218.18/218.31  |- skos__hiddenLabel mesh__D020424 Ulnar Nerve Palsies
% 218.18/218.31  |- skos__hiddenLabel mesh__D020424 Palsies, Ulnar Nerve
% 218.18/218.31  |- skos__hiddenLabel mesh__D020424 Nerve Diseases, Ulnar
% 218.18/218.31  |- skos__altLabel mesh__D020424 Ulnar Nerve Diseases
% 218.18/218.31  |- skos__scopeNote mesh__D020424
% 218.18/218.31       Disease involving the ULNAR NERVE from its origin in the BRACHIAL PLEXUS to its termination in the hand. Clinical manifestations may include PARESIS or PARALYSIS of wrist flexion, finger flexion, thumb adduction, finger abduction, and finger adduction. Sensation over the medial palm, fifth finger, and ulnar aspect of the ring finger may also be impaired. Common sites of injury include the AXILLA, cubital tunnel at the ELBOW, and Guyon%27%s canal at the wrist. %28%From Joynt, Clinical Neurology, 1995, Ch51 pp43-5%29%%A%    
% 218.18/218.31  |- skos__prefLabel mesh__D020424 Ulnar Neuropathies
% 218.18/218.31  |- mesh__activeMeSHYear mesh__D020424 2002
% 218.18/218.31  |- skos__hiddenLabel mesh__D020424 Neuritides, Ulnar
% 218.18/218.31  |- skos__hiddenLabel mesh__D020424 Ulnar Neuritides
% 218.18/218.31  |- skos__historyNote mesh__D020424 Ulnar Nerve %28%1966-1999%29%
% 218.18/218.31  |- mesh__publicMeSHNote mesh__D020424 2000   
% 218.18/218.31  |- skos__hiddenLabel mesh__D020424 Ulnar Nerve Disease
% 218.18/218.31  |- rdf__type mesh__D020424sskos__Concept
% 218.18/218.31  |- mesh__activeMeSHYear mesh__D020424 2005
% 218.18/218.31  |- mesh__activeMeSHYear mesh__D020424 2003
% 218.18/218.31  |- mesh__activeMeSHYear mesh__D020424 2006
% 218.18/218.31  |- mesh__dateEstablished mesh__D020424 2000-01-01
% 218.18/218.31  |- skos__hiddenLabel mesh__D020424 Palsy, Ulnar Nerve
% 218.18/218.31  |- skos__hiddenLabel mesh__D020424 Ulnar Neuropathy
% 218.18/218.31  |- mesh__activeMeSHYear mesh__D020424 2004
% 218.18/218.31  |- mesh__dateCreated mesh__D011698 1983-03-10
% 218.18/218.31  |- mesh__recordMaintainer mesh__D011698 nns
% 218.18/218.31  |- mesh__dateRevised mesh__D011698 2003-07-09
% 218.18/218.31  |- mesh__dateEstablished mesh__D011698 1991-01-01
% 218.18/218.31  |- skos__hiddenLabel mesh__D011698 Smooth Pursuits
% 218.18/218.31  |- skos__historyNote mesh__D011698 Eye Movements %28%1966-1983%29%
% 218.18/218.31  |- mesh__activeMeSHYear mesh__D011698 2006
% 218.18/218.31  |- mesh__recordOriginator mesh__D011698 RC
% 218.18/218.31  |- mesh__publicMeSHNote mesh__D011698
% 218.18/218.31       91; was see under EYE MOVEMENTS 1984-90   
% 218.18/218.31  |- skos__broader mesh__D011698smesh__D005133
% 218.18/218.31  |- skos__hiddenLabel mesh__D011698 Pursuits, Smooth
% 218.18/218.31  |- mesh__recordAuthorizer mesh__D011698 sjn
% 218.18/218.31  |- mesh__activeMeSHYear mesh__D011698 2005
% 218.18/218.32  |- mesh__historyNote mesh__D011698
% 218.18/218.32       91%28%84%29%; was see under EYE MOVEMENTS 1984-90   
% 218.18/218.32  |- skos__hiddenLabel mesh__D011698 Smooth Pursuit
% 218.18/218.32  |- skos__scopeNote mesh__D011698
% 218.18/218.32       Eye movements that are slow, continuous, and conjugate and occur when a fixed object is moved slowly.%A%    
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D011698 2004
% 218.18/218.32  |- skos__prefLabel mesh__D011698 Pursuit, Smooth
% 218.18/218.32  |- rdf__type mesh__D011698sskos__Concept
% 218.18/218.32  |- skos__annotation mesh__D011698 refers to eye movements   
% 218.18/218.32  |- skos__altLabel mesh__D002363 Case Reports
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D002363 2006
% 218.18/218.32  |- skos__prefLabel mesh__D002363 Case Reports %5B%Publication Type%5D%
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D002363 2006A
% 218.18/218.32  |- skos__altLabel mesh__D002363 Case Studies
% 218.18/218.32  |- mesh__recordAuthorizer mesh__D002363 jls
% 218.18/218.32  |- mesh__dateRevised mesh__D002363 2005-11-10
% 218.18/218.32  |- skos__annotation mesh__D002363
% 218.18/218.32       permitted for veterinary case reports but not for historical articles; case reports as a form of writing are indexed under MEDICAL RECORDS or specific records term %28%IM%29%;  CATALOG: do not use for institutional case reports. Use instead the topical heading ORGANIZATIONAL CASE STUDIES%A%  
% 218.18/218.32  |- skos__altLabel mesh__D002363 Case Reports %5B%Pub Type%5D%
% 218.18/218.32  |- skos__altLabel mesh__D002363 Case Reports %5B%PT%5D%
% 218.18/218.32  |- mesh__dateCreated mesh__D002363 1999-01-01
% 218.18/218.32  |- mesh__recordOriginator mesh__D002363 NLM
% 218.18/218.32  |- rdf__type mesh__D002363sskos__Concept
% 218.18/218.32  |- skos__scopeNote mesh__D002363
% 218.18/218.32       Clinical presentations that may be followed by evaluative studies that eventually lead to a diagnosis.%A%    
% 218.18/218.32  |- mesh__recordMaintainer mesh__D002363 jls
% 218.18/218.32  |- skos__broader mesh__D002363smesh__D052182
% 218.18/218.32  |- mesh__historyNote mesh__D002363
% 218.18/218.32       1966; for articles that were case reports 1967-1975, that contained case reports 1966%A%  
% 218.18/218.32  |- skos__altLabel mesh__D012791 Orthostatic Hypotension, Dysautonomic
% 218.18/218.32  |- skos__prefLabel mesh__D012791 Shy-Drager Syndrome
% 218.18/218.32  |- mesh__dateCreated mesh__D012791 1980-05-12
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D012791 2004
% 218.18/218.32  |- skos__broader mesh__D012791smesh__D019636
% 218.18/218.32  |- skos__hiddenLabel mesh__D012791 Shy Drager Syndrome
% 218.18/218.32  |- skos__hiddenLabel mesh__D012791 Failure, Progressive Autonomic
% 218.18/218.32  |- skos__altLabel mesh__D012791 Autonomic Failure, Progressive
% 218.18/218.32  |- mesh__recordMaintainer mesh__D012791 ags
% 218.18/218.32  |- skos__hiddenLabel mesh__D012791
% 218.18/218.32       Syndromes, Dysautonomia-Orthostatic Hypotension
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D012791 2000A
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D012791 2000
% 218.18/218.32  |- skos__hiddenLabel mesh__D012791
% 218.18/218.32       Dysautonomia-Orthostatic Hypotension Syndromes
% 218.18/218.32  |- skos__hiddenLabel mesh__D012791 Dysautonomic Orthostatic Hypotensions
% 218.18/218.32  |- skos__altLabel mesh__D012791
% 218.18/218.32       Dysautonomia-Orthostatic Hypotension Syndrome
% 218.18/218.32  |- skos__altLabel mesh__D012791
% 218.18/218.32       Syndrome, Dysautonomia-Orthostatic Hypotension
% 218.18/218.32  |- skos__hiddenLabel mesh__D012791 Dysautonomic Orthostatic Hypotension
% 218.18/218.32  |- mesh__recordOriginator mesh__D012791 RC
% 218.18/218.32  |- skos__broader mesh__D012791smesh__D007024
% 218.18/218.32  |- skos__historyNote mesh__D012791
% 218.18/218.32       Hypotension, Orthostatic %28%1966-1980%29%
% 218.18/218.32  |- skos__hiddenLabel mesh__D012791 Failures, Progressive Autonomic
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D012791 2005
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D012791 2001
% 218.18/218.32  |- mesh__historyNote mesh__D012791 1991%28%1981%29%   
% 218.18/218.32  |- mesh__recordAuthorizer mesh__D012791 ags
% 218.18/218.32  |- mesh__publicMeSHNote mesh__D012791
% 218.18/218.32       1991; see AUTONOMIC NERVOUS SYSTEM DISEASES 1981-1990   
% 218.18/218.32  |- mesh__dateEstablished mesh__D012791 1991-01-01
% 218.18/218.32  |- skos__broader mesh__D012791smesh__D001342
% 218.18/218.32  |- skos__hiddenLabel mesh__D012791 Orthostatic Hypotensions, Dysautonomic
% 218.18/218.32  |- skos__hiddenLabel mesh__D012791
% 218.18/218.32       Dysautonomia Orthostatic Hypotension Syndrome
% 218.18/218.32  |- rdf__type mesh__D012791sskos__Concept
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D012791 2006
% 218.18/218.32  |- skos__hiddenLabel mesh__D012791 Syndrome, Shy-Drager
% 218.18/218.32  |- skos__historyNote mesh__D012791
% 218.18/218.32       Nervous System Diseases %28%1966-1980%29%
% 218.18/218.32  |- skos__related mesh__D012791smesh__D019578
% 218.18/218.32  |- skos__broader mesh__D012791smesh__D019578
% 218.18/218.32  |- skos__hiddenLabel mesh__D012791 Hypotension, Dysautonomic Orthostatic
% 218.18/218.32  |- skos__hiddenLabel mesh__D012791
% 218.18/218.32       Syndrome, Dysautonomia Orthostatic Hypotension
% 218.18/218.32  |- skos__hiddenLabel mesh__D012791 Progressive Autonomic Failure
% 218.18/218.32  |- skos__hiddenLabel mesh__D012791
% 218.18/218.32       Hypotension Syndrome, Dysautonomia-Orthostatic
% 218.18/218.32  |- skos__altLabel mesh__D012791
% 218.18/218.32       Idiopathic Orthostatic Hypotension, Shy-Drager Type
% 218.18/218.32  |- skos__hiddenLabel mesh__D012791 Autonomic Failures, Progressive
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D012791 2002
% 218.18/218.32  |- skos__hiddenLabel mesh__D012791
% 218.18/218.32       Idiopathic Orthostatic Hypotension, Shy Drager Type
% 218.18/218.32  |- mesh__dateRevised mesh__D012791 1999-11-26
% 218.18/218.32  |- skos__hiddenLabel mesh__D012791 Progressive Autonomic Failures
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D012791 2003
% 218.18/218.32  |- skos__hiddenLabel mesh__D012791 Hypotensions, Dysautonomic Orthostatic
% 218.18/218.32  |- skos__scopeNote mesh__D012791
% 218.18/218.32       A progressive neurodegenerative condition of the central and autonomic nervous systems characterized by atrophy of the preganglionic lateral horn neurons of the thoracic spinal cord, which differentiates this condition from other forms of idiopathic orthostatic hypotension %28%HYPOTENSION, ORTHOSTATIC%29%. This disease is generally considered a clinical variant of MULTIPLE SYSTEM ATROPHY. Affected individuals present in the fifth or sixth decade with orthostasis and bladder dysfunction; and later develop FECAL INCONTINENCE; anhidrosis; ATAXIA; IMPOTENCE; and alterations of tone suggestive of basal ganglia dysfunction. %28%From Adams et al., Principles of Neurology, 6th ed, p536%29%%A%    
% 218.18/218.32  |- skos__hiddenLabel mesh__D012791
% 218.18/218.32       Hypotension Syndromes, Dysautonomia-Orthostatic
% 218.18/218.32  |- mesh__recordAuthorizer mesh__D034445 sjn
% 218.18/218.32  |- mesh__publicMeSHNote mesh__D034445 2003   
% 218.18/218.32  |- mesh__dateRevised mesh__D034445 2005-06-30
% 218.18/218.32  |- skos__hiddenLabel mesh__D034445 Inhibition, Ovulation
% 218.18/218.32  |- mesh__dateEstablished mesh__D034445 2003-01-01
% 218.18/218.32  |- skos__scopeNote mesh__D034445
% 218.18/218.32       Blocking the process leading to OVULATION. Various factors are known to inhibit ovulation, such as neuroendocrine, psychological, and pharmacological agents.%A%    
% 218.18/218.32  |- mesh__dateCreated mesh__D034445 2002-07-03
% 218.18/218.32  |- mesh__recordMaintainer mesh__D034445 lkt
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D034445 2006
% 218.18/218.32  |- mesh__recordOriginator mesh__D034445 lkt
% 218.18/218.32  |- skos__historyNote mesh__D034445 Contraceptives, Oral %28%1964-2002%29%
% 218.18/218.32  |- skos__broader mesh__D034445smesh__D003267
% 218.18/218.32  |- skos__hiddenLabel mesh__D034445 Suppression, Ovulation
% 218.18/218.32  |- rdf__type mesh__D034445sskos__Concept
% 218.18/218.32  |- skos__prefLabel mesh__D034445 Ovulation Inhibition
% 218.18/218.32  |- mesh__historyNote mesh__D034445 2003   
% 218.18/218.32  |- skos__broader mesh__D034445smesh__D010060
% 218.18/218.32  |- skos__altLabel mesh__D034445 Ovulation Suppression
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006754 2005
% 218.18/218.32  |- skos__prefLabel mesh__D006754 Hospital Restructuring
% 218.18/218.32  |- mesh__dateCreated mesh__D006754 1983-06-10
% 218.18/218.32  |- skos__hiddenLabel mesh__D006754 Reorganizations, Hospital
% 218.18/218.32  |- mesh__recordMaintainer mesh__D006754 JLS
% 218.18/218.32  |- skos__annotation mesh__D006754 restruct the corporate struct   
% 218.18/218.32  |- skos__broader mesh__D006754smesh__D006739
% 218.18/218.32  |- skos__historyNote mesh__D006754
% 218.18/218.32       Hospital Administration %28%1966-1983%29%
% 218.18/218.32  |- skos__hiddenLabel mesh__D006754 Hospital Reorganizations
% 218.18/218.32  |- mesh__recordOriginator mesh__D006754 EC
% 218.18/218.32  |- mesh__publicMeSHNote mesh__D006754
% 218.18/218.32       91; was see under HOSPITAL ADMINISTRATION 1984-90   
% 218.18/218.32  |- mesh__historyNote mesh__D006754
% 218.18/218.32       91%28%84%29%; was see under HOSPITAL ADMINISTRATION 1984-90   
% 218.18/218.32  |- skos__altLabel mesh__D006754 Reorganization, Hospital
% 218.18/218.32  |- mesh__recordAuthorizer mesh__D006754 PLS
% 218.18/218.32  |- skos__altLabel mesh__D006754 Hospital Reorganization
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006754 1997
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006754 2002
% 218.18/218.32  |- mesh__dateRevised mesh__D006754 1994-05-27
% 218.18/218.32  |- skos__scopeNote mesh__D006754
% 218.18/218.32       Reorganization of the hospital corporate structure.     
% 218.18/218.32  |- skos__historyNote mesh__D006754 Financial Management %28%1978-1983%29%
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006754 1999
% 218.18/218.32  |- rdf__type mesh__D006754sskos__Concept
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006754 2004
% 218.18/218.32  |- skos__altLabel mesh__D006754 Restructuring, Hospital
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006754 1996
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006754 1995
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006754 2001
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006754 2006
% 218.18/218.32  |- mesh__dateEstablished mesh__D006754 1991-01-01
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006754 1998
% 218.18/218.32  |- skos__altLabel mesh__D006754 Diversification, Hospital
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006754 2003
% 218.18/218.32  |- skos__hiddenLabel mesh__D006754 Restructurings, Hospital
% 218.18/218.32  |- skos__hiddenLabel mesh__D006754 Hospital Restructurings
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006754 2000
% 218.18/218.32  |- skos__broader mesh__D020425smesh__D020422
% 218.18/218.32  |- mesh__dateRevised mesh__D020425 2001-07-25
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D020425 2006
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D020425 2003
% 218.18/218.32  |- mesh__publicMeSHNote mesh__D020425 2000   
% 218.18/218.32  |- skos__hiddenLabel mesh__D020425 Lesions, Radial Nerve
% 218.18/218.32  |- skos__altLabel mesh__D020425 Superficial Radial Nerve Lesion
% 218.18/218.32  |- mesh__dateCreated mesh__D020425 1999-11-03
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D020425 2002
% 218.18/218.32  |- skos__hiddenLabel mesh__D020425 Saturday Night Palsies
% 218.18/218.32  |- skos__hiddenLabel mesh__D020425 Radial Neuropathies
% 218.18/218.32  |- skos__hiddenLabel mesh__D020425 Nerve Lesion, Radial
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D020425 2005
% 218.18/218.32  |- mesh__recordMaintainer mesh__D020425 nns
% 218.18/218.32  |- skos__hiddenLabel mesh__D020425 Radial Nerve Lesions
% 218.18/218.32  |- skos__hiddenLabel mesh__D020425 Nerve Disease, Radial
% 218.18/218.32  |- skos__altLabel mesh__D020425 Radial Nerve Diseases
% 218.18/218.32  |- skos__prefLabel mesh__D020425 Radial Neuropathy
% 218.18/218.32  |- skos__hiddenLabel mesh__D020425 Neuropathy, Radial
% 218.18/218.32  |- mesh__recordAuthorizer mesh__D020425 sjn
% 218.18/218.32  |- skos__hiddenLabel mesh__D020425 Lesion, Radial Nerve
% 218.18/218.32  |- skos__hiddenLabel mesh__D020425 Nerve Diseases, Radial
% 218.18/218.32  |- skos__hiddenLabel mesh__D020425 Palsy, Crutch
% 218.18/218.32  |- mesh__recordOriginator mesh__D020425 KEV
% 218.18/218.32  |- skos__hiddenLabel mesh__D020425 Nerve Lesions, Radial
% 218.18/218.32  |- skos__scopeNote mesh__D020425
% 218.18/218.32       Disease involving the RADIAL NERVE. Clinical features include weakness of elbow extension, elbow flexion, supination of the forearm, wrist and finger extension, and thumb abduction. Sensation may be impaired over regions of the dorsal forearm. Common sites of compression or traumatic injury include the AXILLA and radial groove of the HUMERUS.%A%    
% 218.18/218.32  |- skos__hiddenLabel mesh__D020425 Palsies, Crutch
% 218.18/218.32  |- mesh__historyNote mesh__D020425 2000   
% 218.18/218.32  |- skos__historyNote mesh__D020425
% 218.18/218.32       Peripheral Nervous System Diseases %28%1966-1999%29%
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D020425 2004
% 218.18/218.32  |- rdf__type mesh__D020425sskos__Concept
% 218.18/218.32  |- skos__hiddenLabel mesh__D020425 Radial Nerve Disease
% 218.18/218.32  |- skos__hiddenLabel mesh__D020425 Neuropathies, Radial
% 218.18/218.32  |- skos__hiddenLabel mesh__D020425 Crutch Palsies
% 218.18/218.32  |- mesh__dateEstablished mesh__D020425 2000-01-01
% 218.18/218.32  |- mesh__onlineNote mesh__D011699
% 218.18/218.32       search CORPUS STRIATUM 1974-78 %26% GANGLIA, BASAL 1963-73   
% 218.18/218.32  |- skos__historyNote mesh__D011699 Corpus Striatum %28%1974%29%
% 218.18/218.32  |- skos__broader mesh__D011699smesh__D017072
% 218.18/218.32  |- skos__related mesh__D011699smesh__D020146
% 218.18/218.32  |- mesh__recordMaintainer mesh__D011699 KEV
% 218.18/218.32  |- mesh__recordOriginator mesh__D011699 NLM
% 218.18/218.32  |- skos__annotation mesh__D011699 part of the neostriatum   
% 218.18/218.32  |- skos__prefLabel mesh__D011699 Putamen
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D011699 2006
% 218.18/218.32  |- mesh__dateEstablished mesh__D011699 1979-01-01
% 218.18/218.32  |- skos__historyNote mesh__D011699 Basal Ganglia %28%1966-1973%29%
% 218.18/218.32  |- mesh__historyNote mesh__D011699
% 218.18/218.32       79%28%75%29%; was see under CORPUS STRIATUM 1974-78; was see under GANGLIA, BASAL 1963-73%A%  
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D011699 2005
% 218.18/218.32  |- mesh__dateRevised mesh__D011699 1999-11-03
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D011699 2002
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D011699 2004
% 218.18/218.32  |- rdf__type mesh__D011699sskos__Concept
% 218.18/218.32  |- mesh__publicMeSHNote mesh__D011699
% 218.18/218.32       79; was see under CORPUS STRIATUM 1974-78; was see under GANGLIA, BASAL 1963-73%A%  
% 218.18/218.32  |- skos__scopeNote mesh__D011699
% 218.18/218.32       The largest and most lateral of the basal ganglia lying between the lateral medullary lamina of the globus pallidus and the external capsule. It is part of the neostriatum and forms part of the lentiform nucleus along with the globus pallidus.%A%    
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D011699 2001
% 218.18/218.32  |- skos__hiddenLabel mesh__D011699 Putamens
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D011699 2003
% 218.18/218.32  |- mesh__recordAuthorizer mesh__D011699 sjn
% 218.18/218.32  |- mesh__dateCreated mesh__D011699 1999-01-01
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D011699 2000
% 218.18/218.32  |- skos__historyNote mesh__D016384
% 218.18/218.32       Molecular Sequence Data %28%1988-1990%29%
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D016384 2005
% 218.18/218.32  |- skos__broader mesh__D016384smesh__D017124
% 218.18/218.32  |- skos__annotation mesh__D016384 DF: CONSENSUS SEQ   
% 218.18/218.32  |- mesh__recordOriginator mesh__D016384 PXP
% 218.18/218.32  |- mesh__recordAuthorizer mesh__D016384 sjn
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D016384 2006
% 218.18/218.32  |- skos__hiddenLabel mesh__D016384 Sequences, Consensus
% 218.18/218.32  |- mesh__recordMaintainer mesh__D016384 nns
% 218.18/218.32  |- skos__related mesh__D016384smesh__D020816
% 218.18/218.32  |- mesh__historyNote mesh__D016384 91   
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D016384 2003
% 218.18/218.32  |- rdf__type mesh__D016384sskos__Concept
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D016384 2004
% 218.18/218.32  |- mesh__dateRevised mesh__D016384 2002-07-03
% 218.18/218.32  |- skos__historyNote mesh__D016384 Base Sequence %28%1983-1990%29%
% 218.18/218.32  |- skos__hiddenLabel mesh__D016384 Sequence, Consensus
% 218.18/218.32  |- skos__hiddenLabel mesh__D016384 Consensus Sequences
% 218.18/218.32  |- skos__scopeNote mesh__D016384
% 218.18/218.32       A theoretical representative nucleotide or amino acid sequence in which each nucleotide or amino acid is the one which occurs most frequently at that site in the different sequences which occur in nature. The phrase also refers to an actual sequence which approximates the theoretical consensus. A known CONSERVED SEQUENCE set is represented by a consensus sequence. Commonly observed supersecondary protein structures %28%AMINO ACID MOTIFS%29% are often formed by conserved sequences.%A%    
% 218.18/218.32  |- mesh__dateCreated mesh__D016384 1990-05-25
% 218.18/218.32  |- mesh__dateEstablished mesh__D016384 1991-01-01
% 218.18/218.32  |- mesh__publicMeSHNote mesh__D016384 91   
% 218.18/218.32  |- skos__related mesh__D016384smesh__D017124
% 218.18/218.32  |- skos__prefLabel mesh__D016384 Consensus Sequence
% 218.18/218.32  |- mesh__historyNote mesh__D002364 82; was CASEIN 1963-81   
% 218.18/218.32  |- skos__hiddenLabel mesh__D002364 Caseinate, Sodium
% 218.18/218.32  |- skos__hiddenLabel mesh__D002364 gamma Caseins
% 218.18/218.32  |- skos__broader mesh__D002364smesh__D010750
% 218.18/218.32  |- mesh__publicMeSHNote mesh__D002364 82; was CASEIN 1963-81   
% 218.18/218.32  |- mesh__recordAuthorizer mesh__D002364 sjn
% 218.18/218.32  |- skos__hiddenLabel mesh__D002364 kappa Casein
% 218.18/218.32  |- skos__hiddenLabel mesh__D002364 epsilon Casein
% 218.18/218.32  |- skos__altLabel mesh__D002364 kappa-Casein
% 218.18/218.32  |- mesh__dateCreated mesh__D002364 1999-01-01
% 218.18/218.32  |- rdf__type mesh__D002364sskos__Concept
% 218.18/218.32  |- skos__hiddenLabel mesh__D002364 AD beta Casein
% 218.18/218.32  |- skos__altLabel mesh__D002364 Casein
% 218.18/218.32  |- mesh__dateRevised mesh__D002364 2005-06-30
% 218.18/218.32  |- skos__scopeNote mesh__D002364
% 218.18/218.32       A mixture of related phosphoproteins occurring in milk and cheese. The group is characterized as one of the most nutritive milk proteins, containing all of the common amino acids and rich in the essential ones.%A%    
% 218.18/218.32  |- skos__hiddenLabel mesh__D002364 beta Caseins
% 218.18/218.32  |- skos__hiddenLabel mesh__D002364 beta-Casein, AD
% 218.18/218.32  |- skos__altLabel mesh__D002364 beta-Casein
% 218.18/218.32  |- skos__prefLabel mesh__D002364 Caseins
% 218.18/218.32  |- mesh__onlineNote mesh__D002364 use CASEINS to search CASEIN 1966-81   
% 218.18/218.32  |- skos__hiddenLabel mesh__D002364 alpha Caseins
% 218.18/218.32  |- skos__hiddenLabel mesh__D002364 beta Casein
% 218.18/218.32  |- mesh__recordOriginator mesh__D002364 NLM
% 218.18/218.32  |- skos__broader mesh__D002364smesh__D008894
% 218.18/218.32  |- skos__altLabel mesh__D002364 AD beta-Casein
% 218.18/218.32  |- skos__hiddenLabel mesh__D002364 K Casein
% 218.18/218.32  |- skos__hiddenLabel mesh__D002364 kappa Caseins
% 218.18/218.32  |- skos__hiddenLabel mesh__D002364 beta-Casein Acetylated, Dephosphorylated
% 218.18/218.32  |- mesh__recordMaintainer mesh__D002364 SYSTEM
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D002364 2006
% 218.18/218.32  |- mesh__recordAuthorizer mesh__D029501 sjn
% 218.18/218.32  |- mesh__recordOriginator mesh__D029501 ssb
% 218.18/218.32  |- skos__altLabel mesh__D029501 Witch Hazel
% 218.18/218.32  |- skos__scopeNote mesh__D029501
% 218.18/218.32       A plant genus of the family Hamamelidaceae, order Hamamelidales.  It is known for the astringent %28%ASTRINGENTS%29% extract of leaves and bark used in over the counter preparations. This should not be confused with the similar named Hamelia genus %28%RUBIACEAE%29%.%A%    
% 218.18/218.32  |- skos__prefLabel mesh__D029501 Hamamelis
% 218.18/218.32  |- mesh__recordMaintainer mesh__D029501 ssb
% 218.18/218.32  |- mesh__historyNote mesh__D029501 2002   
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D029501 2004
% 218.18/218.32  |- skos__annotation mesh__D029501
% 218.18/218.32       do not confuse with HAMELIA; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D029501 2006
% 218.18/218.32  |- rdf__type mesh__D029501sskos__Concept
% 218.18/218.32  |- skos__broader mesh__D029501smesh__D029201
% 218.18/218.32  |- mesh__publicMeSHNote mesh__D029501 2002   
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D029501 2003
% 218.18/218.32  |- mesh__dateRevised mesh__D029501 2002-07-03
% 218.18/218.32  |- mesh__dateCreated mesh__D029501 2001-07-25
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D029501 2005
% 218.18/218.32  |- mesh__dateEstablished mesh__D029501 2002-01-01
% 218.18/218.32  |- mesh__dateEstablished mesh__D012792 1987-01-01
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D012792 2004
% 218.18/218.32  |- mesh__publicMeSHNote mesh__D012792 87   
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D012792 2005
% 218.18/218.32  |- mesh__dateCreated mesh__D012792 1986-03-25
% 218.18/218.32  |- mesh__recordAuthorizer mesh__D012792 sjn
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D012792 2006
% 218.18/218.32  |- skos__prefLabel mesh__D012792 Shyness
% 218.18/218.32  |- mesh__historyNote mesh__D012792 87   
% 218.18/218.32  |- mesh__dateRevised mesh__D012792 2002-07-03
% 218.18/218.32  |- mesh__recordMaintainer mesh__D012792 JLS
% 218.18/218.32  |- mesh__recordOriginator mesh__D012792 EC
% 218.18/218.32  |- skos__scopeNote mesh__D012792
% 218.18/218.32       Discomfort and partial inhibition of the usual forms of behavior when in the presence of others.%A%    
% 218.18/218.32  |- skos__broader mesh__D012792smesh__D012919
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D012792 2003
% 218.18/218.32  |- rdf__type mesh__D012792sskos__Concept
% 218.18/218.32  |- skos__annotation mesh__D012792 no qualif   
% 218.18/218.32  |- skos__altLabel mesh__D006755 Services, Shared Hospital
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006755 1997
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006755 2001
% 218.18/218.32  |- skos__broader mesh__D006755smesh__D009096
% 218.18/218.32  |- mesh__dateRevised mesh__D006755 1995-05-22
% 218.18/218.32  |- mesh__recordOriginator mesh__D006755 NLM
% 218.18/218.32  |- skos__altLabel mesh__D006755 Hospital Services, Shared
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006755 1999
% 218.18/218.32  |- rdf__type mesh__D006755sskos__Concept
% 218.18/218.32  |- skos__hiddenLabel mesh__D006755 Shared Service, Hospital
% 218.18/218.32  |- skos__hiddenLabel mesh__D006755 Service, Hospital Shared
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006755 2004
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006755 1996
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006755 2000
% 218.18/218.32  |- skos__historyNote mesh__D006755
% 218.18/218.32       Hospital Administration %28%1966-1967%29%
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006755 2006
% 218.18/218.32  |- mesh__dateCreated mesh__D006755 1999-01-01
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006755 1998
% 218.18/218.32  |- mesh__recordMaintainer mesh__D006755 KEV
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006755 2003
% 218.18/218.32  |- skos__historyNote mesh__D006755 specific department
% 218.18/218.32  |- mesh__publicMeSHNote mesh__D006755 72   
% 218.18/218.32  |- skos__scopeNote mesh__D006755
% 218.18/218.32       Cooperation among hospitals for the purpose of sharing various departmental services, e.g., pharmacy, laundry, data processing, etc.%A%    
% 218.18/218.32  |- mesh__historyNote mesh__D006755 72%28%68%29%   
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006755 2005
% 218.18/218.32  |- skos__annotation mesh__D006755 sharing between or among hosp   
% 218.18/218.32  |- skos__altLabel mesh__D006755 Shared Services, Hospital
% 218.18/218.32  |- skos__hiddenLabel mesh__D006755 Hospital Shared Service
% 218.18/218.32  |- skos__broader mesh__D006755smesh__D006739
% 218.18/218.32  |- skos__altLabel mesh__D006755 Services, Hospital Shared
% 218.18/218.32  |- skos__hiddenLabel mesh__D006755 Shared Hospital Service
% 218.18/218.32  |- skos__hiddenLabel mesh__D006755 Service, Shared Hospital
% 218.18/218.32  |- mesh__dateEstablished mesh__D006755 1972-01-01
% 218.18/218.32  |- skos__altLabel mesh__D006755 Shared Hospital Services
% 218.18/218.32  |- mesh__recordAuthorizer mesh__D006755 PLS
% 218.18/218.32  |- skos__hiddenLabel mesh__D006755 Hospital Service, Shared
% 218.18/218.32  |- skos__prefLabel mesh__D006755 Hospital Shared Services
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D006755 2002
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Neuralgia-Neuritides, Sciatic Nerve
% 218.18/218.32  |- skos__altLabel mesh__D020426 Sciatic Nerve Diseases
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Sciatic Nerve Palsies
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D020426 2004
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Neuritis, Sciatic
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Sciatic Nerve Lesion
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Nerve Lesions, Sciatic
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Palsy, Sciatic Nerve
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Sciatic Nerve Lesions
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Sciatic Nerve Neuralgia-Neuritis
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Neuralgia Neuritis, Sciatic Nerve
% 218.18/218.32  |- rdf__type mesh__D020426sskos__Concept
% 218.18/218.32  |- skos__broader mesh__D020426smesh__D020422
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Sciatic Nerve Neuralgia-Neuritides
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Neuropathies, Sciatic
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Nerve Lesion, Sciatic
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Sciatic Neuropathies
% 218.18/218.32  |- skos__scopeNote mesh__D020426
% 218.18/218.32       Disease or damage involving the SCIATIC NERVE, which divides into the PERONEAL NERVE and TIBIAL NERVE %28%see also PERONEAL NEUROPATHIES and TIBIAL NEUROPATHY%29%. Clinical manifestations may include SCIATICA or pain localized to the hip, PARESIS or PARALYSIS of posterior thigh muscles and muscles innervated by the peroneal and tibial nerves, and sensory loss involving the lateral and posterior thigh, posterior and lateral leg, and sole of the foot. The sciatic nerve may be affected by trauma; ISCHEMIA; COLLAGEN DISEASES; and other conditions. %28%From Adams et al., Principles of Neurology, 6th ed, p1363%29%%A%    
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Nerve Palsies, Sciatic
% 218.18/218.32  |- skos__historyNote mesh__D020426 Sciatic Nerve %28%1966-1999%29%
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D020426 2000
% 218.18/218.32  |- mesh__dateEstablished mesh__D020426 2000-01-01
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Nerve Palsy, Sciatic
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D020426 2005
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Nerve Disease, Sciatic
% 218.18/218.32  |- skos__historyNote mesh__D020426
% 218.18/218.32       Peripheral Nervous System Diseases %28%1966-1999%29%
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Sciatic Nerve Disease
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Palsies, Sciatic Nerve
% 218.18/218.32  |- skos__prefLabel mesh__D020426 Sciatic Neuropathy
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Sciatic Neuritides
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Neuritides, Sciatic
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D020426 2001
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D020426 2006
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Neuropathy, Sciatic
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D020426 2003
% 218.18/218.32  |- mesh__dateCreated mesh__D020426 1999-11-03
% 218.18/218.32  |- mesh__historyNote mesh__D020426 2000   
% 218.18/218.32  |- skos__hiddenLabel mesh__D020426 Nerve Diseases, Sciatic
% 218.18/218.32  |- mesh__publicMeSHNote mesh__D020426 2000   
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D020426 2002
% 218.18/218.32  |- skos__broader mesh__D014730Q000193smesh__D014730
% 218.18/218.32  |- mesh__preferredCombination mesh__D014730Q000193smesh__D004520
% 218.18/218.32  |- rdf__type mesh__D014730Q000193smesh__CompoundConcept
% 218.18/218.32  |- skos__broader mesh__D016385smesh__D011401
% 218.18/218.32  |- skos__hiddenLabel mesh__D016385 Box, TATA
% 218.18/218.32  |- mesh__activeMeSHYear mesh__D016385 2006
% 218.18/218.32  |- mesh__publicMeSHNote mesh__D016385 91   
% 218.18/218.32  |- skos__scopeNote mesh__D016385
% 218.18/218.32       A conserved A-T rich sequence which is contained in promoters for RNA polymerase II. The segment is seven base pairs long and the nucleotides most commonly found are TATAAAA.%A%    
% 218.18/218.32  |- mesh__historyNote mesh__D016385 91   
% 218.18/218.32  |- skos__hiddenLabel mesh__D016385 Box, Hogness
% 218.18/218.32  |- skos__historyNote mesh__D016385
% 218.18/218.32       Molecular Sequence Data %28%1988-1990%29%
% 218.18/218.32  |- mesh__dateRevised mesh__D016385 2005-06-30
% 218.18/218.32  |- mesh__dateCreated mesh__D016385 1990-05-29
% 218.18/218.32  |- rdf__type mesh__D016385sskos__Concept
% 218.18/218.32  |- mesh__recordAuthorizer mesh__D016385 sjn
% 218.18/218.32  |- mesh__recordMaintainer mesh__D016385 nns
% 218.18/218.32  |- skos__prefLabel mesh__D016385 TATA Box
% 218.18/218.32  |- mesh__dateEstablished mesh__D016385 1991-01-01
% 218.18/218.32  |- skos__historyNote mesh__D016385 Base Sequence %28%1981-1990%29%
% 218.18/218.32  |- skos__altLabel mesh__D016385 Hogness Box
% 218.18/218.32  |- mesh__recordOriginator mesh__D016385 PXP
% 218.18/218.33  |- skos__broader mesh__D002365smesh__D019665
% 218.18/218.33  |- mesh__dateCreated mesh__D002365 1999-01-01
% 218.18/218.33  |- mesh__dateEstablished mesh__D002365 1991-01-01
% 218.18/218.33  |- mesh__recordMaintainer mesh__D002365 ssb
% 218.18/218.33  |- skos__annotation mesh__D002365
% 218.18/218.33       ARROWROOT see MARANTACEAE is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.18/218.33  |- skos__altLabel mesh__D002365 Cassava
% 218.18/218.33  |- mesh__recordOriginator mesh__D002365 NLM
% 218.18/218.33  |- skos__altLabel mesh__D002365 Arrowroot, Brazilian
% 218.18/218.33  |- mesh__dateRevised mesh__D002365 2002-07-02
% 218.18/218.33  |- skos__altLabel mesh__D002365 Kasaba
% 218.18/218.33  |- rdf__type mesh__D002365sskos__Concept
% 218.18/218.33  |- skos__prefLabel mesh__D002365 Manihot
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D002365 2003
% 218.18/218.33  |- mesh__recordAuthorizer mesh__D002365 sjn
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D002365 2005
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D002365 2004
% 218.18/218.33  |- mesh__historyNote mesh__D002365 2003%28%1963%29%   
% 218.18/218.33  |- skos__altLabel mesh__D002365 Manioc
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D002365 2006
% 218.18/218.33  |- skos__altLabel mesh__D002365 Brazilian Arrowroot
% 218.18/218.33  |- mesh__publicMeSHNote mesh__D002365
% 218.18/218.33       2003; see CASSAVA 1991-2002, see PLANTS, EDIBLE 1986-1990, see CASSAVA 1963-1985%A%  
% 218.18/218.33  |- skos__scopeNote mesh__D002365
% 218.18/218.33       A plant genus of the family EUPHORBIACEAE that is perennial with conspicuous, almost palmate leaves like those of RICINUS but more deeply parted into five to nine lobes.  It is a source of a starch after removal of the cyanogenic glucosides. The common name of Arrowroot is also used with Maranta %28%MARANTACEAE%29%. The common name of yuca is also used for YUCCA.%A%    
% 218.18/218.33  |- skos__historyNote mesh__D029502 Anemia, Aplastic %28%1970-1991%29%
% 218.18/218.33  |- mesh__publicMeSHNote mesh__D029502 2002;see FANCONI ANEMIA 1992-2001   
% 218.18/218.33  |- skos__historyNote mesh__D029502 Fanconi Anemia %28%1992-2001%29%
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D029502 2002
% 218.18/218.33  |- skos__altLabel mesh__D029502 Congenital Hypoplastic Anemia
% 218.18/218.33  |- skos__scopeNote mesh__D029502
% 218.18/218.33       An inborn condition characterized by deficiencies of red cell precursors that sometimes also includes LEUKOPENIA and THROMBOCYTOPENIA.%A%    
% 218.18/218.33  |- skos__altLabel mesh__D029502 Hypoplastic Anemia, Congenital
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D029502 2004
% 218.18/218.33  |- skos__broader mesh__D029502smesh__D030342
% 218.18/218.33  |- skos__prefLabel mesh__D029502 Anemia, Hypoplastic, Congenital
% 218.18/218.33  |- skos__hiddenLabel mesh__D029502 Anemia, Congenital Hypoplastic
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D029502 2006
% 218.18/218.33  |- rdf__type mesh__D029502sskos__Concept
% 218.18/218.33  |- skos__hiddenLabel mesh__D029502 Hypoplastic Anemias, Congenital
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D029502 2003
% 218.18/218.33  |- mesh__dateEstablished mesh__D029502 2002-01-01
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D029502 2005
% 218.18/218.33  |- skos__broader mesh__D029502smesh__D000741
% 218.18/218.33  |- skos__hiddenLabel mesh__D029502 Anemias, Congenital Hypoplastic
% 218.18/218.33  |- mesh__historyNote mesh__D029502 2002; use FANCONI ANEMIA 1992-2001   
% 218.18/218.33  |- skos__hiddenLabel mesh__D029502 Congenital Hypoplastic Anemias
% 218.18/218.33  |- mesh__dateCreated mesh__D029502 2001-07-25
% 218.18/218.33  |- mesh__recordOriginator mesh__D007050 SH
% 218.18/218.33  |- skos__broader mesh__D007050smesh__D046948
% 218.18/218.33  |- skos__historyNote mesh__D007050 Benzazepines %28%1969-1974%29%
% 218.18/218.33  |- skos__prefLabel mesh__D007050 Ibogaine
% 218.18/218.33  |- skos__hiddenLabel mesh__D007050 NIH 10567
% 218.18/218.33  |- mesh__publicMeSHNote mesh__D007050
% 218.18/218.33       91; was see under ALKALOIDS 1976-90   
% 218.18/218.33  |- mesh__dateEstablished mesh__D007050 1991-01-01
% 218.18/218.33  |- skos__scopeNote mesh__D007050
% 218.18/218.33       One of several indole alkaloids extracted from Tabernanthe iboga, Baill. It has a complex pharmacological profile, and interacts with multiple systems of neurotransmission. Ibogaine has psychoactive properties and appears to modulate tolerance to opiates.%A%    
% 218.18/218.33  |- rdf__type mesh__D007050sskos__Concept
% 218.18/218.33  |- skos__historyNote mesh__D007050 Azepines %28%1975%29%
% 218.18/218.33  |- skos__hiddenLabel mesh__D007050 NIH10567
% 218.18/218.33  |- mesh__recordAuthorizer mesh__D007050 sjn
% 218.18/218.33  |- mesh__recordMaintainer mesh__D007050 ssb
% 218.18/218.33  |- skos__historyNote mesh__D007050 Alkaloids %28%1969-1975%29%
% 218.18/218.33  |- skos__altLabel mesh__D007050 12-Methoxyibogamine
% 218.18/218.33  |- skos__historyNote mesh__D007050 Indoles %28%1972-1975%29%
% 218.18/218.33  |- mesh__dateCreated mesh__D007050 1975-07-23
% 218.18/218.33  |- mesh__dateRevised mesh__D007050 2004-07-07
% 218.18/218.33  |- mesh__historyNote mesh__D007050
% 218.18/218.33       91%28%76%29%; was see under ALKALOIDS 1976-90   
% 218.18/218.33  |- skos__hiddenLabel mesh__D007050 12 Methoxyibogamine
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D007050 2005
% 218.18/218.33  |- skos__broader mesh__D007050smesh__D007211
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D007050 2006
% 218.18/218.33  |- mesh__dateRevised mesh__D012793 2005-06-30
% 218.18/218.33  |- mesh__publicMeSHNote mesh__D012793
% 218.18/218.33       91; was see under SALIVARY GLAND DISEASES 1975-90   
% 218.18/218.33  |- skos__scopeNote mesh__D012793
% 218.18/218.33       INFLAMMATION of salivary tissue %28%SALIVARY GLANDS%29%, usually due to INFECTION or injuries.%A%    
% 218.18/218.33  |- skos__altLabel mesh__D012793 Sialitis
% 218.18/218.33  |- mesh__recordOriginator mesh__D012793 NLM
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D012793 2006
% 218.18/218.33  |- skos__prefLabel mesh__D012793 Sialadenitis
% 218.18/218.33  |- skos__annotation mesh__D012793
% 218.18/218.33       tuberculous sialitis: coordinate IM with TUBERCULOSIS, ORAL %28%IM%29%%A%  
% 218.18/218.33  |- mesh__dateCreated mesh__D012793 1999-01-01
% 218.18/218.33  |- mesh__recordAuthorizer mesh__D012793 sjn
% 218.18/218.33  |- skos__hiddenLabel mesh__D012793 Sialadenitides
% 218.18/218.33  |- mesh__dateEstablished mesh__D012793 1991-01-01
% 218.18/218.33  |- skos__broader mesh__D012793smesh__D012466
% 218.18/218.33  |- skos__hiddenLabel mesh__D012793 Sialitides
% 218.18/218.33  |- rdf__type mesh__D012793sskos__Concept
% 218.18/218.33  |- mesh__historyNote mesh__D012793
% 218.18/218.33       91%28%75%29%; was see under SALIVARY GLAND DISEASES 1975-90   
% 218.18/218.33  |- mesh__onlineNote mesh__D012793 search SALIVARY GLAND DISEASES 1966-74   
% 218.18/218.33  |- mesh__recordMaintainer mesh__D012793 lkt
% 218.18/218.33  |- rdf__type mesh__D006756sskos__Concept
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006756 1999
% 218.18/218.33  |- mesh__recordAuthorizer mesh__D006756 PLS
% 218.18/218.33  |- mesh__dateCreated mesh__D006756 1977-05-11
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006756 2004
% 218.18/218.33  |- skos__annotation mesh__D006756
% 218.18/218.33       for purchases by visitors, patients or staff   
% 218.18/218.33  |- skos__altLabel mesh__D006756 Shops, Hospital Gift
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006756 2002
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006756 1996
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006756 1995
% 218.18/218.33  |- skos__altLabel mesh__D006756 Shops, Hospital
% 218.18/218.33  |- skos__altLabel mesh__D006756 Shop, Hospital Gift
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006756 2006
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006756 1998
% 218.18/218.33  |- mesh__historyNote mesh__D006756
% 218.18/218.33       91%28%Aug 77%29%; was see under HOSPITAL ADMINISTRATION 1977-90%A%  
% 218.18/218.33  |- skos__altLabel mesh__D006756 Gift Shops, Hospital
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006756 2003
% 218.18/218.33  |- skos__prefLabel mesh__D006756 Hospital Shops
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006756 2001
% 218.18/218.33  |- mesh__dateEstablished mesh__D006756 1991-01-01
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006756 2005
% 218.18/218.33  |- skos__altLabel mesh__D006756 Shop, Hospital
% 218.18/218.33  |- skos__scopeNote mesh__D006756
% 218.18/218.33       Stores located in hospitals selling merchandise or services for the convenience of patients, staff, and visitors.%A%    
% 218.18/218.33  |- mesh__recordMaintainer mesh__D006756 JLS
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006756 2000
% 218.18/218.33  |- mesh__recordOriginator mesh__D006756 EC
% 218.18/218.33  |- skos__altLabel mesh__D006756 Gift Shop, Hospital
% 218.18/218.33  |- skos__altLabel mesh__D006756 Hospital Shop
% 218.18/218.33  |- skos__broader mesh__D006756smesh__D006739
% 218.18/218.33  |- skos__altLabel mesh__D006756 Hospital Gift Shop
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006756 1997
% 218.18/218.33  |- mesh__publicMeSHNote mesh__D006756
% 218.18/218.33       91; was see under HOSPITAL ADMINISTRATION Aug 1977-90   
% 218.18/218.33  |- mesh__dateRevised mesh__D006756 1994-05-27
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D020427 2003
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Neuropathy, Peroneal
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Neuropathies, Fibular
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Common Peroneal Neuropathies
% 218.18/218.33  |- skos__scopeNote mesh__D020427
% 218.18/218.33       Disease involving the common PERONEAL NERVE or its branches, the deep and superficial peroneal nerves. Lesions of the deep peroneal nerve are associated with PARALYSIS of dorsiflexion of the ankle and toes and loss of sensation from the web space between the first and second toe. Lesions of the superficial peroneal nerve result in weakness or paralysis of the peroneal muscles %28%which evert the foot%29% and loss of sensation over the dorsal and lateral surface of the leg. Traumatic injury to the common peroneal nerve near the head of the FIBULA is a relatively common cause of this condition. %28%From Joynt, Clinical Neurology, 1995, Ch51, p31%29%%A%    
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Neuropathies, Superficial Peroneal
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Peroneal Neuropathy
% 218.18/218.33  |- skos__broader mesh__D020427smesh__D020422
% 218.18/218.33  |- mesh__historyNote mesh__D020427 2000   
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Peroneal Neuropathy, Deep
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Nerve Diseases, Peroneal
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Superficial Peroneal Neuropathy
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Neuropathies, Common Peroneal
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Popliteal Neuropathies, External
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Neuropathy, Fibular
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Neuropathies, External Popliteal
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D020427 2004
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Fibular Neuropathies
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Peroneal Nerve Disease
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Peroneal Neuropathies, Superficial
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Popliteal Neuropathies, Lateral
% 218.18/218.33  |- skos__historyNote mesh__D020427 Sciatic Nerve %28%1966-1999%29%
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Peroneal Neuropathy, Superficial
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Nerve Paralysis, Peroneal
% 218.18/218.33  |- rdf__type mesh__D020427sskos__Concept
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Neuropathies, Peroneal
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D020427 2000
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Nerve Disease, Peroneal
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Neuropathies, Deep Peroneal
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Deep Peroneal Neuropathy
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Paralysis, Peroneal Nerve
% 218.18/218.33  |- mesh__dateEstablished mesh__D020427 2000-01-01
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Fibular Nerve Disease
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Nerve Paralyses, Peroneal
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Nerve Diseases, Fibular
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Peroneal Nerve Paralyses
% 218.18/218.33  |- skos__historyNote mesh__D020427
% 218.18/218.33       Peripheral Nervous System Diseases %28%1966-1999%29%
% 218.18/218.33  |- skos__altLabel mesh__D020427 Lateral Popliteal Neuropathy
% 218.18/218.33  |- skos__altLabel mesh__D020427 Peroneal Nerve Diseases
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D020427 2001
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Peroneal Neuropathies, Deep
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Lateral Popliteal Neuropathies
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Popliteal Neuropathy, External
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Superficial Peroneal Neuropathies
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Nerve Disease, Fibular
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D020427 2005
% 218.18/218.33  |- skos__altLabel mesh__D020427 Fibular Nerve Diseases
% 218.18/218.33  |- mesh__publicMeSHNote mesh__D020427 2000   
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Common Peroneal Neuropathy
% 218.18/218.33  |- skos__prefLabel mesh__D020427 Peroneal Neuropathies
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D020427 2002
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Neuropathy, Lateral Popliteal
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Popliteal Neuropathy, Lateral
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Paralyses, Peroneal Nerve
% 218.18/218.33  |- skos__altLabel mesh__D020427 External Popliteal Neuropathy
% 218.18/218.33  |- skos__historyNote mesh__D020427 Paralysis/etiology %28%1966-1999%29%
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Peroneal Neuropathies, Common
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Neuropathies, Lateral Popliteal
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 External Popliteal Neuropathies
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Peroneal Neuropathy, Common
% 218.18/218.33  |- mesh__dateCreated mesh__D020427 1999-11-03
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D020427 2006
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Deep Peroneal Neuropathies
% 218.18/218.33  |- skos__hiddenLabel mesh__D020427 Neuropathy, External Popliteal
% 218.18/218.33  |- skos__related mesh__D020427smesh__D007869
% 218.18/218.33  |- rdf__type mesh__D016386sskos__Concept
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D016386 2004
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D016386 1995
% 218.18/218.33  |- skos__annotation mesh__D016386
% 218.18/218.33       technique for exploring an unknown region of a CHROMOSOME%A%  
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D016386 1998
% 218.18/218.33  |- skos__hiddenLabel mesh__D016386 Walkings, Chromosome
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D016386 2002
% 218.18/218.33  |- mesh__dateCreated mesh__D016386 1990-05-25
% 218.18/218.33  |- skos__hiddenLabel mesh__D016386 Chromosome Walkings
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D016386 2005
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D016386 1999
% 218.18/218.33  |- mesh__publicMeSHNote mesh__D016386 91   
% 218.18/218.33  |- mesh__dateRevised mesh__D016386 1992-05-07
% 218.18/218.33  |- mesh__recordAuthorizer mesh__D016386 PLS
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D016386 1993
% 218.18/218.33  |- mesh__dateEstablished mesh__D016386 1991-01-01
% 218.18/218.33  |- skos__hiddenLabel mesh__D016386 Walking, Chromosome
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D016386 1996
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D016386 2006
% 218.18/218.33  |- skos__prefLabel mesh__D016386 Chromosome Walking
% 218.18/218.33  |- skos__broader mesh__D016386smesh__D002874
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D016386 2000
% 218.18/218.33  |- mesh__historyNote mesh__D016386 91   
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D016386 2003
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D016386 1997
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D016386 1994
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D016386 2001
% 218.18/218.33  |- mesh__recordOriginator mesh__D016386 PXP
% 218.18/218.33  |- mesh__recordMaintainer mesh__D016386 TAP
% 218.18/218.33  |- skos__historyNote mesh__D016386 Chromosome Mapping %28%1983-1990%29%
% 218.18/218.33  |- skos__scopeNote mesh__D016386
% 218.18/218.33       A technique with which an unknown region of a chromosome can be explored. It is generally used to isolate a locus of interest for which no probe is available but that is known to be linked to a gene which has been identified and cloned. A fragment containing a known gene is selected and used as a probe to identify other overlapping fragments which contain the same gene. The nucleotide sequences of these fragments can then be characterized. This process continues for the length of the chromosome.%A%    
% 218.18/218.33  |- skos__historyNote mesh__D016386 Cloning, Molecular %28%1983-1990%29%
% 218.18/218.33  |- mesh__recordMaintainer mesh__D002366 sjn
% 218.18/218.33  |- skos__related mesh__D002366smesh__D012676
% 218.18/218.33  |- skos__broader mesh__D002366smesh__D007887
% 218.18/218.33  |- rdf__type mesh__D002366sskos__Concept
% 218.18/218.33  |- mesh__historyNote mesh__D002366
% 218.18/218.33       91%28%78%29%; was see under PLANTS, MEDICINAL 1978-90   
% 218.18/218.33  |- mesh__publicMeSHNote mesh__D002366
% 218.18/218.33       91; was see under PLANTS, MEDICINAL 1978-90   
% 218.18/218.33  |- mesh__dateRevised mesh__D002366 2002-07-03
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D002366 2003
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D002366 2005
% 218.18/218.33  |- skos__prefLabel mesh__D002366 Cassia
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D002366 2004
% 218.18/218.33  |- skos__scopeNote mesh__D002366
% 218.18/218.33       A plant genus of the family FABACEAE.  Many species of this genus, including the medicinal C. senna and C. angustifolia, have been reclassified into the Senna genus %28%SENNA PLANT%29% and some to CHAMAECRISTA.%A%    
% 218.18/218.33  |- skos__annotation mesh__D002366
% 218.18/218.33       CASSIA SENNA;  CASSIA ANGUSTIFOLIA and CASSIA OCCIDENTALIS see SENNA PLANT are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D002366 2006
% 218.18/218.33  |- mesh__recordOriginator mesh__D002366 SH
% 218.18/218.33  |- skos__historyNote mesh__D002366 Senna %28%1966-1977%29%
% 218.18/218.33  |- mesh__dateCreated mesh__D002366 1977-03-01
% 218.18/218.33  |- mesh__recordAuthorizer mesh__D002366 sjn
% 218.18/218.33  |- mesh__dateEstablished mesh__D002366 1991-01-01
% 218.18/218.33  |- skos__altLabel mesh__D002366 Indian Laburnum
% 218.18/218.33  |- rdf__type mesh__D029503sskos__Concept
% 218.18/218.33  |- skos__prefLabel mesh__D029503 Anemia, Diamond-Blackfan
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D029503 2003
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D029503 2005
% 218.18/218.33  |- skos__scopeNote mesh__D029503
% 218.18/218.33       A rare congenital hypoplastic anemia that usually presents early in infancy. The disease is characterized by a moderate to severe macrocytic anemia, occasional neutropenia or thrombocytosis, a normocellular bone marrow with erythroid hypoplasia, and an increased risk of developing leukemia. %28%Curr Opin Hematol 2000 Mar;7%28%2%29%:85-94%29%%A%    
% 218.18/218.33  |- skos__historyNote mesh__D029503 Anemia, Aplastic %28%1974-1991%29%
% 218.18/218.33  |- mesh__dateCreated mesh__D029503 2001-07-25
% 218.18/218.33  |- mesh__dateEstablished mesh__D029503 2002-01-01
% 218.18/218.33  |- mesh__historyNote mesh__D029503 2002; use FANCONI ANEMIA 1992-2001   
% 218.18/218.33  |- skos__broader mesh__D029503smesh__D029502
% 218.18/218.33  |- skos__hiddenLabel mesh__D029503 Anemia, Diamond Blackfan
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D029503 2002
% 218.18/218.33  |- skos__broader mesh__D029503smesh__D012010
% 218.18/218.33  |- skos__altLabel mesh__D029503 Diamond-Blackfan Anemia
% 218.18/218.33  |- skos__historyNote mesh__D029503 Fanconi Anemia %28%1992-2001%29%
% 218.18/218.33  |- mesh__publicMeSHNote mesh__D029503 2002; see FANCONI ANEMIA 1992-2001   
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D029503 2004
% 218.18/218.33  |- skos__hiddenLabel mesh__D029503 Diamond Blackfan Anemia
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D029503 2006
% 218.18/218.33  |- rdf__type mesh__D007051sskos__Concept
% 218.18/218.33  |- mesh__publicMeSHNote mesh__D007051 91; was see under OXAZOLES 1976-90   
% 218.18/218.33  |- skos__historyNote mesh__D007051 Mushrooms %28%1973-1975%29%
% 218.18/218.33  |- skos__historyNote mesh__D007051 Oxazoles %28%1973-1975%29%
% 218.18/218.33  |- skos__prefLabel mesh__D007051 Ibotenic Acid
% 218.18/218.33  |- mesh__dateCreated mesh__D007051 1975-07-18
% 218.18/218.33  |- skos__scopeNote mesh__D007051
% 218.18/218.33       A neurotoxic isoxazole %28%similar to KAINIC ACID and MUSCIMOL%29% found in AMANITA mushrooms. It causes motor depression, ataxia, and changes in mood, perceptions and feelings, and is a potent excitatory amino acid agonist.%A%    
% 218.18/218.33  |- skos__broader mesh__D007051smesh__D009183
% 218.18/218.33  |- mesh__dateRevised mesh__D007051 2005-06-30
% 218.18/218.33  |- skos__broader mesh__D007051smesh__D007555
% 218.18/218.33  |- mesh__recordAuthorizer mesh__D007051 sjn
% 218.18/218.33  |- skos__hiddenLabel mesh__D007051 Acid, Ibotenic
% 218.18/218.33  |- mesh__recordMaintainer mesh__D007051 ssb
% 218.18/218.33  |- skos__historyNote mesh__D007051 Ammonium Compounds %28%1973-1975%29%
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D007051 2006
% 218.18/218.33  |- mesh__recordOriginator mesh__D007051 SH
% 218.18/218.33  |- mesh__historyNote mesh__D007051
% 218.18/218.33       91%28%76%29%; was see under OXAZOLES 1976-90   
% 218.18/218.33  |- mesh__dateEstablished mesh__D007051 1991-01-01
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D048468 2006
% 218.18/218.33  |- mesh__recordAuthorizer mesh__D048468 sjn
% 218.18/218.33  |- mesh__historyNote mesh__D048468 2005   
% 218.18/218.33  |- mesh__dateEstablished mesh__D048468 2005-01-01
% 218.18/218.33  |- rdf__type mesh__D048468sskos__Concept
% 218.18/218.33  |- skos__prefLabel mesh__D048468 Podospora
% 218.18/218.33  |- mesh__recordMaintainer mesh__D048468 SYSTEM
% 218.18/218.33  |- skos__historyNote mesh__D048468 Ascomycota %28%1967-2004%29%
% 218.18/218.33  |- mesh__publicMeSHNote mesh__D048468 2005   
% 218.18/218.33  |- skos__scopeNote mesh__D048468
% 218.18/218.33       A genus of ascomycete FUNGI in the order SORDARIALES, which is found on SOIL and herbivore dung %28%FECES%29%.%A%    
% 218.18/218.33  |- mesh__recordOriginator mesh__D048468 ags
% 218.18/218.33  |- mesh__dateCreated mesh__D048468 2004-07-07
% 218.18/218.33  |- skos__broader mesh__D048468smesh__D020037
% 218.18/218.33  |- mesh__dateRevised mesh__D048468 2005-06-30
% 218.18/218.33  |- skos__historyNote mesh__D048468 Sordariales %28%1999-2004%29%
% 218.18/218.33  |- mesh__dateEstablished mesh__D012794 1975-01-01
% 218.18/218.33  |- mesh__recordMaintainer mesh__D012794 ssb
% 218.18/218.33  |- mesh__publicMeSHNote mesh__D012794
% 218.18/218.33       75; was see under NEURAMINIC ACIDS 1963-74   
% 218.18/218.33  |- skos__broader mesh__D012794smesh__D009438
% 218.18/218.33  |- skos__hiddenLabel mesh__D012794 Acids, N-Acetylneuraminic
% 218.18/218.33  |- rdf__type mesh__D012794sskos__Concept
% 218.18/218.33  |- mesh__dateRevised mesh__D012794 2004-07-07
% 218.18/218.33  |- mesh__onlineNote mesh__D012794 search NEURAMINIC ACIDS 1966-74   
% 218.18/218.33  |- skos__scopeNote mesh__D012794
% 218.18/218.33       A group of naturally occurring N-and O-acyl derivatives of the deoxyamino sugar neuraminic acid. They are ubiquitously distributed in many tissues.%A%    
% 218.18/218.33  |- skos__hiddenLabel mesh__D012794 Acids, Sialic
% 218.18/218.33  |- skos__hiddenLabel mesh__D012794 N Acetylneuraminic Acids
% 218.18/218.33  |- skos__altLabel mesh__D012794 N-Acetylneuraminic Acids
% 218.18/218.33  |- mesh__recordOriginator mesh__D012794 NLM
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D012794 2005
% 218.18/218.33  |- skos__prefLabel mesh__D012794 Sialic Acids
% 218.18/218.33  |- mesh__recordAuthorizer mesh__D012794 sjn
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D012794 2006
% 218.18/218.33  |- skos__historyNote mesh__D012794 Neuraminic Acids %28%1966-1974%29%
% 218.18/218.33  |- mesh__historyNote mesh__D012794
% 218.18/218.33       75; was see under NEURAMINIC ACIDS 1963-74   
% 218.18/218.33  |- mesh__dateCreated mesh__D012794 1999-01-01
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Regions, Scaffold-Attached
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Region, Matrix Attachment
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Element, MAR
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Scaffold-Attached Region
% 218.18/218.33  |- skos__altLabel mesh__D045170 Scaffold-Attached Regions
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Elements, SAR/MAR
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Element, SAR/MAR
% 218.18/218.33  |- mesh__publicMeSHNote mesh__D045170 2004   
% 218.18/218.33  |- skos__broader mesh__D045170smesh__D001483
% 218.18/218.33  |- skos__altLabel mesh__D045170 MARs/SARs
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Scaffold Attachment Region
% 218.18/218.33  |- skos__altLabel mesh__D045170 MAR/SAR Elements
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 MAR Element
% 218.18/218.33  |- mesh__historyNote mesh__D045170 2004   
% 218.18/218.33  |- skos__prefLabel mesh__D045170 Matrix Attachment Regions
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 MAR/SAR
% 218.18/218.33  |- skos__historyNote mesh__D045170
% 218.18/218.33       Nuclear Matrix/metabolism %28%1990-2003%29%
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 MAR/SAR Element
% 218.18/218.33  |- mesh__dateEstablished mesh__D045170 2004-01-01
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D045170 2004
% 218.18/218.33  |- skos__scopeNote mesh__D045170
% 218.18/218.33       Regions of the CHROMATIN or DNA that bind to the NUCLEAR MATRIX. They are found in INTERGENIC DNA, especially flanking the 5%27% ends of genes or clusters of genes. Many of the regions that have been isolated contain a bipartite sequence motif called the MAR/SAR recognition signature sequence that binds to MATRIX ATTACHMENT REGION BINDING PROTEINS.%A%    
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Region, Matrix-Attached
% 218.18/218.33  |- skos__altLabel mesh__D045170 MRS Sequence
% 218.18/218.33  |- skos__altLabel mesh__D045170 SAR Elements
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Region, Scaffold Attachment
% 218.18/218.33  |- skos__altLabel mesh__D045170 MAR/SARs
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Sequences, MRS
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 MRS Sequences
% 218.18/218.33  |- skos__altLabel mesh__D045170 MAR Elements
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 SAR/MAR Element
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Regions, Matrix-Attached
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Element, SAR
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Region, Scaffold-Attached
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Regions, Matrix Attachment
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Matrix Attachment Region
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D045170 2006
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 SAR Element
% 218.18/218.33  |- mesh__dateCreated mesh__D045170 2003-07-09
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Elements, MAR/SAR
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Elements, SAR
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Matrix-Attached Region
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Element, MAR/SAR
% 218.18/218.33  |- rdf__type mesh__D045170sskos__Concept
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Scaffold Attached Regions
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D045170 2005
% 218.18/218.33  |- skos__altLabel mesh__D045170 Matrix-Attached Regions
% 218.18/218.33  |- skos__altLabel mesh__D045170 SAR/MAR Elements
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Regions, Scaffold Attachment
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Elements, MAR
% 218.18/218.33  |- skos__altLabel mesh__D045170 Scaffold Attachment Regions
% 218.18/218.33  |- skos__hiddenLabel mesh__D045170 Matrix Attached Regions
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006757 1994
% 218.18/218.33  |- rdf__type mesh__D006757sskos__Concept
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006757 1999
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006757 2005
% 218.18/218.33  |- mesh__onlineNote mesh__D006757
% 218.18/218.33       use HOSPITAL UNITS to search WARDS, HOSPITAL 1974-78   
% 218.18/218.33  |- skos__annotation mesh__D006757
% 218.18/218.33       special care wards go here or specific unit; consider also PATIENTS%27% ROOMS %26% see X refs there%A%  
% 218.18/218.33  |- mesh__recordAuthorizer mesh__D006757 PLS
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006757 2004
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006757 1993
% 218.18/218.33  |- mesh__recordMaintainer mesh__D006757 TGC
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006757 1995
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006757 2002
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006757 2006
% 218.18/218.33  |- skos__hiddenLabel mesh__D006757 Unit, Hospital
% 218.18/218.33  |- skos__broader mesh__D006757smesh__D006268
% 218.18/218.33  |- mesh__dateRevised mesh__D006757 1992-05-15
% 218.18/218.33  |- skos__prefLabel mesh__D006757 Hospital Units
% 218.18/218.33  |- mesh__publicMeSHNote mesh__D006757 74   
% 218.18/218.33  |- mesh__historyNote mesh__D006757
% 218.18/218.33       74; WARDS, HOSPITAL was see under HOSPITAL UNITS 1974-78   
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006757 2000
% 218.18/218.33  |- skos__scopeNote mesh__D006757
% 218.18/218.33       Those areas of the hospital organization not considered departments which provide specialized patient care. They include various hospital special care wards.%A%    
% 218.18/218.33  |- skos__hiddenLabel mesh__D006757 Units, Hospital
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006757 2001
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006757 1996
% 218.18/218.33  |- mesh__recordOriginator mesh__D006757 NLM
% 218.18/218.33  |- mesh__dateCreated mesh__D006757 1999-01-01
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006757 1998
% 218.18/218.33  |- skos__hiddenLabel mesh__D006757 Hospital Unit
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006757 1997
% 218.18/218.33  |- mesh__dateEstablished mesh__D006757 1974-01-01
% 218.18/218.33  |- mesh__activeMeSHYear mesh__D006757 2003
% 218.18/218.33  |- mesh__historyNote mesh__D020428 2000   
% 218.18/218.33  |- skos__hiddenLabel mesh__D020428 Nerve Diseases, Femoral
% 218.18/218.33  |- skos__hiddenLabel mesh__D020428 Femoral Nerve Disease
% 218.18/218.33  |- skos__altLabel mesh__D020428 Femoral Nerve Diseases
% 218.18/218.33  |- skos__historyNote mesh__D020428
% 218.18/218.33       Peripheral Nervous System Diseases %28%1966-1999%29%
% 218.18/218.33  |- skos__altLabel mesh__D020428 Mononeuropathy, Femoral
% 218.18/218.33  |- skos__hiddenLabel mesh__D020428 Femoral Neuropathies
% 218.18/218.33  |- rdf__type mesh__D020428sskos__Concept
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D020428 2006
% 218.18/218.34  |- skos__altLabel mesh__D020428 Femoral Mononeuropathy
% 218.18/218.34  |- mesh__dateEstablished mesh__D020428 2000-01-01
% 218.18/218.34  |- mesh__recordOriginator mesh__D020428 KEV
% 218.18/218.34  |- skos__historyNote mesh__D020428 Neuritis %28%1966-1999%29%
% 218.18/218.34  |- skos__hiddenLabel mesh__D020428 Nerve Disease, Femoral
% 218.18/218.34  |- skos__historyNote mesh__D020428 Femoral Nerve %28%1966-1999%29%
% 218.18/218.34  |- mesh__recordAuthorizer mesh__D020428 sjn
% 218.18/218.34  |- mesh__dateRevised mesh__D020428 2005-06-30
% 218.18/218.34  |- skos__altLabel mesh__D020428 Neuropathy, Femoral
% 218.18/218.34  |- skos__prefLabel mesh__D020428 Femoral Neuropathy
% 218.18/218.34  |- skos__hiddenLabel mesh__D020428 Femoral Mononeuropathies
% 218.18/218.34  |- skos__hiddenLabel mesh__D020428 Neuropathies, Femoral
% 218.18/218.34  |- mesh__dateCreated mesh__D020428 1999-11-03
% 218.18/218.34  |- skos__broader mesh__D020428smesh__D020422
% 218.18/218.34  |- skos__hiddenLabel mesh__D020428 Mononeuropathies, Femoral
% 218.18/218.34  |- mesh__recordMaintainer mesh__D020428 ags
% 218.18/218.34  |- skos__scopeNote mesh__D020428
% 218.18/218.34       Disease involving the femoral nerve. The femoral nerve may be injured by ISCHEMIA %28%e.g., in association with DIABETIC NEUROPATHIES%29%, nerve compression, trauma, COLLAGEN DISEASES, and other disease processes. Clinical features include MUSCLE WEAKNESS or PARALYSIS of hip flexion and knee extension, ATROPHY of the QUADRICEPS MUSCLE, reduced or absent patellar reflex, and impaired sensation over the anterior and medial thigh.%A%    
% 218.18/218.34  |- mesh__publicMeSHNote mesh__D020428 2000   
% 218.18/218.34  |- skos__scopeNote mesh__D016387
% 218.18/218.34       The concept covering the physical and mental conditions of women.%A%    
% 218.18/218.34  |- mesh__recordAuthorizer mesh__D016387 sjn
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D016387 2005
% 218.18/218.34  |- skos__annotation mesh__D016387 specify geog if pertinent   
% 218.18/218.34  |- mesh__dateEstablished mesh__D016387 1991-01-01
% 218.18/218.34  |- skos__hiddenLabel mesh__D016387 Women Health
% 218.18/218.34  |- mesh__recordMaintainer mesh__D016387 lkt
% 218.18/218.34  |- skos__prefLabel mesh__D016387 Women%27%s Health
% 218.18/218.34  |- mesh__recordOriginator mesh__D016387 JHM
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D016387 2006
% 218.18/218.34  |- mesh__historyNote mesh__D016387 91   
% 218.18/218.34  |- mesh__dateCreated mesh__D016387 1990-05-29
% 218.18/218.34  |- mesh__publicMeSHNote mesh__D016387 91   
% 218.18/218.34  |- skos__broader mesh__D016387smesh__D006262
% 218.18/218.34  |- skos__hiddenLabel mesh__D016387 Health, Women%27%s
% 218.18/218.34  |- skos__altLabel mesh__D016387 Woman%27%s Health
% 218.18/218.34  |- skos__hiddenLabel mesh__D016387 Health, Woman%27%s
% 218.18/218.34  |- rdf__type mesh__D016387sskos__Concept
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D016387 2004
% 218.18/218.34  |- mesh__dateRevised mesh__D016387 2003-07-09
% 218.18/218.34  |- skos__hiddenLabel mesh__D016387 Woman Health
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D002367 2003
% 218.18/218.34  |- skos__broader mesh__D002367smesh__D012278
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D002367 2005
% 218.18/218.34  |- skos__related mesh__D002367smesh__D002368
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D002367 2004
% 218.18/218.34  |- mesh__recordAuthorizer mesh__D002367 sjn
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D002367 2006
% 218.18/218.34  |- skos__scopeNote mesh__D002367
% 218.18/218.34       Common name for Ricinus communis, a species in the family EUPHORBIACEAE. It is the source of CASTOR OIL.%A%    
% 218.18/218.34  |- mesh__dateCreated mesh__D002367 1999-01-01
% 218.18/218.34  |- mesh__onlineNote mesh__D002367 search RICINUS 1966-74   
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D002367 2002
% 218.18/218.34  |- mesh__dateEstablished mesh__D002367 1991-01-01
% 218.18/218.34  |- mesh__historyNote mesh__D002367
% 218.18/218.34       91%28%75%29%; was see under RICINUS 1975-90   
% 218.18/218.34  |- mesh__recordMaintainer mesh__D002367 ssb
% 218.18/218.34  |- mesh__publicMeSHNote mesh__D002367 91; was see under RICINUS 1975-90   
% 218.18/218.34  |- mesh__recordOriginator mesh__D002367 NLM
% 218.18/218.34  |- mesh__dateRevised mesh__D002367 2001-07-25
% 218.18/218.34  |- rdf__type mesh__D002367sskos__Concept
% 218.18/218.34  |- skos__prefLabel mesh__D002367 Castor Bean
% 218.18/218.34  |- skos__broader mesh__D007850smesh__D005227
% 218.18/218.34  |- mesh__recordAuthorizer mesh__D007850 sjn
% 218.18/218.34  |- mesh__dateEstablished mesh__D007850 1975-09-01
% 218.18/218.34  |- skos__altLabel mesh__D007850 Dodecanoic Acids
% 218.18/218.34  |- mesh__historyNote mesh__D007850 75   
% 218.18/218.34  |- rdf__type mesh__D007850sskos__Concept
% 218.18/218.34  |- skos__prefLabel mesh__D007850 Lauric Acids
% 218.18/218.34  |- mesh__recordMaintainer mesh__D007850 ssb
% 218.18/218.34  |- skos__hiddenLabel mesh__D007850 Acids, Lauric
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D007850 2005
% 218.18/218.34  |- mesh__publicMeSHNote mesh__D007850 75   
% 218.18/218.34  |- skos__hiddenLabel mesh__D007850 Acids, Dodecanoic
% 218.18/218.34  |- mesh__dateCreated mesh__D007850 1974-11-11
% 218.18/218.34  |- skos__historyNote mesh__D007850 Fatty Acids %28%1966-1974%29%
% 218.18/218.34  |- mesh__dateRevised mesh__D007850 2003-07-09
% 218.18/218.34  |- mesh__recordOriginator mesh__D007850 NLM
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D007850 2006
% 218.18/218.34  |- skos__scopeNote mesh__D007850
% 218.18/218.34       12-Carbon saturated monocarboxylic acids.     
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D007850 2004
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D021521 2001
% 218.18/218.34  |- skos__historyNote mesh__D021521 DNA, Ribosomal %28%1992-2000%29%
% 218.18/218.34  |- mesh__dateCreated mesh__D021521 2000-06-22
% 218.18/218.34  |- mesh__historyNote mesh__D021521 2001   
% 218.18/218.34  |- rdf__type mesh__D021521sskos__Concept
% 218.18/218.34  |- mesh__publicMeSHNote mesh__D021521 2001   
% 218.18/218.34  |- skos__broader mesh__D021521smesh__D015373
% 218.18/218.34  |- skos__historyNote mesh__D021521 RNA, Ribosomal %28%1991-2000%29%
% 218.18/218.34  |- skos__scopeNote mesh__D021521
% 218.18/218.34       RESTRICTION FRAGMENT LENGTH POLYMORPHISM analysis of rRNA genes that is used for differentiating between species or strains.%A%    
% 218.18/218.34  |- mesh__dateEstablished mesh__D021521 2001-01-01
% 218.18/218.34  |- skos__historyNote mesh__D021521
% 218.18/218.34       Bacterial Typing Techniques %28%1991-2000%29%
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D021521 2006
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D021521 2002
% 218.18/218.34  |- skos__hiddenLabel mesh__D021521 Ribotypes
% 218.18/218.34  |- skos__prefLabel mesh__D021521 Ribotyping
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D021521 2004
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D021521 2005
% 218.18/218.34  |- skos__broader mesh__D021521smesh__D016172
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D021521 2003
% 218.18/218.34  |- skos__hiddenLabel mesh__D007052 TraumaDolgit Gel
% 218.18/218.34  |- skos__prefLabel mesh__D007052 Ibuprofen
% 218.18/218.34  |- mesh__recordAuthorizer mesh__D007052 sjn
% 218.18/218.34  |- skos__hiddenLabel mesh__D007052 Sodium Salt Ibuprofen
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D007052 2001
% 218.18/218.34  |- skos__hiddenLabel mesh__D007052 Calcium Salt Ibuprofen
% 218.18/218.34  |- skos__hiddenLabel mesh__D007052 Ibuprofen Zinc
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D007052 2005
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D007052 2004
% 218.18/218.34  |- mesh__dateEstablished mesh__D007052 1978-01-01
% 218.18/218.34  |- skos__broader mesh__D007052smesh__D010666
% 218.18/218.34  |- skos__hiddenLabel mesh__D007052 Magnesium Salt Ibuprofen
% 218.18/218.34  |- skos__hiddenLabel mesh__D007052 Zinc Salt Ibuprofen
% 218.18/218.34  |- skos__hiddenLabel mesh__D007052 Potassium Salt Ibuprofen
% 218.18/218.34  |- mesh__dateRevised mesh__D007052 2000-06-21
% 218.18/218.34  |- mesh__historyNote mesh__D007052 78%28%75%29%   
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D007052 2006
% 218.18/218.34  |- skos__hiddenLabel mesh__D007052 IP 82
% 218.18/218.34  |- mesh__publicMeSHNote mesh__D007052 78; see PHENYLPROPIONATES 1975-77   
% 218.18/218.34  |- mesh__recordOriginator mesh__D007052 NLM
% 218.18/218.34  |- skos__historyNote mesh__D007052 Propionates %28%1972-1974%29%
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D007052 2002
% 218.18/218.34  |- skos__hiddenLabel mesh__D007052 Salt Ibuprofen, Magnesium
% 218.18/218.34  |- rdf__type mesh__D007052sskos__Concept
% 218.18/218.34  |- skos__altLabel mesh__D007052
% 218.18/218.34       alpha-Methyl-4-%28%2-methylpropyl%29%benzeneacetic Acid
% 218.18/218.34  |- skos__hiddenLabel mesh__D007052 Trauma Dolgit Gel
% 218.18/218.34  |- skos__hiddenLabel mesh__D007052 Salt Ibuprofen, Zinc
% 218.18/218.34  |- skos__hiddenLabel mesh__D007052 IP82
% 218.18/218.34  |- mesh__recordMaintainer mesh__D007052 CCR
% 218.18/218.34  |- skos__hiddenLabel mesh__D007052 Aluminum Salt Ibuprofen
% 218.18/218.34  |- skos__hiddenLabel mesh__D007052 Salt Ibuprofen, Sodium
% 218.18/218.34  |- skos__hiddenLabel mesh__D007052 I.V. Solution, Ibuprofen
% 218.18/218.34  |- skos__scopeNote mesh__D007052
% 218.18/218.34       A nonsteroidal anti-inflammatory agent with analgesic properties used in the therapy of rheumatism and arthritis.%A%    
% 218.18/218.34  |- mesh__dateCreated mesh__D007052 1974-11-11
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D007052 2003
% 218.18/218.34  |- mesh__recordAuthorizer mesh__D012795 sjn
% 218.18/218.34  |- skos__annotation mesh__D012795
% 218.18/218.34       glycoproteins containing sialic acid: do not confuse with SALIVARY PROTEINS, proteins found in saliva; /biosyn /physiol permitted%A%  
% 218.18/218.34  |- mesh__historyNote mesh__D012795 77   
% 218.18/218.34  |- skos__prefLabel mesh__D012795 Sialoglycoproteins
% 218.18/218.34  |- rdf__type mesh__D012795sskos__Concept
% 218.18/218.34  |- skos__scopeNote mesh__D012795
% 218.18/218.34       Glycoproteins which contain sialic acid as one of their carbohydrates. They are often found on or in the cell or tissue membranes and participate in a variety of biological activities.%A%    
% 218.18/218.34  |- skos__historyNote mesh__D012795 Glycoproteins %28%1966-1976%29%
% 218.18/218.34  |- skos__broader mesh__D012795smesh__D006023
% 218.18/218.34  |- mesh__recordOriginator mesh__D012795 RLS
% 218.18/218.34  |- skos__historyNote mesh__D012795 Glycopeptides %28%1973-1976%29%
% 218.18/218.34  |- mesh__dateEstablished mesh__D012795 1977-01-01
% 218.18/218.34  |- mesh__recordMaintainer mesh__D012795 SYSTEM
% 218.18/218.34  |- mesh__dateCreated mesh__D012795 1976-04-27
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D012795 2006
% 218.18/218.34  |- mesh__dateRevised mesh__D012795 2005-06-30
% 218.18/218.34  |- skos__historyNote mesh__D012795 Neuraminic Acids %28%1966-1974%29%
% 218.18/218.34  |- skos__broader mesh__D012795smesh__D006020
% 218.18/218.34  |- mesh__publicMeSHNote mesh__D012795 77   
% 218.18/218.34  |- skos__related mesh__D012795smesh__D001212
% 218.18/218.34  |- skos__historyNote mesh__D012795 Sialic Acids %28%1975-1976%29%
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Neuropathies, Tibial
% 218.18/218.34  |- skos__altLabel mesh__D020429 Internal Popliteal Neuropathy
% 218.18/218.34  |- rdf__type mesh__D020429sskos__Concept
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Post-Traumatic Tibial Neuropathy
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Nerve Disease, Tibial
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D020429 2003
% 218.18/218.34  |- mesh__publicMeSHNote mesh__D020429 2000   
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D020429 2002
% 218.18/218.34  |- skos__altLabel mesh__D020429 Tibial Nerve Diseases
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Tibial Nerve Disease
% 218.18/218.34  |- mesh__historyNote mesh__D020429 2000   
% 218.18/218.34  |- skos__historyNote mesh__D020429
% 218.18/218.34       Peripheral Nervous System Diseases %28%1968-1999%29%
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Neuropathy, Medial Plantar
% 218.18/218.34  |- skos__altLabel mesh__D020429 Posterior Tibial Nerve Diseases
% 218.18/218.34  |- skos__prefLabel mesh__D020429 Tibial Neuropathy
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Neuropathies, Lateral Plantar
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Popliteal Neuropathies, Medial
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Medial Popliteal Neuropathies
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Plantar Neuropathy, Lateral
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Tibial Neuropathies, Posterior
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Neuropathy, Post-Traumatic Tibial
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Neuropathies, Internal Popliteal
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Post-Traumatic Tibial Neuropathies
% 218.18/218.34  |- skos__broader mesh__D020429smesh__D020422
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Tibial Neuropathy, Post Traumatic
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Lateral Plantar Neuropathies
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Medial Plantar Neuropathies
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D020429 2001
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Posterior Tibial Neuropathies
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Neuropathy, Lateral Plantar
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Plantar Neuropathy, Medial
% 218.18/218.34  |- skos__altLabel mesh__D020429 Posterior Tibial Neuropathy
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Neuropathies, Posterior Tibial
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Popliteal Neuropathy, Medial
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Tibial Neuropathies, Post-Traumatic
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D020429 2006
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D020429 2000
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Neuropathy, Medial Popliteal
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Nerve Diseases, Tibial
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Tibial Neuropathies
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Neuropathy, Tibial
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Popliteal Neuropathy, Internal
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Popliteal Neuropathies, Internal
% 218.18/218.34  |- mesh__dateEstablished mesh__D020429 2000-01-01
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Tibial Neuropathy, Posterior
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D020429 2005
% 218.18/218.34  |- mesh__dateCreated mesh__D020429 1999-11-04
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Internal Popliteal Neuropathies
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D020429 2004
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Neuropathy, Internal Popliteal
% 218.18/218.34  |- skos__scopeNote mesh__D020429
% 218.18/218.34       Disease of the TIBIAL NERVE %28%also referred to as the posterior tibial nerve%29%. The most commonly associated condition is the TARSAL TUNNEL SYNDROME. However, LEG INJURIES; ISCHEMIA; and inflammatory conditions %28%e.g., COLLAGEN DISEASES%29% may also affect the nerve. Clinical features include PARALYSIS of plantar flexion, ankle inversion and toe flexion as well as loss of sensation over the sole of the foot. %28%From Joynt, Clinical Neurology, 1995, Ch51, p32%29%%A%    
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Neuropathy, Posterior Tibial
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Neuropathies, Medial Popliteal
% 218.18/218.34  |- skos__altLabel mesh__D020429 Medial Popliteal Neuropathy
% 218.18/218.34  |- skos__hiddenLabel mesh__D020429 Neuropathies, Medial Plantar
% 218.18/218.34  |- mesh__historyNote mesh__D006758 66%28%65%29%   
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D006758 2005
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D006758 1994
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D006758 2002
% 218.18/218.34  |- skos__scopeNote mesh__D006758
% 218.18/218.34       Individuals who donate their services to the hospital.     
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D006758 2004
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D006758 1993
% 218.18/218.34  |- skos__prefLabel mesh__D006758 Hospital Volunteers
% 218.18/218.34  |- mesh__dateEstablished mesh__D006758 1966-01-01
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D006758 1995
% 218.18/218.34  |- mesh__dateRevised mesh__D006758 1992-05-15
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D006758 2006
% 218.18/218.34  |- skos__broader mesh__D006758smesh__D010564
% 218.18/218.34  |- skos__altLabel mesh__D006758 Volunteers, Hospital
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D006758 2000
% 218.18/218.34  |- mesh__publicMeSHNote mesh__D006758 66   
% 218.18/218.34  |- mesh__recordMaintainer mesh__D006758 TAP
% 218.18/218.34  |- skos__annotation mesh__D006758
% 218.18/218.34       do not confuse with HOSPITAL AUXILIARIES, volunteer organizations%A%  
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D006758 1996
% 218.18/218.34  |- mesh__recordOriginator mesh__D006758 NLM
% 218.18/218.34  |- skos__broader mesh__D006758smesh__D014838
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D006758 2001
% 218.18/218.34  |- mesh__dateCreated mesh__D006758 1999-01-01
% 218.18/218.34  |- skos__altLabel mesh__D006758 Volunteer, Hospital
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D006758 1998
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D006758 1997
% 218.18/218.34  |- skos__altLabel mesh__D006758 Hospital Volunteer
% 218.18/218.34  |- rdf__type mesh__D006758sskos__Concept
% 218.18/218.34  |- mesh__recordAuthorizer mesh__D006758 PLS
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D006758 2003
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D006758 1999
% 218.18/218.34  |- skos__broader mesh__D017480smesh__D011957
% 218.18/218.34  |- mesh__recordMaintainer mesh__D017480 jmp
% 218.18/218.34  |- skos__annotation mesh__D017480 opioid receptors; DF: RECEPT SIGMA   
% 218.18/218.34  |- mesh__dateRevised mesh__D017480 2003-07-09
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D017480 2006
% 218.18/218.34  |- skos__scopeNote mesh__D017480
% 218.18/218.34       A class of cell surface receptors recognized by its pharmacological profile. Sigma receptors were originally considered to be opioid receptors because they bind certain synthetic opioids. However they also interact with a variety of other psychoactive drugs, and their endogenous ligand is not known %28%although they can react to certain endogenous steroids%29%. Sigma receptors are found in the immune, endocrine, and nervous systems, and in some peripheral tissues.%A%    
% 218.18/218.34  |- skos__altLabel mesh__D017480 sigma Receptor
% 218.18/218.34  |- mesh__dateEstablished mesh__D017480 1993-01-01
% 218.18/218.34  |- skos__altLabel mesh__D017480 Receptors, sigma Opioid
% 218.18/218.34  |- mesh__publicMeSHNote mesh__D017480
% 218.18/218.34       93; SIGMA RECEPTOR was indexed under RECEPTORS, ENDORPHIN 1981-92%A%  
% 218.18/218.34  |- mesh__recordOriginator mesh__D017480 PXP
% 218.18/218.34  |- skos__historyNote mesh__D017480 Receptors, Endorphin %28%1981-1992%29%
% 218.18/218.34  |- rdf__type mesh__D017480sskos__Concept
% 218.18/218.34  |- skos__altLabel mesh__D017480 sigma Receptors
% 218.18/218.34  |- mesh__dateCreated mesh__D017480 1992-05-22
% 218.18/218.34  |- mesh__onlineNote mesh__D017480
% 218.18/218.34       use RECEPTORS, SIGMA %28%NM%29% to search SIGMA RECEPTOR 1981-92%A%  
% 218.18/218.34  |- skos__hiddenLabel mesh__D017480 Receptor, sigma
% 218.18/218.34  |- skos__prefLabel mesh__D017480 Receptors, sigma
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D017480 2004
% 218.18/218.34  |- skos__altLabel mesh__D017480 Receptors, Opioid, sigma
% 218.18/218.34  |- mesh__historyNote mesh__D017480
% 218.18/218.34       93; was SIGMA RECEPTOR %28%NM%29% 1981-92   
% 218.18/218.34  |- skos__altLabel mesh__D017480 Opioid Receptors, sigma
% 218.18/218.34  |- skos__hiddenLabel mesh__D017480 sigma Opioid Receptors
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D017480 2005
% 218.18/218.34  |- mesh__recordAuthorizer mesh__D017480 sjn
% 218.18/218.34  |- rdf__type mesh__D003460sskos__Concept
% 218.18/218.34  |- mesh__recordAuthorizer mesh__D003460 sjn
% 218.18/218.34  |- skos__broader mesh__D003460smesh__D002623
% 218.18/218.34  |- skos__prefLabel mesh__D003460 Crystallization
% 218.18/218.34  |- mesh__dateEstablished mesh__D003460 1966-01-01
% 218.18/218.34  |- mesh__publicMeSHNote mesh__D003460 66   
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D003460 2005
% 218.18/218.34  |- mesh__dateRevised mesh__D003460 2002-07-03
% 218.18/218.34  |- mesh__recordMaintainer mesh__D003460 lkt
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D003460 2003
% 218.18/218.34  |- skos__scopeNote mesh__D003460
% 218.18/218.34       The formation of crystalline substances from solutions or melts. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D003460 2006
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D003460 2004
% 218.18/218.34  |- skos__broader mesh__D003460smesh__D002627
% 218.18/218.34  |- mesh__historyNote mesh__D003460 66%28%64%29%   
% 218.18/218.34  |- mesh__recordOriginator mesh__D003460 NLM
% 218.18/218.34  |- mesh__dateCreated mesh__D003460 1999-01-01
% 218.18/218.34  |- skos__annotation mesh__D003460
% 218.18/218.34       NIM; no qualif; coord with substance being crystallized %28%IM or NIM%29%%A%  
% 218.18/218.34  |- skos__hiddenLabel mesh__D003460 Crystallizations
% 218.18/218.34  |- mesh__publicMeSHNote mesh__D016388 91   
% 218.18/218.34  |- rdf__type mesh__D016388sskos__Concept
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D016388 1995
% 218.18/218.34  |- skos__hiddenLabel mesh__D016388 Loss, Tooth
% 218.18/218.34  |- mesh__dateRevised mesh__D016388 1993-06-03
% 218.18/218.34  |- skos__broader mesh__D016388smesh__D014076
% 218.18/218.34  |- skos__scopeNote mesh__D016388
% 218.18/218.34       The failure to retain teeth as a result of disease or injury.%A%    
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D016388 1994
% 218.18/218.34  |- skos__annotation mesh__D016388 from dis or inj; note category   
% 218.18/218.34  |- skos__broader mesh__D016388smesh__D010510
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D016388 2002
% 218.18/218.34  |- mesh__recordOriginator mesh__D016388 MXR
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D016388 1999
% 218.18/218.34  |- mesh__recordMaintainer mesh__D016388 TGC
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D016388 1998
% 218.18/218.34  |- skos__prefLabel mesh__D016388 Tooth Loss
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D016388 1997
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D016388 2006
% 218.18/218.34  |- mesh__recordAuthorizer mesh__D016388 PLS
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D016388 2001
% 218.18/218.34  |- mesh__dateEstablished mesh__D016388 1991-01-01
% 218.18/218.34  |- mesh__historyNote mesh__D016388 91   
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D016388 1996
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D016388 2005
% 218.18/218.34  |- mesh__dateCreated mesh__D016388 1990-05-29
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D016388 2004
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D016388 2000
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D016388 2003
% 218.18/218.34  |- mesh__recordMaintainer mesh__D002368 ssb
% 218.18/218.34  |- mesh__recordOriginator mesh__D002368 NLM
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D002368 2006
% 218.18/218.34  |- mesh__dateCreated mesh__D002368 1999-01-01
% 218.18/218.34  |- skos__hiddenLabel mesh__D002368 Oil, Castor
% 218.18/218.34  |- skos__broader mesh__D002368smesh__D005224
% 218.18/218.34  |- mesh__recordAuthorizer mesh__D002368 sjn
% 218.18/218.34  |- rdf__type mesh__D002368sskos__Concept
% 218.18/218.34  |- skos__prefLabel mesh__D002368 Castor Oil
% 218.18/218.34  |- mesh__dateRevised mesh__D002368 2005-06-30
% 218.18/218.34  |- skos__scopeNote mesh__D002368
% 218.18/218.34       Oil obtained from seeds of Ricinus communis that is used as a cathartic and as a plasticizer.%A%    
% 218.18/218.34  |- skos__broader mesh__D002368smesh__D010938
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D013090 2004
% 218.18/218.34  |- skos__prefLabel mesh__D013090 Spermatocytes
% 218.18/218.34  |- mesh__dateEstablished mesh__D013090 1985-01-01
% 218.18/218.34  |- skos__altLabel mesh__D013090 Spermiocytes
% 218.18/218.34  |- skos__broader mesh__D013090smesh__D013094
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D013090 2003
% 218.18/218.34  |- skos__hiddenLabel mesh__D013090 Spermiocyte
% 218.18/218.34  |- rdf__type mesh__D013090sskos__Concept
% 218.18/218.34  |- mesh__recordAuthorizer mesh__D013090 sjn
% 218.18/218.34  |- mesh__recordMaintainer mesh__D013090 lkt
% 218.18/218.34  |- skos__scopeNote mesh__D013090
% 218.18/218.34       Male germ cells derived from SPERMATOGONIA. The euploid primary spermatocytes undergo MEIOSIS and give rise to the haploid secondary spermatocytes which in turn give rise to SPERMATIDS.%A%    
% 218.18/218.34  |- skos__hiddenLabel mesh__D013090 Spermatocyte
% 218.18/218.34  |- skos__historyNote mesh__D013090 Spermatozoa %28%1966-1974%29%
% 218.18/218.34  |- mesh__recordOriginator mesh__D013090 NLM
% 218.18/218.34  |- mesh__historyNote mesh__D013090
% 218.18/218.34       85%28%75%29%; was see under SPERMATOZOA 1975-84   
% 218.18/218.34  |- skos__related mesh__D013090smesh__D013079
% 218.18/218.34  |- mesh__dateRevised mesh__D013090 2002-07-03
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D013090 2006
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D013090 2005
% 218.18/218.34  |- mesh__dateCreated mesh__D013090 1974-11-11
% 218.18/218.34  |- mesh__publicMeSHNote mesh__D013090
% 218.18/218.34       85; was see under SPERMATOZOA 1975-84   
% 218.18/218.34  |- mesh__dateEstablished mesh__D007851 1991-01-01
% 218.18/218.34  |- rdf__type mesh__D007851sskos__Concept
% 218.18/218.34  |- skos__altLabel mesh__D007851 1-Dodecanol
% 218.18/218.34  |- skos__hiddenLabel mesh__D007851 Alcohol, n-Dodecyl
% 218.18/218.34  |- skos__prefLabel mesh__D007851 Dodecanol
% 218.18/218.34  |- skos__hiddenLabel mesh__D007851 Alcohol, Dodecyl
% 218.18/218.34  |- mesh__publicMeSHNote mesh__D007851
% 218.18/218.34       98; see LAURYL ALCOHOL 1991-97; see FATTY ALCOHOLS 1975-90%A%  
% 218.18/218.34  |- skos__historyNote mesh__D007851 Fatty Alcohols %28%1972-1974%29%
% 218.18/218.34  |- skos__hiddenLabel mesh__D007851 1 Dodecanol
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D007851 2005
% 218.18/218.34  |- skos__hiddenLabel mesh__D007851 Alcohol, Lauryl
% 218.18/218.34  |- mesh__recordAuthorizer mesh__D007851 sjn
% 218.18/218.34  |- skos__altLabel mesh__D007851 Lauryl Alcohol
% 218.18/218.34  |- skos__altLabel mesh__D007851 n-Dodecyl Alcohol
% 218.18/218.34  |- mesh__dateCreated mesh__D007851 1974-11-11
% 218.18/218.34  |- mesh__dateRevised mesh__D007851 2003-07-09
% 218.18/218.34  |- skos__broader mesh__D007851smesh__D005233
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D007851 2006
% 218.18/218.34  |- mesh__recordMaintainer mesh__D007851 ssb
% 218.18/218.34  |- skos__hiddenLabel mesh__D007851 n Dodecyl Alcohol
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D007851 2004
% 218.18/218.34  |- skos__scopeNote mesh__D007851
% 218.18/218.34       A saturated 12-carbon fatty alcohol obtained from coconut oil fatty acids. It has a floral odor and is used in detergents, lubricating oils, and pharmaceuticals. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%    
% 218.18/218.34  |- skos__altLabel mesh__D007851 Dodecyl Alcohol
% 218.18/218.34  |- mesh__historyNote mesh__D007851 98%28%75%29%   
% 218.18/218.34  |- mesh__recordOriginator mesh__D007851 NLM
% 218.18/218.34  |- skos__prefLabel mesh__D021522 Bioartificial Organs
% 218.18/218.34  |- skos__broader mesh__D021522smesh__D001187
% 218.18/218.34  |- skos__hiddenLabel mesh__D021522 Organs, Bioartificial
% 218.18/218.34  |- rdf__type mesh__D021522sskos__Concept
% 218.18/218.34  |- mesh__publicMeSHNote mesh__D021522 2001   
% 218.18/218.34  |- mesh__dateEstablished mesh__D021522 2001-01-01
% 218.18/218.34  |- skos__scopeNote mesh__D021522
% 218.18/218.34       Artificial organs that are composites of biomaterials and cells. The biomaterial can act as a membrane %28%container%29% as in BIOARTIFICIAL LIVER or a scaffold as in bioartificial skin.%A%    
% 218.18/218.34  |- skos__hiddenLabel mesh__D021522 Organ, Bioartificial
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D021522 2005
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D021522 2001
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D021522 2003
% 218.18/218.34  |- mesh__dateCreated mesh__D021522 2000-06-22
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D021522 2006
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D021522 2002
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D021522 2004
% 218.18/218.34  |- mesh__historyNote mesh__D021522 2001   
% 218.18/218.34  |- skos__hiddenLabel mesh__D021522 Bioartificial Organ
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D007053 2004
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D007053 1994
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D007053 2000
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D007053 1993
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D007053 1999
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D007053 2006
% 218.18/218.34  |- skos__broader mesh__D007053smesh__D014867
% 218.18/218.34  |- mesh__activeMeSHYear mesh__D007053 1995
% 218.18/218.35  |- skos__related mesh__D007053smesh__D004367
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D007053 2001
% 218.18/218.35  |- mesh__recordMaintainer mesh__D007053 TAP
% 218.18/218.35  |- mesh__recordAuthorizer mesh__D007053 PLS
% 218.18/218.35  |- rdf__type mesh__D007053sskos__Concept
% 218.18/218.35  |- mesh__dateRevised mesh__D007053 1992-05-14
% 218.18/218.35  |- skos__prefLabel mesh__D007053 Ice
% 218.18/218.35  |- mesh__dateCreated mesh__D007053 1999-01-01
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D007053 1996
% 218.18/218.35  |- mesh__recordOriginator mesh__D007053 NLM
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D007053 2002
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D007053 2003
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D007053 1998
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D007053 1997
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D007053 2005
% 218.18/218.35  |- skos__hiddenLabel mesh__D012796 Sialographies
% 218.18/218.35  |- skos__prefLabel mesh__D012796 Sialography
% 218.18/218.35  |- mesh__historyNote mesh__D012796 65   
% 218.18/218.35  |- mesh__dateRevised mesh__D012796 2005-06-30
% 218.18/218.35  |- skos__annotation mesh__D012796 DF: SIALOGR   
% 218.18/218.35  |- mesh__recordOriginator mesh__D012796 NLM
% 218.18/218.35  |- rdf__type mesh__D012796sskos__Concept
% 218.18/218.35  |- skos__broader mesh__D012796smesh__D011861
% 218.18/218.35  |- mesh__recordAuthorizer mesh__D012796 sjn
% 218.18/218.35  |- skos__scopeNote mesh__D012796
% 218.18/218.35       Radiography of the SALIVARY GLANDS or ducts following injection of contrast medium.%A%    
% 218.18/218.35  |- mesh__recordMaintainer mesh__D012796 ssb
% 218.18/218.35  |- mesh__dateCreated mesh__D012796 1999-01-01
% 218.18/218.35  |- mesh__dateEstablished mesh__D012796 1965-01-01
% 218.18/218.35  |- mesh__publicMeSHNote mesh__D012796 65   
% 218.18/218.35  |- skos__broader mesh__D012796smesh__D003938
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D012796 2006
% 218.18/218.35  |- mesh__publicMeSHNote mesh__D031950 2003   
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D031950 2005
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D031950 2004
% 218.18/218.35  |- skos__altLabel mesh__D031950 Yellowroot
% 218.18/218.35  |- skos__prefLabel mesh__D031950 Xanthorhiza
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D031950 2006
% 218.18/218.35  |- skos__broader mesh__D031950smesh__D029626
% 218.18/218.35  |- mesh__dateEstablished mesh__D031950 2003-01-01
% 218.18/218.35  |- skos__scopeNote mesh__D031950
% 218.18/218.35       A plant genus of the family RANUNCULACEAE. Members contain isoquinoline alkaloids.%A%    
% 218.18/218.35  |- mesh__dateCreated mesh__D031950 2002-07-03
% 218.18/218.35  |- mesh__historyNote mesh__D031950 2003   
% 218.18/218.35  |- rdf__type mesh__D031950sskos__Concept
% 218.18/218.35  |- skos__annotation mesh__D031950
% 218.18/218.35       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D031950 2003
% 218.18/218.35  |- skos__historyNote mesh__D006759 Hospital Restructuring %28%1984-1985%29%
% 218.18/218.35  |- mesh__dateRevised mesh__D006759 2000-06-22
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D006759 2005
% 218.18/218.35  |- skos__hiddenLabel mesh__D006759 Venture, Joint
% 218.18/218.35  |- skos__hiddenLabel mesh__D006759 Hospital Physician Joint Venture
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D006759 2004
% 218.18/218.35  |- skos__prefLabel mesh__D006759 Hospital-Physician Joint Ventures
% 218.18/218.35  |- skos__altLabel mesh__D006759 Organizations, Physician-Hospital
% 218.18/218.35  |- mesh__recordAuthorizer mesh__D006759 sjn
% 218.18/218.35  |- skos__altLabel mesh__D006759 Physician-Hospital Organizations
% 218.18/218.35  |- skos__hiddenLabel mesh__D006759 Venture, Hospital-Physician Joint
% 218.18/218.35  |- skos__hiddenLabel mesh__D006759 Ventures, Joint
% 218.18/218.35  |- skos__scopeNote mesh__D006759
% 218.18/218.35       A formal financial agreement made between one or more physicians and a hospital to provide ambulatory alternative services to those patients who do not require hospitalization.%A%    
% 218.18/218.35  |- skos__hiddenLabel mesh__D006759 Organization, Hospital-Physician
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D006759 2003
% 218.18/218.35  |- skos__hiddenLabel mesh__D006759 Joint Venture, Hospital Physician
% 218.18/218.35  |- skos__hiddenLabel mesh__D006759 Hospital Physician Joint Ventures
% 218.18/218.35  |- skos__hiddenLabel mesh__D006759 Ventures, Hospital-Physician Joint
% 218.18/218.35  |- skos__hiddenLabel mesh__D006759 Organization, Physician-Hospital
% 218.18/218.35  |- skos__altLabel mesh__D006759 Organizations, Hospital-Physician
% 218.18/218.35  |- skos__hiddenLabel mesh__D006759 Hospital-Physician Organization
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D006759 2002
% 218.18/218.35  |- skos__broader mesh__D006759smesh__D006754
% 218.18/218.35  |- mesh__recordMaintainer mesh__D006759 jls
% 218.18/218.35  |- skos__hiddenLabel mesh__D006759 Physician Hospital Organizations
% 218.18/218.35  |- skos__hiddenLabel mesh__D006759 Joint Ventures, Hospital Physician
% 218.18/218.35  |- skos__historyNote mesh__D006759
% 218.18/218.35       Medical Staff, Hospital %28%1978-1985%29%
% 218.18/218.35  |- skos__hiddenLabel mesh__D006759 Hospital Physician Organizations
% 218.18/218.35  |- skos__altLabel mesh__D006759 Joint Ventures, Hospital-Physician
% 218.18/218.35  |- mesh__historyNote mesh__D006759
% 218.18/218.35       91%28%86%29%; was see under HOSPITAL ADMINISTRATION 1986-90   
% 218.18/218.35  |- mesh__recordOriginator mesh__D006759 EC
% 218.18/218.35  |- mesh__dateEstablished mesh__D006759 1991-01-01
% 218.18/218.35  |- skos__hiddenLabel mesh__D006759 Organizations, Physician Hospital
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D006759 2001
% 218.18/218.35  |- skos__annotation mesh__D006759 DF: JOINT VENTURES   
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D006759 2006
% 218.18/218.35  |- mesh__dateCreated mesh__D006759 1985-05-23
% 218.18/218.35  |- skos__altLabel mesh__D006759 Joint Venture, Hospital-Physician
% 218.18/218.35  |- skos__hiddenLabel mesh__D006759 Organizations, Hospital Physician
% 218.18/218.35  |- mesh__publicMeSHNote mesh__D006759
% 218.18/218.35       91; was see under HOSPITAL ADMINISTRATION 1986-90   
% 218.18/218.35  |- skos__hiddenLabel mesh__D006759 Joint Venture
% 218.18/218.35  |- skos__altLabel mesh__D006759 Hospital-Physician Joint Venture
% 218.18/218.35  |- skos__hiddenLabel mesh__D006759 Physician-Hospital Organization
% 218.18/218.35  |- rdf__type mesh__D006759sskos__Concept
% 218.18/218.35  |- skos__broader mesh__D017481smesh__D018026
% 218.18/218.35  |- mesh__publicMeSHNote mesh__D017481
% 218.18/218.35       93; SOMATOSTATIN RECEPTOR was indexed under RECEPTORS, NEUROHUMOR 1986-92 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1981-86%A%  
% 218.18/218.35  |- mesh__onlineNote mesh__D017481
% 218.18/218.35       use RECEPTORS, SOMATOSTATIN %28%NM%29% to search SOMATOSTATIN RECEPTOR 1981-92%A%  
% 218.18/218.35  |- skos__annotation mesh__D017481 DF: RECEPT SRIH   
% 218.18/218.35  |- mesh__recordMaintainer mesh__D017481 jmp
% 218.18/218.35  |- skos__hiddenLabel mesh__D017481 Receptor, Somatostatin
% 218.18/218.35  |- skos__altLabel mesh__D017481 Somatostatin Receptor
% 218.18/218.35  |- mesh__dateCreated mesh__D017481 1992-05-22
% 218.18/218.35  |- skos__altLabel mesh__D017481 SRIH Receptors
% 218.18/218.35  |- skos__broader mesh__D017481smesh__D043562
% 218.18/218.35  |- skos__related mesh__D017481smesh__D013004
% 218.18/218.35  |- skos__scopeNote mesh__D017481
% 218.18/218.35       Cell surface proteins that bind somatostatin and trigger intracellular changes which influence the behavior of cells. Somatostatin is a hypothalamic hormone, a pancreatic hormone, and a central and peripheral neurotransmitter. Activated somatostatin receptors on pituitary cells inhibit the release of growth hormone; those on endocrine and gastrointestinal cells regulate the absorption and utilization of nutrients; and those on neurons mediate somatostatin%27%s role as a neurotransmitter.%A%    
% 218.18/218.35  |- mesh__recordAuthorizer mesh__D017481 sjn
% 218.18/218.35  |- skos__historyNote mesh__D017481 Receptors, Neurohumor %28%1986-1992%29%
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D017481 2006
% 218.18/218.35  |- skos__prefLabel mesh__D017481 Receptors, Somatostatin
% 218.18/218.35  |- skos__altLabel mesh__D017481 Receptors, SRIH
% 218.18/218.35  |- skos__altLabel mesh__D017481 Somatostatin Receptors
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D017481 2005
% 218.18/218.35  |- skos__broader mesh__D017481smesh__D018013
% 218.18/218.35  |- skos__altLabel mesh__D017481
% 218.18/218.35       Receptors, Somatotropin Release Inhibiting Hormone
% 218.18/218.35  |- mesh__dateEstablished mesh__D017481 1993-01-01
% 218.18/218.35  |- mesh__recordOriginator mesh__D017481 PXP
% 218.18/218.35  |- mesh__dateRevised mesh__D017481 2003-07-09
% 218.18/218.35  |- skos__broader mesh__D017481smesh__D018017
% 218.18/218.35  |- mesh__historyNote mesh__D017481
% 218.18/218.35       93; was SOMATOSTATIN RECEPTOR %28%NM%29% 1981-92   
% 218.18/218.35  |- skos__historyNote mesh__D017481
% 218.18/218.35       Receptors, Endogenous Substances %28%1981-1986%29%
% 218.18/218.35  |- rdf__type mesh__D017481sskos__Concept
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D017481 2004
% 218.18/218.35  |- skos__hiddenLabel mesh__D003461 Crystallographies
% 218.18/218.35  |- mesh__recordOriginator mesh__D003461 NLM
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D003461 2005
% 218.18/218.35  |- skos__broader mesh__D003461smesh__D002623
% 218.18/218.35  |- mesh__recordAuthorizer mesh__D003461 sjn
% 218.18/218.35  |- skos__annotation mesh__D003461
% 218.18/218.35       NIM; coord with crystalline substance %28%IM or NIM%29%; DF: CRYSTALLOGR%A%  
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D003461 2003
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D003461 2006
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D003461 2004
% 218.18/218.35  |- skos__prefLabel mesh__D003461 Crystallography
% 218.18/218.35  |- mesh__recordMaintainer mesh__D003461 TGC
% 218.18/218.35  |- skos__scopeNote mesh__D003461
% 218.18/218.35       The branch of science that deals with the geometric description of crystals and their internal arrangement. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 218.18/218.35  |- mesh__dateRevised mesh__D003461 2002-07-03
% 218.18/218.35  |- mesh__dateCreated mesh__D003461 1999-01-01
% 218.18/218.35  |- skos__broader mesh__D003461smesh__D002627
% 218.18/218.35  |- rdf__type mesh__D003461sskos__Concept
% 218.18/218.35  |- skos__broader mesh__D005170Q000172smesh__D005170
% 218.18/218.35  |- mesh__preferredCombination mesh__D005170Q000172smesh__D005171
% 218.18/218.35  |- rdf__type mesh__D005170Q000172smesh__CompoundConcept
% 218.18/218.35  |- skos__hiddenLabel mesh__D016389 Nursing, Maternal Child
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D016389 1994
% 218.18/218.35  |- skos__altLabel mesh__D016389 Maternity Nursing
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D016389 2000
% 218.18/218.35  |- mesh__publicMeSHNote mesh__D016389 91   
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D016389 1999
% 218.18/218.35  |- skos__prefLabel mesh__D016389 Maternal-Child Nursing
% 218.18/218.35  |- skos__hiddenLabel mesh__D016389 Maternal Child Nursing
% 218.18/218.35  |- skos__scopeNote mesh__D016389
% 218.18/218.35       The nursing specialty that deals with the care of women throughout their pregnancy and childbirth and the care of their newborn children.%A%    
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D016389 1998
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D016389 1997
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D016389 2006
% 218.18/218.35  |- mesh__recordMaintainer mesh__D016389 JLS
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D016389 2002
% 218.18/218.35  |- mesh__dateRevised mesh__D016389 1993-06-04
% 218.18/218.35  |- mesh__dateEstablished mesh__D016389 1991-01-01
% 218.18/218.35  |- mesh__historyNote mesh__D016389 91   
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D016389 1996
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D016389 2005
% 218.18/218.35  |- mesh__dateCreated mesh__D016389 1990-05-29
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D016389 2004
% 218.18/218.35  |- skos__annotation mesh__D016389
% 218.18/218.35       SPEC: SPEC qualif; nurs of pregnant women %26% their newborn infants: do not confuse with PEDIATRIC NURSING, nurs of only infants %26% children; NEONATAL NURSING %26% OBSTETRICAL NURSING are available; check also tags PREGNANCY %26% INFANT, NEWBORN; DF: MATERNAL CHILD NURS%A%  
% 218.18/218.35  |- skos__altLabel mesh__D016389 Nursing, Maternal-Child
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D016389 2003
% 218.18/218.35  |- rdf__type mesh__D016389sskos__Concept
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D016389 1995
% 218.18/218.35  |- mesh__recordAuthorizer mesh__D016389 PLS
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D016389 2001
% 218.18/218.35  |- skos__broader mesh__D016389smesh__D009732
% 218.18/218.35  |- skos__broader mesh__D016389smesh__D013041
% 218.18/218.35  |- mesh__recordOriginator mesh__D016389 JHM
% 218.18/218.35  |- mesh__dateRevised mesh__D002369 1997-06-20
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D002369 2005
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D002369 2004
% 218.18/218.35  |- mesh__recordAuthorizer mesh__D002369 SJN
% 218.18/218.35  |- mesh__dateCreated mesh__D002369 1999-01-01
% 218.18/218.35  |- skos__broader mesh__D002369smesh__D013519
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D002369 2001
% 218.18/218.35  |- skos__broader mesh__D002369smesh__D013507
% 218.18/218.35  |- skos__prefLabel mesh__D002369 Castration
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D002369 2006
% 218.18/218.35  |- mesh__recordMaintainer mesh__D002369 PXP
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D002369 1998
% 218.18/218.35  |- rdf__type mesh__D002369sskos__Concept
% 218.18/218.35  |- skos__related mesh__D002369smesh__D005058
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D002369 2002
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D002369 1999
% 218.18/218.35  |- skos__scopeNote mesh__D002369
% 218.18/218.35       Surgical removal or artificial destruction of gonads.     
% 218.18/218.35  |- skos__annotation mesh__D002369
% 218.18/218.35       GEN or unspecified: prefer OVARIECTOMY or ORCHIECTOMY; do not use /util except by MeSH definition%A%  
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D002369 2003
% 218.18/218.35  |- mesh__recordOriginator mesh__D002369 NLM
% 218.18/218.35  |- skos__hiddenLabel mesh__D002369 Castrations
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D002369 2000
% 218.18/218.35  |- skos__historyNote mesh__D013091 Spermatozoa %28%1966-1970%29%
% 218.18/218.35  |- mesh__dateRevised mesh__D013091 2005-08-01
% 218.18/218.35  |- mesh__recordAuthorizer mesh__D013091 ags
% 218.18/218.35  |- skos__broader mesh__D013091smesh__D005718
% 218.18/218.35  |- mesh__dateCreated mesh__D013091 1999-01-01
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D013091 2006
% 218.18/218.35  |- mesh__historyNote mesh__D013091 73%28%71%29%   
% 218.18/218.35  |- mesh__recordMaintainer mesh__D013091 ags
% 218.18/218.35  |- mesh__dateEstablished mesh__D013091 1973-01-01
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D013091 2006A
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D013091 2005
% 218.18/218.35  |- skos__related mesh__D013091smesh__D013092
% 218.18/218.35  |- skos__related mesh__D013091smesh__D000988
% 218.18/218.35  |- mesh__publicMeSHNote mesh__D013091 73   
% 218.18/218.35  |- skos__prefLabel mesh__D013091 Spermatogenesis
% 218.18/218.35  |- mesh__recordOriginator mesh__D013091 NLM
% 218.18/218.35  |- rdf__type mesh__D013091sskos__Concept
% 218.18/218.35  |- skos__scopeNote mesh__D013091
% 218.18/218.35       The process of germ cell development in the male from the primordial germ cells, through SPERMATOGONIA; SPERMATOCYTES; SPERMATIDS; to the mature haploid SPERMATOZOA, SPERM.%A%    
% 218.18/218.35  |- skos__annotation mesh__D007852 naturally radioactive; IM   
% 218.18/218.35  |- skos__historyNote mesh__D007852 Elements %28%1966-1974%29%
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D007852 2006
% 218.18/218.35  |- skos__broader mesh__D007852smesh__D019216
% 218.18/218.35  |- mesh__publicMeSHNote mesh__D007852 75   
% 218.18/218.35  |- mesh__dateCreated mesh__D007852 1999-01-01
% 218.18/218.35  |- mesh__recordOriginator mesh__D007852 NLM
% 218.18/218.35  |- skos__broader mesh__D007852smesh__D008671
% 218.18/218.35  |- skos__prefLabel mesh__D007852 Lawrencium
% 218.18/218.35  |- mesh__recordMaintainer mesh__D007852 jmp
% 218.18/218.35  |- skos__broader mesh__D007852smesh__D028561
% 218.18/218.35  |- skos__scopeNote mesh__D007852
% 218.18/218.35       Lawrencium. A radioactive actinide discovered in 1961. It has the atomic symbol Lr, atomic number 103, and atomic weight of 257. There are two isotopes with mass number 257 or 258, and mass number 256.%A%    
% 218.18/218.35  |- mesh__dateRevised mesh__D007852 2005-06-30
% 218.18/218.35  |- mesh__dateEstablished mesh__D007852 1975-01-01
% 218.18/218.35  |- mesh__historyNote mesh__D007852 75   
% 218.18/218.35  |- rdf__type mesh__D007852sskos__Concept
% 218.18/218.35  |- mesh__recordAuthorizer mesh__D007852 sjn
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D007054 2000
% 218.18/218.35  |- skos__scopeNote mesh__D007054
% 218.18/218.35       A frozen dairy food made from cream or butterfat, milk, sugar, and flavorings. Frozen custard and French-type ice creams also contain eggs.%A%    
% 218.18/218.35  |- mesh__dateRevised mesh__D007054 1997-06-20
% 218.18/218.35  |- mesh__recordOriginator mesh__D007054 NLM
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D007054 2003
% 218.18/218.35  |- skos__hiddenLabel mesh__D007054 Cream, Ice
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D007054 1999
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D007054 2006
% 218.18/218.35  |- skos__hiddenLabel mesh__D007054 Creams, Ice
% 218.18/218.35  |- skos__broader mesh__D007054smesh__D003611
% 218.18/218.35  |- skos__hiddenLabel mesh__D007054 Ice Creams
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D007054 2002
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D007054 1998
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D007054 2005
% 218.18/218.35  |- mesh__recordMaintainer mesh__D007054 JLS
% 218.18/218.35  |- rdf__type mesh__D007054sskos__Concept
% 218.18/218.35  |- mesh__recordAuthorizer mesh__D007054 SJN
% 218.18/218.35  |- skos__prefLabel mesh__D007054 Ice Cream
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D007054 2004
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D007054 2001
% 218.18/218.35  |- mesh__dateCreated mesh__D007054 1999-01-01
% 218.18/218.35  |- skos__historyNote mesh__D012797 Salivary Glands %28%1966-1982%29%
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D012797 1997
% 218.18/218.35  |- skos__historyNote mesh__D012797
% 218.18/218.35       Salivary Gland Diseases %28%1966-1982%29%
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D012797 2006
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D012797 2000
% 218.18/218.35  |- mesh__historyNote mesh__D012797
% 218.18/218.35       91%28%83%29%; was see under SALIVARY GLAND DISEASES 1983-90   
% 218.18/218.35  |- mesh__dateRevised mesh__D012797 1993-06-03
% 218.18/218.35  |- mesh__recordAuthorizer mesh__D012797 PLS
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D012797 1996
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D012797 2005
% 218.18/218.35  |- rdf__type mesh__D012797sskos__Concept
% 218.18/218.35  |- mesh__publicMeSHNote mesh__D012797
% 218.18/218.35       91; was see under SALIVARY GLAND DISEASES 1983-90   
% 218.18/218.35  |- skos__altLabel mesh__D012797 Necrotizing Sialometaplasia
% 218.18/218.35  |- mesh__recordOriginator mesh__D012797 RC
% 218.18/218.35  |- skos__hiddenLabel mesh__D012797 Necrotizing Sialometaplasias
% 218.18/218.35  |- skos__historyNote mesh__D012797 Necrosis %28%1966-1982%29%
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D012797 2004
% 218.18/218.35  |- skos__annotation mesh__D012797
% 218.18/218.35       benign inflamm self-healing lesions of minor salivary glands%A%  
% 218.18/218.35  |- skos__broader mesh__D012797smesh__D012466
% 218.18/218.35  |- mesh__recordMaintainer mesh__D012797 TGC
% 218.18/218.35  |- mesh__dateCreated mesh__D012797 1982-04-26
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D012797 1995
% 218.18/218.35  |- mesh__dateEstablished mesh__D012797 1991-01-01
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D012797 2003
% 218.18/218.35  |- skos__scopeNote mesh__D012797
% 218.18/218.35       A benign, inflammatory, variably ulcerated, occasionally bilateral, self-healing lesion of the minor salivary glands that is often confused clinically and histologically with carcinoma.%A%    
% 218.18/218.35  |- skos__prefLabel mesh__D012797 Sialometaplasia, Necrotizing
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D012797 1999
% 218.18/218.35  |- skos__historyNote mesh__D012797 Salivary Glands, Minor %28%1979-1982%29%
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D012797 1994
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D012797 2002
% 218.18/218.35  |- skos__historyNote mesh__D012797 Metaplasia %28%1966-1982%29%
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D012797 1998
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D012797 2001
% 218.18/218.35  |- skos__hiddenLabel mesh__D012797 Sialometaplasias, Necrotizing
% 218.18/218.35  |- skos__prefLabel mesh__D031951 Resedaceae
% 218.18/218.35  |- mesh__dateCreated mesh__D031951 2002-07-03
% 218.18/218.35  |- mesh__historyNote mesh__D031951 2003   
% 218.18/218.35  |- rdf__type mesh__D031951sskos__Concept
% 218.18/218.35  |- skos__annotation mesh__D031951
% 218.18/218.35       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D031951 2003
% 218.18/218.35  |- mesh__publicMeSHNote mesh__D031951 2003   
% 218.18/218.35  |- skos__scopeNote mesh__D031951
% 218.18/218.35       A plant family of the order Capparales, subclass Dilleniidae, class Magnoliopsida. It is a small family of herbs and shrubs. Some produce GLUCOSINOLATES.%A%    
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D031951 2005
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D031951 2004
% 218.18/218.35  |- mesh__dateEstablished mesh__D031951 2003-01-01
% 218.18/218.35  |- skos__broader mesh__D031951smesh__D019684
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D031951 2006
% 218.18/218.35  |- skos__altLabel mesh__D017482 Thromboxane Receptors
% 218.18/218.35  |- skos__altLabel mesh__D017482 TP Receptors
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D017482 2006
% 218.18/218.35  |- skos__hiddenLabel mesh__D017482 Thromboxanes Receptors
% 218.18/218.35  |- skos__hiddenLabel mesh__D017482 Receptors, TP
% 218.18/218.35  |- mesh__onlineNote mesh__D017482
% 218.18/218.35       use RECEPTORS, THROMBOXANE %28%NM%29% to search THROMBOXANE RECEPTOR 1981-92%A%  
% 218.18/218.35  |- mesh__historyNote mesh__D017482
% 218.18/218.35       93; was THROMBOXANE RECEPTOR %28%NM%29% 1981-92   
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D017482 2005
% 218.18/218.35  |- mesh__publicMeSHNote mesh__D017482
% 218.18/218.35       93; THROMBOXANE RECEPTOR was indexed under RECEPTORS, PROSTAGLANDIN 1981-92%A%  
% 218.18/218.35  |- mesh__recordOriginator mesh__D017482 PXP
% 218.18/218.35  |- mesh__dateCreated mesh__D017482 1992-05-22
% 218.18/218.35  |- skos__altLabel mesh__D017482 Receptors, Thromboxanes
% 218.18/218.35  |- mesh__dateRevised mesh__D017482 2003-07-09
% 218.18/218.35  |- skos__scopeNote mesh__D017482
% 218.18/218.35       Cell surface proteins that bind THROMBOXANES with high affinity and trigger intracellular changes influencing the behavior of cells. Some thromboxane receptors act via the inositol phosphate and diacylglycerol second messenger systems.%A%    
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D017482 2004
% 218.18/218.35  |- rdf__type mesh__D017482sskos__Concept
% 218.18/218.35  |- mesh__recordAuthorizer mesh__D017482 sjn
% 218.18/218.35  |- skos__historyNote mesh__D017482
% 218.18/218.35       Receptors, Prostaglandin %28%1981-1992%29%
% 218.18/218.35  |- skos__altLabel mesh__D017482 TP Receptor
% 218.18/218.35  |- skos__hiddenLabel mesh__D017482 Receptor, TP
% 218.18/218.35  |- skos__annotation mesh__D017482
% 218.18/218.35       coord IM with specific thromboxane %28%IM%29%; RECEPTORS, THROMBOXANE A2 is also available; DF: TP RECEPT%A%  
% 218.18/218.35  |- mesh__dateEstablished mesh__D017482 1993-01-01
% 218.18/218.35  |- skos__altLabel mesh__D017482 Thromboxane Receptor
% 218.18/218.35  |- skos__hiddenLabel mesh__D017482 Receptor, Thromboxane
% 218.18/218.35  |- skos__broader mesh__D017482smesh__D018055
% 218.18/218.35  |- mesh__recordMaintainer mesh__D017482 jmp
% 218.18/218.35  |- skos__prefLabel mesh__D017482 Receptors, Thromboxane
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D003462 2002
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D003462 2001
% 218.18/218.35  |- rdf__type mesh__D003462sskos__Concept
% 218.18/218.35  |- skos__scopeNote mesh__D003462
% 218.18/218.35       An island in the Greater Antilles in the West Indies, south of Florida. With the adjacent islands it forms the Republic of Cuba. Its capital is Havana. It was discovered by Columbus on his first voyage in 1492 and conquered by Spain in 1511. It has a varied history under Spain, Great Britain, and the United States but has been independent since 1902. The name Cuba is said to be an Indian name of unknown origin but the language that gave the name is extinct, so the etymology is a conjecture. %28%From Webster%27%s New Geographical Dictionary, 1988, p302 %26% Room, Brewer%27%s Dictionary of Names, 1992, p132%29%%A%    
% 218.18/218.35  |- skos__broader mesh__D003462smesh__D014900
% 218.18/218.35  |- skos__annotation mesh__D003462
% 218.18/218.35       an island in the Greater Antilles in the West Indies   
% 218.18/218.35  |- mesh__recordMaintainer mesh__D003462 TGC
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D003462 2000
% 218.18/218.35  |- mesh__dateRevised mesh__D003462 1995-02-17
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D003462 2004
% 218.18/218.35  |- mesh__recordOriginator mesh__D003462 NLM
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D003462 1997
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D003462 2006
% 218.18/218.35  |- skos__prefLabel mesh__D003462 Cuba
% 218.18/218.35  |- mesh__dateCreated mesh__D003462 1999-01-01
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D003462 1999
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D003462 2003
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D003462 1996
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D003462 2005
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D003462 1998
% 218.18/218.35  |- mesh__recordAuthorizer mesh__D003462 PLS
% 218.18/218.35  |- mesh__dateEstablished mesh__D041581 2004-01-01
% 218.18/218.35  |- mesh__recordOriginator mesh__D041581 ags
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D041581 2006
% 218.18/218.35  |- skos__broader mesh__D041581smesh__D017013
% 218.18/218.35  |- mesh__recordMaintainer mesh__D041581 SYSTEM
% 218.18/218.35  |- rdf__type mesh__D041581sskos__Concept
% 218.18/218.35  |- mesh__dateCreated mesh__D041581 2003-07-09
% 218.18/218.35  |- skos__historyNote mesh__D041581 Bacteria %28%1982-2003%29%
% 218.18/218.35  |- mesh__recordAuthorizer mesh__D041581 sjn
% 218.18/218.35  |- mesh__historyNote mesh__D041581 2004   
% 218.18/218.35  |- skos__prefLabel mesh__D041581 Methanobrevibacter
% 218.18/218.35  |- mesh__dateRevised mesh__D041581 2005-06-30
% 218.18/218.35  |- mesh__publicMeSHNote mesh__D041581 2004   
% 218.18/218.35  |- skos__scopeNote mesh__D041581
% 218.18/218.35       A genus of gram-positive, anaerobic, cocci to short rod-shaped ARCHAEA, in the family METHANOBACTERIACEAE, order METHANOBACTERIALES.  They are found in the GASTROINTESTINAL TRACT or other anoxic environments.%A%    
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D013890 2002
% 218.18/218.35  |- skos__scopeNote mesh__D013890
% 218.18/218.35       A photographic fixative used also in the manufacture of resins.  According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%, this substance may reasonably be anticipated to be a carcinogen %28%Merck Index, 9th ed%29%. Many of its derivatives are ANTITHYROID AGENTS and/or FREE RADICAL SCAVENGERS.%A%    
% 218.18/218.35  |- mesh__recordMaintainer mesh__D013890 jls
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D013890 2004
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D013890 2003
% 218.18/218.35  |- skos__broader mesh__D013890smesh__D014508
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D013890 2001
% 218.18/218.35  |- skos__annotation mesh__D013890 a thyroid antag   
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D013890 2006
% 218.18/218.35  |- mesh__dateCreated mesh__D013890 1999-01-01
% 218.18/218.35  |- skos__broader mesh__D013890smesh__D013457
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D013890 2005
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D013890 2000
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D013890 2005A
% 218.18/218.35  |- rdf__type mesh__D013890sskos__Concept
% 218.18/218.35  |- mesh__recordAuthorizer mesh__D013890 jls
% 218.18/218.35  |- mesh__recordOriginator mesh__D013890 NLM
% 218.18/218.35  |- mesh__dateRevised mesh__D013890 2004-08-02
% 218.18/218.35  |- skos__prefLabel mesh__D013890 Thiourea
% 218.18/218.35  |- skos__broader mesh__D013092smesh__D000988
% 218.18/218.35  |- skos__hiddenLabel mesh__D013092 Agents, Spermatogenesis Blocking
% 218.18/218.35  |- mesh__recordOriginator mesh__D013092 NLM
% 218.18/218.35  |- mesh__dateEstablished mesh__D013092 1975-01-01
% 218.18/218.35  |- mesh__dateCreated mesh__D013092 1999-01-01
% 218.18/218.35  |- mesh__activeMeSHYear mesh__D013092 2006
% 218.18/218.35  |- skos__historyNote mesh__D013092 Contraceptive Agents %28%1967-1974%29%
% 218.18/218.35  |- mesh__publicMeSHNote mesh__D013092
% 218.18/218.35       94; was SPERMATOGENESIS BLOCKING AGENTS 1975-93   
% 218.18/218.35  |- skos__scopeNote mesh__D013092
% 218.18/218.35       Chemical substances which inhibit the process of spermatozoa formation at either the first stage, in which spermatogonia develop into spermatocytes and then into spermatids, or the second stage, in which spermatids transform into spermatozoa.%A%    
% 218.18/218.35  |- skos__hiddenLabel mesh__D013092 Agents, Spermatogenesis-Blocking
% 218.18/218.35  |- mesh__historyNote mesh__D013092
% 218.18/218.35       94; was SPERMATOGENESIS BLOCKING AGENTS 1975-93   
% 218.18/218.35  |- skos__prefLabel mesh__D013092 Spermatogenesis-Blocking Agents
% 218.18/218.35  |- skos__historyNote mesh__D013092
% 218.18/218.35       Spermatogenesis/drug effects %28%1971-1974%29%
% 218.18/218.35  |- mesh__onlineNote mesh__D013092
% 218.18/218.35       use SPERMATOGENESIS-BLOCKING AGENTS to search SPERMATOGENESIS BLOCKING AGENTS 1975-93%A%  
% 218.18/218.35  |- mesh__dateRevised mesh__D013092 2005-06-30
% 218.18/218.35  |- mesh__recordMaintainer mesh__D013092 ssb
% 218.18/218.35  |- rdf__type mesh__D013092sskos__Concept
% 218.18/218.35  |- skos__annotation mesh__D013092
% 218.18/218.35       consider also SPERMATOGENESIS /drug eff %26% ANTISPERMATOGENIC AGENTS%A%  
% 218.18/218.35  |- mesh__recordAuthorizer mesh__D013092 sjn
% 218.18/218.35  |- skos__altLabel mesh__D013092 Spermatogenesis Blocking Agents
% 218.18/218.36  |- mesh__recordMaintainer mesh__D007055 PLS
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007055 1992
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007055 1999
% 218.18/218.36  |- skos__prefLabel mesh__D007055 Iceland
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007055 2001
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007055 2006
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007055 1995
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007055 1990
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007055 2000
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007055 1998
% 218.18/218.36  |- mesh__recordOriginator mesh__D007055 NLM
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007055 2005
% 218.18/218.36  |- rdf__type mesh__D007055sskos__Concept
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007055 1994
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007055 1989
% 218.18/218.36  |- mesh__recordAuthorizer mesh__D007055 PLS
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007055 1997
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007055 2002
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007055 2004
% 218.18/218.36  |- mesh__dateCreated mesh__D007055 1999-01-01
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007055 1991
% 218.18/218.36  |- skos__broader mesh__D007055smesh__D005060
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007055 1993
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007055 1996
% 218.18/218.36  |- mesh__dateRevised mesh__D007055 1991-11-14
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007055 2003
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D012798 2005
% 218.18/218.36  |- mesh__recordOriginator mesh__D012798 SMH
% 218.18/218.36  |- mesh__dateCreated mesh__D012798 1976-04-27
% 218.18/218.36  |- rdf__type mesh__D012798sskos__Concept
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D012798 2001
% 218.18/218.36  |- skos__annotation mesh__D012798 %22%increased salivary flow%22%   
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D012798 2004
% 218.18/218.36  |- skos__broader mesh__D012798smesh__D012466
% 218.18/218.36  |- mesh__dateRevised mesh__D012798 1991-06-19
% 218.18/218.36  |- skos__historyNote mesh__D012798 Salivation %28%1966-1976%29%
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D012798 2000
% 218.18/218.36  |- mesh__onlineNote mesh__D012798 search SALIVARY GLAND DISEASES 1966-74   
% 218.18/218.36  |- skos__altLabel mesh__D012798 Hypersalivation
% 218.18/218.36  |- mesh__recordMaintainer mesh__D012798 TGC
% 218.18/218.36  |- mesh__historyNote mesh__D012798
% 218.18/218.36       77; was see under SALIVARY GLAND DISEASES 1965-74   
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D012798 2003
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D012798 1995
% 218.18/218.36  |- skos__prefLabel mesh__D012798 Sialorrhea
% 218.18/218.36  |- mesh__dateEstablished mesh__D012798 1977-01-01
% 218.18/218.36  |- mesh__recordAuthorizer mesh__D012798 PLS
% 218.18/218.36  |- mesh__publicMeSHNote mesh__D012798
% 218.18/218.36       77; was see under SALIVARY GLAND DISEASES 1965-74   
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D012798 1999
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D012798 1994
% 218.18/218.36  |- skos__scopeNote mesh__D012798 Increased salivary flow.     
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D012798 1998
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D012798 1993
% 218.18/218.36  |- skos__historyNote mesh__D012798
% 218.18/218.36       Salivary Gland Diseases %28%1966-1976%29%
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D012798 1997
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D012798 1992
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D012798 2006
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D012798 2002
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D012798 1996
% 218.18/218.36  |- mesh__dateEstablished mesh__D031952 2003-01-01
% 218.18/218.36  |- skos__prefLabel mesh__D031952 Ceanothus
% 218.18/218.36  |- rdf__type mesh__D031952sskos__Concept
% 218.18/218.36  |- mesh__dateCreated mesh__D031952 2002-07-03
% 218.18/218.36  |- skos__scopeNote mesh__D031952
% 218.18/218.36       A plant genus of the family RHAMNACEAE. Root nodules host the Frankia  %28%ACTINOMYCETES%29% nitrogen-fixing bacteria.%A%    
% 218.18/218.36  |- skos__annotation mesh__D031952
% 218.18/218.36       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.18/218.36  |- mesh__historyNote mesh__D031952 2003   
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D031952 2003
% 218.18/218.36  |- mesh__publicMeSHNote mesh__D031952 2003   
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D031952 2004
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D031952 2005
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D031952 2006
% 218.18/218.36  |- skos__broader mesh__D031952smesh__D027823
% 218.18/218.36  |- skos__scopeNote mesh__D017483
% 218.18/218.36       Specific molecular sites or structures on or in cells that vasopressins react or to which they bind in order to modify the function of the cells. Two types of vasopressin receptor exist, the V1 receptor and the V2 receptor. The V1 receptor can be subdivided into V1a and V1b %28%formerly V3%29% receptors.%A%    
% 218.18/218.36  |- skos__broader mesh__D017483smesh__D018013
% 218.18/218.36  |- mesh__dateRevised mesh__D017483 2003-07-09
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D017483 2004
% 218.18/218.36  |- rdf__type mesh__D017483sskos__Concept
% 218.18/218.36  |- skos__historyNote mesh__D017483
% 218.18/218.36       Receptors, Cell Surface %28%1981-1984%29%
% 218.18/218.36  |- skos__altLabel mesh__D017483 Receptors, V2
% 218.18/218.36  |- skos__broader mesh__D017483smesh__D011979
% 218.18/218.36  |- mesh__recordOriginator mesh__D017483 PXP
% 218.18/218.36  |- skos__altLabel mesh__D017483 Vasopressin Receptors
% 218.18/218.36  |- skos__altLabel mesh__D017483 Receptors, V1
% 218.18/218.36  |- skos__hiddenLabel mesh__D017483 Receptor, V1
% 218.18/218.36  |- skos__altLabel mesh__D017483 V1 Receptor
% 218.18/218.36  |- skos__historyNote mesh__D017483 Receptors, Angiotensin %28%1984-1992%29%
% 218.18/218.36  |- skos__hiddenLabel mesh__D017483 Receptor, V2
% 218.18/218.36  |- skos__altLabel mesh__D017483 Vasopressin Receptor
% 218.18/218.36  |- mesh__historyNote mesh__D017483
% 218.18/218.36       93; was VASOPRESSIN RECEPTOR %28%NM%29% 1981-92   
% 218.18/218.36  |- mesh__publicMeSHNote mesh__D017483
% 218.18/218.36       93; VASOPRESSIN RECEPTOR was indexed under RECEPTORS, ANGIOTENSIN 1984-92 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1981-84%A%  
% 218.18/218.36  |- mesh__onlineNote mesh__D017483
% 218.18/218.36       use RECEPTORS, VASOPRESSIN %28%NM%29% to search VASOPRESSIN RECEPTOR 1981-92%A%  
% 218.18/218.36  |- skos__annotation mesh__D017483
% 218.18/218.36       coord IM with specific vasopressin %28%IM%29%; DF: RECEPT VASOPRESSIN%A%  
% 218.18/218.36  |- skos__altLabel mesh__D017483 V2 Receptors
% 218.18/218.36  |- skos__prefLabel mesh__D017483 Receptors, Vasopressin
% 218.18/218.36  |- mesh__recordMaintainer mesh__D017483 jmp
% 218.18/218.36  |- skos__broader mesh__D017483smesh__D043562
% 218.18/218.36  |- skos__hiddenLabel mesh__D017483 Receptor, Vasopressin
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D017483 2006
% 218.18/218.36  |- mesh__dateCreated mesh__D017483 1992-05-22
% 218.18/218.36  |- mesh__recordAuthorizer mesh__D017483 sjn
% 218.18/218.36  |- mesh__dateEstablished mesh__D017483 1993-01-01
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D017483 2005
% 218.18/218.36  |- rdf__type mesh__D003463sskos__Concept
% 218.18/218.36  |- mesh__dateRevised mesh__D003463 1989-04-28
% 218.18/218.36  |- skos__scopeNote mesh__D003463
% 218.18/218.36       Signals for an action; that specific portion of a perceptual field or pattern of stimuli to which a subject has learned to respond.%A%    
% 218.18/218.36  |- mesh__recordAuthorizer mesh__D003463 PLS
% 218.18/218.36  |- mesh__historyNote mesh__D003463 66%28%64%29%   
% 218.18/218.36  |- mesh__recordMaintainer mesh__D003463 TGC
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D003463 2002
% 218.18/218.36  |- mesh__dateEstablished mesh__D003463 1966-01-01
% 218.18/218.36  |- skos__broader mesh__D003463smesh__D007858
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D003463 2004
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D003463 2001
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D003463 1997
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D003463 2006
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D003463 1991
% 218.18/218.36  |- mesh__dateCreated mesh__D003463 1999-01-01
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D003463 1999
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D003463 2003
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D003463 2005
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D003463 2000
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D003463 1996
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D003463 1993
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D003463 1990
% 218.18/218.36  |- skos__annotation mesh__D003463 no qualif   
% 218.18/218.36  |- mesh__publicMeSHNote mesh__D003463 66   
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D003463 1995
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D003463 1998
% 218.18/218.36  |- mesh__recordOriginator mesh__D003463 NLM
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D003463 1992
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D003463 1994
% 218.18/218.36  |- skos__hiddenLabel mesh__D003463 Cue
% 218.18/218.36  |- skos__prefLabel mesh__D003463 Cues
% 218.18/218.36  |- skos__broader mesh__D004958Q000037smesh__D004958
% 218.18/218.36  |- mesh__preferredCombination mesh__D004958Q000037smesh__D004959
% 218.18/218.36  |- rdf__type mesh__D004958Q000037smesh__CompoundConcept
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D013891 2006
% 218.18/218.36  |- mesh__dateCreated mesh__D013891 1999-01-01
% 218.18/218.36  |- skos__historyNote mesh__D013891 Uridine %28%1966-1971%29%
% 218.18/218.36  |- mesh__recordOriginator mesh__D013891 NLM
% 218.18/218.36  |- mesh__recordMaintainer mesh__D013891 ssb
% 218.18/218.36  |- skos__broader mesh__D013891smesh__D014529
% 218.18/218.36  |- rdf__type mesh__D013891sskos__Concept
% 218.18/218.36  |- skos__scopeNote mesh__D013891
% 218.18/218.36       A photoactivable URIDINE analog that is used as an affinity label.%A%    
% 218.18/218.36  |- mesh__historyNote mesh__D013891 74%28%72%29%   
% 218.18/218.36  |- skos__altLabel mesh__D013891 4-Thiouridine
% 218.18/218.36  |- skos__hiddenLabel mesh__D013891 4 Thiouridine
% 218.18/218.36  |- mesh__dateEstablished mesh__D013891 1974-01-01
% 218.18/218.36  |- mesh__dateRevised mesh__D013891 2005-06-30
% 218.18/218.36  |- skos__prefLabel mesh__D013891 Thiouridine
% 218.18/218.36  |- skos__broader mesh__D013891smesh__D013872
% 218.18/218.36  |- skos__annotation mesh__D013891 an antimetabolite   
% 218.18/218.36  |- mesh__recordAuthorizer mesh__D013891 sjn
% 218.18/218.36  |- mesh__publicMeSHNote mesh__D013891 74   
% 218.18/218.36  |- mesh__dateEstablished mesh__D013093 1991-01-01
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D013093 2006
% 218.18/218.36  |- skos__prefLabel mesh__D013093 Spermatogonia
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D013093 2003
% 218.18/218.36  |- mesh__recordAuthorizer mesh__D013093 sjn
% 218.18/218.36  |- skos__hiddenLabel mesh__D013093 Spermatogonias
% 218.18/218.36  |- mesh__recordMaintainer mesh__D013093 lkt
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D013093 2004
% 218.18/218.36  |- mesh__recordOriginator mesh__D013093 NLM
% 218.18/218.36  |- skos__hiddenLabel mesh__D013093 Spermatophore
% 218.18/218.36  |- mesh__dateRevised mesh__D013093 2002-07-03
% 218.18/218.36  |- rdf__type mesh__D013093sskos__Concept
% 218.18/218.36  |- skos__altLabel mesh__D013093 Spermatophores
% 218.18/218.36  |- mesh__publicMeSHNote mesh__D013093
% 218.18/218.36       91; was see under SPERMATOZOA 1975-90   
% 218.18/218.36  |- skos__broader mesh__D013093smesh__D013094
% 218.18/218.36  |- skos__scopeNote mesh__D013093
% 218.18/218.36       Euploid male germ cells of an early stage of SPERMATOGENESIS, derived from prespermatogonia. With the onset of puberty, spermatogonia at the basement membrane of the seminiferous tubule proliferate by mitotic then meiotic divisions and give rise to the haploid SPERMATOCYTES.%A%    
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D013093 2005
% 218.18/218.36  |- mesh__historyNote mesh__D013093
% 218.18/218.36       91%28%75%29%; was see under SPERMATOZOA 1975-90   
% 218.18/218.36  |- mesh__dateCreated mesh__D013093 1974-11-11
% 218.18/218.36  |- skos__scopeNote mesh__D007854
% 218.18/218.36       A soft, grayish metal with poisonous salts; atomic number 82, atomic weight 207.19, symbol Pb. %28%Dorland, 28th%29%%A%    
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007854 2004
% 218.18/218.36  |- skos__annotation mesh__D007854
% 218.18/218.36       Pb-208; Pb-204, 206, 207 = LEAD %28%IM%29% + ISOTOPES %28%NIM%29%; Pb-194-203, 205, 209-214 = LEAD RADIOISOTOPES %28%IM%29%%A%  
% 218.18/218.36  |- skos__prefLabel mesh__D007854 Lead
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007854 1998
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007854 2006
% 218.18/218.36  |- mesh__dateRevised mesh__D007854 1997-06-20
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007854 2003
% 218.18/218.36  |- skos__broader mesh__D007854smesh__D019216
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007854 2005
% 218.18/218.36  |- mesh__recordAuthorizer mesh__D007854 SJN
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007854 2002
% 218.18/218.36  |- skos__related mesh__D007854smesh__D007856
% 218.18/218.36  |- mesh__recordMaintainer mesh__D007854 ADP
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007854 2001
% 218.18/218.36  |- rdf__type mesh__D007854sskos__Concept
% 218.18/218.36  |- mesh__dateCreated mesh__D007854 1999-01-01
% 218.18/218.36  |- mesh__recordOriginator mesh__D007854 NLM
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007854 1999
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007854 2000
% 218.18/218.36  |- skos__broader mesh__D013909Q000530smesh__D013909
% 218.18/218.36  |- mesh__preferredCombination mesh__D013909Q000530smesh__D013902
% 218.18/218.36  |- rdf__type mesh__D013909Q000530smesh__CompoundConcept
% 218.18/218.36  |- skos__historyNote mesh__D012799 Transferases %28%1972-1974%29%
% 218.18/218.36  |- mesh__historyNote mesh__D012799
% 218.18/218.36       87%28%79%29%; was see under TRANSFERASES 1979-86; was SIALYLTRANSFERASE see under TRANSFERASES 1975-78%A%  
% 218.18/218.36  |- mesh__onlineNote mesh__D012799
% 218.18/218.36       use SIALYLTRANSFERASES to search SIALYLTRANSFERASE 1975-78%A%  
% 218.18/218.36  |- skos__prefLabel mesh__D012799 Sialyltransferases
% 218.18/218.36  |- mesh__dateCreated mesh__D012799 1974-11-19
% 218.18/218.36  |- skos__historyNote mesh__D012799 Neuraminic Acids %28%1972-1974%29%
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D012799 2006
% 218.18/218.36  |- skos__scopeNote mesh__D012799
% 218.18/218.36       A group of enzymes with the general formula CMP-N-acetylneuraminate:acceptor N-acetylneuraminyl transferase. They catalyze the transfer of N-acetylneuraminic acid from CMP-N-acetylneuraminic acid to an acceptor, which is usually the terminal sugar residue of an oligosaccharide, a glycoprotein, or a glycolipid. EC 2.4.99.-.%A%    
% 218.18/218.36  |- mesh__recordOriginator mesh__D012799 NLM
% 218.18/218.36  |- rdf__type mesh__D012799sskos__Concept
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D012799 2005
% 218.18/218.36  |- skos__broader mesh__D012799smesh__D016695
% 218.18/218.36  |- skos__hiddenLabel mesh__D012799 Sialyltransferase, Glycoprotein
% 218.18/218.36  |- mesh__dateEstablished mesh__D012799 1987-01-01
% 218.18/218.36  |- skos__hiddenLabel mesh__D012799 Sialyltransferases, Glycoprotein
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D012799 2004
% 218.18/218.36  |- mesh__publicMeSHNote mesh__D012799
% 218.18/218.36       87; was see under TRANSFERASES 1979-86; was SIALYLTRANSFERASE see under TRANSFERASES 1975-78%A%  
% 218.18/218.36  |- mesh__dateRevised mesh__D012799 2003-07-09
% 218.18/218.36  |- mesh__recordAuthorizer mesh__D012799 sjn
% 218.18/218.36  |- skos__altLabel mesh__D012799 Glycoprotein Sialyltransferases
% 218.18/218.36  |- mesh__recordMaintainer mesh__D012799 ssb
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D031953 2005
% 218.18/218.36  |- skos__annotation mesh__D031953
% 218.18/218.36       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.18/218.36  |- rdf__type mesh__D031953sskos__Concept
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D031953 2004
% 218.18/218.36  |- skos__broader mesh__D031953smesh__D027823
% 218.18/218.36  |- mesh__dateCreated mesh__D031953 2002-07-03
% 218.18/218.36  |- mesh__publicMeSHNote mesh__D031953 2003   
% 218.18/218.36  |- mesh__historyNote mesh__D031953 2003   
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D031953 2003
% 218.18/218.36  |- skos__prefLabel mesh__D031953 Colubrina
% 218.18/218.36  |- skos__scopeNote mesh__D031953
% 218.18/218.36       A plant genus of the family RHAMNACEAE. Members contain antifungal jujubogenin saponins.%A%    
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D031953 2006
% 218.18/218.36  |- mesh__dateEstablished mesh__D031953 2003-01-01
% 218.18/218.36  |- skos__hiddenLabel mesh__D017484 Dermatitis, Phototoxic Contact
% 218.18/218.36  |- skos__scopeNote mesh__D017484
% 218.18/218.36       A nonimmunologic, chemically induced type of photosensitivity producing a sometimes vesiculating dermatitis. It results in hyperpigmentation and desquamation of the light-exposed areas of the skin.%A%    
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D017484 2002
% 218.18/218.36  |- mesh__recordMaintainer mesh__D017484 TAP
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D017484 1994
% 218.18/218.36  |- skos__hiddenLabel mesh__D017484 Contact Dermatitides, Phototoxic
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D017484 2003
% 218.18/218.36  |- mesh__dateRevised mesh__D017484 1993-06-02
% 218.18/218.36  |- skos__prefLabel mesh__D017484 Dermatitis, Phototoxic
% 218.18/218.36  |- mesh__dateEstablished mesh__D017484 1993-01-01
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D017484 1999
% 218.18/218.36  |- mesh__publicMeSHNote mesh__D017484
% 218.18/218.36       93; PHOTOTOXICITY was see PHOTOSENSITIVITY DISORDERS 1979-92%A%  
% 218.18/218.36  |- skos__hiddenLabel mesh__D017484 Contact Dermatitis, Phototoxic
% 218.18/218.36  |- mesh__recordAuthorizer mesh__D017484 PLS
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D017484 2001
% 218.18/218.36  |- skos__annotation mesh__D017484
% 218.18/218.36       non-immunol irritant dermatitis; DF: DERMATITIS PHOTOTOX   
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D017484 2000
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D017484 1998
% 218.18/218.36  |- skos__altLabel mesh__D017484 Dermatitis, Contact, Phototoxic
% 218.18/218.36  |- mesh__recordOriginator mesh__D017484 PLS
% 218.18/218.36  |- skos__broader mesh__D017484smesh__D010787
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D017484 1997
% 218.18/218.36  |- mesh__historyNote mesh__D017484
% 218.18/218.36       93; PHOTOTOXICITY was see PHOTOSENSITIVITY DISORDERS 1979-92%A%  
% 218.18/218.36  |- skos__historyNote mesh__D017484
% 218.18/218.36       Photosensitivity Disorders %28%1966-1992%29%
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D017484 2006
% 218.18/218.36  |- skos__broader mesh__D017484smesh__D017453
% 218.18/218.36  |- skos__hiddenLabel mesh__D017484 Phototoxic Dermatitides
% 218.18/218.36  |- skos__altLabel mesh__D017484 Phototoxic Contact Dermatitis
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D017484 1996
% 218.18/218.36  |- mesh__onlineNote mesh__D017484
% 218.18/218.36       use PHOTOSENSITIVITY DISORDERS to search PHOTOTOXICITY 1979-92%A%  
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D017484 2005
% 218.18/218.36  |- skos__hiddenLabel mesh__D017484 Dermatitides, Phototoxic Contact
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D017484 1995
% 218.18/218.36  |- rdf__type mesh__D017484sskos__Concept
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D017484 2004
% 218.18/218.36  |- skos__hiddenLabel mesh__D017484 Phototoxic Contact Dermatitides
% 218.18/218.36  |- skos__hiddenLabel mesh__D017484 Dermatitides, Phototoxic
% 218.18/218.36  |- skos__altLabel mesh__D017484 Phototoxic Dermatitis
% 218.18/218.36  |- mesh__dateCreated mesh__D017484 1992-05-20
% 218.18/218.36  |- skos__altLabel mesh__D003464 Culdoscopic Surgery
% 218.18/218.36  |- skos__broader mesh__D003464smesh__D003944
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D003464 2006
% 218.18/218.36  |- mesh__dateCreated mesh__D003464 1999-01-01
% 218.18/218.36  |- skos__hiddenLabel mesh__D003464 Procedures, Culdoscopic Surgical
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D003464 2003
% 218.18/218.36  |- mesh__recordOriginator mesh__D003464 NLM
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D003464 2005
% 218.18/218.36  |- skos__scopeNote mesh__D003464
% 218.18/218.36       Endoscopic examination, therapy or surgery of the female pelvic viscera by means of an endoscope introduced into the pelvic cavity through the posterior vaginal fornix.%A%    
% 218.18/218.36  |- mesh__recordAuthorizer mesh__D003464 sjn
% 218.18/218.36  |- skos__hiddenLabel mesh__D003464 Culdoscopic Surgical Procedure
% 218.18/218.36  |- skos__hiddenLabel mesh__D003464 Surgeries, Culdoscopic
% 218.18/218.36  |- skos__prefLabel mesh__D003464 Culdoscopy
% 218.18/218.36  |- skos__altLabel mesh__D003464 Surgery, Culdoscopic
% 218.18/218.36  |- mesh__recordMaintainer mesh__D003464 nns
% 218.18/218.36  |- skos__broader mesh__D003464smesh__D013509
% 218.18/218.36  |- skos__hiddenLabel mesh__D003464 Surgical Procedure, Culdoscopic
% 218.18/218.36  |- rdf__type mesh__D003464sskos__Concept
% 218.18/218.36  |- skos__hiddenLabel mesh__D003464 Procedure, Culdoscopic Surgical
% 218.18/218.36  |- mesh__dateRevised mesh__D003464 2002-07-03
% 218.18/218.36  |- skos__broader mesh__D003464smesh__D013513
% 218.18/218.36  |- skos__hiddenLabel mesh__D003464 Culdoscopic Surgeries
% 218.18/218.36  |- skos__broader mesh__D003464smesh__D004724
% 218.18/218.36  |- skos__hiddenLabel mesh__D003464 Culdoscopies
% 218.18/218.36  |- skos__altLabel mesh__D003464 Surgical Procedures, Culdoscopic
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D003464 2004
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D013892 2001
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D013892 2005
% 218.18/218.36  |- rdf__type mesh__D013892sskos__Concept
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D013892 2000
% 218.18/218.36  |- mesh__historyNote mesh__D013892 74   
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D013892 1997
% 218.18/218.36  |- mesh__recordOriginator mesh__D013892 NLM
% 218.18/218.36  |- skos__prefLabel mesh__D013892 Thioxanthenes
% 218.18/218.36  |- mesh__dateRevised mesh__D013892 1992-05-20
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D013892 1993
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D013892 1996
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D013892 2004
% 218.18/218.36  |- mesh__recordMaintainer mesh__D013892 TAP
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D013892 2002
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D013892 1999
% 218.18/218.36  |- mesh__recordAuthorizer mesh__D013892 PLS
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D013892 2003
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D013892 1995
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D013892 1998
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D013892 2006
% 218.18/218.36  |- mesh__dateEstablished mesh__D013892 1974-01-01
% 218.18/218.36  |- mesh__dateCreated mesh__D013892 1999-01-01
% 218.18/218.36  |- skos__broader mesh__D013892smesh__D014966
% 218.18/218.36  |- mesh__publicMeSHNote mesh__D013892
% 218.18/218.36       74; CLOPENTHIXOL was see under TRANQUILIZING AGENTS 1967-74%A%  
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D013892 1994
% 218.18/218.36  |- mesh__historyNote mesh__D013094
% 218.18/218.36       1963; for X-BEARING SPERM use X CHROMOSOME 1980-2005; for Y-BEARING SPERM use Y CHROMOSOME 1980-2005%A%  
% 218.18/218.36  |- skos__hiddenLabel mesh__D013094 Sperms, X-Bearing
% 218.18/218.36  |- mesh__publicMeSHNote mesh__D013094
% 218.18/218.36       1963; for X-BEARING SPERM see X CHROMOSOME 1980-2005; for Y-BEARING SPERM see Y CHROMOSOME 1980-2005%A%  
% 218.18/218.36  |- skos__hiddenLabel mesh__D013094 Sperm, X-Chromosome-Bearing
% 218.18/218.36  |- mesh__dateRevised mesh__D013094 2005-06-30
% 218.18/218.36  |- skos__prefLabel mesh__D013094 Spermatozoa
% 218.18/218.36  |- skos__hiddenLabel mesh__D013094 X Chromosome Bearing Sperm
% 218.18/218.36  |- skos__related mesh__D013094smesh__D013089
% 218.18/218.36  |- skos__altLabel mesh__D013094 Y-Bearing Sperm
% 218.18/218.36  |- skos__altLabel mesh__D013094 Spermatozoon
% 218.18/218.36  |- skos__broader mesh__D013094smesh__D005854
% 218.18/218.36  |- skos__altLabel mesh__D013094 X-Bearing Sperm
% 218.18/218.36  |- skos__hiddenLabel mesh__D013094 Sperms, Y-Chromosome-Bearing
% 218.18/218.36  |- skos__hiddenLabel mesh__D013094 Sperms, Y-Bearing
% 218.18/218.36  |- skos__hiddenLabel mesh__D013094 Sperm, X-Bearing
% 218.18/218.36  |- skos__hiddenLabel mesh__D013094 X-Bearing Sperms
% 218.18/218.36  |- skos__annotation mesh__D013094
% 218.18/218.36       polyspermia %26% polyspermy = SPERMATOZOA if excessive sperm or = FERTILIZATION if fertilization of ovum by more than one sperm; sperm donors: coordinate SPERMATOZOA %28%IM%29% + TISSUE DONORS %28%IM%29%; consider also INSEMINATION, ARTIFICIAL, HOMOLOGOUS %28%husband%29%%28%IM%29% or INSEMINATION, ARTIFICIAL, HETEROLOGOUS %28%non-husband%29%%28%IM%29% if pertinent but note SPERM BANKS is available; SPERM PRESERVATION is available; HEMOSPERMIA is available%A%  
% 218.18/218.36  |- rdf__type mesh__D013094sskos__Concept
% 218.18/218.36  |- skos__hiddenLabel mesh__D013094 Y-Chromosome-Bearing Sperms
% 218.18/218.36  |- mesh__dateCreated mesh__D013094 1999-01-01
% 218.18/218.36  |- mesh__recordAuthorizer mesh__D013094 sjn
% 218.18/218.36  |- skos__hiddenLabel mesh__D013094 Sperm, Y-Bearing
% 218.18/218.36  |- skos__hiddenLabel mesh__D013094 X Bearing Sperm
% 218.18/218.36  |- mesh__recordMaintainer mesh__D013094 lkt
% 218.18/218.36  |- skos__related mesh__D013094smesh__D000988
% 218.18/218.36  |- skos__hiddenLabel mesh__D013094 Y-Bearing Sperms
% 218.18/218.36  |- skos__hiddenLabel mesh__D013094 Sperm, Y-Chromosome-Bearing
% 218.18/218.36  |- skos__hiddenLabel mesh__D013094 Y Bearing Sperm
% 218.18/218.36  |- skos__altLabel mesh__D013094 Sperm
% 218.18/218.36  |- skos__hiddenLabel mesh__D013094 Y Chromosome Bearing Sperm
% 218.18/218.36  |- skos__related mesh__D013094smesh__D013074
% 218.18/218.36  |- mesh__recordOriginator mesh__D013094 NLM
% 218.18/218.36  |- skos__hiddenLabel mesh__D013094 X-Chromosome-Bearing Sperms
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D013094 2006
% 218.18/218.36  |- skos__related mesh__D013094smesh__D009845
% 218.18/218.36  |- skos__hiddenLabel mesh__D013094 Sperms, X-Chromosome-Bearing
% 218.18/218.36  |- skos__scopeNote mesh__D013094
% 218.18/218.36       Mature male germ cells derived from SPERMATIDS. As spermatids move toward the lumen of the SEMINIFEROUS TUBULES, they undergo extensive structural changes including the loss of cytoplasm, condensation of CHROMATIN into the SPERM HEAD, formation of the ACROSOME cap, the SPERM MIDPIECE and the SPERM TAIL that provides motility.%A%    
% 218.18/218.36  |- skos__hiddenLabel mesh__D007855 Lead Poisonings
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007855 2003
% 218.18/218.36  |- mesh__recordOriginator mesh__D007855 NLM
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007855 2000
% 218.18/218.36  |- skos__altLabel mesh__D007855 Poisoning, Lead
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007855 2005
% 218.18/218.36  |- skos__broader mesh__D007855smesh__D011041
% 218.18/218.36  |- skos__annotation mesh__D007855
% 218.18/218.36       occup lead pois: coord IM with OCCUPATIONAL DISEASES %28%IM%29% but not also ENVIRONMENTAL EXPOSURE %28%see note there%29%; in infant or child = LEAD POISONING, NERVOUS SYSTEM, CHILDHOOD; in adolescent or adult, consider also LEAD POISONING, NERVOUS SYSTEM, ADULT%A%  
% 218.18/218.36  |- mesh__dateRevised mesh__D007855 1999-11-03
% 218.18/218.36  |- skos__prefLabel mesh__D007855 Lead Poisoning
% 218.18/218.36  |- mesh__recordAuthorizer mesh__D007855 sjn
% 218.18/218.36  |- rdf__type mesh__D007855sskos__Concept
% 218.18/218.36  |- skos__hiddenLabel mesh__D007855 Poisonings, Lead
% 218.18/218.36  |- mesh__dateCreated mesh__D007855 1999-01-01
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007855 2002
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007855 2004
% 218.18/218.36  |- mesh__recordMaintainer mesh__D007855 KEV
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007855 2001
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007855 2006
% 218.18/218.36  |- mesh__historyNote mesh__D007057
% 218.18/218.36       ERYTHRODERMA ICHTHYOSIFORME was see under ICHTHYOSIS 1963-78%A%  
% 218.18/218.36  |- skos__prefLabel mesh__D007057 Ichthyosis
% 218.18/218.36  |- mesh__recordMaintainer mesh__D007057 nns
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007057 2004
% 218.18/218.36  |- mesh__dateCreated mesh__D007057 1999-01-01
% 218.18/218.36  |- skos__hiddenLabel mesh__D007057 Xerodermas
% 218.18/218.36  |- skos__hiddenLabel mesh__D007057 Ichthyoses
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007057 2002
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007057 2003
% 218.18/218.36  |- skos__broader mesh__D007057smesh__D007232
% 218.18/218.36  |- mesh__recordAuthorizer mesh__D007057 sjn
% 218.18/218.36  |- mesh__dateRevised mesh__D007057 2001-07-25
% 218.18/218.36  |- skos__annotation mesh__D007057
% 218.18/218.36       GEN or unspecified; prefer specifics; unspecified dryness of skin is indexed under SKIN DISEASES, not here%A%  
% 218.18/218.36  |- mesh__publicMeSHNote mesh__D007057
% 218.18/218.36       ERYTHRODERMA ICHTHYOSIFORME was see under ICHTHYOSIS 1963-78%A%  
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007057 2006
% 218.18/218.36  |- skos__broader mesh__D007057smesh__D012868
% 218.18/218.36  |- skos__broader mesh__D007057smesh__D007642
% 218.18/218.36  |- mesh__onlineNote mesh__D007057
% 218.18/218.36       use ICHTHYOSIS %26% SKIN DISEASES, VESCICULOBULLOUS to search ERYTHRODERMA ICHTHYOSIFORME 1975-78; use ICHTHYOSIS 1966-74%A%  
% 218.18/218.36  |- mesh__activeMeSHYear mesh__D007057 2005
% 218.18/218.36  |- rdf__type mesh__D007057sskos__Concept
% 218.18/218.37  |- skos__scopeNote mesh__D007057
% 218.18/218.37       Any of several generalized skin disorders characterized by dryness, roughness, and scaliness, due to hypertrophy of the stratum corneum epidermis. Most are genetic, but some are acquired, developing in association with other systemic disease or genetic syndrome.%A%    
% 218.18/218.37  |- mesh__recordOriginator mesh__D007057 NLM
% 218.18/218.37  |- skos__scopeNote mesh__D031954
% 218.18/218.37       A highly malignant CHORIOCARCINOMA derived from the non-placental origin such as the totipotent cells in the TESTIS, the OVARY, and the PINEAL GLAND. It produces high levels of CHORIONIC GONADOTROPIN and can metastasize widely through the bloodstream to the lungs, brain, liver, bone, and other viscera by the time of diagnosis.%A%    
% 218.18/218.37  |- skos__hiddenLabel mesh__D031954 Choriocarcinoma, Non gestational
% 218.18/218.37  |- mesh__dateEstablished mesh__D031954 2003-01-01
% 218.18/218.37  |- rdf__type mesh__D031954sskos__Concept
% 218.18/218.37  |- skos__hiddenLabel mesh__D031954 Non gestational Choriocarcinoma
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D031954 2004
% 218.18/218.37  |- skos__altLabel mesh__D031954 Non-gestational Choriocarcinoma
% 218.18/218.37  |- skos__hiddenLabel mesh__D031954 Non-gestational Choriocarcinomas
% 218.18/218.37  |- mesh__publicMeSHNote mesh__D031954 2003   
% 218.18/218.37  |- skos__historyNote mesh__D031954 Choriocarcinoma %28%1984-2002%29%
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D031954 2003
% 218.18/218.37  |- skos__broader mesh__D031954smesh__D002822
% 218.18/218.37  |- skos__prefLabel mesh__D031954 Choriocarcinoma, Non-gestational
% 218.18/218.37  |- skos__hiddenLabel mesh__D031954 Choriocarcinomas, Non-gestational
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D031954 2006
% 218.18/218.37  |- skos__historyNote mesh__D031954
% 218.18/218.37       Trophoblastic Neoplasms %28%1986-2002%29%
% 218.18/218.37  |- mesh__dateCreated mesh__D031954 2002-07-03
% 218.18/218.37  |- mesh__historyNote mesh__D031954 2003   
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D031954 2005
% 218.18/218.37  |- skos__hiddenLabel mesh__D017485 1 Deoxymannojirimycin
% 218.18/218.37  |- mesh__recordOriginator mesh__D017485 AGS
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D017485 2002
% 218.18/218.37  |- mesh__historyNote mesh__D017485
% 218.18/218.37       93; was DEOXYNOJIRIMYCIN %28%NM%29% 1981-92; 1,5-DIDEOXY-1,5-IMINO-D-MANNITOL was NM 1984-92%A%  
% 218.18/218.37  |- mesh__recordMaintainer mesh__D017485 TWD
% 218.18/218.37  |- skos__prefLabel mesh__D017485 1-Deoxynojirimycin
% 218.18/218.37  |- skos__hiddenLabel mesh__D017485 1 Deoxynojirimycin Hydrochloride
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D017485 2005
% 218.18/218.37  |- mesh__dateCreated mesh__D017485 1992-05-22
% 218.18/218.37  |- skos__scopeNote mesh__D017485
% 218.18/218.37       An alpha-glucosidase inhibitor with antiviral action. Derivatives of deoxynojirimycin may have anti-HIV activity.%A%    
% 218.18/218.37  |- skos__historyNote mesh__D017485
% 218.18/218.37       Glucosamine/analogs %26% derivatives %28%1981-1992%29%
% 218.18/218.37  |- mesh__publicMeSHNote mesh__D017485
% 218.18/218.37       93; DEOXYNOJIRIMYCIN was indexed under GLUCOSAMINE/analogs %26% derivatives 1981-92; 1,5-DEOXY-1,5-IMINO-D-MANNITOL was indexed under MANNITOL/analogs %26% derivatives 1984-92%A%  
% 218.18/218.37  |- mesh__recordAuthorizer mesh__D017485 sjn
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D017485 2006
% 218.18/218.37  |- skos__hiddenLabel mesh__D017485 1 Deoxynojirimycin
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D017485 2001
% 218.18/218.37  |- mesh__dateRevised mesh__D017485 2000-06-21
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D017485 2003
% 218.18/218.37  |- mesh__dateEstablished mesh__D017485 1993-01-01
% 218.18/218.37  |- mesh__onlineNote mesh__D017485
% 218.18/218.37       use 1-DEOXYNOJIRIMYCIN %28%NM%29% to search 1,5-DIDEOXY-1,5-IMINO-D-MANNITOL 1984-92 %26% DEOXYNOJIRIMYCIN 1981-92%A%  
% 218.18/218.37  |- rdf__type mesh__D017485sskos__Concept
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D017485 2004
% 218.18/218.37  |- skos__broader mesh__D017485smesh__D010880
% 218.18/218.37  |- skos__scopeNote mesh__D003465
% 218.18/218.37       A genus of mosquitoes %28%CULICIDAE%29% commonly found in tropical regions. Species of this genus are vectors for St. Louis encephalitis %28%ENCEPHALITIS, ST. LOUIS%29% as well as many other diseases of man and domestic and wild animals.%A%    
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D003465 2005
% 218.18/218.37  |- mesh__recordMaintainer mesh__D003465 ags
% 218.18/218.37  |- skos__broader mesh__D003465smesh__D009033
% 218.18/218.37  |- mesh__dateRevised mesh__D003465 2003-07-09
% 218.18/218.37  |- rdf__type mesh__D003465sskos__Concept
% 218.18/218.37  |- mesh__recordOriginator mesh__D003465 NLM
% 218.18/218.37  |- mesh__recordAuthorizer mesh__D003465 sjn
% 218.18/218.37  |- skos__prefLabel mesh__D003465 Culex
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D003465 2004
% 218.18/218.37  |- skos__annotation mesh__D003465
% 218.18/218.37       mosquito: do not confuse with CULICOIDES, gnat; do not use /drug eff for insecticides: TN 111; /microbiol /parasitol /virol permitted%A%  
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D003465 2006
% 218.18/218.37  |- mesh__dateCreated mesh__D003465 1999-01-01
% 218.18/218.37  |- skos__altLabel mesh__D008150 Decompression, Abdominal
% 218.18/218.37  |- skos__broader mesh__D008150smesh__D003664
% 218.18/218.37  |- rdf__type mesh__D008150sskos__Concept
% 218.18/218.37  |- mesh__recordAuthorizer mesh__D008150 sjn
% 218.18/218.37  |- mesh__dateEstablished mesh__D008150 1991-01-01
% 218.18/218.37  |- skos__altLabel mesh__D008150 Abdominal Decompression
% 218.18/218.37  |- mesh__historyNote mesh__D008150
% 218.18/218.37       91%28%80%29%; was see under DECOMPRESSION 1980-90   
% 218.18/218.37  |- skos__altLabel mesh__D008150 LBNP
% 218.18/218.37  |- skos__annotation mesh__D008150
% 218.18/218.37       %22%external decompression applied to the lower body%22%; used in physiol research %26% ther%A%  
% 218.18/218.37  |- mesh__recordOriginator mesh__D008150 SMH
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D008150 2006
% 218.18/218.37  |- skos__historyNote mesh__D008150 Atmospheric Pressure %28%1966-1979%29%
% 218.18/218.37  |- mesh__dateRevised mesh__D008150 2005-06-30
% 218.18/218.37  |- skos__prefLabel mesh__D008150 Lower Body Negative Pressure
% 218.18/218.37  |- mesh__dateCreated mesh__D008150 1979-03-08
% 218.18/218.37  |- mesh__publicMeSHNote mesh__D008150
% 218.18/218.37       91; was see under DECOMPRESSION 1980-90   
% 218.18/218.37  |- mesh__recordMaintainer mesh__D008150 lkt
% 218.18/218.37  |- skos__scopeNote mesh__D008150
% 218.18/218.37       External decompression applied to the lower body. It is used to study orthostatic intolerance and the effects of gravitation and acceleration, to produce simulated hemorrhage in physiologic research, to assess cardiovascular function, and to reduce abdominal stress during childbirth.%A%    
% 218.18/218.37  |- skos__historyNote mesh__D008150 Pressure %28%1966-1979%29%
% 218.18/218.37  |- mesh__publicMeSHNote mesh__D013893
% 218.18/218.37       91; was see under THIOCARBAMATES 1966-90   
% 218.18/218.37  |- skos__altLabel mesh__D013893 Thiuram
% 218.18/218.37  |- rdf__type mesh__D013893sskos__Concept
% 218.18/218.37  |- mesh__dateRevised mesh__D013893 2000-06-21
% 218.18/218.37  |- skos__altLabel mesh__D013893 TMT Disulfide
% 218.18/218.37  |- skos__prefLabel mesh__D013893 Thiram
% 218.18/218.37  |- mesh__dateEstablished mesh__D013893 1991-01-01
% 218.18/218.37  |- mesh__recordMaintainer mesh__D013893 CCR
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D013893 2003
% 218.18/218.37  |- skos__altLabel mesh__D013893 Tetramethylthiuram Disulfide
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D013893 2001
% 218.18/218.37  |- mesh__historyNote mesh__D013893
% 218.18/218.37       91%28%66%29%; was see under THIOCARBAMATES 1966-90   
% 218.18/218.37  |- mesh__dateCreated mesh__D013893 1999-01-01
% 218.18/218.37  |- mesh__recordAuthorizer mesh__D013893 sjn
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D013893 2004
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D013893 2002
% 218.18/218.37  |- skos__scopeNote mesh__D013893
% 218.18/218.37       A dithiocarbamate chemical, used commercially in the rubber processing industry and as a fungicide. In vivo studies indicate that it inactivates the enzyme glutathione reductase. It has mutagenic activity and may induce chromosomal aberrations.%A%    
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D013893 2005
% 218.18/218.37  |- skos__hiddenLabel mesh__D013893 Disulfide, Tetramethylthiuram
% 218.18/218.37  |- skos__altLabel mesh__D013893 TMTD
% 218.18/218.37  |- skos__broader mesh__D013893smesh__D004125
% 218.18/218.37  |- mesh__recordOriginator mesh__D013893 NLM
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D013893 2006
% 218.18/218.37  |- skos__hiddenLabel mesh__D013893 Disulfide, TMT
% 218.18/218.37  |- rdf__type mesh__D013095sskos__Concept
% 218.18/218.37  |- mesh__recordOriginator mesh__D013095 NLM
% 218.18/218.37  |- mesh__dateCreated mesh__D013095 1999-01-01
% 218.18/218.37  |- mesh__dateRevised mesh__D013095 2000-06-22
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D013095 2002
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D013095 2005
% 218.18/218.37  |- skos__scopeNote mesh__D013095
% 218.18/218.37       A polyamine formed from putrescine. It is found in almost all tissues in association with nucleic acids. It is found as a cation at all pH values, and is thought to help stabilize some membranes and nucleic acid structures. It is a precursor of spermine.%A%    
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D013095 2006
% 218.18/218.37  |- mesh__historyNote mesh__D013095 73%28%71%29%   
% 218.18/218.37  |- mesh__dateEstablished mesh__D013095 1973-01-01
% 218.18/218.37  |- skos__broader mesh__D013095smesh__D011073
% 218.18/218.37  |- skos__broader mesh__D013095smesh__D011700
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D013095 2003
% 218.18/218.37  |- mesh__recordMaintainer mesh__D013095 CCR
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D013095 2001
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D013095 2004
% 218.18/218.37  |- mesh__recordAuthorizer mesh__D013095 sjn
% 218.18/218.37  |- skos__historyNote mesh__D013095 Amines %28%1966-1970%29%
% 218.18/218.37  |- skos__prefLabel mesh__D013095 Spermidine
% 218.18/218.37  |- mesh__publicMeSHNote mesh__D013095 73   
% 218.18/218.37  |- skos__scopeNote mesh__D007856
% 218.18/218.37       Unstable isotopes of lead that decay or disintegrate emitting radiation. Pb atoms with atomic weights 194-203, 205, and 209-214 are radioactive lead isotopes.%A%    
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007856 2002
% 218.18/218.37  |- skos__prefLabel mesh__D007856 Lead Radioisotopes
% 218.18/218.37  |- mesh__recordOriginator mesh__D007856 RLS
% 218.18/218.37  |- mesh__dateCreated mesh__D007856 1987-04-08
% 218.18/218.37  |- mesh__recordMaintainer mesh__D007856 TPW
% 218.18/218.37  |- skos__historyNote mesh__D007856 Lead %28%1966-1987%29%
% 218.18/218.37  |- rdf__type mesh__D007856sskos__Concept
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007856 1997
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007856 2001
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007856 1999
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007856 1996
% 218.18/218.37  |- mesh__dateRevised mesh__D007856 1993-06-02
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007856 1995
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007856 2004
% 218.18/218.37  |- skos__historyNote mesh__D007856 Radioisotopes %28%1966-1987%29%
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007856 2000
% 218.18/218.37  |- skos__hiddenLabel mesh__D007856 Radioisotopes, Lead
% 218.18/218.37  |- mesh__historyNote mesh__D007856 88   
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007856 1998
% 218.18/218.37  |- mesh__dateEstablished mesh__D007856 1988-01-01
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007856 2006
% 218.18/218.37  |- skos__broader mesh__D007856smesh__D011868
% 218.18/218.37  |- mesh__publicMeSHNote mesh__D007856 88   
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007856 1994
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007856 2003
% 218.18/218.37  |- mesh__recordAuthorizer mesh__D007856 PLS
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007856 2005
% 218.18/218.37  |- skos__annotation mesh__D007856
% 218.18/218.37       Pb-194-203, 205, 209-214; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 218.18/218.37  |- skos__broader mesh__D012730Q000002smesh__D012730
% 218.18/218.37  |- mesh__preferredCombination mesh__D012730Q000002smesh__D012729
% 218.18/218.37  |- rdf__type mesh__D012730Q000002smesh__CompoundConcept
% 218.18/218.37  |- skos__broader mesh__D031955smesh__D027823
% 218.18/218.37  |- skos__prefLabel mesh__D031955 Frangula
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D031955 2003
% 218.18/218.37  |- skos__historyNote mesh__D031955 Rhamnus %28%1991-2002%29%
% 218.18/218.37  |- mesh__historyNote mesh__D031955
% 218.18/218.37       2003; 1963-1990; use RHAMNUS 1991-2002   
% 218.18/218.37  |- mesh__dateCreated mesh__D031955 2002-07-03
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D031955 2006
% 218.18/218.37  |- mesh__dateEstablished mesh__D031955 2003-01-01
% 218.18/218.37  |- skos__altLabel mesh__D031955 Rhammus purshiana
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D031955 2005
% 218.18/218.37  |- skos__altLabel mesh__D031955 Rhammus frangula
% 218.18/218.37  |- skos__annotation mesh__D031955
% 218.18/218.37       note X refs: RHAMNUS is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29; for help on which genus to use see http://www.ars-grin.gov/cgi-bin/npgs/html/taxlist.pl?Rhamnaceae%A%  
% 218.18/218.37  |- rdf__type mesh__D031955sskos__Concept
% 218.18/218.37  |- skos__scopeNote mesh__D031955
% 218.18/218.37       A plant genus of the family RHAMNACEAE. This genus is often called buckthorn but should not be confused with other plants called that such as HIPPOPHAE or KARWINSKIA.  Some RHAMNUS species have been reclassified into this genus. F. purshiana bark is cascara sagrada %28%CASCARA%29%. Members contain emodine, frangulanin, frangulin, and anthraquinones such as EMODIN.%A%    
% 218.18/218.37  |- mesh__publicMeSHNote mesh__D031955
% 218.18/218.37       2003; 1963-1985; see RHAMNUS 1991-2002, see PLANTS, TOXIC 1986-1990%A%  
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D031955 2004
% 218.18/218.37  |- skos__hiddenLabel mesh__D017486 Eruptions, Acneiform
% 218.18/218.37  |- skos__historyNote mesh__D017486 Acne Vulgaris %28%1966-1997%29%
% 218.18/218.37  |- skos__hiddenLabel mesh__D017486 Acneiform Eruption
% 218.18/218.37  |- skos__prefLabel mesh__D017486 Acneiform Eruptions
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D017486 2005
% 218.18/218.37  |- mesh__historyNote mesh__D017486 98; use explode 1993-97   
% 218.18/218.37  |- mesh__dateRevised mesh__D017486 1998-06-05
% 218.18/218.37  |- mesh__recordMaintainer mesh__D017486 SJN
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D017486 2002
% 218.18/218.37  |- skos__broader mesh__D017486smesh__D012871
% 218.18/218.37  |- mesh__recordOriginator mesh__D017486 PLS
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D017486 2006
% 218.18/218.37  |- skos__hiddenLabel mesh__D017486 Eruption, Acneiform
% 218.18/218.37  |- mesh__publicMeSHNote mesh__D017486 98   
% 218.18/218.37  |- mesh__recordAuthorizer mesh__D017486 PLS
% 218.18/218.37  |- mesh__dateCreated mesh__D017486 1992-05-20
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D017486 2003
% 218.18/218.37  |- skos__scopeNote mesh__D017486
% 218.18/218.37       Visible efflorescent lesions of the skin caused by acne or resembling acne. %28%Dorland, 28th ed, p18, 575%29%%A%    
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D017486 2000
% 218.18/218.37  |- skos__broader mesh__D017486smesh__D005148
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D017486 1998
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D017486 2004
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D017486 2001
% 218.18/218.37  |- rdf__type mesh__D017486sskos__Concept
% 218.18/218.37  |- skos__annotation mesh__D017486 GEN or unspecified; prefer specifics   
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D017486 1999
% 218.18/218.37  |- mesh__dateEstablished mesh__D017486 1998-01-01
% 218.18/218.37  |- skos__broader mesh__D007906Q000151smesh__D007906
% 218.18/218.37  |- mesh__preferredCombination mesh__D007906Q000151smesh__D004479
% 218.18/218.37  |- rdf__type mesh__D007906Q000151smesh__CompoundConcept
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D003466 1995
% 218.18/218.37  |- skos__related mesh__D003466smesh__D003431
% 218.18/218.37  |- skos__annotation mesh__D003466
% 218.18/218.37       not for microbial or tissue cultures; no qualif   
% 218.18/218.37  |- skos__hiddenLabel mesh__D003466 Characteristic, Cultural
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D003466 2000
% 218.18/218.37  |- rdf__type mesh__D003466sskos__Concept
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D003466 2001
% 218.18/218.37  |- mesh__publicMeSHNote mesh__D003466 91; was see under CULTURE 1975-90   
% 218.18/218.37  |- mesh__dateRevised mesh__D003466 1991-06-20
% 218.18/218.37  |- mesh__dateCreated mesh__D003466 1999-01-01
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D003466 2003
% 218.18/218.37  |- mesh__recordMaintainer mesh__D003466 TGC
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D003466 1996
% 218.18/218.37  |- skos__broader mesh__D003466smesh__D003469
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D003466 2005
% 218.18/218.37  |- skos__prefLabel mesh__D003466 Cultural Characteristics
% 218.18/218.37  |- mesh__recordAuthorizer mesh__D003466 PLS
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D003466 1998
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D003466 2004
% 218.18/218.37  |- skos__scopeNote mesh__D003466
% 218.18/218.37       Those aspects or characteristics which identify a culture.%A%    
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D003466 2002
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D003466 1997
% 218.18/218.37  |- mesh__historyNote mesh__D003466
% 218.18/218.37       91%28%75%29%; was see under CULTURE 1975-90   
% 218.18/218.37  |- mesh__recordOriginator mesh__D003466 NLM
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D003466 1992
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D003466 2006
% 218.18/218.37  |- mesh__dateEstablished mesh__D003466 1991-01-01
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D003466 1994
% 218.18/218.37  |- skos__hiddenLabel mesh__D003466 Characteristics, Cultural
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D003466 1999
% 218.18/218.37  |- mesh__onlineNote mesh__D003466 search CULTURE 1968-74   
% 218.18/218.37  |- skos__hiddenLabel mesh__D003466 Cultural Characteristic
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D003466 1993
% 218.18/218.37  |- skos__broader mesh__D004777Q000382smesh__D004777
% 218.18/218.37  |- mesh__preferredCombination mesh__D004777Q000382smesh__D004783
% 218.18/218.37  |- rdf__type mesh__D004777Q000382smesh__CompoundConcept
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D008151 2001
% 218.18/218.37  |- skos__historyNote mesh__D008151 Arrhythmia %28%1966-1985%29%
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D008151 2003
% 218.18/218.37  |- rdf__type mesh__D008151sskos__Concept
% 218.18/218.37  |- mesh__historyNote mesh__D008151
% 218.18/218.37       91%28%86%29%; was see under PRE-EXCITATION SYNDROMES 1986-90   
% 218.18/218.37  |- skos__prefLabel mesh__D008151 Lown-Ganong-Levine Syndrome
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D008151 2005
% 218.18/218.37  |- skos__annotation mesh__D008151
% 218.18/218.37       note X ref: normal PR interval %26% long QRS interval = PRE-EXCITATION, MAHAIN- TYPE%A%  
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D008151 2004
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D008151 2006A
% 218.18/218.37  |- skos__scopeNote mesh__D008151
% 218.18/218.37       A form of pre-excitation characterized by a short PR interval associated with a normal QRS complex.%A%    
% 218.18/218.37  |- skos__historyNote mesh__D008151 Tachycardia %28%1966-1985%29%
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D008151 2002
% 218.18/218.37  |- mesh__recordMaintainer mesh__D008151 ags
% 218.18/218.37  |- skos__altLabel mesh__D008151 Short PR-Normal QRS Complex Syndrome
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D008151 2006
% 218.18/218.37  |- skos__hiddenLabel mesh__D008151 Syndrome, Lown-Ganong-Levine
% 218.18/218.37  |- mesh__publicMeSHNote mesh__D008151
% 218.18/218.37       91; was see under PRE-EXCITATION SYNDROMES 1986-90   
% 218.18/218.37  |- mesh__recordOriginator mesh__D008151 VDK
% 218.18/218.37  |- mesh__recordAuthorizer mesh__D008151 ags
% 218.18/218.37  |- skos__hiddenLabel mesh__D008151 Lown Ganong Levine Syndrome
% 218.18/218.37  |- mesh__dateEstablished mesh__D008151 1991-01-01
% 218.18/218.37  |- skos__historyNote mesh__D008151
% 218.18/218.37       Tachycardia, Paroxysmal %28%1966-1985%29%
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D008151 2000
% 218.18/218.37  |- mesh__dateRevised mesh__D008151 2005-07-27
% 218.18/218.37  |- mesh__dateCreated mesh__D008151 1985-03-11
% 218.18/218.37  |- skos__hiddenLabel mesh__D008151 Short PR Normal QRS Complex Syndrome
% 218.18/218.37  |- skos__broader mesh__D008151smesh__D011226
% 218.18/218.37  |- mesh__recordOriginator mesh__D013894 NLM
% 218.18/218.37  |- skos__broader mesh__D013894smesh__D004328
% 218.18/218.37  |- mesh__dateCreated mesh__D013894 1999-01-01
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D013894 2004
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D013894 2005
% 218.18/218.37  |- skos__scopeNote mesh__D013894
% 218.18/218.37       A drive stemming from a physiological need for WATER.     
% 218.18/218.37  |- skos__related mesh__D013894smesh__D014868
% 218.18/218.37  |- skos__hiddenLabel mesh__D013894 Thirsts
% 218.18/218.37  |- mesh__recordMaintainer mesh__D013894 lkt
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D013894 2006
% 218.18/218.37  |- skos__prefLabel mesh__D013894 Thirst
% 218.18/218.37  |- mesh__recordAuthorizer mesh__D013894 sjn
% 218.18/218.37  |- mesh__dateRevised mesh__D013894 2003-07-09
% 218.18/218.37  |- rdf__type mesh__D013894sskos__Concept
% 218.18/218.37  |- mesh__recordAuthorizer mesh__D013096 sjn
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D013096 2005
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D013096 2006
% 218.18/218.37  |- mesh__recordOriginator mesh__D013096 NLM
% 218.18/218.37  |- skos__prefLabel mesh__D013096 Spermine
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D013096 2002
% 218.18/218.37  |- skos__broader mesh__D013096smesh__D011073
% 218.18/218.37  |- skos__scopeNote mesh__D013096
% 218.18/218.37       A biogenic polyamine formed from spermidine. It is found in a wide variety of organisms and tissues and is an essential growth factor in some bacteria. It is found as a polycation at all pH values. Spermine is associated with nucleic acids, particularly in viruses, and is thought to stabilize the helical structure.%A%    
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D013096 2003
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D013096 2004
% 218.18/218.37  |- rdf__type mesh__D013096sskos__Concept
% 218.18/218.37  |- skos__broader mesh__D013096smesh__D013095
% 218.18/218.37  |- mesh__dateCreated mesh__D013096 1999-01-01
% 218.18/218.37  |- mesh__dateRevised mesh__D013096 2000-06-22
% 218.18/218.37  |- mesh__recordMaintainer mesh__D013096 CCR
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D013096 2001
% 218.18/218.37  |- skos__scopeNote mesh__D007857
% 218.18/218.37       The function of directing or controlling the actions or attitudes of an individual or group with more or less willing acquiescence of the followers.%A%    
% 218.18/218.37  |- rdf__type mesh__D007857sskos__Concept
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007857 1997
% 218.18/218.37  |- mesh__dateCreated mesh__D007857 1999-01-01
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007857 1999
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007857 1993
% 218.18/218.37  |- skos__prefLabel mesh__D007857 Leadership
% 218.18/218.37  |- skos__broader mesh__D007857smesh__D010551
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007857 1996
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007857 1995
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007857 2004
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007857 2002
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007857 1998
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007857 2006
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007857 1992
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007857 2003
% 218.18/218.37  |- mesh__dateRevised mesh__D007857 1991-11-26
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007857 1994
% 218.18/218.37  |- skos__annotation mesh__D007857 no qualif   
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007857 2001
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007857 2005
% 218.18/218.37  |- mesh__recordMaintainer mesh__D007857 PLS
% 218.18/218.37  |- mesh__recordOriginator mesh__D007857 NLM
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007857 2000
% 218.18/218.37  |- mesh__recordAuthorizer mesh__D007857 PLS
% 218.18/218.37  |- mesh__publicMeSHNote mesh__D007059 91; was see under CATFISH 1987-90   
% 218.18/218.37  |- mesh__recordAuthorizer mesh__D007059 sjn
% 218.18/218.37  |- mesh__dateCreated mesh__D007059 1986-04-15
% 218.18/218.37  |- skos__altLabel mesh__D007059 Channel Catfishes
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D007059 2006
% 218.18/218.37  |- skos__scopeNote mesh__D007059
% 218.18/218.37       A family of North American freshwater CATFISHES. It consists of four genera %28%Ameiurus, Ictalurus, Noturus, Pylodictis,%29% comprising several species, two of which are eyeless.%A%    
% 218.18/218.37  |- skos__altLabel mesh__D007059 Catfish, Channel
% 218.18/218.37  |- rdf__type mesh__D007059sskos__Concept
% 218.18/218.37  |- skos__altLabel mesh__D007059 Pylodictus
% 218.18/218.37  |- mesh__dateEstablished mesh__D007059 1991-01-01
% 218.18/218.37  |- skos__altLabel mesh__D007059 Bullhead Catfishes
% 218.18/218.37  |- mesh__historyNote mesh__D007059
% 218.18/218.37       91%28%87%29%; was see under CATFISH 1987-90   
% 218.18/218.37  |- mesh__recordOriginator mesh__D007059 EC
% 218.18/218.37  |- skos__hiddenLabel mesh__D007059 Catfishes, Bullhead
% 218.18/218.37  |- mesh__recordMaintainer mesh__D007059 ags
% 218.18/218.37  |- skos__prefLabel mesh__D007059 Ictaluridae
% 218.18/218.37  |- skos__broader mesh__D007059smesh__D002397
% 218.18/218.37  |- skos__altLabel mesh__D007059 Ictalurus punctatus
% 218.18/218.37  |- mesh__dateRevised mesh__D007059 2005-06-30
% 218.18/218.37  |- skos__altLabel mesh__D007059 Channel Catfish
% 218.18/218.37  |- skos__historyNote mesh__D007059 Fishes %28%1966-1986%29%
% 218.18/218.37  |- skos__broader mesh__D008027Q000627smesh__D008027
% 218.18/218.37  |- mesh__preferredCombination mesh__D008027Q000627smesh__D010789
% 218.18/218.37  |- rdf__type mesh__D008027Q000627smesh__CompoundConcept
% 218.18/218.37  |- skos__prefLabel mesh__D031956 Karwinskia
% 218.18/218.37  |- skos__scopeNote mesh__D031956
% 218.18/218.37       A plant genus of the family RHAMNACEAE that contains tullidinol %28%toxin T-544%29% and peroxisomicine %28%toxin T-514%29%. It is sometimes called buckthorn but should not be confused with other plants called that.%A%    
% 218.18/218.37  |- mesh__publicMeSHNote mesh__D031956
% 218.18/218.37       2003; see RHAMNUS 1985-2002; for Tullidora see RHAMNUS 1986-2002%A%  
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D031956 2006
% 218.18/218.37  |- mesh__recordAuthorizer mesh__D031956 sjn
% 218.18/218.37  |- skos__altLabel mesh__D031956 Tullidora
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D031956 2005
% 218.18/218.37  |- skos__broader mesh__D031956smesh__D027823
% 218.18/218.37  |- skos__altLabel mesh__D031956 Coyotillo
% 218.18/218.37  |- skos__historyNote mesh__D031956 Rhamnus %28%1985-2002%29%
% 218.18/218.37  |- skos__annotation mesh__D031956
% 218.18/218.37       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.18/218.37  |- mesh__recordMaintainer mesh__D031956 ssb
% 218.18/218.37  |- mesh__dateEstablished mesh__D031956 2003-01-01
% 218.18/218.37  |- mesh__dateCreated mesh__D031956 2002-07-03
% 218.18/218.37  |- rdf__type mesh__D031956sskos__Concept
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D031956 2004
% 218.18/218.37  |- mesh__recordOriginator mesh__D031956 ssb
% 218.18/218.37  |- mesh__historyNote mesh__D031956
% 218.18/218.37       2003; use RHAMNUS 1985-2002; for Tullidora use RHAMNUS 1986-2002%A%  
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D031956 2003
% 218.18/218.37  |- skos__altLabel mesh__D017487 Ankyrin
% 218.18/218.37  |- skos__historyNote mesh__D017487 Membrane Proteins %28%1979-1992%29%
% 218.18/218.37  |- mesh__dateEstablished mesh__D017487 1993-01-01
% 218.18/218.37  |- mesh__recordAuthorizer mesh__D017487 sjn
% 218.18/218.37  |- mesh__recordMaintainer mesh__D017487 SYSTEM
% 218.18/218.37  |- mesh__publicMeSHNote mesh__D017487
% 218.18/218.37       93; ANKYRIN was indexed under BLOOD PROTEINS %26% MEMBRANE PROTEINS 1979-92%A%  
% 218.18/218.37  |- skos__prefLabel mesh__D017487 Ankyrins
% 218.18/218.37  |- mesh__historyNote mesh__D017487 93; was ANKYRIN %28%NM%29% 1979-92   
% 218.18/218.37  |- rdf__type mesh__D017487sskos__Concept
% 218.18/218.37  |- skos__scopeNote mesh__D017487
% 218.18/218.37       A family of membrane-associated proteins responsible for the attachment of the cytoskeleton. Erythrocyte-related isoforms of ankyrin attach the SPECTRIN cytoskeleton to a transmembrane protein %28%ANION EXCHANGE PROTEIN 1, ERYTHROCYTE%29% in the erythrocyte plasma membrane. Brain-related isoforms of ankyrin also exist.%A%    
% 218.18/218.37  |- skos__broader mesh__D017487smesh__D008565
% 218.18/218.37  |- mesh__onlineNote mesh__D017487
% 218.18/218.37       use ANKYRINS %28%NM%29% to search ANKYRINS 1979-92   
% 218.18/218.37  |- skos__broader mesh__D017487smesh__D001798
% 218.18/218.37  |- skos__annotation mesh__D017487
% 218.18/218.37       membrane proteins; from the Greek word for anchor with ref to their role in attachment of the cytoskeleton; /drug eff /ultrastruct permitted%A%  
% 218.18/218.37  |- mesh__dateCreated mesh__D017487 1992-05-13
% 218.18/218.37  |- mesh__recordOriginator mesh__D017487 AGS
% 218.18/218.37  |- mesh__dateRevised mesh__D017487 2005-06-30
% 218.18/218.37  |- skos__historyNote mesh__D017487 Blood Proteins %28%1979-1992%29%
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D017487 2006
% 218.18/218.37  |- mesh__activeMeSHYear mesh__D036641 2006
% 218.18/218.37  |- skos__scopeNote mesh__D036641
% 218.18/218.37       Fluorescence microscopy utilizing multiple low-energy photons to produce the excitation event of the fluorophore.  Multiphoton microscopes have a simplified optical path in the emission side due to the lack of an emission pinhole, which is necessary with normal confocal microscopes. Ultimately this allows spatial isolation of the excitation event, enabling deeper imaging into optically thick tissue, while restricting photobleaching and phototoxicity to the area being imaged.%A%    
% 218.18/218.37  |- mesh__dateEstablished mesh__D036641 2003-01-01
% 218.18/218.37  |- mesh__historyNote mesh__D036641 2003   
% 218.18/218.37  |- mesh__recordMaintainer mesh__D036641 jls
% 218.18/218.37  |- skos__altLabel mesh__D036641 Multiphoton Fluorescence Microscopy
% 218.18/218.37  |- mesh__publicMeSHNote mesh__D036641 2003   
% 218.18/218.37  |- skos__broader mesh__D036641smesh__D008856
% 218.18/218.37  |- mesh__dateRevised mesh__D036641 2004-07-28
% 218.18/218.37  |- skos__historyNote mesh__D036641
% 218.18/218.37       Microscopy, Fluorescence %28%1996-2002%29%
% 218.18/218.37  |- skos__altLabel mesh__D036641 Fluorescence Microscopy, Multiphoton
% 218.18/218.37  |- skos__prefLabel mesh__D036641 Microscopy, Fluorescence, Multiphoton
% 218.18/218.37  |- skos__historyNote mesh__D036641 Microscopy, Confocal %28%1997-2002%29%
% 218.18/218.38  |- skos__hiddenLabel mesh__D036641 Microscopy, Multiphoton Fluorescence
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D036641 2005A
% 218.18/218.38  |- mesh__dateCreated mesh__D036641 2002-07-03
% 218.18/218.38  |- rdf__type mesh__D036641sskos__Concept
% 218.18/218.38  |- mesh__recordAuthorizer mesh__D036641 jls
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D036641 2005
% 218.18/218.38  |- mesh__recordOriginator mesh__D036641 ags
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D003467 2002
% 218.18/218.38  |- skos__altLabel mesh__D003467 Cultural Disadvantagement
% 218.18/218.38  |- mesh__publicMeSHNote mesh__D003467 68   
% 218.18/218.38  |- skos__hiddenLabel mesh__D003467 Deprivation, Cultural
% 218.18/218.38  |- mesh__historyNote mesh__D003467 68   
% 218.18/218.38  |- rdf__type mesh__D003467sskos__Concept
% 218.18/218.38  |- skos__hiddenLabel mesh__D003467 Cultural Deprivations
% 218.18/218.38  |- skos__hiddenLabel mesh__D003467 Disadvantagement, Cultural
% 218.18/218.38  |- skos__prefLabel mesh__D003467 Cultural Deprivation
% 218.18/218.38  |- mesh__dateCreated mesh__D003467 1999-01-01
% 218.18/218.38  |- skos__scopeNote mesh__D003467
% 218.18/218.38       The absence of certain expected and acceptable cultural phenomena in the environment which results in the failure of the individual to communicate and respond in the most appropriate manner within the context of society. Language acquisition and language use are commonly used in assessing this concept.%A%    
% 218.18/218.38  |- skos__hiddenLabel mesh__D003467 Disadvantagements, Cultural
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D003467 2003
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D003467 2000
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D003467 2005
% 218.18/218.38  |- mesh__recordAuthorizer mesh__D003467 SJN
% 218.18/218.38  |- mesh__dateEstablished mesh__D003467 1968-01-01
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D003467 1998
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D003467 2004
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D003467 2001
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D003467 2006
% 218.18/218.38  |- mesh__dateRevised mesh__D003467 1997-06-20
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D003467 1999
% 218.18/218.38  |- mesh__recordMaintainer mesh__D003467 JLS
% 218.18/218.38  |- skos__hiddenLabel mesh__D003467 Cultural Disadvantagements
% 218.18/218.38  |- skos__broader mesh__D003467smesh__D003469
% 218.18/218.38  |- skos__annotation mesh__D003467 no qualif   
% 218.18/218.38  |- mesh__recordOriginator mesh__D003467 NLM
% 218.18/218.38  |- skos__hiddenLabel mesh__D003467 Deprivations, Cultural
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008950 2003
% 218.18/218.38  |- mesh__recordMaintainer mesh__D008950 TAP
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008950 1995
% 218.18/218.38  |- rdf__type mesh__D008950sskos__Concept
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008950 1993
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008950 1994
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008950 2001
% 218.18/218.38  |- skos__scopeNote mesh__D008950
% 218.18/218.38       A personality inventory consisting of statements to be asserted or denied by the individual. The patterns of response are characteristic of certain personality attributes.%A%    
% 218.18/218.38  |- skos__broader mesh__D008950smesh__D010555
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008950 1999
% 218.18/218.38  |- mesh__dateRevised mesh__D008950 1992-05-15
% 218.18/218.38  |- skos__prefLabel mesh__D008950 MMPI
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008950 2000
% 218.18/218.38  |- mesh__recordAuthorizer mesh__D008950 PLS
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008950 1998
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008950 1997
% 218.18/218.38  |- mesh__dateCreated mesh__D008950 1999-01-01
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008950 2006
% 218.18/218.38  |- skos__altLabel mesh__D008950 Minnesota Multiphasic Personality Inventory
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008950 1996
% 218.18/218.38  |- mesh__recordOriginator mesh__D008950 NLM
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008950 2005
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008950 2004
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008950 2002
% 218.18/218.38  |- mesh__recordMaintainer mesh__D022621 ssb
% 218.18/218.38  |- skos__altLabel mesh__D022621 Stx Protein, Shigella dysenteria
% 218.18/218.38  |- skos__annotation mesh__D022621 SHIGA TOXINS is available   
% 218.18/218.38  |- skos__historyNote mesh__D022621 Bacterial Toxins %28%1980-2000%29%
% 218.18/218.38  |- skos__altLabel mesh__D022621 Shigella Cytotoxin
% 218.18/218.38  |- skos__prefLabel mesh__D022621 Shiga Toxin
% 218.18/218.38  |- skos__related mesh__D022621smesh__D012762
% 218.18/218.38  |- mesh__dateEstablished mesh__D022621 2001-01-01
% 218.18/218.38  |- skos__scopeNote mesh__D022621
% 218.18/218.38       A toxin produced by SHIGELLA DYSENTERIAE. It is the prototype of class of toxins that inhibit protein synthesis by blocking the interaction of ribosomal RNA; %28%RNA, RIBOSOMAL%29% with PEPTIDE ELONGATION FACTORS.%A%    
% 218.18/218.38  |- mesh__dateRevised mesh__D022621 2005-06-30
% 218.18/218.38  |- mesh__recordOriginator mesh__D022621 jmp
% 218.18/218.38  |- skos__hiddenLabel mesh__D022621 Cytotoxin, Shigella
% 218.18/218.38  |- mesh__publicMeSHNote mesh__D022621
% 218.18/218.38       2001; SHIGA TOXIN was indexed under BACTERIAL TOXINS 1980-2000%A%  
% 218.18/218.38  |- mesh__dateCreated mesh__D022621 2000-06-27
% 218.18/218.38  |- skos__hiddenLabel mesh__D022621 Toxin, Shiga
% 218.18/218.38  |- mesh__recordAuthorizer mesh__D022621 sjn
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D022621 2006
% 218.18/218.38  |- skos__altLabel mesh__D022621 Stx Protein
% 218.18/218.38  |- mesh__historyNote mesh__D022621
% 218.18/218.38       2001; use SHIGA TOXINS %28%NM%29% 1980-2000   
% 218.18/218.38  |- skos__hiddenLabel mesh__D022621 Toxin, Shigella
% 218.18/218.38  |- skos__broader mesh__D022621smesh__D022603
% 218.18/218.38  |- rdf__type mesh__D022621sskos__Concept
% 218.18/218.38  |- skos__altLabel mesh__D022621 Shigella Toxin
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008152 2005
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008152 2004
% 218.18/218.38  |- mesh__dateRevised mesh__D008152 2000-06-21
% 218.18/218.38  |- mesh__dateCreated mesh__D008152 1974-11-19
% 218.18/218.38  |- skos__historyNote mesh__D008152 Piperazines %28%1971-1974%29%
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008152 2001
% 218.18/218.38  |- skos__scopeNote mesh__D008152
% 218.18/218.38       An antipsychotic agent used in schizophrenia.     
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008152 2006
% 218.18/218.38  |- skos__altLabel mesh__D008152
% 218.18/218.38       2-Chloro-11-%28%4-methyl-1-piperazinyl%29%-dibenz%28%b,f%29%%28%1,4%29%oxazepine
% 218.18/218.38  |- skos__hiddenLabel mesh__D008152 CL 71,563
% 218.18/218.38  |- skos__historyNote mesh__D008152 Dibenzoxazepines %28%1971-1974%29%
% 218.18/218.38  |- skos__altLabel mesh__D008152 Cloxazepine
% 218.18/218.38  |- mesh__publicMeSHNote mesh__D008152
% 218.18/218.38       91; was see under DIBENZOXAZEPINES 1975-90   
% 218.18/218.38  |- mesh__recordOriginator mesh__D008152 NLM
% 218.18/218.38  |- mesh__dateEstablished mesh__D008152 1991-01-01
% 218.18/218.38  |- skos__prefLabel mesh__D008152 Loxapine
% 218.18/218.38  |- skos__altLabel mesh__D008152 Loxapinsuccinate
% 218.18/218.38  |- skos__altLabel mesh__D008152 Oxilapine
% 218.18/218.38  |- mesh__recordMaintainer mesh__D008152 TWD
% 218.18/218.38  |- mesh__historyNote mesh__D008152
% 218.18/218.38       91%28%75%29%; was see under DIBENZOXAZEPINES 1975-90   
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008152 2002
% 218.18/218.38  |- skos__hiddenLabel mesh__D008152 Maleate, Loxipine
% 218.18/218.38  |- skos__hiddenLabel mesh__D008152 CL71,563
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008152 2003
% 218.18/218.38  |- mesh__recordAuthorizer mesh__D008152 sjn
% 218.18/218.38  |- rdf__type mesh__D008152sskos__Concept
% 218.18/218.38  |- skos__broader mesh__D008152smesh__D003989
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D013895 1994
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D013895 2001
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D013895 1999
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D013895 2005
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D013895 1995
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D013895 2002
% 218.18/218.38  |- skos__hiddenLabel mesh__D013895 Arteries, Thoracic
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D013895 2006
% 218.18/218.38  |- mesh__recordAuthorizer mesh__D013895 PLS
% 218.18/218.38  |- skos__scopeNote mesh__D013895
% 218.18/218.38       Arteries originating from the subclavian or axillary arteries and distributing to the anterior thoracic wall, mediastinal structures, diaphragm, pectoral muscles, mammary gland and the axillary aspect of the chest wall.%A%    
% 218.18/218.38  |- skos__prefLabel mesh__D013895 Thoracic Arteries
% 218.18/218.38  |- mesh__recordOriginator mesh__D013895 NLM
% 218.18/218.38  |- mesh__dateRevised mesh__D013895 1992-05-18
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D013895 1996
% 218.18/218.38  |- rdf__type mesh__D013895sskos__Concept
% 218.18/218.38  |- mesh__recordMaintainer mesh__D013895 TAP
% 218.18/218.38  |- skos__hiddenLabel mesh__D013895 Artery, Thoracic
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D013895 1997
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D013895 2003
% 218.18/218.38  |- skos__hiddenLabel mesh__D013895 Thoracic Artery
% 218.18/218.38  |- skos__broader mesh__D013895smesh__D001158
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D013895 1993
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D013895 2000
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D013895 1998
% 218.18/218.38  |- mesh__dateCreated mesh__D013895 1999-01-01
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D013895 2004
% 218.18/218.38  |- rdf__type mesh__D013097sskos__Concept
% 218.18/218.38  |- skos__hiddenLabel mesh__D013097 Aminopropyltransferase, Spermidine
% 218.18/218.38  |- skos__hiddenLabel mesh__D013097 Synthetase, Spermine
% 218.18/218.38  |- skos__altLabel mesh__D013097 Spermine Synthetase
% 218.18/218.38  |- skos__broader mesh__D013097smesh__D019883
% 218.18/218.38  |- skos__historyNote mesh__D013097 Spermine %28%1972-1974%29%
% 218.18/218.38  |- skos__hiddenLabel mesh__D013097 Synthase, Spermine
% 218.18/218.38  |- mesh__historyNote mesh__D013097
% 218.18/218.38       91%28%75%29%; was see under TRANSFERASES 1975-90   
% 218.18/218.38  |- skos__annotation mesh__D013097
% 218.18/218.38       do not confuse with SPERMIDINE SYNTHASE   
% 218.18/218.38  |- skos__historyNote mesh__D013097 Transferases %28%1972-1974%29%
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D013097 2006
% 218.18/218.38  |- mesh__recordMaintainer mesh__D013097 ssb
% 218.18/218.38  |- mesh__recordAuthorizer mesh__D013097 sjn
% 218.18/218.38  |- skos__historyNote mesh__D013097 Propylamines %28%1972-1974%29%
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D013097 2005
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D013097 2004
% 218.18/218.38  |- skos__scopeNote mesh__D013097
% 218.18/218.38       An enzyme that catalyzes the transfer of the propylamine moiety from 5%27%-deoxy-5%27%-S-%28%3-methylthiopropylamine%29%sulfonium adenosine to spermidine in the biosynthesis of spermine. It has an acidic isoelectric point at pH 5.0. EC 2.5.1.22.%A%    
% 218.18/218.38  |- skos__altLabel mesh__D013097 Spermidine Aminopropyltransferase
% 218.18/218.38  |- mesh__recordOriginator mesh__D013097 NLM
% 218.18/218.38  |- mesh__dateCreated mesh__D013097 1974-11-19
% 218.18/218.38  |- skos__prefLabel mesh__D013097 Spermine Synthase
% 218.18/218.38  |- mesh__dateRevised mesh__D013097 2003-07-09
% 218.18/218.38  |- mesh__dateEstablished mesh__D013097 1991-01-01
% 218.18/218.38  |- mesh__publicMeSHNote mesh__D013097
% 218.18/218.38       91; was see under TRANSFERASES 1975-90   
% 218.18/218.38  |- skos__scopeNote mesh__D007858
% 218.18/218.38       Relatively permanent change in behavior that is the result of past experience or practice. The concept includes the acquisition of knowledge.%A%    
% 218.18/218.38  |- skos__hiddenLabel mesh__D007858 Learnings
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D007858 1999
% 218.18/218.38  |- mesh__recordAuthorizer mesh__D007858 SJN
% 218.18/218.38  |- skos__annotation mesh__D007858 more psychol than educ: Manual 30.12   
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D007858 1998
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D007858 2002
% 218.18/218.38  |- mesh__recordMaintainer mesh__D007858 TGC
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D007858 2004
% 218.18/218.38  |- skos__broader mesh__D007858smesh__D008606
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D007858 2001
% 218.18/218.38  |- skos__broader mesh__D007858smesh__D011588
% 218.18/218.38  |- mesh__recordOriginator mesh__D007858 NLM
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D007858 2003
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D007858 2006
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D007858 2000
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D007858 2005
% 218.18/218.38  |- skos__prefLabel mesh__D007858 Learning
% 218.18/218.38  |- mesh__dateRevised mesh__D007858 1997-06-20
% 218.18/218.38  |- rdf__type mesh__D007858sskos__Concept
% 218.18/218.38  |- mesh__dateCreated mesh__D007858 1999-01-01
% 218.18/218.38  |- skos__historyNote mesh__D018580
% 218.18/218.38       specific infectious disease/prevention %26% control %28%1989-1994%29%
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D018580 2004
% 218.18/218.38  |- skos__scopeNote mesh__D018580
% 218.18/218.38       Testing or screening required by federal, state, or local law or other agencies for the diagnosis of specified conditions. It is usually limited to specific populations such as categories of health care providers, members of the military, and prisoners or to specific situations such as premarital examinations or donor screening.%A%    
% 218.18/218.38  |- mesh__dateRevised mesh__D018580 2002-10-31
% 218.18/218.38  |- skos__broader mesh__D018580smesh__D003140
% 218.18/218.38  |- mesh__dateEstablished mesh__D018580 1995-01-01
% 218.18/218.38  |- skos__hiddenLabel mesh__D018580 Screening, Mandatory
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D018580 2005
% 218.18/218.38  |- mesh__publicMeSHNote mesh__D018580 95   
% 218.18/218.38  |- skos__annotation mesh__D018580
% 218.18/218.38       for prev of commun dis; IM; coord with specific dis or population group %28%IM%29%%A%  
% 218.18/218.38  |- skos__altLabel mesh__D018580 Mandatory Screening
% 218.18/218.38  |- mesh__recordMaintainer mesh__D018580 jls
% 218.18/218.38  |- skos__related mesh__D018580smesh__D015813
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D018580 2006
% 218.18/218.38  |- mesh__dateCreated mesh__D018580 1994-06-01
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D018580 2003A
% 218.18/218.38  |- mesh__recordAuthorizer mesh__D018580 jls
% 218.18/218.38  |- skos__broader mesh__D018580smesh__D037141
% 218.18/218.38  |- skos__broader mesh__D018580smesh__D008403
% 218.18/218.38  |- rdf__type mesh__D018580sskos__Concept
% 218.18/218.38  |- skos__hiddenLabel mesh__D018580 Testing, Mandatory
% 218.18/218.38  |- skos__historyNote mesh__D018580
% 218.18/218.38       specific infectious disease/diagnosis %28%1989-1994%29%
% 218.18/218.38  |- mesh__recordOriginator mesh__D018580 JLS
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D018580 2003
% 218.18/218.38  |- mesh__historyNote mesh__D018580 95   
% 218.18/218.38  |- skos__prefLabel mesh__D018580 Mandatory Testing
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D004560 2006
% 218.18/218.38  |- skos__related mesh__D004560smesh__D001674
% 218.18/218.38  |- mesh__dateCreated mesh__D004560 1999-01-01
% 218.18/218.38  |- rdf__type mesh__D004560sskos__Concept
% 218.18/218.38  |- skos__related mesh__D004560smesh__D008030
% 218.18/218.38  |- skos__prefLabel mesh__D004560 Electricity
% 218.18/218.38  |- mesh__recordMaintainer mesh__D004560 ags
% 218.18/218.38  |- mesh__historyNote mesh__D004560 was in Cat H only 1963-81   
% 218.18/218.38  |- skos__annotation mesh__D004560
% 218.18/218.38       adv eff: consider also ELECTRIC INJURIES; ELECTRIC CAPACITANCE; ELECTRIC IMPEDANCE; ELECTRIC RESISTANCE; and ELECTROSTATICS are also available; shock: see note under ELECTROSHOCK%A%  
% 218.18/218.38  |- skos__scopeNote mesh__D004560
% 218.18/218.38       A physical phenomenon involving electric charges and their effects when at rest and when in motion. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed%29%%A%    
% 218.18/218.38  |- mesh__dateRevised mesh__D004560 2005-07-13
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D004560 2006A
% 218.18/218.38  |- mesh__recordAuthorizer mesh__D004560 ags
% 218.18/218.38  |- mesh__recordOriginator mesh__D004560 NLM
% 218.18/218.38  |- skos__broader mesh__D004560smesh__D010825
% 218.18/218.38  |- skos__altLabel mesh__D031957 Zizyphus
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D031957 2006
% 218.18/218.38  |- skos__annotation mesh__D031957
% 218.18/218.38       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D031957 2003
% 218.18/218.38  |- mesh__dateEstablished mesh__D031957 2003-01-01
% 218.18/218.38  |- skos__broader mesh__D031957smesh__D027823
% 218.18/218.38  |- rdf__type mesh__D031957sskos__Concept
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D031957 2004
% 218.18/218.38  |- mesh__publicMeSHNote mesh__D031957 2003   
% 218.18/218.38  |- mesh__historyNote mesh__D031957 2003   
% 218.18/218.38  |- skos__prefLabel mesh__D031957 Ziziphus
% 218.18/218.38  |- skos__scopeNote mesh__D031957
% 218.18/218.38       A plant genus of the family RHAMNACEAE. Members contain nummularogenin %28%a spirostane%29% and is the source of an edible fruit.%A%    
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D031957 2005
% 218.18/218.38  |- mesh__dateCreated mesh__D031957 2002-07-03
% 218.18/218.38  |- skos__prefLabel mesh__D017488 Hyperkeratosis, Epidermolytic
% 218.18/218.38  |- skos__scopeNote mesh__D017488
% 218.18/218.38       A form of congenital ichthyosis inherited as an autosomal dominant trait and characterized by erythroderma and severe hyperkeratosis. It is manifested at birth by blisters followed by the appearance of thickened, horny, verruciform scales over the entire body, but accentuated in flexural areas.%A%    
% 218.18/218.38  |- mesh__dateCreated mesh__D017488 1992-05-20
% 218.18/218.38  |- skos__hiddenLabel mesh__D017488 Epidermolytic Hyperkeratosis
% 218.18/218.38  |- rdf__type mesh__D017488sskos__Concept
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D017488 2004
% 218.18/218.38  |- skos__broader mesh__D017488smesh__D016113
% 218.18/218.38  |- mesh__historyNote mesh__D017488
% 218.18/218.38       93; was see ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL 1991-92; ERYTHRODERMA ICHTHYOSIFORME, BULLOUS was see ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL 1991-92, was see SKIN DISEASES, BULLOUS 1979-90%A%  
% 218.18/218.38  |- skos__altLabel mesh__D017488 Erythroderma Ichthyosiforme, Bullous
% 218.18/218.38  |- mesh__onlineNote mesh__D017488
% 218.18/218.38       use ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL to search HYPERKERATOSIS, EPIDERMOLYTIC %26% ERYTHRODERMA ICHTHYOSIFORME, BULLOUS 1991-92; use SKIN DISEASES, VESCULOBULLOUS to search ERYTHRODERMA ICHTHYOSIFORME, BULLOUS 1979-90%A%  
% 218.18/218.38  |- mesh__dateEstablished mesh__D017488 1993-01-01
% 218.18/218.38  |- mesh__recordAuthorizer mesh__D017488 sjn
% 218.18/218.38  |- skos__historyNote mesh__D017488 Ichthyosis %28%1966-1992%29%
% 218.18/218.38  |- skos__historyNote mesh__D017488
% 218.18/218.38       Ichthyosiform Erythroderma, Congenital %28%1991-1992%29%
% 218.18/218.38  |- skos__hiddenLabel mesh__D017488 Epidermolytic Hyperkeratoses
% 218.18/218.38  |- skos__annotation mesh__D017488
% 218.18/218.38       a form of congen ichthyosis; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 218.18/218.38  |- skos__historyNote mesh__D017488 Keratosis %28%1972-1992%29%
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D017488 2005
% 218.18/218.38  |- mesh__recordMaintainer mesh__D017488 nns
% 218.18/218.38  |- skos__hiddenLabel mesh__D017488 Bullous Erythroderma Ichthyosiforme
% 218.18/218.38  |- mesh__recordOriginator mesh__D017488 PLS
% 218.18/218.38  |- skos__altLabel mesh__D017488
% 218.18/218.38       Bullous Congenital Ichthyosiform Erythroderma
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D017488 2006
% 218.18/218.38  |- mesh__dateRevised mesh__D017488 2001-07-25
% 218.18/218.38  |- skos__historyNote mesh__D017488
% 218.18/218.38       Skin Diseases, Vesiculobullous %28%1972-1992%29%
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D017488 2002
% 218.18/218.38  |- skos__hiddenLabel mesh__D017488 Hyperkeratoses, Epidermolytic
% 218.18/218.38  |- mesh__publicMeSHNote mesh__D017488
% 218.18/218.38       93; was see ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL 1991-92; ERYTHRODERMA ICHTHYOSIFORME, BULLOUS was see ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL 1991-92, was see SKIN DISEASES, BULLOUS 1979-90%A%  
% 218.18/218.38  |- skos__altLabel mesh__D017488
% 218.18/218.38       Congenital Bullous Ichthyosiform Erythroderma
% 218.18/218.38  |- skos__altLabel mesh__D017488
% 218.18/218.38       Ichthyosiform Erythroderma, Bullous Congenital
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D017488 2003
% 218.18/218.38  |- skos__prefLabel mesh__D003468 Cultural Evolution
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D003468 1996
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D003468 2005
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D003468 1998
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D003468 2004
% 218.18/218.38  |- mesh__recordMaintainer mesh__D003468 KEV
% 218.18/218.38  |- mesh__dateCreated mesh__D003468 1977-04-22
% 218.18/218.38  |- skos__broader mesh__D003468smesh__D003469
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D003468 1997
% 218.18/218.38  |- mesh__publicMeSHNote mesh__D003468 91; was see under CULTURE 1978-90   
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D003468 2006
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D003468 1999
% 218.18/218.38  |- mesh__recordOriginator mesh__D003468 EC
% 218.18/218.38  |- mesh__recordAuthorizer mesh__D003468 PLS
% 218.18/218.38  |- skos__hiddenLabel mesh__D003468 Evolution, Cultural
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D003468 2002
% 218.18/218.38  |- skos__hiddenLabel mesh__D003468 Cultural Evolutions
% 218.18/218.38  |- mesh__dateEstablished mesh__D003468 1991-01-01
% 218.18/218.38  |- mesh__dateRevised mesh__D003468 1995-05-23
% 218.18/218.38  |- mesh__historyNote mesh__D003468
% 218.18/218.38       91%28%78%29%; was see under CULTURE 1978-90   
% 218.18/218.38  |- skos__scopeNote mesh__D003468
% 218.18/218.38       The continuous developmental process of a culture from simple to complex forms and from homogeneous to heterogeneous qualities.%A%    
% 218.18/218.38  |- skos__hiddenLabel mesh__D003468 Evolutions, Cultural
% 218.18/218.38  |- skos__annotation mesh__D003468 no qualif   
% 218.18/218.38  |- rdf__type mesh__D003468sskos__Concept
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D003468 2000
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D003468 2003
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D003468 2001
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D014190 2004
% 218.18/218.38  |- skos__hiddenLabel mesh__D014190 Transvestic Fetishisms
% 218.18/218.38  |- mesh__recordAuthorizer mesh__D014190 SJN
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D014190 2003
% 218.18/218.38  |- rdf__type mesh__D014190sskos__Concept
% 218.18/218.38  |- skos__altLabel mesh__D014190 Transvestic Fetishism
% 218.18/218.38  |- skos__hiddenLabel mesh__D014190 Transvestisms
% 218.18/218.38  |- mesh__dateCreated mesh__D014190 1999-01-01
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D014190 2002
% 218.18/218.38  |- skos__broader mesh__D014190smesh__D010262
% 218.18/218.38  |- skos__hiddenLabel mesh__D014190 Fetishisms, Transvestic
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D014190 2006
% 218.18/218.38  |- skos__scopeNote mesh__D014190
% 218.18/218.38       Disorder characterized by recurrent, intense sexually arousing fantasies, sexual urges, or behaviors involving cross-dressing in a heterosexual male. The fantasies, urges, or behaviors cause clinically significant distress or impairment in social, occupational or other areas of functioning. %28%from APA, DSM-IV, 1994%29%%A%    
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D014190 2001
% 218.18/218.38  |- skos__hiddenLabel mesh__D014190 Fetishism, Transvestic
% 218.18/218.38  |- skos__prefLabel mesh__D014190 Transvestism
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D014190 2005
% 218.18/218.38  |- mesh__recordMaintainer mesh__D014190 JLS
% 218.18/218.38  |- mesh__dateRevised mesh__D014190 1998-06-11
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D014190 2000
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D014190 1999
% 218.18/218.38  |- mesh__recordOriginator mesh__D014190 NLM
% 218.18/218.38  |- skos__prefLabel mesh__D008951 MNSs Blood-Group System
% 218.18/218.38  |- rdf__type mesh__D008951sskos__Concept
% 218.18/218.38  |- skos__hiddenLabel mesh__D008951 MNSs Blood Group System
% 218.18/218.38  |- mesh__dateEstablished mesh__D008951 1976-01-01
% 218.18/218.38  |- mesh__publicMeSHNote mesh__D008951 76   
% 218.18/218.38  |- mesh__recordMaintainer mesh__D008951 ssb
% 218.18/218.38  |- skos__scopeNote mesh__D008951
% 218.18/218.38       A system of universal human blood group isoantigens with many associated subgroups. The M and N traits are codominant and the S and s traits are probably very closely linked alleles, including the U antigen. This system is most frequently used in paternity studies.%A%    
% 218.18/218.38  |- skos__annotation mesh__D008951
% 218.18/218.38       IM; coord with disease /blood %28%IM%29%, not /immunol nor /genet; TN 230%A%  
% 218.18/218.38  |- skos__hiddenLabel mesh__D008951 Blood-Group System, MNSs
% 218.18/218.38  |- skos__hiddenLabel mesh__D008951 Blood-Group Systems, MNSs
% 218.18/218.38  |- mesh__recordOriginator mesh__D008951 SH
% 218.18/218.38  |- skos__hiddenLabel mesh__D008951 Systems, MNSs Blood-Group
% 218.18/218.38  |- skos__hiddenLabel mesh__D008951 MNSs Blood-Group Systems
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008951 2006
% 218.18/218.38  |- skos__broader mesh__D008951smesh__D001789
% 218.18/218.38  |- mesh__dateCreated mesh__D008951 1975-07-25
% 218.18/218.38  |- mesh__dateRevised mesh__D008951 2005-06-30
% 218.18/218.38  |- skos__historyNote mesh__D008951 Blood Groups %28%1966-1975%29%
% 218.18/218.38  |- mesh__historyNote mesh__D008951 76   
% 218.18/218.38  |- skos__hiddenLabel mesh__D008951 System, MNSs Blood-Group
% 218.18/218.38  |- mesh__recordAuthorizer mesh__D008951 sjn
% 218.18/218.38  |- skos__historyNote mesh__D022622 Bacterial Toxins %28%1980-2000%29%
% 218.18/218.38  |- skos__broader mesh__D022622smesh__D022603
% 218.18/218.38  |- skos__altLabel mesh__D022622 VT1 Cytotoxin
% 218.18/218.38  |- skos__altLabel mesh__D022622 Shiga Toxin 1
% 218.18/218.38  |- mesh__recordMaintainer mesh__D022622 ssb
% 218.18/218.38  |- mesh__dateEstablished mesh__D022622 2001-01-01
% 218.18/218.38  |- skos__prefLabel mesh__D022622 Shiga-Like Toxin I
% 218.18/218.38  |- skos__altLabel mesh__D022622 Verotoxin I
% 218.18/218.38  |- skos__hiddenLabel mesh__D022622 Protein, Stx1
% 218.18/218.38  |- skos__altLabel mesh__D022622 Stx1 Protein
% 218.18/218.38  |- skos__related mesh__D022622smesh__D019453
% 218.18/218.38  |- skos__altLabel mesh__D022622 SLTI
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D022622 2006
% 218.18/218.38  |- skos__hiddenLabel mesh__D022622 SLT I
% 218.18/218.38  |- mesh__historyNote mesh__D022622
% 218.18/218.38       2001; use SHIGA-LIKE TOXIN I %28%NM%29% 1984-2000; for SHIGA TOXIN 1 %26% STX1 PROTEIN use SHIGA TOXIN %28%NM%29% 1997-2000%A%  
% 218.18/218.38  |- skos__altLabel mesh__D022622 SLT-I
% 218.18/218.38  |- rdf__type mesh__D022622sskos__Concept
% 218.18/218.38  |- mesh__publicMeSHNote mesh__D022622
% 218.18/218.38       2001; SHIGA-LIKE TOXIN 1 was indexed under BACTERIAL TOXINS 1984-2000; SHIGA TOXIN 1 %26% STX1 PROTEIN was indexed under BACTERIAL TOXINS 1997-2000%A%  
% 218.18/218.38  |- skos__altLabel mesh__D022622 Verocytotoxin 1
% 218.18/218.38  |- skos__altLabel mesh__D022622 Vero Cytotoxin VT1
% 218.18/218.38  |- mesh__recordOriginator mesh__D022622 jmp
% 218.18/218.38  |- mesh__dateRevised mesh__D022622 2005-06-30
% 218.18/218.38  |- mesh__dateCreated mesh__D022622 2000-06-27
% 218.18/218.38  |- mesh__recordAuthorizer mesh__D022622 sjn
% 218.18/218.38  |- skos__scopeNote mesh__D022622
% 218.18/218.38       A toxin produced by certain pathogenic strains of ESCHERICHIA COLI such as ESCHERICHIA COLI O157. It is closely related to SHIGA TOXIN produced by SHIGELLA DYSENTERIAE.%A%    
% 218.18/218.38  |- skos__hiddenLabel mesh__D022622 Shiga Like Toxin I
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008153 1996
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008153 2002
% 218.18/218.38  |- skos__broader mesh__D008153smesh__D010825
% 218.18/218.38  |- skos__annotation mesh__D008153
% 218.18/218.38       NIM; no qualif; coord with lubricant %28%IM%29%; do not use for natural %22%lubrication%22% of joints: = probably SYNOVIAL FLUID%A%  
% 218.18/218.38  |- skos__prefLabel mesh__D008153 Lubrication
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008153 1998
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008153 1997
% 218.18/218.38  |- skos__scopeNote mesh__D008153
% 218.18/218.38       The application of a substance to diminish friction between two surfaces. It may refer to oils, greases, and similar substances for the lubrication of medical equipment but it can be used for the application of substances to tissue to reduce friction, such as lotions for skin and vaginal lubricants.%A%    
% 218.18/218.38  |- mesh__dateEstablished mesh__D008153 1991-01-01
% 218.18/218.38  |- skos__hiddenLabel mesh__D008153 Lubricant
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008153 2000
% 218.18/218.38  |- mesh__historyNote mesh__D008153
% 218.18/218.38       91%28%64%29%; was see under PHYSICS 1964-90   
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008153 1999
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008153 2003
% 218.18/218.38  |- rdf__type mesh__D008153sskos__Concept
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008153 2001
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008153 2005
% 218.18/218.38  |- mesh__publicMeSHNote mesh__D008153 91; was see under PHYSICS 1964-90   
% 218.18/218.38  |- mesh__dateCreated mesh__D008153 1999-01-01
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008153 2004
% 218.18/218.38  |- mesh__dateRevised mesh__D008153 1995-05-25
% 218.18/218.38  |- skos__hiddenLabel mesh__D008153 Lubrications
% 218.18/218.38  |- mesh__activeMeSHYear mesh__D008153 2006
% 218.18/218.38  |- mesh__recordMaintainer mesh__D008153 PLS
% 218.18/218.38  |- mesh__recordOriginator mesh__D008153 NLM
% 218.18/218.38  |- mesh__recordAuthorizer mesh__D008153 PLS
% 218.18/218.38  |- skos__altLabel mesh__D000170 Pink Disease
% 218.18/218.38  |- mesh__recordOriginator mesh__D000170 NLM
% 218.18/218.38  |- skos__altLabel mesh__D000170 Swift Disease
% 218.18/218.38  |- skos__altLabel mesh__D000170 Acrodynic Erythema
% 218.18/218.38  |- skos__broader mesh__D000170smesh__D020262
% 218.18/218.39  |- skos__hiddenLabel mesh__D000170 Erythema, Acrodynic
% 218.18/218.39  |- skos__hiddenLabel mesh__D000170 Swifts Disease
% 218.18/218.39  |- skos__altLabel mesh__D000170 Swift%27%s Disease
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D000170 2001
% 218.18/218.39  |- skos__altLabel mesh__D000170 Feer%27%s Disease
% 218.18/218.39  |- mesh__dateRevised mesh__D000170 2005-07-13
% 218.18/218.39  |- skos__hiddenLabel mesh__D000170 Childhood Mercurialisms, Chronic
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D000170 2005
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D000170 2002
% 218.18/218.39  |- skos__altLabel mesh__D000170 Feer Disease
% 218.18/218.39  |- skos__prefLabel mesh__D000170 Acrodynia
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D000170 2003
% 218.18/218.39  |- skos__broader mesh__D000170smesh__D010523
% 218.18/218.39  |- skos__hiddenLabel mesh__D000170 Chronic Childhood Mercurialisms
% 218.18/218.39  |- skos__hiddenLabel mesh__D000170 Childhood Mercurialism, Chronic
% 218.18/218.39  |- skos__altLabel mesh__D000170 Chronic Childhood Mercurialism
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D000170 2006
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D000170 2004
% 218.18/218.39  |- skos__hiddenLabel mesh__D000170 Mercurialism, Chronic Childhood
% 218.18/218.39  |- skos__hiddenLabel mesh__D000170 Feers Disease
% 218.18/218.39  |- mesh__dateCreated mesh__D000170 1999-01-01
% 218.18/218.39  |- mesh__recordAuthorizer mesh__D000170 ags
% 218.18/218.39  |- skos__scopeNote mesh__D000170
% 218.18/218.39       A condition seen primarily in childhood, most often resulting from chronic exposure to MERCURY COMPOUNDS which may result in encephalopathy and POLYNEUROPATHY. Clinical features include pain, swelling and pinkish discoloration of the fingers and toes, weakness in the extremities, extreme irritability, HYPERESTHESIA, and alterations in level of consciousness. %28%From Menkes, Textbook of Child Neurology, 5th ed, p603%29%%A%    
% 218.18/218.39  |- rdf__type mesh__D000170sskos__Concept
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D000170 2006A
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D000170 2000
% 218.18/218.39  |- mesh__recordMaintainer mesh__D000170 ags
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D013896 2006
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D013896 2000
% 218.18/218.39  |- skos__hiddenLabel mesh__D013896 Diseases, Thoracic
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D013896 2001
% 218.18/218.39  |- skos__hiddenLabel mesh__D013896 Disease, Thoracic
% 218.18/218.39  |- mesh__recordAuthorizer mesh__D013896 sjn
% 218.18/218.39  |- rdf__type mesh__D013896sskos__Concept
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D013896 2002
% 218.18/218.39  |- skos__scopeNote mesh__D013896
% 218.18/218.39       Disorders affecting the organs of the thorax.     
% 218.18/218.39  |- skos__hiddenLabel mesh__D013896 Thoracic Disease
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D013896 2003
% 218.18/218.39  |- skos__annotation mesh__D013896
% 218.18/218.39       GEN: prefer specifics; CHEST PAIN is available   
% 218.18/218.39  |- mesh__recordOriginator mesh__D013896 NLM
% 218.18/218.39  |- mesh__recordMaintainer mesh__D013896 KEV
% 218.18/218.39  |- mesh__dateCreated mesh__D013896 1999-01-01
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D013896 2004
% 218.18/218.39  |- skos__prefLabel mesh__D013896 Thoracic Diseases
% 218.18/218.39  |- mesh__dateRevised mesh__D013896 1999-11-03
% 218.18/218.39  |- skos__broader mesh__D013896smesh__D012140
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D013896 2005
% 218.18/218.39  |- skos__altLabel mesh__D013098 Sphaeriales
% 218.18/218.39  |- mesh__dateCreated mesh__D013098 1999-01-01
% 218.18/218.39  |- skos__broader mesh__D013098smesh__D001203
% 218.18/218.39  |- mesh__recordMaintainer mesh__D013098 ags
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D013098 2006
% 218.18/218.39  |- skos__scopeNote mesh__D013098
% 218.18/218.39       An order of ascomycetous FUNGI which includes many economically important plant parasites as well as saprophytes.%A%    
% 218.18/218.39  |- mesh__dateRevised mesh__D013098 2005-06-30
% 218.18/218.39  |- skos__prefLabel mesh__D013098 Xylariales
% 218.18/218.39  |- mesh__historyNote mesh__D013098 2006 %28%1975%29%   
% 218.18/218.39  |- mesh__dateEstablished mesh__D013098 1991-01-01
% 218.18/218.39  |- mesh__recordAuthorizer mesh__D013098 sjn
% 218.18/218.39  |- mesh__publicMeSHNote mesh__D013098
% 218.18/218.39       2006; see SPHAERIALES 1991-2005, see ASCOMYCETES 1975-1990%A%  
% 218.18/218.39  |- mesh__recordOriginator mesh__D013098 NLM
% 218.18/218.39  |- rdf__type mesh__D013098sskos__Concept
% 218.18/218.39  |- mesh__dateEstablished mesh__D007859 1966-01-01
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D007859 2003
% 218.18/218.39  |- skos__altLabel mesh__D007859 Learning Disorders, Adult
% 218.18/218.39  |- skos__altLabel mesh__D007859
% 218.18/218.39       Developmental Disorders of Scholastic Skills
% 218.18/218.39  |- skos__hiddenLabel mesh__D007859 Learning Disorder, Adult
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D007859 2002
% 218.18/218.39  |- mesh__publicMeSHNote mesh__D007859 1966   
% 218.18/218.39  |- mesh__recordMaintainer mesh__D007859 KEV
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D007859 2005
% 218.18/218.39  |- skos__hiddenLabel mesh__D007859 Learning Disorder
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D007859 2004
% 218.18/218.39  |- skos__hiddenLabel mesh__D007859 Adult Learning Disorder
% 218.18/218.39  |- mesh__recordAuthorizer mesh__D007859 sjn
% 218.18/218.39  |- skos__scopeNote mesh__D007859
% 218.18/218.39       Conditions characterized by a significant discrepancy between an individual%27%s perceived level of intellect and their ability to acquire new language and other cognitive skills. These disorders may result from organic or psychological conditions. Relatively common subtypes include DYSLEXIA, dyscalculia, and dysgraphia.%A%    
% 218.18/218.39  |- mesh__dateRevised mesh__D007859 1999-11-03
% 218.18/218.39  |- skos__broader mesh__D007859smesh__D003147
% 218.18/218.39  |- skos__hiddenLabel mesh__D007859 Disabilities, Learning
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D007859 2006
% 218.18/218.39  |- mesh__dateCreated mesh__D007859 1999-01-01
% 218.18/218.39  |- skos__hiddenLabel mesh__D007859 Disturbances, Learning
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D007859 2000
% 218.18/218.39  |- skos__broader mesh__D007859smesh__D019952
% 218.18/218.39  |- skos__hiddenLabel mesh__D007859 Learning Disturbances
% 218.18/218.39  |- skos__hiddenLabel mesh__D007859 Disability, Learning
% 218.18/218.39  |- mesh__historyNote mesh__D007859 1966%28%1964%29%   
% 218.18/218.39  |- skos__hiddenLabel mesh__D007859 Disturbance, Learning
% 218.18/218.39  |- skos__related mesh__D007859smesh__D004410
% 218.18/218.39  |- skos__altLabel mesh__D007859 Academic Disorder, Developmental
% 218.18/218.39  |- skos__prefLabel mesh__D007859 Learning Disorders
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D007859 2001
% 218.18/218.39  |- rdf__type mesh__D007859sskos__Concept
% 218.18/218.39  |- skos__altLabel mesh__D007859 Scholastic Skills Development Disorders
% 218.18/218.39  |- mesh__recordOriginator mesh__D007859 NLM
% 218.18/218.39  |- skos__hiddenLabel mesh__D007859 Learning Disability
% 218.18/218.39  |- skos__hiddenLabel mesh__D007859 Developmental Academic Disorders
% 218.18/218.39  |- skos__hiddenLabel mesh__D007859 Academic Disorders, Developmental
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D018581 1996
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D018581 2005
% 218.18/218.39  |- skos__historyNote mesh__D018581 Technology, Medical %28%1976-1994%29%
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D018581 2000
% 218.18/218.39  |- skos__annotation mesh__D018581
% 218.18/218.39       transfer geographically, between disciplines or between govt %26% non-govt sectors; DF: TECHNOL TRANSFER%A%  
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D018581 1997
% 218.18/218.39  |- skos__broader mesh__D018581smesh__D013672
% 218.18/218.39  |- skos__broader mesh__D018581smesh__D004059
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D018581 2006
% 218.18/218.39  |- mesh__dateCreated mesh__D018581 1994-07-01
% 218.18/218.39  |- skos__hiddenLabel mesh__D018581 Transfers, Technology
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D018581 2001
% 218.18/218.39  |- mesh__dateEstablished mesh__D018581 1995-01-01
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D018581 1998
% 218.18/218.39  |- skos__hiddenLabel mesh__D018581 Technology Transfers
% 218.18/218.39  |- skos__scopeNote mesh__D018581
% 218.18/218.39       Spread and adoption of inventions and techniques from one geographic area to another, from one discipline to another, or from one sector of the economy to another. For example, improvements in medical equipment may be transferred from industrial countries to developing countries, advances arising from aerospace engineering may be applied to equipment for persons with disabilities, and innovations in science arising from government research are made available to private enterprise.%A%    
% 218.18/218.39  |- mesh__publicMeSHNote mesh__D018581 95   
% 218.18/218.39  |- skos__prefLabel mesh__D018581 Technology Transfer
% 218.18/218.39  |- rdf__type mesh__D018581sskos__Concept
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D018581 2002
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D018581 2003
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D018581 1999
% 218.18/218.39  |- mesh__historyNote mesh__D018581 95   
% 218.18/218.39  |- skos__hiddenLabel mesh__D018581 Transfer, Technology
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D018581 1995
% 218.18/218.39  |- skos__historyNote mesh__D018581 Technology %28%1976-1994%29%
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D018581 2004
% 218.18/218.39  |- mesh__dateCreated mesh__D004561 1983-06-13
% 218.18/218.39  |- skos__hiddenLabel mesh__D004561 Nerve Stimulation, Transcutaneous
% 218.18/218.39  |- mesh__recordMaintainer mesh__D004561 lkt
% 218.18/218.39  |- skos__hiddenLabel mesh__D004561 Electrostimulation, Transdermal
% 218.18/218.39  |- skos__altLabel mesh__D004561 Transdermal Electrostimulation
% 218.18/218.39  |- skos__altLabel mesh__D004561 TENS
% 218.18/218.39  |- skos__scopeNote mesh__D004561
% 218.18/218.39       The use of specifically placed small electrodes to deliver electrical impulses across the SKIN to relieve PAIN. It is used less frequently to produce ANESTHESIA.%A%    
% 218.18/218.39  |- mesh__dateEstablished mesh__D004561 1990-01-01
% 218.18/218.39  |- skos__historyNote mesh__D004561 Electric Stimulation %28%1966-1983%29%
% 218.18/218.39  |- mesh__publicMeSHNote mesh__D004561
% 218.18/218.39       90; was ELECTROANALGESIA see under ELECTROTHERAPY l984-89%A%  
% 218.18/218.39  |- skos__broader mesh__D004561smesh__D004599
% 218.18/218.39  |- skos__annotation mesh__D004561 do not confuse with ELECTRONARCOSIS   
% 218.18/218.39  |- skos__hiddenLabel mesh__D004561 Stimulation, Transcutaneous Electric
% 218.18/218.39  |- skos__broader mesh__D004561smesh__D000698
% 218.18/218.39  |- skos__hiddenLabel mesh__D004561 Transcutaneous Electric Stimulation
% 218.18/218.39  |- skos__prefLabel mesh__D004561 Transcutaneous Electric Nerve Stimulation
% 218.18/218.39  |- skos__altLabel mesh__D004561 Percutaneous Electrical Nerve Stimulation
% 218.18/218.39  |- mesh__dateRevised mesh__D004561 2005-06-30
% 218.18/218.39  |- skos__altLabel mesh__D004561 Electric Stimulation, Transcutaneous
% 218.18/218.39  |- mesh__onlineNote mesh__D004561
% 218.18/218.39       use TRANSCUTANEOUS ELECTRIC NERVE STIMULATION to search ELECTROANALGESIA 1984-89%A%  
% 218.18/218.39  |- skos__hiddenLabel mesh__D004561 Stimulation, Transcutaneous Nerve
% 218.18/218.39  |- skos__hiddenLabel mesh__D004561 Stimulation, Transcutaneous Electrical
% 218.18/218.39  |- skos__historyNote mesh__D004561
% 218.18/218.39       Electric Stimulation Therapy %28%1966-1983%29%
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D004561 2006
% 218.18/218.39  |- skos__altLabel mesh__D004561 Transcutaneous Electrical Nerve Stimulation
% 218.18/218.39  |- skos__altLabel mesh__D004561 Electrical Stimulation, Transcutaneous
% 218.18/218.39  |- skos__altLabel mesh__D004561 Percutaneous Electric Nerve Stimulation
% 218.18/218.39  |- skos__hiddenLabel mesh__D004561 Electrostimulation, Analgesic Cutaneous
% 218.18/218.39  |- skos__hiddenLabel mesh__D004561 Transcutaneous Electrical Stimulation
% 218.18/218.39  |- mesh__historyNote mesh__D004561
% 218.18/218.39       90; was ELECTROANALGESIA see under ELECTROTHERAPY 1984-89%A%  
% 218.18/218.39  |- skos__hiddenLabel mesh__D004561 Cutaneous Electrostimulation, Analgesic
% 218.18/218.39  |- mesh__recordOriginator mesh__D004561 SH
% 218.18/218.39  |- skos__altLabel mesh__D004561 Transcutaneous Nerve Stimulation
% 218.18/218.39  |- mesh__recordAuthorizer mesh__D004561 sjn
% 218.18/218.39  |- rdf__type mesh__D004561sskos__Concept
% 218.18/218.39  |- mesh__dateRevised mesh__D017489 2004-07-07
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D017489 2005
% 218.18/218.39  |- mesh__dateEstablished mesh__D017489 1993-01-01
% 218.18/218.39  |- skos__historyNote mesh__D017489 Protein Kinases %28%1988-1993%29%
% 218.18/218.39  |- skos__broader mesh__D017489smesh__D029701
% 218.18/218.39  |- mesh__recordOriginator mesh__D017489 TPW
% 218.18/218.39  |- skos__altLabel mesh__D017489 CDC28 protein, S cerevisiae
% 218.18/218.39  |- rdf__type mesh__D017489sskos__Concept
% 218.18/218.39  |- mesh__dateCreated mesh__D017489 1992-05-13
% 218.18/218.39  |- mesh__historyNote mesh__D017489 2004%28%1993%29%   
% 218.18/218.39  |- skos__scopeNote mesh__D017489
% 218.18/218.39       A protein kinase encoded by the Saccharomyces cerevisiae CDC28 gene and required for progression from the G1 PHASE to the S PHASE in the CELL CYCLE.%A%    
% 218.18/218.39  |- skos__prefLabel mesh__D017489 CDC28 Protein Kinase, S cerevisiae
% 218.18/218.39  |- mesh__recordMaintainer mesh__D017489 jmp
% 218.18/218.39  |- skos__broader mesh__D017489smesh__D042846
% 218.18/218.39  |- mesh__recordAuthorizer mesh__D017489 sjn
% 218.18/218.39  |- mesh__publicMeSHNote mesh__D017489
% 218.18/218.39       1993; CDC28 PROTEIN KINASE %28%now CDC28 PROTEIN KINASE, S CEREVISIAE%29% was indexed under PROTEIN KINASES 1991-1993%A%  
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D017489 2006
% 218.18/218.39  |- skos__hiddenLabel mesh__D003469 Backgrounds, Cultural
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D003469 1998
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D003469 1997
% 218.18/218.39  |- mesh__recordMaintainer mesh__D003469 PLS
% 218.18/218.39  |- skos__hiddenLabel mesh__D003469 Cultural Backgrounds
% 218.18/218.39  |- skos__hiddenLabel mesh__D003469 Background, Cultural
% 218.18/218.39  |- skos__broader mesh__D003469smesh__D000884
% 218.18/218.39  |- mesh__recordAuthorizer mesh__D003469 PLS
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D003469 2005
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D003469 2004
% 218.18/218.39  |- mesh__recordOriginator mesh__D003469 NLM
% 218.18/218.39  |- skos__hiddenLabel mesh__D003469 Cultures
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D003469 1999
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D003469 2002
% 218.18/218.39  |- mesh__dateRevised mesh__D003469 1992-05-13
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D003469 1994
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D003469 2006
% 218.18/218.39  |- skos__annotation mesh__D003469
% 218.18/218.39       not for microbial or tissue cultures; no qualif; subhead with coord is probably /ethnol%A%  
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D003469 1993
% 218.18/218.39  |- skos__hiddenLabel mesh__D003469 Belief
% 218.18/218.39  |- skos__broader mesh__D003469smesh__D012961
% 218.18/218.39  |- skos__related mesh__D003469smesh__D003431
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D003469 1995
% 218.18/218.39  |- rdf__type mesh__D003469sskos__Concept
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D003469 2000
% 218.18/218.39  |- mesh__dateCreated mesh__D003469 1999-01-01
% 218.18/218.39  |- skos__prefLabel mesh__D003469 Culture
% 218.18/218.39  |- skos__hiddenLabel mesh__D003469 Custom
% 218.18/218.39  |- skos__scopeNote mesh__D003469
% 218.18/218.39       A collective expression for all behavior patterns acquired and socially transmitted through symbols. Culture includes customs, traditions, and language.%A%    
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D003469 1996
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D003469 2001
% 218.18/218.39  |- mesh__activeMeSHYear mesh__D003469 2003
% 218.18/218.39  |- rdf__type mesh__D014191sskos__Concept
% 218.18/218.39  |- skos__broader mesh__D014191smesh__D011437
% 218.18/218.39  |- skos__altLabel mesh__D014191 esparma Brand of Tranylcypromine Sulfate
% 218.18/218.39  |- mesh__recordOriginator mesh__D014191 NLM
% 218.18/218.39  |- skos__prefLabel mesh__D014191 Tranylcypromine
% 218.18/218.39  |- mesh__dateCreated mesh__D014191 1999-01-01
% 218.18/218.39  |- mesh__dateRevised mesh__D014191 2005-06-30
% 218.18/218.39  |- skos__altLabel mesh__D014191 Link Brand of Tranylcypromine Sulfate
% 218.18/218.39  |- skos__altLabel mesh__D014191 Allphar Brand of Tranylcypromine Sulfate
% 218.27/218.44  |- skos__altLabel mesh__D014191 SmithKline Brand of Tranylcypromine Sulfate
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D014191 2006
% 218.27/218.44  |- skos__scopeNote mesh__D014191
% 218.27/218.44       A propylamine formed from the cyclization of the side chain of amphetamine. This monoamine oxidase inhibitor is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in panic and phobic disorders. %28%From AMA Drug Evaluations Annual, 1994, p311%29%%A%    
% 218.27/218.44  |- mesh__recordMaintainer mesh__D014191 CCR
% 218.27/218.44  |- skos__hiddenLabel mesh__D014191 Sulfate, Tranylcypromine
% 218.27/218.44  |- skos__altLabel mesh__D014191 trans-2-Phenylcyclopropylamine
% 218.27/218.44  |- skos__altLabel mesh__D014191
% 218.27/218.44       GlaxoSmithKline Brand of Tranylcypromine Sulfate
% 218.27/218.44  |- mesh__recordAuthorizer mesh__D014191 sjn
% 218.27/218.44  |- skos__altLabel mesh__D014191 Goldshield Brand of Tranylcypromine Sulfate
% 218.27/218.44  |- skos__hiddenLabel mesh__D014191 trans 2 Phenylcyclopropylamine
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D008952 1998
% 218.27/218.44  |- mesh__dateCreated mesh__D008952 1999-01-01
% 218.27/218.44  |- mesh__publicMeSHNote mesh__D008952 70   
% 218.27/218.44  |- mesh__recordMaintainer mesh__D008952 PLS
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D008952 2002
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D008952 1996
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D008952 1999
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D008952 2005
% 218.27/218.44  |- skos__scopeNote mesh__D008952
% 218.27/218.44       Movable facilities in which diagnostic and therapeutic services are provided to the community.%A%    
% 218.27/218.44  |- skos__prefLabel mesh__D008952 Mobile Health Units
% 218.27/218.44  |- skos__hiddenLabel mesh__D008952 Unit, Mobile Health
% 218.27/218.44  |- skos__broader mesh__D008952smesh__D003954
% 218.27/218.44  |- skos__historyNote mesh__D008952 Health Facilities %28%1968-1969%29%
% 218.27/218.44  |- mesh__historyNote mesh__D008952 70   
% 218.27/218.44  |- mesh__recordOriginator mesh__D008952 NLM
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D008952 1997
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D008952 2003
% 218.27/218.44  |- mesh__dateRevised mesh__D008952 1993-06-03
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D008952 2006
% 218.27/218.44  |- skos__hiddenLabel mesh__D008952 Mobile Health Unit
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D008952 2004
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D008952 1994
% 218.27/218.44  |- skos__hiddenLabel mesh__D008952 Health Unit, Mobile
% 218.27/218.44  |- skos__hiddenLabel mesh__D008952 Health Units, Mobile
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D008952 2000
% 218.27/218.44  |- mesh__recordAuthorizer mesh__D008952 PLS
% 218.27/218.44  |- skos__hiddenLabel mesh__D008952 Units, Mobile Health
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D008952 1995
% 218.27/218.44  |- mesh__dateEstablished mesh__D008952 1970-01-01
% 218.27/218.44  |- rdf__type mesh__D008952sskos__Concept
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D008952 2001
% 218.27/218.44  |- mesh__recordOriginator mesh__D008154 NLM
% 218.27/218.44  |- mesh__historyNote mesh__D008154 67; was MIRACIL 1963-66   
% 218.27/218.44  |- rdf__type mesh__D008154sskos__Concept
% 218.27/218.44  |- skos__scopeNote mesh__D008154
% 218.27/218.44       One of the SCHISTOSOMICIDES, it has been replaced largely by HYCANTHONE and more recently PRAZIQUANTEL. %28%From Martindale The Extrapharmacopoeia, 30th ed., p46%29%%A%    
% 218.27/218.44  |- skos__prefLabel mesh__D008154 Lucanthone
% 218.27/218.44  |- mesh__dateCreated mesh__D008154 1999-01-01
% 218.27/218.44  |- mesh__recordAuthorizer mesh__D008154 sjn
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D008154 2005
% 218.27/218.44  |- mesh__dateRevised mesh__D008154 2004-07-07
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D008154 2006
% 218.27/218.44  |- skos__broader mesh__D008154smesh__D013892
% 218.27/218.44  |- skos__broader mesh__D008154smesh__D044004
% 218.27/218.44  |- mesh__dateEstablished mesh__D008154 1967-01-01
% 218.27/218.44  |- mesh__recordMaintainer mesh__D008154 ssb
% 218.27/218.44  |- mesh__publicMeSHNote mesh__D008154 67; was MIRACIL 1963-66   
% 218.27/218.44  |- mesh__onlineNote mesh__D008154 use LUCANTHONE to search MIRACIL 1966   
% 218.27/218.44  |- mesh__onlineNote mesh__D000171 search ALDEHYDES 1966-72   
% 218.27/218.44  |- skos__hiddenLabel mesh__D000171 Aldehyde, Acrylic
% 218.27/218.44  |- mesh__publicMeSHNote mesh__D000171
% 218.27/218.44       91; was see under ALDEHYDES 1973-90   
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D000171 2002
% 218.27/218.44  |- rdf__type mesh__D000171sskos__Concept
% 218.27/218.44  |- skos__altLabel mesh__D000171 Acrylaldehyde
% 218.27/218.44  |- mesh__dateEstablished mesh__D000171 1991-01-01
% 218.27/218.44  |- skos__altLabel mesh__D000171 Acraldehyde
% 218.27/218.44  |- skos__hiddenLabel mesh__D000171 Aldehyde, Allyl
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D000171 2001
% 218.27/218.44  |- skos__broader mesh__D000171smesh__D000447
% 218.27/218.44  |- mesh__historyNote mesh__D000171
% 218.27/218.44       91%28%73%29%; was see under ALDEHYDES 1973-90   
% 218.27/218.44  |- skos__altLabel mesh__D000171 Acrylic Aldehyde
% 218.27/218.44  |- skos__prefLabel mesh__D000171 Acrolein
% 218.27/218.44  |- mesh__recordOriginator mesh__D000171 NLM
% 218.27/218.44  |- skos__altLabel mesh__D000171 2-Propenal
% 218.27/218.44  |- mesh__recordMaintainer mesh__D000171 CCR
% 218.27/218.44  |- skos__hiddenLabel mesh__D000171 2 Propenal
% 218.27/218.44  |- skos__altLabel mesh__D000171 Ethylene Aldehyde
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D000171 2004
% 218.27/218.44  |- mesh__dateCreated mesh__D000171 1999-01-01
% 218.27/218.44  |- mesh__dateRevised mesh__D000171 2000-06-21
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D000171 2006
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D000171 2003
% 218.27/218.44  |- mesh__recordAuthorizer mesh__D000171 sjn
% 218.27/218.44  |- skos__hiddenLabel mesh__D000171 Aldehyde, Ethylene
% 218.27/218.44  |- skos__altLabel mesh__D000171 Allyl Aldehyde
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D000171 2005
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D013897 2005
% 218.27/218.44  |- skos__hiddenLabel mesh__D013897 Cisterna Chylus
% 218.27/218.44  |- mesh__historyNote mesh__D013897
% 218.27/218.44       CISTERNA CHYLI was see under THORACIC DUCT 1963-78   
% 218.27/218.44  |- mesh__recordAuthorizer mesh__D013897 sjn
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D013897 2006
% 218.27/218.44  |- rdf__type mesh__D013897sskos__Concept
% 218.27/218.44  |- skos__hiddenLabel mesh__D013897 Thoracic Ducts
% 218.27/218.44  |- skos__hiddenLabel mesh__D013897 Ducts, Thoracic
% 218.27/218.44  |- mesh__dateRevised mesh__D013897 2003-07-09
% 218.27/218.44  |- mesh__recordOriginator mesh__D013897 NLM
% 218.27/218.44  |- skos__hiddenLabel mesh__D013897 Chyli, Cisterna
% 218.27/218.44  |- mesh__recordMaintainer mesh__D013897 jmp
% 218.27/218.44  |- mesh__dateCreated mesh__D013897 1999-01-01
% 218.27/218.44  |- skos__hiddenLabel mesh__D013897 Chylus, Cisterna
% 218.27/218.44  |- skos__prefLabel mesh__D013897 Thoracic Duct
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D013897 2004
% 218.27/218.44  |- skos__broader mesh__D013897smesh__D042601
% 218.27/218.44  |- skos__hiddenLabel mesh__D013897 Duct, Thoracic
% 218.27/218.44  |- mesh__onlineNote mesh__D013897
% 218.27/218.44       use THORACIC DUCT to search CISTERNA CHYLI 1966-78   
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D018582 2003
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D018582 1998
% 218.27/218.44  |- skos__hiddenLabel mesh__D018582 Leaves, Disability
% 218.27/218.44  |- skos__hiddenLabel mesh__D018582 Day, Illness
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D018582 1997
% 218.27/218.44  |- skos__historyNote mesh__D018582 Absenteeism %28%1966-1994%29%
% 218.27/218.44  |- mesh__dateCreated mesh__D018582 1994-06-01
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D018582 2002
% 218.27/218.44  |- mesh__historyNote mesh__D018582 95   
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D018582 1996
% 218.27/218.44  |- skos__hiddenLabel mesh__D018582 Days, Sick
% 218.27/218.44  |- skos__hiddenLabel mesh__D018582 Illness Day
% 218.27/218.44  |- mesh__dateEstablished mesh__D018582 1995-01-01
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D018582 2006
% 218.27/218.44  |- skos__prefLabel mesh__D018582 Sick Leave
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D018582 1995
% 218.27/218.44  |- skos__annotation mesh__D018582
% 218.27/218.44       permitted absence for sickness, often paid leave   
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D018582 2001
% 218.27/218.44  |- skos__altLabel mesh__D018582 Illness Days
% 218.27/218.44  |- skos__broader mesh__D018582smesh__D012456
% 218.27/218.44  |- skos__hiddenLabel mesh__D018582 Leave, Sick
% 218.27/218.44  |- skos__hiddenLabel mesh__D018582 Disability Leaves
% 218.27/218.44  |- skos__hiddenLabel mesh__D018582 Days, Illness
% 218.27/218.44  |- skos__scopeNote mesh__D018582
% 218.27/218.44       An absence from work permitted because of illness or the number of days per year for which an employer agrees to pay employees who are sick. %28%Webster%27%s New Collegiate Dictionary, 1981%29%%A%    
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D018582 2000
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D018582 2005
% 218.27/218.44  |- rdf__type mesh__D018582sskos__Concept
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D018582 2004
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D018582 1999
% 218.27/218.44  |- mesh__publicMeSHNote mesh__D018582 95   
% 218.27/218.44  |- skos__hiddenLabel mesh__D018582 Leave, Disability
% 218.27/218.44  |- skos__hiddenLabel mesh__D018582 Day, Sick
% 218.27/218.44  |- skos__hiddenLabel mesh__D018582 Sick Day
% 218.27/218.44  |- skos__altLabel mesh__D004562 ECG
% 218.27/218.44  |- skos__scopeNote mesh__D004562
% 218.27/218.44       Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body%27%s surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY.%A%    
% 218.27/218.44  |- mesh__recordAuthorizer mesh__D004562 sjn
% 218.27/218.44  |- skos__broader mesh__D004562smesh__D004568
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D004562 2005
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D004562 2006
% 218.27/218.44  |- mesh__recordOriginator mesh__D004562 NLM
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D004562 2004
% 218.27/218.44  |- skos__hiddenLabel mesh__D004562 Cardioscopes
% 218.27/218.44  |- mesh__recordMaintainer mesh__D004562 nns
% 218.27/218.44  |- mesh__dateCreated mesh__D004562 1999-01-01
% 218.27/218.44  |- skos__altLabel mesh__D004562 EKG
% 218.27/218.44  |- rdf__type mesh__D004562sskos__Concept
% 218.27/218.44  |- skos__broader mesh__D004562smesh__D006334
% 218.27/218.44  |- mesh__dateRevised mesh__D004562 2003-07-09
% 218.27/218.44  |- skos__prefLabel mesh__D004562 Electrocardiography
% 218.27/218.44  |- mesh__onlineNote mesh__D014990 to search XYLAN use CELLULOSE 1966-74   
% 218.27/218.44  |- skos__historyNote mesh__D014990 Cellulose %28%1966-1974%29%
% 218.27/218.44  |- mesh__dateRevised mesh__D014990 2004-07-07
% 218.27/218.44  |- mesh__dateCreated mesh__D014990 1974-11-19
% 218.27/218.44  |- mesh__dateEstablished mesh__D014990 1991-01-01
% 218.27/218.44  |- rdf__type mesh__D014990sskos__Concept
% 218.27/218.44  |- skos__historyNote mesh__D014990 Carbohydrates %28%1966-1974%29%
% 218.27/218.44  |- mesh__recordAuthorizer mesh__D014990 sjn
% 218.27/218.44  |- mesh__recordOriginator mesh__D014990 NLM
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D014990 2006
% 218.27/218.44  |- skos__broader mesh__D014990smesh__D011134
% 218.27/218.44  |- skos__historyNote mesh__D014990 Polysaccharides %28%1966-1974%29%
% 218.27/218.44  |- skos__prefLabel mesh__D014990 Xylans
% 218.27/218.44  |- mesh__historyNote mesh__D014990
% 218.27/218.44       91%28%75%29%; was see under POLYSACCHARIDES 1975-90; was XYLAN see under CELLULOSE 1963-74%A%  
% 218.27/218.44  |- mesh__publicMeSHNote mesh__D014990
% 218.27/218.44       91; was see under POLYSACCHARIDES 1975-90; was XYLAN see under CELLULOSE 1963-74%A%  
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D014990 2005
% 218.27/218.44  |- mesh__recordMaintainer mesh__D014990 ssb
% 218.27/218.44  |- skos__scopeNote mesh__D014990
% 218.27/218.44       Polysaccharides consisting of xylose units.     
% 218.27/218.44  |- mesh__historyNote mesh__D014192
% 218.27/218.44       91%28%84%29%; was see under PYRIMIDINES 1984-90; was TRAPYMIN see under PYRIMIDINES 1975-83%A%  
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D014192 2006
% 218.27/218.44  |- mesh__dateEstablished mesh__D014192 1991-01-01
% 218.27/218.44  |- skos__historyNote mesh__D014192 Triazoles %28%1966-1974%29%
% 218.27/218.44  |- skos__scopeNote mesh__D014192 A coronary vasodilator agent.     
% 218.27/218.44  |- skos__prefLabel mesh__D014192 Trapidil
% 218.27/218.44  |- mesh__recordAuthorizer mesh__D014192 sjn
% 218.27/218.44  |- mesh__dateCreated mesh__D014192 1974-11-19
% 218.27/218.44  |- skos__altLabel mesh__D014192 UCB Brand of Trapidil
% 218.27/218.44  |- mesh__recordMaintainer mesh__D014192 ssb
% 218.27/218.44  |- mesh__recordOriginator mesh__D014192 NLM
% 218.27/218.44  |- rdf__type mesh__D014192sskos__Concept
% 218.27/218.44  |- skos__historyNote mesh__D014192 Pyrimidines %28%1966-1974%29%
% 218.27/218.44  |- mesh__publicMeSHNote mesh__D014192
% 218.27/218.44       91; was see under PYRIMIDINES 1984-90; was TRAPYMIN see under PYRIMIDINES 1975-83%A%  
% 218.27/218.44  |- skos__broader mesh__D014192smesh__D014230
% 218.27/218.44  |- mesh__dateRevised mesh__D014192 2005-06-30
% 218.27/218.44  |- skos__broader mesh__D014192smesh__D011743
% 218.27/218.44  |- skos__altLabel mesh__D014192 Trapymin
% 218.27/218.44  |- mesh__onlineNote mesh__D014192
% 218.27/218.44       use TRAPIDIL to search TRAPYMIN 1975-83   
% 218.27/218.44  |- mesh__historyNote mesh__D008953
% 218.27/218.44       84%28%75%29%; was ANATOMIC MODELS see under MODELS, STRUCTURAL 1968-83; MOULAGES was see under MEDICAL ILLUSTRATION 1963-83%A%  
% 218.27/218.44  |- skos__scopeNote mesh__D008953
% 218.27/218.44       Three-dimensional representation to show anatomic structures. Models may be used in place of intact animals or organisms for teaching, practice, and study.%A%    
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D008953 2006
% 218.27/218.44  |- mesh__onlineNote mesh__D008953
% 218.27/218.44       use MODELS, ANATOMIC to search ANATOMIC MODELS 1975-83; use MODELS, STRUCTURAL 1968-74; use MODELS, ANATOMIC to search MOULAGES 1975-83; use MEDICAL ILLUSTRATION 1966-74%A%  
% 218.27/218.44  |- mesh__recordMaintainer mesh__D008953 ags
% 218.27/218.44  |- skos__hiddenLabel mesh__D008953 Moulage
% 218.27/218.44  |- mesh__dateEstablished mesh__D008953 1984-01-01
% 218.27/218.44  |- skos__annotation mesh__D008953
% 218.27/218.44       no qualif; note X ref MOULAGES; DF: MODELS ANAT   
% 218.27/218.44  |- mesh__publicMeSHNote mesh__D008953
% 218.27/218.44       84; was ANATOMIC MODELS see under MODELS, STRUCTURAL 1963-83; MOULAGES was see under MEDICAL ILLUSTRATION 1963-83%A%  
% 218.27/218.44  |- skos__hiddenLabel mesh__D008953 Surgical Model
% 218.27/218.44  |- skos__hiddenLabel mesh__D008953 Model, Anatomical
% 218.27/218.44  |- rdf__type mesh__D008953sskos__Concept
% 218.27/218.44  |- skos__related mesh__D008953smesh__D008348
% 218.27/218.44  |- mesh__recordAuthorizer mesh__D008953 sjn
% 218.27/218.44  |- skos__hiddenLabel mesh__D008953 Model, Anatomic
% 218.27/218.44  |- mesh__dateCreated mesh__D008953 1999-01-01
% 218.27/218.44  |- mesh__dateRevised mesh__D008953 2004-07-07
% 218.27/218.44  |- skos__hiddenLabel mesh__D008953 Anatomic Model
% 218.27/218.44  |- skos__hiddenLabel mesh__D008953 Model, Surgical
% 218.27/218.44  |- skos__altLabel mesh__D008953 Models, Anatomical
% 218.27/218.44  |- mesh__recordOriginator mesh__D008953 NLM
% 218.27/218.44  |- skos__prefLabel mesh__D008953 Models, Anatomic
% 218.27/218.44  |- skos__hiddenLabel mesh__D008953 Surgical Models
% 218.27/218.44  |- skos__hiddenLabel mesh__D008953 Anatomical Models
% 218.27/218.44  |- mesh__activeMeSHYear mesh__D008953 2005
% 218.27/218.44  |- skos__broader mesh__D008953smesh__D008961
% 218.27/218.44  |- skos__hiddenLabel mesh__D008953 Anatomical Model
% 218.27/218.44  |- skos__altLabel mesh__D008953 Anatomic Models
% 218.27/218.44  |- skos__altLabel mesh__D000970 Cytostatic Drugs
% 218.27/218.44  |- skos__related mesh__D000970smesh__D010478
% 218.27/218.45  |- mesh__recordAuthorizer mesh__D000970 sjn
% 218.27/218.45  |- skos__hiddenLabel mesh__D000970 Drugs, Antineoplastic
% 218.27/218.45  |- mesh__dateCreated mesh__D000970 1999-01-01
% 218.27/218.45  |- skos__annotation mesh__D000970
% 218.27/218.45       /admin: various administration procedures are available, as CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CHEMOEMBOLIZATION, THERAPEUTIC and INFUSIONS, INTRA-ARTERIAL; for combined anticancer agents, ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS is available; Manual 24.4.2.1+%A%  
% 218.27/218.45  |- skos__altLabel mesh__D000970 Antineoplastic Drugs
% 218.27/218.45  |- skos__related mesh__D000970smesh__D016461
% 218.27/218.45  |- skos__related mesh__D000970smesh__D015275
% 218.27/218.45  |- skos__related mesh__D000970smesh__D016588
% 218.27/218.45  |- mesh__dateRevised mesh__D000970 2005-06-30
% 218.27/218.45  |- skos__hiddenLabel mesh__D000970 Drugs, Cytostatic
% 218.27/218.45  |- skos__scopeNote mesh__D000970
% 218.27/218.45       Substances that inhibit or prevent the proliferation of NEOPLASMS.%A%    
% 218.27/218.45  |- mesh__recordMaintainer mesh__D000970 ssb
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D000970 2006
% 218.27/218.45  |- skos__broader mesh__D000970smesh__D045506
% 218.27/218.45  |- skos__prefLabel mesh__D000970 Antineoplastic Agents
% 218.27/218.45  |- skos__related mesh__D000970smesh__D007261
% 218.27/218.45  |- rdf__type mesh__D000970sskos__Concept
% 218.27/218.45  |- skos__altLabel mesh__D000970 Antineoplastics
% 218.27/218.45  |- skos__hiddenLabel mesh__D000970 Agents, Cytostatic
% 218.27/218.45  |- skos__hiddenLabel mesh__D000970 Agents, Antineoplastic
% 218.27/218.45  |- skos__altLabel mesh__D000970 Cytostatics
% 218.27/218.45  |- mesh__recordOriginator mesh__D000970 NLM
% 218.27/218.45  |- skos__broader mesh__D004194Q000276smesh__D004194
% 218.27/218.45  |- mesh__preferredCombination mesh__D004194Q000276smesh__D007109
% 218.27/218.45  |- rdf__type mesh__D004194Q000276smesh__CompoundConcept
% 218.27/218.45  |- skos__broader mesh__D008155smesh__D018942
% 218.27/218.45  |- mesh__publicMeSHNote mesh__D008155
% 218.27/218.45       91; was see under ANTIBIOTICS, MACROLIDE 1990-90; was see under ANTIBIOTICS, ANTIFUNGAL 1975-89%A%  
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D008155 2005
% 218.27/218.45  |- skos__prefLabel mesh__D008155 Lucensomycin
% 218.27/218.45  |- skos__historyNote mesh__D008155
% 218.27/218.45       Antibiotics, Antifungal %28%1971-1974%29%
% 218.27/218.45  |- skos__altLabel mesh__D008155 Lucimycin
% 218.27/218.45  |- rdf__type mesh__D008155sskos__Concept
% 218.27/218.45  |- mesh__dateEstablished mesh__D008155 1991-01-01
% 218.27/218.45  |- skos__historyNote mesh__D008155 Glycosides %28%1972-1974%29%
% 218.27/218.45  |- mesh__dateCreated mesh__D008155 1974-11-19
% 218.27/218.45  |- mesh__recordOriginator mesh__D008155 NLM
% 218.27/218.45  |- mesh__historyNote mesh__D008155
% 218.27/218.45       91%28%75%29%; was see under ANTIBIOTICS, MACROLIDE 1990-90; was see under ANTIBIOTICS, ANTIFUNGAL 1975-89%A%  
% 218.27/218.45  |- skos__annotation mesh__D008155
% 218.27/218.45       do not use /biosyn unless by living matter   
% 218.27/218.45  |- mesh__recordAuthorizer mesh__D008155 sjn
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D008155 2006
% 218.27/218.45  |- mesh__recordMaintainer mesh__D008155 ssb
% 218.27/218.45  |- mesh__dateRevised mesh__D008155 2004-07-07
% 218.27/218.45  |- skos__scopeNote mesh__D008155
% 218.27/218.45       A macrolide isolated from cultures of Streptomyces lucensis.%A%    
% 218.27/218.45  |- rdf__type mesh__D000172sskos__Concept
% 218.27/218.45  |- skos__broader mesh__D000172smesh__D006964
% 218.27/218.45  |- skos__altLabel mesh__D000172
% 218.27/218.45       Inappropriate GH Secretion Syndrome %28%Acromegaly%29%
% 218.27/218.45  |- mesh__recordAuthorizer mesh__D000172 sjn
% 218.27/218.45  |- skos__scopeNote mesh__D000172
% 218.27/218.45       A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw %28%PROGNATHISM%29%; hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. %28%From Joynt, Clinical Neurology, 1992, Ch36, pp79-80%29%%A%    
% 218.27/218.45  |- skos__broader mesh__D000172smesh__D001849
% 218.27/218.45  |- skos__hiddenLabel mesh__D000172
% 218.27/218.45       Somatotropin Hypersecretion Syndromes %28%Acromegaly%29%
% 218.27/218.45  |- skos__hiddenLabel mesh__D000172
% 218.27/218.45       Hypersecretion Syndromes, Somatotropin %28%Acromegaly%29%
% 218.27/218.45  |- skos__hiddenLabel mesh__D000172
% 218.27/218.45       Hypersecretion Syndrome, Somatotropin %28%Acromegaly%29%
% 218.27/218.45  |- mesh__recordMaintainer mesh__D000172 lkt
% 218.27/218.45  |- mesh__dateRevised mesh__D000172 2005-06-30
% 218.27/218.45  |- mesh__dateCreated mesh__D000172 1999-01-01
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D000172 2006
% 218.27/218.45  |- skos__annotation mesh__D000172
% 218.27/218.45       coordinate with GROWTH HORMONE/secret in animals or HUMAN GROWTH HORMONE/secret in humans if pertinent%A%  
% 218.27/218.45  |- mesh__recordOriginator mesh__D000172 NLM
% 218.27/218.45  |- skos__hiddenLabel mesh__D000172
% 218.27/218.45       Syndromes, Somatotropin Hypersecretion %28%Acromegaly%29%
% 218.27/218.45  |- skos__hiddenLabel mesh__D000172
% 218.27/218.45       Syndrome, Somatotropin Hypersecretion %28%Acromegaly%29%
% 218.27/218.45  |- skos__prefLabel mesh__D000172 Acromegaly
% 218.27/218.45  |- skos__altLabel mesh__D000172
% 218.27/218.45       Inappropriate Growth Hormone Secretion Syndrome %28%Acromegaly%29%
% 218.27/218.45  |- skos__altLabel mesh__D000172
% 218.27/218.45       Somatotropin Hypersecretion Syndrome %28%Acromegaly%29%
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D013898 1999
% 218.27/218.45  |- skos__hiddenLabel mesh__D013898 Chest Injury
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D013898 2002
% 218.27/218.45  |- skos__hiddenLabel mesh__D013898 Injury, Chest
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D013898 1998
% 218.27/218.45  |- mesh__recordMaintainer mesh__D013898 TPW
% 218.27/218.45  |- skos__broader mesh__D013898smesh__D014947
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D013898 2001
% 218.27/218.45  |- skos__prefLabel mesh__D013898 Thoracic Injuries
% 218.27/218.45  |- mesh__dateRevised mesh__D013898 1997-06-20
% 218.27/218.45  |- skos__annotation mesh__D013898
% 218.27/218.45       GEN or unspecified only: prefer specifics like HEART INJURIES, LUNG /inj, etc.; consider also /inj with specific parts of the chest%A%  
% 218.27/218.45  |- mesh__dateCreated mesh__D013898 1999-01-01
% 218.27/218.45  |- skos__altLabel mesh__D013898 Chest Injuries
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D013898 2006
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D013898 2000
% 218.27/218.45  |- rdf__type mesh__D013898sskos__Concept
% 218.27/218.45  |- skos__altLabel mesh__D013898 Injuries, Chest
% 218.27/218.45  |- mesh__recordAuthorizer mesh__D013898 SJN
% 218.27/218.45  |- skos__hiddenLabel mesh__D013898 Thoracic Injury
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D013898 2005
% 218.27/218.45  |- skos__altLabel mesh__D013898 Injuries, Thoracic
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D013898 2004
% 218.27/218.45  |- mesh__recordOriginator mesh__D013898 NLM
% 218.27/218.45  |- skos__scopeNote mesh__D013898
% 218.27/218.45       General or unspecified injuries to the chest area.     
% 218.27/218.45  |- skos__hiddenLabel mesh__D013898 Injury, Thoracic
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D013898 2003
% 218.27/218.45  |- skos__scopeNote mesh__D018583
% 218.27/218.45       The quality or state of being able to be bent or creased repeatedly. %28%From Webster, 3d ed%29%%A%    
% 218.27/218.45  |- skos__altLabel mesh__D018583 Flexibility
% 218.27/218.45  |- mesh__recordAuthorizer mesh__D018583 sjn
% 218.27/218.45  |- skos__broader mesh__D018583smesh__D001696
% 218.27/218.45  |- mesh__publicMeSHNote mesh__D018583 95   
% 218.27/218.45  |- mesh__historyNote mesh__D018583 95   
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D018583 2006
% 218.27/218.45  |- skos__prefLabel mesh__D018583 Pliability
% 218.27/218.45  |- mesh__recordMaintainer mesh__D018583 nns
% 218.27/218.45  |- mesh__recordOriginator mesh__D018583 TGC
% 218.27/218.45  |- skos__annotation mesh__D018583 NIM; biol %26% non-biol application   
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D018583 2005
% 218.27/218.45  |- rdf__type mesh__D018583sskos__Concept
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D018583 2004
% 218.27/218.45  |- mesh__dateEstablished mesh__D018583 1995-01-01
% 218.27/218.45  |- skos__broader mesh__D018583smesh__D019563
% 218.27/218.45  |- mesh__dateCreated mesh__D018583 1994-04-16
% 218.27/218.45  |- mesh__dateRevised mesh__D018583 2003-07-09
% 218.27/218.45  |- skos__broader mesh__D004563smesh__D002627
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D004563 2001
% 218.27/218.45  |- mesh__dateRevised mesh__D004563 1998-06-10
% 218.27/218.45  |- skos__hiddenLabel mesh__D004563 Electrochemistries
% 218.27/218.45  |- mesh__dateEstablished mesh__D004563 1966-01-01
% 218.27/218.45  |- mesh__historyNote mesh__D004563 66   
% 218.27/218.45  |- mesh__recordAuthorizer mesh__D004563 SJN
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D004563 2000
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D004563 2004
% 218.27/218.45  |- mesh__dateCreated mesh__D004563 1999-01-01
% 218.27/218.45  |- mesh__publicMeSHNote mesh__D004563 66   
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D004563 2006
% 218.27/218.45  |- skos__prefLabel mesh__D004563 Electrochemistry
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D004563 2003
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D004563 2005
% 218.27/218.45  |- skos__annotation mesh__D004563
% 218.27/218.45       NIM with no qualif; when IM, SPEC qualif   
% 218.27/218.45  |- skos__scopeNote mesh__D004563
% 218.27/218.45       The study of chemical changes resulting from electrical action and electrical activity resulting from chemical changes.%A%    
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D004563 1999
% 218.27/218.45  |- mesh__recordOriginator mesh__D004563 NLM
% 218.27/218.45  |- mesh__recordMaintainer mesh__D004563 NNS
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D004563 2002
% 218.27/218.45  |- rdf__type mesh__D004563sskos__Concept
% 218.27/218.45  |- mesh__publicMeSHNote mesh__D042682 2004   
% 218.27/218.45  |- mesh__dateEstablished mesh__D042682 2004-01-01
% 218.27/218.45  |- skos__broader mesh__D042682smesh__D042501
% 218.27/218.45  |- skos__scopeNote mesh__D042682
% 218.27/218.45       A family of structurally-related angiogenic proteins of approximately 70 kDa in size. They have high specificity for members of the TIE RECEPTOR FAMILY.%A%    
% 218.27/218.45  |- rdf__type mesh__D042682sskos__Concept
% 218.27/218.45  |- mesh__recordMaintainer mesh__D042682 ssb
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D042682 2006
% 218.27/218.45  |- mesh__historyNote mesh__D042682 2004   
% 218.27/218.45  |- mesh__recordOriginator mesh__D042682 jmp
% 218.27/218.45  |- mesh__recordAuthorizer mesh__D042682 sjn
% 218.27/218.45  |- skos__prefLabel mesh__D042682 Angiopoietins
% 218.27/218.45  |- mesh__dateCreated mesh__D042682 2003-07-09
% 218.27/218.45  |- mesh__dateRevised mesh__D042682 2005-06-30
% 218.27/218.45  |- mesh__recordMaintainer mesh__D014991 ssb
% 218.27/218.45  |- skos__altLabel mesh__D014991 Xylaxine
% 218.27/218.45  |- skos__historyNote mesh__D014991 Xylene %28%1971-1974%29%
% 218.27/218.45  |- skos__altLabel mesh__D014991 Xylazin
% 218.27/218.45  |- mesh__dateEstablished mesh__D014991 1991-01-01
% 218.27/218.45  |- skos__historyNote mesh__D014991 Thiazines %28%1969-1974%29%
% 218.27/218.45  |- rdf__type mesh__D014991sskos__Concept
% 218.27/218.45  |- mesh__publicMeSHNote mesh__D014991 91; see THIAZINES 1975-90   
% 218.27/218.45  |- mesh__historyNote mesh__D014991 91%28%75%29%   
% 218.27/218.45  |- skos__hiddenLabel mesh__D014991 BAYVa 1470
% 218.27/218.45  |- skos__hiddenLabel mesh__D014991 BAY Va 1470
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D014991 2006
% 218.27/218.45  |- mesh__dateCreated mesh__D014991 1974-11-19
% 218.27/218.45  |- mesh__dateRevised mesh__D014991 2005-06-30
% 218.27/218.45  |- skos__scopeNote mesh__D014991
% 218.27/218.45       An adrenergic alpha-agonist used as a sedative, analgesic, and muscle relaxant in veterinary medicine.%A%    
% 218.27/218.45  |- skos__broader mesh__D014991smesh__D013843
% 218.27/218.45  |- mesh__recordOriginator mesh__D014991 NLM
% 218.27/218.45  |- mesh__recordAuthorizer mesh__D014991 sjn
% 218.27/218.45  |- skos__prefLabel mesh__D014991 Xylazine
% 218.27/218.45  |- skos__historyNote mesh__D014991 Aniline Compounds %28%1971-1974%29%
% 218.27/218.45  |- mesh__recordMaintainer mesh__D050316 ags
% 218.27/218.45  |- mesh__dateEstablished mesh__D050316 2006-01-01
% 218.27/218.45  |- skos__altLabel mesh__D050316 CPOE
% 218.27/218.45  |- skos__related mesh__D050316smesh__D019095
% 218.27/218.45  |- skos__broader mesh__D050316smesh__D006751
% 218.27/218.45  |- mesh__publicMeSHNote mesh__D050316 2006   
% 218.27/218.45  |- skos__broader mesh__D050316smesh__D016347
% 218.27/218.45  |- skos__altLabel mesh__D050316 Order Entry Systems, Medical
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D050316 2006
% 218.27/218.45  |- mesh__historyNote mesh__D050316 2006   
% 218.27/218.45  |- mesh__dateCreated mesh__D050316 2005-06-30
% 218.27/218.45  |- skos__scopeNote mesh__D050316
% 218.27/218.45       Information systems, usually computer-assisted, that enable providers to initiate medical procedures, prescribe medications, etc. These systems support medical decision-making and error-reduction during patient care.%A%    
% 218.27/218.45  |- skos__related mesh__D050316smesh__D004360
% 218.27/218.45  |- rdf__type mesh__D050316sskos__Concept
% 218.27/218.45  |- mesh__recordOriginator mesh__D050316 ags
% 218.27/218.45  |- skos__related mesh__D050316smesh__D008510
% 218.27/218.45  |- skos__prefLabel mesh__D050316 Medical Order Entry Systems
% 218.27/218.45  |- mesh__recordAuthorizer mesh__D050316 sjn
% 218.27/218.45  |- mesh__dateEstablished mesh__D014193 1975-09-01
% 218.27/218.45  |- mesh__dateRevised mesh__D014193 1997-06-20
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D014193 2005
% 218.27/218.45  |- mesh__historyNote mesh__D014193 75   
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D014193 1999
% 218.27/218.45  |- skos__scopeNote mesh__D014193
% 218.27/218.45       Specialized hospital facilities which provide diagnostic and therapeutic services for trauma patients.%A%    
% 218.27/218.45  |- skos__hiddenLabel mesh__D014193 Centers, Trauma
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D014193 2004
% 218.27/218.45  |- skos__hiddenLabel mesh__D014193 Trauma Unit
% 218.27/218.45  |- skos__prefLabel mesh__D014193 Trauma Centers
% 218.27/218.45  |- mesh__publicMeSHNote mesh__D014193 75   
% 218.27/218.45  |- skos__hiddenLabel mesh__D014193 Trauma Center
% 218.27/218.45  |- mesh__recordMaintainer mesh__D014193 TPW
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D014193 2002
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D014193 1998
% 218.27/218.45  |- skos__broader mesh__D014193smesh__D004636
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D014193 2003
% 218.27/218.45  |- rdf__type mesh__D014193sskos__Concept
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D014193 2001
% 218.27/218.45  |- skos__historyNote mesh__D014193
% 218.27/218.45       Emergency Service, Hospital %28%1966-1974%29%
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D014193 2000
% 218.27/218.45  |- skos__hiddenLabel mesh__D014193 Unit, Trauma
% 218.27/218.45  |- mesh__dateCreated mesh__D014193 1974-11-11
% 218.27/218.45  |- skos__hiddenLabel mesh__D014193 Center, Trauma
% 218.27/218.45  |- skos__hiddenLabel mesh__D014193 Units, Trauma
% 218.27/218.45  |- mesh__recordOriginator mesh__D014193 NLM
% 218.27/218.45  |- mesh__recordAuthorizer mesh__D014193 SJN
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D014193 2006
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D008954 2004
% 218.27/218.45  |- mesh__recordOriginator mesh__D008954 NLM
% 218.27/218.45  |- skos__historyNote mesh__D008954 Models, Theoretical %28%1966-1967%29%
% 218.27/218.45  |- skos__related mesh__D008954smesh__D001701
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D008954 1995
% 218.27/218.45  |- mesh__onlineNote mesh__D008954
% 218.27/218.45       use MODELS, BIOLOGICAL to search MODELS, BIOLOGIC 1968-72%A%  
% 218.27/218.45  |- rdf__type mesh__D008954sskos__Concept
% 218.27/218.45  |- skos__hiddenLabel mesh__D008954 Biologic Model
% 218.27/218.45  |- skos__hiddenLabel mesh__D008954 Biologic Models
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D008954 2000
% 218.27/218.45  |- mesh__recordAuthorizer mesh__D008954 PLS
% 218.27/218.45  |- skos__prefLabel mesh__D008954 Models, Biological
% 218.27/218.45  |- skos__altLabel mesh__D008954 Model, Biological
% 218.27/218.45  |- mesh__dateCreated mesh__D008954 1999-01-01
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D008954 1998
% 218.27/218.45  |- skos__scopeNote mesh__D008954
% 218.27/218.45       Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment.%A%    
% 218.27/218.45  |- skos__hiddenLabel mesh__D008954 Model, Biologic
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D008954 2001
% 218.27/218.45  |- skos__broader mesh__D008954smesh__D008962
% 218.27/218.45  |- skos__annotation mesh__D008954
% 218.27/218.45       no qualif; TN 128: definition %26% relation to MODELS, THEORETICAL; DF: MODELS BIOL%A%  
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D008954 1999
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D008954 1996
% 218.27/218.45  |- mesh__dateEstablished mesh__D008954 1973-01-01
% 218.27/218.45  |- skos__altLabel mesh__D008954 Biological Models
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D008954 2005
% 218.27/218.45  |- mesh__historyNote mesh__D008954 73; was MODELS, BIOLOGIC 1968-72   
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D008954 2002
% 218.27/218.45  |- mesh__publicMeSHNote mesh__D008954 73; was MODELS, BIOLOGIC 1968-72   
% 218.27/218.45  |- mesh__recordMaintainer mesh__D008954 TGC
% 218.27/218.45  |- skos__altLabel mesh__D008954 Biological Model
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D008954 1997
% 218.27/218.45  |- mesh__dateRevised mesh__D008954 1994-05-23
% 218.27/218.45  |- skos__altLabel mesh__D008954 Models, Biologic
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D008954 2006
% 218.27/218.45  |- skos__related mesh__D008954smesh__D004195
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D008954 2003
% 218.27/218.45  |- skos__hiddenLabel mesh__D000971 Anticancer Drug Combination
% 218.27/218.45  |- skos__hiddenLabel mesh__D000971 Drug Combination, Antineoplastic
% 218.27/218.45  |- skos__altLabel mesh__D000971
% 218.27/218.45       Antineoplastic Combined Chemotherapy Regimens
% 218.27/218.45  |- skos__hiddenLabel mesh__D000971 Antineoplastic Agent, Combined
% 218.27/218.45  |- skos__annotation mesh__D000971
% 218.27/218.45       administered simultaneously or sequentially; coordinate IM with specific antineoplastic agents /admin %28%NIM%29%%A%  
% 218.27/218.45  |- mesh__dateCreated mesh__D000971 1983-06-17
% 218.27/218.45  |- skos__broader mesh__D000971smesh__D004359
% 218.27/218.45  |- skos__altLabel mesh__D000971 Antineoplastic Agents, Combined
% 218.27/218.45  |- skos__hiddenLabel mesh__D000971 Chemotherapy Protocol, Cancer
% 218.27/218.45  |- skos__hiddenLabel mesh__D000971 Antineoplastic Chemotherapy Protocol
% 218.27/218.45  |- skos__hiddenLabel mesh__D000971 Protocols, Cancer Chemotherapy
% 218.27/218.45  |- skos__altLabel mesh__D000971 Chemotherapy Protocols, Antineoplastic
% 218.27/218.45  |- skos__altLabel mesh__D000971 Combined Antineoplastic Agents
% 218.27/218.45  |- skos__hiddenLabel mesh__D000971 Cancer Chemotherapy Protocol
% 218.27/218.45  |- skos__hiddenLabel mesh__D000971 Protocols, Antineoplastic Chemotherapy
% 218.27/218.45  |- skos__scopeNote mesh__D000971
% 218.27/218.45       The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form.%A%    
% 218.27/218.45  |- mesh__recordOriginator mesh__D000971 SH
% 218.27/218.45  |- skos__altLabel mesh__D000971 Anticancer Drug Combinations
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D000971 2006
% 218.27/218.45  |- skos__hiddenLabel mesh__D000971 Drug Combination, Anticancer
% 218.27/218.45  |- skos__hiddenLabel mesh__D000971 Agent, Combined Antineoplastic
% 218.27/218.45  |- skos__historyNote mesh__D000971
% 218.27/218.45       Drug Therapy, Combination %28%1974-1983%29%
% 218.27/218.45  |- mesh__recordMaintainer mesh__D000971 ssb
% 218.27/218.45  |- mesh__dateEstablished mesh__D000971 1984-01-01
% 218.27/218.45  |- mesh__historyNote mesh__D000971 2002%28%1984%29%   
% 218.27/218.45  |- skos__hiddenLabel mesh__D000971 Combinations, Antineoplastic Drug
% 218.27/218.45  |- rdf__type mesh__D000971sskos__Concept
% 218.27/218.45  |- skos__broader mesh__D000971smesh__D024221
% 218.27/218.45  |- skos__hiddenLabel mesh__D000971 Combined Antineoplastic Agent
% 218.27/218.45  |- skos__hiddenLabel mesh__D000971 Chemotherapy Protocol, Antineoplastic
% 218.27/218.45  |- skos__hiddenLabel mesh__D000971 Protocol, Antineoplastic Chemotherapy
% 218.27/218.45  |- skos__hiddenLabel mesh__D000971 Agents, Combined Antineoplastic
% 218.27/218.45  |- skos__hiddenLabel mesh__D000971 Drug Combinations, Anticancer
% 218.27/218.45  |- mesh__dateRevised mesh__D000971 2005-06-30
% 218.27/218.45  |- skos__altLabel mesh__D000971 Drug Combinations, Antineoplastic
% 218.27/218.45  |- skos__altLabel mesh__D000971 Cancer Chemotherapy Protocols
% 218.27/218.45  |- skos__altLabel mesh__D000971 Antineoplastic Drug Combinations
% 218.27/218.45  |- mesh__recordAuthorizer mesh__D000971 sjn
% 218.27/218.45  |- skos__hiddenLabel mesh__D000971 Chemotherapy Protocols, Cancer
% 218.27/218.45  |- skos__prefLabel mesh__D000971
% 218.27/218.45       Antineoplastic Combined Chemotherapy Protocols
% 218.27/218.45  |- mesh__publicMeSHNote mesh__D000971
% 218.27/218.45       2002; see ANTINEOPLASTIC AGENTS, COMBINED  %28%1984-2001%29%   
% 218.27/218.45  |- skos__hiddenLabel mesh__D000971 Antineoplastic Drug Combination
% 218.27/218.45  |- skos__hiddenLabel mesh__D000971 Protocol, Cancer Chemotherapy
% 218.27/218.45  |- skos__scopeNote mesh__D008156
% 218.27/218.45       Enzymes that oxidize certain LUMINESCENT AGENTS to emit light %28%PHYSICAL LUMINESCENCE%29%. The luciferases from different organisms have evolved differently so have different structures and substrates.%A%    
% 218.27/218.45  |- mesh__recordAuthorizer mesh__D008156 sjn
% 218.27/218.45  |- skos__altLabel mesh__D008156 Luciferase
% 218.27/218.45  |- mesh__recordMaintainer mesh__D008156 ssb
% 218.27/218.45  |- mesh__dateEstablished mesh__D008156 1968-01-01
% 218.27/218.45  |- rdf__type mesh__D008156sskos__Concept
% 218.27/218.45  |- mesh__historyNote mesh__D008156 2005%28%1963%29%   
% 218.27/218.45  |- mesh__dateCreated mesh__D008156 1999-01-01
% 218.27/218.45  |- skos__broader mesh__D008156smesh__D010088
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D008156 2006
% 218.27/218.45  |- mesh__recordOriginator mesh__D008156 NLM
% 218.27/218.45  |- mesh__dateRevised mesh__D008156 2004-07-07
% 218.27/218.45  |- skos__annotation mesh__D008156
% 218.27/218.45       general; prefer specifics; note species specific luciferases in SCR%A%  
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D008156 2005
% 218.27/218.45  |- skos__broader mesh__D008156smesh__D008164
% 218.27/218.45  |- mesh__publicMeSHNote mesh__D008156 2005; see LUCIFERASE 1963-2004   
% 218.27/218.45  |- skos__prefLabel mesh__D008156 Luciferases
% 218.27/218.45  |- mesh__publicMeSHNote mesh__D000173
% 218.27/218.45       79; was see under SHOULDER JOINT 1965-78, was see under SHOULDER 1963-64%A%  
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D000173 2004
% 218.27/218.45  |- mesh__recordOriginator mesh__D000173 NLM
% 218.27/218.45  |- mesh__dateCreated mesh__D000173 1999-01-01
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D000173 2000
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D000173 2006
% 218.27/218.45  |- skos__scopeNote mesh__D000173
% 218.27/218.45       The gliding joint formed by the outer extremity of the CLAVICLE and the inner margin of the acromion process of the SCAPULA.%A%    
% 218.27/218.45  |- skos__annotation mesh__D000173
% 218.27/218.45       dislocation: coord %28%IM%29% with DISLOCATIONS %28%IM%29%   
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D000173 2003
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D000173 2005
% 218.27/218.45  |- skos__prefLabel mesh__D000173 Acromioclavicular Joint
% 218.27/218.45  |- mesh__dateEstablished mesh__D000173 1979-01-01
% 218.27/218.45  |- mesh__recordAuthorizer mesh__D000173 sjn
% 218.27/218.45  |- skos__hiddenLabel mesh__D000173 Joints, Acromioclavicular
% 218.27/218.45  |- rdf__type mesh__D000173sskos__Concept
% 218.27/218.45  |- skos__hiddenLabel mesh__D000173 Acromioclavicular Joints
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D000173 2002
% 218.27/218.45  |- mesh__historyNote mesh__D000173
% 218.27/218.45       79%28%75%29%; was see under SHOULDER JOINT 1965-78, was see under SHOULDER 1963-64%A%  
% 218.27/218.45  |- mesh__onlineNote mesh__D000173 search SHOULDER JOINT 1966-74   
% 218.27/218.45  |- skos__hiddenLabel mesh__D000173 Joint, Acromioclavicular
% 218.27/218.45  |- skos__historyNote mesh__D000173 Shoulder Joint %28%1966-1974%29%
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D000173 2001
% 218.27/218.45  |- skos__broader mesh__D000173smesh__D007596
% 218.27/218.45  |- mesh__recordMaintainer mesh__D000173 jls
% 218.27/218.45  |- mesh__dateRevised mesh__D000173 1999-11-08
% 218.27/218.45  |- mesh__recordOriginator mesh__D013899 NLM
% 218.27/218.45  |- skos__annotation mesh__D013899
% 218.27/218.45       GEN or unspecified only; prefer specifics like HEART NEOPLASMS; LUNG NEOPLASMS; etc; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%  
% 218.27/218.45  |- skos__hiddenLabel mesh__D013899 Thoracic Neoplasm
% 218.27/218.45  |- mesh__recordMaintainer mesh__D013899 mdb
% 218.27/218.45  |- mesh__dateCreated mesh__D013899 1999-01-01
% 218.27/218.45  |- rdf__type mesh__D013899sskos__Concept
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D013899 2006
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D013899 2002
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D013899 2005
% 218.27/218.45  |- skos__prefLabel mesh__D013899 Thoracic Neoplasms
% 218.27/218.45  |- skos__broader mesh__D013899smesh__D009371
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D013899 2004
% 218.27/218.45  |- mesh__dateRevised mesh__D013899 2001-07-25
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D013899 2003
% 218.27/218.45  |- mesh__recordAuthorizer mesh__D013899 sjn
% 218.27/218.45  |- skos__hiddenLabel mesh__D013899 Neoplasms, Thoracic
% 218.27/218.45  |- skos__hiddenLabel mesh__D013899 Neoplasm, Thoracic
% 218.27/218.45  |- skos__broader mesh__D018584smesh__D012017
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D018584 2002
% 218.27/218.45  |- skos__broader mesh__D018584smesh__D016265
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D018584 2005
% 218.27/218.45  |- skos__historyNote mesh__D018584
% 218.27/218.45       Referral and Consultation %28%1983-1994%29%
% 218.27/218.45  |- rdf__type mesh__D018584sskos__Concept
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D018584 2004
% 218.27/218.45  |- skos__hiddenLabel mesh__D018584 Self Referral, Physician
% 218.27/218.45  |- skos__scopeNote mesh__D018584
% 218.27/218.45       Referral by physicians to testing or treatment facilities in which they have financial interest. The practice is regulated by the Ethics in Patient Referrals Act of 1989.%A%    
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D018584 2003
% 218.27/218.45  |- mesh__publicMeSHNote mesh__D018584 95   
% 218.27/218.45  |- skos__prefLabel mesh__D018584 Physician Self-Referral
% 218.27/218.45  |- skos__hiddenLabel mesh__D018584 Self-Referrals, Physician
% 218.27/218.45  |- skos__hiddenLabel mesh__D018584 Physician Self Referral
% 218.27/218.45  |- skos__broader mesh__D018584smesh__D006759
% 218.27/218.45  |- mesh__recordAuthorizer mesh__D018584 jls
% 218.27/218.45  |- mesh__dateRevised mesh__D018584 2002-10-31
% 218.27/218.45  |- mesh__recordMaintainer mesh__D018584 jls
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D018584 2003A
% 218.27/218.45  |- mesh__historyNote mesh__D018584 95   
% 218.27/218.45  |- mesh__recordOriginator mesh__D018584 JLS
% 218.27/218.45  |- skos__altLabel mesh__D018584 Self-Referral, Physician
% 218.27/218.45  |- mesh__dateEstablished mesh__D018584 1995-01-01
% 218.27/218.45  |- mesh__dateCreated mesh__D018584 1994-06-01
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D018584 2006
% 218.27/218.45  |- skos__hiddenLabel mesh__D018584 Physician Self-Referrals
% 218.27/218.45  |- mesh__recordMaintainer mesh__D004564 TGC
% 218.27/218.45  |- mesh__recordOriginator mesh__D004564 NLM
% 218.27/218.45  |- skos__altLabel mesh__D004564 Endocavitary Fulguration
% 218.27/218.45  |- skos__broader mesh__D004564smesh__D002425
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D004564 2002
% 218.27/218.45  |- skos__altLabel mesh__D004564 Electrocautery
% 218.27/218.45  |- skos__altLabel mesh__D004564 Diathermy, Surgical
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D004564 2004
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D004564 2001
% 218.27/218.45  |- mesh__dateCreated mesh__D004564 1999-01-01
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D004564 2006
% 218.27/218.45  |- skos__prefLabel mesh__D004564 Electrocoagulation
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D004564 2003
% 218.27/218.45  |- skos__hiddenLabel mesh__D004564 Fulguration, Endocavitary
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D004564 2005
% 218.27/218.45  |- mesh__recordAuthorizer mesh__D004564 SJN
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D004564 2000
% 218.27/218.45  |- skos__altLabel mesh__D004564 Galvanocautery
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D004564 1999
% 218.27/218.45  |- skos__altLabel mesh__D004564 Surgical Diathermy
% 218.27/218.45  |- skos__scopeNote mesh__D004564
% 218.27/218.45       Electrosurgical procedures used to treat hemorrhage %28%e.g., bleeding ulcers%29% and to ablate tumors, mucosal lesions, and refractory arrhythmias.%A%    
% 218.27/218.45  |- rdf__type mesh__D004564sskos__Concept
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D004564 1998
% 218.27/218.45  |- skos__annotation mesh__D004564
% 218.27/218.45       IM; do not use /util except by MeSH definition; coord organ or disease with /surg; DF: ELECTROCOAG%A%  
% 218.27/218.45  |- mesh__dateRevised mesh__D004564 1997-06-20
% 218.27/218.45  |- skos__altLabel mesh__D004564 Thermocoagulation
% 218.27/218.45  |- rdf__type mesh__D042683sskos__Concept
% 218.27/218.45  |- mesh__activeMeSHYear mesh__D042683 2006
% 218.27/218.45  |- skos__prefLabel mesh__D042683 Angiopoietin-1
% 218.27/218.45  |- skos__hiddenLabel mesh__D042683 Angiopoietin 1
% 218.27/218.45  |- mesh__dateEstablished mesh__D042683 2004-01-01
% 218.27/218.46  |- mesh__dateCreated mesh__D042683 2003-07-09
% 218.27/218.46  |- skos__broader mesh__D042683smesh__D042682
% 218.27/218.46  |- skos__historyNote mesh__D042683 Membrane Glycoproteins %28%1997-2003%29%
% 218.27/218.46  |- mesh__historyNote mesh__D042683
% 218.27/218.46       2004; use ANGIOPOIETIN-1 %28%NM%29% 1997-2003   
% 218.27/218.46  |- skos__annotation mesh__D042683 see SCR for organism-specific terms   
% 218.27/218.46  |- skos__historyNote mesh__D042683 Angiogenesis Factor %28%2003%29%
% 218.27/218.46  |- mesh__recordMaintainer mesh__D042683 ssb
% 218.27/218.46  |- mesh__recordOriginator mesh__D042683 jmp
% 218.27/218.46  |- mesh__recordAuthorizer mesh__D042683 sjn
% 218.27/218.46  |- skos__scopeNote mesh__D042683
% 218.27/218.46       The first to be discovered member of the angiopoietin family. It may play a role in increasing the sprouting and branching of BLOOD VESSELS. Angiopoietin-1 specifically binds to and stimulates the TIE-2 RECEPTOR. Several isoforms of angiopoietin-1 occur due to ALTERNATIVE SPLICING of its mRNA.%A%    
% 218.27/218.46  |- mesh__dateRevised mesh__D042683 2005-06-30
% 218.27/218.46  |- mesh__publicMeSHNote mesh__D042683
% 218.27/218.46       2004; ANGIOPOIETIN-1 was indexed under MEMBRANE GLYCOPROTEINS 1997-2003 %26% ANGIOGENESIS FACTOR 2003%A%  
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014992 2000
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014992 2006
% 218.27/218.46  |- skos__altLabel mesh__D014992 Dimethylbenzenes
% 218.27/218.46  |- mesh__dateCreated mesh__D014992 1999-01-01
% 218.27/218.46  |- mesh__recordOriginator mesh__D014992 NLM
% 218.27/218.46  |- skos__broader mesh__D014992smesh__D001555
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014992 2005
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014992 1997
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014992 2002
% 218.27/218.46  |- skos__scopeNote mesh__D014992
% 218.27/218.46       A family of isomeric, colorless aromatic hydrocarbon liquids, that contain the general formula C6H4%28%CH3%29%2. They are produced by the destructive distillation of coal or by the catalytic reforming of petroleum naphthenic fractions. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%    
% 218.27/218.46  |- mesh__onlineNote mesh__D014992 use XYLENES to search XYLENE 1966-74   
% 218.27/218.46  |- mesh__recordAuthorizer mesh__D014992 jls
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014992 1996
% 218.27/218.46  |- mesh__dateRevised mesh__D014992 2004-08-03
% 218.27/218.46  |- mesh__publicMeSHNote mesh__D014992 75; was XYLENE 1963-74   
% 218.27/218.46  |- skos__prefLabel mesh__D014992 Xylenes
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014992 1999
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014992 2004
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014992 2001
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014992 1998
% 218.27/218.46  |- rdf__type mesh__D014992sskos__Concept
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014992 2005A
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014992 2003
% 218.27/218.46  |- mesh__recordMaintainer mesh__D014992 jls
% 218.27/218.46  |- mesh__historyNote mesh__D014992 75; was XYLENE 1963-74   
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014194 2003
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014194 2004
% 218.27/218.46  |- skos__prefLabel mesh__D014194 Traumatology
% 218.27/218.46  |- mesh__recordMaintainer mesh__D014194 lkt
% 218.27/218.46  |- skos__annotation mesh__D014194 DF: TRAUMATOL   
% 218.27/218.46  |- rdf__type mesh__D014194sskos__Concept
% 218.27/218.46  |- mesh__historyNote mesh__D014194 87   
% 218.27/218.46  |- skos__broader mesh__D014194smesh__D008511
% 218.27/218.46  |- mesh__publicMeSHNote mesh__D014194 87   
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014194 2005
% 218.27/218.46  |- skos__scopeNote mesh__D014194
% 218.27/218.46       The medical specialty which deals with WOUNDS and INJURIES as well as resulting disability, disorders, and STRESS from physical and psychological traumas.%A%    
% 218.27/218.46  |- mesh__recordOriginator mesh__D014194 EC
% 218.27/218.46  |- mesh__recordAuthorizer mesh__D014194 sjn
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014194 2006
% 218.27/218.46  |- mesh__dateEstablished mesh__D014194 1987-01-01
% 218.27/218.46  |- skos__related mesh__D014194smesh__D014947
% 218.27/218.46  |- mesh__dateCreated mesh__D014194 1986-03-25
% 218.27/218.46  |- mesh__dateRevised mesh__D014194 2002-07-03
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008955 1998
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008955 2006
% 218.27/218.46  |- skos__historyNote mesh__D008955 Models, Biological %28%1968-1979%29%
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008955 1992
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008955 1994
% 218.27/218.46  |- mesh__dateCreated mesh__D008955 1979-05-25
% 218.27/218.46  |- mesh__publicMeSHNote mesh__D008955 80   
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008955 2003
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008955 2005
% 218.27/218.46  |- skos__broader mesh__D008955smesh__D008954
% 218.27/218.46  |- skos__hiddenLabel mesh__D008955 Cardiovascular Model
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008955 1991
% 218.27/218.46  |- skos__annotation mesh__D008955
% 218.27/218.46       no qualif; apply TN 128 for relation to MODELS, THEORETICAL%A%  
% 218.27/218.46  |- mesh__recordAuthorizer mesh__D008955 PLS
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008955 2002
% 218.27/218.46  |- mesh__recordOriginator mesh__D008955 VDK
% 218.27/218.46  |- mesh__dateRevised mesh__D008955 1989-06-14
% 218.27/218.46  |- mesh__recordMaintainer mesh__D008955 TGC
% 218.27/218.46  |- rdf__type mesh__D008955sskos__Concept
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008955 1990
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008955 2001
% 218.27/218.46  |- mesh__historyNote mesh__D008955 80   
% 218.27/218.46  |- skos__prefLabel mesh__D008955 Models, Cardiovascular
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008955 1997
% 218.27/218.46  |- skos__hiddenLabel mesh__D008955 Model, Cardiovascular
% 218.27/218.46  |- skos__scopeNote mesh__D008955
% 218.27/218.46       Theoretical representations that simulate the behavior or activity of the cardiovascular system, processes, or phenomena; includes the use of mathematical equations, computers and other electronic equipment.%A%    
% 218.27/218.46  |- skos__hiddenLabel mesh__D008955 Cardiovascular Models
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008955 1999
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008955 2000
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008955 1993
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008955 2004
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008955 1996
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008955 1995
% 218.27/218.46  |- mesh__dateEstablished mesh__D008955 1980-01-01
% 218.27/218.46  |- rdf__type mesh__D000972sskos__Concept
% 218.27/218.46  |- mesh__onlineNote mesh__D000972
% 218.27/218.46       use ANTINEOPLASTIC AGENTS, PHYTOGENIC to search ANTINEOPLASTICS, PHYTOGENIC 1975%A%  
% 218.27/218.46  |- mesh__dateRevised mesh__D000972 2005-06-30
% 218.27/218.46  |- skos__historyNote mesh__D000972 Antineoplastic Agents %28%1966-1974%29%
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D000972 2006
% 218.27/218.46  |- mesh__recordOriginator mesh__D000972 NLM
% 218.27/218.46  |- skos__altLabel mesh__D000972 Antineoplastics, Botanical
% 218.27/218.46  |- skos__broader mesh__D000972smesh__D000970
% 218.27/218.46  |- skos__hiddenLabel mesh__D000972 Phytogenic Antineoplastics
% 218.27/218.46  |- skos__scopeNote mesh__D000972
% 218.27/218.46       Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity.%A%    
% 218.27/218.46  |- skos__annotation mesh__D000972
% 218.27/218.46       from plants of Cat B6 only, not from lower plants %28%Cat B5: algae %26% fungi%29%; /biosyn permitted if by plant; TN 4: coverage%A%  
% 218.27/218.46  |- skos__hiddenLabel mesh__D000972 Botanical Antineoplastics
% 218.27/218.46  |- skos__hiddenLabel mesh__D000972 Phytogenic Antineoplastic Agents
% 218.27/218.46  |- skos__hiddenLabel mesh__D000972 Agents, Phytogenic Antineoplastic
% 218.27/218.46  |- mesh__recordAuthorizer mesh__D000972 sjn
% 218.27/218.46  |- mesh__dateCreated mesh__D000972 1999-01-01
% 218.27/218.46  |- skos__prefLabel mesh__D000972 Antineoplastic Agents, Phytogenic
% 218.27/218.46  |- mesh__dateEstablished mesh__D000972 1975-09-01
% 218.27/218.46  |- mesh__recordMaintainer mesh__D000972 ssb
% 218.27/218.46  |- mesh__historyNote mesh__D000972
% 218.27/218.46       76; was ANTINEOPLASTICS, PHYTOGENIC 1975   
% 218.27/218.46  |- skos__altLabel mesh__D000972 Antineoplastics, Phytogenic
% 218.27/218.46  |- mesh__publicMeSHNote mesh__D000972
% 218.27/218.46       76; was ANTINEOPLASTICS, PHYTOGENIC 1975   
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D000174 2003
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D000174 2001
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D000174 2005
% 218.27/218.46  |- mesh__recordAuthorizer mesh__D000174 ags
% 218.27/218.46  |- skos__scopeNote mesh__D000174
% 218.27/218.46       The lateral extension of the spine of the SCAPULA and the highest point of the SHOULDER.%A%    
% 218.27/218.46  |- mesh__recordOriginator mesh__D000174 NLM
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D000174 2000
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D000174 2006A
% 218.27/218.46  |- rdf__type mesh__D000174sskos__Concept
% 218.27/218.46  |- mesh__historyNote mesh__D000174
% 218.27/218.46       91%28%75%29%; was see under SCAPULA 1975-90   
% 218.27/218.46  |- skos__broader mesh__D000174smesh__D012540
% 218.27/218.46  |- mesh__publicMeSHNote mesh__D000174 91; was see under SCAPULA 1975-90   
% 218.27/218.46  |- mesh__dateRevised mesh__D000174 2005-07-14
% 218.27/218.46  |- mesh__dateEstablished mesh__D000174 1991-01-01
% 218.27/218.46  |- skos__annotation mesh__D000174
% 218.27/218.46       part of the scapula; fracture = ACROMION /inj %28%IM%29% + FRACTURES, BONE %28%IM%29%, not SHOULDER FRACTURES%A%  
% 218.27/218.46  |- skos__hiddenLabel mesh__D000174 Acromions
% 218.27/218.46  |- mesh__onlineNote mesh__D000174 search SCAPULA 1966-74   
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D000174 2004
% 218.27/218.46  |- skos__prefLabel mesh__D000174 Acromion
% 218.27/218.46  |- mesh__dateCreated mesh__D000174 1999-01-01
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D000174 2002
% 218.27/218.46  |- mesh__recordMaintainer mesh__D000174 ags
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D000174 2006
% 218.27/218.46  |- skos__annotation mesh__D018585
% 218.27/218.46        prefer SPOUSE ABUSE for battering of wives; check tags  HUMANS %26% FEMALE%A%  
% 218.27/218.46  |- skos__altLabel mesh__D018585 Woman, Battered
% 218.27/218.46  |- rdf__type mesh__D018585sskos__Concept
% 218.27/218.46  |- skos__altLabel mesh__D018585 Women, Battered
% 218.27/218.46  |- mesh__recordOriginator mesh__D018585 TGC
% 218.27/218.46  |- mesh__dateEstablished mesh__D018585 1995-01-01
% 218.27/218.46  |- skos__broader mesh__D018585smesh__D014930
% 218.27/218.46  |- skos__related mesh__D018585smesh__D013179
% 218.27/218.46  |- mesh__recordMaintainer mesh__D018585 sjn
% 218.27/218.46  |- mesh__dateCreated mesh__D018585 1994-04-16
% 218.27/218.46  |- skos__altLabel mesh__D018585 Woman, Abused
% 218.27/218.46  |- skos__altLabel mesh__D018585 Abused Woman
% 218.27/218.46  |- mesh__recordAuthorizer mesh__D018585 sjn
% 218.27/218.46  |- mesh__historyNote mesh__D018585 95   
% 218.27/218.46  |- skos__altLabel mesh__D018585 Women, Abused
% 218.27/218.46  |- skos__scopeNote mesh__D018585
% 218.27/218.46       Women who are physically and mentally abused over an extended period, usually by a husband or other dominant male figure. Characteristics of the battered woman syndrome are helplessness, constant fear, and a perceived inability to escape. %28%From American Heritage Dictionary of the English Language, 3d ed%29%%A%    
% 218.27/218.46  |- skos__altLabel mesh__D018585 Battered Woman
% 218.27/218.46  |- mesh__publicMeSHNote mesh__D018585 95   
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D018585 2006
% 218.27/218.46  |- mesh__dateRevised mesh__D018585 2004-07-13
% 218.27/218.46  |- skos__altLabel mesh__D018585 Abused Women
% 218.27/218.46  |- skos__prefLabel mesh__D018585 Battered Women
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D018585 2005
% 218.27/218.46  |- skos__prefLabel mesh__D004565 Electroconvulsive Therapy
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D004565 2005
% 218.27/218.46  |- skos__hiddenLabel mesh__D004565 Therapies, Electroshock
% 218.27/218.46  |- mesh__dateCreated mesh__D004565 1999-01-01
% 218.27/218.46  |- skos__hiddenLabel mesh__D004565 Therapies, Electroconvulsive
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D004565 2002
% 218.27/218.46  |- skos__hiddenLabel mesh__D004565 Electric Convulsive Therapy
% 218.27/218.46  |- mesh__recordOriginator mesh__D004565 NLM
% 218.27/218.46  |- skos__altLabel mesh__D004565 Electroshock Therapy
% 218.27/218.46  |- skos__hiddenLabel mesh__D004565 ECTs %28%Psychotherapy%29%
% 218.27/218.46  |- mesh__historyNote mesh__D004565
% 218.27/218.46       81; was SHOCK THERAPY, ELECTRIC 1963-80; ELECTROCONVULSIVE SHOCK was heading 1966-67%A%  
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D004565 2006
% 218.27/218.46  |- skos__hiddenLabel mesh__D004565 Convulsive Therapies, Electric
% 218.27/218.46  |- mesh__dateRevised mesh__D004565 2000-06-22
% 218.27/218.46  |- skos__hiddenLabel mesh__D004565 Therapy, Electric Shock
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D004565 2003
% 218.27/218.46  |- skos__hiddenLabel mesh__D004565 Therapies, Electric Convulsive
% 218.27/218.46  |- skos__altLabel mesh__D004565 ECT %28%Psychotherapy%29%
% 218.27/218.46  |- skos__hiddenLabel mesh__D004565 Electroconvulsive Therapies
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D004565 2004
% 218.27/218.46  |- mesh__onlineNote mesh__D004565
% 218.27/218.46       use ELECTROCONVULSIVE THERAPY to search SHOCK THERAPY, ELECTRIC 1966-80 %26% ELECTROCONVULSIVE SHOCK 1966-67%A%  
% 218.27/218.46  |- mesh__recordMaintainer mesh__D004565 ags
% 218.27/218.46  |- skos__annotation mesh__D004565
% 218.27/218.46       a psychother technique: do not confuse with ELECTROSHOCK, also called %22%electroconvulsive shock%22%, an exper tool; /adv eff /mortal permitted; DF: note short X ref%A%  
% 218.27/218.46  |- skos__hiddenLabel mesh__D004565 Therapy, Electroconvulsive
% 218.27/218.46  |- skos__altLabel mesh__D004565 Convulsive Therapy, Electric
% 218.27/218.46  |- skos__hiddenLabel mesh__D004565 Electric Shock Therapies
% 218.27/218.46  |- skos__scopeNote mesh__D004565
% 218.27/218.46       Electrically induced convulsions primarily used in the treatment of severe affective disorders and schizophrenia.%A%    
% 218.27/218.46  |- skos__hiddenLabel mesh__D004565 Therapies, Electric Shock
% 218.27/218.46  |- skos__hiddenLabel mesh__D004565 Electroshock Therapies
% 218.27/218.46  |- skos__hiddenLabel mesh__D004565 Electric Convulsive Therapies
% 218.27/218.46  |- skos__broader mesh__D004565smesh__D003295
% 218.27/218.46  |- skos__hiddenLabel mesh__D004565 Shock Therapies, Electric
% 218.27/218.46  |- skos__hiddenLabel mesh__D004565 Electric Shock Therapy
% 218.27/218.46  |- mesh__recordAuthorizer mesh__D004565 sjn
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D004565 2001
% 218.27/218.46  |- rdf__type mesh__D004565sskos__Concept
% 218.27/218.46  |- skos__hiddenLabel mesh__D004565 Therapy, Electric Convulsive
% 218.27/218.46  |- mesh__publicMeSHNote mesh__D004565
% 218.27/218.46       81; was SHOCK THERAPY, ELECTRIC 1963-80; ELECTROCONVULSIVE SHOCK was heading 1966-67%A%  
% 218.27/218.46  |- skos__hiddenLabel mesh__D004565 Therapy, Electroshock
% 218.27/218.46  |- skos__altLabel mesh__D004565 Shock Therapy, Electric
% 218.27/218.46  |- skos__prefLabel mesh__D009250 NADP Transhydrogenase
% 218.27/218.46  |- mesh__publicMeSHNote mesh__D009250
% 218.27/218.46       91; was see under NADH, NADPH OXIDOREDUCTASES 1979-90   
% 218.27/218.46  |- skos__altLabel mesh__D009250 NAD Transhydrogenase
% 218.27/218.46  |- skos__historyNote mesh__D009250
% 218.27/218.46       NADH, NADPH Oxidoreductases %28%1973-1978%29%
% 218.27/218.46  |- skos__hiddenLabel mesh__D009250 Transhydrogenase, NAD
% 218.27/218.46  |- skos__broader mesh__D009250smesh__D009247
% 218.27/218.46  |- skos__hiddenLabel mesh__D009250
% 218.27/218.46       Nucleotide Transhydrogenase, Nicotinamide
% 218.27/218.46  |- skos__hiddenLabel mesh__D009250 Energy Linked Transhydrogenase
% 218.27/218.46  |- skos__altLabel mesh__D009250 Energy-Linked Transhydrogenase
% 218.27/218.46  |- mesh__dateRevised mesh__D009250 2003-07-09
% 218.27/218.46  |- mesh__recordMaintainer mesh__D009250 ssb
% 218.27/218.46  |- rdf__type mesh__D009250sskos__Concept
% 218.27/218.46  |- skos__historyNote mesh__D009250 Oxidoreductases %28%1966-1972%29%
% 218.27/218.46  |- skos__hiddenLabel mesh__D009250 Nucleotide Transhydrogenase, Pyridine
% 218.27/218.46  |- skos__altLabel mesh__D009250 Mitochondrial Transhydrogenase
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D009250 2004
% 218.27/218.46  |- skos__hiddenLabel mesh__D009250 Transferase, NADPH
% 218.27/218.46  |- skos__altLabel mesh__D009250 Pyridine Nucleotide Transhydrogenase
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D009250 2006
% 218.27/218.46  |- skos__hiddenLabel mesh__D009250 Transhydrogenase, NADPH NAD
% 218.27/218.46  |- mesh__historyNote mesh__D009250
% 218.27/218.46       91%28%79%29%; was see under NADH, NADPH OXIDOREDUCTASES 1979-90%A%  
% 218.27/218.46  |- skos__hiddenLabel mesh__D009250 Transhydrogenase, NADP
% 218.27/218.46  |- mesh__dateEstablished mesh__D009250 1991-01-01
% 218.27/218.46  |- skos__hiddenLabel mesh__D009250
% 218.27/218.46       Transhydrogenase, Nicotinamide Nucleotide
% 218.27/218.46  |- mesh__dateCreated mesh__D009250 1978-03-13
% 218.27/218.46  |- mesh__recordOriginator mesh__D009250 RLS
% 218.27/218.46  |- mesh__recordAuthorizer mesh__D009250 sjn
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D009250 2005
% 218.27/218.46  |- skos__scopeNote mesh__D009250
% 218.27/218.46       An enzyme present in the mitochondrial membrane of animals and in microorganisms. In the presence of energy %28%ATP%29% it catalyzes reversibly the reduction of NAD by NADPH to yield NADP and NADH. This reaction permits the utilization of the reducing properties of NADPH by the respiratory chain and in the reverse direction it allows the reduction of NADP for biosynthetic purposes. EC 1.6.1.1.%A%    
% 218.27/218.46  |- skos__hiddenLabel mesh__D009250 Transhydrogenase, Pyridine Nucleotide
% 218.27/218.46  |- skos__hiddenLabel mesh__D009250 NAD Transhydrogenase, NADPH
% 218.27/218.46  |- skos__hiddenLabel mesh__D009250 Transhydrogenase, Energy-Linked
% 218.27/218.46  |- skos__hiddenLabel mesh__D009250 Transhydrogenase, Mitochondrial
% 218.27/218.46  |- skos__altLabel mesh__D009250 NADPH Transferase
% 218.27/218.46  |- skos__altLabel mesh__D009250 Nicotinamide Nucleotide Transhydrogenase
% 218.27/218.46  |- skos__altLabel mesh__D009250 NADPH NAD Transhydrogenase
% 218.27/218.46  |- skos__altLabel mesh__D009250 Transhydrogenase
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014993 2005
% 218.27/218.46  |- mesh__historyNote mesh__D014993 72%28%63%29%   
% 218.27/218.46  |- skos__broader mesh__D014993smesh__D013402
% 218.27/218.46  |- mesh__recordAuthorizer mesh__D014993 sjn
% 218.27/218.46  |- skos__scopeNote mesh__D014993
% 218.27/218.46       A five-carbon sugar alcohol derived from XYLOSE by reduction of the carbonyl group. It is as sweet as sucrose and used as a noncariogenic sweetener.%A%    
% 218.27/218.46  |- mesh__dateRevised mesh__D014993 2004-07-07
% 218.27/218.46  |- mesh__recordOriginator mesh__D014993 NLM
% 218.27/218.46  |- mesh__publicMeSHNote mesh__D014993 72   
% 218.27/218.46  |- skos__prefLabel mesh__D014993 Xylitol
% 218.27/218.46  |- mesh__recordMaintainer mesh__D014993 ssb
% 218.27/218.46  |- rdf__type mesh__D014993sskos__Concept
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014993 2006
% 218.27/218.46  |- mesh__dateEstablished mesh__D014993 1972-01-01
% 218.27/218.46  |- mesh__dateCreated mesh__D014993 1999-01-01
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014195 2004
% 218.27/218.46  |- mesh__recordMaintainer mesh__D014195 mdb
% 218.27/218.46  |- mesh__dateCreated mesh__D014195 1999-01-01
% 218.27/218.46  |- skos__hiddenLabel mesh__D014195 Travels
% 218.27/218.46  |- skos__annotation mesh__D014195
% 218.27/218.46       med, physiol, social, psychol aspects of travel %26% tourism; for articles on %22%the hazards of travel%22% or %22%the spread of disease by travel%22%; note X ref EMPORIATRICS for the field of travel medicine or medicine for travelers but do not coord with MEDICINE; not for study tours to various countries: index object of study + geog, as HOSPITALS + GHANA; PEDIATRICS + CHINA; consider also MEDICAL MISSIONS, OFFICIAL or MISSIONS AND MISSIONARIES; jet lag: index JET LAG SYNDROME; traveler%27%s diarrhea: coord IM with DIARRHEA %28%IM%29%%A%  
% 218.27/218.46  |- rdf__type mesh__D014195sskos__Concept
% 218.27/218.46  |- skos__scopeNote mesh__D014195
% 218.27/218.46       Aspects of health and disease related to travel. It includes the physiologic and psychologic beneficial or adverse effects of travel in general or with regard to specific diseases. It includes also emporiatrics, the specialty devoted to the medical aspects of travel. It excludes study tours.%A%    
% 218.27/218.46  |- mesh__recordOriginator mesh__D014195 NLM
% 218.27/218.46  |- skos__hiddenLabel mesh__D014195 Emporiatric Medicine
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014195 2005
% 218.27/218.46  |- skos__prefLabel mesh__D014195 Travel
% 218.27/218.46  |- skos__broader mesh__D014195smesh__D006802
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014195 2002
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014195 2006
% 218.27/218.46  |- skos__related mesh__D014195smesh__D020179
% 218.27/218.46  |- mesh__dateRevised mesh__D014195 2001-07-25
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D014195 2003
% 218.27/218.46  |- mesh__recordAuthorizer mesh__D014195 sjn
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008956 1994
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008956 2003
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008956 2000
% 218.27/218.46  |- mesh__dateCreated mesh__D008956 1999-01-01
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008956 2005
% 218.27/218.46  |- mesh__dateEstablished mesh__D008956 1968-01-01
% 218.27/218.46  |- skos__historyNote mesh__D008956 Models, Theoretical %28%1966-1967%29%
% 218.27/218.46  |- skos__scopeNote mesh__D008956
% 218.27/218.46       Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment.%A%    
% 218.27/218.46  |- rdf__type mesh__D008956sskos__Concept
% 218.27/218.46  |- skos__annotation mesh__D008956
% 218.27/218.46       no qualif; TN 37: relation to MODELS, STRUCTURAL; TN 128: definition %26% relation to MODELS, THEORETICAL; DF: MODELS CHEM%A%  
% 218.27/218.46  |- mesh__dateRevised mesh__D008956 1989-06-26
% 218.27/218.46  |- mesh__historyNote mesh__D008956 68   
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008956 1997
% 218.27/218.46  |- mesh__recordMaintainer mesh__D008956 PLS
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008956 1991
% 218.27/218.46  |- skos__hiddenLabel mesh__D008956 Model, Chemical
% 218.27/218.46  |- mesh__recordAuthorizer mesh__D008956 PLS
% 218.27/218.46  |- mesh__recordOriginator mesh__D008956 NLM
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008956 2002
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008956 1999
% 218.27/218.46  |- skos__prefLabel mesh__D008956 Models, Chemical
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008956 1993
% 218.27/218.46  |- mesh__publicMeSHNote mesh__D008956 68   
% 218.27/218.46  |- skos__altLabel mesh__D008956 Chemical Models
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008956 2004
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008956 1996
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008956 1995
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008956 1990
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008956 2001
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008956 1998
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008956 2006
% 218.27/218.46  |- skos__hiddenLabel mesh__D008956 Chemical Model
% 218.27/218.46  |- skos__broader mesh__D008956smesh__D008962
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008956 1992
% 218.27/218.46  |- mesh__recordAuthorizer mesh__D008158 PLS
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008158 2006
% 218.27/218.46  |- mesh__dateCreated mesh__D008158 1999-01-01
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008158 2001
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008158 2005
% 218.27/218.46  |- skos__broader mesh__D008158smesh__D009059
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008158 1997
% 218.27/218.46  |- skos__prefLabel mesh__D008158 Ludwig%27%s Angina
% 218.27/218.46  |- mesh__recordOriginator mesh__D008158 NLM
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008158 2000
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008158 1996
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008158 1999
% 218.27/218.46  |- mesh__recordMaintainer mesh__D008158 TAP
% 218.27/218.46  |- skos__hiddenLabel mesh__D008158 Ludwig Angina
% 218.27/218.46  |- skos__annotation mesh__D008158 submaxillary cellulitis   
% 218.27/218.46  |- skos__broader mesh__D008158smesh__D007239
% 218.27/218.46  |- mesh__dateRevised mesh__D008158 1993-06-02
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008158 2004
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008158 1995
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008158 2002
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008158 1998
% 218.27/218.46  |- rdf__type mesh__D008158sskos__Concept
% 218.27/218.46  |- skos__hiddenLabel mesh__D008158 Ludwigs Angina
% 218.27/218.46  |- skos__hiddenLabel mesh__D008158 Angina, Ludwig%27%s
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008158 2003
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D008158 1994
% 218.27/218.46  |- skos__scopeNote mesh__D008158
% 218.27/218.46       Severe cellulitis of the submaxillary space with secondary involvement of the sublingual and submental space. It usually results from infection in the lower molar area or from a penetrating injury to the mouth floor. %28%From Dorland, 27th ed%29%%A%    
% 218.27/218.46  |- mesh__dateCreated mesh__D000175 1974-11-19
% 218.27/218.46  |- mesh__dateEstablished mesh__D000175 1991-01-01
% 218.27/218.46  |- mesh__recordAuthorizer mesh__D000175 sjn
% 218.27/218.46  |- skos__scopeNote mesh__D000175
% 218.27/218.46       A pyrano-acridone alkaloid found in RUTACEAE plants.     
% 218.27/218.46  |- mesh__historyNote mesh__D000175
% 218.27/218.46       91%28%75%29%; was see under ALKALOIDS 1975-90   
% 218.27/218.46  |- skos__broader mesh__D000175smesh__D000166
% 218.27/218.46  |- skos__historyNote mesh__D000175 Acridines %28%1971-1974%29%
% 218.27/218.46  |- skos__altLabel mesh__D000175 Acronycine
% 218.27/218.46  |- rdf__type mesh__D000175sskos__Concept
% 218.27/218.46  |- skos__historyNote mesh__D000175 Alkaloids %28%1971-1974%29%
% 218.27/218.46  |- mesh__publicMeSHNote mesh__D000175
% 218.27/218.46       91; was see under ALKALOIDS 1975-90   
% 218.27/218.46  |- skos__broader mesh__D000175smesh__D000470
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D000175 2003
% 218.27/218.46  |- mesh__recordOriginator mesh__D000175 NLM
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D000175 2005
% 218.27/218.46  |- skos__annotation mesh__D000175 /biosyn permitted if by plant   
% 218.27/218.46  |- skos__altLabel mesh__D000175 Acronycin
% 218.27/218.46  |- skos__prefLabel mesh__D000175 Acronine
% 218.27/218.46  |- mesh__dateRevised mesh__D000175 2002-07-02
% 218.27/218.46  |- mesh__recordMaintainer mesh__D000175 ssb
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D000175 2004
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D000175 2006
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D018586 1999
% 218.27/218.46  |- mesh__publicMeSHNote mesh__D018586 95   
% 218.27/218.46  |- rdf__type mesh__D018586sskos__Concept
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D018586 2004
% 218.27/218.46  |- skos__scopeNote mesh__D018586
% 218.27/218.46       Centers for acquiring, characterizing, and storing bones or bone tissue for future use.%A%    
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D018586 2002
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D018586 1996
% 218.27/218.46  |- skos__historyNote mesh__D018586 Tissue Banks %28%1966-1994%29%
% 218.27/218.46  |- skos__hiddenLabel mesh__D018586 Bone Bank
% 218.27/218.46  |- skos__hiddenLabel mesh__D018586 Banks, Bone
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D018586 2005
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D018586 1997
% 218.27/218.46  |- skos__broader mesh__D018586smesh__D014015
% 218.27/218.46  |- mesh__historyNote mesh__D018586 95   
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D018586 2000
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D018586 2006
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D018586 1995
% 218.27/218.46  |- skos__hiddenLabel mesh__D018586 Bank, Bone
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D018586 2001
% 218.27/218.46  |- mesh__dateEstablished mesh__D018586 1995-01-01
% 218.27/218.46  |- skos__prefLabel mesh__D018586 Bone Banks
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D018586 1998
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D018586 2003
% 218.27/218.46  |- mesh__dateCreated mesh__D018586 1994-04-16
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D004566 1999
% 218.27/218.46  |- mesh__recordMaintainer mesh__D004566 PXP
% 218.27/218.46  |- mesh__recordAuthorizer mesh__D004566 SJN
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D004566 2000
% 218.27/218.46  |- rdf__type mesh__D004566sskos__Concept
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D004566 1998
% 218.27/218.46  |- mesh__dateEstablished mesh__D004566 1972-01-01
% 218.27/218.46  |- skos__hiddenLabel mesh__D004566 Cathodes
% 218.27/218.46  |- skos__prefLabel mesh__D004566 Electrodes
% 218.27/218.46  |- skos__annotation mesh__D004566 NIM   
% 218.27/218.46  |- mesh__dateRevised mesh__D004566 1997-06-20
% 218.27/218.46  |- skos__broader mesh__D004566smesh__D004864
% 218.27/218.46  |- skos__hiddenLabel mesh__D004566 Electrode
% 218.27/218.46  |- skos__broader mesh__D004566smesh__D004560
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D004566 2004
% 218.27/218.46  |- mesh__recordOriginator mesh__D004566 NLM
% 218.27/218.46  |- mesh__dateCreated mesh__D004566 1999-01-01
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D004566 2002
% 218.27/218.46  |- skos__hiddenLabel mesh__D004566 Anodes
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D004566 2006
% 218.27/218.46  |- skos__historyNote mesh__D004566 Equipment and Supplies %28%1966-1967%29%
% 218.27/218.46  |- skos__scopeNote mesh__D004566
% 218.27/218.46       Mediums used between an electric conductor and the object to which the current is to be applied. In electrotherapy, electrodes are instruments with a point or surface from which to transmit electric current to the body of a patient or to another instrument; in electrodiagnosis, they are needles or metal plates used to stimulate or record the electrical activity of tissue. %28%From Dorland, 28th ed%29%%A%    
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D004566 2003
% 218.27/218.46  |- mesh__publicMeSHNote mesh__D004566 72   
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D004566 2001
% 218.27/218.46  |- mesh__historyNote mesh__D004566 72%28%68%29%   
% 218.27/218.46  |- mesh__activeMeSHYear mesh__D004566 2005
% 218.27/218.46  |- skos__hiddenLabel mesh__D009251 Reductase, Ferrihemoprotein P450
% 218.27/218.46  |- skos__hiddenLabel mesh__D009251 Ferrihemoprotein P 450 Reductase
% 218.27/218.46  |- skos__hiddenLabel mesh__D009251 P-450 Oxidase, Cytochrome
% 218.27/218.47  |- skos__historyNote mesh__D009251 Cytochromes %28%1966-1972%29%
% 218.27/218.47  |- skos__hiddenLabel mesh__D009251 NADPH Ferrihemoprotein Reductase
% 218.27/218.47  |- skos__historyNote mesh__D009251 Cytochrome Reductases %28%1973-1974%29%
% 218.27/218.47  |- skos__hiddenLabel mesh__D009251 P450 Reductase, Cytochrome
% 218.27/218.47  |- skos__altLabel mesh__D009251 Ferrihemoprotein P450 Reductase
% 218.27/218.47  |- skos__hiddenLabel mesh__D009251 NADPH P450 Reductase
% 218.27/218.47  |- mesh__publicMeSHNote mesh__D009251
% 218.27/218.47       1992; see NADPH CYTOCHROME C REDUCTASE 1980-1991 %26% CYTOCHROME REDUCTASES 1975-1979; CYTOCHROME P-450 OXIDASE was indexed under NADH, NADPH OXIDOREDUCTASES 1997-2000 %26% OXIDOREDUCTASES 1983-1996%A%  
% 218.27/218.47  |- skos__hiddenLabel mesh__D009251 Oxidase, Cytochrome P-450
% 218.27/218.47  |- skos__hiddenLabel mesh__D009251 Reductase, Ferrihemoprotein P-450
% 218.27/218.47  |- skos__altLabel mesh__D009251 NADPH Cytochrome P450 Oxidoreductase
% 218.27/218.47  |- skos__altLabel mesh__D009251 NADPH Cytochrome P-450 Reductase
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D009251 2005
% 218.27/218.47  |- skos__hiddenLabel mesh__D009251 NADPH Cytochrome P 450 Reductase
% 218.27/218.47  |- skos__hiddenLabel mesh__D009251 Reductase, Cytochrome P-450
% 218.27/218.47  |- skos__hiddenLabel mesh__D009251 Reductase, NADPH-Ferrihemoprotein
% 218.27/218.47  |- mesh__historyNote mesh__D009251
% 218.27/218.47       1992%28%1975%29%; for CYTOCHROME P-450 OXIDASE use NADPH-FERRIHEMOPROTEIN REDUCTASE %28%NM%29% 1983-2000%A%  
% 218.27/218.47  |- skos__hiddenLabel mesh__D009251 Reductase, NADPH-P450
% 218.27/218.47  |- mesh__dateCreated mesh__D009251 1974-11-19
% 218.27/218.47  |- skos__historyNote mesh__D009251 Oxidoreductases %28%1966-1974%29%
% 218.27/218.47  |- skos__altLabel mesh__D009251 NADPH-P450 Reductase
% 218.27/218.47  |- skos__historyNote mesh__D009251 Cytochrome C %28%1973-1974%29%
% 218.27/218.47  |- skos__altLabel mesh__D009251 Cytochrome P450 Reductase
% 218.27/218.47  |- skos__altLabel mesh__D009251 Cytochrome P-450 Reductase
% 218.27/218.47  |- skos__prefLabel mesh__D009251 NADPH-Ferrihemoprotein Reductase
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D009251 2006
% 218.27/218.47  |- skos__hiddenLabel mesh__D009251 Reductase, NADPH-Cytochrome P450
% 218.27/218.47  |- mesh__recordOriginator mesh__D009251 NLM
% 218.27/218.47  |- mesh__dateEstablished mesh__D009251 1980-01-01
% 218.27/218.47  |- skos__hiddenLabel mesh__D009251 Cytochrome P 450 Oxidase
% 218.27/218.47  |- mesh__dateRevised mesh__D009251 2003-07-09
% 218.27/218.47  |- skos__altLabel mesh__D009251 NADPH Cytochrome P450 Reductase
% 218.27/218.47  |- rdf__type mesh__D009251sskos__Concept
% 218.27/218.47  |- skos__altLabel mesh__D009251 NADPH-Cytochrome P450 Reductase
% 218.27/218.47  |- skos__altLabel mesh__D009251 NADPH Cytochrome P-450 Oxidoreductase
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D009251 2004
% 218.27/218.47  |- skos__broader mesh__D009251smesh__D003579
% 218.27/218.47  |- mesh__recordMaintainer mesh__D009251 ssb
% 218.27/218.47  |- skos__altLabel mesh__D009251 NADPH Cytochrome c Reductase
% 218.27/218.47  |- skos__scopeNote mesh__D009251
% 218.27/218.47       A flavoprotein that catalyzes the reduction of heme-thiolate-dependent monooxygenases and is part of the microsomal hydroxylating system. EC 1.6.2.4.%A%    
% 218.27/218.47  |- skos__hiddenLabel mesh__D009251 P450 Reductase, NADPH-Cytochrome
% 218.27/218.47  |- skos__altLabel mesh__D009251 Ferrihemoprotein P-450 Reductase
% 218.27/218.47  |- mesh__recordAuthorizer mesh__D009251 sjn
% 218.27/218.47  |- skos__altLabel mesh__D009251 Cytochrome P-450 Oxidase
% 218.27/218.47  |- skos__hiddenLabel mesh__D009251 Reductase, Cytochrome P450
% 218.27/218.47  |- skos__hiddenLabel mesh__D009251 Cytochrome P 450 Reductase
% 218.27/218.47  |- skos__hiddenLabel mesh__D009251 NADPH Cytochrome P 450 Oxidoreductase
% 218.27/218.47  |- skos__broader mesh__D014994smesh__D010429
% 218.27/218.47  |- skos__hiddenLabel mesh__D014994 D Xylose
% 218.27/218.47  |- mesh__dateCreated mesh__D014994 1999-01-01
% 218.27/218.47  |- skos__prefLabel mesh__D014994 Xylose
% 218.27/218.47  |- mesh__recordMaintainer mesh__D014994 ssb
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D014994 2005
% 218.27/218.47  |- rdf__type mesh__D014994sskos__Concept
% 218.27/218.47  |- mesh__recordAuthorizer mesh__D014994 sjn
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D014994 2006
% 218.27/218.47  |- mesh__recordOriginator mesh__D014994 NLM
% 218.27/218.47  |- skos__altLabel mesh__D014994 D-Xylose
% 218.27/218.47  |- mesh__dateRevised mesh__D014994 2004-07-07
% 218.27/218.47  |- skos__scopeNote mesh__D014196
% 218.27/218.47       A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. %28%From AMA Drug Evaluations Annual, 1994, p309%29%%A%    
% 218.27/218.47  |- skos__hiddenLabel mesh__D014196 Nu Trazodone
% 218.27/218.47  |- mesh__recordAuthorizer mesh__D014196 sjn
% 218.27/218.47  |- skos__altLabel mesh__D014196 Ratiopharm Brand of Trazodone Hydrochloride
% 218.27/218.47  |- rdf__type mesh__D014196sskos__Concept
% 218.27/218.47  |- skos__altLabel mesh__D014196
% 218.27/218.47       Bristol-Myers Squibb Brand of Trazodone Hydrochloride
% 218.27/218.47  |- skos__hiddenLabel mesh__D014196 PMS Trazodone
% 218.27/218.47  |- mesh__recordMaintainer mesh__D014196 CCR
% 218.27/218.47  |- skos__broader mesh__D014196smesh__D011728
% 218.27/218.47  |- skos__prefLabel mesh__D014196 Trazodone
% 218.27/218.47  |- skos__historyNote mesh__D014196 Pyridines %28%1971-1974%29%
% 218.27/218.47  |- skos__hiddenLabel mesh__D014196 ratio Trazodone
% 218.27/218.47  |- skos__hiddenLabel mesh__D014196 Apo Trazodone
% 218.27/218.47  |- skos__altLabel mesh__D014196 Aventis Brand of Trazodone Hydrochloride
% 218.27/218.47  |- skos__hiddenLabel mesh__D014196 Trazodon neuraxpharm
% 218.27/218.47  |- skos__hiddenLabel mesh__D014196
% 218.27/218.47       Nu Pharm Brand of Trazodone Hydrochloride
% 218.27/218.47  |- skos__altLabel mesh__D014196 Novopharm Brand of Trazodone Hydrochloride
% 218.27/218.47  |- skos__altLabel mesh__D014196
% 218.27/218.47       Pharmascience Brand of Trazodone Hydrochloride
% 218.27/218.47  |- mesh__dateRevised mesh__D014196 2005-06-30
% 218.27/218.47  |- skos__hiddenLabel mesh__D014196 AF1161
% 218.27/218.47  |- skos__hiddenLabel mesh__D014196 Gen Trazodone
% 218.27/218.47  |- mesh__recordOriginator mesh__D014196 NLM
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D014196 2006
% 218.27/218.47  |- skos__altLabel mesh__D014196 Tradozone
% 218.27/218.47  |- skos__altLabel mesh__D014196 Nu-Pharm Brand of Trazodone Hydrochloride
% 218.27/218.47  |- skos__altLabel mesh__D014196 Apotex Brand of Trazodone Hydrochloride
% 218.27/218.47  |- mesh__dateCreated mesh__D014196 1974-11-19
% 218.27/218.47  |- skos__altLabel mesh__D014196 Hexal Brand of Trazodone Hydrochloride
% 218.27/218.47  |- skos__hiddenLabel mesh__D014196
% 218.27/218.47       Bristol Myers Squibb Brand of Trazodone Hydrochloride
% 218.27/218.47  |- skos__altLabel mesh__D014196 Sidmark Brand of Trazodone Hydrochloride
% 218.27/218.47  |- skos__altLabel mesh__D014196
% 218.27/218.47       Boehringer Ingelheim Brand of Trazodone Hydrochloride
% 218.27/218.47  |- skos__altLabel mesh__D014196 Apothecon Brand of Trazodone Hydrochloride
% 218.27/218.47  |- skos__altLabel mesh__D014196
% 218.27/218.47       Aventis Pharma Brand of Trazodone Hydrochloride
% 218.27/218.47  |- skos__historyNote mesh__D014196 Triazoles %28%1971-1974%29%
% 218.27/218.47  |- mesh__historyNote mesh__D014196
% 218.27/218.47       86%28%75%29%; was see under PIPERAZINES 1975-85   
% 218.27/218.47  |- skos__altLabel mesh__D014196
% 218.27/218.47       neuraxpharm Brand of Trazodone Hydrochloride
% 218.27/218.47  |- skos__altLabel mesh__D014196 Genpharm Brand of Trazodone Hydrochloride
% 218.27/218.47  |- skos__hiddenLabel mesh__D014196 Novo Trazodone
% 218.27/218.47  |- skos__altLabel mesh__D014196
% 218.27/218.47       Farma Lepori Brand of Trazodone Hydrochloride
% 218.27/218.47  |- skos__historyNote mesh__D014196 Piperazines %28%1971-1974%29%
% 218.27/218.47  |- mesh__publicMeSHNote mesh__D014196
% 218.27/218.47       86; was see under PIPERAZINES 1975-85   
% 218.27/218.47  |- skos__hiddenLabel mesh__D014196 AF 1161
% 218.27/218.47  |- skos__broader mesh__D014196smesh__D010879
% 218.27/218.47  |- mesh__dateEstablished mesh__D014196 1986-01-01
% 218.27/218.47  |- skos__prefLabel mesh__D008957 Models, Genetic
% 218.27/218.47  |- mesh__recordMaintainer mesh__D008957 TGC
% 218.27/218.47  |- mesh__historyNote mesh__D008957 80   
% 218.27/218.47  |- skos__hiddenLabel mesh__D008957 Genetic Model
% 218.27/218.47  |- skos__hiddenLabel mesh__D008957 Model, Genetic
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D008957 2004
% 218.27/218.47  |- skos__altLabel mesh__D008957 Genetic Models
% 218.27/218.47  |- skos__annotation mesh__D008957
% 218.27/218.47       no qualif; apply TN 128 for relation to MODELS, THEORETICAL; DF: MODELS GENET%A%  
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D008957 2006
% 218.27/218.47  |- skos__historyNote mesh__D008957 Models, Biological %28%1968-1979%29%
% 218.27/218.47  |- mesh__dateCreated mesh__D008957 1979-05-25
% 218.27/218.47  |- mesh__dateEstablished mesh__D008957 1980-01-01
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D008957 2003
% 218.27/218.47  |- mesh__recordAuthorizer mesh__D008957 sjn
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D008957 2005
% 218.27/218.47  |- skos__broader mesh__D008957smesh__D008954
% 218.27/218.47  |- mesh__dateRevised mesh__D008957 2002-07-03
% 218.27/218.47  |- mesh__publicMeSHNote mesh__D008957 80   
% 218.27/218.47  |- mesh__recordOriginator mesh__D008957 VDK
% 218.27/218.47  |- skos__scopeNote mesh__D008957
% 218.27/218.47       Theoretical representations that simulate the behavior or activity of genetic processes or phenomena. They include the use of mathematical equations, computers, and other electronic equipment.%A%    
% 218.27/218.47  |- rdf__type mesh__D008957sskos__Concept
% 218.27/218.47  |- skos__altLabel mesh__D000974 Anti-DNA Antibodies
% 218.27/218.47  |- mesh__recordAuthorizer mesh__D000974 sjn
% 218.27/218.47  |- skos__hiddenLabel mesh__D000974 Factor, Antinuclear
% 218.27/218.47  |- skos__annotation mesh__D000974
% 218.27/218.47       coordinate with specific nuclear antigen; do not coordinate with ANTIBODY FORMATION for /biosyn%A%  
% 218.27/218.47  |- skos__hiddenLabel mesh__D000974 Antinuclear Antibodies, Fluorescent
% 218.27/218.47  |- skos__related mesh__D000974smesh__D003095
% 218.27/218.47  |- mesh__recordMaintainer mesh__D000974 ssb
% 218.27/218.47  |- skos__hiddenLabel mesh__D000974 Antibodies, Fluorescent Antinuclear
% 218.27/218.47  |- skos__altLabel mesh__D000974 Antinuclear Antibodies
% 218.27/218.47  |- mesh__dateEstablished mesh__D000974 1970-01-01
% 218.27/218.47  |- mesh__historyNote mesh__D000974
% 218.27/218.47       90; was ANTINUCLEAR FACTORS 1966-89 %28%Prov 1966-69%29%   
% 218.27/218.47  |- skos__hiddenLabel mesh__D000974 Factors, Antinuclear
% 218.27/218.47  |- skos__hiddenLabel mesh__D000974 Antibody, Antinuclear
% 218.27/218.47  |- rdf__type mesh__D000974sskos__Concept
% 218.27/218.47  |- mesh__publicMeSHNote mesh__D000974
% 218.27/218.47       90; was ANTINUCLEAR FACTORS 1970-89   
% 218.27/218.47  |- skos__altLabel mesh__D000974 Antinuclear Factors
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D000974 2006
% 218.27/218.47  |- skos__hiddenLabel mesh__D000974 Antibodies, Anti DNA
% 218.27/218.47  |- skos__altLabel mesh__D000974 Antinuclear Antibody
% 218.27/218.47  |- skos__scopeNote mesh__D000974
% 218.27/218.47       Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren%27%s syndrome, scleroderma, polymyositis, and mixed connective tissue disease.%A%    
% 218.27/218.47  |- mesh__dateRevised mesh__D000974 2005-06-30
% 218.27/218.47  |- mesh__onlineNote mesh__D000974
% 218.27/218.47       use ANTIBODIES, ANTINUCLEAR to search ANTINUCLEAR FACTORS 1966-89 %28%Prov 1966-69%29%%A%  
% 218.27/218.47  |- mesh__recordOriginator mesh__D000974 NLM
% 218.27/218.47  |- skos__broader mesh__D000974smesh__D001323
% 218.27/218.47  |- mesh__dateCreated mesh__D000974 1999-01-01
% 218.27/218.47  |- skos__altLabel mesh__D000974 Antinuclear Factor
% 218.27/218.47  |- skos__prefLabel mesh__D000974 Antibodies, Antinuclear
% 218.27/218.47  |- skos__hiddenLabel mesh__D000974 Anti DNA Antibodies
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D008159 2006
% 218.27/218.47  |- mesh__recordAuthorizer mesh__D008159 sjn
% 218.27/218.47  |- mesh__recordMaintainer mesh__D008159 ags
% 218.27/218.47  |- skos__hiddenLabel mesh__D008159 Vertebrae, Lumbar
% 218.27/218.47  |- mesh__dateRevised mesh__D008159 1999-11-03
% 218.27/218.47  |- skos__annotation mesh__D008159
% 218.27/218.47       do not confuse with LUMBOSACRAL REGION; IM when discussed as bones or as coord with specific spinal disease %28%IM%29%; NIM when locational; inflammation = LUMBAR VERTEBRAE %28%IM%29% + SPONDYLITIS %28%IM%29%%A%  
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D008159 2000
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D008159 2003
% 218.27/218.47  |- skos__broader mesh__D008159smesh__D013131
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D008159 2001
% 218.27/218.47  |- mesh__dateCreated mesh__D008159 1999-01-01
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D008159 2004
% 218.27/218.47  |- rdf__type mesh__D008159sskos__Concept
% 218.27/218.47  |- mesh__recordOriginator mesh__D008159 NLM
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D008159 2002
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D008159 2005
% 218.27/218.47  |- skos__prefLabel mesh__D008159 Lumbar Vertebrae
% 218.27/218.47  |- skos__altLabel mesh__D000176 Acrosomal proteinase
% 218.27/218.47  |- mesh__recordMaintainer mesh__D000176 ssb
% 218.27/218.47  |- skos__altLabel mesh__D000176 Akrosin
% 218.27/218.47  |- rdf__type mesh__D000176sskos__Concept
% 218.27/218.47  |- skos__scopeNote mesh__D000176
% 218.27/218.47       A trypsin-like enzyme of spermatozoa which is not inhibited by alpha 1 antitrypsin.%A%    
% 218.27/218.47  |- mesh__historyNote mesh__D000176
% 218.27/218.47       91%28%75%29%; was see under SERINE ENDOPEPTIDASES 1975-90   
% 218.27/218.47  |- skos__prefLabel mesh__D000176 Acrosin
% 218.27/218.47  |- mesh__dateRevised mesh__D000176 2003-07-09
% 218.27/218.47  |- mesh__recordAuthorizer mesh__D000176 sjn
% 218.27/218.47  |- mesh__dateCreated mesh__D000176 1974-11-19
% 218.27/218.47  |- skos__historyNote mesh__D000176
% 218.27/218.47       Peptide Peptidohydrolases %28%1973-1974%29%
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D000176 2005
% 218.27/218.47  |- mesh__publicMeSHNote mesh__D000176
% 218.27/218.47       91; was see under SERINE PROTEINASES 1975-90   
% 218.27/218.47  |- skos__broader mesh__D000176smesh__D012697
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D000176 2004
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D000176 2006
% 218.27/218.47  |- skos__hiddenLabel mesh__D000176 M beta Acrosin
% 218.27/218.47  |- skos__hiddenLabel mesh__D000176 proteinase, Acrosomal
% 218.27/218.47  |- mesh__dateEstablished mesh__D000176 1991-01-01
% 218.27/218.47  |- mesh__recordOriginator mesh__D000176 NLM
% 218.27/218.47  |- skos__hiddenLabel mesh__D000176 beta-Acrosin, M
% 218.27/218.47  |- skos__historyNote mesh__D018587 Oocytes %28%1980-1994%29%
% 218.27/218.47  |- skos__prefLabel mesh__D018587 Oocyte Donation
% 218.27/218.47  |- skos__hiddenLabel mesh__D018587 Donation, Ovum
% 218.27/218.47  |- mesh__recordAuthorizer mesh__D018587 sjn
% 218.27/218.47  |- mesh__publicMeSHNote mesh__D018587 95   
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D018587 2005
% 218.27/218.47  |- mesh__dateCreated mesh__D018587 1994-06-01
% 218.27/218.47  |- mesh__historyNote mesh__D018587 95   
% 218.27/218.47  |- mesh__recordOriginator mesh__D018587 JLS
% 218.27/218.47  |- skos__scopeNote mesh__D018587
% 218.27/218.47       Transfer of preovulatory oocytes from donor to a suitable host. Oocytes are collected, fertilized in vitro, and transferred to a host that can be human or animal.%A%    
% 218.27/218.47  |- mesh__dateRevised mesh__D018587 2004-07-13
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D018587 2006
% 218.27/218.47  |- skos__hiddenLabel mesh__D018587 Oocyte Donations
% 218.27/218.47  |- skos__related mesh__D018587smesh__D033001
% 218.27/218.47  |- mesh__recordMaintainer mesh__D018587 sjn
% 218.27/218.47  |- skos__hiddenLabel mesh__D018587 Donation, Oocyte
% 218.27/218.47  |- skos__broader mesh__D018587smesh__D027724
% 218.27/218.47  |- skos__historyNote mesh__D018587 Tissue Donors %28%1983-1994%29%
% 218.27/218.47  |- skos__hiddenLabel mesh__D018587 Donations, Oocyte
% 218.27/218.47  |- rdf__type mesh__D018587sskos__Concept
% 218.27/218.47  |- skos__hiddenLabel mesh__D018587 Ovum Donations
% 218.27/218.47  |- skos__hiddenLabel mesh__D018587 Donations, Ovum
% 218.27/218.47  |- mesh__dateEstablished mesh__D018587 1995-01-01
% 218.27/218.47  |- skos__altLabel mesh__D037741 Buckyballs
% 218.27/218.47  |- skos__broader mesh__D037741smesh__D002244
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D037741 2005
% 218.27/218.47  |- mesh__recordAuthorizer mesh__D037741 sjn
% 218.27/218.47  |- mesh__historyNote mesh__D037741 2003   
% 218.27/218.47  |- skos__altLabel mesh__D037741 Buckminsterfullerenes
% 218.27/218.47  |- skos__prefLabel mesh__D037741 Fullerenes
% 218.27/218.47  |- skos__historyNote mesh__D037741 Carbon %28%1991-2002%29%
% 218.27/218.47  |- rdf__type mesh__D037741sskos__Concept
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D037741 2004
% 218.27/218.47  |- mesh__publicMeSHNote mesh__D037741 2003   
% 218.27/218.47  |- mesh__dateEstablished mesh__D037741 2003-01-01
% 218.27/218.47  |- mesh__recordMaintainer mesh__D037741 ssb
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D037741 2003
% 218.27/218.47  |- mesh__recordOriginator mesh__D037741 ssb
% 218.27/218.47  |- mesh__dateCreated mesh__D037741 2002-07-02
% 218.27/218.47  |- skos__scopeNote mesh__D037741
% 218.27/218.47       A polyhedral CARBON structure composed of around 60-80 carbon atoms in pentagon and hexagon configuration. They are named after Buckminster Fuller because of structural resemblance to geodesic domes. Fullerenes can be made in high temperature such as arc discharge in an inert atmosphere.%A%    
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D037741 2006
% 218.27/218.47  |- skos__hiddenLabel mesh__D004567 Implanted Electrode
% 218.27/218.47  |- skos__prefLabel mesh__D004567 Electrodes, Implanted
% 218.27/218.47  |- skos__annotation mesh__D004567 NIM   
% 218.27/218.47  |- mesh__recordOriginator mesh__D004567 NLM
% 218.27/218.47  |- mesh__recordMaintainer mesh__D004567 PXP
% 218.27/218.47  |- rdf__type mesh__D004567sskos__Concept
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D004567 2000
% 218.27/218.47  |- skos__hiddenLabel mesh__D004567 Electrode, Implanted
% 218.27/218.47  |- skos__hiddenLabel mesh__D004567 Implanted Electrodes
% 218.27/218.47  |- skos__historyNote mesh__D004567 Electrodes %28%1968-1970%29%
% 218.27/218.47  |- mesh__dateCreated mesh__D004567 1999-01-01
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D004567 2001
% 218.27/218.47  |- skos__broader mesh__D004567smesh__D004566
% 218.27/218.47  |- mesh__publicMeSHNote mesh__D004567 73   
% 218.27/218.47  |- mesh__dateRevised mesh__D004567 1999-11-05
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D004567 2003
% 218.27/218.47  |- skos__scopeNote mesh__D004567
% 218.27/218.47       Electric conductors through which an electric current enters or leaves a medium. When inserted, usually surgically, they are referred to as implanted electrodes.%A%    
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D004567 2005
% 218.27/218.47  |- mesh__recordAuthorizer mesh__D004567 sjn
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D004567 2004
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D004567 2002
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D004567 2006
% 218.27/218.47  |- mesh__historyNote mesh__D004567 73%28%71%29%   
% 218.27/218.47  |- mesh__dateEstablished mesh__D004567 1973-01-01
% 218.27/218.47  |- mesh__dateCreated mesh__D023721 2001-07-25
% 218.27/218.47  |- mesh__dateEstablished mesh__D023721 2002-01-01
% 218.27/218.47  |- skos__historyNote mesh__D023721 Fishes %28%1981-2001%29%
% 218.27/218.47  |- skos__altLabel mesh__D023721 Puffers
% 218.27/218.47  |- skos__altLabel mesh__D023721 Puffer Fish
% 218.27/218.47  |- skos__hiddenLabel mesh__D023721 Fish, Puffer
% 218.27/218.47  |- skos__prefLabel mesh__D023721 Tetraodontiformes
% 218.27/218.47  |- mesh__recordOriginator mesh__D023721 ags
% 218.27/218.47  |- rdf__type mesh__D023721sskos__Concept
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D023721 2006
% 218.27/218.47  |- mesh__dateRevised mesh__D023721 2005-06-30
% 218.27/218.47  |- skos__altLabel mesh__D023721 Ostraciidae
% 218.27/218.47  |- skos__altLabel mesh__D023721 Tetraodontidae
% 218.27/218.47  |- skos__scopeNote mesh__D023721
% 218.27/218.47       A small order of primarily marine fish containing 340 species. Most have a rotund or box-like shape. TETRODOTOXIN is found in their liver and ovaries.%A%    
% 218.27/218.47  |- mesh__recordMaintainer mesh__D023721 ags
% 218.27/218.47  |- mesh__publicMeSHNote mesh__D023721 2002   
% 218.27/218.47  |- skos__broader mesh__D023721smesh__D005399
% 218.27/218.47  |- mesh__recordAuthorizer mesh__D023721 sjn
% 218.27/218.47  |- mesh__historyNote mesh__D023721 2002   
% 218.27/218.47  |- skos__altLabel mesh__D009252 TPN Diaphorase
% 218.27/218.47  |- mesh__onlineNote mesh__D009252
% 218.27/218.47       use NADPH DEHYDROGENASE to search OLD YELLOW ENZYME 1975-79 %26% OXIDOREDUCTASES 1967-74; use NADPH DEHYDROGENASE to search NADP DIAPHORASE 1975-79%A%  
% 218.27/218.47  |- rdf__type mesh__D009252sskos__Concept
% 218.27/218.47  |- skos__scopeNote mesh__D009252
% 218.27/218.47       A flavoprotein that reversibly oxidizes NADPH to NADP and a reduced acceptor. EC 1.6.99.1.%A%    
% 218.27/218.47  |- mesh__dateRevised mesh__D009252 2003-07-09
% 218.27/218.47  |- skos__altLabel mesh__D009252 NADP Diaphorase
% 218.27/218.47  |- skos__hiddenLabel mesh__D009252 Dehydrogenase, NADP
% 218.27/218.47  |- skos__prefLabel mesh__D009252 NADPH Dehydrogenase
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D009252 2005
% 218.27/218.47  |- skos__hiddenLabel mesh__D009252 Diaphorase, NADPH
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D009252 2004
% 218.27/218.47  |- mesh__historyNote mesh__D009252
% 218.27/218.47       91%28%80%29%; was see under NADH, NADPH OXIDOREDUCTASES 1980-90; was OLD YELLOW ENZYME see under NADH, NADPH OXIDOREDUCTASES 1975-79, see under OXIDOREDUCTASES 1967-74; NADP DIAPHORASE was see under LIPOAMIDE DEHYDROGENASE 1975-79%A%  
% 218.27/218.47  |- mesh__publicMeSHNote mesh__D009252
% 218.27/218.47       91; was see under NADH, NADPH OXIDOREDUCTASES 1980-90; was OLD YELLOW ENZYME see under NADH, NADPH OXIDOREDUCTASES 1975-79, see under OXIDOREDUCTASES 1967-74; NADP DIAPHORASE was see under LIPOAMIDE DEHYDROGENASE 1975-79%A%  
% 218.27/218.47  |- skos__hiddenLabel mesh__D009252 Enzyme, Old Yellow
% 218.27/218.47  |- mesh__recordAuthorizer mesh__D009252 sjn
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D009252 2006
% 218.27/218.47  |- mesh__recordOriginator mesh__D009252 NLM
% 218.27/218.47  |- skos__broader mesh__D009252smesh__D009247
% 218.27/218.47  |- mesh__recordMaintainer mesh__D009252 ssb
% 218.27/218.47  |- skos__annotation mesh__D009252 do not confuse with NADH DEHYDROGENASE   
% 218.27/218.47  |- skos__altLabel mesh__D009252 Old Yellow Enzyme
% 218.27/218.47  |- skos__altLabel mesh__D009252 NADP Dehydrogenase
% 218.27/218.47  |- skos__altLabel mesh__D009252 NADPH Diaphorase
% 218.27/218.47  |- skos__hiddenLabel mesh__D009252 Diaphorase, TPN
% 218.27/218.47  |- skos__hiddenLabel mesh__D009252 Diaphorase, NADP
% 218.27/218.47  |- skos__hiddenLabel mesh__D009252 Dehydrogenase, NADPH
% 218.27/218.47  |- mesh__dateEstablished mesh__D009252 1991-01-01
% 218.27/218.47  |- mesh__dateCreated mesh__D009252 1999-01-01
% 218.27/218.47  |- mesh__dateRevised mesh__D014995 2003-07-09
% 218.27/218.47  |- skos__broader mesh__D014995smesh__D006026
% 218.27/218.47  |- mesh__publicMeSHNote mesh__D014995
% 218.27/218.47       91; was see under GLYCOSIDE HYDROLASES 1978-90   
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D014995 2004
% 218.27/218.47  |- rdf__type mesh__D014995sskos__Concept
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D014995 2005
% 218.27/218.47  |- mesh__recordOriginator mesh__D014995 RLS
% 218.27/218.47  |- skos__historyNote mesh__D014995 Glycoside Hydrolases %28%1966-1977%29%
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D014995 2006
% 218.27/218.47  |- mesh__dateCreated mesh__D014995 1977-04-15
% 218.27/218.47  |- skos__altLabel mesh__D014995 Xylobiases
% 218.27/218.47  |- mesh__recordMaintainer mesh__D014995 ssb
% 218.27/218.47  |- skos__prefLabel mesh__D014995 Xylosidases
% 218.27/218.47  |- mesh__historyNote mesh__D014995
% 218.27/218.47       91%28%78%29%; was see under GLYCOSIDE HYDROLASES 1978-90   
% 218.27/218.47  |- mesh__dateEstablished mesh__D014995 1991-01-01
% 218.27/218.47  |- mesh__recordAuthorizer mesh__D014995 sjn
% 218.27/218.47  |- skos__scopeNote mesh__D014995
% 218.27/218.47       A group of enzymes that catalyze the hydrolysis of alpha- or beta-xylosidic linkages. EC 3.2.1.8 catalyzes the endo-hydrolysis of 1,4-beta-D-xylosidic linkages; EC 3.2.1.32 catalyzes the endo-hydrolysis of 1,3-beta-D-xylosidic linkages; EC 3.2.1.37 catalyzes the exo-hydrolysis of 1,4-beta-D-linkages from the non-reducing termini of xylans; and EC 3.2.1.72 catalyzes the exo-hydrolysis of 1,3-beta-D-linkages from the non-reducing termini of xylans. Other xylosidases have been identified that catalyze the hydrolysis of alpha-xylosidic bonds.%A%    
% 218.27/218.47  |- skos__altLabel mesh__D014995 Xylan Hydrolases
% 218.27/218.47  |- skos__hiddenLabel mesh__D014995 Hydrolases, Xylan
% 218.27/218.47  |- mesh__recordOriginator mesh__D014197 NLM
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D014197 2006
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D014197 2002
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D014197 2003
% 218.27/218.47  |- mesh__historyNote mesh__D014197
% 218.27/218.47       ACACIA %26% EUCALYPTUS were headings 1963-85   
% 218.27/218.47  |- skos__annotation mesh__D014197
% 218.27/218.47       IM; use qualif discreetly: few apply; includes foliage, needles, acorns, cones, buds, flowers, but remember FRUIT; POLLEN; RESINS,PLANT; SEEDS; WOOD are available %28%coord these IM with TREES %28%NIM%29% when a specific genus of tree is discussed%29%; do not confuse X ref FORESTS with FORESTRY, the specialty; coord IM with GEOGRAPHY %28%IM%29% or ECOLOGY %28%IM%29% or other aspect if pertinent%A%  
% 218.27/218.47  |- skos__scopeNote mesh__D014197
% 218.27/218.47       Woody, usually tall, perennial higher plants %28%Angiosperms, Gymnosperms, and some Pterophyta%29% having usually a main stem and numerous branches.%A%    
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D014197 2006A
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D014197 2004
% 218.27/218.47  |- mesh__recordAuthorizer mesh__D014197 ags
% 218.27/218.47  |- mesh__dateRevised mesh__D014197 2005-07-28
% 218.27/218.47  |- skos__prefLabel mesh__D014197 Trees
% 218.27/218.47  |- mesh__dateCreated mesh__D014197 1999-01-01
% 218.27/218.47  |- skos__broader mesh__D014197smesh__D010944
% 218.27/218.47  |- mesh__publicMeSHNote mesh__D014197
% 218.27/218.47       ACACIA %26% EUCALYPTUS were headings 1963-85   
% 218.27/218.47  |- rdf__type mesh__D014197sskos__Concept
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D014197 2005
% 218.27/218.47  |- mesh__recordMaintainer mesh__D014197 ags
% 218.27/218.47  |- skos__hiddenLabel mesh__D008958 Molecular Model
% 218.27/218.47  |- mesh__publicMeSHNote mesh__D008958
% 218.27/218.47       84; was MOLECULAR MODELS see under MODELS, STRUCTURAL 1969-83%A%  
% 218.27/218.47  |- mesh__dateRevised mesh__D008958 2004-07-07
% 218.27/218.47  |- mesh__recordMaintainer mesh__D008958 nns
% 218.27/218.47  |- skos__scopeNote mesh__D008958
% 218.27/218.47       Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures.%A%    
% 218.27/218.47  |- mesh__historyNote mesh__D008958
% 218.27/218.47       84%28%75%29%; was MOLECULAR MODELS see under MODELS, STRUCTURAL 1969-83%A%  
% 218.27/218.47  |- skos__broader mesh__D008958smesh__D008962
% 218.27/218.47  |- mesh__onlineNote mesh__D008958
% 218.27/218.47       use MODELS, MOLECULAR to search MOLECULAR MODELS 1975-83; use MODELS, STRUCTURAL 1969-74%A%  
% 218.27/218.47  |- skos__annotation mesh__D008958
% 218.27/218.47       no qualif; TN 37: relation to MODELS, CHEMICAL; DF: MODELS MOL%A%  
% 218.27/218.47  |- skos__related mesh__D008958smesh__D008968
% 218.27/218.47  |- mesh__recordAuthorizer mesh__D008958 sjn
% 218.27/218.47  |- mesh__dateCreated mesh__D008958 1999-01-01
% 218.27/218.47  |- mesh__dateEstablished mesh__D008958 1984-01-01
% 218.27/218.47  |- skos__prefLabel mesh__D008958 Models, Molecular
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D008958 2006
% 218.27/218.47  |- skos__altLabel mesh__D008958 Molecular Models
% 218.27/218.47  |- skos__hiddenLabel mesh__D008958 Model, Molecular
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D008958 2005
% 218.27/218.47  |- rdf__type mesh__D008958sskos__Concept
% 218.27/218.47  |- mesh__recordOriginator mesh__D008958 NLM
% 218.27/218.47  |- skos__related mesh__D008958smesh__D015394
% 218.27/218.47  |- mesh__recordAuthorizer mesh__D000975 sjn
% 218.27/218.47  |- rdf__type mesh__D000975sskos__Concept
% 218.27/218.47  |- skos__prefLabel mesh__D000975 Antioxidants
% 218.27/218.47  |- skos__broader mesh__D000975smesh__D020011
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D000975 2006
% 218.27/218.47  |- mesh__recordMaintainer mesh__D000975 ssb
% 218.27/218.47  |- skos__related mesh__D000975smesh__D018384
% 218.27/218.47  |- skos__related mesh__D000975smesh__D010592
% 218.27/218.47  |- mesh__dateCreated mesh__D000975 1999-01-01
% 218.27/218.47  |- skos__broader mesh__D000975smesh__D045504
% 218.27/218.47  |- mesh__dateRevised mesh__D000975 2005-06-30
% 218.27/218.47  |- skos__scopeNote mesh__D000975
% 218.27/218.47       Naturally occurring or synthetic substances that inhibit or retard the oxidation of a substance to which it is added. They counteract the harmful and damaging effects of oxidation in animal tissues.%A%    
% 218.27/218.47  |- mesh__recordOriginator mesh__D000975 NLM
% 218.27/218.47  |- skos__historyNote mesh__D019680
% 218.27/218.47       Repetitive Sequences, Nucleic Acid %28%1981-1997%29%
% 218.27/218.47  |- mesh__recordOriginator mesh__D019680 NDW
% 218.27/218.47  |- skos__broader mesh__D019680smesh__D018911
% 218.27/218.47  |- skos__related mesh__D019680smesh__D009223
% 218.27/218.47  |- skos__hiddenLabel mesh__D019680 Repeat, Expanded Trinucleotide
% 218.27/218.47  |- skos__hiddenLabel mesh__D019680 Expansion, Trinucleotide Repeat
% 218.27/218.47  |- mesh__dateCreated mesh__D019680 1997-06-20
% 218.27/218.47  |- skos__scopeNote mesh__D019680
% 218.27/218.47       An increased number of contiguous trinucleotide repeats in the DNA sequence from one generation to the next. The presence of these regions is associated with diseases such as FRAGILE X SYNDROME and MYOTONIC DYSTROPHY. Some CHROMOSOME FRAGILE SITES are composed of sequences where trinucleotide repeat expansion occurs.%A%    
% 218.27/218.47  |- skos__broader mesh__D019680smesh__D042622
% 218.27/218.47  |- skos__hiddenLabel mesh__D019680 Trinucleotide Repeats, Expanded
% 218.27/218.47  |- skos__altLabel mesh__D019680 Expanded Trinucleotide Repeat
% 218.27/218.47  |- skos__hiddenLabel mesh__D019680 Repeats, Expanded Trinucleotide
% 218.27/218.47  |- skos__hiddenLabel mesh__D019680 Repeat Expansion, Trinucleotide
% 218.27/218.47  |- skos__related mesh__D019680smesh__D002873
% 218.27/218.47  |- skos__related mesh__D019680smesh__D005600
% 218.27/218.47  |- skos__hiddenLabel mesh__D019680 Repeat Expansions, Trinucleotide
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D019680 2006
% 218.27/218.47  |- skos__hiddenLabel mesh__D019680 Expanded Trinucleotide Repeats
% 218.27/218.47  |- skos__hiddenLabel mesh__D019680 Expansions, Trinucleotide Repeat
% 218.27/218.47  |- rdf__type mesh__D019680sskos__Concept
% 218.27/218.47  |- skos__related mesh__D019680smesh__D043283
% 218.27/218.47  |- mesh__dateEstablished mesh__D019680 1998-01-01
% 218.27/218.47  |- mesh__recordMaintainer mesh__D019680 nns
% 218.27/218.47  |- mesh__publicMeSHNote mesh__D019680
% 218.27/218.47       99; see DNA SEQUENCE, UNSTABLE 1998   
% 218.27/218.47  |- skos__related mesh__D019680smesh__D020132
% 218.27/218.47  |- mesh__recordAuthorizer mesh__D019680 sjn
% 218.27/218.47  |- skos__hiddenLabel mesh__D019680 Trinucleotide Repeat, Expanded
% 218.27/218.47  |- mesh__historyNote mesh__D019680 99%28%98%29%   
% 218.27/218.47  |- skos__prefLabel mesh__D019680 Trinucleotide Repeat Expansion
% 218.27/218.47  |- mesh__dateRevised mesh__D019680 2005-06-30
% 218.27/218.47  |- skos__hiddenLabel mesh__D019680 Trinucleotide Repeat Expansions
% 218.27/218.47  |- skos__scopeNote mesh__D000177
% 218.27/218.47       The cap-like structure covering the anterior portion of SPERM HEAD. Acrosome, derived from LYSOSOMES, is a membrane-bound organelle that contains the required hydrolytic and proteolytic enzymes necessary for sperm penetration of the egg in FERTILIZATION.%A%    
% 218.27/218.47  |- skos__broader mesh__D000177smesh__D008247
% 218.27/218.47  |- skos__related mesh__D000177smesh__D020101
% 218.27/218.47  |- mesh__activeMeSHYear mesh__D000177 2005
% 218.27/218.48  |- mesh__dateCreated mesh__D000177 1974-11-11
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D000177 2004
% 218.27/218.48  |- mesh__recordOriginator mesh__D000177 NLM
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D000177 2006
% 218.27/218.48  |- mesh__recordMaintainer mesh__D000177 nns
% 218.27/218.48  |- mesh__dateEstablished mesh__D000177 1991-01-01
% 218.27/218.48  |- mesh__recordAuthorizer mesh__D000177 sjn
% 218.27/218.48  |- skos__broader mesh__D000177smesh__D013077
% 218.27/218.48  |- skos__hiddenLabel mesh__D000177 Acrosomes
% 218.27/218.48  |- rdf__type mesh__D000177sskos__Concept
% 218.27/218.48  |- mesh__dateRevised mesh__D000177 2003-07-09
% 218.27/218.48  |- mesh__publicMeSHNote mesh__D000177
% 218.27/218.48       91; was see under SPERMATOZOA 1975-90   
% 218.27/218.48  |- skos__prefLabel mesh__D000177 Acrosome
% 218.27/218.48  |- mesh__historyNote mesh__D000177
% 218.27/218.48       91%28%75%29%; was see under SPERMATOZOA 1975-90   
% 218.27/218.48  |- mesh__recordOriginator mesh__D005660 NLM
% 218.27/218.48  |- skos__scopeNote mesh__D005660
% 218.27/218.48       A developmental anomaly in which the lower sternum is posteriorly dislocated and concavely deformed, resulting in a funnel-shaped thorax.%A%    
% 218.27/218.48  |- mesh__dateRevised mesh__D005660 1999-11-03
% 218.27/218.48  |- skos__broader mesh__D005660smesh__D009139
% 218.27/218.48  |- mesh__dateCreated mesh__D005660 1999-01-01
% 218.27/218.48  |- skos__hiddenLabel mesh__D005660 Chests, Funnel
% 218.27/218.48  |- mesh__recordMaintainer mesh__D005660 kle
% 218.27/218.48  |- rdf__type mesh__D005660sskos__Concept
% 218.27/218.48  |- skos__hiddenLabel mesh__D005660 Funnel Chests
% 218.27/218.48  |- mesh__recordAuthorizer mesh__D005660 sjn
% 218.27/218.48  |- skos__broader mesh__D005660smesh__D001848
% 218.27/218.48  |- skos__hiddenLabel mesh__D005660 Excavatum, Pectus
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D005660 2000
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D005660 2005
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D005660 2003
% 218.27/218.48  |- skos__prefLabel mesh__D005660 Funnel Chest
% 218.27/218.48  |- skos__altLabel mesh__D005660 Pectus Excavatum
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D005660 2006
% 218.27/218.48  |- skos__annotation mesh__D005660
% 218.27/218.48       a sternum abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D005660 2004
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D005660 2001
% 218.27/218.48  |- skos__hiddenLabel mesh__D005660 Chest, Funnel
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D005660 2002
% 218.27/218.48  |- skos__hiddenLabel mesh__D018588 Fees for Services
% 218.27/218.48  |- skos__scopeNote mesh__D018588
% 218.27/218.48       Method of charging whereby a physician or other practitioner bills for each encounter or service rendered. In addition to physicians, other health care professionals are reimbursed via this mechanism. Fee-for-service plans contrast with salary, per capita, and prepayment systems, where the payment does not change with the number of services actually used or if none are used. %28%From Discursive Dictionary of Health Care, 1976%29%%A%    
% 218.27/218.48  |- skos__hiddenLabel mesh__D018588 Reimbursements, Fee-for-Service
% 218.27/218.48  |- skos__prefLabel mesh__D018588 Fee-for-Service Plans
% 218.27/218.48  |- skos__hiddenLabel mesh__D018588 Services, Fees for
% 218.27/218.48  |- skos__hiddenLabel mesh__D018588 Fee for Services
% 218.27/218.48  |- mesh__onlineNote mesh__D018588
% 218.27/218.48       use FEES, MEDICAL to search FEE FOR SERVICE, MEDICAL 1982-94%A%  
% 218.27/218.48  |- skos__hiddenLabel mesh__D018588 Fee-for-Service Plan
% 218.27/218.48  |- skos__hiddenLabel mesh__D018588 Medical Fee-for-Services
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D018588 2004
% 218.27/218.48  |- skos__hiddenLabel mesh__D018588 Fee-for-Service Reimbursement
% 218.27/218.48  |- skos__broader mesh__D018588smesh__D011331
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D018588 2002
% 218.27/218.48  |- skos__hiddenLabel mesh__D018588 Fee for Service, Medical
% 218.27/218.48  |- rdf__type mesh__D018588sskos__Concept
% 218.27/218.48  |- skos__hiddenLabel mesh__D018588 Fee for Service Plans
% 218.27/218.48  |- mesh__recordMaintainer mesh__D018588 KEV
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D018588 2003
% 218.27/218.48  |- mesh__recordOriginator mesh__D018588 JLS
% 218.27/218.48  |- skos__hiddenLabel mesh__D018588 Plans, Fee-for-Service
% 218.27/218.48  |- skos__broader mesh__D018588smesh__D005249
% 218.27/218.48  |- skos__altLabel mesh__D018588 Fees for Service
% 218.27/218.48  |- skos__hiddenLabel mesh__D018588 Fee-for-Services, Medical
% 218.27/218.48  |- mesh__historyNote mesh__D018588
% 218.27/218.48       95; FEE FOR SERVICE, MEDICAL was see FEES, MEDICAL 1982-94%A%  
% 218.27/218.48  |- skos__hiddenLabel mesh__D018588 Service, Fees for
% 218.27/218.48  |- skos__hiddenLabel mesh__D018588 Fee-for-Service Reimbursements
% 218.27/218.48  |- mesh__dateRevised mesh__D018588 1999-11-08
% 218.27/218.48  |- mesh__dateEstablished mesh__D018588 1995-01-01
% 218.27/218.48  |- skos__altLabel mesh__D018588 Fee for Service
% 218.27/218.48  |- mesh__dateCreated mesh__D018588 1994-07-06
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D018588 2006
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D018588 2001
% 218.27/218.48  |- skos__hiddenLabel mesh__D018588 Medical Fee-for-Service
% 218.27/218.48  |- mesh__recordAuthorizer mesh__D018588 sjn
% 218.27/218.48  |- skos__hiddenLabel mesh__D018588 Services, Fee for
% 218.27/218.48  |- skos__hiddenLabel mesh__D018588 Reimbursement, Fee for Service
% 218.27/218.48  |- skos__broader mesh__D018588smesh__D012051
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D018588 2005
% 218.27/218.48  |- mesh__publicMeSHNote mesh__D018588
% 218.27/218.48       95; FEE FOR SERVICE, MEDICAL was see FEES, MEDICAL 1982-94%A%  
% 218.27/218.48  |- skos__historyNote mesh__D018588 Fees, Medical %28%1969-1994%29%
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D018588 2000
% 218.27/218.48  |- skos__hiddenLabel mesh__D018588 Plan, Fee-for-Service
% 218.27/218.48  |- skos__hiddenLabel mesh__D018588 Service, Fee for
% 218.27/218.48  |- skos__altLabel mesh__D037742 Carbon Nanotubes
% 218.27/218.48  |- skos__historyNote mesh__D037742 Carbon %28%1996-2002%29%
% 218.27/218.48  |- mesh__recordOriginator mesh__D037742 ssb
% 218.27/218.48  |- skos__altLabel mesh__D037742 Buckytubes
% 218.27/218.48  |- skos__annotation mesh__D037742
% 218.27/218.48       distinguish from protein MICROTUBULES and from nanotubes made of other chemicals such as peptides, boron, etc%A%  
% 218.27/218.48  |- skos__broader mesh__D037742smesh__D043942
% 218.27/218.48  |- skos__hiddenLabel mesh__D037742 Nanotube, Carbon
% 218.27/218.48  |- skos__hiddenLabel mesh__D037742 Carbon Nanotube
% 218.27/218.48  |- rdf__type mesh__D037742sskos__Concept
% 218.27/218.48  |- mesh__recordAuthorizer mesh__D037742 sjn
% 218.27/218.48  |- mesh__publicMeSHNote mesh__D037742 2003   
% 218.27/218.48  |- mesh__historyNote mesh__D037742 2003   
% 218.27/218.48  |- skos__broader mesh__D037742smesh__D037741
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D037742 2005
% 218.27/218.48  |- mesh__dateRevised mesh__D037742 2004-07-07
% 218.27/218.48  |- skos__prefLabel mesh__D037742 Nanotubes, Carbon
% 218.27/218.48  |- skos__scopeNote mesh__D037742
% 218.27/218.48       Nanometer-sized tubes composed mainly of CARBON.  Such nanotubes are used as probes for high-resolution structural and chemical imaging of biomolecules with ATOMIC FORCE MICROSCOPY.%A%    
% 218.27/218.48  |- mesh__recordMaintainer mesh__D037742 ssb
% 218.27/218.48  |- skos__hiddenLabel mesh__D037742 Buckytube
% 218.27/218.48  |- mesh__dateCreated mesh__D037742 2002-07-02
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D037742 2006
% 218.27/218.48  |- mesh__dateEstablished mesh__D037742 2003-01-01
% 218.27/218.48  |- skos__broader mesh__D004568smesh__D019937
% 218.27/218.48  |- skos__annotation mesh__D004568
% 218.27/218.48       IM; do not use /util except by MeSH definition   
% 218.27/218.48  |- mesh__dateCreated mesh__D004568 1999-01-01
% 218.27/218.48  |- mesh__recordOriginator mesh__D004568 NLM
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D004568 2003
% 218.27/218.48  |- mesh__recordMaintainer mesh__D004568 PXP
% 218.27/218.48  |- skos__scopeNote mesh__D004568
% 218.27/218.48       Diagnosis of disease states by recording the spontaneous electrical activity of tissues or organs or by the response to stimulation of electrically excitable tissue.%A%    
% 218.27/218.48  |- mesh__recordAuthorizer mesh__D004568 SJN
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D004568 2000
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D004568 2005
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D004568 2004
% 218.27/218.48  |- skos__prefLabel mesh__D004568 Electrodiagnosis
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D004568 2001
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D004568 2006
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D004568 1998
% 218.27/218.48  |- mesh__dateRevised mesh__D004568 1997-06-20
% 218.27/218.48  |- skos__hiddenLabel mesh__D004568 Electrodiagnoses
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D004568 1999
% 218.27/218.48  |- rdf__type mesh__D004568sskos__Concept
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D004568 2002
% 218.27/218.48  |- skos__hiddenLabel mesh__D015290 System, Second Messenger
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D015290 2000
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D015290 1999
% 218.27/218.48  |- skos__hiddenLabel mesh__D015290 Second Messenger, Intracellular
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D015290 2006
% 218.27/218.48  |- mesh__publicMeSHNote mesh__D015290 89   
% 218.27/218.48  |- skos__prefLabel mesh__D015290 Second Messenger Systems
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D015290 2001
% 218.27/218.48  |- skos__scopeNote mesh__D015290
% 218.27/218.48       Systems in which an intracellular signal is generated in response to an intercellular primary messenger such as a hormone or neurotransmitter. They are intermediate signals in cellular processes such as metabolism, secretion, contraction, phototransduction, and cell growth. Examples of second messenger systems are the adenyl cyclase-cyclic AMP system, the phosphatidylinositol diphosphate-inositol triphosphate system, and the cyclic GMP system.%A%    
% 218.27/218.48  |- mesh__recordOriginator mesh__D015290 RLS
% 218.27/218.48  |- mesh__recordAuthorizer mesh__D015290 PLS
% 218.27/218.48  |- skos__hiddenLabel mesh__D015290 Second Messengers, Intracellular
% 218.27/218.48  |- rdf__type mesh__D015290sskos__Concept
% 218.27/218.48  |- skos__annotation mesh__D015290
% 218.27/218.48       a metab concept; IM; coord with substance acting as the second messenger %28%IM%29% with /physiol or /antag as applicable; DF: SECOND MESSENGERS%A%  
% 218.27/218.48  |- skos__altLabel mesh__D015290 Intracellular Second Messengers
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D015290 2002
% 218.27/218.48  |- mesh__historyNote mesh__D015290 89   
% 218.27/218.48  |- skos__hiddenLabel mesh__D015290 Intracellular Second Messenger
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D015290 2003
% 218.27/218.48  |- mesh__dateCreated mesh__D015290 1988-05-24
% 218.27/218.48  |- skos__hiddenLabel mesh__D015290 Second Messenger System
% 218.27/218.48  |- skos__hiddenLabel mesh__D015290 Second Messenger
% 218.27/218.48  |- skos__hiddenLabel mesh__D015290 Systems, Second Messenger
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D015290 1997
% 218.27/218.48  |- mesh__recordMaintainer mesh__D015290 AGS
% 218.27/218.48  |- skos__broader mesh__D015290smesh__D015398
% 218.27/218.48  |- skos__hiddenLabel mesh__D015290 Messenger, Second
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D015290 2004
% 218.27/218.48  |- mesh__dateEstablished mesh__D015290 1989-01-01
% 218.27/218.48  |- skos__altLabel mesh__D015290 Second Messengers
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D015290 1998
% 218.27/218.48  |- skos__hiddenLabel mesh__D015290 Messengers, Second
% 218.27/218.48  |- skos__hiddenLabel mesh__D015290 Messengers, Intracellular Second
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D015290 2005
% 218.27/218.48  |- mesh__dateRevised mesh__D015290 1996-06-10
% 218.27/218.48  |- mesh__recordOriginator mesh__D009253 EC
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D009253 2005
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D009253 2004
% 218.27/218.48  |- mesh__publicMeSHNote mesh__D009253 88   
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D009253 2006
% 218.27/218.48  |- skos__prefLabel mesh__D009253 Naegleria
% 218.27/218.48  |- mesh__recordMaintainer mesh__D009253 ags
% 218.27/218.48  |- skos__scopeNote mesh__D009253
% 218.27/218.48       A free-living soil amoeba pathogenic to humans and animals. It occurs also in water and sewage. The most commonly found species in man is NAEGLERIA FOWLERI which is the pathogen for primary amebic meningoencephalitis in primates.%A%    
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D009253 2006A
% 218.27/218.48  |- skos__broader mesh__D009253smesh__D016847
% 218.27/218.48  |- mesh__recordAuthorizer mesh__D009253 ags
% 218.27/218.48  |- skos__historyNote mesh__D009253 Amoeba %28%1966-1987%29%
% 218.27/218.48  |- mesh__dateEstablished mesh__D009253 1988-01-01
% 218.27/218.48  |- skos__annotation mesh__D009253
% 218.27/218.48       pathogenic ameba in soil, water %26% sewage; infection: coord IM with AMEBIASIS %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 218.27/218.48  |- mesh__historyNote mesh__D009253 88   
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D009253 2006B
% 218.27/218.48  |- mesh__dateCreated mesh__D009253 1987-04-30
% 218.27/218.48  |- rdf__type mesh__D009253sskos__Concept
% 218.27/218.48  |- mesh__dateRevised mesh__D009253 2005-07-21
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D001270 2004
% 218.27/218.48  |- rdf__type mesh__D001270sskos__Concept
% 218.27/218.48  |- mesh__recordAuthorizer mesh__D001270 sjn
% 218.27/218.48  |- mesh__recordOriginator mesh__D001270 NLM
% 218.27/218.48  |- mesh__recordMaintainer mesh__D001270 mdb
% 218.27/218.48  |- skos__prefLabel mesh__D001270 Atlas
% 218.27/218.48  |- mesh__dateRevised mesh__D001270 2002-07-02
% 218.27/218.48  |- skos__annotation mesh__D001270
% 218.27/218.48       a bone; do not confuse with ATLASES, a bound volume of maps%A%  
% 218.27/218.48  |- skos__hiddenLabel mesh__D001270 Atla
% 218.27/218.48  |- skos__broader mesh__D001270smesh__D002574
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D001270 2005
% 218.27/218.48  |- mesh__dateCreated mesh__D001270 1999-01-01
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D001270 2003
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D001270 2006
% 218.27/218.48  |- skos__scopeNote mesh__D014996 A 5-carbon keto sugar.     
% 218.27/218.48  |- rdf__type mesh__D014996sskos__Concept
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D014996 2005
% 218.27/218.48  |- skos__historyNote mesh__D014996 Ketoses %28%1974%29%
% 218.27/218.48  |- mesh__publicMeSHNote mesh__D014996 91; was see under PENTOSES 1975-90   
% 218.27/218.48  |- mesh__recordMaintainer mesh__D014996 ssb
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D014996 2006
% 218.27/218.48  |- skos__historyNote mesh__D014996 Pentoses %28%1972-1974%29%
% 218.27/218.48  |- mesh__recordAuthorizer mesh__D014996 sjn
% 218.27/218.48  |- mesh__recordOriginator mesh__D014996 NLM
% 218.27/218.48  |- mesh__dateRevised mesh__D014996 2004-07-07
% 218.27/218.48  |- mesh__dateCreated mesh__D014996 1974-11-19
% 218.27/218.48  |- skos__historyNote mesh__D014996 Xylose %28%1974%29%
% 218.27/218.48  |- skos__prefLabel mesh__D014996 Xylulose
% 218.27/218.48  |- skos__broader mesh__D014996smesh__D010429
% 218.27/218.48  |- skos__broader mesh__D014996smesh__D007661
% 218.27/218.48  |- mesh__dateEstablished mesh__D014996 1991-01-01
% 218.27/218.48  |- skos__altLabel mesh__D014996 Lyxulose
% 218.27/218.48  |- mesh__historyNote mesh__D014996
% 218.27/218.48       91%28%75%29%; was see under PENTOSES 1975-90   
% 218.27/218.48  |- mesh__recordAuthorizer mesh__D014198 sjn
% 218.27/218.48  |- mesh__historyNote mesh__D014198 73%28%71%29%   
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D014198 2006
% 218.27/218.48  |- mesh__publicMeSHNote mesh__D014198 73   
% 218.27/218.48  |- mesh__recordOriginator mesh__D014198 NLM
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D014198 2005
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D014198 2004
% 218.27/218.48  |- mesh__dateRevised mesh__D014198 2003-07-09
% 218.27/218.48  |- mesh__recordMaintainer mesh__D014198 ssb
% 218.27/218.48  |- skos__scopeNote mesh__D014198
% 218.27/218.48       An enzyme that catalyzes the conversion of alpha,alpha-trehalose and water to D-glucose. EC 3.2.1.28.%A%    
% 218.27/218.48  |- mesh__dateEstablished mesh__D014198 1973-01-01
% 218.27/218.48  |- skos__historyNote mesh__D014198 Glycoside Hydrolases %28%1966-1970%29%
% 218.27/218.48  |- skos__prefLabel mesh__D014198 Trehalase
% 218.27/218.48  |- mesh__dateCreated mesh__D014198 1999-01-01
% 218.27/218.48  |- skos__annotation mesh__D014198 do not confuse with TREHALOSE   
% 218.27/218.48  |- rdf__type mesh__D014198sskos__Concept
% 218.27/218.48  |- skos__broader mesh__D014198smesh__D004186
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D008959 1999
% 218.27/218.48  |- skos__altLabel mesh__D008959 Neurological Model
% 218.27/218.48  |- mesh__recordOriginator mesh__D008959 NLM
% 218.27/218.48  |- mesh__recordAuthorizer mesh__D008959 PLS
% 218.27/218.48  |- skos__prefLabel mesh__D008959 Models, Neurological
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D008959 1998
% 218.27/218.48  |- skos__altLabel mesh__D008959 Neurological Models
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D008959 2002
% 218.27/218.48  |- skos__related mesh__D008959smesh__D007696
% 218.27/218.48  |- mesh__historyNote mesh__D008959 77; was MODELS, NEUROLOGIC 1968-76   
% 218.27/218.48  |- skos__annotation mesh__D008959
% 218.27/218.48       no qualif; TN 128: definition %26% relation to MODELS, THEORETICAL; DF: MODELS NEUROL%A%  
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D008959 2004
% 218.27/218.48  |- skos__altLabel mesh__D008959 Model, Neurological
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D008959 2001
% 218.27/218.48  |- mesh__dateCreated mesh__D008959 1999-01-01
% 218.27/218.48  |- mesh__dateRevised mesh__D008959 1995-05-18
% 218.27/218.48  |- mesh__recordMaintainer mesh__D008959 TAP
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D008959 2003
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D008959 2006
% 218.27/218.48  |- mesh__onlineNote mesh__D008959
% 218.27/218.48       use MODELS, NEUROLOGICAL to search MODELS, NEUROLOGIC 1968-76%A%  
% 218.27/218.48  |- skos__altLabel mesh__D008959 Neurologic Model
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D008959 2000
% 218.27/218.48  |- skos__scopeNote mesh__D008959
% 218.27/218.48       Theoretical representations that simulate the behavior or activity of the neurological system, processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment.%A%    
% 218.27/218.48  |- skos__historyNote mesh__D008959 Models, Theoretical %28%1966-1967%29%
% 218.27/218.48  |- skos__altLabel mesh__D008959 Neurologic Models
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D008959 2005
% 218.27/218.48  |- rdf__type mesh__D008959sskos__Concept
% 218.27/218.48  |- mesh__dateEstablished mesh__D008959 1968-01-01
% 218.27/218.48  |- skos__broader mesh__D008959smesh__D008954
% 218.27/218.48  |- skos__hiddenLabel mesh__D008959 Models, Neurologic
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D008959 1997
% 218.27/218.48  |- skos__hiddenLabel mesh__D008959 Model, Neurologic
% 218.27/218.48  |- mesh__publicMeSHNote mesh__D008959 77; was MODELS, NEUROLOGIC 1968-76   
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D008959 1996
% 218.27/218.48  |- mesh__recordOriginator mesh__D000976 RLS
% 218.27/218.48  |- mesh__dateCreated mesh__D000976 1979-05-23
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D000976 2005
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D000976 2001
% 218.27/218.48  |- rdf__type mesh__D000976sskos__Concept
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D000976 1998
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D000976 2003
% 218.27/218.48  |- mesh__historyNote mesh__D000976
% 218.27/218.48       91%28%80%29%; was see under OLIGOPEPTIDES 1980-90   
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D000976 2006
% 218.27/218.48  |- skos__annotation mesh__D000976
% 218.27/218.48       nothing to do with pain: a bacterial protease inhibitor   
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D000976 1996
% 218.27/218.48  |- skos__historyNote mesh__D000976 Protease Inhibitors %28%1979%29%
% 218.27/218.48  |- skos__prefLabel mesh__D000976 Antipain
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D000976 2002
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D000976 1999
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D000976 2004
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D000976 1997
% 218.27/218.48  |- skos__historyNote mesh__D000976
% 218.27/218.48       Peptide Peptidohydrolases/AI %28%1968-1978%29%
% 218.27/218.48  |- mesh__recordAuthorizer mesh__D000976 PLS
% 218.27/218.48  |- mesh__recordMaintainer mesh__D000976 JRT
% 218.27/218.48  |- skos__broader mesh__D000976smesh__D009842
% 218.27/218.48  |- skos__historyNote mesh__D000976 Peptides %28%1966-1972%29%
% 218.27/218.48  |- mesh__publicMeSHNote mesh__D000976
% 218.27/218.48       91; was see under OLIGOPEPTIDES 1980-90   
% 218.27/218.48  |- skos__scopeNote mesh__D000976
% 218.27/218.48       An oligopeptide produced by various bacteria which acts as a protease inhibitor.%A%    
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D000976 2000
% 218.27/218.48  |- mesh__dateEstablished mesh__D000976 1991-01-01
% 218.27/218.48  |- mesh__dateRevised mesh__D000976 1995-06-08
% 218.27/218.48  |- skos__historyNote mesh__D000976 Oligopeptides %28%1973-1979%29%
% 218.27/218.48  |- skos__historyNote mesh__D000976 Peptide Hydrolases/AI %28%1968-1978%29%
% 218.27/218.48  |- skos__annotation mesh__D019681
% 218.27/218.48       GEN or unspecified; prefer specifics; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D019681 2006
% 218.27/218.48  |- skos__scopeNote mesh__D019681
% 218.27/218.48       Gymnosperms are a group of vascular plants whose seeds are not enclosed by a ripened ovary %28%fruit%29%, in contrast to ANGIOSPERMS whose seeds are surrounded by an ovary wall. The seeds of many gymnosperms %28%literally, %22%naked seed%22%%29% are borne in cones and are not visible. Taxonomists now recognize four distinct divisions of extant gymnospermous plants %28%CONIFEROPHYTA; CYCADOPHYTA; GINKGOPHYTA; and GNETOPHYTA%29%.%A%    
% 218.27/218.48  |- rdf__type mesh__D019681sskos__Concept
% 218.27/218.48  |- mesh__historyNote mesh__D019681 98   
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D019681 2006A
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D019681 2003
% 218.27/218.48  |- mesh__recordAuthorizer mesh__D019681 ags
% 218.27/218.48  |- skos__broader mesh__D019681smesh__D019669
% 218.27/218.48  |- mesh__recordMaintainer mesh__D019681 ags
% 218.27/218.48  |- mesh__dateRevised mesh__D019681 2005-07-12
% 218.27/218.48  |- mesh__dateCreated mesh__D019681 1997-06-20
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D019681 2004
% 218.27/218.48  |- mesh__dateEstablished mesh__D019681 1998-01-01
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D019681 2005
% 218.27/218.48  |- mesh__publicMeSHNote mesh__D019681 98   
% 218.27/218.48  |- skos__prefLabel mesh__D019681 Gymnosperms
% 218.27/218.48  |- mesh__recordOriginator mesh__D019681 JLS
% 218.27/218.48  |- skos__scopeNote mesh__D000178
% 218.27/218.48       Colorless, odorless crystals that are used extensively in research laboratories for the preparation of polyacrylamide gels for electrophoresis and in organic synthesis, and polymerization. Some of its polymers are used in sewage and wastewater treatment, permanent press fabrics, and as soil conditioning agents.%A%    
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D000178 2004
% 218.27/218.48  |- mesh__recordMaintainer mesh__D000178 ADP
% 218.27/218.48  |- skos__historyNote mesh__D000178 Acrylates %28%1966-1970%29%
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D000178 2006
% 218.27/218.48  |- mesh__publicMeSHNote mesh__D000178 73   
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D000178 2000
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D000178 1999
% 218.27/218.48  |- mesh__dateRevised mesh__D000178 1998-06-10
% 218.27/218.48  |- mesh__dateEstablished mesh__D000178 1973-01-01
% 218.27/218.48  |- skos__annotation mesh__D000178 ACRYLAMIDE is also available   
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D000178 2001
% 218.27/218.48  |- skos__broader mesh__D000178smesh__D000577
% 218.27/218.48  |- skos__prefLabel mesh__D000178 Acrylamides
% 218.27/218.48  |- skos__broader mesh__D000178smesh__D000179
% 218.27/218.48  |- mesh__recordOriginator mesh__D000178 NLM
% 218.27/218.48  |- rdf__type mesh__D000178sskos__Concept
% 218.27/218.48  |- mesh__dateCreated mesh__D000178 1999-01-01
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D000178 2002
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D000178 2003
% 218.27/218.48  |- mesh__recordAuthorizer mesh__D000178 SJN
% 218.27/218.48  |- mesh__historyNote mesh__D000178 73%28%71%29%   
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D000178 2005
% 218.27/218.48  |- skos__prefLabel mesh__D005661 Furagin
% 218.27/218.48  |- skos__scopeNote mesh__D005661
% 218.27/218.48       Nitrofuran derivative anti-infective agent used for urinary tract infections.%A%    
% 218.27/218.48  |- mesh__dateCreated mesh__D005661 1977-04-22
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D005661 2002
% 218.27/218.48  |- skos__broader mesh__D005661smesh__D009581
% 218.27/218.48  |- skos__historyNote mesh__D005661 Hydantoins %28%1966-1977%29%
% 218.27/218.48  |- rdf__type mesh__D005661sskos__Concept
% 218.27/218.48  |- mesh__historyNote mesh__D005661
% 218.27/218.48       91%28%78%29%; was see under NITROFURANS 1978-90   
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D005661 2005
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D005661 2003
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D005661 2006
% 218.27/218.48  |- mesh__recordMaintainer mesh__D005661 jmp
% 218.27/218.48  |- mesh__dateRevised mesh__D005661 2000-06-22
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D005661 2004
% 218.27/218.48  |- mesh__recordAuthorizer mesh__D005661 sjn
% 218.27/218.48  |- skos__historyNote mesh__D005661 Nitrofurans %28%1966-1977%29%
% 218.27/218.48  |- mesh__dateEstablished mesh__D005661 1991-01-01
% 218.27/218.48  |- mesh__recordOriginator mesh__D005661 SH
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D005661 2001
% 218.27/218.48  |- mesh__publicMeSHNote mesh__D005661
% 218.27/218.48       91; was see under NITROFURANS 1978-90   
% 218.27/218.48  |- skos__hiddenLabel mesh__D018589 Stases, Gastric
% 218.27/218.48  |- skos__broader mesh__D018589smesh__D010243
% 218.27/218.48  |- mesh__recordMaintainer mesh__D018589 lkt
% 218.27/218.48  |- mesh__dateCreated mesh__D018589 1994-04-19
% 218.27/218.48  |- mesh__dateRevised mesh__D018589 2004-07-07
% 218.27/218.48  |- rdf__type mesh__D018589sskos__Concept
% 218.27/218.48  |- skos__hiddenLabel mesh__D018589 Gastric Stases
% 218.27/218.48  |- skos__broader mesh__D018589smesh__D013272
% 218.27/218.48  |- skos__prefLabel mesh__D018589 Gastroparesis
% 218.27/218.48  |- skos__altLabel mesh__D018589 Gastric Stasis
% 218.27/218.48  |- mesh__dateEstablished mesh__D018589 1995-01-01
% 218.27/218.48  |- skos__hiddenLabel mesh__D018589 Gastropareses
% 218.27/218.48  |- skos__historyNote mesh__D018589 Stomach Diseases %28%1966-1994%29%
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D018589 2005
% 218.27/218.48  |- mesh__recordOriginator mesh__D018589 JLS
% 218.27/218.48  |- mesh__historyNote mesh__D018589 95   
% 218.27/218.48  |- skos__hiddenLabel mesh__D018589 Stasis, Gastric
% 218.27/218.48  |- mesh__publicMeSHNote mesh__D018589 95   
% 218.27/218.48  |- mesh__recordAuthorizer mesh__D018589 sjn
% 218.27/218.48  |- skos__scopeNote mesh__D018589
% 218.27/218.48       Chronic delayed gastric emptying. Gastroparesis may be caused by motor dysfunction or paralysis of  STOMACH muscles or may be associated with other systemic diseases such as DIABETES MELLITUS.%A%    
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D018589 2006
% 218.27/218.48  |- mesh__recordOriginator mesh__D004569 NLM
% 218.27/218.48  |- skos__broader mesh__D004569smesh__D004568
% 218.27/218.48  |- skos__hiddenLabel mesh__D004569 Electroencephalograms
% 218.27/218.48  |- mesh__recordAuthorizer mesh__D004569 SJN
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D004569 2000
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D004569 2003
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D004569 2001
% 218.27/218.48  |- skos__annotation mesh__D004569
% 218.27/218.48       /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: note short X ref%A%  
% 218.27/218.48  |- mesh__recordMaintainer mesh__D004569 PXP
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D004569 2005
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D004569 2004
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D004569 1998
% 218.27/218.48  |- mesh__dateRevised mesh__D004569 1997-06-20
% 218.27/218.48  |- skos__broader mesh__D004569smesh__D003943
% 218.27/218.48  |- skos__prefLabel mesh__D004569 Electroencephalography
% 218.27/218.48  |- skos__scopeNote mesh__D004569
% 218.27/218.48       Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain.%A%    
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D004569 2006
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D004569 1999
% 218.27/218.48  |- rdf__type mesh__D004569sskos__Concept
% 218.27/218.48  |- skos__altLabel mesh__D004569 EEG
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D004569 2002
% 218.27/218.48  |- mesh__dateCreated mesh__D004569 1999-01-01
% 218.27/218.48  |- skos__hiddenLabel mesh__D015291 Growth Factor, Transforming
% 218.27/218.48  |- mesh__recordAuthorizer mesh__D015291 sjn
% 218.27/218.48  |- mesh__historyNote mesh__D015291 89   
% 218.27/218.48  |- skos__historyNote mesh__D015291 Growth Substances %28%1966-1988%29%
% 218.27/218.48  |- skos__prefLabel mesh__D015291 Transforming Growth Factors
% 218.27/218.48  |- skos__scopeNote mesh__D015291
% 218.27/218.48       Hormonally active polypeptides that can induce the transformed phenotype when added to normal, non-transformed cells. They have been found in culture fluids from retrovirally transformed cells and in tumor-derived cells as well as in non-neoplastic sources. Their transforming activities are due to the simultaneous action of two otherwise unrelated factors, TRANSFORMING GROWTH FACTOR ALPHA and TRANSFORMING GROWTH FACTOR BETA.%A%    
% 218.27/218.48  |- skos__annotation mesh__D015291
% 218.27/218.48       GEN or unspecified; prefer specifics; /drug eff permitted%A%  
% 218.27/218.48  |- mesh__dateCreated mesh__D015291 1988-05-24
% 218.27/218.48  |- mesh__activeMeSHYear mesh__D015291 2006
% 218.27/218.48  |- mesh__recordMaintainer mesh__D015291 ssb
% 218.27/218.48  |- skos__hiddenLabel mesh__D015291 Factors, Transforming Growth
% 218.27/218.48  |- skos__altLabel mesh__D015291 Transforming Growth Factor
% 218.27/218.48  |- skos__hiddenLabel mesh__D015291 Factor, Transforming Growth
% 218.27/218.48  |- mesh__dateRevised mesh__D015291 2005-06-30
% 218.27/218.49  |- skos__broader mesh__D015291smesh__D036341
% 218.27/218.49  |- mesh__recordOriginator mesh__D015291 RLS
% 218.27/218.49  |- skos__broader mesh__D015291smesh__D006133
% 218.27/218.49  |- skos__historyNote mesh__D015291 Peptides %28%1966-1988%29%
% 218.27/218.49  |- mesh__publicMeSHNote mesh__D015291 89   
% 218.27/218.49  |- mesh__dateEstablished mesh__D015291 1989-01-01
% 218.27/218.49  |- rdf__type mesh__D015291sskos__Concept
% 218.27/218.49  |- skos__hiddenLabel mesh__D015291 Growth Factors, Transforming
% 218.27/218.49  |- skos__prefLabel mesh__D009254 Nafcillin
% 218.27/218.49  |- mesh__dateEstablished mesh__D009254 1968-01-01
% 218.27/218.49  |- mesh__recordMaintainer mesh__D009254 ssb
% 218.27/218.49  |- mesh__recordOriginator mesh__D009254 NLM
% 218.27/218.49  |- skos__altLabel mesh__D009254 Sodium Nafcillin
% 218.27/218.49  |- skos__hiddenLabel mesh__D009254 Sodium, Nafcillin
% 218.27/218.49  |- mesh__dateCreated mesh__D009254 1999-01-01
% 218.27/218.49  |- mesh__publicMeSHNote mesh__D009254 68   
% 218.27/218.49  |- mesh__dateRevised mesh__D009254 2004-07-07
% 218.27/218.49  |- mesh__historyNote mesh__D009254 68%28%65%29%   
% 218.27/218.49  |- skos__broader mesh__D009254smesh__D010406
% 218.27/218.49  |- rdf__type mesh__D009254sskos__Concept
% 218.27/218.49  |- skos__scopeNote mesh__D009254
% 218.27/218.49       A semi-synthetic antibiotic related to penicillin.     
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D009254 2005
% 218.27/218.49  |- skos__altLabel mesh__D009254 Naphthamidopenicillin
% 218.27/218.49  |- skos__altLabel mesh__D009254 Nafcillin, Monosodium Salt, Anhydrous
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D009254 2006
% 218.27/218.49  |- skos__hiddenLabel mesh__D009254 Nafcillin, Sodium
% 218.27/218.49  |- mesh__recordAuthorizer mesh__D009254 sjn
% 218.27/218.49  |- skos__broader mesh__D001271smesh__D012013
% 218.27/218.49  |- mesh__recordMaintainer mesh__D001271 mdb
% 218.27/218.49  |- skos__annotation mesh__D001271
% 218.27/218.49       a cataloging term; do not confuse with ATLAS, a bone; use for geographic atlases only: anatomical atlases go under MEDICAL ILLUSTRATION %28%IM%29% + ANATOMY, ARTISTIC %28%IM%29%%A%  
% 218.27/218.49  |- mesh__recordAuthorizer mesh__D001271 sjn
% 218.27/218.49  |- mesh__recordOriginator mesh__D001271 NLM
% 218.27/218.49  |- skos__prefLabel mesh__D001271 Atlases
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D001271 2005
% 218.27/218.49  |- mesh__dateCreated mesh__D001271 1999-01-01
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D001271 2003
% 218.27/218.49  |- mesh__dateRevised mesh__D001271 2002-07-02
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D001271 2006
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D001271 2004
% 218.27/218.49  |- rdf__type mesh__D001271sskos__Concept
% 218.27/218.49  |- skos__historyNote mesh__D014997
% 218.27/218.49       Sex Chromosome Abnormalities %28%1968-1977%29%
% 218.27/218.49  |- skos__prefLabel mesh__D014997 XYY Karyotype
% 218.27/218.49  |- mesh__dateRevised mesh__D014997 2004-07-13
% 218.27/218.49  |- mesh__historyNote mesh__D014997
% 218.27/218.49       91%28%78%29%; was see under SEX CHROMOSOME ABNORMALITIES 1978-90%A%  
% 218.27/218.49  |- skos__historyNote mesh__D014997
% 218.27/218.49       Chromosome Abnormalities %28%1966-1967%29%
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D014997 2005
% 218.27/218.49  |- mesh__recordMaintainer mesh__D014997 sjn
% 218.27/218.49  |- mesh__dateCreated mesh__D014997 1977-04-22
% 218.27/218.49  |- mesh__recordAuthorizer mesh__D014997 sjn
% 218.27/218.49  |- skos__broader mesh__D014997smesh__D012729
% 218.27/218.49  |- skos__hiddenLabel mesh__D014997 Karyotypes, XYY
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D014997 2006
% 218.27/218.49  |- skos__scopeNote mesh__D014997
% 218.27/218.49       Abnormal genetic constitution in males characterized by an extra Y chromosome.%A%    
% 218.27/218.49  |- skos__annotation mesh__D014997
% 218.27/218.49        do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; check the tags  HUMANS %26% MALE%A%  
% 218.27/218.49  |- mesh__publicMeSHNote mesh__D014997
% 218.27/218.49       91; was see under SEX CHROMOSOME ABNORMALITIES 1978-90   
% 218.27/218.49  |- mesh__dateEstablished mesh__D014997 1991-01-01
% 218.27/218.49  |- mesh__recordOriginator mesh__D014997 AEP
% 218.27/218.49  |- skos__hiddenLabel mesh__D014997 XYY Karyotypes
% 218.27/218.49  |- skos__hiddenLabel mesh__D014997 Karyotype, XYY
% 218.27/218.49  |- rdf__type mesh__D014997sskos__Concept
% 218.27/218.49  |- mesh__dateEstablished mesh__D014199 1991-01-01
% 218.27/218.49  |- mesh__publicMeSHNote mesh__D014199
% 218.27/218.49       91; was see under DISACCHARIDES 1973-90   
% 218.27/218.49  |- skos__annotation mesh__D014199
% 218.27/218.49       called ergot sugar %26% mycose; do not confuse with TREHALASE%A%  
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D014199 2006
% 218.27/218.49  |- mesh__dateRevised mesh__D014199 2004-07-07
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D014199 2005
% 218.27/218.49  |- mesh__recordAuthorizer mesh__D014199 sjn
% 218.27/218.49  |- skos__prefLabel mesh__D014199 Trehalose
% 218.27/218.49  |- mesh__historyNote mesh__D014199
% 218.27/218.49       91%28%73%29%; was see under DISACCHARIDES 1973-90   
% 218.27/218.49  |- mesh__recordMaintainer mesh__D014199 jmp
% 218.27/218.49  |- mesh__recordOriginator mesh__D014199 NLM
% 218.27/218.49  |- mesh__dateCreated mesh__D014199 1999-01-01
% 218.27/218.49  |- rdf__type mesh__D014199sskos__Concept
% 218.27/218.49  |- skos__broader mesh__D014199smesh__D005936
% 218.27/218.49  |- skos__broader mesh__D014199smesh__D004187
% 218.27/218.49  |- rdf__type mesh__D000977sskos__Concept
% 218.27/218.49  |- mesh__dateCreated mesh__D000977 1999-01-01
% 218.27/218.49  |- skos__prefLabel mesh__D000977 Antiparasitic Agents
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D000977 2006
% 218.27/218.49  |- mesh__dateRevised mesh__D000977 2003-07-09
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D000977 2004
% 218.27/218.49  |- skos__broader mesh__D000977smesh__D000890
% 218.27/218.49  |- skos__hiddenLabel mesh__D000977 Agents, Antiparasitic
% 218.27/218.49  |- skos__altLabel mesh__D000977 Antiparasitics
% 218.27/218.49  |- mesh__onlineNote mesh__D000977
% 218.27/218.49       use ANTIPROTOZOAL AGENTS to search PARASITICIDES 1966   
% 218.27/218.49  |- skos__altLabel mesh__D000977 Antiparasitic Drugs
% 218.27/218.49  |- mesh__recordOriginator mesh__D000977 NLM
% 218.27/218.49  |- skos__hiddenLabel mesh__D000977 Drugs, Antiparasitic
% 218.27/218.49  |- mesh__recordMaintainer mesh__D000977 ssb
% 218.27/218.49  |- mesh__historyNote mesh__D000977
% 218.27/218.49       96; was NON MESH 1967-95; PARASITICIDES was heading 1963-66%A%  
% 218.27/218.49  |- mesh__recordAuthorizer mesh__D000977 sjn
% 218.27/218.49  |- skos__scopeNote mesh__D000977
% 218.27/218.49       Drugs used to treat or prevent parasitic infections.     
% 218.27/218.49  |- mesh__dateEstablished mesh__D000977 1996-01-01
% 218.27/218.49  |- mesh__publicMeSHNote mesh__D000977
% 218.27/218.49       96; PARASITICIDES was heading 1963-66   
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D000977 2005
% 218.27/218.49  |- skos__altLabel mesh__D000977 Parasiticides
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D000179 2004
% 218.27/218.49  |- mesh__dateCreated mesh__D000179 1999-01-01
% 218.27/218.49  |- mesh__historyNote mesh__D000179 66   
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D000179 1997
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D000179 2000
% 218.27/218.49  |- mesh__publicMeSHNote mesh__D000179 66   
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D000179 2003
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D000179 1993
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D000179 1996
% 218.27/218.49  |- mesh__recordMaintainer mesh__D000179 TAP
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D000179 2006
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D000179 1999
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D000179 2002
% 218.27/218.49  |- skos__broader mesh__D000179smesh__D000144
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D000179 1995
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D000179 2005
% 218.27/218.49  |- mesh__dateEstablished mesh__D000179 1966-01-01
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D000179 1998
% 218.27/218.49  |- mesh__dateRevised mesh__D000179 1992-05-07
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D000179 1994
% 218.27/218.49  |- mesh__recordAuthorizer mesh__D000179 PLS
% 218.27/218.49  |- rdf__type mesh__D000179sskos__Concept
% 218.27/218.49  |- skos__prefLabel mesh__D000179 Acrylates
% 218.27/218.49  |- mesh__recordOriginator mesh__D000179 NLM
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D000179 2001
% 218.27/218.49  |- mesh__recordMaintainer mesh__D005662 TGC
% 218.27/218.49  |- skos__altLabel mesh__D005662 Furfural
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D005662 2003
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D005662 1997
% 218.27/218.49  |- mesh__recordAuthorizer mesh__D005662 PLS
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D005662 2006
% 218.27/218.49  |- skos__broader mesh__D005662smesh__D000447
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D005662 2000
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D005662 2004
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D005662 2001
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D005662 1994
% 218.27/218.49  |- skos__broader mesh__D005662smesh__D005663
% 218.27/218.49  |- skos__prefLabel mesh__D005662 Furaldehyde
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D005662 2002
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D005662 1995
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D005662 1998
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D005662 1993
% 218.27/218.49  |- mesh__dateCreated mesh__D005662 1999-01-01
% 218.27/218.49  |- mesh__recordOriginator mesh__D005662 NLM
% 218.27/218.49  |- rdf__type mesh__D005662sskos__Concept
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D005662 1996
% 218.27/218.49  |- mesh__dateRevised mesh__D005662 1992-05-19
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D005662 2005
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D005662 1999
% 218.27/218.49  |- mesh__dateEstablished mesh__D015292 1989-01-01
% 218.27/218.49  |- skos__historyNote mesh__D015292
% 218.27/218.49       Gonadotropins, Chorionic %28%1972-1988%29%
% 218.27/218.49  |- skos__hiddenLabel mesh__D015292 HCG alpha
% 218.27/218.49  |- mesh__activeMeSHYear mesh__D015292 2004
% 218.27/218.49  |- mesh__recordMaintainer mesh__D015292 lkt
% 218.27/218.49  |- skos__altLabel mesh__D015292
% 218.27/218.49       Pituitary Glycoprotein Hormone, alpha Subunit
% 218.27/218.49  |- skos__hiddenLabel mesh__D015292 LH alpha
% 218.27/218.49  |- skos__hiddenLabel mesh__D015292 TSH alpha
% 218.27/218.49  |- skos__altLabel mesh__D015292 Common alpha Subunit Glycoprotein Hormones
% 218.27/218.49  |- skos__hiddenLabel mesh__D015292
% 218.27/218.49       Thyroid Stimulating Hormone, alpha Subunit
% 218.27/218.49  |- skos__historyNote mesh__D015292 Menotropins %28%1973-1988%29%
% 218.27/218.49  |- skos__altLabel mesh__D015292 Follicle Stimulating Hormone, alpha Subunit
% 218.27/218.49  |- skos__historyNote mesh__D015292 FSH %28%1972-1988%29%
% 218.34/218.49  |- skos__altLabel mesh__D015292 Chorionic Gonadotropin, alpha
% 218.34/218.49  |- skos__hiddenLabel mesh__D015292 FSH alpha
% 218.34/218.49  |- skos__altLabel mesh__D015292 LH, alpha Subunit
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D015292 2005
% 218.34/218.49  |- skos__hiddenLabel mesh__D015292 Lutotropin alpha
% 218.34/218.49  |- skos__broader mesh__D015292smesh__D006063
% 218.34/218.49  |- skos__historyNote mesh__D015292 Thyrotropin %28%1972-1988%29%
% 218.34/218.49  |- skos__prefLabel mesh__D015292 Glycoprotein Hormones, alpha Subunit
% 218.34/218.49  |- skos__altLabel mesh__D015292 ASGPH
% 218.34/218.49  |- rdf__type mesh__D015292sskos__Concept
% 218.34/218.49  |- skos__historyNote mesh__D015292
% 218.34/218.49       Pituitary Hormones, Anterior %28%1972-1988%29%
% 218.34/218.49  |- skos__altLabel mesh__D015292 Follicle-Stimulating Hormone, alpha Subunit
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D015292 2006
% 218.34/218.49  |- skos__historyNote mesh__D015292 LH %28%1972-1988%29%
% 218.34/218.49  |- mesh__dateCreated mesh__D015292 1988-05-24
% 218.34/218.49  |- skos__altLabel mesh__D015292 Chorionic Gonadotropin, alpha Subunit
% 218.34/218.49  |- mesh__publicMeSHNote mesh__D015292 1989   
% 218.34/218.49  |- skos__altLabel mesh__D015292 FSH-alpha
% 218.34/218.49  |- skos__altLabel mesh__D015292 LH-alpha
% 218.34/218.49  |- skos__altLabel mesh__D015292 HCG, alpha Subunit
% 218.34/218.49  |- skos__hiddenLabel mesh__D015292 CG alpha
% 218.34/218.49  |- skos__annotation mesh__D015292
% 218.34/218.49       DF: GPHAS; coord with THYROTROPIN, FOLLICLE STIMULATING HORMONE, LUTEINIZING HORMONE or CHORIONIC GONADOTROPIN if particularly discussed%A%  
% 218.34/218.49  |- skos__altLabel mesh__D015292 Glycoprotein Hormones, alpha Polypeptide
% 218.34/218.49  |- skos__altLabel mesh__D015292 TSH, alpha Subunit
% 218.34/218.49  |- skos__altLabel mesh__D015292 HCG-alpha
% 218.34/218.49  |- skos__altLabel mesh__D015292 Luteinizing Hormone, alpha Subunit
% 218.34/218.49  |- skos__broader mesh__D015292smesh__D013972
% 218.34/218.49  |- skos__altLabel mesh__D015292 Thyroid-Stimulating Hormone, alpha Subunit
% 218.34/218.49  |- skos__scopeNote mesh__D015292
% 218.34/218.49       The alpha chain of pituitary glycoprotein hormones %28%THYROTROPIN; FOLLICLE STIMULATING HORMONE; LUTEINIZING HORMONE%29% and the placental CHORIONIC GONADOTROPIN. Within a species, the alpha subunits of these four hormones are identical; the distinct functional characteristics of these glycoprotein hormones are determined by the unique beta subunits. Both subunits, the non-covalently bound heterodimers, are required for full biologic activity.%A%    
% 218.34/218.49  |- skos__altLabel mesh__D015292 CG-alpha
% 218.34/218.49  |- skos__altLabel mesh__D015292 TSH-alpha
% 218.34/218.49  |- mesh__recordAuthorizer mesh__D015292 sjn
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D015292 2003
% 218.34/218.49  |- skos__altLabel mesh__D015292 Lutotropin-alpha
% 218.34/218.49  |- skos__broader mesh__D015292smesh__D007986
% 218.34/218.49  |- skos__broader mesh__D015292smesh__D005640
% 218.34/218.49  |- mesh__dateRevised mesh__D015292 2002-07-02
% 218.34/218.49  |- skos__historyNote mesh__D015292
% 218.34/218.49       Gonadotropins, Pituitary %28%1972-1988%29%
% 218.34/218.49  |- mesh__recordOriginator mesh__D015292 RLS
% 218.34/218.49  |- skos__altLabel mesh__D015292 Glycoprotein Hormones, alpha Chain
% 218.34/218.49  |- skos__altLabel mesh__D015292 FSH, alpha Subunit
% 218.34/218.49  |- mesh__historyNote mesh__D015292 1989   
% 218.34/218.49  |- skos__altLabel mesh__D015292 Thyrotropin alpha Subunit
% 218.34/218.49  |- mesh__publicMeSHNote mesh__D009255
% 218.34/218.49       91; was see under PROPIONATES 1973-90   
% 218.34/218.49  |- mesh__dateRevised mesh__D009255 2000-06-21
% 218.34/218.49  |- mesh__recordMaintainer mesh__D009255 CCR
% 218.34/218.49  |- mesh__dateCreated mesh__D009255 1999-01-01
% 218.34/218.49  |- mesh__recordAuthorizer mesh__D009255 sjn
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D009255 2002
% 218.34/218.49  |- skos__altLabel mesh__D009255 Nafenoic Acid
% 218.34/218.49  |- skos__altLabel mesh__D009255 Melipan
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D009255 2003
% 218.34/218.49  |- mesh__dateEstablished mesh__D009255 1991-01-01
% 218.34/218.49  |- rdf__type mesh__D009255sskos__Concept
% 218.34/218.49  |- skos__historyNote mesh__D009255
% 218.34/218.49       Anticholesteremic Agents %28%1966-1972%29%
% 218.34/218.49  |- mesh__recordOriginator mesh__D009255 NLM
% 218.34/218.49  |- skos__prefLabel mesh__D009255 Nafenopin
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D009255 2004
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D009255 2005
% 218.34/218.49  |- skos__historyNote mesh__D009255 Propionates %28%1966-1972%29%
% 218.34/218.49  |- skos__historyNote mesh__D009255 Antilipemic Agents %28%1966-1972%29%
% 218.34/218.49  |- skos__hiddenLabel mesh__D009255 SU13,437
% 218.34/218.49  |- mesh__historyNote mesh__D009255
% 218.34/218.49       91%28%73%29%; was see under PROPIONATES 1973-90   
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D009255 2006
% 218.34/218.49  |- skos__hiddenLabel mesh__D009255 CH 13437
% 218.34/218.49  |- skos__hiddenLabel mesh__D009255 SU 13,437
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D009255 2001
% 218.34/218.49  |- skos__scopeNote mesh__D009255
% 218.34/218.49       A peroxisome proliferator that is used experimentally to promote liver tumors. It has been used as an antihyperlipoproteinemic agent.%A%    
% 218.34/218.49  |- skos__broader mesh__D009255smesh__D011426
% 218.34/218.49  |- skos__hiddenLabel mesh__D009255 Acid, Nafenoic
% 218.34/218.49  |- skos__hiddenLabel mesh__D009255 CH13437
% 218.34/218.49  |- mesh__publicMeSHNote mesh__D001272 74   
% 218.34/218.49  |- skos__historyNote mesh__D001272 Air %28%1966-1971%29%
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D001272 2005
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D001272 1998
% 218.34/218.49  |- skos__historyNote mesh__D001272
% 218.34/218.49       Extraterrestrial Environment %28%1966-1971%29%
% 218.34/218.49  |- skos__annotation mesh__D001272 /anal /chem permitted   
% 218.34/218.49  |- rdf__type mesh__D001272sskos__Concept
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D001272 2002
% 218.34/218.49  |- skos__scopeNote mesh__D001272
% 218.34/218.49       The gaseous envelope surrounding a planet or similar body. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 218.34/218.49  |- mesh__historyNote mesh__D001272 74%28%72%29%   
% 218.34/218.49  |- mesh__dateEstablished mesh__D001272 1974-01-01
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D001272 2001
% 218.34/218.49  |- skos__hiddenLabel mesh__D001272 Atmospheres
% 218.34/218.49  |- skos__broader mesh__D001272smesh__D008685
% 218.34/218.49  |- mesh__dateCreated mesh__D001272 1999-01-01
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D001272 2000
% 218.34/218.49  |- mesh__recordOriginator mesh__D001272 NLM
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D001272 2004
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D001272 2006
% 218.34/218.49  |- skos__prefLabel mesh__D001272 Atmosphere
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D001272 1999
% 218.34/218.49  |- mesh__recordMaintainer mesh__D001272 JLS
% 218.34/218.49  |- mesh__dateRevised mesh__D001272 1997-06-20
% 218.34/218.49  |- mesh__recordAuthorizer mesh__D001272 SJN
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D001272 2003
% 218.34/218.49  |- mesh__dateCreated mesh__D014998 1977-04-29
% 218.34/218.49  |- skos__historyNote mesh__D014998 Sex Chromosomes %28%1968-1977%29%
% 218.34/218.49  |- skos__hiddenLabel mesh__D014998 Chromosomes, Y
% 218.34/218.49  |- skos__historyNote mesh__D014998 Karyotyping %28%1967%29%
% 218.34/218.49  |- mesh__recordMaintainer mesh__D014998 lkt
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D014998 2006
% 218.34/218.49  |- mesh__historyNote mesh__D014998
% 218.34/218.49       84%28%78%29%; was see under SEX CHROMOSOMES 1968-83   
% 218.34/218.49  |- mesh__dateRevised mesh__D014998 2005-06-30
% 218.34/218.49  |- skos__broader mesh__D014998smesh__D012730
% 218.34/218.49  |- skos__scopeNote mesh__D014998
% 218.34/218.49       The male sex chromosome, being the differential sex chromosome carried by half the male gametes and none of the female gametes in humans and in some other male-heterogametic species in which the homologue of the X chromosome has been retained.%A%    
% 218.34/218.49  |- mesh__recordAuthorizer mesh__D014998 sjn
% 218.34/218.49  |- mesh__recordOriginator mesh__D014998 VDK
% 218.34/218.49  |- mesh__onlineNote mesh__D014998 search SEX CHROMOSOMES 1968-77   
% 218.34/218.49  |- skos__prefLabel mesh__D014998 Y Chromosome
% 218.34/218.49  |- skos__annotation mesh__D014998
% 218.34/218.49       abnormalities; coordinate IM with SEX CHROMOSOME ABERRATIONS %28%IM%29% or specific disease %28%IM%29% + SEX CHROMOSOME ABERRATIONS %28%NIM%29%; Y CHROMOSOME, HUMAN is also available%A%  
% 218.34/218.49  |- mesh__dateEstablished mesh__D014998 1984-01-01
% 218.34/218.49  |- skos__historyNote mesh__D014998 Chromosomes %28%1966-1967%29%
% 218.34/218.49  |- rdf__type mesh__D014998sskos__Concept
% 218.34/218.49  |- skos__hiddenLabel mesh__D014998 Y Chromosomes
% 218.34/218.49  |- skos__hiddenLabel mesh__D014998 Chromosome, Y
% 218.34/218.49  |- mesh__publicMeSHNote mesh__D014998
% 218.34/218.49       84; was see under SEX CHROMOSOMES 1968-83   
% 218.34/218.49  |- skos__broader mesh__D013131Q000293smesh__D013131
% 218.34/218.49  |- mesh__preferredCombination mesh__D013131Q000293smesh__D013124
% 218.34/218.49  |- rdf__type mesh__D013131Q000293smesh__CompoundConcept
% 218.34/218.49  |- skos__prefLabel mesh__D000978 Antiparkinson Agents
% 218.34/218.49  |- skos__hiddenLabel mesh__D000978 Agents, Antiparkinson
% 218.34/218.49  |- skos__hiddenLabel mesh__D000978 Agents, Antiparkinsonian
% 218.34/218.49  |- skos__hiddenLabel mesh__D000978 Drugs, Antiparkinson
% 218.34/218.49  |- mesh__recordAuthorizer mesh__D000978 sjn
% 218.34/218.49  |- mesh__historyNote mesh__D000978
% 218.34/218.49       76; was ANTIPARKINSON DRUGS 1972-75 %28%Prov 1972%29%; was ANTIPARKINSON DRUGS see under PARASYMPATHOLYTICS 1963-72%A%  
% 218.34/218.49  |- skos__altLabel mesh__D000978 Antiparkinsonians
% 218.34/218.49  |- skos__altLabel mesh__D000978 Antiparkinsonian Agents
% 218.34/218.49  |- skos__altLabel mesh__D000978 Antiparkinson Drugs
% 218.34/218.49  |- skos__broader mesh__D000978smesh__D018726
% 218.34/218.49  |- skos__historyNote mesh__D000978 Parasympatholytics %28%1966-1972%29%
% 218.34/218.49  |- rdf__type mesh__D000978sskos__Concept
% 218.34/218.49  |- mesh__dateEstablished mesh__D000978 1973-01-01
% 218.34/218.49  |- mesh__dateCreated mesh__D000978 1999-01-01
% 218.34/218.49  |- skos__historyNote mesh__D000978
% 218.34/218.49       Parkinsonism/drug therapy %28%1966-1972%29%
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D000978 2006
% 218.34/218.49  |- mesh__onlineNote mesh__D000978
% 218.34/218.49       use ANTIPARKINSON AGENTS to search ANTIPARKINSON DRUGS 1972-75 %28%as Prov 1972%29% %26% PARASYMPATHOLYTICS 1966-71%A%  
% 218.34/218.49  |- skos__annotation mesh__D000978
% 218.34/218.49       GEN or unspecified; prefer specifics; consider also PARKINSON DISEASE /drug ther%A%  
% 218.34/218.49  |- mesh__dateRevised mesh__D000978 2005-06-30
% 218.34/218.49  |- skos__scopeNote mesh__D000978
% 218.34/218.49       Agents used in the treatment of Parkinson%27%s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.%A%    
% 218.34/218.49  |- mesh__recordOriginator mesh__D000978 NLM
% 218.34/218.49  |- mesh__publicMeSHNote mesh__D000978
% 218.34/218.49       76; was ANTIPARKINSON DRUGS 1973-75; was ANTIPARKINSON DRUGS see under PARASYMPATHOLYTICS 1963-72%A%  
% 218.34/218.49  |- mesh__recordMaintainer mesh__D000978 ssb
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D019683 2006
% 218.34/218.49  |- rdf__type mesh__D019683sskos__Concept
% 218.34/218.49  |- mesh__dateEstablished mesh__D019683 1998-01-01
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D019683 2005
% 218.34/218.49  |- mesh__historyNote mesh__D019683 98   
% 218.34/218.49  |- mesh__dateCreated mesh__D019683 1997-06-20
% 218.34/218.49  |- skos__broader mesh__D019683smesh__D010641
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D019683 2004
% 218.34/218.49  |- skos__scopeNote mesh__D019683
% 218.34/218.49       The percent frequency with which a dominant or homozygous recessive gene or gene combination manifests itself in the phenotype of the carriers. %28%From Glossary of Genetics, 5th ed%29%%A%    
% 218.34/218.49  |- mesh__dateRevised mesh__D019683 2002-07-03
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D019683 2003
% 218.34/218.49  |- skos__historyNote mesh__D019683 Phenotype %28%1968-1997%29%
% 218.34/218.49  |- skos__related mesh__D019683smesh__D020132
% 218.34/218.49  |- skos__prefLabel mesh__D019683 Penetrance
% 218.34/218.49  |- skos__annotation mesh__D019683
% 218.34/218.49       frequency a gene or gene combination is manifested in the phenotype%A%  
% 218.34/218.49  |- mesh__publicMeSHNote mesh__D019683 98   
% 218.34/218.49  |- skos__broader mesh__D011969Q000819smesh__D011969
% 218.34/218.49  |- mesh__preferredCombination mesh__D011969Q000819smesh__D017442
% 218.34/218.49  |- rdf__type mesh__D011969Q000819smesh__CompoundConcept
% 218.34/218.49  |- skos__scopeNote mesh__D005663
% 218.34/218.49       Compounds with a 5-membered ring of four carbons and an oxygen.  They are aromatic heterocycles. The reduced form is tetrahydrofuran.%A%    
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D005663 2004
% 218.34/218.49  |- mesh__recordAuthorizer mesh__D005663 sjn
% 218.34/218.49  |- mesh__dateRevised mesh__D005663 2002-07-03
% 218.34/218.49  |- mesh__dateCreated mesh__D005663 1999-01-01
% 218.34/218.49  |- rdf__type mesh__D005663sskos__Concept
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D005663 2005
% 218.34/218.49  |- skos__broader mesh__D005663smesh__D006573
% 218.34/218.49  |- skos__prefLabel mesh__D005663 Furans
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D005663 2003
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D005663 2006
% 218.34/218.49  |- mesh__recordMaintainer mesh__D005663 ssb
% 218.34/218.49  |- mesh__recordOriginator mesh__D005663 NLM
% 218.34/218.49  |- mesh__recordAuthorizer mesh__D043782 sjn
% 218.34/218.49  |- mesh__recordMaintainer mesh__D043782 jmp
% 218.34/218.49  |- mesh__publicMeSHNote mesh__D043782
% 218.34/218.49       2004; BRANDYKININ B2 RECEPTOR %26% BRADYKININ TYPE 2 RECEPTOR %28%now RECEPTOR, BRADYKININ B2%29% were indexed under RECEPTORS, BRADYKININ 1994-2003%A%  
% 218.34/218.49  |- skos__hiddenLabel mesh__D043782 B2 Receptors, Bradykinin
% 218.34/218.49  |- skos__hiddenLabel mesh__D043782 Receptors, Bradykinin B2
% 218.34/218.49  |- skos__prefLabel mesh__D043782 Receptor, Bradykinin B2
% 218.34/218.49  |- mesh__dateEstablished mesh__D043782 2004-01-01
% 218.34/218.49  |- skos__hiddenLabel mesh__D043782 B2 Receptor, Bradykinin
% 218.34/218.49  |- skos__altLabel mesh__D043782 Bradykinin Type 2 Receptor
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D043782 2006
% 218.34/218.49  |- skos__altLabel mesh__D043782 Receptor, Bradykinin Type 2
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D043782 2004
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D043782 2005
% 218.34/218.49  |- skos__broader mesh__D043782smesh__D018002
% 218.34/218.49  |- skos__scopeNote mesh__D043782
% 218.34/218.49       A constitutively expressed subtype of bradykinin receptor that may play a role in the acute phase of the inflammatory and pain response. It has high specificity for intact forms of BRADYKININ and KALLIDIN. The receptor is coupled to G-PROTEIN, GQ-G11 ALPHA FAMILY and G-PROTEIN, GI-GO ALPHA FAMILY signaling proteins.%A%    
% 218.34/218.49  |- rdf__type mesh__D043782sskos__Concept
% 218.34/218.49  |- skos__altLabel mesh__D043782 Bradykinin B2 Receptor
% 218.34/218.49  |- mesh__recordOriginator mesh__D043782 jmp
% 218.34/218.49  |- skos__historyNote mesh__D043782 Receptors, Bradykinin %28%1996-2003%29%
% 218.34/218.49  |- mesh__dateCreated mesh__D043782 2003-07-09
% 218.34/218.49  |- mesh__historyNote mesh__D043782
% 218.34/218.49       2004; use RECEPTOR, BRADYKININ B2 %28%NM%29% 1994-2003   
% 218.34/218.49  |- skos__altLabel mesh__D043782 Bradykinin B2 Receptors
% 218.34/218.49  |- skos__prefLabel mesh__D051416 Focal Adhesion Protein-Tyrosine Kinases
% 218.34/218.49  |- skos__altLabel mesh__D051416 Focal Adhesion Protein-Tyrosine Kinase
% 218.34/218.49  |- mesh__activeMeSHYear mesh__D051416 2006
% 218.34/218.49  |- mesh__publicMeSHNote mesh__D051416
% 218.34/218.49       2006; FOCAL ADHESION KINASE was indexed under under PROTEIN-TYROSINE KINASE 2001-2005, CELL ADHESION MOLECULES 1990-2000,  MEMBRANE GLYCOPROTEINS 1987-1992, %26% MEMBRANE PROTEINS 1986-1987%A%  
% 218.34/218.49  |- mesh__dateCreated mesh__D051416 2005-06-30
% 218.34/218.49  |- skos__altLabel mesh__D051416
% 218.34/218.49       Focal Adhesion Protein-Tyrosine Kinase Family
% 218.34/218.49  |- skos__hiddenLabel mesh__D051416
% 218.34/218.49       Focal Adhesion Protein Tyrosine Kinase Family
% 218.34/218.49  |- skos__broader mesh__D051416smesh__D047908
% 218.34/218.49  |- skos__broader mesh__D051416smesh__D011505
% 218.34/218.49  |- mesh__recordAuthorizer mesh__D051416 sjn
% 218.34/218.49  |- rdf__type mesh__D051416sskos__Concept
% 218.34/218.49  |- mesh__dateEstablished mesh__D051416 2006-01-01
% 218.34/218.49  |- skos__scopeNote mesh__D051416
% 218.34/218.49       A family of non-receptor, PROLINE-rich protein-tyrosine kinases.%A%    
% 218.34/218.49  |- mesh__recordMaintainer mesh__D051416 DRC
% 218.34/218.49  |- skos__altLabel mesh__D051416 Focal Adhesion Kinase
% 218.34/218.49  |- mesh__recordOriginator mesh__D051416 DRC
% 218.34/218.49  |- mesh__historyNote mesh__D051416 2006%28%1999%29%   
% 218.34/218.49  |- skos__hiddenLabel mesh__D051416 Focal Adhesion Protein Tyrosine Kinases
% 218.34/218.49  |- skos__hiddenLabel mesh__D015293 Transducin G-Protein Gt
% 218.34/218.49  |- skos__hiddenLabel mesh__D015293 gamma Transducin
% 218.34/218.49  |- skos__hiddenLabel mesh__D015293 G Protein, Inhibitory Gt
% 218.34/218.49  |- mesh__recordOriginator mesh__D015293 RLS
% 218.34/218.49  |- mesh__publicMeSHNote mesh__D015293 89   
% 218.34/218.49  |- rdf__type mesh__D015293sskos__Concept
% 218.34/218.49  |- skos__altLabel mesh__D015293 Gt, Transducin G-Protein
% 218.34/218.49  |- mesh__dateEstablished mesh__D015293 1989-01-01
% 218.34/218.50  |- skos__broader mesh__D015293smesh__D020962
% 218.34/218.50  |- skos__annotation mesh__D015293
% 218.34/218.50       alpha, beta and gamma transducins refer to its subunits   
% 218.34/218.50  |- skos__hiddenLabel mesh__D015293 alpha Transducin
% 218.34/218.50  |- mesh__dateRevised mesh__D015293 2004-07-07
% 218.34/218.50  |- skos__scopeNote mesh__D015293
% 218.34/218.50       A heterotrimeric GTP-binding protein that mediates the light activation signal from photolyzed rhodopsin to cyclic GMP phosphodiesterase and is pivotal in the visual excitation process. Activation of rhodopsin on the outer membrane of rod and cone cells causes GTP to bind to transducin followed by dissociation of the alpha subunit-GTP complex from the beta/gamma subunits of transducin. The alpha subunit-GTP complex activates the cyclic GMP phosphodiesterase which catalyzes the hydrolysis of cyclic GMP to 5%27%-GMP. This leads to closure of the sodium and calcium channels and therefore hyperpolarization of the rod cells. EC 3.6.1.-.%A%    
% 218.34/218.50  |- mesh__recordMaintainer mesh__D015293 jmp
% 218.34/218.50  |- skos__prefLabel mesh__D015293 Transducin
% 218.34/218.50  |- skos__historyNote mesh__D015293 Membrane Proteins %28%1980-1988%29%
% 218.34/218.50  |- skos__hiddenLabel mesh__D015293 Inhibitory Gt G-Protein
% 218.34/218.50  |- skos__hiddenLabel mesh__D015293 beta Subunit Transducin
% 218.34/218.50  |- skos__altLabel mesh__D015293 G-Protein, Inhibitory Gt
% 218.34/218.50  |- skos__altLabel mesh__D015293 Transducin, alpha Subunit
% 218.34/218.50  |- mesh__recordAuthorizer mesh__D015293 sjn
% 218.34/218.50  |- skos__hiddenLabel mesh__D015293 G-Protein Gt, Transducin
% 218.34/218.50  |- skos__altLabel mesh__D015293 Transducin G-Protein %28%Gt%29%
% 218.34/218.50  |- skos__altLabel mesh__D015293 Transducin, beta Subunit
% 218.34/218.50  |- skos__hiddenLabel mesh__D015293 alpha Subunit Transducin
% 218.34/218.50  |- mesh__historyNote mesh__D015293 89   
% 218.34/218.50  |- skos__hiddenLabel mesh__D015293 Gt G-Protein, Inhibitory
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D015293 2006
% 218.34/218.50  |- skos__hiddenLabel mesh__D015293 beta Transducin
% 218.34/218.50  |- skos__hiddenLabel mesh__D015293 gamma Subunit Transducin
% 218.34/218.50  |- mesh__dateCreated mesh__D015293 1988-05-24
% 218.34/218.50  |- skos__historyNote mesh__D015293
% 218.34/218.50       Guanine Nucleotide Regulatory Protein %28%1985-1988%29%
% 218.34/218.50  |- skos__hiddenLabel mesh__D015293 Gt, Transducin G Protein
% 218.34/218.50  |- skos__altLabel mesh__D015293 Transducin, gamma Subunit
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D015293 2005
% 218.34/218.50  |- skos__hiddenLabel mesh__D009256 Hydrochloride, Nafoxidine
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D009256 2005
% 218.34/218.50  |- skos__hiddenLabel mesh__D009256 U 11,100A
% 218.34/218.50  |- skos__hiddenLabel mesh__D009256 U11,100A
% 218.34/218.50  |- mesh__publicMeSHNote mesh__D009256
% 218.34/218.50       91; was see under PYRROLIDINES 1973-90   
% 218.34/218.50  |- mesh__historyNote mesh__D009256
% 218.34/218.50       91%28%73%29%; was see under PYRROLIDINES 1973-90   
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D009256 2004
% 218.34/218.50  |- skos__prefLabel mesh__D009256 Nafoxidine
% 218.34/218.50  |- mesh__dateCreated mesh__D009256 1999-01-01
% 218.34/218.50  |- rdf__type mesh__D009256sskos__Concept
% 218.34/218.50  |- mesh__recordAuthorizer mesh__D009256 sjn
% 218.34/218.50  |- mesh__recordMaintainer mesh__D009256 CCR
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D009256 2003
% 218.34/218.50  |- skos__broader mesh__D009256smesh__D011759
% 218.34/218.50  |- skos__altLabel mesh__D009256 U-11000A
% 218.34/218.50  |- skos__hiddenLabel mesh__D009256 U 11000A
% 218.34/218.50  |- mesh__dateEstablished mesh__D009256 1991-01-01
% 218.34/218.50  |- mesh__recordOriginator mesh__D009256 NLM
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D009256 2006
% 218.34/218.50  |- mesh__dateRevised mesh__D009256 2001-07-25
% 218.34/218.50  |- skos__scopeNote mesh__D009256
% 218.34/218.50       An estrogen antagonist that has been used in the treatment of breast cancer.%A%    
% 218.34/218.50  |- skos__hiddenLabel mesh__D009256 U11000A
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D009256 2002
% 218.34/218.50  |- skos__hiddenLabel mesh__D001273 Chambers, Atmosphere Exposure
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001273 1994
% 218.34/218.50  |- rdf__type mesh__D001273sskos__Concept
% 218.34/218.50  |- mesh__recordAuthorizer mesh__D001273 PLS
% 218.34/218.50  |- mesh__recordMaintainer mesh__D001273 TAP
% 218.34/218.50  |- skos__hiddenLabel mesh__D001273 Exposure Chambers, Atmosphere
% 218.34/218.50  |- mesh__dateCreated mesh__D001273 1999-01-01
% 218.34/218.50  |- mesh__publicMeSHNote mesh__D001273 73   
% 218.34/218.50  |- mesh__dateEstablished mesh__D001273 1973-01-01
% 218.34/218.50  |- skos__prefLabel mesh__D001273 Atmosphere Exposure Chambers
% 218.34/218.50  |- skos__broader mesh__D001273smesh__D004864
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001273 2002
% 218.34/218.50  |- skos__hiddenLabel mesh__D001273 Atmosphere Exposure Chamber
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001273 2004
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001273 1997
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001273 2001
% 218.34/218.50  |- mesh__historyNote mesh__D001273 73   
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001273 2006
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001273 1999
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001273 1993
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001273 2003
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001273 1996
% 218.34/218.50  |- skos__hiddenLabel mesh__D001273 Exposure Chamber, Atmosphere
% 218.34/218.50  |- skos__hiddenLabel mesh__D001273 Chamber, Atmosphere Exposure
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001273 2005
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001273 1995
% 218.34/218.50  |- mesh__dateRevised mesh__D001273 1992-03-25
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001273 1998
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001273 2000
% 218.34/218.50  |- mesh__recordOriginator mesh__D001273 NLM
% 218.34/218.50  |- skos__scopeNote mesh__D014999
% 218.34/218.50       The type species of YATAPOXVIRUS, a tumor-producing DNA virus discovered in monkeys in Yaba, Nigeria. It has been found to produce histiocytomas in monkeys and humans.%A%    
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D014999 2002
% 218.34/218.50  |- skos__annotation mesh__D014999
% 218.34/218.50       infection: coord IM with POXVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%; DF: note short X ref%A%  
% 218.34/218.50  |- mesh__recordMaintainer mesh__D014999 ags
% 218.34/218.50  |- mesh__dateRevised mesh__D014999 2001-07-25
% 218.34/218.50  |- mesh__publicMeSHNote mesh__D014999
% 218.34/218.50       94; was YABA VIRUS 1966-93 %28%see under POXVIRIDAE 1990%29%   
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D014999 2006
% 218.34/218.50  |- mesh__dateCreated mesh__D014999 1999-01-01
% 218.34/218.50  |- mesh__dateEstablished mesh__D014999 1966-01-01
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D014999 2005
% 218.34/218.50  |- skos__altLabel mesh__D014999 Yaba Virus
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D014999 2004
% 218.34/218.50  |- mesh__historyNote mesh__D014999
% 218.34/218.50       94; was YABA VIRUS 1964-93 %28%see under POXVIRIDAE 1990, Prov 1964-65%29%%A%  
% 218.34/218.50  |- mesh__recordOriginator mesh__D014999 NLM
% 218.34/218.50  |- skos__prefLabel mesh__D014999 Yaba monkey tumor virus
% 218.34/218.50  |- mesh__recordAuthorizer mesh__D014999 sjn
% 218.34/218.50  |- mesh__onlineNote mesh__D014999
% 218.34/218.50       use YABA MONKEY TUMOR VIRUS to search YABA VIRUS 1966-93   
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D014999 2003
% 218.34/218.50  |- rdf__type mesh__D014999sskos__Concept
% 218.34/218.50  |- skos__broader mesh__D014999smesh__D018158
% 218.34/218.50  |- skos__scopeNote mesh__D000979
% 218.34/218.50       A member of the serpin superfamily found in human plasma that inhibits the lysis of fibrin clots which are induced by plasminogen activator. It is a glycoprotein, molecular weight approximately 70,000 that migrates in the alpha 2 region in immunoelectrophoresis. It is the principal plasmin inactivator in blood, rapidly forming a very stable complex with plasmin.%A%    
% 218.34/218.50  |- skos__annotation mesh__D000979
% 218.34/218.50       do not confuse with ANTIPLASMINS see ANTIFIBRINOLYTIC AGENTS%A%  
% 218.34/218.50  |- mesh__publicMeSHNote mesh__D000979 80   
% 218.34/218.50  |- skos__prefLabel mesh__D000979 Antiplasmin
% 218.34/218.50  |- skos__altLabel mesh__D000979 alpha%28%2%29%-Plasmin Inhibitor
% 218.34/218.50  |- mesh__historyNote mesh__D000979 80   
% 218.34/218.50  |- skos__altLabel mesh__D000979 alpha 2-Plasmin Inhibitor
% 218.34/218.50  |- skos__hiddenLabel mesh__D000979 alpha 2 Plasmin Inhibitor
% 218.34/218.50  |- skos__altLabel mesh__D000979 alpha-2-Antiplasmin
% 218.34/218.50  |- mesh__dateCreated mesh__D000979 1979-05-23
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D000979 2005
% 218.34/218.50  |- mesh__recordAuthorizer mesh__D000979 sjn
% 218.34/218.50  |- skos__historyNote mesh__D000979
% 218.34/218.50       Fibrinolysin/antagonists %26% inhibitors %28%1968-1979%29%
% 218.34/218.50  |- rdf__type mesh__D000979sskos__Concept
% 218.34/218.50  |- skos__hiddenLabel mesh__D000979 Inhibitor, alpha 2-Plasmin
% 218.34/218.50  |- skos__broader mesh__D000979smesh__D000510
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D000979 2006
% 218.34/218.50  |- mesh__recordMaintainer mesh__D000979 sjn
% 218.34/218.50  |- mesh__recordOriginator mesh__D000979 RLS
% 218.34/218.50  |- skos__hiddenLabel mesh__D000979 Antiactivator, Plasmin
% 218.34/218.50  |- skos__altLabel mesh__D000979 alpha-2 Antiplasmin
% 218.34/218.50  |- skos__broader mesh__D000979smesh__D015843
% 218.34/218.50  |- skos__hiddenLabel mesh__D000979 Antiplasmin, alpha-2
% 218.34/218.50  |- skos__altLabel mesh__D000979 Plasmin Antiactivator
% 218.34/218.50  |- skos__hiddenLabel mesh__D000979 alpha 2 Antiplasmin
% 218.34/218.50  |- mesh__dateEstablished mesh__D000979 1980-01-01
% 218.34/218.50  |- mesh__dateRevised mesh__D000979 2004-07-13
% 218.34/218.50  |- skos__prefLabel mesh__D019684 Angiosperms
% 218.34/218.50  |- rdf__type mesh__D019684sskos__Concept
% 218.34/218.50  |- skos__annotation mesh__D019684
% 218.34/218.50       GEN or unspecified; prefer specific families or specific plants%A%  
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D019684 2005
% 218.34/218.50  |- mesh__historyNote mesh__D019684 98   
% 218.34/218.50  |- mesh__publicMeSHNote mesh__D019684 98   
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D019684 2004
% 218.34/218.50  |- mesh__recordOriginator mesh__D019684 JLS
% 218.34/218.50  |- skos__broader mesh__D019684smesh__D019669
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D019684 2003
% 218.34/218.50  |- mesh__dateRevised mesh__D019684 2002-07-02
% 218.34/218.50  |- mesh__dateEstablished mesh__D019684 1998-01-01
% 218.34/218.50  |- mesh__dateCreated mesh__D019684 1997-06-20
% 218.34/218.50  |- skos__altLabel mesh__D019684 Magnoliophyta
% 218.34/218.50  |- mesh__recordMaintainer mesh__D019684 lkt
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D019684 2006
% 218.34/218.50  |- skos__scopeNote mesh__D019684
% 218.34/218.50       Any member of the more than 250,000 species of flowering plants. Angiosperms are often differentiated from GYMNOSPERMS by their production of seeds within a closed chamber %28%OVARY, PLANT%29%. The Angiosperms division is composed of two classes, the monocotyledons %28%Liliopsida%29% and dicotyledons %28%Magnoliopsida%29%.%A%    
% 218.34/218.50  |- mesh__recordAuthorizer mesh__D019684 sjn
% 218.34/218.50  |- skos__altLabel mesh__D005664 Furazolidine
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D005664 2006
% 218.34/218.50  |- skos__altLabel mesh__D005664 Nifurazolidone
% 218.34/218.50  |- mesh__recordOriginator mesh__D005664 NLM
% 218.34/218.50  |- mesh__dateCreated mesh__D005664 1999-01-01
% 218.34/218.50  |- skos__broader mesh__D005664smesh__D023303
% 218.34/218.50  |- mesh__recordAuthorizer mesh__D005664 sjn
% 218.34/218.50  |- mesh__dateRevised mesh__D005664 2005-06-30
% 218.34/218.50  |- skos__scopeNote mesh__D005664
% 218.34/218.50       A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p514%29%%A%    
% 218.34/218.50  |- rdf__type mesh__D005664sskos__Concept
% 218.34/218.50  |- skos__broader mesh__D005664smesh__D009581
% 218.34/218.50  |- skos__prefLabel mesh__D005664 Furazolidone
% 218.34/218.50  |- mesh__recordMaintainer mesh__D005664 ssb
% 218.34/218.50  |- mesh__historyNote mesh__D043783
% 218.34/218.50       2004; use RECEPTOR, BRADYKININ B1 %28%NM%29% 1996-2003   
% 218.34/218.50  |- mesh__publicMeSHNote mesh__D043783
% 218.34/218.50       2004; BRADKININ B1 RECEPTOR %28%now RECEPTOR, BRADYKININ B1%29% was indexed under RECEPTORS, BRADYKININ 1996-2003%A%  
% 218.34/218.50  |- skos__hiddenLabel mesh__D043783 B1 Receptor, Bradykinin
% 218.34/218.50  |- skos__altLabel mesh__D043783 Bradykinin B1 Receptors
% 218.34/218.50  |- skos__historyNote mesh__D043783 Receptors, Bradykinin %28%1996-2003%29%
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D043783 2004
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D043783 2005
% 218.34/218.50  |- skos__altLabel mesh__D043783 Bradykinin B1 Receptor
% 218.34/218.50  |- rdf__type mesh__D043783sskos__Concept
% 218.34/218.50  |- skos__hiddenLabel mesh__D043783 Receptors, Bradykinin B1
% 218.34/218.50  |- skos__hiddenLabel mesh__D043783 B1 Receptors, Bradykinin
% 218.34/218.50  |- mesh__dateEstablished mesh__D043783 2004-01-01
% 218.34/218.50  |- mesh__dateCreated mesh__D043783 2003-07-09
% 218.34/218.50  |- skos__scopeNote mesh__D043783
% 218.34/218.50       A subtype of bradykinin receptor that is induced in response to INFLAMMATION. It may play a role in chronic inflammation and has a high specificity for KININS lacking the C-terminal ARGININE such as des-Arg%28%10%29%-kallidin and des-Arg%28%9%29%-bradykinin. The receptor is coupled to G-PROTEIN, GQ-G11 ALPHA FAMILY and G-PROTEIN, GI-GO ALPHA FAMILY signaling proteins.%A%    
% 218.34/218.50  |- skos__altLabel mesh__D043783 Bradykinin Type 1 Receptor
% 218.34/218.50  |- skos__prefLabel mesh__D043783 Receptor, Bradykinin B1
% 218.34/218.50  |- skos__broader mesh__D043783smesh__D018002
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D043783 2006
% 218.34/218.50  |- skos__broader mesh__D010000smesh__D001850
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D010000 2004
% 218.34/218.50  |- skos__related mesh__D010000smesh__D010007
% 218.34/218.50  |- mesh__recordAuthorizer mesh__D010000 sjn
% 218.34/218.50  |- skos__hiddenLabel mesh__D010000 Inflammation, Bone
% 218.34/218.50  |- skos__annotation mesh__D010000 coord IM with specific bone %28%IM%29%   
% 218.34/218.50  |- mesh__dateCreated mesh__D010000 1999-01-01
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D010000 2005
% 218.34/218.50  |- skos__broader mesh__D010000smesh__D001847
% 218.34/218.50  |- mesh__dateRevised mesh__D010000 2002-07-02
% 218.34/218.50  |- mesh__recordOriginator mesh__D010000 NLM
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D010000 2006
% 218.34/218.50  |- mesh__recordMaintainer mesh__D010000 TGC
% 218.34/218.50  |- rdf__type mesh__D010000sskos__Concept
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D010000 2003
% 218.34/218.50  |- skos__altLabel mesh__D010000 Bone Inflammation
% 218.34/218.50  |- skos__prefLabel mesh__D010000 Osteitis
% 218.34/218.50  |- skos__broader mesh__D051417smesh__D010750
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D051417 2006A
% 218.34/218.50  |- skos__hiddenLabel mesh__D051417
% 218.34/218.50       Focal Adhesion Associated Protein Tyrosine Kinase pp125FAK
% 218.34/218.50  |- skos__scopeNote mesh__D051417
% 218.34/218.50       A non-receptor protein tyrosine kinase that is localized to FOCAL ADHESIONS and is a central component of integrin-mediated SIGNAL TRANSDUCTION PATHWAYS. Focal adhesion kinase 1 interacts with PAXILLIN and undergoes PHOSPHORYLATION in response to adhesion of cell surface integrins to the EXTRACELLULAR MATRIX. Phosphorylated p125FAK protein binds to a variety of SH2 DOMAIN and SH3 DOMAIN containing proteins and helps regulate CELL ADHESION and CELL MIGRATION.%A%    
% 218.34/218.50  |- mesh__publicMeSHNote mesh__D051417
% 218.34/218.50       2006; ENDOGENOUS SUBSTRATE PP120, FOCAL ADHESION-ASSOCIATED, PROTEIN-TYROSINE KINASE PP125FAK, %26% P125FAK PROTEIN were indexed under PROTEIN-TYROSINE KINASE 2001-2005, %26% under CELL ADHESION MOLECULES 1990-2000, %26% MEMBRANE GLYCOPROTEINS 1987-1992, MEMBRANE PROTEINS 1986-1987%A%  
% 218.34/218.50  |- skos__altLabel mesh__D051417 p125FAK Protein
% 218.34/218.50  |- mesh__dateCreated mesh__D051417 2005-06-30
% 218.34/218.50  |- skos__broader mesh__D051417smesh__D051416
% 218.34/218.50  |- rdf__type mesh__D051417sskos__Concept
% 218.34/218.50  |- mesh__recordMaintainer mesh__D051417 ags
% 218.34/218.50  |- skos__altLabel mesh__D051417
% 218.34/218.50       Focal Adhesion-Associated Protein-Tyrosine Kinase pp125FAK
% 218.34/218.50  |- skos__prefLabel mesh__D051417 Focal Adhesion Kinase 1
% 218.34/218.50  |- skos__altLabel mesh__D051417 Endogenous Substrate pp120
% 218.34/218.50  |- mesh__recordOriginator mesh__D051417 DRC
% 218.34/218.50  |- mesh__recordAuthorizer mesh__D051417 ags
% 218.34/218.50  |- mesh__dateRevised mesh__D051417 2005-07-18
% 218.34/218.50  |- mesh__historyNote mesh__D051417 2006%28%1986%29%   
% 218.34/218.50  |- mesh__dateEstablished mesh__D051417 2006-01-01
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D051417 2006
% 218.34/218.50  |- mesh__publicMeSHNote mesh__D009257 91; was see under FURANS 1975-90   
% 218.34/218.50  |- skos__altLabel mesh__D009257
% 218.34/218.50       Merck Lipha Sant%C3%%A9% Brand 2 of Naftidrofuryl Oxalate
% 218.34/218.50  |- skos__hiddenLabel mesh__D009257 Oxalate, Nafronyl
% 218.34/218.50  |- skos__prefLabel mesh__D009257 Nafronyl
% 218.34/218.50  |- skos__broader mesh__D009257smesh__D005663
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D009257 2005A
% 218.34/218.50  |- skos__altLabel mesh__D009257 Faes Brand of Naftidrofuryl Oxalate
% 218.34/218.50  |- skos__altLabel mesh__D009257 Alpharma Brand of Naftidrofuryl Oxalate
% 218.34/218.50  |- mesh__recordAuthorizer mesh__D009257 jls
% 218.34/218.50  |- skos__altLabel mesh__D009257 ratiopharm Brand of Naftidrofuryl Oxalate
% 218.34/218.50  |- skos__altLabel mesh__D009257 Azupharma Brand of Naftidrofuryl Oxalate
% 218.34/218.50  |- skos__altLabel mesh__D009257 Menarini Brand of Naftidrofuryl Oxalate
% 218.34/218.50  |- skos__altLabel mesh__D009257 Naftidrofuryl
% 218.34/218.50  |- mesh__recordOriginator mesh__D009257 NLM
% 218.34/218.50  |- skos__altLabel mesh__D009257 Praxil%C3%%A8%ne
% 218.34/218.50  |- mesh__historyNote mesh__D009257
% 218.34/218.50       91%28%75%29%; was see under FURANS 1975-90   
% 218.34/218.50  |- skos__altLabel mesh__D009257 Naftifurin Oxalate
% 218.34/218.50  |- skos__altLabel mesh__D009257 Lipha Brand of Naftidrofuryl Oxalate
% 218.34/218.50  |- mesh__dateEstablished mesh__D009257 1991-01-01
% 218.34/218.50  |- skos__scopeNote mesh__D009257
% 218.34/218.50       A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1310%29% It may also be an antagonist at 5HT-2 serotonin receptors.%A%    
% 218.34/218.50  |- mesh__recordMaintainer mesh__D009257 jls
% 218.34/218.50  |- skos__altLabel mesh__D009257 Merck Brand of Nafronyl Oxalate
% 218.34/218.50  |- skos__hiddenLabel mesh__D009257 NaftiPuren
% 218.34/218.50  |- skos__historyNote mesh__D009257 Propionates %28%1971-1974%29%
% 218.34/218.50  |- mesh__dateRevised mesh__D009257 2004-07-29
% 218.34/218.50  |- skos__altLabel mesh__D009257 Abbott Brand of Naftidrofuryl Oxalate
% 218.34/218.50  |- skos__hiddenLabel mesh__D009257 DiActane
% 218.34/218.50  |- skos__hiddenLabel mesh__D009257 Di Actane
% 218.34/218.50  |- skos__altLabel mesh__D009257
% 218.34/218.50       Th%C3%%A9%rabel Brand of Naftidrofuryl Oxalate
% 218.34/218.50  |- skos__hiddenLabel mesh__D009257
% 218.34/218.50       ct Arzneimittel Brand of Naftidrofuryl Oxalate
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D009257 2005
% 218.34/218.50  |- skos__altLabel mesh__D009257
% 218.34/218.50       Merck Lipha Sant%C3%%A9% Brand 1 of Naftidrofuryl Oxalate
% 218.34/218.50  |- skos__altLabel mesh__D009257 Nafronyl Oxalate
% 218.34/218.50  |- skos__hiddenLabel mesh__D009257 LS121
% 218.34/218.50  |- skos__historyNote mesh__D009257 Furans %28%1971-1974%29%
% 218.34/218.50  |- skos__hiddenLabel mesh__D009257 Naftiratiopharm
% 218.34/218.50  |- skos__altLabel mesh__D009257 Hexal Brand of Naftidrofuryl Oxalate
% 218.34/218.50  |- skos__historyNote mesh__D009257 Diethylamines %28%1974%29%
% 218.34/218.50  |- skos__altLabel mesh__D009257
% 218.34/218.50       ct-Arzneimittel Brand of Naftidrofuryl Oxalate
% 218.34/218.50  |- skos__hiddenLabel mesh__D009257 Nafti ratiopharm
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D009257 2006
% 218.34/218.50  |- skos__hiddenLabel mesh__D009257 Oxalate, Naftifurin
% 218.34/218.50  |- mesh__dateCreated mesh__D009257 1974-11-19
% 218.34/218.50  |- skos__historyNote mesh__D009257 Naphthalenes %28%1971-1974%29%
% 218.34/218.50  |- skos__hiddenLabel mesh__D009257 Nafti Puren
% 218.34/218.50  |- rdf__type mesh__D009257sskos__Concept
% 218.34/218.50  |- skos__hiddenLabel mesh__D009257 LS 121
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001274 2001
% 218.34/218.50  |- skos__prefLabel mesh__D001274 Atmospheric Pressure
% 218.34/218.50  |- skos__hiddenLabel mesh__D001274 Pressures, Atmospheric
% 218.34/218.50  |- skos__related mesh__D001274smesh__D003665
% 218.34/218.50  |- skos__hiddenLabel mesh__D001274 Pressure, Atmospheric
% 218.34/218.50  |- skos__hiddenLabel mesh__D001274 Atmospheric Pressures
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001274 2004
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001274 1997
% 218.34/218.50  |- skos__broader mesh__D001274smesh__D001272
% 218.34/218.50  |- skos__scopeNote mesh__D001274
% 218.34/218.50       The pressure at any point in an atmosphere due solely to the weight of the atmospheric gases above the point concerned.%A%    
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001274 2000
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001274 2006
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001274 1999
% 218.34/218.50  |- mesh__recordOriginator mesh__D001274 NLM
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001274 1993
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001274 2003
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001274 1996
% 218.34/218.50  |- skos__related mesh__D001274smesh__D001469
% 218.34/218.50  |- skos__related mesh__D001274smesh__D000860
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001274 1995
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001274 2005
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001274 1998
% 218.34/218.50  |- skos__related mesh__D001274smesh__D000531
% 218.34/218.50  |- skos__annotation mesh__D001274 no qualif   
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001274 1992
% 218.34/218.50  |- mesh__recordMaintainer mesh__D001274 TGC
% 218.34/218.50  |- rdf__type mesh__D001274sskos__Concept
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001274 1994
% 218.34/218.50  |- mesh__recordAuthorizer mesh__D001274 PLS
% 218.34/218.50  |- skos__related mesh__D001274smesh__D006931
% 218.34/218.50  |- mesh__dateRevised mesh__D001274 1991-06-20
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D001274 2002
% 218.34/218.50  |- mesh__dateCreated mesh__D001274 1999-01-01
% 218.34/218.50  |- skos__broader mesh__D019685smesh__D019684
% 218.34/218.50  |- mesh__recordMaintainer mesh__D019685 ssb
% 218.34/218.50  |- mesh__publicMeSHNote mesh__D019685 1998   
% 218.34/218.50  |- mesh__recordAuthorizer mesh__D019685 sjn
% 218.34/218.50  |- skos__prefLabel mesh__D019685 Rosales
% 218.34/218.50  |- skos__annotation mesh__D019685
% 218.34/218.50       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D019685 2006
% 218.34/218.50  |- rdf__type mesh__D019685sskos__Concept
% 218.34/218.50  |- mesh__dateEstablished mesh__D019685 1998-01-01
% 218.34/218.50  |- mesh__historyNote mesh__D019685 1998   
% 218.34/218.50  |- mesh__dateRevised mesh__D019685 2003-07-09
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D019685 2005
% 218.34/218.50  |- skos__scopeNote mesh__D019685
% 218.34/218.50       An order of the ANGIOSPERMS, subclass Rosidae. Its members include some of the most known ornamental and edible plants of temperate zones including roses, apples, cherries, and peaches.%A%    
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D019685 2004
% 218.34/218.50  |- mesh__recordOriginator mesh__D019685 JLS
% 218.34/218.50  |- mesh__dateCreated mesh__D019685 1997-06-20
% 218.34/218.50  |- skos__altLabel mesh__D005665 Fursemide
% 218.34/218.50  |- skos__prefLabel mesh__D005665 Furosemide
% 218.34/218.50  |- skos__scopeNote mesh__D005665
% 218.34/218.50       A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.%A%    
% 218.34/218.50  |- mesh__dateCreated mesh__D005665 1999-01-01
% 218.34/218.50  |- mesh__recordMaintainer mesh__D005665 ssb
% 218.34/218.50  |- mesh__onlineNote mesh__D005665
% 218.34/218.50       use FUROSEMIDE to search FRUSEMID 1977-91   
% 218.34/218.50  |- skos__broader mesh__D005665smesh__D013424
% 218.34/218.50  |- mesh__publicMeSHNote mesh__D005665
% 218.34/218.50       67; FRUSEMIDE was FRUSEMID see FUROSEMIDE 1977-91   
% 218.34/218.50  |- skos__altLabel mesh__D005665 Frusemide
% 218.34/218.50  |- mesh__recordOriginator mesh__D005665 NLM
% 218.34/218.50  |- mesh__historyNote mesh__D005665
% 218.34/218.50       67%28%65%29%; FRUSEMIDE was FRUSEMID see FUROSEMIDE 1977-91   
% 218.34/218.50  |- rdf__type mesh__D005665sskos__Concept
% 218.34/218.50  |- mesh__dateEstablished mesh__D005665 1967-01-01
% 218.34/218.50  |- skos__altLabel mesh__D005665 Frusemid
% 218.34/218.50  |- mesh__recordAuthorizer mesh__D005665 sjn
% 218.34/218.50  |- mesh__dateRevised mesh__D005665 2005-06-30
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D005665 2006
% 218.34/218.50  |- mesh__historyNote mesh__D038041 2003   
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D038041 2006
% 218.34/218.50  |- mesh__recordAuthorizer mesh__D038041 sjn
% 218.34/218.50  |- mesh__recordOriginator mesh__D038041 lkt
% 218.34/218.50  |- skos__scopeNote mesh__D038041
% 218.34/218.50       Formation of  LYMPHOCYTES and PLASMA CELLS from the lymphoid stem cells which develop from the pluripotent HEMATOPOIETIC STEM CELLS in the BONE MARROW. These lymphoid stem cells differentiate into T-LYMPHOCYTES; B-LYMPHOCYTES; PLASMA CELLS; or NK-cells %28%KILLER CELLS, NATURAL%29% depending on the organ or tissues %28%LYMPHOID TISSUE%29% to which they migrate.%A%    
% 218.34/218.50  |- skos__historyNote mesh__D038041 Lymphocytes %28%1965-2002%29%
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D038041 2005
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D038041 2004
% 218.34/218.50  |- skos__broader mesh__D038041smesh__D019891
% 218.34/218.50  |- rdf__type mesh__D038041sskos__Concept
% 218.34/218.50  |- mesh__dateCreated mesh__D038041 2002-07-03
% 218.34/218.50  |- mesh__recordMaintainer mesh__D038041 nns
% 218.34/218.50  |- mesh__dateEstablished mesh__D038041 2003-01-01
% 218.34/218.50  |- mesh__dateRevised mesh__D038041 2003-07-09
% 218.34/218.50  |- mesh__publicMeSHNote mesh__D038041 2003   
% 218.34/218.50  |- skos__prefLabel mesh__D038041 Lymphopoiesis
% 218.34/218.50  |- skos__hiddenLabel mesh__D024021 Collagens, FACIT
% 218.34/218.50  |- mesh__dateEstablished mesh__D024021 2002-01-01
% 218.34/218.50  |- mesh__historyNote mesh__D024021 2002   
% 218.34/218.50  |- skos__hiddenLabel mesh__D024021
% 218.34/218.50       Fibril Associated Collagens With Interrupted Triple Helices
% 218.34/218.50  |- skos__altLabel mesh__D024021 Fibril-Associated Collagen
% 218.34/218.50  |- mesh__recordOriginator mesh__D024021 jmp
% 218.34/218.50  |- mesh__recordAuthorizer mesh__D024021 sjn
% 218.34/218.50  |- skos__altLabel mesh__D024021
% 218.34/218.50       Fibril-Associated Collagens With Interrupted Triple Helices
% 218.34/218.50  |- rdf__type mesh__D024021sskos__Concept
% 218.34/218.50  |- skos__hiddenLabel mesh__D024021 Fibril Associated Collagen
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D024021 2006
% 218.34/218.50  |- skos__altLabel mesh__D024021 FACIT Collagens
% 218.34/218.50  |- skos__historyNote mesh__D024021 Collagen %28%1992-2001%29%
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D024021 2005
% 218.34/218.50  |- mesh__publicMeSHNote mesh__D024021 2002   
% 218.34/218.50  |- skos__hiddenLabel mesh__D024021 Collagen, Fibril-Associated
% 218.34/218.50  |- skos__hiddenLabel mesh__D024021 Fibril Associated Collagens
% 218.34/218.50  |- skos__prefLabel mesh__D024021 Fibril-Associated Collagens
% 218.34/218.50  |- mesh__dateRevised mesh__D024021 2004-07-07
% 218.34/218.50  |- skos__scopeNote mesh__D024021
% 218.34/218.50       A family of non-fibrillar collagens that interact with FIBRILLAR COLLAGENS. They contain short triple helical domains interrupted by short non-helical domains and do not form into collagen fibrils.%A%    
% 218.34/218.50  |- skos__altLabel mesh__D024021 FACIT Collagen
% 218.34/218.50  |- skos__broader mesh__D024021smesh__D024041
% 218.34/218.50  |- skos__hiddenLabel mesh__D024021 Collagens, Fibril-Associated
% 218.34/218.50  |- mesh__recordMaintainer mesh__D024021 jmp
% 218.34/218.50  |- mesh__dateCreated mesh__D024021 2001-07-25
% 218.34/218.50  |- skos__annotation mesh__D024021
% 218.34/218.50       do not confuse with FIBRILLAR COLLAGENS or MICROFIBRIL COLLAGEN HEMOSTAT see COLLAGEN; precursors: coord IM with PROCOLLAGEN %28%IM%29%%A%  
% 218.34/218.50  |- skos__broader mesh__D018723Q000031smesh__D018723
% 218.34/218.50  |- mesh__preferredCombination mesh__D018723Q000031smesh__D001626
% 218.34/218.50  |- rdf__type mesh__D018723Q000031smesh__CompoundConcept
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D010001 1999
% 218.34/218.50  |- mesh__recordAuthorizer mesh__D010001 PLS
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D010001 2004
% 218.34/218.50  |- mesh__recordMaintainer mesh__D010001 PLS
% 218.34/218.50  |- mesh__dateCreated mesh__D010001 1999-01-01
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D010001 1993
% 218.34/218.50  |- rdf__type mesh__D010001sskos__Concept
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D010001 1998
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D010001 2003
% 218.34/218.50  |- skos__hiddenLabel mesh__D010001 Pagets Disease, Bone
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D010001 1997
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D010001 2002
% 218.34/218.50  |- mesh__dateRevised mesh__D010001 1992-05-22
% 218.34/218.50  |- skos__scopeNote mesh__D010001
% 218.34/218.50       A disease marked by repeated episodes of increased bone resorption followed by excessive attempts at repair, resulting in weakened, deformed bones of increased mass. The resultant architecture of the bone assumes a mosaic pattern in which the fibers take on a haphazard pattern instead of the normal parallel symmetry.%A%    
% 218.34/218.50  |- skos__broader mesh__D010001smesh__D001847
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D010001 2006
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D010001 1996
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D010001 1995
% 218.34/218.50  |- mesh__recordOriginator mesh__D010001 NLM
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D010001 2001
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D010001 2005
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D010001 1994
% 218.34/218.50  |- skos__prefLabel mesh__D010001 Osteitis Deformans
% 218.34/218.50  |- skos__altLabel mesh__D010001 Paget Disease of Bone
% 218.34/218.50  |- mesh__activeMeSHYear mesh__D010001 2000
% 218.34/218.50  |- skos__altLabel mesh__D010001 Paget%27%s Disease of Bone
% 218.34/218.50  |- skos__hiddenLabel mesh__D010001 Paget Disease, Bone
% 218.34/218.50  |- skos__altLabel mesh__D051418 PYK2 Protein Tyrosine Kinase
% 218.34/218.50  |- skos__broader mesh__D051418smesh__D051416
% 218.34/218.50  |- mesh__recordMaintainer mesh__D051418 ags
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D051418 2006
% 218.34/218.51  |- skos__altLabel mesh__D051418 CADTK Protein
% 218.34/218.51  |- skos__altLabel mesh__D051418 RAFTK Protein
% 218.34/218.51  |- skos__altLabel mesh__D051418 Related Adhesion Focal Tyrosine Kinase
% 218.34/218.51  |- mesh__historyNote mesh__D051418 2006%28%1995%29%   
% 218.34/218.51  |- skos__altLabel mesh__D051418 Cell Adhesion Kinase Beta
% 218.34/218.51  |- mesh__dateCreated mesh__D051418 2005-06-30
% 218.34/218.51  |- skos__altLabel mesh__D051418 FAK Autokinase
% 218.34/218.51  |- skos__hiddenLabel mesh__D051418 Proline Rich Tyrosine Kinase 2
% 218.34/218.51  |- skos__scopeNote mesh__D051418
% 218.34/218.51       A non-receptor protein-tyrosine kinase that is expressed primarily in the BRAIN; OSTEOBLASTS; and LYMPHOID CELLS. In the CENTRAL NERVOUS SYSTEM focal adhesion kinase 2 modulates ION CHANNEL function and MITOGEN-ACTIVATED PROTEIN KINASES activity.%A%    
% 218.34/218.51  |- skos__hiddenLabel mesh__D051418
% 218.34/218.51       Calcium Dependent Protein Tyrosine Kinase
% 218.34/218.51  |- mesh__dateEstablished mesh__D051418 2006-01-01
% 218.34/218.51  |- mesh__dateRevised mesh__D051418 2005-07-20
% 218.34/218.51  |- skos__altLabel mesh__D051418 Calcium-Dependent Protein Tyrosine Kinase
% 218.34/218.51  |- mesh__recordOriginator mesh__D051418 DRC
% 218.34/218.51  |- skos__prefLabel mesh__D051418 Focal Adhesion Kinase 2
% 218.34/218.51  |- rdf__type mesh__D051418sskos__Concept
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D051418 2006A
% 218.34/218.51  |- skos__altLabel mesh__D051418 Focal Adhesion Kinase Autokinase
% 218.34/218.51  |- skos__altLabel mesh__D051418 Proline-Rich Tyrosine Kinase 2
% 218.34/218.51  |- mesh__publicMeSHNote mesh__D051418
% 218.34/218.51       2006; FOCAL ADHESION KINASE 2 was indexed under PROTEIN-TYROSINE KINASE 1995-2005%A%  
% 218.34/218.51  |- skos__altLabel mesh__D051418 Protein Tyrosine Kinase PYK2
% 218.34/218.51  |- mesh__recordAuthorizer mesh__D051418 ags
% 218.34/218.51  |- skos__annotation mesh__D015295
% 218.34/218.51       GEN or unspecified; prefer specifics; DF: note short X ref%A%  
% 218.34/218.51  |- skos__hiddenLabel mesh__D015295 Antigens, CA
% 218.34/218.51  |- skos__scopeNote mesh__D015295
% 218.34/218.51       Carbohydrate antigens expressed by malignant tissue. They are useful as tumor markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies.%A%    
% 218.34/218.51  |- mesh__recordMaintainer mesh__D015295 ssb
% 218.34/218.51  |- mesh__dateCreated mesh__D015295 1988-05-24
% 218.34/218.51  |- mesh__recordAuthorizer mesh__D015295 sjn
% 218.34/218.51  |- skos__hiddenLabel mesh__D015295 Tumor Associated Carbohydrate Antigens
% 218.34/218.51  |- skos__altLabel mesh__D015295 Antigens, Carbohydrate, Tumor-Associated
% 218.34/218.51  |- mesh__historyNote mesh__D015295 89   
% 218.34/218.51  |- skos__broader mesh__D015295smesh__D000951
% 218.34/218.51  |- skos__altLabel mesh__D015295 Tumor-Associated Carbohydrate Antigens
% 218.34/218.51  |- skos__altLabel mesh__D015295 Carcinoma-Associated Antigen
% 218.34/218.51  |- skos__hiddenLabel mesh__D015295 Antigen, CA
% 218.34/218.51  |- skos__hiddenLabel mesh__D015295 Antigens, Cancer-Associated Carbohydrate
% 218.34/218.51  |- skos__hiddenLabel mesh__D015295 Carbohydrate Antigens, Cancer-Associated
% 218.34/218.51  |- skos__altLabel mesh__D015295 CA%28%Oxford%29% Antigen
% 218.34/218.51  |- skos__hiddenLabel mesh__D015295 Cancer Associated Carbohydrate Antigens
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D015295 2006
% 218.34/218.51  |- skos__altLabel mesh__D015295 Carbohydrate Antigens, Tumor-Associated
% 218.34/218.51  |- skos__broader mesh__D015295smesh__D014408
% 218.34/218.51  |- skos__altLabel mesh__D015295 Epitectin
% 218.34/218.51  |- skos__altLabel mesh__D015295 Antigen, Carcinoma-Associated
% 218.34/218.51  |- skos__prefLabel mesh__D015295 Antigens, Tumor-Associated, Carbohydrate
% 218.34/218.51  |- skos__historyNote mesh__D015295 Antigens, Neoplasm %28%1973-1988%29%
% 218.34/218.51  |- skos__hiddenLabel mesh__D015295 Carbohydrate Antigens, Tumor Associated
% 218.34/218.51  |- skos__broader mesh__D015295smesh__D000939
% 218.34/218.51  |- skos__hiddenLabel mesh__D015295 Carcinoma Associated Antigen
% 218.34/218.51  |- mesh__dateRevised mesh__D015295 2005-06-30
% 218.34/218.51  |- skos__altLabel mesh__D015295 CA Antigens
% 218.34/218.51  |- skos__hiddenLabel mesh__D015295 Antigens, Tumor-Associated Carbohydrate
% 218.34/218.51  |- mesh__recordOriginator mesh__D015295 RLS
% 218.34/218.51  |- skos__hiddenLabel mesh__D015295 Antigen, Carcinoma Associated
% 218.34/218.51  |- skos__altLabel mesh__D015295 CA Antigen
% 218.34/218.51  |- mesh__publicMeSHNote mesh__D015295 89   
% 218.34/218.51  |- rdf__type mesh__D015295sskos__Concept
% 218.34/218.51  |- skos__altLabel mesh__D015295 Cancer-Associated Carbohydrate Antigens
% 218.34/218.51  |- mesh__dateEstablished mesh__D015295 1989-01-01
% 218.34/218.51  |- mesh__historyNote mesh__D001275 98%28%73%29%   
% 218.34/218.51  |- mesh__dateEstablished mesh__D001275 1977-01-01
% 218.34/218.51  |- skos__altLabel mesh__D001275 ATP Citrate Synthase
% 218.34/218.51  |- skos__prefLabel mesh__D001275 ATP Citrate %28%pro-S%29%-Lyase
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D001275 2006
% 218.34/218.51  |- skos__hiddenLabel mesh__D001275 Synthase, ATP Citrate
% 218.34/218.51  |- skos__hiddenLabel mesh__D001275 Lyase, ATP-Dependent Citrate
% 218.34/218.51  |- skos__hiddenLabel mesh__D001275 Citrate Lyase, ATP-Dependent
% 218.34/218.51  |- skos__altLabel mesh__D001275 ATP Citrate Lyase
% 218.34/218.51  |- skos__scopeNote mesh__D001275
% 218.34/218.51       An enzyme that, in the presence of ATP and COENZYME A, catalyzes the cleavage of citrate to yield acetyl CoA, oxaloacetate, ADP, and ORTHOPHOSPHATE. This reaction represents an important step in fatty acid biosynthesis. This enzyme was formerly listed as EC 4.1.3.8.%A%    
% 218.34/218.51  |- rdf__type mesh__D001275sskos__Concept
% 218.34/218.51  |- mesh__publicMeSHNote mesh__D001275
% 218.34/218.51       98; see ATP CITRATE LYASE 1977-97; see KETOACID-LYASES 1973-76%A%  
% 218.34/218.51  |- skos__hiddenLabel mesh__D001275 Citrate Lyase, ATP
% 218.34/218.51  |- mesh__recordOriginator mesh__D001275 NLM
% 218.34/218.51  |- mesh__recordAuthorizer mesh__D001275 sjn
% 218.34/218.51  |- skos__hiddenLabel mesh__D001275 Citrate Synthase, ATP
% 218.34/218.51  |- skos__historyNote mesh__D001275 Lyases %28%1966-1972%29%
% 218.34/218.51  |- skos__altLabel mesh__D001275 Citrate Cleavage Enzyme
% 218.34/218.51  |- mesh__dateRevised mesh__D001275 2005-06-30
% 218.34/218.51  |- mesh__dateCreated mesh__D001275 1999-01-01
% 218.34/218.51  |- skos__hiddenLabel mesh__D001275 ATP Dependent Citrate Lyase
% 218.34/218.51  |- skos__hiddenLabel mesh__D001275 Lyase, ATP Citrate
% 218.34/218.51  |- mesh__recordMaintainer mesh__D001275 jmp
% 218.34/218.51  |- skos__altLabel mesh__D001275 ATP Citrate %28%pro-3S%29%-Lyase
% 218.34/218.51  |- skos__broader mesh__D001275smesh__D000217
% 218.34/218.51  |- skos__hiddenLabel mesh__D001275 Cleavage Enzyme, Citrate
% 218.34/218.51  |- skos__altLabel mesh__D001275 ATP-Dependent Citrate Lyase
% 218.34/218.51  |- skos__altLabel mesh__D019686 Hyssop
% 218.34/218.51  |- mesh__publicMeSHNote mesh__D019686 1998   
% 218.34/218.51  |- mesh__dateCreated mesh__D019686 1997-06-20
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D019686 2006
% 218.34/218.51  |- skos__broader mesh__D019686smesh__D019684
% 218.34/218.51  |- mesh__dateRevised mesh__D019686 2002-07-03
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D019686 2005
% 218.34/218.51  |- rdf__type mesh__D019686sskos__Concept
% 218.34/218.51  |- mesh__recordMaintainer mesh__D019686 ssb
% 218.34/218.51  |- skos__scopeNote mesh__D019686
% 218.34/218.51       The mint plant family. They are characteristically aromatic, and many of them are cultivated for their oils. Most have square stems, opposite leaves, and two-lipped, open-mouthed, tubular corollas %28%united petals%29%, with five-lobed, bell-like calyxes %28%united sepals%29%.%A%    
% 218.34/218.51  |- mesh__recordOriginator mesh__D019686 JLS
% 218.34/218.51  |- mesh__recordAuthorizer mesh__D019686 sjn
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D019686 2004
% 218.34/218.51  |- skos__annotation mesh__D019686
% 218.34/218.51       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.34/218.51  |- skos__altLabel mesh__D019686 Labiatae
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D019686 2003
% 218.34/218.51  |- mesh__dateEstablished mesh__D019686 1998-01-01
% 218.34/218.51  |- skos__prefLabel mesh__D019686 Lamiaceae
% 218.34/218.51  |- mesh__historyNote mesh__D019686 1998   
% 218.34/218.51  |- skos__historyNote mesh__D005666 Disulfides %28%1973-1974%29%
% 218.34/218.51  |- skos__historyNote mesh__D005666 Pyrimidines %28%1973-1974%29%
% 218.34/218.51  |- mesh__recordAuthorizer mesh__D005666 sjn
% 218.34/218.51  |- rdf__type mesh__D005666sskos__Concept
% 218.34/218.51  |- mesh__dateRevised mesh__D005666 2005-06-30
% 218.34/218.51  |- mesh__publicMeSHNote mesh__D005666
% 218.34/218.51       91; was see under PYRIMIDINES 1979-90; was THIAMINE TETRAHYDROFURFURYL DISULFIDE see under PYRIMIDINES 1975-78%A%  
% 218.34/218.51  |- skos__hiddenLabel mesh__D005666 Disulfide, Thiamine Tetrahydrofurfuryl
% 218.34/218.51  |- skos__altLabel mesh__D005666 Thiamine Tetrahydrofurfuryl Disulfide
% 218.34/218.51  |- mesh__dateEstablished mesh__D005666 1991-01-01
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D005666 2006
% 218.34/218.51  |- mesh__recordMaintainer mesh__D005666 ssb
% 218.34/218.51  |- mesh__historyNote mesh__D005666
% 218.34/218.51       91%28%79%29%; was see under PYRIMIDINES 1979-90; was THIAMINE TETRAHYDROFURFURYL DISULFIDE see under PYRIMIDINES 1975-78%A%  
% 218.34/218.51  |- skos__prefLabel mesh__D005666 Fursultiamin
% 218.34/218.51  |- skos__broader mesh__D005666smesh__D011743
% 218.34/218.51  |- skos__hiddenLabel mesh__D005666 Monohydrochloride, Fursultiamin
% 218.34/218.51  |- mesh__onlineNote mesh__D005666
% 218.34/218.51       use FURSULTIAMIN to search THIAMINE TETRAHYDROFURFURYL DISULFIDE 1975-78%A%  
% 218.34/218.51  |- skos__broader mesh__D005666smesh__D013831
% 218.34/218.51  |- skos__hiddenLabel mesh__D005666 Hydrochloride, Fursultiamin
% 218.34/218.51  |- skos__altLabel mesh__D005666 Fursultiamine
% 218.34/218.51  |- skos__scopeNote mesh__D005666
% 218.34/218.51       Compound used for therapy of thiamine deficiency. It has also been suggested for several non-deficiency disorders but has not yet proven useful.%A%    
% 218.34/218.51  |- skos__historyNote mesh__D005666 Furans %28%1973-1974%29%
% 218.34/218.51  |- skos__annotation mesh__D005666 DF: TTFD   
% 218.34/218.51  |- mesh__recordOriginator mesh__D005666 NLM
% 218.34/218.51  |- mesh__dateCreated mesh__D005666 1974-11-19
% 218.34/218.51  |- skos__scopeNote mesh__D038042
% 218.34/218.51       Formation of MYELOID CELLS from the pluripotent HEMATOPOIETIC STEM CELLS in the BONE MARROW via MYELOID STEM CELLS. Myelopoiesis generally refers to the production of leukocytes in blood, such as MONOCYTES and GRANULOCYTES. This process also produces precursor cells for MACROPHAGE and DENDRITIC CELLS found in the lymphoid tissue.%A%    
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D038042 2005A
% 218.34/218.51  |- mesh__recordMaintainer mesh__D038042 jls
% 218.34/218.51  |- mesh__publicMeSHNote mesh__D038042 2003; see LEUKOPOIESIS 1998-2002   
% 218.34/218.51  |- mesh__recordOriginator mesh__D038042 lkt
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D038042 2005
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D038042 2004
% 218.34/218.51  |- skos__historyNote mesh__D038042 Hematopoiesis %28%1966-1997%29%
% 218.34/218.51  |- mesh__historyNote mesh__D038042 2003; use LEUKOPOIESIS 1998-2002   
% 218.34/218.51  |- mesh__dateRevised mesh__D038042 2004-07-29
% 218.34/218.51  |- rdf__type mesh__D038042sskos__Concept
% 218.34/218.51  |- mesh__recordAuthorizer mesh__D038042 jls
% 218.34/218.51  |- skos__prefLabel mesh__D038042 Myelopoiesis
% 218.34/218.51  |- skos__broader mesh__D038042smesh__D019891
% 218.34/218.51  |- mesh__dateCreated mesh__D038042 2002-07-03
% 218.34/218.51  |- skos__historyNote mesh__D038042 Leukopoiesis %28%1998-2002%29%
% 218.34/218.51  |- mesh__dateEstablished mesh__D038042 2003-01-01
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D038042 2006
% 218.34/218.51  |- rdf__type mesh__D024022sskos__Concept
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D024022 2006
% 218.34/218.51  |- skos__scopeNote mesh__D024022
% 218.34/218.51       A family of structurally related collagens that form the characteristic collagen fibril bundles seen in CONNECTIVE TISSUE.%A%    
% 218.34/218.51  |- skos__prefLabel mesh__D024022 Fibrillar Collagens
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D024022 2005
% 218.34/218.51  |- mesh__publicMeSHNote mesh__D024022 2002   
% 218.34/218.51  |- mesh__dateCreated mesh__D024022 2001-07-25
% 218.34/218.51  |- skos__historyNote mesh__D024022 Collagen %28%1966-2001%29%
% 218.34/218.51  |- mesh__dateRevised mesh__D024022 2004-07-07
% 218.34/218.51  |- skos__altLabel mesh__D024022 Fibrillar Collagen
% 218.34/218.51  |- skos__annotation mesh__D024022
% 218.34/218.51       GEN; prefer specifics; do not confuse with FIBRIL-ASSOCIATED COLLAGENS or MICROFIBRIL COLLAGEN HEMOSTAT see COLLAGEN; precusors: coord IM with PROCOLLAGEN %28%IM%29%%A%  
% 218.34/218.51  |- skos__hiddenLabel mesh__D024022 Collagen, Fibrillar
% 218.34/218.51  |- mesh__historyNote mesh__D024022 2002   
% 218.34/218.51  |- skos__broader mesh__D024022smesh__D003094
% 218.34/218.51  |- mesh__recordMaintainer mesh__D024022 jmp
% 218.34/218.51  |- skos__hiddenLabel mesh__D024022 Collagens, Fibrillar
% 218.34/218.51  |- mesh__recordOriginator mesh__D024022 jmp
% 218.34/218.51  |- mesh__recordAuthorizer mesh__D024022 sjn
% 218.34/218.51  |- mesh__dateEstablished mesh__D024022 2002-01-01
% 218.34/218.51  |- mesh__historyNote mesh__D010800 91%28%75%29%   
% 218.34/218.51  |- mesh__dateEstablished mesh__D010800 1991-01-01
% 218.34/218.51  |- mesh__dateRevised mesh__D010800 2005-06-30
% 218.34/218.51  |- rdf__type mesh__D010800sskos__Concept
% 218.34/218.51  |- mesh__recordOriginator mesh__D010800 NLM
% 218.34/218.51  |- mesh__dateCreated mesh__D010800 1974-12-12
% 218.34/218.51  |- mesh__recordMaintainer mesh__D010800 SYSTEM
% 218.34/218.51  |- mesh__recordAuthorizer mesh__D010800 sjn
% 218.34/218.51  |- skos__scopeNote mesh__D010800
% 218.34/218.51       A genus of zygomycetous fungi in the family Mucoraceae, order MUCORALES, forming mycelia having a metallic sheen. It has been used for research on phototropism.%A%    
% 218.34/218.51  |- mesh__publicMeSHNote mesh__D010800
% 218.34/218.51       91; see MUCORALES 1986-90, see PHYCOMYCETES 1975-85   
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D010800 2006
% 218.34/218.51  |- skos__broader mesh__D010800smesh__D009090
% 218.34/218.51  |- skos__prefLabel mesh__D010800 Phycomyces
% 218.34/218.51  |- skos__broader mesh__D010002smesh__D001849
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D010002 2003
% 218.34/218.51  |- skos__altLabel mesh__D010002 Recklinghausen%27%s Disease of Bone
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D010002 2000
% 218.34/218.51  |- mesh__historyNote mesh__D010002 67; was OSTEITIS FIBROSA 1963-66   
% 218.34/218.51  |- skos__altLabel mesh__D010002 Recklinghausen Disease of Bone
% 218.34/218.51  |- mesh__publicMeSHNote mesh__D010002 67; was OSTEITIS FIBROSA 1963-66   
% 218.34/218.51  |- skos__scopeNote mesh__D010002
% 218.34/218.51       A fibrous degeneration, cyst formation, and the presence of fibrous nodules in bone, usually due to HYPERPARATHYROIDISM.%A%    
% 218.34/218.51  |- mesh__onlineNote mesh__D010002
% 218.34/218.51       use OSTEITIS FIBROSA CYSTICA to search OSTEITIS FIBROSA 1966%A%  
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D010002 2006
% 218.34/218.51  |- mesh__recordMaintainer mesh__D010002 KEV
% 218.34/218.51  |- skos__prefLabel mesh__D010002 Osteitis Fibrosa Cystica
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D010002 2005
% 218.34/218.51  |- skos__hiddenLabel mesh__D010002 Recklinghausen Disease, Bone
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D010002 2002
% 218.34/218.51  |- skos__hiddenLabel mesh__D010002 Recklinghausens Disease, Bone
% 218.34/218.51  |- mesh__recordAuthorizer mesh__D010002 sjn
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D010002 2004
% 218.34/218.51  |- mesh__dateCreated mesh__D010002 1999-01-01
% 218.34/218.51  |- rdf__type mesh__D010002sskos__Concept
% 218.34/218.51  |- mesh__recordOriginator mesh__D010002 NLM
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D010002 2001
% 218.34/218.51  |- mesh__dateEstablished mesh__D010002 1967-01-01
% 218.34/218.51  |- mesh__dateRevised mesh__D010002 1999-11-03
% 218.34/218.51  |- mesh__historyNote mesh__D051419 2006%28%1991%29%   
% 218.34/218.51  |- skos__broader mesh__D051419smesh__D010750
% 218.34/218.51  |- mesh__publicMeSHNote mesh__D051419
% 218.34/218.51       2006; PAXILLIN was indexed under CYTOSKELETAL PROTEINS %26% PHOSPHOPROTEINS 1991-2005%A%  
% 218.34/218.51  |- skos__prefLabel mesh__D051419 Paxillin
% 218.34/218.51  |- mesh__recordOriginator mesh__D051419 DRC
% 218.34/218.51  |- mesh__dateCreated mesh__D051419 2005-06-30
% 218.34/218.51  |- rdf__type mesh__D051419sskos__Concept
% 218.34/218.51  |- skos__scopeNote mesh__D051419
% 218.34/218.51       Paxillin is a signal transducing adaptor protein for CELL MIGRATION that localizes primarily to FOCAL ADHESIONS. It undergoes PHOSPHORYLATION in response to integrin-mediated CELL ADHESION, and interacts with a variety of proteins including VINCULIN; FOCAL ADHESION KINASE; PROTO-ONCOGENE PROTEIN PP60%28%C-SRC%29%; and PROTO-ONCOGENE PROTEIN C-CRK.%A%    
% 218.34/218.51  |- skos__broader mesh__D051419smesh__D048868
% 218.34/218.51  |- mesh__dateEstablished mesh__D051419 2006-01-01
% 218.34/218.51  |- mesh__recordAuthorizer mesh__D051419 ags
% 218.34/218.51  |- mesh__dateRevised mesh__D051419 2005-07-18
% 218.34/218.51  |- mesh__recordMaintainer mesh__D051419 ags
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D051419 2006A
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D051419 2006
% 218.34/218.51  |- mesh__dateCreated mesh__D015296 1988-05-24
% 218.34/218.51  |- skos__broader mesh__D015296smesh__D002439
% 218.34/218.51  |- mesh__recordMaintainer mesh__D015296 lkw
% 218.34/218.51  |- mesh__recordOriginator mesh__D015296 RLS
% 218.34/218.51  |- skos__hiddenLabel mesh__D015296 FK 749
% 218.34/218.51  |- skos__hiddenLabel mesh__D015296 Sodium, Ceftizoxime
% 218.34/218.51  |- skos__hiddenLabel mesh__D015296 FR13749
% 218.34/218.51  |- skos__hiddenLabel mesh__D015296 SKF88373
% 218.34/218.51  |- skos__hiddenLabel mesh__D015296 SK%26%F 883732
% 218.34/218.51  |- skos__historyNote mesh__D015296 Cephalosporins %28%1979-1981%29%
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D015296 2006
% 218.34/218.51  |- skos__hiddenLabel mesh__D015296 Monosodium Salt, Ceftizoxime
% 218.34/218.51  |- mesh__recordAuthorizer mesh__D015296 sjn
% 218.34/218.51  |- skos__hiddenLabel mesh__D015296 SK%26%F 88373 2
% 218.34/218.51  |- mesh__historyNote mesh__D015296 89   
% 218.34/218.51  |- skos__prefLabel mesh__D015296 Ceftizoxime
% 218.34/218.51  |- skos__hiddenLabel mesh__D015296 FR 13749
% 218.34/218.51  |- rdf__type mesh__D015296sskos__Concept
% 218.34/218.51  |- skos__hiddenLabel mesh__D015296 SKF 88373
% 218.34/218.51  |- skos__altLabel mesh__D015296 Ceftizoxime Monosodium Salt
% 218.34/218.51  |- skos__altLabel mesh__D015296 GlaxoSmithKline Brand of Cetizoxime Sodium
% 218.34/218.51  |- mesh__publicMeSHNote mesh__D015296 89   
% 218.34/218.51  |- skos__historyNote mesh__D015296
% 218.34/218.51       Cefotaxime/analogs %26% derivatives %28%1982-1988%29%
% 218.34/218.51  |- skos__altLabel mesh__D015296 Fujiwasa Brand of Cetizoxime Sodium
% 218.34/218.51  |- mesh__dateEstablished mesh__D015296 1989-01-01
% 218.34/218.51  |- skos__altLabel mesh__D015296 Yamanouchi Brand of Ceftizoxime Sodium
% 218.34/218.51  |- skos__scopeNote mesh__D015296
% 218.34/218.51       A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.%A%    
% 218.34/218.51  |- skos__hiddenLabel mesh__D015296 Salt, Ceftizoxime Monosodium
% 218.34/218.51  |- mesh__dateRevised mesh__D015296 2005-06-30
% 218.34/218.51  |- skos__altLabel mesh__D015296 FK-749
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D009259 2006
% 218.34/218.51  |- skos__prefLabel mesh__D009259 Nail Biting
% 218.34/218.51  |- skos__altLabel mesh__D009259 Onychophagia
% 218.34/218.51  |- skos__scopeNote mesh__D009259
% 218.34/218.51       Common form of habitual body manipulation which is an expression of tension.%A%    
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D009259 2005
% 218.34/218.51  |- skos__hiddenLabel mesh__D009259 Biting, Nail
% 218.34/218.51  |- mesh__recordMaintainer mesh__D009259 JLS
% 218.34/218.51  |- mesh__recordAuthorizer mesh__D009259 sjn
% 218.34/218.51  |- mesh__recordOriginator mesh__D009259 NLM
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D009259 2004
% 218.34/218.51  |- skos__broader mesh__D009259smesh__D006184
% 218.34/218.51  |- mesh__dateCreated mesh__D009259 1999-01-01
% 218.34/218.51  |- mesh__dateRevised mesh__D009259 2002-07-02
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D009259 2003
% 218.34/218.51  |- rdf__type mesh__D009259sskos__Concept
% 218.34/218.51  |- skos__broader mesh__D001276smesh__D010430
% 218.34/218.51  |- skos__hiddenLabel mesh__D001276 Pyrophosphorylase, Phosphoribosyl-ATP
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D001276 2006
% 218.34/218.51  |- skos__altLabel mesh__D001276 Phosphoribosyl-ATP Pyrophosphorylase
% 218.34/218.51  |- mesh__dateEstablished mesh__D001276 1991-01-01
% 218.34/218.51  |- skos__historyNote mesh__D001276 Pentosephosphates %28%1971-1975%29%
% 218.34/218.51  |- mesh__dateCreated mesh__D001276 1975-07-23
% 218.34/218.51  |- skos__historyNote mesh__D001276 Adenosine Triphosphate %28%1972-1975%29%
% 218.34/218.51  |- mesh__recordOriginator mesh__D001276 RLS
% 218.34/218.51  |- mesh__dateRevised mesh__D001276 2003-07-09
% 218.34/218.51  |- rdf__type mesh__D001276sskos__Concept
% 218.34/218.51  |- skos__prefLabel mesh__D001276 ATP Phosphoribosyltransferase
% 218.34/218.51  |- mesh__publicMeSHNote mesh__D001276
% 218.34/218.51       91; was see under PENTOSYLTRANSFERASES 1976-90   
% 218.34/218.51  |- mesh__historyNote mesh__D001276
% 218.34/218.51       91%28%76%29%; was see under PENTOSYLTRANSFERASES 1976-90   
% 218.34/218.51  |- mesh__recordMaintainer mesh__D001276 ssb
% 218.34/218.51  |- skos__hiddenLabel mesh__D001276 Phosphoribosyltransferase, ATP
% 218.34/218.51  |- skos__historyNote mesh__D001276 Pyrophosphoric Acids %28%1971-1975%29%
% 218.34/218.51  |- skos__historyNote mesh__D001276 Pentosyltransferases %28%1971-1975%29%
% 218.34/218.51  |- skos__hiddenLabel mesh__D001276 Phosphoribosyl ATP Pyrophosphorylase
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D001276 2005
% 218.34/218.51  |- skos__scopeNote mesh__D001276
% 218.34/218.51       An enzyme that catalyzes the first step of the pathway for histidine biosynthesis in Salmonella typhimurium. ATP reacts reversibly with 5-phosphoribosyl-1-pyrophosphate to yield N-1-%28%5%27%-phosphoribosyl%29%-ATP and pyrophosphate. EC 2.4.2.17.%A%    
% 218.34/218.51  |- mesh__recordAuthorizer mesh__D001276 sjn
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D001276 2004
% 218.34/218.51  |- skos__broader mesh__D006505Q000662smesh__D006505
% 218.34/218.51  |- mesh__preferredCombination mesh__D006505Q000662smesh__D006520
% 218.34/218.51  |- rdf__type mesh__D006505Q000662smesh__CompoundConcept
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D020430 2002
% 218.34/218.51  |- mesh__historyNote mesh__D020430
% 218.34/218.51       2000; for CUBITAL TUNNEL SYNDROME use ULNAR NERVE COMPRESSION SYNDROMES 1994-1999%A%  
% 218.34/218.51  |- skos__broader mesh__D020430smesh__D017769
% 218.34/218.51  |- skos__hiddenLabel mesh__D020430 Cubital Tunnel Syndromes
% 218.34/218.51  |- skos__historyNote mesh__D020430 Elbow/injuries %28%1969-1999%29%
% 218.34/218.51  |- mesh__dateCreated mesh__D020430 1999-11-03
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D020430 2006
% 218.34/218.51  |- skos__broader mesh__D020430smesh__D020424
% 218.34/218.51  |- rdf__type mesh__D020430sskos__Concept
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D020430 2004
% 218.34/218.51  |- skos__historyNote mesh__D020430
% 218.34/218.51       Nerve Compression Syndromes %28%1974-1999%29%
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D020430 2005
% 218.34/218.51  |- skos__historyNote mesh__D020430 Ulnar Nerve %28%1969-1999%29%
% 218.34/218.51  |- mesh__publicMeSHNote mesh__D020430
% 218.34/218.51       2000; for CUBITAL TUNNEL SYNDROME see ULNAR NERVE COMPRESSION SYNDROME 1994-1999%A%  
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D020430 2001
% 218.34/218.51  |- skos__altLabel mesh__D020430 Ulnar Nerve Compression, Cubital Tunnel
% 218.34/218.51  |- skos__hiddenLabel mesh__D020430 Syndrome, Cubital Tunnel
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D020430 2003
% 218.34/218.51  |- skos__altLabel mesh__D020430 Ulnar Nerve Entrapment, Elbow
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D020430 2000
% 218.34/218.51  |- skos__prefLabel mesh__D020430 Cubital Tunnel Syndrome
% 218.34/218.51  |- mesh__dateEstablished mesh__D020430 2000-01-01
% 218.34/218.51  |- skos__hiddenLabel mesh__D020430 Tunnel Syndromes, Cubital
% 218.34/218.51  |- skos__hiddenLabel mesh__D020430 Syndromes, Cubital Tunnel
% 218.34/218.51  |- skos__hiddenLabel mesh__D020430 Tunnel Syndrome, Cubital
% 218.34/218.51  |- skos__scopeNote mesh__D020430
% 218.34/218.51       Compression of the ULNAR NERVE in the cubital tunnel, which is formed by the two heads of the flexor carpi ulnaris muscle, humeral-ulnar aponeurosis, and medial ligaments of the elbow. This condition may follow trauma or occur in association with processes which produce nerve enlargement or narrowing of the canal. Manifestations include elbow pain and PARESTHESIA radiating distally, weakness of ulnar innervated intrinsic hand muscles, and loss of sensation over the hypothenar region, fifth finger, and ulnar aspect of the ring finger. %28%Joynt, Clinical Neurology, 1995, Ch51, p43%29%%A%    
% 218.34/218.51  |- mesh__recordAuthorizer mesh__D019687 sjn
% 218.34/218.51  |- skos__altLabel mesh__D019687 Inversion of Uterus
% 218.34/218.51  |- skos__historyNote mesh__D019687 Uterine Prolapse %28%1966-1992%29%
% 218.34/218.51  |- mesh__dateEstablished mesh__D019687 1998-01-01
% 218.34/218.51  |- skos__hiddenLabel mesh__D019687 Uterus Inversion
% 218.34/218.51  |- mesh__dateRevised mesh__D019687 2005-06-30
% 218.34/218.51  |- mesh__dateCreated mesh__D019687 1997-06-20
% 218.34/218.51  |- skos__annotation mesh__D019687 do not confuse with UTERINE PROLAPSE   
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D019687 2006
% 218.34/218.51  |- skos__broader mesh__D019687smesh__D014591
% 218.34/218.51  |- skos__hiddenLabel mesh__D019687 Inversion, Uterine
% 218.34/218.51  |- skos__scopeNote mesh__D019687
% 218.34/218.51       A complication of OBSTETRIC LABOR in which the corpus of the UTERUS is forced completely or partially through the UTERINE CERVIX. This can occur during the late stages of labor and is associated with IMMEDIATE POSTPARTUM HEMORRHAGE.%A%    
% 218.34/218.51  |- rdf__type mesh__D019687sskos__Concept
% 218.34/218.51  |- skos__prefLabel mesh__D019687 Uterine Inversion
% 218.34/218.51  |- skos__historyNote mesh__D019687 Uterine Diseases %28%1966-1997%29%
% 218.34/218.51  |- mesh__recordOriginator mesh__D019687 TGC
% 218.34/218.51  |- skos__broader mesh__D019687smesh__D007744
% 218.34/218.51  |- mesh__historyNote mesh__D019687 98; was see UTERINE DISEASES 1993-97   
% 218.34/218.51  |- mesh__recordMaintainer mesh__D019687 lkt
% 218.34/218.51  |- mesh__publicMeSHNote mesh__D019687
% 218.34/218.51       98; was see UTERINE DISEASES 1993-97   
% 218.34/218.51  |- rdf__type mesh__D005667sskos__Concept
% 218.34/218.51  |- skos__altLabel mesh__D005667 Furuncles
% 218.34/218.51  |- skos__related mesh__D005667smesh__D002270
% 218.34/218.51  |- mesh__recordOriginator mesh__D005667 NLM
% 218.34/218.51  |- mesh__dateRevised mesh__D005667 2004-07-27
% 218.34/218.51  |- skos__broader mesh__D005667smesh__D013207
% 218.34/218.51  |- skos__hiddenLabel mesh__D005667 Furuncle
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D005667 2006
% 218.34/218.51  |- skos__annotation mesh__D005667
% 218.34/218.51       consider also CARBUNCLE, also usually caused by Staph %28%but not malignant carbuncle which = ANTHRAX%29%%A%  
% 218.34/218.51  |- mesh__recordAuthorizer mesh__D005667 jls
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D005667 2005
% 218.34/218.51  |- mesh__dateCreated mesh__D005667 1999-01-01
% 218.34/218.51  |- skos__broader mesh__D005667smesh__D005393
% 218.34/218.51  |- skos__hiddenLabel mesh__D005667 Furunculoses
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D005667 2005A
% 218.34/218.51  |- skos__scopeNote mesh__D005667
% 218.34/218.51       A persistent skin infection marked by the presence of furuncles, often chronic and recurrent. In humans, the causative agent is various species of STAPHYLOCOCCUS. In salmonid fish %28%SALMONIDS%29%, the pathogen is AEROMONAS SALMONICIDA.%A%    
% 218.34/218.51  |- mesh__recordMaintainer mesh__D005667 jls
% 218.34/218.51  |- skos__prefLabel mesh__D005667 Furunculosis
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D024821 2006
% 218.34/218.51  |- skos__hiddenLabel mesh__D024821 Cardiovascular Syndromes, Metabolic
% 218.34/218.51  |- skos__altLabel mesh__D024821 Metabolic Cardiovascular Syndrome
% 218.34/218.51  |- skos__broader mesh__D024821smesh__D007333
% 218.34/218.51  |- skos__altLabel mesh__D024821 Insulin Resistance Syndrome X
% 218.34/218.51  |- skos__scopeNote mesh__D024821
% 218.34/218.51       A cluster of metabolic risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome X include excess ABDOMINAL FAT; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic %28%THROMBOSIS%29% state. %28%from AHA/NHLBI/ADA Conference Proceedings, Circulation 2004; 109:551-556%29%%A%    
% 218.34/218.51  |- mesh__recordOriginator mesh__D024821 nns
% 218.34/218.51  |- mesh__recordMaintainer mesh__D024821 ags
% 218.34/218.51  |- skos__related mesh__D024821smesh__D003924
% 218.34/218.51  |- mesh__recordAuthorizer mesh__D024821 ags
% 218.34/218.51  |- skos__altLabel mesh__D024821 Dysmetabolic Syndrome X
% 218.34/218.51  |- mesh__dateRevised mesh__D024821 2005-07-20
% 218.34/218.51  |- skos__related mesh__D024821smesh__D017566
% 218.34/218.51  |- skos__altLabel mesh__D024821 Syndrome X, Insulin Resistance
% 218.34/218.51  |- skos__historyNote mesh__D024821 Insulin Resistance %28%1992-2001%29%
% 218.34/218.51  |- skos__hiddenLabel mesh__D024821 X Syndrome, Metabolic
% 218.34/218.51  |- skos__hiddenLabel mesh__D024821 Syndrome, Metabolic Cardiovascular
% 218.34/218.51  |- skos__hiddenLabel mesh__D024821 Syndrome X, Reaven
% 218.34/218.51  |- skos__altLabel mesh__D024821 Metabolic X Syndrome
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D024821 2006A
% 218.34/218.51  |- skos__broader mesh__D024821smesh__D008659
% 218.34/218.51  |- skos__annotation mesh__D024821
% 218.34/218.51       do not confuse with SYNDROME X, CARDIAC or X SYNDROME, ANGINA see MICROVASCULAR ANGINA%A%  
% 218.34/218.51  |- skos__altLabel mesh__D024821 Syndrome X, Metabolic
% 218.34/218.51  |- mesh__dateCreated mesh__D024821 2001-07-25
% 218.34/218.51  |- skos__hiddenLabel mesh__D024821 Syndrome X, Dysmetabolic
% 218.34/218.51  |- skos__prefLabel mesh__D024821 Metabolic Syndrome X
% 218.34/218.51  |- skos__hiddenLabel mesh__D024821 Syndrome, Metabolic X
% 218.34/218.51  |- skos__altLabel mesh__D024821 Reaven Syndrome X
% 218.34/218.51  |- skos__hiddenLabel mesh__D024821 Cardiovascular Syndrome, Metabolic
% 218.34/218.51  |- mesh__dateEstablished mesh__D024821 2002-01-01
% 218.34/218.51  |- mesh__publicMeSHNote mesh__D024821
% 218.34/218.51       2002; for REAVEN SYNDROME X see INSULIN RESISTANCE 1998-2001%A%  
% 218.34/218.51  |- mesh__historyNote mesh__D024821
% 218.34/218.51       2002; for REAVEN SYNDROME X use INSULIN RESISTANCE 1998-2001%A%  
% 218.34/218.51  |- skos__historyNote mesh__D024821 Syndrome X %28%1996-2001%29%
% 218.34/218.51  |- rdf__type mesh__D024821sskos__Concept
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D010003 2000
% 218.34/218.51  |- skos__hiddenLabel mesh__D010003 Degenerative Arthritides
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D010003 2003
% 218.34/218.51  |- mesh__recordAuthorizer mesh__D010003 PLS
% 218.34/218.51  |- mesh__activeMeSHYear mesh__D010003 1997
% 218.34/218.51  |- skos__altLabel mesh__D010003 Osteoarthrosis
% 218.34/218.51  |- skos__hiddenLabel mesh__D010003 Osteoarthritides
% 218.34/218.51  |- mesh__dateRevised mesh__D010003 1996-06-10
% 218.34/218.51  |- skos__broader mesh__D010003smesh__D001168
% 218.34/218.51  |- skos__hiddenLabel mesh__D010003 Arthritides, Degenerative
% 218.34/218.51  |- skos__scopeNote mesh__D010003
% 218.34/218.51       A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.%A%    
% 218.34/218.51  |- skos__altLabel mesh__D010003 Arthritis, Degenerative
% 218.34/218.51  |- skos__hiddenLabel mesh__D010003 Degenerative Arthritis
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D010003 2006
% 218.34/218.52  |- skos__broader mesh__D010003smesh__D012216
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D010003 2002
% 218.34/218.52  |- mesh__recordMaintainer mesh__D010003 TPW
% 218.34/218.52  |- mesh__recordOriginator mesh__D010003 NLM
% 218.34/218.52  |- mesh__dateCreated mesh__D010003 1999-01-01
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D010003 2005
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D010003 1999
% 218.34/218.52  |- rdf__type mesh__D010003sskos__Concept
% 218.34/218.52  |- skos__hiddenLabel mesh__D010003 Osteoarthroses
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D010003 2001
% 218.34/218.52  |- skos__prefLabel mesh__D010003 Osteoarthritis
% 218.34/218.52  |- skos__annotation mesh__D010003 most common form of arthritis   
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D010003 2004
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D010003 1998
% 218.34/218.52  |- skos__altLabel mesh__D001277
% 218.34/218.52       ATP-Guanosine Phosphate Pyrophosphotransferase
% 218.34/218.52  |- skos__hiddenLabel mesh__D001277 Factor, Stringent
% 218.34/218.52  |- skos__historyNote mesh__D001277 Guanine Nucleotides %28%1966-1979%29%
% 218.34/218.52  |- skos__hiddenLabel mesh__D001277
% 218.34/218.52       ATP Guanosine Phosphate Pyrophosphotransferase
% 218.34/218.52  |- skos__broader mesh__D001277smesh__D017854
% 218.34/218.52  |- mesh__recordAuthorizer mesh__D001277 sjn
% 218.34/218.52  |- mesh__dateRevised mesh__D001277 2003-07-09
% 218.34/218.52  |- rdf__type mesh__D001277sskos__Concept
% 218.34/218.52  |- skos__historyNote mesh__D001277 Ribosomal Proteins %28%1975-1979%29%
% 218.34/218.52  |- skos__historyNote mesh__D001277 Pyrophosphates %28%1966-1979%29%
% 218.34/218.52  |- mesh__onlineNote mesh__D001277
% 218.34/218.52       use GTP PYROPHOSPHOKINASE to search ATP-GUANOSINE PHOSPHATE PYROPHOSPHOTRANSFERASE 1980-91%A%  
% 218.34/218.52  |- skos__scopeNote mesh__D001277
% 218.34/218.52       An enzyme that catalyzes reversibly the transfer of a pyrophosphate group from ATP to the 3%27%-OH group of GDP or GTP with the formation of guanosine 3%27%-diphosphate 5%27%-diphosphate or guanosine 3%27%-diphosphate 5%27%-triphosphate and AMP. The enzyme, also called stringent factor, is located in the relA gene in stringent strains of bacteria. The above synthesis is induced by mRNA and uncharged tRNA which is bound to the aminoacyl-t-RNA binding site of the ribosome by a codon-specific association. EC 2.7.6.5.%A%    
% 218.34/218.52  |- mesh__dateCreated mesh__D001277 1979-05-23
% 218.34/218.52  |- skos__hiddenLabel mesh__D001277
% 218.34/218.52       Pyrophosphotransferase, ATP-Guanosine Phosphate
% 218.34/218.52  |- mesh__recordOriginator mesh__D001277 RLS
% 218.34/218.52  |- skos__historyNote mesh__D001277 Phosphotransferases %28%1966-1973%29%
% 218.34/218.52  |- skos__historyNote mesh__D001277 Adenosine Triphosphate %28%1966-1979%29%
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D001277 2005
% 218.34/218.52  |- skos__historyNote mesh__D001277
% 218.34/218.52       Phosphotransferases, ATP %28%1974-1979%29%
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D001277 2004
% 218.34/218.52  |- mesh__recordMaintainer mesh__D001277 ssb
% 218.34/218.52  |- mesh__publicMeSHNote mesh__D001277
% 218.34/218.52       92; was ATP-GUANOSINE PHOSPHATE PYROPHOSPHOTRANSFERASE 1980-91 %28%see under PHOSPHOTRANSFERASES, ATP 1980-90%29%%A%  
% 218.34/218.52  |- skos__altLabel mesh__D001277 Stringent Factor
% 218.34/218.52  |- skos__hiddenLabel mesh__D001277 Pyrophosphokinase, GTP
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D001277 2006
% 218.34/218.52  |- skos__historyNote mesh__D001277 Bacterial Proteins %28%1966-1979%29%
% 218.34/218.52  |- skos__prefLabel mesh__D001277 GTP Pyrophosphokinase
% 218.34/218.52  |- mesh__dateEstablished mesh__D001277 1991-01-01
% 218.34/218.52  |- mesh__historyNote mesh__D001277
% 218.34/218.52       92; was ATP-GUANOSINE PHOSPHATE PYROPHOSPHOTRANSFERASE 1980-91 %28%see under PHOSPHOTRANSFERASES, ATP 1980-90%29%%A%  
% 218.34/218.52  |- skos__broader mesh__D008084Q000037smesh__D008084
% 218.34/218.52  |- mesh__preferredCombination mesh__D008084Q000037smesh__D016859
% 218.34/218.52  |- rdf__type mesh__D008084Q000037smesh__CompoundConcept
% 218.34/218.52  |- skos__annotation mesh__D006760
% 218.34/218.52       being in a hosp or being placed in a hosp: do not confuse with PATIENT ADMISSION or PATIENT READMISSION%A%  
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D006760 2006
% 218.34/218.52  |- mesh__recordMaintainer mesh__D006760 PXP
% 218.34/218.52  |- skos__related mesh__D006760smesh__D007902
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D006760 1998
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D006760 2004
% 218.34/218.52  |- skos__related mesh__D006760smesh__D010351
% 218.34/218.52  |- skos__related mesh__D006760smesh__D002673
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D006760 2005
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D006760 2002
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D006760 2003
% 218.34/218.52  |- skos__hiddenLabel mesh__D006760 Hospitalizations
% 218.34/218.52  |- mesh__recordAuthorizer mesh__D006760 SJN
% 218.34/218.52  |- mesh__recordOriginator mesh__D006760 NLM
% 218.34/218.52  |- skos__related mesh__D006760smesh__D007326
% 218.34/218.52  |- skos__scopeNote mesh__D006760
% 218.34/218.52       The confinement of a patient in a hospital.     
% 218.34/218.52  |- mesh__dateRevised mesh__D006760 1997-06-20
% 218.34/218.52  |- skos__broader mesh__D006760smesh__D005791
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D006760 2001
% 218.34/218.52  |- mesh__dateCreated mesh__D006760 1999-01-01
% 218.34/218.52  |- rdf__type mesh__D006760sskos__Concept
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D006760 2000
% 218.34/218.52  |- skos__prefLabel mesh__D006760 Hospitalization
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D006760 1999
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D020431 2002
% 218.34/218.52  |- mesh__dateCreated mesh__D020431 1999-11-08
% 218.34/218.52  |- mesh__publicMeSHNote mesh__D020431 2000   
% 218.34/218.52  |- rdf__type mesh__D020431sskos__Concept
% 218.34/218.52  |- mesh__historyNote mesh__D020431 2000   
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D020431 2006
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D020431 2001
% 218.34/218.52  |- skos__historyNote mesh__D020431 Olfactory Nerve %28%1963-1999%29%
% 218.34/218.52  |- skos__historyNote mesh__D020431 Olfaction Disorders %28%1963-1999%29%
% 218.34/218.52  |- skos__historyNote mesh__D020431 Cranial Nerve Diseases %28%1981-1999%29%
% 218.34/218.52  |- skos__altLabel mesh__D020431 Cranial Nerve I Diseases
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D020431 2004
% 218.34/218.52  |- skos__prefLabel mesh__D020431 Olfactory Nerve Diseases
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D020431 2005
% 218.34/218.52  |- skos__annotation mesh__D020431
% 218.34/218.52       neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D020431 2000
% 218.34/218.52  |- skos__scopeNote mesh__D020431
% 218.34/218.52       Diseases of the first cranial %28%olfactory%29% nerve, which usually feature anosmia or other alterations in the sense of smell and taste. Anosmia may be associated with NEOPLASMS; CENTRAL NERVOUS SYSTEM INFECTIONS; CRANIOCEREBRAL TRAUMA; inherited conditions; toxins; METABOLIC DISEASES; tobacco abuse; and other conditions. %28%Adams et al., Principles of Neurology, 6th ed, pp229-31%29%%A%    
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D020431 2003
% 218.34/218.52  |- mesh__dateEstablished mesh__D020431 2000-01-01
% 218.34/218.52  |- skos__altLabel mesh__D020431 Cranial Nerve I Disorders
% 218.34/218.52  |- skos__related mesh__D020431smesh__D000857
% 218.34/218.52  |- skos__related mesh__D020431smesh__D020209
% 218.34/218.52  |- skos__related mesh__D020431smesh__D006259
% 218.34/218.52  |- skos__broader mesh__D020431smesh__D003389
% 218.34/218.52  |- skos__altLabel mesh__D020431 First Cranial Nerve Diseases
% 218.34/218.52  |- skos__hiddenLabel mesh__D020431 Olfactory Nerve Disease
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D019688 2006
% 218.34/218.52  |- skos__prefLabel mesh__D019688
% 218.34/218.52       Gram-Negative Oxygenic Photosynthetic Bacteria
% 218.34/218.52  |- rdf__type mesh__D019688sskos__Concept
% 218.34/218.52  |- mesh__dateEstablished mesh__D019688 1998-01-01
% 218.34/218.52  |- mesh__dateCreated mesh__D019688 1997-06-20
% 218.34/218.52  |- mesh__historyNote mesh__D019688 98   
% 218.34/218.52  |- mesh__recordOriginator mesh__D019688 NDW
% 218.34/218.52  |- skos__historyNote mesh__D019688 Cyanobacteria %28%1970-1997%29%
% 218.34/218.52  |- mesh__publicMeSHNote mesh__D019688 98   
% 218.34/218.52  |- skos__scopeNote mesh__D019688
% 218.34/218.52       Widely distributed unicellular or multicellular bacteria. The CYANOBACTERIA use chlorophyll a and phycobilins for oxygenic photosynthesis while genera in the Prochlorales use both chlorophyll a and b but not phycobilins.%A%    
% 218.34/218.52  |- skos__annotation mesh__D019688
% 218.34/218.52       GEN or unspecified; prefer specifics; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%; DF: GRAM NEG OXYGENIC PHOTOSYN BACT%A%  
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D019688 2006A
% 218.34/218.52  |- skos__altLabel mesh__D019688
% 218.34/218.52       Gram Negative Oxygenic Photosynthetic Bacteria
% 218.34/218.52  |- skos__broader mesh__D019688smesh__D006090
% 218.34/218.52  |- mesh__dateRevised mesh__D019688 2005-07-27
% 218.34/218.52  |- mesh__recordMaintainer mesh__D019688 ags
% 218.34/218.52  |- mesh__recordAuthorizer mesh__D019688 ags
% 218.34/218.52  |- rdf__type mesh__D005668sskos__Concept
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D005668 2003
% 218.34/218.52  |- skos__scopeNote mesh__D005668
% 218.34/218.52       Used formerly as antimicrobial food additive. It causes mutations in many cell cultures and may be carcinogenic.%A%    
% 218.34/218.52  |- skos__historyNote mesh__D005668 Nitrofurans %28%1966-1977%29%
% 218.34/218.52  |- skos__broader mesh__D005668smesh__D009581
% 218.34/218.52  |- skos__historyNote mesh__D005668 Acrylamides %28%1973-1977%29%
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D005668 2005
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D005668 2004
% 218.34/218.52  |- skos__hiddenLabel mesh__D005668 AF 2
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D005668 2002
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D005668 2006
% 218.34/218.52  |- mesh__recordMaintainer mesh__D005668 CCR
% 218.34/218.52  |- mesh__publicMeSHNote mesh__D005668
% 218.34/218.52       91; was see under NITROFURANS 1978-90   
% 218.34/218.52  |- mesh__dateRevised mesh__D005668 2000-06-21
% 218.34/218.52  |- skos__hiddenLabel mesh__D005668 AF2
% 218.34/218.52  |- skos__prefLabel mesh__D005668 Furylfuramide
% 218.34/218.52  |- mesh__historyNote mesh__D005668
% 218.34/218.52       91%28%78%29%; was see under NITROFURANS 1978-90   
% 218.34/218.52  |- skos__historyNote mesh__D005668 Acrylates %28%1966-1972%29%
% 218.34/218.52  |- mesh__dateEstablished mesh__D005668 1991-01-01
% 218.34/218.52  |- mesh__dateCreated mesh__D005668 1977-04-22
% 218.34/218.52  |- mesh__recordOriginator mesh__D005668 SH
% 218.34/218.52  |- mesh__recordAuthorizer mesh__D005668 sjn
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D005668 2001
% 218.34/218.52  |- skos__annotation mesh__D005668 D25-26 qualif   
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D016390 2000
% 218.34/218.52  |- skos__hiddenLabel mesh__D016390 Occupation, Allied Health
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D016390 1999
% 218.34/218.52  |- mesh__dateEstablished mesh__D016390 1991-01-01
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D016390 2004
% 218.34/218.52  |- mesh__recordAuthorizer mesh__D016390 PLS
% 218.34/218.52  |- skos__hiddenLabel mesh__D016390 Allied Health Occupation
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D016390 2001
% 218.34/218.52  |- skos__broader mesh__D016390smesh__D006281
% 218.34/218.52  |- mesh__recordMaintainer mesh__D016390 KEV
% 218.34/218.52  |- mesh__dateRevised mesh__D016390 1995-05-18
% 218.34/218.52  |- skos__annotation mesh__D016390
% 218.34/218.52       SPEC: SPEC qualif; DF: ALLIED HEALTH OCCUP   
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D016390 2005
% 218.34/218.52  |- skos__altLabel mesh__D016390 Occupations, Allied Health
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D016390 1996
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D016390 2002
% 218.34/218.52  |- mesh__historyNote mesh__D016390
% 218.34/218.52       91; was see HEALTH OCCUPATIONS 1975-90   
% 218.34/218.52  |- mesh__onlineNote mesh__D016390
% 218.34/218.52       use HEALTH OCCUPATIONS to search ALLIED HEALTH OCCUPATIONS 1975-90%A%  
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D016390 2006
% 218.34/218.52  |- skos__scopeNote mesh__D016390
% 218.34/218.52       Occupations of medical personnel who are not physicians, and are qualified by special training and, frequently, by licensure to work in supporting roles in the health care field. These occupations include, but are not limited to, medical technology, physical therapy, physician assistant, etc.%A%    
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D016390 1997
% 218.34/218.52  |- mesh__dateCreated mesh__D016390 1990-05-25
% 218.34/218.52  |- mesh__publicMeSHNote mesh__D016390
% 218.34/218.52       91; was see HEALTH OCCUPATIONS 1975-90   
% 218.34/218.52  |- rdf__type mesh__D016390sskos__Concept
% 218.34/218.52  |- mesh__recordOriginator mesh__D016390 MXR
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D016390 1998
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D016390 2003
% 218.34/218.52  |- skos__prefLabel mesh__D016390 Allied Health Occupations
% 218.34/218.52  |- skos__historyNote mesh__D016390 Health Occupations %28%1974-1990%29%
% 218.34/218.52  |- mesh__dateEstablished mesh__D030061 2002-01-01
% 218.34/218.52  |- mesh__publicMeSHNote mesh__D030061 2002   
% 218.34/218.52  |- skos__prefLabel mesh__D030061 Parechovirus
% 218.34/218.52  |- rdf__type mesh__D030061sskos__Concept
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D030061 2005
% 218.34/218.52  |- skos__altLabel mesh__D030061 Echovirus 22
% 218.34/218.52  |- skos__altLabel mesh__D030061 Human echovirus 22
% 218.34/218.52  |- mesh__recordOriginator mesh__D030061 ags
% 218.34/218.52  |- skos__annotation mesh__D030061
% 218.34/218.52       infection: coord IM with PICORNAVIRIDAE INFECTIONS %28%IM%29%   
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D030061 2006
% 218.34/218.52  |- skos__scopeNote mesh__D030061
% 218.34/218.52       A genus in the family PICORNAVIRIDAE containing one species: Human parechovirus.%A%    
% 218.34/218.52  |- skos__altLabel mesh__D030061 Human echovirus 23
% 218.34/218.52  |- mesh__dateCreated mesh__D030061 2001-07-25
% 218.34/218.52  |- skos__altLabel mesh__D030061 Echovirus 23
% 218.34/218.52  |- skos__broader mesh__D030061smesh__D010849
% 218.34/218.52  |- mesh__historyNote mesh__D030061 2002   
% 218.34/218.52  |- mesh__dateRevised mesh__D030061 2004-07-13
% 218.34/218.52  |- mesh__recordMaintainer mesh__D030061 sjn
% 218.34/218.52  |- mesh__recordAuthorizer mesh__D030061 sjn
% 218.34/218.52  |- skos__altLabel mesh__D002370 Surgical Cast
% 218.34/218.52  |- mesh__dateRevised mesh__D002370 1992-05-07
% 218.34/218.52  |- rdf__type mesh__D002370sskos__Concept
% 218.34/218.52  |- skos__hiddenLabel mesh__D002370 Cast, Fiberglass
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D002370 1998
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D002370 2001
% 218.34/218.52  |- skos__hiddenLabel mesh__D002370 Plastic Cast
% 218.34/218.52  |- skos__annotation mesh__D002370
% 218.34/218.52       %22%cast syndrome%22% %28%duodenal compression caused by wearing a body cast%29% = SUPERIOR MESENTERIC ARTERY SYNDROME if confirmed by text but do not index under CASTS, SURGICAL /adv eff unless particularly discussed%A%  
% 218.34/218.52  |- skos__altLabel mesh__D002370 Surgical Casts
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D002370 1996
% 218.34/218.52  |- skos__scopeNote mesh__D002370
% 218.34/218.52       Dressings made of fiberglass, plastic, or bandage impregnated with plaster of paris used for immobilization of various parts of the body in cases of fractures, dislocations, and infected wounds. In comparison with plaster casts, casts made of fiberglass or plastic are lightweight, radiolucent, able to withstand moisture, and less rigid.%A%    
% 218.34/218.52  |- skos__hiddenLabel mesh__D002370 Casts, Plaster
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D002370 1999
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D002370 2002
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D002370 1997
% 218.34/218.52  |- mesh__dateCreated mesh__D002370 1999-01-01
% 218.34/218.52  |- skos__altLabel mesh__D002370 Cast, Surgical
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D002370 2005
% 218.34/218.52  |- skos__hiddenLabel mesh__D002370 Cast, Plaster
% 218.34/218.52  |- skos__hiddenLabel mesh__D002370 Plaster Cast
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D002370 2003
% 218.34/218.52  |- mesh__recordOriginator mesh__D002370 NLM
% 218.34/218.52  |- skos__broader mesh__D002370smesh__D009984
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D002370 2006
% 218.34/218.52  |- mesh__recordMaintainer mesh__D002370 TGC
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D002370 2004
% 218.34/218.52  |- mesh__recordAuthorizer mesh__D002370 PLS
% 218.34/218.52  |- skos__prefLabel mesh__D002370 Casts, Surgical
% 218.34/218.52  |- skos__hiddenLabel mesh__D002370 Cast, Plastic
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D002370 1994
% 218.34/218.52  |- skos__hiddenLabel mesh__D002370 Casts, Fiberglass
% 218.34/218.52  |- skos__hiddenLabel mesh__D002370 Fiberglass Cast
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D002370 2000
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D002370 1995
% 218.34/218.52  |- skos__hiddenLabel mesh__D002370 Casts, Plastic
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D002370 1993
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D010802 2005
% 218.34/218.52  |- skos__broader mesh__D010802smesh__D002965
% 218.34/218.52  |- mesh__dateRevised mesh__D010802 2002-07-03
% 218.34/218.52  |- skos__prefLabel mesh__D010802 Phylogeny
% 218.34/218.52  |- mesh__publicMeSHNote mesh__D010802
% 218.34/218.52       78; was see under EVOLUTION 1967-77   
% 218.34/218.52  |- mesh__recordAuthorizer mesh__D010802 sjn
% 218.34/218.52  |- rdf__type mesh__D010802sskos__Concept
% 218.34/218.52  |- skos__broader mesh__D010802smesh__D040341
% 218.34/218.52  |- mesh__dateCreated mesh__D010802 1999-01-01
% 218.34/218.52  |- skos__related mesh__D010802smesh__D002965
% 218.34/218.52  |- mesh__historyNote mesh__D010802
% 218.34/218.52       78%28%75%29%; was see under EVOLUTION 1967-77   
% 218.34/218.52  |- mesh__onlineNote mesh__D010802 search EVOLUTION 1967-74   
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D010802 2004
% 218.34/218.52  |- mesh__recordMaintainer mesh__D010802 TGC
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D010802 2003
% 218.34/218.52  |- skos__hiddenLabel mesh__D010802 Phylogenies
% 218.34/218.52  |- skos__broader mesh__D010802smesh__D005075
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D010802 2006
% 218.34/218.52  |- mesh__recordOriginator mesh__D010802 NLM
% 218.34/218.52  |- skos__historyNote mesh__D010802 Evolution %28%1966-1974%29%
% 218.34/218.52  |- mesh__dateEstablished mesh__D010802 1978-01-01
% 218.34/218.52  |- skos__scopeNote mesh__D010802
% 218.34/218.52       The relationships of groups of organisms as reflected by their genetic makeup.%A%    
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D010004 2002
% 218.34/218.52  |- mesh__recordOriginator mesh__D010004 NLM
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D010004 2006
% 218.34/218.52  |- skos__scopeNote mesh__D010004
% 218.34/218.52       A conditioned chiefly characterized by thickening of the skin of the head and distal extremities, deep folds and furrows of the skin of the forehead, cheeks, and scalp, seborrhea, hyperhidrosis, periostosis of the long bones, digital clubbing, and spadelike enlargement of the hands and feet. It is more prevalent in the male, and is usually first evident during adolescence. It is believed to be inherited as an autosomal dominant trait. %28%From Dorland, 27th ed%29%%A%    
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D010004 2001
% 218.34/218.52  |- skos__prefLabel mesh__D010004 Osteoarthropathy, Primary Hypertrophic
% 218.34/218.52  |- mesh__dateEstablished mesh__D010004 1965-01-01
% 218.34/218.52  |- skos__broader mesh__D010004smesh__D001847
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D010004 2005
% 218.34/218.52  |- mesh__dateCreated mesh__D010004 1999-01-01
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D010004 1999
% 218.34/218.52  |- mesh__recordMaintainer mesh__D010004 TGC
% 218.34/218.52  |- rdf__type mesh__D010004sskos__Concept
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D010004 2000
% 218.34/218.52  |- mesh__publicMeSHNote mesh__D010004 65   
% 218.34/218.52  |- skos__hiddenLabel mesh__D010004 Osteoarthropathies, Primary Hypertrophic
% 218.34/218.52  |- skos__hiddenLabel mesh__D010004 Hypertrophic Osteoarthropathy, Primary
% 218.34/218.52  |- mesh__recordAuthorizer mesh__D010004 PLS
% 218.34/218.52  |- skos__broader mesh__D010004smesh__D007592
% 218.34/218.52  |- skos__hiddenLabel mesh__D010004 Primary Hypertrophic Osteoarthropathies
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D010004 2004
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D010004 1998
% 218.34/218.52  |- skos__hiddenLabel mesh__D010004 Primary Hypertrophic Osteoarthropathy
% 218.34/218.52  |- skos__hiddenLabel mesh__D010004 Hypertrophic Osteoarthropathies, Primary
% 218.34/218.52  |- skos__altLabel mesh__D010004 Pachydermoperiostosis
% 218.34/218.52  |- mesh__dateRevised mesh__D010004 1996-06-10
% 218.34/218.52  |- skos__annotation mesh__D010004
% 218.34/218.52       OSTEOARTHROPATHY, SECONDARY HYPERTROPHIC is also available%A%  
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D010004 2003
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D010004 1997
% 218.34/218.52  |- skos__hiddenLabel mesh__D010004 Pachydermoperiostoses
% 218.34/218.52  |- mesh__historyNote mesh__D010004 65%28%64%29%   
% 218.34/218.52  |- skos__scopeNote mesh__D001278
% 218.34/218.52       A glycoside of a kaurene type diterpene that is found in some plants including Atractylis gummifera %28%ATRACTYLIS%29%; COFFEE; XANTHIUM, and CALLILEPIS. Toxicity is due to inhibition of ADENINE NUCLEOTIDE TRANSLOCASE.%A%    
% 218.34/218.52  |- mesh__recordMaintainer mesh__D001278 ssb
% 218.34/218.52  |- mesh__dateRevised mesh__D001278 2004-07-07
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D001278 2005
% 218.34/218.52  |- mesh__publicMeSHNote mesh__D001278
% 218.34/218.52       91; was see under GLYCOSIDES 1975-90   
% 218.34/218.52  |- skos__historyNote mesh__D001278 Phenanthrenes %28%1973-1974%29%
% 218.34/218.52  |- skos__altLabel mesh__D001278 Atractylic Acid
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D001278 2006
% 218.34/218.52  |- skos__broader mesh__D001278smesh__D006027
% 218.34/218.52  |- mesh__recordOriginator mesh__D001278 NLM
% 218.34/218.52  |- mesh__recordAuthorizer mesh__D001278 sjn
% 218.34/218.52  |- mesh__dateCreated mesh__D001278 1974-11-19
% 218.34/218.52  |- mesh__historyNote mesh__D001278
% 218.34/218.52       91%28%75%29%; was see under GLYCOSIDES 1975-90   
% 218.34/218.52  |- skos__altLabel mesh__D001278 Atractylate
% 218.34/218.52  |- skos__broader mesh__D001278smesh__D004224
% 218.34/218.52  |- skos__hiddenLabel mesh__D001278 Acid, Atractylic
% 218.34/218.52  |- mesh__dateEstablished mesh__D001278 1991-01-01
% 218.34/218.52  |- rdf__type mesh__D001278sskos__Concept
% 218.34/218.52  |- skos__prefLabel mesh__D001278 Atractyloside
% 218.34/218.52  |- skos__historyNote mesh__D001278 Glycosides %28%1968-1975%29%
% 218.34/218.52  |- skos__prefLabel mesh__D006761 Hospitals
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D006761 2003
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D006761 2006
% 218.34/218.52  |- skos__annotation mesh__D006761
% 218.34/218.52       /legis = LEGISLATION, HOSPITAL or HOSPITALS %28%IM%29% + JURISPRUDENCE %28%IM%29%; note specific hosp depts %26% specific types of hosp available; hosp admission, discharge %26% readmiss are available as PATIENT ADMISSION; PATIENT DISCHARGE %26% PATIENT READMISSION %28%see notes under each%29%; specify geog: Manual 36.19%A%  
% 218.34/218.52  |- skos__scopeNote mesh__D006761
% 218.34/218.52       Institutions with an organized medical staff which provide medical care to patients.%A%    
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D006761 2004
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D006761 2002
% 218.34/218.52  |- skos__related mesh__D006761smesh__D004865
% 218.34/218.52  |- mesh__dateCreated mesh__D006761 1999-01-01
% 218.34/218.52  |- skos__broader mesh__D006761smesh__D006268
% 218.34/218.52  |- skos__related mesh__D006761smesh__D004469
% 218.34/218.52  |- mesh__recordMaintainer mesh__D006761 mdb
% 218.34/218.52  |- mesh__recordAuthorizer mesh__D006761 sjn
% 218.34/218.52  |- skos__hiddenLabel mesh__D006761 Hospital
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D006761 2005
% 218.34/218.52  |- skos__related mesh__D006761smesh__D006739
% 218.34/218.52  |- mesh__recordOriginator mesh__D006761 NLM
% 218.34/218.52  |- rdf__type mesh__D006761sskos__Concept
% 218.34/218.52  |- mesh__dateRevised mesh__D006761 2001-07-25
% 218.34/218.52  |- skos__altLabel mesh__D020432 Cranial Nerve IV Diseases
% 218.34/218.52  |- mesh__dateRevised mesh__D020432 2001-07-25
% 218.34/218.52  |- skos__hiddenLabel mesh__D020432 Neuropathies, Trochlear
% 218.34/218.52  |- skos__hiddenLabel mesh__D020432 Palsy, Trochlear Nerve
% 218.34/218.52  |- skos__hiddenLabel mesh__D020432 Palsy, Fourth Nerve
% 218.34/218.52  |- skos__hiddenLabel mesh__D020432 Fourth Nerve Palsies
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D020432 2006
% 218.34/218.52  |- skos__altLabel mesh__D020432 Trochlear Nerve Palsy
% 218.34/218.52  |- skos__hiddenLabel mesh__D020432 Palsies, Fourth Nerve
% 218.34/218.52  |- skos__hiddenLabel mesh__D020432 Trochlear Nerve Disorder
% 218.34/218.52  |- skos__hiddenLabel mesh__D020432 Myokymias, Superior Oblique
% 218.34/218.52  |- mesh__dateEstablished mesh__D020432 2000-01-01
% 218.34/218.52  |- skos__historyNote mesh__D020432 Trochlear Nerve %28%1965-1999%29%
% 218.34/218.52  |- skos__hiddenLabel mesh__D020432 Trochlear Nerve Disease
% 218.34/218.52  |- skos__hiddenLabel mesh__D020432 Superior Oblique Myokymias
% 218.34/218.52  |- skos__altLabel mesh__D020432 Trochlear Neuropathy
% 218.34/218.52  |- skos__hiddenLabel mesh__D020432 Trochlear Neuropathies
% 218.34/218.52  |- mesh__dateCreated mesh__D020432 1999-11-03
% 218.34/218.52  |- mesh__publicMeSHNote mesh__D020432 2000   
% 218.34/218.52  |- skos__scopeNote mesh__D020432
% 218.34/218.52       Diseases of the fourth cranial %28%trochlear%29% nerve or its nucleus in the midbrain. The nerve crosses as it exits the midbrain dorsally and may be injured along its course through the intracranial space, cavernous sinus, superior orbital fissure, or orbit. Clinical manifestations include weakness of the superior oblique muscle which causes vertical DIPLOPIA that is maximal when the affected eye is adducted and directed inferiorly. Head tilt may be seen as a compensatory mechanism for diplopia and rotation of the visual axis. Common etiologies include CRANIOCEREBRAL TRAUMA and INFRATENTORIAL NEOPLASMS.%A%    
% 218.34/218.52  |- skos__prefLabel mesh__D020432 Trochlear Nerve Diseases
% 218.34/218.52  |- skos__annotation mesh__D020432
% 218.34/218.52       neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 218.34/218.52  |- skos__altLabel mesh__D020432 Neurogenic Superior Oblique Palsy
% 218.34/218.52  |- rdf__type mesh__D020432sskos__Concept
% 218.34/218.52  |- mesh__recordMaintainer mesh__D020432 nns
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D020432 2002
% 218.34/218.52  |- skos__hiddenLabel mesh__D020432 Myokymia, Superior Oblique
% 218.34/218.52  |- skos__broader mesh__D020432smesh__D003389
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D020432 2003
% 218.34/218.52  |- skos__altLabel mesh__D020432 Fourth Cranial Nerve Diseases
% 218.34/218.52  |- skos__altLabel mesh__D020432 Trochlear Nerve Disorders
% 218.34/218.52  |- skos__hiddenLabel mesh__D020432 Trochlear Nerve Palsies
% 218.34/218.52  |- mesh__historyNote mesh__D020432 2000   
% 218.34/218.52  |- skos__historyNote mesh__D020432 Cranial Nerve Diseases %28%1981-1999%29%
% 218.34/218.52  |- skos__hiddenLabel mesh__D020432 Neuropathy, Trochlear
% 218.34/218.52  |- mesh__recordOriginator mesh__D020432 KEV
% 218.34/218.52  |- skos__hiddenLabel mesh__D020432 Palsies, Trochlear Nerve
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D020432 2004
% 218.34/218.52  |- skos__altLabel mesh__D020432 Fourth Nerve Palsy
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D020432 2005
% 218.34/218.52  |- mesh__recordAuthorizer mesh__D020432 sjn
% 218.34/218.52  |- mesh__recordAuthorizer mesh__D044082 sjn
% 218.34/218.52  |- mesh__dateCreated mesh__D044082 2003-07-09
% 218.34/218.52  |- skos__annotation mesh__D044082
% 218.34/218.52       infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 218.34/218.52  |- skos__broader mesh__D044082smesh__D002954
% 218.34/218.52  |- mesh__dateEstablished mesh__D044082 2004-01-01
% 218.34/218.52  |- mesh__dateRevised mesh__D044082 2005-06-30
% 218.34/218.52  |- mesh__recordOriginator mesh__D044082 ags
% 218.34/218.52  |- mesh__recordMaintainer mesh__D044082 SYSTEM
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D044082 2006
% 218.34/218.52  |- mesh__historyNote mesh__D044082
% 218.34/218.52       2004; use CITROBACTER FREUNDII 2001-2003   
% 218.34/218.52  |- mesh__publicMeSHNote mesh__D044082
% 218.34/218.52       2004; see CITROBACTER FREUNDII 2001-2003   
% 218.34/218.52  |- rdf__type mesh__D044082sskos__Concept
% 218.34/218.52  |- skos__altLabel mesh__D044082 Citrobacter freundii Biotype 4280
% 218.34/218.52  |- skos__prefLabel mesh__D044082 Citrobacter rodentium
% 218.34/218.52  |- skos__historyNote mesh__D044082 Citrobacter freundii %28%1995-2003%29%
% 218.34/218.52  |- skos__scopeNote mesh__D044082
% 218.34/218.52       A species of gram-negative bacteria in the genus CITROBACTER, family ENTEROBACTERIACEAE. As an important pathogen of laboratory mice, it serves as a model for investigating epithelial hyperproliferation and tumor promotion. It was previously considered a strain of CITROBACTER FREUNDII.%A%    
% 218.34/218.52  |- skos__hiddenLabel mesh__D005669 Fusarate, Calcium
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D005669 2003
% 218.34/218.52  |- skos__hiddenLabel mesh__D005669 Acid, Fusaric
% 218.34/218.52  |- skos__broader mesh__D005669smesh__D010848
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D005669 2002
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D005669 2005
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D005669 2004
% 218.34/218.52  |- mesh__dateCreated mesh__D005669 1974-11-19
% 218.34/218.52  |- mesh__dateRevised mesh__D005669 2000-06-21
% 218.34/218.52  |- mesh__recordOriginator mesh__D005669 NLM
% 218.34/218.52  |- mesh__recordMaintainer mesh__D005669 TWD
% 218.34/218.52  |- skos__hiddenLabel mesh__D005669 Acid, 5-Butyl-2-pyridinedicarboxylic
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D005669 2006
% 218.34/218.52  |- mesh__dateEstablished mesh__D005669 1991-01-01
% 218.34/218.52  |- skos__altLabel mesh__D005669 5-Butyl-2-pyridinedicarboxylic Acid
% 218.34/218.52  |- skos__annotation mesh__D005669 /biosyn permitted if by organism   
% 218.34/218.52  |- skos__prefLabel mesh__D005669 Fusaric Acid
% 218.34/218.52  |- mesh__historyNote mesh__D005669
% 218.34/218.52       91%28%75%29%; was see under PICOLINIC ACIDS 1975-90   
% 218.34/218.52  |- mesh__recordAuthorizer mesh__D005669 sjn
% 218.34/218.52  |- skos__scopeNote mesh__D005669
% 218.34/218.52       A picolinic acid derivative isolated from various Fusarium species. It has been proposed for a variety of therapeutic applications but is primarily used as a research tool. Its mechanisms of action are poorly understood. It probably inhibits DOPAMINE BETA-HYDROXYLASE, the enzyme that converts dopamine to norepinephrine. It may also have other actions, including the inhibition of cell proliferation and DNA synthesis.%A%    
% 218.34/218.52  |- skos__historyNote mesh__D005669 Picolinic Acids %28%1969-1974%29%
% 218.34/218.52  |- mesh__activeMeSHYear mesh__D005669 2001
% 218.34/218.52  |- mesh__publicMeSHNote mesh__D005669
% 218.34/218.52       91; was see under PICOLINIC ACIDS 1975-90   
% 218.34/218.52  |- skos__hiddenLabel mesh__D005669 5 Butyl 2 pyridinedicarboxylic Acid
% 218.34/218.52  |- rdf__type mesh__D005669sskos__Concept
% 218.34/218.52  |- skos__hiddenLabel mesh__D016391 Gene, src
% 218.34/218.52  |- skos__hiddenLabel mesh__D016391 c src Genes
% 218.34/218.52  |- skos__hiddenLabel mesh__D016391 v-src Oncogene
% 218.34/218.52  |- skos__altLabel mesh__D016391 v-src Genes
% 218.34/218.52  |- rdf__type mesh__D016391sskos__Concept
% 218.34/218.52  |- skos__hiddenLabel mesh__D016391 v src Oncogenes
% 218.34/218.52  |- skos__broader mesh__D016391smesh__D011519
% 218.34/218.52  |- mesh__dateRevised mesh__D016391 2005-06-30
% 218.34/218.52  |- skos__scopeNote mesh__D016391
% 218.34/218.52       Retrovirus-associated DNA sequences %28%src%29% originally isolated from the Rous sarcoma virus %28%RSV%29%. The proto-oncogene src %28%c-src%29% codes for a protein that is a member of the tyrosine kinase family and was the first proto-oncogene identified in the human genome. The human c-src gene is located at 20q12-13 on the long arm of chromosome 20.%A%    
% 218.34/218.52  |- skos__annotation mesh__D016391
% 218.34/218.52       src stands for %22%SaRComa%22%: see MeSH definition   
% 218.34/218.52  |- skos__hiddenLabel mesh__D016391 Oncogene, src
% 218.34/218.52  |- skos__prefLabel mesh__D016391 Genes, src
% 218.34/218.53  |- skos__hiddenLabel mesh__D016391 Oncogene, v-src
% 218.34/218.53  |- skos__altLabel mesh__D016391 v-src Oncogenes
% 218.34/218.53  |- skos__altLabel mesh__D016391 src Gene
% 218.34/218.53  |- skos__historyNote mesh__D016391 Genes, Structural %28%1980-1990%29%
% 218.34/218.53  |- skos__hiddenLabel mesh__D016391 v src Genes
% 218.34/218.53  |- mesh__historyNote mesh__D016391
% 218.34/218.53       91; was SRC GENES see ONCOGENES 1985-90   
% 218.34/218.53  |- skos__hiddenLabel mesh__D016391 Genes, v-src
% 218.34/218.53  |- skos__historyNote mesh__D016391 Genes, Viral %28%1977-1990%29%
% 218.34/218.53  |- skos__related mesh__D016391smesh__D018909
% 218.34/218.53  |- skos__altLabel mesh__D016391 src Genes
% 218.34/218.53  |- mesh__recordOriginator mesh__D016391 AGS
% 218.34/218.53  |- skos__hiddenLabel mesh__D016391 Gene, v-src
% 218.34/218.53  |- skos__hiddenLabel mesh__D016391 Proto-Oncogene, c-src
% 218.34/218.53  |- skos__hiddenLabel mesh__D016391 Genes, c-src
% 218.34/218.53  |- skos__hiddenLabel mesh__D016391 c src Proto Oncogenes
% 218.34/218.53  |- skos__hiddenLabel mesh__D016391 Oncogenes, src
% 218.34/218.53  |- skos__historyNote mesh__D016391 Oncogenes %28%1983-1990%29%
% 218.34/218.53  |- mesh__dateEstablished mesh__D016391 1991-01-01
% 218.34/218.53  |- skos__hiddenLabel mesh__D016391 Proto-Oncogenes, c-src
% 218.34/218.53  |- skos__hiddenLabel mesh__D016391 v-src Gene
% 218.34/218.53  |- mesh__recordAuthorizer mesh__D016391 sjn
% 218.34/218.53  |- skos__hiddenLabel mesh__D016391 Gene, c-src
% 218.34/218.53  |- skos__hiddenLabel mesh__D016391 c-src Gene
% 218.34/218.53  |- skos__hiddenLabel mesh__D016391 c-src Proto-Oncogene
% 218.34/218.53  |- mesh__dateCreated mesh__D016391 1990-05-29
% 218.34/218.53  |- mesh__onlineNote mesh__D016391
% 218.34/218.53       use ONCOGENES to search SRC GENES 1985-90   
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D016391 2006
% 218.34/218.53  |- mesh__publicMeSHNote mesh__D016391
% 218.34/218.53       91; was SRC GENES see ONCOGENES 1985-90   
% 218.34/218.53  |- skos__hiddenLabel mesh__D016391 src Oncogenes
% 218.34/218.53  |- skos__hiddenLabel mesh__D016391 Oncogenes, v-src
% 218.34/218.53  |- skos__altLabel mesh__D016391 c-src Proto-Oncogenes
% 218.34/218.53  |- mesh__recordMaintainer mesh__D016391 nns
% 218.34/218.53  |- skos__prefLabel mesh__D002371 Cat Diseases
% 218.34/218.53  |- mesh__dateCreated mesh__D002371 1999-01-01
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D002371 2005
% 218.34/218.53  |- mesh__dateRevised mesh__D002371 2003-07-30
% 218.34/218.53  |- skos__broader mesh__D002371smesh__D000820
% 218.34/218.53  |- skos__hiddenLabel mesh__D002371 Feline Disease
% 218.34/218.53  |- skos__hiddenLabel mesh__D002371 Diseases, Feline
% 218.34/218.53  |- skos__hiddenLabel mesh__D002371 Cat Disease
% 218.34/218.53  |- skos__altLabel mesh__D002371 Feline Diseases
% 218.34/218.53  |- skos__hiddenLabel mesh__D002371 Disease, Feline
% 218.34/218.53  |- skos__hiddenLabel mesh__D002371 Disease, Cat
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D002371 2006
% 218.34/218.53  |- mesh__recordMaintainer mesh__D002371 ags
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D002371 2004
% 218.34/218.53  |- mesh__recordAuthorizer mesh__D002371 sjn
% 218.34/218.53  |- skos__annotation mesh__D002371
% 218.34/218.53       IM GEN or unspecified; coord IM with specific dis /vet %28%IM%29% or specific cat dis %28%IM%29%; for abnormalities or injuries, index under CATS /abnorm or CATS /inj; does not include diseases of the so-called %22%big cats%22% %28%LIONS; CHEETAHS; tigers, panthers, etc.%29%; don%27%t forget also check tags CATS %28%NIM%29% %26% ANIMALS; DF: CAT DIS%A%  
% 218.34/218.53  |- rdf__type mesh__D002371sskos__Concept
% 218.34/218.53  |- skos__scopeNote mesh__D002371
% 218.34/218.53       Diseases of the domestic cat %28%Felis catus or F. domesticus%29%. This term does not include diseases of the so-called big cats such as CHEETAHS; LIONS; tigers, cougars, panthers, leopards, and other Felidae for which the heading CARNIVORA is used.%A%    
% 218.34/218.53  |- skos__hiddenLabel mesh__D002371 Diseases, Cat
% 218.34/218.53  |- mesh__recordOriginator mesh__D002371 NLM
% 218.34/218.53  |- mesh__publicMeSHNote mesh__D010803
% 218.34/218.53       91; was see under TACHYKININS 1989-90; was see under KININS 1977-88%A%  
% 218.34/218.53  |- mesh__dateRevised mesh__D010803 2005-06-30
% 218.34/218.53  |- rdf__type mesh__D010803sskos__Concept
% 218.34/218.53  |- skos__historyNote mesh__D010803 Peptides %28%1969-1976%29%
% 218.34/218.53  |- skos__scopeNote mesh__D010803
% 218.34/218.53       An oligopeptide isolated from the skin of Physalaemus fuscumaculatus, a South American frog. It is a typical kinin, resembling SUBSTANCE P in structure and action and has been proposed as a sialagogue, antihypertensive, and vasodilator.%A%    
% 218.34/218.53  |- mesh__dateEstablished mesh__D010803 1991-01-01
% 218.34/218.53  |- skos__altLabel mesh__D010803 Physalemin
% 218.34/218.53  |- skos__broader mesh__D010803smesh__D015320
% 218.34/218.53  |- mesh__recordAuthorizer mesh__D010803 sjn
% 218.34/218.53  |- mesh__historyNote mesh__D010803
% 218.34/218.53       91%28%77%29%; was see under TACHYKININS 1989-90; was see under KININS 1977-88%A%  
% 218.34/218.53  |- mesh__recordOriginator mesh__D010803 SH
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D010803 2006
% 218.34/218.53  |- mesh__recordMaintainer mesh__D010803 ssb
% 218.34/218.53  |- mesh__dateCreated mesh__D010803 1976-04-16
% 218.34/218.53  |- skos__prefLabel mesh__D010803 Physalaemin
% 218.34/218.53  |- skos__broader mesh__D010803smesh__D000664
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D010005 2006
% 218.34/218.53  |- skos__hiddenLabel mesh__D010005
% 218.34/218.53       Osteoarthropathies, Secondary Hypertrophic
% 218.34/218.53  |- rdf__type mesh__D010005sskos__Concept
% 218.34/218.53  |- skos__scopeNote mesh__D010005
% 218.34/218.53       Symmetrical osteitis of the four limbs, chiefly localized to the phalanges and the terminal epiphyses of the long bones of the forearm and leg, sometimes extending to the proximal ends of the limbs and the flat bones, and accompanied by dorsal kyphosis and joint involvement. It is often secondary to chronic conditions of the lungs and heart. %28%Dorland, 27th ed%29%%A%    
% 218.34/218.53  |- skos__hiddenLabel mesh__D010005 Clubbed Finger
% 218.34/218.53  |- mesh__recordMaintainer mesh__D010005 TGC
% 218.34/218.53  |- mesh__dateCreated mesh__D010005 1999-01-01
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D010005 2005
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D010005 1999
% 218.34/218.53  |- skos__hiddenLabel mesh__D010005 Marie Bamberger Disease
% 218.34/218.53  |- skos__hiddenLabel mesh__D010005 Fingers, Clubbed
% 218.34/218.53  |- skos__altLabel mesh__D010005 Secondary Hypertrophic Osteoarthropathy
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D010005 2002
% 218.34/218.53  |- mesh__recordOriginator mesh__D010005 NLM
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D010005 2004
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D010005 1998
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D010005 2001
% 218.34/218.53  |- skos__broader mesh__D010005smesh__D001847
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D010005 2003
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D010005 1997
% 218.34/218.53  |- skos__annotation mesh__D010005
% 218.34/218.53       OSTEOARTHROPATHY, PRIMARY HYPERTROPHIC is also available   
% 218.34/218.53  |- skos__altLabel mesh__D010005 Hypertrophic Osteoarthropathy, Secondary
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D010005 2000
% 218.34/218.53  |- skos__broader mesh__D010005smesh__D007592
% 218.34/218.53  |- skos__hiddenLabel mesh__D010005
% 218.34/218.53       Secondary Hypertrophic Osteoarthropathies
% 218.34/218.53  |- mesh__recordAuthorizer mesh__D010005 PLS
% 218.34/218.53  |- skos__prefLabel mesh__D010005 Osteoarthropathy, Secondary Hypertrophic
% 218.34/218.53  |- skos__hiddenLabel mesh__D010005 Disease, Marie-Bamberger
% 218.34/218.53  |- skos__altLabel mesh__D010005 Marie-Bamberger Disease
% 218.34/218.53  |- mesh__dateRevised mesh__D010005 1996-06-10
% 218.34/218.53  |- skos__hiddenLabel mesh__D010005
% 218.34/218.53       Hypertrophic Osteoarthropathies, Secondary
% 218.34/218.53  |- skos__hiddenLabel mesh__D010005 Finger, Clubbed
% 218.34/218.53  |- mesh__publicMeSHNote mesh__D015299 89   
% 218.34/218.53  |- skos__hiddenLabel mesh__D015299 Spondylodiscitides
% 218.34/218.53  |- mesh__dateEstablished mesh__D015299 1989-01-01
% 218.34/218.53  |- skos__hiddenLabel mesh__D015299 Spondylodiskitides
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D015299 2005
% 218.34/218.53  |- mesh__dateCreated mesh__D015299 1988-05-26
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D015299 2004
% 218.34/218.53  |- skos__annotation mesh__D015299
% 218.34/218.53       coord IM with specific vertebrae %28%IM%29%   
% 218.34/218.53  |- skos__prefLabel mesh__D015299 Discitis
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D015299 2003
% 218.34/218.53  |- mesh__dateRevised mesh__D015299 2002-07-03
% 218.34/218.53  |- mesh__recordOriginator mesh__D015299 EJB
% 218.34/218.53  |- skos__altLabel mesh__D015299 Diskitis
% 218.34/218.53  |- rdf__type mesh__D015299sskos__Concept
% 218.34/218.53  |- skos__historyNote mesh__D015299 Spinal Diseases %28%1966-1988%29%
% 218.34/218.53  |- skos__hiddenLabel mesh__D015299 Discitides
% 218.34/218.53  |- skos__altLabel mesh__D015299 Spondylodiskitis
% 218.34/218.53  |- mesh__recordAuthorizer mesh__D015299 sjn
% 218.34/218.53  |- skos__altLabel mesh__D015299 Spondylodiscitis
% 218.34/218.53  |- skos__hiddenLabel mesh__D015299 Diskitides
% 218.34/218.53  |- skos__broader mesh__D015299smesh__D013166
% 218.34/218.53  |- mesh__historyNote mesh__D015299 89   
% 218.34/218.53  |- skos__scopeNote mesh__D015299
% 218.34/218.53       Inflammation of an intervertebral disk or disk space which may lead to disk erosion. Until recently, discitis has been defined as a nonbacterial inflammation and has been attributed to aseptic processes %28%e.g., chemical reaction to an injected substance%29%. However, recent studies provide evidence that infection may be the initial cause, but perhaps not the promoter, of most cases of discitis. Discitis has been diagnosed in patients following discography, myelography, lumbar puncture, paravertebral injection, and obstetrical epidural anesthesia. Discitis following chemonucleolysis %28%especially with chymopapain%29% is attributed to chemical reaction by some and to introduction of microorganisms by others.%A%    
% 218.34/218.53  |- mesh__recordMaintainer mesh__D015299 PLS
% 218.34/218.53  |- skos__historyNote mesh__D015299 Spondylitis %28%1966-1988%29%
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D015299 2006
% 218.34/218.53  |- skos__historyNote mesh__D015299 Intervertebral Disk %28%1966-1988%29%
% 218.34/218.53  |- skos__altLabel mesh__D001279 Glaxo Wellcome Brand of Atracurium Besilate
% 218.34/218.53  |- skos__broader mesh__D001279smesh__D044182
% 218.34/218.53  |- mesh__publicMeSHNote mesh__D001279 87   
% 218.34/218.53  |- skos__altLabel mesh__D001279 Atracurium Dibesylate
% 218.34/218.53  |- skos__altLabel mesh__D001279 Pisa Brand of Atracurium Besilate
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D001279 2006
% 218.34/218.53  |- skos__hiddenLabel mesh__D001279 Besilate, Atracurium
% 218.34/218.53  |- skos__hiddenLabel mesh__D001279 BW33A
% 218.34/218.53  |- mesh__recordMaintainer mesh__D001279 CCR
% 218.34/218.53  |- mesh__dateEstablished mesh__D001279 1987-01-01
% 218.34/218.53  |- skos__hiddenLabel mesh__D001279 A 74, 33
% 218.34/218.53  |- skos__altLabel mesh__D001279 Atracurium Besilate
% 218.34/218.53  |- skos__historyNote mesh__D001279 Isoquinolines %28%1966-1986%29%
% 218.34/218.53  |- skos__prefLabel mesh__D001279 Atracurium
% 218.34/218.53  |- skos__hiddenLabel mesh__D001279 BW 33A
% 218.34/218.53  |- rdf__type mesh__D001279sskos__Concept
% 218.34/218.53  |- mesh__dateCreated mesh__D001279 1986-07-14
% 218.34/218.53  |- skos__scopeNote mesh__D001279
% 218.34/218.53       A non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.%A%    
% 218.34/218.53  |- mesh__recordAuthorizer mesh__D001279 sjn
% 218.34/218.53  |- mesh__historyNote mesh__D001279 87   
% 218.34/218.53  |- skos__altLabel mesh__D001279 Wellcome Brand of Atracurium Besilate
% 218.34/218.53  |- mesh__dateRevised mesh__D001279 2005-06-30
% 218.34/218.53  |- mesh__recordOriginator mesh__D001279 RLS
% 218.34/218.53  |- skos__broader mesh__D006762smesh__D006799
% 218.34/218.53  |- mesh__recordMaintainer mesh__D006762 kle
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D006762 2004
% 218.34/218.53  |- skos__hiddenLabel mesh__D006762 Clinic, Veterinary
% 218.34/218.53  |- mesh__recordOriginator mesh__D006762 NLM
% 218.34/218.53  |- skos__hiddenLabel mesh__D006762 Hospital, Animal
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D006762 2000
% 218.34/218.53  |- skos__altLabel mesh__D006762 Animal Hospitals
% 218.34/218.53  |- mesh__dateCreated mesh__D006762 1999-01-01
% 218.34/218.53  |- skos__hiddenLabel mesh__D006762 Veterinary Clinic
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D006762 2001
% 218.34/218.53  |- skos__hiddenLabel mesh__D006762 Hospital, Veterinary
% 218.34/218.53  |- skos__altLabel mesh__D006762 Veterinary Hospitals
% 218.34/218.53  |- mesh__dateEstablished mesh__D006762 1974-01-01
% 218.34/218.53  |- skos__prefLabel mesh__D006762 Hospitals, Animal
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D006762 2002
% 218.34/218.53  |- skos__altLabel mesh__D006762 Clinics, Veterinary
% 218.34/218.53  |- mesh__publicMeSHNote mesh__D006762 74   
% 218.34/218.53  |- skos__annotation mesh__D006762 specify geog   
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D006762 2005
% 218.34/218.53  |- rdf__type mesh__D006762sskos__Concept
% 218.34/218.53  |- skos__hiddenLabel mesh__D006762 Veterinary Hospital
% 218.34/218.53  |- mesh__dateRevised mesh__D006762 1999-11-03
% 218.34/218.53  |- skos__hiddenLabel mesh__D006762 Animal Hospital
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D006762 2003
% 218.34/218.53  |- skos__altLabel mesh__D006762 Hospitals, Veterinary
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D006762 2006
% 218.34/218.53  |- skos__altLabel mesh__D006762 Veterinary Clinics
% 218.34/218.53  |- mesh__recordAuthorizer mesh__D006762 sjn
% 218.34/218.53  |- mesh__historyNote mesh__D006762 74   
% 218.34/218.53  |- skos__historyNote mesh__D020433 Trigeminal Neuralgia %28%1966-1999%29%
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D020433 2001
% 218.34/218.53  |- skos__hiddenLabel mesh__D020433 Trigeminal Nerve Disorder
% 218.34/218.53  |- skos__hiddenLabel mesh__D020433 Trigeminal Neuropathies
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D020433 2003
% 218.34/218.53  |- skos__historyNote mesh__D020433 Cranial Nerve Diseases %28%1981-1999%29%
% 218.34/218.53  |- skos__prefLabel mesh__D020433 Trigeminal Nerve Diseases
% 218.34/218.53  |- skos__hiddenLabel mesh__D020433 Trigeminal Nerve Disease
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D020433 2006
% 218.34/218.53  |- skos__altLabel mesh__D020433 Fifth Cranial Nerve Diseases
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D020433 2002
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D020433 2004
% 218.34/218.53  |- skos__altLabel mesh__D020433 Cranial Nerve V Diseases
% 218.34/218.53  |- mesh__publicMeSHNote mesh__D020433 2000   
% 218.34/218.53  |- skos__hiddenLabel mesh__D020433 Neuropathy, Idiopathic Trigeminal
% 218.34/218.53  |- skos__related mesh__D020433smesh__D020209
% 218.34/218.53  |- skos__hiddenLabel mesh__D020433 Neuropathies, Trigeminal
% 218.34/218.53  |- skos__hiddenLabel mesh__D020433 Neuropathies, Idiopathic Trigeminal
% 218.34/218.53  |- mesh__dateCreated mesh__D020433 1999-11-08
% 218.34/218.53  |- skos__hiddenLabel mesh__D020433 Idiopathic Trigeminal Neuropathies
% 218.34/218.53  |- skos__altLabel mesh__D020433 Trigeminal Neuropathy
% 218.34/218.53  |- skos__hiddenLabel mesh__D020433 Idiopathic Trigeminal Neuropathy
% 218.34/218.53  |- skos__altLabel mesh__D020433 Trigeminal Nerve Disorders
% 218.34/218.53  |- skos__hiddenLabel mesh__D020433 Syndrome, Raeder Paratrigeminal
% 218.34/218.53  |- skos__broader mesh__D020433smesh__D003389
% 218.34/218.53  |- skos__historyNote mesh__D020433 Trigeminal Nerve %28%1966-1999%29%
% 218.34/218.53  |- skos__hiddenLabel mesh__D020433 Trigeminal Neuropathies, Idiopathic
% 218.34/218.53  |- mesh__historyNote mesh__D020433 2000   
% 218.34/218.53  |- skos__annotation mesh__D020433
% 218.34/218.53       neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 218.34/218.53  |- skos__scopeNote mesh__D020433
% 218.34/218.53       Diseases of the trigeminal nerve or its nuclei, which are located in the pons and medulla. The nerve is composed of three divisions: ophthalmic, maxillary, and mandibular, which provide sensory innervation to structures of the face, sinuses, and portions of the cranial vault. The mandibular nerve also innervates muscles of mastication. Clinical features include loss of facial and intra-oral sensation and weakness of jaw closure. Common conditions affecting the nerve include brain stem ischemia, INFRATENTORIAL NEOPLASMS, and TRIGEMINAL NEURALGIA.%A%    
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D020433 2000
% 218.34/218.53  |- skos__hiddenLabel mesh__D020433 Neuropathy, Trigeminal
% 218.34/218.53  |- mesh__dateEstablished mesh__D020433 2000-01-01
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D020433 2005
% 218.34/218.53  |- rdf__type mesh__D020433sskos__Concept
% 218.34/218.53  |- skos__broader mesh__D044083smesh__D004754
% 218.34/218.53  |- mesh__recordAuthorizer mesh__D044083 sjn
% 218.34/218.53  |- skos__scopeNote mesh__D044083
% 218.34/218.53       A species of gram-negative bacteria in the genus ENTEROBACTER, found in the environment and in foods. It has biochemical characteristics similar to ENTEROBACTER CLOACAE, but is yellow-pigmented.%A%    
% 218.34/218.53  |- mesh__recordMaintainer mesh__D044083 SYSTEM
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D044083 2006
% 218.34/218.53  |- skos__annotation mesh__D044083
% 218.34/218.53       infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 218.34/218.53  |- skos__historyNote mesh__D044083 Enterobacter %28%1979-2003%29%
% 218.34/218.53  |- rdf__type mesh__D044083sskos__Concept
% 218.34/218.53  |- skos__prefLabel mesh__D044083 Enterobacter sakazakii
% 218.34/218.53  |- mesh__dateEstablished mesh__D044083 2004-01-01
% 218.34/218.53  |- mesh__dateRevised mesh__D044083 2005-06-30
% 218.34/218.53  |- mesh__recordOriginator mesh__D044083 ags
% 218.34/218.53  |- mesh__publicMeSHNote mesh__D044083 2004   
% 218.34/218.53  |- mesh__historyNote mesh__D044083 2004   
% 218.34/218.53  |- mesh__dateCreated mesh__D044083 2003-07-09
% 218.34/218.53  |- skos__broader mesh__D030861smesh__D004467
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D030861 2002
% 218.34/218.53  |- skos__scopeNote mesh__D030861
% 218.34/218.53       A political and economic system characterized by individual rights, by private or corporate ownership of capital goods, and by prices, production, and the distribution of goods that are determined mainly by competition in a free market. %28%From Merriam-Webster%27%s Collegiate Dictionary, 10th ed%29%%A%    
% 218.34/218.53  |- skos__annotation mesh__D030861 specify geog   
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D030861 2003
% 218.34/218.53  |- mesh__dateEstablished mesh__D030861 2002-01-01
% 218.34/218.53  |- mesh__publicMeSHNote mesh__D030861
% 218.34/218.53       2002; see POLITICAL SYSTEMS 1990-2001   
% 218.34/218.53  |- mesh__dateCreated mesh__D030861 2001-07-25
% 218.34/218.53  |- skos__broader mesh__D030861smesh__D011056
% 218.34/218.53  |- mesh__historyNote mesh__D030861 2002; use POLITICAL SYSTEMS 1990-2001   
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D030861 2005
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D030861 2004
% 218.34/218.53  |- skos__prefLabel mesh__D030861 Capitalism
% 218.34/218.53  |- skos__historyNote mesh__D030861 Political Systems %28%1990-2001%29%
% 218.34/218.53  |- rdf__type mesh__D030861sskos__Concept
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D030861 2006
% 218.34/218.53  |- skos__altLabel mesh__D016392 pp60%28%c-src%29%
% 218.34/218.53  |- skos__altLabel mesh__D016392 Proto-Oncogene Protein src
% 218.34/218.53  |- skos__hiddenLabel mesh__D016392 src Proto Oncogene Protein pp60
% 218.34/218.53  |- skos__broader mesh__D016392smesh__D019061
% 218.34/218.53  |- mesh__dateEstablished mesh__D016392 1991-01-01
% 218.34/218.53  |- mesh__dateCreated mesh__D016392 1990-06-19
% 218.34/218.53  |- skos__hiddenLabel mesh__D016392 c-src, pp60
% 218.34/218.53  |- skos__hiddenLabel mesh__D016392 src Proto Oncogene Product
% 218.34/218.53  |- skos__hiddenLabel mesh__D016392 pp60 c src
% 218.34/218.53  |- skos__hiddenLabel mesh__D016392 Protein src, Proto-Oncogene
% 218.34/218.53  |- skos__altLabel mesh__D016392 Proto-Oncogene Protein pp60%28%c-src%29%
% 218.34/218.53  |- mesh__publicMeSHNote mesh__D016392
% 218.34/218.53       2006; see PROTO-ONCOGENE PROTEIN PP60%28%C-SRC%29% 1991-2005   
% 218.34/218.53  |- mesh__dateRevised mesh__D016392 2005-06-30
% 218.34/218.53  |- mesh__recordAuthorizer mesh__D016392 sjn
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D016392 2006
% 218.34/218.53  |- skos__hiddenLabel mesh__D016392 c src Protein pp60
% 218.34/218.53  |- skos__altLabel mesh__D016392 c-src Protein pp60
% 218.34/218.53  |- skos__altLabel mesh__D016392 pp60 c-src
% 218.34/218.53  |- skos__historyNote mesh__D016392
% 218.34/218.53       Proto-Oncogene Proteins %28%1986-1990%29%
% 218.34/218.53  |- skos__hiddenLabel mesh__D016392 Protein pp60, c-src
% 218.34/218.53  |- skos__altLabel mesh__D016392 Phosphoprotein pp60%28%c-src%29%
% 218.34/218.53  |- mesh__historyNote mesh__D016392 2006%28%1991%29%   
% 218.34/218.53  |- skos__scopeNote mesh__D016392
% 218.34/218.53       Membrane-associated tyrosine-specific kinases encoded by the c-src genes. They have an important role in cellular growth control. Truncation of carboxy-terminal residues in pp60%28%c-src%29% leads to PP60%28%V-SRC%29% which has the ability to transform cells. This kinase pp60 c-src should not be confused with csk, also known as c-src kinase.%A%    
% 218.34/218.53  |- skos__broader mesh__D016392smesh__D011518
% 218.34/218.53  |- skos__altLabel mesh__D016392 src Proto-Oncogene Protein pp60
% 218.34/218.53  |- rdf__type mesh__D016392sskos__Concept
% 218.34/218.53  |- skos__hiddenLabel mesh__D016392 Proto Oncogene Protein src
% 218.34/218.53  |- mesh__recordOriginator mesh__D016392 AGS
% 218.34/218.53  |- skos__historyNote mesh__D016392 Phosphoproteins %28%1983-1985%29%
% 218.34/218.53  |- skos__hiddenLabel mesh__D016392 Proto-Oncogene Product, src
% 218.34/218.53  |- mesh__recordMaintainer mesh__D016392 DRC
% 218.34/218.53  |- skos__prefLabel mesh__D016392 Proto-Oncogene Proteins pp60%28%c-src%29%
% 218.34/218.53  |- skos__altLabel mesh__D016392 src Proto-Oncogene Product
% 218.34/218.53  |- skos__hiddenLabel mesh__D016392 pp60, c-src Protein
% 218.34/218.53  |- skos__broader mesh__D010758Q000737smesh__D010758
% 218.34/218.53  |- rdf__type mesh__D010758Q000737smesh__CompoundConcept
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D002372 2006
% 218.34/218.53  |- mesh__recordMaintainer mesh__D002372 ags
% 218.34/218.53  |- skos__hiddenLabel mesh__D002372 Lymphoreticuloses, Inoculative
% 218.34/218.53  |- skos__prefLabel mesh__D002372 Cat-Scratch Disease
% 218.34/218.53  |- skos__scopeNote mesh__D002372
% 218.34/218.53       A self-limiting bacterial infection of the regional lymph nodes caused by AFIPIA felis, a gram-negative bacterium recently identified by the Centers for Disease Control and Prevention and by BARTONELLA HENSELAE. It usually arises one or more weeks following a feline scratch, with raised inflammatory nodules at the site of the scratch being the primary symptom.%A%    
% 218.34/218.53  |- skos__broader mesh__D002372smesh__D008199
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D002372 2004
% 218.34/218.53  |- mesh__recordOriginator mesh__D002372 NLM
% 218.34/218.53  |- skos__hiddenLabel mesh__D002372 Lymphoreticuloses, Inoculation
% 218.34/218.53  |- skos__hiddenLabel mesh__D002372 Inoculative Lymphoreticuloses
% 218.34/218.53  |- mesh__dateRevised mesh__D002372 2003-07-09
% 218.34/218.53  |- skos__altLabel mesh__D002372 Catscratch Disease
% 218.34/218.53  |- skos__broader mesh__D002372smesh__D016905
% 218.34/218.53  |- rdf__type mesh__D002372sskos__Concept
% 218.34/218.53  |- skos__hiddenLabel mesh__D002372 Disease, Catscratch
% 218.34/218.53  |- mesh__recordAuthorizer mesh__D002372 sjn
% 218.34/218.53  |- skos__broader mesh__D002372smesh__D001474
% 218.34/218.53  |- skos__hiddenLabel mesh__D002372 Inoculation Lymphoreticuloses
% 218.34/218.53  |- skos__hiddenLabel mesh__D002372 Cat Scratch Disease
% 218.34/218.53  |- skos__hiddenLabel mesh__D002372 Disease, Cat-Scratch
% 218.34/218.53  |- skos__hiddenLabel mesh__D002372 Lymphoreticulosis, Inoculative
% 218.34/218.53  |- skos__altLabel mesh__D002372 Inoculative Lymphoreticulosis
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D002372 2005
% 218.34/218.53  |- skos__annotation mesh__D002372
% 218.34/218.53       coord IM with AFIPIA %28%IM%29% or BARTONELLA HENSELAE %28%IM%29% if appropriate%A%  
% 218.34/218.53  |- mesh__dateCreated mesh__D002372 1999-01-01
% 218.34/218.53  |- skos__hiddenLabel mesh__D002372 Lymphoreticulosis, Inoculation
% 218.34/218.53  |- skos__altLabel mesh__D002372 Inoculation Lymphoreticulosis
% 218.34/218.53  |- skos__prefLabel mesh__D010804 Physarum
% 218.34/218.53  |- mesh__historyNote mesh__D010804 79%28%75%29%   
% 218.34/218.53  |- skos__scopeNote mesh__D010804
% 218.34/218.53       A genus of protozoa, formerly also considered a fungus. Characteristics include the presence of violet to brown spores.%A%    
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D010804 2006
% 218.34/218.53  |- skos__annotation mesh__D010804 a protozoan   
% 218.34/218.53  |- mesh__publicMeSHNote mesh__D010804 79; see MYXOMYCETES 1975-78   
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D010804 2005
% 218.34/218.53  |- mesh__recordMaintainer mesh__D010804 ags
% 218.34/218.53  |- mesh__recordOriginator mesh__D010804 NLM
% 218.34/218.53  |- mesh__dateEstablished mesh__D010804 1979-01-01
% 218.34/218.53  |- mesh__dateCreated mesh__D010804 1974-12-12
% 218.34/218.53  |- skos__historyNote mesh__D010804 Myxomycetes %28%1966-1974%29%
% 218.34/218.53  |- rdf__type mesh__D010804sskos__Concept
% 218.34/218.53  |- skos__broader mesh__D010804smesh__D016838
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D010804 2004
% 218.34/218.53  |- mesh__recordAuthorizer mesh__D010804 sjn
% 218.34/218.53  |- mesh__dateRevised mesh__D010804 2003-07-09
% 218.34/218.53  |- mesh__recordMaintainer mesh__D010006 nns
% 218.34/218.53  |- mesh__dateEstablished mesh__D010006 1965-01-01
% 218.34/218.53  |- skos__related mesh__D010006smesh__D010010
% 218.34/218.53  |- rdf__type mesh__D010006sskos__Concept
% 218.34/218.53  |- skos__prefLabel mesh__D010006 Osteoblasts
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D010006 2004
% 218.34/218.53  |- mesh__dateRevised mesh__D010006 2003-07-09
% 218.34/218.53  |- mesh__historyNote mesh__D010006 65%28%64%29%   
% 218.34/218.53  |- mesh__recordAuthorizer mesh__D010006 sjn
% 218.34/218.53  |- mesh__publicMeSHNote mesh__D010006 65   
% 218.34/218.53  |- mesh__recordOriginator mesh__D010006 NLM
% 218.34/218.53  |- skos__scopeNote mesh__D010006
% 218.34/218.53       Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone.%A%    
% 218.34/218.53  |- mesh__dateCreated mesh__D010006 1999-01-01
% 218.34/218.53  |- skos__hiddenLabel mesh__D010006 Osteoblast
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D010006 2005
% 218.34/218.53  |- skos__broader mesh__D010006smesh__D003239
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D010006 2006
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D006763 2005
% 218.34/218.53  |- rdf__type mesh__D006763sskos__Concept
% 218.34/218.53  |- skos__altLabel mesh__D006763 Chronic Disease Hospitals
% 218.34/218.53  |- mesh__dateEstablished mesh__D006763 1991-01-01
% 218.34/218.53  |- mesh__recordAuthorizer mesh__D006763 sjn
% 218.34/218.53  |- skos__prefLabel mesh__D006763 Hospitals, Chronic Disease
% 218.34/218.53  |- mesh__recordMaintainer mesh__D006763 kle
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D006763 2003
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D006763 2006
% 218.34/218.53  |- skos__hiddenLabel mesh__D006763 Chronic Disease Hospital
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D006763 2000
% 218.34/218.53  |- skos__annotation mesh__D006763
% 218.34/218.53       coord IM with hosp ownership term %28%e.g., HOSPITALS, COUNTY; HOSPITALS, PROPRIETARY; etc.%29% %28%IM or NIM%29% if pertinent; specify geog%A%  
% 218.34/218.53  |- skos__broader mesh__D006763smesh__D006782
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D006763 2004
% 218.34/218.53  |- mesh__publicMeSHNote mesh__D006763
% 218.34/218.53       91; was see under HOSPITALS, SPECIAL 1977-90   
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D006763 2001
% 218.34/218.53  |- mesh__dateCreated mesh__D006763 1976-05-05
% 218.34/218.53  |- skos__scopeNote mesh__D006763
% 218.34/218.53       Hospitals which provide care to patients with long-term illnesses.%A%    
% 218.34/218.53  |- mesh__historyNote mesh__D006763
% 218.34/218.53       91%28%77%29%; was see under HOSPITALS, SPECIAL 1977-90   
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D006763 2002
% 218.34/218.53  |- mesh__recordOriginator mesh__D006763 EC
% 218.34/218.53  |- mesh__dateRevised mesh__D006763 1999-11-03
% 218.34/218.53  |- skos__hiddenLabel mesh__D006763 Hospital, Chronic Disease
% 218.34/218.53  |- skos__historyNote mesh__D006763 Hospitals, Special %28%1968-1977%29%
% 218.34/218.53  |- skos__hiddenLabel mesh__D020434 Palsies, Abducens Nerve
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D020434 2005
% 218.34/218.53  |- skos__hiddenLabel mesh__D020434 Lateral Rectus Palsies
% 218.34/218.53  |- mesh__dateCreated mesh__D020434 1999-11-03
% 218.34/218.53  |- skos__hiddenLabel mesh__D020434 Palsies, Lateral Rectus
% 218.34/218.53  |- skos__altLabel mesh__D020434 Sixth Cranial Nerve Palsy
% 218.34/218.53  |- skos__hiddenLabel mesh__D020434 Palsy, Lateral Rectus
% 218.34/218.53  |- mesh__recordMaintainer mesh__D020434 ags
% 218.34/218.53  |- skos__altLabel mesh__D020434 Sixth Cranial Nerve Diseases
% 218.34/218.53  |- rdf__type mesh__D020434sskos__Concept
% 218.34/218.53  |- skos__hiddenLabel mesh__D020434 Palsy, Sixth Nerve
% 218.34/218.53  |- skos__altLabel mesh__D020434 Abducens Nerve Palsy
% 218.34/218.53  |- mesh__dateRevised mesh__D020434 2001-07-25
% 218.34/218.53  |- skos__altLabel mesh__D020434 Cranial Nerve VI Diseases
% 218.34/218.53  |- skos__broader mesh__D020434smesh__D003389
% 218.34/218.53  |- skos__hiddenLabel mesh__D020434 Abducens Nerve Disease
% 218.34/218.53  |- skos__historyNote mesh__D020434 Abducens Nerve %28%1968-1980%29%
% 218.34/218.53  |- mesh__dateEstablished mesh__D020434 2000-01-01
% 218.34/218.53  |- mesh__recordOriginator mesh__D020434 KEV
% 218.34/218.53  |- skos__altLabel mesh__D020434 VIth Cranial Nerve Diseases
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D020434 2004
% 218.34/218.53  |- skos__hiddenLabel mesh__D020434 Palsy, Abducens Nerve
% 218.34/218.53  |- skos__altLabel mesh__D020434 Lateral Rectus Palsy
% 218.34/218.53  |- skos__hiddenLabel mesh__D020434 Sixth Nerve Palsies
% 218.34/218.53  |- skos__prefLabel mesh__D020434 Abducens Nerve Diseases
% 218.34/218.53  |- skos__altLabel mesh__D020434 Sixth Cranial Nerve Disorders
% 218.34/218.53  |- skos__historyNote mesh__D020434 Cranial Nerve Diseases %28%1981-1999%29%
% 218.34/218.53  |- mesh__publicMeSHNote mesh__D020434 2000   
% 218.34/218.53  |- skos__altLabel mesh__D020434
% 218.34/218.53       Benign Recurrent Abducens Palsy of Childhood
% 218.34/218.53  |- skos__hiddenLabel mesh__D020434 Palsies, Sixth Nerve
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D020434 2003
% 218.34/218.53  |- skos__annotation mesh__D020434
% 218.34/218.53       neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 218.34/218.53  |- skos__altLabel mesh__D020434 Sixth Nerve Palsy
% 218.34/218.53  |- mesh__activeMeSHYear mesh__D020434 2006
% 218.34/218.54  |- mesh__recordAuthorizer mesh__D020434 sjn
% 218.34/218.54  |- skos__hiddenLabel mesh__D020434 Abducens Nerve Palsies
% 218.34/218.54  |- mesh__historyNote mesh__D020434 2000   
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D020434 2002
% 218.34/218.54  |- skos__historyNote mesh__D020434
% 218.34/218.54       Peripheral Nervous System Diseases %28%1968-1980%29%
% 218.34/218.54  |- skos__altLabel mesh__D020434 Benign Recurrent Abducens Palsy, Children
% 218.34/218.54  |- skos__scopeNote mesh__D020434
% 218.34/218.54       Diseases of the sixth cranial %28%abducens%29% nerve or its nucleus in the pons. The nerve may be injured along its course in the pons, intracranially as it travels along the base of the brain, in the cavernous sinus, or at the level of superior orbital fissure or orbit. Dysfunction of the nerve causes lateral rectus muscle weakness, resulting in horizontal diplopia that is maximal when the affected eye is abducted and ESOTROPIA. Common conditions associated with nerve injury include INTRACRANIAL HYPERTENSION; CRANIOCEREBRAL TRAUMA; ISCHEMIA; and INFRATENTORIAL NEOPLASMS.%A%    
% 218.34/218.54  |- mesh__dateEstablished mesh__D044882 2004-01-01
% 218.34/218.54  |- skos__hiddenLabel mesh__D044882 Metabolism Disorders, Glucose
% 218.34/218.54  |- skos__hiddenLabel mesh__D044882 Disorders, Glucose Metabolic
% 218.34/218.54  |- rdf__type mesh__D044882sskos__Concept
% 218.34/218.54  |- skos__historyNote mesh__D044882 Diabetes Mellitus %28%1969-2003%29%
% 218.34/218.54  |- skos__hiddenLabel mesh__D044882 Metabolism Disorder, Glucose
% 218.34/218.54  |- skos__hiddenLabel mesh__D044882 Metabolic Disorder, Glucose
% 218.34/218.54  |- skos__altLabel mesh__D044882 Glucose Metabolism Disorder
% 218.34/218.54  |- mesh__dateCreated mesh__D044882 2003-07-09
% 218.34/218.54  |- skos__hiddenLabel mesh__D044882 Disorders, Glucose Metabolism
% 218.34/218.54  |- skos__scopeNote mesh__D044882
% 218.34/218.54       Pathological conditions in which the BLOOD GLUCOSE cannot be maintained within the normal range, such as in HYPOGLYCEMIA and HYPERGLYCEMIA. Etiology of these disorders varies. Plasma glucose concentration is critical to survival for it is the predominant fuel for the CENTRAL NERVOUS SYSTEM.%A%    
% 218.34/218.54  |- skos__historyNote mesh__D044882 Glucose %28%1965-2003%29%
% 218.34/218.54  |- skos__hiddenLabel mesh__D044882 Disorder, Glucose Metabolism
% 218.34/218.54  |- skos__hiddenLabel mesh__D044882 Disorder, Glucose Metabolic
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D044882 2006
% 218.34/218.54  |- skos__broader mesh__D044882smesh__D008659
% 218.34/218.54  |- skos__prefLabel mesh__D044882 Glucose Metabolism Disorders
% 218.34/218.54  |- mesh__historyNote mesh__D044882 2004   
% 218.34/218.54  |- skos__hiddenLabel mesh__D044882 Metabolic Disorders, Glucose
% 218.34/218.54  |- mesh__publicMeSHNote mesh__D044882 2004   
% 218.34/218.54  |- skos__altLabel mesh__D044882 Glucose Metabolic Disorders
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D044882 2004
% 218.34/218.54  |- skos__altLabel mesh__D044882 Glucose Metabolic Disorder
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D044882 2005
% 218.34/218.54  |- skos__prefLabel mesh__D044084 Erwinia amylovora
% 218.34/218.54  |- skos__scopeNote mesh__D044084
% 218.34/218.54       A species of gram-negative bacteria, in the genus ERWINIA, causing a necrotic disease of plants.%A%    
% 218.34/218.54  |- mesh__dateRevised mesh__D044084 2005-06-30
% 218.34/218.54  |- mesh__recordMaintainer mesh__D044084 SYSTEM
% 218.34/218.54  |- mesh__recordOriginator mesh__D044084 ags
% 218.34/218.54  |- skos__historyNote mesh__D044084 Erwinia %28%1965-2003%29%
% 218.34/218.54  |- rdf__type mesh__D044084sskos__Concept
% 218.34/218.54  |- mesh__historyNote mesh__D044084 2004   
% 218.34/218.54  |- skos__broader mesh__D044084smesh__D004885
% 218.34/218.54  |- mesh__dateCreated mesh__D044084 2003-07-09
% 218.34/218.54  |- mesh__publicMeSHNote mesh__D044084 2004   
% 218.34/218.54  |- mesh__recordAuthorizer mesh__D044084 sjn
% 218.34/218.54  |- mesh__dateEstablished mesh__D044084 2004-01-01
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D044084 2006
% 218.34/218.54  |- skos__hiddenLabel mesh__D016393 Lymphoma, B Cell
% 218.34/218.54  |- mesh__dateEstablished mesh__D016393 1991-01-01
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D016393 1998
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D016393 1997
% 218.34/218.54  |- mesh__publicMeSHNote mesh__D016393 91   
% 218.34/218.54  |- skos__altLabel mesh__D016393 B-Cell Lymphoma
% 218.34/218.54  |- mesh__recordMaintainer mesh__D016393 KEV
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D016393 2006
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D016393 1996
% 218.34/218.54  |- mesh__dateCreated mesh__D016393 1990-06-01
% 218.34/218.54  |- skos__prefLabel mesh__D016393 Lymphoma, B-Cell
% 218.34/218.54  |- skos__broader mesh__D016393smesh__D008228
% 218.34/218.54  |- mesh__recordAuthorizer mesh__D016393 PLS
% 218.34/218.54  |- rdf__type mesh__D016393sskos__Concept
% 218.34/218.54  |- skos__historyNote mesh__D016393 B-Lymphocytes %28%1977-1990%29%
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D016393 2005
% 218.34/218.54  |- mesh__historyNote mesh__D016393 91   
% 218.34/218.54  |- mesh__dateRevised mesh__D016393 1995-06-08
% 218.34/218.54  |- skos__scopeNote mesh__D016393
% 218.34/218.54       A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.%A%    
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D016393 2002
% 218.34/218.54  |- skos__hiddenLabel mesh__D016393 B Cell Lymphoma
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D016393 2004
% 218.34/218.54  |- skos__annotation mesh__D016393
% 218.34/218.54       a non-Hodgkin%27%s lymphoma; LYMPHOMA, T-CELL is also available%A%  
% 218.34/218.54  |- skos__hiddenLabel mesh__D016393 B-Cell Lymphomas
% 218.34/218.54  |- skos__historyNote mesh__D016393
% 218.34/218.54       Lymphoma, Non-Hodgkin%27%s %28%1987-1990%29%
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D016393 2001
% 218.34/218.54  |- skos__hiddenLabel mesh__D016393 Lymphomas, B-Cell
% 218.34/218.54  |- mesh__recordOriginator mesh__D016393 PLS
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D016393 2003
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D016393 1999
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D016393 2000
% 218.34/218.54  |- mesh__historyNote mesh__D002373
% 218.34/218.54       94; was CATABOLITE GENE ACTIVATOR PROTEINS 1988-93; CYCLIC AMP RECEPTOR PROTEIN was see CATABOLITE GENE ACTIVATOR PROTEIN 1990-93; CATABOLITE GENE ACTIVATOR PROTEIN was see RECEPTORS, CYCLIC AMP 1987; CATABOLITE ACTIVATOR PROTEIN was see RECEPTORS, CYCLIC AMP 1987; CATABOLIC GENE ACTIVATORS was see RECEPTORS, CYCLIC AMP 1977-87%A%  
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D002373 2006
% 218.34/218.54  |- skos__hiddenLabel mesh__D002373 Proteins, cAMP Receptor
% 218.34/218.54  |- skos__prefLabel mesh__D002373 Cyclic AMP Receptor Protein
% 218.34/218.54  |- skos__altLabel mesh__D002373 Protein, Catabolite Regulator
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D002373 2003
% 218.34/218.54  |- mesh__dateRevised mesh__D002373 1997-06-20
% 218.34/218.54  |- skos__altLabel mesh__D002373 Regulator Proteins, Catabolite
% 218.34/218.54  |- skos__altLabel mesh__D002373 Catabolic Gene Activator
% 218.34/218.54  |- skos__broader mesh__D002373smesh__D014157
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D002373 2002
% 218.34/218.54  |- skos__historyNote mesh__D002373 Receptors, Cyclic AMP %28%1980-1993%29%
% 218.34/218.54  |- mesh__publicMeSHNote mesh__D002373
% 218.34/218.54       94; was CATABOLITE GENE ACTIVATOR PROTEINS 1988-93; CYCLIC AMP RECEPTOR PROTEIN was see CATABOLITE GENE ACTIVATOR PROTEIN 1990-93; CATABOLITE GENE ACTIVATOR PROTEIN was see RECEPTORS, CYCLIC AMP 1987; CATABOLITE ACTIVATOR PROTEIN was see RECEPTORS, CYCLIC AMP 1987; CATABOLIC GENE ACTIVATORS was see RECEPTORS, CYCLIC AMP 1977-87%A%  
% 218.34/218.54  |- skos__historyNote mesh__D002373 Transcription Factors %28%1980-1987%29%
% 218.34/218.54  |- skos__altLabel mesh__D002373 Proteins, Catabolite Activator
% 218.34/218.54  |- skos__altLabel mesh__D002373 Gene Activators, Catabolic
% 218.34/218.54  |- skos__altLabel mesh__D002373 Catabolite Activator Protein
% 218.34/218.54  |- skos__altLabel mesh__D002373 Catabolite Gene Activator Protein
% 218.34/218.54  |- skos__altLabel mesh__D002373 Gene Activator, Catabolic
% 218.34/218.54  |- skos__altLabel mesh__D002373 Regulator Protein, Catabolite
% 218.34/218.54  |- mesh__dateEstablished mesh__D002373 1988-01-01
% 218.34/218.54  |- skos__altLabel mesh__D002373 Catabolite Regulator Proteins
% 218.34/218.54  |- skos__altLabel mesh__D002373 Activator Proteins, Catabolite
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D002373 2004
% 218.34/218.54  |- skos__altLabel mesh__D002373 Catabolite Gene Activator Proteins
% 218.34/218.54  |- skos__altLabel mesh__D002373 Activators, Catabolic Gene
% 218.34/218.54  |- skos__historyNote mesh__D002373 Amino Acid Sequence %28%1975-1987%29%
% 218.34/218.54  |- skos__historyNote mesh__D002373 Bacterial Proteins %28%1972-1987%29%
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D002373 1998
% 218.34/218.54  |- mesh__recordAuthorizer mesh__D002373 SJN
% 218.34/218.54  |- mesh__dateCreated mesh__D002373 1987-05-11
% 218.34/218.54  |- skos__altLabel mesh__D002373 Catabolite Activator Proteins
% 218.34/218.54  |- skos__altLabel mesh__D002373 cAMP Receptor Proteins
% 218.34/218.54  |- skos__altLabel mesh__D002373 Activator Protein, Catabolite
% 218.34/218.54  |- skos__hiddenLabel mesh__D002373 Receptor Protein, cAMP
% 218.34/218.54  |- skos__historyNote mesh__D002373 Base Sequence %28%1980-1987%29%
% 218.34/218.54  |- skos__altLabel mesh__D002373 cAMP Receptor Protein
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D002373 1999
% 218.34/218.54  |- skos__altLabel mesh__D002373 Catabolite Regulator Protein
% 218.34/218.54  |- skos__altLabel mesh__D002373 Cyclic AMP Receptor Proteins
% 218.34/218.54  |- mesh__recordOriginator mesh__D002373 SCD
% 218.34/218.54  |- skos__hiddenLabel mesh__D002373 Protein, cAMP Receptor
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D002373 2000
% 218.34/218.54  |- skos__hiddenLabel mesh__D002373 Receptor Proteins, cAMP
% 218.34/218.54  |- skos__altLabel mesh__D002373 Proteins, Catabolite Regulator
% 218.34/218.54  |- skos__scopeNote mesh__D002373
% 218.34/218.54       A transcriptional regulator in prokaryotes which, when activated by binding cyclic AMP, acts at several promoters. Cyclic AMP receptor protein was originally identified as a catabolite gene activator protein. It was subsequently shown to regulate several functions unrelated to catabolism, and to be both a negative and a positive regulator of transcription. Cell surface cyclic AMP receptors are not included %28%CYCLIC AMP RECEPTORS%29%, nor are the eukaryotic cytoplasmic cyclic AMP receptor proteins, which are the regulatory subunits of CYCLIC AMP-DEPENDENT PROTEIN KINASES.%A%    
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D002373 2005
% 218.34/218.54  |- skos__altLabel mesh__D002373 Protein, Catabolite Activator
% 218.34/218.54  |- mesh__onlineNote mesh__D002373
% 218.34/218.54       use CYCLIC AMP RECEPTOR PROTEIN to search CATABOLITE GENE ACTIVATOR PROTEINS 1988-93; use RECEPTORS, CYCLIC AMP to search CATABOLITE GENE ACTIVATOR PROTEINS %26% CATABOLITE ACTIVATOR PROTEIN 1987 %26% CATABOLIC GENE ACTIVATORS 1977-87%A%  
% 218.34/218.54  |- skos__altLabel mesh__D002373 Catabolic Gene Activators
% 218.34/218.54  |- skos__altLabel mesh__D002373 Activator, Catabolic Gene
% 218.34/218.54  |- mesh__recordMaintainer mesh__D002373 KEV
% 218.34/218.54  |- skos__historyNote mesh__D002373 Transcription, Genetic %28%1978-1987%29%
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D002373 2001
% 218.34/218.54  |- rdf__type mesh__D002373sskos__Concept
% 218.34/218.54  |- mesh__recordAuthorizer mesh__D010805 sjn
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D010805 2005
% 218.34/218.54  |- mesh__recordMaintainer mesh__D010805 ags
% 218.34/218.54  |- skos__hiddenLabel mesh__D010805 Conditioning, Animal Physical
% 218.34/218.54  |- skos__hiddenLabel mesh__D010805 Animal Physical Conditioning
% 218.34/218.54  |- skos__broader mesh__D010805smesh__D008919
% 218.34/218.54  |- mesh__dateRevised mesh__D010805 2003-07-30
% 218.34/218.54  |- skos__hiddenLabel mesh__D010805 Physical Conditionings, Animal
% 218.34/218.54  |- rdf__type mesh__D010805sskos__Concept
% 218.34/218.54  |- mesh__historyNote mesh__D010805 76   
% 218.34/218.54  |- skos__hiddenLabel mesh__D010805 Animal Physical Conditionings
% 218.34/218.54  |- mesh__dateCreated mesh__D010805 1975-07-25
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D010805 2004
% 218.34/218.54  |- skos__hiddenLabel mesh__D010805 Conditionings, Animal Physical
% 218.34/218.54  |- mesh__recordOriginator mesh__D010805 FPG
% 218.34/218.54  |- skos__annotation mesh__D010805
% 218.34/218.54       domestic, veterinary %26% exper animals; do not use /vet; don%27%t forget check tag ANIMALS; exercising of animals goes here; animal running in exercise wheel is probably MOTOR ACTIVITY or EXERTION%A%  
% 218.34/218.54  |- skos__prefLabel mesh__D010805 Physical Conditioning, Animal
% 218.34/218.54  |- mesh__publicMeSHNote mesh__D010805 76   
% 218.34/218.54  |- skos__scopeNote mesh__D010805
% 218.34/218.54       Physical conditioning of domestic, laboratory, and zoo animals. Includes exercising of animals.%A%    
% 218.34/218.54  |- mesh__dateEstablished mesh__D010805 1976-01-01
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D010805 2006
% 218.34/218.54  |- skos__hiddenLabel mesh__D010007 Osteochondritides
% 218.34/218.54  |- skos__related mesh__D010007smesh__D010000
% 218.34/218.54  |- skos__altLabel mesh__D010007 Koehler%27%s Disease
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D010007 2004
% 218.34/218.54  |- skos__broader mesh__D010007smesh__D001847
% 218.34/218.54  |- skos__hiddenLabel mesh__D010007 Koehlers Disease
% 218.34/218.54  |- skos__prefLabel mesh__D010007 Osteochondritis
% 218.34/218.54  |- mesh__recordMaintainer mesh__D010007 ags
% 218.34/218.54  |- mesh__dateCreated mesh__D010007 1999-01-01
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D010007 2005
% 218.34/218.54  |- skos__hiddenLabel mesh__D010007 Osgood Schlatter Disease
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D010007 2006
% 218.34/218.54  |- mesh__recordAuthorizer mesh__D010007 sjn
% 218.34/218.54  |- mesh__dateRevised mesh__D010007 2002-07-03
% 218.34/218.54  |- skos__hiddenLabel mesh__D010007 Osteochondroses
% 218.34/218.54  |- skos__broader mesh__D010007smesh__D002357
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D010007 2003
% 218.34/218.54  |- rdf__type mesh__D010007sskos__Concept
% 218.34/218.54  |- mesh__recordOriginator mesh__D010007 NLM
% 218.34/218.54  |- skos__scopeNote mesh__D010007 Inflammation of bone and cartilage.     
% 218.34/218.54  |- skos__scopeNote mesh__D006764
% 218.34/218.54       Institutions with permanent facilities and organized medical staff which provide the full range of hospital services primarily to a neighborhood area.%A%    
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D006764 2005
% 218.34/218.54  |- rdf__type mesh__D006764sskos__Concept
% 218.34/218.54  |- skos__historyNote mesh__D006764
% 218.34/218.54       Community Health Services %28%1966-1972%29%
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D006764 2002
% 218.34/218.54  |- skos__prefLabel mesh__D006764 Hospitals, Community
% 218.34/218.54  |- mesh__dateRevised mesh__D006764 1999-11-03
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D006764 2003
% 218.34/218.54  |- skos__hiddenLabel mesh__D006764 Community Hospitals
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D006764 2006
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D006764 2004
% 218.34/218.54  |- skos__altLabel mesh__D006764 Community Hospital
% 218.34/218.54  |- skos__broader mesh__D006764smesh__D006761
% 218.34/218.54  |- skos__annotation mesh__D006764
% 218.34/218.54       coord IM with special hosp %28%e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.%29% or med specialty %28%IM or NIM%29% if pertinent; specify geog%A%  
% 218.34/218.54  |- mesh__recordAuthorizer mesh__D006764 sjn
% 218.34/218.54  |- mesh__recordMaintainer mesh__D006764 kle
% 218.34/218.54  |- mesh__dateCreated mesh__D006764 1999-01-01
% 218.34/218.54  |- mesh__recordOriginator mesh__D006764 NLM
% 218.34/218.54  |- mesh__historyNote mesh__D006764 73   
% 218.34/218.54  |- mesh__dateEstablished mesh__D006764 1973-01-01
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D006764 2000
% 218.34/218.54  |- skos__historyNote mesh__D006764 Hospitals %28%1966-1972%29%
% 218.34/218.54  |- skos__hiddenLabel mesh__D006764 Hospital, Community
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D006764 2001
% 218.34/218.54  |- mesh__publicMeSHNote mesh__D006764 73   
% 218.34/218.54  |- skos__broader mesh__D020435smesh__D003389
% 218.34/218.54  |- skos__scopeNote mesh__D020435
% 218.34/218.54       Diseases of the ninth cranial %28%glossopharyngeal%29% nerve or its nuclei in the medulla. The nerve may be injured by diseases affecting the lower brain stem, floor of the posterior fossa, jugular foramen, or the nerve%27%s extracranial course. Clinical manifestations include loss of sensation from the pharynx, decreased salivation, and syncope. Glossopharyngeal neuralgia refers to a condition that features recurrent unilateral sharp pain in the tongue, angle of the jaw, external auditory meatus and throat that may be associated with SYNCOPE. Episodes may be triggered by cough, sneeze, swallowing, or pressure on the tragus of the ear. %28%Adams et al., Principles of Neurology, 6th ed, p1390%29%%A%    
% 218.34/218.54  |- skos__related mesh__D020435smesh__D020209
% 218.34/218.54  |- mesh__historyNote mesh__D020435 2000   
% 218.34/218.54  |- mesh__recordOriginator mesh__D020435 KEV
% 218.34/218.54  |- mesh__dateRevised mesh__D020435 2003-07-25
% 218.34/218.54  |- mesh__dateCreated mesh__D020435 1999-11-04
% 218.34/218.54  |- skos__hiddenLabel mesh__D020435 Neuralgias, Glossopharyngeal
% 218.34/218.54  |- skos__hiddenLabel mesh__D020435 Glossopharyngeal Motor Neuropathies
% 218.34/218.54  |- skos__annotation mesh__D020435
% 218.34/218.54       neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 218.34/218.54  |- skos__prefLabel mesh__D020435 Glossopharyngeal Nerve Diseases
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D020435 2005
% 218.34/218.54  |- rdf__type mesh__D020435sskos__Concept
% 218.34/218.54  |- mesh__recordAuthorizer mesh__D020435 sjn
% 218.34/218.54  |- skos__altLabel mesh__D020435 Taste Disorder, Glossopharyngeal Nerve
% 218.34/218.54  |- mesh__dateEstablished mesh__D020435 2000-01-01
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D020435 2006
% 218.34/218.54  |- skos__altLabel mesh__D020435 Ninth Cranial Nerve Diseases
% 218.34/218.54  |- skos__historyNote mesh__D020435 Glossopharyngeal Nerve %28%1965-1980%29%
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D020435 2004
% 218.34/218.54  |- skos__historyNote mesh__D020435 Cranial Nerve Diseases %28%1981-1999%29%
% 218.34/218.54  |- mesh__recordMaintainer mesh__D020435 sjn
% 218.34/218.54  |- skos__hiddenLabel mesh__D020435 Glossopharyngeal Neuralgias
% 218.34/218.54  |- skos__altLabel mesh__D020435 Cranial Nerve IX Disorders
% 218.34/218.54  |- skos__hiddenLabel mesh__D020435 Glossopharyngeal Nerve Disease
% 218.34/218.54  |- skos__altLabel mesh__D020435 Sensory Neuropathy, Glossopharyngeal Nerve
% 218.34/218.54  |- skos__hiddenLabel mesh__D020435 Neuralgia, Glossopharyngeal
% 218.34/218.54  |- skos__hiddenLabel mesh__D020435 Motor Neuropathy, Glossopharyngeal
% 218.34/218.54  |- mesh__publicMeSHNote mesh__D020435 2000   
% 218.34/218.54  |- skos__hiddenLabel mesh__D020435 Motor Neuropathies, Glossopharyngeal
% 218.34/218.54  |- skos__altLabel mesh__D020435 Cranial Nerve IX Diseases
% 218.34/218.54  |- mesh__dateRevised mesh__D044883 2005-06-30
% 218.34/218.54  |- mesh__historyNote mesh__D044883 2004   
% 218.34/218.54  |- mesh__recordMaintainer mesh__D044883 SYSTEM
% 218.34/218.54  |- skos__annotation mesh__D044883
% 218.34/218.54       infection: coord IM with CAMPYLOBACTER INFECTIONS %28%IM%29%   
% 218.34/218.54  |- mesh__recordOriginator mesh__D044883 ags
% 218.34/218.54  |- skos__prefLabel mesh__D044883 Campylobacter rectus
% 218.34/218.54  |- mesh__dateCreated mesh__D044883 2003-07-09
% 218.34/218.54  |- skos__scopeNote mesh__D044883
% 218.34/218.54       A species of CAMPYLOBACTER isolated from cases of human PERIODONTITIS. It is a microaerophile, capable of respiring with OXYGEN.%A%    
% 218.34/218.54  |- mesh__dateEstablished mesh__D044883 2004-01-01
% 218.34/218.54  |- skos__historyNote mesh__D044883 Campylobacter %28%1992-2003%29%
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D044883 2006
% 218.34/218.54  |- mesh__publicMeSHNote mesh__D044883 2004   
% 218.34/218.54  |- skos__broader mesh__D044883smesh__D002167
% 218.34/218.54  |- rdf__type mesh__D044883sskos__Concept
% 218.34/218.54  |- mesh__recordAuthorizer mesh__D044883 sjn
% 218.34/218.54  |- skos__broader mesh__D044085smesh__D036103
% 218.34/218.54  |- skos__scopeNote mesh__D044085
% 218.34/218.54       The study of fluid channels and chambers of tiny dimensions of tens to hundreds of micrometers and volumes of nanoliters or picoliters.  This is of interest in biological MICROCIRCULATION and used in MICROCHEMISTRY and INVESTIGATIVE TECHNIQUES.%A%    
% 218.34/218.54  |- mesh__dateCreated mesh__D044085 2003-07-09
% 218.34/218.54  |- mesh__publicMeSHNote mesh__D044085 2004   
% 218.34/218.54  |- skos__prefLabel mesh__D044085 Microfluidics
% 218.34/218.54  |- mesh__historyNote mesh__D044085 2004   
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D044085 2004
% 218.34/218.54  |- skos__hiddenLabel mesh__D044085 Microfluidic
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D044085 2006
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D044085 2005
% 218.34/218.54  |- skos__broader mesh__D044085smesh__D012212
% 218.34/218.54  |- mesh__dateEstablished mesh__D044085 2004-01-01
% 218.34/218.54  |- rdf__type mesh__D044085sskos__Concept
% 218.34/218.54  |- skos__hiddenLabel mesh__D011100 DexonS
% 218.34/218.54  |- mesh__recordAuthorizer mesh__D011100 sjn
% 218.34/218.54  |- skos__scopeNote mesh__D011100
% 218.34/218.54       A biocompatible polymer used as a surgical suture material.%A%    
% 218.34/218.54  |- mesh__dateEstablished mesh__D011100 1973-01-01
% 218.34/218.54  |- skos__historyNote mesh__D011100 Glycolates %28%1966-1972%29%
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D011100 2005
% 218.34/218.54  |- mesh__historyNote mesh__D011100 73   
% 218.34/218.54  |- mesh__recordOriginator mesh__D011100 NLM
% 218.34/218.54  |- skos__hiddenLabel mesh__D011100 Dexon S
% 218.34/218.54  |- skos__prefLabel mesh__D011100 Polyglycolic Acid
% 218.34/218.54  |- mesh__recordMaintainer mesh__D011100 jmp
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D011100 2006
% 218.34/218.54  |- mesh__publicMeSHNote mesh__D011100 73   
% 218.34/218.54  |- mesh__dateRevised mesh__D011100 2004-07-07
% 218.34/218.54  |- skos__broader mesh__D011100smesh__D011091
% 218.34/218.54  |- skos__altLabel mesh__D011100 Polyglycolide
% 218.34/218.54  |- rdf__type mesh__D011100sskos__Concept
% 218.34/218.54  |- skos__annotation mesh__D011100 D25-26 qualif   
% 218.34/218.54  |- mesh__dateCreated mesh__D011100 1999-01-01
% 218.34/218.54  |- skos__broader mesh__D016888Q000151smesh__D016888
% 218.34/218.54  |- mesh__preferredCombination mesh__D016888Q000151smesh__D001165
% 218.34/218.54  |- rdf__type mesh__D016888Q000151smesh__CompoundConcept
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D002374 2006
% 218.34/218.54  |- mesh__recordMaintainer mesh__D002374 ssb
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D002374 2005
% 218.34/218.54  |- mesh__recordAuthorizer mesh__D002374 sjn
% 218.34/218.54  |- skos__altLabel mesh__D002374 Manganese Catalase
% 218.34/218.54  |- mesh__dateCreated mesh__D002374 1999-01-01
% 218.34/218.54  |- mesh__dateRevised mesh__D002374 2003-07-09
% 218.34/218.54  |- rdf__type mesh__D002374sskos__Concept
% 218.34/218.54  |- skos__prefLabel mesh__D002374 Catalase
% 218.34/218.54  |- mesh__recordOriginator mesh__D002374 NLM
% 218.34/218.54  |- skos__broader mesh__D002374smesh__D010544
% 218.34/218.54  |- skos__scopeNote mesh__D002374
% 218.34/218.54       An oxidoreductase that catalyzes the conversion of hydrogen peroxide to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in ACATALASIA. EC 1.11.1.6.%A%    
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D002374 2004
% 218.34/218.54  |- mesh__recordOriginator mesh__D010806 NLM
% 218.34/218.54  |- mesh__recordMaintainer mesh__D010806 kle
% 218.34/218.54  |- skos__annotation mesh__D010806
% 218.34/218.54       %22%instructional%22% %26% %22%often in schools%22%: differentiate from EXERCISE %28%see MeSH definition there%29%, from GYMNASTICS %28%see note there%29% %26% from EXERCISE THERAPY %28%prescribed exercise %26% physical activity%29%; DF: PHYS ED or PHYSICAL EDUC or PHYSICAL EDUCATION%A%  
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D010806 2000
% 218.34/218.54  |- mesh__dateCreated mesh__D010806 1999-01-01
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D010806 2001
% 218.34/218.54  |- skos__altLabel mesh__D010806 Physical Education, Training
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D010806 2003
% 218.34/218.54  |- skos__altLabel mesh__D010806 Education, Physical
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D010806 2002
% 218.34/218.54  |- mesh__recordAuthorizer mesh__D010806 sjn
% 218.34/218.54  |- rdf__type mesh__D010806sskos__Concept
% 218.34/218.54  |- skos__broader mesh__D010806smesh__D004505
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D010806 2004
% 218.34/218.54  |- skos__scopeNote mesh__D010806
% 218.34/218.54       Instructional programs in the care and development of the body, often in schools. The concept does not include prescribed exercises, which is EXERCISE THERAPY.%A%    
% 218.34/218.54  |- skos__prefLabel mesh__D010806 Physical Education and Training
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D010806 2005
% 218.34/218.54  |- mesh__dateRevised mesh__D010806 1999-11-03
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D010806 2006
% 218.34/218.54  |- skos__historyNote mesh__D010008 Osteochondritis %28%1966-1984%29%
% 218.34/218.54  |- mesh__dateCreated mesh__D010008 1984-04-06
% 218.34/218.54  |- mesh__dateRevised mesh__D010008 2002-07-03
% 218.34/218.54  |- mesh__recordAuthorizer mesh__D010008 sjn
% 218.34/218.54  |- skos__prefLabel mesh__D010008 Osteochondritis Dissecans
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D010008 2005
% 218.34/218.54  |- mesh__recordOriginator mesh__D010008 RC
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D010008 2006
% 218.34/218.54  |- mesh__publicMeSHNote mesh__D010008
% 218.34/218.54       91; was see under OSTEOCHONDRITIS 1985-90   
% 218.34/218.54  |- mesh__historyNote mesh__D010008
% 218.34/218.54       91%28%85%29%; was see under OSTEOCHONDRITIS 1985-90   
% 218.34/218.54  |- mesh__recordMaintainer mesh__D010008 mdb
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D010008 2003
% 218.34/218.54  |- rdf__type mesh__D010008sskos__Concept
% 218.34/218.54  |- skos__hiddenLabel mesh__D010008 Dissecans, Osteochondritis
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D010008 2004
% 218.34/218.54  |- skos__broader mesh__D010008smesh__D010007
% 218.34/218.54  |- mesh__dateEstablished mesh__D010008 1991-01-01
% 218.34/218.54  |- skos__scopeNote mesh__D010008
% 218.34/218.54       A type of osteochondritis in which articular cartilage and associated bone becomes partially or totally detached to form joint loose bodies. Affects mainly the knee, ankle, and elbow joints.%A%    
% 218.34/218.54  |- skos__prefLabel mesh__D006765 Hospitals, Convalescent
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D006765 2001
% 218.34/218.54  |- skos__altLabel mesh__D006765 Convalescent Hospital
% 218.34/218.54  |- skos__hiddenLabel mesh__D006765 Convalescent Hospitals
% 218.34/218.54  |- mesh__recordOriginator mesh__D006765 NLM
% 218.34/218.54  |- rdf__type mesh__D006765sskos__Concept
% 218.34/218.54  |- skos__hiddenLabel mesh__D006765 Hospital, Convalescent
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D006765 2000
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D006765 2004
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D006765 2006
% 218.34/218.54  |- skos__broader mesh__D006765smesh__D006782
% 218.34/218.54  |- mesh__recordMaintainer mesh__D006765 kle
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D006765 2003
% 218.34/218.54  |- mesh__dateCreated mesh__D006765 1999-01-01
% 218.34/218.54  |- skos__scopeNote mesh__D006765
% 218.34/218.54       Hospitals which provide care to the patient for the period following an acute illness until health is restored.%A%    
% 218.34/218.54  |- mesh__dateRevised mesh__D006765 1999-11-03
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D006765 2005
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D006765 2002
% 218.34/218.54  |- skos__annotation mesh__D006765
% 218.34/218.54       coord IM with special hosp or med specialty %28%IM or NIM%29% or with hosp ownership term %28%e.g., HOSPITALS, COUNTY%29% %28%IM or NIM%29% if pertinent; specify geog%A%  
% 218.34/218.54  |- mesh__recordAuthorizer mesh__D006765 sjn
% 218.34/218.54  |- mesh__dateCreated mesh__D020436 1999-11-08
% 218.34/218.54  |- mesh__publicMeSHNote mesh__D020436 2000   
% 218.34/218.54  |- skos__altLabel mesh__D020436 Spinal Accessory Nerve Diseases
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D020436 2005
% 218.34/218.54  |- rdf__type mesh__D020436sskos__Concept
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D020436 2003
% 218.34/218.54  |- mesh__dateEstablished mesh__D020436 2000-01-01
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D020436 2006
% 218.34/218.54  |- skos__prefLabel mesh__D020436 Accessory Nerve Diseases
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D020436 2004
% 218.34/218.54  |- skos__annotation mesh__D020436
% 218.34/218.54       neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 218.34/218.54  |- skos__historyNote mesh__D020436 Accessory Nerve %28%1965-1999%29%
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D020436 2000
% 218.34/218.54  |- skos__altLabel mesh__D020436 Cranial Nerve Eleven Disorders
% 218.34/218.54  |- skos__altLabel mesh__D020436 Eleventh Cranial Nerve Disease
% 218.34/218.54  |- skos__altLabel mesh__D020436 Cranial Nerve Eleven Diseases
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D020436 2001
% 218.34/218.54  |- skos__scopeNote mesh__D020436
% 218.34/218.54       Diseases of the eleventh cranial %28%spinal accessory%29% nerve. This nerve originates from motor neurons in the lower medulla %28%accessory portion of nerve%29% and upper spinal cord %28%spinal portion of nerve%29%. The two components of the nerve join and exit the skull via the jugular foramen, innervating the sternocleidomastoid and trapezius muscles, which become weak or paralyzed if the nerve is injured. The nerve is commonly involved in MOTOR NEURON DISEASE, and may be injured by trauma to the posterior triangle of the neck.%A%    
% 218.34/218.54  |- skos__historyNote mesh__D020436 Cranial Nerve Diseases %28%1981-1999%29%
% 218.34/218.54  |- mesh__historyNote mesh__D020436 2000   
% 218.34/218.54  |- skos__related mesh__D020436smesh__D020209
% 218.34/218.54  |- skos__broader mesh__D020436smesh__D003389
% 218.34/218.54  |- skos__altLabel mesh__D020436 Cranial Nerve XI Diseases
% 218.34/218.54  |- skos__hiddenLabel mesh__D020436 Accessory Nerve Disease
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D020436 2002
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D039141 2006
% 218.34/218.54  |- mesh__dateEstablished mesh__D039141 2003-01-01
% 218.34/218.54  |- skos__hiddenLabel mesh__D039141 Muscular Dystrophies, Oculopharyngeal
% 218.34/218.54  |- skos__related mesh__D039141smesh__D039103
% 218.34/218.54  |- mesh__recordMaintainer mesh__D039141 jls
% 218.34/218.54  |- mesh__publicMeSHNote mesh__D039141
% 218.34/218.54       2003; see MUSCULAR DYSTROPHIES 2001-2002   
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D039141 2005
% 218.34/218.54  |- skos__broader mesh__D039141smesh__D009136
% 218.34/218.54  |- skos__hiddenLabel mesh__D039141 Oculopharyngeal Muscular Dystrophy
% 218.34/218.54  |- mesh__recordAuthorizer mesh__D039141 jls
% 218.34/218.54  |- skos__hiddenLabel mesh__D039141 Dystrophies, Oculopharyngeal Muscular
% 218.34/218.54  |- skos__annotation mesh__D039141
% 218.34/218.54       /vet: coord with MUSCULAR DYSTROPHY, ANIMAL   
% 218.34/218.54  |- mesh__historyNote mesh__D039141
% 218.34/218.54       2003; use MUSCULAR DYSTROPHIES 2001-2002   
% 218.34/218.54  |- skos__hiddenLabel mesh__D039141 Dystrophy, Oculopharyngeal Muscular
% 218.34/218.54  |- rdf__type mesh__D039141sskos__Concept
% 218.34/218.54  |- skos__historyNote mesh__D039141 Muscular Dystrophies %28%1969-2002%29%
% 218.34/218.54  |- mesh__dateCreated mesh__D039141 2002-07-03
% 218.34/218.54  |- skos__hiddenLabel mesh__D039141 Oculopharyngeal Muscular Dystrophies
% 218.34/218.54  |- skos__prefLabel mesh__D039141 Muscular Dystrophy, Oculopharyngeal
% 218.34/218.54  |- mesh__recordOriginator mesh__D039141 jmp
% 218.34/218.54  |- skos__scopeNote mesh__D039141
% 218.34/218.54       An autosomal dominant hereditary disease that presents in late in life and is characterized by DYSPHAGIA and progressive ptosis of the eyelids. Mutations in the gene for POLY%28%A%29%-BINDING PROTEIN II have been associated with oculopharyngeal muscular dystrophy.%A%    
% 218.34/218.54  |- mesh__dateRevised mesh__D039141 2004-07-29
% 218.34/218.54  |- mesh__activeMeSHYear mesh__D039141 2005A
% 218.34/218.54  |- skos__prefLabel mesh__D025121 Myosin Type IV
% 218.34/218.54  |- mesh__dateRevised mesh__D025121 2005-06-30
% 218.34/218.54  |- skos__altLabel mesh__D025121 Myosin IV
% 218.34/218.54  |- mesh__historyNote mesh__D025121 2002   
% 218.34/218.54  |- skos__altLabel mesh__D025121 HMWMI
% 218.34/218.55  |- skos__historyNote mesh__D025121 Myosins %28%1990-2001%29%
% 218.34/218.55  |- mesh__dateCreated mesh__D025121 2001-07-25
% 218.34/218.55  |- mesh__recordMaintainer mesh__D025121 DRC
% 218.34/218.55  |- skos__altLabel mesh__D025121 High Molecular Weight Myosin I
% 218.34/218.55  |- mesh__dateEstablished mesh__D025121 2002-01-01
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D025121 2006
% 218.34/218.55  |- skos__broader mesh__D025121smesh__D009218
% 218.34/218.55  |- mesh__publicMeSHNote mesh__D025121 2002   
% 218.34/218.55  |- skos__scopeNote mesh__D025121
% 218.34/218.55       A subclass of myosin found in ACANTHAMOEBA. It is a non-filamentous myosin containing a single 180-kDa myosin heavy chain.%A%    
% 218.34/218.55  |- mesh__recordOriginator mesh__D025121 jmp
% 218.34/218.55  |- skos__hiddenLabel mesh__D025121 Type IV, Myosin
% 218.34/218.55  |- rdf__type mesh__D025121sskos__Concept
% 218.34/218.55  |- mesh__recordAuthorizer mesh__D025121 sjn
% 218.34/218.55  |- mesh__recordOriginator mesh__D044884 ags
% 218.34/218.55  |- skos__broader mesh__D044884smesh__D002167
% 218.34/218.55  |- mesh__dateRevised mesh__D044884 2005-06-30
% 218.34/218.55  |- mesh__historyNote mesh__D044884 2004   
% 218.34/218.55  |- mesh__dateCreated mesh__D044884 2003-07-09
% 218.34/218.55  |- mesh__recordMaintainer mesh__D044884 SYSTEM
% 218.34/218.55  |- mesh__dateEstablished mesh__D044884 2004-01-01
% 218.34/218.55  |- skos__prefLabel mesh__D044884 Campylobacter sputorum
% 218.34/218.55  |- mesh__publicMeSHNote mesh__D044884 2004   
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D044884 2006
% 218.34/218.55  |- skos__scopeNote mesh__D044884
% 218.34/218.55       A species of CAMPYLOBACTER comprised of three biovars based on their reaction to CATALASE and UREASE. They have been isolated from humans, CATTLE, and SHEEP.%A%    
% 218.34/218.55  |- rdf__type mesh__D044884sskos__Concept
% 218.34/218.55  |- mesh__recordAuthorizer mesh__D044884 sjn
% 218.34/218.55  |- skos__historyNote mesh__D044884 Campylobacter %28%1975-2003%29%
% 218.34/218.55  |- skos__annotation mesh__D044884
% 218.34/218.55       infection: coord IM with CAMPYLOBACTER INFECTIONS %28%IM%29%   
% 218.34/218.55  |- skos__annotation mesh__D044086
% 218.34/218.55       infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 218.34/218.55  |- skos__prefLabel mesh__D044086 Kluyvera
% 218.34/218.55  |- mesh__recordMaintainer mesh__D044086 SYSTEM
% 218.34/218.55  |- mesh__dateCreated mesh__D044086 2003-07-09
% 218.34/218.55  |- mesh__publicMeSHNote mesh__D044086 2004   
% 218.34/218.55  |- mesh__recordAuthorizer mesh__D044086 sjn
% 218.34/218.55  |- mesh__dateEstablished mesh__D044086 2004-01-01
% 218.34/218.55  |- skos__scopeNote mesh__D044086
% 218.34/218.55       A genus of gram-negative, facultatively anaerobic bacteria in the family ENTEROBACTERIACEAE. It is found in FOOD; SOIL; and SEWAGE; and is an opportunistic pathogen of humans.%A%    
% 218.34/218.55  |- mesh__dateRevised mesh__D044086 2005-06-30
% 218.34/218.55  |- mesh__recordOriginator mesh__D044086 ags
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D044086 2006
% 218.34/218.55  |- skos__broader mesh__D044086smesh__D004755
% 218.34/218.55  |- mesh__historyNote mesh__D044086 2004   
% 218.34/218.55  |- rdf__type mesh__D044086sskos__Concept
% 218.34/218.55  |- skos__historyNote mesh__D044086 Enterobacteriaceae %28%1974-2003%29%
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D016395 2004
% 218.34/218.55  |- mesh__dateCreated mesh__D016395 1990-06-01
% 218.34/218.55  |- skos__hiddenLabel mesh__D016395 Lymphomas, High-Grade
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D016395 2002
% 218.34/218.55  |- mesh__recordOriginator mesh__D016395 PLS
% 218.34/218.55  |- mesh__dateRevised mesh__D016395 1997-06-20
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D016395 2003
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D016395 1999
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D016395 2001
% 218.34/218.55  |- skos__prefLabel mesh__D016395 Lymphoma, High-Grade
% 218.34/218.55  |- skos__scopeNote mesh__D016395
% 218.34/218.55       One of the three major prognostic groupings for non-Hodgkin lymphomas as proposed in the Working Formulation of the Non-Hodgkin%27%s Lymphoma Pathologic Classification Project sponsored by the National Cancer Institute %28%1981%29%. Lymphomas falling within this group have a relatively unfavorable survival potential.%A%    
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D016395 1998
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D016395 2000
% 218.34/218.55  |- skos__hiddenLabel mesh__D016395 Lymphoma, High Grade
% 218.34/218.55  |- skos__hiddenLabel mesh__D016395 High-Grade Lymphomas
% 218.34/218.55  |- skos__hiddenLabel mesh__D016395 High-Grade Lymphoma
% 218.34/218.55  |- mesh__dateEstablished mesh__D016395 1991-01-01
% 218.34/218.55  |- mesh__recordAuthorizer mesh__D016395 SJN
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D016395 2006
% 218.34/218.55  |- skos__annotation mesh__D016395
% 218.34/218.55       a grade of non-Hodgkin%27%s lymphoma; prefer specific; LYMPHOMA, LOW-GRADE %26% LYMPHOMA, INTERMEDIATE-GRADE %26% their specifics are also available%A%  
% 218.34/218.55  |- mesh__publicMeSHNote mesh__D016395 91   
% 218.34/218.55  |- skos__broader mesh__D016395smesh__D008228
% 218.34/218.55  |- mesh__recordMaintainer mesh__D016395 PXP
% 218.34/218.55  |- rdf__type mesh__D016395sskos__Concept
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D016395 2005
% 218.34/218.55  |- mesh__historyNote mesh__D016395 91   
% 218.34/218.55  |- skos__annotation mesh__D002375 do not confuse with CATAPLEXY   
% 218.34/218.55  |- mesh__recordMaintainer mesh__D002375 nns
% 218.34/218.55  |- mesh__dateCreated mesh__D002375 1999-01-01
% 218.34/218.55  |- skos__related mesh__D002375smesh__D002389
% 218.34/218.55  |- skos__hiddenLabel mesh__D002375 Anochlesias
% 218.34/218.55  |- mesh__recordOriginator mesh__D002375 NLM
% 218.34/218.55  |- rdf__type mesh__D002375sskos__Concept
% 218.34/218.55  |- skos__hiddenLabel mesh__D002375 Flexibilitas, Cerea
% 218.34/218.55  |- mesh__dateRevised mesh__D002375 2004-07-07
% 218.34/218.55  |- skos__hiddenLabel mesh__D002375 Waxy Flexibility
% 218.34/218.55  |- skos__altLabel mesh__D002375 Flexibility, Waxy
% 218.34/218.55  |- skos__hiddenLabel mesh__D002375 Catalepsies
% 218.34/218.55  |- skos__altLabel mesh__D002375 Anochlesia
% 218.34/218.55  |- mesh__recordAuthorizer mesh__D002375 sjn
% 218.34/218.55  |- skos__scopeNote mesh__D002375
% 218.34/218.55       A condition characterized by inactivity, decreased responsiveness to stimuli, and a tendency to maintain an immobile posture. The limbs tend to remain in whatever position they are placed %28%waxy flexibility%29%. Catalepsy may be associated with PSYCHOTIC DISORDERS %28%e.g., SCHIZOPHRENIA, CATATONIC%29%, nervous system drug toxicity, and other conditions.%A%    
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D002375 2006
% 218.34/218.55  |- skos__related mesh__D002375smesh__D002385
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D002375 2005
% 218.34/218.55  |- skos__broader mesh__D002375smesh__D020820
% 218.34/218.55  |- skos__hiddenLabel mesh__D002375 Waxy Flexibilities
% 218.34/218.55  |- skos__hiddenLabel mesh__D002375 Flexibilities, Waxy
% 218.34/218.55  |- skos__related mesh__D002375smesh__D046352
% 218.34/218.55  |- skos__prefLabel mesh__D002375 Catalepsy
% 218.34/218.55  |- mesh__recordOriginator mesh__D010807 MM
% 218.34/218.55  |- skos__annotation mesh__D010807
% 218.34/218.55       differs from PHYSICAL FITNESS in that here the emphasis is on %22%endurance%22%%A%  
% 218.34/218.55  |- rdf__type mesh__D010807sskos__Concept
% 218.34/218.55  |- mesh__recordMaintainer mesh__D010807 nns
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010807 2004
% 218.34/218.55  |- skos__prefLabel mesh__D010807 Physical Endurance
% 218.34/218.55  |- skos__hiddenLabel mesh__D010807 Endurances, Physical
% 218.34/218.55  |- skos__broader mesh__D010807smesh__D043703
% 218.34/218.55  |- mesh__publicMeSHNote mesh__D010807 77   
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010807 2005
% 218.34/218.55  |- skos__scopeNote mesh__D010807
% 218.34/218.55       The time span between the beginning of physical activity by an individual and the termination because of exhaustion.%A%    
% 218.34/218.55  |- mesh__dateRevised mesh__D010807 2003-07-09
% 218.34/218.55  |- mesh__recordAuthorizer mesh__D010807 sjn
% 218.34/218.55  |- mesh__dateCreated mesh__D010807 1976-04-27
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010807 2006
% 218.34/218.55  |- skos__historyNote mesh__D010807 Exertion %28%1966-1976%29%
% 218.34/218.55  |- skos__hiddenLabel mesh__D010807 Endurance, Physical
% 218.34/218.55  |- mesh__historyNote mesh__D010807 77   
% 218.34/218.55  |- skos__historyNote mesh__D010807 Fatigue %28%1966-1976%29%
% 218.34/218.55  |- skos__hiddenLabel mesh__D010807 Physical Endurances
% 218.34/218.55  |- mesh__dateEstablished mesh__D010807 1977-01-01
% 218.34/218.55  |- skos__broader mesh__D000743Q000151smesh__D000743
% 218.34/218.55  |- mesh__preferredCombination mesh__D000743Q000151smesh__D000745
% 218.34/218.55  |- rdf__type mesh__D000743Q000151smesh__CompoundConcept
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010009 1998
% 218.34/218.55  |- skos__hiddenLabel mesh__D010009 Melnick Needles Syndrome
% 218.34/218.55  |- skos__hiddenLabel mesh__D010009 Schwartz Jampel Syndrome
% 218.34/218.55  |- rdf__type mesh__D010009sskos__Concept
% 218.34/218.55  |- skos__annotation mesh__D010009 abnorm develop of cartilage %26% bone   
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010009 2006
% 218.34/218.55  |- mesh__publicMeSHNote mesh__D010009
% 218.34/218.55       85; DYSCHONDRODYSPLASIAS was heading DYSCHONDROPLASIA 1963-84; SPONDYLEPIPHYSEAL DYSPLASIA was see MUCOPOLYSACCHARIDOSIS 4 1980-84, was see ECCENTROOSTEOCHONDRODYSPLASIA 1968-79%A%  
% 218.34/218.55  |- skos__hiddenLabel mesh__D010009 Dysplasias, Multiple Epiphyseal
% 218.34/218.55  |- mesh__recordAuthorizer mesh__D010009 PLS
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010009 2001
% 218.34/218.55  |- skos__hiddenLabel mesh__D010009 Epiphyseal Dysplasias, Multiple
% 218.34/218.55  |- skos__historyNote mesh__D010009
% 218.34/218.55       Bone Diseases, Developmental %28%1970-1984%29%
% 218.34/218.55  |- skos__historyNote mesh__D010009 Bone Diseases %28%1966-1969%29%
% 218.34/218.55  |- skos__scopeNote mesh__D010009
% 218.34/218.55       Abnormal development of cartilage and bone.     
% 218.34/218.55  |- skos__hiddenLabel mesh__D010009 Osteochondrodysplasia
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010009 2005
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010009 1997
% 218.34/218.55  |- skos__hiddenLabel mesh__D010009 Dysplasia, Spondyloepiphyseal
% 218.34/218.55  |- skos__hiddenLabel mesh__D010009 Multiple Epiphyseal Dysplasias
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010009 2000
% 218.34/218.55  |- skos__hiddenLabel mesh__D010009 Epiphyseal Dysplasia, Multiple
% 218.34/218.55  |- skos__prefLabel mesh__D010009 Osteochondrodysplasias
% 218.34/218.55  |- mesh__dateCreated mesh__D010009 1984-04-06
% 218.34/218.55  |- mesh__dateRevised mesh__D010009 1994-05-24
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010009 1996
% 218.34/218.55  |- mesh__onlineNote mesh__D010009
% 218.34/218.55       use OSTECHONDRODYSPLASIAS to search DYSCHONDROPLASIAS 1966-84; use MUCOPOLYSACCHARIDOSIS 4 to search SPONDYLOEPIPHYSEAL DYSPLASIA 1968-84%A%  
% 218.34/218.55  |- skos__hiddenLabel mesh__D010009 Dysplasia, Multiple Epiphyseal
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010009 2004
% 218.34/218.55  |- mesh__recordOriginator mesh__D010009 RC
% 218.34/218.55  |- mesh__dateEstablished mesh__D010009 1985-01-01
% 218.34/218.55  |- skos__broader mesh__D010009smesh__D001848
% 218.34/218.55  |- mesh__historyNote mesh__D010009
% 218.34/218.55       85; DYSCHONDRODYSPLASIAS was heading DYSCHONDROPLASIA 1963-84; SPONDYLOEPIPHYSEAL DYSPLASIA was see MUCOPOLYSACCHARIDOSIS 4 1980-84, was see ECCENTROOSTEOCHONDRODYSPLASIA 1968-79%A%  
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010009 1999
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010009 2002
% 218.34/218.55  |- skos__hiddenLabel mesh__D010009 Syndrome, Melnick-Needles
% 218.34/218.55  |- skos__altLabel mesh__D010009 Dyschondroplasia
% 218.34/218.55  |- mesh__recordMaintainer mesh__D010009 TGC
% 218.34/218.55  |- skos__hiddenLabel mesh__D010009 Dysplasias, Spondyloepiphyseal
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010009 2003
% 218.34/218.55  |- skos__hiddenLabel mesh__D010009 Syndrome, Schwartz-Jampel
% 218.34/218.55  |- skos__hiddenLabel mesh__D010009 Spondyloepiphyseal Dysplasias
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010009 1995
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D007060 2002
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D007060 1994
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D007060 1991
% 218.34/218.55  |- mesh__dateEstablished mesh__D007060 1968-01-01
% 218.34/218.55  |- mesh__recordMaintainer mesh__D007060 PLS
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D007060 2001
% 218.34/218.55  |- mesh__publicMeSHNote mesh__D007060 68   
% 218.34/218.55  |- skos__broader mesh__D007060smesh__D011574
% 218.34/218.55  |- skos__scopeNote mesh__D007060
% 218.34/218.55       The part of the personality structure which harbors the unconscious instinctive desires and strivings of the individual.%A%    
% 218.34/218.55  |- skos__historyNote mesh__D007060 Psychoanalytic Theory %28%1966-1967%29%
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D007060 1997
% 218.34/218.55  |- mesh__dateCreated mesh__D007060 1999-01-01
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D007060 2000
% 218.34/218.55  |- skos__prefLabel mesh__D007060 Id
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D007060 1999
% 218.34/218.55  |- mesh__dateRevised mesh__D007060 1990-08-31
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D007060 2004
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D007060 1996
% 218.34/218.55  |- mesh__historyNote mesh__D007060 68   
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D007060 2006
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D007060 1998
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D007060 1993
% 218.34/218.55  |- mesh__recordAuthorizer mesh__D007060 PLS
% 218.34/218.55  |- mesh__recordOriginator mesh__D007060 NLM
% 218.34/218.55  |- skos__historyNote mesh__D007060 Personality %28%1966-1967%29%
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D007060 2003
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D007060 1995
% 218.34/218.55  |- skos__annotation mesh__D007060 no qualif   
% 218.34/218.55  |- skos__hiddenLabel mesh__D007060 Ids
% 218.34/218.55  |- rdf__type mesh__D007060sskos__Concept
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D007060 2005
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D007060 1992
% 218.34/218.55  |- skos__broader mesh__D007060smesh__D010553
% 218.34/218.55  |- mesh__historyNote mesh__D006766
% 218.34/218.55       91%28%78%29%; was see under HOSPITALS, PUBLIC 1978-90   
% 218.34/218.55  |- mesh__publicMeSHNote mesh__D006766
% 218.34/218.55       91; was see under HOSPITALS, PUBLIC 1978-90   
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D006766 2002
% 218.34/218.55  |- mesh__recordAuthorizer mesh__D006766 sjn
% 218.34/218.55  |- mesh__dateCreated mesh__D006766 1977-05-11
% 218.34/218.55  |- skos__broader mesh__D006766smesh__D006779
% 218.34/218.55  |- skos__hiddenLabel mesh__D006766 County Hospital
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D006766 2004
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D006766 2001
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D006766 2006
% 218.34/218.55  |- skos__scopeNote mesh__D006766
% 218.34/218.55       Hospitals controlled by the county government.     
% 218.34/218.55  |- mesh__dateEstablished mesh__D006766 1991-01-01
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D006766 2003
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D006766 2000
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D006766 2005
% 218.34/218.55  |- skos__altLabel mesh__D006766 County Hospitals
% 218.34/218.55  |- skos__hiddenLabel mesh__D006766 Hospital, County
% 218.34/218.55  |- skos__prefLabel mesh__D006766 Hospitals, County
% 218.34/218.55  |- mesh__recordMaintainer mesh__D006766 kle
% 218.34/218.55  |- skos__annotation mesh__D006766
% 218.34/218.55       coord IM with special hosp %28%e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.%29% or med specialty %28%IM or NIM%29% if pertinent; specify geog%A%  
% 218.34/218.55  |- mesh__dateRevised mesh__D006766 1999-11-03
% 218.34/218.55  |- mesh__recordOriginator mesh__D006766 EC
% 218.34/218.55  |- rdf__type mesh__D006766sskos__Concept
% 218.34/218.55  |- skos__historyNote mesh__D020437 Hypoglossal Nerve %28%1965-1980%29%
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D020437 2000
% 218.34/218.55  |- skos__hiddenLabel mesh__D020437 Hypoglossal Neuropathies
% 218.34/218.55  |- skos__altLabel mesh__D020437 Cranial Nerve XII Diseases
% 218.34/218.55  |- skos__hiddenLabel mesh__D020437 Hypoglossal Nerve Palsies
% 218.34/218.55  |- skos__hiddenLabel mesh__D020437 Neuropathies, Hypoglossal
% 218.34/218.55  |- mesh__historyNote mesh__D020437 2000   
% 218.34/218.55  |- skos__annotation mesh__D020437
% 218.34/218.55       neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 218.34/218.55  |- skos__prefLabel mesh__D020437 Hypoglossal Nerve Diseases
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D020437 2004
% 218.34/218.55  |- skos__broader mesh__D020437smesh__D003389
% 218.34/218.55  |- rdf__type mesh__D020437sskos__Concept
% 218.34/218.55  |- skos__hiddenLabel mesh__D020437 Palsies, Hypoglossal Nerve
% 218.34/218.55  |- mesh__dateEstablished mesh__D020437 2000-01-01
% 218.34/218.55  |- skos__historyNote mesh__D020437 Cranial Nerve Diseases %28%1981-1999%29%
% 218.34/218.55  |- skos__hiddenLabel mesh__D020437 Hypoglossal Neuralgias
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D020437 2006
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D020437 2003
% 218.34/218.55  |- mesh__publicMeSHNote mesh__D020437 2000   
% 218.34/218.55  |- skos__altLabel mesh__D020437 Cranial Nerve XII Disorders
% 218.34/218.55  |- skos__altLabel mesh__D020437 Twelfth Cranial Nerve Disorder
% 218.34/218.55  |- skos__altLabel mesh__D020437 Twelfth Cranial Nerve Diseases
% 218.34/218.55  |- skos__hiddenLabel mesh__D020437 Neuralgia, Hypoglossal
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D020437 2002
% 218.34/218.55  |- mesh__dateCreated mesh__D020437 1999-11-03
% 218.34/218.55  |- skos__hiddenLabel mesh__D020437 Neuropathy, Hypoglossal
% 218.34/218.55  |- skos__hiddenLabel mesh__D020437 Neuralgias, Hypoglossal
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D020437 2005
% 218.34/218.55  |- skos__historyNote mesh__D020437
% 218.34/218.55       Peripheral Nervous System Diseases %28%1966-1980%29%
% 218.34/218.55  |- skos__hiddenLabel mesh__D020437 Hypoglossal Nerve Disease
% 218.34/218.55  |- skos__scopeNote mesh__D020437
% 218.34/218.55       Diseases of the twelfth cranial %28%hypoglossal%29% nerve or nuclei. The nuclei and fascicles of the nerve are located in the medulla, and the nerve exits the skull via the hypoglossal foramen and innervates the muscles of the tongue. Lower brain stem diseases, including ischemia and MOTOR NEURON DISEASES may affect the nuclei or nerve fascicles. The nerve may also be injured by diseases of the posterior fossa or skull base. Clinical manifestations include unilateral weakness of tongue musculature and lingual dysarthria, with deviation of the tongue towards the side of weakness upon attempted protrusion.%A%    
% 218.34/218.55  |- skos__related mesh__D020437smesh__D020209
% 218.34/218.55  |- skos__hiddenLabel mesh__D020437 Palsy, Hypoglossal Nerve
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D020437 2001
% 218.34/218.55  |- skos__annotation mesh__D044885
% 218.34/218.55       infection: coord IM with CAMPYLOBACTER INFECTIONS %28%IM%29%   
% 218.34/218.55  |- mesh__recordAuthorizer mesh__D044885 sjn
% 218.34/218.55  |- mesh__publicMeSHNote mesh__D044885 2004   
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D044885 2006
% 218.34/218.55  |- rdf__type mesh__D044885sskos__Concept
% 218.34/218.55  |- mesh__recordOriginator mesh__D044885 ags
% 218.34/218.55  |- skos__scopeNote mesh__D044885
% 218.34/218.55       A species of CAMPYLOBACTER isolated from DOGS; CATS; and humans.%A%    
% 218.34/218.55  |- mesh__dateRevised mesh__D044885 2005-06-30
% 218.34/218.55  |- mesh__historyNote mesh__D044885 2004   
% 218.34/218.55  |- mesh__dateEstablished mesh__D044885 2004-01-01
% 218.34/218.55  |- skos__broader mesh__D044885smesh__D002167
% 218.34/218.55  |- mesh__dateCreated mesh__D044885 2003-07-09
% 218.34/218.55  |- skos__historyNote mesh__D044885 Campylobacter %28%1989-2003%29%
% 218.34/218.55  |- skos__prefLabel mesh__D044885 Campylobacter upsaliensis
% 218.34/218.55  |- mesh__recordMaintainer mesh__D044885 SYSTEM
% 218.34/218.55  |- skos__scopeNote mesh__D011900
% 218.34/218.55       A form of retention cyst of the floor of the mouth, usually due to obstruction of the ducts of the submaxillary or sublingual glands, presenting a slowly enlarging painless deep burrowing mucocele of one side of the mouth. It is also called sublingual cyst and sublingual ptyalocele.%A%    
% 218.34/218.55  |- mesh__dateCreated mesh__D011900 1999-01-01
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D011900 2002
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D011900 1996
% 218.34/218.55  |- mesh__recordAuthorizer mesh__D011900 PLS
% 218.34/218.55  |- rdf__type mesh__D011900sskos__Concept
% 218.34/218.55  |- mesh__recordMaintainer mesh__D011900 TGC
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D011900 1997
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D011900 1998
% 218.34/218.55  |- skos__prefLabel mesh__D011900 Ranula
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D011900 2000
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D011900 1999
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D011900 2003
% 218.34/218.55  |- mesh__dateRevised mesh__D011900 1994-05-24
% 218.34/218.55  |- skos__hiddenLabel mesh__D011900 Ranulas
% 218.34/218.55  |- mesh__dateEstablished mesh__D011900 1965-01-01
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D011900 2001
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D011900 2004
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D011900 2005
% 218.34/218.55  |- skos__broader mesh__D011900smesh__D009059
% 218.34/218.55  |- mesh__recordOriginator mesh__D011900 NLM
% 218.34/218.55  |- mesh__historyNote mesh__D011900 65   
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D011900 1995
% 218.34/218.55  |- mesh__publicMeSHNote mesh__D011900 65   
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D011900 2006
% 218.34/218.55  |- skos__broader mesh__D011900smesh__D003560
% 218.34/218.55  |- skos__annotation mesh__D011900
% 218.34/218.55       non-neoplastic; /blood supply /chem /secret /ultrastruct permitted%A%  
% 218.34/218.55  |- skos__broader mesh__D044087smesh__D015703
% 218.34/218.55  |- mesh__dateCreated mesh__D044087 2003-07-09
% 218.34/218.55  |- skos__altLabel mesh__D044087 Antigens, CD88
% 218.34/218.55  |- skos__broader mesh__D044087smesh__D043562
% 218.34/218.55  |- skos__historyNote mesh__D044087 Antigens, CD %28%1985-2003%29%
% 218.34/218.55  |- skos__prefLabel mesh__D044087 Receptor, Anaphylatoxin C5a
% 218.34/218.55  |- skos__historyNote mesh__D044087 Receptors, Complement %28%1985-2003%29%
% 218.34/218.55  |- mesh__recordMaintainer mesh__D044087 sjn
% 218.34/218.55  |- skos__broader mesh__D044087smesh__D011951
% 218.34/218.55  |- skos__altLabel mesh__D044087 Complement 5a Receptor
% 218.34/218.55  |- skos__scopeNote mesh__D044087
% 218.34/218.55       A G-protein-coupled receptor that signals an increase in intracellular calcium in response to the potent ANAPHYLATOXIN peptide COMPLEMENT C5A.%A%    
% 218.34/218.55  |- mesh__recordAuthorizer mesh__D044087 sjn
% 218.34/218.55  |- skos__altLabel mesh__D044087 C5a Receptors
% 218.34/218.55  |- skos__altLabel mesh__D044087 Receptor, Complement 5a
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D044087 2006
% 218.34/218.55  |- skos__altLabel mesh__D044087 CD88 Antigen
% 218.34/218.55  |- skos__hiddenLabel mesh__D044087 Antigen, CD88
% 218.34/218.55  |- skos__altLabel mesh__D044087 Anaphylatoxin C5a Receptor
% 218.34/218.55  |- rdf__type mesh__D044087sskos__Concept
% 218.34/218.55  |- skos__hiddenLabel mesh__D044087 Receptors, C5a
% 218.34/218.55  |- mesh__dateRevised mesh__D044087 2005-07-01
% 218.34/218.55  |- mesh__dateEstablished mesh__D044087 2004-01-01
% 218.34/218.55  |- mesh__recordOriginator mesh__D044087 jmp
% 218.34/218.55  |- skos__altLabel mesh__D044087 CD88 Antigens
% 218.34/218.55  |- mesh__historyNote mesh__D044087
% 218.34/218.55       2004; use RECEPTOR, ANAPHYLATOXIN C5A %28%NM%29% 1985-2003   
% 218.34/218.55  |- mesh__publicMeSHNote mesh__D044087
% 218.34/218.55       2004; COMPLEMENT 5A RECEPTOR %28%now RECEPTOR, ANAPHYLATOXIN C5A%29% was indexed under RECEPTORS, COMPLEMENT %26% ANTIGENS, CD 1985-2003%A%  
% 218.34/218.55  |- skos__hiddenLabel mesh__D011102 Methacrylate Gel, Glycol
% 218.34/218.55  |- mesh__recordOriginator mesh__D011102 SH
% 218.34/218.55  |- skos__hiddenLabel mesh__D011102 Methacrylate, Polyglycol
% 218.34/218.55  |- mesh__dateEstablished mesh__D011102 1991-01-01
% 218.34/218.55  |- mesh__historyNote mesh__D011102
% 218.34/218.55       91%28%78%29%; was see under POLYMETHACRYLIC ACIDS 1981-90; was see under ACRYLIC RESINS 1978-80%A%  
% 218.34/218.55  |- skos__historyNote mesh__D011102 Acrylates %28%1966-1974%29%
% 218.34/218.55  |- skos__altLabel mesh__D011102 Hydroxymethacrylate Gel
% 218.34/218.55  |- skos__altLabel mesh__D011102 Poly-Hema
% 218.34/218.55  |- mesh__recordMaintainer mesh__D011102 jmp
% 218.34/218.55  |- mesh__publicMeSHNote mesh__D011102
% 218.34/218.55       91; was see under POLYMETHACRYLIC ACIDS 1981-90; was see under ACRYLIC RESINS 1978-80%A%  
% 218.34/218.55  |- skos__annotation mesh__D011102 D25-26 qualif   
% 218.34/218.55  |- skos__altLabel mesh__D011102 Glycol Methacrylate Gel
% 218.34/218.55  |- skos__scopeNote mesh__D011102
% 218.34/218.55       A biocompatible, hydrophilic, inert gel that is permeable to tissue fluids. It is used as an embedding medium for microscopy, as a coating for implants and prostheses, for contact lenses, as microspheres in adsorption research, etc.%A%    
% 218.34/218.55  |- skos__prefLabel mesh__D011102 Polyhydroxyethyl Methacrylate
% 218.34/218.55  |- skos__historyNote mesh__D011102 Polyethylene Glycols %28%1975-1977%29%
% 218.34/218.55  |- skos__altLabel mesh__D011102 PHEMA
% 218.34/218.55  |- skos__altLabel mesh__D011102 Polyglycol Methacrylate
% 218.34/218.55  |- skos__hiddenLabel mesh__D011102 Poly Hema
% 218.34/218.55  |- skos__historyNote mesh__D011102 Polymers %28%1966-1974%29%
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D011102 2006
% 218.34/218.55  |- skos__hiddenLabel mesh__D011102 Gel, Hydroxymethacrylate
% 218.34/218.55  |- mesh__recordAuthorizer mesh__D011102 sjn
% 218.34/218.55  |- skos__hiddenLabel mesh__D011102 Gel, Glycol Methacrylate
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D011102 2005
% 218.34/218.55  |- skos__broader mesh__D011102smesh__D011109
% 218.34/218.55  |- skos__hiddenLabel mesh__D011102 Methacrylate, Polyhydroxyethyl
% 218.34/218.55  |- rdf__type mesh__D011102sskos__Concept
% 218.34/218.55  |- mesh__dateRevised mesh__D011102 2004-07-07
% 218.34/218.55  |- mesh__dateCreated mesh__D011102 1977-04-27
% 218.34/218.55  |- skos__historyNote mesh__D011102 Polymethacrylic Acids %28%1975-1977%29%
% 218.34/218.55  |- skos__broader mesh__D011102smesh__D011092
% 218.34/218.55  |- skos__annotation mesh__D016396
% 218.34/218.55       a grade of non-Hodgkin%27%s lymphoma; prefer specific; LYMPHOMA, HIGH-GRADE %26% LYMPHOMA, LOW-GRADE %26% their specifics are also available%A%  
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D016396 2004
% 218.34/218.55  |- mesh__dateCreated mesh__D016396 1990-06-01
% 218.34/218.55  |- mesh__dateEstablished mesh__D016396 1991-01-01
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D016396 1998
% 218.34/218.55  |- skos__hiddenLabel mesh__D016396 Intermediate-Grade Lymphomas
% 218.34/218.55  |- skos__scopeNote mesh__D016396
% 218.34/218.55       One of the three major prognostic groupings for non-Hodgkin lymphomas as proposed in the Working Formulation of the Non-Hodgkin%27%s Lymphoma Pathologic Classification Project sponsored by the National Cancer Institute %28%1981%29%. Lymphomas falling within this group have an intermediate survival potential.%A%    
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D016396 2002
% 218.34/218.55  |- mesh__publicMeSHNote mesh__D016396 91   
% 218.34/218.55  |- mesh__recordOriginator mesh__D016396 PLS
% 218.34/218.55  |- skos__hiddenLabel mesh__D016396 Intermediate-Grade Lymphoma
% 218.34/218.55  |- mesh__dateRevised mesh__D016396 1997-06-20
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D016396 1999
% 218.34/218.55  |- skos__hiddenLabel mesh__D016396 Lymphoma, Intermediate Grade
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D016396 2000
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D016396 2005
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D016396 2006
% 218.34/218.55  |- mesh__recordAuthorizer mesh__D016396 SJN
% 218.34/218.55  |- skos__hiddenLabel mesh__D016396 Lymphomas, Intermediate-Grade
% 218.34/218.55  |- skos__prefLabel mesh__D016396 Lymphoma, Intermediate-Grade
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D016396 2001
% 218.34/218.55  |- skos__broader mesh__D016396smesh__D008228
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D016396 2003
% 218.34/218.55  |- mesh__recordMaintainer mesh__D016396 PXP
% 218.34/218.55  |- rdf__type mesh__D016396sskos__Concept
% 218.34/218.55  |- mesh__historyNote mesh__D016396 91   
% 218.34/218.55  |- rdf__type mesh__D002376sskos__Concept
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D002376 2004
% 218.34/218.55  |- mesh__dateRevised mesh__D002376 2002-07-03
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D002376 2006
% 218.34/218.55  |- mesh__recordOriginator mesh__D002376 NLM
% 218.34/218.55  |- skos__scopeNote mesh__D002376
% 218.34/218.55       Activities performed in the preparation of bibliographic records for CATALOGS. It is carried out according to a set of rules and contains information enabling the user to know what is available and where items can be found.%A%    
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D002376 2003
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D002376 2005
% 218.34/218.55  |- mesh__recordAuthorizer mesh__D002376 sjn
% 218.34/218.55  |- skos__broader mesh__D002376smesh__D008001
% 218.34/218.55  |- mesh__recordMaintainer mesh__D002376 tpw
% 218.34/218.55  |- mesh__dateCreated mesh__D002376 1999-01-01
% 218.34/218.55  |- skos__broader mesh__D002376smesh__D004282
% 218.34/218.55  |- skos__prefLabel mesh__D002376 Cataloging
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010808 2004
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010808 2002
% 218.34/218.55  |- mesh__dateRevised mesh__D010808 1997-06-20
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010808 2005
% 218.34/218.55  |- skos__hiddenLabel mesh__D010808 Examinations, Physical
% 218.34/218.55  |- mesh__recordMaintainer mesh__D010808 PXP
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010808 2006
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010808 1998
% 218.34/218.55  |- mesh__dateCreated mesh__D010808 1999-01-01
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010808 1999
% 218.34/218.55  |- skos__broader mesh__D010808smesh__D019937
% 218.34/218.55  |- mesh__recordOriginator mesh__D010808 NLM
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010808 2000
% 218.34/218.55  |- skos__annotation mesh__D010808
% 218.34/218.55       NEUROLOGIC EXAMINATION is also available; DF: PHYSICAL EXAM%A%  
% 218.34/218.55  |- skos__prefLabel mesh__D010808 Physical Examination
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010808 2003
% 218.34/218.55  |- skos__hiddenLabel mesh__D010808 Physical Examinations
% 218.34/218.55  |- mesh__activeMeSHYear mesh__D010808 2001
% 218.34/218.55  |- rdf__type mesh__D010808sskos__Concept
% 218.34/218.56  |- skos__scopeNote mesh__D010808
% 218.34/218.56       Systematic and thorough inspection of the patient for physical signs of disease or abnormality.%A%    
% 218.34/218.56  |- mesh__recordAuthorizer mesh__D010808 SJN
% 218.34/218.56  |- skos__altLabel mesh__D010808 Examination, Physical
% 218.34/218.56  |- mesh__recordMaintainer mesh__D007061 PXP
% 218.34/218.56  |- skos__prefLabel mesh__D007061 Idaho
% 218.34/218.56  |- skos__broader mesh__D007061smesh__D015205
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007061 2004
% 218.34/218.56  |- mesh__dateCreated mesh__D007061 1999-01-01
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007061 2002
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007061 2003
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007061 1999
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007061 2006
% 218.34/218.56  |- mesh__recordAuthorizer mesh__D007061 SJN
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007061 2001
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007061 1998
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007061 2005
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007061 2000
% 218.34/218.56  |- rdf__type mesh__D007061sskos__Concept
% 218.34/218.56  |- mesh__dateRevised mesh__D007061 1997-06-20
% 218.34/218.56  |- mesh__recordOriginator mesh__D007061 NLM
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D039941 2005
% 218.34/218.56  |- mesh__recordMaintainer mesh__D039941 ags
% 218.34/218.56  |- mesh__dateRevised mesh__D039941 2005-07-08
% 218.34/218.56  |- rdf__type mesh__D039941sskos__Concept
% 218.34/218.56  |- mesh__publicMeSHNote mesh__D039941 2003   
% 218.34/218.56  |- skos__hiddenLabel mesh__D039941 Bifidobacteriales Infection
% 218.34/218.56  |- mesh__historyNote mesh__D039941 2003   
% 218.34/218.56  |- mesh__dateCreated mesh__D039941 2002-07-02
% 218.34/218.56  |- mesh__recordOriginator mesh__D039941 ags
% 218.34/218.56  |- skos__scopeNote mesh__D039941
% 218.34/218.56       Infections with BACTERIA of the order Bifidobacteriales. This includes infections in the genera BIFIDOBACTERIUM and GARDNERELLA, in the family Bifidobacteriaceae.%A%    
% 218.34/218.56  |- mesh__dateEstablished mesh__D039941 2003-01-01
% 218.34/218.56  |- skos__altLabel mesh__D039941 Infections, Bifidobacteriales
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D039941 2004
% 218.34/218.56  |- skos__broader mesh__D039941smesh__D016908
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D039941 2006A
% 218.34/218.56  |- mesh__recordAuthorizer mesh__D039941 ags
% 218.34/218.56  |- skos__prefLabel mesh__D039941 Bifidobacteriales Infections
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D039941 2003
% 218.34/218.56  |- skos__hiddenLabel mesh__D039941 Infection, Bifidobacteriales
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D039941 2006
% 218.34/218.56  |- skos__historyNote mesh__D039941
% 218.34/218.56       Actinomycetales Infections %28%1984-2002%29%
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D006767 2003
% 218.34/218.56  |- mesh__recordOriginator mesh__D006767 EC
% 218.34/218.56  |- mesh__dateRevised mesh__D006767 1999-11-03
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D006767 2005
% 218.34/218.56  |- skos__altLabel mesh__D006767 District Hospitals
% 218.34/218.56  |- mesh__recordMaintainer mesh__D006767 kle
% 218.34/218.56  |- mesh__dateEstablished mesh__D006767 1991-01-01
% 218.34/218.56  |- mesh__publicMeSHNote mesh__D006767
% 218.34/218.56       91; was see under HOSPITALS, PUBLIC 1978-90   
% 218.34/218.56  |- skos__hiddenLabel mesh__D006767 District Hospital
% 218.34/218.56  |- skos__annotation mesh__D006767
% 218.34/218.56       coord IM with special hosp %28%e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.%29% or med specialty %28%IM or NIM%29% if pertinent; specify geog%A%  
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D006767 2002
% 218.34/218.56  |- skos__scopeNote mesh__D006767
% 218.34/218.56       Government-controlled hospitals which represent the major health facility for a designated geographic area.%A%    
% 218.34/218.56  |- mesh__recordAuthorizer mesh__D006767 sjn
% 218.34/218.56  |- rdf__type mesh__D006767sskos__Concept
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D006767 2001
% 218.34/218.56  |- mesh__dateCreated mesh__D006767 1977-05-11
% 218.34/218.56  |- skos__broader mesh__D006767smesh__D006779
% 218.34/218.56  |- skos__prefLabel mesh__D006767 Hospitals, District
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D006767 2004
% 218.34/218.56  |- mesh__historyNote mesh__D006767
% 218.34/218.56       91%28%78%29%; was see under HOSPITALS, PUBLIC 1978-90   
% 218.34/218.56  |- skos__hiddenLabel mesh__D006767 Hospital, District
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D006767 2000
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D006767 2006
% 218.34/218.56  |- skos__scopeNote mesh__D025921
% 218.34/218.56       A genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE, with a single species: HERPESVIRUS 1, GALLID.%A%    
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D025921 2005
% 218.34/218.56  |- rdf__type mesh__D025921sskos__Concept
% 218.34/218.56  |- skos__annotation mesh__D025921
% 218.34/218.56       infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29%; DF: INFECT LT LIKE VIRUSES%A%  
% 218.34/218.56  |- mesh__dateEstablished mesh__D025921 2002-01-01
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D025921 2002
% 218.34/218.56  |- skos__broader mesh__D025921smesh__D018138
% 218.34/218.56  |- mesh__publicMeSHNote mesh__D025921 2002   
% 218.34/218.56  |- skos__hiddenLabel mesh__D025921 Infectious Laryngotracheitis-like Virus
% 218.34/218.56  |- mesh__dateRevised mesh__D025921 2005-07-07
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D025921 2006
% 218.34/218.56  |- skos__hiddenLabel mesh__D025921
% 218.34/218.56       Laryngotracheitis-like Viruses, Infectious
% 218.34/218.56  |- skos__prefLabel mesh__D025921 Infectious Laryngotracheitis-like Viruses
% 218.34/218.56  |- mesh__recordOriginator mesh__D025921 ags
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D025921 2003
% 218.34/218.56  |- mesh__recordAuthorizer mesh__D025921 ags
% 218.34/218.56  |- skos__hiddenLabel mesh__D025921 Laryngotracheitis-like Virus, Infectious
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D025921 2004
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D025921 2006A
% 218.34/218.56  |- mesh__recordMaintainer mesh__D025921 ags
% 218.34/218.56  |- mesh__dateCreated mesh__D025921 2001-07-25
% 218.34/218.56  |- skos__hiddenLabel mesh__D025921
% 218.34/218.56       Infectious Laryngotracheitis like Viruses
% 218.34/218.56  |- mesh__historyNote mesh__D025921 2002   
% 218.34/218.56  |- mesh__recordMaintainer mesh__D011901 TGC
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D011901 2001
% 218.34/218.56  |- skos__broader mesh__D011901smesh__D021961
% 218.34/218.56  |- mesh__dateEstablished mesh__D011901 1973-01-01
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D011901 2003
% 218.34/218.56  |- mesh__recordOriginator mesh__D011901 NLM
% 218.34/218.56  |- skos__broader mesh__D011901smesh__D009186
% 218.34/218.56  |- mesh__recordAuthorizer mesh__D011901 sjn
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D011901 2004
% 218.34/218.56  |- skos__hiddenLabel mesh__D011901 Ranviers Nodes
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D011901 2005
% 218.34/218.56  |- skos__altLabel mesh__D011901 Nodes of Ranvier
% 218.34/218.56  |- mesh__dateRevised mesh__D011901 2000-06-22
% 218.34/218.56  |- skos__annotation mesh__D011901
% 218.34/218.56       regular gaps in myelin sheath; A 11 qualif except /cytol; /genet permitted%A%  
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D011901 2002
% 218.34/218.56  |- skos__prefLabel mesh__D011901 Ranvier%27%s Nodes
% 218.34/218.56  |- skos__hiddenLabel mesh__D011901 Ranvier Nodes
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D011901 2006
% 218.34/218.56  |- mesh__publicMeSHNote mesh__D011901 73   
% 218.34/218.56  |- mesh__dateCreated mesh__D011901 1999-01-01
% 218.34/218.56  |- skos__scopeNote mesh__D011901
% 218.34/218.56       Regularly spaced gaps in the myelin sheaths of peripheral axons. Ranvier%27%s nodes allow saltatory conduction, that is, jumping of impulses from node to node, which is faster and more energetically favorable than continuous conduction.%A%    
% 218.34/218.56  |- rdf__type mesh__D011901sskos__Concept
% 218.34/218.56  |- mesh__historyNote mesh__D011901 73%28%65%29%   
% 218.34/218.56  |- skos__hiddenLabel mesh__D011901 Nodes, Ranvier%27%s
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D044088 2004
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D044088 2006
% 218.34/218.56  |- skos__altLabel mesh__D044088 Galanin Receptor
% 218.34/218.56  |- mesh__recordOriginator mesh__D044088 jmp
% 218.34/218.56  |- skos__hiddenLabel mesh__D044088 Receptor, Galanin
% 218.34/218.56  |- skos__annotation mesh__D044088 GEN or unspecified; prefer specifics   
% 218.34/218.56  |- rdf__type mesh__D044088sskos__Concept
% 218.34/218.56  |- skos__broader mesh__D044088smesh__D018013
% 218.34/218.56  |- skos__prefLabel mesh__D044088 Receptors, Galanin
% 218.34/218.56  |- skos__altLabel mesh__D044088 Galanin Receptors
% 218.34/218.56  |- skos__scopeNote mesh__D044088
% 218.34/218.56       A family of G-protein-coupled receptors that are specific for GALANIN and galanin peptides. They are generally considered to be coupled to the GI, INHIBITORY G-PROTEIN to meditate the neurological effects of galanin. Several subtypes of galanin receptors occur with differing specificities for the full length galanin, galanin peptide fragments, and galanin-like peptide.%A%    
% 218.34/218.56  |- mesh__publicMeSHNote mesh__D044088
% 218.34/218.56       2004; GALANIN RECEPTOR was indexed under RECEPTORS, NEUROPEPTIDE 1999-2003 %26% RECEPTORS, GASTROINTESTINAL HORMONE 1987-1998%A%  
% 218.34/218.56  |- skos__historyNote mesh__D044088
% 218.34/218.56       Receptors, Gastrointestinal Hormone %28%1987-1998%29%
% 218.34/218.56  |- mesh__dateCreated mesh__D044088 2003-07-09
% 218.34/218.56  |- skos__broader mesh__D044088smesh__D043562
% 218.34/218.56  |- mesh__historyNote mesh__D044088
% 218.34/218.56       2004; use RECEPTORS, GALANIN %28%NM%29% 1999-2003   
% 218.34/218.56  |- mesh__recordAuthorizer mesh__D044088 sjn
% 218.34/218.56  |- mesh__dateEstablished mesh__D044088 2004-01-01
% 218.34/218.56  |- skos__historyNote mesh__D044088
% 218.34/218.56       Receptors, Neuropeptide %28%1999-2003%29%
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D044088 2005
% 218.34/218.56  |- mesh__recordMaintainer mesh__D044088 jmp
% 218.34/218.56  |- skos__broader mesh__D011103smesh__D011105
% 218.34/218.56  |- mesh__dateEstablished mesh__D011103 1991-01-01
% 218.34/218.56  |- skos__scopeNote mesh__D011103
% 218.34/218.56       These compounds function as activated monosaccharide carriers in the biosynthesis of glycoproteins and oligosaccharide phospholipids. Obtained from a nucleoside diphosphate sugar and a polyisoprenyl phosphate.%A%    
% 218.34/218.56  |- mesh__recordOriginator mesh__D011103 RLS
% 218.34/218.56  |- skos__historyNote mesh__D011103 Sugar Phosphates %28%1974-1977%29%
% 218.34/218.56  |- mesh__historyNote mesh__D011103
% 218.34/218.56       91%28%78%29%; was see under POLYISOPRENYL PHOSPHATE SUGARS 1978-90%A%  
% 218.34/218.56  |- skos__hiddenLabel mesh__D011103 Phosphate Monosaccharides, Polyisoprenyl
% 218.34/218.56  |- mesh__publicMeSHNote mesh__D011103
% 218.34/218.56       91; was see under POLYISOPRENYL PHOSPHATE SUGARS 1978-90   
% 218.34/218.56  |- mesh__recordAuthorizer mesh__D011103 sjn
% 218.34/218.56  |- skos__altLabel mesh__D011103 Isoprenoid Phosphate Monosaccharides
% 218.34/218.56  |- skos__hiddenLabel mesh__D011103 Phosphate Monosaccharides, Isoprenoid
% 218.34/218.56  |- mesh__dateCreated mesh__D011103 1977-05-17
% 218.34/218.56  |- skos__prefLabel mesh__D011103 Polyisoprenyl Phosphate Monosaccharides
% 218.34/218.56  |- skos__hiddenLabel mesh__D011103 Monosaccharides, Isoprenoid Phosphate
% 218.34/218.56  |- rdf__type mesh__D011103sskos__Concept
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D011103 2006
% 218.34/218.56  |- skos__hiddenLabel mesh__D011103 Monosaccharides, Polyisoprenyl Phosphate
% 218.34/218.56  |- skos__historyNote mesh__D011103 Terpenes %28%1966-1977%29%
% 218.34/218.56  |- mesh__recordMaintainer mesh__D011103 ssb
% 218.34/218.56  |- skos__historyNote mesh__D011103
% 218.34/218.56       specific sugar phosphate%28%1974-1977%29%
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D011103 2005
% 218.34/218.56  |- mesh__dateRevised mesh__D011103 2004-07-07
% 218.34/218.56  |- skos__historyNote mesh__D011103 specific terpene or terpene group
% 218.34/218.56  |- mesh__recordAuthorizer mesh__D016397 SJN
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D016397 1999
% 218.34/218.56  |- mesh__recordOriginator mesh__D016397 PLS
% 218.34/218.56  |- mesh__recordMaintainer mesh__D016397 PXP
% 218.34/218.56  |- skos__annotation mesh__D016397
% 218.34/218.56       a grade of non-Hodgkin%27%s lymphoma; prefer specific; LYMPHOMA, HIGH-GRADE %26% LYMPHOMA, INTERMEDIATE-GRADE %26% their specifics are also available%A%  
% 218.34/218.56  |- skos__hiddenLabel mesh__D016397 Low-Grade Lymphoma
% 218.34/218.56  |- mesh__dateCreated mesh__D016397 1990-06-01
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D016397 2005
% 218.34/218.56  |- skos__hiddenLabel mesh__D016397 Lymphomas, Low-Grade
% 218.34/218.56  |- mesh__publicMeSHNote mesh__D016397 91   
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D016397 2002
% 218.34/218.56  |- skos__scopeNote mesh__D016397
% 218.34/218.56       One of the three major prognostic groupings for non-Hodgkin lymphomas as proposed in the Working Formulation of the Non-Hodgkin%27%s Lymphoma Pathologic Classification Project sponsored by the National Cancer Institute %28%1981%29%. Lymphomas falling within this group have a relatively favorable survival potential.%A%    
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D016397 2006
% 218.34/218.56  |- mesh__dateRevised mesh__D016397 1997-06-20
% 218.34/218.56  |- skos__hiddenLabel mesh__D016397 Low-Grade Lymphomas
% 218.34/218.56  |- skos__broader mesh__D016397smesh__D008228
% 218.34/218.56  |- skos__prefLabel mesh__D016397 Lymphoma, Low-Grade
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D016397 2003
% 218.34/218.56  |- mesh__historyNote mesh__D016397 91   
% 218.34/218.56  |- rdf__type mesh__D016397sskos__Concept
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D016397 2000
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D016397 1998
% 218.34/218.56  |- skos__hiddenLabel mesh__D016397 Lymphoma, Low Grade
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D016397 2004
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D016397 2001
% 218.34/218.56  |- mesh__dateEstablished mesh__D016397 1991-01-01
% 218.34/218.56  |- rdf__type mesh__D002377sskos__Concept
% 218.34/218.56  |- skos__annotation mesh__D002377
% 218.34/218.56       GEN or unspecified; prefer specifics; no qualif; do not confuse with CATALOGS %5B%PUBLICATION TYPE%5D%%A%  
% 218.34/218.56  |- skos__prefLabel mesh__D002377 Catalogs
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D002377 2003
% 218.34/218.56  |- mesh__recordAuthorizer mesh__D002377 sjn
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D002377 2005
% 218.34/218.56  |- skos__broader mesh__D002377smesh__D011642
% 218.34/218.56  |- mesh__recordMaintainer mesh__D002377 sjn
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D002377 2004
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D002377 2002
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D002377 2006
% 218.34/218.56  |- mesh__dateCreated mesh__D002377 1999-01-01
% 218.34/218.56  |- mesh__dateRevised mesh__D002377 2001-07-25
% 218.34/218.56  |- skos__hiddenLabel mesh__D002377 Catalog
% 218.34/218.56  |- mesh__recordOriginator mesh__D002377 NLM
% 218.34/218.56  |- skos__scopeNote mesh__D002377
% 218.34/218.56       Ordered compilations of item descriptions and sufficient information to afford access to them.%A%    
% 218.34/218.56  |- mesh__publicMeSHNote mesh__D010809
% 218.34/218.56       PHYSICAL CONDITIONING, HUMAN was see EXERCISE THERAPY 1986-96%A%  
% 218.34/218.56  |- skos__prefLabel mesh__D010809 Physical Fitness
% 218.34/218.56  |- skos__hiddenLabel mesh__D010809 Human Physical Conditioning
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D010809 2006
% 218.34/218.56  |- skos__scopeNote mesh__D010809
% 218.34/218.56       A state of well-being in which performance is optimal, often as a result of physical conditioning which may be prescribed for disease therapy.%A%    
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D010809 2002
% 218.34/218.56  |- mesh__recordAuthorizer mesh__D010809 sjn
% 218.34/218.56  |- mesh__dateCreated mesh__D010809 1999-01-01
% 218.34/218.56  |- skos__broader mesh__D010809smesh__D006262
% 218.34/218.56  |- skos__related mesh__D010809smesh__D015444
% 218.34/218.56  |- skos__hiddenLabel mesh__D010809 Human Physical Conditionings
% 218.34/218.56  |- skos__hiddenLabel mesh__D010809 Conditionings, Human Physical
% 218.34/218.56  |- skos__broader mesh__D010809smesh__D006802
% 218.34/218.56  |- mesh__dateRevised mesh__D010809 2001-07-25
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D010809 2003
% 218.34/218.56  |- skos__hiddenLabel mesh__D010809 Conditioning, Human Physical
% 218.34/218.56  |- rdf__type mesh__D010809sskos__Concept
% 218.34/218.56  |- mesh__onlineNote mesh__D010809
% 218.34/218.56       use EXERCISE THERAPY to search PHYSICAL CONDITIONING, HUMAN 1986-96%A%  
% 218.34/218.56  |- skos__hiddenLabel mesh__D010809 Fitness, Physical
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D010809 2004
% 218.34/218.56  |- mesh__recordOriginator mesh__D010809 NLM
% 218.34/218.56  |- mesh__historyNote mesh__D010809
% 218.34/218.56       PHYSICAL CONDITIONING, HUMAN was see EXERCISE THERAPY 1986-96%A%  
% 218.34/218.56  |- skos__hiddenLabel mesh__D010809 Physical Conditionings, Human
% 218.34/218.56  |- mesh__recordMaintainer mesh__D010809 ssb
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D010809 2005
% 218.34/218.56  |- rdf__type mesh__D007860sskos__Concept
% 218.34/218.56  |- mesh__dateRevised mesh__D007860 1998-06-10
% 218.34/218.56  |- skos__hiddenLabel mesh__D007860 Property Leasing
% 218.34/218.56  |- skos__prefLabel mesh__D007860 Leasing, Property
% 218.34/218.56  |- mesh__recordOriginator mesh__D007860 EC
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007860 1999
% 218.34/218.56  |- mesh__recordMaintainer mesh__D007860 JLS
% 218.34/218.56  |- skos__hiddenLabel mesh__D007860 Leasings, Property
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007860 2002
% 218.34/218.56  |- mesh__publicMeSHNote mesh__D007860
% 218.34/218.56       91; was see under FINANCIAL MANAGEMENT 1978-90   
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007860 2006
% 218.34/218.56  |- mesh__dateEstablished mesh__D007860 1991-01-01
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007860 2004
% 218.34/218.56  |- skos__hiddenLabel mesh__D007860 Property Leasings
% 218.34/218.56  |- skos__broader mesh__D007860smesh__D005376
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007860 2005
% 218.34/218.56  |- skos__scopeNote mesh__D007860
% 218.34/218.56       Contractual arrangement between the lessor %28%owner%29% and the lessee in which the use of equipment or facilities is granted to the lessee for a period of time and at a specified rate.%A%    
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007860 2001
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007860 2003
% 218.34/218.56  |- mesh__historyNote mesh__D007860
% 218.34/218.56       91%28%78%29%; was see under FINANCIAL MANAGEMENT 1978-90   
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007860 2000
% 218.34/218.56  |- mesh__dateCreated mesh__D007860 1977-05-11
% 218.34/218.56  |- mesh__recordAuthorizer mesh__D007860 SJN
% 218.34/218.56  |- skos__historyNote mesh__D007062 Personality %28%1966-1967%29%
% 218.34/218.56  |- mesh__publicMeSHNote mesh__D007062
% 218.34/218.56       68; was IDENTIFICATION see under DEFENSE MECHANISMS 1963-67%A%  
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007062 2003
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007062 1998
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007062 2005
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007062 2004
% 218.34/218.56  |- mesh__historyNote mesh__D007062
% 218.34/218.56       68; was IDENTIFICATION see under DEFENSE MECHANISMS 1963-67%A%  
% 218.34/218.56  |- mesh__recordOriginator mesh__D007062 NLM
% 218.34/218.56  |- skos__broader mesh__D007062smesh__D003674
% 218.34/218.56  |- skos__historyNote mesh__D007062 Defense Mechanisms %28%1966-1967%29%
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007062 2002
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007062 1999
% 218.34/218.56  |- skos__altLabel mesh__D007062 Identification
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007062 2006
% 218.34/218.56  |- skos__hiddenLabel mesh__D007062 Identifications %28%Psychology%29%
% 218.34/218.56  |- mesh__recordAuthorizer mesh__D007062 SJN
% 218.34/218.56  |- skos__scopeNote mesh__D007062
% 218.34/218.56       A process by which an individual unconsciously endeavors to pattern himself after another. This process is also important in the development of the personality, particularly the superego or conscience, which is modeled largely on the behavior of adult significant others.%A%    
% 218.34/218.56  |- mesh__dateEstablished mesh__D007062 1968-01-01
% 218.34/218.56  |- mesh__onlineNote mesh__D007062 search DEFENSE MECHANISMS 1966-67   
% 218.34/218.56  |- skos__annotation mesh__D007062 no qualif; DF: IDENTIFICATION   
% 218.34/218.56  |- rdf__type mesh__D007062sskos__Concept
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007062 2000
% 218.34/218.56  |- skos__broader mesh__D007062smesh__D010553
% 218.34/218.56  |- skos__prefLabel mesh__D007062 Identification %28%Psychology%29%
% 218.34/218.56  |- mesh__recordMaintainer mesh__D007062 JLS
% 218.34/218.56  |- mesh__dateRevised mesh__D007062 1997-06-20
% 218.34/218.56  |- mesh__dateCreated mesh__D007062 1999-01-01
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D007062 2001
% 218.34/218.56  |- skos__hiddenLabel mesh__D039942 Antigen, A5
% 218.34/218.56  |- mesh__publicMeSHNote mesh__D039942
% 218.34/218.56       2003; A5 ANTIGEN %28%now NEUROPILIN-1%29% was indexed under NERVE TISSUE PROTEINS 1991-2002%A%  
% 218.34/218.56  |- skos__historyNote mesh__D039942 Nerve Tissue Proteins %28%1991-2002%29%
% 218.34/218.56  |- skos__broader mesh__D039942smesh__D039921
% 218.34/218.56  |- skos__hiddenLabel mesh__D039942 Receptor, Sema III
% 218.34/218.56  |- skos__hiddenLabel mesh__D039942 Npn 1 Protein
% 218.34/218.56  |- skos__altLabel mesh__D039942 A5 Antigen
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D039942 2006
% 218.34/218.56  |- skos__scopeNote mesh__D039942
% 218.34/218.56       Dimeric cell surface receptor involved in angiogenesis %28%NEOVASCULARIZATION, PHYSIOLOGICAL%29% and axonal guidance.  Neuropilin-1 is a 140-kDa transmembrane protein that binds CLASS 3 SEMAPHORINS, and several other growth factors.  Neuropilin-1 forms complexes with plexins or VEGF RECEPTORS, and binding affinity and specificity are determined by the composition of the neuropilin dimer and the identity of other receptors complexed with it. Neuropilin-1 is expressed in distinct patterns during neural development, complementary to those described for NEUROPILIN-2.%A%    
% 218.34/218.56  |- mesh__recordMaintainer mesh__D039942 jmp
% 218.34/218.56  |- skos__altLabel mesh__D039942 Semaphorin III Receptor
% 218.34/218.56  |- mesh__dateEstablished mesh__D039942 2003-01-01
% 218.34/218.56  |- skos__altLabel mesh__D039942 Sema III Receptor
% 218.34/218.56  |- mesh__historyNote mesh__D039942
% 218.34/218.56       2003; use NEUROPILIN-1 %28%NM%29% 1991-2002   
% 218.34/218.56  |- rdf__type mesh__D039942sskos__Concept
% 218.34/218.56  |- skos__hiddenLabel mesh__D039942 Neuropilin 1
% 218.34/218.56  |- mesh__dateRevised mesh__D039942 2005-06-30
% 218.34/218.56  |- mesh__recordOriginator mesh__D039942 MDJ
% 218.34/218.56  |- skos__altLabel mesh__D039942 Npn-1 Protein
% 218.34/218.56  |- mesh__recordAuthorizer mesh__D039942 sjn
% 218.34/218.56  |- mesh__dateCreated mesh__D039942 2002-07-03
% 218.34/218.56  |- skos__altLabel mesh__D039942 NRP1 Protein
% 218.34/218.56  |- skos__prefLabel mesh__D039942 Neuropilin-1
% 218.34/218.56  |- mesh__dateRevised mesh__D020439 2000-06-22
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D020439 2003
% 218.34/218.56  |- skos__related mesh__D020439smesh__D016501
% 218.34/218.56  |- skos__historyNote mesh__D020439 Neurites %28%1991-1998%29%
% 218.34/218.56  |- mesh__dateCreated mesh__D020439 1998-06-10
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D020439 2005
% 218.34/218.56  |- skos__broader mesh__D020439smesh__D003712
% 218.34/218.56  |- skos__broader mesh__D020439smesh__D016501
% 218.34/218.56  |- skos__prefLabel mesh__D020439 Growth Cones
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D020439 2002
% 218.34/218.56  |- mesh__dateEstablished mesh__D020439 1999-01-01
% 218.34/218.56  |- skos__scopeNote mesh__D020439
% 218.34/218.56       Bulbous enlargement of the growing tip of nerve axons and dendrites. They are crucial to neuronal development because of their pathfinding ability and their role in synaptogenesis.%A%    
% 218.34/218.56  |- mesh__publicMeSHNote mesh__D020439 99   
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D020439 2001
% 218.34/218.56  |- skos__hiddenLabel mesh__D020439 Growth Cone
% 218.34/218.56  |- skos__broader mesh__D020439smesh__D009474
% 218.34/218.56  |- skos__historyNote mesh__D020439 Axons %28%1968-1998%29%
% 218.34/218.56  |- skos__broader mesh__D020439smesh__D001369
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D020439 2004
% 218.34/218.56  |- mesh__historyNote mesh__D020439 99   
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D020439 2006
% 218.34/218.56  |- rdf__type mesh__D020439sskos__Concept
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D006768 2000
% 218.34/218.56  |- skos__hiddenLabel mesh__D006768 Hospital, Federal
% 218.34/218.56  |- skos__hiddenLabel mesh__D006768 Federal Hospital
% 218.34/218.56  |- mesh__recordOriginator mesh__D006768 EC
% 218.34/218.56  |- skos__annotation mesh__D006768
% 218.34/218.56       US only; add UNITED STATES + state for location if pertinent%A%  
% 218.34/218.56  |- rdf__type mesh__D006768sskos__Concept
% 218.34/218.56  |- mesh__publicMeSHNote mesh__D006768
% 218.34/218.56       91; was see under HOSPITALS, PUBLIC 1978-90   
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D006768 1997
% 218.34/218.56  |- mesh__dateCreated mesh__D006768 1977-05-11
% 218.34/218.56  |- skos__broader mesh__D006768smesh__D006779
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D006768 2004
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D006768 1999
% 218.34/218.56  |- mesh__historyNote mesh__D006768
% 218.34/218.56       91%28%78%29%; was see under HOSPITALS, PUBLIC 1978-90   
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D006768 2002
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D006768 1993
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D006768 2006
% 218.34/218.56  |- mesh__recordAuthorizer mesh__D006768 PLS
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D006768 1996
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D006768 1995
% 218.34/218.56  |- mesh__recordMaintainer mesh__D006768 TGC
% 218.34/218.56  |- skos__scopeNote mesh__D006768
% 218.34/218.56       Hospitals controlled by agencies and departments of the U.S. federal government.%A%    
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D006768 1998
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D006768 2003
% 218.34/218.56  |- mesh__dateRevised mesh__D006768 1992-05-15
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D006768 2001
% 218.34/218.56  |- skos__prefLabel mesh__D006768 Hospitals, Federal
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D006768 2005
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D006768 1994
% 218.34/218.56  |- mesh__dateEstablished mesh__D006768 1991-01-01
% 218.34/218.56  |- skos__hiddenLabel mesh__D006768 Federal Hospitals
% 218.34/218.56  |- skos__altLabel mesh__D017490
% 218.34/218.56       Nonbullous Congenital Ichthyosiform Erythroderma
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D017490 2005
% 218.34/218.56  |- skos__hiddenLabel mesh__D017490 Ichthyosis, Harlequin
% 218.34/218.56  |- skos__hiddenLabel mesh__D017490 Lamellar Ichthyoses
% 218.34/218.56  |- mesh__onlineNote mesh__D017490
% 218.34/218.56       use ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL to search ICHTHYOSIS, LAMELLAR %26% ERYTHRODERMA ICHTHYOSIFORME, NONBULLOUS 1991-92; use ICHTHYOSIS to search ERYTHRODERMA ICHTHYOSIFORME, NONBULLOUS 1979-90%A%  
% 218.34/218.56  |- mesh__publicMeSHNote mesh__D017490
% 218.34/218.56       93; was see ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL 1991-92; ERYTHRODERMA ICHTHYOSIFORME, NONBULLOUS was see ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL 1991-92, was see ICHTHYOSIS 1979-90%A%  
% 218.34/218.56  |- skos__hiddenLabel mesh__D017490 Lamellar Ichthyosis
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D017490 2006
% 218.34/218.56  |- mesh__dateEstablished mesh__D017490 1993-01-01
% 218.34/218.56  |- skos__hiddenLabel mesh__D017490 Harlequin Ichthyoses
% 218.34/218.56  |- skos__altLabel mesh__D017490
% 218.34/218.56       Ichthyosiform Erythroderma, Nonbullous Congenital
% 218.34/218.56  |- skos__altLabel mesh__D017490
% 218.34/218.56       Congenital Nonbullous Ichthyosiform Erythroderma
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D017490 2002
% 218.34/218.56  |- skos__prefLabel mesh__D017490 Ichthyosis, Lamellar
% 218.34/218.56  |- skos__hiddenLabel mesh__D017490 Ichthyoses, Harlequin
% 218.34/218.56  |- skos__scopeNote mesh__D017490
% 218.34/218.56       A chronic, congenital ichthyosis inherited as an autosomal recessive trait. Infants are usually born encased in a collodion membrane which sheds within a few weeks. Scaling is generalized and marked with grayish-brown quadrilateral scales, adherent at their centers and free at the edges. In some cases, scales are so thick that they resemble armored plate.%A%    
% 218.34/218.56  |- mesh__recordMaintainer mesh__D017490 nns
% 218.34/218.56  |- mesh__dateRevised mesh__D017490 2001-07-25
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D017490 2003
% 218.34/218.56  |- skos__broader mesh__D017490smesh__D016113
% 218.34/218.56  |- rdf__type mesh__D017490sskos__Concept
% 218.34/218.56  |- skos__hiddenLabel mesh__D017490 Nonbullous Erythroderma Ichthyosiforme
% 218.34/218.56  |- skos__hiddenLabel mesh__D017490 Ichthyoses, Lamellar
% 218.34/218.56  |- mesh__historyNote mesh__D017490
% 218.34/218.56       93; was see ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL 1991-92; ERYTHRODERMA ICHTHYOSIFORME, NONBULLOUS was see ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL 1991-92, was see ICHTHYOSIS 1979-90%A%  
% 218.34/218.56  |- skos__altLabel mesh__D017490 Erythroderma Ichthyosiforme, Nonbullous
% 218.34/218.56  |- skos__altLabel mesh__D017490 Harlequin Ichthyosis
% 218.34/218.56  |- mesh__dateCreated mesh__D017490 1992-05-20
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D017490 2004
% 218.34/218.56  |- skos__historyNote mesh__D017490 Ichthyosis %28%1966-1992%29%
% 218.34/218.56  |- mesh__recordAuthorizer mesh__D017490 sjn
% 218.34/218.56  |- mesh__recordOriginator mesh__D017490 PLS
% 218.34/218.56  |- skos__hiddenLabel mesh__D017490 Fetus, Harlequin
% 218.34/218.56  |- skos__annotation mesh__D017490
% 218.34/218.56       do not coord with INFANT, NEWBORN, DISEASES   
% 218.34/218.56  |- skos__historyNote mesh__D017490
% 218.34/218.56       Ichthyosiform Erythroderma, Congenital %28%1991-1992%29%
% 218.34/218.56  |- mesh__recordOriginator mesh__D031161 ags
% 218.34/218.56  |- mesh__historyNote mesh__D031161 2003   
% 218.34/218.56  |- skos__scopeNote mesh__D031161
% 218.34/218.56       A genus of GRAM-NEGATIVE AEROBIC BACTERIA of marine origin. Many species were formerly classified under ALTEROMONAS.%A%    
% 218.34/218.56  |- mesh__dateRevised mesh__D031161 2005-06-30
% 218.34/218.56  |- mesh__recordMaintainer mesh__D031161 SYSTEM
% 218.34/218.56  |- rdf__type mesh__D031161sskos__Concept
% 218.34/218.56  |- mesh__dateCreated mesh__D031161 2002-07-03
% 218.34/218.56  |- skos__prefLabel mesh__D031161 Pseudoalteromonas
% 218.34/218.56  |- skos__broader mesh__D031161smesh__D034241
% 218.34/218.56  |- mesh__publicMeSHNote mesh__D031161 2003   
% 218.34/218.56  |- mesh__dateEstablished mesh__D031161 2003-01-01
% 218.34/218.56  |- mesh__recordAuthorizer mesh__D031161 sjn
% 218.34/218.56  |- skos__historyNote mesh__D031161
% 218.34/218.56       Gram-Negative Aerobic Bacteria %28%1995-2002%29%
% 218.34/218.56  |- mesh__activeMeSHYear mesh__D031161 2006
% 218.34/218.56  |- skos__broader mesh__D031161smesh__D016946
% 218.34/218.56  |- skos__broader mesh__D025922smesh__D018138
% 218.34/218.56  |- rdf__type mesh__D025922sskos__Concept
% 218.34/218.56  |- mesh__historyNote mesh__D025922 2002   
% 218.34/218.56  |- mesh__publicMeSHNote mesh__D025922 2002   
% 218.34/218.57  |- skos__prefLabel mesh__D025922 Marek%27%s Disease-like Viruses
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D025922 2006
% 218.34/218.57  |- mesh__dateEstablished mesh__D025922 2002-01-01
% 218.34/218.57  |- skos__scopeNote mesh__D025922
% 218.34/218.57       A genus in the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE, associated with malignancy in birds.%A%    
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D025922 2004
% 218.34/218.57  |- skos__hiddenLabel mesh__D025922 Marek%27%s Disease like Viruses
% 218.34/218.57  |- skos__hiddenLabel mesh__D025922 Mareks Disease-like Viruses
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D025922 2005
% 218.34/218.57  |- skos__altLabel mesh__D025922 Marek Disease-like Viruses
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D025922 2003
% 218.34/218.57  |- mesh__dateCreated mesh__D025922 2001-07-25
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D025922 2002
% 218.34/218.57  |- skos__hiddenLabel mesh__D025922 Marek Disease like Viruses
% 218.34/218.57  |- mesh__dateCreated mesh__D003470 1999-01-01
% 218.34/218.57  |- rdf__type mesh__D003470sskos__Concept
% 218.34/218.57  |- skos__broader mesh__D003470smesh__D004864
% 218.34/218.57  |- skos__prefLabel mesh__D003470 Culture Media
% 218.34/218.57  |- skos__scopeNote mesh__D003470
% 218.34/218.57       Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN.%A%    
% 218.34/218.57  |- mesh__dateRevised mesh__D003470 2004-07-07
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D003470 2005
% 218.34/218.57  |- mesh__recordMaintainer mesh__D003470 lkt
% 218.34/218.57  |- skos__hiddenLabel mesh__D003470 Media, Culture
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D003470 2006
% 218.34/218.57  |- mesh__recordOriginator mesh__D003470 NLM
% 218.34/218.57  |- skos__broader mesh__D003470smesh__D019995
% 218.34/218.57  |- mesh__recordAuthorizer mesh__D003470 sjn
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011902 2003
% 218.34/218.57  |- mesh__dateRevised mesh__D011902 1993-05-06
% 218.34/218.57  |- skos__hiddenLabel mesh__D011902 Rapes
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011902 2000
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011902 1994
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011902 2004
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011902 2005
% 218.34/218.57  |- skos__prefLabel mesh__D011902 Rape
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011902 1995
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011902 2001
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011902 2006
% 218.34/218.57  |- mesh__recordOriginator mesh__D011902 NLM
% 218.34/218.57  |- mesh__dateCreated mesh__D011902 1999-01-01
% 218.34/218.57  |- skos__broader mesh__D011902smesh__D012742
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011902 1996
% 218.34/218.57  |- mesh__recordMaintainer mesh__D011902 PLS
% 218.34/218.57  |- rdf__type mesh__D011902sskos__Concept
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011902 2002
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011902 1997
% 218.34/218.57  |- skos__scopeNote mesh__D011902
% 218.34/218.57       Unlawful sexual intercourse without consent of the victim.%A%    
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011902 1998
% 218.34/218.57  |- mesh__recordAuthorizer mesh__D011902 PLS
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011902 1999
% 218.34/218.57  |- skos__broader mesh__D044089smesh__D009479
% 218.34/218.57  |- mesh__recordAuthorizer mesh__D044089 sjn
% 218.34/218.57  |- skos__altLabel mesh__D044089 Galanin-Like Protein
% 218.34/218.57  |- mesh__dateEstablished mesh__D044089 2004-01-01
% 218.34/218.57  |- skos__prefLabel mesh__D044089 Galanin-Like Peptide
% 218.34/218.57  |- rdf__type mesh__D044089sskos__Concept
% 218.34/218.57  |- mesh__historyNote mesh__D044089
% 218.34/218.57       2004; use GALANIN-LIKE PEPTIDE %28%NM%29% 2000-2003   
% 218.34/218.57  |- skos__scopeNote mesh__D044089
% 218.34/218.57       A neuropeptide that is highly homologous to GALANIN. It is produced by proteolytic processing of a larger protein that is unrelated to prepro-galanin and preferentially binds to GALANIN-2 RECEPTOR.%A%    
% 218.34/218.57  |- mesh__publicMeSHNote mesh__D044089
% 218.34/218.57       2004; GALANIN-LIKE PROTEIN %28%now GALANIN-LIKE PEPTIDE%29% was indexed under NERVE TISSUE PROTEINS 2000-2003%A%  
% 218.34/218.57  |- skos__hiddenLabel mesh__D044089 Galanin Like Protein
% 218.34/218.57  |- mesh__recordOriginator mesh__D044089 jmp
% 218.34/218.57  |- mesh__dateRevised mesh__D044089 2005-06-30
% 218.34/218.57  |- mesh__dateCreated mesh__D044089 2003-07-09
% 218.34/218.57  |- mesh__recordMaintainer mesh__D044089 ssb
% 218.34/218.57  |- skos__altLabel mesh__D044089 GALP Peptide
% 218.34/218.57  |- skos__hiddenLabel mesh__D044089 Galanin Like Peptide
% 218.34/218.57  |- skos__historyNote mesh__D044089 Nerve Tissue Proteins %28%2000-2003%29%
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D044089 2006
% 218.34/218.57  |- mesh__recordMaintainer mesh__D011104 ssb
% 218.34/218.57  |- skos__historyNote mesh__D011104
% 218.34/218.57       specific terpene or terpene group %28%1966-1977%29%
% 218.34/218.57  |- skos__altLabel mesh__D011104 Isoprenoid Phosphate Oligosaccharides
% 218.34/218.57  |- skos__broader mesh__D011104smesh__D011105
% 218.34/218.57  |- mesh__recordOriginator mesh__D011104 RLS
% 218.34/218.57  |- skos__scopeNote mesh__D011104
% 218.34/218.57       These compounds function as activated glycosyl carriers in the biosynthesis of glycoproteins and glycophospholipids. Include the pyrophosphates.%A%    
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011104 2006
% 218.34/218.57  |- rdf__type mesh__D011104sskos__Concept
% 218.34/218.57  |- skos__historyNote mesh__D011104 Terpenes %28%1966-1977%29%
% 218.34/218.57  |- mesh__historyNote mesh__D011104
% 218.34/218.57       91%28%78%29%; was see under POLYISOPRENYL PHOSPHATE SUGARS 1978-90%A%  
% 218.34/218.57  |- skos__hiddenLabel mesh__D011104 Phosphate Oligosaccharides, Isoprenoid
% 218.34/218.57  |- skos__hiddenLabel mesh__D011104 Oligosaccharides, Isoprenoid Phosphate
% 218.34/218.57  |- mesh__publicMeSHNote mesh__D011104
% 218.34/218.57       91; was see under POLYISOPRENYL PHOSPHATE SUGARS 1978-90   
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011104 2005
% 218.34/218.57  |- mesh__recordAuthorizer mesh__D011104 sjn
% 218.34/218.57  |- mesh__dateRevised mesh__D011104 2004-07-07
% 218.34/218.57  |- mesh__dateEstablished mesh__D011104 1991-01-01
% 218.34/218.57  |- mesh__dateCreated mesh__D011104 1977-05-17
% 218.34/218.57  |- skos__hiddenLabel mesh__D011104
% 218.34/218.57       Phosphate Oligosaccharides, Polyisoprenyl
% 218.34/218.57  |- skos__prefLabel mesh__D011104 Polyisoprenyl Phosphate Oligosaccharides
% 218.34/218.57  |- skos__hiddenLabel mesh__D011104
% 218.34/218.57       Oligosaccharides, Polyisoprenyl Phosphate
% 218.34/218.57  |- skos__historyNote mesh__D011104 Sugar Phosphates %28%1974-1977%29%
% 218.34/218.57  |- skos__annotation mesh__D016398 a non-Hodgkin%27%s lymphoma   
% 218.34/218.57  |- mesh__historyNote mesh__D016398
% 218.34/218.57       91; LYMPHOSARCOMA was see LYMPHOMA, NON-HODGKIN%27%S 1987-90; was heading 1963-86%A%  
% 218.34/218.57  |- skos__altLabel mesh__D016398 Sarcoma, Lymphatic
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D016398 1997
% 218.34/218.57  |- mesh__recordMaintainer mesh__D016398 KEV
% 218.34/218.57  |- skos__hiddenLabel mesh__D016398 Diffuse Lymphoma
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D016398 2006
% 218.34/218.57  |- skos__altLabel mesh__D016398 Lymphatic Sarcoma
% 218.34/218.57  |- skos__hiddenLabel mesh__D016398 Lymphatic Sarcomas
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D016398 2000
% 218.34/218.57  |- skos__hiddenLabel mesh__D016398 Lymphomas, Diffuse
% 218.34/218.57  |- skos__broader mesh__D016398smesh__D008228
% 218.34/218.57  |- mesh__publicMeSHNote mesh__D016398
% 218.34/218.57       91; LYMPHOSARCOMA was see LYMPHOMA, NON-HODGKIN%27%S 1987-90; was heading 1963-86%A%  
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D016398 2003
% 218.34/218.57  |- skos__historyNote mesh__D016398
% 218.34/218.57       Lymphoma, Non-Hodgkin%27%s %28%1986-1990%29%
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D016398 2001
% 218.34/218.57  |- skos__hiddenLabel mesh__D016398 Sarcomas, Lymphatic
% 218.34/218.57  |- rdf__type mesh__D016398sskos__Concept
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D016398 1998
% 218.34/218.57  |- mesh__dateRevised mesh__D016398 1995-06-08
% 218.34/218.57  |- skos__hiddenLabel mesh__D016398 Lymphosarcomas
% 218.34/218.57  |- skos__altLabel mesh__D016398 Lymphosarcoma
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D016398 2004
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D016398 1999
% 218.34/218.57  |- skos__prefLabel mesh__D016398 Lymphoma, Diffuse
% 218.34/218.57  |- mesh__dateCreated mesh__D016398 1990-06-01
% 218.34/218.57  |- skos__scopeNote mesh__D016398
% 218.34/218.57       Malignant lymphoma in which neoplastic cells diffusely infiltrate the entire lymph node without any definite organized pattern. Patients whose lymphomas present a diffuse pattern generally have a more unfavorable survival outlook than those presenting with a follicular or nodular pattern.%A%    
% 218.34/218.57  |- mesh__recordOriginator mesh__D016398 PLS
% 218.34/218.57  |- mesh__onlineNote mesh__D016398
% 218.34/218.57       use LYMPHOMA, NON-HODGKIN%27%S to search LYMPHOSARCOMA 1966-90%A%  
% 218.34/218.57  |- mesh__dateEstablished mesh__D016398 1991-01-01
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D016398 2002
% 218.34/218.57  |- mesh__recordAuthorizer mesh__D016398 PLS
% 218.34/218.57  |- skos__hiddenLabel mesh__D016398 Diffuse Lymphomas
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D016398 1996
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D016398 2005
% 218.34/218.57  |- skos__broader mesh__D000758Q000193smesh__D000758
% 218.34/218.57  |- mesh__preferredCombination mesh__D000758Q000193smesh__D000776Q000193
% 218.34/218.57  |- rdf__type mesh__D000758Q000193smesh__CompoundConcept
% 218.34/218.57  |- mesh__recordOriginator mesh__D002378 NLM
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D002378 2000
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D002378 2005
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D002378 2004
% 218.34/218.57  |- skos__hiddenLabel mesh__D002378 Bookseller%27%s Catalogs
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D002378 2001
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D002378 2006
% 218.34/218.57  |- mesh__dateRevised mesh__D002378 1999-11-03
% 218.34/218.57  |- skos__hiddenLabel mesh__D002378 Booksellers Catalogs
% 218.34/218.57  |- mesh__dateCreated mesh__D002378 1999-01-01
% 218.34/218.57  |- skos__hiddenLabel mesh__D002378 Catalogs, Booksellers
% 218.34/218.57  |- mesh__recordAuthorizer mesh__D002378 sjn
% 218.34/218.57  |- skos__hiddenLabel mesh__D002378 Catalogs, Bookseller%27%s
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D002378 2002
% 218.34/218.57  |- skos__altLabel mesh__D002378 Booksellers%27% Catalogs
% 218.34/218.57  |- skos__annotation mesh__D002378 no qualif   
% 218.34/218.57  |- skos__hiddenLabel mesh__D002378 Bookseller Catalogs
% 218.34/218.57  |- skos__hiddenLabel mesh__D002378 Catalogs, Bookseller
% 218.34/218.57  |- skos__broader mesh__D002378smesh__D002379
% 218.34/218.57  |- rdf__type mesh__D002378sskos__Concept
% 218.34/218.57  |- mesh__recordMaintainer mesh__D002378 kle
% 218.34/218.57  |- skos__hiddenLabel mesh__D002378 Booksellers%27% Catalog
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D002378 2003
% 218.34/218.57  |- skos__prefLabel mesh__D002378 Catalogs, Booksellers%27%
% 218.34/218.57  |- skos__hiddenLabel mesh__D002378 Catalog, Booksellers%27%
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007861 1999
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007861 2000
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007861 1998
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007861 1997
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007861 2006
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007861 1996
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007861 2005
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007861 2004
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007861 2002
% 218.34/218.57  |- mesh__recordMaintainer mesh__D007861 PLS
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007861 2003
% 218.34/218.57  |- skos__prefLabel mesh__D007861 Lebanon
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007861 1995
% 218.34/218.57  |- skos__broader mesh__D007861smesh__D008877
% 218.34/218.57  |- mesh__dateCreated mesh__D007861 1999-01-01
% 218.34/218.57  |- mesh__dateRevised mesh__D007861 1992-05-20
% 218.34/218.57  |- mesh__recordAuthorizer mesh__D007861 PLS
% 218.34/218.57  |- mesh__recordOriginator mesh__D007861 NLM
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007861 1993
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007861 1994
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007861 2001
% 218.34/218.57  |- rdf__type mesh__D007861sskos__Concept
% 218.34/218.57  |- skos__hiddenLabel mesh__D007063 Crisis, Identity
% 218.34/218.57  |- skos__hiddenLabel mesh__D007063 Crises, Identity
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007063 1998
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007063 2005
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007063 1997
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007063 2004
% 218.34/218.57  |- mesh__dateEstablished mesh__D007063 1973-01-01
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007063 1994
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007063 2001
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007063 1993
% 218.34/218.57  |- skos__historyNote mesh__D007063 Defense Mechanisms %28%1966-1967%29%
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007063 1999
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007063 2006
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007063 1990
% 218.34/218.57  |- skos__annotation mesh__D007063 no qualif   
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007063 1995
% 218.34/218.57  |- mesh__historyNote mesh__D007063 1973%28%1971%29%   
% 218.34/218.57  |- rdf__type mesh__D007063sskos__Concept
% 218.34/218.57  |- skos__historyNote mesh__D007063 Self Concept %28%1966-1970%29%
% 218.34/218.57  |- mesh__recordOriginator mesh__D007063 NLM
% 218.34/218.57  |- mesh__recordMaintainer mesh__D007063 ags
% 218.34/218.57  |- mesh__publicMeSHNote mesh__D007063 1973   
% 218.34/218.57  |- skos__hiddenLabel mesh__D007063 Identity Crises
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007063 2002
% 218.34/218.57  |- skos__prefLabel mesh__D007063 Identity Crisis
% 218.34/218.57  |- skos__historyNote mesh__D007063
% 218.34/218.57       Identification %28%Psychology%29% %28%1968-1970%29%
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007063 2000A
% 218.34/218.57  |- mesh__dateCreated mesh__D007063 1999-01-01
% 218.34/218.57  |- skos__scopeNote mesh__D007063
% 218.34/218.57       Chaotic concept of self wherein one%27%s role in life appears to be an insoluble dilemma often expressed by isolation, withdrawal, rebellion and extremism.%A%    
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007063 1991
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007063 1996
% 218.34/218.57  |- mesh__dateRevised mesh__D007063 1999-12-16
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007063 2003
% 218.34/218.57  |- skos__broader mesh__D007063smesh__D010553
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007063 2000
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D007063 1992
% 218.34/218.57  |- mesh__recordAuthorizer mesh__D007063 ags
% 218.34/218.57  |- mesh__historyNote mesh__D045182 2004   
% 218.34/218.57  |- mesh__recordMaintainer mesh__D045182 SYSTEM
% 218.34/218.57  |- mesh__recordAuthorizer mesh__D045182 sjn
% 218.34/218.57  |- mesh__dateEstablished mesh__D045182 2004-01-01
% 218.34/218.57  |- mesh__publicMeSHNote mesh__D045182 2004   
% 218.34/218.57  |- mesh__dateRevised mesh__D045182 2005-06-30
% 218.34/218.57  |- skos__annotation mesh__D045182
% 218.34/218.57       FUSOBACTERIUM is also available; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 218.34/218.57  |- rdf__type mesh__D045182sskos__Concept
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D045182 2006
% 218.34/218.57  |- skos__prefLabel mesh__D045182 Fusobacteria
% 218.34/218.57  |- skos__scopeNote mesh__D045182
% 218.34/218.57       A phylum of anaerobic, gram-negative bacteria with a chemoorganotrophic heterotrophic metabolism. They are resident flora of the OROPHARYNX.%A%    
% 218.34/218.57  |- skos__broader mesh__D045182smesh__D001419
% 218.34/218.57  |- mesh__recordOriginator mesh__D045182 ags
% 218.34/218.57  |- skos__historyNote mesh__D045182 Fusobacterium %28%1965-2003%29%
% 218.34/218.57  |- mesh__dateCreated mesh__D045182 2003-07-09
% 218.34/218.57  |- mesh__dateRevised mesh__D039943 2005-06-30
% 218.34/218.57  |- skos__broader mesh__D039943smesh__D039921
% 218.34/218.57  |- mesh__recordAuthorizer mesh__D039943 sjn
% 218.34/218.57  |- skos__altLabel mesh__D039943 Npn-2 Protein
% 218.34/218.57  |- mesh__dateCreated mesh__D039943 2002-07-03
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D039943 2006
% 218.34/218.57  |- skos__historyNote mesh__D039943 Nerve Tissue Proteins %28%1998-2002%29%
% 218.34/218.57  |- mesh__historyNote mesh__D039943
% 218.34/218.57       2003; for NPN-2 PROTEIN use NEUROPILIN-1 1998-2002   
% 218.34/218.57  |- skos__altLabel mesh__D039943 NRP2 Protein
% 218.34/218.57  |- mesh__recordMaintainer mesh__D039943 jmp
% 218.34/218.57  |- skos__prefLabel mesh__D039943 Neuropilin-2
% 218.34/218.57  |- rdf__type mesh__D039943sskos__Concept
% 218.34/218.57  |- mesh__recordOriginator mesh__D039943 MDJ
% 218.34/218.57  |- skos__scopeNote mesh__D039943
% 218.34/218.57       Transmembrane receptor for CLASS 3 SEMAPHORINS and several vascular endothelial growth factor isoforms.  Neuropilin-2 functions either as a homodimer or as a heterodimer with NEUROPILIN-1. The binding affinity of neuropilin-2 varies for different class 3 semaphorin isoforms and is dependent on the composition of the dimer.  The protein also forms receptor complexes with plexins and with VEGF RECEPTORS, which alters the binding characteristics of the receptor.%A%    
% 218.34/218.57  |- mesh__publicMeSHNote mesh__D039943
% 218.34/218.57       2003; NPN-2 PROTEIN was indexed under NERVE TISSUE PROTEINS 1998-2002%A%  
% 218.34/218.57  |- skos__hiddenLabel mesh__D039943 Neuropilin 2
% 218.34/218.57  |- skos__hiddenLabel mesh__D039943 Npn 2 Protein
% 218.34/218.57  |- mesh__dateEstablished mesh__D039943 2003-01-01
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D006769 2005
% 218.34/218.57  |- skos__historyNote mesh__D006769 Hospitals %28%1966-1967%29%
% 218.34/218.57  |- rdf__type mesh__D006769sskos__Concept
% 218.34/218.57  |- mesh__recordMaintainer mesh__D006769 kle
% 218.34/218.57  |- skos__annotation mesh__D006769
% 218.34/218.57       coord IM with hosp ownership term %28%e.g., HOSPITALS, COUNTY; HOSPITALS, PROPRIETARY; etc.%29% %28%IM or NIM%29% if pertinent; specify geog%A%  
% 218.34/218.57  |- skos__hiddenLabel mesh__D006769 Hospital, General
% 218.34/218.57  |- mesh__dateRevised mesh__D006769 1999-11-03
% 218.34/218.57  |- skos__prefLabel mesh__D006769 Hospitals, General
% 218.34/218.57  |- mesh__historyNote mesh__D006769 68   
% 218.34/218.57  |- mesh__recordAuthorizer mesh__D006769 sjn
% 218.34/218.57  |- mesh__publicMeSHNote mesh__D006769 68   
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D006769 2002
% 218.34/218.57  |- mesh__dateEstablished mesh__D006769 1968-01-01
% 218.34/218.57  |- skos__scopeNote mesh__D006769
% 218.34/218.57       Large hospitals with a resident medical staff which provides continuous care to maternity, surgical and medical patients.%A%    
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D006769 2004
% 218.34/218.57  |- skos__hiddenLabel mesh__D006769 General Hospital
% 218.34/218.57  |- mesh__dateCreated mesh__D006769 1999-01-01
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D006769 2001
% 218.34/218.57  |- skos__broader mesh__D006769smesh__D006761
% 218.34/218.57  |- mesh__recordOriginator mesh__D006769 NLM
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D006769 2003
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D006769 2006
% 218.34/218.57  |- skos__hiddenLabel mesh__D006769 General Hospitals
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D006769 2000
% 218.34/218.57  |- skos__related mesh__D017491smesh__D011125
% 218.34/218.57  |- skos__scopeNote mesh__D017491
% 218.34/218.57       Tumor suppressor genes located in the 5q21 region on the long arm of human chromosome 5. The mutation of these genes is associated with familial adenomatous polyposis %28%ADENOMATOUS POLYPOSIS COLI%29% and GARDNER SYNDROME, as well as some sporadic colorectal cancers.%A%    
% 218.34/218.57  |- skos__related mesh__D017491smesh__D005736
% 218.34/218.57  |- skos__hiddenLabel mesh__D017491 Gene, APC
% 218.34/218.57  |- skos__prefLabel mesh__D017491 Genes, APC
% 218.34/218.57  |- skos__hiddenLabel mesh__D017491 APC Gene
% 218.34/218.57  |- mesh__dateCreated mesh__D017491 1992-05-20
% 218.34/218.57  |- skos__historyNote mesh__D017491
% 218.34/218.57       Genes, Suppressor, Tumor %28%1991-1992%29%
% 218.34/218.57  |- skos__historyNote mesh__D017491
% 218.34/218.57       Polyposis Syndrome, Familial/genetics %28%1989-1992%29%
% 218.34/218.57  |- rdf__type mesh__D017491sskos__Concept
% 218.34/218.57  |- skos__related mesh__D017491smesh__D025601
% 218.34/218.57  |- mesh__recordAuthorizer mesh__D017491 sjn
% 218.34/218.57  |- mesh__dateEstablished mesh__D017491 1993-01-01
% 218.34/218.57  |- mesh__historyNote mesh__D017491 93   
% 218.34/218.57  |- mesh__publicMeSHNote mesh__D017491 93   
% 218.34/218.57  |- skos__hiddenLabel mesh__D017491 APC Genes
% 218.34/218.57  |- mesh__recordOriginator mesh__D017491 AGS
% 218.34/218.57  |- skos__broader mesh__D017491smesh__D016147
% 218.34/218.57  |- mesh__recordMaintainer mesh__D017491 nns
% 218.34/218.57  |- mesh__dateRevised mesh__D017491 2005-06-30
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D017491 2006
% 218.34/218.57  |- skos__altLabel mesh__D017491 Genes, Adenomatous Polyposis Coli
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D031162 2004
% 218.34/218.57  |- mesh__dateCreated mesh__D031162 2002-07-02
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D031162 2005
% 218.34/218.57  |- mesh__publicMeSHNote mesh__D031162 2003   
% 218.34/218.57  |- skos__broader mesh__D031162smesh__D019659
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D031162 2006
% 218.34/218.57  |- mesh__historyNote mesh__D031162 2003   
% 218.34/218.57  |- skos__prefLabel mesh__D031162 Achillea
% 218.34/218.57  |- skos__altLabel mesh__D031162 Yarrow
% 218.34/218.57  |- skos__annotation mesh__D031162
% 218.34/218.57       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.34/218.57  |- skos__scopeNote mesh__D031162
% 218.34/218.57       A plant genus of the family ASTERACEAE that has long been used in folk medicine for treating wounds.%A%    
% 218.34/218.57  |- mesh__dateEstablished mesh__D031162 2003-01-01
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D031162 2003
% 218.34/218.57  |- rdf__type mesh__D031162sskos__Concept
% 218.34/218.57  |- mesh__recordOriginator mesh__D003471 NLM
% 218.34/218.57  |- mesh__recordAuthorizer mesh__D003471 sjn
% 218.34/218.57  |- mesh__dateRevised mesh__D003471 2004-07-07
% 218.34/218.57  |- skos__altLabel mesh__D003471 Biscyclohexanone Oxaldihydrazone
% 218.34/218.57  |- skos__historyNote mesh__D003471 Hydrazones %28%1972-1974%29%
% 218.34/218.57  |- skos__hiddenLabel mesh__D003471 Oxaldihydrazone, Biscyclohexanone
% 218.34/218.57  |- skos__scopeNote mesh__D003471
% 218.34/218.57       Copper chelator that inhibits monoamine oxidase and causes liver and brain damage.%A%    
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D003471 2005
% 218.34/218.57  |- skos__broader mesh__D003471smesh__D003510
% 218.34/218.57  |- mesh__dateEstablished mesh__D003471 1991-01-01
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D003471 2006
% 218.34/218.57  |- skos__annotation mesh__D003471 D25-26 qualif   
% 218.34/218.57  |- mesh__historyNote mesh__D003471
% 218.34/218.57       91%28%75%29%; was see under CYCLOHEXANES 1975-90   
% 218.34/218.57  |- mesh__dateCreated mesh__D003471 1974-11-19
% 218.34/218.57  |- skos__historyNote mesh__D003471 Cyclohexanes %28%1969-1974%29%
% 218.34/218.57  |- skos__prefLabel mesh__D003471 Cuprizone
% 218.34/218.57  |- mesh__recordMaintainer mesh__D003471 ssb
% 218.34/218.57  |- mesh__publicMeSHNote mesh__D003471
% 218.34/218.57       91; was see under CYCLOHEXANES 1975-90   
% 218.34/218.57  |- rdf__type mesh__D003471sskos__Concept
% 218.34/218.57  |- skos__scopeNote mesh__D011903
% 218.34/218.57       Collections of small neurons centrally scattered among many fibers from the level of the trochlear nucleus in the midbrain to the hypoglossal area in the medulla oblongata.%A%    
% 218.34/218.57  |- skos__historyNote mesh__D011903 Brain Stem %28%1966-1977%29%
% 218.34/218.57  |- skos__hiddenLabel mesh__D011903 Nuclei, Raphe
% 218.34/218.57  |- mesh__historyNote mesh__D011903
% 218.34/218.57       85%28%78%29%; was see under BRAIN STEM 1978-84   
% 218.34/218.57  |- mesh__dateEstablished mesh__D011903 1985-01-01
% 218.34/218.57  |- skos__broader mesh__D011903smesh__D012249
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011903 2000
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011903 1999
% 218.34/218.57  |- skos__hiddenLabel mesh__D011903 Raphe Nucleus
% 218.34/218.57  |- skos__historyNote mesh__D011903 Mesencephalon %28%1966-1977%29%
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011903 1993
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011903 2004
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011903 1998
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011903 2003
% 218.34/218.57  |- mesh__dateRevised mesh__D011903 1992-05-18
% 218.34/218.57  |- skos__broader mesh__D011903smesh__D008636
% 218.34/218.57  |- mesh__recordMaintainer mesh__D011903 TAP
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011903 2002
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011903 1995
% 218.34/218.57  |- mesh__recordOriginator mesh__D011903 RC
% 218.34/218.57  |- mesh__publicMeSHNote mesh__D011903
% 218.34/218.57       85; was see under BRAIN STEM 1978-84   
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011903 2006
% 218.34/218.57  |- skos__prefLabel mesh__D011903 Raphe Nuclei
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011903 1994
% 218.34/218.57  |- skos__historyNote mesh__D011903 Reticular Formation %28%1966-1977%29%
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011903 2005
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011903 1997
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011903 2001
% 218.34/218.57  |- mesh__recordAuthorizer mesh__D011903 PLS
% 218.34/218.57  |- mesh__dateCreated mesh__D011903 1977-04-27
% 218.34/218.57  |- skos__hiddenLabel mesh__D011903 Nucleus, Raphe
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011903 1996
% 218.34/218.57  |- rdf__type mesh__D011903sskos__Concept
% 218.34/218.57  |- skos__historyNote mesh__D011105 Carbohydrates %28%1966-1977%29%
% 218.34/218.57  |- skos__historyNote mesh__D011105
% 218.34/218.57       specific terpene groups or specific terpene %28%1966-1977%29%
% 218.34/218.57  |- rdf__type mesh__D011105sskos__Concept
% 218.34/218.57  |- mesh__recordAuthorizer mesh__D011105 sjn
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011105 2006
% 218.34/218.57  |- skos__historyNote mesh__D011105 Terpenes %28%1966-1977%29%
% 218.34/218.57  |- skos__scopeNote mesh__D011105
% 218.34/218.57       Compounds functioning as activated glycosyl carriers in the biosynthesis of glycoproteins and glycophospholipids. They include the polyisoprenyl pyrophosphates.%A%    
% 218.34/218.57  |- skos__prefLabel mesh__D011105 Polyisoprenyl Phosphate Sugars
% 218.34/218.57  |- skos__altLabel mesh__D011105 Sugar Pyrophosphorylpolyprenols
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D011105 2005
% 218.34/218.57  |- skos__hiddenLabel mesh__D011105 Phosphate Sugars, Isoprenoid
% 218.34/218.57  |- mesh__dateRevised mesh__D011105 2004-07-07
% 218.34/218.57  |- skos__hiddenLabel mesh__D011105 Sugars, Polyisoprenyl Phosphate
% 218.34/218.57  |- skos__hiddenLabel mesh__D011105 Pyrophosphorylpolyprenols, Sugar
% 218.34/218.57  |- mesh__recordMaintainer mesh__D011105 ssb
% 218.34/218.57  |- mesh__dateCreated mesh__D011105 1977-04-15
% 218.34/218.57  |- mesh__publicMeSHNote mesh__D011105 78   
% 218.34/218.57  |- mesh__recordOriginator mesh__D011105 RLS
% 218.34/218.57  |- skos__broader mesh__D011105smesh__D013403
% 218.34/218.57  |- skos__hiddenLabel mesh__D011105 Phosphate Sugars, Polyisoprenyl
% 218.34/218.57  |- skos__historyNote mesh__D011105 specific carbohydrate %28%1966-1977%29%
% 218.34/218.57  |- mesh__dateEstablished mesh__D011105 1978-01-01
% 218.34/218.57  |- skos__historyNote mesh__D011105 Sugar Phosphates %28%1974-1977%29%
% 218.34/218.57  |- skos__hiddenLabel mesh__D011105 Sugars, Isoprenoid Phosphate
% 218.34/218.57  |- skos__broader mesh__D011105smesh__D011106
% 218.34/218.57  |- mesh__historyNote mesh__D011105 78   
% 218.34/218.57  |- skos__broader mesh__D011105smesh__D006017
% 218.34/218.57  |- skos__altLabel mesh__D011105 Isoprenoid Phosphate Sugars
% 218.34/218.57  |- skos__broader mesh__D016399smesh__D008228
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D016399 2003
% 218.34/218.57  |- mesh__historyNote mesh__D016399 91   
% 218.34/218.57  |- mesh__recordMaintainer mesh__D016399 TGC
% 218.34/218.57  |- skos__prefLabel mesh__D016399 Lymphoma, T-Cell
% 218.34/218.57  |- rdf__type mesh__D016399sskos__Concept
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D016399 1998
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D016399 2004
% 218.34/218.57  |- skos__altLabel mesh__D016399 T-Cell Lymphoma
% 218.34/218.57  |- skos__hiddenLabel mesh__D016399 Lymphoma, T Cell
% 218.34/218.57  |- skos__hiddenLabel mesh__D016399 T-Cell Lymphomas
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D016399 2000
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D016399 1999
% 218.34/218.57  |- mesh__recordOriginator mesh__D016399 PLS
% 218.34/218.57  |- skos__hiddenLabel mesh__D016399 Lymphomas, T-Cell
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D016399 2001
% 218.34/218.57  |- mesh__dateEstablished mesh__D016399 1991-01-01
% 218.34/218.57  |- skos__historyNote mesh__D016399
% 218.34/218.57       Lymphoma, Non-Hodgkin%27%s %28%1980-1990%29%
% 218.34/218.57  |- mesh__activeMeSHYear mesh__D016399 2005
% 218.34/218.58  |- skos__hiddenLabel mesh__D016399 T Cell Lymphoma
% 218.34/218.58  |- mesh__dateCreated mesh__D016399 1990-06-01
% 218.34/218.58  |- skos__historyNote mesh__D016399 T-Lymphocytes %28%1980-1990%29%
% 218.34/218.58  |- mesh__activeMeSHYear mesh__D016399 1997
% 218.34/218.58  |- mesh__activeMeSHYear mesh__D016399 2006
% 218.34/218.58  |- skos__scopeNote mesh__D016399
% 218.34/218.58       A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.%A%    
% 218.34/218.58  |- skos__annotation mesh__D016399
% 218.34/218.58       a non-Hodgkin%27%s lymphoma; LYMPHOMA, T-CELL, CUTANEOUS %26% LYMPHOMA, T-CELL, PERIPHERAL are also available%A%  
% 218.34/218.58  |- mesh__dateRevised mesh__D016399 1996-06-10
% 218.34/218.58  |- mesh__activeMeSHYear mesh__D016399 2002
% 218.34/218.58  |- mesh__publicMeSHNote mesh__D016399 91   
% 218.34/218.58  |- mesh__recordAuthorizer mesh__D016399 PLS
% 218.34/218.58  |- skos__hiddenLabel mesh__D002379 Commercial Catalogs
% 218.34/218.58  |- mesh__recordMaintainer mesh__D002379 kle
% 218.34/218.58  |- skos__prefLabel mesh__D002379 Catalogs, Commercial
% 218.34/218.58  |- mesh__recordOriginator mesh__D002379 NLM
% 218.34/218.58  |- mesh__activeMeSHYear mesh__D002379 2000
% 218.34/218.58  |- rdf__type mesh__D002379sskos__Concept
% 218.34/218.58  |- skos__annotation mesh__D002379 no qualif   
% 218.34/218.58  |- mesh__dateRevised mesh__D002379 1999-11-03
% 218.34/218.58  |- skos__hiddenLabel mesh__D002379 Commercial Catalog
% 218.34/218.58  |- mesh__activeMeSHYear mesh__D002379 2003
% 218.34/218.58  |- mesh__activeMeSHYear mesh__D002379 2001
% 218.34/218.58  |- mesh__activeMeSHYear mesh__D002379 2005
% 218.34/218.58  |- skos__hiddenLabel mesh__D002379 Catalog, Commercial
% 218.34/218.58  |- mesh__activeMeSHYear mesh__D002379 2004
% 218.34/218.58  |- mesh__recordAuthorizer mesh__D002379 sjn
% 218.34/218.58  |- mesh__activeMeSHYear mesh__D002379 2006
% 218.34/218.58  |- skos__broader mesh__D002379smesh__D002377
% 218.34/218.58  |- mesh__dateCreated mesh__D002379 1999-01-01
% 218.34/218.58  |- mesh__activeMeSHYear mesh__D002379 2002
% 218.34/218.58  |- mesh__activeMeSHYear mesh__D007862 2005
% 218.34/218.58  |- skos__hiddenLabel mesh__D007862
% 218.34/218.58       Phosophatidylcholine Sterol Acyltransferase
% 218.34/218.58  |- mesh__historyNote mesh__D007862 98%28%75%29%   
% 218.34/218.58  |- mesh__recordOriginator mesh__D007862 NLM
% 218.34/218.58  |- mesh__activeMeSHYear mesh__D007862 2006
% 218.34/218.58  |- mesh__dateCreated mesh__D007862 1974-11-11
% 218.34/218.58  |- mesh__dateRevised mesh__D007862 2003-07-09
% 218.34/218.58  |- skos__historyNote mesh__D007862 Cholesterol %28%1966-1974%29%
% 218.34/218.58  |- skos__hiddenLabel mesh__D007862 Acyltransferase, Lecithin
% 218.34/218.58  |- mesh__activeMeSHYear mesh__D007862 2004
% 218.34/218.58  |- mesh__dateEstablished mesh__D007862 1978-01-01
% 218.34/218.58  |- skos__historyNote mesh__D007862 Acyltransferases %28%1966-1974%29%
% 218.34/218.58  |- skos__altLabel mesh__D007862
% 218.34/218.58       Cholesterol Ester Lysolecithin Acyltransferase
% 218.34/218.58  |- skos__altLabel mesh__D007862 Phosophatidylcholine-Sterol Acyltransferase
% 218.34/218.58  |- skos__historyNote mesh__D007862 Phosphatidylcholines %28%1966-1974%29%
% 218.34/218.58  |- skos__hiddenLabel mesh__D007862
% 218.34/218.58       O-Acyltransferase, Phosphatidylcholine-Sterol
% 218.34/218.58  |- skos__hiddenLabel mesh__D007862
% 218.34/218.58       Acyltransferase, Phosophatidylcholine-Sterol
% 218.34/218.58  |- skos__altLabel mesh__D007862 Lecithin Acyltransferase
% 218.34/218.58  |- mesh__recordAuthorizer mesh__D007862 sjn
% 218.34/218.58  |- skos__hiddenLabel mesh__D007862 Cholesterol Acyltransferase, Lecithin
% 218.34/218.58  |- mesh__publicMeSHNote mesh__D007862
% 218.34/218.58       98; see LECITHIN ACYLTRANSFERASE 1978-97; see ACYLTRANSFERASES 1975-77%A%  
% 218.34/218.58  |- skos__hiddenLabel mesh__D007862
% 218.34/218.58       Phosphatidylcholine Sterol O Acyltransferase
% 218.34/218.58  |- skos__hiddenLabel mesh__D007862 Acyltransferase, Lecithin Cholesterol
% 218.34/218.58  |- skos__broader mesh__D007862smesh__D000217
% 218.34/218.58  |- skos__scopeNote mesh__D007862
% 218.34/218.58       An enzyme secreted from the liver into the plasma of many mammalian species. It catalyzes the esterification of the hydroxyl group of lipoprotein cholesterol by the transfer of a fatty acid from the C-2 position of lecithin. In familial lecithin:cholesterol acyltransferase deficiency disease, the absence of the enzyme results in an excess of unesterified cholesterol in plasma. EC 2.3.1.43.%A%    
% 218.34/218.58  |- skos__altLabel mesh__D007862 Lecithin Cholesterol Acyltransferase
% 218.34/218.58  |- skos__prefLabel mesh__D007862
% 218.34/218.58       Phosphatidylcholine-Sterol O-Acyltransferase
% 218.34/218.58  |- mesh__recordMaintainer mesh__D007862 ssb
% 218.34/218.58  |- rdf__type mesh__D007862sskos__Concept
% 218.34/218.58  |- mesh__historyNote mesh__D007064 2000%28%1997%29%   
% 218.34/218.58  |- rdf__type mesh__D007064sskos__Concept
% 218.34/218.58  |- skos__hiddenLabel mesh__D007064 2-Dehydrogenase, L-Iditol
% 218.34/218.58  |- mesh__dateCreated mesh__D007064 1976-04-27
% 218.34/218.58  |- skos__altLabel mesh__D007064 Polyol Dehydrogenase
% 218.34/218.58  |- skos__hiddenLabel mesh__D007064 Dehydrogenase, Iditol
% 218.34/218.58  |- skos__broader mesh__D007064smesh__D013401
% 218.34/218.58  |- skos__historyNote mesh__D007064
% 218.34/218.58       Alcohol Oxidoreductases %28%1966-1976%29%
% 218.34/218.58  |- mesh__dateEstablished mesh__D007064 1991-01-01
% 218.34/218.58  |- skos__prefLabel mesh__D007064 L-Iditol 2-Dehydrogenase
% 218.34/218.58  |- mesh__dateRevised mesh__D007064 2003-07-09
% 218.34/218.58  |- skos__hiddenLabel mesh__D007064 Dehydrogenase, Sorbitol
% 218.34/218.58  |- skos__scopeNote mesh__D007064
% 218.34/218.58       An alcohol oxidoreductase which catalyzes the oxidation of L-iditol to L-sorbose in the presence of NAD. It also acts on D-glucitol to form D-fructose. It also acts on other closely related sugar alcohols to form the corresponding sugar. EC 1.1.1.14%A%    
% 218.34/218.58  |- mesh__recordOriginator mesh__D007064 RLS
% 218.34/218.58  |- mesh__recordMaintainer mesh__D007064 ssb
% 218.34/218.58  |- skos__hiddenLabel mesh__D007064 Dehydrogenase, Polyol
% 218.34/218.58  |- mesh__recordAuthorizer mesh__D007064 sjn
% 218.34/218.58  |- skos__altLabel mesh__D007064 Sorbitol Dehydrogenase
% 218.34/218.58  |- mesh__publicMeSHNote mesh__D007064
% 218.34/218.58       2000; see IDITOL DEHYDROGENASE 1991-1999, see SUGAR ALCOHOL DEHYDROGENASES 1978-90, see ALCOHOL OXIDOREDUCTASES 1977%A%  
% 218.34/218.58  |- mesh__activeMeSHYear mesh__D007064 2005
% 218.34/218.58  |- skos__hiddenLabel mesh__D007064 L Iditol 2 Dehydrogenase
% 218.34/218.58  |- mesh__activeMeSHYear mesh__D007064 2004
% 218.34/218.58  |- skos__altLabel mesh__D007064 Iditol Dehydrogenase
% 218.34/218.58  |- mesh__activeMeSHYear mesh__D007064 2006
% 218.34/218.58  |- mesh__dateCreated mesh__D045183 2003-07-09
% 218.34/218.58  |- mesh__recordMaintainer mesh__D045183 SYSTEM
% 218.34/218.58  |- skos__broader mesh__D045183smesh__D045182
% 218.34/218.58  |- mesh__publicMeSHNote mesh__D045183 2004   
% 218.34/218.58  |- skos__scopeNote mesh__D045183
% 218.34/218.58       A genus of anaerobic, gram-negative bacteria in the family Fusobacteriaceae. Some species cause BACTEREMIA and some intra-amniotic infections.%A%    
% 218.34/218.58  |- skos__prefLabel mesh__D045183 Leptotrichia
% 218.34/218.58  |- mesh__dateEstablished mesh__D045183 2004-01-01
% 218.34/218.58  |- skos__annotation mesh__D045183
% 218.34/218.58       infection: coord IM with FUSOBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 218.34/218.58  |- mesh__recordOriginator mesh__D045183 ags
% 218.43/218.58  |- skos__broader mesh__D045183smesh__D016965
% 218.43/218.58  |- mesh__historyNote mesh__D045183 2004   
% 218.43/218.58  |- mesh__recordAuthorizer mesh__D045183 sjn
% 218.43/218.58  |- rdf__type mesh__D045183sskos__Concept
% 218.43/218.58  |- mesh__dateRevised mesh__D045183 2005-06-30
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D045183 2006
% 218.43/218.58  |- skos__historyNote mesh__D045183 Bacteroidaceae %28%1971-2003%29%
% 218.43/218.58  |- skos__prefLabel mesh__D031961 Connaraceae
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D031961 2006
% 218.43/218.58  |- mesh__dateRevised mesh__D031961 2004-07-19
% 218.43/218.58  |- mesh__historyNote mesh__D031961 2003   
% 218.43/218.58  |- mesh__recordMaintainer mesh__D031961 jls
% 218.43/218.58  |- mesh__dateCreated mesh__D031961 2002-07-02
% 218.43/218.58  |- mesh__recordOriginator mesh__D031961 ssb
% 218.43/218.58  |- skos__scopeNote mesh__D031961
% 218.43/218.58       A plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida that are tropical plants. The flowers are usually bisexual and have 5 sepals and petals; 5 or 10 stamens; and 1, 4, or usually 5 separate, one-chambered, female ovule-bearing structures %28%carpels%29%.%A%    
% 218.43/218.58  |- skos__broader mesh__D031961smesh__D019685
% 218.43/218.58  |- rdf__type mesh__D031961sskos__Concept
% 218.43/218.58  |- mesh__recordAuthorizer mesh__D031961 sjn
% 218.43/218.58  |- skos__annotation mesh__D031961
% 218.43/218.58       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.43/218.58  |- mesh__publicMeSHNote mesh__D031961 2003   
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D031961 2005
% 218.43/218.58  |- mesh__dateEstablished mesh__D031961 2003-01-01
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D017492 2003
% 218.43/218.58  |- rdf__type mesh__D017492sskos__Concept
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D017492 1993
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D017492 1998
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D017492 1994
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D017492 2004
% 218.43/218.58  |- skos__hiddenLabel mesh__D017492 Seborrheic Keratoses
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D017492 1999
% 218.43/218.58  |- mesh__dateCreated mesh__D017492 1992-05-20
% 218.43/218.58  |- mesh__historyNote mesh__D017492 93   
% 218.43/218.58  |- skos__scopeNote mesh__D017492
% 218.43/218.58       Benign eccrine poromas that present as multiple oval, brown-to-black plaques, located mostly on the chest and back. The age of onset is usually in the fourth or fifth decade.%A%    
% 218.43/218.58  |- skos__prefLabel mesh__D017492 Keratosis, Seborrheic
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D017492 1995
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D017492 2005
% 218.43/218.58  |- skos__broader mesh__D017492smesh__D007642
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D017492 2000
% 218.43/218.58  |- skos__historyNote mesh__D017492 Keratosis %28%1966-1992%29%
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D017492 1996
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D017492 2006
% 218.43/218.58  |- skos__hiddenLabel mesh__D017492 Keratoses, Seborrheic
% 218.43/218.58  |- skos__altLabel mesh__D017492 Seborrheic Keratosis
% 218.43/218.58  |- mesh__dateEstablished mesh__D017492 1993-01-01
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D017492 2001
% 218.43/218.58  |- mesh__publicMeSHNote mesh__D017492 93   
% 218.43/218.58  |- skos__historyNote mesh__D017492 Dermatitis, Seborrheic %28%1966-1992%29%
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D017492 1997
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D017492 2002
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D031163 2005
% 218.43/218.58  |- mesh__publicMeSHNote mesh__D031163 2003   
% 218.43/218.58  |- mesh__dateEstablished mesh__D031163 2003-01-01
% 218.43/218.58  |- skos__broader mesh__D031163smesh__D019659
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D031163 2006
% 218.43/218.58  |- mesh__dateCreated mesh__D031163 2002-07-02
% 218.43/218.58  |- skos__prefLabel mesh__D031163 Ageratum
% 218.43/218.58  |- skos__annotation mesh__D031163
% 218.43/218.58       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D031163 2003
% 218.43/218.58  |- rdf__type mesh__D031163sskos__Concept
% 218.43/218.58  |- skos__scopeNote mesh__D031163
% 218.43/218.58       A plant genus of the family ASTERACEAE that contains PYRROLIZIDINE ALKALOIDS. Yellow vein disease of Ageratum is caused by a viral DNA complex of a begomovirus %28%GEMINIVIRIDAE%29%.%A%    
% 218.43/218.58  |- mesh__historyNote mesh__D031163 2003   
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D031163 2004
% 218.43/218.58  |- mesh__recordAuthorizer mesh__D025924 sjn
% 218.43/218.58  |- skos__annotation mesh__D025924 DF: SFC Chromatogr   
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D025924 2005
% 218.43/218.58  |- mesh__dateEstablished mesh__D025924 2002-01-01
% 218.43/218.58  |- skos__historyNote mesh__D025924 Chromatography %28%1976-2001%29%
% 218.43/218.58  |- skos__altLabel mesh__D025924
% 218.43/218.58       SFC %28%Supercritical Fluid Chromatography%29%
% 218.43/218.58  |- mesh__dateCreated mesh__D025924 2001-07-25
% 218.43/218.58  |- skos__scopeNote mesh__D025924
% 218.43/218.58       A CHROMATOGRAPHY method using supercritical fluid, usually carbon dioxide under very high pressure %28%around 73 atmospheres or 1070 psi at room temperature%29% as the mobile phase.  Other solvents are sometimes added as modifiers.  This is used both for analytical %28%SFC%29% and extraction %28%SFE%29% purposes.%A%    
% 218.43/218.58  |- skos__hiddenLabel mesh__D025924 Fluid Chromatography, Supercritical
% 218.43/218.58  |- mesh__recordOriginator mesh__D025924 ssb
% 218.43/218.58  |- skos__prefLabel mesh__D025924 Chromatography, Supercritical Fluid
% 218.43/218.58  |- skos__altLabel mesh__D025924 SFE %28%Supercritical Fluid Extraction%29%
% 218.43/218.58  |- rdf__type mesh__D025924sskos__Concept
% 218.43/218.58  |- mesh__recordMaintainer mesh__D025924 jls
% 218.43/218.58  |- mesh__publicMeSHNote mesh__D025924 2002   
% 218.43/218.58  |- skos__broader mesh__D025924smesh__D002845
% 218.43/218.58  |- skos__altLabel mesh__D025924 Supercritical Fluid Chromatography
% 218.43/218.58  |- skos__hiddenLabel mesh__D025924 Fluid Extraction, Supercritical
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D025924 2006
% 218.43/218.58  |- mesh__dateRevised mesh__D025924 2004-07-19
% 218.43/218.58  |- mesh__historyNote mesh__D025924 2002   
% 218.43/218.58  |- skos__altLabel mesh__D025924 Extraction, Supercritical Fluid
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D003472 2006
% 218.43/218.58  |- skos__annotation mesh__D003472
% 218.43/218.58       /analogs: consider also CURARE-LIKE AGENTS  see NEUROMUSCULAR NONDEPOLARIZING AGENTS%A%  
% 218.43/218.58  |- skos__prefLabel mesh__D003472 Curare
% 218.43/218.58  |- mesh__recordMaintainer mesh__D003472 ssb
% 218.43/218.58  |- mesh__dateRevised mesh__D003472 2005-06-30
% 218.43/218.58  |- skos__scopeNote mesh__D003472
% 218.43/218.58       Plant extracts from several species, including Strychnos toxifera, S. castelnaei, S. crevauxii, and Chondodendron tomentosum, that produce paralysis of skeletal muscle and are used adjunctively with general anesthesia.  These extracts are toxic and must be used with the administration of artificial respiration.%A%    
% 218.43/218.58  |- mesh__recordOriginator mesh__D003472 NLM
% 218.43/218.58  |- mesh__publicMeSHNote mesh__D003472
% 218.43/218.58       CURARIFORM ANTAGONISTS was heading 1963-69   
% 218.43/218.58  |- mesh__dateCreated mesh__D003472 1999-01-01
% 218.43/218.58  |- mesh__historyNote mesh__D003472
% 218.43/218.58       CURARIFORM ANTAGONISTS was heading 1963-69   
% 218.43/218.58  |- mesh__onlineNote mesh__D003472
% 218.43/218.58       use CURARE to search CURARIFORM ANTAGONISTS 1966-69   
% 218.43/218.58  |- mesh__recordAuthorizer mesh__D003472 sjn
% 218.43/218.58  |- skos__broader mesh__D003472smesh__D010936
% 218.43/218.58  |- rdf__type mesh__D003472sskos__Concept
% 218.43/218.58  |- skos__broader mesh__D003472smesh__D026121
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011904 2004
% 218.43/218.58  |- skos__hiddenLabel mesh__D011904 Rare Book
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011904 2001
% 218.43/218.58  |- mesh__recordOriginator mesh__D011904 NLM
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011904 1998
% 218.43/218.58  |- mesh__recordAuthorizer mesh__D011904 PLS
% 218.43/218.58  |- skos__prefLabel mesh__D011904 Rare Books
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011904 2003
% 218.43/218.58  |- mesh__dateRevised mesh__D011904 1992-05-18
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011904 1995
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011904 2000
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011904 2006
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011904 1994
% 218.43/218.58  |- skos__hiddenLabel mesh__D011904 Books, Rare
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011904 2005
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011904 1997
% 218.43/218.58  |- mesh__recordMaintainer mesh__D011904 TAP
% 218.43/218.58  |- skos__broader mesh__D011904smesh__D001877
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011904 2002
% 218.43/218.58  |- mesh__dateCreated mesh__D011904 1999-01-01
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011904 1996
% 218.43/218.58  |- rdf__type mesh__D011904sskos__Concept
% 218.43/218.58  |- skos__hiddenLabel mesh__D011904 Book, Rare
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011904 1999
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011904 1993
% 218.43/218.58  |- skos__broader mesh__D011106smesh__D013729
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011106 1994
% 218.43/218.58  |- mesh__historyNote mesh__D011106 78   
% 218.43/218.58  |- skos__hiddenLabel mesh__D011106 Phosphates, Isoprenoid
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011106 2005
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011106 1993
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011106 1998
% 218.43/218.58  |- skos__broader mesh__D011106smesh__D009943
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011106 2002
% 218.43/218.58  |- mesh__dateCreated mesh__D011106 1977-04-15
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011106 2004
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011106 1997
% 218.43/218.58  |- mesh__publicMeSHNote mesh__D011106 78   
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011106 2001
% 218.43/218.58  |- skos__prefLabel mesh__D011106 Polyisoprenyl Phosphates
% 218.43/218.58  |- mesh__recordMaintainer mesh__D011106 TAP
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011106 2003
% 218.43/218.58  |- mesh__recordAuthorizer mesh__D011106 PLS
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011106 1996
% 218.43/218.58  |- mesh__dateEstablished mesh__D011106 1978-01-01
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011106 2000
% 218.43/218.58  |- skos__hiddenLabel mesh__D011106 Phosphates, Terpene
% 218.43/218.58  |- skos__scopeNote mesh__D011106
% 218.43/218.58       Phosphoric or pyrophosphoric acid esters of polyisoprenoids.%A%    
% 218.43/218.58  |- skos__historyNote mesh__D011106
% 218.43/218.58       Organophosphorus Compounds %28%1971-1977%29%
% 218.43/218.58  |- skos__hiddenLabel mesh__D011106 Phosphates, Polyisoprenyl
% 218.43/218.58  |- mesh__dateRevised mesh__D011106 1992-05-20
% 218.43/218.58  |- mesh__recordOriginator mesh__D011106 RLS
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011106 1995
% 218.43/218.58  |- rdf__type mesh__D011106sskos__Concept
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011106 2006
% 218.43/218.58  |- skos__historyNote mesh__D011106 Terpenes %28%1966-1977%29%
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D011106 1999
% 218.43/218.58  |- skos__broader mesh__D007863smesh__D007009
% 218.43/218.58  |- skos__scopeNote mesh__D007863
% 218.43/218.58       A disease characterized by deficiency or low levels of plasma lecithin cholesterol acyl transferase. Clinical manifestations include corneal opacity, anemia, and proteinuria.%A%    
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D007863 2006
% 218.43/218.58  |- skos__annotation mesh__D007863
% 218.43/218.58       a hypolipoproteinemia; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 218.43/218.58  |- mesh__dateCreated mesh__D007863 1977-04-29
% 218.43/218.58  |- skos__historyNote mesh__D007863 Lipoproteins %28%1966-1977%29%
% 218.43/218.58  |- mesh__recordOriginator mesh__D007863 VDK
% 218.43/218.58  |- skos__prefLabel mesh__D007863 Lecithin Acyltransferase Deficiency
% 218.43/218.58  |- skos__historyNote mesh__D007863
% 218.43/218.58       Lipid Metabolism, Inborn Errors %28%1966-1977%29%
% 218.43/218.58  |- skos__historyNote mesh__D007863 Acyltransferases %28%1966-1977%29%
% 218.43/218.58  |- skos__hiddenLabel mesh__D007863 Deficiencies, Lecithin Acyltransferase
% 218.43/218.58  |- skos__hiddenLabel mesh__D007863 Acyltransferase Deficiency, Lecithin
% 218.43/218.58  |- skos__hiddenLabel mesh__D007863 Lecithin Acyltransferase Deficiencies
% 218.43/218.58  |- skos__historyNote mesh__D007863
% 218.43/218.58       Lecithin Acyltransferase/DF %28%1975-1977%29%
% 218.43/218.58  |- mesh__dateEstablished mesh__D007863 1991-01-01
% 218.43/218.58  |- mesh__dateRevised mesh__D007863 2005-06-30
% 218.43/218.58  |- rdf__type mesh__D007863sskos__Concept
% 218.43/218.58  |- mesh__historyNote mesh__D007863
% 218.43/218.58       91%28%78%29%; was see under HYPOLIPOPROTEINEMIA 1980-90; was see under HYPOLIPOPROTEINEMIAS 1978-79%A%  
% 218.43/218.58  |- mesh__recordMaintainer mesh__D007863 lkt
% 218.43/218.58  |- skos__hiddenLabel mesh__D007863 Acyltransferase Deficiencies, Lecithin
% 218.43/218.58  |- mesh__recordAuthorizer mesh__D007863 sjn
% 218.43/218.58  |- mesh__publicMeSHNote mesh__D007863
% 218.43/218.58       91; was see under HYPOLIPOPROTEINEMIA 1980-90; was see under HYPOLIPOPROTEINEMIAS 1978-79%A%  
% 218.43/218.58  |- skos__altLabel mesh__D007863 Deficiency, Lecithin Acyltransferase
% 218.43/218.58  |- skos__prefLabel mesh__D007065 Idoxuridine
% 218.43/218.58  |- skos__hiddenLabel mesh__D007065 Idoxuridine, 131I Labeled
% 218.43/218.58  |- mesh__dateCreated mesh__D007065 1999-01-01
% 218.43/218.58  |- skos__hiddenLabel mesh__D007065 Liquifilm, Herplex
% 218.43/218.58  |- mesh__dateRevised mesh__D007065 2001-07-25
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D007065 2002
% 218.43/218.58  |- mesh__recordOriginator mesh__D007065 NLM
% 218.43/218.58  |- skos__hiddenLabel mesh__D007065 Idoxuridine, 125I Labeled
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D007065 2003
% 218.43/218.58  |- skos__historyNote mesh__D007065 Antimetabolites %28%1966-1991%29%
% 218.43/218.58  |- skos__hiddenLabel mesh__D007065 5 Iodo 2%27% deoxyuridine
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D007065 2004
% 218.43/218.58  |- skos__hiddenLabel mesh__D007065 NSC39661
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D007065 2005
% 218.43/218.58  |- skos__hiddenLabel mesh__D007065 Idoxuridine, 123I Labeled
% 218.43/218.58  |- skos__altLabel mesh__D007065 IUdR
% 218.43/218.58  |- skos__hiddenLabel mesh__D007065 123I-Labeled Idoxuridine
% 218.43/218.58  |- skos__hiddenLabel mesh__D007065 125I-Labeled Idoxuridine
% 218.43/218.58  |- skos__broader mesh__D007065smesh__D003857
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D007065 2006
% 218.43/218.58  |- skos__hiddenLabel mesh__D007065 5 Iododeoxyuridine
% 218.43/218.58  |- skos__hiddenLabel mesh__D007065 Oftan IDU
% 218.43/218.58  |- skos__hiddenLabel mesh__D007065 3H-Labeled Idoxuridine
% 218.43/218.58  |- skos__scopeNote mesh__D007065
% 218.43/218.58       An analog of DEOXYURIDINE that inhibits viral DNA synthesis. The drug is used as an antiviral agent.%A%    
% 218.43/218.58  |- skos__historyNote mesh__D007065 Deoxyuridine %28%1966-1991%29%
% 218.43/218.58  |- mesh__recordAuthorizer mesh__D007065 sjn
% 218.43/218.58  |- skos__historyNote mesh__D007065 Antiviral Agents %28%1966-1991%29%
% 218.43/218.58  |- skos__hiddenLabel mesh__D007065 131I-Labeled Idoxuridine
% 218.43/218.58  |- skos__altLabel mesh__D007065 5-Iodo-2%27%-deoxyuridine
% 218.43/218.58  |- mesh__recordMaintainer mesh__D007065 jmp
% 218.43/218.58  |- skos__hiddenLabel mesh__D007065 NSC 39661
% 218.43/218.58  |- skos__hiddenLabel mesh__D007065 OftanIDU
% 218.43/218.58  |- skos__altLabel mesh__D007065 5-Iododeoxyuridine
% 218.43/218.58  |- rdf__type mesh__D007065sskos__Concept
% 218.43/218.58  |- skos__altLabel mesh__D007065 Iododeoxyuridine
% 218.43/218.58  |- skos__hiddenLabel mesh__D007065 Idoxuridine, 3H Labeled
% 218.43/218.58  |- mesh__publicMeSHNote mesh__D045184 2004   
% 218.43/218.58  |- mesh__dateRevised mesh__D045184 2005-06-30
% 218.43/218.58  |- skos__broader mesh__D045184smesh__D016965
% 218.43/218.58  |- skos__prefLabel mesh__D045184 Propionigenium
% 218.43/218.58  |- mesh__dateEstablished mesh__D045184 2004-01-01
% 218.43/218.58  |- skos__broader mesh__D045184smesh__D045182
% 218.43/218.58  |- skos__scopeNote mesh__D045184
% 218.43/218.58       A genus of strictly anaerobic, nonsporeforming gram-negative bacteria in the family Fusobacteriaceae. Species in this genus are popularly used in biochemical research.%A%    
% 218.43/218.58  |- mesh__recordOriginator mesh__D045184 ags
% 218.43/218.58  |- skos__annotation mesh__D045184
% 218.43/218.58       do not confuse with PROPIONIBACTERIUM, a gram-positive bacterium; infection: coord IM with FUSOBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D045184 2006
% 218.43/218.58  |- rdf__type mesh__D045184sskos__Concept
% 218.43/218.58  |- mesh__historyNote mesh__D045184 2004   
% 218.43/218.58  |- mesh__dateCreated mesh__D045184 2003-07-09
% 218.43/218.58  |- mesh__recordMaintainer mesh__D045184 SYSTEM
% 218.43/218.58  |- mesh__recordAuthorizer mesh__D045184 sjn
% 218.43/218.58  |- mesh__dateEstablished mesh__D031962 2003-01-01
% 218.43/218.58  |- skos__prefLabel mesh__D031962 Kalanchoe
% 218.43/218.58  |- mesh__dateCreated mesh__D031962 2002-07-03
% 218.43/218.58  |- mesh__historyNote mesh__D031962 2003   
% 218.43/218.58  |- rdf__type mesh__D031962sskos__Concept
% 218.43/218.58  |- skos__annotation mesh__D031962
% 218.43/218.58       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D031962 2003
% 218.43/218.58  |- mesh__publicMeSHNote mesh__D031962 2003   
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D031962 2005
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D031962 2004
% 218.43/218.58  |- skos__broader mesh__D031962smesh__D029627
% 218.43/218.58  |- skos__scopeNote mesh__D031962
% 218.43/218.58       A plant genus of the family CRASSULACEAE. Members contain bryophyllins %28%also called bryotoxins%29% which are bufadienolides %28%BUFANOLIDES%29% that have insecticidal activity.%A%    
% 218.43/218.58  |- mesh__activeMeSHYear mesh__D031962 2006
% 218.44/218.58  |- skos__hiddenLabel mesh__D017493 Antigen, CD45
% 218.44/218.58  |- skos__altLabel mesh__D017493 T200 Antigens
% 218.44/218.58  |- skos__hiddenLabel mesh__D017493 Antigens, B220
% 218.44/218.58  |- skos__hiddenLabel mesh__D017493 Antigens, L-CA
% 218.44/218.58  |- skos__scopeNote mesh__D017493
% 218.44/218.58       High-molecular weight glycoproteins uniquely expressed on the surface of all leukocytes and their hemopoietic progenitors. The CD45 family consists of multiple members that are all products of a single gene. CD45 expression is necessary for signaling through the T-cell receptor.%A%    
% 218.44/218.58  |- skos__historyNote mesh__D017493
% 218.44/218.58       Antigens, Differentiation %28%1984-1991%29%
% 218.44/218.58  |- skos__broader mesh__D017493smesh__D015703
% 218.44/218.58  |- skos__hiddenLabel mesh__D017493 Antigens, CD45RA
% 218.44/218.58  |- skos__prefLabel mesh__D017493 Antigens, CD45
% 218.44/218.58  |- skos__hiddenLabel mesh__D017493 Antigen, Leukocyte Common
% 218.44/218.58  |- skos__hiddenLabel mesh__D017493 Antigen, B220
% 218.44/218.58  |- skos__altLabel mesh__D017493 CD45 Antigen
% 218.44/218.58  |- skos__altLabel mesh__D017493 Leukocyte Common Antigens
% 218.44/218.58  |- skos__annotation mesh__D017493
% 218.44/218.58       human %26% mouse differentiation antigens   
% 218.44/218.58  |- skos__hiddenLabel mesh__D017493 Antigens, CD45RO
% 218.44/218.58  |- skos__altLabel mesh__D017493 B220 Antigen
% 218.44/218.58  |- skos__hiddenLabel mesh__D017493 Antigens, 2H4
% 218.44/218.58  |- skos__altLabel mesh__D017493 RT7 Antigen
% 218.44/218.58  |- skos__broader mesh__D017493smesh__D017027
% 218.44/218.58  |- skos__altLabel mesh__D017493 2H4 Antigens
% 218.44/218.58  |- skos__altLabel mesh__D017493 CD45 Antigens
% 218.44/218.58  |- skos__hiddenLabel mesh__D017493 Antigens, CD45R0
% 218.44/218.58  |- skos__hiddenLabel mesh__D017493 L CA Antigens
% 218.44/218.58  |- mesh__activeMeSHYear mesh__D017493 2006
% 218.44/218.58  |- skos__historyNote mesh__D017493 Antigens, CD %28%1989-1992%29%
% 218.44/218.58  |- rdf__type mesh__D017493sskos__Concept
% 218.44/218.58  |- mesh__recordOriginator mesh__D017493 AGS
% 218.44/218.58  |- mesh__onlineNote mesh__D017493
% 218.44/218.58       use ANTIGENS, CD45 %28%NM%29% to search B220 ANTIGEN 1990-95 %26% CD45 ANTIGEN 1984-92; use HISTOCOMPATIBILITY ANTIGENS RT %28%NM%29% to search RT7 1983-92%A%  
% 218.44/218.58  |- skos__hiddenLabel mesh__D017493 Antigens, Leukocyte Common
% 218.44/218.58  |- mesh__recordMaintainer mesh__D017493 ssb
% 218.44/218.58  |- skos__hiddenLabel mesh__D017493 Antigens, CD45R
% 218.44/218.58  |- mesh__dateCreated mesh__D017493 1992-05-13
% 218.44/218.58  |- skos__hiddenLabel mesh__D017493 Antigens, RT7
% 218.44/218.58  |- skos__altLabel mesh__D017493 Leukocyte Common Antigen
% 218.44/218.58  |- skos__historyNote mesh__D017493
% 218.44/218.58       Histocompatibility Antigens %28%1984-1992%29%
% 218.44/218.58  |- mesh__dateEstablished mesh__D017493 1993-01-01
% 218.44/218.58  |- skos__altLabel mesh__D017493 L-CA Antigens
% 218.44/218.58  |- skos__hiddenLabel mesh__D017493 Antigens, UCHL1
% 218.44/218.58  |- mesh__recordAuthorizer mesh__D017493 sjn
% 218.44/218.58  |- mesh__historyNote mesh__D017493
% 218.44/218.58       93; was CD45 ANTIGEN %28%NM%29% 1984-92; RT7 ANTIGEN was RT7 %28%SY%29% to HISTOCOMPATIBILITY ANTIGENS RT %28%NM%29%; B220 ANTIGEN was NM 1990-95%A%  
% 218.44/218.58  |- skos__hiddenLabel mesh__D017493 Antigens, T200
% 218.44/218.58  |- mesh__dateRevised mesh__D017493 2005-06-30
% 218.44/218.58  |- skos__hiddenLabel mesh__D017493 Antigens, CD45RB
% 218.44/218.58  |- mesh__publicMeSHNote mesh__D017493
% 218.44/218.58       93; CD45 ANTIGEN was indexed under ANTIGENS, CD 1989-92 and HISTOCOMPATIBILITY ANTIGENS %26% ANTIGENS, DIFFERENTIATION 1984-92; RT7 ANTIGEN was indexed under HISTOCOMPATIBILITY ANTIGENS 1983-92; B220 ANTIGEN was indexed under ANTIGENS, SURFACE 1990-95%A%  
% 218.44/218.59  |- skos__altLabel mesh__D017493 CD45R0 Antigens
% 218.44/218.59  |- skos__hiddenLabel mesh__D017493 Antigen, RT7
% 218.44/218.59  |- skos__annotation mesh__D031164
% 218.44/218.59       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D031164 2003
% 218.44/218.59  |- skos__broader mesh__D031164smesh__D019659
% 218.44/218.59  |- mesh__publicMeSHNote mesh__D031164 2003   
% 218.44/218.59  |- mesh__dateCreated mesh__D031164 2002-07-02
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D031164 2006
% 218.44/218.59  |- mesh__dateEstablished mesh__D031164 2003-01-01
% 218.44/218.59  |- skos__scopeNote mesh__D031164
% 218.44/218.59       A plant genus of the family ASTERACEAE.  The POLLEN is one cause of HAYFEVER.%A%    
% 218.44/218.59  |- mesh__historyNote mesh__D031164 2003   
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D031164 2005
% 218.44/218.59  |- skos__altLabel mesh__D031164 Ragweed
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D031164 2004
% 218.44/218.59  |- skos__prefLabel mesh__D031164 Ambrosia
% 218.44/218.59  |- rdf__type mesh__D031164sskos__Concept
% 218.44/218.59  |- skos__broader mesh__D003473smesh__D009466
% 218.44/218.59  |- skos__prefLabel mesh__D003473 Neuromuscular Nondepolarizing Agents
% 218.44/218.59  |- skos__scopeNote mesh__D003473
% 218.44/218.59       Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants.%A%    
% 218.44/218.59  |- skos__hiddenLabel mesh__D003473 Nondepolarizing Agents, Neuromuscular
% 218.44/218.59  |- skos__hiddenLabel mesh__D003473 Curare Like Agents
% 218.44/218.59  |- skos__altLabel mesh__D003473 Muscle Relaxants, Non-Depolarizing
% 218.44/218.59  |- skos__historyNote mesh__D003473 Muscles %28%1966-1969%29%
% 218.44/218.59  |- mesh__dateEstablished mesh__D003473 1970-01-01
% 218.44/218.59  |- mesh__dateCreated mesh__D003473 1999-01-01
% 218.44/218.59  |- skos__hiddenLabel mesh__D003473 Agents, Neuromuscular Nondepolarizing
% 218.44/218.59  |- skos__hiddenLabel mesh__D003473 Muscle Relaxants, Non Depolarizing
% 218.44/218.59  |- rdf__type mesh__D003473sskos__Concept
% 218.44/218.59  |- skos__hiddenLabel mesh__D003473 Blockers, Nondepolarizing
% 218.44/218.59  |- mesh__recordMaintainer mesh__D003473 ssb
% 218.44/218.59  |- mesh__dateRevised mesh__D003473 2005-06-30
% 218.44/218.59  |- skos__altLabel mesh__D003473 Nondepolarizing Blockers
% 218.44/218.59  |- mesh__historyNote mesh__D003473
% 218.44/218.59       93; was CURARE-LIKE AGENTS 1970-92; MUSCLE RELAXANTS, POLARIZING was see NEUROMUSCULAR NONDEPOLARIZING AGENTS 1989-94; NEUROMUSCULAR NONDEPOLARIZING AGENTS %26% PACHYCURARES were see CURARE-LIKE AGENTS 1975-92; CURARIFORM DRUGS was see under MUSCLE RELAXANTS 1963-69; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS %26% MUSCLE RELAXANTS, CENTRAL %26% NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69; CURARIFORM ANTAGONISTS was heading 1963-69%A%  
% 218.44/218.59  |- skos__hiddenLabel mesh__D003473 Drugs, Curariform
% 218.44/218.59  |- mesh__publicMeSHNote mesh__D003473
% 218.44/218.59       93; was CURARE-LIKE AGENTS 1970-92; MUSCLE RELAXANTS, POLARIZING was see NEUROMUSCULAR NONDEPOLARIZING AGENTS 1989-94; NEUROMUSCULAR NONDEPOLARIZING AGENTS %26% PACHYCURARES were see CURARE-LIKE AGENTS 1970-92; CURARIFORM DRUGS was see MUSCLE RELAXANTS 1963-69; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS %26% MUSCLE RELAXANTS, CENTRAL %26% NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69; CURARIFORM ANTAGONISTS was heading 1963-69%A%  
% 218.44/218.59  |- mesh__recordOriginator mesh__D003473 NLM
% 218.44/218.59  |- skos__hiddenLabel mesh__D003473 Non-Depolarizing Muscle Relaxants
% 218.44/218.59  |- mesh__onlineNote mesh__D003473
% 218.44/218.59       use NEUROMUSCULAR NONDEPOLARIZING AGENTS to search MUSCLE RELAXANTS, POLARIZING 1989-94 %26% CURARE-LIKE AGENTS %26% PACHYCURARES 1970-92; search MUSCLE RELAXANTS under NEUROMUSCULAR NONDEPOLARIZING AGENTS, MUSCLE RELAXANTS, CENTRAL %26% NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74 %26% MUSCLES 1966-69; search CURARIFORM ANTAGONISTS under CURARE 1966-69%A%  
% 218.44/218.59  |- skos__altLabel mesh__D003473 Curare-Like Agents
% 218.44/218.59  |- skos__related mesh__D003473smesh__D018733
% 218.44/218.59  |- skos__annotation mesh__D003473
% 218.44/218.59       GEN or unspecified; prefer specifics; note X ref CURARE-LIKE AGENTS: consider also CURARE; DF: note short X ref%A%  
% 218.44/218.59  |- skos__altLabel mesh__D003473 Curariform Drugs
% 218.44/218.59  |- mesh__recordAuthorizer mesh__D003473 sjn
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D003473 2006
% 218.44/218.59  |- skos__altLabel mesh__D003473 Neuromuscular Blocking Agents, Competitive
% 218.44/218.59  |- skos__hiddenLabel mesh__D003473 Agents, Curare-Like
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 Genes, Ha-ras
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 c H ras Genes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 v Ki ras Oncogenes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 ras Gene
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 c Ki ras Proto Oncogenes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 Ha ras Oncogenes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 N-ras Gene
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 v-H-ras Gene
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 Genes, N-ras
% 218.44/218.59  |- mesh__recordMaintainer mesh__D011905 nns
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 Gene, Ki-ras
% 218.44/218.59  |- skos__altLabel mesh__D011905 ras Genes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 c K ras Genes
% 218.44/218.59  |- mesh__historyNote mesh__D011905
% 218.44/218.59       91; was RAS GENES 1988-90; was RAS GENES see ONCOGENES 1985-87%A%  
% 218.44/218.59  |- skos__related mesh__D011905smesh__D018631
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 v-K-ras Oncogene
% 218.44/218.59  |- mesh__onlineNote mesh__D011905
% 218.44/218.59       use GENES, RAS to search RAS GENES 1988-90 %26% use ONCOGENES 1985-87%A%  
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 Ha-ras Gene
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 c-Ki-ras Proto-Oncogene
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 v-Ha-ras Oncogene
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 v Ha ras Genes
% 218.44/218.59  |- mesh__recordAuthorizer mesh__D011905 sjn
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 c N ras Genes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 K ras Genes
% 218.44/218.59  |- skos__scopeNote mesh__D011905
% 218.44/218.59       Family of retrovirus-associated DNA sequences %28%ras%29% originally isolated from Harvey %28%H-ras, Ha-ras, rasH%29% and Kirsten %28%K-ras, Ki-ras, rasK%29% murine sarcoma viruses. Ras genes are widely conserved among animal species and sequences corresponding to both H-ras and K-ras genes have been detected in human, avian, murine, and non-vertebrate genomes. The closely related N-ras gene has been detected in human neuroblastoma and sarcoma cell lines. All genes of the family have a similar exon-intron structure and each encodes a p21 protein.%A%    
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 v-Ki-ras Gene
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 c-Ki-ras Gene
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 N ras Genes
% 218.44/218.59  |- skos__prefLabel mesh__D011905 Genes, ras
% 218.44/218.59  |- skos__broader mesh__D011905smesh__D011519
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 H ras Genes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 v-Ki-ras Oncogene
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 c-Ha-ras Proto-Oncogene
% 218.44/218.59  |- skos__annotation mesh__D011905
% 218.44/218.59       ras stands for %22%Retrovirus Associated Sequences%22%   
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 K-ras Gene
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 H-ras Gene
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 Genes, v-Ha-ras
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 v-H-ras Oncogene
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 ras Oncogenes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 c-H-ras Proto-Oncogene
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 c K ras Proto Oncogenes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 N ras Oncogenes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 c-N-ras Proto-Oncogene
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 c-H-ras Gene
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 c H ras Proto Oncogenes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 Ha-ras Oncogene
% 218.44/218.59  |- mesh__recordOriginator mesh__D011905 SCD
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 Gene, Ha-ras
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 Ki ras Genes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 c Ha ras Genes
% 218.44/218.59  |- rdf__type mesh__D011905sskos__Concept
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 Ki-ras Gene
% 218.44/218.59  |- skos__altLabel mesh__D011905 N-ras Oncogenes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 c-Ha-ras Gene
% 218.44/218.59  |- mesh__dateRevised mesh__D011905 2005-06-30
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 v K ras Oncogenes
% 218.44/218.59  |- skos__related mesh__D011905smesh__D016283
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 v-K-ras Gene
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 c N ras Proto Oncogenes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 v-Ha-ras Gene
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D011905 2006
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 c-K-ras Gene
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 N-ras Oncogene
% 218.44/218.59  |- mesh__dateEstablished mesh__D011905 1988-01-01
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 Genes, Ki-ras
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 Ki-ras Oncogene
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 K ras Oncogenes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 v K ras Genes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 Gene, v-Ki-ras
% 218.44/218.59  |- skos__historyNote mesh__D011905 Oncogenes %28%1983-1987%29%
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 K-ras Oncogene
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 Ha ras Genes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 c Ki ras Genes
% 218.44/218.59  |- mesh__dateCreated mesh__D011905 1987-05-09
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 H ras Oncogenes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 c-K-ras Proto-Oncogene
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 v H ras Oncogenes
% 218.44/218.59  |- mesh__publicMeSHNote mesh__D011905
% 218.44/218.59       91; was RAS GENES 1988-90; was RAS GENES see ONCOGENES 1985-87%A%  
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 Ki ras Oncogenes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 v Ha ras Oncogenes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 c Ha ras Proto Oncogenes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 Genes, v-Ki-ras
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 Gene, v-Ha-ras
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 v Ki ras Genes
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 H-ras Oncogene
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 v H ras Genes
% 218.44/218.59  |- skos__related mesh__D011905smesh__D015689
% 218.44/218.59  |- skos__hiddenLabel mesh__D011905 c-N-ras Gene
% 218.44/218.59  |- skos__historyNote mesh__D011905 Genes, Viral %28%1978-1987%29%
% 218.44/218.59  |- mesh__recordOriginator mesh__D011107 NLM
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D011107 2003
% 218.44/218.59  |- skos__historyNote mesh__D011107 Peptides %28%1973-1974%29%
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D011107 2002
% 218.44/218.59  |- mesh__publicMeSHNote mesh__D011107 86; was see under PEPTIDES 1975-85   
% 218.44/218.59  |- mesh__historyNote mesh__D011107
% 218.44/218.59       86%28%75%29%; was see under PEPTIDES 1975-85   
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D011107 2004
% 218.44/218.59  |- skos__historyNote mesh__D011107 Lysine %28%1969-1974%29%
% 218.44/218.59  |- skos__prefLabel mesh__D011107 Polylysine
% 218.44/218.59  |- skos__hiddenLabel mesh__D011107 Epsilon Polylysine
% 218.44/218.59  |- mesh__dateEstablished mesh__D011107 1986-01-01
% 218.44/218.59  |- mesh__recordMaintainer mesh__D011107 nns
% 218.44/218.59  |- skos__broader mesh__D011107smesh__D008239
% 218.44/218.59  |- mesh__recordAuthorizer mesh__D011107 sjn
% 218.44/218.59  |- mesh__dateCreated mesh__D011107 1974-11-19
% 218.44/218.59  |- skos__broader mesh__D011107smesh__D010455
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D011107 2005
% 218.44/218.59  |- skos__scopeNote mesh__D011107
% 218.44/218.59       A peptide which is a homopolymer of lysine.     
% 218.44/218.59  |- mesh__dateRevised mesh__D011107 2001-07-25
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D011107 2006
% 218.44/218.59  |- rdf__type mesh__D011107sskos__Concept
% 218.44/218.59  |- skos__hiddenLabel mesh__D007066 Corrective Factor, Hunter
% 218.44/218.59  |- skos__historyNote mesh__D007066 Iduronic Acid %28%1975%29%
% 218.44/218.59  |- skos__hiddenLabel mesh__D007066 Sulfatase, Iduronate
% 218.44/218.59  |- skos__altLabel mesh__D007066 Sulfoiduronate Sulfatase
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D007066 2005
% 218.44/218.59  |- skos__broader mesh__D007066smesh__D013429
% 218.44/218.59  |- skos__hiddenLabel mesh__D007066 Sulfatase, Iduronate Sulfate
% 218.44/218.59  |- mesh__recordAuthorizer mesh__D007066 sjn
% 218.44/218.59  |- rdf__type mesh__D007066sskos__Concept
% 218.44/218.59  |- mesh__dateRevised mesh__D007066 2003-07-09
% 218.44/218.59  |- mesh__historyNote mesh__D007066
% 218.44/218.59       91%28%76%29%; was see under SULFATASES 1976-90   
% 218.44/218.59  |- mesh__dateCreated mesh__D007066 1975-07-25
% 218.44/218.59  |- skos__hiddenLabel mesh__D007066 Factor, Hunter Corrective
% 218.44/218.59  |- skos__scopeNote mesh__D007066
% 218.44/218.59       An enzyme that specifically cleaves the ester sulfate of iduronic acid. Its deficiency has been demonstrated in Hunter%27%s syndrome, which is characterized by an excess of dermatan sulfate and heparan sulfate. EC 3.1.6.13.%A%    
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D007066 2004
% 218.44/218.59  |- skos__historyNote mesh__D007066 Sulfatases %28%1972-1975%29%
% 218.44/218.59  |- skos__historyNote mesh__D007066 Uronic Acids %28%1972-1975%29%
% 218.44/218.59  |- skos__prefLabel mesh__D007066 Iduronate Sulfatase
% 218.44/218.59  |- mesh__recordOriginator mesh__D007066 RLS
% 218.44/218.59  |- mesh__dateEstablished mesh__D007066 1991-01-01
% 218.44/218.59  |- skos__altLabel mesh__D007066 Hunter Corrective Factor
% 218.44/218.59  |- skos__hiddenLabel mesh__D007066 Sulfate Sulfatase, Iduronate
% 218.44/218.59  |- mesh__recordMaintainer mesh__D007066 ssb
% 218.44/218.59  |- skos__altLabel mesh__D007066 Iduronatesulfate Sulfohydrolase
% 218.44/218.59  |- skos__altLabel mesh__D007066 Iduronate Sulfate Sulfatase
% 218.44/218.59  |- mesh__publicMeSHNote mesh__D007066
% 218.44/218.59       91; was see under SULFATASES 1976-90   
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D007066 2006
% 218.44/218.59  |- skos__hiddenLabel mesh__D007066 Sulfohydrolase, Iduronatesulfate
% 218.44/218.59  |- skos__hiddenLabel mesh__D007066 Sulfatase, Sulfoiduronate
% 218.44/218.59  |- skos__scopeNote mesh__D031963
% 218.44/218.59       A plant genus of the family CRASSULACEAE. Some species in this genus are called stonecrop which is also a common name for RHODIOLA.%A%    
% 218.44/218.59  |- skos__annotation mesh__D031963
% 218.44/218.59       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.44/218.59  |- skos__altLabel mesh__D031963 Cockscomb, Green
% 218.44/218.59  |- skos__broader mesh__D031963smesh__D029627
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D031963 2003
% 218.44/218.59  |- mesh__publicMeSHNote mesh__D031963 2003   
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D031963 2004
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D031963 2005
% 218.44/218.59  |- mesh__dateEstablished mesh__D031963 2003-01-01
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D031963 2006
% 218.44/218.59  |- mesh__dateCreated mesh__D031963 2002-07-03
% 218.44/218.59  |- mesh__historyNote mesh__D031963 2003   
% 218.44/218.59  |- skos__prefLabel mesh__D031963 Sedum
% 218.44/218.59  |- rdf__type mesh__D031963sskos__Concept
% 218.44/218.59  |- skos__hiddenLabel mesh__D017494 Pumps, Proton
% 218.44/218.59  |- mesh__recordAuthorizer mesh__D017494 sjn
% 218.44/218.59  |- rdf__type mesh__D017494sskos__Concept
% 218.44/218.59  |- mesh__publicMeSHNote mesh__D017494 2002; see PROTON PUMP 1993-2001   
% 218.44/218.59  |- skos__hiddenLabel mesh__D017494 Pump, Proton
% 218.44/218.59  |- mesh__dateEstablished mesh__D017494 1993-01-01
% 218.44/218.59  |- mesh__historyNote mesh__D017494 2002%28%1993%29%   
% 218.44/218.59  |- skos__altLabel mesh__D017494 Proton Pump
% 218.44/218.59  |- mesh__recordMaintainer mesh__D017494 ssb
% 218.44/218.59  |- skos__scopeNote mesh__D017494
% 218.44/218.59       Integral membrane proteins that transport protons across a membrane. This transport can be linked to the hydrolysis of ADENOSINE TRIPHOSPHATE. What is referred to as proton pump inhibitors frequently is about POTASSIUM HYDROGEN ATPASE.%A%    
% 218.44/218.59  |- mesh__dateRevised mesh__D017494 2005-06-30
% 218.44/218.59  |- mesh__recordOriginator mesh__D017494 TPW
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D017494 2006
% 218.44/218.59  |- skos__prefLabel mesh__D017494 Proton Pumps
% 218.44/218.59  |- skos__annotation mesh__D017494
% 218.44/218.59       /antag - consider also POTASSIUM HYDROGEN ATPASE /antag   
% 218.44/218.59  |- skos__broader mesh__D017494smesh__D027682
% 218.44/218.59  |- mesh__dateCreated mesh__D017494 1992-05-22
% 218.44/218.59  |- skos__historyNote mesh__D017494
% 218.44/218.59       Proton-Translocating ATPases %28%1984-1992%29%
% 218.44/218.59  |- skos__altLabel mesh__D017494 H+ Pump
% 218.44/218.59  |- skos__hiddenLabel mesh__D017494 Pump, H+
% 218.44/218.59  |- skos__altLabel mesh__D017494 H%28%+%29% Pump
% 218.44/218.59  |- mesh__publicMeSHNote mesh__D031165 2003   
% 218.44/218.59  |- skos__prefLabel mesh__D031165 Ammi
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D031165 2006
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D031165 2005
% 218.44/218.59  |- mesh__dateCreated mesh__D031165 2002-07-02
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D031165 2004
% 218.44/218.59  |- rdf__type mesh__D031165sskos__Concept
% 218.44/218.59  |- mesh__dateEstablished mesh__D031165 2003-01-01
% 218.44/218.59  |- skos__scopeNote mesh__D031165
% 218.44/218.59       A plant genus of the family ASTERACEAE that is the primary plant source of KHELLIN.%A%    
% 218.44/218.59  |- skos__annotation mesh__D031165
% 218.44/218.59       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.44/218.59  |- mesh__historyNote mesh__D031165 2003   
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D031165 2003
% 218.44/218.59  |- skos__broader mesh__D031165smesh__D019659
% 218.44/218.59  |- skos__altLabel mesh__D003474 Diferuloylmethane
% 218.44/218.59  |- skos__annotation mesh__D003474
% 218.44/218.59       X ref TURMERIC YELLOW: TUMERIC see CURCUMA is also available%A%  
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D003474 2006
% 218.44/218.59  |- mesh__recordOriginator mesh__D003474 NLM
% 218.44/218.59  |- mesh__publicMeSHNote mesh__D003474
% 218.44/218.59       91; was see under CATECHOLS 1975-90   
% 218.44/218.59  |- skos__historyNote mesh__D003474 Catechols %28%1966-1974%29%
% 218.44/218.59  |- skos__broader mesh__D003474smesh__D036381
% 218.44/218.59  |- mesh__dateCreated mesh__D003474 1974-11-19
% 218.44/218.59  |- mesh__recordAuthorizer mesh__D003474 NLM
% 218.44/218.59  |- mesh__historyNote mesh__D003474
% 218.44/218.59       91%28%75%29%; was see under CATECHOLS 1975-90   
% 218.44/218.59  |- rdf__type mesh__D003474sskos__Concept
% 218.44/218.59  |- skos__altLabel mesh__D003474 Turmeric Yellow
% 218.44/218.59  |- mesh__dateRevised mesh__D003474 2005-07-06
% 218.44/218.59  |- mesh__dateEstablished mesh__D003474 1991-01-01
% 218.44/218.59  |- skos__hiddenLabel mesh__D003474 Yellow, Turmeric
% 218.44/218.59  |- skos__scopeNote mesh__D003474
% 218.44/218.59       A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes.%A%    
% 218.44/218.59  |- skos__historyNote mesh__D003474 Alkadienes %28%1974%29%
% 218.44/218.59  |- skos__prefLabel mesh__D003474 Curcumin
% 218.44/218.59  |- skos__broader mesh__D003474smesh__D002396
% 218.44/218.59  |- mesh__recordMaintainer mesh__D003474 NLM
% 218.44/218.59  |- mesh__publicMeSHNote mesh__D011906
% 218.44/218.59       RAT-BITE FEVER, SPIRILLARY was heading 1963-67   
% 218.44/218.59  |- skos__annotation mesh__D011906
% 218.44/218.59       a disease entity caused by a gram-neg bact   
% 218.44/218.59  |- mesh__dateCreated mesh__D011906 1999-01-01
% 218.44/218.59  |- rdf__type mesh__D011906sskos__Concept
% 218.44/218.59  |- skos__altLabel mesh__D011906 Ratbite Fever
% 218.44/218.59  |- skos__hiddenLabel mesh__D011906 Ratbite Fevers
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D011906 2004
% 218.44/218.59  |- skos__prefLabel mesh__D011906 Rat-Bite Fever
% 218.44/218.59  |- skos__hiddenLabel mesh__D011906 Rat-Bite Fevers
% 218.44/218.59  |- skos__hiddenLabel mesh__D011906 Fevers, Rat-Bite
% 218.44/218.59  |- mesh__recordMaintainer mesh__D011906 ags
% 218.44/218.59  |- skos__broader mesh__D011906smesh__D045825
% 218.44/218.59  |- mesh__recordOriginator mesh__D011906 NLM
% 218.44/218.59  |- skos__broader mesh__D011906smesh__D016905
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D011906 2006
% 218.44/218.59  |- mesh__recordAuthorizer mesh__D011906 sjn
% 218.44/218.59  |- skos__scopeNote mesh__D011906
% 218.44/218.59       A syndrome characterized by recurring fever, rash, and arthralgias occurring days to weeks after a rat bite. The causative agents are either Streptobacillus moniliformis or Spirillum minus.%A%    
% 218.44/218.59  |- mesh__onlineNote mesh__D011906
% 218.44/218.59       use RAT-BITE FEVER to search RAT-BITE FEVER, SPIRILLARY 1966-67%A%  
% 218.44/218.59  |- skos__hiddenLabel mesh__D011906 Fever, Ratbite
% 218.44/218.59  |- mesh__historyNote mesh__D011906
% 218.44/218.59       RAT-BITE FEVER, SPIRILLARY was heading 1963-67   
% 218.44/218.59  |- skos__hiddenLabel mesh__D011906 Fever, Rat-Bite
% 218.44/218.59  |- mesh__dateRevised mesh__D011906 2003-07-09
% 218.44/218.59  |- skos__hiddenLabel mesh__D011906 Rat Bite Fever
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D011906 2005
% 218.44/218.59  |- skos__hiddenLabel mesh__D011906 Fevers, Ratbite
% 218.44/218.59  |- mesh__dateCreated mesh__D011108 1999-01-01
% 218.44/218.59  |- skos__scopeNote mesh__D011108
% 218.44/218.59       Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules %28%e.g., BIOPOLYMERS; PLASTICS%29%.%A%    
% 218.44/218.59  |- mesh__recordOriginator mesh__D011108 NLM
% 218.44/218.59  |- mesh__recordMaintainer mesh__D011108 jmp
% 218.44/218.59  |- skos__hiddenLabel mesh__D011108 Polymer
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D011108 2005
% 218.44/218.59  |- mesh__dateRevised mesh__D011108 2004-07-07
% 218.44/218.59  |- skos__prefLabel mesh__D011108 Polymers
% 218.44/218.59  |- skos__broader mesh__D011108smesh__D046911
% 218.44/218.59  |- mesh__historyNote mesh__D011108
% 218.44/218.59       was in Cat D %26% J 1975-82, was in Cat D only 1963-74   
% 218.44/218.59  |- skos__broader mesh__D011108smesh__D001697
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D011108 2006
% 218.44/218.59  |- rdf__type mesh__D011108sskos__Concept
% 218.44/218.59  |- mesh__recordAuthorizer mesh__D011108 sjn
% 218.44/218.59  |- mesh__recordOriginator mesh__D007865 NLM
% 218.44/218.59  |- rdf__type mesh__D007865sskos__Concept
% 218.44/218.59  |- mesh__dateRevised mesh__D007865 2004-07-07
% 218.44/218.59  |- skos__scopeNote mesh__D007865
% 218.44/218.59       Annelids of the class Hirudinea. Some species, the bloodsuckers, may become temporarily parasitic upon animals, including man. Medicinal leeches %28%HIRUDO MEDICINALIS%29% have been used therapeutically for drawing blood since ancient times.%A%    
% 218.44/218.59  |- skos__prefLabel mesh__D007865 Leeches
% 218.44/218.59  |- skos__altLabel mesh__D007865 Hirudinea
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D007865 2005
% 218.44/218.59  |- skos__broader mesh__D007865smesh__D000845
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D007865 2006
% 218.44/218.59  |- mesh__recordAuthorizer mesh__D007865 sjn
% 218.44/218.59  |- mesh__dateCreated mesh__D007865 1999-01-01
% 218.44/218.59  |- skos__related mesh__D007865smesh__D024763
% 218.44/218.59  |- mesh__recordMaintainer mesh__D007865 ags
% 218.44/218.59  |- skos__broader mesh__D019355Q000031smesh__D019355
% 218.44/218.59  |- mesh__preferredCombination mesh__D019355Q000031smesh__D002951
% 218.44/218.59  |- rdf__type mesh__D019355Q000031smesh__CompoundConcept
% 218.44/218.59  |- skos__broader mesh__D007067smesh__D006603
% 218.44/218.59  |- skos__scopeNote mesh__D007067
% 218.44/218.59       Component of dermatan sulfate. Differs in configuration from glucuronic acid only at the C-5 position.%A%    
% 218.44/218.59  |- mesh__dateCreated mesh__D007067 1974-11-19
% 218.44/218.59  |- skos__prefLabel mesh__D007067 Iduronic Acid
% 218.44/218.59  |- mesh__publicMeSHNote mesh__D007067
% 218.44/218.59       91; was see under URONIC ACIDS 1975-90   
% 218.44/218.59  |- mesh__recordAuthorizer mesh__D007067 sjn
% 218.44/218.59  |- mesh__dateEstablished mesh__D007067 1991-01-01
% 218.44/218.59  |- skos__historyNote mesh__D007067 Uronic Acids %28%1971-1974%29%
% 218.44/218.59  |- skos__hiddenLabel mesh__D007067 Acid, Iduronic
% 218.44/218.59  |- mesh__dateRevised mesh__D007067 2004-07-07
% 218.44/218.59  |- mesh__historyNote mesh__D007067
% 218.44/218.59       91%28%75%29%; was see under URONIC ACIDS 1975-90   
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D007067 2006
% 218.44/218.59  |- mesh__recordOriginator mesh__D007067 NLM
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D007067 2005
% 218.44/218.59  |- mesh__recordMaintainer mesh__D007067 ssb
% 218.44/218.59  |- rdf__type mesh__D007067sskos__Concept
% 218.44/218.59  |- skos__hiddenLabel mesh__D012201 Rewards
% 218.44/218.59  |- rdf__type mesh__D012201sskos__Concept
% 218.44/218.59  |- skos__scopeNote mesh__D012201
% 218.44/218.59       An object or a situation that can serve to reinforce a response, to satisfy a motive, or to afford pleasure.%A%    
% 218.44/218.59  |- mesh__dateEstablished mesh__D012201 1965-01-01
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D012201 1996
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D012201 2003
% 218.44/218.59  |- skos__prefLabel mesh__D012201 Reward
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D012201 2000
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D012201 1997
% 218.44/218.59  |- mesh__dateRevised mesh__D012201 1989-05-16
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D012201 1992
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D012201 2004
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D012201 2001
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D012201 1998
% 218.44/218.59  |- skos__annotation mesh__D012201 human %26% animal; no qualif   
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D012201 1993
% 218.44/218.59  |- mesh__historyNote mesh__D012201
% 218.44/218.59       65%28%64%29%; was see under MOTIVATION %26% REINFORCEMENT LEARNING 1963-64%A%  
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D012201 2005
% 218.44/218.59  |- mesh__recordOriginator mesh__D012201 NLM
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D012201 1990
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D012201 2002
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D012201 1994
% 218.44/218.59  |- mesh__publicMeSHNote mesh__D012201
% 218.44/218.59       65; was see under MOTIVATION %26% REINFORCEMENT LEARNING 1963-64%A%  
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D012201 1999
% 218.44/218.59  |- mesh__dateCreated mesh__D012201 1999-01-01
% 218.44/218.59  |- mesh__recordMaintainer mesh__D012201 TGC
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D012201 2006
% 218.44/218.59  |- skos__broader mesh__D012201smesh__D012054
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D012201 1991
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D012201 1995
% 218.44/218.59  |- mesh__recordAuthorizer mesh__D012201 PLS
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D031964 2004
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D031964 2005
% 218.44/218.59  |- skos__broader mesh__D031964smesh__D019685
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D031964 2006
% 218.44/218.59  |- mesh__dateEstablished mesh__D031964 2003-01-01
% 218.44/218.59  |- skos__annotation mesh__D031964
% 218.44/218.59       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.44/218.59  |- skos__scopeNote mesh__D031964
% 218.44/218.59       A plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida. They are deciduous woody shrubs with alternate leaves. The flowers are in terminal racemes with 5 petals and 5 stamens.%A%    
% 218.44/218.59  |- rdf__type mesh__D031964sskos__Concept
% 218.44/218.59  |- mesh__dateCreated mesh__D031964 2002-07-03
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D031964 2003
% 218.44/218.59  |- mesh__historyNote mesh__D031964 2003   
% 218.44/218.59  |- skos__prefLabel mesh__D031964 Grossulariaceae
% 218.44/218.59  |- mesh__publicMeSHNote mesh__D031964 2003   
% 218.44/218.59  |- mesh__recordOriginator mesh__D017495 PLS
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D017495 2006
% 218.44/218.59  |- mesh__dateCreated mesh__D017495 1992-05-20
% 218.44/218.59  |- mesh__dateRevised mesh__D017495 2001-07-25
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D017495 2002
% 218.44/218.59  |- skos__hiddenLabel mesh__D017495 Hypermelanoses
% 218.44/218.59  |- skos__annotation mesh__D017495 do not confuse with HYPOPIGMENTATION   
% 218.44/218.59  |- mesh__recordAuthorizer mesh__D017495 sjn
% 218.44/218.59  |- mesh__dateEstablished mesh__D017495 1993-01-01
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D017495 2005
% 218.44/218.59  |- mesh__historyNote mesh__D017495 93   
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D017495 2004
% 218.44/218.59  |- rdf__type mesh__D017495sskos__Concept
% 218.44/218.59  |- skos__historyNote mesh__D017495 Pigmentation Disorders %28%1966-1992%29%
% 218.44/218.59  |- mesh__publicMeSHNote mesh__D017495 93   
% 218.44/218.59  |- mesh__activeMeSHYear mesh__D017495 2003
% 218.44/218.60  |- skos__altLabel mesh__D017495 Hypermelanosis
% 218.44/218.60  |- skos__prefLabel mesh__D017495 Hyperpigmentation
% 218.44/218.60  |- skos__scopeNote mesh__D017495
% 218.44/218.60       Excessive pigmentation of the skin, usually as a result of increased epidermal or dermal melanin pigmentation, hypermelanosis. Hyperpigmentation can be localized or generalized. The condition may arise from exposure to light, chemicals or other substances, or from a primary metabolic imbalance.%A%    
% 218.44/218.60  |- mesh__recordMaintainer mesh__D017495 lkt
% 218.44/218.60  |- skos__broader mesh__D017495smesh__D010859
% 218.44/218.60  |- mesh__dateCreated mesh__D031166 2002-07-02
% 218.44/218.60  |- skos__altLabel mesh__D031166 Mayweed, Stinking
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D031166 2005
% 218.44/218.60  |- skos__altLabel mesh__D031166 Camomile, Stinking
% 218.44/218.60  |- skos__prefLabel mesh__D031166 Anthemis
% 218.44/218.60  |- skos__annotation mesh__D031166
% 218.44/218.60       X refs: distinguish from related plants with similar common names; check text and MeSH; ANTHEMIS NOBILIS see CHAMAEMELUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.44/218.60  |- mesh__historyNote mesh__D031166 2003   
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D031166 2004
% 218.44/218.60  |- skos__broader mesh__D031166smesh__D020843
% 218.44/218.60  |- rdf__type mesh__D031166sskos__Concept
% 218.44/218.60  |- skos__scopeNote mesh__D031166
% 218.44/218.60       A plant genus of the family ASTERACEAE that is similar to MATRICARIA but this has tiny chaffy bract scales between each pair of florets. Members contain sesquiterpene lactones. Other plants with similar common names include FERULA; FOENICULUM; MATRICARIA; CHAMAEMELUM and TRIPLEUROSPERMUM.%A%    
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D031166 2003
% 218.44/218.60  |- mesh__publicMeSHNote mesh__D031166 2003   
% 218.44/218.60  |- skos__altLabel mesh__D031166 Chamomile, Stinking
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D031166 2006
% 218.44/218.60  |- skos__altLabel mesh__D031166 Fennel, Dog
% 218.44/218.60  |- mesh__dateEstablished mesh__D031166 2003-01-01
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D003475 2003
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D003475 1999
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D003475 2005
% 218.44/218.60  |- mesh__dateCreated mesh__D003475 1999-01-01
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D003475 2000
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D003475 1996
% 218.44/218.60  |- mesh__publicMeSHNote mesh__D003475 65   
% 218.44/218.60  |- mesh__dateRevised mesh__D003475 1995-03-13
% 218.44/218.60  |- skos__broader mesh__D003475smesh__D013514
% 218.44/218.60  |- skos__prefLabel mesh__D003475 Curettage
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D003475 1998
% 218.44/218.60  |- mesh__recordOriginator mesh__D003475 NLM
% 218.44/218.60  |- rdf__type mesh__D003475sskos__Concept
% 218.44/218.60  |- skos__hiddenLabel mesh__D003475 Curettages
% 218.44/218.60  |- mesh__historyNote mesh__D003475 65%28%64%29%   
% 218.44/218.60  |- skos__scopeNote mesh__D003475
% 218.44/218.60       A scraping, usually of the interior of a cavity or tract, for removal of new growth or other abnormal tissue, or to obtain material for tissue diagnosis. It is performed with a curet %28%curette%29%, a spoon-shaped instrument designed for that purpose. %28%From Stedman, 25th ed %26% Dorland, 27th ed%29%%A%    
% 218.44/218.60  |- mesh__recordMaintainer mesh__D003475 TGC
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D003475 2002
% 218.44/218.60  |- mesh__recordAuthorizer mesh__D003475 PLS
% 218.44/218.60  |- skos__annotation mesh__D003475
% 218.44/218.60       of any cavity but note DILATATION AND CURETTAGE for cervix %26% endometrium; do not use /util except by MeSH definition; gingival curettage = SUBGINGIVAL CURETTAGE%A%  
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D003475 2004
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D003475 2001
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D003475 2006
% 218.44/218.60  |- mesh__dateEstablished mesh__D003475 1965-01-01
% 218.44/218.60  |- skos__related mesh__D003475smesh__D004107
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D003475 1997
% 218.44/218.60  |- skos__hiddenLabel mesh__D011907 Review Rate Setting
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D011907 2001
% 218.44/218.60  |- skos__altLabel mesh__D011907 Review and Rate Setting
% 218.44/218.60  |- rdf__type mesh__D011907sskos__Concept
% 218.44/218.60  |- skos__related mesh__D011907smesh__D015895
% 218.44/218.60  |- skos__hiddenLabel mesh__D011907 Review Rate Settings
% 218.44/218.60  |- mesh__recordAuthorizer mesh__D011907 sjn
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D011907 2003
% 218.44/218.60  |- skos__annotation mesh__D011907 DF: RATE SETTING   
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D011907 2002
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D011907 2004
% 218.44/218.60  |- mesh__recordOriginator mesh__D011907 EC
% 218.44/218.60  |- skos__hiddenLabel mesh__D011907 Settings, Review Rate
% 218.44/218.60  |- skos__broader mesh__D011907smesh__D005249
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D011907 2005
% 218.44/218.60  |- skos__altLabel mesh__D011907 Rate Setting, Review
% 218.44/218.60  |- skos__prefLabel mesh__D011907 Rate Setting and Review
% 218.44/218.60  |- skos__historyNote mesh__D011907 Fees and Charges %28%1968-1979%29%
% 218.44/218.60  |- mesh__dateEstablished mesh__D011907 1980-01-01
% 218.44/218.60  |- mesh__dateRevised mesh__D011907 1999-11-03
% 218.44/218.60  |- mesh__publicMeSHNote mesh__D011907 80   
% 218.44/218.60  |- skos__hiddenLabel mesh__D011907 Setting, Review Rate
% 218.44/218.60  |- skos__scopeNote mesh__D011907
% 218.44/218.60       A method of examining and setting levels of payments.     
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D011907 2006
% 218.44/218.60  |- mesh__historyNote mesh__D011907 80   
% 218.44/218.60  |- skos__historyNote mesh__D011907 Economics, Hospital %28%1966-1979%29%
% 218.44/218.60  |- skos__hiddenLabel mesh__D011907 Rate Settings, Review
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D011907 2000
% 218.44/218.60  |- skos__broader mesh__D011907smesh__D002017
% 218.44/218.60  |- mesh__dateCreated mesh__D011907 1979-06-01
% 218.44/218.60  |- mesh__recordMaintainer mesh__D011907 kle
% 218.44/218.60  |- skos__altLabel mesh__D011109 Methacrylic Acid Polymers
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D011109 2005
% 218.44/218.60  |- mesh__dateCreated mesh__D011109 1974-11-19
% 218.44/218.60  |- mesh__recordMaintainer mesh__D011109 jmp
% 218.44/218.60  |- mesh__dateRevised mesh__D011109 2004-07-07
% 218.44/218.60  |- skos__broader mesh__D011109smesh__D000180
% 218.44/218.60  |- rdf__type mesh__D011109sskos__Concept
% 218.44/218.60  |- mesh__publicMeSHNote mesh__D011109
% 218.44/218.60       81; was see under ACRYLIC RESINS 1975-80; POLYHYDROXYETHYL METHACRYLATE was see under ACRYLIC RESINS 1978-80%A%  
% 218.44/218.60  |- mesh__recordAuthorizer mesh__D011109 sjn
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D011109 2006
% 218.44/218.60  |- mesh__dateEstablished mesh__D011109 1981-01-01
% 218.44/218.60  |- skos__hiddenLabel mesh__D011109 Polymers, Methacrylic Acid
% 218.44/218.60  |- skos__prefLabel mesh__D011109 Polymethacrylic Acids
% 218.44/218.60  |- skos__historyNote mesh__D011109 Acrylates %28%1966-1974%29%
% 218.44/218.60  |- skos__hiddenLabel mesh__D011109 Acid Polymers, Methacrylic
% 218.44/218.60  |- skos__scopeNote mesh__D011109
% 218.44/218.60       Poly-2-methylpropenoic acids. Used in the manufacture of methacrylate resins and plastics in the form of pellets and granules, as absorbent for biological materials and as filters; also as biological membranes and as hydrogens. Synonyms: methylacrylate polymer; poly%28%methylacrylate%29%; acrylic acid methyl ester polymer.%A%    
% 218.44/218.60  |- skos__hiddenLabel mesh__D011109 Acids, Polymethacrylic
% 218.44/218.60  |- mesh__recordOriginator mesh__D011109 NLM
% 218.44/218.60  |- skos__annotation mesh__D011109 D25-26 qualif   
% 218.44/218.60  |- skos__broader mesh__D011109smesh__D000179
% 218.44/218.60  |- skos__historyNote mesh__D011109 Polymers %28%1966-1974%29%
% 218.44/218.60  |- mesh__historyNote mesh__D011109
% 218.44/218.60       81%28%75%29%; was see under ACRYLIC RESINS 1975-80   
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D008160 1996
% 218.44/218.60  |- rdf__type mesh__D008160sskos__Concept
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D008160 2002
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D008160 1998
% 218.44/218.60  |- mesh__recordAuthorizer mesh__D008160 PLS
% 218.44/218.60  |- mesh__dateRevised mesh__D008160 1993-06-29
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D008160 1995
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D008160 2001
% 218.44/218.60  |- skos__hiddenLabel mesh__D008160 Plexus, Lumbosacral
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D008160 1994
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D008160 2004
% 218.44/218.60  |- skos__broader mesh__D008160smesh__D013127
% 218.44/218.60  |- mesh__recordMaintainer mesh__D008160 RAZ
% 218.44/218.60  |- skos__hiddenLabel mesh__D008160 Plexus, Lumbar
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D008160 2000
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D008160 2006
% 218.44/218.60  |- mesh__dateCreated mesh__D008160 1999-01-01
% 218.44/218.60  |- skos__prefLabel mesh__D008160 Lumbosacral Plexus
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D008160 2003
% 218.44/218.60  |- skos__hiddenLabel mesh__D008160 Plexus, Sacral
% 218.44/218.60  |- skos__annotation mesh__D008160 a network of spinal nerves   
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D008160 2005
% 218.44/218.60  |- mesh__recordOriginator mesh__D008160 NLM
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D008160 1997
% 218.44/218.60  |- skos__scopeNote mesh__D008160
% 218.44/218.60       The lumbar and sacral plexuses taken together. The fibers of the lumbosacral plexus originate in the lumbar and upper sacral spinal cord %28%L1 to S3%29% and innervate the lower extremities.%A%    
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D008160 1999
% 218.44/218.60  |- skos__related mesh__D007866smesh__D006614
% 218.44/218.60  |- skos__scopeNote mesh__D007866
% 218.44/218.60       The inferior part of the lower extremity between the KNEE and the ANKLE.%A%    
% 218.44/218.60  |- rdf__type mesh__D007866sskos__Concept
% 218.44/218.60  |- mesh__dateCreated mesh__D007866 1999-01-01
% 218.44/218.60  |- mesh__recordOriginator mesh__D007866 NLM
% 218.44/218.60  |- mesh__recordMaintainer mesh__D007866 ags
% 218.44/218.60  |- mesh__dateEstablished mesh__D007866 1963-01-01
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D007866 2004
% 218.44/218.60  |- mesh__dateRevised mesh__D007866 2002-07-03
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D007866 2006
% 218.44/218.60  |- skos__annotation mesh__D007866
% 218.44/218.60       primates only but see note on LEG INJURIES; for whole leg or lower leg %28%THIGH is available for upper leg%29%; for bones use TIBIA or FIBULA; Manual 21.58: table of human, primate %26% non-primate extremities%A%  
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D007866 2003
% 218.44/218.60  |- mesh__recordAuthorizer mesh__D007866 sjn
% 218.44/218.60  |- skos__related mesh__D007866smesh__D007867
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D007866 2005
% 218.44/218.60  |- skos__hiddenLabel mesh__D007866 Legs
% 218.44/218.60  |- skos__prefLabel mesh__D007866 Leg
% 218.44/218.60  |- skos__broader mesh__D007866smesh__D035002
% 218.44/218.60  |- skos__prefLabel mesh__D007068 Iduronidase
% 218.44/218.60  |- mesh__dateEstablished mesh__D007068 1991-01-01
% 218.44/218.60  |- skos__related mesh__D007068smesh__D008059
% 218.44/218.60  |- skos__hiddenLabel mesh__D007068 alpha L Idosiduronase
% 218.44/218.60  |- mesh__recordOriginator mesh__D007068 NLM
% 218.44/218.60  |- mesh__publicMeSHNote mesh__D007068
% 218.44/218.60       91; was see under GLYCOSIDE HYDROLASES 1975-90   
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D007068 2006
% 218.44/218.60  |- mesh__recordMaintainer mesh__D007068 ssb
% 218.44/218.60  |- mesh__dateCreated mesh__D007068 1974-11-19
% 218.44/218.60  |- skos__altLabel mesh__D007068 alpha-L-Iduronidase
% 218.44/218.60  |- skos__hiddenLabel mesh__D007068 alpha L Iduronidase
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D007068 2005
% 218.44/218.60  |- skos__historyNote mesh__D007068 Glycoside Hydrolases %28%1972-1974%29%
% 218.44/218.60  |- rdf__type mesh__D007068sskos__Concept
% 218.44/218.60  |- skos__altLabel mesh__D007068 alpha-L-Idosiduronase
% 218.44/218.60  |- mesh__dateRevised mesh__D007068 2003-07-09
% 218.44/218.60  |- skos__broader mesh__D007068smesh__D006026
% 218.44/218.60  |- skos__annotation mesh__D007068
% 218.44/218.60       /defic: consider also MUCOPOLYSACCHARIDOSIS I   
% 218.44/218.60  |- skos__historyNote mesh__D007068 Uronic Acids %28%1972-1974%29%
% 218.44/218.60  |- mesh__recordAuthorizer mesh__D007068 sjn
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D007068 2004
% 218.44/218.60  |- skos__historyNote mesh__D007068 Hexoses %28%1972-1974%29%
% 218.44/218.60  |- skos__scopeNote mesh__D007068
% 218.44/218.60       An enzyme that hydrolyzes iduronosidic linkages in desulfated dermatan. Deficiency of this enzyme produces Hurler%27%s syndrome. EC 3.2.1.76.%A%    
% 218.44/218.60  |- mesh__historyNote mesh__D007068
% 218.44/218.60       91%28%75%29%; was see under GLYCOSIDE HYDROLASES 1975-90   
% 218.44/218.60  |- skos__altLabel mesh__D012202 Reye%27%s Syndrome, Adult
% 218.44/218.60  |- mesh__recordMaintainer mesh__D012202 lkt
% 218.44/218.60  |- skos__altLabel mesh__D012202 Reye%27%s Syndrome
% 218.44/218.60  |- skos__hiddenLabel mesh__D012202 Reye Like Syndrome
% 218.44/218.60  |- mesh__dateEstablished mesh__D012202 1977-01-01
% 218.44/218.60  |- skos__broader mesh__D012202smesh__D005234
% 218.44/218.60  |- skos__hiddenLabel mesh__D012202 Reye%27%s Like Syndrome
% 218.44/218.60  |- mesh__dateRevised mesh__D012202 2004-07-07
% 218.44/218.60  |- skos__scopeNote mesh__D012202
% 218.44/218.60       A form of encephalopathy with fatty infiltration of the LIVER, characterized by brain EDEMA and VOMITING that may rapidly progress to SEIZURES; COMA; and DEATH. It is caused by a generalized loss of mitochondrial function leading to disturbances in fatty acid and CARNITINE metabolism.%A%    
% 218.44/218.60  |- skos__hiddenLabel mesh__D012202 Adult Reye Syndrome
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D012202 2005
% 218.44/218.60  |- mesh__dateCreated mesh__D012202 1999-01-01
% 218.44/218.60  |- mesh__publicMeSHNote mesh__D012202
% 218.44/218.60       1998; see REYE%27%S SYNDROME 1977-97   
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D012202 2006
% 218.44/218.60  |- skos__historyNote mesh__D012202 Brain Diseases %28%1966-1972%29%
% 218.44/218.60  |- skos__hiddenLabel mesh__D012202 Reye Johnson Syndrome
% 218.44/218.60  |- skos__broader mesh__D012202smesh__D001928
% 218.44/218.60  |- skos__altLabel mesh__D012202 Reye-Johnson Syndrome
% 218.44/218.60  |- skos__altLabel mesh__D012202 Reye%27%s-Like Syndrome
% 218.44/218.60  |- skos__prefLabel mesh__D012202 Reye Syndrome
% 218.44/218.60  |- mesh__recordAuthorizer mesh__D012202 sjn
% 218.44/218.60  |- mesh__recordOriginator mesh__D012202 NLM
% 218.44/218.60  |- mesh__historyNote mesh__D012202 1998%28%1977%29%   
% 218.44/218.60  |- rdf__type mesh__D012202sskos__Concept
% 218.44/218.60  |- skos__hiddenLabel mesh__D012202 Adult Reye%27%s Syndrome
% 218.44/218.60  |- mesh__dateCreated mesh__D031965 2002-07-02
% 218.44/218.60  |- mesh__recordMaintainer mesh__D031965 ssb
% 218.44/218.60  |- skos__broader mesh__D031965smesh__D031964
% 218.44/218.60  |- mesh__publicMeSHNote mesh__D031965 2003   
% 218.44/218.60  |- mesh__historyNote mesh__D031965 2003   
% 218.44/218.60  |- skos__altLabel mesh__D031965 Currant, Black
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D031965 2006
% 218.44/218.60  |- skos__scopeNote mesh__D031965
% 218.44/218.60       A plant genus of the family GROSSULARIACEAE. GAMMA-LINOLENIC ACID is obtained from the black currant oil of the seeds.%A%    
% 218.44/218.60  |- mesh__dateEstablished mesh__D031965 2003-01-01
% 218.44/218.60  |- mesh__dateRevised mesh__D031965 2004-07-07
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D031965 2005
% 218.44/218.60  |- mesh__recordAuthorizer mesh__D031965 sjn
% 218.44/218.60  |- skos__annotation mesh__D031965
% 218.44/218.60       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.44/218.60  |- skos__prefLabel mesh__D031965 Ribes
% 218.44/218.60  |- mesh__recordOriginator mesh__D031965 ssb
% 218.44/218.60  |- rdf__type mesh__D031965sskos__Concept
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D017496 2006
% 218.44/218.60  |- skos__annotation mesh__D017496 do not confuse with HYPERPIGMENTATION   
% 218.44/218.60  |- skos__scopeNote mesh__D017496
% 218.44/218.60       A condition caused by a deficiency or a loss of melanin pigmentation in the epidermis, also known as hypomelanosis. Hypopigmentation can be localized or generalized, and may result from genetic defects, trauma, inflammation, or infections.%A%    
% 218.44/218.60  |- mesh__recordMaintainer mesh__D017496 lkt
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D017496 2005
% 218.44/218.60  |- mesh__historyNote mesh__D017496 93   
% 218.44/218.60  |- skos__prefLabel mesh__D017496 Hypopigmentation
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D017496 2004
% 218.44/218.60  |- rdf__type mesh__D017496sskos__Concept
% 218.44/218.60  |- mesh__dateCreated mesh__D017496 1992-05-20
% 218.44/218.60  |- mesh__dateRevised mesh__D017496 2001-07-25
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D017496 2002
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D017496 2003
% 218.44/218.60  |- mesh__recordAuthorizer mesh__D017496 sjn
% 218.44/218.60  |- skos__altLabel mesh__D017496 Hypomelanosis
% 218.44/218.60  |- mesh__dateEstablished mesh__D017496 1993-01-01
% 218.44/218.60  |- skos__broader mesh__D017496smesh__D010859
% 218.44/218.60  |- skos__historyNote mesh__D017496 Pigmentation Disorders %28%1966-1992%29%
% 218.44/218.60  |- skos__hiddenLabel mesh__D017496 Hypomelanoses
% 218.44/218.60  |- mesh__recordOriginator mesh__D017496 PLS
% 218.44/218.60  |- mesh__publicMeSHNote mesh__D017496 93   
% 218.44/218.60  |- mesh__historyNote mesh__D031167
% 218.44/218.60       2003; for CHAMAEMELUM NOBILE use CHAMOMILE 1999-2002   
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D031167 2006
% 218.44/218.60  |- mesh__dateCreated mesh__D031167 2002-07-02
% 218.44/218.60  |- mesh__dateEstablished mesh__D031167 2003-01-01
% 218.44/218.60  |- skos__altLabel mesh__D031167 Chamomile, Roman
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D031167 2005
% 218.44/218.60  |- mesh__recordAuthorizer mesh__D031167 sjn
% 218.44/218.60  |- rdf__type mesh__D031167sskos__Concept
% 218.44/218.60  |- skos__altLabel mesh__D031167 English Chamomile
% 218.44/218.60  |- skos__altLabel mesh__D031167 Anthemis nobilis
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D031167 2004
% 218.44/218.60  |- mesh__recordMaintainer mesh__D031167 ssb
% 218.44/218.60  |- skos__broader mesh__D031167smesh__D020843
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D031167 2003
% 218.44/218.60  |- skos__prefLabel mesh__D031167 Chamaemelum
% 218.44/218.60  |- skos__annotation mesh__D031167
% 218.44/218.60       X refs: distinguish from related plants with similar common names; check text and MeSH; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.44/218.60  |- mesh__publicMeSHNote mesh__D031167
% 218.44/218.60       2003; for CHAMAEMELUM NOBILE see CHAMOMILE 1999-2002   
% 218.44/218.60  |- mesh__recordOriginator mesh__D031167 ssb
% 218.44/218.60  |- skos__scopeNote mesh__D031167
% 218.44/218.60       A plant genus of the family ASTERACEAE that is used in folk medicine as CHAMOMILE. Other plants with similar common names include MATRICARIA; TRIPLEUROSPERMUM and ANTHEMIS.%A%    
% 218.44/218.60  |- skos__altLabel mesh__D031167 Camomile, Roman
% 218.44/218.60  |- skos__prefLabel mesh__D003476 Curium
% 218.44/218.60  |- skos__annotation mesh__D003476 naturally radioactive; IM   
% 218.44/218.60  |- skos__scopeNote mesh__D003476
% 218.44/218.60       A radioactive actinide with atomic symbol Cm, atomic number 96, and atomic weight 247. Thirteen curium isotopes have been produced with mass numbers ranging from 238-250. Its valence can be +3 or +4. It is intensely radioactive and decays by alpha-emission.%A%    
% 218.44/218.60  |- mesh__dateRevised mesh__D003476 2005-06-30
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D003476 2006
% 218.44/218.60  |- skos__broader mesh__D003476smesh__D008671
% 218.44/218.60  |- skos__broader mesh__D003476smesh__D019216
% 218.44/218.60  |- mesh__dateCreated mesh__D003476 1999-01-01
% 218.44/218.60  |- mesh__recordAuthorizer mesh__D003476 sjn
% 218.44/218.60  |- mesh__recordOriginator mesh__D003476 NLM
% 218.44/218.60  |- mesh__recordMaintainer mesh__D003476 jmp
% 218.44/218.60  |- rdf__type mesh__D003476sskos__Concept
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D011908 2003
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D011908 1999
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D011908 2000
% 218.44/218.60  |- mesh__dateEstablished mesh__D011908 1991-01-01
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D011908 2004
% 218.44/218.60  |- mesh__historyNote mesh__D011908
% 218.44/218.60       91%28%75%29%; was see under DEFENSE MECHANISMS 1975-90   
% 218.44/218.60  |- mesh__dateRevised mesh__D011908 1997-06-20
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D011908 2001
% 218.44/218.60  |- mesh__recordOriginator mesh__D011908 NLM
% 218.44/218.60  |- skos__scopeNote mesh__D011908
% 218.44/218.60       A defense mechanism operating unconsciously, in which the individual attempts to justify or make consciously tolerable, by plausible means, feelings, behavior, and motives that would otherwise be intolerable.%A%    
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D011908 2005
% 218.44/218.60  |- mesh__recordAuthorizer mesh__D011908 SJN
% 218.44/218.60  |- skos__prefLabel mesh__D011908 Rationalization
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D011908 2002
% 218.44/218.60  |- mesh__publicMeSHNote mesh__D011908
% 218.44/218.60       91; was see under DEFENSE MECHANISMS 1975-90   
% 218.44/218.60  |- skos__broader mesh__D011908smesh__D003674
% 218.44/218.60  |- mesh__activeMeSHYear mesh__D011908 2006
% 218.46/218.60  |- mesh__dateCreated mesh__D011908 1999-01-01
% 218.46/218.60  |- mesh__onlineNote mesh__D011908 search DEFENSE MECHANISMS 1966-74   
% 218.46/218.60  |- skos__annotation mesh__D011908 no qualif   
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D011908 1998
% 218.46/218.60  |- mesh__recordMaintainer mesh__D011908 JLS
% 218.46/218.60  |- rdf__type mesh__D011908sskos__Concept
% 218.46/218.60  |- skos__broader mesh__D019813Q000031smesh__D019813
% 218.46/218.60  |- mesh__preferredCombination mesh__D019813Q000031smesh__D004127
% 218.46/218.60  |- rdf__type mesh__D019813Q000031smesh__CompoundConcept
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D008161 1994
% 218.46/218.60  |- skos__related mesh__D008161smesh__D017116
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D008161 2000
% 218.46/218.60  |- skos__hiddenLabel mesh__D008161 Regions, Lumbosacral
% 218.46/218.60  |- skos__annotation mesh__D008161
% 218.46/218.60       do not confuse with LUMBAR VERTEBRAE or SACROCOCCYGEAL REGION: use term in the text; NIM when merely locational; pain: note see related ref%A%  
% 218.46/218.60  |- skos__hiddenLabel mesh__D008161 Region, Lumbosacral
% 218.46/218.60  |- skos__hiddenLabel mesh__D008161 Region, Lumbar
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D008161 2003
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D008161 2006
% 218.46/218.60  |- skos__prefLabel mesh__D008161 Lumbosacral Region
% 218.46/218.60  |- mesh__recordOriginator mesh__D008161 NLM
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D008161 2005
% 218.46/218.60  |- mesh__dateCreated mesh__D008161 1999-01-01
% 218.46/218.60  |- skos__hiddenLabel mesh__D008161 Regions, Lumbar
% 218.46/218.60  |- mesh__dateRevised mesh__D008161 1992-05-22
% 218.46/218.60  |- skos__hiddenLabel mesh__D008161 Lumbosacral Regions
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D008161 1997
% 218.46/218.60  |- mesh__recordMaintainer mesh__D008161 TGC
% 218.46/218.60  |- mesh__recordAuthorizer mesh__D008161 PLS
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D008161 2002
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D008161 1996
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D008161 1993
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D008161 1999
% 218.46/218.60  |- skos__broader mesh__D008161smesh__D001415
% 218.46/218.60  |- rdf__type mesh__D008161sskos__Concept
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D008161 1995
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D008161 2001
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D008161 1998
% 218.46/218.60  |- skos__hiddenLabel mesh__D008161 Lumbar Regions
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D008161 2004
% 218.46/218.60  |- mesh__recordAuthorizer mesh__D007867 sjn
% 218.46/218.60  |- skos__altLabel mesh__D007867 Bones of Leg
% 218.46/218.60  |- rdf__type mesh__D007867sskos__Concept
% 218.46/218.60  |- skos__historyNote mesh__D007867 specific bones of leg %28%1966-1997%29%
% 218.46/218.60  |- skos__hiddenLabel mesh__D007867 Bones, Leg
% 218.46/218.60  |- mesh__dateCreated mesh__D007867 1999-01-01
% 218.46/218.60  |- mesh__recordMaintainer mesh__D007867 ags
% 218.46/218.60  |- skos__hiddenLabel mesh__D007867 Leg Bone
% 218.46/218.60  |- mesh__publicMeSHNote mesh__D007867 98   
% 218.46/218.60  |- mesh__dateEstablished mesh__D007867 1998-01-01
% 218.46/218.60  |- skos__scopeNote mesh__D007867
% 218.46/218.60       The bones of the free part of the lower extremity in humans and of any of the four extremities in animals. It includes the FEMUR; PATELLA; TIBIA; and FIBULA.%A%    
% 218.46/218.60  |- skos__annotation mesh__D007867
% 218.46/218.60       general or unspecified; prefer specifics; primates only; Manual 21.58%A%  
% 218.46/218.60  |- skos__prefLabel mesh__D007867 Leg Bones
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D007867 2006
% 218.46/218.60  |- mesh__recordOriginator mesh__D007867 NLM
% 218.46/218.60  |- mesh__historyNote mesh__D007867 98; use explode 1975-97   
% 218.46/218.60  |- skos__broader mesh__D007867smesh__D050281
% 218.46/218.60  |- skos__historyNote mesh__D007867 Leg %28%1966-1997%29%
% 218.46/218.60  |- mesh__dateRevised mesh__D007867 2005-06-30
% 218.46/218.60  |- skos__hiddenLabel mesh__D007867 Bone, Leg
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D007069 2006
% 218.46/218.60  |- skos__hiddenLabel mesh__D007069 NSC 109,724
% 218.46/218.60  |- skos__historyNote mesh__D007069 Oxazines %28%1972-1974%29%
% 218.46/218.60  |- skos__hiddenLabel mesh__D007069 NSC109,724
% 218.46/218.60  |- skos__hiddenLabel mesh__D007069 NSC109724
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D007069 2005
% 218.46/218.60  |- skos__broader mesh__D007069smesh__D010078
% 218.46/218.60  |- skos__altLabel mesh__D007069 NSC-109724
% 218.46/218.60  |- mesh__dateRevised mesh__D007069 2003-07-09
% 218.46/218.60  |- skos__altLabel mesh__D007069 Isophosphamide
% 218.46/218.60  |- skos__altLabel mesh__D007069 Iso-Endoxan
% 218.46/218.60  |- rdf__type mesh__D007069sskos__Concept
% 218.46/218.60  |- mesh__recordOriginator mesh__D007069 NLM
% 218.46/218.60  |- skos__historyNote mesh__D007069 Ethylamines %28%1972-1974%29%
% 218.46/218.60  |- skos__broader mesh__D007069smesh__D003520
% 218.46/218.60  |- mesh__dateCreated mesh__D007069 1974-11-19
% 218.46/218.60  |- skos__altLabel mesh__D007069 Isofosfamide
% 218.46/218.60  |- mesh__publicMeSHNote mesh__D007069
% 218.46/218.60       86; was see under CYCLOPHOSPHAMIDE 1975-85   
% 218.46/218.60  |- mesh__recordMaintainer mesh__D007069 ssb
% 218.46/218.60  |- mesh__dateEstablished mesh__D007069 1986-01-01
% 218.46/218.60  |- mesh__historyNote mesh__D007069
% 218.46/218.60       86%28%75%29%; was see under CYCLOPHOSPHAMIDE 1975-85   
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D007069 2004
% 218.46/218.60  |- skos__altLabel mesh__D007069 Iphosphamide
% 218.46/218.60  |- skos__hiddenLabel mesh__D007069 NSC 109724
% 218.46/218.60  |- skos__historyNote mesh__D007069 Cyclic P-Oxides %28%1972-1974%29%
% 218.46/218.60  |- skos__hiddenLabel mesh__D007069 Iso Endoxan
% 218.46/218.60  |- skos__scopeNote mesh__D007069
% 218.46/218.60       Positional isomer of CYCLOPHOSPHAMIDE which is active as an alkylating agent and an immunosuppressive agent.%A%    
% 218.46/218.60  |- skos__prefLabel mesh__D007069 Ifosfamide
% 218.46/218.60  |- mesh__recordAuthorizer mesh__D007069 sjn
% 218.46/218.60  |- mesh__recordMaintainer mesh__D012203 sjn
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D012203 2003
% 218.46/218.60  |- mesh__publicMeSHNote mesh__D012203 85   
% 218.46/218.60  |- skos__annotation mesh__D012203
% 218.46/218.60       a blood group incompatibility; note categories; use only Cat C qualif%A%  
% 218.46/218.60  |- mesh__historyNote mesh__D012203 85   
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D012203 2004
% 218.46/218.60  |- skos__altLabel mesh__D012203 Isoimmunization, Rhesus
% 218.46/218.60  |- skos__historyNote mesh__D012203
% 218.46/218.60       RH-HR Blood-Group System %28%1966-1984%29%
% 218.46/218.60  |- mesh__recordOriginator mesh__D012203 AEP
% 218.46/218.60  |- mesh__dateCreated mesh__D012203 1984-05-30
% 218.46/218.60  |- skos__related mesh__D012203smesh__D004899
% 218.46/218.60  |- skos__prefLabel mesh__D012203 Rh Isoimmunization
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D012203 2005
% 218.46/218.60  |- skos__hiddenLabel mesh__D012203 Rh Isoimmunizations
% 218.46/218.60  |- skos__hiddenLabel mesh__D012203 Isoimmunizations, Rh
% 218.46/218.60  |- mesh__recordAuthorizer mesh__D012203 sjn
% 218.46/218.60  |- skos__hiddenLabel mesh__D012203 Isoimmunization, Rh
% 218.46/218.60  |- mesh__dateRevised mesh__D012203 2001-08-07
% 218.46/218.60  |- mesh__activeMeSHYear mesh__D012203 2006
% 218.46/218.60  |- skos__broader mesh__D012203smesh__D001787
% 218.46/218.60  |- mesh__dateEstablished mesh__D012203 1985-01-01
% 218.46/218.60  |- skos__broader mesh__D012203smesh__D000937
% 218.46/218.61  |- rdf__type mesh__D012203sskos__Concept
% 218.46/218.61  |- skos__scopeNote mesh__D012203
% 218.46/218.61       The process by which fetal Rh+ erythrocytes enter the circulation of an Rh- mother during delivery, causing her to produce IMMUNOGLOBULIN G antibodies, which can cross the placenta and destroy the erythrocytes of Rh- fetuses in subsequent pregnancies.%A%    
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D012203 2002
% 218.46/218.61  |- skos__hiddenLabel mesh__D012203 Rhesus Isoimmunizations
% 218.46/218.61  |- skos__hiddenLabel mesh__D012203 Rhesus Isoimmunization
% 218.46/218.61  |- skos__hiddenLabel mesh__D012203 Isoimmunizations, Rhesus
% 218.46/218.61  |- mesh__publicMeSHNote mesh__D031966 2003   
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D031966 2003
% 218.46/218.61  |- skos__broader mesh__D031966smesh__D029628
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D031966 2006
% 218.46/218.61  |- skos__scopeNote mesh__D031966
% 218.46/218.61       A plant genus of the family HYDRANGEACEAE. Members contain hydrangenol, thunberginols, hydramacrosides A and B, and secoiridoid glucosides.%A%    
% 218.46/218.61  |- mesh__dateCreated mesh__D031966 2002-07-03
% 218.46/218.61  |- mesh__historyNote mesh__D031966 2003   
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D031966 2005
% 218.46/218.61  |- skos__prefLabel mesh__D031966 Hydrangea
% 218.46/218.61  |- skos__annotation mesh__D031966
% 218.46/218.61       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.46/218.61  |- mesh__dateEstablished mesh__D031966 2003-01-01
% 218.46/218.61  |- rdf__type mesh__D031966sskos__Concept
% 218.46/218.61  |- skos__altLabel mesh__D031966 Hydrangeae
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D031966 2004
% 218.46/218.61  |- mesh__recordOriginator mesh__D017497 PLS
% 218.46/218.61  |- skos__altLabel mesh__D017497 Suppurative Hidradenitis
% 218.46/218.61  |- mesh__recordAuthorizer mesh__D017497 sjn
% 218.46/218.61  |- skos__hiddenLabel mesh__D017497 Suppurative Hidradenitides
% 218.46/218.61  |- skos__broader mesh__D017497smesh__D017192
% 218.46/218.61  |- mesh__dateEstablished mesh__D017497 1993-01-01
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D017497 2003
% 218.46/218.61  |- skos__prefLabel mesh__D017497 Hidradenitis Suppurativa
% 218.46/218.61  |- mesh__historyNote mesh__D017497 93   
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D017497 2004
% 218.46/218.61  |- mesh__publicMeSHNote mesh__D017497 93   
% 218.46/218.61  |- mesh__dateRevised mesh__D017497 2001-07-25
% 218.46/218.61  |- rdf__type mesh__D017497sskos__Concept
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D017497 2002
% 218.46/218.61  |- skos__historyNote mesh__D017497 Sweat Glands %28%1966-1975%29%
% 218.46/218.61  |- skos__hiddenLabel mesh__D017497 Hidradenitis, Suppurative
% 218.46/218.61  |- skos__historyNote mesh__D017497 Sweat Gland Diseases %28%1976-1991%29%
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D017497 2005
% 218.46/218.61  |- mesh__recordMaintainer mesh__D017497 lkt
% 218.46/218.61  |- mesh__dateCreated mesh__D017497 1992-05-20
% 218.46/218.61  |- skos__hiddenLabel mesh__D017497 Hidradenitides, Suppurative
% 218.46/218.61  |- skos__scopeNote mesh__D017497
% 218.46/218.61       A chronic suppurative and cicatricial disease of the apocrine glands occurring chiefly in the axillae in women and in the groin and anal regions in men. It is characterized by poral occlusion with secondary bacterial infection, evolving into abscesses which eventually rupture. As the disease becomes chronic, ulcers appear, sinus tracts enlarge, fistulas develop, and fibrosis and scarring become evident. Hormonal mechanisms are expected in its pathogenesis.%A%    
% 218.46/218.61  |- skos__annotation mesh__D017497 bact skin dis   
% 218.46/218.61  |- skos__broader mesh__D017497smesh__D016575
% 218.46/218.61  |- skos__historyNote mesh__D017497 Hidradenitis %28%1992%29%
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D017497 2006
% 218.46/218.61  |- skos__altLabel mesh__D031168 Chamomilla recutita
% 218.46/218.61  |- skos__altLabel mesh__D031168 Camomile, German
% 218.46/218.61  |- rdf__type mesh__D031168sskos__Concept
% 218.46/218.61  |- skos__historyNote mesh__D031168 Chamomile %28%1999-2002%29%
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D031168 2004
% 218.46/218.61  |- mesh__historyNote mesh__D031168
% 218.46/218.61       2003; for MATRICARIA CHAMOMILLA use CHAMOMILE 1999-2002   
% 218.46/218.61  |- skos__scopeNote mesh__D031168
% 218.46/218.61       A plant genus of the family ASTERACEAE. M. chamomilla appears similar to Anthemis but this flower disk is conical and hollow and lacks chaffy bract scales and the odor is weaker. The common name of %27%manzanilla%27% is confused with other meanings of the word. %27%Matricaria chamomilla sensu%27% is classified by some as Tripleurospermum perforata. Other plants with similar common names include CHAMAEMELUM; TRIPLEUROSPERMUM and ANTHEMIS.%A%    
% 218.46/218.61  |- mesh__dateEstablished mesh__D031168 2003-01-01
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D031168 2003
% 218.46/218.61  |- mesh__recordAuthorizer mesh__D031168 sjn
% 218.46/218.61  |- skos__altLabel mesh__D031168 Pineapple Weed
% 218.46/218.61  |- skos__annotation mesh__D031168
% 218.46/218.61       X refs: distinguish from related plants with similar common names; check text and MeSH;  for Matricaria parthenium use TANACETUM; MATRICARIA PERFORATA see TRIPLEUROSPERMUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.46/218.61  |- skos__altLabel mesh__D031168 Mayweed, Crown
% 218.46/218.61  |- mesh__recordMaintainer mesh__D031168 ssb
% 218.46/218.61  |- mesh__publicMeSHNote mesh__D031168
% 218.46/218.61       2003; for MATRICARIA CHAMOMILLA see CHAMOMILE 1999-2002   
% 218.46/218.61  |- skos__broader mesh__D031168smesh__D020843
% 218.46/218.61  |- skos__altLabel mesh__D031168 Chamomile, German
% 218.46/218.61  |- mesh__dateCreated mesh__D031168 2002-07-03
% 218.46/218.61  |- mesh__recordOriginator mesh__D031168 ssb
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D031168 2006
% 218.46/218.61  |- skos__prefLabel mesh__D031168 Matricaria
% 218.46/218.61  |- skos__altLabel mesh__D031168 German Chamomile
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D031168 2005
% 218.46/218.61  |- skos__hiddenLabel mesh__D008960 Psychologic Models
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D008960 2005
% 218.46/218.61  |- skos__hiddenLabel mesh__D008960 Psychologic Model
% 218.46/218.61  |- skos__scopeNote mesh__D008960
% 218.46/218.61       Theoretical representations that simulate psychological processes and/or social processes. These include the use of mathematical equations, computers, and other electronic equipment.%A%    
% 218.46/218.61  |- skos__related mesh__D008960smesh__D011337
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D008960 2003
% 218.46/218.61  |- skos__historyNote mesh__D008960 Models, Theoretical %28%1966-1967%29%
% 218.46/218.61  |- rdf__type mesh__D008960sskos__Concept
% 218.46/218.61  |- skos__altLabel mesh__D008960 Model, Psychological
% 218.46/218.61  |- skos__prefLabel mesh__D008960 Models, Psychological
% 218.46/218.61  |- mesh__dateRevised mesh__D008960 1997-06-20
% 218.46/218.61  |- skos__annotation mesh__D008960
% 218.46/218.61       no qualif; TN 128: definition %26% relation to MODELS, THEORETICAL; DF: MODELS PSYCHOL%A%  
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D008960 2001
% 218.46/218.61  |- skos__altLabel mesh__D008960 Psychological Models
% 218.46/218.61  |- skos__hiddenLabel mesh__D008960 Model, Psychologic
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D008960 2000
% 218.46/218.61  |- mesh__dateEstablished mesh__D008960 1973-01-01
% 218.46/218.61  |- skos__hiddenLabel mesh__D008960 Psychological Model
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D008960 1999
% 218.46/218.61  |- mesh__recordAuthorizer mesh__D008960 SJN
% 218.46/218.61  |- mesh__dateCreated mesh__D008960 1999-01-01
% 218.46/218.61  |- mesh__recordOriginator mesh__D008960 NLM
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D008960 1998
% 218.46/218.61  |- skos__altLabel mesh__D008960 Models, Psychologic
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D008960 2006
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D008960 2002
% 218.46/218.61  |- skos__broader mesh__D008960smesh__D008962
% 218.46/218.61  |- mesh__onlineNote mesh__D008960
% 218.46/218.61       use MODELS, PSYCHOLOGICAL to search MODELS, PSYCHOLOGIC 1968-72%A%  
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D008960 2004
% 218.46/218.61  |- mesh__publicMeSHNote mesh__D008960
% 218.46/218.61       73; was MODELS, PSYCHOLOGIC 1968-72   
% 218.46/218.61  |- mesh__historyNote mesh__D008960 73; was MODELS, PSYCHOLOGIC 1968-72   
% 218.46/218.61  |- mesh__recordMaintainer mesh__D008960 PXP
% 218.46/218.61  |- skos__broader mesh__D008162smesh__D003078
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D008162 2001
% 218.46/218.61  |- mesh__dateCreated mesh__D008162 1979-03-02
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D008162 2005
% 218.46/218.61  |- skos__prefLabel mesh__D008162 Lumicolchicines
% 218.46/218.61  |- skos__historyNote mesh__D008162
% 218.46/218.61       Colchicine %28%1966-1974%29% /AA %28%1975-1979%29%
% 218.46/218.61  |- mesh__recordOriginator mesh__D008162 SH
% 218.46/218.61  |- mesh__dateRevised mesh__D008162 2000-06-22
% 218.46/218.61  |- skos__scopeNote mesh__D008162
% 218.46/218.61       Three, alpha, beta, and gamma isomers of ultraviolet degradation products of colchicine that lack many of the physiological actions of the parent; used as experimental control for colchicine actions.%A%    
% 218.46/218.61  |- mesh__publicMeSHNote mesh__D008162
% 218.46/218.61       91; was see under COLCHICINE 1980-90   
% 218.46/218.61  |- mesh__historyNote mesh__D008162
% 218.46/218.61       91%28%80%29%; was see under COLCHICINE 1980-90   
% 218.46/218.61  |- rdf__type mesh__D008162sskos__Concept
% 218.46/218.61  |- mesh__recordAuthorizer mesh__D008162 sjn
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D008162 2004
% 218.46/218.61  |- mesh__dateEstablished mesh__D008162 1991-01-01
% 218.46/218.61  |- skos__hiddenLabel mesh__D008162 beta Lumicolchicine
% 218.46/218.61  |- skos__hiddenLabel mesh__D008162 gamma Lumicolchicine
% 218.46/218.61  |- mesh__recordMaintainer mesh__D008162 TWD
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D008162 2002
% 218.46/218.61  |- skos__annotation mesh__D008162 /biosyn permitted if by plant   
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D008162 2003
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D008162 2006
% 218.46/218.61  |- mesh__recordOriginator mesh__D007868 NLM
% 218.46/218.61  |- skos__altLabel mesh__D007868 Leg Dermatosis
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D007868 2006
% 218.46/218.61  |- skos__hiddenLabel mesh__D007868 Dermatoses, Leg
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D007868 2005
% 218.46/218.61  |- skos__annotation mesh__D007868
% 218.46/218.61       GEN %26% as coord for specific skin diseases of the leg but not as coord for neoplasms on the leg %28%use neopl coords %28%IM%29% with LEG %28%IM%29%%29%; consider synonym for leg dermatitis %26% do not add DERMATITIS unless one of the specific DERMATITIS terms in MeSH%A%  
% 218.46/218.61  |- mesh__recordAuthorizer mesh__D007868 sjn
% 218.46/218.61  |- mesh__dateRevised mesh__D007868 2003-07-09
% 218.46/218.61  |- mesh__recordMaintainer mesh__D007868 mdb
% 218.46/218.61  |- skos__broader mesh__D007868smesh__D012871
% 218.46/218.61  |- skos__scopeNote mesh__D007868
% 218.46/218.61       A nonspecific term used to denote any cutaneous lesion or group of lesions, or eruptions of any type on the leg. %28%From Stedman, 25th ed%29%%A%    
% 218.46/218.61  |- skos__hiddenLabel mesh__D007868 Dermatosis, Leg
% 218.46/218.61  |- skos__prefLabel mesh__D007868 Leg Dermatoses
% 218.46/218.61  |- rdf__type mesh__D007868sskos__Concept
% 218.46/218.61  |- mesh__dateCreated mesh__D007868 1999-01-01
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D007868 2004
% 218.46/218.61  |- skos__hiddenLabel mesh__D018590 Uterine Monitorings
% 218.46/218.61  |- skos__scopeNote mesh__D018590
% 218.46/218.61       Measurement or recording of contraction activity of the uterine muscle. It is used to determine progress of LABOR, OBSTETRIC and assess status of pregnancy. It is also used in conjunction with FETAL MONITORING to determine fetal response to stress of maternal uterine contractions.%A%    
% 218.46/218.61  |- skos__hiddenLabel mesh__D018590 Monitorings, Uterine
% 218.46/218.61  |- skos__broader mesh__D018590smesh__D008991
% 218.46/218.61  |- mesh__recordAuthorizer mesh__D018590 sjn
% 218.46/218.61  |- skos__altLabel mesh__D018590 Tocography
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D018590 2004
% 218.46/218.61  |- skos__historyNote mesh__D018590
% 218.46/218.61       Monitoring, Physiologic %28%1972-1994%29%
% 218.46/218.61  |- mesh__dateEstablished mesh__D018590 1995-01-01
% 218.46/218.61  |- skos__prefLabel mesh__D018590 Uterine Monitoring
% 218.46/218.61  |- mesh__publicMeSHNote mesh__D018590
% 218.46/218.61       95; TOCODYNAMOMETRY %26% TOCOGRAPHY were see CARDIOTOCOGRAPHY 1989-94%A%  
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D018590 2005
% 218.46/218.61  |- skos__hiddenLabel mesh__D018590 Tocogram
% 218.46/218.61  |- skos__annotation mesh__D018590
% 218.46/218.61       do not use /util except by MeSH definition   
% 218.46/218.61  |- mesh__dateRevised mesh__D018590 2002-07-03
% 218.46/218.61  |- mesh__dateCreated mesh__D018590 1994-06-01
% 218.46/218.61  |- skos__altLabel mesh__D018590 Tocodynamometry
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D018590 2006
% 218.46/218.61  |- mesh__recordMaintainer mesh__D018590 sjn
% 218.46/218.61  |- skos__historyNote mesh__D018590 Uterine Contraction %28%1976-1994%29%
% 218.46/218.61  |- mesh__onlineNote mesh__D018590
% 218.46/218.61       use CARDIOTOCOGRAPHY to search TOCODYNAMOMETRY %26% TOCOGRAPHY 1989-94%A%  
% 218.46/218.61  |- mesh__historyNote mesh__D018590
% 218.46/218.61       95; TOCODYNAMOMETRY %26% TOCOGRAPHY were see CARDIOTOCOGRAPHY 1989-94%A%  
% 218.46/218.61  |- skos__hiddenLabel mesh__D018590 Monitoring, Uterine
% 218.46/218.61  |- skos__broader mesh__D018590smesh__D003944
% 218.46/218.61  |- rdf__type mesh__D018590sskos__Concept
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D018590 2003
% 218.46/218.61  |- mesh__recordOriginator mesh__D018590 JLS
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D032261 2006
% 218.46/218.61  |- mesh__historyNote mesh__D032261 2003   
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D032261 2003
% 218.46/218.61  |- rdf__type mesh__D032261sskos__Concept
% 218.46/218.61  |- mesh__dateCreated mesh__D032261 2002-07-03
% 218.46/218.61  |- mesh__publicMeSHNote mesh__D032261 2003   
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D032261 2004
% 218.46/218.61  |- skos__broader mesh__D032261smesh__D028083
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D032261 2005
% 218.46/218.61  |- skos__prefLabel mesh__D032261 Picrorhiza
% 218.46/218.61  |- skos__scopeNote mesh__D032261
% 218.46/218.61       A plant genus of the family SCROPHULARIACEAE. Members contain scrosides %28%CINNAMATES%29% and phenylethanoid glycoside.  P. kurrooa is the source of picroliv %28%a purified iridoid glycoside fraction from the roots having hepatoprotective, anti- inflammatory and antioxidant properties%29%.%A%    
% 218.46/218.61  |- mesh__dateEstablished mesh__D032261 2003-01-01
% 218.46/218.61  |- skos__annotation mesh__D032261
% 218.46/218.61       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D004570 2003
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D004570 1997
% 218.46/218.61  |- mesh__recordAuthorizer mesh__D004570 PLS
% 218.46/218.61  |- skos__annotation mesh__D004570 IM; no qualif   
% 218.46/218.61  |- mesh__historyNote mesh__D004570 72; was ELECTROGALVANISM 1965-71   
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D004570 1998
% 218.46/218.61  |- skos__hiddenLabel mesh__D004570 Oral Galvanisms
% 218.46/218.61  |- mesh__dateRevised mesh__D004570 1991-05-15
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D004570 1996
% 218.46/218.61  |- skos__hiddenLabel mesh__D004570 Oral Galvanism
% 218.46/218.61  |- mesh__dateCreated mesh__D004570 1999-01-01
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D004570 2001
% 218.46/218.61  |- skos__broader mesh__D004570smesh__D003813
% 218.46/218.61  |- skos__hiddenLabel mesh__D004570 Electrogalvanisms, Intraoral
% 218.46/218.61  |- mesh__dateEstablished mesh__D004570 1972-01-01
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D004570 2000
% 218.46/218.61  |- mesh__onlineNote mesh__D004570
% 218.46/218.61       use ELECTROGALVANISM, INTRAORAL to search ELECTROGALVANISM 1966-71%A%  
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D004570 1995
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D004570 1993
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D004570 2006
% 218.46/218.61  |- skos__altLabel mesh__D004570 Galvanism, Oral
% 218.46/218.61  |- skos__hiddenLabel mesh__D004570 Intraoral Electrogalvanisms
% 218.46/218.61  |- mesh__recordOriginator mesh__D004570 NLM
% 218.46/218.61  |- mesh__publicMeSHNote mesh__D004570 72; was ELECTROGALVANISM 1965-71   
% 218.46/218.61  |- mesh__recordMaintainer mesh__D004570 TGC
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D004570 2004
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D004570 1994
% 218.46/218.61  |- skos__prefLabel mesh__D004570 Electrogalvanism, Intraoral
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D004570 1992
% 218.46/218.61  |- skos__hiddenLabel mesh__D004570 Intraoral Electrogalvanism
% 218.46/218.61  |- skos__hiddenLabel mesh__D004570 Galvanisms, Oral
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D004570 2005
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D004570 2002
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D004570 1999
% 218.46/218.61  |- rdf__type mesh__D004570sskos__Concept
% 218.46/218.61  |- skos__hiddenLabel mesh__D012204 Rh Sensitizations
% 218.46/218.61  |- mesh__recordAuthorizer mesh__D012204 sjn
% 218.46/218.61  |- rdf__type mesh__D012204sskos__Concept
% 218.46/218.61  |- skos__annotation mesh__D012204
% 218.46/218.61       IM; coord with disease /blood %28%IM%29%, not /immunol nor /genet; TN 230%A%  
% 218.46/218.61  |- skos__hiddenLabel mesh__D012204 Factor, Rh
% 218.46/218.61  |- skos__hiddenLabel mesh__D012204 Blood-Group Systems, Rhesus
% 218.46/218.61  |- mesh__onlineNote mesh__D012204
% 218.46/218.61       use RH-HR BLOOD-GROUP SYSTEM to search RH FACTORS 1966-75%A%  
% 218.46/218.61  |- skos__hiddenLabel mesh__D012204 Blood-Group System, Rh-Hr
% 218.46/218.61  |- skos__broader mesh__D012204smesh__D001789
% 218.46/218.61  |- skos__related mesh__D012204smesh__D004899
% 218.46/218.61  |- mesh__historyNote mesh__D012204 76; was RH FACTORS 1963-75   
% 218.46/218.61  |- mesh__recordMaintainer mesh__D012204 ssb
% 218.46/218.61  |- skos__hiddenLabel mesh__D012204 Factors, Rh
% 218.46/218.61  |- skos__hiddenLabel mesh__D012204 Systems, Rh-Hr Blood-Group
% 218.46/218.61  |- skos__hiddenLabel mesh__D012204 System, Rhesus Blood-Group
% 218.46/218.61  |- skos__altLabel mesh__D012204 Rhesus Blood-Group System
% 218.46/218.61  |- skos__hiddenLabel mesh__D012204 Blood-Group System, Rhesus
% 218.46/218.61  |- skos__hiddenLabel mesh__D012204 Rhesus Blood-Group Systems
% 218.46/218.61  |- skos__hiddenLabel mesh__D012204 Rh-Hr Blood-Group Systems
% 218.46/218.61  |- mesh__dateRevised mesh__D012204 2005-06-30
% 218.46/218.61  |- skos__hiddenLabel mesh__D012204 Sensitizations, Rh
% 218.46/218.61  |- skos__hiddenLabel mesh__D012204 Rh Hr Blood Group System
% 218.46/218.61  |- skos__hiddenLabel mesh__D012204 System, Rh-Hr Blood-Group
% 218.46/218.61  |- mesh__recordOriginator mesh__D012204 SH
% 218.46/218.61  |- skos__prefLabel mesh__D012204 Rh-Hr Blood-Group System
% 218.46/218.61  |- skos__hiddenLabel mesh__D012204 Rhesus Blood Group System
% 218.46/218.61  |- skos__hiddenLabel mesh__D012204 Blood-Group Systems, Rh-Hr
% 218.46/218.61  |- skos__hiddenLabel mesh__D012204 Rh Factor
% 218.46/218.61  |- skos__scopeNote mesh__D012204
% 218.46/218.61       Erythrocyte isoantigens of the Rh %28%Rhesus%29% blood group system, the most complex of all human blood groups, because the genes differ by determining a different number of the over thirty antigens thus far described and do so with remarkably different quality. The major antigen Rh or D is the most common cause of erythroblastosis fetalis.%A%    
% 218.46/218.61  |- skos__hiddenLabel mesh__D012204 Systems, Rhesus Blood-Group
% 218.46/218.61  |- mesh__publicMeSHNote mesh__D012204 76; was RH FACTORS 1963-75   
% 218.46/218.61  |- mesh__dateCreated mesh__D012204 1975-07-25
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D012204 2006
% 218.46/218.61  |- skos__hiddenLabel mesh__D012204 Sensitization, Rh
% 218.46/218.61  |- mesh__dateEstablished mesh__D012204 1976-01-01
% 218.46/218.61  |- skos__broader mesh__D017498smesh__D017456
% 218.46/218.61  |- mesh__historyNote mesh__D017498 93   
% 218.46/218.61  |- skos__broader mesh__D017498smesh__D017874
% 218.46/218.61  |- skos__hiddenLabel mesh__D017498 E1 Proteins, Adenovirus
% 218.46/218.61  |- skos__prefLabel mesh__D017498 Adenovirus E1 Proteins
% 218.46/218.61  |- mesh__recordMaintainer mesh__D017498 ssb
% 218.46/218.61  |- mesh__recordAuthorizer mesh__D017498 sjn
% 218.46/218.61  |- rdf__type mesh__D017498sskos__Concept
% 218.46/218.61  |- mesh__dateEstablished mesh__D017498 1993-01-01
% 218.46/218.61  |- skos__hiddenLabel mesh__D017498 Proteins, Adenovirus E1
% 218.46/218.61  |- mesh__dateCreated mesh__D017498 1992-05-13
% 218.46/218.61  |- mesh__recordOriginator mesh__D017498 AGS
% 218.46/218.61  |- mesh__publicMeSHNote mesh__D017498 93   
% 218.46/218.61  |- skos__scopeNote mesh__D017498
% 218.46/218.61       The very first viral gene products synthesized after cells are infected with adenovirus. The E1 region of the genome has been divided into two major transcriptional units, E1A and E1B, each expressing proteins of the same name %28%ADENOVIRUS E1A PROTEINS and ADENOVIRUS E1B PROTEINS%29%.%A%    
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D017498 2006
% 218.46/218.61  |- mesh__dateRevised mesh__D017498 2005-06-30
% 218.46/218.61  |- skos__historyNote mesh__D017498
% 218.46/218.61       Oncogene Proteins, Viral %28%1986-1992%29%
% 218.46/218.61  |- skos__annotation mesh__D017498
% 218.46/218.61       adenovirus early proteins; /drug eff /ultrastruct permitted%A%  
% 218.46/218.61  |- skos__broader mesh__D031169smesh__D020843
% 218.46/218.61  |- rdf__type mesh__D031169sskos__Concept
% 218.46/218.61  |- mesh__dateCreated mesh__D031169 2002-07-03
% 218.46/218.61  |- skos__altLabel mesh__D031169 Matricaria perforata
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D031169 2004
% 218.46/218.61  |- mesh__recordOriginator mesh__D031169 ssb
% 218.46/218.61  |- skos__altLabel mesh__D031169 Tripleurosperum perforatum
% 218.46/218.61  |- skos__altLabel mesh__D031169 Camomile, Scentless
% 218.46/218.61  |- skos__annotation mesh__D031169
% 218.46/218.61       X refs: distinguish from related plants with similar common names; check text and MeSH; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.46/218.61  |- skos__historyNote mesh__D031169 Chamomile %28%1999-2002%29%
% 218.46/218.61  |- mesh__dateEstablished mesh__D031169 2003-01-01
% 218.46/218.61  |- skos__scopeNote mesh__D031169
% 218.46/218.61       A plant genus of the family ASTERACEAE.  It is easily confused with related plants with similar common names of Chamomile and Mayweed %28%MATRICARIA; CHAMAEMELUM; and ANTHEMIS%29%.%A%    
% 218.46/218.61  |- mesh__recordMaintainer mesh__D031169 ssb
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D031169 2005
% 218.46/218.61  |- mesh__historyNote mesh__D031169
% 218.46/218.61       2003; for MATRICARIA PERFORATA use CHAMOMILE 1999-2002   
% 218.46/218.61  |- skos__altLabel mesh__D031169 Chamomile, Scentless
% 218.46/218.61  |- skos__prefLabel mesh__D031169 Tripleurospermum
% 218.46/218.61  |- skos__altLabel mesh__D031169 Mayweed, False
% 218.46/218.61  |- mesh__recordAuthorizer mesh__D031169 sjn
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D031169 2006
% 218.46/218.61  |- mesh__publicMeSHNote mesh__D031169
% 218.46/218.61       2003; for MATRICARIA PERFORATA see CHAMOMILE 1999-2002   
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D031169 2003
% 218.46/218.61  |- mesh__historyNote mesh__D008961 68   
% 218.46/218.61  |- mesh__recordMaintainer mesh__D008961 jls
% 218.46/218.61  |- skos__hiddenLabel mesh__D008961 Structural Models
% 218.46/218.61  |- mesh__recordOriginator mesh__D008961 NLM
% 218.46/218.61  |- skos__prefLabel mesh__D008961 Models, Structural
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D008961 2005A
% 218.46/218.61  |- mesh__recordAuthorizer mesh__D008961 jls
% 218.46/218.61  |- skos__broader mesh__D008961smesh__D001296
% 218.46/218.61  |- skos__hiddenLabel mesh__D008961 Model, Structural
% 218.46/218.61  |- mesh__dateCreated mesh__D008961 1999-01-01
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D008961 2006
% 218.46/218.61  |- skos__hiddenLabel mesh__D008961 Structural Model
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D008961 2005
% 218.46/218.61  |- mesh__dateEstablished mesh__D008961 1968-01-01
% 218.46/218.61  |- mesh__dateRevised mesh__D008961 2004-07-28
% 218.46/218.61  |- skos__annotation mesh__D008961
% 218.46/218.61       no qualif; TN 37: relation to MODELS, CHEMICAL   
% 218.46/218.61  |- mesh__publicMeSHNote mesh__D008961 68   
% 218.46/218.61  |- rdf__type mesh__D008961sskos__Concept
% 218.46/218.61  |- skos__scopeNote mesh__D008961
% 218.46/218.61       A representation, generally small in scale, to show the structure, construction, or appearance of something. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 218.46/218.61  |- mesh__publicMeSHNote mesh__D008163 2005; see LUMINESCENCE 1963-2004   
% 218.46/218.61  |- skos__altLabel mesh__D008163 Luminescence Measurements
% 218.46/218.61  |- skos__hiddenLabel mesh__D008163 Measurements, Phosphorescent
% 218.46/218.61  |- skos__prefLabel mesh__D008163 Luminescent Measurements
% 218.46/218.61  |- mesh__recordAuthorizer mesh__D008163 sjn
% 218.46/218.61  |- skos__hiddenLabel mesh__D008163 Assay, Luminescent
% 218.46/218.61  |- skos__hiddenLabel mesh__D008163 Measurement, Luminescent
% 218.46/218.61  |- skos__hiddenLabel mesh__D008163 Luminescence Measurement
% 218.46/218.61  |- skos__altLabel mesh__D008163 Luminescent Assays
% 218.46/218.61  |- skos__hiddenLabel mesh__D008163 Measurements, Luminescent
% 218.46/218.61  |- skos__altLabel mesh__D008163 Phosphorescence Measurements
% 218.46/218.61  |- skos__broader mesh__D008163smesh__D010783
% 218.46/218.61  |- skos__hiddenLabel mesh__D008163 Phosphorescent Assay
% 218.46/218.61  |- skos__hiddenLabel mesh__D008163 Assay, Phosphorescent
% 218.46/218.61  |- skos__hiddenLabel mesh__D008163 Measurements, Luminescence
% 218.46/218.61  |- skos__hiddenLabel mesh__D008163 Measurement, Phosphorescent
% 218.46/218.61  |- skos__hiddenLabel mesh__D008163 Assays, Luminescent
% 218.46/218.61  |- skos__hiddenLabel mesh__D008163 Measurement, Phosphorescence
% 218.46/218.61  |- mesh__historyNote mesh__D008163 2005%28%1963%29%   
% 218.46/218.61  |- mesh__dateRevised mesh__D008163 2004-07-13
% 218.46/218.61  |- skos__hiddenLabel mesh__D008163 Luminescent Measurement
% 218.46/218.61  |- skos__altLabel mesh__D008163 Phosphorescent Assays
% 218.46/218.61  |- rdf__type mesh__D008163sskos__Concept
% 218.46/218.61  |- skos__scopeNote mesh__D008163
% 218.46/218.61       Techniques using light resulting from PHYSICAL LUMINESCENCE emitted by LUMINESCENT PROTEINS and LUMINESCENT AGENTS.%A%    
% 218.46/218.61  |- skos__altLabel mesh__D008163 Luminescent Techniques
% 218.46/218.61  |- skos__hiddenLabel mesh__D008163 Measurement, Luminescence
% 218.46/218.61  |- skos__hiddenLabel mesh__D008163 Luminescent Technique
% 218.46/218.61  |- skos__hiddenLabel mesh__D008163 Luminescent Assay
% 218.46/218.61  |- skos__hiddenLabel mesh__D008163 Assays, Phosphorescent
% 218.46/218.61  |- skos__hiddenLabel mesh__D008163 Techniques, Luminescent
% 218.46/218.61  |- skos__hiddenLabel mesh__D008163 Measurements, Phosphorescence
% 218.46/218.61  |- mesh__dateCreated mesh__D008163 1999-01-01
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D008163 2005
% 218.46/218.61  |- skos__hiddenLabel mesh__D008163 Phosphorescent Measurement
% 218.46/218.61  |- mesh__recordOriginator mesh__D008163 NLM
% 218.46/218.61  |- skos__hiddenLabel mesh__D008163 Phosphorescence Measurement
% 218.46/218.61  |- mesh__recordMaintainer mesh__D008163 sjn
% 218.46/218.61  |- mesh__activeMeSHYear mesh__D008163 2006
% 218.47/218.61  |- skos__hiddenLabel mesh__D008163 Technique, Luminescent
% 218.47/218.61  |- rdf__type mesh__D000180sskos__Concept
% 218.47/218.61  |- skos__broader mesh__D000180smesh__D012117
% 218.47/218.61  |- skos__annotation mesh__D000180 D25-26 qualif   
% 218.47/218.61  |- mesh__recordMaintainer mesh__D000180 jmp
% 218.47/218.61  |- mesh__recordAuthorizer mesh__D000180 sjn
% 218.47/218.61  |- skos__hiddenLabel mesh__D000180 Resins, Acrylic
% 218.47/218.61  |- mesh__activeMeSHYear mesh__D000180 2005
% 218.47/218.61  |- skos__related mesh__D000180smesh__D003764
% 218.47/218.61  |- mesh__activeMeSHYear mesh__D000180 2006
% 218.47/218.61  |- mesh__dateRevised mesh__D000180 2004-07-07
% 218.47/218.61  |- skos__prefLabel mesh__D000180 Acrylic Resins
% 218.47/218.61  |- mesh__dateCreated mesh__D000180 1999-01-01
% 218.47/218.61  |- mesh__recordOriginator mesh__D000180 NLM
% 218.47/218.61  |- mesh__recordMaintainer mesh__D007869 KEV
% 218.47/218.61  |- mesh__activeMeSHYear mesh__D007869 2004
% 218.47/218.61  |- mesh__dateRevised mesh__D007869 1999-11-08
% 218.47/218.61  |- mesh__activeMeSHYear mesh__D007869 2003
% 218.47/218.61  |- skos__annotation mesh__D007869
% 218.47/218.61       GEN or unspecified; consider also /inj with specific parts of the leg; /vet permitted for non-primates%A%  
% 218.47/218.61  |- mesh__activeMeSHYear mesh__D007869 2006
% 218.47/218.61  |- mesh__recordAuthorizer mesh__D007869 sjn
% 218.47/218.61  |- mesh__activeMeSHYear mesh__D007869 2005
% 218.47/218.61  |- skos__hiddenLabel mesh__D007869 Injury, Leg
% 218.47/218.61  |- skos__hiddenLabel mesh__D007869 Leg Injury
% 218.47/218.61  |- skos__scopeNote mesh__D007869
% 218.47/218.61       General or unspecified injuries involving the leg.     
% 218.47/218.61  |- mesh__activeMeSHYear mesh__D007869 2002
% 218.47/218.61  |- rdf__type mesh__D007869sskos__Concept
% 218.47/218.61  |- mesh__dateCreated mesh__D007869 1999-01-01
% 218.47/218.61  |- mesh__activeMeSHYear mesh__D007869 2001
% 218.47/218.61  |- skos__related mesh__D007869smesh__D020427
% 218.47/218.61  |- skos__prefLabel mesh__D007869 Leg Injuries
% 218.47/218.61  |- mesh__recordOriginator mesh__D007869 NLM
% 218.47/218.61  |- skos__related mesh__D007869smesh__D020429
% 218.47/218.61  |- mesh__activeMeSHYear mesh__D007869 2000
% 218.47/218.61  |- skos__broader mesh__D007869smesh__D014947
% 218.47/218.61  |- skos__altLabel mesh__D007869 Injuries, Leg
% 218.47/218.61  |- mesh__dateEstablished mesh__D032262 2003-01-01
% 218.47/218.61  |- mesh__activeMeSHYear mesh__D032262 2003
% 218.47/218.61  |- rdf__type mesh__D032262sskos__Concept
% 218.47/218.61  |- skos__prefLabel mesh__D032262 Pedicularis
% 218.47/218.61  |- mesh__historyNote mesh__D032262 2003   
% 218.47/218.61  |- mesh__publicMeSHNote mesh__D032262 2003   
% 218.47/218.61  |- mesh__activeMeSHYear mesh__D032262 2004
% 218.47/218.61  |- mesh__activeMeSHYear mesh__D032262 2005
% 218.47/218.62  |- skos__scopeNote mesh__D032262
% 218.47/218.62       A plant genus of the family SCROPHULARIACEAE. Members contain phenylpropanoid glycosides and iridoids.%A%    
% 218.47/218.62  |- skos__annotation mesh__D032262
% 218.47/218.62       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D032262 2006
% 218.47/218.62  |- mesh__dateCreated mesh__D032262 2002-07-03
% 218.47/218.62  |- skos__broader mesh__D032262smesh__D028083
% 218.47/218.62  |- skos__altLabel mesh__D004571 Radiographic Kymography
% 218.47/218.62  |- skos__hiddenLabel mesh__D004571 Roentgenkymographies
% 218.47/218.62  |- skos__hiddenLabel mesh__D004571 Electrokymographies
% 218.47/218.62  |- mesh__recordOriginator mesh__D004571 NLM
% 218.47/218.62  |- skos__hiddenLabel mesh__D004571 Photokymographies
% 218.47/218.62  |- mesh__dateRevised mesh__D004571 1997-06-20
% 218.47/218.62  |- skos__hiddenLabel mesh__D004571 Radiographic Kymographies
% 218.47/218.62  |- skos__broader mesh__D004571smesh__D004568
% 218.47/218.62  |- skos__hiddenLabel mesh__D004571 Kymographies, Radiographic
% 218.47/218.62  |- skos__altLabel mesh__D004571 Roentgenkymography
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004571 2000
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004571 2005
% 218.47/218.62  |- mesh__recordMaintainer mesh__D004571 PXP
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004571 2003
% 218.47/218.62  |- skos__prefLabel mesh__D004571 Electrokymography
% 218.47/218.62  |- skos__scopeNote mesh__D004571
% 218.47/218.62       Radiographic technique combining a photoelectric recording system with fluoroscopy. It is used especially with electrocardiography to study heart motion.%A%    
% 218.47/218.62  |- skos__annotation mesh__D004571
% 218.47/218.62       NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ELECTROKYMOGR%A%  
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004571 2006
% 218.47/218.62  |- skos__altLabel mesh__D004571 Kymography, Radiographic
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004571 1998
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004571 2004
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004571 2001
% 218.47/218.62  |- mesh__dateCreated mesh__D004571 1999-01-01
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004571 1999
% 218.47/218.62  |- skos__broader mesh__D004571smesh__D011859
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004571 2002
% 218.47/218.62  |- rdf__type mesh__D004571sskos__Concept
% 218.47/218.62  |- skos__broader mesh__D004571smesh__D007734
% 218.47/218.62  |- mesh__recordAuthorizer mesh__D004571 SJN
% 218.47/218.62  |- rdf__type mesh__D045988sskos__Concept
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D045988 2006
% 218.47/218.62  |- mesh__recordOriginator mesh__D045988 ags
% 218.47/218.62  |- skos__scopeNote mesh__D045988
% 218.47/218.62       A family of long-tailed terrestrial omnivores including RACCOONS, lesser panda, ringtails, and coatimundis.%A%    
% 218.47/218.62  |- skos__annotation mesh__D045988
% 218.47/218.62       note X ref PANDAS, LESSER: PANDAS, GIANT and PANDAS, GREATER see URSIDAE is also available%A%  
% 218.47/218.62  |- skos__historyNote mesh__D045988 Carnivora %28%1970-2004%29%
% 218.47/218.62  |- mesh__recordAuthorizer mesh__D045988 sjn
% 218.47/218.62  |- mesh__dateEstablished mesh__D045988 2005-01-01
% 218.47/218.62  |- skos__hiddenLabel mesh__D045988 Lesser Pandas
% 218.47/218.62  |- skos__hiddenLabel mesh__D045988 Panda, Lesser
% 218.47/218.62  |- mesh__historyNote mesh__D045988
% 218.47/218.62       2005; use CARNIVORA 1998; for PANDAS, LESSER use CARNIVORA 1997-2004%A%  
% 218.47/218.62  |- skos__prefLabel mesh__D045988 Procyonidae
% 218.47/218.62  |- skos__broader mesh__D045988smesh__D002335
% 218.47/218.62  |- mesh__publicMeSHNote mesh__D045988
% 218.47/218.62       2005; see CARNIVORA 1998-2004; for PANDAS, LESSER see CARNIVORA 1997-2004%A%  
% 218.47/218.62  |- skos__hiddenLabel mesh__D045988 Lesser Panda
% 218.47/218.62  |- mesh__recordMaintainer mesh__D045988 ags
% 218.47/218.62  |- mesh__dateCreated mesh__D045988 2004-07-07
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D045988 2005
% 218.47/218.62  |- skos__altLabel mesh__D045988 Pandas, Lesser
% 218.47/218.62  |- skos__broader mesh__D012987Q000382smesh__D012987
% 218.47/218.62  |- mesh__preferredCombination mesh__D012987Q000382smesh__D012988
% 218.47/218.62  |- rdf__type mesh__D012987Q000382smesh__CompoundConcept
% 218.47/218.62  |- mesh__publicMeSHNote mesh__D012205 86   
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D012205 2004
% 218.47/218.62  |- mesh__dateEstablished mesh__D012205 1986-01-01
% 218.47/218.62  |- skos__broader mesh__D012205smesh__D017168
% 218.47/218.62  |- skos__prefLabel mesh__D012205 Rhabdiasoidea
% 218.47/218.62  |- mesh__recordAuthorizer mesh__D012205 sjn
% 218.47/218.62  |- skos__annotation mesh__D012205
% 218.47/218.62       a superfamily of nematodes; infection: coord IM with RHABDITIDA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 218.47/218.62  |- skos__scopeNote mesh__D012205
% 218.47/218.62       A superfamily of intestinal nematode parasites containing one genus, STRONGYLOIDES, and several species. It is transmitted through fecal material onto the skin and occurs in animals and humans.%A%    
% 218.47/218.62  |- mesh__dateRevised mesh__D012205 2003-07-09
% 218.47/218.62  |- mesh__recordMaintainer mesh__D012205 ags
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D012205 2006
% 218.47/218.62  |- mesh__dateCreated mesh__D012205 1985-03-11
% 218.47/218.62  |- rdf__type mesh__D012205sskos__Concept
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D012205 2005
% 218.47/218.62  |- mesh__recordOriginator mesh__D012205 EC
% 218.47/218.62  |- mesh__historyNote mesh__D012205 86   
% 218.47/218.62  |- skos__prefLabel mesh__D017499 Porokeratosis
% 218.47/218.62  |- mesh__publicMeSHNote mesh__D017499 93   
% 218.47/218.62  |- mesh__dateRevised mesh__D017499 2001-07-25
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D017499 2002
% 218.47/218.62  |- skos__hiddenLabel mesh__D017499 Linear Porokeratosis
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D017499 2005
% 218.47/218.62  |- skos__broader mesh__D017499smesh__D007642
% 218.47/218.62  |- skos__altLabel mesh__D017499
% 218.47/218.62       Porokeratosis Palmaris et Plantaris Disseminata
% 218.47/218.62  |- skos__altLabel mesh__D017499 Porokeratosis of Mibelli
% 218.47/218.62  |- skos__scopeNote mesh__D017499
% 218.47/218.62       A heritable disorder of faulty keratinization characterized by the proliferation of abnormal clones of KERATINOCYTES and lesions showing varying atrophic patches surrounded by an elevated, keratotic border. These keratotic lesions can progress to overt cutaneous neoplasm. Several clinical variants are recognized, including porokeratosis of Mibelli, linear porokeratosis, disseminated superficial actinic porokeratosis, palmoplantar porokeratosis, and punctate porokeratosis.%A%    
% 218.47/218.62  |- skos__hiddenLabel mesh__D017499 Punctate Porokeratosis
% 218.47/218.62  |- skos__hiddenLabel mesh__D017499 Palmoplantar Porokeratosis
% 218.47/218.62  |- skos__hiddenLabel mesh__D017499 Mibelli Porokeratosis
% 218.47/218.62  |- mesh__recordOriginator mesh__D017499 PLS
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D017499 2006
% 218.47/218.62  |- mesh__dateCreated mesh__D017499 1992-05-22
% 218.47/218.62  |- skos__annotation mesh__D017499 do not confuse with PARAKERATOSIS   
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D017499 2003
% 218.47/218.62  |- mesh__dateEstablished mesh__D017499 1993-01-01
% 218.47/218.62  |- skos__historyNote mesh__D017499 Keratosis %28%1966-1992%29%
% 218.47/218.62  |- mesh__recordAuthorizer mesh__D017499 sjn
% 218.47/218.62  |- mesh__historyNote mesh__D017499 93   
% 218.47/218.62  |- skos__broader mesh__D017499smesh__D012873
% 218.47/218.62  |- mesh__recordMaintainer mesh__D017499 nns
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D017499 2004
% 218.47/218.62  |- rdf__type mesh__D017499sskos__Concept
% 218.47/218.62  |- skos__broader mesh__D013335Q000193smesh__D013335
% 218.47/218.62  |- mesh__preferredCombination mesh__D013335Q000193smesh__D004497
% 218.47/218.62  |- rdf__type mesh__D013335Q000193smesh__CompoundConcept
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D003479 2004
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D003479 2001
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D003479 1998
% 218.47/218.62  |- mesh__historyNote mesh__D003479 66   
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D003479 2006
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D003479 1997
% 218.47/218.62  |- skos__prefLabel mesh__D003479 Curriculum
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D003479 1994
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D003479 1999
% 218.47/218.62  |- skos__scopeNote mesh__D003479
% 218.47/218.62       A course of study offered by an educational institution.%A%    
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D003479 1993
% 218.47/218.62  |- skos__altLabel mesh__D003479 Curricula
% 218.47/218.62  |- mesh__publicMeSHNote mesh__D003479 66   
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D003479 1995
% 218.47/218.62  |- mesh__dateEstablished mesh__D003479 1966-01-01
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D003479 2002
% 218.47/218.62  |- rdf__type mesh__D003479sskos__Concept
% 218.47/218.62  |- skos__hiddenLabel mesh__D003479 Courses, Short-Term
% 218.47/218.62  |- mesh__recordAuthorizer mesh__D003479 PLS
% 218.47/218.62  |- mesh__recordOriginator mesh__D003479 NLM
% 218.47/218.62  |- skos__broader mesh__D003479smesh__D004493
% 218.47/218.62  |- skos__hiddenLabel mesh__D003479 Course, Short-Term
% 218.47/218.62  |- mesh__recordMaintainer mesh__D003479 TGC
% 218.47/218.62  |- skos__hiddenLabel mesh__D003479 Short-Term Course
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D003479 2003
% 218.47/218.62  |- skos__hiddenLabel mesh__D003479 Short Term Courses
% 218.47/218.62  |- mesh__dateRevised mesh__D003479 1992-05-14
% 218.47/218.62  |- mesh__dateCreated mesh__D003479 1999-01-01
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D003479 2000
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D003479 2005
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D003479 1996
% 218.47/218.62  |- skos__annotation mesh__D008962
% 218.47/218.62       no qualif; TN 128: definition %26% relation to its specifics; physiol models are indexed under MODELS, BIOLOGICAL; models of social behavior are indexed under MODELS, PSYCHOLOGICAL%A%  
% 218.47/218.62  |- skos__altLabel mesh__D008962 Models %28%Theoretical%29%
% 218.47/218.62  |- mesh__recordAuthorizer mesh__D008962 sjn
% 218.47/218.62  |- mesh__dateCreated mesh__D008962 1999-01-01
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D008962 2006
% 218.47/218.62  |- skos__hiddenLabel mesh__D008962 Study, Theoretical
% 218.47/218.62  |- skos__hiddenLabel mesh__D008962 Theoretical Models
% 218.47/218.62  |- mesh__recordMaintainer mesh__D008962 jls
% 218.47/218.62  |- skos__hiddenLabel mesh__D008962 Theoretical Model
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D008962 2005
% 218.47/218.62  |- mesh__recordOriginator mesh__D008962 NLM
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D008962 2004
% 218.47/218.62  |- skos__altLabel mesh__D008962 Models, Theoretic
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D008962 2002
% 218.47/218.62  |- mesh__dateEstablished mesh__D008962 1968-01-01
% 218.47/218.62  |- skos__hiddenLabel mesh__D008962 Model %28%Theoretical%29%
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D008962 2003
% 218.47/218.62  |- mesh__historyNote mesh__D008962 68; MODELS was heading 1966-67   
% 218.47/218.62  |- skos__altLabel mesh__D008962 Model, Experimental
% 218.47/218.62  |- rdf__type mesh__D008962sskos__Concept
% 218.47/218.62  |- skos__altLabel mesh__D008962 Models, Experimental
% 218.47/218.62  |- skos__scopeNote mesh__D008962
% 218.47/218.62       Theoretical representations that simulate the behavior or activity of systems, processes, or phenomena. They include the use of mathematical equations, computers, and other electronic equipment.%A%    
% 218.47/218.62  |- skos__hiddenLabel mesh__D008962 Studies, Theoretical
% 218.47/218.62  |- skos__broader mesh__D008962smesh__D012586
% 218.47/218.62  |- mesh__dateRevised mesh__D008962 2001-07-25
% 218.47/218.62  |- mesh__onlineNote mesh__D008962
% 218.47/218.62       use MODELS, THEORETICAL to search MODELS 1966-67   
% 218.47/218.62  |- mesh__publicMeSHNote mesh__D008962 68; MODELS was heading 1966-67   
% 218.47/218.62  |- skos__hiddenLabel mesh__D008962 Model, Theoretical
% 218.47/218.62  |- skos__prefLabel mesh__D008962 Models, Theoretical
% 218.47/218.62  |- skos__altLabel mesh__D008962 Experimental Models
% 218.47/218.62  |- skos__hiddenLabel mesh__D008962 Theoretical Studies
% 218.47/218.62  |- skos__prefLabel mesh__D008164 Luminescent Proteins
% 218.47/218.62  |- skos__altLabel mesh__D008164 Photoproteins
% 218.47/218.62  |- skos__scopeNote mesh__D008164
% 218.47/218.62       Proteins which are involved in the phenomenon of light emission in living systems. Included are the %22%enzymatic%22% and %22%non-enzymatic%22% types of system with or without the presence of oxygen or co-factors.%A%    
% 218.47/218.62  |- skos__hiddenLabel mesh__D008164 Proteins, Luminescent
% 218.47/218.62  |- skos__hiddenLabel mesh__D008164 Proteins, Bioluminescent
% 218.47/218.62  |- mesh__dateCreated mesh__D008164 1978-03-09
% 218.47/218.62  |- skos__historyNote mesh__D008164 Luminescence %28%1966-1978%29%
% 218.47/218.62  |- mesh__dateEstablished mesh__D008164 1979-01-01
% 218.47/218.62  |- mesh__recordMaintainer mesh__D008164 SYSTEM
% 218.47/218.62  |- mesh__recordOriginator mesh__D008164 RLS
% 218.47/218.62  |- mesh__recordAuthorizer mesh__D008164 sjn
% 218.47/218.62  |- rdf__type mesh__D008164sskos__Concept
% 218.47/218.62  |- skos__altLabel mesh__D008164 Bioluminescent Proteins
% 218.47/218.62  |- mesh__publicMeSHNote mesh__D008164
% 218.47/218.62       79; AEQUORIN was see under PROTEINS 1975-78   
% 218.47/218.62  |- mesh__historyNote mesh__D008164 79   
% 218.47/218.62  |- skos__historyNote mesh__D008164 Proteins %28%1966-1978%29%
% 218.47/218.62  |- skos__annotation mesh__D008164 /biosyn /physiol permitted   
% 218.47/218.62  |- mesh__dateRevised mesh__D008164 2005-06-30
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D008164 2006
% 218.47/218.62  |- skos__broader mesh__D008164smesh__D011506
% 218.47/218.62  |- mesh__publicMeSHNote mesh__D000181 91; see NITRILES 1977-90   
% 218.47/218.62  |- skos__broader mesh__D000181smesh__D009570
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D000181 2005
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D000181 2003
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D000181 2006
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D000181 2000
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D000181 1999
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D000181 2004
% 218.47/218.62  |- mesh__historyNote mesh__D000181 91%28%77%29%   
% 218.47/218.62  |- mesh__recordOriginator mesh__D000181 RLS
% 218.47/218.62  |- mesh__dateEstablished mesh__D000181 1991-01-01
% 218.47/218.62  |- skos__prefLabel mesh__D000181 Acrylonitrile
% 218.47/218.62  |- mesh__recordAuthorizer mesh__D000181 SJN
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D000181 2001
% 218.47/218.62  |- rdf__type mesh__D000181sskos__Concept
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D000181 2002
% 218.47/218.62  |- skos__historyNote mesh__D000181 Acrylates %28%1968-1976%29%
% 218.47/218.62  |- mesh__dateRevised mesh__D000181 1998-06-10
% 218.47/218.62  |- skos__scopeNote mesh__D000181
% 218.47/218.62       A highly poisonous compound used widely in the manufacture of plastics, adhesives and synthetic rubber.%A%    
% 218.47/218.62  |- mesh__dateCreated mesh__D000181 1976-04-13
% 218.47/218.62  |- skos__historyNote mesh__D000181 Nitriles %28%1968-1976%29%
% 218.47/218.62  |- mesh__recordMaintainer mesh__D000181 KEV
% 218.47/218.62  |- skos__historyNote mesh__D000181 Vinyl Compounds %28%1973-1976%29%
% 218.47/218.62  |- skos__altLabel mesh__D000181 Vinyl Cyanide
% 218.47/218.62  |- skos__hiddenLabel mesh__D000181 Cyanide, Vinyl
% 218.47/218.62  |- skos__hiddenLabel mesh__D018592 Cross-Over Study
% 218.47/218.62  |- skos__hiddenLabel mesh__D018592 Cross Over Design
% 218.47/218.62  |- skos__hiddenLabel mesh__D018592 Design, Cross-Over
% 218.47/218.62  |- mesh__recordMaintainer mesh__D018592 ags
% 218.47/218.62  |- skos__hiddenLabel mesh__D018592 Crossover Study
% 218.47/218.62  |- skos__broader mesh__D018592smesh__D015340
% 218.47/218.62  |- skos__hiddenLabel mesh__D018592 Designs, Crossover
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D018592 2005
% 218.47/218.62  |- mesh__recordOriginator mesh__D018592 TGC
% 218.47/218.62  |- mesh__dateCreated mesh__D018592 1994-04-16
% 218.47/218.62  |- skos__hiddenLabel mesh__D018592 Trials, Cross-Over
% 218.47/218.62  |- skos__hiddenLabel mesh__D018592 Cross Over Trials
% 218.47/218.62  |- skos__annotation mesh__D018592
% 218.47/218.62       usually drug or other ther study; IM GEN only; coord NIM with specific ther %28%IM%29%; coord NIM also with any other study design such as RANDOM ALLOCATION; DOUBLE-BLIND METHOD; etc. %28%NIM%29%; when pertinent add CLINICAL TRIAL %28%PT%29% or RANDOMIZED CONTROLLED TRIAL %28%PT%29%; no qualif%A%  
% 218.47/218.62  |- rdf__type mesh__D018592sskos__Concept
% 218.47/218.62  |- skos__hiddenLabel mesh__D018592 Studies, Crossover
% 218.47/218.62  |- skos__hiddenLabel mesh__D018592 Study, Crossover
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D018592 2004
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D018592 2002
% 218.47/218.62  |- mesh__dateRevised mesh__D018592 2001-07-25
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D018592 2003
% 218.47/218.62  |- skos__altLabel mesh__D018592 Crossover Trials
% 218.47/218.62  |- skos__altLabel mesh__D018592 Crossover Studies
% 218.47/218.62  |- skos__hiddenLabel mesh__D018592 Designs, Cross-Over
% 218.47/218.62  |- mesh__publicMeSHNote mesh__D018592 95   
% 218.47/218.62  |- skos__hiddenLabel mesh__D018592 Studies, Cross-Over
% 218.47/218.62  |- skos__prefLabel mesh__D018592 Cross-Over Studies
% 218.47/218.62  |- mesh__dateEstablished mesh__D018592 1995-01-01
% 218.47/218.62  |- skos__altLabel mesh__D018592 Crossover Design
% 218.47/218.62  |- mesh__historyNote mesh__D018592 95   
% 218.47/218.62  |- skos__altLabel mesh__D018592 Cross-Over Trials
% 218.47/218.62  |- skos__hiddenLabel mesh__D018592 Trial, Cross-Over
% 218.47/218.62  |- skos__hiddenLabel mesh__D018592 Design, Crossover
% 218.47/218.62  |- skos__hiddenLabel mesh__D018592 Trial, Crossover
% 218.47/218.62  |- skos__hiddenLabel mesh__D018592 Study, Cross-Over
% 218.47/218.62  |- skos__hiddenLabel mesh__D018592 Trials, Crossover
% 218.47/218.62  |- mesh__recordAuthorizer mesh__D018592 sjn
% 218.47/218.62  |- skos__hiddenLabel mesh__D018592 Crossover Designs
% 218.47/218.62  |- skos__hiddenLabel mesh__D018592 Cross-Over Designs
% 218.47/218.62  |- skos__hiddenLabel mesh__D018592 Cross Over Studies
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D018592 2006
% 218.47/218.62  |- skos__scopeNote mesh__D018592
% 218.47/218.62       Studies comparing two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. In the case of two treatments, A and B, half the subjects are randomly allocated to receive these in the order A, B and half to receive them in the order B, A. A criticism of this design is that effects of the first treatment may carry over into the period when the second is given. %28%Last, A Dictionary of Epidemiology, 2d ed%29%%A%    
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D032263 2004
% 218.47/218.62  |- mesh__publicMeSHNote mesh__D032263 2003   
% 218.47/218.62  |- skos__prefLabel mesh__D032263 Penstemon
% 218.47/218.62  |- skos__broader mesh__D032263smesh__D028083
% 218.47/218.62  |- mesh__dateCreated mesh__D032263 2002-07-03
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D032263 2005
% 218.47/218.62  |- skos__annotation mesh__D032263
% 218.47/218.62       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.47/218.62  |- mesh__dateEstablished mesh__D032263 2003-01-01
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D032263 2006
% 218.47/218.62  |- skos__scopeNote mesh__D032263
% 218.47/218.62       A plant genus of the family SCROPHULARIACEAE. Members contain phenylpropanoid and iridoid glycosides.%A%    
% 218.47/218.62  |- mesh__historyNote mesh__D032263 2003   
% 218.47/218.62  |- rdf__type mesh__D032263sskos__Concept
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D032263 2003
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004572 2002
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004572 1994
% 218.47/218.62  |- mesh__dateRevised mesh__D004572 1992-05-15
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004572 2005
% 218.47/218.62  |- skos__scopeNote mesh__D004572
% 218.47/218.62       Destruction by passage of a galvanic electric current, as in disintegration of a chemical compound in solution.%A%    
% 218.47/218.62  |- mesh__recordAuthorizer mesh__D004572 PLS
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004572 1995
% 218.47/218.62  |- skos__prefLabel mesh__D004572 Electrolysis
% 218.47/218.62  |- mesh__recordOriginator mesh__D004572 NLM
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004572 2003
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004572 2006
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004572 1998
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004572 1993
% 218.47/218.62  |- skos__hiddenLabel mesh__D004572 Electrolyses
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004572 2004
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004572 1996
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004572 1999
% 218.47/218.62  |- mesh__dateCreated mesh__D004572 1999-01-01
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004572 2000
% 218.47/218.62  |- skos__broader mesh__D004572smesh__D004563
% 218.47/218.62  |- rdf__type mesh__D004572sskos__Concept
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004572 1997
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D004572 2001
% 218.47/218.62  |- mesh__recordMaintainer mesh__D004572 TAP
% 218.47/218.62  |- skos__hiddenLabel mesh__D045989 Snow Leopard
% 218.47/218.62  |- skos__hiddenLabel mesh__D045989 Leopard, Snow
% 218.47/218.62  |- skos__scopeNote mesh__D045989
% 218.47/218.62       The cat family in the order CARNIVORA comprised of muscular, deep-chested terrestrial carnivores with a highly predatory lifestyle.%A%    
% 218.47/218.62  |- skos__altLabel mesh__D045989 Uncia uncia
% 218.47/218.62  |- mesh__recordOriginator mesh__D045989 ags
% 218.47/218.62  |- skos__altLabel mesh__D045989 Leopardus pardalis
% 218.47/218.62  |- skos__hiddenLabel mesh__D045989 Clouded Leopards
% 218.47/218.62  |- skos__hiddenLabel mesh__D045989 Leopard, Clouded
% 218.47/218.62  |- skos__hiddenLabel mesh__D045989 Ocelot
% 218.47/218.62  |- mesh__recordAuthorizer mesh__D045989 sjn
% 218.47/218.62  |- mesh__dateEstablished mesh__D045989 2005-01-01
% 218.47/218.62  |- skos__broader mesh__D045989smesh__D002335
% 218.47/218.62  |- skos__prefLabel mesh__D045989 Felidae
% 218.47/218.62  |- mesh__recordMaintainer mesh__D045989 ags
% 218.47/218.62  |- skos__historyNote mesh__D045989 Carnivora %28%1966-2004%29%
% 218.47/218.62  |- mesh__dateCreated mesh__D045989 2004-07-07
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D045989 2005
% 218.47/218.62  |- mesh__publicMeSHNote mesh__D045989 2005; see CARNIVORA 1998-2004   
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D045989 2006
% 218.47/218.62  |- rdf__type mesh__D045989sskos__Concept
% 218.47/218.62  |- skos__hiddenLabel mesh__D045989 Clouded Leopard
% 218.47/218.62  |- mesh__historyNote mesh__D045989 2005; use CARNIVORA 1998-2004   
% 218.47/218.62  |- skos__altLabel mesh__D045989 Leopards, Snow
% 218.47/218.62  |- skos__historyNote mesh__D012206 Myoglobinuria %28%1966-1983%29%
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D012206 1999
% 218.47/218.62  |- mesh__publicMeSHNote mesh__D012206
% 218.47/218.62       84; MYOGLOBINURIA was heading 1965-83   
% 218.47/218.62  |- mesh__recordMaintainer mesh__D012206 KEV
% 218.47/218.62  |- skos__historyNote mesh__D012206 Muscular Diseases %28%1966-1983%29%
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D012206 2002
% 218.47/218.62  |- skos__prefLabel mesh__D012206 Rhabdomyolysis
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D012206 1998
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D012206 2006
% 218.47/218.62  |- mesh__dateEstablished mesh__D012206 1984-01-01
% 218.47/218.62  |- mesh__dateCreated mesh__D012206 1983-04-21
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D012206 2001
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D012206 1997
% 218.47/218.62  |- rdf__type mesh__D012206sskos__Concept
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D012206 2005
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D012206 2000
% 218.47/218.62  |- mesh__recordAuthorizer mesh__D012206 PLS
% 218.47/218.62  |- mesh__historyNote mesh__D012206 84   
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D012206 1996
% 218.47/218.62  |- skos__hiddenLabel mesh__D012206 Rhabdomyolyses
% 218.47/218.62  |- skos__scopeNote mesh__D012206
% 218.47/218.62       Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.%A%    
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D012206 2004
% 218.47/218.62  |- skos__annotation mesh__D012206
% 218.47/218.62       %22%necrosis or disintegration of skeletal muscle often followed by myoglobinuria%22%: do not index under MYOGLOBINURIA unless this is particularly discussed %26% then probably NIM%A%  
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D012206 2003
% 218.47/218.62  |- mesh__recordOriginator mesh__D012206 RC
% 218.47/218.62  |- skos__broader mesh__D012206smesh__D009135
% 218.47/218.62  |- skos__historyNote mesh__D012206 Kidney Failure, Acute %28%1967-1983%29%
% 218.47/218.62  |- mesh__dateRevised mesh__D012206 1995-06-08
% 218.47/218.62  |- mesh__historyNote mesh__D008963 65   
% 218.47/218.62  |- mesh__recordMaintainer mesh__D008963 lkt
% 218.47/218.62  |- skos__scopeNote mesh__D008963
% 218.47/218.62       The most posterior teeth on either side of the jaw, totaling eight in the deciduous dentition %28%2 on each side, upper and lower%29%, and usually 12 in the permanent dentition %28%three on each side, upper and lower%29%. They are grinding teeth, having large crowns and broad chewing surfaces. %28%Jablonski, Dictionary of Dentistry, 1992, p821%29%%A%    
% 218.47/218.62  |- skos__annotation mesh__D008963
% 218.47/218.62       the most posterior teeth; for grinding; NIM when merely locational%A%  
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D008963 2006
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D008963 2004
% 218.47/218.62  |- mesh__dateRevised mesh__D008963 2003-07-09
% 218.47/218.62  |- mesh__dateEstablished mesh__D008963 1965-01-01
% 218.47/218.62  |- mesh__publicMeSHNote mesh__D008963 65   
% 218.47/218.62  |- skos__prefLabel mesh__D008963 Molar
% 218.47/218.62  |- mesh__recordAuthorizer mesh__D008963 sjn
% 218.47/218.62  |- rdf__type mesh__D008963sskos__Concept
% 218.47/218.62  |- mesh__recordOriginator mesh__D008963 NLM
% 218.47/218.62  |- mesh__dateCreated mesh__D008963 1999-01-01
% 218.47/218.62  |- skos__broader mesh__D008963smesh__D014070
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D008963 2005
% 218.47/218.62  |- skos__hiddenLabel mesh__D008963 Molars
% 218.47/218.62  |- mesh__recordAuthorizer mesh__D000980 sjn
% 218.47/218.62  |- skos__hiddenLabel mesh__D000980 Drugs, Antiplatyhelmintic
% 218.47/218.62  |- mesh__dateEstablished mesh__D000980 1975-09-01
% 218.47/218.62  |- skos__prefLabel mesh__D000980 Antiplatyhelmintic Agents
% 218.47/218.62  |- mesh__dateRevised mesh__D000980 2003-07-09
% 218.47/218.62  |- skos__altLabel mesh__D000980 Antiplatyhelmintic Drugs
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D000980 2004
% 218.47/218.62  |- skos__hiddenLabel mesh__D000980 Agents, Antiplatyhelmintic
% 218.47/218.62  |- skos__altLabel mesh__D000980 Antiplatyhelmintics
% 218.47/218.62  |- skos__historyNote mesh__D000980 Anthelmintics %28%1966-1974%29%
% 218.47/218.62  |- mesh__dateCreated mesh__D000980 1999-01-01
% 218.47/218.62  |- skos__scopeNote mesh__D000980
% 218.47/218.62       Agents used to treat cestode, trematode, or other flatworm infestations in man or animals.%A%    
% 218.47/218.62  |- mesh__recordMaintainer mesh__D000980 ssb
% 218.47/218.62  |- mesh__historyNote mesh__D000980 75   
% 218.47/218.62  |- skos__broader mesh__D000980smesh__D000871
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D000980 2005
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D000980 2006
% 218.47/218.62  |- mesh__publicMeSHNote mesh__D000980 75   
% 218.47/218.62  |- rdf__type mesh__D000980sskos__Concept
% 218.47/218.62  |- skos__annotation mesh__D000980
% 218.47/218.62       consider also PLATYHELMINTHS /drug eff or pertinent specifics%A%  
% 218.47/218.62  |- mesh__recordOriginator mesh__D000980 NLM
% 218.47/218.62  |- rdf__type mesh__D008165sskos__Concept
% 218.47/218.62  |- skos__historyNote mesh__D008165 Pyridazines %28%1968-1974%29%
% 218.47/218.62  |- mesh__historyNote mesh__D008165
% 218.47/218.62       91%28%75%29%; was see under PYRIDAZINES 1975-90   
% 218.47/218.62  |- mesh__recordMaintainer mesh__D008165 JRT
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D008165 2001
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D008165 2004
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D008165 2005
% 218.47/218.62  |- skos__annotation mesh__D008165
% 218.47/218.62       a reagent; D25-26 qualif; do not confuse with Luminal, a brand of PHENOBARBITAL%A%  
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D008165 2006
% 218.47/218.62  |- mesh__recordAuthorizer mesh__D008165 PLS
% 218.47/218.62  |- mesh__recordOriginator mesh__D008165 NLM
% 218.47/218.62  |- mesh__publicMeSHNote mesh__D008165
% 218.47/218.62       91; was see under PYRIDAZINES 1975-90   
% 218.47/218.62  |- mesh__activeMeSHYear mesh__D008165 2002
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D008165 1996
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D008165 1997
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D008165 1998
% 218.47/218.63  |- skos__prefLabel mesh__D008165 Luminol
% 218.47/218.63  |- mesh__dateEstablished mesh__D008165 1991-01-01
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D008165 2000
% 218.47/218.63  |- skos__broader mesh__D008165smesh__D011724
% 218.47/218.63  |- mesh__dateRevised mesh__D008165 1995-06-08
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D008165 1999
% 218.47/218.63  |- mesh__dateCreated mesh__D008165 1974-11-19
% 218.47/218.63  |- skos__scopeNote mesh__D008165
% 218.47/218.63       5-Amino-2,3-dihydro-1,4-phthalazinedione. Substance that emits light on oxidation. It is used in chemical determinations.%A%    
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D008165 2003
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D000182 2006
% 218.47/218.63  |- skos__broader mesh__D000182smesh__D009384
% 218.47/218.63  |- mesh__recordMaintainer mesh__D000182 lkt
% 218.47/218.63  |- mesh__dateRevised mesh__D000182 2004-07-07
% 218.47/218.63  |- skos__altLabel mesh__D000182 Ectopic ACTH Syndrome
% 218.47/218.63  |- mesh__dateEstablished mesh__D000182 1991-01-01
% 218.47/218.63  |- rdf__type mesh__D000182sskos__Concept
% 218.47/218.63  |- skos__prefLabel mesh__D000182 ACTH Syndrome, Ectopic
% 218.47/218.63  |- skos__hiddenLabel mesh__D000182 Syndromes, Ectopic ACTH
% 218.47/218.63  |- skos__scopeNote mesh__D000182
% 218.47/218.63       Symptom complex due to ACTH production by non-pituitary neoplasms.%A%    
% 218.47/218.63  |- skos__hiddenLabel mesh__D000182 ACTH Syndromes, Ectopic
% 218.47/218.63  |- mesh__historyNote mesh__D000182
% 218.47/218.63       91%28%80%29%; was see under NEOPLASTIC ENDOCRINE-LIKE SYNDROMES 1980-90%A%  
% 218.47/218.63  |- mesh__publicMeSHNote mesh__D000182
% 218.47/218.63       91; was see under NEOPLASTIC ENDOCRINE-LIKE SYNDROMES 1980-90%A%  
% 218.47/218.63  |- skos__annotation mesh__D000182
% 218.47/218.63       caused by %22%ACTH production by non-pituitary neoplasms%22%; do not use /blood supply /chem /second /secret /ultrastruct; coord IM with precoord organ/neopl term with /secret %28%IM%29% + histol type of neopl /secret %28%IM%29%%A%  
% 218.47/218.63  |- skos__historyNote mesh__D000182
% 218.47/218.63       Adrenocorticotropic Hormone %28%1966-1979%29%
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D000182 2005
% 218.47/218.63  |- mesh__recordOriginator mesh__D000182 VDK
% 218.47/218.63  |- skos__hiddenLabel mesh__D000182 Syndrome, Ectopic ACTH
% 218.47/218.63  |- skos__hiddenLabel mesh__D000182 Ectopic ACTH Syndromes
% 218.47/218.63  |- mesh__recordAuthorizer mesh__D000182 sjn
% 218.47/218.63  |- mesh__dateCreated mesh__D000182 1979-05-29
% 218.47/218.63  |- skos__prefLabel mesh__D032264 Veronica
% 218.47/218.63  |- mesh__historyNote mesh__D032264 2003   
% 218.47/218.63  |- skos__scopeNote mesh__D032264
% 218.47/218.63       A plant genus of the family SCROPHULARIACEAE. Members contain bis-sesquiterpene and iridoid glucosides.%A%    
% 218.47/218.63  |- skos__annotation mesh__D032264
% 218.47/218.63       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D032264 2006
% 218.47/218.63  |- skos__broader mesh__D032264smesh__D028083
% 218.47/218.63  |- mesh__dateCreated mesh__D032264 2002-07-03
% 218.47/218.63  |- mesh__dateEstablished mesh__D032264 2003-01-01
% 218.47/218.63  |- rdf__type mesh__D032264sskos__Concept
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D032264 2003
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D032264 2004
% 218.47/218.63  |- mesh__publicMeSHNote mesh__D032264 2003   
% 218.47/218.63  |- skos__altLabel mesh__D032264 Speedwell
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D032264 2005
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004573 2003
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004573 2006
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004573 1998
% 218.47/218.63  |- mesh__recordMaintainer mesh__D004573 TGC
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004573 2000
% 218.47/218.63  |- skos__related mesh__D004573smesh__D005440
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004573 2004
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004573 1996
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004573 2001
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004573 1999
% 218.47/218.63  |- mesh__dateCreated mesh__D004573 1999-01-01
% 218.47/218.63  |- rdf__type mesh__D004573sskos__Concept
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004573 1997
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004573 2002
% 218.47/218.63  |- skos__scopeNote mesh__D004573
% 218.47/218.63       Substances that dissociate into two or more ions, to some extent, in water. Solutions of electrolytes thus conduct an electric current and can be decomposed by it %28%ELECTROLYSIS%29%. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 218.47/218.63  |- skos__related mesh__D004573smesh__D014883
% 218.47/218.63  |- skos__related mesh__D004573smesh__D014882
% 218.47/218.63  |- mesh__recordAuthorizer mesh__D004573 PLS
% 218.47/218.63  |- skos__annotation mesh__D004573
% 218.47/218.63       GEN: prefer specifics but use for more than three; /ther use: consider also ORAL REHYDRATION THERAPY see FLUID THERAPY%A%  
% 218.47/218.63  |- skos__prefLabel mesh__D004573 Electrolytes
% 218.47/218.63  |- mesh__recordOriginator mesh__D004573 NLM
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004573 2005
% 218.47/218.63  |- mesh__dateRevised mesh__D004573 1995-03-16
% 218.47/218.63  |- skos__broader mesh__D004573smesh__D007287
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D012207 1998
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D012207 2006
% 218.47/218.63  |- skos__hiddenLabel mesh__D012207 Rhabdomyomas
% 218.47/218.63  |- skos__broader mesh__D012207smesh__D009214
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D012207 1997
% 218.47/218.63  |- rdf__type mesh__D012207sskos__Concept
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D012207 2005
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D012207 2002
% 218.47/218.63  |- mesh__dateCreated mesh__D012207 1999-01-01
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D012207 1996
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D012207 2004
% 218.47/218.63  |- skos__prefLabel mesh__D012207 Rhabdomyoma
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D012207 2001
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D012207 2003
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D012207 2000
% 218.47/218.63  |- mesh__recordAuthorizer mesh__D012207 PLS
% 218.47/218.63  |- mesh__dateRevised mesh__D012207 1995-06-08
% 218.47/218.63  |- skos__annotation mesh__D012207
% 218.47/218.63       /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 218.47/218.63  |- skos__scopeNote mesh__D012207
% 218.47/218.63       A benign tumor derived from striated muscle. It is extremely rare, generally occurring in the tongue, neck muscles, larynx, uvula, nasal cavity, axilla, vulva, and heart. These tumors are treated by simple excision. %28%Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1354%29%%A%    
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D012207 1999
% 218.47/218.63  |- mesh__recordOriginator mesh__D012207 NLM
% 218.47/218.63  |- mesh__recordMaintainer mesh__D012207 KEV
% 218.47/218.63  |- skos__scopeNote mesh__D008964
% 218.47/218.63       The aftermost permanent tooth on each side in the maxilla and mandible.%A%    
% 218.47/218.63  |- mesh__publicMeSHNote mesh__D008964 82   
% 218.47/218.63  |- mesh__dateRevised mesh__D008964 2004-07-13
% 218.47/218.63  |- skos__annotation mesh__D008964
% 218.47/218.63       the last tooth, behind the 2d molar; human only; IM   
% 218.47/218.63  |- skos__altLabel mesh__D008964 Tooth, Wisdom
% 218.47/218.63  |- skos__hiddenLabel mesh__D008964 Third Molars
% 218.47/218.63  |- skos__hiddenLabel mesh__D008964 Wisdom Tooth
% 218.47/218.63  |- rdf__type mesh__D008964sskos__Concept
% 218.47/218.63  |- mesh__dateCreated mesh__D008964 1981-02-24
% 218.47/218.63  |- mesh__dateEstablished mesh__D008964 1982-01-01
% 218.47/218.63  |- skos__historyNote mesh__D008964 Molar %28%1966-1981%29%
% 218.47/218.63  |- skos__hiddenLabel mesh__D008964 Molars, Third
% 218.47/218.63  |- mesh__recordOriginator mesh__D008964 RC
% 218.47/218.63  |- skos__altLabel mesh__D008964 Teeth, Wisdom
% 218.47/218.63  |- mesh__recordMaintainer mesh__D008964 sjn
% 218.47/218.63  |- skos__hiddenLabel mesh__D008964 Third Molar
% 218.47/218.63  |- skos__prefLabel mesh__D008964 Molar, Third
% 218.47/218.63  |- mesh__recordAuthorizer mesh__D008964 sjn
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D008964 2005
% 218.47/218.63  |- skos__hiddenLabel mesh__D008964 Wisdom Teeth
% 218.47/218.63  |- mesh__historyNote mesh__D008964 82   
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D008964 2006
% 218.47/218.63  |- skos__broader mesh__D008964smesh__D008963
% 218.47/218.63  |- mesh__historyNote mesh__D000981 67   
% 218.47/218.63  |- skos__prefLabel mesh__D000981 Antiprotozoal Agents
% 218.47/218.63  |- mesh__dateCreated mesh__D000981 1999-01-01
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D000981 2005
% 218.47/218.63  |- mesh__recordOriginator mesh__D000981 NLM
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D000981 2006
% 218.47/218.63  |- mesh__recordAuthorizer mesh__D000981 sjn
% 218.47/218.63  |- rdf__type mesh__D000981sskos__Concept
% 218.47/218.63  |- mesh__dateEstablished mesh__D000981 1967-01-01
% 218.47/218.63  |- skos__annotation mesh__D000981
% 218.47/218.63       GEN or unspecified; prefer specific groups or specific antiprotozoal agent%A%  
% 218.47/218.63  |- skos__hiddenLabel mesh__D000981 Agents, Antiprotozoal
% 218.47/218.63  |- mesh__dateRevised mesh__D000981 2003-07-09
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D000981 2004
% 218.47/218.63  |- mesh__publicMeSHNote mesh__D000981 67   
% 218.47/218.63  |- skos__broader mesh__D000981smesh__D000977
% 218.47/218.63  |- skos__scopeNote mesh__D000981
% 218.47/218.63       Substances that are destructive to protozoans.     
% 218.47/218.63  |- mesh__recordMaintainer mesh__D000981 ssb
% 218.47/218.63  |- skos__broader mesh__D008166smesh__D002418
% 218.47/218.63  |- skos__historyNote mesh__D008166 Virus Diseases %28%1966-1969%29%
% 218.47/218.63  |- mesh__dateEstablished mesh__D008166 1970-01-01
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D008166 2006
% 218.47/218.63  |- skos__scopeNote mesh__D008166
% 218.47/218.63       A poxvirus infection of cattle characterized by the appearance of nodules on all parts of the skin.%A%    
% 218.47/218.63  |- mesh__recordMaintainer mesh__D008166 ags
% 218.47/218.63  |- mesh__dateRevised mesh__D008166 2003-07-30
% 218.47/218.63  |- skos__hiddenLabel mesh__D008166 Skin Diseases, Lumpy
% 218.47/218.63  |- skos__hiddenLabel mesh__D008166 Skin Disease, Lumpy
% 218.47/218.63  |- skos__hiddenLabel mesh__D008166 Diseases, Lumpy Skin
% 218.47/218.63  |- skos__annotation mesh__D008166
% 218.47/218.63       caused by a poxvirus; usually animal; check tag ANIMALS; don%27%t forget also CATTLE %28%NIM%29% but do not index under CATTLE DISEASES%A%  
% 218.47/218.63  |- mesh__recordOriginator mesh__D008166 NLM
% 218.47/218.63  |- skos__prefLabel mesh__D008166 Lumpy Skin Disease
% 218.47/218.63  |- rdf__type mesh__D008166sskos__Concept
% 218.47/218.63  |- skos__broader mesh__D008166smesh__D011213
% 218.47/218.63  |- mesh__historyNote mesh__D008166
% 218.47/218.63       91%28%90%29%70; was see under POXVIRUS INFECTIONS 1990   
% 218.47/218.63  |- mesh__publicMeSHNote mesh__D008166
% 218.47/218.63       91,70; was see under POXVIRUS INFECTIONS 1990   
% 218.47/218.63  |- skos__hiddenLabel mesh__D008166 Disease, Lumpy Skin
% 218.47/218.63  |- mesh__recordAuthorizer mesh__D008166 sjn
% 218.47/218.63  |- mesh__dateCreated mesh__D008166 1999-01-01
% 218.47/218.63  |- skos__hiddenLabel mesh__D008166 Lumpy Skin Diseases
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D008166 2004
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D008166 2005
% 218.47/218.63  |- skos__historyNote mesh__D008166 Cattle Diseases %28%1966-1969%29%
% 218.47/218.63  |- skos__historyNote mesh__D000183 Blood %28%1973-1974%29%
% 218.47/218.63  |- mesh__recordOriginator mesh__D000183 NLM
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D000183 2006
% 218.47/218.63  |- mesh__recordAuthorizer mesh__D000183 sjn
% 218.47/218.63  |- skos__scopeNote mesh__D000183
% 218.47/218.63       An extract from calf blood containing inorganic salts, amino acids, polypeptides and purines, but no proteins nor antigenic substances or blood group characteristics. Its exact composition is unknown. It has been proposed as a radiation-protective agent.%A%    
% 218.47/218.63  |- mesh__recordMaintainer mesh__D000183 ssb
% 218.47/218.63  |- skos__prefLabel mesh__D000183 Actihaemyl
% 218.47/218.63  |- mesh__publicMeSHNote mesh__D000183
% 218.47/218.63       91; was see under TISSUE EXTRACTS 1975-90   
% 218.47/218.63  |- skos__broader mesh__D000183smesh__D014020
% 218.47/218.63  |- rdf__type mesh__D000183sskos__Concept
% 218.47/218.63  |- mesh__dateRevised mesh__D000183 2005-06-30
% 218.47/218.63  |- skos__altLabel mesh__D000183 Solcoseryl
% 218.47/218.63  |- skos__hiddenLabel mesh__D000183 1021, S
% 218.47/218.63  |- mesh__dateCreated mesh__D000183 1974-11-19
% 218.47/218.63  |- mesh__dateEstablished mesh__D000183 1991-01-01
% 218.47/218.63  |- mesh__historyNote mesh__D000183
% 218.47/218.63       91%28%75%29%; was see under TISSUE EXTRACTS 1975-90   
% 218.47/218.63  |- skos__historyNote mesh__D000183 Tissue Extracts %28%1973-1974%29%
% 218.47/218.63  |- skos__annotation mesh__D013300
% 218.47/218.63       an enzyme; see note on STREPTODORNASE AND STREPTOKINASE   
% 218.47/218.63  |- mesh__dateEstablished mesh__D013300 1966-01-01
% 218.47/218.63  |- mesh__recordMaintainer mesh__D013300 ssb
% 218.47/218.63  |- rdf__type mesh__D013300sskos__Concept
% 218.47/218.63  |- skos__broader mesh__D013300smesh__D010450
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D013300 2006
% 218.47/218.63  |- skos__scopeNote mesh__D013300
% 218.47/218.63       Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase %28%STREPTODORNASE AND STREPTOKINASE%29%. EC 3.4.-.%A%    
% 218.47/218.63  |- mesh__recordOriginator mesh__D013300 NLM
% 218.47/218.63  |- mesh__dateRevised mesh__D013300 2005-06-30
% 218.47/218.63  |- skos__related mesh__D013300smesh__D013299
% 218.47/218.63  |- mesh__historyNote mesh__D013300 66   
% 218.47/218.63  |- mesh__dateCreated mesh__D013300 1999-01-01
% 218.47/218.63  |- skos__prefLabel mesh__D013300 Streptokinase
% 218.47/218.63  |- mesh__publicMeSHNote mesh__D013300 66   
% 218.47/218.63  |- mesh__recordAuthorizer mesh__D013300 sjn
% 218.47/218.63  |- skos__broader mesh__D013300smesh__D010960
% 218.47/218.63  |- skos__hiddenLabel mesh__D018594 Human Bodies
% 218.47/218.63  |- mesh__dateEstablished mesh__D018594 1995-01-01
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D018594 2006
% 218.47/218.63  |- skos__hiddenLabel mesh__D018594 Figure, Human
% 218.47/218.63  |- skos__broader mesh__D018594smesh__D001154
% 218.47/218.63  |- skos__scopeNote mesh__D018594
% 218.47/218.63       The human being as a non-anatomical and non-zoological entity. The emphasis is on the philosophical or artistic treatment of the human being, and includes lay and social attitudes toward the body in history. %28%From J. Cassedy, NLM History of Medicine Division%29%%A%    
% 218.47/218.63  |- skos__annotation mesh__D018594
% 218.47/218.63       the human body as a whole, viewed from an artistic, cultural, historical, or social perspective; no qualif%A%  
% 218.47/218.63  |- mesh__recordMaintainer mesh__D018594 sjn
% 218.47/218.63  |- skos__altLabel mesh__D018594 Human Figure
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D018594 2005
% 218.47/218.63  |- mesh__dateCreated mesh__D018594 1994-04-19
% 218.47/218.63  |- skos__hiddenLabel mesh__D018594 Figures, Human
% 218.47/218.63  |- mesh__recordAuthorizer mesh__D018594 sjn
% 218.47/218.63  |- mesh__publicMeSHNote mesh__D018594 95   
% 218.47/218.63  |- rdf__type mesh__D018594sskos__Concept
% 218.47/218.63  |- skos__broader mesh__D018594smesh__D003469
% 218.47/218.63  |- mesh__dateRevised mesh__D018594 2004-07-13
% 218.47/218.63  |- skos__hiddenLabel mesh__D018594 Bodies, Human
% 218.47/218.63  |- skos__prefLabel mesh__D018594 Human Body
% 218.47/218.63  |- skos__altLabel mesh__D018594 Body, Human
% 218.47/218.63  |- mesh__recordOriginator mesh__D018594 TGC
% 218.47/218.63  |- skos__hiddenLabel mesh__D018594 Human Figures
% 218.47/218.63  |- mesh__historyNote mesh__D018594 95   
% 218.47/218.63  |- skos__hiddenLabel mesh__D018594 Parts, Body
% 218.47/218.63  |- mesh__dateEstablished mesh__D032265 2003-01-01
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D032265 2003
% 218.47/218.63  |- skos__broader mesh__D032265smesh__D028083
% 218.47/218.63  |- mesh__publicMeSHNote mesh__D032265 2003   
% 218.47/218.63  |- skos__prefLabel mesh__D032265 Verbascum
% 218.47/218.63  |- mesh__dateCreated mesh__D032265 2002-07-03
% 218.47/218.63  |- skos__altLabel mesh__D032265 Mullein
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D032265 2006
% 218.47/218.63  |- skos__annotation mesh__D032265
% 218.47/218.63       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D032265 2005
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D032265 2004
% 218.47/218.63  |- rdf__type mesh__D032265sskos__Concept
% 218.47/218.63  |- mesh__historyNote mesh__D032265 2003   
% 218.47/218.63  |- skos__scopeNote mesh__D032265
% 218.47/218.63       A plant genus of the family SCROPHULARIACEAE.     
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004574 2004
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004574 1996
% 218.47/218.63  |- mesh__publicMeSHNote mesh__D004574
% 218.47/218.63       91; was see under ELECTROMAGNETICS 1975-90   
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004574 1999
% 218.47/218.63  |- mesh__historyNote mesh__D004574
% 218.47/218.63       91%28%75%29%; was see under ELECTROMAGNETICS 1975-90   
% 218.47/218.63  |- rdf__type mesh__D004574sskos__Concept
% 218.47/218.63  |- skos__broader mesh__D004574smesh__D004575
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004574 1997
% 218.47/218.63  |- skos__hiddenLabel mesh__D004574 Electromagnetic Field
% 218.47/218.63  |- skos__hiddenLabel mesh__D004574 Fields, Electromagnetic
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004574 2000
% 218.47/218.63  |- mesh__dateEstablished mesh__D004574 1991-01-01
% 218.47/218.63  |- skos__hiddenLabel mesh__D004574 Field, Electromagnetic
% 218.47/218.63  |- mesh__dateCreated mesh__D004574 1974-11-19
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004574 2001
% 218.47/218.63  |- skos__scopeNote mesh__D004574
% 218.47/218.63       Fields representing the joint interplay of electric and magnetic forces.%A%    
% 218.47/218.63  |- mesh__recordMaintainer mesh__D004574 TAP
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004574 1994
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004574 2005
% 218.47/218.63  |- skos__prefLabel mesh__D004574 Electromagnetic Fields
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004574 2002
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004574 1995
% 218.47/218.63  |- mesh__dateRevised mesh__D004574 1992-05-15
% 218.47/218.63  |- skos__annotation mesh__D004574 IM   
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004574 2003
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004574 2006
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004574 1998
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D004574 1993
% 218.47/218.63  |- mesh__recordAuthorizer mesh__D004574 PLS
% 218.47/218.63  |- skos__broader mesh__D004574smesh__D011827
% 218.47/218.63  |- mesh__recordOriginator mesh__D004574 NLM
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D012208 2006
% 218.47/218.63  |- rdf__type mesh__D012208sskos__Concept
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D012208 2003
% 218.47/218.63  |- mesh__recordOriginator mesh__D012208 NLM
% 218.47/218.63  |- skos__prefLabel mesh__D012208 Rhabdomyosarcoma
% 218.47/218.63  |- skos__broader mesh__D012208smesh__D009217
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D012208 2002
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D012208 2004
% 218.47/218.63  |- mesh__recordAuthorizer mesh__D012208 SJN
% 218.47/218.63  |- mesh__recordMaintainer mesh__D012208 TGC
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D012208 1998
% 218.47/218.63  |- skos__scopeNote mesh__D012208
% 218.47/218.63       A malignant solid tumor arising from mesenchymal tissues which normally differentiate to form striated muscle. It can occur in a wide variety of sites. It is divided into four distinct types: pleomorphic, predominantly in male adults; alveolar %28%RHABDOMYOSARCOMA, ALVEOLAR%29%, mainly in adolescents and young adults; embryonal %28%RHABDOMYOSARCOMA, EMBRYONAL%29%, predominantly in infants and children; and botryoidal, also in young children. It is one of the most frequently occurring soft tissue sarcomas and the most common in children under 15. %28%From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p2186; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, pp1647-9%29%%A%    
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D012208 2000
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D012208 1999
% 218.47/218.63  |- mesh__dateRevised mesh__D012208 1997-06-20
% 218.47/218.63  |- skos__annotation mesh__D012208
% 218.47/218.63       GEN; prefer specifics; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 218.47/218.63  |- skos__hiddenLabel mesh__D012208 Rhabdomyosarcomas
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D012208 2005
% 218.47/218.63  |- mesh__activeMeSHYear mesh__D012208 2001
% 218.47/218.63  |- mesh__dateCreated mesh__D012208 1999-01-01
% 218.47/218.63  |- mesh__recordAuthorizer mesh__D008965 sjn
% 218.47/218.63  |- skos__prefLabel mesh__D008965 Molasses
% 218.47/218.63  |- rdf__type mesh__D008965sskos__Concept
% 218.47/218.63  |- mesh__dateCreated mesh__D008965 1999-01-01
% 218.47/218.63  |- mesh__dateRevised mesh__D008965 2004-07-07
% 218.47/218.63  |- mesh__recordOriginator mesh__D008965 NLM
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D008965 2005
% 218.47/218.68  |- skos__scopeNote mesh__D008965
% 218.47/218.68       The syrup remaining after sugar is crystallized out of SUGARCANE or sugar beet juice. It is also used in ANIMAL FEED, and in a fermented form, is used to make industrial ETHYL ALCOHOL and ALCOHOLIC BEVERAGES.%A%    
% 218.47/218.68  |- mesh__recordMaintainer mesh__D008965 ssb
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D008965 2006
% 218.47/218.68  |- skos__hiddenLabel mesh__D008965 Molasse
% 218.47/218.68  |- skos__broader mesh__D008965smesh__D005502
% 218.47/218.68  |- skos__altLabel mesh__D000982 Antipruritic Agents
% 218.47/218.68  |- skos__hiddenLabel mesh__D000982 Drugs, Antipruritic
% 218.47/218.68  |- mesh__recordMaintainer mesh__D000982 ssb
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D000982 2006
% 218.47/218.68  |- rdf__type mesh__D000982sskos__Concept
% 218.47/218.68  |- skos__annotation mesh__D000982
% 218.47/218.68       GEN or unspecified; prefer specifics; D25-26 qualif; consider also PRURITUS /drug ther%A%  
% 218.47/218.68  |- skos__broader mesh__D000982smesh__D003879
% 218.47/218.68  |- skos__scopeNote mesh__D000982
% 218.47/218.68       Agents, usually topical, that relieve itching %28%pruritus%29%.%A%    
% 218.47/218.68  |- mesh__dateEstablished mesh__D000982 1991-01-01
% 218.47/218.68  |- mesh__recordOriginator mesh__D000982 NLM
% 218.47/218.68  |- skos__altLabel mesh__D000982 Antipruritic Drugs
% 218.47/218.68  |- mesh__historyNote mesh__D000982
% 218.47/218.68       91%28%75%29%; was see under DERMATOLOGIC AGENTS 1975-90   
% 218.47/218.68  |- skos__hiddenLabel mesh__D000982 Agents, Antipruritic
% 218.47/218.68  |- mesh__recordAuthorizer mesh__D000982 sjn
% 218.47/218.68  |- skos__prefLabel mesh__D000982 Antipruritics
% 218.47/218.68  |- mesh__onlineNote mesh__D000982 search DERMATOLOGIC AGENTS 1967-74   
% 218.47/218.68  |- mesh__dateCreated mesh__D000982 1999-01-01
% 218.47/218.68  |- mesh__publicMeSHNote mesh__D000982
% 218.47/218.68       91; was see under DERMATOLOGIC AGENTS 1975-90   
% 218.47/218.68  |- mesh__dateRevised mesh__D000982 2005-06-30
% 218.47/218.68  |- mesh__dateEstablished mesh__D008167 1991-01-01
% 218.47/218.68  |- rdf__type mesh__D008167sskos__Concept
% 218.47/218.68  |- mesh__recordOriginator mesh__D008167 NLM
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D008167 2003
% 218.47/218.68  |- skos__altLabel mesh__D008167 Neethling Virus
% 218.47/218.68  |- skos__broader mesh__D008167smesh__D018151
% 218.47/218.68  |- mesh__dateCreated mesh__D008167 1974-12-12
% 218.47/218.68  |- mesh__historyNote mesh__D008167
% 218.47/218.68       91%28%75%29%; was see under POXVIRIDAE 1981-90; was see under POXVIRUSES 1975-80%A%  
% 218.47/218.68  |- mesh__recordAuthorizer mesh__D008167 sjn
% 218.47/218.68  |- skos__annotation mesh__D008167
% 218.47/218.68       infection = LUMPY SKIN DISEASE: see note there; DF: note short X ref or LUMPY SKIN DIS VIRUS%A%  
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D008167 2006
% 218.47/218.68  |- mesh__recordMaintainer mesh__D008167 ags
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D008167 2002
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D008167 2005
% 218.47/218.68  |- mesh__publicMeSHNote mesh__D008167
% 218.47/218.68       91; was see under POXVIRIDAE 1981-90; was see under POXVIRUSES 1975-80%A%  
% 218.47/218.68  |- mesh__dateRevised mesh__D008167 2001-07-25
% 218.47/218.68  |- skos__scopeNote mesh__D008167
% 218.47/218.68       A species of CAPRIPOXVIRUS causing a cattle disease occurring in Africa.%A%    
% 218.47/218.68  |- skos__prefLabel mesh__D008167 Lumpy skin disease virus
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D008167 2004
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D000184 2006
% 218.47/218.68  |- skos__prefLabel mesh__D000184 Acting Out
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D000184 2003
% 218.47/218.68  |- mesh__dateCreated mesh__D000184 1999-01-01
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D000184 1999
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D000184 2005
% 218.47/218.68  |- mesh__recordMaintainer mesh__D000184 PXP
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D000184 2000
% 218.47/218.68  |- mesh__recordOriginator mesh__D000184 NLM
% 218.47/218.68  |- skos__annotation mesh__D000184 no qualif   
% 218.47/218.68  |- skos__historyNote mesh__D000184 Psychoanalytic Therapy %28%1966-1967%29%
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D000184 1998
% 218.47/218.68  |- mesh__publicMeSHNote mesh__D000184 68   
% 218.47/218.68  |- rdf__type mesh__D000184sskos__Concept
% 218.47/218.68  |- mesh__historyNote mesh__D000184 68   
% 218.47/218.68  |- skos__broader mesh__D000184smesh__D003674
% 218.47/218.68  |- mesh__dateRevised mesh__D000184 1997-06-20
% 218.47/218.68  |- skos__scopeNote mesh__D000184
% 218.47/218.68       Expressing unconscious emotional conflicts or feelings, often of hostility or love, through overt behavior.%A%    
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D000184 2002
% 218.47/218.68  |- mesh__recordAuthorizer mesh__D000184 SJN
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D000184 2004
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D000184 2001
% 218.47/218.68  |- mesh__dateEstablished mesh__D000184 1968-01-01
% 218.47/218.68  |- mesh__recordAuthorizer mesh__D027321 sjn
% 218.47/218.68  |- mesh__dateRevised mesh__D027321 2005-06-30
% 218.47/218.68  |- mesh__publicMeSHNote mesh__D027321
% 218.47/218.68       2002; ANION TRANSPORT PROTEINS was indexed under CARRIER PROTEINS 1983-2001 %26% MEMBRANE PROTEINS 1980-1982; for ANION PUMP %26% ANION PUMPS use ION PUMPS 1992-2001%A%  
% 218.47/218.68  |- mesh__dateEstablished mesh__D027321 2002-01-01
% 218.47/218.68  |- skos__broader mesh__D027321smesh__D016623
% 218.47/218.68  |- skos__altLabel mesh__D027321 ATPHPM
% 218.47/218.68  |- mesh__historyNote mesh__D027321
% 218.47/218.68       2002; use ANION TRANSPORT PROTEINS %28%NM%29% 1980-2001; for ANION PUMP %26% ANION PUMPS use ION PUMPS 1992-2001%A%  
% 218.47/218.68  |- skos__prefLabel mesh__D027321 Anion Transport Proteins
% 218.47/218.68  |- skos__scopeNote mesh__D027321
% 218.47/218.68       Membrane proteins whose primary function is to facilitate the transport of negatively charged molecules %28%anions%29% across a biological membrane.%A%    
% 218.47/218.68  |- mesh__recordOriginator mesh__D027321 jmp
% 218.47/218.68  |- skos__annotation mesh__D027321
% 218.47/218.68       ORGANIC ANION TRANSPORTERS is also available   
% 218.47/218.68  |- mesh__recordMaintainer mesh__D027321 SYSTEM
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D027321 2006
% 218.47/218.68  |- mesh__dateCreated mesh__D027321 2001-07-25
% 218.47/218.68  |- skos__historyNote mesh__D027321 Ion Pumps %28%1991-2001%29%
% 218.47/218.68  |- skos__historyNote mesh__D027321 Carrier Proteins %28%1980-2001%29%
% 218.47/218.68  |- skos__historyNote mesh__D027321 Membrane Proteins %28%1980-1982%29%
% 218.47/218.68  |- skos__hiddenLabel mesh__D027321 Pump, Anion
% 218.47/218.68  |- rdf__type mesh__D027321sskos__Concept
% 218.47/218.68  |- skos__hiddenLabel mesh__D027321 Pumps, Anion
% 218.47/218.68  |- skos__altLabel mesh__D027321 Anion Pump
% 218.47/218.68  |- rdf__type mesh__D013301sskos__Concept
% 218.47/218.68  |- mesh__recordAuthorizer mesh__D013301 sjn
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D013301 2006
% 218.47/218.68  |- skos__broader mesh__D013301smesh__D001427
% 218.47/218.68  |- mesh__recordMaintainer mesh__D013301 ssb
% 218.47/218.68  |- skos__broader mesh__D013301smesh__D005098
% 218.47/218.68  |- skos__annotation mesh__D013301
% 218.47/218.68       /antag permitted but consider also ANTISTREPTOLYSIN   
% 218.47/218.68  |- skos__related mesh__D013301smesh__D000989
% 218.47/218.68  |- mesh__publicMeSHNote mesh__D013301 78; was STREPTOLYSIN 1963-77   
% 218.47/218.68  |- skos__prefLabel mesh__D013301 Streptolysins
% 218.47/218.68  |- mesh__dateCreated mesh__D013301 1999-01-01
% 218.47/218.68  |- mesh__onlineNote mesh__D013301
% 218.47/218.68       use STREPTOLYSINS to search STREPTOLYSIN 1966-77   
% 218.47/218.68  |- mesh__historyNote mesh__D013301 78; was STREPTOLYSIN 1963-77   
% 218.47/218.68  |- skos__scopeNote mesh__D013301
% 218.47/218.68       Exotoxins produced by certain strains of streptococci, particularly those of group A %28%STREPTOCOCCUS PYOGENES%29%, that cause HEMOLYSIS.%A%    
% 218.47/218.68  |- mesh__recordOriginator mesh__D013301 NLM
% 218.47/218.68  |- mesh__dateRevised mesh__D013301 2005-06-30
% 218.47/218.68  |- skos__altLabel mesh__D013301 Streptolysin
% 218.47/218.68  |- mesh__recordOriginator mesh__D018595 TGC
% 218.47/218.68  |- skos__annotation mesh__D018595 IM; specify geog %26% hist period   
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D018595 2005
% 218.47/218.68  |- mesh__dateCreated mesh__D018595 1994-04-19
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D018595 2002
% 218.47/218.68  |- rdf__type mesh__D018595sskos__Concept
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D018595 2004
% 218.47/218.68  |- skos__prefLabel mesh__D018595 Colonialism
% 218.47/218.68  |- mesh__publicMeSHNote mesh__D018595
% 218.47/218.68       95; was see POLITICAL SYSTEMS 1990-94   
% 218.47/218.68  |- mesh__onlineNote mesh__D018595
% 218.47/218.68       use POLITICAL SYSTEMS to search COLONIALISM 1990-94   
% 218.47/218.68  |- mesh__dateEstablished mesh__D018595 1995-01-01
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D018595 2001
% 218.47/218.68  |- mesh__historyNote mesh__D018595 95; was see POLITICAL SYSTEMS 1990-94   
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D018595 2003
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D018595 2000
% 218.47/218.68  |- mesh__recordMaintainer mesh__D018595 kle
% 218.47/218.68  |- mesh__recordAuthorizer mesh__D018595 sjn
% 218.47/218.68  |- skos__scopeNote mesh__D018595
% 218.47/218.68       The aggregate of various economic, political, and social policies by which an imperial power maintains or extends its control over other areas or peoples. It includes the practice of or belief in acquiring and retaining colonies. The emphasis is less on its identity as an ideological political system than on its designation in a period of history. %28%Webster, 3d ed; from Dr. J. Cassedy, NLM History of Medicine Division%29%%A%    
% 218.47/218.68  |- mesh__dateRevised mesh__D018595 1999-11-03
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D018595 2006
% 218.47/218.68  |- skos__broader mesh__D018595smesh__D011056
% 218.47/218.68  |- mesh__historyNote mesh__D032266 2003   
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D032266 2006
% 218.47/218.68  |- mesh__dateEstablished mesh__D032266 2003-01-01
% 218.47/218.68  |- skos__broader mesh__D032266smesh__D028083
% 218.47/218.68  |- skos__annotation mesh__D032266
% 218.47/218.68       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D032266 2005
% 218.47/218.68  |- skos__altLabel mesh__D032266 Figwort Betony
% 218.47/218.68  |- mesh__dateCreated mesh__D032266 2002-07-03
% 218.47/218.68  |- skos__scopeNote mesh__D032266
% 218.47/218.68       A plant genus of the family SCROPHULARIACEAE. Members contain iridoids.%A%    
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D032266 2004
% 218.47/218.68  |- rdf__type mesh__D032266sskos__Concept
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D032266 2003
% 218.47/218.68  |- mesh__publicMeSHNote mesh__D032266 2003   
% 218.47/218.68  |- skos__prefLabel mesh__D032266 Scrophularia
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D004575 2004
% 218.47/218.68  |- mesh__dateCreated mesh__D004575 1999-01-01
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D004575 2006
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D004575 2003
% 218.47/218.68  |- mesh__dateEstablished mesh__D004575 1973-01-01
% 218.47/218.68  |- skos__broader mesh__D004575smesh__D008280
% 218.47/218.68  |- skos__annotation mesh__D004575
% 218.47/218.68       SPEC qualif as IM; no qualif when NIM coord; electromagnetic energy or radiation = RADIATION; electromagnetic frequency also goes under RADIATION; ELECTROMAGNETIC FIELDS is also available; MAGNETOMETRY see MAGNETICS is available%A%  
% 218.47/218.68  |- mesh__historyNote mesh__D004575 73   
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D004575 1997
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D004575 2005
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D004575 1999
% 218.47/218.68  |- mesh__recordOriginator mesh__D004575 NLM
% 218.47/218.68  |- skos__scopeNote mesh__D004575
% 218.47/218.68       Phenomena involving magnets, electric currents through conductors and the electric and magnetic fields thus produced, as in electric motors.%A%    
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D004575 2002
% 218.47/218.68  |- skos__broader mesh__D004575smesh__D004560
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D004575 1998
% 218.47/218.68  |- rdf__type mesh__D004575sskos__Concept
% 218.47/218.68  |- skos__historyNote mesh__D004575 Electricity %28%1966-1972%29%
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D004575 2001
% 218.47/218.68  |- skos__prefLabel mesh__D004575 Electromagnetics
% 218.47/218.68  |- mesh__recordMaintainer mesh__D004575 TGC
% 218.47/218.68  |- skos__hiddenLabel mesh__D004575 Electromagnetic
% 218.47/218.68  |- mesh__publicMeSHNote mesh__D004575 73   
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D004575 2000
% 218.47/218.68  |- skos__historyNote mesh__D004575 Magnetics %28%1966-1972%29%
% 218.47/218.68  |- mesh__recordAuthorizer mesh__D004575 PLS
% 218.47/218.68  |- mesh__dateRevised mesh__D004575 1996-06-10
% 218.47/218.68  |- mesh__historyNote mesh__D012209 81; was RHABDOVIRUSES 1978-80   
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D012209 2003
% 218.47/218.68  |- skos__broader mesh__D012209smesh__D018096
% 218.47/218.68  |- skos__prefLabel mesh__D012209 Rhabdoviridae
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D012209 2004
% 218.47/218.68  |- mesh__dateEstablished mesh__D012209 1978-01-01
% 218.47/218.68  |- mesh__dateCreated mesh__D012209 1977-05-04
% 218.47/218.68  |- skos__annotation mesh__D012209 infection = RHABDOVIRIDAE INFECTIONS   
% 218.47/218.68  |- skos__scopeNote mesh__D012209
% 218.47/218.68       A family of bullet-shaped viruses of the order MONONEGAVIRALES, infecting vertebrates, arthropods, protozoa, and plants. Genera include VESICULOVIRUS; LYSSAVIRUS; EPHEMEROVIRUS; NOVIRHABDOVIRUS; Cytorhabdovirus;  and Nucleorhabdovirus.%A%    
% 218.47/218.68  |- mesh__recordAuthorizer mesh__D012209 sjn
% 218.47/218.68  |- mesh__publicMeSHNote mesh__D012209 81; was RHABDOVIRUSES 1978-80   
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D012209 2002
% 218.47/218.68  |- mesh__dateRevised mesh__D012209 2001-07-25
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D012209 2005
% 218.47/218.68  |- mesh__onlineNote mesh__D012209
% 218.47/218.68       use RHABDOVIRIDAE to search RHABDOVIRUSES 1978-80   
% 218.47/218.68  |- mesh__recordMaintainer mesh__D012209 ags
% 218.47/218.68  |- skos__historyNote mesh__D012209 RNA Viruses %28%1966-1977%29%
% 218.47/218.68  |- mesh__activeMeSHYear mesh__D012209 2006
% 218.47/218.68  |- mesh__recordOriginator mesh__D012209 AEP
% 218.47/218.68  |- skos__altLabel mesh__D012209 Rhabdoviruses
% 218.47/218.68  |- skos__hiddenLabel mesh__D012209 Rhabdovirus
% 218.47/218.68  |- rdf__type mesh__D012209sskos__Concept
% 218.47/218.68  |- mesh__recordMaintainer mesh__D009260 lkt
% 218.47/218.68  |- rdf__type mesh__D009260sskos__Concept
% 218.47/218.68  |- skos__hiddenLabel mesh__D009260 Disease, Nail
% 218.47/218.68  |- skos__scopeNote mesh__D009260
% 218.47/218.68       Diseases of the nail plate and tissues surrounding it. The concept is limited to primates.%A%    
% 218.47/218.68  |- skos__hiddenLabel mesh__D009260 Nail Disease
% 218.47/218.68  |- mesh__dateEstablished mesh__D009260 1979-01-01
% 218.47/218.69  |- mesh__publicMeSHNote mesh__D009260 79   
% 218.47/218.69  |- mesh__recordAuthorizer mesh__D009260 sjn
% 218.47/218.69  |- skos__annotation mesh__D009260
% 218.47/218.69       primates only; neopl: coord IM with SKIN NEOPLASMS %28%IM%29%   
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D009260 2004
% 218.47/218.69  |- skos__hiddenLabel mesh__D009260 Diseases, Nail
% 218.47/218.69  |- mesh__historyNote mesh__D009260 79; was NON MESH before 1979   
% 218.47/218.69  |- mesh__dateCreated mesh__D009260 1999-01-01
% 218.47/218.69  |- skos__historyNote mesh__D009260 Nails %28%1966-1978%29%
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D009260 2006
% 218.47/218.69  |- mesh__dateRevised mesh__D009260 2001-07-25
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D009260 2003
% 218.47/218.69  |- skos__broader mesh__D009260smesh__D012871
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D009260 2002
% 218.47/218.69  |- mesh__recordOriginator mesh__D009260 NLM
% 218.47/218.69  |- skos__prefLabel mesh__D009260 Nail Diseases
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D009260 2005
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008966 2001
% 218.47/218.69  |- skos__altLabel mesh__D008966 Moldavia
% 218.47/218.69  |- mesh__recordMaintainer mesh__D008966 PLS
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008966 1999
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008966 1996
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008966 2005
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008966 2002
% 218.47/218.69  |- skos__prefLabel mesh__D008966 Moldova
% 218.47/218.69  |- skos__broader mesh__D008966smesh__D005061
% 218.47/218.69  |- skos__altLabel mesh__D008966 Moldavian SSR
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008966 1997
% 218.47/218.69  |- skos__broader mesh__D008966smesh__D014586
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008966 2006
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008966 2003
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008966 2004
% 218.47/218.69  |- mesh__dateRevised mesh__D008966 1994-03-17
% 218.47/218.69  |- mesh__recordOriginator mesh__D008966 NLM
% 218.47/218.69  |- mesh__onlineNote mesh__D008966
% 218.47/218.69       use MOLDOVA to search MOLDAVIAN S.S.R. 1982-92 %26% MOLDAVIA 1966-81%A%  
% 218.47/218.69  |- skos__broader mesh__D008966smesh__D017517
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008966 1995
% 218.47/218.69  |- skos__altLabel mesh__D008966 Moldavian S.S.R.
% 218.47/218.69  |- rdf__type mesh__D008966sskos__Concept
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008966 2000
% 218.47/218.69  |- mesh__historyNote mesh__D008966
% 218.47/218.69       93; was MOLDAVIAN S.S.R. 1982-92; was MOLDAVIA 1963-81   
% 218.47/218.69  |- mesh__recordAuthorizer mesh__D008966 PLS
% 218.47/218.69  |- mesh__dateCreated mesh__D008966 1999-01-01
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008966 1998
% 218.47/218.69  |- mesh__dateRevised mesh__D000983 2005-06-30
% 218.47/218.69  |- mesh__recordMaintainer mesh__D000983 ssb
% 218.47/218.69  |- rdf__type mesh__D000983sskos__Concept
% 218.47/218.69  |- skos__scopeNote mesh__D000983
% 218.47/218.69       An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p29%29%%A%    
% 218.47/218.69  |- skos__altLabel mesh__D000983 Phenazone
% 218.47/218.69  |- mesh__recordOriginator mesh__D000983 NLM
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D000983 2006
% 218.47/218.69  |- mesh__recordAuthorizer mesh__D000983 sjn
% 218.47/218.69  |- skos__prefLabel mesh__D000983 Antipyrine
% 218.47/218.69  |- skos__broader mesh__D000983smesh__D047069
% 218.47/218.69  |- mesh__dateCreated mesh__D000983 1999-01-01
% 218.47/218.69  |- mesh__dateCreated mesh__D008168 1999-01-01
% 218.47/218.69  |- skos__related mesh__D008168smesh__D000400
% 218.47/218.69  |- skos__annotation mesh__D008168
% 218.47/218.69       /abnorm: CYSTIC ADENOMATOID MALFORMATION OF LUNG, CONGENITAL is available; /blood supply: consider also PULMONARY CIRCULATION; /surg: consider also PNEUMONECTOMY but PULMONARY SURGICAL PROCEDURES is also available; /transpl = LUNG TRANSPLANTATION or HEART-LUNG TRANSPLANTATION: do not coord with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; inflammation = PNEUMONIA; collapse of lung = ATELECTASIS%A%  
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008168 2006
% 218.47/218.69  |- skos__related mesh__D008168smesh__D011013
% 218.47/218.69  |- mesh__recordMaintainer mesh__D008168 ags
% 218.47/218.69  |- mesh__recordOriginator mesh__D008168 NLM
% 218.47/218.69  |- mesh__dateRevised mesh__D008168 2004-07-07
% 218.47/218.69  |- skos__related mesh__D008168smesh__D011652
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008168 2005
% 218.47/218.69  |- skos__broader mesh__D008168smesh__D012137
% 218.47/218.69  |- mesh__recordAuthorizer mesh__D008168 sjn
% 218.47/218.69  |- skos__scopeNote mesh__D008168
% 218.47/218.69       Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.%A%    
% 218.47/218.69  |- skos__prefLabel mesh__D008168 Lung
% 218.47/218.69  |- skos__hiddenLabel mesh__D008168 Lungs
% 218.47/218.69  |- rdf__type mesh__D008168sskos__Concept
% 218.47/218.69  |- skos__related mesh__D008168smesh__D012119
% 218.47/218.69  |- mesh__considerAlso mesh__D008168
% 218.47/218.69       consider also terms at PNEUMO- and PULMON-   
% 218.47/218.69  |- skos__historyNote mesh__D000185 Muscle Proteins %28%1970-1975%29%
% 218.47/218.69  |- mesh__recordOriginator mesh__D000185 RLS
% 218.47/218.69  |- skos__hiddenLabel mesh__D000185 alpha Actinin
% 218.47/218.69  |- mesh__dateRevised mesh__D000185 2005-06-30
% 218.47/218.69  |- mesh__publicMeSHNote mesh__D000185
% 218.47/218.69       85; was see under MUSCLE PROTEINS 1976-84   
% 218.47/218.69  |- mesh__dateCreated mesh__D000185 1975-07-23
% 218.47/218.69  |- skos__hiddenLabel mesh__D000185 beta Actinin
% 218.47/218.69  |- skos__scopeNote mesh__D000185
% 218.47/218.69       A protein factor that regulates the length of R-actin. It is chemically similar, but immunochemically distinguishable from actin.%A%    
% 218.47/218.69  |- skos__broader mesh__D000185smesh__D008840
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D000185 2006
% 218.47/218.69  |- mesh__recordMaintainer mesh__D000185 DRC
% 218.47/218.69  |- skos__hiddenLabel mesh__D000185 Eu Actinin
% 218.47/218.69  |- skos__prefLabel mesh__D000185 Actinin
% 218.47/218.69  |- mesh__historyNote mesh__D000185
% 218.47/218.69       85%28%76%29%; was see under MUSCLE PROTEINS 1976-84   
% 218.47/218.69  |- skos__broader mesh__D000185smesh__D009124
% 218.47/218.69  |- rdf__type mesh__D000185sskos__Concept
% 218.47/218.69  |- mesh__dateEstablished mesh__D000185 1985-01-01
% 218.47/218.69  |- mesh__recordAuthorizer mesh__D000185 sjn
% 218.47/218.69  |- skos__annotation mesh__D000185
% 218.47/218.69       a muscle %26% microfilament protein; /biosyn /physiol permitted%A%  
% 218.47/218.69  |- skos__hiddenLabel mesh__D027322 Amino Acid Transport System X AG
% 218.47/218.69  |- skos__scopeNote mesh__D027322
% 218.47/218.69       A family of POTASSIUM and SODIUM-dependent acidic amino acid transporters that demonstrate a high affinity for GLUTAMIC ACID and ASPARTIC ACID. Several variants of this system are found in neuronal tissue.%A%    
% 218.47/218.69  |- skos__altLabel mesh__D027322 Amino Acid Transport System XAG
% 218.47/218.69  |- skos__broader mesh__D027322smesh__D026922
% 218.47/218.69  |- mesh__recordAuthorizer mesh__D027322 sjn
% 218.47/218.69  |- mesh__dateRevised mesh__D027322 2005-06-30
% 218.47/218.69  |- skos__hiddenLabel mesh__D027322 Transporters, GLAST Glutamate-Aspartate
% 218.47/218.69  |- skos__hiddenLabel mesh__D027322 Transport Glycoprotein, Glutamate
% 218.47/218.69  |- mesh__recordMaintainer mesh__D027322 jmp
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D027322 2006
% 218.47/218.69  |- skos__altLabel mesh__D027322 GLAST Glutamate-Aspartate Transporters
% 218.47/218.69  |- skos__hiddenLabel mesh__D027322 Glutamate Aspartate Transporter
% 218.47/218.69  |- skos__prefLabel mesh__D027322 Amino Acid Transport System X-AG
% 218.47/218.69  |- skos__hiddenLabel mesh__D027322 Transporter, Glutamate-Aspartate
% 218.47/218.69  |- skos__hiddenLabel mesh__D027322 Glutamate-Aspartate Transporters, GLAST
% 218.47/218.69  |- skos__historyNote mesh__D027322 Glutamates/metabolism %28%1979-1989%29%
% 218.47/218.69  |- skos__hiddenLabel mesh__D027322 GLAST Glutamate Aspartate Transporters
% 218.47/218.69  |- mesh__recordOriginator mesh__D027322 jmp
% 218.47/218.69  |- rdf__type mesh__D027322sskos__Concept
% 218.47/218.69  |- skos__altLabel mesh__D027322 Glutamate Transport Glycoprotein
% 218.47/218.69  |- mesh__historyNote mesh__D027322
% 218.47/218.69       2002; for GLUTAMATE TRANSLOCASE use AMINO ACID TRANSPORT SYSTEM X-AG %28%NM%29% 1979-2001; for GLUTAMATE TRANSPORTER use AMINO ACID TRANSPORT SYSTEM X-AG 1989-2001; for GLUTAMATE TRANSPORT GLYCOPROTEIN use AMINO ACID TRANSPORT SYSTEM X-AG 1990-2001; for GLUTAMATE-ASPARTATE TRANSPORTER use AMINO ACID TRANSPORT SYSTEM X-AG %28%NM%29% 1997-2001%A%  
% 218.47/218.69  |- skos__historyNote mesh__D027322 Glycoproteins %28%1979-1995%29%
% 218.47/218.69  |- skos__altLabel mesh__D027322 Glutamate Translocase
% 218.47/218.69  |- mesh__publicMeSHNote mesh__D027322
% 218.47/218.69       2002; GLUTAMATE TRANSLOCASE  was indexed under ABC TRANSPORTERS 1996-2001, under GLYCOPROTEINS 1979-1995 %26% under GLUTAMATES/me 1979-1989; GLUTAMATE TRANSPORTER was indexed under ABC TRANSPORTERS 1996-2001, under GLYCOPROTEINS 1989-1995 %26% under GLUTAMATES/me 1989; GLUTAMATE TRANSPORT GLYCOPROTEIN was indexed under ABC TRANSPORTERS 1996-2001 %26% under GLYCOPROTEINS 1990-1995; GLUTAMATE-ASPARTATE TRANSPORTER%A%  
% 218.47/218.69  |- mesh__dateEstablished mesh__D027322 2002-01-01
% 218.47/218.69  |- mesh__dateCreated mesh__D027322 2001-07-25
% 218.47/218.69  |- skos__historyNote mesh__D027322 ABC Transporters %28%1996-2001%29%
% 218.47/218.69  |- mesh__recordOriginator mesh__D013302 NLM
% 218.47/218.69  |- skos__scopeNote mesh__D013302
% 218.47/218.69       A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.%A%    
% 218.47/218.69  |- mesh__dateRevised mesh__D013302 2005-06-30
% 218.47/218.69  |- skos__prefLabel mesh__D013302 Streptomyces
% 218.47/218.69  |- skos__broader mesh__D013302smesh__D013306
% 218.47/218.69  |- mesh__dateCreated mesh__D013302 1999-01-01
% 218.47/218.69  |- skos__annotation mesh__D013302
% 218.47/218.69       the bacterium that produces many antibiotics   
% 218.47/218.69  |- mesh__recordMaintainer mesh__D013302 SYSTEM
% 218.47/218.69  |- mesh__recordAuthorizer mesh__D013302 sjn
% 218.47/218.69  |- rdf__type mesh__D013302sskos__Concept
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D013302 2006
% 218.47/218.69  |- skos__hiddenLabel mesh__D018596 Ethics, Hindu
% 218.47/218.69  |- skos__prefLabel mesh__D018596 Hinduism
% 218.47/218.69  |- skos__related mesh__D018596smesh__D008515
% 218.47/218.69  |- mesh__historyNote mesh__D018596 95   
% 218.47/218.69  |- mesh__recordOriginator mesh__D018596 TGC
% 218.47/218.69  |- mesh__dateEstablished mesh__D018596 1995-01-01
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D018596 2006
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D018596 2002
% 218.47/218.69  |- skos__annotation mesh__D018596 IM; specify geog if pertinent   
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D018596 2005
% 218.47/218.69  |- mesh__dateCreated mesh__D018596 1994-04-19
% 218.47/218.69  |- skos__broader mesh__D018596smesh__D012067
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D018596 2001
% 218.47/218.69  |- rdf__type mesh__D018596sskos__Concept
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D018596 2004
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D018596 2000
% 218.47/218.69  |- mesh__dateRevised mesh__D018596 1999-11-03
% 218.47/218.69  |- mesh__recordMaintainer mesh__D018596 kle
% 218.47/218.69  |- mesh__recordAuthorizer mesh__D018596 sjn
% 218.47/218.69  |- skos__historyNote mesh__D018596 Religion %28%1966-1994%29%
% 218.47/218.69  |- skos__scopeNote mesh__D018596
% 218.47/218.69       A complex body of social, cultural, and religious beliefs and practices evolved in and largely confined to the Indian subcontinent and marked by a caste system, an outlook tending to view all forms and theories as aspects of one eternal being and truth, and the practice of the way of works, the way of knowledge, or the way of devotion as a means of release from the round of rebirths. %28%From Webster, 3d ed%29%%A%    
% 218.47/218.69  |- mesh__publicMeSHNote mesh__D018596 95   
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D018596 2003
% 218.47/218.69  |- mesh__publicMeSHNote mesh__D032267 2003   
% 218.47/218.69  |- skos__broader mesh__D032267smesh__D028083
% 218.47/218.69  |- mesh__historyNote mesh__D032267 2003   
% 218.47/218.69  |- mesh__dateEstablished mesh__D032267 2003-01-01
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D032267 2006
% 218.47/218.69  |- skos__annotation mesh__D032267
% 218.47/218.69       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.47/218.69  |- skos__prefLabel mesh__D032267 Rehmannia
% 218.47/218.69  |- skos__altLabel mesh__D032267 Foxglove, Chinese
% 218.47/218.69  |- mesh__dateCreated mesh__D032267 2002-07-03
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D032267 2005
% 218.47/218.69  |- rdf__type mesh__D032267sskos__Concept
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D032267 2004
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D032267 2003
% 218.47/218.69  |- skos__scopeNote mesh__D032267
% 218.47/218.69       A plant genus of the family SCROPHULARIACEAE. Members contain catapol, rehmannin and ALKALOIDS.%A%    
% 218.47/218.69  |- mesh__recordMaintainer mesh__D004576 PXP
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D004576 2000
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D004576 2005
% 218.47/218.69  |- mesh__recordAuthorizer mesh__D004576 SJN
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D004576 1999
% 218.47/218.69  |- skos__prefLabel mesh__D004576 Electromyography
% 218.47/218.69  |- rdf__type mesh__D004576sskos__Concept
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D004576 1998
% 218.47/218.69  |- skos__broader mesh__D004576smesh__D009213
% 218.47/218.69  |- skos__scopeNote mesh__D004576
% 218.47/218.69       Recording of the changes in electric potential of muscle by means of surface or needle electrodes.%A%    
% 218.47/218.69  |- mesh__dateRevised mesh__D004576 1997-06-20
% 218.47/218.69  |- skos__annotation mesh__D004576
% 218.47/218.69       NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ELECTROMYOGR%A%  
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D004576 2002
% 218.47/218.69  |- mesh__recordOriginator mesh__D004576 NLM
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D004576 2004
% 218.47/218.69  |- mesh__dateCreated mesh__D004576 1999-01-01
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D004576 2001
% 218.47/218.69  |- skos__broader mesh__D004576smesh__D004568
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D004576 2006
% 218.47/218.69  |- skos__hiddenLabel mesh__D004576 Electromyographies
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D004576 2003
% 218.47/218.69  |- skos__hiddenLabel mesh__D009261 Osteo-Onychodysplasias, Hereditary
% 218.47/218.69  |- skos__altLabel mesh__D009261 Fong Disease
% 218.47/218.69  |- mesh__publicMeSHNote mesh__D009261 65   
% 218.47/218.69  |- skos__hiddenLabel mesh__D009261 Syndrome, Nail-Patella
% 218.47/218.69  |- skos__hiddenLabel mesh__D009261 Disease, Fong
% 218.47/218.69  |- rdf__type mesh__D009261sskos__Concept
% 218.47/218.69  |- mesh__recordOriginator mesh__D009261 NLM
% 218.47/218.69  |- skos__broader mesh__D009261smesh__D009260
% 218.47/218.69  |- skos__broader mesh__D009261smesh__D030342
% 218.47/218.69  |- skos__hiddenLabel mesh__D009261 Turner Kieser Syndrome
% 218.47/218.69  |- skos__altLabel mesh__D009261 Osteo-Onychodysplasia, Hereditary
% 218.47/218.69  |- skos__hiddenLabel mesh__D009261 Syndrome, Pelvic Horn
% 218.47/218.69  |- skos__scopeNote mesh__D009261
% 218.47/218.69       A syndrome of multiple abnormalities characterized by the absence or hypoplasia of the PATELLA and congenital nail dystrophy. It is a genetically determined autosomal dominant trait.%A%    
% 218.47/218.69  |- mesh__dateRevised mesh__D009261 2004-07-07
% 218.47/218.69  |- skos__broader mesh__D009261smesh__D000015
% 218.47/218.69  |- skos__altLabel mesh__D009261 Turner-Kieser Syndrome
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D009261 2006
% 218.47/218.69  |- skos__hiddenLabel mesh__D009261 Hereditary Osteo-Onychodysplasias
% 218.47/218.69  |- mesh__dateCreated mesh__D009261 1999-01-01
% 218.47/218.69  |- skos__hiddenLabel mesh__D009261 Nail Patella Syndrome
% 218.47/218.69  |- skos__altLabel mesh__D009261 Pelvic Horn Syndrome
% 218.47/218.69  |- mesh__dateEstablished mesh__D009261 1965-01-01
% 218.47/218.69  |- skos__hiddenLabel mesh__D009261 Syndrome, Turner-Kieser
% 218.47/218.69  |- skos__altLabel mesh__D009261 Osterreicher Syndrome
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D009261 2005
% 218.47/218.69  |- skos__hiddenLabel mesh__D009261 Syndrome, Osterreicher
% 218.47/218.69  |- skos__hiddenLabel mesh__D009261 Hereditary Osteo-Onychodysplasia
% 218.47/218.69  |- skos__hiddenLabel mesh__D009261 Osteo Onychodysplasia, Hereditary
% 218.47/218.69  |- mesh__recordAuthorizer mesh__D009261 sjn
% 218.47/218.69  |- mesh__recordMaintainer mesh__D009261 nns
% 218.47/218.69  |- mesh__historyNote mesh__D009261 65%28%63%29%   
% 218.47/218.69  |- skos__broader mesh__D009261smesh__D007592
% 218.47/218.69  |- skos__prefLabel mesh__D009261 Nail-Patella Syndrome
% 218.47/218.69  |- skos__historyNote mesh__D008967 Biology %28%1966-1967%29%
% 218.47/218.69  |- mesh__dateEstablished mesh__D008967 1970-01-01
% 218.47/218.69  |- skos__related mesh__D008967smesh__D001669
% 218.47/218.69  |- rdf__type mesh__D008967sskos__Concept
% 218.47/218.69  |- skos__altLabel mesh__D008967 Molecular Genetics
% 218.47/218.69  |- skos__broader mesh__D008967smesh__D001695
% 218.47/218.69  |- skos__related mesh__D008967smesh__D040342
% 218.47/218.69  |- mesh__dateRevised mesh__D008967 2002-07-02
% 218.47/218.69  |- skos__altLabel mesh__D008967 Biochemical Genetics
% 218.47/218.69  |- skos__annotation mesh__D008967
% 218.47/218.69       GEN or SPEC;  molecular biology,molecular genetics or biochemical genetics of a disease, biological process or substance: coord, using an appropriate subheading such as / genet / metab or /chem, with the specific genetics term or biochemical term: Manual 28.24.1; DF: MOL BIOL%A%  
% 218.47/218.69  |- skos__related mesh__D008967smesh__D040341
% 218.47/218.69  |- skos__hiddenLabel mesh__D008967 Biochemical Genetic
% 218.47/218.69  |- skos__related mesh__D008967smesh__D039361
% 218.47/218.69  |- skos__hiddenLabel mesh__D008967 Molecular Genetic
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008967 2004
% 218.47/218.69  |- mesh__recordMaintainer mesh__D008967 nns
% 218.47/218.69  |- skos__broader mesh__D008967smesh__D005823
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008967 2006
% 218.47/218.69  |- mesh__recordAuthorizer mesh__D008967 sjn
% 218.47/218.69  |- skos__altLabel mesh__D008967 Biology, Molecular
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008967 2003
% 218.47/218.69  |- mesh__historyNote mesh__D008967 70%28%68%29%   
% 218.47/218.69  |- skos__hiddenLabel mesh__D008967 Genetic, Biochemical
% 218.47/218.69  |- mesh__dateCreated mesh__D008967 1999-01-01
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008967 2005
% 218.47/218.69  |- mesh__recordOriginator mesh__D008967 NLM
% 218.47/218.69  |- skos__hiddenLabel mesh__D008967 Genetic, Molecular
% 218.47/218.69  |- mesh__publicMeSHNote mesh__D008967 70   
% 218.47/218.69  |- skos__prefLabel mesh__D008967 Molecular Biology
% 218.47/218.69  |- skos__scopeNote mesh__D008967
% 218.47/218.69       A discipline concerned with studying biological phenomena in terms of the chemical and physical interactions of molecules.%A%    
% 218.47/218.69  |- skos__annotation mesh__D008169 for coord read note on ABSCESS   
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008169 2002
% 218.47/218.69  |- skos__prefLabel mesh__D008169 Lung Abscess
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008169 1996
% 218.47/218.69  |- skos__hiddenLabel mesh__D008169 Abscesses, Lung
% 218.47/218.69  |- skos__broader mesh__D008169smesh__D008171
% 218.47/218.69  |- skos__altLabel mesh__D008169 Abscesses, Pulmonary
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008169 1999
% 218.47/218.69  |- skos__broader mesh__D008169smesh__D012141
% 218.47/218.69  |- mesh__recordAuthorizer mesh__D008169 PLS
% 218.47/218.69  |- skos__scopeNote mesh__D008169
% 218.47/218.69       A complication of a localized area of pneumonia or when a neoplasm becomes necrotic and contains purulent material that cannot drain easily from the area because of partial or complete bronchial obstruction. %28%Harrison%27%s Principles of Internal Medicine, 12th ed, p1068%29%%A%    
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008169 2004
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008169 1995
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008169 2001
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008169 1998
% 218.47/218.69  |- rdf__type mesh__D008169sskos__Concept
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008169 2003
% 218.47/218.69  |- mesh__dateRevised mesh__D008169 1994-05-27
% 218.47/218.69  |- skos__broader mesh__D008169smesh__D000038
% 218.47/218.69  |- mesh__recordOriginator mesh__D008169 NLM
% 218.47/218.69  |- skos__altLabel mesh__D008169 Abscess, Pulmonary
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008169 2000
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008169 2006
% 218.47/218.69  |- skos__hiddenLabel mesh__D008169 Lung Abscesses
% 218.47/218.69  |- mesh__dateCreated mesh__D008169 1999-01-01
% 218.47/218.69  |- mesh__recordMaintainer mesh__D008169 PLS
% 218.47/218.69  |- skos__altLabel mesh__D008169 Pulmonary Abscesses
% 218.47/218.69  |- skos__altLabel mesh__D008169 Pulmonary Abscess
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008169 2005
% 218.47/218.69  |- skos__hiddenLabel mesh__D008169 Abscess, Lung
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D008169 1997
% 218.47/218.69  |- skos__broader mesh__D000186smesh__D019216
% 218.47/218.69  |- skos__scopeNote mesh__D000186
% 218.47/218.69       Actinium. A trivalent radioactive element and the prototypical member of the actinide family. It has the atomic symbol Ac, atomic number 89, and atomic weight 227.0278. Its principal isotope is 227 and decays primarily by beta-emission.%A%    
% 218.47/218.69  |- skos__broader mesh__D000186smesh__D008671
% 218.47/218.69  |- mesh__recordAuthorizer mesh__D000186 sjn
% 218.47/218.69  |- skos__prefLabel mesh__D000186 Actinium
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D000186 2006
% 218.47/218.69  |- skos__annotation mesh__D000186 naturally radioactive; IM   
% 218.47/218.69  |- mesh__dateRevised mesh__D000186 2005-06-30
% 218.47/218.69  |- mesh__recordMaintainer mesh__D000186 jmp
% 218.47/218.69  |- mesh__dateCreated mesh__D000186 1999-01-01
% 218.47/218.69  |- rdf__type mesh__D000186sskos__Concept
% 218.47/218.69  |- mesh__recordOriginator mesh__D000186 NLM
% 218.47/218.69  |- skos__hiddenLabel mesh__D046288 Piercings, Eyebrow
% 218.47/218.69  |- skos__hiddenLabel mesh__D046288 Piercings, Body
% 218.47/218.69  |- skos__hiddenLabel mesh__D046288 Lip Piercings
% 218.47/218.69  |- mesh__recordMaintainer mesh__D046288 nns
% 218.47/218.69  |- skos__hiddenLabel mesh__D046288 Piercings, Navel
% 218.47/218.69  |- skos__hiddenLabel mesh__D046288 Piercing, Tongue
% 218.47/218.69  |- skos__broader mesh__D046288smesh__D046289
% 218.47/218.69  |- skos__hiddenLabel mesh__D046288 Navel Piercings
% 218.47/218.69  |- skos__prefLabel mesh__D046288 Body Piercing
% 218.47/218.69  |- skos__hiddenLabel mesh__D046288 Tongue Piercings
% 218.47/218.69  |- rdf__type mesh__D046288sskos__Concept
% 218.47/218.69  |- skos__hiddenLabel mesh__D046288 Piercing, Eyebrow
% 218.47/218.69  |- skos__hiddenLabel mesh__D046288 Eyebrow Piercings
% 218.47/218.69  |- skos__scopeNote mesh__D046288
% 218.47/218.69       The perforation of an anatomical region for the wearing of jewelry.%A%    
% 218.47/218.69  |- skos__hiddenLabel mesh__D046288 Piercings, Lip
% 218.47/218.69  |- skos__hiddenLabel mesh__D046288 Piercing, Nipple
% 218.47/218.69  |- skos__hiddenLabel mesh__D046288 Piercing, Navel
% 218.47/218.69  |- skos__hiddenLabel mesh__D046288 Nipple Piercings
% 218.47/218.69  |- mesh__publicMeSHNote mesh__D046288 2005   
% 218.47/218.69  |- skos__broader mesh__D046288smesh__D011677
% 218.47/218.69  |- mesh__recordAuthorizer mesh__D046288 sjn
% 218.47/218.69  |- mesh__historyNote mesh__D046288 2005   
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D046288 2005
% 218.47/218.69  |- skos__hiddenLabel mesh__D046288 Piercings, Tongue
% 218.47/218.69  |- skos__hiddenLabel mesh__D046288 Piercing, Lip
% 218.47/218.69  |- skos__altLabel mesh__D046288 Piercing, Body
% 218.47/218.69  |- skos__hiddenLabel mesh__D046288 Ear Piercings
% 218.47/218.69  |- skos__hiddenLabel mesh__D046288 Body Piercings
% 218.47/218.69  |- mesh__dateCreated mesh__D046288 2004-07-07
% 218.47/218.69  |- skos__hiddenLabel mesh__D046288 Piercing, Ear
% 218.47/218.69  |- skos__hiddenLabel mesh__D046288 Piercings, Nipple
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D046288 2006
% 218.47/218.69  |- mesh__recordOriginator mesh__D046288 nns
% 218.47/218.69  |- mesh__dateEstablished mesh__D046288 2005-01-01
% 218.47/218.69  |- skos__hiddenLabel mesh__D046288 Piercings, Ear
% 218.47/218.69  |- mesh__recordOriginator mesh__D013303 NLM
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D013303 2006
% 218.47/218.69  |- mesh__dateCreated mesh__D013303 1999-01-01
% 218.47/218.69  |- skos__annotation mesh__D013303 yields oleandomycin   
% 218.47/218.69  |- mesh__dateRevised mesh__D013303 2005-06-30
% 218.47/218.69  |- mesh__dateEstablished mesh__D013303 1991-01-01
% 218.47/218.69  |- mesh__recordAuthorizer mesh__D013303 sjn
% 218.47/218.69  |- skos__broader mesh__D013303smesh__D013302
% 218.47/218.69  |- skos__historyNote mesh__D013303 Streptomyces %28%1966-1971%29%
% 218.47/218.69  |- skos__prefLabel mesh__D013303 Streptomyces antibioticus
% 218.47/218.69  |- rdf__type mesh__D013303sskos__Concept
% 218.47/218.69  |- mesh__historyNote mesh__D013303
% 218.47/218.69       91%28%72%29%; was see under STREPTOMYCES 1972-90   
% 218.47/218.69  |- mesh__recordMaintainer mesh__D013303 SYSTEM
% 218.47/218.69  |- skos__scopeNote mesh__D013303
% 218.47/218.69       An actinomycete from which the antibiotic OLEANDOMYCIN is obtained.%A%    
% 218.47/218.69  |- mesh__publicMeSHNote mesh__D013303
% 218.47/218.69       91; was see under STREPTOMYCES 1972-90   
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D018597 1997
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D018597 2000
% 218.47/218.69  |- mesh__historyNote mesh__D018597 95   
% 218.47/218.69  |- mesh__publicMeSHNote mesh__D018597 95   
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D018597 2006
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D018597 1996
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D018597 1995
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D018597 2005
% 218.47/218.69  |- skos__hiddenLabel mesh__D018597 Saint
% 218.47/218.69  |- mesh__dateCreated mesh__D018597 1994-04-19
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D018597 2004
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D018597 1999
% 218.47/218.69  |- rdf__type mesh__D018597sskos__Concept
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D018597 2002
% 218.47/218.69  |- mesh__dateEstablished mesh__D018597 1995-01-01
% 218.47/218.69  |- skos__scopeNote mesh__D018597
% 218.47/218.69       Persons officially recognized or acknowledged as pre-eminent for consecration, holiness, and piety, especially through canonization by a branch of the Christian church. %28%From Webster, 3d ed%29%%A%    
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D018597 2003
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D018597 1998
% 218.47/218.69  |- skos__prefLabel mesh__D018597 Saints
% 218.47/218.69  |- skos__historyNote mesh__D018597 Religion and Medicine %28%1966-1994%29%
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D018597 2001
% 218.47/218.69  |- skos__annotation mesh__D018597
% 218.47/218.69       IM; coord with RELIGION AND MEDICINE %28%IM%29% if pertinent + specific med aspect %28%IM%29%; TN H: form of Saint names as subject name%A%  
% 218.47/218.69  |- skos__broader mesh__D018597smesh__D002835
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D032268 2005
% 218.47/218.69  |- rdf__type mesh__D032268sskos__Concept
% 218.47/218.69  |- skos__broader mesh__D032268smesh__D029641
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D032268 2004
% 218.47/218.69  |- mesh__dateCreated mesh__D032268 2002-07-02
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D032268 2003
% 218.47/218.69  |- skos__scopeNote mesh__D032268
% 218.47/218.69       A plant genus of the family SIMAROUBACEAE. Members contain ailantinols and other quassinoids.%A%    
% 218.47/218.69  |- skos__altLabel mesh__D032268 Tree Of Heaven
% 218.47/218.69  |- mesh__dateEstablished mesh__D032268 2003-01-01
% 218.47/218.69  |- mesh__publicMeSHNote mesh__D032268 2003   
% 218.47/218.69  |- mesh__historyNote mesh__D032268 2003   
% 218.47/218.69  |- skos__altLabel mesh__D032268 Sumac, China
% 218.47/218.69  |- skos__altLabel mesh__D032268 China-Sumac
% 218.47/218.69  |- skos__prefLabel mesh__D032268 Ailanthus
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D032268 2006
% 218.47/218.69  |- skos__annotation mesh__D032268
% 218.47/218.69       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.47/218.69  |- mesh__recordOriginator mesh__D004577 NLM
% 218.47/218.69  |- skos__altLabel mesh__D004577 X Ray Emission Spectrometry, Electron Probe
% 218.47/218.69  |- skos__altLabel mesh__D004577
% 218.47/218.69       Spectrometry, X Ray Emission, Electron Microscopic
% 218.47/218.69  |- skos__hiddenLabel mesh__D004577 X Ray Microanalysis
% 218.47/218.69  |- skos__scopeNote mesh__D004577
% 218.47/218.69       Identification and measurement of ELEMENTS and their location based on the fact that X-RAYS emitted by an element excited by an electron beam have a wavelength characteristic of that element and an intensity related to its concentration. It is performed with an electron microscope fitted with an x-ray spectrometer, in scanning or transmission mode.%A%    
% 218.47/218.69  |- skos__hiddenLabel mesh__D004577 Probe Microanalysis, Electron
% 218.47/218.69  |- skos__altLabel mesh__D004577
% 218.47/218.69       X Ray Emission Spectrometry, Electron Microscopic
% 218.47/218.69  |- mesh__recordMaintainer mesh__D004577 nns
% 218.47/218.69  |- skos__broader mesh__D004577smesh__D013052
% 218.47/218.69  |- skos__hiddenLabel mesh__D004577 Microanalyses, Electron Probe
% 218.47/218.69  |- skos__broader mesh__D004577smesh__D008854
% 218.47/218.69  |- mesh__dateCreated mesh__D004577 1999-01-01
% 218.47/218.69  |- skos__hiddenLabel mesh__D004577 X Ray Microanalysis, Electron Probe
% 218.47/218.69  |- skos__altLabel mesh__D004577
% 218.47/218.69       Spectrometry, X Ray Emission, Electron Probe
% 218.47/218.69  |- mesh__activeMeSHYear mesh__D004577 2006
% 218.47/218.69  |- mesh__dateEstablished mesh__D004577 1970-01-01
% 218.47/218.70  |- mesh__recordAuthorizer mesh__D004577 sjn
% 218.47/218.70  |- mesh__historyNote mesh__D004577 70%28%67%29%   
% 218.47/218.70  |- mesh__publicMeSHNote mesh__D004577 70   
% 218.47/218.70  |- skos__hiddenLabel mesh__D004577 Electron Probe Microanalyses
% 218.47/218.70  |- skos__historyNote mesh__D004577 Electrons %28%1966%29%
% 218.47/218.70  |- skos__altLabel mesh__D004577 Microscopy, Electron, X-Ray Microanalysis
% 218.47/218.70  |- skos__hiddenLabel mesh__D004577
% 218.47/218.70       X Ray Microanalysis, Electron Microscopic
% 218.47/218.70  |- skos__prefLabel mesh__D004577 Electron Probe Microanalysis
% 218.47/218.70  |- skos__altLabel mesh__D004577 X-Ray Emission Spectrometry, Electron Probe
% 218.47/218.70  |- skos__altLabel mesh__D004577 X-Ray Microanalysis
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D004577 2005
% 218.47/218.70  |- skos__hiddenLabel mesh__D004577 Probe Microanalyses, Electron
% 218.47/218.70  |- skos__altLabel mesh__D004577
% 218.47/218.70       Spectrometry, X-Ray Emission, Electron Microscopic
% 218.47/218.70  |- skos__altLabel mesh__D004577
% 218.47/218.70       X-Ray Emission Spectrometry, Electron Microscopic
% 218.47/218.70  |- skos__altLabel mesh__D004577 X-Ray Microanalysis, Electron Probe
% 218.47/218.70  |- skos__altLabel mesh__D004577
% 218.47/218.70       Spectrometry, X-Ray Emission, Electron Probe
% 218.47/218.70  |- skos__historyNote mesh__D004577 Spectrum Analysis %28%1966%29%
% 218.47/218.70  |- skos__altLabel mesh__D004577 Microanalysis, Electron Probe
% 218.47/218.70  |- skos__annotation mesh__D004577 DF: ELECTRON PROBE MICROANAL   
% 218.47/218.70  |- rdf__type mesh__D004577sskos__Concept
% 218.47/218.70  |- skos__hiddenLabel mesh__D004577 Microanalysis, X-Ray
% 218.47/218.70  |- skos__altLabel mesh__D004577 X-Ray Microanalysis, Electron Microscopic
% 218.47/218.70  |- mesh__dateRevised mesh__D004577 2004-07-07
% 218.47/218.70  |- skos__hiddenLabel mesh__D009262 Nail
% 218.47/218.70  |- skos__hiddenLabel mesh__D009262 Toenail
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D009262 2003
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D009262 2006
% 218.47/218.70  |- skos__annotation mesh__D009262
% 218.47/218.70       primates only: use HOOF AND CLAW for other vertebrates: Manual 21.58; /abnorm permitted but consider NAILS, MALFORMED%A%  
% 218.47/218.70  |- mesh__dateCreated mesh__D009262 1999-01-01
% 218.47/218.70  |- mesh__considerAlso mesh__D009262 consider also terms at ONYCHO-   
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D009262 2005
% 218.47/218.70  |- skos__broader mesh__D009262smesh__D034582
% 218.47/218.70  |- mesh__recordAuthorizer mesh__D009262 jls
% 218.47/218.70  |- skos__scopeNote mesh__D009262
% 218.47/218.70       The thin, horny plates that cover the dorsal surfaces of the distal phalanges of the fingers and toes of primates.%A%    
% 218.47/218.70  |- mesh__recordOriginator mesh__D009262 NLM
% 218.47/218.70  |- skos__prefLabel mesh__D009262 Nails
% 218.47/218.70  |- mesh__dateRevised mesh__D009262 2004-07-29
% 218.47/218.70  |- rdf__type mesh__D009262sskos__Concept
% 218.47/218.70  |- skos__hiddenLabel mesh__D009262 Fingernail
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D009262 2005A
% 218.47/218.70  |- mesh__recordMaintainer mesh__D009262 jls
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D009262 2004
% 218.47/218.70  |- skos__annotation mesh__D008968
% 218.47/218.70       NIM; do not confuse with MOLECULAR STRUCTURE; PROTEIN CONFORMATION; NUCLEIC ACID CONFORMATION; and CARBOHYDRATE CONFORMATION; DF: MOL CONFORMATION%A%  
% 218.47/218.70  |- mesh__recordOriginator mesh__D008968 NLM
% 218.47/218.70  |- skos__altLabel mesh__D008968 Configuration, Molecular
% 218.47/218.70  |- mesh__dateRevised mesh__D008968 2004-07-07
% 218.47/218.70  |- skos__hiddenLabel mesh__D008968 Conformations, Molecular
% 218.47/218.70  |- skos__hiddenLabel mesh__D008968 Configurations, Molecular
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D008968 2006
% 218.47/218.70  |- skos__altLabel mesh__D008968 Molecular Stereochemistry
% 218.47/218.70  |- skos__related mesh__D008968smesh__D008958
% 218.47/218.70  |- skos__hiddenLabel mesh__D008968 Conformation, Molecular
% 218.47/218.70  |- mesh__historyNote mesh__D008968 73   
% 218.47/218.70  |- skos__scopeNote mesh__D008968
% 218.47/218.70       The characteristic three-dimensional shape of a molecule.%A%    
% 218.47/218.70  |- skos__prefLabel mesh__D008968 Molecular Conformation
% 218.47/218.70  |- mesh__dateCreated mesh__D008968 1999-01-01
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D008968 2005
% 218.47/218.70  |- skos__hiddenLabel mesh__D008968 Molecular Conformations
% 218.47/218.70  |- skos__altLabel mesh__D008968 Molecular Configuration
% 218.47/218.70  |- mesh__dateEstablished mesh__D008968 1973-01-01
% 218.47/218.70  |- mesh__recordMaintainer mesh__D008968 nns
% 218.47/218.70  |- skos__broader mesh__D008968smesh__D015394
% 218.47/218.70  |- mesh__recordAuthorizer mesh__D008968 sjn
% 218.47/218.70  |- skos__hiddenLabel mesh__D008968 Molecular Configurations
% 218.47/218.70  |- rdf__type mesh__D008968sskos__Concept
% 218.47/218.70  |- skos__altLabel mesh__D008968 Stereochemistry, Molecular
% 218.47/218.70  |- mesh__publicMeSHNote mesh__D008968 73   
% 218.47/218.70  |- rdf__type mesh__D000985sskos__Concept
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D000985 2002
% 218.47/218.70  |- mesh__recordMaintainer mesh__D000985 TAP
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D000985 2006
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D000985 1995
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D000985 1993
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D000985 2004
% 218.47/218.70  |- skos__prefLabel mesh__D000985 Antisepsis
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D000985 1999
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D000985 2005
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D000985 1994
% 218.47/218.70  |- skos__broader mesh__D000985smesh__D017053
% 218.47/218.70  |- mesh__dateRevised mesh__D000985 1992-05-18
% 218.47/218.70  |- mesh__recordAuthorizer mesh__D000985 PLS
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D000985 2001
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D000985 1997
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D000985 2003
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D000985 1998
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D000985 2000
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D000985 1996
% 218.47/218.70  |- mesh__dateCreated mesh__D000985 1999-01-01
% 218.47/218.70  |- skos__scopeNote mesh__D000985
% 218.47/218.70       The destruction of germs causing disease.     
% 218.47/218.70  |- skos__annotation mesh__D000985
% 218.47/218.70       differentiate from ASEPSIS: ANTISEPSIS is the destruction of pathogens, ASEPSIS is the prev of their invasion%A%  
% 218.47/218.70  |- mesh__recordOriginator mesh__D000985 NLM
% 218.47/218.70  |- mesh__publicMeSHNote mesh__D019690
% 218.47/218.70       98; TECHNETIUM TC 99M EXAMETAZINE was indexed under ORGANOTECHNETIUM COMPOUNDS 1990-97, OXIMES 1985-97, %26% ORGANOMETALLIC COMPOUNDS 1985-89%A%  
% 218.47/218.70  |- skos__altLabel mesh__D019690 Tc-99m-Exametazime
% 218.47/218.70  |- skos__broader mesh__D019690smesh__D010091
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D019690 2006
% 218.47/218.70  |- skos__annotation mesh__D019690 as label, use /diag use; DF: TC HMPAO   
% 218.47/218.70  |- skos__prefLabel mesh__D019690 Technetium Tc 99m Exametazime
% 218.47/218.70  |- skos__hiddenLabel mesh__D019690
% 218.47/218.70       Technetium Tc 99m Hexamethylpropylene amine Oxime
% 218.47/218.70  |- skos__altLabel mesh__D019690 99mTc-HMPAO
% 218.47/218.70  |- skos__scopeNote mesh__D019690
% 218.47/218.70       A gamma-emitting radionuclide imaging agent used in the evaluation of regional cerebral blood flow and in non-invasive dynamic biodistribution studies and myocardial imaging. It has also been used to label leukocytes in the investigation of inflammatory bowel diseases.%A%    
% 218.47/218.70  |- skos__historyNote mesh__D019690
% 218.47/218.70       Organotechnetium Compounds %28%1990-1997%29%
% 218.47/218.70  |- rdf__type mesh__D019690sskos__Concept
% 218.47/218.70  |- mesh__historyNote mesh__D019690
% 218.47/218.70       98; see TECHNETIUM TC 99M EXAMETAZIME %28%NM%29% 1985-97   
% 218.47/218.70  |- mesh__recordMaintainer mesh__D019690 exl
% 218.47/218.70  |- skos__hiddenLabel mesh__D019690 Tc 99m Hexamethylpropyleneamine Oxime
% 218.47/218.70  |- skos__hiddenLabel mesh__D019690 Oxime, Tc-99m-Hexamethylpropyleneamine
% 218.47/218.70  |- mesh__dateCreated mesh__D019690 1997-06-20
% 218.47/218.70  |- skos__altLabel mesh__D019690 99m-Tc-HMPAO
% 218.47/218.70  |- skos__historyNote mesh__D019690
% 218.47/218.70       Organometallic Compounds %28%1985-1989%29%
% 218.47/218.70  |- mesh__recordAuthorizer mesh__D019690 sjn
% 218.47/218.70  |- skos__altLabel mesh__D019690 Tc-99m HMPAO
% 218.47/218.70  |- mesh__dateEstablished mesh__D019690 1998-01-01
% 218.47/218.70  |- skos__hiddenLabel mesh__D019690 Tc 99m Exametazime
% 218.47/218.70  |- skos__historyNote mesh__D019690 Oximes %28%1985-1997%29%
% 218.47/218.70  |- skos__altLabel mesh__D019690
% 218.47/218.70       Technetium Tc 99m Hexamethylpropylene-amine Oxime
% 218.47/218.70  |- skos__altLabel mesh__D019690
% 218.47/218.70       Technetium Tc 99m Hexamethylpropyleneamine Oxime
% 218.47/218.70  |- skos__altLabel mesh__D019690 Tc-99m-Hexamethylpropyleneamine Oxime
% 218.47/218.70  |- mesh__dateRevised mesh__D019690 2005-06-30
% 218.47/218.70  |- mesh__recordOriginator mesh__D019690 ADP
% 218.47/218.70  |- skos__broader mesh__D019690smesh__D015609
% 218.47/218.70  |- skos__broader mesh__D033361smesh__D003445
% 218.47/218.70  |- rdf__type mesh__D033361sskos__Concept
% 218.47/218.70  |- skos__historyNote mesh__D033361 Crustacea %28%1968-2002%29%
% 218.47/218.70  |- mesh__dateCreated mesh__D033361 2002-07-03
% 218.47/218.70  |- skos__scopeNote mesh__D033361
% 218.47/218.70       A suborder of CRUSTACEA, order Diplostraca, comprising the water fleas. They are benthic filter feeders that consume PHYTOPLANKTON. The body is laterally compressed and enclosed in a bivalved carapace, from which the head extends.%A%    
% 218.47/218.70  |- mesh__publicMeSHNote mesh__D033361 2003   
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D033361 2004
% 218.47/218.70  |- mesh__historyNote mesh__D033361 2003   
% 218.47/218.70  |- skos__altLabel mesh__D033361 Water Flea
% 218.47/218.70  |- skos__prefLabel mesh__D033361 Cladocera
% 218.47/218.70  |- mesh__dateRevised mesh__D033361 2003-07-09
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D033361 2006
% 218.47/218.70  |- mesh__dateEstablished mesh__D033361 2003-01-01
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D033361 2005
% 218.47/218.70  |- skos__scopeNote mesh__D000187
% 218.47/218.70       A disease characterized by suppurative and granulomatous lesions in the respiratory tract, upper alimentary tract, skin, kidneys, joints, and other tissues. Actinobacillus lignieresii infects cattle and sheep while A. equuli infects horses and pigs.%A%    
% 218.47/218.70  |- skos__annotation mesh__D000187
% 218.47/218.70       a vet dis entity caused by Actinobacillus lignieresii: do not confuse with ACTINOBACILLUS INFECTIONS; check tag ANIMALS%A%  
% 218.47/218.70  |- mesh__dateCreated mesh__D000187 1999-01-01
% 218.47/218.70  |- mesh__recordMaintainer mesh__D000187 ags
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D000187 2005
% 218.47/218.70  |- skos__broader mesh__D000187smesh__D000820
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D000187 2004
% 218.47/218.70  |- mesh__recordOriginator mesh__D000187 NLM
% 218.47/218.70  |- skos__hiddenLabel mesh__D000187 Actinobacilloses
% 218.47/218.70  |- skos__prefLabel mesh__D000187 Actinobacillosis
% 218.47/218.70  |- skos__broader mesh__D000187smesh__D000189
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D000187 2006
% 218.47/218.70  |- mesh__historyNote mesh__D000187 68   
% 218.47/218.70  |- mesh__recordAuthorizer mesh__D000187 sjn
% 218.47/218.70  |- mesh__publicMeSHNote mesh__D000187 68   
% 218.47/218.70  |- rdf__type mesh__D000187sskos__Concept
% 218.47/218.70  |- mesh__dateRevised mesh__D000187 2003-07-30
% 218.47/218.70  |- skos__historyNote mesh__D000187 Cattle Diseases %28%1966-1967%29%
% 218.47/218.70  |- mesh__dateEstablished mesh__D000187 1968-01-01
% 218.47/218.70  |- mesh__recordOriginator mesh__D005670 NLM
% 218.47/218.70  |- rdf__type mesh__D005670sskos__Concept
% 218.47/218.70  |- skos__prefLabel mesh__D005670 Fusarium
% 218.47/218.70  |- mesh__recordMaintainer mesh__D005670 SYSTEM
% 218.47/218.70  |- skos__broader mesh__D005670smesh__D003904
% 218.47/218.70  |- mesh__recordAuthorizer mesh__D005670 sjn
% 218.47/218.70  |- mesh__dateCreated mesh__D005670 1999-01-01
% 218.47/218.70  |- mesh__dateRevised mesh__D005670 2005-06-30
% 218.47/218.70  |- skos__annotation mesh__D005670
% 218.47/218.70       infection: coord IM with MYCOSES %28%IM%29% or specific mycosis %28%IM%29%%A%  
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D005670 2006
% 218.47/218.70  |- skos__scopeNote mesh__D005670
% 218.47/218.70       A mitosporic Hypocreales fungal genus, various species of which are important parasitic pathogens of plants and a variety of vertebrates. Teleomorphs include GIBBERELLA.%A%    
% 218.47/218.70  |- skos__related mesh__D005670smesh__D005874
% 218.47/218.70  |- skos__hiddenLabel mesh__D046289 Body Modification, Non Therapeutic
% 218.47/218.70  |- rdf__type mesh__D046289sskos__Concept
% 218.47/218.70  |- mesh__dateEstablished mesh__D046289 2005-01-01
% 218.47/218.70  |- skos__prefLabel mesh__D046289 Body Modification, Non-Therapeutic
% 218.47/218.70  |- mesh__recordMaintainer mesh__D046289 nns
% 218.47/218.70  |- mesh__publicMeSHNote mesh__D046289 2005   
% 218.47/218.70  |- skos__broader mesh__D046289smesh__D013514
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D046289 2005
% 218.47/218.70  |- skos__scopeNote mesh__D046289
% 218.47/218.70       The wounding of the body or body parts by branding, cutting, piercing %28%BODY PIERCING%29%, or TATTOOING as a cultural practice or expression of creativity or identity.%A%    
% 218.47/218.70  |- mesh__dateCreated mesh__D046289 2004-07-07
% 218.47/218.70  |- skos__related mesh__D046289smesh__D016728
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D046289 2006
% 218.47/218.70  |- mesh__recordOriginator mesh__D046289 nns
% 218.47/218.70  |- skos__hiddenLabel mesh__D046289 Body Modification, Cultural
% 218.47/218.70  |- skos__altLabel mesh__D046289 Non-Therapeutic Body Modification
% 218.47/218.70  |- skos__hiddenLabel mesh__D046289 Cultural Body Modifications
% 218.47/218.70  |- mesh__recordAuthorizer mesh__D046289 sjn
% 218.47/218.70  |- skos__hiddenLabel mesh__D046289 Non-Therapeutic Body Modifications
% 218.47/218.70  |- mesh__historyNote mesh__D046289 2005   
% 218.47/218.70  |- skos__related mesh__D046289smesh__D019093
% 218.47/218.70  |- skos__broader mesh__D046289smesh__D003357
% 218.47/218.70  |- skos__hiddenLabel mesh__D046289 Non Therapeutic Body Modification
% 218.47/218.70  |- skos__hiddenLabel mesh__D046289 Body Modifications, Cultural
% 218.47/218.70  |- skos__hiddenLabel mesh__D046289 Body Modifications, Non-Therapeutic
% 218.47/218.70  |- mesh__publicMeSHNote mesh__D013304 74   
% 218.47/218.70  |- skos__scopeNote mesh__D013304
% 218.47/218.70       An actinomycete from which the antibiotic CHLORTETRACYCLINE is obtained.%A%    
% 218.47/218.70  |- mesh__recordOriginator mesh__D013304 NLM
% 218.47/218.70  |- skos__broader mesh__D013304smesh__D013302
% 218.47/218.70  |- rdf__type mesh__D013304sskos__Concept
% 218.47/218.70  |- skos__prefLabel mesh__D013304 Streptomyces aureofaciens
% 218.47/218.70  |- mesh__dateRevised mesh__D013304 2005-06-30
% 218.47/218.70  |- mesh__recordMaintainer mesh__D013304 SYSTEM
% 218.47/218.70  |- mesh__recordAuthorizer mesh__D013304 sjn
% 218.47/218.70  |- skos__historyNote mesh__D013304 Streptomyces %28%1966-1971%29%
% 218.47/218.70  |- mesh__historyNote mesh__D013304 74%28%72%29%   
% 218.47/218.70  |- skos__annotation mesh__D013304 yields chlortetracycline   
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D013304 2006
% 218.47/218.70  |- mesh__dateCreated mesh__D013304 1999-01-01
% 218.47/218.70  |- mesh__dateEstablished mesh__D013304 1974-01-01
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 Tandem Repeat, Variable
% 218.47/218.70  |- skos__altLabel mesh__D018598 Simple Repetitive Sequence
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 Loci, VNTR
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 Regions, VNTR
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 Repeats, Minisatellite
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 Variable Tandem Repeat
% 218.47/218.70  |- mesh__dateCreated mesh__D018598 1994-06-01
% 218.47/218.70  |- mesh__recordOriginator mesh__D018598 JLS
% 218.47/218.70  |- skos__altLabel mesh__D018598 Minisatellites
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 Sequences, Simple Repetitive
% 218.47/218.70  |- skos__altLabel mesh__D018598 VNTR Region
% 218.47/218.70  |- mesh__dateRevised mesh__D018598 2005-06-30
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 VNTR Sequence
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 Simple Repetitive Sequences
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 Sequences, VNTR
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 Repeat, Variable Tandem
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 Repeat, Minisatellite
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D018598 2006
% 218.47/218.70  |- skos__scopeNote mesh__D018598
% 218.47/218.70       Tandem arrays of moderately repetitive %28%5-50 repeats%29% short %28%10-60 bases%29% DNA sequences found dispersed throughout the genome and clustered near telomeres. Their degree of repetition is two to several hundred at each locus. Loci number in the thousands but each locus shows a distinctive repeat unit. Minisatellite repeats are often called variable number of tandem repeats.%A%    
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 Minisatellite Repeat
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 Minisatellite
% 218.47/218.70  |- skos__altLabel mesh__D018598 Variable Tandem Repeats
% 218.47/218.70  |- skos__altLabel mesh__D018598 Variable Number of Tandem Repeats
% 218.47/218.70  |- skos__historyNote mesh__D018598
% 218.47/218.70       Repetitive Sequences, Nucleic Acid %28%1985-1994%29%
% 218.47/218.70  |- mesh__historyNote mesh__D018598
% 218.47/218.70       97%28%95%29%; for SIMPLE REPETITIVE SEQUENCE use REPETITIVE SEQUENCE, NUCLEIC ACID 1990-98%A%  
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 Region, VNTR
% 218.47/218.70  |- skos__broader mesh__D018598smesh__D020080
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 Tandem Repeats, Variable
% 218.47/218.70  |- skos__altLabel mesh__D018598 VNTR Loci
% 218.47/218.70  |- mesh__recordAuthorizer mesh__D018598 sjn
% 218.47/218.70  |- skos__related mesh__D018598smesh__D016172
% 218.47/218.70  |- mesh__recordMaintainer mesh__D018598 nns
% 218.47/218.70  |- skos__prefLabel mesh__D018598 Minisatellite Repeats
% 218.47/218.70  |- rdf__type mesh__D018598sskos__Concept
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 Locus, VNTR
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 Sequence, Simple Repetitive
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 VNTR Locus
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 Repetitive Sequences, Simple
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 VNTR Regions
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 Repeats, Variable Tandem
% 218.47/218.70  |- skos__altLabel mesh__D018598 VNTR
% 218.47/218.70  |- skos__altLabel mesh__D018598 VNTR Sequences
% 218.47/218.70  |- mesh__publicMeSHNote mesh__D018598
% 218.47/218.70       97; see VARIABLE NUMBER OF TANDEM REPEATS 1995-96; for SIMPLE REPETITIVE SEQUENCE see REPETITIVE SEQUENCE, NUCLEIC ACID 1990-98%A%  
% 218.47/218.70  |- mesh__dateEstablished mesh__D018598 1995-01-01
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 Repetitive Sequence, Simple
% 218.47/218.70  |- skos__hiddenLabel mesh__D018598 Sequence, VNTR
% 218.47/218.70  |- skos__broader mesh__D032269smesh__D029641
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D032269 2004
% 218.47/218.70  |- skos__prefLabel mesh__D032269 Brucea
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D032269 2003
% 218.47/218.70  |- mesh__publicMeSHNote mesh__D032269 2003   
% 218.47/218.70  |- mesh__dateCreated mesh__D032269 2002-07-02
% 218.47/218.70  |- mesh__dateEstablished mesh__D032269 2003-01-01
% 218.47/218.70  |- skos__annotation mesh__D032269
% 218.47/218.70       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D032269 2006
% 218.47/218.70  |- skos__scopeNote mesh__D032269
% 218.47/218.70       A plant genus of the family SIMAROUBACEAE. Members contain bruceosides and bruceanols %28%quassinoids%29%. The astringent seeds have been used to treat dysentery in southeastern Asia.%A%    
% 218.47/218.70  |- mesh__historyNote mesh__D032269 2003   
% 218.47/218.70  |- rdf__type mesh__D032269sskos__Concept
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D032269 2005
% 218.47/218.70  |- skos__annotation mesh__D004578 usually NIM   
% 218.47/218.70  |- mesh__historyNote mesh__D004578
% 218.47/218.70       94; was ELECTRON SPIN RESONANCE 1966-93 %28%Prov 1964-66%29%   
% 218.47/218.70  |- skos__prefLabel mesh__D004578 Electron Spin Resonance Spectroscopy
% 218.47/218.70  |- mesh__onlineNote mesh__D004578
% 218.47/218.70       use ELECTRON SPIN RESONANCE SPECTROSCOPY to search ELECTRON SPIN RESONANCE 1966-93%A%  
% 218.47/218.70  |- skos__hiddenLabel mesh__D004578 Resonance, Electron Paramagnetic
% 218.47/218.70  |- skos__broader mesh__D004578smesh__D009682
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D004578 2004
% 218.47/218.70  |- mesh__recordOriginator mesh__D004578 NLM
% 218.47/218.70  |- mesh__dateCreated mesh__D004578 1999-01-01
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D004578 2006
% 218.47/218.70  |- mesh__publicMeSHNote mesh__D004578
% 218.47/218.70       94; was ELECTRON SPIN RESONANCE 1966-93   
% 218.47/218.70  |- skos__hiddenLabel mesh__D004578 Paramagnetic Resonance, Electron
% 218.47/218.70  |- skos__altLabel mesh__D004578 Electron Nuclear Double Resonance
% 218.47/218.70  |- mesh__dateEstablished mesh__D004578 1966-01-01
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D004578 2003
% 218.47/218.70  |- skos__related mesh__D004578smesh__D019097
% 218.47/218.70  |- mesh__dateRevised mesh__D004578 2002-07-03
% 218.47/218.70  |- skos__scopeNote mesh__D004578
% 218.47/218.70       A technique applicable to the wide variety of substances which exhibit paramagnetism because of the magnetic moments of unpaired electrons. The spectra are useful for detection and identification, for determination of electron structure, for study of interactions between molecules, and for measurement of nuclear spins and moments. %28%From McGraw-Hill Encyclopedia of Science and Technology, 7th edition%29% Electron nuclear double resonance %28%ENDOR%29% spectroscopy is a variant of the technique which can give enhanced resolution. Electron spin resonance analysis can now be used in vivo, including imaging applications such as MAGNETIC RESONANCE IMAGING.%A%    
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D004578 2005
% 218.47/218.70  |- skos__hiddenLabel mesh__D004578 Resonance, Electron Spin
% 218.47/218.70  |- skos__altLabel mesh__D004578 Paramagnetic Resonance
% 218.47/218.70  |- rdf__type mesh__D004578sskos__Concept
% 218.47/218.70  |- skos__hiddenLabel mesh__D004578 Resonance, Paramagnetic
% 218.47/218.70  |- mesh__recordAuthorizer mesh__D004578 sjn
% 218.47/218.70  |- skos__altLabel mesh__D004578 Electron Spin Resonance
% 218.47/218.70  |- skos__altLabel mesh__D004578 Electron Paramagnetic Resonance
% 218.47/218.70  |- mesh__recordMaintainer mesh__D004578 lkt
% 218.47/218.70  |- mesh__dateCreated mesh__D009263 1999-01-01
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D009263 2005
% 218.47/218.70  |- skos__scopeNote mesh__D009263
% 218.47/218.70       Excessive lateral nail growth into the nail fold. Because the lateral margin of the nail acts as a foreign body, inflammation and granulation may result. It is caused by improperly fitting shoes and by improper trimming of the nail.%A%    
% 218.47/218.70  |- skos__hiddenLabel mesh__D009263 Nail, Ingrown
% 218.47/218.70  |- skos__hiddenLabel mesh__D009263 Ingrown Nails
% 218.47/218.70  |- mesh__recordAuthorizer mesh__D009263 sjn
% 218.47/218.70  |- mesh__dateRevised mesh__D009263 2001-07-25
% 218.47/218.70  |- rdf__type mesh__D009263sskos__Concept
% 218.47/218.70  |- mesh__recordMaintainer mesh__D009263 lkt
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D009263 2004
% 218.47/218.70  |- mesh__recordOriginator mesh__D009263 NLM
% 218.47/218.70  |- skos__broader mesh__D009263smesh__D009260
% 218.47/218.70  |- skos__prefLabel mesh__D009263 Nails, Ingrown
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D009263 2002
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D009263 2003
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D009263 2006
% 218.47/218.70  |- skos__hiddenLabel mesh__D009263 Ingrown Nail
% 218.47/218.70  |- mesh__historyNote mesh__D001280 74%28%72%29%   
% 218.47/218.70  |- mesh__recordAuthorizer mesh__D001280 sjn
% 218.47/218.70  |- mesh__recordOriginator mesh__D001280 NLM
% 218.47/218.70  |- skos__scopeNote mesh__D001280
% 218.47/218.70       A selective triazine herbicide. Inhalation hazard is low and there are no apparent skin manifestations or other toxicity in humans. Acutely poisoned sheep and cattle may show muscular spasms, fasciculations, stiff gait, increased respiratory rates, adrenal degeneration, and congestion of the lungs, liver, and kidneys. %28%From The Merck Index, 11th ed%29%%A%    
% 218.47/218.70  |- mesh__dateRevised mesh__D001280 2004-07-19
% 218.47/218.70  |- mesh__publicMeSHNote mesh__D001280 74   
% 218.47/218.70  |- skos__prefLabel mesh__D001280 Atrazine
% 218.47/218.70  |- skos__historyNote mesh__D001280 Triazines %28%1966-1971%29%
% 218.47/218.70  |- skos__historyNote mesh__D001280 Herbicides %28%1966-1971%29%
% 218.47/218.70  |- rdf__type mesh__D001280sskos__Concept
% 218.47/218.70  |- mesh__recordMaintainer mesh__D001280 ssb
% 218.47/218.70  |- mesh__dateEstablished mesh__D001280 1974-01-01
% 218.47/218.70  |- skos__broader mesh__D001280smesh__D014227
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D001280 2005
% 218.47/218.70  |- mesh__dateCreated mesh__D001280 1999-01-01
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D001280 2006
% 218.47/218.70  |- mesh__historyNote mesh__D008969 88   
% 218.47/218.70  |- skos__related mesh__D008969smesh__D016415
% 218.47/218.70  |- skos__historyNote mesh__D008969 Amino Acid Sequence %28%1966-1987%29%
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D008969 2004
% 218.47/218.70  |- mesh__dateCreated mesh__D008969 1987-05-09
% 218.47/218.70  |- skos__altLabel mesh__D008969 Sequence Data, Molecular
% 218.47/218.70  |- skos__historyNote mesh__D008969 Base Sequence %28%1971-1987%29%
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D008969 2003
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D008969 2006
% 218.47/218.70  |- skos__annotation mesh__D008969
% 218.47/218.70       never IM; coord NIM with BASE SEQUENCE or AMINO ACID SEQUENCE or CARBOHYDRATE SEQUENCE %28%NIM%29% + specific nucleotide or protein or carbohydrate %28%IM%29%; index here only for base sequences containing 50 or more nucleotides %28%exclude primers or probes%29%, only for amino acid sequences containing 15 or more amino acids, only for carbohydrate sequences containing 3 or more carbohydrate units %28%trisaccharides%29%; DF: MOL SEQ DATA%A%  
% 218.47/218.70  |- skos__prefLabel mesh__D008969 Molecular Sequence Data
% 218.47/218.70  |- mesh__recordAuthorizer mesh__D008969 sjn
% 218.47/218.70  |- mesh__recordMaintainer mesh__D008969 nns
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D008969 2005
% 218.47/218.70  |- mesh__dateEstablished mesh__D008969 1988-01-01
% 218.47/218.70  |- skos__historyNote mesh__D008969 Information Systems %28%1983-1987%29%
% 218.47/218.70  |- skos__hiddenLabel mesh__D008969 Data, Molecular Sequence
% 218.47/218.70  |- rdf__type mesh__D008969sskos__Concept
% 218.47/218.70  |- skos__altLabel mesh__D008969 Molecular Sequencing Data
% 218.47/218.70  |- skos__scopeNote mesh__D008969
% 218.47/218.70       Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory %28%EMBL%29%, National Biomedical Research Foundation %28%NBRF%29%, or other sequence repositories.%A%    
% 218.47/218.70  |- skos__broader mesh__D008969smesh__D004282
% 218.47/218.70  |- mesh__recordOriginator mesh__D008969 SCD
% 218.47/218.70  |- mesh__publicMeSHNote mesh__D008969 88   
% 218.47/218.70  |- skos__hiddenLabel mesh__D008969 Data, Molecular Sequencing
% 218.47/218.70  |- mesh__dateRevised mesh__D008969 2002-07-03
% 218.47/218.70  |- skos__historyNote mesh__D008969 Cloning, Molecular %28%1980-1987%29%
% 218.47/218.70  |- skos__hiddenLabel mesh__D008969 Sequencing Data, Molecular
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D000986 2006
% 218.47/218.70  |- mesh__dateRevised mesh__D000986 2005-06-30
% 218.47/218.70  |- skos__hiddenLabel mesh__D000986 Agents, Antisickling
% 218.47/218.70  |- mesh__historyNote mesh__D000986 77   
% 218.47/218.70  |- mesh__publicMeSHNote mesh__D000986 77   
% 218.47/218.70  |- skos__annotation mesh__D000986
% 218.47/218.70       consider also ANEMIA, SICKLE CELL /drug ther   
% 218.47/218.70  |- skos__historyNote mesh__D000986 Hemoglobin, Sickle %28%1975-1976%29%
% 218.47/218.70  |- skos__historyNote mesh__D000986 Anemia, Sickle Cell %28%1966-1976%29%
% 218.47/218.70  |- mesh__dateCreated mesh__D000986 1976-04-13
% 218.47/218.70  |- mesh__recordAuthorizer mesh__D000986 sjn
% 218.47/218.70  |- skos__prefLabel mesh__D000986 Antisickling Agents
% 218.47/218.70  |- skos__hiddenLabel mesh__D000986 Agents, Desickling
% 218.47/218.70  |- mesh__recordOriginator mesh__D000986 SH
% 218.47/218.70  |- mesh__recordMaintainer mesh__D000986 ssb
% 218.47/218.70  |- mesh__dateEstablished mesh__D000986 1977-01-01
% 218.47/218.70  |- rdf__type mesh__D000986sskos__Concept
% 218.47/218.70  |- skos__broader mesh__D000986smesh__D006401
% 218.47/218.70  |- skos__scopeNote mesh__D000986
% 218.47/218.70       Agents used to prevent or reverse the pathological events leading to sickling of erythrocytes in sickle cell conditions.%A%    
% 218.47/218.70  |- skos__historyNote mesh__D000986 Hemoglobins, Abnormal %28%1966-1974%29%
% 218.47/218.70  |- skos__scopeNote mesh__D019691
% 218.47/218.70       A genus of PROCHLOROPHYTES containing unicellular, spherical bacteria without a mucilaginous sheath. They are found almost exclusively as extracellular symbionts of colonial ASCIDIANS on subtropical or tropical marine shores.%A%    
% 218.47/218.70  |- mesh__recordAuthorizer mesh__D019691 sjn
% 218.47/218.70  |- mesh__recordMaintainer mesh__D019691 SYSTEM
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D019691 2006
% 218.47/218.70  |- mesh__dateRevised mesh__D019691 2005-06-30
% 218.47/218.70  |- rdf__type mesh__D019691sskos__Concept
% 218.47/218.70  |- mesh__historyNote mesh__D019691 98   
% 218.47/218.70  |- mesh__dateCreated mesh__D019691 1997-06-20
% 218.47/218.70  |- skos__prefLabel mesh__D019691 Prochloron
% 218.47/218.70  |- mesh__recordOriginator mesh__D019691 NDW
% 218.47/218.70  |- mesh__publicMeSHNote mesh__D019691 98   
% 218.47/218.70  |- skos__broader mesh__D019691smesh__D048928
% 218.47/218.70  |- mesh__dateEstablished mesh__D019691 1998-01-01
% 218.47/218.70  |- skos__historyNote mesh__D033362 Powders %28%1971-2002%29%
% 218.47/218.70  |- rdf__type mesh__D033362sskos__Concept
% 218.47/218.70  |- mesh__dateEstablished mesh__D033362 2003-01-01
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D033362 2003
% 218.47/218.70  |- mesh__publicMeSHNote mesh__D033362 2003   
% 218.47/218.70  |- skos__hiddenLabel mesh__D033362 Diffraction, Powder
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D033362 2004
% 218.47/218.70  |- skos__broader mesh__D033362smesh__D003461
% 218.47/218.70  |- mesh__activeMeSHYear mesh__D033362 2005
% 218.47/218.70  |- mesh__dateCreated mesh__D033362 2002-07-03
% 218.47/218.70  |- skos__historyNote mesh__D033362 X-Ray Diffraction %28%1971-2002%29%
% 218.47/218.70  |- skos__scopeNote mesh__D033362
% 218.47/218.70       Method of using a polycrystalline powder and Rietveld refinement %28%LEAST SQUARES ANALYSIS%29% of X-RAY DIFFRACTION or NEUTRON DIFFRACTION.  It circumvents the difficulties of producing single large crystals.%A%    
% 218.47/218.71  |- mesh__activeMeSHYear mesh__D033362 2006
% 218.47/218.71  |- skos__prefLabel mesh__D033362 Powder Diffraction
% 218.47/218.71  |- mesh__historyNote mesh__D033362 2003   
% 218.47/218.71  |- skos__scopeNote mesh__D000188
% 218.47/218.71       A genus of PASTEURELLACEAE described as gram-negative, nonsporeforming, nonmotile, facultative anaerobes.  Most members are found both as pathogens and commensal organisms in the respiratory, alimentary, and genital tracts of animals.%A%    
% 218.47/218.71  |- skos__broader mesh__D000188smesh__D006092
% 218.47/218.71  |- mesh__activeMeSHYear mesh__D000188 2006
% 218.47/218.71  |- skos__broader mesh__D000188smesh__D015661
% 218.47/218.71  |- mesh__recordMaintainer mesh__D000188 SYSTEM
% 218.47/218.71  |- mesh__recordOriginator mesh__D000188 NLM
% 218.47/218.71  |- rdf__type mesh__D000188sskos__Concept
% 218.47/218.71  |- skos__prefLabel mesh__D000188 Actinobacillus
% 218.47/218.71  |- mesh__recordAuthorizer mesh__D000188 sjn
% 218.47/218.71  |- mesh__dateCreated mesh__D000188 1999-01-01
% 218.47/218.71  |- skos__annotation mesh__D000188
% 218.47/218.71       infection = ACTINOBACILLUS INFECTIONS or ACTINOBACILLOSIS: see notes there%A%  
% 218.47/218.71  |- mesh__dateRevised mesh__D000188 2005-06-30
% 218.47/218.71  |- mesh__activeMeSHYear mesh__D005671 2000
% 218.47/218.71  |- mesh__dateEstablished mesh__D005671 1991-01-01
% 218.47/218.71  |- skos__annotation mesh__D005671
% 218.47/218.71       tooth abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 218.47/218.71  |- mesh__dateCreated mesh__D005671 1999-01-01
% 218.47/218.71  |- mesh__dateRevised mesh__D005671 1999-11-03
% 218.47/218.71  |- mesh__historyNote mesh__D005671
% 218.47/218.71       91%28%75%29%; was see under TOOTH ABNORMALITIES 1975-90   
% 218.47/218.71  |- mesh__activeMeSHYear mesh__D005671 2006
% 218.47/218.71  |- mesh__recordOriginator mesh__D005671 NLM
% 218.47/218.71  |- mesh__activeMeSHYear mesh__D005671 2004
% 218.47/218.71  |- mesh__onlineNote mesh__D005671 search TOOTH ABNORMALITIES 1966-74   
% 218.47/218.71  |- skos__prefLabel mesh__D005671 Fused Teeth
% 218.47/218.71  |- mesh__recordMaintainer mesh__D005671 kle
% 218.47/218.71  |- mesh__activeMeSHYear mesh__D005671 2005
% 218.47/218.71  |- mesh__publicMeSHNote mesh__D005671
% 218.47/218.71       91; was see under TOOTH ABNORMALITIES 1975-90   
% 218.47/218.71  |- mesh__activeMeSHYear mesh__D005671 2002
% 218.47/218.71  |- skos__scopeNote mesh__D005671
% 218.47/218.71       Two teeth united during development by the union of their tooth germs; the teeth may be joined by the enamel of their crowns, by their root dentin, or by both.%A%    
% 218.47/218.71  |- mesh__activeMeSHYear mesh__D005671 2003
% 218.47/218.71  |- mesh__recordAuthorizer mesh__D005671 sjn
% 218.47/218.71  |- skos__hiddenLabel mesh__D005671 Teeth, Fused
% 218.47/218.71  |- rdf__type mesh__D005671sskos__Concept
% 218.47/218.71  |- mesh__activeMeSHYear mesh__D005671 2001
% 218.47/218.71  |- skos__broader mesh__D005671smesh__D014071
% 218.47/218.71  |- mesh__recordAuthorizer mesh__D013305 sjn
% 218.47/218.71  |- mesh__activeMeSHYear mesh__D013305 2006
% 218.47/218.71  |- mesh__recordMaintainer mesh__D013305 SYSTEM
% 218.47/218.71  |- skos__prefLabel mesh__D013305 Streptomyces griseus
% 218.47/218.71  |- rdf__type mesh__D013305sskos__Concept
% 218.47/218.71  |- mesh__recordOriginator mesh__D013305 NLM
% 218.47/218.71  |- skos__scopeNote mesh__D013305
% 218.47/218.71       An actinomycete from which the antibiotics STREPTOMYCIN, grisein, and CANDICIDIN are obtained.%A%    
% 218.47/218.71  |- skos__annotation mesh__D013305
% 218.47/218.71       yields streptomycin, candicidin %26% grisein   
% 218.47/218.71  |- mesh__dateEstablished mesh__D013305 1974-01-01
% 218.47/218.71  |- mesh__historyNote mesh__D013305 74%28%72%29%   
% 218.47/218.71  |- mesh__publicMeSHNote mesh__D013305 74   
% 218.47/218.71  |- mesh__dateCreated mesh__D013305 1999-01-01
% 218.47/218.71  |- skos__historyNote mesh__D013305 Streptomyces %28%1966-1971%29%
% 218.47/218.71  |- mesh__dateRevised mesh__D013305 2005-06-30
% 218.47/218.71  |- skos__broader mesh__D013305smesh__D013302
% 218.47/218.71  |- mesh__activeMeSHYear mesh__D018599 2006
% 218.47/218.71  |- skos__scopeNote mesh__D018599
% 218.47/218.71       An act of employing sorcery %28%the use of power gained from the assistance or control of spirits%29%, especially with malevolent intent, and the exercise of supernatural powers and alleged intercourse with the devil or a familiar. %28%From Webster, 3d ed%29%%A%    
% 218.47/218.71  |- skos__prefLabel mesh__D018599 Witchcraft
% 218.47/218.71  |- mesh__dateRevised mesh__D018599 2001-07-25
% 218.47/218.71  |- skos__broader mesh__D018599smesh__D026443
% 218.47/218.71  |- mesh__activeMeSHYear mesh__D018599 2003
% 218.47/218.71  |- skos__broader mesh__D018599smesh__D008273
% 218.47/218.71  |- skos__annotation mesh__D018599 IM; MAGIC is also available   
% 218.47/218.71  |- mesh__dateCreated mesh__D018599 1994-04-19
% 218.47/218.71  |- mesh__recordOriginator mesh__D018599 TGC
% 218.47/218.71  |- rdf__type mesh__D018599sskos__Concept
% 218.47/218.71  |- mesh__activeMeSHYear mesh__D018599 2004
% 218.47/218.71  |- mesh__dateEstablished mesh__D018599 1995-01-01
% 218.47/218.71  |- skos__hiddenLabel mesh__D018599 Sorceries
% 218.47/218.71  |- skos__historyNote mesh__D018599 Magic %28%1966-1994%29%
% 218.47/218.71  |- mesh__recordMaintainer mesh__D018599 ssb
% 218.47/218.71  |- mesh__publicMeSHNote mesh__D018599 95   
% 218.47/218.71  |- mesh__activeMeSHYear mesh__D018599 2005
% 218.47/218.71  |- mesh__recordAuthorizer mesh__D018599 sjn
% 218.47/218.71  |- mesh__activeMeSHYear mesh__D018599 2002
% 218.47/218.71  |- mesh__historyNote mesh__D018599 95   
% 218.47/218.71  |- skos__broader mesh__D018666Q000295smesh__D018666
% 218.47/218.71  |- mesh__preferredCombination mesh__D018666Q000295smesh__D020709
% 218.47/218.71  |- rdf__type mesh__D018666Q000295smesh__CompoundConcept
% 218.47/218.71  |- skos__broader mesh__D004579smesh__D008660
% 218.47/218.71  |- mesh__dateRevised mesh__D004579 2003-07-09
% 218.47/218.71  |- mesh__activeMeSHYear mesh__D004579 2005
% 218.47/218.71  |- mesh__recordAuthorizer mesh__D004579 sjn
% 218.47/218.71  |- skos__hiddenLabel mesh__D004579 Chains, Respiratory
% 218.47/218.71  |- mesh__activeMeSHYear mesh__D004579 2004
% 218.47/218.71  |- skos__scopeNote mesh__D004579
% 218.47/218.71       The process by which ELECTRONS are transported from a reduced substrate to molecular OXYGEN. %28%From Bennington, Saunders Dictionary and Encyclopedia of Laboratory Medicine and Technology, 1984, p270%29%%A%    
% 218.47/218.71  |- mesh__publicMeSHNote mesh__D004579 66   
% 218.47/218.71  |- mesh__activeMeSHYear mesh__D004579 2006
% 218.47/218.71  |- skos__hiddenLabel mesh__D004579 Respiratory Chains
% 218.47/218.71  |- skos__prefLabel mesh__D004579 Electron Transport
% 218.47/218.71  |- mesh__recordOriginator mesh__D004579 NLM
% 218.47/218.71  |- mesh__dateEstablished mesh__D004579 1966-01-01
% 218.47/218.71  |- skos__broader mesh__D004579smesh__D010084
% 218.47/218.71  |- skos__hiddenLabel mesh__D004579 Chain, Respiratory
% 218.47/218.71  |- skos__hiddenLabel mesh__D004579 Transport, Electron
% 218.47/218.71  |- mesh__recordMaintainer mesh__D004579 nns
% 218.47/218.71  |- rdf__type mesh__D004579sskos__Concept
% 218.56/218.71  |- skos__annotation mesh__D004579
% 218.56/218.71       usually NIM; not for %22%proton transport%22% %28% = PROTON PUMPS %28%IM%29% or PROTONS %28%IM%29% + BIOLOGICAL TRANSPORT %28%NIM%29%%29%%A%  
% 218.56/218.71  |- mesh__dateCreated mesh__D004579 1999-01-01
% 218.56/218.71  |- mesh__historyNote mesh__D004579 66%28%64%29%   
% 218.56/218.71  |- mesh__recordOriginator mesh__D009264 NLM
% 218.56/218.71  |- skos__prefLabel mesh__D009264 Nails, Malformed
% 218.56/218.71  |- mesh__recordMaintainer mesh__D009264 lkt
% 218.56/218.71  |- skos__hiddenLabel mesh__D009264 Malformed Nail
% 218.56/218.71  |- skos__annotation mesh__D009264 consider also NAILS /abnorm   
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D009264 2003
% 218.56/218.71  |- rdf__type mesh__D009264sskos__Concept
% 218.56/218.71  |- mesh__dateRevised mesh__D009264 2001-07-25
% 218.56/218.71  |- mesh__dateCreated mesh__D009264 1999-01-01
% 218.56/218.71  |- skos__broader mesh__D009264smesh__D009260
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D009264 2005
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D009264 2004
% 218.56/218.71  |- skos__scopeNote mesh__D009264
% 218.56/218.71       Deformities in nail structure or appearance, including hypertrophy, splitting, clubbing, furrowing, etc.%A%    
% 218.56/218.71  |- mesh__recordAuthorizer mesh__D009264 sjn
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D009264 2002
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D009264 2006
% 218.56/218.71  |- skos__hiddenLabel mesh__D009264 Nail, Malformed
% 218.56/218.71  |- skos__hiddenLabel mesh__D009264 Malformed Nails
% 218.56/218.71  |- skos__hiddenLabel mesh__D001281 Auricular Fibrillations
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D001281 2000
% 218.56/218.71  |- mesh__historyNote mesh__D001281
% 218.56/218.71       84; was AURICULAR FIBRILLATION 1963-83   
% 218.56/218.71  |- skos__hiddenLabel mesh__D001281 Fibrillations, Auricular
% 218.56/218.71  |- mesh__dateRevised mesh__D001281 1999-11-03
% 218.56/218.71  |- skos__hiddenLabel mesh__D001281 Fibrillation, Atrial
% 218.56/218.71  |- mesh__onlineNote mesh__D001281
% 218.56/218.71       use ATRIAL FIBRILLATION to search AURICULAR FIBRILLATION 1966-83%A%  
% 218.56/218.71  |- skos__broader mesh__D001281smesh__D001145
% 218.56/218.71  |- skos__hiddenLabel mesh__D001281 Fibrillations, Atrial
% 218.56/218.71  |- mesh__recordOriginator mesh__D001281 NLM
% 218.56/218.71  |- mesh__recordAuthorizer mesh__D001281 sjn
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D001281 2001
% 218.56/218.71  |- mesh__recordMaintainer mesh__D001281 PLS
% 218.56/218.71  |- skos__altLabel mesh__D001281 Auricular Fibrillation
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D001281 2002
% 218.56/218.71  |- skos__prefLabel mesh__D001281 Atrial Fibrillation
% 218.56/218.71  |- skos__scopeNote mesh__D001281
% 218.56/218.71       Disorder of cardiac rhythm characterized by rapid, irregular atrial impulses and ineffective atrial contractions.%A%    
% 218.56/218.71  |- skos__annotation mesh__D001281 do not confuse with ATRIAL FLUTTER   
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D001281 2005
% 218.56/218.71  |- mesh__dateCreated mesh__D001281 1999-01-01
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D001281 2003
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D001281 2006
% 218.56/218.71  |- mesh__publicMeSHNote mesh__D001281
% 218.56/218.71       84; was AURICULAR FIBRILLATION 1963-83   
% 218.56/218.71  |- skos__hiddenLabel mesh__D001281 Fibrillation, Auricular
% 218.56/218.71  |- skos__hiddenLabel mesh__D001281 Atrial Fibrillations
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D001281 2004
% 218.56/218.71  |- rdf__type mesh__D001281sskos__Concept
% 218.56/218.71  |- mesh__dateRevised mesh__D000987 1997-06-20
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000987 2004
% 218.56/218.71  |- mesh__publicMeSHNote mesh__D000987
% 218.56/218.71       81; was ANTISOCIAL PERSONALITY 1976-80, was SOCIOPATHIC PERSONALITY 1963-75%A%  
% 218.56/218.71  |- mesh__recordMaintainer mesh__D000987 TPW
% 218.56/218.71  |- mesh__recordAuthorizer mesh__D000987 SJN
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000987 2005
% 218.56/218.71  |- mesh__historyNote mesh__D000987
% 218.56/218.71       81; was ANTISOCIAL PERSONALITY 1976-80, was ANTISOCIAL PERSONALITY see under SOCIOPATHIC PERSONALITY 1969-75; SOCIOPATHIC PERSONALITY was heading 1963-75%A%  
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000987 1999
% 218.56/218.71  |- skos__hiddenLabel mesh__D000987 Personality, Antisocial
% 218.56/218.71  |- skos__hiddenLabel mesh__D000987 Personality, Sociopathic
% 218.56/218.71  |- skos__hiddenLabel mesh__D000987 Behaviors, Dyssocial
% 218.56/218.71  |- skos__scopeNote mesh__D000987
% 218.56/218.71       A personality disorder whose essential feature is a pervasive pattern of disregard for, and violation of, the rights of others that begins in childhood or early adolescence and continues into adulthood. The individual must be at least age 18 and must have a history of some symptoms of CONDUCT DISORDER before age 15. %28%From DSM-IV, 1994%29%%A%    
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000987 2000
% 218.56/218.71  |- skos__related mesh__D000987smesh__D019955
% 218.56/218.71  |- skos__hiddenLabel mesh__D000987 Personality, Psychopathic
% 218.56/218.71  |- mesh__recordOriginator mesh__D000987 NLM
% 218.56/218.71  |- skos__hiddenLabel mesh__D000987 Personalities, Antisocial
% 218.56/218.71  |- skos__hiddenLabel mesh__D000987 Personalities, Psychopathic
% 218.56/218.71  |- skos__hiddenLabel mesh__D000987 Psychopathic Personalities
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000987 2006
% 218.56/218.71  |- skos__prefLabel mesh__D000987 Antisocial Personality Disorder
% 218.56/218.71  |- mesh__onlineNote mesh__D000987
% 218.56/218.71       use ANTISOCIAL PERSONALITY DISORDER to search ANTISOCIAL PERSONALITY 1976-80 %26% SOCIOPATHIC PERSONALITY 1966-75%A%  
% 218.56/218.71  |- rdf__type mesh__D000987sskos__Concept
% 218.56/218.71  |- skos__hiddenLabel mesh__D000987 Behavior, Dyssocial
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000987 2001
% 218.56/218.71  |- skos__altLabel mesh__D000987 Psychopathic Personality
% 218.56/218.71  |- skos__broader mesh__D000987smesh__D010554
% 218.56/218.71  |- skos__altLabel mesh__D000987 Personality Disorder, Antisocial
% 218.56/218.71  |- skos__hiddenLabel mesh__D000987 Personality Disorders, Antisocial
% 218.56/218.71  |- skos__hiddenLabel mesh__D000987 Antisocial Personalities
% 218.56/218.71  |- skos__hiddenLabel mesh__D000987 Antisocial Personality Disorders
% 218.56/218.71  |- skos__hiddenLabel mesh__D000987 Personalities, Sociopathic
% 218.56/218.71  |- skos__hiddenLabel mesh__D000987 Disorder, Antisocial Personality
% 218.56/218.71  |- skos__hiddenLabel mesh__D000987 Dyssocial Behaviors
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000987 2002
% 218.56/218.71  |- mesh__dateEstablished mesh__D000987 1976-01-01
% 218.56/218.71  |- mesh__dateCreated mesh__D000987 1999-01-01
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000987 2003
% 218.56/218.71  |- skos__altLabel mesh__D000987 Sociopathic Personality
% 218.56/218.71  |- skos__hiddenLabel mesh__D000987 Sociopathic Personalities
% 218.56/218.71  |- skos__hiddenLabel mesh__D000987 Disorders, Antisocial Personality
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000987 1998
% 218.56/218.71  |- skos__altLabel mesh__D000987 Antisocial Personality
% 218.56/218.71  |- skos__broader mesh__D019692smesh__D048928
% 218.56/218.71  |- rdf__type mesh__D019692sskos__Concept
% 218.56/218.71  |- mesh__dateEstablished mesh__D019692 1998-01-01
% 218.56/218.71  |- mesh__historyNote mesh__D019692 98   
% 218.56/218.71  |- skos__historyNote mesh__D019692 Cyanobacteria %28%1985-1997%29%
% 218.56/218.71  |- mesh__recordAuthorizer mesh__D019692 sjn
% 218.56/218.71  |- skos__scopeNote mesh__D019692
% 218.56/218.71       A genus of PROCHLOROPHYTES occurring in unbranched chains of indefinite length and containing both chlorophylls a and b.%A%    
% 218.56/218.71  |- skos__prefLabel mesh__D019692 Prochlorothrix
% 218.56/218.71  |- mesh__dateRevised mesh__D019692 2005-06-30
% 218.56/218.71  |- mesh__recordOriginator mesh__D019692 NDW
% 218.56/218.71  |- mesh__dateCreated mesh__D019692 1997-06-20
% 218.56/218.71  |- mesh__recordMaintainer mesh__D019692 SYSTEM
% 218.56/218.71  |- mesh__publicMeSHNote mesh__D019692 98   
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D019692 2006
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D033363 2003
% 218.56/218.71  |- skos__hiddenLabel mesh__D033363 Diffractions, Neutron
% 218.56/218.71  |- mesh__historyNote mesh__D033363 2003   
% 218.56/218.71  |- skos__hiddenLabel mesh__D033363 Diffraction, Neutron
% 218.56/218.71  |- mesh__publicMeSHNote mesh__D033363 2003   
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D033363 2004
% 218.56/218.71  |- skos__prefLabel mesh__D033363 Neutron Diffraction
% 218.56/218.71  |- skos__historyNote mesh__D033363 Crystallography %28%1968-2002%29%
% 218.56/218.71  |- skos__broader mesh__D033363smesh__D003461
% 218.56/218.71  |- skos__historyNote mesh__D033363 Neutrons %28%1967-2002%29%
% 218.56/218.71  |- mesh__dateEstablished mesh__D033363 2003-01-01
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D033363 2005
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D033363 2006
% 218.56/218.71  |- skos__hiddenLabel mesh__D033363 Neutron Diffractions
% 218.56/218.71  |- skos__scopeNote mesh__D033363
% 218.56/218.71       The scattering of NEUTRONS by matter, especially crystals, with accompanying variation in intensity due to interference effects. It is useful in CRYSTALLOGRAPHY and POWDER DIFFRACTION.%A%    
% 218.56/218.71  |- mesh__dateCreated mesh__D033363 2002-07-03
% 218.56/218.71  |- rdf__type mesh__D033363sskos__Concept
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000189 1995
% 218.56/218.71  |- rdf__type mesh__D000189sskos__Concept
% 218.56/218.71  |- skos__historyNote mesh__D000189 Actinobacillosis %28%1968-1971%29%
% 218.56/218.71  |- mesh__recordAuthorizer mesh__D000189 PLS
% 218.56/218.71  |- skos__broader mesh__D000189smesh__D016871
% 218.56/218.71  |- mesh__recordMaintainer mesh__D000189 PXP
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000189 2000
% 218.56/218.71  |- mesh__dateRevised mesh__D000189 1991-06-17
% 218.56/218.71  |- skos__hiddenLabel mesh__D000189 Actinobacillus Infection
% 218.56/218.71  |- mesh__dateCreated mesh__D000189 1999-01-01
% 218.56/218.71  |- skos__hiddenLabel mesh__D000189 Infection, Actinobacillus
% 218.56/218.71  |- skos__altLabel mesh__D000189 Infections, Actinobacillus
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000189 2003
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000189 2001
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000189 2005
% 218.56/218.71  |- skos__scopeNote mesh__D000189
% 218.56/218.71       Infections with bacteria of the genus ACTINOBACILLUS.     
% 218.56/218.71  |- skos__prefLabel mesh__D000189 Actinobacillus Infections
% 218.56/218.71  |- skos__annotation mesh__D000189
% 218.56/218.71       do not confuse with ACTINOBACILLOSIS, a specific vet dis entity caused by A. lignieresii%A%  
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000189 1996
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000189 2004
% 218.56/218.71  |- skos__historyNote mesh__D000189 Actinobacillus %28%1966-1971%29%
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000189 1998
% 218.56/218.71  |- mesh__publicMeSHNote mesh__D000189 72   
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000189 2006
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000189 1992
% 218.56/218.71  |- mesh__dateEstablished mesh__D000189 1972-01-01
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000189 1997
% 218.56/218.71  |- mesh__recordOriginator mesh__D000189 NLM
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000189 1994
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000189 1999
% 218.56/218.71  |- mesh__historyNote mesh__D000189 72   
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000189 2002
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000189 1993
% 218.56/218.71  |- skos__hiddenLabel mesh__D005672 Fusidate, Sodium
% 218.56/218.71  |- skos__broader mesh__D005672smesh__D002775
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D005672 2006
% 218.56/218.71  |- skos__altLabel mesh__D005672 Sodium Fusidate
% 218.56/218.71  |- skos__hiddenLabel mesh__D005672 Sodium, Fusidate
% 218.56/218.71  |- mesh__recordMaintainer mesh__D005672 SYSTEM
% 218.56/218.71  |- skos__hiddenLabel mesh__D005672 Acid, Fusidic
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D005672 2004
% 218.56/218.71  |- skos__scopeNote mesh__D005672
% 218.56/218.71       An antibiotic isolated from the fermentation broth of Fusidium coccineum. %28%From Merck Index, 11th ed%29% It acts by inhibiting translocation during protein synthesis.%A%    
% 218.56/218.71  |- skos__hiddenLabel mesh__D005672 Fusidate, Silver
% 218.56/218.71  |- mesh__recordAuthorizer mesh__D005672 NLM
% 218.56/218.71  |- mesh__dateEstablished mesh__D005672 1965-01-01
% 218.56/218.71  |- mesh__historyNote mesh__D005672
% 218.56/218.71       65; FUSIDIN was see FUSIDIC ACID 1965-95   
% 218.56/218.71  |- mesh__recordOriginator mesh__D005672 NLM
% 218.56/218.71  |- skos__altLabel mesh__D005672 Fusidate Sodium
% 218.56/218.71  |- mesh__dateCreated mesh__D005672 1999-01-01
% 218.56/218.71  |- skos__prefLabel mesh__D005672 Fusidic Acid
% 218.56/218.71  |- skos__broader mesh__D005672smesh__D013261
% 218.56/218.71  |- mesh__publicMeSHNote mesh__D005672
% 218.56/218.71       65; FUSIDIN was see FUSIDIC ACID 1965-95   
% 218.56/218.71  |- rdf__type mesh__D005672sskos__Concept
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D005672 2005
% 218.56/218.71  |- mesh__dateRevised mesh__D005672 2003-07-30
% 218.56/218.71  |- mesh__historyNote mesh__D013306 75   
% 218.56/218.71  |- mesh__dateRevised mesh__D013306 2005-06-30
% 218.56/218.71  |- mesh__publicMeSHNote mesh__D013306 75   
% 218.56/218.71  |- skos__scopeNote mesh__D013306
% 218.56/218.71       A family of soil bacteria. It also includes some parasitic forms.%A%    
% 218.56/218.71  |- mesh__recordMaintainer mesh__D013306 SYSTEM
% 218.56/218.71  |- skos__annotation mesh__D013306 soil bacteria   
% 218.56/218.71  |- mesh__recordAuthorizer mesh__D013306 sjn
% 218.56/218.71  |- rdf__type mesh__D013306sskos__Concept
% 218.56/218.71  |- skos__broader mesh__D013306smesh__D016937
% 218.56/218.71  |- mesh__dateCreated mesh__D013306 1999-01-01
% 218.56/218.71  |- skos__prefLabel mesh__D013306 Streptomycetaceae
% 218.56/218.71  |- mesh__recordOriginator mesh__D013306 NLM
% 218.56/218.71  |- skos__historyNote mesh__D013306 Bacteria %28%1966-1974%29%
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D013306 2006
% 218.56/218.71  |- skos__broader mesh__D013306smesh__D000192
% 218.56/218.71  |- mesh__dateEstablished mesh__D013306 1975-01-01
% 218.56/218.71  |- mesh__recordAuthorizer mesh__D009265 sjn
% 218.56/218.71  |- mesh__publicMeSHNote mesh__D009265 70   
% 218.56/218.71  |- skos__hiddenLabel mesh__D009265 Sheep Disease, Nairobi
% 218.56/218.71  |- skos__annotation mesh__D009265
% 218.56/218.71       caused by a nairovirus; don%27%t forget also SHEEP %28%NIM%29% %26% check tag ANIMALS%A%  
% 218.56/218.71  |- skos__broader mesh__D009265smesh__D002044
% 218.56/218.71  |- skos__historyNote mesh__D009265 Arbovirus Infections %28%1966-1969%29%
% 218.56/218.71  |- mesh__dateEstablished mesh__D009265 1970-01-01
% 218.56/218.71  |- skos__broader mesh__D009265smesh__D012757
% 218.56/218.71  |- skos__broader mesh__D009265smesh__D017282
% 218.56/218.71  |- rdf__type mesh__D009265sskos__Concept
% 218.56/218.71  |- mesh__dateRevised mesh__D009265 2003-07-30
% 218.56/218.71  |- mesh__dateCreated mesh__D009265 1999-01-01
% 218.56/218.71  |- mesh__recordOriginator mesh__D009265 NLM
% 218.56/218.71  |- skos__scopeNote mesh__D009265
% 218.56/218.71       An arbovirus infection of sheep and goats transmitted by ticks. It is characterized by high fever and hemorrhagic gastroenteritis.%A%    
% 218.56/218.71  |- skos__historyNote mesh__D009265 Sheep Diseases %28%1966-1969%29%
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D009265 2004
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D009265 2005
% 218.56/218.71  |- skos__hiddenLabel mesh__D009265 Disease, Nairobi Sheep
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D009265 2006
% 218.56/218.71  |- mesh__recordMaintainer mesh__D009265 ags
% 218.56/218.71  |- mesh__historyNote mesh__D009265 70   
% 218.56/218.71  |- skos__prefLabel mesh__D009265 Nairobi Sheep Disease
% 218.56/218.71  |- skos__scopeNote mesh__D001282
% 218.56/218.71       Rapid, irregular atrial contractions due to an abnormality of atrial excitation.%A%    
% 218.56/218.71  |- skos__hiddenLabel mesh__D001282 Flutter, Atrial
% 218.56/218.71  |- mesh__publicMeSHNote mesh__D001282 84; was AURICULAR FLUTTER 1963-83   
% 218.56/218.71  |- skos__hiddenLabel mesh__D001282 Flutter, Auricular
% 218.56/218.71  |- skos__hiddenLabel mesh__D001282 Auricular Flutters
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D001282 2005
% 218.56/218.71  |- skos__prefLabel mesh__D001282 Atrial Flutter
% 218.56/218.71  |- mesh__dateRevised mesh__D001282 1999-11-03
% 218.56/218.71  |- mesh__dateCreated mesh__D001282 1999-01-01
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D001282 2003
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D001282 2006
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D001282 2000
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D001282 2004
% 218.56/218.71  |- skos__hiddenLabel mesh__D001282 Atrial Flutters
% 218.56/218.71  |- skos__hiddenLabel mesh__D001282 Flutters, Auricular
% 218.56/218.71  |- mesh__recordMaintainer mesh__D001282 PLS
% 218.56/218.71  |- rdf__type mesh__D001282sskos__Concept
% 218.56/218.71  |- skos__hiddenLabel mesh__D001282 Flutters, Atrial
% 218.56/218.71  |- mesh__recordOriginator mesh__D001282 NLM
% 218.56/218.71  |- mesh__recordAuthorizer mesh__D001282 sjn
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D001282 2001
% 218.56/218.71  |- skos__annotation mesh__D001282
% 218.56/218.71       do not confuse with ATRIAL FIBRILLATION   
% 218.56/218.71  |- mesh__historyNote mesh__D001282 84; was AURICULAR FLUTTER 1963-83   
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D001282 2002
% 218.56/218.71  |- skos__broader mesh__D001282smesh__D001145
% 218.56/218.71  |- mesh__onlineNote mesh__D001282
% 218.56/218.71       use ATRIAL FLUTTER to search AURICULAR FLUTTER 1966-83   
% 218.56/218.71  |- skos__altLabel mesh__D001282 Auricular Flutter
% 218.56/218.71  |- mesh__recordAuthorizer mesh__D000988 sjn
% 218.56/218.71  |- skos__annotation mesh__D000988
% 218.56/218.71       MeSH definition says %22%mechanical or chemical%22%; consider also SPERMATOZOA /drug eff %26% SPERMATOGENESIS /drug eff, etc.%A%  
% 218.56/218.71  |- skos__altLabel mesh__D000988 Sperm Maturation Blocking Agents
% 218.56/218.71  |- skos__prefLabel mesh__D000988 Antispermatogenic Agents
% 218.56/218.71  |- mesh__historyNote mesh__D000988
% 218.56/218.71       75; SPERM MATURATION BLOCKING AGENTS was heading 1975-91   
% 218.56/218.71  |- skos__broader mesh__D000988smesh__D045505
% 218.56/218.71  |- skos__historyNote mesh__D000988
% 218.56/218.71       Spermatogenesis/drug effects %28%1971-1974%29%
% 218.56/218.71  |- skos__hiddenLabel mesh__D000988 Agents, Antispermatogenic
% 218.56/218.71  |- mesh__publicMeSHNote mesh__D000988
% 218.56/218.71       75; SPERM MATURATION BLOCKING AGENTS was heading 1975-91   
% 218.56/218.71  |- rdf__type mesh__D000988sskos__Concept
% 218.56/218.71  |- mesh__dateRevised mesh__D000988 2005-06-30
% 218.56/218.71  |- skos__historyNote mesh__D000988 Contraceptive Agents %28%1967-1974%29%
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D000988 2006
% 218.56/218.71  |- skos__broader mesh__D000988smesh__D003272
% 218.56/218.71  |- mesh__recordMaintainer mesh__D000988 ssb
% 218.56/218.71  |- mesh__dateEstablished mesh__D000988 1975-01-01
% 218.56/218.71  |- skos__scopeNote mesh__D000988
% 218.56/218.71       Agents, either mechanical or chemical, which destroy spermatozoa in the male genitalia and block spermatogenesis.%A%    
% 218.56/218.71  |- mesh__dateCreated mesh__D000988 1999-01-01
% 218.56/218.71  |- skos__broader mesh__D000988smesh__D009676
% 218.56/218.71  |- mesh__onlineNote mesh__D000988
% 218.56/218.71       use ANTISPERMATOGENIC AGENTS to search SPERM MATURATION BLOCKING AGENTS 1975-91%A%  
% 218.56/218.71  |- mesh__recordOriginator mesh__D000988 NLM
% 218.56/218.71  |- skos__broader mesh__D019693smesh__D006521
% 218.56/218.71  |- skos__broader mesh__D019693smesh__D001327
% 218.56/218.71  |- mesh__dateCreated mesh__D019693 1997-06-20
% 218.56/218.71  |- skos__scopeNote mesh__D019693
% 218.56/218.71       A chronic self-perpetuating hepatocellular INFLAMMATION of unknown cause, usually with HYPERGAMMAGLOBULINEMIA and serum AUTOANTIBODIES.%A%    
% 218.56/218.71  |- mesh__dateEstablished mesh__D019693 1998-01-01
% 218.56/218.71  |- mesh__recordMaintainer mesh__D019693 lkt
% 218.56/218.71  |- mesh__publicMeSHNote mesh__D019693 98   
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D019693 2005
% 218.56/218.71  |- skos__prefLabel mesh__D019693 Hepatitis, Autoimmune
% 218.56/218.71  |- skos__historyNote mesh__D019693 Hepatitis %28%1967-1997%29%
% 218.56/218.71  |- skos__historyNote mesh__D019693 Autoimmune Diseases %28%1967-1997%29%
% 218.56/218.71  |- mesh__activeMeSHYear mesh__D019693 2006
% 218.56/218.71  |- mesh__recordOriginator mesh__D019693 AGS
% 218.56/218.71  |- mesh__recordAuthorizer mesh__D019693 sjn
% 218.56/218.71  |- rdf__type mesh__D019693sskos__Concept
% 218.56/218.71  |- mesh__historyNote mesh__D019693 98   
% 218.56/218.71  |- mesh__dateRevised mesh__D019693 2004-07-07
% 218.56/218.71  |- skos__altLabel mesh__D019693 Autoimmune Hepatitis
% 218.56/218.71  |- skos__historyNote mesh__D033364 Crustacea %28%1966-2002%29%
% 218.56/218.71  |- skos__broader mesh__D033364smesh__D003445
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D033364 2006
% 218.56/218.72  |- mesh__dateCreated mesh__D033364 2002-07-03
% 218.56/218.72  |- skos__annotation mesh__D033364
% 218.56/218.72       do not confuse with Decapoda, a genus of cephalopod molluscs; note X ref ROCK SHRIMP: several other shrimp terms are available; check text and MeSH; as animal %26% food; as food coord IM with SHELLFISH %28%IM%29%; unspecified shrimp as food is probably PENAEIDAE%A%  
% 218.56/218.72  |- skos__altLabel mesh__D033364 Decapods
% 218.56/218.72  |- mesh__dateRevised mesh__D033364 2004-07-19
% 218.56/218.72  |- skos__prefLabel mesh__D033364 Decapoda %28%Crustacea%29%
% 218.56/218.72  |- rdf__type mesh__D033364sskos__Concept
% 218.56/218.72  |- mesh__recordMaintainer mesh__D033364 jls
% 218.56/218.72  |- mesh__historyNote mesh__D033364 2003   
% 218.56/218.72  |- mesh__dateEstablished mesh__D033364 2003-01-01
% 218.56/218.72  |- skos__altLabel mesh__D033364 Rock Shrimp
% 218.56/218.72  |- mesh__recordAuthorizer mesh__D033364 sjn
% 218.56/218.72  |- mesh__publicMeSHNote mesh__D033364 2003   
% 218.56/218.72  |- skos__scopeNote mesh__D033364
% 218.56/218.72       The largest order of CRUSTACEA, comprising over 10,000 species. They are characterized by three pairs of thoracic appendages modified as maxillipeds, and five pairs of thoracic legs. The order includes the familiar shrimps, crayfish %28%ASTACOIDEA%29%, true crabs %28%BRACHYURA%29%, and lobsters %28%NEPHROPIDAE and PALINURIDAE%29%, among others.%A%    
% 218.56/218.72  |- skos__altLabel mesh__D033364 Shrimp, Rock
% 218.56/218.72  |- mesh__recordOriginator mesh__D033364 ags
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D033364 2005
% 218.56/218.72  |- skos__annotation mesh__D005673
% 218.56/218.72       infection = FUSOBACTERIUM INFECTIONS; DF: FUSOBACT   
% 218.56/218.72  |- mesh__recordMaintainer mesh__D005673 SYSTEM
% 218.56/218.72  |- mesh__recordAuthorizer mesh__D005673 sjn
% 218.56/218.72  |- mesh__dateRevised mesh__D005673 2005-06-30
% 218.56/218.72  |- mesh__publicMeSHNote mesh__D005673
% 218.56/218.72       SPHAEROPHORUS was heading 1963-76 %28%see under BACTEROIDACEAE 1976%29%%A%  
% 218.56/218.72  |- mesh__onlineNote mesh__D005673
% 218.56/218.72       use FUSOBACTERIUM to search SPHAEROPHORUS 1966-76   
% 218.56/218.72  |- mesh__dateCreated mesh__D005673 1999-01-01
% 218.56/218.72  |- rdf__type mesh__D005673sskos__Concept
% 218.56/218.72  |- skos__broader mesh__D005673smesh__D016965
% 218.56/218.72  |- mesh__historyNote mesh__D005673
% 218.56/218.72       SPHAEROPHORUS was heading 1963-76 %28%see under BACTEROIDACEAE 1976%29%%A%  
% 218.56/218.72  |- skos__broader mesh__D005673smesh__D045182
% 218.56/218.72  |- skos__prefLabel mesh__D005673 Fusobacterium
% 218.56/218.72  |- mesh__recordOriginator mesh__D005673 NLM
% 218.56/218.72  |- skos__altLabel mesh__D005673 Sphaerophorus
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D005673 2006
% 218.56/218.72  |- skos__scopeNote mesh__D005673
% 218.56/218.72       A genus of gram-negative, anaerobic, rod-shaped bacteria found in cavities of humans and other animals. No endospores are formed. Some species are pathogenic and occur in various purulent or gangrenous infections.%A%    
% 218.56/218.72  |- skos__hiddenLabel mesh__D013307 Strepto Hefa
% 218.56/218.72  |- skos__altLabel mesh__D013307
% 218.56/218.72       Gr%C3%%BC%nenthal Brand of Streptomycin Sulfate
% 218.56/218.72  |- mesh__publicMeSHNote mesh__D013307
% 218.56/218.72       /adverse effects /poisoning /toxicity were STREPTOMYCIN TOXICOLOGY 1963-65%A%  
% 218.56/218.72  |- mesh__dateCreated mesh__D013307 1999-01-01
% 218.56/218.72  |- mesh__recordOriginator mesh__D013307 NLM
% 218.56/218.72  |- skos__altLabel mesh__D013307 Sanavita Brand of Streptomycin Sulfate
% 218.56/218.72  |- skos__altLabel mesh__D013307 Streptomycin Sulphate
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D013307 2006
% 218.56/218.72  |- mesh__recordMaintainer mesh__D013307 CCR
% 218.56/218.72  |- mesh__dateRevised mesh__D013307 2005-06-30
% 218.56/218.72  |- skos__broader mesh__D013307smesh__D000617
% 218.56/218.72  |- skos__altLabel mesh__D013307 Clariana Brand of Streptomycin Sulfate
% 218.56/218.72  |- mesh__recordAuthorizer mesh__D013307 sjn
% 218.56/218.72  |- mesh__historyNote mesh__D013307
% 218.56/218.72       /adv eff-pois-tox was STREPTOMYCIN TOXICOLOGY 1963-65   
% 218.56/218.72  |- skos__scopeNote mesh__D013307
% 218.56/218.72       An antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by inhibiting the initiation and elongation processes during protein synthesis.%A%    
% 218.56/218.72  |- skos__altLabel mesh__D013307 Streptomycin Sulfate %28%2:3%29% Salt
% 218.56/218.72  |- skos__altLabel mesh__D013307 Fatol Brand of Streptomycin Sulfate
% 218.56/218.72  |- skos__altLabel mesh__D013307 Normon Brand of Streptomycin Sulfate
% 218.56/218.72  |- skos__prefLabel mesh__D013307 Streptomycin
% 218.56/218.72  |- skos__altLabel mesh__D013307 CEPA Brand of Streptomycin Sulfate
% 218.56/218.72  |- skos__altLabel mesh__D013307 Panpharma Brand of Streptomycin Sulfate
% 218.56/218.72  |- skos__altLabel mesh__D013307 Wernigerode Brand of Streptomycin Sulfate
% 218.56/218.72  |- rdf__type mesh__D013307sskos__Concept
% 218.56/218.72  |- skos__hiddenLabel mesh__D013307 Strepto Fatol
% 218.56/218.72  |- skos__hiddenLabel mesh__D009266 EN 2234A
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D009266 2001
% 218.56/218.72  |- mesh__dateEstablished mesh__D009266 1991-01-01
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D009266 2004
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D009266 2005
% 218.56/218.72  |- skos__historyNote mesh__D009266 Narcotic Antagonists %28%1966-1971%29%
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D009266 2006
% 218.56/218.72  |- mesh__recordMaintainer mesh__D009266 TWD
% 218.56/218.72  |- skos__hiddenLabel mesh__D009266 Hydrochloride, Nalbuphine
% 218.56/218.72  |- skos__prefLabel mesh__D009266 Nalbuphine
% 218.56/218.72  |- mesh__recordAuthorizer mesh__D009266 sjn
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D009266 2002
% 218.56/218.72  |- mesh__dateRevised mesh__D009266 2000-06-22
% 218.56/218.72  |- skos__broader mesh__D009266smesh__D009019
% 218.56/218.72  |- skos__hiddenLabel mesh__D009266 EN2234A
% 218.56/218.72  |- skos__historyNote mesh__D009266 Morphinans %28%1966-1971%29%
% 218.56/218.72  |- mesh__recordOriginator mesh__D009266 NLM
% 218.56/218.72  |- mesh__publicMeSHNote mesh__D009266
% 218.56/218.72       91; was see under MORPHINANS 1972-90   
% 218.56/218.72  |- skos__scopeNote mesh__D009266
% 218.56/218.72       A narcotic used as a pain medication. It appears to be an agonist at kappa opioid receptors and an antagonist or partial agonist at mu opioid receptors.%A%    
% 218.56/218.72  |- mesh__historyNote mesh__D009266
% 218.56/218.72       91%28%72%29%; was see under MORPHINANS 1972-90   
% 218.56/218.72  |- rdf__type mesh__D009266sskos__Concept
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D009266 2003
% 218.56/218.72  |- mesh__dateCreated mesh__D009266 1999-01-01
% 218.56/218.72  |- skos__hiddenLabel mesh__D001283 Node, Atrio-Ventricular
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D001283 2000
% 218.56/218.72  |- skos__hiddenLabel mesh__D001283 Nodes, Atrioventricular
% 218.56/218.72  |- rdf__type mesh__D001283sskos__Concept
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D001283 1997
% 218.56/218.72  |- skos__hiddenLabel mesh__D001283 Node, A-V
% 218.56/218.72  |- skos__hiddenLabel mesh__D001283 Atrio Ventricular Node
% 218.56/218.72  |- mesh__recordAuthorizer mesh__D001283 PLS
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D001283 1996
% 218.56/218.72  |- skos__altLabel mesh__D001283 A-V Node
% 218.56/218.72  |- mesh__recordOriginator mesh__D001283 NLM
% 218.56/218.72  |- skos__hiddenLabel mesh__D001283 A-V Nodes
% 218.56/218.72  |- skos__hiddenLabel mesh__D001283 Nodes, A-V
% 218.56/218.72  |- skos__hiddenLabel mesh__D001283 Atrio-Ventricular Nodes
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D001283 1999
% 218.56/218.72  |- skos__altLabel mesh__D001283 AV Node
% 218.56/218.72  |- skos__hiddenLabel mesh__D001283 Nodes, Atrio-Ventricular
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D001283 2004
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D001283 1995
% 218.56/218.72  |- mesh__dateCreated mesh__D001283 1999-01-01
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D001283 1998
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D001283 1993
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D001283 2002
% 218.56/218.72  |- mesh__onlineNote mesh__D001283 search HEART CONDUCTION SYSTEM 1966-74   
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D001283 2003
% 218.56/218.72  |- skos__prefLabel mesh__D001283 Atrioventricular Node
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D001283 2006
% 218.56/218.72  |- skos__broader mesh__D001283smesh__D006329
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D001283 1994
% 218.56/218.72  |- mesh__publicMeSHNote mesh__D001283
% 218.56/218.72       91; was see under HEART CONDUCTION SYSTEM 1975-90   
% 218.56/218.72  |- skos__hiddenLabel mesh__D001283 A V Node
% 218.56/218.72  |- skos__scopeNote mesh__D001283
% 218.56/218.72       A small nodular mass of specialized muscle fibers located in the interatrial septum near the opening of the coronary sinus. It gives rise to the atrioventricular bundle of the conduction system of the heart.%A%    
% 218.56/218.72  |- mesh__dateRevised mesh__D001283 1992-03-25
% 218.56/218.72  |- skos__hiddenLabel mesh__D001283 Node, Atrioventricular
% 218.56/218.72  |- skos__hiddenLabel mesh__D001283 Atrioventricular Nodes
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D001283 2001
% 218.56/218.72  |- skos__hiddenLabel mesh__D001283 Node, AV
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D001283 2005
% 218.56/218.72  |- mesh__historyNote mesh__D001283
% 218.56/218.72       91%28%75%29%; was see under HEART CONDUCTION SYSTEM 1975-90   
% 218.56/218.72  |- skos__altLabel mesh__D001283 Atrio-Ventricular Node
% 218.56/218.72  |- mesh__dateEstablished mesh__D001283 1991-01-01
% 218.56/218.72  |- mesh__recordMaintainer mesh__D001283 TAP
% 218.56/218.72  |- skos__hiddenLabel mesh__D001283 Nodes, AV
% 218.56/218.72  |- skos__hiddenLabel mesh__D001283 AV Nodes
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D014400 1998
% 218.56/218.72  |- skos__prefLabel mesh__D014400 Tuberculosis, Splenic
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D014400 2003
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D014400 1994
% 218.56/218.72  |- skos__scopeNote mesh__D014400
% 218.56/218.72       Infection of the spleen with species of MYCOBACTERIUM.     
% 218.56/218.72  |- mesh__recordOriginator mesh__D014400 NLM
% 218.56/218.72  |- skos__hiddenLabel mesh__D014400 Splenic Tuberculoses
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D014400 2006
% 218.56/218.72  |- mesh__dateRevised mesh__D014400 1991-06-12
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D014400 2001
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D014400 2005
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D014400 1997
% 218.56/218.72  |- skos__hiddenLabel mesh__D014400 Splenic Tuberculosis
% 218.56/218.72  |- mesh__recordAuthorizer mesh__D014400 PLS
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D014400 2000
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D014400 1993
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D014400 1996
% 218.56/218.72  |- skos__broader mesh__D014400smesh__D014376
% 218.56/218.72  |- mesh__recordMaintainer mesh__D014400 PXP
% 218.56/218.72  |- skos__broader mesh__D014400smesh__D013158
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D014400 1999
% 218.56/218.72  |- skos__hiddenLabel mesh__D014400 Tuberculoses, Splenic
% 218.56/218.72  |- mesh__dateCreated mesh__D014400 1999-01-01
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D014400 1992
% 218.56/218.72  |- rdf__type mesh__D014400sskos__Concept
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D014400 2004
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D014400 1995
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D014400 2002
% 218.56/218.72  |- mesh__recordMaintainer mesh__D000989 ssb
% 218.56/218.72  |- skos__broader mesh__D000989smesh__D000907
% 218.56/218.72  |- mesh__recordOriginator mesh__D000989 NLM
% 218.56/218.72  |- mesh__recordAuthorizer mesh__D000989 sjn
% 218.56/218.72  |- skos__hiddenLabel mesh__D000989 O, Antistreptolysin
% 218.56/218.72  |- rdf__type mesh__D000989sskos__Concept
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D000989 2006
% 218.56/218.72  |- skos__prefLabel mesh__D000989 Antistreptolysin
% 218.56/218.72  |- mesh__dateCreated mesh__D000989 1999-01-01
% 218.56/218.72  |- skos__scopeNote mesh__D000989
% 218.56/218.72       Antibodies specific to STREPTOLYSINS which indicate STREPTOCOCCAL INFECTIONS.%A%    
% 218.56/218.72  |- mesh__dateRevised mesh__D000989 2005-06-30
% 218.56/218.72  |- skos__historyNote mesh__D019694 Chronic Disease %28%1973-1997%29%
% 218.56/218.72  |- mesh__dateRevised mesh__D019694 2004-07-13
% 218.56/218.72  |- skos__historyNote mesh__D019694 Hepatitis, Chronic %28%1983-1997%29%
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D019694 2005
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D019694 2006
% 218.56/218.72  |- mesh__dateCreated mesh__D019694 1997-06-20
% 218.56/218.72  |- rdf__type mesh__D019694sskos__Concept
% 218.56/218.72  |- mesh__recordMaintainer mesh__D019694 sjn
% 218.56/218.72  |- mesh__historyNote mesh__D019694 98   
% 218.56/218.72  |- mesh__dateEstablished mesh__D019694 1998-01-01
% 218.56/218.72  |- skos__prefLabel mesh__D019694 Hepatitis B, Chronic
% 218.56/218.72  |- mesh__publicMeSHNote mesh__D019694 98   
% 218.56/218.72  |- skos__broader mesh__D019694smesh__D006509
% 218.56/218.72  |- skos__historyNote mesh__D019694 Hepatitis B %28%1973-1997%29%
% 218.56/218.72  |- skos__altLabel mesh__D019694 Chronic Hepatitis B
% 218.56/218.72  |- mesh__recordOriginator mesh__D019694 AGS
% 218.56/218.72  |- mesh__recordAuthorizer mesh__D019694 sjn
% 218.56/218.72  |- skos__broader mesh__D019694smesh__D006521
% 218.56/218.72  |- skos__scopeNote mesh__D019694
% 218.56/218.72       INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.%A%    
% 218.56/218.72  |- skos__hiddenLabel mesh__D005674 Infection, Fusobacterium
% 218.56/218.72  |- mesh__recordOriginator mesh__D005674 FPG
% 218.56/218.72  |- skos__hiddenLabel mesh__D005674 Sphaerophorus Infection
% 218.56/218.72  |- rdf__type mesh__D005674sskos__Concept
% 218.56/218.72  |- skos__hiddenLabel mesh__D005674 Fusobacterium Infection
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D005674 2005
% 218.56/218.72  |- skos__annotation mesh__D005674
% 218.56/218.72       gram-neg bact infect; DF: FUSOBACT INFECT   
% 218.56/218.72  |- skos__prefLabel mesh__D005674 Fusobacterium Infections
% 218.56/218.72  |- mesh__publicMeSHNote mesh__D005674
% 218.56/218.72       77; was SPHAEROPHORUS INFECTIONS 1968-76   
% 218.56/218.72  |- mesh__onlineNote mesh__D005674
% 218.56/218.72       use FUSOBACTERIUM INFECTIONS to search SPHAEROPHORUS INFECTIONS 1968-76%A%  
% 218.56/218.72  |- mesh__dateCreated mesh__D005674 1976-04-16
% 218.56/218.72  |- skos__broader mesh__D005674smesh__D045825
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D005674 2006
% 218.56/218.72  |- mesh__recordAuthorizer mesh__D005674 sjn
% 218.56/218.72  |- skos__hiddenLabel mesh__D005674 Necrobacilloses
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D005674 2004
% 218.56/218.72  |- mesh__historyNote mesh__D005674
% 218.56/218.72       77; was SPHAEROPHORUS INFECTIONS 1968-76   
% 218.56/218.72  |- skos__scopeNote mesh__D005674
% 218.56/218.72       Infections with bacteria of the genus FUSOBACTERIUM.     
% 218.56/218.72  |- mesh__dateRevised mesh__D005674 2003-07-09
% 218.56/218.72  |- mesh__dateEstablished mesh__D005674 1977-01-01
% 218.56/218.72  |- skos__altLabel mesh__D005674 Infections, Fusobacterium
% 218.56/218.72  |- skos__historyNote mesh__D005674 Fusobacterium %28%1966-1967%29%
% 218.56/218.72  |- mesh__recordMaintainer mesh__D005674 ags
% 218.56/218.72  |- skos__hiddenLabel mesh__D005674 Infection, Sphaerophorus
% 218.56/218.72  |- skos__altLabel mesh__D005674 Sphaerophorus Infections
% 218.56/218.72  |- skos__altLabel mesh__D005674 Infections, Sphaerophorus
% 218.56/218.72  |- mesh__dateRevised mesh__D013308 2000-06-22
% 218.56/218.72  |- skos__altLabel mesh__D013308 Rufocromomycin
% 218.56/218.72  |- skos__hiddenLabel mesh__D013308 NSC45383
% 218.56/218.72  |- skos__broader mesh__D013308smesh__D010848
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D013308 2006
% 218.56/218.72  |- skos__prefLabel mesh__D013308 Streptonigrin
% 218.56/218.72  |- mesh__dateEstablished mesh__D013308 1973-01-01
% 218.56/218.72  |- skos__altLabel mesh__D013308 Brunemycin
% 218.56/218.72  |- skos__scopeNote mesh__D013308
% 218.56/218.72       Complex cytotoxic antibiotic obtained from Streptomyces flocculus or S. rufochronmogenus. It is used in advanced carcinoma and causes leukopenia.%A%    
% 218.56/218.72  |- mesh__recordOriginator mesh__D013308 NLM
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D013308 2005
% 218.56/218.72  |- mesh__recordMaintainer mesh__D013308 TWD
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D013308 2002
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D013308 2004
% 218.56/218.72  |- skos__hiddenLabel mesh__D013308 NSC 45383
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D013308 2001
% 218.56/218.72  |- skos__altLabel mesh__D013308 Bruneomycin
% 218.56/218.72  |- rdf__type mesh__D013308sskos__Concept
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D013308 2003
% 218.56/218.72  |- mesh__recordAuthorizer mesh__D013308 sjn
% 218.56/218.72  |- mesh__historyNote mesh__D013308 73%28%65%29%   
% 218.56/218.72  |- mesh__publicMeSHNote mesh__D013308 73   
% 218.56/218.72  |- mesh__dateCreated mesh__D013308 1999-01-01
% 218.56/218.72  |- rdf__type mesh__D010010sskos__Concept
% 218.56/218.72  |- mesh__recordAuthorizer mesh__D010010 sjn
% 218.56/218.72  |- skos__related mesh__D010010smesh__D001862
% 218.56/218.72  |- skos__broader mesh__D010010smesh__D008264
% 218.56/218.72  |- mesh__publicMeSHNote mesh__D010010 ODONTOCLASTS was heading 1965-77   
% 218.56/218.72  |- skos__related mesh__D010010smesh__D010006
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D010010 2004
% 218.56/218.72  |- mesh__recordOriginator mesh__D010010 NLM
% 218.56/218.72  |- skos__scopeNote mesh__D010010
% 218.56/218.72       A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption.%A%    
% 218.56/218.72  |- mesh__dateCreated mesh__D010010 1999-01-01
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D010010 2005
% 218.56/218.72  |- skos__altLabel mesh__D010010 Cementoclasts
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D010010 2006
% 218.56/218.72  |- mesh__historyNote mesh__D010010 ODONTOCLASTS was heading 1965-77   
% 218.56/218.72  |- skos__prefLabel mesh__D010010 Osteoclasts
% 218.56/218.72  |- mesh__onlineNote mesh__D010010
% 218.56/218.72       use OSTEOCLASTS to search ODONTOCLASTS 1966-77   
% 218.56/218.72  |- mesh__recordMaintainer mesh__D010010 nns
% 218.56/218.72  |- skos__altLabel mesh__D010010 Odontoclast
% 218.56/218.72  |- skos__altLabel mesh__D010010 Osteoclast
% 218.56/218.72  |- mesh__dateRevised mesh__D010010 2003-07-09
% 218.56/218.72  |- skos__altLabel mesh__D010010 Cementoclast
% 218.56/218.72  |- skos__scopeNote mesh__D009267
% 218.56/218.72       An organophosphate cholinesterase inhibitor that is used as an insecticide and as an acaricide.%A%    
% 218.56/218.72  |- skos__historyNote mesh__D009267 Insecticides %28%1966-1971%29%
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D009267 2006
% 218.56/218.72  |- mesh__publicMeSHNote mesh__D009267
% 218.56/218.72       91; was see under INSECTICIDES, ORGANOPHOSPHATE 1972-90   
% 218.56/218.72  |- skos__prefLabel mesh__D009267 Naled
% 218.56/218.72  |- skos__annotation mesh__D009267 TN 111 for eff on insects   
% 218.56/218.72  |- skos__broader mesh__D009267smesh__D009943
% 218.56/218.72  |- mesh__recordAuthorizer mesh__D009267 sjn
% 218.56/218.72  |- mesh__dateRevised mesh__D009267 2004-07-07
% 218.56/218.72  |- rdf__type mesh__D009267sskos__Concept
% 218.56/218.72  |- mesh__historyNote mesh__D009267
% 218.56/218.72       91%28%72%29%; was see under INSECTICIDES, ORGANOPHOSPHATE 1972-90%A%  
% 218.56/218.72  |- mesh__dateCreated mesh__D009267 1999-01-01
% 218.56/218.72  |- mesh__recordMaintainer mesh__D009267 ssb
% 218.56/218.72  |- mesh__dateEstablished mesh__D009267 1991-01-01
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D009267 2005
% 218.56/218.72  |- mesh__recordOriginator mesh__D009267 NLM
% 218.56/218.72  |- mesh__dateCreated mesh__D001284 1999-01-01
% 218.56/218.72  |- mesh__dateRevised mesh__D001284 1999-11-08
% 218.56/218.72  |- skos__prefLabel mesh__D001284 Atrophy
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D001284 2000
% 218.56/218.72  |- mesh__recordMaintainer mesh__D001284 KEV
% 218.56/218.72  |- skos__annotation mesh__D001284
% 218.56/218.72       NIM; coord with organ/pathol %28%IM%29%   
% 218.56/218.72  |- mesh__recordOriginator mesh__D001284 NLM
% 218.56/218.72  |- mesh__recordAuthorizer mesh__D001284 sjn
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D001284 2004
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D001284 2006
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D001284 2003
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D001284 2005
% 218.56/218.72  |- skos__scopeNote mesh__D001284
% 218.56/218.72       Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.%A%    
% 218.56/218.72  |- skos__broader mesh__D001284smesh__D020763
% 218.56/218.72  |- rdf__type mesh__D001284sskos__Concept
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D001284 2002
% 218.56/218.72  |- skos__hiddenLabel mesh__D001284 Atrophies
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D001284 2001
% 218.56/218.72  |- skos__scopeNote mesh__D028421
% 218.56/218.72       A series of prostaglandin-like compounds that are produced by the attack of free-radical species on unsaturated fatty acids, especially ARACHIDONIC ACID, of cellular MEMBRANES.  Once cleaved from the lipid membrane by the action of phospholipases they can circulate into various bodily fluids and eventually be excreted. Although these compounds resemble enzymatically synthesized prostaglandins their stereoisometric arrangement is usually different than the %22%naturally occurring%22% compounds.%A%    
% 218.56/218.72  |- skos__altLabel mesh__D028421 Isoprostane
% 218.56/218.72  |- mesh__historyNote mesh__D028421 2002   
% 218.56/218.72  |- mesh__dateRevised mesh__D028421 2003-07-09
% 218.56/218.72  |- mesh__dateCreated mesh__D028421 2001-08-03
% 218.56/218.72  |- mesh__recordOriginator mesh__D028421 jmp
% 218.56/218.72  |- skos__historyNote mesh__D028421 Lipid Peroxides %28%1992-2001%29%
% 218.56/218.72  |- mesh__recordMaintainer mesh__D028421 ssb
% 218.56/218.72  |- skos__historyNote mesh__D028421 Dinoprost %28%1992-2001%29%
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D028421 2005
% 218.56/218.72  |- skos__broader mesh__D028421smesh__D001095
% 218.56/218.72  |- mesh__recordAuthorizer mesh__D028421 sjn
% 218.56/218.72  |- skos__broader mesh__D028421smesh__D005231
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D028421 2006
% 218.56/218.72  |- mesh__publicMeSHNote mesh__D028421 2002   
% 218.56/218.72  |- rdf__type mesh__D028421sskos__Concept
% 218.56/218.72  |- mesh__dateEstablished mesh__D028421 2002-01-01
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D028421 2004
% 218.56/218.72  |- skos__prefLabel mesh__D028421 Isoprostanes
% 218.56/218.72  |- skos__broader mesh__D014401smesh__D014569
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D014401 2006A
% 218.56/218.72  |- skos__scopeNote mesh__D014401
% 218.56/218.72       A general term for MYCOBACTERIUM infections of any part of the UROGENITAL SYSTEM in either the male or the female.%A%    
% 218.56/218.72  |- skos__broader mesh__D014401smesh__D016146
% 218.56/218.72  |- mesh__dateRevised mesh__D014401 2005-08-02
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D014401 2006
% 218.56/218.72  |- skos__altLabel mesh__D014401 Urogenital Tuberculosis
% 218.56/218.72  |- mesh__recordMaintainer mesh__D014401 ags
% 218.56/218.72  |- mesh__dateCreated mesh__D014401 1999-01-01
% 218.56/218.72  |- skos__annotation mesh__D014401
% 218.56/218.72       general; prefer TUBERCULOSIS, FEMALE GENITAL; TUBERCULOSIS, MALE GENITAL; or TUBERCULOSIS, RENAL%A%  
% 218.56/218.72  |- mesh__recordOriginator mesh__D014401 NLM
% 218.56/218.72  |- skos__hiddenLabel mesh__D014401 Urogenital Tuberculoses
% 218.56/218.72  |- skos__broader mesh__D014401smesh__D014376
% 218.56/218.72  |- mesh__recordAuthorizer mesh__D014401 ags
% 218.56/218.72  |- skos__hiddenLabel mesh__D014401 Tuberculoses, Urogenital
% 218.56/218.72  |- skos__prefLabel mesh__D014401 Tuberculosis, Urogenital
% 218.56/218.72  |- rdf__type mesh__D014401sskos__Concept
% 218.56/218.72  |- skos__hiddenLabel mesh__D019695 Glycyrrhizate, Zinc
% 218.56/218.72  |- skos__hiddenLabel mesh__D019695 Glycyrrhizinate, Dipotassium
% 218.56/218.72  |- mesh__historyNote mesh__D019695
% 218.56/218.72       98; see GLYCYRRHIZIC ACID %28%NM%29% 1976-97   
% 218.56/218.72  |- skos__altLabel mesh__D019695 Glycyrrhizin
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D019695 2003
% 218.56/218.72  |- skos__historyNote mesh__D019695 Glycyrrhiza %28%1976-1985%29%
% 218.56/218.72  |- skos__broader mesh__D019695smesh__D014315
% 218.56/218.72  |- mesh__recordAuthorizer mesh__D019695 sjn
% 218.56/218.72  |- skos__altLabel mesh__D019695 Glycyrrhizinic Acid
% 218.56/218.72  |- skos__prefLabel mesh__D019695 Glycyrrhizic Acid
% 218.56/218.72  |- skos__hiddenLabel mesh__D019695 Acid, Glycyrrhizic
% 218.56/218.72  |- mesh__publicMeSHNote mesh__D019695
% 218.56/218.72       98; GLYCYRRHIZIC ACID was indexed under GLYCYRRHETINIC ACID 1979-97, GLYCYRRHIZA 1976-79, GLUCOSIDURONATES 1976-79, %26% ENOXOLONE 1977-79%A%  
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D019695 2002
% 218.56/218.72  |- skos__scopeNote mesh__D019695
% 218.56/218.72       A widely used anti-inflammatory agent isolated from the licorice root. It is metabolized to glycyrrhetic acid, which inhibits 11 beta-hydroxysteroid dehydrogenase and other enzymes involved in the metabolism of corticosteroids. Therefore, glycyrrhizic acid, which is the main and sweet component of licorice, has been investigated for its ability to cause hypermineralocorticoidism with sodium retention and potassium loss, edema, increased blood pressure, as well as depression of the renin-angiotensin-aldosterone system.%A%    
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D019695 2006
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D019695 2001
% 218.56/218.72  |- skos__hiddenLabel mesh__D019695 Acid, Glycyrrhizinic
% 218.56/218.72  |- rdf__type mesh__D019695sskos__Concept
% 218.56/218.72  |- mesh__dateEstablished mesh__D019695 1998-01-01
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D019695 2005
% 218.56/218.72  |- mesh__recordMaintainer mesh__D019695 CCR
% 218.56/218.72  |- mesh__dateCreated mesh__D019695 1997-06-20
% 218.56/218.72  |- mesh__dateRevised mesh__D019695 2000-06-21
% 218.56/218.72  |- mesh__recordOriginator mesh__D019695 ADP
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D019695 2004
% 218.56/218.72  |- skos__historyNote mesh__D019695 Glycyrrhetinic Acid %28%1977-1997%29%
% 218.56/218.72  |- skos__annotation mesh__D019695
% 218.56/218.72       do not confuse with GLYCYRRHETINIC ACID   
% 218.56/218.72  |- mesh__onlineNote mesh__D005675
% 218.56/218.72       use FUSOBACTERIUM NECROPHORUM to search SPHAEROPHORUS NECROPHORUS 1975%A%  
% 218.56/218.72  |- rdf__type mesh__D005675sskos__Concept
% 218.56/218.72  |- mesh__publicMeSHNote mesh__D005675
% 218.56/218.72       76; was SPHAEROPHORUS NECROPHORUS see under SPHAEROPHORUS 1975%A%  
% 218.56/218.72  |- mesh__recordOriginator mesh__D005675 JW
% 218.56/218.72  |- skos__altLabel mesh__D005675 Sphaerophorus necrophorus
% 218.56/218.72  |- skos__historyNote mesh__D005675 Fusobacterium %28%1966-1974%29%
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D005675 2006
% 218.56/218.72  |- skos__prefLabel mesh__D005675 Fusobacterium necrophorum
% 218.56/218.72  |- skos__related mesh__D005675smesh__D005535
% 218.56/218.72  |- skos__scopeNote mesh__D005675
% 218.56/218.72       A species of gram-negative, non-spore-forming bacteria isolated from the natural cavities of man and other animals and from necrotic lesions, abscesses, and blood.%A%    
% 218.56/218.72  |- skos__annotation mesh__D005675
% 218.56/218.72       infection: coord IM with FUSOBACTERIUM INFECTIONS %28%IM%29%; DF: FUSOBACT NECROPHORUM%A%  
% 218.56/218.72  |- mesh__recordMaintainer mesh__D005675 SYSTEM
% 218.56/218.72  |- mesh__recordAuthorizer mesh__D005675 sjn
% 218.56/218.72  |- mesh__dateCreated mesh__D005675 1975-07-25
% 218.56/218.72  |- mesh__dateRevised mesh__D005675 2005-06-30
% 218.56/218.72  |- skos__broader mesh__D005675smesh__D005673
% 218.56/218.72  |- mesh__dateEstablished mesh__D005675 1976-01-01
% 218.56/218.72  |- mesh__historyNote mesh__D005675
% 218.56/218.72       76; was SPHAEROPHORUS NECROPHORUS see under SPHAEROPHORUS 1975%A%  
% 218.56/218.72  |- skos__broader mesh__D013309smesh__D000617
% 218.56/218.72  |- skos__prefLabel mesh__D013309 Streptothricins
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D013309 2005
% 218.56/218.72  |- mesh__dateCreated mesh__D013309 1974-11-19
% 218.56/218.72  |- mesh__recordAuthorizer mesh__D013309 sjn
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D013309 2006
% 218.56/218.72  |- skos__historyNote mesh__D013309 Peptides %28%1972-1974%29%
% 218.56/218.72  |- skos__altLabel mesh__D013309 Racemomycins
% 218.56/218.72  |- mesh__dateEstablished mesh__D013309 1991-01-01
% 218.56/218.72  |- skos__historyNote mesh__D013309 Aminoglycosides %28%1974%29%
% 218.56/218.72  |- mesh__dateRevised mesh__D013309 2004-07-07
% 218.56/218.72  |- skos__historyNote mesh__D013309 Antibiotics %28%1972-1974%29%
% 218.56/218.72  |- skos__altLabel mesh__D013309 Yazumycins
% 218.56/218.72  |- mesh__recordMaintainer mesh__D013309 ssb
% 218.56/218.72  |- rdf__type mesh__D013309sskos__Concept
% 218.56/218.72  |- mesh__historyNote mesh__D013309
% 218.56/218.72       1991%28%1978%29%; use ANTIBIOTICS, AMINOGLYCOSIDE 1978-1990; was STREPTOTHRICIN use ANTIBIOTICS 1975-1977; NOURSEOTHRICIN was %28%NM%29% 1975-1993; for RACEMOMYCINS use RACEMOMYCIN %28%NM%29% 2000-2003%A%  
% 218.56/218.72  |- skos__scopeNote mesh__D013309
% 218.56/218.72       A group of antibiotic aminoglycosides differing only in the number of repeating residues in the peptide side chain. They are produced by Streptomyces and Actinomyces and may have broad spectrum antimicrobial and some antiviral properties.%A%    
% 218.56/218.72  |- mesh__recordOriginator mesh__D013309 NLM
% 218.56/218.72  |- mesh__publicMeSHNote mesh__D013309
% 218.56/218.72       1991; see ANTIBIOTICS, AMINOGLYCOSIDE 1978-1990; was STREPTOTHRICIN see ANTIBIOTICS 1975-77; NOURSEOTHRICIN was indexed under STREPTOTHRICINS 1975-1993;  RACEMOMYCINS was indexed under RACEMOMYCIN %28%NM%29% 2000-2003%A%  
% 218.56/218.72  |- skos__altLabel mesh__D013309 Streptothricin
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D010011 2002
% 218.56/218.72  |- skos__broader mesh__D010011smesh__D010006
% 218.56/218.72  |- mesh__activeMeSHYear mesh__D010011 2006
% 218.56/218.72  |- mesh__dateEstablished mesh__D010011 1965-01-01
% 218.56/218.72  |- mesh__publicMeSHNote mesh__D010011 65   
% 218.56/218.72  |- skos__scopeNote mesh__D010011
% 218.56/218.72       Mature osteoblasts that have become embedded in the BONE MATRIX. They occupy a small cavity, called lacuna, in the matrix and are connected to adjacent osteocytes via protoplasmic projections called canaliculi.%A%    
% 218.56/218.72  |- mesh__dateRevised mesh__D010011 1999-11-03
% 218.56/218.72  |- mesh__recordAuthorizer mesh__D010011 sjn
% 218.56/218.72  |- skos__hiddenLabel mesh__D010011 Osteocyte
% 218.56/218.73  |- mesh__recordOriginator mesh__D010011 NLM
% 218.56/218.73  |- mesh__historyNote mesh__D010011 65   
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D010011 2003
% 218.56/218.73  |- rdf__type mesh__D010011sskos__Concept
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D010011 2000
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D010011 2004
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D010011 2001
% 218.56/218.73  |- mesh__dateCreated mesh__D010011 1999-01-01
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D010011 2005
% 218.56/218.73  |- mesh__recordMaintainer mesh__D010011 KEV
% 218.56/218.73  |- skos__prefLabel mesh__D010011 Osteocytes
% 218.56/218.73  |- mesh__recordAuthorizer mesh__D009268 sjn
% 218.56/218.73  |- skos__altLabel mesh__D009268 Sodium Nalidixic Acid, Monohydrate
% 218.56/218.73  |- mesh__dateCreated mesh__D009268 1999-01-01
% 218.56/218.73  |- mesh__historyNote mesh__D009268 66%28%64%29%   
% 218.56/218.73  |- skos__broader mesh__D009268smesh__D009287
% 218.56/218.73  |- skos__hiddenLabel mesh__D009268 Sodium, Nalidixate
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D009268 2006
% 218.56/218.73  |- mesh__recordOriginator mesh__D009268 NLM
% 218.56/218.73  |- skos__scopeNote mesh__D009268
% 218.56/218.73       A synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA GYRASE.%A%    
% 218.56/218.73  |- mesh__publicMeSHNote mesh__D009268 66   
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D009268 2005
% 218.56/218.73  |- skos__hiddenLabel mesh__D009268 Acid, Nalidixic
% 218.56/218.73  |- skos__prefLabel mesh__D009268 Nalidixic Acid
% 218.56/218.73  |- mesh__dateEstablished mesh__D009268 1966-01-01
% 218.56/218.73  |- mesh__recordMaintainer mesh__D009268 ssb
% 218.56/218.73  |- skos__altLabel mesh__D009268 Nalidixin
% 218.56/218.73  |- skos__broader mesh__D009268smesh__D042462
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D009268 2004
% 218.56/218.73  |- rdf__type mesh__D009268sskos__Concept
% 218.56/218.73  |- mesh__dateRevised mesh__D009268 2003-07-09
% 218.56/218.73  |- skos__broader mesh__D019820Q000031smesh__D019820
% 218.56/218.73  |- mesh__preferredCombination mesh__D019820Q000031smesh__D014970
% 218.56/218.73  |- rdf__type mesh__D019820Q000031smesh__CompoundConcept
% 218.56/218.73  |- skos__scopeNote mesh__D001285
% 218.56/218.73       An alkaloid, originally from Atropa belladonna, but found in other plants, mainly SOLANACEAE.%A%    
% 218.56/218.73  |- skos__prefLabel mesh__D001285 Atropine
% 218.56/218.73  |- skos__altLabel mesh__D001285 Hyoscyamine Sulfate
% 218.56/218.73  |- skos__altLabel mesh__D001285 Winzer Brand of Atropine
% 218.56/218.73  |- mesh__recordMaintainer mesh__D001285 mdb
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D001285 2006
% 218.56/218.73  |- skos__hiddenLabel mesh__D001285 Sulfate, Hyoscyamine
% 218.56/218.73  |- skos__broader mesh__D001285smesh__D001533
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D001285 2005
% 218.56/218.73  |- skos__altLabel mesh__D001285 Survival Technology Brand of Atropine
% 218.56/218.73  |- skos__altLabel mesh__D001285 Chauvin Brand of Atropine
% 218.56/218.73  |- mesh__dateRevised mesh__D001285 2004-07-07
% 218.56/218.73  |- skos__hiddenLabel mesh__D001285 Atropine Chauvin Brand
% 218.56/218.73  |- mesh__recordOriginator mesh__D001285 NLM
% 218.56/218.73  |- mesh__historyNote mesh__D001285
% 218.56/218.73       75; for HYOSCYAMINE use BELLADONNA 1963-74   
% 218.56/218.73  |- mesh__recordAuthorizer mesh__D001285 sjn
% 218.56/218.73  |- rdf__type mesh__D001285sskos__Concept
% 218.56/218.73  |- skos__hiddenLabel mesh__D001285 Augen%C3%%B6%l, Atropin
% 218.56/218.73  |- mesh__publicMeSHNote mesh__D001285
% 218.56/218.73       75; for HYOSCYAMINE see BELLADONNA 1963-74   
% 218.56/218.73  |- skos__hiddenLabel mesh__D001285 Atropine Winzer Brand
% 218.56/218.73  |- skos__altLabel mesh__D001285 Hyoscyamine
% 218.56/218.73  |- skos__broader mesh__D001285smesh__D014326
% 218.56/218.73  |- mesh__dateCreated mesh__D001285 1999-01-01
% 218.56/218.73  |- skos__hiddenLabel mesh__D001285 Sulfate, Atropine
% 218.56/218.73  |- skos__altLabel mesh__D014402 Phakomatosis, Bourneville
% 218.56/218.73  |- skos__scopeNote mesh__D014402
% 218.56/218.73       An autosomal dominant disorder which is generally classified as a phacomatosis. Pathologically, the condition is characterized by glial cell tumors which arise in the cerebral hemispheres and retina. There is an increased incidence of benign rhabdomyomas of the heart and angiomyolipomas of kidney, liver, lungs, thyroid, and testes. Clinical manifestations include MENTAL RETARDATION; adenoma sebaceum of the face %28%actually angiofibromas%29%; EPILEPSY; SPASMS, INFANTILE; Shagreen patches on the trunk; and subungual fibromas. %28%From Adams et al., Principles of Neurology, 6th ed, p1011%29%%A%    
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D014402 2006
% 218.56/218.73  |- skos__hiddenLabel mesh__D014402 Bourneville Phacomatosis
% 218.56/218.73  |- mesh__recordMaintainer mesh__D014402 ags
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D014402 2002
% 218.56/218.73  |- mesh__dateCreated mesh__D014402 1999-01-01
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D014402 2006A
% 218.56/218.73  |- skos__altLabel mesh__D014402 Bourneville%27%s Disease
% 218.56/218.73  |- skos__prefLabel mesh__D014402 Tuberous Sclerosis
% 218.56/218.73  |- skos__hiddenLabel mesh__D014402 Epiloias
% 218.56/218.73  |- skos__hiddenLabel mesh__D014402 Sclerosis, Tuberous
% 218.56/218.73  |- skos__broader mesh__D014402smesh__D020752
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D014402 2003
% 218.56/218.73  |- mesh__recordAuthorizer mesh__D014402 ags
% 218.56/218.73  |- skos__broader mesh__D014402smesh__D006222
% 218.56/218.73  |- mesh__dateRevised mesh__D014402 2005-07-18
% 218.56/218.73  |- rdf__type mesh__D014402sskos__Concept
% 218.56/218.73  |- skos__altLabel mesh__D014402 Bourneville Disease
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D014402 2004
% 218.56/218.73  |- skos__hiddenLabel mesh__D014402 Bourneville Phakomatosis
% 218.56/218.73  |- mesh__recordOriginator mesh__D014402 NLM
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D014402 2005
% 218.56/218.73  |- skos__broader mesh__D014402smesh__D020271
% 218.56/218.73  |- skos__altLabel mesh__D014402 Phacomatosis, Bourneville
% 218.56/218.73  |- skos__altLabel mesh__D014402 Epiloia
% 218.56/218.73  |- skos__altLabel mesh__D019696 Prolyl Isomerase
% 218.56/218.73  |- mesh__dateCreated mesh__D019696 1997-06-20
% 218.56/218.73  |- skos__hiddenLabel mesh__D019696 Isomerase, Proline
% 218.56/218.73  |- skos__hiddenLabel mesh__D019696 Isomerase, Prolyl
% 218.56/218.73  |- mesh__recordOriginator mesh__D019696 KEV
% 218.56/218.73  |- skos__altLabel mesh__D019696 Proline Rotamase
% 218.56/218.73  |- skos__altLabel mesh__D019696 PPIase
% 218.56/218.73  |- mesh__historyNote mesh__D019696
% 218.56/218.73       98; use PEPTIDYLPROLYL ISOMERASE %28%NM%29% 1984-97   
% 218.56/218.73  |- skos__altLabel mesh__D019696 Proline Isomerase
% 218.56/218.73  |- skos__hiddenLabel mesh__D019696 Peptidyl Prolyl cis trans Isomerase
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D019696 2006
% 218.56/218.73  |- mesh__recordMaintainer mesh__D019696 ssb
% 218.56/218.73  |- skos__scopeNote mesh__D019696
% 218.56/218.73       An enzyme that catalyzes the isomerization of proline residues within proteins. EC 5.2.1.8.%A%    
% 218.56/218.73  |- skos__prefLabel mesh__D019696 Peptidylprolyl Isomerase
% 218.56/218.73  |- mesh__recordAuthorizer mesh__D019696 sjn
% 218.56/218.73  |- skos__historyNote mesh__D019696 Carrier Proteins %28%1984-1997%29%
% 218.56/218.73  |- rdf__type mesh__D019696sskos__Concept
% 218.56/218.73  |- skos__hiddenLabel mesh__D019696 cis-trans-Isomerase, Peptidyl-Prolyl
% 218.56/218.73  |- mesh__dateRevised mesh__D019696 2003-07-09
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D019696 2005
% 218.56/218.73  |- mesh__publicMeSHNote mesh__D019696
% 218.56/218.73       98; PEPTIDYLPROLYL ISOMERASE was indexed under CARRIER PROTEINS %26% AMINO ACID ISOMERASES 1984-97%A%  
% 218.56/218.73  |- skos__historyNote mesh__D019696 Amino Acid Isomerases %28%1984-1997%29%
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D019696 2004
% 218.56/218.73  |- skos__broader mesh__D019696smesh__D019745
% 218.56/218.73  |- skos__hiddenLabel mesh__D019696 Rotamase, Proline
% 218.56/218.73  |- skos__hiddenLabel mesh__D019696 Isomerase, Peptidylprolyl
% 218.56/218.73  |- skos__altLabel mesh__D019696 Peptidyl-Prolyl cis-trans-Isomerase
% 218.56/218.73  |- mesh__dateEstablished mesh__D019696 1998-01-01
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 Trousers, Antishock
% 218.56/218.73  |- mesh__dateCreated mesh__D005676 1974-12-12
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 Antishock Trousers, Military
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D005676 2000
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 Suits, Pressure
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 Pressure Suit
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 Suits, Antigravity
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 Suits, Gravity
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D005676 2005
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D005676 1998
% 218.56/218.73  |- mesh__recordMaintainer mesh__D005676 TGC
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 Anti-Shock Trousers, Military
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 Trousers, Military Anti-Shock
% 218.56/218.73  |- skos__altLabel mesh__D005676 Military Anti-Shock Trousers
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D005676 2001
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 Suit, G
% 218.56/218.73  |- skos__altLabel mesh__D005676 Antishock Trousers
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 Military Anti Shock Trousers
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 Trousers, Anti-Shock
% 218.56/218.73  |- skos__altLabel mesh__D005676 Pressure Suits
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 Suit, Gravity
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 Pneumatic Suit
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D005676 2006
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 Gravity Suit
% 218.56/218.73  |- mesh__publicMeSHNote mesh__D005676 76; was see under CLOTHING 1975   
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D005676 1999
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 G Suit
% 218.56/218.73  |- skos__historyNote mesh__D005676 Protective Clothing %28%1970-1974%29%
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D005676 2003
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 Suits, Pneumatic
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 Anti Shock Trousers
% 218.56/218.73  |- skos__scopeNote mesh__D005676
% 218.56/218.73       Double-layered inflatable suits which, when inflated, exert pressure on the lower part of the wearer%27%s body. The suits are used to improve or stabilize the circulatory state, i.e., to prevent hypotension, control hemorrhage, and regulate blood pressure. The suits are also used by pilots under positive acceleration.%A%    
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 Suit, Pressure
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D005676 2002
% 218.56/218.73  |- skos__prefLabel mesh__D005676 G Suits
% 218.56/218.73  |- skos__broader mesh__D005676smesh__D004864
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 Suits, G
% 218.56/218.73  |- mesh__historyNote mesh__D005676
% 218.56/218.73       76%28%75%29%; was see under CLOTHING 1975   
% 218.56/218.73  |- skos__historyNote mesh__D005676 Clothing %28%1966-1974%29%
% 218.56/218.73  |- mesh__recordAuthorizer mesh__D005676 PLS
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D005676 2004
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D005676 1997
% 218.56/218.73  |- skos__altLabel mesh__D005676 Pneumatic Suits
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 Suit, Pneumatic
% 218.56/218.73  |- mesh__dateRevised mesh__D005676 1996-06-10
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 Suit, Antigravity
% 218.56/218.73  |- mesh__dateEstablished mesh__D005676 1976-01-01
% 218.56/218.73  |- skos__altLabel mesh__D005676 Antigravity Suits
% 218.56/218.73  |- skos__altLabel mesh__D005676 Gravity Suits
% 218.56/218.73  |- skos__annotation mesh__D005676
% 218.56/218.73       MAST suit %28%Military or Medical Anti-Shock Trousers%29% goes here %28%do not add MILITARY MEDICINE%29%; SPACE SUITS is also available; DF: MAST%A%  
% 218.56/218.73  |- mesh__recordOriginator mesh__D005676 NLM
% 218.56/218.73  |- rdf__type mesh__D005676sskos__Concept
% 218.56/218.73  |- skos__hiddenLabel mesh__D005676 Trousers, Military Antishock
% 218.56/218.73  |- mesh__dateRevised mesh__D010810 1999-11-03
% 218.56/218.73  |- skos__prefLabel mesh__D010810 Physical Medicine
% 218.56/218.73  |- skos__altLabel mesh__D010810 Medicine, Physical
% 218.56/218.73  |- mesh__dateCreated mesh__D010810 1999-01-01
% 218.56/218.73  |- mesh__recordOriginator mesh__D010810 NLM
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D010810 2001
% 218.56/218.73  |- skos__altLabel mesh__D010810 Physiatrics
% 218.56/218.73  |- skos__scopeNote mesh__D010810
% 218.56/218.73       A medical specialty concerned with the use of physical agents, mechanical apparatus, and manipulation in rehabilitating physically diseased or injured patients.%A%    
% 218.56/218.73  |- rdf__type mesh__D010810sskos__Concept
% 218.56/218.73  |- skos__altLabel mesh__D010810 Physiatry
% 218.56/218.73  |- skos__broader mesh__D010810smesh__D013040
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D010810 2003
% 218.56/218.73  |- mesh__recordAuthorizer mesh__D010810 sjn
% 218.56/218.73  |- skos__annotation mesh__D010810 SPEC: SPEC qualif; DF: PHYSICAL MED   
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D010810 2002
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D010810 2004
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D010810 2005
% 218.56/218.73  |- mesh__recordMaintainer mesh__D010810 ags
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D010810 2006
% 218.56/218.73  |- skos__related mesh__D010810smesh__D001696
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D010810 2000
% 218.56/218.73  |- skos__altLabel mesh__D010012 Ossification, Physiological
% 218.56/218.73  |- mesh__onlineNote mesh__D010012
% 218.56/218.73       use OSTEOGENESIS to search OSSIFICATION, PHYSIOLOGIC 1966-84%A%  
% 218.56/218.73  |- skos__hiddenLabel mesh__D010012 Physiological Ossification
% 218.56/218.73  |- skos__altLabel mesh__D010012 Ossification, Physiologic
% 218.56/218.73  |- skos__related mesh__D010012smesh__D002146
% 218.56/218.73  |- mesh__recordMaintainer mesh__D010012 lkt
% 218.56/218.73  |- mesh__historyNote mesh__D010012
% 218.56/218.73       65; OSSIFICATION, PHYSIOLOGIC was heading 1965-84   
% 218.56/218.73  |- skos__annotation mesh__D010012 BONE DEVELOPMENT is also available   
% 218.56/218.73  |- rdf__type mesh__D010012sskos__Concept
% 218.56/218.73  |- mesh__dateEstablished mesh__D010012 1965-01-01
% 218.56/218.73  |- mesh__recordAuthorizer mesh__D010012 sjn
% 218.56/218.73  |- skos__prefLabel mesh__D010012 Osteogenesis
% 218.56/218.73  |- skos__altLabel mesh__D010012 Bone Formation
% 218.56/218.73  |- mesh__dateCreated mesh__D010012 1999-01-01
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D010012 2005
% 218.56/218.73  |- mesh__dateRevised mesh__D010012 2004-07-07
% 218.56/218.73  |- mesh__recordOriginator mesh__D010012 NLM
% 218.56/218.73  |- skos__scopeNote mesh__D010012
% 218.56/218.73       The process of bone formation.  Histogenesis of bone including ossification.%A%    
% 218.56/218.73  |- mesh__publicMeSHNote mesh__D010012
% 218.56/218.73       65; OSSIFICATION, PHYSIOLOGIC was heading 1965-84   
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D010012 2006
% 218.56/218.73  |- skos__broader mesh__D010012smesh__D001846
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D009269 2001
% 218.56/218.73  |- mesh__dateCreated mesh__D009269 1999-01-01
% 218.56/218.73  |- mesh__dateRevised mesh__D009269 2000-06-21
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D009269 2006
% 218.56/218.73  |- skos__altLabel mesh__D009269 Allylnormorphine
% 218.56/218.73  |- skos__prefLabel mesh__D009269 Nalorphine
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D009269 2005
% 218.56/218.73  |- mesh__recordAuthorizer mesh__D009269 sjn
% 218.56/218.73  |- mesh__recordMaintainer mesh__D009269 TWD
% 218.56/218.73  |- skos__broader mesh__D009269smesh__D009019
% 218.56/218.73  |- skos__hiddenLabel mesh__D009269 Hydrobromide, Nalorphine
% 218.56/218.73  |- mesh__recordOriginator mesh__D009269 NLM
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D009269 2002
% 218.56/218.73  |- skos__scopeNote mesh__D009269
% 218.56/218.73       A narcotic antagonist with some agonist properties. It is an antagonist at mu opioid receptors and an agonist at kappa opioid receptors. Given alone it produces a broad spectrum of unpleasant effects and it is considered to be clinically obsolete.%A%    
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D009269 2004
% 218.56/218.73  |- rdf__type mesh__D009269sskos__Concept
% 218.56/218.73  |- skos__hiddenLabel mesh__D009269 Hydrochloride, Nalorphine
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D009269 2003
% 218.56/218.73  |- skos__prefLabel mesh__D001286 Atropine Derivatives
% 218.56/218.73  |- skos__hiddenLabel mesh__D001286 Derivatives, Atropine
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D001286 1994
% 218.56/218.73  |- rdf__type mesh__D001286sskos__Concept
% 218.56/218.73  |- mesh__recordAuthorizer mesh__D001286 PLS
% 218.56/218.73  |- skos__broader mesh__D001286smesh__D001285
% 218.56/218.73  |- mesh__recordMaintainer mesh__D001286 TAP
% 218.56/218.73  |- skos__historyNote mesh__D001286 Tropanes %28%1966-1974%29%
% 218.56/218.73  |- mesh__publicMeSHNote mesh__D001286
% 218.56/218.73       78; was see under ATROPINE 1975-77, was see under TROPANES 1969-74; N-ISOPROPYLATROPINE was see under ATROPINE 1975-77%A%  
% 218.56/218.73  |- skos__historyNote mesh__D001286 Atropine %28%1966-1974%29%
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D001286 2002
% 218.56/218.73  |- mesh__onlineNote mesh__D001286 search TROPANES 1969-74   
% 218.56/218.73  |- mesh__dateCreated mesh__D001286 1999-01-01
% 218.56/218.73  |- mesh__historyNote mesh__D001286
% 218.56/218.73       78%28%75%29%; was see under ATROPINE 1975-77, was see under TROPANES 1969-74%A%  
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D001286 2001
% 218.56/218.73  |- mesh__dateEstablished mesh__D001286 1978-01-01
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D001286 2004
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D001286 1997
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D001286 2006
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D001286 2000
% 218.56/218.73  |- skos__scopeNote mesh__D001286 Analogs and derivatives of atropine.     
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D001286 1999
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D001286 2003
% 218.56/218.73  |- mesh__dateRevised mesh__D001286 1992-05-07
% 218.56/218.73  |- mesh__recordOriginator mesh__D001286 NLM
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D001286 1996
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D001286 1993
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D001286 1995
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D001286 2005
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D001286 1998
% 218.56/218.73  |- skos__historyNote mesh__D020440 Multigene Family %28%1987-1998%29%
% 218.56/218.73  |- mesh__historyNote mesh__D020440 99; use MULTIGENE FAMILY 1987-98   
% 218.56/218.73  |- mesh__dateEstablished mesh__D020440 1999-01-01
% 218.56/218.73  |- mesh__recordAuthorizer mesh__D020440 jls
% 218.56/218.73  |- mesh__publicMeSHNote mesh__D020440 99; see MULTIGENE FAMILY 1987-98   
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D020440 2006
% 218.56/218.73  |- skos__hiddenLabel mesh__D020440 Duplication, Gene
% 218.56/218.73  |- skos__related mesh__D020440smesh__D005810
% 218.56/218.73  |- mesh__recordMaintainer mesh__D020440 jls
% 218.56/218.73  |- skos__hiddenLabel mesh__D020440 Duplications, Gene
% 218.56/218.73  |- rdf__type mesh__D020440sskos__Concept
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D020440 2004
% 218.56/218.73  |- skos__prefLabel mesh__D020440 Gene Duplication
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D020440 2005
% 218.56/218.73  |- skos__scopeNote mesh__D020440
% 218.56/218.73       Processes occurring in various organisms by which new genes arise, i.e. the duplication of a single gene. In contiguous gene duplication, the duplicated sequence coexists within the boundaries set by the start and stop signals for protein synthesis of the original, resulting in a larger transcription product and protein at the expense of the preexisting protein. In discrete gene duplication, the duplicated sequence is outside the start and stop signals, resulting in two independent genes %28%GENES, DUPLICATE%29% and gene products. Gene duplication may result in a MULTIGENE FAMILY; supergenes or PSEUDOGENES.  %28%Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A%    
% 218.56/218.73  |- mesh__recordOriginator mesh__D020440 NDW
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D020440 2003
% 218.56/218.73  |- mesh__dateCreated mesh__D020440 1998-06-10
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D020440 2005A
% 218.56/218.73  |- skos__broader mesh__D020440smesh__D016296
% 218.56/218.73  |- skos__hiddenLabel mesh__D020440 Gene Duplications
% 218.56/218.73  |- skos__annotation mesh__D020440 do not confuse with GENES, DUPLICATE   
% 218.56/218.73  |- skos__broader mesh__D020440smesh__D009154
% 218.56/218.73  |- mesh__dateRevised mesh__D020440 2004-07-27
% 218.56/218.73  |- skos__broader mesh__D047388smesh__D047908
% 218.56/218.73  |- mesh__recordOriginator mesh__D047388 jmp
% 218.56/218.73  |- skos__hiddenLabel mesh__D047388 Kinase, Casein
% 218.56/218.73  |- mesh__publicMeSHNote mesh__D047388
% 218.56/218.73       2005; CASEIN KINSES was indexed under PROTEIN KINASES 1974-2004%A%  
% 218.56/218.73  |- mesh__recordAuthorizer mesh__D047388 sjn
% 218.56/218.73  |- skos__scopeNote mesh__D047388
% 218.56/218.73       A group of protein-serine-threonine kinases that was originally identified as being responsible for the PHOSPHORYLATION of CASEINS. They are ubiquitous enzymes that have a preference for acidic proteins. Casein kinases play a role in SIGNAL TRANSDUCTION by phosphorylating a variety of regulatory cytoplasmic and regulatory nuclear proteins.%A%    
% 218.56/218.73  |- mesh__recordMaintainer mesh__D047388 jmp
% 218.56/218.73  |- skos__hiddenLabel mesh__D047388 Kinases, Casein
% 218.56/218.73  |- skos__annotation mesh__D047388
% 218.56/218.73       general or unspecified; prefer specifics   
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D047388 2006
% 218.56/218.73  |- skos__prefLabel mesh__D047388 Casein Kinases
% 218.56/218.73  |- mesh__dateCreated mesh__D047388 2004-07-07
% 218.56/218.73  |- skos__altLabel mesh__D047388 Casein Kinase
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D047388 2005
% 218.56/218.73  |- mesh__historyNote mesh__D047388 2005%28%1974%29%   
% 218.56/218.73  |- skos__broader mesh__D047388smesh__D017346
% 218.56/218.73  |- skos__historyNote mesh__D047388 Protein Kinases %28%1974-2004%29%
% 218.56/218.73  |- rdf__type mesh__D047388sskos__Concept
% 218.56/218.73  |- mesh__dateEstablished mesh__D047388 2005-01-01
% 218.56/218.73  |- mesh__dateCreated mesh__D014403 1999-01-01
% 218.56/218.73  |- skos__hiddenLabel mesh__D014403 d Tubocurare
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D014403 2006
% 218.56/218.73  |- mesh__dateRevised mesh__D014403 2005-06-30
% 218.56/218.73  |- skos__broader mesh__D014403smesh__D003472
% 218.56/218.73  |- skos__scopeNote mesh__D014403
% 218.56/218.73       A neuromuscular blocker and active ingredient in CURARE; plant based alkaloid of Menispermaceae.%A%    
% 218.56/218.73  |- skos__altLabel mesh__D014403 d-Tubocurarine
% 218.56/218.73  |- rdf__type mesh__D014403sskos__Concept
% 218.56/218.73  |- mesh__recordOriginator mesh__D014403 NLM
% 218.56/218.73  |- skos__prefLabel mesh__D014403 Tubocurarine
% 218.56/218.73  |- mesh__recordAuthorizer mesh__D014403 sjn
% 218.56/218.73  |- skos__hiddenLabel mesh__D014403 Chloride, Tubocurarine
% 218.56/218.73  |- skos__broader mesh__D014403smesh__D000644
% 218.56/218.73  |- skos__altLabel mesh__D014403 Tubocurare
% 218.56/218.73  |- skos__altLabel mesh__D014403 d-Tubocurare
% 218.56/218.73  |- mesh__recordMaintainer mesh__D014403 ssb
% 218.56/218.73  |- skos__hiddenLabel mesh__D019697 Onion
% 218.56/218.73  |- skos__scopeNote mesh__D019697
% 218.56/218.73       Herbaceous biennial plants and their edible bulbs, belonging to the Liliaceae.%A%    
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D019697 2005
% 218.56/218.73  |- mesh__dateEstablished mesh__D019697 1998-01-01
% 218.56/218.73  |- mesh__publicMeSHNote mesh__D019697 98; was see ALLIUM 1986-97   
% 218.56/218.73  |- skos__annotation mesh__D019697
% 218.56/218.73       as plant %26% food; selected qualif from Cat B6 %26% J2   
% 218.56/218.73  |- rdf__type mesh__D019697sskos__Concept
% 218.56/218.73  |- mesh__recordOriginator mesh__D019697 JLS
% 218.56/218.73  |- mesh__dateCreated mesh__D019697 1997-06-20
% 218.56/218.73  |- skos__historyNote mesh__D019697 Allium %28%1986-1997%29%
% 218.56/218.73  |- mesh__historyNote mesh__D019697 98; was see ALLIUM 1986-97   
% 218.56/218.73  |- skos__prefLabel mesh__D019697 Onions
% 218.56/218.73  |- skos__historyNote mesh__D019697 Plants %28%1966-1985%29%
% 218.56/218.73  |- mesh__dateRevised mesh__D019697 2004-07-07
% 218.56/218.73  |- skos__broader mesh__D019697smesh__D000490
% 218.56/218.73  |- mesh__recordMaintainer mesh__D019697 ssb
% 218.56/218.73  |- mesh__recordAuthorizer mesh__D019697 sjn
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D019697 2006
% 218.56/218.73  |- skos__broader mesh__D044090smesh__D012705
% 218.56/218.73  |- skos__prefLabel mesh__D044090 Serratia liquefaciens
% 218.56/218.73  |- mesh__dateCreated mesh__D044090 2003-07-09
% 218.56/218.73  |- mesh__recordAuthorizer mesh__D044090 sjn
% 218.56/218.73  |- mesh__dateEstablished mesh__D044090 2004-01-01
% 218.56/218.73  |- skos__historyNote mesh__D044090 Serratia %28%1973-2003%29%
% 218.56/218.73  |- mesh__publicMeSHNote mesh__D044090 2004   
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D044090 2006
% 218.56/218.73  |- mesh__recordMaintainer mesh__D044090 SYSTEM
% 218.56/218.73  |- rdf__type mesh__D044090sskos__Concept
% 218.56/218.73  |- mesh__dateRevised mesh__D044090 2005-06-30
% 218.56/218.73  |- skos__scopeNote mesh__D044090
% 218.56/218.73       A species of gram-negative bacteria in the genus SERRATIA found in plants and the DIGESTIVE TRACT of rodents. It is the most prevalent Serratia species in the natural environment.%A%    
% 218.56/218.73  |- mesh__recordOriginator mesh__D044090 ags
% 218.56/218.73  |- mesh__historyNote mesh__D044090 2004   
% 218.56/218.73  |- skos__annotation mesh__D044090
% 218.56/218.73       infection: coord IM with SERRATIA INFECTIONS %28%IM%29%   
% 218.56/218.73  |- skos__hiddenLabel mesh__D005677 Tetraglycosyl Ceramide, Monosialosyl
% 218.56/218.73  |- mesh__historyNote mesh__D005677
% 218.56/218.73       86%28%77%29%; was see under GANGLIOSIDES 1977-85   
% 218.56/218.73  |- skos__hiddenLabel mesh__D005677 Monosialoganglioside, GM1a
% 218.56/218.73  |- rdf__type mesh__D005677sskos__Concept
% 218.56/218.73  |- mesh__recordAuthorizer mesh__D005677 sjn
% 218.56/218.73  |- skos__scopeNote mesh__D005677
% 218.56/218.73       A specific monosialoganglioside that accumulates abnormally within the nervous system due to a deficiency of GM1-b-galactosidase, resulting in GM1 gangliosidosis.%A%    
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D005677 2006
% 218.56/218.73  |- mesh__publicMeSHNote mesh__D005677
% 218.56/218.73       86; was see under GANGLIOSIDES 1977-85   
% 218.56/218.73  |- mesh__dateCreated mesh__D005677 1976-05-19
% 218.56/218.73  |- mesh__dateRevised mesh__D005677 2005-06-30
% 218.56/218.73  |- skos__altLabel mesh__D005677 Monosialosyl Tetraglycosyl Ceramide
% 218.56/218.73  |- skos__prefLabel mesh__D005677 G%28%M1%29% Ganglioside
% 218.56/218.73  |- skos__broader mesh__D005677smesh__D005732
% 218.56/218.73  |- skos__historyNote mesh__D005677 Gangliosides %28%1966-1976%29%
% 218.56/218.73  |- mesh__recordMaintainer mesh__D005677 ssb
% 218.56/218.73  |- mesh__recordOriginator mesh__D005677 RLS
% 218.56/218.73  |- mesh__dateEstablished mesh__D005677 1986-01-01
% 218.56/218.73  |- skos__hiddenLabel mesh__D005677 Ceramide, Monosialosyl Tetraglycosyl
% 218.56/218.73  |- mesh__dateCreated mesh__D010811 1999-01-01
% 218.56/218.73  |- mesh__dateEstablished mesh__D010811 1998-01-01
% 218.56/218.73  |- mesh__recordMaintainer mesh__D010811 jls
% 218.56/218.73  |- skos__historyNote mesh__D010811 Science %28%1966-1997%29%
% 218.56/218.73  |- rdf__type mesh__D010811sskos__Concept
% 218.56/218.73  |- skos__annotation mesh__D010811
% 218.56/218.73       GEN or unspecified; prefer specifics; SPEC: SPEC qualif   
% 218.56/218.73  |- mesh__publicMeSHNote mesh__D010811
% 218.56/218.73       2002; see Physical Sciences 1998-2001   
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D010811 2003
% 218.56/218.73  |- skos__prefLabel mesh__D010811 Natural Sciences
% 218.56/218.73  |- mesh__recordOriginator mesh__D010811 NLM
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D010811 2004
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D010811 2005
% 218.56/218.73  |- skos__scopeNote mesh__D010811
% 218.56/218.73       The sciences dealing with processes observable in nature.%A%    
% 218.56/218.73  |- skos__hiddenLabel mesh__D010811 Science, Natural
% 218.56/218.73  |- mesh__historyNote mesh__D010811 98; was Physical Sciences 1998-2001   
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D010811 2006
% 218.56/218.73  |- skos__hiddenLabel mesh__D010811 Sciences, Natural
% 218.56/218.73  |- mesh__recordAuthorizer mesh__D010811 sjn
% 218.56/218.73  |- mesh__runningHead mesh__D010811 H1 - NATURAL SCIENCES   
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D010811 2002
% 218.56/218.73  |- skos__hiddenLabel mesh__D010811 Natural Science
% 218.56/218.73  |- mesh__dateRevised mesh__D010811 2001-07-25
% 218.56/218.73  |- mesh__recordAuthorizer mesh__D010013 sjn
% 218.56/218.73  |- skos__prefLabel mesh__D010013 Osteogenesis Imperfecta
% 218.56/218.73  |- skos__broader mesh__D010013smesh__D003095
% 218.56/218.73  |- skos__scopeNote mesh__D010013
% 218.56/218.73       Autosomal dominant COLLAGEN DISEASES resulting from defective biosynthesis of COLLAGEN TYPE I and characterized by brittle, osteoporotic, and easily fractured bones. It may also present with blue sclerae, loose joints, and imperfect dentin formation. There are four major types, I-IV.%A%    
% 218.56/218.73  |- skos__hiddenLabel mesh__D010013 Disease, Lobstein
% 218.56/218.73  |- skos__broader mesh__D010013smesh__D010009
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D010013 2006
% 218.56/218.73  |- mesh__recordOriginator mesh__D010013 NLM
% 218.56/218.73  |- skos__hiddenLabel mesh__D010013 Disease, Lobstein%27%s
% 218.56/218.73  |- mesh__activeMeSHYear mesh__D010013 2005
% 218.56/218.73  |- skos__broader mesh__D010013smesh__D030342
% 218.56/218.74  |- skos__hiddenLabel mesh__D010013 Lobsteins Disease
% 218.56/218.74  |- skos__related mesh__D010013smesh__D003811
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D010013 2004
% 218.56/218.74  |- mesh__dateCreated mesh__D010013 1999-01-01
% 218.56/218.74  |- rdf__type mesh__D010013sskos__Concept
% 218.56/218.74  |- mesh__recordMaintainer mesh__D010013 nns
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D010013 2003
% 218.56/218.74  |- skos__hiddenLabel mesh__D010013 Ossiums, Fragilitas
% 218.56/218.74  |- skos__altLabel mesh__D010013 Fragilitas Ossium
% 218.56/218.74  |- mesh__dateRevised mesh__D010013 2001-07-25
% 218.56/218.74  |- skos__altLabel mesh__D010013 Lobstein Disease
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D010013 2002
% 218.56/218.74  |- mesh__recordMaintainer mesh__D034461 lkt
% 218.56/218.74  |- skos__scopeNote mesh__D034461
% 218.56/218.74       Formation of CORPUS LUTEUM. This process includes capillary invasion of the ruptured OVARIAN FOLLICLE, hypertrophy of the GRANULOSA CELLS and the THECA CELLS, and the production of PROGESTERONE. Luteinization is regulated by LUTEINIZING HORMONE.%A%    
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D034461 2006
% 218.56/218.74  |- mesh__recordAuthorizer mesh__D034461 sjn
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D034461 2005
% 218.56/218.74  |- mesh__historyNote mesh__D034461 2003   
% 218.56/218.74  |- mesh__dateEstablished mesh__D034461 2003-01-01
% 218.56/218.74  |- mesh__dateRevised mesh__D034461 2004-07-07
% 218.56/218.74  |- skos__prefLabel mesh__D034461 Luteinization
% 218.56/218.74  |- skos__broader mesh__D034461smesh__D010060
% 218.56/218.74  |- mesh__dateCreated mesh__D034461 2002-07-03
% 218.56/218.74  |- skos__historyNote mesh__D034461 Corpus Luteum %28%1966-2002%29%
% 218.56/218.74  |- mesh__recordOriginator mesh__D034461 lkt
% 218.56/218.74  |- mesh__publicMeSHNote mesh__D034461 2003   
% 218.56/218.74  |- rdf__type mesh__D034461sskos__Concept
% 218.56/218.74  |- skos__related mesh__D001287smesh__D016662
% 218.56/218.74  |- skos__hiddenLabel mesh__D001287 Attachment Site, Phage
% 218.56/218.74  |- skos__historyNote mesh__D001287 Lysogeny %28%1968-1979%29%
% 218.56/218.74  |- skos__historyNote mesh__D001287 Recombination, Genetic %28%1968-1979%29%
% 218.56/218.74  |- skos__altLabel mesh__D001287 Bacterial Attachment Site
% 218.56/218.74  |- skos__hiddenLabel mesh__D001287 Attachment Sites, AttB
% 218.56/218.74  |- skos__altLabel mesh__D001287 Microbiologic Attachment Sites
% 218.56/218.74  |- skos__altLabel mesh__D001287 Attachment Site %28%Microbiology%29%
% 218.56/218.74  |- mesh__dateEstablished mesh__D001287 1991-01-01
% 218.56/218.74  |- mesh__dateCreated mesh__D001287 1979-05-23
% 218.56/218.74  |- skos__hiddenLabel mesh__D001287 Microbiological Attachment Site
% 218.56/218.74  |- skos__hiddenLabel mesh__D001287 Attachment Site, Microbiologic
% 218.56/218.74  |- skos__hiddenLabel mesh__D001287 Att Attachment Site
% 218.56/218.74  |- mesh__recordOriginator mesh__D001287 AEP
% 218.56/218.74  |- skos__hiddenLabel mesh__D001287 Attachment Sites, Phage
% 218.56/218.74  |- skos__hiddenLabel mesh__D001287 AttP Attachment Site
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D001287 2006
% 218.56/218.74  |- skos__hiddenLabel mesh__D001287 Phage Attachment Site
% 218.56/218.74  |- skos__altLabel mesh__D001287 Microbiologic Attachment Site
% 218.56/218.74  |- skos__related mesh__D001287smesh__D008242
% 218.56/218.74  |- rdf__type mesh__D001287sskos__Concept
% 218.56/218.74  |- mesh__publicMeSHNote mesh__D001287
% 218.56/218.74       2006; see ATTACHMENT SITES %28%MICROBIOLOGY%29% 1991-2006, see LYSOGENY 1980-1990%A%  
% 218.56/218.74  |- skos__hiddenLabel mesh__D001287 Attachment Sites, Att
% 218.56/218.74  |- skos__prefLabel mesh__D001287 Attachment Sites, Microbiological
% 218.56/218.74  |- skos__hiddenLabel mesh__D001287 Attachment Sites, AttP
% 218.56/218.74  |- skos__historyNote mesh__D001287 DNA, Viral %28%1966-1979%29%
% 218.56/218.74  |- skos__hiddenLabel mesh__D001287 Attachment Site, AttP
% 218.56/218.74  |- mesh__dateRevised mesh__D001287 2005-06-30
% 218.56/218.74  |- skos__altLabel mesh__D001287 Attachment Sites, Bacterial
% 218.56/218.74  |- mesh__recordMaintainer mesh__D001287 nns
% 218.56/218.74  |- skos__hiddenLabel mesh__D001287 Microbiological Attachment Sites
% 218.56/218.74  |- skos__historyNote mesh__D001287 Coliphages %28%1966-1979%29%
% 218.56/218.74  |- skos__altLabel mesh__D001287 Attachment Sites %28%Microbiology%29%
% 218.56/218.74  |- skos__scopeNote mesh__D001287
% 218.56/218.74       Specific loci on both the bacterial DNA %28%attB%29% and the phage DNA %28%attP%29% which delineate the sites where recombination takes place between them, as the phage DNA becomes integrated %28%inserted%29% into the BACTERIAL DNA during LYSOGENY.%A%    
% 218.56/218.74  |- skos__hiddenLabel mesh__D001287 Attachment Sites, Microbiologic
% 218.56/218.74  |- skos__altLabel mesh__D001287 Att Attachment Sites
% 218.56/218.74  |- skos__hiddenLabel mesh__D001287 Attachment Site, AttB
% 218.56/218.74  |- skos__altLabel mesh__D001287 AttB Attachment Sites
% 218.56/218.74  |- skos__hiddenLabel mesh__D001287 AttB Attachment Site
% 218.56/218.74  |- mesh__recordAuthorizer mesh__D001287 sjn
% 218.56/218.74  |- skos__annotation mesh__D001287
% 218.56/218.74       for attachment of a virus to a cell membrane, index under RECEPTORS, VIRUS%A%  
% 218.56/218.74  |- skos__hiddenLabel mesh__D001287 Attachment Site, Microbiological
% 218.56/218.74  |- skos__altLabel mesh__D001287 Attachment Site, Bacterial
% 218.56/218.74  |- skos__altLabel mesh__D001287 AttP Attachment Sites
% 218.56/218.74  |- skos__hiddenLabel mesh__D001287 Attachment Site, Att
% 218.56/218.74  |- skos__broader mesh__D001287smesh__D040481
% 218.56/218.74  |- mesh__historyNote mesh__D001287 2006 %28%1980%29%   
% 218.56/218.74  |- skos__historyNote mesh__D006770 Group Practice %28%1966-Jul 1977%29%
% 218.56/218.74  |- skos__hiddenLabel mesh__D006770 Group Practice Hospital
% 218.56/218.74  |- mesh__publicMeSHNote mesh__D006770
% 218.56/218.74       91; was see under HOSPITALS Aug 1977-90   
% 218.56/218.74  |- mesh__dateRevised mesh__D006770 1999-11-03
% 218.56/218.74  |- mesh__recordAuthorizer mesh__D006770 sjn
% 218.56/218.74  |- mesh__dateEstablished mesh__D006770 1991-01-01
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D006770 2006
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D006770 2002
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D006770 2004
% 218.56/218.74  |- skos__altLabel mesh__D006770 Group Practice Hospitals
% 218.56/218.74  |- skos__annotation mesh__D006770
% 218.56/218.74       coord IM with special hosp %28%e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.%29% or med specialty %28%IM or NIM%29% if pertinent; specify geog%A%  
% 218.56/218.74  |- skos__historyNote mesh__D006770 Hospitals %28%1966-Jul 1977%29%
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D006770 2005
% 218.56/218.74  |- mesh__recordMaintainer mesh__D006770 kle
% 218.56/218.74  |- skos__hiddenLabel mesh__D006770 Practice Hospital, Group
% 218.56/218.74  |- skos__hiddenLabel mesh__D006770 Practice Hospitals, Group
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D006770 2003
% 218.56/218.74  |- skos__scopeNote mesh__D006770
% 218.56/218.74       Hospitals organized and controlled by a group of physicians who practice together and provide each other with mutual support.%A%    
% 218.56/218.74  |- mesh__recordOriginator mesh__D006770 EC
% 218.56/218.74  |- skos__broader mesh__D006770smesh__D006761
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D006770 2001
% 218.56/218.74  |- mesh__dateCreated mesh__D006770 1977-05-11
% 218.56/218.74  |- mesh__historyNote mesh__D006770
% 218.56/218.74       91%28%Aug 77%29%; was see under HOSPITALS 1977-90   
% 218.56/218.74  |- skos__prefLabel mesh__D006770 Hospitals, Group Practice
% 218.56/218.74  |- rdf__type mesh__D006770sskos__Concept
% 218.56/218.74  |- skos__hiddenLabel mesh__D006770 Hospital, Group Practice
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D006770 2000
% 218.56/218.74  |- skos__scopeNote mesh__D020441
% 218.56/218.74       The only specie of the genus Ginkgo, family Ginkgoacea. It is the source of extracts of medicinal interest, especially Egb 761. Ginkgo may refer to the genus or species.%A%    
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D020441 2006
% 218.56/218.74  |- mesh__recordOriginator mesh__D020441 JLS
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D020441 2002
% 218.56/218.74  |- rdf__type mesh__D020441sskos__Concept
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D020441 2004
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D020441 2005
% 218.56/218.74  |- mesh__dateEstablished mesh__D020441 1999-01-01
% 218.56/218.74  |- mesh__recordMaintainer mesh__D020441 ssb
% 218.56/218.74  |- skos__historyNote mesh__D020441 Gymnosperms %28%1998%29%
% 218.56/218.74  |- skos__altLabel mesh__D020441 Gingko
% 218.56/218.74  |- mesh__historyNote mesh__D020441
% 218.56/218.74       99; for GINKGOPHYTA see GYMNOSPERMS 1998   
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D020441 2003
% 218.56/218.74  |- mesh__recordAuthorizer mesh__D020441 sjn
% 218.56/218.74  |- skos__altLabel mesh__D020441 Gingko biloba
% 218.56/218.74  |- skos__altLabel mesh__D020441 Maidenhair Tree
% 218.56/218.74  |- skos__altLabel mesh__D020441 Ginko
% 218.56/218.74  |- skos__prefLabel mesh__D020441 Ginkgo biloba
% 218.56/218.74  |- skos__annotation mesh__D020441
% 218.56/218.74       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.56/218.74  |- skos__broader mesh__D020441smesh__D019681
% 218.56/218.74  |- mesh__publicMeSHNote mesh__D020441
% 218.56/218.74       99; for GINKGOPHYTA use GYMNOSPERMS 1998   
% 218.56/218.74  |- skos__altLabel mesh__D020441 Ginkgo
% 218.56/218.74  |- mesh__dateCreated mesh__D020441 1998-06-10
% 218.56/218.74  |- mesh__dateRevised mesh__D020441 2001-07-25
% 218.56/218.74  |- skos__scopeNote mesh__D047389
% 218.56/218.74       A casein kinase that was originally described as a monomeric enzyme with a molecular weight of 30-40 kD. Several ISOENZYMES of casein kinase I have been found which are encoded by separate genes. Many of the casein kinase I isoenzymes have been shown to play distinctive roles in intracellular SIGNAL TRANSDUCTION.%A%    
% 218.56/218.74  |- skos__altLabel mesh__D047389 Protein Kinase CKI
% 218.56/218.74  |- skos__hiddenLabel mesh__D047389 Kinase I, Casein
% 218.56/218.74  |- mesh__recordMaintainer mesh__D047389 jmp
% 218.56/218.74  |- mesh__dateEstablished mesh__D047389 2005-01-01
% 218.56/218.74  |- skos__altLabel mesh__D047389 tau Casein Kinase I
% 218.56/218.74  |- skos__historyNote mesh__D047389 Protein Kinases %28%1980-2004%29%
% 218.56/218.74  |- mesh__dateCreated mesh__D047389 2004-07-07
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D047389 2005
% 218.56/218.74  |- mesh__publicMeSHNote mesh__D047389
% 218.56/218.74       2005; CASEIN KINASE I was indexed under PROTEIN KINASES 1974-2004%A%  
% 218.56/218.74  |- skos__altLabel mesh__D047389 Protein Kinase CK1
% 218.56/218.74  |- skos__altLabel mesh__D047389 Kappa Casein Kinase
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D047389 2006
% 218.56/218.74  |- mesh__recordOriginator mesh__D047389 jmp
% 218.56/218.74  |- mesh__recordAuthorizer mesh__D047389 sjn
% 218.56/218.74  |- skos__altLabel mesh__D047389 Casein Kinase 1
% 218.56/218.74  |- skos__prefLabel mesh__D047389 Casein Kinase I
% 218.56/218.74  |- skos__hiddenLabel mesh__D047389 Kinase 1, Casein
% 218.56/218.74  |- mesh__historyNote mesh__D047389 2005%28%1974%29%   
% 218.56/218.74  |- rdf__type mesh__D047389sskos__Concept
% 218.56/218.74  |- skos__broader mesh__D047389smesh__D047388
% 218.56/218.74  |- skos__historyNote mesh__D014404 Nerve Tissue Proteins %28%1966-1974%29%
% 218.56/218.74  |- mesh__recordAuthorizer mesh__D014404 sjn
% 218.56/218.74  |- rdf__type mesh__D014404sskos__Concept
% 218.56/218.74  |- skos__broader mesh__D014404smesh__D009419
% 218.56/218.74  |- skos__historyNote mesh__D014404 Microtubules %28%1970-1974%29%
% 218.56/218.74  |- mesh__dateEstablished mesh__D014404 1980-01-01
% 218.56/218.74  |- skos__hiddenLabel mesh__D014404 Talpha1 alpha Tubulin
% 218.56/218.74  |- skos__hiddenLabel mesh__D014404 gamma Tubulin
% 218.56/218.74  |- skos__scopeNote mesh__D014404
% 218.56/218.74       A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from sperm flagella, cilia, and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to colchicine, vincristine, and vinblastine.%A%    
% 218.56/218.74  |- skos__broader mesh__D014404smesh__D008868
% 218.56/218.74  |- mesh__recordMaintainer mesh__D014404 ssb
% 218.56/218.74  |- skos__hiddenLabel mesh__D014404 beta Tubulin
% 218.56/218.74  |- skos__hiddenLabel mesh__D014404 alpha Tubulin
% 218.56/218.74  |- mesh__publicMeSHNote mesh__D014404
% 218.56/218.74       80; was see under GLYCOPROTEINS 1975-79   
% 218.56/218.74  |- mesh__historyNote mesh__D014404
% 218.56/218.74       80%28%75%29%; was see under GLYCOPROTEINS 1975-79   
% 218.56/218.74  |- mesh__dateRevised mesh__D014404 2005-06-30
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D014404 2006
% 218.56/218.74  |- skos__prefLabel mesh__D014404 Tubulin
% 218.56/218.74  |- skos__hiddenLabel mesh__D014404 alpha-Tubulin, Talpha1
% 218.56/218.74  |- mesh__dateCreated mesh__D014404 1974-11-11
% 218.56/218.74  |- mesh__recordOriginator mesh__D014404 NLM
% 218.56/218.74  |- rdf__type mesh__D019698sskos__Concept
% 218.56/218.74  |- mesh__historyNote mesh__D019698 98   
% 218.56/218.74  |- mesh__recordAuthorizer mesh__D019698 sjn
% 218.56/218.74  |- mesh__publicMeSHNote mesh__D019698 98   
% 218.56/218.74  |- skos__scopeNote mesh__D019698
% 218.56/218.74       INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.%A%    
% 218.56/218.74  |- mesh__recordOriginator mesh__D019698 AGS
% 218.56/218.74  |- skos__altLabel mesh__D019698 Chronic Hepatitis C
% 218.56/218.74  |- mesh__dateEstablished mesh__D019698 1998-01-01
% 218.56/218.74  |- mesh__dateRevised mesh__D019698 2004-07-07
% 218.56/218.74  |- skos__historyNote mesh__D019698 Hepatitis C %28%1989-1997%29%
% 218.56/218.74  |- skos__historyNote mesh__D019698 Chronic Disease %28%1989-1997%29%
% 218.56/218.74  |- mesh__dateCreated mesh__D019698 1997-06-20
% 218.56/218.74  |- skos__historyNote mesh__D019698 Hepatitis, Chronic %28%1984-1997%29%
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D019698 2006
% 218.56/218.74  |- mesh__recordMaintainer mesh__D019698 lkt
% 218.56/218.74  |- skos__prefLabel mesh__D019698 Hepatitis C, Chronic
% 218.56/218.74  |- skos__broader mesh__D019698smesh__D006521
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D019698 2005
% 218.56/218.74  |- skos__broader mesh__D019698smesh__D006526
% 218.56/218.74  |- skos__altLabel mesh__D044091 GALR1 Galanin Receptor
% 218.56/218.74  |- skos__hiddenLabel mesh__D044091 Receptor, GALR1 Galanin
% 218.56/218.74  |- skos__hiddenLabel mesh__D044091 Galanin 1 Receptor
% 218.56/218.74  |- mesh__dateCreated mesh__D044091 2003-07-09
% 218.56/218.74  |- skos__hiddenLabel mesh__D044091 Receptor, Galanin-1
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D044091 2005
% 218.56/218.74  |- skos__broader mesh__D044091smesh__D044088
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D044091 2006
% 218.56/218.74  |- skos__prefLabel mesh__D044091 Receptor, Galanin, Type 1
% 218.56/218.74  |- mesh__publicMeSHNote mesh__D044091
% 218.56/218.74       2004; GALANIN-1 RECEPTOR %28%now RECEPTOR, GALANIN, TYPE 1%29% was indexed under RECEPTORS, NEUROPEPTIDE 1997-2003%A%  
% 218.56/218.74  |- skos__scopeNote mesh__D044091
% 218.56/218.74       The most abundant galanin receptor subtype. It displays a high affinity for the full-length form of GALANIN.%A%    
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D044091 2004
% 218.56/218.74  |- skos__altLabel mesh__D044091 Galanin Receptor 1
% 218.56/218.74  |- rdf__type mesh__D044091sskos__Concept
% 218.56/218.74  |- skos__altLabel mesh__D044091 Galanin-1 Receptor
% 218.56/218.74  |- skos__historyNote mesh__D044091
% 218.56/218.74       Receptors, Neuropeptide %28%1997-2003%29%
% 218.56/218.74  |- mesh__dateEstablished mesh__D044091 2004-01-01
% 218.56/218.74  |- skos__hiddenLabel mesh__D044091 Galanin Receptor, GALR1
% 218.56/218.74  |- skos__hiddenLabel mesh__D044091 Receptor 1, Galanin
% 218.56/218.74  |- mesh__historyNote mesh__D044091
% 218.56/218.74       2004; use RECEPTOR, GALANIN, TYPE 1 %28%NM%29% 1997-2003   
% 218.56/218.74  |- skos__related mesh__D005678smesh__D012497
% 218.56/218.74  |- skos__broader mesh__D005678smesh__D005732
% 218.56/218.74  |- skos__prefLabel mesh__D005678 G%28%M2%29% Ganglioside
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D005678 2005
% 218.56/218.74  |- skos__altLabel mesh__D005678 Tay-Sachs Disease Ganglioside
% 218.56/218.74  |- skos__historyNote mesh__D005678 Gangliosides %28%1974%29%
% 218.56/218.74  |- mesh__historyNote mesh__D005678
% 218.56/218.74       91%28%75%29%; was see under GANGLIOSIDES 1975-90   
% 218.56/218.74  |- mesh__recordOriginator mesh__D005678 NLM
% 218.56/218.74  |- mesh__dateCreated mesh__D005678 1974-11-19
% 218.56/218.74  |- skos__hiddenLabel mesh__D005678 Tay Sachs Disease Ganglioside
% 218.56/218.74  |- skos__scopeNote mesh__D005678
% 218.56/218.74       A glycosphingolipid that accumulates due to a deficiency of hexosaminidase A or B %28%BETA-N-ACETYLHEXOSAMINIDASE%29%, or GM2 activator protein, resulting in GANGLIOSIDOSES, heredity metabolic disorders that include TAY-SACHS DISEASE and SANDHOFF DISEASE.%A%    
% 218.56/218.74  |- skos__hiddenLabel mesh__D005678 Ganglioside, Tay-Sachs Disease
% 218.56/218.74  |- mesh__dateRevised mesh__D005678 2004-07-07
% 218.56/218.74  |- mesh__recordAuthorizer mesh__D005678 sjn
% 218.56/218.74  |- rdf__type mesh__D005678sskos__Concept
% 218.56/218.74  |- skos__related mesh__D005678smesh__D013661
% 218.56/218.74  |- skos__hiddenLabel mesh__D005678 GM2, Ganglioside
% 218.56/218.74  |- mesh__publicMeSHNote mesh__D005678
% 218.56/218.74       91; was see under GANGLIOSIDES 1975-90   
% 218.56/218.74  |- skos__altLabel mesh__D005678 Ganglioside GM2
% 218.56/218.74  |- mesh__dateEstablished mesh__D005678 1991-01-01
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D005678 2006
% 218.56/218.74  |- mesh__recordMaintainer mesh__D005678 ssb
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D002380 2001
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D002380 2000
% 218.56/218.74  |- skos__altLabel mesh__D002380 Drug Catalogs
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D002380 2006
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D002380 2004
% 218.56/218.74  |- mesh__dateCreated mesh__D002380 1999-01-01
% 218.56/218.74  |- mesh__recordOriginator mesh__D002380 NLM
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D002380 2005
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D002380 2002
% 218.56/218.74  |- skos__hiddenLabel mesh__D002380 Drug Catalog
% 218.56/218.74  |- skos__hiddenLabel mesh__D002380 Catalog, Drug
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D002380 2003
% 218.56/218.74  |- skos__prefLabel mesh__D002380 Catalogs, Drug
% 218.56/218.74  |- mesh__dateRevised mesh__D002380 1999-11-03
% 218.56/218.74  |- skos__broader mesh__D002380smesh__D002377
% 218.56/218.74  |- rdf__type mesh__D002380sskos__Concept
% 218.56/218.74  |- mesh__recordAuthorizer mesh__D002380 sjn
% 218.56/218.74  |- mesh__recordMaintainer mesh__D002380 kle
% 218.56/218.74  |- skos__annotation mesh__D002380 no qualif   
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D010812 2004
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D010812 2005
% 218.56/218.74  |- mesh__recordAuthorizer mesh__D010812 PLS
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D010812 1996
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D010812 2002
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D010812 2006
% 218.56/218.74  |- mesh__recordMaintainer mesh__D010812 TAP
% 218.56/218.74  |- skos__altLabel mesh__D010812 Stimulation, Physical
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D010812 1997
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D010812 1998
% 218.56/218.74  |- mesh__publicMeSHNote mesh__D010812 73   
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D010812 1999
% 218.56/218.74  |- skos__annotation mesh__D010812 NIM   
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D010812 2000
% 218.56/218.74  |- mesh__dateCreated mesh__D010812 1999-01-01
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D010812 1994
% 218.56/218.74  |- mesh__historyNote mesh__D010812 73   
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D010812 1993
% 218.56/218.74  |- rdf__type mesh__D010812sskos__Concept
% 218.56/218.74  |- mesh__recordOriginator mesh__D010812 NLM
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D010812 2001
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D010812 1995
% 218.56/218.74  |- skos__hiddenLabel mesh__D010812 Stimulations, Physical
% 218.56/218.74  |- skos__hiddenLabel mesh__D010812 Physical Stimulations
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D010812 2003
% 218.56/218.74  |- mesh__dateEstablished mesh__D010812 1973-01-01
% 218.56/218.74  |- skos__broader mesh__D010812smesh__D008919
% 218.56/218.74  |- mesh__dateRevised mesh__D010812 1992-05-18
% 218.56/218.74  |- skos__prefLabel mesh__D010812 Physical Stimulation
% 218.56/218.74  |- skos__prefLabel mesh__D010014 Osteolysis
% 218.56/218.74  |- skos__annotation mesh__D010014 only Cat C qualif   
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D010014 2006
% 218.56/218.74  |- mesh__dateCreated mesh__D010014 1999-01-01
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D010014 2005
% 218.56/218.74  |- mesh__onlineNote mesh__D010014 search BONE RESORPTION 1966-74   
% 218.56/218.74  |- mesh__publicMeSHNote mesh__D010014
% 218.56/218.74       87; was see under BONE RESORPTION 1966-86   
% 218.56/218.74  |- rdf__type mesh__D010014sskos__Concept
% 218.56/218.74  |- mesh__historyNote mesh__D010014
% 218.56/218.74       87%28%75%29%; was see under BONE RESORPTION 1966-86   
% 218.56/218.74  |- skos__hiddenLabel mesh__D010014 Osteolyses
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D010014 2004
% 218.56/218.74  |- skos__broader mesh__D010014smesh__D001862
% 218.56/218.74  |- mesh__recordMaintainer mesh__D010014 nns
% 218.56/218.74  |- mesh__dateRevised mesh__D010014 2003-07-09
% 218.56/218.74  |- mesh__recordAuthorizer mesh__D010014 sjn
% 218.56/218.74  |- mesh__dateEstablished mesh__D010014 1987-01-01
% 218.56/218.74  |- skos__scopeNote mesh__D010014
% 218.56/218.74       Dissolution of bone that particularly involves the removal or loss of calcium.%A%    
% 218.56/218.74  |- mesh__recordOriginator mesh__D010014 NLM
% 218.56/218.74  |- skos__hiddenLabel mesh__D034462 Professional-Family Disagreements
% 218.56/218.74  |- skos__hiddenLabel mesh__D034462 Disagreements, Professional-Family
% 218.56/218.74  |- mesh__recordOriginator mesh__D034462 tjk
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D034462 2005
% 218.56/218.74  |- skos__related mesh__D034462smesh__D011050
% 218.56/218.74  |- skos__hiddenLabel mesh__D034462 Dispute
% 218.56/218.74  |- skos__related mesh__D034462smesh__D011057
% 218.56/218.74  |- skos__hiddenLabel mesh__D034462 Dissent, Political
% 218.56/218.74  |- skos__hiddenLabel mesh__D034462 Professional-Patient Disagreements
% 218.56/218.74  |- mesh__recordMaintainer mesh__D034462 jls
% 218.56/218.74  |- skos__prefLabel mesh__D034462 Dissent and Disputes
% 218.56/218.74  |- skos__hiddenLabel mesh__D034462 Professional Patient Disagreement
% 218.56/218.74  |- skos__related mesh__D034462smesh__D002960
% 218.56/218.74  |- mesh__dateRevised mesh__D034462 2003-07-09
% 218.56/218.74  |- mesh__recordAuthorizer mesh__D034462 sjn
% 218.56/218.74  |- skos__hiddenLabel mesh__D034462 Disagreements, Professional-Patient
% 218.56/218.74  |- skos__broader mesh__D034462smesh__D003657
% 218.56/218.74  |- mesh__historyNote mesh__D034462 2003   
% 218.56/218.74  |- skos__related mesh__D034462smesh__D003220
% 218.56/218.74  |- skos__scopeNote mesh__D034462
% 218.56/218.74       Differences of opinion or disagreements that may arise, for example, between health professionals and patients or their families, or against a political regime.%A%    
% 218.56/218.74  |- mesh__dateEstablished mesh__D034462 2003-01-01
% 218.56/218.74  |- skos__hiddenLabel mesh__D034462 Disagreement, Professional-Patient
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D034462 2004
% 218.56/218.74  |- mesh__publicMeSHNote mesh__D034462 2003   
% 218.56/218.74  |- skos__broader mesh__D034462smesh__D007398
% 218.56/218.74  |- skos__annotation mesh__D034462
% 218.56/218.74       do not use for dissent by one author from the opinion of another%A%  
% 218.56/218.74  |- skos__hiddenLabel mesh__D034462 Professional Family Disagreement
% 218.56/218.74  |- rdf__type mesh__D034462sskos__Concept
% 218.56/218.74  |- skos__hiddenLabel mesh__D034462 Disputes and Dissent
% 218.56/218.74  |- mesh__dateCreated mesh__D034462 2002-07-03
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D034462 2006
% 218.56/218.74  |- skos__hiddenLabel mesh__D034462 Disagreement, Professional-Family
% 218.56/218.74  |- skos__related mesh__D034462smesh__D032921
% 218.56/218.74  |- skos__hiddenLabel mesh__D001288 Concentrations
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D001288 2001
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D001288 2003
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D001288 1996
% 218.56/218.74  |- mesh__recordAuthorizer mesh__D001288 PLS
% 218.56/218.74  |- skos__broader mesh__D001288smesh__D001143
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D001288 2005
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D001288 1998
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D001288 2004
% 218.56/218.74  |- skos__prefLabel mesh__D001288 Attention
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D001288 1997
% 218.56/218.74  |- skos__hiddenLabel mesh__D001288 Attentions
% 218.56/218.74  |- mesh__recordOriginator mesh__D001288 NLM
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D001288 2002
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D001288 1994
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D001288 2006
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D001288 1999
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D001288 1993
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D001288 1995
% 218.56/218.74  |- mesh__dateCreated mesh__D001288 1999-01-01
% 218.56/218.74  |- mesh__dateRevised mesh__D001288 1992-03-25
% 218.56/218.74  |- mesh__recordMaintainer mesh__D001288 TAP
% 218.56/218.74  |- rdf__type mesh__D001288sskos__Concept
% 218.56/218.74  |- skos__scopeNote mesh__D001288
% 218.56/218.74       Focusing on certain aspects of current experience to the exclusion of others. It is the act of heeding or taking notice or concentrating.%A%    
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D001288 2000
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D006771 2005
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D006771 2001
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D006771 2003
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D006771 2000
% 218.56/218.74  |- mesh__dateRevised mesh__D006771 1999-11-03
% 218.56/218.74  |- skos__prefLabel mesh__D006771 Hospitals, Maternity
% 218.56/218.74  |- rdf__type mesh__D006771sskos__Concept
% 218.56/218.74  |- skos__broader mesh__D006771smesh__D006782
% 218.56/218.74  |- mesh__recordAuthorizer mesh__D006771 sjn
% 218.56/218.74  |- mesh__onlineNote mesh__D006771 search HOSPITALS, SPECIAL 1968-74   
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D006771 2002
% 218.56/218.74  |- mesh__historyNote mesh__D006771
% 218.56/218.74       91%28%75%29%; was see under HOSPITALS, SPECIAL 1975-90   
% 218.56/218.74  |- mesh__dateCreated mesh__D006771 1999-01-01
% 218.56/218.74  |- skos__hiddenLabel mesh__D006771 Maternity Hospital
% 218.56/218.74  |- skos__hiddenLabel mesh__D006771 Hospital, Maternity
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D006771 2006
% 218.56/218.74  |- mesh__publicMeSHNote mesh__D006771
% 218.56/218.74       91; was see under HOSPITALS, SPECIAL 1975-90   
% 218.56/218.74  |- skos__altLabel mesh__D006771 Maternity Hospitals
% 218.56/218.74  |- mesh__recordMaintainer mesh__D006771 kle
% 218.56/218.74  |- mesh__recordOriginator mesh__D006771 NLM
% 218.56/218.74  |- skos__scopeNote mesh__D006771
% 218.56/218.74       Special hospitals which provide care to women during pregnancy and parturition.%A%    
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D006771 2004
% 218.56/218.74  |- skos__annotation mesh__D006771
% 218.56/218.74       coord IM with hosp ownership term %28%e.g., HOSPITALS, COUNTY; HOSPITALS, PROPRIETARY; etc.%29% %28%IM or NIM%29% if pertinent; specify geog; check also tags FEMALE %26% PREGNANCY%A%  
% 218.56/218.74  |- mesh__dateEstablished mesh__D006771 1991-01-01
% 218.56/218.74  |- skos__historyNote mesh__D020442 Poloxalene %28%1976-1998%29%
% 218.56/218.74  |- skos__hiddenLabel mesh__D020442 Pluronic L 121
% 218.56/218.74  |- skos__hiddenLabel mesh__D020442 Pluronic F 68
% 218.56/218.74  |- skos__hiddenLabel mesh__D020442 Pluronic L81
% 218.56/218.74  |- skos__prefLabel mesh__D020442 Poloxamer
% 218.56/218.74  |- rdf__type mesh__D020442sskos__Concept
% 218.56/218.74  |- mesh__dateEstablished mesh__D020442 1999-01-01
% 218.56/218.74  |- mesh__activeMeSHYear mesh__D020442 2006
% 218.56/218.74  |- mesh__recordMaintainer mesh__D020442 ssb
% 218.56/218.74  |- skos__hiddenLabel mesh__D020442 Pluronic F 108
% 218.56/218.74  |- mesh__recordAuthorizer mesh__D020442 sjn
% 218.56/218.74  |- skos__hiddenLabel mesh__D020442 Pluronic F108
% 218.56/218.74  |- mesh__publicMeSHNote mesh__D020442
% 218.56/218.74       99; for POLOXAMERS see POLOXALENE 1974-98   
% 218.56/218.74  |- mesh__dateRevised mesh__D020442 2005-06-30
% 218.56/218.74  |- skos__scopeNote mesh__D020442
% 218.56/218.74       A nonionic polyoxyethylene-polyoxypropylene block co-polymer with the general formula HO%28%C2H4O%29%a%28%-C3H6O%29%b%28%C2H4O%29%aH. It is available in different grades which vary from liquids to solids. It is used as an emulsifying agent, solubilizing agent, surfactant, and wetting agent for antibiotics. Poloxamer is also used in ointment and suppository bases and as a tablet binder or coater. %28%Martindale The Extra Pharmacopoeia, 31st ed%29%%A%    
% 218.56/218.74  |- mesh__recordOriginator mesh__D020442 ADP
% 218.56/218.74  |- skos__broader mesh__D020442smesh__D011092
% 218.56/218.74  |- skos__hiddenLabel mesh__D020442 Pluronic L 101
% 218.56/218.74  |- skos__hiddenLabel mesh__D020442 Pluronic L121
% 218.56/218.74  |- skos__hiddenLabel mesh__D020442 Pluronic F 127
% 218.56/218.74  |- mesh__dateCreated mesh__D020442 1998-06-10
% 218.56/218.74  |- mesh__historyNote mesh__D020442
% 218.56/218.74       99; for POLOXAMERS use POLOXALENE 1974-98   
% 218.56/218.75  |- skos__hiddenLabel mesh__D020442 Pluronic L 81
% 218.56/218.75  |- skos__hiddenLabel mesh__D020442 Pluronic F127
% 218.56/218.75  |- skos__altLabel mesh__D020442 Pluronic F-68
% 218.56/218.75  |- skos__hiddenLabel mesh__D020442 Pluronic L101
% 218.56/218.75  |- skos__broader mesh__D014405smesh__D005719
% 218.56/218.75  |- skos__scopeNote mesh__D014405
% 218.56/218.75       N%28%2%29%-%28%%28%1-%28%N%28%2%29%-L-Threonyl%29%-L-lysyl%29%-L-prolyl%29%-L-arginine. A tetrapeptide produced in the spleen by enzymatic cleavage of a leukophilic gamma-globulin. It stimulates the phagocytic activity of blood polymorphonuclear leukocytes and neutrophils in particular. The peptide is located in the Fd fragment of the gamma-globulin molecule.%A%    
% 218.56/218.75  |- skos__historyNote mesh__D014405 Oligopeptides %28%1973-1974%29%
% 218.56/218.75  |- mesh__recordOriginator mesh__D014405 NLM
% 218.56/218.75  |- mesh__dateEstablished mesh__D014405 1984-01-01
% 218.56/218.75  |- skos__historyNote mesh__D014405
% 218.56/218.75       Immunoglobulin Fragments %28%1973-1974%29%
% 218.56/218.75  |- mesh__historyNote mesh__D014405
% 218.56/218.75       84%28%75%29%; was see under IMMUNOGLOBULINS, FD 1975-83; LEUKOKININ %28%with LEUCOKININ a see ref to it%29% was see under GAMMA GLOBULINS 1975-83; LEUKOKININ %26% LEUCOKININ were see TUFTSIN 1984-93%A%  
% 218.56/218.75  |- mesh__publicMeSHNote mesh__D014405
% 218.56/218.75       84; was see under IMMUNOGLOBULINS, FD 1975-83; LEUKOKININ %28%with LEUCOKININ a see ref to it%29% was see under GAMMA GLOBULINS 1975-83; LEUKOKININ %26% LEUCOKININ were see TUFTSIN 1984-93%A%  
% 218.56/218.75  |- mesh__recordAuthorizer mesh__D014405 sjn
% 218.56/218.75  |- mesh__dateCreated mesh__D014405 1974-11-19
% 218.56/218.75  |- skos__altLabel mesh__D014405 L-Thr-L-Lys-L-Pro-L-Arg
% 218.56/218.75  |- skos__altLabel mesh__D014405 Taftsin
% 218.56/218.75  |- skos__altLabel mesh__D014405 L-Threonyl-L-Lysyl-L-Prolyl-L-Arginine
% 218.56/218.75  |- mesh__recordMaintainer mesh__D014405 ssb
% 218.56/218.75  |- skos__broader mesh__D014405smesh__D009842
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D014405 2006
% 218.56/218.75  |- skos__prefLabel mesh__D014405 Tuftsin
% 218.56/218.75  |- mesh__dateRevised mesh__D014405 2005-06-30
% 218.56/218.75  |- rdf__type mesh__D014405sskos__Concept
% 218.56/218.75  |- mesh__onlineNote mesh__D014405
% 218.56/218.75       use TUFTSIN to search LEUKOKININ %26% LEUCOKININ 1975-93   
% 218.56/218.75  |- skos__broader mesh__D014405smesh__D007140
% 218.56/218.75  |- skos__historyNote mesh__D019699 Glycoproteins %28%1981-1989%29%
% 218.56/218.75  |- mesh__historyNote mesh__D019699
% 218.56/218.75       98; see THROMBOSPONDINS %28%NM%29% 1981-97   
% 218.56/218.75  |- mesh__recordOriginator mesh__D019699 ADP
% 218.56/218.75  |- skos__historyNote mesh__D019699
% 218.56/218.75       Platelet Membrane Glycoproteins %28%1992-1993%29%
% 218.56/218.75  |- mesh__recordMaintainer mesh__D019699 SYSTEM
% 218.56/218.75  |- skos__annotation mesh__D019699
% 218.56/218.75       membrane glycoproteins; THROMBOSPONDIN 1 is also available%A%  
% 218.56/218.75  |- mesh__publicMeSHNote mesh__D019699
% 218.56/218.75       98; THROMBOSPONDIN was indexed under MEMBRANE GLYCOPROTEINS 1989-97, PLATELET MEMBRANE GLYCOPROTEINS 1992-93, %26% GLYCOPROTEINS 1981-89%A%  
% 218.56/218.75  |- skos__scopeNote mesh__D019699
% 218.56/218.75       A family of related, adhesive glycoproteins which are synthesized, secreted, and incorporated into the extracellular matrix of a variety of cells, including alpha granules of platelets following thrombin activation and endothelial cells. They interact with a number of BLOOD COAGULATION FACTORS and anticoagulant factors. Five distinct forms have been identified, thrombospondin 1, -2, -3, -4, and cartilage oligomeric matrix protein %28%COMP%29%. They are involved in cell adhesion, platelet aggregation, cell proliferation, angiogenesis, tumor metastasis, vascular smooth muscle growth, and tissue repair.%A%    
% 218.56/218.75  |- skos__prefLabel mesh__D019699 Thrombospondins
% 218.56/218.75  |- mesh__recordAuthorizer mesh__D019699 sjn
% 218.56/218.75  |- mesh__dateEstablished mesh__D019699 1998-01-01
% 218.56/218.75  |- mesh__dateRevised mesh__D019699 2005-06-30
% 218.56/218.75  |- mesh__dateCreated mesh__D019699 1997-06-20
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D019699 2006
% 218.56/218.75  |- skos__broader mesh__D019699smesh__D008562
% 218.56/218.75  |- skos__historyNote mesh__D019699 Membrane Glycoproteins %28%1989-1997%29%
% 218.56/218.75  |- skos__altLabel mesh__D019699 Thrombospondin
% 218.56/218.75  |- rdf__type mesh__D019699sskos__Concept
% 218.56/218.75  |- mesh__historyNote mesh__D044092
% 218.56/218.75       2004; use RECEPTOR, GALANIN, TYPE 2 %28%NM%29% 1997-2003   
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D044092 2006
% 218.56/218.75  |- mesh__publicMeSHNote mesh__D044092
% 218.56/218.75       2004; GALANIN-2 RECEPTOR %28%now RECEPTOR, GALANIN, TYPE 2%29% was indexed under RECEPTORS, NEUROPEPTIDE 1997-2003%A%  
% 218.56/218.75  |- skos__altLabel mesh__D044092 GALR2 Galanin Receptor
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D044092 2004
% 218.56/218.75  |- skos__scopeNote mesh__D044092
% 218.56/218.75       A galanin receptor subtype with broad specificity for full length GALANIN, galanin peptide fragments and GALANIN-LIKE PEPTIDE.%A%    
% 218.56/218.75  |- rdf__type mesh__D044092sskos__Concept
% 218.56/218.75  |- skos__historyNote mesh__D044092
% 218.56/218.75       Receptors, Neuropeptide %28%1997-2003%29%
% 218.56/218.75  |- skos__hiddenLabel mesh__D044092 Galanin Receptor, GALR2
% 218.56/218.75  |- skos__hiddenLabel mesh__D044092 Galanin 2 Receptor
% 218.56/218.75  |- skos__hiddenLabel mesh__D044092 Receptor 2, Galanin
% 218.56/218.75  |- skos__altLabel mesh__D044092 Galanin Receptor 2
% 218.56/218.75  |- skos__prefLabel mesh__D044092 Receptor, Galanin, Type 2
% 218.56/218.75  |- skos__hiddenLabel mesh__D044092 Receptor, GALR2 Galanin
% 218.56/218.75  |- mesh__dateCreated mesh__D044092 2003-07-09
% 218.56/218.75  |- mesh__dateEstablished mesh__D044092 2004-01-01
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D044092 2005
% 218.56/218.75  |- skos__broader mesh__D044092smesh__D044088
% 218.56/218.75  |- skos__altLabel mesh__D044092 Galanin-2 Receptor
% 218.56/218.75  |- skos__hiddenLabel mesh__D044092 Receptor, Galanin-2
% 218.56/218.75  |- skos__altLabel mesh__D005679 Sialyllactosylceramide
% 218.56/218.75  |- mesh__recordOriginator mesh__D005679 RLS
% 218.56/218.75  |- mesh__publicMeSHNote mesh__D005679
% 218.56/218.75       91; was see under GANGLIOSIDES 1977-90   
% 218.56/218.75  |- mesh__recordMaintainer mesh__D005679 ssb
% 218.56/218.75  |- skos__prefLabel mesh__D005679 G%28%M3%29% Ganglioside
% 218.56/218.75  |- mesh__dateRevised mesh__D005679 2004-07-07
% 218.56/218.75  |- skos__annotation mesh__D005679
% 218.56/218.75       G%28%M3%29% gangliosidosis: coord NIM with GANGLIOSIDOSIS %28%IM%29%   
% 218.56/218.75  |- rdf__type mesh__D005679sskos__Concept
% 218.56/218.75  |- skos__scopeNote mesh__D005679
% 218.56/218.75       A ganglioside present in abnormally large amounts in the brain and liver due to a deficient biosynthetic enzyme, G%28%M3%29%:UDP-N-acetylgalactosaminyltransferase. Deficiency of this enzyme prevents the formation of G%28%M2%29% ganglioside from G%28%M3%29% ganglioside and is the cause of an anabolic sphingolipidosis.%A%    
% 218.56/218.75  |- skos__altLabel mesh__D005679 Ganglioside GM3
% 218.56/218.75  |- skos__altLabel mesh__D005679 Sialyl Lactosylceramide
% 218.56/218.75  |- mesh__dateEstablished mesh__D005679 1991-01-01
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D005679 2006
% 218.56/218.75  |- mesh__dateCreated mesh__D005679 1976-05-19
% 218.56/218.75  |- skos__altLabel mesh__D005679 II3NeuAcLacCer
% 218.56/218.75  |- skos__altLabel mesh__D005679 Hematoside
% 218.56/218.75  |- mesh__historyNote mesh__D005679
% 218.56/218.75       91%28%77%29%; was see under GANGLIOSIDES 1977-90   
% 218.56/218.75  |- mesh__recordAuthorizer mesh__D005679 sjn
% 218.56/218.75  |- skos__hiddenLabel mesh__D005679 GM3, Ganglioside
% 218.56/218.75  |- skos__broader mesh__D005679smesh__D005732
% 218.56/218.75  |- skos__hiddenLabel mesh__D005679 Lactosylceramide, Sialyl
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D005679 2005
% 218.56/218.75  |- skos__historyNote mesh__D005679 Gangliosides %28%1966-1976%29%
% 218.56/218.75  |- mesh__dateCreated mesh__D002381 1999-01-01
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D002381 2000
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D002381 2005
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D002381 2003
% 218.56/218.75  |- mesh__recordAuthorizer mesh__D002381 sjn
% 218.56/218.75  |- mesh__dateRevised mesh__D002381 1999-11-03
% 218.56/218.75  |- skos__prefLabel mesh__D002381 Catalogs, Library
% 218.56/218.75  |- mesh__recordMaintainer mesh__D002381 kle
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D002381 2006
% 218.56/218.75  |- skos__hiddenLabel mesh__D002381 Catalog, Library
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D002381 2004
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D002381 2001
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D002381 2002
% 218.56/218.75  |- skos__broader mesh__D002381smesh__D002377
% 218.56/218.75  |- skos__hiddenLabel mesh__D002381 Library Catalog
% 218.56/218.75  |- skos__hiddenLabel mesh__D002381 Library Catalogs
% 218.56/218.75  |- skos__annotation mesh__D002381 no qualif   
% 218.56/218.75  |- rdf__type mesh__D002381sskos__Concept
% 218.56/218.75  |- mesh__recordOriginator mesh__D002381 NLM
% 218.56/218.75  |- skos__altLabel mesh__D010015 Gorham Disease
% 218.56/218.75  |- skos__related mesh__D010015smesh__D031845
% 218.56/218.75  |- skos__broader mesh__D010015smesh__D010014
% 218.56/218.75  |- skos__hiddenLabel mesh__D010015 Idiopathic Multicentric Osteolyses
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010015 2006
% 218.56/218.75  |- mesh__recordAuthorizer mesh__D010015 sjn
% 218.56/218.75  |- skos__hiddenLabel mesh__D010015 Massive Osteolysis
% 218.56/218.75  |- skos__prefLabel mesh__D010015 Osteolysis, Essential
% 218.56/218.75  |- mesh__recordOriginator mesh__D010015 NLM
% 218.56/218.75  |- mesh__dateCreated mesh__D010015 1999-01-01
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010015 2005
% 218.56/218.75  |- rdf__type mesh__D010015sskos__Concept
% 218.56/218.75  |- skos__related mesh__D010015smesh__D030981
% 218.56/218.75  |- skos__hiddenLabel mesh__D010015 Idiopathic Multicentric Osteolysis
% 218.56/218.75  |- skos__hiddenLabel mesh__D010015 Osteolyses, Idiopathic Multicentric
% 218.56/218.75  |- skos__hiddenLabel mesh__D010015 Multicentric Osteolyses, Idiopathic
% 218.56/218.75  |- skos__altLabel mesh__D010015 Disappearing Bone Disease
% 218.56/218.75  |- skos__hiddenLabel mesh__D010015 Osteolyses, Massive
% 218.56/218.75  |- skos__hiddenLabel mesh__D010015 Osteolyses, Essential
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010015 2004
% 218.56/218.75  |- skos__hiddenLabel mesh__D010015 Bone Disease, Disappearing
% 218.56/218.75  |- skos__hiddenLabel mesh__D010015 Massive Osteolyses
% 218.56/218.75  |- skos__broader mesh__D010015smesh__D001848
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010015 2003
% 218.56/218.75  |- mesh__dateRevised mesh__D010015 2002-07-02
% 218.56/218.75  |- mesh__recordMaintainer mesh__D010015 ags
% 218.56/218.75  |- skos__scopeNote mesh__D010015
% 218.56/218.75       Syndromes of bone destruction where the cause is not obvious such as neoplasia, infection, or trauma. The destruction follows various patterns: massive %28%Gorham disease%29%, multicentric %28%HAJDU-CHENEY SYNDROME%29%, or carpal/tarsal.%A%    
% 218.56/218.75  |- mesh__onlineNote mesh__D010015
% 218.56/218.75       use BONE DISEASES to search OSTEOLYSIS, ESSENTIAL 1966 %28%as Prov%29%%A%  
% 218.56/218.75  |- skos__hiddenLabel mesh__D010015 Essential Osteolyses
% 218.56/218.75  |- mesh__historyNote mesh__D010015
% 218.56/218.75       91%28%65%29%; was see under OSTEOLYSIS 1987-90; was see under BONE RESORPTION 1980-86; was see under BONE DISEASES 1965-79 %28%Prov 1965-66%29%%A%  
% 218.56/218.75  |- skos__hiddenLabel mesh__D010015 Essential Osteolysis
% 218.56/218.75  |- mesh__dateEstablished mesh__D010015 1991-01-01
% 218.56/218.75  |- mesh__publicMeSHNote mesh__D010015
% 218.56/218.75       91; was see under OSTEOLYSIS 1987-90; was see under BONE RESORPTION 1980-86; was see under BONE DISEASES 1967-79%A%  
% 218.56/218.75  |- skos__hiddenLabel mesh__D010015 Multicentric Osteolysis, Idiopathic
% 218.56/218.75  |- skos__hiddenLabel mesh__D001289 Disorders, Attention Deficit
% 218.56/218.75  |- skos__altLabel mesh__D001289 Hyperkinetic Syndrome
% 218.56/218.75  |- mesh__dateEstablished mesh__D001289 1973-01-01
% 218.56/218.75  |- skos__hiddenLabel mesh__D001289 Syndromes, Hyperkinetic
% 218.56/218.75  |- mesh__publicMeSHNote mesh__D001289
% 218.56/218.75       84; was HYPERKINETIC SYNDROME 1981-83; was MINIMAL BRAIN DYSFUNCTION 1973-80%A%  
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D001289 2003
% 218.56/218.75  |- skos__broader mesh__D001289smesh__D019958
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D001289 2000
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D001289 2005
% 218.56/218.75  |- skos__hiddenLabel mesh__D001289 Attention Deficit Disorders
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D001289 2004
% 218.56/218.75  |- skos__annotation mesh__D001289
% 218.56/218.75       not confined to children; do not confuse with HYPERKINESIS: note X refs under both; DF: ADDH or ADHD%A%  
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D001289 2001
% 218.56/218.75  |- mesh__onlineNote mesh__D001289
% 218.56/218.75       use ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY to search HYPERKINETIC SYNDROME 1981-83 %26% MINIMAL BRAIN DYSFUNCTION 1969-80 %28%as Prov 1969-72%29%%A%  
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D001289 2006
% 218.56/218.75  |- mesh__dateRevised mesh__D001289 1999-11-03
% 218.56/218.75  |- skos__altLabel mesh__D001289 Minimal Brain Dysfunction
% 218.56/218.75  |- skos__hiddenLabel mesh__D001289 Disorder, Attention Deficit
% 218.56/218.75  |- skos__scopeNote mesh__D001289
% 218.56/218.75       A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. %28%From DSM-IV%29%%A%    
% 218.56/218.75  |- skos__altLabel mesh__D001289
% 218.56/218.75       Attention Deficit Disorders with Hyperactivity
% 218.56/218.75  |- skos__hiddenLabel mesh__D001289 Dysfunction, Minimal Brain
% 218.56/218.75  |- mesh__dateCreated mesh__D001289 1999-01-01
% 218.56/218.75  |- rdf__type mesh__D001289sskos__Concept
% 218.56/218.75  |- mesh__historyNote mesh__D001289
% 218.56/218.75       84; was HYPERKINETIC SYNDROME 1981-83; was MINIMAL BRAIN DYSFUNCTION 1969-80 %28%Prov 1969-72%29%%A%  
% 218.56/218.75  |- mesh__recordAuthorizer mesh__D001289 sjn
% 218.56/218.75  |- skos__prefLabel mesh__D001289
% 218.56/218.75       Attention Deficit Disorder with Hyperactivity
% 218.56/218.75  |- mesh__recordOriginator mesh__D001289 NLM
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D001289 2002
% 218.56/218.75  |- skos__hiddenLabel mesh__D001289 Deficit Disorders, Attention
% 218.56/218.75  |- skos__historyNote mesh__D001289 Brain Damage, Chronic %28%1966-1968%29%
% 218.56/218.75  |- skos__altLabel mesh__D001289 Attention Deficit Hyperactivity Disorders
% 218.56/218.75  |- mesh__recordMaintainer mesh__D001289 kle
% 218.56/218.75  |- skos__hiddenLabel mesh__D001289 Deficit Disorder, Attention
% 218.56/218.75  |- skos__altLabel mesh__D001289 Attention Deficit Hyperactivity Disorder
% 218.56/218.75  |- skos__hiddenLabel mesh__D006772 Military Hospital
% 218.56/218.75  |- mesh__dateCreated mesh__D006772 1977-05-11
% 218.56/218.75  |- skos__hiddenLabel mesh__D006772 Navy Hospital
% 218.56/218.75  |- skos__hiddenLabel mesh__D006772 Air Force Hospital
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006772 1995
% 218.56/218.75  |- skos__hiddenLabel mesh__D006772 Hospital, Military
% 218.56/218.75  |- skos__prefLabel mesh__D006772 Hospitals, Military
% 218.56/218.75  |- skos__altLabel mesh__D006772 Hospitals, Navy
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006772 2001
% 218.56/218.75  |- skos__hiddenLabel mesh__D006772 Hospital, Navy
% 218.56/218.75  |- skos__hiddenLabel mesh__D006772 Hospital, Army
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006772 1993
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006772 1994
% 218.56/218.75  |- rdf__type mesh__D006772sskos__Concept
% 218.56/218.75  |- skos__hiddenLabel mesh__D006772 Army Hospital
% 218.56/218.75  |- skos__annotation mesh__D006772
% 218.56/218.75       add UNITED STATES if US or other country, + state for Amer location%A%  
% 218.56/218.75  |- skos__broader mesh__D006772smesh__D006768
% 218.56/218.75  |- skos__altLabel mesh__D006772 Air Force Hospitals
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006772 2000
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006772 1999
% 218.56/218.75  |- mesh__historyNote mesh__D006772
% 218.56/218.75       91%28%78%29%; was see under HOSPITALS, PUBLIC 1978-90   
% 218.56/218.75  |- skos__hiddenLabel mesh__D006772 Hospital, Air Force
% 218.56/218.75  |- skos__altLabel mesh__D006772 Military Hospitals
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006772 2006
% 218.56/218.75  |- mesh__recordAuthorizer mesh__D006772 PLS
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006772 1998
% 218.56/218.75  |- skos__scopeNote mesh__D006772
% 218.56/218.75       Hospitals which provide care for the military personnel and usually for their dependents.%A%    
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006772 1997
% 218.56/218.75  |- mesh__dateRevised mesh__D006772 1992-05-15
% 218.56/218.75  |- skos__altLabel mesh__D006772 Army Hospitals
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006772 2005
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006772 2004
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006772 2002
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006772 1996
% 218.56/218.75  |- mesh__publicMeSHNote mesh__D006772
% 218.56/218.75       91; was see under HOSPITALS, PUBLIC 1978-90   
% 218.56/218.75  |- mesh__dateEstablished mesh__D006772 1991-01-01
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006772 2003
% 218.56/218.75  |- mesh__recordMaintainer mesh__D006772 TGC
% 218.56/218.75  |- mesh__recordOriginator mesh__D006772 EC
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D020443 2005
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D020443 2000
% 218.56/218.75  |- skos__hiddenLabel mesh__D020443 Practice Purchase, Dental
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D020443 2003
% 218.56/218.75  |- mesh__dateCreated mesh__D020443 1998-06-10
% 218.56/218.75  |- mesh__publicMeSHNote mesh__D020443 99   
% 218.56/218.75  |- mesh__dateEstablished mesh__D020443 1999-01-01
% 218.56/218.75  |- skos__hiddenLabel mesh__D020443 Practice Purchase, Medical
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D020443 1999
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D020443 2002
% 218.56/218.75  |- skos__related mesh__D020443smesh__D010067
% 218.56/218.75  |- mesh__historyNote mesh__D020443 99   
% 218.56/218.75  |- skos__historyNote mesh__D020443
% 218.56/218.75       Practice Management, Medical %28%1975-1998%29%
% 218.56/218.75  |- skos__broader mesh__D020443smesh__D020399
% 218.56/218.75  |- rdf__type mesh__D020443sskos__Concept
% 218.56/218.75  |- skos__hiddenLabel mesh__D020443 Medical Practice Purchase
% 218.56/218.75  |- skos__historyNote mesh__D020443
% 218.56/218.75       Practice Management, Dental %28%1975-1998%29%
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D020443 2006
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D020443 2001
% 218.56/218.75  |- skos__prefLabel mesh__D020443 Practice Valuation and Purchase
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D020443 2004
% 218.56/218.75  |- skos__hiddenLabel mesh__D020443 Dental Practice Purchase
% 218.56/218.75  |- skos__scopeNote mesh__D020443
% 218.56/218.75       Determination of economic value of an established health care provider practice including value of patient lists, equipment, and other assets, and process of buying or selling rights to said practice.%A%    
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D014406 2005
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D014406 1995
% 218.56/218.75  |- rdf__type mesh__D014406sskos__Concept
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D014406 2004
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D014406 1999
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D014406 1994
% 218.56/218.75  |- skos__prefLabel mesh__D014406 Tularemia
% 218.56/218.75  |- mesh__recordAuthorizer mesh__D014406 PLS
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D014406 2003
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D014406 1998
% 218.56/218.75  |- mesh__dateCreated mesh__D014406 1999-01-01
% 218.56/218.75  |- mesh__recordMaintainer mesh__D014406 TGC
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D014406 2002
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D014406 1997
% 218.56/218.75  |- skos__broader mesh__D014406smesh__D017282
% 218.56/218.75  |- mesh__recordOriginator mesh__D014406 NLM
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D014406 2001
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D014406 1996
% 218.56/218.75  |- skos__broader mesh__D014406smesh__D016905
% 218.56/218.75  |- skos__annotation mesh__D014406
% 218.56/218.75       caused by Francisella tularensis %28%formerly Pasteurella tularensis%29%%A%  
% 218.56/218.75  |- skos__scopeNote mesh__D014406
% 218.56/218.75       A plague-like disease of rodents, transmissible to man. It is caused by FRANCISELLA TULARENSIS and is characterized by fever, chills, headache, backache, and weakness.%A%    
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D014406 2006
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D014406 2000
% 218.56/218.75  |- skos__hiddenLabel mesh__D014406 Tularemias
% 218.56/218.75  |- mesh__dateRevised mesh__D014406 1993-06-03
% 218.56/218.75  |- mesh__dateEstablished mesh__D044093 2004-01-01
% 218.56/218.75  |- skos__scopeNote mesh__D044093
% 218.56/218.75       A galanin receptor subtype with high affinity for GALANIN-LIKE PEPTIDE and low affinity for full length GALANIN and galanin peptide fragments.%A%    
% 218.56/218.75  |- skos__hiddenLabel mesh__D044093 Galanin 3 Receptor
% 218.56/218.75  |- skos__hiddenLabel mesh__D044093 Galanin Receptor, GALR3
% 218.56/218.75  |- skos__altLabel mesh__D044093 Galanin-3 Receptor
% 218.56/218.75  |- skos__altLabel mesh__D044093 GALR3 Galanin Receptor
% 218.56/218.75  |- skos__altLabel mesh__D044093 Galanin Receptor 3
% 218.56/218.75  |- skos__prefLabel mesh__D044093 Receptor, Galanin, Type 3
% 218.56/218.75  |- mesh__dateCreated mesh__D044093 2003-07-09
% 218.56/218.75  |- skos__hiddenLabel mesh__D044093 Receptor, Galanin-3
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D044093 2005
% 218.56/218.75  |- skos__broader mesh__D044093smesh__D044088
% 218.56/218.75  |- mesh__historyNote mesh__D044093 2004   
% 218.56/218.75  |- mesh__publicMeSHNote mesh__D044093 2004   
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D044093 2006
% 218.56/218.75  |- rdf__type mesh__D044093sskos__Concept
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D044093 2004
% 218.56/218.75  |- skos__historyNote mesh__D044093
% 218.56/218.75       Receptors, Neuropeptide %28%1997-2003%29%
% 218.56/218.75  |- skos__broader mesh__D002382smesh__D002379
% 218.56/218.75  |- skos__hiddenLabel mesh__D002382 Publisher Catalogs
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D002382 2003
% 218.56/218.75  |- mesh__recordOriginator mesh__D002382 NLM
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D002382 2006
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D002382 2004
% 218.56/218.75  |- skos__hiddenLabel mesh__D002382 Publisher%27%s Catalogs
% 218.56/218.75  |- skos__hiddenLabel mesh__D002382 Catalogs, Publishers
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D002382 2000
% 218.56/218.75  |- skos__altLabel mesh__D002382 Publishers%27% Catalogs
% 218.56/218.75  |- skos__hiddenLabel mesh__D002382 Catalog, Publishers%27%
% 218.56/218.75  |- mesh__recordAuthorizer mesh__D002382 sjn
% 218.56/218.75  |- mesh__dateRevised mesh__D002382 1999-11-03
% 218.56/218.75  |- mesh__recordMaintainer mesh__D002382 kle
% 218.56/218.75  |- skos__annotation mesh__D002382 no qualif   
% 218.56/218.75  |- skos__hiddenLabel mesh__D002382 Publishers Catalogs
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D002382 2001
% 218.56/218.75  |- rdf__type mesh__D002382sskos__Concept
% 218.56/218.75  |- skos__hiddenLabel mesh__D002382 Publishers%27% Catalog
% 218.56/218.75  |- skos__hiddenLabel mesh__D002382 Catalogs, Publisher
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D002382 2002
% 218.56/218.75  |- skos__hiddenLabel mesh__D002382 Catalogs, Publisher%27%s
% 218.56/218.75  |- skos__prefLabel mesh__D002382 Catalogs, Publishers%27%
% 218.56/218.75  |- mesh__dateCreated mesh__D002382 1999-01-01
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D002382 2005
% 218.56/218.75  |- mesh__dateRevised mesh__D010814 1992-05-18
% 218.56/218.75  |- mesh__recordOriginator mesh__D010814 EC
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010814 2003
% 218.56/218.75  |- skos__prefLabel mesh__D010814 Physical Therapy Department, Hospital
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010814 2002
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010814 1997
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010814 2006
% 218.56/218.75  |- skos__annotation mesh__D010814 DF: PHYS THER DEP   
% 218.56/218.75  |- skos__altLabel mesh__D010814 Physical Therapy Departments, Hospital
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010814 1996
% 218.56/218.75  |- mesh__dateCreated mesh__D010814 1977-05-19
% 218.56/218.75  |- skos__historyNote mesh__D010814
% 218.56/218.75       Hospital Departments %28%1968-Jul 1977%29%
% 218.56/218.75  |- mesh__recordAuthorizer mesh__D010814 PLS
% 218.56/218.75  |- skos__broader mesh__D010814smesh__D006748
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010814 2005
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010814 1999
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010814 1993
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010814 2001
% 218.56/218.75  |- skos__scopeNote mesh__D010814
% 218.56/218.75       Hospital department which is responsible for the administration and provision of diagnostic and medical rehabilitation services to restore or improve the functional capacity of the patient.%A%    
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010814 1998
% 218.56/218.75  |- mesh__publicMeSHNote mesh__D010814
% 218.56/218.75       91; was see under HOSPITAL DEPARTMENTS Aug 1977-90   
% 218.56/218.75  |- skos__historyNote mesh__D010814 Physical Therapy %28%1966-Jul 1977%29%
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010814 2000
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010814 1995
% 218.56/218.75  |- mesh__historyNote mesh__D010814
% 218.56/218.75       91%28%Aug 77%29%; was see under HOSPITAL DEPARTMENTS 1977-90   
% 218.56/218.75  |- rdf__type mesh__D010814sskos__Concept
% 218.56/218.75  |- mesh__dateEstablished mesh__D010814 1991-01-01
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010814 2004
% 218.56/218.75  |- skos__altLabel mesh__D010814 Hospital Physical Therapy Department
% 218.56/218.75  |- mesh__recordMaintainer mesh__D010814 TGC
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010814 1994
% 218.56/218.75  |- skos__hiddenLabel mesh__D010016 Osteomas
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010016 2004
% 218.56/218.75  |- skos__annotation mesh__D010016
% 218.56/218.75       /blood supply /chem /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS %28%IM%29% or specific precoord bone/neopl term %28%IM%29% or specific bone %28%IM%29% + BONE NEOPLASMS %28%IM%29%%A%  
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010016 1998
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010016 2003
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010016 1997
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010016 1996
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010016 2002
% 218.56/218.75  |- mesh__recordOriginator mesh__D010016 NLM
% 218.56/218.75  |- mesh__recordMaintainer mesh__D010016 KEV
% 218.56/218.75  |- skos__prefLabel mesh__D010016 Osteoma
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010016 2006
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010016 2001
% 218.56/218.75  |- mesh__dateCreated mesh__D010016 1999-01-01
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010016 2005
% 218.56/218.75  |- rdf__type mesh__D010016sskos__Concept
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010016 2000
% 218.56/218.75  |- mesh__dateRevised mesh__D010016 1995-06-08
% 218.56/218.75  |- skos__scopeNote mesh__D010016
% 218.56/218.75       A benign tumor composed of bone tissue or a hard tumor of bonelike structure developing on a bone %28%homoplastic osteoma%29% or on other structures %28%heteroplastic osteoma%29%. %28%From Dorland, 27th ed%29%%A%    
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D010016 1999
% 218.56/218.75  |- mesh__recordAuthorizer mesh__D010016 PLS
% 218.56/218.75  |- skos__broader mesh__D010016smesh__D018213
% 218.56/218.75  |- mesh__publicMeSHNote mesh__D006773
% 218.56/218.75       91; was see under HOSPITALS, PUBLIC 1978-90   
% 218.56/218.75  |- skos__annotation mesh__D006773
% 218.56/218.75       coord IM with special hosp %28%e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.%29% or med specialty %28%IM or NIM%29% if pertinent; specify city if in MeSH or state, province or country if city is not in MeSH%A%  
% 218.56/218.75  |- skos__hiddenLabel mesh__D006773 Hospital, Municipal
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006773 1995
% 218.56/218.75  |- mesh__recordOriginator mesh__D006773 EC
% 218.56/218.75  |- skos__hiddenLabel mesh__D006773 Municipal Hospital
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006773 1998
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006773 1993
% 218.56/218.75  |- mesh__dateEstablished mesh__D006773 1991-01-01
% 218.56/218.75  |- rdf__type mesh__D006773sskos__Concept
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006773 2005
% 218.56/218.75  |- skos__broader mesh__D006773smesh__D006779
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006773 1996
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006773 1999
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006773 2000
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006773 2003
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006773 2006
% 218.56/218.75  |- skos__scopeNote mesh__D006773
% 218.56/218.75       Hospitals controlled by the city government.     
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006773 2001
% 218.56/218.75  |- mesh__recordAuthorizer mesh__D006773 PLS
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006773 1997
% 218.56/218.75  |- skos__altLabel mesh__D006773 Hospitals, City, Public Owned
% 218.56/218.75  |- skos__altLabel mesh__D006773 Municipal Hospitals
% 218.56/218.75  |- mesh__dateCreated mesh__D006773 1977-05-11
% 218.56/218.75  |- mesh__recordMaintainer mesh__D006773 TGC
% 218.56/218.75  |- mesh__dateRevised mesh__D006773 1992-05-15
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006773 2004
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006773 2002
% 218.56/218.75  |- skos__prefLabel mesh__D006773 Hospitals, Municipal
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D006773 1994
% 218.56/218.75  |- mesh__historyNote mesh__D006773
% 218.56/218.75       91%28%78%29%; was see under HOSPITALS, PUBLIC 1978-90   
% 218.56/218.75  |- skos__broader mesh__D006773smesh__D006786
% 218.56/218.75  |- skos__altLabel mesh__D006773 Hospitals, City, Public-Owned
% 218.56/218.75  |- skos__scopeNote mesh__D020444
% 218.56/218.75       Payments that include adjustments to reflect the costs of uncompensated care and higher costs for inpatient care for certain populations receiving mandated services. MEDICARE and MEDICAID include provisions for this type of reimbursement.%A%    
% 218.56/218.75  |- mesh__activeMeSHYear mesh__D020444 2001
% 218.56/218.75  |- skos__hiddenLabel mesh__D020444 Disproportionate Reimbursements
% 218.56/218.75  |- mesh__publicMeSHNote mesh__D020444 99   
% 218.56/218.76  |- skos__hiddenLabel mesh__D020444 Share Reimbursements, Disproportionate
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D020444 2000
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D020444 1999
% 218.56/218.76  |- skos__altLabel mesh__D020444 Disproportionate Share Reimbursement
% 218.56/218.76  |- skos__hiddenLabel mesh__D020444 Reimbursements, Disproportionate Share
% 218.56/218.76  |- skos__altLabel mesh__D020444 Disproportionate Reimbursement
% 218.56/218.76  |- skos__broader mesh__D020444smesh__D012051
% 218.56/218.76  |- rdf__type mesh__D020444sskos__Concept
% 218.56/218.76  |- skos__hiddenLabel mesh__D020444 Disproportionate Share Reimbursements
% 218.56/218.76  |- mesh__dateEstablished mesh__D020444 1999-01-01
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D020444 2006
% 218.56/218.76  |- skos__hiddenLabel mesh__D020444 Reimbursement, Disproportionate
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D020444 2002
% 218.56/218.76  |- mesh__dateCreated mesh__D020444 1998-06-11
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D020444 2004
% 218.56/218.76  |- mesh__historyNote mesh__D020444 99   
% 218.56/218.76  |- skos__prefLabel mesh__D020444 Reimbursement, Disproportionate Share
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D020444 2005
% 218.56/218.76  |- skos__hiddenLabel mesh__D020444 Reimbursements, Disproportionate
% 218.56/218.76  |- skos__annotation mesh__D020444 specify geog   
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D020444 2003
% 218.56/218.76  |- skos__hiddenLabel mesh__D020444 Share Reimbursement, Disproportionate
% 218.56/218.76  |- skos__hiddenLabel mesh__D014407 Neoplastic Cell, Cultured
% 218.56/218.76  |- skos__annotation mesh__D014407
% 218.56/218.76       almost always NIM with no subheadings; check ANIMALS or HUMAN; do not routinely add neoplasm term; policy: Manual 21.57, 22.26.1, 24.4.5+%A%  
% 218.56/218.76  |- mesh__dateEstablished mesh__D014407 1988-01-01
% 218.56/218.76  |- skos__hiddenLabel mesh__D014407 Tumor Cell, Cultured
% 218.56/218.76  |- skos__historyNote mesh__D014407 Cell Line %28%1966-1987%29%
% 218.56/218.76  |- skos__hiddenLabel mesh__D014407 Cells, Cultured Neoplastic
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D014407 2005A
% 218.56/218.76  |- mesh__publicMeSHNote mesh__D014407 88   
% 218.56/218.76  |- skos__altLabel mesh__D014407 Cultured Tumor Cells
% 218.56/218.76  |- skos__historyNote mesh__D014407 Tissue Culture %28%1966-1982%29%
% 218.56/218.76  |- mesh__historyNote mesh__D014407 88   
% 218.56/218.76  |- skos__broader mesh__D014407smesh__D002478
% 218.56/218.76  |- skos__altLabel mesh__D014407 Neoplastic Cells, Cultured
% 218.56/218.76  |- skos__historyNote mesh__D014407 Clone Cells %28%1970-1983%29%
% 218.56/218.76  |- skos__prefLabel mesh__D014407 Tumor Cells, Cultured
% 218.56/218.76  |- skos__hiddenLabel mesh__D014407 Cultured Tumor Cell
% 218.56/218.76  |- skos__hiddenLabel mesh__D014407 Cell, Cultured Tumor
% 218.56/218.76  |- mesh__recordOriginator mesh__D014407 SCD
% 218.56/218.76  |- skos__historyNote mesh__D014407 Cells, Cultured %28%1972-1987%29%
% 218.56/218.76  |- mesh__dateRevised mesh__D014407 2004-08-02
% 218.56/218.76  |- mesh__recordAuthorizer mesh__D014407 jls
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D014407 2006
% 218.56/218.76  |- skos__hiddenLabel mesh__D014407 Cells, Cultured Tumor
% 218.56/218.76  |- skos__altLabel mesh__D014407 Cultured Neoplastic Cells
% 218.56/218.76  |- skos__hiddenLabel mesh__D014407 Cell, Cultured Neoplastic
% 218.56/218.76  |- skos__related mesh__D014407smesh__D018920
% 218.56/218.76  |- skos__scopeNote mesh__D014407
% 218.56/218.76       Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely.%A%    
% 218.56/218.76  |- mesh__dateCreated mesh__D014407 1987-05-08
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D014407 2005
% 218.56/218.76  |- mesh__recordMaintainer mesh__D014407 jls
% 218.56/218.76  |- rdf__type mesh__D014407sskos__Concept
% 218.56/218.76  |- skos__hiddenLabel mesh__D014407 Cultured Neoplastic Cell
% 218.56/218.76  |- skos__related mesh__D014407smesh__D004354
% 218.56/218.76  |- mesh__historyNote mesh__D044094
% 218.56/218.76       2004; use RECEPTORS, MELATONIN %28%NM%29% 1981-2003   
% 218.56/218.76  |- rdf__type mesh__D044094sskos__Concept
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D044094 2006
% 218.56/218.76  |- skos__historyNote mesh__D044094
% 218.56/218.76       Receptors, Cell Surface %28%1984-2003%29%
% 218.56/218.76  |- skos__altLabel mesh__D044094 Mel%28%1c%29% Receptor
% 218.56/218.76  |- skos__broader mesh__D044094smesh__D043562
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D044094 2005
% 218.56/218.76  |- skos__altLabel mesh__D044094 Melatonin MT3 Receptor
% 218.56/218.76  |- mesh__publicMeSHNote mesh__D044094
% 218.56/218.76       2004; MELATONIN RECEPTORS was indexed under RECEPTOR, CELL SURFACE %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1984-2003; RECEPTORS, ENDOGENOUS SUBSTANCES 1981-1986; %26% RECEPTORS, NEUROHUMOR 1987-1993%A%  
% 218.56/218.76  |- skos__altLabel mesh__D044094 MT3 Receptor
% 218.56/218.76  |- mesh__recordMaintainer mesh__D044094 jmp
% 218.56/218.76  |- skos__altLabel mesh__D044094 Receptor, Melatonin
% 218.56/218.76  |- skos__broader mesh__D044094smesh__D018160
% 218.56/218.76  |- skos__altLabel mesh__D044094 Receptor, Mel1c
% 218.56/218.76  |- mesh__dateCreated mesh__D044094 2003-07-09
% 218.56/218.76  |- skos__historyNote mesh__D044094
% 218.56/218.76       Receptors, Cytoplasmic and Nuclear %28%1984-2003%29%
% 218.56/218.76  |- skos__altLabel mesh__D044094 Melatonin Receptors
% 218.56/218.76  |- mesh__recordAuthorizer mesh__D044094 sjn
% 218.56/218.76  |- skos__hiddenLabel mesh__D044094 Receptor, MT3
% 218.56/218.76  |- skos__historyNote mesh__D044094
% 218.56/218.76       Receptors, Endogenous Substances %28%1981-1986%29%
% 218.56/218.76  |- skos__scopeNote mesh__D044094
% 218.56/218.76       A family of G-protein-coupled receptors that are specific for and mediate the effects of MELATONIN. Activation of melatonin receptors has been associated with decreased intracellular CYCLIC AMP and increased hydrolysis of PHOSPHOINOSITIDES.%A%    
% 218.56/218.76  |- skos__hiddenLabel mesh__D044094 MT3 Receptor, Melatonin
% 218.56/218.76  |- skos__hiddenLabel mesh__D044094 Receptor, Melatonin MT3
% 218.56/218.76  |- skos__prefLabel mesh__D044094 Receptors, Melatonin
% 218.56/218.76  |- skos__hiddenLabel mesh__D044094 Melatonin Receptor
% 218.56/218.76  |- skos__hiddenLabel mesh__D044094 Mel1c Receptor
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D044094 2004
% 218.56/218.76  |- skos__annotation mesh__D044094 GEN or unspecified; prefer specifics   
% 218.56/218.76  |- mesh__dateEstablished mesh__D044094 2004-01-01
% 218.56/218.76  |- mesh__recordOriginator mesh__D044094 jmp
% 218.56/218.76  |- skos__historyNote mesh__D044094 Receptors, Neurohumor %28%1987-1993%29%
% 218.56/218.76  |- skos__broader mesh__D002383smesh__D002377
% 218.56/218.76  |- skos__hiddenLabel mesh__D002383 Catalog, Union
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D002383 2002
% 218.56/218.76  |- skos__hiddenLabel mesh__D002383 Union Catalog
% 218.56/218.76  |- skos__annotation mesh__D002383 no qualif   
% 218.56/218.76  |- rdf__type mesh__D002383sskos__Concept
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D002383 2005
% 218.56/218.76  |- mesh__recordOriginator mesh__D002383 NLM
% 218.56/218.76  |- skos__prefLabel mesh__D002383 Catalogs, Union
% 218.56/218.76  |- mesh__dateCreated mesh__D002383 1999-01-01
% 218.56/218.76  |- mesh__dateRevised mesh__D002383 1999-11-03
% 218.56/218.76  |- skos__hiddenLabel mesh__D002383 Union Catalogs
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D002383 2003
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D002383 2006
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D002383 2000
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D002383 2004
% 218.56/218.76  |- mesh__recordMaintainer mesh__D002383 kle
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D002383 2001
% 218.56/218.76  |- mesh__recordAuthorizer mesh__D002383 sjn
% 218.56/218.76  |- skos__historyNote mesh__D010815 specific mental disorder
% 218.56/218.76  |- mesh__publicMeSHNote mesh__D010815 81   
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010815 2000
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010815 2006
% 218.56/218.76  |- mesh__dateEstablished mesh__D010815 1981-01-01
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010815 1996
% 218.56/218.76  |- skos__hiddenLabel mesh__D010815 Impairments, Physician
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010815 2005
% 218.56/218.76  |- skos__scopeNote mesh__D010815
% 218.56/218.76       The physician%27%s inability to practice medicine with reasonable skill and safety to the patient due to the physician%27%s disability. Common causes include alcohol and drug abuse, mental illness, physical disability, and senility.%A%    
% 218.56/218.76  |- mesh__dateCreated mesh__D010815 1980-05-13
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010815 1999
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010815 1993
% 218.56/218.76  |- skos__hiddenLabel mesh__D010815 Physician Impairments
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010815 2002
% 218.56/218.76  |- mesh__historyNote mesh__D010815 81   
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010815 1998
% 218.56/218.76  |- mesh__recordOriginator mesh__D010815 SMH
% 218.56/218.76  |- skos__annotation mesh__D010815
% 218.56/218.76       %22%inability to practice medicine with reasonable skill %26% safety to patient%22%; the causes may include alcohol %26% drug abuse, ment disord, phys disability, senility; coord IM with specific impairment %28%IM%29% + specialty if pertinent %28%IM%29%%A%  
% 218.56/218.76  |- skos__historyNote mesh__D010815 Mental Disorders %28%1966-1980%29%
% 218.56/218.76  |- mesh__recordAuthorizer mesh__D010815 PLS
% 218.56/218.76  |- skos__historyNote mesh__D010815 Clinical Competence %28%1975-1980%29%
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010815 1995
% 218.56/218.76  |- rdf__type mesh__D010815sskos__Concept
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010815 2004
% 218.56/218.76  |- skos__historyNote mesh__D010815 Physicians %28%1966-1980%29%
% 218.56/218.76  |- skos__prefLabel mesh__D010815 Physician Impairment
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010815 2001
% 218.56/218.76  |- mesh__recordMaintainer mesh__D010815 TGC
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010815 1994
% 218.56/218.76  |- skos__hiddenLabel mesh__D010815 Impairment, Physician
% 218.56/218.76  |- mesh__dateRevised mesh__D010815 1992-05-18
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010815 2003
% 218.56/218.76  |- skos__broader mesh__D010815smesh__D011363
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010815 1997
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010017 1997
% 218.56/218.76  |- skos__hiddenLabel mesh__D010017 Osteoid Osteomas
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010017 2000
% 218.56/218.76  |- mesh__recordAuthorizer mesh__D010017 PLS
% 218.56/218.76  |- skos__scopeNote mesh__D010017
% 218.56/218.76       Benign circumscribed tumor of spongy bone occurring especially in the bones of the extremities and vertebrae, most often in young persons. %28%Dorland, 27th ed%29%%A%    
% 218.56/218.76  |- skos__annotation mesh__D010017
% 218.56/218.76       /blood supply /chem /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS %28%IM%29% or specific precoord bone/neopl term %28%IM%29% or specific bone %28%IM%29% + BONE NEOPLASMS %28%IM%29%; do not confuse with OSTEOMA, GIANT OSTEOID see OSTEOBLASTOMA%A%  
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010017 1996
% 218.56/218.76  |- mesh__recordMaintainer mesh__D010017 KEV
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010017 2006
% 218.56/218.76  |- skos__prefLabel mesh__D010017 Osteoma, Osteoid
% 218.56/218.76  |- mesh__dateCreated mesh__D010017 1999-01-01
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010017 2005
% 218.56/218.76  |- rdf__type mesh__D010017sskos__Concept
% 218.56/218.76  |- mesh__dateRevised mesh__D010017 1995-06-08
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010017 1999
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010017 2002
% 218.56/218.76  |- mesh__recordOriginator mesh__D010017 NLM
% 218.56/218.76  |- skos__hiddenLabel mesh__D010017 Osteoid Osteoma
% 218.56/218.76  |- skos__hiddenLabel mesh__D010017 Osteomas, Osteoid
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010017 2004
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010017 1998
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010017 2001
% 218.56/218.76  |- skos__broader mesh__D010017smesh__D010016
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010017 2003
% 218.56/218.76  |- mesh__recordMaintainer mesh__D015500 ssb
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D015500 2004
% 218.56/218.76  |- skos__hiddenLabel mesh__D015500 Chloramphenicol O Acetyltransferase
% 218.56/218.76  |- skos__scopeNote mesh__D015500
% 218.56/218.76       An enzyme that catalyzes the acetylation of chloramphenicol to yield chloramphenicol 3-acetate. Since chloramphenicol 3-acetate does not bind to bacterial ribosomes and is not an inhibitor of peptidyltransferase, the enzyme is responsible for the naturally occurring chloramphenicol resistance in bacteria. The enzyme, for which variants are known, is found in both gram-negative and gram-positive bacteria. EC 2.3.1.28.%A%    
% 218.56/218.76  |- skos__hiddenLabel mesh__D015500 Enzyme, CAT
% 218.56/218.76  |- mesh__recordOriginator mesh__D015500 RLS
% 218.56/218.76  |- skos__hiddenLabel mesh__D015500 Acetyltransferase, Chloramphenicol
% 218.56/218.76  |- skos__hiddenLabel mesh__D015500 O-Acetyltransferase, Chloramphenicol
% 218.56/218.76  |- skos__prefLabel mesh__D015500 Chloramphenicol O-Acetyltransferase
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D015500 2006
% 218.56/218.76  |- skos__altLabel mesh__D015500 CAT Enzyme
% 218.56/218.76  |- skos__related mesh__D015500smesh__D002702
% 218.56/218.76  |- skos__historyNote mesh__D015500 Transferases %28%1966-1972%29%
% 218.56/218.76  |- skos__historyNote mesh__D015500 Acetyltransferases %28%1973-1988%29%
% 218.56/218.76  |- mesh__dateCreated mesh__D015500 1988-07-13
% 218.56/218.76  |- mesh__dateEstablished mesh__D015500 1989-01-01
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D015500 2005
% 218.56/218.76  |- skos__hiddenLabel mesh__D015500 Transacetylase, Chloramphenicol
% 218.56/218.76  |- mesh__historyNote mesh__D015500 98%28%89%29%   
% 218.56/218.76  |- mesh__recordAuthorizer mesh__D015500 sjn
% 218.56/218.76  |- skos__broader mesh__D015500smesh__D000123
% 218.56/218.76  |- rdf__type mesh__D015500sskos__Concept
% 218.56/218.76  |- mesh__dateRevised mesh__D015500 2003-07-09
% 218.56/218.76  |- skos__altLabel mesh__D015500 Chloramphenicol Transacetylase
% 218.56/218.76  |- skos__altLabel mesh__D015500 Chloramphenicol Acetyltransferase
% 218.56/218.76  |- mesh__publicMeSHNote mesh__D015500
% 218.56/218.76       98%28%89%29%; see CHLORAMPHENICOL ACETYLTRANSFERASE 1989-97   
% 218.56/218.76  |- skos__broader mesh__D003464Q000295smesh__D003464
% 218.56/218.76  |- mesh__preferredCombination mesh__D003464Q000295smesh__D020683
% 218.56/218.76  |- rdf__type mesh__D003464Q000295smesh__CompoundConcept
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D006774 2002
% 218.56/218.76  |- rdf__type mesh__D006774sskos__Concept
% 218.56/218.76  |- mesh__dateCreated mesh__D006774 1981-02-26
% 218.56/218.76  |- mesh__dateEstablished mesh__D006774 1991-01-01
% 218.56/218.76  |- skos__broader mesh__D006774smesh__D006782
% 218.56/218.76  |- skos__historyNote mesh__D006774 Hospitals, Special %28%1968-1981%29%
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D006774 2005
% 218.56/218.76  |- skos__altLabel mesh__D006774 Osteopathic Hospitals
% 218.56/218.76  |- mesh__dateRevised mesh__D006774 1999-11-03
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D006774 2003
% 218.56/218.76  |- mesh__recordOriginator mesh__D006774 EC
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D006774 2006
% 218.56/218.76  |- skos__prefLabel mesh__D006774 Hospitals, Osteopathic
% 218.56/218.76  |- mesh__recordAuthorizer mesh__D006774 sjn
% 218.56/218.76  |- mesh__publicMeSHNote mesh__D006774
% 218.56/218.76       91; was see under HOSPITALS, SPECIAL 1982-90   
% 218.56/218.76  |- skos__hiddenLabel mesh__D006774 Osteopathic Hospital
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D006774 2004
% 218.56/218.76  |- mesh__recordMaintainer mesh__D006774 kle
% 218.56/218.76  |- skos__scopeNote mesh__D006774
% 218.56/218.76       Hospitals providing care utilizing the generally accepted medical and surgical methods but with emphasis on the osteopathic system of therapy.%A%    
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D006774 2000
% 218.56/218.76  |- mesh__historyNote mesh__D006774
% 218.56/218.76       91%28%82%29%; was see under HOSPITALS, SPECIAL 1982-90   
% 218.56/218.76  |- skos__hiddenLabel mesh__D006774 Hospital, Osteopathic
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D006774 2001
% 218.56/218.76  |- skos__historyNote mesh__D006774 Osteopathic Medicine %28%1966-1981%29%
% 218.56/218.76  |- skos__annotation mesh__D006774
% 218.56/218.76       coord IM with hosp ownership term %28%e.g., HOSPITALS, PROPRIETARY%29% %28%IM or NIM%29% if pertinent; specify geog%A%  
% 218.56/218.76  |- skos__hiddenLabel mesh__D020445 Hospitalist
% 218.56/218.76  |- skos__broader mesh__D020445smesh__D008505
% 218.56/218.76  |- mesh__dateEstablished mesh__D020445 1999-01-01
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D020445 2000
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D020445 1999
% 218.56/218.76  |- skos__prefLabel mesh__D020445 Hospitalists
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D020445 2005
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D020445 2001
% 218.56/218.76  |- skos__broader mesh__D020445smesh__D010820
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D020445 2003
% 218.56/218.76  |- rdf__type mesh__D020445sskos__Concept
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D020445 2006
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D020445 2002
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D020445 2004
% 218.56/218.76  |- mesh__publicMeSHNote mesh__D020445 99   
% 218.56/218.76  |- mesh__dateCreated mesh__D020445 1998-06-10
% 218.56/218.76  |- mesh__historyNote mesh__D020445 99   
% 218.56/218.76  |- skos__broader mesh__D020445smesh__D013040
% 218.56/218.76  |- skos__scopeNote mesh__D020445
% 218.56/218.76       Physicians who are employed to work exclusively in hospital settings, primarily for managed care organizations. They are the attending or primary responsible physician for the patient during hospitalization.%A%    
% 218.56/218.76  |- skos__altLabel mesh__D014408 Marker, Biological Tumor
% 218.56/218.76  |- skos__hiddenLabel mesh__D014408 Biochemical Tumor Marker
% 218.56/218.76  |- skos__altLabel mesh__D014408 Biological Tumor Markers
% 218.56/218.76  |- skos__hiddenLabel mesh__D014408 Markers, Biologic Tumor
% 218.56/218.76  |- mesh__dateCreated mesh__D014408 1987-03-27
% 218.56/218.76  |- skos__altLabel mesh__D014408 Markers, Tumor Metabolite
% 218.56/218.76  |- skos__hiddenLabel mesh__D014408 Neoplasm Metabolite Marker
% 218.56/218.76  |- mesh__recordAuthorizer mesh__D014408 sjn
% 218.56/218.76  |- skos__altLabel mesh__D014408 Metabolite Markers, Neoplasm
% 218.56/218.76  |- skos__hiddenLabel mesh__D014408 Tumor Marker, Biochemical
% 218.56/218.76  |- mesh__recordOriginator mesh__D014408 SCD
% 218.56/218.76  |- skos__altLabel mesh__D014408 Tumor Markers, Biologic
% 218.56/218.76  |- skos__hiddenLabel mesh__D014408 Biologic Tumor Markers
% 218.56/218.76  |- skos__hiddenLabel mesh__D014408 Tumor Metabolite Markers
% 218.56/218.76  |- mesh__dateEstablished mesh__D014408 1988-01-01
% 218.56/218.76  |- skos__altLabel mesh__D014408 Biological Tumor Marker
% 218.56/218.76  |- skos__annotation mesh__D014408
% 218.56/218.76       IM; coord with specific substance %28%IM%29% if pertinent; DF: TUMOR MARKERS; Manual 24.4.4.5%A%  
% 218.56/218.76  |- skos__hiddenLabel mesh__D014408 Tumor Marker, Biological
% 218.56/218.76  |- mesh__recordMaintainer mesh__D014408 ssb
% 218.56/218.76  |- skos__altLabel mesh__D014408 Tumor Metabolite Marker
% 218.56/218.76  |- skos__altLabel mesh__D014408 Marker, Neoplasm Metabolite
% 218.56/218.76  |- skos__altLabel mesh__D014408 Metabolite Markers, Tumor
% 218.56/218.76  |- skos__broader mesh__D014408smesh__D015415
% 218.56/218.76  |- skos__hiddenLabel mesh__D014408 Tumor Markers
% 218.56/218.76  |- rdf__type mesh__D014408sskos__Concept
% 218.56/218.76  |- skos__hiddenLabel mesh__D014408 Tumor Marker, Biologic
% 218.56/218.76  |- skos__altLabel mesh__D014408 Tumor Markers, Biochemical
% 218.56/218.76  |- skos__scopeNote mesh__D014408
% 218.56/218.76       Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or body fluids. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids.%A%    
% 218.56/218.76  |- skos__hiddenLabel mesh__D014408 Metabolite Marker, Tumor
% 218.56/218.76  |- skos__altLabel mesh__D014408 Marker, Biochemical Tumor
% 218.56/218.76  |- skos__altLabel mesh__D014408 Markers, Neoplasm Metabolite
% 218.56/218.76  |- skos__altLabel mesh__D014408 Markers, Biochemical Tumor
% 218.56/218.76  |- skos__altLabel mesh__D014408 Marker, Tumor Metabolite
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D014408 2006
% 218.56/218.76  |- skos__altLabel mesh__D014408 Biochemical Tumor Markers
% 218.56/218.76  |- skos__hiddenLabel mesh__D014408 Markers, Carcinogen
% 218.56/218.76  |- mesh__dateRevised mesh__D014408 2005-06-30
% 218.56/218.76  |- skos__hiddenLabel mesh__D014408 Metabolite Marker, Neoplasm
% 218.56/218.76  |- skos__altLabel mesh__D014408 Marker, Biologic Tumor
% 218.56/218.76  |- mesh__publicMeSHNote mesh__D014408 88   
% 218.56/218.76  |- skos__hiddenLabel mesh__D014408 Biologic Tumor Marker
% 218.56/218.76  |- skos__prefLabel mesh__D014408 Tumor Markers, Biological
% 218.56/218.76  |- mesh__historyNote mesh__D014408 88   
% 218.56/218.76  |- skos__altLabel mesh__D014408 Carcinogen Markers
% 218.56/218.76  |- skos__altLabel mesh__D014408 Markers, Biological Tumor
% 218.56/218.76  |- skos__altLabel mesh__D014408 Neoplasm Metabolite Markers
% 218.56/218.76  |- mesh__dateEstablished mesh__D044095 2004-01-01
% 218.56/218.76  |- skos__prefLabel mesh__D044095 Proteus penneri
% 218.56/218.76  |- mesh__historyNote mesh__D044095 2004   
% 218.56/218.76  |- skos__broader mesh__D044095smesh__D011511
% 218.56/218.76  |- mesh__recordOriginator mesh__D044095 ags
% 218.56/218.76  |- mesh__dateCreated mesh__D044095 2003-07-09
% 218.56/218.76  |- skos__historyNote mesh__D044095 Proteus %28%1982-2003%29%
% 218.56/218.76  |- mesh__dateRevised mesh__D044095 2005-06-30
% 218.56/218.76  |- skos__annotation mesh__D044095
% 218.56/218.76       infection: coord IM with PROTEUS INFECTIONS %28%IM%29%   
% 218.56/218.76  |- mesh__publicMeSHNote mesh__D044095 2004   
% 218.56/218.76  |- skos__scopeNote mesh__D044095
% 218.56/218.76       A genus of gram-negative bacteria isolated from individuals in LONG-TERM CARE facilities and HOSPITALS.%A%    
% 218.56/218.76  |- mesh__recordAuthorizer mesh__D044095 sjn
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D044095 2006
% 218.56/218.76  |- rdf__type mesh__D044095sskos__Concept
% 218.56/218.76  |- mesh__recordMaintainer mesh__D044095 SYSTEM
% 218.56/218.76  |- mesh__recordMaintainer mesh__D011110 nns
% 218.56/218.76  |- mesh__historyNote mesh__D011110 2005%28%1968%29%   
% 218.56/218.76  |- mesh__dateCreated mesh__D011110 1999-01-01
% 218.56/218.76  |- skos__annotation mesh__D011110 DF: POLYMORPHISM   
% 218.56/218.76  |- skos__altLabel mesh__D011110 Polymorphism %28%Genetics%29%
% 218.56/218.76  |- mesh__recordOriginator mesh__D011110 NLM
% 218.56/218.76  |- skos__broader mesh__D011110smesh__D014644
% 218.56/218.76  |- skos__prefLabel mesh__D011110 Polymorphism, Genetic
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D011110 2005
% 218.56/218.76  |- mesh__publicMeSHNote mesh__D011110
% 218.56/218.76       2005%28%1968%29%; see POLYMORPHISM %28%GENETICS%29% 1968-2004   
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D011110 2006
% 218.56/218.76  |- skos__historyNote mesh__D011110 Genetics, Population %28%1966-1967%29%
% 218.56/218.76  |- skos__altLabel mesh__D011110 Genetic Polymorphism
% 218.56/218.76  |- skos__scopeNote mesh__D011110
% 218.56/218.76       The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site %28%POLYMORPHISM, SINGLE NUCLEOTIDE%29% to large nucleotide sequences visible at a chromosomal level.%A%    
% 218.56/218.76  |- skos__altLabel mesh__D011110 Genetic Polymorphisms
% 218.56/218.76  |- mesh__dateEstablished mesh__D011110 1968-01-01
% 218.56/218.76  |- mesh__dateRevised mesh__D011110 2004-07-07
% 218.56/218.76  |- skos__hiddenLabel mesh__D011110 Polymorphisms, Genetic
% 218.56/218.76  |- skos__historyNote mesh__D011110 Genetics %28%1966-1967%29%
% 218.56/218.76  |- mesh__recordAuthorizer mesh__D011110 sjn
% 218.56/218.76  |- rdf__type mesh__D011110sskos__Concept
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D002384 2000
% 218.56/218.76  |- rdf__type mesh__D002384sskos__Concept
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D002384 2001
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D002384 1996
% 218.56/218.76  |- skos__prefLabel mesh__D002384 Catalysis
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D002384 1999
% 218.56/218.76  |- skos__broader mesh__D002384smesh__D002627
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D002384 2005
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D002384 1997
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D002384 2002
% 218.56/218.76  |- mesh__dateCreated mesh__D002384 1999-01-01
% 218.56/218.76  |- skos__hiddenLabel mesh__D002384 Catalyses
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D002384 2003
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D002384 2006
% 218.56/218.76  |- skos__annotation mesh__D002384 NIM   
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D002384 1994
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D002384 2004
% 218.56/218.76  |- skos__broader mesh__D002384smesh__D001671
% 218.56/218.76  |- mesh__recordOriginator mesh__D002384 NLM
% 218.56/218.76  |- mesh__recordMaintainer mesh__D002384 TAP
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D002384 1995
% 218.56/218.76  |- mesh__recordAuthorizer mesh__D002384 PLS
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D002384 1998
% 218.56/218.76  |- mesh__dateRevised mesh__D002384 1992-05-07
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D002384 1993
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010816 1998
% 218.56/218.76  |- skos__prefLabel mesh__D010816 Physician Incentive Plans
% 218.56/218.76  |- skos__broader mesh__D010816smesh__D010559
% 218.56/218.76  |- skos__hiddenLabel mesh__D010816 Incentive Plan, Physician
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010816 2001
% 218.56/218.76  |- skos__historyNote mesh__D010816 Personnel Management %28%1966-1987%29%
% 218.56/218.76  |- skos__historyNote mesh__D010816
% 218.56/218.76       Employee Incentive Plans %28%1979-1987%29%
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010816 1995
% 218.56/218.76  |- rdf__type mesh__D010816sskos__Concept
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010816 2004
% 218.56/218.76  |- mesh__publicMeSHNote mesh__D010816
% 218.56/218.76       91; was see under PERSONNEL MANAGEMENT 1988-90   
% 218.56/218.76  |- skos__hiddenLabel mesh__D010816 Plan, Physician Incentive
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010816 2000
% 218.56/218.76  |- mesh__recordOriginator mesh__D010816 EC
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010816 2003
% 218.56/218.76  |- mesh__dateEstablished mesh__D010816 1991-01-01
% 218.56/218.76  |- mesh__recordMaintainer mesh__D010816 TGC
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010816 1997
% 218.56/218.76  |- skos__hiddenLabel mesh__D010816 Plans, Physician Incentive
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010816 2006
% 218.56/218.76  |- mesh__historyNote mesh__D010816
% 218.56/218.76       91%28%88%29%; was see under PERSONNEL MANAGEMENT 1988-90   
% 218.56/218.76  |- skos__altLabel mesh__D010816 Incentive Plans, Physician
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010816 1996
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010816 2002
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010816 2005
% 218.56/218.76  |- skos__scopeNote mesh__D010816
% 218.56/218.76       Compensatory plans designed to motivate physicians in relation to patient referral, physician recruitment, and efficient use of the health facility.%A%    
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D010816 1999
% 218.56/218.76  |- mesh__dateRevised mesh__D010816 1994-05-05
% 218.56/218.76  |- mesh__dateCreated mesh__D010816 1987-05-04
% 218.56/218.76  |- skos__hiddenLabel mesh__D010816 Physician Incentive Plan
% 218.56/218.76  |- mesh__recordAuthorizer mesh__D010816 PLS
% 218.56/218.76  |- skos__annotation mesh__D029521
% 218.56/218.76       infection: coordinate IM with INFLUENZA, HUMAN %28%IM%29% in humans or ORTHOMYXOVIRIDAE INFECTIONS %28%IM%29% in animals other than birds; infection in birds = INFLUENZA IN BIRDS; INFLUENZA A VIRUS is also available%A%  
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D029521 2003
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D029521 2006A
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D029521 2006
% 218.56/218.76  |- mesh__recordMaintainer mesh__D029521 ags
% 218.56/218.76  |- rdf__type mesh__D029521sskos__Concept
% 218.56/218.76  |- mesh__historyNote mesh__D029521 2002   
% 218.56/218.76  |- skos__historyNote mesh__D029521 Orthomyxoviridae %28%1997-2001%29%
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D029521 2004
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D029521 2002
% 218.56/218.76  |- skos__broader mesh__D029521smesh__D009975
% 218.56/218.76  |- skos__scopeNote mesh__D029521
% 218.56/218.76       A genus in the family ORTHOMYXOVIRIDAE causing influenza and other diseases in humans and animals. It contains many strains as well as antigenic subtypes of the integral membrane proteins hemagglutinin %28%HEMAGGLUTININS%29% and NEURAMINIDASE. The type species is INFLUENZA A VIRUS.%A%    
% 218.56/218.76  |- mesh__dateEstablished mesh__D029521 2002-01-01
% 218.56/218.76  |- skos__prefLabel mesh__D029521 Influenzavirus A
% 218.56/218.76  |- mesh__publicMeSHNote mesh__D029521 2002   
% 218.56/218.76  |- mesh__dateCreated mesh__D029521 2001-07-25
% 218.56/218.76  |- mesh__dateRevised mesh__D029521 2005-11-10
% 218.56/218.76  |- mesh__activeMeSHYear mesh__D029521 2005
% 218.56/218.76  |- mesh__recordOriginator mesh__D029521 ags
% 218.56/218.77  |- mesh__recordAuthorizer mesh__D029521 ags
% 218.56/218.77  |- mesh__recordAuthorizer mesh__D010018 sjn
% 218.56/218.77  |- mesh__recordMaintainer mesh__D010018 lkt
% 218.56/218.77  |- skos__annotation mesh__D010018
% 218.56/218.77       softening of bones; manifest of calcium %26% vitamin D defic%A%  
% 218.56/218.77  |- mesh__recordOriginator mesh__D010018 NLM
% 218.56/218.77  |- mesh__dateCreated mesh__D010018 1999-01-01
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D010018 2005
% 218.56/218.77  |- skos__broader mesh__D010018smesh__D014808
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D010018 2006
% 218.56/218.77  |- skos__broader mesh__D010018smesh__D002128
% 218.56/218.77  |- skos__broader mesh__D010018smesh__D001851
% 218.56/218.77  |- skos__prefLabel mesh__D010018 Osteomalacia
% 218.56/218.77  |- rdf__type mesh__D010018sskos__Concept
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D010018 2004
% 218.56/218.77  |- skos__hiddenLabel mesh__D010018 Osteomalacias
% 218.56/218.77  |- skos__scopeNote mesh__D010018
% 218.56/218.77       A condition marked by softening of the bones %28%due to impaired mineralization, with excess accumulation of osteoid%29%, with pain, tenderness, muscular weakness, anorexia, and loss of weight, resulting from deficiency of vitamin D and calcium. %28%Dorland, 27th ed%29%%A%    
% 218.56/218.77  |- mesh__dateRevised mesh__D010018 2003-07-09
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D006775 2000
% 218.56/218.77  |- mesh__recordOriginator mesh__D006775 NLM
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D006775 2004
% 218.56/218.77  |- skos__annotation mesh__D006775
% 218.56/218.77       packaged for long-term storage toward an emergency; specify geog%A%  
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D006775 2001
% 218.56/218.77  |- skos__altLabel mesh__D006775 Packaged Hospitals
% 218.56/218.77  |- skos__broader mesh__D006775smesh__D006761
% 218.56/218.77  |- skos__broader mesh__D006775smesh__D004865
% 218.56/218.77  |- skos__historyNote mesh__D006775 Hospitals %28%1966%29%
% 218.56/218.77  |- mesh__dateRevised mesh__D006775 1999-11-03
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D006775 2002
% 218.56/218.77  |- mesh__dateCreated mesh__D006775 1999-01-01
% 218.56/218.77  |- mesh__publicMeSHNote mesh__D006775
% 218.56/218.77       91; was see under HOSPITALS 1967-90   
% 218.56/218.77  |- skos__scopeNote mesh__D006775
% 218.56/218.77       Hospital equipment and supplies, packaged for long-term storage, sufficient to set up a general hospital in an emergency situation. They are also called Packaged Disaster Hospitals and formerly Civil Defense Emergency Hospitals.%A%    
% 218.56/218.77  |- rdf__type mesh__D006775sskos__Concept
% 218.56/218.77  |- skos__prefLabel mesh__D006775 Hospitals, Packaged
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D006775 2005
% 218.56/218.77  |- mesh__recordAuthorizer mesh__D006775 sjn
% 218.56/218.77  |- mesh__dateEstablished mesh__D006775 1991-01-01
% 218.56/218.77  |- mesh__historyNote mesh__D006775
% 218.56/218.77       91%28%67%29%; was see under HOSPITALS 1967-90   
% 218.56/218.77  |- skos__hiddenLabel mesh__D006775 Packaged Hospital
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D006775 2003
% 218.56/218.77  |- skos__hiddenLabel mesh__D006775 Hospital, Packaged
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D006775 2006
% 218.56/218.77  |- mesh__recordMaintainer mesh__D006775 kle
% 218.56/218.77  |- mesh__dateRevised mesh__D020446 1999-11-03
% 218.56/218.77  |- skos__hiddenLabel mesh__D020446 Clubs, Health
% 218.56/218.77  |- skos__hiddenLabel mesh__D020446 Fitness Center
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D020446 2005
% 218.56/218.77  |- rdf__type mesh__D020446sskos__Concept
% 218.56/218.77  |- skos__hiddenLabel mesh__D020446 Centers, Fitness
% 218.56/218.77  |- skos__hiddenLabel mesh__D020446 Center, Wellness
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D020446 2003
% 218.56/218.77  |- mesh__dateEstablished mesh__D020446 1999-01-01
% 218.56/218.77  |- skos__scopeNote mesh__D020446
% 218.56/218.77       Facilities having programs intended to promote and maintain a state of physical well-being for optimal performance and health.%A%    
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D020446 2006
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D020446 2000
% 218.56/218.77  |- mesh__recordOriginator mesh__D020446 JLS
% 218.56/218.77  |- skos__hiddenLabel mesh__D020446 Wellness Center
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D020446 2004
% 218.56/218.77  |- mesh__recordAuthorizer mesh__D020446 sjn
% 218.56/218.77  |- mesh__publicMeSHNote mesh__D020446 99   
% 218.56/218.77  |- skos__hiddenLabel mesh__D020446 Centers, Wellness
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D020446 2001
% 218.56/218.77  |- skos__prefLabel mesh__D020446 Fitness Centers
% 218.56/218.77  |- mesh__recordMaintainer mesh__D020446 kle
% 218.56/218.77  |- skos__hiddenLabel mesh__D020446 Club, Health
% 218.56/218.77  |- skos__hiddenLabel mesh__D020446 Center, Fitness
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D020446 2002
% 218.56/218.77  |- skos__hiddenLabel mesh__D020446 Health Club
% 218.56/218.77  |- mesh__dateCreated mesh__D020446 1998-06-10
% 218.56/218.77  |- mesh__historyNote mesh__D020446 99   
% 218.56/218.77  |- skos__broader mesh__D020446smesh__D006268
% 218.56/218.77  |- skos__broader mesh__D006321Q000601smesh__D006321
% 218.56/218.77  |- mesh__preferredCombination mesh__D006321Q000601smesh__D006348
% 218.56/218.77  |- rdf__type mesh__D006321Q000601smesh__CompoundConcept
% 218.56/218.77  |- mesh__dateRevised mesh__D014409 2005-06-30
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D014409 2006
% 218.56/218.77  |- skos__hiddenLabel mesh__D014409 Tumor Necrosis Factor alpha
% 218.56/218.77  |- skos__altLabel mesh__D014409 Tumor Necrosis Factor
% 218.56/218.77  |- mesh__publicMeSHNote mesh__D014409
% 218.56/218.77       2005; see TUMOR NECROSIS FACTOR 1988-2005   
% 218.56/218.77  |- skos__altLabel mesh__D014409 Cachectin
% 218.56/218.77  |- skos__altLabel mesh__D014409 TNF-alpha
% 218.56/218.77  |- mesh__dateCreated mesh__D014409 1987-05-08
% 218.56/218.77  |- skos__broader mesh__D014409smesh__D006023
% 218.56/218.77  |- skos__hiddenLabel mesh__D014409 Cachectin Tumor Necrosis Factor
% 218.56/218.77  |- rdf__type mesh__D014409sskos__Concept
% 218.56/218.77  |- skos__historyNote mesh__D014409 Glycoproteins %28%1975-1987%29%
% 218.56/218.77  |- skos__historyNote mesh__D014409 Endotoxins %28%1975-1987%29%
% 218.56/218.77  |- mesh__recordMaintainer mesh__D014409 ssb
% 218.56/218.77  |- skos__broader mesh__D014409smesh__D015846
% 218.56/218.77  |- skos__broader mesh__D014409smesh__D001798
% 218.56/218.77  |- skos__scopeNote mesh__D014409
% 218.56/218.77       Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30%25% homologous to TNF-beta %28%LYMPHOTOXIN%29%, but they share TNF RECEPTORS.%A%    
% 218.56/218.77  |- skos__historyNote mesh__D014409 Necrosis %28%1975-1987%29%
% 218.56/218.77  |- mesh__recordAuthorizer mesh__D014409 sjn
% 218.56/218.77  |- skos__prefLabel mesh__D014409 Tumor Necrosis Factor-alpha
% 218.56/218.77  |- mesh__dateEstablished mesh__D014409 1988-01-01
% 218.56/218.77  |- mesh__historyNote mesh__D014409 2005%28%1988%29%   
% 218.56/218.77  |- skos__broader mesh__D014409smesh__D048069
% 218.56/218.77  |- mesh__recordOriginator mesh__D014409 SCD
% 218.56/218.77  |- skos__altLabel mesh__D014409 Cachectin-Tumor Necrosis Factor
% 218.56/218.77  |- skos__broader mesh__D044096smesh__D044007
% 218.56/218.77  |- mesh__recordAuthorizer mesh__D044096 sjn
% 218.56/218.77  |- mesh__publicMeSHNote mesh__D044096 2004   
% 218.56/218.77  |- mesh__dateEstablished mesh__D044096 2004-01-01
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D044096 2006
% 218.56/218.77  |- rdf__type mesh__D044096sskos__Concept
% 218.56/218.77  |- skos__scopeNote mesh__D044096
% 218.56/218.77       A genus of gram-negative, aerobic bacteria in the family MORAXELLACEAE, associated with processed MEAT; FISH PRODUCTS; and POULTRY PRODUCTS.%A%    
% 218.56/218.77  |- mesh__historyNote mesh__D044096 2004   
% 218.56/218.77  |- skos__annotation mesh__D044096
% 218.56/218.77       infection: coord IM with MORAXELLACEAE INFECTIONS %28%IM%29%   
% 218.56/218.77  |- mesh__recordOriginator mesh__D044096 ags
% 218.56/218.77  |- mesh__recordMaintainer mesh__D044096 SYSTEM
% 218.56/218.77  |- mesh__dateRevised mesh__D044096 2005-06-30
% 218.56/218.77  |- mesh__dateCreated mesh__D044096 2003-07-09
% 218.56/218.77  |- skos__prefLabel mesh__D044096 Psychrobacter
% 218.56/218.77  |- skos__altLabel mesh__D011111 Forestier-Certonciny Syndrome
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D011111 2004
% 218.56/218.77  |- skos__hiddenLabel mesh__D011111 Pseudopolyarthritides, Rhizomelic
% 218.56/218.77  |- mesh__recordMaintainer mesh__D011111 PLS
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D011111 1996
% 218.56/218.77  |- mesh__historyNote mesh__D011111 65   
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D011111 2000
% 218.56/218.77  |- skos__hiddenLabel mesh__D011111 Rhizomelic Pseudopolyarthritis
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D011111 2005
% 218.56/218.77  |- mesh__dateEstablished mesh__D011111 1965-01-01
% 218.56/218.77  |- skos__altLabel mesh__D011111 Rheumatism, Peri-Extra-Articular
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D011111 1997
% 218.56/218.77  |- skos__hiddenLabel mesh__D011111 Rheumatism, Peri Extra Articular
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D011111 2001
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D011111 2006
% 218.56/218.77  |- skos__prefLabel mesh__D011111 Polymyalgia Rheumatica
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D011111 1998
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D011111 1993
% 218.56/218.77  |- mesh__recordOriginator mesh__D011111 NLM
% 218.56/218.77  |- mesh__publicMeSHNote mesh__D011111 65   
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D011111 2002
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D011111 1994
% 218.56/218.77  |- mesh__dateRevised mesh__D011111 1994-09-23
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D011111 1999
% 218.56/218.77  |- mesh__recordAuthorizer mesh__D011111 PLS
% 218.56/218.77  |- skos__broader mesh__D011111smesh__D012216
% 218.56/218.77  |- skos__scopeNote mesh__D011111
% 218.56/218.77       A syndrome in the elderly characterized by proximal joint and muscle pain, high erythrocyte sedimentation rate, and a self-limiting course. Pain is usually accompanied by evidence of an inflammatory reaction. Women are affected twice as commonly as men and Caucasians more frequently than other groups. The condition is frequently associated with TEMPORAL ARTERITIS and some theories pose the possibility that the two diseases arise from a single etiology or even that they are the same entity.%A%    
% 218.56/218.77  |- rdf__type mesh__D011111sskos__Concept
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D011111 1995
% 218.56/218.77  |- skos__related mesh__D011111smesh__D013700
% 218.56/218.77  |- skos__hiddenLabel mesh__D011111 Peri-Extra-Articular Rheumatism
% 218.56/218.77  |- mesh__dateCreated mesh__D011111 1999-01-01
% 218.56/218.77  |- skos__hiddenLabel mesh__D011111 Rhizomelic Pseudopolyarthritides
% 218.56/218.77  |- skos__broader mesh__D011111smesh__D009135
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D011111 2003
% 218.56/218.77  |- skos__hiddenLabel mesh__D011111 Syndrome, Forestier-Certonciny
% 218.56/218.77  |- skos__hiddenLabel mesh__D011111 Forestier Certonciny Syndrome
% 218.56/218.77  |- mesh__recordOriginator mesh__D002385 NLM
% 218.56/218.77  |- skos__hiddenLabel mesh__D002385 Syndromes, Tonelessness
% 218.56/218.77  |- mesh__recordMaintainer mesh__D002385 nns
% 218.56/218.77  |- mesh__dateCreated mesh__D002385 1999-01-01
% 218.56/218.77  |- skos__broader mesh__D002385smesh__D009290
% 218.56/218.77  |- skos__altLabel mesh__D002385 Henneberg Syndrome
% 218.56/218.77  |- skos__hiddenLabel mesh__D002385 Syndrome, Henneberg
% 218.56/218.77  |- rdf__type mesh__D002385sskos__Concept
% 218.56/218.77  |- mesh__dateRevised mesh__D002385 2004-07-07
% 218.56/218.77  |- mesh__recordAuthorizer mesh__D002385 sjn
% 218.56/218.77  |- skos__related mesh__D002385smesh__D002375
% 218.56/218.77  |- skos__annotation mesh__D002385 do not confuse with CATALEPSY   
% 218.56/218.77  |- skos__prefLabel mesh__D002385 Cataplexy
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D002385 2006
% 218.56/218.77  |- skos__hiddenLabel mesh__D002385 Tonelessness Syndromes
% 218.56/218.77  |- skos__altLabel mesh__D002385 Tonelessness Syndrome
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D002385 2005
% 218.56/218.77  |- skos__scopeNote mesh__D002385
% 218.56/218.77       A condition characterized by transient weakness or paralysis of somatic musculature triggered by an emotional stimulus or physical exertion. Cataplexy is frequently associated with NARCOLEPSY. During a cataplectic attack, there is a marked reduction in muscle tone similar to the normal physiologic hypotonia that accompanies rapid eye movement sleep %28%SLEEP, REM%29%. %28%From Adams et al., Principles of Neurology, 6th ed, p396%29%%A%    
% 218.56/218.77  |- skos__hiddenLabel mesh__D002385 Syndrome, Tonelessness
% 218.56/218.77  |- skos__altLabel mesh__D010817 Doctor-Patient Relations
% 218.56/218.77  |- skos__hiddenLabel mesh__D010817 Doctor Patient Relation
% 218.56/218.77  |- mesh__dateCreated mesh__D010817 1999-01-01
% 218.56/218.77  |- rdf__type mesh__D010817sskos__Concept
% 218.56/218.77  |- skos__hiddenLabel mesh__D010817 Relation, Physician Patient
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D010817 2004
% 218.56/218.77  |- skos__scopeNote mesh__D010817
% 218.56/218.77       The interactions between physician and patient.     
% 218.56/218.77  |- skos__hiddenLabel mesh__D010817 Relations, Doctor Patient
% 218.56/218.77  |- mesh__recordOriginator mesh__D010817 NLM
% 218.56/218.77  |- skos__hiddenLabel mesh__D010817 Relations, Physician Patient
% 218.56/218.77  |- skos__hiddenLabel mesh__D010817 Relations, Doctor-Patient
% 218.56/218.77  |- skos__hiddenLabel mesh__D010817 Physician Patient Relation
% 218.56/218.77  |- skos__hiddenLabel mesh__D010817 Relation, Doctor-Patient
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D010817 2003
% 218.56/218.77  |- skos__hiddenLabel mesh__D010817 Relations, Physician-Patient
% 218.56/218.77  |- skos__annotation mesh__D010817 no qualif; DF: PHYSICIAN PATIENT RELAT   
% 218.56/218.77  |- mesh__dateRevised mesh__D010817 2002-10-31
% 218.56/218.77  |- mesh__recordMaintainer mesh__D010817 jls
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D010817 2001
% 218.56/218.77  |- skos__hiddenLabel mesh__D010817 Relation, Doctor Patient
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D010817 2006
% 218.56/218.77  |- skos__prefLabel mesh__D010817 Physician-Patient Relations
% 218.56/218.77  |- skos__hiddenLabel mesh__D010817 Relation, Physician-Patient
% 218.56/218.77  |- skos__hiddenLabel mesh__D010817 Physician Patient Relationships
% 218.56/218.77  |- skos__hiddenLabel mesh__D010817 Physician-Patient Relation
% 218.56/218.77  |- skos__related mesh__D010817smesh__D014342
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D010817 2005
% 218.56/218.77  |- skos__hiddenLabel mesh__D010817 Doctor-Patient Relation
% 218.56/218.77  |- skos__broader mesh__D010817smesh__D011369
% 218.56/218.77  |- skos__hiddenLabel mesh__D010817 Relationship, Physician Patient
% 218.56/218.77  |- skos__altLabel mesh__D010817 Physician Patient Relationship
% 218.56/218.77  |- skos__hiddenLabel mesh__D010817 Relationships, Physician Patient
% 218.56/218.77  |- skos__altLabel mesh__D010817 Doctor Patient Relations
% 218.56/218.77  |- skos__altLabel mesh__D010817 Physician Patient Relations
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D010817 2002
% 218.56/218.77  |- mesh__recordAuthorizer mesh__D010817 jls
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D010817 2003A
% 218.56/218.77  |- mesh__dateCreated mesh__D029522 2001-07-25
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D029522 2004
% 218.56/218.77  |- skos__prefLabel mesh__D029522 Hydrophyllaceae
% 218.56/218.77  |- mesh__dateEstablished mesh__D029522 2002-01-01
% 218.56/218.77  |- mesh__historyNote mesh__D029522 2002   
% 218.56/218.77  |- mesh__publicMeSHNote mesh__D029522 2002   
% 218.56/218.77  |- skos__scopeNote mesh__D029522
% 218.56/218.77       The waterleaf plant family of the order Solanales, subclass Asteridae, class Magnoliopsida. They have alternate leaves, regular flowers with five-lobed corollas %28%united petals%29%, and a one- or two-celled ovary.%A%    
% 218.56/218.77  |- skos__broader mesh__D029522smesh__D019684
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D029522 2002
% 218.56/218.77  |- skos__annotation mesh__D029522
% 218.56/218.77       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D029522 2005
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D029522 2003
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D029522 2006
% 218.56/218.77  |- rdf__type mesh__D029522sskos__Concept
% 218.56/218.77  |- mesh__dateCreated mesh__D010019 1999-01-01
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D010019 2005
% 218.56/218.77  |- mesh__recordMaintainer mesh__D010019 PLS
% 218.56/218.77  |- mesh__dateRevised mesh__D010019 2002-07-03
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D010019 2006
% 218.56/218.77  |- mesh__recordAuthorizer mesh__D010019 sjn
% 218.56/218.77  |- mesh__recordOriginator mesh__D010019 NLM
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D010019 2003
% 218.56/218.77  |- rdf__type mesh__D010019sskos__Concept
% 218.56/218.77  |- skos__broader mesh__D010019smesh__D001850
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D010019 2004
% 218.56/218.77  |- skos__prefLabel mesh__D010019 Osteomyelitis
% 218.56/218.77  |- skos__hiddenLabel mesh__D010019 Osteomyelitides
% 218.56/218.77  |- skos__scopeNote mesh__D007070
% 218.56/218.77       Represents 15-20%25% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals.  Secretory IgA %28%IMMUNOGLOBULIN A, SECRETORY%29% is the main immunoglobulin in secretions.%A%    
% 218.56/218.77  |- mesh__historyNote mesh__D007070 2002%28%1971%29%   
% 218.56/218.77  |- mesh__recordAuthorizer mesh__D007070 sjn
% 218.56/218.77  |- skos__broader mesh__D007070smesh__D007132
% 218.56/218.77  |- mesh__dateRevised mesh__D007070 2005-06-30
% 218.56/218.77  |- mesh__dateEstablished mesh__D007070 1973-01-01
% 218.56/218.77  |- skos__altLabel mesh__D007070 IgA
% 218.56/218.77  |- mesh__dateCreated mesh__D007070 1999-01-01
% 218.56/218.77  |- mesh__recordMaintainer mesh__D007070 ssb
% 218.56/218.77  |- skos__annotation mesh__D007070
% 218.56/218.77       gammopathy: coordinate IMMUNOGLOBULIN A %28%IM%29% with PARAPROTEINEMIAS %28%IM%29% but consider also HYPERGAMMAGLOBULINEMIA %28%IM%29%, follow text; salivary immunoglobulin A: index IGA, SECRETORY + SALIVA/ immunol; immunoglobulin A in tears: index IGA, SECRETORY + TEARS/ immunol%A%  
% 218.56/218.77  |- mesh__publicMeSHNote mesh__D007070 2002; see IgA 1973-2001   
% 218.56/218.77  |- mesh__recordOriginator mesh__D007070 NLM
% 218.56/218.77  |- skos__historyNote mesh__D007070 Immunoglobulins %28%1970%29%
% 218.56/218.77  |- skos__prefLabel mesh__D007070 Immunoglobulin A
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D007070 2006
% 218.56/218.77  |- skos__related mesh__D007070smesh__D007144
% 218.56/218.77  |- rdf__type mesh__D007070sskos__Concept
% 218.56/218.77  |- mesh__recordMaintainer mesh__D015502 lkt
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D015502 2005
% 218.56/218.77  |- skos__historyNote mesh__D015502
% 218.56/218.77       Tomography, Emission Computed %28%1980-1989%29%
% 218.56/218.77  |- skos__historyNote mesh__D015502
% 218.56/218.77       Spectrophotometry, Atomic Absorption %28%1974-1982%29%
% 218.56/218.77  |- skos__hiddenLabel mesh__D015502 Absorptiometry, Single-Photon
% 218.56/218.77  |- skos__scopeNote mesh__D015502
% 218.56/218.77       A noninvasive method for quantitating bone mineral content. It is used especially in the diagnosis of osteoporosis and also in measuring bone mineralization in infants.%A%    
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D015502 2006
% 218.56/218.77  |- skos__prefLabel mesh__D015502 Absorptiometry, Photon
% 218.56/218.77  |- skos__broader mesh__D015502smesh__D003720
% 218.56/218.77  |- mesh__onlineNote mesh__D015502
% 218.56/218.77       use RADIONUCLIDE IMAGING to search ABSORPTIOMETRY, PHOTON 1985-89%A%  
% 218.56/218.77  |- skos__hiddenLabel mesh__D015502 Single Photon Absorptiometry
% 218.56/218.77  |- mesh__recordAuthorizer mesh__D015502 sjn
% 218.56/218.77  |- skos__hiddenLabel mesh__D015502 Absorptiometries, Dual-Photon
% 218.56/218.77  |- mesh__dateEstablished mesh__D015502 1990-01-01
% 218.56/218.77  |- mesh__recordOriginator mesh__D015502 AGS
% 218.56/218.77  |- skos__broader mesh__D015502smesh__D011877
% 218.56/218.77  |- skos__historyNote mesh__D015502 Absorption %28%1972-1979%29%
% 218.56/218.77  |- skos__hiddenLabel mesh__D015502 Photon Absorptiometries
% 218.56/218.77  |- skos__hiddenLabel mesh__D015502 Photon Absorptiometry
% 218.56/218.77  |- skos__hiddenLabel mesh__D015502 Dual Photon Absorptiometry
% 218.56/218.77  |- mesh__publicMeSHNote mesh__D015502
% 218.56/218.77       90; was see RADIONUCLIDE IMAGING 1985-89   
% 218.56/218.77  |- skos__hiddenLabel mesh__D015502 Absorptiometry, Dual-Photon
% 218.56/218.77  |- mesh__historyNote mesh__D015502
% 218.56/218.77       90; was see RADIONUCLIDE IMAGING 1985-89   
% 218.56/218.77  |- skos__annotation mesh__D015502
% 218.56/218.77       NIM; measures bone mineral content; do not use /util except by MeSH definition%A%  
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D015502 2003
% 218.56/218.77  |- rdf__type mesh__D015502sskos__Concept
% 218.56/218.77  |- skos__hiddenLabel mesh__D015502 Absorptiometries, Single-Photon
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D015502 2004
% 218.56/218.77  |- skos__hiddenLabel mesh__D015502 Absorptiometries, Photon
% 218.56/218.77  |- skos__historyNote mesh__D015502 Radionuclide Imaging %28%1977-1989%29%
% 218.56/218.77  |- skos__hiddenLabel mesh__D015502 Dual-Photon Absorptiometries
% 218.56/218.77  |- mesh__dateCreated mesh__D015502 1989-10-04
% 218.56/218.77  |- skos__hiddenLabel mesh__D015502 Single-Photon Absorptiometries
% 218.56/218.77  |- skos__historyNote mesh__D015502 Densitometry %28%1966-1989%29%
% 218.56/218.77  |- mesh__dateRevised mesh__D015502 2002-07-02
% 218.56/218.77  |- mesh__recordAuthorizer mesh__D006776 sjn
% 218.56/218.77  |- mesh__historyNote mesh__D006776
% 218.56/218.77       91%28%75%29%; was see under HOSPITALS, SPECIAL 1975-90   
% 218.56/218.77  |- skos__prefLabel mesh__D006776 Hospitals, Pediatric
% 218.56/218.77  |- mesh__recordMaintainer mesh__D006776 kle
% 218.56/218.77  |- skos__altLabel mesh__D006776 Pediatric Hospitals
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D006776 2000
% 218.56/218.77  |- mesh__dateCreated mesh__D006776 1999-01-01
% 218.56/218.77  |- skos__hiddenLabel mesh__D006776 Pediatric Hospital
% 218.56/218.77  |- mesh__recordOriginator mesh__D006776 NLM
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D006776 2001
% 218.56/218.77  |- mesh__publicMeSHNote mesh__D006776
% 218.56/218.77       91; was see under HOSPITALS, SPECIAL 1975-90   
% 218.56/218.77  |- rdf__type mesh__D006776sskos__Concept
% 218.56/218.77  |- skos__hiddenLabel mesh__D006776 Hospital, Pediatric
% 218.56/218.77  |- skos__broader mesh__D006776smesh__D006782
% 218.56/218.77  |- skos__annotation mesh__D006776
% 218.56/218.77       coord IM with hosp ownership term %28%e.g., HOSPITALS, COUNTY; HOSPITALS, PROPRIETARY; etc.%29% %28%IM or NIM%29% if pertinent; check also tag CHILD or specific; specify geog%A%  
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D006776 2005
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D006776 2002
% 218.56/218.77  |- skos__scopeNote mesh__D006776
% 218.56/218.77       Special hospitals which provide care for ill children.     
% 218.56/218.77  |- mesh__dateRevised mesh__D006776 1999-11-03
% 218.56/218.77  |- mesh__dateEstablished mesh__D006776 1991-01-01
% 218.56/218.77  |- mesh__onlineNote mesh__D006776 search HOSPITALS, SPECIAL 1968-74   
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D006776 2006
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D006776 2003
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D006776 2004
% 218.56/218.77  |- skos__historyNote mesh__D020447 Sleep Disorders %28%1979-1999%29%
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D020447 2006
% 218.56/218.77  |- mesh__dateEstablished mesh__D020447 2000-01-01
% 218.56/218.77  |- skos__annotation mesh__D020447
% 218.56/218.77       do not confuse x-ref BENIGN NEONATAL SLEEP MYOCLONUS with MYOCLONUS, NOCTURNAL and MYOCLONUS, SLEEP see MYOCLONUS%A%  
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D020447 2004
% 218.56/218.77  |- skos__historyNote mesh__D020447 Somnambulism %28%1979-1980%29%
% 218.56/218.77  |- mesh__recordMaintainer mesh__D020447 sjn
% 218.56/218.77  |- skos__hiddenLabel mesh__D020447 Sleep Sensory Paroxysms
% 218.56/218.77  |- skos__altLabel mesh__D020447 Myoclonus, Benign Neonatal Sleep
% 218.56/218.77  |- skos__hiddenLabel mesh__D020447 Drunkennesses, Sleep
% 218.56/218.77  |- skos__hiddenLabel mesh__D020447 Sensory Paroxysm, Sleep
% 218.56/218.77  |- mesh__publicMeSHNote mesh__D020447 2000   
% 218.56/218.77  |- skos__hiddenLabel mesh__D020447 Sleep Drunkennesses
% 218.56/218.77  |- skos__prefLabel mesh__D020447 Parasomnias
% 218.56/218.77  |- skos__hiddenLabel mesh__D020447 Parasomnia
% 218.56/218.77  |- mesh__dateRevised mesh__D020447 2003-07-22
% 218.56/218.77  |- mesh__historyNote mesh__D020447 2000   
% 218.56/218.77  |- skos__hiddenLabel mesh__D020447 Paroxysms, Sleep Sensory
% 218.56/218.77  |- skos__scopeNote mesh__D020447
% 218.56/218.77       Movements or behaviors associated with sleep, sleep stages, or partial arousals from sleep that may impair sleep maintenance. Parasomnias are generally divided into four groups: arousal disorders, sleep-wake transition disorders, parasomnias of REM sleep, and nonspecific parasomnias. %28%From Thorpy, Sleep Disorders Medicine, 1994, p191%29%%A%    
% 218.56/218.77  |- skos__altLabel mesh__D020447 Benign Neonatal Sleep Myoclonus
% 218.56/218.77  |- mesh__recordOriginator mesh__D020447 KEV
% 218.56/218.77  |- mesh__dateCreated mesh__D020447 1999-11-04
% 218.56/218.77  |- skos__hiddenLabel mesh__D020447 Drunkenness, Sleep
% 218.56/218.77  |- skos__broader mesh__D020447smesh__D012893
% 218.56/218.77  |- skos__hiddenLabel mesh__D020447 Paroxysm, Sleep Sensory
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D020447 2005
% 218.56/218.77  |- skos__hiddenLabel mesh__D020447
% 218.56/218.77       Sleep Related Abnormal Swallowing Syndrome
% 218.56/218.77  |- mesh__recordAuthorizer mesh__D020447 sjn
% 218.56/218.77  |- rdf__type mesh__D020447sskos__Concept
% 218.56/218.77  |- skos__hiddenLabel mesh__D020447 Sleep Sensory Paroxysm
% 218.56/218.77  |- skos__historyNote mesh__D011910 Rats, Mutant Strains %28%1982%29%
% 218.56/218.77  |- mesh__dateRevised mesh__D011910 2005-06-30
% 218.56/218.77  |- skos__annotation mesh__D011910
% 218.56/218.77       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag RATS%A%  
% 218.56/218.77  |- mesh__recordOriginator mesh__D011910 EC
% 218.56/218.77  |- skos__hiddenLabel mesh__D011910 Brattleboro Rats
% 218.56/218.77  |- mesh__recordMaintainer mesh__D011910 ags
% 218.56/218.77  |- skos__historyNote mesh__D011910 Rats %28%1966-1982%29%
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D011910 2006
% 218.56/218.77  |- skos__broader mesh__D011910smesh__D011922
% 218.56/218.77  |- mesh__historyNote mesh__D011910
% 218.56/218.77       91%28%83%29%; was see under RATS, MUTANT STRAINS 1983-90   
% 218.56/218.77  |- skos__prefLabel mesh__D011910 Rats, Brattleboro
% 218.56/218.77  |- skos__scopeNote mesh__D011910
% 218.56/218.77       A mutant strain of Rattus norvegicus used in research on renal function and hypertension and as a disease model for diabetes insipidus.%A%    
% 218.56/218.77  |- mesh__dateEstablished mesh__D011910 1991-01-01
% 218.56/218.77  |- mesh__recordAuthorizer mesh__D011910 sjn
% 218.56/218.77  |- mesh__publicMeSHNote mesh__D011910
% 218.56/218.77       91; was see under RATS, MUTANT STRAINS 1983-90   
% 218.56/218.77  |- mesh__dateCreated mesh__D011910 1982-04-28
% 218.56/218.77  |- skos__historyNote mesh__D011910 Rats, Inbred Strains %28%1972-1982%29%
% 218.56/218.77  |- rdf__type mesh__D011910sskos__Concept
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D011112 2006
% 218.56/218.77  |- mesh__historyNote mesh__D011112
% 218.56/218.77       91%28%78%29%; was see under POLYMYXINS 1978-90; was AEROSPORIN see under POLYMYXIN 1971-77, see POLYMYXIN 1963-70; AEROSPORIN was see POLYMYXIN B 1978-93%A%  
% 218.56/218.77  |- skos__hiddenLabel mesh__D011112 Sulfate, Polymyxin B
% 218.56/218.77  |- mesh__dateRevised mesh__D011112 2004-07-07
% 218.56/218.77  |- mesh__recordMaintainer mesh__D011112 ssb
% 218.56/218.77  |- rdf__type mesh__D011112sskos__Concept
% 218.56/218.77  |- mesh__dateCreated mesh__D011112 1999-01-01
% 218.56/218.77  |- mesh__dateEstablished mesh__D011112 1991-01-01
% 218.56/218.77  |- skos__prefLabel mesh__D011112 Polymyxin B
% 218.56/218.77  |- mesh__recordAuthorizer mesh__D011112 sjn
% 218.56/218.77  |- mesh__onlineNote mesh__D011112
% 218.56/218.77       use POLYMYXIN B to search AEROSPORIN 1975-93; use POLYMYXINS 1966-74%A%  
% 218.56/218.77  |- skos__broader mesh__D011112smesh__D011113
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D011112 2005
% 218.56/218.77  |- skos__scopeNote mesh__D011112
% 218.56/218.77       A mixture of polymyxins B1 and B2, obtained from Bacillus polymyxa strains. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes. Polymyxin B is used for infections with gram-negative organisms, but may be neurotoxic and nephrotoxic.%A%    
% 218.56/218.77  |- mesh__recordOriginator mesh__D011112 NLM
% 218.56/218.77  |- mesh__publicMeSHNote mesh__D011112
% 218.56/218.77       91; was see under POLYMYXINS 1978-90; was AEROSPORIN see under POLYMYXIN 1971-77, see POLYMYXIN 1963-70; AEROSPORIN was see POLYMYXIN B 1978-93%A%  
% 218.56/218.77  |- mesh__dateCreated mesh__D002386 1999-01-01
% 218.56/218.77  |- skos__hiddenLabel mesh__D002386 Membranous Cataract
% 218.56/218.77  |- rdf__type mesh__D002386sskos__Concept
% 218.56/218.77  |- mesh__recordOriginator mesh__D002386 NLM
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D002386 1999
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D002386 2002
% 218.56/218.77  |- mesh__recordMaintainer mesh__D002386 TGC
% 218.56/218.77  |- skos__hiddenLabel mesh__D002386 Membranous Cataracts
% 218.56/218.77  |- skos__hiddenLabel mesh__D002386 Opacity, Lens
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D002386 1998
% 218.56/218.77  |- skos__hiddenLabel mesh__D002386 Lens Opacity
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D002386 2004
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D002386 2001
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D002386 2006
% 218.56/218.77  |- skos__scopeNote mesh__D002386
% 218.56/218.77       Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology %28%size, shape, location%29% or etiology %28%cause and time of occurrence%29%. %28%Dorland, 27th ed%29%%A%    
% 218.56/218.77  |- skos__hiddenLabel mesh__D002386 Opacities, Lens
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D002386 2003
% 218.56/218.77  |- skos__hiddenLabel mesh__D002386 Pseudoaphakias
% 218.56/218.77  |- skos__annotation mesh__D002386
% 218.56/218.77       lens opacity; do not confuse X ref PSEUDOAPHAKIA %28%a synonym for membranous cataract%29% with PSEUDOPHAKIA, the presence of an intraocular lens after cataract extraction%A%  
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D002386 2005
% 218.56/218.77  |- skos__hiddenLabel mesh__D002386 Cataracts
% 218.56/218.77  |- mesh__activeMeSHYear mesh__D002386 2000
% 218.56/218.77  |- skos__prefLabel mesh__D002386 Cataract
% 218.56/218.77  |- skos__broader mesh__D002386smesh__D007905
% 218.56/218.77  |- mesh__dateRevised mesh__D002386 1997-06-20
% 218.56/218.77  |- skos__hiddenLabel mesh__D002386 Cataracts, Membranous
% 218.56/218.78  |- mesh__recordAuthorizer mesh__D002386 SJN
% 218.56/218.78  |- skos__altLabel mesh__D002386 Pseudoaphakia
% 218.56/218.78  |- skos__hiddenLabel mesh__D010818 Practice Pattern, Professional
% 218.56/218.78  |- skos__altLabel mesh__D010818 Practice Variation, Clinical
% 218.56/218.78  |- skos__hiddenLabel mesh__D010818 Practice Patterns, Physician%27%s
% 218.56/218.78  |- skos__altLabel mesh__D010818 Clinical Practice Variation
% 218.56/218.78  |- skos__hiddenLabel mesh__D010818 Practice Pattern, Physician%27%s
% 218.56/218.78  |- skos__historyNote mesh__D010818 Health Services Misuse %28%1977-1986%29%
% 218.56/218.78  |- skos__hiddenLabel mesh__D010818 Patterns, Professional Practice
% 218.56/218.78  |- skos__altLabel mesh__D010818 Variations, Clinical Practice
% 218.56/218.78  |- mesh__historyNote mesh__D010818 87   
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D010818 2003
% 218.56/218.78  |- mesh__recordMaintainer mesh__D010818 jls
% 218.56/218.78  |- mesh__dateRevised mesh__D010818 1999-11-03
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D010818 2002
% 218.56/218.78  |- skos__hiddenLabel mesh__D010818 Professional Practice Patterns
% 218.56/218.78  |- mesh__dateEstablished mesh__D010818 1987-01-01
% 218.56/218.78  |- skos__hiddenLabel mesh__D010818 Physicians Practice Patterns
% 218.56/218.78  |- skos__broader mesh__D010818smesh__D003695
% 218.56/218.78  |- skos__altLabel mesh__D010818 Clinical Practice Patterns
% 218.56/218.78  |- skos__hiddenLabel mesh__D010818 Practice Pattern Variation
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D010818 2001
% 218.56/218.78  |- mesh__dateCreated mesh__D010818 1986-05-30
% 218.56/218.78  |- skos__altLabel mesh__D010818 Practice Variations, Clinical
% 218.56/218.78  |- skos__altLabel mesh__D010818 Pattern, Clinical Practice
% 218.56/218.78  |- skos__hiddenLabel mesh__D010818 Physician%27%s Practice Pattern
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D010818 2006
% 218.56/218.78  |- skos__annotation mesh__D010818
% 218.56/218.78       diag %26% treatment as influenced by cost of service requested %26% provided: do not confuse with PROFESSIONAL PRACTICE where emphasis is on individual physicians %26% their practices; prescribing patterns goes here%A%  
% 218.56/218.78  |- skos__hiddenLabel mesh__D010818 Variation, Practice Pattern
% 218.56/218.78  |- skos__altLabel mesh__D010818 Practice Patterns, Clinical
% 218.56/218.78  |- skos__hiddenLabel mesh__D010818 Patterns, Physician%27%s Practice
% 218.56/218.78  |- skos__historyNote mesh__D010818
% 218.56/218.78       Costs and Cost Analysis %28%1966-1986%29%
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D010818 2000
% 218.56/218.78  |- skos__broader mesh__D010818smesh__D010346
% 218.56/218.78  |- skos__prefLabel mesh__D010818 Physician%27%s Practice Patterns
% 218.56/218.78  |- mesh__recordAuthorizer mesh__D010818 sjn
% 218.56/218.78  |- rdf__type mesh__D010818sskos__Concept
% 218.56/218.78  |- skos__hiddenLabel mesh__D010818 Variations, Practice Pattern
% 218.56/218.78  |- skos__hiddenLabel mesh__D010818 Pattern, Physician%27%s Practice
% 218.56/218.78  |- skos__historyNote mesh__D010818 Professional Practice %28%1968-1986%29%
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D010818 2005
% 218.56/218.78  |- skos__altLabel mesh__D010818 Practice Pattern, Clinical
% 218.56/218.78  |- skos__hiddenLabel mesh__D010818 Physician Practice Patterns
% 218.56/218.78  |- skos__altLabel mesh__D010818 Patterns, Clinical Practice
% 218.56/218.78  |- skos__hiddenLabel mesh__D010818 Pattern, Professional Practice
% 218.56/218.78  |- skos__altLabel mesh__D010818 Variation, Clinical Practice
% 218.56/218.78  |- mesh__recordOriginator mesh__D010818 EC
% 218.56/218.78  |- skos__hiddenLabel mesh__D010818 Professional Practice Pattern
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D010818 2004
% 218.56/218.78  |- mesh__publicMeSHNote mesh__D010818 87   
% 218.56/218.78  |- skos__scopeNote mesh__D010818
% 218.56/218.78       Patterns of practice related to diagnosis and treatment as especially influenced by cost of the service requested and provided.%A%    
% 218.56/218.78  |- skos__prefLabel mesh__D029523 Illicium
% 218.56/218.78  |- mesh__dateEstablished mesh__D029523 2002-01-01
% 218.56/218.78  |- mesh__dateRevised mesh__D029523 2002-07-03
% 218.56/218.78  |- mesh__recordMaintainer mesh__D029523 sjn
% 218.56/218.78  |- mesh__publicMeSHNote mesh__D029523 2002   
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D029523 2005
% 218.56/218.78  |- mesh__recordAuthorizer mesh__D029523 sjn
% 218.56/218.78  |- mesh__dateCreated mesh__D029523 2001-07-25
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D029523 2003
% 218.56/218.78  |- skos__scopeNote mesh__D029523
% 218.56/218.78       A plant genus of the family Illiciaceae, order Illiciales, subclass Magnoliidae, class Magnoliopsida.  They have evergreen, aromatic leaves and bisexual flowers. The female portion of the flower consists of 7 to 15 carpels.%A%    
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D029523 2006
% 218.56/218.78  |- rdf__type mesh__D029523sskos__Concept
% 218.56/218.78  |- mesh__recordOriginator mesh__D029523 ssb
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D029523 2004
% 218.56/218.78  |- skos__broader mesh__D029523smesh__D019684
% 218.56/218.78  |- skos__altLabel mesh__D029523 Anise, Star
% 218.56/218.78  |- skos__annotation mesh__D029523
% 218.56/218.78       distinguish X ref STAR ANISE from Anise %28%PIMPINELLA%29%;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.56/218.78  |- mesh__historyNote mesh__D029523 2002   
% 218.56/218.78  |- skos__altLabel mesh__D029523 Star Anise
% 218.56/218.78  |- skos__prefLabel mesh__D007071 Immunoglobulin A, Secretory
% 218.56/218.78  |- skos__altLabel mesh__D007071 Secretory Immunoglobulin A
% 218.56/218.78  |- skos__annotation mesh__D007071
% 218.56/218.78       salivary immunoglobulin A: index IGA, SECRETORY + SALIVA/ immunol; immunoglobulin A in tears: index IGA, SECRETORY + TEARS/ immunol; /defic = IMMUNOGLOBULIN A, SECRETORY + IGA DEFICIENCY%A%  
% 218.56/218.78  |- skos__altLabel mesh__D007071 IgA, Secretory
% 218.56/218.78  |- skos__historyNote mesh__D007071
% 218.56/218.78       Immunoglobulin Fragments %28%1973-1975%29%
% 218.56/218.78  |- mesh__recordAuthorizer mesh__D007071 sjn
% 218.56/218.78  |- skos__hiddenLabel mesh__D007071 Exocrine IgA
% 218.56/218.78  |- skos__altLabel mesh__D007071 SIgA
% 218.56/218.78  |- mesh__recordMaintainer mesh__D007071 sjn
% 218.56/218.78  |- skos__historyNote mesh__D007071 IgA %28%1973-1975%29%
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D007071 2006
% 218.56/218.78  |- mesh__dateRevised mesh__D007071 2005-07-01
% 218.56/218.78  |- mesh__recordOriginator mesh__D007071 RLS
% 218.56/218.78  |- mesh__dateCreated mesh__D007071 1975-07-23
% 218.56/218.78  |- mesh__publicMeSHNote mesh__D007071
% 218.56/218.78       2002; see IgA, Secretory 1984-2001, see IGA 1976-1983   
% 218.56/218.78  |- mesh__dateEstablished mesh__D007071 1984-01-01
% 218.56/218.78  |- rdf__type mesh__D007071sskos__Concept
% 218.56/218.78  |- skos__altLabel mesh__D007071 IgA, Exocrine
% 218.56/218.78  |- skos__hiddenLabel mesh__D007071 IgA, Colostral
% 218.56/218.78  |- skos__scopeNote mesh__D007071
% 218.56/218.78       The principle immunoglobulin in exocrine secretions such as milk, respiratory and intestinal mucin, saliva and tears. The complete molecule %28%around 400 kD%29% is composed of two four-chain units of IMMUNOGLOBULIN A, one SECRETORY COMPONENT and one J chain %28%IMMUNOGLOBULIN J-CHAINS%29%.%A%    
% 218.56/218.78  |- skos__altLabel mesh__D007071 Secretory IgA
% 218.56/218.78  |- skos__broader mesh__D007071smesh__D007070
% 218.56/218.78  |- skos__historyNote mesh__D007071 Colostrum %28%1973-1975%29%
% 218.56/218.78  |- mesh__historyNote mesh__D007071 2002%28%1976%29%   
% 218.56/218.78  |- mesh__historyNote mesh__D048488 2005   
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D048488 2005
% 218.56/218.78  |- rdf__type mesh__D048488sskos__Concept
% 218.56/218.78  |- mesh__publicMeSHNote mesh__D048488 2005   
% 218.56/218.78  |- mesh__dateEstablished mesh__D048488 2005-01-01
% 218.56/218.78  |- skos__historyNote mesh__D048488 Paramecium %28%1965-2004%29%
% 218.56/218.78  |- mesh__recordOriginator mesh__D048488 ags
% 218.56/218.78  |- skos__broader mesh__D048488smesh__D010247
% 218.56/218.78  |- skos__scopeNote mesh__D048488
% 218.56/218.78       The most widely distributed species of PARAMECIUM. It is elongated and possesses a bluntly pointed posterior.%A%    
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D048488 2006
% 218.56/218.78  |- mesh__recordMaintainer mesh__D048488 ags
% 218.56/218.78  |- mesh__recordAuthorizer mesh__D048488 sjn
% 218.56/218.78  |- mesh__dateCreated mesh__D048488 2004-07-07
% 218.56/218.78  |- skos__prefLabel mesh__D048488 Paramecium caudatum
% 218.56/218.78  |- skos__historyNote mesh__D015503 Surgical Equipment %28%1966-1989%29%
% 218.56/218.78  |- skos__annotation mesh__D015503
% 218.56/218.78       do not use /util except by MeSH definition; surgical sponge accidentally left in the surg field, called gossypiboma from the classical word for cotton, goes here%A%  
% 218.56/218.78  |- mesh__recordMaintainer mesh__D015503 PXP
% 218.56/218.78  |- mesh__publicMeSHNote mesh__D015503 90   
% 218.56/218.78  |- skos__broader mesh__D015503smesh__D013523
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D015503 2005
% 218.56/218.78  |- skos__scopeNote mesh__D015503
% 218.56/218.78       Gauze material used to absorb body fluids during surgery. Referred to as gossypiboma if accidentally retained in the body following surgery.%A%    
% 218.56/218.78  |- skos__altLabel mesh__D015503 Surgical Sponge
% 218.56/218.78  |- mesh__dateEstablished mesh__D015503 1990-01-01
% 218.56/218.78  |- skos__historyNote mesh__D015503 Foreign Bodies %28%1966-1989%29%
% 218.56/218.78  |- mesh__dateRevised mesh__D015503 1997-06-20
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D015503 2006
% 218.56/218.78  |- mesh__recordAuthorizer mesh__D015503 SJN
% 218.56/218.78  |- mesh__recordOriginator mesh__D015503 AGS
% 218.56/218.78  |- mesh__dateCreated mesh__D015503 1989-04-07
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D015503 2000
% 218.56/218.78  |- skos__historyNote mesh__D015503 Surgical Instruments %28%1974-1989%29%
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D015503 1998
% 218.56/218.78  |- mesh__historyNote mesh__D015503 90   
% 218.56/218.78  |- skos__altLabel mesh__D015503 Sponges, Surgical
% 218.56/218.78  |- skos__altLabel mesh__D015503 Sponge, Surgical
% 218.56/218.78  |- rdf__type mesh__D015503sskos__Concept
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D015503 2001
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D015503 2003
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D015503 1999
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D015503 2002
% 218.56/218.78  |- skos__prefLabel mesh__D015503 Surgical Sponges
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D015503 2004
% 218.56/218.78  |- mesh__dateEstablished mesh__D006777 1991-01-01
% 218.56/218.78  |- mesh__recordMaintainer mesh__D006777 kle
% 218.56/218.78  |- mesh__publicMeSHNote mesh__D006777
% 218.56/218.78       91; was see under HOSPITALS 1975-90   
% 218.56/218.78  |- skos__annotation mesh__D006777
% 218.56/218.78       privately organized %26% controlled hosp operated for profit; coord NIM with special hosp %28%e.g., HOSPITALS, CHRONIC DISEASE%29% or med specialty %28%IM or NIM%29% if pertinent; specify geog%A%  
% 218.56/218.78  |- skos__altLabel mesh__D006777 Private, for-Profit Hospitals
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D006777 2003
% 218.56/218.78  |- skos__altLabel mesh__D006777 Proprietary Hospitals
% 218.56/218.78  |- skos__broader mesh__D006777smesh__D016304
% 218.56/218.78  |- skos__hiddenLabel mesh__D006777 Proprietary Hospital
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D006777 2005
% 218.56/218.78  |- mesh__dateRevised mesh__D006777 1999-11-03
% 218.56/218.78  |- skos__altLabel mesh__D006777 Hospitals, Private, Investor-Owned
% 218.56/218.78  |- skos__prefLabel mesh__D006777 Hospitals, Proprietary
% 218.56/218.78  |- skos__broader mesh__D006777smesh__D006269
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D006777 2002
% 218.56/218.78  |- mesh__historyNote mesh__D006777
% 218.56/218.78       91%28%75%29%; was see under HOSPITALS 1975-90   
% 218.56/218.78  |- mesh__recordAuthorizer mesh__D006777 sjn
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D006777 2001
% 218.56/218.78  |- skos__hiddenLabel mesh__D006777 Hospital, Proprietary
% 218.56/218.78  |- skos__scopeNote mesh__D006777
% 218.56/218.78       Hospitals owned and operated by a corporation or an individual that operate on a for-profit basis, also referred to as investor-owned hospitals.%A%    
% 218.56/218.78  |- skos__altLabel mesh__D006777 Hospitals, Private, for-Profit
% 218.56/218.78  |- mesh__dateCreated mesh__D006777 1974-11-11
% 218.56/218.78  |- mesh__recordOriginator mesh__D006777 NLM
% 218.56/218.78  |- rdf__type mesh__D006777sskos__Concept
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D006777 2000
% 218.56/218.78  |- skos__altLabel mesh__D006777 Private, Investor-Owned Hospitals
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D006777 2004
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D006777 2006
% 218.56/218.78  |- mesh__publicMeSHNote mesh__D020448 1999   
% 218.56/218.78  |- mesh__recordAuthorizer mesh__D020448 sjn
% 218.56/218.78  |- skos__broader mesh__D020448smesh__D019684
% 218.56/218.78  |- skos__scopeNote mesh__D020448
% 218.56/218.78       A plant order of the subclass Dilleniidae, class Magnoliopsida. It includes 18 families, approximately 175 genera, and 3,400 species. Its members are mostly tropical trees and shrubs.%A%    
% 218.56/218.78  |- mesh__recordMaintainer mesh__D020448 ssb
% 218.56/218.78  |- skos__prefLabel mesh__D020448 Theales
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D020448 2005
% 218.56/218.78  |- rdf__type mesh__D020448sskos__Concept
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D020448 2003
% 218.56/218.78  |- mesh__dateEstablished mesh__D020448 1999-01-01
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D020448 2006
% 218.56/218.78  |- mesh__recordOriginator mesh__D020448 JLS
% 218.56/218.78  |- skos__annotation mesh__D020448
% 218.56/218.78       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.56/218.78  |- mesh__dateRevised mesh__D020448 2002-07-03
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D020448 2004
% 218.56/218.78  |- mesh__historyNote mesh__D020448 1999   
% 218.56/218.78  |- mesh__dateCreated mesh__D020448 1998-06-11
% 218.56/218.78  |- skos__altLabel mesh__D031170 Burdock, Lesser
% 218.56/218.78  |- skos__annotation mesh__D031170
% 218.56/218.78       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.56/218.78  |- skos__related mesh__D031170smesh__D012250
% 218.56/218.78  |- mesh__recordAuthorizer mesh__D031170 NLM
% 218.56/218.78  |- skos__altLabel mesh__D031170 Burdock, Greater
% 218.56/218.78  |- rdf__type mesh__D031170sskos__Concept
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D031170 2004
% 218.56/218.78  |- mesh__recordOriginator mesh__D031170 ssb
% 218.56/218.78  |- mesh__publicMeSHNote mesh__D031170 2003   
% 218.56/218.78  |- skos__altLabel mesh__D031170 Gobou
% 218.56/218.78  |- mesh__dateEstablished mesh__D031170 2003-01-01
% 218.56/218.78  |- skos__broader mesh__D031170smesh__D019659
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D031170 2006
% 218.56/218.78  |- mesh__recordMaintainer mesh__D031170 SYSTEM
% 218.56/218.78  |- skos__scopeNote mesh__D031170
% 218.56/218.78       A plant genus of the family ASTERACEAE. Arctiin %28%LIGNANS%29% is in the seed.%A%    
% 218.56/218.78  |- mesh__historyNote mesh__D031170 2003   
% 218.56/218.78  |- skos__prefLabel mesh__D031170 Arctium
% 218.56/218.78  |- mesh__dateRevised mesh__D031170 2003-07-30
% 218.56/218.78  |- mesh__dateCreated mesh__D031170 2002-07-02
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D031170 2005
% 218.56/218.78  |- skos__altLabel mesh__D031170 Burdock Plant
% 218.56/218.78  |- skos__altLabel mesh__D031170 Gobo
% 218.56/218.78  |- mesh__historyNote mesh__D011911
% 218.56/218.78       91%28%82%29%; was see under RATS, MUTANT STRAINS 1982-90   
% 218.56/218.78  |- mesh__recordAuthorizer mesh__D011911 sjn
% 218.56/218.78  |- mesh__recordMaintainer mesh__D011911 ags
% 218.56/218.78  |- mesh__dateEstablished mesh__D011911 1991-01-01
% 218.56/218.78  |- mesh__publicMeSHNote mesh__D011911
% 218.56/218.78       91; was see under RATS, MUTANT STRAINS 1982-90   
% 218.56/218.78  |- skos__scopeNote mesh__D011911
% 218.56/218.78       Mutant strain of Rattus norvegicus which is used as a disease model of kernicterus.%A%    
% 218.56/218.78  |- skos__hiddenLabel mesh__D011911 Gunn Rats
% 218.56/218.78  |- skos__prefLabel mesh__D011911 Rats, Gunn
% 218.56/218.78  |- mesh__recordOriginator mesh__D011911 EC
% 218.56/218.78  |- mesh__dateRevised mesh__D011911 2005-06-30
% 218.56/218.78  |- skos__annotation mesh__D011911
% 218.56/218.78       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag RATS%A%  
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D011911 2006
% 218.56/218.78  |- mesh__dateCreated mesh__D011911 1981-05-15
% 218.56/218.78  |- skos__broader mesh__D011911smesh__D011922
% 218.56/218.78  |- skos__historyNote mesh__D011911 Rats %28%1977-1981%29%
% 218.56/218.78  |- rdf__type mesh__D011911sskos__Concept
% 218.56/218.78  |- mesh__dateRevised mesh__D011113 2004-07-07
% 218.56/218.78  |- skos__prefLabel mesh__D011113 Polymyxins
% 218.56/218.78  |- mesh__recordOriginator mesh__D011113 NLM
% 218.56/218.78  |- rdf__type mesh__D011113sskos__Concept
% 218.56/218.78  |- mesh__dateCreated mesh__D011113 1999-01-01
% 218.56/218.78  |- mesh__publicMeSHNote mesh__D011113
% 218.56/218.78       1994,1963-1977; see POLYMYXIN 1994-2003; see POLYMYXINS 1978-93; see POLYMYXIN 1963-77%A%  
% 218.56/218.78  |- mesh__historyNote mesh__D011113 1994,1963-1977   
% 218.56/218.78  |- skos__altLabel mesh__D011113 Polymyxin
% 218.56/218.78  |- mesh__recordMaintainer mesh__D011113 ssb
% 218.56/218.78  |- skos__scopeNote mesh__D011113
% 218.56/218.78       Basic polypeptide antibiotic group obtained from Bacillus polymyxa. They affect the cell membrane by detergent action and may cause neuromuscular and kidney damage. At least eleven different members of the polymyxin group have been identified, each designated by a letter.%A%    
% 218.56/218.78  |- skos__broader mesh__D011113smesh__D010456
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D011113 2005
% 218.56/218.78  |- mesh__recordAuthorizer mesh__D011113 sjn
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D011113 2006
% 218.56/218.78  |- skos__historyNote mesh__D035561 Transcription Factors %28%1989-2002%29%
% 218.56/218.78  |- mesh__historyNote mesh__D035561
% 218.56/218.78       2003; use TRANSCRIPTION FACTOR TFIIA %28%NM%29% 1989-2002   
% 218.56/218.78  |- mesh__dateEstablished mesh__D035561 2003-01-01
% 218.56/218.78  |- mesh__publicMeSHNote mesh__D035561
% 218.56/218.78       2003; TRANSCRIPTION FACTOR TFIIA was indexed under TRANSCRIPTION FACTORS 1989-2002%A%  
% 218.56/218.78  |- mesh__recordOriginator mesh__D035561 jmp
% 218.56/218.78  |- skos__scopeNote mesh__D035561
% 218.56/218.78       An RNA POLYMERASE II specific transcription factor. It may play a role in transcriptional activation of gene expression by interacting with the TATA-BOX BINDING PROTEIN component of TRANSCRIPTION FACTOR TFIID.%A%    
% 218.56/218.78  |- skos__broader mesh__D035561smesh__D019473
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D035561 2006A
% 218.56/218.78  |- skos__altLabel mesh__D035561 TFIIA
% 218.56/218.78  |- mesh__dateCreated mesh__D035561 2002-07-03
% 218.56/218.78  |- rdf__type mesh__D035561sskos__Concept
% 218.56/218.78  |- skos__altLabel mesh__D035561 RNA Polymerase II, Transcription Factor A
% 218.56/218.78  |- mesh__recordMaintainer mesh__D035561 ags
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D035561 2006
% 218.56/218.78  |- mesh__recordAuthorizer mesh__D035561 ags
% 218.56/218.78  |- mesh__dateRevised mesh__D035561 2005-07-28
% 218.56/218.78  |- skos__prefLabel mesh__D035561 Transcription Factor TFIIA
% 218.56/218.78  |- mesh__dateRevised mesh__D029524 2005-11-10
% 218.56/218.78  |- mesh__historyNote mesh__D029524 2002   
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D029524 2005
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D029524 2002
% 218.56/218.78  |- mesh__recordAuthorizer mesh__D029524 ags
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D029524 2006
% 218.56/218.78  |- skos__scopeNote mesh__D029524
% 218.56/218.78       A genus of the family ORTHOMYXOVIRUS causing HUMAN INFLUENZA and other diseases primarily in humans. In contrast to INFLUENZAVIRUS A, no distinct antigenic subtypes of hemagglutinin %28%HEMAGGLUTINS%29% and NEURAMINIDASE are recognized.%A%    
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D029524 2003
% 218.56/218.78  |- rdf__type mesh__D029524sskos__Concept
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D029524 2004
% 218.56/218.78  |- skos__annotation mesh__D029524
% 218.56/218.78       infection: coordinate IM with INFLUENZA, HUMAN %28%IM%29% in humans or ORTHOMYXOVIRIDAE INFECTIONS %28%IM%29% in animals; INFLUENZA B VIRUS is also available%A%  
% 218.56/218.78  |- skos__historyNote mesh__D029524 Orthomyxoviridae %28%1997-2001%29%
% 218.56/218.78  |- mesh__recordMaintainer mesh__D029524 ags
% 218.56/218.78  |- skos__broader mesh__D029524smesh__D009975
% 218.56/218.78  |- mesh__dateCreated mesh__D029524 2001-07-25
% 218.56/218.78  |- mesh__recordOriginator mesh__D029524 ags
% 218.56/218.78  |- skos__prefLabel mesh__D029524 Influenzavirus B
% 218.56/218.78  |- mesh__dateEstablished mesh__D029524 2002-01-01
% 218.56/218.78  |- mesh__publicMeSHNote mesh__D029524 2002   
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D029524 2006A
% 218.56/218.78  |- skos__annotation mesh__D002387
% 218.56/218.78       do not use /util except by MeSH definition   
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D002387 1998
% 218.56/218.78  |- skos__hiddenLabel mesh__D002387 Zonulolysis, Enzymatic
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D002387 2000
% 218.56/218.78  |- skos__hiddenLabel mesh__D002387 Extractions, Cataract
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D002387 2006
% 218.56/218.78  |- mesh__recordMaintainer mesh__D002387 TGC
% 218.56/218.78  |- mesh__dateRevised mesh__D002387 1997-06-20
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D002387 2003
% 218.56/218.78  |- mesh__recordAuthorizer mesh__D002387 SJN
% 218.56/218.78  |- mesh__publicMeSHNote mesh__D002387
% 218.56/218.78       ENZYMATIC ZONULOLYSIS was heading 1963-96   
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D002387 2005
% 218.56/218.78  |- skos__prefLabel mesh__D002387 Cataract Extraction
% 218.56/218.78  |- skos__scopeNote mesh__D002387
% 218.56/218.78       Surgical removal of a cataractous lens. %28%Dorland, 28th ed%29%%A%    
% 218.56/218.78  |- skos__hiddenLabel mesh__D002387 Zonulolyses, Enzymatic
% 218.56/218.78  |- mesh__dateCreated mesh__D002387 1999-01-01
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D002387 2002
% 218.56/218.78  |- skos__hiddenLabel mesh__D002387 Extraction, Cataract
% 218.56/218.78  |- rdf__type mesh__D002387sskos__Concept
% 218.56/218.78  |- skos__related mesh__D002387smesh__D019591
% 218.56/218.78  |- skos__related mesh__D002387smesh__D001036
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D002387 1999
% 218.56/218.78  |- skos__hiddenLabel mesh__D002387 Enzymatic Zonulolyses
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D002387 2001
% 218.56/218.78  |- mesh__recordOriginator mesh__D002387 SMH
% 218.56/218.78  |- mesh__historyNote mesh__D002387
% 218.56/218.78       ENZYMATIC ZONULOLYSIS was heading 1963-96   
% 218.56/218.78  |- skos__broader mesh__D002387smesh__D013508
% 218.56/218.78  |- skos__hiddenLabel mesh__D002387 Cataract Extractions
% 218.56/218.78  |- skos__related mesh__D002387smesh__D007910
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D002387 2004
% 218.56/218.78  |- skos__hiddenLabel mesh__D010819 Role, Physicians%27%
% 218.56/218.78  |- skos__hiddenLabel mesh__D010819 Physician%27%s Roles
% 218.56/218.78  |- mesh__recordOriginator mesh__D010819 EC
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D010819 2005
% 218.56/218.78  |- skos__hiddenLabel mesh__D010819 Roles, Physician%27%s
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D010819 2002
% 218.56/218.78  |- mesh__recordAuthorizer mesh__D010819 sjn
% 218.56/218.78  |- skos__broader mesh__D010819smesh__D024382
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D010819 2006
% 218.56/218.78  |- mesh__historyNote mesh__D010819
% 218.56/218.78       91%28%78%29%; was see under ROLE 1978-90   
% 218.56/218.78  |- skos__hiddenLabel mesh__D010819 Physician Role
% 218.56/218.78  |- skos__altLabel mesh__D010819 Physicians%27% Role
% 218.56/218.78  |- skos__historyNote mesh__D010819 Role %28%1969-1977%29%
% 218.56/218.78  |- mesh__dateCreated mesh__D010819 1977-04-22
% 218.56/218.78  |- mesh__dateEstablished mesh__D010819 1991-01-01
% 218.56/218.78  |- mesh__dateRevised mesh__D010819 2001-07-25
% 218.56/218.78  |- skos__scopeNote mesh__D010819
% 218.56/218.78       The expected function of a member of  the medical profession.%A%    
% 218.56/218.78  |- skos__hiddenLabel mesh__D010819 Physicians%27% Roles
% 218.56/218.78  |- skos__hiddenLabel mesh__D010819 Physicians Role
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D010819 2003
% 218.56/218.78  |- skos__annotation mesh__D010819
% 218.56/218.78       coord IM with area in which role is played %28%IM%29%, as %22%physician%27%s role in reducing teenage pregnancy%22%= PHYSICIAN%27%S ROLE %28%IM%29% + PREGNANCY IN ADOLESCENCE %28%IM%29%%A%  
% 218.56/218.78  |- skos__hiddenLabel mesh__D010819 Roles, Physicians%27%
% 218.56/218.78  |- mesh__recordMaintainer mesh__D010819 tjk
% 218.56/218.78  |- rdf__type mesh__D010819sskos__Concept
% 218.56/218.78  |- mesh__publicMeSHNote mesh__D010819 91; was see under ROLE 1978-90   
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D010819 2004
% 218.56/218.78  |- skos__prefLabel mesh__D010819 Physician%27%s Role
% 218.56/218.78  |- skos__hiddenLabel mesh__D010819 Role, Physician%27%s
% 218.56/218.78  |- skos__hiddenLabel mesh__D007870 Leg Length Inequalities
% 218.56/218.78  |- rdf__type mesh__D007870sskos__Concept
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D007870 2002
% 218.56/218.78  |- mesh__recordMaintainer mesh__D007870 KEV
% 218.56/218.78  |- skos__hiddenLabel mesh__D007870 Inequalities, Leg Length
% 218.56/218.78  |- skos__broader mesh__D007870smesh__D020763
% 218.56/218.78  |- mesh__historyNote mesh__D007870
% 218.56/218.78       72; LEG LENGTHENING was heading 1964-71 %28%Prov 1964-66%29%   
% 218.56/218.78  |- skos__broader mesh__D007870smesh__D001848
% 218.56/218.78  |- mesh__recordOriginator mesh__D007870 NLM
% 218.56/218.78  |- skos__related mesh__D007870smesh__D001852
% 218.56/218.78  |- skos__hiddenLabel mesh__D007870 Inequality, Leg Length
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D007870 2006
% 218.56/218.78  |- mesh__publicMeSHNote mesh__D007870
% 218.56/218.78       72; LEG LENGTHENING was heading 1967-71   
% 218.56/218.78  |- skos__hiddenLabel mesh__D007870 Length Inequalities, Leg
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D007870 2004
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D007870 2001
% 218.56/218.78  |- skos__hiddenLabel mesh__D007870 Length Inequality, Leg
% 218.56/218.78  |- skos__annotation mesh__D007870
% 218.56/218.78       correction of inequality: coord IM with BONE LENGTHENING %28%IM%29% or specifically ILIZAROV TECHNIQUE %28%IM%29% if pertinent%A%  
% 218.56/218.78  |- mesh__onlineNote mesh__D007870
% 218.56/218.78       use LEG LENGTH INEQUALITY to search LEG LENGTHENING 1966-71 %28%as Prov 1966%29%%A%  
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D007870 2000
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D007870 2005
% 218.56/218.78  |- skos__prefLabel mesh__D007870 Leg Length Inequality
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D007870 2003
% 218.56/218.78  |- mesh__dateRevised mesh__D007870 1999-11-03
% 218.56/218.78  |- mesh__recordAuthorizer mesh__D007870 sjn
% 218.56/218.78  |- skos__scopeNote mesh__D007870
% 218.56/218.78       A condition in which one of a pair of legs fails to grow as long as the other, which could result from injury or surgery.%A%    
% 218.56/218.78  |- mesh__dateCreated mesh__D007870 1999-01-01
% 218.56/218.78  |- mesh__dateEstablished mesh__D007870 1972-01-01
% 218.56/218.78  |- skos__hiddenLabel mesh__D021541 Sea Breams, Gilthead
% 218.56/218.78  |- skos__hiddenLabel mesh__D021541 Gilthead Breams
% 218.56/218.78  |- skos__altLabel mesh__D021541 Seabream
% 218.56/218.78  |- mesh__dateRevised mesh__D021541 2003-07-09
% 218.56/218.78  |- skos__altLabel mesh__D021541 Gilthead Sea Bream
% 218.56/218.78  |- skos__hiddenLabel mesh__D021541 Seabreams
% 218.56/218.78  |- rdf__type mesh__D021541sskos__Concept
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D021541 2006
% 218.56/218.78  |- mesh__recordMaintainer mesh__D021541 ags
% 218.56/218.78  |- skos__hiddenLabel mesh__D021541 Seabream, Gilthead
% 218.56/218.78  |- mesh__historyNote mesh__D021541 2001   
% 218.56/218.78  |- skos__altLabel mesh__D021541 Sparus aurata
% 218.56/218.78  |- skos__broader mesh__D021541smesh__D010473
% 218.56/218.78  |- mesh__dateEstablished mesh__D021541 2001-01-01
% 218.56/218.78  |- skos__historyNote mesh__D021541 Fishes %28%1967-1986%29%
% 218.56/218.78  |- mesh__recordOriginator mesh__D021541 jmp
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D021541 2004
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D021541 2005
% 218.56/218.78  |- mesh__recordAuthorizer mesh__D021541 sjn
% 218.56/218.78  |- skos__altLabel mesh__D021541 Sparus auratus
% 218.56/218.78  |- skos__prefLabel mesh__D021541 Sea Bream
% 218.56/218.78  |- skos__scopeNote mesh__D021541
% 218.56/218.78       A species of PERCIFORMES commonly used in saline aquaculture.%A%    
% 218.56/218.78  |- skos__hiddenLabel mesh__D021541 Gilthead Seabreams
% 218.56/218.78  |- skos__altLabel mesh__D021541 Gilthead Seabream
% 218.56/218.78  |- skos__hiddenLabel mesh__D021541 Seabreams, Gilthead
% 218.56/218.78  |- mesh__publicMeSHNote mesh__D021541 2001   
% 218.56/218.78  |- skos__hiddenLabel mesh__D021541 Sea Breams
% 218.56/218.78  |- skos__altLabel mesh__D021541 Gilthead Bream
% 218.56/218.78  |- skos__historyNote mesh__D021541 Perciformes %28%1987-2000%29%
% 218.56/218.78  |- mesh__dateCreated mesh__D021541 2000-06-22
% 218.56/218.78  |- skos__hiddenLabel mesh__D021541 Sea Bream, Gilthead
% 218.56/218.78  |- skos__hiddenLabel mesh__D021541 Gilthead Sea Breams
% 218.56/218.78  |- skos__altLabel mesh__D007072 IgD
% 218.56/218.78  |- mesh__activeMeSHYear mesh__D007072 2006
% 218.56/218.78  |- skos__annotation mesh__D007072
% 218.56/218.78       /defic = IMMUNOGLOBULIN D / defic + DYSGAMMAGLOBULINEMIA %28%IM%29%; gammopathy: coordinate IMMUNOGLOBULIN D %28%IM%29% with PARAPROTEINEMIAS %28%IM%29% but consider also HYPERGAMMAGLOBULINEMIA %28%IM%29%, follow text;%A%  
% 218.56/218.78  |- skos__historyNote mesh__D007072 Immunoglobulins %28%1970%29%
% 218.56/218.78  |- mesh__recordMaintainer mesh__D007072 ssb
% 218.56/218.78  |- mesh__recordOriginator mesh__D007072 NLM
% 218.56/218.78  |- rdf__type mesh__D007072sskos__Concept
% 218.56/218.78  |- skos__scopeNote mesh__D007072
% 218.56/218.78       An immunoglobulin which accounts for less than 1%25% of plasma immunoglobulin. It is found on the membrane of many circulating B LYMPHOCYTES.%A%    
% 218.56/218.79  |- mesh__historyNote mesh__D007072 2002%28%1971%29%   
% 218.56/218.79  |- mesh__dateEstablished mesh__D007072 1973-01-01
% 218.56/218.79  |- skos__broader mesh__D007072smesh__D007132
% 218.56/218.79  |- mesh__publicMeSHNote mesh__D007072 2002; see IgD 1973-2001   
% 218.56/218.79  |- mesh__dateRevised mesh__D007072 2005-06-30
% 218.56/218.79  |- skos__prefLabel mesh__D007072 Immunoglobulin D
% 218.56/218.79  |- mesh__recordAuthorizer mesh__D007072 sjn
% 218.56/218.79  |- mesh__dateCreated mesh__D007072 1999-01-01
% 218.56/218.79  |- rdf__type mesh__D048489sskos__Concept
% 218.56/218.79  |- mesh__publicMeSHNote mesh__D048489 2005   
% 218.56/218.79  |- mesh__historyNote mesh__D048489 2005   
% 218.56/218.79  |- skos__prefLabel mesh__D048489 Paramecium aurelia
% 218.56/218.79  |- skos__historyNote mesh__D048489 Paramecium %28%1965-2004%29%
% 218.56/218.79  |- mesh__recordMaintainer mesh__D048489 jls
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D048489 2005A
% 218.56/218.79  |- mesh__recordAuthorizer mesh__D048489 jls
% 218.56/218.79  |- skos__scopeNote mesh__D048489
% 218.56/218.79       A species of ciliated PROTOZOA possessing two micronuclei. It is one of the smallest PARAMECIUM.%A%    
% 218.56/218.79  |- mesh__dateEstablished mesh__D048489 2005-01-01
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D048489 2006
% 218.56/218.79  |- mesh__dateCreated mesh__D048489 2004-07-07
% 218.56/218.79  |- mesh__recordOriginator mesh__D048489 ags
% 218.56/218.79  |- mesh__dateRevised mesh__D048489 2004-07-30
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D048489 2005
% 218.56/218.79  |- skos__broader mesh__D048489smesh__D010247
% 218.56/218.79  |- skos__scopeNote mesh__D006778
% 218.56/218.79       Special hospitals which provide care to the mentally ill patient.%A%    
% 218.56/218.79  |- skos__hiddenLabel mesh__D006778 Hospital, Psychiatric
% 218.56/218.79  |- skos__hiddenLabel mesh__D006778 Institutions, Mental
% 218.56/218.79  |- skos__altLabel mesh__D006778 Mental Hospitals
% 218.56/218.79  |- skos__broader mesh__D006778smesh__D006782
% 218.56/218.79  |- skos__annotation mesh__D006778
% 218.56/218.79       coord IM with hosp ownership term %28%e.g., HOSPITALS, COUNTY; HOSPITALS, PROPRIETARY; etc.%29% %28%IM or NIM%29% if pertinent; specify geog%A%  
% 218.56/218.79  |- skos__hiddenLabel mesh__D006778 Mental Hospital
% 218.56/218.79  |- skos__hiddenLabel mesh__D006778 Institution, Mental
% 218.56/218.79  |- mesh__recordMaintainer mesh__D006778 kle
% 218.56/218.79  |- skos__altLabel mesh__D006778 Psychiatric Hospitals
% 218.56/218.79  |- skos__altLabel mesh__D006778 Mental Institutions
% 218.56/218.79  |- mesh__dateRevised mesh__D006778 1999-11-03
% 218.56/218.79  |- rdf__type mesh__D006778sskos__Concept
% 218.56/218.79  |- skos__hiddenLabel mesh__D006778 Mental Institution
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D006778 2002
% 218.56/218.79  |- skos__prefLabel mesh__D006778 Hospitals, Psychiatric
% 218.56/218.79  |- mesh__recordAuthorizer mesh__D006778 sjn
% 218.56/218.79  |- skos__hiddenLabel mesh__D006778 Hospital, Mental
% 218.56/218.79  |- skos__altLabel mesh__D006778 Hospitals, Mental
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D006778 2004
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D006778 2001
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D006778 2006
% 218.56/218.79  |- skos__hiddenLabel mesh__D006778 Psychiatric Hospital
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D006778 2003
% 218.56/218.79  |- mesh__recordOriginator mesh__D006778 NLM
% 218.56/218.79  |- mesh__dateCreated mesh__D006778 1999-01-01
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D006778 2000
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D006778 2005
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D020449 2006
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D020449 2003
% 218.56/218.79  |- skos__altLabel mesh__D020449 Amino Acid Repeat Sequence
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D020449 2005
% 218.56/218.79  |- skos__prefLabel mesh__D020449 Repetitive Sequences, Amino Acid
% 218.56/218.79  |- mesh__dateEstablished mesh__D020449 1999-01-01
% 218.56/218.79  |- skos__historyNote mesh__D020449 Amino Acid Sequence %28%1966-1998%29%
% 218.56/218.79  |- skos__altLabel mesh__D020449 Amino Acid Repetitive Seq
% 218.56/218.79  |- skos__scopeNote mesh__D020449
% 218.56/218.79       A sequential pattern of amino acids occurring more than once in the same protein sequence.%A%    
% 218.56/218.79  |- mesh__publicMeSHNote mesh__D020449 99   
% 218.56/218.79  |- skos__historyNote mesh__D020449
% 218.56/218.79       Repetitive Sequences, Nucleic Acid %28%1981-1998%29%
% 218.56/218.79  |- rdf__type mesh__D020449sskos__Concept
% 218.56/218.79  |- mesh__historyNote mesh__D020449 99   
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D020449 2004
% 218.56/218.79  |- mesh__dateCreated mesh__D020449 1998-06-11
% 218.56/218.79  |- skos__broader mesh__D020449smesh__D000595
% 218.56/218.79  |- mesh__dateRevised mesh__D020449 2002-07-02
% 218.56/218.79  |- mesh__dateCreated mesh__D031171 2002-07-02
% 218.56/218.79  |- skos__prefLabel mesh__D031171 Artemisia absinthium
% 218.56/218.79  |- rdf__type mesh__D031171sskos__Concept
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D031171 2004
% 218.56/218.79  |- mesh__historyNote mesh__D031171 2003; use ARTEMISIA 1998-2002   
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D031171 2003
% 218.56/218.79  |- skos__broader mesh__D031171smesh__D019306
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D031171 2006
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D031171 2005
% 218.56/218.79  |- mesh__publicMeSHNote mesh__D031171 2003; see ARTEMISIA 1998-2002   
% 218.56/218.79  |- mesh__dateEstablished mesh__D031171 2003-01-01
% 218.56/218.79  |- skos__scopeNote mesh__D031171
% 218.56/218.79       A plant species of the genus ARTEMISIA, family ASTERACEAE that has been used in ABSINTHE. The oil contains neurotoxic 1-thujone and d-isothujone.%A%    
% 218.56/218.79  |- skos__annotation mesh__D031171
% 218.56/218.79       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.56/218.79  |- mesh__publicMeSHNote mesh__D003480
% 218.56/218.79       99; see CUSHING%27%S SYNDROME 1966-98   
% 218.56/218.79  |- mesh__dateCreated mesh__D003480 1999-01-01
% 218.56/218.79  |- mesh__dateRevised mesh__D003480 2004-07-07
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D003480 2006
% 218.56/218.79  |- mesh__recordMaintainer mesh__D003480 lkt
% 218.56/218.79  |- skos__hiddenLabel mesh__D003480 Syndrome, Cushing%27%s
% 218.56/218.79  |- skos__related mesh__D003480smesh__D047748
% 218.56/218.79  |- mesh__historyNote mesh__D003480 99%28%66%29%   
% 218.56/218.79  |- skos__scopeNote mesh__D003480
% 218.56/218.79       A condition caused by prolonged exposure to excess levels of cortisol %28%HYDROCORTISONE%29% or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.%A%    
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D003480 2005
% 218.56/218.79  |- rdf__type mesh__D003480sskos__Concept
% 218.56/218.79  |- skos__altLabel mesh__D003480 Hypercortisolism
% 218.56/218.79  |- skos__altLabel mesh__D003480 Cushing%27%s Syndrome
% 218.56/218.79  |- mesh__recordAuthorizer mesh__D003480 sjn
% 218.56/218.79  |- skos__prefLabel mesh__D003480 Cushing Syndrome
% 218.56/218.79  |- mesh__recordOriginator mesh__D003480 NLM
% 218.56/218.79  |- skos__hiddenLabel mesh__D003480 Syndrome, Cushing
% 218.56/218.79  |- skos__annotation mesh__D003480
% 218.56/218.79       do not confuse with CUSHING DISEASE see PITUITARY ACTH HYPERSECRETION%A%  
% 218.56/218.79  |- skos__broader mesh__D003480smesh__D000308
% 218.56/218.79  |- mesh__recordMaintainer mesh__D011912 ags
% 218.56/218.79  |- mesh__dateEstablished mesh__D011912 1991-01-01
% 218.56/218.79  |- skos__hiddenLabel mesh__D011912 Inbred ACI Rat
% 218.56/218.79  |- mesh__publicMeSHNote mesh__D011912
% 218.56/218.79       91; was see under RATS, INBRED STRAINS 1972-90   
% 218.56/218.79  |- mesh__historyNote mesh__D011912
% 218.56/218.79       91%28%72%29%; was see under RATS, INBRED STRAINS 1972-90   
% 218.56/218.79  |- skos__altLabel mesh__D011912 Rats, Inbred A x C 9935 Irish
% 218.56/218.79  |- mesh__recordOriginator mesh__D011912 NLM
% 218.56/218.79  |- skos__prefLabel mesh__D011912 Rats, Inbred ACI
% 218.56/218.79  |- skos__hiddenLabel mesh__D011912 ACI Rat, Inbred
% 218.56/218.79  |- skos__broader mesh__D011912smesh__D011919
% 218.56/218.79  |- skos__hiddenLabel mesh__D011912 ACI Rats, Inbred
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D011912 2006
% 218.56/218.79  |- mesh__recordAuthorizer mesh__D011912 sjn
% 218.56/218.79  |- skos__hiddenLabel mesh__D011912 Rat, ACI
% 218.56/218.79  |- mesh__dateCreated mesh__D011912 1999-01-01
% 218.56/218.79  |- skos__historyNote mesh__D011912 Rats %28%1966-1971%29%
% 218.56/218.79  |- skos__annotation mesh__D011912
% 218.56/218.79       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag RATS%A%  
% 218.56/218.79  |- mesh__dateRevised mesh__D011912 2005-06-30
% 218.56/218.79  |- rdf__type mesh__D011912sskos__Concept
% 218.56/218.79  |- skos__hiddenLabel mesh__D011912 Rat, Inbred ACI
% 218.56/218.79  |- skos__hiddenLabel mesh__D011912 ACI Rat
% 218.56/218.79  |- skos__altLabel mesh__D011912 Rats, ACI
% 218.56/218.79  |- skos__hiddenLabel mesh__D011912 ACI Rats
% 218.56/218.79  |- skos__hiddenLabel mesh__D011912 Inbred ACI Rats
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D011114 2006
% 218.56/218.79  |- mesh__recordAuthorizer mesh__D011114 jls
% 218.56/218.79  |- rdf__type mesh__D011114sskos__Concept
% 218.56/218.79  |- skos__broader mesh__D011114smesh__D010139
% 218.56/218.79  |- mesh__dateCreated mesh__D011114 1999-01-01
% 218.56/218.79  |- skos__annotation mesh__D011114
% 218.56/218.79       a group of islands in the central Pacific   
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D011114 2002
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D011114 2003
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D011114 2006A
% 218.56/218.79  |- mesh__recordMaintainer mesh__D011114 jls
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D011114 2004
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D011114 2006B
% 218.56/218.79  |- skos__prefLabel mesh__D011114 Polynesia
% 218.56/218.79  |- mesh__onlineNote mesh__D011114
% 218.56/218.79       use CHILE to search EASTER ISLAND 1975-77   
% 218.56/218.79  |- mesh__historyNote mesh__D011114
% 218.56/218.79       68; EASTER ISLAND was see CHILE 1975-77   
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D011114 2005
% 218.56/218.79  |- mesh__dateRevised mesh__D011114 2005-09-28
% 218.56/218.79  |- mesh__recordOriginator mesh__D011114 NLM
% 218.56/218.79  |- skos__scopeNote mesh__D011114
% 218.56/218.79       The collective name for the islands of the central Pacific Ocean, including the Austral Islands, Cook Islands, Easter Island, HAWAII; NEW ZEALAND; Phoenix Islands, PITCAIRN ISLAND; SAMOA, TONGA; Tuamotu Archipelago, Wake Island, and Wallis and Futuna Islands. Polynesians are of the Caucasoid race, but many are of mixed origin. Polynesia is from the Greek poly, many + nesos, island, with reference to the many islands in the group. %28%From Webster%27%s New Geographical Dictionary, 1988, p966 %26% Room, Brewer%27%s Dictionary of Names, 1992, p426%29%%A%    
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D002388 2003
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D002388 2001
% 218.56/218.79  |- skos__annotation mesh__D002388
% 218.56/218.79       usually GEN %26% IM; if a specific catastrophic illiness, coord NIM with specific dis %28%IM%29%%A%  
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D002388 2005
% 218.56/218.79  |- mesh__publicMeSHNote mesh__D002388 82   
% 218.56/218.79  |- skos__related mesh__D002388smesh__D007354
% 218.56/218.79  |- skos__hiddenLabel mesh__D002388 Illness, Catastrophic
% 218.56/218.79  |- mesh__recordAuthorizer mesh__D002388 sjn
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D002388 2000
% 218.56/218.79  |- skos__prefLabel mesh__D002388 Catastrophic Illness
% 218.56/218.79  |- skos__scopeNote mesh__D002388
% 218.56/218.79       An acute or prolonged illness usually considered to be life-threatening or with the threat of serious residual disability. Treatment may be radical and is frequently costly.%A%    
% 218.56/218.79  |- mesh__recordOriginator mesh__D002388 EC
% 218.56/218.79  |- rdf__type mesh__D002388sskos__Concept
% 218.56/218.79  |- skos__hiddenLabel mesh__D002388 Catastrophic Illnesses
% 218.56/218.79  |- mesh__dateCreated mesh__D002388 1981-02-26
% 218.56/218.79  |- mesh__dateEstablished mesh__D002388 1982-01-01
% 218.56/218.79  |- skos__hiddenLabel mesh__D002388 Illnesses, Catastrophic
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D002388 2004
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D002388 2002
% 218.56/218.79  |- mesh__recordMaintainer mesh__D002388 KEV
% 218.56/218.79  |- mesh__historyNote mesh__D002388 82   
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D002388 2006
% 218.56/218.79  |- mesh__dateRevised mesh__D002388 1999-11-08
% 218.56/218.79  |- skos__broader mesh__D002388smesh__D020969
% 218.56/218.79  |- skos__annotation mesh__D029525
% 218.56/218.79       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.56/218.79  |- skos__scopeNote mesh__D029525
% 218.56/218.79       The walnut plant family of the order Juglandales, subclass Hamamelidae, class Magnoliopsida. They are mainly temperate zone trees.%A%    
% 218.56/218.79  |- mesh__historyNote mesh__D029525 2002   
% 218.56/218.79  |- skos__prefLabel mesh__D029525 Juglandaceae
% 218.56/218.79  |- skos__broader mesh__D029525smesh__D019684
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D029525 2004
% 218.56/218.79  |- rdf__type mesh__D029525sskos__Concept
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D029525 2006
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D029525 2003
% 218.56/218.79  |- mesh__publicMeSHNote mesh__D029525 2002   
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D029525 2005
% 218.56/218.79  |- mesh__dateEstablished mesh__D029525 2002-01-01
% 218.56/218.79  |- mesh__dateCreated mesh__D029525 2001-07-25
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D029525 2002
% 218.56/218.79  |- skos__scopeNote mesh__D007871
% 218.56/218.79       Ulceration of the skin and underlying structures of the lower extremity. About 90%25% of the cases are due to venous insufficiency %28%VARICOSE ULCER%29%, 5%25% to arterial disease, and the remaining 5%25% to other causes.%A%    
% 218.56/218.79  |- mesh__recordAuthorizer mesh__D007871 SJN
% 218.56/218.79  |- skos__hiddenLabel mesh__D007871 Ulcers, Leg
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D007871 1999
% 218.56/218.79  |- mesh__recordMaintainer mesh__D007871 TGC
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D007871 1998
% 218.56/218.79  |- skos__annotation mesh__D007871
% 218.56/218.79       if varicose, index instead under VARICOSE ULCER; FOOT ULCER is also available%A%  
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D007871 2006
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D007871 2002
% 218.56/218.79  |- skos__prefLabel mesh__D007871 Leg Ulcer
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D007871 2004
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D007871 2005
% 218.56/218.79  |- skos__hiddenLabel mesh__D007871 Leg Ulcers
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D007871 2003
% 218.56/218.79  |- mesh__recordOriginator mesh__D007871 NLM
% 218.56/218.79  |- mesh__dateRevised mesh__D007871 1997-06-20
% 218.56/218.79  |- mesh__dateCreated mesh__D007871 1999-01-01
% 218.56/218.79  |- skos__broader mesh__D007871smesh__D012883
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D007871 2001
% 218.56/218.79  |- skos__hiddenLabel mesh__D007871 Ulcer, Leg
% 218.56/218.79  |- rdf__type mesh__D007871sskos__Concept
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D007871 2000
% 218.56/218.79  |- mesh__historyNote mesh__D021542 2001   
% 218.56/218.79  |- rdf__type mesh__D021542sskos__Concept
% 218.56/218.79  |- mesh__dateEstablished mesh__D021542 2001-01-01
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D021542 2001
% 218.56/218.79  |- skos__prefLabel mesh__D021542 Amino Acids, Neutral
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D021542 2006
% 218.56/218.79  |- skos__altLabel mesh__D021542 Neutral Amino Acids
% 218.56/218.79  |- mesh__publicMeSHNote mesh__D021542 2001   
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D021542 2004
% 218.56/218.79  |- mesh__dateCreated mesh__D021542 2000-06-21
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D021542 2005
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D021542 2003
% 218.56/218.79  |- skos__scopeNote mesh__D021542
% 218.56/218.79       Amino acids with uncharged R groups or side chains.     
% 218.56/218.79  |- skos__broader mesh__D021542smesh__D000596
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D021542 2002
% 218.56/218.79  |- skos__hiddenLabel mesh__D021542 Acids, Neutral Amino
% 218.56/218.79  |- skos__historyNote mesh__D007073 Immunoglobulins %28%1970%29%
% 218.56/218.79  |- mesh__recordAuthorizer mesh__D007073 sjn
% 218.56/218.79  |- skos__prefLabel mesh__D007073 Immunoglobulin E
% 218.56/218.79  |- rdf__type mesh__D007073sskos__Concept
% 218.56/218.79  |- mesh__historyNote mesh__D007073 2002%28%1971%29%   
% 218.56/218.79  |- skos__hiddenLabel mesh__D007073 E, Immunoglobulin
% 218.56/218.79  |- mesh__recordMaintainer mesh__D007073 ssb
% 218.56/218.79  |- mesh__recordOriginator mesh__D007073 NLM
% 218.56/218.79  |- skos__scopeNote mesh__D007073
% 218.56/218.79       An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity %28%HYPERSENSITIVITY, IMMEDIATE%29%.%A%    
% 218.56/218.79  |- mesh__publicMeSHNote mesh__D007073 2002; see IgE 1973-2001   
% 218.56/218.79  |- mesh__dateEstablished mesh__D007073 1973-01-01
% 218.56/218.79  |- mesh__dateCreated mesh__D007073 1999-01-01
% 218.56/218.79  |- skos__broader mesh__D007073smesh__D007132
% 218.56/218.79  |- skos__related mesh__D007073smesh__D017455
% 218.56/218.79  |- skos__annotation mesh__D007073
% 218.56/218.79       /defic = IMMUNOGLOBULIN E / defic + DYSGAMMAGLOBULINEMIA %28%IM%29%; gammopathy: coordinate IMMUNOGLOBULIN E %28%IM%29% with PARAPROTEINEMIAS %28%IM%29% but consider also HYPERGAMMAGLOBULINEMIA %28%IM%29%, follow text;%A%  
% 218.56/218.79  |- mesh__dateRevised mesh__D007073 2005-06-30
% 218.56/218.79  |- skos__altLabel mesh__D007073 IgE
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D007073 2006
% 218.56/218.79  |- mesh__recordAuthorizer mesh__D015505 SJN
% 218.56/218.79  |- rdf__type mesh__D015505sskos__Concept
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D015505 2000
% 218.56/218.79  |- skos__historyNote mesh__D015505 Drainage %28%1966-1989%29%
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D015505 2003
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D015505 1999
% 218.56/218.79  |- skos__historyNote mesh__D015505 Intubation %28%1966-1989%29%
% 218.56/218.79  |- skos__historyNote mesh__D015505 Catheterization %28%1977-1989%29%
% 218.56/218.79  |- skos__hiddenLabel mesh__D015505 Tube, Chest
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D015505 2001
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D015505 2004
% 218.56/218.79  |- skos__historyNote mesh__D015505
% 218.56/218.79       Respiration, Artificial %28%1983-1985%29%
% 218.56/218.79  |- skos__prefLabel mesh__D015505 Chest Tubes
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D015505 2002
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D015505 2005
% 218.56/218.79  |- skos__historyNote mesh__D015505 Catheters, Indwelling %28%1980-1982%29%
% 218.56/218.79  |- mesh__recordMaintainer mesh__D015505 PXP
% 218.56/218.79  |- mesh__dateCreated mesh__D015505 1989-04-13
% 218.56/218.79  |- skos__broader mesh__D015505smesh__D013523
% 218.56/218.79  |- skos__historyNote mesh__D015505 Suction %28%1977-1989%29%
% 218.56/218.79  |- mesh__publicMeSHNote mesh__D015505 90   
% 218.56/218.79  |- skos__hiddenLabel mesh__D015505 Chest Tube
% 218.56/218.79  |- skos__scopeNote mesh__D015505
% 218.56/218.79       Plastic tubes used for drainage of air or fluid from the pleural space. Their surgical insertion is called tube thoracostomy.%A%    
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D015505 2006
% 218.56/218.79  |- mesh__dateEstablished mesh__D015505 1990-01-01
% 218.56/218.79  |- skos__hiddenLabel mesh__D015505 Tubes, Chest
% 218.56/218.79  |- mesh__dateRevised mesh__D015505 1997-06-20
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D015505 1998
% 218.56/218.79  |- mesh__historyNote mesh__D015505 90   
% 218.56/218.79  |- skos__annotation mesh__D015505
% 218.56/218.79       %22%used for drainage of air or fluid from the pleural space%22%%A%  
% 218.56/218.79  |- mesh__recordOriginator mesh__D015505 AGS
% 218.56/218.79  |- skos__hiddenLabel mesh__D006779 Public Hospital
% 218.56/218.79  |- skos__altLabel mesh__D006779 Public Hospitals
% 218.56/218.79  |- rdf__type mesh__D006779sskos__Concept
% 218.56/218.79  |- mesh__dateEstablished mesh__D006779 1978-01-01
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D006779 2001
% 218.56/218.79  |- mesh__publicMeSHNote mesh__D006779 78   
% 218.56/218.79  |- mesh__dateCreated mesh__D006779 1977-05-11
% 218.56/218.79  |- skos__hiddenLabel mesh__D006779 Hospital, Public
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D006779 2004
% 218.56/218.79  |- mesh__dateRevised mesh__D006779 2000-06-22
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D006779 2006
% 218.56/218.79  |- skos__broader mesh__D006779smesh__D006761
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D006779 2003
% 218.56/218.79  |- skos__scopeNote mesh__D006779
% 218.56/218.79       Hospitals controlled by various types of government, i.e., city, county, district, state or federal.%A%    
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D006779 2005
% 218.56/218.79  |- mesh__recordOriginator mesh__D006779 EC
% 218.56/218.79  |- skos__prefLabel mesh__D006779 Hospitals, Public
% 218.56/218.79  |- mesh__recordMaintainer mesh__D006779 jls
% 218.56/218.79  |- mesh__historyNote mesh__D006779 78   
% 218.56/218.79  |- skos__annotation mesh__D006779
% 218.56/218.79       government-owned; coord IM with special hosp %28%e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.%29% or med specialty %28%IM or NIM%29% if pertinent; specify geog%A%  
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D006779 2002
% 218.56/218.79  |- mesh__recordAuthorizer mesh__D006779 sjn
% 218.56/218.79  |- mesh__dateEstablished mesh__D031172 2003-01-01
% 218.56/218.79  |- rdf__type mesh__D031172sskos__Concept
% 218.56/218.79  |- mesh__dateCreated mesh__D031172 2002-07-02
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D031172 2004
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D031172 2005
% 218.56/218.79  |- mesh__publicMeSHNote mesh__D031172 2003   
% 218.56/218.79  |- skos__broader mesh__D031172smesh__D019306
% 218.56/218.79  |- mesh__historyNote mesh__D031172 2003   
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D031172 2006
% 218.56/218.79  |- skos__prefLabel mesh__D031172 Artemisia annua
% 218.56/218.79  |- skos__scopeNote mesh__D031172
% 218.56/218.79       A plant species of the genus ARTEMISIA, family ASTERACEAE. It is the source of the antimalarial artemisinin %28%ANTIMALARIALS%29%.%A%    
% 218.56/218.79  |- skos__historyNote mesh__D031172 Artemisia %28%1996-2002%29%
% 218.56/218.79  |- skos__annotation mesh__D031172
% 218.56/218.79       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D031172 2003
% 218.56/218.79  |- mesh__recordOriginator mesh__D003481 NLM
% 218.56/218.79  |- mesh__dateCreated mesh__D003481 1999-01-01
% 218.56/218.79  |- mesh__recordAuthorizer mesh__D003481 sjn
% 218.56/218.79  |- skos__prefLabel mesh__D003481 Cuspid
% 218.56/218.79  |- skos__hiddenLabel mesh__D003481 Cuspids
% 218.56/218.79  |- skos__altLabel mesh__D003481 Canine Teeth
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D003481 2006
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D003481 2004
% 218.56/218.79  |- skos__scopeNote mesh__D003481
% 218.56/218.79       The third tooth to the left and to the right of the midline of either jaw, situated between the second INCISOR and the premolar teeth %28%BICUSPID%29%. %28%Jablonski, Dictionary of Dentistry, 1992, p817%29%%A%    
% 218.56/218.79  |- skos__hiddenLabel mesh__D003481 Tooth, Canine
% 218.56/218.79  |- mesh__dateRevised mesh__D003481 2003-07-09
% 218.56/218.79  |- skos__hiddenLabel mesh__D003481 Teeth, Canine
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D003481 2005
% 218.56/218.79  |- skos__altLabel mesh__D003481 Canine Tooth
% 218.56/218.79  |- rdf__type mesh__D003481sskos__Concept
% 218.56/218.79  |- mesh__publicMeSHNote mesh__D003481 65   
% 218.56/218.79  |- skos__annotation mesh__D003481
% 218.56/218.79       between the 2d incisor %26% premolars; NIM when merely locational%A%  
% 218.56/218.79  |- mesh__recordMaintainer mesh__D003481 lkt
% 218.56/218.79  |- skos__broader mesh__D003481smesh__D014070
% 218.56/218.79  |- mesh__historyNote mesh__D003481 65   
% 218.56/218.79  |- mesh__dateEstablished mesh__D003481 1965-01-01
% 218.56/218.79  |- skos__hiddenLabel mesh__D011913 Rat, Bio-Breeding Inbred
% 218.56/218.79  |- skos__hiddenLabel mesh__D011913 BB Rats, Inbred
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D011913 2006
% 218.56/218.79  |- skos__hiddenLabel mesh__D011913 BB Rat
% 218.56/218.79  |- mesh__dateRevised mesh__D011913 2005-06-30
% 218.56/218.79  |- skos__broader mesh__D011913smesh__D011919
% 218.56/218.79  |- skos__hiddenLabel mesh__D011913 Rat, BB
% 218.56/218.79  |- skos__altLabel mesh__D011913 Bio-Breeding Inbred Rats
% 218.56/218.79  |- skos__annotation mesh__D011913
% 218.56/218.79       a model for DIABETES MELLITUS, INSULIN-DEPENDENT; do not confuse with RATS, BRATTLEBORO; NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag RATS%A%  
% 218.56/218.79  |- skos__hiddenLabel mesh__D011913 Inbred BB Rat
% 218.56/218.79  |- skos__hiddenLabel mesh__D011913 Rat, Inbred BB
% 218.56/218.79  |- skos__prefLabel mesh__D011913 Rats, Inbred BB
% 218.56/218.79  |- rdf__type mesh__D011913sskos__Concept
% 218.56/218.79  |- mesh__dateCreated mesh__D011913 1985-03-15
% 218.56/218.79  |- mesh__historyNote mesh__D011913
% 218.56/218.79       91%28%86%29%; was see under RATS, INBRED STRAINS 1986-90   
% 218.56/218.79  |- skos__hiddenLabel mesh__D011913 BB Rat, Inbred
% 218.56/218.79  |- skos__hiddenLabel mesh__D011913 Inbred Rats, Bio-Breeding
% 218.56/218.79  |- skos__hiddenLabel mesh__D011913 Inbred BB Rats
% 218.56/218.79  |- mesh__publicMeSHNote mesh__D011913
% 218.56/218.79       91; was see under RATS, INBRED STRAINS 1986-90   
% 218.56/218.79  |- skos__altLabel mesh__D011913 BB Wistar Rats
% 218.56/218.79  |- skos__historyNote mesh__D011913 Rats, Inbred Strains %28%1972-1985%29%
% 218.56/218.79  |- skos__hiddenLabel mesh__D011913 Rats, BB Wistar
% 218.56/218.79  |- skos__hiddenLabel mesh__D011913 Inbred Rat, Bio-Breeding
% 218.56/218.79  |- skos__scopeNote mesh__D011913
% 218.56/218.79       A strain of Rattus norvegicus which is a model for spontaneous insulin-dependent diabetes mellitus %28%DIABETES MELLITUS, INSULIN-DEPENDENT%29%.%A%    
% 218.56/218.79  |- skos__hiddenLabel mesh__D011913 Bio-Breeding Inbred Rat
% 218.56/218.79  |- skos__hiddenLabel mesh__D011913 Bio Breeding Inbred Rats
% 218.56/218.79  |- skos__altLabel mesh__D011913 Rats, BB
% 218.56/218.79  |- mesh__recordAuthorizer mesh__D011913 sjn
% 218.56/218.79  |- mesh__recordMaintainer mesh__D011913 ags
% 218.56/218.79  |- mesh__dateEstablished mesh__D011913 1991-01-01
% 218.56/218.79  |- skos__hiddenLabel mesh__D011913 BB Rats
% 218.56/218.79  |- skos__hiddenLabel mesh__D011913 Wistar Rats, BB
% 218.56/218.79  |- mesh__recordOriginator mesh__D011913 EC
% 218.56/218.79  |- skos__hiddenLabel mesh__D011913 Rats, Bio-Breeding Inbred
% 218.56/218.79  |- skos__hiddenLabel mesh__D011115 Motor Polyneuropathy
% 218.56/218.79  |- mesh__recordAuthorizer mesh__D011115 sjn
% 218.56/218.79  |- skos__broader mesh__D011115smesh__D010523
% 218.56/218.79  |- skos__hiddenLabel mesh__D011115 Familial Polyneuropathies
% 218.56/218.79  |- mesh__recordMaintainer mesh__D011115 lkt
% 218.56/218.79  |- skos__hiddenLabel mesh__D011115 Acquired Polyneuropathy
% 218.56/218.79  |- mesh__activeMeSHYear mesh__D011115 2006
% 218.56/218.79  |- skos__altLabel mesh__D011115 Polyneuropathy, Inherited
% 218.56/218.80  |- skos__hiddenLabel mesh__D011115 Polyneuropathies, Motor
% 218.56/218.80  |- rdf__type mesh__D011115sskos__Concept
% 218.56/218.80  |- skos__hiddenLabel mesh__D011115 Inherited Polyneuropathy
% 218.56/218.80  |- skos__scopeNote mesh__D011115
% 218.56/218.80       Diseases of multiple peripheral nerves simultaneously.  Polyneuropathies usually are characterized by symmetrical, bilateral distal motor and sensory impairment with a graded increase in severity distally. The pathological processes affecting peripheral nerves include degeneration of the axon, myelin or both. The various forms of polyneuropathy are categorized by the type of nerve affected %28%e.g., sensory, motor, or autonomic%29%, by the distribution of nerve injury %28%e.g., distal vs. proximal%29%, by nerve component primarily affected %28%e.g., demyelinating vs. axonal%29%, by etiology, or by pattern of inheritance.%A%    
% 218.56/218.80  |- mesh__recordOriginator mesh__D011115 NLM
% 218.56/218.80  |- skos__hiddenLabel mesh__D011115 Acquired Polyneuropathies
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D011115 2005
% 218.56/218.80  |- skos__hiddenLabel mesh__D011115 Critical Illness Polyneuropathies
% 218.56/218.80  |- mesh__publicMeSHNote mesh__D011115 2000; see POLYNEURITIS 1966-1999   
% 218.56/218.80  |- skos__hiddenLabel mesh__D011115 Inherited Polyneuropathies
% 218.56/218.80  |- mesh__historyNote mesh__D011115 2000%28%1966%29%   
% 218.56/218.80  |- skos__hiddenLabel mesh__D011115 Polyneuropathies, Familial
% 218.56/218.80  |- skos__hiddenLabel mesh__D011115 Critical Illness Polyneuropathy
% 218.56/218.80  |- mesh__dateRevised mesh__D011115 2001-07-25
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D011115 2004
% 218.56/218.80  |- skos__hiddenLabel mesh__D011115 Polyneuropathy
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D011115 2003
% 218.56/218.80  |- skos__hiddenLabel mesh__D011115 Familial Polyneuropathy
% 218.56/218.80  |- skos__prefLabel mesh__D011115 Polyneuropathies
% 218.56/218.80  |- skos__hiddenLabel mesh__D011115 Motor Polyneuropathies
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D011115 2002
% 218.56/218.80  |- skos__hiddenLabel mesh__D011115 Polyneuropathies, Inherited
% 218.56/218.80  |- skos__hiddenLabel mesh__D011115 Polyneuropathies, Critical Illness
% 218.56/218.80  |- mesh__dateCreated mesh__D011115 1999-01-01
% 218.56/218.80  |- skos__hiddenLabel mesh__D011115 Polyneuropathies, Acquired
% 218.56/218.80  |- mesh__dateCreated mesh__D002389 1999-01-01
% 218.56/218.80  |- skos__hiddenLabel mesh__D002389 Organic Catatonia
% 218.56/218.80  |- skos__hiddenLabel mesh__D002389 Lethal Catatonias
% 218.56/218.80  |- mesh__recordMaintainer mesh__D002389 nns
% 218.56/218.80  |- skos__prefLabel mesh__D002389 Catatonia
% 218.56/218.80  |- skos__hiddenLabel mesh__D002389 Catatonia, Schizophreniform
% 218.56/218.80  |- skos__altLabel mesh__D002389 Organic Catatonic Disorder
% 218.56/218.80  |- mesh__dateRevised mesh__D002389 2004-07-07
% 218.56/218.80  |- skos__hiddenLabel mesh__D002389 Organic Catatonic Disorders
% 218.56/218.80  |- skos__hiddenLabel mesh__D002389 Catatonias, Lethal
% 218.56/218.80  |- mesh__recordOriginator mesh__D002389 NLM
% 218.56/218.80  |- skos__hiddenLabel mesh__D002389 Schizophreniform Catatonias
% 218.56/218.80  |- skos__hiddenLabel mesh__D002389 Malignant Catatonia
% 218.56/218.80  |- skos__hiddenLabel mesh__D002389 Catatonic Disorders, Organic
% 218.56/218.80  |- skos__hiddenLabel mesh__D002389 Catatonias, Organic
% 218.56/218.80  |- skos__hiddenLabel mesh__D002389 Catatonias, Malignant
% 218.56/218.80  |- skos__hiddenLabel mesh__D002389 Organic Catatonias
% 218.56/218.80  |- rdf__type mesh__D002389sskos__Concept
% 218.56/218.80  |- skos__hiddenLabel mesh__D002389 Catatonic Disorder, Organic
% 218.56/218.80  |- skos__hiddenLabel mesh__D002389 Malignant Catatonias
% 218.56/218.80  |- skos__altLabel mesh__D002389 Lethal Catatonia
% 218.56/218.80  |- mesh__recordAuthorizer mesh__D002389 sjn
% 218.56/218.80  |- skos__hiddenLabel mesh__D002389 Catatonias, Schizophreniform
% 218.56/218.80  |- skos__hiddenLabel mesh__D002389 Catatonias
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D002389 2005
% 218.56/218.80  |- skos__related mesh__D002389smesh__D002375
% 218.56/218.80  |- skos__hiddenLabel mesh__D002389 Catatonia, Lethal
% 218.56/218.80  |- skos__broader mesh__D002389smesh__D019954
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D002389 2006
% 218.56/218.80  |- skos__broader mesh__D002389smesh__D001526
% 218.56/218.80  |- skos__scopeNote mesh__D002389
% 218.56/218.80       A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism %28%active or passive refusal to follow commands%29%, mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses %28%e.g., SCHIZOPHRENIA; MOOD DISORDERS%29% or organic disorders %28%NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.%29%. %28%From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994%29%%A%    
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007872 2005
% 218.56/218.80  |- mesh__historyNote mesh__D007872 78   
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007872 2004
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007872 2001
% 218.56/218.80  |- mesh__publicMeSHNote mesh__D007872 78   
% 218.56/218.80  |- skos__hiddenLabel mesh__D007872 Guardians, Legal
% 218.56/218.80  |- mesh__dateRevised mesh__D007872 1999-11-03
% 218.56/218.80  |- skos__broader mesh__D007872smesh__D009272
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007872 2003
% 218.56/218.80  |- skos__scopeNote mesh__D007872
% 218.56/218.80       A legal concept for individuals who are designated to act on behalf of persons who are considered incapable of acting in their own behalf, e.g., minors and persons found to be not mentally competent.%A%    
% 218.56/218.80  |- mesh__recordMaintainer mesh__D007872 jls
% 218.56/218.80  |- skos__hiddenLabel mesh__D007872 Legal Guardian
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007872 2000
% 218.56/218.80  |- skos__annotation mesh__D007872 specify state or country if pertinent   
% 218.56/218.80  |- mesh__recordAuthorizer mesh__D007872 sjn
% 218.56/218.80  |- mesh__dateEstablished mesh__D007872 1978-01-01
% 218.56/218.80  |- rdf__type mesh__D007872sskos__Concept
% 218.56/218.80  |- skos__prefLabel mesh__D007872 Legal Guardians
% 218.56/218.80  |- skos__related mesh__D007872smesh__D020458
% 218.56/218.80  |- mesh__recordOriginator mesh__D007872 EC
% 218.56/218.80  |- skos__hiddenLabel mesh__D007872 Guardian, Legal
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007872 2002
% 218.56/218.80  |- mesh__dateCreated mesh__D007872 1977-04-22
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007872 2006
% 218.56/218.80  |- skos__historyNote mesh__D007074 Immunoglobulins %28%1970%29%
% 218.56/218.80  |- skos__altLabel mesh__D007074 Immunoglobulin GT
% 218.56/218.80  |- rdf__type mesh__D007074sskos__Concept
% 218.56/218.80  |- skos__related mesh__D007074smesh__D017452
% 218.56/218.80  |- mesh__dateRevised mesh__D007074 2005-06-30
% 218.56/218.80  |- mesh__dateEstablished mesh__D007074 1973-01-01
% 218.56/218.80  |- mesh__dateCreated mesh__D007074 1999-01-01
% 218.56/218.80  |- mesh__recordAuthorizer mesh__D007074 sjn
% 218.56/218.80  |- mesh__publicMeSHNote mesh__D007074
% 218.56/218.80       2002; see IgG 1973-2001; for GAMMA GLOBULIN, 7S see GAMMA GLOBULIN, 7S 1965-1981%A%  
% 218.56/218.80  |- skos__hiddenLabel mesh__D007074 GT, Immunoglobulin
% 218.56/218.80  |- skos__scopeNote mesh__D007074
% 218.56/218.80       The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.%A%    
% 218.56/218.80  |- skos__altLabel mesh__D007074 IgG
% 218.56/218.80  |- skos__altLabel mesh__D007074 Gamma Globulin, 7S
% 218.56/218.80  |- mesh__recordMaintainer mesh__D007074 nns
% 218.56/218.80  |- skos__annotation mesh__D007074
% 218.56/218.80       gammopathy: coordinate IMMUNOGLOBULIN G %28%IM%29% with PARAPROTEINEMIAS %28%IM%29% but consider also HYPERGAMMAGLOBULINEMIA, follow text%A%  
% 218.56/218.80  |- skos__prefLabel mesh__D007074 Immunoglobulin G
% 218.56/218.80  |- skos__hiddenLabel mesh__D007074 7S Gamma Globulin
% 218.56/218.80  |- mesh__recordOriginator mesh__D007074 NLM
% 218.56/218.80  |- mesh__historyNote mesh__D007074 2002%28%1971%29%   
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007074 2006
% 218.56/218.80  |- skos__broader mesh__D007074smesh__D007132
% 218.56/218.80  |- mesh__dateEstablished mesh__D045991 2005-01-01
% 218.56/218.80  |- rdf__type mesh__D045991sskos__Concept
% 218.56/218.80  |- mesh__recordOriginator mesh__D045991 ags
% 218.56/218.80  |- skos__scopeNote mesh__D045991
% 218.56/218.80       Genus in the family FELIDAE comprised of small felines including the domestic cat, Felis catus %28%CATS%29% and its ancestor the wild cat, Felis silvestris.%A%    
% 218.56/218.80  |- mesh__publicMeSHNote mesh__D045991 2005; see CARNIVORA 1998-2004   
% 218.56/218.80  |- mesh__historyNote mesh__D045991 2005; use CARNIVORA 1998-2004   
% 218.56/218.80  |- mesh__recordAuthorizer mesh__D045991 sjn
% 218.56/218.80  |- skos__historyNote mesh__D045991 Carnivora %28%1964-2004%29%
% 218.56/218.80  |- mesh__recordMaintainer mesh__D045991 ags
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D045991 2005
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D045991 2006
% 218.56/218.80  |- mesh__dateCreated mesh__D045991 2004-07-07
% 218.56/218.80  |- skos__prefLabel mesh__D045991 Felis
% 218.56/218.80  |- skos__broader mesh__D045991smesh__D045989
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D031173 2004
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D031173 2005
% 218.56/218.80  |- mesh__publicMeSHNote mesh__D031173 2003   
% 218.56/218.80  |- mesh__dateEstablished mesh__D031173 2003-01-01
% 218.56/218.80  |- skos__prefLabel mesh__D031173 Aster Plant
% 218.56/218.80  |- skos__broader mesh__D031173smesh__D019659
% 218.56/218.80  |- mesh__dateCreated mesh__D031173 2002-07-02
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D031173 2006
% 218.56/218.80  |- mesh__historyNote mesh__D031173 2003   
% 218.56/218.80  |- skos__annotation mesh__D031173
% 218.56/218.80       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D031173 2003
% 218.56/218.80  |- rdf__type mesh__D031173sskos__Concept
% 218.56/218.80  |- skos__scopeNote mesh__D031173
% 218.56/218.80       A plant genus of the family ASTERACEAE.  This plant should not be confused with microtubule asters %28%MICROTUBULES%29% nor with aster yellows phytoplasma %28%mycoplasma-like organisms%29%.%A%    
% 218.56/218.80  |- mesh__dateRevised mesh__D003482 2000-06-22
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D003482 2005
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D003482 2003
% 218.56/218.80  |- mesh__recordOriginator mesh__D003482 EC
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D003482 2006
% 218.56/218.80  |- mesh__dateEstablished mesh__D003482 1978-01-01
% 218.56/218.80  |- mesh__recordMaintainer mesh__D003482 jls
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D003482 2004
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D003482 2001
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D003482 2002
% 218.56/218.80  |- mesh__recordAuthorizer mesh__D003482 sjn
% 218.56/218.80  |- skos__annotation mesh__D003482
% 218.56/218.80       %22%board, room %26% other personal assist serv%22%   
% 218.56/218.80  |- skos__broader mesh__D003482smesh__D005791
% 218.56/218.80  |- rdf__type mesh__D003482sskos__Concept
% 218.56/218.80  |- skos__prefLabel mesh__D003482 Custodial Care
% 218.56/218.80  |- mesh__historyNote mesh__D003482 78   
% 218.56/218.80  |- skos__scopeNote mesh__D003482
% 218.56/218.80       Board, room, and other personal assistance services generally provided on a long term basis. It excludes regular medical care.%A%    
% 218.56/218.80  |- skos__hiddenLabel mesh__D003482 Care, Custodial
% 218.56/218.80  |- mesh__publicMeSHNote mesh__D003482 78   
% 218.56/218.80  |- mesh__dateCreated mesh__D003482 1977-05-19
% 218.56/218.80  |- skos__hiddenLabel mesh__D011914 BN Rat
% 218.56/218.80  |- mesh__dateCreated mesh__D011914 1999-01-01
% 218.56/218.80  |- mesh__recordAuthorizer mesh__D011914 sjn
% 218.56/218.80  |- skos__hiddenLabel mesh__D011914 BN Rat, Inbred
% 218.56/218.80  |- skos__prefLabel mesh__D011914 Rats, Inbred BN
% 218.56/218.80  |- skos__altLabel mesh__D011914 Rats, Inbred Brown Norway
% 218.56/218.80  |- rdf__type mesh__D011914sskos__Concept
% 218.56/218.80  |- skos__annotation mesh__D011914
% 218.56/218.80       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag RATS%A%  
% 218.56/218.80  |- skos__altLabel mesh__D011914 Rats, BN
% 218.56/218.80  |- skos__historyNote mesh__D011914 Rats %28%1966-1971%29%
% 218.56/218.80  |- skos__hiddenLabel mesh__D011914 Inbred BN Rat
% 218.56/218.80  |- mesh__dateRevised mesh__D011914 2005-06-30
% 218.56/218.80  |- skos__hiddenLabel mesh__D011914 Inbred BN Rats
% 218.56/218.80  |- skos__hiddenLabel mesh__D011914 BN Rats
% 218.56/218.80  |- skos__hiddenLabel mesh__D011914 Rat, BN
% 218.56/218.80  |- mesh__recordMaintainer mesh__D011914 ags
% 218.56/218.80  |- skos__hiddenLabel mesh__D011914 BN Rats, Inbred
% 218.56/218.80  |- mesh__dateEstablished mesh__D011914 1991-01-01
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D011914 2006
% 218.56/218.80  |- mesh__historyNote mesh__D011914
% 218.56/218.80       91%28%72%29%; was see under RATS, INBRED STRAINS 1972-90   
% 218.56/218.80  |- mesh__publicMeSHNote mesh__D011914
% 218.56/218.80       91; was see under RATS, INBRED STRAINS 1972-90   
% 218.56/218.80  |- skos__broader mesh__D011914smesh__D011919
% 218.56/218.80  |- mesh__recordOriginator mesh__D011914 NLM
% 218.56/218.80  |- skos__hiddenLabel mesh__D011914 Rat, Inbred BN
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D011116 2006
% 218.56/218.80  |- rdf__type mesh__D011116sskos__Concept
% 218.56/218.80  |- skos__altLabel mesh__D011116 DNA 5%27%-Hydroxylkinase
% 218.56/218.80  |- skos__hiddenLabel mesh__D011116 Kinase, Polynucleotide 5%27%-Hydroxyl
% 218.56/218.80  |- skos__broader mesh__D011116smesh__D045643
% 218.56/218.80  |- skos__hiddenLabel mesh__D011116 5%27% Hydroxylpolynucleotide Kinase
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D011116 2005
% 218.56/218.80  |- skos__annotation mesh__D011116 DF: DNA KINASE   
% 218.56/218.80  |- mesh__recordAuthorizer mesh__D011116 sjn
% 218.56/218.80  |- skos__hiddenLabel mesh__D011116 Hydroxylkinase, Polynucleotide
% 218.56/218.80  |- skos__altLabel mesh__D011116 Polynucleotide Kinase
% 218.56/218.80  |- mesh__dateEstablished mesh__D011116 1991-01-01
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D011116 2004
% 218.56/218.80  |- skos__prefLabel mesh__D011116 Polynucleotide 5%27%-Hydroxyl-Kinase
% 218.56/218.80  |- skos__altLabel mesh__D011116 Polynucleotide Hydroxylkinase
% 218.56/218.80  |- mesh__historyNote mesh__D011116 98%28%75%29%   
% 218.56/218.80  |- mesh__dateRevised mesh__D011116 2003-07-09
% 218.56/218.80  |- skos__altLabel mesh__D011116 5%27%-Hydroxylpolynucleotide Kinase
% 218.56/218.80  |- mesh__recordOriginator mesh__D011116 NLM
% 218.56/218.80  |- skos__historyNote mesh__D011116 Phosphotransferases, ATP %28%1974%29%
% 218.56/218.80  |- skos__hiddenLabel mesh__D011116 Kinase, Polynucleotide
% 218.56/218.80  |- skos__broader mesh__D011116smesh__D017853
% 218.56/218.80  |- mesh__dateCreated mesh__D011116 1974-11-19
% 218.56/218.80  |- skos__altLabel mesh__D011116 Polynucleotide Hydroxykinase
% 218.56/218.80  |- mesh__recordMaintainer mesh__D011116 jmp
% 218.56/218.80  |- skos__hiddenLabel mesh__D011116 5%27%-Hydroxyl-Kinase, Polynucleotide
% 218.56/218.80  |- skos__hiddenLabel mesh__D011116 Polynucleotide 5%27% Hydroxyl Kinase
% 218.56/218.80  |- skos__hiddenLabel mesh__D011116 DNA 5%27% Hydroxylkinase
% 218.56/218.80  |- skos__hiddenLabel mesh__D011116 5%27%-Hydroxyl Kinase, Polynucleotide
% 218.56/218.80  |- skos__hiddenLabel mesh__D011116 Kinase, DNA
% 218.56/218.80  |- skos__altLabel mesh__D011116 Polynucleotide 5%27%-Hydroxyl Kinase
% 218.56/218.80  |- skos__hiddenLabel mesh__D011116 5%27%-Hydroxylkinase, DNA
% 218.56/218.80  |- skos__historyNote mesh__D011116 Polynucleotides %28%1974%29%
% 218.56/218.80  |- skos__scopeNote mesh__D011116
% 218.56/218.80       An enzyme that catalyzes the transfer of a phosphate group to the 5%27%-terminal hydroxyl groups of DNA and RNA. EC 2.7.1.78.%A%    
% 218.56/218.80  |- skos__altLabel mesh__D011116 DNA Kinase
% 218.56/218.80  |- skos__hiddenLabel mesh__D011116 Kinase, 5%27%-Hydroxylpolynucleotide
% 218.56/218.80  |- skos__hiddenLabel mesh__D011116 Hydroxykinase, Polynucleotide
% 218.56/218.80  |- mesh__publicMeSHNote mesh__D011116
% 218.56/218.80       98; see POLYNUCLEOTIDE HYDROXYLKINASE 1991-97; see PHOSPHOTRANSFERASES, ATP 1975-90%A%  
% 218.56/218.80  |- mesh__historyNote mesh__D007873
% 218.56/218.80       91%28%75%29%; was see under FEMUR HEAD NECROSIS 1979-90; was see under OSTEOCHONDRITIS 1963-78; COXA PLANA was see under OSTEOCHONDRITIS 1963-78%A%  
% 218.56/218.80  |- skos__historyNote mesh__D007873 Femur Head %28%1966-1972%29%
% 218.56/218.80  |- skos__broader mesh__D007873smesh__D005271
% 218.56/218.80  |- skos__altLabel mesh__D007873 Perthes Disease
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007873 2003
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007873 1995
% 218.56/218.80  |- skos__altLabel mesh__D007873 Coxa Plana
% 218.56/218.80  |- mesh__publicMeSHNote mesh__D007873
% 218.56/218.80       91; was see under FEMUR HEAD NECROSIS 1979-90; was see under OSTEOCHRONDRITIS 1963-78; COXA PLANA was see under OSTEOCHRONDRITIS 1963-78%A%  
% 218.56/218.80  |- mesh__dateCreated mesh__D007873 1999-01-01
% 218.56/218.80  |- skos__hiddenLabel mesh__D007873 Disease, Perthes
% 218.56/218.80  |- mesh__recordAuthorizer mesh__D007873 PLS
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007873 1994
% 218.56/218.80  |- mesh__recordOriginator mesh__D007873 NLM
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007873 1993
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007873 2001
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007873 1991
% 218.56/218.80  |- rdf__type mesh__D007873sskos__Concept
% 218.56/218.80  |- skos__historyNote mesh__D007873 Necrosis %28%1966-1972%29%
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007873 1999
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007873 1992
% 218.56/218.80  |- skos__scopeNote mesh__D007873
% 218.56/218.80       A particular type of FEMUR HEAD NECROSIS occurring in children, mainly male, with a course of four years or so.%A%    
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007873 2000
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007873 1998
% 218.56/218.80  |- skos__annotation mesh__D007873 a type of femur head necrosis   
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007873 1997
% 218.56/218.80  |- skos__prefLabel mesh__D007873 Legg-Perthes Disease
% 218.56/218.80  |- mesh__onlineNote mesh__D007873
% 218.56/218.80       search OSTEOCHONDRITIS 1966-74; use LEGG-PERTHES DISEASE to search COXA PLANA 1975-78, use OSTEOCHONDRITIS 1966-74%A%  
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007873 2006
% 218.56/218.80  |- skos__historyNote mesh__D007873 Femur Head Necrosis %28%1973-1974%29%
% 218.56/218.80  |- mesh__recordMaintainer mesh__D007873 TGC
% 218.56/218.80  |- skos__hiddenLabel mesh__D007873 Legg Perthes Disease
% 218.56/218.80  |- skos__hiddenLabel mesh__D007873 Disease, Legg-Perthes
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007873 1996
% 218.56/218.80  |- mesh__dateEstablished mesh__D007873 1991-01-01
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007873 2005
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007873 2004
% 218.56/218.80  |- skos__historyNote mesh__D007873 Osteochondritis %28%1966-1974%29%
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007873 2002
% 218.56/218.80  |- mesh__dateRevised mesh__D007873 1990-05-29
% 218.56/218.80  |- skos__hiddenLabel mesh__D007075 19S Gamma Globulin
% 218.56/218.80  |- rdf__type mesh__D007075sskos__Concept
% 218.56/218.80  |- mesh__recordOriginator mesh__D007075 NLM
% 218.56/218.80  |- skos__related mesh__D007075smesh__D007144
% 218.56/218.80  |- skos__broader mesh__D007075smesh__D007132
% 218.56/218.80  |- mesh__dateCreated mesh__D007075 1999-01-01
% 218.56/218.80  |- mesh__historyNote mesh__D007075 2002%28%1973%29%   
% 218.56/218.80  |- skos__scopeNote mesh__D007075
% 218.56/218.80       A class of immunoglobulin bearing mu chains %28%IMMUNOGLOBULIN MU-CHAINS%29%. IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally being called a macroglobulin.%A%    
% 218.56/218.80  |- mesh__publicMeSHNote mesh__D007075
% 218.56/218.80       2002; see IgM 1973-2001; for GAMMA GLOBULIN, 19S see GAMMA GLOBULIN, 19S 1965-1981%A%  
% 218.56/218.80  |- skos__altLabel mesh__D007075 IgM
% 218.56/218.80  |- skos__annotation mesh__D007075
% 218.56/218.80       /defic = IMMUNOGLOBULIN M / defic + DYSGAMMAGLOBULINEMIA %28%IM%29%; gammopathy: coordinate IMMUNOGLOBULIN M %28%IM%29% with PARAPROTEINEMIAS %28%IM%29% but consider also HYPERGAMMAGLOBULINEMIA %28%IM%29%, follow text;%A%  
% 218.56/218.80  |- skos__altLabel mesh__D007075 Gamma Globulin, 19S
% 218.56/218.80  |- mesh__dateRevised mesh__D007075 2005-06-30
% 218.56/218.80  |- mesh__dateEstablished mesh__D007075 1973-01-01
% 218.56/218.80  |- mesh__recordMaintainer mesh__D007075 ssb
% 218.56/218.80  |- mesh__recordAuthorizer mesh__D007075 sjn
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D007075 2006
% 218.56/218.80  |- skos__historyNote mesh__D007075 Immunoglobulins %28%1970%29%
% 218.56/218.80  |- skos__prefLabel mesh__D007075 Immunoglobulin M
% 218.56/218.80  |- mesh__recordOriginator mesh__D015507 AGS
% 218.56/218.80  |- rdf__type mesh__D015507sskos__Concept
% 218.56/218.80  |- skos__historyNote mesh__D015507 Clinical Trials %28%1966-1989%29%
% 218.56/218.80  |- skos__prefLabel mesh__D015507 Drugs, Investigational
% 218.56/218.80  |- skos__hiddenLabel mesh__D015507 New Drugs, Investigational
% 218.56/218.80  |- skos__related mesh__D015507smesh__D004341
% 218.56/218.80  |- skos__altLabel mesh__D015507 Investigational New Drugs
% 218.56/218.80  |- skos__broader mesh__D015507smesh__D004364
% 218.56/218.80  |- skos__historyNote mesh__D015507 Drugs %28%1966-1989%29%
% 218.56/218.80  |- skos__scopeNote mesh__D015507
% 218.56/218.80       Drugs which have received FDA approval for human testing but have yet to be approved for commercial marketing. This includes drugs used for treatment while they still are undergoing clinical trials %28%Treatment IND%29%. The main heading includes drugs under investigation in foreign countries.%A%    
% 218.56/218.80  |- mesh__recordMaintainer mesh__D015507 sjn
% 218.56/218.80  |- mesh__recordAuthorizer mesh__D015507 sjn
% 218.56/218.80  |- skos__annotation mesh__D015507
% 218.56/218.80       D25-26 qualif; coord IM with specific drug %28%IM%29%; not restricted to FDA studies: may be used for investigational drugs in other countries%A%  
% 218.56/218.80  |- mesh__dateRevised mesh__D015507 2004-07-13
% 218.56/218.80  |- skos__hiddenLabel mesh__D015507 Drugs, Investigational New
% 218.56/218.80  |- skos__related mesh__D015507smesh__D002986
% 218.56/218.80  |- skos__historyNote mesh__D015507 Drug Evaluation %28%1974-1989%29%
% 218.56/218.80  |- mesh__dateEstablished mesh__D015507 1990-01-01
% 218.56/218.80  |- mesh__dateCreated mesh__D015507 1989-04-07
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D015507 2006
% 218.56/218.80  |- mesh__publicMeSHNote mesh__D015507 90   
% 218.56/218.80  |- skos__related mesh__D015507smesh__D017387
% 218.56/218.80  |- skos__altLabel mesh__D015507 Investigational Drugs
% 218.56/218.80  |- mesh__historyNote mesh__D015507 90   
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D015507 2005
% 218.56/218.80  |- skos__prefLabel mesh__D031174 Atractylodes
% 218.56/218.80  |- mesh__historyNote mesh__D031174 2003   
% 218.56/218.80  |- skos__annotation mesh__D031174
% 218.56/218.80       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D031174 2003
% 218.56/218.80  |- mesh__dateEstablished mesh__D031174 2003-01-01
% 218.56/218.80  |- rdf__type mesh__D031174sskos__Concept
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D031174 2004
% 218.56/218.80  |- skos__scopeNote mesh__D031174
% 218.56/218.80       A plant genus of the family ASTERACEAE. Members contain hinesol and atractylon. Atractylodes rhizome is Byaku-jutsu. A. lancea rhizome is So-jutsu.%A%    
% 218.56/218.80  |- mesh__dateCreated mesh__D031174 2002-07-02
% 218.56/218.80  |- skos__altLabel mesh__D031174 Jutsu
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D031174 2005
% 218.56/218.80  |- mesh__publicMeSHNote mesh__D031174 2003   
% 218.56/218.80  |- skos__broader mesh__D031174smesh__D019659
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D031174 2006
% 218.56/218.80  |- skos__broader mesh__D003483smesh__D012873
% 218.56/218.80  |- mesh__dateRevised mesh__D003483 2001-07-25
% 218.56/218.80  |- skos__hiddenLabel mesh__D003483 Dermatolyses
% 218.56/218.80  |- mesh__publicMeSHNote mesh__D003483 68; was DERMATOLYSIS 1963-67   
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D003483 2004
% 218.56/218.80  |- skos__prefLabel mesh__D003483 Cutis Laxa
% 218.56/218.80  |- skos__altLabel mesh__D003483 Dermatolysis
% 218.56/218.80  |- mesh__historyNote mesh__D003483 68; was DERMATOLYSIS 1963-67   
% 218.56/218.80  |- mesh__onlineNote mesh__D003483
% 218.56/218.80       use CUTIS LAXA to search DERMATOLYSIS 1966-67   
% 218.56/218.80  |- skos__altLabel mesh__D003483 Dermatomegaly
% 218.56/218.80  |- rdf__type mesh__D003483sskos__Concept
% 218.56/218.80  |- mesh__dateCreated mesh__D003483 1999-01-01
% 218.56/218.80  |- skos__related mesh__D003483smesh__D004535
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D003483 2002
% 218.56/218.80  |- skos__broader mesh__D003483smesh__D003240
% 218.56/218.80  |- mesh__recordOriginator mesh__D003483 NLM
% 218.56/218.80  |- mesh__recordAuthorizer mesh__D003483 sjn
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D003483 2005
% 218.56/218.80  |- skos__annotation mesh__D003483 loose pendulous skin   
% 218.56/218.80  |- mesh__recordMaintainer mesh__D003483 nns
% 218.56/218.80  |- skos__scopeNote mesh__D003483
% 218.56/218.80       A group of connective tissue diseases in which skin hangs in loose pendulous folds. It is believed to be associated with decreased elastic tissue formation as well as an abnormality in elastin formation. Cutis laxa is usually a genetic disease, but acquired cases have been reported. %28%From Dorland, 27th ed%29%%A%    
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D003483 2003
% 218.56/218.80  |- mesh__dateEstablished mesh__D003483 1968-01-01
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D003483 2006
% 218.56/218.80  |- skos__hiddenLabel mesh__D011915 BUF Rat, Inbred
% 218.56/218.80  |- mesh__activeMeSHYear mesh__D011915 2006
% 218.56/218.80  |- skos__altLabel mesh__D011915 Rats, BUF
% 218.56/218.80  |- skos__prefLabel mesh__D011915 Rats, Inbred BUF
% 218.56/218.80  |- mesh__dateEstablished mesh__D011915 1991-01-01
% 218.56/218.80  |- mesh__historyNote mesh__D011915
% 218.56/218.80       91%28%72%29%; was see under RATS, INBRED STRAINS 1972-90   
% 218.56/218.80  |- skos__hiddenLabel mesh__D011915 Inbred Buffalo Rats
% 218.56/218.80  |- mesh__recordOriginator mesh__D011915 NLM
% 218.56/218.80  |- skos__hiddenLabel mesh__D011915 BUF Rat
% 218.56/218.80  |- skos__hiddenLabel mesh__D011915 Inbred BUF Rat
% 218.56/218.80  |- mesh__dateCreated mesh__D011915 1999-01-01
% 218.56/218.80  |- skos__hiddenLabel mesh__D011915 BUF Rats
% 218.56/218.80  |- rdf__type mesh__D011915sskos__Concept
% 218.56/218.80  |- mesh__recordAuthorizer mesh__D011915 sjn
% 218.56/218.80  |- skos__hiddenLabel mesh__D011915 Inbred BUF Rats
% 218.56/218.80  |- skos__hiddenLabel mesh__D011915 Rat, BUF
% 218.56/218.80  |- skos__hiddenLabel mesh__D011915 BUF Rats, Inbred
% 218.56/218.80  |- skos__broader mesh__D011915smesh__D011919
% 218.56/218.80  |- skos__annotation mesh__D011915
% 218.56/218.80       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag RATS%A%  
% 218.56/218.80  |- mesh__recordMaintainer mesh__D011915 ags
% 218.56/218.80  |- mesh__dateRevised mesh__D011915 2005-06-30
% 218.56/218.80  |- skos__altLabel mesh__D011915 Rats, Inbred Buffalo
% 218.56/218.80  |- skos__hiddenLabel mesh__D011915 Rat, Inbred BUF
% 218.56/218.80  |- mesh__publicMeSHNote mesh__D011915
% 218.56/218.80       91; was see under RATS, INBRED STRAINS 1972-90   
% 218.56/218.80  |- skos__hiddenLabel mesh__D011915 Buffalo Rats, Inbred
% 218.56/218.80  |- skos__historyNote mesh__D011915 Rats %28%1966-1971%29%
% 218.56/218.80  |- mesh__dateRevised mesh__D011117 2003-07-09
% 218.56/218.80  |- skos__historyNote mesh__D011117
% 218.56/218.80       RNA Nucleotidyltransferases %28%1968-1971%29%
% 218.56/218.80  |- skos__hiddenLabel mesh__D011117 Phosphorylase, Polynucleotide
% 218.56/218.81  |- skos__scopeNote mesh__D011117
% 218.56/218.81       An enzyme of the transferase class that catalyzes the reaction RNA%28%n+1%29% and orthophosphate to yield RNA%28%n%29% and a nucleoside diphosphate, or the reverse reaction. ADP, IDP, GDP, UDP, and CDP can act as donors in the latter case. %28%From Dorland, 27th ed%29% EC 2.7.7.8.%A%    
% 218.56/218.81  |- skos__historyNote mesh__D011117
% 218.56/218.81       Nucleotidyltransferases %28%1966-1971%29%
% 218.56/218.81  |- skos__broader mesh__D011117smesh__D012316
% 218.56/218.81  |- skos__hiddenLabel mesh__D011117
% 218.56/218.81       Nucleotidyltransferase, Polyribonucleotide
% 218.56/218.81  |- mesh__dateCreated mesh__D011117 1999-01-01
% 218.56/218.81  |- mesh__publicMeSHNote mesh__D011117
% 218.56/218.81       98; see POLYNUCLEOTIDE PHOSPHORYLASE 1973-97, NUCLEOTIDYLTRANSFERASES 1968-72, %26% NUCLEOTIDYL TRANSFERASES 1963-67%A%  
% 218.56/218.81  |- skos__prefLabel mesh__D011117 Polyribonucleotide Nucleotidyltransferase
% 218.56/218.81  |- mesh__historyNote mesh__D011117
% 218.56/218.81       98%28%72%29%; use NUCLEOTIDYLTRANSFERASES 1968-72, use NUCLEOTIDYL TRANSFERASES 1963-67%A%  
% 218.56/218.81  |- mesh__dateEstablished mesh__D011117 1974-01-01
% 218.56/218.81  |- mesh__recordAuthorizer mesh__D011117 sjn
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D011117 2006
% 218.56/218.81  |- rdf__type mesh__D011117sskos__Concept
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D011117 2005
% 218.56/218.81  |- skos__altLabel mesh__D011117 Polynucleotide Phosphorylase
% 218.56/218.81  |- mesh__recordOriginator mesh__D011117 NLM
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D011117 2004
% 218.56/218.81  |- mesh__recordMaintainer mesh__D011117 ssb
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D007874 2002
% 218.56/218.81  |- mesh__publicMeSHNote mesh__D007874
% 218.56/218.81       91; was see under HEMEPROTEINS 1975-90   
% 218.56/218.81  |- mesh__dateCreated mesh__D007874 1974-11-19
% 218.56/218.81  |- skos__annotation mesh__D007874 from leguminous plants   
% 218.56/218.81  |- skos__broader mesh__D007874smesh__D006420
% 218.56/218.81  |- skos__scopeNote mesh__D007874
% 218.56/218.81       A hemoglobin-like oxygen-binding hemeprotein present in the nitrogen-fixing root nodules of leguminous plants. The red pigment has a molecular weight approximately 1/4 that of hemoglobin and has been suggested to act as an oxido-reduction catalyst in symbiotic nitrogen fixation.%A%    
% 218.56/218.81  |- skos__historyNote mesh__D007874 Plant Proteins %28%1972-1974%29%
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D007874 1998
% 218.56/218.81  |- mesh__dateRevised mesh__D007874 1995-05-19
% 218.56/218.81  |- mesh__recordAuthorizer mesh__D007874 PLS
% 218.56/218.81  |- mesh__dateEstablished mesh__D007874 1991-01-01
% 218.56/218.81  |- skos__broader mesh__D007874smesh__D010940
% 218.56/218.81  |- rdf__type mesh__D007874sskos__Concept
% 218.56/218.81  |- mesh__recordMaintainer mesh__D007874 KEV
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D007874 1996
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D007874 1999
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D007874 2005
% 218.56/218.81  |- mesh__historyNote mesh__D007874
% 218.56/218.81       91%28%75%29%; was see under HEMEPROTEINS 1975-90   
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D007874 2000
% 218.56/218.81  |- skos__prefLabel mesh__D007874 Leghemoglobin
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D007874 1997
% 218.56/218.81  |- mesh__recordOriginator mesh__D007874 NLM
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D007874 2003
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D007874 2006
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D007874 2001
% 218.56/218.81  |- skos__historyNote mesh__D007874 Hemeproteins %28%1973-1974%29%
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D007874 2004
% 218.56/218.81  |- mesh__recordAuthorizer mesh__D007076 sjn
% 218.56/218.81  |- skos__annotation mesh__D007076 IM; qualif permitted   
% 218.56/218.81  |- mesh__historyNote mesh__D007076
% 218.56/218.81       91%28%75%29%; was see under LIZARDS 1975-90   
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D007076 2004
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D007076 2005
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D007076 2006
% 218.56/218.81  |- skos__prefLabel mesh__D007076 Iguanas
% 218.56/218.81  |- mesh__recordOriginator mesh__D007076 NLM
% 218.56/218.81  |- rdf__type mesh__D007076sskos__Concept
% 218.56/218.81  |- skos__broader mesh__D007076smesh__D008116
% 218.56/218.81  |- skos__hiddenLabel mesh__D007076 Iguana
% 218.56/218.81  |- mesh__dateEstablished mesh__D007076 1991-01-01
% 218.56/218.81  |- skos__scopeNote mesh__D007076
% 218.56/218.81       Large herbivorous tropical American lizards.     
% 218.56/218.81  |- mesh__publicMeSHNote mesh__D007076 91; was see under LIZARDS 1975-90   
% 218.56/218.81  |- mesh__dateRevised mesh__D007076 2003-07-09
% 218.56/218.81  |- mesh__recordMaintainer mesh__D007076 ags
% 218.56/218.81  |- mesh__dateCreated mesh__D007076 1974-12-12
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D015508 1994
% 218.56/218.81  |- skos__annotation mesh__D015508
% 218.56/218.81       may be anywhere in the nasal passages or cavity   
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D015508 1993
% 218.56/218.81  |- skos__historyNote mesh__D015508 Nose Diseases %28%1966-1989%29%
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D015508 2003
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D015508 1998
% 218.56/218.81  |- skos__broader mesh__D015508smesh__D000402
% 218.56/218.81  |- mesh__historyNote mesh__D015508 90   
% 218.56/218.81  |- skos__historyNote mesh__D015508 Airway Obstruction %28%1972-1989%29%
% 218.56/218.81  |- skos__scopeNote mesh__D015508
% 218.56/218.81       Any hindrance to the passage of air into and out of the nose. The obstruction may be in the nasal vestibule, fossae, or other areas of the nasal cavity.%A%    
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D015508 1997
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D015508 1992
% 218.56/218.81  |- skos__hiddenLabel mesh__D015508 Obstruction, Nasal
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D015508 1996
% 218.56/218.81  |- mesh__dateEstablished mesh__D015508 1990-01-01
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D015508 2006
% 218.56/218.81  |- mesh__recordAuthorizer mesh__D015508 NLM
% 218.56/218.81  |- mesh__publicMeSHNote mesh__D015508 90   
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D015508 2002
% 218.56/218.81  |- mesh__recordMaintainer mesh__D015508 PLS
% 218.56/218.81  |- skos__prefLabel mesh__D015508 Nasal Obstruction
% 218.56/218.81  |- skos__hiddenLabel mesh__D015508 Obstructions, Nasal
% 218.56/218.81  |- skos__hiddenLabel mesh__D015508 Nasal Obstructions
% 218.56/218.81  |- skos__historyNote mesh__D015508 Airway Resistance %28%1980-1989%29%
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D015508 2005
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D015508 1995
% 218.56/218.81  |- rdf__type mesh__D015508sskos__Concept
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D015508 1991
% 218.56/218.81  |- mesh__dateRevised mesh__D015508 1990-05-29
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D015508 2001
% 218.56/218.81  |- mesh__activeMeSHYear mesh__D015508 2004
% 218.56/218.81  |- mesh__recordOriginator mesh__D015508 PXP
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D015508 1999
% 218.67/218.81  |- mesh__dateCreated mesh__D015508 1989-04-07
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D015508 2000
% 218.67/218.81  |- skos__broader mesh__D015508smesh__D009668
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D012210 2005
% 218.67/218.81  |- mesh__recordMaintainer mesh__D012210 ssb
% 218.67/218.81  |- mesh__recordAuthorizer mesh__D012210 sjn
% 218.67/218.81  |- skos__altLabel mesh__D012210 Deoxymannose
% 218.67/218.81  |- rdf__type mesh__D012210sskos__Concept
% 218.67/218.81  |- skos__broader mesh__D012210smesh__D003837
% 218.67/218.81  |- mesh__recordOriginator mesh__D012210 NLM
% 218.67/218.81  |- mesh__publicMeSHNote mesh__D012210 66   
% 218.67/218.81  |- mesh__dateCreated mesh__D012210 1999-01-01
% 218.67/218.81  |- skos__hiddenLabel mesh__D012210 Rhamnose, L Isomer
% 218.67/218.81  |- skos__prefLabel mesh__D012210 Rhamnose
% 218.67/218.81  |- skos__scopeNote mesh__D012210
% 218.67/218.81       A methylpentose whose L- isomer is found naturally in many plant glycosides and some gram-negative bacterial lipopolysaccharides.%A%    
% 218.67/218.81  |- skos__broader mesh__D012210smesh__D006601
% 218.67/218.81  |- mesh__historyNote mesh__D012210 66%28%63%29%   
% 218.67/218.81  |- mesh__dateEstablished mesh__D012210 1966-01-01
% 218.67/218.81  |- mesh__dateRevised mesh__D012210 2004-07-07
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D012210 2006
% 218.67/218.81  |- skos__annotation mesh__D031175
% 218.67/218.81       X ref BROOM, DESERT: several other Broom terms are also available; check text and MeSH; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D031175 2003
% 218.67/218.81  |- rdf__type mesh__D031175sskos__Concept
% 218.67/218.81  |- mesh__historyNote mesh__D031175 2003   
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D031175 2004
% 218.67/218.81  |- skos__altLabel mesh__D031175 Willow, Water
% 218.67/218.81  |- skos__altLabel mesh__D031175 Broom, Desert
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D031175 2005
% 218.67/218.81  |- mesh__publicMeSHNote mesh__D031175 2003   
% 218.67/218.81  |- skos__prefLabel mesh__D031175 Baccharis
% 218.67/218.81  |- mesh__dateEstablished mesh__D031175 2003-01-01
% 218.67/218.81  |- skos__broader mesh__D031175smesh__D019659
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D031175 2006
% 218.67/218.81  |- skos__altLabel mesh__D031175 Water Willow
% 218.67/218.81  |- skos__scopeNote mesh__D031175
% 218.67/218.81       A plant genus of the family ASTERACEAE. Other plants called broom include CYTISUS; SPARTIUM; and BROMUS.%A%    
% 218.67/218.81  |- mesh__dateCreated mesh__D031175 2002-07-02
% 218.67/218.81  |- rdf__type mesh__D003484sskos__Concept
% 218.67/218.81  |- skos__altLabel mesh__D003484 Calcium Cyanamide
% 218.67/218.81  |- mesh__recordAuthorizer mesh__D003484 sjn
% 218.67/218.81  |- skos__historyNote mesh__D003484 Cyanides %28%1966-1978%29%
% 218.67/218.81  |- skos__broader mesh__D003484smesh__D003486
% 218.67/218.81  |- skos__hiddenLabel mesh__D003484 Cyanamide, Calcium
% 218.67/218.81  |- skos__altLabel mesh__D003484 Calcium Carbimide
% 218.67/218.81  |- mesh__recordOriginator mesh__D003484 RLS
% 218.67/218.81  |- skos__hiddenLabel mesh__D003484 Cyanamide, Citrated Calcium
% 218.67/218.81  |- skos__historyNote mesh__D003484 Amines %28%1966-1978%29%
% 218.67/218.81  |- skos__prefLabel mesh__D003484 Cyanamide
% 218.67/218.81  |- skos__scopeNote mesh__D003484
% 218.67/218.81       A cyanide compound which has been used as a fertilizer, defoliant and in many manufacturing processes. It often occurs as the calcium salt, sometimes also referred to as cyanamide. The citrated calcium salt is used in the treatment of alcoholism.%A%    
% 218.67/218.81  |- skos__altLabel mesh__D003484 Colme
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D003484 2006
% 218.67/218.81  |- skos__hiddenLabel mesh__D003484 Calcium Salt Cyanamide
% 218.67/218.81  |- mesh__historyNote mesh__D003484
% 218.67/218.81       91%28%79%29%; was see under CYANIDES 1979-90   
% 218.67/218.81  |- skos__hiddenLabel mesh__D003484 Calcium Cyanamide, Citrated
% 218.67/218.81  |- mesh__dateRevised mesh__D003484 2005-06-30
% 218.67/218.81  |- mesh__publicMeSHNote mesh__D003484 91; was see under CYANIDES 1979-90   
% 218.67/218.81  |- skos__altLabel mesh__D003484 Carbimide
% 218.67/218.81  |- mesh__recordMaintainer mesh__D003484 ssb
% 218.67/218.81  |- skos__hiddenLabel mesh__D003484 Carbimide, Calcium
% 218.67/218.81  |- mesh__dateCreated mesh__D003484 1978-05-18
% 218.67/218.81  |- mesh__dateEstablished mesh__D003484 1991-01-01
% 218.67/218.81  |- skos__altLabel mesh__D003484 Ipsen Brand of Calcium Carbimide
% 218.67/218.81  |- skos__hiddenLabel mesh__D011916 F344 Rat, Inbred
% 218.67/218.81  |- mesh__dateRevised mesh__D011916 2005-06-30
% 218.67/218.81  |- mesh__publicMeSHNote mesh__D011916
% 218.67/218.81       91; was see under RATS, INBRED STRAINS 1972-90   
% 218.67/218.81  |- skos__hiddenLabel mesh__D011916 Inbred F344 Rat
% 218.67/218.81  |- skos__hiddenLabel mesh__D011916 Rat, F344
% 218.67/218.81  |- skos__historyNote mesh__D011916 Rats %28%1966-1971%29%
% 218.67/218.81  |- skos__hiddenLabel mesh__D011916 Rat, Inbred F344
% 218.67/218.81  |- skos__altLabel mesh__D011916 Rats, Inbred Fischer 344
% 218.67/218.81  |- mesh__dateCreated mesh__D011916 1999-01-01
% 218.67/218.81  |- skos__altLabel mesh__D011916 Rats, F344
% 218.67/218.81  |- skos__altLabel mesh__D011916 Fischer Rats
% 218.67/218.81  |- rdf__type mesh__D011916sskos__Concept
% 218.67/218.81  |- skos__hiddenLabel mesh__D011916 Inbred CDF Rats
% 218.67/218.81  |- skos__prefLabel mesh__D011916 Rats, Inbred F344
% 218.67/218.81  |- skos__altLabel mesh__D011916 Rats, Inbred CDF
% 218.67/218.81  |- skos__hiddenLabel mesh__D011916 F344 Rat
% 218.67/218.81  |- skos__hiddenLabel mesh__D011916 CDF Rat, Inbred
% 218.67/218.81  |- mesh__historyNote mesh__D011916
% 218.67/218.81       91%28%72%29%; was see under RATS, INBRED STRAINS 1972-90   
% 218.67/218.81  |- skos__hiddenLabel mesh__D011916 F344 Rats, Inbred
% 218.67/218.81  |- skos__broader mesh__D011916smesh__D011919
% 218.67/218.81  |- skos__hiddenLabel mesh__D011916 Rats, Fischer
% 218.67/218.81  |- skos__hiddenLabel mesh__D011916 F344 Rats
% 218.67/218.81  |- mesh__recordOriginator mesh__D011916 NLM
% 218.67/218.81  |- mesh__recordMaintainer mesh__D011916 ags
% 218.67/218.81  |- mesh__recordAuthorizer mesh__D011916 sjn
% 218.67/218.81  |- skos__hiddenLabel mesh__D011916 Rat, Inbred CDF
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D011916 2006
% 218.67/218.81  |- skos__annotation mesh__D011916
% 218.67/218.81       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag RATS%A%  
% 218.67/218.81  |- skos__altLabel mesh__D011916 Rats, Inbred Fisher 344
% 218.67/218.81  |- mesh__dateEstablished mesh__D011916 1991-01-01
% 218.67/218.81  |- skos__hiddenLabel mesh__D011916 Inbred F344 Rats
% 218.67/218.81  |- skos__hiddenLabel mesh__D011916 CDF Rats, Inbred
% 218.67/218.81  |- skos__hiddenLabel mesh__D011916 Inbred CDF Rat
% 218.67/218.81  |- skos__prefLabel mesh__D011118 Polynucleotide Ligases
% 218.67/218.81  |- mesh__publicMeSHNote mesh__D011118
% 218.67/218.81       98; see POLYNUCLEOTIDE SYNTHETASES 1974-97   
% 218.67/218.81  |- mesh__recordMaintainer mesh__D011118 ssb
% 218.67/218.81  |- mesh__dateCreated mesh__D011118 1999-01-01
% 218.67/218.81  |- mesh__recordOriginator mesh__D011118 NLM
% 218.67/218.81  |- skos__broader mesh__D011118smesh__D008025
% 218.67/218.81  |- skos__altLabel mesh__D011118 Polynucleotide Synthetases
% 218.67/218.81  |- skos__annotation mesh__D011118
% 218.67/218.81       do not confuse X ref POLYNUCLEOTIDE SYNTHETASES with X refs POLYRIBONUCLEOTIDE SYNTHETASE or POLYDEOXYRIBONUCLEOTIDE SYNTHETASES%A%  
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D011118 2006
% 218.67/218.81  |- rdf__type mesh__D011118sskos__Concept
% 218.67/218.81  |- skos__hiddenLabel mesh__D011118 Ligases, Polynucleotide
% 218.67/218.81  |- skos__historyNote mesh__D011118 Ligases %28%1966-1973%29%
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D011118 2005
% 218.67/218.81  |- mesh__historyNote mesh__D011118 98%28%74%29%   
% 218.67/218.81  |- skos__hiddenLabel mesh__D011118 Synthetases, Polynucleotide
% 218.67/218.81  |- skos__scopeNote mesh__D011118
% 218.67/218.81       Catalyze the joining of preformed ribonucleotides or deoxyribonucleotides in phosphodiester linkage during genetic processes. EC 6.5.1.%A%    
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D011118 2004
% 218.67/218.81  |- mesh__recordAuthorizer mesh__D011118 sjn
% 218.67/218.81  |- mesh__dateRevised mesh__D011118 2003-07-09
% 218.67/218.81  |- mesh__recordAuthorizer mesh__D016601 sjn
% 218.67/218.81  |- skos__hiddenLabel mesh__D016601 RNA Binding Protein
% 218.67/218.81  |- mesh__publicMeSHNote mesh__D016601
% 218.67/218.81       92; RNA-BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-91%A%  
% 218.67/218.81  |- mesh__recordOriginator mesh__D016601 RLS
% 218.67/218.81  |- mesh__dateEstablished mesh__D016601 1992-01-01
% 218.67/218.81  |- mesh__recordMaintainer mesh__D016601 SYSTEM
% 218.67/218.81  |- skos__broader mesh__D016601smesh__D009698
% 218.67/218.81  |- mesh__historyNote mesh__D016601
% 218.67/218.81       92; was RNA-BINDING PROTEINS %28%NM%29% 1980-91   
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D016601 2006
% 218.67/218.81  |- skos__altLabel mesh__D016601 RNA-Binding Protein
% 218.67/218.81  |- skos__prefLabel mesh__D016601 RNA-Binding Proteins
% 218.67/218.81  |- skos__hiddenLabel mesh__D016601 RNA Binding Proteins
% 218.67/218.81  |- mesh__onlineNote mesh__D016601
% 218.67/218.81       use RNA-BINDING PROTEINS %28%NM%29% to search RNA-BINDING PROTEINS 1980-91%A%  
% 218.67/218.81  |- skos__scopeNote mesh__D016601
% 218.67/218.81       Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other proteins whose function is to bind specifically to RNA.%A%    
% 218.67/218.81  |- mesh__dateRevised mesh__D016601 2005-06-30
% 218.67/218.81  |- skos__hiddenLabel mesh__D016601 Double Stranded RNA Binding Proteins
% 218.67/218.81  |- mesh__dateCreated mesh__D016601 1991-01-25
% 218.67/218.81  |- skos__hiddenLabel mesh__D016601 RNA-Binding Proteins, Double-Stranded
% 218.67/218.81  |- rdf__type mesh__D016601sskos__Concept
% 218.67/218.81  |- skos__historyNote mesh__D016601 RNA %28%1966-1991%29%
% 218.67/218.81  |- skos__historyNote mesh__D016601 Carrier Proteins %28%1971-1991%29%
% 218.67/218.81  |- skos__altLabel mesh__D016601 ds RNA-Binding Proteins
% 218.67/218.81  |- skos__annotation mesh__D016601 GEN; prefer specifics   
% 218.67/218.81  |- skos__broader mesh__D016601smesh__D002352
% 218.67/218.81  |- skos__historyNote mesh__D007875
% 218.67/218.81       Legionnaires%27% Disease %28%1978-1980%29%
% 218.67/218.81  |- skos__scopeNote mesh__D007875
% 218.67/218.81       Gram-negative aerobic rods, isolated from surface water, mud, or thermally polluted lakes or streams. It is pathogenic for man and it has no known soil or animal sources.%A%    
% 218.67/218.81  |- mesh__dateRevised mesh__D007875 2005-06-30
% 218.67/218.81  |- rdf__type mesh__D007875sskos__Concept
% 218.67/218.81  |- mesh__historyNote mesh__D007875 81   
% 218.67/218.81  |- mesh__recordAuthorizer mesh__D007875 sjn
% 218.67/218.81  |- mesh__recordOriginator mesh__D007875 RC
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D007875 2006
% 218.67/218.81  |- mesh__recordMaintainer mesh__D007875 SYSTEM
% 218.67/218.81  |- skos__historyNote mesh__D007875 Bacteria %28%1978-1980%29%
% 218.67/218.81  |- mesh__dateEstablished mesh__D007875 1981-01-01
% 218.67/218.81  |- mesh__dateCreated mesh__D007875 1980-05-14
% 218.67/218.81  |- skos__broader mesh__D007875smesh__D016951
% 218.67/218.81  |- skos__annotation mesh__D007875
% 218.67/218.81       infection = LEGIONELLOSIS but Legionella pneumophila infect = LEGIONNAIRES%27% DISEASE%A%  
% 218.67/218.81  |- skos__prefLabel mesh__D007875 Legionella
% 218.67/218.81  |- mesh__publicMeSHNote mesh__D007875 81   
% 218.67/218.81  |- skos__historyNote mesh__D007077 Ileum %28%1966-1979%29%
% 218.67/218.81  |- skos__hiddenLabel mesh__D007077 Diseases, Ileal
% 218.67/218.81  |- mesh__publicMeSHNote mesh__D007077 80   
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D007077 2006
% 218.67/218.81  |- mesh__dateCreated mesh__D007077 1979-04-27
% 218.67/218.81  |- mesh__recordAuthorizer mesh__D007077 sjn
% 218.67/218.81  |- skos__hiddenLabel mesh__D007077 Ileal Disease
% 218.67/218.81  |- mesh__recordOriginator mesh__D007077 SMH
% 218.67/218.81  |- skos__hiddenLabel mesh__D007077 Disease, Ileal
% 218.67/218.81  |- rdf__type mesh__D007077sskos__Concept
% 218.67/218.81  |- skos__historyNote mesh__D007077 specific intestinal disease
% 218.67/218.81  |- skos__prefLabel mesh__D007077 Ileal Diseases
% 218.67/218.81  |- skos__scopeNote mesh__D007077
% 218.67/218.81       Pathological development in the ILEUM including the ILEOCECAL VALVE.%A%    
% 218.67/218.81  |- skos__broader mesh__D007077smesh__D007410
% 218.67/218.81  |- mesh__dateRevised mesh__D007077 2003-07-09
% 218.67/218.81  |- skos__historyNote mesh__D007077 Intestinal Diseases %28%1966-1979%29%
% 218.67/218.81  |- mesh__dateEstablished mesh__D007077 1980-01-01
% 218.67/218.81  |- skos__annotation mesh__D007077 inflamm dis = ILEITIS   
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D007077 2004
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D007077 2005
% 218.67/218.81  |- mesh__historyNote mesh__D007077 80   
% 218.67/218.81  |- mesh__recordMaintainer mesh__D007077 lkt
% 218.67/218.81  |- skos__related mesh__D015509smesh__D005314
% 218.67/218.81  |- mesh__recordAuthorizer mesh__D015509 sjn
% 218.67/218.81  |- skos__broader mesh__D015509smesh__D001695
% 218.67/218.81  |- mesh__dateRevised mesh__D015509 2004-07-07
% 218.67/218.81  |- mesh__dateCreated mesh__D015509 1989-09-01
% 218.67/218.81  |- skos__historyNote mesh__D015509 Cell Differentiation %28%1968-1989%29%
% 218.67/218.81  |- skos__related mesh__D015509smesh__D048788
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D015509 2006
% 218.67/218.81  |- skos__annotation mesh__D015509
% 218.67/218.81       SPEC: SPEC qualif; DF: DEVELOPMENTAL BIOL   
% 218.67/218.81  |- skos__prefLabel mesh__D015509 Developmental Biology
% 218.67/218.81  |- mesh__dateEstablished mesh__D015509 1990-01-01
% 218.67/218.81  |- skos__historyNote mesh__D015509 Models, Biological %28%1968-1972%29%
% 218.67/218.81  |- skos__altLabel mesh__D015509 Biology, Developmental
% 218.67/218.81  |- mesh__historyNote mesh__D015509 90   
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D015509 2005
% 218.67/218.81  |- mesh__publicMeSHNote mesh__D015509 90   
% 218.67/218.81  |- rdf__type mesh__D015509sskos__Concept
% 218.67/218.81  |- skos__historyNote mesh__D015509 Embryology %28%1978-1989%29%
% 218.67/218.81  |- mesh__recordMaintainer mesh__D015509 lkt
% 218.67/218.81  |- mesh__recordOriginator mesh__D015509 PXP
% 218.67/218.81  |- skos__scopeNote mesh__D015509
% 218.67/218.81       The field of biology which deals with the process of the growth and differentiation of an organism.%A%    
% 218.67/218.81  |- skos__broader mesh__D012211smesh__D028561
% 218.67/218.81  |- rdf__type mesh__D012211sskos__Concept
% 218.67/218.81  |- skos__prefLabel mesh__D012211 Rhenium
% 218.67/218.81  |- mesh__recordMaintainer mesh__D012211 jmp
% 218.67/218.81  |- skos__annotation mesh__D012211
% 218.67/218.81       Re-187; Re-185 = RHENIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Re-177-184, 186, 188-192 = RHENIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D012211 2003
% 218.67/218.81  |- mesh__recordAuthorizer mesh__D012211 sjn
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D012211 2004
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D012211 2002
% 218.67/218.81  |- mesh__dateRevised mesh__D012211 2001-07-25
% 218.67/218.81  |- mesh__recordOriginator mesh__D012211 NLM
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D012211 2005
% 218.67/218.81  |- skos__broader mesh__D012211smesh__D019216
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D012211 2006
% 218.67/218.81  |- mesh__dateCreated mesh__D012211 1999-01-01
% 218.67/218.81  |- skos__scopeNote mesh__D012211
% 218.67/218.81       Rhenium. A metal, atomic number 75, atomic weight 186.2, symbol Re. %28%Dorland, 28th ed%29%%A%    
% 218.67/218.81  |- mesh__dateEstablished mesh__D031176 2003-01-01
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D031176 2005
% 218.67/218.81  |- mesh__historyNote mesh__D031176 2003   
% 218.67/218.81  |- skos__prefLabel mesh__D031176 Bidens
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D031176 2004
% 218.67/218.81  |- rdf__type mesh__D031176sskos__Concept
% 218.67/218.81  |- skos__annotation mesh__D031176
% 218.67/218.81       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D031176 2003
% 218.67/218.81  |- skos__broader mesh__D031176smesh__D019659
% 218.67/218.81  |- skos__altLabel mesh__D031176 Beggarticks
% 218.67/218.81  |- skos__scopeNote mesh__D031176
% 218.67/218.81       A plant genus of the family ASTERACEAE. Members contain bidensyneosides %28%polyacetylene glucosides%29%.%A%    
% 218.67/218.81  |- mesh__publicMeSHNote mesh__D031176 2003   
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D031176 2006
% 218.67/218.81  |- mesh__dateCreated mesh__D031176 2002-07-02
% 218.67/218.81  |- mesh__dateRevised mesh__D003485 1993-02-16
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D003485 2001
% 218.67/218.81  |- mesh__recordAuthorizer mesh__D003485 PLS
% 218.67/218.81  |- mesh__recordMaintainer mesh__D003485 TPW
% 218.67/218.81  |- skos__scopeNote mesh__D003485
% 218.67/218.81       Organic salts of cyanic acid containing the -OCN radical.%A%    
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D003485 2005
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D003485 1995
% 218.67/218.81  |- skos__prefLabel mesh__D003485 Cyanates
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D003485 2002
% 218.67/218.81  |- mesh__recordOriginator mesh__D003485 NLM
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D003485 1998
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D003485 2003
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D003485 2006
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D003485 1996
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D003485 1999
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D003485 2004
% 218.67/218.81  |- skos__broader mesh__D003485smesh__D009930
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D003485 1997
% 218.67/218.81  |- rdf__type mesh__D003485sskos__Concept
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D003485 2000
% 218.67/218.81  |- mesh__dateCreated mesh__D003485 1999-01-01
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D003485 1994
% 218.67/218.81  |- skos__altLabel mesh__D011917 Rats, Inbred Lewis
% 218.67/218.81  |- mesh__recordAuthorizer mesh__D011917 sjn
% 218.67/218.81  |- skos__broader mesh__D011917smesh__D011919
% 218.67/218.81  |- skos__annotation mesh__D011917
% 218.67/218.81       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag RATS%A%  
% 218.67/218.81  |- skos__hiddenLabel mesh__D011917 Rat, Inbred Lew
% 218.67/218.81  |- skos__hiddenLabel mesh__D011917 Lew Rat, Inbred
% 218.67/218.81  |- mesh__recordMaintainer mesh__D011917 ags
% 218.67/218.81  |- skos__altLabel mesh__D011917 Rats, Lew
% 218.67/218.81  |- skos__hiddenLabel mesh__D011917 Rat, Lew
% 218.67/218.81  |- mesh__dateRevised mesh__D011917 2005-06-30
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D011917 2006
% 218.67/218.81  |- mesh__publicMeSHNote mesh__D011917
% 218.67/218.81       91; was see under RATS, INBRED STRAINS 1972-90   
% 218.67/218.81  |- skos__prefLabel mesh__D011917 Rats, Inbred Lew
% 218.67/218.81  |- skos__hiddenLabel mesh__D011917 Lew Rats, Inbred
% 218.67/218.81  |- skos__historyNote mesh__D011917 Rats %28%1966-1971%29%
% 218.67/218.81  |- skos__hiddenLabel mesh__D011917 Lew Rat
% 218.67/218.81  |- skos__hiddenLabel mesh__D011917 Inbred Lewis Rats
% 218.67/218.81  |- skos__hiddenLabel mesh__D011917 Lewis Rats, Inbred
% 218.67/218.81  |- mesh__dateEstablished mesh__D011917 1991-01-01
% 218.67/218.81  |- mesh__historyNote mesh__D011917
% 218.67/218.81       91%28%72%29%; was see under RATS, INBRED STRAINS 1972-90   
% 218.67/218.81  |- mesh__dateCreated mesh__D011917 1999-01-01
% 218.67/218.81  |- rdf__type mesh__D011917sskos__Concept
% 218.67/218.81  |- skos__hiddenLabel mesh__D011917 Lew Rats
% 218.67/218.81  |- mesh__recordOriginator mesh__D011917 NLM
% 218.67/218.81  |- skos__hiddenLabel mesh__D011917 Inbred Lew Rats
% 218.67/218.81  |- skos__hiddenLabel mesh__D011917 Inbred Lew Rat
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D011119 2000
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D011119 1994
% 218.67/218.81  |- mesh__activeMeSHYear mesh__D011119 2005
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D011119 2001
% 218.67/218.82  |- mesh__recordMaintainer mesh__D011119 TGC
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D011119 1998
% 218.67/218.82  |- skos__annotation mesh__D011119 13 or more nucleotides   
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D011119 1995
% 218.67/218.82  |- skos__broader mesh__D011119smesh__D009711
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D011119 2006
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D011119 1999
% 218.67/218.82  |- rdf__type mesh__D011119sskos__Concept
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D011119 2003
% 218.67/218.82  |- mesh__dateRevised mesh__D011119 1992-05-20
% 218.67/218.82  |- mesh__recordOriginator mesh__D011119 NLM
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D011119 1996
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D011119 1993
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D011119 2002
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D011119 2004
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D011119 1997
% 218.67/218.82  |- mesh__dateCreated mesh__D011119 1999-01-01
% 218.67/218.82  |- skos__prefLabel mesh__D011119 Polynucleotides
% 218.67/218.82  |- mesh__recordAuthorizer mesh__D011119 PLS
% 218.67/218.82  |- skos__historyNote mesh__D008170 Elasticity %28%1966-1967%29%
% 218.67/218.82  |- skos__hiddenLabel mesh__D008170 Lung Compliances
% 218.67/218.82  |- mesh__recordAuthorizer mesh__D008170 sjn
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D008170 2006
% 218.67/218.82  |- mesh__dateEstablished mesh__D008170 1970-01-01
% 218.67/218.82  |- mesh__recordMaintainer mesh__D008170 nns
% 218.67/218.82  |- mesh__dateRevised mesh__D008170 2003-07-09
% 218.67/218.82  |- skos__related mesh__D008170smesh__D015656
% 218.67/218.82  |- skos__broader mesh__D008170smesh__D012129
% 218.67/218.82  |- skos__hiddenLabel mesh__D008170 Compliance, Lung
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D008170 2004
% 218.67/218.82  |- skos__hiddenLabel mesh__D008170 Compliances, Lung
% 218.67/218.82  |- mesh__historyNote mesh__D008170 70%28%68%29%   
% 218.67/218.82  |- skos__scopeNote mesh__D008170
% 218.67/218.82       The capability of the LUNGS to distend under pressure as measured by pulmonary volume change per unit pressure change. While not a complete description of the pressure-volume properties of the lung, it is nevertheless useful in practice as a measure of the comparative stiffness of the lung. %28%From Best %26% Taylor%27%s Physiological Basis of Medical Practice, 12th ed, p562%29%%A%    
% 218.67/218.82  |- skos__prefLabel mesh__D008170 Lung Compliance
% 218.67/218.82  |- mesh__publicMeSHNote mesh__D008170 70   
% 218.67/218.82  |- mesh__dateCreated mesh__D008170 1999-01-01
% 218.67/218.82  |- rdf__type mesh__D008170sskos__Concept
% 218.67/218.82  |- skos__annotation mesh__D008170 usually NIM   
% 218.67/218.82  |- mesh__recordOriginator mesh__D008170 NLM
% 218.67/218.82  |- skos__broader mesh__D008170smesh__D044702
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D008170 2005
% 218.67/218.82  |- skos__historyNote mesh__D008170 Lung/physiology %28%1966-1967%29%
% 218.67/218.82  |- skos__hiddenLabel mesh__D016602 Needle-Stick Injury
% 218.67/218.82  |- mesh__recordMaintainer mesh__D016602 ags
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D016602 2006
% 218.67/218.82  |- skos__prefLabel mesh__D016602 Needlestick Injuries
% 218.67/218.82  |- mesh__publicMeSHNote mesh__D016602 92   
% 218.67/218.82  |- mesh__recordAuthorizer mesh__D016602 sjn
% 218.67/218.82  |- mesh__recordOriginator mesh__D016602 AGS
% 218.67/218.82  |- skos__historyNote mesh__D016602 Needles %28%1978-1991%29%
% 218.67/218.82  |- skos__hiddenLabel mesh__D016602 Needlestick
% 218.67/218.82  |- skos__hiddenLabel mesh__D016602 Injury, Sharps
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D016602 2005
% 218.67/218.82  |- skos__broader mesh__D016602smesh__D014951
% 218.67/218.82  |- skos__scopeNote mesh__D016602
% 218.67/218.82       Penetrating stab wounds caused by needles. They are of special concern to health care workers since such injuries put them at risk for developing infectious disease.%A%    
% 218.67/218.82  |- skos__hiddenLabel mesh__D016602 Injury, Needlestick
% 218.67/218.82  |- skos__hiddenLabel mesh__D016602 Sharps Injury
% 218.67/218.82  |- mesh__dateEstablished mesh__D016602 1992-01-01
% 218.67/218.82  |- skos__hiddenLabel mesh__D016602 Needle Sticks
% 218.67/218.82  |- skos__altLabel mesh__D016602 Needlesticks
% 218.67/218.82  |- skos__hiddenLabel mesh__D016602 Needle Stick Injuries
% 218.67/218.82  |- mesh__dateCreated mesh__D016602 1991-01-25
% 218.67/218.82  |- skos__hiddenLabel mesh__D016602 Needle-Stick
% 218.67/218.82  |- skos__annotation mesh__D016602
% 218.67/218.82       IM; coord with organ/inj or precoord inj term %28%IM%29%   
% 218.67/218.82  |- rdf__type mesh__D016602sskos__Concept
% 218.67/218.82  |- mesh__dateRevised mesh__D016602 2004-07-07
% 218.67/218.82  |- skos__altLabel mesh__D016602 Needle-Stick Injuries
% 218.67/218.82  |- skos__altLabel mesh__D016602 Needle-Sticks
% 218.67/218.82  |- skos__hiddenLabel mesh__D016602 Injury, Needle-Stick
% 218.67/218.82  |- mesh__historyNote mesh__D016602 92   
% 218.67/218.82  |- skos__hiddenLabel mesh__D016602 Needlestick Injury
% 218.67/218.82  |- skos__hiddenLabel mesh__D016602 Injuries, Needle-Stick
% 218.67/218.82  |- skos__altLabel mesh__D016602 Injuries, Needlestick
% 218.67/218.82  |- skos__hiddenLabel mesh__D016602 Injuries, Sharps
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007876 1997
% 218.67/218.82  |- mesh__recordOriginator mesh__D007876 RC
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007876 2006
% 218.67/218.82  |- skos__broader mesh__D007876smesh__D016905
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007876 2003
% 218.67/218.82  |- skos__prefLabel mesh__D007876 Legionellosis
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007876 2000
% 218.67/218.82  |- mesh__dateCreated mesh__D007876 1986-06-18
% 218.67/218.82  |- skos__broader mesh__D007876smesh__D012141
% 218.67/218.82  |- skos__historyNote mesh__D007876
% 218.67/218.82       Legionnaires%27% Disease %28%1978-1986%29%
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007876 2004
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007876 1994
% 218.67/218.82  |- mesh__dateEstablished mesh__D007876 1987-01-01
% 218.67/218.82  |- mesh__dateRevised mesh__D007876 1993-06-02
% 218.67/218.82  |- mesh__historyNote mesh__D007876 87   
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007876 2001
% 218.67/218.82  |- skos__historyNote mesh__D007876 Legionella %28%1981-1986%29%
% 218.67/218.82  |- skos__historyNote mesh__D007876 Bacterial Infections %28%1972-1986%29%
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007876 1995
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007876 2002
% 218.67/218.82  |- skos__hiddenLabel mesh__D007876 Legionelloses
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007876 1998
% 218.67/218.82  |- mesh__publicMeSHNote mesh__D007876 87   
% 218.67/218.82  |- skos__annotation mesh__D007876
% 218.67/218.82       gram-neg bact infect by any species of Legionella except L. pneumophila %28% = LEGIONNAIRES%27% DISEASE%29%%A%  
% 218.67/218.82  |- rdf__type mesh__D007876sskos__Concept
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007876 1999
% 218.67/218.82  |- mesh__recordAuthorizer mesh__D007876 PLS
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007876 1996
% 218.67/218.82  |- skos__historyNote mesh__D007876 Pneumonia %28%1966-1986%29%
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007876 2005
% 218.67/218.82  |- mesh__recordMaintainer mesh__D007876 TAP
% 218.67/218.82  |- skos__scopeNote mesh__D007876
% 218.67/218.82       Infections with bacteria of the genus LEGIONELLA.     
% 218.67/218.82  |- skos__altLabel mesh__D007078 Cancer of ILEUM
% 218.67/218.82  |- skos__historyNote mesh__D007078 Intestinal Neoplasms %28%1966-1979%29%
% 218.67/218.82  |- skos__scopeNote mesh__D007078
% 218.67/218.82       Tumors or cancer in the ILEUM region of the small intestine %28%INTESTINE, SMALL%29%.%A%    
% 218.67/218.82  |- skos__historyNote mesh__D007078 Ileum %28%1966-1979%29%
% 218.67/218.82  |- skos__hiddenLabel mesh__D007078 ILEUM Cancers
% 218.67/218.82  |- skos__hiddenLabel mesh__D007078 ILEUM Cancer
% 218.67/218.82  |- skos__annotation mesh__D007078
% 218.67/218.82       coord IM with histol type of neopl %28%IM%29%   
% 218.67/218.82  |- skos__altLabel mesh__D007078 Ileal Cancer
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007078 2006
% 218.67/218.82  |- skos__hiddenLabel mesh__D007078 Neoplasms, Ileal
% 218.67/218.82  |- skos__hiddenLabel mesh__D007078 Cancers, Ileal
% 218.67/218.82  |- mesh__dateCreated mesh__D007078 1979-04-25
% 218.67/218.82  |- skos__altLabel mesh__D007078 Cancer, Ileal
% 218.67/218.82  |- mesh__recordMaintainer mesh__D007078 lkt
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007078 2005
% 218.67/218.82  |- mesh__historyNote mesh__D007078 80   
% 218.67/218.82  |- mesh__recordAuthorizer mesh__D007078 sjn
% 218.67/218.82  |- rdf__type mesh__D007078sskos__Concept
% 218.67/218.82  |- skos__prefLabel mesh__D007078 Ileal Neoplasms
% 218.67/218.82  |- skos__broader mesh__D007078smesh__D007414
% 218.67/218.82  |- mesh__dateRevised mesh__D007078 2003-07-09
% 218.67/218.82  |- skos__broader mesh__D007078smesh__D007077
% 218.67/218.82  |- skos__hiddenLabel mesh__D007078 Neoplasm, Ileal
% 218.67/218.82  |- skos__hiddenLabel mesh__D007078 Ileal Neoplasm
% 218.67/218.82  |- mesh__dateEstablished mesh__D007078 1980-01-01
% 218.67/218.82  |- skos__hiddenLabel mesh__D007078 Ileal Cancers
% 218.67/218.82  |- mesh__publicMeSHNote mesh__D007078 80   
% 218.67/218.82  |- mesh__recordOriginator mesh__D007078 VDK
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007078 2004
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D040701 2006
% 218.67/218.82  |- skos__historyNote mesh__D040701
% 218.67/218.82       Stress Disorders, Post-Traumatic %28%1995-2002%29%
% 218.67/218.82  |- skos__prefLabel mesh__D040701 Stress Disorders, Traumatic, Acute
% 218.67/218.82  |- skos__scopeNote mesh__D040701
% 218.67/218.82       A class of traumatic stress disorders that is characterized by the significant dissociative states seen immediately after overwhelming trauma. By definition it cannot last longer than 1 month, if it persists, a diagnosis of post-traumatic stress disorder %28%STRESS DISORDERS, POST-TRAUMATIC%29% is more appropriate.%A%    
% 218.67/218.82  |- mesh__dateEstablished mesh__D040701 2003-01-01
% 218.67/218.82  |- skos__altLabel mesh__D040701 Acute Stress Disorders
% 218.67/218.82  |- rdf__type mesh__D040701sskos__Concept
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D040701 2005
% 218.67/218.82  |- skos__hiddenLabel mesh__D040701 Stress Disorder, Acute
% 218.67/218.82  |- mesh__publicMeSHNote mesh__D040701 2003   
% 218.67/218.82  |- skos__annotation mesh__D040701
% 218.67/218.82       STRESS DISORDERS, TRAUMATIC is also available   
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D040701 2004
% 218.67/218.82  |- skos__altLabel mesh__D040701 Stress Disorders, Acute
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D040701 2003
% 218.67/218.82  |- mesh__dateCreated mesh__D040701 2002-07-02
% 218.67/218.82  |- skos__hiddenLabel mesh__D040701 Acute Stress Disorder
% 218.67/218.82  |- skos__broader mesh__D040701smesh__D040921
% 218.67/218.82  |- mesh__historyNote mesh__D040701 2003   
% 218.67/218.82  |- mesh__dateRevised mesh__D012212 2003-07-09
% 218.67/218.82  |- skos__scopeNote mesh__D012212
% 218.67/218.82       The study of the deformation and flow of matter, usually liquids or fluids, and of the plastic flow of solids. The concept covers consistency, dilatancy, liquefaction, resistance to flow, shearing, thixotrophy, and VISCOSITY.%A%    
% 218.67/218.82  |- mesh__recordMaintainer mesh__D012212 ssb
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D012212 2004
% 218.67/218.82  |- skos__hiddenLabel mesh__D012212 Velocimetries
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D012212 2005
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D012212 2006
% 218.67/218.82  |- mesh__recordAuthorizer mesh__D012212 sjn
% 218.67/218.82  |- skos__broader mesh__D012212smesh__D010825
% 218.67/218.82  |- skos__annotation mesh__D012212
% 218.67/218.82       usually NIM coord with no qualif; for non-plethysmographic rheography: for plethysmographic rheology, index under PLETHYSMOGRAPHY or its specifics; DF: RHEOL%A%  
% 218.67/218.82  |- mesh__dateCreated mesh__D012212 1999-01-01
% 218.67/218.82  |- skos__broader mesh__D012212smesh__D008919
% 218.67/218.82  |- skos__related mesh__D012212smesh__D044085
% 218.67/218.82  |- skos__prefLabel mesh__D012212 Rheology
% 218.67/218.82  |- mesh__historyNote mesh__D012212 1966%28%1964%29%   
% 218.67/218.82  |- mesh__recordOriginator mesh__D012212 NLM
% 218.67/218.82  |- rdf__type mesh__D012212sskos__Concept
% 218.67/218.82  |- mesh__publicMeSHNote mesh__D012212 1966   
% 218.67/218.82  |- mesh__dateEstablished mesh__D012212 1966-01-01
% 218.67/218.82  |- skos__altLabel mesh__D031177 Thistle, Musk
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D031177 2004
% 218.67/218.82  |- skos__altLabel mesh__D031177 Thistle, Plumeless
% 218.67/218.82  |- rdf__type mesh__D031177sskos__Concept
% 218.67/218.82  |- mesh__dateEstablished mesh__D031177 2003-01-01
% 218.67/218.82  |- skos__prefLabel mesh__D031177 Carduus
% 218.67/218.82  |- mesh__historyNote mesh__D031177 2003   
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D031177 2003
% 218.67/218.82  |- skos__broader mesh__D031177smesh__D019659
% 218.67/218.82  |- skos__scopeNote mesh__D031177
% 218.67/218.82       A plant genus of the family ASTERACEAE. Members contain arctiin and onopordopicrin.%A%    
% 218.67/218.82  |- mesh__dateCreated mesh__D031177 2002-07-03
% 218.67/218.82  |- mesh__publicMeSHNote mesh__D031177 2003   
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D031177 2006
% 218.67/218.82  |- skos__annotation mesh__D031177
% 218.67/218.82       CARDUUS MARIANUS see MILK THISTLE is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D031177 2005
% 218.67/218.82  |- rdf__type mesh__D003486sskos__Concept
% 218.67/218.82  |- skos__annotation mesh__D003486
% 218.67/218.82       inorganic salts having -CN radical: differentiate from NITRILES which are organic with -CN%A%  
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D003486 2001
% 218.67/218.82  |- skos__scopeNote mesh__D003486
% 218.67/218.82       Inorganic salts of HYDROGEN CYANIDE containing the -CN radical. The concept also includes isocyanides. It is distinguished from NITRILES, which denotes organic compounds containing the -CN radical.%A%    
% 218.67/218.82  |- skos__broader mesh__D003486smesh__D006856
% 218.67/218.82  |- mesh__recordMaintainer mesh__D003486 TGC
% 218.67/218.82  |- skos__prefLabel mesh__D003486 Cyanides
% 218.67/218.82  |- mesh__recordAuthorizer mesh__D003486 SJN
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D003486 2000
% 218.67/218.82  |- skos__related mesh__D003486smesh__D009570
% 218.67/218.82  |- skos__broader mesh__D003486smesh__D000838
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D003486 2004
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D003486 2006
% 218.67/218.82  |- mesh__recordOriginator mesh__D003486 NLM
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D003486 2003
% 218.67/218.82  |- mesh__dateRevised mesh__D003486 1997-06-20
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D003486 1999
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D003486 2005
% 218.67/218.82  |- mesh__dateCreated mesh__D003486 1999-01-01
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D003486 1998
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D003486 2002
% 218.67/218.82  |- skos__hiddenLabel mesh__D011918 Rat, SHR
% 218.67/218.82  |- skos__historyNote mesh__D011918 Blood Pressure %28%1966-1984%29%
% 218.67/218.82  |- skos__historyNote mesh__D011918 Hypertension %28%1966-1984%29%
% 218.67/218.82  |- mesh__dateCreated mesh__D011918 1984-04-06
% 218.67/218.82  |- skos__broader mesh__D011918smesh__D011919
% 218.67/218.82  |- skos__hiddenLabel mesh__D011918 SHR Rats
% 218.67/218.82  |- mesh__recordMaintainer mesh__D011918 ags
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D011918 2006
% 218.67/218.82  |- mesh__recordAuthorizer mesh__D011918 sjn
% 218.67/218.82  |- skos__altLabel mesh__D011918 Rats, SHR
% 218.67/218.82  |- skos__scopeNote mesh__D011918
% 218.67/218.82       A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke.%A%    
% 218.67/218.82  |- skos__hiddenLabel mesh__D011918 SHR Rat
% 218.67/218.82  |- mesh__historyNote mesh__D011918
% 218.67/218.82       91%28%85%29%; was see under RATS, INBRED STRAINS 1985-90   
% 218.67/218.82  |- skos__prefLabel mesh__D011918 Rats, Inbred SHR
% 218.67/218.82  |- skos__hiddenLabel mesh__D011918 SHR Rats, Inbred
% 218.67/218.82  |- skos__annotation mesh__D011918
% 218.67/218.82       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag RATS%A%  
% 218.67/218.82  |- mesh__dateEstablished mesh__D011918 1991-01-01
% 218.67/218.82  |- skos__hiddenLabel mesh__D011918 Rat, Spontaneously Hypertensive
% 218.67/218.82  |- skos__hiddenLabel mesh__D011918 Inbred SHR Rat
% 218.67/218.82  |- mesh__publicMeSHNote mesh__D011918
% 218.67/218.82       91; was see under RATS, INBRED STRAINS 1985-90   
% 218.67/218.82  |- mesh__dateRevised mesh__D011918 2005-06-30
% 218.67/218.82  |- skos__hiddenLabel mesh__D011918 Spontaneously Hypertensive Rat
% 218.67/218.82  |- skos__hiddenLabel mesh__D011918 Rat, Inbred SHR
% 218.67/218.82  |- mesh__recordOriginator mesh__D011918 EC
% 218.67/218.82  |- rdf__type mesh__D011918sskos__Concept
% 218.67/218.82  |- skos__hiddenLabel mesh__D011918 Spontaneously Hypertensive Rats
% 218.67/218.82  |- skos__historyNote mesh__D011918 Rats, Inbred Strains %28%1972-1984%29%
% 218.67/218.82  |- skos__hiddenLabel mesh__D011918 Inbred SHR Rats
% 218.67/218.82  |- skos__altLabel mesh__D011918 Rats, Spontaneously Hypertensive
% 218.67/218.82  |- skos__hiddenLabel mesh__D011918 SHR Rat, Inbred
% 218.67/218.82  |- skos__annotation mesh__D008171
% 218.67/218.82       GEN; prefer specifics; inflamm dis = PNEUMONIA; lung collapse = ATELECTASIS%A%  
% 218.67/218.82  |- mesh__recordOriginator mesh__D008171 NLM
% 218.67/218.82  |- mesh__recordAuthorizer mesh__D008171 SJN
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D008171 2004
% 218.67/218.82  |- skos__hiddenLabel mesh__D008171 Disease, Lung
% 218.67/218.82  |- skos__prefLabel mesh__D008171 Lung Diseases
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D008171 2006
% 218.67/218.82  |- skos__altLabel mesh__D008171 Pulmonary Diseases
% 218.67/218.82  |- mesh__dateCreated mesh__D008171 1999-01-01
% 218.67/218.82  |- skos__related mesh__D008171smesh__D011660
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D008171 2003
% 218.67/218.82  |- skos__altLabel mesh__D008171 Pulmonary Disease
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D008171 2002
% 218.67/218.82  |- skos__broader mesh__D008171smesh__D012140
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D008171 2005
% 218.67/218.82  |- mesh__recordMaintainer mesh__D008171 TGC
% 218.67/218.82  |- skos__hiddenLabel mesh__D008171 Diseases, Lung
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D008171 2001
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D008171 1999
% 218.67/218.82  |- skos__altLabel mesh__D008171 Diseases, Pulmonary
% 218.67/218.82  |- skos__altLabel mesh__D008171 Disease, Pulmonary
% 218.67/218.82  |- rdf__type mesh__D008171sskos__Concept
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D008171 2000
% 218.67/218.82  |- skos__hiddenLabel mesh__D008171 Lung Disease
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D008171 1998
% 218.67/218.82  |- mesh__dateRevised mesh__D008171 1997-06-20
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D016603 2003
% 218.67/218.82  |- skos__altLabel mesh__D016603
% 218.67/218.82       Syndrome, Eosinophilia-Myalgia, L-Tryptophan-Related
% 218.67/218.82  |- skos__hiddenLabel mesh__D016603 Eosinophilia-Myalgia Syndromes
% 218.67/218.82  |- skos__historyNote mesh__D016603
% 218.67/218.82       Muscular Diseases/chemically induced %28%1990%29%
% 218.67/218.82  |- mesh__recordMaintainer mesh__D016603 ags
% 218.67/218.82  |- skos__hiddenLabel mesh__D016603
% 218.67/218.82       L-Tryptophan-Related Eosinophilia-Myalgia Syndromes
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D016603 2001
% 218.67/218.82  |- skos__broader mesh__D016603smesh__D004802
% 218.67/218.82  |- mesh__publicMeSHNote mesh__D016603 92   
% 218.67/218.82  |- mesh__recordOriginator mesh__D016603 PXP
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D016603 2006
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D016603 2000
% 218.67/218.82  |- skos__altLabel mesh__D016603
% 218.67/218.82       L-Tryptophan-Related Eosinophilia-Myalgia Syndrome
% 218.67/218.82  |- skos__scopeNote mesh__D016603
% 218.67/218.82       A complex systemic syndrome with inflammatory and autoimmune components that affect the skin, fascia, muscle, nerve, blood vessels, lung, and heart. Diagnostic features generally include EOSINOPHILIA, myalgia severe enough to limit usual activities of daily living, and the absence of coexisting infectious, autoimmune or other conditions that may induce eosinophilia. Biopsy of affected tissue reveals a microangiopathy associated with diffuse inflammation involving connective tissue. %28%From Spitzer et al., J Rheumatol Suppl 1996 Oct;46:73-9; Blackburn WD, Semin Arthritis Rheum 1997 Jun;26%28%6%29%:788-93%29%%A%    
% 218.67/218.82  |- skos__hiddenLabel mesh__D016603 Eosinophilia Myalgia Syndrome
% 218.67/218.82  |- mesh__recordAuthorizer mesh__D016603 ags
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D016603 2005
% 218.67/218.82  |- mesh__dateRevised mesh__D016603 2005-07-13
% 218.67/218.82  |- skos__hiddenLabel mesh__D016603
% 218.67/218.82       Eosinophilia-Myalgia Syndromes, L-Tryptophan-Related
% 218.67/218.82  |- mesh__dateEstablished mesh__D016603 1992-01-01
% 218.67/218.82  |- rdf__type mesh__D016603sskos__Concept
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D016603 2006A
% 218.67/218.82  |- skos__prefLabel mesh__D016603 Eosinophilia-Myalgia Syndrome
% 218.67/218.82  |- mesh__dateCreated mesh__D016603 1991-01-25
% 218.67/218.82  |- skos__historyNote mesh__D016603
% 218.67/218.82       Eosinophilia/chemically induced %28%1989-1990%29%
% 218.67/218.82  |- skos__broader mesh__D016603smesh__D009135
% 218.67/218.82  |- skos__hiddenLabel mesh__D016603 Syndrome, Eosinophilia-Myalgia
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D016603 2002
% 218.67/218.82  |- skos__historyNote mesh__D016603
% 218.67/218.82       Tryptophan/adverse effects %28%1989-1990%29%
% 218.67/218.82  |- skos__hiddenLabel mesh__D016603
% 218.67/218.82       Syndrome, L-Tryptophan-Related Eosinophilia-Myalgia
% 218.67/218.82  |- skos__hiddenLabel mesh__D016603
% 218.67/218.82       Syndromes, L-Tryptophan-Related Eosinophilia-Myalgia
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D016603 2004
% 218.67/218.82  |- mesh__historyNote mesh__D016603 92   
% 218.67/218.82  |- skos__hiddenLabel mesh__D016603 Syndromes, Eosinophilia-Myalgia
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D046290 2006
% 218.67/218.82  |- skos__hiddenLabel mesh__D046290 Pyogenic Liver Abscesses
% 218.67/218.82  |- mesh__dateCreated mesh__D046290 2004-07-07
% 218.67/218.82  |- mesh__recordAuthorizer mesh__D046290 sjn
% 218.67/218.82  |- skos__historyNote mesh__D046290 Liver Abscess %28%1966-2004%29%
% 218.67/218.82  |- skos__hiddenLabel mesh__D046290 Pyogenic Hepatic Abscesses
% 218.67/218.82  |- skos__broader mesh__D046290smesh__D008100
% 218.67/218.82  |- skos__hiddenLabel mesh__D046290 Abscess, Pyogenic Liver
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D046290 2005
% 218.67/218.82  |- mesh__dateEstablished mesh__D046290 2005-01-01
% 218.67/218.82  |- rdf__type mesh__D046290sskos__Concept
% 218.67/218.82  |- skos__hiddenLabel mesh__D046290 Abscess, Pyogenic Hepatic
% 218.67/218.82  |- skos__altLabel mesh__D046290 Pyogenic Liver Abscess
% 218.67/218.82  |- mesh__recordOriginator mesh__D046290 lkt
% 218.67/218.82  |- skos__scopeNote mesh__D046290
% 218.67/218.82       Single or multiple areas of PUS due to bacterial infection within the hepatic parenchyma. It can be caused by a variety of BACTERIA, local or disseminated from infections elsewhere such as in APPENDICITIS; CHOLECYSTITIS; PERITONITIS; and after LIVER TRANSPLANTATION.%A%    
% 218.67/218.82  |- skos__hiddenLabel mesh__D046290 Abscesses, Pyogenic Hepatic
% 218.67/218.82  |- skos__prefLabel mesh__D046290 Liver Abscess, Pyogenic
% 218.67/218.82  |- skos__hiddenLabel mesh__D046290 Abscesses, Pyogenic Liver
% 218.67/218.82  |- mesh__publicMeSHNote mesh__D046290 2005   
% 218.67/218.82  |- mesh__historyNote mesh__D046290 2005   
% 218.67/218.82  |- skos__hiddenLabel mesh__D046290 Hepatic Abscess, Pyogenic
% 218.67/218.82  |- skos__hiddenLabel mesh__D046290 Liver Abscesses, Pyogenic
% 218.67/218.82  |- skos__hiddenLabel mesh__D046290 Hepatic Abscesses, Pyogenic
% 218.67/218.82  |- skos__altLabel mesh__D046290 Pyogenic Hepatic Abscess
% 218.67/218.82  |- mesh__recordMaintainer mesh__D046290 lkt
% 218.67/218.82  |- skos__annotation mesh__D046290
% 218.67/218.82       coordinate IM with specific organism infection term %28%IM%29%   
% 218.67/218.82  |- skos__historyNote mesh__D007877 Disease Outbreaks %28%1976-1978%29%
% 218.67/218.82  |- skos__altLabel mesh__D007877 Legionnaire Disease
% 218.67/218.82  |- skos__hiddenLabel mesh__D007877 Legionnaire%27%s Disease
% 218.67/218.82  |- mesh__dateRevised mesh__D007877 1991-05-30
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007877 2000
% 218.67/218.82  |- skos__hiddenLabel mesh__D007877 Disease, Legionnaires%27%
% 218.67/218.82  |- skos__altLabel mesh__D007877 Legionella pneumophila Infections
% 218.67/218.82  |- skos__scopeNote mesh__D007877
% 218.67/218.82       An acute, sometimes fatal, pneumonia-like bacterial infection characterized by high fever, malaise, muscle aches, respiratory disorders and headache. It is named for an outbreak at the 1976 Philadelphia convention of the American Legion.%A%    
% 218.67/218.82  |- skos__hiddenLabel mesh__D007877 pneumophila Infection, Legionella
% 218.67/218.82  |- skos__historyNote mesh__D007877 Bacterial Infections %28%1976-1978%29%
% 218.67/218.82  |- mesh__dateEstablished mesh__D007877 1979-01-01
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007877 1997
% 218.67/218.82  |- mesh__recordOriginator mesh__D007877 AEP
% 218.67/218.82  |- mesh__recordMaintainer mesh__D007877 PXP
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007877 2004
% 218.67/218.82  |- mesh__dateCreated mesh__D007877 1978-02-15
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007877 1993
% 218.67/218.82  |- mesh__historyNote mesh__D007877
% 218.67/218.82       79%28%78%29%; was see under RESPIRATORY TRACT INFECTIONS 1978   
% 218.67/218.82  |- skos__hiddenLabel mesh__D007877 Legionella pneumophila Infection
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007877 1996
% 218.67/218.82  |- skos__hiddenLabel mesh__D007877 Legionnaires Disease
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007877 1999
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007877 2002
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007877 2003
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007877 1992
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007877 2006
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007877 1995
% 218.67/218.82  |- skos__hiddenLabel mesh__D007877 Disease, Legionnaire
% 218.67/218.82  |- skos__annotation mesh__D007877
% 218.67/218.82       caused by Legionella pneumophila: infect by other Legionella species = LEGIONELLOSIS%A%  
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007877 1998
% 218.67/218.82  |- skos__hiddenLabel mesh__D007877 Infection, Legionella pneumophila
% 218.67/218.82  |- skos__altLabel mesh__D007877 Infections, Legionella pneumophila
% 218.67/218.82  |- skos__broader mesh__D007877smesh__D007876
% 218.67/218.82  |- mesh__recordAuthorizer mesh__D007877 PLS
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007877 2001
% 218.67/218.82  |- skos__hiddenLabel mesh__D007877 pneumophila Infections, Legionella
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007877 2005
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D007877 1994
% 218.67/218.82  |- skos__prefLabel mesh__D007877 Legionnaires%27% Disease
% 218.67/218.82  |- mesh__publicMeSHNote mesh__D007877
% 218.67/218.82       79; was see under RESPIRATORY TRACT INFECTIONS 1978   
% 218.67/218.82  |- rdf__type mesh__D007877sskos__Concept
% 218.67/218.82  |- skos__annotation mesh__D032270
% 218.67/218.82       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.67/218.82  |- mesh__dateCreated mesh__D032270 2002-07-03
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D032270 2006
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D032270 2005
% 218.67/218.82  |- skos__scopeNote mesh__D032270
% 218.67/218.82       A plant genus of the family SIMAROUBACEAE. Members contain javanicins, picrasinoside and other quassinoids.%A%    
% 218.67/218.82  |- skos__broader mesh__D032270smesh__D029641
% 218.67/218.82  |- rdf__type mesh__D032270sskos__Concept
% 218.67/218.82  |- mesh__publicMeSHNote mesh__D032270 2003   
% 218.67/218.82  |- mesh__historyNote mesh__D032270 2003   
% 218.67/218.82  |- mesh__activeMeSHYear mesh__D032270 2004
% 218.67/218.82  |- mesh__dateEstablished mesh__D032270 2003-01-01
% 218.67/218.82  |- skos__prefLabel mesh__D032270 Picrasma
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D032270 2003
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D007079 2006
% 218.67/218.83  |- mesh__recordOriginator mesh__D007079 NLM
% 218.67/218.83  |- skos__prefLabel mesh__D007079 Ileitis
% 218.67/218.83  |- skos__broader mesh__D007079smesh__D004751
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D007079 2005
% 218.67/218.83  |- rdf__type mesh__D007079sskos__Concept
% 218.67/218.83  |- mesh__dateRevised mesh__D007079 2003-07-09
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D007079 2004
% 218.67/218.83  |- skos__scopeNote mesh__D007079
% 218.67/218.83       Inflammation of any segment of the ILEUM and the ILEOCECAL VALVE.%A%    
% 218.67/218.83  |- mesh__dateCreated mesh__D007079 1999-01-01
% 218.67/218.83  |- mesh__recordMaintainer mesh__D007079 lkt
% 218.67/218.83  |- mesh__recordAuthorizer mesh__D007079 sjn
% 218.67/218.83  |- skos__broader mesh__D007079smesh__D007077
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012213 2006
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012213 1996
% 218.67/218.83  |- skos__prefLabel mesh__D012213 Rheumatic Fever
% 218.67/218.83  |- skos__broader mesh__D012213smesh__D013290
% 218.67/218.83  |- skos__hiddenLabel mesh__D012213 Rheumatic Arthritis, Acute
% 218.67/218.83  |- mesh__recordOriginator mesh__D012213 NLM
% 218.67/218.83  |- skos__hiddenLabel mesh__D012213 Fever, Rheumatic
% 218.67/218.83  |- mesh__recordAuthorizer mesh__D012213 PLS
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012213 2005
% 218.67/218.83  |- skos__hiddenLabel mesh__D012213 Rheumatic Arthritides, Acute
% 218.67/218.83  |- mesh__dateCreated mesh__D012213 1999-01-01
% 218.67/218.83  |- skos__hiddenLabel mesh__D012213 Acute Rheumatic Arthritides
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012213 1999
% 218.67/218.83  |- skos__hiddenLabel mesh__D012213 Acute Articular Rheumatisms
% 218.67/218.83  |- skos__hiddenLabel mesh__D012213 Polyarthritis Rheumaticas
% 218.67/218.83  |- rdf__type mesh__D012213sskos__Concept
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012213 2004
% 218.67/218.83  |- skos__hiddenLabel mesh__D012213 Articular Rheumatisms, Acute
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012213 2002
% 218.67/218.83  |- mesh__recordMaintainer mesh__D012213 PLS
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012213 1998
% 218.67/218.83  |- skos__hiddenLabel mesh__D012213 Rheumatic Fevers
% 218.67/218.83  |- skos__altLabel mesh__D012213 Arthritis, Rheumatic, Acute
% 218.67/218.83  |- skos__hiddenLabel mesh__D012213 Fevers, Rheumatic
% 218.67/218.83  |- skos__hiddenLabel mesh__D012213 Articular Rheumatism, Acute
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012213 2003
% 218.67/218.83  |- skos__hiddenLabel mesh__D012213 Rheumatisms, Acute Articular
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012213 2001
% 218.67/218.83  |- skos__altLabel mesh__D012213 Rheumatism, Articular, Acute
% 218.67/218.83  |- skos__broader mesh__D012213smesh__D001168
% 218.67/218.83  |- skos__altLabel mesh__D012213 Rheumatism, Acute Articular
% 218.67/218.83  |- skos__broader mesh__D012213smesh__D012216
% 218.67/218.83  |- skos__hiddenLabel mesh__D012213 Acute Articular Rheumatism
% 218.67/218.83  |- mesh__dateRevised mesh__D012213 1995-05-25
% 218.67/218.83  |- skos__hiddenLabel mesh__D012213 Acute Rheumatic Arthritis
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012213 1997
% 218.67/218.83  |- skos__scopeNote mesh__D012213
% 218.67/218.83       A febrile disease occurring as a delayed sequela of infections with group A hemolytic streptococci and characterized by multiple focal inflammatory lesions of the connective tissue structures, especially of the heart, blood vessels, and joints %28%polyarthritis%29%, and by the presence of Aschoff bodies in the myocardium and skin. %28%Dorland, 27th ed%29%%A%    
% 218.67/218.83  |- skos__annotation mesh__D012213
% 218.67/218.83       Strep infect; rheum fever with heart dis, unspecified or specific = RHEUMATIC HEART DISEASE %28%IM%29% + the specific heart dis %28%IM or NIM%29%, but not HEART DISEASES%A%  
% 218.67/218.83  |- skos__altLabel mesh__D012213 Arthritis, Acute Rheumatic
% 218.67/218.83  |- skos__altLabel mesh__D012213 Polyarthritis Rheumatica
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012213 2000
% 218.67/218.83  |- skos__hiddenLabel mesh__D012213 Arthritides, Acute Rheumatic
% 218.67/218.83  |- skos__broader mesh__D007070Q000172smesh__D007070
% 218.67/218.83  |- mesh__preferredCombination mesh__D007070Q000172smesh__D017098
% 218.67/218.83  |- rdf__type mesh__D007070Q000172smesh__CompoundConcept
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D031178 2005
% 218.67/218.83  |- rdf__type mesh__D031178sskos__Concept
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D031178 2004
% 218.67/218.83  |- skos__scopeNote mesh__D031178
% 218.67/218.83       A plant genus of the family ASTERACEAE.     
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D031178 2003
% 218.67/218.83  |- mesh__dateEstablished mesh__D031178 2003-01-01
% 218.67/218.83  |- mesh__historyNote mesh__D031178 2003   
% 218.67/218.83  |- skos__broader mesh__D031178smesh__D019659
% 218.67/218.83  |- skos__annotation mesh__D031178
% 218.67/218.83       other %27%thistle%27% plants are available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.67/218.83  |- skos__prefLabel mesh__D031178 Carthamus
% 218.67/218.83  |- mesh__dateCreated mesh__D031178 2002-07-03
% 218.67/218.83  |- mesh__publicMeSHNote mesh__D031178 2003   
% 218.67/218.83  |- skos__altLabel mesh__D031178 Thistle, Distaff
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D031178 2006
% 218.67/218.83  |- mesh__publicMeSHNote mesh__D036661 2003   
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D036661 2005
% 218.67/218.83  |- skos__broader mesh__D036661smesh__D028082
% 218.67/218.83  |- skos__annotation mesh__D036661
% 218.67/218.83       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.67/218.83  |- mesh__historyNote mesh__D036661 2003   
% 218.67/218.83  |- rdf__type mesh__D036661sskos__Concept
% 218.67/218.83  |- mesh__dateCreated mesh__D036661 2002-07-03
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D036661 2004
% 218.67/218.83  |- mesh__dateEstablished mesh__D036661 2003-01-01
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D036661 2003
% 218.67/218.83  |- skos__scopeNote mesh__D036661
% 218.67/218.83       A plant genus of the family BORAGINACEAE. Members contain GAMMA-LINOLENIC ACID and PYRROLIZIDINE ALKALOIDS.%A%    
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D036661 2006
% 218.67/218.83  |- skos__prefLabel mesh__D036661 Echium
% 218.67/218.83  |- mesh__dateEstablished mesh__D003487 1972-01-01
% 218.67/218.83  |- mesh__dateRevised mesh__D003487 2004-07-07
% 218.67/218.83  |- skos__historyNote mesh__D003487 Tissue Adhesives %28%1966-1971%29%
% 218.67/218.83  |- skos__broader mesh__D003487smesh__D011108
% 218.67/218.83  |- skos__historyNote mesh__D003487 Acrylates %28%1966-1971%29%
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D003487 2006
% 218.67/218.83  |- mesh__publicMeSHNote mesh__D003487 72   
% 218.67/218.83  |- skos__historyNote mesh__D003487 Acetates %28%1966-1971%29%
% 218.67/218.83  |- mesh__dateCreated mesh__D003487 1999-01-01
% 218.67/218.83  |- skos__prefLabel mesh__D003487 Cyanoacrylates
% 218.67/218.83  |- mesh__recordMaintainer mesh__D003487 jmp
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D003487 2005
% 218.67/218.83  |- skos__scopeNote mesh__D003487
% 218.67/218.83       A group of compounds having the general formula CH2=C%28%CN%29%-COOR; it polymerizes on contact with moisture; used as tissue adhesive; higher homologs have hemostatic and antibacterial properties.%A%    
% 218.67/218.83  |- skos__broader mesh__D003487smesh__D014014
% 218.67/218.83  |- mesh__historyNote mesh__D003487 72   
% 218.67/218.83  |- mesh__recordAuthorizer mesh__D003487 sjn
% 218.67/218.83  |- rdf__type mesh__D003487sskos__Concept
% 218.67/218.83  |- mesh__recordOriginator mesh__D003487 NLM
% 218.67/218.83  |- skos__annotation mesh__D003487 tissue adhesives; D25-26 qualif   
% 218.67/218.83  |- skos__broader mesh__D003487smesh__D000179
% 218.67/218.83  |- skos__hiddenLabel mesh__D011919 Inbred Strains Rats
% 218.67/218.83  |- skos__hiddenLabel mesh__D011919 Rats, Inbred Strain
% 218.67/218.83  |- skos__hiddenLabel mesh__D011919 Strain Rats, Inbred
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D011919 2006
% 218.67/218.83  |- skos__prefLabel mesh__D011919 Rats, Inbred Strains
% 218.67/218.83  |- skos__historyNote mesh__D011919 Rats %28%1966-1971%29%
% 218.67/218.83  |- skos__hiddenLabel mesh__D011919 Strain, Inbred Rat
% 218.67/218.83  |- skos__hiddenLabel mesh__D011919 Inbred Strain Rat
% 218.67/218.83  |- skos__altLabel mesh__D011919 Rat, Inbred Strain
% 218.67/218.83  |- skos__hiddenLabel mesh__D011919 Rat Strain, Inbred
% 218.67/218.83  |- mesh__recordMaintainer mesh__D011919 ags
% 218.67/218.83  |- skos__altLabel mesh__D011919 Inbred Strain of Rat
% 218.67/218.83  |- mesh__publicMeSHNote mesh__D011919 72   
% 218.67/218.83  |- skos__altLabel mesh__D011919 Inbred Strains of Rats
% 218.67/218.83  |- skos__hiddenLabel mesh__D011919 Inbred Strains Rat
% 218.67/218.83  |- skos__hiddenLabel mesh__D011919 Rats, August
% 218.67/218.83  |- skos__hiddenLabel mesh__D011919 Rat, August
% 218.67/218.83  |- mesh__dateCreated mesh__D011919 1999-01-01
% 218.67/218.83  |- skos__annotation mesh__D011919
% 218.67/218.83       GEN or unspecified; prefer specifics; NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag RATS: Manual 18.6.14, 22.36; X ref AUGUST RATS is seen often in Russian lit%A%  
% 218.67/218.83  |- skos__broader mesh__D011919smesh__D017849
% 218.67/218.83  |- skos__hiddenLabel mesh__D011919 Rat Strains, Inbred
% 218.67/218.83  |- skos__hiddenLabel mesh__D011919 Strains, Inbred Rat
% 218.67/218.83  |- rdf__type mesh__D011919sskos__Concept
% 218.67/218.83  |- skos__hiddenLabel mesh__D011919 Rat, Inbred Strains
% 218.67/218.83  |- skos__hiddenLabel mesh__D011919 Rat Inbred Strains
% 218.67/218.83  |- skos__hiddenLabel mesh__D011919 Inbred Rat Strain
% 218.67/218.83  |- mesh__recordOriginator mesh__D011919 NLM
% 218.67/218.83  |- mesh__dateEstablished mesh__D011919 1972-01-01
% 218.67/218.83  |- mesh__recordAuthorizer mesh__D011919 sjn
% 218.67/218.83  |- skos__hiddenLabel mesh__D011919 Rat Inbred Strain
% 218.67/218.83  |- skos__broader mesh__D011919smesh__D051381
% 218.67/218.83  |- mesh__dateRevised mesh__D011919 2005-06-30
% 218.67/218.83  |- skos__altLabel mesh__D011919 Inbred Rat Strains
% 218.67/218.83  |- skos__hiddenLabel mesh__D011919 Strain Rat, Inbred
% 218.67/218.83  |- skos__scopeNote mesh__D011919
% 218.67/218.83       Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding.%A%    
% 218.67/218.83  |- skos__hiddenLabel mesh__D011919 Inbred Strain Rats
% 218.67/218.83  |- skos__hiddenLabel mesh__D011919 Rats Inbred Strain
% 218.67/218.83  |- skos__altLabel mesh__D011919 Inbred Strain of Rats
% 218.67/218.83  |- skos__hiddenLabel mesh__D011919 Rats Inbred Strains
% 218.67/218.83  |- mesh__historyNote mesh__D011919 72   
% 218.67/218.83  |- skos__hiddenLabel mesh__D011919 August Rat
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008970 1993
% 218.67/218.83  |- skos__annotation mesh__D008970
% 218.67/218.83       almost never IM; no qualif; DF: MOL WEIGHT   
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008970 2005
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008970 1999
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008970 2006
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008970 1996
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008970 2002
% 218.67/218.83  |- skos__prefLabel mesh__D008970 Molecular Weight
% 218.67/218.83  |- mesh__publicMeSHNote mesh__D008970 67   
% 218.67/218.83  |- skos__hiddenLabel mesh__D008970 Weights, Molecular
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008970 1990
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008970 2003
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008970 1997
% 218.67/218.83  |- skos__hiddenLabel mesh__D008970 Weight, Molecular
% 218.67/218.83  |- mesh__recordMaintainer mesh__D008970 TGC
% 218.67/218.83  |- skos__hiddenLabel mesh__D008970 Molecular Weights
% 218.67/218.83  |- mesh__recordOriginator mesh__D008970 NLM
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008970 2004
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008970 1994
% 218.67/218.83  |- rdf__type mesh__D008970sskos__Concept
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008970 2000
% 218.67/218.83  |- mesh__recordAuthorizer mesh__D008970 PLS
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008970 1995
% 218.67/218.83  |- mesh__dateEstablished mesh__D008970 1967-01-01
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008970 1991
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008970 1992
% 218.67/218.83  |- mesh__historyNote mesh__D008970 67%28%64%29%   
% 218.67/218.83  |- skos__broader mesh__D008970smesh__D002627
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008970 1998
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008970 2001
% 218.67/218.83  |- mesh__dateRevised mesh__D008970 1989-05-02
% 218.67/218.83  |- mesh__dateCreated mesh__D008970 1999-01-01
% 218.67/218.83  |- skos__altLabel mesh__D022641 Verotoxin 2
% 218.67/218.83  |- mesh__historyNote mesh__D022641
% 218.67/218.83       2001; use SHIGA-LIKE TOXIN II %28%NM%29% 1988-2000; for SHIGA TOXIN 2 %26% STX2 PROTEIN use SHIGA TOXIN %28%NM%29% 1997-2000%A%  
% 218.67/218.83  |- skos__hiddenLabel mesh__D022641 Cytotoxin, VT2
% 218.67/218.83  |- skos__prefLabel mesh__D022641 Shiga-Like Toxin II
% 218.67/218.83  |- rdf__type mesh__D022641sskos__Concept
% 218.67/218.83  |- skos__hiddenLabel mesh__D022641 SLT II
% 218.67/218.83  |- skos__altLabel mesh__D022641 Vero Cytotoxin VT2
% 218.67/218.83  |- skos__altLabel mesh__D022641 Shiga Toxin 2, Escherichia coli
% 218.67/218.83  |- mesh__recordMaintainer mesh__D022641 ssb
% 218.67/218.83  |- skos__altLabel mesh__D022641 VT2 Cytotoxin
% 218.67/218.83  |- skos__altLabel mesh__D022641 Shiga Toxin 2
% 218.67/218.83  |- mesh__recordOriginator mesh__D022641 jmp
% 218.67/218.83  |- skos__broader mesh__D022641smesh__D022603
% 218.67/218.83  |- skos__altLabel mesh__D022641 Shiga Like Toxin II
% 218.67/218.83  |- skos__historyNote mesh__D022641 Bacterial Toxins %28%1980-2000%29%
% 218.67/218.83  |- skos__altLabel mesh__D022641 SLT-II
% 218.67/218.83  |- mesh__dateRevised mesh__D022641 2005-06-30
% 218.67/218.83  |- mesh__publicMeSHNote mesh__D022641
% 218.67/218.83       2001; SHIGA-LIKE TOXIN II was indexed under BACTERIAL TOXINS 1988-2000; SHIGA TOXIN 2 %26% STX2 PROTEIN was indexed under BACTERIAL TOXINS 1997-2000%A%  
% 218.67/218.83  |- skos__altLabel mesh__D022641 SLTII
% 218.67/218.83  |- mesh__dateCreated mesh__D022641 2000-06-27
% 218.67/218.83  |- skos__scopeNote mesh__D022641
% 218.67/218.83       A toxin produced by certain pathogenic strains of ESCHERICHIA COLI such as ESCHERICHIA COLI O157. It is shares 50-60%25% homology with SHIGA TOXIN and SHIGA-LIKE TOXIN I.%A%    
% 218.67/218.83  |- mesh__recordAuthorizer mesh__D022641 sjn
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D022641 2006
% 218.67/218.83  |- skos__altLabel mesh__D022641 Stx2 protein
% 218.67/218.83  |- mesh__dateEstablished mesh__D022641 2001-01-01
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008172 2003
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008172 2006
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008172 2000
% 218.67/218.83  |- skos__annotation mesh__D008172
% 218.67/218.83       coord IM with specific fungal disease %28%IM%29%; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY is available%A%  
% 218.67/218.83  |- mesh__dateRevised mesh__D008172 1981-03-16
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008172 2005
% 218.67/218.83  |- mesh__dateCreated mesh__D008172 1999-01-01
% 218.67/218.83  |- mesh__recordMaintainer mesh__D008172 SMH
% 218.67/218.83  |- mesh__recordOriginator mesh__D008172 NLM
% 218.67/218.83  |- skos__hiddenLabel mesh__D008172 Disease, Fungal Lung
% 218.67/218.83  |- skos__hiddenLabel mesh__D008172 Fungal Lung Disease
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008172 1989
% 218.67/218.83  |- skos__broader mesh__D008172smesh__D008171
% 218.67/218.83  |- skos__hiddenLabel mesh__D008172 Lung Disease, Fungal
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008172 1997
% 218.67/218.83  |- mesh__recordAuthorizer mesh__D008172 NLM
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008172 1991
% 218.67/218.83  |- skos__broader mesh__D008172smesh__D012141
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008172 1993
% 218.67/218.83  |- skos__broader mesh__D008172smesh__D009181
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008172 1996
% 218.67/218.83  |- skos__hiddenLabel mesh__D008172 Fungal Lung Diseases
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008172 1999
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008172 1990
% 218.67/218.83  |- rdf__type mesh__D008172sskos__Concept
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008172 1992
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008172 2002
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008172 1995
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008172 1998
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008172 2004
% 218.67/218.83  |- skos__prefLabel mesh__D008172 Lung Diseases, Fungal
% 218.67/218.83  |- skos__hiddenLabel mesh__D008172 Diseases, Fungal Lung
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008172 2001
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D008172 1994
% 218.67/218.83  |- skos__broader mesh__D016604smesh__D000348
% 218.67/218.83  |- mesh__recordOriginator mesh__D016604 RLS
% 218.67/218.83  |- mesh__publicMeSHNote mesh__D016604
% 218.67/218.83       92; AFLATOXIN B1 was indexed under AFLATOXINS 1980-91   
% 218.67/218.83  |- mesh__dateRevised mesh__D016604 2005-06-30
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D016604 2006
% 218.67/218.83  |- mesh__historyNote mesh__D016604
% 218.67/218.83       92; was AFLATOXIN B1 %28%NM%29% 1980-91   
% 218.67/218.83  |- mesh__dateCreated mesh__D016604 1991-01-24
% 218.67/218.83  |- skos__prefLabel mesh__D016604 Aflatoxin B1
% 218.67/218.83  |- mesh__recordAuthorizer mesh__D016604 sjn
% 218.67/218.83  |- rdf__type mesh__D016604sskos__Concept
% 218.67/218.83  |- skos__annotation mesh__D016604
% 218.67/218.83       /antag permitted but consider also ANTITOXINS; DF: AFB1   
% 218.67/218.83  |- skos__scopeNote mesh__D016604
% 218.67/218.83       A potent hepatotoxic and hepatocarcinogenic mycotoxin produced by the Aspergillus flavus group of fungi. It is also mutagenic, teratogenic, and causes immunosuppression in animals. It is found as a contaminant in peanuts, cottonseed meal, corn, and other grains. The mycotoxin requires epoxidation to aflatoxin B1 2,3-oxide for activation. Microsomal monooxygenases biotransform the toxin to the less toxic metabolites aflatoxin M1 and Q1.%A%    
% 218.67/218.83  |- mesh__dateEstablished mesh__D016604 1992-01-01
% 218.67/218.83  |- mesh__recordMaintainer mesh__D016604 ssb
% 218.67/218.83  |- mesh__onlineNote mesh__D016604
% 218.67/218.83       use AFLATOXIN B1 %28%NM%29% to search AFLATOXIN B1 1979-91   
% 218.67/218.83  |- skos__historyNote mesh__D016604 Aflatoxins %28%1966-1991%29%
% 218.67/218.83  |- mesh__recordOriginator mesh__D007878 NLM
% 218.67/218.83  |- skos__hiddenLabel mesh__D007878 Legislation, Model
% 218.67/218.83  |- skos__scopeNote mesh__D007878
% 218.67/218.83       The enactment of laws and ordinances and their regulation by official organs of a nation, state, or other legislative organization. It refers also to health-related laws and regulations in general or for which there is no specific heading.%A%    
% 218.67/218.83  |- mesh__recordMaintainer mesh__D007878 jls
% 218.67/218.83  |- skos__altLabel mesh__D007878 Laws and Statutes
% 218.67/218.83  |- skos__broader mesh__D007878smesh__D012926
% 218.67/218.83  |- skos__altLabel mesh__D007878 Statutes and Laws
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D007878 2006
% 218.67/218.83  |- skos__hiddenLabel mesh__D007878 Constitutional Amendment
% 218.67/218.83  |- skos__related mesh__D007878smesh__D008004
% 218.67/218.83  |- skos__annotation mesh__D007878
% 218.67/218.83       general or unspecified; prefer specifics; prefer /legis: Manual 19.7+, 19.8.42; specify country or state%A%  
% 218.67/218.83  |- skos__hiddenLabel mesh__D007878 Population Laws
% 218.67/218.83  |- skos__hiddenLabel mesh__D007878 Amendments, Constitutional
% 218.67/218.83  |- mesh__recordAuthorizer mesh__D007878 sjn
% 218.67/218.83  |- mesh__dateRevised mesh__D007878 2005-06-30
% 218.67/218.83  |- skos__hiddenLabel mesh__D007878 Laws, Population
% 218.67/218.83  |- skos__altLabel mesh__D007878 Legislation, Health
% 218.67/218.83  |- skos__hiddenLabel mesh__D007878 Law, Population
% 218.67/218.83  |- skos__hiddenLabel mesh__D007878 Amendment, Constitutional
% 218.67/218.83  |- rdf__type mesh__D007878sskos__Concept
% 218.67/218.83  |- mesh__dateCreated mesh__D007878 1999-01-01
% 218.67/218.83  |- skos__prefLabel mesh__D007878 Legislation
% 218.67/218.83  |- mesh__dateEstablished mesh__D032271 2003-01-01
% 218.67/218.83  |- skos__annotation mesh__D032271
% 218.67/218.83       QUASSIA SIMAROUBA see SIMAROUBA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.67/218.83  |- mesh__historyNote mesh__D032271 2003   
% 218.67/218.83  |- skos__broader mesh__D032271smesh__D029641
% 218.67/218.83  |- rdf__type mesh__D032271sskos__Concept
% 218.67/218.83  |- mesh__publicMeSHNote mesh__D032271 2003   
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D032271 2004
% 218.67/218.83  |- mesh__dateCreated mesh__D032271 2002-07-03
% 218.67/218.83  |- skos__scopeNote mesh__D032271
% 218.67/218.83       A plant genus of the family SIMAROUBACEAE. Members contain quassinoids. Quassia simarouba has been reclassified as SIMAROUBA.%A%    
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D032271 2003
% 218.67/218.83  |- skos__prefLabel mesh__D032271 Quassia
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D032271 2006
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D032271 2005
% 218.67/218.83  |- skos__altLabel mesh__D004580 Anesthesia, Electric
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D004580 2003
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D004580 1997
% 218.67/218.83  |- rdf__type mesh__D004580sskos__Concept
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D004580 1998
% 218.67/218.83  |- skos__broader mesh__D004580smesh__D000760
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D004580 2001
% 218.67/218.83  |- skos__hiddenLabel mesh__D004580 Anesthesias, Electric
% 218.67/218.83  |- skos__altLabel mesh__D004580 Electric Anesthesia
% 218.67/218.83  |- mesh__dateCreated mesh__D004580 1999-01-01
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D004580 2000
% 218.67/218.83  |- skos__altLabel mesh__D004580 Electroanesthesia
% 218.67/218.83  |- skos__annotation mesh__D004580
% 218.67/218.83       do not use /util except by MeSH definition; current applied through the brain: do not confuse with ELECTROANALGESIA %28%%22%applied through the skin%22%%29%%A%  
% 218.67/218.83  |- mesh__dateRevised mesh__D004580 1996-06-10
% 218.67/218.83  |- skos__hiddenLabel mesh__D004580 Electric Anesthesias
% 218.67/218.83  |- mesh__recordMaintainer mesh__D004580 TGC
% 218.67/218.83  |- skos__altLabel mesh__D004580 Electrosleep
% 218.67/218.83  |- mesh__recordOriginator mesh__D004580 NLM
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D004580 2006
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D004580 2002
% 218.67/218.83  |- skos__prefLabel mesh__D004580 Electronarcosis
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D004580 2004
% 218.67/218.83  |- skos__hiddenLabel mesh__D004580 Electroanesthesias
% 218.67/218.83  |- mesh__recordAuthorizer mesh__D004580 PLS
% 218.67/218.83  |- skos__scopeNote mesh__D004580
% 218.67/218.83       Profound stupor produced by passing an electric current through the brain.%A%    
% 218.67/218.83  |- skos__hiddenLabel mesh__D004580 Electronarcoses
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D004580 2005
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D004580 1999
% 218.67/218.83  |- skos__annotation mesh__D012214
% 218.67/218.83       most important manifest of rheum fever; coord IM with specific dis of the heart %28%myocardium or valves%29% %28%IM or NIM%29%%A%  
% 218.67/218.83  |- mesh__recordMaintainer mesh__D012214 PLS
% 218.67/218.83  |- mesh__recordOriginator mesh__D012214 NLM
% 218.67/218.83  |- mesh__publicMeSHNote mesh__D012214
% 218.67/218.83       BOUILLAUD%27%S DISEASE was see RHEUMATIC FEVER 1964-91   
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012214 2002
% 218.67/218.83  |- skos__prefLabel mesh__D012214 Rheumatic Heart Disease
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012214 2005
% 218.67/218.83  |- mesh__dateCreated mesh__D012214 1999-01-01
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012214 1999
% 218.67/218.83  |- skos__hiddenLabel mesh__D012214 Disease, Rheumatic Heart
% 218.67/218.83  |- mesh__dateRevised mesh__D012214 1995-05-25
% 218.67/218.83  |- skos__hiddenLabel mesh__D012214 Bouillauds Disease
% 218.67/218.83  |- skos__hiddenLabel mesh__D012214 Diseases, Rheumatic Heart
% 218.67/218.83  |- skos__hiddenLabel mesh__D012214 Disease, Bouillaud
% 218.67/218.83  |- skos__broader mesh__D012214smesh__D006331
% 218.67/218.83  |- mesh__recordAuthorizer mesh__D012214 PLS
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012214 2006
% 218.67/218.83  |- rdf__type mesh__D012214sskos__Concept
% 218.67/218.83  |- mesh__historyNote mesh__D012214
% 218.67/218.83       BOUILLAUD%27%S DISEASE was see RHEUMATIC FEVER 1964-91   
% 218.67/218.83  |- mesh__onlineNote mesh__D012214
% 218.67/218.83       use RHEUMATIC FEVER to search BOUILLAUD%27%S DISEASE 1966-91%A%  
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012214 1996
% 218.67/218.83  |- skos__scopeNote mesh__D012214
% 218.67/218.83       The most important manifestation of and sequel to rheumatic fever, i.e., any cardiac involvement in rheumatic fever. %28%Dorland, 27th ed%29%%A%    
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012214 2000
% 218.67/218.83  |- skos__hiddenLabel mesh__D012214 Disease, Bouillaud%27%s
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012214 2003
% 218.67/218.83  |- skos__hiddenLabel mesh__D012214 Heart Diseases, Rheumatic
% 218.67/218.83  |- skos__broader mesh__D012214smesh__D012213
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012214 1997
% 218.67/218.83  |- skos__hiddenLabel mesh__D012214 Heart Disease, Rheumatic
% 218.67/218.83  |- skos__altLabel mesh__D012214 Bouillaud%27%s Disease
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012214 2001
% 218.67/218.83  |- skos__hiddenLabel mesh__D012214 Rheumatic Heart Diseases
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012214 2004
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D012214 1998
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D031179 2003
% 218.67/218.83  |- skos__broader mesh__D031179smesh__D019659
% 218.67/218.83  |- mesh__publicMeSHNote mesh__D031179 2003   
% 218.67/218.83  |- skos__altLabel mesh__D031179 Knapweed
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D031179 2006
% 218.67/218.83  |- mesh__dateEstablished mesh__D031179 2003-01-01
% 218.67/218.83  |- skos__scopeNote mesh__D031179
% 218.67/218.83       A plant genus of the family ASTERACEAE. Members contain 5-methyl-8-hydroxycoumarin.  The common name of centaury is more often used for CENTAURIUM%A%    
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D031179 2005
% 218.67/218.83  |- skos__altLabel mesh__D031179 Cornflower
% 218.67/218.83  |- skos__annotation mesh__D031179
% 218.67/218.83       other %27%thistle%27% plants are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.67/218.83  |- rdf__type mesh__D031179sskos__Concept
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D031179 2004
% 218.67/218.83  |- mesh__historyNote mesh__D031179 2003   
% 218.67/218.83  |- skos__prefLabel mesh__D031179 Centaurea
% 218.67/218.83  |- skos__altLabel mesh__D031179 Thistle, Red Star
% 218.67/218.83  |- skos__altLabel mesh__D031179 Thistle, Yellow Star
% 218.67/218.83  |- mesh__dateCreated mesh__D031179 2002-07-03
% 218.67/218.83  |- skos__scopeNote mesh__D003488
% 218.67/218.83       Cyanogen bromide %28%CNBr%29%. A compound used in molecular biology to digest some proteins and as a coupling reagent for phosphoroamidate or pyrophosphate internucleotide bonds in DNA duplexes.%A%    
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D003488 1997
% 218.67/218.83  |- skos__annotation mesh__D003488 useful reagent in molec biol   
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D003488 2003
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D003488 1999
% 218.67/218.83  |- mesh__dateCreated mesh__D003488 1999-01-01
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D003488 2005
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D003488 1996
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D003488 1995
% 218.67/218.83  |- mesh__recordOriginator mesh__D003488 NLM
% 218.67/218.83  |- skos__broader mesh__D003488smesh__D017672
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D003488 1998
% 218.67/218.83  |- mesh__historyNote mesh__D003488 73%28%71%29%   
% 218.67/218.83  |- skos__broader mesh__D003488smesh__D001965
% 218.67/218.83  |- rdf__type mesh__D003488sskos__Concept
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D003488 1994
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D003488 2002
% 218.67/218.83  |- mesh__recordAuthorizer mesh__D003488 PLS
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D003488 2001
% 218.67/218.83  |- mesh__recordMaintainer mesh__D003488 TPW
% 218.67/218.83  |- skos__prefLabel mesh__D003488 Cyanogen Bromide
% 218.67/218.83  |- skos__hiddenLabel mesh__D003488 Bromide, Cyanogen
% 218.67/218.83  |- mesh__dateEstablished mesh__D003488 1973-01-01
% 218.67/218.83  |- mesh__publicMeSHNote mesh__D003488 73   
% 218.67/218.83  |- skos__historyNote mesh__D003488 Cyanides %28%1966-1970%29%
% 218.67/218.83  |- mesh__dateRevised mesh__D003488 1993-06-04
% 218.67/218.83  |- mesh__activeMeSHYear mesh__D003488 2004
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D003488 2000
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D003488 2006
% 218.67/218.84  |- skos__altLabel mesh__D022642 Vaccines, Antifertility
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D022642 2006
% 218.67/218.84  |- mesh__recordOriginator mesh__D022642 ags
% 218.67/218.84  |- mesh__historyNote mesh__D022642
% 218.67/218.84       2001; use CONTRACEPTION, IMMUNOLOGIC %28%1996-2000%29%   
% 218.67/218.84  |- skos__broader mesh__D022642smesh__D014612
% 218.67/218.84  |- rdf__type mesh__D022642sskos__Concept
% 218.67/218.84  |- skos__prefLabel mesh__D022642 Vaccines, Contraceptive
% 218.67/218.84  |- skos__altLabel mesh__D022642 Antifertility Vaccines
% 218.67/218.84  |- mesh__recordMaintainer mesh__D022642 ssb
% 218.67/218.84  |- skos__scopeNote mesh__D022642
% 218.67/218.84       Vaccines or candidate vaccines used to prevent conception.%A%    
% 218.67/218.84  |- mesh__dateCreated mesh__D022642 2000-06-21
% 218.67/218.84  |- mesh__publicMeSHNote mesh__D022642
% 218.67/218.84       2001; see CONTRACEPTION, IMMUNOLOGIC %28%1996-2000%29%   
% 218.67/218.84  |- skos__altLabel mesh__D022642 Contraceptive Vaccines
% 218.67/218.84  |- mesh__recordAuthorizer mesh__D022642 sjn
% 218.67/218.84  |- mesh__dateEstablished mesh__D022642 2001-01-01
% 218.67/218.84  |- mesh__dateRevised mesh__D022642 2005-06-30
% 218.67/218.84  |- skos__related mesh__D022642smesh__D003269
% 218.67/218.84  |- skos__historyNote mesh__D022642
% 218.67/218.84       Contraception, Immunologic %28%1977-2000%29%
% 218.67/218.84  |- skos__historyNote mesh__D022642 Vaccines %28%1977-2000%29%
% 218.67/218.84  |- skos__scopeNote mesh__D008971
% 218.67/218.84       Any of numerous burrowing mammals found in temperate regions and having minute eyes often covered with skin.%A%    
% 218.67/218.84  |- mesh__publicMeSHNote mesh__D008971
% 218.67/218.84       91; was see under INSECTIVORA 1975-90   
% 218.67/218.84  |- mesh__recordMaintainer mesh__D008971 ags
% 218.67/218.84  |- mesh__dateEstablished mesh__D008971 1991-01-01
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008971 2006
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008971 2004
% 218.67/218.84  |- skos__annotation mesh__D008971 IM; qualif permitted   
% 218.67/218.84  |- mesh__recordAuthorizer mesh__D008971 sjn
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008971 2005
% 218.67/218.84  |- skos__prefLabel mesh__D008971 Moles
% 218.67/218.84  |- mesh__dateRevised mesh__D008971 2003-07-09
% 218.67/218.84  |- skos__hiddenLabel mesh__D008971 Mole
% 218.67/218.84  |- rdf__type mesh__D008971sskos__Concept
% 218.67/218.84  |- mesh__historyNote mesh__D008971
% 218.67/218.84       91%28%75%29%; was see under INSECTIVORA 1975-90   
% 218.67/218.84  |- mesh__recordOriginator mesh__D008971 NLM
% 218.67/218.84  |- skos__broader mesh__D008971smesh__D007312
% 218.67/218.84  |- mesh__dateCreated mesh__D008971 1974-12-12
% 218.67/218.84  |- mesh__recordAuthorizer mesh__D008173 sjn
% 218.67/218.84  |- mesh__dateRevised mesh__D008173 2001-07-25
% 218.67/218.84  |- skos__related mesh__D008173smesh__D000402
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008173 2002
% 218.67/218.84  |- mesh__dateEstablished mesh__D008173 1972-01-01
% 218.67/218.84  |- skos__broader mesh__D008173smesh__D008171
% 218.67/218.84  |- skos__hiddenLabel mesh__D008173 Obstructive Lung Disease
% 218.67/218.84  |- mesh__publicMeSHNote mesh__D008173 72   
% 218.67/218.84  |- rdf__type mesh__D008173sskos__Concept
% 218.67/218.84  |- mesh__historyNote mesh__D008173 72%28%71%29%   
% 218.67/218.84  |- skos__hiddenLabel mesh__D008173 Diseases, Obstructive Lung
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008173 2004
% 218.67/218.84  |- mesh__recordMaintainer mesh__D008173 lkt
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008173 2003
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008173 2006
% 218.67/218.84  |- skos__hiddenLabel mesh__D008173 Obstructive Lung Diseases
% 218.67/218.84  |- skos__scopeNote mesh__D008173
% 218.67/218.84       Any disorder marked by persistent obstruction of bronchial air flow.%A%    
% 218.67/218.84  |- mesh__recordOriginator mesh__D008173 NLM
% 218.67/218.84  |- skos__hiddenLabel mesh__D008173 Lung Disease, Obstructive
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008173 2005
% 218.67/218.84  |- mesh__dateCreated mesh__D008173 1999-01-01
% 218.67/218.84  |- skos__prefLabel mesh__D008173 Lung Diseases, Obstructive
% 218.67/218.84  |- skos__hiddenLabel mesh__D008173 Disease, Obstructive Lung
% 218.67/218.84  |- skos__historyNote mesh__D008173 Lung Diseases %28%1966-1970%29%
% 218.67/218.84  |- skos__annotation mesh__D008173
% 218.67/218.84       PULMONARY DISEASE, CHRONIC OBSTRUCTIVE and AIRWAY OBSTRUCTION are also available%A%  
% 218.67/218.84  |- skos__broader mesh__D011572Q000266smesh__D011572
% 218.67/218.84  |- rdf__type mesh__D011572Q000266smesh__CompoundConcept
% 218.67/218.84  |- mesh__dateCreated mesh__D000190 1999-01-01
% 218.67/218.84  |- skos__scopeNote mesh__D000190
% 218.67/218.84       A genus of gram-positive, rod-shaped bacteria whose organisms are nonmotile. Filaments that may be present in certain species are either straight or wavy and may have swollen or clubbed heads.%A%    
% 218.67/218.84  |- skos__prefLabel mesh__D000190 Actinomyces
% 218.67/218.84  |- mesh__recordAuthorizer mesh__D000190 sjn
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D000190 2006
% 218.67/218.84  |- mesh__dateRevised mesh__D000190 2005-06-30
% 218.67/218.84  |- rdf__type mesh__D000190sskos__Concept
% 218.67/218.84  |- mesh__recordMaintainer mesh__D000190 SYSTEM
% 218.67/218.84  |- skos__annotation mesh__D000190
% 218.67/218.84       a genus of the family ACTINOMYCETACEAE of the order ACTINOMYCETALES; infection = ACTINOMYCOSIS%A%  
% 218.67/218.84  |- skos__broader mesh__D000190smesh__D000191
% 218.67/218.84  |- mesh__recordOriginator mesh__D000190 NLM
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D007879 2003
% 218.67/218.84  |- skos__altLabel mesh__D007879 Dental Legislation
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D007879 2000
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D007879 2005
% 218.67/218.84  |- mesh__recordOriginator mesh__D007879 NLM
% 218.67/218.84  |- skos__annotation mesh__D007879
% 218.67/218.84       IM; specify country or state; DF: LEGIS DENT   
% 218.67/218.84  |- mesh__dateRevised mesh__D007879 1999-11-03
% 218.67/218.84  |- skos__broader mesh__D007879smesh__D007878
% 218.67/218.84  |- mesh__recordAuthorizer mesh__D007879 sjn
% 218.67/218.84  |- mesh__dateCreated mesh__D007879 1999-01-01
% 218.67/218.84  |- rdf__type mesh__D007879sskos__Concept
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D007879 2002
% 218.67/218.84  |- mesh__recordMaintainer mesh__D007879 kle
% 218.67/218.84  |- skos__scopeNote mesh__D007879
% 218.67/218.84       Laws and regulations pertaining to the field of dentistry, proposed for enactment or recently enacted by a legislative body.%A%    
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D007879 2004
% 218.67/218.84  |- skos__prefLabel mesh__D007879 Legislation, Dental
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D007879 2001
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D007879 2006
% 218.67/218.84  |- rdf__type mesh__D032272sskos__Concept
% 218.67/218.84  |- mesh__publicMeSHNote mesh__D032272 2003   
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D032272 2004
% 218.67/218.84  |- skos__prefLabel mesh__D032272 Simarouba
% 218.67/218.84  |- mesh__dateEstablished mesh__D032272 2003-01-01
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D032272 2003
% 218.67/218.84  |- mesh__historyNote mesh__D032272 2003   
% 218.67/218.84  |- skos__annotation mesh__D032272
% 218.67/218.84       X ref QUASSIA SIMAROUBA: QUASSIA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.67/218.84  |- skos__altLabel mesh__D032272 Quassia simarouba
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D032272 2006
% 218.67/218.84  |- mesh__dateCreated mesh__D032272 2002-07-03
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D032272 2005
% 218.67/218.84  |- skos__scopeNote mesh__D032272
% 218.67/218.84       A plant genus of the family SIMAROUBACEAE. Members produce quassinoids.%A%    
% 218.67/218.84  |- skos__broader mesh__D032272smesh__D029641
% 218.67/218.84  |- mesh__recordOriginator mesh__D004581 NLM
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004581 1991
% 218.67/218.84  |- skos__prefLabel mesh__D004581 Electronics
% 218.67/218.84  |- skos__hiddenLabel mesh__D004581 Electronic
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004581 2002
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004581 1995
% 218.67/218.84  |- mesh__recordAuthorizer mesh__D004581 PLS
% 218.67/218.84  |- mesh__dateRevised mesh__D004581 1990-03-22
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004581 1993
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004581 2006
% 218.67/218.84  |- mesh__recordMaintainer mesh__D004581 TGC
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004581 2004
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004581 1994
% 218.67/218.84  |- skos__broader mesh__D004581smesh__D010811
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004581 1992
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004581 2005
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004581 1999
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004581 2001
% 218.67/218.84  |- rdf__type mesh__D004581sskos__Concept
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004581 2003
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004581 1997
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004581 2000
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004581 1998
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004581 1996
% 218.67/218.84  |- mesh__dateCreated mesh__D004581 1999-01-01
% 218.67/218.84  |- skos__annotation mesh__D004581 SPEC: SPEC qualif   
% 218.67/218.84  |- skos__broader mesh__D005333Q000637smesh__D005333
% 218.67/218.84  |- mesh__preferredCombination mesh__D005333Q000637smesh__D016332
% 218.67/218.84  |- rdf__type mesh__D005333Q000637smesh__CompoundConcept
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D012215 1999
% 218.67/218.84  |- skos__scopeNote mesh__D012215
% 218.67/218.84       A small round or oval, mostly subcutaneous nodule made up chiefly of a mass of Aschoff bodies and seen in cases of rheumatic fever. It is differentiated from the RHEUMATOID NODULE which appears in rheumatoid arthritis, most frequently over bony prominences. %28%From Dorland, 27th ed%29%%A%    
% 218.67/218.84  |- mesh__dateEstablished mesh__D012215 1967-01-01
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D012215 2001
% 218.67/218.84  |- mesh__recordMaintainer mesh__D012215 TGC
% 218.67/218.84  |- skos__hiddenLabel mesh__D012215 Nodule, Rheumatic
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D012215 2006
% 218.67/218.84  |- rdf__type mesh__D012215sskos__Concept
% 218.67/218.84  |- mesh__recordOriginator mesh__D012215 NLM
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D012215 2002
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D012215 1995
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D012215 1996
% 218.67/218.84  |- skos__hiddenLabel mesh__D012215 Nodules, Rheumatic
% 218.67/218.84  |- skos__annotation mesh__D012215
% 218.67/218.84       in rheum fever; do not confuse with RHEUMATOID NODULE in rheum arthritis%A%  
% 218.67/218.84  |- skos__hiddenLabel mesh__D012215 Rheumatic Nodules
% 218.67/218.84  |- skos__broader mesh__D012215smesh__D012213
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D012215 2003
% 218.67/218.84  |- mesh__historyNote mesh__D012215
% 218.67/218.84       67; ASCHOFF BODIES was see under RHEUMATIC NODULE 1967-78%A%  
% 218.67/218.84  |- mesh__recordAuthorizer mesh__D012215 PLS
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D012215 1997
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D012215 2004
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D012215 1998
% 218.67/218.84  |- mesh__publicMeSHNote mesh__D012215 67   
% 218.67/218.84  |- skos__hiddenLabel mesh__D012215 Bodies, Aschoff
% 218.67/218.84  |- mesh__onlineNote mesh__D012215
% 218.67/218.84       use RHEUMATIC NODULE to search ASCHOFF BODIES 1967-78   
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D012215 2000
% 218.67/218.84  |- mesh__dateRevised mesh__D012215 1994-05-24
% 218.67/218.84  |- skos__prefLabel mesh__D012215 Rheumatic Nodule
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D012215 2005
% 218.67/218.84  |- mesh__dateCreated mesh__D012215 1999-01-01
% 218.67/218.84  |- skos__historyNote mesh__D003489 Nitriles %28%1974%29%
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D003489 2005
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D003489 1996
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D003489 1995
% 218.67/218.84  |- mesh__dateRevised mesh__D003489 1993-06-04
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D003489 1998
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D003489 2000
% 218.67/218.84  |- skos__historyNote mesh__D003489 Androstenols %28%1974%29%
% 218.67/218.84  |- rdf__type mesh__D003489sskos__Concept
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D003489 1994
% 218.67/218.84  |- mesh__historyNote mesh__D003489
% 218.67/218.84       91%28%75%29%; was see under ANDROSTENOLS 1975-90   
% 218.67/218.84  |- skos__historyNote mesh__D003489 Ketosteroids %28%1974%29%
% 218.67/218.84  |- mesh__dateEstablished mesh__D003489 1991-01-01
% 218.67/218.84  |- mesh__recordOriginator mesh__D003489 NLM
% 218.67/218.84  |- mesh__recordMaintainer mesh__D003489 TPW
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D003489 2004
% 218.67/218.84  |- skos__prefLabel mesh__D003489 Cyanoketone
% 218.67/218.84  |- skos__scopeNote mesh__D003489
% 218.67/218.84       2 alpha-Cyano-17 beta-hydroxy-4,4%27%,17 alpha-trimethylandrost-5-ene-3-one. An androstenolone-nitrile compound with steroidogenesis-blocking activity.%A%    
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D003489 2002
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D003489 2006
% 218.67/218.84  |- mesh__recordAuthorizer mesh__D003489 PLS
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D003489 1997
% 218.67/218.84  |- mesh__dateCreated mesh__D003489 1974-11-11
% 218.67/218.84  |- mesh__publicMeSHNote mesh__D003489
% 218.67/218.84       91; was see under ANDROSTENOLS 1975-90   
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D003489 2003
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D003489 1999
% 218.67/218.84  |- skos__broader mesh__D003489smesh__D000737
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D003489 2001
% 218.67/218.84  |- mesh__recordOriginator mesh__D008972 NLM
% 218.67/218.84  |- mesh__dateCreated mesh__D008972 1999-01-01
% 218.67/218.84  |- skos__hiddenLabel mesh__D008972 Hydrochloride, Molindone
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008972 2006
% 218.67/218.84  |- mesh__dateEstablished mesh__D008972 1991-01-01
% 218.67/218.84  |- skos__altLabel mesh__D008972 Molindone Monohydrochloride
% 218.67/218.84  |- skos__hiddenLabel mesh__D008972 Monohydrochloride, Molindone
% 218.67/218.84  |- mesh__recordMaintainer mesh__D008972 CCR
% 218.67/218.84  |- skos__scopeNote mesh__D008972
% 218.67/218.84       An indole derivative effective in schizophrenia and other psychoses and possibly useful in the treatment of the aggressive type of undersocialized conduct disorder. Molindone has much lower affinity for D2 receptors than most antipsychotic agents and has a relatively low affinity for D1 receptors. It has only low to moderate affinity for cholinergic and alpha-adrenergic receptors. Some electrophysiologic data from animals indicate that molindone has certain characteristics that resemble those of CLOZAPINE. %28%From AMA Drug Evaluations Annual, 1994, p283%29%%A%    
% 218.67/218.84  |- skos__historyNote mesh__D008972 Indoles %28%1966-1971%29%
% 218.67/218.84  |- skos__broader mesh__D008972smesh__D007211
% 218.67/218.84  |- skos__prefLabel mesh__D008972 Molindone
% 218.67/218.84  |- mesh__historyNote mesh__D008972
% 218.67/218.84       91%28%72%29%; was see under INDOLES 1972-90   
% 218.67/218.84  |- rdf__type mesh__D008972sskos__Concept
% 218.67/218.84  |- mesh__dateRevised mesh__D008972 2005-06-30
% 218.67/218.84  |- skos__altLabel mesh__D008972 Endo Brand of Molindone Hydrochloride
% 218.67/218.84  |- mesh__publicMeSHNote mesh__D008972 91; was see under INDOLES 1972-90   
% 218.67/218.84  |- skos__historyNote mesh__D008972 Antidepressive Agents %28%1966-1971%29%
% 218.67/218.84  |- mesh__recordAuthorizer mesh__D008972 sjn
% 218.67/218.84  |- skos__broader mesh__D008174smesh__D010272
% 218.67/218.84  |- skos__broader mesh__D008174smesh__D012141
% 218.67/218.84  |- skos__broader mesh__D008174smesh__D008171
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008174 1996
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008174 1999
% 218.67/218.84  |- skos__hiddenLabel mesh__D008174 Parasitic Lung Disease
% 218.67/218.84  |- rdf__type mesh__D008174sskos__Concept
% 218.67/218.84  |- mesh__dateRevised mesh__D008174 1994-04-16
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008174 1995
% 218.67/218.84  |- skos__scopeNote mesh__D008174
% 218.67/218.84       Infections of the lungs with a parasite. They are caused most commonly by nematodes %28%roundworms%29%.%A%    
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008174 1998
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008174 2004
% 218.67/218.84  |- mesh__recordAuthorizer mesh__D008174 PLS
% 218.67/218.84  |- mesh__recordMaintainer mesh__D008174 PXP
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008174 2002
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008174 2003
% 218.67/218.84  |- skos__annotation mesh__D008174
% 218.67/218.84       coord IM with specific parasitic disease %28%IM%29% but note that available also is ECHINOCOCCOSIS, PULMONARY%A%  
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008174 2006
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008174 2001
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008174 2005
% 218.67/218.84  |- mesh__dateCreated mesh__D008174 1999-01-01
% 218.67/218.84  |- skos__altLabel mesh__D008174 Parasitic Lung Diseases
% 218.67/218.84  |- skos__prefLabel mesh__D008174 Lung Diseases, Parasitic
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008174 2000
% 218.67/218.84  |- skos__hiddenLabel mesh__D008174 Lung Disease, Parasitic
% 218.67/218.84  |- skos__hiddenLabel mesh__D008174 Disease, Parasitic Lung
% 218.67/218.84  |- mesh__recordOriginator mesh__D008174 NLM
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008174 1997
% 218.67/218.84  |- skos__hiddenLabel mesh__D008174 Diseases, Parasitic Lung
% 218.67/218.84  |- mesh__publicMeSHNote mesh__D000191 75   
% 218.67/218.84  |- mesh__recordMaintainer mesh__D000191 SYSTEM
% 218.67/218.84  |- skos__broader mesh__D000191smesh__D000192
% 218.67/218.84  |- mesh__dateEstablished mesh__D000191 1975-01-01
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D000191 2006
% 218.67/218.84  |- mesh__recordOriginator mesh__D000191 NLM
% 218.67/218.84  |- skos__historyNote mesh__D000191 Actinomycetales %28%1966-1974%29%
% 218.67/218.84  |- skos__annotation mesh__D000191 a family of the order ACTINOMYCETALES   
% 218.67/218.84  |- rdf__type mesh__D000191sskos__Concept
% 218.67/218.84  |- skos__broader mesh__D000191smesh__D039903
% 218.67/218.84  |- mesh__historyNote mesh__D000191 75   
% 218.67/218.84  |- mesh__recordAuthorizer mesh__D000191 sjn
% 218.67/218.84  |- mesh__dateCreated mesh__D000191 1999-01-01
% 218.67/218.84  |- skos__prefLabel mesh__D000191 Actinomycetaceae
% 218.67/218.84  |- mesh__dateRevised mesh__D000191 2005-06-30
% 218.67/218.84  |- skos__scopeNote mesh__D000191
% 218.67/218.84       A family of bacteria including numerous parasitic and pathogenic forms.%A%    
% 218.67/218.84  |- mesh__recordAuthorizer mesh__D016606 sjn
% 218.67/218.84  |- mesh__dateEstablished mesh__D016606 1992-01-01
% 218.67/218.84  |- mesh__publicMeSHNote mesh__D016606 92   
% 218.67/218.84  |- mesh__recordOriginator mesh__D016606 PXP
% 218.67/218.84  |- skos__historyNote mesh__D016606 Thyroid Neoplasms %28%1966-1991%29%
% 218.67/218.84  |- skos__hiddenLabel mesh__D016606 Nodule, Thyroid
% 218.67/218.84  |- mesh__historyNote mesh__D016606 92   
% 218.67/218.84  |- skos__prefLabel mesh__D016606 Thyroid Nodule
% 218.67/218.84  |- skos__historyNote mesh__D016606 Thyroid Diseases %28%1966-1991%29%
% 218.67/218.84  |- skos__hiddenLabel mesh__D016606 Thyroid Nodules
% 218.67/218.84  |- mesh__dateCreated mesh__D016606 1991-01-25
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D016606 2006
% 218.67/218.84  |- skos__hiddenLabel mesh__D016606 Nodules, Thyroid
% 218.67/218.84  |- skos__scopeNote mesh__D016606
% 218.67/218.84       A small circumscribed mass in the THYROID GLAND that can be of neoplastic growth or non-neoplastic abnormality. It lacks a well-defined capsule or glandular architecture. Thyroid nodules are often benign but can be malignant. The growth of nodules can lead to a multinodular goiter %28%GOITER, NODULAR%29%.%A%    
% 218.67/218.84  |- skos__broader mesh__D016606smesh__D013964
% 218.67/218.84  |- mesh__dateRevised mesh__D016606 2005-06-30
% 218.67/218.84  |- rdf__type mesh__D016606sskos__Concept
% 218.67/218.84  |- mesh__recordMaintainer mesh__D016606 lkt
% 218.67/218.84  |- skos__related mesh__D016606smesh__D006044
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004582 1995
% 218.67/218.84  |- skos__prefLabel mesh__D004582 Electronics, Medical
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004582 1993
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004582 2006
% 218.67/218.84  |- mesh__publicMeSHNote mesh__D004582 68   
% 218.67/218.84  |- mesh__recordMaintainer mesh__D004582 TGC
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004582 2004
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004582 1994
% 218.67/218.84  |- mesh__recordOriginator mesh__D004582 NLM
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004582 1991
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004582 1992
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004582 2005
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004582 2002
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004582 1999
% 218.67/218.84  |- rdf__type mesh__D004582sskos__Concept
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004582 2003
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004582 1997
% 218.67/218.84  |- mesh__recordAuthorizer mesh__D004582 PLS
% 218.67/218.84  |- skos__annotation mesh__D004582 SPEC: SPEC qualif; DF: ELECTRONICS MED   
% 218.67/218.84  |- skos__altLabel mesh__D004582 Medical Electronics
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004582 1998
% 218.67/218.84  |- mesh__dateRevised mesh__D004582 1990-05-17
% 218.67/218.84  |- skos__broader mesh__D004582smesh__D004581
% 218.67/218.84  |- mesh__dateEstablished mesh__D004582 1968-01-01
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004582 1996
% 218.67/218.84  |- skos__historyNote mesh__D004582 Electronics %28%1966-1967%29%
% 218.67/218.84  |- mesh__dateCreated mesh__D004582 1999-01-01
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004582 2001
% 218.67/218.84  |- mesh__historyNote mesh__D004582 68   
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D004582 2000
% 218.67/218.84  |- skos__broader mesh__D012216smesh__D003240
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D012216 2002
% 218.67/218.84  |- mesh__publicMeSHNote mesh__D012216 90; was RHEUMATISM 1966-89   
% 218.67/218.84  |- mesh__historyNote mesh__D012216 90; was RHEUMATISM 1966-89   
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D012216 2001
% 218.67/218.84  |- rdf__type mesh__D012216sskos__Concept
% 218.67/218.84  |- skos__scopeNote mesh__D012216
% 218.67/218.84       Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.%A%    
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D012216 2006
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D012216 2000
% 218.67/218.84  |- mesh__recordMaintainer mesh__D012216 kle
% 218.67/218.84  |- mesh__onlineNote mesh__D012216
% 218.67/218.84       90; use RHEUMATIC DISEASES to search RHEUMATISM 1966-89   
% 218.67/218.84  |- mesh__recordAuthorizer mesh__D012216 sjn
% 218.67/218.84  |- skos__hiddenLabel mesh__D012216 Diseases, Rheumatic
% 218.67/218.84  |- skos__hiddenLabel mesh__D012216 Disease, Rheumatic
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D012216 2005
% 218.67/218.84  |- skos__broader mesh__D012216smesh__D009140
% 218.67/218.84  |- mesh__recordOriginator mesh__D012216 NLM
% 218.67/218.84  |- mesh__dateRevised mesh__D012216 1999-11-03
% 218.67/218.84  |- skos__hiddenLabel mesh__D012216 Enthesopathies
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D012216 2004
% 218.67/218.84  |- skos__annotation mesh__D012216
% 218.67/218.84       do not confuse with the specialty RHEUMATOLOGY; /drug ther: consider also ANTIRHEUMATIC AGENTS%A%  
% 218.67/218.84  |- skos__hiddenLabel mesh__D012216 Rheumatic Disease
% 218.67/218.84  |- skos__prefLabel mesh__D012216 Rheumatic Diseases
% 218.67/218.84  |- mesh__dateCreated mesh__D012216 1999-01-01
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D012216 2003
% 218.67/218.84  |- skos__altLabel mesh__D012216 Rheumatism
% 218.67/218.84  |- mesh__recordMaintainer mesh__D008973 SYSTEM
% 218.67/218.84  |- mesh__recordOriginator mesh__D008973 JW
% 218.67/218.84  |- mesh__publicMeSHNote mesh__D008973 92   
% 218.67/218.84  |- mesh__dateRevised mesh__D008973 2005-06-30
% 218.67/218.84  |- skos__prefLabel mesh__D008973 Mollicutes
% 218.67/218.84  |- mesh__dateCreated mesh__D008973 1975-07-18
% 218.67/218.84  |- mesh__recordAuthorizer mesh__D008973 sjn
% 218.67/218.84  |- mesh__historyNote mesh__D008973
% 218.67/218.84       92; was MOLLICUTES %28%NON MESH%29% 1976-91   
% 218.67/218.84  |- rdf__type mesh__D008973sskos__Concept
% 218.67/218.84  |- skos__scopeNote mesh__D008973
% 218.67/218.84       A class of gram-negative bacteria consisting of cells bounded by a plasma membrane. Its organisms differ from other bacteria in that they are devoid of cell walls. It contains a single order, MYCOPLASMATALES.%A%    
% 218.67/218.84  |- skos__annotation mesh__D008973
% 218.67/218.84       a class of bacteria; mollis = soft, cutis = skin, with ref to its pliable cell boundary; includes the MYCOPLASMATALES%A%  
% 218.67/218.84  |- skos__broader mesh__D008973smesh__D006090
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008973 2006
% 218.67/218.84  |- mesh__dateEstablished mesh__D008973 1992-01-01
% 218.67/218.84  |- mesh__onlineNote mesh__D000990
% 218.67/218.84       use ANTITHROMBIN III to search HEPARIN CO-FACTOR 1966-78 %28%as Prov 66-74%29%%A%  
% 218.67/218.84  |- skos__broader mesh__D000990smesh__D019774
% 218.67/218.84  |- mesh__dateRevised mesh__D000990 2005-07-08
% 218.67/218.84  |- skos__broader mesh__D000990smesh__D000991
% 218.67/218.84  |- mesh__recordAuthorizer mesh__D000990 ags
% 218.67/218.84  |- mesh__publicMeSHNote mesh__D000990
% 218.67/218.84       79; was HEPARIN CO-FACTOR see under ALPHA GLOBULINS 1975-78%A%  
% 218.67/218.84  |- skos__hiddenLabel mesh__D000990 Antithrombin III Alpha
% 218.67/218.84  |- mesh__recordMaintainer mesh__D000990 ags
% 218.67/218.84  |- skos__hiddenLabel mesh__D000990 Antithrombin Grifols Brand
% 218.67/218.84  |- skos__altLabel mesh__D000990 Pharmacia Brand of Antithrombin
% 218.67/218.84  |- skos__related mesh__D000990smesh__D000925
% 218.67/218.84  |- skos__hiddenLabel mesh__D000990 Heparin Co Factor I
% 218.67/218.84  |- skos__hiddenLabel mesh__D000990 Cofactor I, Heparin
% 218.67/218.84  |- skos__hiddenLabel mesh__D000990 Antithrombin Pharmacia Brand
% 218.67/218.84  |- mesh__dateEstablished mesh__D000990 1979-01-01
% 218.67/218.84  |- skos__hiddenLabel mesh__D000990 Antithrombin Baxter Brand
% 218.67/218.84  |- skos__altLabel mesh__D000990 Heparin Co-Factor I
% 218.67/218.84  |- skos__hiddenLabel mesh__D000990 Antithrombin IIIAlpha
% 218.67/218.84  |- skos__altLabel mesh__D000990 Bayer Brand of Antithrombin
% 218.67/218.84  |- skos__altLabel mesh__D000990 Antithrombin II
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D000990 2006
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D000990 2006A
% 218.67/218.84  |- mesh__dateCreated mesh__D000990 1999-01-01
% 218.67/218.84  |- skos__altLabel mesh__D000990 Heparin Cofactor I
% 218.67/218.84  |- rdf__type mesh__D000990sskos__Concept
% 218.67/218.84  |- skos__altLabel mesh__D000990 Factor Xa Inhibitor
% 218.67/218.84  |- mesh__historyNote mesh__D000990
% 218.67/218.84       79; was HEPARIN CO-FACTOR see under ALPHA GLOBULINS 1975-78, was HEPARIN CO-FACTOR 1963-74 %28%Prov%29%%A%  
% 218.67/218.84  |- skos__scopeNote mesh__D000990
% 218.67/218.84       A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes; it was formerly called Antithrombin II %28%AT II%29% which has now been shown to be identical to AT III; ANTITHROMBIN III DEFICIENCY, hereditary or acquired, results in thromboembolism. It is a member of the serpin superfamily. Some authors use the term antithrombin to refer to antithrombin III.%A%    
% 218.67/218.84  |- skos__altLabel mesh__D000990 Baxter Brand of Antithrombin
% 218.67/218.84  |- skos__broader mesh__D000990smesh__D000510
% 218.67/218.84  |- mesh__recordOriginator mesh__D000990 NLM
% 218.67/218.84  |- skos__prefLabel mesh__D000990 Antithrombin III
% 218.67/218.84  |- skos__altLabel mesh__D000990 Grifols Brand of Antithrombin
% 218.67/218.84  |- skos__hiddenLabel mesh__D000990 Antithrombin Bayer Brand
% 218.67/218.84  |- skos__altLabel mesh__D008175 Neoplasms, Pulmonary
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008175 2003
% 218.67/218.84  |- rdf__type mesh__D008175sskos__Concept
% 218.67/218.84  |- skos__prefLabel mesh__D008175 Lung Neoplasms
% 218.67/218.84  |- skos__altLabel mesh__D008175 Neoplasms, Lung
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008175 2005
% 218.67/218.84  |- mesh__dateCreated mesh__D008175 1999-01-01
% 218.67/218.84  |- skos__scopeNote mesh__D008175 Tumors or cancer of the LUNG.     
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008175 2004
% 218.67/218.84  |- mesh__recordOriginator mesh__D008175 NLM
% 218.67/218.84  |- skos__altLabel mesh__D008175 Pulmonary Neoplasms
% 218.67/218.84  |- skos__hiddenLabel mesh__D008175 Neoplasm, Pulmonary
% 218.67/218.84  |- skos__related mesh__D008175smesh__D002289
% 218.67/218.84  |- skos__related mesh__D008175smesh__D018288
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008175 2002
% 218.67/218.84  |- mesh__activeMeSHYear mesh__D008175 2006
% 218.67/218.84  |- skos__altLabel mesh__D008175 Cancer of Lung
% 218.67/218.85  |- skos__altLabel mesh__D008175 Cancer of the Lung
% 218.67/218.85  |- skos__annotation mesh__D008175
% 218.67/218.85       coord IM with histol type of neopl %28%IM%29%   
% 218.67/218.85  |- skos__hiddenLabel mesh__D008175 Cancer, Pulmonary
% 218.67/218.85  |- skos__altLabel mesh__D008175 Pulmonary Cancer
% 218.67/218.85  |- mesh__recordAuthorizer mesh__D008175 sjn
% 218.67/218.85  |- skos__broader mesh__D008175smesh__D012142
% 218.67/218.85  |- skos__hiddenLabel mesh__D008175 Lung Cancers
% 218.67/218.85  |- mesh__recordMaintainer mesh__D008175 nns
% 218.67/218.85  |- skos__hiddenLabel mesh__D008175 Lung Neoplasm
% 218.67/218.85  |- skos__hiddenLabel mesh__D008175 Cancers, Pulmonary
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D008175 2000
% 218.67/218.85  |- skos__hiddenLabel mesh__D008175 Neoplasm, Lung
% 218.67/218.85  |- mesh__dateRevised mesh__D008175 1999-11-03
% 218.67/218.85  |- skos__broader mesh__D008175smesh__D008171
% 218.67/218.85  |- skos__hiddenLabel mesh__D008175 Pulmonary Cancers
% 218.67/218.85  |- skos__hiddenLabel mesh__D008175 Cancer, Lung
% 218.67/218.85  |- skos__hiddenLabel mesh__D008175 Pulmonary Neoplasm
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D008175 2001
% 218.67/218.85  |- skos__hiddenLabel mesh__D008175 Cancers, Lung
% 218.67/218.85  |- skos__prefLabel mesh__D000192 Actinomycetales
% 218.67/218.85  |- mesh__dateRevised mesh__D000192 2005-06-30
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D000192 2006
% 218.67/218.85  |- skos__scopeNote mesh__D000192
% 218.67/218.85       An order of gram-positive, primarily aerobic BACTERIA that tend to form branching filaments.%A%    
% 218.67/218.85  |- skos__annotation mesh__D000192 infection = ACTINOMYCETALES INFECTIONS   
% 218.67/218.85  |- rdf__type mesh__D000192sskos__Concept
% 218.67/218.85  |- mesh__publicMeSHNote mesh__D000192
% 218.67/218.85       67; was ACTINOMYCETES 1963-66; CORYNEBACTERIACEAE was heading 1975-91 %28%see under CORYNEFORM GROUP 1976-90%29%; CORYNEFORM GROUP was heading 1976-91%A%  
% 218.67/218.85  |- mesh__onlineNote mesh__D000192
% 218.67/218.85       use ACTINOMYCETALES to search ACTINOMYCETES 1966; CORYNEBACTERIACEAE 1975-91; CORYNEFORM GROUP 1976-91%A%  
% 218.67/218.85  |- mesh__dateCreated mesh__D000192 1999-01-01
% 218.67/218.85  |- mesh__historyNote mesh__D000192
% 218.67/218.85       67; was ACTINOMYCETES 1963-66; CORYNEBACTERIACEAE was heading 1975-91 %28%see under CORYNEFORM GROUP 1976-90%29%; CORYNEFORM GROUP was heading 1976-91%A%  
% 218.67/218.85  |- mesh__recordOriginator mesh__D000192 NLM
% 218.67/218.85  |- skos__broader mesh__D000192smesh__D039903
% 218.67/218.85  |- mesh__recordAuthorizer mesh__D000192 sjn
% 218.67/218.85  |- mesh__recordMaintainer mesh__D000192 SYSTEM
% 218.67/218.85  |- mesh__dateEstablished mesh__D000192 1967-01-01
% 218.67/218.85  |- mesh__dateRevised mesh__D016607 2005-06-30
% 218.67/218.85  |- mesh__historyNote mesh__D016607 92; was AFLATOXIN %28%NM%29% 1980-91   
% 218.67/218.85  |- skos__altLabel mesh__D016607 4-Hydroxyaflatoxin B1
% 218.67/218.85  |- skos__annotation mesh__D016607
% 218.67/218.85       /antag permitted but consider also ANTITOXINS; DF: AFM1   
% 218.67/218.85  |- mesh__onlineNote mesh__D016607
% 218.67/218.85       use AFLATOXIN M1 %28%NM%29% to search AFLATOXIN M1 1979-91   
% 218.67/218.85  |- mesh__recordAuthorizer mesh__D016607 sjn
% 218.67/218.85  |- mesh__dateEstablished mesh__D016607 1992-01-01
% 218.67/218.85  |- mesh__dateCreated mesh__D016607 1991-01-25
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D016607 2006
% 218.67/218.85  |- mesh__recordMaintainer mesh__D016607 ssb
% 218.67/218.85  |- mesh__publicMeSHNote mesh__D016607
% 218.67/218.85       92; AFLATOXIN M1 was indexed under AFLATOXINS 1980-91   
% 218.67/218.85  |- skos__scopeNote mesh__D016607
% 218.67/218.85       A 4-hydroxylated metabolite of AFLATOXIN B1, one of the MYCOTOXINS from ASPERGILLUS tainted food.  It is associated with LIVER damage and cancer resulting from its P450 activation to the epoxide which alkylates DNA. Toxicity depends on the balance of liver enzymes that activate it %28%CYTOCHROME P-450%29% and others that detoxify it %28%GLUTATHIONE S TRANSFERASE%29% %28%Pharmac Ther 50.443 1991%29%. Primates %26% rat are sensitive while mouse and hamster are tolerant %28%Canc Res 29.236  1969%29%.%A%    
% 218.67/218.85  |- rdf__type mesh__D016607sskos__Concept
% 218.67/218.85  |- skos__historyNote mesh__D016607 Aflatoxins %28%1969-1991%29%
% 218.67/218.85  |- mesh__recordOriginator mesh__D016607 RLS
% 218.67/218.85  |- skos__prefLabel mesh__D016607 Aflatoxin M1
% 218.67/218.85  |- skos__broader mesh__D016607smesh__D000348
% 218.67/218.85  |- skos__hiddenLabel mesh__D016607 4 Hydroxyaflatoxin B1
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D004583 2000
% 218.67/218.85  |- skos__altLabel mesh__D004583 Negatrons
% 218.67/218.85  |- skos__hiddenLabel mesh__D004583 Positron
% 218.67/218.85  |- skos__hiddenLabel mesh__D004583 Electron, Fast
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D004583 2003
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D004583 2006
% 218.67/218.85  |- skos__annotation mesh__D004583 elementary particles; IM   
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D004583 1998
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D004583 2001
% 218.67/218.85  |- mesh__recordMaintainer mesh__D004583 KEV
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D004583 2004
% 218.67/218.85  |- skos__prefLabel mesh__D004583 Electrons
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D004583 1999
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D004583 2002
% 218.67/218.85  |- skos__related mesh__D004583smesh__D001610
% 218.67/218.85  |- mesh__dateCreated mesh__D004583 1999-01-01
% 218.67/218.85  |- skos__scopeNote mesh__D004583
% 218.67/218.85       Stable elementary particles having the smallest known negative charge, present in all elements; also called negatrons. Positively charged electrons are called positrons. The numbers, energies and arrangement of electrons around atomic nuclei determine the chemical identities of elements. Beams of electrons are called CATHODE RAYS or BETA RAYS, the latter being a high-energy biproduct of nuclear decay.%A%    
% 218.67/218.85  |- rdf__type mesh__D004583sskos__Concept
% 218.67/218.85  |- mesh__recordAuthorizer mesh__D004583 SJN
% 218.67/218.85  |- skos__hiddenLabel mesh__D004583 Electron
% 218.67/218.85  |- skos__broader mesh__D004583smesh__D004601
% 218.67/218.85  |- mesh__recordOriginator mesh__D004583 NLM
% 218.67/218.85  |- skos__hiddenLabel mesh__D004583 Electrons, Fast
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D004583 2005
% 218.67/218.85  |- mesh__dateRevised mesh__D004583 1997-06-20
% 218.67/218.85  |- skos__hiddenLabel mesh__D004583 Negatron
% 218.67/218.85  |- skos__hiddenLabel mesh__D004583 Fast Electron
% 218.67/218.85  |- mesh__dateRevised mesh__D012217 2005-06-30
% 218.67/218.85  |- rdf__type mesh__D012217sskos__Concept
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D012217 2006
% 218.67/218.85  |- skos__hiddenLabel mesh__D012217 Factor, Rheumatoid
% 218.67/218.85  |- skos__prefLabel mesh__D012217 Rheumatoid Factor
% 218.67/218.85  |- mesh__dateCreated mesh__D012217 1999-01-01
% 218.67/218.85  |- mesh__recordAuthorizer mesh__D012217 sjn
% 218.67/218.85  |- mesh__recordOriginator mesh__D012217 NLM
% 218.67/218.85  |- skos__scopeNote mesh__D012217
% 218.67/218.85       Antibodies found in adult RHEUMATOID ARTHRITIS patients that are directed against GAMMA-CHAIN IMMUNOGLOBULINS.%A%    
% 218.67/218.85  |- skos__broader mesh__D012217smesh__D001323
% 218.67/218.85  |- mesh__recordMaintainer mesh__D012217 ssb
% 218.67/218.85  |- skos__annotation mesh__D017700
% 218.67/218.85       lipid debris from atheromatous deposit; do not confuse with EMBOLISM, FAT, from fat entering circ%A%  
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D017700 1997
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D017700 2001
% 218.67/218.85  |- mesh__recordAuthorizer mesh__D017700 PLS
% 218.67/218.85  |- skos__hiddenLabel mesh__D017700 Embolisms, Cholesterol
% 218.67/218.85  |- mesh__historyNote mesh__D017700 94   
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D017700 2004
% 218.67/218.85  |- skos__scopeNote mesh__D017700
% 218.67/218.85       An embolism of lipid debris from an ulcerated atheromatous deposit, generally from a large artery to small arterial branches. It is usually small and rarely causes infarction. %28%Stedman, 25th ed%29%%A%    
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D017700 1996
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D017700 2000
% 218.67/218.85  |- mesh__dateEstablished mesh__D017700 1994-01-01
% 218.67/218.85  |- skos__hiddenLabel mesh__D017700 Atheroembolisms
% 218.67/218.85  |- mesh__publicMeSHNote mesh__D017700 94   
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D017700 1999
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D017700 2003
% 218.67/218.85  |- mesh__dateCreated mesh__D017700 1992-12-28
% 218.67/218.85  |- mesh__recordMaintainer mesh__D017700 TGC
% 218.67/218.85  |- skos__altLabel mesh__D017700 Atheroembolism
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D017700 1995
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D017700 2006
% 218.67/218.85  |- rdf__type mesh__D017700sskos__Concept
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D017700 1998
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D017700 2002
% 218.67/218.85  |- skos__altLabel mesh__D017700 Cholesterol Embolism
% 218.67/218.85  |- skos__prefLabel mesh__D017700 Embolism, Cholesterol
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D017700 2005
% 218.67/218.85  |- mesh__dateRevised mesh__D017700 1994-01-25
% 218.67/218.85  |- skos__historyNote mesh__D017700 Embolism %28%1966-1993%29%
% 218.67/218.85  |- skos__hiddenLabel mesh__D017700 Cholesterol Embolisms
% 218.67/218.85  |- skos__historyNote mesh__D017700 Cholesterol %28%1966-1993%29%
% 218.67/218.85  |- skos__related mesh__D017700smesh__D018438
% 218.67/218.85  |- mesh__recordOriginator mesh__D017700 TGC
% 218.67/218.85  |- skos__broader mesh__D017700smesh__D004617
% 218.67/218.85  |- skos__hiddenLabel mesh__D050336 Nanism Syndrome, Mulibrey
% 218.67/218.85  |- mesh__recordOriginator mesh__D050336 lkt
% 218.67/218.85  |- skos__altLabel mesh__D050336 Muscle-Liver-Brain-Eye Nanism
% 218.67/218.85  |- mesh__publicMeSHNote mesh__D050336 2006; see DWARFISM 1998-2005   
% 218.67/218.85  |- skos__altLabel mesh__D050336 Mulibrey Nanism Syndrome
% 218.67/218.85  |- mesh__dateCreated mesh__D050336 2005-06-30
% 218.67/218.85  |- skos__altLabel mesh__D050336 Nanism, Mulibrey
% 218.67/218.85  |- rdf__type mesh__D050336sskos__Concept
% 218.67/218.85  |- mesh__recordMaintainer mesh__D050336 lkt
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D050336 2006
% 218.67/218.85  |- skos__prefLabel mesh__D050336 Mulibrey Nanism
% 218.67/218.85  |- skos__broader mesh__D050336smesh__D004392
% 218.67/218.85  |- skos__scopeNote mesh__D050336
% 218.67/218.85       Growth failure from birth that is due to mutations in a gene %28%TRIM37%29% on chromosome 17q22-q23 which encodes a RING-B-box-coiled-coil protein.%A%    
% 218.67/218.85  |- skos__annotation mesh__D050336
% 218.67/218.85       mulibrey %28%stands for MUscle, LIver, BRain, EYes%29%: spell in titles %26% translations with lowercase m%A%  
% 218.67/218.85  |- skos__hiddenLabel mesh__D050336 Syndrome, Mulibrey Nanism
% 218.67/218.85  |- mesh__historyNote mesh__D050336 2006; use DWARFISM 1998-2005   
% 218.67/218.85  |- skos__altLabel mesh__D050336 Perheentupa Syndrome
% 218.67/218.85  |- mesh__recordAuthorizer mesh__D050336 sjn
% 218.67/218.85  |- skos__hiddenLabel mesh__D050336 Nanism, Muscle-Liver-Brain-Eye
% 218.67/218.85  |- skos__hiddenLabel mesh__D050336 Muscle Liver Brain Eye Nanism
% 218.67/218.85  |- skos__hiddenLabel mesh__D050336 Syndrome, Perheentupa
% 218.67/218.85  |- mesh__dateEstablished mesh__D050336 2006-01-01
% 218.67/218.85  |- skos__prefLabel mesh__D008974 Mollusca
% 218.67/218.85  |- skos__related mesh__D008974smesh__D012758
% 218.67/218.85  |- rdf__type mesh__D008974sskos__Concept
% 218.67/218.85  |- skos__annotation mesh__D008974
% 218.67/218.85       as animal %26% food; IM; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH %28%IM%29%%A%  
% 218.67/218.85  |- skos__broader mesh__D008974smesh__D007448
% 218.67/218.85  |- skos__scopeNote mesh__D008974
% 218.67/218.85       A phylum of the kingdom Metazoa. Mollusca have soft, unsegmented bodies with an anterior head, a dorsal visceral mass, and a ventral foot. Most are encased in a protective calcareous shell. It includes the classes GASTROPODA; BIVALVIA; CEPHALOPODA; Aplacophora; Scaphopoda; Polyplacophora; and Monoplacophora.%A%    
% 218.67/218.85  |- mesh__dateRevised mesh__D008974 2005-06-30
% 218.67/218.85  |- mesh__recordAuthorizer mesh__D008974 sjn
% 218.67/218.85  |- mesh__dateCreated mesh__D008974 1999-01-01
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D008974 2006
% 218.67/218.85  |- mesh__recordOriginator mesh__D008974 NLM
% 218.67/218.85  |- mesh__recordMaintainer mesh__D008974 ags
% 218.67/218.85  |- skos__altLabel mesh__D008974 Molluscs
% 218.67/218.85  |- skos__altLabel mesh__D008974 Mollusks
% 218.67/218.85  |- mesh__historyNote mesh__D000991
% 218.67/218.85       76; was ANTITHROMBIN 1964-75 %28%Prov 1964-66%29%   
% 218.67/218.85  |- mesh__dateCreated mesh__D000991 1999-01-01
% 218.67/218.85  |- mesh__publicMeSHNote mesh__D000991 76; was ANTITHROMBIN 1967-75   
% 218.67/218.85  |- mesh__recordOriginator mesh__D000991 NLM
% 218.67/218.85  |- mesh__recordAuthorizer mesh__D000991 sjn
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D000991 2005
% 218.67/218.85  |- skos__annotation mesh__D000991 serpins %26% anticoagulants   
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D000991 2006
% 218.67/218.85  |- mesh__dateEstablished mesh__D000991 1967-01-01
% 218.67/218.85  |- rdf__type mesh__D000991sskos__Concept
% 218.67/218.85  |- mesh__recordMaintainer mesh__D000991 jls
% 218.67/218.85  |- mesh__dateRevised mesh__D000991 2004-07-19
% 218.67/218.85  |- mesh__onlineNote mesh__D000991
% 218.67/218.85       use ANTITHROMBINS to search ANTITHROMBIN 1967-76 %28%as Prov 1966%29%%A%  
% 218.67/218.85  |- skos__related mesh__D000991smesh__D000925
% 218.67/218.85  |- skos__broader mesh__D000991smesh__D015843
% 218.67/218.85  |- skos__scopeNote mesh__D000991
% 218.67/218.85       An endogenous family of proteins belonging to the serpin superfamily that neutralizes the action of thrombin. Six naturally occurring antithrombins have been identified and are designated by Roman numerals I to VI. Of these, Antithrombin I %28%see FIBRIN%29% and ANTITHROMBIN III appear to be of major importance.%A%    
% 218.67/218.85  |- skos__prefLabel mesh__D000991 Antithrombins
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D008176 2004
% 218.67/218.85  |- mesh__dateRevised mesh__D008176 1997-06-20
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D008176 2005
% 218.67/218.85  |- skos__historyNote mesh__D008176 Lung %28%1966-1974%29%
% 218.67/218.85  |- skos__prefLabel mesh__D008176 Lung Volume Measurements
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D008176 2001
% 218.67/218.85  |- mesh__recordAuthorizer mesh__D008176 SJN
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D008176 2006
% 218.67/218.85  |- mesh__dateCreated mesh__D008176 1974-11-19
% 218.67/218.85  |- skos__hiddenLabel mesh__D008176 Lung Volume Measurement
% 218.67/218.85  |- mesh__dateEstablished mesh__D008176 1975-09-01
% 218.67/218.85  |- skos__scopeNote mesh__D008176
% 218.67/218.85       Measurement of the amount of air that the lungs may contain at various points in the respiratory cycle.%A%    
% 218.67/218.85  |- mesh__historyNote mesh__D008176 75   
% 218.67/218.85  |- skos__historyNote mesh__D008176 Respiration %28%1966-1974%29%
% 218.67/218.85  |- skos__annotation mesh__D008176
% 218.67/218.85       NIM; see FORCED EXPIRATORY FLOW RATES %26% FORCED EXPIRATORY VOLUME for more cross-refs%A%  
% 218.67/218.85  |- skos__hiddenLabel mesh__D008176 Measurements, Lung Volume
% 218.67/218.85  |- mesh__recordOriginator mesh__D008176 NLM
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D008176 2002
% 218.67/218.85  |- mesh__recordMaintainer mesh__D008176 PXP
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D008176 1998
% 218.67/218.85  |- skos__hiddenLabel mesh__D008176 Lung Capacity
% 218.67/218.85  |- skos__historyNote mesh__D008176
% 218.67/218.85       Respiratory Function Tests %28%1966-1974%29%
% 218.67/218.85  |- skos__hiddenLabel mesh__D008176 Capacity, Lung
% 218.67/218.85  |- mesh__publicMeSHNote mesh__D008176 75   
% 218.67/218.85  |- skos__hiddenLabel mesh__D008176 Capacities, Lung
% 218.67/218.85  |- skos__broader mesh__D008176smesh__D012129
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D008176 1999
% 218.67/218.85  |- skos__hiddenLabel mesh__D008176 Measurement, Lung Volume
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D008176 2003
% 218.67/218.85  |- rdf__type mesh__D008176sskos__Concept
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D008176 2000
% 218.67/218.85  |- mesh__recordMaintainer mesh__D000193 PLS
% 218.67/218.85  |- mesh__recordAuthorizer mesh__D000193 PLS
% 218.67/218.85  |- mesh__dateCreated mesh__D000193 1999-01-01
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D000193 2002
% 218.67/218.85  |- skos__historyNote mesh__D000193 Actinomyces %28%1966-1971%29%
% 218.67/218.85  |- skos__broader mesh__D000193smesh__D016908
% 218.67/218.85  |- skos__hiddenLabel mesh__D000193 Actinomycetales Infection
% 218.67/218.85  |- mesh__onlineNote mesh__D000193
% 218.67/218.85       use ACTINOMYCETALES INFECTIONS to search ACTINOMYCETE INFECTIONS 1972-76%A%  
% 218.67/218.85  |- skos__altLabel mesh__D000193 Actinomycete Infections
% 218.67/218.85  |- skos__annotation mesh__D000193
% 218.67/218.85       gram-pos bact infect by organism of the order ACTINOMYCETALES; do not confuse with ACTINOMYCOSIS, infection by genus ACTINOMYCES%A%  
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D000193 1994
% 218.67/218.85  |- skos__altLabel mesh__D000193 Infections, Actinomycete
% 218.67/218.85  |- mesh__dateRevised mesh__D000193 1993-06-02
% 218.67/218.85  |- skos__altLabel mesh__D000193 Infections, Actinomycetales
% 218.67/218.85  |- skos__scopeNote mesh__D000193
% 218.67/218.85       Infections with bacteria of the order ACTINOMYCETALES.     
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D000193 1995
% 218.67/218.85  |- skos__prefLabel mesh__D000193 Actinomycetales Infections
% 218.67/218.85  |- skos__hiddenLabel mesh__D000193 Actinomycete Infection
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D000193 2005
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D000193 2003
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D000193 1998
% 218.67/218.85  |- mesh__publicMeSHNote mesh__D000193
% 218.67/218.85       77; was ACTINOMYCETE INFECTIONS 1972-76   
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D000193 2006
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D000193 2000
% 218.67/218.85  |- skos__historyNote mesh__D000193 Actinomycetales %28%1966-1971%29%
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D000193 1996
% 218.67/218.85  |- skos__hiddenLabel mesh__D000193 Infection, Actinomycetales
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D000193 2004
% 218.67/218.85  |- mesh__historyNote mesh__D000193
% 218.67/218.85       77; was ACTINOMYCETE INFECTIONS 1972-76   
% 218.67/218.85  |- skos__hiddenLabel mesh__D000193 Infection, Actinomycete
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D000193 1999
% 218.67/218.85  |- mesh__dateEstablished mesh__D000193 1972-01-01
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D000193 1997
% 218.67/218.85  |- rdf__type mesh__D000193sskos__Concept
% 218.67/218.85  |- mesh__recordOriginator mesh__D000193 NLM
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D000193 2001
% 218.67/218.85  |- skos__altLabel mesh__D016608 Band 2 Protein
% 218.67/218.85  |- mesh__recordOriginator mesh__D016608 RLS
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D016608 2003
% 218.67/218.85  |- mesh__dateCreated mesh__D016608 1991-07-12
% 218.67/218.85  |- skos__historyNote mesh__D016608 Contractile Proteins %28%1982-1986%29%
% 218.67/218.85  |- mesh__dateEstablished mesh__D016608 1992-01-01
% 218.67/218.85  |- skos__annotation mesh__D016608
% 218.67/218.85       a cytoplasmic protein; /drug eff /ultrastruct permitted   
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D016608 2002
% 218.67/218.85  |- skos__historyNote mesh__D016608 Muscle Proteins %28%1984-1986%29%
% 218.67/218.85  |- mesh__publicMeSHNote mesh__D016608
% 218.67/218.85       92; TALIN was indexed under CYTOSKELETAL PROTEINS 1987-91, under MUSCLE PROTEINS 1984-86 %26% under CONTRACTILE PROTEINS 1982-86%A%  
% 218.67/218.85  |- skos__historyNote mesh__D016608 Blood Proteins %28%1984-1986%29%
% 218.67/218.85  |- mesh__historyNote mesh__D016608 92; was TALIN %28%NM%29% 1984-91   
% 218.67/218.85  |- skos__historyNote mesh__D016608 Cytoskeletal Proteins %28%1985-1991%29%
% 218.67/218.85  |- mesh__recordMaintainer mesh__D016608 mdb
% 218.67/218.85  |- skos__broader mesh__D016608smesh__D003598
% 218.67/218.85  |- skos__scopeNote mesh__D016608
% 218.67/218.85       A 235-kDa cytoplasmic protein that is also found in platelets. It has been localized to regions of cell-substrate adhesion. It binds to INTEGRINS; VINCULIN; and ACTINS and appears to participate in generating a transmembrane connection between the extracellular matrix and the cytoskeleton.%A%    
% 218.67/218.85  |- skos__prefLabel mesh__D016608 Talin
% 218.67/218.85  |- mesh__recordAuthorizer mesh__D016608 sjn
% 218.67/218.85  |- mesh__dateRevised mesh__D016608 2001-07-25
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D016608 2006
% 218.67/218.85  |- skos__hiddenLabel mesh__D016608 Protein, Band 2
% 218.67/218.85  |- skos__hiddenLabel mesh__D016608 Protein p235, Platelet
% 218.67/218.85  |- mesh__onlineNote mesh__D016608
% 218.67/218.85       use TALIN %28%NM%29% to search TALIN 1977-91   
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D016608 2005
% 218.67/218.85  |- rdf__type mesh__D016608sskos__Concept
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D016608 2004
% 218.67/218.85  |- mesh__dateCreated mesh__D041001 2002-07-02
% 218.67/218.85  |- skos__scopeNote mesh__D041001
% 218.67/218.85       A species of protozoa infecting humans via the intermediate tick vector IXODES scapularis. The other hosts are the mouse PEROMYSCUS leucopus and  meadow vole MICROTUS pennsylvanicus, which are fed on by the tick. Other primates can be experimentally infected with Babesia microti.%A%    
% 218.67/218.85  |- skos__prefLabel mesh__D041001 Babesia microti
% 218.67/218.85  |- skos__historyNote mesh__D041001 Babesia %28%1969-2002%29%
% 218.67/218.85  |- skos__broader mesh__D041001smesh__D001403
% 218.67/218.85  |- mesh__dateRevised mesh__D041001 2003-07-09
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D041001 2006
% 218.67/218.85  |- skos__annotation mesh__D041001
% 218.67/218.85       infection: coord IM with BABESIOSIS %28%IM%29%   
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D041001 2004
% 218.67/218.85  |- rdf__type mesh__D041001sskos__Concept
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D041001 2005
% 218.67/218.85  |- mesh__dateEstablished mesh__D041001 2003-01-01
% 218.67/218.85  |- mesh__historyNote mesh__D041001 2003   
% 218.67/218.85  |- mesh__publicMeSHNote mesh__D041001 2003   
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D013310 2006
% 218.67/218.85  |- mesh__dateRevised mesh__D013310 2004-07-07
% 218.67/218.85  |- skos__broader mesh__D013310smesh__D017828
% 218.67/218.85  |- skos__altLabel mesh__D013310 Streptovaricins
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D013310 2005
% 218.67/218.85  |- skos__prefLabel mesh__D013310 Streptovaricin
% 218.67/218.85  |- mesh__publicMeSHNote mesh__D013310
% 218.67/218.85       95; was STREPTOVARICINS 1973-94; was STREPTOVARICIN 1963-72%A%  
% 218.67/218.85  |- mesh__recordOriginator mesh__D013310 NLM
% 218.67/218.85  |- mesh__recordMaintainer mesh__D013310 ssb
% 218.67/218.85  |- mesh__onlineNote mesh__D013310
% 218.67/218.85       use STREPTOVARICIN to search STREPTOVARICINS 1966-94   
% 218.67/218.85  |- skos__scopeNote mesh__D013310
% 218.67/218.85       A complex of ansamycin antibiotics consisting of streptovaricins A, B, C, D, E, F, G, J, and K of which streptovaricin C is the major component. %28%From Merck Index, 11th ed%29%%A%    
% 218.67/218.85  |- mesh__recordAuthorizer mesh__D013310 sjn
% 218.67/218.85  |- mesh__historyNote mesh__D013310
% 218.67/218.85       95; was STREPTOVARICINS 1973-94; was STREPTOVARICIN 1963-72%A%  
% 218.67/218.85  |- mesh__dateCreated mesh__D013310 1999-01-01
% 218.67/218.85  |- rdf__type mesh__D013310sskos__Concept
% 218.67/218.85  |- skos__broader mesh__D014123Q000151smesh__D014123
% 218.67/218.85  |- mesh__preferredCombination mesh__D014123Q000151smesh__D014125
% 218.67/218.85  |- rdf__type mesh__D014123Q000151smesh__CompoundConcept
% 218.67/218.85  |- skos__hiddenLabel mesh__D004584 Electronystagmographies
% 218.67/218.85  |- mesh__historyNote mesh__D004584
% 218.67/218.85       79%28%75%29%; was see under ELECTROOCULOGRAPHY 1973-78   
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D004584 2004
% 218.67/218.85  |- mesh__dateRevised mesh__D004584 1997-06-20
% 218.67/218.85  |- mesh__dateEstablished mesh__D004584 1979-01-01
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D004584 1999
% 218.67/218.85  |- skos__scopeNote mesh__D004584
% 218.67/218.85       Recording of nystagmus based on changes in the electrical field surrounding the eye produced by the difference in potential between the cornea and the retina.%A%    
% 218.67/218.85  |- mesh__recordMaintainer mesh__D004584 PXP
% 218.67/218.85  |- skos__annotation mesh__D004584
% 218.67/218.85       NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ELECTRONYSTAGMOGR%A%  
% 218.67/218.85  |- mesh__dateCreated mesh__D004584 1999-01-01
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D004584 2000
% 218.67/218.85  |- skos__broader mesh__D004584smesh__D005133
% 218.67/218.85  |- rdf__type mesh__D004584sskos__Concept
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D004584 2001
% 218.67/218.85  |- mesh__onlineNote mesh__D004584 search ELECTROOCULOGRAPHY 1973-74   
% 218.67/218.85  |- mesh__publicMeSHNote mesh__D004584
% 218.67/218.85       79; was see under ELECTROOCULOGRAPHY 1973-78   
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D004584 2002
% 218.67/218.85  |- skos__historyNote mesh__D004584 Electrooculography %28%1973-1974%29%
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D004584 2005
% 218.67/218.85  |- mesh__recordAuthorizer mesh__D004584 SJN
% 218.67/218.85  |- skos__broader mesh__D004584smesh__D004568
% 218.67/218.85  |- skos__prefLabel mesh__D004584 Electronystagmography
% 218.67/218.85  |- skos__broader mesh__D004584smesh__D014724
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D004584 2003
% 218.67/218.85  |- mesh__recordOriginator mesh__D004584 NLM
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D004584 2006
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D004584 1998
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D012218 2005
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D012218 2004
% 218.67/218.85  |- mesh__recordAuthorizer mesh__D012218 PLS
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D012218 1996
% 218.67/218.85  |- mesh__dateCreated mesh__D012218 1999-01-01
% 218.67/218.85  |- skos__broader mesh__D012218smesh__D001172
% 218.67/218.85  |- skos__scopeNote mesh__D012218
% 218.67/218.85       Subcutaneous nodules seen in 20-30%25% of rheumatoid arthritis patients. They may arise anywhere on the body, but are most frequently found over the bony prominences. The nodules are characterized histologically by dense areas of fibrinoid necrosis with basophilic streaks and granules, surrounded by a palisade of cells, mainly fibroblasts and histiocytes.%A%    
% 218.67/218.85  |- mesh__recordOriginator mesh__D012218 NLM
% 218.67/218.85  |- skos__hiddenLabel mesh__D012218 Nodule, Rheumatoid
% 218.67/218.85  |- skos__prefLabel mesh__D012218 Rheumatoid Nodule
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D012218 2003
% 218.67/218.85  |- skos__hiddenLabel mesh__D012218 Rheumatoid Nodules
% 218.67/218.85  |- mesh__recordMaintainer mesh__D012218 PLS
% 218.67/218.85  |- mesh__publicMeSHNote mesh__D012218 67   
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D012218 1995
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D012218 1999
% 218.67/218.85  |- mesh__dateRevised mesh__D012218 1994-05-24
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D012218 2002
% 218.67/218.85  |- mesh__dateEstablished mesh__D012218 1967-01-01
% 218.67/218.85  |- skos__hiddenLabel mesh__D012218 Nodules, Rheumatoid
% 218.67/218.85  |- rdf__type mesh__D012218sskos__Concept
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D012218 2006
% 218.67/218.85  |- skos__annotation mesh__D012218
% 218.67/218.85       in rheum arthritis; do not confuse with RHEUMATIC NODULE in rheum fever%A%  
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D012218 1998
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D012218 2001
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D012218 1997
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D012218 2000
% 218.67/218.85  |- mesh__historyNote mesh__D012218 67%28%63%29%   
% 218.67/218.85  |- mesh__recordMaintainer mesh__D017701 nns
% 218.67/218.85  |- mesh__recordOriginator mesh__D017701 TGC
% 218.67/218.85  |- skos__altLabel mesh__D017701 Reticulocyte Number
% 218.67/218.85  |- skos__hiddenLabel mesh__D017701 Reticulocyte Numbers
% 218.67/218.85  |- mesh__dateRevised mesh__D017701 2003-07-09
% 218.67/218.85  |- skos__scopeNote mesh__D017701
% 218.67/218.85       The number of RETICULOCYTES per unit volume of BLOOD. The values are expressed as a percentage of the ERYTHROCYTE COUNT or in the form of an index %28%%22%corrected reticulocyte index%22%%29%, which attempts to account for the number of circulating erythrocytes.%A%    
% 218.67/218.85  |- mesh__recordAuthorizer mesh__D017701 sjn
% 218.67/218.85  |- mesh__dateCreated mesh__D017701 1992-12-28
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D017701 2006
% 218.67/218.85  |- rdf__type mesh__D017701sskos__Concept
% 218.67/218.85  |- skos__related mesh__D017701smesh__D045262
% 218.67/218.85  |- skos__historyNote mesh__D017701 Reticulocytes %28%1966-1993%29%
% 218.67/218.85  |- mesh__dateEstablished mesh__D017701 1994-01-01
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D017701 2005
% 218.67/218.85  |- mesh__publicMeSHNote mesh__D017701 94   
% 218.67/218.85  |- skos__hiddenLabel mesh__D017701 Numbers, Reticulocyte
% 218.67/218.85  |- skos__hiddenLabel mesh__D017701 Number, Reticulocyte
% 218.67/218.85  |- skos__historyNote mesh__D017701 Blood Cell Count %28%1968-1988%29%
% 218.67/218.85  |- skos__annotation mesh__D017701
% 218.67/218.85       usually NIM; coord with disease /blood, not /physiopathol%A%  
% 218.67/218.85  |- skos__prefLabel mesh__D017701 Reticulocyte Count
% 218.67/218.85  |- skos__hiddenLabel mesh__D017701 Reticulocyte Counts
% 218.67/218.85  |- skos__hiddenLabel mesh__D017701 Count, Reticulocyte
% 218.67/218.85  |- skos__historyNote mesh__D017701 Erythrocyte Count %28%1966-1993%29%
% 218.67/218.85  |- mesh__historyNote mesh__D017701 94   
% 218.67/218.85  |- skos__broader mesh__D017701smesh__D004906
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D017701 2004
% 218.67/218.85  |- skos__hiddenLabel mesh__D017701 Counts, Reticulocyte
% 218.67/218.85  |- skos__scopeNote mesh__D050337
% 218.67/218.85       QUATERNARY AMMONIUM COMPOUNDS containing three methyl groups, having the general formula of %28%CH3%29%3N+R.%A%    
% 218.67/218.85  |- mesh__recordAuthorizer mesh__D050337 sjn
% 218.67/218.85  |- skos__historyNote mesh__D050337
% 218.67/218.85       Quaternary Ammonium Compounds %28%1963-2005%29%
% 218.67/218.85  |- skos__hiddenLabel mesh__D050337 Ammonium Compounds, Trimethyl
% 218.67/218.85  |- mesh__publicMeSHNote mesh__D050337 2006   
% 218.67/218.85  |- mesh__activeMeSHYear mesh__D050337 2006
% 218.67/218.85  |- mesh__recordMaintainer mesh__D050337 ssb
% 218.67/218.85  |- rdf__type mesh__D050337sskos__Concept
% 218.67/218.85  |- mesh__dateEstablished mesh__D050337 2006-01-01
% 218.67/218.85  |- skos__prefLabel mesh__D050337 Trimethyl Ammonium Compounds
% 218.67/218.86  |- skos__broader mesh__D050337smesh__D000644
% 218.67/218.86  |- mesh__dateCreated mesh__D050337 2005-06-30
% 218.67/218.86  |- mesh__historyNote mesh__D050337 2006   
% 218.67/218.86  |- mesh__recordOriginator mesh__D050337 ssb
% 218.67/218.86  |- rdf__type mesh__D008975sskos__Concept
% 218.67/218.86  |- mesh__recordOriginator mesh__D008975 NLM
% 218.67/218.86  |- mesh__dateCreated mesh__D008975 1999-01-01
% 218.67/218.86  |- mesh__recordMaintainer mesh__D008975 ssb
% 218.67/218.86  |- skos__broader mesh__D008975smesh__D010575
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008975 2005
% 218.67/218.86  |- skos__prefLabel mesh__D008975 Molluscacides
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008975 2006
% 218.67/218.86  |- skos__scopeNote mesh__D008975
% 218.67/218.86       Agents destructive to snails and other mollusks.     
% 218.67/218.86  |- skos__annotation mesh__D008975
% 218.67/218.86       specify the mollusk if pertinent; eff of molluscacides on mollusks is indexed under each without a qualif: cf TN 111 for eff of insecticides on insects%A%  
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008975 2004
% 218.67/218.86  |- mesh__dateRevised mesh__D008975 2003-07-09
% 218.67/218.86  |- mesh__recordAuthorizer mesh__D008975 sjn
% 218.67/218.86  |- mesh__publicMeSHNote mesh__D000992
% 218.67/218.86       66; TOXINS AND ANTITOXINS was heading 1963-65   
% 218.67/218.86  |- mesh__historyNote mesh__D000992
% 218.67/218.86       66; TOXINS AND ANTITOXINS was heading 1963-65   
% 218.67/218.86  |- mesh__recordMaintainer mesh__D000992 ssb
% 218.67/218.86  |- skos__broader mesh__D000992smesh__D007106
% 218.67/218.86  |- skos__broader mesh__D000992smesh__D000906
% 218.67/218.86  |- skos__scopeNote mesh__D000992
% 218.67/218.86       Antisera from immunized animals that is purified and used as a passive immunizing agent against specific BACTERIAL TOXINS.%A%    
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D000992 2006
% 218.67/218.86  |- skos__prefLabel mesh__D000992 Antitoxins
% 218.67/218.86  |- rdf__type mesh__D000992sskos__Concept
% 218.67/218.86  |- mesh__recordOriginator mesh__D000992 NLM
% 218.67/218.86  |- skos__annotation mesh__D000992
% 218.67/218.86       coordinate IM with specific toxin %28%IM or NIM%29%   
% 218.67/218.86  |- mesh__dateEstablished mesh__D000992 1966-01-01
% 218.67/218.86  |- mesh__recordAuthorizer mesh__D000992 sjn
% 218.67/218.86  |- skos__broader mesh__D000992smesh__D001688
% 218.67/218.86  |- mesh__dateRevised mesh__D000992 2005-06-30
% 218.67/218.86  |- mesh__dateCreated mesh__D000992 1999-01-01
% 218.67/218.86  |- skos__prefLabel mesh__D008177 Lupus
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008177 1997
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008177 1998
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008177 2000
% 218.67/218.86  |- mesh__recordMaintainer mesh__D008177 TGC
% 218.67/218.86  |- skos__broader mesh__D008177smesh__D014382
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008177 1999
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008177 2003
% 218.67/218.86  |- mesh__dateRevised mesh__D008177 1996-06-10
% 218.67/218.86  |- rdf__type mesh__D008177sskos__Concept
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008177 2001
% 218.67/218.86  |- mesh__dateCreated mesh__D008177 1999-01-01
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008177 2004
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008177 2005
% 218.67/218.86  |- skos__altLabel mesh__D008177 Lupus Vulgaris
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008177 2006
% 218.67/218.86  |- skos__annotation mesh__D008177
% 218.67/218.86       a type of cutaneous tuberc; do not confuse with LUPUS ERYTHEMATOSUS, CUTANEOUS%A%  
% 218.67/218.86  |- mesh__recordAuthorizer mesh__D008177 PLS
% 218.67/218.86  |- mesh__recordOriginator mesh__D008177 NLM
% 218.67/218.86  |- skos__scopeNote mesh__D008177
% 218.67/218.86       A form of cutaneous tuberculosis. It is seen predominantly in women and typically involves the nasal, buccal, and conjunctival mucosa.%A%    
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008177 2002
% 218.67/218.86  |- skos__prefLabel mesh__D016609 Neoplasms, Second Primary
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Neoplasms, Treatment Related
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Therapy-Associated Cancers
% 218.67/218.86  |- mesh__publicMeSHNote mesh__D016609 92   
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Cancers, Therapy-Related
% 218.67/218.86  |- skos__altLabel mesh__D016609 Treatment-Related Neoplasms
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Metachronous Neoplasm
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D016609 2005
% 218.67/218.86  |- mesh__dateRevised mesh__D016609 2001-07-25
% 218.67/218.86  |- skos__broader mesh__D016609smesh__D009369
% 218.67/218.86  |- skos__altLabel mesh__D016609 Neoplasms, Metachronous
% 218.67/218.86  |- skos__related mesh__D016609smesh__D009378
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Cancer, Treatment-Associated
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Treatment-Related Neoplasm
% 218.67/218.86  |- mesh__historyNote mesh__D016609 92   
% 218.67/218.86  |- skos__altLabel mesh__D016609 Second Primary Neoplasms, Metachronous
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Cancer, Second
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D016609 2006
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Malignancy, Second
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Cancer, Therapy-Related
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Treatment-Associated Cancers
% 218.67/218.86  |- skos__altLabel mesh__D016609 Second Malignancy
% 218.67/218.86  |- skos__altLabel mesh__D016609 Therapy-Related Neoplasms
% 218.67/218.86  |- skos__altLabel mesh__D016609 Neoplasms, Therapy-Related
% 218.67/218.86  |- skos__altLabel mesh__D016609 Treatment-Associated Cancer
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Second Primary Neoplasm
% 218.67/218.86  |- skos__altLabel mesh__D016609 Neoplasms, Treatment-Related
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Treatment Related Neoplasms
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Treatment-Associated Neoplasm
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Therapy Related Cancer
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Second Primary Cancers
% 218.67/218.86  |- skos__altLabel mesh__D016609 Second Primary Neoplasms
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Second Neoplasms
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Neoplasms, Second
% 218.67/218.86  |- skos__altLabel mesh__D016609 Metachronous Second Primary Neoplasms
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Cancers, Therapy-Associated
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Therapy-Associated Neoplasm
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Cancers, Treatment-Associated
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Neoplasms, Therapy Related
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Neoplasm, Second Primary
% 218.67/218.86  |- skos__altLabel mesh__D016609 Metachronous Neoplasms
% 218.67/218.86  |- rdf__type mesh__D016609sskos__Concept
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Second Malignancies
% 218.67/218.86  |- skos__altLabel mesh__D016609 Second Neoplasm
% 218.67/218.86  |- skos__annotation mesh__D016609
% 218.67/218.86       a 2d or more neopl of same or different histol type at same or different sites: do not confuse with NEOPLASMS, MULTIPLE PRIMARY %28%see note there%29%; often follows ther %28%note X refs%29%; IM; coord with each specific histol type %28%IM%29% %26% each precoord organ/neopl term %28%IM%29%; do not use /compl with specific multiple neopl terms to show multiplicity; Manual 24.4.1.7; differentiate from NEOPLASM METASTASIS %28%Manual 24.4.1.3+%29% %26% NEOPLASM RECURRENCE, LOCAL: Manual 24.4.1.5%A%  
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Second Primary Cancer
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Therapy Associated Cancer
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Cancers, Treatment-Related
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Neoplasms, Treatment Associated
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Neoplasm, Metachronous
% 218.67/218.86  |- skos__scopeNote mesh__D016609
% 218.67/218.86       Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. The development of the second neoplasm may or may not be related to the treatment for the previous neoplasm since genetic risk or predisposing factors may actually be the cause.%A%    
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Treatment-Related Cancers
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Neoplasm, Treatment-Related
% 218.67/218.86  |- mesh__recordAuthorizer mesh__D016609 sjn
% 218.67/218.86  |- skos__altLabel mesh__D016609 Treatment-Associated Neoplasms
% 218.67/218.86  |- mesh__recordOriginator mesh__D016609 AGS
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D016609 2003
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Neoplasm, Treatment-Associated
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Treatment Associated Cancer
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Treatment Associated Neoplasms
% 218.67/218.86  |- skos__altLabel mesh__D016609 Neoplasms, Treatment-Associated
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Neoplasms, Therapy Associated
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Therapy Related Neoplasms
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Neoplasm, Therapy-Related
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Therapy-Related Neoplasm
% 218.67/218.86  |- skos__altLabel mesh__D016609 Second Cancer
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Therapy-Related Cancers
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D016609 2002
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Second Cancers
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Cancer, Therapy-Associated
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Neoplasm, Therapy-Associated
% 218.67/218.86  |- skos__altLabel mesh__D016609 Neoplasms, Metachronous Second Primary
% 218.67/218.86  |- skos__altLabel mesh__D016609 Therapy-Associated Neoplasms
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Treatment Related Cancer
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Cancers, Second
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D016609 2004
% 218.67/218.86  |- mesh__dateCreated mesh__D016609 1991-01-25
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Therapy Associated Neoplasms
% 218.67/218.86  |- skos__altLabel mesh__D016609 Therapy-Related Cancer
% 218.67/218.86  |- skos__altLabel mesh__D016609 Treatment-Related Cancer
% 218.67/218.86  |- skos__historyNote mesh__D016609
% 218.67/218.86       Neoplasms, Multiple Primary %28%1966-1991%29%
% 218.67/218.86  |- mesh__recordMaintainer mesh__D016609 nns
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Neoplasm, Second
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Cancer, Treatment-Related
% 218.67/218.86  |- mesh__dateEstablished mesh__D016609 1992-01-01
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Malignancies, Second
% 218.67/218.86  |- skos__hiddenLabel mesh__D016609 Cancers, Second Primary
% 218.67/218.86  |- skos__historyNote mesh__D041002 Brucella %28%1968-2002%29%
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D041002 2006
% 218.67/218.86  |- mesh__dateCreated mesh__D041002 2002-07-02
% 218.67/218.86  |- rdf__type mesh__D041002sskos__Concept
% 218.67/218.86  |- skos__scopeNote mesh__D041002
% 218.67/218.86       A species of gram-negative bacteria infecting DOGS, the natural hosts, and causing canine BRUCELLOSIS. It can also cause a mild infection in humans.%A%    
% 218.67/218.86  |- skos__altLabel mesh__D041002 Brucella melitensis biovar canis
% 218.67/218.86  |- mesh__recordAuthorizer mesh__D041002 sjn
% 218.67/218.86  |- mesh__recordOriginator mesh__D041002 ags
% 218.67/218.86  |- skos__annotation mesh__D041002
% 218.67/218.86       infection: coord IM with BRUCELLOSIS %28%IM%29%   
% 218.67/218.86  |- skos__broader mesh__D041002smesh__D002002
% 218.67/218.86  |- skos__prefLabel mesh__D041002 Brucella canis
% 218.67/218.86  |- mesh__publicMeSHNote mesh__D041002 2003   
% 218.67/218.86  |- mesh__dateEstablished mesh__D041002 2003-01-01
% 218.67/218.86  |- mesh__dateRevised mesh__D041002 2005-06-30
% 218.67/218.86  |- mesh__historyNote mesh__D041002 2003   
% 218.67/218.86  |- mesh__recordMaintainer mesh__D041002 SYSTEM
% 218.67/218.86  |- mesh__recordAuthorizer mesh__D013311 sjn
% 218.67/218.86  |- mesh__onlineNote mesh__D013311
% 218.67/218.86       use STREPTOZOCIN to search STREPTOZOTOCIN 1972-92 %28%as Prov 1972%29%%A%  
% 218.67/218.86  |- skos__altLabel mesh__D013311 Pharmacia Brand of Streptozocin
% 218.67/218.86  |- skos__prefLabel mesh__D013311 Streptozocin
% 218.67/218.86  |- skos__altLabel mesh__D013311 Streptozotocine
% 218.67/218.86  |- skos__scopeNote mesh__D013311
% 218.67/218.86       An antibiotic that is produced by Stretomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals.%A%    
% 218.67/218.86  |- skos__altLabel mesh__D013311 Streptozotocin
% 218.67/218.86  |- mesh__recordMaintainer mesh__D013311 CCR
% 218.67/218.86  |- skos__historyNote mesh__D013311 Nitroso Compounds %28%1966-1971%29%
% 218.67/218.86  |- mesh__dateEstablished mesh__D013311 1973-01-01
% 218.67/218.86  |- skos__altLabel mesh__D013311
% 218.67/218.86       2-Deoxy-2-%28%%28%methylnitrosoamino%29%carbonyl%29%amino-D-glucose
% 218.67/218.86  |- skos__broader mesh__D013311smesh__D009607
% 218.67/218.86  |- mesh__recordOriginator mesh__D013311 NLM
% 218.67/218.86  |- mesh__dateRevised mesh__D013311 2005-06-30
% 218.67/218.86  |- mesh__dateCreated mesh__D013311 1999-01-01
% 218.67/218.86  |- rdf__type mesh__D013311sskos__Concept
% 218.67/218.86  |- skos__historyNote mesh__D013311 Antibiotics %28%1966-1971%29%
% 218.67/218.86  |- mesh__historyNote mesh__D013311
% 218.67/218.86       93; was STREPTOZOTOCIN 1972-92 %28%Prov 1972%29%; STREPTOZOCIN was see STREPTOZOTOCIN 1977-92%A%  
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D013311 2006
% 218.67/218.86  |- skos__broader mesh__D013311smesh__D000617
% 218.67/218.86  |- mesh__publicMeSHNote mesh__D013311
% 218.67/218.86       93; was STREPTOZOTOCIN 1973-92; STREPTOZOCIN was see STREPTOZOTOCIN 1977-92%A%  
% 218.67/218.86  |- skos__scopeNote mesh__D004585
% 218.67/218.86       Recording of the average amplitude of the resting potential arising between the cornea and the retina in light and dark adaptation as the eyes turn a standard distance to the right and the left. The increase in potential with light adaptation is used to evaluate the condition of the retinal pigment epithelium.%A%    
% 218.67/218.86  |- mesh__recordAuthorizer mesh__D004585 SJN
% 218.67/218.86  |- mesh__recordOriginator mesh__D004585 NLM
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D004585 2005
% 218.67/218.86  |- skos__broader mesh__D004585smesh__D004568
% 218.67/218.86  |- skos__hiddenLabel mesh__D004585 Electrooculogram
% 218.67/218.86  |- mesh__dateEstablished mesh__D004585 1967-01-01
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D004585 2003
% 218.67/218.86  |- mesh__dateRevised mesh__D004585 1997-06-20
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D004585 2006
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D004585 1998
% 218.67/218.86  |- mesh__recordMaintainer mesh__D004585 PXP
% 218.67/218.86  |- skos__annotation mesh__D004585
% 218.67/218.86       NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: note short X ref%A%  
% 218.67/218.86  |- skos__altLabel mesh__D004585 EOG
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D004585 2000
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D004585 2004
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D004585 2001
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D004585 1999
% 218.67/218.86  |- mesh__publicMeSHNote mesh__D004585 67   
% 218.67/218.86  |- mesh__dateCreated mesh__D004585 1999-01-01
% 218.67/218.86  |- skos__prefLabel mesh__D004585 Electrooculography
% 218.67/218.86  |- mesh__historyNote mesh__D004585 67%28%64%29%   
% 218.67/218.86  |- skos__broader mesh__D004585smesh__D005133
% 218.67/218.86  |- rdf__type mesh__D004585sskos__Concept
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D004585 2002
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D012219 2001
% 218.67/218.86  |- skos__annotation mesh__D012219
% 218.67/218.86       SPEC only; SPEC qualif; field covers collagen dis, rheum dis %26% arthritis; DF: RHEUMATOL%A%  
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D012219 2003
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D012219 2000
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D012219 1995
% 218.67/218.86  |- mesh__recordMaintainer mesh__D012219 JLS
% 218.67/218.86  |- skos__prefLabel mesh__D012219 Rheumatology
% 218.67/218.86  |- skos__related mesh__D012219smesh__D003095
% 218.67/218.86  |- mesh__recordAuthorizer mesh__D012219 PLS
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D012219 1999
% 218.67/218.86  |- mesh__dateEstablished mesh__D012219 1980-01-01
% 218.67/218.86  |- skos__scopeNote mesh__D012219
% 218.67/218.86       A subspecialty of internal medicine concerned with the study of inflammatory or degenerative processes and metabolic derangement of connective tissue structures which pertain to a variety of musculoskeletal disorders, such as arthritis.%A%    
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D012219 1994
% 218.67/218.86  |- mesh__dateRevised mesh__D012219 1993-06-04
% 218.67/218.86  |- mesh__dateCreated mesh__D012219 1979-05-29
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D012219 2006
% 218.67/218.86  |- rdf__type mesh__D012219sskos__Concept
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D012219 1998
% 218.67/218.86  |- mesh__historyNote mesh__D012219 80   
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D012219 1997
% 218.67/218.86  |- skos__related mesh__D012219smesh__D012216
% 218.67/218.86  |- skos__historyNote mesh__D012219 Rheumatism %28%1966-1979%29%
% 218.67/218.86  |- mesh__publicMeSHNote mesh__D012219 80   
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D012219 2005
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D012219 2002
% 218.67/218.86  |- mesh__recordOriginator mesh__D012219 EC
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D012219 2004
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D012219 1996
% 218.67/218.86  |- skos__broader mesh__D012219smesh__D007388
% 218.67/218.86  |- skos__altLabel mesh__D009270 Curamed Brand of Naloxone Hydrochloride
% 218.67/218.86  |- skos__altLabel mesh__D009270 Lamepro Brand of Naloxone Hydrochloride
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D009270 2005
% 218.67/218.86  |- skos__historyNote mesh__D009270 Narcotic Antagonists %28%1966-1971%29%
% 218.67/218.86  |- skos__altLabel mesh__D009270 SERB Brand of Naloxone Hydrochloride
% 218.67/218.86  |- skos__altLabel mesh__D009270 Abello Brand of Naloxone Hydrochloride
% 218.67/218.86  |- mesh__dateRevised mesh__D009270 2004-07-07
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D009270 2006
% 218.67/218.86  |- skos__prefLabel mesh__D009270 Naloxone
% 218.67/218.86  |- mesh__publicMeSHNote mesh__D009270 73   
% 218.67/218.86  |- skos__altLabel mesh__D009270 Endo Brand of Naloxone Hydrochloride
% 218.67/218.86  |- mesh__historyNote mesh__D009270 73%28%72%29%   
% 218.67/218.86  |- skos__hiddenLabel mesh__D009270 Curamed, Naloxon
% 218.67/218.86  |- skos__hiddenLabel mesh__D009270 Hydrochloride, Naloxone
% 218.67/218.86  |- skos__historyNote mesh__D009270 Morphinans %28%1969-1971%29%
% 218.67/218.86  |- skos__hiddenLabel mesh__D009270 Naloxon ratiopharm
% 218.67/218.86  |- skos__hiddenLabel mesh__D009270 Abello, Naloxone
% 218.67/218.86  |- skos__altLabel mesh__D009270 ratiopharm Brand of Naloxone Hydrochloride
% 218.67/218.86  |- skos__altLabel mesh__D009270
% 218.67/218.86       Bristol-Myers Squibb Brand of Naloxone Hydrochloride
% 218.67/218.86  |- skos__hiddenLabel mesh__D009270 Hydrobromide, Naloxone
% 218.67/218.86  |- mesh__recordAuthorizer mesh__D009270 sjn
% 218.67/218.86  |- mesh__dateCreated mesh__D009270 1999-01-01
% 218.67/218.86  |- skos__hiddenLabel mesh__D009270 Dihydride, Naloxone Hydrochloride
% 218.67/218.86  |- skos__broader mesh__D009270smesh__D009019
% 218.67/218.86  |- skos__altLabel mesh__D009270 Boots Brand of Naloxone Hydrochloride
% 218.67/218.86  |- mesh__dateEstablished mesh__D009270 1973-01-01
% 218.67/218.86  |- rdf__type mesh__D009270sskos__Concept
% 218.67/218.86  |- skos__hiddenLabel mesh__D009270
% 218.67/218.86       Bristol Myers Squibb Brand of Naloxone Hydrochloride
% 218.67/218.86  |- mesh__recordMaintainer mesh__D009270 lkw
% 218.67/218.86  |- skos__altLabel mesh__D009270 United Drug Brand of Naloxone Hydrochloride
% 218.67/218.86  |- skos__scopeNote mesh__D009270
% 218.67/218.86       A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors.%A%    
% 218.67/218.86  |- skos__altLabel mesh__D009270 Narcanti
% 218.67/218.86  |- mesh__recordOriginator mesh__D009270 NLM
% 218.67/218.86  |- skos__hiddenLabel mesh__D009270 Hydrochloride Dihydride, Naloxone
% 218.67/218.86  |- skos__hiddenLabel mesh__D009270 Naloxonratiopharm
% 218.67/218.86  |- mesh__publicMeSHNote mesh__D050338 2006   
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D050338 2006
% 218.67/218.86  |- mesh__recordAuthorizer mesh__D050338 sjn
% 218.67/218.86  |- rdf__type mesh__D050338sskos__Concept
% 218.67/218.86  |- skos__prefLabel mesh__D050338 Phenylammonium Compounds
% 218.67/218.86  |- skos__historyNote mesh__D050338
% 218.67/218.86       Quaternary Ammonium Compounds %28%1963-2005%29%
% 218.67/218.86  |- mesh__recordMaintainer mesh__D050338 ssb
% 218.67/218.86  |- mesh__recordOriginator mesh__D050338 ssb
% 218.67/218.86  |- skos__scopeNote mesh__D050338
% 218.67/218.86       QUATERNARY AMMONIUM COMPOUNDS based on PHENYLAMINES with the general formula phenyl-N+R3.%A%    
% 218.67/218.86  |- mesh__dateEstablished mesh__D050338 2006-01-01
% 218.67/218.86  |- skos__broader mesh__D050338smesh__D000644
% 218.67/218.86  |- mesh__dateCreated mesh__D050338 2005-06-30
% 218.67/218.86  |- mesh__historyNote mesh__D050338 2006   
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008976 1993
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008976 2002
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008976 1998
% 218.67/218.86  |- skos__annotation mesh__D008976 a skin dis caused by a poxvirus   
% 218.67/218.86  |- mesh__recordMaintainer mesh__D008976 MXR
% 218.67/218.86  |- skos__broader mesh__D008976smesh__D017193
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008976 2005
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008976 1999
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008976 1996
% 218.67/218.86  |- skos__broader mesh__D008976smesh__D011213
% 218.67/218.86  |- mesh__dateRevised mesh__D008976 1992-05-22
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008976 2006
% 218.67/218.86  |- mesh__recordOriginator mesh__D008976 NLM
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008976 2003
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008976 1997
% 218.67/218.86  |- skos__scopeNote mesh__D008976
% 218.67/218.86       A common, benign, usually self-limited viral infection of the skin and occasionally the conjunctivae by a poxvirus %28%MOLLUSCUM CONTAGIOSUM VIRUS%29%. %28%Dorland, 27th ed%29%%A%    
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008976 2004
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008976 2000
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008976 1994
% 218.67/218.86  |- mesh__recordAuthorizer mesh__D008976 PLS
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008976 2001
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008976 1995
% 218.67/218.86  |- rdf__type mesh__D008976sskos__Concept
% 218.67/218.86  |- skos__prefLabel mesh__D008976 Molluscum Contagiosum
% 218.67/218.86  |- mesh__dateCreated mesh__D008976 1999-01-01
% 218.67/218.86  |- rdf__type mesh__D000993sskos__Concept
% 218.67/218.86  |- mesh__recordMaintainer mesh__D000993 jls
% 218.67/218.86  |- mesh__historyNote mesh__D000993 96; was NON MESH 1975-95   
% 218.67/218.86  |- mesh__recordAuthorizer mesh__D000993 jls
% 218.67/218.86  |- skos__hiddenLabel mesh__D000993 Drugs, Antisyphilitic
% 218.67/218.86  |- skos__hiddenLabel mesh__D000993 Drugs, Antitreponemal
% 218.67/218.86  |- skos__scopeNote mesh__D000993
% 218.67/218.86       Agents used to treat infections with bacteria of the genus TREPONEMA. This includes SYPHILIS %26% YAWS.%A%    
% 218.67/218.86  |- mesh__publicMeSHNote mesh__D000993 96   
% 218.67/218.86  |- mesh__dateRevised mesh__D000993 2005-07-20
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D000993 2004
% 218.67/218.86  |- skos__hiddenLabel mesh__D000993 Agents, Antitreponemal
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D000993 2006A
% 218.67/218.86  |- skos__broader mesh__D000993smesh__D000900
% 218.67/218.86  |- mesh__dateCreated mesh__D000993 1999-01-01
% 218.67/218.86  |- skos__prefLabel mesh__D000993 Antitreponemal Agents
% 218.67/218.86  |- skos__altLabel mesh__D000993 Antisyphilitics
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D000993 2005
% 218.67/218.86  |- mesh__dateEstablished mesh__D000993 1996-01-01
% 218.67/218.86  |- skos__altLabel mesh__D000993 Antitreponemal Drugs
% 218.67/218.86  |- mesh__recordOriginator mesh__D000993 NLM
% 218.67/218.86  |- skos__hiddenLabel mesh__D000993 Agents, Antisyphilitic
% 218.67/218.86  |- skos__altLabel mesh__D000993 Antisyphilitic Drugs
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D000993 2006
% 218.67/218.86  |- mesh__dateCreated mesh__D008178 1986-04-04
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008178 1998
% 218.67/218.86  |- mesh__recordMaintainer mesh__D008178 TGC
% 218.67/218.86  |- skos__broader mesh__D008178smesh__D012871
% 218.67/218.86  |- skos__scopeNote mesh__D008178
% 218.67/218.86       A form of lupus erythematosus in which the skin may be the only organ involved or in which skin involvement precedes the spread into other body systems. It has been classified into three forms - acute %28%= LUPUS ERYTHEMATOSUS, SYSTEMIC with skin lesions%29%, subacute, and chronic %28%= LUPUS ERYTHEMATOSUS, DISCOID%29%.%A%    
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008178 2002
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008178 1999
% 218.67/218.86  |- skos__hiddenLabel mesh__D008178 Cutaneous Lupus Erythematosus
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008178 2003
% 218.67/218.86  |- rdf__type mesh__D008178sskos__Concept
% 218.67/218.86  |- skos__annotation mesh__D008178
% 218.67/218.86       acute: consider LUPUS ERYTHEMATOSUS, SYSTEMIC if skin lesions are paramount%A%  
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008178 2004
% 218.67/218.86  |- mesh__recordOriginator mesh__D008178 RC
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008178 2005
% 218.67/218.86  |- skos__historyNote mesh__D008178
% 218.67/218.86       Lupus Erythematosus, Systemic %28%1966-1986%29%
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008178 2000
% 218.67/218.86  |- skos__broader mesh__D008178smesh__D003240
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008178 2006
% 218.67/218.86  |- mesh__dateEstablished mesh__D008178 1987-01-01
% 218.67/218.86  |- mesh__publicMeSHNote mesh__D008178 87   
% 218.67/218.86  |- mesh__dateRevised mesh__D008178 1997-06-20
% 218.67/218.86  |- skos__historyNote mesh__D008178
% 218.67/218.86       Lupus Erythematosus, Discoid %28%1966-1986%29%
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D008178 2001
% 218.67/218.86  |- mesh__recordAuthorizer mesh__D008178 SJN
% 218.67/218.86  |- mesh__historyNote mesh__D008178 87   
% 218.67/218.86  |- skos__prefLabel mesh__D008178 Lupus Erythematosus, Cutaneous
% 218.67/218.86  |- skos__altLabel mesh__D008178 Lupus Erythematosus, Cutaneous, Subacute
% 218.67/218.86  |- mesh__recordMaintainer mesh__D041801 ags
% 218.67/218.86  |- rdf__type mesh__D041801sskos__Concept
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D041801 2006
% 218.67/218.86  |- mesh__historyNote mesh__D041801 2004; use Acetobacteraceae 2000-2003   
% 218.67/218.86  |- skos__historyNote mesh__D041801
% 218.67/218.86       Gram-Negative Chemolithotrophic Bacteria %28%1989-1998%29%
% 218.67/218.86  |- skos__broader mesh__D041801smesh__D016947
% 218.67/218.86  |- skos__historyNote mesh__D041801 Acetobacteraceae %28%1999-2003%29%
% 218.67/218.86  |- skos__prefLabel mesh__D041801 Acidiphilium
% 218.67/218.86  |- mesh__publicMeSHNote mesh__D041801
% 218.67/218.86       2004; see Acetobacteraceae 2000-2003   
% 218.67/218.86  |- skos__scopeNote mesh__D041801
% 218.67/218.86       A genus in the family ACETOBACTERACEAE consisting of chemoorganotrophic, straight rods with rounded ends. They are aerobic and acidophilic.%A%    
% 218.67/218.86  |- mesh__dateCreated mesh__D041801 2003-07-09
% 218.67/218.86  |- mesh__dateEstablished mesh__D041801 2004-01-01
% 218.67/218.86  |- mesh__recordAuthorizer mesh__D041801 sjn
% 218.67/218.86  |- mesh__dateRevised mesh__D041801 2005-06-30
% 218.67/218.86  |- mesh__recordOriginator mesh__D041801 ags
% 218.67/218.86  |- skos__scopeNote mesh__D013312
% 218.67/218.86       A pathological process resulting from the reaction of the body to external forces and abnormal conditions that tend to disturb the organism%27%s homeostasis.%A%    
% 218.67/218.86  |- mesh__dateRevised mesh__D013312 1999-11-03
% 218.67/218.86  |- mesh__recordOriginator mesh__D013312 NLM
% 218.67/218.86  |- skos__prefLabel mesh__D013312 Stress
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D013312 2000
% 218.67/218.86  |- mesh__dateCreated mesh__D013312 1999-01-01
% 218.67/218.86  |- mesh__publicMeSHNote mesh__D013312
% 218.67/218.86       GENERAL ADAPTATION SYNDROME was see under STRESS %26% ADAPTATION, PHYSIOLOGICAL 1963-74%A%  
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D013312 2003
% 218.67/218.86  |- mesh__recordAuthorizer mesh__D013312 sjn
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D013312 2001
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D013312 2004
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D013312 2002
% 218.67/218.86  |- rdf__type mesh__D013312sskos__Concept
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D013312 2005
% 218.67/218.86  |- skos__hiddenLabel mesh__D013312 Stresses
% 218.67/218.86  |- skos__broader mesh__D013312smesh__D010335
% 218.67/218.86  |- mesh__recordMaintainer mesh__D013312 KEV
% 218.67/218.86  |- skos__related mesh__D013312smesh__D005790
% 218.67/218.86  |- mesh__activeMeSHYear mesh__D013312 2006
% 218.67/218.86  |- skos__annotation mesh__D013312
% 218.67/218.86       includes %22%aggressology%22% %28%French: agressologie%29% %26% the French %22%agression%22%; stress ulcer: index under PEPTIC ULCER or specific %28%IM%29% + STRESS or STRESS, PSYCHOLOGICAL %28%IM or NIM%29%; not for stress in lower animals, plants or microorganisms%A%  
% 218.67/218.87  |- mesh__recordAuthorizer mesh__D004586 sjn
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D004586 2005
% 218.67/218.87  |- mesh__recordMaintainer mesh__D004586 lkt
% 218.67/218.87  |- skos__prefLabel mesh__D004586 Electrophoresis
% 218.67/218.87  |- skos__hiddenLabel mesh__D004586 Isotachophoreses
% 218.67/218.87  |- skos__scopeNote mesh__D004586
% 218.67/218.87       An electrochemical process in which macromolecules or colloidal particles with a net electric charge migrate in a solution under the influence of an electric current.%A%    
% 218.67/218.87  |- skos__broader mesh__D004586smesh__D002623
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D004586 2003
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D004586 2006
% 218.67/218.87  |- mesh__recordOriginator mesh__D004586 NLM
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D004586 2004
% 218.67/218.87  |- skos__related mesh__D004586smesh__D007122
% 218.67/218.87  |- skos__related mesh__D004586smesh__D001797
% 218.67/218.87  |- mesh__dateCreated mesh__D004586 1999-01-01
% 218.67/218.87  |- skos__broader mesh__D004586smesh__D004563
% 218.67/218.87  |- skos__annotation mesh__D004586
% 218.67/218.87       GEN or unspecified; prefer specifics; NIM   
% 218.67/218.87  |- rdf__type mesh__D004586sskos__Concept
% 218.67/218.87  |- skos__hiddenLabel mesh__D004586 Electrophoreses
% 218.67/218.87  |- mesh__dateRevised mesh__D004586 2002-07-03
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D009271 2006
% 218.67/218.87  |- skos__hiddenLabel mesh__D009271 EN 1639A
% 218.67/218.87  |- skos__altLabel mesh__D009271 Du Pont Brand of Naltrexone Hydrochloride
% 218.67/218.87  |- skos__altLabel mesh__D009271
% 218.67/218.87       United Drug Brand of Naltrexone Hydrochloride
% 218.67/218.87  |- skos__altLabel mesh__D009271
% 218.67/218.87       Bristol-Myers Squibb Brand of Naltrexone Hydrochloride
% 218.67/218.87  |- skos__historyNote mesh__D009271 Cyclopropanes %28%1973-1975%29%
% 218.67/218.87  |- skos__hiddenLabel mesh__D009271
% 218.67/218.87       Schering Plough Brand of Naltrexone Hydrochloride
% 218.67/218.87  |- skos__altLabel mesh__D009271 Pharmazam Brand of Naltrexone Hydrochloride
% 218.67/218.87  |- skos__hiddenLabel mesh__D009271 Hydrochloride, Naltrexone
% 218.67/218.87  |- skos__historyNote mesh__D009271
% 218.67/218.87       Naloxone/analogs %26% derivatives %28%1975%29%
% 218.67/218.87  |- skos__altLabel mesh__D009271 Nemexin
% 218.67/218.87  |- skos__altLabel mesh__D009271 Lamepro Brand of Naltrexone Hydrochloride
% 218.67/218.87  |- mesh__publicMeSHNote mesh__D009271 86; was see under NALOXONE 1976-85   
% 218.67/218.87  |- skos__altLabel mesh__D009271 Nalorex
% 218.67/218.87  |- mesh__dateCreated mesh__D009271 1975-07-23
% 218.67/218.87  |- mesh__historyNote mesh__D009271
% 218.67/218.87       86%28%76%29%; was see under NALOXONE 1976-85   
% 218.67/218.87  |- skos__altLabel mesh__D009271 Lacer Brand of Naltrexone Hydrochloride
% 218.67/218.87  |- skos__prefLabel mesh__D009271 Naltrexone
% 218.67/218.87  |- skos__hiddenLabel mesh__D009271
% 218.67/218.87       Bristol Myers Squibb Brand of Naltrexone Hydrochloride
% 218.67/218.87  |- rdf__type mesh__D009271sskos__Concept
% 218.67/218.87  |- mesh__dateEstablished mesh__D009271 1986-01-01
% 218.67/218.87  |- skos__broader mesh__D009271smesh__D009270
% 218.67/218.87  |- skos__scopeNote mesh__D009271
% 218.67/218.87       Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.%A%    
% 218.67/218.87  |- skos__historyNote mesh__D009271 Morphinans %28%1973-1974%29%
% 218.67/218.87  |- mesh__recordAuthorizer mesh__D009271 sjn
% 218.67/218.87  |- skos__hiddenLabel mesh__D009271 EN1639A
% 218.67/218.87  |- skos__altLabel mesh__D009271 Orphan Brand of Naltrexone Hydrochloride
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D009271 2005
% 218.67/218.87  |- skos__altLabel mesh__D009271
% 218.67/218.87       Schering-Plough Brand of Naltrexone Hydrochloride
% 218.67/218.87  |- mesh__recordOriginator mesh__D009271 SH
% 218.67/218.87  |- mesh__recordMaintainer mesh__D009271 lkw
% 218.67/218.87  |- mesh__dateRevised mesh__D009271 2004-07-07
% 218.67/218.87  |- skos__broader mesh__D017703smesh__D010608
% 218.67/218.87  |- skos__annotation mesh__D017703 for coord read note on ABSCESS   
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D017703 1995
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D017703 2006
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D017703 2002
% 218.67/218.87  |- skos__historyNote mesh__D017703 Pharyngeal Diseases %28%1977-1992%29%
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D017703 2005
% 218.67/218.87  |- skos__scopeNote mesh__D017703
% 218.67/218.87       A soft tissue infection of the throat with entry usually by the pharynx but sometimes as an extension of a lateral neck infection resulting from a neck injury. The major risk is upper airway obstruction caused by pharyngeal swelling. %28%Daniel R. Masys, from a written communication%29%%A%    
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D017703 1997
% 218.67/218.87  |- mesh__recordOriginator mesh__D017703 TGC
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D017703 1996
% 218.67/218.87  |- skos__broader mesh__D017703smesh__D000038
% 218.67/218.87  |- skos__historyNote mesh__D017703 Abscess %28%1977-1992%29%
% 218.67/218.87  |- mesh__recordAuthorizer mesh__D017703 PLS
% 218.67/218.87  |- mesh__historyNote mesh__D017703 94   
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D017703 2001
% 218.67/218.87  |- mesh__dateRevised mesh__D017703 1994-05-27
% 218.67/218.87  |- skos__historyNote mesh__D017703 Pharyngitis %28%1979-1990%29%
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D017703 2004
% 218.67/218.87  |- skos__prefLabel mesh__D017703 Retropharyngeal Abscess
% 218.67/218.87  |- skos__hiddenLabel mesh__D017703 Abscesses, Retropharyngeal
% 218.67/218.87  |- skos__altLabel mesh__D017703 Abscess, Retropharyngeal
% 218.67/218.87  |- mesh__dateEstablished mesh__D017703 1994-01-01
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D017703 1999
% 218.67/218.87  |- mesh__recordMaintainer mesh__D017703 PLS
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D017703 2000
% 218.67/218.87  |- mesh__dateCreated mesh__D017703 1992-12-28
% 218.67/218.87  |- rdf__type mesh__D017703sskos__Concept
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D017703 2003
% 218.67/218.87  |- skos__historyNote mesh__D017703 Pharynx %28%1984-1992%29%
% 218.67/218.87  |- skos__hiddenLabel mesh__D017703 Retropharyngeal Abscesses
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D017703 1998
% 218.67/218.87  |- mesh__publicMeSHNote mesh__D017703 94   
% 218.67/218.87  |- skos__historyNote mesh__D050339
% 218.67/218.87       Quaternary Ammonium Compounds %28%1963-2005%29%
% 218.67/218.87  |- skos__altLabel mesh__D050339 Phenylmethyl Ammonium Compounds
% 218.67/218.87  |- mesh__dateEstablished mesh__D050339 2006-01-01
% 218.67/218.87  |- mesh__recordMaintainer mesh__D050339 ssb
% 218.67/218.87  |- skos__scopeNote mesh__D050339
% 218.67/218.87       QUATERNARY AMMONIUM COMPOUNDS based on BENZYLAMINES with the general formula phenyl-CN+R3.%A%    
% 218.67/218.87  |- skos__altLabel mesh__D050339 Benzyl Ammonium Compounds
% 218.67/218.87  |- skos__broader mesh__D050339smesh__D000644
% 218.67/218.87  |- skos__altLabel mesh__D050339 Benzenemethanaminium Compounds
% 218.67/218.87  |- mesh__dateCreated mesh__D050339 2005-06-30
% 218.67/218.87  |- mesh__historyNote mesh__D050339 2006   
% 218.67/218.87  |- skos__hiddenLabel mesh__D050339 Ammonium Compounds, Benzyl
% 218.67/218.87  |- skos__hiddenLabel mesh__D050339 Ammonium Compounds, Phenylmethyl
% 218.67/218.87  |- skos__prefLabel mesh__D050339 Benzylammonium Compounds
% 218.67/218.87  |- mesh__recordOriginator mesh__D050339 ssb
% 218.67/218.87  |- mesh__recordAuthorizer mesh__D050339 sjn
% 218.67/218.87  |- mesh__publicMeSHNote mesh__D050339 2006   
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D050339 2006
% 218.67/218.87  |- rdf__type mesh__D050339sskos__Concept
% 218.67/218.87  |- mesh__publicMeSHNote mesh__D047390
% 218.67/218.87       2005; CASEIN KINASE II was indexed under PROTEIN-SERINE-THREONINE KINASES 1992-2004%A%  
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D047390 2006
% 218.67/218.87  |- skos__altLabel mesh__D047390 Casein Kinase 2
% 218.67/218.87  |- mesh__recordOriginator mesh__D047390 jmp
% 218.67/218.87  |- skos__altLabel mesh__D047390 Casein Kinase 2alpha%27%
% 218.67/218.87  |- skos__prefLabel mesh__D047390 Casein Kinase II
% 218.67/218.87  |- skos__hiddenLabel mesh__D047390 Kinase CKII, Protein
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D047390 2005
% 218.67/218.87  |- skos__historyNote mesh__D047390
% 218.67/218.87       Protein-Serine-Threonine Kinases %28%1992-2004%29%
% 218.67/218.87  |- rdf__type mesh__D047390sskos__Concept
% 218.67/218.87  |- mesh__dateEstablished mesh__D047390 2005-01-01
% 218.67/218.87  |- mesh__recordMaintainer mesh__D047390 jmp
% 218.67/218.87  |- skos__altLabel mesh__D047390 Protein Kinase CK2
% 218.67/218.87  |- skos__altLabel mesh__D047390 Casein Kinase 2alpha
% 218.67/218.87  |- skos__hiddenLabel mesh__D047390 2alpha%27%, Casein Kinase
% 218.67/218.87  |- skos__scopeNote mesh__D047390
% 218.67/218.87       A ubiquitous casein kinase that is comprised of two distinct catalytic subunits and dimeric regulatory subunit. Casein kinase II has been shown to phosphorylate a large number of substrates, many of which are proteins involved in the regulation of gene expression.%A%    
% 218.67/218.87  |- mesh__historyNote mesh__D047390 2005%28%1992%29%   
% 218.67/218.87  |- mesh__recordAuthorizer mesh__D047390 sjn
% 218.67/218.87  |- skos__hiddenLabel mesh__D047390 Kinase 2alpha%27%, Casein
% 218.67/218.87  |- skos__broader mesh__D047390smesh__D047388
% 218.67/218.87  |- skos__altLabel mesh__D047390 Protein Kinase CKII
% 218.67/218.87  |- skos__altLabel mesh__D047390 Casein Kinase-2
% 218.67/218.87  |- mesh__dateCreated mesh__D047390 2004-07-07
% 218.67/218.87  |- skos__altLabel mesh__D047390 Casein Kinase TS
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D008977 2006
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D008977 2003
% 218.67/218.87  |- skos__annotation mesh__D008977 infection = MOLLUSCUM CONTAGIOSUM   
% 218.67/218.87  |- mesh__publicMeSHNote mesh__D008977
% 218.67/218.87       66; was see under TUMOR VIRUSES %28%now see ONCOGENIC VIRUSES%29% 1963-65%A%  
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D008977 2004
% 218.67/218.87  |- mesh__recordMaintainer mesh__D008977 ags
% 218.67/218.87  |- mesh__historyNote mesh__D008977
% 218.67/218.87       66%28%63%29%; was see under TUMOR VIRUSES %28%now see ONCOGENIC VIRUSES%29% 1963-65%A%  
% 218.67/218.87  |- skos__scopeNote mesh__D008977
% 218.67/218.87       A species of MOLLUSCIPOXVIRUS causing skin lesions in humans. It is transmitted by direct contact or from non-living reservoirs %28%fomites%29%, such as books or clothing.%A%    
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D008977 2002
% 218.67/218.87  |- mesh__recordAuthorizer mesh__D008977 sjn
% 218.67/218.87  |- rdf__type mesh__D008977sskos__Concept
% 218.67/218.87  |- mesh__dateCreated mesh__D008977 1999-01-01
% 218.67/218.87  |- skos__hiddenLabel mesh__D008977 Molluscum contagiosum viruses
% 218.67/218.87  |- mesh__recordOriginator mesh__D008977 NLM
% 218.67/218.87  |- skos__prefLabel mesh__D008977 Molluscum contagiosum virus
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D008977 2005
% 218.67/218.87  |- mesh__dateRevised mesh__D008977 2001-07-25
% 218.67/218.87  |- skos__broader mesh__D008977smesh__D018169
% 218.67/218.87  |- mesh__dateEstablished mesh__D008977 1966-01-01
% 218.67/218.87  |- skos__scopeNote mesh__D000994
% 218.67/218.87       Agents used to treat trichomonas infections.     
% 218.67/218.87  |- skos__hiddenLabel mesh__D000994 Drugs, Antitrichomonal
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D000994 2006
% 218.67/218.87  |- mesh__publicMeSHNote mesh__D000994 72   
% 218.67/218.87  |- skos__prefLabel mesh__D000994 Antitrichomonal Agents
% 218.67/218.87  |- mesh__historyNote mesh__D000994 72%28%66%29%   
% 218.67/218.87  |- skos__annotation mesh__D000994
% 218.67/218.87       consider also TRICHOMONAS /drug eff %26% TRICHOMONAS INFECTIONS /drug ther or pertinent specifics%A%  
% 218.67/218.87  |- skos__altLabel mesh__D000994 Trichomonicides
% 218.67/218.87  |- mesh__recordMaintainer mesh__D000994 ssb
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D000994 2004
% 218.67/218.87  |- mesh__dateRevised mesh__D000994 2003-07-09
% 218.67/218.87  |- mesh__dateCreated mesh__D000994 1999-01-01
% 218.67/218.87  |- skos__altLabel mesh__D000994 Antitrichomonals
% 218.67/218.87  |- mesh__recordOriginator mesh__D000994 NLM
% 218.67/218.87  |- mesh__dateEstablished mesh__D000994 1972-01-01
% 218.67/218.87  |- mesh__recordAuthorizer mesh__D000994 sjn
% 218.67/218.87  |- skos__altLabel mesh__D000994 Antitrichomonal Drugs
% 218.67/218.87  |- skos__hiddenLabel mesh__D000994 Agents, Antitrichomonal
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D000994 2005
% 218.67/218.87  |- rdf__type mesh__D000994sskos__Concept
% 218.67/218.87  |- skos__broader mesh__D000994smesh__D000981
% 218.67/218.87  |- mesh__recordMaintainer mesh__D008179 PLS
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D008179 1997
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D008179 2005
% 218.67/218.87  |- skos__scopeNote mesh__D008179
% 218.67/218.87       A chronic form of cutaneous lupus erythematosus %28%LUPUS ERYTHEMATOSUS, CUTANEOUS%29% in which the skin lesions mimic those of the systemic form but in which systemic signs are rare. It is characterized by the presence of discoid skin plaques showing varying degrees of edema, erythema, scaliness, follicular plugging, and skin atrophy. Lesions are surrounded by an elevated erythematous border. The condition typically involves the face and scalp, but widespread dissemination may occur.%A%    
% 218.67/218.87  |- mesh__recordAuthorizer mesh__D008179 PLS
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D008179 1993
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D008179 1996
% 218.67/218.87  |- skos__altLabel mesh__D008179 Lupus Erythematosus, Chronic Cutaneous
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D008179 2004
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D008179 2001
% 218.67/218.87  |- skos__broader mesh__D008179smesh__D008178
% 218.67/218.87  |- skos__related mesh__D008179smesh__D015435
% 218.67/218.87  |- skos__annotation mesh__D008179
% 218.67/218.87       do not confuse with systemic or disseminated: discoid is usually in dermatol jrnls, systemic in arthritis or rheumat jrnls; when unspecified in title, %22%discoid%22% is usually discernible from text or bibliog refs; note X ref: do not confuse with LUPUS ERYTHEMATOSUS, CUTANEOUS%A%  
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D008179 1999
% 218.67/218.87  |- skos__prefLabel mesh__D008179 Lupus Erythematosus, Discoid
% 218.67/218.87  |- mesh__recordOriginator mesh__D008179 NLM
% 218.67/218.87  |- rdf__type mesh__D008179sskos__Concept
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D008179 2000
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D008179 1995
% 218.67/218.87  |- skos__hiddenLabel mesh__D008179 Discoid Lupus Erythematosus
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D008179 2003
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D008179 1998
% 218.67/218.87  |- mesh__dateCreated mesh__D008179 1999-01-01
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D008179 1994
% 218.67/218.87  |- skos__altLabel mesh__D008179 Lupus Erythematosus, Cutaneous, Chronic
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D008179 2006
% 218.67/218.87  |- mesh__dateRevised mesh__D008179 1992-05-22
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D008179 2002
% 218.67/218.87  |- skos__annotation mesh__D000196
% 218.67/218.87       bact infect, not fungal despite %22%-mycosis%22%: = infection by genus ACTINOMYCES; do not confuse with ACTINOMYCETALES INFECTIONS, infection by order ACTINOMYCETALES; pulm actinomycosis = ACTINOMYCOSIS %28%IM%29% + LUNG DISEASES %28%IM%29%, not LUNG DISEASES, FUNGAL%A%  
% 218.67/218.87  |- skos__prefLabel mesh__D000196 Actinomycosis
% 218.67/218.87  |- mesh__recordMaintainer mesh__D000196 PLS
% 218.67/218.87  |- mesh__dateRevised mesh__D000196 1993-06-02
% 218.67/218.87  |- skos__broader mesh__D000196smesh__D000193
% 218.67/218.87  |- skos__hiddenLabel mesh__D000196 Infection, Actinomyces
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D000196 2002
% 218.67/218.87  |- skos__hiddenLabel mesh__D000196 Actinomyces Infection
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D000196 2004
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D000196 2001
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D000196 2006
% 218.67/218.87  |- mesh__recordAuthorizer mesh__D000196 PLS
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D000196 1997
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D000196 2003
% 218.67/218.87  |- mesh__dateCreated mesh__D000196 1999-01-01
% 218.67/218.87  |- skos__altLabel mesh__D000196 Infections, Actinomyces
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D000196 1999
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D000196 2005
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D000196 2000
% 218.67/218.87  |- skos__hiddenLabel mesh__D000196 Actinomycoses
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D000196 1996
% 218.67/218.87  |- skos__scopeNote mesh__D000196
% 218.67/218.87       Infections with bacteria of the genus ACTINOMYCES.     
% 218.67/218.87  |- mesh__recordOriginator mesh__D000196 NLM
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D000196 1995
% 218.67/218.87  |- skos__altLabel mesh__D000196 Actinomyces Infections
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D000196 1998
% 218.67/218.87  |- rdf__type mesh__D000196sskos__Concept
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D000196 1994
% 218.67/218.87  |- skos__broader mesh__D011969Q000037smesh__D011969
% 218.67/218.87  |- mesh__preferredCombination mesh__D011969Q000037smesh__D006634
% 218.67/218.87  |- rdf__type mesh__D011969Q000037smesh__CompoundConcept
% 218.67/218.87  |- skos__hiddenLabel mesh__D013313 Stress Disorder, Posttraumatic
% 218.67/218.87  |- skos__altLabel mesh__D013313 PTSD
% 218.67/218.87  |- skos__altLabel mesh__D013313 Stress Disorder, Post Traumatic
% 218.67/218.87  |- skos__altLabel mesh__D013313 Posttraumatic Stress Disorders
% 218.67/218.87  |- skos__altLabel mesh__D013313 Post-Traumatic Stress Disorders
% 218.67/218.87  |- skos__scopeNote mesh__D013313
% 218.67/218.87       A class of traumatic stress disorders with symptoms that last more than one month. There are various forms of post-traumatic stress disorder, depending on the time of onset and the duration of these stress symptoms. In the acute form, the duration of the symptoms is between 1 to 3 months. In the chronic form, symptoms last more than 3 months. With delayed onset, symptoms develop more than 6 months after the traumatic event.%A%    
% 218.67/218.87  |- mesh__dateCreated mesh__D013313 1999-01-01
% 218.67/218.87  |- skos__altLabel mesh__D013313 Stress Disorders, Posttraumatic
% 218.67/218.87  |- skos__related mesh__D013313smesh__D003130
% 218.67/218.87  |- mesh__onlineNote mesh__D013313
% 218.67/218.87       use STRESS DISORDERS, POST-TRAUMATIC to search NEUROSES, POST-TRAUMATIC 1966-80%A%  
% 218.67/218.87  |- mesh__dateRevised mesh__D013313 2002-07-02
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D013313 2003
% 218.67/218.87  |- skos__hiddenLabel mesh__D013313 Chronic Post Traumatic Stress Disorder
% 218.67/218.87  |- skos__hiddenLabel mesh__D013313 Posttraumatic Stress Disorder
% 218.67/218.87  |- skos__hiddenLabel mesh__D013313 Neuroses, Post Traumatic
% 218.67/218.87  |- mesh__recordOriginator mesh__D013313 NLM
% 218.67/218.87  |- skos__prefLabel mesh__D013313 Stress Disorders, Post-Traumatic
% 218.67/218.87  |- skos__altLabel mesh__D013313 Neuroses, Posttraumatic
% 218.67/218.87  |- mesh__publicMeSHNote mesh__D013313
% 218.67/218.87       81; was NEUROSES, POST-TRAUMATIC 1963-80   
% 218.67/218.87  |- skos__altLabel mesh__D013313 Neuroses, Post-Traumatic
% 218.67/218.87  |- skos__hiddenLabel mesh__D013313 Post Traumatic Stress Disorders
% 218.67/218.87  |- skos__hiddenLabel mesh__D013313 Post-Traumatic Stress Disorder
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D013313 2004
% 218.67/218.87  |- mesh__historyNote mesh__D013313
% 218.67/218.87       81; was NEUROSES, POST-TRAUMATIC 1963-80   
% 218.67/218.87  |- skos__hiddenLabel mesh__D013313 Post-Traumatic Neuroses
% 218.67/218.87  |- skos__hiddenLabel mesh__D013313 Acute Post Traumatic Stress Disorder
% 218.67/218.87  |- rdf__type mesh__D013313sskos__Concept
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D013313 2005
% 218.67/218.87  |- skos__hiddenLabel mesh__D013313
% 218.67/218.87       Delayed Onset Post Traumatic Stress Disorder
% 218.67/218.87  |- skos__hiddenLabel mesh__D013313 Stress Disorder, Post-Traumatic
% 218.67/218.87  |- mesh__recordAuthorizer mesh__D013313 sjn
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D013313 2006
% 218.67/218.87  |- skos__hiddenLabel mesh__D013313 Stress Disorders, Post Traumatic
% 218.67/218.87  |- skos__annotation mesh__D013313 COMBAT DISORDERS is also available   
% 218.67/218.87  |- skos__broader mesh__D013313smesh__D040921
% 218.67/218.87  |- skos__hiddenLabel mesh__D013313 Posttraumatic Neuroses
% 218.67/218.87  |- mesh__recordMaintainer mesh__D013313 JLS
% 218.67/218.87  |- skos__broader mesh__D012559Q000523smesh__D012559
% 218.67/218.87  |- mesh__preferredCombination mesh__D012559Q000523smesh__D012565
% 218.67/218.87  |- rdf__type mesh__D012559Q000523smesh__CompoundConcept
% 218.67/218.87  |- mesh__dateEstablished mesh__D037761 2003-01-01
% 218.67/218.87  |- skos__broader mesh__D037761smesh__D000581
% 218.67/218.87  |- mesh__publicMeSHNote mesh__D037761 2003   
% 218.67/218.87  |- mesh__dateRevised mesh__D037761 2003-07-09
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D037761 2005
% 218.67/218.87  |- skos__broader mesh__D037761smesh__D036002
% 218.67/218.87  |- skos__annotation mesh__D037761 note specific sirtuins in SCR   
% 218.67/218.87  |- skos__altLabel mesh__D037761
% 218.67/218.87       Silent Mating Type Information Regulator 2-like Proteins
% 218.67/218.87  |- skos__hiddenLabel mesh__D037761 Sir2 like Proteins
% 218.67/218.87  |- skos__hiddenLabel mesh__D037761 NAD Dependent Protein Deacetylases
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D037761 2004
% 218.67/218.87  |- skos__hiddenLabel mesh__D037761 Sir2 like Deacetylases
% 218.67/218.87  |- skos__hiddenLabel mesh__D037761 Deacetylases, NAD-Dependent Protein
% 218.67/218.87  |- skos__hiddenLabel mesh__D037761 Deacetylases, Sir2-like
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D037761 2006
% 218.67/218.87  |- skos__historyNote mesh__D037761 Histone Deacetylase %28%2000-2002%29%
% 218.67/218.87  |- skos__scopeNote mesh__D037761
% 218.67/218.87       A homologous family of proteins that includes the NAD-dependent protein deacetylases which deacetylate proteins by catalyzing the formation of  O-acetyl-ADP-ribose from the ADP-RIBOSE moiety %28%of NAD%29% and the acetyl group that is being removed from the protein. Sir2p, from Saccharomyces cerevisiae, is the founding member and the family includes other homologs %28%HSTs - homologs of Sir Two%29%. Some HISTONE DEACETYLASES %28%the Sir2-like HDACs%29% belong to this family of proteins.%A%    
% 218.67/218.87  |- skos__hiddenLabel mesh__D037761 Protein Deacetylases, NAD-Dependent
% 218.67/218.87  |- skos__related mesh__D037761smesh__D038281
% 218.67/218.87  |- skos__altLabel mesh__D037761 Sir2-like Deacetylases
% 218.67/218.87  |- skos__related mesh__D037761smesh__D006655
% 218.67/218.87  |- skos__altLabel mesh__D037761 Sir2-like Proteins
% 218.67/218.87  |- mesh__dateCreated mesh__D037761 2002-07-03
% 218.67/218.87  |- skos__prefLabel mesh__D037761 Sirtuins
% 218.67/218.87  |- mesh__historyNote mesh__D037761 2003   
% 218.67/218.87  |- rdf__type mesh__D037761sskos__Concept
% 218.67/218.87  |- skos__hiddenLabel mesh__D037761
% 218.67/218.87       Silent Mating Type Information Regulator 2 like Proteins
% 218.67/218.87  |- skos__altLabel mesh__D004587 Electrophoresis, Agarose Gel
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D004587 2004
% 218.67/218.87  |- mesh__dateEstablished mesh__D004587 1991-01-01
% 218.67/218.87  |- skos__hiddenLabel mesh__D004587 Gel Electrophoresis, Agarose
% 218.67/218.87  |- mesh__publicMeSHNote mesh__D004587
% 218.67/218.87       91; was see under ELECTROPHORESIS 1975-90   
% 218.67/218.87  |- skos__hiddenLabel mesh__D004587 Agarose Gel Electrophoresis
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D004587 2006
% 218.67/218.87  |- skos__annotation mesh__D004587 NIM   
% 218.67/218.87  |- skos__hiddenLabel mesh__D004587 Gel Electrophoresis, Agar
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D004587 2003
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D004587 2005
% 218.67/218.87  |- mesh__recordAuthorizer mesh__D004587 sjn
% 218.67/218.87  |- mesh__recordOriginator mesh__D004587 NLM
% 218.67/218.87  |- mesh__historyNote mesh__D004587
% 218.67/218.87       91%28%75%29%; was see under ELECTROPHORESIS 1975-90   
% 218.67/218.87  |- rdf__type mesh__D004587sskos__Concept
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D004587 2002
% 218.67/218.87  |- skos__prefLabel mesh__D004587 Electrophoresis, Agar Gel
% 218.67/218.87  |- mesh__dateRevised mesh__D004587 1999-11-03
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D004587 2001
% 218.67/218.87  |- mesh__dateCreated mesh__D004587 1974-12-12
% 218.67/218.87  |- skos__scopeNote mesh__D004587
% 218.67/218.87       Electrophoresis in which agar or agarose gel is used as the diffusion medium.%A%    
% 218.67/218.87  |- mesh__recordMaintainer mesh__D004587 ags
% 218.67/218.87  |- skos__hiddenLabel mesh__D004587 Agar Gel Electrophoresis
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D004587 2000
% 218.67/218.87  |- skos__broader mesh__D004587smesh__D004586
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D023741 2004
% 218.67/218.87  |- skos__broader mesh__D023741smesh__D023721
% 218.67/218.87  |- skos__altLabel mesh__D023741 Torafugu
% 218.67/218.87  |- skos__historyNote mesh__D023741 Fishes, Poisonous %28%1993-2001%29%
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D023741 2005
% 218.67/218.87  |- mesh__dateEstablished mesh__D023741 2002-01-01
% 218.67/218.87  |- skos__historyNote mesh__D023741 Fishes %28%1983-2001%29%
% 218.67/218.87  |- skos__altLabel mesh__D023741 Fugu
% 218.67/218.87  |- skos__prefLabel mesh__D023741 Takifugu
% 218.67/218.87  |- skos__scopeNote mesh__D023741
% 218.67/218.87       A genus of pufferfish commonly used for research.     
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D023741 2006
% 218.67/218.87  |- mesh__dateCreated mesh__D023741 2001-07-25
% 218.67/218.87  |- rdf__type mesh__D023741sskos__Concept
% 218.67/218.87  |- skos__altLabel mesh__D023741 Fugu rubripes
% 218.67/218.87  |- mesh__historyNote mesh__D023741 2002   
% 218.67/218.87  |- mesh__dateRevised mesh__D023741 2003-07-09
% 218.67/218.87  |- mesh__publicMeSHNote mesh__D023741 2002   
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D009272 2004
% 218.67/218.87  |- mesh__historyNote mesh__D009272 98; use explode   
% 218.67/218.87  |- mesh__dateRevised mesh__D009272 2002-07-03
% 218.67/218.87  |- mesh__dateEstablished mesh__D009272 1998-01-01
% 218.67/218.87  |- skos__annotation mesh__D009272
% 218.67/218.87       not used for indexing      CATALOG: do not use   
% 218.67/218.87  |- mesh__recordAuthorizer mesh__D009272 sjn
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D009272 2003
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D009272 2006
% 218.67/218.87  |- mesh__dateCreated mesh__D009272 1999-01-01
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D009272 2005
% 218.67/218.87  |- mesh__recordMaintainer mesh__D009272 hjn
% 218.67/218.87  |- mesh__recordOriginator mesh__D009272 NLM
% 218.67/218.87  |- mesh__runningHead mesh__D009272 M1 - PERSONS   
% 218.67/218.87  |- skos__hiddenLabel mesh__D009272 Person
% 218.67/218.87  |- skos__prefLabel mesh__D009272 Persons
% 218.67/218.87  |- mesh__publicMeSHNote mesh__D009272 98   
% 218.67/218.87  |- rdf__type mesh__D009272sskos__Concept
% 218.67/218.87  |- skos__scopeNote mesh__D009272
% 218.67/218.87       Persons as individuals %28%e.g., ABORTION APPLICANTS%29% or as members of a group %28%e.g., HISPANIC AMERICANS%29%. It is not used for members of the various professions %28%e.g., PHYSICIANS%29% or occupations %28%e.g., LIBRARIANS%29% for which OCCUPATIONAL GROUPS is available.%A%    
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D017704 2005
% 218.67/218.87  |- mesh__publicMeSHNote mesh__D017704 94   
% 218.67/218.87  |- skos__altLabel mesh__D017704 Baroreceptor Reflexes
% 218.67/218.87  |- mesh__dateRevised mesh__D017704 2005-07-08
% 218.67/218.87  |- skos__broader mesh__D017704smesh__D006439
% 218.67/218.87  |- skos__broader mesh__D017704smesh__D012018
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D017704 2006A
% 218.67/218.87  |- mesh__historyNote mesh__D017704 94   
% 218.67/218.87  |- skos__altLabel mesh__D017704 Baroreceptor Reflex
% 218.67/218.87  |- skos__altLabel mesh__D017704 Reflex, Baroreceptor
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D017704 2004
% 218.67/218.87  |- skos__historyNote mesh__D017704 Pressoreceptors %28%1966-1993%29%
% 218.67/218.87  |- mesh__recordAuthorizer mesh__D017704 ags
% 218.67/218.87  |- mesh__dateCreated mesh__D017704 1992-12-28
% 218.67/218.87  |- mesh__recordOriginator mesh__D017704 RAZ
% 218.67/218.87  |- rdf__type mesh__D017704sskos__Concept
% 218.67/218.87  |- skos__prefLabel mesh__D017704 Baroreflex
% 218.67/218.87  |- mesh__recordMaintainer mesh__D017704 ags
% 218.67/218.87  |- skos__altLabel mesh__D017704 Baroreflexes
% 218.67/218.87  |- skos__hiddenLabel mesh__D017704 Reflexes, Baroreceptor
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D017704 2006
% 218.67/218.87  |- mesh__dateEstablished mesh__D017704 1994-01-01
% 218.67/218.87  |- skos__scopeNote mesh__D017704
% 218.67/218.87       A response by the BARORECEPTORS to increased BLOOD PRESSURE. Increased pressure stretches BLOOD VESSELS which activates the baroreceptors in the vessel walls. The net response of the CENTRAL NERVOUS SYSTEM is a reduction of central sympathetic outflow. This reduces blood pressure both by decreasing peripheral VASCULAR RESISTANCE and by lowering CARDIAC OUTPUT. Because the baroreceptors are tonically active, the baroreflex can compensate rapidly for both increases and decreases in blood pressure.%A%    
% 218.67/218.87  |- skos__scopeNote mesh__D047391
% 218.67/218.87       Cyclic GLUCANS consisting of six %28%6%29% glucopyranose units linked by 1,4-glycosidic bonds.%A%    
% 218.67/218.87  |- mesh__recordAuthorizer mesh__D047391 sjn
% 218.67/218.87  |- skos__prefLabel mesh__D047391 alpha-Cyclodextrins
% 218.67/218.87  |- skos__broader mesh__D047391smesh__D003505
% 218.67/218.87  |- mesh__publicMeSHNote mesh__D047391 2005   
% 218.67/218.87  |- skos__hiddenLabel mesh__D047391 alpha Cyclodextrins
% 218.67/218.87  |- mesh__historyNote mesh__D047391 2005   
% 218.67/218.87  |- mesh__dateCreated mesh__D047391 2004-07-07
% 218.67/218.87  |- mesh__dateEstablished mesh__D047391 2005-01-01
% 218.67/218.87  |- skos__historyNote mesh__D047391 Cyclodextrins %28%1991-2004%29%
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D047391 2006
% 218.67/218.87  |- skos__historyNote mesh__D047391 Oligosaccharides %28%1975-2004%29%
% 218.67/218.87  |- mesh__recordMaintainer mesh__D047391 ssb
% 218.67/218.87  |- mesh__recordOriginator mesh__D047391 ssb
% 218.67/218.87  |- mesh__activeMeSHYear mesh__D047391 2005
% 218.67/218.87  |- rdf__type mesh__D047391sskos__Concept
% 218.67/218.88  |- mesh__dateCreated mesh__D008978 1977-04-22
% 218.67/218.88  |- mesh__recordMaintainer mesh__D008978 ssb
% 218.67/218.88  |- skos__hiddenLabel mesh__D008978 Venoms, Octopus
% 218.67/218.88  |- skos__hiddenLabel mesh__D008978 Venom, Mollusk
% 218.67/218.88  |- skos__historyNote mesh__D008978 Mollusca %28%1966-1977%29%
% 218.67/218.88  |- mesh__historyNote mesh__D008978 78   
% 218.67/218.88  |- skos__hiddenLabel mesh__D008978 Venoms, Mollusk
% 218.67/218.88  |- skos__scopeNote mesh__D008978
% 218.67/218.88       Venoms from mollusks, including CONUS and OCTOPUS species. The venoms contain proteins, enzymes, choline derivatives, slow-reacting substances, and several characterized polypeptide toxins that affect the nervous system. Mollusk venoms include cephalotoxin, venerupin, maculotoxin, surugatoxin, conotoxins, and murexine.%A%    
% 218.67/218.88  |- skos__altLabel mesh__D008978 Octopus Venom
% 218.67/218.88  |- skos__hiddenLabel mesh__D008978 Venom, Octopus
% 218.67/218.88  |- skos__altLabel mesh__D008978 Snail Venoms
% 218.67/218.88  |- skos__hiddenLabel mesh__D008978 Venoms, Conus
% 218.67/218.88  |- mesh__dateEstablished mesh__D008978 1978-01-01
% 218.67/218.88  |- skos__hiddenLabel mesh__D008978 Venoms, Snail
% 218.67/218.88  |- rdf__type mesh__D008978sskos__Concept
% 218.67/218.88  |- skos__altLabel mesh__D008978 Mollusc Venoms
% 218.67/218.88  |- skos__prefLabel mesh__D008978 Mollusk Venoms
% 218.67/218.88  |- skos__hiddenLabel mesh__D008978 Venom, Snail
% 218.67/218.88  |- skos__broader mesh__D008978smesh__D014688
% 218.67/218.88  |- skos__hiddenLabel mesh__D008978 Venom, Conus
% 218.67/218.88  |- mesh__dateRevised mesh__D008978 2005-06-30
% 218.67/218.88  |- mesh__publicMeSHNote mesh__D008978 78   
% 218.67/218.88  |- skos__historyNote mesh__D008978 Venoms %28%1966-1977%29%
% 218.67/218.88  |- skos__altLabel mesh__D008978 Conus Venom
% 218.67/218.88  |- mesh__recordAuthorizer mesh__D008978 sjn
% 218.67/218.88  |- skos__annotation mesh__D008978
% 218.67/218.88       /antag permitted but consider also ANTIVENINS; /enzymol permitted; coordinate IM with specific mollusk %28%IM or NIM%29%%A%  
% 218.67/218.88  |- mesh__recordOriginator mesh__D008978 SH
% 218.67/218.88  |- mesh__activeMeSHYear mesh__D008978 2006
% 218.67/218.88  |- skos__hiddenLabel mesh__D008978 Venoms, Mollusc
% 218.67/218.88  |- skos__altLabel mesh__D008978 Mollusk Venom
% 218.67/218.88  |- skos__broader mesh__D008978smesh__D008387
% 218.67/218.88  |- skos__altLabel mesh__D000995 Tuberculostatic Agents
% 218.67/218.88  |- mesh__activeMeSHYear mesh__D000995 2004
% 218.67/218.88  |- mesh__dateRevised mesh__D000995 2003-07-09
% 218.67/218.88  |- mesh__dateCreated mesh__D000995 1999-01-01
% 218.67/218.88  |- skos__scopeNote mesh__D000995
% 218.67/218.88       Drugs used in the treatment of tuberculosis. They are divided into two main classes: %22%first-line%22% agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and %22%second-line%22% drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.%A%    
% 218.67/218.88  |- skos__prefLabel mesh__D000995 Antitubercular Agents
% 218.67/218.88  |- skos__altLabel mesh__D000995 Antitubercular Drugs
% 218.67/218.88  |- mesh__recordMaintainer mesh__D000995 ssb
% 218.67/218.88  |- mesh__activeMeSHYear mesh__D000995 2005
% 218.67/218.88  |- skos__related mesh__D000995smesh__D018088
% 218.67/218.88  |- skos__hiddenLabel mesh__D000995 Agents, Tuberculostatic
% 218.67/218.88  |- rdf__type mesh__D000995sskos__Concept
% 218.67/218.88  |- skos__hiddenLabel mesh__D000995 Drugs, Antitubercular
% 218.67/218.88  |- skos__hiddenLabel mesh__D000995 Agents, Antitubercular
% 218.67/218.88  |- skos__broader mesh__D000995smesh__D000900
% 218.67/218.88  |- mesh__activeMeSHYear mesh__D000995 2006
% 218.67/218.88  |- mesh__recordOriginator mesh__D000995 NLM
% 218.67/218.88  |- skos__annotation mesh__D000995
% 218.67/218.88       consider also MYCOBACTERIUM TUBERCULOSIS /drug eff %26% TUBERCULOSIS /drug ther%A%  
% 218.67/218.88  |- mesh__recordAuthorizer mesh__D000995 sjn
% 218.67/218.88  |- mesh__activeMeSHYear mesh__D000197 2004
% 218.67/218.88  |- mesh__recordMaintainer mesh__D000197 PXP
% 218.67/218.88  |- skos__hiddenLabel mesh__D000197 Actinomycoses, Cervicofacial
% 218.67/218.88  |- mesh__activeMeSHYear mesh__D000197 2000
% 218.67/218.88  |- mesh__activeMeSHYear mesh__D000197 2006
% 218.67/218.88  |- skos__hiddenLabel mesh__D000197 Cervicofacial Actinomycoses
% 218.67/218.88  |- mesh__activeMeSHYear mesh__D000197 2003
% 218.67/218.88  |- mesh__activeMeSHYear mesh__D000197 1997
% 218.67/218.88  |- mesh__recordOriginator mesh__D000197 NLM
% 218.67/218.88  |- mesh__dateCreated mesh__D000197 1999-01-01
% 218.67/218.88  |- mesh__dateRevised mesh__D000197 1994-02-08
% 218.67/218.88  |- mesh__activeMeSHYear mesh__D000197 1999
% 218.67/218.88  |- mesh__activeMeSHYear mesh__D000197 2005
% 218.67/218.88  |- skos__hiddenLabel mesh__D000197 Cervicofacial Actinomycosis
% 218.67/218.88  |- mesh__activeMeSHYear mesh__D000197 1996
% 218.67/218.88  |- mesh__activeMeSHYear mesh__D000197 1995
% 218.67/218.88  |- skos__prefLabel mesh__D000197 Actinomycosis, Cervicofacial
% 218.67/218.88  |- mesh__activeMeSHYear mesh__D000197 1998
% 218.67/218.88  |- skos__annotation mesh__D000197
% 218.67/218.88       bact infect, not fungal despite %22%-mycosis%22%: = infect by genus ACTINOMYCES%A%  
% 218.67/218.88  |- rdf__type mesh__D000197sskos__Concept
% 218.67/218.88  |- mesh__activeMeSHYear mesh__D000197 2002
% 218.67/218.88  |- skos__broader mesh__D000197smesh__D017192
% 218.67/218.88  |- mesh__activeMeSHYear mesh__D000197 2001
% 218.67/218.88  |- skos__broader mesh__D000197smesh__D000196
% 218.67/218.88  |- skos__scopeNote mesh__D000197
% 218.67/218.88       A form of ACTINOMYCOSIS characterized by slow-growing inflammatory lesions of the lymph nodes that drain the mouth %28%lumpy jaw%29%, reddening of the overlying skin, and intraperitoneal abscesses.%A%    
% 218.67/218.88  |- mesh__recordAuthorizer mesh__D000197 PLS
% 218.67/218.88  |- skos__prefLabel mesh__D005680 gamma-Aminobutyric Acid
% 218.67/218.88  |- skos__altLabel mesh__D005680 GABA
% 218.67/218.88  |- skos__altLabel mesh__D005680 4-Aminobutyric Acid
% 218.67/218.88  |- skos__altLabel mesh__D005680 Aminalone
% 218.67/218.88  |- skos__hiddenLabel mesh__D005680 GABA, Lithium
% 218.67/218.88  |- rdf__type mesh__D005680sskos__Concept
% 218.67/218.88  |- mesh__recordAuthorizer mesh__D005680 sjn
% 218.67/218.88  |- mesh__recordMaintainer mesh__D005680 ssb
% 218.67/218.88  |- skos__broader mesh__D005680smesh__D000613
% 218.67/218.88  |- mesh__dateEstablished mesh__D005680 1979-01-01
% 218.67/218.88  |- mesh__dateRevised mesh__D005680 2005-06-30
% 218.67/218.88  |- skos__altLabel mesh__D005680 4-Aminobutanoic Acid
% 218.67/218.88  |- skos__altLabel mesh__D005680 Lithium GABA
% 218.67/218.88  |- skos__hiddenLabel mesh__D005680 Acid, Hydrochloride gamma-Aminobutyric
% 218.67/218.88  |- skos__hiddenLabel mesh__D005680
% 218.67/218.88       gamma Aminobutyric Acid, Monolithium Salt
% 218.67/218.88  |- mesh__dateCreated mesh__D005680 1999-01-01
% 218.67/218.88  |- mesh__historyNote mesh__D005680
% 218.67/218.88       2001%28%1975%29%; use AMINOBUTYRIC ACIDS 1966-1974   
% 218.67/218.88  |- skos__scopeNote mesh__D005680
% 218.67/218.88       The most common inhibitory neurotransmitter in the central nervous system.%A%    
% 218.67/218.88  |- mesh__activeMeSHYear mesh__D005680 2006
% 218.67/218.88  |- mesh__publicMeSHNote mesh__D005680
% 218.67/218.88       2001; see GABA 1979-2001, see AMINOBUTYRIC ACIDS 1975-1978, see AMINOBUTYRIC ACID 1963-1974%A%  
% 218.67/218.88  |- skos__hiddenLabel mesh__D005680 gamma Aminobutyric Acid, Monosodium Salt
% 218.67/218.88  |- skos__hiddenLabel mesh__D005680 Hydrochloride gamma-Aminobutyric Acid
% 218.67/218.88  |- skos__hiddenLabel mesh__D005680 4 Aminobutyric Acid
% 218.67/218.88  |- skos__related mesh__D005680smesh__D018079
% 218.67/218.88  |- skos__hiddenLabel mesh__D005680 4 Aminobutanoic Acid
% 218.67/218.88  |- skos__related mesh__D005680smesh__D018682
% 218.67/218.88  |- skos__altLabel mesh__D005680 Aminalon
% 218.67/218.88  |- skos__historyNote mesh__D005680 Aminobutyric Acids %28%1966-1974%29%
% 218.67/218.88  |- skos__hiddenLabel mesh__D005680 gamma Aminobutyric Acid, Hydrochloride
% 218.67/218.88  |- mesh__recordOriginator mesh__D005680 NLM
% 218.67/218.88  |- skos__hiddenLabel mesh__D005680 gamma Aminobutyric Acid
% 218.67/218.88  |- skos__broader mesh__D013314smesh__D019563
% 218.67/218.88  |- mesh__dateCreated mesh__D013314 1999-01-01
% 218.67/218.88  |- skos__annotation mesh__D013314
% 218.67/218.88       NIM; no qualif; see MeSH definition: does not refer to stress response to mechanical stimuli such as vibration %28% = STRESS + VIBRATION, not STRESS, MECHANICAL%29%%A%  
% 218.76/218.92  |- mesh__recordOriginator mesh__D013314 NLM
% 218.76/218.92  |- skos__hiddenLabel mesh__D013314 Mechanical Stress
% 218.76/218.92  |- skos__broader mesh__D013314smesh__D001696
% 218.76/218.92  |- mesh__dateEstablished mesh__D013314 1973-01-01
% 218.76/218.92  |- rdf__type mesh__D013314sskos__Concept
% 218.76/218.92  |- mesh__activeMeSHYear mesh__D013314 2004
% 218.76/218.92  |- mesh__dateRevised mesh__D013314 2003-07-09
% 218.76/218.92  |- mesh__recordAuthorizer mesh__D013314 sjn
% 218.76/218.92  |- skos__historyNote mesh__D013314 Biomechanics %28%1968-1970%29%
% 218.76/218.92  |- skos__hiddenLabel mesh__D013314 Mechanical Stresses
% 218.76/218.92  |- mesh__activeMeSHYear mesh__D013314 2005
% 218.76/218.92  |- skos__hiddenLabel mesh__D013314 Stresses, Mechanical
% 218.76/218.92  |- skos__historyNote mesh__D013314 Physics %28%1966-1970%29%
% 218.76/218.92  |- mesh__recordMaintainer mesh__D013314 nns
% 218.76/218.92  |- skos__prefLabel mesh__D013314 Stress, Mechanical
% 218.76/218.92  |- mesh__historyNote mesh__D013314 73%28%71%29%   
% 218.76/218.92  |- mesh__publicMeSHNote mesh__D013314 73   
% 218.76/218.92  |- mesh__activeMeSHYear mesh__D013314 2006
% 218.76/218.92  |- skos__scopeNote mesh__D013314
% 218.76/218.92       A purely physical condition which exists within any material because of strain or deformation by external forces or by non-uniform thermal expansion; expressed quantitatively in units of force per unit area.%A%    
% 218.76/218.93  |- skos__broader mesh__D002794Q000172smesh__D002794
% 218.76/218.93  |- mesh__preferredCombination mesh__D002794Q000172smesh__D002796
% 218.76/218.93  |- rdf__type mesh__D002794Q000172smesh__CompoundConcept
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D004588 2003
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D004588 2005
% 218.76/218.93  |- rdf__type mesh__D004588sskos__Concept
% 218.76/218.93  |- skos__annotation mesh__D004588 NIM   
% 218.76/218.93  |- skos__scopeNote mesh__D004588
% 218.76/218.93       Electrophoresis in which cellulose acetate is the diffusion medium.%A%    
% 218.76/218.93  |- skos__hiddenLabel mesh__D004588 Cellulose Acetate Electrophoresis
% 218.76/218.93  |- mesh__dateCreated mesh__D004588 1974-12-12
% 218.76/218.93  |- mesh__recordAuthorizer mesh__D004588 sjn
% 218.76/218.93  |- mesh__recordOriginator mesh__D004588 NLM
% 218.76/218.93  |- mesh__historyNote mesh__D004588
% 218.76/218.93       91%28%75%29%; was see under ELECTROPHORESIS 1975-90   
% 218.76/218.93  |- skos__hiddenLabel mesh__D004588 Cellulose Acetate Electrophoreses
% 218.76/218.93  |- skos__broader mesh__D004588smesh__D004586
% 218.76/218.93  |- skos__prefLabel mesh__D004588 Electrophoresis, Cellulose Acetate
% 218.76/218.93  |- mesh__dateRevised mesh__D004588 2002-07-03
% 218.76/218.93  |- mesh__recordMaintainer mesh__D004588 lkt
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D004588 2004
% 218.76/218.93  |- mesh__dateEstablished mesh__D004588 1991-01-01
% 218.76/218.93  |- skos__hiddenLabel mesh__D004588 Electrophoreses, Cellulose Acetate
% 218.76/218.93  |- mesh__publicMeSHNote mesh__D004588
% 218.76/218.93       91; was see under ELECTROPHORESIS 1975-90   
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D004588 2006
% 218.76/218.93  |- mesh__recordMaintainer mesh__D009273 ags
% 218.76/218.93  |- mesh__dateCreated mesh__D009273 1999-01-01
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D009273 2005
% 218.76/218.93  |- skos__hiddenLabel mesh__D009273 Groups, Age
% 218.76/218.93  |- skos__scopeNote mesh__D009273
% 218.76/218.93       Persons classified by age from birth %28%INFANT, NEWBORN%29% to octogenarians and older %28%AGED, 80 AND OVER%29%.%A%    
% 218.76/218.93  |- skos__historyNote mesh__D009273 specific age group %28%1966-1997%29%
% 218.76/218.93  |- mesh__historyNote mesh__D009273 98; use explode 1975-97   
% 218.76/218.93  |- skos__hiddenLabel mesh__D009273 Age Group
% 218.76/218.93  |- skos__annotation mesh__D009273 not used for indexing or cataloging   
% 218.76/218.93  |- mesh__dateEstablished mesh__D009273 1998-01-01
% 218.76/218.93  |- mesh__recordAuthorizer mesh__D009273 sjn
% 218.76/218.93  |- skos__hiddenLabel mesh__D009273 Group, Age
% 218.76/218.93  |- rdf__type mesh__D009273sskos__Concept
% 218.76/218.93  |- mesh__recordOriginator mesh__D009273 NLM
% 218.76/218.93  |- mesh__dateRevised mesh__D009273 2003-07-09
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D009273 2004
% 218.76/218.93  |- skos__broader mesh__D009273smesh__D009272
% 218.76/218.93  |- skos__prefLabel mesh__D009273 Age Groups
% 218.76/218.93  |- mesh__publicMeSHNote mesh__D009273 98   
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D009273 2006
% 218.76/218.93  |- mesh__historyNote mesh__D001290
% 218.76/218.93       65%28%64%29%; was see under BEHAVIOR 1963-64   
% 218.76/218.93  |- skos__related mesh__D001290smesh__D011639
% 218.76/218.93  |- skos__altLabel mesh__D001290 Attitudes
% 218.76/218.93  |- skos__related mesh__D001290smesh__D033182
% 218.76/218.93  |- skos__scopeNote mesh__D001290
% 218.76/218.93       An enduring, learned predisposition to behave in a consistent way toward a given class of objects, or a persistent mental and/or neural state of readiness to react to a certain class of objects, not as they are but as they are conceived to be.%A%    
% 218.76/218.93  |- mesh__publicMeSHNote mesh__D001290 65; was see under BEHAVIOR 1963-64   
% 218.76/218.93  |- skos__related mesh__D001290smesh__D012718
% 218.76/218.93  |- mesh__recordMaintainer mesh__D001290 jrf
% 218.76/218.93  |- skos__prefLabel mesh__D001290 Attitude
% 218.76/218.93  |- mesh__dateRevised mesh__D001290 2002-07-02
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D001290 2006
% 218.76/218.93  |- skos__broader mesh__D001290smesh__D001520
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D001290 2004
% 218.76/218.93  |- mesh__dateEstablished mesh__D001290 1965-01-01
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D001290 2005
% 218.76/218.93  |- rdf__type mesh__D001290sskos__Concept
% 218.76/218.93  |- mesh__recordAuthorizer mesh__D001290 sjn
% 218.76/218.93  |- mesh__dateCreated mesh__D001290 1999-01-01
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D001290 2003
% 218.76/218.93  |- mesh__recordOriginator mesh__D001290 NLM
% 218.76/218.93  |- mesh__recordAuthorizer mesh__D017705 sjn
% 218.76/218.93  |- mesh__onlineNote mesh__D017705
% 218.76/218.93       use LIGNANS %28%NM%29% to search LIGNANS 1980-93   
% 218.76/218.93  |- mesh__dateEstablished mesh__D017705 1994-01-01
% 218.76/218.93  |- mesh__publicMeSHNote mesh__D017705
% 218.76/218.93       94; LIGNANS was indexed under LIGNIN 1990-93 %26% PLANT EXTRACTS 1979-89%A%  
% 218.76/218.93  |- skos__historyNote mesh__D017705 Plant Extracts %28%1981-1989%29%
% 218.76/218.93  |- mesh__dateCreated mesh__D017705 1993-02-16
% 218.76/218.93  |- skos__historyNote mesh__D017705 Lignin %28%1990-1993%29%
% 218.76/218.93  |- mesh__recordMaintainer mesh__D017705 sjn
% 218.76/218.93  |- mesh__historyNote mesh__D017705 94; was LIGNANS %28%NM%29% 1979-93   
% 218.76/218.93  |- skos__scopeNote mesh__D017705
% 218.76/218.93       A class of dibenzylbutane derivatives which occurs in higher plants and in fluids %28%bile, serum, urine, etc.%29% in man and other animals. These compounds, which have a potential anti-cancer role, can be synthesized in vitro by human fecal flora. %28%From Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed%29%%A%    
% 218.76/218.93  |- rdf__type mesh__D017705sskos__Concept
% 218.76/218.93  |- skos__prefLabel mesh__D017705 Lignans
% 218.76/218.93  |- skos__broader mesh__D017705smesh__D001593
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D017705 2005
% 218.76/218.93  |- skos__annotation mesh__D017705
% 218.76/218.93       do not confuse with LIGNIN, also found in plants   
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D017705 2006
% 218.76/218.93  |- mesh__dateRevised mesh__D017705 2004-07-13
% 218.76/218.93  |- mesh__recordOriginator mesh__D017705 TPW
% 218.76/218.93  |- mesh__recordMaintainer mesh__D047392 ssb
% 218.76/218.93  |- mesh__publicMeSHNote mesh__D047392 2005   
% 218.76/218.93  |- skos__historyNote mesh__D047392 Oligosaccharides %28%1974-2004%29%
% 218.76/218.93  |- mesh__recordAuthorizer mesh__D047392 sjn
% 218.76/218.93  |- mesh__dateCreated mesh__D047392 2004-07-07
% 218.76/218.93  |- skos__historyNote mesh__D047392 Cyclodextrins %28%1980-2004%29%
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D047392 2006
% 218.76/218.93  |- skos__prefLabel mesh__D047392 beta-Cyclodextrins
% 218.76/218.93  |- skos__broader mesh__D047392smesh__D003505
% 218.76/218.93  |- mesh__recordOriginator mesh__D047392 ssb
% 218.76/218.93  |- mesh__historyNote mesh__D047392 2005   
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D047392 2005
% 218.76/218.93  |- rdf__type mesh__D047392sskos__Concept
% 218.76/218.93  |- mesh__dateEstablished mesh__D047392 2005-01-01
% 218.76/218.93  |- skos__hiddenLabel mesh__D047392 beta Cyclodextrins
% 218.76/218.93  |- skos__scopeNote mesh__D047392
% 218.76/218.93       Cyclic GLUCANS consisting of seven %28%7%29% glucopyranose units linked by 1,4-glycosidic bonds.%A%    
% 218.76/218.93  |- skos__hiddenLabel mesh__D008979 Virus, Moloney Leukemia
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D008979 2006
% 218.76/218.93  |- mesh__recordAuthorizer mesh__D008979 sjn
% 218.76/218.93  |- mesh__dateRevised mesh__D008979 2002-07-03
% 218.76/218.93  |- skos__altLabel mesh__D008979 Moloney Leukemia Virus
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D008979 2003
% 218.76/218.93  |- mesh__dateCreated mesh__D008979 1999-01-01
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D008979 2005
% 218.76/218.93  |- mesh__recordOriginator mesh__D008979 NLM
% 218.76/218.93  |- skos__broader mesh__D008979smesh__D009052
% 218.76/218.93  |- mesh__recordMaintainer mesh__D008979 ags
% 218.76/218.93  |- rdf__type mesh__D008979sskos__Concept
% 218.76/218.93  |- skos__scopeNote mesh__D008979
% 218.76/218.93       A strain of Murine leukemia virus %28%LEUKEMIA VIRUS, MURINE%29% arising during the propagation of S37 mouse sarcoma, and causing lymphoid leukemia in mice. It also infects rats and newborn hamsters. It is apparently transmitted to embryos in utero and to newborns through mother%27%s milk.%A%    
% 218.76/218.93  |- skos__hiddenLabel mesh__D008979 Leukemia Virus, Moloney
% 218.76/218.93  |- mesh__dateEstablished mesh__D008979 1966-01-01
% 218.76/218.93  |- mesh__historyNote mesh__D008979 2002 %28%1966%29%   
% 218.76/218.93  |- skos__prefLabel mesh__D008979 Moloney murine leukemia virus
% 218.76/218.93  |- skos__annotation mesh__D008979
% 218.76/218.93       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29%+ TUMOR VIRUS INFECTIONS %28%IM%29% + LEUKEMIA, EXPERIMENTAL %28%IM%29% or LEUKEMIA %28%IM%29% %28%for spontaneous leukemia%29%%A%  
% 218.76/218.93  |- mesh__publicMeSHNote mesh__D008979
% 218.76/218.93       2002; see MOLONEY LEUKEMIA VIRUS 1985-2001, see MOLONEY VIRUS 1966-1984%A%  
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D008979 2004
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D000996 2006
% 218.76/218.93  |- skos__broader mesh__D000996smesh__D002491
% 218.76/218.93  |- skos__hiddenLabel mesh__D000996 Drugs, Antitussive
% 218.76/218.93  |- skos__broader mesh__D000996smesh__D019141
% 218.76/218.93  |- mesh__recordOriginator mesh__D000996 NLM
% 218.76/218.93  |- skos__hiddenLabel mesh__D000996 Agents, Antitussive
% 218.76/218.93  |- skos__annotation mesh__D000996
% 218.76/218.93       GEN or unspecified; consider also COUGH /drug ther   
% 218.76/218.93  |- mesh__recordAuthorizer mesh__D000996 sjn
% 218.76/218.93  |- skos__scopeNote mesh__D000996
% 218.76/218.93       Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally.%A%    
% 218.76/218.93  |- skos__altLabel mesh__D000996 Antitussives
% 218.76/218.93  |- mesh__recordMaintainer mesh__D000996 ssb
% 218.76/218.93  |- mesh__dateCreated mesh__D000996 1999-01-01
% 218.76/218.93  |- skos__altLabel mesh__D000996 Antitussive Drugs
% 218.76/218.93  |- rdf__type mesh__D000996sskos__Concept
% 218.76/218.93  |- skos__related mesh__D000996smesh__D005100
% 218.76/218.93  |- skos__prefLabel mesh__D000996 Antitussive Agents
% 218.76/218.93  |- mesh__dateRevised mesh__D000996 2005-06-30
% 218.76/218.93  |- skos__prefLabel mesh__D000198 Spectinomycin
% 218.76/218.93  |- skos__scopeNote mesh__D000198
% 218.76/218.93       An antibiotic produced by Streptomyces spectabilis. It is active against gram-negative bacteria and used for the treatment of gonorrhea.%A%    
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D000198 2005
% 218.76/218.93  |- mesh__historyNote mesh__D000198
% 218.76/218.93       93; was ACTINOSPECTACIN 1973-92; SPECTINOMYCIN was see ACTINOSPECTACIN 1978-92%A%  
% 218.76/218.93  |- skos__hiddenLabel mesh__D000198 Anhydrous Spectinomycin Dihydrochloride
% 218.76/218.93  |- rdf__type mesh__D000198sskos__Concept
% 218.76/218.93  |- mesh__recordOriginator mesh__D000198 NLM
% 218.76/218.93  |- skos__altLabel mesh__D000198 Spectinomycin Dihydrochloride, Pentahydrate
% 218.76/218.93  |- mesh__dateRevised mesh__D000198 2003-07-30
% 218.76/218.93  |- mesh__recordMaintainer mesh__D000198 SYSTEM
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D000198 2004
% 218.76/218.93  |- mesh__recordAuthorizer mesh__D000198 NLM
% 218.76/218.93  |- mesh__publicMeSHNote mesh__D000198
% 218.76/218.93       93; was ACTINOSPECTACIN 1965-92 %28%Prov 1965-72%29%; SPECTINOMYCIN was see ACTINOSPECTACIN 1978-92%A%  
% 218.76/218.93  |- mesh__onlineNote mesh__D000198
% 218.76/218.93       use SPECTINOMYCIN to search ACTINOSPECTACIN 1966-92 %28%as Prov 1966-72%29%%A%  
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D000198 2006
% 218.76/218.93  |- skos__broader mesh__D000198smesh__D006575
% 218.76/218.93  |- mesh__dateEstablished mesh__D000198 1973-01-01
% 218.76/218.93  |- mesh__dateCreated mesh__D000198 1999-01-01
% 218.76/218.93  |- skos__altLabel mesh__D000198 Actinospectacin
% 218.76/218.93  |- mesh__recordMaintainer mesh__D005681 TGC
% 218.76/218.93  |- mesh__recordOriginator mesh__D005681 NLM
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D005681 1999
% 218.76/218.93  |- mesh__dateCreated mesh__D005681 1999-01-01
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D005681 1997
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D005681 2006
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D005681 2002
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D005681 1998
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D005681 2004
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D005681 1996
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D005681 2005
% 218.76/218.93  |- skos__prefLabel mesh__D005681 Gabon
% 218.76/218.93  |- mesh__dateRevised mesh__D005681 1995-02-17
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D005681 2003
% 218.76/218.93  |- skos__annotation mesh__D005681 a republic in west equatorial Africa   
% 218.76/218.93  |- mesh__recordAuthorizer mesh__D005681 PLS
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D005681 2001
% 218.76/218.93  |- skos__scopeNote mesh__D005681
% 218.76/218.93       A republic in west equatorial Africa, south of CAMEROON and west of CONGO. Its capital is Libreville. It was the first part of French Equatorial Africa to be settled in 1841. Gabon achieved independence from France in 1960. Gabon was named for the Gabon River, whose estuary was discovered by the Portuguese in the late 15th century: gabao is the word for hood, probably with reference to its shape. %28%From Webster%27%s New Geographical Dictionary, 1988, p423 %26% Room, Brewer%27%s Dictionary of Names, 1992, p198%29%%A%    
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D005681 2000
% 218.76/218.93  |- skos__broader mesh__D005681smesh__D000350
% 218.76/218.93  |- rdf__type mesh__D005681sskos__Concept
% 218.76/218.93  |- skos__hiddenLabel mesh__D013315 Stress, Emotional
% 218.76/218.93  |- rdf__type mesh__D013315sskos__Concept
% 218.76/218.93  |- skos__prefLabel mesh__D013315 Stress, Psychological
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D013315 2004
% 218.76/218.93  |- skos__hiddenLabel mesh__D013315 Stresses, Life
% 218.76/218.93  |- skos__altLabel mesh__D013315 Stress, Psychologic
% 218.76/218.93  |- mesh__historyNote mesh__D013315 73; was STRESS, PSYCHOLOGIC 1969-72   
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D013315 2005
% 218.76/218.93  |- mesh__dateEstablished mesh__D013315 1969-01-01
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D013315 2003A
% 218.76/218.93  |- skos__altLabel mesh__D013315 Psychological Stress
% 218.76/218.93  |- skos__altLabel mesh__D013315 Suffering
% 218.76/218.93  |- mesh__dateRevised mesh__D013315 2002-10-23
% 218.76/218.93  |- skos__related mesh__D013315smesh__D003441
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D013315 2006
% 218.76/218.93  |- mesh__recordOriginator mesh__D013315 NLM
% 218.76/218.93  |- skos__altLabel mesh__D013315 Life Stress
% 218.76/218.93  |- skos__hiddenLabel mesh__D013315 Psychological Stresses
% 218.76/218.93  |- skos__hiddenLabel mesh__D013315 Life Stresses
% 218.76/218.93  |- skos__related mesh__D013315smesh__D008016
% 218.76/218.93  |- skos__altLabel mesh__D013315 Anguish
% 218.76/218.93  |- mesh__dateCreated mesh__D013315 1999-01-01
% 218.76/218.93  |- skos__broader mesh__D013315smesh__D001526
% 218.76/218.93  |- mesh__recordMaintainer mesh__D013315 sjn
% 218.76/218.93  |- skos__hiddenLabel mesh__D013315 Stress, Life
% 218.76/218.93  |- mesh__onlineNote mesh__D013315
% 218.76/218.93       use STRESS, PSYCHOLOGICAL to search STRESS, PSYCHOLOGIC 1969-72%A%  
% 218.76/218.93  |- mesh__publicMeSHNote mesh__D013315
% 218.76/218.93       73; was STRESS, PSYCHOLOGIC 1969-72   
% 218.76/218.93  |- skos__hiddenLabel mesh__D013315 Psychologic Stress
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D013315 2003
% 218.76/218.93  |- skos__scopeNote mesh__D013315
% 218.76/218.93       Stress wherein emotional factors predominate.     
% 218.76/218.93  |- skos__hiddenLabel mesh__D013315 Stresses, Psychological
% 218.76/218.93  |- mesh__recordAuthorizer mesh__D013315 sjn
% 218.76/218.93  |- skos__annotation mesh__D013315
% 218.76/218.93       human %26% animal; coord IM with type of stress if relevant %28%IM or NIM%29%;  %22%stressful events%22% is indexed under LIFE CHANGE EVENTS %28%restrict to humans%29% but note LIFE STRESS goes here; stress ulcer: index under PEPTIC ULCER or specific %28%IM%29% + STRESS, PSYCHOLOGICAL or STRESS %28%IM or NIM%29%; DF: STRESS PSYCHOL%A%  
% 218.76/218.93  |- skos__hiddenLabel mesh__D013315 Suffering, Mental
% 218.76/218.93  |- skos__broader mesh__D013315smesh__D011603
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D018000 2005
% 218.76/218.93  |- mesh__historyNote mesh__D018000 94   
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D018000 2000
% 218.76/218.93  |- skos__broader mesh__D018000smesh__D011956
% 218.76/218.93  |- skos__hiddenLabel mesh__D018000 Receptor, Peptide
% 218.76/218.93  |- skos__hiddenLabel mesh__D018000 Hormone Receptors, Peptide
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D018000 2006
% 218.76/218.93  |- mesh__dateCreated mesh__D018000 1993-06-21
% 218.76/218.93  |- skos__hiddenLabel mesh__D018000 Peptide Hormones Receptors
% 218.76/218.93  |- skos__altLabel mesh__D018000 Receptors, Peptide Hormones
% 218.76/218.93  |- skos__hiddenLabel mesh__D018000 Receptors, Peptide Hormone
% 218.76/218.93  |- mesh__recordOriginator mesh__D018000 RAZ
% 218.76/218.93  |- rdf__type mesh__D018000sskos__Concept
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D018000 2001
% 218.76/218.93  |- skos__hiddenLabel mesh__D018000 Hormones Receptors, Peptide
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D018000 1998
% 218.76/218.93  |- skos__altLabel mesh__D018000 Peptide Hormone Receptor
% 218.76/218.93  |- skos__altLabel mesh__D018000 Receptors, Peptides
% 218.76/218.93  |- skos__altLabel mesh__D018000 Peptide Receptors
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D018000 2002
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D018000 1999
% 218.76/218.93  |- mesh__dateRevised mesh__D018000 1997-06-20
% 218.76/218.93  |- skos__historyNote mesh__D018000
% 218.76/218.93       Receptors, Cell Surface %28%1973-1993%29%
% 218.76/218.93  |- skos__prefLabel mesh__D018000 Receptors, Peptide
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D018000 2003
% 218.76/218.93  |- skos__hiddenLabel mesh__D018000 Peptides Receptors
% 218.76/218.93  |- skos__hiddenLabel mesh__D018000 Receptor, Peptide Hormone
% 218.76/218.93  |- skos__annotation mesh__D018000
% 218.76/218.93       GEN; prefer specifics; coord IM with specific peptide %28%IM%29%; DF: RECEPT PEPTIDE%A%  
% 218.76/218.93  |- skos__hiddenLabel mesh__D018000 Hormone Receptor, Peptide
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D018000 2004
% 218.76/218.93  |- skos__altLabel mesh__D018000 Peptide Receptor
% 218.76/218.93  |- mesh__publicMeSHNote mesh__D018000 94   
% 218.76/218.93  |- mesh__dateEstablished mesh__D018000 1994-01-01
% 218.76/218.93  |- skos__scopeNote mesh__D018000
% 218.76/218.93       Cell surface receptors that bind peptide messengers with high affinity and regulate intracellular signals which influence the behavior of cells.%A%    
% 218.76/218.93  |- mesh__recordAuthorizer mesh__D018000 SJN
% 218.76/218.93  |- mesh__recordMaintainer mesh__D018000 NDW
% 218.76/218.93  |- skos__broader mesh__D004589smesh__D004591
% 218.76/218.93  |- skos__altLabel mesh__D004589 Electrophoresis, Disk
% 218.76/218.93  |- mesh__recordMaintainer mesh__D004589 lkt
% 218.76/218.93  |- skos__hiddenLabel mesh__D004589 Disk Electrophoresis
% 218.76/218.93  |- skos__annotation mesh__D004589
% 218.76/218.93       disc stands for %22%discontinous%22%; NIM   
% 218.76/218.93  |- mesh__dateRevised mesh__D004589 2002-07-03
% 218.76/218.93  |- skos__historyNote mesh__D004589 Electrophoresis %28%1966%29%
% 218.76/218.93  |- skos__prefLabel mesh__D004589 Electrophoresis, Disc
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D004589 2004
% 218.76/218.93  |- mesh__dateEstablished mesh__D004589 1970-01-01
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D004589 2006
% 218.76/218.93  |- mesh__publicMeSHNote mesh__D004589
% 218.76/218.93       91,74-84; was see under ELECTROPHORESIS, POLYACRYLAMIDE GEL 1985-91; was heading 1974-84; was ELECTROPHORESIS, DISK 1970-73%A%  
% 218.76/218.93  |- skos__scopeNote mesh__D004589
% 218.76/218.93       Electrophoresis in which discontinuities in both the voltage and pH gradients are introduced by using buffers of different composition and pH in the different parts of the gel column. The term %27%disc%27% was originally used as an abbreviation for %27%discontinuous%27% referring to the buffers employed, and does not have anything to do with the shape of the separated zones.%A%    
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D004589 2003
% 218.76/218.93  |- mesh__dateCreated mesh__D004589 1999-01-01
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D004589 2005
% 218.76/218.93  |- mesh__onlineNote mesh__D004589
% 218.76/218.93       use ELECTROPHORESIS, DISC to search ELECTROPHORESIS, DISK 1967-73 %28%as Prov 1967-69%29%%A%  
% 218.76/218.93  |- skos__hiddenLabel mesh__D004589 Disc Electrophoresis
% 218.76/218.93  |- rdf__type mesh__D004589sskos__Concept
% 218.76/218.93  |- mesh__historyNote mesh__D004589
% 218.76/218.93       91%28%85%29%74%28%67%29%; was see under ELECTROPHORESIS, POLYACRYLAMIDE GEL 1985-91; was heading 1974-84; was ELECTROPHORESIS, DISK 1967-73 %28%Prov 1967-69%29%%A%  
% 218.76/218.93  |- mesh__recordAuthorizer mesh__D004589 sjn
% 218.76/218.93  |- mesh__recordOriginator mesh__D004589 NLM
% 218.76/218.93  |- skos__broader mesh__D009274smesh__D009272
% 218.76/218.93  |- skos__altLabel mesh__D009274 Group, Occupational
% 218.76/218.93  |- mesh__recordOriginator mesh__D009274 NLM
% 218.76/218.93  |- mesh__historyNote mesh__D009274 98; use explode 1975-97   
% 218.76/218.93  |- skos__altLabel mesh__D009274 Groups, Occupational
% 218.76/218.93  |- skos__prefLabel mesh__D009274 Occupational Groups
% 218.76/218.93  |- skos__annotation mesh__D009274
% 218.76/218.93       not used for indexing; DF: OCCUP GROUPS   
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D009274 2002
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D009274 1999
% 218.76/218.93  |- rdf__type mesh__D009274sskos__Concept
% 218.76/218.93  |- skos__historyNote mesh__D009274 specific occupation %28%1966-1997%29%
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D009274 2001
% 218.76/218.93  |- mesh__publicMeSHNote mesh__D009274 98   
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D009274 2004
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D009274 2000
% 218.76/218.93  |- mesh__dateEstablished mesh__D009274 1998-01-01
% 218.76/218.93  |- mesh__recordMaintainer mesh__D009274 MSR
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D009274 2003
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D009274 2006
% 218.76/218.93  |- skos__historyNote mesh__D009274
% 218.76/218.93       specific occupational group %28%1966-1997%29%
% 218.76/218.93  |- skos__altLabel mesh__D009274 Occupational Group
% 218.76/218.93  |- mesh__dateCreated mesh__D009274 1999-01-01
% 218.76/218.93  |- mesh__recordAuthorizer mesh__D009274 SJN
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D009274 2005
% 218.76/218.93  |- mesh__dateRevised mesh__D009274 1998-06-10
% 218.76/218.93  |- skos__related mesh__D009274smesh__D009790
% 218.76/218.93  |- skos__scopeNote mesh__D009274
% 218.76/218.93       Members of the various professions %28%e.g., PHYSICIANS%29% or occupations %28%e.g., POLICE%29%.%A%    
% 218.76/218.93  |- skos__historyNote mesh__D009274 Occupations %28%1966-1997%29%
% 218.76/218.93  |- mesh__dateRevised mesh__D001291 1997-06-20
% 218.76/218.93  |- mesh__recordAuthorizer mesh__D001291 SJN
% 218.76/218.93  |- mesh__historyNote mesh__D001291 68   
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D001291 2001
% 218.76/218.93  |- mesh__recordMaintainer mesh__D001291 JLS
% 218.76/218.93  |- skos__hiddenLabel mesh__D001291 Health Personnel Attitudes
% 218.76/218.93  |- mesh__recordOriginator mesh__D001291 NLM
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D001291 2000
% 218.76/218.93  |- mesh__dateEstablished mesh__D001291 1968-01-01
% 218.76/218.93  |- skos__hiddenLabel mesh__D001291 Health Personnel Attitude
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D001291 2006
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D001291 1999
% 218.76/218.93  |- skos__historyNote mesh__D001291 Attitude %28%1966-1967%29%
% 218.76/218.93  |- skos__broader mesh__D001291smesh__D001290
% 218.76/218.93  |- skos__scopeNote mesh__D001291
% 218.76/218.93       Attitudes of personnel toward their patients, other professionals, toward the medical care system, etc.%A%    
% 218.76/218.93  |- skos__hiddenLabel mesh__D001291 Staff Attitudes
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D001291 2004
% 218.76/218.93  |- skos__hiddenLabel mesh__D001291 Attitudes, Staff
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D001291 2005
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D001291 1998
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D001291 2002
% 218.76/218.93  |- skos__broader mesh__D001291smesh__D003695
% 218.76/218.93  |- rdf__type mesh__D001291sskos__Concept
% 218.76/218.93  |- mesh__dateCreated mesh__D001291 1999-01-01
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D001291 2003
% 218.76/218.93  |- skos__hiddenLabel mesh__D001291 Attitude, Staff
% 218.76/218.93  |- skos__prefLabel mesh__D001291 Attitude of Health Personnel
% 218.76/218.93  |- mesh__publicMeSHNote mesh__D001291 68   
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D017706 2003
% 218.76/218.93  |- skos__historyNote mesh__D017706 Dipeptides %28%1981-1993%29%
% 218.76/218.93  |- mesh__recordOriginator mesh__D017706 TPW
% 218.76/218.93  |- mesh__dateCreated mesh__D017706 1993-02-16
% 218.76/218.93  |- mesh__onlineNote mesh__D017706
% 218.76/218.93       use LISINOPRIL %28%NM%29% to search LISINOPRIL 1981-93   
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D017706 2004
% 218.76/218.93  |- mesh__recordAuthorizer mesh__D017706 sjn
% 218.76/218.93  |- mesh__dateEstablished mesh__D017706 1994-01-01
% 218.76/218.93  |- skos__broader mesh__D017706smesh__D004151
% 218.76/218.93  |- rdf__type mesh__D017706sskos__Concept
% 218.76/218.93  |- mesh__publicMeSHNote mesh__D017706
% 218.76/218.93       94; LISINOPRIL was indexed under ENALAPRIL/analogs %26% derivatives 1986-92 %26% DIPEPTIDES 1981-85, 93%A%  
% 218.76/218.93  |- mesh__historyNote mesh__D017706 94; was LISINOPRIL %28%NM%29% 1981-93   
% 218.76/218.93  |- skos__altLabel mesh__D017706 Lysinopril
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D017706 2005
% 218.76/218.93  |- mesh__recordMaintainer mesh__D017706 ssb
% 218.76/218.93  |- mesh__dateRevised mesh__D017706 2001-07-25
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D017706 2002
% 218.76/218.93  |- skos__historyNote mesh__D017706
% 218.76/218.93       Enalapril/analogs %26% derivatives %28%1986-1992%29%
% 218.76/218.93  |- skos__scopeNote mesh__D017706
% 218.76/218.93       One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS %28%ACE inhibitors%29%, orally active, that has been used in the treatment of hypertension and congestive heart failure.%A%    
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D017706 2006
% 218.76/218.93  |- skos__prefLabel mesh__D017706 Lisinopril
% 218.76/218.93  |- skos__hiddenLabel mesh__D000997 Anti Venins
% 218.76/218.93  |- skos__prefLabel mesh__D000997 Antivenins
% 218.76/218.93  |- mesh__dateRevised mesh__D000997 2005-06-30
% 218.76/218.93  |- skos__hiddenLabel mesh__D000997 Anti Venoms
% 218.76/218.93  |- skos__altLabel mesh__D000997 Antivenoms
% 218.76/218.93  |- skos__altLabel mesh__D000997 Anti-Venins
% 218.76/218.93  |- skos__annotation mesh__D000997 coordinate IM with specific venom   
% 218.76/218.93  |- mesh__dateEstablished mesh__D000997 1965-01-01
% 218.76/218.93  |- skos__altLabel mesh__D000997 Anti-Venoms
% 218.76/218.93  |- mesh__dateCreated mesh__D000997 1999-01-01
% 218.76/218.93  |- skos__broader mesh__D000997smesh__D000992
% 218.76/218.93  |- mesh__recordOriginator mesh__D000997 NLM
% 218.76/218.93  |- mesh__recordAuthorizer mesh__D000997 sjn
% 218.76/218.93  |- skos__related mesh__D000997smesh__D000931
% 218.76/218.93  |- rdf__type mesh__D000997sskos__Concept
% 218.76/218.93  |- mesh__recordMaintainer mesh__D000997 ssb
% 218.76/218.93  |- mesh__historyNote mesh__D000997 65%28%63%29%   
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D000997 2006
% 218.76/218.93  |- mesh__publicMeSHNote mesh__D000997 65   
% 218.76/218.93  |- skos__scopeNote mesh__D000997
% 218.76/218.93       Antisera used to counteract poisoning by animal VENOMS, especially SNAKE VENOMS.%A%    
% 218.76/218.93  |- mesh__recordAuthorizer mesh__D000199 sjn
% 218.76/218.93  |- rdf__type mesh__D000199sskos__Concept
% 218.76/218.93  |- skos__hiddenLabel mesh__D000199 N Actin
% 218.76/218.93  |- skos__hiddenLabel mesh__D000199 beta Actin
% 218.76/218.93  |- mesh__dateRevised mesh__D000199 2005-06-30
% 218.76/218.93  |- skos__hiddenLabel mesh__D000199 G Actin
% 218.76/218.93  |- skos__hiddenLabel mesh__D000199 F Actin
% 218.76/218.93  |- skos__altLabel mesh__D000199 Actin
% 218.76/218.93  |- mesh__onlineNote mesh__D000199
% 218.76/218.93       use ACTINS to search ACTIN 1971-81 %28%as Prov 1971-72%29%   
% 218.76/218.93  |- skos__prefLabel mesh__D000199 Actins
% 218.76/218.93  |- skos__historyNote mesh__D000199 Muscle Proteins %28%1966-1970%29%
% 218.76/218.93  |- mesh__historyNote mesh__D000199
% 218.76/218.93       82; was ACTIN 1971-81 %28%Prov 1971-72%29%   
% 218.76/218.93  |- skos__scopeNote mesh__D000199
% 218.76/218.93       Filamentous proteins that are the main constituent of the thin filaments of muscle fibers. The filaments %28%known also as filamentous or F-actin%29% can be dissociated into their globular subunits; each subunit is composed of a single polypeptide 375 amino acids long. This is known as globular or G-actin. In conjunction with MYOSINS, actin is responsible for the contraction and relaxation of muscle.%A%    
% 218.76/218.93  |- mesh__dateEstablished mesh__D000199 1973-01-01
% 218.76/218.93  |- mesh__dateCreated mesh__D000199 1999-01-01
% 218.76/218.93  |- skos__hiddenLabel mesh__D000199 alpha Actin
% 218.76/218.93  |- skos__hiddenLabel mesh__D000199 alpha Isoactin
% 218.76/218.93  |- mesh__recordMaintainer mesh__D000199 DRC
% 218.76/218.93  |- mesh__recordOriginator mesh__D000199 NLM
% 218.76/218.93  |- skos__broader mesh__D000199smesh__D009124
% 218.76/218.93  |- skos__hiddenLabel mesh__D000199 gamma Actin
% 218.76/218.93  |- mesh__publicMeSHNote mesh__D000199 82; was ACTIN 1973-81   
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D000199 2006
% 218.76/218.93  |- skos__broader mesh__D000199smesh__D008840
% 218.76/218.93  |- skos__broader mesh__D005682smesh__D028581
% 218.76/218.93  |- mesh__dateRevised mesh__D005682 2001-07-25
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D005682 2005
% 218.76/218.93  |- skos__scopeNote mesh__D005682
% 218.76/218.93       Gadolinium. An element of the rare earth family of metals. It has the atomic symbol Gd, atomic number 64, and atomic weight 157.25. Its oxide is used in the control rods of some nuclear reactors.%A%    
% 218.76/218.93  |- mesh__recordMaintainer mesh__D005682 jmp
% 218.76/218.93  |- skos__prefLabel mesh__D005682 Gadolinium
% 218.76/218.93  |- mesh__activeMeSHYear mesh__D005682 2003
% 218.76/218.93  |- skos__annotation mesh__D005682
% 218.76/218.93       a rare earth metal; Gd-158; Gd-154-157, 160 = GADOLINIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Gd-145-153, 159, 161 = GADOLINIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 218.76/218.94  |- mesh__recordOriginator mesh__D005682 NLM
% 218.76/218.94  |- rdf__type mesh__D005682sskos__Concept
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D005682 2002
% 218.76/218.94  |- mesh__recordAuthorizer mesh__D005682 sjn
% 218.76/218.94  |- mesh__dateCreated mesh__D005682 1999-01-01
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D005682 2006
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D005682 2004
% 218.76/218.94  |- skos__broader mesh__D013316smesh__D003053
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D013316 2005
% 218.76/218.94  |- mesh__recordAuthorizer mesh__D013316 sjn
% 218.76/218.94  |- mesh__historyNote mesh__D013316
% 218.76/218.94       91%28%79%29%; was see under COCHLEA 1979-90   
% 218.76/218.94  |- skos__scopeNote mesh__D013316
% 218.76/218.94       A layer of highly vascular pigmented granular cells on the outer wall of the cochlear duct.%A%    
% 218.76/218.94  |- mesh__dateCreated mesh__D013316 1978-05-19
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D013316 2006
% 218.76/218.94  |- mesh__publicMeSHNote mesh__D013316 91; was see under COCHLEA 1979-90   
% 218.76/218.94  |- mesh__dateRevised mesh__D013316 2002-07-03
% 218.76/218.94  |- mesh__recordMaintainer mesh__D013316 mdb
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D013316 2003
% 218.76/218.94  |- mesh__dateEstablished mesh__D013316 1991-01-01
% 218.76/218.94  |- mesh__recordOriginator mesh__D013316 RC
% 218.76/218.94  |- rdf__type mesh__D013316sskos__Concept
% 218.76/218.94  |- skos__historyNote mesh__D013316 Organ of Corti %28%1968-1978%29%
% 218.76/218.94  |- skos__historyNote mesh__D013316 Cochlea %28%1966-1978%29%
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D013316 2004
% 218.76/218.94  |- skos__prefLabel mesh__D013316 Stria Vascularis
% 218.76/218.94  |- skos__hiddenLabel mesh__D013316 Vascularis, Stria
% 218.76/218.94  |- mesh__dateRevised mesh__D009275 2001-07-25
% 218.76/218.94  |- rdf__type mesh__D009275sskos__Concept
% 218.76/218.94  |- skos__annotation mesh__D009275
% 218.76/218.94       for articles %26% books on personal given or surnames; history of names %26% name changes of agencies, societies, organizations, universities, medical schools, hospitals %26% other corporate bodies go here %28%NIM%29% + specific body if in MeSH as main heading %28%IM%29% or GOVERNMENT AGENCIES; SOCIETIES; UNIVERSITIES; HOSPITALS or other generic heading if specific corporate body is not in MeSH %28%IM%29%; no qualif%A%  
% 218.76/218.94  |- skos__hiddenLabel mesh__D009275 Isonymies
% 218.76/218.94  |- skos__broader mesh__D009275smesh__D009626
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D009275 2004
% 218.76/218.94  |- mesh__recordOriginator mesh__D009275 NLM
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D009275 2002
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D009275 2003
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D009275 2006
% 218.76/218.94  |- mesh__recordMaintainer mesh__D009275 mdb
% 218.76/218.94  |- mesh__dateCreated mesh__D009275 1999-01-01
% 218.76/218.94  |- skos__scopeNote mesh__D009275
% 218.76/218.94       Personal names, given or surname, as cultural characteristics, as ethnological or religious patterns, as indications of the geographic distribution of families and inbreeding, etc. Analysis of isonymy, the quality of having the same or similar names, is useful in the study of population genetics. NAMES is used also for the history of names or name changes of corporate bodies, such as medical societies, universities, hospitals, government agencies, etc.%A%    
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D009275 2005
% 218.76/218.94  |- skos__prefLabel mesh__D009275 Names
% 218.76/218.94  |- skos__hiddenLabel mesh__D009275 Name
% 218.76/218.94  |- mesh__recordAuthorizer mesh__D009275 sjn
% 218.76/218.94  |- mesh__dateEstablished mesh__D001292 1987-01-01
% 218.76/218.94  |- mesh__recordAuthorizer mesh__D001292 SJN
% 218.76/218.94  |- mesh__dateRevised mesh__D001292 1997-06-20
% 218.76/218.94  |- skos__broader mesh__D001292smesh__D001290
% 218.76/218.94  |- skos__hiddenLabel mesh__D001292 Computer, Attitude to
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D001292 2005
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D001292 2000
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D001292 1998
% 218.76/218.94  |- skos__hiddenLabel mesh__D001292 to Computer, Attitude
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D001292 2003
% 218.76/218.94  |- skos__prefLabel mesh__D001292 Attitude to Computers
% 218.76/218.94  |- mesh__publicMeSHNote mesh__D001292 87   
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D001292 2006
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D001292 1999
% 218.76/218.94  |- mesh__recordOriginator mesh__D001292 EC
% 218.76/218.94  |- mesh__dateCreated mesh__D001292 1986-06-18
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D001292 2004
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D001292 2001
% 218.76/218.94  |- rdf__type mesh__D001292sskos__Concept
% 218.76/218.94  |- skos__hiddenLabel mesh__D001292 to Computers, Attitude
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D001292 2002
% 218.76/218.94  |- mesh__recordMaintainer mesh__D001292 JLS
% 218.76/218.94  |- skos__hiddenLabel mesh__D001292 Computers, Attitude to
% 218.76/218.94  |- skos__scopeNote mesh__D001292
% 218.76/218.94       The attitude and behavior associated with an individual using the computer.%A%    
% 218.76/218.94  |- skos__annotation mesh__D001292 /ethnol permitted   
% 218.76/218.94  |- skos__hiddenLabel mesh__D001292 Attitude to Computer
% 218.76/218.94  |- mesh__historyNote mesh__D001292 87   
% 218.76/218.94  |- skos__hiddenLabel mesh__D017707 Erythrocyte Transfusions
% 218.76/218.94  |- skos__altLabel mesh__D017707 Red Blood Cell Transfusions
% 218.76/218.94  |- mesh__publicMeSHNote mesh__D017707
% 218.76/218.94       94; was see BLOOD COMPONENT TRANSFUSION 1992-93   
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017707 1994
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017707 2005
% 218.76/218.94  |- skos__hiddenLabel mesh__D017707 Transfusions, Erythrocyte
% 218.76/218.94  |- skos__altLabel mesh__D017707 Transfusions, Red Blood Cell
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017707 1995
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017707 2006
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017707 1996
% 218.76/218.94  |- mesh__historyNote mesh__D017707
% 218.76/218.94       94; was see BLOOD COMPONENT TRANSFUSION 1992-93   
% 218.76/218.94  |- skos__annotation mesh__D017707
% 218.76/218.94       do not use /util except by MeSH definition; for transfusion back to donor, coord IM with BLOOD TRANSFUSION, AUTOLOGOUS %28%NIM%29%%A%  
% 218.76/218.94  |- skos__historyNote mesh__D017707
% 218.76/218.94       Blood Component Transfusion %28%1992-1993%29%
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017707 1997
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017707 2000
% 218.76/218.94  |- mesh__dateEstablished mesh__D017707 1994-01-01
% 218.76/218.94  |- skos__broader mesh__D017707smesh__D016913
% 218.76/218.94  |- skos__altLabel mesh__D017707 Red Blood Cell Transfusion
% 218.76/218.94  |- mesh__onlineNote mesh__D017707
% 218.76/218.94       use BLOOD COMPONENT TRANSFUSION to search ERYTHROCYTE TRANSFUSION 1992-93%A%  
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017707 2003
% 218.76/218.94  |- skos__scopeNote mesh__D017707
% 218.76/218.94       The transfer of erythrocytes from a donor to a recipient or reinfusion to the donor.%A%    
% 218.76/218.94  |- skos__altLabel mesh__D017707 Transfusion, Red Blood Cell
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017707 1998
% 218.76/218.94  |- skos__historyNote mesh__D017707
% 218.76/218.94       Erythrocytes/transplantation %28%1968-1992%29%
% 218.76/218.94  |- skos__historyNote mesh__D017707 Blood Transfusion %28%1969-1992%29%
% 218.76/218.94  |- skos__hiddenLabel mesh__D017707 Transfusion, Erythrocyte
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017707 2001
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017707 2004
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017707 1999
% 218.76/218.94  |- skos__prefLabel mesh__D017707 Erythrocyte Transfusion
% 218.76/218.94  |- skos__historyNote mesh__D017707 Erythrocytes %28%1969-1975%29%
% 218.76/218.94  |- mesh__dateCreated mesh__D017707 1992-12-28
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017707 2002
% 218.76/218.94  |- rdf__type mesh__D017707sskos__Concept
% 218.76/218.94  |- mesh__recordMaintainer mesh__D000998 ssb
% 218.76/218.94  |- rdf__type mesh__D000998sskos__Concept
% 218.76/218.94  |- skos__altLabel mesh__D000998 Antivirals
% 218.76/218.94  |- skos__scopeNote mesh__D000998
% 218.76/218.94       Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.%A%    
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D000998 2006
% 218.76/218.94  |- mesh__dateRevised mesh__D000998 2005-06-30
% 218.76/218.94  |- skos__broader mesh__D000998smesh__D000890
% 218.76/218.94  |- skos__altLabel mesh__D000998 Antiviral Drugs
% 218.76/218.94  |- skos__related mesh__D000998smesh__D038301
% 218.76/218.94  |- skos__related mesh__D000998smesh__D018894
% 218.76/218.94  |- skos__annotation mesh__D000998
% 218.76/218.94       do not confuse with VIRUS INHIBITORS %28%substances found in normal serum, body fluids, etc.%29%; for resistance to antiviral agents, DRUG RESISTANCE, VIRAL and DRUG RESISTANCE, MULTIPLE, VIRAL are  available%A%  
% 218.76/218.94  |- mesh__recordOriginator mesh__D000998 NLM
% 218.76/218.94  |- skos__prefLabel mesh__D000998 Antiviral Agents
% 218.76/218.94  |- mesh__recordAuthorizer mesh__D000998 sjn
% 218.76/218.94  |- mesh__dateCreated mesh__D000998 1999-01-01
% 218.76/218.94  |- skos__hiddenLabel mesh__D000998 Agents, Antiviral
% 218.76/218.94  |- skos__hiddenLabel mesh__D000998 Drugs, Antiviral
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D005683 2003
% 218.76/218.94  |- mesh__recordAuthorizer mesh__D005683 sjn
% 218.76/218.94  |- mesh__historyNote mesh__D005683
% 218.76/218.94       91%28%71%29%; was see under REFLEX 1971-90   
% 218.76/218.94  |- skos__broader mesh__D005683smesh__D012018
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D005683 2001
% 218.76/218.94  |- rdf__type mesh__D005683sskos__Concept
% 218.76/218.94  |- mesh__dateRevised mesh__D005683 1999-11-03
% 218.76/218.94  |- skos__historyNote mesh__D005683 Reflex %28%1966-1970%29%
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D005683 2000
% 218.76/218.94  |- mesh__recordMaintainer mesh__D005683 KEV
% 218.76/218.94  |- skos__hiddenLabel mesh__D005683 Pharyngeal Reflex
% 218.76/218.94  |- mesh__dateEstablished mesh__D005683 1991-01-01
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D005683 2006
% 218.76/218.94  |- skos__prefLabel mesh__D005683 Gagging
% 218.76/218.94  |- mesh__dateCreated mesh__D005683 1999-01-01
% 218.76/218.94  |- mesh__recordOriginator mesh__D005683 NLM
% 218.76/218.94  |- mesh__publicMeSHNote mesh__D005683 91; was see under REFLEX 1971-90   
% 218.76/218.94  |- skos__altLabel mesh__D005683 Reflex, Pharyngeal
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D005683 2005
% 218.76/218.94  |- skos__scopeNote mesh__D005683
% 218.76/218.94       Clinical manifestation of the digestive system consisting of contraction of the muscle of the pharynx caused by stimulation of sensory receptors on the soft palate, by psychic stimuli, or systemically by drugs.%A%    
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D005683 2004
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D005683 2002
% 218.76/218.94  |- skos__broader mesh__D005683smesh__D012817
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D013317 2003
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D013317 1996
% 218.76/218.94  |- skos__historyNote mesh__D013317 Collective Bargaining %28%1971-1979%29%
% 218.76/218.94  |- rdf__type mesh__D013317sskos__Concept
% 218.76/218.94  |- skos__hiddenLabel mesh__D013317 Employee Strike
% 218.76/218.94  |- mesh__dateRevised mesh__D013317 1995-05-23
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D013317 2002
% 218.76/218.94  |- mesh__recordOriginator mesh__D013317 EC
% 218.76/218.94  |- skos__hiddenLabel mesh__D013317 Strike, Employee
% 218.76/218.94  |- skos__hiddenLabel mesh__D013317 Strike
% 218.76/218.94  |- skos__scopeNote mesh__D013317
% 218.76/218.94       Work-related situations in which the employees as a group refuse to work until certain conditions of employment are granted by the employer.%A%    
% 218.76/218.94  |- skos__broader mesh__D013317smesh__D007750
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D013317 2001
% 218.76/218.94  |- skos__annotation mesh__D013317 DF: STRIKES   
% 218.76/218.94  |- mesh__historyNote mesh__D013317 80   
% 218.76/218.94  |- skos__broader mesh__D013317smesh__D010559
% 218.76/218.94  |- skos__historyNote mesh__D013317 Labor Unions %28%1966-1970%29%
% 218.76/218.94  |- skos__prefLabel mesh__D013317 Strikes, Employee
% 218.76/218.94  |- skos__altLabel mesh__D013317 Employee Strikes
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D013317 2006
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D013317 2000
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D013317 1999
% 218.76/218.94  |- mesh__dateEstablished mesh__D013317 1980-01-01
% 218.76/218.94  |- mesh__publicMeSHNote mesh__D013317 80   
% 218.76/218.94  |- mesh__recordMaintainer mesh__D013317 KEV
% 218.76/218.94  |- mesh__dateCreated mesh__D013317 1979-04-11
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D013317 2005
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D013317 1998
% 218.76/218.94  |- mesh__recordAuthorizer mesh__D013317 PLS
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D013317 2004
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D013317 1997
% 218.76/218.94  |- skos__altLabel mesh__D013317 Strikes
% 218.76/218.94  |- skos__scopeNote mesh__D018800
% 218.76/218.94       A group of differentiation surface antigens, among the first to be discovered on thymocytes and T-lymphocytes. Originally identified in the mouse, they are also found in other species including humans, and are expressed on brain neurons and other cells.%A%    
% 218.76/218.94  |- skos__hiddenLabel mesh__D018800 Thy 1.2 Antigen
% 218.76/218.94  |- skos__broader mesh__D018800smesh__D015703
% 218.76/218.94  |- skos__hiddenLabel mesh__D018800 Antigens, Thy 1
% 218.76/218.94  |- skos__altLabel mesh__D018800 Antigens, CD90
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D018800 2006
% 218.76/218.94  |- mesh__dateEstablished mesh__D018800 1995-01-01
% 218.76/218.94  |- skos__broader mesh__D018800smesh__D000943
% 218.76/218.94  |- skos__altLabel mesh__D018800 Thy-1 Antigens
% 218.76/218.94  |- skos__historyNote mesh__D018800 Membrane Glycoproteins %28%1983-1994%29%
% 218.76/218.94  |- mesh__dateRevised mesh__D018800 2005-06-30
% 218.76/218.94  |- skos__prefLabel mesh__D018800 Antigens, Thy-1
% 218.76/218.94  |- skos__hiddenLabel mesh__D018800 Thy 1 Antigens
% 218.76/218.94  |- skos__altLabel mesh__D018800 CD90 Antigens
% 218.76/218.94  |- mesh__publicMeSHNote mesh__D018800
% 218.76/218.94       95; THY-1 ANTIGEN was indexed under MEMBRANE GLYCOPROTEINS 1983-94, ANTIGENS, SURFACE 1981-94, MEMBRANE PROTEINS 1979-82, %26% ANTIGENS 1979-80%A%  
% 218.76/218.94  |- skos__hiddenLabel mesh__D018800 Antigen, Thy-1.1
% 218.76/218.94  |- mesh__onlineNote mesh__D018800
% 218.76/218.94       use ANTIGENS, THY-1 %28%NM%29% to search THY-1 ANTIGEN 1979-94   
% 218.76/218.94  |- skos__broader mesh__D018800smesh__D008562
% 218.76/218.94  |- skos__hiddenLabel mesh__D018800 Thy 1.1 Antigen
% 218.76/218.94  |- mesh__historyNote mesh__D018800
% 218.76/218.94       95; was THY-1 ANTIGEN %28%NM%29% 1979-94   
% 218.76/218.94  |- rdf__type mesh__D018800sskos__Concept
% 218.76/218.94  |- skos__hiddenLabel mesh__D018800 Antigen, CD90
% 218.76/218.94  |- skos__annotation mesh__D018800
% 218.76/218.94       differentiation antigens; Thy stands for %22%THYmocyte%22%   
% 218.76/218.94  |- skos__historyNote mesh__D018800 Antigens %28%1979-1980%29%
% 218.76/218.94  |- skos__altLabel mesh__D018800 CD90 Antigen
% 218.76/218.94  |- skos__hiddenLabel mesh__D018800 Thy 1 Antigen
% 218.76/218.94  |- mesh__recordOriginator mesh__D018800 AGS
% 218.76/218.94  |- mesh__dateCreated mesh__D018800 1994-05-31
% 218.76/218.94  |- mesh__recordAuthorizer mesh__D018800 sjn
% 218.76/218.94  |- mesh__recordMaintainer mesh__D018800 ssb
% 218.76/218.94  |- skos__altLabel mesh__D018800 Thy-1 Antigen
% 218.76/218.94  |- skos__historyNote mesh__D018800 Antigens, Surface %28%1981-1994%29%
% 218.76/218.94  |- skos__historyNote mesh__D018800 Membrane Proteins %28%1979-1982%29%
% 218.76/218.94  |- skos__hiddenLabel mesh__D018800 Antigen, Thy-1.2
% 218.76/218.94  |- skos__hiddenLabel mesh__D018800 Antigen, Thy-1
% 218.76/218.94  |- skos__scopeNote mesh__D018002
% 218.76/218.94       Cell surface receptors that bind BRADYKININ and related KININS with high affinity and trigger intracellular changes which influence the behavior of cells. The identified receptor types %28%B-1 and B-2, or BK-1 and BK-2%29% recognize endogenous KALLIDIN; t-kinins; and certain bradykinin fragments as well as bradykinin itself.%A%    
% 218.76/218.94  |- mesh__recordMaintainer mesh__D018002 ags
% 218.76/218.94  |- skos__altLabel mesh__D018002 Bradykinin Receptors
% 218.76/218.94  |- mesh__recordOriginator mesh__D018002 RAZ
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D018002 2006
% 218.76/218.94  |- skos__prefLabel mesh__D018002 Receptors, Bradykinin
% 218.76/218.94  |- mesh__dateCreated mesh__D018002 1993-06-21
% 218.76/218.94  |- rdf__type mesh__D018002sskos__Concept
% 218.76/218.94  |- skos__broader mesh__D018002smesh__D043562
% 218.76/218.94  |- mesh__recordAuthorizer mesh__D018002 ags
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D018002 2005
% 218.76/218.94  |- skos__altLabel mesh__D018002 Bradykinin Receptor
% 218.76/218.94  |- skos__broader mesh__D018002smesh__D018013
% 218.76/218.94  |- skos__historyNote mesh__D018002
% 218.76/218.94       Receptors, Cell Surface %28%1980-1984%29%
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D018002 2004
% 218.76/218.94  |- mesh__historyNote mesh__D018002
% 218.76/218.94       94; was KININ RECEPTOR %28%NM%29% 1980-93   
% 218.76/218.94  |- mesh__publicMeSHNote mesh__D018002
% 218.76/218.94       94; KININ RECEPTORS was indexed under RECEPTORS, SYNAPTIC 1985-93 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1980-84%A%  
% 218.76/218.94  |- mesh__onlineNote mesh__D018002
% 218.76/218.94       use RECEPTORS, BRADYKININ %28%NM%29% to search RECEPTORS, KININ 1980-93%A%  
% 218.76/218.94  |- skos__historyNote mesh__D018002
% 218.76/218.94       Receptors, Neurotransmitter %28%1985-1993%29%
% 218.76/218.94  |- skos__hiddenLabel mesh__D018002 Receptor, Bradykinin
% 218.76/218.94  |- mesh__dateRevised mesh__D018002 2005-07-18
% 218.76/218.94  |- skos__annotation mesh__D018002
% 218.76/218.94       note specific subtypes; DF: RECEPT BRADYKININ   
% 218.76/218.94  |- mesh__dateEstablished mesh__D018002 1994-01-01
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D018002 2006A
% 218.76/218.94  |- skos__hiddenLabel mesh__D051436 Chronic Renal Insufficiencies
% 218.76/218.94  |- mesh__recordOriginator mesh__D051436 lkt
% 218.76/218.94  |- mesh__dateCreated mesh__D051436 2005-06-30
% 218.76/218.94  |- mesh__recordMaintainer mesh__D051436 lkt
% 218.76/218.94  |- skos__prefLabel mesh__D051436 Renal Insufficiency, Chronic
% 218.76/218.94  |- skos__historyNote mesh__D051436 Kidney Diseases %28%1965-1966%29%
% 218.76/218.94  |- skos__broader mesh__D051436smesh__D051437
% 218.76/218.94  |- mesh__recordAuthorizer mesh__D051436 sjn
% 218.76/218.94  |- mesh__dateEstablished mesh__D051436 2006-01-01
% 218.76/218.94  |- rdf__type mesh__D051436sskos__Concept
% 218.76/218.94  |- skos__historyNote mesh__D051436
% 218.76/218.94       Kidney Failure, Chronic %28%1966-2005%29%
% 218.76/218.94  |- skos__hiddenLabel mesh__D051436 Kidney Insufficiencies, Chronic
% 218.76/218.94  |- skos__scopeNote mesh__D051436
% 218.76/218.94       Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage %28%as measured by the level of PROTEINURIA%29%. The most severe form is the end-stage renal disease %28%CHRONIC KIDNEY FAILURE%29%. %28%Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002%29%%A%    
% 218.76/218.94  |- skos__hiddenLabel mesh__D051436 Renal Insufficiencies, Chronic
% 218.76/218.94  |- skos__altLabel mesh__D051436 Chronic Renal Insufficiency
% 218.76/218.94  |- skos__hiddenLabel mesh__D051436 Chronic Kidney Insufficiencies
% 218.76/218.94  |- mesh__publicMeSHNote mesh__D051436
% 218.76/218.94       2006; see KIDNEY FAILURE, CHRONIC 1993-2005   
% 218.76/218.94  |- mesh__historyNote mesh__D051436
% 218.76/218.94       2006; use KIDNEY FAILURE, CHRONIC 1993-2005   
% 218.76/218.94  |- skos__altLabel mesh__D051436 Chronic Kidney Insufficiency
% 218.76/218.94  |- skos__altLabel mesh__D051436 Kidney Insufficiency, Chronic
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D051436 2006
% 218.76/218.94  |- skos__broader mesh__D005123Q000002smesh__D005123
% 218.76/218.94  |- mesh__preferredCombination mesh__D005123Q000002smesh__D005124
% 218.76/218.94  |- rdf__type mesh__D005123Q000002smesh__CompoundConcept
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D009276 2003
% 218.76/218.94  |- skos__historyNote mesh__D009276 South Africa %28%1966-1974%29%
% 218.76/218.94  |- rdf__type mesh__D009276sskos__Concept
% 218.76/218.94  |- skos__prefLabel mesh__D009276 Namibia
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D009276 2004
% 218.76/218.94  |- skos__historyNote mesh__D009276 Africa, Southern %28%1966-1977%29%
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D009276 2005
% 218.76/218.94  |- mesh__dateRevised mesh__D009276 1995-02-21
% 218.76/218.94  |- mesh__recordOriginator mesh__D009276 AEP
% 218.76/218.94  |- skos__altLabel mesh__D009276 Southwest Africa
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D009276 2002
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D009276 2006
% 218.76/218.94  |- skos__scopeNote mesh__D009276
% 218.76/218.94       A republic in southern Africa, south of ANGOLA and west of BOTSWANA. Its capital is Windhoek. It was a region not much visited before the middle of the 19th century although the Portuguese landed at one of its harbors in 1486. Namibia was annexed by Germany in 1885. As the former German colony of South West Africa, it was mandated to South Africa 1920-1966, and made a direct dependent of the United Nations 1966. Its name was changed from South West Africa to Namibia in 1968. The name is from Nama, the Hottentot people who inhabit it; its origin is unknown. %28%From Webster%27%s New Geographical Dictionary, 1988, p1144 %26% Room, Brewer%27%s Dictionary of Names, 1992, p369%29%%A%    
% 218.76/218.94  |- mesh__recordMaintainer mesh__D009276 TGC
% 218.76/218.94  |- mesh__historyNote mesh__D009276 78   
% 218.76/218.94  |- skos__broader mesh__D009276smesh__D000353
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D009276 1996
% 218.76/218.94  |- skos__annotation mesh__D009276 a republic in southern Africa   
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D009276 2000
% 218.76/218.94  |- mesh__dateCreated mesh__D009276 1977-05-13
% 218.76/218.94  |- mesh__dateEstablished mesh__D009276 1978-01-01
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D009276 1997
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D009276 1998
% 218.76/218.94  |- skos__altLabel mesh__D009276 South West Africa
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D009276 2001
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D009276 1999
% 218.76/218.94  |- mesh__recordAuthorizer mesh__D009276 PLS
% 218.76/218.94  |- skos__broader mesh__D001293smesh__D003695
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D001293 2005
% 218.76/218.94  |- mesh__recordMaintainer mesh__D001293 jls
% 218.76/218.94  |- mesh__historyNote mesh__D001293 74   
% 218.76/218.94  |- mesh__dateCreated mesh__D001293 1999-01-01
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D001293 2003
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D001293 2006
% 218.76/218.94  |- skos__hiddenLabel mesh__D001293 Death, Attitudes to
% 218.76/218.94  |- skos__broader mesh__D001293smesh__D001290
% 218.76/218.94  |- skos__prefLabel mesh__D001293 Attitude to Death
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D001293 2004
% 218.76/218.94  |- mesh__dateEstablished mesh__D001293 1974-01-01
% 218.76/218.94  |- rdf__type mesh__D001293sskos__Concept
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D001293 2000
% 218.76/218.94  |- mesh__dateRevised mesh__D001293 1999-11-03
% 218.76/218.94  |- skos__hiddenLabel mesh__D001293 Death, Attitude to
% 218.76/218.94  |- skos__altLabel mesh__D001293 Attitudes to Death
% 218.76/218.94  |- mesh__recordAuthorizer mesh__D001293 sjn
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D001293 2001
% 218.76/218.94  |- mesh__recordOriginator mesh__D001293 NLM
% 218.76/218.94  |- skos__scopeNote mesh__D001293
% 218.76/218.94       Conceptual response of the person to the various aspects of death, which are based on individual psychosocial and cultural experience.%A%    
% 218.76/218.94  |- mesh__publicMeSHNote mesh__D001293 74   
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D001293 2002
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017708 2001
% 218.76/218.94  |- skos__historyNote mesh__D017708 Blood Transfusion %28%1966-1992%29%
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017708 1995
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017708 2006
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017708 1996
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017708 2002
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017708 1997
% 218.76/218.94  |- skos__related mesh__D017708smesh__D017710
% 218.76/218.94  |- skos__historyNote mesh__D017708
% 218.76/218.94       Leukocytes/transplantation %28%1973-1992%29%
% 218.76/218.94  |- skos__altLabel mesh__D017708 White Blood Cell Transfusions
% 218.76/218.94  |- skos__annotation mesh__D017708
% 218.76/218.94       do not use /util except by MeSH definition; coord IM with specific leukocyte %28%NIM%29% but LYMPHOCYTE TRANSFUSION is available; for transfusion back to donor, coord IM with BLOOD TRANSFUSION, AUTOLOGOUS %28%NIM%29%%A%  
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017708 2003
% 218.76/218.94  |- skos__historyNote mesh__D017708 Leukocytes %28%1966-1976%29%
% 218.76/218.94  |- skos__hiddenLabel mesh__D017708 Transfusion, Leukocyte
% 218.76/218.94  |- skos__prefLabel mesh__D017708 Leukocyte Transfusion
% 218.76/218.94  |- mesh__historyNote mesh__D017708
% 218.76/218.94       94; was see BLOOD COMPONENT TRANSFUSION 1992-93   
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017708 1998
% 218.76/218.94  |- skos__scopeNote mesh__D017708
% 218.76/218.94       The transfer of leukocytes from a donor to a recipient or reinfusion to the donor.%A%    
% 218.76/218.94  |- skos__hiddenLabel mesh__D017708 Leukocyte Transfusions
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017708 2004
% 218.76/218.94  |- skos__historyNote mesh__D017708
% 218.76/218.94       Blood Component Transfusion %28%1992-1993%29%
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017708 1999
% 218.76/218.94  |- skos__broader mesh__D017708smesh__D016913
% 218.76/218.94  |- skos__altLabel mesh__D017708 White Blood Cell Transfusion
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017708 2000
% 218.76/218.94  |- mesh__dateEstablished mesh__D017708 1994-01-01
% 218.76/218.94  |- mesh__dateCreated mesh__D017708 1992-12-28
% 218.76/218.94  |- skos__altLabel mesh__D017708 Transfusions, White Blood Cell
% 218.76/218.94  |- rdf__type mesh__D017708sskos__Concept
% 218.76/218.94  |- skos__hiddenLabel mesh__D017708 Transfusions, Leukocyte
% 218.76/218.94  |- skos__altLabel mesh__D017708 Transfusion, White Blood Cell
% 218.76/218.94  |- mesh__publicMeSHNote mesh__D017708
% 218.76/218.94       94; was see BLOOD COMPONENT TRANSFUSION 1992-93   
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017708 1994
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D017708 2005
% 218.76/218.94  |- mesh__onlineNote mesh__D017708
% 218.76/218.94       use BLOOD COMPONENT TRANSFUSION to search LEUKOCYTE TRANSFUSION 1992-93%A%  
% 218.76/218.94  |- skos__scopeNote mesh__D042101
% 218.76/218.94       Inflammation of the GALLBLADDER wall in the absence of GALLSTONES.%A%    
% 218.76/218.94  |- skos__historyNote mesh__D042101 Cholecystitis %28%1966-2003%29%
% 218.76/218.94  |- mesh__publicMeSHNote mesh__D042101 2004   
% 218.76/218.94  |- skos__altLabel mesh__D042101 Acalculous Gallbladder Inflammation
% 218.76/218.94  |- skos__prefLabel mesh__D042101 Acalculous Cholecystitis
% 218.76/218.94  |- skos__altLabel mesh__D042101 Gallbladder Inflammation, Acalculous
% 218.76/218.94  |- mesh__dateEstablished mesh__D042101 2004-01-01
% 218.76/218.94  |- skos__altLabel mesh__D042101 Cholecystitis, Acalculous
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D042101 2006
% 218.76/218.94  |- rdf__type mesh__D042101sskos__Concept
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D042101 2004
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D042101 2005
% 218.76/218.94  |- mesh__dateCreated mesh__D042101 2003-07-09
% 218.76/218.94  |- mesh__historyNote mesh__D042101 2004   
% 218.76/218.94  |- skos__broader mesh__D042101smesh__D002764
% 218.76/218.94  |- skos__altLabel mesh__D014410 Colony Forming Units Assay, Tumor
% 218.76/218.94  |- skos__broader mesh__D014410smesh__D004354
% 218.76/218.94  |- mesh__recordAuthorizer mesh__D014410 sjn
% 218.76/218.94  |- skos__annotation mesh__D014410
% 218.76/218.94       coord IM with histol type of neopl + precoord organ/neopl term %28%IM or NIM%29% if pertinent; DF: TCFU ASSAY%A%  
% 218.76/218.94  |- mesh__dateRevised mesh__D014410 2000-06-22
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D014410 2003
% 218.76/218.94  |- mesh__recordOriginator mesh__D014410 AEP
% 218.76/218.94  |- skos__broader mesh__D014410smesh__D003114
% 218.76/218.94  |- mesh__dateCreated mesh__D014410 1983-04-04
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D014410 2001
% 218.76/218.94  |- skos__altLabel mesh__D014410 Colony-Forming Units Assay, Tumor
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D014410 2006
% 218.76/218.94  |- mesh__recordMaintainer mesh__D014410 TPW
% 218.76/218.94  |- skos__historyNote mesh__D014410
% 218.76/218.94       Colony-Forming Units Assay %28%1979-1983%29%
% 218.76/218.94  |- skos__altLabel mesh__D014410 Neoplasm Stem Cell Assay
% 218.76/218.94  |- skos__scopeNote mesh__D014410
% 218.76/218.94       A cytologic technique for measuring the functional capacity of tumor stem cells by assaying their activity. It is used primarily for the in vitro testing of antineoplastic agents.%A%    
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D014410 2005
% 218.76/218.94  |- mesh__dateEstablished mesh__D014410 1991-01-01
% 218.76/218.94  |- skos__altLabel mesh__D014410 Clonogenic Cell Assay, Tumor
% 218.76/218.94  |- mesh__historyNote mesh__D014410
% 218.76/218.94       91%28%84%29%; was see under COLONY-FORMING UNITS ASSAY 1984-90   
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D014410 2002
% 218.76/218.94  |- skos__historyNote mesh__D014410 specific neoplasm %28%1972-1983%29%
% 218.76/218.94  |- skos__altLabel mesh__D014410 Stem Cell Assay, Tumor
% 218.76/218.94  |- mesh__publicMeSHNote mesh__D014410
% 218.76/218.94       91; was see under COLONY-FORMING UNITS ASSAY 1984-90   
% 218.76/218.94  |- skos__prefLabel mesh__D014410 Tumor Stem Cell Assay
% 218.76/218.94  |- rdf__type mesh__D014410sskos__Concept
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D014410 2004
% 218.76/218.94  |- mesh__recordOriginator mesh__D000999 NLM
% 218.76/218.94  |- rdf__type mesh__D000999sskos__Concept
% 218.76/218.94  |- skos__annotation mesh__D000999
% 218.76/218.94       a type of horn, on males of the deer family   
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D000999 2006
% 218.76/218.94  |- mesh__recordMaintainer mesh__D000999 TGC
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D000999 2002
% 218.76/218.94  |- skos__scopeNote mesh__D000999
% 218.76/218.94       The horn of an animal of the deer family, typically present only in the male. It differs from the HORNS of other animals in being a solid, generally branched bony outgrowth that is shed and renewed annually. The word antler comes from the Latin anteocularis, ante %28%before%29% + oculus %28%eye%29%. %28%From Webster, 3d ed%29%%A%    
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D000999 2004
% 218.76/218.94  |- mesh__dateRevised mesh__D000999 1995-03-13
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D000999 1999
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D000999 2005
% 218.76/218.94  |- mesh__activeMeSHYear mesh__D000999 1997
% 218.76/218.94  |- mesh__publicMeSHNote mesh__D000999 91; was see under HORNS 1975-90   
% 218.76/218.95  |- mesh__dateEstablished mesh__D000999 1991-01-01
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D000999 2003
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D000999 1998
% 218.76/218.95  |- mesh__recordAuthorizer mesh__D000999 PLS
% 218.76/218.95  |- mesh__onlineNote mesh__D000999 search HORNS 1968-74   
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D000999 1996
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D000999 2001
% 218.76/218.95  |- mesh__dateCreated mesh__D000999 1999-01-01
% 218.76/218.95  |- skos__hiddenLabel mesh__D000999 Antler
% 218.76/218.95  |- skos__broader mesh__D000999smesh__D006733
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D000999 2000
% 218.76/218.95  |- skos__prefLabel mesh__D000999 Antlers
% 218.76/218.95  |- mesh__historyNote mesh__D000999
% 218.76/218.95       91%28%75%29%; was see under HORNS 1975-90   
% 218.76/218.95  |- mesh__recordMaintainer mesh__D005684 nns
% 218.76/218.95  |- skos__broader mesh__D005684smesh__D009068
% 218.76/218.95  |- mesh__recordOriginator mesh__D005684 NLM
% 218.76/218.95  |- mesh__dateCreated mesh__D005684 1999-01-01
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D005684 2005
% 218.76/218.95  |- rdf__type mesh__D005684sskos__Concept
% 218.76/218.95  |- mesh__recordAuthorizer mesh__D005684 sjn
% 218.76/218.95  |- skos__broader mesh__D005684smesh__D010808
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D005684 2006
% 218.76/218.95  |- skos__prefLabel mesh__D005684 Gait
% 218.76/218.95  |- skos__hiddenLabel mesh__D005684 Gaits
% 218.76/218.95  |- skos__scopeNote mesh__D005684 Manner or style of walking.     
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D005684 2004
% 218.76/218.95  |- mesh__dateRevised mesh__D005684 2003-07-09
% 218.76/218.95  |- skos__annotation mesh__D005684
% 218.76/218.95       differentiate from LOCOMOTION %26% WALKING: gait is the way one locomotes or walks%A%  
% 218.76/218.95  |- skos__hiddenLabel mesh__D013318 Ventricular Ejection Fractions
% 218.76/218.95  |- skos__hiddenLabel mesh__D013318 Volume, Ventricular End-Diastolic
% 218.76/218.95  |- skos__hiddenLabel mesh__D013318 Ventricular End Systolic Volume
% 218.76/218.95  |- skos__hiddenLabel mesh__D013318 Ventricular End-Systolic Volumes
% 218.76/218.95  |- skos__hiddenLabel mesh__D013318 Volumes, Ventricular End-Systolic
% 218.76/218.95  |- mesh__recordMaintainer mesh__D013318 nns
% 218.76/218.95  |- mesh__publicMeSHNote mesh__D013318
% 218.76/218.95       86; was see under CARDIAC OUTPUT 1979-85; was see CARDIAC OUTPUT 1974-78%A%  
% 218.76/218.95  |- mesh__dateRevised mesh__D013318 2003-07-09
% 218.76/218.95  |- mesh__historyNote mesh__D013318
% 218.76/218.95       86%28%79%29%; was see under CARDIAC OUTPUT 1979-85; was see CARDIAC OUTPUT 1974-78%A%  
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D013318 2006
% 218.76/218.95  |- skos__hiddenLabel mesh__D013318 Ventricular End Diastolic Volume
% 218.76/218.95  |- skos__hiddenLabel mesh__D013318 Fraction, Ventricular Ejection
% 218.76/218.95  |- skos__hiddenLabel mesh__D013318 End-Diastolic Volume, Ventricular
% 218.76/218.95  |- skos__scopeNote mesh__D013318
% 218.76/218.95       The amount of BLOOD pumped out of the HEART per beat not to be confused with cardiac output %28%volume/time%29%.%A%    
% 218.76/218.95  |- skos__broader mesh__D013318smesh__D002302
% 218.76/218.95  |- skos__hiddenLabel mesh__D013318 Ventricular End-Diastolic Volumes
% 218.76/218.95  |- skos__hiddenLabel mesh__D013318 End-Diastolic Volumes, Ventricular
% 218.76/218.95  |- skos__hiddenLabel mesh__D013318 End-Systolic Volumes, Ventricular
% 218.76/218.95  |- skos__historyNote mesh__D013318 Cardiac Output %28%1966-1978%29%
% 218.76/218.95  |- mesh__dateEstablished mesh__D013318 1986-01-01
% 218.76/218.95  |- skos__hiddenLabel mesh__D013318 Ejection Fractions, Ventricular
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D013318 2005
% 218.76/218.95  |- skos__hiddenLabel mesh__D013318 Ejection Fraction, Ventricular
% 218.76/218.95  |- skos__hiddenLabel mesh__D013318 Volumes, Ventricular End-Diastolic
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D013318 2004
% 218.76/218.95  |- skos__hiddenLabel mesh__D013318 Stroke Volumes
% 218.76/218.95  |- mesh__recordAuthorizer mesh__D013318 sjn
% 218.76/218.95  |- skos__prefLabel mesh__D013318 Stroke Volume
% 218.76/218.95  |- mesh__dateCreated mesh__D013318 1978-03-10
% 218.76/218.95  |- skos__hiddenLabel mesh__D013318 End-Systolic Volume, Ventricular
% 218.76/218.95  |- skos__hiddenLabel mesh__D013318 Volume, Stroke
% 218.76/218.95  |- skos__hiddenLabel mesh__D013318 Fractions, Ventricular Ejection
% 218.76/218.95  |- rdf__type mesh__D013318sskos__Concept
% 218.76/218.95  |- mesh__onlineNote mesh__D013318 search CARDIAC OUTPUT 1974-78   
% 218.76/218.95  |- skos__hiddenLabel mesh__D013318 Volume, Ventricular End-Systolic
% 218.76/218.95  |- mesh__recordOriginator mesh__D013318 VDK
% 218.76/218.95  |- skos__hiddenLabel mesh__D013318 Volumes, Stroke
% 218.76/218.95  |- skos__hiddenLabel mesh__D018801 Erythrocyte-Binding Glycoprotein, T11
% 218.76/218.95  |- skos__hiddenLabel mesh__D018801 Antigen, CD2
% 218.76/218.95  |- skos__historyNote mesh__D018801 Carrier Proteins %28%1985-1988%29%
% 218.76/218.95  |- mesh__publicMeSHNote mesh__D018801
% 218.76/218.95       95; T11 ERYTHROCYTE-BINDING GLYCOPROTEIN was indexed under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE %26% RECEPTORS, IMMUNOLOGIC 1989-94, ANTIGENS, DIFFERENTIATION 1988, %26% CARRIER PROTEINS 1985-88%A%  
% 218.76/218.95  |- skos__historyNote mesh__D018801 Antigens, Differentiation %28%1988%29%
% 218.76/218.95  |- mesh__recordAuthorizer mesh__D018801 sjn
% 218.76/218.95  |- skos__altLabel mesh__D018801 CD2 Antigens
% 218.76/218.95  |- skos__hiddenLabel mesh__D018801 T11 Erythrocyte Binding Glycoprotein
% 218.76/218.95  |- skos__prefLabel mesh__D018801 Antigens, CD2
% 218.76/218.95  |- skos__historyNote mesh__D018801
% 218.76/218.95       Antigens, Differentiation, T-Lymphocyte %28%1989-1994%29%
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D018801 2006
% 218.76/218.95  |- skos__altLabel mesh__D018801 CD2 Antigen
% 218.76/218.95  |- skos__annotation mesh__D018801 T-lymphocyte differentiation antigens   
% 218.76/218.95  |- mesh__historyNote mesh__D018801
% 218.76/218.95       95; was T11 ERYTHROCYTE-BINDING GLYCOPROTEIN %28%NM%29% 1985-94%A%  
% 218.76/218.95  |- mesh__recordOriginator mesh__D018801 AGS
% 218.76/218.95  |- skos__scopeNote mesh__D018801
% 218.76/218.95       Glycoprotein members of the immunoglobulin superfamily which participate in T-cell adhesion and activation. They are expressed on most peripheral T-lymphocytes, natural killer cells, and thymocytes, and function as co-receptors or accessory molecules in the T-cell receptor complex.%A%    
% 218.76/218.95  |- mesh__dateCreated mesh__D018801 1994-05-27
% 218.76/218.95  |- mesh__dateRevised mesh__D018801 2005-06-30
% 218.76/218.95  |- skos__broader mesh__D018801smesh__D015703
% 218.76/218.95  |- skos__altLabel mesh__D018801 T11 Erythrocyte-Binding Glycoprotein
% 218.76/218.95  |- mesh__dateEstablished mesh__D018801 1995-01-01
% 218.76/218.95  |- rdf__type mesh__D018801sskos__Concept
% 218.76/218.95  |- mesh__recordMaintainer mesh__D018801 ssb
% 218.76/218.95  |- mesh__onlineNote mesh__D018801
% 218.76/218.95       use ANTIGENS, CD2 %28%NM%29% to search T11 ERYTHROCYTE-BINDING GLYCOPROTEIN 1985-94%A%  
% 218.76/218.95  |- skos__historyNote mesh__D018801 Receptors, Immunologic %28%1989-1994%29%
% 218.76/218.95  |- skos__broader mesh__D018801smesh__D000945
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D018003 2005
% 218.76/218.95  |- mesh__dateEstablished mesh__D018003 1994-01-01
% 218.76/218.95  |- rdf__type mesh__D018003sskos__Concept
% 218.76/218.95  |- skos__broader mesh__D018003smesh__D043562
% 218.76/218.95  |- skos__annotation mesh__D018003 DF: RECEPT CALCITONIN   
% 218.76/218.95  |- mesh__recordMaintainer mesh__D018003 jmp
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D018003 2004
% 218.76/218.95  |- skos__altLabel mesh__D018003 Calcitonin Receptor
% 218.76/218.95  |- skos__historyNote mesh__D018003
% 218.76/218.95       Receptors, Cell Surface %28%1974-1993%29%
% 218.76/218.95  |- skos__broader mesh__D018003smesh__D018000
% 218.76/218.95  |- skos__scopeNote mesh__D018003
% 218.76/218.95       Cell surface proteins that bind calcitonin and trigger intracellular changes which influence the behavior of cells. Calcitonin receptors outside the nervous system mediate the role of calcitonin in calcium homeostasis. The role of calcitonin receptors in the brain is not well understood.%A%    
% 218.76/218.95  |- mesh__historyNote mesh__D018003
% 218.76/218.95       94; was CALCITONIN RECEPTOR %28%NM%29% 1981-93   
% 218.76/218.95  |- mesh__onlineNote mesh__D018003
% 218.76/218.95       use RECEPTORS, CALCITONIN %28%NM%29% to search CALCITONIN RECEPTOR 1981-93%A%  
% 218.76/218.95  |- mesh__recordOriginator mesh__D018003 RAZ
% 218.76/218.95  |- skos__altLabel mesh__D018003 Calcitonin Receptors
% 218.76/218.95  |- mesh__dateCreated mesh__D018003 1993-06-21
% 218.76/218.95  |- skos__broader mesh__D018003smesh__D018013
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D018003 2006
% 218.76/218.95  |- skos__hiddenLabel mesh__D018003 Receptor, Calcitonin
% 218.76/218.95  |- mesh__recordAuthorizer mesh__D018003 sjn
% 218.76/218.95  |- mesh__dateRevised mesh__D018003 2003-07-09
% 218.76/218.95  |- mesh__publicMeSHNote mesh__D018003
% 218.76/218.95       94; CALCITONIN RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-93%A%  
% 218.76/218.95  |- skos__prefLabel mesh__D018003 Receptors, Calcitonin
% 218.76/218.95  |- skos__broader mesh__D010020smesh__D001847
% 218.76/218.95  |- mesh__dateRevised mesh__D010020 2005-06-30
% 218.76/218.95  |- mesh__historyNote mesh__D010020
% 218.76/218.95       1977; for KIENBOCK DISEASE, use OSTEOCHONDRITIS 1963-2002%A%  
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D010020 2006
% 218.76/218.95  |- skos__historyNote mesh__D010020 Bone Diseases %28%1966-1976%29%
% 218.76/218.95  |- mesh__dateCreated mesh__D010020 1976-04-16
% 218.76/218.95  |- skos__altLabel mesh__D010020 Aseptic Necrosis of Bone
% 218.76/218.95  |- skos__altLabel mesh__D010020 Kienboeck Disease
% 218.76/218.95  |- skos__prefLabel mesh__D010020 Osteonecrosis
% 218.76/218.95  |- skos__scopeNote mesh__D010020
% 218.76/218.95       Death of a bone or part of a bone, either atraumatic or posttraumatic.%A%    
% 218.76/218.95  |- mesh__publicMeSHNote mesh__D010020
% 218.76/218.95       1977; for KIENBOCK DISEASE, see OSTEOCHONDRITIS 1963-2002%A%  
% 218.76/218.95  |- skos__altLabel mesh__D010020 Avascular Necrosis of Bone
% 218.76/218.95  |- skos__broader mesh__D010020smesh__D009336
% 218.76/218.95  |- skos__hiddenLabel mesh__D010020 Kienboecks Disease
% 218.76/218.95  |- mesh__recordMaintainer mesh__D010020 ags
% 218.76/218.95  |- skos__annotation mesh__D010020
% 218.76/218.95       OSTEORADIONECROSIS %26% FEMUR HEAD NECROSIS are available   
% 218.76/218.95  |- mesh__dateEstablished mesh__D010020 1977-01-01
% 218.76/218.95  |- skos__altLabel mesh__D010020 Kienbock%27%s Disease
% 218.76/218.95  |- rdf__type mesh__D010020sskos__Concept
% 218.76/218.95  |- skos__altLabel mesh__D010020 Kienboeck%27%s Disease
% 218.76/218.95  |- mesh__recordOriginator mesh__D010020 MM
% 218.76/218.95  |- skos__hiddenLabel mesh__D010020 Bone Aseptic Necrosis
% 218.76/218.95  |- skos__hiddenLabel mesh__D010020 Bone Avascular Necrosis
% 218.76/218.95  |- mesh__recordAuthorizer mesh__D010020 sjn
% 218.76/218.95  |- skos__historyNote mesh__D010020 Necrosis %28%1966-1976%29%
% 218.76/218.95  |- skos__hiddenLabel mesh__D010020 Osteonecroses
% 218.76/218.95  |- skos__scopeNote mesh__D051437
% 218.76/218.95       Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage %28%as measured by the level of PROTEINURIA%29% and reduction in GLOMERULAR FILTRATION RATE. The most severe form is KIDNEY FAILURE. Renal function may deteriorate slowly %28%RENAL INSUFFICIENCY, CHRONIC%29% or precipitously %28%RENAL INSUFFICIENCY, ACUTE%29%.%A%    
% 218.76/218.95  |- skos__annotation mesh__D051437
% 218.76/218.95       RENAL INSUFFICIENCY, ACUTE; RENAL INSUFFICIENCY, CHRONIC; and RENAL FAILURE are also available%A%  
% 218.76/218.95  |- skos__hiddenLabel mesh__D051437 Insufficiency, Kidney
% 218.76/218.95  |- mesh__publicMeSHNote mesh__D051437 2006; see KIDNEY FAILURE 1993-2005   
% 218.76/218.95  |- mesh__historyNote mesh__D051437 2006; use KIDNEY FAILURE 1993-2005   
% 218.76/218.95  |- skos__prefLabel mesh__D051437 Renal Insufficiency
% 218.76/218.95  |- skos__hiddenLabel mesh__D051437 Renal Insufficiencies
% 218.76/218.95  |- mesh__dateCreated mesh__D051437 2005-06-30
% 218.76/218.95  |- skos__broader mesh__D051437smesh__D007674
% 218.76/218.95  |- rdf__type mesh__D051437sskos__Concept
% 218.76/218.95  |- mesh__recordMaintainer mesh__D051437 lkt
% 218.76/218.95  |- skos__historyNote mesh__D051437 Kidney Failure %28%1992-2005%29%
% 218.76/218.95  |- skos__hiddenLabel mesh__D051437 Kidney Insufficiencies
% 218.76/218.95  |- mesh__recordAuthorizer mesh__D051437 sjn
% 218.76/218.95  |- mesh__dateEstablished mesh__D051437 2006-01-01
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D051437 2006
% 218.76/218.95  |- mesh__recordOriginator mesh__D051437 lkt
% 218.76/218.95  |- skos__altLabel mesh__D051437 Kidney Insufficiency
% 218.76/218.95  |- skos__historyNote mesh__D051437 Kidney Diseases %28%1965-1992%29%
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D009277 2005
% 218.76/218.95  |- mesh__dateRevised mesh__D009277 2003-07-09
% 218.76/218.95  |- skos__scopeNote mesh__D009277
% 218.76/218.95       C18 steroid with androgenic and anabolic properties. It is generally prepared from alkyl ethers of ESTRADIOL to resemble TESTOSTERONE but less one carbon at the 19 position.%A%    
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D009277 2006
% 218.76/218.95  |- skos__broader mesh__D009277smesh__D004963
% 218.76/218.95  |- mesh__historyNote mesh__D009277 65; was NORTESTOSTERONE 1963-64   
% 218.76/218.95  |- skos__altLabel mesh__D009277 19-Nortestosterone
% 218.76/218.95  |- mesh__publicMeSHNote mesh__D009277 65; was NORTESTOSTERONE 1963-64   
% 218.76/218.95  |- mesh__dateEstablished mesh__D009277 1965-01-01
% 218.76/218.95  |- skos__altLabel mesh__D009277 Estrenolone
% 218.76/218.95  |- mesh__recordAuthorizer mesh__D009277 sjn
% 218.76/218.95  |- skos__prefLabel mesh__D009277 Nandrolone
% 218.76/218.95  |- skos__hiddenLabel mesh__D009277 17beta Hydroxy 19 Nor 4 Androsten 3 One
% 218.76/218.95  |- skos__altLabel mesh__D009277 17beta-Hydroxy-19-Nor-4-Androsten-3-One
% 218.76/218.95  |- skos__broader mesh__D009277smesh__D045165
% 218.76/218.95  |- rdf__type mesh__D009277sskos__Concept
% 218.76/218.95  |- mesh__dateCreated mesh__D009277 1999-01-01
% 218.76/218.95  |- skos__altLabel mesh__D009277 17-Hydroxy-Estr-4-Ene-3-One
% 218.76/218.95  |- mesh__recordOriginator mesh__D009277 NLM
% 218.76/218.95  |- skos__altLabel mesh__D009277 Norandrostenolone
% 218.76/218.95  |- mesh__recordMaintainer mesh__D009277 lkt
% 218.76/218.95  |- skos__altLabel mesh__D009277 Nortestosterone
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D009277 2004
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D001294 2004
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D001294 2001
% 218.76/218.95  |- skos__related mesh__D001294smesh__D012803
% 218.76/218.95  |- mesh__historyNote mesh__D001294 68   
% 218.76/218.95  |- mesh__recordMaintainer mesh__D001294 JLS
% 218.76/218.95  |- skos__hiddenLabel mesh__D001294 Health, Attitude to
% 218.76/218.95  |- rdf__type mesh__D001294sskos__Concept
% 218.76/218.95  |- mesh__recordOriginator mesh__D001294 NLM
% 218.76/218.95  |- skos__scopeNote mesh__D001294
% 218.76/218.95       Public attitudes toward health, disease, and the medical care system.%A%    
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D001294 2002
% 218.76/218.95  |- mesh__dateEstablished mesh__D001294 1968-01-01
% 218.76/218.95  |- skos__altLabel mesh__D001294 Health Attitude
% 218.76/218.95  |- mesh__publicMeSHNote mesh__D001294 68   
% 218.76/218.95  |- skos__prefLabel mesh__D001294 Attitude to Health
% 218.76/218.95  |- skos__historyNote mesh__D001294 Attitude %28%1966-1967%29%
% 218.76/218.95  |- skos__broader mesh__D001294smesh__D001290
% 218.76/218.95  |- skos__hiddenLabel mesh__D001294 Health Attitudes
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D001294 2005
% 218.76/218.95  |- skos__annotation mesh__D001294 includes attitude to disease   
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D001294 1998
% 218.76/218.95  |- skos__hiddenLabel mesh__D001294 Attitudes, Health
% 218.76/218.95  |- mesh__dateRevised mesh__D001294 1997-06-20
% 218.76/218.95  |- mesh__recordAuthorizer mesh__D001294 SJN
% 218.76/218.95  |- skos__broader mesh__D001294smesh__D003695
% 218.76/218.95  |- skos__hiddenLabel mesh__D001294 Attitude, Health
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D001294 2006
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D001294 2003
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D001294 1999
% 218.76/218.95  |- mesh__dateCreated mesh__D001294 1999-01-01
% 218.76/218.95  |- skos__related mesh__D001294smesh__D010352
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D001294 2000
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D017709 1994
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D017709 1998
% 218.76/218.95  |- skos__broader mesh__D017709smesh__D008433
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D017709 2001
% 218.76/218.95  |- skos__related mesh__D017709smesh__D017711
% 218.76/218.95  |- mesh__publicMeSHNote mesh__D017709 94   
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D017709 1997
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D017709 2006
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D017709 2000
% 218.76/218.95  |- skos__prefLabel mesh__D017709 Fractals
% 218.76/218.95  |- skos__scopeNote mesh__D017709
% 218.76/218.95       Patterns %28%real or mathematical%29% which look similar at different scales, for example the network of airways in the lung which shows similar branching patterns at progressively higher magnifications. Natural fractals are self-similar across a finite range of scales while mathematical fractals are the same across an infinite range. Many natural, including biological, structures are fractal %28%or fractal-like%29%. Fractals are related to %22%chaos%22% %28%see NONLINEAR DYNAMICS%29% in that chaotic processes can produce fractal structures in nature, and appropriate representations of chaotic processes usually reveal self-similarity over time.%A%    
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D017709 1996
% 218.76/218.95  |- mesh__dateEstablished mesh__D017709 1994-01-01
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D017709 2005
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D017709 2004
% 218.76/218.95  |- skos__broader mesh__D017709smesh__D008962
% 218.76/218.95  |- skos__hiddenLabel mesh__D017709 Fractal
% 218.76/218.95  |- mesh__dateCreated mesh__D017709 1992-12-28
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D017709 1995
% 218.76/218.95  |- skos__annotation mesh__D017709
% 218.76/218.95       patterns which look similar at different magnifications; used in math %26% theoret models%A%  
% 218.76/218.95  |- mesh__historyNote mesh__D017709 94   
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D017709 2003
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D017709 1999
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D017709 2002
% 218.76/218.95  |- rdf__type mesh__D017709sskos__Concept
% 218.76/218.95  |- skos__historyNote mesh__D014411 Neoplasms/pathology %28%1975-1983%29%
% 218.76/218.95  |- skos__broader mesh__D014411smesh__D013234
% 218.76/218.95  |- skos__hiddenLabel mesh__D014411 Unit, Neoplastic Colony-Forming
% 218.76/218.95  |- mesh__recordOriginator mesh__D014411 AEP
% 218.76/218.95  |- mesh__historyNote mesh__D014411
% 218.76/218.95       86%28%84%29%; was see under STEM CELLS 1984-85; EC CELLS was see TUMOR STEM CELLS 1986-96%A%  
% 218.76/218.95  |- skos__hiddenLabel mesh__D014411 Cells, Embryonal Carcinoma
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D014411 2003
% 218.76/218.95  |- mesh__dateEstablished mesh__D014411 1986-01-01
% 218.76/218.95  |- skos__historyNote mesh__D014411 Clone Cells %28%1975-1983%29%
% 218.76/218.95  |- skos__historyNote mesh__D014411 Cell Line %28%1969-1985%29%
% 218.76/218.95  |- skos__hiddenLabel mesh__D014411 Carcinoma Cell, Embryonal
% 218.76/218.95  |- mesh__dateRevised mesh__D014411 1996-06-10
% 218.76/218.95  |- mesh__recordAuthorizer mesh__D014411 PLS
% 218.76/218.95  |- skos__historyNote mesh__D014411
% 218.76/218.95       Neoplasms, Experimental %28%1975-1983%29%
% 218.76/218.95  |- skos__hiddenLabel mesh__D014411 Stem Cells, Tumor
% 218.76/218.95  |- skos__hiddenLabel mesh__D014411 Cells, Tumor Stem
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D014411 1997
% 218.76/218.95  |- skos__hiddenLabel mesh__D014411 Neoplastic Colony Forming Units
% 218.76/218.95  |- skos__altLabel mesh__D014411 Neoplastic Stem Cells
% 218.76/218.95  |- skos__hiddenLabel mesh__D014411 Stem Cell, Neoplastic
% 218.76/218.95  |- mesh__publicMeSHNote mesh__D014411
% 218.76/218.95       86; was see under STEM CELLS 1984-85; EC CELLS was see TUMOR STEM CELLS 1986-96%A%  
% 218.76/218.95  |- skos__hiddenLabel mesh__D014411 Stem Cell, Tumor
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D014411 2004
% 218.76/218.95  |- skos__altLabel mesh__D014411 Colony-Forming Units, Neoplastic
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D014411 2000
% 218.76/218.95  |- skos__hiddenLabel mesh__D014411 Neoplastic Colony-Forming Unit
% 218.76/218.95  |- skos__hiddenLabel mesh__D014411 Tumor Stem Cell
% 218.76/218.95  |- rdf__type mesh__D014411sskos__Concept
% 218.76/218.95  |- mesh__recordMaintainer mesh__D014411 AGS
% 218.76/218.95  |- skos__altLabel mesh__D014411 Neoplastic Colony-Forming Units
% 218.76/218.95  |- skos__hiddenLabel mesh__D014411 Embryonal Carcinoma Cell
% 218.76/218.95  |- skos__scopeNote mesh__D014411
% 218.76/218.95       Colony-forming cells which give rise to neoplasms.     
% 218.76/218.95  |- skos__hiddenLabel mesh__D014411 Cells, Neoplastic Stem
% 218.76/218.95  |- mesh__onlineNote mesh__D014411
% 218.76/218.95       use TUMOR STEM CELLS to search EC CELLS 1986-96   
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D014411 1998
% 218.76/218.95  |- skos__hiddenLabel mesh__D014411 Neoplastic Stem Cell
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D014411 2001
% 218.76/218.95  |- mesh__dateCreated mesh__D014411 1983-02-24
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D014411 2005
% 218.76/218.95  |- skos__annotation mesh__D014411
% 218.76/218.95       %22%colony-forming cells which give rise to neoplasms%22%; A 11 qualif%A%  
% 218.76/218.95  |- skos__hiddenLabel mesh__D014411 Units, Neoplastic Colony-Forming
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D014411 1999
% 218.76/218.95  |- skos__historyNote mesh__D014411
% 218.76/218.95       Colony-Forming Units Assay %28%1979-1983%29%
% 218.76/218.95  |- skos__hiddenLabel mesh__D014411 Cell, Embryonal Carcinoma
% 218.76/218.95  |- skos__hiddenLabel mesh__D014411 Cell, Tumor Stem
% 218.76/218.95  |- skos__altLabel mesh__D014411 Stem Cells, Neoplastic
% 218.76/218.95  |- skos__historyNote mesh__D014411 Stem Cells %28%1984-1985%29%
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D014411 2006
% 218.76/218.95  |- skos__hiddenLabel mesh__D014411 Carcinoma Cells, Embryonal
% 218.76/218.95  |- skos__hiddenLabel mesh__D014411 Colony-Forming Unit, Neoplastic
% 218.76/218.95  |- skos__prefLabel mesh__D014411 Tumor Stem Cells
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D014411 2002
% 218.76/218.95  |- skos__hiddenLabel mesh__D014411 Cell, Neoplastic Stem
% 218.76/218.95  |- skos__historyNote mesh__D014411 specific neoplasm/PA %28%1975-1983%29%
% 218.76/218.95  |- skos__hiddenLabel mesh__D014411 Colony Forming Units, Neoplastic
% 218.76/218.95  |- mesh__dateRevised mesh__D005685 2004-07-07
% 218.76/218.95  |- skos__related mesh__D005685smesh__D005690
% 218.76/218.95  |- mesh__historyNote mesh__D005685 79   
% 218.76/218.95  |- rdf__type mesh__D005685sskos__Concept
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D005685 2005
% 218.76/218.95  |- mesh__dateEstablished mesh__D005685 1979-01-01
% 218.76/218.95  |- mesh__recordOriginator mesh__D005685 RLS
% 218.76/218.95  |- mesh__dateCreated mesh__D005685 1977-12-15
% 218.76/218.95  |- mesh__recordMaintainer mesh__D005685 ssb
% 218.76/218.95  |- skos__broader mesh__D005685smesh__D011134
% 218.76/218.95  |- skos__historyNote mesh__D005685 Galactose %28%1966-1978%29%
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D005685 2006
% 218.76/218.95  |- skos__scopeNote mesh__D005685
% 218.76/218.95       Polysaccharides composed of repeating galactose units. They can consist of branched or unbranched chains in any linkages.%A%    
% 218.76/218.95  |- skos__annotation mesh__D005685 polysaccharides   
% 218.76/218.95  |- skos__historyNote mesh__D005685 Polysaccharides %28%1966-1978%29%
% 218.76/218.95  |- mesh__recordAuthorizer mesh__D005685 sjn
% 218.76/218.95  |- skos__prefLabel mesh__D005685 Galactans
% 218.76/218.95  |- skos__altLabel mesh__D005685 Polygalactoses
% 218.76/218.95  |- mesh__publicMeSHNote mesh__D005685 79   
% 218.76/218.95  |- mesh__dateCreated mesh__D038061 2002-07-03
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D038061 2003
% 218.76/218.95  |- rdf__type mesh__D038061sskos__Concept
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D038061 2004
% 218.76/218.95  |- skos__altLabel mesh__D038061 Lower Limb Deformities, Congenital
% 218.76/218.95  |- mesh__publicMeSHNote mesh__D038061 2003   
% 218.76/218.95  |- mesh__historyNote mesh__D038061 2003   
% 218.76/218.95  |- skos__prefLabel mesh__D038061 Lower Extremity Deformities, Congenital
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D038061 2005
% 218.76/218.95  |- mesh__dateEstablished mesh__D038061 2003-01-01
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D038061 2006
% 218.76/218.95  |- skos__scopeNote mesh__D038061
% 218.76/218.95       Congenital structural abnormalities of the LOWER EXTREMITY.%A%    
% 218.76/218.95  |- skos__broader mesh__D038061smesh__D017880
% 218.76/218.95  |- skos__hiddenLabel mesh__D013319 Equine Strongylosis
% 218.76/218.95  |- skos__scopeNote mesh__D013319
% 218.76/218.95       Infection of horses with parasitic nematodes of the superfamily STRONGYLOIDEA. Characteristics include the development of hemorrhagic nodules on the abdominal peritoneum.%A%    
% 218.76/218.95  |- skos__hiddenLabel mesh__D013319 Equine Strongyle Infection
% 218.76/218.95  |- skos__prefLabel mesh__D013319 Strongyle Infections, Equine
% 218.76/218.95  |- mesh__recordMaintainer mesh__D013319 ags
% 218.76/218.95  |- mesh__recordAuthorizer mesh__D013319 sjn
% 218.76/218.95  |- mesh__historyNote mesh__D013319 68   
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D013319 2005
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D013319 2004
% 218.76/218.95  |- skos__broader mesh__D013319smesh__D006374
% 218.76/218.95  |- skos__hiddenLabel mesh__D013319 Strongyloses, Equine
% 218.76/218.95  |- mesh__publicMeSHNote mesh__D013319 68   
% 218.76/218.95  |- rdf__type mesh__D013319sskos__Concept
% 218.76/218.95  |- skos__altLabel mesh__D013319 Infections, Equine Strongyle
% 218.76/218.95  |- skos__hiddenLabel mesh__D013319 Equine Strongyloses
% 218.76/218.95  |- skos__altLabel mesh__D013319 Strongylosis, Equine
% 218.76/218.95  |- mesh__dateCreated mesh__D013319 1999-01-01
% 218.76/218.95  |- skos__altLabel mesh__D013319 Equine Strongyle Infections
% 218.76/218.95  |- mesh__recordOriginator mesh__D013319 NLM
% 218.76/218.95  |- mesh__dateRevised mesh__D013319 2003-07-30
% 218.76/218.95  |- skos__historyNote mesh__D013319 Nematode Infections %28%1966-1967%29%
% 218.76/218.95  |- skos__hiddenLabel mesh__D013319 Strongyle Infection, Equine
% 218.76/218.95  |- skos__broader mesh__D013319smesh__D017206
% 218.76/218.95  |- mesh__dateEstablished mesh__D013319 1968-01-01
% 218.76/218.95  |- skos__broader mesh__D013319smesh__D006734
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D013319 2006
% 218.76/218.95  |- skos__hiddenLabel mesh__D013319 Infection, Equine Strongyle
% 218.76/218.95  |- skos__annotation mesh__D013319
% 218.76/218.95       nematode infect; don%27%t forget also HORSES %28%NIM%29% %26% check tag ANIMALS; for organism coord IM with STRONGYLUS %28%NIM%29% or other genus of superfamily STRONGYLOIDEA %26% its taxonomic families %28%NIM%29%%A%  
% 218.76/218.95  |- skos__hiddenLabel mesh__D024041 Collagens, Nonfibrillar
% 218.76/218.95  |- mesh__historyNote mesh__D024041 2002   
% 218.76/218.95  |- mesh__dateCreated mesh__D024041 2001-07-25
% 218.76/218.95  |- mesh__recordAuthorizer mesh__D024041 sjn
% 218.76/218.95  |- mesh__dateRevised mesh__D024041 2004-07-07
% 218.76/218.95  |- mesh__recordMaintainer mesh__D024041 jmp
% 218.76/218.95  |- skos__historyNote mesh__D024041 Collagen %28%1966-2001%29%
% 218.76/218.95  |- skos__hiddenLabel mesh__D024041 Collagens, Short-Chain
% 218.76/218.95  |- skos__altLabel mesh__D024041 Short-Chain Collagens
% 218.76/218.95  |- skos__prefLabel mesh__D024041 Non-Fibrillar Collagens
% 218.76/218.95  |- skos__annotation mesh__D024041
% 218.76/218.95       precusors: coord IM with PROCOLLAGEN %28%IM%29%   
% 218.76/218.95  |- skos__hiddenLabel mesh__D024041 Collagens, Non-Fibrillar
% 218.76/218.95  |- mesh__publicMeSHNote mesh__D024041 2002   
% 218.76/218.95  |- mesh__recordOriginator mesh__D024041 jmp
% 218.76/218.95  |- skos__broader mesh__D024041smesh__D003094
% 218.76/218.95  |- skos__hiddenLabel mesh__D024041 Non Fibrillar Collagens
% 218.76/218.95  |- mesh__dateEstablished mesh__D024041 2002-01-01
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D024041 2005
% 218.76/218.95  |- rdf__type mesh__D024041sskos__Concept
% 218.76/218.95  |- skos__scopeNote mesh__D024041
% 218.76/218.95       A family of structurally-related short-chain collagens that do not form large fibril bundles.%A%    
% 218.76/218.95  |- skos__altLabel mesh__D024041 Nonfibrillar Collagens
% 218.76/218.95  |- skos__hiddenLabel mesh__D024041 Short Chain Collagens
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D024041 2006
% 218.76/218.95  |- skos__hiddenLabel mesh__D018802 Care, Patient-Centered
% 218.76/218.95  |- skos__hiddenLabel mesh__D018802 Care, Patient-Focused
% 218.76/218.95  |- skos__prefLabel mesh__D018802 Patient-Centered Care
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D018802 2003
% 218.76/218.95  |- mesh__dateRevised mesh__D018802 1999-11-03
% 218.76/218.95  |- skos__hiddenLabel mesh__D018802 Nursing, Patient Centered
% 218.76/218.95  |- skos__annotation mesh__D018802
% 218.76/218.95       institutional %26% admin management: do not confuse with PATIENT CARE PLANNING involving individual patient%A%  
% 218.76/218.95  |- mesh__recordOriginator mesh__D018802 JLS
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D018802 2001
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D018802 2006
% 218.76/218.95  |- skos__broader mesh__D018802smesh__D011320
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D018802 2000
% 218.76/218.95  |- mesh__recordAuthorizer mesh__D018802 sjn
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D018802 2005
% 218.76/218.95  |- mesh__historyNote mesh__D018802 95   
% 218.76/218.95  |- mesh__publicMeSHNote mesh__D018802 95   
% 218.76/218.95  |- rdf__type mesh__D018802sskos__Concept
% 218.76/218.95  |- mesh__dateCreated mesh__D018802 1994-07-01
% 218.76/218.95  |- mesh__activeMeSHYear mesh__D018802 2002
% 218.76/218.95  |- skos__broader mesh__D018802smesh__D003191
% 218.76/218.95  |- skos__hiddenLabel mesh__D018802 Patient Centered Care
% 218.76/218.95  |- skos__altLabel mesh__D018802 Patient-Centered Nursing
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D018802 2004
% 218.76/218.96  |- skos__hiddenLabel mesh__D018802 Patient Focused Care
% 218.76/218.96  |- mesh__recordMaintainer mesh__D018802 kle
% 218.76/218.96  |- skos__scopeNote mesh__D018802
% 218.76/218.96       Design of patient care wherein institutional resources and personnel are organized around patients rather than around specialized departments. %28%From Hospitals 1993 Feb 5;67%28%3%29%:14%29%%A%    
% 218.76/218.96  |- skos__hiddenLabel mesh__D018802 Patient Centered Nursing
% 218.76/218.96  |- skos__broader mesh__D018802smesh__D010346
% 218.76/218.96  |- mesh__dateEstablished mesh__D018802 1995-01-01
% 218.76/218.96  |- skos__hiddenLabel mesh__D018004 B Receptor, Neuromedin
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D018004 2004
% 218.76/218.96  |- mesh__recordAuthorizer mesh__D018004 sjn
% 218.76/218.96  |- skos__altLabel mesh__D018004 Receptors, Gastrin-Releasing Peptide
% 218.76/218.96  |- skos__hiddenLabel mesh__D018004 Receptor, Bombesin
% 218.76/218.96  |- mesh__dateEstablished mesh__D018004 1994-01-01
% 218.76/218.96  |- skos__hiddenLabel mesh__D018004 Receptors, Gastrin Releasing Peptide
% 218.76/218.96  |- mesh__publicMeSHNote mesh__D018004
% 218.76/218.96       94; BOMBESIN RECEPTOR was indexed under RECEPTORS, NEUROHUMOR 1987-93 %26% RECEPTORS, ENDOGENOUS SUBSTANCE 1982-86; NEUROMEDIN B RECEPTOR was indexed under RECEPTORS, NEUROHUMOR 1992-93%A%  
% 218.76/218.96  |- skos__altLabel mesh__D018004 Neuromedin B Receptor
% 218.76/218.96  |- skos__scopeNote mesh__D018004
% 218.76/218.96       Cell surface proteins that bind bombesin or closely related peptides with high affinity and trigger intracellular changes influencing the behavior of cells. Gastrin- releasing peptide %28%GRP%29%; GRP 18-27 %28%neuromedin C%29%, and neuromedin B are endogenous ligands of bombesin receptors in mammals.%A%    
% 218.76/218.96  |- skos__altLabel mesh__D018004 Gastrin-Releasing Peptide Receptors
% 218.76/218.96  |- skos__hiddenLabel mesh__D018004 Peptide Receptors, Gastrin-Releasing
% 218.76/218.96  |- skos__altLabel mesh__D018004 Gastrin-Releasing Peptide Receptor
% 218.76/218.96  |- skos__hiddenLabel mesh__D018004 Peptide Receptor, Gastrin-Releasing
% 218.76/218.96  |- skos__altLabel mesh__D018004 Bombesin Receptors
% 218.76/218.96  |- skos__historyNote mesh__D018004
% 218.76/218.96       Receptors, Neurotransmitter %28%1987-1993%29%
% 218.76/218.96  |- skos__hiddenLabel mesh__D018004 Receptor, Gastrin-Releasing Peptide
% 218.76/218.96  |- skos__historyNote mesh__D018004
% 218.76/218.96       Receptors, Cell Surface %28%1982-1986%29%
% 218.76/218.96  |- skos__hiddenLabel mesh__D018004 Gastrin Releasing Peptide Receptors
% 218.76/218.96  |- skos__hiddenLabel mesh__D018004 B Receptors, Neuromedin
% 218.76/218.96  |- skos__altLabel mesh__D018004 Neuromedin B Receptors
% 218.76/218.96  |- skos__altLabel mesh__D018004 Bombesin Receptor
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D018004 2006
% 218.76/218.96  |- skos__annotation mesh__D018004 DF: RECEPT BOMBESIN   
% 218.76/218.96  |- skos__prefLabel mesh__D018004 Receptors, Bombesin
% 218.76/218.96  |- mesh__dateRevised mesh__D018004 2003-07-09
% 218.76/218.96  |- mesh__onlineNote mesh__D018004
% 218.76/218.96       use RECEPTORS, BOMBESIN %28%NM%29% to search BOMBESIN RECEPTOR 1982-93 %26% NEUROMEDIN B RECEPTOR 1992-93%A%  
% 218.76/218.96  |- mesh__historyNote mesh__D018004
% 218.76/218.96       94; was BOMBESIN RECEPTOR %28%NM%29% 1982-93; NEUROMEDIN B RECEPTOR was %28%NM%29% 1992-93%A%  
% 218.76/218.96  |- skos__hiddenLabel mesh__D018004 Gastrin Releasing Peptide Receptor
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D018004 2005
% 218.76/218.96  |- mesh__recordOriginator mesh__D018004 RAZ
% 218.76/218.96  |- skos__altLabel mesh__D018004 Receptors, Neuromedin B
% 218.76/218.96  |- rdf__type mesh__D018004sskos__Concept
% 218.76/218.96  |- skos__broader mesh__D018004smesh__D043562
% 218.76/218.96  |- mesh__recordMaintainer mesh__D018004 jmp
% 218.76/218.96  |- skos__broader mesh__D018004smesh__D018013
% 218.76/218.96  |- mesh__dateCreated mesh__D018004 1993-06-21
% 218.76/218.96  |- skos__hiddenLabel mesh__D018004 Receptor, Neuromedin B
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010021 1996
% 218.76/218.96  |- skos__broader mesh__D010021smesh__D008511
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010021 2006
% 218.76/218.96  |- mesh__recordAuthorizer mesh__D010021 PLS
% 218.76/218.96  |- skos__annotation mesh__D010021
% 218.76/218.96       SPEC: SPEC qualif; OSTEOPATHY is not a substitute for BONE AND BONES /pathol; TN 143: do not confuse with BONE DISEASES; DF: OSTEOPATHIC MED%A%  
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010021 1997
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010021 1992
% 218.76/218.96  |- mesh__onlineNote mesh__D010021
% 218.76/218.96       use OSTEOPATHIC MEDICINE to search OSTEOPATHY 1966-86   
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010021 1998
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010021 1993
% 218.76/218.96  |- mesh__recordOriginator mesh__D010021 NLM
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010021 1991
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010021 2000
% 218.76/218.96  |- skos__prefLabel mesh__D010021 Osteopathic Medicine
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010021 1994
% 218.76/218.96  |- skos__scopeNote mesh__D010021
% 218.76/218.96       A system of therapy and medicine based on the theory that the normal body is a vital mechanical organism whose structural and functional states are of equal importance and is capable of making its own remedies against infections and toxic conditions when there are favorable environmental circumstances and adequate nutrition.%A%    
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010021 1999
% 218.76/218.96  |- mesh__publicMeSHNote mesh__D010021 87; was OSTEOPATHY 1963-86   
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010021 2003
% 218.76/218.96  |- skos__altLabel mesh__D010021 Osteopathy
% 218.76/218.96  |- mesh__recordMaintainer mesh__D010021 PLS
% 218.76/218.96  |- rdf__type mesh__D010021sskos__Concept
% 218.76/218.96  |- skos__altLabel mesh__D010021 Medicine, Osteopathic
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010021 2001
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010021 1995
% 218.76/218.96  |- mesh__dateRevised mesh__D010021 1990-05-17
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010021 2004
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010021 2002
% 218.76/218.96  |- skos__hiddenLabel mesh__D010021 Osteopathies
% 218.76/218.96  |- mesh__historyNote mesh__D010021 87; was OSTEOPATHY 1963-86   
% 218.76/218.96  |- mesh__dateCreated mesh__D010021 1999-01-01
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010021 2005
% 218.76/218.96  |- mesh__recordMaintainer mesh__D051438 nns
% 218.76/218.96  |- mesh__recordAuthorizer mesh__D051438 sjn
% 218.76/218.96  |- mesh__recordOriginator mesh__D051438 nns
% 218.76/218.96  |- skos__broader mesh__D051438smesh__D050765
% 218.76/218.96  |- mesh__dateEstablished mesh__D051438 2006-01-01
% 218.76/218.96  |- rdf__type mesh__D051438sskos__Concept
% 218.76/218.96  |- skos__historyNote mesh__D051438 Membrane Proteins %28%1998-2005%29%
% 218.76/218.96  |- skos__scopeNote mesh__D051438
% 218.76/218.96       A ubiquitously expressed member of the syntaxin subfamily of SNARE proteins that localizes to the GOLGI APPARATUS.%A%    
% 218.76/218.96  |- skos__historyNote mesh__D051438
% 218.76/218.96       Vesicular Transport Proteins %28%1998-2005%29%
% 218.76/218.96  |- skos__altLabel mesh__D051438 Syntaxin 16 Protein
% 218.76/218.96  |- mesh__publicMeSHNote mesh__D051438
% 218.76/218.96       2006; SYNTAXIN 16 was indexed under MEMBRANE PROTEINS and VESICULAR TRANSPORT PROTEINS 1998-2005%A%  
% 218.76/218.96  |- mesh__dateCreated mesh__D051438 2005-06-30
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D051438 2006
% 218.76/218.96  |- mesh__historyNote mesh__D051438 2006 %28%1998%29%   
% 218.76/218.96  |- skos__prefLabel mesh__D051438 Syntaxin 16
% 218.76/218.96  |- skos__altLabel mesh__D009278
% 218.76/218.96       Whitehall Brand of Naphazoline Hydrochloride
% 218.76/218.96  |- skos__hiddenLabel mesh__D009278 Hydrochloride, Naphazoline
% 218.76/218.96  |- skos__altLabel mesh__D009278
% 218.76/218.96       Novartis Brand 2 of Naphazoline Hydrochloride
% 218.76/218.96  |- skos__altLabel mesh__D009278
% 218.76/218.96       Novartis Brand 1 of Naphazoline Hydrochloride
% 218.76/218.96  |- skos__hiddenLabel mesh__D009278 Tele Stulln
% 218.76/218.96  |- skos__hiddenLabel mesh__D009278 Eyes, Clear
% 218.76/218.96  |- skos__hiddenLabel mesh__D009278
% 218.76/218.96       Warner Lambert Brand of Naphazoline Nitrate
% 218.76/218.96  |- skos__altLabel mesh__D009278 Vasoconstrictor Pensa
% 218.76/218.96  |- skos__altLabel mesh__D009278
% 218.76/218.96       Bausch %26% Lomb Brand 1 of Naphazoline Hydrochloride
% 218.76/218.96  |- skos__altLabel mesh__D009278 Naphazoline Monohydrochloride
% 218.76/218.96  |- skos__altLabel mesh__D009278 Abbot Brand of Naphazoline Hydrochloride
% 218.76/218.96  |- mesh__historyNote mesh__D009278
% 218.76/218.96       91%28%63%29%; was see under IMIDAZOLES 1975-90; was see under VASOCONSTRICTOR AGENTS, NASAL 1967-74; was see under SYMPATHOMIMETICS 1963-66%A%  
% 218.76/218.96  |- skos__broader mesh__D009278smesh__D007093
% 218.76/218.96  |- mesh__recordMaintainer mesh__D009278 ssb
% 218.76/218.96  |- skos__altLabel mesh__D009278 Chauvin Brand of Naphazoline Hydrochloride
% 218.76/218.96  |- mesh__recordOriginator mesh__D009278 NLM
% 218.76/218.96  |- skos__altLabel mesh__D009278 Allergan Brand of Naphazoline Hydrochloride
% 218.76/218.96  |- skos__altLabel mesh__D009278 Febena Brand of Naphazoline Hydrochloride
% 218.76/218.96  |- skos__altLabel mesh__D009278 Warner-Lambert Brand of Naphazoline Nitrate
% 218.76/218.96  |- skos__altLabel mesh__D009278 Iquinosa Brand of Naphazoline Hydrochloride
% 218.76/218.96  |- skos__hiddenLabel mesh__D009278 forte, Naphcon
% 218.76/218.96  |- skos__scopeNote mesh__D009278
% 218.76/218.96       An adrenergic vasoconstrictor agent used as a decongestant.%A%    
% 218.76/218.96  |- skos__altLabel mesh__D009278
% 218.76/218.96       Bausch %26% Lomb Brand 2 of Naphazoline Hydrochloride
% 218.76/218.96  |- skos__hiddenLabel mesh__D009278 TeleStulln
% 218.76/218.96  |- skos__altLabel mesh__D009278
% 218.76/218.96       Ciba Vision Brand 1 of Naphazoline Hydrochloride
% 218.76/218.96  |- skos__altLabel mesh__D009278 Alcon Brand 1 of Naphazoline Hydrochloride
% 218.76/218.96  |- rdf__type mesh__D009278sskos__Concept
% 218.76/218.96  |- skos__altLabel mesh__D009278 Akorn Brand of Naphazoline Hydrochloride
% 218.76/218.96  |- skos__hiddenLabel mesh__D009278 Grin, Afazol
% 218.76/218.96  |- skos__hiddenLabel mesh__D009278 Clear, All
% 218.76/218.96  |- skos__hiddenLabel mesh__D009278 AKCon
% 218.76/218.96  |- skos__hiddenLabel mesh__D009278 AK Con
% 218.76/218.96  |- mesh__dateRevised mesh__D009278 2005-06-30
% 218.76/218.96  |- skos__altLabel mesh__D009278
% 218.76/218.96       Ciba Vision Brand 2 of Naphazoline Hydrochloride
% 218.76/218.96  |- mesh__dateCreated mesh__D009278 1999-01-01
% 218.76/218.96  |- skos__prefLabel mesh__D009278 Naphazoline
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D009278 2006
% 218.76/218.96  |- mesh__publicMeSHNote mesh__D009278
% 218.76/218.96       91; was see under IMIDAZOLES 1975-90; was see under VASOCONSTRICTOR AGENTS, NASAL 1967-74; was see under SYMPATHOMIMETICS 1963-66%A%  
% 218.76/218.96  |- skos__altLabel mesh__D009278 Alcon Brand 2 of Naphazoline Hydrochloride
% 218.76/218.96  |- skos__hiddenLabel mesh__D009278 Alfa, Colirio
% 218.76/218.96  |- mesh__dateEstablished mesh__D009278 1991-01-01
% 218.76/218.96  |- skos__altLabel mesh__D009278 Privin
% 218.76/218.96  |- skos__hiddenLabel mesh__D009278 Pensa, Vasoconstrictor
% 218.76/218.96  |- skos__altLabel mesh__D009278 Stulln Brand of Naphazoline Hydrochloride
% 218.76/218.96  |- skos__hiddenLabel mesh__D009278 Monohydrochloride, Naphazoline
% 218.76/218.96  |- skos__altLabel mesh__D009278 Winzer Brand of Naphazoline Hydrochloride
% 218.76/218.96  |- skos__altLabel mesh__D009278 Optima Brand of Naphazoline Hydrochloride
% 218.76/218.96  |- skos__altLabel mesh__D009278 Grin Brand of Naphazoline Hydrochloride
% 218.76/218.96  |- skos__hiddenLabel mesh__D009278 Regular, Vasocon
% 218.76/218.96  |- skos__hiddenLabel mesh__D009278 Nitrate, Naphazoline
% 218.76/218.96  |- mesh__recordAuthorizer mesh__D009278 sjn
% 218.76/218.96  |- skos__altLabel mesh__D009278 Ross Brand of Naphazoline Hydrochloride
% 218.76/218.96  |- rdf__type mesh__D001295sskos__Concept
% 218.76/218.96  |- mesh__recordMaintainer mesh__D001295 SYSTEM
% 218.76/218.96  |- skos__broader mesh__D001295smesh__D001419
% 218.76/218.96  |- skos__prefLabel mesh__D001295 Atypical Bacterial Forms
% 218.76/218.96  |- mesh__recordOriginator mesh__D001295 NLM
% 218.76/218.96  |- mesh__recordAuthorizer mesh__D001295 sjn
% 218.76/218.96  |- skos__altLabel mesh__D001295 Bacterial Forms, Atypical
% 218.76/218.96  |- mesh__dateRevised mesh__D001295 2005-06-30
% 218.76/218.96  |- skos__scopeNote mesh__D001295
% 218.76/218.96       Microorganisms that have undergone greater changes than normal in morphology, physiology, or cultural characteristics.%A%    
% 218.76/218.96  |- mesh__dateCreated mesh__D001295 1999-01-01
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D001295 2006
% 218.76/218.96  |- skos__annotation mesh__D001295 DF: ATYPICAL BACT FORMS   
% 218.76/218.96  |- skos__historyNote mesh__D001295 Bacteria %28%1966-1974%29%
% 218.76/218.96  |- mesh__dateEstablished mesh__D001295 1975-01-01
% 218.76/218.96  |- mesh__historyNote mesh__D001295 75   
% 218.76/218.96  |- mesh__publicMeSHNote mesh__D001295 75   
% 218.76/218.96  |- skos__hiddenLabel mesh__D014412 Shope Papilloma
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D014412 1997
% 218.76/218.96  |- mesh__onlineNote mesh__D014412
% 218.76/218.96       use TUMOR VIRUS INFECTIONS to search FIBROMA, SHOPE 1968-81 %26% PAPILLOMA, SHOPE 1966-81%A%  
% 218.76/218.96  |- mesh__recordAuthorizer mesh__D014412 PLS
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D014412 2000
% 218.76/218.96  |- mesh__publicMeSHNote mesh__D014412
% 218.76/218.96       72; FIBROMA, SHOPE was heading 1968-81; PAPILLOMA, SHOPE was heading 1963-81%A%  
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D014412 1996
% 218.76/218.96  |- mesh__historyNote mesh__D014412
% 218.76/218.96       72; FIBROMA, SHOPE was heading 1968-81; PAPILLOMA, SHOPE was heading 1963-81%A%  
% 218.76/218.96  |- mesh__recordMaintainer mesh__D014412 KEV
% 218.76/218.96  |- skos__annotation mesh__D014412
% 218.76/218.96       coord IM with specific oncogenic virus %28%IM%29%   
% 218.76/218.96  |- mesh__dateCreated mesh__D014412 1999-01-01
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D014412 1999
% 218.76/218.96  |- skos__scopeNote mesh__D014412
% 218.76/218.96       Infections produced by oncogenic viruses. The infections caused by DNA viruses are less numerous but more diverse than those caused by the RNA oncogenic viruses.%A%    
% 218.76/218.96  |- rdf__type mesh__D014412sskos__Concept
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D014412 2004
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D014412 2002
% 218.76/218.96  |- skos__hiddenLabel mesh__D014412 Tumor Virus Infection
% 218.76/218.96  |- skos__hiddenLabel mesh__D014412 Shope Fibroma
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D014412 1998
% 218.76/218.96  |- mesh__recordOriginator mesh__D014412 NLM
% 218.76/218.96  |- skos__broader mesh__D014412smesh__D014777
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D014412 2003
% 218.76/218.96  |- mesh__dateEstablished mesh__D014412 1972-01-01
% 218.76/218.96  |- skos__prefLabel mesh__D014412 Tumor Virus Infections
% 218.76/218.96  |- skos__historyNote mesh__D014412 Oncogenic Viruses %28%1966-1971%29%
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D014412 2006
% 218.76/218.96  |- mesh__dateRevised mesh__D014412 1995-06-08
% 218.76/218.96  |- skos__broader mesh__D014412smesh__D009369
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D014412 2001
% 218.76/218.96  |- skos__historyNote mesh__D014412 Virus Diseases %28%1966-1971%29%
% 218.76/218.96  |- skos__altLabel mesh__D014412 Infections, Tumor Virus
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D014412 2005
% 218.76/218.96  |- skos__hiddenLabel mesh__D014412 Infection, Tumor Virus
% 218.76/218.96  |- skos__broader mesh__D014412smesh__D009374
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D005686 2006
% 218.76/218.96  |- mesh__recordAuthorizer mesh__D005686 sjn
% 218.76/218.96  |- skos__broader mesh__D005686smesh__D017853
% 218.76/218.96  |- skos__related mesh__D005686smesh__D005693
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D005686 2004
% 218.76/218.96  |- skos__historyNote mesh__D005686
% 218.76/218.96       Phosphotransferases, ATP %28%1974-1978%29%
% 218.76/218.96  |- mesh__dateRevised mesh__D005686 2003-07-09
% 218.76/218.96  |- skos__scopeNote mesh__D005686
% 218.76/218.96       An enzyme that catalyzes reversibly the formation of galactose 1-phosphate and ADP from ATP and D-galactose. Galactosamine can also act as the acceptor. A deficiency of this enzyme results in GALACTOSEMIA. EC 2.7.1.6.%A%    
% 218.76/218.96  |- mesh__recordOriginator mesh__D005686 RLS
% 218.76/218.96  |- mesh__dateCreated mesh__D005686 1977-12-15
% 218.76/218.96  |- mesh__historyNote mesh__D005686 79   
% 218.76/218.96  |- skos__historyNote mesh__D005686 Galactose %28%1966-1978%29%
% 218.76/218.96  |- mesh__publicMeSHNote mesh__D005686 79   
% 218.76/218.96  |- skos__prefLabel mesh__D005686 Galactokinase
% 218.76/218.96  |- mesh__recordMaintainer mesh__D005686 ssb
% 218.76/218.96  |- rdf__type mesh__D005686sskos__Concept
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D005686 2005
% 218.76/218.96  |- mesh__dateEstablished mesh__D005686 1979-01-01
% 218.76/218.96  |- skos__historyNote mesh__D005686 Phosphotransferases %28%1966-1973%29%
% 218.76/218.96  |- skos__annotation mesh__D005686 /defic: consider also GALACTOSEMIAS   
% 218.76/218.96  |- skos__broader mesh__D038062smesh__D017880
% 218.76/218.96  |- rdf__type mesh__D038062sskos__Concept
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D038062 2004
% 218.76/218.96  |- mesh__publicMeSHNote mesh__D038062 2003   
% 218.76/218.96  |- skos__altLabel mesh__D038062 Upper Limb Deformities, Congenital
% 218.76/218.96  |- mesh__dateCreated mesh__D038062 2002-07-03
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D038062 2005
% 218.76/218.96  |- skos__prefLabel mesh__D038062 Upper Extremity Deformities, Congenital
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D038062 2006
% 218.76/218.96  |- skos__scopeNote mesh__D038062
% 218.76/218.96       Congenital structural abnormalities of the UPPER EXTREMITY.%A%    
% 218.76/218.96  |- mesh__historyNote mesh__D038062 2003   
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D038062 2003
% 218.76/218.96  |- mesh__dateEstablished mesh__D038062 2003-01-01
% 218.76/218.96  |- skos__hiddenLabel mesh__D024042 Collagen, Type 1
% 218.76/218.96  |- mesh__recordOriginator mesh__D024042 jmp
% 218.76/218.96  |- skos__prefLabel mesh__D024042 Collagen Type I
% 218.76/218.96  |- skos__hiddenLabel mesh__D024042 Collagen, Type I
% 218.76/218.96  |- skos__altLabel mesh__D024042 Type I Collagen
% 218.76/218.96  |- skos__altLabel mesh__D024042 Collagen alpha1%28%I%29%
% 218.76/218.96  |- skos__altLabel mesh__D024042 Collagen alpha2%28%I%29%
% 218.76/218.96  |- mesh__recordMaintainer mesh__D024042 jmp
% 218.76/218.96  |- skos__annotation mesh__D024042
% 218.76/218.96       precursors: coord IM with PROCOLLAGEN %28%IM%29%   
% 218.76/218.96  |- skos__broader mesh__D024042smesh__D024022
% 218.76/218.96  |- skos__altLabel mesh__D024042 Collagen Type I, alpha2 Chain
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D024042 2005
% 218.76/218.96  |- skos__related mesh__D024042smesh__D010013
% 218.76/218.96  |- mesh__publicMeSHNote mesh__D024042
% 218.76/218.96       2002; see COLLAGEN 1966-2001; for ALPHA-2 TYPE 1 COLLAGEN see COLLAGEN 1987-2001; for PROCOLLAGEN TYPE I see PROCOLLAGEN 1986-2001; for TYPE I PROCOLLAGEN %26% PRO ALPHA 2 COLLAGEN see PROCOLLAGEN 1982-2001; for PRO ALPHA 1 COLLAGEN see PROCOLLAGEN 1988-2001%A%  
% 218.76/218.96  |- skos__altLabel mesh__D024042 Type 1 Collagen
% 218.76/218.96  |- mesh__dateCreated mesh__D024042 2001-07-25
% 218.76/218.96  |- mesh__historyNote mesh__D024042
% 218.76/218.96       2002; use COLLAGEN 1966-2001; for ALPHA-2 TYPE 1 COLLAGEN use COLLAGEN 1987-2001; for PROCOLLAGEN TYPE I use PROCOLLAGEN 1986-2001; for TYPE I PROCOLLAGEN %26% PRO ALPHA 2 COLLAGEN use PROCOLLAGEN 1982-2001; for PRO ALPHA 1 COLLAGEN use PROCOLLAGEN 1988-2001%A%  
% 218.76/218.96  |- skos__altLabel mesh__D024042 alpha1 Type 1 Collagen
% 218.76/218.96  |- skos__altLabel mesh__D024042 alpha2 Type 1 Collagen
% 218.76/218.96  |- skos__altLabel mesh__D024042 alpha-2 Type 1 Collagen
% 218.76/218.96  |- mesh__recordAuthorizer mesh__D024042 sjn
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D024042 2006
% 218.76/218.96  |- skos__altLabel mesh__D024042 Collagen Type I, alpha1 Chain
% 218.76/218.96  |- skos__historyNote mesh__D024042 Collagen %28%1966-2001%29%
% 218.76/218.96  |- rdf__type mesh__D024042sskos__Concept
% 218.76/218.96  |- mesh__dateEstablished mesh__D024042 2002-01-01
% 218.76/218.96  |- skos__altLabel mesh__D024042 Type I Procollagen
% 218.76/218.96  |- skos__scopeNote mesh__D024042
% 218.76/218.96       The most common form of fibrillar collagen. It is a major constituent of bone %28%BONE AND BONES%29% and SKIN and consists of a heterotrimer of two alpha1%28%I%29% and one alpha2%28%I%29% chains.%A%    
% 218.76/218.96  |- mesh__dateRevised mesh__D024042 2004-07-07
% 218.76/218.96  |- skos__hiddenLabel mesh__D024042 Procollagen, Type I
% 218.76/218.96  |- skos__scopeNote mesh__D018803
% 218.76/218.96       Statistical models of the production, distribution, and consumption of goods and services, as well as of financial considerations. For the application of statistics to the testing and quantifying of economic theories MODELS, ECONOMETRIC is available.%A%    
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D018803 1998
% 218.76/218.96  |- mesh__dateEstablished mesh__D018803 1995-01-01
% 218.76/218.96  |- skos__altLabel mesh__D018803 Model, Economic
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D018803 2001
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D018803 2003
% 218.76/218.96  |- skos__broader mesh__D018803smesh__D015233
% 218.76/218.96  |- mesh__onlineNote mesh__D018803
% 218.76/218.96       use ECONOMICS to search MODELS, ECONOMIC and ECONOMIC MODELS 1994%A%  
% 218.76/218.96  |- mesh__recordMaintainer mesh__D018803 TGC
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D018803 2000
% 218.76/218.96  |- mesh__recordAuthorizer mesh__D018803 PLS
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D018803 2006
% 218.76/218.96  |- mesh__recordOriginator mesh__D018803 TGC
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D018803 1997
% 218.76/218.96  |- rdf__type mesh__D018803sskos__Concept
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D018803 2005
% 218.76/218.96  |- skos__annotation mesh__D018803
% 218.76/218.96       no qualif; TN 128: application of MODELS, THEORETICAL; MODELS, ECONOMETRIC is also available; DF: MODELS ECON%A%  
% 218.76/218.96  |- skos__historyNote mesh__D018803 Economics %28%1994%29%
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D018803 2002
% 218.76/218.96  |- mesh__publicMeSHNote mesh__D018803
% 218.76/218.96       95; was see ECONOMICS 1994; ECONOMIC MODELS was see ECONOMICS 1994%A%  
% 218.76/218.96  |- mesh__dateCreated mesh__D018803 1994-05-23
% 218.76/218.96  |- skos__altLabel mesh__D018803 Economic Model
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D018803 1999
% 218.76/218.96  |- mesh__dateRevised mesh__D018803 1996-06-10
% 218.76/218.96  |- skos__altLabel mesh__D018803 Economic Models
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D018803 2004
% 218.76/218.96  |- mesh__historyNote mesh__D018803
% 218.76/218.96       95; was see ECONOMICS 1994; ECONOMIC MODELS was see ECONOMICS 1994%A%  
% 218.76/218.96  |- skos__prefLabel mesh__D018803 Models, Economic
% 218.76/218.96  |- skos__scopeNote mesh__D010820
% 218.76/218.96       Individuals licensed to practice medicine.     
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010820 2003
% 218.76/218.96  |- mesh__dateCreated mesh__D010820 1999-01-01
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010820 2006
% 218.76/218.96  |- skos__annotation mesh__D010820
% 218.76/218.96       /educ = EDUCATION, MEDICAL or its specifics; Manual 35.2.3; in biographies: Manual 32.16.7; when not to use: Manual 34.11.1; %22%role of physician in ...%22% = PHYSICIAN%27%S ROLE: see note there%A%  
% 218.76/218.96  |- mesh__recordAuthorizer mesh__D010820 sjn
% 218.76/218.96  |- mesh__recordMaintainer mesh__D010820 kle
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010820 2005
% 218.76/218.96  |- mesh__dateRevised mesh__D010820 1999-11-03
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010820 2002
% 218.76/218.96  |- rdf__type mesh__D010820sskos__Concept
% 218.76/218.96  |- skos__prefLabel mesh__D010820 Physicians
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010820 2001
% 218.76/218.96  |- skos__broader mesh__D010820smesh__D006282
% 218.76/218.96  |- mesh__recordOriginator mesh__D010820 NLM
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010820 2000
% 218.76/218.96  |- skos__hiddenLabel mesh__D010820 Physician
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010820 2004
% 218.76/218.96  |- skos__altLabel mesh__D018005 Vasoactive Intestinal Peptide Receptors
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D018005 2004
% 218.76/218.96  |- skos__altLabel mesh__D018005 VIP Receptor
% 218.76/218.96  |- mesh__recordOriginator mesh__D018005 RAZ
% 218.76/218.96  |- skos__prefLabel mesh__D018005 Receptors, Vasoactive Intestinal Peptide
% 218.76/218.96  |- skos__hiddenLabel mesh__D018005 Receptor, VIP
% 218.76/218.96  |- skos__altLabel mesh__D018005 Vasoactive Intestinal Peptide Receptor
% 218.76/218.96  |- skos__annotation mesh__D018005 DF: RECEPT VIP   
% 218.76/218.96  |- skos__altLabel mesh__D018005 VIP Receptors
% 218.76/218.96  |- mesh__dateCreated mesh__D018005 1993-06-21
% 218.76/218.96  |- skos__scopeNote mesh__D018005
% 218.76/218.96       Cell surface proteins that bind VASOACTIVE INTESTINAL PEPTIDE; %28%VIP%29%; with high affinity and trigger intracellular changes which influence the behavior of cells.%A%    
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D018005 2005
% 218.76/218.96  |- mesh__dateEstablished mesh__D018005 1994-01-01
% 218.76/218.96  |- skos__historyNote mesh__D018005
% 218.76/218.96       Receptors, Cell Surface %28%1980-1986%29%
% 218.76/218.96  |- mesh__recordAuthorizer mesh__D018005 sjn
% 218.76/218.96  |- skos__broader mesh__D018005smesh__D043562
% 218.76/218.96  |- skos__broader mesh__D018005smesh__D018013
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D018005 2006
% 218.76/218.96  |- skos__broader mesh__D018005smesh__D011964
% 218.76/218.96  |- skos__historyNote mesh__D018005
% 218.76/218.96       Receptors, Gastrointestinal Hormone %28%1987-1993%29%
% 218.76/218.96  |- mesh__dateRevised mesh__D018005 2003-07-09
% 218.76/218.96  |- mesh__recordMaintainer mesh__D018005 jmp
% 218.76/218.96  |- mesh__onlineNote mesh__D018005
% 218.76/218.96       use RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE %28%NM%29% to search VASOACTIVE INTESTINAL PEPTIDE RECEPTOR 1980-93%A%  
% 218.76/218.96  |- rdf__type mesh__D018005sskos__Concept
% 218.76/218.96  |- skos__altLabel mesh__D018005 Receptors, VIP
% 218.76/218.96  |- mesh__publicMeSHNote mesh__D018005
% 218.76/218.96       94; VASOACTIVE INTESTINAL PEPTIDE RECEPTOR was indexed under RECEPTORS, GASTROINTESTINAL HORMONE 1987-93 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1980-86%A%  
% 218.76/218.96  |- mesh__historyNote mesh__D018005
% 218.76/218.96       94; was VASOACTIVE INTESTINAL PEPTIDE RECEPTOR %28%NM%29% 1980-93%A%  
% 218.76/218.96  |- skos__broader mesh__D010022smesh__D010026
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010022 2002
% 218.76/218.96  |- mesh__recordMaintainer mesh__D010022 ags
% 218.76/218.96  |- skos__scopeNote mesh__D010022
% 218.76/218.96       Excessive formation of dense trabecular bone leading to pathological fractures; OSTEITIS; SPLENOMEGALY with infarct; ANEMIA; and extramedullary hemopoiesis %28%HEMATOPOIESIS, EXTRAMEDULLARY%29%.%A%    
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010022 2006A
% 218.76/218.96  |- skos__hiddenLabel mesh__D010022 Albers Schoenberg Disease
% 218.76/218.96  |- skos__prefLabel mesh__D010022 Osteopetrosis
% 218.76/218.96  |- skos__hiddenLabel mesh__D010022 Osteopetroses
% 218.76/218.96  |- skos__altLabel mesh__D010022 Marble Bone Disease
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010022 2003
% 218.76/218.96  |- mesh__dateRevised mesh__D010022 2005-07-22
% 218.76/218.96  |- rdf__type mesh__D010022sskos__Concept
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010022 2004
% 218.76/218.96  |- mesh__recordOriginator mesh__D010022 NLM
% 218.76/218.96  |- mesh__recordAuthorizer mesh__D010022 ags
% 218.76/218.96  |- skos__annotation mesh__D010022 do not confuse with OSTEOPOROSIS   
% 218.76/218.96  |- skos__hiddenLabel mesh__D010022 Disease, Marble Bone
% 218.76/218.96  |- mesh__dateCreated mesh__D010022 1999-01-01
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010022 2005
% 218.76/218.96  |- skos__altLabel mesh__D010022 Albers-Schoenberg Disease
% 218.76/218.96  |- skos__altLabel mesh__D010022 Osteosclerosis Fragilis
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D010022 2006
% 218.76/218.96  |- skos__hiddenLabel mesh__D010022 Disease, Albers-Schoenberg
% 218.76/218.96  |- skos__broader mesh__D048490smesh__D020930
% 218.76/218.96  |- mesh__recordMaintainer mesh__D048490 DRC
% 218.76/218.96  |- skos__hiddenLabel mesh__D048490 mil raf Protein Kinases
% 218.76/218.96  |- mesh__publicMeSHNote mesh__D048490
% 218.76/218.96       2005; MIL-RAF PROTEIN KINASES %26% MIL-RAF PROTEINS was indexed under PROTEIN-SERINE-THREONINE KINASES 1993-97 %26% PROTO-ONCOGENE PROTEINS 1986-97%A%  
% 218.76/218.96  |- skos__hiddenLabel mesh__D048490 Proteins raf, Proto-Oncogene
% 218.76/218.96  |- mesh__dateRevised mesh__D048490 2005-06-30
% 218.76/218.96  |- skos__hiddenLabel mesh__D048490 raf Serine Theonine Protein Kinases
% 218.76/218.96  |- skos__hiddenLabel mesh__D048490 Kinases, mil-raf Protein
% 218.76/218.96  |- mesh__dateCreated mesh__D048490 2004-07-07
% 218.76/218.96  |- skos__altLabel mesh__D048490 raf Serine-Theonine Protein Kinases
% 218.76/218.96  |- skos__hiddenLabel mesh__D048490 Protein Kinases, mil-raf
% 218.76/218.96  |- skos__scopeNote mesh__D048490
% 218.76/218.96       A family of closely-related serine-threonine kinases that were originally identified as the cellular homologs of the retrovirus-derived V-RAF KINASES. They are MAP kinase kinase kinases that play important roles in SIGNAL TRANSDUCTION.%A%    
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D048490 2006
% 218.76/218.96  |- mesh__recordAuthorizer mesh__D048490 sjn
% 218.76/218.96  |- skos__hiddenLabel mesh__D048490 Proto Oncogene Proteins raf
% 218.76/218.96  |- skos__broader mesh__D048490smesh__D011518
% 218.76/218.96  |- skos__hiddenLabel mesh__D048490 Kinases, raf
% 218.76/218.96  |- skos__altLabel mesh__D048490 MIL-RAF Proteins
% 218.76/218.96  |- skos__historyNote mesh__D048490
% 218.76/218.96       Proto-Oncogene Proteins c-raf %28%1986-2004%29%
% 218.76/218.96  |- rdf__type mesh__D048490sskos__Concept
% 218.76/218.96  |- skos__prefLabel mesh__D048490 raf Kinases
% 218.76/218.96  |- skos__altLabel mesh__D048490 Proto-Oncogene Proteins raf
% 218.76/218.96  |- skos__altLabel mesh__D048490 raf Proto-Oncogene Proteins
% 218.76/218.96  |- skos__hiddenLabel mesh__D048490 Proto-Oncogene Proteins, raf
% 218.76/218.96  |- skos__altLabel mesh__D048490 raf MAP Kinase Kinase Kinases
% 218.76/218.96  |- mesh__dateEstablished mesh__D048490 2005-01-01
% 218.76/218.96  |- skos__hiddenLabel mesh__D048490 raf Proto Oncogene Proteins
% 218.76/218.96  |- skos__hiddenLabel mesh__D048490 MIL RAF Proteins
% 218.76/218.96  |- mesh__historyNote mesh__D048490 2005   
% 218.76/218.96  |- mesh__recordOriginator mesh__D048490 jmp
% 218.76/218.96  |- skos__altLabel mesh__D009279 Tetracenes
% 218.76/218.96  |- mesh__historyNote mesh__D009279 66   
% 218.76/218.96  |- mesh__recordAuthorizer mesh__D009279 sjn
% 218.76/218.96  |- mesh__dateRevised mesh__D009279 2004-07-07
% 218.76/218.96  |- rdf__type mesh__D009279sskos__Concept
% 218.76/218.96  |- skos__broader mesh__D009279smesh__D011084
% 218.76/218.96  |- mesh__dateEstablished mesh__D009279 1966-01-01
% 218.76/218.96  |- mesh__dateCreated mesh__D009279 1999-01-01
% 218.76/218.96  |- mesh__recordMaintainer mesh__D009279 ssb
% 218.76/218.96  |- mesh__activeMeSHYear mesh__D009279 2005
% 218.76/218.96  |- skos__prefLabel mesh__D009279 Naphthacenes
% 218.76/218.97  |- mesh__recordOriginator mesh__D009279 NLM
% 218.76/218.97  |- skos__altLabel mesh__D009279 Benz%28%b%29%Anthracenes
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D009279 2006
% 218.76/218.97  |- mesh__publicMeSHNote mesh__D009279 66   
% 218.76/218.97  |- skos__scopeNote mesh__D009279
% 218.76/218.97       Polyacenes with four ortho-fused benzene rings in a straight linear arrangement. This group is best known for the subclass called TETRACYCLINES.%A%    
% 218.76/218.97  |- skos__hiddenLabel mesh__D001296 Aid, Audiovisual
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D001296 2005
% 218.76/218.97  |- skos__hiddenLabel mesh__D001296 Aid, Audio-Visual
% 218.76/218.97  |- rdf__type mesh__D001296sskos__Concept
% 218.76/218.97  |- skos__hiddenLabel mesh__D001296 Aids, Audiovisual
% 218.76/218.97  |- skos__hiddenLabel mesh__D001296 Aid, Visual
% 218.76/218.97  |- mesh__dateRevised mesh__D001296 2004-07-07
% 218.76/218.97  |- skos__broader mesh__D001296smesh__D013664
% 218.76/218.97  |- skos__hiddenLabel mesh__D001296 Aids, Visual
% 218.76/218.97  |- mesh__dateCreated mesh__D001296 1999-01-01
% 218.76/218.97  |- skos__hiddenLabel mesh__D001296 Audio Visual Aids
% 218.76/218.97  |- skos__hiddenLabel mesh__D001296 Audio-Visual Aid
% 218.76/218.97  |- skos__hiddenLabel mesh__D001296 Visual Aid
% 218.76/218.97  |- skos__altLabel mesh__D001296 Audio-Visual Aids
% 218.76/218.97  |- mesh__publicMeSHNote mesh__D001296 96; was AUDIO-VISUAL AIDS 1963-95   
% 218.76/218.97  |- skos__hiddenLabel mesh__D001296 Aids, Audio-Visual
% 218.76/218.97  |- mesh__historyNote mesh__D001296 96; was AUDIO-VISUAL AIDS 1963-95   
% 218.76/218.97  |- skos__annotation mesh__D001296 TEACHING MATERIALS is also available   
% 218.76/218.97  |- mesh__recordAuthorizer mesh__D001296 sjn
% 218.76/218.97  |- skos__broader mesh__D001296smesh__D018961
% 218.76/218.97  |- skos__hiddenLabel mesh__D001296 Audiovisual Aid
% 218.76/218.97  |- mesh__recordOriginator mesh__D001296 NLM
% 218.76/218.97  |- mesh__recordMaintainer mesh__D001296 ags
% 218.76/218.97  |- skos__prefLabel mesh__D001296 Audiovisual Aids
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D001296 2006
% 218.76/218.97  |- skos__scopeNote mesh__D001296
% 218.76/218.97       Auditory and visual instructional materials.     
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D020450 2003
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D020450 2001
% 218.76/218.97  |- skos__hiddenLabel mesh__D020450 Ion, Heavy
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D020450 2004
% 218.76/218.97  |- skos__broader mesh__D020450smesh__D004601
% 218.76/218.97  |- mesh__historyNote mesh__D020450 99   
% 218.76/218.97  |- skos__prefLabel mesh__D020450 Heavy Ions
% 218.76/218.97  |- skos__hiddenLabel mesh__D020450 Heavy Ion
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D020450 2002
% 218.76/218.97  |- skos__annotation mesh__D020450 coord with specific element   
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D020450 2005
% 218.76/218.97  |- mesh__dateCreated mesh__D020450 1998-06-10
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D020450 1999
% 218.76/218.97  |- skos__scopeNote mesh__D020450
% 218.76/218.97       Positively-charged atomic nuclei that have been stripped of their electrons. These particles have one or more units of electric charge and a mass exceeding that of the Helium-4 nucleus %28%alpha particle%29%.%A%    
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D020450 2006
% 218.76/218.97  |- skos__altLabel mesh__D020450 Ions, Heavy
% 218.76/218.97  |- rdf__type mesh__D020450sskos__Concept
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D020450 2000
% 218.76/218.97  |- mesh__dateEstablished mesh__D020450 1999-01-01
% 218.76/218.97  |- skos__historyNote mesh__D020450 Protons %28%1977-1998%29%
% 218.76/218.97  |- mesh__publicMeSHNote mesh__D020450 99   
% 218.76/218.97  |- skos__scopeNote mesh__D014413
% 218.76/218.97       Common name for various species of  large, vigorous ocean fishes in the family Scombridae.%A%    
% 218.76/218.97  |- skos__broader mesh__D014413smesh__D010473
% 218.76/218.97  |- mesh__recordAuthorizer mesh__D014413 sjn
% 218.76/218.97  |- rdf__type mesh__D014413sskos__Concept
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D014413 2004
% 218.76/218.97  |- skos__hiddenLabel mesh__D014413 Tunas
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D014413 2005
% 218.76/218.97  |- mesh__dateCreated mesh__D014413 1974-12-12
% 218.76/218.97  |- mesh__publicMeSHNote mesh__D014413 91; was see under FISHES 1975-90   
% 218.76/218.97  |- mesh__historyNote mesh__D014413
% 218.76/218.97       91%28%75%29%; was see under FISHES 1975-90   
% 218.76/218.97  |- mesh__dateEstablished mesh__D014413 1991-01-01
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D014413 2006
% 218.76/218.97  |- mesh__dateRevised mesh__D014413 2003-07-09
% 218.76/218.97  |- mesh__recordMaintainer mesh__D014413 ags
% 218.76/218.97  |- skos__annotation mesh__D014413
% 218.76/218.97       canned tuna = TUNA %28%IM%29% + FOOD PRESERVATION %28%IM%29%   
% 218.76/218.97  |- skos__prefLabel mesh__D014413 Tuna
% 218.76/218.97  |- mesh__recordOriginator mesh__D014413 NLM
% 218.76/218.97  |- skos__altLabel mesh__D038861 Tibetan Traditional Medicine
% 218.76/218.97  |- skos__historyNote mesh__D038861
% 218.76/218.97       Medicine, Oriental Traditional %28%1972-2002%29%
% 218.76/218.97  |- mesh__dateCreated mesh__D038861 2002-07-03
% 218.76/218.97  |- rdf__type mesh__D038861sskos__Concept
% 218.76/218.97  |- skos__altLabel mesh__D038861 Tibetan Medicine, Traditional
% 218.76/218.97  |- skos__historyNote mesh__D038861
% 218.76/218.97       Medicine, Chinese Traditional %28%1983-2002%29%
% 218.76/218.97  |- mesh__dateEstablished mesh__D038861 2003-01-01
% 218.76/218.97  |- mesh__publicMeSHNote mesh__D038861 2003   
% 218.76/218.97  |- skos__broader mesh__D038861smesh__D008518
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D038861 2003
% 218.76/218.97  |- skos__hiddenLabel mesh__D038861 Medicine, Traditional Tibetan
% 218.76/218.97  |- skos__scopeNote mesh__D038861
% 218.76/218.97       A system of traditional medicine which is based on the beliefs and practices of the Tibetan culture.%A%    
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D038861 2005
% 218.76/218.97  |- skos__altLabel mesh__D038861 Traditional Medicine, Tibetan
% 218.76/218.97  |- skos__related mesh__D038861smesh__D008516
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D038861 2004
% 218.76/218.97  |- skos__prefLabel mesh__D038861 Medicine, Tibetan Traditional
% 218.76/218.97  |- mesh__historyNote mesh__D038861 2003   
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D038861 2006
% 218.76/218.97  |- skos__hiddenLabel mesh__D038861 Traditional Tibetan Medicine
% 218.76/218.97  |- skos__annotation mesh__D005687
% 218.76/218.97       usually check tags PREGNANCY %26% FEMALE   
% 218.76/218.97  |- mesh__recordMaintainer mesh__D005687 lkt
% 218.76/218.97  |- mesh__recordAuthorizer mesh__D005687 sjn
% 218.76/218.97  |- skos__prefLabel mesh__D005687 Galactorrhea
% 218.76/218.97  |- mesh__dateRevised mesh__D005687 2005-06-30
% 218.76/218.97  |- mesh__historyNote mesh__D005687
% 218.76/218.97       91%28%75%29%; was see under LACTATION DISORDERS 1975-90   
% 218.76/218.97  |- skos__scopeNote mesh__D005687
% 218.76/218.97       Excessive or inappropriate LACTATION in females or males, and not necessarily related to PREGNANCY. Galactorrhea can occur either unilaterally or bilaterally, and be profuse or sparse. Its most common cause is HYPERPROLACTINEMIA.%A%    
% 218.76/218.97  |- mesh__dateEstablished mesh__D005687 1991-01-01
% 218.76/218.97  |- mesh__dateCreated mesh__D005687 1999-01-01
% 218.76/218.97  |- skos__hiddenLabel mesh__D005687 Galactorrheas
% 218.76/218.97  |- rdf__type mesh__D005687sskos__Concept
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D005687 2006
% 218.76/218.97  |- mesh__onlineNote mesh__D005687 search LACTATION DISORDERS 1966-74   
% 218.76/218.97  |- skos__broader mesh__D005687smesh__D007775
% 218.76/218.97  |- mesh__recordOriginator mesh__D005687 NLM
% 218.76/218.97  |- mesh__publicMeSHNote mesh__D005687
% 218.76/218.97       91; was see under LACTATION DISORDERS 1975-90   
% 218.76/218.97  |- mesh__dateCreated mesh__D024841 2001-07-25
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D024841 2005
% 218.76/218.97  |- mesh__publicMeSHNote mesh__D024841 2002   
% 218.76/218.97  |- mesh__dateEstablished mesh__D024841 2002-01-01
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D024841 2002
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D024841 2006
% 218.76/218.97  |- skos__historyNote mesh__D024841 Quinolines %28%1984-1986%29%
% 218.76/218.97  |- skos__broader mesh__D024841smesh__D015363
% 218.76/218.97  |- skos__prefLabel mesh__D024841 Fluoroquinolones
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D024841 2003
% 218.76/218.97  |- rdf__type mesh__D024841sskos__Concept
% 218.76/218.97  |- skos__historyNote mesh__D024841 Quinolones %28%1987-2001%29%
% 218.76/218.97  |- skos__historyNote mesh__D024841
% 218.76/218.97       Anti-Infective Agents, Quinolone %28%1987-2001%29%
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D024841 2004
% 218.76/218.97  |- mesh__historyNote mesh__D024841 2002   
% 218.76/218.97  |- skos__scopeNote mesh__D024841
% 218.76/218.97       A group of QUINOLONES with at least one fluorine atom and a piperazinyl group.%A%    
% 218.76/218.97  |- skos__hiddenLabel mesh__D024043 Collagen, Type II
% 218.76/218.97  |- skos__altLabel mesh__D024043 Collagen alpha1%28%II%29%
% 218.76/218.97  |- skos__annotation mesh__D024043
% 218.76/218.97       precursors: coord IM with PROCOLLAGEN %28%IM%29%   
% 218.76/218.97  |- skos__broader mesh__D024043smesh__D024022
% 218.76/218.97  |- skos__hiddenLabel mesh__D024043 Procollagen, Type II
% 218.76/218.97  |- skos__scopeNote mesh__D024043
% 218.76/218.97       A fibrillar collagen found predominantly in CARTILAGE and vitreous humor. It consists of three identical alpha1%28%II%29% chains.%A%    
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D024043 2005
% 218.76/218.97  |- mesh__publicMeSHNote mesh__D024043
% 218.76/218.97       2002; see COLLAGEN 1990-2001; for PROCOLLAGEN TYPE II see PROCOLLAGEN 1984-2001%A%  
% 218.76/218.97  |- mesh__recordOriginator mesh__D024043 jmp
% 218.76/218.97  |- skos__hiddenLabel mesh__D024043 II Procollagen, Type
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D024043 2006
% 218.76/218.97  |- rdf__type mesh__D024043sskos__Concept
% 218.76/218.97  |- mesh__dateEstablished mesh__D024043 2002-01-01
% 218.76/218.97  |- skos__prefLabel mesh__D024043 Collagen Type II
% 218.76/218.97  |- mesh__dateRevised mesh__D024043 2004-07-07
% 218.76/218.97  |- mesh__dateCreated mesh__D024043 2001-07-25
% 218.76/218.97  |- skos__historyNote mesh__D024043 Collagen %28%1977-2001%29%
% 218.76/218.97  |- mesh__historyNote mesh__D024043
% 218.76/218.97       2002; use COLLAGEN 1990-2001; for PROCOLLAGEN TYPE II use PROCOLLAGEN 1982-2001%A%  
% 218.76/218.97  |- mesh__recordAuthorizer mesh__D024043 sjn
% 218.76/218.97  |- skos__altLabel mesh__D024043 Type II Collagen
% 218.76/218.97  |- skos__altLabel mesh__D024043 Type II Procollagen
% 218.76/218.97  |- skos__altLabel mesh__D024043 Collagen Type II, alpha1 Chain
% 218.76/218.97  |- mesh__recordMaintainer mesh__D024043 jmp
% 218.76/218.97  |- skos__annotation mesh__D018804
% 218.76/218.97       causes resp failure; DF: HANTAVIRUS PULM SYNDROME   
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D018804 1997
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D018804 2002
% 218.76/218.97  |- rdf__type mesh__D018804sskos__Concept
% 218.76/218.97  |- mesh__dateCreated mesh__D018804 1994-05-23
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D018804 2005
% 218.76/218.97  |- mesh__historyNote mesh__D018804 95   
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D018804 1996
% 218.76/218.97  |- mesh__dateEstablished mesh__D018804 1995-01-01
% 218.76/218.97  |- skos__broader mesh__D018804smesh__D018778
% 218.76/218.97  |- skos__broader mesh__D018804smesh__D012131
% 218.76/218.97  |- skos__historyNote mesh__D018804
% 218.76/218.97       Bunyaviridae Infections %28%1993-1994%29%
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D018804 2001
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D018804 1999
% 218.76/218.97  |- skos__hiddenLabel mesh__D018804 Hantavirus Pulmonary Syndromes
% 218.76/218.97  |- skos__scopeNote mesh__D018804
% 218.76/218.97       Acute respiratory illness in humans caused by the Muerto Canyon virus whose primary rodent reservoir is the deer mouse Peromyscus maniculatus. First identified in the southwestern United States, this syndrome is characterized most commonly by fever, myalgias, headache, cough, and rapid respiratory failure.%A%    
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D018804 2004
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D018804 2000
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D018804 1998
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D018804 2003
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D018804 1995
% 218.76/218.97  |- mesh__publicMeSHNote mesh__D018804 95   
% 218.76/218.97  |- skos__prefLabel mesh__D018804 Hantavirus Pulmonary Syndrome
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D018804 2006
% 218.76/218.97  |- mesh__dateEstablished mesh__D010821 1974-01-01
% 218.76/218.97  |- skos__historyNote mesh__D010821 Physicians %28%1966-1971%29%
% 218.76/218.97  |- skos__hiddenLabel mesh__D010821 Physician, Primary Care
% 218.76/218.97  |- mesh__recordOriginator mesh__D010821 NLM
% 218.76/218.97  |- skos__hiddenLabel mesh__D010821 Physicians, Primary Care
% 218.76/218.97  |- mesh__dateCreated mesh__D010821 1999-01-01
% 218.76/218.97  |- skos__annotation mesh__D010821
% 218.76/218.97       /educ permitted: coord with specific type of educ   
% 218.76/218.97  |- skos__broader mesh__D010821smesh__D010820
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010821 2000
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010821 1994
% 218.76/218.97  |- skos__hiddenLabel mesh__D010821 Family Physicians
% 218.76/218.97  |- skos__altLabel mesh__D010821 Generalists
% 218.76/218.97  |- skos__hiddenLabel mesh__D010821 Practitioners, General
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010821 1998
% 218.76/218.97  |- skos__hiddenLabel mesh__D010821 Generalist
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010821 2001
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010821 1995
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010821 2005
% 218.76/218.97  |- skos__scopeNote mesh__D010821
% 218.76/218.97       Those physicians who have completed the education requirements specified by the American Academy of Family Physicians.%A%    
% 218.76/218.97  |- skos__prefLabel mesh__D010821 Physicians, Family
% 218.76/218.97  |- mesh__recordMaintainer mesh__D010821 TAP
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010821 1999
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010821 1996
% 218.76/218.97  |- mesh__recordAuthorizer mesh__D010821 PLS
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010821 2002
% 218.76/218.97  |- skos__hiddenLabel mesh__D010821 Physician, Family
% 218.76/218.97  |- mesh__publicMeSHNote mesh__D010821 74   
% 218.76/218.97  |- skos__hiddenLabel mesh__D010821 Practitioner, General
% 218.76/218.97  |- mesh__dateRevised mesh__D010821 1992-05-18
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010821 2006
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010821 1993
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010821 2003
% 218.76/218.97  |- skos__hiddenLabel mesh__D010821 General Practitioner
% 218.76/218.97  |- skos__hiddenLabel mesh__D010821 Family Physician
% 218.76/218.97  |- rdf__type mesh__D010821sskos__Concept
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010821 1997
% 218.76/218.97  |- skos__hiddenLabel mesh__D010821 Primary Care Physician
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010821 2004
% 218.76/218.97  |- mesh__historyNote mesh__D010821 74%28%72%29%   
% 218.76/218.97  |- skos__historyNote mesh__D010821 Family Practice %28%1966-1971%29%
% 218.76/218.97  |- mesh__dateRevised mesh__D018006 2005-06-30
% 218.76/218.97  |- skos__annotation mesh__D018006
% 218.76/218.97       muscle-specific transcription factors; DF: MYOGENIC REG FACTORS%A%  
% 218.76/218.97  |- mesh__publicMeSHNote mesh__D018006 94   
% 218.76/218.97  |- skos__broader mesh__D018006smesh__D009124
% 218.76/218.97  |- mesh__historyNote mesh__D018006 94   
% 218.76/218.97  |- skos__prefLabel mesh__D018006 Myogenic Regulatory Factors
% 218.76/218.97  |- skos__historyNote mesh__D018006 Muscle Proteins %28%1989-1993%29%
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D018006 2006
% 218.76/218.97  |- skos__scopeNote mesh__D018006
% 218.76/218.97       A family of muscle-specific transcription factors which bind to DNA in control regions and thus regulate myogenesis. All members of this family contain a conserved helix-loop-helix motif which is homologous to the myc family proteins. These factors are only found in skeletal muscle. Members include the myoD protein %28%MYOD PROTEIN%29%; MYOGENIN; myf-5, and myf-6 %28%also called MRF4 or herculin%29%.%A%    
% 218.76/218.97  |- mesh__recordOriginator mesh__D018006 AGS
% 218.76/218.97  |- rdf__type mesh__D018006sskos__Concept
% 218.76/218.97  |- mesh__dateEstablished mesh__D018006 1994-01-01
% 218.76/218.97  |- mesh__recordAuthorizer mesh__D018006 sjn
% 218.76/218.97  |- mesh__dateCreated mesh__D018006 1993-06-04
% 218.76/218.97  |- skos__hiddenLabel mesh__D018006 Regulatory Factors, Myogenic
% 218.76/218.97  |- skos__hiddenLabel mesh__D018006 Factors, Myogenic Regulatory
% 218.76/218.97  |- mesh__recordMaintainer mesh__D018006 DRC
% 218.76/218.97  |- skos__broader mesh__D018006smesh__D051792
% 218.76/218.97  |- mesh__recordMaintainer mesh__D010023 TAP
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010023 1999
% 218.76/218.97  |- mesh__historyNote mesh__D010023
% 218.76/218.97       91%28%64%29%; was see under OSTEOSCLEROSIS 1970-90; was see under BONE DISEASES 1967-69%A%  
% 218.76/218.97  |- skos__hiddenLabel mesh__D010023 Osteopoikiloses
% 218.76/218.97  |- mesh__recordOriginator mesh__D010023 NLM
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010023 2003
% 218.76/218.97  |- rdf__type mesh__D010023sskos__Concept
% 218.76/218.97  |- skos__prefLabel mesh__D010023 Osteopoikilosis
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010023 2000
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010023 2004
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010023 2001
% 218.76/218.97  |- mesh__dateRevised mesh__D010023 1995-06-08
% 218.76/218.97  |- mesh__dateCreated mesh__D010023 1999-01-01
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010023 2005
% 218.76/218.97  |- skos__broader mesh__D010023smesh__D010026
% 218.76/218.97  |- mesh__publicMeSHNote mesh__D010023
% 218.76/218.97       91; was see under OSTEOSCLEROSIS 1970-90; was see under BONE DISEASES 1967-69%A%  
% 218.76/218.97  |- mesh__dateEstablished mesh__D010023 1991-01-01
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010023 2002
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010023 1996
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010023 2006
% 218.76/218.97  |- skos__broader mesh__D010023smesh__D003240
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010023 1997
% 218.76/218.97  |- skos__scopeNote mesh__D010023
% 218.76/218.97       An asymptomatic, autosomal dominant trait in which pea-sized sclerotic spots, prominent in the metaphyseal area, are accompanied by unique cutaneous lesions. These are yellowish papules or plaques with increased elastin content. %28%From Cecil Textbook of Medicine, 19th ed, pp1434-35%29%%A%    
% 218.76/218.97  |- mesh__recordAuthorizer mesh__D010023 PLS
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D010023 1998
% 218.76/218.97  |- skos__annotation mesh__D010023 a form of osteosclerosis   
% 218.76/218.97  |- skos__altLabel mesh__D048491 A-raf Protein Kinase
% 218.76/218.97  |- skos__hiddenLabel mesh__D048491 A raf Kinase
% 218.76/218.97  |- mesh__dateEstablished mesh__D048491 2005-01-01
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D048491 2006
% 218.76/218.97  |- mesh__recordOriginator mesh__D048491 jmp
% 218.76/218.97  |- skos__scopeNote mesh__D048491
% 218.76/218.97       A raf kinase subclass expressed primarily in non-neuronal tissues such as SKELETAL MUSCLE. The A-raf kinases are MAP kinase kinase kinases that have specificity for MAP KINASE KINASE 1.%A%    
% 218.76/218.97  |- skos__broader mesh__D048491smesh__D048490
% 218.76/218.97  |- skos__hiddenLabel mesh__D048491 Proto Oncogene Protein A raf
% 218.76/218.97  |- skos__hiddenLabel mesh__D048491 Kinase, A-raf
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D048491 2005
% 218.76/218.97  |- skos__prefLabel mesh__D048491 Proto-Oncogene Proteins A-raf
% 218.76/218.97  |- mesh__recordMaintainer mesh__D048491 jmp
% 218.76/218.97  |- rdf__type mesh__D048491sskos__Concept
% 218.76/218.97  |- skos__hiddenLabel mesh__D048491 Proteins A-raf, Proto-Oncogene
% 218.76/218.97  |- skos__hiddenLabel mesh__D048491 Proto Oncogene Proteins A raf
% 218.76/218.97  |- mesh__recordAuthorizer mesh__D048491 sjn
% 218.76/218.97  |- mesh__publicMeSHNote mesh__D048491
% 218.76/218.97       2005; PROTO-ONCOGENE PROTEIN A-RAF was indexed under PROTO-ONCOGENE PROTEINS C-RAF 2001-2004%A%  
% 218.76/218.97  |- skos__historyNote mesh__D048491
% 218.76/218.97       Proto-Oncogene Proteins c-raf %28%1989-2004%29%
% 218.76/218.97  |- skos__altLabel mesh__D048491 Proto-Oncogene Protein A-raf
% 218.76/218.97  |- skos__historyNote mesh__D048491 Neoplasm Proteins %28%1985-1988%29%
% 218.76/218.97  |- skos__altLabel mesh__D048491 A-raf Kinase
% 218.76/218.97  |- skos__altLabel mesh__D048491 A-raf-1 Protein
% 218.76/218.97  |- mesh__historyNote mesh__D048491 2005%28%2001%29%   
% 218.76/218.97  |- skos__hiddenLabel mesh__D048491 A raf 1 Protein
% 218.76/218.97  |- skos__hiddenLabel mesh__D048491 Kinase, A-raf Protein
% 218.76/218.97  |- mesh__dateCreated mesh__D048491 2004-07-07
% 218.76/218.97  |- skos__hiddenLabel mesh__D048491 A raf Protein Kinase
% 218.76/218.97  |- mesh__recordOriginator mesh__D001297 NLM
% 218.76/218.97  |- mesh__recordAuthorizer mesh__D001297 PLS
% 218.76/218.97  |- mesh__dateCreated mesh__D001297 1999-01-01
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D001297 1989
% 218.76/218.97  |- mesh__publicMeSHNote mesh__D001297 65   
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D001297 1997
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D001297 1991
% 218.76/218.97  |- skos__prefLabel mesh__D001297 Audioanalgesia
% 218.76/218.97  |- skos__broader mesh__D001297smesh__D000698
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D001297 2002
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D001297 1999
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D001297 1996
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D001297 1993
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D001297 1990
% 218.76/218.97  |- mesh__historyNote mesh__D001297 65   
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D001297 2004
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D001297 2001
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D001297 1995
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D001297 1998
% 218.76/218.97  |- skos__hiddenLabel mesh__D001297 Audioanalgesias
% 218.76/218.97  |- mesh__dateEstablished mesh__D001297 1965-01-01
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D001297 2006
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D001297 1992
% 218.76/218.97  |- mesh__dateRevised mesh__D001297 1991-11-02
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D001297 2003
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D001297 1994
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D001297 2005
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D001297 2000
% 218.76/218.97  |- rdf__type mesh__D001297sskos__Concept
% 218.76/218.97  |- skos__annotation mesh__D001297
% 218.76/218.97       do not use /util except by MeSH definition   
% 218.76/218.97  |- mesh__recordMaintainer mesh__D001297 PLS
% 218.76/218.97  |- mesh__recordAuthorizer mesh__D006780 sjn
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D006780 2000
% 218.76/218.97  |- mesh__publicMeSHNote mesh__D006780
% 218.76/218.97       91; was see under HOSPITALS 1986-90   
% 218.76/218.97  |- skos__broader mesh__D006780smesh__D006761
% 218.76/218.97  |- rdf__type mesh__D006780sskos__Concept
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D006780 2001
% 218.76/218.97  |- mesh__recordMaintainer mesh__D006780 kle
% 218.76/218.97  |- skos__historyNote mesh__D006780 Rural Health %28%1966-1985%29%
% 218.76/218.97  |- mesh__dateEstablished mesh__D006780 1991-01-01
% 218.76/218.97  |- skos__hiddenLabel mesh__D006780 Hospital, Rural
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D006780 2005
% 218.76/218.97  |- mesh__dateCreated mesh__D006780 1985-05-23
% 218.76/218.97  |- skos__prefLabel mesh__D006780 Hospitals, Rural
% 218.76/218.97  |- mesh__historyNote mesh__D006780
% 218.76/218.97       91%28%86%29%; was see under HOSPITALS 1986-90   
% 218.76/218.97  |- skos__scopeNote mesh__D006780 Hospitals located in a rural area.     
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D006780 2006
% 218.76/218.97  |- skos__historyNote mesh__D006780 Rural Population %28%1968-1985%29%
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D006780 2002
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D006780 2003
% 218.76/218.97  |- mesh__dateRevised mesh__D006780 1999-11-03
% 218.76/218.97  |- skos__annotation mesh__D006780
% 218.76/218.97       coord IM with special hosp or med specialty %28%IM or NIM%29% if pertinent; specify geog%A%  
% 218.76/218.97  |- mesh__recordOriginator mesh__D006780 EC
% 218.76/218.97  |- skos__altLabel mesh__D006780 Rural Hospitals
% 218.76/218.97  |- skos__hiddenLabel mesh__D006780 Rural Hospital
% 218.76/218.97  |- skos__historyNote mesh__D006780 Hospitals %28%1966-1985%29%
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D006780 2004
% 218.76/218.97  |- mesh__dateEstablished mesh__D020451 1999-01-01
% 218.76/218.97  |- skos__scopeNote mesh__D020451
% 218.76/218.97       Overlapping of cloned or sequenced DNA to construct a continuous region of a gene, chromosome or genome.%A%    
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D020451 2001
% 218.76/218.97  |- skos__broader mesh__D020451smesh__D005821
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D020451 2005
% 218.76/218.97  |- mesh__recordAuthorizer mesh__D020451 sjn
% 218.76/218.97  |- skos__hiddenLabel mesh__D020451 Mapping, Contig
% 218.76/218.97  |- skos__broader mesh__D020451smesh__D020161
% 218.76/218.97  |- mesh__recordMaintainer mesh__D020451 nns
% 218.76/218.97  |- mesh__historyNote mesh__D020451 99   
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D020451 2006
% 218.76/218.97  |- mesh__recordOriginator mesh__D020451 NNS
% 218.76/218.97  |- rdf__type mesh__D020451sskos__Concept
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D020451 2002
% 218.76/218.97  |- mesh__dateCreated mesh__D020451 1998-06-18
% 218.76/218.97  |- skos__prefLabel mesh__D020451 Contig Mapping
% 218.76/218.97  |- mesh__publicMeSHNote mesh__D020451 99   
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D020451 2003
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D020451 2004
% 218.76/218.97  |- mesh__dateRevised mesh__D020451 2000-06-22
% 218.76/218.97  |- mesh__recordAuthorizer mesh__D014414 sjn
% 218.76/218.97  |- rdf__type mesh__D014414sskos__Concept
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D014414 2003
% 218.76/218.97  |- mesh__dateRevised mesh__D014414 2001-07-25
% 218.76/218.97  |- mesh__recordMaintainer mesh__D014414 jmp
% 218.76/218.97  |- skos__annotation mesh__D014414
% 218.76/218.97       W-184; W-180, 182, 183, 186 = TUNGSTEN %28%IM%29% + ISOTOPES %28%NIM%29%; W-176-179, 181, 185, 187-189 = TUNGSTEN %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 218.76/218.97  |- skos__altLabel mesh__D014414 Wolfram
% 218.76/218.97  |- skos__broader mesh__D014414smesh__D019216
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D014414 2002
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D014414 2004
% 218.76/218.97  |- skos__prefLabel mesh__D014414 Tungsten
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D014414 2005
% 218.76/218.97  |- skos__broader mesh__D014414smesh__D028561
% 218.76/218.97  |- mesh__dateCreated mesh__D014414 1999-01-01
% 218.76/218.97  |- mesh__recordOriginator mesh__D014414 NLM
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D014414 2006
% 218.76/218.97  |- skos__scopeNote mesh__D014414
% 218.76/218.97       Tungsten. A metallic element with the atomic symbol W, atomic number 74, and atomic weight 183.85. It is used in many manufacturing applications, including increasing the hardness, toughness, and tensile strength of steel; manufacture of filaments for incandescent light bulbs; and in contact points for automotive and electrical apparatus.%A%    
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D005688 2006
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D005688 2005
% 218.76/218.97  |- mesh__dateCreated mesh__D005688 1999-01-01
% 218.76/218.97  |- mesh__dateEstablished mesh__D005688 1973-01-01
% 218.76/218.97  |- skos__historyNote mesh__D005688 Hexosamines %28%1966-1970%29%
% 218.76/218.97  |- skos__prefLabel mesh__D005688 Galactosamine
% 218.76/218.97  |- mesh__recordOriginator mesh__D005688 NLM
% 218.76/218.97  |- mesh__recordAuthorizer mesh__D005688 sjn
% 218.76/218.97  |- mesh__dateRevised mesh__D005688 2004-07-07
% 218.76/218.97  |- mesh__historyNote mesh__D005688 73%28%71%29%   
% 218.76/218.97  |- rdf__type mesh__D005688sskos__Concept
% 218.76/218.97  |- mesh__recordMaintainer mesh__D005688 ssb
% 218.76/218.97  |- mesh__publicMeSHNote mesh__D005688 73   
% 218.76/218.97  |- skos__broader mesh__D005688smesh__D006595
% 218.76/218.97  |- skos__broader mesh__D003815Q000193smesh__D003815
% 218.76/218.97  |- mesh__preferredCombination mesh__D003815Q000193smesh__D004497
% 218.76/218.97  |- rdf__type mesh__D003815Q000193smesh__CompoundConcept
% 218.76/218.97  |- mesh__publicMeSHNote mesh__D030081 2002; see ORBIVIRUS 1994-2001   
% 218.76/218.97  |- skos__historyNote mesh__D030081 Arboviruses %28%1971-1988%29%
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D030081 2003
% 218.76/218.97  |- skos__annotation mesh__D030081
% 218.76/218.97       infection: coord IM with REOVIRIDAE INFECTIONS %28%IM%29%   
% 218.76/218.97  |- mesh__historyNote mesh__D030081 2002; use ORBIVIRUS 1994-2001   
% 218.76/218.97  |- skos__altLabel mesh__D030081 Chuzan virus
% 218.76/218.97  |- skos__prefLabel mesh__D030081 Palyam Virus
% 218.76/218.97  |- mesh__activeMeSHYear mesh__D030081 2006
% 218.76/218.97  |- skos__historyNote mesh__D030081 Reoviridae %28%1988-1993%29%
% 218.76/218.98  |- skos__historyNote mesh__D030081 Orbivirus %28%1994-2001%29%
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D030081 2005
% 218.76/218.98  |- mesh__dateCreated mesh__D030081 2001-07-25
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D030081 2002
% 218.76/218.98  |- skos__scopeNote mesh__D030081
% 218.76/218.98       A species of ORBIVIRUS infecting cattle and sheep. It is transmitted by culicine mosquitoes and gnats %28%CULICOIDES%29%.%A%    
% 218.76/218.98  |- skos__broader mesh__D030081smesh__D018163
% 218.76/218.98  |- mesh__dateEstablished mesh__D030081 2002-01-01
% 218.76/218.98  |- rdf__type mesh__D030081sskos__Concept
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D030081 2004
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D018805 1996
% 218.76/218.98  |- mesh__publicMeSHNote mesh__D018805 95   
% 218.76/218.98  |- skos__historyNote mesh__D018805 Septicemia %28%1966-1994%29%
% 218.76/218.98  |- skos__historyNote mesh__D018805 specific infection %28%1966-1994%29%
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D018805 2002
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D018805 1999
% 218.76/218.98  |- mesh__dateCreated mesh__D018805 1994-05-23
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D018805 2004
% 218.76/218.98  |- skos__scopeNote mesh__D018805
% 218.76/218.98       The presence of pathogenic microorganisms or their toxins in tissues or in the blood. Systemic disease caused by the spread of the microorganisms via the circulating blood is commonly called SEPTICEMIA. %28%From Stedman, 25th ed%29%%A%    
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D018805 1998
% 218.76/218.98  |- mesh__dateEstablished mesh__D018805 1995-01-01
% 218.76/218.98  |- skos__broader mesh__D018805smesh__D007239
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D018805 2003
% 218.76/218.98  |- skos__annotation mesh__D018805
% 218.76/218.98       a type of infect; do not confuse with SEPTICEMIA; SEPSIS SYNDROME is also available%A%  
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D018805 1995
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D018805 2001
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D018805 2006
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D018805 2000
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D018805 1997
% 218.76/218.98  |- rdf__type mesh__D018805sskos__Concept
% 218.76/218.98  |- skos__prefLabel mesh__D018805 Sepsis
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D018805 2005
% 218.76/218.98  |- mesh__historyNote mesh__D018805 95   
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010822 2000
% 218.76/218.98  |- skos__prefLabel mesh__D010822 Physicians, Women
% 218.76/218.98  |- skos__scopeNote mesh__D010822 Women licensed to practice medicine.     
% 218.76/218.98  |- skos__broader mesh__D010822smesh__D014930
% 218.76/218.98  |- mesh__dateRevised mesh__D010822 1999-11-03
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010822 2001
% 218.76/218.98  |- skos__annotation mesh__D010822
% 218.76/218.98       /educ = EDUCATION, MEDICAL or its specifics; Manual 34.1l.2%A%  
% 218.76/218.98  |- rdf__type mesh__D010822sskos__Concept
% 218.76/218.98  |- mesh__recordOriginator mesh__D010822 NLM
% 218.76/218.98  |- mesh__dateCreated mesh__D010822 1999-01-01
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010822 2003
% 218.76/218.98  |- skos__hiddenLabel mesh__D010822 Woman Physician
% 218.76/218.98  |- skos__broader mesh__D010822smesh__D010820
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010822 2002
% 218.76/218.98  |- skos__altLabel mesh__D010822 Women Physicians
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010822 2004
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010822 2005
% 218.76/218.98  |- skos__hiddenLabel mesh__D010822 Woman Physicians
% 218.76/218.98  |- mesh__recordAuthorizer mesh__D010822 sjn
% 218.76/218.98  |- skos__hiddenLabel mesh__D010822 Physicians, Woman
% 218.76/218.98  |- mesh__recordMaintainer mesh__D010822 kle
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010822 2006
% 218.76/218.98  |- skos__altLabel mesh__D010822 Physician, Woman
% 218.76/218.98  |- skos__hiddenLabel mesh__D010024 Post-Traumatic Osteoporosis
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010024 2004
% 218.76/218.98  |- skos__hiddenLabel mesh__D010024 Osteoporosis, Age Related
% 218.76/218.98  |- skos__hiddenLabel mesh__D010024 Senile Osteoporoses
% 218.76/218.98  |- mesh__recordAuthorizer mesh__D010024 sjn
% 218.76/218.98  |- mesh__dateCreated mesh__D010024 1999-01-01
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010024 2005
% 218.76/218.98  |- skos__hiddenLabel mesh__D010024 Age-Related Bone Losses
% 218.76/218.98  |- skos__hiddenLabel mesh__D010024 Age-Related Bone Loss
% 218.76/218.98  |- mesh__recordOriginator mesh__D010024 NLM
% 218.76/218.98  |- skos__hiddenLabel mesh__D010024 Osteoporosis, Post Traumatic
% 218.76/218.98  |- skos__hiddenLabel mesh__D010024 Bone Loss, Age Related
% 218.76/218.98  |- skos__altLabel mesh__D010024 Age-Related Osteoporosis
% 218.76/218.98  |- skos__altLabel mesh__D010024 Senile Osteoporosis
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010024 2006
% 218.76/218.98  |- skos__hiddenLabel mesh__D010024 Age-Related Osteoporoses
% 218.76/218.98  |- skos__altLabel mesh__D010024 Bone Loss, Age-Related
% 218.76/218.98  |- skos__hiddenLabel mesh__D010024 Post-Traumatic Osteoporoses
% 218.76/218.98  |- skos__hiddenLabel mesh__D010024 Bone Losses, Age-Related
% 218.76/218.98  |- skos__hiddenLabel mesh__D010024 Osteoporoses
% 218.76/218.98  |- mesh__dateRevised mesh__D010024 2003-07-22
% 218.76/218.98  |- skos__hiddenLabel mesh__D010024 Osteoporoses, Age-Related
% 218.76/218.98  |- mesh__recordMaintainer mesh__D010024 ags
% 218.76/218.98  |- skos__annotation mesh__D010024
% 218.76/218.98       related to aging: note X refs; age-related osteoporosis in men goes here; age-related osteoporosis in women is probably OSTEOPOROSIS, POSTMENOPAUSAL%A%  
% 218.76/218.98  |- skos__broader mesh__D010024smesh__D001851
% 218.76/218.98  |- skos__scopeNote mesh__D010024
% 218.76/218.98       Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis %28%OSTEOPOROSIS, POSTMENOPAUSAL%29% and age-related or senile osteoporosis.%A%    
% 218.76/218.98  |- skos__hiddenLabel mesh__D010024 Age Related Osteoporosis
% 218.76/218.98  |- rdf__type mesh__D010024sskos__Concept
% 218.76/218.98  |- skos__prefLabel mesh__D010024 Osteoporosis
% 218.76/218.98  |- skos__hiddenLabel mesh__D010024 Osteoporoses, Senile
% 218.76/218.98  |- mesh__recordAuthorizer mesh__D048492 sjn
% 218.76/218.98  |- rdf__type mesh__D048492sskos__Concept
% 218.76/218.98  |- skos__broader mesh__D048492smesh__D010238
% 218.76/218.98  |- mesh__recordMaintainer mesh__D048492 ags
% 218.76/218.98  |- mesh__publicMeSHNote mesh__D048492 2005   
% 218.76/218.98  |- mesh__dateEstablished mesh__D048492 2005-01-01
% 218.76/218.98  |- skos__historyNote mesh__D048492 Paragonimus %28%1965-2004%29%
% 218.76/218.98  |- mesh__dateCreated mesh__D048492 2004-07-07
% 218.76/218.98  |- mesh__historyNote mesh__D048492 2005   
% 218.76/218.98  |- skos__scopeNote mesh__D048492
% 218.76/218.98       A species of lung fluke infecting humans and other animals, and found chiefly in Asia and the Far East.%A%    
% 218.76/218.98  |- skos__annotation mesh__D048492
% 218.76/218.98       infection: coordinate IM with PARAGONIMIASIS %28%IM%29%; coordinate with specific helminth terms %28%for example, ANTIGENS, HELMINTH%29% if pertinent%A%  
% 218.76/218.98  |- mesh__recordOriginator mesh__D048492 ags
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D048492 2006
% 218.76/218.98  |- skos__prefLabel mesh__D048492 Paragonimus westermani
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D048492 2005
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D001298 2001
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D001298 1999
% 218.76/218.98  |- skos__historyNote mesh__D001298 Hearing %28%1966-1977%29%
% 218.76/218.98  |- mesh__recordOriginator mesh__D001298 EC
% 218.76/218.98  |- skos__prefLabel mesh__D001298 Audiology
% 218.76/218.98  |- mesh__publicMeSHNote mesh__D001298 78; was see under HEARING 1963-74   
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D001298 2004
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D001298 1996
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D001298 1995
% 218.76/218.98  |- skos__annotation mesh__D001298
% 218.76/218.98       SPEC: SPEC qualif; do not confuse with HEARING %28%physiol process%29% or HEARING TESTS or AUDIOMETRY %28%a specific type of hearing test%29%; AMERICAN SPEECH-LANGUAGE-HEARING ASSOCIATION is also available; DF: AUDIOL%A%  
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D001298 2000
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D001298 1998
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D001298 2006
% 218.76/218.98  |- mesh__dateRevised mesh__D001298 1993-06-04
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D001298 2003
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D001298 1994
% 218.76/218.98  |- mesh__dateEstablished mesh__D001298 1978-01-01
% 218.76/218.98  |- mesh__recordAuthorizer mesh__D001298 PLS
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D001298 2005
% 218.76/218.98  |- rdf__type mesh__D001298sskos__Concept
% 218.76/218.98  |- mesh__onlineNote mesh__D001298 search HEARING 1966-74   
% 218.76/218.98  |- mesh__recordMaintainer mesh__D001298 JLS
% 218.76/218.98  |- mesh__historyNote mesh__D001298 78; was see under HEARING 1963-74   
% 218.76/218.98  |- skos__scopeNote mesh__D001298
% 218.76/218.98       The study of hearing and hearing impairment.     
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D001298 2002
% 218.76/218.98  |- mesh__dateCreated mesh__D001298 1977-05-12
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D001298 1997
% 218.76/218.98  |- skos__broader mesh__D001298smesh__D016390
% 218.76/218.98  |- skos__hiddenLabel mesh__D006781 Branch Hospital
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D006781 2000
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D006781 2005
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D006781 2003
% 218.76/218.98  |- skos__altLabel mesh__D006781 Satellite Hospitals
% 218.76/218.98  |- skos__broader mesh__D006781smesh__D006761
% 218.76/218.98  |- skos__altLabel mesh__D006781 Hospitals, Branch
% 218.76/218.98  |- skos__annotation mesh__D006781
% 218.76/218.98       extensions of a main hosp %26% admin by it; coord IM with hosp ownership term %28%e.g., HOSPITALS, FEDERAL; HOSPITALS, PROPRIETARY; etc.%29% %28%IM or NIM%29% or specialty hosp or med specialty %28%IM or NIM%29% if relevant; specify geog%A%  
% 218.76/218.98  |- mesh__publicMeSHNote mesh__D006781
% 218.76/218.98       91; was see under HOSPITALS Aug 1977-90   
% 218.76/218.98  |- mesh__dateCreated mesh__D006781 1977-05-11
% 218.76/218.98  |- skos__scopeNote mesh__D006781
% 218.76/218.98       Those hospitals which are extensions of a main hospital and are wholly or partly administered by that hospital.%A%    
% 218.76/218.98  |- mesh__dateRevised mesh__D006781 1999-11-03
% 218.76/218.98  |- mesh__historyNote mesh__D006781
% 218.76/218.98       91%28%Aug 77%29%; was see under HOSPITALS 1977-90   
% 218.76/218.98  |- skos__altLabel mesh__D006781 Branch Hospitals
% 218.76/218.98  |- skos__prefLabel mesh__D006781 Hospitals, Satellite
% 218.76/218.98  |- mesh__recordAuthorizer mesh__D006781 sjn
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D006781 2002
% 218.76/218.98  |- rdf__type mesh__D006781sskos__Concept
% 218.76/218.98  |- skos__hiddenLabel mesh__D006781 Hospital, Satellite
% 218.76/218.98  |- mesh__recordMaintainer mesh__D006781 kle
% 218.76/218.98  |- skos__hiddenLabel mesh__D006781 Hospital, Branch
% 218.76/218.98  |- mesh__recordOriginator mesh__D006781 EC
% 218.76/218.98  |- mesh__dateEstablished mesh__D006781 1991-01-01
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D006781 2006
% 218.76/218.98  |- skos__hiddenLabel mesh__D006781 Satellite Hospital
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D006781 2004
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D006781 2001
% 218.76/218.98  |- skos__prefLabel mesh__D020452 Journalism
% 218.76/218.98  |- mesh__publicMeSHNote mesh__D020452 99; JOURNALISM was heading 1994-97   
% 218.76/218.98  |- mesh__dateRevised mesh__D020452 2000-06-22
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D020452 2003
% 218.76/218.98  |- mesh__dateCreated mesh__D020452 1998-06-10
% 218.76/218.98  |- mesh__historyNote mesh__D020452 99; see JOURNALISM, MEDICAL 1994-97   
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D020452 2002
% 218.76/218.98  |- skos__historyNote mesh__D020452 Journalism %28%1994-1997%29%
% 218.76/218.98  |- skos__broader mesh__D020452smesh__D011643
% 218.76/218.98  |- skos__scopeNote mesh__D020452
% 218.76/218.98       The collection, preparation, and distribution of news and related commentary and feature materials through such media as pamphlets, newsletters, newspapers, magazines, radio, motion pictures, television, and books. While originally applied to the reportage of current events in printed form, specifically newspapers, with the advent of radio and television the use of the term has broadened to include all printed and electronic communication dealing with current affairs.%A%    
% 218.76/218.98  |- mesh__dateEstablished mesh__D020452 1999-01-01
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D020452 2006
% 218.76/218.98  |- mesh__recordAuthorizer mesh__D020452 sjn
% 218.76/218.98  |- mesh__recordMaintainer mesh__D020452 jls
% 218.76/218.98  |- rdf__type mesh__D020452sskos__Concept
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D020452 2001
% 218.76/218.98  |- mesh__recordOriginator mesh__D020452 JLS
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D020452 2004
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D020452 2005
% 218.76/218.98  |- skos__broader mesh__D010535Q000295smesh__D010535
% 218.76/218.98  |- mesh__preferredCombination mesh__D010535Q000295smesh__D020706
% 218.76/218.98  |- rdf__type mesh__D010535Q000295smesh__CompoundConcept
% 218.76/218.98  |- mesh__dateEstablished mesh__D014415 1987-01-01
% 218.76/218.98  |- rdf__type mesh__D014415sskos__Concept
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D014415 2004
% 218.76/218.98  |- skos__broader mesh__D014415smesh__D011741
% 218.76/218.98  |- skos__historyNote mesh__D014415 Glucosamine %28%1966-1978%29%
% 218.76/218.98  |- mesh__recordAuthorizer mesh__D014415 NLM
% 218.76/218.98  |- mesh__dateRevised mesh__D014415 2003-07-30
% 218.76/218.98  |- skos__historyNote mesh__D014415 Antibiotics %28%1966-1978%29%
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D014415 2005
% 218.76/218.98  |- skos__annotation mesh__D014415
% 218.76/218.98       an antibiotic; do not use /biosyn unless by living matter%A%  
% 218.76/218.98  |- mesh__recordOriginator mesh__D014415 SH
% 218.76/218.98  |- mesh__publicMeSHNote mesh__D014415
% 218.76/218.98       87; was see under GLUCOSAMINE 1979-86   
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D014415 2006
% 218.76/218.98  |- mesh__recordMaintainer mesh__D014415 SYSTEM
% 218.76/218.98  |- skos__scopeNote mesh__D014415
% 218.76/218.98       An N-acetylglycosamine containing antiviral antibiotic obtained from Streptomyces lysosuperificus. It is also active against some bacteria and fungi, because it inhibits the glucosylation of proteins. Tunicamycin is used as tool in the study of microbial biosynthetic mechanisms.%A%    
% 218.76/218.98  |- skos__prefLabel mesh__D014415 Tunicamycin
% 218.76/218.98  |- mesh__dateCreated mesh__D014415 1978-02-08
% 218.76/218.98  |- mesh__historyNote mesh__D014415
% 218.76/218.98       87%28%79%29%; was see under GLUCOSAMINE 1979-86   
% 218.76/218.98  |- skos__broader mesh__D016245Q000193smesh__D016245
% 218.76/218.98  |- mesh__preferredCombination mesh__D016245Q000193smesh__D007998Q000193
% 218.76/218.98  |- rdf__type mesh__D016245Q000193smesh__CompoundConcept
% 218.76/218.98  |- skos__prefLabel mesh__D002391 Catchment Area %28%Health%29%
% 218.76/218.98  |- skos__broader mesh__D002391smesh__D012040
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D002391 2004
% 218.76/218.98  |- mesh__recordAuthorizer mesh__D002391 sjn
% 218.76/218.98  |- skos__altLabel mesh__D002391 Service Area, Health
% 218.76/218.98  |- mesh__historyNote mesh__D002391 78   
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D002391 2005
% 218.76/218.98  |- skos__hiddenLabel mesh__D002391 Areas, Catchment %28%Health%29%
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D002391 2001
% 218.76/218.98  |- mesh__recordMaintainer mesh__D002391 kle
% 218.76/218.98  |- skos__hiddenLabel mesh__D002391 Areas, Health Service
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D002391 2003
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D002391 2000
% 218.76/218.98  |- skos__broader mesh__D002391smesh__D012111
% 218.76/218.98  |- skos__hiddenLabel mesh__D002391 Health Service Areas
% 218.76/218.98  |- rdf__type mesh__D002391sskos__Concept
% 218.76/218.98  |- skos__hiddenLabel mesh__D002391 Service Areas, Health
% 218.76/218.98  |- mesh__dateEstablished mesh__D002391 1978-01-01
% 218.76/218.98  |- skos__scopeNote mesh__D002391
% 218.76/218.98       A geographic area defined and served by a health program or institution.%A%    
% 218.76/218.98  |- skos__hiddenLabel mesh__D002391 Catchment Areas %28%Health%29%
% 218.76/218.98  |- skos__altLabel mesh__D002391 Health Service Area
% 218.76/218.98  |- mesh__publicMeSHNote mesh__D002391 78   
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D002391 2002
% 218.76/218.98  |- skos__hiddenLabel mesh__D002391 Area, Health Service
% 218.76/218.98  |- skos__annotation mesh__D002391 specify geog; DF: CATCHMENT AREA   
% 218.76/218.98  |- mesh__recordOriginator mesh__D002391 EC
% 218.76/218.98  |- skos__hiddenLabel mesh__D002391 Area, Catchment %28%Health%29%
% 218.76/218.98  |- mesh__dateRevised mesh__D002391 1999-11-03
% 218.76/218.98  |- mesh__dateCreated mesh__D002391 1977-05-12
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D002391 2006
% 218.76/218.98  |- skos__annotation mesh__D018806
% 218.76/218.98       an acronym explained by X ref; no qualif   
% 218.76/218.98  |- mesh__dateEstablished mesh__D018806 1995-01-01
% 218.76/218.98  |- skos__altLabel mesh__D018806
% 218.76/218.98       Acute Physiology and Chronic Health Evaluation
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D018806 2001
% 218.76/218.98  |- mesh__recordMaintainer mesh__D018806 KEV
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D018806 2003
% 218.76/218.98  |- mesh__dateRevised mesh__D018806 1999-11-03
% 218.76/218.98  |- mesh__recordAuthorizer mesh__D018806 sjn
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D018806 2002
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D018806 2004
% 218.76/218.98  |- mesh__dateCreated mesh__D018806 1994-05-23
% 218.76/218.98  |- mesh__recordOriginator mesh__D018806 TGC
% 218.76/218.98  |- skos__prefLabel mesh__D018806 APACHE
% 218.76/218.98  |- mesh__publicMeSHNote mesh__D018806 95   
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D018806 2005
% 218.76/218.98  |- skos__historyNote mesh__D018806
% 218.76/218.98       Severity of Illness Index %28%1986-1994%29%
% 218.76/218.98  |- skos__scopeNote mesh__D018806
% 218.76/218.98       An acronym for Acute Physiology and Chronic Health Evaluation, a scoring system using routinely collected data and providing an accurate, objective description for a broad range of intensive care unit admissions, measuring severity of illness in critically ill patients.%A%    
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D018806 2006
% 218.76/218.98  |- rdf__type mesh__D018806sskos__Concept
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D018806 2000
% 218.76/218.98  |- skos__broader mesh__D018806smesh__D006305
% 218.76/218.98  |- mesh__historyNote mesh__D018806 95   
% 218.76/218.98  |- mesh__recordOriginator mesh__D010823 NLM
% 218.76/218.98  |- skos__hiddenLabel mesh__D010823 Doctor Assistants
% 218.76/218.98  |- skos__altLabel mesh__D010823 Physicians%27% Extenders
% 218.76/218.98  |- mesh__onlineNote mesh__D010823
% 218.76/218.98       use PHYSICIAN ASSISTANTS to search PHYSICIANS%27% ASSISTANTS 1971-94%A%  
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010823 1995
% 218.76/218.98  |- skos__hiddenLabel mesh__D010823 Assistant, Physician
% 218.76/218.98  |- skos__prefLabel mesh__D010823 Physician Assistants
% 218.76/218.98  |- mesh__dateEstablished mesh__D010823 1971-01-01
% 218.76/218.98  |- mesh__dateCreated mesh__D010823 1999-01-01
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010823 1999
% 218.76/218.98  |- skos__hiddenLabel mesh__D010823 Physicians%27% Extender
% 218.76/218.98  |- skos__hiddenLabel mesh__D010823 Physicians Assistants
% 218.76/218.98  |- skos__broader mesh__D010823smesh__D000488
% 218.76/218.98  |- mesh__dateRevised mesh__D010823 1994-06-03
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010823 2001
% 218.76/218.98  |- skos__hiddenLabel mesh__D010823 Assistant, Doctor%27%s
% 218.76/218.98  |- skos__hiddenLabel mesh__D010823 Physician Assistant
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010823 2006
% 218.76/218.98  |- skos__hiddenLabel mesh__D010823 Physician%27%s Extenders
% 218.76/218.98  |- skos__hiddenLabel mesh__D010823 Assistant, Physicians%27%
% 218.76/218.98  |- skos__historyNote mesh__D010823 Health Manpower %28%1968-1970%29%
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010823 1998
% 218.76/218.98  |- rdf__type mesh__D010823sskos__Concept
% 218.76/218.98  |- skos__hiddenLabel mesh__D010823 Assistants, Anesthesia
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010823 1997
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010823 2000
% 218.76/218.98  |- skos__hiddenLabel mesh__D010823 Assistants, Doctor%27%s
% 218.76/218.98  |- skos__hiddenLabel mesh__D010823 Assistants, Physicians%27%
% 218.76/218.98  |- skos__scopeNote mesh__D010823
% 218.76/218.98       Persons academically trained, licensed, or credentialed to provide medical care under the supervision of a physician. The concept does not include nurses, but does include orthopedic assistants, surgeon%27%s assistants, and assistants to other specialists.%A%    
% 218.76/218.98  |- skos__hiddenLabel mesh__D010823 Physician%27%s Assistants
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010823 2005
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010823 2004
% 218.76/218.98  |- skos__hiddenLabel mesh__D010823 Physician Extenders
% 218.76/218.98  |- skos__hiddenLabel mesh__D010823 Assistants, Physician
% 218.76/218.98  |- skos__hiddenLabel mesh__D010823 Feldsher
% 218.76/218.98  |- skos__hiddenLabel mesh__D010823 Doctor%27%s Assistant
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010823 1996
% 218.76/218.98  |- skos__hiddenLabel mesh__D010823 Physicians%27% Assistant
% 218.76/218.98  |- skos__altLabel mesh__D010823 Doctor%27%s Assistants
% 218.76/218.98  |- mesh__historyNote mesh__D010823
% 218.76/218.98       95; was PHYSICIANS%27% ASSISTANTS 1971-94   
% 218.76/218.98  |- skos__hiddenLabel mesh__D010823 Assistant, Anesthesia
% 218.76/218.98  |- mesh__publicMeSHNote mesh__D010823
% 218.76/218.98       95; was PHYSICIANS%27% ASSISTANTS 1971-94   
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010823 2003
% 218.76/218.98  |- skos__historyNote mesh__D010823 Physicians %28%1968-1970%29%
% 218.76/218.98  |- skos__annotation mesh__D010823
% 218.76/218.98       coord IM with specialty %28%IM%29%; PARAMEDICS see ALLIED HEALTH PERSONNEL is available; DF: note short X ref%A%  
% 218.76/218.98  |- skos__hiddenLabel mesh__D010823 Extenders, Physicians%27%
% 218.76/218.98  |- skos__hiddenLabel mesh__D010823 Anesthesia Assistant
% 218.76/218.98  |- mesh__recordAuthorizer mesh__D010823 PLS
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010823 2002
% 218.76/218.98  |- mesh__recordMaintainer mesh__D010823 JLS
% 218.76/218.98  |- skos__hiddenLabel mesh__D010823 Extender, Physicians%27%
% 218.76/218.98  |- skos__altLabel mesh__D010823 Physicians%27% Assistants
% 218.76/218.98  |- mesh__historyNote mesh__D018008 94; was MYOGENIN %28%NM%29% 1989-93   
% 218.76/218.98  |- rdf__type mesh__D018008sskos__Concept
% 218.76/218.98  |- skos__prefLabel mesh__D018008 Myogenin
% 218.76/218.98  |- mesh__dateEstablished mesh__D018008 1994-01-01
% 218.76/218.98  |- mesh__recordOriginator mesh__D018008 AGS
% 218.76/218.98  |- mesh__dateCreated mesh__D018008 1993-06-04
% 218.76/218.98  |- mesh__recordAuthorizer mesh__D018008 sjn
% 218.76/218.98  |- mesh__recordMaintainer mesh__D018008 DRC
% 218.76/218.98  |- mesh__publicMeSHNote mesh__D018008
% 218.76/218.98       94; MYOGENIN was indexed under MUSCLE PROTEINS 1989-93   
% 218.76/218.98  |- skos__broader mesh__D018008smesh__D018006
% 218.76/218.98  |- mesh__dateRevised mesh__D018008 2005-06-30
% 218.76/218.98  |- mesh__onlineNote mesh__D018008
% 218.76/218.98       use MYOGENIN %28%NM%29% to search MYOGENIN 1989-93   
% 218.76/218.98  |- skos__annotation mesh__D018008
% 218.76/218.98       a myogenic regulatory factor controlling myogenesis   
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D018008 2006
% 218.76/218.98  |- skos__scopeNote mesh__D018008
% 218.76/218.98       A myogenic regulatory factor that controls myogenesis. Myogenin is induced during differentiation of every skeletal muscle cell line that has been investigated, in contrast to the other myogenic regulatory factors that only appear in certain cell types.%A%    
% 218.76/218.98  |- skos__historyNote mesh__D018008 Muscle Proteins %28%1989-1993%29%
% 218.76/218.98  |- mesh__recordMaintainer mesh__D010025 TGC
% 218.76/218.98  |- mesh__dateCreated mesh__D010025 1999-01-01
% 218.76/218.98  |- mesh__dateRevised mesh__D010025 1993-06-02
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010025 2004
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010025 1995
% 218.76/218.98  |- mesh__recordOriginator mesh__D010025 NLM
% 218.76/218.98  |- mesh__dateEstablished mesh__D010025 1991-01-01
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010025 1996
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010025 2000
% 218.76/218.98  |- skos__scopeNote mesh__D010025
% 218.76/218.98       Necrosis of bone following radiation injury.     
% 218.76/218.98  |- skos__broader mesh__D010025smesh__D011832
% 218.76/218.98  |- skos__annotation mesh__D010025
% 218.76/218.98       bone necrosis after radiation inj; coord IM with bone/dis %28%IM%29%, not organ /inj%A%  
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010025 2005
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010025 1997
% 218.76/218.98  |- mesh__publicMeSHNote mesh__D010025
% 218.76/218.98       91; was see under RADIATION INJURIES 1963-90   
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010025 2001
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010025 2006
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010025 1998
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010025 2002
% 218.76/218.98  |- skos__prefLabel mesh__D010025 Osteoradionecrosis
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010025 1999
% 218.76/218.98  |- rdf__type mesh__D010025sskos__Concept
% 218.76/218.98  |- mesh__recordAuthorizer mesh__D010025 PLS
% 218.76/218.98  |- skos__hiddenLabel mesh__D010025 Osteoradionecroses
% 218.76/218.98  |- mesh__historyNote mesh__D010025
% 218.76/218.98       91%28%63%29%; was see under RADIATION INJURIES 1963-90   
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010025 2003
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D010025 1994
% 218.76/218.98  |- skos__altLabel mesh__D048493 BRAF Kinases
% 218.76/218.98  |- mesh__recordAuthorizer mesh__D048493 sjn
% 218.76/218.98  |- mesh__publicMeSHNote mesh__D048493
% 218.76/218.98       2005; PROTO-ONCOGENE PROTEIN B-RAF was indexed under PROTO-OCOGENES C-RAF 2001-2004%A%  
% 218.76/218.98  |- skos__hiddenLabel mesh__D048493 Proteins B-raf, Proto-Oncogene
% 218.76/218.98  |- skos__prefLabel mesh__D048493 Proto-Oncogene Proteins B-raf
% 218.76/218.98  |- mesh__dateCreated mesh__D048493 2004-07-07
% 218.76/218.98  |- skos__hiddenLabel mesh__D048493 B-raf, Proto-Oncogene Protein
% 218.76/218.98  |- mesh__historyNote mesh__D048493 2005%28%2001%29%   
% 218.76/218.98  |- mesh__dateEstablished mesh__D048493 2005-01-01
% 218.76/218.98  |- skos__altLabel mesh__D048493 Proto-Oncogene Protein B-raf
% 218.76/218.98  |- skos__hiddenLabel mesh__D048493 Protein B-raf, Proto-Oncogene
% 218.76/218.98  |- skos__hiddenLabel mesh__D048493 Proto Oncogene Proteins B raf
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D048493 2006
% 218.76/218.98  |- skos__scopeNote mesh__D048493
% 218.76/218.98       A raf kinase subclass found at high levels in neuronal tissue. The B-raf Kinases are MAP kinase kinase kinases that have specificity for MAP KINASE KINASE 1 and MAP KINASE KINASE 2.%A%    
% 218.76/218.98  |- skos__historyNote mesh__D048493
% 218.76/218.98       Proto-Oncogene Proteins c-raf %28%1988-2004%29%
% 218.76/218.98  |- skos__broader mesh__D048493smesh__D048490
% 218.76/218.98  |- mesh__recordMaintainer mesh__D048493 DRC
% 218.76/218.98  |- skos__hiddenLabel mesh__D048493 B-raf, Proto-Oncogene Proteins
% 218.76/218.98  |- rdf__type mesh__D048493sskos__Concept
% 218.76/218.98  |- skos__altLabel mesh__D048493 B-raf Kinases
% 218.76/218.98  |- mesh__recordOriginator mesh__D048493 jmp
% 218.76/218.98  |- skos__hiddenLabel mesh__D048493 Proto Oncogene Protein B raf
% 218.76/218.98  |- skos__hiddenLabel mesh__D048493 B raf Kinases
% 218.76/218.98  |- mesh__dateRevised mesh__D048493 2005-06-30
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D001299 2002
% 218.76/218.98  |- mesh__dateRevised mesh__D001299 1999-11-03
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D001299 2006
% 218.76/218.98  |- skos__related mesh__D001299smesh__D000158
% 218.76/218.98  |- skos__broader mesh__D001299smesh__D006320
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D001299 2003
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D001299 2001
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D001299 2005
% 218.76/218.98  |- rdf__type mesh__D001299sskos__Concept
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D001299 2000
% 218.76/218.98  |- skos__hiddenLabel mesh__D001299 Audiometries
% 218.76/218.98  |- mesh__dateCreated mesh__D001299 1999-01-01
% 218.76/218.98  |- mesh__recordAuthorizer mesh__D001299 sjn
% 218.76/218.98  |- mesh__recordMaintainer mesh__D001299 KEV
% 218.76/218.98  |- mesh__recordOriginator mesh__D001299 NLM
% 218.76/218.98  |- skos__annotation mesh__D001299
% 218.76/218.98       a specific type of hearing test: do not use as a general term for %22%the measurement of hearing%22% %28% = HEARING TESTS%29%%A%  
% 218.76/218.98  |- skos__scopeNote mesh__D001299
% 218.76/218.98       The testing of the acuity of the sense of hearing to determine the thresholds of the lowest intensity levels at which an individual can hear a set of tones. The frequencies between 125 and 8000 Hz are used to test air conduction thresholds and the frequencies between 250 and 4000 Hz are used to test bone conduction thresholds.%A%    
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D001299 2004
% 218.76/218.98  |- skos__prefLabel mesh__D001299 Audiometry
% 218.76/218.98  |- skos__altLabel mesh__D006782 Special Hospital
% 218.76/218.98  |- skos__historyNote mesh__D006782 Hospitals %28%1966-1967%29%
% 218.76/218.98  |- skos__broader mesh__D006782smesh__D006761
% 218.76/218.98  |- skos__prefLabel mesh__D006782 Hospitals, Special
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D006782 2001
% 218.76/218.98  |- skos__scopeNote mesh__D006782
% 218.76/218.98       Hospitals which provide care for a single category of illness with facilities and staff directed toward a specific service.%A%    
% 218.76/218.98  |- mesh__activeMeSHYear mesh__D006782 2000
% 218.76/218.98  |- rdf__type mesh__D006782sskos__Concept
% 218.76/218.98  |- mesh__historyNote mesh__D006782 68   
% 218.76/218.98  |- mesh__dateEstablished mesh__D006782 1968-01-01
% 218.76/218.98  |- mesh__dateCreated mesh__D006782 1999-01-01
% 218.76/218.99  |- mesh__dateRevised mesh__D006782 1999-11-03
% 218.76/218.99  |- skos__annotation mesh__D006782
% 218.76/218.99       coord IM with med special %28%IM%29% %26% hosp ownership term %28%e.g., HOSPITALS, COUNTY%29% %28%IM or NIM%29% if pertinent; specify geog; sanatoria %26% sanitaria %28%often used interchangeably%29% can go here but consider also HEALTH RESORTS%A%  
% 218.76/218.99  |- mesh__recordAuthorizer mesh__D006782 sjn
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D006782 2006
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D006782 2002
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D006782 2004
% 218.76/218.99  |- skos__hiddenLabel mesh__D006782 Special Hospitals
% 218.76/218.99  |- skos__hiddenLabel mesh__D006782 Hospital, Special
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D006782 2005
% 218.76/218.99  |- mesh__recordMaintainer mesh__D006782 kle
% 218.76/218.99  |- mesh__publicMeSHNote mesh__D006782 68   
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D006782 2003
% 218.76/218.99  |- mesh__recordOriginator mesh__D006782 NLM
% 218.76/218.99  |- mesh__dateCreated mesh__D020453 1998-06-11
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D020453 2004
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D020453 2005
% 218.76/218.99  |- mesh__publicMeSHNote mesh__D020453
% 218.76/218.99       99; see MAMMALS 1998; see SIRENIA 1963-67   
% 218.76/218.99  |- skos__broader mesh__D020453smesh__D008322
% 218.76/218.99  |- skos__prefLabel mesh__D020453 Sirenia
% 218.76/218.99  |- mesh__historyNote mesh__D020453
% 218.76/218.99       99; 63-97; use MAMMALS 1998; use SIRENIA 1963-67   
% 218.76/218.99  |- mesh__dateEstablished mesh__D020453 1999-01-01
% 218.76/218.99  |- skos__historyNote mesh__D020453 Mammals %28%1966-1998%29%
% 218.76/218.99  |- rdf__type mesh__D020453sskos__Concept
% 218.76/218.99  |- mesh__dateRevised mesh__D020453 2003-07-09
% 218.76/218.99  |- skos__scopeNote mesh__D020453
% 218.76/218.99       An order of heavy-bodied, slow-moving, completely aquatic, herbivorous mammals. The body is fusiform, plump, and hairless, except for bristles on the snout. Hindlimbs are absent, the forelimbs are modified to flippers, and the tail is a horizontal fluke. %28%From Scott, Concise Encyclopedia Biology, 1996%29%%A%    
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D020453 2006
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D014416 2002
% 218.76/218.99  |- skos__broader mesh__D014416smesh__D000352
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D014416 1996
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D014416 2005
% 218.76/218.99  |- skos__annotation mesh__D014416 a republic in northern Africa   
% 218.76/218.99  |- mesh__dateCreated mesh__D014416 1999-01-01
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D014416 1997
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D014416 2006
% 218.76/218.99  |- mesh__recordOriginator mesh__D014416 NLM
% 218.76/218.99  |- mesh__dateRevised mesh__D014416 1995-05-23
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D014416 1998
% 218.76/218.99  |- skos__scopeNote mesh__D014416
% 218.76/218.99       A republic in northern Africa between ALGERIA and LIBYA. Its capital is Tunis, which occupies the site of ancient Carthage. Tunisia became a French protectorate in 1881 but was reorganized in 1922. France recognized its independence in 1956. The country takes its name from the capital, which some authorities derive from the name of the Phoenician goddess Tanith, the meaning of which is uncertain. %28%Webster%27%s New Geographical Dictionary, 1988, p1235 %26% Room, Brewer%27%s Dictionary of Names, 1992, p558%29%%A%    
% 218.76/218.99  |- mesh__recordAuthorizer mesh__D014416 PLS
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D014416 2000
% 218.76/218.99  |- rdf__type mesh__D014416sskos__Concept
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D014416 2003
% 218.76/218.99  |- mesh__recordMaintainer mesh__D014416 KEV
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D014416 1999
% 218.76/218.99  |- skos__prefLabel mesh__D014416 Tunisia
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D014416 2001
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D014416 2004
% 218.76/218.99  |- skos__related mesh__D030881smesh__D033283
% 218.76/218.99  |- skos__related mesh__D030881smesh__D007258
% 218.76/218.99  |- mesh__publicMeSHNote mesh__D030881
% 218.76/218.99       2002; see TRUTH DISCLOSURE 1978-2001; for WHISTLEBLOWING see TRUTH DISCLOSURE 1997-2001%A%  
% 218.76/218.99  |- skos__related mesh__D030881smesh__D003219
% 218.76/218.99  |- skos__scopeNote mesh__D030881
% 218.76/218.99       Revealing of information, by oral or written communication.%A%    
% 218.76/218.99  |- mesh__recordOriginator mesh__D030881 ags
% 218.76/218.99  |- skos__annotation mesh__D030881 TRUTH DISCLOSURE is also available   
% 218.76/218.99  |- skos__broader mesh__D030881smesh__D003142
% 218.76/218.99  |- mesh__recordMaintainer mesh__D030881 lkt
% 218.76/218.99  |- skos__hiddenLabel mesh__D030881 Disclosure, Information
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D030881 2004
% 218.76/218.99  |- mesh__historyNote mesh__D030881
% 218.76/218.99       2002; use TRUTH DISCLOSURE 1978-2001; for WHISTLEBLOWING use TRUTH DISCLOSURE 1997-2001%A%  
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D030881 2006
% 218.76/218.99  |- skos__altLabel mesh__D030881 Information Disclosure
% 218.76/218.99  |- mesh__dateCreated mesh__D030881 2001-07-25
% 218.76/218.99  |- mesh__dateRevised mesh__D030881 2003-07-09
% 218.76/218.99  |- mesh__dateEstablished mesh__D030881 2002-01-01
% 218.76/218.99  |- skos__hiddenLabel mesh__D030881 Financial Disclosures
% 218.76/218.99  |- rdf__type mesh__D030881sskos__Concept
% 218.76/218.99  |- mesh__recordAuthorizer mesh__D030881 sjn
% 218.76/218.99  |- skos__hiddenLabel mesh__D030881 Disclosures, Financial
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D030881 2005
% 218.76/218.99  |- skos__hiddenLabel mesh__D030881 Disclosure, Financial
% 218.76/218.99  |- skos__historyNote mesh__D030881 Truth Disclosure %28%1977-2001%29%
% 218.76/218.99  |- skos__prefLabel mesh__D030881 Disclosure
% 218.76/218.99  |- skos__broader mesh__D009420Q000601smesh__D009420
% 218.76/218.99  |- mesh__preferredCombination mesh__D009420Q000601smesh__D019635
% 218.76/218.99  |- rdf__type mesh__D009420Q000601smesh__CompoundConcept
% 218.76/218.99  |- skos__scopeNote mesh__D002392
% 218.76/218.99       An antioxidant flavonoid, occurring especially in woody plants as both %28%+%29%-catechin and %28%-%29%-epicatechin %28%cis%29% forms.%A%    
% 218.76/218.99  |- skos__altLabel mesh__D002392 Cianidanol
% 218.76/218.99  |- mesh__publicMeSHNote mesh__D002392
% 218.76/218.99       87; was see under BENZOPYRANS 1977-86   
% 218.76/218.99  |- skos__altLabel mesh__D002392 Catechuic Acid
% 218.76/218.99  |- skos__altLabel mesh__D002392 %28%+%29%-Catechin
% 218.76/218.99  |- skos__historyNote mesh__D002392 Benzopyrans %28%1973-1976%29%
% 218.76/218.99  |- skos__broader mesh__D002392smesh__D002839
% 218.76/218.99  |- skos__hiddenLabel mesh__D002392 Acid, Catechuic
% 218.76/218.99  |- mesh__recordAuthorizer mesh__D002392 sjn
% 218.76/218.99  |- rdf__type mesh__D002392sskos__Concept
% 218.76/218.99  |- skos__historyNote mesh__D002392 Catechols %28%1973-1976%29%
% 218.76/218.99  |- mesh__dateEstablished mesh__D002392 1987-01-01
% 218.76/218.99  |- skos__altLabel mesh__D002392
% 218.76/218.99       2H-1-Benzopyran-3,5,7-triol, 2-%28%3,4-dihydroxyphenyl%29%-3,4-dihydro-, %28%2R-cis%29%-
% 218.76/218.99  |- mesh__historyNote mesh__D002392
% 218.76/218.99       87%28%77%29%; was see under BENZOPYRANS 1977-86   
% 218.76/218.99  |- skos__broader mesh__D002392smesh__D005419
% 218.76/218.99  |- mesh__dateCreated mesh__D002392 1976-04-13
% 218.76/218.99  |- skos__hiddenLabel mesh__D002392 KB53
% 218.76/218.99  |- skos__hiddenLabel mesh__D002392 KB 53
% 218.76/218.99  |- skos__altLabel mesh__D002392 3,3%27%,4%27%,5,7-Flavanpentol
% 218.76/218.99  |- mesh__dateRevised mesh__D002392 2005-06-30
% 218.76/218.99  |- skos__hiddenLabel mesh__D002392 Cyanidanol 3
% 218.76/218.99  |- skos__hiddenLabel mesh__D002392 Acid, Catechinic
% 218.76/218.99  |- skos__altLabel mesh__D002392 Catechinic Acid
% 218.76/218.99  |- skos__prefLabel mesh__D002392 Catechin
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D002392 2006
% 218.76/218.99  |- skos__altLabel mesh__D002392 %28%+%29%-Cyanidanol
% 218.76/218.99  |- mesh__recordOriginator mesh__D002392 SH
% 218.76/218.99  |- mesh__recordMaintainer mesh__D002392 ssb
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D018807 2004
% 218.76/218.99  |- mesh__recordOriginator mesh__D018807 PXP
% 218.76/218.99  |- mesh__historyNote mesh__D018807 1995   
% 218.76/218.99  |- mesh__dateEstablished mesh__D018807 1995-01-01
% 218.76/218.99  |- mesh__publicMeSHNote mesh__D018807 1995   
% 218.76/218.99  |- skos__prefLabel mesh__D018807
% 218.76/218.99       Polymorphism, Single-Stranded Conformational
% 218.76/218.99  |- skos__hiddenLabel mesh__D018807
% 218.76/218.99       Polymorphisms, Single-Stranded Conformational
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D018807 2005
% 218.76/218.99  |- skos__hiddenLabel mesh__D018807
% 218.76/218.99       Conformational Polymorphisms, Single-Stranded
% 218.76/218.99  |- mesh__recordAuthorizer mesh__D018807 sjn
% 218.76/218.99  |- skos__hiddenLabel mesh__D018807
% 218.76/218.99       Single Stranded Conformational Polymorphism
% 218.76/218.99  |- skos__altLabel mesh__D018807 Single-Stranded Conformational Polymorphism
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D018807 2006
% 218.76/218.99  |- mesh__recordMaintainer mesh__D018807 nns
% 218.76/218.99  |- skos__broader mesh__D018807smesh__D011110
% 218.76/218.99  |- mesh__dateCreated mesh__D018807 1994-05-31
% 218.76/218.99  |- rdf__type mesh__D018807sskos__Concept
% 218.76/218.99  |- skos__hiddenLabel mesh__D018807
% 218.76/218.99       Polymorphism, Single Stranded Conformational
% 218.76/218.99  |- mesh__dateRevised mesh__D018807 2002-07-03
% 218.76/218.99  |- skos__scopeNote mesh__D018807
% 218.76/218.99       Variation in a population%27%s DNA sequence that is detected by determining alterations in the conformation of denatured DNA fragments. Denatured DNA fragments are allowed to renature under conditions that prevent the formation of double-stranded DNA and allow secondary structure to form in single stranded fragments. These fragments are then run through polyacrylamide gels to detect variations in the secondary structure that is manifested as an alteration in migration through the gels.%A%    
% 218.76/218.99  |- skos__hiddenLabel mesh__D018807
% 218.76/218.99       Single-Stranded Conformational Polymorphisms
% 218.76/218.99  |- skos__altLabel mesh__D018807 SSCP
% 218.76/218.99  |- skos__hiddenLabel mesh__D018807
% 218.76/218.99       Conformational Polymorphism, Single-Stranded
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D018807 2003
% 218.76/218.99  |- skos__annotation mesh__D018807
% 218.76/218.99       POLYMORPHISM, SINGLE NUCLEOTIDE is also available   
% 218.76/218.99  |- skos__historyNote mesh__D018807
% 218.76/218.99       Polymorphism %28%Genetics%29% %28%1990-1994%29%
% 218.76/218.99  |- mesh__historyNote mesh__D010824
% 218.76/218.99       91%28%80%29%; was see under HEALTH FACILITIES 1980-90   
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D010824 2004
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D010824 2005
% 218.76/218.99  |- skos__hiddenLabel mesh__D010824 Office, Physician%27%s
% 218.76/218.99  |- skos__hiddenLabel mesh__D010824 Physician Office
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D010824 2002
% 218.76/218.99  |- mesh__dateEstablished mesh__D010824 1991-01-01
% 218.76/218.99  |- mesh__dateCreated mesh__D010824 1979-04-11
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D010824 2006
% 218.76/218.99  |- skos__hiddenLabel mesh__D010824 Physicians Offices
% 218.76/218.99  |- mesh__recordAuthorizer mesh__D010824 sjn
% 218.76/218.99  |- skos__hiddenLabel mesh__D010824 Physician Offices
% 218.76/218.99  |- mesh__recordOriginator mesh__D010824 EC
% 218.76/218.99  |- skos__scopeNote mesh__D010824
% 218.76/218.99       The room or rooms in which the physician and staff provide patient care. The offices include all rooms in the physician%27%s office suite.%A%    
% 218.76/218.99  |- skos__hiddenLabel mesh__D010824 Physician%27%s Offices
% 218.76/218.99  |- skos__altLabel mesh__D010824 Physician%27%s Office
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D010824 2000
% 218.76/218.99  |- skos__hiddenLabel mesh__D010824 Offices, Physicians%27%
% 218.76/218.99  |- skos__prefLabel mesh__D010824 Physicians%27% Offices
% 218.76/218.99  |- mesh__dateRevised mesh__D010824 1999-11-03
% 218.76/218.99  |- skos__hiddenLabel mesh__D010824 Physicians Office
% 218.76/218.99  |- mesh__publicMeSHNote mesh__D010824
% 218.76/218.99       91; was see under HEALTH FACILITIES 1980-90   
% 218.76/218.99  |- rdf__type mesh__D010824sskos__Concept
% 218.76/218.99  |- mesh__recordMaintainer mesh__D010824 jls
% 218.76/218.99  |- skos__annotation mesh__D010824
% 218.76/218.99       restrict to physical office: includes reception rooms, examining rooms, treatment rooms, office, labs, etc.; not for articles with title reading, e.g., %22%office assessment of nutrition disord%22% or %22%office use of microscopes in otology%22%%A%  
% 218.76/218.99  |- skos__hiddenLabel mesh__D010824 Offices, Physician%27%s
% 218.76/218.99  |- skos__hiddenLabel mesh__D010824 Office, Physicians%27%
% 218.76/218.99  |- skos__broader mesh__D010824smesh__D006268
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D010824 2001
% 218.76/218.99  |- skos__hiddenLabel mesh__D010824 Physicians%27% Office
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D010824 2003
% 218.76/218.99  |- skos__historyNote mesh__D018009
% 218.76/218.99       Receptors, Neurotransmitter %28%1985-1993%29%
% 218.76/218.99  |- mesh__dateRevised mesh__D018009 2005-06-30
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D018009 2006
% 218.76/218.99  |- mesh__recordMaintainer mesh__D018009 jmp
% 218.76/218.99  |- rdf__type mesh__D018009sskos__Concept
% 218.76/218.99  |- mesh__dateEstablished mesh__D018009 1994-01-01
% 218.76/218.99  |- skos__prefLabel mesh__D018009 Receptors, Glycine
% 218.76/218.99  |- mesh__onlineNote mesh__D018009
% 218.76/218.99       use RECEPTORS, GLYCINE %28%NM%29% to search GLYCINE RECEPTOR 1981-93%A%  
% 218.76/218.99  |- skos__hiddenLabel mesh__D018009 Receptor, Glycine
% 218.76/218.99  |- skos__historyNote mesh__D018009
% 218.76/218.99       Receptors, Cell Surface %28%1981-1984%29%
% 218.76/218.99  |- mesh__dateCreated mesh__D018009 1993-06-21
% 218.76/218.99  |- mesh__publicMeSHNote mesh__D018009
% 218.76/218.99       94; GLYCINE RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1985-93 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1981-84%A%  
% 218.76/218.99  |- mesh__recordAuthorizer mesh__D018009 sjn
% 218.76/218.99  |- mesh__recordOriginator mesh__D018009 RAZ
% 218.76/218.99  |- skos__broader mesh__D018009smesh__D017459
% 218.76/218.99  |- skos__annotation mesh__D018009 DF: RECEPT GLYCINE   
% 218.76/218.99  |- skos__scopeNote mesh__D018009
% 218.76/218.99       Cell surface receptors that bind glycine with high affinity and trigger intracellular changes which influence the behavior of cells. Glycine receptors in the central nervous system have an intrinsic chloride channel and are usually inhibitory.%A%    
% 218.76/218.99  |- skos__altLabel mesh__D018009 Glycine Receptors
% 218.76/218.99  |- skos__altLabel mesh__D018009 Glycine Receptor
% 218.76/218.99  |- skos__related mesh__D018009smesh__D050487
% 218.76/218.99  |- mesh__historyNote mesh__D018009
% 218.76/218.99       94; was GLYCINE RECEPTOR %28%NM%29% 1981-93   
% 218.76/218.99  |- rdf__type mesh__D010026sskos__Concept
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D010026 2004
% 218.76/218.99  |- skos__scopeNote mesh__D010026
% 218.76/218.99       An abnormal hardening or increased density of bone tissue.%A%    
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D010026 2003
% 218.76/218.99  |- mesh__recordAuthorizer mesh__D010026 sjn
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D010026 2002
% 218.76/218.99  |- mesh__recordOriginator mesh__D010026 NLM
% 218.76/218.99  |- skos__hiddenLabel mesh__D010026 Osteoscleroses
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D010026 2001
% 218.76/218.99  |- mesh__recordMaintainer mesh__D010026 KEV
% 218.76/218.99  |- skos__broader mesh__D010026smesh__D010009
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D010026 2006
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D010026 2000
% 218.76/218.99  |- mesh__dateRevised mesh__D010026 1999-11-03
% 218.76/218.99  |- skos__prefLabel mesh__D010026 Osteosclerosis
% 218.76/218.99  |- mesh__dateCreated mesh__D010026 1999-01-01
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D010026 2005
% 218.76/218.99  |- mesh__dateCreated mesh__D048494 2004-07-07
% 218.76/218.99  |- mesh__publicMeSHNote mesh__D048494 2005   
% 218.76/218.99  |- mesh__historyNote mesh__D048494 2005   
% 218.76/218.99  |- skos__scopeNote mesh__D048494
% 218.76/218.99       A genus of TICKS, in the family IXODIDAE, widespread in Africa. Members of the genus include many important vectors of animal and human pathogens.%A%    
% 218.76/218.99  |- mesh__recordOriginator mesh__D048494 ags
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D048494 2005
% 218.76/218.99  |- skos__historyNote mesh__D048494 Ticks %28%1966-2001%29%
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D048494 2006
% 218.76/218.99  |- mesh__recordAuthorizer mesh__D048494 sjn
% 218.76/218.99  |- mesh__dateEstablished mesh__D048494 2005-01-01
% 218.76/218.99  |- skos__broader mesh__D048494smesh__D026863
% 218.76/218.99  |- skos__historyNote mesh__D048494 Ixodidae %28%2002-2004%29%
% 218.76/218.99  |- rdf__type mesh__D048494sskos__Concept
% 218.76/218.99  |- mesh__recordMaintainer mesh__D048494 ags
% 218.76/218.99  |- skos__prefLabel mesh__D048494 Rhipicephalus
% 218.76/218.99  |- rdf__type mesh__D006783sskos__Concept
% 218.76/218.99  |- skos__hiddenLabel mesh__D006783 State Hospital
% 218.76/218.99  |- skos__prefLabel mesh__D006783 Hospitals, State
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D006783 2002
% 218.76/218.99  |- skos__broader mesh__D006783smesh__D006779
% 218.76/218.99  |- mesh__publicMeSHNote mesh__D006783
% 218.76/218.99       91; was see under HOSPITALS, PUBLIC 1978-90   
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D006783 1999
% 218.76/218.99  |- mesh__recordMaintainer mesh__D006783 KEV
% 218.76/218.99  |- mesh__historyNote mesh__D006783
% 218.76/218.99       91%28%78%29%; was see under HOSPITALS, PUBLIC 1978-90   
% 218.76/218.99  |- mesh__dateRevised mesh__D006783 1996-06-10
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D006783 2006
% 218.76/218.99  |- mesh__recordOriginator mesh__D006783 EC
% 218.76/218.99  |- skos__scopeNote mesh__D006783
% 218.76/218.99       Hospitals controlled by agencies and departments of the state government.%A%    
% 218.76/218.99  |- skos__hiddenLabel mesh__D006783 Hospital, State
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D006783 1998
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D006783 1997
% 218.76/218.99  |- skos__altLabel mesh__D006783 State Hospitals
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D006783 2005
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D006783 2004
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D006783 2001
% 218.76/218.99  |- mesh__dateEstablished mesh__D006783 1991-01-01
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D006783 2003
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D006783 2000
% 218.76/218.99  |- mesh__dateCreated mesh__D006783 1977-05-11
% 218.76/218.99  |- skos__annotation mesh__D006783
% 218.76/218.99       coord IM with special hosp %28%e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.%29% or med specialty %28%IM or NIM%29% if pertinent; specify state if US, province if Canada, or other country%A%  
% 218.76/218.99  |- mesh__recordAuthorizer mesh__D006783 PLS
% 218.76/218.99  |- mesh__historyNote mesh__D020454
% 218.76/218.99       99; for DUGONGS %26% SEA COWS use MAMMALS 1998   
% 218.76/218.99  |- skos__hiddenLabel mesh__D020454 dugon, Dugong
% 218.76/218.99  |- skos__altLabel mesh__D020454 Dugong dugon
% 218.76/218.99  |- skos__hiddenLabel mesh__D020454 Sea Cow
% 218.76/218.99  |- mesh__publicMeSHNote mesh__D020454
% 218.76/218.99       99; for DUGONGS %26% SEA COWS see MAMMALS 1998   
% 218.76/218.99  |- skos__broader mesh__D020454smesh__D020453
% 218.76/218.99  |- mesh__dateCreated mesh__D020454 1998-06-10
% 218.76/218.99  |- skos__altLabel mesh__D020454 Dugongs
% 218.76/218.99  |- skos__historyNote mesh__D020454 Mammals %28%1968-1998%29%
% 218.76/218.99  |- skos__scopeNote mesh__D020454
% 218.76/218.99       A genus of the order Sirenia characterized by a notched tail, the presence of nasal bones and a long nasal cavity, and large columnar teeth lacking enamel. Dugongs inhabit the coastal waters of the Indian Ocean, Red Sea, and the Malay Archipelago. %28%From Scott, Concise Encyclopedia Biology, 1996%29%%A%    
% 218.76/218.99  |- skos__hiddenLabel mesh__D020454 Cows, Sea
% 218.76/218.99  |- skos__prefLabel mesh__D020454 Dugong
% 218.76/218.99  |- rdf__type mesh__D020454sskos__Concept
% 218.76/218.99  |- mesh__dateRevised mesh__D020454 2003-07-09
% 218.76/218.99  |- skos__hiddenLabel mesh__D020454 Cow, Sea
% 218.76/218.99  |- mesh__dateEstablished mesh__D020454 1999-01-01
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D020454 2006
% 218.76/218.99  |- skos__altLabel mesh__D020454 Dugong dugong
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D020454 2004
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D020454 2005
% 218.76/218.99  |- skos__hiddenLabel mesh__D020454 dugong, Dugong
% 218.76/218.99  |- mesh__dateRevised mesh__D014417 2003-07-09
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D014417 2006
% 218.76/218.99  |- skos__scopeNote mesh__D014417
% 218.76/218.99       A genus of tree shrews of the family TUPAIIDAE which consists of about 12 species. One of the most frequently encountered species is T. glis. Members of this genus inhabit rain forests and secondary growth areas in southeast Asia.%A%    
% 218.76/218.99  |- mesh__recordMaintainer mesh__D014417 ags
% 218.76/218.99  |- skos__annotation mesh__D014417 tree shrew; IM; qualif permitted   
% 218.76/218.99  |- skos__broader mesh__D014417smesh__D014418
% 218.76/218.99  |- rdf__type mesh__D014417sskos__Concept
% 218.76/218.99  |- skos__historyNote mesh__D014417 Primates %28%1972-1974%29%
% 218.76/218.99  |- mesh__historyNote mesh__D014417
% 218.76/218.99       91%28%81%29%; was see under TUPAIIDAE 1981-90   
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D014417 2004
% 218.76/218.99  |- mesh__dateCreated mesh__D014417 1980-05-09
% 218.76/218.99  |- skos__historyNote mesh__D014417 Tupaiidae %28%1975-1980%29%
% 218.76/218.99  |- mesh__recordAuthorizer mesh__D014417 sjn
% 218.76/218.99  |- mesh__publicMeSHNote mesh__D014417
% 218.76/218.99       91; was see under TUPAIIDAE 1981-90   
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D014417 2005
% 218.76/218.99  |- skos__prefLabel mesh__D014417 Tupaia
% 218.76/218.99  |- mesh__recordOriginator mesh__D014417 EC
% 218.76/218.99  |- mesh__dateEstablished mesh__D014417 1991-01-01
% 218.76/218.99  |- skos__altLabel mesh__D019900
% 218.76/218.99       trans-3,4-Dichloro-N-methyl-N-%28%2-%28%1-pyrrolidinyl%29%-cyclohexyl%29%-benzeneacetamide Hydrochloride
% 218.76/218.99  |- mesh__publicMeSHNote mesh__D019900
% 218.76/218.99       2002; see U-50488 1998-2001; U-50488 %28%now 3,4-DICHLORO-N-METHYL-N-%28%2-%28%1-PYRROLIDINYL%29%-CYCLOHEXYL%29%-BENZENEACETAMIDE, %28%TRANS%29%-ISOMER%29% was indexed under PYRROLIDINES 1982-97%A%  
% 218.76/218.99  |- skos__hiddenLabel mesh__D019900 U 50,488H
% 218.76/218.99  |- skos__altLabel mesh__D019900
% 218.76/218.99       trans-3,4-Dichloro-N-methyl-N-%28%2-%28%1-pyrrolidinyl%29%-cyclohexyl%29%-benzeneacetamide
% 218.76/218.99  |- skos__hiddenLabel mesh__D019900 U50488
% 218.76/218.99  |- skos__altLabel mesh__D019900 U-50,488H
% 218.76/218.99  |- skos__scopeNote mesh__D019900
% 218.76/218.99       A non-peptide, kappa-opioid receptor agonist which has also been found to stimulate the release of adrenocorticotropin %28%CORTICOTROPIN%29% via the release of hypothalamic arginine vasopressin %28%ARGIPRESSIN%29% and CORTICOTROPIN-RELEASING HORMONE. %28%From J Pharmacol Exp Ther 1997;280%28%1%29%:416-21%29%%A%    
% 218.76/218.99  |- skos__prefLabel mesh__D019900
% 218.76/218.99       3,4-Dichloro-N-methyl-N-%28%2-%28%1-pyrrolidinyl%29%-cyclohexyl%29%-benzeneacetamide, %28%trans%29%-Isomer
% 218.76/218.99  |- skos__altLabel mesh__D019900 U50488H
% 218.76/218.99  |- rdf__type mesh__D019900sskos__Concept
% 218.76/218.99  |- mesh__recordAuthorizer mesh__D019900 sjn
% 218.76/218.99  |- skos__altLabel mesh__D019900
% 218.76/218.99       3,4-Dichloro-N-methyl-N-%28%2-%28%1-pyrrolidinyl%29%cyclohexyl%29%-benzeneacetamide Mesylate, %28%trans%29%-%28%+-%29%-Isomer
% 218.76/218.99  |- skos__altLabel mesh__D019900 U-50488H
% 218.76/218.99  |- mesh__dateCreated mesh__D019900 1997-06-20
% 218.76/218.99  |- skos__hiddenLabel mesh__D019900 U 50488
% 218.76/218.99  |- mesh__dateRevised mesh__D019900 2004-07-19
% 218.76/218.99  |- mesh__historyNote mesh__D019900
% 218.76/218.99       2002%28%1998%29%; use 3,4-DICHLORO-N-METHYL-N-%28%2-%28%1-PYRROLIDINYL%29%-CYCLOHEXYL%29%-BENZENEACETAMIDE, %28%TRANS%29%-ISOMER %28%NM%29% 1982-97%A%  
% 218.76/218.99  |- mesh__recordOriginator mesh__D019900 KEV
% 218.76/218.99  |- skos__broader mesh__D019900smesh__D011759
% 218.76/218.99  |- skos__altLabel mesh__D019900
% 218.76/218.99       3,4-Dichloro-N-methyl-N-%28%2-%28%1-pyrrolidinyl%29%cyclohexyl%29%-benzeneacetamide Mesylate, %28%trans%29%-%28%+%29%-Isomer
% 218.76/218.99  |- skos__hiddenLabel mesh__D019900 U50,488H
% 218.76/218.99  |- skos__altLabel mesh__D019900
% 218.76/218.99       Benzeneacetamide, 3,4-dichloro-N-methyl-N-%28%2-%28%1-pyrrolidinyl%29%cyclohexyl%29%-, %28%trans%29%-Isomer
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D019900 2005
% 218.76/218.99  |- skos__historyNote mesh__D019900 Pyrrolidines %28%1982-1997%29%
% 218.76/218.99  |- mesh__dateEstablished mesh__D019900 1998-01-01
% 218.76/218.99  |- mesh__recordMaintainer mesh__D019900 jmp
% 218.76/218.99  |- skos__hiddenLabel mesh__D019900 U 50488H
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D019900 2006
% 218.76/218.99  |- mesh__recordMaintainer mesh__D019102 KEV
% 218.76/218.99  |- skos__hiddenLabel mesh__D019102 Infants, Very-Low-Birth-Weight
% 218.76/218.99  |- mesh__dateRevised mesh__D019102 2002-07-03
% 218.76/218.99  |- skos__scopeNote mesh__D019102
% 218.76/218.99       An infant whose weight at birth is less than 1500 grams %28%3.3 lbs%29%, regardless of gestational age.%A%    
% 218.76/218.99  |- skos__historyNote mesh__D019102 Infant, Premature %28%1970-1974%29%
% 218.76/218.99  |- skos__altLabel mesh__D019102 Very-Low-Birth-Weight Infant
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D019102 2006
% 218.76/218.99  |- skos__prefLabel mesh__D019102 Infant, Very Low Birth Weight
% 218.76/218.99  |- mesh__recordAuthorizer mesh__D019102 sjn
% 218.76/218.99  |- mesh__dateEstablished mesh__D019102 1996-01-01
% 218.76/218.99  |- rdf__type mesh__D019102sskos__Concept
% 218.76/218.99  |- skos__annotation mesh__D019102
% 218.76/218.99       born weighing 1500 gms %28%3.3 lb%29% or less; check the tag INFANT, NEWBORN; DF: INFANT VLBW%A%  
% 218.76/218.99  |- skos__hiddenLabel mesh__D019102 Very-Low-Birth-Weight Infants
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D019102 2005
% 218.76/218.99  |- skos__broader mesh__D019102smesh__D007230
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D019102 2004
% 218.76/218.99  |- skos__hiddenLabel mesh__D019102 Very Low Birth Weight Infant
% 218.76/218.99  |- mesh__publicMeSHNote mesh__D019102 96   
% 218.76/218.99  |- skos__historyNote mesh__D019102 Birth Weight %28%1967-1978%29%
% 218.76/218.99  |- skos__hiddenLabel mesh__D019102 Infant, Very-Low-Birth-Weight
% 218.76/218.99  |- mesh__historyNote mesh__D019102 96   
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D019102 2003
% 218.76/218.99  |- mesh__recordOriginator mesh__D019102 TGC
% 218.76/218.99  |- mesh__dateCreated mesh__D019102 1995-06-05
% 218.76/218.99  |- skos__historyNote mesh__D019102
% 218.76/218.99       Infant, Low Birth Weight %28%1977-1995%29%
% 218.76/218.99  |- skos__broader mesh__D002393smesh__D002396
% 218.76/218.99  |- skos__altLabel mesh__D002393 Catecholestrogens
% 218.76/218.99  |- skos__historyNote mesh__D002393 Catechols %28%1966-1981%29%
% 218.76/218.99  |- mesh__dateCreated mesh__D002393 1981-05-13
% 218.76/218.99  |- mesh__recordMaintainer mesh__D002393 lkt
% 218.76/218.99  |- mesh__historyNote mesh__D002393
% 218.76/218.99       94; was CATECHOL ESTROGENS 1982-93; ESTROGENS, CATECHOL was see CATECHOL ESTROGENS 1982-93%A%  
% 218.76/218.99  |- mesh__dateEstablished mesh__D002393 1982-01-01
% 218.76/218.99  |- skos__scopeNote mesh__D002393
% 218.76/218.99       2- or 4-Hydroxyestrogens. Substances that are physiologically active in mammals, especially in the control of gonadotropin secretion. Physiological activity can be ascribed to either an estrogenic action or interaction with the catecholaminergic system.%A%    
% 218.76/218.99  |- mesh__dateRevised mesh__D002393 2003-07-09
% 218.76/218.99  |- rdf__type mesh__D002393sskos__Concept
% 218.76/218.99  |- mesh__publicMeSHNote mesh__D002393
% 218.76/218.99       94; was CATECHOL ESTROGENS 1982-93; ESTROGENS, CATECHOL was see CATECHOL ESTROGENS 1982-93%A%  
% 218.76/218.99  |- skos__prefLabel mesh__D002393 Estrogens, Catechol
% 218.76/218.99  |- skos__annotation mesh__D002393 /biosyn /physiol permitted   
% 218.76/218.99  |- skos__broader mesh__D002393smesh__D045166
% 218.76/218.99  |- skos__historyNote mesh__D002393 specific estrogen %28%1966-1981%29%
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D002393 2005
% 218.76/218.99  |- mesh__recordAuthorizer mesh__D002393 sjn
% 218.76/218.99  |- skos__altLabel mesh__D002393 Catechol Estrogens
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D002393 2006
% 218.76/218.99  |- mesh__recordOriginator mesh__D002393 RLS
% 218.76/218.99  |- mesh__onlineNote mesh__D002393
% 218.76/218.99       use ESTROGENS, CATECHOL to search CATECHOL ESTROGENS 1982-93%A%  
% 218.76/218.99  |- skos__historyNote mesh__D002393 Estrogens %28%1966-1981%29%
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D002393 2004
% 218.76/218.99  |- mesh__dateCreated mesh__D018808 1994-05-31
% 218.76/218.99  |- mesh__historyNote mesh__D018808
% 218.76/218.99       95; was TRANSCRIPTION FACTOR, AP-1 see PROTO-ONCOGENE PROTEINS C-JUN 1992-94; AP-1 ENHANCER-BINDING PROTEIN was see PROTO-ONCOGENE PROTEINS C-JUN 1992-94%A%  
% 218.76/218.99  |- skos__altLabel mesh__D018808 AP-1
% 218.76/218.99  |- skos__historyNote mesh__D018808 Transcription Factors %28%1988-1994%29%
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D018808 2006
% 218.76/218.99  |- skos__broader mesh__D018808smesh__D050976
% 218.76/218.99  |- skos__altLabel mesh__D018808 AP-1 Enhancer-Binding Protein
% 218.76/218.99  |- mesh__onlineNote mesh__D018808
% 218.76/218.99       use PROTO-ONCOGENE PROTEINS C-JUN to search TRANSCRIPTION FACTOR, AP-1 %26% AP-1 ENHANCER-BINDING PROTEIN 1992-94%A%  
% 218.76/218.99  |- mesh__recordMaintainer mesh__D018808 DRC
% 218.76/218.99  |- rdf__type mesh__D018808sskos__Concept
% 218.76/218.99  |- skos__scopeNote mesh__D018808
% 218.76/218.99       A multiprotein complex composed of the products of c-jun and c-fos proto-oncogenes. These proteins must dimerize in order to bind to the AP-1 recognition site, also known as the TPA-responsive element %28%TRE%29%. AP-1 controls both basal and inducible transcription of several genes.%A%    
% 218.76/218.99  |- mesh__dateEstablished mesh__D018808 1995-01-01
% 218.76/218.99  |- skos__related mesh__D018808smesh__D016755
% 218.76/218.99  |- mesh__dateRevised mesh__D018808 2005-06-30
% 218.76/218.99  |- skos__hiddenLabel mesh__D018808 Activator Protein 1
% 218.76/218.99  |- skos__historyNote mesh__D018808
% 218.76/218.99       Proto-Oncogene Proteins c-jun %28%1992-1994%29%
% 218.76/218.99  |- skos__hiddenLabel mesh__D018808 AP 1 Enhancer Binding Protein
% 218.76/218.99  |- skos__hiddenLabel mesh__D018808 Transcription Factor AP 1
% 218.76/218.99  |- skos__altLabel mesh__D018808 AP-1 Enhancer Binding Protein
% 218.76/218.99  |- skos__hiddenLabel mesh__D018808 Enhancer-Binding Protein, AP-1
% 218.76/218.99  |- skos__annotation mesh__D018808
% 218.76/218.99       in genetic transcription; /biosyn /physiol permitted; DF: AP 1%A%  
% 218.76/218.99  |- skos__prefLabel mesh__D018808 Transcription Factor AP-1
% 218.76/218.99  |- skos__related mesh__D018808smesh__D016760
% 218.76/218.99  |- mesh__recordAuthorizer mesh__D018808 sjn
% 218.76/218.99  |- mesh__publicMeSHNote mesh__D018808
% 218.76/218.99       95; was TRANSCRIPTION FACTOR, AP-1 see PROTO-ONCOGENE PROTEINS C-JUN 1992-94; AP-1 ENHANCER-BINDING PROTEIN was see PROTO-ONCOGENE PROTEINS C-JUN 1992-94%A%  
% 218.76/218.99  |- skos__altLabel mesh__D018808 Activator Protein-1
% 218.76/218.99  |- mesh__recordOriginator mesh__D018808 AGS
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D010825 2004
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D010825 2001
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D010825 1994
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D010825 2006
% 218.76/218.99  |- skos__annotation mesh__D010825
% 218.76/218.99       IM SPEC only: SPEC qualif; may be used as NIM coord, without qualif; Manual 29.11%A%  
% 218.76/218.99  |- mesh__recordAuthorizer mesh__D010825 PLS
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D010825 1993
% 218.76/218.99  |- mesh__activeMeSHYear mesh__D010825 1990
% 218.76/218.99  |- skos__prefLabel mesh__D010825 Physics
% 218.76/219.00  |- mesh__recordOriginator mesh__D010825 NLM
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010825 1995
% 218.76/219.00  |- mesh__dateRevised mesh__D010825 1989-05-16
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010825 2002
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010825 1996
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010825 1991
% 218.76/219.00  |- rdf__type mesh__D010825sskos__Concept
% 218.76/219.00  |- skos__hiddenLabel mesh__D010825 Physic
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010825 1998
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010825 2003
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010825 1997
% 218.76/219.00  |- mesh__dateCreated mesh__D010825 1999-01-01
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010825 2005
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010825 2000
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010825 1999
% 218.76/219.00  |- skos__broader mesh__D010825smesh__D010811
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010825 1992
% 218.76/219.00  |- mesh__recordMaintainer mesh__D010825 TGC
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010027 2003
% 218.76/219.00  |- mesh__dateEstablished mesh__D010027 1965-01-01
% 218.76/219.00  |- mesh__publicMeSHNote mesh__D010027 65   
% 218.76/219.00  |- skos__hiddenLabel mesh__D010027 Osteotomies
% 218.76/219.00  |- mesh__dateRevised mesh__D010027 1997-06-20
% 218.76/219.00  |- mesh__historyNote mesh__D010027 65   
% 218.76/219.00  |- skos__broader mesh__D010027smesh__D019637
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010027 2006
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010027 2002
% 218.76/219.00  |- mesh__recordOriginator mesh__D010027 NLM
% 218.76/219.00  |- mesh__dateCreated mesh__D010027 1999-01-01
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010027 2005
% 218.76/219.00  |- rdf__type mesh__D010027sskos__Concept
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010027 2001
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010027 1999
% 218.76/219.00  |- mesh__recordMaintainer mesh__D010027 PXP
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010027 2004
% 218.76/219.00  |- skos__scopeNote mesh__D010027
% 218.76/219.00       The surgical cutting of a bone. %28%Dorland, 28th ed%29%     
% 218.76/219.00  |- mesh__recordAuthorizer mesh__D010027 SJN
% 218.76/219.00  |- skos__prefLabel mesh__D010027 Osteotomy
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010027 2000
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010027 1998
% 218.76/219.00  |- skos__annotation mesh__D010027
% 218.76/219.00       do not use /util except by MeSH definition   
% 218.76/219.00  |- skos__related mesh__D015510smesh__D019317
% 218.76/219.00  |- mesh__dateCreated mesh__D015510 1989-04-07
% 218.76/219.00  |- mesh__recordMaintainer mesh__D015510 jls
% 218.76/219.00  |- skos__altLabel mesh__D015510 Medicine, Clinical
% 218.76/219.00  |- rdf__type mesh__D015510sskos__Concept
% 218.76/219.00  |- mesh__historyNote mesh__D015510 90; was see MEDICINE 1986-89   
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D015510 2004
% 218.76/219.00  |- skos__scopeNote mesh__D015510
% 218.76/219.00       The study and practice of medicine by direct examination of the patient.%A%    
% 218.76/219.00  |- skos__historyNote mesh__D015510 Medicine %28%1966-1989%29%
% 218.76/219.00  |- mesh__dateRevised mesh__D015510 2003-07-14
% 218.76/219.00  |- mesh__recordOriginator mesh__D015510 PXP
% 218.76/219.00  |- skos__annotation mesh__D015510 DF: CLIN MED   
% 218.76/219.00  |- skos__prefLabel mesh__D015510 Clinical Medicine
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D015510 2006
% 218.76/219.00  |- mesh__onlineNote mesh__D015510 search MEDICINE 1986-89   
% 218.76/219.00  |- mesh__recordAuthorizer mesh__D015510 sjn
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D015510 2005
% 218.76/219.00  |- mesh__dateEstablished mesh__D015510 1990-01-01
% 218.76/219.00  |- skos__broader mesh__D015510smesh__D008511
% 218.76/219.00  |- mesh__publicMeSHNote mesh__D015510 90; was see MEDICINE 1986-89   
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D006784 2006
% 218.76/219.00  |- mesh__historyNote mesh__D006784 68   
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D006784 2005
% 218.76/219.00  |- skos__hiddenLabel mesh__D006784 Teaching Hospitals
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D006784 2004
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D006784 2002
% 218.76/219.00  |- skos__annotation mesh__D006784
% 218.76/219.00       coord IM with special hosp %28%e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.%29% or med specialty %28%IM or NIM%29% if pertinent; specify geog; consider also INTERNSHIP AND RESIDENCY%A%  
% 218.76/219.00  |- skos__prefLabel mesh__D006784 Hospitals, Teaching
% 218.76/219.00  |- mesh__recordAuthorizer mesh__D006784 sjn
% 218.76/219.00  |- mesh__publicMeSHNote mesh__D006784 68   
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D006784 2003
% 218.76/219.00  |- skos__broader mesh__D006784smesh__D000046
% 218.76/219.00  |- skos__broader mesh__D006784smesh__D006761
% 218.76/219.00  |- mesh__recordMaintainer mesh__D006784 kle
% 218.76/219.00  |- mesh__recordOriginator mesh__D006784 NLM
% 218.76/219.00  |- skos__historyNote mesh__D006784 Hospitals %28%1966-1967%29%
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D006784 2001
% 218.76/219.00  |- skos__hiddenLabel mesh__D006784 Teaching Hospital
% 218.76/219.00  |- rdf__type mesh__D006784sskos__Concept
% 218.76/219.00  |- skos__hiddenLabel mesh__D006784 Hospital, Teaching
% 218.76/219.00  |- mesh__dateEstablished mesh__D006784 1968-01-01
% 218.76/219.00  |- skos__scopeNote mesh__D006784
% 218.76/219.00       Hospitals engaged in educational and research programs, as well as providing medical care to the patients.%A%    
% 218.76/219.00  |- mesh__dateRevised mesh__D006784 1999-11-03
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D006784 2000
% 218.76/219.00  |- mesh__dateCreated mesh__D006784 1999-01-01
% 218.76/219.00  |- mesh__publicMeSHNote mesh__D020455 99; for MANATEES see MAMMALS 1998   
% 218.76/219.00  |- skos__scopeNote mesh__D020455
% 218.76/219.00       A genus of the order Sirenia comprising what are commonly called manatees. The distinguishing characteristics include a tail that is not notched, a short nasal cavity, the absence of nasal bones, and enamel-covered teeth. Members of this genus are found in marine bays and/or sluggish rivers, usually in turbid water. %28%From Scott, Concise Encyclopedia Biology, 1996%29%%A%    
% 218.76/219.00  |- rdf__type mesh__D020455sskos__Concept
% 218.76/219.00  |- skos__hiddenLabel mesh__D020455 Manatee
% 218.76/219.00  |- skos__altLabel mesh__D020455 Manatees
% 218.76/219.00  |- mesh__dateRevised mesh__D020455 2003-07-09
% 218.76/219.00  |- skos__prefLabel mesh__D020455 Trichechus
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D020455 2006
% 218.76/219.00  |- mesh__dateCreated mesh__D020455 1998-06-11
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D020455 2004
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D020455 2005
% 218.76/219.00  |- skos__broader mesh__D020455smesh__D020453
% 218.76/219.00  |- mesh__historyNote mesh__D020455 99; for MANATEES use MAMMALS 1998   
% 218.76/219.00  |- skos__historyNote mesh__D020455 Mammals %28%1977-1998%29%
% 218.76/219.00  |- mesh__dateEstablished mesh__D020455 1999-01-01
% 218.76/219.00  |- mesh__recordOriginator mesh__D014418 NLM
% 218.76/219.00  |- skos__broader mesh__D014418smesh__D016675
% 218.76/219.00  |- mesh__publicMeSHNote mesh__D014418
% 218.76/219.00       81; was TREE SHREWS see under PROSIMIANS 1975-80, see under PRIMATES 1972-74%A%  
% 218.76/219.00  |- mesh__recordAuthorizer mesh__D014418 sjn
% 218.76/219.00  |- skos__annotation mesh__D014418
% 218.76/219.00       family of tree shrews; do not confuse X ref TREE SHREWS with SHREWS %28%insectivore%29%; IM; qualif permitted%A%  
% 218.76/219.00  |- skos__prefLabel mesh__D014418 Tupaiidae
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D014418 2006
% 218.76/219.00  |- skos__hiddenLabel mesh__D014418 Shrew, Tree
% 218.76/219.00  |- skos__altLabel mesh__D014418 Treeshrews
% 218.76/219.00  |- mesh__dateEstablished mesh__D014418 1981-01-01
% 218.76/219.00  |- skos__hiddenLabel mesh__D014418 Treeshrew
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D014418 2005
% 218.76/219.00  |- mesh__dateRevised mesh__D014418 2003-07-09
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D014418 2004
% 218.76/219.00  |- rdf__type mesh__D014418sskos__Concept
% 218.76/219.00  |- skos__altLabel mesh__D014418 Tree Shrews
% 218.76/219.00  |- skos__altLabel mesh__D014418 Shrews, Tree
% 218.76/219.00  |- mesh__onlineNote mesh__D014418
% 218.76/219.00       use TUPAIIDAE to search TREE SHREWS 1975-80; use PRIMATES 1972-74%A%  
% 218.76/219.00  |- mesh__dateCreated mesh__D014418 1999-01-01
% 218.76/219.00  |- mesh__historyNote mesh__D014418
% 218.76/219.00       81; was TREE SHREWS see under PROSIMIANS 1975-80, see under PRIMATES 1972-74%A%  
% 218.76/219.00  |- skos__hiddenLabel mesh__D014418 Tree Shrew
% 218.76/219.00  |- mesh__recordMaintainer mesh__D014418 ags
% 218.76/219.00  |- skos__scopeNote mesh__D014418
% 218.76/219.00       The only family of the order SCANDENTIA, variously included in the order Insectivora or in the order Primates, and often in the order Microscelidea, consisting of five genera. They are TUPAIA, Ananthana %28%Indian tree shrew%29%, Dendrogale %28%small smooth-tailed tree shrew%29%, Urogale %28%Mindanao tree shrew%29%, and Ptilocercus %28%pen-tailed tree shrew%29%. The tree shrews inhabit the forest areas of eastern Asia from India and southwestern China to Borneo and the Philippines.%A%    
% 218.76/219.00  |- mesh__dateEstablished mesh__D019901 1998-01-01
% 218.76/219.00  |- rdf__type mesh__D019901sskos__Concept
% 218.76/219.00  |- skos__hiddenLabel mesh__D019901 Regions, Locus Control
% 218.76/219.00  |- skos__hiddenLabel mesh__D019901 Control Regions, Locus
% 218.76/219.00  |- skos__hiddenLabel mesh__D019901 Region, Locus Control
% 218.76/219.00  |- skos__prefLabel mesh__D019901 Locus Control Region
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D019901 2006A
% 218.76/219.00  |- mesh__publicMeSHNote mesh__D019901 98   
% 218.76/219.00  |- skos__hiddenLabel mesh__D019901 Control Region, Locus
% 218.76/219.00  |- mesh__dateRevised mesh__D019901 2005-08-03
% 218.76/219.00  |- mesh__recordMaintainer mesh__D019901 ags
% 218.76/219.00  |- mesh__historyNote mesh__D019901 98   
% 218.76/219.00  |- skos__hiddenLabel mesh__D019901 Locus Control Regions
% 218.76/219.00  |- skos__scopeNote mesh__D019901
% 218.76/219.00       A regulatory region first identified in the human beta-globin locus but subsequently found in other loci. The region is believed to regulate GENETIC TRANSCRIPTION by opening and remodeling CHROMATIN structure. It may also have ENHANCER activity.%A%    
% 218.76/219.00  |- mesh__recordAuthorizer mesh__D019901 ags
% 218.76/219.00  |- mesh__dateCreated mesh__D019901 1997-06-20
% 218.76/219.00  |- mesh__recordOriginator mesh__D019901 NDW
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D019901 2006
% 218.76/219.00  |- skos__broader mesh__D019901smesh__D012045
% 218.76/219.00  |- skos__broader mesh__D019901smesh__D040481
% 218.76/219.00  |- mesh__publicMeSHNote mesh__D011120
% 218.76/219.00       94; was POLYOMAVIRUSES 1978-93; was POLYOMA VIRUS 1963-77%A%  
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D011120 2004
% 218.76/219.00  |- mesh__recordOriginator mesh__D011120 NLM
% 218.76/219.00  |- mesh__dateCreated mesh__D011120 1999-01-01
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D011120 2003
% 218.76/219.00  |- skos__hiddenLabel mesh__D011120 Viruses, Polyoma
% 218.76/219.00  |- mesh__onlineNote mesh__D011120
% 218.76/219.00       use POLYOMAVIRUS to search POLYOMAVIRUSES 1978-93 %26% POLYOMA VIRUS 1966-77%A%  
% 218.76/219.00  |- skos__hiddenLabel mesh__D011120 Polyomaviruses
% 218.76/219.00  |- mesh__dateRevised mesh__D011120 2001-07-25
% 218.76/219.00  |- skos__prefLabel mesh__D011120 Polyomavirus
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D011120 2006
% 218.76/219.00  |- mesh__historyNote mesh__D011120
% 218.76/219.00       94; was POLYOMAVIRUSES 1978-93; was POLYOMA VIRUS 1963-77%A%  
% 218.76/219.00  |- skos__broader mesh__D011120smesh__D027382
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D011120 2005
% 218.76/219.00  |- skos__hiddenLabel mesh__D011120 Virus, Polyoma
% 218.76/219.00  |- skos__altLabel mesh__D011120 Polyoma Virus
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D011120 2002
% 218.76/219.00  |- rdf__type mesh__D011120sskos__Concept
% 218.76/219.00  |- skos__scopeNote mesh__D011120
% 218.76/219.00       A genus of potentially oncogenic viruses of the family POLYOMAVIRIDAE. These viruses are normally present in their natural hosts as latent infections. The virus is oncogenic in hosts different from the species of origin.%A%    
% 218.76/219.00  |- mesh__recordAuthorizer mesh__D011120 sjn
% 218.76/219.00  |- skos__annotation mesh__D011120
% 218.76/219.00       infection: coord IM with POLYOMAVIRUS INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%%A%  
% 218.76/219.00  |- skos__altLabel mesh__D011120 Polyoma Viruses
% 218.76/219.00  |- mesh__recordMaintainer mesh__D011120 ags
% 218.76/219.00  |- mesh__recordAuthorizer mesh__D002394 sjn
% 218.76/219.00  |- mesh__historyNote mesh__D002394 98%28%72%29%   
% 218.76/219.00  |- skos__prefLabel mesh__D002394 Catechol O-Methyltransferase
% 218.76/219.00  |- skos__historyNote mesh__D002394 Transferase %28%1966-1971%29%
% 218.76/219.00  |- rdf__type mesh__D002394sskos__Concept
% 218.76/219.00  |- mesh__recordMaintainer mesh__D002394 ssb
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D002394 2005
% 218.76/219.00  |- mesh__publicMeSHNote mesh__D002394
% 218.76/219.00       98; see CATECHOL METHYLTRANSFERASE 1974-97   
% 218.76/219.00  |- mesh__dateEstablished mesh__D002394 1974-01-01
% 218.76/219.00  |- mesh__dateCreated mesh__D002394 1999-01-01
% 218.76/219.00  |- skos__hiddenLabel mesh__D002394 Catechol O Methyltransferase
% 218.76/219.00  |- skos__broader mesh__D002394smesh__D008780
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D002394 2006
% 218.76/219.00  |- mesh__recordOriginator mesh__D002394 NLM
% 218.76/219.00  |- skos__scopeNote mesh__D002394
% 218.76/219.00       Enzyme that catalyzes the movement of a methyl group from S-adenosylmethionone to a catechol or a catecholamine. EC 2.1.1.6.%A%    
% 218.76/219.00  |- skos__altLabel mesh__D002394 Catechol Methyltransferase
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D002394 2004
% 218.76/219.00  |- skos__historyNote mesh__D002394 Methyltransferases %28%1971%29%
% 218.76/219.00  |- skos__hiddenLabel mesh__D002394 Methyltransferase, Catechol
% 218.76/219.00  |- skos__hiddenLabel mesh__D002394 O-Methyltransferase, Catechol
% 218.76/219.00  |- mesh__dateRevised mesh__D002394 2003-07-09
% 218.76/219.00  |- skos__altLabel mesh__D002394 Catechol-O-Methyltransferase
% 218.76/219.00  |- mesh__historyNote mesh__D018809
% 218.76/219.00       95; was PROLIFERATING CELL NUCLEAR ANTIGEN %28%NM%29% 1983-94   
% 218.76/219.00  |- rdf__type mesh__D018809sskos__Concept
% 218.76/219.00  |- mesh__recordAuthorizer mesh__D018809 sjn
% 218.76/219.00  |- skos__broader mesh__D018809smesh__D034961
% 218.76/219.00  |- mesh__recordOriginator mesh__D018809 AGS
% 218.76/219.00  |- skos__historyNote mesh__D018809 Nuclear Proteins %28%1988-1994%29%
% 218.76/219.00  |- skos__scopeNote mesh__D018809
% 218.76/219.00       Nuclear antigen with a role in DNA synthesis, DNA repair, and cell cycle progression. PCNA is required for the coordinated synthesis of both leading and lagging strands at the replication fork during DNA replication. PCNA expression correlates with the proliferation activity of several malignant and non-malignant cell types.%A%    
% 218.76/219.00  |- mesh__dateCreated mesh__D018809 1994-05-31
% 218.76/219.00  |- skos__annotation mesh__D018809
% 218.76/219.00       a nuclear protein; DF: note short X ref   
% 218.76/219.00  |- mesh__recordMaintainer mesh__D018809 ssb
% 218.76/219.00  |- mesh__onlineNote mesh__D018809
% 218.76/219.00       use PROLIFERATING CELL NUCLEAR ANTIGEN %28%NM%29% to search PROLIFERATING CELL NUCLEAR ANTIGEN 1983-94%A%  
% 218.76/219.00  |- skos__hiddenLabel mesh__D018809 PCNA Cyclin
% 218.76/219.00  |- skos__broader mesh__D018809smesh__D009687
% 218.76/219.00  |- skos__prefLabel mesh__D018809 Proliferating Cell Nuclear Antigen
% 218.76/219.00  |- skos__altLabel mesh__D018809 PCNA-Cyclin
% 218.76/219.00  |- skos__broader mesh__D018809smesh__D014408
% 218.76/219.00  |- skos__historyNote mesh__D018809 Nucleoproteins %28%1983-1987%29%
% 218.76/219.00  |- skos__altLabel mesh__D018809 PCNA
% 218.76/219.00  |- mesh__dateEstablished mesh__D018809 1995-01-01
% 218.76/219.00  |- mesh__dateRevised mesh__D018809 2005-06-30
% 218.76/219.00  |- skos__altLabel mesh__D018809 Antigen, Proliferating Cell Nuclear
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D018809 2006
% 218.76/219.00  |- mesh__publicMeSHNote mesh__D018809
% 218.76/219.00       95; PROLIFERATING CELL NUCLEAR ANTIGEN was indexed under NUCLEAR PROTEINS 1988-94 %26% NUCLEOPROTEINS 1983-87%A%  
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010826 2004
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010826 1999
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010826 1993
% 218.76/219.00  |- mesh__recordAuthorizer mesh__D010826 PLS
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010826 2003
% 218.76/219.00  |- mesh__dateCreated mesh__D010826 1999-01-01
% 218.76/219.00  |- skos__broader mesh__D010826smesh__D008919
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010826 2002
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010826 1998
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010826 1992
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010826 2006
% 218.76/219.00  |- skos__hiddenLabel mesh__D010826 Physiognomies
% 218.76/219.00  |- skos__prefLabel mesh__D010826 Physiognomy
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010826 1995
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010826 2005
% 218.76/219.00  |- mesh__dateRevised mesh__D010826 1991-06-20
% 218.76/219.00  |- mesh__recordOriginator mesh__D010826 NLM
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010826 1994
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010826 2001
% 218.76/219.00  |- skos__annotation mesh__D010826 no qualif   
% 218.76/219.00  |- mesh__recordMaintainer mesh__D010826 TGC
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010826 1997
% 218.76/219.00  |- rdf__type mesh__D010826sskos__Concept
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010826 2000
% 218.76/219.00  |- skos__related mesh__D010826smesh__D005149
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010826 1996
% 218.76/219.00  |- mesh__publicMeSHNote mesh__D043202 2004   
% 218.76/219.00  |- mesh__dateEstablished mesh__D043202 2004-01-01
% 218.76/219.00  |- skos__altLabel mesh__D043202 Congenital Errors of Steroid Metabolism
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D043202 2006
% 218.76/219.00  |- rdf__type mesh__D043202sskos__Concept
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D043202 2004
% 218.76/219.00  |- skos__altLabel mesh__D043202 Steroid Metabolic Diseases, Inborn
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D043202 2005
% 218.76/219.00  |- skos__prefLabel mesh__D043202 Steroid Metabolism, Inborn Errors
% 218.76/219.00  |- skos__annotation mesh__D043202
% 218.76/219.00       coord IM with specific steriod/metab %28%IM%29%;   
% 218.76/219.00  |- skos__scopeNote mesh__D043202
% 218.76/219.00       Errors in metabolic processing of STEROIDS resulting from inborn genetic mutations that are inherited or acquired in utero.%A%    
% 218.76/219.00  |- mesh__historyNote mesh__D043202 2004   
% 218.76/219.00  |- mesh__dateCreated mesh__D043202 2003-07-09
% 218.76/219.00  |- skos__broader mesh__D043202smesh__D008661
% 218.76/219.00  |- skos__altLabel mesh__D043202 Inborn Errors of Steroid Metabolism
% 218.76/219.00  |- skos__historyNote mesh__D010028 Trichostrongyloidea %28%1966-1985%29%
% 218.76/219.00  |- mesh__dateEstablished mesh__D010028 1986-01-01
% 218.76/219.00  |- mesh__dateCreated mesh__D010028 1985-03-11
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010028 2006
% 218.76/219.00  |- skos__broader mesh__D010028smesh__D014251
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010028 2005
% 218.76/219.00  |- rdf__type mesh__D010028sskos__Concept
% 218.76/219.00  |- skos__prefLabel mesh__D010028 Ostertagia
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D010028 2004
% 218.76/219.00  |- mesh__dateRevised mesh__D010028 2003-07-09
% 218.76/219.00  |- skos__scopeNote mesh__D010028
% 218.76/219.00       A genus of parasitic nematodes occurring in the stomach of ruminants.%A%    
% 218.76/219.00  |- mesh__recordOriginator mesh__D010028 EC
% 218.76/219.00  |- skos__annotation mesh__D010028
% 218.76/219.00       a genus of nematodes; infection = OSTERTAGIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 218.76/219.00  |- mesh__publicMeSHNote mesh__D010028 86   
% 218.76/219.00  |- mesh__recordMaintainer mesh__D010028 ags
% 218.76/219.00  |- mesh__recordAuthorizer mesh__D010028 sjn
% 218.76/219.00  |- mesh__historyNote mesh__D010028 86   
% 218.76/219.00  |- skos__hiddenLabel mesh__D015511 Goat Disease
% 218.76/219.00  |- skos__hiddenLabel mesh__D015511 Diseases, Goat
% 218.76/219.00  |- skos__hiddenLabel mesh__D015511 Caprine Disease
% 218.76/219.00  |- mesh__historyNote mesh__D015511 90   
% 218.76/219.00  |- mesh__recordOriginator mesh__D015511 PXP
% 218.76/219.00  |- skos__hiddenLabel mesh__D015511 Disease, Goat
% 218.76/219.00  |- mesh__dateCreated mesh__D015511 1989-04-07
% 218.76/219.00  |- mesh__activeMeSHYear mesh__D015511 2006
% 218.76/219.00  |- mesh__publicMeSHNote mesh__D015511 90   
% 218.76/219.00  |- mesh__recordMaintainer mesh__D015511 ags
% 218.86/219.00  |- skos__scopeNote mesh__D015511
% 218.86/219.00       Diseases of the domestic or wild goat of the genus Capra.%A%    
% 218.86/219.00  |- mesh__activeMeSHYear mesh__D015511 2005
% 218.86/219.00  |- skos__annotation mesh__D015511
% 218.86/219.00       IM GEN or unspecified; coord IM with specific dis /vet %28%IM%29%; for abnormalities or injuries, index under GOATS /abnorm or GOATS /inj; don%27%t forget also GOATS %28%NIM%29% %26% check tag ANIMALS; DF: GOAT DIS%A%  
% 218.86/219.00  |- skos__broader mesh__D015511smesh__D000820
% 218.86/219.00  |- mesh__dateEstablished mesh__D015511 1990-01-01
% 218.86/219.00  |- skos__prefLabel mesh__D015511 Goat Diseases
% 218.86/219.00  |- skos__historyNote mesh__D015511 Goats %28%1966-1989%29%
% 218.86/219.00  |- skos__hiddenLabel mesh__D015511 Disease, Caprine
% 218.86/219.00  |- mesh__recordAuthorizer mesh__D015511 sjn
% 218.86/219.00  |- rdf__type mesh__D015511sskos__Concept
% 218.86/219.00  |- mesh__dateRevised mesh__D015511 2003-07-30
% 218.86/219.00  |- mesh__activeMeSHYear mesh__D015511 2004
% 218.86/219.00  |- skos__altLabel mesh__D015511 Caprine Diseases
% 218.86/219.00  |- skos__hiddenLabel mesh__D015511 Diseases, Caprine
% 218.86/219.00  |- skos__annotation mesh__D006785
% 218.86/219.00       coord IM with special hosp %28%e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.%29% or med specialty %28%IM or NIM%29% if pertinent; specify geog; DF: HOSP UNIV%A%  
% 218.86/219.00  |- mesh__recordOriginator mesh__D006785 NLM
% 218.86/219.00  |- mesh__activeMeSHYear mesh__D006785 2003
% 218.86/219.00  |- mesh__activeMeSHYear mesh__D006785 2006
% 218.86/219.00  |- mesh__publicMeSHNote mesh__D006785
% 218.86/219.00       91; was see under HOSPITALS, TEACHING 1978-90; was UNIVERSITY HOSPITALS see under HOSPITALS, TEACHING 1968-77%A%  
% 218.86/219.00  |- mesh__activeMeSHYear mesh__D006785 2001
% 218.86/219.00  |- skos__altLabel mesh__D006785 University Hospitals
% 218.86/219.00  |- skos__broader mesh__D006785smesh__D006784
% 218.86/219.00  |- mesh__activeMeSHYear mesh__D006785 2004
% 218.86/219.00  |- mesh__activeMeSHYear mesh__D006785 2002
% 218.86/219.00  |- mesh__dateRevised mesh__D006785 1999-11-03
% 218.86/219.00  |- mesh__historyNote mesh__D006785
% 218.86/219.00       91%28%78%29%; was see under HOSPITALS, TEACHING 1978-90; was UNIVERSITY HOSPITALS see under HOSPITALS, TEACHING 1968-77%A%  
% 218.86/219.00  |- mesh__onlineNote mesh__D006785
% 218.86/219.00       use HOSPITALS, UNIVERSITY to search UNIVERSITY HOSPITALS  1975-77; use HOSPITALS, TEACHING 1968-74%A%  
% 218.86/219.00  |- mesh__dateCreated mesh__D006785 1999-01-01
% 218.86/219.00  |- skos__scopeNote mesh__D006785
% 218.86/219.00       Hospitals maintained by a university for the teaching of medical students, postgraduate training programs, and clinical research.%A%    
% 218.86/219.00  |- mesh__recordAuthorizer mesh__D006785 sjn
% 218.86/219.00  |- mesh__dateEstablished mesh__D006785 1991-01-01
% 218.86/219.00  |- rdf__type mesh__D006785sskos__Concept
% 218.86/219.00  |- mesh__activeMeSHYear mesh__D006785 2005
% 218.86/219.00  |- mesh__recordMaintainer mesh__D006785 kle
% 218.86/219.00  |- skos__prefLabel mesh__D006785 Hospitals, University
% 218.86/219.00  |- mesh__activeMeSHYear mesh__D006785 2000
% 218.86/219.00  |- mesh__dateRevised mesh__D020456 2003-07-09
% 218.86/219.00  |- skos__hiddenLabel mesh__D020456 inunguis, Trichechus
% 218.86/219.00  |- mesh__activeMeSHYear mesh__D020456 2006
% 218.86/219.00  |- mesh__dateEstablished mesh__D020456 1999-01-01
% 218.86/219.00  |- skos__hiddenLabel mesh__D020456 Brazilian Manatees
% 218.86/219.00  |- mesh__dateCreated mesh__D020456 1998-06-11
% 218.86/219.00  |- skos__altLabel mesh__D020456 Manatee, Amazon
% 218.86/219.00  |- mesh__activeMeSHYear mesh__D020456 2004
% 218.86/219.00  |- skos__altLabel mesh__D020456 Brazilian Manatee
% 218.86/219.00  |- mesh__historyNote mesh__D020456 99   
% 218.86/219.00  |- skos__scopeNote mesh__D020456
% 218.86/219.00       Member of the genus Trichechus found in the Amazon and Orinoco drainages of northeastern South America. %28%From Scott, Concise Encyclopedia Biology, 1996%29%%A%    
% 218.86/219.00  |- mesh__activeMeSHYear mesh__D020456 2005
% 218.86/219.00  |- skos__hiddenLabel mesh__D020456 Manatees, Brazilian
% 218.86/219.00  |- skos__hiddenLabel mesh__D020456 Amazon Manatees
% 218.86/219.00  |- skos__broader mesh__D020456smesh__D020455
% 218.86/219.00  |- skos__prefLabel mesh__D020456 Trichechus inunguis
% 218.86/219.00  |- skos__historyNote mesh__D020456 Mammals %28%1987-1998%29%
% 218.86/219.00  |- skos__hiddenLabel mesh__D020456 Manatees, Amazon
% 218.86/219.00  |- skos__altLabel mesh__D020456 Amazon Manatee
% 218.86/219.00  |- mesh__publicMeSHNote mesh__D020456 99   
% 218.86/219.00  |- skos__historyNote mesh__D020456 Pinnipedia %28%1986%29%
% 218.86/219.00  |- skos__altLabel mesh__D020456 Manatee, Brazilian
% 218.86/219.00  |- rdf__type mesh__D020456sskos__Concept
% 218.86/219.00  |- mesh__dateRevised mesh__D039161 2005-07-18
% 218.86/219.00  |- skos__hiddenLabel mesh__D039161 Integrin, alpha6 beta4
% 218.86/219.00  |- skos__altLabel mesh__D039161
% 218.86/219.00       alpha%28%6%29%beta%28%4%29% Epithelial Integrin
% 218.86/219.00  |- skos__hiddenLabel mesh__D039161 Tumor Specific Protein 180 Complex
% 218.86/219.00  |- mesh__recordAuthorizer mesh__D039161 ags
% 218.86/219.00  |- rdf__type mesh__D039161sskos__Concept
% 218.86/219.00  |- mesh__recordOriginator mesh__D039161 MDJ
% 218.86/219.00  |- skos__broader mesh__D039161smesh__D016024
% 218.86/219.00  |- skos__historyNote mesh__D039161 Integrins %28%1988-2002%29%
% 218.86/219.00  |- skos__hiddenLabel mesh__D039161 beta4 Integrin, alpha6
% 218.86/219.00  |- mesh__activeMeSHYear mesh__D039161 2004
% 218.86/219.00  |- mesh__dateEstablished mesh__D039161 2003-01-01
% 218.86/219.00  |- skos__altLabel mesh__D039161 TSP-180
% 218.86/219.00  |- mesh__dateCreated mesh__D039161 2002-07-02
% 218.86/219.00  |- skos__historyNote mesh__D039161 Antigens, Surface %28%1988-2002%29%
% 218.86/219.00  |- skos__hiddenLabel mesh__D039161 Antigen, A9
% 218.86/219.00  |- mesh__activeMeSHYear mesh__D039161 2005
% 218.86/219.00  |- skos__altLabel mesh__D039161
% 218.86/219.00       Laminin-5 Receptor %28%alpha6beta4 Integrin%29%
% 218.86/219.00  |- skos__altLabel mesh__D039161 Integrin alpha%28%6%29%,beta%28%4%29%
% 218.86/219.00  |- mesh__activeMeSHYear mesh__D039161 2006
% 218.86/219.00  |- skos__altLabel mesh__D039161 alpha6 beta4 Integrin
% 218.86/219.00  |- skos__altLabel mesh__D039161 A9 Antigen
% 218.86/219.00  |- skos__broader mesh__D039161smesh__D017474
% 218.86/219.00  |- mesh__publicMeSHNote mesh__D039161
% 218.86/219.00       2003; INTEGRIN ALPHA6BETA4 was indexed under INTEGRINS; %26% ANTIGENS, SURFACE 1988-2002%A%  
% 218.86/219.00  |- skos__altLabel mesh__D039161 Tumor Specific Protein-180 Complex
% 218.86/219.00  |- skos__prefLabel mesh__D039161 Integrin alpha6beta4
% 218.86/219.00  |- skos__scopeNote mesh__D039161
% 218.86/219.00       This intrgrin is a key component of HEMIDESMOSOMES and is required for their formation and maintenance in epithelial cells. Integrin alpha6beta4 is also found on thymocytes, fibroblasts, and Schwann cells, where it functions as a laminin receptor %28%RECEPTORS, LAMININ%29% and is involved in wound healing, cell migration, and tumor invasiveness.%A%    
% 218.86/219.00  |- mesh__activeMeSHYear mesh__D039161 2006A
% 218.86/219.00  |- mesh__historyNote mesh__D039161
% 218.86/219.00       2003; use INTEGRIN ALPHA6BETA4 %28%NM%29% 1988-2002   
% 218.86/219.00  |- skos__hiddenLabel mesh__D039161 alpha6beta4, Integrin
% 218.86/219.00  |- skos__altLabel mesh__D039161 alpha%28%6%29%beta%28%4%29% Integrin
% 218.86/219.00  |- mesh__recordMaintainer mesh__D039161 ags
% 218.86/219.00  |- mesh__activeMeSHYear mesh__D014419 2006
% 218.86/219.00  |- mesh__historyNote mesh__D014419 65   
% 218.86/219.00  |- skos__prefLabel mesh__D014419 Turbellaria
% 218.86/219.00  |- mesh__recordOriginator mesh__D014419 NLM
% 218.86/219.00  |- mesh__activeMeSHYear mesh__D014419 2005
% 218.86/219.00  |- mesh__dateRevised mesh__D014419 2003-07-09
% 218.86/219.00  |- mesh__recordAuthorizer mesh__D014419 sjn
% 218.86/219.00  |- mesh__activeMeSHYear mesh__D014419 2004
% 218.86/219.00  |- rdf__type mesh__D014419sskos__Concept
% 218.86/219.00  |- mesh__publicMeSHNote mesh__D014419 65   
% 218.86/219.00  |- mesh__dateCreated mesh__D014419 1999-01-01
% 218.86/219.00  |- mesh__dateEstablished mesh__D014419 1965-01-01
% 218.86/219.00  |- mesh__recordMaintainer mesh__D014419 ags
% 218.86/219.00  |- skos__broader mesh__D014419smesh__D010986
% 218.86/219.00  |- skos__annotation mesh__D014419
% 218.86/219.00       a class of platyhelminths not usually parasitic   
% 218.86/219.00  |- skos__scopeNote mesh__D014419
% 218.86/219.00       A class of free-living freshwater flatworms of North America.%A%    
% 218.86/219.00  |- skos__broader mesh__D025141smesh__D004352
% 218.86/219.00  |- skos__historyNote mesh__D025141
% 218.86/219.00       Drug Resistance, Microbial %28%1966-2001%29%
% 218.86/219.01  |- mesh__historyNote mesh__D025141 2002   
% 218.86/219.01  |- mesh__dateEstablished mesh__D025141 2002-01-01
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D025141 2006
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D025141 2004
% 218.86/219.01  |- mesh__recordMaintainer mesh__D025141 ssb
% 218.86/219.01  |- mesh__dateRevised mesh__D025141 2003-07-09
% 218.86/219.01  |- rdf__type mesh__D025141sskos__Concept
% 218.86/219.01  |- skos__hiddenLabel mesh__D025141 Resistance, Antifungal Drug
% 218.86/219.01  |- mesh__dateCreated mesh__D025141 2001-07-25
% 218.86/219.01  |- skos__prefLabel mesh__D025141 Drug Resistance, Fungal
% 218.86/219.01  |- mesh__recordAuthorizer mesh__D025141 sjn
% 218.86/219.01  |- skos__altLabel mesh__D025141 Antifungal Drug Resistance
% 218.86/219.01  |- mesh__recordOriginator mesh__D025141 lkt
% 218.86/219.01  |- mesh__publicMeSHNote mesh__D025141 2002   
% 218.86/219.01  |- skos__scopeNote mesh__D025141
% 218.86/219.01       The ability of fungi to resist or to become tolerant to chemotherapeutic agents, antifungal agents, or antibiotics. This resistance may be acquired through gene mutation.%A%    
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D025141 2005
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D019902 2002
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D019902 2005
% 218.86/219.01  |- mesh__dateEstablished mesh__D019902 1998-01-01
% 218.86/219.01  |- mesh__recordOriginator mesh__D019902 JLS
% 218.86/219.01  |- rdf__type mesh__D019902sskos__Concept
% 218.86/219.01  |- skos__prefLabel mesh__D019902 Chondrocytes
% 218.86/219.01  |- skos__scopeNote mesh__D019902
% 218.86/219.01       Polymorphic cells that form cartilage.     
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D019902 2001
% 218.86/219.01  |- skos__broader mesh__D019902smesh__D003239
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D019902 2004
% 218.86/219.01  |- mesh__dateCreated mesh__D019902 1997-06-20
% 218.86/219.01  |- mesh__publicMeSHNote mesh__D019902 98   
% 218.86/219.01  |- mesh__recordMaintainer mesh__D019902 KEV
% 218.86/219.01  |- mesh__historyNote mesh__D019902 98   
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D019902 2000
% 218.86/219.01  |- skos__historyNote mesh__D019902 Cartilage %28%1966-1997%29%
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D019902 2003
% 218.86/219.01  |- mesh__dateRevised mesh__D019902 1999-11-03
% 218.86/219.01  |- skos__hiddenLabel mesh__D019902 Chondrocyte
% 218.86/219.01  |- mesh__recordAuthorizer mesh__D019902 sjn
% 218.86/219.01  |- skos__hiddenLabel mesh__D019902 Chondroblast
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D019902 2006
% 218.86/219.01  |- mesh__dateEstablished mesh__D011121 1991-01-01
% 218.86/219.01  |- skos__broader mesh__D011121smesh__D011108
% 218.86/219.01  |- mesh__recordAuthorizer mesh__D011121 sjn
% 218.86/219.01  |- mesh__recordMaintainer mesh__D011121 jmp
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D011121 2006
% 218.86/219.01  |- skos__historyNote mesh__D011121 Polymers %28%1966-1974%29%
% 218.86/219.01  |- skos__prefLabel mesh__D011121 Polyphloretin Phosphate
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D011121 2005
% 218.86/219.01  |- skos__broader mesh__D011121smesh__D010693
% 218.86/219.01  |- mesh__recordOriginator mesh__D011121 NLM
% 218.86/219.01  |- skos__historyNote mesh__D011121
% 218.86/219.01       Organophosphorus Compounds %28%1972-1974%29%
% 218.86/219.01  |- skos__hiddenLabel mesh__D011121 Phosphate, Polyphloretin
% 218.86/219.01  |- rdf__type mesh__D011121sskos__Concept
% 218.86/219.01  |- skos__scopeNote mesh__D011121
% 218.86/219.01       A polymeric mixture of polyesters of phosphoric acid and phloretin. It blocks some cellular responses to prostaglandins.%A%    
% 218.86/219.01  |- mesh__onlineNote mesh__D011121 search PHLORETIN 1973-74   
% 218.86/219.01  |- mesh__publicMeSHNote mesh__D011121
% 218.86/219.01       91; was see under PHLORETIN 1975-90   
% 218.86/219.01  |- mesh__dateRevised mesh__D011121 2004-07-07
% 218.86/219.01  |- mesh__dateCreated mesh__D011121 1999-01-01
% 218.86/219.01  |- mesh__historyNote mesh__D011121
% 218.86/219.01       91%28%75%29%; was see under PHLORETIN 1975-90   
% 218.86/219.01  |- skos__historyNote mesh__D011121 Phloretin %28%1973-1974%29%
% 218.86/219.01  |- mesh__dateCreated mesh__D002395 1999-01-01
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002395 1997
% 218.86/219.01  |- skos__broader mesh__D002395smesh__D000588
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002395 2003
% 218.86/219.01  |- mesh__recordAuthorizer mesh__D002395 PLS
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002395 2006
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002395 2000
% 218.86/219.01  |- skos__scopeNote mesh__D002395
% 218.86/219.01       A general class of ortho-dihydroxyphenylalkylamines derived from tyrosine.%A%    
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002395 1994
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002395 2004
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002395 2001
% 218.86/219.01  |- skos__prefLabel mesh__D002395 Catecholamines
% 218.86/219.01  |- skos__related mesh__D002395smesh__D017983
% 218.86/219.01  |- skos__altLabel mesh__D002395 Sympathins
% 218.86/219.01  |- mesh__dateRevised mesh__D002395 1993-06-21
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002395 1995
% 218.86/219.01  |- skos__broader mesh__D002395smesh__D015306
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002395 2002
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002395 1998
% 218.86/219.01  |- rdf__type mesh__D002395sskos__Concept
% 218.86/219.01  |- mesh__recordMaintainer mesh__D002395 RAZ
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002395 1996
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002395 1999
% 218.86/219.01  |- skos__annotation mesh__D002395
% 218.86/219.01       if only EPINEPHRINE %26% NOREPINEPHRINE are discussed index under each %26% not also here%A%  
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002395 2005
% 218.86/219.01  |- mesh__recordOriginator mesh__D002395 NLM
% 218.86/219.01  |- skos__broader mesh__D010827smesh__D001690
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D010827 2006
% 218.86/219.01  |- mesh__recordAuthorizer mesh__D010827 sjn
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D010827 2005
% 218.86/219.01  |- mesh__recordMaintainer mesh__D010827 jls
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D010827 2002
% 218.86/219.01  |- skos__annotation mesh__D010827
% 218.86/219.01       SPEC only: SPEC qualif; PHYSIOLOGICAL PROCESSES or /physiol with organs, organisms %26% psychol processes: Manual 19.7+, 19.8.55; DF: PHYSIOL%A%  
% 218.86/219.01  |- mesh__dateRevised mesh__D010827 2001-07-25
% 218.86/219.01  |- rdf__type mesh__D010827sskos__Concept
% 218.86/219.01  |- skos__prefLabel mesh__D010827 Physiology
% 218.86/219.01  |- skos__scopeNote mesh__D010827
% 218.86/219.01       The science which treats of the functions of the living organism and its parts, and of the physical and chemical factors and processes involved. %28%Dorland, 27th ed%29%%A%    
% 218.86/219.01  |- mesh__recordOriginator mesh__D010827 NLM
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D010827 2004
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D010827 2003
% 218.86/219.01  |- mesh__dateCreated mesh__D010827 1999-01-01
% 218.86/219.01  |- skos__hiddenLabel mesh__D043203 Acetylhydrolase, PAF
% 218.86/219.01  |- skos__hiddenLabel mesh__D043203 Platelet Activating Factor Hydrolase
% 218.86/219.01  |- skos__hiddenLabel mesh__D043203 Hydrolase, Platelet-Activating Factor
% 218.86/219.01  |- skos__altLabel mesh__D043203 PAF 2-Acetylhydrolase
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D043203 2006
% 218.86/219.01  |- rdf__type mesh__D043203sskos__Concept
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D043203 2004
% 218.86/219.01  |- skos__altLabel mesh__D043203 PAF 2-Acylhydrolase
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D043203 2005
% 218.86/219.01  |- skos__altLabel mesh__D043203 PAF Acetylhydrolase
% 218.86/219.01  |- skos__scopeNote mesh__D043203
% 218.86/219.01       A lipoprotein-associated PHOSPHOLIPASE A2 which modulates the action of PLATELET ACTIVATING FACTOR by hydrolyzing the SN-2 ester bond to yield the biologically inactive lyso-platelet-activating factor.  It has specificity for phospholipid substrates with short-chain residues at the SN-2 position, but inactive against long-chain phospholipids. Deficiency in this enzyme is associated with many diseases including ASTHMA, and HYPERCHOLESTEROLEMIA.%A%    
% 218.86/219.01  |- skos__altLabel mesh__D043203 Platelet-Activating Factor Hydrolase
% 218.86/219.01  |- mesh__historyNote mesh__D043203
% 218.86/219.01       2004; use 1-ALKYL-2-ACETYLGLYCEROLPHOSPHOCHOLINE ESTERASE %28%NM%29% 1983-2003%A%  
% 218.86/219.01  |- skos__hiddenLabel mesh__D043203 PAF 2 Acylhydrolase
% 218.86/219.01  |- mesh__dateCreated mesh__D043203 2003-07-09
% 218.86/219.01  |- skos__hiddenLabel mesh__D043203
% 218.86/219.01       Platelet activating Factor Acetylhydrolase IB
% 218.86/219.01  |- mesh__dateEstablished mesh__D043203 2004-01-01
% 218.86/219.01  |- skos__hiddenLabel mesh__D043203 PAF 2 Acetylhydrolase
% 218.86/219.01  |- skos__hiddenLabel mesh__D043203 2-Acetylhydrolase, PAF
% 218.86/219.01  |- skos__prefLabel mesh__D043203
% 218.86/219.01       1-Alkyl-2-acetylglycerophosphocholine Esterase
% 218.86/219.01  |- skos__hiddenLabel mesh__D043203 Factor Hydrolase, Platelet-Activating
% 218.86/219.01  |- skos__hiddenLabel mesh__D043203
% 218.86/219.01       1 Alkyl 2 acetylglycerophosphocholine Esterase
% 218.86/219.01  |- skos__hiddenLabel mesh__D043203 Acetylhydrolase II, PAF
% 218.86/219.01  |- skos__altLabel mesh__D043203 PAF Acetylhydrolase II
% 218.86/219.01  |- mesh__publicMeSHNote mesh__D043203
% 218.86/219.01       2004; 1-ALKYL-2-ACETYLGLYCEROLPHOSPHOCHOLINE ESTERASE was indexed under PHOSPHOLIPASES A 1983-2003%A%  
% 218.86/219.01  |- skos__broader mesh__D043203smesh__D010741
% 218.86/219.01  |- skos__hiddenLabel mesh__D043203
% 218.86/219.01       Esterase, 1-Alkyl-2-acetylglycerophosphocholine
% 218.86/219.01  |- skos__historyNote mesh__D043203 Phospholipases %28%1983-2003%29%
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D010029 1995
% 218.86/219.01  |- mesh__dateRevised mesh__D010029 1993-06-02
% 218.86/219.01  |- mesh__dateCreated mesh__D010029 1999-01-01
% 218.86/219.01  |- mesh__historyNote mesh__D010029
% 218.86/219.01       91%28%75%29%; was see under TRICHOSTRONGYLOIDIASIS 1975-90   
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D010029 2005
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D010029 1999
% 218.86/219.01  |- mesh__recordMaintainer mesh__D010029 TGC
% 218.86/219.01  |- rdf__type mesh__D010029sskos__Concept
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D010029 2002
% 218.86/219.01  |- skos__hiddenLabel mesh__D010029 Ostertagiases
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D010029 1994
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D010029 2004
% 218.86/219.01  |- mesh__recordOriginator mesh__D010029 NLM
% 218.86/219.01  |- skos__annotation mesh__D010029 roundworm infect   
% 218.86/219.01  |- skos__scopeNote mesh__D010029
% 218.86/219.01       A disease of herbivorous mammals, particularly cattle and sheep, caused by stomach worms of the genus OSTERTAGIA.%A%    
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D010029 1998
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D010029 2001
% 218.86/219.01  |- skos__prefLabel mesh__D010029 Ostertagiasis
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D010029 2003
% 218.86/219.01  |- skos__broader mesh__D010029smesh__D014252
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D010029 1997
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D010029 2000
% 218.86/219.01  |- mesh__recordAuthorizer mesh__D010029 PLS
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D010029 1996
% 218.86/219.01  |- mesh__onlineNote mesh__D010029 search TRICHOSTRONGYLOIDIASIS 1968-74   
% 218.86/219.01  |- mesh__publicMeSHNote mesh__D010029
% 218.86/219.01       91; was see under TRICHOSTRONGYLOIDIASIS 1975-90   
% 218.86/219.01  |- mesh__dateEstablished mesh__D010029 1991-01-01
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D010029 2006
% 218.86/219.01  |- skos__broader mesh__D007080smesh__D007082
% 218.86/219.01  |- skos__annotation mesh__D007080
% 218.86/219.01       diseases: coord IM with ILEAL DISEASES %28%IM%29%; neopl: coord IM with ILEAL NEOPLASMS %28%IM%29%; ileocecal intussusception or invagination: index under ILEOCECAL VALVE %28%IM%29% + INTUSSUSCEPTION %28%IM%29% + ILEAL DISEASES %28%IM%29% but not also CECAL DISEASES%A%  
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D007080 2005
% 218.86/219.01  |- mesh__recordMaintainer mesh__D007080 lkt
% 218.86/219.01  |- mesh__recordAuthorizer mesh__D007080 sjn
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D007080 2006
% 218.86/219.01  |- skos__hiddenLabel mesh__D007080 Ileocecal Valves
% 218.86/219.01  |- mesh__dateCreated mesh__D007080 1999-01-01
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D007080 2004
% 218.86/219.01  |- rdf__type mesh__D007080sskos__Concept
% 218.86/219.01  |- skos__scopeNote mesh__D007080
% 218.86/219.01       The valve, at the junction of the CECUM with the COLON, that guards the opening where the ILEUM enters the LARGE INTESTINE.%A%    
% 218.86/219.01  |- mesh__dateRevised mesh__D007080 2003-07-09
% 218.86/219.01  |- mesh__recordOriginator mesh__D007080 NLM
% 218.86/219.01  |- skos__hiddenLabel mesh__D007080 Valves, Ileocecal
% 218.86/219.01  |- skos__prefLabel mesh__D007080 Ileocecal Valve
% 218.86/219.01  |- skos__hiddenLabel mesh__D007080 Valve, Ileocecal
% 218.86/219.01  |- skos__historyNote mesh__D006786 Urban Population %28%1968-1985%29%
% 218.86/219.01  |- skos__hiddenLabel mesh__D006786 Hospital, Non-Public-Owned City
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D006786 2004
% 218.86/219.01  |- skos__hiddenLabel mesh__D006786 Metropolitan Hospital
% 218.86/219.01  |- mesh__recordOriginator mesh__D006786 EC
% 218.86/219.01  |- skos__hiddenLabel mesh__D006786 City Hospitals, Non Public Owned
% 218.86/219.01  |- skos__altLabel mesh__D006786 Hospitals, City
% 218.86/219.01  |- mesh__dateRevised mesh__D006786 1999-11-08
% 218.86/219.01  |- skos__annotation mesh__D006786
% 218.86/219.01       coord IM with special hosp or med specialty %28%IM or NIM%29% if pertinent; specify geog%A%  
% 218.86/219.01  |- mesh__recordAuthorizer mesh__D006786 sjn
% 218.86/219.01  |- skos__altLabel mesh__D006786 Non-Public-Owned City Hospitals
% 218.86/219.01  |- rdf__type mesh__D006786sskos__Concept
% 218.86/219.01  |- skos__hiddenLabel mesh__D006786 Non Public Owned City Hospitals
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D006786 2003
% 218.86/219.01  |- skos__hiddenLabel mesh__D006786 Non-Public-Owned City Hospital
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D006786 2006
% 218.86/219.01  |- skos__hiddenLabel mesh__D006786 City Hospital, Non-Public-Owned
% 218.86/219.01  |- skos__prefLabel mesh__D006786 Hospitals, Urban
% 218.86/219.01  |- mesh__dateCreated mesh__D006786 1985-05-23
% 218.86/219.01  |- skos__historyNote mesh__D006786 Hospitals %28%1966-1985%29%
% 218.86/219.01  |- skos__hiddenLabel mesh__D006786 City Hospital
% 218.86/219.01  |- skos__hiddenLabel mesh__D006786 Hospital, Urban
% 218.86/219.01  |- mesh__publicMeSHNote mesh__D006786
% 218.86/219.01       91; was see under HOSPITALS 1986-90   
% 218.86/219.01  |- skos__hiddenLabel mesh__D006786 Hospitals, Non-Public-Owned City
% 218.86/219.01  |- skos__hiddenLabel mesh__D006786 Urban Hospital
% 218.86/219.01  |- skos__altLabel mesh__D006786 Metropolitan Hospitals
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D006786 2002
% 218.86/219.01  |- skos__scopeNote mesh__D006786
% 218.86/219.01       Hospitals located in metropolitan areas.     
% 218.86/219.01  |- skos__altLabel mesh__D006786 City Hospitals
% 218.86/219.01  |- skos__altLabel mesh__D006786 Urban Hospitals
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D006786 2005
% 218.86/219.01  |- skos__altLabel mesh__D006786 Hospitals, Metropolitan
% 218.86/219.01  |- mesh__historyNote mesh__D006786
% 218.86/219.01       91%28%86%29%; was see under HOSPITALS 1986-90   
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D006786 2001
% 218.86/219.01  |- mesh__dateEstablished mesh__D006786 1991-01-01
% 218.86/219.01  |- skos__hiddenLabel mesh__D006786 Hospital, City
% 218.86/219.01  |- skos__historyNote mesh__D006786 Urban Health %28%1979-1985%29%
% 218.86/219.01  |- skos__broader mesh__D006786smesh__D006761
% 218.86/219.01  |- skos__hiddenLabel mesh__D006786 Hospital, Metropolitan
% 218.86/219.01  |- skos__altLabel mesh__D006786 City Hospitals, Non-Public-Owned
% 218.86/219.01  |- mesh__recordMaintainer mesh__D006786 kle
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D006786 2000
% 218.86/219.01  |- skos__altLabel mesh__D020457 Manatee, Florida
% 218.86/219.01  |- mesh__dateRevised mesh__D020457 2003-07-09
% 218.86/219.01  |- skos__altLabel mesh__D020457 Manatee, Caribbean
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D020457 2006
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D020457 2004
% 218.86/219.01  |- mesh__dateCreated mesh__D020457 1998-06-11
% 218.86/219.01  |- skos__altLabel mesh__D020457 Caribbean Manatee
% 218.86/219.01  |- mesh__historyNote mesh__D020457 99   
% 218.86/219.01  |- mesh__publicMeSHNote mesh__D020457 99   
% 218.86/219.01  |- skos__hiddenLabel mesh__D020457 Manatees, Caribbean
% 218.86/219.01  |- skos__hiddenLabel mesh__D020457 Indian Manatee, West
% 218.86/219.01  |- skos__altLabel mesh__D020457 Florida Manatee
% 218.86/219.01  |- skos__altLabel mesh__D020457 West Indian Manatee
% 218.86/219.01  |- skos__scopeNote mesh__D020457
% 218.86/219.01       Member of the genus Trichechus inhabiting the coast and coastal rivers of the southeastern United States as well as the West Indies and the adjacent mainland from Vera Cruz, Mexico to northern South America. %28%From Scott, Concise Encyclopedia Biology, 1996%29%%A%    
% 218.86/219.01  |- skos__hiddenLabel mesh__D020457 Caribbean Manatees
% 218.86/219.01  |- skos__prefLabel mesh__D020457 Trichechus manatus
% 218.86/219.01  |- skos__hiddenLabel mesh__D020457 Indian Manatees, West
% 218.86/219.01  |- mesh__dateEstablished mesh__D020457 1999-01-01
% 218.86/219.01  |- skos__broader mesh__D020457smesh__D020455
% 218.86/219.01  |- skos__hiddenLabel mesh__D020457 West Indian Manatees
% 218.86/219.01  |- skos__hiddenLabel mesh__D020457 Florida Manatees
% 218.86/219.01  |- skos__hiddenLabel mesh__D020457 Manatees, West Indian
% 218.86/219.01  |- skos__hiddenLabel mesh__D020457 manatus, Trichechus
% 218.86/219.01  |- rdf__type mesh__D020457sskos__Concept
% 218.86/219.01  |- skos__hiddenLabel mesh__D020457 Manatees, Florida
% 218.86/219.01  |- skos__historyNote mesh__D020457 Mammals %28%1977-1998%29%
% 218.86/219.01  |- skos__altLabel mesh__D020457 Manatee, West Indian
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D020457 2005
% 218.86/219.01  |- skos__hiddenLabel mesh__D011920 WF Rats, Inbred
% 218.86/219.01  |- skos__historyNote mesh__D011920 Rats %28%1966-1971%29%
% 218.86/219.01  |- skos__annotation mesh__D011920
% 218.86/219.01       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag RATS%A%  
% 218.86/219.01  |- skos__hiddenLabel mesh__D011920 Wistar Furth Rats
% 218.86/219.01  |- skos__altLabel mesh__D011920 Rats, Inbred Wistar Furth
% 218.86/219.01  |- mesh__dateRevised mesh__D011920 2005-06-30
% 218.86/219.01  |- rdf__type mesh__D011920sskos__Concept
% 218.86/219.01  |- skos__hiddenLabel mesh__D011920 Inbred WF Rat
% 218.86/219.01  |- mesh__dateCreated mesh__D011920 1999-01-01
% 218.86/219.01  |- mesh__recordMaintainer mesh__D011920 ags
% 218.86/219.01  |- skos__altLabel mesh__D011920 Rats, WF
% 218.86/219.01  |- mesh__historyNote mesh__D011920
% 218.86/219.01       91%28%72%29%; was see under RATS, INBRED STRAINS 1972-90   
% 218.86/219.01  |- mesh__recordOriginator mesh__D011920 NLM
% 218.86/219.01  |- skos__prefLabel mesh__D011920 Rats, Inbred WF
% 218.86/219.01  |- skos__broader mesh__D011920smesh__D011919
% 218.86/219.01  |- skos__hiddenLabel mesh__D011920 WF Rats
% 218.86/219.01  |- skos__altLabel mesh__D011920 Rats, Wistar Furth
% 218.86/219.01  |- mesh__recordAuthorizer mesh__D011920 sjn
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D011920 2006
% 218.86/219.01  |- mesh__dateEstablished mesh__D011920 1991-01-01
% 218.86/219.01  |- skos__hiddenLabel mesh__D011920 WF Rat
% 218.86/219.01  |- skos__hiddenLabel mesh__D011920 Inbred WF Rats
% 218.86/219.01  |- skos__hiddenLabel mesh__D011920 WF Rat, Inbred
% 218.86/219.01  |- mesh__publicMeSHNote mesh__D011920
% 218.86/219.01       91; was see under RATS, INBRED STRAINS 1972-90   
% 218.86/219.01  |- skos__hiddenLabel mesh__D011920 Rat, WF
% 218.86/219.01  |- skos__hiddenLabel mesh__D011920 Rat, Inbred WF
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D019105 2004
% 218.86/219.01  |- mesh__historyNote mesh__D019105 96   
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D019105 2002
% 218.86/219.01  |- mesh__recordOriginator mesh__D019105 AGS
% 218.86/219.01  |- skos__hiddenLabel mesh__D019105 RAPD Technics
% 218.86/219.01  |- skos__scopeNote mesh__D019105
% 218.86/219.01       Technique that utilizes low-stringency polymerase chain reaction %28%PCR%29% amplification with single primers of arbitrary sequence to generate strain-specific arrays of anonymous DNA fragments. RAPD technique may be used to determine taxonomic identity, assess kinship relationships, analyze mixed genome samples, and create specific probes.%A%    
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D019105 2003
% 218.86/219.01  |- mesh__dateCreated mesh__D019105 1995-06-05
% 218.86/219.01  |- mesh__dateRevised mesh__D019105 2000-06-21
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D019105 2001
% 218.86/219.01  |- skos__broader mesh__D019105smesh__D016133
% 218.86/219.01  |- skos__altLabel mesh__D019105 RAPD-PCR
% 218.86/219.01  |- mesh__recordAuthorizer mesh__D019105 sjn
% 218.86/219.01  |- skos__related mesh__D019105smesh__D005819
% 218.86/219.01  |- skos__altLabel mesh__D019105 Arbitrarily Primed PCR Reaction
% 218.86/219.01  |- mesh__recordMaintainer mesh__D019105 sjn
% 218.86/219.01  |- mesh__publicMeSHNote mesh__D019105 96   
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D019105 2006
% 218.86/219.01  |- skos__related mesh__D019105smesh__D016172
% 218.86/219.01  |- skos__altLabel mesh__D019105 RAPD Technique
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D019105 2005
% 218.86/219.01  |- skos__prefLabel mesh__D019105 Random Amplified Polymorphic DNA Technique
% 218.86/219.01  |- rdf__type mesh__D019105sskos__Concept
% 218.86/219.01  |- skos__hiddenLabel mesh__D019105 RAPD Techniques
% 218.86/219.01  |- skos__altLabel mesh__D019105 Random Amplified Polymorphic DNA Technic
% 218.86/219.01  |- skos__historyNote mesh__D019105
% 218.86/219.01       Polymerase Chain Reaction %28%1991-1995%29%
% 218.86/219.01  |- skos__altLabel mesh__D019105 RAPD Technic
% 218.86/219.01  |- skos__broader mesh__D019105smesh__D015336
% 218.86/219.01  |- mesh__dateEstablished mesh__D019105 1996-01-01
% 218.86/219.01  |- mesh__publicMeSHNote mesh__D011122 78   
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D011122 1997
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D011122 2006
% 218.86/219.01  |- mesh__recordOriginator mesh__D011122 RLS
% 218.86/219.01  |- mesh__dateCreated mesh__D011122 1977-04-15
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D011122 1998
% 218.86/219.01  |- mesh__historyNote mesh__D011122 78   
% 218.86/219.01  |- mesh__dateRevised mesh__D011122 1993-06-02
% 218.86/219.01  |- skos__scopeNote mesh__D011122
% 218.86/219.01       Linear polymers in which orthophosphate residues are linked with energy-rich phosphoanhydride bonds. They are found in plants, animals, and microorganisms.%A%    
% 218.86/219.01  |- mesh__recordMaintainer mesh__D011122 TPW
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D011122 1994
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D011122 1999
% 218.86/219.01  |- mesh__dateEstablished mesh__D011122 1978-01-01
% 218.86/219.01  |- rdf__type mesh__D011122sskos__Concept
% 218.86/219.01  |- skos__prefLabel mesh__D011122 Polyphosphates
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D011122 2000
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D011122 1995
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D011122 2003
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D011122 2001
% 218.86/219.01  |- skos__broader mesh__D011122smesh__D010710
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D011122 2004
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D011122 2002
% 218.86/219.01  |- skos__historyNote mesh__D011122 Phosphates %28%1966-1977%29%
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D011122 1996
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D011122 2005
% 218.86/219.01  |- mesh__recordAuthorizer mesh__D011122 PLS
% 218.86/219.01  |- mesh__dateEstablished mesh__D049590 2005-01-01
% 218.86/219.01  |- skos__prefLabel mesh__D049590 Postpartum Period
% 218.86/219.01  |- mesh__recordMaintainer mesh__D049590 lkt
% 218.86/219.01  |- mesh__dateCreated mesh__D049590 2004-07-07
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D049590 2006
% 218.86/219.01  |- skos__altLabel mesh__D049590 Postpartum
% 218.86/219.01  |- skos__hiddenLabel mesh__D049590 Period, Postpartum
% 218.86/219.01  |- rdf__type mesh__D049590sskos__Concept
% 218.86/219.01  |- mesh__dateRevised mesh__D049590 2005-06-30
% 218.86/219.01  |- mesh__recordOriginator mesh__D049590 lkt
% 218.86/219.01  |- skos__historyNote mesh__D049590 Puerperium %28%1965-2004%29%
% 218.86/219.01  |- mesh__historyNote mesh__D049590 2005   
% 218.86/219.01  |- mesh__publicMeSHNote mesh__D049590 2005; see PUERPERIUM 1980-2004   
% 218.86/219.01  |- skos__scopeNote mesh__D049590
% 218.86/219.01       In females, the period that is shortly after giving birth %28%PARTURITION%29%.%A%    
% 218.86/219.01  |- skos__broader mesh__D049590smesh__D012098
% 218.86/219.01  |- mesh__recordAuthorizer mesh__D049590 sjn
% 218.86/219.01  |- skos__annotation mesh__D049590
% 218.86/219.01       human %26% animal; qualif permitted as for PREGNANCY; check the tag FEMALE: Manual 18.4.3; puerperal psychoses = PUERPERAL DISORDERS %28%IM%29% + PSYCHOTIC DISORDERS %28%IM%29%; %22%postpartum amenorrhea%22% is indexed under PUERPERIUM %28%IM%29% + AMENORRHEA %28%IM%29% %26% not LACTATION unless lactation is particularly discussed%A%  
% 218.86/219.01  |- skos__hiddenLabel mesh__D049590 Women, Postpartum
% 218.86/219.01  |- skos__broader mesh__D019802Q000031smesh__D019802
% 218.86/219.01  |- mesh__preferredCombination mesh__D019802Q000031smesh__D019822
% 218.86/219.01  |- rdf__type mesh__D019802Q000031smesh__CompoundConcept
% 218.86/219.01  |- mesh__onlineNote mesh__D002396
% 218.86/219.01       use CATECHOLS to search CATECHOL 1966-74   
% 218.86/219.01  |- mesh__recordOriginator mesh__D002396 NLM
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002396 2004
% 218.86/219.01  |- skos__scopeNote mesh__D002396
% 218.86/219.01       A group of 1,2-benzenediols that contain the general formula R-C6H5O2.%A%    
% 218.86/219.01  |- skos__altLabel mesh__D002396 o-Dihydroxybenzenes
% 218.86/219.01  |- mesh__historyNote mesh__D002396 75; was CATECHOL 1963-74   
% 218.86/219.01  |- skos__broader mesh__D002396smesh__D010636
% 218.86/219.01  |- mesh__recordAuthorizer mesh__D002396 PLS
% 218.86/219.01  |- skos__hiddenLabel mesh__D002396 o Dihydroxybenzenes
% 218.86/219.01  |- mesh__publicMeSHNote mesh__D002396 75; was CATECHOL 1963-74   
% 218.86/219.01  |- skos__altLabel mesh__D002396 Pyrocatechols
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002396 1998
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002396 2000
% 218.86/219.01  |- mesh__dateRevised mesh__D002396 1995-05-18
% 218.86/219.01  |- skos__altLabel mesh__D002396 ortho-Dihydroxybenzenes
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002396 2001
% 218.86/219.01  |- rdf__type mesh__D002396sskos__Concept
% 218.86/219.01  |- mesh__recordMaintainer mesh__D002396 KEV
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002396 1996
% 218.86/219.01  |- skos__hiddenLabel mesh__D002396 ortho Dihydroxybenzenes
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002396 1999
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002396 2005
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002396 2002
% 218.86/219.01  |- mesh__dateCreated mesh__D002396 1999-01-01
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002396 1997
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002396 2003
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D002396 2006
% 218.86/219.01  |- skos__prefLabel mesh__D002396 Catechols
% 218.86/219.01  |- skos__broader mesh__D010828smesh__D010827
% 218.86/219.01  |- mesh__dateRevised mesh__D010828 2001-07-25
% 218.86/219.01  |- mesh__recordOriginator mesh__D010828 NLM
% 218.86/219.01  |- rdf__type mesh__D010828sskos__Concept
% 218.86/219.01  |- skos__annotation mesh__D010828
% 218.86/219.01       SPEC qualif when IM; no qualif when NIM; Manual 18.13.4; DF: PHYSIOL COMPARATIVE%A%  
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D010828 2004
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D010828 2003
% 218.86/219.01  |- mesh__dateCreated mesh__D010828 1999-01-01
% 218.86/219.01  |- mesh__recordMaintainer mesh__D010828 jls
% 218.86/219.01  |- mesh__recordAuthorizer mesh__D010828 sjn
% 218.86/219.01  |- skos__altLabel mesh__D010828 Comparative Physiology
% 218.86/219.01  |- mesh__activeMeSHYear mesh__D010828 2006
% 218.86/219.01  |- skos__prefLabel mesh__D010828 Physiology, Comparative
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D010828 2002
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D010828 2005
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D043204 2004
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D043204 2005
% 218.86/219.02  |- skos__broader mesh__D043204smesh__D043202
% 218.86/219.02  |- mesh__dateCreated mesh__D043204 2003-07-09
% 218.86/219.02  |- mesh__historyNote mesh__D043204 2004   
% 218.86/219.02  |- skos__altLabel mesh__D043204 Apparent Mineralocorticoid Excess Syndrome
% 218.86/219.02  |- mesh__publicMeSHNote mesh__D043204 2004   
% 218.86/219.02  |- skos__prefLabel mesh__D043204
% 218.86/219.02       Mineralocorticoid Excess Syndrome, Apparent
% 218.86/219.02  |- skos__historyNote mesh__D043204
% 218.86/219.02       Metabolism, Inborn Errors %28%1977-2003%29%
% 218.86/219.02  |- mesh__dateEstablished mesh__D043204 2004-01-01
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D043204 2006
% 218.86/219.02  |- rdf__type mesh__D043204sskos__Concept
% 218.86/219.02  |- skos__scopeNote mesh__D043204
% 218.86/219.02       A hereditary disease characterized by childhood onset HYPERTENSION, hypokalemic alkalosis, and low RENIN and ALDOSTERONE secretion. It results from a defect in the activity of the 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2 enzyme which results in inadequate conversion of CORTISOL to CORTISONE. The build up of unprocessed cortisol to levels that stimulate MINERALOCORTICOID RECEPTORS creates the appearance of having excessive MINERALOCORTICOIDS.%A%    
% 218.86/219.02  |- skos__hiddenLabel mesh__D007081 Incontinent Ileostomies
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D007081 2006
% 218.86/219.02  |- skos__hiddenLabel mesh__D007081 Continent Ileostomies
% 218.86/219.02  |- skos__hiddenLabel mesh__D007081 Ileostomy, Continent
% 218.86/219.02  |- skos__hiddenLabel mesh__D007081 Ileostomy, Tube
% 218.86/219.02  |- skos__hiddenLabel mesh__D007081 Ileostomy, Loop
% 218.86/219.02  |- mesh__dateCreated mesh__D007081 1999-01-01
% 218.86/219.02  |- skos__hiddenLabel mesh__D007081 Loop Ileostomies
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D007081 2004
% 218.86/219.02  |- rdf__type mesh__D007081sskos__Concept
% 218.86/219.02  |- skos__scopeNote mesh__D007081
% 218.86/219.02       Surgical creation of an external opening into the ILEUM for fecal diversion or drainage. This replacement for the RECTUM is usually created in patients with severe INFLAMMATORY BOWEL DISEASES. Loop %28%continent%29% or tube %28%incontinent%29% procedures are most often employed.%A%    
% 218.86/219.02  |- mesh__recordMaintainer mesh__D007081 lkt
% 218.86/219.02  |- mesh__recordAuthorizer mesh__D007081 sjn
% 218.86/219.02  |- skos__altLabel mesh__D007081 Continent Ileostomy
% 218.86/219.02  |- mesh__dateRevised mesh__D007081 2003-07-09
% 218.86/219.02  |- skos__hiddenLabel mesh__D007081 Ileostomies, Incontinent
% 218.86/219.02  |- skos__hiddenLabel mesh__D007081 Ileostomies
% 218.86/219.02  |- skos__hiddenLabel mesh__D007081 Ileostomy, Incontinent
% 218.86/219.02  |- skos__prefLabel mesh__D007081 Ileostomy
% 218.86/219.02  |- skos__annotation mesh__D007081
% 218.86/219.02       restrict to ileal stoma on abdom wall: do not confuse with JEJUNOILEAL BYPASS%A%  
% 218.86/219.02  |- skos__altLabel mesh__D007081 Incontinent Ileostomy
% 218.86/219.02  |- skos__broader mesh__D007081smesh__D004766
% 218.86/219.02  |- skos__hiddenLabel mesh__D007081 Tube Ileostomies
% 218.86/219.02  |- mesh__recordOriginator mesh__D007081 NLM
% 218.86/219.02  |- skos__hiddenLabel mesh__D007081 Ileostomies, Tube
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D007081 2005
% 218.86/219.02  |- skos__hiddenLabel mesh__D007081 Ileostomies, Loop
% 218.86/219.02  |- skos__hiddenLabel mesh__D007081 Ileostomies, Continent
% 218.86/219.02  |- skos__broader mesh__D015513smesh__D009363
% 218.86/219.02  |- mesh__historyNote mesh__D015513
% 218.86/219.02       93; was ONCOGENE PRODUCTS 1990-92; ONCOGENE PROTEINS was see ONCOGENE PRODUCTS 1990-92%A%  
% 218.86/219.02  |- mesh__dateEstablished mesh__D015513 1990-01-01
% 218.86/219.02  |- mesh__dateCreated mesh__D015513 1989-06-19
% 218.86/219.02  |- rdf__type mesh__D015513sskos__Concept
% 218.86/219.02  |- skos__historyNote mesh__D015513 Viral Proteins %28%1983-1989%29%
% 218.86/219.02  |- skos__altLabel mesh__D015513 Oncogene Product
% 218.86/219.02  |- skos__prefLabel mesh__D015513 Oncogene Proteins
% 218.86/219.02  |- skos__altLabel mesh__D015513 Oncogene Products
% 218.86/219.02  |- mesh__recordAuthorizer mesh__D015513 sjn
% 218.86/219.02  |- mesh__recordMaintainer mesh__D015513 DRC
% 218.86/219.02  |- skos__altLabel mesh__D015513 Oncoproteins
% 218.86/219.02  |- mesh__onlineNote mesh__D015513
% 218.86/219.02       use ONCOGENE PROTEINS to search ONCOGENE PRODUCTS 1990-92%A%  
% 218.86/219.02  |- skos__scopeNote mesh__D015513
% 218.86/219.02       Proteins coded by oncogenes. They include proteins resulting from the fusion of an oncogene and another gene %28%ONCOGENE PROTEINS, FUSION%29%.%A%    
% 218.86/219.02  |- skos__historyNote mesh__D015513 Neoplasm Proteins %28%1983-1989%29%
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D015513 2006
% 218.86/219.02  |- mesh__publicMeSHNote mesh__D015513
% 218.86/219.02       93; was ONCOGENE PRODUCTS 1990-92; ONCOGENE PROTEINS was see ONCOGENE PRODUCTS 1990-92%A%  
% 218.86/219.02  |- skos__hiddenLabel mesh__D015513 Products, Oncogene
% 218.86/219.02  |- mesh__dateRevised mesh__D015513 2005-06-30
% 218.86/219.02  |- skos__altLabel mesh__D015513 Oncogene Protein
% 218.86/219.02  |- skos__hiddenLabel mesh__D015513 Protein, Oncogene
% 218.86/219.02  |- skos__hiddenLabel mesh__D015513 Product, Oncogene
% 218.86/219.02  |- skos__annotation mesh__D015513
% 218.86/219.02       GEN or unspecified; prefer specifics; /drug eff /ultrastruct permitted%A%  
% 218.86/219.02  |- mesh__recordOriginator mesh__D015513 AGS
% 218.86/219.02  |- skos__hiddenLabel mesh__D015513 Proteins, Oncogene
% 218.86/219.02  |- skos__hiddenLabel mesh__D039961 Semaphorins, Class 4
% 218.86/219.02  |- skos__altLabel mesh__D039961 Semaphorin-1
% 218.86/219.02  |- skos__hiddenLabel mesh__D039961 Semaphorin 6
% 218.86/219.02  |- mesh__historyNote mesh__D039961
% 218.86/219.02       2003; for SEMA 1 %26% SEMAPHORIN-1 use SEMAPHORIN 1A, GRASSHOPPER %28%NM%29% 1994-2002%A%  
% 218.86/219.02  |- skos__prefLabel mesh__D039961 Semaphorins
% 218.86/219.02  |- skos__hiddenLabel mesh__D039961 Semaphorins, Class 2
% 218.86/219.02  |- skos__hiddenLabel mesh__D039961 Semaphorin 1
% 218.86/219.02  |- skos__altLabel mesh__D039961 Sema 1
% 218.86/219.02  |- skos__altLabel mesh__D039961 Semaphorin-5
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D039961 2003
% 218.86/219.02  |- mesh__recordMaintainer mesh__D039961 MDJ
% 218.86/219.02  |- skos__broader mesh__D039961smesh__D036341
% 218.86/219.02  |- skos__hiddenLabel mesh__D039961 Semaphorin 2
% 218.86/219.02  |- mesh__dateCreated mesh__D039961 2002-07-03
% 218.86/219.02  |- skos__hiddenLabel mesh__D039961 V Semaphorins, Class
% 218.86/219.02  |- skos__altLabel mesh__D039961 Semaphorin-4
% 218.86/219.02  |- skos__hiddenLabel mesh__D039961 Semaphorins, Class 5
% 218.86/219.02  |- rdf__type mesh__D039961sskos__Concept
% 218.86/219.02  |- mesh__recordOriginator mesh__D039961 MDJ
% 218.86/219.02  |- skos__hiddenLabel mesh__D039961 Semaphorin 7
% 218.86/219.02  |- skos__altLabel mesh__D039961 Semaphorin-3
% 218.86/219.02  |- mesh__dateEstablished mesh__D039961 2003-01-01
% 218.86/219.02  |- skos__hiddenLabel mesh__D039961 Semaphorin 3
% 218.86/219.02  |- skos__hiddenLabel mesh__D039961 Semaphorins, Class 6
% 218.86/219.02  |- mesh__publicMeSHNote mesh__D039961
% 218.86/219.02       2003; SEMA 1 %26% SEMAPHORIN-1 was indexed under CELL ADHESION MOLECULES, NEURONAL 1994-2002%A%  
% 218.86/219.02  |- skos__hiddenLabel mesh__D039961 Semaphorins, Class 7
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D039961 2006
% 218.86/219.02  |- skos__altLabel mesh__D039961 Semaphorin-7
% 218.86/219.02  |- skos__altLabel mesh__D039961 Semaphorin
% 218.86/219.02  |- skos__hiddenLabel mesh__D039961 Semaphorins, Class V
% 218.86/219.02  |- skos__scopeNote mesh__D039961
% 218.86/219.02       A family of proteins that mediate axonal guidance.  Semaphorins act as repulsive cues for neuronal GROWTH CONES and bind to receptors on their filopodia. At least 20 different molecules have been described and divided into eight classes based on domain organization and species of origin.  Classes 1 and 2 are invertebrate, classes 3-7 are vertebrate, and class V are viral.  Semaphorins may be secreted %28%classes 2, 3, and V%29%, transmembrane %28%classes 1, 4, 5, and 6%29%, or membrane-anchored %28%class 7%29%.  All semaphorins possess a common 500-amino acid extracellular domain which is critical for receptor binding and specificity, and is also found in plexins and scatter factor receptors.  Their C termini are class-specific and may contain additional sequence motifs.%A%    
% 218.86/219.02  |- skos__altLabel mesh__D039961 Semaphorin-2
% 218.86/219.02  |- mesh__recordAuthorizer mesh__D039961 sjn
% 218.86/219.02  |- skos__hiddenLabel mesh__D039961 Semaphorins, Class 3
% 218.86/219.02  |- skos__altLabel mesh__D039961 Semaphorin-V
% 218.86/219.02  |- skos__hiddenLabel mesh__D039961 Semaphorin 4
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D039961 2005
% 218.86/219.02  |- skos__altLabel mesh__D039961 Semaphorin-6
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D039961 2004
% 218.86/219.02  |- skos__hiddenLabel mesh__D039961 Semaphorins, Class 1
% 218.86/219.02  |- skos__broader mesh__D006787smesh__D006768
% 218.86/219.02  |- skos__prefLabel mesh__D006787 Hospitals, Veterans
% 218.86/219.02  |- skos__hiddenLabel mesh__D006787 Veterans Hospital
% 218.86/219.02  |- rdf__type mesh__D006787sskos__Concept
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D006787 2005
% 218.86/219.02  |- skos__annotation mesh__D006787
% 218.86/219.02       coord IM with special hosp %28%e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, PSYCHIATRIC; etc.%29% or med specialty %28%IM or NIM%29% if pertinent; specify geog%A%  
% 218.86/219.02  |- mesh__recordAuthorizer mesh__D006787 sjn
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D006787 2006
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D006787 2003
% 218.86/219.02  |- mesh__recordMaintainer mesh__D006787 kle
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D006787 2000
% 218.86/219.02  |- skos__altLabel mesh__D006787 Veterans Hospitals
% 218.86/219.02  |- skos__hiddenLabel mesh__D006787 Hospital, Veterans
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D006787 2004
% 218.86/219.02  |- mesh__recordOriginator mesh__D006787 NLM
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D006787 2001
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D006787 2002
% 218.86/219.02  |- mesh__dateRevised mesh__D006787 1999-11-03
% 218.86/219.02  |- mesh__dateCreated mesh__D006787 1999-01-01
% 218.86/219.02  |- skos__scopeNote mesh__D006787
% 218.86/219.02       Hospitals providing medical care to veterans of wars.     
% 218.86/219.02  |- skos__annotation mesh__D020458
% 218.86/219.02       do not confuse with THIRD-PARTY PAYMENTS see INSURANCE, HEALTH, REIMBURSEMENT%A%  
% 218.86/219.02  |- mesh__recordOriginator mesh__D020458 JLS
% 218.86/219.02  |- mesh__recordAuthorizer mesh__D020458 jls
% 218.86/219.02  |- mesh__dateRevised mesh__D020458 2002-10-31
% 218.86/219.02  |- skos__related mesh__D020458smesh__D016312
% 218.86/219.02  |- skos__hiddenLabel mesh__D020458 Consent, Third Party
% 218.86/219.02  |- skos__related mesh__D020458smesh__D019727
% 218.86/219.02  |- skos__hiddenLabel mesh__D020458 Consent, Spousal
% 218.86/219.02  |- skos__related mesh__D020458smesh__D007872
% 218.86/219.02  |- skos__hiddenLabel mesh__D020458 Consent, Community
% 218.86/219.02  |- skos__prefLabel mesh__D020458 Third-Party Consent
% 218.86/219.02  |- skos__altLabel mesh__D020458 Third Party Consent
% 218.86/219.02  |- mesh__publicMeSHNote mesh__D020458
% 218.86/219.02       1999; use INFORMED CONSENT for SPOUSAL CONSENT 1979-1998   
% 218.86/219.02  |- skos__scopeNote mesh__D020458
% 218.86/219.02       Informed consent given by someone other than the patient or research subject.%A%    
% 218.86/219.02  |- skos__hiddenLabel mesh__D020458 Consents, Community
% 218.86/219.02  |- rdf__type mesh__D020458sskos__Concept
% 218.86/219.02  |- mesh__recordMaintainer mesh__D020458 jls
% 218.86/219.02  |- skos__hiddenLabel mesh__D020458 Community Consents
% 218.86/219.02  |- skos__hiddenLabel mesh__D020458 Consent, Third-Party
% 218.86/219.02  |- skos__historyNote mesh__D020458 Informed Consent %28%1979-1998%29%
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D020458 2005
% 218.86/219.02  |- mesh__dateCreated mesh__D020458 1998-06-18
% 218.86/219.02  |- skos__broader mesh__D020458smesh__D007258
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D020458 2003A
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D020458 2003
% 218.86/219.02  |- mesh__historyNote mesh__D020458
% 218.86/219.02       1999; use INFORMED CONSENT for SPOUSAL CONSENT 1979-1998   
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D020458 2006
% 218.86/219.02  |- mesh__dateEstablished mesh__D020458 1999-01-01
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D020458 2004
% 218.86/219.02  |- skos__altLabel mesh__D031180 Thistle, White
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D031180 2005
% 218.86/219.02  |- rdf__type mesh__D031180sskos__Concept
% 218.86/219.02  |- skos__scopeNote mesh__D031180
% 218.86/219.02       A plant genus of the family ASTERACEAE. Members contain pectolinarin %28%a flavonoid glycoside%29%.%A%    
% 218.86/219.02  |- skos__altLabel mesh__D031180 Thistle, Common
% 218.86/219.02  |- skos__altLabel mesh__D031180 Thistle, Yellowspine
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D031180 2004
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D031180 2003
% 218.86/219.02  |- mesh__dateEstablished mesh__D031180 2003-01-01
% 218.86/219.02  |- skos__altLabel mesh__D031180 Thistle, Canadian
% 218.86/219.02  |- skos__prefLabel mesh__D031180 Cirsium
% 218.86/219.02  |- mesh__historyNote mesh__D031180 2003   
% 218.86/219.02  |- skos__altLabel mesh__D031180 Thistle, Plume
% 218.86/219.02  |- skos__broader mesh__D031180smesh__D019659
% 218.86/219.02  |- mesh__publicMeSHNote mesh__D031180 2003   
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D031180 2006
% 218.86/219.02  |- skos__annotation mesh__D031180
% 218.86/219.02       other %27%thistle%27% plants are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.02  |- mesh__dateCreated mesh__D031180 2002-07-03
% 218.86/219.02  |- skos__hiddenLabel mesh__D025941 Maps, Protein-Protein Interaction
% 218.86/219.02  |- skos__hiddenLabel mesh__D025941 Interaction Map, Protein-Protein
% 218.86/219.02  |- mesh__recordOriginator mesh__D025941 nns
% 218.86/219.02  |- skos__related mesh__D025941smesh__D019151
% 218.86/219.02  |- mesh__historyNote mesh__D025941 2002   
% 218.86/219.02  |- skos__hiddenLabel mesh__D025941 Map, Protein-Protein Interaction
% 218.86/219.02  |- skos__hiddenLabel mesh__D025941 Mapping, Protein Interaction
% 218.86/219.02  |- skos__broader mesh__D025941smesh__D015336
% 218.86/219.02  |- mesh__dateCreated mesh__D025941 2001-08-06
% 218.86/219.02  |- skos__hiddenLabel mesh__D025941 Interaction Mapping, Protein
% 218.86/219.02  |- skos__hiddenLabel mesh__D025941 Mappings, Protein Interaction
% 218.86/219.02  |- skos__hiddenLabel mesh__D025941 Interaction Maps, Protein-Protein
% 218.86/219.02  |- skos__scopeNote mesh__D025941
% 218.86/219.02       Methods for determining interaction between proteins.     
% 218.86/219.02  |- mesh__recordAuthorizer mesh__D025941 sjn
% 218.86/219.02  |- skos__hiddenLabel mesh__D025941 Protein-Protein Interaction Maps
% 218.86/219.02  |- skos__prefLabel mesh__D025941 Protein Interaction Mapping
% 218.86/219.02  |- skos__hiddenLabel mesh__D025941 Protein Protein Interaction Map
% 218.86/219.02  |- skos__hiddenLabel mesh__D025941 Interaction Map, Protein
% 218.86/219.02  |- skos__related mesh__D025941smesh__D001665
% 218.86/219.02  |- skos__hiddenLabel mesh__D025941 Maps, Protein Interaction
% 218.86/219.02  |- skos__hiddenLabel mesh__D025941 Map, Protein Interaction
% 218.86/219.02  |- skos__related mesh__D025941smesh__D040081
% 218.86/219.02  |- skos__altLabel mesh__D025941 Protein-Protein Interaction Map
% 218.86/219.02  |- skos__hiddenLabel mesh__D025941 Protein Interaction Mappings
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D025941 2005
% 218.86/219.02  |- skos__historyNote mesh__D025941 Protein Binding %28%1993-2001%29%
% 218.86/219.02  |- skos__hiddenLabel mesh__D025941 Interaction Maps, Protein
% 218.86/219.02  |- mesh__publicMeSHNote mesh__D025941 2002   
% 218.86/219.02  |- skos__hiddenLabel mesh__D025941 Protein Interaction Map
% 218.86/219.02  |- skos__related mesh__D025941smesh__D011485
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D025941 2006
% 218.86/219.02  |- mesh__dateEstablished mesh__D025941 2002-01-01
% 218.86/219.02  |- mesh__recordMaintainer mesh__D025941 nns
% 218.86/219.02  |- mesh__dateRevised mesh__D025941 2004-07-07
% 218.86/219.02  |- skos__hiddenLabel mesh__D025941 Interaction Mappings, Protein
% 218.86/219.02  |- rdf__type mesh__D025941sskos__Concept
% 218.86/219.02  |- skos__historyNote mesh__D025941 Binding Sites %28%1993-2001%29%
% 218.86/219.02  |- rdf__type mesh__D019904sskos__Concept
% 218.86/219.02  |- skos__hiddenLabel mesh__D019904 Isostatic Polymethyl Methacrylate
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D019904 2005
% 218.86/219.02  |- mesh__publicMeSHNote mesh__D019904
% 218.86/219.02       98; METHYLMETHACRYLATE %28%now POLYMETHYL METHACRYLATE%29% was indexed under METHYLMETHACRYLATES 1974-97 and POLYMERS 1974-80; for POLYMETHYLMETHACRYLATE see METHYLMETHACRYLATES 1981-97%A%  
% 218.86/219.02  |- skos__altLabel mesh__D019904 Polymethylmethacrylate
% 218.86/219.02  |- skos__hiddenLabel mesh__D019904 Methacrylate, Syndiostatic Polymethyl
% 218.86/219.02  |- skos__altLabel mesh__D019904 PMMA
% 218.86/219.02  |- mesh__dateEstablished mesh__D019904 1998-01-01
% 218.86/219.02  |- skos__scopeNote mesh__D019904
% 218.86/219.02       Polymerized methyl methacrylate monomers which are used as sheets, moulding, extrusion powders, surface coating resins, emulsion polymers, fibers, inks, and films %28%From International Labor Organization, 1983%29%. This material is also used in tooth implants, bone cements, and hard corneal contact lenses.%A%    
% 218.86/219.02  |- skos__historyNote mesh__D019904 Polymers %28%1974-1980%29%
% 218.86/219.02  |- skos__hiddenLabel mesh__D019904 Methacrylate, Polymethyl
% 218.86/219.02  |- skos__altLabel mesh__D019904 Poly%28%methyl methacrylate%29%
% 218.86/219.02  |- skos__historyNote mesh__D019904 Methylmethacrylates %28%1974-1997%29%
% 218.86/219.02  |- mesh__recordMaintainer mesh__D019904 jmp
% 218.86/219.02  |- skos__prefLabel mesh__D019904 Polymethyl Methacrylate
% 218.86/219.02  |- skos__altLabel mesh__D019904 Polymethylmetacrylate
% 218.86/219.02  |- mesh__dateRevised mesh__D019904 2004-07-07
% 218.86/219.02  |- mesh__historyNote mesh__D019904
% 218.86/219.02       98; use METHYLMETHACRYLATE %28%NM%29% 1977-97; for POLYMETHYLMETHACRYLATE use METHYLMETHACRYLATES 1981-97%A%  
% 218.86/219.02  |- mesh__dateCreated mesh__D019904 1997-06-20
% 218.86/219.02  |- skos__broader mesh__D019904smesh__D008768
% 218.86/219.02  |- mesh__recordOriginator mesh__D019904 KEV
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D019904 2006
% 218.86/219.02  |- skos__hiddenLabel mesh__D019904 Syndiostatic Polymethyl Methacrylate
% 218.86/219.02  |- mesh__recordAuthorizer mesh__D019904 sjn
% 218.86/219.02  |- skos__prefLabel mesh__D011921 Rats, Inbred WKY
% 218.86/219.02  |- skos__altLabel mesh__D011921 Rats, WKY
% 218.86/219.02  |- mesh__recordAuthorizer mesh__D011921 sjn
% 218.86/219.02  |- mesh__historyNote mesh__D011921
% 218.86/219.02       91%28%85%29%; was see under RATS, INBRED STRAINS 1985-90   
% 218.86/219.02  |- mesh__recordMaintainer mesh__D011921 ags
% 218.86/219.02  |- mesh__dateCreated mesh__D011921 1984-04-06
% 218.86/219.02  |- mesh__publicMeSHNote mesh__D011921
% 218.86/219.02       91; was see under RATS, INBRED STRAINS 1985-90   
% 218.86/219.02  |- skos__hiddenLabel mesh__D011921 Inbred WKY Rat
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D011921 2006
% 218.86/219.02  |- skos__hiddenLabel mesh__D011921 Rat, Inbred WKY
% 218.86/219.02  |- skos__hiddenLabel mesh__D011921 WKY Rats, Inbred
% 218.86/219.02  |- skos__historyNote mesh__D011921 Rats, Inbred Strains %28%1972-1984%29%
% 218.86/219.02  |- skos__annotation mesh__D011921
% 218.86/219.02       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag RATS%A%  
% 218.86/219.02  |- skos__hiddenLabel mesh__D011921 Rat, WKY
% 218.86/219.02  |- mesh__dateRevised mesh__D011921 2005-06-30
% 218.86/219.02  |- skos__broader mesh__D011921smesh__D011919
% 218.86/219.02  |- skos__hiddenLabel mesh__D011921 WKY Rat, Inbred
% 218.86/219.02  |- mesh__dateEstablished mesh__D011921 1991-01-01
% 218.86/219.02  |- skos__scopeNote mesh__D011921
% 218.86/219.02       A strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats %28%SHR%29%.%A%    
% 218.86/219.02  |- skos__hiddenLabel mesh__D011921 Inbred WKY Rats
% 218.86/219.02  |- skos__hiddenLabel mesh__D011921 Wistar Kyoto Rats
% 218.86/219.02  |- mesh__recordOriginator mesh__D011921 EC
% 218.86/219.02  |- rdf__type mesh__D011921sskos__Concept
% 218.86/219.02  |- skos__hiddenLabel mesh__D011921 WKY Rats
% 218.86/219.02  |- skos__altLabel mesh__D011921 Rats, Wistar Kyoto
% 218.86/219.02  |- skos__hiddenLabel mesh__D011921 WKY Rat
% 218.86/219.02  |- mesh__historyNote mesh__D019106 96   
% 218.86/219.02  |- skos__altLabel mesh__D019106 Hemorrhage, Postoperative
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D019106 2002
% 218.86/219.02  |- skos__annotation mesh__D019106
% 218.86/219.02       IM; do not confuse with BLOOD LOSS, SURGICAL which is perioperative; coord with specific type of hemorrhage %28%IM%29% or specific type of surg %28%IM%29%; see note on HEMORRHAGE for additional instructions on coords; DF: POSTOP HEMORRHAGE%A%  
% 218.86/219.02  |- skos__broader mesh__D019106smesh__D006470
% 218.86/219.02  |- skos__prefLabel mesh__D019106 Postoperative Hemorrhage
% 218.86/219.02  |- mesh__dateEstablished mesh__D019106 1996-01-01
% 218.86/219.02  |- mesh__recordOriginator mesh__D019106 TGC
% 218.86/219.02  |- skos__altLabel mesh__D019106 Hemorrhages, Postoperative
% 218.86/219.02  |- skos__altLabel mesh__D019106 Blood Loss, Postoperative
% 218.86/219.02  |- skos__hiddenLabel mesh__D019106 Postoperative Blood Loss
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D019106 2005
% 218.86/219.02  |- mesh__dateRevised mesh__D019106 1999-11-08
% 218.86/219.02  |- mesh__recordMaintainer mesh__D019106 KEV
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D019106 2000
% 218.86/219.02  |- skos__historyNote mesh__D019106
% 218.86/219.02       specific hemorrhage terms %28%1966-1995%29%
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D019106 2006
% 218.86/219.02  |- skos__historyNote mesh__D019106 Hemorrhage %28%1966-1995%29%
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D019106 2001
% 218.86/219.02  |- skos__broader mesh__D019106smesh__D011183
% 218.86/219.02  |- mesh__recordAuthorizer mesh__D019106 sjn
% 218.86/219.02  |- rdf__type mesh__D019106sskos__Concept
% 218.86/219.02  |- skos__scopeNote mesh__D019106
% 218.86/219.02       Hemorrhage following any surgical procedure. It may be immediate or delayed and is not restricted to the surgical wound.%A%    
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D019106 2003
% 218.86/219.02  |- mesh__dateCreated mesh__D019106 1995-06-05
% 218.86/219.02  |- skos__historyNote mesh__D019106
% 218.86/219.02       Postoperative Complications %28%1966-1995%29%
% 218.86/219.02  |- skos__hiddenLabel mesh__D019106 Loss, Postoperative Blood
% 218.86/219.02  |- skos__altLabel mesh__D019106 Postoperative Hemorrhages
% 218.86/219.02  |- mesh__publicMeSHNote mesh__D019106 96   
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D019106 2004
% 218.86/219.02  |- mesh__dateEstablished mesh__D011123 1968-01-01
% 218.86/219.02  |- skos__hiddenLabel mesh__D011123 Polyploidies
% 218.86/219.02  |- skos__hiddenLabel mesh__D011123 Polyploids
% 218.86/219.02  |- mesh__dateRevised mesh__D011123 2003-07-09
% 218.86/219.02  |- skos__broader mesh__D011123smesh__D011003
% 218.86/219.02  |- rdf__type mesh__D011123sskos__Concept
% 218.86/219.02  |- skos__historyNote mesh__D011123 Chromosomes %28%1966-1967%29%
% 218.86/219.02  |- skos__annotation mesh__D011123 no qualif   
% 218.86/219.02  |- mesh__dateCreated mesh__D011123 1999-01-01
% 218.86/219.02  |- skos__hiddenLabel mesh__D011123 Polyploid Cells
% 218.86/219.02  |- skos__altLabel mesh__D011123 Polyploid
% 218.86/219.02  |- skos__historyNote mesh__D011123
% 218.86/219.02       Chromosome Abnormalities %28%1966-1967%29%
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D011123 2004
% 218.86/219.02  |- skos__scopeNote mesh__D011123
% 218.86/219.02       The chromosomal constitution of a cell containing multiples of the normal number of CHROMOSOMES; includes triploidy %28%symbol: 3N%29%, tetraploidy %28%symbol: 4N%29%, etc.%A%    
% 218.86/219.02  |- mesh__publicMeSHNote mesh__D011123 68   
% 218.86/219.02  |- mesh__recordAuthorizer mesh__D011123 sjn
% 218.86/219.02  |- mesh__recordMaintainer mesh__D011123 nns
% 218.86/219.02  |- skos__hiddenLabel mesh__D011123 Cell, Polyploid
% 218.86/219.02  |- skos__hiddenLabel mesh__D011123 Cells, Polyploid
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D011123 2005
% 218.86/219.02  |- mesh__historyNote mesh__D011123 68   
% 218.86/219.02  |- skos__prefLabel mesh__D011123 Polyploidy
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D011123 2006
% 218.86/219.02  |- mesh__recordOriginator mesh__D011123 NLM
% 218.86/219.02  |- mesh__dateCreated mesh__D002397 1986-04-15
% 218.86/219.02  |- skos__altLabel mesh__D002397 Colombian Catfish
% 218.86/219.02  |- skos__annotation mesh__D002397
% 218.86/219.02       BULLHEAD CATFISHES and CHANNEL CATFISH see ICTALURIDAE are also available; X ref EREMOPHILUS MUTISII: EREMOPHILA PLANT and EREMOPHILA ALPESTRIS see SONGBIRDS are also available%A%  
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D002397 2004
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D002397 2006
% 218.86/219.02  |- skos__prefLabel mesh__D002397 Catfishes
% 218.86/219.02  |- mesh__historyNote mesh__D002397 2002 %28%1987%29%   
% 218.86/219.02  |- mesh__recordOriginator mesh__D002397 EC
% 218.86/219.02  |- skos__scopeNote mesh__D002397
% 218.86/219.02       Common name of the order Siluriformes. This order contains many families and over 2,000 species, including venomous species. Heteropneustes and Plotosus genera have dangerous stings and are aggressive. Most species are passive stingers.%A%    
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D002397 2005
% 218.86/219.02  |- skos__broader mesh__D002397smesh__D005399
% 218.86/219.02  |- mesh__dateEstablished mesh__D002397 1987-01-01
% 218.86/219.02  |- skos__altLabel mesh__D002397 Catfish
% 218.86/219.02  |- mesh__publicMeSHNote mesh__D002397 2002; see CATFISH 1987-2001   
% 218.86/219.02  |- skos__altLabel mesh__D002397 Siluriformes
% 218.86/219.02  |- skos__hiddenLabel mesh__D002397 Catfish, Colombian
% 218.86/219.02  |- skos__historyNote mesh__D002397 Fishes %28%1966-1986%29%
% 218.86/219.02  |- mesh__dateRevised mesh__D002397 2003-07-09
% 218.86/219.02  |- rdf__type mesh__D002397sskos__Concept
% 218.86/219.02  |- mesh__recordMaintainer mesh__D002397 ssb
% 218.86/219.02  |- mesh__recordAuthorizer mesh__D002397 sjn
% 218.86/219.02  |- rdf__type mesh__D010829sskos__Concept
% 218.86/219.02  |- mesh__recordMaintainer mesh__D010829 lkt
% 218.86/219.02  |- mesh__runningHead mesh__D010829 G7 - PHYSIOLOGY-GENERAL   
% 218.86/219.02  |- skos__scopeNote mesh__D010829
% 218.86/219.02       The functions of living organisms, including both the physical and chemical factors and processes, supporting life in single- or multi-cell organisms from their origin through the progression of life.%A%    
% 218.86/219.02  |- mesh__publicMeSHNote mesh__D010829 98   
% 218.86/219.02  |- skos__altLabel mesh__D010829 Processes, Physiological
% 218.86/219.02  |- mesh__dateCreated mesh__D010829 1999-01-01
% 218.86/219.02  |- skos__altLabel mesh__D010829 Physiologic Processes
% 218.86/219.02  |- mesh__recordOriginator mesh__D010829 NLM
% 218.86/219.02  |- mesh__historyNote mesh__D010829 98; use pre-explosion 1975-97   
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D010829 2006
% 218.86/219.02  |- mesh__dateEstablished mesh__D010829 1998-01-01
% 218.86/219.02  |- mesh__dateRevised mesh__D010829 2004-07-07
% 218.86/219.02  |- mesh__onlineNote mesh__D010829
% 218.86/219.02       pre-explosion = PHYSIOLOGICAL PROCESSES %28%PX%29%   
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D010829 2005
% 218.86/219.02  |- mesh__recordAuthorizer mesh__D010829 sjn
% 218.86/219.02  |- skos__annotation mesh__D010829
% 218.86/219.02       GEN or unspecified; prefer specifics; differentiate from PHYSIOLOGY, the specialty or discipline; DF: PHYSIOL PROCESSES%A%  
% 218.86/219.02  |- skos__hiddenLabel mesh__D010829 Processes, Physiologic
% 218.86/219.02  |- skos__prefLabel mesh__D010829 Physiological Processes
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D007880 2006
% 218.86/219.02  |- skos__hiddenLabel mesh__D007880 Laws, Narcotic
% 218.86/219.02  |- mesh__dateCreated mesh__D007880 1999-01-01
% 218.86/219.02  |- mesh__dateEstablished mesh__D007880 1968-01-01
% 218.86/219.02  |- mesh__publicMeSHNote mesh__D007880
% 218.86/219.02       68; FOOD AND DRUG LAWS was see under LEGISLATION, DRUG 1968-78%A%  
% 218.86/219.02  |- mesh__historyNote mesh__D007880
% 218.86/219.02       68; FOOD AND DRUG LAWS was see under LEGISLATION, DRUG 1968-78; FOOD, DRUG AND COSMETIC ACT was see under LEGISLATION, DRUG 1968-77%A%  
% 218.86/219.02  |- skos__historyNote mesh__D007880 Legislation, Medical %28%1966-1967%29%
% 218.86/219.02  |- skos__broader mesh__D007880smesh__D007878
% 218.86/219.02  |- skos__annotation mesh__D007880
% 218.86/219.02       specify country or state; DF: LEGIS DRUG   
% 218.86/219.02  |- rdf__type mesh__D007880sskos__Concept
% 218.86/219.02  |- skos__hiddenLabel mesh__D007880 Law, Narcotic
% 218.86/219.02  |- skos__prefLabel mesh__D007880 Legislation, Drug
% 218.86/219.02  |- mesh__recordOriginator mesh__D007880 NLM
% 218.86/219.02  |- skos__altLabel mesh__D007880 Drug Laws
% 218.86/219.02  |- skos__altLabel mesh__D007880 Drug Legislation
% 218.86/219.02  |- mesh__onlineNote mesh__D007880
% 218.86/219.02       search FOOD AND DRUG LAWS under LEGISLATION, DRUG 1968-78; search FOOD, DRUG AND COSMETIC ACT under LEGISLATION, DRUG 1968-77%A%  
% 218.86/219.02  |- skos__hiddenLabel mesh__D007880 Law, Drug
% 218.86/219.02  |- mesh__recordMaintainer mesh__D007880 ssb
% 218.86/219.02  |- mesh__recordAuthorizer mesh__D007880 sjn
% 218.86/219.02  |- mesh__dateRevised mesh__D007880 2005-06-30
% 218.86/219.02  |- skos__broader mesh__D007880smesh__D012926
% 218.86/219.02  |- skos__related mesh__D007880smesh__D011307
% 218.86/219.02  |- skos__hiddenLabel mesh__D007880 Laws, Drug
% 218.86/219.02  |- skos__hiddenLabel mesh__D007880 Drug Law
% 218.86/219.02  |- skos__scopeNote mesh__D007880
% 218.86/219.02       Laws concerned with manufacturing, dispensing, and marketing of drugs.%A%    
% 218.86/219.02  |- skos__hiddenLabel mesh__D007880 Narcotic Law
% 218.86/219.02  |- skos__scopeNote mesh__D043205
% 218.86/219.02       A low-affinity 11 beta-hydroxysteroid dehydrogenase found in a variety of tissues, most notably in LIVER; LUNG; ADIPOSE TISSUE; vascular tissue; OVARY; and the CENTRAL NERVOUS SYSTEM. The enzyme acts reversibly and can use either NAD or NADP as cofactors.%A%    
% 218.86/219.02  |- skos__altLabel mesh__D043205 11beta-HSD1
% 218.86/219.02  |- mesh__publicMeSHNote mesh__D043205
% 218.86/219.02       2004; 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 was indexed under HYDROXYSTEROID DEHYDROGENASES 1999-2003%A%  
% 218.86/219.02  |- skos__hiddenLabel mesh__D043205 11beta HSD1 Reductase
% 218.86/219.02  |- skos__historyNote mesh__D043205
% 218.86/219.02       Hydroxysteroid Dehydrogenases %28%1999-2003%29%
% 218.86/219.02  |- skos__hiddenLabel mesh__D043205
% 218.86/219.02       11beta Hydroxysteroid Dehydrogenase Type 1
% 218.86/219.02  |- skos__prefLabel mesh__D043205
% 218.86/219.02       11-beta-Hydroxysteroid Dehydrogenase Type 1
% 218.86/219.02  |- mesh__recordAuthorizer mesh__D043205 sjn
% 218.86/219.02  |- skos__broader mesh__D043205smesh__D042842
% 218.86/219.02  |- mesh__dateCreated mesh__D043205 2003-07-09
% 218.86/219.02  |- mesh__recordOriginator mesh__D043205 AKE
% 218.86/219.02  |- mesh__dateEstablished mesh__D043205 2004-01-01
% 218.86/219.02  |- skos__altLabel mesh__D043205 11beta-HSD1 Reductase
% 218.86/219.02  |- skos__altLabel mesh__D043205 11beta-Hydroxysteroid Dehydrogenase Type 1
% 218.86/219.02  |- skos__altLabel mesh__D043205 11 beta-Hydroxysteroid Dehydrogenase Type 1
% 218.86/219.02  |- mesh__activeMeSHYear mesh__D043205 2005
% 218.86/219.03  |- mesh__historyNote mesh__D043205
% 218.86/219.03       2004; use 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 %28%NM%29% 1999-2003%A%  
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D043205 2006
% 218.86/219.03  |- mesh__recordMaintainer mesh__D043205 AKE
% 218.86/219.03  |- rdf__type mesh__D043205sskos__Concept
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D043205 2004
% 218.86/219.03  |- skos__related mesh__D007082smesh__D007081
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007082 2005
% 218.86/219.03  |- skos__broader mesh__D007082smesh__D007421
% 218.86/219.03  |- skos__scopeNote mesh__D007082
% 218.86/219.03       The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.%A%    
% 218.86/219.03  |- skos__broader mesh__D007082smesh__D041741
% 218.86/219.03  |- skos__annotation mesh__D007082
% 218.86/219.03       do not confuse with ILEUS or ILIUM; /surg: consider ILEOSTOMY; inflammation = ILEITIS; ileocecal intussusception or invagination: index under ILEOCECAL VALVE %28%IM%29% + INTUSSUSCEPTION %28%IM%29% + ILEAL DISEASES %28%NIM%29%; ileocolic intussusception: index under ILEAL DISEASES %28%IM%29% + INTUSSUSCEPTION %28%IM%29% but not also COLONIC DISEASES; ileum as smooth muscle is probably MUSCLE, SMOOTH %28%IM%29% + ILEUM %28%NIM%29%; jejuno-ileal bypass or shunt or jejuno-ileostomy in obesity: index under JEJUNOILEAL BYPASS %28%note XR ref%29%%A%  
% 218.86/219.03  |- mesh__recordOriginator mesh__D007082 NLM
% 218.86/219.03  |- mesh__recordAuthorizer mesh__D007082 sjn
% 218.86/219.03  |- mesh__recordMaintainer mesh__D007082 lkt
% 218.86/219.03  |- skos__prefLabel mesh__D007082 Ileum
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007082 2004
% 218.86/219.03  |- mesh__dateCreated mesh__D007082 1999-01-01
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007082 2006
% 218.86/219.03  |- mesh__dateRevised mesh__D007082 2003-07-09
% 218.86/219.03  |- rdf__type mesh__D007082sskos__Concept
% 218.86/219.03  |- mesh__recordMaintainer mesh__D015514 nns
% 218.86/219.03  |- skos__hiddenLabel mesh__D015514 Proteins, Chimeric Oncogene
% 218.86/219.03  |- skos__altLabel mesh__D015514 Oncogene Fusion Proteins
% 218.86/219.03  |- skos__altLabel mesh__D015514 Fusion Proteins, Oncogene
% 218.86/219.03  |- rdf__type mesh__D015514sskos__Concept
% 218.86/219.03  |- mesh__recordAuthorizer mesh__D015514 sjn
% 218.86/219.03  |- skos__altLabel mesh__D015514 Chimeric Oncogene Proteins
% 218.86/219.03  |- mesh__historyNote mesh__D015514 90   
% 218.86/219.03  |- skos__historyNote mesh__D015514 Retroviridae Proteins %28%1986-1989%29%
% 218.86/219.03  |- skos__historyNote mesh__D015514 Viral Proteins %28%1980-1985%29%
% 218.86/219.03  |- skos__altLabel mesh__D015514 Oncogene Proteins, Chimeric
% 218.86/219.03  |- skos__hiddenLabel mesh__D015514 Proteins, Fusion Oncogene
% 218.86/219.03  |- skos__hiddenLabel mesh__D015514 Oncogene Chimeric Proteins
% 218.86/219.03  |- skos__prefLabel mesh__D015514 Oncogene Proteins, Fusion
% 218.86/219.03  |- skos__broader mesh__D015514smesh__D050506
% 218.86/219.03  |- skos__hiddenLabel mesh__D015514 Proteins, Oncogene Chimeric
% 218.86/219.03  |- skos__broader mesh__D015514smesh__D015513
% 218.86/219.03  |- mesh__publicMeSHNote mesh__D015514 90   
% 218.86/219.03  |- skos__scopeNote mesh__D015514
% 218.86/219.03       The GENETIC TRANSLATION products of the fusion between an ONCOGENE and another gene. The latter may be of viral or cellular origin.%A%    
% 218.86/219.03  |- skos__hiddenLabel mesh__D015514 Proteins, Oncogene Fusion
% 218.86/219.03  |- mesh__dateRevised mesh__D015514 2005-06-30
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D015514 2006
% 218.86/219.03  |- skos__altLabel mesh__D015514 Chimeric Proteins, Oncogene
% 218.86/219.03  |- mesh__recordOriginator mesh__D015514 AGS
% 218.86/219.03  |- mesh__dateCreated mesh__D015514 1989-05-25
% 218.86/219.03  |- skos__hiddenLabel mesh__D015514 Fusion Oncogene Proteins
% 218.86/219.03  |- mesh__dateEstablished mesh__D015514 1990-01-01
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D006788 2005
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D006788 2002
% 218.86/219.03  |- skos__altLabel mesh__D006788 Hospitals Privates, Not-for-Profit
% 218.86/219.03  |- mesh__dateEstablished mesh__D006788 1991-01-01
% 218.86/219.03  |- mesh__dateRevised mesh__D006788 1999-11-03
% 218.86/219.03  |- skos__hiddenLabel mesh__D006788 Voluntary Hospital
% 218.86/219.03  |- skos__altLabel mesh__D006788 Private, Not-for-Profit Hospitals
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D006788 2006
% 218.86/219.03  |- skos__altLabel mesh__D006788 Voluntary Hospitals
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D006788 2003
% 218.86/219.03  |- mesh__recordOriginator mesh__D006788 EC
% 218.86/219.03  |- skos__hiddenLabel mesh__D006788 Private, Not for Profit Hospitals
% 218.86/219.03  |- skos__hiddenLabel mesh__D006788 Hospitals Private, Not-for-Profit
% 218.86/219.03  |- skos__hiddenLabel mesh__D006788 Not for Profit Hospitals Privates
% 218.86/219.03  |- skos__hiddenLabel mesh__D006788 Hospital, Voluntary
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D006788 2004
% 218.86/219.03  |- skos__altLabel mesh__D006788 Hospitals, Private, Not-for-Profit
% 218.86/219.03  |- mesh__publicMeSHNote mesh__D006788
% 218.86/219.03       91; was see under HOSPITALS 1979-90   
% 218.86/219.03  |- skos__prefLabel mesh__D006788 Hospitals, Voluntary
% 218.86/219.03  |- skos__hiddenLabel mesh__D006788 Hospitals Privates, Not for Profit
% 218.86/219.03  |- mesh__recordAuthorizer mesh__D006788 sjn
% 218.86/219.03  |- skos__scopeNote mesh__D006788
% 218.86/219.03       Private, not-for-profit hospitals that are autonomous, self-established, and self-supported.%A%    
% 218.86/219.03  |- skos__altLabel mesh__D006788 Not-for-Profit Hospitals Privates
% 218.86/219.03  |- skos__broader mesh__D006788smesh__D016304
% 218.86/219.03  |- mesh__recordMaintainer mesh__D006788 kle
% 218.86/219.03  |- mesh__dateCreated mesh__D006788 1978-05-04
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D006788 2000
% 218.86/219.03  |- skos__hiddenLabel mesh__D006788 Privates, Not-for-Profit Hospitals
% 218.86/219.03  |- skos__annotation mesh__D006788
% 218.86/219.03       coord NIM with special hosp %28%e.g., HOSPITALS, CHRONIC DISEASE%29% or med specialty %28%IM or NIM%29% if pertinent; specify geog%A%  
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D006788 2001
% 218.86/219.03  |- mesh__historyNote mesh__D006788
% 218.86/219.03       91%28%79%29%; was see under HOSPITALS 1979-90   
% 218.86/219.03  |- skos__hiddenLabel mesh__D006788 Not for Profit Hospitals Private
% 218.86/219.03  |- skos__altLabel mesh__D006788 Not-for-Profit Hospitals Private
% 218.86/219.03  |- rdf__type mesh__D006788sskos__Concept
% 218.86/219.03  |- skos__prefLabel mesh__D020459 Genes, rRNA
% 218.86/219.03  |- mesh__historyNote mesh__D020459
% 218.86/219.03       99; use rRNA OPERON 1988-98; for rRNA GENES use rRNA OPERON 1988-98%A%  
% 218.86/219.03  |- mesh__dateEstablished mesh__D020459 1999-01-01
% 218.86/219.03  |- skos__hiddenLabel mesh__D020459 Genes, Ribosomal RNA
% 218.86/219.03  |- skos__altLabel mesh__D020459 Ribosomal RNA Genes
% 218.86/219.03  |- skos__hiddenLabel mesh__D020459 RNA Genes, Ribosomal
% 218.86/219.03  |- skos__hiddenLabel mesh__D020459 Gene, rRNA
% 218.86/219.03  |- rdf__type mesh__D020459sskos__Concept
% 218.86/219.03  |- skos__related mesh__D020459smesh__D012407
% 218.86/219.03  |- skos__hiddenLabel mesh__D020459 RNA Gene, Ribosomal
% 218.86/219.03  |- mesh__recordAuthorizer mesh__D020459 sjn
% 218.86/219.03  |- mesh__dateRevised mesh__D020459 2005-06-30
% 218.86/219.03  |- skos__hiddenLabel mesh__D020459 Gene, Ribosomal RNA
% 218.86/219.03  |- skos__broader mesh__D020459smesh__D005810
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D020459 2006
% 218.86/219.03  |- skos__hiddenLabel mesh__D020459 rRNA Gene
% 218.86/219.03  |- mesh__publicMeSHNote mesh__D020459
% 218.86/219.03       99; see rRNA OPERON 1988-98; for rRNA GENES see rRNA OPERON 1988-98%A%  
% 218.86/219.03  |- skos__altLabel mesh__D020459 rRNA Genes
% 218.86/219.03  |- mesh__recordOriginator mesh__D020459 NDW
% 218.86/219.03  |- skos__scopeNote mesh__D020459
% 218.86/219.03       Genes, found in both prokaryotes and eukaryotes, which are transcribed to produce the RNA which is incorporated into RIBOSOMES. Prokaryotic rRNA genes are usually found in OPERONS dispersed throughout the GENOME, whereas eukaryotic rRNA genes are clustered, multicistronic transcriptional units.%A%    
% 218.86/219.03  |- skos__historyNote mesh__D020459 rRNA Operon %28%1988-1998%29%
% 218.86/219.03  |- mesh__dateCreated mesh__D020459 1998-06-10
% 218.86/219.03  |- mesh__recordMaintainer mesh__D020459 nns
% 218.86/219.03  |- skos__hiddenLabel mesh__D020459 Ribosomal RNA Gene
% 218.86/219.03  |- rdf__type mesh__D031181sskos__Concept
% 218.86/219.03  |- skos__annotation mesh__D031181
% 218.86/219.03       other %27%thistle%27% plants are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.03  |- skos__altLabel mesh__D031181 Cardo-santo
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D031181 2004
% 218.86/219.03  |- skos__altLabel mesh__D031181 Blessed Thistle
% 218.86/219.03  |- skos__altLabel mesh__D031181 Thistle, Blessed
% 218.86/219.03  |- skos__prefLabel mesh__D031181 Cnicus
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D031181 2003
% 218.86/219.03  |- mesh__publicMeSHNote mesh__D031181 2003   
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D031181 2006
% 218.86/219.03  |- skos__scopeNote mesh__D031181
% 218.86/219.03       A plant genus of the family ASTERACEAE. Members contain cnicin.%A%    
% 218.86/219.03  |- skos__broader mesh__D031181smesh__D019659
% 218.86/219.03  |- mesh__dateEstablished mesh__D031181 2003-01-01
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D031181 2005
% 218.86/219.03  |- mesh__historyNote mesh__D031181 2003   
% 218.86/219.03  |- mesh__dateCreated mesh__D031181 2002-07-02
% 218.86/219.03  |- skos__prefLabel mesh__D025942 Oligosaccharides, Branched-Chain
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D025942 2006
% 218.86/219.03  |- skos__broader mesh__D025942smesh__D009844
% 218.86/219.03  |- mesh__historyNote mesh__D025942 2002   
% 218.86/219.03  |- mesh__recordAuthorizer mesh__D025942 ags
% 218.86/219.03  |- skos__historyNote mesh__D025942 Oligosaccharides %28%1977-2001%29%
% 218.86/219.03  |- skos__scopeNote mesh__D025942
% 218.86/219.03       Oligosaccharides containing various types of glycosidic linkages that yield branching or antennae. The number of antennae %28%such as bi-, tri-, tetra-, or penta-antennary%29% in the oligosaccharides on the PROTEOGLYCANS; GLYCOPROTEINS; or LIPOPOLYSACCHARIDES contribute to their biological activities, such as receptor binding and  metabolism.%A%    
% 218.86/219.03  |- mesh__recordMaintainer mesh__D025942 ags
% 218.86/219.03  |- mesh__recordOriginator mesh__D025942 lkt
% 218.86/219.03  |- mesh__dateRevised mesh__D025942 2005-07-27
% 218.86/219.03  |- skos__altLabel mesh__D025942 Branched-Chain Oligosaccharides
% 218.86/219.03  |- mesh__dateEstablished mesh__D025942 2002-01-01
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D025942 2005
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D025942 2006A
% 218.86/219.03  |- rdf__type mesh__D025942sskos__Concept
% 218.86/219.03  |- mesh__dateCreated mesh__D025942 2001-07-25
% 218.86/219.03  |- mesh__publicMeSHNote mesh__D025942 2002   
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003490 2002
% 218.86/219.03  |- skos__hiddenLabel mesh__D003490 Cyanoses
% 218.86/219.03  |- mesh__recordMaintainer mesh__D003490 KEV
% 218.86/219.03  |- mesh__dateRevised mesh__D003490 1999-11-08
% 218.86/219.03  |- mesh__dateCreated mesh__D003490 1999-01-01
% 218.86/219.03  |- skos__scopeNote mesh__D003490
% 218.86/219.03       A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule.%A%    
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003490 2006
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003490 2004
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003490 2001
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003490 2000
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003490 2005
% 218.86/219.03  |- mesh__recordAuthorizer mesh__D003490 sjn
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003490 2003
% 218.86/219.03  |- mesh__recordOriginator mesh__D003490 NLM
% 218.86/219.03  |- skos__annotation mesh__D003490
% 218.86/219.03       do not use for cyanotic heart disease unless particularly discussed %28%=probably HEART DEFECTS, CONGENITAL%29%%A%  
% 218.86/219.03  |- rdf__type mesh__D003490sskos__Concept
% 218.86/219.03  |- skos__prefLabel mesh__D003490 Cyanosis
% 218.86/219.03  |- skos__broader mesh__D003490smesh__D012816
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D019905 2001
% 218.86/219.03  |- skos__annotation mesh__D019905 BENZYL ALCOHOLS also available   
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D019905 2004
% 218.86/219.03  |- skos__hiddenLabel mesh__D019905 Alcohol, Benzyl
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D019905 2000
% 218.86/219.03  |- mesh__historyNote mesh__D019905
% 218.86/219.03       98; use BENZYL ALCOHOL %28%NM%29% 1981-97   
% 218.86/219.03  |- mesh__dateCreated mesh__D019905 1997-06-20
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D019905 2003
% 218.86/219.03  |- skos__historyNote mesh__D019905 Benzyl Alcohols %28%1981-1997%29%
% 218.86/219.03  |- mesh__dateRevised mesh__D019905 1999-11-03
% 218.86/219.03  |- mesh__recordAuthorizer mesh__D019905 sjn
% 218.86/219.03  |- mesh__publicMeSHNote mesh__D019905
% 218.86/219.03       98; BENZYL ALCOHOL was indexed under BENZYL ALCOHOLS 1981-97%A%  
% 218.86/219.03  |- mesh__dateEstablished mesh__D019905 1998-01-01
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D019905 2006
% 218.86/219.03  |- rdf__type mesh__D019905sskos__Concept
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D019905 2002
% 218.86/219.03  |- skos__prefLabel mesh__D019905 Benzyl Alcohol
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D019905 2005
% 218.86/219.03  |- skos__broader mesh__D019905smesh__D001592
% 218.86/219.03  |- mesh__recordMaintainer mesh__D019905 adp
% 218.86/219.03  |- skos__scopeNote mesh__D019905
% 218.86/219.03       A colorless liquid with a sharp burning taste and slight odor. It is used as a local anesthetic and to reduce pain associated with LIDOCAINE injection. Also, it is used in the manufacture of other benzyl compounds, as a pharmaceutic aid, and in perfumery and flavoring.%A%    
% 218.86/219.03  |- mesh__recordOriginator mesh__D019905 ADP
% 218.86/219.03  |- skos__altLabel mesh__D019905 Benzenemethanol
% 218.86/219.03  |- skos__broader mesh__D011922smesh__D051381
% 218.86/219.03  |- skos__scopeNote mesh__D011922
% 218.86/219.03       Rats bearing mutant genes which are phenotypically expressed in the animals.%A%    
% 218.86/219.03  |- skos__hiddenLabel mesh__D011922 Strains Rats, Mutant
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D011922 2006
% 218.86/219.03  |- skos__hiddenLabel mesh__D011922 Mutant Strains Rats
% 218.86/219.03  |- mesh__recordAuthorizer mesh__D011922 sjn
% 218.86/219.03  |- skos__hiddenLabel mesh__D011922 Rat, Mutant Strains
% 218.86/219.03  |- rdf__type mesh__D011922sskos__Concept
% 218.86/219.03  |- skos__annotation mesh__D011922
% 218.86/219.03       GEN or unspecified; prefer specifics; NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag RATS%A%  
% 218.86/219.03  |- skos__prefLabel mesh__D011922 Rats, Mutant Strains
% 218.86/219.03  |- mesh__publicMeSHNote mesh__D011922
% 218.86/219.03       82; RATS, ZUCKER was see under RATS 1981   
% 218.86/219.03  |- skos__historyNote mesh__D011922 Rats %28%1977-1981%29%
% 218.86/219.03  |- mesh__historyNote mesh__D011922 82   
% 218.86/219.03  |- mesh__dateRevised mesh__D011922 2005-06-30
% 218.86/219.03  |- mesh__dateCreated mesh__D011922 1981-05-15
% 218.86/219.03  |- skos__hiddenLabel mesh__D011922 Mutant Strains Rat
% 218.86/219.03  |- mesh__recordOriginator mesh__D011922 EC
% 218.86/219.03  |- skos__hiddenLabel mesh__D011922 Strains Rat, Mutant
% 218.86/219.03  |- mesh__dateEstablished mesh__D011922 1982-01-01
% 218.86/219.03  |- mesh__recordMaintainer mesh__D011922 ags
% 218.86/219.03  |- mesh__dateRevised mesh__D011124 2005-06-30
% 218.86/219.03  |- mesh__dateEstablished mesh__D011124 1991-01-01
% 218.86/219.03  |- mesh__recordAuthorizer mesh__D011124 sjn
% 218.86/219.03  |- mesh__recordMaintainer mesh__D011124 ags
% 218.86/219.03  |- mesh__historyNote mesh__D011124
% 218.86/219.03       91%28%75%29%; use BASIDIOMYCOTA 1963-74   
% 218.86/219.03  |- mesh__publicMeSHNote mesh__D011124 91; see BASIDIOMYCETES 1975-90   
% 218.86/219.03  |- mesh__recordOriginator mesh__D011124 NLM
% 218.86/219.03  |- skos__prefLabel mesh__D011124 Polyporaceae
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D011124 2006
% 218.86/219.03  |- skos__scopeNote mesh__D011124
% 218.86/219.03       A family of basidiomycetous fungi, order POLYPORALES, living in decaying plant matter and timber.%A%    
% 218.86/219.03  |- rdf__type mesh__D011124sskos__Concept
% 218.86/219.03  |- mesh__dateCreated mesh__D011124 1999-01-01
% 218.86/219.03  |- skos__broader mesh__D011124smesh__D020072
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D002398 1994
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D002398 2003
% 218.86/219.03  |- mesh__recordOriginator mesh__D002398 SH
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D002398 2000
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D002398 2005
% 218.86/219.03  |- skos__scopeNote mesh__D002398
% 218.86/219.03       Sterile collagen strands obtained from healthy mammals. They are used as absorbable surgical ligatures and are frequently impregnated with chromium or silver for increased strength. They tend to cause tissue reaction.%A%    
% 218.86/219.03  |- mesh__publicMeSHNote mesh__D002398 91; was see under SUTURES 1979-90   
% 218.86/219.03  |- mesh__recordAuthorizer mesh__D002398 PLS
% 218.86/219.03  |- skos__broader mesh__D002398smesh__D013537
% 218.86/219.03  |- mesh__dateEstablished mesh__D002398 1991-01-01
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D002398 1997
% 218.86/219.03  |- skos__historyNote mesh__D002398 Sutures %28%1966-1978%29%
% 218.86/219.03  |- rdf__type mesh__D002398sskos__Concept
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D002398 1999
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D002398 2002
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D002398 1993
% 218.86/219.03  |- mesh__historyNote mesh__D002398
% 218.86/219.03       91%28%79%29%; was see under SUTURES 1979-90   
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D002398 1996
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D002398 1995
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D002398 2004
% 218.86/219.03  |- skos__prefLabel mesh__D002398 Catgut
% 218.86/219.03  |- skos__hiddenLabel mesh__D002398 Catguts
% 218.86/219.03  |- mesh__dateCreated mesh__D002398 1978-02-01
% 218.86/219.03  |- mesh__recordMaintainer mesh__D002398 TAP
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D002398 1998
% 218.86/219.03  |- mesh__dateRevised mesh__D002398 1992-05-07
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D002398 2001
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D002398 2006
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007881 2003
% 218.86/219.03  |- mesh__dateEstablished mesh__D007881 1979-01-01
% 218.86/219.03  |- skos__altLabel mesh__D007881 Food Legislation
% 218.86/219.03  |- mesh__onlineNote mesh__D007881
% 218.86/219.03       search FOOD AND DRUG LAWS under LEGISLATION, DRUG 1968-78%A%  
% 218.86/219.03  |- skos__hiddenLabel mesh__D007881 Food Law
% 218.86/219.03  |- skos__prefLabel mesh__D007881 Legislation, Food
% 218.86/219.03  |- skos__hiddenLabel mesh__D007881 Legislations, Food
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007881 2004
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007881 2000
% 218.86/219.03  |- skos__broader mesh__D007881smesh__D007878
% 218.86/219.03  |- rdf__type mesh__D007881sskos__Concept
% 218.86/219.03  |- mesh__publicMeSHNote mesh__D007881
% 218.86/219.03       79; FOOD AND DRUG LAWS was see under LEGISLATION, DRUG 1968-78%A%  
% 218.86/219.03  |- skos__altLabel mesh__D007881 Food Laws
% 218.86/219.03  |- mesh__dateCreated mesh__D007881 1978-05-04
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007881 2001
% 218.86/219.03  |- skos__hiddenLabel mesh__D007881 Laws, Food
% 218.86/219.03  |- skos__hiddenLabel mesh__D007881 Law, Food
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007881 2005
% 218.86/219.03  |- mesh__historyNote mesh__D007881
% 218.86/219.03       79; FOOD AND DRUG LAWS was see under LEGISLATION, DRUG 1968-78%A%  
% 218.86/219.03  |- skos__hiddenLabel mesh__D007881 Food Legislations
% 218.86/219.03  |- mesh__dateRevised mesh__D007881 1999-11-03
% 218.86/219.03  |- skos__historyNote mesh__D007881 Legislation, Drug %28%1975-1978%29%
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007881 2006
% 218.86/219.03  |- mesh__recordMaintainer mesh__D007881 kle
% 218.86/219.03  |- skos__scopeNote mesh__D007881
% 218.86/219.03       Laws and regulations concerned with industrial processing and marketing of foods.%A%    
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007881 2002
% 218.86/219.03  |- mesh__recordOriginator mesh__D007881 EC
% 218.86/219.03  |- skos__annotation mesh__D007881
% 218.86/219.03       IM; specify country or state; DF: LEGIS FOOD   
% 218.86/219.03  |- mesh__recordAuthorizer mesh__D007881 sjn
% 218.86/219.03  |- mesh__recordMaintainer mesh__D007083 TAP
% 218.86/219.03  |- mesh__dateRevised mesh__D007083 1992-05-14
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007083 1997
% 218.86/219.03  |- mesh__recordAuthorizer mesh__D007083 PLS
% 218.86/219.03  |- skos__hiddenLabel mesh__D007083 Artery, Iliac
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007083 1993
% 218.86/219.03  |- skos__broader mesh__D007083smesh__D001158
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007083 1996
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007083 2002
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007083 1999
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007083 2004
% 218.86/219.03  |- skos__prefLabel mesh__D007083 Iliac Artery
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007083 1995
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007083 2001
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007083 1998
% 218.86/219.03  |- skos__hiddenLabel mesh__D007083 Iliac Arteries
% 218.86/219.03  |- skos__scopeNote mesh__D007083
% 218.86/219.03       Either of two large arteries originating from the abdominal aorta; they supply blood to the pelvis, abdominal wall and legs.%A%    
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007083 2003
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007083 2006
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007083 1994
% 218.86/219.03  |- mesh__dateCreated mesh__D007083 1999-01-01
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007083 2000
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D007083 2005
% 218.86/219.03  |- rdf__type mesh__D007083sskos__Concept
% 218.86/219.03  |- skos__hiddenLabel mesh__D007083 Arteries, Iliac
% 218.86/219.03  |- mesh__recordOriginator mesh__D007083 NLM
% 218.86/219.03  |- mesh__dateRevised mesh__D006789 1992-05-15
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D006789 2001
% 218.86/219.03  |- skos__scopeNote mesh__D006789
% 218.86/219.03       The immune responses of a host to a graft. A specific response is GRAFT REJECTION.%A%    
% 218.86/219.03  |- mesh__dateCreated mesh__D006789 1976-05-19
% 218.86/219.03  |- mesh__recordOriginator mesh__D006789 MM
% 218.86/219.03  |- rdf__type mesh__D006789sskos__Concept
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D006789 2000
% 218.86/219.03  |- skos__historyNote mesh__D006789 Graft Rejection %28%1971-1976%29%
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D006789 1997
% 218.86/219.03  |- mesh__dateEstablished mesh__D006789 1977-01-01
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D006789 2004
% 218.86/219.03  |- skos__prefLabel mesh__D006789 Host vs Graft Reaction
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D006789 1999
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D006789 2006
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D006789 1993
% 218.86/219.03  |- mesh__historyNote mesh__D006789 77   
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D006789 1996
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D006789 1995
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D006789 2003
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D006789 1998
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D006789 2005
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D006789 1994
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D006789 2002
% 218.86/219.03  |- skos__annotation mesh__D006789
% 218.86/219.03       do not confuse with GRAFT VS HOST REACTION %28%Cat G%29% nor GRAFT VS HOST DISEASE %28%Cat C%29%%A%  
% 218.86/219.03  |- mesh__recordAuthorizer mesh__D006789 PLS
% 218.86/219.03  |- mesh__recordMaintainer mesh__D006789 TAP
% 218.86/219.03  |- mesh__publicMeSHNote mesh__D006789 77   
% 218.86/219.03  |- skos__broader mesh__D006789smesh__D014181
% 218.86/219.03  |- skos__historyNote mesh__D006789
% 218.86/219.03       Transplantation Immunology %28%1966-1972%29%
% 218.86/219.03  |- mesh__recordAuthorizer mesh__D031182 ags
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D031182 2003
% 218.86/219.03  |- mesh__dateRevised mesh__D031182 2005-07-29
% 218.86/219.03  |- mesh__recordOriginator mesh__D031182 ssb
% 218.86/219.03  |- skos__scopeNote mesh__D031182
% 218.86/219.03       A plant genus of the family ASTERACEAE. Members contain a pseudoguaiane sesquiterpene. San-fang-feng is the root of E. grijisii used in DRUGS, CHINESE HERBAL.%A%    
% 218.86/219.03  |- mesh__publicMeSHNote mesh__D031182 2003   
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D031182 2006
% 218.86/219.03  |- mesh__historyNote mesh__D031182 2003   
% 218.86/219.03  |- skos__annotation mesh__D031182
% 218.86/219.03       other %27%thistle%27% plants are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.03  |- skos__broader mesh__D031182smesh__D019659
% 218.86/219.03  |- skos__prefLabel mesh__D031182 Echinops Plant
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D031182 2005
% 218.86/219.03  |- mesh__recordMaintainer mesh__D031182 ags
% 218.86/219.03  |- mesh__dateCreated mesh__D031182 2002-07-03
% 218.86/219.03  |- rdf__type mesh__D031182sskos__Concept
% 218.86/219.03  |- skos__altLabel mesh__D031182 Thistle, Globe
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D031182 2004
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D031182 2006A
% 218.86/219.03  |- mesh__dateEstablished mesh__D031182 2003-01-01
% 218.86/219.03  |- mesh__recordOriginator mesh__D003491 NLM
% 218.86/219.03  |- mesh__recordAuthorizer mesh__D003491 PLS
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003491 1995
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003491 1991
% 218.86/219.03  |- mesh__dateCreated mesh__D003491 1999-01-01
% 218.86/219.03  |- mesh__dateRevised mesh__D003491 1989-09-01
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003491 1993
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003491 2006
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003491 1994
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003491 2002
% 218.86/219.03  |- skos__prefLabel mesh__D003491 Cybernetics
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003491 2004
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003491 1992
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003491 1999
% 218.86/219.03  |- mesh__recordMaintainer mesh__D003491 PLS
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003491 2005
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003491 1997
% 218.86/219.03  |- skos__related mesh__D003491smesh__D001701
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003491 1990
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003491 2003
% 218.86/219.03  |- skos__hiddenLabel mesh__D003491 Cybernetic
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003491 1998
% 218.86/219.03  |- rdf__type mesh__D003491sskos__Concept
% 218.86/219.03  |- skos__scopeNote mesh__D003491
% 218.86/219.03       That branch of learning which brings together theories and studies on communication and control in living organisms and machines.%A%    
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003491 1996
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003491 2001
% 218.86/219.03  |- skos__broader mesh__D003491smesh__D003142
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D003491 2000
% 218.86/219.03  |- skos__annotation mesh__D003491 SPEC: SPEC qualif   
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D019906 2003
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D019906 2001
% 218.86/219.03  |- skos__hiddenLabel mesh__D019906 Multinuclear NMR
% 218.86/219.03  |- skos__hiddenLabel mesh__D019906 NMR Spectroscopies, Protein
% 218.86/219.03  |- skos__altLabel mesh__D019906 NMR, Biomolecular
% 218.86/219.03  |- mesh__publicMeSHNote mesh__D019906 98   
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D019906 2006
% 218.86/219.03  |- rdf__type mesh__D019906sskos__Concept
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D019906 2000
% 218.86/219.03  |- mesh__dateCreated mesh__D019906 1997-06-20
% 218.86/219.03  |- skos__hiddenLabel mesh__D019906 Biomolecular NMR
% 218.86/219.03  |- skos__altLabel mesh__D019906 Heteronuclear Nuclear Magnetic Resonance
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D019906 2005
% 218.86/219.03  |- skos__scopeNote mesh__D019906
% 218.86/219.03       NMR spectroscopy on small- to medium-size biological macromolecules. This is often used for structural investigation of proteins and nucleic acids, and often involves more than one isotope.%A%    
% 218.86/219.03  |- skos__hiddenLabel mesh__D019906 Protein NMR Spectroscopies
% 218.86/219.03  |- skos__historyNote mesh__D019906
% 218.86/219.03       Nuclear Magnetic Resonance %28%1994-1997%29%
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D019906 1999
% 218.86/219.03  |- skos__altLabel mesh__D019906 Biomolecular Nuclear Magnetic Resonance
% 218.86/219.03  |- mesh__dateEstablished mesh__D019906 1998-01-01
% 218.86/219.03  |- skos__altLabel mesh__D019906 NMR, Heteronuclear
% 218.86/219.03  |- skos__broader mesh__D019906smesh__D009682
% 218.86/219.03  |- skos__hiddenLabel mesh__D019906 Heteronuclear NMR
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D019906 1998
% 218.86/219.03  |- mesh__historyNote mesh__D019906 98   
% 218.86/219.03  |- skos__prefLabel mesh__D019906 Nuclear Magnetic Resonance, Biomolecular
% 218.86/219.03  |- skos__altLabel mesh__D019906 NMR Spectroscopy, Protein
% 218.86/219.03  |- mesh__activeMeSHYear mesh__D019906 2002
% 218.86/219.04  |- skos__hiddenLabel mesh__D019906 Spectroscopies, Protein NMR
% 218.86/219.04  |- skos__hiddenLabel mesh__D019906 Spectroscopy, Protein NMR
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D019906 2004
% 218.86/219.04  |- skos__annotation mesh__D011923
% 218.86/219.04       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag RATS%A%  
% 218.86/219.04  |- skos__hiddenLabel mesh__D011923 Athymic Rat
% 218.86/219.04  |- mesh__recordOriginator mesh__D011923 EC
% 218.86/219.04  |- mesh__dateRevised mesh__D011923 2005-06-30
% 218.86/219.04  |- skos__altLabel mesh__D011923 Nude Rats
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D011923 2006
% 218.86/219.04  |- skos__broader mesh__D011923smesh__D011922
% 218.86/219.04  |- skos__hiddenLabel mesh__D011923 Nude Rat
% 218.86/219.04  |- skos__historyNote mesh__D011923 Rat, Mutant Strains %28%1982-1986%29%
% 218.86/219.04  |- skos__hiddenLabel mesh__D011923 Rat, Nude
% 218.86/219.04  |- rdf__type mesh__D011923sskos__Concept
% 218.86/219.04  |- skos__hiddenLabel mesh__D011923 Rat, Athymic
% 218.86/219.04  |- skos__scopeNote mesh__D011923
% 218.86/219.04       A mutant strain of Rattus norvegicus without a thymus and with depressed or absent T-cell function. This strain of rats may have a small amount of hair at times, but then lose it.%A%    
% 218.86/219.04  |- mesh__dateCreated mesh__D011923 1986-05-30
% 218.86/219.04  |- skos__altLabel mesh__D011923 Athymic Rats
% 218.86/219.04  |- mesh__recordAuthorizer mesh__D011923 sjn
% 218.86/219.04  |- skos__prefLabel mesh__D011923 Rats, Nude
% 218.86/219.04  |- mesh__dateEstablished mesh__D011923 1991-01-01
% 218.86/219.04  |- mesh__publicMeSHNote mesh__D011923
% 218.86/219.04       91; was see under RATS, MUTANT STRAINS 1987-90   
% 218.86/219.04  |- mesh__recordMaintainer mesh__D011923 ags
% 218.86/219.04  |- mesh__historyNote mesh__D011923
% 218.86/219.04       91%28%87%29%; was see under RATS, MUTANT STRAINS 1987-90   
% 218.86/219.04  |- skos__altLabel mesh__D011923 Rats, Athymic
% 218.86/219.04  |- skos__broader mesh__D019108smesh__D007365
% 218.86/219.04  |- skos__hiddenLabel mesh__D019108 Occluding Junction
% 218.86/219.04  |- skos__hiddenLabel mesh__D019108 Zonula Occluden
% 218.86/219.04  |- skos__hiddenLabel mesh__D019108 Occludens, Zonula
% 218.86/219.04  |- rdf__type mesh__D019108sskos__Concept
% 218.86/219.04  |- skos__hiddenLabel mesh__D019108 Junction, Occluding
% 218.86/219.04  |- mesh__dateCreated mesh__D019108 1995-06-05
% 218.86/219.04  |- skos__scopeNote mesh__D019108
% 218.86/219.04       Cell-cell junctions that seal adjacent epithelial cells together, preventing the passage of most dissolved molecules from one side of the epithelial sheet to the other. %28%Alberts et al., Molecular Biology of the Cell, 2nd ed, p22%29%%A%    
% 218.86/219.04  |- mesh__recordAuthorizer mesh__D019108 sjn
% 218.86/219.04  |- skos__historyNote mesh__D019108
% 218.86/219.04       Intercellular Junctions %28%1970-1995%29%
% 218.86/219.04  |- skos__altLabel mesh__D019108 Occluding Junctions
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D019108 2004
% 218.86/219.04  |- skos__hiddenLabel mesh__D019108 Junctions, Occluding
% 218.86/219.04  |- skos__hiddenLabel mesh__D019108 Occluden, Zonula
% 218.86/219.04  |- mesh__recordMaintainer mesh__D019108 jmp
% 218.86/219.04  |- mesh__publicMeSHNote mesh__D019108
% 218.86/219.04       96; was see INTERCELLULAR JUNCTIONS 1995   
% 218.86/219.04  |- mesh__dateEstablished mesh__D019108 1996-01-01
% 218.86/219.04  |- mesh__onlineNote mesh__D019108
% 218.86/219.04       use INTERCELLULAR JUNCTIONS to search TIGHT JUNCTIONS 1995%A%  
% 218.86/219.04  |- skos__historyNote mesh__D019108 Cell Membrane %28%1966-1969%29%
% 218.86/219.04  |- skos__hiddenLabel mesh__D019108 Junctions, Tight
% 218.86/219.04  |- mesh__recordOriginator mesh__D019108 AGS
% 218.86/219.04  |- skos__prefLabel mesh__D019108 Tight Junctions
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D019108 2005
% 218.86/219.04  |- mesh__dateRevised mesh__D019108 2003-07-09
% 218.86/219.04  |- skos__hiddenLabel mesh__D019108 Tight Junction
% 218.86/219.04  |- skos__altLabel mesh__D019108 Zonula Occludens
% 218.86/219.04  |- skos__hiddenLabel mesh__D019108 Junction, Tight
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D019108 2006
% 218.86/219.04  |- mesh__historyNote mesh__D019108
% 218.86/219.04       96; was see INTERCELLULAR JUNCTIONS 1995   
% 218.86/219.04  |- mesh__recordOriginator mesh__D011125 VDK
% 218.86/219.04  |- skos__related mesh__D011125smesh__D005736
% 218.86/219.04  |- skos__hiddenLabel mesh__D011125 Adenomatous Polyposis, Familial
% 218.86/219.04  |- mesh__onlineNote mesh__D011125
% 218.86/219.04       use ADENOMATOUS POLYPOSIS COLI to search POLYPOSIS SYNDROME, FAMILIAL 1987-93 %26% ADENOMATOUS POLYPOSIS COLI, FAMILIAL 1993%A%  
% 218.86/219.04  |- skos__altLabel mesh__D011125 Familial Adenomatous Polyposis
% 218.86/219.04  |- skos__broader mesh__D011125smesh__D044483
% 218.86/219.04  |- mesh__dateCreated mesh__D011125 1986-06-23
% 218.86/219.04  |- skos__broader mesh__D011125smesh__D015179
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D011125 2004
% 218.86/219.04  |- skos__related mesh__D011125smesh__D025601
% 218.86/219.04  |- skos__broader mesh__D011125smesh__D018256
% 218.86/219.04  |- skos__broader mesh__D011125smesh__D009386
% 218.86/219.04  |- skos__altLabel mesh__D011125 Familial Polyposis Coli
% 218.86/219.04  |- skos__broader mesh__D011125smesh__D003110
% 218.86/219.04  |- skos__altLabel mesh__D011125 Adenomatous Polyposis of the Colon
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D011125 2005
% 218.86/219.04  |- skos__scopeNote mesh__D011125
% 218.86/219.04       A polyposis syndrome due to an autosomal dominant mutation of the APC genes %28%GENES, APC%29% on CHROMOSOME 5. The syndrome is characterized by the development of hundreds of ADENOMATOUS POLYPS in the COLON and RECTUM of affected individuals by early adulthood. The lifetime risk of colorectal cancer in these patients reaches 100 percent by age 60.%A%    
% 218.86/219.04  |- mesh__dateEstablished mesh__D011125 1987-01-01
% 218.86/219.04  |- skos__related mesh__D011125smesh__D017491
% 218.86/219.04  |- skos__prefLabel mesh__D011125 Adenomatous Polyposis Coli
% 218.86/219.04  |- mesh__publicMeSHNote mesh__D011125
% 218.86/219.04       94; was POLYPOSIS SYNDROME, FAMILIAL 1987-93; ADENOMATOUS POLYPOSIS COLI, FAMILIAL was see POLYPOSIS SYNDROME, FAMILIAL 1993%A%  
% 218.86/219.04  |- mesh__historyNote mesh__D011125
% 218.86/219.04       94; was POLYPOSIS SYNDROME, FAMILIAL 1987-93; ADENOMATOUS POLYPOSIS COLI, FAMILIAL was see POLYPOSIS SYNDROME, FAMILIAL 1993%A%  
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D011125 2006
% 218.86/219.04  |- skos__altLabel mesh__D011125 Adenomatous Polyposis Coli, Familial
% 218.86/219.04  |- skos__altLabel mesh__D011125 Polyposis Coli, Familial
% 218.86/219.04  |- rdf__type mesh__D011125sskos__Concept
% 218.86/219.04  |- mesh__recordMaintainer mesh__D011125 lkt
% 218.86/219.04  |- skos__hiddenLabel mesh__D011125 Familial Polyposis Syndrome
% 218.86/219.04  |- skos__altLabel mesh__D011125 Familial Adenomatous Polyposis Coli
% 218.86/219.04  |- mesh__recordAuthorizer mesh__D011125 sjn
% 218.86/219.04  |- mesh__dateRevised mesh__D011125 2003-07-09
% 218.86/219.04  |- skos__altLabel mesh__D011125 Polyposis Syndrome, Familial
% 218.86/219.04  |- mesh__dateCreated mesh__D002399 1999-01-01
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D002399 2002
% 218.86/219.04  |- mesh__publicMeSHNote mesh__D002399
% 218.86/219.04       91; was see under ABREACTION 1975-90   
% 218.86/219.04  |- mesh__recordOriginator mesh__D002399 NLM
% 218.86/219.04  |- skos__annotation mesh__D002399 no qualif   
% 218.86/219.04  |- rdf__type mesh__D002399sskos__Concept
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D002399 1999
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D002399 2001
% 218.86/219.04  |- skos__hiddenLabel mesh__D002399 Catharses
% 218.86/219.04  |- mesh__dateEstablished mesh__D002399 1991-01-01
% 218.86/219.04  |- mesh__historyNote mesh__D002399
% 218.86/219.04       91%28%75%29%; was see under ABREACTION 1975-90   
% 218.86/219.04  |- skos__broader mesh__D002399smesh__D000035
% 218.86/219.04  |- skos__scopeNote mesh__D002399
% 218.86/219.04       The release of ideas, thoughts, and repressed material from the unconscious, accompanied by an emotional response and relief. %28%From Dorland, 28th ed%29%%A%    
% 218.86/219.04  |- skos__prefLabel mesh__D002399 Catharsis
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D002399 2004
% 218.86/219.04  |- mesh__onlineNote mesh__D002399 search ABREACTION 1969-74   
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D002399 1998
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D002399 2000
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D002399 2006
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D002399 2003
% 218.86/219.04  |- mesh__dateRevised mesh__D002399 1997-06-20
% 218.86/219.04  |- mesh__recordMaintainer mesh__D002399 PXP
% 218.86/219.04  |- mesh__recordAuthorizer mesh__D002399 SJN
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D002399 2005
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007882 2006
% 218.86/219.04  |- mesh__publicMeSHNote mesh__D007882 78   
% 218.86/219.04  |- skos__hiddenLabel mesh__D007882 Hospital Legislations
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007882 2004
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007882 2001
% 218.86/219.04  |- skos__broader mesh__D007882smesh__D007878
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007882 2000
% 218.86/219.04  |- mesh__recordMaintainer mesh__D007882 kle
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007882 2005
% 218.86/219.04  |- mesh__dateRevised mesh__D007882 1999-11-03
% 218.86/219.04  |- skos__scopeNote mesh__D007882
% 218.86/219.04       Laws and regulations concerning hospitals, which are proposed for enactment or enacted by a legislative body.%A%    
% 218.86/219.04  |- mesh__historyNote mesh__D007882 78   
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007882 2003
% 218.86/219.04  |- mesh__recordAuthorizer mesh__D007882 sjn
% 218.86/219.04  |- skos__altLabel mesh__D007882 Hospital Legislation
% 218.86/219.04  |- rdf__type mesh__D007882sskos__Concept
% 218.86/219.04  |- skos__prefLabel mesh__D007882 Legislation, Hospital
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007882 2002
% 218.86/219.04  |- mesh__dateCreated mesh__D007882 1977-05-11
% 218.86/219.04  |- skos__hiddenLabel mesh__D007882 Legislations, Hospital
% 218.86/219.04  |- skos__annotation mesh__D007882
% 218.86/219.04       IM; specify country or state; DF: LEGIS HOSP   
% 218.86/219.04  |- mesh__recordOriginator mesh__D007882 EC
% 218.86/219.04  |- mesh__dateEstablished mesh__D007882 1978-01-01
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007084 1999
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007084 2004
% 218.86/219.04  |- skos__prefLabel mesh__D007084 Iliac Vein
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007084 2000
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007084 1995
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007084 1998
% 218.86/219.04  |- skos__hiddenLabel mesh__D007084 Vein, Iliac
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007084 2003
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007084 2006
% 218.86/219.04  |- skos__scopeNote mesh__D007084
% 218.86/219.04       A vein on either side of the body which is formed by the union of the external and internal iliac veins and passes upward to join with its fellow of the opposite side to form the inferior vena cava.%A%    
% 218.86/219.04  |- mesh__recordOriginator mesh__D007084 NLM
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007084 1994
% 218.86/219.04  |- mesh__dateCreated mesh__D007084 1999-01-01
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007084 2005
% 218.86/219.04  |- rdf__type mesh__D007084sskos__Concept
% 218.86/219.04  |- mesh__recordMaintainer mesh__D007084 TAP
% 218.86/219.04  |- mesh__dateRevised mesh__D007084 1992-05-14
% 218.86/219.04  |- mesh__recordAuthorizer mesh__D007084 PLS
% 218.86/219.04  |- skos__hiddenLabel mesh__D007084 Iliac Veins
% 218.86/219.04  |- skos__broader mesh__D007084smesh__D014680
% 218.86/219.04  |- skos__hiddenLabel mesh__D007084 Veins, Iliac
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007084 2002
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007084 1997
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007084 2001
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007084 1993
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007084 1996
% 218.86/219.04  |- skos__broader mesh__D051545Q000037smesh__D051545
% 218.86/219.04  |- mesh__preferredCombination mesh__D051545Q000037smesh__D016861
% 218.86/219.04  |- rdf__type mesh__D051545Q000037smesh__CompoundConcept
% 218.86/219.04  |- skos__scopeNote mesh__D031981
% 218.86/219.04       A plant genus of the family ROSACEAE that has been used in folk treatment of diabetes. Members contain agrimoniin %28%TANNINS%29%.%A%    
% 218.86/219.04  |- rdf__type mesh__D031981sskos__Concept
% 218.86/219.04  |- mesh__dateCreated mesh__D031981 2002-07-02
% 218.86/219.04  |- skos__altLabel mesh__D031981 Agrimony
% 218.86/219.04  |- skos__annotation mesh__D031981
% 218.86/219.04       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D031981 2004
% 218.86/219.04  |- skos__broader mesh__D031981smesh__D027824
% 218.86/219.04  |- mesh__publicMeSHNote mesh__D031981 2003   
% 218.86/219.04  |- skos__prefLabel mesh__D031981 Agrimonia
% 218.86/219.04  |- mesh__historyNote mesh__D031981 2003   
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D031981 2003
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D031981 2006
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D031981 2005
% 218.86/219.04  |- mesh__dateEstablished mesh__D031981 2003-01-01
% 218.86/219.04  |- skos__scopeNote mesh__D031183
% 218.86/219.04       A plant genus of the family ASTERACEAE. Members contain eudesmane and elemane SESQUITERPENES.%A%    
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D031183 2006
% 218.86/219.04  |- skos__broader mesh__D031183smesh__D019659
% 218.86/219.04  |- skos__prefLabel mesh__D031183 Onopordum
% 218.86/219.04  |- mesh__dateEstablished mesh__D031183 2003-01-01
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D031183 2005
% 218.86/219.04  |- skos__altLabel mesh__D031183 Thistle, Cotton
% 218.86/219.04  |- rdf__type mesh__D031183sskos__Concept
% 218.86/219.04  |- skos__annotation mesh__D031183
% 218.86/219.04       other %27%thistle%27% plants are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.04  |- mesh__historyNote mesh__D031183 2003   
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D031183 2004
% 218.86/219.04  |- mesh__dateCreated mesh__D031183 2002-07-03
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D031183 2003
% 218.86/219.04  |- mesh__publicMeSHNote mesh__D031183 2003   
% 218.86/219.04  |- skos__historyNote mesh__D003492 Methylglycosides %28%1974%29%
% 218.86/219.04  |- skos__altLabel mesh__D003492 Methylazoxymethanol Glucuronate
% 218.86/219.04  |- skos__scopeNote mesh__D003492
% 218.86/219.04       Carcinogenic and neurotoxic glycoside occurring in a number of plant species, including Cycas revoluta.%A%    
% 218.86/219.04  |- rdf__type mesh__D003492sskos__Concept
% 218.86/219.04  |- skos__altLabel mesh__D003492 Methylazoxymethanol beta-D-Glucoside
% 218.86/219.04  |- skos__broader mesh__D003492smesh__D001397
% 218.86/219.04  |- mesh__recordAuthorizer mesh__D003492 sjn
% 218.86/219.04  |- mesh__recordMaintainer mesh__D003492 ssb
% 218.86/219.04  |- mesh__historyNote mesh__D003492
% 218.86/219.04       91%28%75%29%; was see under AZO COMPOUNDS 1975-90   
% 218.86/219.04  |- mesh__recordOriginator mesh__D003492 NLM
% 218.86/219.04  |- mesh__dateEstablished mesh__D003492 1991-01-01
% 218.86/219.04  |- skos__altLabel mesh__D003492
% 218.86/219.04       %28%Methyl-ONN-azoxy%29%methyl beta-D-Glucopyranoside
% 218.86/219.04  |- skos__historyNote mesh__D003492 Azo Compounds %28%1970-1974%29%
% 218.86/219.04  |- skos__prefLabel mesh__D003492 Cycasin
% 218.86/219.04  |- skos__historyNote mesh__D003492 Glucose %28%1970-1974%29%
% 218.86/219.04  |- mesh__publicMeSHNote mesh__D003492
% 218.86/219.04       91; was see under AZO COMPOUNDS 1975-90   
% 218.86/219.04  |- skos__hiddenLabel mesh__D003492 Glucuronate, Methylazoxymethanol
% 218.86/219.04  |- mesh__dateCreated mesh__D003492 1974-11-11
% 218.86/219.04  |- skos__hiddenLabel mesh__D003492 Methylazoxymethanol beta D Glucoside
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D003492 2006
% 218.86/219.04  |- skos__hiddenLabel mesh__D003492 beta-D-Glucoside, Methylazoxymethanol
% 218.86/219.04  |- mesh__dateRevised mesh__D003492 2005-06-30
% 218.86/219.04  |- skos__historyNote mesh__D019907 Mycobacterium %28%1966-1990%29%
% 218.86/219.04  |- skos__historyNote mesh__D019907
% 218.86/219.04       Mycobacterium, Atypical %28%1977-1997%29%
% 218.86/219.04  |- mesh__recordMaintainer mesh__D019907 SYSTEM
% 218.86/219.04  |- mesh__dateRevised mesh__D019907 2005-06-30
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D019907 2006
% 218.86/219.04  |- rdf__type mesh__D019907sskos__Concept
% 218.86/219.04  |- mesh__dateCreated mesh__D019907 1997-06-20
% 218.86/219.04  |- mesh__recordOriginator mesh__D019907 PXP
% 218.86/219.04  |- skos__broader mesh__D019907smesh__D009170
% 218.86/219.04  |- skos__prefLabel mesh__D019907 Mycobacterium fortuitum
% 218.86/219.04  |- skos__scopeNote mesh__D019907
% 218.86/219.04       A rapid-growing, nonphotochromogenic species that is potentially pathogenic, producing lesions of lung, bone, or soft tissue following trauma. It has been found in soil and in injection sites of humans, cattle, and cold-blooded animals. %28%Dorland, 28th ed%29%%A%    
% 218.86/219.04  |- skos__annotation mesh__D019907
% 218.86/219.04       infection: coord IM with MYCOBACTERIUM INFECTIONS, ATYPICAL %28%IM%29%; DF: MYCOBACT FORTUITUM%A%  
% 218.86/219.04  |- mesh__publicMeSHNote mesh__D019907 98   
% 218.86/219.04  |- mesh__historyNote mesh__D019907 98   
% 218.86/219.04  |- mesh__dateEstablished mesh__D019907 1998-01-01
% 218.86/219.04  |- mesh__recordAuthorizer mesh__D019907 sjn
% 218.86/219.04  |- skos__scopeNote mesh__D011924
% 218.86/219.04       Two populations of Zucker rats have been cited in research--the %22%fatty%22% or obese and the lean. The %22%fatty%22% rat %28%Rattus norvegicus%29% appeared as a spontaneous mutant. The obese condition appears to be due to a single recessive gene.%A%    
% 218.86/219.04  |- mesh__publicMeSHNote mesh__D011924
% 218.86/219.04       91; was see under RATS, MUTANT STRAINS 1982-90; was see under RATS 1981%A%  
% 218.86/219.04  |- skos__historyNote mesh__D011924 Rats %28%1966-1980%29%
% 218.86/219.04  |- skos__annotation mesh__D011924
% 218.86/219.04       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag RATS%A%  
% 218.86/219.04  |- mesh__recordOriginator mesh__D011924 EC
% 218.86/219.04  |- mesh__dateRevised mesh__D011924 2005-06-30
% 218.86/219.04  |- rdf__type mesh__D011924sskos__Concept
% 218.86/219.04  |- skos__altLabel mesh__D011924 Zucker Rats
% 218.86/219.04  |- mesh__dateCreated mesh__D011924 1980-05-12
% 218.86/219.04  |- skos__prefLabel mesh__D011924 Rats, Zucker
% 218.86/219.04  |- skos__broader mesh__D011924smesh__D011922
% 218.86/219.04  |- mesh__dateEstablished mesh__D011924 1991-01-01
% 218.86/219.04  |- mesh__recordMaintainer mesh__D011924 ags
% 218.86/219.04  |- mesh__historyNote mesh__D011924
% 218.86/219.04       91%28%81%29%; was see under RATS, MUTANT STRAINS 1982-90; was see under RATS 1981%A%  
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D011924 2006
% 218.86/219.04  |- mesh__recordAuthorizer mesh__D011924 sjn
% 218.86/219.04  |- skos__altLabel mesh__D011126 Polypropylene
% 218.86/219.04  |- skos__broader mesh__D011126smesh__D011090
% 218.86/219.04  |- skos__historyNote mesh__D011126 Polymers %28%1972-1974%29%
% 218.86/219.04  |- mesh__recordAuthorizer mesh__D011126 sjn
% 218.86/219.04  |- skos__annotation mesh__D011126 D25-26 qualif   
% 218.86/219.04  |- skos__altLabel mesh__D011126 Propylene Polymers
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D011126 2005
% 218.86/219.04  |- mesh__recordMaintainer mesh__D011126 jmp
% 218.86/219.04  |- skos__historyNote mesh__D011126 Alkenes %28%1972-1974%29%
% 218.86/219.04  |- skos__altLabel mesh__D011126 Marlex Polypropylene
% 218.86/219.04  |- mesh__recordOriginator mesh__D011126 NLM
% 218.86/219.04  |- mesh__historyNote mesh__D011126
% 218.86/219.04       1991%28%1975%29%; for MARLEX use PLASTIPORE %28%NM%29% 1978-1999   
% 218.86/219.04  |- skos__broader mesh__D011126smesh__D010969
% 218.86/219.04  |- skos__scopeNote mesh__D011126
% 218.86/219.04       Propylene or propene polymers. Thermoplastics that can be extruded into fibers, films or solid forms. They are used as a copolymer in plastics, especially polyethylene. The fibers are used for fabrics, filters and surgical sutures.%A%    
% 218.86/219.04  |- skos__hiddenLabel mesh__D011126 Polymers, Propene
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D011126 2006
% 218.86/219.04  |- mesh__dateCreated mesh__D011126 1974-11-19
% 218.86/219.04  |- skos__hiddenLabel mesh__D011126 Polymers, Propylene
% 218.86/219.04  |- skos__altLabel mesh__D011126 Propene Polymers
% 218.86/219.04  |- rdf__type mesh__D011126sskos__Concept
% 218.86/219.04  |- mesh__dateRevised mesh__D011126 2004-07-07
% 218.86/219.04  |- mesh__publicMeSHNote mesh__D011126
% 218.86/219.04       1991; see PLASTICS 1975-1990; MARLEX was indexed under POLYETHYLENES %26% POLYPROPYLENES 1983-1999 %26% POLYMERS 1978-1982%A%  
% 218.86/219.04  |- skos__prefLabel mesh__D011126 Polypropylenes
% 218.86/219.04  |- mesh__dateEstablished mesh__D011126 1991-01-01
% 218.86/219.04  |- skos__hiddenLabel mesh__D011126 Polypropylene, Marlex
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007883 2004
% 218.86/219.04  |- skos__prefLabel mesh__D007883 Legislation, Medical
% 218.86/219.04  |- mesh__dateCreated mesh__D007883 1999-01-01
% 218.86/219.04  |- skos__broader mesh__D007883smesh__D007878
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007883 2003
% 218.86/219.04  |- skos__altLabel mesh__D007883 Medical Legislation
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007883 2001
% 218.86/219.04  |- mesh__recordOriginator mesh__D007883 NLM
% 218.86/219.04  |- rdf__type mesh__D007883sskos__Concept
% 218.86/219.04  |- mesh__dateRevised mesh__D007883 1999-11-03
% 218.86/219.04  |- mesh__recordMaintainer mesh__D007883 kle
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007883 2000
% 218.86/219.04  |- mesh__recordAuthorizer mesh__D007883 sjn
% 218.86/219.04  |- skos__scopeNote mesh__D007883
% 218.86/219.04       Laws and regulations, pertaining to the field of medicine, proposed for enactment or enacted by a legislative body.%A%    
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007883 2006
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007883 2002
% 218.86/219.04  |- skos__annotation mesh__D007883
% 218.86/219.04       IM; specify country or state; DF: LEGIS MED   
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007883 2005
% 218.86/219.04  |- mesh__dateRevised mesh__D007085 2005-06-30
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D007085 2006
% 218.86/219.04  |- mesh__dateCreated mesh__D007085 1999-01-01
% 218.86/219.04  |- mesh__recordMaintainer mesh__D007085 ags
% 218.86/219.04  |- skos__hiddenLabel mesh__D007085 Iliums
% 218.86/219.04  |- rdf__type mesh__D007085sskos__Concept
% 218.86/219.04  |- mesh__recordOriginator mesh__D007085 NLM
% 218.86/219.04  |- mesh__recordAuthorizer mesh__D007085 sjn
% 218.86/219.04  |- skos__annotation mesh__D007085
% 218.86/219.04       part of the hip; do not confuse with ILEUM, part of the small intestine%A%  
% 218.86/219.04  |- skos__prefLabel mesh__D007085 Ilium
% 218.86/219.04  |- skos__broader mesh__D007085smesh__D010384
% 218.86/219.04  |- rdf__type mesh__D031982sskos__Concept
% 218.86/219.04  |- skos__altLabel mesh__D031982 Lady%27%s Mantle
% 218.86/219.04  |- mesh__dateEstablished mesh__D031982 2003-01-01
% 218.86/219.04  |- skos__annotation mesh__D031982
% 218.86/219.04       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D031982 2004
% 218.86/219.04  |- mesh__publicMeSHNote mesh__D031982 2003   
% 218.86/219.04  |- mesh__dateCreated mesh__D031982 2002-07-02
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D031982 2003
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D031982 2006
% 218.86/219.04  |- skos__prefLabel mesh__D031982 Alchemilla
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D031982 2005
% 218.86/219.04  |- skos__broader mesh__D031982smesh__D027824
% 218.86/219.04  |- mesh__historyNote mesh__D031982 2003   
% 218.86/219.04  |- skos__scopeNote mesh__D031982
% 218.86/219.04       A plant genus of the family ROSACEAE. Members contain esculetin and QUERCETIN.%A%    
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D031184 2006
% 218.86/219.04  |- skos__broader mesh__D031184smesh__D019659
% 218.86/219.04  |- mesh__dateCreated mesh__D031184 2002-07-03
% 218.86/219.04  |- skos__scopeNote mesh__D031184
% 218.86/219.04       A plant genus of the family ASTERACEAE.  Sesquiterpene lactone glucosides %28%SESQUITERPENES%29% have been found in it.%A%    
% 218.86/219.04  |- skos__prefLabel mesh__D031184 Sonchus
% 218.86/219.04  |- mesh__dateEstablished mesh__D031184 2003-01-01
% 218.86/219.04  |- rdf__type mesh__D031184sskos__Concept
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D031184 2003
% 218.86/219.04  |- skos__annotation mesh__D031184
% 218.86/219.04       other %27%thistle%27% plants are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D031184 2004
% 218.86/219.04  |- skos__altLabel mesh__D031184 Thistle, Field Milk
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D031184 2005
% 218.86/219.04  |- mesh__historyNote mesh__D031184 2003   
% 218.86/219.04  |- skos__altLabel mesh__D031184 Thistle, Sow
% 218.86/219.04  |- mesh__publicMeSHNote mesh__D031184 2003   
% 218.86/219.04  |- rdf__type mesh__D003493sskos__Concept
% 218.86/219.04  |- mesh__historyNote mesh__D003493
% 218.86/219.04       91%28%75%29%; was see under PENICILLINS 1975-90   
% 218.86/219.04  |- mesh__dateCreated mesh__D003493 1974-11-19
% 218.86/219.04  |- mesh__dateEstablished mesh__D003493 1991-01-01
% 218.86/219.04  |- skos__hiddenLabel mesh__D003493 Wy4508
% 218.86/219.04  |- mesh__publicMeSHNote mesh__D003493
% 218.86/219.04       91; was see under PENICILLINS 1975-90   
% 218.86/219.04  |- skos__altLabel mesh__D003493 Ciclacillin
% 218.86/219.04  |- mesh__recordAuthorizer mesh__D003493 sjn
% 218.86/219.04  |- mesh__recordMaintainer mesh__D003493 ssb
% 218.86/219.04  |- skos__historyNote mesh__D003493 Cyclohexylamines %28%1972-1974%29%
% 218.86/219.04  |- mesh__recordOriginator mesh__D003493 NLM
% 218.86/219.04  |- skos__altLabel mesh__D003493 Aminocyclohexylpenicillin
% 218.86/219.04  |- skos__hiddenLabel mesh__D003493 Wy 4508
% 218.86/219.04  |- mesh__dateRevised mesh__D003493 2004-07-07
% 218.86/219.04  |- skos__historyNote mesh__D003493 Penicillins %28%1972-1974%29%
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D003493 2006
% 218.86/219.04  |- skos__broader mesh__D003493smesh__D010406
% 218.86/219.04  |- skos__prefLabel mesh__D003493 Cyclacillin
% 218.86/219.04  |- skos__scopeNote mesh__D003493
% 218.86/219.04       A cyclohexylamido analog of PENICILLANIC ACID.     
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D003493 2005
% 218.86/219.04  |- skos__altLabel mesh__D019908 c-raf Proteins
% 218.86/219.04  |- skos__hiddenLabel mesh__D019908 Kinases, c-raf
% 218.86/219.04  |- skos__altLabel mesh__D019908 cRaf1 Kinase
% 218.86/219.04  |- mesh__recordOriginator mesh__D019908 KEV
% 218.86/219.04  |- mesh__dateEstablished mesh__D019908 1998-01-01
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D019908 2006
% 218.86/219.04  |- skos__related mesh__D019908smesh__D027384
% 218.86/219.04  |- rdf__type mesh__D019908sskos__Concept
% 218.86/219.04  |- mesh__recordAuthorizer mesh__D019908 sjn
% 218.86/219.04  |- skos__hiddenLabel mesh__D019908 Kinase Raf 1
% 218.86/219.04  |- skos__broader mesh__D019908smesh__D048490
% 218.86/219.04  |- skos__hiddenLabel mesh__D019908 Protein c-raf, Proto-Oncogene
% 218.86/219.04  |- skos__prefLabel mesh__D019908 Proto-Oncogene Proteins c-raf
% 218.86/219.04  |- skos__hiddenLabel mesh__D019908 c raf Proteins
% 218.86/219.04  |- mesh__publicMeSHNote mesh__D019908
% 218.86/219.04       1998; PROTO-ONCOGENE PROTEIN MIL %28%now PROTO-ONCOGENE PROTEINS C-RAF%29% was indexed under PROTEIN-SERINE-THEONINE KINASES 1993-1997 %26% PROTO-ONCOGENE PROTEINS 1986-1997; CRAF1 KINASE was indexed under PROTO-ONCOGENE PROTEINS C-RAF 1993-2004%A%  
% 218.86/219.04  |- skos__altLabel mesh__D019908 c-raf Kinases
% 218.86/219.04  |- skos__hiddenLabel mesh__D019908 Kinase, raf-1
% 218.86/219.04  |- skos__altLabel mesh__D019908 raf-1 Kinase
% 218.86/219.04  |- skos__hiddenLabel mesh__D019908 Proteins c-raf, Proto-Oncogene
% 218.86/219.04  |- skos__scopeNote mesh__D019908
% 218.86/219.04       A ubiquitously expressed raf kinase subclass that plays an important role in SIGNAL TRANSDUCTION.  The c-raf Kinases are MAP kinase kinase kinases that have specificity for MAP KINASE KINASE 1 and MAP KINASE KINASE 2.%A%    
% 218.86/219.04  |- skos__hiddenLabel mesh__D019908 c-raf, Proto-Oncogene Protein
% 218.86/219.04  |- skos__hiddenLabel mesh__D019908 Raf-1, Kinase
% 218.86/219.04  |- skos__hiddenLabel mesh__D019908 Proto Oncogene Protein c raf
% 218.86/219.04  |- mesh__dateRevised mesh__D019908 2005-06-30
% 218.86/219.04  |- skos__altLabel mesh__D019908 Kinase Raf-1
% 218.86/219.04  |- skos__hiddenLabel mesh__D019908 raf 1 Kinase
% 218.86/219.04  |- mesh__dateCreated mesh__D019908 1997-06-20
% 218.86/219.04  |- skos__altLabel mesh__D019908 Proto-Oncogene Protein c-raf
% 218.86/219.04  |- mesh__historyNote mesh__D019908 1998 %28%1986%29%   
% 218.86/219.04  |- skos__hiddenLabel mesh__D019908 Proteins, c-raf
% 218.86/219.04  |- skos__hiddenLabel mesh__D019908 c raf Kinases
% 218.86/219.04  |- mesh__recordMaintainer mesh__D019908 DRC
% 218.86/219.04  |- skos__hiddenLabel mesh__D019908 Proto Oncogene Proteins c raf
% 218.86/219.04  |- skos__hiddenLabel mesh__D019908 Kinase, cRaf1
% 218.86/219.04  |- skos__historyNote mesh__D019908
% 218.86/219.04       Proto-Oncogene Proteins %28%1986-1997%29%
% 218.86/219.04  |- skos__hiddenLabel mesh__D019908 c-raf, Proto-Oncogene Proteins
% 218.86/219.04  |- skos__altLabel mesh__D019908 Kinase p74%28%raf-1%29%
% 218.86/219.04  |- skos__historyNote mesh__D019908
% 218.86/219.04       Protein-Serine-Threonine Kinases %28%1993-1997%29%
% 218.86/219.04  |- skos__broader mesh__D011925smesh__D009052
% 218.86/219.04  |- mesh__dateRevised mesh__D011925 2002-07-03
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D011925 2003
% 218.86/219.04  |- skos__hiddenLabel mesh__D011925 Virus, Rauscher
% 218.86/219.04  |- mesh__recordOriginator mesh__D011925 NLM
% 218.86/219.04  |- skos__prefLabel mesh__D011925 Rauscher Virus
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D011925 2005
% 218.86/219.04  |- mesh__activeMeSHYear mesh__D011925 2004
% 218.86/219.04  |- mesh__historyNote mesh__D011925 66   
% 218.86/219.04  |- mesh__recordAuthorizer mesh__D011925 sjn
% 218.86/219.04  |- mesh__dateEstablished mesh__D011925 1966-01-01
% 218.86/219.05  |- mesh__recordMaintainer mesh__D011925 ags
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D011925 2006
% 218.86/219.05  |- skos__annotation mesh__D011925
% 218.86/219.05       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% + LEUKEMIA, EXPERIMENTAL %28%IM%29% or LEUKEMIA %28%IM%29% %28%for spontaneous leukemia%29%%A%  
% 218.86/219.05  |- mesh__dateCreated mesh__D011925 1999-01-01
% 218.86/219.05  |- skos__scopeNote mesh__D011925
% 218.86/219.05       A strain of Murine leukemia virus %28%LEUKEMIA VIRUS, MURINE%29% associated with mouse tumors similar to those caused by the FRIEND MURINE LEUKEMIA VIRUS.%A%    
% 218.86/219.05  |- mesh__publicMeSHNote mesh__D011925 66   
% 218.86/219.05  |- rdf__type mesh__D011925sskos__Concept
% 218.86/219.05  |- skos__scopeNote mesh__D011127
% 218.86/219.05       Discrete abnormal tissue masses that protrude into the lumen of the DIGESTIVE TRACT or the RESPIRATORY TRACT. Polyps can be spheroidal, hemispheroidal, or irregular mound-shaped structures attached to the MUCOUS MEMBRANE of the lumen wall either by a stalk, pedunculus, or by a broad base.%A%    
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D011127 2004
% 218.86/219.05  |- mesh__dateEstablished mesh__D011127 1965-01-01
% 218.86/219.05  |- mesh__dateRevised mesh__D011127 2003-07-09
% 218.86/219.05  |- skos__annotation mesh__D011127
% 218.86/219.05       if neoplastic, coord IM with  precoord organ/neopl term %28%IM%29%, otherwise coord with  precoord organ/dis term %28%IM%29%; COLONIC POLYPS; INTESTINAL POLYPS %26% NASAL POLYPS are also available%A%  
% 218.86/219.05  |- skos__broader mesh__D011127smesh__D020763
% 218.86/219.05  |- mesh__dateCreated mesh__D011127 1999-01-01
% 218.86/219.05  |- mesh__recordAuthorizer mesh__D011127 sjn
% 218.86/219.05  |- mesh__recordMaintainer mesh__D011127 lkt
% 218.86/219.05  |- mesh__publicMeSHNote mesh__D011127 65; was POLYPI 1963-64   
% 218.86/219.05  |- skos__hiddenLabel mesh__D011127 Polyp
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D011127 2006
% 218.86/219.05  |- mesh__recordOriginator mesh__D011127 NLM
% 218.86/219.05  |- rdf__type mesh__D011127sskos__Concept
% 218.86/219.05  |- mesh__historyNote mesh__D011127 65; was POLYPI 1963-64   
% 218.86/219.05  |- skos__prefLabel mesh__D011127 Polyps
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D011127 2005
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D016610 2004
% 218.86/219.05  |- mesh__dateEstablished mesh__D016610 1992-01-01
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D016610 2006
% 218.86/219.05  |- skos__prefLabel mesh__D016610 Tissue Embedding
% 218.86/219.05  |- mesh__dateCreated mesh__D016610 1991-01-25
% 218.86/219.05  |- skos__broader mesh__D016610smesh__D016591
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D016610 2001
% 218.86/219.05  |- skos__scopeNote mesh__D016610
% 218.86/219.05       The technique of placing cells or tissue in a supporting medium so that thin sections can be cut using a microtome. The medium can be paraffin wax %28%PARAFFIN EMBEDDING%29% or plastics %28%PLASTIC EMBEDDING%29% such as epoxy resins.%A%    
% 218.86/219.05  |- mesh__recordAuthorizer mesh__D016610 sjn
% 218.86/219.05  |- skos__hiddenLabel mesh__D016610 Embedding, Tissue
% 218.86/219.05  |- mesh__dateRevised mesh__D016610 2000-06-22
% 218.86/219.05  |- mesh__recordMaintainer mesh__D016610 TAP
% 218.86/219.05  |- mesh__publicMeSHNote mesh__D016610 92   
% 218.86/219.05  |- rdf__type mesh__D016610sskos__Concept
% 218.86/219.05  |- skos__annotation mesh__D016610
% 218.86/219.05       embedding of cells or tissue in a supporting medium   
% 218.86/219.05  |- mesh__historyNote mesh__D016610 92   
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D016610 2002
% 218.86/219.05  |- mesh__recordOriginator mesh__D016610 MXR
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D016610 2003
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D016610 2005
% 218.86/219.05  |- rdf__type mesh__D007884sskos__Concept
% 218.86/219.05  |- skos__hiddenLabel mesh__D007884 Nursing Legislations
% 218.86/219.05  |- mesh__recordAuthorizer mesh__D007884 sjn
% 218.86/219.05  |- skos__hiddenLabel mesh__D007884 Legislations, Nursing
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007884 2002
% 218.86/219.05  |- mesh__dateEstablished mesh__D007884 1966-01-01
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007884 2006
% 218.86/219.05  |- skos__altLabel mesh__D007884 Nursing Legislation
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007884 2005
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007884 2004
% 218.86/219.05  |- mesh__dateRevised mesh__D007884 1999-11-03
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007884 2001
% 218.86/219.05  |- mesh__recordOriginator mesh__D007884 NLM
% 218.86/219.05  |- skos__annotation mesh__D007884
% 218.86/219.05       IM; specify country or state; DF: LEGIS NURS   
% 218.86/219.05  |- mesh__dateCreated mesh__D007884 1999-01-01
% 218.86/219.05  |- skos__broader mesh__D007884smesh__D007878
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007884 2003
% 218.86/219.05  |- skos__scopeNote mesh__D007884
% 218.86/219.05       Laws and regulations, pertaining to the field of nursing, proposed for enactment by a legislative body.%A%    
% 218.86/219.05  |- mesh__recordMaintainer mesh__D007884 kle
% 218.86/219.05  |- mesh__historyNote mesh__D007884 66   
% 218.86/219.05  |- mesh__publicMeSHNote mesh__D007884 66   
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007884 2000
% 218.86/219.05  |- skos__prefLabel mesh__D007884 Legislation, Nursing
% 218.86/219.05  |- skos__altLabel mesh__D043209 11beta-HSD2 Reductase
% 218.86/219.05  |- mesh__recordOriginator mesh__D043209 AKE
% 218.86/219.05  |- skos__altLabel mesh__D043209 11beta-Hydroxysteroid Dehydrogenase Type 2
% 218.86/219.05  |- skos__altLabel mesh__D043209 11beta-HSD2
% 218.86/219.05  |- mesh__recordMaintainer mesh__D043209 jls
% 218.86/219.05  |- rdf__type mesh__D043209sskos__Concept
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D043209 2006
% 218.86/219.05  |- mesh__historyNote mesh__D043209
% 218.86/219.05       2004; for 11 BETA-HSD2 use 11 BETA-HYDROXYSTEROID DEHYDROGENASES %28%NM%29% 1992-2003%A%  
% 218.86/219.05  |- skos__historyNote mesh__D043209
% 218.86/219.05       Hydroxysteroid Dehydrogenases %28%1992-2003%29%
% 218.86/219.05  |- skos__scopeNote mesh__D043209
% 218.86/219.05       An high-affinity, NAD-dependent 11-beta-hydroxysteroid dehydrogenase that acts unidirectionally to catalyze the dehydrogenation of CORTISOL to CORTISONE. It is found predominantly in mineralocorticoid target tissues such as the KIDNEY; COLON; SWEAT GLANDS; and the PLACENTA. Absence of the enzyme leads to a fatal form of childhood hypertension termed, APPARENT MINERALOCORTICOID EXCESS SYNDROME.%A%    
% 218.86/219.05  |- skos__altLabel mesh__D043209 11 beta-Hydroxysteroid Dehydrogenase Type 2
% 218.86/219.05  |- mesh__dateRevised mesh__D043209 2004-07-19
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D043209 2005
% 218.86/219.05  |- mesh__dateCreated mesh__D043209 2003-07-09
% 218.86/219.05  |- mesh__recordAuthorizer mesh__D043209 sjn
% 218.86/219.05  |- skos__broader mesh__D043209smesh__D042842
% 218.86/219.05  |- skos__hiddenLabel mesh__D043209
% 218.86/219.05       11beta Hydroxysteroid Dehydrogenase Type 2
% 218.86/219.05  |- skos__hiddenLabel mesh__D043209
% 218.86/219.05       11 beta Hydroxysteroid Dehydrogenase Type 2
% 218.86/219.05  |- skos__altLabel mesh__D043209 11 beta-HSD2
% 218.86/219.05  |- skos__prefLabel mesh__D043209
% 218.86/219.05       11-beta-Hydroxysteroid Dehydrogenase Type 2
% 218.86/219.05  |- mesh__dateEstablished mesh__D043209 2004-01-01
% 218.86/219.05  |- mesh__publicMeSHNote mesh__D043209
% 218.86/219.05       2004; 11 BETA-HSD2 was indexed under HYDROXYSTEROID DEHYDROGENASES 1992-2003%A%  
% 218.86/219.05  |- skos__hiddenLabel mesh__D007086 Unmarried Father
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007086 2002
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007086 2006
% 218.86/219.05  |- skos__hiddenLabel mesh__D007086 Fathers, Unmarried
% 218.86/219.05  |- skos__broader mesh__D007086smesh__D005190
% 218.86/219.05  |- skos__hiddenLabel mesh__D007086 Premarital Pregnancies
% 218.86/219.05  |- skos__hiddenLabel mesh__D007086 Pregnancies, Premarital
% 218.86/219.05  |- skos__broader mesh__D007086smesh__D012940
% 218.86/219.05  |- rdf__type mesh__D007086sskos__Concept
% 218.86/219.05  |- mesh__recordMaintainer mesh__D007086 PLS
% 218.86/219.05  |- skos__hiddenLabel mesh__D007086 Mothers, Unmarried
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007086 2000
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007086 1996
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007086 2001
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007086 1998
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007086 1997
% 218.86/219.05  |- skos__scopeNote mesh__D007086
% 218.86/219.05       The state of birth outside of wedlock. It may refer to the offspring or the parents.%A%    
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007086 2003
% 218.86/219.05  |- skos__hiddenLabel mesh__D007086 Mother, Unmarried
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007086 1994
% 218.86/219.05  |- mesh__dateCreated mesh__D007086 1999-01-01
% 218.86/219.05  |- skos__annotation mesh__D007086
% 218.86/219.05       the child or the unwed parents; if with ref to parents, coord IM with PARENTS %28%IM%29%%A%  
% 218.86/219.05  |- skos__hiddenLabel mesh__D007086 Father, Unmarried
% 218.86/219.05  |- skos__hiddenLabel mesh__D007086 Unmarried Mother
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007086 1999
% 218.86/219.05  |- skos__prefLabel mesh__D007086 Illegitimacy
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007086 2005
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007086 2004
% 218.86/219.05  |- mesh__recordAuthorizer mesh__D007086 PLS
% 218.86/219.05  |- mesh__recordOriginator mesh__D007086 NLM
% 218.86/219.05  |- mesh__dateRevised mesh__D007086 1993-12-01
% 218.86/219.05  |- skos__altLabel mesh__D007086 Pregnancy, Premarital
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007086 1995
% 218.86/219.05  |- mesh__publicMeSHNote mesh__D015518 90   
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D015518 2006
% 218.86/219.05  |- skos__altLabel mesh__D015518 Rett%27%s Syndrome
% 218.86/219.05  |- skos__historyNote mesh__D015518 Mental Retardation %28%1983-1989%29%
% 218.86/219.05  |- skos__hiddenLabel mesh__D015518 Hyperammonemias, Cerebroatrophic
% 218.86/219.05  |- mesh__recordMaintainer mesh__D015518 lkt
% 218.86/219.05  |- skos__altLabel mesh__D015518 Rett Disorder
% 218.86/219.05  |- skos__hiddenLabel mesh__D015518 Syndrome, Rett%27%s
% 218.86/219.05  |- mesh__dateEstablished mesh__D015518 1990-01-01
% 218.86/219.05  |- skos__hiddenLabel mesh__D015518 Hyperammonemia, Cerebroatrophic
% 218.86/219.05  |- rdf__type mesh__D015518sskos__Concept
% 218.86/219.05  |- skos__altLabel mesh__D015518
% 218.86/219.05       Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome
% 218.86/219.05  |- mesh__recordOriginator mesh__D015518 PXP
% 218.86/219.05  |- skos__hiddenLabel mesh__D015518 Cerebroatrophic Hyperammonemias
% 218.86/219.05  |- skos__altLabel mesh__D015518 Rett%27%s Disorder
% 218.86/219.05  |- mesh__dateCreated mesh__D015518 1989-04-07
% 218.86/219.05  |- mesh__recordAuthorizer mesh__D015518 sjn
% 218.86/219.05  |- skos__hiddenLabel mesh__D015518 Retts Syndrome
% 218.86/219.05  |- mesh__historyNote mesh__D015518 90   
% 218.86/219.05  |- skos__broader mesh__D015518smesh__D038901
% 218.86/219.05  |- skos__related mesh__D015518smesh__D008607
% 218.86/219.05  |- skos__hiddenLabel mesh__D015518 Syndrome, Rett
% 218.86/219.05  |- skos__altLabel mesh__D015518 Cerebroatrophic Hyperammonemia
% 218.86/219.05  |- skos__historyNote mesh__D015518 Movement Disorders %28%1986-1989%29%
% 218.86/219.05  |- skos__prefLabel mesh__D015518 Rett Syndrome
% 218.86/219.05  |- skos__broader mesh__D015518smesh__D020271
% 218.86/219.05  |- skos__scopeNote mesh__D015518
% 218.86/219.05       An inherited neurological developmental disorder that is associated with X-LINKED INHERITANCE and may be lethal in utero to hemizygous males. The affected female is normal until the age of 6-25 months when progressive loss of voluntary control of hand movements and communication skills; ATAXIA; SEIZURES; autistic behavior; intermittent HYPERVENTILATION; and HYPERAMMONEMIA appear. %28%From Menkes, Textbook of Child Neurology, 5th ed, p199%29%%A%    
% 218.86/219.05  |- skos__hiddenLabel mesh__D015518
% 218.86/219.05       Autism Dementia Ataxia Loss of Purposeful Hand Use Syndrome
% 218.86/219.05  |- skos__broader mesh__D015518smesh__D002659
% 218.86/219.05  |- mesh__dateRevised mesh__D015518 2005-06-30
% 218.86/219.05  |- skos__hiddenLabel mesh__D012220 Rhinitides
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D012220 2005
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D012220 2000
% 218.86/219.05  |- mesh__recordOriginator mesh__D012220 NLM
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D012220 1998
% 218.86/219.05  |- skos__annotation mesh__D012220
% 218.86/219.05       inflamm of nasal mucosa; GEN or unspecified; prefer specifics%A%  
% 218.86/219.05  |- rdf__type mesh__D012220sskos__Concept
% 218.86/219.05  |- skos__broader mesh__D012220smesh__D009668
% 218.86/219.05  |- skos__prefLabel mesh__D012220 Rhinitis
% 218.86/219.05  |- mesh__dateRevised mesh__D012220 1996-06-10
% 218.86/219.05  |- mesh__dateCreated mesh__D012220 1999-01-01
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D012220 2002
% 218.86/219.05  |- skos__scopeNote mesh__D012220
% 218.86/219.05       Inflammation of the mucous membrane of the nose.     
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D012220 2004
% 218.86/219.05  |- skos__broader mesh__D012220smesh__D012141
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D012220 1997
% 218.86/219.05  |- mesh__recordMaintainer mesh__D012220 TGC
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D012220 2003
% 218.86/219.05  |- mesh__recordAuthorizer mesh__D012220 PLS
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D012220 2001
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D012220 2006
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D012220 1999
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D031983 2004
% 218.86/219.05  |- mesh__publicMeSHNote mesh__D031983 2003   
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D031983 2003
% 218.86/219.05  |- skos__broader mesh__D031983smesh__D027824
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D031983 2006
% 218.86/219.05  |- skos__altLabel mesh__D031983 Loquat Tree
% 218.86/219.05  |- mesh__historyNote mesh__D031983 2003   
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D031983 2005
% 218.86/219.05  |- mesh__dateCreated mesh__D031983 2002-07-03
% 218.86/219.05  |- mesh__dateEstablished mesh__D031983 2003-01-01
% 218.86/219.05  |- rdf__type mesh__D031983sskos__Concept
% 218.86/219.05  |- skos__annotation mesh__D031983
% 218.86/219.05       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.05  |- skos__scopeNote mesh__D031983
% 218.86/219.05       A plant genus of the family ROSACEAE that is the source of an edible fruit. Members contain TRITERPENES.%A%    
% 218.86/219.05  |- skos__prefLabel mesh__D031983 Eriobotrya
% 218.86/219.05  |- mesh__recordOriginator mesh__D031185 ssb
% 218.86/219.05  |- mesh__historyNote mesh__D031185 2003   
% 218.86/219.05  |- skos__altLabel mesh__D031185 Thistle, Golden
% 218.86/219.05  |- mesh__recordAuthorizer mesh__D031185 ags
% 218.86/219.05  |- rdf__type mesh__D031185sskos__Concept
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D031185 2003
% 218.86/219.05  |- mesh__dateCreated mesh__D031185 2002-07-03
% 218.86/219.05  |- skos__annotation mesh__D031185
% 218.86/219.05       other %27%thistle%27% plants are also available; do not confuse with CYNARA SCOLYMUS; Common Salsify see TRAGOPOGON is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D031185 2004
% 218.86/219.05  |- mesh__dateRevised mesh__D031185 2005-07-12
% 218.86/219.05  |- mesh__dateEstablished mesh__D031185 2003-01-01
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D031185 2005
% 218.86/219.05  |- skos__scopeNote mesh__D031185
% 218.86/219.05       A plant genus of the family ASTERACEAE with a name that is similar to CYNARA SCOLYMUS. Members contain taraxasteryl acetate.%A%    
% 218.86/219.05  |- skos__prefLabel mesh__D031185 Scolymus
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D031185 2006A
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D031185 2006
% 218.86/219.05  |- mesh__publicMeSHNote mesh__D031185 2003   
% 218.86/219.05  |- skos__altLabel mesh__D031185 Salsify, Spanish
% 218.86/219.05  |- mesh__recordMaintainer mesh__D031185 ags
% 218.86/219.05  |- skos__broader mesh__D031185smesh__D019659
% 218.86/219.05  |- skos__altLabel mesh__D031185 Goldenthistle
% 218.86/219.05  |- mesh__recordAuthorizer mesh__D003494 sjn
% 218.86/219.05  |- mesh__recordOriginator mesh__D003494 NLM
% 218.86/219.05  |- mesh__publicMeSHNote mesh__D003494
% 218.86/219.05       71; was CYCLAMATE see under SWEETENING AGENTS 1963-70; CYCLAMIC ACID was indexed under CYCLAMATES 1982-95%A%  
% 218.86/219.05  |- rdf__type mesh__D003494sskos__Concept
% 218.86/219.05  |- mesh__dateCreated mesh__D003494 1999-01-01
% 218.86/219.05  |- skos__hiddenLabel mesh__D003494 Cyclamate, Calcium
% 218.86/219.05  |- mesh__dateRevised mesh__D003494 2004-07-07
% 218.86/219.05  |- skos__hiddenLabel mesh__D003494 Cyclamate, Sodium
% 218.86/219.05  |- skos__prefLabel mesh__D003494 Cyclamates
% 218.86/219.05  |- mesh__onlineNote mesh__D003494 search SWEETENING AGENTS 1966-69   
% 218.86/219.05  |- mesh__dateEstablished mesh__D003494 1971-01-01
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D003494 2005
% 218.86/219.05  |- mesh__historyNote mesh__D003494
% 218.86/219.05       71%28%70%29%; was CYCLAMATE see under SWEETENING AGENTS 1963-70; was in Cat D %26% J 1973-82, was in Cat D only 1963-72; CYCLAMIC ACID was %28%NM%29% 1982-95%A%  
% 218.86/219.05  |- skos__hiddenLabel mesh__D003494 Cyclamate, Potassium
% 218.86/219.05  |- skos__scopeNote mesh__D003494 Salts and esters of cyclamic acid.     
% 218.86/219.05  |- skos__broader mesh__D003494smesh__D003510
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D003494 2006
% 218.86/219.05  |- mesh__recordMaintainer mesh__D003494 ssb
% 218.86/219.05  |- skos__altLabel mesh__D003494 Cyclamate Calcium %28%2:1%29% Salt
% 218.86/219.05  |- skos__historyNote mesh__D003494 Sweetening Agents %28%1966-1969%29%
% 218.86/219.05  |- skos__altLabel mesh__D003494 Cyclamate, Sodium Salt
% 218.86/219.05  |- skos__altLabel mesh__D003494 Cyclamate
% 218.86/219.05  |- mesh__dateCreated mesh__D019909 1997-06-20
% 218.86/219.05  |- mesh__recordOriginator mesh__D019909 PXP
% 218.86/219.05  |- skos__annotation mesh__D019909
% 218.86/219.05       infection: coord IM with MYCOBACTERIUM INFECTIONS, ATYPICAL %28%IM%29%; DF: MYCOBACT KANSASII%A%  
% 218.86/219.05  |- mesh__historyNote mesh__D019909 98   
% 218.86/219.05  |- skos__broader mesh__D019909smesh__D009170
% 218.86/219.05  |- mesh__dateEstablished mesh__D019909 1998-01-01
% 218.86/219.05  |- mesh__publicMeSHNote mesh__D019909 98   
% 218.86/219.05  |- skos__prefLabel mesh__D019909 Mycobacterium kansasii
% 218.86/219.05  |- mesh__recordAuthorizer mesh__D019909 sjn
% 218.86/219.05  |- skos__scopeNote mesh__D019909
% 218.86/219.05       A slow-growing, photochromogenic species that is the etiologic agent of a tuberculosis-like disease in humans and is frequently isolated from human pulmonary secretions or tubercles. The incidence of infection is sharply increased among immunocompromised individuals. %28%Dorland, 28th ed%29%%A%    
% 218.86/219.05  |- skos__historyNote mesh__D019909 Mycobacterium %28%1966-1990%29%
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D019909 2006
% 218.86/219.05  |- skos__historyNote mesh__D019909
% 218.86/219.05       Mycobacterium, Atypical %28%1977-1997%29%
% 218.86/219.05  |- rdf__type mesh__D019909sskos__Concept
% 218.86/219.05  |- mesh__recordMaintainer mesh__D019909 SYSTEM
% 218.86/219.05  |- mesh__dateRevised mesh__D019909 2005-06-30
% 218.86/219.05  |- mesh__recordMaintainer mesh__D011926 ssb
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D011926 2005
% 218.86/219.05  |- skos__altLabel mesh__D011926 Rauvolfia
% 218.86/219.05  |- mesh__dateRevised mesh__D011926 2004-07-07
% 218.86/219.05  |- mesh__historyNote mesh__D011926 was in Cat B %26% D 1963-77   
% 218.86/219.05  |- skos__broader mesh__D011926smesh__D029062
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D011926 2006
% 218.86/219.05  |- mesh__recordOriginator mesh__D011926 NLM
% 218.86/219.05  |- mesh__dateCreated mesh__D011926 1999-01-01
% 218.86/219.05  |- mesh__recordAuthorizer mesh__D011926 sjn
% 218.86/219.05  |- skos__altLabel mesh__D011926 Rauvolfia serpentina
% 218.86/219.05  |- skos__prefLabel mesh__D011926 Rauwolfia
% 218.86/219.05  |- skos__annotation mesh__D011926
% 218.86/219.05       plant only; deriv alkaloids = RAUWOLFIA ALKALOIDS or specifics; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.05  |- skos__related mesh__D011926smesh__D046948
% 218.86/219.05  |- rdf__type mesh__D011926sskos__Concept
% 218.86/219.05  |- skos__scopeNote mesh__D011926
% 218.86/219.05       A plant genus of the APOCYNACEAE or dogbane family. Alkaloids from plants in this genus have been used as tranquilizers and antihypertensive agents. RESERPINE is derived from R. serpentina.%A%    
% 218.86/219.05  |- rdf__type mesh__D044302sskos__Concept
% 218.86/219.05  |- skos__altLabel mesh__D044302 Serotonin 1D Beta Receptor
% 218.86/219.05  |- skos__altLabel mesh__D044302 Serotonin 1Dbeta Receptor
% 218.86/219.05  |- mesh__recordAuthorizer mesh__D044302 sjn
% 218.86/219.05  |- skos__hiddenLabel mesh__D044302 Receptor, 5 Hydroxytryptamine 1B
% 218.86/219.05  |- skos__altLabel mesh__D044302 5-HT1B Receptor
% 218.86/219.05  |- skos__hiddenLabel mesh__D044302 Receptor, 5-HT1B
% 218.86/219.05  |- skos__altLabel mesh__D044302 5-HT1Dbeta Receptor
% 218.86/219.05  |- skos__broader mesh__D044302smesh__D044263
% 218.86/219.05  |- skos__hiddenLabel mesh__D044302 5 HT1Dbeta Receptor
% 218.86/219.05  |- skos__altLabel mesh__D044302 5-HT%28%1Dbeta%29% Receptor
% 218.86/219.05  |- skos__altLabel mesh__D044302 Receptor, Serotonin Type 1Dbeta
% 218.86/219.05  |- skos__hiddenLabel mesh__D044302 1B Receptors, 5-Hydroxytryptamine
% 218.86/219.05  |- skos__hiddenLabel mesh__D044302 Receptors, 5-Hydroxytryptamine 1B
% 218.86/219.05  |- skos__altLabel mesh__D044302 5-HT%28%1B%29% Receptor
% 218.86/219.05  |- mesh__publicMeSHNote mesh__D044302
% 218.86/219.05       2004; SEROTONIN 1B RECEPTOR %28%now RECEPTOR, SEROTONIN, 5-HT1B%29% was indexed under RECEPTORS, SEROTONIN 1993-2003; SEROTONIN 1D BETA RECEPTOR %28%now RECEPTOR, SEROTONIN, 5-HT1B%29% was indexed under RECEPTORS, SEROTONIN 1995-2003%A%  
% 218.86/219.05  |- skos__altLabel mesh__D044302 Receptor, 5-Hydroxytryptamine 1B
% 218.86/219.05  |- skos__hiddenLabel mesh__D044302 Receptor, 5-HT1Dbeta
% 218.86/219.05  |- skos__prefLabel mesh__D044302 Receptor, Serotonin, 5-HT1B
% 218.86/219.05  |- skos__hiddenLabel mesh__D044302 1B Receptor, Serotonin
% 218.86/219.05  |- skos__hiddenLabel mesh__D044302 5 HT1B Receptor
% 218.86/219.05  |- skos__historyNote mesh__D044302 Receptors, Serotonin %28%1993-2003%29%
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D044302 2006
% 218.86/219.05  |- mesh__dateCreated mesh__D044302 2003-07-09
% 218.86/219.05  |- skos__hiddenLabel mesh__D044302 1B Receptor, 5-Hydroxytryptamine
% 218.86/219.05  |- mesh__dateEstablished mesh__D044302 2004-01-01
% 218.86/219.05  |- mesh__recordOriginator mesh__D044302 jmp
% 218.86/219.05  |- skos__altLabel mesh__D044302 Serotonin 1Dbeta Receptors
% 218.86/219.05  |- skos__hiddenLabel mesh__D044302 1Dbeta Receptors, Serotonin
% 218.86/219.05  |- skos__hiddenLabel mesh__D044302 Receptors, Serotonin 1Dbeta
% 218.86/219.05  |- mesh__dateRevised mesh__D044302 2005-06-30
% 218.86/219.05  |- skos__hiddenLabel mesh__D044302 Receptor, Serotonin 1B
% 218.86/219.05  |- skos__scopeNote mesh__D044302
% 218.86/219.05       A serotonin receptor subtype found at high levels in the BASAL GANGLIA and the frontal cortex. It plays a role as a terminal autoreceptor that regulates the rate of SEROTONIN release from nerve endings. This serotonin receptor subtype is closely related to and has similar drug binding properties as the 5-HT1D RECEPTOR. It is particularly sensitive to the agonist SUMATRIPTAN and may be involved in mediating the drug%27%s antimigraine effect.%A%    
% 218.86/219.05  |- skos__altLabel mesh__D044302 5-Hydroxytryptamine 1B Receptor
% 218.86/219.05  |- skos__hiddenLabel mesh__D044302 5 Hydroxytryptamine 1B Receptor
% 218.86/219.05  |- skos__altLabel mesh__D044302 5-Hydroxytryptamine 1B Receptors
% 218.86/219.05  |- skos__hiddenLabel mesh__D044302 5 Hydroxytryptamine 1B Receptors
% 218.86/219.05  |- mesh__recordMaintainer mesh__D044302 jmp
% 218.86/219.05  |- skos__altLabel mesh__D044302 Serotonin 1B Receptor
% 218.86/219.05  |- mesh__historyNote mesh__D044302
% 218.86/219.05       2004; use RECEPTOR, SEROTONIN, 5-HT1B %28%NM%29% 1993-2003   
% 218.86/219.05  |- skos__broader mesh__D044302smesh__D017660
% 218.86/219.05  |- skos__hiddenLabel mesh__D044302 Receptor, Serotonin 1Dbeta
% 218.86/219.05  |- skos__hiddenLabel mesh__D044302 1Dbeta Receptor, Serotonin
% 218.86/219.05  |- skos__hiddenLabel mesh__D011128 Cauda Equina Syndromes
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D011128 2003
% 218.86/219.05  |- mesh__dateRevised mesh__D011128 1999-11-04
% 218.86/219.05  |- skos__broader mesh__D011128smesh__D011129
% 218.86/219.05  |- mesh__historyNote mesh__D011128 2000%28%1966%29%   
% 218.86/219.05  |- mesh__dateCreated mesh__D011128 1999-01-01
% 218.86/219.05  |- skos__scopeNote mesh__D011128
% 218.86/219.05       Disease or injury involving multiple SPINAL NERVE ROOTS. Polyradiculitis refers to inflammation of multiple spinal nerve roots.%A%    
% 218.86/219.05  |- skos__hiddenLabel mesh__D011128 Abdominal Polyradiculopathies
% 218.86/219.05  |- mesh__recordMaintainer mesh__D011128 KEV
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D011128 2006
% 218.86/219.05  |- rdf__type mesh__D011128sskos__Concept
% 218.86/219.05  |- skos__hiddenLabel mesh__D011128 Syndromes, Cauda Equina
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D011128 2002
% 218.86/219.05  |- skos__hiddenLabel mesh__D011128 Polyradiculopathies
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D011128 2005
% 218.86/219.05  |- mesh__recordAuthorizer mesh__D011128 sjn
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D011128 2001
% 218.86/219.05  |- skos__hiddenLabel mesh__D011128 Polyradiculopathies, Abdominal
% 218.86/219.05  |- skos__hiddenLabel mesh__D011128 Polyradiculitides
% 218.86/219.05  |- skos__hiddenLabel mesh__D011128 Abdominal Polyradiculopathy
% 218.86/219.05  |- skos__hiddenLabel mesh__D011128 Syndrome, Cauda Equina
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D011128 2004
% 218.86/219.05  |- skos__prefLabel mesh__D011128 Polyradiculopathy
% 218.86/219.05  |- skos__annotation mesh__D011128
% 218.86/219.05       do not confuse with POLYRADICULONEUROPATHY %28%dis of both spinal nerve roots %26% peripheral nerves%29% nor with RADICULOPATHY %28%dis of a single spinal nerve root%29%%A%  
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D011128 2000
% 218.86/219.05  |- mesh__recordOriginator mesh__D011128 NLM
% 218.86/219.05  |- mesh__recordMaintainer mesh__D007885 kle
% 218.86/219.05  |- skos__hiddenLabel mesh__D007885 Legislations, Pharmacy
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007885 2000
% 218.86/219.05  |- skos__scopeNote mesh__D007885
% 218.86/219.05       Laws and regulations, pertaining to the field of pharmacy, proposed for enactment or enacted by a legislative body.%A%    
% 218.86/219.05  |- skos__historyNote mesh__D007885 Pharmacy %28%1966-1967%29%
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007885 2006
% 218.86/219.05  |- mesh__recordAuthorizer mesh__D007885 sjn
% 218.86/219.05  |- skos__annotation mesh__D007885
% 218.86/219.05       IM; specify country or state; DF: LEGIS PHARM   
% 218.86/219.05  |- skos__altLabel mesh__D007885 Pharmacy Legislation
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007885 2005
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007885 2004
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007885 2002
% 218.86/219.05  |- mesh__publicMeSHNote mesh__D007885 68   
% 218.86/219.05  |- skos__prefLabel mesh__D007885 Legislation, Pharmacy
% 218.86/219.05  |- skos__broader mesh__D007885smesh__D007878
% 218.86/219.05  |- mesh__dateCreated mesh__D007885 1999-01-01
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007885 2003
% 218.86/219.05  |- skos__hiddenLabel mesh__D007885 Pharmacy Legislations
% 218.86/219.05  |- mesh__dateEstablished mesh__D007885 1968-01-01
% 218.86/219.05  |- rdf__type mesh__D007885sskos__Concept
% 218.86/219.05  |- mesh__dateRevised mesh__D007885 1999-11-03
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007885 2001
% 218.86/219.05  |- mesh__recordOriginator mesh__D007885 NLM
% 218.86/219.05  |- mesh__historyNote mesh__D007885 68   
% 218.86/219.05  |- rdf__type mesh__D007087sskos__Concept
% 218.86/219.05  |- mesh__recordMaintainer mesh__D007087 PXP
% 218.86/219.05  |- mesh__recordOriginator mesh__D007087 NLM
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007087 2002
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007087 1998
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007087 2003
% 218.86/219.05  |- mesh__dateRevised mesh__D007087 1997-06-20
% 218.86/219.05  |- mesh__dateCreated mesh__D007087 1999-01-01
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007087 2000
% 218.86/219.05  |- skos__annotation mesh__D007087 CHICAGO is also available   
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007087 1999
% 218.86/219.05  |- skos__broader mesh__D007087smesh__D006114
% 218.86/219.05  |- skos__prefLabel mesh__D007087 Illinois
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007087 2004
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007087 2005
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007087 2001
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D007087 2006
% 218.86/219.05  |- skos__broader mesh__D007087smesh__D015146
% 218.86/219.05  |- mesh__recordAuthorizer mesh__D007087 SJN
% 218.86/219.05  |- mesh__dateRevised mesh__D015519 2003-07-09
% 218.86/219.05  |- skos__hiddenLabel mesh__D015519 Density, Bone Mineral
% 218.86/219.05  |- skos__broader mesh__D015519smesh__D043703
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D015519 2006
% 218.86/219.05  |- mesh__dateEstablished mesh__D015519 1990-01-01
% 218.86/219.05  |- mesh__publicMeSHNote mesh__D015519 90   
% 218.86/219.05  |- skos__related mesh__D015519smesh__D015502
% 218.86/219.05  |- skos__hiddenLabel mesh__D015519 Bone Densities
% 218.86/219.05  |- skos__hiddenLabel mesh__D015519 Bone Mineral Contents
% 218.86/219.05  |- skos__scopeNote mesh__D015519
% 218.86/219.05       The amount of mineral per square centimeter of BONE. This is the definition used in clinical practice. Actual bone density would be expressed in grams per milliliter. It is most frequently measured by photon absorptiometry or x-ray computed tomography.%A%    
% 218.86/219.05  |- mesh__historyNote mesh__D015519 90   
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D015519 2005
% 218.86/219.05  |- mesh__recordOriginator mesh__D015519 AGS
% 218.86/219.05  |- skos__historyNote mesh__D015519 Bone and Bones %28%1966-1989%29%
% 218.86/219.05  |- rdf__type mesh__D015519sskos__Concept
% 218.86/219.05  |- mesh__activeMeSHYear mesh__D015519 2004
% 218.86/219.05  |- mesh__recordMaintainer mesh__D015519 nns
% 218.86/219.05  |- skos__altLabel mesh__D015519 Bone Mineral Density
% 218.86/219.05  |- skos__hiddenLabel mesh__D015519 Density, Bone
% 218.86/219.05  |- skos__hiddenLabel mesh__D015519 Bone Mineral Densities
% 218.86/219.05  |- mesh__recordAuthorizer mesh__D015519 sjn
% 218.86/219.05  |- mesh__dateCreated mesh__D015519 1989-10-04
% 218.86/219.06  |- skos__prefLabel mesh__D015519 Bone Density
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D026241 2006
% 218.86/219.06  |- skos__broader mesh__D026241smesh__D013812
% 218.86/219.06  |- rdf__type mesh__D026241sskos__Concept
% 218.86/219.06  |- mesh__dateRevised mesh__D026241 2005-07-06
% 218.86/219.06  |- skos__annotation mesh__D026241 GEN or unspecified; prefer specifics   
% 218.86/219.06  |- skos__altLabel mesh__D026241 Exercise Movement Technics
% 218.86/219.06  |- mesh__dateCreated mesh__D026241 2001-07-25
% 218.86/219.06  |- skos__hiddenLabel mesh__D026241 Movement Techniques, Exercise
% 218.86/219.06  |- mesh__recordMaintainer mesh__D026241 NLM
% 218.86/219.06  |- skos__prefLabel mesh__D026241 Exercise Movement Techniques
% 218.86/219.06  |- mesh__recordAuthorizer mesh__D026241 NLM
% 218.86/219.06  |- skos__related mesh__D026241smesh__D026741
% 218.86/219.06  |- skos__scopeNote mesh__D026241
% 218.86/219.06       Physical activities which people can do to benefit their health.%A%    
% 218.86/219.06  |- mesh__dateEstablished mesh__D026241 2002-01-01
% 218.86/219.06  |- mesh__historyNote mesh__D026241 2002   
% 218.86/219.06  |- mesh__publicMeSHNote mesh__D026241 2002   
% 218.86/219.06  |- mesh__recordOriginator mesh__D026241 ssb
% 218.86/219.06  |- mesh__dateCreated mesh__D012221 1979-02-28
% 218.86/219.06  |- skos__altLabel mesh__D012221 Rhinitis, Allergic, Nonseasonal
% 218.86/219.06  |- mesh__recordMaintainer mesh__D012221 ags
% 218.86/219.06  |- mesh__publicMeSHNote mesh__D012221
% 218.86/219.06       80; RHINITIS, ALLERGIC was see HAY FEVER 1963-79   
% 218.86/219.06  |- skos__annotation mesh__D012221
% 218.86/219.06       note X ref: do not confuse with RHINITIS, ALLERGIC, SEASONAL%A%  
% 218.86/219.06  |- skos__prefLabel mesh__D012221 Rhinitis, Allergic, Perennial
% 218.86/219.06  |- mesh__recordAuthorizer mesh__D012221 sjn
% 218.86/219.06  |- mesh__historyNote mesh__D012221
% 218.86/219.06       80; RHINITIS, ALLERGIC was see HAY FEVER 1963-79   
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D012221 2006
% 218.86/219.06  |- skos__broader mesh__D012221smesh__D012220
% 218.86/219.06  |- skos__historyNote mesh__D012221 Rhinitis %28%1966-1979%29%
% 218.86/219.06  |- mesh__dateRevised mesh__D012221 2005-07-01
% 218.86/219.06  |- skos__scopeNote mesh__D012221
% 218.86/219.06       Inflammation of the mucous membrane of the nose similar to that found in hay fever except that symptoms persist throughout the year. The causes are usually air-borne allergens, particularly dusts, feathers, molds, animal fur, etc.%A%    
% 218.86/219.06  |- mesh__dateEstablished mesh__D012221 1980-01-01
% 218.86/219.06  |- mesh__onlineNote mesh__D012221
% 218.86/219.06       search RHINITIS, ALLERGIC under HAY FEVER 1966-79   
% 218.86/219.06  |- rdf__type mesh__D012221sskos__Concept
% 218.86/219.06  |- skos__historyNote mesh__D012221 Hay Fever %28%1966-1979%29%
% 218.86/219.06  |- skos__broader mesh__D012221smesh__D012130
% 218.86/219.06  |- mesh__recordOriginator mesh__D012221 AEP
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D031984 2003
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D031984 2006
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D031984 2005
% 218.86/219.06  |- skos__broader mesh__D031984smesh__D027824
% 218.86/219.06  |- skos__altLabel mesh__D031984 Dropwort
% 218.86/219.06  |- rdf__type mesh__D031984sskos__Concept
% 218.86/219.06  |- mesh__historyNote mesh__D031984 2003   
% 218.86/219.06  |- skos__annotation mesh__D031984
% 218.86/219.06       X ref DROPWORT: WATER DROPWORT = OENANTHE is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.06  |- mesh__dateCreated mesh__D031984 2002-07-03
% 218.86/219.06  |- mesh__dateEstablished mesh__D031984 2003-01-01
% 218.86/219.06  |- skos__prefLabel mesh__D031984 Filipendula
% 218.86/219.06  |- skos__scopeNote mesh__D031984
% 218.86/219.06       A plant genus of the family ROSACEAE. Members contain TANNINS.%A%    
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D031984 2004
% 218.86/219.06  |- mesh__publicMeSHNote mesh__D031984 2003   
% 218.86/219.06  |- skos__altLabel mesh__D031984 Meadowsweet
% 218.86/219.06  |- skos__altLabel mesh__D031186 Scorsonera
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D031186 2004
% 218.86/219.06  |- skos__annotation mesh__D031186
% 218.86/219.06       Common Salsify = TRAGOPOGON is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.06  |- skos__altLabel mesh__D031186 Salsify, Black
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D031186 2005
% 218.86/219.06  |- mesh__publicMeSHNote mesh__D031186 2003   
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D031186 2006
% 218.86/219.06  |- mesh__historyNote mesh__D031186 2003   
% 218.86/219.06  |- skos__broader mesh__D031186smesh__D019659
% 218.86/219.06  |- skos__scopeNote mesh__D031186
% 218.86/219.06       A plant genus of the family ASTERACEAE. INULIN and SESQUITERPENES have been found in it.%A%    
% 218.86/219.06  |- mesh__dateCreated mesh__D031186 2002-07-03
% 218.86/219.06  |- mesh__dateEstablished mesh__D031186 2003-01-01
% 218.86/219.06  |- rdf__type mesh__D031186sskos__Concept
% 218.86/219.06  |- skos__prefLabel mesh__D031186 Scorzonera
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D031186 2003
% 218.86/219.06  |- skos__broader mesh__D003495smesh__D008333
% 218.86/219.06  |- skos__prefLabel mesh__D003495 Cyclandelate
% 218.86/219.06  |- mesh__recordMaintainer mesh__D003495 CCR
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D003495 2002
% 218.86/219.06  |- mesh__recordAuthorizer mesh__D003495 sjn
% 218.86/219.06  |- mesh__recordOriginator mesh__D003495 NLM
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D003495 2005
% 218.86/219.06  |- mesh__publicMeSHNote mesh__D003495
% 218.86/219.06       91; was see under MANDELIC ACIDS 1975-90   
% 218.86/219.06  |- skos__historyNote mesh__D003495 Cyclohexanes %28%1968-1974%29%
% 218.86/219.06  |- mesh__dateRevised mesh__D003495 2000-06-22
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D003495 2003
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D003495 2006
% 218.86/219.06  |- skos__scopeNote mesh__D003495
% 218.86/219.06       A direct-acting smooth muscle relaxant used to dilate blood vessels. It may cause gastrointestinal distress and tachycardia.%A%    
% 218.86/219.06  |- mesh__dateEstablished mesh__D003495 1991-01-01
% 218.86/219.06  |- mesh__dateCreated mesh__D003495 1974-11-19
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D003495 2004
% 218.86/219.06  |- mesh__historyNote mesh__D003495
% 218.86/219.06       91%28%75%29%; was see under MANDELIC ACIDS 1975-90   
% 218.86/219.06  |- skos__historyNote mesh__D003495 Mandelic Acids %28%1968-1974%29%
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D003495 2001
% 218.86/219.06  |- rdf__type mesh__D003495sskos__Concept
% 218.86/219.06  |- skos__altLabel mesh__D011129
% 218.86/219.06       Demyelinating Autoimmune Disease, Peripheral
% 218.86/219.06  |- mesh__recordMaintainer mesh__D011129 KEV
% 218.86/219.06  |- skos__altLabel mesh__D011129
% 218.86/219.06       Demyelinating Disease, Peripheral Autoimmune
% 218.86/219.06  |- mesh__recordAuthorizer mesh__D011129 sjn
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D011129 2006
% 218.86/219.06  |- rdf__type mesh__D011129sskos__Concept
% 218.86/219.06  |- skos__altLabel mesh__D011129 Peripheral Autoimmune Demyelinating Disease
% 218.86/219.06  |- skos__prefLabel mesh__D011129 Polyradiculoneuropathy
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D011129 2001
% 218.86/219.06  |- mesh__dateEstablished mesh__D011129 1979-01-01
% 218.86/219.06  |- mesh__dateRevised mesh__D011129 1999-11-03
% 218.86/219.06  |- mesh__historyNote mesh__D011129 2000%28%1979%29%   
% 218.86/219.06  |- skos__broader mesh__D011129smesh__D011115
% 218.86/219.06  |- skos__annotation mesh__D011129
% 218.86/219.06       do not confuse with POLYRADICULOPATHY %28%dis of multiple nerve roots%29% nor with RADICULOPATHY %28%dis of a single nerve root%29%%A%  
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D011129 2000
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D011129 2005
% 218.86/219.06  |- skos__broader mesh__D011129smesh__D020274
% 218.86/219.06  |- skos__historyNote mesh__D011129 Polyradiculitis %28%1966-1978%29%
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D011129 2004
% 218.86/219.06  |- mesh__recordOriginator mesh__D011129 RC
% 218.86/219.06  |- skos__broader mesh__D011129smesh__D003711
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D011129 2003
% 218.86/219.06  |- mesh__publicMeSHNote mesh__D011129
% 218.86/219.06       2000; see POLYRADICULONEURITIS 1979-1999   
% 218.86/219.06  |- skos__hiddenLabel mesh__D011129 Polyradiculoneuritides
% 218.86/219.06  |- mesh__dateCreated mesh__D011129 1978-05-22
% 218.86/219.06  |- skos__hiddenLabel mesh__D011129 Polyradiculoneuropathies
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D011129 2002
% 218.86/219.06  |- skos__scopeNote mesh__D011129
% 218.86/219.06       Diseases characterized by injury or dysfunction involving multiple peripheral nerves and nerve roots. The process may primarily affect myelin or nerve axons. Two of the more common demyelinating forms are acute inflammatory polyradiculopathy %28%GUILLAIN-BARRE SYNDROME%29% and POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING. Polyradiculoneuritis refers to inflammation of multiple peripheral nerves and spinal nerve roots.%A%    
% 218.86/219.06  |- skos__broader mesh__D008180smesh__D001327
% 218.86/219.06  |- skos__related mesh__D008180smesh__D016736
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D008180 2006
% 218.86/219.06  |- skos__altLabel mesh__D008180 Lupus Erythematosus Disseminatus
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D008180 2003
% 218.86/219.06  |- mesh__dateRevised mesh__D008180 1999-11-08
% 218.86/219.06  |- skos__scopeNote mesh__D008180
% 218.86/219.06       A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.%A%    
% 218.86/219.06  |- skos__related mesh__D008180smesh__D016682
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D008180 2000
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D008180 2004
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D008180 2001
% 218.86/219.06  |- skos__broader mesh__D008180smesh__D003240
% 218.86/219.06  |- skos__hiddenLabel mesh__D008180 Libman Sacks Disease
% 218.86/219.06  |- mesh__dateCreated mesh__D008180 1999-01-01
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D008180 2002
% 218.86/219.06  |- skos__annotation mesh__D008180
% 218.86/219.06       if not specified as %22%systemic%22% it is still probably correct to index here, not also discoid; LUPUS NEPHRITIS is also available; LE CELLS see NEUTROPHILS is also available: use LUPUS ERYTHEMATOSUS, SYSTEMIC /blood or /pathol + NEUTROPHILS for discussion of the LE cells as cells; DF: SLE%A%  
% 218.86/219.06  |- mesh__recordOriginator mesh__D008180 NLM
% 218.86/219.06  |- mesh__recordMaintainer mesh__D008180 KEV
% 218.86/219.06  |- skos__related mesh__D008180smesh__D020293
% 218.86/219.06  |- rdf__type mesh__D008180sskos__Concept
% 218.86/219.06  |- skos__prefLabel mesh__D008180 Lupus Erythematosus, Systemic
% 218.86/219.06  |- skos__altLabel mesh__D008180 Systemic Lupus Erythematosus
% 218.86/219.06  |- mesh__recordAuthorizer mesh__D008180 sjn
% 218.86/219.06  |- skos__hiddenLabel mesh__D008180 Disease, Libman-Sacks
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D008180 2005
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D016612 2003
% 218.86/219.06  |- mesh__recordMaintainer mesh__D016612 TAP
% 218.86/219.06  |- mesh__recordAuthorizer mesh__D016612 sjn
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D016612 2001
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D016612 2006
% 218.86/219.06  |- mesh__publicMeSHNote mesh__D016612 92   
% 218.86/219.06  |- skos__scopeNote mesh__D016612
% 218.86/219.06       The infiltrating of tissue specimens with paraffin, as a supporting substance, to prepare for sectioning with a microtome.%A%    
% 218.86/219.06  |- mesh__dateEstablished mesh__D016612 1992-01-01
% 218.86/219.06  |- mesh__dateCreated mesh__D016612 1991-01-25
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D016612 2005
% 218.86/219.06  |- skos__historyNote mesh__D016612 Paraffin %28%1966-1991%29%
% 218.86/219.06  |- mesh__dateRevised mesh__D016612 2000-06-22
% 218.86/219.06  |- skos__broader mesh__D016612smesh__D016610
% 218.86/219.06  |- mesh__recordOriginator mesh__D016612 MXR
% 218.86/219.06  |- skos__prefLabel mesh__D016612 Paraffin Embedding
% 218.86/219.06  |- rdf__type mesh__D016612sskos__Concept
% 218.86/219.06  |- mesh__historyNote mesh__D016612 92   
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D016612 2002
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D016612 2004
% 218.86/219.06  |- skos__hiddenLabel mesh__D016612 Embedding, Paraffin
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D007886 2005
% 218.86/219.06  |- skos__hiddenLabel mesh__D007886 Legislations, Veterinary
% 218.86/219.06  |- skos__scopeNote mesh__D007886
% 218.86/219.06       Laws and regulations, pertaining to the field of veterinary medicine, proposed for enactment or enacted by a legislative body.%A%    
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D007886 2000
% 218.86/219.06  |- mesh__dateCreated mesh__D007886 1999-01-01
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D007886 2003
% 218.86/219.06  |- skos__hiddenLabel mesh__D007886 Veterinary Legislations
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D007886 2006
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D007886 2001
% 218.86/219.06  |- mesh__recordOriginator mesh__D007886 NLM
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D007886 2004
% 218.86/219.06  |- mesh__recordMaintainer mesh__D007886 kle
% 218.86/219.06  |- skos__prefLabel mesh__D007886 Legislation, Veterinary
% 218.86/219.06  |- mesh__dateRevised mesh__D007886 1999-11-03
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D007886 2002
% 218.86/219.06  |- skos__broader mesh__D007886smesh__D007878
% 218.86/219.06  |- skos__annotation mesh__D007886
% 218.86/219.06       IM; specify country or state; DF: LEGIS VET   
% 218.86/219.06  |- mesh__recordAuthorizer mesh__D007886 sjn
% 218.86/219.06  |- rdf__type mesh__D007886sskos__Concept
% 218.86/219.06  |- skos__altLabel mesh__D007886 Veterinary Legislation
% 218.86/219.06  |- mesh__publicMeSHNote mesh__D007088
% 218.86/219.06       1963; for AUTOKINETIC EFFECT see AUTOKINETIC EFFECT 1991-1996, see ILLUSIONS 1968-1990%A%  
% 218.86/219.06  |- skos__hiddenLabel mesh__D007088 Autokinetic Effects
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D007088 2003
% 218.86/219.06  |- mesh__dateRevised mesh__D007088 1999-11-03
% 218.86/219.06  |- skos__hiddenLabel mesh__D007088 Effects, Autokinetic
% 218.86/219.06  |- skos__altLabel mesh__D007088 Effect, Autokinetic
% 218.86/219.06  |- mesh__dateCreated mesh__D007088 1999-01-01
% 218.86/219.06  |- skos__hiddenLabel mesh__D007088 Auditory Illusions
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D007088 2001
% 218.86/219.06  |- skos__hiddenLabel mesh__D007088 Tactile Illusion
% 218.86/219.06  |- skos__hiddenLabel mesh__D007088 Illusion, Kinesthetic
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D007088 2004
% 218.86/219.06  |- skos__hiddenLabel mesh__D007088 Illusion, Autokinetic
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D007088 2005
% 218.86/219.06  |- skos__hiddenLabel mesh__D007088 Kinesthetic Illusions
% 218.86/219.06  |- mesh__recordMaintainer mesh__D007088 KEV
% 218.86/219.06  |- skos__hiddenLabel mesh__D007088 Kinesthetic Illusion
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D007088 2006
% 218.86/219.06  |- skos__hiddenLabel mesh__D007088 Autokinetic Illusion
% 218.86/219.06  |- skos__broader mesh__D007088smesh__D010465
% 218.86/219.06  |- skos__scopeNote mesh__D007088
% 218.86/219.06       The misinterpretation of a real external, sensory experience.%A%    
% 218.86/219.06  |- mesh__recordAuthorizer mesh__D007088 sjn
% 218.86/219.06  |- skos__hiddenLabel mesh__D007088 Illusions, Autokinetic
% 218.86/219.06  |- mesh__recordOriginator mesh__D007088 NLM
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D007088 2002
% 218.86/219.06  |- skos__annotation mesh__D007088 do not confuse with DELUSIONS   
% 218.86/219.06  |- rdf__type mesh__D007088sskos__Concept
% 218.86/219.06  |- skos__hiddenLabel mesh__D007088 Visual Illusions
% 218.86/219.06  |- skos__hiddenLabel mesh__D007088 Auditory Illusion
% 218.86/219.06  |- skos__hiddenLabel mesh__D007088 Visual Illusion
% 218.86/219.06  |- skos__hiddenLabel mesh__D007088 Illusion
% 218.86/219.06  |- skos__hiddenLabel mesh__D007088 Illusion, Auditory
% 218.86/219.06  |- skos__prefLabel mesh__D007088 Illusions
% 218.86/219.06  |- skos__broader mesh__D007088smesh__D010468
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D007088 2000
% 218.86/219.06  |- skos__hiddenLabel mesh__D007088 Tactile Illusions
% 218.86/219.06  |- skos__hiddenLabel mesh__D007088 Illusion, Tactile
% 218.86/219.06  |- mesh__historyNote mesh__D007088 1963   
% 218.86/219.06  |- skos__hiddenLabel mesh__D007088 Illusion, Visual
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D012222 2002
% 218.86/219.06  |- skos__hiddenLabel mesh__D012222 Atrophic Rhinitides
% 218.86/219.06  |- mesh__dateRevised mesh__D012222 1991-06-18
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D012222 1993
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D012222 2003
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D012222 1996
% 218.86/219.06  |- mesh__recordMaintainer mesh__D012222 TGC
% 218.86/219.06  |- skos__hiddenLabel mesh__D012222 Rhinitides, Atrophic
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D012222 2006
% 218.86/219.06  |- skos__scopeNote mesh__D012222
% 218.86/219.06       A chronic form of rhinitis marked by wasting of the mucous membrane and the glands. It is usually associated with crusting and foul-smelling discharges.%A%    
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D012222 1999
% 218.86/219.06  |- skos__broader mesh__D012222smesh__D012220
% 218.86/219.06  |- mesh__recordAuthorizer mesh__D012222 PLS
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D012222 1992
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D012222 2001
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D012222 1995
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D012222 2005
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D012222 1998
% 218.86/219.06  |- skos__hiddenLabel mesh__D012222 Ozenas
% 218.86/219.06  |- rdf__type mesh__D012222sskos__Concept
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D012222 2000
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D012222 1994
% 218.86/219.06  |- skos__hiddenLabel mesh__D012222 Atrophic Rhinitis
% 218.86/219.06  |- mesh__recordOriginator mesh__D012222 NLM
% 218.86/219.06  |- mesh__dateCreated mesh__D012222 1999-01-01
% 218.86/219.06  |- skos__prefLabel mesh__D012222 Rhinitis, Atrophic
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D012222 2004
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D012222 1997
% 218.86/219.06  |- skos__scopeNote mesh__D031985
% 218.86/219.06       A plant genus of the family ROSACEAE known for the edible fruit.%A%    
% 218.86/219.06  |- skos__prefLabel mesh__D031985 Fragaria
% 218.86/219.06  |- rdf__type mesh__D031985sskos__Concept
% 218.86/219.06  |- skos__broader mesh__D031985smesh__D027824
% 218.86/219.06  |- skos__annotation mesh__D031985
% 218.86/219.06       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D031985 2003
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D031985 2004
% 218.86/219.06  |- mesh__dateEstablished mesh__D031985 2003-01-01
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D031985 2005
% 218.86/219.06  |- mesh__publicMeSHNote mesh__D031985 2003   
% 218.86/219.06  |- mesh__historyNote mesh__D031985 2003   
% 218.86/219.06  |- mesh__dateCreated mesh__D031985 2002-07-03
% 218.86/219.06  |- skos__altLabel mesh__D031985 Strawberries
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D031985 2006
% 218.86/219.06  |- mesh__dateEstablished mesh__D031187 2003-01-01
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D031187 2005
% 218.86/219.06  |- mesh__publicMeSHNote mesh__D031187 2003   
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D031187 2006
% 218.86/219.06  |- skos__broader mesh__D031187smesh__D031178
% 218.86/219.06  |- skos__altLabel mesh__D031187 Safflower
% 218.86/219.06  |- skos__prefLabel mesh__D031187 Carthamus tinctorius
% 218.86/219.06  |- skos__annotation mesh__D031187
% 218.86/219.06       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.06  |- rdf__type mesh__D031187sskos__Concept
% 218.86/219.06  |- mesh__historyNote mesh__D031187 2003   
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D031187 2003
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D031187 2004
% 218.86/219.06  |- skos__scopeNote mesh__D031187
% 218.86/219.06       A plant genus of the family ASTERACEAE. Oil from the seed %28%SAFFLOWER OIL%29% is an important food oil of commerce.%A%    
% 218.86/219.06  |- mesh__dateCreated mesh__D031187 2002-07-03
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D003496 2003
% 218.86/219.06  |- mesh__recordMaintainer mesh__D003496 TWD
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D003496 2006
% 218.86/219.06  |- mesh__dateRevised mesh__D003496 2000-06-22
% 218.86/219.06  |- skos__broader mesh__D003496smesh__D001392
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D003496 2004
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D003496 2001
% 218.86/219.06  |- mesh__dateEstablished mesh__D003496 1973-01-01
% 218.86/219.06  |- mesh__publicMeSHNote mesh__D003496 73   
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D003496 2002
% 218.86/219.06  |- rdf__type mesh__D003496sskos__Concept
% 218.86/219.06  |- mesh__recordOriginator mesh__D003496 NLM
% 218.86/219.06  |- skos__prefLabel mesh__D003496 Cyclazocine
% 218.86/219.06  |- mesh__recordAuthorizer mesh__D003496 sjn
% 218.86/219.06  |- mesh__dateCreated mesh__D003496 1999-01-01
% 218.86/219.06  |- mesh__historyNote mesh__D003496 73%28%64%29%   
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D003496 2005
% 218.86/219.06  |- skos__scopeNote mesh__D003496
% 218.86/219.06       An analgesic with mixed narcotic agonist-antagonist properties.%A%    
% 218.86/219.06  |- skos__broader mesh__D003496smesh__D006572
% 218.86/219.06  |- mesh__recordOriginator mesh__D011928 NLM
% 218.86/219.06  |- skos__prefLabel mesh__D011928 Raynaud Disease
% 218.86/219.06  |- mesh__recordAuthorizer mesh__D011928 sjn
% 218.86/219.06  |- skos__altLabel mesh__D011928 Raynaud%27%s Disease
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D011928 2006
% 218.86/219.06  |- mesh__historyNote mesh__D011928 2004 %28%1966%29%   
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D011928 2005
% 218.86/219.06  |- mesh__dateRevised mesh__D011928 2003-07-09
% 218.86/219.06  |- skos__broader mesh__D011928smesh__D014652
% 218.86/219.06  |- skos__scopeNote mesh__D011928
% 218.86/219.06       An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or STRESS.%A%    
% 218.86/219.06  |- mesh__publicMeSHNote mesh__D011928
% 218.86/219.06       2004; use RAYNAUD%27%S DISEASE 1966-2003   
% 218.86/219.06  |- mesh__recordMaintainer mesh__D011928 lkt
% 218.86/219.06  |- mesh__dateCreated mesh__D011928 1999-01-01
% 218.86/219.06  |- rdf__type mesh__D011928sskos__Concept
% 218.86/219.06  |- skos__hiddenLabel mesh__D011928 Raynauds Disease
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D011928 2004
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D008181 1998
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D008181 1995
% 218.86/219.06  |- skos__hiddenLabel mesh__D008181 Glomerulonephritides, Lupus
% 218.86/219.06  |- skos__broader mesh__D008181smesh__D005921
% 218.86/219.06  |- skos__altLabel mesh__D008181 Lupus Glomerulonephritis
% 218.86/219.06  |- skos__hiddenLabel mesh__D008181 Lupus Glomerulonephritides
% 218.86/219.06  |- skos__scopeNote mesh__D008181
% 218.86/219.06       Glomerulonephritis associated with systemic lupus erythematosus. It is classified into four histologic types: mesangial, focal, diffuse, and membranous.%A%    
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D008181 1999
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D008181 1993
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D008181 1996
% 218.86/219.06  |- mesh__dateEstablished mesh__D008181 1987-01-01
% 218.86/219.06  |- skos__historyNote mesh__D008181 Glomerulonephritis %28%1966-1986%29%
% 218.86/219.06  |- skos__broader mesh__D008181smesh__D008180
% 218.86/219.06  |- mesh__recordOriginator mesh__D008181 EC
% 218.86/219.06  |- skos__historyNote mesh__D008181
% 218.86/219.06       Lupus Erythematosus, Systemic %28%1966-1986%29%
% 218.86/219.06  |- rdf__type mesh__D008181sskos__Concept
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D008181 1997
% 218.86/219.06  |- skos__hiddenLabel mesh__D008181 Nephritides, Lupus
% 218.86/219.06  |- skos__altLabel mesh__D008181 Nephritis, Lupus
% 218.86/219.06  |- mesh__dateRevised mesh__D008181 1992-05-22
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D008181 2005
% 218.86/219.06  |- skos__hiddenLabel mesh__D008181 Lupus Nephritides
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D008181 2000
% 218.86/219.06  |- mesh__dateCreated mesh__D008181 1986-06-18
% 218.86/219.06  |- mesh__recordAuthorizer mesh__D008181 PLS
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D008181 2006
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D008181 2003
% 218.86/219.06  |- skos__historyNote mesh__D008181 Nephritis %28%1966-1986%29%
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D008181 2001
% 218.86/219.06  |- mesh__historyNote mesh__D008181 87   
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D008181 1994
% 218.86/219.06  |- mesh__recordMaintainer mesh__D008181 PLS
% 218.86/219.06  |- skos__prefLabel mesh__D008181 Lupus Nephritis
% 218.86/219.06  |- skos__annotation mesh__D008181
% 218.86/219.06       %22%glomerulonephritis associated with systemic lupus erythematosus%22%%A%  
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D008181 2004
% 218.86/219.06  |- skos__altLabel mesh__D008181 Glomerulonephritis, Lupus
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D008181 2002
% 218.86/219.06  |- mesh__publicMeSHNote mesh__D008181 87   
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D016613 2005
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D016613 2002
% 218.86/219.06  |- skos__broader mesh__D016613smesh__D016610
% 218.86/219.06  |- skos__historyNote mesh__D016613 Plastics %28%1966-1991%29%
% 218.86/219.06  |- rdf__type mesh__D016613sskos__Concept
% 218.86/219.06  |- skos__scopeNote mesh__D016613
% 218.86/219.06       The infiltrating of histological specimens with plastics, including acrylic resins, epoxy resins and polyethylene glycol, for support of the tissues in preparation for sectioning with a microtome.%A%    
% 218.86/219.06  |- mesh__dateRevised mesh__D016613 2000-06-22
% 218.86/219.06  |- mesh__historyNote mesh__D016613 92   
% 218.86/219.06  |- mesh__recordOriginator mesh__D016613 MXR
% 218.86/219.06  |- skos__annotation mesh__D016613
% 218.86/219.06       coord IM with embedding material %28%IM or NIM with no qualif%29%%A%  
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D016613 2004
% 218.86/219.06  |- skos__prefLabel mesh__D016613 Plastic Embedding
% 218.86/219.06  |- mesh__recordAuthorizer mesh__D016613 sjn
% 218.86/219.06  |- mesh__recordMaintainer mesh__D016613 TAP
% 218.86/219.06  |- mesh__dateEstablished mesh__D016613 1992-01-01
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D016613 2001
% 218.86/219.06  |- skos__hiddenLabel mesh__D016613 Embedding, Plastic
% 218.86/219.06  |- mesh__publicMeSHNote mesh__D016613 92   
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D016613 2003
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D016613 2006
% 218.86/219.06  |- mesh__dateCreated mesh__D016613 1991-01-25
% 218.86/219.06  |- skos__scopeNote mesh__D007887
% 218.86/219.06       The large family of plants characterized by pods.  Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various lectins like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots.%A%    
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D007887 2004
% 218.86/219.06  |- mesh__dateRevised mesh__D007887 2005-07-27
% 218.86/219.06  |- skos__altLabel mesh__D007887 Karanja
% 218.86/219.06  |- skos__altLabel mesh__D007887 Karanj
% 218.86/219.06  |- skos__hiddenLabel mesh__D007887 Legume
% 218.86/219.06  |- skos__annotation mesh__D007887
% 218.86/219.06       X ref EUCHRESTA: for Euchresta tenuifolia use MAACKIA; prefer specific plant; X ref PONGAMIA: PONGAMIA PINNATA see MILLETTIA PINNATA and PONGAMIA ULIGINOSA see DERRIS are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.06  |- mesh__recordAuthorizer mesh__D007887 ags
% 218.86/219.06  |- skos__broader mesh__D007887smesh__D019684
% 218.86/219.06  |- skos__altLabel mesh__D007887 Leguminosae
% 218.86/219.06  |- mesh__recordMaintainer mesh__D007887 ags
% 218.86/219.06  |- mesh__dateEstablished mesh__D007887 1978-01-01
% 218.86/219.06  |- rdf__type mesh__D007887sskos__Concept
% 218.86/219.06  |- skos__altLabel mesh__D007887 Legumes
% 218.86/219.06  |- mesh__publicMeSHNote mesh__D007887 2002; see LEGUMES 1978-2001   
% 218.86/219.06  |- skos__broader mesh__D007887smesh__D014675
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D007887 2006A
% 218.86/219.06  |- mesh__dateCreated mesh__D007887 1977-04-27
% 218.86/219.06  |- mesh__historyNote mesh__D007887 2002   
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D007887 2005
% 218.86/219.06  |- skos__prefLabel mesh__D007887 Fabaceae
% 218.86/219.06  |- skos__altLabel mesh__D007887 Pithecollobium
% 218.86/219.06  |- mesh__recordOriginator mesh__D007887 VDK
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D007887 2006
% 218.86/219.06  |- mesh__dateRevised mesh__D007089 2004-07-07
% 218.86/219.06  |- skos__scopeNote mesh__D007089
% 218.86/219.06       Improvement of the quality of a picture by various techniques, including computer processing, digital filtering, echocardiographic techniques, light and ultrastructural microscopy, fluorescence spectrometry and microscopy, scintigraphy, and in vitro image processing at the molecular level.%A%    
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D007089 2005
% 218.86/219.06  |- mesh__dateEstablished mesh__D007089 1973-01-01
% 218.86/219.06  |- mesh__publicMeSHNote mesh__D007089 73   
% 218.86/219.06  |- skos__historyNote mesh__D007089 Photography %28%1966-1970%29%
% 218.86/219.06  |- skos__hiddenLabel mesh__D007089 Image Enhancements
% 218.86/219.06  |- mesh__activeMeSHYear mesh__D007089 2006
% 218.86/219.07  |- skos__hiddenLabel mesh__D007089 Enhancements, Image
% 218.86/219.07  |- skos__broader mesh__D007089smesh__D010781
% 218.86/219.07  |- rdf__type mesh__D007089sskos__Concept
% 218.86/219.07  |- mesh__recordMaintainer mesh__D007089 jls
% 218.86/219.07  |- skos__hiddenLabel mesh__D007089 Enhancement, Image
% 218.86/219.07  |- skos__annotation mesh__D007089
% 218.86/219.07       RADIOGRAPHIC IMAGE ENHANCEMENT is also available   
% 218.86/219.07  |- mesh__recordOriginator mesh__D007089 NLM
% 218.86/219.07  |- mesh__recordAuthorizer mesh__D007089 sjn
% 218.86/219.07  |- skos__related mesh__D007089smesh__D011856
% 218.86/219.07  |- skos__related mesh__D007089smesh__D013382
% 218.86/219.07  |- skos__broader mesh__D007089smesh__D007091
% 218.86/219.07  |- mesh__historyNote mesh__D007089 73%28%72%29%   
% 218.86/219.07  |- mesh__dateCreated mesh__D007089 1999-01-01
% 218.86/219.07  |- skos__historyNote mesh__D007089 Technology, Radiologic %28%1966-1970%29%
% 218.86/219.07  |- skos__prefLabel mesh__D007089 Image Enhancement
% 218.86/219.07  |- mesh__dateEstablished mesh__D031986 2003-01-01
% 218.86/219.07  |- skos__altLabel mesh__D031986 Avens
% 218.86/219.07  |- mesh__historyNote mesh__D031986 2003   
% 218.86/219.07  |- rdf__type mesh__D031986sskos__Concept
% 218.86/219.07  |- skos__scopeNote mesh__D031986
% 218.86/219.07       A plant genus of the family ROSACEAE. Members contain TRITERPENES.%A%    
% 218.86/219.07  |- mesh__dateCreated mesh__D031986 2002-07-02
% 218.86/219.07  |- skos__annotation mesh__D031986
% 218.86/219.07       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D031986 2003
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D031986 2004
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D031986 2005
% 218.86/219.07  |- skos__broader mesh__D031986smesh__D027824
% 218.86/219.07  |- mesh__publicMeSHNote mesh__D031986 2003   
% 218.86/219.07  |- skos__prefLabel mesh__D031986 Geum
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D031986 2006
% 218.86/219.07  |- mesh__recordMaintainer mesh__D012223 TGC
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D012223 2002
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D012223 2005
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D012223 1998
% 218.86/219.07  |- skos__historyNote mesh__D012223 Rhinitis %28%1966-1979%29%
% 218.86/219.07  |- mesh__publicMeSHNote mesh__D012223
% 218.86/219.07       80; VASOMOTOR RHINITIS was see HAY FEVER 1973-79   
% 218.86/219.07  |- mesh__dateEstablished mesh__D012223 1980-01-01
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D012223 2006
% 218.86/219.07  |- mesh__dateRevised mesh__D012223 1996-06-10
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D012223 1999
% 218.86/219.07  |- mesh__recordAuthorizer mesh__D012223 PLS
% 218.86/219.07  |- skos__hiddenLabel mesh__D012223 Vasomotor Rhinitides
% 218.86/219.07  |- skos__scopeNote mesh__D012223
% 218.86/219.07       A form of rhinitis brought about by changes in vascular tone and permeability. The etiology is obscure.%A%    
% 218.86/219.07  |- skos__altLabel mesh__D012223 Vasomotor Rhinitis
% 218.86/219.07  |- mesh__recordOriginator mesh__D012223 AEP
% 218.86/219.07  |- skos__hiddenLabel mesh__D012223 Rhinitides, Vasomotor
% 218.86/219.07  |- rdf__type mesh__D012223sskos__Concept
% 218.86/219.07  |- mesh__historyNote mesh__D012223
% 218.86/219.07       80; VASOMOTOR RHINITIS was see HAY FEVER 1973-79   
% 218.86/219.07  |- skos__annotation mesh__D012223
% 218.86/219.07       do not confuse with other RHINITIS headings; do not make diagnoses: use word of text%A%  
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D012223 2000
% 218.86/219.07  |- skos__historyNote mesh__D012223 Hay Fever %28%1966-1979%29%
% 218.86/219.07  |- skos__prefLabel mesh__D012223 Rhinitis, Vasomotor
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D012223 2003
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D012223 2001
% 218.86/219.07  |- mesh__dateCreated mesh__D012223 1979-02-28
% 218.86/219.07  |- skos__broader mesh__D012223smesh__D012220
% 218.86/219.07  |- mesh__onlineNote mesh__D012223
% 218.86/219.07       use HAY FEVER to search VASOMOTOR RHINITIS 1973-79   
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D012223 2004
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D012223 1997
% 218.86/219.07  |- skos__broader mesh__D002091Q000037smesh__D002091
% 218.86/219.07  |- mesh__preferredCombination mesh__D002091Q000037smesh__D002800
% 218.86/219.07  |- rdf__type mesh__D002091Q000037smesh__CompoundConcept
% 218.86/219.07  |- skos__annotation mesh__D031188
% 218.86/219.07       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.07  |- skos__altLabel mesh__D031188 Salsify, Common
% 218.86/219.07  |- skos__altLabel mesh__D031188 Goat%27%s Beard
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D031188 2003
% 218.86/219.07  |- skos__broader mesh__D031188smesh__D019659
% 218.86/219.07  |- skos__prefLabel mesh__D031188 Tragopogon
% 218.86/219.07  |- skos__scopeNote mesh__D031188
% 218.86/219.07       A plant genus of the family ASTERACEAE. The root and shoots have been used for food.%A%    
% 218.86/219.07  |- mesh__publicMeSHNote mesh__D031188 2003   
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D031188 2006
% 218.86/219.07  |- mesh__dateEstablished mesh__D031188 2003-01-01
% 218.86/219.07  |- mesh__historyNote mesh__D031188 2003   
% 218.86/219.07  |- skos__altLabel mesh__D031188 Salsify, Yellow
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D031188 2005
% 218.86/219.07  |- mesh__dateCreated mesh__D031188 2002-07-03
% 218.86/219.07  |- rdf__type mesh__D031188sskos__Concept
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D031188 2004
% 218.86/219.07  |- mesh__publicMeSHNote mesh__D003497 68   
% 218.86/219.07  |- skos__hiddenLabel mesh__D003497 N Oxides, Cyclic
% 218.86/219.07  |- skos__scopeNote mesh__D003497
% 218.86/219.07       Heterocyclic compounds in which an oxygen is attached to a cyclic nitrogen. They include PYRROLIZIDINE ALKALOIDS; QUINOLIZINES; INDOLES; and TROPANES.%A%    
% 218.86/219.07  |- skos__hiddenLabel mesh__D003497 N-Oxides, Heterocyclic
% 218.86/219.07  |- skos__altLabel mesh__D003497 Heterocyclic N-Oxides
% 218.86/219.07  |- rdf__type mesh__D003497sskos__Concept
% 218.86/219.07  |- mesh__dateCreated mesh__D003497 1999-01-01
% 218.86/219.07  |- mesh__recordMaintainer mesh__D003497 ssb
% 218.86/219.07  |- skos__broader mesh__D003497smesh__D006577
% 218.86/219.07  |- mesh__dateRevised mesh__D003497 2004-07-07
% 218.86/219.07  |- skos__hiddenLabel mesh__D003497 Heterocyclic N Oxides
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D003497 2005
% 218.86/219.07  |- skos__altLabel mesh__D003497 Cyclic N Oxides
% 218.86/219.07  |- mesh__historyNote mesh__D003497 68   
% 218.86/219.07  |- skos__hiddenLabel mesh__D003497 N-Oxides, Cyclic
% 218.86/219.07  |- mesh__recordOriginator mesh__D003497 NLM
% 218.86/219.07  |- mesh__recordAuthorizer mesh__D003497 sjn
% 218.86/219.07  |- skos__prefLabel mesh__D003497 Cyclic N-Oxides
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D003497 2006
% 218.86/219.07  |- mesh__dateEstablished mesh__D003497 1968-01-01
% 218.86/219.07  |- skos__hiddenLabel mesh__D003497 Oxides, Cyclic N
% 218.86/219.07  |- skos__historyNote mesh__D003497 Oxides %28%1966-1967%29%
% 218.86/219.07  |- skos__hiddenLabel mesh__D011929 ICRF 159
% 218.86/219.07  |- skos__broader mesh__D011929smesh__D010879
% 218.86/219.07  |- skos__hiddenLabel mesh__D011929 NSC129943
% 218.86/219.07  |- mesh__dateEstablished mesh__D011929 1991-01-01
% 218.86/219.07  |- mesh__historyNote mesh__D011929
% 218.86/219.07       91%28%79%29%; was see under PIPERAZINES 1979-90; was ICRF 159 see under PIPERAZINES 1975-78%A%  
% 218.86/219.07  |- skos__altLabel mesh__D011929 Cardioxan
% 218.86/219.07  |- skos__prefLabel mesh__D011929 Razoxane
% 218.86/219.07  |- skos__scopeNote mesh__D011929
% 218.86/219.07       An antimitotic agent with immunosuppressive properties. Dexrazoxane, the %28%+%29%-enantiomorph of razoxane, provides cardioprotection against anthracycline toxicity. It appears to inhibit formation of a toxic iron-anthracycline complex.%A%    
% 218.86/219.07  |- skos__hiddenLabel mesh__D011929 ICRF187
% 218.86/219.07  |- rdf__type mesh__D011929sskos__Concept
% 218.86/219.07  |- mesh__dateCreated mesh__D011929 1974-11-19
% 218.86/219.07  |- skos__hiddenLabel mesh__D011929 ICRF159
% 218.86/219.07  |- skos__hiddenLabel mesh__D011929 ICRF 186
% 218.86/219.07  |- mesh__recordMaintainer mesh__D011929 exl
% 218.86/219.07  |- mesh__recordOriginator mesh__D011929 NLM
% 218.86/219.07  |- skos__hiddenLabel mesh__D011929 NSC 129943
% 218.86/219.07  |- skos__hiddenLabel mesh__D011929 ADR 529
% 218.86/219.07  |- mesh__recordAuthorizer mesh__D011929 sjn
% 218.86/219.07  |- skos__hiddenLabel mesh__D011929 ICRF 187
% 218.86/219.07  |- mesh__publicMeSHNote mesh__D011929
% 218.86/219.07       91; was see under PIPERAZINES 1979-90; was ICRF 159 see under PIPERAZINES 1975-78%A%  
% 218.86/219.07  |- skos__historyNote mesh__D011929 Piperazines %28%1966-1974%29%
% 218.86/219.07  |- skos__hiddenLabel mesh__D011929 ADR529
% 218.86/219.07  |- mesh__dateRevised mesh__D011929 2005-06-30
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D011929 2006
% 218.86/219.07  |- skos__hiddenLabel mesh__D011929 ICRF186
% 218.86/219.07  |- mesh__onlineNote mesh__D011929
% 218.86/219.07       use RAZOXANE to search ICRF 159 1975-78   
% 218.86/219.07  |- skos__historyNote mesh__D011929 Propane %28%1973-1974%29%
% 218.86/219.07  |- skos__annotation mesh__D008980
% 218.86/219.07       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% + SARCOMA, EXPERIMENTAL %28%IM%29%%A%  
% 218.86/219.07  |- skos__scopeNote mesh__D008980
% 218.86/219.07       A replication-defective murine sarcoma virus %28%SARCOMA VIRUSES, MURINE%29% isolated from a rhabdomyosarcoma by Moloney in 1966.%A%    
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D008980 2005
% 218.86/219.07  |- mesh__recordAuthorizer mesh__D008980 sjn
% 218.86/219.07  |- mesh__recordMaintainer mesh__D008980 ags
% 218.86/219.07  |- skos__historyNote mesh__D008980 Mouse Sarcoma Viruses %28%1980-1984%29%
% 218.86/219.07  |- mesh__dateRevised mesh__D008980 2002-07-03
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D008980 2006
% 218.86/219.07  |- mesh__dateCreated mesh__D008980 1984-04-06
% 218.86/219.07  |- skos__altLabel mesh__D008980 Moloney Sarcoma Virus
% 218.86/219.07  |- skos__prefLabel mesh__D008980 Moloney murine sarcoma virus
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D008980 2003
% 218.86/219.07  |- skos__broader mesh__D008980smesh__D009053
% 218.86/219.07  |- mesh__publicMeSHNote mesh__D008980
% 218.86/219.07       2002; see MOLONEY SARCOMA VIRUS 1991-2001, see MOUSE SARCOMA VIRUSES 1985-1990%A%  
% 218.86/219.07  |- mesh__historyNote mesh__D008980 2002 %28%1985%29%   
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D008980 2004
% 218.86/219.07  |- rdf__type mesh__D008980sskos__Concept
% 218.86/219.07  |- skos__hiddenLabel mesh__D008980 Sarcoma Virus, Moloney
% 218.86/219.07  |- mesh__dateEstablished mesh__D008980 1991-01-01
% 218.86/219.07  |- mesh__recordOriginator mesh__D008980 RC
% 218.86/219.07  |- skos__hiddenLabel mesh__D008980 Virus, Moloney Sarcoma
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D008182 2001
% 218.86/219.07  |- skos__hiddenLabel mesh__D008182
% 218.86/219.07       Battery, Luria-Nebraska Neuropsychological
% 218.86/219.07  |- rdf__type mesh__D008182sskos__Concept
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D008182 1997
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D008182 2002
% 218.86/219.07  |- mesh__recordMaintainer mesh__D008182 JLS
% 218.86/219.07  |- skos__broader mesh__D008182smesh__D009483
% 218.86/219.07  |- skos__prefLabel mesh__D008182 Luria-Nebraska Neuropsychological Battery
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D008182 2005
% 218.86/219.07  |- skos__hiddenLabel mesh__D008182
% 218.86/219.07       Neuropsychological Battery, Luria Nebraska
% 218.86/219.07  |- mesh__dateRevised mesh__D008182 1993-06-04
% 218.86/219.07  |- mesh__historyNote mesh__D008182
% 218.86/219.07       91%28%85%29%; was see under NEUROPSYCHOLOGICAL TESTS 1985-90   
% 218.86/219.07  |- skos__altLabel mesh__D008182 Neuropsychological Battery, Luria-Nebraska
% 218.86/219.07  |- skos__altLabel mesh__D008182 Luria-Nebraska Neuropsychologic Battery
% 218.86/219.07  |- mesh__recordOriginator mesh__D008182 EC
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D008182 2006
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D008182 2003
% 218.86/219.07  |- skos__annotation mesh__D008182 DF: LURIA   
% 218.86/219.07  |- skos__altLabel mesh__D008182 Luria Nebraska Neuropsychologic Battery
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D008182 1994
% 218.86/219.07  |- skos__historyNote mesh__D008182 Psychological Tests %28%1966-1984%29%
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D008182 2004
% 218.86/219.07  |- mesh__dateCreated mesh__D008182 1984-04-13
% 218.86/219.07  |- skos__altLabel mesh__D008182 Luria Nebraska Neuropsychological Battery
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D008182 1998
% 218.86/219.07  |- skos__scopeNote mesh__D008182
% 218.86/219.07       A series of tests designed to assess neuropsychological function. The battery is used to diagnose specific cerebral dysfunction and also to determine lateralization.%A%    
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D008182 1995
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D008182 2000
% 218.86/219.07  |- skos__hiddenLabel mesh__D008182 Neuropsychologic Battery, Luria-Nebraska
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D008182 1999
% 218.86/219.07  |- mesh__recordAuthorizer mesh__D008182 PLS
% 218.86/219.07  |- mesh__dateEstablished mesh__D008182 1991-01-01
% 218.86/219.07  |- mesh__publicMeSHNote mesh__D008182
% 218.86/219.07       91; was see under NEUROPSYCHOLOGICAL TESTS 1985-90   
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D008182 1996
% 218.86/219.07  |- skos__related mesh__D007888smesh__D030401
% 218.86/219.07  |- skos__altLabel mesh__D007888 Infantile Leigh Disease
% 218.86/219.07  |- skos__historyNote mesh__D007888 Brain Diseases %28%1966-1984%29%
% 218.86/219.07  |- skos__related mesh__D007888smesh__D015325
% 218.86/219.07  |- mesh__publicMeSHNote mesh__D007888
% 218.86/219.07       1991; see BRAIN DISEASES, METABOLIC 1985-1990   
% 218.86/219.07  |- skos__altLabel mesh__D007888 Subacute Necrotizing Encephalopathy
% 218.86/219.07  |- skos__hiddenLabel mesh__D007888 Subacute Necrotizing Encephalomyelopathy
% 218.86/219.07  |- skos__hiddenLabel mesh__D007888
% 218.86/219.07       Necrotizing Encephalomyelopathy, Subacute
% 218.86/219.07  |- mesh__dateCreated mesh__D007888 1984-04-06
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D007888 2004
% 218.86/219.07  |- skos__altLabel mesh__D007888
% 218.86/219.07       Subacute Necrotizing Encephalopathy, Juvenile
% 218.86/219.07  |- mesh__historyNote mesh__D007888 1991%28%1985%29%   
% 218.86/219.07  |- skos__altLabel mesh__D007888 Encephalomyelopathy, Subacute Necrotizing
% 218.86/219.07  |- skos__altLabel mesh__D007888 Leigh Disease, Infantile
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D007888 2002
% 218.86/219.07  |- skos__hiddenLabel mesh__D007888 Subacute Necrotizing Encephalomyelitides
% 218.86/219.07  |- mesh__recordOriginator mesh__D007888 RC
% 218.86/219.07  |- skos__hiddenLabel mesh__D007888 Necrotizing Encephalopathies, Subacute
% 218.86/219.07  |- skos__hiddenLabel mesh__D007888
% 218.86/219.07       Encephalomyelopathies, Subacute Necrotizing
% 218.86/219.07  |- skos__altLabel mesh__D007888 Juvenile Leigh Disease
% 218.86/219.07  |- skos__altLabel mesh__D007888
% 218.86/219.07       Juvenile Subacute Necrotizing Encephalopathy
% 218.86/219.07  |- skos__hiddenLabel mesh__D007888 Leighs Disease
% 218.86/219.07  |- skos__altLabel mesh__D007888
% 218.86/219.07       Infantile Subacute Necrotizing Encephalopathy
% 218.86/219.07  |- skos__hiddenLabel mesh__D007888 Encephalopathies, Subacute Necrotizing
% 218.86/219.07  |- skos__altLabel mesh__D007888
% 218.86/219.07       Subacute Necrotizing Encephalopathy, Infantile
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D007888 2003
% 218.86/219.07  |- skos__scopeNote mesh__D007888
% 218.86/219.07       A group of metabolic disorders primarily of infancy characterized by the subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, dysphagia, and lactic acidosis. Pathological features include spongy degeneration of the neuropile of the basal ganglia, thalamus, brain stem, and spinal cord. Patterns of inheritance include X-linked recessive, autosomal recessive, and mitochondrial. Leigh disease has been associated with mutations in genes for the PYRUVATE DEHYDROGENASE COMPLEX; CYTOCHROME-C OXIDASE; ATP synthase subunit 6; and subunits of mitochondrial complex I. %28%From Menkes, Textbook of Child Neurology, 5th ed, p850%29%.%A%    
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D007888 2006
% 218.86/219.07  |- skos__hiddenLabel mesh__D007888 Subacute Necrotizing Encephalomyelitis
% 218.86/219.07  |- skos__hiddenLabel mesh__D007888
% 218.86/219.07       Encephalomyelitides, Subacute Necrotizing
% 218.86/219.07  |- mesh__dateRevised mesh__D007888 2001-07-25
% 218.86/219.07  |- mesh__recordAuthorizer mesh__D007888 sjn
% 218.86/219.07  |- skos__altLabel mesh__D007888 Encephalopathy, Subacute Necrotizing
% 218.86/219.07  |- skos__hiddenLabel mesh__D007888
% 218.86/219.07       Necrotizing Encephalomyelitides, Subacute
% 218.86/219.07  |- skos__altLabel mesh__D007888 Leigh Disease, Juvenile
% 218.86/219.07  |- skos__broader mesh__D007888smesh__D028361
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D007888 2005
% 218.86/219.07  |- mesh__dateEstablished mesh__D007888 1991-01-01
% 218.86/219.07  |- mesh__recordMaintainer mesh__D007888 nns
% 218.86/219.07  |- skos__prefLabel mesh__D007888 Leigh Disease
% 218.86/219.07  |- skos__hiddenLabel mesh__D007888 Disease, Leigh%27%s
% 218.86/219.07  |- skos__historyNote mesh__D007888
% 218.86/219.07       Pyruvate Carboxylase/deficiency %28%1975-1984%29%
% 218.86/219.07  |- rdf__type mesh__D007888sskos__Concept
% 218.86/219.07  |- skos__hiddenLabel mesh__D007888
% 218.86/219.07       Subacute Necrotizing Encephalomyelopathies
% 218.86/219.07  |- skos__altLabel mesh__D007888
% 218.86/219.07       Subacute Necrotizing Encephalomyelitis, Infantile
% 218.86/219.07  |- skos__hiddenLabel mesh__D007888 Necrotizing Encephalomyelitis, Subacute
% 218.86/219.07  |- skos__hiddenLabel mesh__D007888
% 218.86/219.07       Necrotizing Encephalomyelopathies, Subacute
% 218.86/219.07  |- skos__hiddenLabel mesh__D007888 Subacute Necrotizing Encephalopathies
% 218.86/219.07  |- skos__broader mesh__D007888smesh__D015323
% 218.86/219.07  |- skos__broader mesh__D007888smesh__D020739
% 218.86/219.07  |- skos__altLabel mesh__D007888 Leigh%27%s Disease
% 218.86/219.07  |- skos__altLabel mesh__D007888 Leigh Syndrome
% 218.86/219.07  |- skos__historyNote mesh__D007888 Encephalomalacia %28%1966-1984%29%
% 218.86/219.07  |- skos__altLabel mesh__D007888 Encephalomyelitis, Subacute Necrotizing
% 218.86/219.07  |- skos__hiddenLabel mesh__D007888 Necrotizing Encephalopathy, Subacute
% 218.86/219.07  |- mesh__historyNote mesh__D032281 2003   
% 218.86/219.07  |- mesh__dateEstablished mesh__D032281 2003-01-01
% 218.86/219.07  |- rdf__type mesh__D032281sskos__Concept
% 218.86/219.07  |- mesh__dateCreated mesh__D032281 2002-07-03
% 218.86/219.07  |- skos__prefLabel mesh__D032281 Smilax
% 218.86/219.07  |- mesh__publicMeSHNote mesh__D032281 2003   
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D032281 2004
% 218.86/219.07  |- skos__scopeNote mesh__D032281
% 218.86/219.07       A plant genus of the family SMILACACEAE. Members contain smiglasides %28%phenylpropanoid glycosides%29% and steroidal saponins. Commercially it is sometimes adulterated with HEMIDESMUS, which would affect experimental results.%A%    
% 218.86/219.07  |- skos__altLabel mesh__D032281 Sarsaparilla
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D032281 2003
% 218.86/219.07  |- skos__altLabel mesh__D032281 Zarzaparilla
% 218.86/219.07  |- skos__broader mesh__D032281smesh__D029642
% 218.86/219.07  |- skos__annotation mesh__D032281
% 218.86/219.07       X ref SARSAPARILLA: SARSAPARILLA, WILD see ARALIA and SARSAPARILLA, EAST INDIAN see HEMIDESMUS are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D032281 2006
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D032281 2005
% 218.86/219.07  |- rdf__type mesh__D004590sskos__Concept
% 218.86/219.07  |- mesh__recordAuthorizer mesh__D004590 sjn
% 218.86/219.07  |- mesh__recordOriginator mesh__D004590 NLM
% 218.86/219.07  |- mesh__publicMeSHNote mesh__D004590
% 218.86/219.07       91,73-86; was see under ELECTROPHORESIS 1987-90; was heading 1973-86%A%  
% 218.86/219.07  |- mesh__recordMaintainer mesh__D004590 lkt
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D004590 2004
% 218.86/219.07  |- skos__scopeNote mesh__D004590
% 218.86/219.07       Electrophoresis in which paper is used as the diffusion medium. This technique is confined almost entirely to separations of small molecules such as amino acids, peptides, and nucleotides, and relatively high voltages are nearly always used.%A%    
% 218.86/219.07  |- mesh__historyNote mesh__D004590
% 218.86/219.07       91%28%87%29%73%28%71%29%; was see under ELECTROPHORESIS 1987-90; was heading 1971-86 %28%Prov 1971-73%29%%A%  
% 218.86/219.07  |- skos__historyNote mesh__D004590 Electrophoresis %28%1966-1970%29%
% 218.86/219.07  |- mesh__dateRevised mesh__D004590 2002-07-03
% 218.86/219.07  |- skos__hiddenLabel mesh__D004590 Paper Electrophoresis
% 218.86/219.07  |- mesh__dateCreated mesh__D004590 1999-01-01
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D004590 2005
% 218.86/219.07  |- skos__prefLabel mesh__D004590 Electrophoresis, Paper
% 218.86/219.07  |- skos__broader mesh__D004590smesh__D004586
% 218.86/219.07  |- mesh__dateEstablished mesh__D004590 1973-01-01
% 218.86/219.07  |- skos__annotation mesh__D004590 NIM   
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D004590 2006
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D004590 2003
% 218.86/219.07  |- skos__broader mesh__D012224smesh__D012625
% 218.86/219.07  |- skos__hiddenLabel mesh__D012224 Rhinophymas
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D012224 2006
% 218.86/219.07  |- mesh__recordAuthorizer mesh__D012224 sjn
% 218.86/219.07  |- skos__broader mesh__D012224smesh__D012393
% 218.86/219.07  |- mesh__dateCreated mesh__D012224 1999-01-01
% 218.86/219.07  |- skos__scopeNote mesh__D012224
% 218.86/219.07       A manifestation of severe ROSACEA resulting in significant enlargement of the NOSE and occurring primarily in men. It is caused by hypertrophy of the SEBACEOUS GLANDS and surrounding CONNECTIVE TISSUE. The nose is reddened and marked with TELANGIECTASIS.%A%    
% 218.86/219.07  |- mesh__recordOriginator mesh__D012224 NLM
% 218.86/219.07  |- rdf__type mesh__D012224sskos__Concept
% 218.86/219.07  |- skos__prefLabel mesh__D012224 Rhinophyma
% 218.86/219.07  |- mesh__publicMeSHNote mesh__D012224 91; was see under ROSACEA 1975-90   
% 218.86/219.07  |- mesh__historyNote mesh__D012224
% 218.86/219.07       91%28%75%29%; was see under ROSACEA 1975-90   
% 218.86/219.07  |- mesh__onlineNote mesh__D012224 search ROSACEA 1966-74   
% 218.86/219.07  |- mesh__dateEstablished mesh__D012224 1991-01-01
% 218.86/219.07  |- mesh__dateRevised mesh__D012224 2004-07-07
% 218.86/219.07  |- mesh__recordMaintainer mesh__D012224 lkt
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D012224 2005
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D031987 2003
% 218.86/219.07  |- skos__broader mesh__D031987smesh__D027824
% 218.86/219.07  |- skos__altLabel mesh__D031987 Cinquefoil
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D031987 2004
% 218.86/219.07  |- mesh__dateEstablished mesh__D031987 2003-01-01
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D031987 2005
% 218.86/219.07  |- mesh__publicMeSHNote mesh__D031987 2003   
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D031987 2006
% 218.86/219.07  |- skos__prefLabel mesh__D031987 Potentilla
% 218.86/219.07  |- skos__altLabel mesh__D031987 Silverweed
% 218.86/219.07  |- mesh__historyNote mesh__D031987 2003   
% 218.86/219.07  |- mesh__dateCreated mesh__D031987 2002-07-03
% 218.86/219.07  |- skos__scopeNote mesh__D031987
% 218.86/219.07       A plant genus of the family ROSACEAE. Members contain procyanidins and TANNINS.%A%    
% 218.86/219.07  |- rdf__type mesh__D031987sskos__Concept
% 218.86/219.07  |- skos__annotation mesh__D031987
% 218.86/219.07       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.07  |- skos__hiddenLabel mesh__D003498 Oxides, Cyclic P
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D003498 2006
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D003498 2003
% 218.86/219.07  |- mesh__recordOriginator mesh__D003498 NLM
% 218.86/219.07  |- mesh__historyNote mesh__D003498 68   
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D003498 1997
% 218.86/219.07  |- skos__historyNote mesh__D003498 Oxides %28%1966-1967%29%
% 218.86/219.07  |- mesh__dateCreated mesh__D003498 1999-01-01
% 218.86/219.07  |- skos__hiddenLabel mesh__D003498 P Oxides, Cyclic
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D003498 2005
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D003498 1999
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D003498 1993
% 218.86/219.07  |- skos__prefLabel mesh__D003498 Cyclic P-Oxides
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D003498 2002
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D003498 1996
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D003498 1995
% 218.86/219.07  |- mesh__dateEstablished mesh__D003498 1968-01-01
% 218.86/219.07  |- skos__hiddenLabel mesh__D003498 P-Oxides, Heterocyclic
% 218.86/219.07  |- mesh__recordAuthorizer mesh__D003498 PLS
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D003498 1998
% 218.86/219.07  |- rdf__type mesh__D003498sskos__Concept
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D003498 2001
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D003498 1994
% 218.86/219.07  |- mesh__publicMeSHNote mesh__D003498 68   
% 218.86/219.07  |- skos__altLabel mesh__D003498 Heterocyclic P-Oxides
% 218.86/219.07  |- skos__altLabel mesh__D003498 Cyclic P Oxides
% 218.86/219.07  |- mesh__dateRevised mesh__D003498 1992-05-11
% 218.86/219.07  |- skos__hiddenLabel mesh__D003498 Heterocyclic P Oxides
% 218.86/219.07  |- skos__broader mesh__D003498smesh__D006577
% 218.86/219.07  |- mesh__recordMaintainer mesh__D003498 TAP
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D003498 2000
% 218.86/219.07  |- skos__hiddenLabel mesh__D003498 P-Oxides, Cyclic
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D003498 2004
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 Molsidomine Heumann Brand
% 218.86/219.07  |- skos__altLabel mesh__D008981 Aventis Brand of Molsidomine
% 218.86/219.07  |- mesh__activeMeSHYear mesh__D008981 2006
% 218.86/219.07  |- skos__altLabel mesh__D008981 ratiopharm Brand of Molsidomine
% 218.86/219.07  |- skos__altLabel mesh__D008981 Sanol Brand of Molsidomine
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 Molsidomine Salutas Brand
% 218.86/219.07  |- skos__altLabel mesh__D008981 Korvatone
% 218.86/219.07  |- mesh__dateCreated mesh__D008981 1986-06-12
% 218.86/219.07  |- skos__historyNote mesh__D008981 Sydnones %28%1975-1986%29%
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 Molsidomine Stadapharm Brand
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 Molsidomin ratiopharm
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 Molsidomine Sanol Brand
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 Molsidomine 1A Brand
% 218.86/219.07  |- mesh__recordOriginator mesh__D008981 RLS
% 218.86/219.07  |- skos__altLabel mesh__D008981 Morsydomine
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 Molsidomine Azupharma Brand
% 218.86/219.07  |- skos__broader mesh__D008981smesh__D009025
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 Molsidomine Hexal Brand
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 Molsidomine MTW Brand
% 218.86/219.07  |- rdf__type mesh__D008981sskos__Concept
% 218.86/219.07  |- skos__altLabel mesh__D008981 ct-Arzneimittel Brand of Molsidomine
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 Molsidomine betapharm Brand
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 Molsidomine Normon Brand
% 218.86/219.07  |- skos__altLabel mesh__D008981 Merck dura Brand of Molsidomine
% 218.86/219.07  |- skos__altLabel mesh__D008981 Azupharma Brand of Molsidomine
% 218.86/219.07  |- skos__altLabel mesh__D008981 Normon Brand of Molsidomine
% 218.86/219.07  |- skos__broader mesh__D008981smesh__D013558
% 218.86/219.07  |- skos__altLabel mesh__D008981 Molsidomin
% 218.86/219.07  |- skos__altLabel mesh__D008981 Molsicor
% 218.86/219.07  |- skos__altLabel mesh__D008981 MTW Brand of Molsidomine
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 Molsidominratiopharm
% 218.86/219.07  |- skos__altLabel mesh__D008981 betapharm Brand of Molsidomine
% 218.86/219.07  |- skos__historyNote mesh__D008981 Oxadiazoles %28%1966-1974%29%
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 Molsidomine Schwarz Brand
% 218.86/219.07  |- mesh__publicMeSHNote mesh__D008981 87   
% 218.86/219.07  |- skos__historyNote mesh__D008981 Morpholines %28%1966-1982%29%
% 218.86/219.07  |- mesh__recordMaintainer mesh__D008981 ssb
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 Molsidomine ct-Arzneimittel Brand
% 218.86/219.07  |- mesh__historyNote mesh__D008981 87   
% 218.86/219.07  |- mesh__recordAuthorizer mesh__D008981 sjn
% 218.86/219.07  |- skos__prefLabel mesh__D008981 Molsidomine
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 ct Arzneimittel Brand of Molsidomine
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 Molsidomine Aventis Brand
% 218.86/219.07  |- skos__altLabel mesh__D008981 Molsidain
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 Molsidomine Alpharma Brand
% 218.86/219.07  |- skos__altLabel mesh__D008981 Hexal Brand of Molsidomine
% 218.86/219.07  |- mesh__dateEstablished mesh__D008981 1987-01-01
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 Heumann, Molsidomin
% 218.86/219.07  |- skos__scopeNote mesh__D008981
% 218.86/219.07       A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.%A%    
% 218.86/219.07  |- skos__altLabel mesh__D008981 Schwarz Brand of Molsidomine
% 218.86/219.07  |- skos__altLabel mesh__D008981 Heumann Brand of Molsidomine
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 Molsi Puren
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 Fali Cor
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 Molsi AZU
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 SIN10
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 SIN 10
% 218.86/219.07  |- skos__altLabel mesh__D008981 1A Brand of Molsidomine
% 218.86/219.07  |- skos__altLabel mesh__D008981 Alpharma Brand of Molsidomine
% 218.86/219.07  |- skos__altLabel mesh__D008981 Stadapharm Brand of Molsidomine
% 218.86/219.07  |- skos__altLabel mesh__D008981 Salutas Brand of Molsidomine
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 Molsidomine ratiopharm Brand
% 218.86/219.07  |- mesh__dateRevised mesh__D008981 2005-06-30
% 218.86/219.07  |- skos__hiddenLabel mesh__D008981 MTW Molsidomin
% 218.86/219.08  |- skos__altLabel mesh__D008183 Menstrual Cycle, Luteal Phase
% 218.86/219.08  |- mesh__dateRevised mesh__D008183 2004-07-07
% 218.86/219.08  |- mesh__dateEstablished mesh__D008183 1985-01-01
% 218.86/219.08  |- skos__hiddenLabel mesh__D008183 Secretory Phase, Menstrual
% 218.86/219.08  |- skos__prefLabel mesh__D008183 Luteal Phase
% 218.86/219.08  |- skos__hiddenLabel mesh__D008183 Phase, Luteal
% 218.86/219.08  |- mesh__dateCreated mesh__D008183 1974-11-11
% 218.86/219.08  |- rdf__type mesh__D008183sskos__Concept
% 218.86/219.08  |- mesh__recordMaintainer mesh__D008183 lkt
% 218.86/219.08  |- skos__altLabel mesh__D008183 Postovulatory Phase
% 218.86/219.08  |- mesh__recordOriginator mesh__D008183 NLM
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D008183 2006
% 218.86/219.08  |- skos__hiddenLabel mesh__D008183 Phase, Postovulatory
% 218.86/219.08  |- mesh__publicMeSHNote mesh__D008183
% 218.86/219.08       1985; was MENSTRUATION, LUTEAL PHASE see under MENSTRUATION 1975-1984; for MENSTRUAL SECRETORY PHASE see MENSTRUAL CYCLE 1985-2002%A%  
% 218.86/219.08  |- skos__altLabel mesh__D008183 Menstrual Secretory Phase
% 218.86/219.08  |- mesh__historyNote mesh__D008183
% 218.86/219.08       1985%28%1975%29%; was MENSTRUATION, LUTEAL PHASE see under MENSTRUATION 1975-1984; for MENSTRUAL SECRETORY PHASE use MENSTRUAL CYCLE 1985-2002%A%  
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D008183 2005
% 218.86/219.08  |- mesh__recordAuthorizer mesh__D008183 sjn
% 218.86/219.08  |- skos__scopeNote mesh__D008183
% 218.86/219.08       The period in the MENSTRUAL CYCLE that follows OVULATION, characterized by the development of CORPUS LUTEUM, increase in PROGESTERONE production by the OVARY and secretion by the glandular epithelium of the ENDOMETRIUM. The luteal phase begins with ovulation and ends with the onset of MENSTRUATION.%A%    
% 218.86/219.08  |- skos__altLabel mesh__D008183 Menstrual Cycle, Secretory Phase
% 218.86/219.08  |- skos__broader mesh__D008183smesh__D008597
% 218.86/219.08  |- skos__broader mesh__D016615smesh__D022004
% 218.86/219.08  |- mesh__dateRevised mesh__D016615 2003-07-09
% 218.86/219.08  |- mesh__recordMaintainer mesh__D016615 nns
% 218.86/219.08  |- mesh__historyNote mesh__D016615 92   
% 218.86/219.08  |- skos__historyNote mesh__D016615 Chromosomes %28%1976-1991%29%
% 218.86/219.08  |- skos__historyNote mesh__D016615 Base Sequence %28%1979-1991%29%
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D016615 2004
% 218.86/219.08  |- mesh__recordOriginator mesh__D016615 PXP
% 218.86/219.08  |- skos__prefLabel mesh__D016615 Telomere
% 218.86/219.08  |- skos__hiddenLabel mesh__D016615 Telomeres
% 218.86/219.08  |- mesh__recordAuthorizer mesh__D016615 sjn
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D016615 2006
% 218.86/219.08  |- mesh__dateEstablished mesh__D016615 1992-01-01
% 218.86/219.08  |- skos__scopeNote mesh__D016615
% 218.86/219.08       A terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs.%A%    
% 218.86/219.08  |- skos__annotation mesh__D016615
% 218.86/219.08       terminal section of a chromosome involved in chromosomal replication %26% stability; A 11 qualif except /cytol; /genet permitted%A%  
% 218.86/219.08  |- mesh__publicMeSHNote mesh__D016615 92   
% 218.86/219.08  |- rdf__type mesh__D016615sskos__Concept
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D016615 2005
% 218.86/219.08  |- mesh__dateCreated mesh__D016615 1991-01-25
% 218.86/219.08  |- skos__hiddenLabel mesh__D007889 Fibromas, Uterine
% 218.86/219.08  |- skos__hiddenLabel mesh__D007889 Fibroid Tumors
% 218.86/219.08  |- mesh__recordMaintainer mesh__D007889 ags
% 218.86/219.08  |- skos__hiddenLabel mesh__D007889 Fibroid, Uterine
% 218.86/219.08  |- mesh__recordOriginator mesh__D007889 NLM
% 218.86/219.08  |- skos__altLabel mesh__D007889 Fibroid
% 218.86/219.08  |- skos__hiddenLabel mesh__D007889 Fibroids
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D007889 2005
% 218.86/219.08  |- skos__hiddenLabel mesh__D007889 Uterus, Fibroid
% 218.86/219.08  |- skos__broader mesh__D007889smesh__D009379
% 218.86/219.08  |- skos__altLabel mesh__D007889 Fibroids, Uterine
% 218.86/219.08  |- mesh__dateRevised mesh__D007889 2004-07-07
% 218.86/219.08  |- mesh__dateCreated mesh__D007889 1999-01-01
% 218.86/219.08  |- skos__prefLabel mesh__D007889 Leiomyoma
% 218.86/219.08  |- skos__hiddenLabel mesh__D007889 Uterine Fibromas
% 218.86/219.08  |- skos__hiddenLabel mesh__D007889 Tumor, Fibroid
% 218.86/219.08  |- skos__hiddenLabel mesh__D007889 Fibromyomas
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D007889 2006
% 218.86/219.08  |- mesh__recordAuthorizer mesh__D007889 sjn
% 218.86/219.08  |- skos__hiddenLabel mesh__D007889 Leiomyomas
% 218.86/219.08  |- skos__altLabel mesh__D007889 Fibroma, Uterine
% 218.86/219.08  |- skos__hiddenLabel mesh__D007889 Uterine Fibroid
% 218.86/219.08  |- skos__annotation mesh__D007889
% 218.86/219.08       solitary; multiple = LEIOMYOMATOSIS; coord IM with precoord organ/neopl term %28%IM%29%; for X refs FIBROID UTERUS; FIBROIDS, UTERINE %26% FIBROMA, UTERINE: coord with UTERINE NEOPLASMS %28%IM%29%%A%  
% 218.86/219.08  |- mesh__onlineNote mesh__D007889
% 218.86/219.08       use UTERINE NEOPLASMS to search FIBROIDS, UTERINE 1991-93%A%  
% 218.86/219.08  |- skos__altLabel mesh__D007889 Fibromyoma
% 218.86/219.08  |- skos__altLabel mesh__D007889 Fibroid Tumor
% 218.86/219.08  |- skos__hiddenLabel mesh__D007889 Uterine Fibroma
% 218.86/219.08  |- mesh__historyNote mesh__D007889
% 218.86/219.08       FIBROIDS, UTERINE was see UTERINE NEOPLASMS 1991-93   
% 218.86/219.08  |- skos__hiddenLabel mesh__D007889 Tumors, Fibroid
% 218.86/219.08  |- mesh__publicMeSHNote mesh__D007889
% 218.86/219.08       FIBROIDS, UTERINE was see UTERINE NEOPLASMS 1991-93   
% 218.86/219.08  |- skos__scopeNote mesh__D007889
% 218.86/219.08       A benign tumor derived from smooth muscle tissue, also known as a fibroid tumor. They rarely occur outside of the UTERUS and the GASTROINTESTINAL TRACT but can occur in the SKIN and SUBCUTANEOUS TISSUE, probably arising from the smooth muscle of small blood vessels in these tissues.%A%    
% 218.86/219.08  |- rdf__type mesh__D007889sskos__Concept
% 218.86/219.08  |- skos__hiddenLabel mesh__D007889 Uterine Fibroids
% 218.86/219.08  |- rdf__type mesh__D032282sskos__Concept
% 218.86/219.08  |- mesh__publicMeSHNote mesh__D032282 2003   
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D032282 2004
% 218.86/219.08  |- mesh__historyNote mesh__D032282 2003   
% 218.86/219.08  |- skos__prefLabel mesh__D032282 Atropa
% 218.86/219.08  |- skos__scopeNote mesh__D032282
% 218.86/219.08       A plant genus of the family SOLANACEAE which contain SOLANACEOUS ALKALOIDS including ATROPINE which is named after this genus.%A%    
% 218.86/219.08  |- mesh__dateCreated mesh__D032282 2002-07-02
% 218.86/219.08  |- mesh__dateEstablished mesh__D032282 2003-01-01
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D032282 2003
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D032282 2006
% 218.86/219.08  |- skos__annotation mesh__D032282
% 218.86/219.08       prefer specific plant; ATROPA MANDRAGORA see MANDRAGORA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D032282 2005
% 218.86/219.08  |- skos__broader mesh__D032282smesh__D019657
% 218.86/219.08  |- skos__altLabel mesh__D004591 Polyacrylamide Gel Electrophoresis
% 218.86/219.08  |- skos__hiddenLabel mesh__D004591 Gel Electrophoresis, Polyacrylamide
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D004591 2006
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D004591 2004
% 218.86/219.08  |- skos__annotation mesh__D004591
% 218.86/219.08       do not confuse with POLYACRYLAMIDE GEL ELECTROPHORESIS, TWO-DIMENSIONAL see ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; DF: E PAG%A%  
% 218.86/219.08  |- skos__hiddenLabel mesh__D004591 Sodium Dodecyl Sulfate PAGE
% 218.86/219.08  |- rdf__type mesh__D004591sskos__Concept
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D004591 2005
% 218.86/219.08  |- mesh__publicMeSHNote mesh__D004591 73   
% 218.86/219.08  |- skos__broader mesh__D004591smesh__D004586
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D004591 2003
% 218.86/219.08  |- skos__historyNote mesh__D004591 Acrylamides %28%1971-1972%29%
% 218.86/219.08  |- mesh__recordAuthorizer mesh__D004591 sjn
% 218.86/219.08  |- skos__historyNote mesh__D004591 Electrophoresis %28%1966-1972%29%
% 218.86/219.08  |- mesh__recordOriginator mesh__D004591 NLM
% 218.86/219.08  |- mesh__dateEstablished mesh__D004591 1973-01-01
% 218.86/219.08  |- skos__scopeNote mesh__D004591
% 218.86/219.08       Electrophoresis in which a polyacrylamide gel is used as the diffusion medium.%A%    
% 218.86/219.08  |- mesh__recordMaintainer mesh__D004591 lkt
% 218.86/219.08  |- mesh__dateRevised mesh__D004591 2002-07-03
% 218.86/219.08  |- skos__hiddenLabel mesh__D004591 Sodium Dodecyl Sulfate-PAGEs
% 218.86/219.08  |- skos__prefLabel mesh__D004591 Electrophoresis, Polyacrylamide Gel
% 218.86/219.08  |- mesh__historyNote mesh__D004591 73   
% 218.86/219.08  |- mesh__dateCreated mesh__D004591 1999-01-01
% 218.86/219.08  |- skos__hiddenLabel mesh__D004591 SDS PAGE
% 218.86/219.08  |- skos__altLabel mesh__D004591 Sodium Dodecyl Sulfate-PAGE
% 218.86/219.08  |- skos__historyNote mesh__D004591 Electrophoresis, Disc %28%1967-1972%29%
% 218.86/219.08  |- mesh__recordAuthorizer mesh__D012225 sjn
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D012225 2005
% 218.86/219.08  |- mesh__dateCreated mesh__D012225 1999-01-01
% 218.86/219.08  |- skos__broader mesh__D012225smesh__D003357
% 218.86/219.08  |- mesh__recordOriginator mesh__D012225 NLM
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D012225 2006
% 218.86/219.08  |- rdf__type mesh__D012225sskos__Concept
% 218.86/219.08  |- skos__annotation mesh__D012225
% 218.86/219.08       do not use /util except by MeSH definition   
% 218.86/219.08  |- skos__broader mesh__D012225smesh__D019651
% 218.86/219.08  |- skos__scopeNote mesh__D012225
% 218.86/219.08       A plastic surgical operation on the nose, either reconstructive, restorative, or cosmetic. %28%Dorland, 28th ed%29%%A%    
% 218.86/219.08  |- mesh__recordMaintainer mesh__D012225 nns
% 218.86/219.08  |- skos__hiddenLabel mesh__D012225 Rhinoplasties
% 218.86/219.08  |- mesh__dateRevised mesh__D012225 2004-07-07
% 218.86/219.08  |- skos__broader mesh__D012225smesh__D013517
% 218.86/219.08  |- skos__prefLabel mesh__D012225 Rhinoplasty
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D031988 2004
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D031988 2005
% 218.86/219.08  |- skos__altLabel mesh__D031988 Prune, African
% 218.86/219.08  |- mesh__publicMeSHNote mesh__D031988 2003   
% 218.86/219.08  |- skos__altLabel mesh__D031988 African Prune
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D031988 2006
% 218.86/219.08  |- skos__prefLabel mesh__D031988 Pygeum
% 218.86/219.08  |- skos__broader mesh__D031988smesh__D027824
% 218.86/219.08  |- skos__scopeNote mesh__D031988
% 218.86/219.08       A plant genus of the family ROSACEAE. Bark extract of P. africanum is an ingredient of folk remedies to treat PROSTATIC HYPERPLASIA.%A%    
% 218.86/219.08  |- skos__altLabel mesh__D031988 Prunus africana
% 218.86/219.08  |- mesh__dateEstablished mesh__D031988 2003-01-01
% 218.86/219.08  |- rdf__type mesh__D031988sskos__Concept
% 218.86/219.08  |- mesh__historyNote mesh__D031988 2003   
% 218.86/219.08  |- skos__annotation mesh__D031988
% 218.86/219.08       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D031988 2003
% 218.86/219.08  |- mesh__dateCreated mesh__D031988 2002-07-02
% 218.86/219.08  |- mesh__dateCreated mesh__D003499 1999-01-01
% 218.86/219.08  |- mesh__dateEstablished mesh__D003499 1968-01-01
% 218.86/219.08  |- skos__altLabel mesh__D003499 Cyclic S Oxides
% 218.86/219.08  |- mesh__recordAuthorizer mesh__D003499 sjn
% 218.86/219.08  |- mesh__recordOriginator mesh__D003499 NLM
% 218.86/219.08  |- mesh__historyNote mesh__D003499 68   
% 218.86/219.08  |- rdf__type mesh__D003499sskos__Concept
% 218.86/219.08  |- skos__historyNote mesh__D003499 Oxides %28%1966-1967%29%
% 218.86/219.08  |- skos__hiddenLabel mesh__D003499 Heterocyclic S Oxides
% 218.86/219.08  |- mesh__publicMeSHNote mesh__D003499 68   
% 218.86/219.08  |- skos__broader mesh__D003499smesh__D006577
% 218.86/219.08  |- mesh__recordMaintainer mesh__D003499 ssb
% 218.86/219.08  |- skos__hiddenLabel mesh__D003499 S-Oxides, Cyclic
% 218.86/219.08  |- skos__hiddenLabel mesh__D003499 S Oxides, Cyclic
% 218.86/219.08  |- skos__hiddenLabel mesh__D003499 S-Oxides, Heterocyclic
% 218.86/219.08  |- skos__altLabel mesh__D003499 Heterocyclic S-Oxides
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D003499 2006
% 218.86/219.08  |- skos__prefLabel mesh__D003499 Cyclic S-Oxides
% 218.86/219.08  |- skos__hiddenLabel mesh__D003499 Oxides, Cyclic S
% 218.86/219.08  |- mesh__dateRevised mesh__D003499 2005-06-30
% 218.86/219.08  |- skos__broader mesh__D003499smesh__D013457
% 218.86/219.08  |- mesh__recordOriginator mesh__D008982 NLM
% 218.86/219.08  |- rdf__type mesh__D008982sskos__Concept
% 218.86/219.08  |- skos__annotation mesh__D008982
% 218.86/219.08       Mo-98; Mo-92, 94-97, 100 = MOLYBDENUM %28%IM%29% + ISOTOPES %28%NIM%29%; Mo-88-91, 93, 99, 101-105 = MOLYBDENUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 218.86/219.08  |- skos__scopeNote mesh__D008982
% 218.86/219.08       A metallic element with the atomic symbol Mo, atomic number 42, and atomic weight 95.94. It is an essential trace element, being a component of the enzymes xanthine oxidase, aldehyde oxidase, and nitrate reductase. %28%From Dorland, 27th ed%29%%A%    
% 218.86/219.08  |- mesh__dateCreated mesh__D008982 1999-01-01
% 218.86/219.08  |- skos__prefLabel mesh__D008982 Molybdenum
% 218.86/219.08  |- mesh__dateRevised mesh__D008982 2005-06-30
% 218.86/219.08  |- skos__broader mesh__D008982smesh__D019216
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D008982 2006
% 218.86/219.08  |- mesh__recordAuthorizer mesh__D008982 sjn
% 218.86/219.08  |- skos__broader mesh__D008982smesh__D028561
% 218.86/219.08  |- mesh__recordMaintainer mesh__D008982 ssb
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Luteal Cell, Small
% 218.86/219.08  |- skos__altLabel mesh__D008184 Theca-Lutein Cells
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Luteal Cell, Large
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Luteal Cells, Large
% 218.86/219.08  |- mesh__recordAuthorizer mesh__D008184 sjn
% 218.86/219.08  |- mesh__dateRevised mesh__D008184 2002-07-03
% 218.86/219.08  |- skos__altLabel mesh__D008184 Granulosa-Lutein Cells
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Cells, Large Luteal
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Cell, Large Luteal
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Cells, Small Luteal
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Cells, Luteal
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 cell, Theca-Luteal
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Granulosa Lutein Cells
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Luteal Cells, Small
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Granulosa-Luteal Cell
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Cells, Lutein
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Granulosa Luteal Cells
% 218.86/219.08  |- skos__prefLabel mesh__D008184 Luteal Cells
% 218.86/219.08  |- skos__altLabel mesh__D008184 Lutein Cells
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D008184 2005
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Cell, Theca-Lutein
% 218.86/219.08  |- mesh__publicMeSHNote mesh__D008184
% 218.86/219.08       91; was see under CORPUS LUTEUM 1975-90   
% 218.86/219.08  |- mesh__recordMaintainer mesh__D008184 lkt
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Granulosa-Lutein Cell
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Cell, Granulosa-Luteal
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Theca Lutein Cells
% 218.86/219.08  |- skos__altLabel mesh__D008184 Theca-Luteal cells
% 218.86/219.08  |- mesh__historyNote mesh__D008184
% 218.86/219.08       91%28%75%29%; was see under CORPUS LUTEUM 1975-90   
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Cell, Granulosa-Lutein
% 218.86/219.08  |- skos__altLabel mesh__D008184 Granulosa-Luteal Cells
% 218.86/219.08  |- skos__scopeNote mesh__D008184
% 218.86/219.08       PROGESTERONE-producing cells in the CORPUS LUTEUM. The large luteal cells derive from the GRANULOSA CELLS. The small luteal cells derive from the THECA CELLS.%A%    
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Cell, Small Luteal
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Luteal Cell
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D008184 2006
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 cells, Theca-Luteal
% 218.86/219.08  |- mesh__dateCreated mesh__D008184 1974-11-11
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D008184 2003
% 218.86/219.08  |- skos__broader mesh__D008184smesh__D002477
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Theca-Lutein Cell
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Large Luteal Cell
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Cells, Theca-Lutein
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Lutein Cell
% 218.86/219.08  |- mesh__recordOriginator mesh__D008184 NLM
% 218.86/219.08  |- rdf__type mesh__D008184sskos__Concept
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D008184 2004
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Cells, Granulosa-Luteal
% 218.86/219.08  |- skos__broader mesh__D008184smesh__D003338
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Cell, Luteal
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Small Luteal Cell
% 218.86/219.08  |- mesh__dateEstablished mesh__D008184 1991-01-01
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Theca Luteal cells
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Theca-Luteal cell
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Cells, Granulosa-Lutein
% 218.86/219.08  |- skos__hiddenLabel mesh__D008184 Cell, Lutein
% 218.86/219.08  |- mesh__recordMaintainer mesh__D016616 TAP
% 218.86/219.08  |- mesh__dateEstablished mesh__D016616 1992-01-01
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D016616 2001
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D016616 2003
% 218.86/219.08  |- mesh__historyNote mesh__D016616 92   
% 218.86/219.08  |- skos__hiddenLabel mesh__D016616 Sectioning, Freeze
% 218.86/219.08  |- skos__scopeNote mesh__D016616
% 218.86/219.08       The technique of using a cryostat or freezing microtome, in which the temperature is regulated to -20 degrees Celsius, to cut ultrathin frozen sections for microscopic %28%usually, electron microscopic%29% examination.%A%    
% 218.86/219.08  |- skos__altLabel mesh__D016616 Cryosectioning
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D016616 2002
% 218.86/219.08  |- mesh__publicMeSHNote mesh__D016616 92   
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D016616 2004
% 218.86/219.08  |- mesh__dateRevised mesh__D016616 2000-06-22
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D016616 2005
% 218.86/219.08  |- mesh__dateCreated mesh__D016616 1991-01-24
% 218.86/219.08  |- skos__broader mesh__D016616smesh__D008867
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D016616 2006
% 218.86/219.08  |- mesh__recordOriginator mesh__D016616 MXR
% 218.86/219.08  |- rdf__type mesh__D016616sskos__Concept
% 218.86/219.08  |- skos__historyNote mesh__D016616 Microtomy %28%1975-1991%29%
% 218.86/219.08  |- skos__altLabel mesh__D016616 Freeze Sectioning
% 218.86/219.08  |- skos__prefLabel mesh__D016616 Cryoultramicrotomy
% 218.86/219.08  |- mesh__recordAuthorizer mesh__D016616 sjn
% 218.86/219.08  |- mesh__dateRevised mesh__D004592 2002-07-03
% 218.86/219.08  |- rdf__type mesh__D004592sskos__Concept
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D004592 2005
% 218.86/219.08  |- skos__broader mesh__D004592smesh__D004586
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D004592 2003
% 218.86/219.08  |- skos__hiddenLabel mesh__D004592 Starch Gel Electrophoresis
% 218.86/219.08  |- skos__scopeNote mesh__D004592
% 218.86/219.08       Electrophoresis in which a starch gel %28%a mixture of amylose and amylopectin%29% is used as the diffusion medium.%A%    
% 218.86/219.08  |- mesh__historyNote mesh__D004592
% 218.86/219.08       91%28%87%29%73%28%72%29%; was see under ELECTROPHORESIS 1987-90; was heading 1972-86 %28%Prov 1972%29%%A%  
% 218.86/219.08  |- mesh__recordAuthorizer mesh__D004592 sjn
% 218.86/219.08  |- mesh__recordOriginator mesh__D004592 NLM
% 218.86/219.08  |- mesh__dateCreated mesh__D004592 1999-01-01
% 218.86/219.08  |- skos__historyNote mesh__D004592 Electrophoresis %28%1966-1969%29%
% 218.86/219.08  |- skos__annotation mesh__D004592 NIM   
% 218.86/219.08  |- mesh__dateEstablished mesh__D004592 1973-01-01
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D004592 2006
% 218.86/219.08  |- mesh__recordMaintainer mesh__D004592 lkt
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D004592 2004
% 218.86/219.08  |- skos__prefLabel mesh__D004592 Electrophoresis, Starch Gel
% 218.86/219.08  |- mesh__publicMeSHNote mesh__D004592
% 218.86/219.08       91,73-86; was see under ELECTROPHORESIS 1987-90; was heading 1973-86%A%  
% 218.86/219.08  |- skos__broader mesh__D012226smesh__D012141
% 218.86/219.08  |- skos__altLabel mesh__D012226 Scleroma, Nasal
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D012226 2000
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D012226 2003
% 218.86/219.08  |- skos__hiddenLabel mesh__D012226 Scleromas, Nasal
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D012226 2001
% 218.86/219.08  |- mesh__recordAuthorizer mesh__D012226 sjn
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D012226 2004
% 218.86/219.08  |- mesh__recordMaintainer mesh__D012226 KEV
% 218.86/219.08  |- mesh__recordOriginator mesh__D012226 NLM
% 218.86/219.08  |- skos__broader mesh__D012226smesh__D007710
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D012226 2002
% 218.86/219.08  |- skos__broader mesh__D012226smesh__D017192
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D012226 2005
% 218.86/219.08  |- mesh__dateCreated mesh__D012226 1999-01-01
% 218.86/219.08  |- skos__scopeNote mesh__D012226
% 218.86/219.08       A granulomatous disease affecting the nose and nasopharynx, usually ascribed to KLEBSIELLA RHINOSCLEROMATIS. It occurs in Egypt, eastern Europe, and Central and South America.%A%    
% 218.86/219.08  |- skos__hiddenLabel mesh__D012226 Nasal Scleroma
% 218.86/219.08  |- skos__hiddenLabel mesh__D012226 Rhinoscleromas
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D012226 2006
% 218.86/219.08  |- mesh__dateRevised mesh__D012226 1999-11-08
% 218.86/219.08  |- rdf__type mesh__D012226sskos__Concept
% 218.86/219.08  |- skos__hiddenLabel mesh__D012226 Nasal Scleromas
% 218.86/219.08  |- skos__broader mesh__D012226smesh__D009668
% 218.86/219.08  |- skos__prefLabel mesh__D012226 Rhinoscleroma
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D031989 2004
% 218.86/219.08  |- mesh__historyNote mesh__D031989 2003   
% 218.86/219.08  |- skos__broader mesh__D031989smesh__D027824
% 218.86/219.08  |- mesh__dateCreated mesh__D031989 2002-07-03
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D031989 2003
% 218.86/219.08  |- mesh__publicMeSHNote mesh__D031989 2003   
% 218.86/219.08  |- mesh__dateEstablished mesh__D031989 2003-01-01
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D031989 2006
% 218.86/219.08  |- skos__scopeNote mesh__D031989
% 218.86/219.08       A plant genus of the family ROSACEAE known for the edible fruit.%A%    
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D031989 2005
% 218.86/219.08  |- skos__annotation mesh__D031989
% 218.86/219.08       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 218.86/219.08  |- skos__prefLabel mesh__D031989 Pyrus
% 218.86/219.08  |- rdf__type mesh__D031989sskos__Concept
% 218.86/219.08  |- skos__hiddenLabel mesh__D008983 Cofactor, FeMo
% 218.86/219.08  |- skos__prefLabel mesh__D008983 Molybdoferredoxin
% 218.86/219.08  |- mesh__dateRevised mesh__D008983 2005-06-30
% 218.86/219.08  |- skos__altLabel mesh__D008983 FeMo Cofactor
% 218.86/219.08  |- mesh__historyNote mesh__D008983
% 218.86/219.08       91%28%77%29%; was see under FERREDOXINS 1977-90   
% 218.86/219.08  |- mesh__recordAuthorizer mesh__D008983 sjn
% 218.86/219.08  |- mesh__recordOriginator mesh__D008983 RLS
% 218.86/219.08  |- skos__historyNote mesh__D008983 Ferredoxins %28%1966-1976%29%
% 218.86/219.08  |- skos__hiddenLabel mesh__D008983 Cofactor, Iron-Molybdenum
% 218.86/219.08  |- skos__broader mesh__D008983smesh__D009591
% 218.86/219.08  |- rdf__type mesh__D008983sskos__Concept
% 218.86/219.08  |- skos__broader mesh__D008983smesh__D005288
% 218.86/219.08  |- skos__hiddenLabel mesh__D008983 Protein, Molybdenum-Iron
% 218.86/219.08  |- skos__altLabel mesh__D008983 Iron-Molybdenum Cofactor
% 218.86/219.08  |- skos__altLabel mesh__D008983 Molybdenum-Iron Protein
% 218.86/219.08  |- skos__hiddenLabel mesh__D008983 Protein, MoFe
% 218.86/219.08  |- skos__scopeNote mesh__D008983
% 218.86/219.08       A non-heme iron-sulfur protein isolated from Clostridium pasteurianum and other bacteria. It is a component of NITROGENASE, which is active in nitrogen fixation, and consists of two subunits with molecular weights of 59.5 kDa and 50.7 kDa, respectively.%A%    
% 218.86/219.08  |- skos__annotation mesh__D008983
% 218.86/219.08       from bacteria; a component of nitrogenase   
% 218.86/219.08  |- skos__altLabel mesh__D008983 MoFe Protein
% 218.86/219.08  |- mesh__publicMeSHNote mesh__D008983
% 218.86/219.08       91; was see under FERREDOXINS 1977-90   
% 218.86/219.08  |- mesh__recordMaintainer mesh__D008983 SYSTEM
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D008983 2006
% 218.86/219.08  |- mesh__dateCreated mesh__D008983 1976-04-13
% 218.86/219.08  |- mesh__dateEstablished mesh__D008983 1991-01-01
% 218.86/219.08  |- skos__historyNote mesh__D008983 Molybdenum %28%1966-1976%29%
% 218.86/219.08  |- skos__hiddenLabel mesh__D008983 Molybdenum Iron Protein
% 218.86/219.08  |- skos__hiddenLabel mesh__D008983 Iron Molybdenum Cofactor
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D008185 2000
% 218.86/219.08  |- mesh__dateEstablished mesh__D008185 1991-01-01
% 218.86/219.08  |- skos__hiddenLabel mesh__D008185 Syndrome, Lutembacher%27%s
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D008185 2003
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D008185 2006
% 218.86/219.08  |- mesh__recordOriginator mesh__D008185 NLM
% 218.86/219.08  |- skos__hiddenLabel mesh__D008185 Lutembacher Syndrome
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D008185 2005
% 218.86/219.08  |- mesh__dateCreated mesh__D008185 1999-01-01
% 218.86/219.08  |- skos__annotation mesh__D008185
% 218.86/219.08       atrial septal defect with mitral stenosis; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 218.86/219.08  |- mesh__publicMeSHNote mesh__D008185
% 218.86/219.08       91; was see under HEART SEPTAL DEFECTS, ATRIAL 1964-90; was see under HEART DEFECTS, CONGENITAL 1963%A%  
% 218.86/219.08  |- skos__scopeNote mesh__D008185
% 218.86/219.08       A combination of atrial septal defect and mitral stenosis.%A%    
% 218.86/219.08  |- skos__hiddenLabel mesh__D008185 Lutembachers Syndrome
% 218.86/219.08  |- mesh__recordAuthorizer mesh__D008185 sjn
% 218.86/219.08  |- mesh__onlineNote mesh__D008185
% 218.86/219.08       search HEART SEPTAL DEFECTS, ATRIAL 1966-74   
% 218.86/219.08  |- mesh__dateRevised mesh__D008185 1999-11-03
% 218.86/219.08  |- mesh__recordMaintainer mesh__D008185 kle
% 218.86/219.08  |- mesh__historyNote mesh__D008185
% 218.86/219.08       91%28%75%29%; was see under HEART SEPTAL DEFECTS, ATRIAL 1964-90; was see under HEART DEFECTS, CONGENITAL 1963%A%  
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D008185 2002
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D008185 2001
% 218.86/219.08  |- rdf__type mesh__D008185sskos__Concept
% 218.86/219.08  |- skos__broader mesh__D008185smesh__D006344
% 218.86/219.08  |- skos__prefLabel mesh__D008185 Lutembacher%27%s Syndrome
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D008185 2004
% 218.86/219.08  |- skos__broader mesh__D009900Q000293smesh__D009900
% 218.86/219.08  |- mesh__preferredCombination mesh__D009900Q000293smesh__D020221
% 218.86/219.08  |- rdf__type mesh__D009900Q000293smesh__CompoundConcept
% 218.86/219.08  |- mesh__recordOriginator mesh__D004593 NLM
% 218.86/219.08  |- mesh__recordAuthorizer mesh__D004593 sjn
% 218.86/219.08  |- skos__prefLabel mesh__D004593 Electrophorus
% 218.86/219.08  |- skos__annotation mesh__D004593
% 218.86/219.08       do not confuse X ref EEL, ELECTRIC with ELECTRIC FISH   
% 218.86/219.08  |- mesh__dateCreated mesh__D004593 1999-01-01
% 218.86/219.08  |- mesh__dateEstablished mesh__D004593 1974-01-01
% 218.86/219.08  |- skos__altLabel mesh__D004593 Electric Eel
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D004593 2006
% 218.86/219.08  |- mesh__dateRevised mesh__D004593 2003-07-09
% 218.86/219.08  |- skos__scopeNote mesh__D004593
% 218.86/219.08       A genus of fish, in the family GYMNOTIFORMES, capable of producing an electric shock that immobilizes fish and other prey. The species Electrophorus electricus is also known as the electric eel, though it is not a true eel.%A%    
% 218.86/219.08  |- mesh__publicMeSHNote mesh__D004593 1974   
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D004593 2004
% 218.86/219.08  |- skos__altLabel mesh__D004593 Eel, Electric
% 218.86/219.08  |- rdf__type mesh__D004593sskos__Concept
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D004593 2005
% 218.86/219.08  |- mesh__recordMaintainer mesh__D004593 ags
% 218.86/219.08  |- mesh__historyNote mesh__D004593 1974   
% 218.86/219.08  |- skos__broader mesh__D004593smesh__D023702
% 218.86/219.08  |- mesh__recordMaintainer mesh__D012227 ags
% 218.86/219.08  |- skos__scopeNote mesh__D012227
% 218.86/219.08       Chronic, localized granulomatous infection of mucocutaneous tissues, especially the NOSE, and characterized by HYPERPLASIA and the development of POLYPS. It is found in humans and other animals and is caused by the mesomycetozoean organism RHINOSPORIDIUM SEEBERI.%A%    
% 218.86/219.08  |- mesh__dateRevised mesh__D012227 2004-07-07
% 218.86/219.08  |- skos__hiddenLabel mesh__D012227 Rhinosporidioses
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D012227 2005
% 218.86/219.08  |- mesh__dateCreated mesh__D012227 1999-01-01
% 218.86/219.08  |- mesh__recordAuthorizer mesh__D012227 sjn
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D012227 2006
% 218.86/219.08  |- rdf__type mesh__D012227sskos__Concept
% 218.86/219.08  |- skos__broader mesh__D012227smesh__D009181
% 218.86/219.08  |- mesh__recordOriginator mesh__D012227 NLM
% 218.86/219.08  |- skos__prefLabel mesh__D012227 Rhinosporidiosis
% 218.86/219.08  |- rdf__type mesh__D017710sskos__Concept
% 218.86/219.08  |- skos__scopeNote mesh__D017710
% 218.86/219.08       The transfer of lymphocytes from a donor to a recipient or reinfusion to the donor.%A%    
% 218.86/219.08  |- skos__annotation mesh__D017710
% 218.86/219.08       do not use /util except by MeSH definition; coord IM with specific lymphocyte %28%NIM%29%; for transfusion back to donor, coord IM with BLOOD TRANSFUSION, AUTOLOGOUS %28%NIM%29%%A%  
% 218.86/219.08  |- mesh__dateCreated mesh__D017710 1992-12-28
% 218.86/219.08  |- mesh__activeMeSHYear mesh__D017710 2002
% 218.86/219.08  |- skos__prefLabel mesh__D017710 Lymphocyte Transfusion
% 218.86/219.09  |- mesh__publicMeSHNote mesh__D017710
% 218.86/219.09       94; was see BLOOD COMPONENT TRANSFUSION 1992-93   
% 218.86/219.09  |- mesh__historyNote mesh__D017710
% 218.86/219.09       94; was see BLOOD COMPONENT TRANSFUSION 1992-93   
% 218.86/219.09  |- mesh__onlineNote mesh__D017710
% 218.86/219.09       use BLOOD COMPONENT TRANSFUSION to search LYMPHOCYTE TRANSFUSION 1992-93%A%  
% 218.86/219.09  |- skos__historyNote mesh__D017710
% 218.86/219.09       Blood Component Transfusion %28%1992-1993%29%
% 218.86/219.09  |- mesh__dateEstablished mesh__D017710 1994-01-01
% 218.86/219.09  |- skos__historyNote mesh__D017710 Lymphocytes %28%1969-1977%29%
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017710 2000
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017710 1996
% 218.86/219.09  |- skos__historyNote mesh__D017710 Blood Transfusion %28%1969-1993%29%
% 218.86/219.09  |- skos__broader mesh__D017710smesh__D017708
% 218.86/219.09  |- skos__hiddenLabel mesh__D017710 Transfusions, Lymphocyte
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017710 1998
% 218.86/219.09  |- skos__hiddenLabel mesh__D017710 Lymphocyte Transfusions
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017710 2003
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017710 2001
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017710 1997
% 218.86/219.09  |- skos__historyNote mesh__D017710
% 218.86/219.09       Lymphocytes/transplantation %28%1969-1993%29%
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017710 1994
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017710 2005
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017710 1999
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017710 2004
% 218.86/219.09  |- skos__hiddenLabel mesh__D017710 Transfusion, Lymphocyte
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017710 1995
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017710 2006
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008984 2003
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008984 2001
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008984 1995
% 218.86/219.09  |- rdf__type mesh__D008984sskos__Concept
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008984 1994
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008984 2000
% 218.86/219.09  |- mesh__recordAuthorizer mesh__D008984 PLS
% 218.86/219.09  |- mesh__recordMaintainer mesh__D008984 PLS
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008984 1999
% 218.86/219.09  |- skos__prefLabel mesh__D008984 Monaco
% 218.86/219.09  |- mesh__dateCreated mesh__D008984 1999-01-01
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008984 2006
% 218.86/219.09  |- mesh__recordOriginator mesh__D008984 NLM
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008984 1998
% 218.86/219.09  |- mesh__dateRevised mesh__D008984 1993-06-03
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008984 1997
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008984 2002
% 218.86/219.09  |- skos__broader mesh__D008984smesh__D005060
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008984 2005
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008984 2004
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008984 1996
% 218.86/219.09  |- skos__broader mesh__D009141Q000002smesh__D009141
% 218.86/219.09  |- mesh__preferredCombination mesh__D009141Q000002smesh__D009139
% 218.86/219.09  |- rdf__type mesh__D009141Q000002smesh__CompoundConcept
% 218.86/219.09  |- skos__broader mesh__D009297Q000557smesh__D009297
% 218.86/219.09  |- rdf__type mesh__D009297Q000557smesh__CompoundConcept
% 218.86/219.09  |- skos__annotation mesh__D008186
% 218.86/219.09       consider also CORPUS LUTEUM /drug eff %26% CORPUS LUTEUM REGRESSION%A%  
% 218.86/219.09  |- mesh__dateRevised mesh__D008186 2005-06-30
% 218.86/219.09  |- mesh__historyNote mesh__D008186 75   
% 218.86/219.09  |- mesh__recordOriginator mesh__D008186 NLM
% 218.86/219.09  |- skos__broader mesh__D008186smesh__D012102
% 218.86/219.09  |- mesh__dateEstablished mesh__D008186 1975-09-01
% 218.86/219.09  |- mesh__dateCreated mesh__D008186 1974-11-11
% 218.86/219.09  |- mesh__recordMaintainer mesh__D008186 ssb
% 218.86/219.09  |- rdf__type mesh__D008186sskos__Concept
% 218.86/219.09  |- skos__historyNote mesh__D008186
% 218.86/219.09       Corpus Luteum/drug effects %28%1968-1974%29%
% 218.86/219.09  |- mesh__publicMeSHNote mesh__D008186 75   
% 218.86/219.09  |- mesh__recordAuthorizer mesh__D008186 sjn
% 218.86/219.09  |- skos__broader mesh__D008186smesh__D003271
% 218.86/219.09  |- skos__scopeNote mesh__D008186
% 218.86/219.09       Chemical compounds causing LUTEOLYSIS or degeneration.     
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008186 2006
% 218.86/219.09  |- skos__prefLabel mesh__D008186 Luteolytic Agents
% 218.86/219.09  |- skos__hiddenLabel mesh__D008186 Agents, Luteolytic
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D013320 2005
% 218.86/219.09  |- skos__annotation mesh__D013320
% 218.86/219.09       a superfamily of nematodes: do not confuse with STRONGYLIDA, an order; infection: coord IM with STRONGYLIDA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 218.86/219.09  |- mesh__recordOriginator mesh__D013320 NLM
% 218.86/219.09  |- mesh__dateRevised mesh__D013320 2003-07-09
% 218.86/219.09  |- skos__broader mesh__D013320smesh__D017183
% 218.86/219.09  |- mesh__onlineNote mesh__D013320 search HOOKWORMS 1966   
% 218.86/219.09  |- mesh__dateEstablished mesh__D013320 1973-01-01
% 218.86/219.09  |- skos__scopeNote mesh__D013320
% 218.86/219.09       A superfamily of strongyles or roundworms which are parasites in the intestinal tract of equines, pigs, rodents, and primates %28%including man%29%. It includes the genera Cyasthostomum, Ransomus, Globocephalus, OESOPHAGOSTOMUM, and STRONGYLUS.%A%    
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D013320 2004
% 218.86/219.09  |- mesh__recordAuthorizer mesh__D013320 sjn
% 218.86/219.09  |- skos__historyNote mesh__D013320 Nematoda %28%1967-1972%29%
% 218.86/219.09  |- rdf__type mesh__D013320sskos__Concept
% 218.86/219.09  |- mesh__historyNote mesh__D013320 73; was see under HOOKWORMS 1963-66   
% 218.86/219.09  |- skos__historyNote mesh__D013320 Ancylostomatoidea %28%1966%29%
% 218.86/219.09  |- mesh__publicMeSHNote mesh__D013320
% 218.86/219.09       73; was see under HOOKWORMS 1963-66   
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D013320 2006
% 218.86/219.09  |- mesh__recordMaintainer mesh__D013320 ags
% 218.86/219.09  |- mesh__dateCreated mesh__D013320 1999-01-01
% 218.86/219.09  |- skos__prefLabel mesh__D013320 Strongyloidea
% 218.86/219.09  |- skos__broader mesh__D004594smesh__D010827
% 218.86/219.09  |- skos__annotation mesh__D004594
% 218.86/219.09       as IM, SPEC qualif; as NIM, no qualif; physiol in relation to electricity; coord NIM with organ /physiol or physiol process %28%IM%29%; DF: ELECTROPHYSIOL%A%  
% 218.86/219.09  |- mesh__dateCreated mesh__D004594 1999-01-01
% 218.86/219.09  |- skos__broader mesh__D004594smesh__D001703
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D004594 2006
% 218.86/219.09  |- mesh__recordOriginator mesh__D004594 NLM
% 218.86/219.09  |- mesh__recordAuthorizer mesh__D004594 sjn
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D004594 2005
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D004594 2004
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D004594 2002
% 218.86/219.09  |- skos__broader mesh__D004594smesh__D010829
% 218.86/219.09  |- rdf__type mesh__D004594sskos__Concept
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D004594 2003
% 218.86/219.09  |- mesh__recordMaintainer mesh__D004594 jls
% 218.86/219.09  |- skos__prefLabel mesh__D004594 Electrophysiology
% 218.86/219.09  |- mesh__dateRevised mesh__D004594 2001-07-25
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D045402 2004
% 218.86/219.09  |- mesh__dateEstablished mesh__D045402 2004-01-01
% 218.86/219.09  |- mesh__dateCreated mesh__D045402 2003-07-09
% 218.86/219.09  |- mesh__publicMeSHNote mesh__D045402 2004   
% 218.86/219.09  |- skos__annotation mesh__D045402
% 218.86/219.09       infection: coord IM with RUBULAVIRUS INFECTIONS %28%IM%29%   
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D045402 2005
% 218.86/219.09  |- rdf__type mesh__D045402sskos__Concept
% 218.86/219.09  |- mesh__historyNote mesh__D045402 2004   
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D045402 2006
% 218.86/219.09  |- skos__scopeNote mesh__D045402
% 218.86/219.09       A species of RUBULAVIRUS originally isolated from cultured primary monkey cells. Its natural host is the DOG in which it causes kennel cough, but it can also infect humans.%A%    
% 218.86/219.09  |- skos__prefLabel mesh__D045402 Simian virus 5
% 218.86/219.09  |- skos__broader mesh__D045402smesh__D019213
% 218.86/219.09  |- mesh__recordAuthorizer mesh__D012228 sjn
% 218.86/219.09  |- skos__altLabel mesh__D012228 Hyphochytrium
% 218.86/219.09  |- mesh__recordOriginator mesh__D012228 NLM
% 218.86/219.09  |- mesh__dateCreated mesh__D012228 1999-01-01
% 218.86/219.09  |- mesh__dateRevised mesh__D012228 2005-06-30
% 218.86/219.09  |- skos__broader mesh__D012228smesh__D050298
% 218.86/219.09  |- skos__scopeNote mesh__D012228
% 218.86/219.09       A genus in the order Dermocystidium, class MESOMYCETOZOEA. It causes RHINOSPORIDIOSIS in MAMMALS and BIRDS.%A%    
% 218.86/219.09  |- mesh__recordMaintainer mesh__D012228 ags
% 218.86/219.09  |- skos__annotation mesh__D012228
% 218.86/219.09       infection = RHINOSPORIDIOSIS; use /parasitol not /microbiol on other terms to indicate the presence of Rhinosporidium%A%  
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D012228 2006
% 218.86/219.09  |- rdf__type mesh__D012228sskos__Concept
% 218.86/219.09  |- skos__prefLabel mesh__D012228 Rhinosporidium
% 218.86/219.09  |- skos__historyNote mesh__D017711 Models, Biological %28%1970-1993%29%
% 218.86/219.09  |- skos__hiddenLabel mesh__D017711 Dynamics, Nonlinear
% 218.86/219.09  |- skos__hiddenLabel mesh__D017711 Chaos Theories
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017711 2006
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017711 2000
% 218.86/219.09  |- mesh__publicMeSHNote mesh__D017711 94   
% 218.86/219.09  |- skos__broader mesh__D017711smesh__D008962
% 218.86/219.09  |- mesh__recordAuthorizer mesh__D017711 PLS
% 218.86/219.09  |- skos__hiddenLabel mesh__D017711 Non linear Models
% 218.86/219.09  |- skos__annotation mesh__D017711
% 218.86/219.09       a math principle applied to theoret models   
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017711 1999
% 218.86/219.09  |- rdf__type mesh__D017711sskos__Concept
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017711 2005
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017711 2004
% 218.86/219.09  |- skos__altLabel mesh__D017711 Non-linear Dynamics
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017711 1998
% 218.86/219.09  |- skos__altLabel mesh__D017711 Non-linear Models
% 218.86/219.09  |- mesh__recordOriginator mesh__D017711 RAZ
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017711 2002
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017711 1997
% 218.86/219.09  |- skos__hiddenLabel mesh__D017711 Non-linear Dynamic
% 218.86/219.09  |- skos__hiddenLabel mesh__D017711 Non linear Dynamics
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017711 2003
% 218.86/219.09  |- skos__hiddenLabel mesh__D017711 Non-linear Model
% 218.86/219.09  |- skos__hiddenLabel mesh__D017711 Theories, Chaos
% 218.86/219.09  |- skos__hiddenLabel mesh__D017711 Nonlinear Model
% 218.86/219.09  |- skos__scopeNote mesh__D017711
% 218.86/219.09       The study of systems which respond disproportionately %28%nonlinearly%29% to initial conditions or perturbing stimuli. Nonlinear systems may exhibit %22%chaos%22% which is classically characterized as sensitive dependence on initial conditions. Chaotic systems, while distinguished from more ordered periodic systems, are not random. When their behavior over time is appropriately displayed %28%in %22%phase space%22%%29%, constraints are evident which are described by %22%strange attractors%22%. Phase space representations of chaotic systems, or strange attractors, usually reveal fractal %28%FRACTALS%29% self-similarity across time scales. Natural, including biological, systems often display nonlinear dynamics and chaos.%A%    
% 218.86/219.09  |- skos__hiddenLabel mesh__D017711 Model, Non-linear
% 218.86/219.09  |- mesh__dateRevised mesh__D017711 1996-06-10
% 218.86/219.09  |- mesh__dateEstablished mesh__D017711 1994-01-01
% 218.86/219.09  |- skos__prefLabel mesh__D017711 Nonlinear Dynamics
% 218.86/219.09  |- skos__hiddenLabel mesh__D017711 Nonlinear Dynamic
% 218.86/219.09  |- mesh__recordMaintainer mesh__D017711 TGC
% 218.86/219.09  |- skos__hiddenLabel mesh__D017711 Theory, Chaos
% 218.86/219.09  |- skos__hiddenLabel mesh__D017711 Model, Nonlinear
% 218.86/219.09  |- mesh__dateCreated mesh__D017711 1992-12-28
% 218.86/219.09  |- skos__hiddenLabel mesh__D017711 Models, Non-linear
% 218.86/219.09  |- skos__broader mesh__D017711smesh__D008433
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017711 2001
% 218.86/219.09  |- skos__related mesh__D017711smesh__D017709
% 218.86/219.09  |- skos__hiddenLabel mesh__D017711 Nonlinear Models
% 218.86/219.09  |- mesh__historyNote mesh__D017711 94   
% 218.86/219.09  |- skos__hiddenLabel mesh__D017711 Dynamics, Non-linear
% 218.86/219.09  |- skos__historyNote mesh__D017711 Mathematics %28%1974-1993%29%
% 218.86/219.09  |- skos__broader mesh__D011451Q000037smesh__D011451
% 218.86/219.09  |- mesh__preferredCombination mesh__D011451Q000037smesh__D016861
% 218.86/219.09  |- rdf__type mesh__D011451Q000037smesh__CompoundConcept
% 218.86/219.09  |- mesh__recordOriginator mesh__D008985 NLM
% 218.86/219.09  |- skos__altLabel mesh__D008985 Monensin Monosodium Salt
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008985 2002
% 218.86/219.09  |- mesh__historyNote mesh__D008985
% 218.86/219.09       87%28%75%29%; was see under FURANS 1975-86   
% 218.86/219.09  |- mesh__publicMeSHNote mesh__D008985 87; was see under FURANS 1975-86   
% 218.86/219.09  |- skos__historyNote mesh__D008985 Furans %28%1974%29%
% 218.86/219.09  |- skos__broader mesh__D008985smesh__D005663
% 218.86/219.09  |- skos__historyNote mesh__D008985 Pyrans %28%1974%29%
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008985 2006
% 218.86/219.09  |- skos__prefLabel mesh__D008985 Monensin
% 218.86/219.09  |- skos__altLabel mesh__D008985 Monensin-A-Sodium Complex
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008985 2005
% 218.86/219.09  |- skos__hiddenLabel mesh__D008985 Monensin A Sodium Complex
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008985 2004
% 218.86/219.09  |- mesh__dateRevised mesh__D008985 2001-07-25
% 218.86/219.09  |- mesh__recordMaintainer mesh__D008985 ssb
% 218.86/219.09  |- mesh__dateEstablished mesh__D008985 1987-01-01
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008985 2003
% 218.86/219.09  |- skos__scopeNote mesh__D008985
% 218.86/219.09       An antiprotozoal agent produced by Streptomyces cinnamonensis. It exerts its effect during the development of first-generation trophozoites into first-generation schizonts within the intestinal epithelial cells. It does not interfere with hosts%27% development of acquired immunity to the majority of coccidial species. Monensin is a sodium and proton selective ionophore and is widely used as such in biochemical studies.%A%    
% 218.86/219.09  |- mesh__dateCreated mesh__D008985 1974-11-19
% 218.86/219.09  |- skos__historyNote mesh__D008985 Antibiotics %28%1972-1974%29%
% 218.86/219.09  |- mesh__recordAuthorizer mesh__D008985 sjn
% 218.86/219.09  |- rdf__type mesh__D008985sskos__Concept
% 218.86/219.09  |- skos__annotation mesh__D008187
% 218.86/219.09       a rare earth metal; Lu-175; Lu-167-174, 176-180 = LUTETIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 218.86/219.09  |- mesh__recordAuthorizer mesh__D008187 sjn
% 218.86/219.09  |- skos__scopeNote mesh__D008187
% 218.86/219.09       Lutetium. An element of the rare earth family of metals. It has the atomic symbol Lu, atomic number 71, and atomic weight 175.%A%    
% 218.86/219.09  |- skos__broader mesh__D008187smesh__D028581
% 218.86/219.09  |- skos__broader mesh__D008187smesh__D028561
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008187 2003
% 218.86/219.09  |- skos__prefLabel mesh__D008187 Lutetium
% 218.86/219.09  |- rdf__type mesh__D008187sskos__Concept
% 218.86/219.09  |- mesh__dateCreated mesh__D008187 1999-01-01
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008187 2004
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008187 2005
% 218.86/219.09  |- mesh__dateRevised mesh__D008187 2001-07-25
% 218.86/219.09  |- mesh__recordMaintainer mesh__D008187 jmp
% 218.86/219.09  |- mesh__recordOriginator mesh__D008187 NLM
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008187 2002
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008187 2006
% 218.86/219.09  |- mesh__dateEstablished mesh__D027341 2002-01-01
% 218.86/219.09  |- mesh__recordOriginator mesh__D027341 jmp
% 218.86/219.09  |- skos__altLabel mesh__D027341 GLAST-1 Glutamate Aspartate Transporter
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D027341 2006
% 218.86/219.09  |- mesh__recordMaintainer mesh__D027341 DRC
% 218.86/219.09  |- skos__historyNote mesh__D027341 ABC Transporters %28%1996-2001%29%
% 218.86/219.09  |- skos__scopeNote mesh__D027341
% 218.86/219.09       A glial type glutamate plasma membrane transporter protein found predominately in ASTROCYTES. It is also expressed in HEART and SKELETAL MUSCLE and in the PLACENTA.%A%    
% 218.86/219.09  |- skos__altLabel mesh__D027341 Glutamate Aspartate Transporter 1
% 218.86/219.09  |- rdf__type mesh__D027341sskos__Concept
% 218.86/219.09  |- skos__hiddenLabel mesh__D027341 Transporter, SLC1A3
% 218.86/219.09  |- skos__historyNote mesh__D027341 Glutamates %28%1989%29%
% 218.86/219.09  |- mesh__recordAuthorizer mesh__D027341 sjn
% 218.86/219.09  |- mesh__publicMeSHNote mesh__D027341 2002   
% 218.86/219.09  |- skos__prefLabel mesh__D027341 Excitatory Amino Acid Transporter 1
% 218.86/219.09  |- skos__hiddenLabel mesh__D027341 EAAT 1 Excitatory Amino Acid Transporter
% 218.86/219.09  |- skos__altLabel mesh__D027341 SLC1A3 Transporter
% 218.86/219.09  |- mesh__dateCreated mesh__D027341 2001-07-25
% 218.86/219.09  |- mesh__dateRevised mesh__D027341 2005-06-30
% 218.86/219.09  |- skos__hiddenLabel mesh__D027341 GLAST 1 Glutamate Aspartate Transporter
% 218.86/219.09  |- skos__altLabel mesh__D027341 EAAT-1 Excitatory Amino Acid Transporter
% 218.86/219.09  |- mesh__historyNote mesh__D027341 2002   
% 218.86/219.09  |- skos__historyNote mesh__D027341 Glycoproteins %28%1989-1995%29%
% 218.86/219.09  |- skos__broader mesh__D027341smesh__D050491
% 218.86/219.09  |- skos__broader mesh__D013321smesh__D012205
% 218.86/219.09  |- skos__scopeNote mesh__D013321
% 218.86/219.09       A genus of parasitic nematodes widely distributed as intestinal parasites of mammals.%A%    
% 218.86/219.09  |- skos__prefLabel mesh__D013321 Strongyloides
% 218.86/219.09  |- skos__annotation mesh__D013321
% 218.86/219.09       a genus of nematodes; do not confuse with STRONGYLOIDEA; infection = STRONGYLOIDIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D013321 2004
% 218.86/219.09  |- mesh__recordOriginator mesh__D013321 NLM
% 218.86/219.09  |- rdf__type mesh__D013321sskos__Concept
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D013321 2006
% 218.86/219.09  |- mesh__dateCreated mesh__D013321 1999-01-01
% 218.86/219.09  |- mesh__recordAuthorizer mesh__D013321 sjn
% 218.86/219.09  |- mesh__recordMaintainer mesh__D013321 ags
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D013321 2005
% 218.86/219.09  |- mesh__dateRevised mesh__D013321 2003-07-09
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D004595 1998
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D004595 2000
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D004595 2003
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D004595 1996
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D004595 2006
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D004595 1999
% 218.86/219.09  |- skos__prefLabel mesh__D004595 Electroplating
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D004595 2001
% 218.86/219.09  |- mesh__recordMaintainer mesh__D004595 PLS
% 218.86/219.09  |- skos__historyNote mesh__D004595 Metallurgy %28%1966-1984%29%
% 218.86/219.09  |- skos__altLabel mesh__D004595 Metal Plating
% 218.86/219.09  |- mesh__publicMeSHNote mesh__D004595
% 218.86/219.09       91; was see under ELECTROLYSIS 1985-90   
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D004595 2004
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D004595 1997
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D004595 2002
% 218.86/219.09  |- mesh__recordOriginator mesh__D004595 VDK
% 218.86/219.09  |- rdf__type mesh__D004595sskos__Concept
% 218.86/219.09  |- skos__broader mesh__D004595smesh__D004572
% 218.86/219.09  |- skos__historyNote mesh__D004595 Electrolysis %28%1966-1984%29%
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D004595 1994
% 218.86/219.09  |- skos__hiddenLabel mesh__D004595 Plating, Metal
% 218.86/219.09  |- skos__scopeNote mesh__D004595
% 218.86/219.09       Coating with a metal or alloy by electrolysis.     
% 218.86/219.09  |- mesh__dateCreated mesh__D004595 1984-05-29
% 218.86/219.09  |- mesh__dateEstablished mesh__D004595 1991-01-01
% 218.86/219.09  |- mesh__dateRevised mesh__D004595 1993-03-03
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D004595 1995
% 218.86/219.09  |- skos__altLabel mesh__D004595 Electrodeposition
% 218.86/219.09  |- mesh__recordAuthorizer mesh__D004595 PLS
% 218.86/219.09  |- mesh__historyNote mesh__D004595
% 218.86/219.09       91%28%85%29%; was see under ELECTROLYSIS 1985-90   
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D004595 2005
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D045403 2004
% 218.86/219.09  |- mesh__historyNote mesh__D045403 2004   
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D045403 2005
% 218.86/219.09  |- mesh__dateCreated mesh__D045403 2003-07-09
% 218.86/219.09  |- skos__broader mesh__D045403smesh__D018098
% 218.86/219.09  |- skos__scopeNote mesh__D045403
% 218.86/219.09       A genus in the subfamily PARAMYXOVIRINAE, family PARAMYXOVIRIDAE. It contains species that infect and cause potentially fatal disease in a number of host species, including humans.%A%    
% 218.86/219.09  |- skos__annotation mesh__D045403 infection = HENIPAVIRUS INFECTIONS   
% 218.86/219.09  |- mesh__publicMeSHNote mesh__D045403 2004   
% 218.86/219.09  |- skos__prefLabel mesh__D045403 Henipavirus
% 218.86/219.09  |- rdf__type mesh__D045403sskos__Concept
% 218.86/219.09  |- skos__historyNote mesh__D045403 Paramyxovirinae %28%2001-2003%29%
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D045403 2006
% 218.86/219.09  |- mesh__dateEstablished mesh__D045403 2004-01-01
% 218.86/219.09  |- skos__hiddenLabel mesh__D045403 Henipaviruses
% 218.86/219.09  |- mesh__historyNote mesh__D012229
% 218.86/219.09       94, 64-74; was RHINOVIRUSES 1975-93; COMMON COLD VIRUS was see under RHINOVIRUSES 1975-78, was see under RHINOVIRUS 1964-74, was heading 1963%A%  
% 218.86/219.09  |- mesh__recordMaintainer mesh__D012229 sjn
% 218.86/219.09  |- mesh__dateCreated mesh__D012229 1999-01-01
% 218.86/219.09  |- mesh__recordAuthorizer mesh__D012229 sjn
% 218.86/219.09  |- mesh__onlineNote mesh__D012229
% 218.86/219.09       use RHINOVIRUS to search RHINOVIRUSES 1975-93 %26% COMMON COLD VIRUS 1966-78%A%  
% 218.86/219.09  |- skos__hiddenLabel mesh__D012229 Rhinoviruses
% 218.86/219.09  |- skos__broader mesh__D012229smesh__D010849
% 218.86/219.09  |- mesh__dateEstablished mesh__D012229 1964-01-01
% 218.86/219.09  |- mesh__recordOriginator mesh__D012229 NLM
% 218.86/219.09  |- mesh__publicMeSHNote mesh__D012229
% 218.86/219.09       94, 64-74; was RHINOVIRUSES 1975-93; COMMON COLD VIRUS was see under RHINOVIRUSES 1975-78, was see under RHINOVIRUS 1964-74, was heading 1963%A%  
% 218.86/219.09  |- skos__hiddenLabel mesh__D012229 Cold Virus, Common
% 218.86/219.09  |- mesh__dateRevised mesh__D012229 2004-07-13
% 218.86/219.09  |- skos__annotation mesh__D012229
% 218.86/219.09       infection: coord IM with PICORNAVIRIDAE INFECTIONS %28%IM%29% but consider also COMMON COLD%A%  
% 218.86/219.09  |- skos__hiddenLabel mesh__D012229 Coryza Virus
% 218.86/219.09  |- skos__scopeNote mesh__D012229
% 218.86/219.09       A genus of PICORNAVIRIDAE inhabiting primarily the respiratory tract of mammalian hosts. It includes over 100 human serotypes associated with the COMMON COLD.%A%    
% 218.86/219.09  |- skos__hiddenLabel mesh__D012229 Common Cold Viruses
% 218.86/219.09  |- skos__hiddenLabel mesh__D012229 Cold Viruses, Common
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D012229 2006
% 218.86/219.09  |- rdf__type mesh__D012229sskos__Concept
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D012229 2005
% 218.86/219.09  |- skos__prefLabel mesh__D012229 Rhinovirus
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D009280 2000
% 218.86/219.09  |- skos__prefLabel mesh__D009280 Naphthaleneacetic Acids
% 218.86/219.09  |- skos__broader mesh__D009280smesh__D009281
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D009280 2005
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D009280 2001
% 218.86/219.09  |- skos__scopeNote mesh__D009280
% 218.86/219.09       Naphthalene derivatives containing the -CH2CCO2H radical at the 1-position, the 2-position, or both. Compounds are used as plant growth regulators to delay sprouting, exert weed control, thin fruit, etc.%A%    
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D009280 2006
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D009280 2003
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D009280 2002
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D009280 1994
% 218.86/219.09  |- mesh__dateRevised mesh__D009280 1993-06-03
% 218.86/219.09  |- skos__hiddenLabel mesh__D009280 Acids, Naphthaleneacetic
% 218.86/219.09  |- mesh__historyNote mesh__D009280 68   
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D009280 2004
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D009280 1998
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D009280 1995
% 218.86/219.09  |- mesh__publicMeSHNote mesh__D009280 68   
% 218.86/219.09  |- mesh__dateCreated mesh__D009280 1999-01-01
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D009280 1999
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D009280 1996
% 218.86/219.09  |- mesh__dateEstablished mesh__D009280 1968-01-01
% 218.86/219.09  |- mesh__recordOriginator mesh__D009280 NLM
% 218.86/219.09  |- mesh__recordAuthorizer mesh__D009280 PLS
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D009280 1997
% 218.86/219.09  |- rdf__type mesh__D009280sskos__Concept
% 218.86/219.09  |- mesh__recordMaintainer mesh__D009280 PLS
% 218.86/219.09  |- skos__broader mesh__D017712smesh__D012106
% 218.86/219.09  |- skos__hiddenLabel mesh__D017712 Grant, Peer Review
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017712 1996
% 218.86/219.09  |- mesh__recordMaintainer mesh__D017712 jls
% 218.86/219.09  |- mesh__dateRevised mesh__D017712 2002-10-31
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017712 2004
% 218.86/219.09  |- skos__hiddenLabel mesh__D017712 Review, Publishing Peer
% 218.86/219.09  |- mesh__recordOriginator mesh__D017712 RAZ
% 218.86/219.09  |- skos__hiddenLabel mesh__D017712 Grants Peer Review
% 218.86/219.09  |- skos__altLabel mesh__D017712 Grants, Peer Review
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017712 1997
% 218.86/219.09  |- skos__hiddenLabel mesh__D017712 Reviews, Research Peer
% 218.86/219.09  |- skos__hiddenLabel mesh__D017712 Review Grant, Peer
% 218.86/219.09  |- skos__scopeNote mesh__D017712
% 218.86/219.09       The evaluation by experts of the quality and pertinence of research or research proposals of other experts in the same field. Peer review is used by editors in deciding which submissions warrant publication, by granting agencies to determine which proposals should be funded, and by academic institutions in tenure decisions.%A%    
% 218.86/219.09  |- skos__hiddenLabel mesh__D017712 Review, Grants Peer
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017712 2000
% 218.86/219.09  |- skos__hiddenLabel mesh__D017712 Review Grants, Peer
% 218.86/219.09  |- skos__hiddenLabel mesh__D017712 Peer Reviews, Grants
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017712 1994
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017712 2005
% 218.86/219.09  |- skos__annotation mesh__D017712
% 218.86/219.09       professionals evaluating professionals in research, publishing, granting agencies; DF: PEER REV RESEARCH%A%  
% 218.86/219.09  |- skos__hiddenLabel mesh__D017712 Reviews, Publishing Peer
% 218.86/219.09  |- mesh__recordAuthorizer mesh__D017712 jls
% 218.86/219.09  |- skos__hiddenLabel mesh__D017712 Publishing Peer Review
% 218.86/219.09  |- skos__broader mesh__D017712smesh__D011643
% 218.86/219.09  |- mesh__historyNote mesh__D017712 94   
% 218.86/219.09  |- skos__broader mesh__D017712smesh__D010380
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017712 2001
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017712 2003A
% 218.86/219.09  |- skos__hiddenLabel mesh__D017712 Peer Review Grants
% 218.86/219.09  |- mesh__dateCreated mesh__D017712 1993-07-08
% 218.86/219.09  |- skos__hiddenLabel mesh__D017712 Reviews, Grants Peer
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017712 1998
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017712 1995
% 218.86/219.09  |- skos__hiddenLabel mesh__D017712 Grants Peer Reviews
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017712 2006
% 218.86/219.09  |- skos__prefLabel mesh__D017712 Peer Review, Research
% 218.86/219.09  |- skos__hiddenLabel mesh__D017712 Research Peer Reviews
% 218.86/219.09  |- skos__hiddenLabel mesh__D017712 Publishing Peer Reviews
% 218.86/219.09  |- mesh__dateEstablished mesh__D017712 1994-01-01
% 218.86/219.09  |- skos__hiddenLabel mesh__D017712 Review, Research Peer
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017712 1999
% 218.86/219.09  |- rdf__type mesh__D017712sskos__Concept
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017712 2003
% 218.86/219.09  |- skos__hiddenLabel mesh__D017712 Peer Reviews, Research
% 218.86/219.09  |- skos__hiddenLabel mesh__D017712 Peer Reviews, Publishing
% 218.86/219.09  |- skos__historyNote mesh__D017712 Peer Review %28%1971-1993%29%
% 218.86/219.09  |- skos__hiddenLabel mesh__D017712 Peer Review Grant
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D017712 2002
% 218.86/219.09  |- mesh__publicMeSHNote mesh__D017712 94   
% 218.86/219.09  |- skos__hiddenLabel mesh__D017712 Research Peer Review
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008986 2000
% 218.86/219.09  |- mesh__recordAuthorizer mesh__D008986 PLS
% 218.86/219.09  |- mesh__dateCreated mesh__D008986 1999-01-01
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008986 2006
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008986 1998
% 218.86/219.09  |- mesh__activeMeSHYear mesh__D008986 1997
% 218.86/219.10  |- skos__broader mesh__D008986smesh__D005202
% 218.86/219.10  |- skos__prefLabel mesh__D008986 Mongolia
% 218.86/219.10  |- mesh__recordOriginator mesh__D008986 NLM
% 218.86/219.10  |- mesh__activeMeSHYear mesh__D008986 2005
% 218.86/219.10  |- mesh__activeMeSHYear mesh__D008986 2004
% 218.86/219.10  |- mesh__activeMeSHYear mesh__D008986 1996
% 218.86/219.10  |- mesh__activeMeSHYear mesh__D008986 2002
% 218.86/219.10  |- mesh__activeMeSHYear mesh__D008986 2003
% 218.86/219.10  |- skos__annotation mesh__D008986
% 218.86/219.10       = Outer Mongolia; INNER MONGOLIA is see CHINA   
% 218.86/219.10  |- mesh__activeMeSHYear mesh__D008986 1995
% 218.86/219.10  |- mesh__dateRevised mesh__D008986 1993-04-22
% 218.86/219.10  |- rdf__type mesh__D008986sskos__Concept
% 218.86/219.10  |- mesh__activeMeSHYear mesh__D008986 2001
% 218.86/219.10  |- mesh__activeMeSHYear mesh__D008986 1994
% 218.86/219.10  |- mesh__recordMaintainer mesh__D008986 PLS
% 218.86/219.10  |- mesh__activeMeSHYear mesh__D008986 1999
% 218.86/219.10  |- mesh__recordOriginator mesh__D008188 SH
% 218.86/219.10  |- mesh__publicMeSHNote mesh__D008188 76   
% 218.86/219.10  |- skos__hiddenLabel mesh__D008188 Blood-Group System, Lutheran
% 218.95/219.10  |- skos__historyNote mesh__D008188 Blood Groups %28%1966-1975%29%
% 218.95/219.10  |- mesh__recordAuthorizer mesh__D008188 sjn
% 218.95/219.10  |- mesh__dateCreated mesh__D008188 1975-07-25
% 218.95/219.10  |- skos__hiddenLabel mesh__D008188 System, Lutheran Blood-Group
% 218.95/219.10  |- rdf__type mesh__D008188sskos__Concept
% 218.95/219.10  |- skos__annotation mesh__D008188
% 218.95/219.10       IM; coord with disease /blood %28%IM%29%, not /immunol nor /genet; TN 230%A%  
% 218.95/219.10  |- skos__broader mesh__D008188smesh__D001789
% 218.95/219.10  |- skos__hiddenLabel mesh__D008188 Lutheran Blood Group System
% 218.95/219.10  |- mesh__dateRevised mesh__D008188 2005-06-30
% 218.95/219.10  |- skos__prefLabel mesh__D008188 Lutheran Blood-Group System
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D008188 2006
% 218.95/219.10  |- mesh__historyNote mesh__D008188 76   
% 218.95/219.10  |- mesh__recordMaintainer mesh__D008188 ssb
% 218.95/219.10  |- mesh__dateEstablished mesh__D008188 1976-01-01
% 218.95/219.10  |- skos__scopeNote mesh__D008188
% 218.95/219.10       A complex blood group system having pairs of alternate antigens and amorphic genes, but also subject to a dominant independently segregating repressor.%A%    
% 218.95/219.10  |- mesh__dateCreated mesh__D027342 2001-07-25
% 218.95/219.10  |- skos__altLabel mesh__D027342 GLT-1 Transport Protein
% 218.95/219.10  |- mesh__dateRevised mesh__D027342 2005-06-30
% 218.95/219.10  |- mesh__dateEstablished mesh__D027342 2002-01-01
% 218.95/219.10  |- skos__hiddenLabel mesh__D027342 Neurotransmitter Transporter, EAAT2
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D027342 2006
% 218.95/219.10  |- skos__hiddenLabel mesh__D027342 GluT 1 Glutamate Transporter
% 218.95/219.10  |- mesh__historyNote mesh__D027342
% 218.95/219.10       2002; use EXCITATORY AMINO ACID TRANSPORTER 2 %28%NM%29% 1995-2001; for GLUT-1 GLUTAMATE TRANSPORTER use AMINO ACID TRANSPORT SYSTEM X-AG %28%NM%29% 1996-2001%A%  
% 218.95/219.10  |- skos__historyNote mesh__D027342
% 218.95/219.10       Receptors, Neurotransmitter %28%1995-2001%29%
% 218.95/219.10  |- skos__hiddenLabel mesh__D027342 EAAT 2 Excitatory Amino Acid Transporter
% 218.95/219.10  |- skos__altLabel mesh__D027342 EAAT-2 Excitatory Amino Acid Transporter
% 218.95/219.10  |- mesh__recordOriginator mesh__D027342 jmp
% 218.95/219.10  |- skos__hiddenLabel mesh__D027342 Glutamate Transporter, GluT-1
% 218.95/219.10  |- skos__altLabel mesh__D027342 EAAT2 Neurotransmitter Transporter
% 218.95/219.10  |- rdf__type mesh__D027342sskos__Concept
% 218.95/219.10  |- skos__hiddenLabel mesh__D027342 GLT 1 Transport Protein
% 218.95/219.10  |- skos__altLabel mesh__D027342 GluT-1 Glutamate Transporter
% 218.95/219.10  |- mesh__publicMeSHNote mesh__D027342
% 218.95/219.10       2002; EXCITATORY AMINO ACID TRANSPORTER 2 was indexed under RECEPTORS, NEUROTRANSMITTER 1995-2001; GLUTAMATE TRANSPORTER was indexed under ABC TRANSPORTERS 1996-2001%A%  
% 218.95/219.10  |- skos__altLabel mesh__D027342 SLC1A2 Transporter
% 218.95/219.10  |- skos__hiddenLabel mesh__D027342 Transporter, SLC1A2
% 218.95/219.10  |- skos__broader mesh__D027342smesh__D050491
% 218.95/219.10  |- skos__historyNote mesh__D027342 ABC Transporters %28%1996-2001%29%
% 218.95/219.10  |- mesh__recordMaintainer mesh__D027342 DRC
% 218.95/219.10  |- skos__prefLabel mesh__D027342 Excitatory Amino Acid Transporter 2
% 218.95/219.10  |- skos__scopeNote mesh__D027342
% 218.95/219.10       A  glutamate plasma membrane transporter protein found in ASTROCYTES and in the LIVER.%A%    
% 218.95/219.10  |- mesh__recordAuthorizer mesh__D027342 sjn
% 218.95/219.10  |- skos__hiddenLabel mesh__D027342 Transport Protein, GLT-1
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D013322 2003
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D013322 1995
% 218.95/219.10  |- skos__hiddenLabel mesh__D013322 Anguilluliases
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D013322 2000
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D013322 1998
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D013322 2006
% 218.95/219.10  |- mesh__dateCreated mesh__D013322 1999-01-01
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D013322 1994
% 218.95/219.10  |- skos__scopeNote mesh__D013322
% 218.95/219.10       Infection with nematodes of the genus STRONGYLOIDES. The presence of larvae may produce pneumonitis and the presence of adult worms in the intestine could lead to moderate to severe diarrhea.%A%    
% 218.95/219.10  |- skos__broader mesh__D013322smesh__D017196
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D013322 2005
% 218.95/219.10  |- skos__prefLabel mesh__D013322 Strongyloidiasis
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D013322 2002
% 218.95/219.10  |- mesh__recordMaintainer mesh__D013322 TGC
% 218.95/219.10  |- mesh__recordAuthorizer mesh__D013322 PLS
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D013322 1997
% 218.95/219.10  |- mesh__dateRevised mesh__D013322 1993-06-03
% 218.95/219.10  |- mesh__recordOriginator mesh__D013322 NLM
% 218.95/219.10  |- skos__annotation mesh__D013322
% 218.95/219.10       nematode infect caused by STRONGYLOIDES, not STRONGYLOIDEA%A%  
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D013322 1996
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D013322 2004
% 218.95/219.10  |- skos__hiddenLabel mesh__D013322 Strongyloidiases
% 218.95/219.10  |- rdf__type mesh__D013322sskos__Concept
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D013322 2001
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D013322 1999
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D004596 2003
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D004596 2006
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D004596 1999
% 218.95/219.10  |- mesh__dateRevised mesh__D004596 1998-06-10
% 218.95/219.10  |- skos__broader mesh__D004596smesh__D003941
% 218.95/219.10  |- mesh__recordMaintainer mesh__D004596 NDW
% 218.95/219.10  |- skos__annotation mesh__D004596
% 218.95/219.10       NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ELECTRORETINOGR%A%  
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D004596 2004
% 218.95/219.10  |- rdf__type mesh__D004596sskos__Concept
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D004596 2000
% 218.95/219.10  |- skos__scopeNote mesh__D004596
% 218.95/219.10       Recording of electric potentials in the retina after stimulation by light.%A%    
% 218.95/219.10  |- mesh__recordAuthorizer mesh__D004596 SJN
% 218.95/219.10  |- skos__related mesh__D004596smesh__D012160
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D004596 2001
% 218.95/219.10  |- mesh__dateCreated mesh__D004596 1999-01-01
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D004596 2002
% 218.95/219.10  |- skos__hiddenLabel mesh__D004596 Electroretinographies
% 218.95/219.10  |- skos__broader mesh__D004596smesh__D004568
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D004596 2005
% 218.95/219.10  |- mesh__recordOriginator mesh__D004596 NLM
% 218.95/219.10  |- skos__prefLabel mesh__D004596 Electroretinography
% 218.95/219.10  |- skos__prefLabel mesh__D045404 Hendra Virus
% 218.95/219.10  |- skos__historyNote mesh__D045404 Paramyxovirinae %28%1998-2003%29%
% 218.95/219.10  |- skos__broader mesh__D045404smesh__D045403
% 218.95/219.10  |- mesh__dateEstablished mesh__D045404 2004-01-01
% 218.95/219.10  |- skos__historyNote mesh__D045404 Morbillivirus %28%1995-1999%29%
% 218.95/219.10  |- skos__hiddenLabel mesh__D045404 Equine Morbilliviruses
% 218.95/219.10  |- skos__annotation mesh__D045404
% 218.95/219.10       infection: coord IM with HENIPAVIRUS INFECTIONS %28%IM%29%   
% 218.95/219.10  |- mesh__historyNote mesh__D045404 2004; use PARAMYXOVIRINAE 1994-2003   
% 218.95/219.10  |- skos__hiddenLabel mesh__D045404 Viruses, Hendra
% 218.95/219.10  |- skos__hiddenLabel mesh__D045404 Hendra Viruses
% 218.95/219.10  |- rdf__type mesh__D045404sskos__Concept
% 218.95/219.10  |- skos__hiddenLabel mesh__D045404 Morbilliviruses, Equine
% 218.95/219.10  |- skos__altLabel mesh__D045404 Equine Morbillivirus
% 218.95/219.10  |- mesh__publicMeSHNote mesh__D045404
% 218.95/219.10       2004; see PARAMYXOVIRINAE 1994-2003   
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D045404 2006
% 218.95/219.10  |- skos__hiddenLabel mesh__D045404 Virus, Hendra
% 218.95/219.10  |- skos__hiddenLabel mesh__D045404 Morbillivirus, Equine
% 218.95/219.10  |- skos__scopeNote mesh__D045404
% 218.95/219.10       A species of HENIPAVIRUS first identified in Australia in 1994 in HORSES and transmitted to humans. The natural host appears to be fruit bats %28%PTEROPUS%29%.%A%    
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D045404 2004
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D045404 2005
% 218.95/219.10  |- mesh__dateCreated mesh__D045404 2003-07-09
% 218.95/219.10  |- mesh__recordAuthorizer mesh__D009281 PLS
% 218.95/219.10  |- skos__broader mesh__D009281smesh__D011084
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009281 2006
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009281 2003
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009281 1994
% 218.95/219.10  |- mesh__recordMaintainer mesh__D009281 PLS
% 218.95/219.10  |- skos__prefLabel mesh__D009281 Naphthalenes
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009281 2000
% 218.95/219.10  |- skos__scopeNote mesh__D009281
% 218.95/219.10       Two-ring crystalline hydrocarbons isolated from coal tar. They are used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, preservatives, and, formerly, as topical antiseptics.%A%    
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009281 2004
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009281 1998
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009281 1995
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009281 2001
% 218.95/219.10  |- mesh__dateCreated mesh__D009281 1999-01-01
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009281 1999
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009281 1996
% 218.95/219.10  |- skos__annotation mesh__D009281 aromatic hydrocarbons   
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009281 2002
% 218.95/219.10  |- mesh__dateRevised mesh__D009281 1993-06-03
% 218.95/219.10  |- rdf__type mesh__D009281sskos__Concept
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009281 1997
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009281 2005
% 218.95/219.10  |- mesh__recordOriginator mesh__D009281 NLM
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017713 2005
% 218.95/219.10  |- mesh__dateEstablished mesh__D017713 1994-01-01
% 218.95/219.10  |- skos__historyNote mesh__D017713 Blood Transfusion %28%1966-1991%29%
% 218.95/219.10  |- mesh__onlineNote mesh__D017713
% 218.95/219.10       use BLOOD COMPONENT TRANSFUSION to search PLATELET TRANSFUSION 1992-93%A%  
% 218.95/219.10  |- skos__historyNote mesh__D017713 Blood Platelets %28%1966-1993%29%
% 218.95/219.10  |- mesh__publicMeSHNote mesh__D017713
% 218.95/219.10       94; was see BLOOD COMPONENT TRANSFUSION 1992-93   
% 218.95/219.10  |- skos__hiddenLabel mesh__D017713 Platelet Transfusions, Blood
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017713 2002
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017713 1997
% 218.95/219.10  |- skos__hiddenLabel mesh__D017713 Transfusions, Platelet
% 218.95/219.10  |- skos__hiddenLabel mesh__D017713 Transfusions, Blood Platelet
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017713 2004
% 218.95/219.10  |- skos__hiddenLabel mesh__D017713 Transfusion, Blood Platelet
% 218.95/219.10  |- skos__hiddenLabel mesh__D017713 Transfusion, Platelet
% 218.95/219.10  |- skos__annotation mesh__D017713
% 218.95/219.10       do not use /util except by MeSH definition; for transfusion back to donor, coord IM with BLOOD TRANSFUSION, AUTOLOGOUS %28%NIM%29%%A%  
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017713 1996
% 218.95/219.10  |- skos__historyNote mesh__D017713
% 218.95/219.10       Blood Platelets/transplantation %28%1972-1993%29%
% 218.95/219.10  |- skos__hiddenLabel mesh__D017713 Platelet Transfusion, Blood
% 218.95/219.10  |- skos__scopeNote mesh__D017713
% 218.95/219.10       The transfer of blood platelets from a donor to a recipient or reinfusion to the donor.%A%    
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017713 1999
% 218.95/219.10  |- skos__broader mesh__D017713smesh__D016913
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017713 2003
% 218.95/219.10  |- mesh__historyNote mesh__D017713
% 218.95/219.10       94; was see BLOOD COMPONENT TRANSFUSION 1992-93   
% 218.95/219.10  |- mesh__dateCreated mesh__D017713 1992-12-28
% 218.95/219.10  |- skos__hiddenLabel mesh__D017713 Blood Platelet Transfusions
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017713 2001
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017713 1995
% 218.95/219.10  |- skos__prefLabel mesh__D017713 Platelet Transfusion
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017713 2006
% 218.95/219.10  |- rdf__type mesh__D017713sskos__Concept
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017713 1998
% 218.95/219.10  |- skos__altLabel mesh__D017713 Blood Platelet Transfusion
% 218.95/219.10  |- skos__hiddenLabel mesh__D017713 Platelet Transfusions
% 218.95/219.10  |- skos__historyNote mesh__D017713
% 218.95/219.10       Blood Component Transfusion %28%1992-1993%29%
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017713 2000
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017713 1994
% 218.95/219.10  |- skos__broader mesh__D008189smesh__D005060
% 218.95/219.10  |- rdf__type mesh__D008189sskos__Concept
% 218.95/219.10  |- mesh__dateRevised mesh__D008189 1991-11-26
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D008189 2001
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D008189 1995
% 218.95/219.10  |- mesh__dateCreated mesh__D008189 1999-01-01
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D008189 2004
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D008189 2005
% 218.95/219.10  |- skos__altLabel mesh__D008189 Luxemborg
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D008189 2006
% 218.95/219.10  |- mesh__recordAuthorizer mesh__D008189 PLS
% 218.95/219.10  |- mesh__recordOriginator mesh__D008189 NLM
% 218.95/219.10  |- mesh__recordMaintainer mesh__D008189 PLS
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D008189 2002
% 218.95/219.10  |- skos__prefLabel mesh__D008189 Luxembourg
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D008189 1996
% 218.95/219.10  |- skos__altLabel mesh__D008189 Luxemburg
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D008189 1997
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D008189 1992
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D008189 1998
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D008189 2000
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D008189 1994
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D008189 1993
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D008189 1999
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D008189 2003
% 218.95/219.10  |- mesh__dateCreated mesh__D027343 2001-07-25
% 218.95/219.10  |- mesh__dateRevised mesh__D027343 2002-07-03
% 218.95/219.10  |- skos__broader mesh__D027343smesh__D018517
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D027343 2003
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D027343 2006
% 218.95/219.10  |- skos__broader mesh__D027343smesh__D018547
% 218.95/219.10  |- skos__scopeNote mesh__D027343
% 218.95/219.10       Root-like underground horizontal stem of plants that produces shoots above and roots below.  Distinguished from true roots which don%27%t have buds and nodes.  Similar to true roots in being underground and thickened by storage deposits.%A%    
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D027343 2004
% 218.95/219.10  |- skos__annotation mesh__D027343 coord with specific Plant   
% 218.95/219.10  |- mesh__historyNote mesh__D027343 2002   
% 218.95/219.10  |- mesh__publicMeSHNote mesh__D027343 2002   
% 218.95/219.10  |- mesh__dateEstablished mesh__D027343 2002-01-01
% 218.95/219.10  |- rdf__type mesh__D027343sskos__Concept
% 218.95/219.10  |- skos__prefLabel mesh__D027343 Rhizome
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D027343 2005
% 218.95/219.10  |- skos__broader mesh__D010361Q000193smesh__D010361
% 218.95/219.10  |- mesh__preferredCombination mesh__D010361Q000193smesh__D010353
% 218.95/219.10  |- rdf__type mesh__D010361Q000193smesh__CompoundConcept
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D013323 2006
% 218.95/219.10  |- skos__prefLabel mesh__D013323 Strongylus
% 218.95/219.10  |- skos__annotation mesh__D013323
% 218.95/219.10       a genus of nematodes; infection: coord IM with STRONGYLIDA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D013323 2005
% 218.95/219.10  |- mesh__recordMaintainer mesh__D013323 ags
% 218.95/219.10  |- mesh__recordAuthorizer mesh__D013323 sjn
% 218.95/219.10  |- mesh__dateRevised mesh__D013323 2003-07-09
% 218.95/219.10  |- mesh__historyNote mesh__D013323
% 218.95/219.10       91%28%86%29%; was see under STRONGYLOIDEA 1986-90   
% 218.95/219.10  |- mesh__dateEstablished mesh__D013323 1991-01-01
% 218.95/219.10  |- mesh__recordOriginator mesh__D013323 EC
% 218.95/219.10  |- skos__broader mesh__D013323smesh__D013320
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D013323 2004
% 218.95/219.10  |- rdf__type mesh__D013323sskos__Concept
% 218.95/219.10  |- skos__historyNote mesh__D013323 Strongyloidea %28%1973-1985%29%
% 218.95/219.10  |- mesh__publicMeSHNote mesh__D013323
% 218.95/219.10       91; was see under STRONGYLOIDEA 1986-90   
% 218.95/219.10  |- skos__scopeNote mesh__D013323
% 218.95/219.10       A genus of intestinal parasitic nematodes occurring in animals and man.%A%    
% 218.95/219.10  |- mesh__dateCreated mesh__D013323 1985-03-11
% 218.95/219.10  |- skos__hiddenLabel mesh__D004597 Electroconvulsive Shocks
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D004597 2002
% 218.95/219.10  |- skos__hiddenLabel mesh__D004597 Shock, Electroconvulsive
% 218.95/219.10  |- skos__altLabel mesh__D004597 Electroconvulsive Shock
% 218.95/219.10  |- mesh__dateCreated mesh__D004597 1999-01-01
% 218.95/219.10  |- mesh__historyNote mesh__D004597
% 218.95/219.10       68%28%64%29%; ELECTROCONVULSIVE SHOCK was heading 1966-67   
% 218.95/219.10  |- mesh__recordOriginator mesh__D004597 NLM
% 218.95/219.10  |- skos__broader mesh__D004597smesh__D011580
% 218.95/219.10  |- skos__annotation mesh__D004597
% 218.95/219.10       exper shock by electricity, usually in psychol exper: do not confuse with ELECTRIC INJURIES or ELECTROCONVULSIVE THERAPY; X ref ELECTROCONVULSIVE SHOCK: do not coord with CONVULSIONS; electrocountershock = ELECTRIC COUNTERSHOCK%A%  
% 218.95/219.10  |- skos__broader mesh__D004597smesh__D004558
% 218.95/219.10  |- skos__hiddenLabel mesh__D004597 Electroshocks
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D004597 2005
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D004597 1998
% 218.95/219.10  |- mesh__dateRevised mesh__D004597 1997-06-20
% 218.95/219.10  |- skos__scopeNote mesh__D004597
% 218.95/219.10       Induction of a stress reaction in experimental subjects by means of an electrical shock; applies to either convulsive or non-convulsive states.%A%    
% 218.95/219.10  |- mesh__publicMeSHNote mesh__D004597
% 218.95/219.10       68; ELECTROCONVULSIVE SHOCK was heading 1966-67   
% 218.95/219.10  |- skos__prefLabel mesh__D004597 Electroshock
% 218.95/219.10  |- mesh__dateEstablished mesh__D004597 1968-01-01
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D004597 2006
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D004597 2003
% 218.95/219.10  |- mesh__recordMaintainer mesh__D004597 TGC
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D004597 1999
% 218.95/219.10  |- skos__hiddenLabel mesh__D004597 Shocks, Electroconvulsive
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D004597 2000
% 218.95/219.10  |- mesh__onlineNote mesh__D004597
% 218.95/219.10       search ELECTROCONVULSIVE SHOCK under SHOCK THERAPY, ELECTRIC 1966-67%A%  
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D004597 2004
% 218.95/219.10  |- mesh__recordAuthorizer mesh__D004597 SJN
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D004597 2001
% 218.95/219.10  |- rdf__type mesh__D004597sskos__Concept
% 218.95/219.10  |- rdf__type mesh__D045405sskos__Concept
% 218.95/219.10  |- skos__hiddenLabel mesh__D045405 Virus, Nipah
% 218.95/219.10  |- mesh__historyNote mesh__D045405 2004; use PARAMYXOVIRINAE 2000-2003   
% 218.95/219.10  |- skos__historyNote mesh__D045405 Paramyxovirinae %28%1999-2003%29%
% 218.95/219.10  |- skos__annotation mesh__D045405
% 218.95/219.10       infection: coord IM with HENIPAVIRUS INFECTIONS %28%IM%29%   
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D045405 2006
% 218.95/219.10  |- skos__hiddenLabel mesh__D045405 Viruses, Nipah
% 218.95/219.10  |- mesh__dateEstablished mesh__D045405 2004-01-01
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D045405 2004
% 218.95/219.10  |- skos__hiddenLabel mesh__D045405 Nipah Viruses
% 218.95/219.10  |- skos__broader mesh__D045405smesh__D045403
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D045405 2005
% 218.95/219.10  |- mesh__dateCreated mesh__D045405 2003-07-09
% 218.95/219.10  |- skos__scopeNote mesh__D045405
% 218.95/219.10       A species of HENIPAVIRUS, closely related to HENDRA VIRUS, which emerged in Peninsular Malaysia in 1998. It causes a severe febrile ENCEPHALITIS in humans and also encephalitis and RESPIRATORY TRACT DISEASES in pigs. Fruit bats %28%PTEROPUS%29% are the natural host.%A%    
% 218.95/219.10  |- mesh__publicMeSHNote mesh__D045405
% 218.95/219.10       2004; see PARAMYXOVIRINAE 2000-2003   
% 218.95/219.10  |- skos__prefLabel mesh__D045405 Nipah Virus
% 218.95/219.10  |- mesh__dateCreated mesh__D009282 1999-01-01
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009282 1999
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009282 1996
% 218.95/219.10  |- skos__broader mesh__D009282smesh__D001190
% 218.95/219.10  |- rdf__type mesh__D009282sskos__Concept
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009282 1997
% 218.95/219.10  |- mesh__recordOriginator mesh__D009282 NLM
% 218.95/219.10  |- mesh__recordAuthorizer mesh__D009282 PLS
% 218.95/219.10  |- mesh__recordMaintainer mesh__D009282 TPW
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009282 2005
% 218.95/219.10  |- skos__scopeNote mesh__D009282
% 218.95/219.10       A class of organic compounds that contains a naphthalene moiety linked to a sulfonic acid salt or ester.%A%    
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009282 2000
% 218.95/219.10  |- skos__broader mesh__D009282smesh__D009281
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009282 2006
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009282 2003
% 218.95/219.10  |- mesh__publicMeSHNote mesh__D009282 74   
% 218.95/219.10  |- mesh__historyNote mesh__D009282 74   
% 218.95/219.10  |- mesh__dateRevised mesh__D009282 1993-06-04
% 218.95/219.10  |- mesh__dateEstablished mesh__D009282 1974-01-01
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009282 1994
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009282 2001
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009282 2004
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009282 1998
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009282 1995
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D009282 2002
% 218.95/219.10  |- skos__prefLabel mesh__D009282 Naphthalenesulfonates
% 218.95/219.10  |- mesh__publicMeSHNote mesh__D017714 94   
% 218.95/219.10  |- mesh__dateEstablished mesh__D017714 1994-01-01
% 218.95/219.10  |- mesh__dateCreated mesh__D017714 1993-06-18
% 218.95/219.10  |- skos__broader mesh__D017714smesh__D007239
% 218.95/219.10  |- skos__hiddenLabel mesh__D017714 Infections, Community Acquired
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017714 1994
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017714 2005
% 218.95/219.10  |- skos__altLabel mesh__D017714 Infections, Community-Acquired
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017714 1997
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017714 2002
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017714 1996
% 218.95/219.10  |- skos__hiddenLabel mesh__D017714 Infection, Community-Acquired
% 218.95/219.10  |- skos__hiddenLabel mesh__D017714 Community-Acquired Infection
% 218.95/219.10  |- mesh__historyNote mesh__D017714 94   
% 218.95/219.10  |- skos__hiddenLabel mesh__D017714 Community Acquired Infections
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017714 2004
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017714 1999
% 218.95/219.10  |- skos__annotation mesh__D017714
% 218.95/219.10       contrasted with hospital- or other health facil-acquired %28% = CROSS INFECTION%29%; IM GEN only; coord NIM with specific community-acquired infect %28%IM%29%, if discussed%A%  
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017714 2001
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017714 2003
% 218.95/219.10  |- rdf__type mesh__D017714sskos__Concept
% 218.95/219.10  |- skos__scopeNote mesh__D017714
% 218.95/219.10       Any infection acquired in the community, that is, contrasted with those acquired in a health care facility %28%CROSS INFECTION%29%. An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility.%A%    
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017714 1998
% 218.95/219.10  |- skos__prefLabel mesh__D017714 Community-Acquired Infections
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017714 2000
% 218.95/219.10  |- skos__related mesh__D017714smesh__D003428
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017714 1995
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D017714 2006
% 218.95/219.10  |- mesh__historyNote mesh__D008988 2005 %28%1975%29%   
% 218.95/219.10  |- skos__hiddenLabel mesh__D008988 Mongoose, Liberian
% 218.95/219.10  |- skos__hiddenLabel mesh__D008988 Mongooses, Dwarf
% 218.95/219.10  |- mesh__dateRevised mesh__D008988 2004-07-13
% 218.95/219.10  |- skos__altLabel mesh__D008988 Mongooses
% 218.95/219.10  |- skos__altLabel mesh__D008988 Crossarchus
% 218.95/219.10  |- skos__hiddenLabel mesh__D008988 Mongoose
% 218.95/219.10  |- mesh__dateCreated mesh__D008988 1974-12-12
% 218.95/219.10  |- rdf__type mesh__D008988sskos__Concept
% 218.95/219.10  |- mesh__dateEstablished mesh__D008988 1991-01-01
% 218.95/219.10  |- skos__broader mesh__D008988smesh__D002335
% 218.95/219.10  |- skos__hiddenLabel mesh__D008988 Mongoose, Dwarf
% 218.95/219.10  |- mesh__recordAuthorizer mesh__D008988 sjn
% 218.95/219.10  |- skos__scopeNote mesh__D008988
% 218.95/219.10       The family of agile, keen-sighted mongooses of Asia and Africa that feed on RODENTS and SNAKES.%A%    
% 218.95/219.10  |- mesh__recordMaintainer mesh__D008988 sjn
% 218.95/219.10  |- mesh__publicMeSHNote mesh__D008988
% 218.95/219.10       2005; see MONGOOSES 1998-2004, see MONGOOSE 1991-1997, see CARNIVORA 1975-1990%A%  
% 218.95/219.10  |- skos__hiddenLabel mesh__D008988 Dwarf Mongoose
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D008988 2005
% 218.95/219.10  |- skos__altLabel mesh__D008988 Dwarf Mongooses
% 218.95/219.10  |- skos__prefLabel mesh__D008988 Herpestidae
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D008988 2006
% 218.95/219.10  |- mesh__recordOriginator mesh__D008988 NLM
% 218.95/219.10  |- skos__altLabel mesh__D008988 Liberian Mongoose
% 218.95/219.10  |- skos__altLabel mesh__D033381 Hermit Crab
% 218.95/219.10  |- skos__prefLabel mesh__D033381 Anomura
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D033381 2005
% 218.95/219.10  |- mesh__dateCreated mesh__D033381 2002-07-02
% 218.95/219.10  |- skos__historyNote mesh__D033381 Crustacea %28%1979-2002%29%
% 218.95/219.10  |- skos__broader mesh__D033381smesh__D033364
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D033381 2004
% 218.95/219.10  |- mesh__activeMeSHYear mesh__D033381 2006
% 218.95/219.10  |- skos__scopeNote mesh__D033381
% 218.95/219.10       An infraorder of CRUSTACEA, in the order DECAPODA comprising the hermit crabs and characterized by a small fifth pair of legs.%A%    
% 218.95/219.11  |- mesh__historyNote mesh__D033381 2003   
% 218.95/219.11  |- mesh__dateEstablished mesh__D033381 2003-01-01
% 218.95/219.11  |- mesh__dateRevised mesh__D033381 2003-07-09
% 218.95/219.11  |- rdf__type mesh__D033381sskos__Concept
% 218.95/219.11  |- mesh__publicMeSHNote mesh__D033381 2003   
% 218.95/219.11  |- skos__altLabel mesh__D033381 Hermit Crabs
% 218.95/219.11  |- skos__altLabel mesh__D005690 D-Galactose
% 218.95/219.11  |- skos__broader mesh__D005690smesh__D006601
% 218.95/219.11  |- mesh__recordAuthorizer mesh__D005690 sjn
% 218.95/219.11  |- skos__related mesh__D005690smesh__D005685
% 218.95/219.11  |- skos__altLabel mesh__D005690 Galactopyranose
% 218.95/219.11  |- skos__prefLabel mesh__D005690 Galactose
% 218.95/219.11  |- skos__hiddenLabel mesh__D005690 D Galactose
% 218.95/219.11  |- skos__related mesh__D005690smesh__D005693
% 218.95/219.11  |- skos__altLabel mesh__D005690 Galactopyranoside
% 218.95/219.11  |- mesh__recordMaintainer mesh__D005690 ssb
% 218.95/219.11  |- skos__scopeNote mesh__D005690
% 218.95/219.11       An aldohexose that occurs naturally in the D-form in lactose, cerebrosides, gangliosides, and mucoproteins. Deficiency of galactosyl-1-phosphate uridyltransferase %28%GALACTOSE-1-PHOSPHATE URIDYL-TRANSFERASE DEFICIENCY DISEASE%29% causes an error in galactose metabolism called GALACTOSEMIA, resulting in elevations of galactose in the blood.%A%    
% 218.95/219.11  |- rdf__type mesh__D005690sskos__Concept
% 218.95/219.11  |- mesh__dateCreated mesh__D005690 1999-01-01
% 218.95/219.11  |- mesh__dateRevised mesh__D005690 2004-07-07
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D005690 2005
% 218.95/219.11  |- mesh__recordOriginator mesh__D005690 NLM
% 218.95/219.11  |- skos__annotation mesh__D005690 /blood: consider also GALACTOSEMIAS   
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D005690 2006
% 218.95/219.11  |- skos__broader mesh__D013324smesh__D019216
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013324 2006
% 218.95/219.11  |- mesh__recordMaintainer mesh__D013324 ADP
% 218.95/219.11  |- skos__related mesh__D013324smesh__D013326
% 218.95/219.11  |- skos__related mesh__D013324smesh__D013325
% 218.95/219.11  |- skos__annotation mesh__D013324 an alkaline earth metal; Sr-88   
% 218.95/219.11  |- mesh__recordOriginator mesh__D013324 NLM
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013324 2000
% 218.95/219.11  |- mesh__dateRevised mesh__D013324 1997-06-20
% 218.95/219.11  |- skos__prefLabel mesh__D013324 Strontium
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013324 2003
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013324 2001
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013324 1998
% 218.95/219.11  |- skos__broader mesh__D013324smesh__D008673
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013324 2004
% 218.95/219.11  |- mesh__dateCreated mesh__D013324 1999-01-01
% 218.95/219.11  |- skos__scopeNote mesh__D013324
% 218.95/219.11       An element of the alkaline earth family of metals. It has the atomic symbol Sr, atomic number 38, and atomic weight 87.62.%A%    
% 218.95/219.11  |- rdf__type mesh__D013324sskos__Concept
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013324 2002
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013324 1999
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013324 2005
% 218.95/219.11  |- mesh__recordAuthorizer mesh__D013324 SJN
% 218.95/219.11  |- skos__prefLabel mesh__D004598 Electrosurgery
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D004598 2001
% 218.95/219.11  |- skos__hiddenLabel mesh__D004598 Electrosurgeries
% 218.95/219.11  |- mesh__publicMeSHNote mesh__D004598 65   
% 218.95/219.11  |- mesh__historyNote mesh__D004598 65   
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D004598 2005
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D004598 1998
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D004598 2002
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D004598 2006
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D004598 2003
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D004598 1999
% 218.95/219.11  |- mesh__recordMaintainer mesh__D004598 TGC
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D004598 1996
% 218.95/219.11  |- skos__scopeNote mesh__D004598
% 218.95/219.11       Division of tissues by a high-frequency current applied locally with a metal instrument or needle. %28%Stedman, 25th ed%29%%A%    
% 218.95/219.11  |- mesh__recordOriginator mesh__D004598 NLM
% 218.95/219.11  |- skos__broader mesh__D004598smesh__D013514
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D004598 2004
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D004598 1997
% 218.95/219.11  |- skos__annotation mesh__D004598
% 218.95/219.11       do not use /util except by MeSH definition   
% 218.95/219.11  |- mesh__recordAuthorizer mesh__D004598 PLS
% 218.95/219.11  |- mesh__dateRevised mesh__D004598 1995-03-13
% 218.95/219.11  |- rdf__type mesh__D004598sskos__Concept
% 218.95/219.11  |- mesh__dateEstablished mesh__D004598 1965-01-01
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D004598 2000
% 218.95/219.11  |- mesh__dateCreated mesh__D004598 1999-01-01
% 218.95/219.11  |- skos__hiddenLabel mesh__D009283 Naphthylesterase, alpha
% 218.95/219.11  |- mesh__dateRevised mesh__D009283 2003-07-09
% 218.95/219.11  |- skos__altLabel mesh__D009283 Naphthol AS D Acetatesterase
% 218.95/219.11  |- rdf__type mesh__D009283sskos__Concept
% 218.95/219.11  |- skos__altLabel mesh__D009283 ANAE
% 218.95/219.11  |- skos__hiddenLabel mesh__D009283 Esterase, alpha-Naphthylacetate
% 218.95/219.11  |- mesh__historyNote mesh__D009283
% 218.95/219.11       85%28%75%29%; was see under CARBOXYLIC ESTER HYDROLASES 1976-84, was see under ESTERASES 1975%A%  
% 218.95/219.11  |- mesh__recordMaintainer mesh__D009283 ssb
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D009283 2005
% 218.95/219.11  |- skos__altLabel mesh__D009283 alpha-Naphthylacetate Esterase
% 218.95/219.11  |- mesh__recordAuthorizer mesh__D009283 sjn
% 218.95/219.11  |- skos__historyNote mesh__D009283 Naphthols %28%1972-1974%29%
% 218.95/219.11  |- skos__hiddenLabel mesh__D009283 alpha Naphthyl Acetate Esterase
% 218.95/219.11  |- skos__historyNote mesh__D009283 Esterases %28%1971-1974%29%
% 218.95/219.11  |- skos__hiddenLabel mesh__D009283 Acetate Esterase, alpha-Naphthyl
% 218.95/219.11  |- mesh__publicMeSHNote mesh__D009283
% 218.95/219.11       85; was see under CARBOXYLIC ESTER HYDROLASES 1976-84, was see under ESTERASES 1975%A%  
% 218.95/219.11  |- skos__altLabel mesh__D009283 alpha Naphthylesterase
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D009283 2006
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D009283 2004
% 218.95/219.11  |- mesh__recordOriginator mesh__D009283 NLM
% 218.95/219.11  |- skos__altLabel mesh__D009283 alpha-Naphthyl Acetate Esterase
% 218.95/219.11  |- skos__hiddenLabel mesh__D009283 Esterase, alpha-Naphthyl Acetate
% 218.95/219.11  |- mesh__dateEstablished mesh__D009283 1985-01-01
% 218.95/219.11  |- mesh__dateCreated mesh__D009283 1974-11-19
% 218.95/219.11  |- skos__hiddenLabel mesh__D009283 alpha Naphthylacetate Esterase
% 218.95/219.11  |- skos__scopeNote mesh__D009283
% 218.95/219.11       Hydrolytic enzyme activity used as a histocytochemical test for the presence of esterases in tissue. Substrate used is 3-hydroxy-4%27%-nitro-2-naphthanilide chloroacetate %28%naphthol AS-D%29%.%A%    
% 218.95/219.11  |- skos__prefLabel mesh__D009283 Naphthol AS D Esterase
% 218.95/219.11  |- skos__altLabel mesh__D009283 Naphthol AS D Chloroacetate Esterase
% 218.95/219.11  |- skos__broader mesh__D009283smesh__D002265
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D008989 1995
% 218.95/219.11  |- rdf__type mesh__D008989sskos__Concept
% 218.95/219.11  |- mesh__dateCreated mesh__D008989 1999-01-01
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D008989 1998
% 218.95/219.11  |- mesh__historyNote mesh__D008989 68   
% 218.95/219.11  |- skos__annotation mesh__D008989
% 218.95/219.11       tapeworm infect; usually animal; check tag ANIMAL; for organism index CESTODA %28%IM%29% + MONIEZIASIS %28%NIM%29%%A%  
% 218.95/219.11  |- mesh__recordOriginator mesh__D008989 NLM
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D008989 2005
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D008989 1999
% 218.95/219.11  |- skos__hiddenLabel mesh__D008989 Monieziases
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D008989 1996
% 218.95/219.11  |- mesh__dateEstablished mesh__D008989 1968-01-01
% 218.95/219.11  |- skos__prefLabel mesh__D008989 Monieziasis
% 218.95/219.11  |- mesh__recordMaintainer mesh__D008989 TGC
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D008989 2006
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D008989 2003
% 218.95/219.11  |- mesh__dateRevised mesh__D008989 1994-02-08
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D008989 1997
% 218.95/219.11  |- skos__scopeNote mesh__D008989
% 218.95/219.11       Infection of ruminants with tapeworms of the genus Moniezia.%A%    
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D008989 2000
% 218.95/219.11  |- mesh__recordAuthorizer mesh__D008989 PLS
% 218.95/219.11  |- skos__broader mesh__D008989smesh__D002590
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D008989 2004
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D008989 2001
% 218.95/219.11  |- skos__broader mesh__D008989smesh__D006374
% 218.95/219.11  |- mesh__publicMeSHNote mesh__D008989 68   
% 218.95/219.11  |- skos__historyNote mesh__D008989 Cestode Infections %28%1966-1967%29%
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D008989 2002
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D005691 2004
% 218.95/219.11  |- skos__prefLabel mesh__D005691 Galactose Dehydrogenases
% 218.95/219.11  |- mesh__publicMeSHNote mesh__D005691
% 218.95/219.11       91; was see under CARBOHYDRATE DEHYDROGENASES 1978-90   
% 218.95/219.11  |- mesh__historyNote mesh__D005691
% 218.95/219.11       91%28%78%29%; was see under CARBOHYDRATE DEHYDROGENASES 1978-90%A%  
% 218.95/219.11  |- skos__broader mesh__D005691smesh__D002237
% 218.95/219.11  |- mesh__dateEstablished mesh__D005691 1991-01-01
% 218.95/219.11  |- mesh__recordAuthorizer mesh__D005691 sjn
% 218.95/219.11  |- mesh__dateRevised mesh__D005691 2003-07-09
% 218.95/219.11  |- skos__historyNote mesh__D005691
% 218.95/219.11       Alcohol Oxidoreductases %28%1966-1977%29%
% 218.95/219.11  |- skos__hiddenLabel mesh__D005691 Dehydrogenases, Galactose
% 218.95/219.11  |- skos__hiddenLabel mesh__D005691 Oxidoreductases, Galactose
% 218.95/219.11  |- rdf__type mesh__D005691sskos__Concept
% 218.95/219.11  |- mesh__dateCreated mesh__D005691 1977-05-17
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D005691 2005
% 218.95/219.11  |- mesh__recordOriginator mesh__D005691 RLS
% 218.95/219.11  |- skos__scopeNote mesh__D005691
% 218.95/219.11       D-Galactose:NAD%28%P%29%+ 1-oxidoreductases. Catalyzes the oxidation of D-galactose in the presence of NAD+ or NADP+ to D-galactono-gamma-lactone and NADH or NADPH. Includes EC 1.1.1.48 and EC 1.1.1.120.%A%    
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D005691 2006
% 218.95/219.11  |- mesh__recordMaintainer mesh__D005691 ssb
% 218.95/219.11  |- skos__altLabel mesh__D005691 Galactose Oxidoreductases
% 218.95/219.11  |- mesh__recordOriginator mesh__D013325 NLM
% 218.95/219.11  |- skos__prefLabel mesh__D013325 Strontium Isotopes
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013325 2006
% 218.95/219.11  |- skos__hiddenLabel mesh__D013325 Isotopes, Strontium
% 218.95/219.11  |- mesh__recordMaintainer mesh__D013325 nns
% 218.95/219.11  |- skos__annotation mesh__D013325 Sr-84,86,87; NIM   
% 218.95/219.11  |- mesh__dateRevised mesh__D013325 2000-06-22
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013325 2001
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013325 2003
% 218.95/219.11  |- mesh__dateCreated mesh__D013325 1999-01-01
% 218.95/219.11  |- mesh__recordAuthorizer mesh__D013325 sjn
% 218.95/219.11  |- rdf__type mesh__D013325sskos__Concept
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013325 2002
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013325 2004
% 218.95/219.11  |- skos__scopeNote mesh__D013325
% 218.95/219.11       Stable strontium atoms that have the same atomic number as the element strontium, but differ in the atomic weight. Sr-84, 86, 87, and 88 are the stable strontium isotopes.%A%    
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013325 2005
% 218.95/219.11  |- skos__broader mesh__D013325smesh__D007554
% 218.95/219.11  |- mesh__dateEstablished mesh__D018010 1994-01-01
% 218.95/219.11  |- skos__altLabel mesh__D018010 Receptors, Invertebrate Peptides
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D018010 2000
% 218.95/219.11  |- skos__hiddenLabel mesh__D018010 Peptide Receptor, Invertebrate
% 218.95/219.11  |- skos__prefLabel mesh__D018010 Receptors, Invertebrate Peptide
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D018010 2005
% 218.95/219.11  |- mesh__dateCreated mesh__D018010 1993-06-21
% 218.95/219.11  |- skos__altLabel mesh__D018010 Invertebrate Peptide Receptors
% 218.95/219.11  |- skos__scopeNote mesh__D018010
% 218.95/219.11       Cell surface receptors for invertebrate peptide hormones or neuropeptides.%A%    
% 218.95/219.11  |- mesh__historyNote mesh__D018010 94   
% 218.95/219.11  |- skos__altLabel mesh__D018010 Invertebrate Peptide Receptor
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D018010 2001
% 218.95/219.11  |- mesh__recordOriginator mesh__D018010 RAZ
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D018010 2006
% 218.95/219.11  |- skos__broader mesh__D018010smesh__D018000
% 218.95/219.11  |- rdf__type mesh__D018010sskos__Concept
% 218.95/219.11  |- skos__hiddenLabel mesh__D018010 Receptor, Invertebrate Peptide
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D018010 2002
% 218.95/219.11  |- skos__hiddenLabel mesh__D018010 Invertebrate Peptides Receptors
% 218.95/219.11  |- skos__historyNote mesh__D018010
% 218.95/219.11       Receptors, Cell Surface %28%1973-1993%29%
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D018010 1998
% 218.95/219.11  |- mesh__dateRevised mesh__D018010 1997-06-20
% 218.95/219.11  |- skos__altLabel mesh__D018010 Peptide Receptors, Invertebrate
% 218.95/219.11  |- skos__hiddenLabel mesh__D018010 Peptides Receptors, Invertebrate
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D018010 1999
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D018010 2003
% 218.95/219.11  |- mesh__publicMeSHNote mesh__D018010 94   
% 218.95/219.11  |- skos__altLabel mesh__D018010 Receptors, Peptide, Invertebrate
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D018010 2004
% 218.95/219.11  |- mesh__recordAuthorizer mesh__D018010 SJN
% 218.95/219.11  |- mesh__recordMaintainer mesh__D018010 NDW
% 218.95/219.11  |- skos__annotation mesh__D018010
% 218.95/219.11       receptors for peptide hormones %26% neuropeptides; DF: RECEPT INVERTEBRATE PEPTIDE%A%  
% 218.95/219.11  |- skos__prefLabel mesh__D004599 Electric Stimulation Therapy
% 218.95/219.11  |- skos__broader mesh__D004599smesh__D026741
% 218.95/219.11  |- mesh__recordMaintainer mesh__D004599 lkt
% 218.95/219.11  |- mesh__dateRevised mesh__D004599 2005-06-30
% 218.95/219.11  |- mesh__historyNote mesh__D004599 90; was ELECTROTHERAPY 1966-89   
% 218.95/219.11  |- skos__annotation mesh__D004599
% 218.95/219.11       do not use /util except by MeSH definition   
% 218.95/219.11  |- skos__scopeNote mesh__D004599
% 218.95/219.11       Application of electric current in treatment without the generation of perceptible heat. It includes electric stimulation of nerves or muscles, passage of current into the body, or use of interrupted current of low intensity to raise the threshold of the skin to pain.%A%    
% 218.95/219.11  |- mesh__publicMeSHNote mesh__D004599 90; was ELECTROTHERAPY 1966-89   
% 218.95/219.11  |- mesh__onlineNote mesh__D004599
% 218.95/219.11       use ELECTRIC STIMULATION THERAPY to search ELECTROTHERAPY 1966-89%A%  
% 218.95/219.11  |- skos__hiddenLabel mesh__D004599 Electric Stimulation, Therapeutic
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D004599 2006
% 218.95/219.11  |- skos__hiddenLabel mesh__D004599 Stimulation Therapy, Electric
% 218.95/219.11  |- skos__hiddenLabel mesh__D004599 Stimulation, Therapeutic Electric
% 218.95/219.11  |- skos__altLabel mesh__D004599 Electrotherapy
% 218.95/219.11  |- mesh__dateCreated mesh__D004599 1999-01-01
% 218.95/219.11  |- skos__altLabel mesh__D004599 Therapy, Electric Stimulation
% 218.95/219.11  |- mesh__recordAuthorizer mesh__D004599 sjn
% 218.95/219.11  |- mesh__recordOriginator mesh__D004599 NLM
% 218.95/219.11  |- skos__altLabel mesh__D004599 Therapeutic Electric Stimulation
% 218.95/219.11  |- rdf__type mesh__D004599sskos__Concept
% 218.95/219.11  |- skos__broader mesh__D004599smesh__D013812
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D009284 2002
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D009284 1997
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D009284 2001
% 218.95/219.11  |- mesh__publicMeSHNote mesh__D009284 73   
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D009284 1996
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D009284 1999
% 218.95/219.11  |- mesh__dateRevised mesh__D009284 1993-06-03
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D009284 2000
% 218.95/219.11  |- rdf__type mesh__D009284sskos__Concept
% 218.95/219.11  |- mesh__recordMaintainer mesh__D009284 PLS
% 218.95/219.11  |- skos__scopeNote mesh__D009284
% 218.95/219.11       Naphthalene derivatives carrying one or more hydroxyl %28%-OH%29% groups at any ring position. They are often used in dyes and pigments, as antioxidants for rubber, fats, and oils, as insecticides, in pharmaceuticals, and in numerous other applications.%A%    
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D009284 1995
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D009284 2004
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D009284 1998
% 218.95/219.11  |- skos__broader mesh__D009284smesh__D009281
% 218.95/219.11  |- skos__altLabel mesh__D009284 Hydroxynaphthalenes
% 218.95/219.11  |- skos__prefLabel mesh__D009284 Naphthols
% 218.95/219.11  |- mesh__dateEstablished mesh__D009284 1973-01-01
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D009284 1994
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D009284 2003
% 218.95/219.11  |- mesh__recordAuthorizer mesh__D009284 PLS
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D009284 2006
% 218.95/219.11  |- mesh__dateCreated mesh__D009284 1999-01-01
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D009284 2005
% 218.95/219.11  |- skos__historyNote mesh__D009284 Naphthalenes %28%1966-1971%29%
% 218.95/219.11  |- mesh__historyNote mesh__D009284 73%28%72%29%   
% 218.95/219.11  |- mesh__recordOriginator mesh__D009284 NLM
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D005692 2004
% 218.95/219.11  |- skos__prefLabel mesh__D005692 Galactose Oxidase
% 218.95/219.11  |- skos__historyNote mesh__D005692
% 218.95/219.11       Alcohol Oxidoreductases %28%1966-1977%29%
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D005692 2005
% 218.95/219.11  |- skos__scopeNote mesh__D005692
% 218.95/219.11       An enzyme that oxidizes galactose in the presence of molecular oxygen to D-galacto-hexodialdose. It is a copper protein. EC 1.1.3.9.%A%    
% 218.95/219.11  |- mesh__publicMeSHNote mesh__D005692
% 218.95/219.11       78; was see under ALCOHOL OXIDOREDUCTASES 1975-77   
% 218.95/219.11  |- mesh__dateRevised mesh__D005692 2003-07-09
% 218.95/219.11  |- mesh__dateCreated mesh__D005692 1974-11-19
% 218.95/219.11  |- mesh__historyNote mesh__D005692
% 218.95/219.11       78%28%75%29%; was see under ALCOHOL OXIDOREDUCTASES 1975-77   
% 218.95/219.11  |- mesh__recordOriginator mesh__D005692 NLM
% 218.95/219.11  |- skos__hiddenLabel mesh__D005692 Oxidase, Galactose
% 218.95/219.11  |- mesh__recordAuthorizer mesh__D005692 sjn
% 218.95/219.11  |- rdf__type mesh__D005692sskos__Concept
% 218.95/219.11  |- mesh__recordMaintainer mesh__D005692 ssb
% 218.95/219.11  |- mesh__dateEstablished mesh__D005692 1978-01-01
% 218.95/219.11  |- skos__broader mesh__D005692smesh__D000429
% 218.95/219.11  |- skos__historyNote mesh__D005692 Galactose %28%1966-1974%29%
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D005692 2006
% 218.95/219.11  |- skos__annotation mesh__D013326
% 218.95/219.11       Sr-80-83, 85, 89-95; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 218.95/219.11  |- skos__broader mesh__D013326smesh__D011868
% 218.95/219.11  |- skos__hiddenLabel mesh__D013326 Radioisotopes, Strontium
% 218.95/219.11  |- skos__prefLabel mesh__D013326 Strontium Radioisotopes
% 218.95/219.11  |- mesh__historyNote mesh__D013326 74   
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013326 1997
% 218.95/219.11  |- skos__broader mesh__D013326smesh__D013325
% 218.95/219.11  |- mesh__dateRevised mesh__D013326 1993-06-04
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013326 1998
% 218.95/219.11  |- mesh__recordOriginator mesh__D013326 NLM
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013326 2003
% 218.95/219.11  |- mesh__dateCreated mesh__D013326 1999-01-01
% 218.95/219.11  |- mesh__dateEstablished mesh__D013326 1974-01-01
% 218.95/219.11  |- rdf__type mesh__D013326sskos__Concept
% 218.95/219.11  |- mesh__publicMeSHNote mesh__D013326 74   
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013326 2000
% 218.95/219.11  |- mesh__onlineNote mesh__D013326 search STRONTIUM ISOTOPES 1966-73   
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013326 1999
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013326 2004
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013326 1994
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013326 2001
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013326 2005
% 218.95/219.11  |- skos__scopeNote mesh__D013326
% 218.95/219.11       Unstable isotopes of strontium that decay or disintegrate spontaneously emitting radiation. Sr 80-83, 85, and 89-95 are radioactive strontium isotopes.%A%    
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013326 1995
% 218.95/219.11  |- mesh__recordMaintainer mesh__D013326 TPW
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013326 1996
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013326 2002
% 218.95/219.11  |- mesh__recordAuthorizer mesh__D013326 PLS
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013326 2006
% 218.95/219.11  |- mesh__dateRevised mesh__D018011 2005-07-22
% 218.95/219.11  |- skos__broader mesh__D018011smesh__D004602
% 218.95/219.11  |- rdf__type mesh__D018011sskos__Concept
% 218.95/219.11  |- skos__altLabel mesh__D018011 Group 16 Elements
% 218.95/219.11  |- skos__scopeNote mesh__D018011
% 218.95/219.11       The elements OXYGEN; POLONIUM; SELENIUM; SULFUR; and TELLURIUM; that form group 16 %28%formerly group VI%29% of the periodic table.%A%    
% 218.95/219.11  |- skos__prefLabel mesh__D018011 Chalcogens
% 218.95/219.11  |- skos__hiddenLabel mesh__D018011 Elements, Group 16
% 218.95/219.11  |- mesh__recordAuthorizer mesh__D018011 ags
% 218.95/219.11  |- mesh__historyNote mesh__D018011 1998   
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D018011 2003
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D018011 2006A
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D018011 2004
% 218.95/219.11  |- mesh__recordMaintainer mesh__D018011 ags
% 218.95/219.11  |- mesh__publicMeSHNote mesh__D018011 1998   
% 218.95/219.11  |- mesh__recordOriginator mesh__D018011 TPW
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D018011 2005
% 218.95/219.11  |- skos__annotation mesh__D018011 GEN; prefer specifics   
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D018011 2002
% 218.95/219.11  |- mesh__dateCreated mesh__D018011 1993-08-26
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D018011 2006
% 218.95/219.11  |- mesh__dateEstablished mesh__D018011 1998-01-01
% 218.95/219.11  |- skos__historyNote mesh__D051445 Cartilage %28%1971-2005%29%
% 218.95/219.11  |- skos__prefLabel mesh__D051445 Fibrocartilage
% 218.95/219.11  |- rdf__type mesh__D051445sskos__Concept
% 218.95/219.11  |- mesh__recordMaintainer mesh__D051445 ags
% 218.95/219.11  |- mesh__historyNote mesh__D051445 2006; use CARTILAGE 2000-2005   
% 218.95/219.11  |- skos__scopeNote mesh__D051445
% 218.95/219.11       A type of CARTILAGE whose matrix contains large bundles of COLLAGEN TYPE I. Fibrocartilage is typically found in the INTERVERTEBRAL DISK; SYMPHYSIS PUBIS; TIBIAL MENISCI; and articular disks in synovial JOINTS. %28%From Ross et. al., Histology, 3rd ed., p132,136%29%%A%    
% 218.95/219.11  |- skos__broader mesh__D051445smesh__D002356
% 218.95/219.11  |- mesh__dateCreated mesh__D051445 2005-06-30
% 218.95/219.11  |- mesh__publicMeSHNote mesh__D051445 2006; see CARTILAGE 2000-2005   
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D051445 2006
% 218.95/219.11  |- mesh__recordAuthorizer mesh__D051445 sjn
% 218.95/219.11  |- skos__historyNote mesh__D051445 Cartilage, Articular %28%1965-2005%29%
% 218.95/219.11  |- mesh__dateEstablished mesh__D051445 2006-01-01
% 218.95/219.11  |- mesh__recordOriginator mesh__D051445 ags
% 218.95/219.11  |- skos__scopeNote mesh__D009285
% 218.95/219.11       Naphthalene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.%A%    
% 218.95/219.11  |- mesh__recordOriginator mesh__D009285 NLM
% 218.95/219.11  |- rdf__type mesh__D009285sskos__Concept
% 218.95/219.11  |- skos__broader mesh__D009285smesh__D009281
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D009285 2004
% 218.95/219.11  |- mesh__dateRevised mesh__D009285 2003-07-09
% 218.95/219.11  |- mesh__recordMaintainer mesh__D009285 ssb
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D009285 2006
% 218.95/219.11  |- skos__broader mesh__D009285smesh__D011809
% 218.95/219.11  |- mesh__dateCreated mesh__D009285 1999-01-01
% 218.95/219.11  |- skos__altLabel mesh__D009285 Naphthalenediones
% 218.95/219.11  |- skos__prefLabel mesh__D009285 Naphthoquinones
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D009285 2005
% 218.95/219.11  |- mesh__recordAuthorizer mesh__D009285 sjn
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D005693 2002
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D005693 2004
% 218.95/219.11  |- skos__altLabel mesh__D005693
% 218.95/219.11       Deficiency Disease, UDP-Galactose-4-Epimerase
% 218.95/219.11  |- mesh__recordOriginator mesh__D005693 NLM
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D005693 2005
% 218.95/219.11  |- skos__altLabel mesh__D005693
% 218.95/219.11       UDPglucose Hexose-1-Phosphate Uridylyltransferase Deficiency
% 218.95/219.11  |- skos__hiddenLabel mesh__D005693 Classic Galactosemias
% 218.95/219.11  |- skos__hiddenLabel mesh__D005693
% 218.95/219.11       Deficiency Disease, UDPglucose 4 Epimerase
% 218.95/219.11  |- skos__hiddenLabel mesh__D005693 Galactosemias, Classic
% 218.95/219.11  |- skos__related mesh__D005693smesh__D005686
% 218.95/219.11  |- skos__altLabel mesh__D005693 Deficiency Disease, UDPglucose 4-Epimerase
% 218.95/219.11  |- skos__hiddenLabel mesh__D005693
% 218.95/219.11       Deficiency Disease, Galactose 1 Phosphate Uridyl Transferase
% 218.95/219.11  |- skos__altLabel mesh__D005693
% 218.95/219.11       UTP Hexose-1-Phosphate Uridylyltransferase Deficiency
% 218.95/219.11  |- skos__related mesh__D005693smesh__D005690
% 218.95/219.11  |- mesh__recordMaintainer mesh__D005693 nns
% 218.95/219.11  |- skos__broader mesh__D005693smesh__D002239
% 218.95/219.11  |- skos__hiddenLabel mesh__D005693
% 218.95/219.11       UDPglucose 4 Epimerase Deficiency Disease
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D005693 2006
% 218.95/219.11  |- skos__altLabel mesh__D005693
% 218.95/219.11       UDP-Galactose-4-Epimerase Deficiency Disease
% 218.95/219.11  |- skos__hiddenLabel mesh__D005693
% 218.95/219.11       Galactose 1 Phosphate Uridyl Transferase Deficiency Disease
% 218.95/219.11  |- skos__hiddenLabel mesh__D005693 Galactokinase Deficiency Diseases
% 218.95/219.11  |- skos__related mesh__D005693smesh__D005694
% 218.95/219.11  |- skos__scopeNote mesh__D005693
% 218.95/219.11       A group of inherited enzyme deficiencies which feature elevations of GALACTOSE in the blood. This condition may be associated with deficiencies of GALACTOKINASE; UDPGLUCOSE-HEXOSE-1-PHOSPHATE URIDYLYLTRANSFERASE; or UDPGLUCOSE 4-EPIMERASE. The classic form is caused by UDPglucose-Hexose-1-Phosphate Uridylyltransferase deficiency, and presents in infancy with FAILURE TO THRIVE; VOMITING; and INTRACRANIAL HYPERTENSION. Affected individuals also may develop MENTAL RETARDATION; JAUNDICE; hepatosplenomegaly; ovarian failure %28%OVARIAN FAILURE, PREMATURE%29%; and cataracts. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp61-3%29%%A%    
% 218.95/219.11  |- skos__hiddenLabel mesh__D005693
% 218.95/219.11       UDP-Galactose-4-Epimerase Deficiency Diseases
% 218.95/219.11  |- mesh__recordAuthorizer mesh__D005693 sjn
% 218.95/219.11  |- mesh__publicMeSHNote mesh__D005693 2000; see GALACTOSEMIA 1966-1999   
% 218.95/219.11  |- rdf__type mesh__D005693sskos__Concept
% 218.95/219.11  |- skos__related mesh__D005693smesh__D014534
% 218.95/219.11  |- skos__related mesh__D005693smesh__D006599
% 218.95/219.11  |- mesh__dateRevised mesh__D005693 2001-07-25
% 218.95/219.11  |- skos__hiddenLabel mesh__D005693 Galactosemia
% 218.95/219.11  |- skos__altLabel mesh__D005693
% 218.95/219.11       Deficiency Disease, Galactose-1-Phosphate Uridyl-Transferase
% 218.95/219.11  |- skos__broader mesh__D005693smesh__D020739
% 218.95/219.11  |- skos__hiddenLabel mesh__D005693
% 218.95/219.11       Diseases, UDP-Galactose-4-Epimerase Deficiency
% 218.95/219.11  |- skos__hiddenLabel mesh__D005693
% 218.95/219.11       Deficiency Diseases, UDP-Galactose-4-Epimerase
% 218.95/219.11  |- skos__hiddenLabel mesh__D005693
% 218.95/219.11       Deficiency Disease, UDP Galactose 4 Epimerase
% 218.95/219.11  |- skos__prefLabel mesh__D005693 Galactosemias
% 218.95/219.11  |- skos__hiddenLabel mesh__D005693 Classic Galactosemia
% 218.95/219.11  |- skos__altLabel mesh__D005693 Deficiency Disease, Galactokinase
% 218.95/219.11  |- skos__hiddenLabel mesh__D005693
% 218.95/219.11       Disease, UDP-Galactose-4-Epimerase Deficiency
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D005693 2003
% 218.95/219.11  |- skos__hiddenLabel mesh__D005693
% 218.95/219.11       UDP Galactose 4 Epimerase Deficiency Disease
% 218.95/219.11  |- mesh__historyNote mesh__D005693 2000%28%1966%29%   
% 218.95/219.11  |- skos__altLabel mesh__D005693 Galactosemia, Classic
% 218.95/219.11  |- mesh__dateCreated mesh__D005693 1999-01-01
% 218.95/219.11  |- rdf__type mesh__D013327sskos__Concept
% 218.95/219.11  |- mesh__dateEstablished mesh__D013327 1977-01-01
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013327 1993
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013327 2001
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013327 1999
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013327 2004
% 218.95/219.11  |- skos__altLabel mesh__D013327 Cymarigenin
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013327 1994
% 218.95/219.11  |- mesh__publicMeSHNote mesh__D013327
% 218.95/219.11       77; was see under STROPHANTHINS 1975-76, was see under CARDANOLIDES 1968-74%A%  
% 218.95/219.11  |- mesh__historyNote mesh__D013327
% 218.95/219.11       77%28%75%29%; was see under STROPHANTHINS 1975-76, was see under CARDANOLIDES 1968-74%A%  
% 218.95/219.11  |- mesh__activeMeSHYear mesh__D013327 2002
% 218.95/219.11  |- mesh__recordAuthorizer mesh__D013327 PLS
% 218.95/219.11  |- skos__hiddenLabel mesh__D013327 KStrophanthidin
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D013327 2005
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D013327 1995
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D013327 1996
% 218.95/219.12  |- skos__hiddenLabel mesh__D013327 K Strophanthidin
% 218.95/219.12  |- mesh__dateRevised mesh__D013327 1992-05-20
% 218.95/219.12  |- skos__historyNote mesh__D013327 Cardanolides %28%1968-1974%29%
% 218.95/219.12  |- skos__altLabel mesh__D013327 Corchsularin
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D013327 2006
% 218.95/219.12  |- mesh__onlineNote mesh__D013327 search CARDANOLIDES 1968-74   
% 218.95/219.12  |- mesh__recordOriginator mesh__D013327 NLM
% 218.95/219.12  |- skos__altLabel mesh__D013327 Convallatoxigenin
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D013327 1997
% 218.95/219.12  |- skos__scopeNote mesh__D013327
% 218.95/219.12       3 beta,5,14-Trihydroxy-19-oxo-5 beta-card-20%28%22%29%-enolide. The aglycone cardioactive agent isolated from Strophanthus Kombe, S. gratus and other species; it is a very toxic material formerly used as digitalis. Synonyms: Apocymarin; Corchorin; Cynotoxin; Corchorgenin.%A%    
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D013327 2000
% 218.95/219.12  |- skos__annotation mesh__D013327 a cardioactive agent   
% 218.95/219.12  |- skos__broader mesh__D013327smesh__D013328
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D013327 1998
% 218.95/219.12  |- skos__prefLabel mesh__D013327 Strophanthidin
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D013327 2003
% 218.95/219.12  |- mesh__dateCreated mesh__D013327 1999-01-01
% 218.95/219.12  |- mesh__recordMaintainer mesh__D013327 TGC
% 218.95/219.12  |- skos__hiddenLabel mesh__D018810 Angiography, MRI
% 218.95/219.12  |- skos__hiddenLabel mesh__D018810 Angiographies, Magnetic Resonance
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D018810 2005
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D018810 2004
% 218.95/219.12  |- skos__broader mesh__D018810smesh__D008279
% 218.95/219.12  |- mesh__recordOriginator mesh__D018810 JLS
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D018810 2006
% 218.95/219.12  |- skos__annotation mesh__D018810
% 218.95/219.12       coord with dis/diag not /radiography; DF: MR ANGIOGR   
% 218.95/219.12  |- mesh__dateEstablished mesh__D018810 1995-01-01
% 218.95/219.12  |- skos__hiddenLabel mesh__D018810 MRI Angiographies
% 218.95/219.12  |- skos__altLabel mesh__D018810 Perfusion Weighted MRI
% 218.95/219.12  |- skos__prefLabel mesh__D018810 Magnetic Resonance Angiography
% 218.95/219.12  |- skos__scopeNote mesh__D018810
% 218.95/219.12       Non-invasive method of vascular imaging and determination of internal anatomy without injection of contrast media or radiation exposure. The technique is used especially in CEREBRAL ANGIOGRAPHY as well as for studies of other vascular structures.%A%    
% 218.95/219.12  |- skos__broader mesh__D018810smesh__D000792
% 218.95/219.12  |- skos__altLabel mesh__D018810 MRI Angiography
% 218.95/219.12  |- skos__hiddenLabel mesh__D018810 Magnetic Resonance Angiographies
% 218.95/219.12  |- mesh__recordMaintainer mesh__D018810 lkt
% 218.95/219.12  |- mesh__historyNote mesh__D018810 95   
% 218.95/219.12  |- rdf__type mesh__D018810sskos__Concept
% 218.95/219.12  |- skos__historyNote mesh__D018810 Angiography %28%1983-1994%29%
% 218.95/219.12  |- mesh__recordAuthorizer mesh__D018810 sjn
% 218.95/219.12  |- skos__historyNote mesh__D018810
% 218.95/219.12       Nuclear Magnetic Resonance %28%1983-1987%29%
% 218.95/219.12  |- skos__historyNote mesh__D018810
% 218.95/219.12       Magnetic Resonance Imaging %28%1988-1994%29%
% 218.95/219.12  |- mesh__dateCreated mesh__D018810 1994-05-23
% 218.95/219.12  |- skos__hiddenLabel mesh__D018810 Angiographies, MRI
% 218.95/219.12  |- mesh__publicMeSHNote mesh__D018810 95   
% 218.95/219.12  |- mesh__dateRevised mesh__D018810 2002-07-02
% 218.95/219.12  |- skos__hiddenLabel mesh__D018810 MRI, Perfusion Weighted
% 218.95/219.12  |- skos__altLabel mesh__D018810 Angiography, Magnetic Resonance
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D018810 2003
% 218.95/219.12  |- skos__broader mesh__D009286smesh__D011725
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D009286 1994
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D009286 2003
% 218.95/219.12  |- skos__broader mesh__D009286smesh__D009281
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D009286 2006
% 218.95/219.12  |- mesh__publicMeSHNote mesh__D009286
% 218.95/219.12       91; was see under PYRIDINES 1975-90   
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D009286 2005
% 218.95/219.12  |- mesh__recordAuthorizer mesh__D009286 PLS
% 218.95/219.12  |- mesh__dateEstablished mesh__D009286 1991-01-01
% 218.95/219.12  |- mesh__recordOriginator mesh__D009286 NLM
% 218.95/219.12  |- mesh__historyNote mesh__D009286
% 218.95/219.12       91%28%75%29%; was see under PYRIDINES 1975-90   
% 218.95/219.12  |- mesh__dateRevised mesh__D009286 1992-05-19
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D009286 1997
% 218.95/219.12  |- mesh__dateCreated mesh__D009286 1974-11-19
% 218.95/219.12  |- skos__annotation mesh__D009286 a cholinesterase inhib   
% 218.95/219.12  |- skos__historyNote mesh__D009286 Naphthalenes %28%1971-1974%29%
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D009286 2002
% 218.95/219.12  |- skos__prefLabel mesh__D009286 Naphthylvinylpyridine
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D009286 1993
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D009286 1996
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D009286 1999
% 218.95/219.12  |- rdf__type mesh__D009286sskos__Concept
% 218.95/219.12  |- skos__historyNote mesh__D009286 Vinyl Compounds %28%1971-1974%29%
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D009286 2001
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D009286 2004
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D009286 1995
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D009286 1998
% 218.95/219.12  |- mesh__recordMaintainer mesh__D009286 TAP
% 218.95/219.12  |- skos__scopeNote mesh__D009286
% 218.95/219.12       4%28%1-Naphthylvinyl%29%pyridine hydrochloride. Cholinesterase inhibitor. Synonym: YuB 25.%A%    
% 218.95/219.12  |- skos__historyNote mesh__D009286 Pyridines %28%1971-1974%29%
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D009286 2000
% 218.95/219.12  |- mesh__dateRevised mesh__D014420 1991-01-08
% 218.95/219.12  |- skos__hiddenLabel mesh__D014420 Nasales, Conchae
% 218.95/219.12  |- skos__hiddenLabel mesh__D014420 Nasale, Conchae
% 218.95/219.12  |- skos__prefLabel mesh__D014420 Turbinates
% 218.95/219.12  |- skos__altLabel mesh__D014420 Conchae Nasales
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D014420 1996
% 218.95/219.12  |- mesh__recordMaintainer mesh__D014420 TGC
% 218.95/219.12  |- skos__scopeNote mesh__D014420
% 218.95/219.12       The scroll-like bony plates with curved margins on the lateral wall of the nasal cavity.%A%    
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D014420 1998
% 218.95/219.12  |- mesh__dateCreated mesh__D014420 1999-01-01
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D014420 1992
% 218.95/219.12  |- skos__broader mesh__D014420smesh__D005147
% 218.95/219.12  |- skos__hiddenLabel mesh__D014420 Conchae Nasale
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D014420 1997
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D014420 1994
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D014420 2002
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D014420 1999
% 218.95/219.12  |- rdf__type mesh__D014420sskos__Concept
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D014420 2003
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D014420 1993
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D014420 1995
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D014420 2005
% 218.95/219.12  |- skos__hiddenLabel mesh__D014420 Turbinate
% 218.95/219.12  |- skos__broader mesh__D014420smesh__D009666
% 218.95/219.12  |- skos__annotation mesh__D014420
% 218.95/219.12       fractures: coord TURBINATES /inj %28%IM%29% + SKULL FRACTURES %28%IM%29%%A%  
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D014420 2004
% 218.95/219.12  |- mesh__recordAuthorizer mesh__D014420 PLS
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D014420 2006
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D014420 2000
% 218.95/219.12  |- mesh__recordOriginator mesh__D014420 NLM
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D014420 2001
% 218.95/219.12  |- skos__hiddenLabel mesh__D000400 Swimbladders
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D000400 2003
% 218.95/219.12  |- mesh__dateEstablished mesh__D000400 1968-01-01
% 218.95/219.12  |- skos__historyNote mesh__D000400 Birds %28%1966-1967%29%
% 218.95/219.12  |- skos__hiddenLabel mesh__D000400 Sac, Air
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D000400 2001
% 218.95/219.12  |- mesh__publicMeSHNote mesh__D000400
% 218.95/219.12       68; AIR BLADDER was heading 1968-80   
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D000400 1999
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D000400 2004
% 218.95/219.12  |- skos__hiddenLabel mesh__D000400 Bladders, Air
% 218.95/219.12  |- skos__hiddenLabel mesh__D000400 Air Sac
% 218.95/219.12  |- skos__annotation mesh__D000400
% 218.95/219.12       in birds, fish, insects %26% mammals; sacculitis in veterinary animals: coord IM with RESPIRATORY TRACT DISEASES/vet %28%IM%29% or RESPIRATORY TRACT INFECTIONS/vet %28%IM%29%%A%  
% 218.95/219.12  |- skos__altLabel mesh__D000400 Air Bladder
% 218.95/219.12  |- mesh__recordAuthorizer mesh__D000400 SJN
% 218.95/219.12  |- skos__historyNote mesh__D000400 Bronchi %28%1966-1967%29%
% 218.95/219.12  |- mesh__dateCreated mesh__D000400 1999-01-01
% 218.95/219.12  |- skos__altLabel mesh__D000400 Swimbladder
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D000400 2002
% 218.95/219.12  |- mesh__dateRevised mesh__D000400 1998-06-10
% 218.95/219.12  |- mesh__recordOriginator mesh__D000400 NLM
% 218.95/219.12  |- rdf__type mesh__D000400sskos__Concept
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D000400 2005
% 218.95/219.12  |- mesh__recordMaintainer mesh__D000400 MSR
% 218.95/219.12  |- mesh__historyNote mesh__D000400 68; AIR BLADDER was heading 1968-80   
% 218.95/219.12  |- skos__hiddenLabel mesh__D000400 Bladder, Air
% 218.95/219.12  |- skos__broader mesh__D000400smesh__D000825
% 218.95/219.12  |- skos__hiddenLabel mesh__D000400 Air Bladders
% 218.95/219.12  |- skos__prefLabel mesh__D000400 Air Sacs
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D000400 2006
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D000400 2000
% 218.95/219.12  |- mesh__onlineNote mesh__D000400
% 218.95/219.12       use AIR SACS to search AIR BLADDER 1968-80   
% 218.95/219.12  |- skos__scopeNote mesh__D000400
% 218.95/219.12       Thin-walled sacs or spaces which function as a part of the respiratory system in birds, fishes, insects, and mammals.%A%    
% 218.95/219.12  |- skos__hiddenLabel mesh__D000400 Sacs, Air
% 218.95/219.12  |- mesh__recordOriginator mesh__D005694 NLM
% 218.95/219.12  |- skos__hiddenLabel mesh__D005694 Uridyltransferase, Galactose-1-Phosphate
% 218.95/219.12  |- skos__altLabel mesh__D005694 Galactosephosphate Uridylyltransferase
% 218.95/219.12  |- skos__prefLabel mesh__D005694 UTP-Hexose-1-Phosphate Uridylyltransferase
% 218.95/219.12  |- rdf__type mesh__D005694sskos__Concept
% 218.95/219.12  |- skos__hiddenLabel mesh__D005694 Pyrophosphorylase, UDP Galactose
% 218.95/219.12  |- skos__altLabel mesh__D005694 Galactose-1-Phosphate Uridyltransferase
% 218.95/219.12  |- mesh__historyNote mesh__D005694 98%28%75%29%   
% 218.95/219.12  |- skos__annotation mesh__D005694 /defic: consider also GALACTOSEMIAS   
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D005694 2006
% 218.95/219.12  |- mesh__dateEstablished mesh__D005694 1991-01-01
% 218.95/219.12  |- mesh__recordAuthorizer mesh__D005694 sjn
% 218.95/219.12  |- mesh__recordMaintainer mesh__D005694 ssb
% 218.95/219.12  |- skos__hiddenLabel mesh__D005694 Galactose 1 Phosphate Uridyltransferase
% 218.95/219.12  |- skos__broader mesh__D005694smesh__D009713
% 218.95/219.12  |- skos__historyNote mesh__D005694 Nucleotidyltransferases %28%1974%29%
% 218.95/219.12  |- skos__hiddenLabel mesh__D005694 Galactose Pyrophosphorylase, UDP
% 218.95/219.12  |- skos__hiddenLabel mesh__D005694
% 218.95/219.12       UTP Hexose 1 Phosphate Uridylyltransferase
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D005694 2005
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D005694 2004
% 218.95/219.12  |- skos__scopeNote mesh__D005694
% 218.95/219.12       An enzyme that catalyzes the synthesis of UDPgalactose from UTP and galactose-1-phosphate. It is present in low levels in fetal and infant liver, but increases with age, thereby enabling galactosemic infants who survive to develop the capacity to metabolize galactose. EC 2.7.7.10.%A%    
% 218.95/219.12  |- skos__altLabel mesh__D005694 UDP Galactose Pyrophosphorylase
% 218.95/219.12  |- mesh__dateRevised mesh__D005694 2003-07-09
% 218.95/219.12  |- mesh__dateCreated mesh__D005694 1974-11-19
% 218.95/219.12  |- skos__historyNote mesh__D005694 Uracil Nucleotides %28%1974%29%
% 218.95/219.12  |- skos__hiddenLabel mesh__D005694 Uridylyltransferase, Galactosephosphate
% 218.95/219.12  |- mesh__publicMeSHNote mesh__D005694
% 218.95/219.12       98; see GALACTOSEPHOSPHATE URIDYLYLTRANSFERASE 1991-97; see NUCLEOTIDYLTRANSFERASES 1975-90%A%  
% 218.95/219.12  |- skos__historyNote mesh__D005694 Galactose %28%1974%29%
% 218.95/219.12  |- skos__related mesh__D005694smesh__D005693
% 218.95/219.12  |- skos__historyNote mesh__D005694 Hexosephosphates %28%1974%29%
% 218.95/219.12  |- skos__hiddenLabel mesh__D005694
% 218.95/219.12       Uridylyltransferase, UTP-Hexose-1-Phosphate
% 218.95/219.12  |- skos__broader mesh__D013328smesh__D002301
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D013328 2005
% 218.95/219.12  |- skos__broader mesh__D013328smesh__D002298
% 218.95/219.12  |- mesh__publicMeSHNote mesh__D013328 75; was STROPHANTHIN 1963-74   
% 218.95/219.12  |- mesh__historyNote mesh__D013328 75; was STROPHANTHIN 1963-74   
% 218.95/219.12  |- mesh__recordAuthorizer mesh__D013328 sjn
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D013328 2006
% 218.95/219.12  |- mesh__onlineNote mesh__D013328
% 218.95/219.12       use STROPHANTHINS to search STROPHANTHIN 1972-74   
% 218.95/219.12  |- mesh__recordMaintainer mesh__D013328 ssb
% 218.95/219.12  |- mesh__dateRevised mesh__D013328 2004-07-07
% 218.95/219.12  |- skos__prefLabel mesh__D013328 Strophanthins
% 218.95/219.12  |- mesh__dateCreated mesh__D013328 1999-01-01
% 218.95/219.12  |- rdf__type mesh__D013328sskos__Concept
% 218.95/219.12  |- skos__scopeNote mesh__D013328
% 218.95/219.12       A number of different cardioactive glycosides obtained from Strophanthus species. OUABAIN is from S. gratus and CYMARINE from S. kombe. They are used like the digitalis glycosides.%A%    
% 218.95/219.12  |- mesh__recordOriginator mesh__D013328 NLM
% 218.95/219.12  |- skos__annotation mesh__D013328 cardiac glycosides   
% 218.95/219.12  |- mesh__recordAuthorizer mesh__D018811 sjn
% 218.95/219.12  |- skos__broader mesh__D018811smesh__D004781
% 218.95/219.12  |- mesh__dateCreated mesh__D018811 1994-05-23
% 218.95/219.12  |- skos__hiddenLabel mesh__D018811 Exposure, Maternal
% 218.95/219.12  |- mesh__publicMeSHNote mesh__D018811 95   
% 218.95/219.12  |- skos__scopeNote mesh__D018811
% 218.95/219.12       Exposure of the female parent, human or animal, to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals that may affect offspring. It includes pre-conception maternal exposure.%A%    
% 218.95/219.12  |- mesh__historyNote mesh__D018811 95   
% 218.95/219.12  |- rdf__type mesh__D018811sskos__Concept
% 218.95/219.12  |- skos__related mesh__D018811smesh__D008431
% 218.95/219.12  |- skos__related mesh__D018811smesh__D018812
% 218.95/219.12  |- mesh__dateEstablished mesh__D018811 1995-01-01
% 218.95/219.12  |- skos__hiddenLabel mesh__D018811 Exposures, Maternal
% 218.95/219.12  |- skos__related mesh__D018811smesh__D011297
% 218.95/219.12  |- mesh__activeMeSHYear mesh__D018811 2005
% 218.95/219.12  |- mesh__recordMaintainer mesh__D018811 sjn
% 218.95/219.16  |- skos__annotation mesh__D018811
% 218.95/219.16       restrict to exposure to environ or environ factors   
% 218.95/219.16  |- skos__historyNote mesh__D018811 Environmental Exposure %28%1967-1994%29%
% 218.95/219.16  |- mesh__recordOriginator mesh__D018811 JLS
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D018811 2006
% 218.95/219.16  |- skos__prefLabel mesh__D018811 Maternal Exposure
% 218.95/219.16  |- mesh__dateRevised mesh__D018811 2004-07-13
% 218.95/219.16  |- skos__hiddenLabel mesh__D018811 Maternal Exposures
% 218.95/219.16  |- mesh__recordMaintainer mesh__D018013 NDW
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D018013 2001
% 218.95/219.16  |- skos__hiddenLabel mesh__D018013 Neuropeptides Receptors
% 218.95/219.16  |- rdf__type mesh__D018013sskos__Concept
% 218.95/219.16  |- mesh__dateRevised mesh__D018013 1997-06-20
% 218.95/219.16  |- skos__annotation mesh__D018013
% 218.95/219.16       GEN; prefer specifics; DF: RECEPT NEUROPEPTIDE   
% 218.95/219.16  |- mesh__dateEstablished mesh__D018013 1994-01-01
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D018013 2000
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D018013 2005
% 218.95/219.16  |- skos__prefLabel mesh__D018013 Receptors, Neuropeptide
% 218.95/219.16  |- mesh__publicMeSHNote mesh__D018013 94   
% 218.95/219.16  |- skos__altLabel mesh__D018013 Neuropeptide Receptor
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D018013 2004
% 218.95/219.16  |- skos__historyNote mesh__D018013 Neuropeptides %28%1987-1993%29%
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D018013 1999
% 218.95/219.16  |- skos__scopeNote mesh__D018013
% 218.95/219.16       Cell surface receptors that bind specific neuropeptides with high affinity and trigger intracellular changes influencing the behavior of cells. Many neuropeptides are also hormones outside of the nervous system.%A%    
% 218.95/219.16  |- skos__historyNote mesh__D018013
% 218.95/219.16       Receptors, Neurotransmitter %28%1970-1993%29%
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D018013 2003
% 218.95/219.16  |- mesh__recordAuthorizer mesh__D018013 SJN
% 218.95/219.16  |- mesh__recordOriginator mesh__D018013 RAZ
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D018013 1998
% 218.95/219.16  |- skos__broader mesh__D018013smesh__D018000
% 218.95/219.16  |- mesh__dateCreated mesh__D018013 1993-06-21
% 218.95/219.16  |- skos__broader mesh__D018013smesh__D017981
% 218.95/219.16  |- skos__historyNote mesh__D018013
% 218.95/219.16       Receptors, Cell Surface %28%1983-1993%29%
% 218.95/219.16  |- skos__altLabel mesh__D018013 Receptors, Neuropeptides
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D018013 2002
% 218.95/219.16  |- mesh__historyNote mesh__D018013 94   
% 218.95/219.16  |- skos__altLabel mesh__D018013 Neuropeptide Receptors
% 218.95/219.16  |- skos__hiddenLabel mesh__D018013 Receptor, Neuropeptide
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D018013 2006
% 218.95/219.16  |- mesh__dateRevised mesh__D010030 1992-05-15
% 218.95/219.16  |- mesh__dateEstablished mesh__D010030 1988-01-01
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D010030 2003
% 218.95/219.16  |- skos__scopeNote mesh__D010030
% 218.95/219.16       Surgical construction of an artificial opening %28%stoma%29% for external fistulization of a duct or vessel by insertion of a tube with or without a supportive stent.%A%    
% 218.95/219.16  |- skos__annotation mesh__D010030
% 218.95/219.16       surg creation of an artif opening %28%stoma%29% %22%for external fistulization%22%; GEN only: prefer specific%A%  
% 218.95/219.16  |- skos__hiddenLabel mesh__D010030 Ostomies
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D010030 1997
% 218.95/219.16  |- skos__broader mesh__D010030smesh__D013514
% 218.95/219.16  |- skos__historyNote mesh__D010030 Ileostomy %28%1966-1987%29%
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D010030 2001
% 218.95/219.16  |- skos__historyNote mesh__D010030 Urinary Diversion %28%1973-1987%29%
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D010030 2006
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D010030 1993
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D010030 1996
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D010030 2005
% 218.95/219.16  |- mesh__dateCreated mesh__D010030 1987-05-15
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D010030 2000
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D010030 1999
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D010030 1995
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D010030 1998
% 218.95/219.16  |- rdf__type mesh__D010030sskos__Concept
% 218.95/219.16  |- skos__historyNote mesh__D010030 Colostomy %28%1966-1987%29%
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D010030 2002
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D010030 1994
% 218.95/219.16  |- skos__prefLabel mesh__D010030 Ostomy
% 218.95/219.16  |- mesh__historyNote mesh__D010030 88   
% 218.95/219.16  |- mesh__recordOriginator mesh__D010030 SCD
% 218.95/219.16  |- mesh__recordAuthorizer mesh__D010030 PLS
% 218.95/219.16  |- mesh__recordMaintainer mesh__D010030 TAP
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D010030 2004
% 218.95/219.16  |- mesh__publicMeSHNote mesh__D010030 88   
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D009287 2001
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D009287 2005
% 218.95/219.16  |- mesh__activeMeSHYear mesh__D009287 2000
% 218.95/219.16  |- mesh__recordMaintainer mesh__D009287 TAP
% 218.95/219.16  |- skos__broader mesh__D009287smesh__D006574
% 218.95/219.16  |- mesh__dateRevised mesh__D009287 1992-05-19
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D009287 1997
% 218.95/219.17  |- mesh__recordAuthorizer mesh__D009287 PLS
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D009287 1993
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D009287 1999
% 218.95/219.17  |- skos__prefLabel mesh__D009287 Naphthyridines
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D009287 1996
% 218.95/219.17  |- rdf__type mesh__D009287sskos__Concept
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D009287 1995
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D009287 2004
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D009287 1998
% 218.95/219.17  |- mesh__recordOriginator mesh__D009287 NLM
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D009287 2002
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D009287 2006
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D009287 1994
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D009287 2003
% 218.95/219.17  |- mesh__dateCreated mesh__D009287 1999-01-01
% 218.95/219.17  |- mesh__recordMaintainer mesh__D017719 lkt
% 218.95/219.17  |- mesh__dateRevised mesh__D017719 2005-06-30
% 218.95/219.17  |- skos__altLabel mesh__D017719 Diabetic Feet
% 218.95/219.17  |- mesh__dateEstablished mesh__D017719 1994-01-01
% 218.95/219.17  |- skos__broader mesh__D017719smesh__D016523
% 218.95/219.17  |- skos__historyNote mesh__D017719 Foot Ulcer %28%1992-1993%29%
% 218.95/219.17  |- mesh__recordAuthorizer mesh__D017719 sjn
% 218.95/219.17  |- mesh__recordOriginator mesh__D017719 RAZ
% 218.95/219.17  |- skos__annotation mesh__D017719
% 218.95/219.17       coordinate IM with specific type of diabetes mellitus %28%IM%29% if pertinent%A%  
% 218.95/219.17  |- skos__hiddenLabel mesh__D017719 Feet, Diabetic
% 218.95/219.17  |- mesh__historyNote mesh__D017719 94   
% 218.95/219.17  |- mesh__dateCreated mesh__D017719 1992-12-28
% 218.95/219.17  |- skos__hiddenLabel mesh__D017719 Foot, Diabetic
% 218.95/219.17  |- rdf__type mesh__D017719sskos__Concept
% 218.95/219.17  |- skos__broader mesh__D017719smesh__D003925
% 218.95/219.17  |- skos__historyNote mesh__D017719 Foot Diseases %28%1966-1993%29%
% 218.95/219.17  |- mesh__publicMeSHNote mesh__D017719 94   
% 218.95/219.17  |- skos__historyNote mesh__D017719 Diabetes Mellitus %28%1966-1993%29%
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D017719 2006
% 218.95/219.17  |- skos__broader mesh__D017719smesh__D003929
% 218.95/219.17  |- skos__prefLabel mesh__D017719 Diabetic Foot
% 218.95/219.17  |- skos__scopeNote mesh__D017719
% 218.95/219.17       Common foot problems in persons with DIABETES MELLITUS, caused by any combination of factors such as DIABETIC NEUROPATHIES; PERIPHERAL VASCULAR DISEASES; and INFECTION. With the loss of sensation and poor circulation, injuries and infections often lead to severe foot ulceration, GANGRENE and AMPUTATION.%A%    
% 218.95/219.17  |- mesh__dateEstablished mesh__D028441 2002-01-01
% 218.95/219.17  |- skos__hiddenLabel mesh__D028441 F2 Isoprostane
% 218.95/219.17  |- mesh__dateRevised mesh__D028441 2003-07-09
% 218.95/219.17  |- mesh__recordOriginator mesh__D028441 jmp
% 218.95/219.17  |- skos__historyNote mesh__D028441 Arachidonic Acids %28%1994-1996%29%
% 218.95/219.17  |- skos__historyNote mesh__D028441 Dinoprost %28%1994-2001%29%
% 218.95/219.17  |- mesh__recordAuthorizer mesh__D028441 sjn
% 218.95/219.17  |- skos__hiddenLabel mesh__D028441 F2 Isoprostanes
% 218.95/219.17  |- skos__altLabel mesh__D028441 F2-Isoprostane
% 218.95/219.17  |- skos__broader mesh__D028441smesh__D028421
% 218.95/219.17  |- mesh__historyNote mesh__D028441
% 218.95/219.17       2002; use F2-ISOPROSTANES %28%NM%29% 1994-2001   
% 218.95/219.17  |- mesh__recordMaintainer mesh__D028441 ssb
% 218.95/219.17  |- mesh__dateCreated mesh__D028441 2001-07-25
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D028441 2006
% 218.95/219.17  |- rdf__type mesh__D028441sskos__Concept
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D028441 2004
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D028441 2005
% 218.95/219.17  |- skos__scopeNote mesh__D028441
% 218.95/219.17       Isoprostanes derived from the free radical oxidation of ARACHIDONIC ACID. Although similar in structure to enzymatically synthesized prostaglandin F2alpha %28%DINOPROST%29%, they occur through non-enzymatic oxidation of cell membrane lipids.%A%    
% 218.95/219.17  |- mesh__publicMeSHNote mesh__D028441
% 218.95/219.17       2002; F2-ISOPROSTANE %28%now F2-ISOPROSTANES%29% was indexed under DINOPROST 1994-2001%A%  
% 218.95/219.17  |- skos__prefLabel mesh__D028441 F2-Isoprostanes
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D014421 2006
% 218.95/219.17  |- skos__annotation mesh__D014421 the country, not TURKEYS   
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D014421 2002
% 218.95/219.17  |- mesh__dateRevised mesh__D014421 1995-05-23
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D014421 2005
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D014421 1997
% 218.95/219.17  |- mesh__recordOriginator mesh__D014421 NLM
% 218.95/219.17  |- skos__broader mesh__D014421smesh__D008877
% 218.95/219.17  |- skos__prefLabel mesh__D014421 Turkey
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D014421 1996
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D014421 2001
% 218.95/219.17  |- mesh__recordMaintainer mesh__D014421 KEV
% 218.95/219.17  |- mesh__dateCreated mesh__D014421 1999-01-01
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D014421 1999
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D014421 2004
% 218.95/219.17  |- rdf__type mesh__D014421sskos__Concept
% 218.95/219.17  |- mesh__recordAuthorizer mesh__D014421 PLS
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D014421 2000
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D014421 1998
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D014421 2003
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000401 2002
% 218.95/219.17  |- skos__hiddenLabel mesh__D000401 Seat, Ejection
% 218.95/219.17  |- skos__hiddenLabel mesh__D000401 Helicopter
% 218.95/219.17  |- mesh__recordOriginator mesh__D000401 NLM
% 218.95/219.17  |- mesh__dateCreated mesh__D000401 1999-01-01
% 218.95/219.17  |- mesh__recordMaintainer mesh__D000401 JLS
% 218.95/219.17  |- rdf__type mesh__D000401sskos__Concept
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000401 2005
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000401 2000
% 218.95/219.17  |- skos__broader mesh__D000401smesh__D001359
% 218.95/219.17  |- skos__hiddenLabel mesh__D000401 Aircrafts
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000401 2006
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000401 2001
% 218.95/219.17  |- mesh__publicMeSHNote mesh__D000401 EJECTION SEATS was heading 1963-82   
% 218.95/219.17  |- skos__hiddenLabel mesh__D000401 Ejection Seat
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000401 1998
% 218.95/219.17  |- mesh__historyNote mesh__D000401 EJECTION SEATS was heading 1963-82   
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000401 2003
% 218.95/219.17  |- mesh__onlineNote mesh__D000401
% 218.95/219.17       use AIRCRAFT to search EJECTION SEATS 1966-82   
% 218.95/219.17  |- mesh__dateRevised mesh__D000401 1997-06-20
% 218.95/219.17  |- skos__prefLabel mesh__D000401 Aircraft
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000401 1999
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000401 2004
% 218.95/219.17  |- mesh__recordAuthorizer mesh__D000401 SJN
% 218.95/219.17  |- skos__scopeNote mesh__D000401
% 218.95/219.17       A weight-carrying structure for navigation of the air that is supported either by its own buoyancy or by the dynamic action of the air against its surfaces. %28%Webster, 1973%29%%A%    
% 218.95/219.17  |- skos__hiddenLabel mesh__D000401 Seats, Ejection
% 218.95/219.17  |- mesh__recordOriginator mesh__D005695 RLS
% 218.95/219.17  |- skos__scopeNote mesh__D005695 Phosphoric acid esters of galactose.     
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D005695 2006
% 218.95/219.17  |- mesh__dateEstablished mesh__D005695 1991-01-01
% 218.95/219.17  |- mesh__dateCreated mesh__D005695 1977-04-15
% 218.95/219.17  |- mesh__publicMeSHNote mesh__D005695
% 218.95/219.17       91; was see under HEXOSEPHOSPHATES 1978-90   
% 218.95/219.17  |- mesh__dateRevised mesh__D005695 2004-07-07
% 218.95/219.17  |- skos__broader mesh__D005695smesh__D006600
% 218.95/219.17  |- skos__historyNote mesh__D005695 Galactose %28%1966-1977%29%
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D005695 2005
% 218.95/219.17  |- skos__historyNote mesh__D005695 Hexosephosphates %28%1966-1977%29%
% 218.95/219.17  |- mesh__recordAuthorizer mesh__D005695 sjn
% 218.95/219.17  |- mesh__recordMaintainer mesh__D005695 ssb
% 218.95/219.17  |- mesh__historyNote mesh__D005695
% 218.95/219.17       91%28%78%29%; was see under HEXOSEPHOSPHATES 1978-90   
% 218.95/219.17  |- rdf__type mesh__D005695sskos__Concept
% 218.95/219.17  |- skos__prefLabel mesh__D005695 Galactosephosphates
% 218.95/219.17  |- skos__broader mesh__D013329smesh__D002620
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D013329 1995
% 218.95/219.17  |- rdf__type mesh__D013329sskos__Concept
% 218.95/219.17  |- mesh__dateEstablished mesh__D013329 1972-01-01
% 218.95/219.17  |- skos__broader mesh__D013329smesh__D001669
% 218.95/219.17  |- skos__annotation mesh__D013329
% 218.95/219.17       NIM with specific drug IM; no qualif; DF: STRUCT ACTIV RELAT%A%  
% 218.95/219.17  |- mesh__recordMaintainer mesh__D013329 AGS
% 218.95/219.17  |- skos__hiddenLabel mesh__D013329 Relationships, Structure-Activity
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D013329 2003
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D013329 1999
% 218.95/219.17  |- skos__broader mesh__D013329smesh__D002626
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D013329 1994
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D013329 2002
% 218.95/219.17  |- skos__broader mesh__D013329smesh__D001671
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D013329 1993
% 218.95/219.17  |- mesh__recordOriginator mesh__D013329 NLM
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D013329 1998
% 218.95/219.17  |- skos__prefLabel mesh__D013329 Structure-Activity Relationship
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D013329 2001
% 218.95/219.17  |- mesh__dateRevised mesh__D013329 1990-02-12
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D013329 1997
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D013329 1992
% 218.95/219.17  |- mesh__recordAuthorizer mesh__D013329 PLS
% 218.95/219.17  |- skos__scopeNote mesh__D013329
% 218.95/219.17       The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Other factors contributing to structure-activity relationship include chemical reactivity, electronic effects, resonance, and inductive effects.%A%    
% 218.95/219.17  |- skos__hiddenLabel mesh__D013329 Structure-Activity Relationships
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D013329 2006
% 218.95/219.17  |- mesh__dateCreated mesh__D013329 1999-01-01
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D013329 2000
% 218.95/219.17  |- mesh__historyNote mesh__D013329 72   
% 218.95/219.17  |- skos__hiddenLabel mesh__D013329 Structure Activity Relationship
% 218.95/219.17  |- mesh__publicMeSHNote mesh__D013329 72   
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D013329 1991
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D013329 1996
% 218.95/219.17  |- skos__hiddenLabel mesh__D013329 Relationship, Structure-Activity
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D013329 2005
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D013329 2004
% 218.95/219.17  |- skos__scopeNote mesh__D018812
% 218.95/219.17       Exposure of the male parent, human or animal, to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals that may affect offspring.%A%    
% 218.95/219.17  |- skos__historyNote mesh__D018812 Environmental Exposure %28%1967-1994%29%
% 218.95/219.17  |- mesh__historyNote mesh__D018812 95   
% 218.95/219.17  |- rdf__type mesh__D018812sskos__Concept
% 218.95/219.17  |- mesh__dateRevised mesh__D018812 2004-07-13
% 218.95/219.17  |- mesh__recordAuthorizer mesh__D018812 sjn
% 218.95/219.17  |- mesh__dateCreated mesh__D018812 1994-05-23
% 218.95/219.17  |- mesh__publicMeSHNote mesh__D018812 95   
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D018812 2005
% 218.95/219.17  |- skos__related mesh__D018812smesh__D018811
% 218.95/219.17  |- mesh__recordOriginator mesh__D018812 JLS
% 218.95/219.17  |- skos__hiddenLabel mesh__D018812 Exposure, Paternal
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D018812 2006
% 218.95/219.17  |- skos__hiddenLabel mesh__D018812 Exposures, Paternal
% 218.95/219.17  |- mesh__dateEstablished mesh__D018812 1995-01-01
% 218.95/219.17  |- skos__hiddenLabel mesh__D018812 Paternal Exposures
% 218.95/219.17  |- skos__broader mesh__D018812smesh__D004781
% 218.95/219.17  |- skos__prefLabel mesh__D018812 Paternal Exposure
% 218.95/219.17  |- mesh__recordMaintainer mesh__D018812 sjn
% 218.95/219.17  |- skos__annotation mesh__D018812
% 218.95/219.17       restrict to exposure to environ or environ factors   
% 218.95/219.17  |- rdf__type mesh__D018014sskos__Concept
% 218.95/219.17  |- mesh__recordOriginator mesh__D018014 PXP
% 218.95/219.17  |- skos__prefLabel mesh__D018014 Gene Transfer Techniques
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D018014 2004
% 218.95/219.17  |- mesh__publicMeSHNote mesh__D018014
% 218.95/219.17       2001; see GENE TRANSFER 1994-2000; see TRANSFECTION 1988-93%A%  
% 218.95/219.17  |- mesh__dateCreated mesh__D018014 1993-06-03
% 218.95/219.17  |- skos__hiddenLabel mesh__D018014 Technique, Gene Transfer
% 218.95/219.17  |- skos__hiddenLabel mesh__D018014 Techniques, Gene Transfer
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D018014 2005A
% 218.95/219.17  |- mesh__dateEstablished mesh__D018014 1994-01-01
% 218.95/219.17  |- skos__altLabel mesh__D018014 Gene Transfer Technique
% 218.95/219.17  |- skos__historyNote mesh__D018014 Transfection %28%1988-1993%29%
% 218.95/219.17  |- skos__annotation mesh__D018014
% 218.95/219.17       note category: do not confuse with GENE TRANSFER, HORIZONTAL%A%  
% 218.95/219.17  |- mesh__recordAuthorizer mesh__D018014 jls
% 218.95/219.17  |- mesh__dateRevised mesh__D018014 2004-07-27
% 218.95/219.17  |- mesh__recordMaintainer mesh__D018014 jls
% 218.95/219.17  |- mesh__historyNote mesh__D018014
% 218.95/219.17       2001%28%1994%29%; use TRANSFECTION 1988-93   
% 218.95/219.17  |- skos__broader mesh__D018014smesh__D005821
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D018014 2006
% 218.95/219.17  |- skos__hiddenLabel mesh__D018014 Transfer Techniques, Gene
% 218.95/219.17  |- skos__scopeNote mesh__D018014
% 218.95/219.17       The introduction of functional %28%usually cloned%29% GENES into cells. A variety of techniques and naturally occurring processes are used for the gene transfer such as cell hybridization, LIPOSOMES or microcell-mediated gene transfer,  ELECTROPORATION, chromosome-mediated gene transfer, TRANSFECTION, and GENETIC TRANSDUCTION. Gene transfer may result in genetically transformed cells and individual organisms.%A%    
% 218.95/219.17  |- skos__hiddenLabel mesh__D018014 Transfer Technique, Gene
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D018014 2005
% 218.95/219.17  |- skos__altLabel mesh__D018014 Transgenesis
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D010031 2005
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D010031 1999
% 218.95/219.17  |- skos__annotation mesh__D010031
% 218.95/219.17       inflamm of the ear unspecified as to external, middle or internal; prefer specifics%A%  
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D010031 2002
% 218.95/219.17  |- mesh__dateRevised mesh__D010031 1996-06-10
% 218.95/219.17  |- mesh__recordMaintainer mesh__D010031 TGC
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D010031 1998
% 218.95/219.17  |- skos__hiddenLabel mesh__D010031 Otitides
% 218.95/219.17  |- mesh__recordAuthorizer mesh__D010031 PLS
% 218.95/219.17  |- rdf__type mesh__D010031sskos__Concept
% 218.95/219.17  |- skos__broader mesh__D010031smesh__D004427
% 218.95/219.17  |- mesh__recordOriginator mesh__D010031 NLM
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D010031 2004
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D010031 2001
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D010031 2003
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D010031 1997
% 218.95/219.17  |- skos__scopeNote mesh__D010031
% 218.95/219.17       Inflammation of the ear, which may be marked by pain, fever, abnormalities of hearing, hearing loss, tinnitus, and vertigo. Inflammation of the external ear is OTITIS EXTERNA; of the middle ear, OTITIS MEDIA; of the inner ear, LABYRINTHITIS. %28%From Dorland, 27th ed%29%%A%    
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D010031 2000
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D010031 2006
% 218.95/219.17  |- skos__prefLabel mesh__D010031 Otitis
% 218.95/219.17  |- mesh__dateCreated mesh__D010031 1999-01-01
% 218.95/219.17  |- skos__historyNote mesh__D009288 Naphthalenes %28%1972-1974%29%
% 218.95/219.17  |- skos__prefLabel mesh__D009288 Naproxen
% 218.95/219.17  |- skos__altLabel mesh__D009288 Naprosyn
% 218.95/219.17  |- skos__altLabel mesh__D009288 Methoxypropiocin
% 218.95/219.17  |- mesh__recordOriginator mesh__D009288 NLM
% 218.95/219.17  |- mesh__dateRevised mesh__D009288 2000-06-21
% 218.95/219.17  |- mesh__dateEstablished mesh__D009288 1978-01-01
% 218.95/219.17  |- mesh__publicMeSHNote mesh__D009288
% 218.95/219.17       78; was see under NAPHTHALENEACETIC ACIDS 1975-77   
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D009288 2001
% 218.95/219.17  |- skos__altLabel mesh__D009288 MNPA
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D009288 2003
% 218.95/219.17  |- rdf__type mesh__D009288sskos__Concept
% 218.95/219.17  |- skos__broader mesh__D009288smesh__D009280
% 218.95/219.17  |- skos__scopeNote mesh__D009288
% 218.95/219.17       An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout.%A%    
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D009288 2004
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D009288 2005
% 218.95/219.17  |- skos__historyNote mesh__D009288 Methyl Ethers %28%1973-1974%29%
% 218.95/219.17  |- mesh__dateCreated mesh__D009288 1974-11-11
% 218.95/219.17  |- skos__historyNote mesh__D009288 Propionates %28%1972-1974%29%
% 218.95/219.17  |- mesh__recordAuthorizer mesh__D009288 sjn
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D009288 2002
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D009288 2006
% 218.95/219.17  |- mesh__recordMaintainer mesh__D009288 jmp
% 218.95/219.17  |- mesh__historyNote mesh__D009288
% 218.95/219.17       78%28%75%29%; was see under NAPHTHALENEACETIC ACIDS 1975-77   
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D014422 2005
% 218.95/219.17  |- mesh__recordMaintainer mesh__D014422 ags
% 218.95/219.17  |- skos__prefLabel mesh__D014422 Turkeys
% 218.95/219.17  |- skos__altLabel mesh__D014422 Meleagridinae
% 218.95/219.17  |- skos__annotation mesh__D014422
% 218.95/219.17       diseases: coord IM with POULTRY DISEASES %28%IM%29%   
% 218.95/219.17  |- skos__broader mesh__D014422smesh__D011200
% 218.95/219.17  |- mesh__dateCreated mesh__D014422 1999-01-01
% 218.95/219.17  |- skos__scopeNote mesh__D014422
% 218.95/219.17       Large woodland game BIRDS in the subfamily Meleagridinae, family Phasianidae, order GALLIFORMES. Some sources consider turkeys equivalent to the family Melegridinae.%A%    
% 218.95/219.17  |- rdf__type mesh__D014422sskos__Concept
% 218.95/219.17  |- mesh__dateEstablished mesh__D014422 1968-01-01
% 218.95/219.17  |- mesh__recordOriginator mesh__D014422 NLM
% 218.95/219.17  |- mesh__publicMeSHNote mesh__D014422 1968   
% 218.95/219.17  |- mesh__dateRevised mesh__D014422 2004-07-07
% 218.95/219.17  |- mesh__historyNote mesh__D014422 1968   
% 218.95/219.17  |- mesh__recordAuthorizer mesh__D014422 sjn
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D014422 2006
% 218.95/219.17  |- skos__altLabel mesh__D014422 Meleagrididae
% 218.95/219.17  |- skos__historyNote mesh__D014422 Poultry %28%1966-1967%29%
% 218.95/219.17  |- skos__broader mesh__D014422smesh__D046094
% 218.95/219.17  |- rdf__type mesh__D000402sskos__Concept
% 218.95/219.17  |- skos__hiddenLabel mesh__D000402 Airway Obstructions
% 218.95/219.17  |- skos__hiddenLabel mesh__D000402 Obstruction, Airway
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000402 2005
% 218.95/219.17  |- skos__broader mesh__D000402smesh__D012131
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000402 2002
% 218.95/219.17  |- mesh__recordOriginator mesh__D000402 NLM
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000402 1994
% 218.95/219.17  |- skos__prefLabel mesh__D000402 Airway Obstruction
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000402 2006
% 218.95/219.17  |- skos__scopeNote mesh__D000402
% 218.95/219.17       Any hindrance to the passage of air into and out of the lungs.%A%    
% 218.95/219.17  |- mesh__dateEstablished mesh__D000402 1972-01-01
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000402 1998
% 218.95/219.17  |- mesh__dateRevised mesh__D000402 1991-06-13
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000402 2003
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000402 1995
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000402 2000
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000402 1992
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000402 1999
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000402 2004
% 218.95/219.17  |- skos__historyNote mesh__D000402
% 218.95/219.17       Respiratory Tract Diseases %28%1966-1970%29%
% 218.95/219.17  |- mesh__recordAuthorizer mesh__D000402 PLS
% 218.95/219.17  |- mesh__recordMaintainer mesh__D000402 TGC
% 218.95/219.17  |- mesh__publicMeSHNote mesh__D000402 72   
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000402 1996
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000402 2001
% 218.95/219.17  |- skos__annotation mesh__D000402
% 218.95/219.17       acute: chronic airway obstruct, chronic airflow obstruct %26% COAD %28%chronic obstruct airway dis%29% go under LUNG DISEASES, OBSTRUCTIVE %28%see note there%29%; NASAL OBSTRUCTION is also available%A%  
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000402 1993
% 218.95/219.17  |- mesh__historyNote mesh__D000402 72%28%71%29%   
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D000402 1997
% 218.95/219.17  |- skos__hiddenLabel mesh__D000402 Obstructions, Airway
% 218.95/219.17  |- mesh__dateCreated mesh__D000402 1999-01-01
% 218.95/219.17  |- skos__broader mesh__D008481Q000295smesh__D008481
% 218.95/219.17  |- mesh__preferredCombination mesh__D008481Q000295smesh__D020707
% 218.95/219.17  |- rdf__type mesh__D008481Q000295smesh__CompoundConcept
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D005696 2006
% 218.95/219.17  |- skos__broader mesh__D005696smesh__D006026
% 218.95/219.17  |- mesh__historyNote mesh__D005696 75; was GALACTOSIDASE 1963-74   
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D005696 2004
% 218.95/219.17  |- mesh__dateRevised mesh__D005696 2003-07-09
% 218.95/219.17  |- mesh__recordMaintainer mesh__D005696 ssb
% 218.95/219.17  |- mesh__recordOriginator mesh__D005696 NLM
% 218.95/219.17  |- mesh__publicMeSHNote mesh__D005696 75; was GALACTOSIDASE 1963-74   
% 218.95/219.17  |- skos__prefLabel mesh__D005696 Galactosidases
% 218.95/219.17  |- mesh__onlineNote mesh__D005696
% 218.95/219.17       use GALACTOSIDASES to search GALACTOSIDASE 1966-74   
% 218.95/219.17  |- mesh__dateCreated mesh__D005696 1999-01-01
% 218.95/219.17  |- skos__annotation mesh__D005696
% 218.95/219.17       note ALPHA- %26% BETA-GALACTOSIDASES are also available   
% 218.95/219.17  |- skos__related mesh__D005696smesh__D005733
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D005696 2005
% 218.95/219.17  |- skos__altLabel mesh__D005696 Galactosidase
% 218.95/219.17  |- mesh__recordAuthorizer mesh__D005696 sjn
% 218.95/219.17  |- rdf__type mesh__D005696sskos__Concept
% 218.95/219.17  |- skos__scopeNote mesh__D005696
% 218.95/219.17       A family of galactoside hydrolases that hydrolyze compounds with an O-galactosyl linkage. EC 3.2.1.-.%A%    
% 218.95/219.17  |- skos__altLabel mesh__D018813 MEN2a
% 218.95/219.17  |- skos__annotation mesh__D018813
% 218.95/219.17       coordinate IM with specific endocrine/neoplasm pre-coordinates %28%IM%29% + specific histological type %28%IM%29% if pertinent%A%  
% 218.95/219.17  |- skos__scopeNote mesh__D018813
% 218.95/219.17       A form of multiple endocrine neoplasia characterized by the presence of medullary carcinoma %28%CARCINOMA, MEDULLARY%29% of the THYROID GLAND, and usually with the co-occurrence of PHEOCHROMOCYTOMA, producing CALCITONIN and ADRENALINE, respectively. Less frequently, it can occur with hyperplasia or adenoma of the PARATHYROID GLANDS. This disease is due to gain-of-function mutations of the MEN2 gene on CHROMOSOME 10 %28%Locus: 10q11.2%29%, also known as the RET proto-oncogene that encodes a RECEPTOR PROTEIN-TYROSINE KINASE. It is an autosomal dominant inherited disease.%A%    
% 218.95/219.17  |- mesh__recordOriginator mesh__D018813 AGS
% 218.95/219.17  |- mesh__dateCreated mesh__D018813 1994-05-23
% 218.95/219.17  |- mesh__dateRevised mesh__D018813 2005-06-30
% 218.95/219.17  |- skos__broader mesh__D018813smesh__D009377
% 218.95/219.17  |- skos__altLabel mesh__D018813 MEA II
% 218.95/219.17  |- skos__historyNote mesh__D018813
% 218.95/219.17       Multiple Endocrine Neoplasia %28%1966-1994%29%
% 218.95/219.17  |- mesh__dateEstablished mesh__D018813 1995-01-01
% 218.95/219.17  |- rdf__type mesh__D018813sskos__Concept
% 218.95/219.17  |- skos__altLabel mesh__D018813 MEN II
% 218.95/219.17  |- skos__altLabel mesh__D018813 Neoplasms, Multiple Endocrine Type 2a
% 218.95/219.17  |- skos__altLabel mesh__D018813 MEA IIa
% 218.95/219.17  |- skos__altLabel mesh__D018813 MEN 2a
% 218.95/219.17  |- skos__altLabel mesh__D018813 MEN 2
% 218.95/219.17  |- mesh__recordMaintainer mesh__D018813 lkt
% 218.95/219.17  |- skos__altLabel mesh__D018813 Sipple Syndrome
% 218.95/219.17  |- skos__altLabel mesh__D018813 MEN IIa
% 218.95/219.17  |- skos__prefLabel mesh__D018813 Multiple Endocrine Neoplasia Type 2a
% 218.95/219.17  |- mesh__recordAuthorizer mesh__D018813 sjn
% 218.95/219.17  |- skos__altLabel mesh__D018813 Neoplasia, Multiple Endocrine Type 2a
% 218.95/219.17  |- mesh__publicMeSHNote mesh__D018813
% 218.95/219.17       95; MEA II, MEN II, %26% SIPPLE SYNDROME were see NEOPLASMS, MULTIPLE ENDOCRINE 1983-94%A%  
% 218.95/219.17  |- skos__altLabel mesh__D018813 Multiple Endocrine Neoplasms Type 2a
% 218.95/219.17  |- skos__altLabel mesh__D018813 MEA 2a
% 218.95/219.17  |- mesh__historyNote mesh__D018813
% 218.95/219.17       95; MEA II, MEN II, %26% SIPPLE SYNDROME were see NEOPLASMS, MULTIPLE ENDOCRINE 1983-94%A%  
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D018813 2006
% 218.95/219.17  |- mesh__onlineNote mesh__D018813
% 218.95/219.17       use MULTIPLE ENDOCRINE NEOPLASIA to search MEA II, MEN II, %26% SIPPLE SYNDROME 1983-94%A%  
% 218.95/219.17  |- skos__altLabel mesh__D018813 Multiple Endocrine Neoplasia Type 2
% 218.95/219.17  |- mesh__recordMaintainer mesh__D010830 ssb
% 218.95/219.17  |- mesh__recordAuthorizer mesh__D010830 sjn
% 218.95/219.17  |- mesh__dateCreated mesh__D010830 1999-01-01
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D010830 2006
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D010830 2005
% 218.95/219.17  |- mesh__dateRevised mesh__D010830 2004-07-07
% 218.95/219.17  |- skos__prefLabel mesh__D010830 Physostigmine
% 218.95/219.17  |- skos__broader mesh__D010830smesh__D048448
% 218.95/219.17  |- mesh__recordOriginator mesh__D010830 NLM
% 218.95/219.17  |- rdf__type mesh__D010830sskos__Concept
% 218.95/219.17  |- skos__broader mesh__D010830smesh__D026121
% 218.95/219.17  |- skos__scopeNote mesh__D010830
% 218.95/219.17       A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity.%A%    
% 218.95/219.17  |- skos__hiddenLabel mesh__D018015 Calcitonin Gene Related Peptide Receptor
% 218.95/219.17  |- mesh__recordOriginator mesh__D018015 RAZ
% 218.95/219.17  |- skos__hiddenLabel mesh__D018015 Receptor, CGRP
% 218.95/219.17  |- skos__prefLabel mesh__D018015 Receptors, Calcitonin Gene-Related Peptide
% 218.95/219.17  |- skos__scopeNote mesh__D018015
% 218.95/219.17       Cell surface proteins that bind calcitonin gene-related peptide %28%CGRP%29% with high affinity and trigger intracellular changes which influence the behavior of cells. CGRP receptors are present in both the central nervous system and the periphery and are not the same as calcitonin receptors.%A%    
% 218.95/219.17  |- mesh__dateCreated mesh__D018015 1993-06-21
% 218.95/219.17  |- skos__broader mesh__D018015smesh__D018013
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D018015 2006
% 218.95/219.17  |- mesh__publicMeSHNote mesh__D018015
% 218.95/219.17       94; CALCITONIN GENE-RELATED PEPTIDE RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1986-93%A%  
% 218.95/219.17  |- mesh__recordAuthorizer mesh__D018015 sjn
% 218.95/219.17  |- mesh__dateRevised mesh__D018015 2003-07-09
% 218.95/219.17  |- skos__altLabel mesh__D018015 CGRP Receptors
% 218.95/219.17  |- skos__hiddenLabel mesh__D018015
% 218.95/219.17       Calcitonin Gene Related Peptide Receptors
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D018015 2005
% 218.95/219.17  |- mesh__historyNote mesh__D018015
% 218.95/219.17       94; CALCITONIN GENE-RELATED PEPTIDE RECEPTOR was SY to CALCITONIN RECEPTOR %28%NM%29% 1986-93%A%  
% 218.95/219.17  |- mesh__dateEstablished mesh__D018015 1994-01-01
% 218.95/219.17  |- skos__altLabel mesh__D018015 Calcitonin-Gene Related Peptide Receptor
% 218.95/219.17  |- skos__annotation mesh__D018015 DF: note short X ref   
% 218.95/219.17  |- skos__altLabel mesh__D018015 Calcitonin Gene-Related Peptide Receptors
% 218.95/219.17  |- rdf__type mesh__D018015sskos__Concept
% 218.95/219.17  |- skos__broader mesh__D018015smesh__D043562
% 218.95/219.17  |- skos__hiddenLabel mesh__D018015
% 218.95/219.17       Receptors, Calcitonin Gene Related Peptide
% 218.95/219.17  |- mesh__recordMaintainer mesh__D018015 jmp
% 218.95/219.17  |- mesh__onlineNote mesh__D018015
% 218.95/219.17       use RECEPTORS, CALCITONIN %28%NM%29% to search CALCITONIN GENE-RELATED PEPTIDE RECEPTOR 1986-93%A%  
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D018015 2004
% 218.95/219.17  |- skos__historyNote mesh__D018015
% 218.95/219.17       Receptors, Cell Surface %28%1986-1993%29%
% 218.95/219.17  |- skos__altLabel mesh__D018015 Receptors, CGRP
% 218.95/219.17  |- skos__altLabel mesh__D018015 CGRP Receptor
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D010032 1995
% 218.95/219.17  |- skos__hiddenLabel mesh__D010032 Otitis Externas
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D010032 2000
% 218.95/219.17  |- mesh__recordMaintainer mesh__D010032 TGC
% 218.95/219.17  |- skos__hiddenLabel mesh__D010032 Externa, Otitis
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D010032 1998
% 218.95/219.17  |- rdf__type mesh__D010032sskos__Concept
% 218.95/219.17  |- skos__hiddenLabel mesh__D010032 Externas, Otitis
% 218.95/219.17  |- mesh__activeMeSHYear mesh__D010032 1994
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D010032 2004
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D010032 2002
% 218.95/219.18  |- skos__scopeNote mesh__D010032
% 218.95/219.18       Inflammation of the external auditory canal. %28%Dorland, 27th ed%29%%A%    
% 218.95/219.18  |- skos__annotation mesh__D010032 inflamm of external ear   
% 218.95/219.18  |- mesh__recordAuthorizer mesh__D010032 PLS
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D010032 2003
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D010032 1997
% 218.95/219.18  |- skos__broader mesh__D010032smesh__D010031
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D010032 2006
% 218.95/219.18  |- mesh__recordOriginator mesh__D010032 NLM
% 218.95/219.18  |- mesh__dateCreated mesh__D010032 1999-01-01
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D010032 1996
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D010032 2001
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D010032 2005
% 218.95/219.18  |- mesh__dateRevised mesh__D010032 1993-06-02
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D010032 1999
% 218.95/219.18  |- skos__prefLabel mesh__D010032 Otitis Externa
% 218.95/219.18  |- mesh__dateRevised mesh__D009289 1989-05-02
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D009289 2002
% 218.95/219.18  |- mesh__dateEstablished mesh__D009289 1968-01-01
% 218.95/219.18  |- skos__annotation mesh__D009289 no qualif   
% 218.95/219.18  |- skos__hiddenLabel mesh__D009289 Narcissisms
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D009289 1992
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D009289 1997
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D009289 1998
% 218.95/219.18  |- mesh__historyNote mesh__D009289 68%28%66%29%   
% 218.95/219.18  |- skos__broader mesh__D009289smesh__D011574
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D009289 1993
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D009289 1994
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D009289 2003
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D009289 1999
% 218.95/219.18  |- rdf__type mesh__D009289sskos__Concept
% 218.95/219.18  |- mesh__recordOriginator mesh__D009289 NLM
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D009289 2000
% 218.95/219.18  |- mesh__dateCreated mesh__D009289 1999-01-01
% 218.95/219.18  |- mesh__publicMeSHNote mesh__D009289 68   
% 218.95/219.18  |- skos__prefLabel mesh__D009289 Narcissism
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D009289 1990
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D009289 1995
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D009289 2004
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D009289 2005
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D009289 2001
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D009289 2006
% 218.95/219.18  |- mesh__recordAuthorizer mesh__D009289 PLS
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D009289 1991
% 218.95/219.18  |- mesh__recordMaintainer mesh__D009289 TGC
% 218.95/219.18  |- skos__scopeNote mesh__D009289
% 218.95/219.18       A psychoanalytic term meaning self-love.     
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D009289 1996
% 218.95/219.18  |- mesh__publicMeSHNote mesh__D020460 99   
% 218.95/219.18  |- skos__hiddenLabel mesh__D020460 Melanosome
% 218.95/219.18  |- mesh__historyNote mesh__D020460 99   
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D020460 2004
% 218.95/219.18  |- skos__broader mesh__D020460smesh__D008547
% 218.95/219.18  |- skos__scopeNote mesh__D020460
% 218.95/219.18       Melanin-containing organelles found in melanocytes and melanophores.%A%    
% 218.95/219.18  |- skos__historyNote mesh__D020460 Melanocytes %28%1979-1998%29%
% 218.95/219.18  |- mesh__dateCreated mesh__D020460 1998-06-10
% 218.95/219.18  |- skos__broader mesh__D020460smesh__D008544
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D020460 2005
% 218.95/219.18  |- skos__prefLabel mesh__D020460 Melanosomes
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D020460 2006
% 218.95/219.18  |- skos__broader mesh__D020460smesh__D003594
% 218.95/219.18  |- rdf__type mesh__D020460sskos__Concept
% 218.95/219.18  |- mesh__dateRevised mesh__D020460 2003-07-09
% 218.95/219.18  |- mesh__dateEstablished mesh__D020460 1999-01-01
% 218.95/219.18  |- mesh__dateCreated mesh__D014423 1999-01-01
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D014423 1999
% 218.95/219.18  |- skos__broader mesh__D014423smesh__D001209
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D014423 2004
% 218.95/219.18  |- rdf__type mesh__D014423sskos__Concept
% 218.95/219.18  |- mesh__historyNote mesh__D014423
% 218.95/219.18       93; was TURKMEN S.S.R. l982-92; was heading 1963-81   
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D014423 2001
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D014423 1995
% 218.95/219.18  |- skos__broader mesh__D014423smesh__D014586
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D014423 1998
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D014423 2003
% 218.95/219.18  |- skos__broader mesh__D014423smesh__D017517
% 218.95/219.18  |- skos__prefLabel mesh__D014423 Turkmenistan
% 218.95/219.18  |- mesh__recordAuthorizer mesh__D014423 PLS
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D014423 2000
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D014423 2006
% 218.95/219.18  |- mesh__recordMaintainer mesh__D014423 PLS
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D014423 2005
% 218.95/219.18  |- mesh__onlineNote mesh__D014423
% 218.95/219.18       use TURKMENISTAN to search TURKMEN S.S.R. 1982-92   
% 218.95/219.18  |- skos__altLabel mesh__D014423 Turkmen S.S.R.
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D014423 1997
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D014423 2002
% 218.95/219.18  |- mesh__recordOriginator mesh__D014423 NLM
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D014423 1996
% 218.95/219.18  |- skos__altLabel mesh__D014423 Turkmen SSR
% 218.95/219.18  |- mesh__dateRevised mesh__D014423 1994-03-17
% 218.95/219.18  |- mesh__recordAuthorizer mesh__D000403 sjn
% 218.95/219.18  |- skos__historyNote mesh__D000403
% 218.95/219.18       Respiratory System/physiology %28%1966-1970%29%
% 218.95/219.18  |- skos__hiddenLabel mesh__D000403 Resistance, Airway
% 218.95/219.18  |- mesh__publicMeSHNote mesh__D000403 70   
% 218.95/219.18  |- rdf__type mesh__D000403sskos__Concept
% 218.95/219.18  |- mesh__dateCreated mesh__D000403 1999-01-01
% 218.95/219.18  |- mesh__dateRevised mesh__D000403 2003-07-09
% 218.95/219.18  |- skos__hiddenLabel mesh__D000403 Resistances, Airway
% 218.95/219.18  |- mesh__recordMaintainer mesh__D000403 nns
% 218.95/219.18  |- skos__historyNote mesh__D000403 Respiration %28%1966-1970%29%
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D000403 2006
% 218.95/219.18  |- mesh__dateEstablished mesh__D000403 1970-01-01
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D000403 2004
% 218.95/219.18  |- mesh__recordOriginator mesh__D000403 NLM
% 218.95/219.18  |- skos__broader mesh__D000403smesh__D044702
% 218.95/219.18  |- mesh__historyNote mesh__D000403 70   
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D000403 2005
% 218.95/219.18  |- skos__broader mesh__D000403smesh__D012129
% 218.95/219.18  |- skos__scopeNote mesh__D000403
% 218.95/219.18       Physiologically, the opposition to flow of air caused by the forces of friction. As a part of pulmonary function testing, it is the ratio of driving pressure to the rate of air flow.%A%    
% 218.95/219.18  |- skos__related mesh__D000403smesh__D015656
% 218.95/219.18  |- skos__hiddenLabel mesh__D000403 Airway Resistances
% 218.95/219.18  |- skos__prefLabel mesh__D000403 Airway Resistance
% 218.95/219.18  |- mesh__recordAuthorizer mesh__D005697 sjn
% 218.95/219.18  |- mesh__dateEstablished mesh__D005697 1991-01-01
% 218.95/219.18  |- skos__historyNote mesh__D005697 Galactose %28%1966-1974%29%
% 218.95/219.18  |- skos__prefLabel mesh__D005697 Galactosides
% 218.95/219.18  |- mesh__publicMeSHNote mesh__D005697
% 218.95/219.18       91; was see under GLYCOSIDES 1975-90   
% 218.95/219.18  |- mesh__dateCreated mesh__D005697 1974-11-11
% 218.95/219.18  |- skos__historyNote mesh__D005697 Glycosides %28%1966-1974%29%
% 218.95/219.18  |- mesh__dateRevised mesh__D005697 2004-07-07
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D005697 2005
% 218.95/219.18  |- mesh__historyNote mesh__D005697
% 218.95/219.18       91%28%75%29%; was see under GLYCOSIDES 1975-90   
% 218.95/219.18  |- rdf__type mesh__D005697sskos__Concept
% 218.95/219.18  |- skos__broader mesh__D005697smesh__D006027
% 218.95/219.18  |- mesh__recordMaintainer mesh__D005697 ssb
% 218.95/219.18  |- mesh__recordOriginator mesh__D005697 NLM
% 218.95/219.18  |- skos__scopeNote mesh__D005697
% 218.95/219.18       Glycosides formed by the reaction of the hydroxyl group on the anomeric carbon atom of galactose with an alcohol to form an acetal. They include both alpha- and beta-galactosides.%A%    
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D005697 2006
% 218.95/219.18  |- mesh__onlineNote mesh__D018814
% 218.95/219.18       use MULTIPLE ENDOCRINE NEOPLASIA to search MEA III %26% MEN III 1983-94%A%  
% 218.95/219.18  |- skos__altLabel mesh__D018814 Neoplasia, Multiple Endocrine Type 2b
% 218.95/219.18  |- mesh__recordOriginator mesh__D018814 AGS
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D018814 2006
% 218.95/219.18  |- skos__prefLabel mesh__D018814 Multiple Endocrine Neoplasia Type 2b
% 218.95/219.18  |- skos__altLabel mesh__D018814 Neoplasms, Multiple Endocrine Type 2b
% 218.95/219.18  |- skos__altLabel mesh__D018814 Mucosal Neuroma Syndrome
% 218.95/219.18  |- skos__altLabel mesh__D018814 MEN 2b
% 218.95/219.18  |- rdf__type mesh__D018814sskos__Concept
% 218.95/219.18  |- skos__annotation mesh__D018814
% 218.95/219.18       coordinate IM with specific endocrine/neoplasm pre-coordinates %28%IM%29% + specific histological type %28%IM%29% if pertinent%A%  
% 218.95/219.18  |- skos__altLabel mesh__D018814 MEN III
% 218.95/219.18  |- mesh__dateRevised mesh__D018814 2005-06-30
% 218.95/219.18  |- skos__altLabel mesh__D018814 Multiple Endocrine Neoplasms Type 2b
% 218.95/219.18  |- skos__altLabel mesh__D018814 MEA 2b
% 218.95/219.18  |- skos__broader mesh__D018814smesh__D009377
% 218.95/219.18  |- skos__scopeNote mesh__D018814
% 218.95/219.18       Similar to MEN2A, it is also caused by mutations of the MEN2 gene, also known as the RET proto-oncogene. Its clinical symptoms include medullary carcinoma %28%CARCINOMA, MEDULLARY%29% of THYROID GLAND and PHEOCHROMOCYTOMA of ADRENAL MEDULLA %28%50%25%%29%. Unlike MEN2a, MEN2b does not involve PARATHYROID NEOPLASMS. It can be distinguished from MEN2A by its neural abnormalities such as mucosal NEUROMAS on EYELIDS; LIP; and TONGUE, and ganglioneuromatosis of GASTROINTESTINAL TRACT leading to MEGACOLON. It is an autosomal dominant inherited disease.%A%    
% 218.95/219.18  |- mesh__publicMeSHNote mesh__D018814
% 218.95/219.18       95; MEA III %26% MEN III were see NEOPLASMS, MULTIPLE ENDOCRINE 1983-94%A%  
% 218.95/219.18  |- mesh__dateEstablished mesh__D018814 1995-01-01
% 218.95/219.18  |- mesh__historyNote mesh__D018814
% 218.95/219.18       95; MEA III %26% MEN III were see NEOPLASMS, MULTIPLE ENDOCRINE 1983-94%A%  
% 218.95/219.18  |- skos__altLabel mesh__D018814 MEN2b
% 218.95/219.18  |- skos__altLabel mesh__D018814 MEN 3
% 218.95/219.18  |- mesh__recordAuthorizer mesh__D018814 sjn
% 218.95/219.18  |- skos__hiddenLabel mesh__D018814 Neuroma Syndrome, Mucosal
% 218.95/219.18  |- skos__altLabel mesh__D018814 MEN IIb
% 218.95/219.18  |- mesh__recordMaintainer mesh__D018814 lkt
% 218.95/219.18  |- skos__historyNote mesh__D018814
% 218.95/219.18       Multiple Endocrine Neoplasia %28%1975-1994%29%
% 218.95/219.18  |- skos__altLabel mesh__D018814 MEA IIb
% 218.95/219.18  |- mesh__dateCreated mesh__D018814 1994-05-23
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D010831 2006
% 218.95/219.18  |- skos__hiddenLabel mesh__D010831 Acid, Phytanic
% 218.95/219.18  |- skos__broader mesh__D010831smesh__D004224
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D010831 2005
% 218.95/219.18  |- mesh__dateEstablished mesh__D010831 1991-01-01
% 218.95/219.18  |- mesh__dateCreated mesh__D010831 1974-11-19
% 218.95/219.18  |- mesh__recordMaintainer mesh__D010831 ssb
% 218.95/219.18  |- mesh__recordAuthorizer mesh__D010831 sjn
% 218.95/219.18  |- skos__scopeNote mesh__D010831
% 218.95/219.18       A 20-carbon branched chain fatty acid. In phytanic acid storage disease %28%REFSUM DISEASE%29% this lipid may comprise as much as 30%25% of the total fatty acids of the plasma. This is due to a phytanic acid alpha-hydroxylase deficiency.%A%    
% 218.95/219.18  |- rdf__type mesh__D010831sskos__Concept
% 218.95/219.18  |- mesh__historyNote mesh__D010831
% 218.95/219.18       91%28%75%29%; was see under EICOSANOIC ACIDS 1975-90   
% 218.95/219.18  |- mesh__publicMeSHNote mesh__D010831
% 218.95/219.18       91; was see under EICOSANOIC ACIDS 1975-90   
% 218.95/219.18  |- skos__historyNote mesh__D010831 Diterpenes %28%1974%29%
% 218.95/219.18  |- skos__prefLabel mesh__D010831 Phytanic Acid
% 218.95/219.18  |- mesh__dateRevised mesh__D010831 2003-07-09
% 218.95/219.18  |- skos__broader mesh__D010831smesh__D004537
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D010831 2004
% 218.95/219.18  |- skos__historyNote mesh__D010831 Fatty Acids %28%1970-1974%29%
% 218.95/219.18  |- mesh__recordOriginator mesh__D010831 NLM
% 218.95/219.18  |- mesh__dateRevised mesh__D018016 2005-07-08
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D018016 2006A
% 218.95/219.18  |- skos__broader mesh__D018016smesh__D018000
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D018016 2006
% 218.95/219.18  |- skos__prefLabel mesh__D018016 Receptors, Parathyroid Hormone
% 218.95/219.18  |- mesh__recordMaintainer mesh__D018016 ags
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D018016 2005
% 218.95/219.18  |- mesh__recordOriginator mesh__D018016 RAZ
% 218.95/219.18  |- mesh__recordAuthorizer mesh__D018016 ags
% 218.95/219.18  |- mesh__historyNote mesh__D018016
% 218.95/219.18       94; was PARATHYROID HORMONE RECEPTOR %28%NM%29% 1980-93   
% 218.95/219.18  |- rdf__type mesh__D018016sskos__Concept
% 218.95/219.18  |- skos__historyNote mesh__D018016
% 218.95/219.18       Receptors, Cell Surface %28%1980-1993%29%
% 218.95/219.18  |- skos__broader mesh__D018016smesh__D043562
% 218.95/219.18  |- skos__annotation mesh__D018016
% 218.95/219.18       GEN or unspecified; prefer specifics; DF: RECEPT PARATHYROID HORMONE%A%  
% 218.95/219.18  |- mesh__dateCreated mesh__D018016 1993-06-21
% 218.95/219.18  |- mesh__publicMeSHNote mesh__D018016
% 218.95/219.18       94; PARATHYROID HORMONE RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1980-93%A%  
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D018016 2004
% 218.95/219.18  |- mesh__dateEstablished mesh__D018016 1994-01-01
% 218.95/219.18  |- skos__altLabel mesh__D018016 Parathyroid Hormone Receptors
% 218.95/219.18  |- skos__scopeNote mesh__D018016
% 218.95/219.18       Cell surface proteins that bind PARATHYROID HORMONE with high affinity and trigger intracellular changes which influence the behavior of cells. Parathyroid hormone receptors on BONE; KIDNEY; and gastrointestinal cells mediate the hormone%27%s role in calcium and phosphate homeostasis.%A%    
% 218.95/219.18  |- mesh__onlineNote mesh__D018016
% 218.95/219.18       use RECEPTORS, PARATHYROID HORMONE %28%NM%29% to search PARATHYROID HORMONE RECEPTOR 1980-93%A%  
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D010033 2000
% 218.95/219.18  |- mesh__publicMeSHNote mesh__D010033
% 218.95/219.18       GRADENIGO%27%S SYNDROME was see under OTITIS MEDIA 1963-81, was see OTITIS MEDIA 1982-92%A%  
% 218.95/219.18  |- mesh__recordOriginator mesh__D010033 NLM
% 218.95/219.18  |- rdf__type mesh__D010033sskos__Concept
% 218.95/219.18  |- mesh__onlineNote mesh__D010033
% 218.95/219.18       use OTITIS MEDIA to search GRADENIGO%27%S SYNDROME 1966-92   
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D010033 2003
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D010033 2001
% 218.95/219.18  |- skos__scopeNote mesh__D010033 Inflammation of the middle ear.     
% 218.95/219.18  |- mesh__recordMaintainer mesh__D010033 KEV
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D010033 2004
% 218.95/219.18  |- mesh__dateCreated mesh__D010033 1999-01-01
% 218.95/219.18  |- skos__prefLabel mesh__D010033 Otitis Media
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D010033 2002
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D010033 2005
% 218.95/219.18  |- mesh__dateRevised mesh__D010033 1999-11-08
% 218.95/219.18  |- skos__broader mesh__D010033smesh__D010031
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D010033 2006
% 218.95/219.18  |- skos__related mesh__D010033smesh__D020227
% 218.95/219.18  |- skos__annotation mesh__D010033
% 218.95/219.18       inflamm of middle ear; GEN or unspecified; prefer specifics; nonsuppurative otitis media: index under OTITIS MEDIA WITH EFFUSION%A%  
% 218.95/219.18  |- mesh__recordAuthorizer mesh__D010033 sjn
% 218.95/219.18  |- mesh__historyNote mesh__D010033
% 218.95/219.18       GRADENIGO%27%S SYNDROME was see under OTITIS MEDIA 1963-81, was see OTITIS MEDIA 1982-92%A%  
% 218.95/219.18  |- skos__broader mesh__D008345Q000506smesh__D008345
% 218.95/219.18  |- mesh__preferredCombination mesh__D008345Q000506smesh__D020149
% 218.95/219.18  |- rdf__type mesh__D008345Q000506smesh__CompoundConcept
% 218.95/219.18  |- skos__broader mesh__D034481smesh__D034441
% 218.95/219.18  |- skos__hiddenLabel mesh__D034481 hnRNP A B Proteins
% 218.95/219.18  |- skos__historyNote mesh__D034481 DNA-Binding Proteins %28%1993-2002%29%
% 218.95/219.18  |- skos__broader mesh__D034481smesh__D034501
% 218.95/219.18  |- mesh__recordOriginator mesh__D034481 jmp
% 218.95/219.18  |- skos__hiddenLabel mesh__D034481 A B Family hnRNP Proteins
% 218.95/219.18  |- skos__prefLabel mesh__D034481
% 218.95/219.18       Heterogeneous-Nuclear Ribonucleoprotein Group A-B
% 218.95/219.18  |- skos__hiddenLabel mesh__D034481 Type A B hnRNP Proteins
% 218.95/219.18  |- skos__annotation mesh__D034481 see SCR for specific hnRNP entries   
% 218.95/219.18  |- rdf__type mesh__D034481sskos__Concept
% 218.95/219.18  |- mesh__publicMeSHNote mesh__D034481
% 218.95/219.18       2003; HNRNP A2-B1 was indexed under DNA-BINDING PROTEINS 1993-2001%A%  
% 218.95/219.18  |- mesh__historyNote mesh__D034481
% 218.95/219.18       2003; for HNRNP A2-B1 use TELOMERE-BINDING PROTEINS %28%NM%29% 1993-2002%A%  
% 218.95/219.18  |- skos__altLabel mesh__D034481 A-B Family hnRNP Proteins
% 218.95/219.18  |- skos__scopeNote mesh__D034481
% 218.95/219.18       A class of closely related heterogeneous-nuclear ribonucleoproteins of approximately 34-40 kDa in size. Although they are generally found in the nucleoplasm, they also shuttle between the nucleus and the cytoplasm. Members of this class have been found to have a role in mRNA transport, telomere biogenesis and RNA SPLICING.%A%    
% 218.95/219.18  |- skos__hiddenLabel mesh__D034481
% 218.95/219.18       Heterogeneous Nuclear Ribonucleoprotein Group A B
% 218.95/219.18  |- mesh__dateCreated mesh__D034481 2002-07-02
% 218.95/219.18  |- mesh__recordMaintainer mesh__D034481 ags
% 218.95/219.18  |- mesh__dateEstablished mesh__D034481 2003-01-01
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D034481 2006
% 218.95/219.18  |- skos__altLabel mesh__D034481 hnRNP A-B Proteins
% 218.95/219.18  |- mesh__dateRevised mesh__D034481 2005-06-30
% 218.95/219.18  |- mesh__recordAuthorizer mesh__D034481 sjn
% 218.95/219.18  |- skos__altLabel mesh__D034481 Type A-B hnRNP Proteins
% 218.95/219.18  |- skos__hiddenLabel mesh__D006790 Host Parasite Relations
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D006790 1998
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D006790 2001
% 218.95/219.18  |- mesh__recordMaintainer mesh__D006790 TAP
% 218.95/219.18  |- skos__broader mesh__D006790smesh__D001686
% 218.95/219.18  |- skos__hiddenLabel mesh__D006790 Host-Parasite Relation
% 218.95/219.18  |- skos__hiddenLabel mesh__D006790 Relation, Parasite-Host
% 218.95/219.18  |- mesh__dateCreated mesh__D006790 1978-12-21
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D006790 1994
% 218.95/219.18  |- rdf__type mesh__D006790sskos__Concept
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D006790 2000
% 218.95/219.18  |- skos__hiddenLabel mesh__D006790 Host-Parasite Relationships
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D006790 2004
% 218.95/219.18  |- skos__altLabel mesh__D006790 Parasite-Host Relations
% 218.95/219.18  |- mesh__publicMeSHNote mesh__D006790 80   
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D006790 1997
% 218.95/219.18  |- mesh__historyNote mesh__D006790 80   
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D006790 2003
% 218.95/219.18  |- skos__hiddenLabel mesh__D006790 Relations, Host-Parasite
% 218.95/219.18  |- skos__scopeNote mesh__D006790
% 218.95/219.18       The interactions between two organisms, one of which lives at the expense of the other.%A%    
% 218.95/219.18  |- mesh__recordOriginator mesh__D006790 AEP
% 218.95/219.18  |- mesh__dateRevised mesh__D006790 1992-05-15
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D006790 1996
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D006790 2002
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D006790 2006
% 218.95/219.18  |- skos__historyNote mesh__D006790
% 218.95/219.18       specific host, organ, disease/parasitology %28%1975-1979%29%
% 218.95/219.18  |- skos__altLabel mesh__D006790 Host-Parasite Relationship
% 218.95/219.18  |- skos__hiddenLabel mesh__D006790 Relationships, Host-Parasite
% 218.95/219.18  |- mesh__recordAuthorizer mesh__D006790 PLS
% 218.95/219.18  |- mesh__dateEstablished mesh__D006790 1980-01-01
% 218.95/219.18  |- skos__hiddenLabel mesh__D006790 Relationship, Host-Parasite
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D006790 1999
% 218.95/219.18  |- skos__hiddenLabel mesh__D006790 Relations, Parasite-Host
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D006790 1993
% 218.95/219.18  |- skos__prefLabel mesh__D006790 Host-Parasite Relations
% 218.95/219.18  |- skos__hiddenLabel mesh__D006790 Relation, Host-Parasite
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D006790 2005
% 218.95/219.18  |- skos__hiddenLabel mesh__D006790 Host Parasite Relationship
% 218.95/219.18  |- skos__annotation mesh__D006790
% 218.95/219.18       coord NIM with host /parasitol %28%IM%29% + parasite /physiol or other more specific qualif %28%IM%29%; DF: HOST PARASITE RELAT%A%  
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D006790 1995
% 218.95/219.18  |- skos__hiddenLabel mesh__D006790 Parasite Host Relations
% 218.95/219.18  |- skos__hiddenLabel mesh__D006790 Parasite-Host Relation
% 218.95/219.18  |- mesh__dateRevised mesh__D020461 2005-06-30
% 218.95/219.18  |- mesh__dateEstablished mesh__D020461 1999-01-01
% 218.95/219.18  |- skos__scopeNote mesh__D020461
% 218.95/219.18       A mitosporic fungal genus that causes MADUROMYCOSIS %28%mycetoma%29% in humans. Madurella grisea and M. mycetomatis are the etiological agents.%A%    
% 218.95/219.18  |- mesh__recordAuthorizer mesh__D020461 sjn
% 218.95/219.18  |- mesh__publicMeSHNote mesh__D020461
% 218.95/219.18       99; see HYPHOMYCETES 1986-98, see MADURELLA 1963-85   
% 218.95/219.18  |- mesh__historyNote mesh__D020461
% 218.95/219.18       99, 63-85; use MITOSPORIC FUNGI 1963-98   
% 218.95/219.18  |- skos__prefLabel mesh__D020461 Madurella
% 218.95/219.18  |- mesh__recordMaintainer mesh__D020461 SYSTEM
% 218.95/219.18  |- skos__historyNote mesh__D020461 Mitosporic Fungi %28%1963-1998%29%
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D020461 2006
% 218.95/219.18  |- skos__broader mesh__D020461smesh__D003904
% 218.95/219.18  |- mesh__dateCreated mesh__D020461 1998-06-10
% 218.95/219.18  |- rdf__type mesh__D020461sskos__Concept
% 218.95/219.18  |- mesh__recordOriginator mesh__D020461 AGS
% 218.95/219.18  |- skos__scopeNote mesh__D014424
% 218.95/219.18       A syndrome of defective gonadal development in phenotypic women with a karyotype of sex chromosome monosomy %28%45,X or 45,XO%29%, associated with the loss of a sex chromosome X or Y.  Patients generally are of short stature with undifferentiated %28%streak%29% gonads, sexual infantilism %28%HYPOGONADISM%29%, webbing of the neck, cubitus valgus, elevated GONADOTROPINS and decreased ESTRADIOL level in blood.  Studies of Turner Syndrome and its variants have contributed significantly to the understanding of SEX DIFFERENTIATION. NOONAN SYNDROME bears similarity to this disorder; however, it also occurs in males, has normal karyotype, and is inherited as an autosomal dominant.%A%    
% 218.95/219.18  |- skos__altLabel mesh__D014424 Gonadal Dysgenesis, XO
% 218.95/219.18  |- skos__altLabel mesh__D014424 Turner%27%s Syndrome
% 218.95/219.18  |- mesh__recordOriginator mesh__D014424 NLM
% 218.95/219.18  |- mesh__recordAuthorizer mesh__D014424 ags
% 218.95/219.18  |- skos__related mesh__D014424smesh__D009634
% 218.95/219.18  |- skos__hiddenLabel mesh__D014424 XO Gonadal Dysgenesis
% 218.95/219.18  |- mesh__historyNote mesh__D014424
% 218.95/219.18       2002%28%1963%29%; for BONNEVIE-ULLRICH SYNDROME use SEX CHROMOSOME ABNORMALITIES 1963-2001%A%  
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D014424 2006
% 218.95/219.18  |- skos__broader mesh__D014424smesh__D006059
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D014424 2005
% 218.95/219.18  |- skos__hiddenLabel mesh__D014424 Bonnevie Ullrich Syndrome
% 218.95/219.18  |- skos__hiddenLabel mesh__D014424 Status Bonnevie Ullrich
% 218.95/219.18  |- skos__altLabel mesh__D014424 Status Bonnevie-Ullrich
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D014424 2006A
% 218.95/219.18  |- mesh__recordMaintainer mesh__D014424 ags
% 218.95/219.18  |- skos__prefLabel mesh__D014424 Turner Syndrome
% 218.95/219.18  |- mesh__publicMeSHNote mesh__D014424
% 218.95/219.18       2002; see TURNER%27%S SYNDROME 1963-2001; for BONNEVIE-ULLRICH SYNDROME see SEX CHROMOSOME ABNORMALITIES 1997-2001, see BONNEVIE-ULLRICH SYNDROME 1963-1996%A%  
% 218.95/219.18  |- mesh__dateRevised mesh__D014424 2005-07-15
% 218.95/219.18  |- mesh__dateCreated mesh__D014424 1999-01-01
% 218.95/219.18  |- skos__annotation mesh__D014424
% 218.95/219.18       in females; TURNER SYNDROME, MALE see NOONAN SYNDROME is also available%A%  
% 218.95/219.18  |- skos__broader mesh__D014424smesh__D025064
% 218.95/219.18  |- rdf__type mesh__D014424sskos__Concept
% 218.95/219.18  |- skos__hiddenLabel mesh__D014424 Turners Syndrome
% 218.95/219.18  |- skos__prefLabel mesh__D000404 Ajmaline
% 218.95/219.18  |- skos__altLabel mesh__D000404 Protea Brand of Ajmaline
% 218.95/219.18  |- skos__historyNote mesh__D000404 Rauwolfia %28%1966-1970%29%
% 218.95/219.18  |- rdf__type mesh__D000404sskos__Concept
% 218.95/219.18  |- mesh__dateCreated mesh__D000404 1999-01-01
% 218.95/219.18  |- mesh__publicMeSHNote mesh__D000404 73   
% 218.95/219.18  |- skos__hiddenLabel mesh__D000404 Ajmaline Forest Brand
% 218.95/219.18  |- skos__altLabel mesh__D000404 Giulini Brand of Ajmaline
% 218.95/219.18  |- mesh__recordAuthorizer mesh__D000404 sjn
% 218.95/219.18  |- skos__hiddenLabel mesh__D000404 Ajmaline Protea Brand
% 218.95/219.18  |- mesh__recordMaintainer mesh__D000404 ssb
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D000404 2006
% 218.95/219.18  |- skos__hiddenLabel mesh__D000404 Ajmaline Lacer Brand
% 218.95/219.18  |- skos__altLabel mesh__D000404 Solvay Brand of Ajmaline
% 218.95/219.18  |- skos__altLabel mesh__D000404 Servier Brand of Ajmaline
% 218.95/219.18  |- skos__altLabel mesh__D000404 Lacer Brand of Ajmaline
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D000404 2005
% 218.95/219.18  |- mesh__dateRevised mesh__D000404 2004-07-07
% 218.95/219.18  |- mesh__historyNote mesh__D000404 73%28%71%29%   
% 218.95/219.18  |- skos__altLabel mesh__D000404 Forest Brand of Ajmaline
% 218.95/219.18  |- skos__hiddenLabel mesh__D000404 Ajmaline Solvay Brand
% 218.95/219.18  |- skos__altLabel mesh__D000404 Wolfina
% 218.95/219.18  |- skos__hiddenLabel mesh__D000404 Ajmaline Servier Brand
% 218.95/219.18  |- mesh__dateEstablished mesh__D000404 1973-01-01
% 218.95/219.18  |- skos__broader mesh__D000404smesh__D046948
% 218.95/219.18  |- skos__scopeNote mesh__D000404
% 218.95/219.18       An alkaloid found in the root of Rauwolfia serpentina, among other plant sources. It is a class Ia antiarrhythmic agent that apparently acts by changing the shape and threshold of cardiac action potentials.%A%    
% 218.95/219.18  |- skos__altLabel mesh__D000404 ASTA Medica Brand of Ajmaline
% 218.95/219.18  |- mesh__recordOriginator mesh__D000404 NLM
% 218.95/219.18  |- skos__hiddenLabel mesh__D000404 Ajmaline Giulini Brand
% 218.95/219.18  |- skos__altLabel mesh__D005698 Galactosylceramide Galactosidase
% 218.95/219.18  |- mesh__dateEstablished mesh__D005698 1991-01-01
% 218.95/219.18  |- mesh__recordMaintainer mesh__D005698 ssb
% 218.95/219.18  |- skos__altLabel mesh__D005698 Galactocerebrosidase
% 218.95/219.18  |- mesh__historyNote mesh__D005698
% 218.95/219.18       91%28%75%29%; was see under GALACTOSIDASES 1975-90   
% 218.95/219.18  |- mesh__recordOriginator mesh__D005698 NLM
% 218.95/219.18  |- skos__historyNote mesh__D005698 Glycoside Hydrolases %28%1972-1974%29%
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D005698 2005
% 218.95/219.18  |- rdf__type mesh__D005698sskos__Concept
% 218.95/219.18  |- skos__broader mesh__D005698smesh__D005696
% 218.95/219.18  |- mesh__dateCreated mesh__D005698 1974-11-19
% 218.95/219.18  |- skos__hiddenLabel mesh__D005698 Galactosidase, Galactosylceramide
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D005698 2006
% 218.95/219.18  |- mesh__recordAuthorizer mesh__D005698 sjn
% 218.95/219.18  |- skos__historyNote mesh__D005698 Galactose %28%1972-1974%29%
% 218.95/219.18  |- skos__historyNote mesh__D005698 Cerebrosides %28%1972-1974%29%
% 218.95/219.18  |- skos__hiddenLabel mesh__D005698
% 218.95/219.18       beta-Galactosidase, Galactosylcerebroside
% 218.95/219.18  |- skos__altLabel mesh__D005698 Galactosylceramide beta-Galactosidase
% 218.95/219.18  |- mesh__activeMeSHYear mesh__D005698 2004
% 218.95/219.18  |- skos__related mesh__D005698smesh__D007965
% 218.95/219.18  |- skos__hiddenLabel mesh__D005698 beta-Galactosidase, Galactosylceramide
% 218.95/219.18  |- skos__scopeNote mesh__D005698
% 218.95/219.18       An enzyme that hydrolyzes galactose from ceramide monohexosides. Deficiency of this enzyme may cause globoid cell leukodystrophy %28%LEUKODYSTROPHY, GLOBOID CELL%29%. EC 3.2.1.46.%A%    
% 218.95/219.18  |- skos__annotation mesh__D005698
% 218.95/219.18       /defic: consider also LEUKODYSTROPHY, GLOBOID CELL   
% 218.95/219.18  |- mesh__publicMeSHNote mesh__D005698
% 218.95/219.18       91; was see under GALACTOSIDASES 1975-90   
% 218.95/219.18  |- skos__prefLabel mesh__D005698 Galactosylceramidase
% 218.95/219.18  |- skos__altLabel mesh__D005698 Galactosylcerebroside beta-Galactosidase
% 218.95/219.18  |- mesh__dateRevised mesh__D005698 2003-07-09
% 218.95/219.18  |- rdf__type mesh__D018815sskos__Concept
% 218.95/219.18  |- skos__hiddenLabel mesh__D018815 erbB-3 Gene
% 218.95/219.18  |- mesh__historyNote mesh__D018815 95   
% 218.95/219.18  |- skos__annotation mesh__D018815
% 218.95/219.18       spell in titles %26% translations as erbB; GENES, ERBB-1 %26% GENES, ERBB-2 are also available%A%  
% 218.95/219.18  |- skos__prefLabel mesh__D018815 Genes, erbB
% 218.95/219.18  |- mesh__dateCreated mesh__D018815 1994-05-23
% 218.95/219.19  |- skos__hiddenLabel mesh__D018815 erbB 3 Genes
% 218.95/219.19  |- mesh__recordMaintainer mesh__D018815 nns
% 218.95/219.19  |- skos__hiddenLabel mesh__D018815 c-erbB-3 Gene
% 218.95/219.19  |- skos__altLabel mesh__D018815 erbB Genes
% 218.95/219.19  |- mesh__recordOriginator mesh__D018815 AGS
% 218.95/219.19  |- skos__scopeNote mesh__D018815
% 218.95/219.19       Retrovirus-associated DNA sequences %28%erbB%29% originally isolated from, or related to, the avian erythroblastosis virus %28%AEV%29%. These genes code for the epidermal growth factor receptor %28%EGFR%29% family of receptors which is important in the control of normal cell proliferation and in the pathogenesis of human cancer. The genes include erbB-1 %28%GENES, ERBB-1%29%, erbB-2 %28%GENES, ERBB-2%29%, and erbB-3, all of which show abnormalities of expression in various human neoplasms.%A%    
% 218.95/219.19  |- skos__broader mesh__D018815smesh__D011519
% 218.95/219.19  |- mesh__dateRevised mesh__D018815 2005-06-30
% 218.95/219.19  |- mesh__dateEstablished mesh__D018815 1995-01-01
% 218.95/219.19  |- skos__historyNote mesh__D018815 Proto-Oncogenes %28%1992-1994%29%
% 218.95/219.19  |- skos__hiddenLabel mesh__D018815 c erbB 3 Genes
% 218.95/219.19  |- mesh__recordAuthorizer mesh__D018815 sjn
% 218.95/219.19  |- skos__hiddenLabel mesh__D018815 Genes, c-erbB-3
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D018815 2006
% 218.95/219.19  |- skos__hiddenLabel mesh__D018815 erbB Gene
% 218.95/219.19  |- mesh__publicMeSHNote mesh__D018815 95   
% 218.95/219.19  |- skos__hiddenLabel mesh__D010832 6 Phytase
% 218.95/219.19  |- rdf__type mesh__D010832sskos__Concept
% 218.95/219.19  |- mesh__dateEstablished mesh__D010832 1966-01-01
% 218.95/219.19  |- mesh__publicMeSHNote mesh__D010832
% 218.95/219.19       94; was PHYTASE 1966-93; INOSITOLHEXAPHOSPHATE PHOSPHOHYDROLASE was see PHYTASE 1966-93%A%  
% 218.95/219.19  |- mesh__onlineNote mesh__D010832
% 218.95/219.19       use 6-PHYTASE to search PHYTASE %26% INOSITOLHEXAPHOSPHATE PHOSPHOHYDROLASE 1966-93%A%  
% 218.95/219.19  |- mesh__recordOriginator mesh__D010832 NLM
% 218.95/219.19  |- mesh__dateRevised mesh__D010832 2003-07-09
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D010832 2004
% 218.95/219.19  |- skos__scopeNote mesh__D010832
% 218.95/219.19       An enzyme that catalyzes the conversion of myo-inositol hexakisphosphate and water to 1L-myo-inositol 1,2,3,4,5-pentakisphosphate and orthophosphate. EC 3.1.3.26.%A%    
% 218.95/219.19  |- skos__prefLabel mesh__D010832 6-Phytase
% 218.95/219.19  |- mesh__recordMaintainer mesh__D010832 ssb
% 218.95/219.19  |- mesh__dateCreated mesh__D010832 1999-01-01
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D010832 2006
% 218.95/219.19  |- mesh__historyNote mesh__D010832
% 218.95/219.19       94; was PHYTASE 1966-93; INOSITOLHEXAPHOSPHATE PHOSPHOHYDROLASE was see PHYTASE 1966-93%A%  
% 218.95/219.19  |- mesh__recordAuthorizer mesh__D010832 sjn
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D010832 2005
% 218.95/219.19  |- skos__broader mesh__D010832smesh__D010744
% 218.95/219.19  |- skos__altLabel mesh__D010832 Phytase
% 218.95/219.19  |- mesh__dateRevised mesh__D018017 1997-06-20
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D018017 2000
% 218.95/219.19  |- mesh__historyNote mesh__D018017 94   
% 218.95/219.19  |- skos__hiddenLabel mesh__D018017
% 218.95/219.19       Receptors, Hypothalamic Release Inhibiting Hormones
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D018017 2006
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D018017 2001
% 218.95/219.19  |- skos__annotation mesh__D018017 DF: RECEPT PHRH   
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D018017 1998
% 218.95/219.19  |- skos__broader mesh__D018017smesh__D018000
% 218.95/219.19  |- skos__prefLabel mesh__D018017
% 218.95/219.19       Receptors, Pituitary Hormone-Regulating Hormone
% 218.95/219.19  |- skos__hiddenLabel mesh__D018017
% 218.95/219.19       Receptors, Pituitary Hormone Regulating Hormone
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D018017 2003
% 218.95/219.19  |- skos__altLabel mesh__D018017
% 218.95/219.19       Pituitary Hormone-Regulating Hormone Receptors
% 218.95/219.19  |- rdf__type mesh__D018017sskos__Concept
% 218.95/219.19  |- mesh__recordAuthorizer mesh__D018017 SJN
% 218.95/219.19  |- skos__hiddenLabel mesh__D018017
% 218.95/219.19       Receptors, Pituitary Hormone Releasing Hormone
% 218.95/219.19  |- skos__hiddenLabel mesh__D018017
% 218.95/219.19       Pituitary Hormone Releasing Hormone Receptors
% 218.95/219.19  |- mesh__publicMeSHNote mesh__D018017 94   
% 218.95/219.19  |- skos__altLabel mesh__D018017 Hypothalamic Releasing Hormone Receptors
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D018017 1999
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D018017 2004
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D018017 2002
% 218.95/219.19  |- skos__hiddenLabel mesh__D018017
% 218.95/219.19       Hypothalamic Release Inhibiting Hormone Receptors
% 218.95/219.19  |- mesh__recordOriginator mesh__D018017 RAZ
% 218.95/219.19  |- skos__altLabel mesh__D018017
% 218.95/219.19       Hypothalamic Release-Inhibiting Hormone Receptors
% 218.95/219.19  |- skos__altLabel mesh__D018017
% 218.95/219.19       Pituitary Hormone-Releasing Hormone Receptors
% 218.95/219.19  |- skos__scopeNote mesh__D018017
% 218.95/219.19       Cell surface receptors that bind the hypothalamic hormones regulating pituitary cell differentiation, proliferation, and hormone synthesis and release, including the pituitary-releasing and release-inhibiting hormones. The pituitary hormone-regulating hormones are also released by cells other than hypothalamic neurons, and their receptors also occur on non-pituitary cells, especially brain neurons, where their role is less well understood. Receptors for dopamine, which is a prolactin release-inhibiting hormone as well as a common neurotransmitter, are not included here.%A%    
% 218.95/219.19  |- mesh__recordMaintainer mesh__D018017 NDW
% 218.95/219.19  |- mesh__dateCreated mesh__D018017 1993-06-21
% 218.95/219.19  |- skos__hiddenLabel mesh__D018017
% 218.95/219.19       Pituitary Hormone Regulating Hormone Receptors
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D018017 2005
% 218.95/219.19  |- mesh__dateEstablished mesh__D018017 1994-01-01
% 218.95/219.19  |- mesh__publicMeSHNote mesh__D010034
% 218.95/219.19       86; was OTITIS MEDIA, SEROUS see under OTITIS MEDIA 1979-85%A%  
% 218.95/219.19  |- skos__altLabel mesh__D010034 Otitis Media, Secretory
% 218.95/219.19  |- skos__scopeNote mesh__D010034
% 218.95/219.19       Inflammation of the middle ear with a clear pale yellow-colored transudate.%A%    
% 218.95/219.19  |- skos__hiddenLabel mesh__D010034 Secretory Otitis Media
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D010034 2004
% 218.95/219.19  |- skos__prefLabel mesh__D010034 Otitis Media with Effusion
% 218.95/219.19  |- mesh__dateRevised mesh__D010034 1997-06-20
% 218.95/219.19  |- mesh__dateEstablished mesh__D010034 1986-01-01
% 218.95/219.19  |- skos__hiddenLabel mesh__D010034 Ear Effusion, Middle
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D010034 2000
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D010034 2005
% 218.95/219.19  |- mesh__historyNote mesh__D010034
% 218.95/219.19       86; was OTITIS MEDIA, SEROUS see under OTITIS MEDIA 1979-85%A%  
% 218.95/219.19  |- skos__hiddenLabel mesh__D010034 Serous Otitis Media
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D010034 2001
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D010034 2006
% 218.95/219.19  |- skos__hiddenLabel mesh__D010034 Effusions, Middle Ear
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D010034 1998
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D010034 2002
% 218.95/219.19  |- mesh__dateCreated mesh__D010034 1978-05-22
% 218.95/219.19  |- skos__annotation mesh__D010034 nonsuppurative otitis media   
% 218.95/219.19  |- mesh__onlineNote mesh__D010034
% 218.95/219.19       use OTITIS MEDIA WITH EFFUSION to search OTITIS MEDIA, SEROUS 1979-85%A%  
% 218.95/219.19  |- skos__altLabel mesh__D010034 Middle Ear Effusion
% 218.95/219.19  |- mesh__recordMaintainer mesh__D010034 TGC
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D010034 1999
% 218.95/219.19  |- skos__historyNote mesh__D010034 Otitis Media %28%1966-1978%29%
% 218.95/219.19  |- skos__hiddenLabel mesh__D010034 Ear Effusions, Middle
% 218.95/219.19  |- skos__broader mesh__D010034smesh__D010033
% 218.95/219.19  |- rdf__type mesh__D010034sskos__Concept
% 218.95/219.19  |- mesh__recordAuthorizer mesh__D010034 SJN
% 218.95/219.19  |- skos__hiddenLabel mesh__D010034 Middle Ear Effusions
% 218.95/219.19  |- skos__hiddenLabel mesh__D010034 Effusion, Middle Ear
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D010034 2003
% 218.95/219.19  |- mesh__recordOriginator mesh__D010034 RC
% 218.95/219.19  |- skos__hiddenLabel mesh__D034482
% 218.95/219.19       Heterogeneous Nuclear Ribonucleoprotein C
% 218.95/219.19  |- mesh__recordAuthorizer mesh__D034482 sjn
% 218.95/219.19  |- mesh__recordMaintainer mesh__D034482 SYSTEM
% 218.95/219.19  |- mesh__historyNote mesh__D034482
% 218.95/219.19       2003; for C-TYPE PROTEIN HNRNP %26% HNRNP C PROTEIN use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 1992-2002%A%  
% 218.95/219.19  |- skos__scopeNote mesh__D034482
% 218.95/219.19       A group of closely related heterogeneous-nuclear ribonucleoproteins of approximately 41-43 kDa in size found in the cell nucleus. Members of this class have been implicated in a variety of processes including splicing, polyadenylation, and nuclear retention of RNA.%A%    
% 218.95/219.19  |- skos__altLabel mesh__D034482
% 218.95/219.19       Heterogeneous-Nuclear Ribonucleoprotein Type C1-C2
% 218.95/219.19  |- rdf__type mesh__D034482sskos__Concept
% 218.95/219.19  |- skos__hiddenLabel mesh__D034482
% 218.95/219.19       Heterogeneous Nuclear Ribonucleoprotein Type C1 C2
% 218.95/219.19  |- mesh__recordOriginator mesh__D034482 jmp
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D034482 2006
% 218.95/219.19  |- skos__altLabel mesh__D034482 hnRNP C Proteins
% 218.95/219.19  |- skos__hiddenLabel mesh__D034482
% 218.95/219.19       Ribonucleoprotein C, Heterogeneous-Nuclear
% 218.95/219.19  |- skos__annotation mesh__D034482 see SCR for specific hnRNP entries   
% 218.95/219.19  |- skos__historyNote mesh__D034482 Ribonucleoproteins %28%1986-2002%29%
% 218.95/219.19  |- skos__hiddenLabel mesh__D034482
% 218.95/219.19       Heterogeneous Nuclear Ribonucleoprotein Group C
% 218.95/219.19  |- skos__altLabel mesh__D034482 C-Type Protein HnRNP
% 218.95/219.19  |- skos__altLabel mesh__D034482 Heterogeneous-Nuclear Ribonucleoprotein C
% 218.95/219.19  |- mesh__dateCreated mesh__D034482 2002-07-03
% 218.95/219.19  |- skos__hiddenLabel mesh__D034482 hnRNP C1 C2 Proteins
% 218.95/219.19  |- skos__prefLabel mesh__D034482
% 218.95/219.19       Heterogeneous-Nuclear Ribonucleoprotein Group C
% 218.95/219.19  |- mesh__publicMeSHNote mesh__D034482
% 218.95/219.19       2003; C-TYPE PROTEIN HNRNP %26% HNRNP C PROTEIN was indexed under RIBONUCLEOPROTEINS 1992-2002%A%  
% 218.95/219.19  |- skos__broader mesh__D034482smesh__D034441
% 218.95/219.19  |- mesh__dateEstablished mesh__D034482 2003-01-01
% 218.95/219.19  |- skos__altLabel mesh__D034482 hnRNP C1-C2 Proteins
% 218.95/219.19  |- mesh__dateRevised mesh__D034482 2005-06-30
% 218.95/219.19  |- mesh__recordMaintainer mesh__D006791 TGC
% 218.95/219.19  |- skos__prefLabel mesh__D006791 Hostility
% 218.95/219.19  |- mesh__dateCreated mesh__D006791 1999-01-01
% 218.95/219.19  |- rdf__type mesh__D006791sskos__Concept
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D006791 1992
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D006791 1998
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D006791 2005
% 218.95/219.19  |- mesh__historyNote mesh__D006791 68   
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D006791 1990
% 218.95/219.19  |- mesh__dateRevised mesh__D006791 1989-04-28
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D006791 1993
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D006791 1999
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D006791 2006
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D006791 2000
% 218.95/219.19  |- skos__broader mesh__D006791smesh__D004644
% 218.95/219.19  |- mesh__recordAuthorizer mesh__D006791 PLS
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D006791 1996
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D006791 2003
% 218.95/219.19  |- mesh__publicMeSHNote mesh__D006791 68   
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D006791 2001
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D006791 1991
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D006791 1997
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D006791 2004
% 218.95/219.19  |- mesh__recordOriginator mesh__D006791 NLM
% 218.95/219.19  |- skos__annotation mesh__D006791 no qualif   
% 218.95/219.19  |- mesh__dateEstablished mesh__D006791 1968-01-01
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D006791 1994
% 218.95/219.19  |- skos__historyNote mesh__D006791 Hate %28%1966-1967%29%
% 218.95/219.19  |- skos__scopeNote mesh__D006791
% 218.95/219.19       Tendency to feel anger toward and to seek to inflict harm upon a person or group.%A%    
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D006791 1995
% 218.95/219.19  |- skos__hiddenLabel mesh__D006791 Hostilities
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D006791 2002
% 218.95/219.19  |- skos__broader mesh__D020462smesh__D003904
% 218.95/219.19  |- mesh__recordOriginator mesh__D020462 AGS
% 218.95/219.19  |- mesh__recordMaintainer mesh__D020462 SYSTEM
% 218.95/219.19  |- mesh__historyNote mesh__D020462 99; use MITOSPORIC FUNGI 1975-98   
% 218.95/219.19  |- mesh__activeMeSHYear mesh__D020462 2006
% 218.95/219.19  |- rdf__type mesh__D020462sskos__Concept
% 218.95/219.19  |- skos__prefLabel mesh__D020462 Gliocladium
% 218.95/219.19  |- mesh__dateEstablished mesh__D020462 1999-01-01
% 218.95/219.19  |- mesh__dateCreated mesh__D020462 1998-06-18
% 218.95/219.19  |- skos__scopeNote mesh__D020462
% 218.95/219.19       A mitosporic fungal genus occurring in soil or decaying plant matter. It is structurally similar to Penicillium.%A%    
% 219.04/219.19  |- mesh__dateRevised mesh__D020462 2005-06-30
% 219.04/219.19  |- mesh__recordAuthorizer mesh__D020462 sjn
% 219.04/219.19  |- skos__historyNote mesh__D020462 Mitosporic Fungi %28%1975-1998%29%
% 219.04/219.19  |- mesh__publicMeSHNote mesh__D020462
% 219.04/219.19       99; see HYPHOMYCETES 1986-98, see MONILIALES 1975-85   
% 219.04/219.19  |- mesh__recordAuthorizer mesh__D014425 sjn
% 219.04/219.19  |- skos__annotation mesh__D014425 D25-26 qualif   
% 219.04/219.19  |- skos__broader mesh__D014425smesh__D009822
% 219.04/219.19  |- skos__scopeNote mesh__D014425
% 219.04/219.19       The concrete oleoresin obtained from Pinus palustris Mill. %28%Pinaceae%29% and other species of Pinus. It contains a volatile oil, to which its properties are due, and to which form it is generally used. %28%Dorland, 28th ed%29% Turpentine is used as a solvent and an experimental irritant in biomedical research. Turpentine toxicity is of medical interest.%A%    
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D014425 2006
% 219.04/219.19  |- mesh__dateCreated mesh__D014425 1999-01-01
% 219.04/219.19  |- mesh__dateRevised mesh__D014425 2005-06-30
% 219.04/219.19  |- skos__prefLabel mesh__D014425 Turpentine
% 219.04/219.19  |- mesh__recordMaintainer mesh__D014425 ssb
% 219.04/219.19  |- rdf__type mesh__D014425sskos__Concept
% 219.04/219.19  |- skos__broader mesh__D014425smesh__D010936
% 219.04/219.19  |- mesh__recordOriginator mesh__D014425 NLM
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D000405 2001
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D000405 2004
% 219.04/219.19  |- mesh__dateRevised mesh__D000405 1999-11-03
% 219.04/219.19  |- skos__altLabel mesh__D000405 Akinetic Autism
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D000405 2000
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D000405 2005
% 219.04/219.19  |- skos__prefLabel mesh__D000405 Akinetic Mutism
% 219.04/219.19  |- skos__hiddenLabel mesh__D000405 Vigils, Coma
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D000405 2003
% 219.04/219.19  |- skos__hiddenLabel mesh__D000405 Akinetic Mutisms
% 219.04/219.19  |- mesh__recordOriginator mesh__D000405 NLM
% 219.04/219.19  |- mesh__recordMaintainer mesh__D000405 KEV
% 219.04/219.19  |- skos__altLabel mesh__D000405 Coma Vigilans
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D000405 2002
% 219.04/219.19  |- skos__altLabel mesh__D000405 Coma Vigil
% 219.04/219.19  |- skos__historyNote mesh__D000405 Mutism %28%1966-1970%29%
% 219.04/219.19  |- mesh__recordAuthorizer mesh__D000405 sjn
% 219.04/219.19  |- skos__hiddenLabel mesh__D000405 Vigil, Coma
% 219.04/219.19  |- rdf__type mesh__D000405sskos__Concept
% 219.04/219.19  |- mesh__dateCreated mesh__D000405 1999-01-01
% 219.04/219.19  |- mesh__dateEstablished mesh__D000405 1971-01-01
% 219.04/219.19  |- skos__broader mesh__D000405smesh__D001927
% 219.04/219.19  |- skos__hiddenLabel mesh__D000405 Autism, Akinetic
% 219.04/219.19  |- mesh__publicMeSHNote mesh__D000405 1971   
% 219.04/219.19  |- skos__altLabel mesh__D000405 Mutism, Akinetic
% 219.04/219.19  |- skos__scopeNote mesh__D000405
% 219.04/219.19       A syndrome characterized by a silent and inert state without voluntary motor activity despite preserved sensorimotor pathways and vigilance. Bilateral FRONTAL LOBE dysfunction involving the anterior cingulate gyrus and related brain injuries are associated with this condition. This may result in impaired abilities to communicate and initiate motor activities. %28%From Adams et al., Principles of Neurology, 6th ed, p348; Fortschr Neurol Psychiatr 1995 Feb;63%28%2%29%:59-67%29%%A%    
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D000405 2006
% 219.04/219.19  |- mesh__historyNote mesh__D000405 1971   
% 219.04/219.19  |- skos__related mesh__D000405smesh__D018458
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D019110 2001
% 219.04/219.19  |- skos__historyNote mesh__D019110 Solar System %28%1995%29%
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D019110 2002
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D019110 2005
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D019110 1996
% 219.04/219.19  |- mesh__historyNote mesh__D019110 96; was see SOLAR SYSTEM 1995   
% 219.04/219.19  |- skos__broader mesh__D019110smesh__D016082
% 219.04/219.19  |- rdf__type mesh__D019110sskos__Concept
% 219.04/219.19  |- skos__hiddenLabel mesh__D019110 Chondrite
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D019110 2006
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D019110 1997
% 219.04/219.19  |- skos__hiddenLabel mesh__D019110 Carbonaceous Chondrite
% 219.04/219.19  |- skos__prefLabel mesh__D019110 Meteoroids
% 219.04/219.19  |- mesh__publicMeSHNote mesh__D019110 96; was see SOLAR SYSTEM 1995   
% 219.04/219.19  |- mesh__dateEstablished mesh__D019110 1996-01-01
% 219.04/219.19  |- skos__annotation mesh__D019110 no qualif   
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D019110 1998
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D019110 2000
% 219.04/219.19  |- mesh__dateCreated mesh__D019110 1995-06-05
% 219.04/219.19  |- skos__hiddenLabel mesh__D019110 Meteor
% 219.04/219.19  |- skos__historyNote mesh__D019110 Astronomy %28%1966-1994%29%
% 219.04/219.19  |- skos__hiddenLabel mesh__D019110 Meteoroid
% 219.04/219.19  |- skos__hiddenLabel mesh__D019110 Chondrite, Carbonaceous
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D019110 2003
% 219.04/219.19  |- skos__hiddenLabel mesh__D019110 Comet %28%Astronomy%29%
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D019110 1999
% 219.04/219.19  |- skos__hiddenLabel mesh__D019110 Chondrites, Carbonaceous
% 219.04/219.19  |- mesh__onlineNote mesh__D019110
% 219.04/219.19       use SOLAR SYSTEM to search METEOROIDS 1995   
% 219.04/219.19  |- skos__hiddenLabel mesh__D019110 Meteorite
% 219.04/219.19  |- skos__scopeNote mesh__D019110
% 219.04/219.19       Any solid objects moving in interplanetary space that are smaller than a planet or asteroid but larger than a molecule. Meteorites are any meteoroid that has fallen to a planetary surface. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D019110 2004
% 219.04/219.19  |- skos__historyNote mesh__D005699 Ceramides %28%1972-1978%29%
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D005699 2005
% 219.04/219.19  |- rdf__type mesh__D005699sskos__Concept
% 219.04/219.19  |- skos__historyNote mesh__D005699 Glycosphingolipids %28%1975-1978%29%
% 219.04/219.19  |- skos__altLabel mesh__D005699 Galactosyl Ceramides
% 219.04/219.19  |- mesh__recordOriginator mesh__D005699 RLS
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D005699 2006
% 219.04/219.19  |- mesh__dateCreated mesh__D005699 1978-05-16
% 219.04/219.19  |- mesh__recordMaintainer mesh__D005699 ssb
% 219.04/219.19  |- mesh__historyNote mesh__D005699
% 219.04/219.19       91%28%79%29%; was see under CEREBROSIDES 1979-90   
% 219.04/219.19  |- skos__altLabel mesh__D005699 Galactocerebrosides
% 219.04/219.19  |- skos__broader mesh__D005699smesh__D002554
% 219.04/219.19  |- mesh__publicMeSHNote mesh__D005699
% 219.04/219.19       91; was see under CEREBROSIDES 1979-90   
% 219.04/219.19  |- skos__prefLabel mesh__D005699 Galactosylceramides
% 219.04/219.19  |- skos__scopeNote mesh__D005699
% 219.04/219.19       Cerebrosides which contain as their polar head group a galactose moiety bound in glycosidic linkage to the hydroxyl group of ceramide. Their accumulation in tissue, due to a defect in beta-galactosidase, is the cause of galactosylceramide lipidosis or globoid cell leukodystrophy.%A%    
% 219.04/219.19  |- skos__historyNote mesh__D005699 Cerebrosides %28%1966-1978%29%
% 219.04/219.19  |- mesh__recordAuthorizer mesh__D005699 sjn
% 219.04/219.19  |- skos__hiddenLabel mesh__D005699 Ceramides, Galactosyl
% 219.04/219.19  |- mesh__dateEstablished mesh__D005699 1991-01-01
% 219.04/219.19  |- mesh__dateRevised mesh__D005699 2004-07-07
% 219.04/219.19  |- skos__scopeNote mesh__D018816
% 219.04/219.19       Genes that code for proteins that regulate the CELL DIVISION CYCLE. These genes form a regulatory network that culminates in the onset of MITOSIS by activating the p34cdc2 protein %28%PROTEIN P34CDC2%29%.%A%    
% 219.04/219.19  |- skos__related mesh__D018816smesh__D018797
% 219.04/219.19  |- skos__altLabel mesh__D018816 Genes, Cell Division Cycle
% 219.04/219.19  |- mesh__recordAuthorizer mesh__D018816 sjn
% 219.04/219.19  |- skos__related mesh__D018816smesh__D002453
% 219.04/219.19  |- skos__broader mesh__D018816smesh__D005796
% 219.04/219.19  |- skos__altLabel mesh__D018816 Cell Division Cycle Genes
% 219.04/219.19  |- skos__altLabel mesh__D018816 Cell Cycle Genes
% 219.04/219.19  |- skos__altLabel mesh__D018816 cdc Genes
% 219.04/219.19  |- mesh__publicMeSHNote mesh__D018816 95   
% 219.04/219.19  |- mesh__recordMaintainer mesh__D018816 nns
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D018816 2006
% 219.04/219.19  |- rdf__type mesh__D018816sskos__Concept
% 219.04/219.19  |- mesh__recordOriginator mesh__D018816 AGS
% 219.04/219.19  |- mesh__historyNote mesh__D018816 95   
% 219.04/219.19  |- mesh__dateCreated mesh__D018816 1994-05-31
% 219.04/219.19  |- skos__altLabel mesh__D018816 Checkpoint Genes, Cell Cycle
% 219.04/219.19  |- skos__hiddenLabel mesh__D018816 Cell Cycle Gene
% 219.04/219.19  |- mesh__dateEstablished mesh__D018816 1995-01-01
% 219.04/219.19  |- skos__hiddenLabel mesh__D018816 cdc Gene
% 219.04/219.19  |- skos__prefLabel mesh__D018816 Genes, cdc
% 219.04/219.19  |- mesh__dateRevised mesh__D018816 2005-06-30
% 219.04/219.19  |- skos__hiddenLabel mesh__D010833 Acid, Phytic
% 219.04/219.19  |- skos__hiddenLabel mesh__D010833 Hexakisphosphate, Inositol
% 219.04/219.19  |- skos__hiddenLabel mesh__D010833 Hexaphosphate, Inositol
% 219.04/219.19  |- skos__broader mesh__D010833smesh__D007295
% 219.04/219.19  |- skos__hiddenLabel mesh__D010833 Phytate, Sodium
% 219.04/219.19  |- skos__hiddenLabel mesh__D010833 Phytate, Calcium
% 219.04/219.19  |- mesh__dateCreated mesh__D010833 1999-01-01
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D010833 2006
% 219.04/219.19  |- skos__prefLabel mesh__D010833 Phytic Acid
% 219.04/219.19  |- mesh__onlineNote mesh__D010833
% 219.04/219.19       search INOSITOL 1966-74; use PHYTIC ACID to search PHYTIN  1975-78 %26% use INOSITOL 1966-74%A%  
% 219.04/219.19  |- mesh__recordOriginator mesh__D010833 NLM
% 219.04/219.19  |- skos__historyNote mesh__D010833 Inositol %28%1966-1977%29%
% 219.04/219.19  |- mesh__dateRevised mesh__D010833 2004-07-07
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D010833 2005
% 219.04/219.19  |- skos__altLabel mesh__D010833 Inositol Hexakisphosphate
% 219.04/219.19  |- skos__annotation mesh__D010833 /biosyn permitted if by plant   
% 219.04/219.19  |- skos__scopeNote mesh__D010833
% 219.04/219.19       Complexing agent for removal of traces of heavy metal ions. It acts also as a hypocalcemic agent.%A%    
% 219.04/219.19  |- mesh__dateEstablished mesh__D010833 1978-01-01
% 219.04/219.19  |- mesh__historyNote mesh__D010833
% 219.04/219.19       78%28%75%29%; was see under INOSITOL 1963-77; PHYTIN was see under INOSITOL 1963-77%A%  
% 219.04/219.19  |- mesh__recordMaintainer mesh__D010833 ssb
% 219.04/219.19  |- mesh__publicMeSHNote mesh__D010833
% 219.04/219.19       78; was see under INOSITOL 1963-77; PHYTIN was see under INOSITOL 1963-77%A%  
% 219.04/219.19  |- mesh__recordAuthorizer mesh__D010833 sjn
% 219.04/219.19  |- rdf__type mesh__D010833sskos__Concept
% 219.04/219.19  |- skos__altLabel mesh__D010833 Inositol Hexaphosphate
% 219.04/219.19  |- mesh__recordOriginator mesh__D018018 AGS
% 219.04/219.19  |- rdf__type mesh__D018018sskos__Concept
% 219.04/219.19  |- mesh__recordAuthorizer mesh__D018018 sjn
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D018018 2003
% 219.04/219.19  |- mesh__dateCreated mesh__D018018 1993-06-04
% 219.04/219.19  |- skos__hiddenLabel mesh__D018018 Arteriviruses
% 219.04/219.19  |- mesh__dateEstablished mesh__D018018 1994-01-01
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D018018 2004
% 219.04/219.19  |- mesh__dateRevised mesh__D018018 2001-07-25
% 219.04/219.19  |- skos__prefLabel mesh__D018018 Arterivirus
% 219.04/219.19  |- skos__altLabel mesh__D018018 Monkey Hemorrhagic Disease Virus
% 219.04/219.19  |- mesh__publicMeSHNote mesh__D018018 94   
% 219.04/219.19  |- skos__altLabel mesh__D018018 Hemorrhagic Disease Virus, Simian
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D018018 2005
% 219.04/219.19  |- skos__scopeNote mesh__D018018
% 219.04/219.19       A genus of the family ARTERIVIRIDAE, in the order NIDOVIRALES. The type species is ARTERITIS VIRUS, EQUINE.%A%    
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D018018 2002
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D018018 2006
% 219.04/219.19  |- mesh__historyNote mesh__D018018 94   
% 219.04/219.19  |- mesh__recordMaintainer mesh__D018018 ags
% 219.04/219.19  |- skos__broader mesh__D018018smesh__D028382
% 219.04/219.19  |- skos__annotation mesh__D018018 infection = ARTERIVIRUS INFECTIONS   
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D010035 2006
% 219.04/219.19  |- mesh__recordAuthorizer mesh__D010035 PLS
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D010035 1998
% 219.04/219.19  |- mesh__recordMaintainer mesh__D010035 PXP
% 219.04/219.19  |- mesh__dateCreated mesh__D010035 1978-05-22
% 219.04/219.19  |- skos__hiddenLabel mesh__D010035 Purulent Otitis Media
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D010035 1999
% 219.04/219.19  |- skos__scopeNote mesh__D010035
% 219.04/219.19       Inflammation of the middle ear with purulent discharge.%A%    
% 219.04/219.19  |- mesh__dateRevised mesh__D010035 1996-06-10
% 219.04/219.19  |- skos__broader mesh__D010035smesh__D010033
% 219.04/219.19  |- rdf__type mesh__D010035sskos__Concept
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D010035 2003
% 219.04/219.19  |- mesh__recordOriginator mesh__D010035 RC
% 219.04/219.19  |- mesh__historyNote mesh__D010035
% 219.04/219.19       91%28%79%29%; was see under OTITIS MEDIA 1979-90   
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D010035 2000
% 219.04/219.19  |- mesh__dateEstablished mesh__D010035 1991-01-01
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D010035 2004
% 219.04/219.19  |- skos__prefLabel mesh__D010035 Otitis Media, Suppurative
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D010035 2001
% 219.04/219.19  |- skos__altLabel mesh__D010035 Otitis Media, Purulent
% 219.04/219.19  |- skos__historyNote mesh__D010035 Otitis Media %28%1966-1978%29%
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D010035 2005
% 219.04/219.19  |- skos__broader mesh__D010035smesh__D013492
% 219.04/219.19  |- skos__annotation mesh__D010035
% 219.04/219.19       suppurative refers to purulent discharge   
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D010035 1997
% 219.04/219.19  |- mesh__publicMeSHNote mesh__D010035
% 219.04/219.19       91; was see under OTITIS MEDIA 1979-90   
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D010035 2002
% 219.04/219.19  |- skos__hiddenLabel mesh__D010035 Suppurative Otitis Media
% 219.04/219.19  |- skos__altLabel mesh__D006792 Home Visits
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D006792 1993
% 219.04/219.19  |- skos__hiddenLabel mesh__D006792 Home Visit
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D006792 1999
% 219.04/219.19  |- skos__hiddenLabel mesh__D006792 House Call
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D006792 2006
% 219.04/219.19  |- skos__scopeNote mesh__D006792
% 219.04/219.19       Visits to the patient%27%s home by professional personnel for the purpose of diagnosis and/or treatment.%A%    
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D006792 2002
% 219.04/219.19  |- skos__hiddenLabel mesh__D006792 Visit, Home
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D006792 1996
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D006792 2003
% 219.04/219.19  |- mesh__publicMeSHNote mesh__D006792 68   
% 219.04/219.19  |- mesh__historyNote mesh__D006792 68   
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D006792 1997
% 219.04/219.19  |- skos__hiddenLabel mesh__D006792 Calls, House
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D006792 2004
% 219.04/219.19  |- mesh__dateEstablished mesh__D006792 1968-01-01
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D006792 2000
% 219.04/219.19  |- mesh__activeMeSHYear mesh__D006792 1994
% 219.04/219.19  |- mesh__recordAuthorizer mesh__D006792 PLS
% 219.04/219.19  |- skos__hiddenLabel mesh__D006792 Visits, Home
% 219.04/219.19  |- mesh__recordMaintainer mesh__D006792 TAP
% 219.04/219.20  |- skos__hiddenLabel mesh__D006792 Call, House
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D006792 1995
% 219.04/219.20  |- rdf__type mesh__D006792sskos__Concept
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D006792 2001
% 219.04/219.20  |- mesh__dateCreated mesh__D006792 1999-01-01
% 219.04/219.20  |- mesh__recordOriginator mesh__D006792 NLM
% 219.04/219.20  |- mesh__dateRevised mesh__D006792 1992-05-15
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D006792 1998
% 219.04/219.20  |- skos__prefLabel mesh__D006792 House Calls
% 219.04/219.20  |- skos__broader mesh__D006792smesh__D011364
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D006792 2005
% 219.04/219.20  |- skos__altLabel mesh__D020463 Acronyms %28%Publication Type%29%
% 219.04/219.20  |- mesh__historyNote mesh__D020463 99   
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D020463 2006
% 219.04/219.20  |- mesh__recordMaintainer mesh__D020463 jls
% 219.04/219.20  |- rdf__type mesh__D020463sskos__Concept
% 219.04/219.20  |- mesh__recordOriginator mesh__D020463 JLS
% 219.04/219.20  |- mesh__dateCreated mesh__D020463 1998-06-03
% 219.04/219.20  |- mesh__onlineNote mesh__D020463
% 219.04/219.20       search policy: Online Manual; use: main heading AND ABBREVIATIONS %28%PT%29%%A%  
% 219.04/219.20  |- skos__broader mesh__D020463smesh__D052180
% 219.04/219.20  |- mesh__dateEstablished mesh__D020463 1999-01-01
% 219.04/219.20  |- mesh__dateRevised mesh__D020463 2005-06-30
% 219.04/219.20  |- skos__altLabel mesh__D020463 Abbreviations %28%PT%29%
% 219.04/219.20  |- skos__scopeNote mesh__D020463
% 219.04/219.20       Works consisting of lists of shortened forms of written words or phrases used for brevity. Acronyms are included here.%A%    
% 219.04/219.20  |- mesh__recordAuthorizer mesh__D020463 sjn
% 219.04/219.20  |- skos__prefLabel mesh__D020463 Abbreviations %5B%Publication Type%5D%
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D014426 2005
% 219.04/219.20  |- mesh__publicMeSHNote mesh__D014426 68   
% 219.04/219.20  |- mesh__dateCreated mesh__D014426 1999-01-01
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D014426 2006
% 219.04/219.20  |- mesh__recordOriginator mesh__D014426 NLM
% 219.04/219.20  |- mesh__dateRevised mesh__D014426 2003-07-09
% 219.04/219.20  |- skos__historyNote mesh__D014426 Reptiles %28%1966-1967%29%
% 219.04/219.20  |- skos__annotation mesh__D014426
% 219.04/219.20       sea turtles, fresh water turtles %28%terrapin%29%, land turtles %28%tortoise%29%; IM; qualif permitted%A%  
% 219.04/219.20  |- mesh__recordMaintainer mesh__D014426 ags
% 219.04/219.20  |- mesh__recordAuthorizer mesh__D014426 sjn
% 219.04/219.20  |- skos__broader mesh__D014426smesh__D012104
% 219.04/219.20  |- mesh__historyNote mesh__D014426 68   
% 219.04/219.20  |- mesh__dateEstablished mesh__D014426 1968-01-01
% 219.04/219.20  |- skos__hiddenLabel mesh__D014426 Turtle
% 219.04/219.20  |- rdf__type mesh__D014426sskos__Concept
% 219.04/219.20  |- skos__prefLabel mesh__D014426 Turtles
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D014426 2004
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D000406 2003
% 219.04/219.20  |- mesh__historyNote mesh__D000406 2002 %28%1975%29%   
% 219.04/219.20  |- mesh__recordMaintainer mesh__D000406 ags
% 219.04/219.20  |- mesh__publicMeSHNote mesh__D000406
% 219.04/219.20       2002; see AKR VIRUS 1991-2001, see MOUSE LEUKEMIA VIRUSES 1975-1990%A%  
% 219.04/219.20  |- skos__hiddenLabel mesh__D000406 Virus, AKR
% 219.04/219.20  |- skos__hiddenLabel mesh__D000406 AKR Viruses
% 219.04/219.20  |- rdf__type mesh__D000406sskos__Concept
% 219.04/219.20  |- skos__prefLabel mesh__D000406 AKR murine leukemia virus
% 219.04/219.20  |- mesh__recordOriginator mesh__D000406 NLM
% 219.04/219.20  |- skos__altLabel mesh__D000406 AKR Virus
% 219.04/219.20  |- mesh__dateEstablished mesh__D000406 1991-01-01
% 219.04/219.20  |- skos__annotation mesh__D000406
% 219.04/219.20       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% + LEUKEMIA, EXPERIMENTAL %28%IM%29% or LEUKEMIA %28%IM%29% %28%for spontaneous leukemia%29%%A%  
% 219.04/219.20  |- mesh__dateCreated mesh__D000406 1974-12-12
% 219.04/219.20  |- mesh__dateRevised mesh__D000406 2002-07-02
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D000406 2006
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D000406 2004
% 219.04/219.20  |- mesh__recordAuthorizer mesh__D000406 sjn
% 219.04/219.20  |- skos__hiddenLabel mesh__D000406 Viruses, AKR
% 219.04/219.20  |- skos__scopeNote mesh__D000406
% 219.04/219.20       A strain of Murine leukemia virus %28%LEUKEMIA VIRUS, MURINE%29% isolated from spontaneous leukemia in AKR strain mice.%A%    
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D000406 2005
% 219.04/219.20  |- skos__broader mesh__D000406smesh__D009052
% 219.04/219.20  |- skos__prefLabel mesh__D019111 Condoms, Female
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D019111 2005
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D019111 1996
% 219.04/219.20  |- mesh__publicMeSHNote mesh__D019111 96   
% 219.04/219.20  |- rdf__type mesh__D019111sskos__Concept
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D019111 2001
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D019111 2006
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D019111 1997
% 219.04/219.20  |- skos__scopeNote mesh__D019111
% 219.04/219.20       A soft, loose-fitting polyurethane sheath, closed at one end, with flexible rings at both ends. The device is inserted into the vagina by compressing the inner ring and pushing it in. Properly positioned, the ring at the closed end covers the cervix, and the sheath lines the walls of the vagina. The outer ring remains outside the vagina, covering the labia. %28%Med Lett Drugs Ther 1993 Dec 24;35%28%12%29%:123%29%%A%    
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D019111 2002
% 219.04/219.20  |- skos__hiddenLabel mesh__D019111 Condom, Female
% 219.04/219.20  |- mesh__historyNote mesh__D019111 96   
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D019111 1998
% 219.04/219.20  |- mesh__dateCreated mesh__D019111 1995-06-05
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D019111 2003
% 219.04/219.20  |- skos__altLabel mesh__D019111 Female Condoms
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D019111 1999
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D019111 2004
% 219.04/219.20  |- mesh__dateEstablished mesh__D019111 1996-01-01
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D019111 2000
% 219.04/219.20  |- skos__broader mesh__D019111smesh__D003274
% 219.04/219.20  |- skos__annotation mesh__D019111
% 219.04/219.20       do not use /util except by MeSH definition   
% 219.04/219.20  |- skos__altLabel mesh__D019111 Female Condom
% 219.04/219.20  |- skos__related mesh__D046508smesh__D002478
% 219.04/219.20  |- skos__hiddenLabel mesh__D046508 Techniques, Culture
% 219.04/219.20  |- skos__annotation mesh__D046508
% 219.04/219.20       NIM; Manual 18.7.2-.3, 22.26.1, 26.23+; ORGAN CULTURE; CELL CULTURE; EMBRYO CULTURE TECHNIQUES are also available%A%  
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D046508 2005
% 219.04/219.20  |- mesh__dateRevised mesh__D046508 2005-07-13
% 219.04/219.20  |- skos__historyNote mesh__D046508 Culture Techniques %28%1966-2004%29%
% 219.04/219.20  |- mesh__recordAuthorizer mesh__D046508 ags
% 219.04/219.20  |- skos__scopeNote mesh__D046508
% 219.04/219.20       Methods of maintaining or growing biological materials in controlled laboratory conditions. These include the cultures of CELLS; TISSUES; organs; or EMBRYO in vitro. Both animal and plant tissues may be cultured by a variety of methods. Cultures may derive from normal or abnormal tissues, and consist of a single cell type or mixed cell types.%A%    
% 219.04/219.20  |- skos__related mesh__D046508smesh__D002460
% 219.04/219.20  |- skos__related mesh__D046508smesh__D018914
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D046508 2006
% 219.04/219.20  |- skos__broader mesh__D046508smesh__D019411
% 219.04/219.20  |- mesh__publicMeSHNote mesh__D046508 2005   
% 219.04/219.20  |- skos__related mesh__D046508smesh__D014776
% 219.04/219.20  |- skos__related mesh__D046508smesh__D002999
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D046508 2006A
% 219.04/219.20  |- skos__related mesh__D046508smesh__D014407
% 219.04/219.20  |- mesh__recordMaintainer mesh__D046508 ags
% 219.04/219.20  |- mesh__dateCreated mesh__D046508 2004-07-07
% 219.04/219.20  |- skos__hiddenLabel mesh__D046508 Culture Technique
% 219.04/219.20  |- mesh__dateEstablished mesh__D046508 2005-01-01
% 219.04/219.20  |- skos__prefLabel mesh__D046508 Culture Techniques
% 219.04/219.20  |- mesh__historyNote mesh__D046508 2005   
% 219.04/219.20  |- mesh__recordOriginator mesh__D046508 lkt
% 219.04/219.20  |- rdf__type mesh__D046508sskos__Concept
% 219.04/219.20  |- skos__hiddenLabel mesh__D046508 Technique, Culture
% 219.04/219.20  |- mesh__dateRevised mesh__D018817 2000-06-26
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D018817 2001
% 219.04/219.20  |- skos__annotation mesh__D018817
% 219.04/219.20       street drug Ecstasy goes here; DF: note short X ref   
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D018817 2006
% 219.04/219.20  |- skos__altLabel mesh__D018817 MDMA
% 219.04/219.20  |- mesh__recordAuthorizer mesh__D018817 sjn
% 219.04/219.20  |- skos__broader mesh__D018817smesh__D000662
% 219.04/219.20  |- rdf__type mesh__D018817sskos__Concept
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D018817 2005
% 219.04/219.20  |- skos__prefLabel mesh__D018817 N-Methyl-3,4-methylenedioxyamphetamine
% 219.04/219.20  |- mesh__dateCreated mesh__D018817 1994-06-01
% 219.04/219.20  |- mesh__onlineNote mesh__D018817
% 219.04/219.20       use N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE %28%NM%29% to search  N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE 1984-94%A%  
% 219.04/219.20  |- skos__altLabel mesh__D018817 Methylenedioxymethamphetamine
% 219.04/219.20  |- mesh__historyNote mesh__D018817
% 219.04/219.20       95; was N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE %28%NM%29% 1984-94%A%  
% 219.04/219.20  |- mesh__publicMeSHNote mesh__D018817
% 219.04/219.20       95; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE was indexed under 3,4-METHYLENEDIOXYAMPHETAMINE/analogs %26% derivatives 1984-94%A%  
% 219.04/219.20  |- skos__altLabel mesh__D018817 Ecstasy %28%Drug%29%
% 219.04/219.20  |- skos__hiddenLabel mesh__D018817
% 219.04/219.20       Hydrochloride, N-Methyl-3,4-methylenedioxyamphetamine
% 219.04/219.20  |- skos__hiddenLabel mesh__D018817
% 219.04/219.20       N Methyl 3,4 methylenedioxyamphetamine Hydrochloride
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D018817 2002
% 219.04/219.20  |- mesh__recordMaintainer mesh__D018817 jmp
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D018817 2004
% 219.04/219.20  |- skos__historyNote mesh__D018817
% 219.04/219.20       3,4-Methylenedioxyamphetamine/analogs %26% derivatives %28%1984-1994%29%
% 219.04/219.20  |- skos__hiddenLabel mesh__D018817 N Methyl 3,4 methylenedioxyamphetamine
% 219.04/219.20  |- mesh__recordOriginator mesh__D018817 TPW
% 219.04/219.20  |- skos__scopeNote mesh__D018817
% 219.04/219.20       An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.%A%    
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D018817 2003
% 219.04/219.20  |- mesh__dateEstablished mesh__D018817 1995-01-01
% 219.04/219.20  |- skos__annotation mesh__D010834
% 219.04/219.20       a blue-green pigment of plants; a plant protein   
% 219.04/219.20  |- mesh__publicMeSHNote mesh__D010834
% 219.04/219.20       91; was see under PLANT PROTEINS 1975-90   
% 219.04/219.20  |- mesh__dateEstablished mesh__D010834 1991-01-01
% 219.04/219.20  |- mesh__recordAuthorizer mesh__D010834 sjn
% 219.04/219.20  |- skos__historyNote mesh__D010834 Plant Proteins %28%1972-1974%29%
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D010834 2006
% 219.04/219.20  |- skos__broader mesh__D010834smesh__D010860
% 219.04/219.20  |- skos__prefLabel mesh__D010834 Phytochrome
% 219.04/219.20  |- skos__historyNote mesh__D010834 Bile Pigments %28%1973-1974%29%
% 219.04/219.20  |- skos__broader mesh__D010834smesh__D010940
% 219.04/219.20  |- mesh__dateRevised mesh__D010834 2005-06-30
% 219.04/219.20  |- mesh__historyNote mesh__D010834
% 219.04/219.20       91%28%75%29%; was see under PLANT PROTEINS 1975-90   
% 219.04/219.20  |- mesh__recordMaintainer mesh__D010834 ssb
% 219.04/219.20  |- mesh__dateCreated mesh__D010834 1974-11-19
% 219.04/219.20  |- rdf__type mesh__D010834sskos__Concept
% 219.04/219.20  |- skos__scopeNote mesh__D010834
% 219.04/219.20       A blue-green biliprotein widely distributed in the plant kingdom.%A%    
% 219.04/219.20  |- mesh__recordOriginator mesh__D010834 NLM
% 219.04/219.20  |- skos__altLabel mesh__D018019 CRF Receptors
% 219.04/219.20  |- mesh__recordOriginator mesh__D018019 RAZ
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D018019 2004
% 219.04/219.20  |- skos__hiddenLabel mesh__D018019 Receptor, CRH
% 219.04/219.20  |- skos__historyNote mesh__D018019
% 219.04/219.20       Receptors, Cell Surface %28%1983-1986%29%
% 219.04/219.20  |- skos__hiddenLabel mesh__D018019 Receptor, CRF
% 219.04/219.20  |- skos__altLabel mesh__D018019 Corticotropin Releasing-Hormone Receptors
% 219.04/219.20  |- skos__scopeNote mesh__D018019
% 219.04/219.20       Cell surface proteins that bind corticotropin-releasing hormone with high affinity and trigger intracellular changes which influence the behavior of cells. The corticotropin releasing-hormone receptors on anterior pituitary cells mediate the stimulation of corticotropin release by hypothalamic corticotropin releasing factor. The physiological consequence of activating corticotropin-releasing hormone receptors on central neurons is not well understood.%A%    
% 219.04/219.20  |- skos__altLabel mesh__D018019 CRH Receptors
% 219.04/219.20  |- skos__hiddenLabel mesh__D018019
% 219.04/219.20       Corticotropin-Releasing Hormone Receptors
% 219.04/219.20  |- rdf__type mesh__D018019sskos__Concept
% 219.04/219.20  |- skos__hiddenLabel mesh__D018019
% 219.04/219.20       Hormone Receptors, Corticotropin-Releasing
% 219.04/219.20  |- mesh__recordAuthorizer mesh__D018019 sjn
% 219.04/219.20  |- skos__altLabel mesh__D018019 Corticotropin Releasing-Factor Receptors
% 219.04/219.20  |- skos__broader mesh__D018019smesh__D043562
% 219.04/219.20  |- skos__hiddenLabel mesh__D018019
% 219.04/219.20       Releasing-Factor Receptors, Corticotropin
% 219.04/219.20  |- skos__hiddenLabel mesh__D018019
% 219.04/219.20       Receptors, Corticotropin Releasing-Factor
% 219.04/219.20  |- skos__historyNote mesh__D018019 Receptors, Neurohumor %28%1986-1993%29%
% 219.04/219.20  |- skos__altLabel mesh__D018019 Corticotropin Releasing-Hormone Receptor
% 219.04/219.20  |- skos__altLabel mesh__D018019 CRF Receptor
% 219.04/219.20  |- skos__hiddenLabel mesh__D018019
% 219.04/219.20       Corticotropin Releasing Hormone Receptors
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D018019 2006
% 219.04/219.20  |- mesh__recordMaintainer mesh__D018019 jmp
% 219.04/219.20  |- skos__hiddenLabel mesh__D018019
% 219.04/219.20       Releasing-Hormone Receptor, Corticotropin
% 219.04/219.20  |- skos__annotation mesh__D018019 DF: note short X ref   
% 219.04/219.20  |- skos__prefLabel mesh__D018019 Receptors, Corticotropin-Releasing Hormone
% 219.04/219.20  |- skos__broader mesh__D018019smesh__D018013
% 219.04/219.20  |- skos__altLabel mesh__D018019 CRH Receptor
% 219.04/219.20  |- skos__altLabel mesh__D018019 Receptors, CRF
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D018019 2005
% 219.04/219.20  |- skos__hiddenLabel mesh__D018019
% 219.04/219.20       Releasing-Hormone Receptors, Corticotropin
% 219.04/219.20  |- mesh__dateRevised mesh__D018019 2003-07-09
% 219.04/219.20  |- mesh__dateEstablished mesh__D018019 1994-01-01
% 219.04/219.20  |- mesh__publicMeSHNote mesh__D018019
% 219.04/219.20       94; CORTICOTROPIN RELEASING HORMONE RECEPTOR was indexed under RECEPTORS, NEUROHUMOR 1986-93 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1983-86%A%  
% 219.04/219.20  |- skos__broader mesh__D018019smesh__D018017
% 219.04/219.20  |- skos__altLabel mesh__D018019 Receptors, CRH
% 219.04/219.20  |- skos__hiddenLabel mesh__D018019 Corticotropin Releasing Hormone Receptor
% 219.04/219.20  |- mesh__onlineNote mesh__D018019
% 219.04/219.20       use RECEPTORS, CORTICOTROPIN-RELEASING HORMONE %28%NM%29% to search CORTICOTROPIN RELEASING HORMONE RECEPTOR 1983-93%A%  
% 219.04/219.20  |- skos__hiddenLabel mesh__D018019
% 219.04/219.20       Receptors, Corticotropin Releasing-Hormone
% 219.04/219.20  |- skos__hiddenLabel mesh__D018019 Corticotropin Releasing Factor Receptors
% 219.04/219.20  |- mesh__dateCreated mesh__D018019 1993-06-21
% 219.04/219.20  |- mesh__historyNote mesh__D018019
% 219.04/219.20       94; was CORTICOTROPIN RELEASING HORMONE RECEPTOR %28%NM%29% 1983-93%A%  
% 219.04/219.20  |- skos__hiddenLabel mesh__D018019
% 219.04/219.20       Receptors, Corticotropin Releasing Hormone
% 219.04/219.20  |- skos__hiddenLabel mesh__D018019
% 219.04/219.20       Receptor, Corticotropin Releasing-Hormone
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D010036 2005
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D010036 1998
% 219.04/219.20  |- skos__annotation mesh__D010036 SPEC: SPEC qualif; DF: OTOLARYNGOL   
% 219.04/219.20  |- mesh__recordAuthorizer mesh__D010036 SJN
% 219.04/219.20  |- skos__prefLabel mesh__D010036 Otolaryngology
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D010036 2006
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D010036 1999
% 219.04/219.20  |- skos__broader mesh__D010036smesh__D013043
% 219.04/219.20  |- mesh__historyNote mesh__D010036 80; was OTORHINOLARYNGOLOGY 1963-79   
% 219.04/219.20  |- mesh__publicMeSHNote mesh__D010036
% 219.04/219.20       80; was OTORHINOLARYNGOLOGY 1963-79   
% 219.04/219.20  |- rdf__type mesh__D010036sskos__Concept
% 219.04/219.20  |- mesh__dateRevised mesh__D010036 1997-06-20
% 219.04/219.20  |- mesh__recordOriginator mesh__D010036 NLM
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D010036 2000
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D010036 2003
% 219.04/219.20  |- mesh__dateCreated mesh__D010036 1999-01-01
% 219.04/219.20  |- mesh__recordMaintainer mesh__D010036 TGC
% 219.04/219.20  |- skos__related mesh__D010036smesh__D013506
% 219.04/219.20  |- mesh__onlineNote mesh__D010036
% 219.04/219.20       use OTOLARYNGOLOGY to search OTORHINOLARYNGOLOGY 1966-79   
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D010036 2001
% 219.04/219.20  |- skos__scopeNote mesh__D010036
% 219.04/219.20       A surgical specialty concerned with the study and treatment of disorders of the ear, nose, and throat.%A%    
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D010036 2004
% 219.04/219.20  |- skos__related mesh__D010036smesh__D010038
% 219.04/219.20  |- skos__related mesh__D010036smesh__D013517
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D010036 2002
% 219.04/219.20  |- skos__altLabel mesh__D006793 Musca domestica
% 219.04/219.20  |- rdf__type mesh__D006793sskos__Concept
% 219.04/219.20  |- mesh__recordMaintainer mesh__D006793 sjn
% 219.04/219.20  |- skos__annotation mesh__D006793
% 219.04/219.20       /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111; note X ref MUSCA DOMESTICA but other Musca species %26% genera of family Muscidae go under MUSCIDAE%A%  
% 219.04/219.20  |- mesh__dateCreated mesh__D006793 1999-01-01
% 219.04/219.20  |- mesh__recordOriginator mesh__D006793 NLM
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D006793 2006
% 219.04/219.20  |- mesh__dateRevised mesh__D006793 2004-07-13
% 219.04/219.20  |- skos__scopeNote mesh__D006793
% 219.04/219.20       Flies of the species Musca domestica %28%family MUSCIDAE%29%, which infest human habitations throughout the world and often act as carriers of pathogenic organisms.%A%    
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D006793 2005
% 219.04/219.20  |- skos__broader mesh__D006793smesh__D009117
% 219.04/219.20  |- skos__prefLabel mesh__D006793 Houseflies
% 219.04/219.20  |- mesh__recordAuthorizer mesh__D006793 sjn
% 219.04/219.20  |- mesh__dateCreated mesh__D014427 1999-01-01
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D014427 2006
% 219.04/219.20  |- skos__related mesh__D014427smesh__D004200
% 219.04/219.20  |- skos__scopeNote mesh__D014427
% 219.04/219.20       Two individuals derived from two FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother. Twins are either monozygotic %28%TWINS, MONOZYGOTIC%29% or dizygotic %28%TWINS, DIZYGOTIC%29%.%A%    
% 219.04/219.20  |- mesh__dateRevised mesh__D014427 2004-08-03
% 219.04/219.20  |- mesh__recordMaintainer mesh__D014427 jls
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D014427 2005A
% 219.04/219.20  |- mesh__recordOriginator mesh__D014427 NLM
% 219.04/219.20  |- rdf__type mesh__D014427sskos__Concept
% 219.04/219.20  |- skos__hiddenLabel mesh__D014427 Twin
% 219.04/219.20  |- skos__annotation mesh__D014427
% 219.04/219.20       IM humans only; if pertinent, NIM for animals not usually giving birth to twins; relation to PREGNANCY: Manual 28.16.4, 34.14; TWINNING, MONOZYGOTIC is also available%A%  
% 219.04/219.20  |- skos__broader mesh__D014427smesh__D009099
% 219.04/219.20  |- mesh__recordAuthorizer mesh__D014427 jls
% 219.04/219.20  |- skos__broader mesh__D014427smesh__D011272
% 219.04/219.20  |- skos__prefLabel mesh__D014427 Twins
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D014427 2005
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D019910 2006
% 219.04/219.20  |- skos__prefLabel mesh__D019910 Mycobacterium marinum
% 219.04/219.20  |- mesh__recordAuthorizer mesh__D019910 sjn
% 219.04/219.20  |- skos__historyNote mesh__D019910
% 219.04/219.20       Mycobacterium, Atypical %28%1977-1997%29%
% 219.04/219.20  |- skos__broader mesh__D019910smesh__D009170
% 219.04/219.20  |- mesh__dateRevised mesh__D019910 2005-06-30
% 219.04/219.20  |- mesh__dateCreated mesh__D019910 1997-06-20
% 219.04/219.20  |- rdf__type mesh__D019910sskos__Concept
% 219.04/219.20  |- mesh__historyNote mesh__D019910 98   
% 219.04/219.20  |- skos__historyNote mesh__D019910 Mycobacterium %28%1966-1990%29%
% 219.04/219.20  |- skos__annotation mesh__D019910
% 219.04/219.20       infection: coord IM with MYCOBACTERIUM INFECTIONS, ATYPICAL %28%IM%29%; DF: MYCOBACT MARINUM%A%  
% 219.04/219.20  |- mesh__recordOriginator mesh__D019910 PXP
% 219.04/219.20  |- mesh__dateEstablished mesh__D019910 1998-01-01
% 219.04/219.20  |- mesh__recordMaintainer mesh__D019910 SYSTEM
% 219.04/219.20  |- skos__scopeNote mesh__D019910
% 219.04/219.20       A moderate-growing, photochromogenic species found in aquariums, diseased fish, and swimming pools. It is the cause of cutaneous lesions and granulomas %28%swimming pool granuloma%29% in humans. %28%Dorland, 28th ed%29%%A%    
% 219.04/219.20  |- mesh__publicMeSHNote mesh__D019910 98   
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D000407 1999
% 219.04/219.20  |- mesh__recordMaintainer mesh__D000407 PXP
% 219.04/219.20  |- mesh__dateCreated mesh__D000407 1999-01-01
% 219.04/219.20  |- skos__broader mesh__D000407smesh__D015144
% 219.04/219.20  |- skos__broader mesh__D000407smesh__D001061
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D000407 2000
% 219.04/219.20  |- rdf__type mesh__D000407sskos__Concept
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D000407 2005
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D000407 2001
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D000407 2003
% 219.04/219.20  |- skos__prefLabel mesh__D000407 Alabama
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D000407 2006
% 219.04/219.20  |- mesh__dateRevised mesh__D000407 1997-06-20
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D000407 2002
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D000407 2004
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D000407 1998
% 219.04/219.20  |- mesh__recordOriginator mesh__D000407 NLM
% 219.04/219.20  |- mesh__recordAuthorizer mesh__D000407 SJN
% 219.04/219.20  |- mesh__dateEstablished mesh__D019112 1996-01-01
% 219.04/219.20  |- mesh__historyNote mesh__D019112 96   
% 219.04/219.20  |- mesh__recordOriginator mesh__D019112 JLS
% 219.04/219.20  |- skos__broader mesh__D019112smesh__D017216
% 219.04/219.20  |- mesh__dateCreated mesh__D019112 1995-06-06
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D019112 2003
% 219.04/219.20  |- mesh__dateRevised mesh__D019112 2000-06-22
% 219.04/219.20  |- skos__historyNote mesh__D019112
% 219.04/219.20       Radiology Information Systems %28%1990-1992%29%
% 219.04/219.20  |- mesh__recordAuthorizer mesh__D019112 sjn
% 219.04/219.20  |- skos__historyNote mesh__D019112 Technology, Radiologic %28%1990-1992%29%
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D019112 2004
% 219.04/219.20  |- mesh__publicMeSHNote mesh__D019112 96   
% 219.04/219.20  |- mesh__recordMaintainer mesh__D019112 jls
% 219.04/219.20  |- skos__broader mesh__D019112smesh__D013679
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D019112 2001
% 219.04/219.20  |- skos__annotation mesh__D019112
% 219.04/219.20       %22%electronic transm of radiol images%22%; DF: TELERADIOL   
% 219.04/219.20  |- skos__broader mesh__D019112smesh__D011873
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D019112 2005
% 219.04/219.20  |- skos__scopeNote mesh__D019112
% 219.04/219.20       The electronic transmission of radiological images from one location to another for the purposes of interpretation and/or consultation. Users in different locations may simultaneously view images with greater access to secondary consultations and improved continuing education. %28%From American College of Radiology, ACR Standard for Teleradiology, 1994, p3%29%%A%    
% 219.04/219.20  |- skos__prefLabel mesh__D019112 Teleradiology
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D019112 2002
% 219.04/219.20  |- skos__historyNote mesh__D019112 Telemedicine %28%1993-1995%29%
% 219.04/219.20  |- rdf__type mesh__D019112sskos__Concept
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D019112 2006
% 219.04/219.20  |- mesh__dateEstablished mesh__D046509 2005-01-01
% 219.04/219.20  |- skos__hiddenLabel mesh__D046509 Culture Techniques, Tissue
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D046509 2006
% 219.04/219.20  |- skos__hiddenLabel mesh__D046509 Culture Technique, Tissue
% 219.04/219.20  |- skos__prefLabel mesh__D046509 Tissue Culture Techniques
% 219.04/219.20  |- skos__broader mesh__D046509smesh__D046508
% 219.04/219.20  |- mesh__historyNote mesh__D046509 2005; use TISSUE CULTURE 1966-2004   
% 219.04/219.20  |- skos__hiddenLabel mesh__D046509 Tissue Culture Technique
% 219.04/219.20  |- mesh__recordOriginator mesh__D046509 lkt
% 219.04/219.20  |- mesh__recordMaintainer mesh__D046509 lkt
% 219.04/219.20  |- mesh__dateCreated mesh__D046509 2004-07-15
% 219.04/219.20  |- rdf__type mesh__D046509sskos__Concept
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D046509 2005
% 219.04/219.20  |- mesh__recordAuthorizer mesh__D046509 sjn
% 219.04/219.20  |- mesh__publicMeSHNote mesh__D046509 2005; see TISSUE CULTURE 1966-2004   
% 219.04/219.20  |- skos__scopeNote mesh__D046509
% 219.04/219.20       A technique for maintaining or growing TISSUE in vitro, usually by DIFFUSION, perifusion, or PERFUSION. The tissue is cultured directly after removal from the host without being dispersed for cell culture.%A%    
% 219.04/219.20  |- skos__historyNote mesh__D046509 Culture Techniques %28%1966-2004%29%
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D018818 2005
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D018818 2006
% 219.04/219.20  |- mesh__publicMeSHNote mesh__D018818
% 219.04/219.20       95; FENOLDOPAM was indexed under SK%26%F-38393/analogs %26% derivatives 1989-94 %26% BENZAZEPINES 1982-89%A%  
% 219.04/219.20  |- mesh__historyNote mesh__D018818 95; was FENOLDOPAM %28%NM%29% 1982-94   
% 219.04/219.20  |- skos__hiddenLabel mesh__D018818 SK%26%F 82526
% 219.04/219.20  |- skos__broader mesh__D018818smesh__D001552
% 219.04/219.20  |- skos__historyNote mesh__D018818 Benzazepines %28%1982-1989%29%
% 219.04/219.20  |- skos__historyNote mesh__D018818
% 219.04/219.20       SK%26%F-38393/analogs %26% derivatives %28%1989-1994%29%
% 219.04/219.20  |- mesh__dateRevised mesh__D018818 2000-06-22
% 219.04/219.20  |- mesh__onlineNote mesh__D018818
% 219.04/219.20       use FENOLDOPAM %28%NM%29% to search FENOLDOPAM 1982-94   
% 219.04/219.20  |- rdf__type mesh__D018818sskos__Concept
% 219.04/219.20  |- skos__hiddenLabel mesh__D018818 SKF82526
% 219.04/219.20  |- skos__hiddenLabel mesh__D018818 SK%26%F 82526J
% 219.04/219.20  |- skos__hiddenLabel mesh__D018818 Hydrobromide, Fenoldopam
% 219.04/219.20  |- skos__altLabel mesh__D018818 SKF-82526
% 219.04/219.20  |- mesh__dateCreated mesh__D018818 1994-06-01
% 219.04/219.20  |- skos__hiddenLabel mesh__D018818 SKF82526J
% 219.04/219.20  |- skos__scopeNote mesh__D018818
% 219.04/219.20       A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.%A%    
% 219.04/219.20  |- mesh__recordOriginator mesh__D018818 TPW
% 219.04/219.20  |- mesh__dateEstablished mesh__D018818 1995-01-01
% 219.04/219.20  |- skos__altLabel mesh__D018818 SK%26%F-82526J
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D018818 2001
% 219.04/219.20  |- skos__hiddenLabel mesh__D018818 SKF 82526J
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D018818 2003
% 219.04/219.20  |- skos__prefLabel mesh__D018818 Fenoldopam
% 219.04/219.20  |- skos__hiddenLabel mesh__D018818 SKF 82526
% 219.04/219.20  |- mesh__recordMaintainer mesh__D018818 TWD
% 219.04/219.20  |- mesh__recordAuthorizer mesh__D018818 sjn
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D018818 2002
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D018818 2004
% 219.04/219.20  |- skos__hiddenLabel mesh__D018818 SK%26%F82526J
% 219.04/219.20  |- skos__hiddenLabel mesh__D018818 SK%26%F82526
% 219.04/219.20  |- skos__hiddenLabel mesh__D010835 Bean Lectins, Kidney
% 219.04/219.20  |- mesh__recordMaintainer mesh__D010835 ssb
% 219.04/219.20  |- skos__altLabel mesh__D010835 Kidney Bean Lectins
% 219.04/219.20  |- skos__altLabel mesh__D010835 Lectins, Kidney Bean
% 219.04/219.20  |- mesh__activeMeSHYear mesh__D010835 2006
% 219.04/219.20  |- skos__hiddenLabel mesh__D010835 vulgaris Lectins, Phaseolus
% 219.04/219.20  |- mesh__publicMeSHNote mesh__D010835
% 219.04/219.20       79; was indexed under PLANT AGGLUTININS 1968-78   
% 219.04/219.20  |- skos__historyNote mesh__D010835 Lectins %28%1966-1978%29%
% 219.04/219.20  |- skos__prefLabel mesh__D010835 Phytohemagglutinins
% 219.04/219.20  |- mesh__recordAuthorizer mesh__D010835 sjn
% 219.04/219.20  |- skos__hiddenLabel mesh__D010835 Lectins, Phaseolus vulgaris
% 219.04/219.20  |- mesh__recordOriginator mesh__D010835 SH
% 219.04/219.20  |- skos__broader mesh__D010835smesh__D009088
% 219.04/219.20  |- rdf__type mesh__D010835sskos__Concept
% 219.04/219.20  |- skos__scopeNote mesh__D010835
% 219.04/219.20       Mucoproteins isolated from the kidney bean %28%Phaseolus vulgaris%29%; some of them are mitogenic to lymphocytes, others agglutinate all or certain types of erythrocytes or lymphocytes. They are used mainly in the study of immune mechanisms and in cell culture.%A%    
% 219.04/219.20  |- skos__altLabel mesh__D010835 Phaseolus vulgaris Lectins
% 219.04/219.20  |- mesh__dateEstablished mesh__D010835 1979-01-01
% 219.04/219.20  |- mesh__dateCreated mesh__D010835 1978-05-03
% 219.04/219.20  |- skos__broader mesh__D010835smesh__D037121
% 219.04/219.20  |- mesh__historyNote mesh__D010835
% 219.04/219.20       79; was indexed under PLANT AGGLUTININS 1968-78   
% 219.04/219.20  |- mesh__dateRevised mesh__D010835 2005-06-30
% 219.04/219.20  |- mesh__onlineNote mesh__D010835 search LECTINS 1968-78   
% 219.04/219.20  |- rdf__type mesh__D043211sskos__Concept
% 219.04/219.21  |- mesh__recordOriginator mesh__D043211 AKE
% 219.04/219.21  |- skos__broader mesh__D043211smesh__D005090
% 219.04/219.21  |- skos__altLabel mesh__D043211 RecBCD Enzyme
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D043211 2004
% 219.04/219.21  |- mesh__recordMaintainer mesh__D043211 jmp
% 219.04/219.21  |- skos__altLabel mesh__D043211 RecBC Deoxyribonuclease
% 219.04/219.21  |- mesh__recordAuthorizer mesh__D043211 sjn
% 219.04/219.21  |- skos__altLabel mesh__D043211 RecBC DNase
% 219.04/219.21  |- skos__hiddenLabel mesh__D043211 ATP Dependent DNase
% 219.04/219.21  |- mesh__dateCreated mesh__D043211 2003-07-09
% 219.04/219.21  |- skos__scopeNote mesh__D043211
% 219.04/219.21       An ATP-dependent exodeoxyribonuclease that cleaves in either the 5%27%- to 3%27%- or the 3%27%- to 5%27%-direction to yield 5%27%-phosphooligonucleotides. It is primarily found in BACTERIA.%A%    
% 219.04/219.21  |- skos__altLabel mesh__D043211 Exonuclease V
% 219.04/219.21  |- mesh__publicMeSHNote mesh__D043211
% 219.04/219.21       2004; EXODEOXYRIBONUCLEASE V was indexed under EXODEOXYRIBONUCLEASES 1983-2003 %26% under EXONUCLEASES 1980-1982%A%  
% 219.04/219.21  |- skos__historyNote mesh__D043211 Exodeoxyribonucleases %28%1983-2003%29%
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D043211 2005
% 219.04/219.21  |- mesh__historyNote mesh__D043211
% 219.04/219.21       2004; use EXODEOXYRIBONUCLEASE V %28%NM%29% 1980-2003   
% 219.04/219.21  |- mesh__dateEstablished mesh__D043211 2004-01-01
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D043211 2006
% 219.04/219.21  |- skos__prefLabel mesh__D043211 Exodeoxyribonuclease V
% 219.04/219.21  |- skos__historyNote mesh__D043211 Exonucleases %28%1980-1982%29%
% 219.04/219.21  |- skos__hiddenLabel mesh__D043211 Deoxyribonuclease, RecBC
% 219.04/219.21  |- skos__altLabel mesh__D043211 ATP-Dependent DNase
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010037 2006
% 219.04/219.21  |- skos__hiddenLabel mesh__D010037 Otoconias
% 219.04/219.21  |- skos__prefLabel mesh__D010037 Otolithic Membrane
% 219.04/219.21  |- mesh__dateCreated mesh__D010037 1982-04-22
% 219.04/219.21  |- rdf__type mesh__D010037sskos__Concept
% 219.04/219.21  |- skos__hiddenLabel mesh__D010037 Membranes, Otolithic
% 219.04/219.21  |- mesh__recordMaintainer mesh__D010037 lkt
% 219.04/219.21  |- skos__hiddenLabel mesh__D010037 Otolith
% 219.04/219.21  |- skos__altLabel mesh__D010037 Otoliths
% 219.04/219.21  |- skos__historyNote mesh__D010037 Labyrinth %28%1966-1982%29%
% 219.04/219.21  |- mesh__historyNote mesh__D010037
% 219.04/219.21       91%28%83%29%; was see under SACCULE AND UTRICLE 1983-90   
% 219.04/219.21  |- mesh__dateEstablished mesh__D010037 1991-01-01
% 219.04/219.21  |- skos__historyNote mesh__D010037 Maculae, Acoustic %28%1979-1982%29%
% 219.04/219.21  |- mesh__recordAuthorizer mesh__D010037 sjn
% 219.04/219.21  |- skos__hiddenLabel mesh__D010037 Otolithic Membranes
% 219.04/219.21  |- mesh__recordOriginator mesh__D010037 RC
% 219.04/219.21  |- skos__scopeNote mesh__D010037
% 219.04/219.21       A gelatinous membrane overlying the acoustic maculae of SACCULE AND UTRICLE. It contains minute crystalline particles %28%otoliths%29% of CALCIUM CARBONATE and protein on its outer surface. In response to head movement, the otoliths shift causing distortion of the vestibular hair cells which transduce nerve signals to the BRAIN for interpretation of equilibrium.%A%    
% 219.04/219.21  |- skos__hiddenLabel mesh__D010037 Statoconias
% 219.04/219.21  |- skos__hiddenLabel mesh__D010037 Membrane, Otolithic
% 219.04/219.21  |- mesh__publicMeSHNote mesh__D010037
% 219.04/219.21       91; was see under SACCULE AND UTRICLE 1983-90   
% 219.04/219.21  |- skos__historyNote mesh__D010037 Saccule and Utricle %28%1975-1982%29%
% 219.04/219.21  |- skos__broader mesh__D010037smesh__D008267
% 219.04/219.21  |- skos__altLabel mesh__D010037 Statoconia
% 219.04/219.21  |- mesh__dateRevised mesh__D010037 2005-06-30
% 219.04/219.21  |- skos__altLabel mesh__D015520 Regulatory Proteins, Viral
% 219.04/219.21  |- skos__altLabel mesh__D015520 Proteins, Viral Regulatory
% 219.04/219.21  |- mesh__dateCreated mesh__D015520 1989-05-25
% 219.04/219.21  |- skos__scopeNote mesh__D015520
% 219.04/219.21       Proteins which regulate the rate of transcription of viral structural genes.%A%    
% 219.04/219.21  |- skos__broader mesh__D015520smesh__D014764
% 219.04/219.21  |- mesh__historyNote mesh__D015520 90   
% 219.04/219.21  |- mesh__dateEstablished mesh__D015520 1990-01-01
% 219.04/219.21  |- skos__broader mesh__D015520smesh__D004268
% 219.04/219.21  |- mesh__publicMeSHNote mesh__D015520 90   
% 219.04/219.21  |- mesh__recordAuthorizer mesh__D015520 sjn
% 219.04/219.21  |- rdf__type mesh__D015520sskos__Concept
% 219.04/219.21  |- skos__annotation mesh__D015520
% 219.04/219.21       IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted; DF: VIRAL REG PROTEINS%A%  
% 219.04/219.21  |- skos__historyNote mesh__D015520 Transcription Factors %28%1977-1989%29%
% 219.04/219.21  |- mesh__recordOriginator mesh__D015520 AGS
% 219.04/219.21  |- skos__historyNote mesh__D015520 Viral Proteins %28%1972-1989%29%
% 219.04/219.21  |- skos__historyNote mesh__D015520 Repressor Proteins %28%1979-1989%29%
% 219.04/219.21  |- mesh__dateRevised mesh__D015520 2005-06-30
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D015520 2006
% 219.04/219.21  |- mesh__recordMaintainer mesh__D015520 SYSTEM
% 219.04/219.21  |- skos__prefLabel mesh__D015520 Viral Regulatory Proteins
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D001500 2006
% 219.04/219.21  |- skos__hiddenLabel mesh__D001500 Vaccine, BCG
% 219.04/219.21  |- mesh__recordAuthorizer mesh__D001500 sjn
% 219.04/219.21  |- mesh__publicMeSHNote mesh__D001500
% 219.04/219.21       1979; see TUBERCULOSIS VACCINES 1974-1978   
% 219.04/219.21  |- rdf__type mesh__D001500sskos__Concept
% 219.04/219.21  |- skos__altLabel mesh__D001500 Calmette%27%s Vaccine
% 219.04/219.21  |- skos__annotation mesh__D001500
% 219.04/219.21       BCG vaccination in prev of tuberc = BCG VACCINE %28%IM%29% + TUBERCULOSIS /prev %28%IM%29%; BCG ther of various diseases = BCG VACCINE /ther use %28%IM%29% + dis /drug ther %28%IM%29%%A%  
% 219.04/219.21  |- mesh__recordMaintainer mesh__D001500 ssb
% 219.04/219.21  |- skos__altLabel mesh__D001500 Bacillus Calmette Guerin Vaccine
% 219.04/219.21  |- mesh__dateRevised mesh__D001500 2005-06-30
% 219.04/219.21  |- skos__scopeNote mesh__D001500
% 219.04/219.21       An active immunizing agent and a viable avirulent attenuated strain of Mycobacterium tuberculosis, var. bovis, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity.%A%    
% 219.04/219.21  |- skos__hiddenLabel mesh__D001500 Calmettes Vaccine
% 219.04/219.21  |- skos__prefLabel mesh__D001500 BCG Vaccine
% 219.04/219.21  |- mesh__recordOriginator mesh__D001500 NLM
% 219.04/219.21  |- mesh__dateEstablished mesh__D001500 1979-01-01
% 219.04/219.21  |- skos__hiddenLabel mesh__D001500 Calmette Vaccine
% 219.04/219.21  |- mesh__historyNote mesh__D001500 1979 %28%1974%29%   
% 219.04/219.21  |- skos__hiddenLabel mesh__D001500 Vaccine, Calmette%27%s
% 219.04/219.21  |- skos__broader mesh__D001500smesh__D032581
% 219.04/219.21  |- skos__altLabel mesh__D001500 Calmette Guerin Bacillus Vaccine
% 219.04/219.21  |- mesh__dateCreated mesh__D001500 1999-01-01
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D006794 1999
% 219.04/219.21  |- skos__annotation mesh__D006794
% 219.04/219.21       various household items %26% appliances; do not confuse with HOUSEHOLD PRODUCTS %28%substances %26% material used in %22%housekeeping or personal routine%22%%29%; BEDDING AND LINENS %26% COOKING AND EATING UTENSILS are also available; does not include furniture %28%FURNITURE see INTERIOR DESIGN AND FURNISHINGS%29% or furnishings %28%INTERIOR FURNISHINGS see INTERIOR DESIGN AND FURNISHINGS%29%%A%  
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D006794 2006
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D006794 2002
% 219.04/219.21  |- skos__hiddenLabel mesh__D006794 Article, Household
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D006794 1998
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D006794 2005
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D006794 1997
% 219.04/219.21  |- mesh__dateEstablished mesh__D006794 1976-01-01
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D006794 2004
% 219.04/219.21  |- mesh__recordMaintainer mesh__D006794 TGC
% 219.04/219.21  |- mesh__historyNote mesh__D006794 76; was NON MESH before 1976   
% 219.04/219.21  |- skos__prefLabel mesh__D006794 Household Articles
% 219.04/219.21  |- skos__hiddenLabel mesh__D006794 Household Article
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D006794 1996
% 219.04/219.21  |- mesh__dateRevised mesh__D006794 1993-06-02
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D006794 2003
% 219.04/219.21  |- skos__scopeNote mesh__D006794
% 219.04/219.21       Various material objects and items in the home. It includes temporary or permanent machinery and appliances. It does not include furniture or interior furnishings %28%FURNITURE see INTERIOR DESIGN AND FURNISHINGS; INTERIOR FURNISHINGS see INTERIOR DESIGN AND FURNISHINGS%29%.%A%    
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D006794 2001
% 219.04/219.21  |- skos__hiddenLabel mesh__D006794 Equipment, Household
% 219.04/219.21  |- mesh__dateCreated mesh__D006794 1975-07-25
% 219.04/219.21  |- mesh__recordOriginator mesh__D006794 JW
% 219.04/219.21  |- skos__hiddenLabel mesh__D006794 Articles, Household
% 219.04/219.21  |- mesh__publicMeSHNote mesh__D006794 76   
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D006794 1995
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D006794 2000
% 219.04/219.21  |- skos__broader mesh__D006794smesh__D013676
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D006794 1994
% 219.04/219.21  |- rdf__type mesh__D006794sskos__Concept
% 219.04/219.21  |- mesh__recordAuthorizer mesh__D006794 PLS
% 219.04/219.21  |- mesh__dateEstablished mesh__D020465 1999-01-01
% 219.04/219.21  |- mesh__recordAuthorizer mesh__D020465 sjn
% 219.04/219.21  |- skos__prefLabel mesh__D020465 Anecdotes %5B%Publication Type%5D%
% 219.04/219.21  |- mesh__dateRevised mesh__D020465 2005-06-30
% 219.04/219.21  |- mesh__recordMaintainer mesh__D020465 jls
% 219.04/219.21  |- rdf__type mesh__D020465sskos__Concept
% 219.04/219.21  |- mesh__dateCreated mesh__D020465 1998-06-03
% 219.04/219.21  |- mesh__historyNote mesh__D020465 1999   
% 219.04/219.21  |- skos__altLabel mesh__D020465 Anecdotes %28%PT%29%
% 219.04/219.21  |- skos__scopeNote mesh__D020465
% 219.04/219.21       Works consisting of brief accounts or narratives of incidents or events.%A%    
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D020465 2006
% 219.04/219.21  |- mesh__recordOriginator mesh__D020465 JLS
% 219.04/219.21  |- skos__related mesh__D020465smesh__D020480
% 219.04/219.21  |- skos__broader mesh__D020465smesh__D052180
% 219.04/219.21  |- skos__hiddenLabel mesh__D014428 Conjoined Twins
% 219.04/219.21  |- skos__altLabel mesh__D014428 Siamese Twins
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D014428 2000
% 219.04/219.21  |- mesh__recordAuthorizer mesh__D014428 sjn
% 219.04/219.21  |- mesh__dateEstablished mesh__D014428 1966-01-01
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D014428 2003
% 219.04/219.21  |- rdf__type mesh__D014428sskos__Concept
% 219.04/219.21  |- mesh__historyNote mesh__D014428 66   
% 219.04/219.21  |- skos__hiddenLabel mesh__D014428 Twin, Conjoined
% 219.04/219.21  |- skos__hiddenLabel mesh__D014428 Siamese Twin
% 219.04/219.21  |- mesh__publicMeSHNote mesh__D014428 66   
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D014428 2001
% 219.04/219.21  |- skos__annotation mesh__D014428
% 219.04/219.21       note category; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 219.04/219.21  |- skos__hiddenLabel mesh__D014428 Conjoined Twin
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D014428 2004
% 219.04/219.21  |- skos__altLabel mesh__D014428 Twins, Siamese
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D014428 2002
% 219.04/219.21  |- skos__broader mesh__D014428smesh__D009008
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D014428 2005
% 219.04/219.21  |- mesh__recordMaintainer mesh__D014428 kle
% 219.04/219.21  |- mesh__dateCreated mesh__D014428 1999-01-01
% 219.04/219.21  |- skos__prefLabel mesh__D014428 Twins, Conjoined
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D014428 2006
% 219.04/219.21  |- mesh__dateRevised mesh__D014428 1999-11-03
% 219.04/219.21  |- mesh__recordOriginator mesh__D014428 NLM
% 219.04/219.21  |- skos__hiddenLabel mesh__D014428 Twin, Siamese
% 219.04/219.21  |- mesh__dateEstablished mesh__D019911 1998-01-01
% 219.04/219.21  |- skos__broader mesh__D019911smesh__D009170
% 219.04/219.21  |- mesh__publicMeSHNote mesh__D019911 98   
% 219.04/219.21  |- rdf__type mesh__D019911sskos__Concept
% 219.04/219.21  |- mesh__recordAuthorizer mesh__D019911 sjn
% 219.04/219.21  |- skos__historyNote mesh__D019911
% 219.04/219.21       Mycobacterium, Atypical %28%1977-1997%29%
% 219.04/219.21  |- mesh__dateRevised mesh__D019911 2005-06-30
% 219.04/219.21  |- mesh__historyNote mesh__D019911 98   
% 219.04/219.21  |- mesh__dateCreated mesh__D019911 1997-06-20
% 219.04/219.21  |- skos__historyNote mesh__D019911 Mycobacterium %28%1966-1990%29%
% 219.04/219.21  |- skos__scopeNote mesh__D019911
% 219.04/219.21       A slow-growing, nonphotochromogenic species that causes chronic skin lesions in humans %28%Buruli ulcer%29%. %28%Dorland, 28th ed%29%%A%    
% 219.04/219.21  |- skos__annotation mesh__D019911
% 219.04/219.21       infection: coord IM with MYCOBACTERIUM INFECTIONS, ATYPICAL %28%IM%29%; DF: MYCOBACT ULCERANS%A%  
% 219.04/219.21  |- mesh__recordOriginator mesh__D019911 PXP
% 219.04/219.21  |- mesh__recordMaintainer mesh__D019911 SYSTEM
% 219.04/219.21  |- skos__altLabel mesh__D019911 Mycobacterium buruli
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D019911 2006
% 219.04/219.21  |- skos__prefLabel mesh__D019911 Mycobacterium ulcerans
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D019113 2003
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D019113 1999
% 219.04/219.21  |- mesh__dateRevised mesh__D019113 1997-06-20
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D019113 2004
% 219.04/219.21  |- mesh__dateEstablished mesh__D019113 1996-01-01
% 219.04/219.21  |- skos__prefLabel mesh__D019113 Telepathology
% 219.04/219.21  |- skos__annotation mesh__D019113
% 219.04/219.21       %22%transm %26% interpret of tissue specimens via remote telecommun%22%; DF: TELEPATHOL%A%  
% 219.04/219.21  |- skos__historyNote mesh__D019113 Pathology %28%1990-1992%29%
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D019113 2005
% 219.04/219.21  |- mesh__recordMaintainer mesh__D019113 PXP
% 219.04/219.21  |- skos__broader mesh__D019113smesh__D010336
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D019113 2000
% 219.04/219.21  |- mesh__recordAuthorizer mesh__D019113 SJN
% 219.04/219.21  |- rdf__type mesh__D019113sskos__Concept
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D019113 2006
% 219.04/219.21  |- mesh__publicMeSHNote mesh__D019113 96   
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D019113 2001
% 219.04/219.21  |- skos__scopeNote mesh__D019113
% 219.04/219.21       Transmission and interpretation of tissue specimens via remote telecommunication, generally for the purpose of diagnosis or consultation but may also be used for continuing education.%A%    
% 219.04/219.21  |- mesh__historyNote mesh__D019113 96   
% 219.04/219.21  |- mesh__recordOriginator mesh__D019113 JLS
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D019113 1998
% 219.04/219.21  |- skos__broader mesh__D019113smesh__D017216
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D019113 2002
% 219.04/219.21  |- mesh__dateCreated mesh__D019113 1995-06-05
% 219.04/219.21  |- skos__historyNote mesh__D019113 Telemedicine %28%1993-1995%29%
% 219.04/219.21  |- skos__scopeNote mesh__D000408
% 219.04/219.21       A cyclic nonadecapeptide antibiotic that can act as an ionophore and is produced by strains of Trichoderma viride. %28%From Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed%29%%A%    
% 219.04/219.21  |- mesh__recordOriginator mesh__D000408 NLM
% 219.04/219.21  |- mesh__recordMaintainer mesh__D000408 ssb
% 219.04/219.21  |- mesh__historyNote mesh__D000408
% 219.04/219.21       91%28%75%29%; was see under ANTIBIOTICS 1975-90   
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D000408 2005
% 219.04/219.21  |- rdf__type mesh__D000408sskos__Concept
% 219.04/219.21  |- skos__historyNote mesh__D000408 Peptides, Cyclic %28%1973-1974%29%
% 219.04/219.21  |- mesh__publicMeSHNote mesh__D000408
% 219.04/219.21       91; was see under ANTIBIOTICS 1975-90   
% 219.04/219.21  |- mesh__dateRevised mesh__D000408 2004-07-07
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D000408 2006
% 219.04/219.21  |- mesh__recordAuthorizer mesh__D000408 sjn
% 219.04/219.21  |- skos__broader mesh__D000408smesh__D010456
% 219.04/219.21  |- skos__prefLabel mesh__D000408 Alamethicin
% 219.04/219.21  |- skos__historyNote mesh__D000408 Antibiotics %28%1971-1975%29%
% 219.04/219.21  |- mesh__dateEstablished mesh__D000408 1991-01-01
% 219.04/219.21  |- mesh__dateCreated mesh__D000408 1974-11-19
% 219.04/219.21  |- skos__broader mesh__D011130smesh__D011118
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D011130 2004
% 219.04/219.21  |- skos__hiddenLabel mesh__D011130 Synthetase, Polyribonucleotide
% 219.04/219.21  |- skos__prefLabel mesh__D011130 RNA Ligase %28%ATP%29%
% 219.04/219.21  |- mesh__dateEstablished mesh__D011130 1991-01-01
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D011130 2006
% 219.04/219.21  |- mesh__dateRevised mesh__D011130 2005-07-27
% 219.04/219.21  |- mesh__recordOriginator mesh__D011130 RLS
% 219.04/219.21  |- skos__historyNote mesh__D011130
% 219.04/219.21       Polynucleotide Synthetases %28%1974-1977%29%
% 219.04/219.21  |- mesh__dateCreated mesh__D011130 1977-05-23
% 219.04/219.21  |- skos__hiddenLabel mesh__D011130 Ligase, tRNA
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D011130 2006A
% 219.04/219.21  |- mesh__publicMeSHNote mesh__D011130
% 219.04/219.21       98; see POLYRIBONUCLEOTIDE SYNTHETASE 1991-97; see POLYNUCLEOTIDE SYNTHETASES 1978-90%A%  
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D011130 2005
% 219.04/219.21  |- skos__scopeNote mesh__D011130
% 219.04/219.21       An enzyme that catalyzes the conversion of linear RNA to a circular form by the transfer of the 5%27%-phosphate to the 3%27%-hydroxyl terminus. It also catalyzes the covalent joining of two polyribonucleotides in phosphodiester linkage. EC 6.5.1.3.%A%    
% 219.04/219.21  |- rdf__type mesh__D011130sskos__Concept
% 219.04/219.21  |- skos__annotation mesh__D011130
% 219.04/219.21       do not confuse X ref POLYRIBONUCLEOTIDE SYNTHETASE with X refs POLYDEOXYRIBONUCLEOTIDE SYNTHETASES or POLYNUCLEOTIDE SYNTHETASES%A%  
% 219.04/219.21  |- mesh__historyNote mesh__D011130 98%28%78%29%   
% 219.04/219.21  |- skos__altLabel mesh__D011130 Polyribonucleotide Synthetase
% 219.04/219.21  |- mesh__recordAuthorizer mesh__D011130 ags
% 219.04/219.21  |- mesh__recordMaintainer mesh__D011130 ags
% 219.04/219.21  |- skos__scopeNote mesh__D018819
% 219.04/219.21       Cell-surface glycoproteins and serine protease, also known as dipeptidyl-peptidase IV, that play a role in T-lymphocyte activation. CD26 binds to adenosine deaminase on the T-cell surface. EC 3.4.14.5%A%    
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D018819 2006
% 219.04/219.21  |- skos__hiddenLabel mesh__D018819 Adenosine Deaminase Binding Proteins
% 219.04/219.21  |- skos__altLabel mesh__D018819 CD26 Antigens
% 219.04/219.21  |- skos__historyNote mesh__D018819 Dipeptidyl Peptidases %28%1980-1994%29%
% 219.04/219.21  |- mesh__recordOriginator mesh__D018819 AGS
% 219.04/219.21  |- skos__prefLabel mesh__D018819 Antigens, CD26
% 219.04/219.21  |- mesh__recordMaintainer mesh__D018819 ssb
% 219.04/219.21  |- rdf__type mesh__D018819sskos__Concept
% 219.04/219.21  |- mesh__historyNote mesh__D018819
% 219.04/219.21       95; was CD26 ANTIGEN %28%NM%29% 1990-94, DIPEPTIDYL PEPTIDASE IV %28%NM%29% 1980-94, %26% ADENOSINE DEAMINASE-BINDING PROTEINS %28%NM%29% 1978-94%A%  
% 219.04/219.21  |- mesh__dateCreated mesh__D018819 1994-05-27
% 219.04/219.21  |- skos__broader mesh__D018819smesh__D004152
% 219.04/219.21  |- skos__broader mesh__D018819smesh__D015703
% 219.04/219.21  |- skos__hiddenLabel mesh__D018819 Antigen, CD26
% 219.04/219.21  |- skos__altLabel mesh__D018819 CD26 Antigen
% 219.04/219.21  |- skos__altLabel mesh__D018819 Dipeptidyl-Peptidase IV
% 219.04/219.21  |- skos__broader mesh__D018819smesh__D000945
% 219.04/219.21  |- skos__altLabel mesh__D018819 Adenosine Deaminase-Binding Proteins
% 219.04/219.21  |- mesh__dateRevised mesh__D018819 2005-06-30
% 219.04/219.21  |- mesh__publicMeSHNote mesh__D018819
% 219.04/219.21       95; CD26 ANTIGEN was indexed under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1990-94; DIPEPTIDYL PEPTIDASE IV was indexed under DIPEPTIDYL PEPTIDASES 1980-94; ADENOSINE DEAMINASE-BINDING PROTEINS was indexed under CARRIER PROTEINS 1978-94%A%  
% 219.04/219.21  |- mesh__dateEstablished mesh__D018819 1995-01-01
% 219.04/219.21  |- skos__annotation mesh__D018819 T-lymphocyte differentiation antigens   
% 219.04/219.21  |- mesh__onlineNote mesh__D018819
% 219.04/219.21       use ANTIGENS, CD26 %28%NM%29% to search CD26 ANTIGEN 1990-94, DIPEPTIDYL PEPTIDASE IV 1980-94, %26% ADENOSINE DEAMINASE-BINDING PROTEINS 1978-94%A%  
% 219.04/219.21  |- skos__historyNote mesh__D018819 Carrier Proteins %28%1978-1994%29%
% 219.04/219.21  |- skos__hiddenLabel mesh__D018819 Dipeptidyl Peptidase IV
% 219.04/219.21  |- mesh__recordAuthorizer mesh__D018819 sjn
% 219.04/219.21  |- skos__historyNote mesh__D018819
% 219.04/219.21       Antigens, Differentiation, T-Lymphocyte %28%1990-1994%29%
% 219.04/219.21  |- mesh__historyNote mesh__D010836
% 219.04/219.21       91%28%75%29%; was see under DITERPENES 1975-90; was see under TERPENES 1968-74%A%  
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010836 2000
% 219.04/219.21  |- mesh__dateRevised mesh__D010836 1992-05-19
% 219.04/219.21  |- mesh__publicMeSHNote mesh__D010836
% 219.04/219.21       91; was see under DITERPENES 1975-90; was see under TERPENES 1968-74%A%  
% 219.04/219.21  |- mesh__recordMaintainer mesh__D010836 TAP
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010836 1996
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010836 2001
% 219.04/219.21  |- rdf__type mesh__D010836sskos__Concept
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010836 1998
% 219.04/219.21  |- mesh__recordAuthorizer mesh__D010836 PLS
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010836 2003
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010836 1997
% 219.04/219.21  |- mesh__dateCreated mesh__D010836 1999-01-01
% 219.04/219.21  |- mesh__recordOriginator mesh__D010836 NLM
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010836 2005
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010836 1999
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010836 2004
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010836 1994
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010836 2002
% 219.04/219.21  |- skos__prefLabel mesh__D010836 Phytol
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010836 2006
% 219.04/219.21  |- mesh__onlineNote mesh__D010836 search TERPENES 1968-74   
% 219.04/219.21  |- mesh__dateEstablished mesh__D010836 1991-01-01
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010836 1993
% 219.04/219.21  |- skos__broader mesh__D010836smesh__D004224
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010836 1995
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D029541 2004
% 219.04/219.21  |- mesh__historyNote mesh__D029541 2002   
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D029541 2005
% 219.04/219.21  |- mesh__dateCreated mesh__D029541 2001-07-25
% 219.04/219.21  |- mesh__recordOriginator mesh__D029541 ssb
% 219.04/219.21  |- skos__annotation mesh__D029541
% 219.04/219.21       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.04/219.21  |- skos__broader mesh__D029541smesh__D019684
% 219.04/219.21  |- skos__scopeNote mesh__D029541
% 219.04/219.21       A plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida.  They have leaflike appendages at the base of the leafstalks, have terminal flower clusters. Petals have four or five overlapping lobes and the fruit is a capsule containing winged or wingless seeds.%A%    
% 219.04/219.21  |- mesh__recordAuthorizer mesh__D029541 sjn
% 219.04/219.21  |- mesh__recordMaintainer mesh__D029541 ssb
% 219.04/219.21  |- mesh__dateRevised mesh__D029541 2003-07-09
% 219.04/219.21  |- skos__prefLabel mesh__D029541 Loganiaceae
% 219.04/219.21  |- mesh__dateEstablished mesh__D029541 2002-01-01
% 219.04/219.21  |- mesh__publicMeSHNote mesh__D029541 2002   
% 219.04/219.21  |- rdf__type mesh__D029541sskos__Concept
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D029541 2006
% 219.04/219.21  |- skos__hiddenLabel mesh__D010038 Diseases, Otorhinolaryngologic
% 219.04/219.21  |- skos__related mesh__D010038smesh__D004427
% 219.04/219.21  |- mesh__recordOriginator mesh__D010038 NLM
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010038 2001
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010038 1995
% 219.04/219.21  |- mesh__runningHead mesh__D010038 C9 - DISEASES-OTORHINOLARYNGOLOGIC   
% 219.04/219.21  |- mesh__recordAuthorizer mesh__D010038 PLS
% 219.04/219.21  |- skos__hiddenLabel mesh__D010038 Disease, Otorhinolaryngological
% 219.04/219.21  |- mesh__recordMaintainer mesh__D010038 TGC
% 219.04/219.21  |- skos__annotation mesh__D010038
% 219.04/219.21       GEN: prefer specific precoord; DF: ORL DIS   
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010038 2006
% 219.04/219.21  |- mesh__dateCreated mesh__D010038 1999-01-01
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010038 2000
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010038 1999
% 219.04/219.21  |- skos__related mesh__D010038smesh__D009668
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010038 1994
% 219.04/219.21  |- skos__related mesh__D010038smesh__D007818
% 219.04/219.21  |- skos__hiddenLabel mesh__D010038 Otorhinolaryngological Diseases
% 219.04/219.21  |- skos__hiddenLabel mesh__D010038 Diseases, Otorhinolaryngological
% 219.04/219.21  |- rdf__type mesh__D010038sskos__Concept
% 219.04/219.21  |- skos__related mesh__D010038smesh__D010608
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010038 2005
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010038 1993
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010038 1998
% 219.04/219.21  |- mesh__dateEstablished mesh__D010038 1966-01-01
% 219.04/219.21  |- skos__altLabel mesh__D010038 Otorhinolaryngological Disease
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010038 2004
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010038 1992
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010038 1997
% 219.04/219.21  |- skos__hiddenLabel mesh__D010038 Disease, Otorhinolaryngologic
% 219.04/219.21  |- mesh__dateRevised mesh__D010038 1991-08-23
% 219.04/219.21  |- skos__altLabel mesh__D010038 Otorhinolaryngologic Disease
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010038 2003
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010038 1996
% 219.04/219.21  |- mesh__historyNote mesh__D010038 66   
% 219.04/219.21  |- mesh__publicMeSHNote mesh__D010038 66   
% 219.04/219.21  |- skos__prefLabel mesh__D010038 Otorhinolaryngologic Diseases
% 219.04/219.21  |- skos__scopeNote mesh__D010038
% 219.04/219.21       General or unspecified diseases of the ear, nose, and throat.%A%    
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D010038 2002
% 219.04/219.21  |- skos__scopeNote mesh__D015521
% 219.04/219.21       Inflammation of the ethmoid sinus. It may present itself as an acute %28%associated with viral rhinitis%29% or chronic %28%associated with allergic or hyperplastic sinusitis%29% condition.%A%    
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D015521 1996
% 219.04/219.21  |- mesh__recordMaintainer mesh__D015521 PXP
% 219.04/219.21  |- skos__prefLabel mesh__D015521 Ethmoid Sinusitis
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D015521 1998
% 219.04/219.21  |- mesh__dateEstablished mesh__D015521 1990-01-01
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D015521 1997
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D015521 2002
% 219.04/219.21  |- rdf__type mesh__D015521sskos__Concept
% 219.04/219.21  |- mesh__dateCreated mesh__D015521 1989-04-07
% 219.04/219.21  |- skos__hiddenLabel mesh__D015521 Ethmoidal Sinusitides
% 219.04/219.21  |- mesh__publicMeSHNote mesh__D015521 90   
% 219.04/219.21  |- skos__hiddenLabel mesh__D015521 Ethmoid Sinusitides
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D015521 1999
% 219.04/219.21  |- mesh__dateRevised mesh__D015521 1994-05-12
% 219.04/219.21  |- mesh__recordAuthorizer mesh__D015521 PLS
% 219.04/219.21  |- skos__historyNote mesh__D015521 Sinusitis %28%1966-1989%29%
% 219.04/219.21  |- skos__hiddenLabel mesh__D015521 Sinusitides, Ethmoid
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D015521 2003
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D015521 1995
% 219.04/219.21  |- skos__hiddenLabel mesh__D015521 Sinusitides, Ethmoidal
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D015521 2005
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D015521 2004
% 219.04/219.21  |- mesh__historyNote mesh__D015521 90   
% 219.04/219.21  |- skos__broader mesh__D015521smesh__D012852
% 219.04/219.21  |- skos__altLabel mesh__D015521 Sinusitis, Ethmoid
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D015521 2006
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D015521 2000
% 219.04/219.21  |- skos__altLabel mesh__D015521 Ethmoidal Sinusitis
% 219.04/219.21  |- mesh__recordOriginator mesh__D015521 PXP
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D015521 2001
% 219.04/219.21  |- skos__hiddenLabel mesh__D015521 Sinusitis, Ethmoidal
% 219.04/219.21  |- mesh__recordMaintainer mesh__D001501 SYSTEM
% 219.04/219.21  |- mesh__publicMeSHNote mesh__D001501 77   
% 219.04/219.21  |- skos__broader mesh__D001501smesh__D020564
% 219.04/219.21  |- mesh__recordAuthorizer mesh__D001501 sjn
% 219.04/219.21  |- skos__prefLabel mesh__D001501 Bdellovibrio
% 219.04/219.21  |- skos__broader mesh__D001501smesh__D016946
% 219.04/219.21  |- mesh__historyNote mesh__D001501 77   
% 219.04/219.21  |- mesh__recordOriginator mesh__D001501 FPG
% 219.04/219.21  |- mesh__dateRevised mesh__D001501 2005-06-30
% 219.04/219.21  |- skos__historyNote mesh__D001501 Bacteria %28%1966-1976%29%
% 219.04/219.21  |- mesh__activeMeSHYear mesh__D001501 2006
% 219.04/219.21  |- mesh__dateCreated mesh__D001501 1976-04-16
% 219.04/219.22  |- skos__scopeNote mesh__D001501
% 219.04/219.22       A genus of bacteria capable of developing within other bacteria.%A%    
% 219.04/219.22  |- rdf__type mesh__D001501sskos__Concept
% 219.04/219.22  |- mesh__dateEstablished mesh__D001501 1977-01-01
% 219.04/219.22  |- skos__scopeNote mesh__D006795
% 219.04/219.22       Substances or materials used in the course of housekeeping or personal routine.%A%    
% 219.04/219.22  |- mesh__publicMeSHNote mesh__D006795 75   
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D006795 2003
% 219.04/219.22  |- skos__annotation mesh__D006795
% 219.04/219.22       these are consumable %28%like housecleaning products%29%: differentiate from HOUSEHOLD ARTICLES, more or less permanent %28%like rugs%29%%A%  
% 219.04/219.22  |- mesh__dateEstablished mesh__D006795 1975-01-01
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D006795 2000
% 219.04/219.22  |- mesh__historyNote mesh__D006795 75   
% 219.04/219.22  |- skos__broader mesh__D006795smesh__D013676
% 219.04/219.22  |- rdf__type mesh__D006795sskos__Concept
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D006795 2002
% 219.04/219.22  |- skos__hiddenLabel mesh__D006795 Products, Household
% 219.04/219.22  |- skos__hiddenLabel mesh__D006795 Household Product
% 219.04/219.22  |- skos__hiddenLabel mesh__D006795 Product, Household
% 219.04/219.22  |- mesh__dateCreated mesh__D006795 1999-01-01
% 219.04/219.22  |- mesh__recordAuthorizer mesh__D006795 NLM
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D006795 1999
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D006795 2006
% 219.04/219.22  |- skos__hiddenLabel mesh__D006795 Supplies, Household
% 219.04/219.22  |- skos__altLabel mesh__D006795 Household Supplies
% 219.04/219.22  |- mesh__recordMaintainer mesh__D006795 PLS
% 219.04/219.22  |- mesh__dateRevised mesh__D006795 1997-01-10
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D006795 1998
% 219.04/219.22  |- mesh__recordOriginator mesh__D006795 NLM
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D006795 2005
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D006795 2004
% 219.04/219.22  |- skos__prefLabel mesh__D006795 Household Products
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D006795 2001
% 219.04/219.22  |- skos__related mesh__D020466smesh__D020495
% 219.04/219.22  |- rdf__type mesh__D020466sskos__Concept
% 219.04/219.22  |- skos__related mesh__D020466smesh__D020468
% 219.04/219.22  |- mesh__dateCreated mesh__D020466 1998-06-03
% 219.04/219.22  |- skos__related mesh__D020466smesh__D020472
% 219.04/219.22  |- mesh__historyNote mesh__D020466 1999   
% 219.04/219.22  |- skos__prefLabel mesh__D020466 Atlases %5B%Publication Type%5D%
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D020466 2006
% 219.04/219.22  |- mesh__dateEstablished mesh__D020466 1999-01-01
% 219.04/219.22  |- skos__annotation mesh__D020466
% 219.04/219.22       CATALOG: Use for collections of illustrative plates, charts, etc. and for items in which there are both illustrations and text, even when the text predominates, when the purpose of the text is to explain the illustrations.  Do not use for geographic atlases or maps.  Use instead the publication type MAPS.%A%  
% 219.04/219.22  |- mesh__recordAuthorizer mesh__D020466 sjn
% 219.04/219.22  |- mesh__recordOriginator mesh__D020466 JLS
% 219.04/219.22  |- mesh__recordMaintainer mesh__D020466 jls
% 219.04/219.22  |- skos__altLabel mesh__D020466 Atlases %28%PT%29%
% 219.04/219.22  |- mesh__dateRevised mesh__D020466 2005-06-30
% 219.04/219.22  |- skos__broader mesh__D020466smesh__D052180
% 219.04/219.22  |- skos__scopeNote mesh__D020466
% 219.04/219.22       Works consisting of collections of illustrative plates, charts, etc., usually with explanatory captions.%A%    
% 219.04/219.22  |- skos__related mesh__D020466smesh__D019532
% 219.04/219.22  |- skos__scopeNote mesh__D014429
% 219.04/219.22       Two offspring from the same PREGNANCY. They are from two OVA, fertilized at about the same time by two SPERMATOZOA. Such twins are genetically distinct and can be of different sexes.%A%    
% 219.04/219.22  |- mesh__publicMeSHNote mesh__D014429 91; was see under TWINS 1975-90   
% 219.04/219.22  |- skos__hiddenLabel mesh__D014429 Dizygotic Twins
% 219.04/219.22  |- mesh__recordOriginator mesh__D014429 NLM
% 219.04/219.22  |- mesh__recordMaintainer mesh__D014429 lkt
% 219.04/219.22  |- mesh__dateCreated mesh__D014429 1974-12-12
% 219.04/219.22  |- skos__hiddenLabel mesh__D014429 Dizygotic Twin
% 219.04/219.22  |- mesh__recordAuthorizer mesh__D014429 sjn
% 219.04/219.22  |- skos__broader mesh__D014429smesh__D014427
% 219.04/219.22  |- mesh__historyNote mesh__D014429
% 219.04/219.22       91%28%75%29%; was see under TWINS 1975-90   
% 219.04/219.22  |- skos__hiddenLabel mesh__D014429 Fraternal Twins
% 219.04/219.22  |- skos__hiddenLabel mesh__D014429 Fraternal Twin
% 219.04/219.22  |- mesh__dateEstablished mesh__D014429 1991-01-01
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D014429 2005
% 219.04/219.22  |- skos__hiddenLabel mesh__D014429 Twin, Fraternal
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D014429 2006
% 219.04/219.22  |- skos__hiddenLabel mesh__D014429 Twin, Dizygotic
% 219.04/219.22  |- mesh__dateRevised mesh__D014429 2004-07-07
% 219.04/219.22  |- skos__altLabel mesh__D014429 Twins, Fraternal
% 219.04/219.22  |- rdf__type mesh__D014429sskos__Concept
% 219.04/219.22  |- skos__prefLabel mesh__D014429 Twins, Dizygotic
% 219.04/219.22  |- skos__historyNote mesh__D019912 Mycobacterium %28%1970-1990%29%
% 219.04/219.22  |- mesh__historyNote mesh__D019912 98   
% 219.04/219.22  |- mesh__dateEstablished mesh__D019912 1998-01-01
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D019912 2006
% 219.04/219.22  |- mesh__recordOriginator mesh__D019912 PXP
% 219.04/219.22  |- mesh__recordMaintainer mesh__D019912 SYSTEM
% 219.04/219.22  |- mesh__publicMeSHNote mesh__D019912 98   
% 219.04/219.22  |- skos__annotation mesh__D019912
% 219.04/219.22       infection: coord IM with MYCOBACTERIUM INFECTIONS, ATYPICAL %28%IM%29%; DF: MYCOBACT XENOPI%A%  
% 219.04/219.22  |- skos__scopeNote mesh__D019912
% 219.04/219.22       A slow-growing, scotochromogenic species occurring usually harmlessly in human secretions but occasionally associated with chronic pulmonary disease. %28%Dorland, 28th ed%29%%A%    
% 219.04/219.22  |- rdf__type mesh__D019912sskos__Concept
% 219.04/219.22  |- mesh__recordAuthorizer mesh__D019912 sjn
% 219.04/219.22  |- skos__broader mesh__D019912smesh__D009170
% 219.04/219.22  |- skos__historyNote mesh__D019912
% 219.04/219.22       Mycobacterium, Atypical %28%1977-1997%29%
% 219.04/219.22  |- skos__prefLabel mesh__D019912 Mycobacterium xenopi
% 219.04/219.22  |- mesh__dateRevised mesh__D019912 2005-06-30
% 219.04/219.22  |- mesh__dateCreated mesh__D019912 1997-06-20
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D019114 2005
% 219.04/219.22  |- mesh__historyNote mesh__D019114 96   
% 219.04/219.22  |- skos__hiddenLabel mesh__D019114 Teleconsultations
% 219.04/219.22  |- skos__annotation mesh__D019114
% 219.04/219.22       %22%consult via remote telecommun%22%; usually diag %26% ther but not restricted to med%A%  
% 219.04/219.22  |- skos__historyNote mesh__D019114 Telemedicine %28%1993-1995%29%
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D019114 2000
% 219.04/219.22  |- skos__broader mesh__D019114smesh__D017216
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D019114 2004
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D019114 1999
% 219.04/219.22  |- skos__altLabel mesh__D019114 Consultation, Remote
% 219.04/219.22  |- skos__prefLabel mesh__D019114 Remote Consultation
% 219.04/219.22  |- skos__scopeNote mesh__D019114
% 219.04/219.22       Consultation via remote telecommunications, generally for the purpose of diagnosis or treatment of a patient at a site remote from the patient or primary physician.%A%    
% 219.04/219.22  |- mesh__dateCreated mesh__D019114 1995-06-05
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D019114 2003
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D019114 1998
% 219.04/219.22  |- mesh__publicMeSHNote mesh__D019114 96   
% 219.04/219.22  |- mesh__dateEstablished mesh__D019114 1996-01-01
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D019114 1997
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D019114 2002
% 219.04/219.22  |- skos__broader mesh__D019114smesh__D012017
% 219.04/219.22  |- skos__historyNote mesh__D019114
% 219.04/219.22       Referral and Consultation %28%1990-1992%29%
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D019114 2006
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D019114 1996
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D019114 2001
% 219.04/219.22  |- rdf__type mesh__D019114sskos__Concept
% 219.04/219.22  |- mesh__dateRevised mesh__D000409 2004-07-07
% 219.04/219.22  |- skos__hiddenLabel mesh__D000409 L-Isomer Alanine
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D000409 2006
% 219.04/219.22  |- skos__altLabel mesh__D000409 Doms-Adrian Brand of Alanine
% 219.04/219.22  |- skos__annotation mesh__D000409 BETA-ALANINE is also available   
% 219.04/219.22  |- mesh__recordMaintainer mesh__D000409 mdb
% 219.04/219.22  |- mesh__recordOriginator mesh__D000409 NLM
% 219.04/219.22  |- mesh__dateCreated mesh__D000409 1999-01-01
% 219.04/219.22  |- skos__hiddenLabel mesh__D000409 Alanine Doms-Adrian Brand
% 219.04/219.22  |- skos__hiddenLabel mesh__D000409 Alanine, L Isomer
% 219.04/219.22  |- skos__scopeNote mesh__D000409
% 219.04/219.22       A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.%A%    
% 219.04/219.22  |- skos__altLabel mesh__D000409 L-Alanine
% 219.04/219.22  |- skos__altLabel mesh__D000409 Alanine, L-Isomer
% 219.04/219.22  |- skos__hiddenLabel mesh__D000409 Doms Adrian Brand of Alanine
% 219.04/219.22  |- skos__hiddenLabel mesh__D000409 L Alanine
% 219.04/219.22  |- skos__broader mesh__D000409smesh__D000596
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D000409 2005
% 219.04/219.22  |- skos__prefLabel mesh__D000409 Alanine
% 219.04/219.22  |- mesh__recordAuthorizer mesh__D000409 sjn
% 219.04/219.22  |- rdf__type mesh__D000409sskos__Concept
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D011131 2003
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D011131 2001
% 219.04/219.22  |- skos__prefLabel mesh__D011131 Polyribonucleotides
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D011131 1997
% 219.04/219.22  |- skos__historyNote mesh__D011131 Polynucleotides %28%1966-1975%29%
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D011131 2006
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D011131 1996
% 219.04/219.22  |- mesh__recordMaintainer mesh__D011131 TGC
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D011131 1993
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D011131 2005
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D011131 2000
% 219.04/219.22  |- skos__scopeNote mesh__D011131
% 219.04/219.22       A group of 13 or more ribonucleotides in which the phosphate residues of each ribonucleotide act as bridges in forming diester linkages between the ribose moieties.%A%    
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D011131 1999
% 219.04/219.22  |- skos__annotation mesh__D011131 13 or more nucleotides   
% 219.04/219.22  |- mesh__publicMeSHNote mesh__D011131 76   
% 219.04/219.22  |- mesh__dateEstablished mesh__D011131 1976-01-01
% 219.04/219.22  |- rdf__type mesh__D011131sskos__Concept
% 219.04/219.22  |- mesh__historyNote mesh__D011131 76   
% 219.04/219.22  |- mesh__recordOriginator mesh__D011131 RLS
% 219.04/219.22  |- skos__broader mesh__D011131smesh__D011119
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D011131 1995
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D011131 1998
% 219.04/219.22  |- mesh__dateRevised mesh__D011131 1992-05-20
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D011131 2002
% 219.04/219.22  |- mesh__dateCreated mesh__D011131 1975-07-25
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D011131 1994
% 219.04/219.22  |- mesh__recordAuthorizer mesh__D011131 PLS
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D011131 2004
% 219.04/219.22  |- skos__broader mesh__D003813Q000941smesh__D003813
% 219.04/219.22  |- mesh__preferredCombination mesh__D003813Q000941smesh__D004990
% 219.04/219.22  |- rdf__type mesh__D003813Q000941smesh__CompoundConcept
% 219.04/219.22  |- skos__altLabel mesh__D010837 Phytonadione
% 219.04/219.22  |- skos__annotation mesh__D010837
% 219.04/219.22       deficiency: coordinate VITAMIN K 1 %28%IM%29% with VITAMIN K DEFICIENCY %28%IM%29%%A%  
% 219.04/219.22  |- mesh__recordAuthorizer mesh__D010837 sjn
% 219.04/219.22  |- rdf__type mesh__D010837sskos__Concept
% 219.04/219.22  |- mesh__dateCreated mesh__D010837 1999-01-01
% 219.04/219.22  |- skos__broader mesh__D010837smesh__D009285
% 219.04/219.22  |- skos__scopeNote mesh__D010837
% 219.04/219.22       A family of phylloquinones that contains a ring of 2-methyl-1,4-naphthoquinone and an isoprenoid side chain. Members of this group of vitamin K 1 have only one double bond on the proximal isoprene unit. Rich sources of vitamin K 1 include green plants, algae, and photosynthetic bacteria. Vitamin K1 has antihemorrhagic and prothrombogenic activity.%A%    
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D010837 2006
% 219.04/219.22  |- mesh__dateRevised mesh__D010837 2005-06-30
% 219.04/219.22  |- skos__prefLabel mesh__D010837 Vitamin K 1
% 219.04/219.22  |- skos__altLabel mesh__D010837 Phylloquinone
% 219.04/219.22  |- mesh__recordMaintainer mesh__D010837 ssb
% 219.04/219.22  |- mesh__recordOriginator mesh__D010837 NLM
% 219.04/219.22  |- mesh__publicMeSHNote mesh__D010837 see PHYTONADIONE 1964-2001   
% 219.04/219.22  |- mesh__historyNote mesh__D010837 use PHYTONADIONE 1964-2001   
% 219.04/219.22  |- skos__historyNote mesh__D010837 Phytonadione %28%1964-2001%29%
% 219.04/219.22  |- skos__altLabel mesh__D010837 Phytomenadione
% 219.04/219.22  |- skos__broader mesh__D010837smesh__D014812
% 219.04/219.22  |- skos__altLabel mesh__D010837 Vitamin K1
% 219.04/219.22  |- mesh__recordMaintainer mesh__D029542 sjn
% 219.04/219.22  |- mesh__recordOriginator mesh__D029542 ssb
% 219.04/219.22  |- mesh__historyNote mesh__D029542 2002   
% 219.04/219.22  |- skos__altLabel mesh__D029542 Moss, Club
% 219.04/219.22  |- mesh__dateCreated mesh__D029542 2001-07-25
% 219.04/219.22  |- skos__altLabel mesh__D029542 Clubmoss
% 219.04/219.22  |- mesh__publicMeSHNote mesh__D029542 2002   
% 219.04/219.22  |- mesh__dateEstablished mesh__D029542 2002-01-01
% 219.04/219.22  |- skos__broader mesh__D029542smesh__D019669
% 219.04/219.22  |- rdf__type mesh__D029542sskos__Concept
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D029542 2006
% 219.04/219.22  |- skos__prefLabel mesh__D029542 Lycopodiaceae
% 219.04/219.22  |- skos__scopeNote mesh__D029542
% 219.04/219.22       The club-moss plant family of the order Lycopodiales, class Lycopodiopsida, division Lycopodiophyta, subkingdom Tracheobionta. The common name of clubmoss applies to several genera of this family.  Despite the name this is not one of the true mosses %28%BRYOPSIDA %29%.%A%    
% 219.04/219.22  |- mesh__recordAuthorizer mesh__D029542 sjn
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D029542 2005
% 219.04/219.22  |- skos__annotation mesh__D029542
% 219.04/219.22       do not confuse with the true MOSSES; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D029542 2004
% 219.04/219.22  |- mesh__dateRevised mesh__D029542 2003-07-30
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D010039 2006
% 219.04/219.22  |- mesh__dateCreated mesh__D010039 1999-01-01
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D010039 1999
% 219.04/219.22  |- mesh__historyNote mesh__D010039 84; was NON MESH before 1984   
% 219.04/219.22  |- mesh__dateEstablished mesh__D010039 1984-01-01
% 219.04/219.22  |- skos__altLabel mesh__D010039 Otorhinolaryngological Neoplasms
% 219.04/219.22  |- skos__prefLabel mesh__D010039 Otorhinolaryngologic Neoplasms
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D010039 2002
% 219.04/219.22  |- skos__hiddenLabel mesh__D010039 Otorhinolaryngological Neoplasm
% 219.04/219.22  |- rdf__type mesh__D010039sskos__Concept
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D010039 2005
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D010039 1998
% 219.04/219.22  |- mesh__recordOriginator mesh__D010039 NLM
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D010039 2001
% 219.04/219.22  |- mesh__dateRevised mesh__D010039 1995-06-08
% 219.04/219.22  |- skos__historyNote mesh__D010039
% 219.04/219.22       Otorhinolaryngological Diseases %28%1966-1983%29%
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D010039 2004
% 219.04/219.22  |- mesh__recordAuthorizer mesh__D010039 PLS
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D010039 1997
% 219.04/219.22  |- skos__broader mesh__D010039smesh__D010038
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D010039 2000
% 219.04/219.22  |- skos__broader mesh__D010039smesh__D006258
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D010039 2003
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D010039 1996
% 219.04/219.22  |- skos__scopeNote mesh__D010039
% 219.04/219.22       The general concept of ORL neoplasms or those for which no specific heading exists.%A%    
% 219.04/219.22  |- skos__historyNote mesh__D010039 Neoplasms %28%1966-1983%29%
% 219.04/219.22  |- skos__hiddenLabel mesh__D010039 Neoplasm, Otorhinolaryngological
% 219.04/219.22  |- skos__altLabel mesh__D010039 Otorhinolaryngologic Neoplasm
% 219.04/219.22  |- skos__altLabel mesh__D010039 Neoplasms, Otorhinolaryngologic
% 219.04/219.22  |- mesh__recordMaintainer mesh__D010039 KEV
% 219.04/219.22  |- mesh__publicMeSHNote mesh__D010039 84   
% 219.04/219.22  |- skos__annotation mesh__D010039
% 219.04/219.22       GEN: prefer specific precoord; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%; DF: ORL NEOPL%A%  
% 219.04/219.22  |- skos__hiddenLabel mesh__D010039 Neoplasm, Otorhinolaryngologic
% 219.04/219.22  |- skos__altLabel mesh__D010039 Neoplasms, Otorhinolaryngological
% 219.04/219.22  |- rdf__type mesh__D007090sskos__Concept
% 219.04/219.22  |- mesh__dateRevised mesh__D007090 2004-07-07
% 219.04/219.22  |- mesh__publicMeSHNote mesh__D007090 87   
% 219.04/219.22  |- mesh__historyNote mesh__D007090 87   
% 219.04/219.22  |- skos__annotation mesh__D007090 DF: IMAGE INTERP   
% 219.04/219.22  |- mesh__recordOriginator mesh__D007090 EC
% 219.04/219.22  |- mesh__dateCreated mesh__D007090 1986-06-17
% 219.04/219.22  |- skos__broader mesh__D007090smesh__D003936
% 219.04/219.22  |- mesh__dateEstablished mesh__D007090 1987-01-01
% 219.04/219.22  |- skos__altLabel mesh__D007090 Image Interpretation, Computer Assisted
% 219.04/219.22  |- skos__scopeNote mesh__D007090
% 219.04/219.22       Methods developed to aid in the interpretation of ultrasound, radiographic images, etc., for diagnosis of disease.%A%    
% 219.04/219.22  |- skos__hiddenLabel mesh__D007090 Image Interpretations, Computer-Assisted
% 219.04/219.22  |- skos__prefLabel mesh__D007090 Image Interpretation, Computer-Assisted
% 219.04/219.22  |- skos__broader mesh__D007090smesh__D003952
% 219.04/219.22  |- mesh__recordMaintainer mesh__D007090 ags
% 219.04/219.22  |- skos__hiddenLabel mesh__D007090 Computer-Assisted Image Interpretation
% 219.04/219.22  |- skos__hiddenLabel mesh__D007090 Computer-Assisted Image Interpretations
% 219.04/219.22  |- skos__hiddenLabel mesh__D007090 Interpretations, Computer-Assisted Image
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D007090 2005
% 219.04/219.22  |- skos__hiddenLabel mesh__D007090 Interpretation, Computer-Assisted Image
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D007090 2006
% 219.04/219.22  |- mesh__recordAuthorizer mesh__D007090 sjn
% 219.04/219.22  |- mesh__dateRevised mesh__D015522 1994-05-12
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D015522 2002
% 219.04/219.22  |- skos__hiddenLabel mesh__D015522 Frontal Sinusitides
% 219.04/219.22  |- skos__prefLabel mesh__D015522 Frontal Sinusitis
% 219.04/219.22  |- mesh__recordMaintainer mesh__D015522 PXP
% 219.04/219.22  |- mesh__publicMeSHNote mesh__D015522 90   
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D015522 2005
% 219.04/219.22  |- mesh__dateCreated mesh__D015522 1989-06-21
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D015522 1997
% 219.04/219.22  |- skos__broader mesh__D015522smesh__D012852
% 219.04/219.22  |- mesh__dateEstablished mesh__D015522 1990-01-01
% 219.04/219.22  |- skos__hiddenLabel mesh__D015522 Sinusitides, Frontal
% 219.04/219.22  |- mesh__recordAuthorizer mesh__D015522 PLS
% 219.04/219.22  |- mesh__historyNote mesh__D015522 90   
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D015522 1996
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D015522 2001
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D015522 1999
% 219.04/219.22  |- rdf__type mesh__D015522sskos__Concept
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D015522 2004
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D015522 2000
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D015522 1995
% 219.04/219.22  |- skos__historyNote mesh__D015522 Sinusitis %28%1966-1989%29%
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D015522 1998
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D015522 2003
% 219.04/219.22  |- skos__scopeNote mesh__D015522
% 219.04/219.22       Inflammation of the frontal sinus; in most cases the infection is caused by the bacteria STREPTOCOCCUS PNEUMONIAE and HAEMOPHILUS INFLUENZAE. This condition may be acute or chronic.%A%    
% 219.04/219.22  |- mesh__recordOriginator mesh__D015522 PXP
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D015522 2006
% 219.04/219.22  |- skos__altLabel mesh__D015522 Sinusitis, Frontal
% 219.04/219.22  |- skos__prefLabel mesh__D001502 Beak
% 219.04/219.22  |- mesh__recordOriginator mesh__D001502 NLM
% 219.04/219.22  |- skos__hiddenLabel mesh__D001502 Beaks
% 219.04/219.22  |- skos__hiddenLabel mesh__D001502 Avian Bills
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D001502 2005
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D001502 2000
% 219.04/219.22  |- skos__broader mesh__D001502smesh__D000825
% 219.04/219.22  |- skos__hiddenLabel mesh__D001502 Avian Bill
% 219.04/219.22  |- mesh__dateCreated mesh__D001502 1999-01-01
% 219.04/219.22  |- skos__scopeNote mesh__D001502
% 219.04/219.22       In some animals, the jaws together with their horny covering. The beak usually refers to the bill of birds in which the whole varies greatly in form according of the food and habits of the bird. While the beak refers most commonly to birds, the anatomical counterpart is found also in the turtle, squid, and octopus. %28%From Webster, 3d ed %26% Storer, et al., General Zoology, 6th ed, p491, 755%29%%A%    
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D001502 2006
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D001502 2001
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D001502 1998
% 219.04/219.22  |- mesh__publicMeSHNote mesh__D001502 68   
% 219.04/219.22  |- rdf__type mesh__D001502sskos__Concept
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D001502 2003
% 219.04/219.22  |- skos__historyNote mesh__D001502 Birds %28%1966-1967%29%
% 219.04/219.22  |- skos__hiddenLabel mesh__D001502 Bills, Avian
% 219.04/219.22  |- mesh__recordAuthorizer mesh__D001502 PLS
% 219.04/219.22  |- mesh__dateRevised mesh__D001502 1995-03-13
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D001502 1999
% 219.04/219.22  |- mesh__recordMaintainer mesh__D001502 TGC
% 219.04/219.22  |- skos__annotation mesh__D001502 not restricted to birds   
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D001502 2004
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D001502 1996
% 219.04/219.22  |- mesh__historyNote mesh__D001502 68   
% 219.04/219.22  |- mesh__dateEstablished mesh__D001502 1968-01-01
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D001502 2002
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D001502 1997
% 219.04/219.22  |- skos__scopeNote mesh__D006796 The care and management of property.     
% 219.04/219.22  |- skos__prefLabel mesh__D006796 Housekeeping
% 219.04/219.22  |- mesh__dateEstablished mesh__D006796 1973-01-01
% 219.04/219.22  |- mesh__recordOriginator mesh__D006796 NLM
% 219.04/219.22  |- mesh__historyNote mesh__D006796 73   
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D006796 2001
% 219.04/219.22  |- mesh__publicMeSHNote mesh__D006796 73   
% 219.04/219.22  |- rdf__type mesh__D006796sskos__Concept
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D006796 2000
% 219.04/219.22  |- mesh__dateCreated mesh__D006796 1999-01-01
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D006796 1999
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D006796 2006
% 219.04/219.22  |- skos__altLabel mesh__D006796 Housework
% 219.04/219.22  |- mesh__recordAuthorizer mesh__D006796 PLS
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D006796 1998
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D006796 2005
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D006796 1997
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D006796 2004
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D006796 2002
% 219.04/219.22  |- skos__annotation mesh__D006796
% 219.04/219.22       not restricted to domestic housekeeping; HOUSEKEEPING, HOSPITAL is also available%A%  
% 219.04/219.22  |- skos__broader mesh__D006796smesh__D005159
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D006796 2003
% 219.04/219.22  |- mesh__dateRevised mesh__D006796 1996-06-10
% 219.04/219.22  |- mesh__recordMaintainer mesh__D006796 TGC
% 219.04/219.22  |- skos__related mesh__D020467smesh__D019215
% 219.04/219.22  |- skos__related mesh__D020467smesh__D016417
% 219.04/219.22  |- mesh__dateEstablished mesh__D020467 1999-01-01
% 219.04/219.22  |- skos__prefLabel mesh__D020467 Biobibliography %5B%Publication Type%5D%
% 219.04/219.22  |- skos__altLabel mesh__D020467 Biobibliography %28%PT%29%
% 219.04/219.22  |- mesh__recordMaintainer mesh__D020467 jls
% 219.04/219.22  |- rdf__type mesh__D020467sskos__Concept
% 219.04/219.22  |- skos__scopeNote mesh__D020467
% 219.04/219.22       Works consisting of biographical information as well as lists of the writings of those persons.%A%    
% 219.04/219.22  |- mesh__dateCreated mesh__D020467 1998-06-03
% 219.04/219.22  |- mesh__recordAuthorizer mesh__D020467 sjn
% 219.04/219.22  |- skos__annotation mesh__D020467
% 219.04/219.22       IM for biobibliography as a subject; biobibliography of a biographee  is indexed BIOBIBLIOGRAPHY %28%NIM%29% + BIOGRAPHY %5B%Publication Type%5D%; DF: BIOBIBLIOG or BIOBIBLIOGR%A%  
% 219.04/219.22  |- mesh__dateRevised mesh__D020467 2005-06-30
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D020467 2006
% 219.04/219.22  |- skos__broader mesh__D020467smesh__D016417
% 219.04/219.22  |- mesh__historyNote mesh__D020467 1999   
% 219.04/219.22  |- mesh__recordOriginator mesh__D020467 JLS
% 219.04/219.22  |- mesh__recordAuthorizer mesh__D019913 sjn
% 219.04/219.22  |- skos__hiddenLabel mesh__D019913 Signal, Nuclear Localization
% 219.04/219.22  |- skos__hiddenLabel mesh__D019913 Peptides, NLS
% 219.04/219.22  |- skos__hiddenLabel mesh__D019913 Peptide, NLS
% 219.04/219.22  |- mesh__dateRevised mesh__D019913 2005-06-30
% 219.04/219.22  |- mesh__dateCreated mesh__D019913 1997-06-20
% 219.04/219.22  |- mesh__recordOriginator mesh__D019913 NDW
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D019913 2006
% 219.04/219.22  |- skos__altLabel mesh__D019913 Nuclear Localization Signal
% 219.04/219.22  |- skos__broader mesh__D019913smesh__D021382
% 219.04/219.22  |- mesh__recordMaintainer mesh__D019913 nns
% 219.04/219.22  |- mesh__dateEstablished mesh__D019913 1998-01-01
% 219.04/219.22  |- rdf__type mesh__D019913sskos__Concept
% 219.04/219.22  |- mesh__publicMeSHNote mesh__D019913
% 219.04/219.22       1998; NUCLEAR LOCALIZATION SIGNAL PEPTIDE was indexed under NUCLEAR PROTEINS 1990-2000%A%  
% 219.04/219.22  |- mesh__historyNote mesh__D019913
% 219.04/219.22       1998; for NUCLEAR LOCALIZATION SIGNAL PEPTIDE use NUCLEAR LOCALIZATION SIGNAL %28%NM%29% 1990-2000%A%  
% 219.04/219.22  |- skos__hiddenLabel mesh__D019913 Signals, Nuclear Localization
% 219.04/219.22  |- skos__scopeNote mesh__D019913
% 219.04/219.22       Short, predominantly basic amino acid sequences identified as nuclear import signals for some proteins. These sequences are believed to interact with specific receptors at the NUCLEAR PORE.%A%    
% 219.04/219.22  |- skos__related mesh__D019913smesh__D021581
% 219.04/219.22  |- skos__hiddenLabel mesh__D019913 NLS Peptides
% 219.04/219.22  |- skos__altLabel mesh__D019913 Nuclear Localization Signal Peptide
% 219.04/219.22  |- skos__prefLabel mesh__D019913 Nuclear Localization Signals
% 219.04/219.22  |- skos__altLabel mesh__D019913 NLS Peptide
% 219.04/219.22  |- skos__annotation mesh__D011930 physiol processes only   
% 219.04/219.22  |- mesh__onlineNote mesh__D011930
% 219.04/219.22       use REACTION TIME to search RESPONSE LATENCY 1970-76   
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D011930 2003
% 219.04/219.22  |- mesh__dateCreated mesh__D011930 1999-01-01
% 219.04/219.22  |- skos__altLabel mesh__D011930 Response Time
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D011930 2006
% 219.04/219.22  |- mesh__activeMeSHYear mesh__D011930 2004
% 219.04/219.22  |- skos__hiddenLabel mesh__D011930 Response Times
% 219.04/219.22  |- skos__hiddenLabel mesh__D011930 Latencies, Response
% 219.04/219.22  |- mesh__recordOriginator mesh__D011930 NLM
% 219.04/219.22  |- rdf__type mesh__D011930sskos__Concept
% 219.04/219.22  |- skos__prefLabel mesh__D011930 Reaction Time
% 219.04/219.22  |- skos__hiddenLabel mesh__D011930 Response Latencies
% 219.04/219.22  |- skos__scopeNote mesh__D011930
% 219.04/219.22       The time from the onset of a stimulus until a response is observed.%A%    
% 219.04/219.22  |- mesh__recordAuthorizer mesh__D011930 sjn
% 219.04/219.22  |- skos__hiddenLabel mesh__D011930 Latency, Response
% 219.04/219.22  |- skos__hiddenLabel mesh__D011930 Time, Reaction
% 219.04/219.22  |- skos__broader mesh__D011930smesh__D011580
% 219.04/219.22  |- skos__hiddenLabel mesh__D011930 Times, Response
% 219.04/219.23  |- skos__broader mesh__D011930smesh__D009424
% 219.04/219.23  |- skos__hiddenLabel mesh__D011930 Times, Reaction
% 219.04/219.23  |- mesh__recordMaintainer mesh__D011930 nns
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D011930 2002
% 219.04/219.23  |- mesh__historyNote mesh__D011930
% 219.04/219.23       RESPONSE LATENCY was see under REACTION TIME 1970-76   
% 219.04/219.23  |- skos__broader mesh__D011930smesh__D011603
% 219.04/219.23  |- mesh__dateRevised mesh__D011930 2001-07-25
% 219.04/219.23  |- skos__hiddenLabel mesh__D011930 Time, Response
% 219.04/219.23  |- skos__hiddenLabel mesh__D011930 Reaction Times
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D011930 2005
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D019115 2004
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D019115 1999
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D019115 2001
% 219.04/219.23  |- skos__broader mesh__D019115smesh__D005208
% 219.04/219.23  |- skos__scopeNote mesh__D019115
% 219.04/219.23       A fulminating group A streptococcal infection beginning with severe or extensive cellulitis that spreads to involve the superficial and deep fascia, producing thrombosis of the subcutaneous vessels and gangrene of the underlying tissues. A cutaneous lesion usually serves as a portal of entry for the infection, but sometimes no such lesion is found. %28%Dorland, 28th ed%29%%A%    
% 219.04/219.23  |- mesh__dateCreated mesh__D019115 1995-06-05
% 219.04/219.23  |- skos__hiddenLabel mesh__D019115 Necrotizing Fascitides
% 219.04/219.23  |- skos__hiddenLabel mesh__D019115 Necrotizing Fasciitides
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D019115 2003
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D019115 1998
% 219.04/219.23  |- skos__prefLabel mesh__D019115 Fasciitis, Necrotizing
% 219.04/219.23  |- skos__historyNote mesh__D019115 Fascia %28%1969-1980%29%
% 219.04/219.23  |- skos__broader mesh__D019115smesh__D013290
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D019115 2000
% 219.04/219.23  |- skos__historyNote mesh__D019115 Fasciitis %28%1981-1995%29%
% 219.04/219.23  |- skos__annotation mesh__D019115
% 219.04/219.23       a fulminating Streptococcus pyogenes infect   
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D019115 1997
% 219.04/219.23  |- skos__hiddenLabel mesh__D019115 Necrotizing Fasciitis
% 219.04/219.23  |- skos__hiddenLabel mesh__D019115 Necrotizing Fascitis
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D019115 2006
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D019115 1996
% 219.04/219.23  |- mesh__publicMeSHNote mesh__D019115 96   
% 219.04/219.23  |- rdf__type mesh__D019115sskos__Concept
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D019115 2005
% 219.04/219.23  |- mesh__historyNote mesh__D019115 96   
% 219.04/219.23  |- mesh__dateEstablished mesh__D019115 1996-01-01
% 219.04/219.23  |- skos__historyNote mesh__D019115 Necrosis %28%1969-1995%29%
% 219.04/219.23  |- skos__hiddenLabel mesh__D019115 Fasciitides, Necrotizing
% 219.04/219.23  |- skos__altLabel mesh__D019115 Fascitis, Necrotizing
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D019115 2002
% 219.04/219.23  |- skos__hiddenLabel mesh__D019115 Fascitides, Necrotizing
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D011132 2005
% 219.04/219.23  |- skos__hiddenLabel mesh__D011132 Polyribosome
% 219.04/219.23  |- mesh__dateRevised mesh__D011132 2003-07-09
% 219.04/219.23  |- skos__annotation mesh__D011132
% 219.04/219.23       A 11 qualif except /cytol; /genet permitted   
% 219.04/219.23  |- skos__prefLabel mesh__D011132 Polyribosomes
% 219.04/219.23  |- rdf__type mesh__D011132sskos__Concept
% 219.04/219.23  |- skos__hiddenLabel mesh__D011132 Polysome
% 219.04/219.23  |- mesh__recordAuthorizer mesh__D011132 sjn
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D011132 2004
% 219.04/219.23  |- mesh__recordMaintainer mesh__D011132 nns
% 219.04/219.23  |- mesh__dateEstablished mesh__D011132 1973-01-01
% 219.04/219.23  |- mesh__dateCreated mesh__D011132 1999-01-01
% 219.04/219.23  |- skos__altLabel mesh__D011132 Polysomes
% 219.04/219.23  |- mesh__recordOriginator mesh__D011132 NLM
% 219.04/219.23  |- skos__broader mesh__D011132smesh__D012270
% 219.04/219.23  |- mesh__historyNote mesh__D011132 73   
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D011132 2006
% 219.04/219.23  |- skos__scopeNote mesh__D011132
% 219.04/219.23       A multiribosomal structure representing a linear array of RIBOSOMES held together by messenger RNA; %28%RNA, MESSENGER%29%; They represent the active complexes in cellular protein synthesis and are able to incorporate amino acids into polypeptides both in vivo and in vitro. %28%From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A%    
% 219.04/219.23  |- mesh__publicMeSHNote mesh__D011132 73   
% 219.04/219.23  |- skos__broader mesh__D010838smesh__D009868
% 219.04/219.23  |- mesh__dateRevised mesh__D010838 2005-06-30
% 219.04/219.23  |- mesh__publicMeSHNote mesh__D010838
% 219.04/219.23       91; was see under MASTIGOMYCOTINA 1986-90; was see under PHYCOMYCETES 1975-85%A%  
% 219.04/219.23  |- mesh__dateCreated mesh__D010838 1974-12-12
% 219.04/219.23  |- mesh__dateEstablished mesh__D010838 1991-01-01
% 219.04/219.23  |- mesh__recordOriginator mesh__D010838 NLM
% 219.04/219.23  |- skos__prefLabel mesh__D010838 Phytophthora
% 219.04/219.23  |- rdf__type mesh__D010838sskos__Concept
% 219.04/219.23  |- skos__hiddenLabel mesh__D010838 Phytophthoras
% 219.04/219.23  |- mesh__recordAuthorizer mesh__D010838 sjn
% 219.04/219.23  |- mesh__recordMaintainer mesh__D010838 SYSTEM
% 219.04/219.23  |- mesh__historyNote mesh__D010838
% 219.04/219.23       91%28%75%29%; was see under MASTIGOMYCOTINA 1986-90; was see under PHYCOMYCETES 1975-85%A%  
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D010838 2006
% 219.04/219.23  |- skos__annotation mesh__D010838
% 219.04/219.23       an alga belonging to the group OOMYCETES   
% 219.04/219.23  |- skos__scopeNote mesh__D010838
% 219.04/219.23       A genus of destructive parasitic algae in the family Pythiaceae, order Peronosporales, affecting numerous fruit, vegetable, and other crops. Differentiation of zoospores usually takes place in the sporangium and no vesicle is formed.%A%    
% 219.04/219.23  |- skos__scopeNote mesh__D029543
% 219.04/219.23       Proteins involved in the process of transporting molecules in and out the cell nucleus. Included here are: NUCLEOPORINS, which are membrane proteins that form the NUCLEAR PORE COMPLEX; KARYOPHERINS, which carry molecules through the nuclear pore complex; and proteins that play a direct role in the transport of karyopherin complexes through the nuclear pore complex.%A%    
% 219.04/219.23  |- mesh__publicMeSHNote mesh__D029543 2002   
% 219.04/219.23  |- mesh__dateRevised mesh__D029543 2005-06-30
% 219.04/219.23  |- mesh__recordOriginator mesh__D029543 jmp
% 219.04/219.23  |- mesh__recordAuthorizer mesh__D029543 sjn
% 219.04/219.23  |- rdf__type mesh__D029543sskos__Concept
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D029543 2006
% 219.04/219.23  |- mesh__dateEstablished mesh__D029543 2002-01-01
% 219.04/219.23  |- mesh__recordMaintainer mesh__D029543 SYSTEM
% 219.04/219.23  |- skos__related mesh__D029543smesh__D021581
% 219.04/219.23  |- mesh__dateCreated mesh__D029543 2001-08-03
% 219.04/219.23  |- skos__broader mesh__D029543smesh__D026901
% 219.04/219.23  |- skos__prefLabel mesh__D029543 Nucleocytoplasmic Transport Proteins
% 219.04/219.23  |- mesh__historyNote mesh__D029543 2002   
% 219.04/219.23  |- skos__historyNote mesh__D029543 Carrier Proteins %28%1980-2001%29%
% 219.04/219.23  |- skos__historyNote mesh__D029543 Nuclear Proteins %28%1980-2001%29%
% 219.04/219.23  |- skos__hiddenLabel mesh__D029543 Transport Proteins, Nucleocytoplasmic
% 219.04/219.23  |- skos__hiddenLabel mesh__D007091 Computer Assisted Image Processing
% 219.04/219.23  |- skos__hiddenLabel mesh__D007091 Reconstructions, Image
% 219.04/219.23  |- skos__hiddenLabel mesh__D007091 Image Analysis, Computer Assisted
% 219.04/219.23  |- mesh__recordAuthorizer mesh__D007091 sjn
% 219.04/219.23  |- skos__hiddenLabel mesh__D007091 Image Analyses, Computer-Assisted
% 219.04/219.23  |- skos__altLabel mesh__D007091 Computer-Assisted Image Analysis
% 219.04/219.23  |- mesh__dateRevised mesh__D007091 2004-07-13
% 219.04/219.23  |- skos__broader mesh__D007091smesh__D003205
% 219.04/219.23  |- mesh__publicMeSHNote mesh__D007091 87   
% 219.04/219.23  |- mesh__recordOriginator mesh__D007091 EC
% 219.04/219.23  |- mesh__recordMaintainer mesh__D007091 sjn
% 219.04/219.23  |- mesh__dateEstablished mesh__D007091 1987-01-01
% 219.04/219.23  |- skos__hiddenLabel mesh__D007091 Image Processing, Computer Assisted
% 219.04/219.23  |- skos__hiddenLabel mesh__D007091 Reconstruction, Image
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007091 2005
% 219.04/219.23  |- skos__altLabel mesh__D007091 Computer-Assisted Image Processing
% 219.04/219.23  |- skos__scopeNote mesh__D007091
% 219.04/219.23       A technique of inputting two-dimensional images into a computer and then enhancing or analyzing the imagery into a form that is more useful to the human observer.%A%    
% 219.04/219.23  |- skos__altLabel mesh__D007091 Analysis, Computer-Assisted Image
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007091 2006
% 219.04/219.23  |- skos__hiddenLabel mesh__D007091 Computer-Assisted Image Analyses
% 219.04/219.23  |- rdf__type mesh__D007091sskos__Concept
% 219.04/219.23  |- skos__annotation mesh__D007091
% 219.04/219.23       image analysis for diagnostic purposes is IMAGE INTERPRETATION, COMPUTER-ASSISTED%A%  
% 219.04/219.23  |- mesh__dateCreated mesh__D007091 1986-06-18
% 219.04/219.23  |- skos__hiddenLabel mesh__D007091 Image Reconstructions
% 219.04/219.23  |- mesh__historyNote mesh__D007091 87   
% 219.04/219.23  |- skos__hiddenLabel mesh__D007091 Computer Assisted Image Analysis
% 219.04/219.23  |- skos__prefLabel mesh__D007091 Image Processing, Computer-Assisted
% 219.04/219.23  |- skos__hiddenLabel mesh__D015523 Maxillary Sinusitides
% 219.04/219.23  |- mesh__dateEstablished mesh__D015523 1990-01-01
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D015523 2002
% 219.04/219.23  |- skos__hiddenLabel mesh__D015523 Sinusitides, Maxillary
% 219.04/219.23  |- mesh__recordAuthorizer mesh__D015523 sjn
% 219.04/219.23  |- rdf__type mesh__D015523sskos__Concept
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D015523 2004
% 219.04/219.23  |- skos__prefLabel mesh__D015523 Maxillary Sinusitis
% 219.04/219.23  |- skos__broader mesh__D015523smesh__D012852
% 219.04/219.23  |- mesh__recordMaintainer mesh__D015523 mdb
% 219.04/219.23  |- skos__historyNote mesh__D015523 Sinusitis %28%1966-1989%29%
% 219.04/219.23  |- skos__scopeNote mesh__D015523
% 219.04/219.23       Inflammation of the maxillary sinus. In most cases it is the result of infection by the bacteria HAEMOPHILUS INFLUENZAE; STREPTOCOCCUS PNEUMONIAE; and STAPHYLOCOCCUS AUREUS. This condition may be acute or chronic.%A%    
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D015523 2003
% 219.04/219.23  |- mesh__historyNote mesh__D015523 90   
% 219.04/219.23  |- mesh__recordOriginator mesh__D015523 PXP
% 219.04/219.23  |- mesh__dateRevised mesh__D015523 2001-07-25
% 219.04/219.23  |- mesh__dateCreated mesh__D015523 1989-04-07
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D015523 2006
% 219.04/219.23  |- skos__altLabel mesh__D015523 Sinusitis, Maxillary
% 219.04/219.23  |- mesh__publicMeSHNote mesh__D015523 90   
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D015523 2005
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D001503 2005
% 219.04/219.23  |- mesh__dateCreated mesh__D001503 1974-12-12
% 219.04/219.23  |- skos__hiddenLabel mesh__D001503 Giant Panda
% 219.04/219.23  |- skos__hiddenLabel mesh__D001503 Bears, Grizzly
% 219.04/219.23  |- skos__hiddenLabel mesh__D001503 Spectacled Bears
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D001503 2006
% 219.04/219.23  |- mesh__recordOriginator mesh__D001503 NLM
% 219.04/219.23  |- skos__hiddenLabel mesh__D001503 Bear, Spectacled
% 219.04/219.23  |- rdf__type mesh__D001503sskos__Concept
% 219.04/219.23  |- skos__hiddenLabel mesh__D001503 Greater Pandas
% 219.04/219.23  |- skos__hiddenLabel mesh__D001503 Bear
% 219.04/219.23  |- skos__hiddenLabel mesh__D001503 Bear, Grizzly
% 219.04/219.23  |- mesh__dateRevised mesh__D001503 2004-07-07
% 219.04/219.23  |- skos__altLabel mesh__D001503 Giant Pandas
% 219.04/219.23  |- skos__prefLabel mesh__D001503 Ursidae
% 219.04/219.23  |- skos__hiddenLabel mesh__D001503 Greater Panda
% 219.04/219.23  |- mesh__publicMeSHNote mesh__D001503
% 219.04/219.23       2005; see BEARS 1991-2004, see CARNIVORA 1975-1990; for PANDAS, GREATER see CARNIVORA 1997%A%  
% 219.04/219.23  |- skos__hiddenLabel mesh__D001503 Grizzly Bear
% 219.04/219.23  |- skos__hiddenLabel mesh__D001503 Bear, Polar
% 219.04/219.23  |- mesh__dateEstablished mesh__D001503 1991-01-01
% 219.04/219.23  |- mesh__recordMaintainer mesh__D001503 ags
% 219.04/219.23  |- skos__hiddenLabel mesh__D001503 Bear, Black
% 219.04/219.23  |- skos__broader mesh__D001503smesh__D002335
% 219.04/219.23  |- skos__hiddenLabel mesh__D001503 Polar Bear
% 219.04/219.23  |- skos__hiddenLabel mesh__D001503 Bears, Black
% 219.04/219.23  |- skos__hiddenLabel mesh__D001503 Black Bear
% 219.04/219.23  |- skos__hiddenLabel mesh__D001503 Bears, Spectacled
% 219.04/219.23  |- skos__hiddenLabel mesh__D001503 Bears, Polar
% 219.04/219.23  |- skos__hiddenLabel mesh__D001503 Panda, Giant
% 219.04/219.23  |- mesh__historyNote mesh__D001503
% 219.04/219.23       2005 %28%1975%29%; for PANDAS, GREATER use CARNIVORA 1997   
% 219.04/219.23  |- mesh__recordAuthorizer mesh__D001503 sjn
% 219.04/219.23  |- skos__hiddenLabel mesh__D001503 Panda, Greater
% 219.04/219.23  |- skos__annotation mesh__D001503
% 219.04/219.23       note X refs PANDAS, GIANT and PANDAS, GREATER: PANDAS, LESSER see PROCYONIDAE is also available%A%  
% 219.04/219.23  |- skos__scopeNote mesh__D001503
% 219.04/219.23       The family of carnivorous or omnivorous bears, having massive bodies, coarse heavy fur, relatively short limbs, and almost rudimentary tails.%A%    
% 219.04/219.23  |- skos__altLabel mesh__D001503 Bears
% 219.04/219.23  |- mesh__onlineNote mesh__D006797
% 219.04/219.23       use HOUSEKEEPING, HOSPITAL to search HOSPITAL HOUSEKEEPING 1966-77%A%  
% 219.04/219.23  |- mesh__dateCreated mesh__D006797 1999-01-01
% 219.04/219.23  |- skos__hiddenLabel mesh__D006797 Housekeepings, Hospital
% 219.04/219.23  |- skos__broader mesh__D006797smesh__D006748
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D006797 1995
% 219.04/219.23  |- skos__prefLabel mesh__D006797 Housekeeping, Hospital
% 219.04/219.23  |- skos__altLabel mesh__D006797 Hospital Housekeeping
% 219.04/219.23  |- skos__scopeNote mesh__D006797
% 219.04/219.23       Hospital department which manages and provides the required housekeeping functions in all areas of the hospital.%A%    
% 219.04/219.23  |- skos__hiddenLabel mesh__D006797 Hospital Housekeepings
% 219.04/219.23  |- rdf__type mesh__D006797sskos__Concept
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D006797 1998
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D006797 2005
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D006797 1993
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D006797 2000
% 219.04/219.23  |- mesh__recordOriginator mesh__D006797 NLM
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D006797 1996
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D006797 2003
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D006797 1999
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D006797 2006
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D006797 2001
% 219.04/219.23  |- mesh__recordAuthorizer mesh__D006797 PLS
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D006797 1997
% 219.04/219.23  |- mesh__dateRevised mesh__D006797 1992-05-15
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D006797 2004
% 219.04/219.23  |- mesh__recordMaintainer mesh__D006797 TGC
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D006797 2002
% 219.04/219.23  |- mesh__publicMeSHNote mesh__D006797
% 219.04/219.23       78; was HOSPITAL HOUSEKEEPING 1963-77   
% 219.04/219.23  |- skos__broader mesh__D006797smesh__D006796
% 219.04/219.23  |- mesh__historyNote mesh__D006797 78; was HOSPITAL HOUSEKEEPING 1963-77   
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D006797 1994
% 219.04/219.23  |- skos__broader mesh__D020468smesh__D052181
% 219.04/219.23  |- skos__related mesh__D020468smesh__D020466
% 219.04/219.23  |- skos__scopeNote mesh__D020468
% 219.04/219.23       Information presented in graphic form, for example, graphs or diagrams.%A%    
% 219.04/219.23  |- skos__altLabel mesh__D020468 Charts %28%PT%29%
% 219.04/219.23  |- rdf__type mesh__D020468sskos__Concept
% 219.04/219.23  |- mesh__dateCreated mesh__D020468 1998-06-03
% 219.04/219.23  |- skos__related mesh__D020468smesh__D020501
% 219.04/219.23  |- skos__related mesh__D020468smesh__D020472
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D020468 2006
% 219.04/219.23  |- mesh__dateEstablished mesh__D020468 1999-01-01
% 219.04/219.23  |- mesh__historyNote mesh__D020468 1999   
% 219.04/219.23  |- mesh__recordOriginator mesh__D020468 JLS
% 219.04/219.23  |- mesh__recordMaintainer mesh__D020468 jls
% 219.04/219.23  |- mesh__recordAuthorizer mesh__D020468 sjn
% 219.04/219.23  |- skos__broader mesh__D020468smesh__D052180
% 219.04/219.23  |- skos__prefLabel mesh__D020468 Charts %5B%Publication Type%5D%
% 219.04/219.23  |- mesh__dateRevised mesh__D020468 2005-06-30
% 219.04/219.23  |- skos__hiddenLabel mesh__D019914 Polymerase, Taq1
% 219.04/219.23  |- mesh__publicMeSHNote mesh__D019914
% 219.04/219.23       98; TAQ POLYMERASE was indexed under DNA POLYMERASES 1989-97%A%  
% 219.04/219.23  |- skos__hiddenLabel mesh__D019914 Polymerase, Taq
% 219.04/219.23  |- mesh__historyNote mesh__D019914
% 219.04/219.23       98; use TAQ POLYMERASE %28%NM%29% 1989-97   
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D019914 2005
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D019914 2004
% 219.04/219.23  |- skos__hiddenLabel mesh__D019914 DNA Polymerase, Taq
% 219.04/219.23  |- skos__hiddenLabel mesh__D019914 aquaticus Polymerase, Thermus
% 219.04/219.23  |- skos__altLabel mesh__D019914 Taq1 Polymerase
% 219.04/219.23  |- mesh__dateCreated mesh__D019914 1997-07-02
% 219.04/219.23  |- mesh__dateEstablished mesh__D019914 1998-01-01
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D019914 2006
% 219.04/219.23  |- skos__hiddenLabel mesh__D019914 Polymerase, Thermus aquaticus
% 219.04/219.23  |- rdf__type mesh__D019914sskos__Concept
% 219.04/219.23  |- skos__scopeNote mesh__D019914
% 219.04/219.23       A heat stable DNA-DIRECTED DNA POLYMERASE from the bacteria Thermus aquaticus. It is widely used for the amplification of genes through the process of POLYMERASE CHAIN REACTION. EC 2.7.7.-.%A%    
% 219.04/219.23  |- skos__altLabel mesh__D019914 Taq DNA Polymerase
% 219.04/219.23  |- skos__broader mesh__D019914smesh__D004259
% 219.04/219.23  |- skos__prefLabel mesh__D019914 Taq Polymerase
% 219.04/219.23  |- mesh__dateRevised mesh__D019914 2003-07-09
% 219.04/219.23  |- skos__historyNote mesh__D019914
% 219.04/219.23       DNA-Directed DNA Polymerase %28%1989-1997%29%
% 219.04/219.23  |- skos__hiddenLabel mesh__D019914 Polymerase, Taq DNA
% 219.04/219.23  |- skos__altLabel mesh__D019914 Thermus aquaticus Polymerase
% 219.04/219.23  |- mesh__recordAuthorizer mesh__D011931 sjn
% 219.04/219.23  |- mesh__dateCreated mesh__D011931 1999-01-01
% 219.04/219.23  |- skos__prefLabel mesh__D011931 Reactive Inhibition
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D011931 2004
% 219.04/219.23  |- mesh__onlineNote mesh__D011931
% 219.04/219.23       search INHIBITION %28%PSYCHOLOGY%29% 1971-74   
% 219.04/219.23  |- skos__hiddenLabel mesh__D011931 Reactive Inhibitions
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D011931 2003
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D011931 2006
% 219.04/219.23  |- mesh__recordMaintainer mesh__D011931 NLM
% 219.04/219.23  |- mesh__dateEstablished mesh__D011931 1991-01-01
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D011931 2005
% 219.04/219.23  |- skos__broader mesh__D011931smesh__D007266
% 219.04/219.23  |- mesh__publicMeSHNote mesh__D011931
% 219.04/219.23       91; was see under INHIBITION %28%PSYCHOLOGY%29% 1975-90   
% 219.04/219.23  |- rdf__type mesh__D011931sskos__Concept
% 219.04/219.23  |- skos__annotation mesh__D011931 no qualif   
% 219.04/219.23  |- skos__altLabel mesh__D011931 Inhibition, Reactive
% 219.04/219.23  |- mesh__historyNote mesh__D011931
% 219.04/219.23       91%28%75%29%; was see under INHIBITION %28%PSYCHOLOGY%29% 1975-90   
% 219.04/219.23  |- mesh__dateRevised mesh__D011931 2002-07-03
% 219.04/219.23  |- skos__hiddenLabel mesh__D011931 Inhibitions, Reactive
% 219.04/219.23  |- mesh__recordOriginator mesh__D011931 NLM
% 219.04/219.23  |- skos__scopeNote mesh__D011931
% 219.04/219.23       Tendency toward a lessened strength of response due to practice or activity. It is independent of the effect of reward and is a direct function of time interval since the last response and the number of preceding responses.%A%    
% 219.04/219.23  |- rdf__type mesh__D011133sskos__Concept
% 219.04/219.23  |- mesh__publicMeSHNote mesh__D011133 75   
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D011133 2004
% 219.04/219.23  |- skos__prefLabel mesh__D011133 Polysaccharide-Lyases
% 219.04/219.23  |- mesh__dateCreated mesh__D011133 1999-01-01
% 219.04/219.23  |- mesh__recordAuthorizer mesh__D011133 sjn
% 219.04/219.23  |- mesh__dateEstablished mesh__D011133 1975-01-01
% 219.04/219.23  |- mesh__historyNote mesh__D011133 75   
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D011133 2006
% 219.04/219.23  |- skos__scopeNote mesh__D011133
% 219.04/219.23       A group of carbon-oxygen lyases. These enzymes catalyze the breakage of a carbon-oxygen bond in polysaccharides leading to an unsaturated product and the elimination of an alcohol. EC 4.2.2.%A%    
% 219.04/219.23  |- mesh__recordMaintainer mesh__D011133 ssb
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D011133 2005
% 219.04/219.23  |- skos__hiddenLabel mesh__D011133 Polysaccharide Lyases
% 219.04/219.23  |- mesh__dateRevised mesh__D011133 2003-07-09
% 219.04/219.23  |- skos__historyNote mesh__D011133 Lyases %28%1966-1974%29%
% 219.04/219.23  |- mesh__recordOriginator mesh__D011133 NLM
% 219.04/219.23  |- skos__broader mesh__D011133smesh__D019757
% 219.04/219.23  |- skos__broader mesh__D035581smesh__D019473
% 219.04/219.23  |- skos__scopeNote mesh__D035581
% 219.04/219.23       An RNA POLYMERASE II specific transcription factor. It plays a role in assembly of the pol II transcriptional preinitiation complex and has been implicated as a target of gene-specific transcriptional activators.%A%    
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D035581 2006A
% 219.04/219.23  |- mesh__dateCreated mesh__D035581 2002-07-03
% 219.04/219.23  |- mesh__historyNote mesh__D035581
% 219.04/219.23       2003; use TRANSCRIPTION FACTOR TFIIB %28%NM%29% 1991-2002   
% 219.04/219.23  |- mesh__recordAuthorizer mesh__D035581 ags
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D035581 2006
% 219.04/219.23  |- mesh__recordMaintainer mesh__D035581 ags
% 219.04/219.23  |- skos__altLabel mesh__D035581 TFIIB
% 219.04/219.23  |- mesh__publicMeSHNote mesh__D035581
% 219.04/219.23       2003; TRANSCRIPTION FACTOR TFIIB was indexed under TRANSCRIPTION FACTORS 1991-2002%A%  
% 219.04/219.23  |- mesh__dateRevised mesh__D035581 2005-07-28
% 219.04/219.23  |- skos__prefLabel mesh__D035581 Transcription Factor TFIIB
% 219.04/219.23  |- mesh__dateEstablished mesh__D035581 2003-01-01
% 219.04/219.23  |- skos__historyNote mesh__D035581 Transcription Factors %28%1991-2002%29%
% 219.04/219.23  |- rdf__type mesh__D035581sskos__Concept
% 219.04/219.23  |- mesh__recordOriginator mesh__D035581 jmp
% 219.04/219.23  |- skos__altLabel mesh__D035581 Transcription Factor IIB
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D010839 2006A
% 219.04/219.23  |- mesh__dateRevised mesh__D010839 2005-07-27
% 219.04/219.23  |- skos__related mesh__D010839smesh__D000458
% 219.04/219.23  |- skos__annotation mesh__D010839
% 219.04/219.23       coord with specific organism; phototrophic bacterioplankton: index PHYTOPLANKTON + BACTERIA or specific%A%  
% 219.04/219.23  |- mesh__recordAuthorizer mesh__D010839 ags
% 219.04/219.23  |- rdf__type mesh__D010839sskos__Concept
% 219.04/219.23  |- skos__historyNote mesh__D010839 Plankton %28%1966-1970%29%
% 219.04/219.23  |- mesh__recordMaintainer mesh__D010839 ags
% 219.04/219.23  |- skos__scopeNote mesh__D010839
% 219.04/219.23       Free-floating minute organisms that are photosynthetic. The term is non-taxonomic and refers to a lifestyle %28%energy utilization and motility%29%, rather than a particular type of organism. Most, but not all, are unicellular ALGAE.  Important groups include DIATOMS; DINOFLAGELLATES; CYANOBACTERIA; CHLOROPHYTA; coccolithophorids; CRYPTOMONADS; and silicoflagellates.%A%    
% 219.04/219.23  |- mesh__recordOriginator mesh__D010839 NLM
% 219.04/219.23  |- skos__broader mesh__D010839smesh__D010933
% 219.04/219.23  |- mesh__historyNote mesh__D010839
% 219.04/219.23       91%28%71%29%; was see under PLANKTON 1971-90   
% 219.04/219.23  |- mesh__dateCreated mesh__D010839 1999-01-01
% 219.04/219.23  |- skos__broader mesh__D010839smesh__D011527
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D010839 2006
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D010839 2006B
% 219.04/219.23  |- skos__related mesh__D010839smesh__D004141
% 219.04/219.23  |- skos__prefLabel mesh__D010839 Phytoplankton
% 219.04/219.23  |- skos__related mesh__D010839smesh__D017377
% 219.04/219.23  |- skos__related mesh__D010839smesh__D000460
% 219.04/219.23  |- mesh__dateEstablished mesh__D010839 1991-01-01
% 219.04/219.23  |- mesh__publicMeSHNote mesh__D010839 91; was see under PLANKTON 1971-90   
% 219.04/219.23  |- skos__broader mesh__D007890smesh__D009379
% 219.04/219.23  |- skos__hiddenLabel mesh__D007890 Epithelioid Leiomyosarcoma
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007890 2006
% 219.04/219.23  |- mesh__dateCreated mesh__D007890 1999-01-01
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007890 2001
% 219.04/219.23  |- skos__hiddenLabel mesh__D007890 Leiomyosarcomas
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007890 2003
% 219.04/219.23  |- skos__hiddenLabel mesh__D007890 Leiomyosarcomas, Epithelioid
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007890 2004
% 219.04/219.23  |- mesh__recordAuthorizer mesh__D007890 PLS
% 219.04/219.23  |- mesh__recordOriginator mesh__D007890 NLM
% 219.04/219.23  |- mesh__dateRevised mesh__D007890 1995-06-08
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007890 1998
% 219.04/219.23  |- skos__annotation mesh__D007890
% 219.04/219.23       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 219.04/219.23  |- skos__hiddenLabel mesh__D007890 Myxoid Leiomyosarcoma
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007890 2002
% 219.04/219.23  |- skos__scopeNote mesh__D007890
% 219.04/219.23       A sarcoma containing large spindle cells of smooth muscle. Although it rarely occurs in soft tissue, it is common in the viscera. It is the most common soft tissue sarcoma of the gastrointestinal tract and uterus. The median age of patients is 60 years. %28%From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1865%29%%A%    
% 219.04/219.23  |- rdf__type mesh__D007890sskos__Concept
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007890 1999
% 219.04/219.23  |- skos__hiddenLabel mesh__D007890 Leiomyosarcomas, Myxoid
% 219.04/219.23  |- skos__broader mesh__D007890smesh__D012509
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007890 1996
% 219.04/219.23  |- skos__hiddenLabel mesh__D007890 Epithelioid Leiomyosarcomas
% 219.04/219.23  |- mesh__recordMaintainer mesh__D007890 KEV
% 219.04/219.23  |- skos__prefLabel mesh__D007890 Leiomyosarcoma
% 219.04/219.23  |- skos__hiddenLabel mesh__D007890 Myxoid Leiomyosarcomas
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007890 2000
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007890 2005
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007890 1997
% 219.04/219.23  |- skos__hiddenLabel mesh__D029544 Foot-and-Mouth Disease Viruses
% 219.04/219.23  |- skos__historyNote mesh__D029544 Aphthovirus %28%1964-2001%29%
% 219.04/219.23  |- rdf__type mesh__D029544sskos__Concept
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D029544 2006
% 219.04/219.23  |- mesh__dateEstablished mesh__D029544 2002-01-01
% 219.04/219.23  |- skos__prefLabel mesh__D029544 Foot-and-Mouth Disease Virus
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D029544 2005
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D029544 2004
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D029544 2002
% 219.04/219.23  |- mesh__publicMeSHNote mesh__D029544
% 219.04/219.23       2002, 1963-1993; see APHTHOVIRUS 1994-2001   
% 219.04/219.23  |- skos__broader mesh__D029544smesh__D005537
% 219.04/219.23  |- skos__annotation mesh__D029544 infection = FOOT AND MOUTH DISEASE   
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D029544 2003
% 219.04/219.23  |- skos__hiddenLabel mesh__D029544 Foot and Mouth Disease Virus
% 219.04/219.23  |- mesh__historyNote mesh__D029544
% 219.04/219.23       2002, 1963-1993; use APHTHOVIRUS 1994-2001   
% 219.04/219.23  |- skos__scopeNote mesh__D029544
% 219.04/219.23       The type species of APHTHOVIRUS, causing FOOT-AND-MOUTH DISEASE in cloven-hoofed animals. Several different serotypes exist.%A%    
% 219.04/219.23  |- mesh__dateCreated mesh__D029544 2001-07-25
% 219.04/219.23  |- mesh__recordMaintainer mesh__D007092 TGC
% 219.04/219.23  |- mesh__recordAuthorizer mesh__D007092 SJN
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007092 2005
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007092 2000
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007092 2006
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007092 2003
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007092 2001
% 219.04/219.23  |- rdf__type mesh__D007092sskos__Concept
% 219.04/219.23  |- skos__annotation mesh__D007092
% 219.04/219.23       note see related IMAGERY %28%PSYCHOTHERAPY%29%: use of images %26% imagery as a psychother technique so do not confuse with images produced by the imagination %28% = IMAGINATION%29%%A%  
% 219.04/219.23  |- skos__hiddenLabel mesh__D007092 Imaginations
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007092 2004
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007092 2002
% 219.04/219.23  |- mesh__recordOriginator mesh__D007092 NLM
% 219.04/219.23  |- skos__prefLabel mesh__D007092 Imagination
% 219.04/219.23  |- skos__related mesh__D007092smesh__D019018
% 219.04/219.23  |- skos__scopeNote mesh__D007092
% 219.04/219.23       A new pattern of perceptual or ideational material derived from past experience.%A%    
% 219.04/219.23  |- mesh__dateCreated mesh__D007092 1999-01-01
% 219.04/219.23  |- mesh__dateRevised mesh__D007092 1997-06-20
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007092 1998
% 219.04/219.23  |- skos__broader mesh__D007092smesh__D003071
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D007092 1999
% 219.04/219.23  |- skos__hiddenLabel mesh__D015524 Sinusitides, Sphenoidal
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D015524 1999
% 219.04/219.23  |- mesh__recordAuthorizer mesh__D015524 PLS
% 219.04/219.23  |- mesh__activeMeSHYear mesh__D015524 2004
% 219.04/219.24  |- skos__hiddenLabel mesh__D015524 Sinusitis, Sphenoidal
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D015524 2001
% 219.04/219.24  |- skos__prefLabel mesh__D015524 Sphenoid Sinusitis
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D015524 1995
% 219.04/219.24  |- skos__historyNote mesh__D015524 Sinusitis %28%1966-1989%29%
% 219.04/219.24  |- skos__hiddenLabel mesh__D015524 Sphenoid Sinusitides
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D015524 1998
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D015524 2003
% 219.04/219.24  |- skos__altLabel mesh__D015524 Sphenoidal Sinusitis
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D015524 2000
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D015524 2006
% 219.04/219.24  |- skos__hiddenLabel mesh__D015524 Sinusitides, Sphenoid
% 219.04/219.24  |- mesh__recordOriginator mesh__D015524 PXP
% 219.04/219.24  |- skos__altLabel mesh__D015524 Sinusitis, Sphenoid
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D015524 2005
% 219.04/219.24  |- mesh__dateRevised mesh__D015524 1994-05-12
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D015524 2002
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D015524 1997
% 219.04/219.24  |- mesh__recordMaintainer mesh__D015524 PXP
% 219.04/219.24  |- mesh__publicMeSHNote mesh__D015524 90   
% 219.04/219.24  |- skos__hiddenLabel mesh__D015524 Sphenoidal Sinusitides
% 219.04/219.24  |- skos__broader mesh__D015524smesh__D012852
% 219.04/219.24  |- skos__scopeNote mesh__D015524
% 219.04/219.24       Inflammation of the sphenoid sinus. This condition usually is accompanied by pansinusitis and may present itself in an acute or chronic form.%A%    
% 219.04/219.24  |- mesh__historyNote mesh__D015524 90   
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D015524 1996
% 219.04/219.24  |- mesh__dateEstablished mesh__D015524 1990-01-01
% 219.04/219.24  |- mesh__dateCreated mesh__D015524 1989-04-07
% 219.04/219.24  |- rdf__type mesh__D015524sskos__Concept
% 219.04/219.24  |- skos__broader mesh__D001504smesh__D004954
% 219.04/219.24  |- skos__scopeNote mesh__D001504
% 219.04/219.24       Characteristics or attributes of persons or things which elicit pleasurable feelings.%A%    
% 219.04/219.24  |- mesh__publicMeSHNote mesh__D001504
% 219.04/219.24       91,63-66; was see under ESTHETICS 1967-90; was heading 1963-66%A%  
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001504 2001
% 219.04/219.24  |- skos__annotation mesh__D001504 no qualif   
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001504 2006
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001504 2000
% 219.04/219.24  |- mesh__dateCreated mesh__D001504 1999-01-01
% 219.04/219.24  |- mesh__historyNote mesh__D001504
% 219.04/219.24       91%28%75%29%63; was see under ESTHETICS 1967-90; was heading 1963-66%A%  
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001504 2004
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001504 1995
% 219.04/219.24  |- mesh__recordMaintainer mesh__D001504 NLM
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001504 1993
% 219.04/219.24  |- rdf__type mesh__D001504sskos__Concept
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001504 2005
% 219.04/219.24  |- mesh__onlineNote mesh__D001504 search ESTHETICS 1966-74   
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001504 1999
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001504 2003
% 219.04/219.24  |- mesh__recordOriginator mesh__D001504 NLM
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001504 1994
% 219.04/219.24  |- skos__prefLabel mesh__D001504 Beauty
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001504 1997
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001504 1992
% 219.04/219.24  |- mesh__recordAuthorizer mesh__D001504 PLS
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001504 2002
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001504 1998
% 219.04/219.24  |- mesh__dateRevised mesh__D001504 1990-05-01
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001504 1991
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001504 1996
% 219.04/219.24  |- mesh__dateEstablished mesh__D001504 1991-01-01
% 219.04/219.24  |- skos__altLabel mesh__D006798 Patient-Family Lodging
% 219.04/219.24  |- skos__hiddenLabel mesh__D006798 Lodging, Patient-Family
% 219.04/219.24  |- rdf__type mesh__D006798sskos__Concept
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D006798 2005
% 219.04/219.24  |- skos__hiddenLabel mesh__D006798 Family-Patient Lodgings
% 219.04/219.24  |- mesh__dateRevised mesh__D006798 1999-11-03
% 219.04/219.24  |- skos__prefLabel mesh__D006798 Housing
% 219.04/219.24  |- skos__hiddenLabel mesh__D006798 Lodging, Family-Patient
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D006798 2006
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D006798 2003
% 219.04/219.24  |- mesh__recordAuthorizer mesh__D006798 sjn
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D006798 2004
% 219.04/219.24  |- skos__hiddenLabel mesh__D006798 Patient-Family Lodgings
% 219.04/219.24  |- skos__hiddenLabel mesh__D006798 Family Patient Lodging
% 219.04/219.24  |- skos__hiddenLabel mesh__D006798 Lodgings, Family-Patient
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D006798 2000
% 219.04/219.24  |- mesh__recordMaintainer mesh__D006798 kle
% 219.04/219.24  |- skos__broader mesh__D006798smesh__D004780
% 219.04/219.24  |- skos__broader mesh__D006798smesh__D012111
% 219.04/219.24  |- mesh__recordOriginator mesh__D006798 NLM
% 219.04/219.24  |- skos__scopeNote mesh__D006798 Living facilities for humans.     
% 219.04/219.24  |- skos__annotation mesh__D006798
% 219.04/219.24       for persons; for animals use HOUSING, ANIMAL   
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D006798 2001
% 219.04/219.24  |- skos__hiddenLabel mesh__D006798 Patient Family Lodging
% 219.04/219.24  |- mesh__dateCreated mesh__D006798 1999-01-01
% 219.04/219.24  |- skos__hiddenLabel mesh__D006798 Lodgings, Patient-Family
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D006798 2002
% 219.04/219.24  |- mesh__recordMaintainer mesh__D020469 jls
% 219.04/219.24  |- skos__altLabel mesh__D020469 Chronology %28%PT%29%
% 219.04/219.24  |- skos__scopeNote mesh__D020469
% 219.04/219.24       Works consisting of lists of events arranged in chronological order.%A%    
% 219.04/219.24  |- skos__prefLabel mesh__D020469 Chronology %5B%Publication Type%5D%
% 219.04/219.24  |- mesh__onlineNote mesh__D020469
% 219.04/219.24       search policy: Online Manual; use: main heading AND CHRONOLOGY %28%PT%29%%A%  
% 219.04/219.24  |- mesh__dateEstablished mesh__D020469 1999-01-01
% 219.04/219.24  |- mesh__recordAuthorizer mesh__D020469 sjn
% 219.04/219.24  |- mesh__dateRevised mesh__D020469 2005-06-30
% 219.04/219.24  |- rdf__type mesh__D020469sskos__Concept
% 219.04/219.24  |- mesh__dateCreated mesh__D020469 1998-06-03
% 219.04/219.24  |- skos__related mesh__D020469smesh__D020501
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D020469 2006
% 219.04/219.24  |- mesh__historyNote mesh__D020469 99   
% 219.04/219.24  |- mesh__recordOriginator mesh__D020469 JLS
% 219.04/219.24  |- skos__broader mesh__D020469smesh__D052180
% 219.04/219.24  |- skos__scopeNote mesh__D019915
% 219.04/219.24       A single-stranded DNA-dependent RNA polymerase that functions to initiate, or prime, DNA synthesis by synthesizing oligoribonucleotide primers. EC 2.7.7.-.%A%    
% 219.04/219.24  |- skos__hiddenLabel mesh__D019915 Protein, T7 DNA-Priming
% 219.04/219.24  |- skos__altLabel mesh__D019915 T7 gene-4 protein
% 219.04/219.24  |- skos__altLabel mesh__D019915 Primase
% 219.04/219.24  |- skos__altLabel mesh__D019915 DnaG Gene Product
% 219.04/219.24  |- skos__altLabel mesh__D019915 T7 DNA-Priming Protein
% 219.04/219.24  |- mesh__publicMeSHNote mesh__D019915
% 219.04/219.24       98; DNA PRIMASE was indexed under RNA NUCLEOTIDYLTRANSFERASES 1978-97 %26% DNA 1978-82%A%  
% 219.04/219.24  |- mesh__dateCreated mesh__D019915 1997-06-20
% 219.04/219.24  |- mesh__recordMaintainer mesh__D019915 ssb
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D019915 2004
% 219.04/219.24  |- skos__hiddenLabel mesh__D019915 DNA-Priming Protein, T7
% 219.04/219.24  |- mesh__recordOriginator mesh__D019915 KEV
% 219.04/219.24  |- skos__broader mesh__D019915smesh__D012321
% 219.04/219.24  |- mesh__recordAuthorizer mesh__D019915 sjn
% 219.04/219.24  |- skos__altLabel mesh__D019915 DnaG Protein
% 219.04/219.24  |- skos__hiddenLabel mesh__D019915 T7 DNA Priming Protein
% 219.04/219.24  |- mesh__dateEstablished mesh__D019915 1998-01-01
% 219.04/219.24  |- skos__historyNote mesh__D019915
% 219.04/219.24       RNA Nucleotidyltransferases %28%1978-1997%29%
% 219.04/219.24  |- skos__historyNote mesh__D019915 DNA %28%1978-1982%29%
% 219.04/219.24  |- mesh__historyNote mesh__D019915
% 219.04/219.24       98; use DNA PRIMASE %28%NM%29% 1980-97   
% 219.04/219.24  |- skos__prefLabel mesh__D019915 DNA Primase
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D019915 2006
% 219.04/219.24  |- skos__altLabel mesh__D019915 T7 DNA Primase-Helicase Protein
% 219.04/219.24  |- mesh__dateRevised mesh__D019915 2003-07-25
% 219.04/219.24  |- rdf__type mesh__D019915sskos__Concept
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D019915 2005
% 219.04/219.24  |- skos__hiddenLabel mesh__D019915 T7 gene 4 protein
% 219.04/219.24  |- skos__hiddenLabel mesh__D019915 Primase, DNA
% 219.04/219.24  |- skos__hiddenLabel mesh__D019915 T7 DNA Primase Helicase Protein
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D011932 2004
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D011932 1990
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D011932 2000
% 219.04/219.24  |- skos__hiddenLabel mesh__D011932 Readings
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D011932 1993
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D011932 1998
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D011932 2006
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D011932 2003
% 219.04/219.24  |- mesh__recordOriginator mesh__D011932 NLM
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D011932 1995
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D011932 1992
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D011932 2005
% 219.04/219.24  |- rdf__type mesh__D011932sskos__Concept
% 219.04/219.24  |- skos__annotation mesh__D011932
% 219.04/219.24       no qualif; Braille: coord IM with BLINDNESS %28%IM%29% + SENSORY AIDS %28%IM%29%%A%  
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D011932 1994
% 219.04/219.24  |- mesh__dateRevised mesh__D011932 1989-05-16
% 219.04/219.24  |- mesh__recordMaintainer mesh__D011932 TGC
% 219.04/219.24  |- skos__prefLabel mesh__D011932 Reading
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D011932 1997
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D011932 2002
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D011932 1991
% 219.04/219.24  |- mesh__dateCreated mesh__D011932 1999-01-01
% 219.04/219.24  |- skos__related mesh__D011932smesh__D004411
% 219.04/219.24  |- skos__broader mesh__D011932smesh__D007803
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D011932 1999
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D011932 1996
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D011932 2001
% 219.04/219.24  |- mesh__recordAuthorizer mesh__D011932 PLS
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D019117 2006
% 219.04/219.24  |- rdf__type mesh__D019117sskos__Concept
% 219.04/219.24  |- mesh__recordMaintainer mesh__D019117 SYSTEM
% 219.04/219.24  |- skos__scopeNote mesh__D019117
% 219.04/219.24       A genus of gram-negative, aerobic, rod-shaped bacteria. Organisms in this genus had originally been classified as members of the PSEUDOMONAS genus but overwhelming biochemical and chemical findings indicated the need to separate them from other Pseudomonas species, and hence, this new genus was created.%A%    
% 219.04/219.24  |- skos__broader mesh__D019117smesh__D042521
% 219.04/219.24  |- mesh__historyNote mesh__D019117 96   
% 219.04/219.24  |- mesh__dateEstablished mesh__D019117 1996-01-01
% 219.04/219.24  |- mesh__recordOriginator mesh__D019117 PXP
% 219.04/219.24  |- mesh__publicMeSHNote mesh__D019117 96   
% 219.04/219.24  |- skos__historyNote mesh__D019117 Pseudomonadaceae %28%1992-1995%29%
% 219.04/219.24  |- mesh__dateCreated mesh__D019117 1995-06-05
% 219.04/219.24  |- mesh__dateRevised mesh__D019117 2005-06-30
% 219.04/219.24  |- mesh__recordAuthorizer mesh__D019117 sjn
% 219.04/219.24  |- skos__annotation mesh__D019117
% 219.04/219.24       some species were formerly called Pseudomonas; infection = BURKHOLDERIA INFECTIONS%A%  
% 219.04/219.24  |- skos__prefLabel mesh__D019117 Burkholderia
% 219.04/219.24  |- rdf__type mesh__D011134sskos__Concept
% 219.04/219.24  |- mesh__dateCreated mesh__D011134 1999-01-01
% 219.04/219.24  |- skos__broader mesh__D011134smesh__D002241
% 219.04/219.24  |- mesh__recordOriginator mesh__D011134 NLM
% 219.04/219.24  |- skos__annotation mesh__D011134
% 219.04/219.24       13 or more units; GEN; prefer specifics   
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D011134 2005
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D011134 2006
% 219.04/219.24  |- skos__altLabel mesh__D011134 Glycans
% 219.04/219.24  |- mesh__publicMeSHNote mesh__D011134
% 219.04/219.24       XYLANS was XYLAN see under CELLULOSE 1963-74   
% 219.04/219.24  |- mesh__recordMaintainer mesh__D011134 ssb
% 219.04/219.24  |- skos__prefLabel mesh__D011134 Polysaccharides
% 219.04/219.24  |- mesh__dateRevised mesh__D011134 2004-07-07
% 219.04/219.24  |- mesh__recordAuthorizer mesh__D011134 sjn
% 219.04/219.24  |- mesh__publicMeSHNote mesh__D035582
% 219.04/219.24       2003; TRANSCRIPTION FACTOR TFIIIA was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1984-2002%A%  
% 219.04/219.24  |- skos__broader mesh__D035582smesh__D019474
% 219.04/219.24  |- mesh__dateRevised mesh__D035582 2005-07-28
% 219.04/219.24  |- skos__related mesh__D035582smesh__D012341
% 219.04/219.24  |- mesh__recordMaintainer mesh__D035582 ags
% 219.04/219.24  |- skos__altLabel mesh__D035582 GTF3A Protein
% 219.04/219.24  |- skos__historyNote mesh__D035582 Transcription Factors %28%1984-2002%29%
% 219.04/219.24  |- skos__scopeNote mesh__D035582
% 219.04/219.24       One of several general transcription factors that are specific for RNA POLYMERASE III. It is a zinc finger %28%ZINC FINGERS%29% protein and is required for transcription of 5S ribosomal genes.%A%    
% 219.04/219.24  |- mesh__recordOriginator mesh__D035582 jmp
% 219.04/219.24  |- skos__altLabel mesh__D035582 TFIIIA
% 219.04/219.24  |- rdf__type mesh__D035582sskos__Concept
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D035582 2006A
% 219.04/219.24  |- mesh__dateCreated mesh__D035582 2002-07-03
% 219.04/219.24  |- skos__prefLabel mesh__D035582 Transcription Factor TFIIIA
% 219.04/219.24  |- skos__altLabel mesh__D035582 5S RNA Gene Transcription Factor
% 219.04/219.24  |- mesh__recordAuthorizer mesh__D035582 ags
% 219.04/219.24  |- skos__altLabel mesh__D035582 5S Gene-Specific Transcription Factor
% 219.04/219.24  |- mesh__dateEstablished mesh__D035582 2003-01-01
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D035582 2006
% 219.04/219.24  |- skos__hiddenLabel mesh__D035582 5S Gene Specific Transcription Factor
% 219.04/219.24  |- mesh__historyNote mesh__D035582
% 219.04/219.24       2003; use TRANSCRIPTION FACTOR TFIIIA %28%NM%29% 1984-2002   
% 219.04/219.24  |- skos__historyNote mesh__D035582 DNA-Binding Proteins %28%1984-2002%29%
% 219.04/219.24  |- skos__altLabel mesh__D035582 Transcription Factor IIIA
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D007891 2004
% 219.04/219.24  |- skos__annotation mesh__D007891
% 219.04/219.24       infection = LEISHMANIASIS or its specifics; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN; a virus infecting Leishmania is named LEISHMANIAVIRUS: read MeSH definition there%A%  
% 219.04/219.24  |- skos__altLabel mesh__D007891 Leishmania leishmania
% 219.04/219.24  |- mesh__dateRevised mesh__D007891 2003-07-09
% 219.04/219.24  |- mesh__recordMaintainer mesh__D007891 ags
% 219.04/219.24  |- rdf__type mesh__D007891sskos__Concept
% 219.04/219.24  |- skos__broader mesh__D007891smesh__D014351
% 219.04/219.24  |- skos__related mesh__D007891smesh__D019199
% 219.04/219.24  |- skos__scopeNote mesh__D007891
% 219.04/219.24       A genus of flagellate protozoa comprising several species that are pathogenic for humans. Organisms of this genus have an amastigote and a promastigote stage in their life cycles. As a result of enzymatic studies this single genus has been divided into two subgenera: Leishmania leishmania and Leishmania viannia. Species within the Leishmania leishmania subgenus include: L. aethiopica, L. arabica, L. donovani, L. enrietti, L. gerbilli, L. hertigi, L. infantum, L. major, L. mexicana, and L. tropica. The following species are those that compose the Leishmania viannia subgenus: L. braziliensis, L. guyanensis, L. lainsoni, L. naiffi, and L. shawi.%A%    
% 219.04/219.24  |- skos__prefLabel mesh__D007891 Leishmania
% 219.04/219.24  |- mesh__recordOriginator mesh__D007891 NLM
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D007891 2005
% 219.04/219.24  |- mesh__recordAuthorizer mesh__D007891 sjn
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D007891 2006
% 219.04/219.24  |- skos__altLabel mesh__D007891 Leishmania %28%Viannia%29%
% 219.04/219.24  |- mesh__dateCreated mesh__D007891 1999-01-01
% 219.04/219.24  |- mesh__publicMeSHNote mesh__D007093
% 219.04/219.24       NAPHAZOLINE was see under VASOCONSTRICTOR AGENTS, NASAL 1967-74, was see under SYMPATHOMIMETICS 1963-66%A%  
% 219.04/219.24  |- mesh__recordMaintainer mesh__D007093 ssb
% 219.04/219.24  |- skos__related mesh__D007093smesh__D001562
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D007093 2006
% 219.04/219.24  |- skos__broader mesh__D007093smesh__D001393
% 219.04/219.24  |- rdf__type mesh__D007093sskos__Concept
% 219.04/219.24  |- skos__prefLabel mesh__D007093 Imidazoles
% 219.04/219.24  |- mesh__dateRevised mesh__D007093 2005-06-30
% 219.04/219.24  |- mesh__dateCreated mesh__D007093 1999-01-01
% 219.04/219.24  |- mesh__recordAuthorizer mesh__D007093 sjn
% 219.04/219.24  |- mesh__recordOriginator mesh__D007093 NLM
% 219.04/219.24  |- skos__scopeNote mesh__D007093
% 219.04/219.24       Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole %28%PYRAZOLES%29%.%A%    
% 219.04/219.24  |- skos__altLabel mesh__D015525 n-3 Fatty Acids
% 219.04/219.24  |- skos__altLabel mesh__D015525 Omega-3 Fatty Acids
% 219.04/219.24  |- mesh__publicMeSHNote mesh__D015525
% 219.04/219.24       1990; N-3 POLYUNSATURATED FATTY ACID was indexed under FATTY ACIDS, UNSATURATED 2000-2005%A%  
% 219.04/219.24  |- skos__hiddenLabel mesh__D015525 Fatty Acids, n-3
% 219.04/219.24  |- skos__broader mesh__D015525smesh__D004042
% 219.04/219.24  |- skos__prefLabel mesh__D015525 Fatty Acids, Omega-3
% 219.04/219.24  |- mesh__dateRevised mesh__D015525 2005-06-30
% 219.04/219.24  |- skos__altLabel mesh__D015525 n-3 Polyunsaturated Fatty Acid
% 219.04/219.24  |- skos__broader mesh__D015525smesh__D005395
% 219.04/219.24  |- skos__hiddenLabel mesh__D015525 n 3 Polyunsaturated Fatty Acid
% 219.04/219.24  |- skos__hiddenLabel mesh__D015525 n 3 Fatty Acids
% 219.04/219.24  |- skos__historyNote mesh__D015525
% 219.04/219.24       Fatty Acids, Unsaturated %28%1973-1989%29%
% 219.04/219.24  |- mesh__recordOriginator mesh__D015525 RLS
% 219.04/219.24  |- skos__historyNote mesh__D015525 Fatty Acids %28%1966-1972%29%
% 219.04/219.24  |- skos__historyNote mesh__D015525 Fish Oils %28%1966-1989%29%
% 219.04/219.24  |- skos__hiddenLabel mesh__D015525 Omega 3 Fatty Acids
% 219.04/219.24  |- skos__annotation mesh__D015525 specify source if pertinent   
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D015525 2006
% 219.04/219.24  |- mesh__historyNote mesh__D015525
% 219.04/219.24       1990; for n-3 POLYUNSATURATED FATTY ACID use PIKASOL %28%NM%29% 2000-2005%A%  
% 219.04/219.24  |- mesh__recordAuthorizer mesh__D015525 sjn
% 219.04/219.24  |- skos__hiddenLabel mesh__D015525 Acids, Omega-3 Fatty
% 219.04/219.24  |- mesh__dateEstablished mesh__D015525 1990-01-01
% 219.04/219.24  |- skos__broader mesh__D015525smesh__D005231
% 219.04/219.24  |- mesh__dateCreated mesh__D015525 1989-06-08
% 219.04/219.24  |- rdf__type mesh__D015525sskos__Concept
% 219.04/219.24  |- mesh__recordMaintainer mesh__D015525 ssb
% 219.04/219.24  |- skos__hiddenLabel mesh__D015525 Fatty Acids, Omega 3
% 219.04/219.24  |- skos__scopeNote mesh__D015525
% 219.04/219.24       A group of fatty acids, often of marine origin, which have the first unsaturated bond in the third position from the omega carbon. These fatty acids are believed to reduce serum triglycerides, prevent insulin resistance, improve lipid profile, prolong bleeding times, reduce platelet counts, and decrease platelet adhesiveness.%A%    
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001505 2002
% 219.04/219.24  |- skos__hiddenLabel mesh__D001505 Culture, Beauty
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001505 1991
% 219.04/219.24  |- mesh__recordMaintainer mesh__D001505 TGC
% 219.04/219.24  |- skos__annotation mesh__D001505 SPEC: SPEC qualif   
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001505 2006
% 219.04/219.24  |- mesh__dateCreated mesh__D001505 1999-01-01
% 219.04/219.24  |- skos__broader mesh__D001505smesh__D007221
% 219.04/219.24  |- skos__hiddenLabel mesh__D001505 Beauty Cultures
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001505 2004
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001505 1995
% 219.04/219.24  |- skos__hiddenLabel mesh__D001505 Cultures, Beauty
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001505 1993
% 219.04/219.24  |- rdf__type mesh__D001505sskos__Concept
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001505 2005
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001505 1999
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001505 2003
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001505 2001
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001505 1994
% 219.04/219.24  |- skos__prefLabel mesh__D001505 Beauty Culture
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001505 1997
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001505 1990
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001505 1992
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001505 2000
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001505 1998
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D001505 1996
% 219.04/219.24  |- mesh__dateRevised mesh__D001505 1989-06-14
% 219.04/219.24  |- mesh__recordOriginator mesh__D001505 NLM
% 219.04/219.24  |- mesh__recordAuthorizer mesh__D001505 PLS
% 219.04/219.24  |- mesh__historyNote mesh__D031990 2003   
% 219.04/219.24  |- mesh__publicMeSHNote mesh__D031990 2003   
% 219.04/219.24  |- skos__scopeNote mesh__D031990
% 219.04/219.24       A plant genus of the family ROSACEAE. Members contain SAPONINS.%A%    
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D031990 2006
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D031990 2003
% 219.04/219.24  |- mesh__dateCreated mesh__D031990 2002-07-03
% 219.04/219.24  |- skos__prefLabel mesh__D031990 Quillaja
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D031990 2004
% 219.04/219.24  |- skos__altLabel mesh__D031990 Soapbark
% 219.04/219.24  |- skos__altLabel mesh__D031990 Quillaja saponin
% 219.04/219.24  |- skos__broader mesh__D031990smesh__D027824
% 219.04/219.24  |- mesh__dateEstablished mesh__D031990 2003-01-01
% 219.04/219.24  |- skos__annotation mesh__D031990
% 219.04/219.24       do not confuse X ref QUILLAJA SAPONARIA with the genus SAPONARIA; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.04/219.24  |- rdf__type mesh__D031990sskos__Concept
% 219.04/219.24  |- skos__altLabel mesh__D031990 Soapbush
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D031990 2005
% 219.04/219.24  |- mesh__historyNote mesh__D006799 72   
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D006799 2000
% 219.04/219.24  |- mesh__publicMeSHNote mesh__D006799 72   
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D006799 1997
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D006799 2004
% 219.04/219.24  |- mesh__recordOriginator mesh__D006799 NLM
% 219.04/219.24  |- mesh__recordAuthorizer mesh__D006799 PLS
% 219.04/219.24  |- skos__historyNote mesh__D006799 Housing %28%1966-1971%29%
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D006799 2001
% 219.04/219.24  |- skos__broader mesh__D006799smesh__D006798
% 219.04/219.24  |- skos__historyNote mesh__D006799 Animals, Laboratory %28%1966-1971%29%
% 219.04/219.24  |- mesh__dateRevised mesh__D006799 1992-05-15
% 219.04/219.24  |- mesh__dateEstablished mesh__D006799 1972-01-01
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D006799 2002
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D006799 1994
% 219.04/219.24  |- skos__hiddenLabel mesh__D006799 Animal Housings
% 219.04/219.24  |- mesh__dateCreated mesh__D006799 1999-01-01
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D006799 1995
% 219.04/219.24  |- skos__hiddenLabel mesh__D006799 Housings, Animal
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D006799 1993
% 219.04/219.24  |- rdf__type mesh__D006799sskos__Concept
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D006799 1998
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D006799 2005
% 219.04/219.24  |- mesh__recordMaintainer mesh__D006799 TAP
% 219.04/219.24  |- skos__hiddenLabel mesh__D006799 Animal Housing
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D006799 1999
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D006799 2006
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D006799 1996
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D006799 2003
% 219.04/219.24  |- skos__prefLabel mesh__D006799 Housing, Animal
% 219.04/219.24  |- skos__broader mesh__D008334Q000293smesh__D008334
% 219.04/219.24  |- mesh__preferredCombination mesh__D008334Q000293smesh__D008338
% 219.04/219.24  |- rdf__type mesh__D008334Q000293smesh__CompoundConcept
% 219.04/219.24  |- skos__broader mesh__D019916smesh__D009713
% 219.04/219.24  |- mesh__historyNote mesh__D019916
% 219.04/219.24       98; use CHOLINE-PHOSPHATE CYTIDYLYLTRANSFERASE %28%NM%29% 1980-97%A%  
% 219.04/219.24  |- skos__historyNote mesh__D019916 Choline %28%1975-1977%29%
% 219.04/219.24  |- skos__hiddenLabel mesh__D019916 Cytidylyltransferase, CTP Phosphocholine
% 219.04/219.24  |- skos__prefLabel mesh__D019916 Choline-Phosphate Cytidylyltransferase
% 219.04/219.24  |- skos__hiddenLabel mesh__D019916 Choline Phosphate Cytidylyltransferase
% 219.04/219.24  |- skos__altLabel mesh__D019916 CTP Phosphorylcholine Cytidyltransferase
% 219.04/219.24  |- skos__hiddenLabel mesh__D019916 Synthetase, CDP-Choline
% 219.04/219.24  |- skos__historyNote mesh__D019916
% 219.04/219.24       Nucleotidyltransferases %28%1975-1997%29%
% 219.04/219.24  |- skos__hiddenLabel mesh__D019916 Phosphocholine Cytidylyltransferase, CTP
% 219.04/219.24  |- skos__historyNote mesh__D019916 Cytosine Nucleotides %28%1975-1977%29%
% 219.04/219.24  |- skos__hiddenLabel mesh__D019916 Cytidyltransferase, Phosphocholine
% 219.04/219.24  |- skos__hiddenLabel mesh__D019916 Cytidyl Transferase, Phosphorylcholine
% 219.04/219.24  |- skos__hiddenLabel mesh__D019916 CDP Choline Synthetase
% 219.04/219.24  |- mesh__recordMaintainer mesh__D019916 ssb
% 219.04/219.24  |- mesh__dateCreated mesh__D019916 1997-06-20
% 219.04/219.24  |- skos__altLabel mesh__D019916 Phosphocholine Cytidyltransferase
% 219.04/219.24  |- mesh__recordOriginator mesh__D019916 KEV
% 219.04/219.24  |- skos__hiddenLabel mesh__D019916 Transferase, Phosphorylcholine Cytidyl
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D019916 2006
% 219.04/219.24  |- skos__hiddenLabel mesh__D019916
% 219.04/219.24       Phosphorylcholine Cytidyltransferase, CTP
% 219.04/219.24  |- mesh__dateRevised mesh__D019916 2003-07-09
% 219.04/219.24  |- mesh__recordAuthorizer mesh__D019916 sjn
% 219.04/219.24  |- rdf__type mesh__D019916sskos__Concept
% 219.04/219.24  |- skos__hiddenLabel mesh__D019916
% 219.04/219.24       CTP Phosphocholine Cytidylyl  Transferase
% 219.04/219.24  |- skos__altLabel mesh__D019916 Phosphorylcholine Cytidyl Transferase
% 219.04/219.24  |- skos__altLabel mesh__D019916 CTP Phosphocholine Cytidylyl- Transferase
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D019916 2005
% 219.04/219.24  |- skos__altLabel mesh__D019916 CTP Phosphocholine Cytidylyltransferase
% 219.04/219.24  |- skos__historyNote mesh__D019916
% 219.04/219.24       Cytidine Diphosphate Choline %28%1977-1981%29%
% 219.04/219.24  |- mesh__dateEstablished mesh__D019916 1998-01-01
% 219.04/219.24  |- skos__altLabel mesh__D019916 CDP-Choline Synthetase
% 219.04/219.24  |- skos__hiddenLabel mesh__D019916
% 219.04/219.24       Cytidyltransferase, CTP Phosphorylcholine
% 219.04/219.24  |- skos__annotation mesh__D019916 DF: CDP CHOLINE SYNTHETASE   
% 219.04/219.24  |- skos__hiddenLabel mesh__D019916 Cytidylyltransferase, Choline-Phosphate
% 219.04/219.24  |- skos__scopeNote mesh__D019916
% 219.04/219.24       An enzyme that catalyzes the transfer of cytidylate %28%CMP%29% to choline phosphate to form CDPcholine. It is the rate-limiting enzyme in the choline pathway for the biosynthesis of phosphatidylcholine. Its activity is increased by glucocorticoids. EC 2.7.7.15.%A%    
% 219.04/219.24  |- mesh__publicMeSHNote mesh__D019916
% 219.04/219.24       98; CHOLINE-PHOSPHATE CYTIDYLTRANSFERASE was indexed under CYTOSINE NUCLEOTIDES %26% CHOLINE 1975-77, CYTIDINE DIPHOSPHATE CHOLINE 1977-81 %26% NUCLEOTIDYLTRANSFERASES 1975-97%A%  
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D019916 2004
% 219.04/219.24  |- mesh__activeMeSHYear mesh__D011933 2005
% 219.04/219.24  |- mesh__dateEstablished mesh__D011933 1978-01-01
% 219.04/219.24  |- skos__altLabel mesh__D011933 Kits, Diagnostic Reagent
% 219.04/219.24  |- rdf__type mesh__D011933sskos__Concept
% 219.04/219.24  |- skos__scopeNote mesh__D011933
% 219.04/219.24       Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use.%A%    
% 219.04/219.24  |- skos__broader mesh__D011933smesh__D004864
% 219.04/219.24  |- skos__hiddenLabel mesh__D011933 Kit, Diagnostic Reagent
% 219.04/219.24  |- mesh__dateCreated mesh__D011933 1977-04-22
% 219.04/219.24  |- skos__hiddenLabel mesh__D011933 Diagnostic Reagent Kit
% 219.04/219.24  |- mesh__dateRevised mesh__D011933 2003-07-09
% 219.04/219.24  |- mesh__recordMaintainer mesh__D011933 ssb
% 219.04/219.24  |- skos__altLabel mesh__D011933 Diagnostic Reagent Kits
% 219.04/219.25  |- skos__broader mesh__D011933smesh__D007202
% 219.04/219.25  |- skos__prefLabel mesh__D011933 Reagent Kits, Diagnostic
% 219.04/219.25  |- skos__hiddenLabel mesh__D011933 Reagent Kit, Diagnostic
% 219.04/219.25  |- mesh__recordAuthorizer mesh__D011933 sjn
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D011933 2004
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D011933 2006
% 219.04/219.25  |- mesh__recordOriginator mesh__D011933 SMH
% 219.04/219.25  |- skos__annotation mesh__D011933 laboratory or personal use   
% 219.04/219.25  |- mesh__publicMeSHNote mesh__D011933 78   
% 219.04/219.25  |- mesh__historyNote mesh__D011933 78   
% 219.04/219.25  |- mesh__recordAuthorizer mesh__D011135 sjn
% 219.04/219.25  |- mesh__dateRevised mesh__D011135 2005-06-30
% 219.04/219.25  |- skos__scopeNote mesh__D011135
% 219.04/219.25       Polysaccharides found in bacteria and especially bacterial capsules. %28%Dorland, 28th ed%29%%A%    
% 219.04/219.25  |- skos__prefLabel mesh__D011135 Polysaccharides, Bacterial
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D011135 2006
% 219.04/219.25  |- skos__annotation mesh__D011135
% 219.04/219.25       IM + coord with specific bacterium %28%IM%29% + specific polysaccharide %28%IM%29%; /immunol permitted; note specific bact polysaccharides LIPOPOLYSACCHARIDES %26% PEPTIDOGLYCAN; DF: POLYSACCHARIDES BACT%A%  
% 219.04/219.25  |- skos__altLabel mesh__D011135 Bacterial Polysaccharides
% 219.04/219.25  |- mesh__recordOriginator mesh__D011135 NLM
% 219.04/219.25  |- skos__broader mesh__D011135smesh__D011134
% 219.04/219.25  |- skos__broader mesh__D011135smesh__D000942
% 219.04/219.25  |- rdf__type mesh__D011135sskos__Concept
% 219.04/219.25  |- mesh__dateCreated mesh__D011135 1999-01-01
% 219.04/219.25  |- mesh__recordMaintainer mesh__D011135 ssb
% 219.04/219.25  |- skos__hiddenLabel mesh__D035583 Rare Disease
% 219.04/219.25  |- mesh__dateEstablished mesh__D035583 2003-01-01
% 219.04/219.25  |- mesh__publicMeSHNote mesh__D035583 2003   
% 219.04/219.25  |- skos__hiddenLabel mesh__D035583 Diseases, Orphan
% 219.04/219.25  |- skos__broader mesh__D035583smesh__D020969
% 219.04/219.25  |- skos__historyNote mesh__D035583 Case Report %28%1965-2002%29%
% 219.04/219.25  |- rdf__type mesh__D035583sskos__Concept
% 219.04/219.25  |- skos__hiddenLabel mesh__D035583 Disease, Orphan
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D035583 2003
% 219.04/219.25  |- skos__hiddenLabel mesh__D035583 Orphan Disease
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D035583 2005
% 219.04/219.25  |- skos__hiddenLabel mesh__D035583 Disease, Rare
% 219.04/219.25  |- skos__prefLabel mesh__D035583 Rare Diseases
% 219.04/219.25  |- skos__annotation mesh__D035583
% 219.04/219.25       coord with specific disease; index only when discussed as rare disease%A%  
% 219.04/219.25  |- mesh__historyNote mesh__D035583 2003   
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D035583 2004
% 219.04/219.25  |- skos__hiddenLabel mesh__D035583 Diseases, Rare
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D035583 2006
% 219.04/219.25  |- mesh__dateCreated mesh__D035583 2002-07-03
% 219.04/219.25  |- skos__scopeNote mesh__D035583
% 219.04/219.25       A large group of diseases which are characterized by a low prevalence in the population. They frequently are associated with problems in diagnosis and treatment.%A%    
% 219.04/219.25  |- skos__related mesh__D035583smesh__D009965
% 219.04/219.25  |- skos__altLabel mesh__D007892 Leishmania %28%Viannia%29% braziliensis
% 219.04/219.25  |- rdf__type mesh__D007892sskos__Concept
% 219.04/219.25  |- mesh__historyNote mesh__D007892
% 219.04/219.25       91%28%86%29%; was see under LEISHMANIA 1986-90; LEISHMANIA PERUVIANA was see LEISHMANIA BRAZILIENSIS 1986-91%A%  
% 219.04/219.25  |- mesh__recordMaintainer mesh__D007892 ags
% 219.04/219.25  |- skos__altLabel mesh__D007892 Leishmania viannia brasiliensis
% 219.04/219.25  |- skos__annotation mesh__D007892
% 219.04/219.25       infection: coord IM with LEISHMANIASIS, CUTANEOUS %28%IM%29% or LEISHMANIASIS, DIFFUSE CUTANEOUS %28%IM%29% or LEISHMANIASIS, MUCOCUTANEOUS %28%IM%29%; check text but L. guyanensis %26% L. panamensis infection = LEISHMANIASIS, MUCOCUTANEOUS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 219.04/219.25  |- mesh__onlineNote mesh__D007892
% 219.04/219.25       use LEISHMANIA BRAZILIENSIS to search LEISHMANIA PERUVIANA 1986-91%A%  
% 219.04/219.25  |- skos__prefLabel mesh__D007892 Leishmania braziliensis
% 219.04/219.25  |- mesh__recordAuthorizer mesh__D007892 sjn
% 219.04/219.25  |- mesh__recordOriginator mesh__D007892 EC
% 219.04/219.25  |- mesh__publicMeSHNote mesh__D007892
% 219.04/219.25       91; was see under LEISHMANIA 1986-90; LEISHMANIA PERUVIANA was see LEISHMANIA BRAZILIENSIS 1986-91%A%  
% 219.04/219.25  |- skos__scopeNote mesh__D007892
% 219.04/219.25       A parasitic hemoflagellate of the subgenus Leishmania viannia that infects man and animals. It causes cutaneous %28%LEISHMANIASIS, CUTANEOUS%29%, diffuse cutaneous %28%LEISHMANIASIS, DIFFUSE CUTANEOUS%29%, and mucocutaneous leishmaniasis %28%LEISHMANIASIS, MUCOCUTANEOUS%29% depending on the subspecies of this organism. The sandfly, Lutzomyia, is the vector. The Leishmania braziliensis complex includes the subspecies braziliensis and peruviana. Uta, a form of cutaneous leishmaniasis in the New World, is caused by the subspecies peruviana.%A%    
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007892 2005
% 219.04/219.25  |- skos__altLabel mesh__D007892 Leishmania brasiliensis brasiliensis
% 219.04/219.25  |- skos__broader mesh__D007892smesh__D007891
% 219.04/219.25  |- skos__altLabel mesh__D007892 Leishmania viannia braziliensis
% 219.04/219.25  |- skos__altLabel mesh__D007892 Leishmania %28%Viannia%29% brasiliensis
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007892 2006
% 219.04/219.25  |- skos__historyNote mesh__D007892 Leishmania %28%1966-1985%29%
% 219.04/219.25  |- skos__altLabel mesh__D007892 Leishmania brasiliensis peruviana
% 219.04/219.25  |- mesh__dateCreated mesh__D007892 1985-03-20
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007892 2004
% 219.04/219.25  |- skos__altLabel mesh__D007892 Leishmania brasiliensis
% 219.04/219.25  |- mesh__dateRevised mesh__D007892 2003-07-09
% 219.04/219.25  |- mesh__dateEstablished mesh__D007892 1991-01-01
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007094 2000
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007094 1996
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007094 1993
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007094 1999
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007094 2004
% 219.04/219.25  |- mesh__recordOriginator mesh__D007094 NLM
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007094 1995
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007094 1998
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007094 2003
% 219.04/219.25  |- skos__annotation mesh__D007094 do not confuse with IMINES or AMIDES   
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007094 2006
% 219.04/219.25  |- skos__broader mesh__D007094smesh__D009930
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007094 1994
% 219.04/219.25  |- mesh__dateCreated mesh__D007094 1999-01-01
% 219.04/219.25  |- mesh__recordMaintainer mesh__D007094 TAP
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007094 2005
% 219.04/219.25  |- mesh__recordAuthorizer mesh__D007094 PLS
% 219.04/219.25  |- rdf__type mesh__D007094sskos__Concept
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007094 2002
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007094 2001
% 219.04/219.25  |- mesh__dateRevised mesh__D007094 1992-05-19
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007094 1997
% 219.04/219.25  |- skos__prefLabel mesh__D007094 Imides
% 219.04/219.25  |- skos__hiddenLabel mesh__D015526 Encephalopathies, AIDS
% 219.04/219.25  |- skos__hiddenLabel mesh__D015526 HIV Associated Cognitive Motor Complex
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D015526 2005
% 219.04/219.25  |- skos__hiddenLabel mesh__D015526 HIV Dementias
% 219.04/219.25  |- skos__hiddenLabel mesh__D015526 Encephalopathies, HIV
% 219.04/219.25  |- skos__hiddenLabel mesh__D015526 HIV 1 Cognitive and Motor Complex
% 219.04/219.25  |- skos__scopeNote mesh__D015526
% 219.04/219.25       A neurologic condition associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME and characterized by impaired concentration and memory, slowness of hand movements, ATAXIA, incontinence, apathy, and gait difficulties associated with HIV-1 viral infection of the central nervous system. Pathologic examination of the brain reveals white matter rarefaction, perivascular infiltrates of lymphocytes, foamy macrophages, and multinucleated giant cells. %28%From Adams et al., Principles of Neurology, 6th ed, pp760-1; N Engl J Med, 1995 Apr 6;332%28%14%29%:934-40%29%%A%    
% 219.04/219.25  |- skos__hiddenLabel mesh__D015526 Dementia Complex, AIDS
% 219.04/219.25  |- skos__historyNote mesh__D015526
% 219.04/219.25       Acquired Immunodeficiency Syndrome %28%1983-1989%29%
% 219.04/219.25  |- mesh__dateCreated mesh__D015526 1989-07-21
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D015526 2006A
% 219.04/219.25  |- skos__hiddenLabel mesh__D015526 HIV Encephalopathies
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D015526 2006
% 219.04/219.25  |- mesh__historyNote mesh__D015526 1990   
% 219.04/219.25  |- skos__altLabel mesh__D015526 Encephalopathy, AIDS
% 219.04/219.25  |- skos__hiddenLabel mesh__D015526 AIDS Encephalopathies
% 219.04/219.25  |- skos__hiddenLabel mesh__D015526 AIDS Related Dementia Complex
% 219.04/219.25  |- mesh__recordMaintainer mesh__D015526 ags
% 219.04/219.25  |- skos__hiddenLabel mesh__D015526 HIV 1 Associated Cognitive Motor Complex
% 219.04/219.25  |- skos__broader mesh__D015526smesh__D015658
% 219.04/219.25  |- mesh__dateEstablished mesh__D015526 1990-01-01
% 219.04/219.25  |- mesh__recordOriginator mesh__D015526 AGS
% 219.04/219.25  |- mesh__recordAuthorizer mesh__D015526 ags
% 219.04/219.25  |- skos__hiddenLabel mesh__D015526 Complex, AIDS-Related Dementia
% 219.04/219.25  |- skos__altLabel mesh__D015526 Dementia Complex, AIDS-Related
% 219.04/219.25  |- skos__altLabel mesh__D015526 AIDS-Related Dementia Complex
% 219.04/219.25  |- mesh__publicMeSHNote mesh__D015526 1990   
% 219.04/219.25  |- skos__hiddenLabel mesh__D015526 Dementia Complex, AIDS Related
% 219.04/219.25  |- skos__historyNote mesh__D015526 Dementia %28%1983-1989%29%
% 219.04/219.25  |- skos__altLabel mesh__D015526 Encephalopathy, HIV
% 219.04/219.25  |- skos__prefLabel mesh__D015526 AIDS Dementia Complex
% 219.04/219.25  |- mesh__dateRevised mesh__D015526 2005-07-07
% 219.04/219.25  |- rdf__type mesh__D015526sskos__Concept
% 219.04/219.25  |- skos__altLabel mesh__D015526 HIV-Associated Cognitive Motor Complex
% 219.04/219.25  |- skos__altLabel mesh__D015526 AIDS Encephalopathy
% 219.04/219.25  |- skos__broader mesh__D015526smesh__D003704
% 219.04/219.25  |- skos__hiddenLabel mesh__D015526 Complex, AIDS Dementia
% 219.04/219.25  |- skos__hiddenLabel mesh__D015526 Dementias, HIV
% 219.04/219.25  |- skos__altLabel mesh__D015526
% 219.04/219.25       Dementia Complex, Acquired Immune Deficiency Syndrome
% 219.04/219.25  |- skos__hiddenLabel mesh__D015526 Dementia, HIV
% 219.04/219.25  |- skos__altLabel mesh__D015526
% 219.04/219.25       Acquired-Immune Deficiency Syndrome Dementia Complex
% 219.04/219.25  |- skos__altLabel mesh__D015526 HIV Dementia
% 219.04/219.25  |- skos__altLabel mesh__D015526 HIV-1 Cognitive and Motor Complex
% 219.04/219.25  |- skos__annotation mesh__D015526
% 219.04/219.25       coord IM with HIV-1 or HIV-2 %28%IM or NIM%29% if pertinent   
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D001506 2005
% 219.04/219.25  |- skos__altLabel mesh__D001506 Exomphalos-Macroglossia-Gigantism Syndrome
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D001506 2003
% 219.04/219.25  |- skos__hiddenLabel mesh__D001506 Syndrome, Wiedemann-Beckwith
% 219.04/219.25  |- skos__hiddenLabel mesh__D001506
% 219.04/219.25       Syndrome, Exomphalos-Macroglossia-Gigantism
% 219.04/219.25  |- mesh__historyNote mesh__D001506 83   
% 219.04/219.25  |- mesh__publicMeSHNote mesh__D001506 83   
% 219.04/219.25  |- skos__broader mesh__D001506smesh__D025063
% 219.04/219.25  |- skos__historyNote mesh__D001506 Hernia, Umbilical %28%1966-1982%29%
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D001506 2006A
% 219.04/219.25  |- mesh__recordMaintainer mesh__D001506 ags
% 219.04/219.25  |- mesh__dateCreated mesh__D001506 1982-04-26
% 219.04/219.25  |- skos__hiddenLabel mesh__D001506 Syndrome, Beckwith-Wiedemann
% 219.04/219.25  |- mesh__dateRevised mesh__D001506 2005-07-18
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D001506 2002
% 219.04/219.25  |- skos__prefLabel mesh__D001506 Beckwith-Wiedemann Syndrome
% 219.04/219.25  |- skos__annotation mesh__D001506
% 219.04/219.25       a syndrome of multiple abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: EMG SYNDROME%A%  
% 219.04/219.25  |- skos__historyNote mesh__D001506 Macroglossia %28%1975-1982%29%
% 219.04/219.25  |- mesh__recordAuthorizer mesh__D001506 ags
% 219.04/219.25  |- skos__historyNote mesh__D001506 Tongue/abnormalities %28%1966-1974%29%
% 219.04/219.25  |- skos__hiddenLabel mesh__D001506 Wiedemann Beckwith Syndrome
% 219.04/219.25  |- skos__broader mesh__D001506smesh__D000015
% 219.04/219.25  |- skos__scopeNote mesh__D001506
% 219.04/219.25       A syndrome of multiple defects characterized primarily by umbilical hernia %28%HERNIA, UMBILICAL%29%; MACROGLOSSIA; and GIGANTISM; and secondarily by visceromegaly; HYPOGLYCEMIA; and ear abnormalities.%A%    
% 219.04/219.25  |- mesh__dateEstablished mesh__D001506 1983-01-01
% 219.04/219.25  |- skos__historyNote mesh__D001506
% 219.04/219.25       Abnormalities, Multiple %28%1968-1982%29%
% 219.04/219.25  |- skos__hiddenLabel mesh__D001506
% 219.04/219.25       Exomphalos Macroglossia Gigantism Syndrome
% 219.04/219.25  |- skos__altLabel mesh__D001506 Wiedemann-Beckwith Syndrome
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D001506 2006
% 219.04/219.25  |- skos__hiddenLabel mesh__D001506 Beckwith Wiedemann Syndrome
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D001506 2004
% 219.04/219.25  |- mesh__recordOriginator mesh__D001506 RC
% 219.04/219.25  |- rdf__type mesh__D001506sskos__Concept
% 219.04/219.25  |- skos__historyNote mesh__D001506 Gigantism %28%1966-1982%29%
% 219.04/219.25  |- skos__prefLabel mesh__D031991 Pyracantha
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D031991 2004
% 219.04/219.25  |- mesh__historyNote mesh__D031991 2003   
% 219.04/219.25  |- skos__altLabel mesh__D031991 Firethorn
% 219.04/219.25  |- mesh__dateCreated mesh__D031991 2002-07-03
% 219.04/219.25  |- skos__scopeNote mesh__D031991
% 219.04/219.25       A plant genus of the family ROSACEAE widely cultivated as a prickly hedge with bright red berries.  Members contain pyracrenic acid %28%a lupane triterpenoid%29%.%A%    
% 219.04/219.25  |- skos__annotation mesh__D031991
% 219.04/219.25       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.04/219.25  |- rdf__type mesh__D031991sskos__Concept
% 219.04/219.25  |- skos__broader mesh__D031991smesh__D027824
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D031991 2005
% 219.04/219.25  |- mesh__publicMeSHNote mesh__D031991 2003   
% 219.04/219.25  |- mesh__dateEstablished mesh__D031991 2003-01-01
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D031991 2006
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D031991 2003
% 219.04/219.25  |- skos__altLabel mesh__D047608 Pyrrolo-Iminoquinones
% 219.04/219.25  |- rdf__type mesh__D047608sskos__Concept
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D047608 2005
% 219.04/219.25  |- mesh__historyNote mesh__D047608 2005   
% 219.04/219.25  |- mesh__recordAuthorizer mesh__D047608 sjn
% 219.04/219.25  |- skos__prefLabel mesh__D047608 Pyrroloiminoquinones
% 219.04/219.25  |- mesh__recordOriginator mesh__D047608 ssb
% 219.04/219.25  |- mesh__recordMaintainer mesh__D047608 ssb
% 219.04/219.25  |- skos__broader mesh__D047608smesh__D011804
% 219.04/219.25  |- skos__hiddenLabel mesh__D047608 Pyrrolo Iminoquinones
% 219.04/219.25  |- skos__scopeNote mesh__D047608
% 219.04/219.25       Derivatives of QUINOLINES with fused PYRROLES and a keto group or INDOLEQUINONES with fused PIPERIDINES.%A%    
% 219.04/219.25  |- mesh__dateCreated mesh__D047608 2004-07-07
% 219.04/219.25  |- mesh__publicMeSHNote mesh__D047608 2005   
% 219.04/219.25  |- mesh__dateEstablished mesh__D047608 2005-01-01
% 219.04/219.25  |- skos__broader mesh__D047608smesh__D045563
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D047608 2006
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D019917 2006
% 219.04/219.25  |- rdf__type mesh__D019917sskos__Concept
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D019917 2002
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D019917 2005
% 219.04/219.25  |- skos__prefLabel mesh__D019917 Blood Vessel Prosthesis Implantation
% 219.04/219.25  |- skos__altLabel mesh__D019917 Implantation, Blood Vessel Prosthesis
% 219.04/219.25  |- mesh__historyNote mesh__D019917 98   
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D019917 2001
% 219.04/219.25  |- skos__broader mesh__D019917smesh__D019919
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D019917 2004
% 219.04/219.25  |- mesh__publicMeSHNote mesh__D019917 98   
% 219.04/219.25  |- skos__scopeNote mesh__D019917
% 219.04/219.25       Surgical insertion of synthetic or biological material to repair injured or diseased blood vessels.%A%    
% 219.04/219.25  |- mesh__dateRevised mesh__D019917 2000-06-22
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D019917 2003
% 219.04/219.25  |- mesh__dateCreated mesh__D019917 1997-06-20
% 219.04/219.25  |- skos__related mesh__D019917smesh__D001807
% 219.04/219.25  |- mesh__recordMaintainer mesh__D019917 jmp
% 219.04/219.25  |- mesh__recordOriginator mesh__D019917 PXP
% 219.04/219.25  |- mesh__recordAuthorizer mesh__D019917 sjn
% 219.04/219.25  |- mesh__dateEstablished mesh__D019917 1998-01-01
% 219.04/219.25  |- skos__historyNote mesh__D019917
% 219.04/219.25       Blood Vessel Prosthesis %28%1966-1997%29%
% 219.04/219.25  |- skos__broader mesh__D019917smesh__D014656
% 219.04/219.25  |- skos__hiddenLabel mesh__D011934 Strip, Reagent
% 219.04/219.25  |- skos__broader mesh__D011934smesh__D011933
% 219.04/219.25  |- mesh__dateRevised mesh__D011934 2003-07-09
% 219.04/219.25  |- skos__hiddenLabel mesh__D011934 Reagent Strip
% 219.04/219.25  |- mesh__dateCreated mesh__D011934 1999-01-01
% 219.04/219.25  |- mesh__historyNote mesh__D011934
% 219.04/219.25       87%28%73%29%; was see under INDICATORS AND REAGENTS 1975-86   
% 219.04/219.25  |- skos__historyNote mesh__D011934
% 219.04/219.25       Indicators and Reagents %28%1966-1972%29%
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D011934 2004
% 219.04/219.25  |- skos__hiddenLabel mesh__D011934 Strips, Reagent
% 219.04/219.25  |- mesh__recordMaintainer mesh__D011934 ssb
% 219.04/219.25  |- skos__annotation mesh__D011934 D25-26 qualif with discretion   
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D011934 2006
% 219.04/219.25  |- skos__scopeNote mesh__D011934
% 219.04/219.25       Narrow pieces of material impregnated or covered with a substance used to produce a chemical reaction. The strips are used in detecting, measuring, producing, etc., other substances. %28%From Dorland, 28th ed%29%%A%    
% 219.04/219.25  |- mesh__publicMeSHNote mesh__D011934
% 219.04/219.25       87; was see under INDICATORS AND REAGENTS 1975-86   
% 219.04/219.25  |- skos__prefLabel mesh__D011934 Reagent Strips
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D011934 2005
% 219.04/219.25  |- mesh__recordOriginator mesh__D011934 NLM
% 219.04/219.25  |- mesh__recordAuthorizer mesh__D011934 sjn
% 219.04/219.25  |- mesh__dateEstablished mesh__D011934 1987-01-01
% 219.04/219.25  |- rdf__type mesh__D011934sskos__Concept
% 219.04/219.25  |- mesh__recordAuthorizer mesh__D011136 sjn
% 219.04/219.25  |- skos__annotation mesh__D011136 D25-26 qualif   
% 219.04/219.25  |- skos__hiddenLabel mesh__D011136 Derivatives, Sorbitan
% 219.04/219.25  |- skos__historyNote mesh__D011136 Polyethylene Glycols %28%1974%29%
% 219.04/219.25  |- skos__historyNote mesh__D011136 Glycols %28%1966-1973%29%
% 219.04/219.25  |- mesh__onlineNote mesh__D011136
% 219.04/219.25       to search TWEENS use SURFACE-ACTIVE AGENTS 1966-74   
% 219.04/219.25  |- mesh__recordMaintainer mesh__D011136 jmp
% 219.04/219.25  |- mesh__dateEstablished mesh__D011136 1981-01-01
% 219.04/219.25  |- skos__hiddenLabel mesh__D011136 81, Tween
% 219.04/219.25  |- skos__altLabel mesh__D011136 Polyoxyethylene Sorbitan Monolaurate
% 219.04/219.25  |- skos__historyNote mesh__D011136 specific fatty acid %28%1966-1973%29%
% 219.04/219.25  |- skos__hiddenLabel mesh__D011136 Monolaurate, Polyoxyethylene Sorbitan
% 219.04/219.25  |- skos__historyNote mesh__D011136 Fatty Acids %28%1966-1973%29%
% 219.04/219.25  |- skos__hiddenLabel mesh__D011136 20, Tween
% 219.04/219.25  |- skos__hiddenLabel mesh__D011136 80, Polysorbate
% 219.04/219.25  |- mesh__recordOriginator mesh__D011136 NLM
% 219.04/219.25  |- skos__hiddenLabel mesh__D011136 Sorbitan Monolaurate, Polyoxyethylene
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D011136 2005
% 219.04/219.25  |- skos__prefLabel mesh__D011136 Polysorbates
% 219.04/219.25  |- skos__scopeNote mesh__D011136
% 219.04/219.25       Sorbitan mono-9-octadecanoate poly%28%oxy-1,2-ethanediyl%29% derivatives; complex mixtures of polyoxyethylene ethers used as emulsifiers or dispersing agents in pharmaceuticals.%A%    
% 219.04/219.25  |- skos__historyNote mesh__D011136 Polymers %28%1966-1973%29%
% 219.04/219.25  |- mesh__publicMeSHNote mesh__D011136
% 219.04/219.25       81; was see under POLYETHYLENE GLYCOLS 1975-80; TWEENS was see under SURFACE-ACTIVE AGENTS 1963-74%A%  
% 219.04/219.25  |- skos__hiddenLabel mesh__D011136 80, Tween
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D011136 2006
% 219.04/219.25  |- mesh__dateCreated mesh__D011136 1974-11-19
% 219.04/219.25  |- skos__hiddenLabel mesh__D011136 85, Tween
% 219.04/219.25  |- rdf__type mesh__D011136sskos__Concept
% 219.04/219.25  |- mesh__dateRevised mesh__D011136 2004-07-07
% 219.04/219.25  |- skos__historyNote mesh__D011136 Hexoses %28%1966-1973%29%
% 219.04/219.25  |- mesh__historyNote mesh__D011136
% 219.04/219.25       81%28%75%29%; was see under POLYETHYLENE GLYCOLS 1975-80; TWEENS was see under SURFACE-ACTIVE AGENTS 1963-74%A%  
% 219.04/219.25  |- skos__hiddenLabel mesh__D011136 20, Polysorbate
% 219.04/219.25  |- skos__broader mesh__D011136smesh__D011092
% 219.04/219.25  |- skos__historyNote mesh__D011136 Polyethylenes %28%1966-1973%29%
% 219.04/219.25  |- skos__hiddenLabel mesh__D011136 60, Tween
% 219.04/219.25  |- skos__altLabel mesh__D011136 PSML
% 219.04/219.25  |- skos__prefLabel mesh__D007893 Leishmania donovani
% 219.04/219.25  |- skos__annotation mesh__D007893
% 219.04/219.25       do not confuse with LEISHMANIA DONOVANI CHAGASI see LEISHMANIA INFANTUM or LEISHMANIA DONOVANI INFANTUM see LEISHMANIA INFANTUM; infection: coord IM with LEISHMANIASIS, VISCERAL %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007893 2005
% 219.04/219.25  |- mesh__historyNote mesh__D007893 86   
% 219.04/219.25  |- skos__scopeNote mesh__D007893
% 219.04/219.25       A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes visceral leishmaniasis %28%LEISHMANIASIS, VISCERAL%29%. The sandfly genera Phlebotomus and Lutzomyia are the vectors.%A%    
% 219.04/219.25  |- skos__altLabel mesh__D007893 Leishmania %28%Leishmania%29% donovani
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007893 2006
% 219.04/219.25  |- mesh__publicMeSHNote mesh__D007893 86   
% 219.04/219.25  |- skos__altLabel mesh__D007893 Leishmania leishmania donovani
% 219.04/219.25  |- mesh__recordAuthorizer mesh__D007893 sjn
% 219.04/219.25  |- mesh__recordOriginator mesh__D007893 EC
% 219.04/219.25  |- mesh__dateEstablished mesh__D007893 1986-01-01
% 219.04/219.25  |- skos__broader mesh__D007893smesh__D007891
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007893 2004
% 219.04/219.25  |- mesh__dateRevised mesh__D007893 2003-07-09
% 219.04/219.25  |- skos__historyNote mesh__D007893 Leishmania %28%1966-1985%29%
% 219.04/219.25  |- rdf__type mesh__D007893sskos__Concept
% 219.04/219.25  |- mesh__recordMaintainer mesh__D007893 ags
% 219.04/219.25  |- mesh__dateCreated mesh__D007893 1985-03-20
% 219.04/219.25  |- skos__broader mesh__D007095smesh__D002224
% 219.04/219.25  |- skos__scopeNote mesh__D007095
% 219.04/219.25       One of ANTIPROTOZOAL AGENTS used especially against BABESIA in livestock.  Toxicity has been reported.%A%    
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007095 2003
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007095 2006
% 219.04/219.25  |- skos__hiddenLabel mesh__D007095 Dihydrochloride, Imidocarb
% 219.04/219.25  |- skos__prefLabel mesh__D007095 Imidocarb
% 219.04/219.25  |- mesh__dateCreated mesh__D007095 1974-11-11
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007095 2005
% 219.04/219.25  |- rdf__type mesh__D007095sskos__Concept
% 219.04/219.25  |- mesh__recordOriginator mesh__D007095 NLM
% 219.04/219.25  |- mesh__recordAuthorizer mesh__D007095 sjn
% 219.04/219.25  |- mesh__recordMaintainer mesh__D007095 ssb
% 219.04/219.25  |- mesh__publicMeSHNote mesh__D007095
% 219.04/219.25       91; was see under CARBANILIDES 1975-90   
% 219.04/219.25  |- skos__altLabel mesh__D007095 Imidocarb Dihydrochloride
% 219.04/219.25  |- skos__historyNote mesh__D007095 Imidazoles %28%1966-1974%29%
% 219.04/219.25  |- skos__hiddenLabel mesh__D007095 Hydrochloride, Imidocarb
% 219.04/219.25  |- mesh__historyNote mesh__D007095
% 219.04/219.25       91%28%75%29%; was see under CARBANILIDES 1975-90   
% 219.04/219.25  |- skos__historyNote mesh__D007095 Carbanilides %28%1974%29%
% 219.04/219.25  |- mesh__dateRevised mesh__D007095 2001-07-25
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007095 2002
% 219.04/219.25  |- skos__historyNote mesh__D007095 Urea %28%1966-1973%29%
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D007095 2004
% 219.04/219.25  |- mesh__dateEstablished mesh__D007095 1991-01-01
% 219.04/219.25  |- skos__altLabel mesh__D001507 Propaderm
% 219.04/219.25  |- skos__altLabel mesh__D001507 Asche Brand of Beclomethasone Dipropionate
% 219.04/219.25  |- mesh__publicMeSHNote mesh__D001507
% 219.04/219.25       77; was see under METHYLPREDNISOLONE 1975-76   
% 219.04/219.25  |- skos__altLabel mesh__D001507 Filair Forte
% 219.04/219.25  |- skos__altLabel mesh__D001507
% 219.04/219.25       Schering Brand 2 of Beclomethasone Dipropionate
% 219.04/219.25  |- skos__altLabel mesh__D001507 Becloforte
% 219.04/219.25  |- skos__altLabel mesh__D001507 Becodisks
% 219.04/219.25  |- skos__altLabel mesh__D001507 Sanasthmax
% 219.04/219.25  |- skos__altLabel mesh__D001507
% 219.04/219.25       Celltech Brand of Beclomethasone Dipropionate
% 219.04/219.25  |- skos__altLabel mesh__D001507
% 219.04/219.25       A %26% H Brand of Beclomethasone Dipropionate
% 219.04/219.25  |- skos__broader mesh__D001507smesh__D011246
% 219.04/219.25  |- skos__hiddenLabel mesh__D001507 Dipropionate, Beclomethasone
% 219.04/219.25  |- skos__altLabel mesh__D001507 Beclometasone
% 219.04/219.25  |- skos__altLabel mesh__D001507 Sanasthmyl
% 219.04/219.25  |- skos__altLabel mesh__D001507 Viarin
% 219.04/219.25  |- skos__altLabel mesh__D001507
% 219.04/219.25       Schering Brand 1 of Beclomethasone Dipropionate
% 219.04/219.25  |- skos__prefLabel mesh__D001507 Beclomethasone
% 219.04/219.25  |- mesh__recordAuthorizer mesh__D001507 sjn
% 219.04/219.25  |- skos__altLabel mesh__D001507
% 219.04/219.25       Glaxo Wellcome Brand of Beclomethasone Dipropionate
% 219.04/219.25  |- mesh__dateRevised mesh__D001507 2005-06-30
% 219.04/219.25  |- skos__altLabel mesh__D001507 Ascocortonyl
% 219.04/219.25  |- skos__altLabel mesh__D001507 Becotide
% 219.04/219.25  |- skos__altLabel mesh__D001507 Shire Brand of Beclomethasone Dipropionate
% 219.04/219.25  |- skos__altLabel mesh__D001507 Respocort
% 219.04/219.25  |- skos__altLabel mesh__D001507
% 219.04/219.25       Schering-Plough Brand of Beclomethasone Dipropionate
% 219.04/219.25  |- mesh__recordOriginator mesh__D001507 NLM
% 219.04/219.25  |- skos__altLabel mesh__D001507
% 219.04/219.25       United Drug Brand of Beclomethasone Dipropionate
% 219.04/219.25  |- skos__altLabel mesh__D001507 Nasobec Aqueous
% 219.04/219.25  |- skos__altLabel mesh__D001507 Apotex Brand of Beclomethasone Dipropionate
% 219.04/219.25  |- skos__altLabel mesh__D001507 Beclazone Easy Breathe
% 219.04/219.25  |- skos__altLabel mesh__D001507 Prolair
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D001507 2006
% 219.04/219.25  |- skos__altLabel mesh__D001507
% 219.04/219.25       GlaxoSmithKline Brand 1 of Beclomethasone Dipropionate
% 219.04/219.25  |- skos__altLabel mesh__D001507
% 219.04/219.25       GlaxoSmithKline Brand 2 of Beclomethasone Dipropionate
% 219.04/219.25  |- mesh__dateEstablished mesh__D001507 1977-01-01
% 219.04/219.25  |- skos__altLabel mesh__D001507 Bemedrex Easyhaler
% 219.04/219.25  |- skos__altLabel mesh__D001507 Filair
% 219.04/219.25  |- skos__scopeNote mesh__D001507
% 219.04/219.25       An anti-inflammatory, synthetic glucocorticoid. It is used topically as an anti-inflammatory agent and in aerosol form for the treatment of ASTHMA.%A%    
% 219.04/219.25  |- skos__altLabel mesh__D001507 Beclazone
% 219.04/219.25  |- skos__altLabel mesh__D001507 Medeva Brand of Beclomethasone Dipropionate
% 219.04/219.25  |- skos__altLabel mesh__D001507
% 219.04/219.25       Fujisawa Brand of Beclomethasone Dipropionate
% 219.04/219.25  |- skos__altLabel mesh__D001507 Aerobec
% 219.04/219.25  |- skos__altLabel mesh__D001507 Ecobec
% 219.04/219.25  |- mesh__dateCreated mesh__D001507 1999-01-01
% 219.04/219.25  |- skos__broader mesh__D001507smesh__D013258
% 219.04/219.25  |- skos__altLabel mesh__D001507 Becloturmant
% 219.04/219.25  |- rdf__type mesh__D001507sskos__Concept
% 219.04/219.25  |- skos__altLabel mesh__D001507 Ventolair
% 219.04/219.25  |- skos__altLabel mesh__D001507 AeroBec Forte
% 219.04/219.25  |- mesh__recordMaintainer mesh__D001507 lkw
% 219.04/219.25  |- mesh__historyNote mesh__D001507
% 219.04/219.25       77%28%73%29%; was see under METHYLPREDNISOLONE 1975-76   
% 219.04/219.25  |- skos__altLabel mesh__D001507 Junik
% 219.04/219.25  |- skos__altLabel mesh__D001507 3M Brand of Beclomethasone Dipropionate
% 219.04/219.25  |- skos__altLabel mesh__D001507 Ivax Brand of Beclomethasone Dipropionate
% 219.04/219.25  |- skos__altLabel mesh__D001507
% 219.04/219.25       Azupharma Brand of Beclomethasone Dipropionate
% 219.04/219.25  |- skos__altLabel mesh__D001507 Aldo Brand of Beclomethasone Dipropionate
% 219.04/219.25  |- skos__altLabel mesh__D001507 Norton Brand of Beclomethasone Dipropionate
% 219.04/219.25  |- skos__altLabel mesh__D001507 Orion Brand of Beclomethasone Dipropionate
% 219.04/219.25  |- skos__altLabel mesh__D001507
% 219.04/219.25       Allen %26% Hanburys Brand of Beclomethasone Dipropionate
% 219.04/219.25  |- skos__historyNote mesh__D001507 Pregnanetriol %28%1966-1972%29%
% 219.04/219.25  |- skos__altLabel mesh__D001507
% 219.04/219.25       GlaxoSmithKline Brand 3 of Beclomethasone Dipropionate
% 219.04/219.25  |- mesh__dateEstablished mesh__D031992 2003-01-01
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D031992 2006
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D031992 2004
% 219.04/219.25  |- mesh__historyNote mesh__D031992 2003   
% 219.04/219.25  |- mesh__dateCreated mesh__D031992 2002-07-03
% 219.04/219.25  |- skos__annotation mesh__D031992
% 219.04/219.25       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.04/219.25  |- rdf__type mesh__D031992sskos__Concept
% 219.04/219.25  |- skos__broader mesh__D031992smesh__D027824
% 219.04/219.25  |- skos__scopeNote mesh__D031992
% 219.04/219.25       A plant genus of the family ROSACEAE. Members contain prunioside, spiramine and other diterpene alkaloids.%A%    
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D031992 2005
% 219.04/219.25  |- skos__prefLabel mesh__D031992 Spiraea
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D031992 2003
% 219.04/219.25  |- mesh__publicMeSHNote mesh__D031992 2003   
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D019918 2005
% 219.04/219.25  |- mesh__activeMeSHYear mesh__D019918 1999
% 219.04/219.26  |- mesh__dateEstablished mesh__D019918 1998-01-01
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D019918 1998
% 219.04/219.26  |- mesh__historyNote mesh__D019918 98   
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D019918 2002
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D019918 2004
% 219.04/219.26  |- skos__broader mesh__D019918smesh__D006348
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D019918 2003
% 219.04/219.26  |- skos__altLabel mesh__D019918 Implantation, Heart Valve Prosthesis
% 219.04/219.26  |- skos__historyNote mesh__D019918 Heart Valve Prosthesis %28%1966-1997%29%
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D019918 2001
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D019918 2006
% 219.04/219.26  |- skos__broader mesh__D019918smesh__D019919
% 219.04/219.26  |- mesh__publicMeSHNote mesh__D019918 98   
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D019918 2000
% 219.04/219.26  |- skos__scopeNote mesh__D019918
% 219.04/219.26       Surgical insertion of synthetic material to repair injured or diseased heart valves.%A%    
% 219.04/219.26  |- rdf__type mesh__D019918sskos__Concept
% 219.04/219.26  |- skos__prefLabel mesh__D019918 Heart Valve Prosthesis Implantation
% 219.04/219.26  |- mesh__dateCreated mesh__D019918 1997-06-20
% 219.04/219.26  |- skos__related mesh__D019918smesh__D006350
% 219.04/219.26  |- mesh__recordOriginator mesh__D011935 NLM
% 219.04/219.26  |- mesh__recordAuthorizer mesh__D011935 sjn
% 219.04/219.26  |- mesh__historyNote mesh__D011935
% 219.04/219.26       91%28%75%29%72%28%66-71%29%; was see under ANTIBODIES 1975-90; was see under IGE 1966-71, 1973-74 %28%Prov 1966-71%29%; was heading 1972%A%  
% 219.04/219.26  |- skos__prefLabel mesh__D011935 Reagins
% 219.04/219.26  |- mesh__dateEstablished mesh__D011935 1991-01-01
% 219.04/219.26  |- mesh__dateRevised mesh__D011935 2005-06-30
% 219.04/219.26  |- mesh__onlineNote mesh__D011935
% 219.04/219.26       use IGE to search REAGINS 1966-74 %28%as Prov 1966-71%29%   
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011935 2006
% 219.04/219.26  |- mesh__recordMaintainer mesh__D011935 ssb
% 219.04/219.26  |- skos__scopeNote mesh__D011935
% 219.04/219.26       Antibodies, especially IGE, that bind to tissue of the same species so that ANTIGENS induce release of HISTAMINE and other vasoactive agents. HYPERSENSITIVITY is the clinical manifestation.%A%    
% 219.04/219.26  |- skos__broader mesh__D011935smesh__D000906
% 219.04/219.26  |- mesh__publicMeSHNote mesh__D011935
% 219.04/219.26       91,72; was see under ANTIBODIES 1975-90; was see under IGE 1973-74; was heading 1972%A%  
% 219.04/219.26  |- rdf__type mesh__D011935sskos__Concept
% 219.04/219.26  |- mesh__dateCreated mesh__D011935 1999-01-01
% 219.04/219.26  |- mesh__recordAuthorizer mesh__D011137 ags
% 219.04/219.26  |- skos__scopeNote mesh__D011137
% 219.04/219.26       Polymerized forms of styrene used as a biocompatible material, especially in dentistry. They are thermoplastic and are used as insulators, for injection molding and casting, as sheets, plates, rods, rigid forms and beads.%A%    
% 219.04/219.26  |- skos__broader mesh__D011137smesh__D010969
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011137 2006
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011137 2006A
% 219.04/219.26  |- skos__broader mesh__D011137smesh__D020058
% 219.04/219.26  |- rdf__type mesh__D011137sskos__Concept
% 219.04/219.26  |- mesh__dateCreated mesh__D011137 1999-01-01
% 219.04/219.26  |- skos__altLabel mesh__D011137 Polystyrol
% 219.04/219.26  |- skos__prefLabel mesh__D011137 Polystyrenes
% 219.04/219.26  |- skos__annotation mesh__D011137 STYRENES and STYRENE are available   
% 219.04/219.26  |- mesh__recordOriginator mesh__D011137 NLM
% 219.04/219.26  |- mesh__dateRevised mesh__D011137 2005-08-01
% 219.04/219.26  |- mesh__recordMaintainer mesh__D011137 ags
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011137 2005
% 219.04/219.26  |- skos__broader mesh__D016620smesh__D011459
% 219.04/219.26  |- mesh__onlineNote mesh__D016620
% 219.04/219.26       use ENPROSTIL %28%NM%29% to search ENPROSTIL 1985-91   
% 219.04/219.26  |- mesh__historyNote mesh__D016620 92; was ENPROSTIL %28%NM%29% 1985-91   
% 219.04/219.26  |- mesh__publicMeSHNote mesh__D016620
% 219.04/219.26       92; ENPROSTIL was indexed under PROSTAGLANDINS E, SYNTHETIC 1985-91%A%  
% 219.04/219.26  |- mesh__dateEstablished mesh__D016620 1992-01-01
% 219.04/219.26  |- mesh__dateRevised mesh__D016620 2005-06-30
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D016620 2006
% 219.04/219.26  |- skos__hiddenLabel mesh__D016620 RS84135
% 219.04/219.26  |- mesh__dateCreated mesh__D016620 1991-01-25
% 219.04/219.26  |- skos__prefLabel mesh__D016620 Enprostil
% 219.04/219.26  |- mesh__recordMaintainer mesh__D016620 ssb
% 219.04/219.26  |- mesh__recordAuthorizer mesh__D016620 sjn
% 219.04/219.26  |- skos__scopeNote mesh__D016620
% 219.04/219.26       A synthetic PGE2 analog that has an inhibitory effect on gastric acid secretion, a mucoprotective effect, and a postprandial lowering effect on gastrin. It has been shown to be efficient and safe in the treatment of gastroduodenal ulcers.%A%    
% 219.04/219.26  |- mesh__recordOriginator mesh__D016620 RLS
% 219.04/219.26  |- rdf__type mesh__D016620sskos__Concept
% 219.04/219.26  |- skos__historyNote mesh__D016620
% 219.04/219.26       Prostaglandins E, Synthetic %28%1978-1991%29%
% 219.04/219.26  |- skos__hiddenLabel mesh__D016620 RS 84135
% 219.04/219.26  |- rdf__type mesh__D007894sskos__Concept
% 219.04/219.26  |- mesh__publicMeSHNote mesh__D007894 86   
% 219.04/219.26  |- mesh__recordOriginator mesh__D007894 EC
% 219.04/219.26  |- skos__historyNote mesh__D007894 Leishmania %28%1966-1985%29%
% 219.04/219.26  |- skos__prefLabel mesh__D007894 Leishmania mexicana
% 219.04/219.26  |- mesh__dateEstablished mesh__D007894 1986-01-01
% 219.04/219.26  |- skos__broader mesh__D007894smesh__D007891
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007894 2006
% 219.04/219.26  |- skos__scopeNote mesh__D007894
% 219.04/219.26       A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals including rodents. The Leishmania mexicana complex causes both cutaneous %28%LEISHMANIASIS, CUTANEOUS%29% and diffuse cutaneous leishmaniasis %28%LEISHMANIASIS, DIFFUSE CUTANEOUS%29% and includes the subspecies amazonensis, garnhami, mexicana, pifanoi, and venezuelensis. L. m. mexicana causes chiclero ulcer, a form of cutaneous leishmaniasis %28%LEISHMANIASIS, CUTANEOUS%29% in the New World. The sandfly, Lutzomyia, appears to be the vector.%A%    
% 219.04/219.26  |- skos__altLabel mesh__D007894 Leishmania leishmania mexicana
% 219.04/219.26  |- mesh__dateRevised mesh__D007894 2003-07-09
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007894 2005
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007894 2004
% 219.04/219.26  |- mesh__dateCreated mesh__D007894 1985-03-20
% 219.04/219.26  |- skos__altLabel mesh__D007894 Leishmania %28%Leishmania%29% mexicana
% 219.04/219.26  |- skos__annotation mesh__D007894
% 219.04/219.26       infection: coord IM with LEISHMANIASIS, CUTANEOUS %28%IM%29% or LEISHMANIASIS, DIFFUSE CUTANEOUS %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 219.04/219.26  |- mesh__recordAuthorizer mesh__D007894 sjn
% 219.04/219.26  |- mesh__historyNote mesh__D007894 86   
% 219.04/219.26  |- mesh__recordMaintainer mesh__D007894 ags
% 219.04/219.26  |- skos__prefLabel mesh__D007096 Imidoesters
% 219.04/219.26  |- mesh__dateRevised mesh__D007096 1995-06-08
% 219.04/219.26  |- mesh__recordAuthorizer mesh__D007096 PLS
% 219.04/219.26  |- skos__annotation mesh__D007096 reagents; D25-26 qualif   
% 219.04/219.26  |- mesh__dateCreated mesh__D007096 1979-02-21
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007096 2002
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007096 1997
% 219.04/219.26  |- skos__historyNote mesh__D007096 Imides %28%1966-1979%29%
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007096 2001
% 219.04/219.26  |- skos__scopeNote mesh__D007096
% 219.04/219.26       Esters of the hypothetical imidic acids. They react with amines or amino acids to form amidines and are therefore used to modify protein structures and as cross-linking agents.%A%    
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007096 1996
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007096 1999
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007096 2004
% 219.04/219.26  |- mesh__publicMeSHNote mesh__D007096
% 219.04/219.26       80; DIMETHYL ADIPIMIDATE was see under IMIDES 1978-79; DIMETHYL SUBERIMIDATE was see under IMIDES 1975-79%A%  
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007096 2000
% 219.04/219.26  |- mesh__recordMaintainer mesh__D007096 JRT
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007096 1998
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007096 2003
% 219.04/219.26  |- mesh__dateEstablished mesh__D007096 1980-01-01
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007096 2006
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007096 2005
% 219.04/219.26  |- mesh__historyNote mesh__D007096 80   
% 219.04/219.26  |- skos__broader mesh__D007096smesh__D007094
% 219.04/219.26  |- rdf__type mesh__D007096sskos__Concept
% 219.04/219.26  |- mesh__recordOriginator mesh__D007096 RLS
% 219.04/219.26  |- mesh__dateRevised mesh__D015528 2004-07-13
% 219.04/219.26  |- mesh__dateEstablished mesh__D015528 1990-01-01
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D015528 2006
% 219.04/219.26  |- skos__historyNote mesh__D015528 Antibodies, Viral %28%1983-1987%29%
% 219.04/219.26  |- skos__scopeNote mesh__D015528
% 219.04/219.26       Studies of the number of cases where human immunodeficiency virus %28%HIV%29% is present in a specific population at a designated time. The presence in a given individual is determined by the finding of HIV antibodies in the serum %28%HIV SEROPOSITIVITY%29%.%A%    
% 219.04/219.26  |- mesh__recordAuthorizer mesh__D015528 sjn
% 219.04/219.26  |- skos__historyNote mesh__D015528
% 219.04/219.26       HIV Seropositivity/epidemiology %28%1988-1989%29%
% 219.04/219.26  |- rdf__type mesh__D015528sskos__Concept
% 219.04/219.26  |- skos__broader mesh__D015528smesh__D016036
% 219.04/219.26  |- skos__hiddenLabel mesh__D015528 Seroprevalence, HIV
% 219.04/219.26  |- mesh__recordOriginator mesh__D015528 AGS
% 219.04/219.26  |- mesh__historyNote mesh__D015528 90   
% 219.04/219.26  |- skos__prefLabel mesh__D015528 HIV Seroprevalence
% 219.04/219.26  |- mesh__dateCreated mesh__D015528 1989-05-25
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D015528 2005
% 219.04/219.26  |- skos__annotation mesh__D015528
% 219.04/219.26       IM; an epidemiol concept: do not confuse with HIV SEROPOSITIVITY, a diag finding; specify geog if pertinent%A%  
% 219.04/219.26  |- mesh__recordMaintainer mesh__D015528 sjn
% 219.04/219.26  |- mesh__publicMeSHNote mesh__D015528 90   
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D001508 1997
% 219.04/219.26  |- skos__altLabel mesh__D001508 Swing Beds
% 219.04/219.26  |- skos__prefLabel mesh__D001508 Bed Conversion
% 219.04/219.26  |- mesh__publicMeSHNote mesh__D001508
% 219.04/219.26       91; was see under HEALTH FACILITY PLANNING 1982-90   
% 219.04/219.26  |- skos__hiddenLabel mesh__D001508 Conversions, Bed
% 219.04/219.26  |- skos__historyNote mesh__D001508 Hospital Planning %28%1968-1981%29%
% 219.04/219.26  |- mesh__historyNote mesh__D001508
% 219.04/219.26       91%28%82%29%; was see under HEALTH FACILITY PLANNING 1982-90   
% 219.04/219.26  |- mesh__recordAuthorizer mesh__D001508 NLM
% 219.04/219.26  |- skos__hiddenLabel mesh__D001508 Conversion, Bed
% 219.04/219.26  |- mesh__dateRevised mesh__D001508 1993-09-16
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D001508 2000
% 219.04/219.26  |- skos__hiddenLabel mesh__D001508 Bed Conversions
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D001508 2005
% 219.04/219.26  |- skos__annotation mesh__D001508
% 219.04/219.26       from one type of care service to another   
% 219.04/219.26  |- skos__scopeNote mesh__D001508
% 219.04/219.26       The reallocation of beds from one type of care service to another, as in converting acute care beds to long term care beds.%A%    
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D001508 2001
% 219.04/219.26  |- skos__broader mesh__D001508smesh__D006275
% 219.04/219.26  |- mesh__recordOriginator mesh__D001508 EC
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D001508 2003
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D001508 2006
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D001508 1998
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D001508 2002
% 219.04/219.26  |- skos__historyNote mesh__D001508 Bed Occupancy %28%1978-1981%29%
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D001508 1995
% 219.04/219.26  |- mesh__recordMaintainer mesh__D001508 PLS
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D001508 2004
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D001508 1996
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D001508 1999
% 219.04/219.26  |- rdf__type mesh__D001508sskos__Concept
% 219.04/219.26  |- mesh__dateEstablished mesh__D001508 1991-01-01
% 219.04/219.26  |- skos__hiddenLabel mesh__D001508 Swing Bed
% 219.04/219.26  |- skos__hiddenLabel mesh__D001508 Bed, Swing
% 219.04/219.26  |- mesh__dateCreated mesh__D001508 1981-02-26
% 219.04/219.26  |- skos__prefLabel mesh__D012230 Rhizobiaceae
% 219.04/219.26  |- mesh__dateRevised mesh__D012230 2005-06-30
% 219.04/219.26  |- mesh__publicMeSHNote mesh__D012230 75   
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D012230 2006
% 219.04/219.26  |- skos__broader mesh__D012230smesh__D020561
% 219.04/219.26  |- skos__historyNote mesh__D012230 Bacteria %28%1966-1974%29%
% 219.04/219.26  |- mesh__recordMaintainer mesh__D012230 SYSTEM
% 219.04/219.26  |- mesh__dateEstablished mesh__D012230 1975-01-01
% 219.04/219.26  |- skos__scopeNote mesh__D012230
% 219.04/219.26       A family of gram-negative bacteria which are saprophytes, symbionts, or plant pathogens.%A%    
% 219.04/219.26  |- mesh__dateCreated mesh__D012230 1999-01-01
% 219.04/219.26  |- rdf__type mesh__D012230sskos__Concept
% 219.04/219.26  |- mesh__recordAuthorizer mesh__D012230 sjn
% 219.04/219.26  |- skos__broader mesh__D012230smesh__D016946
% 219.04/219.26  |- mesh__historyNote mesh__D012230 75   
% 219.04/219.26  |- skos__annotation mesh__D012230 in soil, water %26% plants   
% 219.04/219.26  |- mesh__recordOriginator mesh__D012230 NLM
% 219.04/219.26  |- skos__prefLabel mesh__D031993 Sanguisorba
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D031993 2004
% 219.04/219.26  |- mesh__publicMeSHNote mesh__D031993 2003   
% 219.04/219.26  |- skos__broader mesh__D031993smesh__D027824
% 219.04/219.26  |- mesh__historyNote mesh__D031993 2003   
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D031993 2003
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D031993 2006
% 219.04/219.26  |- skos__altLabel mesh__D031993 Burnet
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D031993 2005
% 219.04/219.26  |- mesh__dateEstablished mesh__D031993 2003-01-01
% 219.04/219.26  |- skos__scopeNote mesh__D031993
% 219.04/219.26       A plant genus of the family ROSACEAE. Members contain sanguiin.%A%    
% 219.04/219.26  |- mesh__dateCreated mesh__D031993 2002-07-02
% 219.04/219.26  |- rdf__type mesh__D031993sskos__Concept
% 219.04/219.26  |- skos__annotation mesh__D031993
% 219.04/219.26       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D019919 1999
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D019919 2001
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D019919 2003
% 219.04/219.26  |- mesh__publicMeSHNote mesh__D019919 98   
% 219.04/219.26  |- mesh__historyNote mesh__D019919 98   
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D019919 2002
% 219.04/219.26  |- skos__hiddenLabel mesh__D019919 Implantation, Prosthesis
% 219.04/219.26  |- mesh__dateEstablished mesh__D019919 1998-01-01
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D019919 2004
% 219.04/219.26  |- skos__scopeNote mesh__D019919 Surgical insertion of a prosthesis.     
% 219.04/219.26  |- skos__historyNote mesh__D019919
% 219.04/219.26       Prostheses and Implants %28%1966-1997%29%
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D019919 2005
% 219.04/219.26  |- skos__broader mesh__D019919smesh__D013514
% 219.04/219.26  |- skos__prefLabel mesh__D019919 Prosthesis Implantation
% 219.04/219.26  |- skos__hiddenLabel mesh__D019919 Implantations, Prosthesis
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D019919 2006
% 219.04/219.26  |- skos__hiddenLabel mesh__D019919 Prosthesis Implantations
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D019919 1998
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D019919 2000
% 219.04/219.26  |- rdf__type mesh__D019919sskos__Concept
% 219.04/219.26  |- skos__historyNote mesh__D019919 specific prosthesis %28%1966-1997%29%
% 219.04/219.26  |- mesh__dateCreated mesh__D019919 1997-06-20
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011936 1997
% 219.04/219.26  |- mesh__dateRevised mesh__D011936 1990-04-13
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011936 2003
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011936 2001
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011936 1999
% 219.04/219.26  |- skos__annotation mesh__D011936
% 219.04/219.26       note category: not a diag test: %22%ego function that consists of the objective evaluation %26% judgment of the external world%22%; no qualif%A%  
% 219.04/219.26  |- skos__hiddenLabel mesh__D011936 Reality Testings
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011936 1992
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011936 2005
% 219.04/219.26  |- mesh__dateEstablished mesh__D011936 1991-01-01
% 219.04/219.26  |- skos__scopeNote mesh__D011936
% 219.04/219.26       The individual%27%s objective evaluation of the external world and the ability to differentiate adequately between it and the internal world; considered to be a primary ego function.%A%    
% 219.04/219.26  |- mesh__publicMeSHNote mesh__D011936 91; was see under EGO 1979-90   
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011936 1994
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011936 2004
% 219.04/219.26  |- skos__hiddenLabel mesh__D011936 Testings, Reality
% 219.04/219.26  |- mesh__dateCreated mesh__D011936 1978-04-26
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011936 1993
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011936 2006
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011936 1995
% 219.04/219.26  |- mesh__recordMaintainer mesh__D011936 NLM
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011936 2002
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011936 1991
% 219.04/219.26  |- skos__prefLabel mesh__D011936 Reality Testing
% 219.04/219.26  |- skos__hiddenLabel mesh__D011936 Testing, Reality
% 219.04/219.26  |- rdf__type mesh__D011936sskos__Concept
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011936 1996
% 219.04/219.26  |- mesh__recordOriginator mesh__D011936 EC
% 219.04/219.26  |- skos__broader mesh__D011936smesh__D004532
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011936 1998
% 219.04/219.26  |- mesh__recordAuthorizer mesh__D011936 PLS
% 219.04/219.26  |- mesh__historyNote mesh__D011936
% 219.04/219.26       91%28%79%29%; was see under EGO 1979-90   
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011936 2000
% 219.04/219.26  |- skos__altLabel mesh__D011138 PTFE
% 219.04/219.26  |- mesh__dateEstablished mesh__D011138 1973-01-01
% 219.04/219.26  |- rdf__type mesh__D011138sskos__Concept
% 219.04/219.26  |- mesh__historyNote mesh__D011138
% 219.04/219.26       73; was see under FLUOROCARBON POLYMERS 1966-72   
% 219.04/219.26  |- mesh__dateCreated mesh__D011138 1999-01-01
% 219.04/219.26  |- mesh__dateRevised mesh__D011138 2004-07-07
% 219.04/219.26  |- skos__scopeNote mesh__D011138
% 219.04/219.26       Homopolymer of tetrafluoroethylene. Nonflammable, tough, inert plastic tubing or sheeting; used to line vessels, insulate, protect or lubricate apparatus; also as filter, coating for surgical implants or as prosthetic material. Synonyms: Fluoroflex; Fluoroplast; Ftoroplast; Halon; Polyfene; PTFE; Tetron.%A%    
% 219.04/219.26  |- skos__prefLabel mesh__D011138 Polytetrafluoroethylene
% 219.04/219.26  |- skos__altLabel mesh__D011138 TFE
% 219.04/219.26  |- skos__altLabel mesh__D011138 FEP
% 219.04/219.26  |- mesh__publicMeSHNote mesh__D011138
% 219.04/219.26       73; was see under FLUOROCARBON POLYMERS 1966-72   
% 219.04/219.26  |- skos__annotation mesh__D011138 a fluorocarbon polymer; D25-26 qualif   
% 219.04/219.26  |- skos__historyNote mesh__D011138 Fluorocarbon Polymers %28%1966-1972%29%
% 219.04/219.26  |- mesh__recordMaintainer mesh__D011138 lkt
% 219.04/219.26  |- mesh__recordAuthorizer mesh__D011138 sjn
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011138 2005
% 219.04/219.26  |- skos__altLabel mesh__D011138 Polytef
% 219.04/219.26  |- mesh__recordOriginator mesh__D011138 NLM
% 219.04/219.26  |- skos__broader mesh__D011138smesh__D005465
% 219.04/219.26  |- skos__altLabel mesh__D011138 Politef
% 219.04/219.26  |- skos__hiddenLabel mesh__D011138 PTFE, Expanded
% 219.04/219.26  |- skos__hiddenLabel mesh__D011138 GORE TEX
% 219.04/219.26  |- skos__altLabel mesh__D011138 Goretex
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D011138 2006
% 219.04/219.26  |- mesh__onlineNote mesh__D011138 search FLUOROCARBON POLYMERS 1966-72   
% 219.04/219.26  |- skos__scopeNote mesh__D002601
% 219.04/219.26       The primary sore of syphilis, a painless indurated, eroded papule, occurring at the site of entry of the infection.%A%    
% 219.04/219.26  |- skos__hiddenLabel mesh__D002601 Chancres
% 219.04/219.26  |- skos__broader mesh__D002601smesh__D013587
% 219.04/219.26  |- mesh__dateCreated mesh__D002601 1999-01-01
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D002601 2005
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D002601 1998
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D002601 2001
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D002601 1995
% 219.04/219.26  |- mesh__recordAuthorizer mesh__D002601 PLS
% 219.04/219.26  |- mesh__historyNote mesh__D002601
% 219.04/219.26       91%28%75%29%; was see under SYPHILIS 1975-90   
% 219.04/219.26  |- mesh__onlineNote mesh__D002601 search SYPHILIS 1966-74   
% 219.04/219.26  |- mesh__recordOriginator mesh__D002601 NLM
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D002601 1992
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D002601 2006
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D002601 1999
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D002601 2003
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D002601 1996
% 219.04/219.26  |- mesh__dateRevised mesh__D002601 1991-11-25
% 219.04/219.26  |- mesh__publicMeSHNote mesh__D002601 91; was see under SYPHILIS 1975-90   
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D002601 1993
% 219.04/219.26  |- skos__annotation mesh__D002601
% 219.04/219.26       primary lesion of syphilis: do not confuse with CHANCROID %28%caused by Haemophilus ducreyi%29%%A%  
% 219.04/219.26  |- mesh__dateEstablished mesh__D002601 1991-01-01
% 219.04/219.26  |- mesh__recordMaintainer mesh__D002601 PLS
% 219.04/219.26  |- skos__prefLabel mesh__D002601 Chancre
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D002601 2002
% 219.04/219.26  |- rdf__type mesh__D002601sskos__Concept
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D002601 2004
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D002601 1997
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D002601 2000
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D002601 1994
% 219.04/219.26  |- mesh__recordAuthorizer mesh__D007895 sjn
% 219.04/219.26  |- skos__altLabel mesh__D007895 Leishmania leishmania tropica
% 219.04/219.26  |- skos__prefLabel mesh__D007895 Leishmania tropica
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007895 2006
% 219.04/219.26  |- mesh__onlineNote mesh__D007895
% 219.04/219.26       use LEISHMANIA TROPICA to search LEISHMANIA MINOR 1986-91%A%  
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007895 2005
% 219.04/219.26  |- skos__altLabel mesh__D007895 Leishmania %28%Leishmania%29% tropica
% 219.04/219.26  |- mesh__historyNote mesh__D007895
% 219.04/219.26       86; LEISHMANIA TROPICA MINOR was LEISHMANIA MINOR see LEISHMANIA TROPICA 1986-91%A%  
% 219.04/219.26  |- skos__annotation mesh__D007895
% 219.04/219.26       infection: coordinate IM with probably LEISHMANIASIS, CUTANEOUS %28%IM%29% or other specific leishmaniasis term %28%IM%29% if appropriate; coordinate with specific protozoan terms %28%ANTIGENS, PROTOZOAN, etc%29% if pertinent%A%  
% 219.04/219.26  |- mesh__dateRevised mesh__D007895 2004-07-07
% 219.04/219.26  |- mesh__recordOriginator mesh__D007895 EC
% 219.04/219.26  |- skos__historyNote mesh__D007895 Leishmania %28%1966-1985%29%
% 219.04/219.26  |- mesh__dateEstablished mesh__D007895 1986-01-01
% 219.04/219.26  |- skos__scopeNote mesh__D007895
% 219.04/219.26       A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and rodents. This taxonomic complex includes species which cause a disease called Oriental sore which is a form of cutaneous leishmaniasis %28%LEISHMANIASIS, CUTANEOUS%29% of the Old World.%A%    
% 219.04/219.26  |- skos__broader mesh__D007895smesh__D007891
% 219.04/219.26  |- mesh__publicMeSHNote mesh__D007895
% 219.04/219.26       86; LEISHMANIA TROPICA MINOR was LEISHMANIA MINOR see LEISHMANIA TROPICA 1986-91%A%  
% 219.04/219.26  |- mesh__recordMaintainer mesh__D007895 ags
% 219.04/219.26  |- skos__altLabel mesh__D007895 Leishmania tropica minor
% 219.04/219.26  |- rdf__type mesh__D007895sskos__Concept
% 219.04/219.26  |- mesh__dateCreated mesh__D007895 1985-03-20
% 219.04/219.26  |- mesh__recordOriginator mesh__D007097 NLM
% 219.04/219.26  |- mesh__dateRevised mesh__D007097 1992-05-19
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007097 1997
% 219.04/219.26  |- mesh__recordMaintainer mesh__D007097 TAP
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007097 1996
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007097 1993
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007097 1999
% 219.04/219.26  |- skos__prefLabel mesh__D007097 Imines
% 219.04/219.26  |- mesh__recordAuthorizer mesh__D007097 PLS
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007097 2004
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007097 1995
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007097 1998
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007097 2002
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007097 2003
% 219.04/219.26  |- skos__broader mesh__D007097smesh__D009930
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007097 2006
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007097 1994
% 219.04/219.26  |- mesh__dateCreated mesh__D007097 1999-01-01
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007097 2001
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007097 2005
% 219.04/219.26  |- rdf__type mesh__D007097sskos__Concept
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D007097 2000
% 219.04/219.26  |- skos__annotation mesh__D007097 do not confuse with IMIDES or AMINES   
% 219.04/219.26  |- skos__altLabel mesh__D015529 Choledochal Cyst, Diverticulum
% 219.04/219.26  |- skos__hiddenLabel mesh__D015529 Diverticulum Choledochal Cysts
% 219.04/219.26  |- skos__broader mesh__D015529smesh__D004065
% 219.04/219.26  |- rdf__type mesh__D015529sskos__Concept
% 219.04/219.26  |- skos__altLabel mesh__D015529 Cyst, Common Bile Duct
% 219.04/219.26  |- skos__altLabel mesh__D015529 Cysts, Common Bile Duct
% 219.04/219.26  |- skos__scopeNote mesh__D015529
% 219.04/219.26       A congenital anatomic malformation of a bile duct, including cystic dilatation of the extrahepatic bile duct or the large intrahepatic bile duct. Classification is based on the site and type of dilatation. Type I is most common.%A%    
% 219.04/219.26  |- skos__hiddenLabel mesh__D015529 Choledochal Cysts, Diverticulum
% 219.04/219.26  |- skos__altLabel mesh__D015529 Intrahepatic Choledochal Cyst
% 219.04/219.26  |- skos__altLabel mesh__D015529 Common Bile Duct Cyst
% 219.04/219.26  |- mesh__recordOriginator mesh__D015529 PXP
% 219.04/219.26  |- skos__altLabel mesh__D015529 Choledochocele
% 219.04/219.26  |- skos__historyNote mesh__D015529 Biliary Tract Diseases %28%1972-1979%29%
% 219.04/219.26  |- skos__historyNote mesh__D015529 Common Bile Duct %28%1966-1979%29%
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D015529 2004
% 219.04/219.26  |- mesh__dateRevised mesh__D015529 2003-07-09
% 219.04/219.26  |- skos__hiddenLabel mesh__D015529 Intrahepatic Choledochal Cysts
% 219.04/219.26  |- skos__altLabel mesh__D015529 Choledochal Diverticulum
% 219.04/219.26  |- mesh__recordMaintainer mesh__D015529 lkt
% 219.04/219.26  |- skos__altLabel mesh__D015529 Multiple Choledochal Cysts
% 219.04/219.26  |- skos__prefLabel mesh__D015529 Choledochal Cyst
% 219.04/219.26  |- skos__hiddenLabel mesh__D015529 Choledochoceles
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D015529 2005
% 219.04/219.26  |- skos__hiddenLabel mesh__D015529 Choledochal Cyst, Intrahepatic
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D015529 2006
% 219.04/219.26  |- skos__broader mesh__D015529smesh__D003560
% 219.04/219.26  |- skos__broader mesh__D015529smesh__D001649
% 219.04/219.26  |- skos__hiddenLabel mesh__D015529 Choledochal Cysts
% 219.04/219.26  |- skos__historyNote mesh__D015529 Cysts %28%1966-1989%29%
% 219.04/219.26  |- mesh__publicMeSHNote mesh__D015529 90   
% 219.04/219.26  |- mesh__dateCreated mesh__D015529 1989-04-07
% 219.04/219.26  |- mesh__recordAuthorizer mesh__D015529 sjn
% 219.04/219.26  |- skos__hiddenLabel mesh__D015529 Choledochal Cysts, Intrahepatic
% 219.04/219.26  |- skos__annotation mesh__D015529
% 219.04/219.26       non-neoplastic; /blood supply /chem /secret /ultrastruct permitted%A%  
% 219.04/219.26  |- skos__historyNote mesh__D015529
% 219.04/219.26       Common Bile Duct Diseases %28%1980-1989%29%
% 219.04/219.26  |- skos__hiddenLabel mesh__D015529 Diverticulum Choledochal Cyst
% 219.04/219.26  |- mesh__historyNote mesh__D015529 90   
% 219.04/219.26  |- mesh__dateEstablished mesh__D015529 1990-01-01
% 219.04/219.26  |- skos__annotation mesh__D001509
% 219.04/219.26       coord IM with specific hosp or department %28%IM%29% + geog if pertinent%A%  
% 219.04/219.26  |- mesh__dateRevised mesh__D001509 1997-06-20
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D001509 2005
% 219.04/219.26  |- skos__broader mesh__D001509smesh__D006268
% 219.04/219.26  |- mesh__recordMaintainer mesh__D001509 TGC
% 219.04/219.26  |- skos__hiddenLabel mesh__D001509 Occupancies, Bed
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D001509 2003
% 219.04/219.26  |- skos__hiddenLabel mesh__D001509 Bed Occupancies
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D001509 2006
% 219.04/219.26  |- mesh__activeMeSHYear mesh__D001509 1998
% 219.04/219.26  |- mesh__dateEstablished mesh__D001509 1978-01-01
% 219.04/219.26  |- mesh__publicMeSHNote mesh__D001509 78   
% 219.04/219.26  |- skos__prefLabel mesh__D001509 Bed Occupancy
% 219.04/219.27  |- skos__hiddenLabel mesh__D001509 Occupancy, Bed
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D001509 2000
% 219.04/219.27  |- skos__scopeNote mesh__D001509
% 219.04/219.27       A measure of inpatient health facility use based upon the average number or proportion of beds occupied for a given period of time.%A%    
% 219.04/219.27  |- mesh__historyNote mesh__D001509 78   
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D001509 2004
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D001509 1999
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D001509 2001
% 219.04/219.27  |- rdf__type mesh__D001509sskos__Concept
% 219.04/219.27  |- mesh__recordOriginator mesh__D001509 EC
% 219.04/219.27  |- mesh__dateCreated mesh__D001509 1977-05-05
% 219.04/219.27  |- mesh__recordAuthorizer mesh__D001509 SJN
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D001509 2002
% 219.04/219.27  |- skos__related mesh__D001509smesh__D006742
% 219.04/219.27  |- mesh__dateCreated mesh__D012231 1999-01-01
% 219.04/219.27  |- mesh__recordAuthorizer mesh__D012231 sjn
% 219.04/219.27  |- skos__prefLabel mesh__D012231 Rhizobium
% 219.04/219.27  |- mesh__recordOriginator mesh__D012231 NLM
% 219.04/219.27  |- mesh__dateRevised mesh__D012231 2005-06-30
% 219.04/219.27  |- mesh__historyNote mesh__D012231 1963   
% 219.04/219.27  |- skos__scopeNote mesh__D012231
% 219.04/219.27       A genus of gram-negative, aerobic, rod-shaped bacteria that produce nodules on the roots of leguminous plants. Members of this genus are common soil inhabitants.%A%    
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D012231 2006
% 219.04/219.27  |- skos__broader mesh__D012231smesh__D012230
% 219.04/219.27  |- mesh__publicMeSHNote mesh__D012231
% 219.04/219.27       1963; for AGROBACTERIUM see AGROBACTERIUM 1963-2003   
% 219.04/219.27  |- mesh__recordMaintainer mesh__D012231 SYSTEM
% 219.04/219.27  |- rdf__type mesh__D012231sskos__Concept
% 219.04/219.27  |- skos__prefLabel mesh__D031994 Sorbus
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D031994 2003
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D031994 2006
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D031994 2005
% 219.04/219.27  |- skos__broader mesh__D031994smesh__D027824
% 219.04/219.27  |- mesh__historyNote mesh__D031994 2003   
% 219.04/219.27  |- skos__scopeNote mesh__D031994 A plant genus of the family ROSACEAE.     
% 219.04/219.27  |- rdf__type mesh__D031994sskos__Concept
% 219.04/219.27  |- skos__altLabel mesh__D031994 Mountain Ash
% 219.04/219.27  |- skos__annotation mesh__D031994
% 219.04/219.27       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.04/219.27  |- mesh__dateEstablished mesh__D031994 2003-01-01
% 219.04/219.27  |- skos__altLabel mesh__D031994 Rowan
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D031994 2004
% 219.04/219.27  |- mesh__publicMeSHNote mesh__D031994 2003   
% 219.04/219.27  |- skos__altLabel mesh__D031994 Ash, Mountain
% 219.04/219.27  |- mesh__dateCreated mesh__D031994 2002-07-02
% 219.04/219.27  |- mesh__dateRevised mesh__D011937 1999-11-03
% 219.04/219.27  |- skos__altLabel mesh__D011937 Therapy, Reality
% 219.04/219.27  |- skos__annotation mesh__D011937
% 219.04/219.27       a psychother technique; DF: REALITY THER   
% 219.04/219.27  |- skos__prefLabel mesh__D011937 Reality Therapy
% 219.04/219.27  |- mesh__recordMaintainer mesh__D011937 jls
% 219.04/219.27  |- skos__scopeNote mesh__D011937
% 219.04/219.27       Method of psychotherapeutic treatment based on assumption of patients%27% personal responsibility for their own behavior. The therapist actively guides patients to accurate self-perception for fulfillment of needs of self-worth and respect for others. %28%From APA, Thesaurus of Psychological Index Terms, 8th ed.%29%%A%    
% 219.04/219.27  |- skos__hiddenLabel mesh__D011937 Therapies, Reality
% 219.04/219.27  |- skos__hiddenLabel mesh__D011937 Reality Therapies
% 219.04/219.27  |- rdf__type mesh__D011937sskos__Concept
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D011937 2000
% 219.04/219.27  |- mesh__dateCreated mesh__D011937 1999-01-01
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D011937 2001
% 219.04/219.27  |- mesh__historyNote mesh__D011937 74   
% 219.04/219.27  |- skos__broader mesh__D011937smesh__D011613
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D011937 2003
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D011937 2005
% 219.04/219.27  |- mesh__recordOriginator mesh__D011937 NLM
% 219.04/219.27  |- mesh__dateEstablished mesh__D011937 1974-01-01
% 219.04/219.27  |- mesh__recordAuthorizer mesh__D011937 sjn
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D011937 2004
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D011937 2002
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D011937 2006
% 219.04/219.27  |- mesh__publicMeSHNote mesh__D011937 74   
% 219.04/219.27  |- mesh__recordAuthorizer mesh__D011139 sjn
% 219.04/219.27  |- mesh__publicMeSHNote mesh__D011139 65   
% 219.04/219.27  |- mesh__historyNote mesh__D011139 65%28%64%29%   
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D011139 2006
% 219.04/219.27  |- mesh__dateRevised mesh__D011139 2005-06-30
% 219.04/219.27  |- mesh__recordOriginator mesh__D011139 NLM
% 219.04/219.27  |- rdf__type mesh__D011139sskos__Concept
% 219.04/219.27  |- mesh__recordMaintainer mesh__D011139 ssb
% 219.04/219.27  |- skos__broader mesh__D011139smesh__D001581
% 219.04/219.27  |- mesh__dateEstablished mesh__D011139 1965-01-01
% 219.04/219.27  |- skos__prefLabel mesh__D011139 Polythiazide
% 219.04/219.27  |- mesh__dateCreated mesh__D011139 1999-01-01
% 219.04/219.27  |- skos__scopeNote mesh__D011139
% 219.04/219.27       A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p826%29%%A%    
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D008190 2004
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D008190 2005
% 219.04/219.27  |- mesh__publicMeSHNote mesh__D008190
% 219.04/219.27       DESMOLASES was see under LYASES 1963-80   
% 219.04/219.27  |- skos__prefLabel mesh__D008190 Lyases
% 219.04/219.27  |- mesh__historyNote mesh__D008190
% 219.04/219.27       DESMOLASES was see under LYASES 1963-80   
% 219.04/219.27  |- mesh__recordMaintainer mesh__D008190 ssb
% 219.04/219.27  |- rdf__type mesh__D008190sskos__Concept
% 219.04/219.27  |- skos__broader mesh__D008190smesh__D004798
% 219.04/219.27  |- mesh__recordOriginator mesh__D008190 NLM
% 219.04/219.27  |- mesh__dateCreated mesh__D008190 1999-01-01
% 219.04/219.27  |- mesh__onlineNote mesh__D008190
% 219.04/219.27       use LYASES to search DESMOLASES 1966-80   
% 219.04/219.27  |- mesh__recordAuthorizer mesh__D008190 sjn
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D008190 2006
% 219.04/219.27  |- mesh__dateRevised mesh__D008190 2003-07-09
% 219.04/219.27  |- skos__scopeNote mesh__D008190
% 219.04/219.27       A class of enzymes that catalyze the cleavage of C-C, C-O, and C-N, and other bonds by other means than by hydrolysis or oxidation. %28%Enzyme Nomenclature, 1992%29% EC 4.%A%    
% 219.04/219.27  |- mesh__dateRevised mesh__D016622 2000-06-22
% 219.04/219.27  |- mesh__publicMeSHNote mesh__D016622 92   
% 219.04/219.27  |- skos__hiddenLabel mesh__D016622 Staining, Silver
% 219.04/219.27  |- rdf__type mesh__D016622sskos__Concept
% 219.04/219.27  |- mesh__historyNote mesh__D016622 92   
% 219.04/219.27  |- skos__annotation mesh__D016622
% 219.04/219.27       usually silver nitrate is the reagent in the staining so do not coord with SILVER NITRATE%A%  
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D016622 2002
% 219.04/219.27  |- mesh__recordOriginator mesh__D016622 MXR
% 219.04/219.27  |- skos__hiddenLabel mesh__D016622 Staining, Silver Nitrate
% 219.04/219.27  |- skos__historyNote mesh__D016622 Staining %28%1966-1991%29%
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D016622 2003
% 219.04/219.27  |- mesh__recordMaintainer mesh__D016622 ndw
% 219.04/219.27  |- skos__hiddenLabel mesh__D016622 Nitrate Staining, Silver
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D016622 2005
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D016622 2004
% 219.04/219.27  |- skos__broader mesh__D016622smesh__D013194
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D016622 2006
% 219.04/219.27  |- skos__prefLabel mesh__D016622 Silver Staining
% 219.04/219.27  |- mesh__dateEstablished mesh__D016622 1992-01-01
% 219.04/219.27  |- mesh__dateCreated mesh__D016622 1991-01-25
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D016622 2001
% 219.04/219.27  |- skos__scopeNote mesh__D016622
% 219.04/219.27       The use of silver, usually silver nitrate, as a reagent for producing contrast or coloration in tissue specimens.%A%    
% 219.04/219.27  |- mesh__recordAuthorizer mesh__D016622 sjn
% 219.04/219.27  |- skos__scopeNote mesh__D002602
% 219.04/219.27       Acute, localized autoinoculable infectious disease usually acquired through sexual contact. Caused by HAEMOPHILUS DUCREYI, it occurs endemically almost worldwide, especially in tropical and subtropical countries and more commonly in seaports and urban areas than in rural areas.%A%    
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002602 1995
% 219.04/219.27  |- skos__annotation mesh__D002602
% 219.04/219.27       caused by Haemophilus ducreyi; do not confuse with CHANCRE, the primary lesion of syphilis%A%  
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002602 2006
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002602 1999
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002602 2000
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002602 2003
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002602 1996
% 219.04/219.27  |- skos__hiddenLabel mesh__D002602 Chancroids
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002602 2001
% 219.04/219.27  |- skos__broader mesh__D002602smesh__D015231
% 219.04/219.27  |- mesh__recordAuthorizer mesh__D002602 PLS
% 219.04/219.27  |- rdf__type mesh__D002602sskos__Concept
% 219.04/219.27  |- skos__broader mesh__D002602smesh__D006192
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002602 2004
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002602 1997
% 219.04/219.27  |- mesh__recordOriginator mesh__D002602 NLM
% 219.04/219.27  |- skos__prefLabel mesh__D002602 Chancroid
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002602 2002
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002602 2005
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002602 1998
% 219.04/219.27  |- mesh__dateCreated mesh__D002602 1999-01-01
% 219.04/219.27  |- mesh__dateRevised mesh__D002602 1994-03-17
% 219.04/219.27  |- mesh__recordMaintainer mesh__D002602 PXP
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007896 2005
% 219.04/219.27  |- skos__annotation mesh__D007896
% 219.04/219.27       protozoan infect; GEN or unspecified; prefer specifics; American leishmaniasis is LEISHMANIASIS, AMERICAN see LEISHMANIASIS, CUTANEOUS; tegumentary leishmaniasis = LEISHMANIASIS, CUTANEOUS%A%  
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007896 2004
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007896 2001
% 219.04/219.27  |- mesh__recordOriginator mesh__D007896 NLM
% 219.04/219.27  |- mesh__dateCreated mesh__D007896 1999-01-01
% 219.04/219.27  |- skos__hiddenLabel mesh__D007896 Leishmaniases
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007896 2003
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007896 2000
% 219.04/219.27  |- skos__scopeNote mesh__D007896
% 219.04/219.27       A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous %28%Old and New World%29% %28%LEISHMANIASIS, CUTANEOUS%29%, diffuse cutaneous %28%LEISHMANIASIS, DIFFUSE CUTANEOUS%29%, mucocutaneous %28%LEISHMANIASIS, MUCOCUTANEOUS%29%, and visceral %28%LEISHMANIASIS, VISCERAL%29%.%A%    
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007896 1999
% 219.04/219.27  |- skos__prefLabel mesh__D007896 Leishmaniasis
% 219.04/219.27  |- mesh__recordMaintainer mesh__D007896 PLS
% 219.04/219.27  |- rdf__type mesh__D007896sskos__Concept
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007896 1998
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007896 1997
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007896 2002
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007896 1996
% 219.04/219.27  |- mesh__dateRevised mesh__D007896 1995-05-25
% 219.04/219.27  |- skos__broader mesh__D007896smesh__D012876
% 219.04/219.27  |- mesh__recordAuthorizer mesh__D007896 PLS
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007896 2006
% 219.04/219.27  |- skos__broader mesh__D007896smesh__D016772
% 219.04/219.27  |- mesh__publicMeSHNote mesh__D007098 74   
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007098 2001
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007098 1997
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007098 1998
% 219.04/219.27  |- mesh__historyNote mesh__D007098 74   
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007098 2003
% 219.04/219.27  |- mesh__dateCreated mesh__D007098 1999-01-01
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007098 1994
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007098 1993
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007098 1999
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007098 2004
% 219.04/219.27  |- mesh__recordAuthorizer mesh__D007098 PLS
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007098 2005
% 219.04/219.27  |- skos__broader mesh__D007098smesh__D000144
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007098 1995
% 219.04/219.27  |- skos__altLabel mesh__D007098 Acids, Secondary Amino
% 219.04/219.27  |- skos__annotation mesh__D007098
% 219.04/219.27       do not confuse with AMINO ACIDS; DF: AA SECOND for X ref   
% 219.04/219.27  |- skos__altLabel mesh__D007098 Secondary Amino Acids
% 219.04/219.27  |- mesh__recordOriginator mesh__D007098 NLM
% 219.04/219.27  |- mesh__dateRevised mesh__D007098 1992-05-20
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007098 2002
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007098 2006
% 219.04/219.27  |- mesh__dateEstablished mesh__D007098 1974-01-01
% 219.04/219.27  |- skos__altLabel mesh__D007098 Amino Acids, Secondary
% 219.04/219.27  |- skos__prefLabel mesh__D007098 Imino Acids
% 219.04/219.27  |- rdf__type mesh__D007098sskos__Concept
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007098 2000
% 219.04/219.27  |- mesh__recordMaintainer mesh__D007098 TGC
% 219.04/219.27  |- skos__broader mesh__D007098smesh__D007097
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007098 1996
% 219.04/219.27  |- skos__hiddenLabel mesh__D007098 Acids, Imino
% 219.04/219.27  |- skos__broader mesh__D007098smesh__D000598
% 219.04/219.27  |- skos__broader mesh__D012232smesh__D003904
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D012232 2006
% 219.04/219.27  |- mesh__dateCreated mesh__D012232 1974-12-12
% 219.04/219.27  |- mesh__recordAuthorizer mesh__D012232 sjn
% 219.04/219.27  |- mesh__dateEstablished mesh__D012232 1991-01-01
% 219.04/219.27  |- skos__prefLabel mesh__D012232 Rhizoctonia
% 219.04/219.27  |- mesh__recordOriginator mesh__D012232 NLM
% 219.04/219.27  |- mesh__dateRevised mesh__D012232 2005-06-30
% 219.04/219.27  |- rdf__type mesh__D012232sskos__Concept
% 219.04/219.27  |- mesh__recordMaintainer mesh__D012232 SYSTEM
% 219.04/219.27  |- mesh__publicMeSHNote mesh__D012232
% 219.04/219.27       91; see HYPHOMYCETES 1986-90, see DEUTEROMYCETES 1975-85   
% 219.04/219.27  |- mesh__historyNote mesh__D012232 91%28%75%29%   
% 219.04/219.27  |- skos__scopeNote mesh__D012232
% 219.04/219.27       A mitosporic Ceratobasidiaceae fungal genus that is an important plant pathogen affecting potatoes and other plants. There are numerous teleomorphs.%A%    
% 219.04/219.27  |- skos__scopeNote mesh__D031995
% 219.04/219.27       The saxifrage plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida. The leaves are alternate and sometimes deeply lobed or form rosettes. The flowers have both male and female parts and 4 or 5 sepals and petals; they are usually in branched clusters. The fruit is a capsule with many seeds.%A%    
% 219.04/219.27  |- skos__broader mesh__D031995smesh__D019685
% 219.04/219.27  |- rdf__type mesh__D031995sskos__Concept
% 219.04/219.27  |- skos__annotation mesh__D031995
% 219.04/219.27       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.04/219.27  |- skos__prefLabel mesh__D031995 Saxifragaceae
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D031995 2004
% 219.04/219.27  |- mesh__publicMeSHNote mesh__D031995 2003   
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D031995 2003
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D031995 2006
% 219.04/219.27  |- skos__altLabel mesh__D031995 Saxifrage
% 219.04/219.27  |- mesh__dateCreated mesh__D031995 2002-07-03
% 219.04/219.27  |- mesh__historyNote mesh__D031995 2003   
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D031995 2005
% 219.04/219.27  |- mesh__dateEstablished mesh__D031995 2003-01-01
% 219.04/219.27  |- mesh__recordAuthorizer mesh__D011938 sjn
% 219.04/219.27  |- skos__scopeNote mesh__D011938
% 219.04/219.27       A family of recombinases initially identified in BACTERIA. They catalyze the ATP-driven exchange of DNA strands in GENETIC RECOMBINATION. The product of the reaction consists of a duplex and a displaced single-stranded loop, which has the shape of the letter D and is therefore called a D-loop structure.%A%    
% 219.04/219.27  |- mesh__historyNote mesh__D011938 2004%28%1984%29%   
% 219.04/219.27  |- rdf__type mesh__D011938sskos__Concept
% 219.04/219.27  |- skos__altLabel mesh__D011938 Rec A Protein
% 219.04/219.27  |- mesh__publicMeSHNote mesh__D011938
% 219.04/219.27       2004; see REC A PROTEIN 1984-2003, see REC A PROTEIN %28%NM%29% 1966-1983%A%  
% 219.04/219.27  |- skos__broader mesh__D011938smesh__D009713
% 219.04/219.27  |- mesh__dateRevised mesh__D011938 2005-06-30
% 219.04/219.27  |- skos__broader mesh__D011938smesh__D045522
% 219.04/219.27  |- skos__historyNote mesh__D011938 Bacterial Proteins %28%1966-1983%29%
% 219.04/219.27  |- mesh__dateCreated mesh__D011938 1983-06-15
% 219.04/219.27  |- mesh__dateEstablished mesh__D011938 1984-01-01
% 219.04/219.27  |- mesh__recordMaintainer mesh__D011938 DRC
% 219.04/219.27  |- skos__prefLabel mesh__D011938 Rec A Recombinases
% 219.04/219.27  |- mesh__recordOriginator mesh__D011938 RLS
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D011938 2006
% 219.04/219.27  |- skos__hiddenLabel mesh__D011938 Recombinases, Rec A
% 219.04/219.27  |- skos__altLabel mesh__D011938 RecA Protein
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D008191 2004
% 219.04/219.27  |- skos__broader mesh__D008191smesh__D006878
% 219.04/219.27  |- mesh__dateEstablished mesh__D008191 1991-01-01
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D008191 1998
% 219.04/219.27  |- mesh__dateRevised mesh__D008191 1997-06-20
% 219.04/219.27  |- mesh__recordMaintainer mesh__D008191 ADP
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D008191 1999
% 219.04/219.27  |- mesh__dateCreated mesh__D008191 1999-01-01
% 219.04/219.27  |- mesh__recordAuthorizer mesh__D008191 SJN
% 219.04/219.27  |- rdf__type mesh__D008191sskos__Concept
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D008191 2000
% 219.04/219.27  |- mesh__historyNote mesh__D008191
% 219.04/219.27       91%28%75%29%; was see under CAUSTICS 1975-90   
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D008191 2005
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D008191 2001
% 219.04/219.27  |- mesh__publicMeSHNote mesh__D008191 91; was see under CAUSTICS 1975-90   
% 219.04/219.27  |- skos__scopeNote mesh__D008191
% 219.04/219.27       Generally speaking, it is the alkaline substance obtained from wood ashes by percolation. Preparations of lye can either be solutions of potassium or sodium hydroxide. The term lye, is also used to refer to the household product which is a mixture of sodium hydroxide and sodium carbonate.%A%    
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D008191 2006
% 219.04/219.27  |- mesh__onlineNote mesh__D008191 search CAUSTICS 1966-74   
% 219.04/219.27  |- skos__annotation mesh__D008191 a caustic   
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D008191 2003
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D008191 2002
% 219.04/219.27  |- mesh__recordOriginator mesh__D008191 NLM
% 219.04/219.27  |- skos__prefLabel mesh__D008191 Lye
% 219.04/219.27  |- skos__scopeNote mesh__D016623
% 219.04/219.27       A general class of integral membrane proteins that transport ions across a membrane against an electrochemical gradient.%A%    
% 219.04/219.27  |- skos__historyNote mesh__D016623
% 219.04/219.27       specific ion/metabolism %28%1967-1991%29%
% 219.04/219.27  |- skos__hiddenLabel mesh__D016623 Pumps, Ion
% 219.04/219.27  |- mesh__dateRevised mesh__D016623 2005-06-30
% 219.04/219.27  |- skos__annotation mesh__D016623 GEN: prefer specifics   
% 219.04/219.27  |- rdf__type mesh__D016623sskos__Concept
% 219.04/219.27  |- skos__altLabel mesh__D016623 Ion Pump
% 219.04/219.27  |- mesh__recordAuthorizer mesh__D016623 sjn
% 219.04/219.27  |- mesh__publicMeSHNote mesh__D016623
% 219.04/219.27       1994; see ION PUMP 1992-1993; for ION PUMP see BIOLOGICAL TRANSPORT, ACTIVE 1991%A%  
% 219.04/219.27  |- mesh__dateCreated mesh__D016623 1991-06-13
% 219.04/219.27  |- skos__historyNote mesh__D016623
% 219.04/219.27       Biological Transport, Active %28%1967-1991%29%
% 219.04/219.27  |- skos__broader mesh__D016623smesh__D026901
% 219.04/219.27  |- mesh__dateEstablished mesh__D016623 1992-01-01
% 219.04/219.27  |- mesh__recordOriginator mesh__D016623 PXP
% 219.04/219.27  |- mesh__recordMaintainer mesh__D016623 SYSTEM
% 219.04/219.27  |- mesh__historyNote mesh__D016623 1994%28%1992%29%;   
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D016623 2006
% 219.04/219.27  |- skos__prefLabel mesh__D016623 Ion Pumps
% 219.04/219.27  |- skos__hiddenLabel mesh__D016623 Pump, Ion
% 219.04/219.27  |- rdf__type mesh__D002603sskos__Concept
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002603 2004
% 219.04/219.27  |- skos__annotation mesh__D002603 Channel refers to the English Channel   
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002603 1997
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002603 2002
% 219.04/219.27  |- skos__prefLabel mesh__D002603 Channel Islands
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002603 2005
% 219.04/219.27  |- mesh__dateCreated mesh__D002603 1999-01-01
% 219.04/219.27  |- mesh__dateRevised mesh__D002603 1996-06-10
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002603 1998
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002603 2000
% 219.04/219.27  |- skos__scopeNote mesh__D002603
% 219.04/219.27       A group of four British islands and several islets in the English Channel off the coast of France. They are known to have been occupied prehistorically. They were a part of Normandy in 933 but were united to the British crown at the time of the Norman Conquest in 1066. Guernsey and Jersey originated noted breeds of cattle. %28%From Webster%27%s New Geographical Dictionary, 1988, p242%29%%A%    
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002603 2006
% 219.04/219.27  |- mesh__recordMaintainer mesh__D002603 TGC
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002603 1999
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002603 2001
% 219.04/219.27  |- mesh__recordAuthorizer mesh__D002603 PLS
% 219.04/219.27  |- skos__broader mesh__D002603smesh__D006113
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D002603 2003
% 219.04/219.27  |- mesh__recordOriginator mesh__D002603 NLM
% 219.04/219.27  |- mesh__dateCreated mesh__D007897 1999-01-01
% 219.04/219.27  |- skos__broader mesh__D007897smesh__D016773
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007897 2003
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007897 1994
% 219.04/219.27  |- mesh__recordAuthorizer mesh__D007897 PLS
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007897 1999
% 219.04/219.27  |- rdf__type mesh__D007897sskos__Concept
% 219.04/219.27  |- skos__annotation mesh__D007897
% 219.04/219.27       caused by Leishmania braziliensis or L. guyanensis   
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007897 2001
% 219.04/219.27  |- skos__hiddenLabel mesh__D007897 Mucocutaneous Leishmaniasis
% 219.04/219.27  |- mesh__dateRevised mesh__D007897 1993-06-03
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007897 1998
% 219.04/219.27  |- mesh__recordOriginator mesh__D007897 NLM
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007897 1997
% 219.04/219.27  |- skos__prefLabel mesh__D007897 Leishmaniasis, Mucocutaneous
% 219.04/219.27  |- skos__hiddenLabel mesh__D007897 Mucocutaneous Leishmaniases
% 219.04/219.27  |- skos__hiddenLabel mesh__D007897 Leishmaniases, Mucocutaneous
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007897 1996
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007897 2000
% 219.04/219.27  |- mesh__recordMaintainer mesh__D007897 PXP
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007897 2006
% 219.04/219.27  |- skos__scopeNote mesh__D007897
% 219.04/219.27       A disease characterized by the chronic, progressive spread of lesions from New World cutaneous leishmaniasis caused by species of the L. braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms.%A%    
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007897 2005
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007897 2004
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007897 1995
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007897 2002
% 219.04/219.27  |- skos__broader mesh__D009206Q000254smesh__D009206
% 219.04/219.27  |- mesh__preferredCombination mesh__D009206Q000254smesh__D006321Q000254
% 219.04/219.27  |- rdf__type mesh__D009206Q000254smesh__CompoundConcept
% 219.04/219.27  |- skos__altLabel mesh__D007099 Imidobenzyle
% 219.04/219.27  |- skos__broader mesh__D007099smesh__D003984
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007099 2004
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007099 2005
% 219.04/219.27  |- skos__altLabel mesh__D007099 Imizin
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007099 2001
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007099 2006
% 219.04/219.27  |- skos__scopeNote mesh__D007099
% 219.04/219.27       The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.%A%    
% 219.04/219.27  |- rdf__type mesh__D007099sskos__Concept
% 219.04/219.27  |- mesh__recordMaintainer mesh__D007099 TWD
% 219.04/219.27  |- mesh__recordAuthorizer mesh__D007099 sjn
% 219.04/219.27  |- skos__altLabel mesh__D007099 Imipramine Monohydrochloride
% 219.04/219.27  |- mesh__recordOriginator mesh__D007099 NLM
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007099 2002
% 219.04/219.27  |- skos__altLabel mesh__D007099 Norchlorimipramine
% 219.04/219.27  |- skos__prefLabel mesh__D007099 Imipramine
% 219.04/219.27  |- mesh__dateRevised mesh__D007099 2000-06-21
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D007099 2003
% 219.04/219.27  |- mesh__dateCreated mesh__D007099 1999-01-01
% 219.04/219.27  |- mesh__dateRevised mesh__D012233 2005-06-30
% 219.04/219.27  |- skos__broader mesh__D012233smesh__D009090
% 219.04/219.27  |- skos__annotation mesh__D012233
% 219.04/219.27       infection: coord IM with MUCORMYCOSIS %28%IM%29%   
% 219.04/219.27  |- rdf__type mesh__D012233sskos__Concept
% 219.04/219.27  |- skos__prefLabel mesh__D012233 Rhizopus
% 219.04/219.27  |- mesh__dateCreated mesh__D012233 1999-01-01
% 219.04/219.27  |- mesh__recordMaintainer mesh__D012233 SYSTEM
% 219.04/219.27  |- skos__scopeNote mesh__D012233
% 219.04/219.27       A genus of zygomycetous fungi of the family Mucoraceae, order MUCORALES, a common saprophyte and facultative parasite of mature fruits and vegetables. It may cause cerebral mycoses in diabetes and cutaneous infection in severely burned patients.%A%    
% 219.04/219.27  |- mesh__recordAuthorizer mesh__D012233 sjn
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D012233 2006
% 219.04/219.27  |- mesh__recordOriginator mesh__D012233 NLM
% 219.04/219.27  |- skos__annotation mesh__D031996
% 219.04/219.27       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.04/219.27  |- mesh__historyNote mesh__D031996 2003   
% 219.04/219.27  |- skos__scopeNote mesh__D031996
% 219.04/219.27       A plant genus of the family SAXIFRAGACEAE with dark green round or heart-shaped leaves and tiny flowers.%A%    
% 219.04/219.27  |- mesh__dateEstablished mesh__D031996 2003-01-01
% 219.04/219.27  |- skos__prefLabel mesh__D031996 Heuchera
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D031996 2004
% 219.04/219.27  |- mesh__publicMeSHNote mesh__D031996 2003   
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D031996 2006
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D031996 2003
% 219.04/219.27  |- skos__broader mesh__D031996smesh__D031995
% 219.04/219.27  |- mesh__dateCreated mesh__D031996 2002-07-02
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D031996 2005
% 219.04/219.27  |- skos__altLabel mesh__D031996 Alumroot
% 219.04/219.27  |- rdf__type mesh__D031996sskos__Concept
% 219.04/219.27  |- mesh__dateEstablished mesh__D036681 2003-01-01
% 219.04/219.27  |- rdf__type mesh__D036681sskos__Concept
% 219.04/219.27  |- mesh__historyNote mesh__D036681 2003   
% 219.04/219.27  |- skos__broader mesh__D036681smesh__D005470
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D036681 2005
% 219.04/219.27  |- mesh__dateCreated mesh__D036681 2002-07-03
% 219.04/219.27  |- mesh__dateRevised mesh__D036681 2004-07-07
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D036681 2006
% 219.04/219.27  |- mesh__publicMeSHNote mesh__D036681 2003   
% 219.04/219.27  |- mesh__recordOriginator mesh__D036681 ags
% 219.04/219.27  |- mesh__recordMaintainer mesh__D036681 ssb
% 219.04/219.27  |- skos__altLabel mesh__D036681 Fluorescence Photobleaching Recovery
% 219.04/219.27  |- skos__altLabel mesh__D036681
% 219.04/219.27       FRAP %28%Fluorescence Recovery After Photobleaching%29%
% 219.04/219.27  |- skos__scopeNote mesh__D036681
% 219.04/219.27       A method used to study the lateral movement of MEMBRANE PROTEINS and LIPIDS. A small area of a cell membrane is bleached by laser light and the amount of time necessary for unbleached fluorescent marker-tagged proteins to diffuse back into the bleached site is a measurement of the cell membrane%27%s fluidity. The diffusion coefficient of a protein or lipid in the membrane can be calculated from the data. %28%From Segen, Current Med Talk, 1995%29%.%A%    
% 219.04/219.27  |- skos__prefLabel mesh__D036681 Fluorescence Recovery After Photobleaching
% 219.04/219.27  |- skos__hiddenLabel mesh__D036681
% 219.04/219.27       FRAPs %28%Fluorescence Recovery After Photobleaching%29%
% 219.04/219.27  |- skos__historyNote mesh__D036681 Fluorescence %28%1976-2002%29%
% 219.04/219.27  |- mesh__recordAuthorizer mesh__D036681 sjn
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D011939 2006
% 219.04/219.27  |- mesh__activeMeSHYear mesh__D011939 2005
% 219.04/219.27  |- mesh__dateEstablished mesh__D011939 1991-01-01
% 219.04/219.28  |- mesh__dateRevised mesh__D011939 2002-07-03
% 219.04/219.28  |- skos__broader mesh__D011939smesh__D008568
% 219.04/219.28  |- skos__scopeNote mesh__D011939
% 219.04/219.28       The process whereby a representation of past experience is elicited.%A%    
% 219.04/219.28  |- rdf__type mesh__D011939sskos__Concept
% 219.04/219.28  |- skos__altLabel mesh__D011939 Recall
% 219.04/219.28  |- skos__prefLabel mesh__D011939 Mental Recall
% 219.04/219.28  |- mesh__recordOriginator mesh__D011939 NLM
% 219.04/219.28  |- mesh__recordAuthorizer mesh__D011939 sjn
% 219.04/219.28  |- mesh__dateCreated mesh__D011939 1999-01-01
% 219.04/219.28  |- mesh__historyNote mesh__D011939
% 219.04/219.28       2003 %28%1966%29%; use MEMORY 1966-1990   
% 219.04/219.28  |- mesh__onlineNote mesh__D011939 search MEMORY 1966-74   
% 219.04/219.28  |- mesh__publicMeSHNote mesh__D011939
% 219.04/219.28       2003; see RECALL 1991-2002, see MEMORY 1966-1990   
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D011939 2004
% 219.04/219.28  |- mesh__recordMaintainer mesh__D011939 jrf
% 219.04/219.28  |- skos__hiddenLabel mesh__D011939 Recall, Mental
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D011939 2003
% 219.04/219.28  |- skos__related mesh__D011939smesh__D032882
% 219.04/219.28  |- skos__scopeNote mesh__D008990
% 219.04/219.28       A genus of roundworms of the phylum Acanthocephala, parasitic in rats, mice, hamsters, dogs and cats. Occasional infection in man produces inflammation and ulceration of the intestinal mucosa.%A%    
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008990 2006
% 219.04/219.28  |- mesh__recordMaintainer mesh__D008990 ags
% 219.04/219.28  |- mesh__recordAuthorizer mesh__D008990 sjn
% 219.04/219.28  |- skos__prefLabel mesh__D008990 Moniliformis
% 219.04/219.28  |- mesh__dateEstablished mesh__D008990 1991-01-01
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008990 2005
% 219.04/219.28  |- mesh__dateCreated mesh__D008990 1999-01-01
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008990 2004
% 219.04/219.28  |- rdf__type mesh__D008990sskos__Concept
% 219.04/219.28  |- mesh__publicMeSHNote mesh__D008990
% 219.04/219.28       91; was see under ACANTHOCEPHALA 1975-90   
% 219.04/219.28  |- skos__annotation mesh__D008990
% 219.04/219.28       a genus of roundworms; infection: coord IM with HELMINTHIASIS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 219.04/219.28  |- mesh__recordOriginator mesh__D008990 NLM
% 219.04/219.28  |- mesh__historyNote mesh__D008990
% 219.04/219.28       91%28%75%29%; was see under ACANTHOCEPHALA 1975-90   
% 219.04/219.28  |- mesh__dateRevised mesh__D008990 2003-07-09
% 219.04/219.28  |- mesh__onlineNote mesh__D008990 search ACANTHOCEPHALA 1974   
% 219.04/219.28  |- skos__broader mesh__D008990smesh__D000049
% 219.04/219.28  |- mesh__recordMaintainer mesh__D022661 mdb
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D022661 2004
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D022661 2002
% 219.04/219.28  |- rdf__type mesh__D022661sskos__Concept
% 219.04/219.28  |- mesh__publicMeSHNote mesh__D022661 2001   
% 219.04/219.28  |- skos__hiddenLabel mesh__D022661 Untranslated RNA
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D022661 2003
% 219.04/219.28  |- mesh__recordOriginator mesh__D022661 nns
% 219.04/219.28  |- skos__broader mesh__D022661smesh__D012313
% 219.04/219.28  |- mesh__recordAuthorizer mesh__D022661 sjn
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D022661 2006
% 219.04/219.28  |- skos__hiddenLabel mesh__D022661 Nontranslated RNA
% 219.04/219.28  |- mesh__dateCreated mesh__D022661 2000-06-22
% 219.04/219.28  |- mesh__dateEstablished mesh__D022661 2001-01-01
% 219.04/219.28  |- mesh__historyNote mesh__D022661 2001   
% 219.04/219.28  |- skos__altLabel mesh__D022661 RNA, Nontranslated
% 219.04/219.28  |- skos__hiddenLabel mesh__D022661 Noncoding RNA
% 219.04/219.28  |- mesh__dateRevised mesh__D022661 2001-07-25
% 219.04/219.28  |- skos__annotation mesh__D022661
% 219.04/219.28       GEN: prefer specifics; do not confuse with RNA, MESSENGER, STORED%A%  
% 219.04/219.28  |- skos__prefLabel mesh__D022661 RNA, Untranslated
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D022661 2005
% 219.04/219.28  |- skos__altLabel mesh__D022661 RNA, Noncoding
% 219.04/219.28  |- skos__scopeNote mesh__D022661
% 219.04/219.28       RNA which does not code for protein but has some enzymatic, structural or regulatory function. Although ribosomal RNA; %28%RNA, RIBOSOMAL%29% and transfer RNA; %28%RNA, TRANSFER%29% are also untranslated they are not included here.%A%    
% 219.04/219.28  |- skos__related mesh__D008192smesh__D005607
% 219.04/219.28  |- mesh__dateCreated mesh__D008192 1999-01-01
% 219.04/219.28  |- skos__related mesh__D008192smesh__D028743
% 219.04/219.28  |- mesh__recordOriginator mesh__D008192 NLM
% 219.04/219.28  |- mesh__recordMaintainer mesh__D008192 jrf
% 219.04/219.28  |- skos__annotation mesh__D008192 no qualif   
% 219.04/219.28  |- rdf__type mesh__D008192sskos__Concept
% 219.04/219.28  |- skos__hiddenLabel mesh__D008192 Allegation, False
% 219.04/219.28  |- skos__scopeNote mesh__D008192
% 219.04/219.28       The act of deceiving or the fact %28%or condition%29% of being deceived.%A%    
% 219.04/219.28  |- skos__hiddenLabel mesh__D008192 False Allegation
% 219.04/219.28  |- mesh__recordAuthorizer mesh__D008192 sjn
% 219.04/219.28  |- skos__related mesh__D008192smesh__D008014
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008192 2005
% 219.04/219.28  |- skos__broader mesh__D008192smesh__D012919
% 219.04/219.28  |- mesh__historyNote mesh__D008192 98%28%66%29%   
% 219.04/219.28  |- skos__hiddenLabel mesh__D008192 Deceptions
% 219.04/219.28  |- mesh__dateRevised mesh__D008192 2002-07-02
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008192 2006
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008192 2003
% 219.04/219.28  |- skos__prefLabel mesh__D008192 Deception
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008192 2004
% 219.04/219.28  |- skos__hiddenLabel mesh__D008192 Allegations, False
% 219.04/219.28  |- mesh__publicMeSHNote mesh__D008192 98; see LYING 1966-97   
% 219.04/219.28  |- mesh__dateRevised mesh__D016624 2000-06-22
% 219.04/219.28  |- mesh__recordOriginator mesh__D016624 MXR
% 219.04/219.28  |- rdf__type mesh__D016624sskos__Concept
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D016624 2002
% 219.04/219.28  |- skos__hiddenLabel mesh__D016624 Staining, Negative
% 219.04/219.28  |- skos__prefLabel mesh__D016624 Negative Staining
% 219.04/219.28  |- mesh__recordMaintainer mesh__D016624 ndw
% 219.04/219.28  |- mesh__historyNote mesh__D016624 92   
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D016624 2004
% 219.04/219.28  |- skos__broader mesh__D016624smesh__D013194
% 219.04/219.28  |- skos__historyNote mesh__D016624 Staining %28%1966-1991%29%
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D016624 2003
% 219.04/219.28  |- mesh__recordAuthorizer mesh__D016624 sjn
% 219.04/219.28  |- skos__scopeNote mesh__D016624
% 219.04/219.28       The technique of washing tissue specimens with a concentrated solution of a heavy metal salt and letting it dry. The specimen will be covered with a very thin layer of the metal salt, being excluded in areas where an adsorbed macromolecule is present. The macromolecules allow electrons from the beam of an electron microscope to pass much more readily than the heavy metal; thus, a reversed or negative image of the molecule is created.%A%    
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D016624 2001
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D016624 2006
% 219.04/219.28  |- mesh__publicMeSHNote mesh__D016624 92   
% 219.04/219.28  |- mesh__dateEstablished mesh__D016624 1992-01-01
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D016624 2005
% 219.04/219.28  |- mesh__dateCreated mesh__D016624 1991-01-25
% 219.04/219.28  |- skos__hiddenLabel mesh__D002604 Chaplaincy Hospital Services
% 219.04/219.28  |- skos__altLabel mesh__D002604 Service, Chaplaincy Hospital
% 219.04/219.28  |- skos__altLabel mesh__D002604 Hospital Chaplaincy Service
% 219.04/219.28  |- skos__hiddenLabel mesh__D002604 Hospital Service, Chaplaincy
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002604 2005
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002604 1998
% 219.04/219.28  |- mesh__recordMaintainer mesh__D002604 TPW
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002604 2002
% 219.04/219.28  |- skos__hiddenLabel mesh__D002604 Chaplaincy Services, Hospital
% 219.04/219.28  |- skos__broader mesh__D002604smesh__D006748
% 219.04/219.28  |- skos__altLabel mesh__D002604 Service, Hospital Chaplaincy
% 219.04/219.28  |- skos__scopeNote mesh__D002604
% 219.04/219.28       Hospital department which administers religious activities within the hospital, e.g., pastoral care, religious services.%A%    
% 219.04/219.28  |- mesh__recordOriginator mesh__D002604 EC
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002604 2006
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002604 1999
% 219.04/219.28  |- skos__annotation mesh__D002604
% 219.04/219.28       IM; coord with specific religion %28%IM%29% if pertinent; DF: CHAPLAINCY SERV HOSP%A%  
% 219.04/219.28  |- skos__prefLabel mesh__D002604 Chaplaincy Service, Hospital
% 219.04/219.28  |- skos__hiddenLabel mesh__D002604 Hospital Services, Chaplaincy
% 219.04/219.28  |- mesh__publicMeSHNote mesh__D002604
% 219.04/219.28       91; was see under HOSPITAL DEPARTMENTS Aug 1977-90   
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002604 2003
% 219.04/219.28  |- mesh__historyNote mesh__D002604
% 219.04/219.28       91%28%Aug 77%29%; was see under HOSPITAL DEPARTMENTS 1977-90   
% 219.04/219.28  |- skos__hiddenLabel mesh__D002604 Services, Chaplaincy Hospital
% 219.04/219.28  |- mesh__dateRevised mesh__D002604 1996-06-10
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002604 2000
% 219.04/219.28  |- mesh__dateCreated mesh__D002604 1977-05-19
% 219.04/219.28  |- rdf__type mesh__D002604sskos__Concept
% 219.04/219.28  |- skos__hiddenLabel mesh__D002604 Services, Hospital Chaplaincy
% 219.04/219.28  |- skos__hiddenLabel mesh__D002604 Chaplaincy Hospital Service
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002604 2004
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002604 1997
% 219.04/219.28  |- skos__hiddenLabel mesh__D002604 Hospital Chaplaincy Services
% 219.04/219.28  |- mesh__dateEstablished mesh__D002604 1991-01-01
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002604 2001
% 219.04/219.28  |- mesh__recordAuthorizer mesh__D002604 PLS
% 219.04/219.28  |- skos__hiddenLabel mesh__D007898 Visceral Leishmaniases
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007898 1998
% 219.04/219.28  |- mesh__recordAuthorizer mesh__D007898 PLS
% 219.04/219.28  |- skos__annotation mesh__D007898 caused by L. donovani or L. infantum   
% 219.04/219.28  |- skos__broader mesh__D007898smesh__D007896
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007898 1999
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007898 1996
% 219.04/219.28  |- skos__altLabel mesh__D007898 Kala-Azar
% 219.04/219.28  |- rdf__type mesh__D007898sskos__Concept
% 219.04/219.28  |- skos__hiddenLabel mesh__D007898 Kala Azar
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007898 1997
% 219.04/219.28  |- skos__hiddenLabel mesh__D007898 Leishmaniases, Visceral
% 219.04/219.28  |- skos__scopeNote mesh__D007898
% 219.04/219.28       A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean %28%or infantile%29%, and African.%A%    
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007898 2005
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007898 2000
% 219.04/219.28  |- mesh__dateCreated mesh__D007898 1999-01-01
% 219.04/219.28  |- mesh__recordMaintainer mesh__D007898 PXP
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007898 2006
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007898 2003
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007898 1994
% 219.04/219.28  |- skos__hiddenLabel mesh__D007898 Visceral Leishmaniasis
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007898 2001
% 219.04/219.28  |- mesh__dateRevised mesh__D007898 1993-06-03
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007898 2004
% 219.04/219.28  |- mesh__recordOriginator mesh__D007898 NLM
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007898 1995
% 219.04/219.28  |- skos__hiddenLabel mesh__D007898 Kala-Azars
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007898 2002
% 219.04/219.28  |- skos__prefLabel mesh__D007898 Leishmaniasis, Visceral
% 219.04/219.28  |- mesh__dateEstablished mesh__D012234 1991-01-01
% 219.04/219.28  |- skos__scopeNote mesh__D012234
% 219.04/219.28       A protein which effects termination of RNA synthesis during the genetic transcription process by dissociating the ternary transcription complex RNA;-RNA POLYMERASE DNA at the termination of a gene.%A%    
% 219.04/219.28  |- mesh__recordAuthorizer mesh__D012234 ags
% 219.04/219.28  |- rdf__type mesh__D012234sskos__Concept
% 219.04/219.28  |- skos__broader mesh__D012234smesh__D014157
% 219.04/219.28  |- mesh__historyNote mesh__D012234
% 219.04/219.28       91%28%77%29%; was see under TRANSCRIPTION FACTORS 1977-90   
% 219.04/219.28  |- skos__hiddenLabel mesh__D012234 Factor, Rho
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D012234 2006A
% 219.04/219.28  |- skos__annotation mesh__D012234
% 219.04/219.28       in genetic transcription; do not confuse with blood RH FACTORS%A%  
% 219.04/219.28  |- mesh__dateCreated mesh__D012234 1976-04-19
% 219.04/219.28  |- mesh__recordMaintainer mesh__D012234 ags
% 219.04/219.28  |- skos__historyNote mesh__D012234 Bacterial Proteins %28%1973-1976%29%
% 219.04/219.28  |- mesh__publicMeSHNote mesh__D012234
% 219.04/219.28       91; was see under TRANSCRIPTION FACTORS 1977-90   
% 219.04/219.28  |- skos__prefLabel mesh__D012234 Rho Factor
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D012234 2006
% 219.04/219.28  |- mesh__recordOriginator mesh__D012234 RLS
% 219.04/219.28  |- skos__historyNote mesh__D012234 Transcription, Genetic %28%1973-1976%29%
% 219.04/219.28  |- skos__historyNote mesh__D012234 Proteins %28%1966-1976%29%
% 219.04/219.28  |- mesh__dateRevised mesh__D012234 2005-07-28
% 219.04/219.28  |- mesh__recordAuthorizer mesh__D008991 SJN
% 219.04/219.28  |- skos__prefLabel mesh__D008991 Monitoring, Physiologic
% 219.04/219.28  |- mesh__dateEstablished mesh__D008991 1966-01-01
% 219.04/219.28  |- skos__hiddenLabel mesh__D008991 Physiological Monitoring
% 219.04/219.28  |- skos__hiddenLabel mesh__D008991 Monitoring, Patient
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008991 2001
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008991 2003
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008991 2004
% 219.04/219.28  |- rdf__type mesh__D008991sskos__Concept
% 219.04/219.28  |- skos__broader mesh__D008991smesh__D019937
% 219.04/219.28  |- mesh__recordMaintainer mesh__D008991 PXP
% 219.04/219.28  |- skos__altLabel mesh__D008991 Monitoring, Physiological
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008991 2002
% 219.04/219.28  |- skos__altLabel mesh__D008991 Physiologic Monitoring
% 219.04/219.28  |- skos__annotation mesh__D008991
% 219.04/219.28       IM GEN only; avoid indexing routinely word %22%monitoring%22%: must be %22%continuous%22% %28%see MeSH definition%29%; note see related: there emphasis is on the computer-assisted processing%A%  
% 219.04/219.28  |- skos__related mesh__D008991smesh__D012815
% 219.04/219.28  |- mesh__dateRevised mesh__D008991 1997-06-20
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008991 1998
% 219.04/219.28  |- skos__scopeNote mesh__D008991
% 219.04/219.28       The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine.%A%    
% 219.04/219.28  |- mesh__historyNote mesh__D008991
% 219.04/219.28       78; MONITORING SYSTEMS was heading 1966-77   
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008991 2000
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008991 2005
% 219.04/219.28  |- mesh__publicMeSHNote mesh__D008991
% 219.04/219.28       78; MONITORING SYSTEMS was heading 1966-77   
% 219.04/219.28  |- mesh__dateCreated mesh__D008991 1999-01-01
% 219.04/219.28  |- mesh__recordOriginator mesh__D008991 NLM
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008991 1999
% 219.04/219.28  |- mesh__onlineNote mesh__D008991
% 219.04/219.28       use MONITORING, PHYSIOLOGIC to search MONITORING SYSTEMS 1966-77%A%  
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008991 2006
% 219.04/219.28  |- skos__hiddenLabel mesh__D008193 Arthritis, Lyme
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008193 2005
% 219.04/219.28  |- skos__historyNote mesh__D008193
% 219.04/219.28       Spirochaetales Infections %28%1982-1984%29%
% 219.04/219.28  |- skos__scopeNote mesh__D008193
% 219.04/219.28       An infectious disease caused by a spirochete, BORRELIA BURGDORFERI, which is transmitted chiefly by Ixodes dammini %28%see IXODES%29% and pacificus ticks in the United States and Ixodes ricinis %28%see IXODES%29% in Europe. It is a disease with early and late cutaneous manifestations plus involvement of the nervous system, heart, eye, and joints in variable combinations. The disease was formerly known as Lyme arthritis and first discovered at Old Lyme, Connecticut.%A%    
% 219.04/219.28  |- skos__historyNote mesh__D008193 Arthritis, Infectious %28%1979-1984%29%
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008193 2006
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008193 2003
% 219.04/219.28  |- skos__broader mesh__D008193smesh__D017282
% 219.04/219.28  |- mesh__dateEstablished mesh__D008193 1985-01-01
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008193 2004
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008193 2002
% 219.04/219.28  |- mesh__publicMeSHNote mesh__D008193
% 219.04/219.28       85; was LYME ARTHRITIS see ARTHRITIS, INFECTIOUS 1979-84   
% 219.04/219.28  |- mesh__recordMaintainer mesh__D008193 sjn
% 219.04/219.28  |- mesh__recordOriginator mesh__D008193 RC
% 219.04/219.28  |- skos__prefLabel mesh__D008193 Lyme Disease
% 219.04/219.28  |- skos__broader mesh__D008193smesh__D001899
% 219.04/219.28  |- skos__annotation mesh__D008193
% 219.04/219.28       coord IM with specific Borrelia %28%IM%29%   
% 219.04/219.28  |- skos__altLabel mesh__D008193 Lyme Borreliosis
% 219.04/219.28  |- mesh__dateRevised mesh__D008193 2001-08-07
% 219.04/219.28  |- mesh__dateCreated mesh__D008193 1984-04-06
% 219.04/219.28  |- mesh__recordAuthorizer mesh__D008193 sjn
% 219.04/219.28  |- mesh__historyNote mesh__D008193
% 219.04/219.28       85; was LYME ARTHRITIS see ARTHRITIS, INFECTIOUS l979-84   
% 219.04/219.28  |- mesh__onlineNote mesh__D008193 search ARTHRITIS, INFECTIOUS 1979-84   
% 219.04/219.28  |- rdf__type mesh__D008193sskos__Concept
% 219.04/219.28  |- skos__hiddenLabel mesh__D008193 Disease, Lyme
% 219.04/219.28  |- skos__hiddenLabel mesh__D008193 Borreliosis, Lyme
% 219.04/219.28  |- mesh__recordAuthorizer mesh__D002605 PLS
% 219.04/219.28  |- skos__annotation mesh__D002605 no qualif   
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002605 2003
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002605 1991
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002605 1996
% 219.04/219.28  |- rdf__type mesh__D002605sskos__Concept
% 219.04/219.28  |- skos__hiddenLabel mesh__D002605 Characters
% 219.04/219.28  |- skos__prefLabel mesh__D002605 Character
% 219.04/219.28  |- mesh__dateRevised mesh__D002605 1989-04-28
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002605 2002
% 219.04/219.28  |- mesh__recordMaintainer mesh__D002605 TGC
% 219.04/219.28  |- skos__scopeNote mesh__D002605
% 219.04/219.28       In current usage, approximately equivalent to personality. The sum of the relatively fixed personality traits and habitual modes of response of an individual.%A%    
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002605 1990
% 219.04/219.28  |- mesh__recordOriginator mesh__D002605 NLM
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002605 1995
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002605 2001
% 219.04/219.28  |- mesh__dateCreated mesh__D002605 1999-01-01
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002605 1993
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002605 2006
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002605 2000
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002605 1999
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002605 2004
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002605 1994
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002605 1997
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002605 1992
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002605 2005
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D002605 1998
% 219.04/219.28  |- skos__broader mesh__D002605smesh__D010551
% 219.04/219.28  |- skos__broader mesh__D013514Q000266smesh__D013514
% 219.04/219.28  |- mesh__preferredCombination mesh__D013514Q000266smesh__D013502Q000266
% 219.04/219.28  |- rdf__type mesh__D013514Q000266smesh__CompoundConcept
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007899 1999
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007899 1996
% 219.04/219.28  |- mesh__recordOriginator mesh__D007899 NLM
% 219.04/219.28  |- rdf__type mesh__D007899sskos__Concept
% 219.04/219.28  |- skos__scopeNote mesh__D007899
% 219.04/219.28       Voluntary use of free time for activities outside the daily routine.%A%    
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007899 2002
% 219.04/219.28  |- skos__hiddenLabel mesh__D007899 Leisures
% 219.04/219.28  |- skos__historyNote mesh__D007899 Hobbies %28%1966-1969%29%
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007899 1997
% 219.04/219.28  |- skos__hiddenLabel mesh__D007899 Activity, Leisure
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007899 2005
% 219.04/219.28  |- mesh__recordMaintainer mesh__D007899 TGC
% 219.04/219.28  |- mesh__recordAuthorizer mesh__D007899 PLS
% 219.04/219.28  |- mesh__historyNote mesh__D007899 70   
% 219.04/219.28  |- mesh__dateEstablished mesh__D007899 1970-01-01
% 219.04/219.28  |- skos__hiddenLabel mesh__D007899 Leisure Activity
% 219.04/219.28  |- mesh__dateCreated mesh__D007899 1999-01-01
% 219.04/219.28  |- skos__broader mesh__D007899smesh__D006802
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007899 2006
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007899 2003
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007899 1994
% 219.04/219.28  |- skos__historyNote mesh__D007899 Recreation %28%1966-1969%29%
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007899 2004
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007899 1995
% 219.04/219.28  |- skos__prefLabel mesh__D007899 Leisure Activities
% 219.04/219.28  |- skos__hiddenLabel mesh__D007899 Activities, Leisure
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007899 2000
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007899 1998
% 219.04/219.28  |- mesh__publicMeSHNote mesh__D007899 70   
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007899 1993
% 219.04/219.28  |- mesh__dateRevised mesh__D007899 1992-03-25
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D007899 2001
% 219.04/219.28  |- skos__broader mesh__D004040Q000172smesh__D004040
% 219.04/219.28  |- mesh__preferredCombination mesh__D004040Q000172smesh__D002241Q000172
% 219.04/219.28  |- rdf__type mesh__D004040Q000172smesh__CompoundConcept
% 219.04/219.28  |- mesh__publicMeSHNote mesh__D012235
% 219.04/219.28       91; was see under XANTHENES 1975-90; TETRAETHYLRHODAMINE was see RHODAMINES 1975-93%A%  
% 219.04/219.28  |- mesh__onlineNote mesh__D012235
% 219.04/219.28       use RHODAMINES to search TETRAETHYLRHODAMINE 1975-93   
% 219.04/219.28  |- rdf__type mesh__D012235sskos__Concept
% 219.04/219.28  |- mesh__dateCreated mesh__D012235 1974-11-19
% 219.04/219.28  |- skos__historyNote mesh__D012235 Xanthenes %28%1969-1974%29%
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D012235 2003
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D012235 2001
% 219.04/219.28  |- skos__annotation mesh__D012235 RHODAMINE 123 is available   
% 219.04/219.28  |- skos__prefLabel mesh__D012235 Rhodamines
% 219.04/219.28  |- mesh__recordAuthorizer mesh__D012235 sjn
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D012235 2004
% 219.04/219.28  |- mesh__dateEstablished mesh__D012235 1991-01-01
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D012235 2002
% 219.04/219.28  |- skos__historyNote mesh__D012235 Ammonium Compounds %28%1969-1974%29%
% 219.04/219.28  |- mesh__recordOriginator mesh__D012235 NLM
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D012235 2005
% 219.04/219.28  |- mesh__historyNote mesh__D012235
% 219.04/219.28       91%28%75%29%; was see under XANTHENES 1975-90; TETRAETHYLRHODAMINE was see RHODAMINES 1975-93%A%  
% 219.04/219.28  |- mesh__recordMaintainer mesh__D012235 TWD
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D012235 2006
% 219.04/219.28  |- skos__scopeNote mesh__D012235
% 219.04/219.28       A family of 3,6-di%28%substituted-amino%29%-9-benzoate derivatives of xanthene that are used as dyes and as indicators for various metals; also used as fluorescent tracers in histochemistry.%A%    
% 219.04/219.28  |- mesh__dateRevised mesh__D012235 2000-06-22
% 219.04/219.28  |- skos__historyNote mesh__D012235 Benzoates %28%1974%29%
% 219.04/219.28  |- skos__broader mesh__D012235smesh__D014966
% 219.04/219.28  |- skos__hiddenLabel mesh__D008992 Diseases, Monkey
% 219.04/219.28  |- mesh__recordOriginator mesh__D008992 NLM
% 219.04/219.28  |- rdf__type mesh__D008992sskos__Concept
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008992 2004
% 219.04/219.28  |- skos__hiddenLabel mesh__D008992 Disease, Monkey
% 219.04/219.28  |- skos__hiddenLabel mesh__D008992 Monkey Disease
% 219.04/219.28  |- skos__scopeNote mesh__D008992
% 219.04/219.28       Diseases of Old World and New World monkeys. This term includes diseases of baboons but not of chimpanzees or gorillas %28%= APE DISEASES%29%.%A%    
% 219.04/219.28  |- mesh__dateRevised mesh__D008992 2003-07-30
% 219.04/219.28  |- mesh__recordMaintainer mesh__D008992 ags
% 219.04/219.28  |- mesh__recordAuthorizer mesh__D008992 sjn
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008992 2005
% 219.04/219.28  |- mesh__dateCreated mesh__D008992 1999-01-01
% 219.04/219.28  |- skos__prefLabel mesh__D008992 Monkey Diseases
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008992 2006
% 219.04/219.28  |- skos__broader mesh__D008992smesh__D018419
% 219.04/219.28  |- skos__annotation mesh__D008992
% 219.04/219.28       IM GEN or unspecified; coord IM with specific dis /vet %28%IM%29% or specific monkey dis %28%IM%29%; coord IM with specific monkey %28%IM%29%; for abnormalities or injuries, index under specific monkey heading /abnorm or /inj; does not include diseases of chimpanzees: CHIMPANZEE is an ape, not monkey %28% = APE DISEASES: see note there%29%; don%27%t forget also MONKEYS %28%NIM%29% if no specific monkey is indexed; also check tag ANIMALS; DF: MONKEY DIS%A%  
% 219.04/219.28  |- mesh__onlineNote mesh__D008194
% 219.04/219.28       use LYMECYCLINE to search TETRACYCLINE-L-METHYLENE LYSINE 1966-77 %28%as Prov 1966-74%29%%A%  
% 219.04/219.28  |- skos__prefLabel mesh__D008194 Lymecycline
% 219.04/219.28  |- mesh__recordAuthorizer mesh__D008194 sjn
% 219.04/219.28  |- skos__altLabel mesh__D008194 N-Lysinomethyltetracycline
% 219.04/219.28  |- skos__hiddenLabel mesh__D008194 N Lysinomethyltetracycline
% 219.04/219.28  |- skos__hiddenLabel mesh__D008194 Hydrochloride, Lymecycline
% 219.04/219.28  |- skos__altLabel mesh__D008194 Tetracycline-L-Methylene Lysine
% 219.04/219.28  |- mesh__recordMaintainer mesh__D008194 ssb
% 219.04/219.28  |- mesh__dateRevised mesh__D008194 2004-07-07
% 219.04/219.28  |- skos__hiddenLabel mesh__D008194 Tetracycline L Methylene Lysine
% 219.04/219.28  |- skos__broader mesh__D008194smesh__D013754
% 219.04/219.28  |- skos__hiddenLabel mesh__D008194 Lysine, Tetracyclinemethylene
% 219.04/219.28  |- mesh__dateEstablished mesh__D008194 1991-01-01
% 219.04/219.28  |- mesh__publicMeSHNote mesh__D008194
% 219.04/219.28       91; was see under TETRACYCLINES 1978-90; was TETRACYCLINE-L-METHYLENE LYSINE see under TETRACYCLINE 1975-77%A%  
% 219.04/219.28  |- mesh__dateCreated mesh__D008194 1999-01-01
% 219.04/219.28  |- rdf__type mesh__D008194sskos__Concept
% 219.04/219.28  |- skos__scopeNote mesh__D008194
% 219.04/219.28       A semisynthetic antibiotic related to TETRACYCLINE. It is more readily absorbed than TETRACYCLINE and can be used in lower doses.%A%    
% 219.04/219.28  |- mesh__historyNote mesh__D008194
% 219.04/219.28       91%28%78%29%; was see under TETRACYCLINES 1978-90; was TETRACYCLINE-L-METHYLENE LYSINE see under TETRACYCLINE 1963-77 %28%Prov 1963-74%29%%A%  
% 219.04/219.28  |- mesh__recordOriginator mesh__D008194 NLM
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008194 2005
% 219.04/219.28  |- skos__altLabel mesh__D008194 Tetracyclinemethylene Lysine
% 219.04/219.28  |- skos__hiddenLabel mesh__D008194 Lysine, Tetracycline-L-Methylene
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D008194 2006
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D016626 2004
% 219.04/219.28  |- mesh__dateEstablished mesh__D016626 1992-01-01
% 219.04/219.28  |- skos__historyNote mesh__D016626 Staining %28%1966-1991%29%
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D016626 2003
% 219.04/219.28  |- mesh__publicMeSHNote mesh__D016626 92   
% 219.04/219.28  |- skos__altLabel mesh__D016626 Shadowing
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D016626 2006
% 219.04/219.28  |- mesh__recordMaintainer mesh__D016626 ndw
% 219.04/219.28  |- skos__annotation mesh__D016626
% 219.04/219.28       a visualization method used in electron microscopy; DF: SHADOWING%A%  
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D016626 2002
% 219.04/219.28  |- skos__scopeNote mesh__D016626
% 219.04/219.28       The technique of spraying a tissue specimen with a thin coat of a heavy metal such as platinum. The specimen is sprayed from an oblique angle, which results in the uneven deposition of the coating. The varying thicknesses create a shadow effect and give a three-dimensional appearance to the specimen.%A%    
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D016626 2005
% 219.04/219.28  |- rdf__type mesh__D016626sskos__Concept
% 219.04/219.28  |- skos__broader mesh__D016626smesh__D013194
% 219.04/219.28  |- mesh__dateCreated mesh__D016626 1991-01-25
% 219.04/219.28  |- mesh__recordOriginator mesh__D016626 MXR
% 219.04/219.28  |- skos__historyNote mesh__D016626 Microscopy, Electron %28%1969-1991%29%
% 219.04/219.28  |- skos__hiddenLabel mesh__D016626 Shadowings %28%Histology%29%
% 219.04/219.28  |- mesh__dateRevised mesh__D016626 2000-06-22
% 219.04/219.28  |- skos__prefLabel mesh__D016626 Shadowing %28%Histology%29%
% 219.04/219.28  |- mesh__recordAuthorizer mesh__D016626 sjn
% 219.04/219.28  |- skos__hiddenLabel mesh__D016626 Shadowings
% 219.04/219.28  |- mesh__historyNote mesh__D016626 92   
% 219.04/219.28  |- mesh__activeMeSHYear mesh__D016626 2001
% 219.04/219.28  |- skos__hiddenLabel mesh__D002606 Charcoal, Activated
% 219.04/219.29  |- skos__altLabel mesh__D002606 Pharmascience Brand of Activated Charcoal
% 219.04/219.29  |- skos__altLabel mesh__D002606 Monarch Brand of Activated Charcoal
% 219.04/219.29  |- skos__altLabel mesh__D002606 Hevert Brand of Activated Charcoal
% 219.04/219.29  |- skos__altLabel mesh__D002606 GlaxoSmithKline Brand of Activated Charcoal
% 219.04/219.29  |- mesh__dateRevised mesh__D002606 2005-06-30
% 219.04/219.29  |- skos__altLabel mesh__D002606
% 219.04/219.29       Merck Selbstmedikation Brand of Activated Charcoal
% 219.04/219.29  |- skos__scopeNote mesh__D002606
% 219.04/219.29       An amorphous form of carbon prepared from the incomplete combustion of animal or vegetable matter, e.g., wood. The activated form of charcoal is used in the treatment of poisoning. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 219.04/219.29  |- skos__altLabel mesh__D002606 Paddock Brand 1 of Activated Charcoal
% 219.04/219.29  |- skos__altLabel mesh__D002606 Little Remedies Brand of Activated Charcoal
% 219.04/219.29  |- skos__altLabel mesh__D002606 K%C3%%B6%hler Brand of Activated Charcoal
% 219.04/219.29  |- skos__altLabel mesh__D002606 Requa Brand of Activated Charcoal
% 219.04/219.29  |- skos__altLabel mesh__D002606
% 219.04/219.29       Pharmygi%C3%%A8%ne Brand of Activated Charcoal
% 219.04/219.29  |- skos__altLabel mesh__D002606 Central Brand of Activated Charcoal
% 219.04/219.29  |- skos__altLabel mesh__D002606 Penn Brand of Activated Charcoal
% 219.04/219.29  |- mesh__recordMaintainer mesh__D002606 lkw
% 219.04/219.29  |- mesh__dateCreated mesh__D002606 1999-01-01
% 219.04/219.29  |- skos__altLabel mesh__D002606 Cheplapharm Brand of Activated Charcoal
% 219.04/219.29  |- skos__altLabel mesh__D002606 Kerr Brand of Activated Charcoal
% 219.04/219.29  |- mesh__activeMeSHYear mesh__D002606 2006
% 219.04/219.29  |- mesh__publicMeSHNote mesh__D002606
% 219.04/219.29       1994; for NORIT see CARBON 1982-1993   
% 219.04/219.29  |- mesh__historyNote mesh__D002606 1994; for NORIT use CARBON 1982-1993   
% 219.04/219.29  |- skos__altLabel mesh__D002606 Chefaro Brand of Activated Charcoal
% 219.04/219.29  |- skos__altLabel mesh__D002606
% 219.04/219.29       Cambridge Laboratories Brand of Activated Charcoal
% 219.04/219.29  |- mesh__recordAuthorizer mesh__D002606 sjn
% 219.04/219.29  |- skos__annotation mesh__D002606 D25-26 qualif only   
% 219.04/219.29  |- skos__prefLabel mesh__D002606 Charcoal
% 219.04/219.29  |- mesh__recordOriginator mesh__D002606 NLM
% 219.04/219.29  |- rdf__type mesh__D002606sskos__Concept
% 219.04/219.29  |- skos__altLabel mesh__D002606 Merck Brand of Activated Charcoal
% 219.04/219.29  |- skos__altLabel mesh__D002606 Gambro Brand of Activated Charcoal
% 219.04/219.29  |- skos__broader mesh__D002606smesh__D002244
% 219.04/219.29  |- skos__altLabel mesh__D002606 Paddock Brand 2 of Activated Charcoal
% 219.04/219.29  |- mesh__recordOriginator mesh__D048708 nns
% 219.04/219.29  |- skos__scopeNote mesh__D048708
% 219.04/219.29       Processes required for CELL ENLARGEMENT and CELL PROLIFERATION.%A%    
% 219.04/219.29  |- skos__broader mesh__D048708smesh__D002468
% 219.04/219.29  |- mesh__activeMeSHYear mesh__D048708 2005
% 219.04/219.29  |- mesh__historyNote mesh__D048708 2005   
% 219.04/219.29  |- mesh__dateEstablished mesh__D048708 2005-01-01
% 219.04/219.29  |- mesh__publicMeSHNote mesh__D048708 2005   
% 219.04/219.29  |- skos__annotation mesh__D048708 general; prefer specifics   
% 219.04/219.29  |- skos__related mesh__D048708smesh__D002470
% 219.04/219.29  |- skos__prefLabel mesh__D048708 Cell Growth Processes
% 219.04/219.29  |- mesh__recordMaintainer mesh__D048708 nns
% 219.04/219.29  |- mesh__dateCreated mesh__D048708 2004-07-07
% 219.04/219.29  |- skos__related mesh__D048708smesh__D048429
% 219.04/219.29  |- skos__hiddenLabel mesh__D048708 Processes, Cell Growth
% 219.04/219.29  |- skos__broader mesh__D048708smesh__D006128
% 219.04/219.29  |- mesh__recordAuthorizer mesh__D048708 sjn
% 219.04/219.29  |- rdf__type mesh__D048708sskos__Concept
% 219.04/219.29  |- mesh__activeMeSHYear mesh__D048708 2006
% 219.04/219.29  |- rdf__type mesh__D012236sskos__Concept
% 219.04/219.29  |- mesh__recordAuthorizer mesh__D012236 sjn
% 219.04/219.29  |- mesh__publicMeSHNote mesh__D012236
% 219.04/219.29       91; was see under THIAZOLES 1975-90   
% 219.04/219.29  |- mesh__dateEstablished mesh__D012236 1991-01-01
% 219.04/219.29  |- mesh__recordOriginator mesh__D012236 NLM
% 219.04/219.29  |- skos__prefLabel mesh__D012236 Rhodanine
% 219.04/219.29  |- skos__broader mesh__D012236smesh__D013844
% 219.04/219.29  |- mesh__dateRevised mesh__D012236 2005-06-30
% 219.04/219.29  |- skos__annotation mesh__D012236
% 219.04/219.29       do not confuse with RHODAMINES or rhodanide   
% 219.04/219.29  |- mesh__onlineNote mesh__D012236 search THIAZOLES 1966-74   
% 219.04/219.29  |- mesh__dateCreated mesh__D012236 1999-01-01
% 219.04/219.29  |- mesh__historyNote mesh__D012236
% 219.04/219.29       91%28%75%29%; was see under THIAZOLES 1975-90   
% 219.04/219.29  |- mesh__recordMaintainer mesh__D012236 ssb
% 219.04/219.29  |- mesh__activeMeSHYear mesh__D012236 2006
% 219.04/219.29  |- mesh__dateCreated mesh__D008993 1974-12-12
% 219.04/219.29  |- skos__scopeNote mesh__D008993
% 219.04/219.29       A species of ORTHOPOXVIRUS causing an epidemic disease among captive primates.%A%    
% 219.04/219.29  |- mesh__recordAuthorizer mesh__D008993 sjn
% 219.04/219.29  |- mesh__dateRevised mesh__D008993 2003-07-09
% 219.04/219.29  |- skos__altLabel mesh__D008993 Monkeypoxvirus
% 219.04/219.29  |- skos__hiddenLabel mesh__D008993 Monkeypoxviruses
% 219.04/219.29  |- mesh__dateEstablished mesh__D008993 1991-01-01
% 219.04/219.29  |- mesh__activeMeSHYear mesh__D008993 2005
% 219.04/219.29  |- mesh__historyNote mesh__D008993
% 219.04/219.29       97; was MONKEYPOXVIRUS 1994-96; was MONKEY POX VIRUS 1975-93 %28%see under POXVIRIDAE 1981-90, see under POXVIRUSES 1975-80%29%%A%  
% 219.04/219.29  |- mesh__activeMeSHYear mesh__D008993 2006
% 219.04/219.29  |- mesh__recordMaintainer mesh__D008993 ags
% 219.04/219.29  |- skos__annotation mesh__D008993 infection = MONKEYPOX   
% 219.04/219.29  |- mesh__recordOriginator mesh__D008993 NLM
% 219.04/219.29  |- skos__broader mesh__D008993smesh__D018155
% 219.04/219.29  |- mesh__onlineNote mesh__D008993
% 219.04/219.29       use MONKEYPOX VIRUS to search MONKEYPOXVIRUS 1994-96 %26% MONKEY POX VIRUS 1975-93%A%  
% 219.04/219.29  |- rdf__type mesh__D008993sskos__Concept
% 219.04/219.29  |- mesh__activeMeSHYear mesh__D008993 2004
% 219.04/219.29  |- mesh__publicMeSHNote mesh__D008993
% 219.04/219.29       97; was MONKEYPOXVIRUS 1994-96; was MONKEY POX VIRUS 1975-93 %28%see under POXVIRIDAE 1981-90, see under POXVIRUSES 1975-80%29%%A%  
% 219.04/219.29  |- skos__prefLabel mesh__D008993 Monkeypox virus
% 219.04/219.29  |- skos__altLabel mesh__D008993 Monkey Pox Virus
% 219.04/219.29  |- skos__hiddenLabel mesh__D008993 Monkey Pox Viruses
% 219.04/219.29  |- skos__hiddenLabel mesh__D008993 Monkeypox viruses
% 219.04/219.29  |- mesh__recordMaintainer mesh__D008195 ags
% 219.04/219.29  |- mesh__activeMeSHYear mesh__D008195 2006
% 219.04/219.29  |- mesh__recordOriginator mesh__D008195 NLM
% 219.04/219.29  |- skos__scopeNote mesh__D008195
% 219.04/219.29       A genus of dextrally coiled freshwater snails that includes some species of importance as intermediate hosts of parasitic flukes.%A%    
% 219.04/219.29  |- mesh__historyNote mesh__D008195 72   
% 219.04/219.29  |- skos__altLabel mesh__D008195 Lymnea
% 219.04/219.29  |- mesh__recordAuthorizer mesh__D008195 sjn
% 219.04/219.29  |- skos__annotation mesh__D008195
% 219.04/219.29       freshwater snail; /microbiol /parasitol /virol permitted   
% 219.04/219.29  |- mesh__dateCreated mesh__D008195 1999-01-01
% 219.04/219.29  |- skos__broader mesh__D008195smesh__D012908
% 219.04/219.29  |- mesh__dateRevised mesh__D008195 2005-06-30
% 219.04/219.29  |- mesh__publicMeSHNote mesh__D008195 72   
% 219.04/219.29  |- skos__historyNote mesh__D008195 Snails %28%1966-1971%29%
% 219.04/219.29  |- rdf__type mesh__D008195sskos__Concept
% 219.04/219.29  |- mesh__dateEstablished mesh__D008195 1972-01-01
% 219.04/219.29  |- skos__prefLabel mesh__D008195 Lymnaea
% 219.04/219.29  |- mesh__recordMaintainer mesh__D016627 CCR
% 219.04/219.29  |- mesh__recordAuthorizer mesh__D016627 sjn
% 219.04/219.29  |- mesh__historyNote mesh__D016627
% 219.04/219.29       92; was 6-HYDROXYDOPAMINE %28%NM%29% 1981-91   
% 219.04/219.29  |- skos__hiddenLabel mesh__D016627 Hydrobromide, Oxidopamine
% 219.04/219.29  |- skos__hiddenLabel mesh__D016627 Hydrochloride, Oxidopamine
% 219.04/219.29  |- skos__prefLabel mesh__D016627 Oxidopamine
% 219.04/219.29  |- mesh__activeMeSHYear mesh__D016627 2001
% 219.04/219.29  |- skos__broader mesh__D016627smesh__D006892
% 219.04/219.29  |- mesh__activeMeSHYear mesh__D016627 2006
% 219.04/219.29  |- skos__historyNote mesh__D016627 Hydroxydopamines %28%1973-1991%29%
% 219.04/219.29  |- mesh__dateEstablished mesh__D016627 1992-01-01
% 219.04/219.29  |- rdf__type mesh__D016627sskos__Concept
% 219.04/219.29  |- mesh__activeMeSHYear mesh__D016627 2005
% 219.04/219.29  |- mesh__dateCreated mesh__D016627 1991-07-12
% 219.04/219.29  |- skos__scopeNote mesh__D016627
% 219.04/219.29       A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.%A%    
% 219.04/219.29  |- mesh__dateRevised mesh__D016627 2000-06-22
% 219.04/219.29  |- mesh__recordOriginator mesh__D016627 RLS
% 219.04/219.29  |- mesh__publicMeSHNote mesh__D016627
% 219.04/219.29       92; 6-HYDROXYDOPAMINE was indexed under HYDROXYDOPAMINES 1982-91 %26% under HYDROXYDOPAMINE 1981%A%  
% 219.04/219.29  |- mesh__activeMeSHYear mesh__D016627 2002
% 219.04/219.29  |- mesh__activeMeSHYear mesh__D016627 2004
% 219.04/219.29  |- mesh__onlineNote mesh__D016627
% 219.04/219.29       use OXIDOPAMINE %28%NM%29% to search 6-HYDROXYDOPAMINE %28%NM%29% 1980-91%A%  
% 219.04/219.29  |- skos__altLabel mesh__D016627 6-OHDA
% 219.04/219.29  |- skos__hiddenLabel mesh__D016627 6 Hydroxydopamine
% 219.04/219.29  |- skos__altLabel mesh__D016627 6-Hydroxydopamine
% 219.04/219.29  |- mesh__activeMeSHYear mesh__D016627 2003
% 219.04/219.29  |- skos__hiddenLabel mesh__D002607 Type IIs, HMSN
% 219.04/219.29  |- skos__hiddenLabel mesh__D002607 I, HMSN
% 219.04/219.29  |- skos__altLabel mesh__D002607
% 219.04/219.29       Neuropathy, Type II Hereditary Motor and Sensory
% 219.04/219.29  |- skos__hiddenLabel mesh__D002607 Charcot Marie Disease
% 219.04/219.29  |- skos__hiddenLabel mesh__D002607 Type Is, HMSN
% 219.04/219.29  |- skos__hiddenLabel mesh__D002607 Roussy Levy Syndrome
% 219.04/219.29  |- skos__hiddenLabel mesh__D002607 Atrophies, Peroneal Muscular
% 219.04/219.29  |- skos__altLabel mesh__D002607
% 219.04/219.29       Hereditary Motor, and Sensory Neuropathy Type I
% 219.04/219.29  |- skos__altLabel mesh__D002607 Atrophy, Muscular, Peroneal
% 219.04/219.29  |- skos__hiddenLabel mesh__D002607 Syndrome, Roussy-Levy
% 219.04/219.29  |- skos__altLabel mesh__D002607 HMSN II
% 219.04/219.29  |- skos__altLabel mesh__D002607
% 219.04/219.29       Hereditary Motor and Sensory-Neuropathy Type II
% 219.04/219.29  |- skos__hiddenLabel mesh__D002607 Charcot Marie Tooth Disease, Type I
% 219.04/219.29  |- skos__hiddenLabel mesh__D002607 HMSN Is
% 219.04/219.29  |- mesh__dateCreated mesh__D002607 1999-11-08
% 219.04/219.29  |- skos__hiddenLabel mesh__D002607 IIs, HMSN
% 219.04/219.29  |- skos__hiddenLabel mesh__D002607 Muscular Atrophies, Peroneal
% 219.04/219.29  |- skos__altLabel mesh__D002607 Charcot-Marie Disease
% 219.04/219.29  |- mesh__activeMeSHYear mesh__D002607 2002
% 219.04/219.29  |- skos__hiddenLabel mesh__D002607 IIs, HMSN Type
% 219.04/219.29  |- skos__altLabel mesh__D002607 Peroneal Muscular Atrophy
% 219.04/219.29  |- mesh__recordAuthorizer mesh__D002607 sjn
% 219.04/219.29  |- skos__altLabel mesh__D002607 Charcot-Marie-Tooth Disease, Type II
% 219.04/219.29  |- skos__altLabel mesh__D002607 HMSN Type I
% 219.04/219.29  |- skos__hiddenLabel mesh__D002607 Is, HMSN
% 219.04/219.29  |- skos__hiddenLabel mesh__D002607 Atrophy, Peroneal Muscular
% 219.04/219.29  |- mesh__activeMeSHYear mesh__D002607 2003
% 219.04/219.29  |- mesh__recordMaintainer mesh__D002607 nns
% 219.04/219.29  |- skos__related mesh__D002607smesh__D018993
% 219.04/219.29  |- skos__hiddenLabel mesh__D002607 II, HMSN
% 219.04/219.29  |- mesh__dateRevised mesh__D002607 2001-07-25
% 219.04/219.29  |- skos__altLabel mesh__D002607 Muscular Atrophy, Peroneal
% 219.04/219.29  |- skos__hiddenLabel mesh__D002607 HMSN Type IIs
% 219.04/219.29  |- skos__altLabel mesh__D002607 HMSN I
% 219.04/219.29  |- skos__altLabel mesh__D002607
% 219.04/219.29       Neuropathy, Type I Hereditary Motor and Sensory
% 219.04/219.29  |- skos__altLabel mesh__D002607 Charcot-Marie-Tooth Disease, Type I
% 219.04/219.29  |- mesh__activeMeSHYear mesh__D002607 2004
% 219.04/219.29  |- skos__hiddenLabel mesh__D002607 Charcot Marie Tooth Disease, Type Ib
% 219.04/219.29  |- skos__scopeNote mesh__D002607
% 219.04/219.29       A hereditary motor and sensory neuropathy transmitted most often as an autosomal dominant trait and characterized by progressive distal wasting and loss of reflexes in the muscles of the legs %28%and occasionally involving the arms%29%. Onset is usually in the second to fourth decade of life. This condition has been divided into two subtypes, hereditary motor and sensory neuropathy %28%HMSN%29% types I and II. HMSN I is associated with abnormal nerve conduction velocities and nerve hypertrophy, features not seen in HMSN II. %28%Adams et al., Principles of Neurology, 6th ed, p1343%29%%A%    
% 219.04/219.29  |- skos__hiddenLabel mesh__D002607 HMSN Type Is
% 219.04/219.29  |- mesh__activeMeSHYear mesh__D002607 2005
% 219.04/219.29  |- mesh__publicMeSHNote mesh__D002607
% 219.04/219.29       2000; see CHARCOT-MARIE DISEASE 1991-1999, see MUSCULAR ATROPHY, SPINAL 1988-1990, see MUSCULAR ATROPHY 1966-1987; for CHARCOT-MARIE-TOOTH DISEASE see CHARCOT-MARIE DISEASE 1991-1999%A%  
% 219.04/219.29  |- skos__broader mesh__D002607smesh__D015417
% 219.04/219.29  |- mesh__recordOriginator mesh__D002607 NLM
% 219.04/219.29  |- skos__hiddenLabel mesh__D002607 Peroneal Muscular Atrophies
% 219.04/219.29  |- skos__hiddenLabel mesh__D002607 Charcot Marie Tooth Disease
% 219.04/219.29  |- rdf__type mesh__D002607sskos__Concept
% 219.15/219.29  |- skos__hiddenLabel mesh__D002607 Is, HMSN Type
% 219.15/219.29  |- skos__prefLabel mesh__D002607 Charcot-Marie-Tooth Disease
% 219.15/219.29  |- mesh__historyNote mesh__D002607 2000%28%1966%29%   
% 219.15/219.29  |- skos__hiddenLabel mesh__D002607 HMSN IIs
% 219.15/219.29  |- skos__hiddenLabel mesh__D002607 Charcot Marie Tooth Disease, Type Ia
% 219.15/219.29  |- mesh__dateEstablished mesh__D002607 1991-01-01
% 219.15/219.29  |- skos__hiddenLabel mesh__D002607 Charcot Marie Tooth Disease, Type II
% 219.15/219.29  |- skos__altLabel mesh__D002607 HMN Distal Type I
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D002607 2006
% 219.15/219.29  |- mesh__dateRevised mesh__D012237 1997-06-20
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D012237 2003
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D012237 2000
% 219.15/219.29  |- skos__broader mesh__D012237smesh__D009511
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D012237 2004
% 219.15/219.29  |- mesh__recordMaintainer mesh__D012237 PXP
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D012237 1998
% 219.15/219.29  |- mesh__recordAuthorizer mesh__D012237 SJN
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D012237 2001
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D012237 2005
% 219.15/219.29  |- mesh__dateCreated mesh__D012237 1999-01-01
% 219.15/219.29  |- mesh__recordOriginator mesh__D012237 NLM
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D012237 1999
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D012237 2002
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D012237 2006
% 219.15/219.29  |- rdf__type mesh__D012237sskos__Concept
% 219.15/219.29  |- skos__prefLabel mesh__D012237 Rhode Island
% 219.15/219.29  |- rdf__type mesh__D017720sskos__Concept
% 219.15/219.29  |- mesh__dateRevised mesh__D017720 2002-07-03
% 219.15/219.29  |- skos__hiddenLabel mesh__D017720 Molecular Epidemiologies
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D017720 2006
% 219.15/219.29  |- mesh__publicMeSHNote mesh__D017720 94   
% 219.15/219.29  |- skos__broader mesh__D017720smesh__D004812
% 219.15/219.29  |- mesh__recordOriginator mesh__D017720 RAZ
% 219.15/219.29  |- skos__annotation mesh__D017720
% 219.15/219.29       SPEC: SPEC qualif; GEN or unspecified; IM; also as an epidemiol application of molec biol %28%NIM, no qualif%29%; prefer specific epidemiol concept %26% specific molec or genet concept %28%IM%29% as coord with main headings /epidemiol %28%IM%29% %26% /genet %28%IM%29%, as %22%molecular epidemiology of rabies virus in France%22% = RABIES VIRUS /genet %28%IM%29% + RNA, VIRAL /genet %28%NIM%29% %28%molec aspect from text%29% + RABIES /epidemiol %28%IM%29% %28%epidemiol aspect from text%29% + FRANCE /epidemiol %28%NIM%29%; DF: EPIDEMIOL MOL%A%  
% 219.15/219.29  |- mesh__recordMaintainer mesh__D017720 jls
% 219.15/219.29  |- mesh__dateCreated mesh__D017720 1992-12-28
% 219.15/219.29  |- skos__broader mesh__D017720smesh__D005821
% 219.15/219.29  |- skos__broader mesh__D017720smesh__D008967
% 219.15/219.29  |- mesh__dateEstablished mesh__D017720 1994-01-01
% 219.15/219.29  |- skos__hiddenLabel mesh__D017720 Epidemiologies, Molecular
% 219.15/219.29  |- skos__scopeNote mesh__D017720
% 219.15/219.29       The application of molecular biology to the answering of epidemiological questions. The examination of patterns of changes in DNA to implicate particular carcinogens and the use of molecular markers to predict which individuals are at highest risk for a disease are common examples.%A%    
% 219.15/219.29  |- mesh__historyNote mesh__D017720 94   
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D017720 2003
% 219.15/219.29  |- skos__broader mesh__D017720smesh__D004813
% 219.15/219.29  |- mesh__recordAuthorizer mesh__D017720 sjn
% 219.15/219.29  |- skos__prefLabel mesh__D017720 Epidemiology, Molecular
% 219.15/219.29  |- skos__altLabel mesh__D017720 Molecular Epidemiology
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D017720 2005
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D017720 2004
% 219.15/219.29  |- mesh__dateCreated mesh__D003700 1974-12-12
% 219.15/219.29  |- mesh__dateEstablished mesh__D003700 1991-01-01
% 219.15/219.29  |- mesh__dateRevised mesh__D003700 1999-11-08
% 219.15/219.29  |- mesh__recordOriginator mesh__D003700 NLM
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D003700 2002
% 219.15/219.29  |- skos__hiddenLabel mesh__D003700 Delta Rhythms
% 219.15/219.29  |- mesh__historyNote mesh__D003700
% 219.15/219.29       91%28%75%29%; was see under ELECTROENCEPHALOGRAPHY 1975-90   
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D003700 2006
% 219.15/219.29  |- skos__hiddenLabel mesh__D003700 Rhythms, Delta
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D003700 2001
% 219.15/219.29  |- skos__scopeNote mesh__D003700
% 219.15/219.29       One of the four types of brain waves seen on EEG characterized by a high amplitude and a frequency of 4 Hz and below.  They are considered the %22%deep sleep waves%22% observed during sleep in dreamless states, infancy, and in some brain disorders.%A%    
% 219.15/219.29  |- skos__prefLabel mesh__D003700 Delta Rhythm
% 219.15/219.29  |- rdf__type mesh__D003700sskos__Concept
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D003700 2005
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D003700 2000
% 219.15/219.29  |- skos__hiddenLabel mesh__D003700 Rhythm, Delta
% 219.15/219.29  |- mesh__publicMeSHNote mesh__D003700
% 219.15/219.29       91; was see under ELECTROENCEPHALOGRAPHY 1975-90   
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D003700 2004
% 219.15/219.29  |- skos__annotation mesh__D003700 in EEG   
% 219.15/219.29  |- mesh__recordAuthorizer mesh__D003700 sjn
% 219.15/219.29  |- skos__altLabel mesh__D003700 Electroencephalography, Delta Rhythm
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D003700 2003
% 219.15/219.29  |- mesh__recordMaintainer mesh__D003700 adp
% 219.15/219.29  |- skos__broader mesh__D003700smesh__D004569
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D050356 2006
% 219.15/219.29  |- mesh__publicMeSHNote mesh__D050356 2006   
% 219.15/219.29  |- rdf__type mesh__D050356sskos__Concept
% 219.15/219.29  |- mesh__historyNote mesh__D050356 2006   
% 219.15/219.29  |- skos__broader mesh__D050356smesh__D008660
% 219.15/219.29  |- mesh__dateCreated mesh__D050356 2005-06-30
% 219.15/219.29  |- mesh__recordMaintainer mesh__D050356 lkt
% 219.15/219.29  |- skos__annotation mesh__D050356
% 219.15/219.29       general; prefer/metab with specific lipids   
% 219.15/219.29  |- mesh__recordAuthorizer mesh__D050356 sjn
% 219.15/219.29  |- skos__historyNote mesh__D050356 Lipids/metabolism %28%1965-2005%29%
% 219.15/219.29  |- mesh__recordOriginator mesh__D050356 lkt
% 219.15/219.29  |- mesh__dateEstablished mesh__D050356 2006-01-01
% 219.15/219.29  |- skos__scopeNote mesh__D050356
% 219.15/219.29       Physiological processes in biosynthesis %28%anabolism%29% and degradation %28%catabolism%29% of LIPIDS.%A%    
% 219.15/219.29  |- skos__prefLabel mesh__D050356 Lipid Metabolism
% 219.15/219.29  |- skos__hiddenLabel mesh__D050356 Metabolism, Lipid
% 219.15/219.29  |- skos__broader mesh__D008994smesh__D002265
% 219.15/219.29  |- skos__hiddenLabel mesh__D008994 Esterases, Monoglyceride
% 219.15/219.29  |- mesh__dateEstablished mesh__D008994 1991-01-01
% 219.15/219.29  |- skos__altLabel mesh__D008994 Monoglyceride Esterases
% 219.15/219.29  |- skos__hiddenLabel mesh__D008994 Lipases, Monoglyceride
% 219.15/219.29  |- skos__historyNote mesh__D008994 Esterases %28%1970-1974%29%
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D008994 2006
% 219.15/219.29  |- skos__hiddenLabel mesh__D008994 Lipases, Monoacylglycerol
% 219.15/219.29  |- skos__scopeNote mesh__D008994
% 219.15/219.29       An enzyme that catalyzes the hydrolysis of glycerol monoesters of long-chain fatty acids EC 3.1.1.23.%A%    
% 219.15/219.29  |- mesh__recordAuthorizer mesh__D008994 sjn
% 219.15/219.29  |- mesh__publicMeSHNote mesh__D008994
% 219.15/219.29       91; was see under CARBOXYLIC ESTER HYDROLASES 1976-90; was see under ESTERASES 1975%A%  
% 219.15/219.29  |- skos__hiddenLabel mesh__D008994 Monoester Hydrolases, Glycerol
% 219.15/219.29  |- skos__altLabel mesh__D008994 Monoglyceride Lipases
% 219.15/219.29  |- mesh__recordMaintainer mesh__D008994 ssb
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D008994 2004
% 219.15/219.29  |- rdf__type mesh__D008994sskos__Concept
% 219.15/219.29  |- skos__prefLabel mesh__D008994 Monoacylglycerol Lipases
% 219.15/219.29  |- mesh__recordOriginator mesh__D008994 NLM
% 219.15/219.29  |- skos__hiddenLabel mesh__D008994 Hydrolases, Glycerol Monoester
% 219.15/219.29  |- mesh__dateRevised mesh__D008994 2003-07-09
% 219.15/219.29  |- skos__hiddenLabel mesh__D008994 Hydrolase, Monoglyceride
% 219.15/219.29  |- skos__altLabel mesh__D008994 Monoglyceride Hydrolase
% 219.15/219.29  |- skos__historyNote mesh__D008994 Glycerides %28%1970-1974%29%
% 219.15/219.29  |- mesh__dateCreated mesh__D008994 1974-11-19
% 219.15/219.29  |- mesh__historyNote mesh__D008994
% 219.15/219.29       91%28%75%29%; was see under CARBOXYLIC ESTER HYDROLASES 1976-90; was see under ESTERASES 1975%A%  
% 219.15/219.29  |- skos__altLabel mesh__D008994 Glycerol Monoester Hydrolases
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D008994 2005
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D008196 2006
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D008196 2005
% 219.15/219.29  |- skos__broader mesh__D008196smesh__D045604
% 219.15/219.29  |- mesh__dateCreated mesh__D008196 1999-01-01
% 219.15/219.29  |- mesh__dateRevised mesh__D008196 2003-07-09
% 219.15/219.29  |- mesh__recordOriginator mesh__D008196 NLM
% 219.15/219.29  |- mesh__recordAuthorizer mesh__D008196 sjn
% 219.15/219.29  |- rdf__type mesh__D008196sskos__Concept
% 219.15/219.29  |- skos__hiddenLabel mesh__D008196 Lymphs
% 219.15/219.29  |- skos__prefLabel mesh__D008196 Lymph
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D008196 2004
% 219.15/219.29  |- mesh__recordMaintainer mesh__D008196 jmp
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D016628 2005
% 219.15/219.29  |- skos__altLabel mesh__D016628 Replica Technics
% 219.15/219.29  |- mesh__dateCreated mesh__D016628 1991-01-25
% 219.15/219.29  |- skos__historyNote mesh__D016628 Microscopy, Electron %28%1973-1991%29%
% 219.15/219.29  |- skos__prefLabel mesh__D016628 Replica Techniques
% 219.15/219.29  |- skos__scopeNote mesh__D016628
% 219.15/219.29       Methods of preparing tissue specimens for visualization using an electron microscope, usually a scanning electron microscope. The methods involve the creation of exact copies of the specimens by making a mold or cast %28%i.e., replica%29% of the specimen.%A%    
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D016628 2006
% 219.15/219.29  |- mesh__recordOriginator mesh__D016628 MXR
% 219.15/219.29  |- skos__hiddenLabel mesh__D016628 Technics, Replica
% 219.15/219.29  |- skos__hiddenLabel mesh__D016628 Replica Technic
% 219.15/219.29  |- skos__hiddenLabel mesh__D016628 Techniques, Replica
% 219.15/219.29  |- skos__hiddenLabel mesh__D016628 Replica Technique
% 219.15/219.29  |- rdf__type mesh__D016628sskos__Concept
% 219.15/219.29  |- skos__historyNote mesh__D016628
% 219.15/219.29       Microscopy, Electron, Scanning %28%1967-1991%29%
% 219.15/219.29  |- mesh__recordAuthorizer mesh__D016628 sjn
% 219.15/219.29  |- skos__hiddenLabel mesh__D016628 Technic, Replica
% 219.15/219.29  |- mesh__recordMaintainer mesh__D016628 TAP
% 219.15/219.29  |- mesh__dateEstablished mesh__D016628 1992-01-01
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D016628 2001
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D016628 2003
% 219.15/219.29  |- skos__hiddenLabel mesh__D016628 Technique, Replica
% 219.15/219.29  |- skos__broader mesh__D016628smesh__D016591
% 219.15/219.29  |- mesh__historyNote mesh__D016628 92   
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D016628 2002
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D016628 2004
% 219.15/219.29  |- mesh__publicMeSHNote mesh__D016628 92   
% 219.15/219.29  |- mesh__dateRevised mesh__D016628 2000-06-22
% 219.15/219.29  |- rdf__type mesh__D041021sskos__Concept
% 219.15/219.29  |- skos__historyNote mesh__D041021 Brucella %28%1963-2002%29%
% 219.15/219.29  |- mesh__publicMeSHNote mesh__D041021 2003   
% 219.15/219.29  |- mesh__dateEstablished mesh__D041021 2003-01-01
% 219.15/219.29  |- skos__scopeNote mesh__D041021
% 219.15/219.29       A species of gram-negative bacteria, primarily infecting SWINE, but it can also infect humans, DOGS, and HARES.%A%    
% 219.15/219.29  |- skos__broader mesh__D041021smesh__D002002
% 219.15/219.29  |- mesh__dateCreated mesh__D041021 2002-07-02
% 219.15/219.29  |- skos__prefLabel mesh__D041021 Brucella suis
% 219.15/219.29  |- mesh__recordAuthorizer mesh__D041021 sjn
% 219.15/219.29  |- mesh__recordOriginator mesh__D041021 ags
% 219.15/219.29  |- skos__altLabel mesh__D041021 Brucella melitensis biovar suis
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D041021 2006
% 219.15/219.29  |- mesh__historyNote mesh__D041021 2003   
% 219.15/219.29  |- mesh__dateRevised mesh__D041021 2005-06-30
% 219.15/219.29  |- skos__annotation mesh__D041021
% 219.15/219.29       infection: coord IM with BRUCELLOSIS %28%IM%29%   
% 219.15/219.29  |- mesh__recordMaintainer mesh__D041021 SYSTEM
% 219.15/219.29  |- skos__scopeNote mesh__D002608
% 219.15/219.29       Social welfare organizations with programs designed to assist individuals in times of need.%A%    
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D002608 2005
% 219.15/219.29  |- mesh__dateRevised mesh__D002608 2002-07-03
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D002608 2004
% 219.15/219.29  |- skos__hiddenLabel mesh__D002608 Charity
% 219.15/219.29  |- skos__prefLabel mesh__D002608 Charities
% 219.15/219.29  |- mesh__recordMaintainer mesh__D002608 hjn
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D002608 2003
% 219.15/219.29  |- mesh__recordAuthorizer mesh__D002608 sjn
% 219.15/219.29  |- rdf__type mesh__D002608sskos__Concept
% 219.15/219.29  |- mesh__recordOriginator mesh__D002608 NLM
% 219.15/219.29  |- skos__broader mesh__D002608smesh__D012946
% 219.15/219.29  |- skos__annotation mesh__D002608 IM   
% 219.15/219.29  |- skos__related mesh__D002608smesh__D017664
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D002608 2006
% 219.15/219.29  |- mesh__dateCreated mesh__D002608 1999-01-01
% 219.15/219.29  |- skos__related mesh__D002608smesh__D037921
% 219.15/219.29  |- mesh__recordOriginator mesh__D013330 NLM
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D013330 2003
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D013330 2001
% 219.15/219.29  |- skos__prefLabel mesh__D013330 Struma Ovarii
% 219.15/219.29  |- rdf__type mesh__D013330sskos__Concept
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D013330 1999
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D013330 2005
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D013330 2004
% 219.15/219.29  |- mesh__dateCreated mesh__D013330 1999-01-01
% 219.15/219.29  |- skos__annotation mesh__D013330
% 219.15/219.29       benign or malignant; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with OVARIAN NEOPLASMS %28%IM%29%; struma carcinoid = STRUMA OVARII %28%IM%29% + CARCINOID TUMOR %28%IM%29% + OVARIAN NEOPLASMS %28%IM%29%%A%  
% 219.15/219.29  |- mesh__recordMaintainer mesh__D013330 KEV
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D013330 2006
% 219.15/219.29  |- skos__broader mesh__D013330smesh__D013724
% 219.15/219.29  |- mesh__dateEstablished mesh__D013330 1967-01-01
% 219.15/219.29  |- mesh__recordAuthorizer mesh__D013330 PLS
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D013330 2002
% 219.15/219.29  |- mesh__publicMeSHNote mesh__D013330 67   
% 219.15/219.29  |- mesh__dateRevised mesh__D013330 1995-06-08
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D013330 1996
% 219.15/219.29  |- mesh__activeMeSHYear mesh__D013330 1998
% 219.15/219.30  |- skos__scopeNote mesh__D013330
% 219.15/219.30       A rare teratoid tumor of the ovary composed almost entirely of thyroid tissue, with large follicles containing abundant colloid. Occasionally there are symptoms of hyperthyroidism. 5-10%25% of struma ovarii become malignant, the only absolute criterion for which is the presence of metastasis. %28%Dorland, 27th ed; Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D013330 2000
% 219.15/219.30  |- mesh__historyNote mesh__D013330 67%28%63%29%   
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D013330 1997
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D012238 2002
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D012238 2005
% 219.15/219.30  |- mesh__dateCreated mesh__D012238 1999-01-01
% 219.15/219.30  |- skos__scopeNote mesh__D012238
% 219.15/219.30       Rhodium. A hard and rare metal of the platinum group, atomic number 45, atomic weight 102.905, symbol Rh. %28%Dorland, 28th ed%29%%A%    
% 219.15/219.30  |- mesh__dateRevised mesh__D012238 2001-07-25
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D012238 2006
% 219.15/219.30  |- rdf__type mesh__D012238sskos__Concept
% 219.15/219.30  |- skos__broader mesh__D012238smesh__D028561
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D012238 2003
% 219.15/219.30  |- skos__annotation mesh__D012238
% 219.15/219.30       Rh-103; Rh-97-102, 104-110 = RHODIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 219.15/219.30  |- mesh__recordMaintainer mesh__D012238 jmp
% 219.15/219.30  |- mesh__recordAuthorizer mesh__D012238 sjn
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D012238 2004
% 219.15/219.30  |- skos__broader mesh__D012238smesh__D019216
% 219.15/219.30  |- mesh__recordOriginator mesh__D012238 NLM
% 219.15/219.30  |- skos__prefLabel mesh__D012238 Rhodium
% 219.15/219.30  |- mesh__dateCreated mesh__D017721 1992-12-28
% 219.15/219.30  |- skos__prefLabel mesh__D017721 Hospital Costs
% 219.15/219.30  |- skos__altLabel mesh__D017721 Costs, Hospital
% 219.15/219.30  |- skos__historyNote mesh__D017721 Economics, Hospital %28%1966-1993%29%
% 219.15/219.30  |- skos__altLabel mesh__D017721 Cost, Hospital
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D017721 2002
% 219.15/219.30  |- mesh__publicMeSHNote mesh__D017721 94   
% 219.15/219.30  |- mesh__recordOriginator mesh__D017721 RAZ
% 219.15/219.30  |- skos__broader mesh__D017721smesh__D017048
% 219.15/219.30  |- mesh__historyNote mesh__D017721 94   
% 219.15/219.30  |- skos__annotation mesh__D017721
% 219.15/219.30       expenses incurred by hosp in providing services: do not confuse with HOSPITAL CHARGES, prices for services; DF: HOSP COSTS%A%  
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D017721 2003
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D017721 1998
% 219.15/219.30  |- mesh__recordAuthorizer mesh__D017721 PLS
% 219.15/219.30  |- mesh__recordMaintainer mesh__D017721 KEV
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D017721 2000
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D017721 2005
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D017721 1997
% 219.15/219.30  |- skos__broader mesh__D017721smesh__D004469
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D017721 2004
% 219.15/219.30  |- mesh__dateEstablished mesh__D017721 1994-01-01
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D017721 1999
% 219.15/219.30  |- mesh__dateRevised mesh__D017721 1996-06-10
% 219.15/219.30  |- skos__hiddenLabel mesh__D017721 Hospital Cost
% 219.15/219.30  |- rdf__type mesh__D017721sskos__Concept
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D017721 2001
% 219.15/219.30  |- skos__scopeNote mesh__D017721
% 219.15/219.30       The expenses incurred by a hospital in providing care. The hospital costs attributed to a particular patient care episode include the direct costs plus an appropriate proportion of the overhead for administration, personnel, building maintenance, equipment, etc. Hospital costs are one of the factors which determine HOSPITAL CHARGES %28%the price the hospital sets for its services%29%.%A%    
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D017721 2006
% 219.15/219.30  |- skos__historyNote mesh__D017721
% 219.15/219.30       Costs and Cost Analysis %28%1966-1993%29%
% 219.15/219.30  |- skos__scopeNote mesh__D003701
% 219.15/219.30       A nonapeptide that is found in neurons, peripheral organs, and plasma. This neuropeptide induces mainly delta sleep in mammals. In addition to sleep, the peptide has been observed to affect electrophysiological activity, neurotransmitter levels in the brain, circadian and locomotor patterns, hormonal levels, psychological performance, and the activity of neuropharmacological drugs including their withdrawal.%A%    
% 219.15/219.30  |- mesh__recordOriginator mesh__D003701 RLS
% 219.15/219.30  |- mesh__recordAuthorizer mesh__D003701 sjn
% 219.15/219.30  |- mesh__dateCreated mesh__D003701 1986-04-11
% 219.15/219.30  |- skos__altLabel mesh__D003701 Delta-Sleep Peptide
% 219.15/219.30  |- skos__altLabel mesh__D003701 DSIP
% 219.15/219.30  |- skos__broader mesh__D003701smesh__D009842
% 219.15/219.30  |- skos__altLabel mesh__D003701 Delta-Sleep-Inducing Peptide
% 219.15/219.30  |- skos__altLabel mesh__D003701 Delta Sleep Inducing Peptide
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D003701 2006
% 219.15/219.30  |- skos__hiddenLabel mesh__D003701 Sleep-Inducing Peptide, Delta
% 219.15/219.30  |- mesh__dateEstablished mesh__D003701 1987-01-01
% 219.15/219.30  |- skos__historyNote mesh__D003701 Oligopeptides %28%1973-1986%29%
% 219.15/219.30  |- rdf__type mesh__D003701sskos__Concept
% 219.15/219.30  |- skos__prefLabel mesh__D003701 Delta Sleep-Inducing Peptide
% 219.15/219.30  |- skos__hiddenLabel mesh__D003701 Peptide, Delta Sleep-Inducing
% 219.15/219.30  |- mesh__publicMeSHNote mesh__D003701 87   
% 219.15/219.30  |- skos__altLabel mesh__D003701 Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
% 219.15/219.30  |- skos__broader mesh__D003701smesh__D009479
% 219.15/219.30  |- skos__historyNote mesh__D003701 Peptides %28%1966-1972%29%
% 219.15/219.30  |- skos__hiddenLabel mesh__D003701 Delta Sleep Peptide
% 219.15/219.30  |- skos__hiddenLabel mesh__D003701 Peptide, Delta-Sleep
% 219.15/219.30  |- mesh__dateRevised mesh__D003701 2005-06-30
% 219.15/219.30  |- skos__hiddenLabel mesh__D003701 Peptide, Delta-Sleep-Inducing
% 219.15/219.30  |- mesh__historyNote mesh__D003701 87   
% 219.15/219.30  |- mesh__recordMaintainer mesh__D003701 ssb
% 219.15/219.30  |- skos__altLabel mesh__D003701 Delta-Sleep-Inducing-Peptide
% 219.15/219.30  |- skos__hiddenLabel mesh__D003701 Trp Ala Gly Gly Asp Ala Ser Gly Glu
% 219.15/219.30  |- mesh__publicMeSHNote mesh__D008995
% 219.15/219.30       63; TYRAMINE OXIDASE was indexed under AMINE OXIDOREDUCTASES 1980-98%A%  
% 219.15/219.30  |- skos__scopeNote mesh__D008995
% 219.15/219.30       An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. %28%From Goodman and Gilman%27%s, The Pharmacological Basis of Therapeutics, 8th ed, p415%29% EC 1.4.3.4.%A%    
% 219.15/219.30  |- mesh__recordOriginator mesh__D008995 NLM
% 219.15/219.30  |- skos__altLabel mesh__D008995 Type B Monoamine Oxidase
% 219.15/219.30  |- skos__altLabel mesh__D008995 Monoamine Oxidase A
% 219.15/219.30  |- skos__altLabel mesh__D008995 Tyramine Oxidase
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D008995 2006
% 219.15/219.30  |- skos__hiddenLabel mesh__D008995 MAO A
% 219.15/219.30  |- mesh__dateRevised mesh__D008995 2005-06-30
% 219.15/219.30  |- skos__altLabel mesh__D008995 Amine Oxidase %28%Flavin-Containing%29%
% 219.15/219.30  |- skos__altLabel mesh__D008995 MAO
% 219.15/219.30  |- mesh__dateCreated mesh__D008995 1999-01-01
% 219.15/219.30  |- skos__prefLabel mesh__D008995 Monoamine Oxidase
% 219.15/219.30  |- skos__hiddenLabel mesh__D008995 MAO B
% 219.15/219.30  |- skos__hiddenLabel mesh__D008995 Oxidase, Monoamine
% 219.15/219.30  |- mesh__historyNote mesh__D008995
% 219.15/219.30       63; for TYRAMINE OXIDASE use MONOAMINE OXIDASE %28%NM%29% 1980-98%A%  
% 219.15/219.30  |- skos__hiddenLabel mesh__D008995 Oxidase, Tyramine
% 219.15/219.30  |- skos__altLabel mesh__D008995 MAO-B
% 219.15/219.30  |- mesh__recordMaintainer mesh__D008995 jmp
% 219.15/219.30  |- mesh__recordAuthorizer mesh__D008995 sjn
% 219.15/219.30  |- skos__altLabel mesh__D008995 MAO-A
% 219.15/219.30  |- rdf__type mesh__D008995sskos__Concept
% 219.15/219.30  |- skos__broader mesh__D008995smesh__D050891
% 219.15/219.30  |- skos__scopeNote mesh__D008197
% 219.15/219.30       Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. %28%From Dorland, 28th ed, p966%29%%A%    
% 219.15/219.30  |- mesh__recordMaintainer mesh__D008197 TGC
% 219.15/219.30  |- skos__hiddenLabel mesh__D008197 Node Dissection, Lymph
% 219.15/219.30  |- skos__hiddenLabel mesh__D008197 Lymph Node Dissections
% 219.15/219.30  |- skos__hiddenLabel mesh__D008197 Dissections, Lymph Node
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D008197 1997
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D008197 2002
% 219.15/219.30  |- rdf__type mesh__D008197sskos__Concept
% 219.15/219.30  |- mesh__recordAuthorizer mesh__D008197 PLS
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D008197 1999
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D008197 2001
% 219.15/219.30  |- mesh__dateRevised mesh__D008197 1996-06-10
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D008197 2004
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D008197 1998
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D008197 2000
% 219.15/219.30  |- skos__prefLabel mesh__D008197 Lymph Node Excision
% 219.15/219.30  |- skos__hiddenLabel mesh__D008197 Excisions, Lymph Node
% 219.15/219.30  |- skos__hiddenLabel mesh__D008197 Lymph Node Excisions
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D008197 2003
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D008197 2006
% 219.15/219.30  |- skos__hiddenLabel mesh__D008197 Node Dissections, Lymph
% 219.15/219.30  |- skos__broader mesh__D008197smesh__D013514
% 219.15/219.30  |- skos__annotation mesh__D008197
% 219.15/219.30       coord IM with site of lymph nodes %28%NIM%29% but RADICAL NECK DISSECTION is available; do not use /util except by MeSH definition%A%  
% 219.15/219.30  |- skos__hiddenLabel mesh__D008197 Dissection, Lymph Node
% 219.15/219.30  |- skos__hiddenLabel mesh__D008197 Lymphadenectomies
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D008197 2005
% 219.15/219.30  |- mesh__recordOriginator mesh__D008197 NLM
% 219.15/219.30  |- skos__altLabel mesh__D008197 Lymphadenectomy
% 219.15/219.30  |- mesh__dateCreated mesh__D008197 1999-01-01
% 219.15/219.30  |- skos__hiddenLabel mesh__D008197 Excision, Lymph Node
% 219.15/219.30  |- mesh__publicMeSHNote mesh__D016629 92   
% 219.15/219.30  |- rdf__type mesh__D016629sskos__Concept
% 219.15/219.30  |- skos__historyNote mesh__D016629 Esophagus/surgery %28%1966-1991%29%
% 219.15/219.30  |- skos__annotation mesh__D016629
% 219.15/219.30       includes partial %26% total; do not use /util except by MeSH definition%A%  
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D016629 1998
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D016629 2003
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D016629 2000
% 219.15/219.30  |- skos__broader mesh__D016629smesh__D013505
% 219.15/219.30  |- skos__scopeNote mesh__D016629
% 219.15/219.30       Excision of part %28%partial%29% or all %28%total%29% of the esophagus. %28%Dorland, 28th ed%29%%A%    
% 219.15/219.30  |- mesh__historyNote mesh__D016629 92   
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D016629 1999
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D016629 2004
% 219.15/219.30  |- skos__prefLabel mesh__D016629 Esophagectomy
% 219.15/219.30  |- mesh__dateRevised mesh__D016629 1997-06-20
% 219.15/219.30  |- mesh__recordAuthorizer mesh__D016629 SJN
% 219.15/219.30  |- skos__hiddenLabel mesh__D016629 Esophagectomies
% 219.15/219.30  |- mesh__recordMaintainer mesh__D016629 PXP
% 219.15/219.30  |- mesh__dateEstablished mesh__D016629 1992-01-01
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D016629 2001
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D016629 2005
% 219.15/219.30  |- mesh__dateCreated mesh__D016629 1991-01-25
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D016629 2002
% 219.15/219.30  |- mesh__recordOriginator mesh__D016629 TGC
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D016629 2006
% 219.15/219.30  |- mesh__historyNote mesh__D041022 2003   
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D041022 2006A
% 219.15/219.30  |- mesh__dateEstablished mesh__D041022 2003-01-01
% 219.15/219.30  |- rdf__type mesh__D041022sskos__Concept
% 219.15/219.30  |- mesh__publicMeSHNote mesh__D041022 2003   
% 219.15/219.30  |- skos__scopeNote mesh__D041022
% 219.15/219.30       A species of MITOSPORIC FUNGI that is a major cause of SEPTICEMIA and disseminated CANDIDIASIS, especially in patients with LYMPHOMA; LEUKEMIA; and DIABETES MELLITUS. It is also found as part of the normal human mucocutaneous flora.%A%    
% 219.15/219.30  |- skos__broader mesh__D041022smesh__D002175
% 219.15/219.30  |- mesh__dateCreated mesh__D041022 2002-07-03
% 219.15/219.30  |- skos__annotation mesh__D041022
% 219.15/219.30       infection: coord with CANDIDIASIS %28%IM%29% or its indentions %28%IM%29%%A%  
% 219.15/219.30  |- mesh__recordAuthorizer mesh__D041022 ags
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D041022 2006
% 219.15/219.30  |- mesh__dateRevised mesh__D041022 2005-07-13
% 219.15/219.30  |- mesh__recordMaintainer mesh__D041022 ags
% 219.15/219.30  |- mesh__recordOriginator mesh__D041022 ags
% 219.15/219.30  |- skos__prefLabel mesh__D041022 Candida tropicalis
% 219.15/219.30  |- skos__historyNote mesh__D041022 Candida %28%1964-2002%29%
% 219.15/219.30  |- mesh__historyNote mesh__D002609 71   
% 219.15/219.30  |- skos__annotation mesh__D002609
% 219.15/219.30       %22%a form of phagocyte bactericidal dysfunct%22%   
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D002609 2004
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D002609 1997
% 219.15/219.30  |- mesh__recordMaintainer mesh__D002609 PLS
% 219.15/219.30  |- skos__broader mesh__D002609smesh__D010585
% 219.15/219.30  |- mesh__dateRevised mesh__D002609 1994-06-28
% 219.15/219.30  |- skos__hiddenLabel mesh__D002609 Chediak Higashi Syndrome
% 219.15/219.30  |- rdf__type mesh__D002609sskos__Concept
% 219.15/219.30  |- mesh__publicMeSHNote mesh__D002609 71   
% 219.15/219.30  |- skos__hiddenLabel mesh__D002609 Syndrome, Chediak-Higashi
% 219.15/219.30  |- mesh__dateCreated mesh__D002609 1999-01-01
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D002609 2000
% 219.15/219.30  |- skos__related mesh__D002609smesh__D000453
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D002609 2005
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D002609 1998
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D002609 2001
% 219.15/219.30  |- skos__prefLabel mesh__D002609 Chediak-Higashi Syndrome
% 219.15/219.30  |- mesh__recordOriginator mesh__D002609 NLM
% 219.15/219.30  |- skos__historyNote mesh__D002609 Leukocytes %28%1966-1970%29%
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D002609 1995
% 219.15/219.30  |- mesh__dateEstablished mesh__D002609 1971-01-01
% 219.15/219.30  |- skos__historyNote mesh__D002609
% 219.15/219.30       Immunologic Deficiency Syndromes %28%1968-1970%29%
% 219.15/219.30  |- skos__scopeNote mesh__D002609
% 219.15/219.30       A form of phagocyte bactericidal dysfunction characterized by unusual oculocutaneous albinism, high incidence of lymphoreticular neoplasms, and recurrent pyogenic infections. In many cell types, abnormal lysosomes are present leading to defective pigment distribution and abnormal neutrophil functions. The disease is transmitted by autosomal recessive inheritance and a similar disorder occurs in the beige mouse, the Aleutian mink, and albino Hereford cattle.%A%    
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D002609 2003
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D002609 1996
% 219.15/219.30  |- mesh__recordAuthorizer mesh__D002609 PLS
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D002609 2006
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D002609 1999
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D002609 2002
% 219.15/219.30  |- mesh__dateCreated mesh__D013331 1999-01-01
% 219.15/219.30  |- mesh__historyNote mesh__D013331 NUX VOMICA was heading 1963-78   
% 219.15/219.30  |- skos__hiddenLabel mesh__D013331 Nitrate, Strychnine
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D013331 2006
% 219.15/219.30  |- mesh__recordOriginator mesh__D013331 NLM
% 219.15/219.30  |- skos__prefLabel mesh__D013331 Strychnine
% 219.15/219.30  |- skos__scopeNote mesh__D013331
% 219.15/219.30       An alkaloid found in the seeds of STRYCHNOS NUX-VOMICA. It is a competitive antagonist at glycine receptors and thus a convulsant. It has been used as an analeptic, in the treatment of nonketotic hyperglycinemia and sleep apnea, and as a rat poison.%A%    
% 219.15/219.30  |- mesh__onlineNote mesh__D013331
% 219.15/219.30       use STRYCHNINE to search NUX VOMICA 1966-78   
% 219.15/219.30  |- mesh__publicMeSHNote mesh__D013331 NUX VOMICA was heading 1963-78   
% 219.15/219.30  |- mesh__recordAuthorizer mesh__D013331 sjn
% 219.15/219.30  |- skos__broader mesh__D013331smesh__D046948
% 219.15/219.30  |- mesh__recordMaintainer mesh__D013331 ssb
% 219.15/219.30  |- mesh__dateRevised mesh__D013331 2004-07-07
% 219.15/219.30  |- rdf__type mesh__D013331sskos__Concept
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D013331 2005
% 219.15/219.30  |- mesh__historyNote mesh__D012239
% 219.15/219.30       91%28%75%29%; was see under TRIATOMIDAE 1979-90; was see under TRIATOMINAE 1973-78%A%  
% 219.15/219.30  |- skos__annotation mesh__D012239
% 219.15/219.30       vectors of Trypanosoma cruzi; do not use /drug eff for insecticides: TN 111;%A%  
% 219.15/219.30  |- mesh__recordAuthorizer mesh__D012239 sjn
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D012239 2006
% 219.15/219.30  |- mesh__recordOriginator mesh__D012239 NLM
% 219.15/219.30  |- rdf__type mesh__D012239sskos__Concept
% 219.15/219.30  |- skos__broader mesh__D012239smesh__D014225
% 219.15/219.30  |- skos__prefLabel mesh__D012239 Rhodnius
% 219.15/219.30  |- mesh__onlineNote mesh__D012239
% 219.15/219.30       use TRIATOMINAE to search RHODNIUS 1973-74   
% 219.15/219.30  |- skos__scopeNote mesh__D012239
% 219.15/219.30       A genus of the subfamily TRIATOMINAE. Rhodnius prolixus is a vector for TRYPANOSOMA CRUZI.%A%    
% 219.15/219.30  |- mesh__recordMaintainer mesh__D012239 ags
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D012239 2004
% 219.15/219.30  |- mesh__dateEstablished mesh__D012239 1991-01-01
% 219.15/219.30  |- mesh__dateRevised mesh__D012239 2003-07-09
% 219.15/219.30  |- mesh__publicMeSHNote mesh__D012239
% 219.15/219.30       91; was see under TRIATOMIDAE 1979-90; was see under TRIATOMINAE 1973-78%A%  
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D012239 2005
% 219.15/219.30  |- mesh__dateCreated mesh__D012239 1999-01-01
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D009290 2001
% 219.15/219.30  |- skos__hiddenLabel mesh__D009290 Syndromes, Narcolepsy-Cataplexy
% 219.15/219.30  |- mesh__dateRevised mesh__D009290 1999-11-03
% 219.15/219.30  |- skos__hiddenLabel mesh__D009290 Syndromes, Narcoleptic
% 219.15/219.30  |- skos__hiddenLabel mesh__D009290 Syndrome, Narcolepsy-Cataplexy
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D009290 2004
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D009290 2005
% 219.15/219.30  |- mesh__dateEstablished mesh__D009290 1967-01-01
% 219.15/219.30  |- skos__scopeNote mesh__D009290
% 219.15/219.30       A condition characterized by recurrent episodes of daytime somnolence and lapses in consciousness %28%microsomnias%29% that may be associated with automatic behaviors and AMNESIA. CATAPLEXY; SLEEP PARALYSIS, and hypnagogic HALLUCINATIONS frequently accompany narcolepsy. The pathophysiology of this disorder includes sleep-onset rapid eye movement %28%REM%29% sleep, which normally follows stage III or IV sleep. %28%From Neurology 1998 Feb;50%28%2 Suppl 1%29%:S2-S7%29%%A%    
% 219.15/219.30  |- skos__hiddenLabel mesh__D009290 Syndromes, Gelineau%27%s
% 219.15/219.30  |- skos__hiddenLabel mesh__D009290 Sleep, Paroxysmal
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D009290 2000
% 219.15/219.30  |- mesh__recordAuthorizer mesh__D009290 sjn
% 219.15/219.30  |- mesh__publicMeSHNote mesh__D009290 67   
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D009290 2003
% 219.15/219.30  |- mesh__historyNote mesh__D009290 67%28%63%29%   
% 219.15/219.30  |- skos__altLabel mesh__D009290 Narcoleptic Syndrome
% 219.15/219.30  |- skos__hiddenLabel mesh__D009290 Narcolepsy-Cataplexy Syndromes
% 219.15/219.30  |- skos__prefLabel mesh__D009290 Narcolepsy
% 219.15/219.30  |- skos__hiddenLabel mesh__D009290 Narcolepsy Cataplexy Syndrome
% 219.15/219.30  |- skos__hiddenLabel mesh__D009290 Syndrome, Gelineau
% 219.15/219.30  |- skos__hiddenLabel mesh__D009290 Syndrome, Gelineau%27%s
% 219.15/219.30  |- skos__altLabel mesh__D009290 Paroxysmal Sleep
% 219.15/219.30  |- rdf__type mesh__D009290sskos__Concept
% 219.15/219.30  |- mesh__activeMeSHYear mesh__D009290 2002
% 219.15/219.30  |- mesh__recordOriginator mesh__D009290 NLM
% 219.15/219.30  |- skos__altLabel mesh__D009290 Gelineau%27%s Syndrome
% 219.15/219.30  |- mesh__dateCreated mesh__D009290 1999-01-01
% 219.15/219.30  |- skos__hiddenLabel mesh__D009290 Gelineaus Syndrome
% 219.15/219.30  |- skos__altLabel mesh__D009290 Gelineau Syndrome
% 219.15/219.30  |- skos__hiddenLabel mesh__D009290 Gelineau%27%s Syndromes
% 219.15/219.30  |- skos__hiddenLabel mesh__D009290 Syndrome, Narcoleptic
% 219.16/219.30  |- skos__broader mesh__D009290smesh__D006970
% 219.16/219.30  |- skos__hiddenLabel mesh__D009290 Narcoleptic Syndromes
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D009290 2006
% 219.16/219.30  |- mesh__recordMaintainer mesh__D009290 KEV
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D017722 2000
% 219.16/219.30  |- skos__historyNote mesh__D017722 Economics, Hospital %28%1967-1993%29%
% 219.16/219.30  |- mesh__dateRevised mesh__D017722 1996-06-10
% 219.16/219.30  |- skos__prefLabel mesh__D017722 Hospital Charges
% 219.16/219.30  |- mesh__historyNote mesh__D017722 94   
% 219.16/219.30  |- skos__altLabel mesh__D017722 Charges, Hospital
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D017722 2003
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D017722 2001
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D017722 1998
% 219.16/219.30  |- mesh__recordMaintainer mesh__D017722 KEV
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D017722 2005
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D017722 1997
% 219.16/219.30  |- skos__broader mesh__D017722smesh__D004469
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D017722 2004
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D017722 1999
% 219.16/219.30  |- rdf__type mesh__D017722sskos__Concept
% 219.16/219.30  |- skos__scopeNote mesh__D017722
% 219.16/219.30       The prices a hospital sets for its services. HOSPITAL COSTS %28%the direct and indirect expenses incurred by the hospital in providing the services%29% are one factor in the determination of hospital charges. Other factors may include, for example, profits, competition, and the necessity of recouping the costs of uncompensated care.%A%    
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D017722 2006
% 219.16/219.30  |- skos__altLabel mesh__D017722 Charge, Hospital
% 219.16/219.30  |- skos__annotation mesh__D017722
% 219.16/219.30       prices for services: do not confuse with HOSPITAL COSTS, expenses incurred by hosp in providing services; DF: HOSP CHARGES%A%  
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D017722 2002
% 219.16/219.30  |- mesh__dateCreated mesh__D017722 1992-12-28
% 219.16/219.30  |- mesh__publicMeSHNote mesh__D017722 94   
% 219.16/219.30  |- mesh__recordOriginator mesh__D017722 RAZ
% 219.16/219.30  |- mesh__dateEstablished mesh__D017722 1994-01-01
% 219.16/219.30  |- skos__historyNote mesh__D017722 Fees and Charges %28%1967-1993%29%
% 219.16/219.30  |- skos__altLabel mesh__D017722 Hospital Charge
% 219.16/219.30  |- skos__broader mesh__D017722smesh__D005249
% 219.16/219.30  |- mesh__recordAuthorizer mesh__D017722 PLS
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D003702 2005
% 219.16/219.30  |- skos__hiddenLabel mesh__D003702 Delusion
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D003702 2006
% 219.16/219.30  |- mesh__dateRevised mesh__D003702 2002-07-03
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D003702 2003
% 219.16/219.30  |- rdf__type mesh__D003702sskos__Concept
% 219.16/219.30  |- mesh__recordAuthorizer mesh__D003702 sjn
% 219.16/219.30  |- skos__annotation mesh__D003702
% 219.16/219.30       this is the French %22%d%C3%%A9%lire%22%; do not confuse with ILLUSIONS%A%  
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D003702 2004
% 219.16/219.30  |- mesh__dateCreated mesh__D003702 1999-01-01
% 219.16/219.30  |- skos__broader mesh__D003702smesh__D001526
% 219.16/219.30  |- mesh__recordOriginator mesh__D003702 NLM
% 219.16/219.30  |- skos__scopeNote mesh__D003702
% 219.16/219.30       A false belief regarding the self or persons or objects outside the self that persists despite the facts, and is not considered tenable by one%27%s associates.%A%    
% 219.16/219.30  |- skos__prefLabel mesh__D003702 Delusions
% 219.16/219.30  |- mesh__recordMaintainer mesh__D003702 jls
% 219.16/219.30  |- skos__scopeNote mesh__D008996
% 219.16/219.30       A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. %28%From Gilman, et al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 8th ed, p414%29%%A%    
% 219.16/219.30  |- skos__hiddenLabel mesh__D008996 Inhibitors, Monoamine Oxidase
% 219.16/219.30  |- skos__altLabel mesh__D008996 MAO Inhibitors
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D008996 2006
% 219.16/219.30  |- mesh__recordMaintainer mesh__D008996 jls
% 219.16/219.30  |- mesh__recordAuthorizer mesh__D008996 jls
% 219.16/219.30  |- mesh__recordOriginator mesh__D008996 NLM
% 219.16/219.30  |- mesh__dateCreated mesh__D008996 1999-01-01
% 219.16/219.30  |- skos__hiddenLabel mesh__D008996 Inhibitor, Monoamine Oxidase
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D008996 2005
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D008996 2004
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D008996 2005A
% 219.16/219.30  |- mesh__dateRevised mesh__D008996 2004-07-28
% 219.16/219.30  |- rdf__type mesh__D008996sskos__Concept
% 219.16/219.30  |- skos__altLabel mesh__D008996 Reversible Inhibitor of Monoamine Oxidase
% 219.16/219.30  |- skos__hiddenLabel mesh__D008996 Inhibitors, MAO
% 219.16/219.30  |- skos__altLabel mesh__D008996 Monoamine Oxidase Inhibitor
% 219.16/219.30  |- skos__annotation mesh__D008996 DF: MAO INHIB   
% 219.16/219.30  |- skos__broader mesh__D008996smesh__D004791
% 219.16/219.30  |- skos__related mesh__D008996smesh__D000928
% 219.16/219.30  |- skos__prefLabel mesh__D008996 Monoamine Oxidase Inhibitors
% 219.16/219.30  |- rdf__type mesh__D008198sskos__Concept
% 219.16/219.30  |- skos__prefLabel mesh__D008198 Lymph Nodes
% 219.16/219.30  |- mesh__recordOriginator mesh__D008198 NLM
% 219.16/219.30  |- skos__scopeNote mesh__D008198
% 219.16/219.30       They are oval or bean shaped bodies %28%1 - 30 mm in diameter%29% located along the lymphatic system.%A%    
% 219.16/219.30  |- skos__hiddenLabel mesh__D008198 Node, Lymph
% 219.16/219.30  |- skos__hiddenLabel mesh__D008198 Lymph Node
% 219.16/219.30  |- mesh__recordAuthorizer mesh__D008198 sjn
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D008198 2004
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D008198 2006
% 219.16/219.30  |- skos__hiddenLabel mesh__D008198 Nodes, Lymph
% 219.16/219.30  |- mesh__recordMaintainer mesh__D008198 jmp
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D008198 2005
% 219.16/219.30  |- mesh__dateCreated mesh__D008198 1999-01-01
% 219.16/219.30  |- skos__broader mesh__D008198smesh__D008221
% 219.16/219.30  |- skos__related mesh__D008198smesh__D008220
% 219.16/219.30  |- skos__annotation mesh__D008198
% 219.16/219.30       /radiogr permitted: not necessarily LYMPHOGRAPHY; /surg: probably LYMPH NODE EXCISION or specifics; GIANT LYMPH NODE HYPERPLASIA is also available; %22%axillary lymph nodes%22% = LYMPH NODES %28%IM%29% + AXILLA %28%NIM, no qualif%29%; %22%cervical lymph nodes%22% = LYMPH NODES %28%IM%29% + NECK %28%NIM, no qualif%29%; inflammation = LYMPHADENITIS%A%  
% 219.16/219.30  |- mesh__dateRevised mesh__D008198 2003-07-09
% 219.16/219.30  |- skos__related mesh__D008198smesh__D008197
% 219.16/219.30  |- skos__altLabel mesh__D041821 Acetobacter liquefaciens
% 219.16/219.30  |- mesh__recordMaintainer mesh__D041821 ags
% 219.16/219.30  |- mesh__dateEstablished mesh__D041821 2004-01-01
% 219.16/219.30  |- mesh__dateCreated mesh__D041821 2003-07-09
% 219.16/219.30  |- mesh__recordAuthorizer mesh__D041821 sjn
% 219.16/219.30  |- skos__scopeNote mesh__D041821
% 219.16/219.30       A genus in the family ACETOBACTERACEAE comprised of acetate-oxidizing bacteria.%A%    
% 219.16/219.30  |- rdf__type mesh__D041821sskos__Concept
% 219.16/219.30  |- skos__prefLabel mesh__D041821 Gluconacetobacter
% 219.16/219.30  |- mesh__historyNote mesh__D041821 2004   
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D041821 2006
% 219.16/219.30  |- skos__historyNote mesh__D041821 Acetobacteraceae %28%1999-2003%29%
% 219.16/219.30  |- skos__broader mesh__D041821smesh__D016947
% 219.16/219.30  |- mesh__recordOriginator mesh__D041821 ags
% 219.16/219.30  |- mesh__dateRevised mesh__D041821 2005-06-30
% 219.16/219.30  |- skos__historyNote mesh__D041821 Acetobacter %28%1997-2001%29%
% 219.16/219.30  |- skos__broader mesh__D041821smesh__D016946
% 219.16/219.30  |- mesh__publicMeSHNote mesh__D041821 2004   
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D013332 1999
% 219.16/219.30  |- rdf__type mesh__D013332sskos__Concept
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D013332 2000
% 219.16/219.30  |- skos__altLabel mesh__D013332 School Dropouts
% 219.16/219.30  |- skos__scopeNote mesh__D013332
% 219.16/219.30       Individuals who leave school, secondary or college, prior to completion of specified curriculum requirements.%A%    
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D013332 2003
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D013332 1995
% 219.16/219.30  |- mesh__activeMeSHYear mesh__D013332 1998
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013332 2006
% 219.16/219.31  |- skos__hiddenLabel mesh__D013332 Dropout, School
% 219.16/219.31  |- mesh__historyNote mesh__D013332 67%28%64%29%   
% 219.16/219.31  |- mesh__recordMaintainer mesh__D013332 TAP
% 219.16/219.31  |- mesh__dateCreated mesh__D013332 1999-01-01
% 219.16/219.31  |- mesh__dateEstablished mesh__D013332 1967-01-01
% 219.16/219.31  |- skos__broader mesh__D013332smesh__D013334
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013332 2002
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013332 1994
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013332 2005
% 219.16/219.31  |- mesh__recordAuthorizer mesh__D013332 PLS
% 219.16/219.31  |- skos__hiddenLabel mesh__D013332 Student Dropout
% 219.16/219.31  |- skos__broader mesh__D013332smesh__D011588
% 219.16/219.31  |- mesh__recordOriginator mesh__D013332 NLM
% 219.16/219.31  |- mesh__publicMeSHNote mesh__D013332 67   
% 219.16/219.31  |- skos__hiddenLabel mesh__D013332 Dropouts, School
% 219.16/219.31  |- skos__hiddenLabel mesh__D013332 School Dropout
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013332 1997
% 219.16/219.31  |- mesh__dateRevised mesh__D013332 1992-05-18
% 219.16/219.31  |- skos__hiddenLabel mesh__D013332 Dropouts, Student
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013332 2001
% 219.16/219.31  |- skos__prefLabel mesh__D013332 Student Dropouts
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013332 1993
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013332 1996
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013332 2004
% 219.16/219.31  |- skos__hiddenLabel mesh__D013332 Dropout, Student
% 219.16/219.31  |- mesh__dateRevised mesh__D009291 1997-06-20
% 219.16/219.31  |- skos__hiddenLabel mesh__D009291 Narcotherapies
% 219.16/219.31  |- mesh__onlineNote mesh__D009291
% 219.16/219.31       use NARCOTHERAPY to search NARCOSYNTHESIS 1968-78   
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D009291 2003
% 219.16/219.31  |- mesh__recordAuthorizer mesh__D009291 SJN
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D009291 1999
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D009291 2001
% 219.16/219.31  |- rdf__type mesh__D009291sskos__Concept
% 219.16/219.31  |- skos__prefLabel mesh__D009291 Narcotherapy
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D009291 1998
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D009291 2000
% 219.16/219.31  |- mesh__recordMaintainer mesh__D009291 PXP
% 219.16/219.31  |- skos__hiddenLabel mesh__D009291 Narcosyntheses
% 219.16/219.31  |- mesh__dateCreated mesh__D009291 1999-01-01
% 219.16/219.31  |- mesh__historyNote mesh__D009291
% 219.16/219.31       NARCOSYNTHESIS was see under NARCOTHERAPY 1968-78   
% 219.16/219.31  |- skos__scopeNote mesh__D009291
% 219.16/219.31       Intravenous injections of sodium amytal or sodium pentothal to induce a state in which the patient is more relaxed and communicative. Narcosuggestion, narcosynthesis, and narcoanalysis are therapeutic processes using these drug adjuncts.%A%    
% 219.16/219.31  |- skos__broader mesh__D009291smesh__D011600
% 219.16/219.31  |- skos__annotation mesh__D009291
% 219.16/219.31       a psychother technique using adjuvant sodium amytal or pentothal; DF: NARCOTHER%A%  
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D009291 2006
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D009291 2002
% 219.16/219.31  |- mesh__recordOriginator mesh__D009291 NLM
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D009291 2004
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D009291 2005
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D017723 2004
% 219.16/219.31  |- skos__hiddenLabel mesh__D017723 Reviews, Drug Utilization
% 219.16/219.31  |- mesh__dateRevised mesh__D017723 1994-05-05
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D017723 1995
% 219.16/219.31  |- skos__historyNote mesh__D017723 Drug Utilization %28%1967-1993%29%
% 219.16/219.31  |- skos__hiddenLabel mesh__D017723 Utilization Reviews, Drug
% 219.16/219.31  |- mesh__dateEstablished mesh__D017723 1994-01-01
% 219.16/219.31  |- mesh__recordMaintainer mesh__D017723 TGC
% 219.16/219.31  |- skos__hiddenLabel mesh__D017723 Drug Utilization Evaluations
% 219.16/219.31  |- skos__hiddenLabel mesh__D017723 Drug Use Review
% 219.16/219.31  |- mesh__recordOriginator mesh__D017723 RAZ
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D017723 2002
% 219.16/219.31  |- skos__altLabel mesh__D017723 Review, Drug-Use
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D017723 2003
% 219.16/219.31  |- skos__altLabel mesh__D017723 Review, Drug Utilization
% 219.16/219.31  |- skos__altLabel mesh__D017723 Utilization Review, Drug
% 219.16/219.31  |- skos__altLabel mesh__D017723 Evaluation, Drug Utilization
% 219.16/219.31  |- skos__hiddenLabel mesh__D017723 Drug-Use Reviews
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D017723 1999
% 219.16/219.31  |- skos__altLabel mesh__D017723 Drug Utilization Evaluation
% 219.16/219.31  |- skos__hiddenLabel mesh__D017723 Drug Utilization Reviews
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D017723 1998
% 219.16/219.31  |- mesh__recordAuthorizer mesh__D017723 PLS
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D017723 1997
% 219.16/219.31  |- skos__altLabel mesh__D017723 Drug-Use Review
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D017723 2001
% 219.16/219.31  |- skos__historyNote mesh__D017723 Utilization Review %28%1972-1993%29%
% 219.16/219.31  |- skos__hiddenLabel mesh__D017723 Evaluations, Drug Utilization
% 219.16/219.31  |- skos__hiddenLabel mesh__D017723 Review, Drug Use
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D017723 1996
% 219.16/219.31  |- skos__prefLabel mesh__D017723 Drug Utilization Review
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D017723 2006
% 219.16/219.31  |- skos__hiddenLabel mesh__D017723 Utilization Evaluations, Drug
% 219.16/219.31  |- skos__hiddenLabel mesh__D017723 Utilization Evaluation, Drug
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D017723 2000
% 219.16/219.31  |- skos__scopeNote mesh__D017723
% 219.16/219.31       Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed %28%as in computer systems which advise physicians when prescriptions are entered%29%. Drug utilization review is mandated for Medicaid programs beginning in 1993.%A%    
% 219.16/219.31  |- mesh__publicMeSHNote mesh__D017723 94   
% 219.16/219.31  |- mesh__dateCreated mesh__D017723 1992-12-28
% 219.16/219.31  |- skos__broader mesh__D017723smesh__D004363
% 219.16/219.31  |- rdf__type mesh__D017723sskos__Concept
% 219.16/219.31  |- mesh__historyNote mesh__D017723 94   
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D017723 2005
% 219.16/219.31  |- skos__broader mesh__D017723smesh__D014600
% 219.16/219.31  |- skos__hiddenLabel mesh__D017723 Reviews, Drug-Use
% 219.16/219.31  |- skos__annotation mesh__D017723
% 219.16/219.31       GEN or unspecified, IM; coord IM with specific drug with no qualif %28%IM%29%; DF: DRUG UTIL REV%A%  
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D003703 2006
% 219.16/219.31  |- mesh__recordOriginator mesh__D003703 NLM
% 219.16/219.31  |- mesh__dateEstablished mesh__D003703 1973-01-01
% 219.16/219.31  |- skos__historyNote mesh__D003703 Alkaloids %28%1966-1971%29%
% 219.16/219.31  |- skos__historyNote mesh__D003703 Antineoplastic Agents %28%1966-1971%29%
% 219.16/219.31  |- mesh__dateRevised mesh__D003703 2001-07-25
% 219.16/219.31  |- skos__broader mesh__D003703smesh__D003078
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D003703 2003
% 219.16/219.31  |- rdf__type mesh__D003703sskos__Concept
% 219.16/219.31  |- skos__scopeNote mesh__D003703
% 219.16/219.31       An alkaloid isolated from Colchicum autumnale L. and used as an antineoplastic.%A%    
% 219.16/219.31  |- skos__altLabel mesh__D003703 Colchamine
% 219.16/219.31  |- mesh__publicMeSHNote mesh__D003703 73   
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D003703 2004
% 219.16/219.31  |- mesh__dateCreated mesh__D003703 1999-01-01
% 219.16/219.31  |- skos__historyNote mesh__D003703 Colchicine %28%1966-1971%29%
% 219.16/219.31  |- mesh__historyNote mesh__D003703 73%28%72%29%   
% 219.16/219.31  |- mesh__recordAuthorizer mesh__D003703 sjn
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D003703 2002
% 219.16/219.31  |- skos__altLabel mesh__D003703 Colcemid
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D003703 2005
% 219.16/219.31  |- skos__annotation mesh__D003703 /biosyn permitted if by plant   
% 219.16/219.31  |- skos__prefLabel mesh__D003703 Demecolcine
% 219.16/219.31  |- mesh__recordMaintainer mesh__D003703 jmp
% 219.16/219.31  |- skos__broader mesh__D008997smesh__D007769
% 219.16/219.31  |- mesh__historyNote mesh__D008997 86   
% 219.16/219.31  |- mesh__dateEstablished mesh__D008997 1986-01-01
% 219.16/219.31  |- mesh__recordMaintainer mesh__D008997 ssb
% 219.16/219.31  |- skos__hiddenLabel mesh__D008997 beta Lactams, Monocyclic
% 219.16/219.31  |- skos__broader mesh__D008997smesh__D047090
% 219.16/219.31  |- rdf__type mesh__D008997sskos__Concept
% 219.16/219.31  |- mesh__publicMeSHNote mesh__D008997 86   
% 219.16/219.31  |- mesh__dateCreated mesh__D008997 1985-06-14
% 219.16/219.31  |- mesh__recordAuthorizer mesh__D008997 sjn
% 219.16/219.31  |- skos__historyNote mesh__D008997 Antibiotics %28%1966-1982%29%
% 219.16/219.31  |- skos__altLabel mesh__D008997 Monocyclic beta-Lactams
% 219.16/219.31  |- skos__prefLabel mesh__D008997 Monobactams
% 219.16/219.31  |- skos__annotation mesh__D008997
% 219.16/219.31       do not use /biosyn unless by living matter   
% 219.16/219.31  |- skos__altLabel mesh__D008997 beta-Lactams, Monocyclic
% 219.16/219.31  |- skos__hiddenLabel mesh__D008997 Monocyclic beta Lactams
% 219.16/219.31  |- mesh__dateRevised mesh__D008997 2004-07-07
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008997 2006
% 219.16/219.31  |- mesh__recordOriginator mesh__D008997 SH
% 219.16/219.31  |- skos__historyNote mesh__D008997 Antibiotics, Lactam %28%1983-1985%29%
% 219.16/219.31  |- skos__scopeNote mesh__D008997
% 219.16/219.31       Monocyclic, bacterially produced or semisynthetic beta-lactam antibiotics. They lack the double ring construction of the traditional beta-lactam antibiotics and can be easily synthesized.%A%    
% 219.16/219.31  |- skos__hiddenLabel mesh__D008997 Monobactam Antibiotics
% 219.16/219.31  |- skos__altLabel mesh__D008997 Antibiotics, Monobactam
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008997 2005
% 219.16/219.31  |- rdf__type mesh__D008199sskos__Concept
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008199 2003
% 219.16/219.31  |- skos__broader mesh__D008199smesh__D008206
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008199 2004
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008199 2005
% 219.16/219.31  |- skos__scopeNote mesh__D008199 Inflammation of the lymph nodes.     
% 219.16/219.31  |- mesh__dateCreated mesh__D008199 1999-01-01
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008199 2002
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008199 2006
% 219.16/219.31  |- skos__hiddenLabel mesh__D008199 Adenitides
% 219.16/219.31  |- mesh__recordMaintainer mesh__D008199 KEV
% 219.16/219.31  |- mesh__recordOriginator mesh__D008199 NLM
% 219.16/219.31  |- mesh__recordAuthorizer mesh__D008199 sjn
% 219.16/219.31  |- skos__hiddenLabel mesh__D008199 Lymphadenitides
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008199 2000
% 219.16/219.31  |- mesh__dateRevised mesh__D008199 1999-11-03
% 219.16/219.31  |- skos__prefLabel mesh__D008199 Lymphadenitis
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008199 2001
% 219.16/219.31  |- skos__annotation mesh__D008199
% 219.16/219.31       inflamm of lymph nodes: do not confuse with LYMPHANGITIS, inflamm of lymphatic vessels; consider also MESENTERIC LYMPHADENITIS%A%  
% 219.16/219.31  |- mesh__dateRevised mesh__D041822 2005-06-30
% 219.16/219.31  |- mesh__recordMaintainer mesh__D041822 ags
% 219.16/219.31  |- mesh__dateCreated mesh__D041822 2003-07-09
% 219.16/219.31  |- skos__broader mesh__D041822smesh__D041821
% 219.16/219.31  |- rdf__type mesh__D041822sskos__Concept
% 219.16/219.31  |- skos__historyNote mesh__D041822 Acetobacter %28%2000-2003%29%
% 219.16/219.31  |- skos__altLabel mesh__D041822 Acetobacter xylinum
% 219.16/219.31  |- mesh__dateEstablished mesh__D041822 2004-01-01
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D041822 2006
% 219.16/219.31  |- mesh__recordAuthorizer mesh__D041822 sjn
% 219.16/219.31  |- skos__altLabel mesh__D041822 Gluconacetobacter xylinum
% 219.16/219.31  |- mesh__publicMeSHNote mesh__D041822 2004   
% 219.16/219.31  |- skos__prefLabel mesh__D041822 Gluconacetobacter xylinus
% 219.16/219.31  |- skos__altLabel mesh__D041822 Acetobacter xylinus
% 219.16/219.31  |- mesh__historyNote mesh__D041822 2004   
% 219.16/219.31  |- skos__scopeNote mesh__D041822
% 219.16/219.31       A species of acetate-oxidizing bacteria, formerly known as Acetobacter xylinum.%A%    
% 219.16/219.31  |- mesh__recordOriginator mesh__D041822 ags
% 219.16/219.31  |- skos__altLabel mesh__D013333 University Health Services
% 219.16/219.31  |- skos__prefLabel mesh__D013333 Student Health Services
% 219.16/219.31  |- skos__altLabel mesh__D013333 Health Services, Student
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013333 2001
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013333 2006
% 219.16/219.31  |- mesh__dateCreated mesh__D013333 1999-01-01
% 219.16/219.31  |- skos__scopeNote mesh__D013333
% 219.16/219.31       Health services for college and university students usually provided by the educational institution.%A%    
% 219.16/219.31  |- skos__hiddenLabel mesh__D013333 Service, University Health
% 219.16/219.31  |- mesh__recordAuthorizer mesh__D013333 sjn
% 219.16/219.31  |- mesh__historyNote mesh__D013333
% 219.16/219.31       UNIVERSITY HEALTH SERVICES was see under STUDENT HEALTH SERVICES 1963-78%A%  
% 219.16/219.31  |- mesh__onlineNote mesh__D013333
% 219.16/219.31       use STUDENT HEALTH SERVICES to search UNIVERSITY HEALTH SERVICES 1966-78%A%  
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013333 2000
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013333 2005
% 219.16/219.31  |- skos__hiddenLabel mesh__D013333 Health Service, University
% 219.16/219.31  |- skos__hiddenLabel mesh__D013333 Student Health Service
% 219.16/219.31  |- skos__hiddenLabel mesh__D013333 University Health Service
% 219.16/219.31  |- skos__hiddenLabel mesh__D013333 Service, Student Health
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013333 2002
% 219.16/219.31  |- skos__altLabel mesh__D013333 Services, Student Health
% 219.16/219.31  |- skos__hiddenLabel mesh__D013333 Health Service, Student
% 219.16/219.31  |- skos__broader mesh__D013333smesh__D006296
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013333 2004
% 219.16/219.31  |- mesh__recordMaintainer mesh__D013333 kle
% 219.16/219.31  |- mesh__recordOriginator mesh__D013333 NLM
% 219.16/219.31  |- skos__altLabel mesh__D013333 Services, University Health
% 219.16/219.31  |- mesh__dateRevised mesh__D013333 1999-11-03
% 219.16/219.31  |- rdf__type mesh__D013333sskos__Concept
% 219.16/219.31  |- skos__annotation mesh__D013333
% 219.16/219.31       do not confuse with SCHOOL HEALTH SERVICES for high school %26% under; specify geog; DF: STUDENT HEALTH SERV%A%  
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013333 2003
% 219.16/219.31  |- skos__historyNote mesh__D023761 Fishes %28%1974-2001%29%
% 219.16/219.31  |- skos__broader mesh__D023761smesh__D023701
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D023761 2006
% 219.16/219.31  |- skos__altLabel mesh__D023761 Belonidae
% 219.16/219.31  |- skos__altLabel mesh__D023761 Needlefish
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D023761 2005
% 219.16/219.31  |- mesh__dateEstablished mesh__D023761 2002-01-01
% 219.16/219.31  |- rdf__type mesh__D023761sskos__Concept
% 219.16/219.31  |- mesh__historyNote mesh__D023761 2002   
% 219.16/219.31  |- mesh__publicMeSHNote mesh__D023761 2002   
% 219.16/219.31  |- mesh__dateRevised mesh__D023761 2003-07-09
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D023761 2004
% 219.16/219.31  |- mesh__dateCreated mesh__D023761 2001-07-25
% 219.16/219.31  |- skos__scopeNote mesh__D023761
% 219.16/219.31       An order of fish in the group SMEGMAMORPHA, comprising adrianichthyids, medakas %28%ORYZIAS%29%, needlefishes, halfbeaks, and flying fishes.%A%    
% 219.16/219.31  |- skos__prefLabel mesh__D023761 Beloniformes
% 219.16/219.31  |- skos__annotation mesh__D009292
% 219.16/219.31       GEN or unspecified; prefer specifics; DF: NARCOTIC ANTAG   
% 219.16/219.31  |- skos__broader mesh__D009292smesh__D045505
% 219.16/219.31  |- mesh__dateCreated mesh__D009292 1999-01-01
% 219.16/219.31  |- skos__broader mesh__D009292smesh__D002491
% 219.16/219.31  |- mesh__recordOriginator mesh__D009292 NLM
% 219.16/219.31  |- rdf__type mesh__D009292sskos__Concept
% 219.16/219.31  |- mesh__dateRevised mesh__D009292 2005-06-30
% 219.16/219.31  |- skos__altLabel mesh__D009292 Opioid Antagonists
% 219.16/219.31  |- skos__hiddenLabel mesh__D009292 Antagonists, Opioid
% 219.16/219.31  |- skos__prefLabel mesh__D009292 Narcotic Antagonists
% 219.16/219.31  |- mesh__recordMaintainer mesh__D009292 ssb
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D009292 2006
% 219.16/219.31  |- skos__scopeNote mesh__D009292
% 219.16/219.31       Agents inhibiting the effect of narcotics on the central nervous system.%A%    
% 219.16/219.31  |- skos__hiddenLabel mesh__D009292 Antagonists, Narcotic
% 219.16/219.31  |- mesh__recordAuthorizer mesh__D009292 sjn
% 219.16/219.31  |- skos__hiddenLabel mesh__D003704 Familial Dementias
% 219.16/219.31  |- mesh__recordAuthorizer mesh__D003704 sjn
% 219.16/219.31  |- skos__broader mesh__D003704smesh__D019965
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D003704 2002
% 219.16/219.31  |- skos__altLabel mesh__D003704 Amentia
% 219.16/219.31  |- skos__hiddenLabel mesh__D003704 Dementia, Semantic
% 219.16/219.31  |- skos__hiddenLabel mesh__D003704 Dementias
% 219.16/219.31  |- skos__hiddenLabel mesh__D003704 Lobar Degenerations, Frontotemporal
% 219.16/219.31  |- skos__hiddenLabel mesh__D003704 Paranoid Dementia, Senile
% 219.16/219.31  |- mesh__dateCreated mesh__D003704 1980-05-21
% 219.16/219.31  |- skos__hiddenLabel mesh__D003704 Senile Paranoid Dementias
% 219.16/219.31  |- mesh__recordMaintainer mesh__D003704 lkt
% 219.16/219.31  |- skos__broader mesh__D003704smesh__D001927
% 219.16/219.31  |- skos__hiddenLabel mesh__D003704 Degeneration, Frontotemporal Lobar
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D003704 2005
% 219.16/219.31  |- skos__hiddenLabel mesh__D003704 Dementia, Familial
% 219.16/219.31  |- skos__hiddenLabel mesh__D003704 Lobar Degeneration, Frontotemporal
% 219.16/219.31  |- mesh__dateRevised mesh__D003704 2001-07-25
% 219.16/219.31  |- skos__hiddenLabel mesh__D003704 Amentias
% 219.16/219.31  |- mesh__dateEstablished mesh__D003704 1981-01-01
% 219.16/219.31  |- skos__hiddenLabel mesh__D003704 Frontotemporal Lobar Degenerations
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D003704 2006
% 219.16/219.31  |- mesh__recordOriginator mesh__D003704 EC
% 219.16/219.31  |- skos__scopeNote mesh__D003704
% 219.16/219.31       An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.%A%    
% 219.16/219.31  |- rdf__type mesh__D003704sskos__Concept
% 219.16/219.31  |- skos__hiddenLabel mesh__D003704 Dementias, Semantic
% 219.16/219.31  |- mesh__historyNote mesh__D003704 1981%28%1963%29%   
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D003704 2003
% 219.16/219.31  |- skos__hiddenLabel mesh__D003704 Paranoid Dementias, Senile
% 219.16/219.31  |- skos__hiddenLabel mesh__D003704 Degenerations, Frontotemporal Lobar
% 219.16/219.31  |- skos__prefLabel mesh__D003704 Dementia
% 219.16/219.31  |- mesh__publicMeSHNote mesh__D003704
% 219.16/219.31       1981; see DEMENTIA, SENILE 1979-91; see PSYCHOSES, SENILE 1963-78; see PSYCHOSES, PRESENILE 1963-72; see PICK DISEASE OF BRAIN 1981-91; see PICK%27%S DISEASE OF BRAIN 1966-80; for DEMENTIA, PRESENILE see DEMENTIA 1967-97; for DEMENTIA, SENILE see DEMENTIA 1966-97%A%  
% 219.16/219.31  |- skos__hiddenLabel mesh__D003704 Dementias, Familial
% 219.16/219.31  |- skos__related mesh__D003704smesh__D024801
% 219.16/219.31  |- skos__hiddenLabel mesh__D003704 Dementias, Senile Paranoid
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D003704 2004
% 219.16/219.31  |- skos__hiddenLabel mesh__D003704 Semantic Dementias
% 219.16/219.31  |- skos__hiddenLabel mesh__D008998 Gammopathy, Benign Monoclonal
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008998 2004
% 219.16/219.31  |- skos__hiddenLabel mesh__D008998 Benign Monoclonal Gammapathies
% 219.16/219.31  |- skos__historyNote mesh__D008998
% 219.16/219.31       Blood Protein Disorders %28%1966-1968%29%
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008998 2005
% 219.16/219.31  |- mesh__publicMeSHNote mesh__D008998
% 219.16/219.31       91; was see under HYPERGAMMAGLOBULINEMIA 1986-90   
% 219.16/219.31  |- skos__annotation mesh__D008998 a hypergammaglobulinemia   
% 219.16/219.31  |- skos__hiddenLabel mesh__D008998 Monoclonal Gammopathy, Benign
% 219.16/219.31  |- mesh__recordMaintainer mesh__D008998 TGC
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008998 2000
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008998 2006
% 219.16/219.31  |- skos__hiddenLabel mesh__D008998 Benign Monoclonal Gammapathy
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008998 1996
% 219.16/219.31  |- skos__altLabel mesh__D008998 Monoclonal Gammapathies, Benign
% 219.16/219.31  |- skos__hiddenLabel mesh__D008998 Gammapathy, Benign Monoclonal
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008998 2001
% 219.16/219.31  |- mesh__dateCreated mesh__D008998 1985-02-25
% 219.16/219.31  |- mesh__historyNote mesh__D008998
% 219.16/219.31       91%28%86%29%; was see under HYPERGAMMAGLOBULINEMIA 1986-90   
% 219.16/219.31  |- skos__prefLabel mesh__D008998 Monoclonal Gammopathies, Benign
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008998 1997
% 219.16/219.31  |- mesh__recordAuthorizer mesh__D008998 PLS
% 219.16/219.31  |- skos__hiddenLabel mesh__D008998 Monoclonal Gammapathy, Benign
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008998 1998
% 219.16/219.31  |- skos__altLabel mesh__D008998 Benign Monoclonal Gammopathies
% 219.16/219.31  |- rdf__type mesh__D008998sskos__Concept
% 219.16/219.31  |- skos__broader mesh__D008998smesh__D010265
% 219.16/219.31  |- skos__broader mesh__D008998smesh__D006942
% 219.16/219.31  |- skos__hiddenLabel mesh__D008998 Gammopathies, Benign Monoclonal
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008998 1994
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008998 1999
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008998 2002
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008998 2003
% 219.16/219.31  |- skos__scopeNote mesh__D008998
% 219.16/219.31       Conditions characterized by the presence of a monoclonal serum %28%or urine%29% protein without clinical manifestations of plasma cell dyscrasia.%A%    
% 219.16/219.31  |- mesh__recordOriginator mesh__D008998 AEP
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D008998 1995
% 219.16/219.31  |- skos__hiddenLabel mesh__D008998 Gammapathies, Benign Monoclonal
% 219.16/219.31  |- mesh__dateRevised mesh__D008998 1993-06-02
% 219.16/219.31  |- mesh__dateEstablished mesh__D008998 1991-01-01
% 219.16/219.31  |- skos__historyNote mesh__D008998 Hypergammaglobulinemia %28%1969-1985%29%
% 219.16/219.31  |- skos__hiddenLabel mesh__D008998 Benign Monoclonal Gammopathy
% 219.16/219.31  |- skos__altLabel mesh__D049008 Laser-Assisted Subepithelial Keratectomy
% 219.16/219.31  |- mesh__dateRevised mesh__D049008 2004-07-28
% 219.16/219.31  |- rdf__type mesh__D049008sskos__Concept
% 219.16/219.31  |- skos__hiddenLabel mesh__D049008
% 219.16/219.31       Subepithelial Keratectomy, Laser Assisted
% 219.16/219.31  |- skos__hiddenLabel mesh__D049008
% 219.16/219.31       Photorefractive Keratectomies, Subepithelial
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D049008 2006
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D049008 2005A
% 219.16/219.31  |- skos__altLabel mesh__D049008 LASEK
% 219.16/219.31  |- skos__historyNote mesh__D049008
% 219.16/219.31       Epithelium, Corneal/surgery %28%2001-2004%29%
% 219.16/219.31  |- mesh__dateEstablished mesh__D049008 2005-01-01
% 219.16/219.31  |- skos__altLabel mesh__D049008 Subepithelial Photorefractive Keratectomy
% 219.16/219.31  |- skos__prefLabel mesh__D049008 Keratectomy, Subepithelial, Laser-Assisted
% 219.16/219.31  |- skos__hiddenLabel mesh__D049008 Subepithelial Keratomileusis, Laser
% 219.16/219.31  |- skos__hiddenLabel mesh__D049008
% 219.16/219.31       Laser-Assisted Subepithelial Keratectomies
% 219.16/219.31  |- skos__altLabel mesh__D049008
% 219.16/219.31       Laser-Assisted Sub-Epithelial Keratomileusis
% 219.16/219.31  |- skos__hiddenLabel mesh__D049008
% 219.16/219.31       Laser-Assisted Subepithelial Keratomileusis
% 219.16/219.31  |- skos__hiddenLabel mesh__D049008
% 219.16/219.31       Subepithelial Keratomileusis, Laser Assisted
% 219.16/219.31  |- skos__hiddenLabel mesh__D049008 Laser Assisted Subepithelial Keratectomy
% 219.16/219.31  |- mesh__publicMeSHNote mesh__D049008 2005   
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D049008 2005
% 219.16/219.31  |- skos__altLabel mesh__D049008 Laser Subepithelial Keratomileusis
% 219.16/219.31  |- skos__hiddenLabel mesh__D049008
% 219.16/219.31       Photorefractive Keratectomy, Subepithelial
% 219.16/219.31  |- skos__altLabel mesh__D049008
% 219.16/219.31       Subepithelial Keratomileusis, Laser-Assisted
% 219.16/219.31  |- skos__hiddenLabel mesh__D049008
% 219.16/219.31       Sub-Epithelial Keratomileusis, Laser-Assisted
% 219.16/219.31  |- skos__hiddenLabel mesh__D049008
% 219.16/219.31       Keratectomy, Subepithelial Photorefractive
% 219.16/219.31  |- skos__hiddenLabel mesh__D049008
% 219.16/219.31       Subepithelial Photorefractive Keratectomies
% 219.16/219.31  |- skos__altLabel mesh__D049008
% 219.16/219.31       Excimer Laser Subepithelial Abalation %28%ELSA%29%
% 219.16/219.31  |- mesh__recordAuthorizer mesh__D049008 jls
% 219.16/219.31  |- mesh__recordOriginator mesh__D049008 lkt
% 219.16/219.31  |- mesh__dateCreated mesh__D049008 2004-07-07
% 219.16/219.31  |- skos__scopeNote mesh__D049008
% 219.16/219.31       A surgical technique to correct REFRACTIVE ERRORS of the EYE, such as MYOPIA and ASTIGMATISM. In this method, the flap of CORNEAL EPITHELIUM is lifted then replaced after laser ablation of the subepithelial CORNEA. The hinged flap is created by epithelial marking and exposure of the marking to dilute alcohol.%A%    
% 219.16/219.31  |- skos__altLabel mesh__D049008
% 219.16/219.31       Keratomileusis, Subepithelial, Laser-Assisted
% 219.16/219.31  |- skos__hiddenLabel mesh__D049008
% 219.16/219.31       Subepithelial Keratectomies, Laser-Assisted
% 219.16/219.31  |- skos__broader mesh__D049008smesh__D048988
% 219.16/219.31  |- skos__altLabel mesh__D049008 Subepithelial Keratectomy, Laser-Assisted
% 219.16/219.31  |- mesh__recordMaintainer mesh__D049008 jls
% 219.16/219.31  |- mesh__historyNote mesh__D049008 2005   
% 219.16/219.31  |- skos__hiddenLabel mesh__D049008
% 219.16/219.31       Keratectomies, Subepithelial Photorefractive
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013334 2002
% 219.16/219.31  |- mesh__recordMaintainer mesh__D013334 TGC
% 219.16/219.31  |- skos__broader mesh__D013334smesh__D009272
% 219.16/219.31  |- skos__scopeNote mesh__D013334
% 219.16/219.31       Individuals enrolled in a school or formal educational program.%A%    
% 219.16/219.31  |- mesh__recordAuthorizer mesh__D013334 PLS
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013334 1997
% 219.16/219.31  |- skos__hiddenLabel mesh__D013334 School Enrollments
% 219.16/219.31  |- mesh__recordOriginator mesh__D013334 NLM
% 219.16/219.31  |- skos__annotation mesh__D013334
% 219.16/219.31       /psychol: consider also PSYCHOLOGY, EDUCATIONAL; as persons: Manual 30.7.3; as children: Manual 34.16; relation to EDUCATION: Manual 34.16; /educ = EDUCATION%A%  
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013334 2004
% 219.16/219.31  |- rdf__type mesh__D013334sskos__Concept
% 219.16/219.31  |- mesh__dateRevised mesh__D013334 1996-06-10
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013334 2001
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013334 1999
% 219.16/219.31  |- skos__broader mesh__D013334smesh__D004505
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013334 2003
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013334 2000
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013334 1998
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013334 2006
% 219.16/219.31  |- skos__hiddenLabel mesh__D013334 Enrollments, School
% 219.16/219.31  |- mesh__dateCreated mesh__D013334 1999-01-01
% 219.16/219.31  |- skos__broader mesh__D013334smesh__D004493
% 219.16/219.31  |- skos__hiddenLabel mesh__D013334 Student
% 219.16/219.31  |- mesh__activeMeSHYear mesh__D013334 2005
% 219.16/219.31  |- skos__hiddenLabel mesh__D013334 Enrollment, School
% 219.16/219.31  |- skos__prefLabel mesh__D013334 Students
% 219.16/219.31  |- skos__hiddenLabel mesh__D009293 Dependence, Narcotic
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009293 2002
% 219.16/219.32  |- skos__prefLabel mesh__D009293 Opioid-Related Disorders
% 219.16/219.32  |- skos__scopeNote mesh__D009293
% 219.16/219.32       Disorders related or resulting from abuse or mis-use of opioids.%A%    
% 219.16/219.32  |- mesh__recordAuthorizer mesh__D009293 sjn
% 219.16/219.32  |- mesh__dateRevised mesh__D009293 1999-11-03
% 219.16/219.32  |- rdf__type mesh__D009293sskos__Concept
% 219.16/219.32  |- skos__annotation mesh__D009293
% 219.16/219.32       GEN or unspecified; restrict to only addictive narcotics; coord IM with specific narcotic %28%IM%29% but MORPHINE DEPENDENCE %26% HEROIN DEPENDENCE are also available; X refs OPIATE ADDICTION %26% OPIATE DEPENDENCE do not mean %22%opium%22%: they refer to syn or nat opium deriv %26% other substances with similar eff%A%  
% 219.16/219.32  |- skos__hiddenLabel mesh__D009293 Addiction, Opiate
% 219.16/219.32  |- skos__hiddenLabel mesh__D009293 Dependence, Opiate
% 219.16/219.32  |- skos__historyNote mesh__D009293 Opium %28%1966-1979%29%
% 219.16/219.32  |- skos__hiddenLabel mesh__D009293 Addiction, Narcotic
% 219.16/219.32  |- skos__broader mesh__D009293smesh__D019966
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009293 2005
% 219.16/219.32  |- skos__historyNote mesh__D009293 Narcotics %28%1966-1979%29%
% 219.16/219.32  |- mesh__dateEstablished mesh__D009293 1980-01-01
% 219.16/219.32  |- mesh__historyNote mesh__D009293 98%28%80%29%   
% 219.16/219.32  |- mesh__publicMeSHNote mesh__D009293
% 219.16/219.32       98; see NARCOTIC DEPENDENCE 1981-97, see NARCOTIC ADDICTION 1980%A%  
% 219.16/219.32  |- skos__historyNote mesh__D009293 Substance Dependence %28%1966-1979%29%
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009293 2006
% 219.16/219.32  |- mesh__recordOriginator mesh__D009293 SH
% 219.16/219.32  |- mesh__dateCreated mesh__D009293 1979-05-29
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009293 2003
% 219.16/219.32  |- skos__hiddenLabel mesh__D009293 Narcotic Abuses
% 219.16/219.32  |- skos__hiddenLabel mesh__D009293 Abuses, Narcotic
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009293 2000
% 219.16/219.32  |- skos__hiddenLabel mesh__D009293 Abuse, Narcotic
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009293 2004
% 219.16/219.32  |- skos__hiddenLabel mesh__D009293 Disorder, Opioid-Related
% 219.16/219.32  |- mesh__recordMaintainer mesh__D009293 adp
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009293 2001
% 219.16/219.32  |- skos__scopeNote mesh__D017725
% 219.16/219.32       The pressure within a CARDIAC VENTRICLE. Ventricular pressure waveforms can be measured in the beating heart by catheterization or estimated using imaging techniques %28%e.g., DOPPLER ECHOCARDIOGRAPHY%29%. The information is useful in evaluating the function of the MYOCARDIUM; CARDIAC VALVES; and PERICARDIUM, particularly with simultaneous measurement of other %28%e.g., aortic or atrial%29% pressures.%A%    
% 219.16/219.32  |- skos__hiddenLabel mesh__D017725 Pressure, Ventricular
% 219.16/219.32  |- mesh__historyNote mesh__D017725 94   
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D017725 2004
% 219.16/219.32  |- skos__hiddenLabel mesh__D017725 Pressures, Intraventricular
% 219.16/219.32  |- rdf__type mesh__D017725sskos__Concept
% 219.16/219.32  |- mesh__publicMeSHNote mesh__D017725 94   
% 219.16/219.32  |- mesh__dateEstablished mesh__D017725 1994-01-01
% 219.16/219.32  |- mesh__dateCreated mesh__D017725 1992-12-28
% 219.16/219.32  |- skos__hiddenLabel mesh__D017725 Intraventricular Pressures
% 219.16/219.32  |- mesh__dateRevised mesh__D017725 2003-07-09
% 219.16/219.32  |- skos__altLabel mesh__D017725 Intraventricular Pressure
% 219.16/219.32  |- skos__prefLabel mesh__D017725 Ventricular Pressure
% 219.16/219.32  |- skos__broader mesh__D017725smesh__D016276
% 219.16/219.32  |- skos__hiddenLabel mesh__D017725 Pressures, Ventricular
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D017725 2006
% 219.16/219.32  |- skos__hiddenLabel mesh__D017725 Ventricular Pressures
% 219.16/219.32  |- skos__hiddenLabel mesh__D017725 Pressure, Intraventricular
% 219.16/219.32  |- skos__annotation mesh__D017725 within heart, not cerebral ventricles   
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D017725 2005
% 219.16/219.32  |- skos__broader mesh__D017725smesh__D045472
% 219.16/219.32  |- mesh__publicMeSHNote mesh__D008999
% 219.16/219.32       91; was see under INSECTICIDES, ORGANOPHOSPHATE 1972-90   
% 219.16/219.32  |- rdf__type mesh__D008999sskos__Concept
% 219.16/219.32  |- skos__broader mesh__D008999smesh__D009943
% 219.16/219.32  |- skos__scopeNote mesh__D008999
% 219.16/219.32       An organophosphate insecticide that inhibits monoamine oxidase and acetylcholinesterase. It has been shown to be genotoxic.%A%    
% 219.16/219.32  |- skos__annotation mesh__D008999 TN 111 for eff on insects   
% 219.16/219.32  |- mesh__dateRevised mesh__D008999 2004-07-07
% 219.16/219.32  |- mesh__dateEstablished mesh__D008999 1991-01-01
% 219.16/219.32  |- mesh__recordMaintainer mesh__D008999 ssb
% 219.16/219.32  |- mesh__dateCreated mesh__D008999 1999-01-01
% 219.16/219.32  |- mesh__recordOriginator mesh__D008999 NLM
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D008999 2005
% 219.16/219.32  |- skos__hiddenLabel mesh__D008999 SD 9,129
% 219.16/219.32  |- skos__hiddenLabel mesh__D008999 SD9,129
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D008999 2006
% 219.16/219.32  |- mesh__historyNote mesh__D008999
% 219.16/219.32       91%28%72%29%; was see under INSECTICIDES, ORGANOPHOSPHATE 1972-90%A%  
% 219.16/219.32  |- mesh__recordAuthorizer mesh__D008999 sjn
% 219.16/219.32  |- skos__historyNote mesh__D008999 Insecticides %28%1966-1971%29%
% 219.16/219.32  |- skos__prefLabel mesh__D008999 Monocrotophos
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013335 1993
% 219.16/219.32  |- mesh__recordMaintainer mesh__D013335 TAP
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013335 1996
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013335 2004
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013335 2002
% 219.16/219.32  |- mesh__dateEstablished mesh__D013335 1966-01-01
% 219.16/219.32  |- rdf__type mesh__D013335sskos__Concept
% 219.16/219.32  |- skos__altLabel mesh__D013335 Student, Dental
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013335 1999
% 219.16/219.32  |- mesh__publicMeSHNote mesh__D013335 66   
% 219.16/219.32  |- skos__scopeNote mesh__D013335
% 219.16/219.32       Individuals enrolled a school of dentistry or a formal educational program in leading to a degree in dentistry.%A%    
% 219.16/219.32  |- mesh__recordAuthorizer mesh__D013335 PLS
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013335 2003
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013335 1995
% 219.16/219.32  |- mesh__recordOriginator mesh__D013335 NLM
% 219.16/219.32  |- skos__prefLabel mesh__D013335 Students, Dental
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013335 1998
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013335 2006
% 219.16/219.32  |- skos__altLabel mesh__D013335 Dental Students
% 219.16/219.32  |- mesh__dateCreated mesh__D013335 1999-01-01
% 219.16/219.32  |- mesh__historyNote mesh__D013335 66   
% 219.16/219.32  |- skos__annotation mesh__D013335
% 219.16/219.32       /educ = EDUCATION, DENTAL or its specifics; DF: STUDENTS DENT%A%  
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013335 1994
% 219.16/219.32  |- skos__broader mesh__D013335smesh__D013336
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013335 2001
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013335 2005
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013335 2000
% 219.16/219.32  |- skos__altLabel mesh__D013335 Dental Student
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013335 1997
% 219.16/219.32  |- mesh__dateRevised mesh__D013335 1992-05-18
% 219.16/219.32  |- skos__scopeNote mesh__D018020
% 219.16/219.32       Inorganic compounds that contain lithium as an integral part of the molecule.%A%    
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018020 2006
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018020 1997
% 219.16/219.32  |- mesh__dateEstablished mesh__D018020 1994-01-01
% 219.16/219.32  |- skos__historyNote mesh__D018020 Lithium %28%1966-1993%29%
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018020 2001
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018020 2005
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018020 1996
% 219.16/219.32  |- rdf__type mesh__D018020sskos__Concept
% 219.16/219.32  |- skos__prefLabel mesh__D018020 Lithium Compounds
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018020 2000
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018020 1999
% 219.16/219.32  |- skos__hiddenLabel mesh__D018020 Compounds, Lithium
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018020 2004
% 219.16/219.32  |- mesh__publicMeSHNote mesh__D018020 94   
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018020 1995
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018020 1998
% 219.16/219.32  |- skos__broader mesh__D018020smesh__D007287
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018020 2003
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018020 2002
% 219.16/219.32  |- mesh__dateCreated mesh__D018020 1993-06-04
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018020 1994
% 219.16/219.32  |- mesh__historyNote mesh__D018020 94   
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D004000 2006
% 219.16/219.32  |- skos__annotation mesh__D004000
% 219.16/219.32       do not confuse with ETHYLENE DICHLORIDES   
% 219.16/219.32  |- mesh__dateEstablished mesh__D004000 1991-01-01
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D004000 2005
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D004000 2004
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D004000 2001
% 219.16/219.32  |- mesh__dateCreated mesh__D004000 1975-07-25
% 219.16/219.32  |- mesh__recordMaintainer mesh__D004000 CCR
% 219.16/219.32  |- skos__altLabel mesh__D004000 Vinylidene Chlorides
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D004000 2003
% 219.16/219.32  |- mesh__historyNote mesh__D004000
% 219.16/219.32       91%28%76%29%; was see under HYDROCARBONS, CHLORINATED 1976-90   
% 219.16/219.32  |- skos__broader mesh__D004000smesh__D005030
% 219.16/219.32  |- skos__historyNote mesh__D004000
% 219.16/219.32       Hydrocarbons, Chlorinated %28%1974-1975%29%
% 219.16/219.32  |- mesh__recordAuthorizer mesh__D004000 sjn
% 219.16/219.32  |- skos__hiddenLabel mesh__D004000 Chlorides, Vinylidene
% 219.16/219.32  |- skos__prefLabel mesh__D004000 Dichloroethylenes
% 219.16/219.32  |- rdf__type mesh__D004000sskos__Concept
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D004000 2002
% 219.16/219.32  |- mesh__recordOriginator mesh__D004000 RLS
% 219.16/219.32  |- skos__broader mesh__D004000smesh__D006843
% 219.16/219.32  |- skos__scopeNote mesh__D004000
% 219.16/219.32       Toxic chlorinated unsaturated hydrocarbons. Include both the 1,1- and 1,2-dichloro isomers. Both isomers are toxic, but 1,1-dichloroethylene is the more potent CNS depressant and hepatotoxin. It is used in the manufacture of thermoplastic polymers.%A%    
% 219.16/219.32  |- skos__historyNote mesh__D004000 Ethylenes %28%1974-1975%29%
% 219.16/219.32  |- mesh__publicMeSHNote mesh__D004000
% 219.16/219.32       91; was see under HYDROCARBONS, CHLORINATED 1976-90   
% 219.16/219.32  |- mesh__dateRevised mesh__D004000 2000-06-22
% 219.16/219.32  |- skos__related mesh__D009294smesh__D011957
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009294 2006
% 219.16/219.32  |- skos__scopeNote mesh__D009294
% 219.16/219.32       Originally, agents that caused somnolence or induced sleep; now, any derivative, natural or synthetic, of opium or morphine or any substance that has their effects. Narcotics have potent analgesic effects associated with significant changes in mood and behavior, and with the potential for dependence and tolerance following repeated administration. %28%Stedman, 25th ed%29%%A%    
% 219.16/219.32  |- skos__broader mesh__D009294smesh__D002492
% 219.16/219.32  |- skos__related mesh__D009294smesh__D009293
% 219.16/219.32  |- skos__annotation mesh__D009294
% 219.16/219.32       GEN or unspecified; prefer specifics; addiction to NARCOTICS = OPIOID-RELATED DISORDERS;%A%  
% 219.16/219.32  |- skos__related mesh__D009294smesh__D003042
% 219.16/219.32  |- mesh__recordMaintainer mesh__D009294 ssb
% 219.16/219.32  |- skos__prefLabel mesh__D009294 Narcotics
% 219.16/219.32  |- mesh__recordAuthorizer mesh__D009294 sjn
% 219.16/219.32  |- mesh__dateCreated mesh__D009294 1999-01-01
% 219.16/219.32  |- rdf__type mesh__D009294sskos__Concept
% 219.16/219.32  |- mesh__recordOriginator mesh__D009294 NLM
% 219.16/219.32  |- mesh__dateRevised mesh__D009294 2005-06-30
% 219.16/219.32  |- skos__related mesh__D009294smesh__D000701
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D017726 2004
% 219.16/219.32  |- rdf__type mesh__D017726sskos__Concept
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D017726 2001
% 219.16/219.32  |- skos__hiddenLabel mesh__D017726 Retinitis, Cytomegaloviral
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D017726 1999
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D017726 2003
% 219.16/219.32  |- skos__broader mesh__D017726smesh__D012173
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D017726 2000
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D017726 1998
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D017726 2006
% 219.16/219.32  |- skos__scopeNote mesh__D017726
% 219.16/219.32       Infection of the retina by cytomegalovirus characterized by retinal necrosis, hemorrhage, vessel sheathing, and retinal edema. Cytomegalovirus retinitis is a major opportunistic infection in AIDS patients and can cause blindness.%A%    
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D017726 1995
% 219.16/219.32  |- mesh__publicMeSHNote mesh__D017726 94   
% 219.16/219.32  |- mesh__dateEstablished mesh__D017726 1994-01-01
% 219.16/219.32  |- skos__altLabel mesh__D017726 Retinitis, Cytomegalovirus
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D017726 2005
% 219.16/219.32  |- skos__annotation mesh__D017726 often an opportunistic infect in AIDS   
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D017726 1994
% 219.16/219.32  |- skos__broader mesh__D017726smesh__D003586
% 219.16/219.32  |- skos__historyNote mesh__D017726 Retinitis %28%1972-1993%29%
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D017726 1997
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D017726 2002
% 219.16/219.32  |- skos__prefLabel mesh__D017726 Cytomegalovirus Retinitis
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D017726 1996
% 219.16/219.32  |- mesh__dateCreated mesh__D017726 1993-06-04
% 219.16/219.32  |- skos__altLabel mesh__D017726 Cytomegaloviral Retinitis
% 219.16/219.32  |- skos__historyNote mesh__D017726
% 219.16/219.32       Cytomegalovirus Infections %28%1972-1993%29%
% 219.16/219.32  |- skos__broader mesh__D017726smesh__D015828
% 219.16/219.32  |- mesh__historyNote mesh__D017726 94   
% 219.16/219.32  |- skos__altLabel mesh__D013336 Health Occupations Students
% 219.16/219.32  |- rdf__type mesh__D013336sskos__Concept
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013336 2002
% 219.16/219.32  |- mesh__recordAuthorizer mesh__D013336 PLS
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013336 2004
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013336 1999
% 219.16/219.32  |- mesh__recordMaintainer mesh__D013336 KEV
% 219.16/219.32  |- mesh__recordOriginator mesh__D013336 NLM
% 219.16/219.32  |- skos__historyNote mesh__D013336 Students %28%1966-1967%29%
% 219.16/219.32  |- skos__hiddenLabel mesh__D013336 Student, Health Occupations
% 219.16/219.32  |- skos__prefLabel mesh__D013336 Students, Health Occupations
% 219.16/219.32  |- skos__annotation mesh__D013336
% 219.16/219.32       /educ = HEALTH OCCUPATIONS /educ; DF: STUDENTS HEALTH OCCUP%A%  
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013336 1998
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013336 2003
% 219.16/219.32  |- mesh__dateCreated mesh__D013336 1999-01-01
% 219.16/219.32  |- mesh__dateRevised mesh__D013336 1995-05-18
% 219.16/219.32  |- mesh__dateEstablished mesh__D013336 1968-01-01
% 219.16/219.32  |- skos__hiddenLabel mesh__D013336 Health Occupations Student
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013336 2001
% 219.16/219.32  |- skos__scopeNote mesh__D013336
% 219.16/219.32       Individuals enrolled in a school or formal educational program in the health occupations.%A%    
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013336 2006
% 219.16/219.32  |- skos__broader mesh__D013336smesh__D013334
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013336 2000
% 219.16/219.32  |- mesh__publicMeSHNote mesh__D013336 68   
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013336 1997
% 219.16/219.32  |- mesh__historyNote mesh__D013336 68   
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013336 2005
% 219.16/219.32  |- skos__hiddenLabel mesh__D013336 Occupations Student, Health
% 219.16/219.32  |- skos__hiddenLabel mesh__D013336 Occupations Students, Health
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013336 1996
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018021 2006
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018021 1997
% 219.16/219.32  |- skos__historyNote mesh__D018021 Chlorides %28%1977-1993%29%
% 219.16/219.32  |- rdf__type mesh__D018021sskos__Concept
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018021 1998
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018021 2000
% 219.16/219.32  |- mesh__dateEstablished mesh__D018021 1994-01-01
% 219.16/219.32  |- mesh__publicMeSHNote mesh__D018021
% 219.16/219.32       94; LITHIUM CHLORIDE was indexed under LITHIUM %26% CHLORIDES 1977-93%A%  
% 219.16/219.32  |- mesh__historyNote mesh__D018021
% 219.16/219.32       94; was LITHIUM CHLORIDE %28%NM%29% 1977-93   
% 219.16/219.32  |- skos__broader mesh__D018021smesh__D002712
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018021 2003
% 219.16/219.32  |- mesh__recordAuthorizer mesh__D018021 PLS
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018021 1999
% 219.16/219.32  |- skos__prefLabel mesh__D018021 Lithium Chloride
% 219.16/219.32  |- skos__hiddenLabel mesh__D018021 Chloride, Lithium
% 219.16/219.32  |- mesh__dateRevised mesh__D018021 1995-06-08
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018021 2004
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018021 2001
% 219.16/219.32  |- mesh__recordMaintainer mesh__D018021 JRT
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018021 2002
% 219.16/219.32  |- mesh__dateCreated mesh__D018021 1993-06-04
% 219.16/219.32  |- skos__broader mesh__D018021smesh__D018020
% 219.16/219.32  |- mesh__recordOriginator mesh__D018021 TPW
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018021 2005
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D018021 1996
% 219.16/219.32  |- skos__scopeNote mesh__D018021
% 219.16/219.32       A salt of lithium that has been used experimentally as an immunomodulator.%A%    
% 219.16/219.32  |- skos__historyNote mesh__D018021 Lithium %28%1977-1993%29%
% 219.16/219.32  |- mesh__onlineNote mesh__D018021
% 219.16/219.32       use LITHIUM CHLORIDE %28%NM%29% to search LITHIUM CHLORIDE 1980-93%A%  
% 219.16/219.32  |- skos__annotation mesh__D018021 in exper med as immunomodulator   
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009295 2004
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009295 1994
% 219.16/219.32  |- mesh__recordOriginator mesh__D009295 NLM
% 219.16/219.32  |- skos__historyNote mesh__D009295 Nose %28%1966-1974%29%
% 219.16/219.32  |- skos__scopeNote mesh__D009295
% 219.16/219.32       Either of two small elongated rectangular bones that together form the bridge of the nose.%A%    
% 219.16/219.32  |- mesh__recordAuthorizer mesh__D009295 PLS
% 219.16/219.32  |- skos__hiddenLabel mesh__D009295 Bone, Nasal
% 219.16/219.32  |- mesh__historyNote mesh__D009295
% 219.16/219.32       78%28%75%29%; was see under NOSE 1963-77   
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009295 1995
% 219.16/219.32  |- skos__broader mesh__D009295smesh__D005147
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009295 1993
% 219.16/219.32  |- mesh__dateEstablished mesh__D009295 1978-01-01
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009295 2000
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009295 1998
% 219.16/219.32  |- mesh__dateCreated mesh__D009295 1999-01-01
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009295 1996
% 219.16/219.32  |- skos__related mesh__D009295smesh__D012225
% 219.16/219.32  |- skos__annotation mesh__D009295
% 219.16/219.32       /abnorm permitted for congen deform but acquired deform = NOSE DEFORMITIES, ACQUIRED; /surg: consider also RHINOPLASTY; fractures: coord NASAL BONE /inj %28%IM%29% + SKULL FRACTURES %28%IM%29%; neopl: coord IM + NOSE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009295 2001
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009295 1999
% 219.16/219.32  |- mesh__recordMaintainer mesh__D009295 TGC
% 219.16/219.32  |- mesh__dateRevised mesh__D009295 1992-05-26
% 219.16/219.32  |- rdf__type mesh__D009295sskos__Concept
% 219.16/219.32  |- skos__broader mesh__D009295smesh__D009666
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009295 1997
% 219.16/219.32  |- mesh__publicMeSHNote mesh__D009295 78; was see under NOSE 1963-77   
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009295 2005
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009295 2002
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009295 2003
% 219.16/219.32  |- skos__prefLabel mesh__D009295 Nasal Bone
% 219.16/219.32  |- skos__hiddenLabel mesh__D009295 Bones, Nasal
% 219.16/219.32  |- mesh__onlineNote mesh__D009295 search NOSE 1966-74   
% 219.16/219.32  |- skos__hiddenLabel mesh__D009295 Nasal Bones
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D009295 2006
% 219.16/219.32  |- skos__broader mesh__D017727smesh__D046810
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D017727 2006
% 219.16/219.32  |- skos__historyNote mesh__D017727 DNA Viruses %28%1991-1993%29%
% 219.16/219.32  |- skos__prefLabel mesh__D017727 Chicken anemia virus
% 219.16/219.32  |- skos__hiddenLabel mesh__D017727 Chicken Anemia Agents
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D017727 2005
% 219.16/219.32  |- mesh__dateCreated mesh__D017727 1993-06-04
% 219.16/219.32  |- skos__hiddenLabel mesh__D017727 Chicken anemia viruses
% 219.16/219.32  |- mesh__recordOriginator mesh__D017727 AGS
% 219.16/219.32  |- mesh__recordAuthorizer mesh__D017727 sjn
% 219.16/219.32  |- mesh__historyNote mesh__D017727 94   
% 219.16/219.32  |- rdf__type mesh__D017727sskos__Concept
% 219.16/219.32  |- skos__altLabel mesh__D017727 Chicken Infectious Anemia Virus
% 219.16/219.32  |- skos__historyNote mesh__D017727 Viruses %28%1983-1993%29%
% 219.16/219.32  |- mesh__dateEstablished mesh__D017727 1994-01-01
% 219.16/219.32  |- skos__altLabel mesh__D017727 Chicken Anemia Agent
% 219.16/219.32  |- skos__annotation mesh__D017727
% 219.16/219.32       infection: coord IM with CIRCOVIRIDAE INFECTIONS %28%IM%29%   
% 219.16/219.32  |- mesh__recordMaintainer mesh__D017727 ags
% 219.16/219.32  |- skos__altLabel mesh__D017727 Infectious Anemia Virus, Chicken
% 219.16/219.32  |- skos__scopeNote mesh__D017727
% 219.16/219.32       The type species of GYROVIRUS, a small, non-enveloped DNA virus originally isolated from contaminated vaccines in Japan. It causes chicken infectious anemia and may possibly play a key role in hemorrhagic anemia syndrome, anemia dermatitis, and blue wing disease.%A%    
% 219.16/219.32  |- mesh__dateRevised mesh__D017727 2004-07-07
% 219.16/219.32  |- mesh__publicMeSHNote mesh__D017727 94   
% 219.16/219.32  |- skos__hiddenLabel mesh__D003707 Monohydrochloride, Demeclocycline
% 219.16/219.32  |- skos__hiddenLabel mesh__D003707 Hydrochloride, Demeclocycline
% 219.16/219.32  |- mesh__dateCreated mesh__D003707 1999-01-01
% 219.16/219.32  |- skos__altLabel mesh__D003707 Wyeth Brand of Demeclocycline Hydrochloride
% 219.16/219.32  |- skos__scopeNote mesh__D003707
% 219.16/219.32       A TETRACYCLINE analog having a 7-chloro and a 6-methyl. Because it is excreted more slowly than TETRACYCLINE, it maintains effective blood levels for longer periods of time.%A%    
% 219.16/219.32  |- skos__prefLabel mesh__D003707 Demeclocycline
% 219.16/219.32  |- mesh__recordOriginator mesh__D003707 NLM
% 219.16/219.32  |- skos__altLabel mesh__D003707 L%C3%%A9%dermycine
% 219.16/219.32  |- skos__altLabel mesh__D003707
% 219.16/219.32       Lederle Brand of Demeclocycline Hydrochloride
% 219.16/219.32  |- mesh__onlineNote mesh__D003707
% 219.16/219.32       use DEMECLOCYCLINE to search DEMETHYLCHLORTETRACYCLINE 1966-91%A%  
% 219.16/219.32  |- skos__altLabel mesh__D003707
% 219.16/219.32       Genopharm Brand of Demeclocycline Hydrochloride
% 219.16/219.32  |- skos__altLabel mesh__D003707 Demethylchlortetracycline
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D003707 2006
% 219.16/219.32  |- mesh__historyNote mesh__D003707
% 219.16/219.32       92; was DEMETHYLCHLORTETRACYCLINE 1963-91; DEMECLOCYCLINE was see DEMETHYLCHLORTETRACYCLINE 1975-91%A%  
% 219.16/219.32  |- mesh__recordMaintainer mesh__D003707 exl
% 219.16/219.32  |- rdf__type mesh__D003707sskos__Concept
% 219.16/219.32  |- mesh__dateRevised mesh__D003707 2005-06-30
% 219.16/219.32  |- skos__broader mesh__D003707smesh__D013754
% 219.16/219.32  |- skos__altLabel mesh__D003707 AHP Brand of Demeclocycline Hydrochloride
% 219.16/219.32  |- mesh__recordAuthorizer mesh__D003707 sjn
% 219.16/219.32  |- skos__altLabel mesh__D003707 Ledermycin
% 219.16/219.32  |- mesh__publicMeSHNote mesh__D003707
% 219.16/219.32       92; was DEMETHYLCHLORTETRACYCLINE 1963-91; DEMECLOCYCLINE was see DEMETHYLCHLORTETRACYCLINE 1975-91%A%  
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013337 1998
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013337 2003
% 219.16/219.32  |- mesh__dateCreated mesh__D013337 1999-01-01
% 219.16/219.32  |- skos__annotation mesh__D013337
% 219.16/219.32       /educ = EDUCATION, MEDICAL or its specifics; DF: STUDENTS MED%A%  
% 219.16/219.32  |- rdf__type mesh__D013337sskos__Concept
% 219.16/219.32  |- mesh__historyNote mesh__D013337 66   
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013337 2002
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013337 1999
% 219.16/219.32  |- mesh__recordAuthorizer mesh__D013337 PLS
% 219.16/219.32  |- mesh__recordMaintainer mesh__D013337 KEV
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013337 2004
% 219.16/219.32  |- mesh__dateEstablished mesh__D013337 1966-01-01
% 219.16/219.32  |- skos__altLabel mesh__D013337 Medical Students
% 219.16/219.32  |- skos__altLabel mesh__D013337 Medical Student
% 219.16/219.32  |- mesh__publicMeSHNote mesh__D013337 66   
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013337 2005
% 219.16/219.32  |- mesh__dateRevised mesh__D013337 1995-05-23
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013337 1996
% 219.16/219.32  |- skos__broader mesh__D013337smesh__D013336
% 219.16/219.32  |- mesh__recordOriginator mesh__D013337 NLM
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013337 2006
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013337 2000
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013337 1997
% 219.16/219.32  |- skos__scopeNote mesh__D013337
% 219.16/219.32       Individuals enrolled in a school of medicine or a formal educational program in medicine.%A%    
% 219.16/219.32  |- skos__altLabel mesh__D013337 Student, Medical
% 219.16/219.32  |- skos__prefLabel mesh__D013337 Students, Medical
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D013337 2001
% 219.16/219.32  |- rdf__type mesh__D004800sskos__Concept
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D004800 2004
% 219.16/219.32  |- skos__historyNote mesh__D004800 specific enzyme%28%1966-1976%29%
% 219.16/219.32  |- mesh__recordAuthorizer mesh__D004800 sjn
% 219.16/219.32  |- skos__prefLabel mesh__D004800 Enzymes, Immobilized
% 219.16/219.32  |- skos__broader mesh__D004800smesh__D004798
% 219.16/219.32  |- skos__related mesh__D004800smesh__D004795
% 219.16/219.32  |- skos__scopeNote mesh__D004800
% 219.16/219.32       Enzymes which are immobilized on or in a variety of water-soluble or water-insoluble matrices with little or no loss of their catalytic activity. Since they can be reused continuously, immobilized enzymes have found wide application in the industrial, medical and research fields.%A%    
% 219.16/219.32  |- mesh__publicMeSHNote mesh__D004800 77   
% 219.16/219.32  |- mesh__historyNote mesh__D004800 77   
% 219.16/219.32  |- mesh__recordOriginator mesh__D004800 RLS
% 219.16/219.32  |- mesh__dateRevised mesh__D004800 2003-07-09
% 219.16/219.32  |- mesh__recordMaintainer mesh__D004800 ssb
% 219.16/219.32  |- skos__altLabel mesh__D004800 Immobilized Enzymes
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D004800 2006
% 219.16/219.32  |- mesh__dateEstablished mesh__D004800 1977-01-01
% 219.16/219.32  |- mesh__dateCreated mesh__D004800 1976-05-19
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D004800 2005
% 219.16/219.32  |- mesh__recordAuthorizer mesh__D051456 sjn
% 219.16/219.32  |- skos__historyNote mesh__D051456 Genetics, Population %28%1967-2005%29%
% 219.16/219.32  |- skos__broader mesh__D051456smesh__D005787
% 219.16/219.32  |- mesh__dateEstablished mesh__D051456 2006-01-01
% 219.16/219.32  |- mesh__recordOriginator mesh__D051456 nns
% 219.16/219.32  |- skos__hiddenLabel mesh__D051456 Flow, Gene
% 219.16/219.32  |- mesh__activeMeSHYear mesh__D051456 2006
% 219.16/219.32  |- skos__scopeNote mesh__D051456
% 219.16/219.32       The change in gene frequency in a population due to migration of gametes or individuals %28%ANIMAL MIGRATION%29% across population barriers. In contrast, in GENETIC DRIFT the cause of gene frequency changes are not a result of population or gamete movement.%A%    
% 219.16/219.32  |- mesh__historyNote mesh__D051456 2006   
% 219.16/219.32  |- mesh__publicMeSHNote mesh__D051456 2006   
% 219.16/219.32  |- skos__prefLabel mesh__D051456 Gene Flow
% 219.16/219.32  |- mesh__recordMaintainer mesh__D051456 nns
% 219.16/219.32  |- rdf__type mesh__D051456sskos__Concept
% 219.16/219.32  |- mesh__dateCreated mesh__D051456 2005-06-30
% 219.16/219.32  |- skos__hiddenLabel mesh__D004002 Diphosphonate, Dichloromethylene
% 219.16/219.32  |- mesh__recordAuthorizer mesh__D004002 sjn
% 219.16/219.32  |- skos__historyNote mesh__D004002 Phosphonic Acids %28%1966-1976%29%
% 219.16/219.32  |- skos__altLabel mesh__D004002 Dichloromethanediphosphonate
% 219.16/219.32  |- mesh__historyNote mesh__D004002
% 219.16/219.32       93; was DICHLOROMETHYLENE DIPHOSPHONATE 1977-92 %28%see under DIPHOSPHONATES 1977-90%29%%A%  
% 219.16/219.32  |- mesh__recordMaintainer mesh__D004002 ssb
% 219.16/219.32  |- mesh__dateRevised mesh__D004002 2005-06-30
% 219.16/219.32  |- skos__altLabel mesh__D004002 Dichloromethylene Biphosphonate
% 219.16/219.32  |- skos__hiddenLabel mesh__D004002 Disodium, Clodronate
% 219.16/219.32  |- skos__hiddenLabel mesh__D004002 Biphosphonate, Dichloromethylene
% 219.16/219.32  |- skos__altLabel mesh__D004002 Dichloromethanediphosphonic Acid
% 219.16/219.32  |- mesh__dateEstablished mesh__D004002 1991-01-01
% 219.16/219.33  |- mesh__onlineNote mesh__D004002
% 219.16/219.33       use CLODRONIC ACID to search DICHLOROMETHYLENE DIPHOSPHONATE 1977-92%A%  
% 219.16/219.33  |- skos__historyNote mesh__D004002
% 219.16/219.33       Organophosphorus Compounds %28%1972-1976%29%
% 219.16/219.33  |- skos__scopeNote mesh__D004002
% 219.16/219.33       A diphosphonate which affects calcium metabolism. It inhibits bone resorption and soft tissue calcification.%A%    
% 219.16/219.33  |- skos__hiddenLabel mesh__D004002 Acid, Clodronic
% 219.16/219.33  |- skos__altLabel mesh__D004002 Dichloromethane Diphosphonate
% 219.16/219.33  |- mesh__dateCreated mesh__D004002 1976-04-19
% 219.16/219.33  |- rdf__type mesh__D004002sskos__Concept
% 219.16/219.33  |- skos__hiddenLabel mesh__D004002 Diphosphonate, Dichloromethane
% 219.16/219.33  |- mesh__publicMeSHNote mesh__D004002
% 219.16/219.33       93; was DICHLOROMETHYLENE DIPHOSPHONATE 1977-92 %28%see under DIPHOSPHONATES 1977-90%29%%A%  
% 219.16/219.33  |- skos__hiddenLabel mesh__D004002 Sodium, Clodronate
% 219.16/219.33  |- skos__altLabel mesh__D004002 Dichloromethylene Diphosphonate
% 219.16/219.33  |- mesh__recordOriginator mesh__D004002 RLS
% 219.16/219.33  |- skos__hiddenLabel mesh__D004002 Acid, Dichloromethanediphosphonic
% 219.16/219.33  |- skos__altLabel mesh__D004002 Dichloromethylenebisphosphonate
% 219.16/219.33  |- skos__altLabel mesh__D004002 Cl2MDP
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D004002 2006
% 219.16/219.33  |- skos__broader mesh__D004002smesh__D004164
% 219.16/219.33  |- skos__prefLabel mesh__D004002 Clodronic Acid
% 219.16/219.33  |- mesh__dateRevised mesh__D009296 1997-06-20
% 219.16/219.33  |- skos__scopeNote mesh__D009296
% 219.16/219.33       The proximal portion of the respiratory passages on either side of the nasal septum, lined with ciliated mucosa, extending from the nares to the pharynx.%A%    
% 219.16/219.33  |- mesh__recordMaintainer mesh__D009296 TPW
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D009296 2003
% 219.16/219.33  |- mesh__recordAuthorizer mesh__D009296 SJN
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D009296 2006
% 219.16/219.33  |- skos__hiddenLabel mesh__D009296 Cavity, Nasal
% 219.16/219.33  |- mesh__dateCreated mesh__D009296 1999-01-01
% 219.16/219.33  |- skos__annotation mesh__D009296
% 219.16/219.33       /abnorm permitted for congen deform but acquired deform = NOSE DEFORMITIES, ACQUIRED; neopl: coord IM + NOSE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%; inflammation = RHINITIS; /secret = NASAL MUCOSA /secret%A%  
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D009296 2005
% 219.16/219.33  |- mesh__onlineNote mesh__D009296 search NOSE 1966-74   
% 219.16/219.33  |- mesh__publicMeSHNote mesh__D009296 78; was see under NOSE 1963-77   
% 219.16/219.33  |- skos__hiddenLabel mesh__D009296 Nasal Cavities
% 219.16/219.33  |- skos__prefLabel mesh__D009296 Nasal Cavity
% 219.16/219.33  |- mesh__recordOriginator mesh__D009296 NLM
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D009296 2002
% 219.16/219.33  |- mesh__historyNote mesh__D009296
% 219.16/219.33       78%28%75%29%; was see under NOSE 1963-77   
% 219.16/219.33  |- skos__historyNote mesh__D009296 Nose %28%1966-1974%29%
% 219.16/219.33  |- skos__hiddenLabel mesh__D009296 Cavities, Nasal
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D009296 2001
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D009296 1999
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D009296 2000
% 219.16/219.33  |- rdf__type mesh__D009296sskos__Concept
% 219.16/219.33  |- skos__broader mesh__D009296smesh__D009666
% 219.16/219.33  |- mesh__dateEstablished mesh__D009296 1978-01-01
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D009296 2004
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D009296 1998
% 219.16/219.33  |- skos__hiddenLabel mesh__D017728 Lymphomas, Ki-1 Large-Cell
% 219.16/219.33  |- skos__hiddenLabel mesh__D017728 Lymphomas, Ki-1
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D017728 1996
% 219.16/219.33  |- skos__hiddenLabel mesh__D017728 Ki-1-Positive Large-Cell Lymphomas
% 219.16/219.33  |- skos__altLabel mesh__D017728 Ki-1-Positive Large-Cell Lymphoma
% 219.16/219.33  |- skos__altLabel mesh__D017728 Ki-1 Lymphoma
% 219.16/219.33  |- skos__altLabel mesh__D017728 Ki-1 Large-Cell Lymphoma
% 219.16/219.33  |- skos__hiddenLabel mesh__D017728 Ki-1 Lymphomas
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D017728 2001
% 219.16/219.33  |- skos__hiddenLabel mesh__D017728 Ki 1 Large Cell Lymphoma
% 219.16/219.33  |- mesh__dateRevised mesh__D017728 1995-06-08
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D017728 2005
% 219.16/219.33  |- skos__historyNote mesh__D017728 Lymphoma, Large-Cell %28%1987-1993%29%
% 219.16/219.33  |- skos__altLabel mesh__D017728
% 219.16/219.33       Ki-1-Positive Anaplastic Large-Cell Lymphoma
% 219.16/219.33  |- skos__hiddenLabel mesh__D017728 Large-Cell Lymphomas, Ki-1-Positive
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D017728 1997
% 219.16/219.33  |- mesh__dateEstablished mesh__D017728 1994-01-01
% 219.16/219.33  |- skos__hiddenLabel mesh__D017728
% 219.16/219.33       CD30 Positive Anaplastic Large Cell Lymphoma
% 219.16/219.33  |- skos__altLabel mesh__D017728 Lymphoma, Ki-1
% 219.16/219.33  |- skos__altLabel mesh__D017728 CD30+ Anaplastic Large-Cell Lymphoma
% 219.16/219.33  |- skos__hiddenLabel mesh__D017728 Ki 1+ Anaplastic Large Cell Lymphoma
% 219.16/219.33  |- skos__broader mesh__D017728smesh__D008225
% 219.16/219.33  |- skos__broader mesh__D017728smesh__D016410
% 219.16/219.33  |- skos__hiddenLabel mesh__D017728 Ki-1 Large-Cell Lymphomas
% 219.16/219.33  |- skos__hiddenLabel mesh__D017728 CD30+ Anaplastic Large Cell Lymphoma
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D017728 2006
% 219.16/219.33  |- skos__hiddenLabel mesh__D017728 Lymphomas, Ki-1-Positive Large-Cell
% 219.16/219.33  |- skos__hiddenLabel mesh__D017728 Large-Cell Lymphomas, Ki-1
% 219.16/219.33  |- skos__hiddenLabel mesh__D017728 Ki 1 Lymphoma
% 219.16/219.33  |- skos__prefLabel mesh__D017728 Lymphoma, Large-Cell, Ki-1
% 219.16/219.33  |- skos__hiddenLabel mesh__D017728 Large-Cell Lymphoma, Ki-1
% 219.16/219.33  |- rdf__type mesh__D017728sskos__Concept
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D017728 2002
% 219.16/219.33  |- mesh__dateCreated mesh__D017728 1993-06-15
% 219.16/219.33  |- skos__historyNote mesh__D017728 Lymphoma %28%1987-1993%29%
% 219.16/219.33  |- skos__annotation mesh__D017728
% 219.16/219.33       a non-Hodgkin%27%s lymphoma; DF: note short X ref   
% 219.16/219.33  |- skos__hiddenLabel mesh__D017728 Large-Cell Lymphoma, Ki-1-Positive
% 219.16/219.33  |- mesh__historyNote mesh__D017728 94   
% 219.16/219.33  |- mesh__publicMeSHNote mesh__D017728 94   
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D017728 2003
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D017728 1998
% 219.16/219.33  |- mesh__recordOriginator mesh__D017728 AGS
% 219.16/219.33  |- mesh__recordAuthorizer mesh__D017728 PLS
% 219.16/219.33  |- skos__hiddenLabel mesh__D017728 Lymphoma, Ki 1
% 219.16/219.33  |- skos__altLabel mesh__D017728 Ki-1+ Anaplastic Large-Cell Lymphoma
% 219.16/219.33  |- skos__hiddenLabel mesh__D017728
% 219.16/219.33       Ki 1 Positive Anaplastic Large Cell Lymphoma
% 219.16/219.33  |- skos__altLabel mesh__D017728
% 219.16/219.33       CD30-Positive Anaplastic Large-Cell Lymphoma
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D017728 2004
% 219.16/219.33  |- skos__hiddenLabel mesh__D017728 Lymphoma, Ki-1 Large-Cell
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D017728 1999
% 219.16/219.33  |- skos__historyNote mesh__D017728
% 219.16/219.33       Lymphoma, Non-Hodgkin%27%s %28%1987-1993%29%
% 219.16/219.33  |- skos__related mesh__D017728smesh__D017730
% 219.16/219.33  |- skos__scopeNote mesh__D017728
% 219.16/219.33       A large-cell, non-Hodgkin%27%s, malignant lymphoma with pleomorphic appearance and reactivity with the monoclonal antibody Ki-1. The lymphoma is most often found in the skin and lymph nodes and expresses the Ki-1 %28%CD30%29% antigen %28%ANTIGENS, CD30%29% on its surface. It is often mistaken for metastatic carcinoma and malignant histiocytosis.%A%    
% 219.16/219.33  |- mesh__recordMaintainer mesh__D017728 KEV
% 219.16/219.33  |- skos__hiddenLabel mesh__D017728 Lymphoma, Ki-1-Positive Large-Cell
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D017728 2000
% 219.16/219.33  |- skos__hiddenLabel mesh__D017728 Ki 1 Positive Large Cell Lymphoma
% 219.16/219.33  |- skos__broader mesh__D042121smesh__D003267
% 219.16/219.33  |- skos__scopeNote mesh__D042121
% 219.16/219.33       Methods of contraception in which physical, chemical, or biological means are used to prevent the SPERM from reaching the fertilizable OVUM.%A%    
% 219.16/219.33  |- mesh__dateEstablished mesh__D042121 2004-01-01
% 219.16/219.33  |- skos__historyNote mesh__D042121 Contraceptive Devices %28%1978-2003%29%
% 219.16/219.33  |- skos__prefLabel mesh__D042121 Contraception, Barrier
% 219.16/219.33  |- mesh__recordOriginator mesh__D042121 lkt
% 219.16/219.33  |- mesh__dateCreated mesh__D042121 2003-07-09
% 219.16/219.33  |- mesh__publicMeSHNote mesh__D042121
% 219.16/219.33       2004; for BARRIER METHODS see CONTRACEPTION 1988-2003; for VAGINAL BARRIER METHODS see CONTRACEPTION 1993-2003%A%  
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D042121 2006
% 219.16/219.33  |- mesh__recordMaintainer mesh__D042121 lkt
% 219.16/219.33  |- mesh__historyNote mesh__D042121
% 219.16/219.33       2004; for BARRIER METHODS use CONTRACEPTION 1988-2003; for VAGINAL BARRIER METHODS use CONTRACEPTION 1993-2003%A%  
% 219.16/219.33  |- skos__altLabel mesh__D042121 Barrier Contraception
% 219.16/219.33  |- mesh__dateRevised mesh__D042121 2005-06-30
% 219.16/219.33  |- skos__hiddenLabel mesh__D042121 Barrier Method, Contraceptive
% 219.16/219.33  |- mesh__recordAuthorizer mesh__D042121 sjn
% 219.16/219.33  |- rdf__type mesh__D042121sskos__Concept
% 219.16/219.33  |- skos__altLabel mesh__D042121 Barrier Methods, Contraceptive
% 219.16/219.33  |- mesh__onlineNote mesh__D003708
% 219.16/219.33       use NORDAZEPAM to search DEMETHYLDIAZEPAM 1977-90   
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D003708 2006
% 219.16/219.33  |- mesh__dateRevised mesh__D003708 2005-06-30
% 219.16/219.33  |- mesh__recordMaintainer mesh__D003708 lkw
% 219.16/219.33  |- mesh__dateCreated mesh__D003708 1976-04-16
% 219.16/219.33  |- skos__hiddenLabel mesh__D003708 Ro 52180
% 219.16/219.33  |- skos__historyNote mesh__D003708 Diazepam %28%1973-1976%29%
% 219.16/219.33  |- skos__hiddenLabel mesh__D003708 N Destrifluoroethylhalazepam
% 219.16/219.33  |- skos__scopeNote mesh__D003708
% 219.16/219.33       An intermediate in the metabolism of DIAZEPAM to OXAZEPAM. It may have actions similar to those of diazepam.%A%    
% 219.16/219.33  |- skos__altLabel mesh__D003708 Bouchara Brand of Nordazepam
% 219.16/219.33  |- rdf__type mesh__D003708sskos__Concept
% 219.16/219.33  |- skos__altLabel mesh__D003708 N-Descyclopropylmethyl-Prazepam
% 219.16/219.33  |- mesh__recordAuthorizer mesh__D003708 sjn
% 219.16/219.33  |- skos__hiddenLabel mesh__D003708 N Descyclopropylmethyl Prazepam
% 219.16/219.33  |- skos__altLabel mesh__D003708 N-Descyclopropylmethylprazepam
% 219.16/219.33  |- mesh__publicMeSHNote mesh__D003708
% 219.16/219.33       91; was DEMETHYLDIAZEPAM see under DIAZEPAM 1977-90   
% 219.16/219.33  |- skos__altLabel mesh__D003708 Sanofi Synthelabo Brand of Nordazepam
% 219.16/219.33  |- mesh__historyNote mesh__D003708
% 219.16/219.33       91%28%77%29%; was DEMETHYLDIAZEPAM see under DIAZEPAM 1977-90   
% 219.16/219.33  |- skos__altLabel mesh__D003708 Demethyldiazepam
% 219.16/219.33  |- skos__altLabel mesh__D003708 Deoxydemoxepam
% 219.16/219.33  |- skos__hiddenLabel mesh__D003708 N Desalkylhalazepam
% 219.16/219.33  |- skos__altLabel mesh__D003708 N-Destrifluoroethylhalazepam
% 219.16/219.33  |- skos__altLabel mesh__D003708 Mack Brand of Nordazepam
% 219.16/219.33  |- skos__prefLabel mesh__D003708 Nordazepam
% 219.16/219.33  |- skos__broader mesh__D003708smesh__D003975
% 219.16/219.33  |- skos__altLabel mesh__D003708 Desmethyldiazepam
% 219.16/219.33  |- skos__altLabel mesh__D003708 Will Brand of Nordazepam
% 219.16/219.33  |- skos__historyNote mesh__D003708 Dealkylation %28%1973-1975%29%
% 219.16/219.33  |- skos__hiddenLabel mesh__D003708 N Descyclopropylmethylprazepam
% 219.16/219.33  |- mesh__dateEstablished mesh__D003708 1991-01-01
% 219.16/219.33  |- mesh__recordOriginator mesh__D003708 SH
% 219.16/219.33  |- skos__altLabel mesh__D003708 Norprazepam
% 219.16/219.33  |- skos__altLabel mesh__D003708 N-Desalkylhalazepam
% 219.16/219.33  |- skos__altLabel mesh__D003708 Nordiazepam
% 219.16/219.33  |- skos__hiddenLabel mesh__D003708 Ro 5 2180
% 219.16/219.33  |- skos__broader mesh__D014430smesh__D014427
% 219.16/219.33  |- skos__hiddenLabel mesh__D014430 Twin, Identical
% 219.16/219.33  |- skos__altLabel mesh__D014430 Twins, Identical
% 219.16/219.33  |- skos__hiddenLabel mesh__D014430 Monozygotic Twins
% 219.16/219.33  |- skos__hiddenLabel mesh__D014430 Identical Twins
% 219.16/219.33  |- skos__hiddenLabel mesh__D014430 Identical Twin
% 219.16/219.33  |- mesh__dateRevised mesh__D014430 2004-07-07
% 219.16/219.33  |- skos__annotation mesh__D014430
% 219.16/219.33       TWINNING, MONOZYGOTIC is also available   
% 219.16/219.33  |- skos__hiddenLabel mesh__D014430 Monozygotic Twin
% 219.16/219.33  |- rdf__type mesh__D014430sskos__Concept
% 219.16/219.33  |- skos__prefLabel mesh__D014430 Twins, Monozygotic
% 219.16/219.33  |- mesh__publicMeSHNote mesh__D014430 91; was see under TWINS 1975-90   
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D014430 2005
% 219.16/219.33  |- skos__scopeNote mesh__D014430
% 219.16/219.33       Two off-spring from the same PREGNANCY. They are from a single fertilized OVUM that split into two EMBRYOS. Such twins are usually genetically identical and of the same sex.%A%    
% 219.16/219.33  |- mesh__dateCreated mesh__D014430 1974-12-12
% 219.16/219.33  |- skos__hiddenLabel mesh__D014430 Twin, Monozygotic
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D014430 2006
% 219.16/219.33  |- mesh__recordOriginator mesh__D014430 NLM
% 219.16/219.33  |- mesh__dateEstablished mesh__D014430 1991-01-01
% 219.16/219.33  |- mesh__recordMaintainer mesh__D014430 lkt
% 219.16/219.33  |- mesh__recordAuthorizer mesh__D014430 sjn
% 219.16/219.33  |- mesh__historyNote mesh__D014430
% 219.16/219.33       91%28%75%29%; was see under TWINS 1975-90   
% 219.16/219.33  |- skos__altLabel mesh__D000410 Alanine-2-Oxoglutarate Aminotransferase
% 219.16/219.33  |- skos__hiddenLabel mesh__D000410 Transaminase, Glutamic-Alanine
% 219.16/219.33  |- skos__prefLabel mesh__D000410 Alanine Transaminase
% 219.16/219.33  |- skos__altLabel mesh__D000410 Glutamic-Alanine Transaminase
% 219.16/219.33  |- skos__hiddenLabel mesh__D000410 Transaminase, Alanine
% 219.16/219.33  |- mesh__recordOriginator mesh__D000410 NLM
% 219.16/219.33  |- skos__hiddenLabel mesh__D000410 Alanine 2 Oxoglutarate Aminotransferase
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D000410 2005
% 219.16/219.33  |- rdf__type mesh__D000410sskos__Concept
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D000410 2006
% 219.16/219.33  |- skos__hiddenLabel mesh__D000410 Aminotransferase, Alanine-2-Oxoglutarate
% 219.16/219.33  |- skos__altLabel mesh__D000410 Alanine Aminotransferase
% 219.16/219.33  |- skos__altLabel mesh__D000410 Glutamic-Pyruvic Transaminase
% 219.16/219.33  |- mesh__recordAuthorizer mesh__D000410 sjn
% 219.16/219.33  |- mesh__dateCreated mesh__D000410 1999-01-01
% 219.16/219.33  |- skos__hiddenLabel mesh__D000410 Glutamic Alanine Transaminase
% 219.16/219.33  |- mesh__dateRevised mesh__D000410 2003-07-09
% 219.16/219.33  |- skos__hiddenLabel mesh__D000410 Glutamic Pyruvic Transaminase
% 219.16/219.33  |- skos__broader mesh__D000410smesh__D000637
% 219.16/219.33  |- skos__hiddenLabel mesh__D000410 Aminotransferase, Alanine
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D000410 2004
% 219.16/219.33  |- mesh__recordMaintainer mesh__D000410 ssb
% 219.16/219.33  |- mesh__historyNote mesh__D000410 98%28%66%29%   
% 219.16/219.33  |- skos__annotation mesh__D000410
% 219.16/219.33       /blood = SGPT /blood %28%not just SGPT%29%   
% 219.16/219.33  |- mesh__publicMeSHNote mesh__D000410
% 219.16/219.33       98; see ALANINE AMINOTRANSFERASE 1966-97; for GLUTAMIC-PYRUVIC TRANSMINASE see ALANINE 1963%A%  
% 219.16/219.33  |- skos__scopeNote mesh__D000410
% 219.16/219.33       An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. %28%From Enzyme Nomenclature, 1992%29% EC 2.6.1.2.%A%    
% 219.16/219.33  |- skos__hiddenLabel mesh__D000410 Transaminase, Glutamic-Pyruvic
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D013338 2004
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D013338 1999
% 219.16/219.33  |- mesh__dateRevised mesh__D013338 1997-06-20
% 219.16/219.33  |- skos__prefLabel mesh__D013338 Students, Nursing
% 219.16/219.33  |- skos__altLabel mesh__D013338 Nursing Student
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D013338 2001
% 219.16/219.33  |- skos__altLabel mesh__D013338 Pupil Nurses
% 219.16/219.33  |- skos__altLabel mesh__D013338 Nurses, Pupil
% 219.16/219.33  |- mesh__publicMeSHNote mesh__D013338 66   
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D013338 2005
% 219.16/219.33  |- skos__annotation mesh__D013338
% 219.16/219.33       /educ = EDUCATION, NURSING or its specifics; DF: STUDENTS NURS%A%  
% 219.16/219.33  |- mesh__historyNote mesh__D013338 66   
% 219.16/219.33  |- skos__hiddenLabel mesh__D013338 Nurse, Pupil
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D013338 2002
% 219.16/219.33  |- mesh__recordAuthorizer mesh__D013338 SJN
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D013338 2006
% 219.16/219.33  |- skos__altLabel mesh__D013338 Student, Nursing
% 219.16/219.33  |- mesh__dateEstablished mesh__D013338 1966-01-01
% 219.16/219.33  |- skos__scopeNote mesh__D013338
% 219.16/219.33       Individuals enrolled in a school of nursing or a formal educational program leading to a degree in nursing.%A%    
% 219.16/219.33  |- skos__hiddenLabel mesh__D013338 Pupil Nurse
% 219.16/219.33  |- mesh__recordMaintainer mesh__D013338 TGC
% 219.16/219.33  |- skos__broader mesh__D013338smesh__D013336
% 219.16/219.33  |- skos__altLabel mesh__D013338 Nursing Students
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D013338 2003
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D013338 1998
% 219.16/219.33  |- mesh__recordOriginator mesh__D013338 NLM
% 219.16/219.33  |- mesh__dateCreated mesh__D013338 1999-01-01
% 219.16/219.33  |- rdf__type mesh__D013338sskos__Concept
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D013338 2000
% 219.16/219.33  |- skos__historyNote mesh__D018821
% 219.16/219.33       Receptors, Leukocyte-Adhesion %28%1989-1991%29%
% 219.16/219.33  |- mesh__recordOriginator mesh__D018821 AGS
% 219.16/219.33  |- skos__altLabel mesh__D018821 CD18 Antigens
% 219.16/219.33  |- skos__historyNote mesh__D018821 Membrane Glycoproteins %28%1986-1989%29%
% 219.16/219.33  |- mesh__historyNote mesh__D018821
% 219.16/219.33       95; was CD18 ANTIGEN %28%NM%29% 1986-94; INTEGRIN BETA2 was NM 1994-95%A%  
% 219.16/219.33  |- skos__broader mesh__D018821smesh__D015703
% 219.16/219.33  |- skos__hiddenLabel mesh__D018821 p150,95 beta Subunit
% 219.16/219.33  |- skos__related mesh__D018821smesh__D016167
% 219.16/219.33  |- skos__hiddenLabel mesh__D018821 beta2, Integrin
% 219.16/219.33  |- mesh__onlineNote mesh__D018821
% 219.16/219.33       use ANTIGENS, CD18 %28%NM%29% to search INTEGRIN BETA2 1994-95 %26% CD18 ANTIGEN 1986-94%A%  
% 219.16/219.33  |- skos__related mesh__D018821smesh__D016177
% 219.16/219.33  |- skos__historyNote mesh__D018821 Antigens, CD %28%1990-1994%29%
% 219.16/219.33  |- rdf__type mesh__D018821sskos__Concept
% 219.16/219.33  |- skos__broader mesh__D018821smesh__D000945
% 219.16/219.33  |- skos__altLabel mesh__D018821 p150,95 beta-Subunit
% 219.16/219.33  |- skos__altLabel mesh__D018821 Integrin beta2
% 219.16/219.33  |- mesh__dateRevised mesh__D018821 2005-06-30
% 219.16/219.33  |- mesh__dateEstablished mesh__D018821 1995-01-01
% 219.16/219.33  |- skos__related mesh__D018821smesh__D016169
% 219.16/219.33  |- skos__historyNote mesh__D018821 Membrane Proteins %28%1986-1987%29%
% 219.16/219.33  |- skos__hiddenLabel mesh__D018821 Integrin, beta2
% 219.16/219.33  |- skos__altLabel mesh__D018821 beta2 Integrin
% 219.16/219.33  |- skos__altLabel mesh__D018821 CD18 Antigen
% 219.16/219.33  |- skos__broader mesh__D018821smesh__D039641
% 219.16/219.33  |- skos__scopeNote mesh__D018821
% 219.16/219.33       Cell-surface glycoprotein beta-chains that are non-covalently linked to specific alpha-chains of the CD11 family of leukocyte-adhesion molecules %28%RECEPTORS, LEUKOCYTE-ADHESION%29%. A defect in the gene encoding CD18 causes LEUKOCYTE-ADHESION DEFICIENCY SYNDROME.%A%    
% 219.16/219.33  |- skos__prefLabel mesh__D018821 Antigens, CD18
% 219.16/219.33  |- skos__hiddenLabel mesh__D018821 beta-Subunit, p150,95
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D018821 2006
% 219.16/219.33  |- mesh__publicMeSHNote mesh__D018821
% 219.16/219.33       95; CD18 ANTIGEN was indexed under ANTIGENS, CD 1990-94; RECEPTORS, LEUKOCYTE-ADHESION 1989-91; MEMBRANE GLYCOPROTEINS 1986-89; %26% MEMBRANE PROTEINS 1986-87; INTEGRIN BETA2 was indexed under INTEGRINS 1994-95%A%  
% 219.16/219.33  |- mesh__dateCreated mesh__D018821 1994-05-31
% 219.16/219.33  |- mesh__recordAuthorizer mesh__D018821 sjn
% 219.16/219.33  |- mesh__recordMaintainer mesh__D018821 ssb
% 219.16/219.33  |- skos__related mesh__D018821smesh__D018370
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D018023 1995
% 219.16/219.33  |- skos__annotation mesh__D018023
% 219.16/219.33       note category; HIV SEROPOSITIVITY %28%Cat C%29% is available; DF: HIV SERONEG%A%  
% 219.16/219.33  |- skos__hiddenLabel mesh__D018023 HIV Seronegativities
% 219.16/219.33  |- skos__prefLabel mesh__D018023 HIV Seronegativity
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D018023 2001
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D018023 2005
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D018023 1996
% 219.16/219.33  |- skos__hiddenLabel mesh__D018023 Seronegativities, HTLV-III
% 219.16/219.33  |- mesh__onlineNote mesh__D018023
% 219.16/219.33       use HIV SEROPOSITIVITY to search HIV SERONEGATIVITY %26% HTLV-III SERONEGATIVITY 1988-93%A%  
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D018023 2002
% 219.16/219.33  |- mesh__dateCreated mesh__D018023 1993-06-04
% 219.16/219.33  |- skos__related mesh__D018023smesh__D006679
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D018023 2006
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D018023 1997
% 219.16/219.33  |- skos__hiddenLabel mesh__D018023 Seronegativities, HIV
% 219.16/219.33  |- skos__hiddenLabel mesh__D018023 Seronegativity, HIV
% 219.16/219.33  |- skos__hiddenLabel mesh__D018023 HTLV III Seronegativity
% 219.16/219.33  |- mesh__publicMeSHNote mesh__D018023
% 219.16/219.33       94; was see HIV SEROPOSITIVITY 1988-93; HTLV-III SERONEGATIVITY was see HIV SEROPOSITIVITY 1988-93%A%  
% 219.16/219.33  |- skos__hiddenLabel mesh__D018023 Seronegativity, HTLV-III
% 219.16/219.33  |- rdf__type mesh__D018023sskos__Concept
% 219.16/219.33  |- skos__altLabel mesh__D018023 HTLV-III Seronegativity
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D018023 1998
% 219.16/219.33  |- mesh__dateEstablished mesh__D018023 1994-01-01
% 219.16/219.33  |- mesh__historyNote mesh__D018023
% 219.16/219.33       94; was see HIV SEROPOSITIVITY 1988-93; HTLV-III SERONEGATIVITY was see HIV SEROPOSITIVITY 1988-93%A%  
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D018023 2003
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D018023 1994
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D018023 1999
% 219.16/219.33  |- skos__broader mesh__D018023smesh__D007109
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D018023 2000
% 219.16/219.33  |- skos__scopeNote mesh__D018023
% 219.16/219.33       Immune status consisting of non-production of HIV antibodies, as determined by various serological tests.%A%    
% 219.16/219.33  |- skos__historyNote mesh__D018023 HIV Seropositivity %28%1988-1993%29%
% 219.16/219.33  |- skos__hiddenLabel mesh__D018023 HTLV-III Seronegativities
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D018023 2004
% 219.16/219.33  |- skos__hiddenLabel mesh__D010040 Otospongioses
% 219.16/219.33  |- skos__prefLabel mesh__D010040 Otosclerosis
% 219.16/219.33  |- rdf__type mesh__D010040sskos__Concept
% 219.16/219.33  |- mesh__recordMaintainer mesh__D010040 tpw
% 219.16/219.33  |- skos__altLabel mesh__D010040 Otospongiosis
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D010040 2002
% 219.16/219.33  |- skos__hiddenLabel mesh__D010040 Otoscleroses
% 219.16/219.33  |- skos__related mesh__D010040smesh__D013200
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D010040 2003
% 219.16/219.33  |- skos__scopeNote mesh__D010040
% 219.16/219.33       The formation of spongy bone in the labyrinth capsule. The ossicles can become fixed and unable to transmit sound vibrations, thereby causing deafness.%A%    
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D010040 2005
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D010040 2004
% 219.16/219.33  |- mesh__dateCreated mesh__D010040 1999-01-01
% 219.16/219.33  |- skos__related mesh__D010040smesh__D005276
% 219.16/219.33  |- mesh__recordAuthorizer mesh__D010040 sjn
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D010040 2006
% 219.16/219.33  |- mesh__dateRevised mesh__D010040 2000-06-22
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D010040 2001
% 219.16/219.33  |- skos__broader mesh__D010040smesh__D004427
% 219.16/219.33  |- mesh__recordOriginator mesh__D010040 NLM
% 219.16/219.33  |- skos__prefLabel mesh__D004801 Eosine Yellowish-%28%YS%29%
% 219.16/219.33  |- mesh__recordOriginator mesh__D004801 SH
% 219.16/219.33  |- mesh__historyNote mesh__D004801 94; was EOSIN 1979-93   
% 219.16/219.33  |- skos__scopeNote mesh__D004801
% 219.16/219.33       A versatile red dye used in cosmetics, pharmaceuticals, textiles, etc., and as tissue stain, vital stain, and counterstain with HEMATOXYLIN. It is also used in special culture media.%A%    
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D004801 2002
% 219.16/219.33  |- skos__historyNote mesh__D004801 Fluoresceins %28%1966-1978%29%
% 219.16/219.33  |- skos__altLabel mesh__D004801 Eosin Y
% 219.16/219.33  |- mesh__onlineNote mesh__D004801
% 219.16/219.33       use EOSINE YELLOWISH-%28%YS%29% to search EOSIN 1979-93   
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D004801 2006
% 219.16/219.33  |- mesh__dateRevised mesh__D004801 2001-07-25
% 219.16/219.33  |- mesh__dateCreated mesh__D004801 1978-02-07
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D004801 2005
% 219.16/219.33  |- mesh__recordMaintainer mesh__D004801 jmp
% 219.16/219.33  |- mesh__recordAuthorizer mesh__D004801 sjn
% 219.16/219.33  |- mesh__publicMeSHNote mesh__D004801 94; was EOSIN 1979-93   
% 219.16/219.33  |- rdf__type mesh__D004801sskos__Concept
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D004801 2004
% 219.16/219.33  |- skos__historyNote mesh__D004801 Staining %28%1966-1978%29%
% 219.16/219.33  |- skos__altLabel mesh__D004801 Eosine
% 219.16/219.33  |- skos__annotation mesh__D004801 D25-26 qualif; DF: note short X ref   
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D004801 2003
% 219.16/219.33  |- skos__broader mesh__D004801smesh__D005452
% 219.16/219.33  |- skos__altLabel mesh__D004801 Tetrabromofluorescein
% 219.16/219.33  |- skos__altLabel mesh__D004801 Eosin
% 219.16/219.33  |- mesh__dateEstablished mesh__D004801 1979-01-01
% 219.16/219.33  |- skos__altLabel mesh__D004801 Eosine Yellowish
% 219.16/219.33  |- skos__prefLabel mesh__D051457 Hyaline Cartilage
% 219.16/219.33  |- skos__broader mesh__D051457smesh__D002356
% 219.16/219.33  |- skos__hiddenLabel mesh__D051457 Hyaline Cartilages
% 219.16/219.33  |- mesh__dateCreated mesh__D051457 2005-06-30
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D051457 2006
% 219.16/219.33  |- mesh__recordAuthorizer mesh__D051457 sjn
% 219.16/219.33  |- skos__scopeNote mesh__D051457
% 219.16/219.33       A type of CARTILAGE characterized by a homogenous amorphous matrix containing predominately TYPE II COLLAGEN and ground substance. Hyaline cartilage is found in ARTICULAR CARTILAGE; LARYNGEAL CARTILAGES; and the NASAL SEPTUM.%A%    
% 219.16/219.33  |- mesh__dateEstablished mesh__D051457 2006-01-01
% 219.16/219.33  |- mesh__recordOriginator mesh__D051457 ags
% 219.16/219.33  |- mesh__publicMeSHNote mesh__D051457 2006   
% 219.16/219.33  |- skos__historyNote mesh__D051457 Cartilage, Articular %28%1966-2005%29%
% 219.16/219.33  |- skos__hiddenLabel mesh__D051457 Cartilages, Hyaline
% 219.16/219.33  |- rdf__type mesh__D051457sskos__Concept
% 219.16/219.33  |- mesh__recordMaintainer mesh__D051457 ags
% 219.16/219.33  |- mesh__historyNote mesh__D051457 2006   
% 219.16/219.33  |- skos__historyNote mesh__D051457 Cartilage %28%1964-2005%29%
% 219.16/219.33  |- skos__hiddenLabel mesh__D051457 Cartilage, Hyaline
% 219.16/219.33  |- skos__broader mesh__D004003smesh__D002733
% 219.16/219.33  |- mesh__historyNote mesh__D004003 75   
% 219.16/219.33  |- mesh__recordAuthorizer mesh__D004003 sjn
% 219.16/219.33  |- rdf__type mesh__D004003sskos__Concept
% 219.16/219.33  |- mesh__dateEstablished mesh__D004003 1975-01-01
% 219.16/219.33  |- mesh__dateRevised mesh__D004003 2005-06-30
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D004003 2006
% 219.16/219.33  |- mesh__recordOriginator mesh__D004003 NLM
% 219.16/219.33  |- mesh__publicMeSHNote mesh__D004003 75   
% 219.16/219.33  |- mesh__recordMaintainer mesh__D004003 exl
% 219.16/219.33  |- skos__scopeNote mesh__D004003
% 219.16/219.33       Nontoxic laxative vermicide effective for taenia infestation. It tends to produce colic and nausea. It is also used as a veterinary fungicide, anthelmintic, and antiprotozoan. %28%From Merck, 11th ed.%29%%A%    
% 219.16/219.33  |- skos__prefLabel mesh__D004003 Dichlorophen
% 219.16/219.33  |- mesh__dateCreated mesh__D004003 1999-01-01
% 219.16/219.33  |- skos__historyNote mesh__D004003 Phenols %28%1966-1974%29%
% 219.16/219.33  |- skos__prefLabel mesh__D009297 Nasal Mucosa
% 219.16/219.33  |- mesh__dateCreated mesh__D009297 1999-01-01
% 219.16/219.33  |- mesh__recordAuthorizer mesh__D009297 sjn
% 219.16/219.33  |- skos__scopeNote mesh__D009297
% 219.16/219.33       The mucous lining of the NASAL CAVITY, including lining of the NOSTRIL %28%vestibule%29% and the OLFACTORY MUCOSA. Nasal mucosa consists of ciliated cells, GOBLET CELLS, brush cells, small granule cells, basal cells %28%STEM CELLS%29% and glands containing both mucous and serous cells.%A%    
% 219.16/219.33  |- skos__hiddenLabel mesh__D009297 Epithelium, Nasal
% 219.16/219.33  |- mesh__recordOriginator mesh__D009297 NLM
% 219.16/219.33  |- mesh__recordMaintainer mesh__D009297 lkt
% 219.16/219.33  |- skos__broader mesh__D009297smesh__D009666
% 219.16/219.33  |- rdf__type mesh__D009297sskos__Concept
% 219.16/219.33  |- mesh__dateRevised mesh__D009297 2005-06-30
% 219.16/219.33  |- skos__annotation mesh__D009297 inflammation = RHINITIS   
% 219.16/219.33  |- skos__broader mesh__D009297smesh__D020545
% 219.16/219.33  |- skos__hiddenLabel mesh__D009297 Mucosa, Nasal
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D009297 2006
% 219.16/219.33  |- mesh__activeMeSHYear mesh__D017729 2001
% 219.16/219.33  |- mesh__recordAuthorizer mesh__D017729 sjn
% 219.16/219.33  |- skos__hiddenLabel mesh__D017729 Terminals, Presynaptic
% 219.16/219.33  |- skos__altLabel mesh__D017729 Axon Terminals
% 219.16/219.33  |- mesh__dateRevised mesh__D017729 2000-06-21
% 219.16/219.33  |- skos__hiddenLabel mesh__D017729 Terminal, Synaptic
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D017729 2006
% 219.16/219.34  |- skos__hiddenLabel mesh__D017729 Endings, Presynaptic Nerve
% 219.16/219.34  |- skos__hiddenLabel mesh__D017729 Synaptic Terminal
% 219.16/219.34  |- skos__hiddenLabel mesh__D017729 Presynaptic Nerve Ending
% 219.16/219.34  |- rdf__type mesh__D017729sskos__Concept
% 219.16/219.34  |- mesh__dateCreated mesh__D017729 1993-06-29
% 219.16/219.34  |- skos__altLabel mesh__D017729 Synaptic Terminals
% 219.16/219.34  |- mesh__historyNote mesh__D017729 94   
% 219.16/219.34  |- skos__prefLabel mesh__D017729 Presynaptic Terminals
% 219.16/219.34  |- mesh__dateEstablished mesh__D017729 1994-01-01
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D017729 2005
% 219.16/219.34  |- skos__broader mesh__D017729smesh__D001369
% 219.16/219.34  |- skos__annotation mesh__D017729
% 219.16/219.34       distal terminations of axons: note X ref; A 11 qualif except /cytol%A%  
% 219.16/219.34  |- skos__hiddenLabel mesh__D017729 Boutons, Synaptic
% 219.16/219.34  |- mesh__publicMeSHNote mesh__D017729 94   
% 219.16/219.34  |- skos__hiddenLabel mesh__D017729 Terminal, Axon
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D017729 2004
% 219.16/219.34  |- skos__hiddenLabel mesh__D017729 Bouton, Synaptic
% 219.16/219.34  |- skos__hiddenLabel mesh__D017729 Axon Terminal
% 219.16/219.34  |- mesh__recordOriginator mesh__D017729 RAZ
% 219.16/219.34  |- skos__scopeNote mesh__D017729
% 219.16/219.34       The distal terminations of axons which are specialized for the release of neurotransmitters. Also included are varicosities along the course of axons which have similar specializations and also release transmitters. Presynaptic terminals in both the central and peripheral nervous systems are included.%A%    
% 219.16/219.34  |- skos__hiddenLabel mesh__D017729 Terminal, Presynaptic
% 219.16/219.34  |- skos__historyNote mesh__D017729 Nerve Endings %28%1966-1993%29%
% 219.16/219.34  |- skos__hiddenLabel mesh__D017729 Terminals, Synaptic
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D017729 2003
% 219.16/219.34  |- skos__hiddenLabel mesh__D017729 Ending, Presynaptic Nerve
% 219.16/219.34  |- skos__hiddenLabel mesh__D017729 Presynaptic Nerve Endings
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D017729 2002
% 219.16/219.34  |- skos__altLabel mesh__D017729 Synaptic Boutons
% 219.16/219.34  |- skos__altLabel mesh__D017729 Nerve Endings, Presynaptic
% 219.16/219.34  |- skos__historyNote mesh__D017729 Synapses %28%1966-1993%29%
% 219.16/219.34  |- skos__hiddenLabel mesh__D017729 Terminals, Axon
% 219.16/219.34  |- mesh__recordMaintainer mesh__D017729 TGC
% 219.16/219.34  |- skos__broader mesh__D017729smesh__D013569
% 219.16/219.34  |- skos__hiddenLabel mesh__D017729 Synaptic Bouton
% 219.16/219.34  |- skos__hiddenLabel mesh__D017729 Nerve Ending, Presynaptic
% 219.16/219.34  |- skos__hiddenLabel mesh__D017729 Presynaptic Terminal
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D003709 2004
% 219.16/219.34  |- mesh__recordAuthorizer mesh__D003709 PLS
% 219.16/219.34  |- rdf__type mesh__D003709sskos__Concept
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D003709 2003
% 219.16/219.34  |- skos__annotation mesh__D003709 no qualif   
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D003709 1995
% 219.16/219.34  |- skos__scopeNote mesh__D003709
% 219.16/219.34       A system of government in which there is free and equal participation by the people in the political decision-making process.%A%    
% 219.16/219.34  |- skos__hiddenLabel mesh__D003709 Democracies
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D003709 2001
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D003709 1999
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D003709 2000
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D003709 1998
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D003709 1997
% 219.16/219.34  |- mesh__dateCreated mesh__D003709 1999-01-01
% 219.16/219.34  |- skos__broader mesh__D003709smesh__D011056
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D003709 1996
% 219.16/219.34  |- mesh__dateRevised mesh__D003709 1994-03-17
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D003709 2006
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D003709 2002
% 219.16/219.34  |- skos__prefLabel mesh__D003709 Democracy
% 219.16/219.34  |- mesh__recordOriginator mesh__D003709 NLM
% 219.16/219.34  |- mesh__recordMaintainer mesh__D003709 PLS
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D003709 2005
% 219.16/219.34  |- mesh__dateRevised mesh__D014431 2004-07-13
% 219.16/219.34  |- rdf__type mesh__D014431sskos__Concept
% 219.16/219.34  |- mesh__dateCreated mesh__D014431 1999-01-01
% 219.16/219.34  |- skos__scopeNote mesh__D014431
% 219.16/219.34       A superfamily of nematodes whose members are free-living saprophytes or parasites of plants. Ova are sometimes found in human feces after ingestion of infected plants.%A%    
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D014431 2005
% 219.16/219.34  |- mesh__recordOriginator mesh__D014431 NLM
% 219.16/219.34  |- mesh__recordAuthorizer mesh__D014431 sjn
% 219.16/219.34  |- mesh__historyNote mesh__D014431
% 219.16/219.34       91%28%75%29%; was see under NEMATODA 1975-90   
% 219.16/219.34  |- mesh__recordMaintainer mesh__D014431 sjn
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D014431 2006
% 219.16/219.34  |- skos__prefLabel mesh__D014431 Tylenchoidea
% 219.16/219.34  |- mesh__dateEstablished mesh__D014431 1991-01-01
% 219.16/219.34  |- mesh__onlineNote mesh__D014431 search NEMATODA 1966-74   
% 219.16/219.34  |- skos__annotation mesh__D014431
% 219.16/219.34       a superfamily of nematodes in plants %26% in man after ingestion of infected plants; infection: coord IM with SECERNENTEA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 219.16/219.34  |- skos__broader mesh__D014431smesh__D017187
% 219.16/219.34  |- mesh__publicMeSHNote mesh__D014431 91; was see under NEMATODA 1975-90   
% 219.16/219.34  |- rdf__type mesh__D000411sskos__Concept
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D000411 2005
% 219.16/219.34  |- mesh__recordAuthorizer mesh__D000411 sjn
% 219.16/219.34  |- skos__hiddenLabel mesh__D000411 Racemase, Alanine
% 219.16/219.34  |- skos__prefLabel mesh__D000411 Alanine Racemase
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D000411 2006
% 219.16/219.34  |- mesh__publicMeSHNote mesh__D000411
% 219.16/219.34       91; was see under AMINO ACID ISOMERASES 1976-90   
% 219.16/219.34  |- mesh__dateRevised mesh__D000411 2003-07-09
% 219.16/219.34  |- skos__historyNote mesh__D000411 Alanine %28%1974-1975%29%
% 219.16/219.34  |- mesh__recordMaintainer mesh__D000411 ssb
% 219.16/219.34  |- skos__scopeNote mesh__D000411
% 219.16/219.34       A pyridoxal-phosphate protein that reversibly catalyzes the conversion of L-alanine to D-alanine. EC 5.1.1.1.%A%    
% 219.16/219.34  |- mesh__dateCreated mesh__D000411 1975-07-18
% 219.16/219.34  |- skos__historyNote mesh__D000411 Amino Acid Isomerases %28%1970-1975%29%
% 219.16/219.34  |- skos__broader mesh__D000411smesh__D000591
% 219.16/219.34  |- mesh__recordOriginator mesh__D000411 RLS
% 219.16/219.34  |- mesh__dateEstablished mesh__D000411 1991-01-01
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D000411 2004
% 219.16/219.34  |- mesh__historyNote mesh__D000411
% 219.16/219.34       91%28%76%29%; was see under AMINO ACID ISOMERASES 1976-90   
% 219.16/219.34  |- mesh__recordOriginator mesh__D038081 lkt
% 219.16/219.34  |- mesh__dateEstablished mesh__D038081 2003-01-01
% 219.16/219.34  |- skos__scopeNote mesh__D038081
% 219.16/219.34       Formation of differentiated cells and complicated tissue organization to provide specialized functions.%A%    
% 219.16/219.34  |- skos__annotation mesh__D038081
% 219.16/219.34       mammalian and non-mammalian; coord with specific organ/embryol%A%  
% 219.16/219.34  |- skos__prefLabel mesh__D038081 Organogenesis
% 219.16/219.34  |- skos__historyNote mesh__D038081 Pregnancy %28%1965-2002%29%
% 219.16/219.34  |- skos__historyNote mesh__D038081 Fetal Development %28%1994-2002%29%
% 219.16/219.34  |- mesh__recordMaintainer mesh__D038081 lkt
% 219.16/219.34  |- mesh__historyNote mesh__D038081 2003; use FETAL DEVELOPMENT 1995-2002   
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D038081 2006
% 219.16/219.34  |- skos__broader mesh__D038081smesh__D005314
% 219.16/219.34  |- skos__historyNote mesh__D038081 Cell Differentiation %28%1967-2002%29%
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D038081 2005
% 219.16/219.34  |- mesh__dateCreated mesh__D038081 2002-07-03
% 219.16/219.34  |- mesh__recordAuthorizer mesh__D038081 sjn
% 219.16/219.34  |- mesh__publicMeSHNote mesh__D038081
% 219.16/219.34       2003; see FETAL DEVELOPMENT 1995-2002   
% 219.16/219.34  |- mesh__dateRevised mesh__D038081 2004-07-07
% 219.16/219.34  |- rdf__type mesh__D038081sskos__Concept
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D013339 1996
% 219.16/219.34  |- skos__altLabel mesh__D013339 Pharmacy Student
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D013339 2006
% 219.16/219.34  |- mesh__publicMeSHNote mesh__D013339 68   
% 219.16/219.34  |- skos__broader mesh__D013339smesh__D013336
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D013339 1997
% 219.16/219.34  |- mesh__recordOriginator mesh__D013339 NLM
% 219.16/219.34  |- skos__altLabel mesh__D013339 Student, Pharmacy
% 219.16/219.34  |- mesh__dateRevised mesh__D013339 1993-06-03
% 219.16/219.34  |- skos__annotation mesh__D013339
% 219.16/219.34       /educ = EDUCATION, PHARMACY or its specifics; DF: STUDENTS PHARM%A%  
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D013339 2000
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D013339 1998
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D013339 2003
% 219.16/219.34  |- mesh__dateCreated mesh__D013339 1999-01-01
% 219.16/219.34  |- mesh__recordMaintainer mesh__D013339 TGC
% 219.16/219.34  |- rdf__type mesh__D013339sskos__Concept
% 219.16/219.34  |- mesh__dateEstablished mesh__D013339 1968-01-01
% 219.16/219.34  |- skos__scopeNote mesh__D013339
% 219.16/219.34       Individuals enrolled in a school of pharmacy or a formal educational program leading to a degree in pharmacy.%A%    
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D013339 2001
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D013339 1999
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D013339 2004
% 219.16/219.34  |- skos__historyNote mesh__D013339 Students %28%1966-1967%29%
% 219.16/219.34  |- skos__prefLabel mesh__D013339 Students, Pharmacy
% 219.16/219.34  |- skos__altLabel mesh__D013339 Pharmacy Students
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D013339 1994
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D013339 2002
% 219.16/219.34  |- mesh__recordAuthorizer mesh__D013339 PLS
% 219.16/219.34  |- mesh__historyNote mesh__D013339 68   
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D013339 2005
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D013339 1995
% 219.16/219.34  |- mesh__dateCreated mesh__D024061 2001-07-25
% 219.16/219.34  |- mesh__publicMeSHNote mesh__D024061
% 219.16/219.34       2002; see COLLAGEN 1990-2001; for PROCOLLAGEN TYPE III see PROCOLLAGEN 1990-2001%A%  
% 219.16/219.34  |- skos__broader mesh__D024061smesh__D024022
% 219.16/219.34  |- mesh__recordOriginator mesh__D024061 jmp
% 219.16/219.34  |- skos__scopeNote mesh__D024061
% 219.16/219.34       A fibrillar collagen consisting of three identical alpha1%28%III%29% chains that is widely distributed in many tissues containing COLLAGEN TYPE I. It is particularly abundant in BLOOD VESSELS and may play a role in tissues with elastic characteristics.%A%    
% 219.16/219.34  |- mesh__dateRevised mesh__D024061 2004-07-07
% 219.16/219.34  |- rdf__type mesh__D024061sskos__Concept
% 219.16/219.34  |- skos__altLabel mesh__D024061 Type III Collagen
% 219.16/219.34  |- skos__altLabel mesh__D024061 Procollagen Type III
% 219.16/219.34  |- mesh__dateEstablished mesh__D024061 2002-01-01
% 219.16/219.34  |- skos__prefLabel mesh__D024061 Collagen Type III
% 219.16/219.34  |- skos__altLabel mesh__D024061 Collagen alpha1%28%III%29%
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D024061 2006
% 219.16/219.34  |- skos__annotation mesh__D024061
% 219.16/219.34       precursors: coord IM with PROCOLLAGEN %28%IM%29%   
% 219.16/219.34  |- skos__historyNote mesh__D024061 Collagen %28%1974-2001%29%
% 219.16/219.34  |- mesh__historyNote mesh__D024061
% 219.16/219.34       2002; use COLLAGEN 1990-2001; for PROCOLLAGEN TYPE III use PROCOLLAGEN 1990-2001%A%  
% 219.16/219.34  |- mesh__recordAuthorizer mesh__D024061 sjn
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D024061 2005
% 219.16/219.34  |- skos__hiddenLabel mesh__D024061 Collagen, Type III
% 219.16/219.34  |- mesh__recordMaintainer mesh__D024061 jmp
% 219.16/219.34  |- skos__hiddenLabel mesh__D018822 Sheep alpha-Endorphin
% 219.16/219.34  |- skos__altLabel mesh__D018822 beta-LPH %28%61-76%29%
% 219.16/219.34  |- skos__altLabel mesh__D018822 Lipotropin 61-76
% 219.16/219.34  |- skos__historyNote mesh__D018822 Opioid Peptides %28%1980-1994%29%
% 219.16/219.34  |- mesh__publicMeSHNote mesh__D018822
% 219.16/219.34       95; ALPHA-ENDORPHIN was indexed under ENDORPHINS 1980-94   
% 219.16/219.34  |- mesh__recordAuthorizer mesh__D018822 sjn
% 219.16/219.34  |- mesh__recordMaintainer mesh__D018822 ssb
% 219.16/219.34  |- skos__hiddenLabel mesh__D018822 alpha Endorphin, Sheep
% 219.16/219.34  |- rdf__type mesh__D018822sskos__Concept
% 219.16/219.34  |- mesh__dateCreated mesh__D018822 1994-06-03
% 219.16/219.34  |- skos__prefLabel mesh__D018822 alpha-Endorphin
% 219.16/219.34  |- skos__hiddenLabel mesh__D018822 alpha Endorphin
% 219.16/219.34  |- mesh__onlineNote mesh__D018822
% 219.16/219.34       use ALPHA-ENDORPHIN %28%NM%29% to search ALPHA-ENDORPHIN 1980-94%A%  
% 219.16/219.34  |- skos__scopeNote mesh__D018822
% 219.16/219.34       An endogenous opioid peptide derived from the pro-opiomelanocortin precursor. It differs from GAMMA-ENDORPHIN by one amino acid.%A%    
% 219.16/219.34  |- skos__broader mesh__D018822smesh__D004723
% 219.16/219.34  |- skos__altLabel mesh__D018822 Endorphin, alpha
% 219.16/219.34  |- mesh__historyNote mesh__D018822
% 219.16/219.34       95; was ALPHA-ENDORPHIN %28%NM%29% 1980-94   
% 219.16/219.34  |- mesh__dateRevised mesh__D018822 2005-06-30
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D018822 2006
% 219.16/219.34  |- skos__hiddenLabel mesh__D018822 Lipotropin 61 76
% 219.16/219.34  |- mesh__recordOriginator mesh__D018822 TPW
% 219.16/219.34  |- mesh__dateEstablished mesh__D018822 1995-01-01
% 219.16/219.34  |- skos__scopeNote mesh__D018024
% 219.16/219.34       The concurrent or retrospective review by practicing physicians or other health professionals of the quality and efficiency of patient care practices or services ordered or performed by other physicians or other health professionals %28%From The Facts On File Dictionary of Health Care Management, 1988%29%.%A%    
% 219.16/219.34  |- skos__broader mesh__D018024smesh__D011787
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D018024 2005
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D018024 1996
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D018024 2000
% 219.16/219.34  |- skos__historyNote mesh__D018024 Peer Review %28%1971-1993%29%
% 219.16/219.34  |- mesh__dateCreated mesh__D018024 1992-12-28
% 219.16/219.34  |- mesh__historyNote mesh__D018024 94   
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D018024 2006
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D018024 1997
% 219.16/219.34  |- skos__broader mesh__D018024smesh__D010380
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D018024 2003A
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D018024 2001
% 219.16/219.34  |- mesh__recordOriginator mesh__D018024 RAZ
% 219.16/219.34  |- rdf__type mesh__D018024sskos__Concept
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D018024 1998
% 219.16/219.34  |- skos__prefLabel mesh__D018024 Peer Review, Health Care
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D018024 2002
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D018024 2003
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D018024 1994
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D018024 1999
% 219.16/219.34  |- mesh__recordMaintainer mesh__D018024 sjn
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D018024 2004
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D018024 1995
% 219.16/219.34  |- mesh__recordAuthorizer mesh__D018024 sjn
% 219.16/219.34  |- mesh__publicMeSHNote mesh__D018024 94   
% 219.16/219.34  |- mesh__dateEstablished mesh__D018024 1994-01-01
% 219.16/219.34  |- mesh__dateRevised mesh__D018024 2002-11-06
% 219.16/219.34  |- mesh__publicMeSHNote mesh__D010041
% 219.16/219.34       91; was see under CARNIVORA 1975-90   
% 219.16/219.34  |- mesh__recordAuthorizer mesh__D010041 sjn
% 219.16/219.34  |- skos__hiddenLabel mesh__D010041 Otter
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D010041 2005
% 219.16/219.34  |- skos__hiddenLabel mesh__D010041 Otter, Sea
% 219.16/219.34  |- skos__hiddenLabel mesh__D010041 Sea Otter
% 219.16/219.34  |- skos__hiddenLabel mesh__D010041 Otter, Clawless
% 219.16/219.34  |- skos__hiddenLabel mesh__D010041 Otters, Giant
% 219.16/219.34  |- skos__annotation mesh__D010041
% 219.16/219.34       X ref ENHYDRA LUTRIS: ENHYDRA FLUCTUANS see ASTERACEAE is also available%A%  
% 219.16/219.34  |- skos__scopeNote mesh__D010041
% 219.16/219.34       Fish-eating carnivores of the family MUSTELIDAE, found on both hemispheres.%A%    
% 219.16/219.34  |- mesh__recordMaintainer mesh__D010041 ags
% 219.16/219.34  |- mesh__recordOriginator mesh__D010041 NLM
% 219.16/219.34  |- skos__hiddenLabel mesh__D010041 Otter, Giant
% 219.16/219.34  |- mesh__historyNote mesh__D010041
% 219.16/219.34       91%28%75%29%; was see under CARNIVORA 1975-90   
% 219.16/219.34  |- skos__broader mesh__D010041smesh__D045969
% 219.16/219.34  |- rdf__type mesh__D010041sskos__Concept
% 219.16/219.34  |- mesh__dateRevised mesh__D010041 2004-07-07
% 219.16/219.34  |- skos__hiddenLabel mesh__D010041 Giant Otter
% 219.16/219.34  |- skos__hiddenLabel mesh__D010041 Otters, River
% 219.16/219.34  |- skos__altLabel mesh__D010041 Aonyx
% 219.16/219.34  |- skos__hiddenLabel mesh__D010041 River Otter
% 219.16/219.34  |- skos__hiddenLabel mesh__D010041 Otters, Sea
% 219.16/219.34  |- skos__hiddenLabel mesh__D010041 Lutras
% 219.16/219.34  |- mesh__dateCreated mesh__D010041 1974-12-12
% 219.16/219.34  |- skos__prefLabel mesh__D010041 Otters
% 219.16/219.34  |- mesh__dateEstablished mesh__D010041 1991-01-01
% 219.16/219.34  |- skos__hiddenLabel mesh__D010041 Otters, Clawless
% 219.16/219.34  |- skos__hiddenLabel mesh__D010041 Clawless Otter
% 219.16/219.34  |- skos__hiddenLabel mesh__D010041 Otter, River
% 219.16/219.34  |- skos__altLabel mesh__D010041 Enhydra lutris
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D010041 2006
% 219.16/219.34  |- mesh__recordMaintainer mesh__D004802 TGC
% 219.16/219.34  |- skos__related mesh__D004802smesh__D000796
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D004802 2006
% 219.16/219.34  |- skos__annotation mesh__D004802
% 219.16/219.34       increase in no. of eosinophils; GEN or unspecified; prefer specifics; for eosinophilic states %28%as eosinophilic gastritis, eosinophilic meningitis%29% coord IM with disease %28%IM%29%; /chem ind: consider also EOSINOPHILIA-MYALGIA SYNDROME; HYPEREOSINOPHILIC SYNDROME is also available%A%  
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D004802 2005
% 219.16/219.34  |- rdf__type mesh__D004802sskos__Concept
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D004802 2002
% 219.16/219.34  |- mesh__dateRevised mesh__D004802 1997-06-20
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D004802 2004
% 219.16/219.34  |- skos__hiddenLabel mesh__D004802 Eosinophilias
% 219.16/219.34  |- skos__broader mesh__D004802smesh__D007960
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D004802 2001
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D004802 1999
% 219.16/219.34  |- skos__prefLabel mesh__D004802 Eosinophilia
% 219.16/219.34  |- skos__scopeNote mesh__D004802
% 219.16/219.34       Abnormal increase in eosinophils in the blood, tissues or organs.%A%    
% 219.16/219.34  |- mesh__recordOriginator mesh__D004802 NLM
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D004802 2003
% 219.16/219.34  |- mesh__dateCreated mesh__D004802 1999-01-01
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D004802 2000
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D004802 1998
% 219.16/219.34  |- mesh__recordAuthorizer mesh__D004802 SJN
% 219.16/219.34  |- mesh__historyNote mesh__D004004
% 219.16/219.34       91%28%79%29%; was see under RIBONUCLEOSIDES 1979-90   
% 219.16/219.34  |- mesh__recordOriginator mesh__D004004 RLS
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D004004 2006
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D004004 2003
% 219.16/219.34  |- skos__annotation mesh__D004004 DF: DCRFB   
% 219.16/219.34  |- skos__altLabel mesh__D004004 DRB
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D004004 2000
% 219.16/219.34  |- skos__hiddenLabel mesh__D004004
% 219.16/219.34       5,6 Dichloro 1 beta ribofuranosylbenzimidazole
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D004004 2004
% 219.16/219.34  |- mesh__publicMeSHNote mesh__D004004
% 219.16/219.34       91; was see under RIBONUCLEOSIDES 1979-90   
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D004004 2001
% 219.16/219.34  |- mesh__recordMaintainer mesh__D004004 JAG
% 219.16/219.34  |- skos__historyNote mesh__D004004 Nucleosides %28%1966-1970%29%
% 219.16/219.34  |- mesh__dateRevised mesh__D004004 1998-06-10
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D004004 2002
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D004004 1999
% 219.16/219.34  |- skos__historyNote mesh__D004004 Benzimidazoles %28%1966-1978%29%
% 219.16/219.34  |- skos__scopeNote mesh__D004004
% 219.16/219.34       An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.%A%    
% 219.16/219.34  |- skos__historyNote mesh__D004004 Ribonucleosides %28%1971-1978%29%
% 219.16/219.34  |- mesh__recordAuthorizer mesh__D004004 SJN
% 219.16/219.34  |- mesh__dateCreated mesh__D004004 1978-03-08
% 219.16/219.34  |- skos__broader mesh__D004004smesh__D012263
% 219.16/219.34  |- skos__hiddenLabel mesh__D004004 Riboside, Dichlorobenzimidazole
% 219.16/219.34  |- skos__prefLabel mesh__D004004 Dichlororibofuranosylbenzimidazole
% 219.16/219.34  |- skos__altLabel mesh__D004004
% 219.16/219.34       5,6-Dichloro-1-beta-D-ribofuranosyl-1-H-benzimidazol
% 219.16/219.34  |- mesh__dateEstablished mesh__D004004 1991-01-01
% 219.16/219.34  |- rdf__type mesh__D004004sskos__Concept
% 219.16/219.34  |- skos__altLabel mesh__D004004
% 219.16/219.34       5,6-Dichloro-1-beta-ribofuranosylbenzimidazole
% 219.16/219.34  |- skos__altLabel mesh__D004004 Dichlorobenzimidazole Riboside
% 219.16/219.34  |- skos__hiddenLabel mesh__D004004
% 219.16/219.34       5,6 Dichloro 1 beta D ribofuranosyl 1 H benzimidazol
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D004004 2005
% 219.16/219.34  |- mesh__recordOriginator mesh__D009298 NLM
% 219.16/219.34  |- skos__broader mesh__D009298smesh__D009668
% 219.16/219.34  |- skos__prefLabel mesh__D009298 Nasal Polyps
% 219.16/219.34  |- skos__scopeNote mesh__D009298
% 219.16/219.34       Focal accumulations of EDEMA fluid in the NASAL MUCOSA accompanied by HYPERPLASIA of the associated submucosal connective tissue. Polyps may be NEOPLASMS, foci of INFLAMMATION, degenerative lesions, or malformations.%A%    
% 219.16/219.34  |- rdf__type mesh__D009298sskos__Concept
% 219.16/219.34  |- skos__hiddenLabel mesh__D009298 Polyps, Nasal
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D009298 2004
% 219.16/219.34  |- mesh__dateRevised mesh__D009298 2003-07-09
% 219.16/219.34  |- skos__broader mesh__D009298smesh__D011127
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D009298 2006
% 219.16/219.34  |- mesh__dateCreated mesh__D009298 1999-01-01
% 219.16/219.34  |- skos__hiddenLabel mesh__D009298 Nasal Polyp
% 219.16/219.34  |- mesh__recordAuthorizer mesh__D009298 sjn
% 219.16/219.34  |- skos__hiddenLabel mesh__D009298 Polyp, Nasal
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D009298 2005
% 219.16/219.34  |- mesh__recordMaintainer mesh__D009298 lkt
% 219.16/219.34  |- skos__broader mesh__D014432smesh__D004431
% 219.16/219.34  |- skos__annotation mesh__D014432
% 219.16/219.34       do not confuse with TYMPANUM; /surg: consider MYRINGOPLASTY %26% TYMPANOPLASTY%A%  
% 219.16/219.34  |- skos__hiddenLabel mesh__D014432 Membranes, Tympanic
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D014432 2006
% 219.16/219.34  |- mesh__recordMaintainer mesh__D014432 lkt
% 219.16/219.34  |- skos__scopeNote mesh__D014432
% 219.16/219.34       An oval semitransparent membrane separating the external EAR CANAL from the tympanic cavity %28%EAR, MIDDLE%29%. It contains three layers: the skin of the external ear canal; the core of radially and circularly arranged collagen fibers; and the MUCOSA of the middle ear.%A%    
% 219.16/219.34  |- skos__prefLabel mesh__D014432 Tympanic Membrane
% 219.16/219.34  |- mesh__recordAuthorizer mesh__D014432 sjn
% 219.16/219.34  |- mesh__recordOriginator mesh__D014432 NLM
% 219.16/219.34  |- skos__related mesh__D014432smesh__D009225
% 219.16/219.34  |- skos__related mesh__D014432smesh__D014433
% 219.16/219.34  |- skos__hiddenLabel mesh__D014432 Tympanic Membranes
% 219.16/219.34  |- skos__hiddenLabel mesh__D014432 Membrane, Tympanic
% 219.16/219.34  |- skos__altLabel mesh__D014432 Eardrum
% 219.16/219.34  |- mesh__dateRevised mesh__D014432 2005-06-30
% 219.16/219.34  |- rdf__type mesh__D014432sskos__Concept
% 219.16/219.34  |- mesh__dateCreated mesh__D014432 1999-01-01
% 219.16/219.34  |- skos__hiddenLabel mesh__D014432 Eardrums
% 219.16/219.34  |- skos__altLabel mesh__D000412 Alanyl T RNA Synthetase
% 219.16/219.34  |- skos__broader mesh__D000412smesh__D000604
% 219.16/219.34  |- skos__hiddenLabel mesh__D000412 Synthetase, Alanyl-tRNA
% 219.16/219.34  |- rdf__type mesh__D000412sskos__Concept
% 219.16/219.34  |- skos__hiddenLabel mesh__D000412 Ligase, Alanine-tRNA
% 219.16/219.34  |- mesh__dateCreated mesh__D000412 1974-11-19
% 219.16/219.34  |- skos__hiddenLabel mesh__D000412 Alanine tRNA Ligase
% 219.16/219.34  |- mesh__historyNote mesh__D000412 98%28%75%29%   
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D000412 2005
% 219.16/219.34  |- mesh__recordOriginator mesh__D000412 NLM
% 219.16/219.34  |- skos__prefLabel mesh__D000412 Alanine-tRNA Ligase
% 219.16/219.34  |- skos__scopeNote mesh__D000412
% 219.16/219.34       An enzyme that activates alanine with its specific transfer RNA. EC 6.1.1.7.%A%    
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D000412 2006
% 219.16/219.34  |- skos__hiddenLabel mesh__D000412 Ala tRNA Ligase
% 219.16/219.34  |- mesh__dateRevised mesh__D000412 2003-07-09
% 219.16/219.34  |- skos__historyNote mesh__D000412
% 219.16/219.34       Amino Acyl T RNA Synthetases %28%1973-1974%29%
% 219.16/219.34  |- skos__altLabel mesh__D000412 Alanyl-tRNA Synthetase
% 219.16/219.34  |- mesh__recordAuthorizer mesh__D000412 sjn
% 219.16/219.34  |- mesh__publicMeSHNote mesh__D000412
% 219.16/219.34       98; see ALANYL T RNA SYNTHETASE 1991-97; see AMINOACYL T RNA SYNTHETASES 1975-90%A%  
% 219.16/219.34  |- skos__altLabel mesh__D000412 Ala-tRNA Ligase
% 219.16/219.34  |- mesh__dateEstablished mesh__D000412 1991-01-01
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D000412 2004
% 219.16/219.34  |- skos__historyNote mesh__D000412 Alanine %28%1973-1974%29%
% 219.16/219.34  |- skos__hiddenLabel mesh__D000412 Ligase, Ala-tRNA
% 219.16/219.34  |- skos__hiddenLabel mesh__D000412 Alanyl tRNA Synthetase
% 219.16/219.34  |- mesh__recordMaintainer mesh__D000412 ssb
% 219.16/219.34  |- skos__broader mesh__D024062smesh__D024022
% 219.16/219.34  |- skos__altLabel mesh__D024062 Collagen Type V, alpha1 Chain
% 219.16/219.34  |- mesh__dateRevised mesh__D024062 2004-07-07
% 219.16/219.34  |- skos__altLabel mesh__D024062 Collagen Type V, alpha2 Chain
% 219.16/219.34  |- rdf__type mesh__D024062sskos__Concept
% 219.16/219.34  |- mesh__recordAuthorizer mesh__D024062 sjn
% 219.16/219.34  |- skos__altLabel mesh__D024062 Type V Procollagen
% 219.16/219.34  |- skos__annotation mesh__D024062
% 219.16/219.34       precursors: coord IM with PROCOLLAGEN %28%IM%29%   
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D024062 2006
% 219.16/219.34  |- skos__altLabel mesh__D024062 Collagen Type V, alpha3 Chain
% 219.16/219.34  |- skos__altLabel mesh__D024062 Collagen alpha2%28%V%29%
% 219.16/219.34  |- mesh__dateCreated mesh__D024062 2001-07-25
% 219.16/219.34  |- skos__hiddenLabel mesh__D024062 V Procollagen, Type
% 219.16/219.34  |- mesh__dateEstablished mesh__D024062 2002-01-01
% 219.16/219.34  |- skos__prefLabel mesh__D024062 Collagen Type V
% 219.16/219.34  |- mesh__publicMeSHNote mesh__D024062
% 219.16/219.34       2002; see COLLAGEN 1990-2001; for PROCOLLAGEN TYPE V see PROCOLLAGEN 1983-2001%A%  
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D024062 2005
% 219.16/219.34  |- skos__hiddenLabel mesh__D024062 Procollagen, Type V
% 219.16/219.34  |- skos__hiddenLabel mesh__D024062 Collagen, Type V
% 219.16/219.34  |- skos__historyNote mesh__D024062 Collagen %28%1993-2001%29%
% 219.16/219.34  |- mesh__historyNote mesh__D024062
% 219.16/219.34       2002; use COLLAGEN 1990-2001; for PROCOLLAGEN TYPE V use PROCOLLAGEN 1983-2001%A%  
% 219.16/219.34  |- skos__altLabel mesh__D024062 Type V Collagen
% 219.16/219.34  |- mesh__recordMaintainer mesh__D024062 jmp
% 219.16/219.34  |- skos__altLabel mesh__D024062 Collagen alpha1%28%V%29%
% 219.16/219.34  |- mesh__recordOriginator mesh__D024062 jmp
% 219.16/219.34  |- skos__altLabel mesh__D024062 Collagen alpha3%28%V%29%
% 219.16/219.34  |- skos__scopeNote mesh__D024062
% 219.16/219.34       A fibrillar collagen found widely distributed as a minor component in tissues that contain COLLAGEN TYPE I and COLLAGEN TYPE III. It is a heterotrimeric molecule composed of alpha1%28%V%29%, alpha2%28%V%29% and alpha3%28%V%29% subunits. Several forms of collagen type V exist depending upon the composition of the subunits that form the trimer.%A%    
% 219.16/219.34  |- skos__broader mesh__D018823smesh__D004723
% 219.16/219.34  |- mesh__historyNote mesh__D018823
% 219.16/219.34       95; was GAMMA-ENDORPHIN %28%NM%29% 1980-94   
% 219.16/219.34  |- mesh__dateEstablished mesh__D018823 1995-01-01
% 219.16/219.34  |- skos__altLabel mesh__D018823 beta-LPH %28%61-77%29%
% 219.16/219.34  |- mesh__dateRevised mesh__D018823 2005-06-30
% 219.16/219.34  |- skos__hiddenLabel mesh__D018823 gamma Endorphin
% 219.16/219.34  |- skos__altLabel mesh__D018823 Endorphin, gamma
% 219.16/219.34  |- skos__historyNote mesh__D018823 Opioid Peptides %28%1980-1994%29%
% 219.16/219.34  |- mesh__activeMeSHYear mesh__D018823 2006
% 219.16/219.34  |- skos__altLabel mesh__D018823 Lipotropin 61-77
% 219.16/219.35  |- skos__prefLabel mesh__D018823 gamma-Endorphin
% 219.16/219.35  |- mesh__recordMaintainer mesh__D018823 ssb
% 219.16/219.35  |- mesh__recordAuthorizer mesh__D018823 sjn
% 219.16/219.35  |- mesh__dateCreated mesh__D018823 1994-06-03
% 219.16/219.35  |- mesh__onlineNote mesh__D018823
% 219.16/219.35       use GAMMA-ENDORPHIN %28%NM%29% to search GAMMA-ENDORPHIN 1980-94%A%  
% 219.16/219.35  |- rdf__type mesh__D018823sskos__Concept
% 219.16/219.35  |- skos__hiddenLabel mesh__D018823 Lipotropin 61 77
% 219.16/219.35  |- mesh__publicMeSHNote mesh__D018823
% 219.16/219.35       95; GAMMA-ENDORPHIN was indexed under ENDORPHINS 1980-94   
% 219.16/219.35  |- skos__scopeNote mesh__D018823
% 219.16/219.35       An endogenous opioid peptide derived from the pro-opiomelanocortin precursor peptide. It differs from ALPHA-ENDORPHIN by one amino acid.%A%    
% 219.16/219.35  |- mesh__recordOriginator mesh__D018823 TPW
% 219.16/219.35  |- skos__historyNote mesh__D010840 Cholestanes %28%1968-1972%29%
% 219.16/219.35  |- skos__altLabel mesh__D010840 Plant Sterols
% 219.16/219.35  |- mesh__dateCreated mesh__D010840 1999-01-01
% 219.16/219.35  |- skos__historyNote mesh__D010840 Sterols %28%1968-1972%29%
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010840 1994
% 219.16/219.35  |- rdf__type mesh__D010840sskos__Concept
% 219.16/219.35  |- mesh__recordAuthorizer mesh__D010840 PLS
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010840 1998
% 219.16/219.35  |- mesh__dateEstablished mesh__D010840 1973-01-01
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010840 1995
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010840 1996
% 219.16/219.35  |- mesh__publicMeSHNote mesh__D010840 73   
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010840 1993
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010840 2005
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010840 1999
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010840 2000
% 219.16/219.35  |- skos__broader mesh__D010840smesh__D013261
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010840 2003
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010840 1997
% 219.16/219.35  |- mesh__dateRevised mesh__D010840 1992-05-19
% 219.16/219.35  |- mesh__recordOriginator mesh__D010840 NLM
% 219.16/219.35  |- mesh__historyNote mesh__D010840 73   
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010840 2006
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010840 2001
% 219.16/219.35  |- skos__hiddenLabel mesh__D010840 Sterols, Plant
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010840 2004
% 219.16/219.35  |- mesh__recordMaintainer mesh__D010840 TGC
% 219.16/219.35  |- skos__prefLabel mesh__D010840 Phytosterols
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010840 2002
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D018025 2003
% 219.16/219.35  |- mesh__publicMeSHNote mesh__D018025
% 219.16/219.35       94; THYROTROPIN RELEASING HORMONE RECEPTOR was indexed under RECEPTORS, NEUROHUMOR 1987-93 %26% RECEPTORS, ENDOGENOUS SUSBSTANCES 1981-86%A%  
% 219.16/219.35  |- skos__altLabel mesh__D018025 Protirelin Receptor
% 219.16/219.35  |- mesh__recordOriginator mesh__D018025 RAZ
% 219.16/219.35  |- skos__hiddenLabel mesh__D018025 Receptor, TRH
% 219.16/219.35  |- skos__hiddenLabel mesh__D018025 Receptor, Protirelin
% 219.16/219.35  |- mesh__dateCreated mesh__D018025 1993-06-21
% 219.16/219.35  |- skos__altLabel mesh__D018025 Receptors, Protirelin
% 219.16/219.35  |- skos__hiddenLabel mesh__D018025 Thyrotropin-Releasing Hormone Receptors
% 219.16/219.35  |- mesh__recordAuthorizer mesh__D018025 sjn
% 219.16/219.35  |- skos__altLabel mesh__D018025 Receptors, TRH
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D018025 2002
% 219.16/219.35  |- skos__historyNote mesh__D018025
% 219.16/219.35       Receptors, Neurotransmitter %28%1987-1993%29%
% 219.16/219.35  |- skos__broader mesh__D018025smesh__D018013
% 219.16/219.35  |- skos__altLabel mesh__D018025 Thyrotropin Releasing Hormone Receptors
% 219.16/219.35  |- mesh__dateRevised mesh__D018025 2002-07-12
% 219.16/219.35  |- skos__broader mesh__D018025smesh__D018017
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D018025 2006
% 219.16/219.35  |- skos__altLabel mesh__D018025 Thyroliberin Receptors
% 219.16/219.35  |- skos__hiddenLabel mesh__D018025 Receptors, Thyrotropin Releasing Hormone
% 219.16/219.35  |- mesh__recordMaintainer mesh__D018025 sjn
% 219.16/219.35  |- skos__altLabel mesh__D018025 Receptors, Thyroliberin
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D018025 2005
% 219.16/219.35  |- skos__altLabel mesh__D018025 Protirelin Receptors
% 219.16/219.35  |- mesh__historyNote mesh__D018025
% 219.16/219.35       94; was THYROTROPIN RELEASING HORMONE RECEPTOR %28%NM%29% 1981-93%A%  
% 219.16/219.35  |- mesh__dateEstablished mesh__D018025 1994-01-01
% 219.16/219.35  |- rdf__type mesh__D018025sskos__Concept
% 219.16/219.35  |- skos__prefLabel mesh__D018025 Receptors, Thyrotropin-Releasing Hormone
% 219.16/219.35  |- skos__historyNote mesh__D018025
% 219.16/219.35       Receptors, Cell Surface %28%1981-1986%29%
% 219.16/219.35  |- skos__altLabel mesh__D018025 Thyrotropin Releasing Hormone Receptor
% 219.16/219.35  |- skos__annotation mesh__D018025 DF: RECEPT TRH   
% 219.16/219.35  |- skos__altLabel mesh__D018025 TRH Receptors
% 219.16/219.35  |- mesh__onlineNote mesh__D018025
% 219.16/219.35       use RECEPTORS, THYROTROPIN-RELEASING HORMONE %28%NM%29% to search THYROTROPIN RELEASING HORMONE RECEPTOR 1981-93%A%  
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D018025 2004
% 219.16/219.35  |- skos__scopeNote mesh__D018025
% 219.16/219.35       Cell surface receptors that bind thyrotropin releasing hormone %28%TRH%29% with high affinity and trigger intracellular changes which influence the behavior of cells. Activated TRH receptors in the anterior pituitary stimulate the release of thyrotropin %28%thyroid stimulating hormone, TSH%29%; TRH receptors on neurons mediate neurotransmission by TRH.%A%    
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D018025 2002A
% 219.16/219.35  |- skos__altLabel mesh__D018025 TRH Receptor
% 219.16/219.35  |- skos__scopeNote mesh__D010042
% 219.16/219.35       A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like DIGITALIS. It is commonly used in cell biological studies as an inhibitor of the NA%28%+%29%-K%28%+%29%-EXCHANGING ATPASE.%A%    
% 219.16/219.35  |- rdf__type mesh__D010042sskos__Concept
% 219.16/219.35  |- mesh__dateRevised mesh__D010042 2004-07-07
% 219.16/219.35  |- mesh__recordAuthorizer mesh__D010042 sjn
% 219.16/219.35  |- mesh__historyNote mesh__D010042
% 219.16/219.35       65%28%63%29%; was see under STROPHANTHIN %28%now STROPHANTHINS%29% 1963-64%A%  
% 219.16/219.35  |- skos__altLabel mesh__D010042 Acolongifloroside K
% 219.16/219.35  |- mesh__dateEstablished mesh__D010042 1965-01-01
% 219.16/219.35  |- skos__altLabel mesh__D010042 Acocantherin
% 219.16/219.35  |- mesh__publicMeSHNote mesh__D010042
% 219.16/219.35       65; was see under STROPHANTHIN %28%now STROPHANTHINS%29% 1963-64%A%  
% 219.16/219.35  |- skos__altLabel mesh__D010042 G-Strophanthin
% 219.16/219.35  |- mesh__recordOriginator mesh__D010042 NLM
% 219.16/219.35  |- skos__broader mesh__D010042smesh__D013328
% 219.16/219.35  |- mesh__recordMaintainer mesh__D010042 ssb
% 219.16/219.35  |- skos__hiddenLabel mesh__D010042 G Strophanthin
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010042 2006
% 219.16/219.35  |- mesh__dateCreated mesh__D010042 1999-01-01
% 219.16/219.35  |- skos__hiddenLabel mesh__D010042 K, Acolongifloroside
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010042 2005
% 219.16/219.35  |- skos__prefLabel mesh__D010042 Ouabain
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D004803 2001
% 219.16/219.35  |- mesh__recordOriginator mesh__D004803 NLM
% 219.16/219.35  |- skos__hiddenLabel mesh__D004803 Eosinophilic Granulomas
% 219.16/219.35  |- mesh__dateRevised mesh__D004803 1999-11-03
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D004803 2006
% 219.16/219.35  |- mesh__recordAuthorizer mesh__D004803 sjn
% 219.16/219.35  |- skos__broader mesh__D004803smesh__D006099
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D004803 2003
% 219.16/219.35  |- skos__broader mesh__D004803smesh__D006646
% 219.16/219.35  |- skos__broader mesh__D004803smesh__D004802
% 219.16/219.35  |- mesh__dateCreated mesh__D004803 1999-01-01
% 219.16/219.35  |- mesh__recordMaintainer mesh__D004803 KEV
% 219.16/219.35  |- rdf__type mesh__D004803sskos__Concept
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D004803 2002
% 219.16/219.35  |- skos__hiddenLabel mesh__D004803 Granulomas, Eosinophilic
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D004803 2004
% 219.16/219.35  |- skos__scopeNote mesh__D004803
% 219.16/219.35       The most benign clinical form of Langerhans-cell histiocytosis %28%HISTIOCYTOSIS, LANGERHANS-CELL%29%, which involves localized nodular lesions of the gastric mucosa, small intestine, bones, lungs, or skin, with infiltration by eosinophils. The proliferating cell that appears to be responsible for the clinical manifestations is the Langerhans cell.%A%    
% 219.16/219.35  |- skos__altLabel mesh__D004803 Granuloma, Eosinophilic
% 219.16/219.35  |- skos__prefLabel mesh__D004803 Eosinophilic Granuloma
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D004803 2000
% 219.16/219.35  |- skos__broader mesh__D004803smesh__D001847
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D004803 2005
% 219.16/219.35  |- mesh__dateRevised mesh__D004005 2005-06-30
% 219.16/219.35  |- skos__altLabel mesh__D004005 Diclofenamid
% 219.16/219.35  |- mesh__recordOriginator mesh__D004005 NLM
% 219.16/219.35  |- mesh__dateCreated mesh__D004005 1999-01-01
% 219.16/219.35  |- skos__altLabel mesh__D004005 Merck Brand of Dichlorphenamide
% 219.16/219.35  |- skos__altLabel mesh__D004005 Llorens Brand of Dichlorphenamide
% 219.16/219.35  |- skos__scopeNote mesh__D004005
% 219.16/219.35       A carbonic anhydrase inhibitor that is used in the treatment of glaucoma.%A%    
% 219.16/219.35  |- skos__prefLabel mesh__D004005 Dichlorphenamide
% 219.16/219.35  |- mesh__recordMaintainer mesh__D004005 CCR
% 219.16/219.35  |- rdf__type mesh__D004005sskos__Concept
% 219.16/219.35  |- skos__broader mesh__D004005smesh__D013449
% 219.16/219.35  |- skos__altLabel mesh__D004005 Dichlofenamide
% 219.16/219.35  |- mesh__recordAuthorizer mesh__D004005 sjn
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D004005 2006
% 219.16/219.35  |- skos__broader mesh__D007845Q000627smesh__D007845
% 219.16/219.35  |- mesh__preferredCombination mesh__D007845Q000627smesh__D027641
% 219.16/219.35  |- rdf__type mesh__D007845Q000627smesh__CompoundConcept
% 219.16/219.35  |- rdf__type mesh__D009299sskos__Concept
% 219.16/219.35  |- skos__historyNote mesh__D009299 Hay Fever %28%1966-1979%29%
% 219.16/219.35  |- skos__hiddenLabel mesh__D009299 Test, Nasal Provocation
% 219.16/219.35  |- skos__hiddenLabel mesh__D009299 Nasal Provocation Test
% 219.16/219.35  |- skos__scopeNote mesh__D009299
% 219.16/219.35       Application of allergens to the nasal mucosa. Interpretation includes observation of nasal symptoms, rhinoscopy, and rhinomanometry. Nasal provocation tests are used in the diagnosis of nasal hypersensitivity, including RHINITIS, ALLERGIC, SEASONAL.%A%    
% 219.16/219.35  |- skos__historyNote mesh__D009299 Allergens %28%1966-1979%29%
% 219.16/219.35  |- mesh__recordOriginator mesh__D009299 SMH
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D009299 2006
% 219.16/219.35  |- skos__annotation mesh__D009299 diag of nasal allergy; DF: NP TESTS   
% 219.16/219.35  |- skos__broader mesh__D009299smesh__D003948
% 219.16/219.35  |- skos__altLabel mesh__D009299 Provocation Tests, Nasal
% 219.16/219.35  |- mesh__historyNote mesh__D009299 80   
% 219.16/219.35  |- mesh__dateEstablished mesh__D009299 1980-01-01
% 219.16/219.35  |- mesh__dateCreated mesh__D009299 1979-03-08
% 219.16/219.35  |- skos__prefLabel mesh__D009299 Nasal Provocation Tests
% 219.16/219.35  |- mesh__publicMeSHNote mesh__D009299 80   
% 219.16/219.35  |- mesh__recordMaintainer mesh__D009299 sjn
% 219.16/219.35  |- mesh__recordAuthorizer mesh__D009299 sjn
% 219.16/219.35  |- mesh__dateRevised mesh__D009299 2005-07-01
% 219.16/219.35  |- skos__hiddenLabel mesh__D009299 Tests, Nasal Provocation
% 219.16/219.35  |- skos__historyNote mesh__D009299 Nasal Mucosa %28%1966-1979%29%
% 219.16/219.35  |- skos__hiddenLabel mesh__D009299 Provocation Test, Nasal
% 219.16/219.35  |- skos__prefLabel mesh__D020470 Collected Works %5B%Publication Type%5D%
% 219.16/219.35  |- skos__broader mesh__D020470smesh__D052180
% 219.16/219.35  |- skos__scopeNote mesh__D020470
% 219.16/219.35       Works consisting of collections of previously published works.%A%    
% 219.16/219.35  |- skos__related mesh__D020470smesh__D020474
% 219.16/219.35  |- mesh__recordMaintainer mesh__D020470 jls
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D020470 2006
% 219.16/219.35  |- skos__altLabel mesh__D020470 Collected Works %28%PT%29%
% 219.16/219.35  |- mesh__recordOriginator mesh__D020470 JLS
% 219.16/219.35  |- rdf__type mesh__D020470sskos__Concept
% 219.16/219.35  |- mesh__dateCreated mesh__D020470 1998-06-03
% 219.16/219.35  |- mesh__dateEstablished mesh__D020470 1999-01-01
% 219.16/219.35  |- mesh__dateRevised mesh__D020470 2005-06-30
% 219.16/219.35  |- mesh__historyNote mesh__D020470 1999   
% 219.16/219.35  |- mesh__recordAuthorizer mesh__D020470 sjn
% 219.16/219.35  |- skos__annotation mesh__D014433
% 219.16/219.35       surg reconstruction of hearing mechanism of middle ear; repair of tympanic membrane perforation = MYRINGOPLASTY; do not use /util except by MeSH definition%A%  
% 219.16/219.35  |- mesh__publicMeSHNote mesh__D014433 66   
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D014433 2001
% 219.16/219.35  |- rdf__type mesh__D014433sskos__Concept
% 219.16/219.35  |- skos__prefLabel mesh__D014433 Tympanoplasty
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D014433 2004
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D014433 1999
% 219.16/219.35  |- mesh__recordAuthorizer mesh__D014433 SJN
% 219.16/219.35  |- mesh__dateCreated mesh__D014433 1999-01-01
% 219.16/219.35  |- mesh__dateRevised mesh__D014433 1997-06-20
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D014433 2000
% 219.16/219.35  |- skos__broader mesh__D014433smesh__D013506
% 219.16/219.35  |- skos__hiddenLabel mesh__D014433 Tympanoplasties
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D014433 2003
% 219.16/219.35  |- mesh__recordMaintainer mesh__D014433 PXP
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D014433 1998
% 219.16/219.35  |- mesh__dateEstablished mesh__D014433 1966-01-01
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D014433 2006
% 219.16/219.35  |- mesh__historyNote mesh__D014433 66%28%64%29%   
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D014433 2002
% 219.16/219.35  |- skos__scopeNote mesh__D014433
% 219.16/219.35       Surgical reconstruction of the hearing mechanism of the middle ear, with restoration of the drum membrane to protect the round window from sound pressure, and establishment of ossicular continuity between the tympanic membrane and the oval window. %28%Dorland, 28th ed.%29%%A%    
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D014433 2005
% 219.16/219.35  |- mesh__recordOriginator mesh__D014433 NLM
% 219.16/219.35  |- skos__related mesh__D014433smesh__D009225
% 219.16/219.35  |- skos__broader mesh__D004194Q000517smesh__D004194
% 219.16/219.35  |- mesh__preferredCombination mesh__D004194Q000517smesh__D011315
% 219.16/219.35  |- rdf__type mesh__D004194Q000517smesh__CompoundConcept
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D000413 2006
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D000413 2001
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D000413 2003
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D000413 1998
% 219.16/219.35  |- mesh__recordAuthorizer mesh__D000413 SJN
% 219.16/219.35  |- mesh__dateRevised mesh__D000413 1997-06-20
% 219.16/219.35  |- skos__prefLabel mesh__D000413 Alaska
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D000413 2004
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D000413 1999
% 219.16/219.35  |- mesh__recordMaintainer mesh__D000413 PXP
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D000413 2002
% 219.16/219.35  |- skos__broader mesh__D000413smesh__D019601
% 219.16/219.35  |- rdf__type mesh__D000413sskos__Concept
% 219.16/219.35  |- mesh__recordOriginator mesh__D000413 NLM
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D000413 2005
% 219.16/219.35  |- mesh__dateCreated mesh__D000413 1999-01-01
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D000413 2000
% 219.16/219.35  |- mesh__publicMeSHNote mesh__D024861
% 219.16/219.35       2002; see GENE ENGINEERING 1997-2001   
% 219.16/219.35  |- mesh__dateCreated mesh__D024861 2001-07-25
% 219.16/219.35  |- mesh__dateRevised mesh__D024861 2002-10-31
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D024861 2003
% 219.16/219.35  |- mesh__historyNote mesh__D024861 2002; use GENE ENGINEERING 1997-2001   
% 219.16/219.35  |- skos__prefLabel mesh__D024861 Genetic Enhancement
% 219.16/219.35  |- skos__altLabel mesh__D024861 Enhancements, Genetic
% 219.16/219.35  |- mesh__recordAuthorizer mesh__D024861 jls
% 219.16/219.35  |- skos__altLabel mesh__D024861 Enhancement, Genetic
% 219.16/219.35  |- skos__broader mesh__D024861smesh__D005818
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D024861 2006
% 219.16/219.35  |- mesh__recordOriginator mesh__D024861 jrf
% 219.16/219.35  |- skos__historyNote mesh__D024861 Genetic Engineering %28%1996-2001%29%
% 219.16/219.35  |- skos__altLabel mesh__D024861 Genetic Enhancements
% 219.16/219.35  |- skos__annotation mesh__D024861
% 219.16/219.35       not for therapeutic procedures %28%=GENE THERAPY%29%   
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D024861 2005
% 219.16/219.35  |- skos__broader mesh__D024861smesh__D024803
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D024861 2003A
% 219.16/219.35  |- rdf__type mesh__D024861sskos__Concept
% 219.16/219.35  |- mesh__recordMaintainer mesh__D024861 jls
% 219.16/219.35  |- skos__scopeNote mesh__D024861
% 219.16/219.35       The use of genetic methodologies to improve functional capacities of an organism rather than to treat disease.%A%    
% 219.16/219.35  |- mesh__dateEstablished mesh__D024861 2002-01-01
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D024861 2004
% 219.16/219.35  |- skos__prefLabel mesh__D010841 Pia Mater
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010841 1998
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010841 2002
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010841 1995
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010841 1996
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010841 1993
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010841 2005
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010841 1999
% 219.16/219.35  |- mesh__dateRevised mesh__D010841 1992-05-18
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010841 2003
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010841 1997
% 219.16/219.35  |- mesh__recordAuthorizer mesh__D010841 PLS
% 219.16/219.35  |- skos__hiddenLabel mesh__D010841 Pia Maters
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010841 2006
% 219.16/219.35  |- skos__hiddenLabel mesh__D010841 Mater, Pia
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010841 2004
% 219.16/219.35  |- mesh__recordMaintainer mesh__D010841 TAP
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010841 2000
% 219.16/219.35  |- mesh__recordOriginator mesh__D010841 NLM
% 219.16/219.35  |- skos__broader mesh__D010841smesh__D008578
% 219.16/219.35  |- mesh__dateCreated mesh__D010841 1999-01-01
% 219.16/219.35  |- rdf__type mesh__D010841sskos__Concept
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010841 2001
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010841 1994
% 219.16/219.35  |- skos__hiddenLabel mesh__D010841 Maters, Pia
% 219.16/219.35  |- skos__prefLabel mesh__D018026 Receptors, Pancreatic Hormone
% 219.16/219.35  |- skos__hiddenLabel mesh__D018026 Hormone Receptors, Pancreatic
% 219.16/219.35  |- skos__hiddenLabel mesh__D018026 Pancreatic Hormones Receptors
% 219.16/219.35  |- skos__altLabel mesh__D018026 Pancreatic Hormone Receptor
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D018026 2006
% 219.16/219.35  |- skos__annotation mesh__D018026
% 219.16/219.35       GEN; prefer specifics; DF: RECEPT PANCREATIC HORMONE   
% 219.16/219.35  |- mesh__historyNote mesh__D018026 94   
% 219.16/219.35  |- mesh__recordOriginator mesh__D018026 RAZ
% 219.16/219.35  |- skos__broader mesh__D018026smesh__D018000
% 219.16/219.35  |- mesh__recordAuthorizer mesh__D018026 SJN
% 219.16/219.35  |- mesh__dateCreated mesh__D018026 1993-06-21
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D018026 2005
% 219.16/219.35  |- skos__hiddenLabel mesh__D018026 Receptor, Pancreatic Hormone
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D018026 2002
% 219.16/219.35  |- rdf__type mesh__D018026sskos__Concept
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D018026 2004
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D018026 1999
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D018026 2001
% 219.16/219.35  |- skos__altLabel mesh__D018026 Receptors, Pancreatic Hormones
% 219.16/219.35  |- mesh__recordMaintainer mesh__D018026 NDW
% 219.16/219.35  |- skos__altLabel mesh__D018026 Pancreatic Hormone Receptors
% 219.16/219.35  |- skos__scopeNote mesh__D018026
% 219.16/219.35       Cell surface proteins that bind pancreatic hormones with high affinity and trigger intracellular changes which influence the behavior of cells. These include receptors for glucagon %28%secreted by alpha cells%29%, insulin %28%secreted by beta cells%29%, somatostatin %28%secreted by delta cells%29%, and pancreatic peptide %28%secreted by PP cells%29%. Some of these hormones and receptors also support neurotransmission.%A%    
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D018026 2003
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D018026 1998
% 219.16/219.35  |- skos__hiddenLabel mesh__D018026 Hormone Receptor, Pancreatic
% 219.16/219.35  |- mesh__dateEstablished mesh__D018026 1994-01-01
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D018026 2000
% 219.16/219.35  |- mesh__publicMeSHNote mesh__D018026 94   
% 219.16/219.35  |- mesh__dateRevised mesh__D018026 1997-06-20
% 219.16/219.35  |- skos__hiddenLabel mesh__D018026 Hormones Receptors, Pancreatic
% 219.16/219.35  |- mesh__recordOriginator mesh__D010043 EC
% 219.16/219.35  |- skos__annotation mesh__D010043
% 219.16/219.35       note category; must discuss both outcome %26% process: OUTCOME ASSESSMENT %28%HEALTH CARE%29% is available for only outcome, PROCESS ASSESSMENT %28%HEALTH CARE%29% is available for only process; DF: OUTCOME PROCESS ASSESS%A%  
% 219.16/219.35  |- mesh__dateEstablished mesh__D010043 1979-01-01
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010043 2001
% 219.16/219.35  |- mesh__dateCreated mesh__D010043 1978-05-16
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010043 2003
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010043 2006B
% 219.16/219.35  |- skos__prefLabel mesh__D010043
% 219.16/219.35       Outcome and Process Assessment %28%Health Care%29%
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010043 2000
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010043 2006
% 219.16/219.35  |- skos__broader mesh__D010043smesh__D017531
% 219.16/219.35  |- skos__broader mesh__D010043smesh__D011787
% 219.16/219.35  |- skos__altLabel mesh__D010043 Outcome and Process Assessment
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010043 2005
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010043 1999
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010043 2002
% 219.16/219.35  |- mesh__historyNote mesh__D010043 79   
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010043 2006A
% 219.16/219.35  |- mesh__dateRevised mesh__D010043 2005-07-22
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010043 1998
% 219.16/219.35  |- mesh__recordAuthorizer mesh__D010043 ags
% 219.16/219.35  |- skos__scopeNote mesh__D010043
% 219.16/219.35       Evaluation procedures that focus on both the outcome or status %28%OUTCOME ASSESSMENT %28%HEALTH CARE%29%;%29% of the patient at the end of an episode of care - presence of symptoms, level of activity, and mortality; and the process %28%PROCESS ASSESSMENT %28%HEALTH CARE%29%;%29% - what is done for the patient diagnostically and therapeutically.%A%    
% 219.16/219.35  |- rdf__type mesh__D010043sskos__Concept
% 219.16/219.35  |- mesh__publicMeSHNote mesh__D010043 79   
% 219.16/219.35  |- skos__historyNote mesh__D010043 Quality of Health Care %28%1968-1978%29%
% 219.16/219.35  |- mesh__recordMaintainer mesh__D010043 ags
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D010043 2004
% 219.16/219.35  |- mesh__recordMaintainer mesh__D004804 nns
% 219.16/219.35  |- mesh__dateCreated mesh__D004804 1999-01-01
% 219.16/219.35  |- rdf__type mesh__D004804sskos__Concept
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D004804 2004
% 219.16/219.35  |- mesh__recordOriginator mesh__D004804 NLM
% 219.16/219.35  |- mesh__recordAuthorizer mesh__D004804 sjn
% 219.16/219.35  |- skos__annotation mesh__D004804
% 219.16/219.35       restrict to leukocytes: not for %22%eosinophilic%22%, stainable with eosin %28% = STAINING AND LABELING + EOSIN%29%; eosinophilic states: see note under EOSINOPHILIA; eosinophil count: coord with LEUKOCYTE COUNT%A%  
% 219.16/219.35  |- skos__broader mesh__D004804smesh__D006098
% 219.16/219.35  |- skos__scopeNote mesh__D004804
% 219.16/219.35       Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin.%A%    
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D004804 2005
% 219.16/219.35  |- skos__hiddenLabel mesh__D004804 Eosinophil
% 219.16/219.35  |- mesh__dateRevised mesh__D004804 2003-07-09
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D004804 2006
% 219.16/219.35  |- skos__prefLabel mesh__D004804 Eosinophils
% 219.16/219.35  |- rdf__type mesh__D004006sskos__Concept
% 219.16/219.35  |- skos__altLabel mesh__D004006 Dimethyl Dichlorovinyl Phosphate
% 219.16/219.35  |- skos__altLabel mesh__D004006
% 219.16/219.35       Phosphoric acid 2,2-dichloroethenyl dimethyl ester
% 219.16/219.35  |- skos__annotation mesh__D004006
% 219.16/219.35       = Dimethyl diChloro Vinyl phOSphate; TN 111 for eff on insects%A%  
% 219.16/219.35  |- skos__prefLabel mesh__D004006 Dichlorvos
% 219.16/219.35  |- skos__altLabel mesh__D004006 Dichlofos
% 219.16/219.35  |- skos__altLabel mesh__D004006 Dichlorophos
% 219.16/219.35  |- mesh__dateCreated mesh__D004006 1999-01-01
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D004006 2006
% 219.16/219.35  |- mesh__publicMeSHNote mesh__D004006 73   
% 219.16/219.35  |- mesh__recordAuthorizer mesh__D004006 sjn
% 219.16/219.35  |- mesh__recordMaintainer mesh__D004006 exl
% 219.16/219.35  |- mesh__dateRevised mesh__D004006 2005-06-30
% 219.16/219.35  |- skos__historyNote mesh__D004006 Insecticides %28%1966-1970%29%
% 219.16/219.35  |- mesh__dateEstablished mesh__D004006 1973-01-01
% 219.16/219.35  |- skos__broader mesh__D004006smesh__D009943
% 219.16/219.35  |- mesh__recordOriginator mesh__D004006 NLM
% 219.16/219.35  |- skos__altLabel mesh__D004006 DDVP
% 219.16/219.35  |- mesh__historyNote mesh__D004006 73%28%71%29%   
% 219.16/219.35  |- skos__scopeNote mesh__D004006
% 219.16/219.35       An organophosphorus insecticide that inhibits acetylcholinesterase.%A%    
% 219.16/219.35  |- skos__hiddenLabel mesh__D004006
% 219.16/219.35       Phosphoric acid 2,2 dichloroethenyl dimethyl ester
% 219.16/219.35  |- skos__historyNote mesh__D004006
% 219.16/219.35       Organophosphorus Compounds %28%1966-1970%29%
% 219.16/219.35  |- skos__altLabel mesh__D020471 Collections %28%PT%29%
% 219.16/219.35  |- mesh__dateRevised mesh__D020471 2005-06-30
% 219.16/219.35  |- mesh__recordAuthorizer mesh__D020471 sjn
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D020471 2006
% 219.16/219.35  |- rdf__type mesh__D020471sskos__Concept
% 219.16/219.35  |- mesh__dateCreated mesh__D020471 1998-06-03
% 219.16/219.35  |- mesh__recordOriginator mesh__D020471 JLS
% 219.16/219.35  |- mesh__historyNote mesh__D020471 1999   
% 219.16/219.35  |- mesh__recordMaintainer mesh__D020471 jls
% 219.16/219.35  |- skos__prefLabel mesh__D020471 Collections %5B%Publication Type%5D%
% 219.16/219.35  |- skos__broader mesh__D020471smesh__D052180
% 219.16/219.35  |- mesh__dateEstablished mesh__D020471 1999-01-01
% 219.16/219.35  |- skos__scopeNote mesh__D020471
% 219.16/219.35       Works that consist of collections of objects.     
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D014434 1992
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D014434 1995
% 219.16/219.35  |- skos__annotation mesh__D014434 no qualif   
% 219.16/219.35  |- mesh__dateRevised mesh__D014434 1991-06-11
% 219.16/219.35  |- skos__historyNote mesh__D014434 Coronary Disease %28%1966-1984%29%
% 219.16/219.35  |- mesh__historyNote mesh__D014434 85   
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D014434 2003
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D014434 1998
% 219.16/219.35  |- skos__scopeNote mesh__D014434
% 219.16/219.35       Established behavior pattern characterized by excessive drive and ambition, impatience, competitiveness, sense of time urgency, and poorly contained aggression.%A%    
% 219.16/219.35  |- skos__hiddenLabel mesh__D014434 Type A, Personality
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D014434 2001
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D014434 2006
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D014434 1994
% 219.16/219.35  |- skos__hiddenLabel mesh__D014434 Coronary Prone Personality
% 219.16/219.35  |- skos__hiddenLabel mesh__D014434 Coronary-Prone Personalities
% 219.16/219.35  |- skos__altLabel mesh__D014434 Personality Type A
% 219.16/219.35  |- skos__historyNote mesh__D014434 Personality %28%1966-1984%29%
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D014434 2000
% 219.16/219.35  |- mesh__dateEstablished mesh__D014434 1985-01-01
% 219.16/219.35  |- skos__hiddenLabel mesh__D014434 Personality, Coronary-Prone
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D014434 2005
% 219.16/219.35  |- mesh__dateCreated mesh__D014434 1984-04-06
% 219.16/219.35  |- skos__broader mesh__D014434smesh__D010553
% 219.16/219.35  |- skos__hiddenLabel mesh__D014434 Personalities, Coronary-Prone
% 219.16/219.35  |- skos__hiddenLabel mesh__D014434 Personality, Type A
% 219.16/219.35  |- mesh__recordAuthorizer mesh__D014434 PLS
% 219.16/219.35  |- skos__hiddenLabel mesh__D014434 Type A Personalities
% 219.16/219.35  |- mesh__activeMeSHYear mesh__D014434 1997
% 219.16/219.36  |- skos__hiddenLabel mesh__D014434 Personalities, Type A
% 219.16/219.36  |- skos__prefLabel mesh__D014434 Type A Personality
% 219.16/219.36  |- mesh__publicMeSHNote mesh__D014434 85   
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D014434 1993
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D014434 2002
% 219.16/219.36  |- mesh__recordOriginator mesh__D014434 EC
% 219.16/219.36  |- rdf__type mesh__D014434sskos__Concept
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D014434 1996
% 219.16/219.36  |- mesh__recordMaintainer mesh__D014434 PLS
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D014434 2004
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D014434 1999
% 219.16/219.36  |- skos__hiddenLabel mesh__D024862 Cells, Oxyphil
% 219.16/219.36  |- skos__prefLabel mesh__D024862 Oxyphil Cells
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D024862 2006
% 219.16/219.36  |- skos__altLabel mesh__D024862 Oncocytes
% 219.16/219.36  |- skos__hiddenLabel mesh__D024862 Cells, Hurthle
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D024862 2002
% 219.16/219.36  |- skos__altLabel mesh__D024862 Askenazy Cells
% 219.16/219.36  |- skos__scopeNote mesh__D024862
% 219.16/219.36       Large cells with small irregular nuclei and dense acidophilic granules due to the presence of abundant MITOCHONDRIA. Oxyphil cells, also known as oncocytes, are found in oncocytomas of the kidney, salivary glands, and endocrine glands.  In the thyroid gland, oxyphil cells are known as Hurthle cells and Askenazy cells.%A%    
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D024862 2005
% 219.16/219.36  |- rdf__type mesh__D024862sskos__Concept
% 219.16/219.36  |- mesh__dateCreated mesh__D024862 2001-07-25
% 219.16/219.36  |- skos__hiddenLabel mesh__D024862 Cells, Askenazy
% 219.16/219.36  |- skos__historyNote mesh__D024862 Adenoma, Oxyphilic %28%1992-2001%29%
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D024862 2004
% 219.16/219.36  |- skos__historyNote mesh__D024862 Thyroid Neoplasms %28%1992-2001%29%
% 219.16/219.36  |- skos__historyNote mesh__D024862 Adenoma %28%1967-1991%29%
% 219.16/219.36  |- mesh__dateEstablished mesh__D024862 2002-01-01
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D024862 2003
% 219.16/219.36  |- skos__broader mesh__D024862smesh__D002477
% 219.16/219.36  |- skos__related mesh__D024862smesh__D018249
% 219.16/219.36  |- mesh__publicMeSHNote mesh__D024862 2002   
% 219.16/219.36  |- mesh__historyNote mesh__D024862 2002   
% 219.16/219.36  |- mesh__recordOriginator mesh__D010842 NLM
% 219.16/219.36  |- rdf__type mesh__D010842sskos__Concept
% 219.16/219.36  |- skos__scopeNote mesh__D010842
% 219.16/219.36       The persistent eating of nonnutritive substances for a period of at least one month. %28%DSM-IV%29%%A%    
% 219.16/219.36  |- mesh__publicMeSHNote mesh__D010842 72   
% 219.16/219.36  |- mesh__historyNote mesh__D010842 72%28%68%29%   
% 219.16/219.36  |- skos__broader mesh__D010842smesh__D001068
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D010842 2004
% 219.16/219.36  |- mesh__recordAuthorizer mesh__D010842 sjn
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D010842 2003
% 219.16/219.36  |- mesh__dateCreated mesh__D010842 1999-01-01
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D010842 2006
% 219.16/219.36  |- skos__historyNote mesh__D010842 Appetite Disorders %28%1966-1967%29%
% 219.16/219.36  |- mesh__dateRevised mesh__D010842 2001-07-25
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D010842 2002
% 219.16/219.36  |- skos__prefLabel mesh__D010842 Pica
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D010842 2005
% 219.16/219.36  |- skos__broader mesh__D010842smesh__D019959
% 219.16/219.36  |- mesh__dateEstablished mesh__D010842 1972-01-01
% 219.16/219.36  |- mesh__recordMaintainer mesh__D010842 lkt
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D018027 2005
% 219.16/219.36  |- mesh__publicMeSHNote mesh__D018027
% 219.16/219.36       94; GLUCAGON RECEPTOR was indexed under RECEPTORS, GASTROINTESTINAL HORMONE 1986-93, RECEPTORS, ENDOGENOUS SUBSTANCES 1981-86, %26% GLUCAGON 1980-81%A%  
% 219.16/219.36  |- skos__broader mesh__D018027smesh__D043562
% 219.16/219.36  |- skos__related mesh__D018027smesh__D005934
% 219.16/219.36  |- mesh__recordMaintainer mesh__D018027 jmp
% 219.16/219.36  |- mesh__dateEstablished mesh__D018027 1994-01-01
% 219.16/219.36  |- skos__altLabel mesh__D018027 Glucagon Receptor
% 219.16/219.36  |- rdf__type mesh__D018027sskos__Concept
% 219.16/219.36  |- skos__historyNote mesh__D018027 Glucagon %28%1980-1981%29%
% 219.16/219.36  |- skos__historyNote mesh__D018027
% 219.16/219.36       Receptors, Gastrointestinal Hormone %28%1986-1993%29%
% 219.16/219.36  |- skos__broader mesh__D018027smesh__D018026
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D018027 2004
% 219.16/219.36  |- skos__annotation mesh__D018027 DF: RECEPT GLUCAGON   
% 219.16/219.36  |- skos__prefLabel mesh__D018027 Receptors, Glucagon
% 219.16/219.36  |- skos__historyNote mesh__D018027
% 219.16/219.36       Receptors, Cell Surface %28%1981-1986%29%
% 219.16/219.36  |- skos__altLabel mesh__D018027 Glucagon Receptors
% 219.16/219.36  |- mesh__historyNote mesh__D018027
% 219.16/219.36       94; was GLUCAGON RECEPTOR %28%NM%29% 1980-93   
% 219.16/219.36  |- mesh__recordOriginator mesh__D018027 RAZ
% 219.16/219.36  |- mesh__dateCreated mesh__D018027 1993-06-21
% 219.16/219.36  |- skos__hiddenLabel mesh__D018027 Receptor, Glucagon
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D018027 2006
% 219.16/219.36  |- mesh__recordAuthorizer mesh__D018027 sjn
% 219.16/219.36  |- skos__scopeNote mesh__D018027
% 219.16/219.36       Cell surface receptors that bind glucagon with high affinity and trigger intracellular changes which influence the behavior of cells. Activation of glucagon receptors causes a variety of effects; the best understood is the initiation of a complex enzymatic cascade in the liver which ultimately increases the availability of glucose to body organs.%A%    
% 219.16/219.36  |- mesh__onlineNote mesh__D018027
% 219.16/219.36       use RECEPTORS, GLUCAGON %28%NM%29% to search GLUCAGON RECEPTOR 1980-93%A%  
% 219.16/219.36  |- mesh__dateRevised mesh__D018027 2003-07-09
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D010044 2003
% 219.16/219.36  |- mesh__recordMaintainer mesh__D010044 kle
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D010044 2006
% 219.16/219.36  |- mesh__dateCreated mesh__D010044 1999-01-01
% 219.16/219.36  |- mesh__recordOriginator mesh__D010044 NLM
% 219.16/219.36  |- skos__prefLabel mesh__D010044 Outpatient Clinics, Hospital
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D010044 2001
% 219.16/219.36  |- skos__related mesh__D010044smesh__D000553
% 219.16/219.36  |- skos__altLabel mesh__D010044 Ambulatory Care Facilities, Hospital
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D010044 2005
% 219.16/219.36  |- skos__hiddenLabel mesh__D010044 Clinics, Hospital Outpatient
% 219.16/219.36  |- mesh__onlineNote mesh__D010044
% 219.16/219.36       use OUTPATIENT CLINICS, HOSPITAL to search HOSPITAL OUTPATIENT CLINICS 1968-77 %26% HOSPITAL OUTPATIENT SERVICE 1966-67%A%  
% 219.16/219.36  |- skos__hiddenLabel mesh__D010044 Outpatient Clinic, Hospital
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D010044 2000
% 219.16/219.36  |- mesh__dateEstablished mesh__D010044 1968-01-01
% 219.16/219.36  |- skos__broader mesh__D010044smesh__D000554
% 219.16/219.36  |- rdf__type mesh__D010044sskos__Concept
% 219.16/219.36  |- skos__broader mesh__D010044smesh__D006748
% 219.16/219.36  |- skos__altLabel mesh__D010044 Hospital Outpatient Clinics
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D010044 2004
% 219.16/219.36  |- skos__hiddenLabel mesh__D010044 Hospital Outpatient Clinic
% 219.16/219.36  |- skos__hiddenLabel mesh__D010044 Clinic, Hospital Outpatient
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D010044 2002
% 219.16/219.36  |- skos__annotation mesh__D010044 IM   
% 219.16/219.36  |- mesh__recordAuthorizer mesh__D010044 sjn
% 219.16/219.36  |- skos__scopeNote mesh__D010044
% 219.16/219.36       Organized services in a hospital which provide medical care on an outpatient basis.%A%    
% 219.16/219.36  |- mesh__dateRevised mesh__D010044 1999-11-03
% 219.16/219.36  |- mesh__publicMeSHNote mesh__D010044
% 219.16/219.36       78; was HOSPITAL OUTPATIENT CLINICS 1968-77, was HOSPITAL OUTPATIENT SERVICES 1963-67%A%  
% 219.16/219.36  |- mesh__historyNote mesh__D010044
% 219.16/219.36       78; was HOSPITAL OUTPATIENT CLINICS 1968-77, was HOSPITAL OUTPATIENT SERVICES 1963-67%A%  
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D004805 2002
% 219.16/219.36  |- skos__annotation mesh__D004805
% 219.16/219.36       /radiogr: coord with CEREBRAL VENTRICULOGRAPHY   
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D004805 2000
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D004805 2005
% 219.16/219.36  |- mesh__dateRevised mesh__D004805 1999-11-03
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D004805 2006
% 219.16/219.36  |- skos__scopeNote mesh__D004805
% 219.16/219.36       A thin membrane that lines the ventricles of the brain and the central canal of the SPINAL CORD.%A%    
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D004805 2001
% 219.16/219.36  |- skos__prefLabel mesh__D004805 Ependyma
% 219.16/219.36  |- mesh__recordOriginator mesh__D004805 NLM
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D004805 2003
% 219.16/219.36  |- mesh__recordAuthorizer mesh__D004805 sjn
% 219.16/219.36  |- mesh__dateCreated mesh__D004805 1999-01-01
% 219.16/219.36  |- skos__hiddenLabel mesh__D004805 Ependymas
% 219.16/219.36  |- mesh__recordMaintainer mesh__D004805 KEV
% 219.16/219.36  |- rdf__type mesh__D004805sskos__Concept
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D004805 2004
% 219.16/219.36  |- skos__broader mesh__D004805smesh__D009417
% 219.16/219.36  |- skos__broader mesh__D004805smesh__D002552
% 219.16/219.36  |- mesh__publicMeSHNote mesh__D004007
% 219.16/219.36       91; was see under HEARING TESTS 1980-90   
% 219.16/219.36  |- skos__hiddenLabel mesh__D004007 Listening Test, Dichotic
% 219.16/219.36  |- mesh__dateCreated mesh__D004007 1978-12-14
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D004007 2003
% 219.16/219.36  |- mesh__dateRevised mesh__D004007 1997-06-20
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D004007 2000
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D004007 2005
% 219.16/219.36  |- skos__hiddenLabel mesh__D004007 Tests, Dichotic Listening
% 219.16/219.36  |- mesh__recordAuthorizer mesh__D004007 SJN
% 219.16/219.36  |- skos__historyNote mesh__D004007 Perception %28%1966%29%
% 219.16/219.36  |- skos__historyNote mesh__D004007 Auditory Perception %28%1967-1979%29%
% 219.16/219.36  |- skos__scopeNote mesh__D004007
% 219.16/219.36       Tests for central hearing disorders based on the competing message technique %28%binaural separation%29%.%A%    
% 219.16/219.36  |- skos__annotation mesh__D004007
% 219.16/219.36       dichotic refers to the %22%competing message technique%22%   
% 219.16/219.36  |- skos__hiddenLabel mesh__D004007 Listening Tests, Dichotic
% 219.16/219.36  |- skos__historyNote mesh__D004007 Laterality %28%1966-1979%29%
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D004007 1999
% 219.16/219.36  |- skos__broader mesh__D004007smesh__D006320
% 219.16/219.36  |- mesh__recordMaintainer mesh__D004007 PXP
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D004007 1998
% 219.16/219.36  |- skos__prefLabel mesh__D004007 Dichotic Listening Tests
% 219.16/219.36  |- mesh__recordOriginator mesh__D004007 RC
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D004007 2002
% 219.16/219.36  |- skos__historyNote mesh__D004007 Hearing %28%1966%29%
% 219.16/219.36  |- rdf__type mesh__D004007sskos__Concept
% 219.16/219.36  |- skos__hiddenLabel mesh__D004007 Test, Dichotic Listening
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D004007 2004
% 219.16/219.36  |- skos__hiddenLabel mesh__D004007 Dichotic Listening Test
% 219.16/219.36  |- mesh__historyNote mesh__D004007
% 219.16/219.36       91%28%80%29%; was see under HEARING TESTS 1980-90   
% 219.16/219.36  |- mesh__dateEstablished mesh__D004007 1991-01-01
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D004007 2001
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D004007 2006
% 219.16/219.36  |- skos__related mesh__D020472smesh__D020466
% 219.16/219.36  |- skos__broader mesh__D020472smesh__D020495
% 219.16/219.36  |- skos__prefLabel mesh__D020472 Drawings %5B%Publication Type%5D%
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D020472 2006
% 219.16/219.36  |- skos__altLabel mesh__D020472 Drawings %28%PT%29%
% 219.16/219.36  |- mesh__dateRevised mesh__D020472 2005-06-30
% 219.16/219.36  |- rdf__type mesh__D020472sskos__Concept
% 219.16/219.36  |- mesh__historyNote mesh__D020472 1999   
% 219.16/219.36  |- mesh__dateCreated mesh__D020472 1998-06-03
% 219.16/219.36  |- mesh__recordOriginator mesh__D020472 JLS
% 219.16/219.36  |- mesh__dateEstablished mesh__D020472 1999-01-01
% 219.16/219.36  |- mesh__recordAuthorizer mesh__D020472 sjn
% 219.16/219.36  |- skos__broader mesh__D020472smesh__D019489
% 219.16/219.36  |- skos__scopeNote mesh__D020472
% 219.16/219.36       Works consisting of graphic representations of objects or ideas by lines.%A%    
% 219.16/219.36  |- skos__related mesh__D020472smesh__D019488
% 219.16/219.36  |- mesh__recordMaintainer mesh__D020472 jls
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D014435 2005
% 219.16/219.36  |- skos__hiddenLabel mesh__D014435 Typhoids
% 219.16/219.36  |- mesh__recordMaintainer mesh__D014435 ags
% 219.16/219.36  |- mesh__publicMeSHNote mesh__D014435 2001; see TYPHOID 1963-2000   
% 219.16/219.36  |- skos__broader mesh__D014435smesh__D012480
% 219.16/219.36  |- skos__prefLabel mesh__D014435 Typhoid Fever
% 219.16/219.36  |- mesh__historyNote mesh__D014435 2001%28%1963%29%   
% 219.16/219.36  |- skos__hiddenLabel mesh__D014435 Fevers, Typhoid
% 219.16/219.36  |- skos__scopeNote mesh__D014435
% 219.16/219.36       An acute systemic febrile infection caused by SALMONELLA TYPHI, a serotype of SALMONELLA ENTERICA.%A%    
% 219.16/219.36  |- skos__hiddenLabel mesh__D014435 Fevers, Enteric
% 219.16/219.36  |- mesh__dateRevised mesh__D014435 2002-07-02
% 219.16/219.36  |- skos__hiddenLabel mesh__D014435 Fever, Enteric
% 219.16/219.36  |- rdf__type mesh__D014435sskos__Concept
% 219.16/219.36  |- mesh__recordOriginator mesh__D014435 NLM
% 219.16/219.36  |- mesh__recordAuthorizer mesh__D014435 sjn
% 219.16/219.36  |- skos__hiddenLabel mesh__D014435 Fever, Typhoid
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D014435 2004
% 219.16/219.36  |- skos__altLabel mesh__D014435 Typhus, Abdominal
% 219.16/219.36  |- mesh__dateCreated mesh__D014435 1999-01-01
% 219.16/219.36  |- skos__hiddenLabel mesh__D014435 Typhoid Fevers
% 219.16/219.36  |- skos__hiddenLabel mesh__D014435 Enteric Fevers
% 219.16/219.36  |- skos__altLabel mesh__D014435 Enteric Fever
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D014435 2003
% 219.16/219.36  |- skos__hiddenLabel mesh__D014435 Abdominal Typhus
% 219.16/219.36  |- skos__altLabel mesh__D014435 Typhoid
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D014435 2006
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D000415 2006
% 219.16/219.36  |- skos__broader mesh__D000415smesh__D005061
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D000415 2004
% 219.16/219.36  |- skos__annotation mesh__D000415
% 219.16/219.36       in translations of historical articles use spelling People%27%s Republic, not Peoples%27% nor Peoples%A%  
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D000415 2005
% 219.16/219.36  |- mesh__recordOriginator mesh__D000415 NLM
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D000415 2003
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D000415 2002A
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D000415 2002
% 219.16/219.36  |- mesh__recordAuthorizer mesh__D000415 sjn
% 219.16/219.36  |- rdf__type mesh__D000415sskos__Concept
% 219.16/219.36  |- mesh__dateRevised mesh__D000415 2001-12-03
% 219.16/219.36  |- skos__prefLabel mesh__D000415 Albania
% 219.16/219.36  |- mesh__dateCreated mesh__D000415 1999-01-01
% 219.16/219.36  |- mesh__recordMaintainer mesh__D000415 sjn
% 219.16/219.36  |- skos__hiddenLabel mesh__D005100 Agents, Mucolytic
% 219.16/219.36  |- rdf__type mesh__D005100sskos__Concept
% 219.16/219.36  |- mesh__dateRevised mesh__D005100 2005-06-30
% 219.16/219.36  |- skos__annotation mesh__D005100
% 219.16/219.36       GEN or unspecified; prefer specifics; D25-26 qualif   
% 219.16/219.36  |- skos__broader mesh__D005100smesh__D019141
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D005100 2006
% 219.16/219.36  |- mesh__recordAuthorizer mesh__D005100 sjn
% 219.16/219.36  |- skos__prefLabel mesh__D005100 Expectorants
% 219.16/219.36  |- skos__scopeNote mesh__D005100
% 219.16/219.36       Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here.%A%    
% 219.16/219.36  |- mesh__dateCreated mesh__D005100 1999-01-01
% 219.16/219.36  |- skos__related mesh__D005100smesh__D000996
% 219.16/219.36  |- mesh__recordOriginator mesh__D005100 NLM
% 219.16/219.36  |- skos__altLabel mesh__D005100 Mucolytics
% 219.16/219.36  |- mesh__recordMaintainer mesh__D005100 ssb
% 219.16/219.36  |- skos__altLabel mesh__D018826 Alanine Aminopeptidase
% 219.16/219.36  |- mesh__recordAuthorizer mesh__D018826 sjn
% 219.16/219.36  |- skos__broader mesh__D018826smesh__D045727
% 219.16/219.36  |- skos__broader mesh__D018826smesh__D000945
% 219.16/219.36  |- skos__historyNote mesh__D018826 Antigens, Differentiation %28%1988%29%
% 219.16/219.36  |- skos__altLabel mesh__D018826 Aminopeptidase M
% 219.16/219.36  |- skos__hiddenLabel mesh__D018826 M, Aminopeptidase
% 219.16/219.36  |- skos__altLabel mesh__D018826 Membrane Alanyl Aminopeptidase
% 219.16/219.36  |- mesh__historyNote mesh__D018826
% 219.16/219.36       95; was CD13 ANTIGEN %28%NM%29% 1988-94 %26% ALANINE AMINOPEPTIDASE %28%NM%29% 1975-94%A%  
% 219.16/219.36  |- skos__altLabel mesh__D018826 CD13 Antigen
% 219.16/219.36  |- skos__historyNote mesh__D018826 Antigens, CD %28%1991-1994%29%
% 219.16/219.36  |- skos__prefLabel mesh__D018826 Antigens, CD13
% 219.16/219.36  |- skos__altLabel mesh__D018826 Alanyl Aminopeptidase
% 219.16/219.36  |- skos__broader mesh__D018826smesh__D000626
% 219.16/219.36  |- skos__broader mesh__D018826smesh__D015703
% 219.16/219.36  |- mesh__recordOriginator mesh__D018826 AGS
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D018826 2006
% 219.16/219.36  |- mesh__recordMaintainer mesh__D018826 ssb
% 219.16/219.36  |- rdf__type mesh__D018826sskos__Concept
% 219.16/219.36  |- mesh__dateCreated mesh__D018826 1994-05-27
% 219.16/219.36  |- skos__altLabel mesh__D018826 CD13 Antigens
% 219.16/219.36  |- skos__altLabel mesh__D018826 Amino-oligopeptidase
% 219.16/219.36  |- mesh__dateRevised mesh__D018826 2005-06-30
% 219.16/219.36  |- skos__hiddenLabel mesh__D018826 Antigen, CD13
% 219.16/219.36  |- skos__historyNote mesh__D018826 Alanine %28%1975-1980%29%
% 219.16/219.36  |- mesh__onlineNote mesh__D018826
% 219.16/219.36       use ANTIGENS, CD13 %28%NM%29% to search CD13 ANTIGEN 1988-94 %26% ALANINE AMINOPEPTIDASE 1975-94%A%  
% 219.16/219.36  |- skos__scopeNote mesh__D018826
% 219.16/219.36       Zinc-binding metalloproteases that are members of the type II integral membrane metalloproteases. They are expressed by GRANULOCYTES; MONOCYTES; and their precursors as well as by various non-hematopoietic cells. They release an N-terminal amino acid from a peptide, amide or arylamide.%A%    
% 219.16/219.36  |- mesh__dateEstablished mesh__D018826 1995-01-01
% 219.16/219.36  |- mesh__publicMeSHNote mesh__D018826
% 219.16/219.36       95; CD13 ANTIGEN was indexed under ANTIGENS, CD 1991-94, ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94, %26% ANTIGENS, DIFFERENTIATION 1988; ALANINE AMINOPEPIDASE was indexed under AMINOPEPTIDASES 1981-94 %26% ALANINE 1975-80%A%  
% 219.16/219.36  |- skos__historyNote mesh__D018826 Aminopeptidases %28%1981-1994%29%
% 219.16/219.36  |- skos__altLabel mesh__D018826 Aminopeptidase N
% 219.16/219.36  |- skos__historyNote mesh__D018826
% 219.16/219.36       Antigens, Differentiation, Myelomonocytic %28%1989-1994%29%
% 219.16/219.36  |- rdf__type mesh__D010843sskos__Concept
% 219.16/219.36  |- skos__prefLabel mesh__D010843 Pichia
% 219.16/219.36  |- mesh__historyNote mesh__D010843 91%28%75%29%   
% 219.16/219.36  |- skos__altLabel mesh__D010843 Hansenula
% 219.16/219.36  |- mesh__dateRevised mesh__D010843 2005-06-30
% 219.16/219.36  |- mesh__recordMaintainer mesh__D010843 SYSTEM
% 219.16/219.36  |- mesh__recordOriginator mesh__D010843 NLM
% 219.16/219.36  |- skos__broader mesh__D010843smesh__D015003
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D010843 2006
% 219.16/219.36  |- mesh__dateEstablished mesh__D010843 1991-01-01
% 219.16/219.36  |- skos__scopeNote mesh__D010843
% 219.16/219.36       Yeast-like ascomycetous fungi of the family Saccharomycetaceae, order SACCHAROMYCETALES isolated from exuded tree sap.%A%    
% 219.16/219.36  |- mesh__recordAuthorizer mesh__D010843 sjn
% 219.16/219.36  |- mesh__publicMeSHNote mesh__D010843
% 219.16/219.36       91; see ENDOMYCETALES 1986-90, see ASCOMYCETES 1975-85; for HANSENULA see HANSENULA 1991-98, see ENDOMYCETALES 1986-90, see ASCOMYCETES 1975-85%A%  
% 219.16/219.36  |- skos__broader mesh__D010843smesh__D004718
% 219.16/219.36  |- mesh__dateCreated mesh__D010843 1974-12-12
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D018028 2004
% 219.16/219.36  |- skos__hiddenLabel mesh__D018028 Receptor, Neurotensin
% 219.16/219.36  |- mesh__recordAuthorizer mesh__D018028 sjn
% 219.16/219.36  |- skos__historyNote mesh__D018028
% 219.16/219.36       Receptors, Cell Surface %28%1980-1984%29%
% 219.16/219.36  |- skos__historyNote mesh__D018028
% 219.16/219.36       Receptors, Neurotransmitter %28%1985-1993%29%
% 219.16/219.36  |- mesh__dateEstablished mesh__D018028 1994-01-01
% 219.16/219.36  |- skos__prefLabel mesh__D018028 Receptors, Neurotensin
% 219.16/219.36  |- skos__altLabel mesh__D018028 Neurotensin Receptor
% 219.16/219.36  |- skos__altLabel mesh__D018028 Neurotensin Receptors
% 219.16/219.36  |- skos__scopeNote mesh__D018028
% 219.16/219.36       Cell surface proteins that bind neurotensin with high affinity and trigger intracellular changes which influence the behavior of cells. Neurotensin and neurotensin receptors are found in the central nervous system and in the periphery.%A%    
% 219.16/219.36  |- skos__annotation mesh__D018028 DF: RECEPT NEUROTENSIN   
% 219.16/219.36  |- mesh__publicMeSHNote mesh__D018028
% 219.16/219.36       94; NEUROTENSIN RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1985-93 %26% RECEPTORS, ENDOGENOUS SUSBSTANCES 1980-84%A%  
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D018028 2006
% 219.16/219.36  |- mesh__historyNote mesh__D018028
% 219.16/219.36       94; was NEUROTENSIN RECEPTOR %28%NM%29% 1980-93   
% 219.16/219.36  |- mesh__dateRevised mesh__D018028 2003-07-09
% 219.16/219.36  |- mesh__activeMeSHYear mesh__D018028 2005
% 219.16/219.36  |- mesh__onlineNote mesh__D018028
% 219.16/219.36       use RECEPTORS, NEUROTENSIN %28%NM%29% to search NEUROTENSIN RECEPTOR 1980-93%A%  
% 219.16/219.36  |- mesh__recordOriginator mesh__D018028 RAZ
% 219.16/219.36  |- skos__broader mesh__D018028smesh__D043562
% 219.26/219.41  |- mesh__recordMaintainer mesh__D018028 jmp
% 219.26/219.41  |- rdf__type mesh__D018028sskos__Concept
% 219.26/219.41  |- skos__broader mesh__D018028smesh__D018013
% 219.26/219.41  |- mesh__dateCreated mesh__D018028 1993-06-21
% 219.26/219.41  |- mesh__historyNote mesh__D010045
% 219.26/219.41       91%28%80%29%; was see under PATIENTS 1980-90; was see AMBULATORY CARE 1978-79%A%  
% 219.26/219.41  |- skos__hiddenLabel mesh__D010045 Out patients
% 219.26/219.41  |- skos__historyNote mesh__D010045 Ambulatory Care %28%1966-1979%29%
% 219.26/219.41  |- skos__broader mesh__D010045smesh__D010361
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D010045 2006
% 219.26/219.41  |- skos__prefLabel mesh__D010045 Outpatients
% 219.26/219.41  |- mesh__onlineNote mesh__D010045 search AMBULATORY CARE 1978-79   
% 219.26/219.41  |- mesh__recordAuthorizer mesh__D010045 sjn
% 219.26/219.41  |- skos__related mesh__D010045smesh__D000553
% 219.26/219.41  |- skos__annotation mesh__D010045
% 219.26/219.41       outpatients as people or as a social, sociol, psychol, etc., group; do not confuse the outpatient with the care given him %28% = AMBULATORY CARE%29%%A%  
% 219.26/219.41  |- mesh__recordMaintainer mesh__D010045 ssb
% 219.26/219.41  |- mesh__publicMeSHNote mesh__D010045
% 219.26/219.41       91; was see under PATIENTS 1980-90; was see AMBULATORY CARE 1978-79%A%  
% 219.26/219.41  |- skos__altLabel mesh__D010045 Out-patients
% 219.26/219.41  |- mesh__recordOriginator mesh__D010045 EC
% 219.26/219.41  |- mesh__dateRevised mesh__D010045 2003-07-09
% 219.26/219.41  |- skos__hiddenLabel mesh__D010045 Out-patient
% 219.26/219.41  |- rdf__type mesh__D010045sskos__Concept
% 219.26/219.41  |- mesh__dateEstablished mesh__D010045 1991-01-01
% 219.26/219.41  |- mesh__dateCreated mesh__D010045 1978-12-22
% 219.26/219.41  |- skos__scopeNote mesh__D010045
% 219.26/219.41       Persons who receive ambulatory care at an outpatient department or clinic without room and board being provided.%A%    
% 219.26/219.41  |- skos__hiddenLabel mesh__D010045 Outpatient
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D010045 2004
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D010045 2005
% 219.26/219.41  |- skos__hiddenLabel mesh__D004806 Ependymomas, Clear Cell
% 219.26/219.41  |- mesh__recordMaintainer mesh__D004806 ags
% 219.26/219.41  |- skos__altLabel mesh__D004806 Papillary Ependymoma
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D004806 2005
% 219.26/219.41  |- skos__hiddenLabel mesh__D004806 Myxopapillary Ependymoma
% 219.26/219.41  |- skos__hiddenLabel mesh__D004806 Ependymoma, Anaplastic
% 219.26/219.41  |- skos__hiddenLabel mesh__D004806 Ependymoma, Cellular
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D004806 2006
% 219.26/219.41  |- skos__hiddenLabel mesh__D004806 Clear Cell Ependymomas
% 219.26/219.41  |- mesh__historyNote mesh__D004806
% 219.26/219.41       1963; for EPENDYMOMA, MYXOPAPILLARY use GLIOMA 1994-1999   
% 219.26/219.41  |- skos__hiddenLabel mesh__D004806 Anaplastic Ependymomas
% 219.26/219.41  |- skos__prefLabel mesh__D004806 Ependymoma
% 219.26/219.41  |- skos__hiddenLabel mesh__D004806 Myxopapillary Ependymomas
% 219.26/219.41  |- mesh__dateCreated mesh__D004806 1999-01-01
% 219.26/219.41  |- rdf__type mesh__D004806sskos__Concept
% 219.26/219.41  |- skos__scopeNote mesh__D004806
% 219.26/219.41       Glioma derived from ependymocytes that tend to present as malignant intracranial tumors in children and as benign intraspinal neoplasms in adults. It may arise from any level of the ventricular system or central canal of the spinal cord. Intracranial ependymomas most frequently originate in the FOURTH VENTRICLE and histologically are densely cellular tumors which may contain ependymal tubules and perivascular pseudorosettes. Spinal ependymomas are usually benign papillary or myxopapillary tumors. %28%From DeVita et al., Principles and Practice of Oncology, 5th ed, p2018; Escourolle et al., Manual of Basic Neuropathology, 2nd ed, pp28-9%29%%A%    
% 219.26/219.41  |- skos__hiddenLabel mesh__D004806 Ependymomas, Cellular
% 219.26/219.41  |- skos__hiddenLabel mesh__D004806 Papillary Ependymomas
% 219.26/219.41  |- skos__hiddenLabel mesh__D004806 Cellular Ependymomas
% 219.26/219.41  |- skos__hiddenLabel mesh__D004806 Ependymomas
% 219.26/219.41  |- skos__hiddenLabel mesh__D004806 Ependymomas, Anaplastic
% 219.26/219.41  |- skos__altLabel mesh__D004806 Clear Cell Ependymoma
% 219.26/219.41  |- skos__broader mesh__D004806smesh__D005910
% 219.26/219.41  |- mesh__publicMeSHNote mesh__D004806
% 219.26/219.41       1963; for EPENDYMOMA, MYXOPAPILLARY see GLIOMA 1994-1999   
% 219.26/219.41  |- skos__annotation mesh__D004806
% 219.26/219.41       coord IM with precoord CNS/neopl term %28%IM%29% + site %28%IM%29%; for MIXED OLIGODENDROGLIOMA-EPENDYMOMA see OLIGODENDROGLIOMA%A%  
% 219.26/219.41  |- skos__hiddenLabel mesh__D004806 Ependymoma, Clear Cell
% 219.26/219.41  |- skos__hiddenLabel mesh__D004806 Ependymomas, Myxopapillary
% 219.26/219.41  |- skos__hiddenLabel mesh__D004806 Ependymomas, Papillary
% 219.26/219.41  |- mesh__dateRevised mesh__D004806 2004-07-07
% 219.26/219.41  |- mesh__recordOriginator mesh__D004806 NLM
% 219.26/219.41  |- skos__altLabel mesh__D004806 Cellular Ependymoma
% 219.26/219.41  |- mesh__recordAuthorizer mesh__D004806 sjn
% 219.26/219.41  |- skos__altLabel mesh__D004008 Ortofen
% 219.26/219.41  |- skos__broader mesh__D004008smesh__D010648
% 219.26/219.41  |- mesh__dateCreated mesh__D004008 1976-04-13
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D004008 2003
% 219.26/219.41  |- mesh__recordMaintainer mesh__D004008 ssb
% 219.26/219.41  |- mesh__recordOriginator mesh__D004008 SH
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D004008 2006
% 219.26/219.41  |- skos__altLabel mesh__D004008 Dicrofenac
% 219.26/219.41  |- skos__historyNote mesh__D004008 Phenylacetates %28%1973-1976%29%
% 219.26/219.41  |- skos__historyNote mesh__D004008 Aniline Compounds %28%1973-1975%29%
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D004008 2005
% 219.26/219.41  |- mesh__recordAuthorizer mesh__D004008 sjn
% 219.26/219.41  |- mesh__publicMeSHNote mesh__D004008
% 219.26/219.41       1986; see PHENYLACETATES 1977-1985; for DICLOFENAC SODIUM see  2000-2001%A%  
% 219.26/219.41  |- skos__altLabel mesh__D004008 Diclophenac
% 219.26/219.41  |- skos__hiddenLabel mesh__D004008 GP45,840
% 219.26/219.41  |- skos__hiddenLabel mesh__D004008 SR38
% 219.26/219.41  |- skos__altLabel mesh__D004008 Sodium Diclofenac
% 219.26/219.41  |- mesh__historyNote mesh__D004008 1986%28%1977%29%   
% 219.26/219.41  |- skos__hiddenLabel mesh__D004008 Diclofenac, Sodium
% 219.26/219.41  |- mesh__dateEstablished mesh__D004008 1986-01-01
% 219.26/219.41  |- skos__prefLabel mesh__D004008 Diclofenac
% 219.26/219.41  |- mesh__dateRevised mesh__D004008 2001-07-25
% 219.26/219.41  |- skos__altLabel mesh__D004008 Dichlofenal
% 219.26/219.41  |- skos__hiddenLabel mesh__D004008 GP 45,840
% 219.26/219.41  |- rdf__type mesh__D004008sskos__Concept
% 219.26/219.41  |- skos__scopeNote mesh__D004008
% 219.26/219.41       A non-steroidal anti-inflammatory agent %28%NSAID%29% with antipyretic and analgesic actions. It is primarily available as the sodium salt.%A%    
% 219.26/219.41  |- skos__altLabel mesh__D004008 Orthophen
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D004008 2002
% 219.26/219.41  |- skos__hiddenLabel mesh__D004008 SR 38
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D004008 2004
% 219.26/219.41  |- skos__broader mesh__D042925smesh__D035602
% 219.26/219.41  |- skos__historyNote mesh__D042925
% 219.26/219.41       Protein-Serine-Threonine Kinases %28%1996-2003%29%
% 219.26/219.41  |- skos__altLabel mesh__D042925 tat-Associated Kinase
% 219.26/219.41  |- mesh__historyNote mesh__D042925
% 219.26/219.41       2004; use POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B %28%NM%29% 1996-2003%A%  
% 219.26/219.41  |- skos__altLabel mesh__D042925 Positive Transcription Elongation Factor B
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D042925 2004
% 219.26/219.41  |- skos__hiddenLabel mesh__D042925 tat Associated Kinase
% 219.26/219.41  |- mesh__dateCreated mesh__D042925 2003-07-09
% 219.26/219.41  |- skos__prefLabel mesh__D042925
% 219.26/219.41       Positive Transcriptional Elongation Factor B
% 219.26/219.41  |- mesh__publicMeSHNote mesh__D042925
% 219.26/219.41       2004; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B was indexed under PROTEIN-SERINE-THREONINE KINASES 1996-2003%A%  
% 219.26/219.41  |- skos__scopeNote mesh__D042925
% 219.26/219.41       A transcriptional elongation factor complex that is comprised of a heterodimer of CYCLIN-DEPENDENT KINASE 9 and one of several CYCLINS including cyclin T1, T2 and K. It functions by phosphorylating the carboxy-terminal domain %28%CTD%29% of RNA POLYMERASE II, which results in more processive transcription complexes.%A%    
% 219.26/219.41  |- skos__altLabel mesh__D042925 P-TEFb
% 219.26/219.41  |- mesh__dateEstablished mesh__D042925 2004-01-01
% 219.26/219.41  |- rdf__type mesh__D042925sskos__Concept
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D042925 2006
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D042925 2005
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D014436 2006
% 219.26/219.41  |- skos__altLabel mesh__D014436 Vaccines, Paratyphoid
% 219.26/219.41  |- skos__scopeNote mesh__D014436
% 219.26/219.41       Vaccines used to prevent TYPHOID FEVER and/or PARATYPHOID FEVER which are caused by various species of SALMONELLA. Attenuated, subunit, and inactivated forms of the vaccines exist.%A%    
% 219.26/219.41  |- skos__hiddenLabel mesh__D014436 Vaccines, Typhoid-Paratyphoid
% 219.26/219.41  |- skos__hiddenLabel mesh__D014436 Typhoid Vaccines
% 219.26/219.41  |- mesh__recordOriginator mesh__D014436 NLM
% 219.26/219.41  |- rdf__type mesh__D014436sskos__Concept
% 219.26/219.41  |- skos__hiddenLabel mesh__D014436 Vaccine, Paratyphoid
% 219.26/219.41  |- mesh__recordAuthorizer mesh__D014436 sjn
% 219.26/219.41  |- skos__prefLabel mesh__D014436 Typhoid-Paratyphoid Vaccines
% 219.26/219.41  |- skos__hiddenLabel mesh__D014436 Paratyphoid Vaccines
% 219.26/219.41  |- mesh__dateCreated mesh__D014436 1999-01-01
% 219.26/219.41  |- skos__hiddenLabel mesh__D014436 Typhoid Paratyphoid Vaccines
% 219.26/219.41  |- skos__hiddenLabel mesh__D014436 Vaccine, Typhoid
% 219.26/219.41  |- skos__altLabel mesh__D014436 Typhoid Vaccine
% 219.26/219.41  |- mesh__dateRevised mesh__D014436 2005-06-30
% 219.26/219.41  |- skos__broader mesh__D014436smesh__D022562
% 219.26/219.41  |- mesh__recordMaintainer mesh__D014436 ssb
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D000416 2005
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D000416 2001
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D000416 2003
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D000416 1999
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D000416 2000
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D000416 1997
% 219.26/219.41  |- skos__annotation mesh__D000416 a province of Canada   
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D000416 1998
% 219.26/219.41  |- rdf__type mesh__D000416sskos__Concept
% 219.26/219.41  |- mesh__recordAuthorizer mesh__D000416 PLS
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D000416 1996
% 219.26/219.41  |- mesh__recordOriginator mesh__D000416 NLM
% 219.26/219.41  |- skos__broader mesh__D000416smesh__D002170
% 219.26/219.41  |- skos__prefLabel mesh__D000416 Alberta
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D000416 2002
% 219.26/219.41  |- mesh__recordMaintainer mesh__D000416 TGC
% 219.26/219.41  |- mesh__dateCreated mesh__D000416 1999-01-01
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D000416 2006
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D000416 2004
% 219.26/219.41  |- skos__scopeNote mesh__D000416
% 219.26/219.41       A province of western Canada, lying between the provinces of British Columbia and Saskatchewan. Its capital is Edmonton. It was named in honor of Princess Louise Caroline Alberta, the fourth daughter of Queen Victoria. %28%From Webster%27%s New Geographical Dictionary, 1988, p26 %26% Room, Brewer%27%s Dictionary of Names, 1992, p12%29%%A%    
% 219.26/219.41  |- mesh__dateRevised mesh__D000416 1995-02-17
% 219.26/219.41  |- mesh__publicMeSHNote mesh__D019121 96   
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D019121 2001
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D019121 2005
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D019121 2000
% 219.26/219.41  |- mesh__recordMaintainer mesh__D019121 AGS
% 219.26/219.41  |- mesh__historyNote mesh__D019121 96   
% 219.26/219.41  |- skos__hiddenLabel mesh__D019121 Burkholderia Infection
% 219.26/219.41  |- mesh__recordAuthorizer mesh__D019121 SJN
% 219.26/219.41  |- mesh__recordOriginator mesh__D019121 PXP
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D019121 1999
% 219.26/219.41  |- skos__scopeNote mesh__D019121
% 219.26/219.41       Infections with bacteria of the genus BURKHOLDERIA.     
% 219.26/219.41  |- skos__annotation mesh__D019121
% 219.26/219.41       gram-neg bact infect; coord IM with species %28%IM%29%   
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D019121 2004
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D019121 1998
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D019121 2002
% 219.26/219.41  |- mesh__dateCreated mesh__D019121 1995-06-05
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D019121 2003
% 219.26/219.41  |- skos__prefLabel mesh__D019121 Burkholderia Infections
% 219.26/219.41  |- skos__altLabel mesh__D019121 Infections, Burkholderia
% 219.26/219.41  |- skos__hiddenLabel mesh__D019121 Infection, Burkholderia
% 219.26/219.41  |- skos__historyNote mesh__D019121 Pseudomonas Infections %28%1992-1995%29%
% 219.26/219.41  |- mesh__dateRevised mesh__D019121 1997-06-20
% 219.26/219.41  |- skos__broader mesh__D019121smesh__D016905
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D019121 2006
% 219.26/219.41  |- mesh__dateEstablished mesh__D019121 1996-01-01
% 219.26/219.41  |- rdf__type mesh__D019121sskos__Concept
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D005101 1994
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D005101 1993
% 219.26/219.41  |- skos__prefLabel mesh__D005101 Expeditions
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D005101 2006
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D005101 1999
% 219.26/219.41  |- mesh__recordOriginator mesh__D005101 NLM
% 219.26/219.41  |- mesh__recordMaintainer mesh__D005101 TGC
% 219.26/219.41  |- mesh__dateCreated mesh__D005101 1999-01-01
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D005101 2005
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D005101 1998
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D005101 2004
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D005101 1997
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D005101 2001
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D005101 2003
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D005101 1996
% 219.26/219.41  |- skos__scopeNote mesh__D005101
% 219.26/219.41       Usually refers to planned scientific data-gathering excursions.%A%    
% 219.26/219.41  |- mesh__dateRevised mesh__D005101 1992-05-15
% 219.26/219.41  |- mesh__recordAuthorizer mesh__D005101 PLS
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D005101 2000
% 219.26/219.41  |- skos__hiddenLabel mesh__D005101 Expedition
% 219.26/219.41  |- rdf__type mesh__D005101sskos__Concept
% 219.26/219.41  |- skos__broader mesh__D005101smesh__D014195
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D005101 1995
% 219.26/219.41  |- skos__annotation mesh__D005101
% 219.26/219.41       IM; coord with type of exped %26% geog destination %28%IM%29%   
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D005101 2002
% 219.26/219.41  |- mesh__recordMaintainer mesh__D018827 ags
% 219.26/219.41  |- skos__broader mesh__D018827smesh__D002277
% 219.26/219.41  |- mesh__dateEstablished mesh__D018827 1995-01-01
% 219.26/219.41  |- mesh__recordAuthorizer mesh__D018827 sjn
% 219.26/219.41  |- mesh__recordOriginator mesh__D018827 JLS
% 219.26/219.41  |- skos__hiddenLabel mesh__D018827 Lung Carcinoma, Lewis
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D018827 2006
% 219.26/219.41  |- skos__historyNote mesh__D018827 Lung Neoplasms %28%1972-1994%29%
% 219.26/219.41  |- mesh__dateCreated mesh__D018827 1994-06-01
% 219.26/219.41  |- skos__prefLabel mesh__D018827 Carcinoma, Lewis Lung
% 219.26/219.41  |- rdf__type mesh__D018827sskos__Concept
% 219.26/219.41  |- skos__scopeNote mesh__D018827
% 219.26/219.41       A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. %28%From Cancer Chemother Rep 2 1972 Nov;%28%3%29%1:325%29% It is also called 3LL and LLC and is used as a transplantable malignancy.%A%    
% 219.26/219.41  |- skos__annotation mesh__D018827
% 219.26/219.41       exper neopl; do not confuse text ref LLC for Lewis Lung Carcinoma with LLC-PK1 CELLS where LLC stands for Lilly Laboratories Cell; /blood supply /chem /second /secret /ultrastruct permitted; don%27%t forget check tag ANIMALS%A%  
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D018827 2005
% 219.26/219.41  |- mesh__publicMeSHNote mesh__D018827 95   
% 219.26/219.41  |- skos__hiddenLabel mesh__D018827 Lewis Lung Carcinoma
% 219.26/219.41  |- mesh__historyNote mesh__D018827 95   
% 219.26/219.41  |- skos__broader mesh__D018827smesh__D009374
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D018827 2004
% 219.26/219.41  |- mesh__dateRevised mesh__D018827 2003-07-30
% 219.26/219.41  |- skos__hiddenLabel mesh__D010844 OK432
% 219.26/219.41  |- mesh__recordMaintainer mesh__D010844 ssb
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D010844 2006
% 219.26/219.41  |- mesh__recordAuthorizer mesh__D010844 sjn
% 219.26/219.41  |- skos__related mesh__D010844smesh__D013297
% 219.26/219.41  |- skos__hiddenLabel mesh__D010844 Streptococcal Preparation OK432
% 219.26/219.41  |- skos__altLabel mesh__D010844 Streptococcal Preparation OK-432
% 219.26/219.41  |- skos__altLabel mesh__D010844 Streptococcal OK-432
% 219.26/219.41  |- mesh__onlineNote mesh__D010844
% 219.26/219.41       use PICIBANIL to search STREPTOCOCCAL PREPARATION OK-432 1978-82%A%  
% 219.26/219.41  |- skos__hiddenLabel mesh__D010844 NSC B116209
% 219.26/219.41  |- mesh__dateEstablished mesh__D010844 1991-01-01
% 219.26/219.41  |- mesh__recordOriginator mesh__D010844 SH
% 219.26/219.41  |- rdf__type mesh__D010844sskos__Concept
% 219.26/219.41  |- skos__hiddenLabel mesh__D010844 Streptococcal OK 432
% 219.26/219.41  |- skos__hiddenLabel mesh__D010844 OK 432
% 219.26/219.41  |- skos__hiddenLabel mesh__D010844 NSCB116209
% 219.26/219.41  |- mesh__dateCreated mesh__D010844 1977-04-22
% 219.26/219.41  |- skos__hiddenLabel mesh__D010844 Streptococcal Preparation OK 432
% 219.26/219.41  |- mesh__dateRevised mesh__D010844 2005-06-30
% 219.26/219.41  |- skos__altLabel mesh__D010844 Picibanyl
% 219.26/219.41  |- skos__broader mesh__D010844smesh__D001688
% 219.26/219.41  |- skos__scopeNote mesh__D010844
% 219.26/219.41       A lyophilized preparation of a low-virulence strain %28%SU%29% of Streptococcus pyogenes %28%S. hemolyticus%29%, inactivated by heating with penicillin G. It has been proposed as a noncytotoxic antineoplastic agent because of its immune system-stimulating activity.%A%    
% 219.26/219.41  |- mesh__publicMeSHNote mesh__D010844
% 219.26/219.41       91; was see under BIOLOGICAL PRODUCTS 1983-90; was STREPTOCOCCAL PREPARATION OK-432 see under BIOLOGICAL PRODUCTS 1978-82%A%  
% 219.26/219.41  |- mesh__historyNote mesh__D010844
% 219.26/219.41       91%28%83%29%; was see under BIOLOGICAL PRODUCTS 1983-90; was STREPTOCOCCAL PREPARATION OK-432 see under BIOLOGICAL PRODUCTS 1978-82%A%  
% 219.26/219.41  |- skos__hiddenLabel mesh__D010844 Streptococcal OK432
% 219.26/219.41  |- skos__prefLabel mesh__D010844 Picibanil
% 219.26/219.41  |- skos__historyNote mesh__D010844 Streptococcus %28%1966-1977%29%
% 219.26/219.41  |- skos__altLabel mesh__D018029 Rh Immune Globulin
% 219.26/219.41  |- skos__altLabel mesh__D018029 Immune Globulin, Rh
% 219.26/219.41  |- skos__broader mesh__D018029smesh__D007074
% 219.26/219.41  |- skos__altLabel mesh__D018029 Anti-D-Immunoglobulin
% 219.26/219.41  |- skos__prefLabel mesh__D018029 Rho%28%D%29% Immune Globulin
% 219.26/219.41  |- skos__scopeNote mesh__D018029
% 219.26/219.41       Immunizing agent containing IMMUNOGLOBULIN G anti-Rho%28%D%29% used for preventing Rh immunization in Rh-negative individuals exposed to Rh-positive red blood cells.%A%    
% 219.26/219.41  |- skos__historyNote mesh__D018029
% 219.26/219.41       Antibodies, Anti-Idiotypic %28%1980-1983%29%
% 219.26/219.41  |- mesh__recordAuthorizer mesh__D018029 sjn
% 219.26/219.41  |- mesh__recordOriginator mesh__D018029 AGS
% 219.26/219.41  |- mesh__dateEstablished mesh__D018029 1994-01-01
% 219.26/219.41  |- mesh__dateCreated mesh__D018029 1993-06-15
% 219.26/219.41  |- skos__historyNote mesh__D018029 Immunoglobulins %28%1973-1993%29%
% 219.26/219.41  |- mesh__onlineNote mesh__D018029
% 219.26/219.41       use RHO%28%D%29% IMMUNE GLOBULIN %28%NM%29% to search RHO%28%D%29% IMMUNE GLOBULIN 1980-93%A%  
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D018029 2006
% 219.26/219.41  |- mesh__historyNote mesh__D018029
% 219.26/219.41       94; was RHO%28%D%29% IMMUNE GLOBULIN %28%NM%29% 1973-93   
% 219.26/219.41  |- mesh__recordMaintainer mesh__D018029 jmp
% 219.26/219.41  |- skos__hiddenLabel mesh__D018029 Globulin, Rh Immune
% 219.26/219.41  |- skos__altLabel mesh__D018029
% 219.26/219.41       ZLB Bioplasma AG Brand of Rho%28%D%29% Immune Globulin
% 219.26/219.41  |- skos__historyNote mesh__D018029 Gamma Globulins %28%1978-1983%29%
% 219.26/219.41  |- skos__hiddenLabel mesh__D018029 Anti D Immunoglobulin
% 219.26/219.41  |- mesh__dateRevised mesh__D018029 2005-06-30
% 219.26/219.41  |- rdf__type mesh__D018029sskos__Concept
% 219.26/219.41  |- skos__altLabel mesh__D018029 Rho%28%D%29% Immune Human Globulin
% 219.26/219.41  |- mesh__publicMeSHNote mesh__D018029
% 219.26/219.41       94; RHO%28%D%29% IMMUNE GLOBULIN was indexed under IMMUNOGLOBULINS 1973-93, ANTI-ANTIBODIES 1980-83, %26% GAMMA GLOBULINS 1978-83%A%  
% 219.26/219.41  |- skos__scopeNote mesh__D010046
% 219.26/219.41       Fenestra of the vestibule; an oval opening in the medial wall of the middle ear leading into the vestibule. Normally it is covered by the base of the stapes.%A%    
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D010046 2002
% 219.26/219.41  |- skos__annotation mesh__D010046
% 219.26/219.41       do not confuse with ROUND WINDOW in cochlea   
% 219.26/219.41  |- skos__hiddenLabel mesh__D010046 Window, Oval
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D010046 1994
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D010046 1999
% 219.26/219.41  |- mesh__recordAuthorizer mesh__D010046 PLS
% 219.26/219.41  |- skos__prefLabel mesh__D010046 Oval Window
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D010046 1995
% 219.26/219.41  |- mesh__dateCreated mesh__D010046 1978-05-19
% 219.26/219.41  |- rdf__type mesh__D010046sskos__Concept
% 219.26/219.41  |- mesh__dateEstablished mesh__D010046 1991-01-01
% 219.26/219.41  |- mesh__historyNote mesh__D010046
% 219.26/219.41       91%28%79%29%; was see under VESTIBULE 1990-90; was see under VESTIBULAR APPARATUS 1979-89%A%  
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D010046 2003
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D010046 1991
% 219.26/219.41  |- skos__hiddenLabel mesh__D010046 Oval Windows
% 219.26/219.41  |- mesh__recordOriginator mesh__D010046 RC
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D010046 2004
% 219.26/219.41  |- skos__historyNote mesh__D010046 Ear, Middle %28%1966-1978%29%
% 219.26/219.41  |- mesh__publicMeSHNote mesh__D010046
% 219.26/219.41       91; was see under VESTIBULE 1990-90; was see under VESTIBULAR APPARATUS 1979-89%A%  
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D010046 1996
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D010046 2000
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D010046 2005
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D010046 1997
% 219.26/219.41  |- mesh__dateRevised mesh__D010046 1990-04-13
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D010046 1992
% 219.26/219.41  |- skos__broader mesh__D010046smesh__D014722
% 219.26/219.41  |- skos__hiddenLabel mesh__D010046 Windows, Oval
% 219.26/219.41  |- mesh__recordMaintainer mesh__D010046 NLM
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D010046 2001
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D010046 2006
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D010046 1998
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D010046 1993
% 219.26/219.41  |- mesh__dateEstablished mesh__D004009 1973-01-01
% 219.26/219.41  |- mesh__recordOriginator mesh__D004009 NLM
% 219.26/219.41  |- skos__altLabel mesh__D004009 Sanfer Brand of Dicloxacillin Sodium
% 219.26/219.41  |- mesh__dateRevised mesh__D004009 2005-06-30
% 219.26/219.41  |- skos__altLabel mesh__D004009
% 219.26/219.41       SmithKline Beecham Brand of Dicloxacillin Sodium
% 219.26/219.41  |- skos__altLabel mesh__D004009 Dicloxaciclin
% 219.26/219.41  |- skos__altLabel mesh__D004009 Wyeth Brand of Dicloxacillin Sodium
% 219.26/219.41  |- skos__prefLabel mesh__D004009 Dicloxacillin
% 219.26/219.41  |- skos__altLabel mesh__D004009 Alphapharm Brand of Dicloxacillin Sodium
% 219.26/219.41  |- skos__altLabel mesh__D004009 Infectopharm Brand of Dicloxacillin Sodium
% 219.26/219.41  |- rdf__type mesh__D004009sskos__Concept
% 219.26/219.41  |- skos__scopeNote mesh__D004009
% 219.26/219.41       One of the PENICILLINS which is resistant to PENICILLINASE.%A%    
% 219.26/219.41  |- skos__altLabel mesh__D004009 Sigma Brand of Dicloxacillin Sodium
% 219.26/219.41  |- skos__altLabel mesh__D004009 Fustery Brand of Dicloxacillin Sodium
% 219.26/219.41  |- mesh__dateCreated mesh__D004009 1999-01-01
% 219.26/219.41  |- skos__altLabel mesh__D004009 Antibioticos Brand of Dicloxacillin Sodium
% 219.26/219.41  |- skos__altLabel mesh__D004009
% 219.26/219.41       Bristol-Myers Squibb Brand of Dicloxacillin Sodium
% 219.26/219.41  |- mesh__recordMaintainer mesh__D004009 exl
% 219.26/219.41  |- skos__altLabel mesh__D004009 Geneva Brand of Dicloxacillin Sodium
% 219.26/219.41  |- skos__altLabel mesh__D004009
% 219.26/219.41       Dicloxacillin, Monosodium Salt, Mono-Hydrate
% 219.26/219.41  |- skos__broader mesh__D004009smesh__D003023
% 219.26/219.41  |- skos__hiddenLabel mesh__D004009
% 219.26/219.41       Bristol Myers Squibb Brand of Dicloxacillin Sodium
% 219.26/219.41  |- mesh__recordAuthorizer mesh__D004009 sjn
% 219.26/219.41  |- skos__hiddenLabel mesh__D004009 Sodium, Dicloxacillin
% 219.26/219.41  |- skos__altLabel mesh__D004009 Dicloxacycline
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D004009 2006
% 219.26/219.41  |- mesh__publicMeSHNote mesh__D004009 73   
% 219.26/219.41  |- skos__altLabel mesh__D004009 Dichloroxacillin
% 219.26/219.41  |- mesh__historyNote mesh__D004009 73%28%66%29%   
% 219.26/219.41  |- skos__broader mesh__D004032Q000627smesh__D004032
% 219.26/219.41  |- mesh__preferredCombination mesh__D004032Q000627smesh__D004035
% 219.26/219.41  |- rdf__type mesh__D004032Q000627smesh__CompoundConcept
% 219.26/219.41  |- skos__altLabel mesh__D042926 Cytochrome P-450 CYP4A
% 219.26/219.41  |- skos__hiddenLabel mesh__D042926 Laurate Omega Hydroxylase
% 219.26/219.41  |- skos__altLabel mesh__D042926 Cytochrome P-450 4A
% 219.26/219.41  |- skos__altLabel mesh__D042926 Lauric Acid Omega-hydroxylase
% 219.26/219.41  |- skos__hiddenLabel mesh__D042926 P-450 4A, Cytochrome
% 219.26/219.41  |- mesh__recordAuthorizer mesh__D042926 sjn
% 219.26/219.41  |- skos__hiddenLabel mesh__D042926 Alkane 1 Hydroxylase
% 219.26/219.41  |- skos__hiddenLabel mesh__D042926 Omega Lauryl Hydroxylase
% 219.26/219.41  |- skos__hiddenLabel mesh__D042926 Omega 1 Hydroxylase
% 219.26/219.41  |- skos__hiddenLabel mesh__D042926 Cytochrome P 450 4A
% 219.26/219.41  |- mesh__activeMeSHYear mesh__D042926 2006
% 219.26/219.41  |- skos__altLabel mesh__D042926 Lauric Acid Hydroxylase
% 219.26/219.41  |- skos__historyNote mesh__D042926 Lauric Acids %28%1979-1981%29%
% 219.26/219.41  |- skos__historyNote mesh__D042926
% 219.26/219.41       Mixed Function Oxygenases %28%1982-2003%29%
% 219.26/219.41  |- skos__altLabel mesh__D042926 Cytochrome P-450 IVA
% 219.26/219.41  |- rdf__type mesh__D042926sskos__Concept
% 219.26/219.41  |- skos__hiddenLabel mesh__D042926 Alkane 1 Monooxygenase
% 219.26/219.41  |- skos__altLabel mesh__D042926 Laurate Omega-Hydroxylase
% 219.26/219.41  |- mesh__dateCreated mesh__D042926 2003-07-09
% 219.26/219.41  |- mesh__recordOriginator mesh__D042926 AKE
% 219.26/219.41  |- skos__hiddenLabel mesh__D042926 Omega-Hydroxylase, Laurate
% 219.26/219.42  |- skos__hiddenLabel mesh__D042926 Hydroxylase, Omega-Lauryl
% 219.26/219.42  |- mesh__historyNote mesh__D042926
% 219.26/219.42       2004; use ALKENE 1-MONOOXYGENASE %28%NM%29% 1980-2003   
% 219.26/219.42  |- skos__hiddenLabel mesh__D042926 Fatty Acid Omega Hydroxylase
% 219.26/219.42  |- skos__altLabel mesh__D042926 Omega-Lauryl Hydroxylase
% 219.26/219.42  |- skos__hiddenLabel mesh__D042926 Acid Omega-Hydroxylase, Fatty
% 219.26/219.42  |- skos__broader mesh__D042926smesh__D003577
% 219.26/219.42  |- skos__hiddenLabel mesh__D042926 Hydroxylase, Omega-1
% 219.26/219.42  |- skos__altLabel mesh__D042926 Lauric Acid Monooxygenase
% 219.26/219.42  |- skos__hiddenLabel mesh__D042926 Omega-hydroxylase, Lauric Acid
% 219.26/219.42  |- skos__hiddenLabel mesh__D042926 Hydroxylase, Alkane
% 219.26/219.42  |- skos__hiddenLabel mesh__D042926 Acid Hydroxylase, Lauric
% 219.26/219.42  |- skos__hiddenLabel mesh__D042926 Cytochrome P 450 IVA
% 219.26/219.42  |- skos__hiddenLabel mesh__D042926 Omega Hydroxylase
% 219.26/219.42  |- skos__hiddenLabel mesh__D042926 P-450 CYP4A, Cytochrome
% 219.26/219.42  |- skos__hiddenLabel mesh__D042926 Omega-Hydroxylase, Fatty Acid
% 219.26/219.42  |- skos__altLabel mesh__D042926 Alkane 1-Hydroxylase
% 219.26/219.42  |- skos__historyNote mesh__D042926
% 219.26/219.42       Cytochrome P-450 Enzyme System %28%1982-2003%29%
% 219.26/219.42  |- skos__hiddenLabel mesh__D042926 Lauric Acid Omega hydroxylase
% 219.26/219.42  |- skos__prefLabel mesh__D042926 Alkane 1-Monooxygenase
% 219.26/219.42  |- skos__hiddenLabel mesh__D042926 P-450 IVA, Cytochrome
% 219.26/219.42  |- skos__hiddenLabel mesh__D042926 Cytochrome P 450 CYP4A
% 219.26/219.42  |- skos__altLabel mesh__D042926 Alkane Hydroxylase
% 219.26/219.42  |- skos__altLabel mesh__D042926 CYP4A
% 219.26/219.42  |- skos__scopeNote mesh__D042926
% 219.26/219.42       A P450 oxidoreductase that catalyzes the hydroxylation of the terminal carbon of linear hydrocarbons such as OCTANE and FATTY ACIDS in the omega position. The enzyme may also play a role in the oxidation of a variety of structurally unrelated compounds such as XENOBIOTICS, and STEROIDS.%A%    
% 219.26/219.42  |- skos__altLabel mesh__D042926 Omega-Hydroxylase
% 219.26/219.42  |- mesh__dateRevised mesh__D042926 2004-07-07
% 219.26/219.42  |- skos__hiddenLabel mesh__D042926 CYP4A, Cytochrome P-450
% 219.26/219.42  |- skos__altLabel mesh__D042926 Fatty Acid Omega-Hydroxylase
% 219.26/219.42  |- mesh__recordMaintainer mesh__D042926 ssb
% 219.26/219.42  |- skos__hiddenLabel mesh__D042926 Acid Omega-hydroxylase, Lauric
% 219.26/219.42  |- mesh__publicMeSHNote mesh__D042926
% 219.26/219.42       2004; LAURIC ACID HYDROLASE %28%now ALKANE 1-MONOXYGENASE%29% was indexed under CYTOCHROME P-450 ENZYME SYSTEM %26% MIXED FUNCTION OXYGENASES 1982-2003, under LAURIC ACIDS 1979-1981%A%  
% 219.26/219.42  |- mesh__dateEstablished mesh__D042926 2004-01-01
% 219.26/219.42  |- skos__altLabel mesh__D042926 Omega-1 Hydroxylase
% 219.26/219.42  |- skos__altLabel mesh__D042926 Lauric Acid %28%Omega-1%29%-Hydroxylase
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D042926 2005
% 219.26/219.42  |- mesh__historyNote mesh__D020474 1999   
% 219.26/219.42  |- skos__prefLabel mesh__D020474 Essays %5B%Publication Type%5D%
% 219.26/219.42  |- skos__scopeNote mesh__D020474
% 219.26/219.42       Works consisting of collections of papers or interpretive literary compositions not previously published.%A%    
% 219.26/219.42  |- skos__broader mesh__D020474smesh__D052180
% 219.26/219.42  |- mesh__recordAuthorizer mesh__D020474 ags
% 219.26/219.42  |- skos__annotation mesh__D020474
% 219.26/219.42       CATALOG: use for original publications only. Use COLLECTED WORKS %5B%PUBLICATION TYPE%5D% for collections of previously published papers%A%  
% 219.26/219.42  |- mesh__dateRevised mesh__D020474 2005-07-12
% 219.26/219.42  |- skos__related mesh__D020474smesh__D020470
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D020474 2006
% 219.26/219.42  |- skos__altLabel mesh__D020474 Essays %28%PT%29%
% 219.26/219.42  |- rdf__type mesh__D020474sskos__Concept
% 219.26/219.42  |- mesh__recordOriginator mesh__D020474 JLS
% 219.26/219.42  |- mesh__dateCreated mesh__D020474 1998-06-03
% 219.26/219.42  |- mesh__recordMaintainer mesh__D020474 ags
% 219.26/219.42  |- mesh__dateEstablished mesh__D020474 1999-01-01
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D020474 2006A
% 219.26/219.42  |- skos__scopeNote mesh__D014437
% 219.26/219.42       An infectious disease clinically similar to epidemic louse-borne typhus %28%TYPHUS, EPIDEMIC LOUSE-BORNE%29%, but caused by RICKETTSIA TYPHI, which is transmitted from rat to man by the rat flea, Xenopsylla cheopis.%A%    
% 219.26/219.42  |- mesh__recordMaintainer mesh__D014437 ags
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D014437 2005
% 219.26/219.42  |- skos__hiddenLabel mesh__D014437 Endemic Flea-Borne Typhus
% 219.26/219.42  |- rdf__type mesh__D014437sskos__Concept
% 219.26/219.42  |- skos__prefLabel mesh__D014437 Typhus, Endemic Flea-Borne
% 219.26/219.42  |- skos__broader mesh__D014437smesh__D012282
% 219.26/219.42  |- mesh__dateCreated mesh__D014437 1999-01-01
% 219.26/219.42  |- skos__annotation mesh__D014437 caused by Rickettsia typhi   
% 219.26/219.42  |- mesh__historyNote mesh__D014437 77; was TYPHUS, MURINE 1963-76   
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D014437 2004
% 219.26/219.42  |- skos__hiddenLabel mesh__D014437 Murine Typhus
% 219.26/219.42  |- mesh__recordOriginator mesh__D014437 NLM
% 219.26/219.42  |- mesh__recordAuthorizer mesh__D014437 sjn
% 219.26/219.42  |- skos__hiddenLabel mesh__D014437 Typhus, Endemic Flea Borne
% 219.26/219.42  |- mesh__publicMeSHNote mesh__D014437 77; was TYPHUS, MURINE 1963-76   
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D014437 2006
% 219.26/219.42  |- mesh__dateRevised mesh__D014437 2003-07-09
% 219.26/219.42  |- mesh__onlineNote mesh__D014437
% 219.26/219.42       use TYPHUS, ENDEMIC FLEA-BORNE to search TYPHUS, MURINE 1966-76%A%  
% 219.26/219.42  |- skos__hiddenLabel mesh__D014437 Flea-Borne Typhus, Endemic
% 219.26/219.42  |- skos__altLabel mesh__D014437 Typhus, Murine
% 219.26/219.42  |- mesh__recordOriginator mesh__D019920 NDW
% 219.26/219.42  |- mesh__dateRevised mesh__D019920 2003-07-09
% 219.26/219.42  |- mesh__recordAuthorizer mesh__D019920 sjn
% 219.26/219.42  |- rdf__type mesh__D019920sskos__Concept
% 219.26/219.42  |- skos__scopeNote mesh__D019920
% 219.26/219.42       Biologically active molecules which are covalently bound to the enzymes or binding proteins normally acting on them. Binding occurs due to activation of the label by ultraviolet light. These labels are used primarily to identify binding sites on proteins.%A%    
% 219.26/219.42  |- skos__hiddenLabel mesh__D019920 Labels, Photoaffinity
% 219.26/219.42  |- skos__broader mesh__D019920smesh__D000345
% 219.26/219.42  |- skos__historyNote mesh__D019920 Affinity Labels %28%1975-1997%29%
% 219.26/219.42  |- mesh__historyNote mesh__D019920 98   
% 219.26/219.42  |- skos__prefLabel mesh__D019920 Photoaffinity Labels
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019920 2004
% 219.26/219.42  |- mesh__dateCreated mesh__D019920 1997-06-20
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019920 2006
% 219.26/219.42  |- mesh__recordMaintainer mesh__D019920 ssb
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019920 2005
% 219.26/219.42  |- mesh__publicMeSHNote mesh__D019920 98   
% 219.26/219.42  |- mesh__dateEstablished mesh__D019920 1998-01-01
% 219.26/219.42  |- skos__broader mesh__D000417smesh__D015785
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D000417 2002
% 219.26/219.42  |- rdf__type mesh__D000417sskos__Concept
% 219.26/219.42  |- mesh__recordAuthorizer mesh__D000417 sjn
% 219.26/219.42  |- skos__annotation mesh__D000417
% 219.26/219.42       hypopigmentation of skin, hair, eye; GEN or unspecified; prefer specifics; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 219.26/219.42  |- skos__scopeNote mesh__D000417
% 219.26/219.42       General term for a number of inherited defects of amino acid metabolism in which there is a deficiency or absence of pigment in the eyes, skin, or hair.%A%    
% 219.26/219.42  |- mesh__dateCreated mesh__D000417 1999-01-01
% 219.26/219.42  |- mesh__recordMaintainer mesh__D000417 nns
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D000417 2006
% 219.26/219.42  |- skos__broader mesh__D000417smesh__D012873
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D000417 2004
% 219.26/219.42  |- skos__broader mesh__D000417smesh__D017496
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D000417 2005
% 219.26/219.42  |- skos__broader mesh__D000417smesh__D000592
% 219.26/219.42  |- skos__prefLabel mesh__D000417 Albinism
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D000417 2003
% 219.26/219.42  |- mesh__dateRevised mesh__D000417 2001-07-25
% 219.26/219.42  |- skos__related mesh__D000417smesh__D002609
% 219.26/219.42  |- mesh__recordOriginator mesh__D000417 NLM
% 219.26/219.42  |- skos__broader mesh__D019122smesh__D026443
% 219.26/219.42  |- mesh__dateEstablished mesh__D019122 1996-01-01
% 219.26/219.42  |- mesh__historyNote mesh__D019122 96   
% 219.26/219.42  |- mesh__recordAuthorizer mesh__D019122 sjn
% 219.26/219.42  |- skos__broader mesh__D019122smesh__D012064
% 219.26/219.42  |- skos__scopeNote mesh__D019122
% 219.26/219.42       A state of consciousness in which the individual eliminates environmental stimuli from awareness so that the mind can focus on a single thing, producing a state of relaxation and relief from stress. A wide variety of techniques are used to clear the mind of stressful outside interferences. It includes meditation therapy. %28%Mosby%27%s Medical, Nursing, and Allied Health Dictionary, 4th ed%29%%A%    
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019122 2003
% 219.26/219.42  |- skos__related mesh__D019122smesh__D015013
% 219.26/219.42  |- mesh__publicMeSHNote mesh__D019122 96   
% 219.26/219.42  |- skos__broader mesh__D019122smesh__D026441
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019122 2004
% 219.26/219.42  |- skos__prefLabel mesh__D019122 Meditation
% 219.26/219.42  |- mesh__recordMaintainer mesh__D019122 ssb
% 219.26/219.42  |- skos__annotation mesh__D019122 a relaxation technique   
% 219.26/219.42  |- skos__historyNote mesh__D019122 Relaxation %28%1966-1976%29%
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019122 2002
% 219.26/219.42  |- mesh__recordOriginator mesh__D019122 TGC
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019122 2005
% 219.26/219.42  |- mesh__dateRevised mesh__D019122 2001-07-25
% 219.26/219.42  |- skos__historyNote mesh__D019122 Thinking %28%1970-1974%29%
% 219.26/219.42  |- mesh__dateCreated mesh__D019122 1995-06-08
% 219.26/219.42  |- skos__historyNote mesh__D019122 Relaxation Techniques %28%1975-1995%29%
% 219.26/219.42  |- skos__historyNote mesh__D019122 Yoga %28%1966-1975%29%
% 219.26/219.42  |- skos__hiddenLabel mesh__D019122 Meditation, Transcendental
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019122 2006
% 219.26/219.42  |- rdf__type mesh__D019122sskos__Concept
% 219.26/219.42  |- skos__altLabel mesh__D005900 Kirondrin
% 219.26/219.42  |- skos__broader mesh__D005900smesh__D036702
% 219.26/219.42  |- mesh__dateEstablished mesh__D005900 1991-01-01
% 219.26/219.42  |- mesh__recordMaintainer mesh__D005900 ssb
% 219.26/219.42  |- mesh__dateCreated mesh__D005900 1999-01-01
% 219.26/219.42  |- mesh__dateRevised mesh__D005900 2005-06-30
% 219.26/219.42  |- skos__broader mesh__D005900smesh__D011714
% 219.26/219.42  |- skos__scopeNote mesh__D005900
% 219.26/219.42       %28%1 beta,2 alpha,11 beta,12 alpha,15 beta%28%S%29%%29%-11,20-Epoxy-1,2,11,12-tetrahydroxy-15-%28%2-hydroxy-2-methyl-1-oxobutoxy%29%picras-3-en-16-one. A quassinoid %28%Simaroubolide%29% from Simaruba glauca, a tropical shrub. It has been used as an antiamebic agent and is found to be cytotoxic. It may be of use in cancer chemotherapy.%A%    
% 219.26/219.42  |- mesh__publicMeSHNote mesh__D005900
% 219.26/219.42       91; was see under PHENANTHRENES 1981-90; was see under PYRANS 1975-80%A%  
% 219.26/219.42  |- mesh__historyNote mesh__D005900
% 219.26/219.42       91%28%66%29%; was see under PHENANTHRENES 1981-90; was see under PYRANS 1975-80%A%  
% 219.26/219.42  |- mesh__recordAuthorizer mesh__D005900 sjn
% 219.26/219.42  |- skos__prefLabel mesh__D005900 Glaucarubin
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D005900 2006
% 219.26/219.42  |- mesh__recordOriginator mesh__D005900 NLM
% 219.26/219.42  |- rdf__type mesh__D005900sskos__Concept
% 219.26/219.42  |- skos__hiddenLabel mesh__D005102 Expenditure
% 219.26/219.42  |- skos__hiddenLabel mesh__D005102 Health Expenditure
% 219.26/219.42  |- mesh__dateRevised mesh__D005102 1999-11-03
% 219.26/219.42  |- mesh__dateCreated mesh__D005102 1999-01-01
% 219.26/219.42  |- skos__prefLabel mesh__D005102 Health Expenditures
% 219.26/219.42  |- skos__hiddenLabel mesh__D005102 Indirect Expenditure
% 219.26/219.42  |- skos__annotation mesh__D005102
% 219.26/219.42       amount spent for health care: do not confuse with HEALTH CARE COSTS %28%actual costs of providing care%29% or with FEES AND CHARGES %28%amount charged regardless of cost%29%%A%  
% 219.26/219.42  |- skos__hiddenLabel mesh__D005102 Indirect Expenditures
% 219.26/219.42  |- skos__hiddenLabel mesh__D005102 Expenditure, Direct
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D005102 2005
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D005102 2004
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D005102 2002
% 219.26/219.42  |- skos__hiddenLabel mesh__D005102 Direct Expenditures
% 219.26/219.42  |- mesh__recordMaintainer mesh__D005102 kle
% 219.26/219.42  |- mesh__recordAuthorizer mesh__D005102 sjn
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D005102 2003
% 219.26/219.42  |- skos__broader mesh__D005102smesh__D003365
% 219.26/219.42  |- skos__related mesh__D005102smesh__D017048
% 219.26/219.42  |- mesh__recordOriginator mesh__D005102 NLM
% 219.26/219.42  |- skos__broader mesh__D005102smesh__D003695
% 219.26/219.42  |- mesh__dateEstablished mesh__D005102 1968-01-01
% 219.26/219.42  |- rdf__type mesh__D005102sskos__Concept
% 219.26/219.42  |- mesh__publicMeSHNote mesh__D005102
% 219.26/219.42       92; was EXPENDITURES, HEALTH 1968-91   
% 219.26/219.42  |- skos__scopeNote mesh__D005102
% 219.26/219.42       The amounts spent by individuals, groups, nations, or private or public organizations for total health care and/or its various components. These amounts may or may not be equivalent to the actual costs %28%HEALTH CARE COSTS%29% and may or may not be shared among the patient, insurers, and/or employers.%A%    
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D005102 2001
% 219.26/219.42  |- skos__altLabel mesh__D005102 Expenditures, Health
% 219.26/219.42  |- mesh__historyNote mesh__D005102 92; was EXPENDITURES, HEALTH 1968-91   
% 219.26/219.42  |- skos__historyNote mesh__D005102 Economics, Medical %28%1966-1967%29%
% 219.26/219.42  |- skos__historyNote mesh__D005102 Economics %28%1966-1967%29%
% 219.26/219.42  |- skos__hiddenLabel mesh__D005102 Direct Expenditure
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D005102 2000
% 219.26/219.42  |- mesh__onlineNote mesh__D005102
% 219.26/219.42       use HEALTH EXPENDITURES to search EXPENDITURES, HEALTH 1968-91%A%  
% 219.26/219.42  |- skos__hiddenLabel mesh__D005102 Expenditure, Indirect
% 219.26/219.42  |- skos__hiddenLabel mesh__D005102 Expenditure, Health
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D005102 2006
% 219.26/219.42  |- mesh__historyNote mesh__D018828
% 219.26/219.42       95; was THYROID-STIMULATING IMMUNOGLOBULIN %28%NM%29% 1977-94   
% 219.26/219.42  |- skos__hiddenLabel mesh__D018828 Immunoglobulin, Thyroid Stimulating
% 219.26/219.42  |- skos__scopeNote mesh__D018828
% 219.26/219.42       Autoantibodies that bind to the thyroid-stimulating hormone %28%TSH%29% receptor %28%RECEPTORS, THYROTROPIN%29% on thyroid epithelial cells. The autoantibodies mimic TSH causing an unregulated production of thyroid hormones characteristic of GRAVES DISEASE.%A%    
% 219.26/219.42  |- rdf__type mesh__D018828sskos__Concept
% 219.26/219.42  |- mesh__recordOriginator mesh__D018828 AGS
% 219.26/219.42  |- skos__altLabel mesh__D018828 Thyroid-Stimulating Immunoglobulin
% 219.26/219.42  |- skos__annotation mesh__D018828 DF: IG THYROID STIMULATING   
% 219.26/219.42  |- skos__altLabel mesh__D018828 Antibodies, Thyroid-Stimulating
% 219.26/219.42  |- mesh__dateCreated mesh__D018828 1994-05-31
% 219.26/219.42  |- skos__hiddenLabel mesh__D018828 Thyroid Stimulating Antibodies
% 219.26/219.42  |- mesh__onlineNote mesh__D018828
% 219.26/219.42       use IMMUNOGLOBULINS, THYROID-STIMULATING %28%NM%29% to search THYROID-STIMULATING IMMUNOGLOBULIN 1977-94%A%  
% 219.26/219.42  |- mesh__dateEstablished mesh__D018828 1995-01-01
% 219.26/219.42  |- skos__hiddenLabel mesh__D018828 Thyroid Stimulating Immunoglobulins
% 219.26/219.42  |- skos__related mesh__D018828smesh__D006111
% 219.26/219.42  |- skos__altLabel mesh__D018828 Thyroid Stimulating Antibody
% 219.26/219.42  |- skos__altLabel mesh__D018828 Thyroid-Stimulating Immunoglobulins
% 219.26/219.42  |- skos__altLabel mesh__D018828 Thyroid-Stimulating Antibodies
% 219.26/219.42  |- skos__hiddenLabel mesh__D018828 Antibody, Thyroid Stimulating
% 219.26/219.42  |- mesh__recordAuthorizer mesh__D018828 sjn
% 219.26/219.42  |- skos__hiddenLabel mesh__D018828 Stimulating Antibody, Thyroid
% 219.26/219.42  |- skos__prefLabel mesh__D018828 Immunoglobulins, Thyroid-Stimulating
% 219.26/219.42  |- mesh__dateRevised mesh__D018828 2005-07-01
% 219.26/219.42  |- skos__hiddenLabel mesh__D018828 Thyroid Stimulating Immunoglobulin
% 219.26/219.42  |- mesh__publicMeSHNote mesh__D018828
% 219.26/219.42       95; THYROID-STIMULATING IMMUNOGLOBULIN was indexed under AUTOANTIBODIES 1977-94 %26% IGG 1977-90%A%  
% 219.26/219.42  |- skos__related mesh__D018828smesh__D011989
% 219.26/219.42  |- skos__historyNote mesh__D018828 Autoantibodies %28%1969-1994%29%
% 219.26/219.42  |- mesh__recordMaintainer mesh__D018828 sjn
% 219.26/219.42  |- skos__broader mesh__D018828smesh__D001323
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D018828 2006
% 219.26/219.42  |- skos__altLabel mesh__D018828 Immunoglobulin, Thyroid-Stimulating
% 219.26/219.42  |- skos__broader mesh__D018828smesh__D000906
% 219.26/219.42  |- skos__hiddenLabel mesh__D010845 Syndrome, Obesity Hypoventilation
% 219.26/219.42  |- skos__hiddenLabel mesh__D010845 Syndrome, Pickwickian
% 219.26/219.42  |- mesh__recordAuthorizer mesh__D010845 sjn
% 219.26/219.42  |- rdf__type mesh__D010845sskos__Concept
% 219.26/219.42  |- skos__broader mesh__D010845smesh__D009765
% 219.26/219.42  |- mesh__publicMeSHNote mesh__D010845
% 219.26/219.42       2006 %28%1970%29%; see PICKWICK SYNDROME 1964-1969   
% 219.26/219.42  |- skos__altLabel mesh__D010845 Pickwickian Syndrome
% 219.26/219.42  |- mesh__recordMaintainer mesh__D010845 lkt
% 219.26/219.42  |- skos__prefLabel mesh__D010845 Obesity Hypoventilation Syndrome
% 219.26/219.42  |- skos__broader mesh__D010845smesh__D020181
% 219.26/219.42  |- skos__scopeNote mesh__D010845
% 219.26/219.42       HYPOVENTILATION syndrome in very obese persons with excessive ADIPOSE TISSUE around the ABDOMEN and DIAPHRAGM. It is characterized by diminished to absent ventilatory chemoresponsiveness; chronic HYPOXIA; HYPERCAPNIA; POLYCYTHEMIA; and long periods of sleep during day and night %28%HYPERSOMNOLENCE%29%. It is a condition often related to OBSTRUCTIVE SLEEP APNEA but can occur separately.%A%    
% 219.26/219.42  |- skos__broader mesh__D010845smesh__D007040
% 219.26/219.42  |- mesh__dateEstablished mesh__D010845 1970-01-01
% 219.26/219.42  |- mesh__dateRevised mesh__D010845 2005-06-30
% 219.26/219.42  |- mesh__historyNote mesh__D010845
% 219.26/219.42       2006 %28%1970%29%; use PICKWICK SYNDROME 1964-1969   
% 219.26/219.42  |- mesh__dateCreated mesh__D010845 1999-01-01
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D010845 2006
% 219.26/219.42  |- skos__hiddenLabel mesh__D010845 Hypoventilation Syndrome, Obesity
% 219.26/219.42  |- mesh__recordOriginator mesh__D010845 NLM
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D010047 2002
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D010047 2006
% 219.26/219.42  |- skos__broader mesh__D010047smesh__D000418
% 219.26/219.42  |- skos__broader mesh__D010047smesh__D015843
% 219.26/219.42  |- rdf__type mesh__D010047sskos__Concept
% 219.26/219.42  |- mesh__recordAuthorizer mesh__D010047 sjn
% 219.26/219.42  |- skos__broader mesh__D010047smesh__D015387
% 219.26/219.42  |- skos__broader mesh__D010047smesh__D004527
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D010047 2003
% 219.26/219.42  |- mesh__dateCreated mesh__D010047 1999-01-01
% 219.26/219.42  |- skos__scopeNote mesh__D010047
% 219.26/219.42       An albumin obtained from the white of eggs. It is a member of the serpin superfamily.%A%    
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D010047 2000
% 219.26/219.42  |- mesh__recordMaintainer mesh__D010047 jmp
% 219.26/219.42  |- mesh__recordOriginator mesh__D010047 NLM
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D010047 2004
% 219.26/219.42  |- skos__prefLabel mesh__D010047 Ovalbumin
% 219.26/219.42  |- mesh__dateRevised mesh__D010047 1999-11-03
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D010047 2001
% 219.26/219.42  |- skos__annotation mesh__D010047
% 219.26/219.42       a serpin; /drug eff /ultrastruct permitted; differentiate OVALBUMIN %28%the chemical albumin in egg white%29% from EGG WHITE %28%the food%29%%A%  
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D010047 2005
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D015530 2006
% 219.26/219.42  |- skos__scopeNote mesh__D015530
% 219.26/219.42       The residual framework structure of the CELL NUCLEUS that maintains many of the overall architectural features of the cell nucleus including the nuclear lamina with NUCLEAR PORE complex structures, residual CELL NUCLEOLI and an extensive fibrogranular structure in the nuclear interior. %28%Advan. Enzyme Regul. 2002; 42:39-52%29%%A%    
% 219.26/219.42  |- skos__hiddenLabel mesh__D015530 Nuclear Scaffolds
% 219.26/219.42  |- mesh__recordMaintainer mesh__D015530 ags
% 219.26/219.42  |- mesh__dateCreated mesh__D015530 1989-04-07
% 219.26/219.42  |- skos__hiddenLabel mesh__D015530 Scaffold, Nuclear
% 219.26/219.42  |- skos__hiddenLabel mesh__D015530 Matrices, Nuclear
% 219.26/219.42  |- mesh__dateEstablished mesh__D015530 1990-01-01
% 219.26/219.42  |- skos__broader mesh__D015530smesh__D042581
% 219.26/219.42  |- mesh__publicMeSHNote mesh__D015530 90   
% 219.26/219.42  |- mesh__historyNote mesh__D015530 90   
% 219.26/219.42  |- skos__hiddenLabel mesh__D015530 Scaffolds, Nuclear
% 219.26/219.42  |- mesh__dateRevised mesh__D015530 2005-07-21
% 219.26/219.42  |- skos__historyNote mesh__D015530 Cell Nucleus %28%1972-1989%29%
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D015530 2005A
% 219.26/219.42  |- skos__altLabel mesh__D015530 Nuclear Scaffold
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D015530 2006A
% 219.26/219.42  |- mesh__recordAuthorizer mesh__D015530 ags
% 219.26/219.42  |- skos__prefLabel mesh__D015530 Nuclear Matrix
% 219.26/219.42  |- rdf__type mesh__D015530sskos__Concept
% 219.26/219.42  |- skos__hiddenLabel mesh__D015530 Matrix, Nuclear
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D015530 2005
% 219.26/219.42  |- skos__hiddenLabel mesh__D015530 Nuclear Matrices
% 219.26/219.42  |- mesh__recordOriginator mesh__D015530 PXP
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D015530 2004
% 219.26/219.42  |- skos__broader mesh__D001510smesh__D013812
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D001510 2001
% 219.26/219.42  |- mesh__publicMeSHNote mesh__D001510 77   
% 219.26/219.42  |- skos__annotation mesh__D001510
% 219.26/219.42       do not confuse with IMMOBILIZATION: TN 166   
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D001510 1997
% 219.26/219.42  |- skos__hiddenLabel mesh__D001510 Bed Rests
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D001510 2000
% 219.26/219.42  |- skos__altLabel mesh__D001510 Bedrest
% 219.26/219.42  |- skos__hiddenLabel mesh__D001510 Rest, Bed
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D001510 2006
% 219.26/219.42  |- skos__scopeNote mesh__D001510
% 219.26/219.42       Confinement of an individual to bed for therapeutic or experimental reasons.%A%    
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D001510 1996
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D001510 1995
% 219.26/219.42  |- mesh__recordOriginator mesh__D001510 SMH
% 219.26/219.42  |- skos__hiddenLabel mesh__D001510 Rests, Bed
% 219.26/219.42  |- mesh__dateRevised mesh__D001510 1992-03-25
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D001510 2005
% 219.26/219.42  |- mesh__historyNote mesh__D001510 77   
% 219.26/219.42  |- mesh__recordAuthorizer mesh__D001510 PLS
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D001510 1994
% 219.26/219.42  |- rdf__type mesh__D001510sskos__Concept
% 219.26/219.42  |- mesh__dateCreated mesh__D001510 1976-05-19
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D001510 2004
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D001510 1999
% 219.26/219.42  |- skos__historyNote mesh__D001510 Rest %28%1966-1976%29%
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D001510 2002
% 219.26/219.42  |- mesh__recordMaintainer mesh__D001510 TAP
% 219.26/219.42  |- skos__hiddenLabel mesh__D001510 Bedrests
% 219.26/219.42  |- skos__prefLabel mesh__D001510 Bed Rest
% 219.26/219.42  |- mesh__dateEstablished mesh__D001510 1977-01-01
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D001510 1993
% 219.26/219.42  |- skos__historyNote mesh__D001510 Immobilization %28%1966-1976%29%
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D001510 2003
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D001510 1998
% 219.26/219.42  |- mesh__recordOriginator mesh__D020475 JLS
% 219.26/219.42  |- mesh__recordAuthorizer mesh__D020475 sjn
% 219.26/219.42  |- skos__altLabel mesh__D020475 Examination Questions %28%PT%29%
% 219.26/219.42  |- mesh__dateRevised mesh__D020475 2005-06-30
% 219.26/219.42  |- skos__broader mesh__D020475smesh__D019514
% 219.26/219.42  |- skos__scopeNote mesh__D020475
% 219.26/219.42       Works consisting of compilations of questions and answers pertaining to a particular subject, used for study and review.%A%    
% 219.26/219.42  |- mesh__recordMaintainer mesh__D020475 jls
% 219.26/219.42  |- mesh__historyNote mesh__D020475 1999   
% 219.26/219.42  |- skos__related mesh__D020475smesh__D020497
% 219.26/219.42  |- skos__prefLabel mesh__D020475
% 219.26/219.42       Examination Questions %5B%Publication Type%5D%
% 219.26/219.42  |- rdf__type mesh__D020475sskos__Concept
% 219.26/219.42  |- mesh__dateEstablished mesh__D020475 1999-01-01
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D020475 2006
% 219.26/219.42  |- mesh__dateCreated mesh__D020475 1998-06-03
% 219.26/219.42  |- skos__hiddenLabel mesh__D014438 Disease, Brill
% 219.26/219.42  |- rdf__type mesh__D014438sskos__Concept
% 219.26/219.42  |- skos__hiddenLabel mesh__D014438 Disease, Brill-Zinsser
% 219.26/219.42  |- skos__prefLabel mesh__D014438 Typhus, Epidemic Louse-Borne
% 219.26/219.42  |- skos__hiddenLabel mesh__D014438 Brills Disease
% 219.26/219.42  |- skos__hiddenLabel mesh__D014438 Brill Zinsser Disease
% 219.26/219.42  |- skos__broader mesh__D014438smesh__D012282
% 219.26/219.42  |- mesh__onlineNote mesh__D014438
% 219.26/219.42       use TYPHUS, EPIDEMIC LOUSE-BORNE to search BRILL-ZINSSER DISEASE 1992-96, BRILL%27%S DISEASE 1966-96, %26% TYPHUS 1966-76%A%  
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D014438 2004
% 219.26/219.42  |- skos__altLabel mesh__D014438 Brill Disease
% 219.26/219.42  |- skos__hiddenLabel mesh__D014438 Disease, Brill%27%s
% 219.26/219.42  |- skos__annotation mesh__D014438 caused by Rickettsia prowazekii   
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D014438 2005
% 219.26/219.42  |- skos__scopeNote mesh__D014438
% 219.26/219.42       The classic form of typhus, caused by RICKETTSIA PROWAZEKII, which is transmitted from man to man by the louse Pediculus humanus corporis. This disease is characterized by the sudden onset of intense headache, malaise, and generalized myalgia followed by the formation of a macular skin eruption and vascular and neurologic disturbances.%A%    
% 219.26/219.42  |- skos__hiddenLabel mesh__D014438 Louse-Borne Typhus, Epidemic
% 219.26/219.42  |- skos__altLabel mesh__D014438 Brill%27%s Disease
% 219.26/219.42  |- mesh__recordMaintainer mesh__D014438 ags
% 219.26/219.42  |- skos__hiddenLabel mesh__D014438 Epidemic Louse-Borne Typhus
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D014438 2006
% 219.26/219.42  |- skos__hiddenLabel mesh__D014438 Typhus, Epidemic Louse Borne
% 219.26/219.42  |- mesh__dateCreated mesh__D014438 1999-01-01
% 219.26/219.42  |- mesh__dateRevised mesh__D014438 2003-07-09
% 219.26/219.42  |- mesh__recordOriginator mesh__D014438 NLM
% 219.26/219.42  |- mesh__publicMeSHNote mesh__D014438
% 219.26/219.42       77; was TYPHUS 1963-76; BRILL%27%S DISEASE was heading 1975-96 %28%see under TYPHUS, EPIDEMIC LOUSE-BORNE 1977-90, see under TYPHUS 1975-76%29%, was see under TYPHUS 1963-74; BRILL-ZINSSER DISEASE was see BRILL%27%S DISEASE 1992-96%A%  
% 219.26/219.42  |- mesh__historyNote mesh__D014438
% 219.26/219.42       77; was TYPHUS 1963-76; BRILL%27%S DISEASE was heading 1975-96 %28%see under TYPHUS, EPIDEMIC LOUSE-BORNE 1977-90, see under TYPHUS 1975-76%29%, was see under TYPHUS 1963-74; BRILL-ZINSSER DISEASE was see BRILL%27%S DISEASE 1992-96%A%  
% 219.26/219.42  |- mesh__recordAuthorizer mesh__D014438 sjn
% 219.26/219.42  |- mesh__publicMeSHNote mesh__D019921 98   
% 219.26/219.42  |- mesh__dateEstablished mesh__D019921 1998-01-01
% 219.26/219.42  |- skos__hiddenLabel mesh__D019921 Biotinylations
% 219.26/219.42  |- mesh__recordMaintainer mesh__D019921 adp
% 219.26/219.42  |- mesh__historyNote mesh__D019921 98   
% 219.26/219.42  |- mesh__recordAuthorizer mesh__D019921 sjn
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019921 2004
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019921 2002
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019921 2006
% 219.26/219.42  |- skos__broader mesh__D019921smesh__D008660
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019921 2003
% 219.26/219.42  |- skos__scopeNote mesh__D019921
% 219.26/219.42       Incorporation of biotinyl groups into molecules.     
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019921 2001
% 219.26/219.42  |- mesh__dateRevised mesh__D019921 2000-06-22
% 219.26/219.42  |- skos__prefLabel mesh__D019921 Biotinylation
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019921 2005
% 219.26/219.42  |- mesh__recordOriginator mesh__D019921 ADP
% 219.26/219.42  |- mesh__dateCreated mesh__D019921 1997-06-20
% 219.26/219.42  |- skos__broader mesh__D019921smesh__D015336
% 219.26/219.42  |- rdf__type mesh__D019921sskos__Concept
% 219.26/219.42  |- mesh__historyNote mesh__D019123 96   
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019123 2005A
% 219.26/219.42  |- skos__annotation mesh__D019123
% 219.26/219.42       coord IM with specific food or type of food %28%IM%29%   
% 219.26/219.42  |- mesh__recordAuthorizer mesh__D019123 jls
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019123 2003
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019123 1999
% 219.26/219.42  |- mesh__dateRevised mesh__D019123 2004-07-27
% 219.26/219.42  |- skos__related mesh__D019123smesh__D015623
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019123 2004
% 219.26/219.42  |- mesh__dateEstablished mesh__D019123 1996-01-01
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019123 2000
% 219.26/219.42  |- skos__altLabel mesh__D019123 Food, Health
% 219.26/219.42  |- skos__hiddenLabel mesh__D019123 Health Foods
% 219.26/219.42  |- skos__broader mesh__D019123smesh__D019648
% 219.26/219.42  |- skos__hiddenLabel mesh__D019123 Organic Foods
% 219.26/219.42  |- skos__hiddenLabel mesh__D019123 Foods, Organic
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019123 2005
% 219.26/219.42  |- skos__altLabel mesh__D019123 Food, Organic
% 219.26/219.42  |- mesh__publicMeSHNote mesh__D019123 96   
% 219.26/219.42  |- mesh__dateCreated mesh__D019123 1995-06-08
% 219.26/219.42  |- skos__scopeNote mesh__D019123
% 219.26/219.42       A non-medical term defined by the lay public as a food that has little or no preservatives, which has not undergone major processing, enrichment or refinement and which may be grown without pesticides. Health foods have been attributed with the ability to prevent the development of diseases, slow the aging process, and prolong life. %28%from Segen, The Dictionary of Modern Medicine, 1992%29%%A%    
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019123 2001
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019123 2006
% 219.26/219.42  |- rdf__type mesh__D019123sskos__Concept
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019123 2002
% 219.26/219.42  |- mesh__recordMaintainer mesh__D019123 jls
% 219.26/219.42  |- skos__prefLabel mesh__D019123 Health Food
% 219.26/219.42  |- mesh__recordOriginator mesh__D019123 TGC
% 219.26/219.42  |- skos__hiddenLabel mesh__D019123 Foods, Health
% 219.26/219.42  |- mesh__activeMeSHYear mesh__D019123 1998
% 219.26/219.42  |- mesh__recordOriginator mesh__D000418 NLM
% 219.26/219.43  |- mesh__dateCreated mesh__D000418 1999-01-01
% 219.26/219.43  |- mesh__recordMaintainer mesh__D000418 SYSTEM
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D000418 2006
% 219.26/219.43  |- mesh__recordAuthorizer mesh__D000418 sjn
% 219.26/219.43  |- skos__scopeNote mesh__D000418
% 219.26/219.43       Water-soluble proteins found in egg whites, blood, lymph, and other tissues and fluids. They coagulate upon heating.%A%    
% 219.26/219.43  |- skos__related mesh__D000418smesh__D017457
% 219.26/219.43  |- skos__prefLabel mesh__D000418 Albumins
% 219.26/219.43  |- skos__related mesh__D000418smesh__D011228
% 219.26/219.43  |- mesh__dateRevised mesh__D000418 2005-06-30
% 219.26/219.43  |- rdf__type mesh__D000418sskos__Concept
% 219.26/219.43  |- skos__broader mesh__D000418smesh__D011506
% 219.26/219.43  |- skos__annotation mesh__D011140 URETHANE is available   
% 219.26/219.43  |- skos__altLabel mesh__D011140 Pellethane
% 219.26/219.43  |- mesh__recordOriginator mesh__D011140 NLM
% 219.26/219.43  |- skos__broader mesh__D011140smesh__D010969
% 219.26/219.43  |- mesh__dateEstablished mesh__D011140 1968-01-01
% 219.26/219.43  |- rdf__type mesh__D011140sskos__Concept
% 219.26/219.43  |- skos__scopeNote mesh__D011140
% 219.26/219.43       A group of thermoplastic or thermosetting polymers containing polyisocyanate. They are used as ELASTOMERS, as coatings, as fibers and as foams.%A%    
% 219.26/219.43  |- skos__hiddenLabel mesh__D011140 Ostamers
% 219.26/219.43  |- skos__broader mesh__D011140smesh__D020724
% 219.26/219.43  |- mesh__dateRevised mesh__D011140 2004-07-07
% 219.26/219.43  |- skos__hiddenLabel mesh__D011140 Spandices
% 219.26/219.43  |- skos__hiddenLabel mesh__D011140 Polyurethane
% 219.26/219.43  |- skos__altLabel mesh__D011140 Ostamer
% 219.26/219.43  |- skos__hiddenLabel mesh__D011140 Polyisocyanate
% 219.26/219.43  |- mesh__historyNote mesh__D011140
% 219.26/219.43       1968; for SPANDEX use POLYURETHANES %28%NM%29% 1975-1999   
% 219.26/219.43  |- skos__altLabel mesh__D011140 Polyisocyanates
% 219.26/219.43  |- mesh__publicMeSHNote mesh__D011140
% 219.26/219.43       1968; SPANDEX was indexed under POLYURETHANES 1975-1999   
% 219.26/219.43  |- mesh__recordAuthorizer mesh__D011140 sjn
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D011140 2005
% 219.26/219.43  |- skos__prefLabel mesh__D011140 Polyurethanes
% 219.26/219.43  |- mesh__dateCreated mesh__D011140 1999-01-01
% 219.26/219.43  |- skos__hiddenLabel mesh__D011140 Pellethanes
% 219.26/219.43  |- skos__historyNote mesh__D011140 Urethane %28%1966-1967%29%
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D011140 2006
% 219.26/219.43  |- skos__broader mesh__D011140smesh__D014520
% 219.26/219.43  |- mesh__recordMaintainer mesh__D011140 jmp
% 219.26/219.43  |- mesh__recordOriginator mesh__D005901 NLM
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D005901 2003
% 219.26/219.43  |- skos__hiddenLabel mesh__D005901 Glaucomas
% 219.26/219.43  |- skos__related mesh__D005901smesh__D014130
% 219.26/219.43  |- mesh__dateRevised mesh__D005901 1994-04-16
% 219.26/219.43  |- mesh__recordAuthorizer mesh__D005901 PLS
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D005901 1995
% 219.26/219.43  |- skos__related mesh__D005901smesh__D018463
% 219.26/219.43  |- skos__annotation mesh__D005901
% 219.26/219.43       pathol increase in intraocular pressure: differentiate from OCULAR HYPERTENSION %28%%22%intraocular pressure above normal %26% which may lead to glaucoma%22%%29%; /surg: consider also FILTERING SURGERY or SCLEROSTOMY or TRABECULECTOMY%A%  
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D005901 1999
% 219.26/219.43  |- skos__scopeNote mesh__D005901
% 219.26/219.43       An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. %28%Dictionary of Visual Science, 4th ed%29%%A%    
% 219.26/219.43  |- skos__related mesh__D005901smesh__D012599
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D005901 2006
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D005901 1998
% 219.26/219.43  |- skos__prefLabel mesh__D005901 Glaucoma
% 219.26/219.43  |- skos__broader mesh__D005901smesh__D009798
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D005901 2002
% 219.26/219.43  |- rdf__type mesh__D005901sskos__Concept
% 219.26/219.43  |- mesh__recordMaintainer mesh__D005901 TGC
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D005901 2005
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D005901 1997
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D005901 2001
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D005901 2004
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D005901 1996
% 219.26/219.43  |- mesh__dateCreated mesh__D005901 1999-01-01
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D005901 2000
% 219.26/219.43  |- mesh__dateCreated mesh__D005103 1986-06-18
% 219.26/219.43  |- mesh__recordOriginator mesh__D005103 EC
% 219.26/219.43  |- mesh__dateEstablished mesh__D005103 1987-01-01
% 219.26/219.43  |- skos__prefLabel mesh__D005103 Expert Systems
% 219.26/219.43  |- skos__hiddenLabel mesh__D005103 Expert System
% 219.26/219.43  |- mesh__recordMaintainer mesh__D005103 jls
% 219.26/219.43  |- mesh__historyNote mesh__D005103 87   
% 219.26/219.43  |- mesh__publicMeSHNote mesh__D005103 87   
% 219.26/219.43  |- rdf__type mesh__D005103sskos__Concept
% 219.26/219.43  |- skos__hiddenLabel mesh__D005103 System, Expert
% 219.26/219.43  |- skos__scopeNote mesh__D005103
% 219.26/219.43       Computer programs based on knowledge developed from consultation with experts on a problem, and the processing and/or formalizing of this knowledge using these programs in such a manner that the problems may be solved.%A%    
% 219.26/219.43  |- mesh__recordAuthorizer mesh__D005103 sjn
% 219.26/219.43  |- skos__annotation mesh__D005103
% 219.26/219.43       IM; restrict to field of computer programs %26% artificial intelligence%A%  
% 219.26/219.43  |- mesh__dateRevised mesh__D005103 2004-07-07
% 219.26/219.43  |- skos__broader mesh__D005103smesh__D001185
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D005103 2005
% 219.26/219.43  |- skos__hiddenLabel mesh__D005103 Systems, Expert
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D005103 2006
% 219.26/219.43  |- skos__broader mesh__D018829smesh__D001425
% 219.26/219.43  |- mesh__publicMeSHNote mesh__D018829 95   
% 219.26/219.43  |- skos__historyNote mesh__D018829 specific Adhesins %28%1975-1994%29%
% 219.26/219.43  |- skos__altLabel mesh__D018829 Adhesin, Bacterial
% 219.26/219.43  |- skos__prefLabel mesh__D018829 Adhesins, Bacterial
% 219.26/219.43  |- mesh__recordOriginator mesh__D018829 AGS
% 219.26/219.43  |- mesh__dateCreated mesh__D018829 1994-05-31
% 219.26/219.43  |- skos__altLabel mesh__D018829 Bacterial Adhesin
% 219.26/219.43  |- mesh__recordMaintainer mesh__D018829 ssb
% 219.26/219.43  |- mesh__dateEstablished mesh__D018829 1995-01-01
% 219.26/219.43  |- skos__scopeNote mesh__D018829
% 219.26/219.43       Cell-surface components or appendages of bacteria that facilitate adhesion %28%BACTERIAL ADHESION%29% to other cells or to inanimate surfaces. Most fimbriae %28%FIMBRIAE, BACTERIAL%29% of gram-negative bacteria function as adhesins, but in many cases it is a minor subunit protein at the tip of the fimbriae that is the actual adhesin. In gram-positive bacteria, a protein or polysaccharide surface layer serves as the specific adhesin.%A%    
% 219.26/219.43  |- mesh__dateRevised mesh__D018829 2005-06-30
% 219.26/219.43  |- skos__annotation mesh__D018829
% 219.26/219.43       bact antigens; coord IM with specific bacterium %28%IM%29% but note that ADHESINS, ESCHERICHIA COLI is available; do not confuse with BACTERIAL ADHESION; DF: ADHESINS BACT%A%  
% 219.26/219.43  |- skos__altLabel mesh__D018829 Bacterial Adhesins
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D018829 2006
% 219.26/219.43  |- skos__related mesh__D018829smesh__D001422
% 219.26/219.43  |- mesh__recordAuthorizer mesh__D018829 sjn
% 219.26/219.43  |- skos__altLabel mesh__D018829 Adhesins, Fimbrial
% 219.26/219.43  |- skos__broader mesh__D018829smesh__D000942
% 219.26/219.43  |- rdf__type mesh__D018829sskos__Concept
% 219.26/219.43  |- mesh__historyNote mesh__D018829 95   
% 219.26/219.43  |- skos__scopeNote mesh__D010846
% 219.26/219.43       A picolinic acid derivative that is used as a herbicide.%A%    
% 219.26/219.43  |- mesh__historyNote mesh__D010846
% 219.26/219.43       91%28%71%29%; was see under PICOLINIC ACIDS 1971-90   
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D010846 2001
% 219.26/219.43  |- skos__broader mesh__D010846smesh__D010848
% 219.26/219.43  |- mesh__recordOriginator mesh__D010846 NLM
% 219.26/219.43  |- rdf__type mesh__D010846sskos__Concept
% 219.26/219.43  |- mesh__dateCreated mesh__D010846 1999-01-01
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D010846 2003
% 219.26/219.43  |- mesh__recordMaintainer mesh__D010846 TWD
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D010846 2002
% 219.26/219.43  |- mesh__dateRevised mesh__D010846 2000-06-22
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D010846 2004
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D010846 2005
% 219.26/219.43  |- mesh__publicMeSHNote mesh__D010846
% 219.26/219.43       91; was see under PICOLINIC ACIDS 1971-90   
% 219.26/219.43  |- mesh__dateEstablished mesh__D010846 1991-01-01
% 219.26/219.43  |- mesh__recordAuthorizer mesh__D010846 sjn
% 219.26/219.43  |- skos__altLabel mesh__D010846 Chloramp
% 219.26/219.43  |- skos__historyNote mesh__D010846 Picolinic Acids %28%1968-1970%29%
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D010846 2006
% 219.26/219.43  |- skos__prefLabel mesh__D010846 Picloram
% 219.26/219.43  |- mesh__dateEstablished mesh__D043222 2004-01-01
% 219.26/219.43  |- mesh__recordAuthorizer mesh__D043222 jls
% 219.26/219.43  |- skos__hiddenLabel mesh__D043222 Ubiquitin Carboxy Terminal Hydrolase
% 219.26/219.43  |- skos__hiddenLabel mesh__D043222 Ubiquitin Carboxy Terminal Esterase
% 219.26/219.43  |- skos__hiddenLabel mesh__D043222 Esterase, Ubiquitin C-Terminal
% 219.26/219.43  |- skos__hiddenLabel mesh__D043222 C-Terminal Hydrolase, Ubiquitin
% 219.26/219.43  |- mesh__dateCreated mesh__D043222 2003-07-09
% 219.26/219.43  |- skos__hiddenLabel mesh__D043222 Ubiquitin C Terminal Esterase
% 219.26/219.43  |- skos__scopeNote mesh__D043222
% 219.26/219.43       A thioester hydrolase which acts on esters formed between thiols such as DITHIOTHREITOL or GLUTATHIONE and the C-terminal glycine residue of UBIQUITIN.%A%    
% 219.26/219.43  |- skos__altLabel mesh__D043222 Ubiquitin C-Terminal Hydrolase
% 219.26/219.43  |- skos__hiddenLabel mesh__D043222 Carboxy-Terminal Hydrolase, Ubiquitin
% 219.26/219.43  |- mesh__recordOriginator mesh__D043222 AKE
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D043222 2005
% 219.26/219.43  |- mesh__historyNote mesh__D043222
% 219.26/219.43       2004; use UBIQUITIN THIOLESTERASE %28%NM%29% 1983-2003   
% 219.26/219.43  |- skos__altLabel mesh__D043222 Ubiquitin C-Terminal Esterase
% 219.26/219.43  |- skos__hiddenLabel mesh__D043222 Carboxy-Terminal Esterase, Ubiquitin
% 219.26/219.43  |- skos__hiddenLabel mesh__D043222 Thiolesterase, Ubiquitin
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D043222 2006
% 219.26/219.43  |- skos__hiddenLabel mesh__D043222 Esterase, Ubiquitin Carboxy-Terminal
% 219.26/219.43  |- skos__hiddenLabel mesh__D043222 Hydrolase, Ubiquitin C-Terminal
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D043222 2005A
% 219.26/219.43  |- mesh__dateRevised mesh__D043222 2004-08-03
% 219.26/219.43  |- skos__broader mesh__D043222smesh__D013869
% 219.26/219.43  |- rdf__type mesh__D043222sskos__Concept
% 219.26/219.43  |- skos__hiddenLabel mesh__D043222 Hydrolase, Ubiquitin Carboxy-Terminal
% 219.26/219.43  |- mesh__publicMeSHNote mesh__D043222
% 219.26/219.43       2004; UBIQUITIN THIOLESTERASE was indexed under THIOLESTER HYDROLASES 1983-2003%A%  
% 219.26/219.43  |- mesh__recordMaintainer mesh__D043222 jls
% 219.26/219.43  |- skos__hiddenLabel mesh__D043222 Ubiquitin C Terminal Hydrolase
% 219.26/219.43  |- skos__altLabel mesh__D043222 Ubiquitin Carboxy-Terminal Esterase
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D043222 2004
% 219.26/219.43  |- skos__historyNote mesh__D043222 Thiolester Hydrolases %28%1983-2003%29%
% 219.26/219.43  |- skos__prefLabel mesh__D043222 Ubiquitin Thiolesterase
% 219.26/219.43  |- skos__altLabel mesh__D043222 Ubiquitin Carboxy-Terminal Hydrolase
% 219.26/219.43  |- skos__hiddenLabel mesh__D043222 C-Terminal Esterase, Ubiquitin
% 219.26/219.43  |- mesh__recordOriginator mesh__D010048 NLM
% 219.26/219.43  |- mesh__dateCreated mesh__D010048 1999-01-01
% 219.26/219.43  |- skos__prefLabel mesh__D010048 Ovarian Cysts
% 219.26/219.43  |- skos__hiddenLabel mesh__D010048 Cyst, Corpus Luteum
% 219.26/219.43  |- skos__historyNote mesh__D010048 Ovarian Diseases %28%1966-1967%29%
% 219.26/219.43  |- mesh__dateRevised mesh__D010048 2005-06-30
% 219.26/219.43  |- skos__related mesh__D010048smesh__D016471
% 219.26/219.43  |- mesh__recordMaintainer mesh__D010048 lkt
% 219.26/219.43  |- skos__broader mesh__D010048smesh__D010049
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D010048 2006
% 219.26/219.43  |- skos__hiddenLabel mesh__D010048 Cysts, Corpus Luteum
% 219.26/219.43  |- mesh__recordAuthorizer mesh__D010048 sjn
% 219.26/219.43  |- mesh__dateEstablished mesh__D010048 1968-01-01
% 219.26/219.43  |- skos__historyNote mesh__D010048 Cysts %28%1966-1967%29%
% 219.26/219.43  |- skos__annotation mesh__D010048
% 219.26/219.43       non-neoplastic; POLYCYSTIC OVARY SYNDROME is also available%A%  
% 219.26/219.43  |- skos__hiddenLabel mesh__D010048 Cysts, Ovarian
% 219.26/219.43  |- rdf__type mesh__D010048sskos__Concept
% 219.26/219.43  |- skos__hiddenLabel mesh__D010048 Ovarian Cyst
% 219.26/219.43  |- skos__scopeNote mesh__D010048
% 219.26/219.43       General term for CYSTS and cystic diseases of the OVARY.%A%    
% 219.26/219.43  |- skos__hiddenLabel mesh__D010048 Corpus Luteum Cysts
% 219.26/219.43  |- mesh__onlineNote mesh__D010048
% 219.26/219.43       use OVARIAN CYSTS to search CORPUS LUTEUM CYST  1966-84   
% 219.26/219.43  |- mesh__publicMeSHNote mesh__D010048
% 219.26/219.43       68; CORPUS LUTEUM CYST was heading 1963-84   
% 219.26/219.43  |- mesh__historyNote mesh__D010048
% 219.26/219.43       68; CORPUS LUTEUM CYST was heading 1963-84   
% 219.26/219.43  |- skos__hiddenLabel mesh__D010048 Cyst, Ovarian
% 219.26/219.43  |- skos__broader mesh__D010048smesh__D003560
% 219.26/219.43  |- skos__hiddenLabel mesh__D004809 SalPhedrine
% 219.26/219.43  |- mesh__recordAuthorizer mesh__D004809 sjn
% 219.26/219.43  |- skos__hiddenLabel mesh__D004809 Hydrochloride, Pseudoephedrine
% 219.26/219.43  |- skos__hiddenLabel mesh__D004809 Renaudin, Ephedrine
% 219.26/219.43  |- mesh__recordMaintainer mesh__D004809 jls
% 219.26/219.43  |- skos__altLabel mesh__D004809 Renaudin Brand of Ephedrine Hydrochloride
% 219.26/219.43  |- skos__broader mesh__D004809smesh__D011412
% 219.26/219.43  |- rdf__type mesh__D004809sskos__Concept
% 219.26/219.43  |- mesh__dateCreated mesh__D004809 1999-01-01
% 219.26/219.43  |- skos__prefLabel mesh__D004809 Ephedrine
% 219.26/219.43  |- skos__scopeNote mesh__D004809
% 219.26/219.43       An alpha- and beta-adrenergic agonist that may also enhance release of norepinephrine. It has been used in the treatment of several disorders including asthma, heart failure, rhinitis, and urinary incontinence, and for its central nervous system stimulatory effects in the treatment of narcolepsy and depression. It has become less extensively used with the advent of more selective agonists.%A%    
% 219.26/219.43  |- skos__hiddenLabel mesh__D004809 Sulfate, Ephedrine
% 219.26/219.43  |- skos__altLabel mesh__D004809 Pseudoephedrine HCl
% 219.26/219.43  |- skos__hiddenLabel mesh__D004809 Hydrochloride, Ephedrine
% 219.26/219.43  |- mesh__dateRevised mesh__D004809 2005-06-30
% 219.26/219.43  |- mesh__recordOriginator mesh__D004809 NLM
% 219.26/219.43  |- skos__hiddenLabel mesh__D004809 Sal Phedrine
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D004809 2006
% 219.26/219.43  |- skos__altLabel mesh__D004809 Wendt Brand of Ephedrine Sulfate
% 219.26/219.43  |- skos__altLabel mesh__D015531 Farr Assay
% 219.26/219.43  |- skos__historyNote mesh__D015531 Precipitin Tests %28%1972-1989%29%
% 219.26/219.43  |- mesh__dateRevised mesh__D015531 2004-07-07
% 219.26/219.43  |- skos__scopeNote mesh__D015531
% 219.26/219.43       Sensitive assay using radiolabeled ANTIGENS to detect specific ANTIBODIES in SERUM. The antigens are allowed to react with the serum and then precipitated using a special reagent such as PROTEIN A sepharose beads. The bound radiolabeled immunoprecipitate is then commonly analyzed by gel electrophoresis. Radioimmunoprecipitation assay %28%RIPA%29% is often used as a confirmatory test for diagnosing the presence of HIV ANTIBODIES.%A%    
% 219.26/219.43  |- skos__hiddenLabel mesh__D015531 Radioimmunoprecipitation Analyses
% 219.26/219.43  |- mesh__dateEstablished mesh__D015531 1990-01-01
% 219.26/219.43  |- skos__broader mesh__D015531smesh__D011863
% 219.26/219.43  |- mesh__publicMeSHNote mesh__D015531 90   
% 219.26/219.43  |- skos__prefLabel mesh__D015531 Radioimmunoprecipitation Assay
% 219.26/219.43  |- skos__hiddenLabel mesh__D015531 Analysis, Radioimmunoprecipitation
% 219.26/219.43  |- mesh__dateCreated mesh__D015531 1989-04-07
% 219.26/219.43  |- skos__altLabel mesh__D015531 Radioimmunoprecipitation Analysis
% 219.26/219.43  |- skos__historyNote mesh__D015531 Precipitation %28%1966-1982%29%
% 219.26/219.43  |- rdf__type mesh__D015531sskos__Concept
% 219.26/219.43  |- skos__hiddenLabel mesh__D015531 Assay, Radioimmunoprecipitation
% 219.26/219.43  |- skos__hiddenLabel mesh__D015531 Assay, Farr
% 219.26/219.43  |- skos__broader mesh__D015531smesh__D012698
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D015531 2005
% 219.26/219.43  |- skos__broader mesh__D015531smesh__D047468
% 219.26/219.43  |- skos__historyNote mesh__D015531 Radioimmunoassay %28%1966-1989%29%
% 219.26/219.43  |- skos__hiddenLabel mesh__D015531 Assays, Radioimmunoprecipitation
% 219.26/219.43  |- mesh__recordAuthorizer mesh__D015531 sjn
% 219.26/219.43  |- mesh__historyNote mesh__D015531 90   
% 219.26/219.43  |- skos__broader mesh__D015531smesh__D007163
% 219.26/219.43  |- skos__hiddenLabel mesh__D015531 Radioimmunoprecipitation Assays
% 219.26/219.43  |- mesh__recordOriginator mesh__D015531 AGS
% 219.26/219.43  |- mesh__recordMaintainer mesh__D015531 nns
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D015531 2006
% 219.26/219.43  |- skos__historyNote mesh__D015531
% 219.26/219.43       Immunosorbent Techniques %28%1972-1977%29%
% 219.26/219.43  |- skos__hiddenLabel mesh__D015531 Analyses, Radioimmunoprecipitation
% 219.26/219.43  |- skos__scopeNote mesh__D001511
% 219.26/219.43       Bugs of the family CIMICIDAE, genus Cimex. They are flattened, oval, reddish insects which inhabit houses, wallpaper, furniture, and beds. C. lectularius, of temperate regions, is the common bedbug that attacks humans and is frequently a serious pest in houses, hotels, barracks, and other living quarters. Experiments have shown that bedbugs can transmit a variety of diseases, but they are not normal vectors under natural conditions. %28%From Dorland, 27th ed; Borror, et al., An Introduction to the Study of Insects, 4th ed, p272%29%%A%    
% 219.26/219.43  |- mesh__recordAuthorizer mesh__D001511 sjn
% 219.26/219.43  |- skos__altLabel mesh__D001511 Bed Bugs
% 219.26/219.43  |- skos__broader mesh__D001511smesh__D020063
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D001511 2006
% 219.26/219.43  |- skos__prefLabel mesh__D001511 Bedbugs
% 219.26/219.43  |- mesh__recordOriginator mesh__D001511 NLM
% 219.26/219.43  |- skos__annotation mesh__D001511
% 219.26/219.43       do not use /drug eff for insecticides: TN 111   
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D001511 2005
% 219.26/219.43  |- rdf__type mesh__D001511sskos__Concept
% 219.26/219.43  |- mesh__dateCreated mesh__D001511 1999-01-01
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D001511 2004
% 219.26/219.43  |- skos__altLabel mesh__D001511 Cimex
% 219.26/219.43  |- mesh__dateRevised mesh__D001511 2003-07-09
% 219.26/219.43  |- mesh__recordMaintainer mesh__D001511 ags
% 219.26/219.43  |- mesh__historyNote mesh__D020476 1999   
% 219.26/219.43  |- skos__broader mesh__D020476smesh__D052180
% 219.26/219.43  |- mesh__recordAuthorizer mesh__D020476 sjn
% 219.26/219.43  |- mesh__dateRevised mesh__D020476 2005-06-30
% 219.26/219.43  |- mesh__recordMaintainer mesh__D020476 jls
% 219.26/219.43  |- rdf__type mesh__D020476sskos__Concept
% 219.26/219.43  |- skos__scopeNote mesh__D020476
% 219.26/219.43       Works consisting of descriptions or catalogs of public displays or items representative of a given subject.%A%    
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D020476 2006
% 219.26/219.43  |- mesh__dateCreated mesh__D020476 1998-06-03
% 219.26/219.43  |- skos__prefLabel mesh__D020476 Exhibitions %5B%Publication Type%5D%
% 219.26/219.43  |- mesh__recordOriginator mesh__D020476 JLS
% 219.26/219.43  |- skos__annotation mesh__D020476
% 219.26/219.43       Use for works describing an exhibition. Use the main heading EXHIBITS with  the Publication Type CATALOGS for exhibition catalogs%A%  
% 219.26/219.43  |- skos__altLabel mesh__D020476 Exhibitions %28%PT%29%
% 219.26/219.43  |- mesh__dateEstablished mesh__D020476 1999-01-01
% 219.26/219.43  |- mesh__recordOriginator mesh__D039181 lkt
% 219.26/219.43  |- skos__hiddenLabel mesh__D039181 16-alpha-Hydroxylase, Steroid
% 219.26/219.43  |- skos__altLabel mesh__D039181 Estrogen 16-alpha Hydroxylase
% 219.26/219.43  |- skos__altLabel mesh__D039181 Progesterone 16 alpha-Hydroxylase
% 219.26/219.43  |- mesh__dateRevised mesh__D039181 2004-07-07
% 219.26/219.43  |- skos__altLabel mesh__D039181 Steroid 16alpha-Hydroxylase
% 219.26/219.43  |- skos__hiddenLabel mesh__D039181 Estradiol 16 alpha Hydroxylase
% 219.26/219.43  |- skos__altLabel mesh__D039181 Estrone 16-alpha Hydroxylase
% 219.26/219.43  |- mesh__publicMeSHNote mesh__D039181
% 219.26/219.43       2003; PROGESTERONE 16 ALPHA-HYDROXYLASE was indexed under STEROID HYDROXYLASES 1977-2002%A%  
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D039181 2006
% 219.26/219.43  |- skos__scopeNote mesh__D039181
% 219.26/219.43       A liver microsomal cytochrome P450 enzyme that catalyzes the 16-alpha-hydroxylation of a broad spectrum of steroids, fatty acids, and xenobiotics in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme is encoded by a number of genes from several CYP2 subfamilies.%A%    
% 219.26/219.43  |- mesh__dateEstablished mesh__D039181 2003-01-01
% 219.26/219.43  |- skos__altLabel mesh__D039181 Progesterone-16-alpha-Hydroxylase
% 219.26/219.43  |- mesh__historyNote mesh__D039181
% 219.26/219.43       2003; use PROGESTERONE 16 ALPHA-HYDROXYLASE %28%NM%29% 1977-2002%A%  
% 219.26/219.43  |- skos__historyNote mesh__D039181 Hydroxylases %28%1966-2002%29%
% 219.26/219.43  |- skos__hiddenLabel mesh__D039181 Progesterone 16 alpha Hydroxylase
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D039181 2005
% 219.26/219.43  |- mesh__recordMaintainer mesh__D039181 ssb
% 219.26/219.43  |- skos__altLabel mesh__D039181 Estrone-3-sulfate 16-alpha Hydroxylase
% 219.26/219.43  |- skos__altLabel mesh__D039181 16alpha-Hydroxylase
% 219.26/219.43  |- skos__altLabel mesh__D039181 16-alpha Hydroxylase
% 219.26/219.43  |- skos__altLabel mesh__D039181 Estradiol 16-alpha Hydroxylase
% 219.26/219.43  |- mesh__recordAuthorizer mesh__D039181 sjn
% 219.26/219.43  |- skos__hiddenLabel mesh__D039181 Estrogen 16 alpha Hydroxylase
% 219.26/219.43  |- skos__broader mesh__D039181smesh__D013250
% 219.26/219.43  |- skos__altLabel mesh__D039181 Testosterone 16-alpha Hydroxylase
% 219.26/219.43  |- skos__hiddenLabel mesh__D039181 16 alpha Hydroxylase
% 219.26/219.43  |- skos__altLabel mesh__D039181 Progesterone 16-alpha-Hydroxylase
% 219.26/219.43  |- skos__hiddenLabel mesh__D039181 Steroid 16alpha Hydroxylase
% 219.26/219.43  |- skos__hiddenLabel mesh__D039181 Steroid 16 alpha Hydroxylase
% 219.26/219.43  |- skos__hiddenLabel mesh__D039181 Testosterone 16 alpha Hydroxylase
% 219.26/219.43  |- skos__hiddenLabel mesh__D039181 Estrone 3 sulfate 16 alpha Hydroxylase
% 219.26/219.43  |- skos__prefLabel mesh__D039181 Steroid 16-alpha-Hydroxylase
% 219.26/219.43  |- skos__hiddenLabel mesh__D039181 Estrone 16 alpha Hydroxylase
% 219.26/219.43  |- skos__altLabel mesh__D039181 Cytochrome P-450%28%16 alpha%29%
% 219.26/219.43  |- mesh__dateCreated mesh__D039181 2002-07-18
% 219.26/219.43  |- skos__altLabel mesh__D039181 Testosterone 16alpha Hydroxylase
% 219.26/219.43  |- rdf__type mesh__D039181sskos__Concept
% 219.26/219.43  |- mesh__recordOriginator mesh__D014439 NLM
% 219.26/219.43  |- mesh__recordAuthorizer mesh__D014439 sjn
% 219.26/219.43  |- skos__altLabel mesh__D014439 4-%28%2-Aminoethyl%29%phenol
% 219.26/219.43  |- mesh__recordMaintainer mesh__D014439 ssb
% 219.26/219.43  |- skos__scopeNote mesh__D014439
% 219.26/219.43       An indirect sympathomimetic. Tyramine does not directly activate adrenergic receptors, but it can serve as a substrate for adrenergic uptake systems and monoamine oxidase so it prolongs the actions of adrenergic transmitters. It also provokes transmitter release from adrenergic terminals. Tyramine may be a neurotransmitter in some invertebrate nervous systems.%A%    
% 219.26/219.43  |- skos__annotation mesh__D014439 a biogenic amine   
% 219.26/219.43  |- skos__prefLabel mesh__D014439 Tyramine
% 219.26/219.43  |- mesh__dateRevised mesh__D014439 2005-06-30
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D014439 2006
% 219.26/219.43  |- mesh__dateCreated mesh__D014439 1999-01-01
% 219.26/219.43  |- skos__altLabel mesh__D014439 p-Tyramine
% 219.26/219.43  |- skos__broader mesh__D014439smesh__D015306
% 219.26/219.43  |- rdf__type mesh__D014439sskos__Concept
% 219.26/219.43  |- mesh__publicMeSHNote mesh__D019922
% 219.26/219.43       98; NERVE GROWTH CONE MEMBRANE PROTEIN GAP-43 %28%now GAP-43 PROTEIN%29% was indexed under NERVE TISSUE PROTEINS 1986-97, MEMBRANE GLYCOPROTEINS 1988-97, CALMODULIN-BINDING PROTEINS 1986-92, %26% MEMBRANE PROTEINS 1986-89.%A%  
% 219.26/219.43  |- skos__historyNote mesh__D019922 Membrane Proteins %28%1986-1989%29%
% 219.26/219.43  |- skos__broader mesh__D019922smesh__D008562
% 219.26/219.43  |- mesh__recordMaintainer mesh__D019922 jmp
% 219.26/219.43  |- mesh__recordOriginator mesh__D019922 KEV
% 219.26/219.43  |- mesh__dateRevised mesh__D019922 2004-07-07
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D019922 2005
% 219.26/219.43  |- skos__altLabel mesh__D019922 Nerve Growth Cone Membrane Protein GAP-43
% 219.26/219.43  |- mesh__dateEstablished mesh__D019922 1998-01-01
% 219.26/219.43  |- skos__historyNote mesh__D019922
% 219.26/219.43       Calmodulin-Binding Proteins %28%1986-1992%29%
% 219.26/219.43  |- skos__altLabel mesh__D019922 Phosphoprotein B-50
% 219.26/219.43  |- skos__altLabel mesh__D019922 Neuromodulin
% 219.26/219.43  |- skos__historyNote mesh__D019922 Nerve Tissue Proteins %28%1986-1997%29%
% 219.26/219.43  |- skos__altLabel mesh__D019922 Growth-Associated Protein 43
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D019922 2006
% 219.26/219.43  |- skos__altLabel mesh__D019922 Phosphoprotein F1
% 219.26/219.43  |- skos__hiddenLabel mesh__D019922 Growth Associated Protein 43
% 219.26/219.43  |- skos__hiddenLabel mesh__D019922 Phosphoprotein B 50
% 219.26/219.43  |- skos__hiddenLabel mesh__D019922 GAP 43 Protein
% 219.26/219.43  |- mesh__recordAuthorizer mesh__D019922 sjn
% 219.26/219.43  |- skos__historyNote mesh__D019922 Membrane Glycoproteins %28%1988-1997%29%
% 219.26/219.43  |- skos__hiddenLabel mesh__D019922
% 219.26/219.43       Nerve Growth Cone Membrane Protein GAP 43
% 219.26/219.43  |- skos__altLabel mesh__D019922 Phosphoprotein pp46
% 219.26/219.43  |- skos__altLabel mesh__D019922 GAP-43
% 219.26/219.43  |- skos__broader mesh__D019922smesh__D009419
% 219.26/219.43  |- mesh__historyNote mesh__D019922
% 219.26/219.43       98; use GAP-43 PROTEIN %28%NM%29% 1986-97   
% 219.26/219.43  |- mesh__dateCreated mesh__D019922 1997-06-20
% 219.26/219.43  |- rdf__type mesh__D019922sskos__Concept
% 219.26/219.43  |- skos__scopeNote mesh__D019922
% 219.26/219.43       A nervous tissue specific protein which is highly expressed in NEURONS during development and NERVE REGENERATION. It has been implicated in neurite outgrowth, long-term potentiation, SIGNAL TRANSDUCTION, and NEUROTRANSMITTER release. %28%From Neurotoxicology 1994;15%28%1%29%:41-7%29% It is also a substrate of PROTEIN KINASE C.%A%    
% 219.26/219.43  |- skos__hiddenLabel mesh__D019922 B 50 Protein
% 219.26/219.43  |- skos__altLabel mesh__D019922 GAP43 Protein
% 219.26/219.43  |- skos__prefLabel mesh__D019922 GAP-43 Protein
% 219.26/219.43  |- skos__altLabel mesh__D019922 B-50 Protein
% 219.26/219.43  |- mesh__publicMeSHNote mesh__D019124 96   
% 219.26/219.43  |- skos__altLabel mesh__D019124 Touch, Therapeutic
% 219.26/219.43  |- skos__annotation mesh__D019124
% 219.26/219.43       coord IM with disease /ther %28%IM%29%; do not confuse with MASSAGE or other MUSCULOSKELETAL MANIPULATIONS%A%  
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D019124 2005
% 219.26/219.43  |- mesh__recordMaintainer mesh__D019124 ssb
% 219.26/219.43  |- skos__historyNote mesh__D019124 Alternative Medicine %28%1985-1995%29%
% 219.26/219.43  |- skos__historyNote mesh__D019124 Touch %28%1975-1995%29%
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D019124 2002
% 219.26/219.43  |- mesh__dateCreated mesh__D019124 1995-06-08
% 219.26/219.43  |- mesh__recordOriginator mesh__D019124 TGC
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D019124 2006
% 219.26/219.43  |- rdf__type mesh__D019124sskos__Concept
% 219.26/219.43  |- skos__scopeNote mesh__D019124
% 219.26/219.43       Placing of the hands of the healer upon the person to be cured with the intent of  spiritual energetic healing.%A%    
% 219.26/219.43  |- mesh__dateRevised mesh__D019124 2001-07-25
% 219.26/219.43  |- skos__broader mesh__D019124smesh__D026443
% 219.26/219.43  |- mesh__dateEstablished mesh__D019124 1996-01-01
% 219.26/219.43  |- skos__historyNote mesh__D019124 Holistic Health %28%1983-1992%29%
% 219.26/219.43  |- mesh__historyNote mesh__D019124 96   
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D019124 2003
% 219.26/219.43  |- mesh__recordAuthorizer mesh__D019124 sjn
% 219.26/219.43  |- skos__broader mesh__D019124smesh__D026441
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D019124 2004
% 219.26/219.43  |- skos__prefLabel mesh__D019124 Therapeutic Touch
% 219.26/219.43  |- skos__scopeNote mesh__D000419
% 219.26/219.43       The presence of albumin in the urine, an indicator of KIDNEY DISEASES.%A%    
% 219.26/219.43  |- skos__hiddenLabel mesh__D000419 Albuminurias
% 219.26/219.43  |- skos__prefLabel mesh__D000419 Albuminuria
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D000419 2003
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D000419 2006
% 219.26/219.43  |- mesh__dateRevised mesh__D000419 2002-07-02
% 219.26/219.43  |- mesh__recordMaintainer mesh__D000419 lkt
% 219.26/219.43  |- skos__broader mesh__D000419smesh__D011507
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D000419 2004
% 219.26/219.43  |- mesh__recordOriginator mesh__D000419 NLM
% 219.26/219.43  |- mesh__recordAuthorizer mesh__D000419 sjn
% 219.26/219.43  |- mesh__dateCreated mesh__D000419 1999-01-01
% 219.26/219.43  |- rdf__type mesh__D000419sskos__Concept
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D000419 2005
% 219.26/219.43  |- skos__broader mesh__D011141smesh__D014555
% 219.26/219.43  |- skos__broader mesh__D011141smesh__D020924
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D011141 2002
% 219.26/219.43  |- mesh__recordOriginator mesh__D011141 NLM
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D011141 2003
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D011141 2005
% 219.26/219.43  |- mesh__dateCreated mesh__D011141 1999-01-01
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D011141 2004
% 219.26/219.43  |- mesh__dateRevised mesh__D011141 1999-11-03
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D011141 2006
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D011141 2000
% 219.26/219.43  |- skos__hiddenLabel mesh__D011141 Polyurias
% 219.26/219.43  |- mesh__activeMeSHYear mesh__D011141 2001
% 219.26/219.43  |- skos__scopeNote mesh__D011141
% 219.26/219.43       Urination of a large volume of urine with an increase in urinary frequency, commonly seen in diabetes.%A%    
% 219.26/219.43  |- skos__prefLabel mesh__D011141 Polyuria
% 219.26/219.43  |- mesh__recordAuthorizer mesh__D011141 sjn
% 219.26/219.43  |- mesh__recordMaintainer mesh__D011141 KEV
% 219.26/219.43  |- rdf__type mesh__D011141sskos__Concept
% 219.26/219.43  |- skos__hiddenLabel mesh__D005902 Pigmentary Glaucoma
% 219.26/219.43  |- skos__hiddenLabel mesh__D005902 Simple Glaucomas
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005902 2002
% 219.26/219.44  |- mesh__historyNote mesh__D005902 82   
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005902 1999
% 219.26/219.44  |- skos__broader mesh__D005902smesh__D005901
% 219.26/219.44  |- skos__hiddenLabel mesh__D005902 Open Angle Glaucoma
% 219.26/219.44  |- skos__altLabel mesh__D005902 Glaucoma, Simple
% 219.26/219.44  |- skos__hiddenLabel mesh__D005902 Compensative Glaucoma
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005902 2003
% 219.26/219.44  |- skos__altLabel mesh__D005902 Open-Angle Glaucoma
% 219.26/219.44  |- mesh__recordOriginator mesh__D005902 RC
% 219.26/219.44  |- mesh__dateCreated mesh__D005902 1981-02-24
% 219.26/219.44  |- skos__hiddenLabel mesh__D005902 Compensated Glaucomas
% 219.26/219.44  |- skos__hiddenLabel mesh__D005902 Compensated Glaucoma
% 219.26/219.44  |- skos__hiddenLabel mesh__D005902 Glaucomas, Compensative
% 219.26/219.44  |- mesh__dateEstablished mesh__D005902 1982-01-01
% 219.26/219.44  |- mesh__recordAuthorizer mesh__D005902 SJN
% 219.26/219.44  |- skos__hiddenLabel mesh__D005902 Glaucomas, Open-Angle
% 219.26/219.44  |- skos__hiddenLabel mesh__D005902 Open-Angle Glaucomas
% 219.26/219.44  |- skos__altLabel mesh__D005902 Glaucoma, Compensated
% 219.26/219.44  |- skos__hiddenLabel mesh__D005902 Glaucomas, Simple
% 219.26/219.44  |- skos__annotation mesh__D005902
% 219.26/219.44       do not confuse with GLAUCOMA, CLOSED-ANGLE see GLAUCOMA, ANGLE-CLOSURE%A%  
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005902 2004
% 219.26/219.44  |- skos__hiddenLabel mesh__D005902 Pigmentary Glaucomas
% 219.26/219.44  |- mesh__recordMaintainer mesh__D005902 MSR
% 219.26/219.44  |- skos__prefLabel mesh__D005902 Glaucoma, Open-Angle
% 219.26/219.44  |- rdf__type mesh__D005902sskos__Concept
% 219.26/219.44  |- skos__hiddenLabel mesh__D005902 Simplex, Glaucoma
% 219.26/219.44  |- skos__hiddenLabel mesh__D005902 Glaucomas, Pigmentary
% 219.26/219.44  |- skos__hiddenLabel mesh__D005902 Glaucomas, Compensated
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005902 2000
% 219.26/219.44  |- skos__altLabel mesh__D005902 Glaucoma, Open Angle
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005902 2005
% 219.26/219.44  |- skos__hiddenLabel mesh__D005902 Compensative Glaucomas
% 219.26/219.44  |- mesh__dateRevised mesh__D005902 1998-06-10
% 219.26/219.44  |- skos__hiddenLabel mesh__D005902 Glaucomas, Open Angle
% 219.26/219.44  |- skos__hiddenLabel mesh__D005902 Simple Glaucoma
% 219.26/219.44  |- skos__historyNote mesh__D005902 Glaucoma %28%1966-1981%29%
% 219.26/219.44  |- skos__hiddenLabel mesh__D005902 Open Angle Glaucomas
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005902 2001
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005902 2006
% 219.26/219.44  |- skos__scopeNote mesh__D005902
% 219.26/219.44       Glaucoma in which the angle of the anterior chamber is open and the trabecular meshwork does not encroach on the base of the iris.%A%    
% 219.26/219.44  |- skos__altLabel mesh__D005902 Glaucoma, Compensative
% 219.26/219.44  |- mesh__publicMeSHNote mesh__D005902 82   
% 219.26/219.44  |- skos__altLabel mesh__D005902 Glaucoma, Pigmentary
% 219.26/219.44  |- skos__hiddenLabel mesh__D005902 Simplices, Glaucoma
% 219.26/219.44  |- skos__altLabel mesh__D005902 Glaucoma Simplex
% 219.26/219.44  |- mesh__publicMeSHNote mesh__D005104 66   
% 219.26/219.44  |- mesh__recordOriginator mesh__D005104 NLM
% 219.26/219.44  |- skos__hiddenLabel mesh__D005104 Expert Witnesses
% 219.26/219.44  |- skos__hiddenLabel mesh__D005104 Expert Testimonies
% 219.26/219.44  |- skos__hiddenLabel mesh__D005104 Witness, Expert
% 219.26/219.44  |- skos__hiddenLabel mesh__D005104 Witnesses, Expert
% 219.26/219.44  |- mesh__historyNote mesh__D005104 66   
% 219.26/219.44  |- mesh__dateEstablished mesh__D005104 1966-01-01
% 219.26/219.44  |- skos__hiddenLabel mesh__D005104 Opinion, Expert
% 219.26/219.44  |- rdf__type mesh__D005104sskos__Concept
% 219.26/219.44  |- mesh__dateRevised mesh__D005104 2005-06-30
% 219.26/219.44  |- mesh__dateCreated mesh__D005104 1999-01-01
% 219.26/219.44  |- skos__hiddenLabel mesh__D005104 Expert Opinions
% 219.26/219.44  |- skos__hiddenLabel mesh__D005104 Testimony, Expert
% 219.26/219.44  |- skos__prefLabel mesh__D005104 Expert Testimony
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005104 2006
% 219.26/219.44  |- mesh__recordMaintainer mesh__D005104 jls
% 219.26/219.44  |- mesh__recordAuthorizer mesh__D005104 sjn
% 219.26/219.44  |- skos__broader mesh__D005104smesh__D007603
% 219.26/219.44  |- skos__scopeNote mesh__D005104
% 219.26/219.44       Presentation of pertinent data by one with special skill or knowledge representing mastery of a particular subject.%A%    
% 219.26/219.44  |- mesh__publicMeSHNote mesh__D010847 79; was PICOLINE 1963-78   
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010847 1996
% 219.26/219.44  |- rdf__type mesh__D010847sskos__Concept
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010847 2000
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010847 1998
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010847 2003
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010847 2001
% 219.26/219.44  |- mesh__dateCreated mesh__D010847 1999-01-01
% 219.26/219.44  |- mesh__dateRevised mesh__D010847 1995-05-18
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010847 2005
% 219.26/219.44  |- skos__prefLabel mesh__D010847 Picolines
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010847 1997
% 219.26/219.44  |- mesh__recordAuthorizer mesh__D010847 PLS
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010847 1999
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010847 2004
% 219.26/219.44  |- mesh__recordOriginator mesh__D010847 NLM
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010847 2006
% 219.26/219.44  |- skos__broader mesh__D010847smesh__D011725
% 219.26/219.44  |- mesh__recordMaintainer mesh__D010847 KEV
% 219.26/219.44  |- mesh__onlineNote mesh__D010847
% 219.26/219.44       use PICOLINES to search PICOLINE 1966-78   
% 219.26/219.44  |- skos__scopeNote mesh__D010847
% 219.26/219.44       A group of compounds that are monomethyl derivatives of pyridines. %28%From Dorland, 28th ed%29%%A%    
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010847 2002
% 219.26/219.44  |- mesh__historyNote mesh__D010847 79; was PICOLINE 1963-78   
% 219.26/219.44  |- mesh__historyNote mesh__D043223
% 219.26/219.44       2004; use DEOXYRIBONUCLEASE IV %28%PHAGE T4-INDUCED%29% %28%NM%29% 1987-2002%A%  
% 219.26/219.44  |- mesh__publicMeSHNote mesh__D043223
% 219.26/219.44       2004; DEOXYRIBONUCLEASE IV %28%PHAGE T4-INDUCED%29% was indexed under ENDODEOXYRIBONUCLEASES 1987-2003%A%  
% 219.26/219.44  |- mesh__dateEstablished mesh__D043223 2004-01-01
% 219.26/219.44  |- mesh__dateCreated mesh__D043223 2003-07-09
% 219.26/219.44  |- mesh__recordOriginator mesh__D043223 AKE
% 219.26/219.44  |- skos__altLabel mesh__D043223 Endonuclease IV
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D043223 2005
% 219.26/219.44  |- mesh__recordAuthorizer mesh__D043223 sjn
% 219.26/219.44  |- skos__scopeNote mesh__D043223
% 219.26/219.44       An enzyme which catalyzes the endonucleolytic cleavage of  phosphodiester bonds at purinic or apyrimidinic sites %28%AP-sites%29% to produce 5%27%-Phosphooligonucleotide end products. The enzyme prefers single-stranded DNA %28%ssDNA%29% and was formerly classified as EC 3.1.4.30.%A%    
% 219.26/219.44  |- skos__prefLabel mesh__D043223
% 219.26/219.44       Deoxyribonuclease IV %28%Phage T4-Induced%29%
% 219.26/219.44  |- skos__historyNote mesh__D043223 Endodeoxyribonucleases %28%1987-2003%29%
% 219.26/219.44  |- skos__altLabel mesh__D043223 Redoxyendonuclease
% 219.26/219.44  |- rdf__type mesh__D043223sskos__Concept
% 219.26/219.44  |- skos__altLabel mesh__D043223 Deoxyriboendonuclease IV
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D043223 2006
% 219.26/219.44  |- mesh__recordMaintainer mesh__D043223 jls
% 219.26/219.44  |- skos__broader mesh__D043223smesh__D004706
% 219.26/219.44  |- mesh__dateRevised mesh__D043223 2004-07-19
% 219.26/219.44  |- skos__annotation mesh__D010049 inflammatory disease  = OOPHORITIS   
% 219.26/219.44  |- mesh__recordOriginator mesh__D010049 NLM
% 219.26/219.44  |- skos__prefLabel mesh__D010049 Ovarian Diseases
% 219.26/219.44  |- skos__hiddenLabel mesh__D010049 Disease, Ovarian
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010049 2006
% 219.26/219.44  |- mesh__dateRevised mesh__D010049 2005-06-30
% 219.26/219.44  |- mesh__dateEstablished mesh__D010049 1966-01-01
% 219.26/219.44  |- mesh__publicMeSHNote mesh__D010049 66   
% 219.26/219.44  |- skos__hiddenLabel mesh__D010049 Diseases, Ovarian
% 219.26/219.44  |- mesh__recordMaintainer mesh__D010049 lkt
% 219.26/219.44  |- rdf__type mesh__D010049sskos__Concept
% 219.26/219.44  |- skos__broader mesh__D010049smesh__D006058
% 219.26/219.44  |- skos__scopeNote mesh__D010049 Pathological processes of the OVARY.     
% 219.26/219.44  |- mesh__dateCreated mesh__D010049 1999-01-01
% 219.26/219.44  |- skos__hiddenLabel mesh__D010049 Ovarian Disease
% 219.26/219.44  |- mesh__historyNote mesh__D010049 66   
% 219.26/219.44  |- mesh__recordAuthorizer mesh__D010049 sjn
% 219.26/219.44  |- skos__broader mesh__D010049smesh__D000291
% 219.26/219.44  |- skos__altLabel mesh__D015532 Solutions, Rehydration
% 219.26/219.44  |- skos__annotation mesh__D015532
% 219.26/219.44       IM; coord with specific substance in the solution %28%IM%29%; D25-26 qualif%A%  
% 219.26/219.44  |- mesh__publicMeSHNote mesh__D015532 90   
% 219.26/219.44  |- mesh__recordAuthorizer mesh__D015532 sjn
% 219.26/219.44  |- skos__broader mesh__D015532smesh__D012996
% 219.26/219.44  |- rdf__type mesh__D015532sskos__Concept
% 219.26/219.44  |- mesh__recordOriginator mesh__D015532 AGS
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D015532 2005
% 219.26/219.44  |- mesh__dateRevised mesh__D015532 2003-07-09
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D015532 2004
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D015532 2006
% 219.26/219.44  |- mesh__dateCreated mesh__D015532 1989-04-07
% 219.26/219.44  |- skos__scopeNote mesh__D015532
% 219.26/219.44       Fluids restored to the body in order to maintain normal water-electrolyte balance.%A%    
% 219.26/219.44  |- skos__historyNote mesh__D015532 Solutions %28%1972-1978%29%
% 219.26/219.44  |- mesh__recordMaintainer mesh__D015532 ssb
% 219.26/219.44  |- skos__historyNote mesh__D015532 Fluid Therapy %28%1979-1989%29%
% 219.26/219.44  |- skos__prefLabel mesh__D015532 Rehydration Solutions
% 219.26/219.44  |- mesh__historyNote mesh__D015532 90   
% 219.26/219.44  |- mesh__dateEstablished mesh__D015532 1990-01-01
% 219.26/219.44  |- mesh__recordOriginator mesh__D001512 NLM
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001512 1997
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001512 2000
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001512 2005
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001512 2001
% 219.26/219.44  |- mesh__recordMaintainer mesh__D001512 AGS
% 219.26/219.44  |- skos__broader mesh__D001512smesh__D006794
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001512 1994
% 219.26/219.44  |- skos__hiddenLabel mesh__D001512 Linen
% 219.26/219.44  |- mesh__dateCreated mesh__D001512 1999-01-01
% 219.26/219.44  |- skos__hiddenLabel mesh__D001512 Beddings
% 219.26/219.44  |- mesh__recordAuthorizer mesh__D001512 PLS
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001512 2006
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001512 1998
% 219.26/219.44  |- mesh__publicMeSHNote mesh__D001512 68   
% 219.26/219.44  |- skos__annotation mesh__D001512
% 219.26/219.44       includes all bedclothes %26% towels, washcloths, gowns, pajamas; DF: BEDDING%A%  
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001512 1995
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001512 2003
% 219.26/219.44  |- skos__hiddenLabel mesh__D001512 Linens and Bedding
% 219.26/219.44  |- rdf__type mesh__D001512sskos__Concept
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001512 1999
% 219.26/219.44  |- skos__prefLabel mesh__D001512 Bedding and Linens
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001512 2002
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001512 2004
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001512 1996
% 219.26/219.44  |- mesh__dateRevised mesh__D001512 1993-06-04
% 219.26/219.44  |- mesh__historyNote mesh__D001512 68%28%63%29%   
% 219.26/219.44  |- skos__broader mesh__D001512smesh__D004865
% 219.26/219.44  |- skos__scopeNote mesh__D001512
% 219.26/219.44       Articles of cloth, usually cotton or rayon and other synthetic or cotton-blend fabrics, used in households, hospitals, physicians%27% examining rooms, nursing homes, etc., for sheets, pillow cases, toweling, gowns, drapes, and the like.%A%    
% 219.26/219.44  |- mesh__dateEstablished mesh__D001512 1968-01-01
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D019923 2003
% 219.26/219.44  |- mesh__historyNote mesh__D019923 98   
% 219.26/219.44  |- skos__scopeNote mesh__D019923
% 219.26/219.44       The making of a continuous circular tear in the anterior capsule during cataract surgery in order to allow expression or phacoemulsification of the nucleus of the lens. %28%Dorland, 28th ed%29%%A%    
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D019923 2000
% 219.26/219.44  |- mesh__dateCreated mesh__D019923 1997-06-20
% 219.26/219.44  |- skos__annotation mesh__D019923
% 219.26/219.44       incision of the lens during cataract surg; do not use /util except by MeSH definition; do not coord with PHACOEMULSIFICATION unless particularly discussed%A%  
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D019923 2005
% 219.26/219.44  |- skos__historyNote mesh__D019923
% 219.26/219.44       Lens, Crystalline/surgery %28%1987-1997%29%
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D019923 2004
% 219.26/219.44  |- skos__broader mesh__D019923smesh__D002387
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D019923 2001
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D019923 2006
% 219.26/219.44  |- skos__historyNote mesh__D019923 Phacoemulsification %28%1996-1997%29%
% 219.26/219.44  |- mesh__dateEstablished mesh__D019923 1998-01-01
% 219.26/219.44  |- skos__altLabel mesh__D019923 Capsulorrhexis
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D019923 1998
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D019923 2002
% 219.26/219.44  |- rdf__type mesh__D019923sskos__Concept
% 219.26/219.44  |- skos__prefLabel mesh__D019923 Capsulorhexis
% 219.26/219.44  |- mesh__publicMeSHNote mesh__D019923 98   
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D019923 1999
% 219.26/219.44  |- skos__historyNote mesh__D019923 Cataract Extraction %28%1987-1997%29%
% 219.26/219.44  |- skos__related mesh__D019923smesh__D007903
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D011940 1999
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D011940 2005
% 219.26/219.44  |- mesh__recordMaintainer mesh__D011940 NDW
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D011940 2003
% 219.26/219.44  |- skos__scopeNote mesh__D011940
% 219.26/219.44       Chemically stimulated aggregation of cell surface receptors, which potentiates the action of the effector cell.%A%    
% 219.26/219.44  |- skos__broader mesh__D011940smesh__D002468
% 219.26/219.44  |- skos__prefLabel mesh__D011940 Receptor Aggregation
% 219.26/219.44  |- skos__altLabel mesh__D011940 Capping, Receptor
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D011940 2006
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D011940 2000
% 219.26/219.44  |- mesh__publicMeSHNote mesh__D011940 84   
% 219.26/219.44  |- skos__altLabel mesh__D011940 Receptor Capping
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D011940 2004
% 219.26/219.44  |- mesh__historyNote mesh__D011940 84   
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D011940 2001
% 219.26/219.44  |- mesh__dateEstablished mesh__D011940 1984-01-01
% 219.26/219.44  |- mesh__dateCreated mesh__D011940 1983-02-24
% 219.26/219.44  |- rdf__type mesh__D011940sskos__Concept
% 219.26/219.44  |- skos__related mesh__D011940smesh__D020239
% 219.26/219.44  |- skos__annotation mesh__D011940 DF: RECEPT AGGREGATION   
% 219.26/219.44  |- mesh__dateRevised mesh__D011940 1998-06-11
% 219.26/219.44  |- mesh__recordOriginator mesh__D011940 AEP
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D011940 2002
% 219.26/219.44  |- skos__historyNote mesh__D011940 specific receptor %28%1968-1983%29%
% 219.26/219.44  |- skos__altLabel mesh__D011940 Aggregation, Receptor
% 219.26/219.44  |- mesh__recordAuthorizer mesh__D011940 SJN
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D011142 2005
% 219.26/219.44  |- skos__historyNote mesh__D011142 Polyvinyls %28%1966-1970%29%
% 219.26/219.44  |- skos__scopeNote mesh__D011142
% 219.26/219.44       A polymer prepared from polyvinyl acetates by replacement of the acetate groups with hydroxyl groups. It is used as a pharmaceutic aid and ophthalmic lubricant as well as in the manufacture of surface coatings artificial sponges, cosmetics, and other products.%A%    
% 219.26/219.44  |- skos__broader mesh__D011142smesh__D011145
% 219.26/219.44  |- rdf__type mesh__D011142sskos__Concept
% 219.26/219.44  |- mesh__recordAuthorizer mesh__D011142 sjn
% 219.26/219.44  |- skos__annotation mesh__D011142 D25-26 qualif   
% 219.26/219.44  |- mesh__dateRevised mesh__D011142 2004-07-07
% 219.26/219.44  |- skos__hiddenLabel mesh__D011142 Alcohol, Polyvinyl
% 219.26/219.44  |- skos__prefLabel mesh__D011142 Polyvinyl Alcohol
% 219.26/219.44  |- mesh__dateEstablished mesh__D011142 1974-01-01
% 219.26/219.44  |- skos__broader mesh__D011142smesh__D000438
% 219.26/219.44  |- mesh__recordOriginator mesh__D011142 NLM
% 219.26/219.44  |- mesh__historyNote mesh__D011142 74%28%71%29%   
% 219.26/219.44  |- mesh__recordMaintainer mesh__D011142 jmp
% 219.26/219.44  |- mesh__publicMeSHNote mesh__D011142 74   
% 219.26/219.44  |- skos__hiddenLabel mesh__D011142 Tears, Liquifilm
% 219.26/219.44  |- mesh__dateCreated mesh__D011142 1999-01-01
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D011142 2006
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005903 1998
% 219.26/219.44  |- rdf__type mesh__D005903sskos__Concept
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005903 2005
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005903 1997
% 219.26/219.44  |- skos__annotation mesh__D005903 from gluten   
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005903 2002
% 219.26/219.44  |- mesh__publicMeSHNote mesh__D005903
% 219.26/219.44       91; was see under PLANT PROTEINS 1975-90   
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005903 2004
% 219.26/219.44  |- skos__prefLabel mesh__D005903 Gliadin
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005903 1996
% 219.26/219.44  |- mesh__historyNote mesh__D005903
% 219.26/219.44       91%28%75%29%; was see under PLANT PROTEINS 1975-90   
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005903 2001
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005903 2003
% 219.26/219.44  |- mesh__dateEstablished mesh__D005903 1991-01-01
% 219.26/219.44  |- skos__broader mesh__D005903smesh__D005983
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005903 2000
% 219.26/219.44  |- mesh__recordOriginator mesh__D005903 NLM
% 219.26/219.44  |- mesh__dateRevised mesh__D005903 1995-05-19
% 219.26/219.44  |- skos__hiddenLabel mesh__D005903 alpha Gliadin
% 219.26/219.44  |- skos__historyNote mesh__D005903 Plant Proteins %28%1973-1974%29%
% 219.26/219.44  |- skos__scopeNote mesh__D005903
% 219.26/219.44       Simple protein, one of the prolamines, derived from the gluten of wheat, rye, etc. May be separated into 4 discrete electrophoretic fractions. It is the toxic factor associated with celiac disease.%A%    
% 219.26/219.44  |- mesh__recordMaintainer mesh__D005903 KEV
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005903 1999
% 219.26/219.44  |- mesh__recordAuthorizer mesh__D005903 PLS
% 219.26/219.44  |- mesh__dateCreated mesh__D005903 1974-11-19
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005903 2006
% 219.26/219.44  |- skos__scopeNote mesh__D005105
% 219.26/219.44       The extra volume of air that can be expired with maximum effort beyond the level reached at the end of a normal, quiet expiration. Common abbreviation is ERV.%A%    
% 219.26/219.44  |- mesh__dateEstablished mesh__D005105 1991-01-01
% 219.26/219.44  |- skos__annotation mesh__D005105 NIM; in texts as ERV   
% 219.26/219.44  |- mesh__recordMaintainer mesh__D005105 nns
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005105 2005
% 219.26/219.44  |- skos__broader mesh__D005105smesh__D005652
% 219.26/219.44  |- mesh__recordAuthorizer mesh__D005105 sjn
% 219.26/219.44  |- skos__hiddenLabel mesh__D005105 Expiratory Reserve Volumes
% 219.26/219.44  |- mesh__dateCreated mesh__D005105 1974-12-12
% 219.26/219.44  |- mesh__historyNote mesh__D005105
% 219.26/219.44       91%28%75%29%; was see under LUNG VOLUME MEASUREMENTS 1975-90   
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005105 2006
% 219.26/219.44  |- skos__hiddenLabel mesh__D005105 Volume, Expiratory Reserve
% 219.26/219.44  |- mesh__recordOriginator mesh__D005105 NLM
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D005105 2004
% 219.26/219.44  |- mesh__publicMeSHNote mesh__D005105
% 219.26/219.44       91; was see under LUNG VOLUME MEASUREMENTS 1975-90   
% 219.26/219.44  |- skos__hiddenLabel mesh__D005105 Reserve Volumes, Expiratory
% 219.26/219.44  |- skos__prefLabel mesh__D005105 Expiratory Reserve Volume
% 219.26/219.44  |- skos__hiddenLabel mesh__D005105 Volumes, Expiratory Reserve
% 219.26/219.44  |- skos__broader mesh__D005105smesh__D014797
% 219.26/219.44  |- skos__hiddenLabel mesh__D005105 Reserve Volume, Expiratory
% 219.26/219.44  |- mesh__dateRevised mesh__D005105 2003-07-09
% 219.26/219.44  |- rdf__type mesh__D005105sskos__Concept
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010848 2005
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010848 1997
% 219.26/219.44  |- skos__broader mesh__D010848smesh__D011725
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010848 1999
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010848 2004
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010848 2002
% 219.26/219.44  |- skos__prefLabel mesh__D010848 Picolinic Acids
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010848 2006
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010848 1994
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010848 1993
% 219.26/219.44  |- mesh__publicMeSHNote mesh__D010848 68   
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010848 1995
% 219.26/219.44  |- skos__broader mesh__D010848smesh__D000147
% 219.26/219.44  |- skos__hiddenLabel mesh__D010848 Acids, Picolinic
% 219.26/219.44  |- mesh__dateRevised mesh__D010848 1992-05-19
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010848 2000
% 219.26/219.44  |- mesh__historyNote mesh__D010848 68   
% 219.26/219.44  |- mesh__dateEstablished mesh__D010848 1968-01-01
% 219.26/219.44  |- mesh__recordMaintainer mesh__D010848 TAP
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010848 2001
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010848 1996
% 219.26/219.44  |- rdf__type mesh__D010848sskos__Concept
% 219.26/219.44  |- mesh__recordAuthorizer mesh__D010848 PLS
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010848 1998
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D010848 2003
% 219.26/219.44  |- mesh__recordOriginator mesh__D010848 NLM
% 219.26/219.44  |- mesh__dateCreated mesh__D010848 1999-01-01
% 219.26/219.44  |- skos__altLabel mesh__D043224 Corrective Endonuclease
% 219.26/219.44  |- mesh__dateCreated mesh__D043224 2003-07-09
% 219.26/219.44  |- skos__scopeNote mesh__D043224
% 219.26/219.44       An enzyme which catalyzes an endonucleolytic cleavage near PYRIMIDINE DIMERS to produce a 5%27%-phosphate product. The enzyme acts on the damaged DNA strand, from the 5%27% side of the damaged site.%A%    
% 219.26/219.44  |- skos__historyNote mesh__D043224 Deoxyribonucleases %28%1975-1979%29%
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D043224 2005
% 219.26/219.44  |- skos__altLabel mesh__D043224
% 219.26/219.44       Endodeoxyribonuclease %28%Pyrimidine Dimer%29%
% 219.26/219.44  |- mesh__historyNote mesh__D043224
% 219.26/219.44       2004; use DEOXYRIBONUCLEASE %28%PYRIMIDINE DIMER%29% %28%NM%29% 1980-2003%A%  
% 219.26/219.44  |- skos__historyNote mesh__D043224 Endodeoxyribonucleases %28%1983-2003%29%
% 219.26/219.44  |- skos__altLabel mesh__D043224 Endodeoxyribonuclease VIII
% 219.26/219.44  |- rdf__type mesh__D043224sskos__Concept
% 219.26/219.44  |- mesh__publicMeSHNote mesh__D043224
% 219.26/219.44       2004; DEOXYRIBONUCLEASE was indexed under ENDODEOXYRIBONUCLEASES 1983-2003, under ENDONUCLEASES %26% DEOXYRIBONUCLEASE 1976-1982%A%  
% 219.26/219.44  |- mesh__dateEstablished mesh__D043224 2004-01-01
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D043224 2006
% 219.26/219.44  |- mesh__recordOriginator mesh__D043224 AKE
% 219.26/219.44  |- skos__prefLabel mesh__D043224 Deoxyribonuclease %28%Pyrimidine Dimer%29%
% 219.26/219.44  |- mesh__recordAuthorizer mesh__D043224 sjn
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D043224 2004
% 219.26/219.44  |- skos__historyNote mesh__D043224 Endonucleases %28%1975-1979%29%
% 219.26/219.44  |- skos__hiddenLabel mesh__D043224 Endonuclease, Corrective
% 219.26/219.44  |- mesh__recordMaintainer mesh__D043224 jmp
% 219.26/219.44  |- skos__broader mesh__D043224smesh__D004706
% 219.26/219.44  |- skos__historyNote mesh__D015533 Virus Activation %28%1983-1987%29%
% 219.26/219.44  |- skos__hiddenLabel mesh__D015533 Activations, Transcription
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D015533 2005
% 219.26/219.44  |- skos__scopeNote mesh__D015533
% 219.26/219.44       Increased rate of gene expression directed by either viral or cellular proteins. These regulatory factors %28%diffusible gene products%29% act in trans -- that is, act on homologous or heterologous molecules of DNA. %28%Cis-acting factors act only on homologous molecules.%29%%A%    
% 219.26/219.44  |- skos__broader mesh__D015533smesh__D005786
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D015533 2004
% 219.26/219.44  |- mesh__historyNote mesh__D015533 90   
% 219.26/219.44  |- skos__hiddenLabel mesh__D015533 Transcriptional Activations
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D015533 2006
% 219.26/219.44  |- mesh__recordAuthorizer mesh__D015533 sjn
% 219.26/219.44  |- skos__annotation mesh__D015533
% 219.26/219.44       %22%increased rate of gene expression%22%; DF: TRANS ACTIVATION%A%  
% 219.26/219.44  |- skos__altLabel mesh__D015533 Transcription Activation
% 219.26/219.44  |- skos__altLabel mesh__D015533 Transactivation
% 219.26/219.44  |- skos__hiddenLabel mesh__D015533 Trans Activation %28%Genetics%29%
% 219.26/219.44  |- mesh__recordOriginator mesh__D015533 AGS
% 219.26/219.44  |- skos__hiddenLabel mesh__D015533 Activation, Transcriptional
% 219.26/219.44  |- mesh__dateCreated mesh__D015533 1989-06-19
% 219.26/219.44  |- skos__prefLabel mesh__D015533 Trans-Activation %28%Genetics%29%
% 219.26/219.44  |- skos__hiddenLabel mesh__D015533 Activation, Transcription
% 219.26/219.44  |- mesh__dateRevised mesh__D015533 2002-07-02
% 219.26/219.44  |- skos__hiddenLabel mesh__D015533 Trans-Activations %28%Genetics%29%
% 219.26/219.44  |- skos__hiddenLabel mesh__D015533 Transactivations
% 219.26/219.44  |- skos__hiddenLabel mesh__D015533 Activations, Transcriptional
% 219.26/219.44  |- mesh__dateEstablished mesh__D015533 1990-01-01
% 219.26/219.44  |- mesh__publicMeSHNote mesh__D015533 90   
% 219.26/219.44  |- skos__hiddenLabel mesh__D015533 Transcription Activations
% 219.26/219.44  |- rdf__type mesh__D015533sskos__Concept
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D015533 2003
% 219.26/219.44  |- mesh__recordMaintainer mesh__D015533 NDW
% 219.26/219.44  |- skos__historyNote mesh__D015533
% 219.26/219.44       Gene Expression Regulation %28%1983-1989%29%
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001513 2002
% 219.26/219.44  |- skos__hiddenLabel mesh__D001513 Bed
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001513 2005
% 219.26/219.44  |- mesh__recordMaintainer mesh__D001513 AGS
% 219.26/219.44  |- mesh__dateCreated mesh__D001513 1999-01-01
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001513 1994
% 219.26/219.44  |- mesh__recordOriginator mesh__D001513 NLM
% 219.26/219.44  |- skos__prefLabel mesh__D001513 Beds
% 219.26/219.44  |- mesh__dateRevised mesh__D001513 1993-06-03
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001513 2006
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001513 1998
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001513 2000
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001513 1995
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001513 2003
% 219.26/219.44  |- rdf__type mesh__D001513sskos__Concept
% 219.26/219.44  |- skos__scopeNote mesh__D001513
% 219.26/219.44       Equipment on which one may lie and sleep, especially as used to care for the hospital patient.%A%    
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001513 1999
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001513 2001
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001513 2004
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001513 1996
% 219.26/219.44  |- skos__broader mesh__D001513smesh__D004865
% 219.26/219.44  |- mesh__recordAuthorizer mesh__D001513 PLS
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D001513 1997
% 219.26/219.44  |- mesh__dateEstablished mesh__D039981 2003-01-01
% 219.26/219.44  |- skos__altLabel mesh__D039981 House Dust Mites
% 219.26/219.44  |- skos__broader mesh__D039981smesh__D008925
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D039981 2004
% 219.26/219.44  |- skos__prefLabel mesh__D039981 Pyroglyphidae
% 219.26/219.44  |- mesh__dateCreated mesh__D039981 2002-07-03
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D039981 2006
% 219.26/219.44  |- mesh__activeMeSHYear mesh__D039981 2005
% 219.26/219.44  |- mesh__dateRevised mesh__D039981 2003-07-09
% 219.26/219.44  |- rdf__type mesh__D039981sskos__Concept
% 219.26/219.44  |- skos__historyNote mesh__D039981 Mites %28%1969-2002%29%
% 219.26/219.44  |- skos__altLabel mesh__D039981 Mites, House Dust
% 219.26/219.45  |- skos__scopeNote mesh__D039981
% 219.26/219.45       Family of house dust mites, in the superfamily Analgoidea, order Astigmata. They include the genera Dermatophagoides and Euroglyphus.%A%    
% 219.26/219.45  |- skos__altLabel mesh__D039981 Dust Mites, House
% 219.26/219.45  |- skos__related mesh__D039981smesh__D004391
% 219.26/219.45  |- mesh__publicMeSHNote mesh__D039981 2003   
% 219.26/219.45  |- mesh__historyNote mesh__D039981 2003   
% 219.26/219.45  |- skos__altLabel mesh__D039981 Housedust Mites
% 219.26/219.45  |- skos__broader mesh__D020478smesh__D052180
% 219.26/219.45  |- skos__altLabel mesh__D020478 Forms %28%PT%29%
% 219.26/219.45  |- skos__scopeNote mesh__D020478
% 219.26/219.45       Works consisting of or containing a substantial number of blank forms.%A%    
% 219.26/219.45  |- mesh__dateCreated mesh__D020478 1998-06-03
% 219.26/219.45  |- rdf__type mesh__D020478sskos__Concept
% 219.26/219.45  |- mesh__historyNote mesh__D020478 1999   
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D020478 2006
% 219.26/219.45  |- skos__prefLabel mesh__D020478 Forms %5B%Publication Type%5D%
% 219.26/219.45  |- mesh__dateEstablished mesh__D020478 1999-01-01
% 219.26/219.45  |- mesh__recordMaintainer mesh__D020478 jls
% 219.26/219.45  |- mesh__recordOriginator mesh__D020478 JLS
% 219.26/219.45  |- mesh__recordAuthorizer mesh__D020478 sjn
% 219.26/219.45  |- mesh__dateRevised mesh__D020478 2005-06-30
% 219.26/219.45  |- skos__altLabel mesh__D025961 Gallid herpesvirus 3
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D025961 2004
% 219.26/219.45  |- mesh__dateEstablished mesh__D025961 2002-01-01
% 219.26/219.45  |- mesh__dateCreated mesh__D025961 2001-07-25
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D025961 2003
% 219.26/219.45  |- skos__broader mesh__D025961smesh__D025922
% 219.26/219.45  |- skos__altLabel mesh__D025961 Marek%27%s Disease Virus Serotype 2
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D025961 2002
% 219.26/219.45  |- skos__prefLabel mesh__D025961 Herpesvirus 3, Gallid
% 219.26/219.45  |- skos__scopeNote mesh__D025961
% 219.26/219.45       A species in the genus MAREK%27%S DISEASE-LIKE VIRUSES, in the family HERPESVIRIDAE, infecting chickens.%A%    
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D025961 2006
% 219.26/219.45  |- skos__altLabel mesh__D025961 Marek%27%s Disease Herpesvirus 2
% 219.26/219.45  |- mesh__publicMeSHNote mesh__D025961 2002   
% 219.26/219.45  |- mesh__historyNote mesh__D025961 2002   
% 219.26/219.45  |- rdf__type mesh__D025961sskos__Concept
% 219.26/219.45  |- skos__altLabel mesh__D025961 Marek Disease Herpesvirus 2
% 219.26/219.45  |- skos__annotation mesh__D025961 infection = MAREK DISEASE   
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D025961 2005
% 219.26/219.45  |- skos__hiddenLabel mesh__D019924 Embryo Dispositions
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D019924 2002
% 219.26/219.45  |- mesh__historyNote mesh__D019924 99   
% 219.26/219.45  |- mesh__recordOriginator mesh__D019924 JLS
% 219.26/219.45  |- skos__hiddenLabel mesh__D019924 Dispositions, Embryo
% 219.26/219.45  |- mesh__recordAuthorizer mesh__D019924 sjn
% 219.26/219.45  |- mesh__dateEstablished mesh__D019924 1999-01-01
% 219.26/219.45  |- rdf__type mesh__D019924sskos__Concept
% 219.26/219.45  |- mesh__publicMeSHNote mesh__D019924 99   
% 219.26/219.45  |- skos__broader mesh__D019924smesh__D012099
% 219.26/219.45  |- mesh__dateRevised mesh__D019924 2001-07-25
% 219.26/219.45  |- mesh__recordMaintainer mesh__D019924 lkt
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D019924 2003
% 219.26/219.45  |- skos__annotation mesh__D019924 mammalian only   
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D019924 2005
% 219.26/219.45  |- mesh__dateCreated mesh__D019924 1998-06-10
% 219.26/219.45  |- skos__scopeNote mesh__D019924
% 219.26/219.45       Process for deciding utilization or disposal of an embryo that is fertilized but not immediately transplanted and resulting course of action.%A%    
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D019924 2004
% 219.26/219.45  |- skos__hiddenLabel mesh__D019924 Disposition, Embryo
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D019924 2006
% 219.26/219.45  |- skos__prefLabel mesh__D019924 Embryo Disposition
% 219.26/219.45  |- skos__altLabel mesh__D011941 Adrenoceptors
% 219.26/219.45  |- mesh__dateEstablished mesh__D011941 1973-01-01
% 219.26/219.45  |- mesh__publicMeSHNote mesh__D011941
% 219.26/219.45       73; RECEPTORS, NOREPINEPHRINE was heading 1993; NORADRENALINE RECEPTORS, NOREPINEPHRINE RECEPTORS, %26% RECEPTORS, NORADRENALINE were see RECEPTORS, NOREPINEPHRINE 1993%A%  
% 219.26/219.45  |- rdf__type mesh__D011941sskos__Concept
% 219.26/219.45  |- mesh__dateRevised mesh__D011941 2005-06-30
% 219.26/219.45  |- mesh__historyNote mesh__D011941
% 219.26/219.45       73%28%71%29%; RECEPTORS, NOREPINEPHRINE was heading 1993; NORADRENALINE RECEPTORS, NOREPINEPHRINE RECEPTORS, %26% RECEPTORS, NORADRENALINE were see RECEPTORS, NOREPINEPHRINE 1993%A%  
% 219.26/219.45  |- skos__altLabel mesh__D011941 Epinephrine Receptors
% 219.26/219.45  |- skos__annotation mesh__D011941
% 219.26/219.45       GEN; prefer specifics; coord IM with specific adrenergic agent %28%IM%29%; DF: RECEPT ADREN%A%  
% 219.26/219.45  |- skos__altLabel mesh__D011941 Adrenergic Receptor
% 219.26/219.45  |- skos__historyNote mesh__D011941 Receptors, Drug %28%1968-1970%29%
% 219.26/219.45  |- skos__scopeNote mesh__D011941
% 219.26/219.45       Cell-surface proteins that bind epinephrine and/or norepinephrine with high affinity and trigger intracellular changes. The two major classes of adrenergic receptors, alpha and beta, were originally discriminated based on their cellular actions but now are distinguished by their relative affinity for characteristic synthetic ligands. Adrenergic receptors may also be classified according to the subtypes of G-proteins with which they bind; this scheme does not respect the alpha-beta distinction.%A%    
% 219.26/219.45  |- mesh__onlineNote mesh__D011941
% 219.26/219.45       use RECEPTORS, ADRENERGIC to search RECEPTORS, NOREPINEPHRINE, NORADRENALINE RECEPTORS, NOREPINEPHRINE RECEPTORS %26% RECEPTORS NORADRENALINE 1993%A%  
% 219.26/219.45  |- skos__altLabel mesh__D011941 Receptors, Epinephrine
% 219.26/219.45  |- skos__prefLabel mesh__D011941 Receptors, Adrenergic
% 219.26/219.45  |- skos__broader mesh__D011941smesh__D017983
% 219.26/219.45  |- skos__altLabel mesh__D011941 Receptors, Norepinephrine
% 219.26/219.45  |- skos__altLabel mesh__D011941 Adrenergic Receptors
% 219.26/219.45  |- mesh__recordMaintainer mesh__D011941 jmp
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D011941 2006
% 219.26/219.45  |- mesh__recordOriginator mesh__D011941 NLM
% 219.26/219.45  |- skos__hiddenLabel mesh__D011941 Receptor, Adrenergic
% 219.26/219.45  |- mesh__dateCreated mesh__D011941 1999-01-01
% 219.26/219.45  |- mesh__recordAuthorizer mesh__D011941 sjn
% 219.26/219.45  |- skos__hiddenLabel mesh__D011143 Chloride, Polyvinyl
% 219.26/219.45  |- skos__hiddenLabel mesh__D011143 Polymer, Chloroethylene
% 219.26/219.45  |- mesh__dateRevised mesh__D011143 2004-07-07
% 219.26/219.45  |- skos__historyNote mesh__D011143 Hydrocarbons, Chlorinated %28%1974%29%
% 219.26/219.45  |- skos__altLabel mesh__D011143 Chloroethylene Polymer
% 219.26/219.45  |- mesh__recordAuthorizer mesh__D011143 sjn
% 219.26/219.45  |- skos__hiddenLabel mesh__D011143 Polymer, Vinyl Chloride
% 219.26/219.45  |- skos__altLabel mesh__D011143 PVC
% 219.26/219.45  |- mesh__dateEstablished mesh__D011143 1991-01-01
% 219.26/219.45  |- skos__historyNote mesh__D011143 Hydrocarbons %28%1966%29%
% 219.26/219.45  |- skos__altLabel mesh__D011143 Polychloroethylene
% 219.26/219.45  |- mesh__recordMaintainer mesh__D011143 jmp
% 219.26/219.45  |- skos__annotation mesh__D011143 D25-26 qualif   
% 219.26/219.45  |- skos__altLabel mesh__D011143 Vinyl Chloride Polymer
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D011143 2006
% 219.26/219.45  |- skos__hiddenLabel mesh__D011143 Homopolymer, Chloroethylene
% 219.26/219.45  |- mesh__dateCreated mesh__D011143 1974-11-11
% 219.26/219.45  |- skos__scopeNote mesh__D011143
% 219.26/219.45       A polyvinyl resin used extensively in the manufacture of plastics, including medical devices, tubing, and other packaging. It is also used as a rubber substitute.%A%    
% 219.26/219.45  |- skos__prefLabel mesh__D011143 Polyvinyl Chloride
% 219.26/219.45  |- mesh__historyNote mesh__D011143
% 219.26/219.45       91%28%75%29%; was see under POLYVINYLS 1975-90   
% 219.26/219.45  |- skos__historyNote mesh__D011143 Polyvinyls %28%1966-1974%29%
% 219.26/219.45  |- skos__altLabel mesh__D011143 Chloroethylene Homopolymer
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D011143 2005
% 219.26/219.45  |- mesh__recordOriginator mesh__D011143 NLM
% 219.26/219.45  |- skos__historyNote mesh__D011143
% 219.26/219.45       Hydrocarbons, Halogenated %28%1966-1973%29%
% 219.26/219.45  |- mesh__publicMeSHNote mesh__D011143
% 219.26/219.45       91; was see under POLYVINYLS 1975-90   
% 219.26/219.45  |- skos__broader mesh__D011143smesh__D011145
% 219.26/219.45  |- rdf__type mesh__D011143sskos__Concept
% 219.26/219.45  |- rdf__type mesh__D005904sskos__Concept
% 219.26/219.45  |- skos__broader mesh__D005904smesh__D007381
% 219.26/219.45  |- skos__historyNote mesh__D005904
% 219.26/219.45       Intermediate Filament Proteins %28%1983-1984%29%
% 219.26/219.45  |- mesh__dateRevised mesh__D005904 2004-07-07
% 219.26/219.45  |- skos__altLabel mesh__D005904 Glial Fibrillary Acid Protein
% 219.26/219.45  |- mesh__publicMeSHNote mesh__D005904
% 219.26/219.45       85; was GLIAL INTERMEDIATE FILAMENT PROTEINS see INTERMEDIATE FILAMENT PROTEINS 1983-84; GFA-PROTEIN was indexed under NERVE TISSUE PROTEINS 1980-93%A%  
% 219.26/219.45  |- mesh__dateCreated mesh__D005904 1984-04-16
% 219.26/219.45  |- skos__annotation mesh__D005904
% 219.26/219.45       an intermediate filament protein; /biosyn /physiol permitted; DF: GFAP%A%  
% 219.26/219.45  |- mesh__recordOriginator mesh__D005904 RLS
% 219.26/219.45  |- skos__hiddenLabel mesh__D005904 GFA Protein
% 219.26/219.45  |- skos__prefLabel mesh__D005904 Glial Fibrillary Acidic Protein
% 219.26/219.45  |- skos__altLabel mesh__D005904 GFA-Protein
% 219.26/219.45  |- mesh__historyNote mesh__D005904
% 219.26/219.45       85; was GLIAL INTERMEDIATE FILAMENT PROTEINS see INTERMEDIATE FILAMENT PROTEINS 1983-84; GFA-PROTEIN was %28%NM%29% 1980-93%A%  
% 219.26/219.45  |- skos__scopeNote mesh__D005904
% 219.26/219.45       An intermediate filament protein found only in glial cells or cells of glial origin. MW 51,000.%A%    
% 219.26/219.45  |- skos__altLabel mesh__D005904 Glial Intermediate Filament Protein
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005904 2005
% 219.26/219.45  |- mesh__onlineNote mesh__D005904
% 219.26/219.45       use INTERMEDIATE FILAMENT PROTEINS to search GLIAL INTERMEDIATE FILAMENT PROTEINS 1983-84; use GLIAL FIBRILLARY ACIDIC PROTEIN %28%NM%29% to search GFA-PROTEIN 1980-93%A%  
% 219.26/219.45  |- skos__altLabel mesh__D005904 Astroprotein
% 219.26/219.45  |- mesh__recordMaintainer mesh__D005904 jmp
% 219.26/219.45  |- mesh__recordAuthorizer mesh__D005904 sjn
% 219.26/219.45  |- skos__historyNote mesh__D005904 Nerve Tissue Proteins %28%1966-1984%29%
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005904 2006
% 219.26/219.45  |- mesh__dateEstablished mesh__D005904 1985-01-01
% 219.26/219.45  |- skos__broader mesh__D006325Q000502smesh__D006325
% 219.26/219.45  |- mesh__preferredCombination mesh__D006325Q000502smesh__D016275
% 219.26/219.45  |- rdf__type mesh__D006325Q000502smesh__CompoundConcept
% 219.26/219.45  |- skos__hiddenLabel mesh__D005106 Novelty-Seeking Behaviors
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005106 2006
% 219.26/219.45  |- mesh__historyNote mesh__D005106
% 219.26/219.45       68; was BEHAVIOR, EXPLORATORY 1965-67; CURIOSITY was see under EXPLORATORY BEHAVIOR 1969-78%A%  
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005106 2003
% 219.26/219.45  |- skos__scopeNote mesh__D005106
% 219.26/219.45       The tendency to explore or investigate a novel environment. It is considered a motivation not clearly distinguishable from curiosity.%A%    
% 219.26/219.45  |- mesh__dateEstablished mesh__D005106 1968-01-01
% 219.26/219.45  |- mesh__onlineNote mesh__D005106
% 219.26/219.45       use EXPLORATORY BEHAVIOR to search BEHAVIOR, EXPLORATORY 1966-67 %26% CURIOSITY 1969-78%A%  
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005106 2004
% 219.26/219.45  |- skos__prefLabel mesh__D005106 Exploratory Behavior
% 219.26/219.45  |- skos__annotation mesh__D005106 human %26% animal   
% 219.26/219.45  |- skos__hiddenLabel mesh__D005106 Behaviors, Exploratory
% 219.26/219.45  |- skos__hiddenLabel mesh__D005106 Exploratory Behaviors
% 219.26/219.45  |- mesh__recordAuthorizer mesh__D005106 sjn
% 219.26/219.45  |- skos__hiddenLabel mesh__D005106 Behavior, Exploratory
% 219.26/219.45  |- skos__hiddenLabel mesh__D005106 Behaviors, Novelty-Seeking
% 219.26/219.45  |- skos__hiddenLabel mesh__D005106 Behavior, Novelty-Seeking
% 219.26/219.45  |- mesh__recordOriginator mesh__D005106 NLM
% 219.26/219.45  |- mesh__dateRevised mesh__D005106 2002-07-02
% 219.26/219.45  |- mesh__recordMaintainer mesh__D005106 TAP
% 219.26/219.45  |- skos__hiddenLabel mesh__D005106 Curiosities
% 219.26/219.45  |- skos__broader mesh__D005106smesh__D009042
% 219.26/219.45  |- rdf__type mesh__D005106sskos__Concept
% 219.26/219.45  |- skos__hiddenLabel mesh__D005106 Novelty Seeking Behavior
% 219.26/219.45  |- mesh__publicMeSHNote mesh__D005106
% 219.26/219.45       68; was BEHAVIOR, EXPLORATORY 1965-67   
% 219.26/219.45  |- mesh__dateCreated mesh__D005106 1999-01-01
% 219.26/219.45  |- skos__broader mesh__D005106smesh__D001519
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005106 2005
% 219.26/219.45  |- skos__annotation mesh__D010849 infection = PICORNAVIRIDAE INFECTIONS   
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D010849 2006
% 219.26/219.45  |- mesh__recordOriginator mesh__D010849 NLM
% 219.26/219.45  |- mesh__onlineNote mesh__D010849
% 219.26/219.45       use PICORNAVIRIDAE to search PICORNAVIRUSES 1975-80 %26% PICORNAVIRUS 1966-74%A%  
% 219.26/219.45  |- mesh__dateRevised mesh__D010849 2001-07-25
% 219.26/219.45  |- mesh__dateEstablished mesh__D010849 1964-01-01
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D010849 2002
% 219.26/219.45  |- skos__scopeNote mesh__D010849
% 219.26/219.45       A family of small RNA viruses comprising some important pathogens of humans and animals. Transmission usually occurs mechanically. There are six genera: APHTHOVIRUS; CARDIOVIRUS; ENTEROVIRUS; HEPATOVIRUS; PARECHOVIRUS; and RHINOVIRUS.%A%    
% 219.26/219.45  |- skos__altLabel mesh__D010849 Picornaviruses
% 219.26/219.45  |- mesh__recordAuthorizer mesh__D010849 sjn
% 219.26/219.45  |- rdf__type mesh__D010849sskos__Concept
% 219.26/219.45  |- mesh__publicMeSHNote mesh__D010849
% 219.26/219.45       81; was PICORNAVIRUSES 1975-80, was PICORNAVIRUS 1964-74   
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D010849 2003
% 219.26/219.45  |- mesh__dateCreated mesh__D010849 1999-01-01
% 219.26/219.45  |- mesh__historyNote mesh__D010849
% 219.26/219.45       81; was PICORNAVIRUSES 1975-80, was PICORNAVIRUS 1964-74   
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D010849 2005
% 219.26/219.45  |- skos__prefLabel mesh__D010849 Picornaviridae
% 219.26/219.45  |- mesh__recordMaintainer mesh__D010849 ags
% 219.26/219.45  |- skos__broader mesh__D010849smesh__D012328
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D010849 2004
% 219.26/219.45  |- skos__hiddenLabel mesh__D015534 Trans Activators
% 219.26/219.45  |- mesh__dateRevised mesh__D015534 2005-06-30
% 219.26/219.45  |- rdf__type mesh__D015534sskos__Concept
% 219.26/219.45  |- skos__historyNote mesh__D015534 Viral Proteins %28%1986-1989%29%
% 219.26/219.45  |- skos__prefLabel mesh__D015534 Trans-Activators
% 219.26/219.45  |- skos__scopeNote mesh__D015534
% 219.26/219.45       Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins.%A%    
% 219.26/219.45  |- skos__hiddenLabel mesh__D015534 Trans Activator
% 219.26/219.45  |- mesh__dateCreated mesh__D015534 1989-07-06
% 219.26/219.45  |- mesh__recordOriginator mesh__D015534 AGS
% 219.26/219.45  |- mesh__historyNote mesh__D015534
% 219.26/219.45       90; EPSTEIN-BARR VIRUS TRANS-ACTING FACTOR was see TRANSACTIVATORS 1990-92; LOR PROTEINS %26% PX PROTEINS were see TRANS-ACTIVATORS 1990%A%  
% 219.26/219.45  |- skos__historyNote mesh__D015534 Transcription Factors %28%1986-1989%29%
% 219.26/219.45  |- skos__hiddenLabel mesh__D015534 Factor, Trans-Acting
% 219.26/219.45  |- skos__hiddenLabel mesh__D015534 Trans-Acting Factor, Nuclear
% 219.26/219.45  |- skos__altLabel mesh__D015534 Trans-Acting Factor
% 219.26/219.45  |- skos__hiddenLabel mesh__D015534 Factors, Trans-Acting
% 219.26/219.45  |- skos__hiddenLabel mesh__D015534 Factor, Nuclear Trans-Acting
% 219.26/219.45  |- skos__broader mesh__D015534smesh__D015520
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D015534 2006
% 219.26/219.45  |- skos__altLabel mesh__D015534 Trans-Acting Factors
% 219.26/219.45  |- mesh__publicMeSHNote mesh__D015534
% 219.26/219.45       90; EPSTEIN-BARR VIRUS TRANS-ACTING FACTOR was see TRANSACTIVATORS 1990-92; LOR PROTEINS %26% PX PROTEINS were see TRANS-ACTIVATORS 1990%A%  
% 219.26/219.45  |- skos__altLabel mesh__D015534 Transactivator
% 219.26/219.45  |- skos__historyNote mesh__D015534 Retroviridae Proteins %28%1986-1989%29%
% 219.26/219.45  |- skos__hiddenLabel mesh__D015534 Trans Acting Factor
% 219.26/219.45  |- skos__hiddenLabel mesh__D015534 Trans Acting Factors
% 219.26/219.45  |- mesh__recordAuthorizer mesh__D015534 sjn
% 219.26/219.45  |- skos__altLabel mesh__D015534 Transactivators
% 219.26/219.45  |- mesh__recordMaintainer mesh__D015534 SYSTEM
% 219.26/219.45  |- skos__hiddenLabel mesh__D015534 Nuclear Trans Acting Factor
% 219.26/219.45  |- skos__broader mesh__D015534smesh__D014157
% 219.26/219.45  |- mesh__dateEstablished mesh__D015534 1990-01-01
% 219.26/219.45  |- skos__annotation mesh__D015534
% 219.26/219.45       in genetics, regulate expression of viral proteins; /biosyn /drug eff /physiol /ultrastruct permitted%A%  
% 219.26/219.45  |- mesh__onlineNote mesh__D015534
% 219.26/219.45       use TRANS-ACTIVATORS to search EPSTEIN-BARR VIRUS TRANS-ACTING FACTOR 1990-92 and LOR PROTEINS %26% PX PROTEINS 1990%A%  
% 219.26/219.45  |- skos__altLabel mesh__D015534 Trans-Activator
% 219.26/219.45  |- skos__historyNote mesh__D001514 Venoms %28%1966-1977%29%
% 219.26/219.45  |- rdf__type mesh__D001514sskos__Concept
% 219.26/219.45  |- mesh__recordAuthorizer mesh__D001514 sjn
% 219.26/219.45  |- skos__prefLabel mesh__D001514 Bee Venoms
% 219.26/219.45  |- mesh__publicMeSHNote mesh__D001514 78   
% 219.26/219.45  |- skos__scopeNote mesh__D001514
% 219.26/219.45       Venoms obtained from Apis mellifera %28%honey bee%29% and related species. They contain various enzymes, polypeptide toxins, and other substances, some of which are allergenic or immunogenic or both. These venoms were formerly used in rheumatism to stimulate the pituitary-adrenal system.%A%    
% 219.26/219.45  |- skos__historyNote mesh__D001514 Bees %28%1966-1977%29%
% 219.26/219.45  |- skos__hiddenLabel mesh__D001514 Venoms, Apis
% 219.26/219.45  |- skos__altLabel mesh__D001514 Apis Venoms
% 219.26/219.45  |- mesh__recordMaintainer mesh__D001514 ssb
% 219.26/219.45  |- skos__broader mesh__D001514smesh__D001180
% 219.26/219.45  |- skos__altLabel mesh__D001514 Bee Venom
% 219.26/219.45  |- mesh__dateRevised mesh__D001514 2005-06-30
% 219.26/219.45  |- mesh__dateCreated mesh__D001514 1977-04-22
% 219.26/219.45  |- skos__annotation mesh__D001514
% 219.26/219.45       /antag permitted but consider also ANTIVENINS; /enzymol permitted%A%  
% 219.26/219.45  |- mesh__recordOriginator mesh__D001514 SH
% 219.26/219.45  |- skos__hiddenLabel mesh__D001514 Venoms, Bee
% 219.26/219.45  |- skos__hiddenLabel mesh__D001514 Venom, Bee
% 219.26/219.45  |- mesh__historyNote mesh__D001514 78   
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D001514 2006
% 219.26/219.45  |- mesh__dateEstablished mesh__D001514 1978-01-01
% 219.26/219.45  |- skos__altLabel mesh__D020479 Handbooks %28%PT%29%
% 219.26/219.45  |- mesh__recordMaintainer mesh__D020479 jls
% 219.26/219.45  |- skos__related mesh__D020479smesh__D020507
% 219.26/219.45  |- rdf__type mesh__D020479sskos__Concept
% 219.26/219.45  |- mesh__recordAuthorizer mesh__D020479 sjn
% 219.26/219.45  |- skos__related mesh__D020479smesh__D020484
% 219.26/219.45  |- mesh__dateRevised mesh__D020479 2005-06-30
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D020479 2006
% 219.26/219.45  |- mesh__historyNote mesh__D020479 1999   
% 219.26/219.45  |- skos__prefLabel mesh__D020479 Handbooks %5B%Publication Type%5D%
% 219.26/219.45  |- mesh__recordOriginator mesh__D020479 JLS
% 219.26/219.45  |- skos__broader mesh__D020479smesh__D052180
% 219.26/219.45  |- skos__scopeNote mesh__D020479
% 219.26/219.45       Works consisting of concise reference works in which facts and information pertaining to a certain subject or field are arranged for ready reference and consultation rather than for continuous reading and study.%A%    
% 219.26/219.45  |- mesh__dateCreated mesh__D020479 1998-06-08
% 219.26/219.45  |- mesh__dateEstablished mesh__D020479 1999-01-01
% 219.26/219.45  |- skos__prefLabel mesh__D025962 Septo-Optic Dysplasia
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D025962 2003
% 219.26/219.45  |- skos__historyNote mesh__D025962 Hypogonadism %28%1966-1971%29%
% 219.26/219.45  |- skos__historyNote mesh__D025962 Septum Pellucidum %28%1972-2001%29%
% 219.26/219.45  |- mesh__dateCreated mesh__D025962 2001-07-25
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D025962 2006
% 219.26/219.45  |- mesh__publicMeSHNote mesh__D025962 2002   
% 219.26/219.45  |- rdf__type mesh__D025962sskos__Concept
% 219.26/219.45  |- skos__broader mesh__D025962smesh__D009421
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D025962 2005
% 219.26/219.45  |- skos__scopeNote mesh__D025962
% 219.26/219.45       A condition resulting from congenital malformations involving the brain. The syndrome of septo-optic dysplasia combines hypoplasia or agenesis of the SEPTUM PELLUCIDUM and the OPTIC NERVE. The extent of the abnormalities can vary. Septo-optic dysplasia is often associated with abnormalities of the hypothalamic and other diencephalic structures, and HYPOPITUITARISM.%A%    
% 219.26/219.45  |- skos__historyNote mesh__D025962 Optic Nerve %28%1972-2001%29%
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D025962 2002
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D025962 2004
% 219.26/219.45  |- mesh__dateEstablished mesh__D025962 2002-01-01
% 219.26/219.45  |- mesh__historyNote mesh__D025962 2002   
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D019925 2006
% 219.26/219.45  |- skos__broader mesh__D019925smesh__D016213
% 219.26/219.45  |- mesh__recordAuthorizer mesh__D019925 sjn
% 219.26/219.45  |- skos__altLabel mesh__D019925 E1A p60
% 219.26/219.45  |- mesh__recordOriginator mesh__D019925 AGS
% 219.26/219.45  |- skos__altLabel mesh__D019925 Adenovirus E1A-Associated Protein p60
% 219.26/219.45  |- rdf__type mesh__D019925sskos__Concept
% 219.26/219.45  |- mesh__recordMaintainer mesh__D019925 ssb
% 219.26/219.45  |- mesh__dateCreated mesh__D019925 1997-06-20
% 219.26/219.45  |- mesh__historyNote mesh__D019925 98; use CYCLINS 1993-97   
% 219.26/219.45  |- mesh__publicMeSHNote mesh__D019925 98; see CYCLINS 1993-97   
% 219.26/219.45  |- mesh__dateRevised mesh__D019925 2005-06-30
% 219.26/219.45  |- skos__scopeNote mesh__D019925
% 219.26/219.45       A 33-kDa protein identical to adenovirus E1A-associated protein p60. Cyclin A regulates p33cdk2 and p34cdc2, and is necessary for progression through the S phase of the cell cycle.%A%    
% 219.26/219.45  |- mesh__dateEstablished mesh__D019925 1998-01-01
% 219.26/219.45  |- skos__hiddenLabel mesh__D019925 Adenovirus E1A Associated Protein p60
% 219.26/219.45  |- skos__historyNote mesh__D019925 Invertebrate Hormones %28%1986-1990%29%
% 219.26/219.45  |- skos__historyNote mesh__D019925 Cyclins %28%1991-1997%29%
% 219.26/219.45  |- skos__prefLabel mesh__D019925 Cyclin A
% 219.26/219.45  |- skos__hiddenLabel mesh__D011942 Adrenergic alpha Receptors
% 219.26/219.45  |- skos__altLabel mesh__D011942 Adrenergic alpha-Receptors
% 219.26/219.45  |- skos__hiddenLabel mesh__D011942 Receptors, alpha Adrenergic
% 219.26/219.45  |- skos__altLabel mesh__D011942 alpha-Adrenergic Receptors
% 219.26/219.45  |- mesh__recordAuthorizer mesh__D011942 sjn
% 219.26/219.45  |- skos__broader mesh__D011942smesh__D011941
% 219.26/219.45  |- mesh__dateCreated mesh__D011942 1976-05-03
% 219.26/219.45  |- skos__annotation mesh__D011942
% 219.26/219.45       coord IM with specific alpha adrenergic agent %28%IM%29%; DF: ADREN ALPHA RECEPT%A%  
% 219.26/219.45  |- mesh__dateRevised mesh__D011942 2005-06-30
% 219.26/219.45  |- skos__scopeNote mesh__D011942
% 219.26/219.45       One of the two major pharmacological subdivisions of adrenergic receptors. The alpha-beta distinction was originally based on cellular effects of receptor activation but now relies on the relative affinities for certain synthetic ligands. alpha-Adrenergic receptors are further subdivided into several subclasses based on studies of endogenous and cloned receptors.%A%    
% 219.26/219.45  |- mesh__historyNote mesh__D011942
% 219.26/219.45       84%28%77%29%; was see under RECEPTORS, ADRENERGIC 1977-83   
% 219.26/219.45  |- skos__historyNote mesh__D011942 Receptors, Drug %28%1968-1976%29%
% 219.26/219.45  |- skos__altLabel mesh__D011942 Receptors, alpha-Adrenergic
% 219.26/219.45  |- mesh__recordMaintainer mesh__D011942 jmp
% 219.26/219.45  |- skos__hiddenLabel mesh__D011942 alpha Adrenergic Receptors
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D011942 2006
% 219.26/219.45  |- mesh__publicMeSHNote mesh__D011942
% 219.26/219.45       84; was see under RECEPTORS, ADRENERGIC 1977-83   
% 219.26/219.45  |- skos__altLabel mesh__D011942 Receptor, Adrenergic, alpha
% 219.26/219.45  |- skos__historyNote mesh__D011942 Receptors, Adrenergic %28%1973-1976%29%
% 219.26/219.45  |- skos__hiddenLabel mesh__D011942 alpha-Receptors, Adrenergic
% 219.26/219.45  |- mesh__recordOriginator mesh__D011942 SH
% 219.26/219.45  |- mesh__dateEstablished mesh__D011942 1984-01-01
% 219.26/219.45  |- rdf__type mesh__D011942sskos__Concept
% 219.26/219.45  |- skos__prefLabel mesh__D011942 Receptors, Adrenergic, alpha
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D011144 2001
% 219.26/219.45  |- skos__scopeNote mesh__D011144
% 219.26/219.45       Inhibits the cytotoxic action of quartz and is reported to have delayed the development of experimental silicosis in rats.%A%    
% 219.26/219.45  |- skos__altLabel mesh__D011144 Poly-2-vinylpyridine N-Oxide
% 219.26/219.45  |- skos__historyNote mesh__D011144 Polyvinyls %28%1971-1974%29%
% 219.26/219.45  |- skos__broader mesh__D011144smesh__D011725
% 219.26/219.45  |- skos__historyNote mesh__D011144 Cyclic N-Oxides %28%1971-1974%29%
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D011144 2003
% 219.26/219.45  |- skos__prefLabel mesh__D011144 Polyvinylpyridine N-Oxide
% 219.26/219.45  |- skos__hiddenLabel mesh__D011144 N-Oxide, Poly-2-vinylpyridine
% 219.26/219.45  |- skos__hiddenLabel mesh__D011144 Poly 2 vinylpyridine N Oxide
% 219.26/219.45  |- mesh__recordMaintainer mesh__D011144 CCR
% 219.26/219.45  |- skos__historyNote mesh__D011144 Pyridines %28%1971-1974%29%
% 219.26/219.45  |- mesh__dateEstablished mesh__D011144 1991-01-01
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D011144 2006
% 219.26/219.45  |- mesh__recordOriginator mesh__D011144 NLM
% 219.26/219.45  |- mesh__publicMeSHNote mesh__D011144
% 219.26/219.45       91; was see under POLYVINYLS 1975-90   
% 219.26/219.45  |- mesh__historyNote mesh__D011144
% 219.26/219.45       91%28%75%29%; was see under POLYVINYLS 1975-90   
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D011144 2005
% 219.26/219.45  |- skos__broader mesh__D011144smesh__D011145
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D011144 2002
% 219.26/219.45  |- mesh__dateCreated mesh__D011144 1974-11-19
% 219.26/219.45  |- rdf__type mesh__D011144sskos__Concept
% 219.26/219.45  |- skos__hiddenLabel mesh__D011144 Polyvinylpyridine N Oxide
% 219.26/219.45  |- skos__hiddenLabel mesh__D011144 N-Oxide, Polyvinylpyridine
% 219.26/219.45  |- mesh__recordAuthorizer mesh__D011144 sjn
% 219.26/219.45  |- mesh__dateRevised mesh__D011144 2000-06-22
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D011144 2004
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005905 2004
% 219.26/219.45  |- mesh__recordAuthorizer mesh__D005905 sjn
% 219.26/219.45  |- skos__hiddenLabel mesh__D005905 HB420
% 219.26/219.45  |- skos__hiddenLabel mesh__D005905 HB 419
% 219.26/219.45  |- skos__altLabel mesh__D005905 Glibenclamide
% 219.26/219.45  |- skos__hiddenLabel mesh__D005905 HB419
% 219.26/219.45  |- mesh__dateEstablished mesh__D005905 1973-01-01
% 219.26/219.45  |- mesh__recordOriginator mesh__D005905 NLM
% 219.26/219.45  |- mesh__onlineNote mesh__D005905
% 219.26/219.45       use GLYBURIDE to search GLIBENCLAMIDE 1971-91 %28%as Prov 1971-72%29%%A%  
% 219.26/219.45  |- skos__hiddenLabel mesh__D005905 HB 420
% 219.26/219.45  |- skos__prefLabel mesh__D005905 Glyburide
% 219.26/219.45  |- mesh__dateRevised mesh__D005905 2001-07-25
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005905 2002
% 219.26/219.45  |- skos__broader mesh__D005905smesh__D013453
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005905 2005
% 219.26/219.45  |- mesh__publicMeSHNote mesh__D005905
% 219.26/219.45       92; was GLIBENCLAMIDE 1973-91; GLYBURIDE was see GLIBENCLAMIDE 1973-91%A%  
% 219.26/219.45  |- skos__scopeNote mesh__D005905
% 219.26/219.45       An antidiabetic sulfonylurea derivative with actions similar to those of chlorpropamide.%A%    
% 219.26/219.45  |- mesh__dateCreated mesh__D005905 1999-01-01
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005905 2006
% 219.26/219.45  |- skos__historyNote mesh__D005905 Hypoglycemic Agents %28%1966-1970%29%
% 219.26/219.45  |- rdf__type mesh__D005905sskos__Concept
% 219.26/219.45  |- skos__altLabel mesh__D005905 Glybenclamide
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005905 2003
% 219.26/219.45  |- mesh__recordMaintainer mesh__D005905 ags
% 219.26/219.45  |- mesh__historyNote mesh__D005905
% 219.26/219.45       92; was GLIBENCLAMIDE 1971-91 %28%Prov 1971-72%29%; GLYBURIDE was see GLIBENCLAMIDE 1973-91%A%  
% 219.26/219.45  |- skos__broader mesh__D011978Q000819smesh__D011978
% 219.26/219.45  |- mesh__preferredCombination mesh__D011978Q000819smesh__D018722
% 219.26/219.45  |- rdf__type mesh__D011978Q000819smesh__CompoundConcept
% 219.26/219.45  |- rdf__type mesh__D005107sskos__Concept
% 219.26/219.45  |- mesh__recordMaintainer mesh__D005107 TAP
% 219.26/219.45  |- skos__hiddenLabel mesh__D005107 Explosion
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005107 2000
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005107 2004
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005107 1997
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005107 2006
% 219.26/219.45  |- skos__broader mesh__D005107smesh__D004190
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005107 1999
% 219.26/219.45  |- skos__related mesh__D005107smesh__D001753
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005107 2003
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005107 1993
% 219.26/219.45  |- skos__prefLabel mesh__D005107 Explosions
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005107 2005
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005107 1996
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005107 1995
% 219.26/219.45  |- mesh__dateRevised mesh__D005107 1992-05-15
% 219.26/219.45  |- mesh__recordAuthorizer mesh__D005107 PLS
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005107 1998
% 219.26/219.45  |- mesh__dateCreated mesh__D005107 1999-01-01
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005107 2002
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005107 1994
% 219.26/219.45  |- mesh__recordOriginator mesh__D005107 NLM
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D005107 2001
% 219.26/219.45  |- skos__hiddenLabel mesh__D015535 Arthritic Psoriasis
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D015535 2003
% 219.26/219.45  |- mesh__historyNote mesh__D015535 90   
% 219.26/219.45  |- skos__broader mesh__D015535smesh__D025242
% 219.26/219.45  |- skos__historyNote mesh__D015535 Arthritis %28%1966-1989%29%
% 219.26/219.45  |- mesh__dateRevised mesh__D015535 2001-07-25
% 219.26/219.45  |- mesh__dateCreated mesh__D015535 1989-04-07
% 219.26/219.45  |- mesh__activeMeSHYear mesh__D015535 2006
% 219.26/219.45  |- mesh__recordOriginator mesh__D015535 AGS
% 219.26/219.46  |- skos__broader mesh__D015535smesh__D011565
% 219.26/219.46  |- skos__altLabel mesh__D015535 Psoriasis, Arthritic
% 219.26/219.46  |- mesh__publicMeSHNote mesh__D015535 90   
% 219.26/219.46  |- mesh__recordMaintainer mesh__D015535 ags
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D015535 2005
% 219.26/219.46  |- skos__historyNote mesh__D015535 Psoriasis %28%1966-1989%29%
% 219.26/219.46  |- mesh__dateEstablished mesh__D015535 1990-01-01
% 219.26/219.46  |- skos__hiddenLabel mesh__D015535 Psoriatic Arthritis
% 219.26/219.46  |- skos__broader mesh__D015535smesh__D001168
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D015535 2002
% 219.26/219.46  |- mesh__recordAuthorizer mesh__D015535 sjn
% 219.26/219.46  |- rdf__type mesh__D015535sskos__Concept
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D015535 2004
% 219.26/219.46  |- skos__scopeNote mesh__D015535
% 219.26/219.46       Syndrome in which psoriasis is associated with arthritis, often involving inflammation in terminal interphalangeal joints. A rheumatoid factor is not usually present in the sera of affected individuals.%A%    
% 219.26/219.46  |- skos__prefLabel mesh__D015535 Arthritis, Psoriatic
% 219.26/219.46  |- skos__altLabel mesh__D015535 Psoriasis Arthropathica
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D001515 2004
% 219.26/219.46  |- skos__hiddenLabel mesh__D001515 Beers
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D001515 2001
% 219.26/219.46  |- skos__broader mesh__D001515smesh__D000434
% 219.26/219.46  |- skos__scopeNote mesh__D001515
% 219.26/219.46       An alcoholic beverage usually made from malted cereal grain %28%as barley%29%, flavored with hops, and brewed by slow fermentation.%A%    
% 219.26/219.46  |- mesh__recordAuthorizer mesh__D001515 SJN
% 219.26/219.46  |- mesh__dateRevised mesh__D001515 1997-06-20
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D001515 2005
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D001515 2002
% 219.26/219.46  |- mesh__dateCreated mesh__D001515 1999-01-01
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D001515 2006
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D001515 1998
% 219.26/219.46  |- skos__prefLabel mesh__D001515 Beer
% 219.26/219.46  |- mesh__recordOriginator mesh__D001515 NLM
% 219.26/219.46  |- mesh__recordMaintainer mesh__D001515 JLS
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D001515 2003
% 219.26/219.46  |- rdf__type mesh__D001515sskos__Concept
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D001515 2000
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D001515 1999
% 219.26/219.46  |- skos__broader mesh__D006200smesh__D010858
% 219.26/219.46  |- mesh__historyNote mesh__D006200 76   
% 219.26/219.46  |- mesh__recordOriginator mesh__D006200 SMH
% 219.26/219.46  |- rdf__type mesh__D006200sskos__Concept
% 219.26/219.46  |- skos__prefLabel mesh__D006200 Hair Color
% 219.26/219.46  |- skos__hiddenLabel mesh__D006200 Color, Hair
% 219.26/219.46  |- skos__historyNote mesh__D006200 Pigmentation %28%1966-1975%29%
% 219.26/219.46  |- skos__annotation mesh__D006200
% 219.26/219.46       natural color of human hair or animal fur; do not use for color of hair after dyeing%A%  
% 219.26/219.46  |- skos__hiddenLabel mesh__D006200 Hair Colors
% 219.26/219.46  |- mesh__dateEstablished mesh__D006200 1976-01-01
% 219.26/219.46  |- skos__broader mesh__D006200smesh__D012879
% 219.26/219.46  |- skos__historyNote mesh__D006200 Pigments %28%1966-1975%29%
% 219.26/219.46  |- skos__scopeNote mesh__D006200 Color of hair or fur.     
% 219.26/219.46  |- skos__historyNote mesh__D006200 Color %28%1966-1975%29%
% 219.26/219.46  |- skos__historyNote mesh__D006200 Hair %28%1966-1975%29%
% 219.26/219.46  |- mesh__recordAuthorizer mesh__D006200 sjn
% 219.26/219.46  |- mesh__publicMeSHNote mesh__D006200 76   
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D006200 2006
% 219.26/219.46  |- mesh__dateRevised mesh__D006200 2004-07-13
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D006200 2005
% 219.26/219.46  |- mesh__dateCreated mesh__D006200 1975-07-25
% 219.26/219.46  |- skos__hiddenLabel mesh__D006200 Colors, Hair
% 219.26/219.46  |- mesh__recordMaintainer mesh__D006200 sjn
% 219.26/219.46  |- rdf__type mesh__D019926sskos__Concept
% 219.26/219.46  |- skos__scopeNote mesh__D019926
% 219.26/219.46       A 58-kDa protein that is regulated post-transcriptionally and post-translationally in the cell cycle.%A%    
% 219.26/219.46  |- skos__altLabel mesh__D019926 cdc13 Protein
% 219.26/219.46  |- mesh__recordAuthorizer mesh__D019926 sjn
% 219.26/219.46  |- skos__altLabel mesh__D019926 p56cdc13
% 219.26/219.46  |- mesh__recordOriginator mesh__D019926 AGS
% 219.26/219.46  |- skos__historyNote mesh__D019926 Invertebrate Hormones %28%1989-1990%29%
% 219.26/219.46  |- mesh__recordMaintainer mesh__D019926 ssb
% 219.26/219.46  |- skos__historyNote mesh__D019926 Cyclins %28%1991-1997%29%
% 219.26/219.46  |- mesh__dateCreated mesh__D019926 1997-06-20
% 219.26/219.46  |- mesh__publicMeSHNote mesh__D019926
% 219.26/219.46       98; see CYCLINS 1993-97; CDC13 PROTEIN %28%now CYCLIN B%29% was indexed under CYCLINS 1993-97%A%  
% 219.26/219.46  |- mesh__historyNote mesh__D019926
% 219.26/219.46       98; use CYCLINS %26% CYCLIN B %28%NM%29% 1993-97   
% 219.26/219.46  |- mesh__dateRevised mesh__D019926 2005-06-30
% 219.26/219.46  |- mesh__dateEstablished mesh__D019926 1998-01-01
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D019926 2006
% 219.26/219.46  |- skos__broader mesh__D019926smesh__D016213
% 219.26/219.46  |- skos__prefLabel mesh__D019926 Cyclin B
% 219.26/219.46  |- skos__prefLabel mesh__D011943 Receptors, Adrenergic, beta
% 219.26/219.46  |- mesh__recordOriginator mesh__D011943 SH
% 219.26/219.46  |- rdf__type mesh__D011943sskos__Concept
% 219.26/219.46  |- skos__scopeNote mesh__D011943
% 219.26/219.46       One of the two major pharmacologically defined classes of adrenergic receptors. The alpha-beta distinction was originally based on the cellular effects of receptor activation but now relies on the relative affinities for characteristic synthetic ligands. Beta adrenergic receptors are further subdivided based on information from endogenous and cloned receptors.%A%    
% 219.26/219.46  |- skos__altLabel mesh__D011943 beta-Adrenergic Receptors
% 219.26/219.46  |- skos__broader mesh__D011943smesh__D011941
% 219.26/219.46  |- skos__historyNote mesh__D011943 Receptors, Adrenergic %28%1973-1976%29%
% 219.26/219.46  |- skos__altLabel mesh__D011943 Receptors, beta-Adrenergic
% 219.26/219.46  |- skos__hiddenLabel mesh__D011943 beta Adrenergic Receptors
% 219.26/219.46  |- mesh__publicMeSHNote mesh__D011943
% 219.26/219.46       84; was see under RECEPTORS, ADRENERGIC 1977-83   
% 219.26/219.46  |- skos__altLabel mesh__D011943 Receptor, Adrenergic, beta
% 219.26/219.46  |- mesh__recordAuthorizer mesh__D011943 sjn
% 219.26/219.46  |- mesh__dateCreated mesh__D011943 1976-05-03
% 219.26/219.46  |- skos__annotation mesh__D011943
% 219.26/219.46       coord IM with specific beta adrenergic agent %28%IM%29%; DF: ADREN BETA RECEPT%A%  
% 219.26/219.46  |- skos__historyNote mesh__D011943 Receptors, Drug %28%1968-1972%29%
% 219.26/219.46  |- mesh__dateEstablished mesh__D011943 1984-01-01
% 219.26/219.46  |- mesh__historyNote mesh__D011943
% 219.26/219.46       84%28%77%29%; was see under RECEPTORS, ADRENERGIC 1977-83   
% 219.26/219.46  |- skos__hiddenLabel mesh__D011943 Receptors, beta Adrenergic
% 219.26/219.46  |- skos__hiddenLabel mesh__D011943 beta-Receptors, Adrenergic
% 219.26/219.46  |- mesh__dateRevised mesh__D011943 2005-06-30
% 219.26/219.46  |- skos__hiddenLabel mesh__D011943 Adrenergic beta Receptors
% 219.26/219.46  |- mesh__recordMaintainer mesh__D011943 jmp
% 219.26/219.46  |- skos__altLabel mesh__D011943 Adrenergic beta-Receptors
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011943 2006
% 219.26/219.46  |- mesh__recordAuthorizer mesh__D011145 sjn
% 219.26/219.46  |- skos__prefLabel mesh__D011145 Polyvinyls
% 219.26/219.46  |- mesh__dateCreated mesh__D011145 1999-01-01
% 219.26/219.46  |- skos__broader mesh__D011145smesh__D014753
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011145 2006
% 219.26/219.46  |- mesh__recordMaintainer mesh__D011145 jmp
% 219.26/219.46  |- skos__annotation mesh__D011145 D25-26 qualif   
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011145 2005
% 219.26/219.46  |- skos__broader mesh__D011145smesh__D010969
% 219.26/219.46  |- rdf__type mesh__D011145sskos__Concept
% 219.26/219.46  |- mesh__recordOriginator mesh__D011145 NLM
% 219.26/219.46  |- skos__broader mesh__D011145smesh__D011090
% 219.26/219.46  |- mesh__dateRevised mesh__D011145 2004-07-07
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D005108 2000
% 219.26/219.46  |- mesh__dateEstablished mesh__D005108 1965-01-01
% 219.26/219.46  |- mesh__recordMaintainer mesh__D005108 JLS
% 219.26/219.46  |- mesh__publicMeSHNote mesh__D005108
% 219.26/219.46       65; was EXTINCTION LEARNING 1963-64   
% 219.26/219.46  |- skos__scopeNote mesh__D005108
% 219.26/219.46       The procedure of presenting the conditioned stimulus without reinforcement to an organism previously conditioned. It refers also to the diminution of a conditioned response resulting from this procedure.%A%    
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D005108 1997
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D005108 2004
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D005108 1996
% 219.26/219.46  |- skos__annotation mesh__D005108 DF: EXTINCTION   
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D005108 1999
% 219.26/219.46  |- mesh__recordAuthorizer mesh__D005108 PLS
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D005108 2003
% 219.26/219.46  |- skos__broader mesh__D005108smesh__D012054
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D005108 2006
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D005108 1998
% 219.26/219.46  |- mesh__dateCreated mesh__D005108 1999-01-01
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D005108 2002
% 219.26/219.46  |- skos__altLabel mesh__D005108 Extinction
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D005108 2005
% 219.26/219.46  |- mesh__recordOriginator mesh__D005108 NLM
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D005108 1995
% 219.26/219.46  |- skos__hiddenLabel mesh__D005108 Extinctions %28%Psychology%29%
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D005108 2001
% 219.26/219.46  |- rdf__type mesh__D005108sskos__Concept
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D005108 1994
% 219.26/219.46  |- mesh__historyNote mesh__D005108 65; was EXTINCTION LEARNING 1963-64   
% 219.26/219.46  |- skos__prefLabel mesh__D005108 Extinction %28%Psychology%29%
% 219.26/219.46  |- mesh__dateRevised mesh__D005108 1993-06-04
% 219.26/219.46  |- skos__hiddenLabel mesh__D015536 Down-Regulation, Receptor
% 219.26/219.46  |- skos__prefLabel mesh__D015536 Down-Regulation
% 219.26/219.46  |- skos__altLabel mesh__D015536 Down-Regulation %28%Physiology%29%
% 219.26/219.46  |- mesh__publicMeSHNote mesh__D015536
% 219.26/219.46       2002; see Down-Regulation %28%Physiology%29% 1990-2001   
% 219.26/219.46  |- mesh__dateCreated mesh__D015536 1989-05-26
% 219.26/219.46  |- skos__broader mesh__D015536smesh__D001669
% 219.26/219.46  |- skos__broader mesh__D015536smesh__D002620
% 219.26/219.46  |- skos__hiddenLabel mesh__D015536 Down Regulation
% 219.26/219.46  |- skos__related mesh__D015536smesh__D025461
% 219.26/219.46  |- mesh__historyNote mesh__D015536 2002 %28%1990%29%   
% 219.26/219.46  |- mesh__recordOriginator mesh__D015536 AGS
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D015536 2006
% 219.26/219.46  |- skos__broader mesh__D015536smesh__D005786
% 219.26/219.46  |- mesh__dateEstablished mesh__D015536 1990-01-01
% 219.26/219.46  |- skos__broader mesh__D015536smesh__D025461
% 219.26/219.46  |- mesh__recordMaintainer mesh__D015536 lkt
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D015536 2005
% 219.26/219.46  |- skos__annotation mesh__D015536 DF: DOWN REG   
% 219.26/219.46  |- skos__scopeNote mesh__D015536
% 219.26/219.46       A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes %28%GENE EXPRESSION REGULATION%29%, mRNAs %28%RNA, MESSENGER%29%, and proteins.%A%    
% 219.26/219.46  |- mesh__recordAuthorizer mesh__D015536 sjn
% 219.26/219.46  |- rdf__type mesh__D015536sskos__Concept
% 219.26/219.46  |- skos__related mesh__D015536smesh__D015854
% 219.26/219.46  |- skos__altLabel mesh__D015536 Downregulation
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D015536 2004
% 219.26/219.46  |- mesh__dateRevised mesh__D015536 2003-07-09
% 219.26/219.46  |- skos__related mesh__D001516smesh__D011429
% 219.26/219.46  |- rdf__type mesh__D001516sskos__Concept
% 219.26/219.46  |- mesh__dateRevised mesh__D001516 2003-07-09
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D001516 2005
% 219.26/219.46  |- mesh__recordMaintainer mesh__D001516 ags
% 219.26/219.46  |- mesh__recordOriginator mesh__D001516 NLM
% 219.26/219.46  |- skos__related mesh__D001516smesh__D006722
% 219.26/219.46  |- skos__annotation mesh__D001516
% 219.26/219.46       does not include WASPS; for stings, coord IM with INSECT BITES AND STINGS %28%IM%29%%A%  
% 219.26/219.46  |- skos__broader mesh__D001516smesh__D006927
% 219.26/219.46  |- skos__scopeNote mesh__D001516
% 219.26/219.46       Insect members of the superfamily Apoidea, found almost everywhere, particularly on flowers. About 3500 species occur in North America. They differ from most WASPS in that their young are fed honey and pollen rather than animal food. Honey is collected in the form of nectar from flowers and concentrated into honey by evaporation. For most people bee stings are of little significance and are treated locally; other persons, however, react with hypersensitivity putting them in serious danger. %28%Borror, et al., An Introduction to the Study of Insects, 4th ed; Smith, Insects and Other Arthropods of Medical Importance, 1973, p409%29%%A%    
% 219.26/219.46  |- mesh__recordAuthorizer mesh__D001516 sjn
% 219.26/219.46  |- skos__prefLabel mesh__D001516 Bees
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D001516 2006
% 219.26/219.46  |- mesh__dateCreated mesh__D001516 1999-01-01
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D001516 2004
% 219.26/219.46  |- mesh__publicMeSHNote mesh__D006201
% 219.26/219.46       80; HAIR FOLLICLE DISEASES was see HAIR DISEASES 1993-95   
% 219.26/219.46  |- mesh__historyNote mesh__D006201
% 219.26/219.46       80; was HAIR FOLLICLE DISEASES %28%NON MESH%29% before 1980; HAIR FOLLICLE DISEASES was see HAIR DISEASES 1993-95%A%  
% 219.26/219.46  |- mesh__dateRevised mesh__D006201 2001-07-25
% 219.26/219.46  |- mesh__recordOriginator mesh__D006201 NLM
% 219.26/219.46  |- skos__prefLabel mesh__D006201 Hair Diseases
% 219.26/219.46  |- skos__scopeNote mesh__D006201
% 219.26/219.46       Diseases affecting the orderly growth and persistence of hair.%A%    
% 219.26/219.46  |- mesh__dateCreated mesh__D006201 1999-01-01
% 219.26/219.46  |- mesh__dateEstablished mesh__D006201 1980-01-01
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D006201 2006
% 219.26/219.46  |- skos__annotation mesh__D006201
% 219.26/219.46       GEN or unspecified; prefer specifics; dis of hair follicles: coord IM with HAIR FOLLICLES %28%IM%29% but FOLLICULITIS is also available%A%  
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D006201 2002
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D006201 2005
% 219.26/219.46  |- mesh__recordMaintainer mesh__D006201 lkt
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D006201 2004
% 219.26/219.46  |- skos__historyNote mesh__D006201 Hair %28%1966-1979%29%
% 219.26/219.46  |- mesh__onlineNote mesh__D006201
% 219.26/219.46       use HAIR DISEASES to search HAIR FOLLICLE DISEASES 1993-95%A%  
% 219.26/219.46  |- skos__hiddenLabel mesh__D006201 Hair Disease
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D006201 2003
% 219.26/219.46  |- skos__historyNote mesh__D006201
% 219.26/219.46       Skin Appendage Diseases %28%1968-1979%29%
% 219.26/219.46  |- mesh__recordAuthorizer mesh__D006201 sjn
% 219.26/219.46  |- rdf__type mesh__D006201sskos__Concept
% 219.26/219.46  |- skos__broader mesh__D006201smesh__D012871
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D019927 2006
% 219.26/219.46  |- skos__broader mesh__D019927smesh__D016213
% 219.26/219.46  |- mesh__recordOriginator mesh__D019927 AGS
% 219.26/219.46  |- mesh__dateRevised mesh__D019927 2005-06-30
% 219.26/219.46  |- rdf__type mesh__D019927sskos__Concept
% 219.26/219.46  |- skos__scopeNote mesh__D019927
% 219.26/219.46       A 50-kDa protein that complexes with cdk2 in the late G1 phase of the cell cycle.%A%    
% 219.26/219.46  |- skos__prefLabel mesh__D019927 Cyclin E
% 219.26/219.46  |- mesh__historyNote mesh__D019927 98   
% 219.26/219.46  |- mesh__publicMeSHNote mesh__D019927 98   
% 219.26/219.46  |- mesh__recordMaintainer mesh__D019927 ssb
% 219.26/219.46  |- mesh__dateCreated mesh__D019927 1997-06-20
% 219.26/219.46  |- mesh__recordAuthorizer mesh__D019927 sjn
% 219.26/219.46  |- skos__historyNote mesh__D019927 Cyclins %28%1991-1997%29%
% 219.26/219.46  |- mesh__dateEstablished mesh__D019927 1998-01-01
% 219.26/219.46  |- rdf__type mesh__D011944sskos__Concept
% 219.26/219.46  |- skos__broader mesh__D011944smesh__D011987
% 219.26/219.46  |- skos__prefLabel mesh__D011944 Receptors, Androgen
% 219.26/219.46  |- skos__altLabel mesh__D011944 Receptors, Androgens
% 219.26/219.46  |- mesh__historyNote mesh__D011944
% 219.26/219.46       86%28%77%29%; was see under RECEPTORS, STEROID 1977-85   
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011944 1997
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011944 2002
% 219.26/219.46  |- skos__annotation mesh__D011944
% 219.26/219.46       coord IM with specific androgen %28%IM%29%; DF: RECEPT ANDROGEN%A%  
% 219.26/219.46  |- skos__historyNote mesh__D011944
% 219.26/219.46       Receptors, Endogenous Substances %28%1973-1976%29%
% 219.26/219.46  |- skos__hiddenLabel mesh__D011944 Androgens Receptors
% 219.26/219.46  |- skos__altLabel mesh__D011944 Androgen Receptors
% 219.26/219.46  |- skos__altLabel mesh__D011944 Androgen Receptor
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011944 1999
% 219.26/219.46  |- mesh__dateRevised mesh__D011944 1995-06-08
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011944 1996
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011944 2001
% 219.26/219.46  |- mesh__recordAuthorizer mesh__D011944 PLS
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011944 2004
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011944 2000
% 219.26/219.46  |- mesh__recordMaintainer mesh__D011944 KEV
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011944 1998
% 219.26/219.46  |- skos__historyNote mesh__D011944 Androgens %28%1966-1976%29%
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011944 2006
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011944 2003
% 219.26/219.46  |- skos__historyNote mesh__D011944 Receptors, Drug %28%1968-1972%29%
% 219.26/219.46  |- skos__scopeNote mesh__D011944
% 219.26/219.46       Proteins, generally found in the cytoplasm, that specifically bind androgens and mediate their cellular actions. The complex of the androgen and receptor migrates to the nucleus where it induces transcription of specific segments of DNA.%A%    
% 219.26/219.46  |- mesh__publicMeSHNote mesh__D011944
% 219.26/219.46       86; was see under RECEPTORS, STEROID 1977-85   
% 219.26/219.46  |- mesh__dateEstablished mesh__D011944 1986-01-01
% 219.26/219.46  |- mesh__dateCreated mesh__D011944 1976-05-05
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011944 2005
% 219.26/219.46  |- skos__hiddenLabel mesh__D011944 Receptor, Androgen
% 219.26/219.46  |- mesh__recordOriginator mesh__D011944 SH
% 219.26/219.46  |- mesh__onlineNote mesh__D011146
% 219.26/219.46       use ECZEMA, DYSHIDROTIC to search POMPHOLYX 1966-92   
% 219.26/219.46  |- skos__altLabel mesh__D011146 Vesicular Palmoplantar Eczema
% 219.26/219.46  |- skos__hiddenLabel mesh__D011146 Palmoplantar Eczema, Vesicular
% 219.26/219.46  |- mesh__dateRevised mesh__D011146 1993-06-02
% 219.26/219.46  |- skos__annotation mesh__D011146 eczema with hyperhidrosis   
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011146 2006
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011146 1997
% 219.26/219.46  |- skos__altLabel mesh__D011146 Eczema, Vesicular Palmoplantar
% 219.26/219.46  |- skos__hiddenLabel mesh__D011146 Eczemas, Dyshidrotic
% 219.26/219.46  |- skos__hiddenLabel mesh__D011146 Dyshidrotic Eczema
% 219.26/219.46  |- mesh__dateCreated mesh__D011146 1999-01-01
% 219.26/219.46  |- skos__broader mesh__D011146smesh__D012872
% 219.26/219.46  |- skos__altLabel mesh__D011146 Pompholyx
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011146 2000
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011146 2005
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011146 1996
% 219.26/219.46  |- skos__altLabel mesh__D011146 Eczema, Dyshydrotic
% 219.26/219.46  |- mesh__recordMaintainer mesh__D011146 TAP
% 219.26/219.46  |- skos__scopeNote mesh__D011146
% 219.26/219.46       A recurrent eczematous reaction characterized by the development of vesicular eruptions on the palms and soles, particularly along the sides and between the digits. It is accompanied by pruritus, a burning sensation, and hyperhidrosis. The disease is self-limiting, lasting only a few weeks. %28%Dorland, 27th ed%29%%A%    
% 219.26/219.46  |- mesh__historyNote mesh__D011146
% 219.26/219.46       93; was POMPHOLYX 1963-92; ECZEMA, DYSHIDROTIC was see POMPHOLYX 1991-92%A%  
% 219.26/219.46  |- mesh__recordOriginator mesh__D011146 NLM
% 219.26/219.46  |- rdf__type mesh__D011146sskos__Concept
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011146 1995
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011146 2004
% 219.26/219.46  |- mesh__publicMeSHNote mesh__D011146
% 219.26/219.46       93; was POMPHOLYX 1963-92; ECZEMA, DYSHIDROTIC was see POMPHOLYX 1991-92%A%  
% 219.26/219.46  |- skos__hiddenLabel mesh__D011146 Palmoplantar Eczemas, Vesicular
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011146 1999
% 219.26/219.46  |- skos__hiddenLabel mesh__D011146 Eczemas, Vesicular Palmoplantar
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011146 1994
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011146 2003
% 219.26/219.46  |- skos__prefLabel mesh__D011146 Eczema, Dyshidrotic
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011146 2002
% 219.26/219.46  |- mesh__recordAuthorizer mesh__D011146 PLS
% 219.26/219.46  |- skos__broader mesh__D011146smesh__D004485
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011146 1998
% 219.26/219.46  |- skos__hiddenLabel mesh__D011146 Dyshidrotic Eczemas
% 219.26/219.46  |- skos__hiddenLabel mesh__D011146 Eczemas, Dyshydrotic
% 219.26/219.46  |- skos__hiddenLabel mesh__D011146 Dyshydrotic Eczema
% 219.26/219.46  |- skos__hiddenLabel mesh__D011146 Vesicular Palmoplantar Eczemas
% 219.26/219.46  |- skos__hiddenLabel mesh__D011146 Dyshydrotic Eczemas
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D011146 2001
% 219.26/219.46  |- mesh__dateCreated mesh__D005907 1974-11-11
% 219.26/219.46  |- skos__hiddenLabel mesh__D005907 Gen Gliclazide
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D005907 2006
% 219.26/219.46  |- rdf__type mesh__D005907sskos__Concept
% 219.26/219.46  |- skos__hiddenLabel mesh__D005907 S1702
% 219.26/219.46  |- skos__hiddenLabel mesh__D005907 S 852
% 219.26/219.46  |- mesh__dateRevised mesh__D005907 2005-06-30
% 219.26/219.46  |- skos__altLabel mesh__D005907 Helsinn Brand of Gliclazide
% 219.26/219.46  |- skos__hiddenLabel mesh__D005907 S 1702
% 219.26/219.46  |- mesh__publicMeSHNote mesh__D005907
% 219.26/219.46       91; was see under SULFONYLUREA COMPOUNDS 1975-90   
% 219.26/219.46  |- mesh__dateEstablished mesh__D005907 1991-01-01
% 219.26/219.46  |- skos__altLabel mesh__D005907 Gliklazid
% 219.26/219.46  |- skos__altLabel mesh__D005907 Alphapharm Brand of Gliclazide
% 219.26/219.46  |- skos__historyNote mesh__D005907 Sulfonylurea Compounds %28%1972-1974%29%
% 219.26/219.46  |- skos__altLabel mesh__D005907 Servier Brand of Gliclazide
% 219.26/219.46  |- skos__prefLabel mesh__D005907 Gliclazide
% 219.26/219.46  |- mesh__recordAuthorizer mesh__D005907 sjn
% 219.26/219.46  |- skos__historyNote mesh__D005907 Cyclopentanes %28%1972-1974%29%
% 219.26/219.46  |- skos__altLabel mesh__D005907 Novopharm Brand of Gliclazide
% 219.26/219.46  |- mesh__historyNote mesh__D005907
% 219.26/219.46       91%28%75%29%; was see under SULFONYLUREA COMPOUNDS 1975-90   
% 219.26/219.46  |- skos__altLabel mesh__D005907 Genpharm Brand of Gliclazide
% 219.26/219.46  |- skos__hiddenLabel mesh__D005907 Novo Gliclazide
% 219.26/219.46  |- mesh__recordMaintainer mesh__D005907 CCR
% 219.26/219.46  |- mesh__recordOriginator mesh__D005907 NLM
% 219.26/219.46  |- skos__historyNote mesh__D005907 Pyrroles %28%1972-1974%29%
% 219.26/219.46  |- skos__hiddenLabel mesh__D005907 Gliclazide Servier Brand
% 219.26/219.46  |- skos__altLabel mesh__D005907 Generics Brand of Gliclazide
% 219.26/219.46  |- skos__broader mesh__D005907smesh__D013453
% 219.26/219.46  |- skos__altLabel mesh__D005907 Glyclazide
% 219.26/219.46  |- skos__scopeNote mesh__D005907
% 219.26/219.46       An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.%A%    
% 219.26/219.46  |- skos__hiddenLabel mesh__D005907 S852
% 219.26/219.46  |- skos__scopeNote mesh__D005109
% 219.26/219.46       A meshwork-like substance found within the extracellular space and in association with the basement membrane of the cell surface. It promotes cellular proliferation and provides a supporting structure to which cells or cell lysates in culture dishes adhere.%A%    
% 219.26/219.46  |- mesh__dateCreated mesh__D005109 1983-05-31
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D005109 2001
% 219.26/219.46  |- mesh__publicMeSHNote mesh__D005109 84   
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D005109 2004
% 219.26/219.46  |- skos__altLabel mesh__D005109 Matrix, Extracellular
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D005109 2003
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D005109 2006
% 219.26/219.46  |- skos__historyNote mesh__D005109 Extracellular Space %28%1966-1983%29%
% 219.26/219.46  |- mesh__dateRevised mesh__D005109 2000-06-22
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D005109 2005
% 219.26/219.46  |- skos__hiddenLabel mesh__D005109 Matrices, Extracellular
% 219.26/219.46  |- skos__prefLabel mesh__D005109 Extracellular Matrix
% 219.26/219.46  |- rdf__type mesh__D005109sskos__Concept
% 219.26/219.46  |- skos__hiddenLabel mesh__D005109 Extracellular Matrices
% 219.26/219.46  |- skos__broader mesh__D005109smesh__D005110
% 219.26/219.46  |- mesh__recordAuthorizer mesh__D005109 sjn
% 219.26/219.46  |- mesh__historyNote mesh__D005109 84   
% 219.26/219.46  |- mesh__recordOriginator mesh__D005109 AEP
% 219.26/219.46  |- skos__annotation mesh__D005109
% 219.26/219.46       A 11 qualif except /cytol; /genet permitted   
% 219.26/219.46  |- mesh__dateEstablished mesh__D005109 1984-01-01
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D005109 2002
% 219.26/219.46  |- skos__historyNote mesh__D005109 Cells, Cultured %28%1972-1983%29%
% 219.26/219.46  |- mesh__recordMaintainer mesh__D005109 TGC
% 219.26/219.46  |- skos__broader mesh__D006133Q000037smesh__D006133
% 219.26/219.46  |- mesh__preferredCombination mesh__D006133Q000037smesh__D006131
% 219.26/219.46  |- rdf__type mesh__D006133Q000037smesh__CompoundConcept
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D015537 2006
% 219.26/219.46  |- mesh__recordMaintainer mesh__D015537 TGC
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D015537 1997
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D015537 2002
% 219.26/219.46  |- skos__broader mesh__D015537smesh__D011041
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D015537 2005
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D015537 1996
% 219.26/219.46  |- mesh__dateEstablished mesh__D015537 1990-01-01
% 219.26/219.46  |- mesh__historyNote mesh__D015537 90; was see POISONING 1981-89   
% 219.26/219.46  |- mesh__publicMeSHNote mesh__D015537 90; was see POISONING 1981-89   
% 219.26/219.46  |- skos__hiddenLabel mesh__D015537 Overdoses
% 219.26/219.46  |- skos__prefLabel mesh__D015537 Overdose
% 219.26/219.46  |- mesh__recordAuthorizer mesh__D015537 PLS
% 219.26/219.46  |- rdf__type mesh__D015537sskos__Concept
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D015537 1999
% 219.26/219.46  |- mesh__dateCreated mesh__D015537 1989-04-07
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D015537 2001
% 219.26/219.46  |- mesh__onlineNote mesh__D015537 search POISONING 1966-89   
% 219.26/219.46  |- skos__historyNote mesh__D015537 Poisoning %28%1966-1989%29%
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D015537 2004
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D015537 1998
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D015537 2000
% 219.26/219.46  |- mesh__recordOriginator mesh__D015537 AGS
% 219.26/219.46  |- skos__scopeNote mesh__D015537
% 219.26/219.46       An accidental or deliberate dose of a medication or street drug that is in excess of what is normally used.%A%    
% 219.26/219.46  |- skos__annotation mesh__D015537
% 219.26/219.46       note category: accidental or deliberate overdose; almost never IM %26% seldom with qualif; coord NIM with specific substance /adv eff-pois-tox %28%IM%29%%A%  
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D015537 2003
% 219.26/219.46  |- mesh__dateRevised mesh__D015537 1995-03-13
% 219.26/219.46  |- mesh__dateRevised mesh__D001517 2004-07-07
% 219.26/219.46  |- skos__altLabel mesh__D001517 Coleoptera
% 219.26/219.46  |- mesh__publicMeSHNote mesh__D001517
% 219.26/219.46       1963; for COLEPTERA see COLEPTERA 1975-2004   
% 219.26/219.46  |- mesh__historyNote mesh__D001517 1963   
% 219.26/219.46  |- mesh__recordOriginator mesh__D001517 NLM
% 219.26/219.46  |- skos__prefLabel mesh__D001517 Beetles
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D001517 2006
% 219.26/219.46  |- skos__annotation mesh__D001517
% 219.26/219.46       for killing beetles with insecticides, see note at INSECTICIDES%A%  
% 219.26/219.46  |- mesh__dateCreated mesh__D001517 1999-01-01
% 219.26/219.46  |- rdf__type mesh__D001517sskos__Concept
% 219.26/219.46  |- skos__scopeNote mesh__D001517
% 219.26/219.46       INSECTS of the order Coleoptera, containing over 350,000 species in 150 families. They possess hard bodies and their mouthparts are adapted for chewing.%A%    
% 219.26/219.46  |- skos__broader mesh__D001517smesh__D007313
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D001517 2005
% 219.26/219.46  |- mesh__recordAuthorizer mesh__D001517 sjn
% 219.26/219.46  |- mesh__recordMaintainer mesh__D001517 ags
% 219.26/219.46  |- skos__broader mesh__D006202smesh__D006203
% 219.26/219.46  |- skos__hiddenLabel mesh__D006202 Colorants, Hair
% 219.26/219.46  |- skos__historyNote mesh__D006202 Hair Color %28%1976-1978%29%
% 219.26/219.46  |- skos__altLabel mesh__D006202 Dyes, Hair
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D006202 2006
% 219.26/219.46  |- skos__altLabel mesh__D006202 Hair Colorants
% 219.26/219.46  |- mesh__dateEstablished mesh__D006202 1991-01-01
% 219.26/219.46  |- mesh__activeMeSHYear mesh__D006202 2005
% 219.26/219.46  |- mesh__recordAuthorizer mesh__D006202 sjn
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D006202 2004
% 219.26/219.47  |- mesh__dateCreated mesh__D006202 1978-05-01
% 219.26/219.47  |- skos__historyNote mesh__D006202 Cosmetics %28%1966-1978%29%
% 219.26/219.47  |- skos__historyNote mesh__D006202 Hair %28%1966-1978%29%
% 219.26/219.47  |- skos__altLabel mesh__D006202 Coloring Agents, Hair
% 219.26/219.47  |- mesh__dateRevised mesh__D006202 2003-07-09
% 219.26/219.47  |- rdf__type mesh__D006202sskos__Concept
% 219.26/219.47  |- skos__historyNote mesh__D006202 Dyes %28%1966-1978%29%
% 219.26/219.47  |- skos__scopeNote mesh__D006202
% 219.26/219.47       Dyes used as cosmetics to change hair color either permanently or temporarily.%A%    
% 219.26/219.47  |- skos__hiddenLabel mesh__D006202 Agents, Hair Coloring
% 219.26/219.47  |- skos__annotation mesh__D006202 D25-26 qualif   
% 219.26/219.47  |- skos__hiddenLabel mesh__D006202 Hair Coloring Agents
% 219.26/219.47  |- mesh__recordOriginator mesh__D006202 SH
% 219.26/219.47  |- mesh__recordMaintainer mesh__D006202 ssb
% 219.26/219.47  |- mesh__historyNote mesh__D006202
% 219.26/219.47       91%28%79%29%; was see under HAIR PREPARATIONS 1980-90; was see under COSMETICS 1979%A%  
% 219.26/219.47  |- mesh__publicMeSHNote mesh__D006202
% 219.26/219.47       91; was see under HAIR PREPARATIONS 1980-90; was see under COSMETICS 1979%A%  
% 219.26/219.47  |- skos__prefLabel mesh__D006202 Hair Dyes
% 219.26/219.47  |- skos__broader mesh__D006321Q000637smesh__D006321
% 219.26/219.47  |- mesh__preferredCombination mesh__D006321Q000637smesh__D016027
% 219.26/219.47  |- rdf__type mesh__D006321Q000637smesh__CompoundConcept
% 219.26/219.47  |- skos__broader mesh__D009333Q000293smesh__D009333
% 219.26/219.47  |- mesh__preferredCombination mesh__D009333Q000293smesh__D019838
% 219.26/219.47  |- rdf__type mesh__D009333Q000293smesh__CompoundConcept
% 219.26/219.47  |- rdf__type mesh__D019928sskos__Concept
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D019928 2005
% 219.26/219.47  |- mesh__dateEstablished mesh__D019928 1998-01-01
% 219.26/219.47  |- skos__hiddenLabel mesh__D019928 Implantation, Breast Prosthesis
% 219.26/219.47  |- mesh__recordMaintainer mesh__D019928 nns
% 219.26/219.47  |- skos__historyNote mesh__D019928 Breast Implants %28%1995-1997%29%
% 219.26/219.47  |- mesh__historyNote mesh__D019928 98   
% 219.26/219.47  |- skos__related mesh__D019928smesh__D018427
% 219.26/219.47  |- skos__broader mesh__D019928smesh__D016462
% 219.26/219.47  |- skos__hiddenLabel mesh__D019928 Prosthesis Implantations, Breast
% 219.26/219.47  |- mesh__recordOriginator mesh__D019928 PXP
% 219.26/219.47  |- skos__hiddenLabel mesh__D019928 Breast Implantations
% 219.26/219.47  |- skos__prefLabel mesh__D019928 Breast Implantation
% 219.26/219.47  |- skos__hiddenLabel mesh__D019928 Implantations, Breast
% 219.26/219.47  |- mesh__dateRevised mesh__D019928 2004-07-07
% 219.26/219.47  |- skos__broader mesh__D019928smesh__D019919
% 219.26/219.47  |- skos__hiddenLabel mesh__D019928 Implantation, Breast
% 219.26/219.47  |- skos__scopeNote mesh__D019928
% 219.26/219.47       Surgical insertion of an inert sac filled with silicone or other material to augment the female form cosmetically.%A%    
% 219.26/219.47  |- mesh__publicMeSHNote mesh__D019928 98   
% 219.26/219.47  |- skos__hiddenLabel mesh__D019928 Prosthesis Implantation, Breast
% 219.26/219.47  |- skos__hiddenLabel mesh__D019928 Implantations, Breast Prosthesis
% 219.26/219.47  |- skos__altLabel mesh__D019928 Breast Prosthesis Implantation
% 219.26/219.47  |- mesh__dateCreated mesh__D019928 1997-06-20
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D019928 2006
% 219.26/219.47  |- skos__historyNote mesh__D019928
% 219.26/219.47       Prostheses and Implants %28%1967-1994%29%
% 219.26/219.47  |- mesh__recordAuthorizer mesh__D019928 sjn
% 219.26/219.47  |- skos__hiddenLabel mesh__D019928 Breast Prosthesis Implantations
% 219.26/219.47  |- skos__prefLabel mesh__D011945 Receptors, Angiotensin
% 219.26/219.47  |- mesh__recordAuthorizer mesh__D011945 sjn
% 219.26/219.47  |- mesh__dateEstablished mesh__D011945 1987-01-01
% 219.26/219.47  |- skos__broader mesh__D011945smesh__D043562
% 219.26/219.47  |- mesh__historyNote mesh__D011945
% 219.26/219.47       87%28%77%29%; was see under RECEPTORS, ENDOGENOUS SUBSTANCES 1977-86%A%  
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D011945 2006
% 219.26/219.47  |- skos__annotation mesh__D011945
% 219.26/219.47       coord IM with specific angiotensin %28%IM%29%; see also specific subtypes, don%27%t confuse receptors that bind to ANGIOTENSIN II and ANGIOTENSIN III with specific angiotensin receptor subtypes;  DF: RECEPT ANGIOTENSIN%A%  
% 219.26/219.47  |- mesh__dateRevised mesh__D011945 2004-07-07
% 219.26/219.47  |- skos__altLabel mesh__D011945 Angiotensin Receptors
% 219.26/219.47  |- skos__related mesh__D011945smesh__D047228
% 219.26/219.47  |- skos__altLabel mesh__D011945 Angiotensin III Receptor
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D011945 2005
% 219.26/219.47  |- skos__historyNote mesh__D011945 Receptors, Drug %28%1968-1976%29%
% 219.26/219.47  |- skos__broader mesh__D011945smesh__D018013
% 219.26/219.47  |- mesh__recordOriginator mesh__D011945 SH
% 219.26/219.47  |- rdf__type mesh__D011945sskos__Concept
% 219.26/219.47  |- skos__altLabel mesh__D011945 Angiotensin II Receptor
% 219.26/219.47  |- skos__historyNote mesh__D011945
% 219.26/219.47       Receptors, Endogenous Substances %28%1973-1976%29%
% 219.26/219.47  |- skos__historyNote mesh__D011945 Angiotensin II %28%1966-1976%29%
% 219.26/219.47  |- skos__broader mesh__D011945smesh__D018000
% 219.26/219.47  |- skos__scopeNote mesh__D011945
% 219.26/219.47       Cell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells.%A%    
% 219.26/219.47  |- mesh__publicMeSHNote mesh__D011945
% 219.26/219.47       87; was see under RECEPTORS, ENDOGENOUS SUBSTANCES 1977-86%A%  
% 219.26/219.47  |- mesh__recordMaintainer mesh__D011945 ssb
% 219.26/219.47  |- mesh__dateCreated mesh__D011945 1976-05-03
% 219.26/219.47  |- skos__hiddenLabel mesh__D016630 RWJ15927
% 219.26/219.47  |- skos__hiddenLabel mesh__D016630 RWJ 15927
% 219.26/219.47  |- mesh__dateRevised mesh__D016630 2005-06-30
% 219.26/219.47  |- skos__broader mesh__D016630smesh__D011459
% 219.26/219.47  |- mesh__publicMeSHNote mesh__D016630
% 219.26/219.47       92; RIOPROSTIL was indexed under PROSTAGLANDINS E 1985-91%A%  
% 219.26/219.47  |- mesh__dateEstablished mesh__D016630 1992-01-01
% 219.26/219.47  |- mesh__recordAuthorizer mesh__D016630 sjn
% 219.26/219.47  |- skos__historyNote mesh__D016630 Anti-Ulcer Agents %28%1977-1991%29%
% 219.26/219.47  |- mesh__dateCreated mesh__D016630 1991-01-25
% 219.26/219.47  |- mesh__historyNote mesh__D016630 92; was RIOPROSTIL %28%NM%29% 1985-91   
% 219.26/219.47  |- mesh__recordOriginator mesh__D016630 RLS
% 219.26/219.47  |- rdf__type mesh__D016630sskos__Concept
% 219.26/219.47  |- skos__scopeNote mesh__D016630
% 219.26/219.47       A synthetic methylprostaglandin E1 analog that reduces gastric acid secretion and enhances the gastric mucus-bicarbonate barrier. It is effective in the therapy of gastric ulcers and gives significant protection against NSAID-induced gastric mucosal damage. The drug also prevents cyclosporin A-induced damage to endocrine and exocrine pancreatic secretions. It shows a low order of acute toxicity and there is no evidence of embryotoxicity, fetotoxicity, teratogenicity, or mutagenicity in animal studies.%A%    
% 219.26/219.47  |- skos__hiddenLabel mesh__D016630 ORF15927
% 219.26/219.47  |- skos__historyNote mesh__D016630 Prostaglandins E %28%1975-1991%29%
% 219.26/219.47  |- skos__hiddenLabel mesh__D016630 ORF 15927
% 219.26/219.47  |- mesh__recordMaintainer mesh__D016630 ssb
% 219.26/219.47  |- skos__hiddenLabel mesh__D016630 TR 4698
% 219.26/219.47  |- skos__hiddenLabel mesh__D016630 TR4698
% 219.26/219.47  |- skos__prefLabel mesh__D016630 Rioprostil
% 219.26/219.47  |- mesh__onlineNote mesh__D016630
% 219.26/219.47       use RIOPROSTIL %28%NM%29% to search RIOPROSTIL 1985-91   
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D016630 2006
% 219.26/219.47  |- skos__historyNote mesh__D016630
% 219.26/219.47       Prostaglandins, Synthetic %28%1977-1991%29%
% 219.26/219.47  |- mesh__dateEstablished mesh__D030301 2002-01-01
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D030301 2004
% 219.26/219.47  |- skos__altLabel mesh__D030301 Activin Receptor Like Kinases, Type II
% 219.26/219.47  |- mesh__historyNote mesh__D030301
% 219.26/219.47       2002; use ACTIVIN RECEPTORS, TYPE II %28%NM%29% 1991-2001   
% 219.26/219.47  |- mesh__recordMaintainer mesh__D030301 ssb
% 219.26/219.47  |- mesh__dateRevised mesh__D030301 2003-07-09
% 219.26/219.47  |- skos__historyNote mesh__D030301
% 219.26/219.47       Receptors, Cell Surface %28%1991-1993%29%
% 219.26/219.47  |- skos__scopeNote mesh__D030301
% 219.26/219.47       One of the two types of ACTIVIN RECEPTORS. They are membrane protein kinases belonging to the family of PROTEIN-SERINE-THREONINE KINASES.   The major type II activin receptors are ActR-IIA and ActR-IIB.%A%    
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D030301 2006
% 219.26/219.47  |- skos__prefLabel mesh__D030301 Activin Receptors, Type II
% 219.26/219.47  |- skos__broader mesh__D030301smesh__D029404
% 219.26/219.47  |- skos__historyNote mesh__D030301
% 219.26/219.47       Receptors, Growth Factor %28%1994-2001%29%
% 219.26/219.47  |- mesh__dateCreated mesh__D030301 2001-07-25
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D030301 2005
% 219.26/219.47  |- mesh__recordAuthorizer mesh__D030301 sjn
% 219.26/219.47  |- rdf__type mesh__D030301sskos__Concept
% 219.26/219.47  |- mesh__recordOriginator mesh__D030301 lkt
% 219.26/219.47  |- skos__altLabel mesh__D030301 Activin Receptors Type II
% 219.26/219.47  |- mesh__publicMeSHNote mesh__D030301
% 219.26/219.47       2002; ACTIVIN RECEPTOR TYPE II was indexed under RECEPTORS, GROWTH FACTORS 1991-2001%A%  
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002610 1994
% 219.26/219.47  |- skos__hiddenLabel mesh__D002610 Cheeks
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002610 2005
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002610 2001
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002610 1999
% 219.26/219.47  |- skos__broader mesh__D002610smesh__D005145
% 219.26/219.47  |- skos__hiddenLabel mesh__D002610 Buccas
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002610 1993
% 219.26/219.47  |- skos__annotation mesh__D002610
% 219.26/219.47       for that external portion of face or that internal portion of mouth; NIM for hamster cheek pouch; buccal mucosa = MOUTH MUCOSA %28%IM%29% + CHEEK %28%NIM%29%; cheek bone fracture = ZYGOMATIC FRACTURES%A%  
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002610 2004
% 219.26/219.47  |- mesh__dateCreated mesh__D002610 1999-01-01
% 219.26/219.47  |- mesh__recordOriginator mesh__D002610 NLM
% 219.26/219.47  |- mesh__dateRevised mesh__D002610 1991-01-07
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002610 2000
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002610 1998
% 219.26/219.47  |- skos__broader mesh__D002610smesh__D013284
% 219.26/219.47  |- skos__prefLabel mesh__D002610 Cheek
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002610 1992
% 219.26/219.47  |- rdf__type mesh__D002610sskos__Concept
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002610 2003
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002610 1997
% 219.26/219.47  |- mesh__recordAuthorizer mesh__D002610 PLS
% 219.26/219.47  |- skos__altLabel mesh__D002610 Bucca
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002610 1996
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002610 1995
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002610 2006
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002610 2002
% 219.26/219.47  |- mesh__recordMaintainer mesh__D002610 TGC
% 219.26/219.47  |- mesh__dateEstablished mesh__D015538 1990-01-01
% 219.26/219.47  |- skos__historyNote mesh__D015538 Nitrates %28%1966-1989%29%
% 219.26/219.47  |- skos__broader mesh__D015538smesh__D008660
% 219.26/219.47  |- skos__historyNote mesh__D015538 Nitrosamines %28%1966-1989%29%
% 219.26/219.47  |- rdf__type mesh__D015538sskos__Concept
% 219.26/219.47  |- skos__historyNote mesh__D015538 Nitroso Compounds %28%1966-1989%29%
% 219.26/219.47  |- skos__scopeNote mesh__D015538
% 219.26/219.47       Conversion into nitroso compounds. An example is the reaction of nitrites with amino compounds to form carcinogenic N-nitrosamines.%A%    
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D015538 1999
% 219.26/219.47  |- mesh__dateCreated mesh__D015538 1989-06-19
% 219.26/219.47  |- skos__prefLabel mesh__D015538 Nitrosation
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D015538 2002
% 219.26/219.47  |- mesh__historyNote mesh__D015538 90   
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D015538 2004
% 219.26/219.47  |- skos__annotation mesh__D015538
% 219.26/219.47       almost never IM; enzymatic nitrosation: coord NIM with NITRATES %28%IM%29% + substrate %28%NIM%29%%A%  
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D015538 1998
% 219.26/219.47  |- skos__historyNote mesh__D015538 Nitrites %28%1966-1989%29%
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D015538 2003
% 219.26/219.47  |- mesh__recordMaintainer mesh__D015538 PXP
% 219.26/219.47  |- skos__broader mesh__D015538smesh__D002625
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D015538 2001
% 219.26/219.47  |- skos__broader mesh__D015538smesh__D001669
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D015538 2006
% 219.26/219.47  |- mesh__publicMeSHNote mesh__D015538 90   
% 219.26/219.47  |- skos__hiddenLabel mesh__D015538 Nitrosations
% 219.26/219.47  |- mesh__dateRevised mesh__D015538 1997-06-20
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D015538 2000
% 219.26/219.47  |- mesh__recordOriginator mesh__D015538 AGS
% 219.26/219.47  |- mesh__recordAuthorizer mesh__D015538 SJN
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D015538 2005
% 219.26/219.47  |- skos__annotation mesh__D012240
% 219.26/219.47       infection: coord IM with ACTINOMYCETALES INFECTIONS %28%IM%29%   
% 219.26/219.47  |- skos__historyNote mesh__D012240 Rhodospirillaceae %28%1976-1986%29%
% 219.26/219.47  |- mesh__publicMeSHNote mesh__D012240 87   
% 219.26/219.47  |- skos__prefLabel mesh__D012240 Rhodococcus
% 219.26/219.47  |- skos__scopeNote mesh__D012240
% 219.26/219.47       A bacterial genus of the order ACTINOMYCETALES.     
% 219.26/219.47  |- mesh__recordOriginator mesh__D012240 RC
% 219.26/219.47  |- skos__historyNote mesh__D012240 Coryneform Group %28%1976-1986%29%
% 219.26/219.47  |- skos__historyNote mesh__D012240 Actinomycetales %28%1967-1986%29%
% 219.26/219.47  |- skos__broader mesh__D012240smesh__D009618
% 219.26/219.47  |- skos__historyNote mesh__D012240 Corynebacterium %28%1966-1986%29%
% 219.26/219.47  |- mesh__recordMaintainer mesh__D012240 SYSTEM
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D012240 2006
% 219.26/219.47  |- mesh__dateEstablished mesh__D012240 1987-01-01
% 219.26/219.47  |- mesh__dateCreated mesh__D012240 1986-06-16
% 219.26/219.47  |- mesh__recordAuthorizer mesh__D012240 sjn
% 219.26/219.47  |- mesh__historyNote mesh__D012240 87   
% 219.26/219.47  |- rdf__type mesh__D012240sskos__Concept
% 219.26/219.47  |- mesh__dateRevised mesh__D012240 2005-06-30
% 219.26/219.47  |- mesh__recordMaintainer mesh__D006203 ssb
% 219.26/219.47  |- skos__historyNote mesh__D006203 Cosmetics %28%1966-1979%29%
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D006203 2005
% 219.26/219.47  |- mesh__publicMeSHNote mesh__D006203 80   
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D006203 2004
% 219.26/219.47  |- skos__historyNote mesh__D006203 Hair %28%1966-1979%29%
% 219.26/219.47  |- skos__scopeNote mesh__D006203
% 219.26/219.47       Hair grooming and cleansing aids or other products meant for topical application to hair, usually human. They include sprays, bleaches, conditioners, rinses, shampoos, nutrient lotions, etc.%A%    
% 219.26/219.47  |- skos__hiddenLabel mesh__D006203 Hair Cosmetics
% 219.26/219.47  |- mesh__dateRevised mesh__D006203 2003-07-09
% 219.26/219.47  |- rdf__type mesh__D006203sskos__Concept
% 219.26/219.47  |- skos__broader mesh__D006203smesh__D003358
% 219.26/219.47  |- mesh__historyNote mesh__D006203 80   
% 219.26/219.47  |- skos__prefLabel mesh__D006203 Hair Preparations
% 219.26/219.47  |- skos__hiddenLabel mesh__D006203 Preparations, Hair
% 219.26/219.47  |- mesh__recordAuthorizer mesh__D006203 sjn
% 219.26/219.47  |- skos__altLabel mesh__D006203 Cosmetics, Hair
% 219.26/219.47  |- mesh__dateCreated mesh__D006203 1979-05-30
% 219.26/219.47  |- mesh__recordOriginator mesh__D006203 SH
% 219.26/219.47  |- skos__annotation mesh__D006203
% 219.26/219.47       D25-26 qualif; HAIR DYES is also available   
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D006203 2006
% 219.26/219.47  |- mesh__dateEstablished mesh__D006203 1980-01-01
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D019929 2004
% 219.26/219.47  |- skos__broader mesh__D019929smesh__D019919
% 219.26/219.47  |- mesh__publicMeSHNote mesh__D019929 98   
% 219.26/219.47  |- mesh__dateCreated mesh__D019929 1997-06-20
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D019929 2003
% 219.26/219.47  |- mesh__dateRevised mesh__D019929 2002-07-03
% 219.26/219.47  |- mesh__recordAuthorizer mesh__D019929 sjn
% 219.26/219.47  |- skos__broader mesh__D019929smesh__D013506
% 219.26/219.47  |- skos__hiddenLabel mesh__D019929 Prosthesis Implantation, Cochlear
% 219.26/219.47  |- skos__hiddenLabel mesh__D019929 Implantations, Cochlear Prosthesis
% 219.26/219.47  |- mesh__recordOriginator mesh__D019929 PXP
% 219.26/219.47  |- skos__hiddenLabel mesh__D019929 Implantations, Cochlear
% 219.26/219.47  |- mesh__dateEstablished mesh__D019929 1998-01-01
% 219.26/219.47  |- skos__hiddenLabel mesh__D019929 Prosthesis Implantations, Cochlear
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D019929 2006
% 219.26/219.47  |- skos__historyNote mesh__D019929
% 219.26/219.47       Prostheses and Implants %28%1966-1979%29%
% 219.26/219.47  |- rdf__type mesh__D019929sskos__Concept
% 219.26/219.47  |- mesh__recordMaintainer mesh__D019929 lkt
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D019929 2005
% 219.26/219.47  |- skos__hiddenLabel mesh__D019929 Cochlear Prosthesis Implantations
% 219.26/219.47  |- skos__altLabel mesh__D019929 Cochlear Prosthesis Implantation
% 219.26/219.47  |- skos__hiddenLabel mesh__D019929 Implantation, Cochlear
% 219.26/219.47  |- skos__hiddenLabel mesh__D019929 Implantation, Cochlear Prosthesis
% 219.26/219.47  |- skos__scopeNote mesh__D019929
% 219.26/219.47       Surgical insertion of an electronic hearing device %28%COCHLEAR IMPLANTS%29% with electrodes to the COCHLEAR NERVE in the inner ear to create sound sensation in patients with residual nerve fibers.%A%    
% 219.26/219.47  |- skos__hiddenLabel mesh__D019929 Cochlear Implantations
% 219.26/219.47  |- skos__prefLabel mesh__D019929 Cochlear Implantation
% 219.26/219.47  |- mesh__historyNote mesh__D019929 98   
% 219.26/219.47  |- skos__related mesh__D019929smesh__D003054
% 219.26/219.47  |- skos__historyNote mesh__D019929 Cochlear Implants %28%1980-1997%29%
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D011946 2006
% 219.26/219.47  |- mesh__dateEstablished mesh__D011946 1980-01-01
% 219.26/219.47  |- mesh__recordOriginator mesh__D011946 AEP
% 219.26/219.47  |- mesh__recordMaintainer mesh__D011946 jmp
% 219.26/219.47  |- skos__hiddenLabel mesh__D011946 Receptor, Antigen
% 219.26/219.47  |- skos__broader mesh__D011946smesh__D011971
% 219.26/219.47  |- mesh__publicMeSHNote mesh__D011946 80   
% 219.26/219.47  |- skos__prefLabel mesh__D011946 Receptors, Antigen
% 219.26/219.47  |- skos__altLabel mesh__D011946 Antigen Receptor
% 219.26/219.47  |- mesh__recordAuthorizer mesh__D011946 sjn
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D011946 2005
% 219.26/219.47  |- skos__historyNote mesh__D011946 T Lymphocytes %28%1973-1979%29%
% 219.26/219.47  |- skos__historyNote mesh__D011946 Lymphocytes %28%1966-1979%29%
% 219.26/219.47  |- rdf__type mesh__D011946sskos__Concept
% 219.26/219.47  |- skos__altLabel mesh__D011946 Antigen Receptors
% 219.26/219.47  |- mesh__historyNote mesh__D011946 80   
% 219.26/219.47  |- skos__annotation mesh__D011946
% 219.26/219.47       GEN; prefer specific; DF: RECEPT ANTIGEN   
% 219.26/219.47  |- mesh__dateRevised mesh__D011946 2003-07-09
% 219.26/219.47  |- skos__scopeNote mesh__D011946
% 219.26/219.47       Molecules on the surface of B- and T-lymphocytes that recognize and combine with specific antigens.%A%    
% 219.26/219.47  |- mesh__dateCreated mesh__D011946 1979-05-24
% 219.26/219.47  |- skos__historyNote mesh__D011946 B Lymphocytes %28%1973-1979%29%
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D011946 2004
% 219.26/219.47  |- skos__historyNote mesh__D011946
% 219.26/219.47       Binding Sites, Antibody %28%1973-1979%29%
% 219.26/219.47  |- rdf__type mesh__D011148sskos__Concept
% 219.26/219.47  |- skos__historyNote mesh__D011148 Pongidae %28%1966-1980%29%
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D011148 2006
% 219.26/219.47  |- mesh__publicMeSHNote mesh__D011148 91; was see under PONGIDAE 1981-90   
% 219.26/219.47  |- skos__scopeNote mesh__D011148
% 219.26/219.47       The single species of orangutan belonging to the HOMINIDAE family and found only in lowland forests of Sumatra and Borneo. Among the PRIMATES, the orangutan is second in size only to the gorilla %28%GORILLA GORILLA%29%.%A%    
% 219.26/219.47  |- mesh__dateEstablished mesh__D011148 1991-01-01
% 219.26/219.47  |- skos__hiddenLabel mesh__D011148 Orang-utans
% 219.26/219.47  |- mesh__recordMaintainer mesh__D011148 ags
% 219.26/219.47  |- skos__hiddenLabel mesh__D011148 Orang utan
% 219.26/219.47  |- skos__altLabel mesh__D011148 Orangutan
% 219.26/219.47  |- mesh__recordAuthorizer mesh__D011148 sjn
% 219.26/219.47  |- skos__annotation mesh__D011148
% 219.26/219.47       diseases: coordinate IM with APE DISEASES %28%IM%29% + specific disease /vet %28%IM%29%; DF: PONGO%A%  
% 219.26/219.47  |- mesh__dateCreated mesh__D011148 1980-05-09
% 219.26/219.47  |- skos__hiddenLabel mesh__D011148 Orangutans
% 219.26/219.47  |- mesh__historyNote mesh__D011148
% 219.26/219.47       91%28%81%29%; was see under PONGIDAE 1981-90   
% 219.26/219.47  |- mesh__dateRevised mesh__D011148 2005-06-30
% 219.26/219.47  |- skos__altLabel mesh__D011148 Orang-utan
% 219.26/219.47  |- skos__prefLabel mesh__D011148 Pongo pygmaeus
% 219.26/219.47  |- mesh__recordOriginator mesh__D011148 EC
% 219.26/219.47  |- skos__broader mesh__D011148smesh__D015186
% 219.26/219.47  |- skos__prefLabel mesh__D005909 Glioblastoma
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D005909 2006
% 219.26/219.47  |- skos__hiddenLabel mesh__D005909 Glioblastoma, Giant Cell
% 219.26/219.47  |- mesh__dateRevised mesh__D005909 1999-11-03
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D005909 2005
% 219.26/219.47  |- rdf__type mesh__D005909sskos__Concept
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D005909 2004
% 219.26/219.47  |- mesh__recordAuthorizer mesh__D005909 sjn
% 219.26/219.47  |- mesh__publicMeSHNote mesh__D005909
% 219.26/219.47       94; was GLIOBLASTOMA MULTIFORME 1963-93; GLIOBLASTOMA was see ASTROCYTOMA 1993%A%  
% 219.26/219.47  |- mesh__dateCreated mesh__D005909 1999-01-01
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D005909 2001
% 219.26/219.47  |- skos__broader mesh__D005909smesh__D001254
% 219.26/219.47  |- mesh__recordOriginator mesh__D005909 NLM
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D005909 2003
% 219.26/219.47  |- mesh__historyNote mesh__D005909
% 219.26/219.47       94; was GLIOBLASTOMA MULTIFORME 1963-93; GLIOBLASTOMA was see ASTROCYTOMA 1993%A%  
% 219.26/219.47  |- skos__hiddenLabel mesh__D005909 Grade IV Astrocytoma
% 219.26/219.47  |- skos__scopeNote mesh__D005909
% 219.26/219.47       A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.%A%    
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D005909 2000
% 219.26/219.47  |- mesh__onlineNote mesh__D005909
% 219.26/219.47       use GLIOBLASTOMA to search GLIOBLASTOMA MULTIFORME 1966-93; search GLIOBLASTOMA under GLIOMA 1980-93%A%  
% 219.26/219.47  |- skos__altLabel mesh__D005909 Astrocytoma, Grade IV
% 219.26/219.47  |- skos__annotation mesh__D005909
% 219.26/219.47       coord IM with probably precoord CNS/neopl term + site %28%IM%29%; for GLIOBLASTOMA WITH SARCOMATOUS COMPONENT see GLIOSARCOMA; for GLIOBLASTOMA, RETINAL see RETINOBLASTOMA%A%  
% 219.26/219.47  |- skos__hiddenLabel mesh__D005909 Glioblastomas, Giant Cell
% 219.26/219.47  |- skos__hiddenLabel mesh__D005909 Giant Cell Glioblastomas
% 219.26/219.47  |- mesh__recordMaintainer mesh__D005909 KEV
% 219.26/219.47  |- skos__hiddenLabel mesh__D005909 Glioblastomas
% 219.26/219.47  |- skos__hiddenLabel mesh__D005909 Grade IV Astrocytomas
% 219.26/219.47  |- skos__hiddenLabel mesh__D005909 Astrocytomas, Grade IV
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D005909 2002
% 219.26/219.47  |- skos__broader mesh__D016631smesh__D002479
% 219.26/219.47  |- skos__scopeNote mesh__D016631
% 219.26/219.47       Intracytoplasmic, eosinophilic, round to elongated inclusions found in vacuoles of injured or fragmented neurons. The presence of Lewy bodies is the histological marker of the degenerative changes in LEWY BODY DISEASE and PARKINSON DISEASE but they may be seen in other neurological conditions. They are typically found in the substantia nigra and locus coeruleus but they are also seen in the basal forebrain, hypothalamic nuclei, and neocortex.%A%    
% 219.26/219.47  |- skos__related mesh__D016631smesh__D020961
% 219.26/219.47  |- skos__hiddenLabel mesh__D016631 Body, Lewy
% 219.26/219.47  |- mesh__recordOriginator mesh__D016631 AGS
% 219.26/219.47  |- skos__historyNote mesh__D016631 Cytoplasmic Granules %28%1966-1991%29%
% 219.26/219.47  |- skos__prefLabel mesh__D016631 Lewy Bodies
% 219.26/219.47  |- skos__altLabel mesh__D016631 Lewy Body
% 219.26/219.47  |- skos__historyNote mesh__D016631 Cellular Inclusions %28%1972-1991%29%
% 219.26/219.47  |- mesh__dateRevised mesh__D016631 2001-07-25
% 219.26/219.47  |- skos__hiddenLabel mesh__D016631 Bodies, Lewy
% 219.26/219.47  |- skos__broader mesh__D016631smesh__D009474
% 219.26/219.47  |- mesh__historyNote mesh__D016631 92   
% 219.26/219.47  |- skos__related mesh__D016631smesh__D010300
% 219.26/219.47  |- rdf__type mesh__D016631sskos__Concept
% 219.26/219.47  |- mesh__dateEstablished mesh__D016631 1992-01-01
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D016631 2003
% 219.26/219.47  |- skos__annotation mesh__D016631 LEWY BODY DISEASE is also available   
% 219.26/219.47  |- mesh__recordAuthorizer mesh__D016631 sjn
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D016631 2005
% 219.26/219.47  |- mesh__publicMeSHNote mesh__D016631 92   
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D016631 2004
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D016631 2002
% 219.26/219.47  |- mesh__recordMaintainer mesh__D016631 ags
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D016631 2006
% 219.26/219.47  |- mesh__dateCreated mesh__D016631 1991-01-25
% 219.26/219.47  |- mesh__recordMaintainer mesh__D002611 JLS
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002611 2006
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002611 2001
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002611 1999
% 219.26/219.47  |- mesh__recordOriginator mesh__D002611 NLM
% 219.26/219.47  |- mesh__dateCreated mesh__D002611 1999-01-01
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002611 2005
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002611 2000
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002611 1998
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002611 2004
% 219.26/219.47  |- rdf__type mesh__D002611sskos__Concept
% 219.26/219.47  |- skos__scopeNote mesh__D002611
% 219.26/219.47       A nutritious food consisting primarily of the curd or the semisolid substance formed when milk coagulates.%A%    
% 219.26/219.47  |- mesh__recordAuthorizer mesh__D002611 SJN
% 219.26/219.47  |- skos__broader mesh__D002611smesh__D003611
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002611 2003
% 219.26/219.47  |- skos__prefLabel mesh__D002611 Cheese
% 219.26/219.47  |- skos__hiddenLabel mesh__D002611 Cheeses
% 219.26/219.47  |- mesh__dateRevised mesh__D002611 1997-06-20
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D002611 2002
% 219.26/219.47  |- skos__historyNote mesh__D015539 Blood Platelets %28%1972-1989%29%
% 219.26/219.47  |- skos__hiddenLabel mesh__D015539 Platelet Activations
% 219.26/219.47  |- mesh__recordOriginator mesh__D015539 PXP
% 219.26/219.47  |- skos__hiddenLabel mesh__D015539 Activation, Platelet
% 219.26/219.47  |- mesh__recordMaintainer mesh__D015539 nns
% 219.26/219.47  |- rdf__type mesh__D015539sskos__Concept
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D015539 2004
% 219.26/219.47  |- mesh__dateRevised mesh__D015539 2003-07-09
% 219.26/219.47  |- skos__historyNote mesh__D015539 Platelet Aggregation %28%1977-1989%29%
% 219.26/219.47  |- skos__hiddenLabel mesh__D015539 Activations, Platelet
% 219.26/219.47  |- skos__scopeNote mesh__D015539
% 219.26/219.47       A series of progressive, overlapping events, triggered by exposure of the PLATELETS to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.%A%    
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D015539 2005
% 219.26/219.47  |- mesh__publicMeSHNote mesh__D015539 90   
% 219.26/219.47  |- mesh__recordAuthorizer mesh__D015539 sjn
% 219.26/219.47  |- skos__prefLabel mesh__D015539 Platelet Activation
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D015539 2006
% 219.26/219.47  |- mesh__dateEstablished mesh__D015539 1990-01-01
% 219.26/219.47  |- skos__related mesh__D015539smesh__D001760
% 219.26/219.47  |- mesh__dateCreated mesh__D015539 1989-04-07
% 219.26/219.47  |- skos__broader mesh__D015539smesh__D006487
% 219.26/219.47  |- mesh__historyNote mesh__D015539 90   
% 219.26/219.47  |- skos__broader mesh__D005542Q000293smesh__D005542
% 219.26/219.47  |- mesh__preferredCombination mesh__D005542Q000293smesh__D005543
% 219.26/219.47  |- rdf__type mesh__D005542Q000293smesh__CompoundConcept
% 219.26/219.47  |- skos__altLabel mesh__D026261 DBI Peptide
% 219.26/219.47  |- skos__prefLabel mesh__D026261 Diazepam Binding Inhibitor
% 219.26/219.47  |- skos__scopeNote mesh__D026261
% 219.26/219.47       An 86-amino acid polypeptide, found in central and peripheral tissues, that displaces diazepam from the benzodiazepine recognition site on the gamma-aminobutyric acid receptor %28%RECEPTORS, GABA%29%. It also binds medium- and long-chain acyl-CoA esters and serves as an acyl-CoA transporter. This peptide regulates lipid metabolism.%A%    
% 219.26/219.47  |- skos__hiddenLabel mesh__D026261 Protein, Acyl-CoA-Binding
% 219.26/219.47  |- skos__altLabel mesh__D026261 Acyl-CoA-Binding Protein
% 219.26/219.47  |- skos__historyNote mesh__D026261 Neuropeptides %28%1987-1992%29%
% 219.26/219.47  |- skos__historyNote mesh__D026261 Carrier Proteins %28%1992-2001%29%
% 219.26/219.47  |- skos__broader mesh__D026261smesh__D010455
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D026261 2005
% 219.26/219.47  |- mesh__dateCreated mesh__D026261 2001-07-25
% 219.26/219.47  |- skos__hiddenLabel mesh__D026261 Inhibitor, Diazepam Binding
% 219.26/219.47  |- mesh__publicMeSHNote mesh__D026261
% 219.26/219.47       2002; DIAZEPAM BINDING INHIBITOR was indexed under CARRIER PROTEINS 1984-2001%A%  
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D026261 2006
% 219.26/219.47  |- mesh__activeMeSHYear mesh__D026261 2002
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D026261 2003
% 219.26/219.48  |- mesh__historyNote mesh__D026261
% 219.26/219.48       2002; use DIAZEPAM BINDING INHIBITOR %28%NM%29% 1984-2001   
% 219.26/219.48  |- rdf__type mesh__D026261sskos__Concept
% 219.26/219.48  |- skos__altLabel mesh__D026261 EpDBI
% 219.26/219.48  |- skos__hiddenLabel mesh__D026261 Binding Inhibitor, Diazepam
% 219.26/219.48  |- skos__hiddenLabel mesh__D026261 Medium Chain Acyl CoA Binding Protein
% 219.26/219.48  |- mesh__dateEstablished mesh__D026261 2002-01-01
% 219.26/219.48  |- skos__hiddenLabel mesh__D026261 Peptide, DBI
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D026261 2004
% 219.26/219.48  |- skos__hiddenLabel mesh__D026261 Acyl CoA Binding Protein
% 219.26/219.48  |- skos__altLabel mesh__D026261 Endozepine
% 219.26/219.48  |- skos__historyNote mesh__D026261 Nerve Tissue Proteins %28%1984-1986%29%
% 219.26/219.48  |- skos__broader mesh__D001519smesh__D001520
% 219.26/219.48  |- skos__annotation mesh__D001519 human only; GEN; prefer specifics   
% 219.26/219.48  |- mesh__recordOriginator mesh__D001519 NLM
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D001519 2006
% 219.26/219.48  |- skos__related mesh__D001519smesh__D005824
% 219.26/219.48  |- skos__hiddenLabel mesh__D001519 Process, Acceptance
% 219.26/219.48  |- mesh__dateRevised mesh__D001519 2002-07-02
% 219.26/219.48  |- mesh__dateCreated mesh__D001519 1999-01-01
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D001519 2005
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D001519 2004
% 219.26/219.48  |- skos__hiddenLabel mesh__D001519 Processes, Acceptance
% 219.26/219.48  |- rdf__type mesh__D001519sskos__Concept
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D001519 2003
% 219.26/219.48  |- mesh__recordMaintainer mesh__D001519 jrf
% 219.26/219.48  |- skos__hiddenLabel mesh__D001519 Behaviors
% 219.26/219.48  |- skos__scopeNote mesh__D001519
% 219.26/219.48       The observable response a person makes to any situation.%A%    
% 219.26/219.48  |- mesh__recordAuthorizer mesh__D001519 sjn
% 219.26/219.48  |- skos__altLabel mesh__D001519 Acceptance Process
% 219.26/219.48  |- skos__prefLabel mesh__D001519 Behavior
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D012241 2006
% 219.26/219.48  |- skos__broader mesh__D012241smesh__D041841
% 219.26/219.48  |- mesh__recordAuthorizer mesh__D012241 sjn
% 219.26/219.48  |- mesh__recordMaintainer mesh__D012241 SYSTEM
% 219.26/219.48  |- mesh__recordOriginator mesh__D012241 NLM
% 219.26/219.48  |- mesh__dateRevised mesh__D012241 2005-06-30
% 219.26/219.48  |- skos__prefLabel mesh__D012241 Rhodopseudomonas
% 219.26/219.48  |- mesh__dateCreated mesh__D012241 1999-01-01
% 219.26/219.48  |- rdf__type mesh__D012241sskos__Concept
% 219.26/219.48  |- skos__annotation mesh__D012241 in mud %26% stagnant water   
% 219.26/219.48  |- skos__scopeNote mesh__D012241
% 219.26/219.48       A genus of gram-negative, rod-shaped, phototrophic bacteria found in aquatic environments. Internal photosynthetic membranes are present as lamellae underlying the cytoplasmic membrane.%A%    
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006204 2004
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006204 1993
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006204 1998
% 219.26/219.48  |- skos__hiddenLabel mesh__D006204 Depilations, Electrolytic
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006204 2002
% 219.26/219.48  |- skos__hiddenLabel mesh__D006204 Electrolytic Depilations
% 219.26/219.48  |- skos__hiddenLabel mesh__D006204 Depilation, Electrolytic
% 219.26/219.48  |- skos__hiddenLabel mesh__D006204 Removal, Hair
% 219.26/219.48  |- skos__broader mesh__D006204smesh__D003357
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006204 1999
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006204 1996
% 219.26/219.48  |- mesh__recordOriginator mesh__D006204 NLM
% 219.26/219.48  |- rdf__type mesh__D006204sskos__Concept
% 219.26/219.48  |- skos__prefLabel mesh__D006204 Hair Removal
% 219.26/219.48  |- skos__altLabel mesh__D006204 Epilation
% 219.26/219.48  |- mesh__dateCreated mesh__D006204 1999-01-01
% 219.26/219.48  |- skos__hiddenLabel mesh__D006204 Hair Removals
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006204 1997
% 219.26/219.48  |- skos__annotation mesh__D006204
% 219.26/219.48       do not use /util except by MeSH definition   
% 219.26/219.48  |- skos__hiddenLabel mesh__D006204 Removals, Hair
% 219.26/219.48  |- mesh__recordMaintainer mesh__D006204 TGC
% 219.26/219.48  |- skos__altLabel mesh__D006204 Depilation
% 219.26/219.48  |- skos__hiddenLabel mesh__D006204 Depilations
% 219.26/219.48  |- mesh__dateRevised mesh__D006204 1991-05-15
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006204 2005
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006204 1994
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006204 2000
% 219.26/219.48  |- skos__hiddenLabel mesh__D006204 Epilations
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006204 2006
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006204 2003
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006204 1992
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006204 1995
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006204 2001
% 219.26/219.48  |- mesh__recordAuthorizer mesh__D006204 PLS
% 219.26/219.48  |- skos__historyNote mesh__D011947
% 219.26/219.48       Immunoglobulin Variable Region %28%1977-1979%29%
% 219.26/219.48  |- mesh__dateRevised mesh__D011947 2005-06-30
% 219.26/219.48  |- skos__altLabel mesh__D011947 Immunoglobulins, Surface
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D011947 2006
% 219.26/219.48  |- skos__altLabel mesh__D011947 Receptors, Antigen, B Cell
% 219.26/219.48  |- skos__annotation mesh__D011947 DF: RECEPT ANTIGEN B CELL   
% 219.26/219.48  |- skos__historyNote mesh__D011947 B Lymphocytes %28%1973-1979%29%
% 219.26/219.48  |- skos__hiddenLabel mesh__D011947 B Cell Antigen Receptors
% 219.26/219.48  |- skos__scopeNote mesh__D011947
% 219.26/219.48       IMMUNOGLOBULINS on the surface of B-LYMPHOCYTES. Their MESSENGER RNA contains an EXON with a membrane spanning sequence, producing immunoglobulins in the form of type I transmembrane proteins as opposed to secreted immunoglobulins %28%ANTIBODIES%29% which do not contain the membrane spanning segment.%A%    
% 219.26/219.48  |- skos__hiddenLabel mesh__D011947 Antigen Receptors, B Cell
% 219.26/219.48  |- mesh__historyNote mesh__D011947 1980 %28%1975%29%   
% 219.26/219.48  |- skos__prefLabel mesh__D011947 Receptors, Antigen, B-Cell
% 219.26/219.48  |- skos__altLabel mesh__D011947 Membrane-Bound Immunoglobulins
% 219.26/219.48  |- skos__broader mesh__D011947smesh__D007136
% 219.26/219.48  |- skos__hiddenLabel mesh__D011947 Bound Immunoglobulin, Membrane
% 219.26/219.48  |- skos__altLabel mesh__D011947 Membrane Bound Immunoglobulin
% 219.26/219.48  |- skos__altLabel mesh__D011947 Antigen Receptors, B-Cell
% 219.26/219.48  |- rdf__type mesh__D011947sskos__Concept
% 219.26/219.48  |- skos__historyNote mesh__D011947 Immunoglobulins, Fab %28%1973-1979%29%
% 219.26/219.48  |- skos__hiddenLabel mesh__D011947 Immunoglobulin, Membrane Bound
% 219.26/219.48  |- skos__historyNote mesh__D011947
% 219.26/219.48       Binding Sites, Antibody %28%1973-1979%29%
% 219.26/219.48  |- mesh__recordOriginator mesh__D011947 AEP
% 219.26/219.48  |- skos__hiddenLabel mesh__D011947 Immunoglobulins, Membrane Bound
% 219.26/219.48  |- skos__altLabel mesh__D011947 Surface Immunoglobulins
% 219.26/219.48  |- skos__altLabel mesh__D011947 Immunoglobulins, Membrane-Bound
% 219.26/219.48  |- skos__altLabel mesh__D011947 B-Cell Antigen Receptors
% 219.26/219.48  |- mesh__dateCreated mesh__D011947 1979-05-24
% 219.26/219.48  |- mesh__recordAuthorizer mesh__D011947 sjn
% 219.26/219.48  |- mesh__recordMaintainer mesh__D011947 nns
% 219.26/219.48  |- skos__broader mesh__D011947smesh__D011946
% 219.26/219.48  |- mesh__publicMeSHNote mesh__D011947
% 219.26/219.48       1980; for IMMUNOGLOBULINS, SURFACE see IMMUNOGLOBULINS, SURFACE 1975-2005; for MEMBRANE-BOUND IMMUNOGLOBULINS see IMMUNOGLOBULINS, SURFACE 1975-2005%A%  
% 219.26/219.48  |- skos__historyNote mesh__D011947 Lymphocytes %28%1966-1979%29%
% 219.26/219.48  |- skos__hiddenLabel mesh__D011947 Membrane Bound Immunoglobulins
% 219.26/219.48  |- mesh__dateEstablished mesh__D011947 1980-01-01
% 219.26/219.48  |- skos__hiddenLabel mesh__D011947 Receptors, B-Cell Antigen
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D011149 2003
% 219.26/219.48  |- mesh__recordMaintainer mesh__D011149 ags
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D011149 2001
% 219.26/219.48  |- skos__scopeNote mesh__D011149
% 219.26/219.48       The part of the central nervous system lying between the medulla oblongata and the mesencephalon, ventral to the cerebellum, and consisting of a pars dorsalis and a pars ventralis.%A%    
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D011149 2004
% 219.26/219.48  |- mesh__recordOriginator mesh__D011149 NLM
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D011149 2002
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D011149 2005
% 219.26/219.48  |- skos__prefLabel mesh__D011149 Pons
% 219.26/219.48  |- rdf__type mesh__D011149sskos__Concept
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D011149 2006
% 219.26/219.48  |- mesh__recordAuthorizer mesh__D011149 sjn
% 219.26/219.48  |- skos__broader mesh__D011149smesh__D020540
% 219.26/219.48  |- mesh__dateCreated mesh__D011149 1999-01-01
% 219.26/219.48  |- mesh__dateRevised mesh__D011149 1999-11-03
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D011149 2000
% 219.26/219.48  |- skos__altLabel mesh__D016632 Apolipoprotein A-1
% 219.26/219.48  |- mesh__historyNote mesh__D016632
% 219.26/219.48       92; was APOLIPOPROTEIN A-I %28%NM%29% 1974-91   
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016632 2002
% 219.26/219.48  |- mesh__recordAuthorizer mesh__D016632 PLS
% 219.26/219.48  |- skos__altLabel mesh__D016632 Apolipoprotein A1
% 219.26/219.48  |- mesh__onlineNote mesh__D016632
% 219.26/219.48       use APOLIPOPROTEIN A-I %28%NM%29% to search APOLIPOPROTEIN A-I 1977-91%A%  
% 219.26/219.48  |- rdf__type mesh__D016632sskos__Concept
% 219.26/219.48  |- mesh__recordOriginator mesh__D016632 RLS
% 219.26/219.48  |- skos__altLabel mesh__D016632 Apo A-I
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016632 1996
% 219.26/219.48  |- skos__broader mesh__D016632smesh__D001054
% 219.26/219.48  |- mesh__publicMeSHNote mesh__D016632
% 219.26/219.48       92; APOLIPOPROTEIN A-I was indexed under APOLIPOPROTEINS A 1985-91, under APOLIPOPROTEINS 1979-84 %26% under APOPROTEINS 1974-78%A%  
% 219.26/219.48  |- skos__prefLabel mesh__D016632 Apolipoprotein A-I
% 219.26/219.48  |- mesh__dateRevised mesh__D016632 1994-05-12
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016632 1998
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016632 2003
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016632 1997
% 219.26/219.48  |- skos__altLabel mesh__D016632 Apo A-1
% 219.26/219.48  |- skos__altLabel mesh__D016632 ApoA-I
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016632 2000
% 219.26/219.48  |- mesh__recordMaintainer mesh__D016632 TPW
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016632 2005
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016632 1999
% 219.26/219.48  |- skos__altLabel mesh__D016632 ApoA-1
% 219.26/219.48  |- skos__historyNote mesh__D016632 Apolipoproteins A %28%1985-1991%29%
% 219.26/219.48  |- skos__historyNote mesh__D016632 Apolipoproteins %28%1977-1984%29%
% 219.26/219.48  |- skos__hiddenLabel mesh__D016632 Apolipoprotein A I
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016632 2004
% 219.26/219.48  |- skos__hiddenLabel mesh__D016632 Apolipoprotein A 1
% 219.26/219.48  |- skos__altLabel mesh__D016632 Apo AI
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016632 2001
% 219.26/219.48  |- mesh__dateEstablished mesh__D016632 1992-01-01
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016632 1995
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016632 2006
% 219.26/219.48  |- skos__altLabel mesh__D016632 Apolipoprotein AI
% 219.26/219.48  |- skos__altLabel mesh__D016632 Apo A1
% 219.26/219.48  |- mesh__dateCreated mesh__D016632 1991-01-24
% 219.26/219.48  |- skos__annotation mesh__D016632
% 219.26/219.48       /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X ref%A%  
% 219.26/219.48  |- skos__scopeNote mesh__D016632
% 219.26/219.48       The major protein component of high density lipoproteins. It is instrumental in promoting efflux of cholesterol from extrahepatic tissue to the liver where it is metabolized and excreted from the body. The compound is the activator of lecithin-cholesterol acyltransferase which forms cholesteryl esters in HDL. The gene for this apolipoprotein is found on the long arm of chromosome 11.%A%    
% 219.26/219.48  |- mesh__historyNote mesh__D002612 2005 %28%1975%29%   
% 219.26/219.48  |- skos__altLabel mesh__D002612 Cheetahs
% 219.26/219.48  |- rdf__type mesh__D002612sskos__Concept
% 219.26/219.48  |- skos__prefLabel mesh__D002612 Acinonyx
% 219.26/219.48  |- mesh__recordOriginator mesh__D002612 NLM
% 219.26/219.48  |- mesh__recordAuthorizer mesh__D002612 sjn
% 219.26/219.48  |- mesh__dateCreated mesh__D002612 1974-12-12
% 219.26/219.48  |- skos__broader mesh__D002612smesh__D045989
% 219.26/219.48  |- mesh__dateEstablished mesh__D002612 1991-01-01
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D002612 2006
% 219.26/219.48  |- skos__scopeNote mesh__D002612
% 219.26/219.48       A genus of long-legged, swift-moving felines %28%FELIDAE%29% from Africa %28%and formerly Asia%29% about the size of a small leopard.%A%    
% 219.26/219.48  |- mesh__dateRevised mesh__D002612 2004-07-07
% 219.26/219.48  |- mesh__recordMaintainer mesh__D002612 ags
% 219.26/219.48  |- skos__hiddenLabel mesh__D002612 Cheetah
% 219.26/219.48  |- mesh__publicMeSHNote mesh__D002612
% 219.26/219.48       2005; see CHEETAHS 1991-2004, see CARNIVORA 1975-1990   
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D002612 2005
% 219.26/219.48  |- mesh__recordMaintainer mesh__D012242 SYSTEM
% 219.26/219.48  |- skos__scopeNote mesh__D012242
% 219.26/219.48       Spherical phototrophic bacteria found in mud and stagnant water exposed to light.%A%    
% 219.26/219.48  |- skos__altLabel mesh__D012242 Rhodopseudomonas spheroides
% 219.26/219.48  |- mesh__dateCreated mesh__D012242 1999-01-01
% 219.26/219.48  |- rdf__type mesh__D012242sskos__Concept
% 219.26/219.48  |- skos__broader mesh__D012242smesh__D016992
% 219.26/219.48  |- mesh__recordAuthorizer mesh__D012242 sjn
% 219.26/219.48  |- skos__altLabel mesh__D012242 Rhodobacter spheroides
% 219.26/219.48  |- mesh__publicMeSHNote mesh__D012242
% 219.26/219.48       90; was RHODOPSEUDOMONAS SPHEROIDES 1972-89 %28%see under RHODOPSEUDOMONAS 1972-73%29%%A%  
% 219.26/219.48  |- mesh__historyNote mesh__D012242
% 219.26/219.48       90%28%72%29%; was RHODOPSEUDOMONAS SPHEROIDES 1972-89 %28%see under RHODOPSEUDOMONAS 1972-73%29%%A%  
% 219.26/219.48  |- mesh__recordOriginator mesh__D012242 NLM
% 219.26/219.48  |- mesh__onlineNote mesh__D012242
% 219.26/219.48       use RHODOBACTER SPHAEROIDES to search RHODOPSEUDOMONAS SPHEROIDES 1972-89%A%  
% 219.26/219.48  |- mesh__dateRevised mesh__D012242 2005-06-30
% 219.26/219.48  |- skos__historyNote mesh__D012242 Rhodopseudomonas %28%1966-1971%29%
% 219.26/219.48  |- mesh__dateEstablished mesh__D012242 1974-01-01
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D012242 2006
% 219.26/219.48  |- skos__annotation mesh__D012242 in mud %26% stagnant water   
% 219.26/219.48  |- skos__prefLabel mesh__D012242 Rhodobacter sphaeroides
% 219.26/219.48  |- skos__altLabel mesh__D012242 Rhodopseudomonas sphaeroides
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006205 1999
% 219.26/219.48  |- skos__annotation mesh__D006205
% 219.26/219.48       with the Dominican Republic = Hispaniola, a hist name for the island in the Greater Antilles in the West Indies%A%  
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006205 1996
% 219.26/219.48  |- rdf__type mesh__D006205sskos__Concept
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006205 2001
% 219.26/219.48  |- mesh__recordAuthorizer mesh__D006205 PLS
% 219.26/219.48  |- mesh__dateCreated mesh__D006205 1999-01-01
% 219.26/219.48  |- skos__prefLabel mesh__D006205 Haiti
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006205 1997
% 219.26/219.48  |- mesh__dateRevised mesh__D006205 1995-02-17
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006205 2002
% 219.26/219.48  |- mesh__recordMaintainer mesh__D006205 TGC
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006205 2005
% 219.26/219.48  |- mesh__recordOriginator mesh__D006205 NLM
% 219.26/219.48  |- skos__scopeNote mesh__D006205
% 219.26/219.48       A republic in the Greater Antilles in the West Indies. Its capital is Port-au-Prince. With the Dominican Republic it forms the island of Hispaniola - Haiti occupying the western third and the Dominican Republic, the eastern two thirds. Haiti belonged to France from 1697 until its rule was challenged by slave insurrections from 1791. It became a republic in 1820. It was virtually an American protectorate from 1915 to 1934. It adopted its present constitution in 1964 and amended it in 1971. The name may represent either of two Caribbean words, haiti, mountain land, or jhaiti, nest. %28%From Webster%27%s New Geographical Dictionary, 1988, p481 %26% Room, Brewer%27%s Dictionary of Names, 1992, p225%29%%A%    
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006205 2006
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006205 2003
% 219.26/219.48  |- skos__broader mesh__D006205smesh__D014900
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006205 2004
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006205 1998
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006205 2000
% 219.26/219.48  |- mesh__historyNote mesh__D011948 80   
% 219.26/219.48  |- skos__broader mesh__D011948smesh__D011946
% 219.26/219.48  |- skos__hiddenLabel mesh__D011948 T Cell Antigen Receptor
% 219.26/219.48  |- skos__historyNote mesh__D011948 Lymphocytes %28%1966-1979%29%
% 219.26/219.48  |- skos__hiddenLabel mesh__D011948 Receptor, T-Cell Antigen
% 219.26/219.48  |- skos__hiddenLabel mesh__D011948 Receptor, T-Cell
% 219.26/219.48  |- skos__hiddenLabel mesh__D011948 Antigen Receptors, T Cell
% 219.26/219.48  |- rdf__type mesh__D011948sskos__Concept
% 219.26/219.48  |- skos__altLabel mesh__D011948 Antigen Receptors, T-Cell
% 219.26/219.48  |- skos__related mesh__D011948smesh__D015329
% 219.26/219.48  |- skos__prefLabel mesh__D011948 Receptors, Antigen, T-Cell
% 219.26/219.48  |- skos__hiddenLabel mesh__D011948 T Cell Receptor
% 219.26/219.48  |- skos__annotation mesh__D011948
% 219.26/219.48       GEN; prefer specifics; do not confuse their gamma-delta chains with gamma %26% delta chains which are subunits of CD3 antigens %28%index under ANTIGENS, CD3%29%; DF: RECEPT ANTIGEN T CELL%A%  
% 219.26/219.48  |- skos__hiddenLabel mesh__D011948 T-Cell Antigen Receptors
% 219.26/219.48  |- mesh__dateRevised mesh__D011948 2003-07-09
% 219.26/219.48  |- mesh__publicMeSHNote mesh__D011948 80   
% 219.26/219.48  |- skos__hiddenLabel mesh__D011948 Receptors, T-Cell
% 219.26/219.48  |- mesh__dateCreated mesh__D011948 1979-05-24
% 219.26/219.48  |- skos__hiddenLabel mesh__D011948 Receptors, T Cell Antigen
% 219.26/219.48  |- skos__altLabel mesh__D011948 T-Cell Receptor
% 219.26/219.48  |- skos__scopeNote mesh__D011948
% 219.26/219.48       Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens %28%ANTIGENS, CD3%29%. Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta %28%RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA%29% or gamma-delta %28%RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA%29% chains.%A%    
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D011948 2005
% 219.26/219.48  |- mesh__dateEstablished mesh__D011948 1980-01-01
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D011948 2004
% 219.26/219.48  |- skos__historyNote mesh__D011948 T Lymphocytes %28%1973-1979%29%
% 219.26/219.48  |- skos__altLabel mesh__D011948 T-Cell Receptors
% 219.26/219.48  |- mesh__recordMaintainer mesh__D011948 jmp
% 219.26/219.48  |- skos__altLabel mesh__D011948 Receptors, T-Cell Antigen
% 219.26/219.48  |- skos__altLabel mesh__D011948 T-Cell Antigen Receptor
% 219.26/219.48  |- mesh__recordOriginator mesh__D011948 AEP
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D011948 2006
% 219.26/219.48  |- skos__hiddenLabel mesh__D011948 Antigen Receptor, T-Cell
% 219.26/219.48  |- skos__related mesh__D011948smesh__D019672
% 219.26/219.48  |- skos__hiddenLabel mesh__D011948 T Cell Receptors
% 219.26/219.48  |- mesh__recordAuthorizer mesh__D011948 sjn
% 219.26/219.48  |- skos__related mesh__D011948smesh__D017252
% 219.26/219.48  |- skos__historyNote mesh__D016633 Apolipoproteins A %28%1985-1991%29%
% 219.26/219.48  |- skos__historyNote mesh__D016633 Apolipoproteins %28%1977-1984%29%
% 219.26/219.48  |- skos__altLabel mesh__D016633 Apo A-2
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016633 2003
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016633 1997
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016633 2001
% 219.26/219.48  |- skos__altLabel mesh__D016633 Apolipoprotein A2
% 219.26/219.48  |- skos__altLabel mesh__D016633 ApoA-2
% 219.26/219.48  |- mesh__recordMaintainer mesh__D016633 TPW
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016633 2005
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016633 1999
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016633 2004
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016633 1995
% 219.26/219.48  |- skos__altLabel mesh__D016633 Apo A2
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016633 2006
% 219.26/219.48  |- skos__annotation mesh__D016633
% 219.26/219.48       /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X ref%A%  
% 219.26/219.48  |- skos__altLabel mesh__D016633 Apo A-II
% 219.26/219.48  |- mesh__historyNote mesh__D016633
% 219.26/219.48       92; was APOLIPOPROTEIN A-II %28%NM%29% 1978-91   
% 219.26/219.48  |- skos__altLabel mesh__D016633 Apolipoprotein AII
% 219.26/219.48  |- mesh__recordOriginator mesh__D016633 RLS
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016633 2002
% 219.26/219.48  |- skos__scopeNote mesh__D016633
% 219.26/219.48       A component of high density lipoproteins. It is instrumental in promoting efflux of cholesterol from extrahepatic tissue to the liver where it is metabolized and excreted from the body. This protein modulates the activation of lecithin-cholesterol acyltransferase in the presence of apolipoprotein A-I.%A%    
% 219.26/219.48  |- mesh__recordAuthorizer mesh__D016633 PLS
% 219.26/219.48  |- mesh__publicMeSHNote mesh__D016633
% 219.26/219.48       92; APOLIPOPROTEIN A-II was indexed under APOLIPOPROTEINS A 1985-91 %26% under APOLIPOPROTEINS 1978-84%A%  
% 219.26/219.48  |- skos__hiddenLabel mesh__D016633 Apolipoprotein A 2
% 219.26/219.48  |- mesh__dateCreated mesh__D016633 1991-01-24
% 219.26/219.48  |- skos__altLabel mesh__D016633 ApoA-II
% 219.26/219.48  |- skos__prefLabel mesh__D016633 Apolipoprotein A-II
% 219.26/219.48  |- mesh__dateRevised mesh__D016633 1994-05-12
% 219.26/219.48  |- rdf__type mesh__D016633sskos__Concept
% 219.26/219.48  |- skos__altLabel mesh__D016633 Apo AII
% 219.26/219.48  |- mesh__dateEstablished mesh__D016633 1992-01-01
% 219.26/219.48  |- skos__hiddenLabel mesh__D016633 Apolipoprotein A II
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016633 1996
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016633 2000
% 219.26/219.48  |- skos__broader mesh__D016633smesh__D001054
% 219.26/219.48  |- skos__altLabel mesh__D016633 Apolipoprotein A-2
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D016633 1998
% 219.26/219.48  |- mesh__onlineNote mesh__D016633
% 219.26/219.48       use APOLIPOPROTEIN A-II %28%NM%29% to search APOLIPOPROTEIN A-II 1980-91%A%  
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D002613 1996
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D002613 2002
% 219.26/219.48  |- rdf__type mesh__D002613sskos__Concept
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D002613 2004
% 219.26/219.48  |- skos__prefLabel mesh__D002613 Cheilitis
% 219.26/219.48  |- skos__hiddenLabel mesh__D002613 Cheilitides
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D002613 1997
% 219.26/219.48  |- mesh__dateRevised mesh__D002613 1993-05-26
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D002613 2000
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D002613 1994
% 219.26/219.48  |- skos__scopeNote mesh__D002613
% 219.26/219.48       Inflammation of the lips. It is of various etiologies and degrees of pathology.%A%    
% 219.26/219.48  |- mesh__dateCreated mesh__D002613 1999-01-01
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D002613 2005
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D002613 2001
% 219.26/219.48  |- skos__annotation mesh__D002613 inflamm of the lips   
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D002613 1998
% 219.26/219.48  |- mesh__recordMaintainer mesh__D002613 TGC
% 219.26/219.48  |- mesh__recordAuthorizer mesh__D002613 PLS
% 219.26/219.48  |- mesh__recordOriginator mesh__D002613 NLM
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D002613 1995
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D002613 2006
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D002613 1999
% 219.26/219.48  |- skos__broader mesh__D002613smesh__D008047
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D002613 2003
% 219.26/219.48  |- skos__broader mesh__D009726Q000193smesh__D009726
% 219.26/219.48  |- mesh__preferredCombination mesh__D009726Q000193smesh__D004506
% 219.26/219.48  |- rdf__type mesh__D009726Q000193smesh__CompoundConcept
% 219.26/219.48  |- skos__broader mesh__D012243smesh__D043562
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D012243 2006
% 219.26/219.48  |- mesh__dateEstablished mesh__D012243 1991-01-01
% 219.26/219.48  |- skos__annotation mesh__D012243
% 219.26/219.48       do not confuse with ROD-OPSIN see OPSIN   
% 219.26/219.48  |- mesh__historyNote mesh__D012243
% 219.26/219.48       91%28%75%29%; was see under RETINAL PIGMENTS 1975-90   
% 219.26/219.48  |- skos__altLabel mesh__D012243 Visual Purple
% 219.26/219.48  |- mesh__dateRevised mesh__D012243 2005-07-29
% 219.26/219.48  |- mesh__recordAuthorizer mesh__D012243 ags
% 219.26/219.48  |- rdf__type mesh__D012243sskos__Concept
% 219.26/219.48  |- mesh__dateCreated mesh__D012243 1999-01-01
% 219.26/219.48  |- mesh__recordMaintainer mesh__D012243 ags
% 219.26/219.48  |- skos__prefLabel mesh__D012243 Rhodopsin
% 219.26/219.48  |- skos__scopeNote mesh__D012243
% 219.26/219.48       A photoreceptor protein found in retinal rods. It is a complex formed by the binding of RETINALDEHYDE, the oxidized form of retinol, to the protein OPSIN and undergoes a series of complex reactions in response to visible light resulting in the transmission of nerve impulses to the brain.%A%    
% 219.26/219.48  |- mesh__onlineNote mesh__D012243 search RETINAL PIGMENTS 1966-74   
% 219.26/219.48  |- skos__broader mesh__D012243smesh__D017299
% 219.26/219.48  |- mesh__publicMeSHNote mesh__D012243
% 219.26/219.48       91; was see under RETINAL PIGMENTS 1975-90   
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D012243 2006A
% 219.26/219.48  |- mesh__recordOriginator mesh__D012243 NLM
% 219.26/219.48  |- skos__broader mesh__D006206smesh__D011282
% 219.26/219.48  |- mesh__recordOriginator mesh__D006206 SH
% 219.26/219.48  |- skos__altLabel mesh__D006206 Dermalog
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006206 2005
% 219.26/219.48  |- skos__altLabel mesh__D006206 Bristol-Myers Squibb Brand of Halcinonide
% 219.26/219.48  |- skos__altLabel mesh__D006206 Halog
% 219.26/219.48  |- skos__hiddenLabel mesh__D006206 SQ 18,566
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006206 2006
% 219.26/219.48  |- mesh__dateRevised mesh__D006206 2005-07-22
% 219.26/219.48  |- mesh__recordMaintainer mesh__D006206 ags
% 219.26/219.48  |- skos__altLabel mesh__D006206 Alcinonide
% 219.26/219.48  |- mesh__publicMeSHNote mesh__D006206
% 219.26/219.48       91; was see under PREGNENEDIONES 1979-90   
% 219.26/219.48  |- skos__hiddenLabel mesh__D006206 SQ18,566
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006206 2004
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D006206 2006A
% 219.26/219.48  |- skos__historyNote mesh__D006206 Pregnanes %28%1968-1973%29%
% 219.26/219.48  |- mesh__historyNote mesh__D006206
% 219.26/219.48       91%28%79%29%; was see under PREGNENEDIONES 1979-90   
% 219.26/219.48  |- mesh__dateCreated mesh__D006206 1978-02-07
% 219.26/219.48  |- skos__scopeNote mesh__D006206
% 219.26/219.48       A glucocorticoid used topically in the treatment of DERMATITIS; ECZEMA; or PSORIASIS. It may cause skin irritation.%A%    
% 219.26/219.48  |- skos__altLabel mesh__D006206 Halcimat
% 219.26/219.48  |- rdf__type mesh__D006206sskos__Concept
% 219.26/219.48  |- skos__historyNote mesh__D006206 Pregnenediones %28%1974-1978%29%
% 219.26/219.48  |- skos__hiddenLabel mesh__D006206
% 219.26/219.48       Bristol Myers Squibb Brand of Halcinonide
% 219.26/219.48  |- mesh__recordAuthorizer mesh__D006206 ags
% 219.26/219.48  |- skos__prefLabel mesh__D006206 Halcinonide
% 219.26/219.48  |- mesh__dateEstablished mesh__D006206 1991-01-01
% 219.26/219.48  |- skos__altLabel mesh__D011949 Receptors, CCK-8
% 219.26/219.48  |- mesh__publicMeSHNote mesh__D011949 87   
% 219.26/219.48  |- skos__altLabel mesh__D011949 Cholecystokinin Octapeptide Receptors
% 219.26/219.48  |- skos__hiddenLabel mesh__D011949 Receptors, CCK 4
% 219.26/219.48  |- mesh__recordAuthorizer mesh__D011949 sjn
% 219.26/219.48  |- skos__broader mesh__D011949smesh__D011964
% 219.26/219.48  |- mesh__recordMaintainer mesh__D011949 jmp
% 219.26/219.48  |- skos__hiddenLabel mesh__D011949 CCK 4 Receptors
% 219.26/219.48  |- skos__altLabel mesh__D011949 Cholecystokinin Receptor
% 219.26/219.48  |- skos__annotation mesh__D011949 DF: RECEPT CCK   
% 219.26/219.48  |- skos__hiddenLabel mesh__D011949 Receptor, CCK
% 219.26/219.48  |- skos__altLabel mesh__D011949 Receptors, Pancreozymin
% 219.26/219.48  |- skos__altLabel mesh__D011949 Caerulein Receptors
% 219.26/219.48  |- skos__hiddenLabel mesh__D011949 CCK 8 Receptors
% 219.26/219.48  |- skos__hiddenLabel mesh__D011949 Receptor, Cholecystokinin
% 219.26/219.48  |- skos__altLabel mesh__D011949 Sincalide Receptors
% 219.26/219.48  |- mesh__dateRevised mesh__D011949 2003-07-09
% 219.26/219.48  |- skos__historyNote mesh__D011949
% 219.26/219.48       Receptors, Endogenous Substances %28%1973-1986%29%
% 219.26/219.48  |- mesh__historyNote mesh__D011949 87   
% 219.26/219.48  |- skos__prefLabel mesh__D011949 Receptors, Cholecystokinin
% 219.26/219.48  |- rdf__type mesh__D011949sskos__Concept
% 219.26/219.48  |- skos__altLabel mesh__D011949 Pancreozymin Receptors
% 219.26/219.48  |- skos__altLabel mesh__D011949 CCK Receptors
% 219.26/219.48  |- skos__historyNote mesh__D011949 Cholecystokinin %28%1966-1986%29%
% 219.26/219.48  |- mesh__activeMeSHYear mesh__D011949 2006
% 219.26/219.48  |- skos__altLabel mesh__D011949 CCK Receptor
% 219.26/219.48  |- skos__altLabel mesh__D011949 Cholecystokinin Receptors
% 219.26/219.48  |- skos__altLabel mesh__D011949 Receptors, Cholecystokinin Octapeptide
% 219.26/219.48  |- mesh__recordOriginator mesh__D011949 SH
% 219.26/219.48  |- skos__altLabel mesh__D011949 Receptors, CCK-4
% 219.26/219.48  |- skos__broader mesh__D011949smesh__D043562
% 219.26/219.48  |- skos__hiddenLabel mesh__D011949 Octapeptide Receptors, Cholecystokinin
% 219.26/219.48  |- skos__hiddenLabel mesh__D011949 Receptors, CCK 8
% 219.26/219.48  |- skos__altLabel mesh__D011949 Receptors, CCK
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D011949 2005
% 219.26/219.49  |- mesh__dateCreated mesh__D011949 1986-03-31
% 219.26/219.49  |- mesh__dateEstablished mesh__D011949 1987-01-01
% 219.26/219.49  |- skos__scopeNote mesh__D011949
% 219.26/219.49       Cell surface proteins that bind cholecystokinin %28%CCK%29% with high affinity and trigger intracellular changes influencing the behavior of cells. Cholecystokinin receptors are activated by GASTRIN as well as by CCK-4; CCK-8; and CCK-33. Activation of these receptors evokes secretion of AMYLASE by pancreatic acinar cells, acid and PEPSIN by stomach mucosal cells, and contraction of the PYLORUS and GALLBLADDER. The role of the widespread CCK receptors in the central nervous system is not well understood.%A%    
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D011949 2004
% 219.26/219.49  |- skos__broader mesh__D011949smesh__D018013
% 219.26/219.49  |- skos__prefLabel mesh__D016634 Radiosurgery
% 219.26/219.49  |- skos__altLabel mesh__D016634 Stereotactic Radiosurgery
% 219.26/219.49  |- mesh__recordMaintainer mesh__D016634 lkt
% 219.26/219.49  |- skos__hiddenLabel mesh__D016634 Radiosurgeries, Linac
% 219.26/219.49  |- skos__hiddenLabel mesh__D016634 Gamma Knife Radiosurgeries
% 219.26/219.49  |- mesh__dateEstablished mesh__D016634 1992-01-01
% 219.26/219.49  |- skos__altLabel mesh__D016634 Linac Radiosurgery
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016634 2006
% 219.26/219.49  |- skos__hiddenLabel mesh__D016634 Radiosurgeries, Gamma Knife
% 219.26/219.49  |- mesh__dateCreated mesh__D016634 1991-01-25
% 219.26/219.49  |- skos__broader mesh__D016634smesh__D013238
% 219.26/219.49  |- skos__altLabel mesh__D016634 Linear Accelerator Radiosurgery
% 219.26/219.49  |- mesh__dateRevised mesh__D016634 2005-06-30
% 219.26/219.49  |- skos__altLabel mesh__D016634 Radiosurgery, Gamma Knife
% 219.26/219.49  |- skos__hiddenLabel mesh__D016634 Stereotactic Radiosurgeries
% 219.26/219.49  |- mesh__recordAuthorizer mesh__D016634 sjn
% 219.26/219.49  |- skos__altLabel mesh__D016634 Radiosurgery, Linac
% 219.26/219.49  |- skos__hiddenLabel mesh__D016634 Radiosurgeries, Linear Accelerator
% 219.26/219.49  |- rdf__type mesh__D016634sskos__Concept
% 219.26/219.49  |- mesh__historyNote mesh__D016634 92   
% 219.26/219.49  |- mesh__recordOriginator mesh__D016634 TGC
% 219.26/219.49  |- mesh__publicMeSHNote mesh__D016634 92   
% 219.26/219.49  |- skos__scopeNote mesh__D016634
% 219.26/219.49       A stereotactic neurosurgery in which the usual rigid needles or probes are replaced with beams of ionizing radiation directed toward an intracranial target so as to achieve local tissue destruction. No skin incision or skull opening is required. It is performed with the %22%gamma knife%22%, a self-contained unit with 201 cobalt-60 sources or with an isocentric linear accelerator %28%linac%29%. %28%Goodman, M.L., Southern Medical Journal, vol. 83, May 1990, pp. 551-4%29%%A%    
% 219.26/219.49  |- skos__annotation mesh__D016634
% 219.26/219.49       IM; a specific type of stereotactic brain surg; do not confuse with COMBINED MODALITY THERAPY %28%see note there%29% using surg + radiother; coord IM with dis /surg %28%IM%29%, not /radiother; gamma knife %26% linear accelerator: index under RADIOSURGERY /instrum %26% do not coord with GAMMA RAYS or PARTICLE ACCELERATORS unless particularly discussed%A%  
% 219.26/219.49  |- skos__hiddenLabel mesh__D016634 Linear Accelerator Radiosurgeries
% 219.26/219.49  |- skos__hiddenLabel mesh__D016634 Radiosurgeries, Stereotactic
% 219.26/219.49  |- skos__historyNote mesh__D016634 Stereotaxic Techniques %28%1971-1991%29%
% 219.26/219.49  |- skos__broader mesh__D016634smesh__D011878
% 219.26/219.49  |- skos__altLabel mesh__D016634 Radiosurgery, Stereotactic
% 219.26/219.49  |- skos__hiddenLabel mesh__D016634 Radiosurgeries
% 219.26/219.49  |- mesh__recordMaintainer mesh__D002614 ssb
% 219.26/219.49  |- mesh__publicMeSHNote mesh__D002614
% 219.26/219.49       HEAVY METAL DETOXICANTS was heading 1963-65   
% 219.26/219.49  |- skos__related mesh__D002614smesh__D000931
% 219.26/219.49  |- skos__altLabel mesh__D002614 Complexons
% 219.26/219.49  |- mesh__dateRevised mesh__D002614 2003-07-09
% 219.26/219.49  |- skos__prefLabel mesh__D002614 Chelating Agents
% 219.26/219.49  |- mesh__historyNote mesh__D002614
% 219.26/219.49       HEAVY METAL DETOXICANTS was heading 1963-65   
% 219.26/219.49  |- skos__annotation mesh__D002614
% 219.26/219.49       D25-26 qualif; coord IM with specific chelating agent %28%IM%29% + metal being chelated %28%IM%29%%A%  
% 219.26/219.49  |- mesh__dateCreated mesh__D002614 1999-01-01
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D002614 2005
% 219.26/219.49  |- skos__related mesh__D002614smesh__D007502
% 219.26/219.49  |- skos__altLabel mesh__D002614 Chelators
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D002614 2006
% 219.26/219.49  |- skos__hiddenLabel mesh__D002614 Antagonists, Metal
% 219.26/219.49  |- skos__broader mesh__D002614smesh__D045504
% 219.26/219.49  |- skos__hiddenLabel mesh__D002614 Agents, Chelating
% 219.26/219.49  |- skos__broader mesh__D002614smesh__D020313
% 219.26/219.49  |- skos__scopeNote mesh__D002614
% 219.26/219.49       Organic chemicals that form two or more coordination bonds with a central metal ion. Heterocyclic rings are formed with the central metal atom as part of the ring. Some biological systems form metal chelates, e.g., the iron-binding porphyrin group of hemoglobin and the magnesium-binding chlorophyll of plants. %28%From Hawley%27%s Condensed Chemical Dictionary, 12th ed%29% They are used chemically to remove ions from solutions, medicinally against microorganisms, to treat metal poisoning, and in chemotherapy protocols.%A%    
% 219.26/219.49  |- rdf__type mesh__D002614sskos__Concept
% 219.26/219.49  |- mesh__recordOriginator mesh__D002614 NLM
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D002614 2004
% 219.26/219.49  |- mesh__recordAuthorizer mesh__D002614 sjn
% 219.26/219.49  |- mesh__recordOriginator mesh__D012244 JW
% 219.26/219.49  |- mesh__historyNote mesh__D012244 76; was ATHIORHODACEAE 1975   
% 219.26/219.49  |- skos__historyNote mesh__D012244 Bacteria %28%1966-1974%29%
% 219.26/219.49  |- skos__broader mesh__D012244smesh__D012245
% 219.26/219.49  |- mesh__dateRevised mesh__D012244 2005-06-30
% 219.26/219.49  |- rdf__type mesh__D012244sskos__Concept
% 219.26/219.49  |- mesh__onlineNote mesh__D012244
% 219.26/219.49       use RHODOSPIRILLACEAE to search ATHIORHODACEAE 1975   
% 219.26/219.49  |- mesh__recordMaintainer mesh__D012244 ags
% 219.26/219.49  |- mesh__dateEstablished mesh__D012244 1976-01-01
% 219.26/219.49  |- skos__prefLabel mesh__D012244 Rhodospirillaceae
% 219.26/219.49  |- skos__broader mesh__D012244smesh__D016946
% 219.26/219.49  |- mesh__dateCreated mesh__D012244 1975-07-23
% 219.26/219.49  |- skos__scopeNote mesh__D012244
% 219.26/219.49       A family of phototrophic bacteria, in the order Rhodospirillales, isolated from stagnant water and mud.%A%    
% 219.26/219.49  |- skos__altLabel mesh__D012244 Bacteria, Purple Nonsulfur
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D012244 2006
% 219.26/219.49  |- mesh__recordAuthorizer mesh__D012244 sjn
% 219.26/219.49  |- skos__altLabel mesh__D012244 Purple Nonsulfur Bacteria
% 219.26/219.49  |- mesh__publicMeSHNote mesh__D012244 76; was ATHIORHODACEAE 1975   
% 219.26/219.49  |- skos__broader mesh__D006207smesh__D013995
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006207 2006
% 219.26/219.49  |- mesh__historyNote mesh__D006207 74%28%71%29%   
% 219.26/219.49  |- mesh__recordOriginator mesh__D006207 NLM
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006207 2003
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006207 1992
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006207 1995
% 219.26/219.49  |- skos__hiddenLabel mesh__D006207 Half Life
% 219.26/219.49  |- mesh__dateEstablished mesh__D006207 1974-01-01
% 219.26/219.49  |- skos__hiddenLabel mesh__D006207 Halflifes
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006207 2004
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006207 1993
% 219.26/219.49  |- skos__historyNote mesh__D006207
% 219.26/219.49       specific radioisotope, substance, or cell
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006207 1998
% 219.26/219.49  |- skos__historyNote mesh__D006207 Time %28%1966-1970%29%
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006207 1999
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006207 1996
% 219.26/219.49  |- rdf__type mesh__D006207sskos__Concept
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006207 2000
% 219.26/219.49  |- mesh__dateCreated mesh__D006207 1999-01-01
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006207 1997
% 219.26/219.49  |- skos__annotation mesh__D006207
% 219.26/219.49       almost never IM; no qualif; may refer to radioactivity, metabolized substances or cells%A%  
% 219.26/219.49  |- mesh__publicMeSHNote mesh__D006207 74   
% 219.26/219.49  |- skos__scopeNote mesh__D006207
% 219.26/219.49       The time it takes for a substance %28%drug, radioactive nuclide, or other%29% to lose half of its pharmacologic, physiologic, or radiologic activity.%A%    
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006207 2001
% 219.26/219.49  |- mesh__recordAuthorizer mesh__D006207 PLS
% 219.26/219.49  |- skos__prefLabel mesh__D006207 Half-Life
% 219.26/219.49  |- skos__altLabel mesh__D006207 Halflife
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006207 2005
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006207 2002
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006207 1994
% 219.26/219.49  |- mesh__dateRevised mesh__D006207 1991-01-08
% 219.26/219.49  |- skos__hiddenLabel mesh__D006207 Half-Lifes
% 219.26/219.49  |- mesh__recordMaintainer mesh__D006207 TGC
% 219.26/219.49  |- skos__broader mesh__D009732Q000331smesh__D009732
% 219.26/219.49  |- mesh__preferredCombination mesh__D009732Q000331smesh__D007884
% 219.26/219.49  |- rdf__type mesh__D009732Q000331smesh__CompoundConcept
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016635 2004
% 219.26/219.49  |- mesh__publicMeSHNote mesh__D016635 92   
% 219.26/219.49  |- mesh__dateEstablished mesh__D016635 1992-01-01
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016635 1996
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016635 2000
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016635 1999
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016635 2003
% 219.26/219.49  |- mesh__recordOriginator mesh__D016635 TGC
% 219.26/219.49  |- skos__hiddenLabel mesh__D016635 Precaution, Universal
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016635 1995
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016635 2006
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016635 1998
% 219.26/219.49  |- skos__historyNote mesh__D016635
% 219.26/219.49       specific disease/prevention %26% control %28%1988-1991%29%
% 219.26/219.49  |- skos__altLabel mesh__D016635 Precautions, Universal
% 219.26/219.49  |- mesh__dateRevised mesh__D016635 1992-05-18
% 219.26/219.49  |- skos__broader mesh__D016635smesh__D003140
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016635 2002
% 219.26/219.49  |- skos__hiddenLabel mesh__D016635 Universal Precaution
% 219.26/219.49  |- mesh__dateCreated mesh__D016635 1991-06-20
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016635 1994
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016635 2005
% 219.26/219.49  |- skos__annotation mesh__D016635
% 219.26/219.49       restrict to %22%prudent prev measures%22% in contacts with patients having communicable dis; IM; coord IM with specific dis /prev %28%IM%29%%A%  
% 219.26/219.49  |- mesh__recordAuthorizer mesh__D016635 PLS
% 219.26/219.49  |- rdf__type mesh__D016635sskos__Concept
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016635 1997
% 219.26/219.49  |- mesh__historyNote mesh__D016635 92   
% 219.26/219.49  |- skos__prefLabel mesh__D016635 Universal Precautions
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016635 2001
% 219.26/219.49  |- mesh__recordMaintainer mesh__D016635 TAP
% 219.26/219.49  |- skos__scopeNote mesh__D016635
% 219.26/219.49       Prudent standard preventive measures to be taken by professional and other health personnel in contact with persons afflicted with a communicable disease, to avoid contracting the disease by contagion or infection. Precautions are especially applicable in the diagnosis and care of AIDS patients.%A%    
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016635 1993
% 219.26/219.49  |- skos__historyNote mesh__D002615 Skin Diseases %28%1966-1976%29%
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D002615 2005
% 219.26/219.49  |- skos__scopeNote mesh__D002615
% 219.26/219.49       Application of a cauterant to the skin for the purpose of causing a superficial destruction of the epidermis and upper layers of the dermis. After healing, the treated area has new epithelium.%A%    
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D002615 2006
% 219.26/219.49  |- skos__prefLabel mesh__D002615 Chemexfoliation
% 219.26/219.49  |- mesh__recordAuthorizer mesh__D002615 sjn
% 219.26/219.49  |- skos__historyNote mesh__D002615 Skin %28%1966-1976%29%
% 219.26/219.49  |- mesh__dateCreated mesh__D002615 1976-04-13
% 219.26/219.49  |- skos__historyNote mesh__D002615 Surgery, Plastic %28%1966-1976%29%
% 219.26/219.49  |- mesh__dateEstablished mesh__D002615 1977-01-01
% 219.26/219.49  |- rdf__type mesh__D002615sskos__Concept
% 219.26/219.49  |- skos__historyNote mesh__D002615 Face %28%1966-1976%29%
% 219.26/219.49  |- mesh__recordMaintainer mesh__D002615 nns
% 219.26/219.49  |- skos__broader mesh__D002615smesh__D019651
% 219.26/219.49  |- skos__hiddenLabel mesh__D002615 Chemexfoliations
% 219.26/219.49  |- mesh__publicMeSHNote mesh__D002615 77   
% 219.26/219.49  |- mesh__recordOriginator mesh__D002615 SMH
% 219.26/219.49  |- mesh__dateRevised mesh__D002615 2004-07-07
% 219.26/219.49  |- mesh__historyNote mesh__D002615 77   
% 219.26/219.49  |- skos__altLabel mesh__D002615 Chemical Face Peeling
% 219.26/219.49  |- skos__broader mesh__D002615smesh__D003357
% 219.26/219.49  |- skos__related mesh__D007300smesh__D002629
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D007300 2004
% 219.26/219.49  |- skos__related mesh__D007300smesh__D010572
% 219.26/219.49  |- mesh__dateCreated mesh__D007300 1999-01-01
% 219.26/219.49  |- skos__annotation mesh__D007300
% 219.26/219.49       for sterilization of insects, coord specific insect %28%IM%29% + PEST CONTROL, BIOLOGICAL %28%IM%29% but not also STERILIZATION, REPRODUCTIVE %28%see note there%29% %26% not also INSECT CONTROL%A%  
% 219.26/219.49  |- rdf__type mesh__D007300sskos__Concept
% 219.26/219.49  |- mesh__recordOriginator mesh__D007300 NLM
% 219.26/219.49  |- skos__related mesh__D007300smesh__D007305
% 219.26/219.49  |- mesh__dateRevised mesh__D007300 2003-07-09
% 219.26/219.49  |- mesh__recordAuthorizer mesh__D007300 sjn
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D007300 2005
% 219.26/219.49  |- mesh__recordMaintainer mesh__D007300 lkt
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D007300 2006
% 219.26/219.49  |- skos__scopeNote mesh__D007300
% 219.26/219.49       The reduction or regulation of the population of noxious, destructive, or dangerous insects through chemical, biological, or other means.%A%    
% 219.26/219.49  |- skos__broader mesh__D007300smesh__D010571
% 219.26/219.49  |- skos__hiddenLabel mesh__D007300 Control, Insect
% 219.26/219.49  |- skos__prefLabel mesh__D007300 Insect Control
% 219.26/219.49  |- mesh__recordMaintainer mesh__D012245 SYSTEM
% 219.26/219.49  |- skos__annotation mesh__D012245 in water   
% 219.26/219.49  |- mesh__publicMeSHNote mesh__D012245 76   
% 219.26/219.49  |- skos__scopeNote mesh__D012245
% 219.26/219.49       An order of photosynthetic bacteria representing a physiological community of predominantly aquatic bacteria.%A%    
% 219.26/219.49  |- mesh__historyNote mesh__D012245 76   
% 219.26/219.49  |- skos__broader mesh__D012245smesh__D020561
% 219.26/219.49  |- mesh__recordAuthorizer mesh__D012245 sjn
% 219.26/219.49  |- mesh__recordOriginator mesh__D012245 JW
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D012245 2006
% 219.26/219.49  |- mesh__dateRevised mesh__D012245 2005-06-30
% 219.26/219.49  |- mesh__dateCreated mesh__D012245 1975-07-21
% 219.26/219.49  |- mesh__dateEstablished mesh__D012245 1976-01-01
% 219.26/219.49  |- skos__prefLabel mesh__D012245 Rhodospirillales
% 219.26/219.49  |- skos__historyNote mesh__D012245 Rhodospirillaceae %28%1975%29%
% 219.26/219.49  |- skos__historyNote mesh__D012245 Bacteria %28%1966-1974%29%
% 219.26/219.49  |- rdf__type mesh__D012245sskos__Concept
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006208 2005
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006208 2003
% 219.26/219.49  |- skos__prefLabel mesh__D006208 Halfway Houses
% 219.26/219.49  |- mesh__recordMaintainer mesh__D006208 kle
% 219.26/219.49  |- skos__hiddenLabel mesh__D006208 Houses, Halfway
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006208 2006
% 219.26/219.49  |- mesh__historyNote mesh__D006208 67%28%65%29%   
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006208 2004
% 219.26/219.49  |- rdf__type mesh__D006208sskos__Concept
% 219.26/219.49  |- skos__hiddenLabel mesh__D006208 House, Halfway
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006208 2000
% 219.26/219.49  |- mesh__dateCreated mesh__D006208 1999-01-01
% 219.26/219.49  |- mesh__recordAuthorizer mesh__D006208 sjn
% 219.26/219.49  |- mesh__dateRevised mesh__D006208 1999-11-03
% 219.26/219.49  |- mesh__dateEstablished mesh__D006208 1967-01-01
% 219.26/219.49  |- skos__annotation mesh__D006208 IM   
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006208 2001
% 219.26/219.49  |- skos__broader mesh__D006208smesh__D012112
% 219.26/219.49  |- skos__scopeNote mesh__D006208
% 219.26/219.49       Specialized residences for persons who do not require full hospitalization, and are not well enough to function completely within the community without professional supervision, protection and support.%A%    
% 219.26/219.49  |- skos__hiddenLabel mesh__D006208 Halfway House
% 219.26/219.49  |- mesh__publicMeSHNote mesh__D006208 67   
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006208 2002
% 219.26/219.49  |- mesh__recordOriginator mesh__D006208 NLM
% 219.26/219.49  |- skos__altLabel mesh__D049810 Cladogenesis
% 219.26/219.49  |- skos__hiddenLabel mesh__D049810 Speciation, Genetic
% 219.26/219.49  |- skos__scopeNote mesh__D049810
% 219.26/219.49       The splitting of an ancestral species into daughter species that coexist in time %28%King, Dictionary of Genetics, 6th ed%29%. Causal factors may include geographic isolation, MUTATION, migration, random GENETIC DRIFT, and HABITAT geometry.%A%    
% 219.26/219.49  |- skos__altLabel mesh__D049810 Speciation, Genetics
% 219.26/219.49  |- mesh__recordOriginator mesh__D049810 ags
% 219.26/219.49  |- skos__prefLabel mesh__D049810 Genetic Speciation
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D049810 2006
% 219.26/219.49  |- mesh__dateEstablished mesh__D049810 2006-01-01
% 219.26/219.49  |- mesh__publicMeSHNote mesh__D049810 2006   
% 219.26/219.49  |- skos__hiddenLabel mesh__D049810 Cladogeneses
% 219.26/219.49  |- mesh__historyNote mesh__D049810 2006   
% 219.26/219.49  |- mesh__recordAuthorizer mesh__D049810 sjn
% 219.26/219.49  |- mesh__dateCreated mesh__D049810 2005-06-30
% 219.26/219.49  |- skos__broader mesh__D049810smesh__D005075
% 219.26/219.49  |- rdf__type mesh__D049810sskos__Concept
% 219.26/219.49  |- mesh__recordMaintainer mesh__D049810 ags
% 219.26/219.49  |- skos__broader mesh__D016636smesh__D013685
% 219.26/219.49  |- skos__broader mesh__D016636smesh__D003308
% 219.26/219.49  |- skos__annotation mesh__D016636
% 219.26/219.49       do not use /util except by MeSH definition; DF: note short X ref%A%  
% 219.26/219.49  |- skos__scopeNote mesh__D016636
% 219.26/219.49       A telecommunication system combining the transmission of a document scanned at a transmitter, its reconstruction at a receiving station, and its duplication there by a copier.%A%    
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016636 2004
% 219.26/219.49  |- skos__hiddenLabel mesh__D016636 Transmission, Facsimile
% 219.26/219.49  |- skos__hiddenLabel mesh__D016636 Transceivers, Facsimile
% 219.26/219.49  |- mesh__recordOriginator mesh__D016636 TGC
% 219.26/219.49  |- mesh__publicMeSHNote mesh__D016636 92   
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016636 1999
% 219.26/219.49  |- mesh__dateEstablished mesh__D016636 1992-01-01
% 219.26/219.49  |- skos__altLabel mesh__D016636 Fax
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016636 2003
% 219.26/219.49  |- mesh__recordMaintainer mesh__D016636 TGC
% 219.26/219.49  |- skos__hiddenLabel mesh__D016636 Telefacsimiles
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016636 1998
% 219.26/219.49  |- skos__altLabel mesh__D016636 Telefax
% 219.26/219.49  |- skos__historyNote mesh__D016636 Telecommunications %28%1986-1991%29%
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016636 2002
% 219.26/219.49  |- skos__hiddenLabel mesh__D016636 Transmissions, Facsimile
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016636 1995
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016636 2006
% 219.26/219.49  |- mesh__recordAuthorizer mesh__D016636 PLS
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016636 1994
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016636 2005
% 219.26/219.49  |- mesh__dateCreated mesh__D016636 1991-01-25
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016636 1997
% 219.26/219.49  |- mesh__dateRevised mesh__D016636 1993-06-03
% 219.26/219.49  |- rdf__type mesh__D016636sskos__Concept
% 219.26/219.49  |- skos__hiddenLabel mesh__D016636 Facsimile Transmissions
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016636 2001
% 219.26/219.49  |- skos__hiddenLabel mesh__D016636 Transceiver, Facsimile
% 219.26/219.49  |- skos__prefLabel mesh__D016636 Telefacsimile
% 219.26/219.49  |- skos__hiddenLabel mesh__D016636 Facsimile Transceivers
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016636 1996
% 219.26/219.49  |- mesh__historyNote mesh__D016636 92   
% 219.26/219.49  |- skos__historyNote mesh__D016636 Copying Processes %28%1986-1991%29%
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D016636 2000
% 219.26/219.49  |- mesh__historyNote mesh__D002616 66   
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D002616 2003
% 219.26/219.49  |- mesh__dateEstablished mesh__D002616 1966-01-01
% 219.26/219.49  |- skos__prefLabel mesh__D002616 Chemical Engineering
% 219.26/219.49  |- mesh__recordMaintainer mesh__D002616 mdb
% 219.26/219.49  |- mesh__publicMeSHNote mesh__D002616 66   
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D002616 2004
% 219.26/219.49  |- rdf__type mesh__D002616sskos__Concept
% 219.26/219.49  |- mesh__dateRevised mesh__D002616 2002-07-03
% 219.26/219.49  |- skos__altLabel mesh__D002616 Engineering, Chemical
% 219.26/219.49  |- mesh__recordAuthorizer mesh__D002616 sjn
% 219.26/219.49  |- skos__broader mesh__D002616smesh__D004738
% 219.26/219.49  |- mesh__recordOriginator mesh__D002616 NLM
% 219.26/219.49  |- skos__annotation mesh__D002616 SPEC: SPEC qualif   
% 219.26/219.49  |- mesh__dateCreated mesh__D002616 1999-01-01
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D002616 2005
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D002616 2006
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D007301 2006
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D007301 2001
% 219.26/219.49  |- mesh__recordMaintainer mesh__D007301 TAP
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D007301 1995
% 219.26/219.49  |- skos__historyNote mesh__D007301 Invertebrate Hormones %28%1967-1974%29%
% 219.26/219.49  |- mesh__publicMeSHNote mesh__D007301
% 219.26/219.49       77; was see under INVERTEBRATE HORMONES 1967-76   
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D007301 2005
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D007301 2004
% 219.26/219.49  |- skos__broader mesh__D007301smesh__D007447
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D007301 1994
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D007301 1993
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D007301 2000
% 219.26/219.49  |- skos__hiddenLabel mesh__D007301 Hormones, Insect
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D007301 2003
% 219.26/219.49  |- mesh__dateEstablished mesh__D007301 1977-01-01
% 219.26/219.49  |- skos__scopeNote mesh__D007301
% 219.26/219.49       Hormones secreted by insects. They influence their growth and development. Also synthetic substances that act like insect hormones.%A%    
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D007301 1999
% 219.26/219.49  |- mesh__dateRevised mesh__D007301 1992-05-19
% 219.26/219.49  |- rdf__type mesh__D007301sskos__Concept
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D007301 1998
% 219.26/219.49  |- mesh__recordAuthorizer mesh__D007301 PLS
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D007301 1997
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D007301 2002
% 219.26/219.49  |- mesh__historyNote mesh__D007301
% 219.26/219.49       77%28%75%29%; was see under INVERTEBRATE HORMONES 1967-76   
% 219.26/219.49  |- mesh__dateCreated mesh__D007301 1999-01-01
% 219.26/219.49  |- mesh__recordOriginator mesh__D007301 NLM
% 219.26/219.49  |- skos__prefLabel mesh__D007301 Insect Hormones
% 219.26/219.49  |- skos__annotation mesh__D007301
% 219.26/219.49       coord IM with specific insect %28%IM%29%   
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D007301 1996
% 219.26/219.49  |- mesh__onlineNote mesh__D007301 search INVERTEBRATE HORMONES 1967-74   
% 219.26/219.49  |- skos__annotation mesh__D012246 in mud %26% stagnant water   
% 219.26/219.49  |- skos__broader mesh__D012246smesh__D012244
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D012246 2006
% 219.26/219.49  |- skos__prefLabel mesh__D012246 Rhodospirillum
% 219.26/219.49  |- mesh__recordAuthorizer mesh__D012246 sjn
% 219.26/219.49  |- rdf__type mesh__D012246sskos__Concept
% 219.26/219.49  |- mesh__recordOriginator mesh__D012246 NLM
% 219.26/219.49  |- skos__scopeNote mesh__D012246
% 219.26/219.49       A genus of gram-negative, spiral bacteria that possesses internal photosynthetic membranes. Its organisms divide by binary fission, are motile by means of polar flagella, and are found in aquatic environments.%A%    
% 219.26/219.49  |- mesh__dateRevised mesh__D012246 2005-06-30
% 219.26/219.49  |- mesh__dateCreated mesh__D012246 1999-01-01
% 219.26/219.49  |- mesh__recordMaintainer mesh__D012246 ags
% 219.26/219.49  |- mesh__dateRevised mesh__D006209 1999-11-03
% 219.26/219.49  |- skos__prefLabel mesh__D006209 Halitosis
% 219.26/219.49  |- skos__scopeNote mesh__D006209
% 219.26/219.49       An offensive, foul breath odor resulting from a variety of causes such as poor oral hygiene, dental or oral infections, or the ingestion of certain foods.%A%    
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006209 2004
% 219.26/219.49  |- mesh__dateCreated mesh__D006209 1999-01-01
% 219.26/219.49  |- mesh__recordOriginator mesh__D006209 NLM
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006209 2003
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006209 2006
% 219.26/219.49  |- mesh__recordMaintainer mesh__D006209 KEV
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006209 2002
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006209 2005
% 219.26/219.49  |- rdf__type mesh__D006209sskos__Concept
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006209 2001
% 219.26/219.49  |- mesh__recordAuthorizer mesh__D006209 sjn
% 219.26/219.49  |- skos__hiddenLabel mesh__D006209 Halitoses
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D006209 2000
% 219.26/219.49  |- skos__broader mesh__D006209smesh__D012817
% 219.26/219.49  |- mesh__historyNote mesh__D049811 2006   
% 219.26/219.49  |- mesh__recordAuthorizer mesh__D049811 sjn
% 219.26/219.49  |- mesh__dateCreated mesh__D049811 2005-06-30
% 219.26/219.49  |- skos__broader mesh__D049811smesh__D004267
% 219.26/219.49  |- skos__prefLabel mesh__D049811 Anellovirus
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D049811 2006
% 219.26/219.49  |- mesh__publicMeSHNote mesh__D049811 2006   
% 219.26/219.49  |- skos__hiddenLabel mesh__D049811 Anelloviruses
% 219.26/219.49  |- skos__scopeNote mesh__D049811
% 219.26/219.49       A free-floating DNA virus genus, unattached to any family, comprising several species of hepatitis-related viruses.%A%    
% 219.26/219.49  |- rdf__type mesh__D049811sskos__Concept
% 219.26/219.49  |- mesh__recordOriginator mesh__D049811 ags
% 219.26/219.49  |- mesh__recordMaintainer mesh__D049811 ags
% 219.26/219.49  |- skos__broader mesh__D049811smesh__D014713
% 219.26/219.49  |- mesh__dateEstablished mesh__D049811 2006-01-01
% 219.26/219.49  |- skos__prefLabel mesh__D002617 Chemical Industry
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D002617 2001
% 219.26/219.49  |- mesh__dateCreated mesh__D002617 1999-01-01
% 219.26/219.49  |- skos__scopeNote mesh__D002617
% 219.26/219.49       The aggregate enterprise of manufacturing and technically producing chemicals. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D002617 2006
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D002617 2000
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D002617 2004
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D002617 1999
% 219.26/219.49  |- skos__hiddenLabel mesh__D002617 Industries, Chemical
% 219.26/219.49  |- mesh__dateRevised mesh__D002617 1995-05-22
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D002617 1997
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D002617 2005
% 219.26/219.49  |- mesh__recordAuthorizer mesh__D002617 PLS
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D002617 2003
% 219.26/219.49  |- skos__annotation mesh__D002617 SPEC: SPEC qualif; DF: CHEM INDUST   
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D002617 1998
% 219.26/219.49  |- rdf__type mesh__D002617sskos__Concept
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D002617 1996
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D002617 2002
% 219.26/219.49  |- mesh__recordMaintainer mesh__D002617 KEV
% 219.26/219.49  |- skos__hiddenLabel mesh__D002617 Chemical Industries
% 219.26/219.49  |- skos__altLabel mesh__D002617 Industry, Chemical
% 219.26/219.49  |- mesh__recordOriginator mesh__D002617 NLM
% 219.26/219.49  |- skos__broader mesh__D002617smesh__D007221
% 219.26/219.49  |- mesh__recordOriginator mesh__D007302 NLM
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D007302 2005
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D007302 2004
% 219.26/219.49  |- mesh__recordAuthorizer mesh__D007302 sjn
% 219.26/219.49  |- skos__prefLabel mesh__D007302 Insect Repellents
% 219.26/219.49  |- mesh__dateRevised mesh__D007302 2003-07-09
% 219.26/219.49  |- skos__broader mesh__D007302smesh__D010575
% 219.26/219.49  |- skos__scopeNote mesh__D007302
% 219.26/219.49       Substances causing insects to turn away from them or reject them as food.%A%    
% 219.26/219.49  |- mesh__recordMaintainer mesh__D007302 ssb
% 219.26/219.49  |- rdf__type mesh__D007302sskos__Concept
% 219.26/219.49  |- skos__annotation mesh__D007302 specify insect if pertinent   
% 219.26/219.49  |- mesh__dateCreated mesh__D007302 1999-01-01
% 219.26/219.49  |- mesh__activeMeSHYear mesh__D007302 2006
% 219.26/219.50  |- skos__hiddenLabel mesh__D007302 Repellents, Insect
% 219.26/219.50  |- mesh__recordMaintainer mesh__D012247 ags
% 219.26/219.50  |- skos__prefLabel mesh__D012247 Rhodospirillum rubrum
% 219.26/219.50  |- mesh__historyNote mesh__D012247 74%28%72%29%   
% 219.26/219.50  |- mesh__recordAuthorizer mesh__D012247 sjn
% 219.26/219.50  |- mesh__activeMeSHYear mesh__D012247 2006
% 219.26/219.50  |- skos__scopeNote mesh__D012247
% 219.26/219.50       Vibrio- to spiral-shaped phototrophic bacteria found in stagnant water and mud exposed to light.%A%    
% 219.26/219.50  |- mesh__recordOriginator mesh__D012247 NLM
% 219.26/219.50  |- rdf__type mesh__D012247sskos__Concept
% 219.35/219.50  |- mesh__dateEstablished mesh__D012247 1974-01-01
% 219.35/219.50  |- mesh__dateCreated mesh__D012247 1999-01-01
% 219.35/219.50  |- skos__historyNote mesh__D012247 Rhodospirillum %28%1966-1971%29%
% 219.35/219.50  |- mesh__publicMeSHNote mesh__D012247 74   
% 219.35/219.50  |- skos__broader mesh__D012247smesh__D012246
% 219.35/219.50  |- mesh__dateRevised mesh__D012247 2005-06-30
% 219.35/219.50  |- skos__annotation mesh__D012247 in mud %26% stagnant water   
% 219.35/219.50  |- skos__altLabel mesh__D017730 CD30 Antigen
% 219.35/219.50  |- skos__broader mesh__D017730smesh__D014408
% 219.35/219.50  |- skos__historyNote mesh__D017730
% 219.35/219.50       Antigens, Differentiation %28%1988-1993%29%
% 219.35/219.50  |- skos__altLabel mesh__D017730 Ber-H2 Antigens
% 219.35/219.50  |- mesh__recordMaintainer mesh__D017730 ssb
% 219.35/219.50  |- skos__hiddenLabel mesh__D017730 Ki 1 Antigen
% 219.35/219.50  |- skos__hiddenLabel mesh__D017730 Antigens, Ber-H2
% 219.35/219.50  |- skos__broader mesh__D017730smesh__D018124
% 219.35/219.50  |- skos__hiddenLabel mesh__D017730 Receptor, TNFRSF8
% 219.35/219.50  |- skos__broader mesh__D017730smesh__D015703
% 219.35/219.50  |- mesh__historyNote mesh__D017730
% 219.35/219.50       94; CD30 ANTIGENS was CD30 ANTIGEN %28%NM%29% 1983-93   
% 219.35/219.50  |- skos__prefLabel mesh__D017730 Antigens, CD30
% 219.35/219.50  |- skos__hiddenLabel mesh__D017730 Antigens, Ki 1
% 219.35/219.50  |- skos__hiddenLabel mesh__D017730 Antigen, CD30
% 219.35/219.50  |- skos__altLabel mesh__D017730 Antigens, Ki-1
% 219.35/219.50  |- mesh__dateRevised mesh__D017730 2005-06-30
% 219.35/219.50  |- skos__historyNote mesh__D017730 Antigens, Neoplasm %28%1985-1993%29%
% 219.35/219.50  |- skos__altLabel mesh__D017730 CD30 Antigens
% 219.35/219.50  |- skos__altLabel mesh__D017730 Ki-1 Antigen
% 219.35/219.50  |- skos__hiddenLabel mesh__D017730 Ki 1 Antigens
% 219.35/219.50  |- skos__altLabel mesh__D017730
% 219.35/219.50       Tumor Necrosis Factor Receptor Superfamily, Member 8
% 219.35/219.50  |- mesh__recordOriginator mesh__D017730 AGS
% 219.35/219.50  |- mesh__dateEstablished mesh__D017730 1994-01-01
% 219.35/219.50  |- skos__broader mesh__D017730smesh__D000951
% 219.35/219.50  |- mesh__recordAuthorizer mesh__D017730 sjn
% 219.35/219.50  |- skos__scopeNote mesh__D017730
% 219.35/219.50       A member of the tumor necrosis factor receptor superfamily that may play a role in the regulation of NF-KAPPA B and APOPTOSIS. They normally present in a small number of cells in the LYMPH NODES and TONSILS in vivo, but also capable of being induced in a wide range of cells in vitro. CD30 antigens are clinically useful as tumor markers for Ki-1 lymphoma %28%LYMPHOMA, LARGE-CELL, KI-1%29% and some cases of LYMPHOMATOID PAPULOSIS; MYCOSIS FUNGOIDES; and HODGKIN%27%S DISEASE.%A%    
% 219.35/219.50  |- skos__hiddenLabel mesh__D017730 Antigen, Ber-H2
% 219.35/219.50  |- skos__hiddenLabel mesh__D017730 Ber H2 Antigens
% 219.35/219.50  |- rdf__type mesh__D017730sskos__Concept
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D017730 2006
% 219.35/219.50  |- mesh__onlineNote mesh__D017730
% 219.35/219.50       use ANTIGENS, CD30 to search CD30 Antigen %28%NM%29% 1983-93   
% 219.35/219.50  |- skos__altLabel mesh__D017730 Ber-H2 Antigen
% 219.35/219.50  |- skos__hiddenLabel mesh__D017730 Ber H2 Antigen
% 219.35/219.50  |- skos__historyNote mesh__D017730 Antigens, CD %28%1990-1993%29%
% 219.35/219.50  |- skos__altLabel mesh__D017730 Ki-1 Antigens
% 219.35/219.50  |- skos__altLabel mesh__D017730 TNFRSF8 Receptor
% 219.35/219.50  |- mesh__publicMeSHNote mesh__D017730
% 219.35/219.50       94; CD30 ANTIGENS was CD30 ANTIGEN %28%NM%29% 1983-93   
% 219.35/219.50  |- skos__hiddenLabel mesh__D017730 Antigen, Ki-1
% 219.35/219.50  |- mesh__dateCreated mesh__D017730 1992-12-28
% 219.35/219.50  |- mesh__publicMeSHNote mesh__D031401 2003   
% 219.35/219.50  |- skos__annotation mesh__D031401
% 219.35/219.50       SMILACINA, FALSE and SOLOMON SEAL see POLYGONATUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.35/219.50  |- mesh__dateEstablished mesh__D031401 2003-01-01
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D031401 2005
% 219.35/219.50  |- rdf__type mesh__D031401sskos__Concept
% 219.35/219.50  |- skos__prefLabel mesh__D031401 Smilacina
% 219.35/219.50  |- mesh__historyNote mesh__D031401 2003   
% 219.35/219.50  |- mesh__dateCreated mesh__D031401 2002-07-03
% 219.35/219.50  |- skos__broader mesh__D031401smesh__D019668
% 219.35/219.50  |- skos__altLabel mesh__D031401 Solomon Seal, False
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D031401 2004
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D031401 2003
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D031401 2006
% 219.35/219.50  |- skos__scopeNote mesh__D031401
% 219.35/219.50       A plant genus of the family LILIACEAE. The cluster of flowers at the end of the stalk distinguishes this plant from %22%true%22% Solomon%27%s seal %28%POLYGONATUM%29%, which has flowers that grow along the stem.%A%    
% 219.35/219.50  |- rdf__type mesh__D003710sskos__Concept
% 219.35/219.50  |- skos__altLabel mesh__D003710 Demographic Impact
% 219.35/219.50  |- skos__altLabel mesh__D003710 Demographics
% 219.35/219.50  |- skos__scopeNote mesh__D003710
% 219.35/219.50       Statistical interpretation and description of a population with reference to distribution, composition, or structure.%A%    
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Reverse Survival Methods
% 219.35/219.50  |- skos__altLabel mesh__D003710 Brass Technic
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D003710 2006
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Demographer
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Analysis, Multiregional
% 219.35/219.50  |- skos__altLabel mesh__D003710 Demography, Prehistoric
% 219.35/219.50  |- skos__altLabel mesh__D003710 Demography, Historical
% 219.35/219.50  |- skos__altLabel mesh__D003710 Demographic Survey
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Population Distributions
% 219.35/219.50  |- skos__altLabel mesh__D003710 Demographic Factors
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D003710 2000
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Distributions, Spatial
% 219.35/219.50  |- skos__altLabel mesh__D003710 Analyses, Multiregional
% 219.35/219.50  |- skos__altLabel mesh__D003710 Analysis, Period
% 219.35/219.50  |- skos__altLabel mesh__D003710 Analyses, Demographic
% 219.35/219.50  |- skos__prefLabel mesh__D003710 Demography
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Period Analyses
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Family Reconstitutions
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Population Methods, Stable
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Historical Demographies
% 219.35/219.50  |- skos__altLabel mesh__D003710 Demographic Factor
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Methods, Stable Population
% 219.35/219.50  |- mesh__dateCreated mesh__D003710 1999-01-01
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Analysis, Demographic
% 219.35/219.50  |- mesh__recordMaintainer mesh__D003710 kle
% 219.35/219.50  |- mesh__dateRevised mesh__D003710 1999-11-03
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Distributions, Population
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D003710 2001
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Demographic Analyses
% 219.35/219.50  |- skos__altLabel mesh__D003710 Demographic Impacts
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D003710 2003
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Technique, Brass
% 219.35/219.50  |- skos__altLabel mesh__D003710 Demographic Surveys
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Stable Population Methods
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Spatial Distributions
% 219.35/219.50  |- mesh__recordOriginator mesh__D003710 NLM
% 219.35/219.50  |- skos__altLabel mesh__D003710 Accounting, Demographic
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Reconstitution, Family
% 219.35/219.50  |- skos__altLabel mesh__D003710 Survey, Demographic
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Prehistoric Demographies
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D003710 2002
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D003710 2004
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Method, Reverse Survival
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Analyses, Period
% 219.35/219.50  |- skos__broader mesh__D003710smesh__D015991
% 219.35/219.50  |- skos__broader mesh__D003710smesh__D011154
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Demographies, Prehistoric
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Methods, Reverse Survival
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Demographies, Historical
% 219.35/219.50  |- skos__annotation mesh__D003710
% 219.35/219.50       the statist study of population characteristics; do not confuse with the POPULATION itself; no qualif; CENSUSES is also available; DF: DEMOGR%A%  
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Distribution, Population
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D003710 2005
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Distribution, Spatial
% 219.35/219.50  |- skos__altLabel mesh__D003710 Impact, Demographic
% 219.35/219.50  |- skos__broader mesh__D003710smesh__D012942
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Reconstitutions, Family
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Multiregional Analyses
% 219.35/219.50  |- skos__altLabel mesh__D003710 Factor, Demographic
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Method, Stable Population
% 219.35/219.50  |- mesh__recordAuthorizer mesh__D003710 sjn
% 219.35/219.50  |- skos__hiddenLabel mesh__D003710 Technic, Brass
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D016638 2002
% 219.35/219.50  |- skos__altLabel mesh__D016638 Critically Ill
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D016638 2005
% 219.35/219.50  |- rdf__type mesh__D016638sskos__Concept
% 219.35/219.50  |- mesh__recordAuthorizer mesh__D016638 sjn
% 219.35/219.50  |- mesh__historyNote mesh__D016638 92   
% 219.35/219.50  |- skos__broader mesh__D016638smesh__D020969
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D016638 2001
% 219.35/219.50  |- skos__hiddenLabel mesh__D016638 Critical Illnesses
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D016638 2004
% 219.35/219.50  |- skos__scopeNote mesh__D016638
% 219.35/219.50       A disease or state in which death is possible or imminent.%A%    
% 219.35/219.50  |- mesh__dateEstablished mesh__D016638 1992-01-01
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D016638 2000
% 219.35/219.50  |- mesh__dateRevised mesh__D016638 1999-11-08
% 219.35/219.50  |- mesh__recordMaintainer mesh__D016638 KEV
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D016638 2003
% 219.35/219.50  |- skos__hiddenLabel mesh__D016638 Illnesses, Critical
% 219.35/219.50  |- mesh__recordOriginator mesh__D016638 TGC
% 219.35/219.50  |- mesh__publicMeSHNote mesh__D016638 92   
% 219.35/219.50  |- skos__prefLabel mesh__D016638 Critical Illness
% 219.35/219.50  |- skos__historyNote mesh__D016638 Critical Care %28%1975-1991%29%
% 219.35/219.50  |- skos__hiddenLabel mesh__D016638 Illness, Critical
% 219.35/219.50  |- mesh__dateCreated mesh__D016638 1991-01-24
% 219.35/219.50  |- skos__annotation mesh__D016638
% 219.35/219.50       IM GEN only; do not index with specific dis of critically ill patient unless particularly discussed %26% then NIM with no qualif; /ther: consider also CRITICAL CARE%A%  
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D016638 2006
% 219.35/219.50  |- skos__related mesh__D002618smesh__D003666
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D002618 2006
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D002618 1993
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D002618 2004
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D002618 1999
% 219.35/219.50  |- mesh__recordOriginator mesh__D002618 NLM
% 219.35/219.50  |- skos__broader mesh__D002618smesh__D014857
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D002618 1994
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D002618 1997
% 219.35/219.50  |- skos__hiddenLabel mesh__D002618 Chemical Warfares
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D002618 2005
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D002618 2003
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D002618 2001
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D002618 1998
% 219.35/219.50  |- rdf__type mesh__D002618sskos__Concept
% 219.35/219.50  |- skos__hiddenLabel mesh__D002618 Warfares, Chemical
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D002618 2000
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D002618 1996
% 219.35/219.50  |- skos__altLabel mesh__D002618 Warfare, Chemical
% 219.35/219.50  |- mesh__dateRevised mesh__D002618 1992-05-07
% 219.35/219.50  |- skos__scopeNote mesh__D002618
% 219.35/219.50       Tactical warfare using incendiary mixtures, smokes, or irritant, burning, or asphyxiating gases.%A%    
% 219.35/219.50  |- skos__related mesh__D002618smesh__D005739
% 219.35/219.50  |- mesh__recordMaintainer mesh__D002618 TGC
% 219.35/219.50  |- skos__annotation mesh__D002618 DF: CHEM WARFARE   
% 219.35/219.50  |- mesh__recordAuthorizer mesh__D002618 PLS
% 219.35/219.50  |- skos__prefLabel mesh__D002618 Chemical Warfare
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D002618 2002
% 219.35/219.50  |- mesh__dateCreated mesh__D002618 1999-01-01
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D002618 1995
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D013340 1998
% 219.35/219.50  |- mesh__historyNote mesh__D013340 66   
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D013340 2003
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D013340 1997
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D013340 1994
% 219.35/219.50  |- skos__annotation mesh__D013340
% 219.35/219.50       /educ = EDUCATION, PREMEDICAL; DF: STUDENTS PREMED   
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D013340 2005
% 219.35/219.50  |- rdf__type mesh__D013340sskos__Concept
% 219.35/219.50  |- mesh__publicMeSHNote mesh__D013340 66   
% 219.35/219.50  |- skos__scopeNote mesh__D013340
% 219.35/219.50       Individuals enrolled in a preparatory course for medical school.%A%    
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D013340 1999
% 219.35/219.50  |- mesh__recordAuthorizer mesh__D013340 PLS
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D013340 1993
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D013340 2004
% 219.35/219.50  |- mesh__dateCreated mesh__D013340 1999-01-01
% 219.35/219.50  |- skos__altLabel mesh__D013340 Premedical Student
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D013340 2002
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D013340 1995
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D013340 2006
% 219.35/219.50  |- skos__prefLabel mesh__D013340 Students, Premedical
% 219.35/219.50  |- skos__altLabel mesh__D013340 Premedical Students
% 219.35/219.50  |- mesh__dateEstablished mesh__D013340 1966-01-01
% 219.35/219.50  |- skos__broader mesh__D013340smesh__D013336
% 219.35/219.50  |- skos__altLabel mesh__D013340 Student, Premedical
% 219.35/219.50  |- mesh__dateRevised mesh__D013340 1992-05-18
% 219.35/219.50  |- mesh__recordMaintainer mesh__D013340 TAP
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D013340 2000
% 219.35/219.50  |- mesh__recordOriginator mesh__D013340 NLM
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D013340 2001
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D013340 1996
% 219.35/219.50  |- rdf__type mesh__D007303sskos__Concept
% 219.35/219.50  |- skos__prefLabel mesh__D007303 Insect Vectors
% 219.35/219.50  |- mesh__dateCreated mesh__D007303 1999-01-01
% 219.35/219.50  |- mesh__recordMaintainer mesh__D007303 SYSTEM
% 219.35/219.50  |- skos__annotation mesh__D007303
% 219.35/219.50       coord IM with specific insect %28%IM%29%; specify both infecting organism %26% vector if pertinent; in the trypanosome-tsetse fly-cow relationship, the fly %28%not the cow%29% is the insect vector%A%  
% 219.35/219.50  |- skos__hiddenLabel mesh__D007303 Vector, Insect
% 219.35/219.50  |- mesh__recordOriginator mesh__D007303 NLM
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D007303 2006
% 219.35/219.50  |- mesh__recordAuthorizer mesh__D007303 sjn
% 219.35/219.50  |- skos__hiddenLabel mesh__D007303 Insect Vector
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D007303 2005
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D007303 2004
% 219.35/219.50  |- skos__scopeNote mesh__D007303
% 219.35/219.50       Insects that transmit infective organisms from one host to another or from an inanimate reservoir to an animate host.%A%    
% 219.35/219.50  |- skos__broader mesh__D007303smesh__D001179
% 219.35/219.50  |- skos__hiddenLabel mesh__D007303 Vectors, Insect
% 219.35/219.50  |- mesh__dateRevised mesh__D007303 2003-07-09
% 219.35/219.50  |- mesh__dateCreated mesh__D045422 2003-07-09
% 219.35/219.50  |- skos__hiddenLabel mesh__D045422 Ventilation, nCPAP
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D045422 2005
% 219.35/219.50  |- mesh__publicMeSHNote mesh__D045422 2004   
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D045422 2006
% 219.35/219.50  |- skos__hiddenLabel mesh__D045422 APRV Ventilation Modes
% 219.35/219.50  |- skos__hiddenLabel mesh__D045422 Ventilation Mode, APRV
% 219.35/219.50  |- mesh__dateEstablished mesh__D045422 2004-01-01
% 219.35/219.50  |- skos__hiddenLabel mesh__D045422 Ventilation Modes, APRV
% 219.35/219.50  |- skos__altLabel mesh__D045422 CPAP Ventilation
% 219.35/219.50  |- rdf__type mesh__D045422sskos__Concept
% 219.35/219.50  |- skos__hiddenLabel mesh__D045422 Ventilation, CPAP
% 219.35/219.50  |- skos__historyNote mesh__D045422
% 219.35/219.50       Positive-Pressure Respiration %28%1971-2003%29%
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D045422 2004
% 219.35/219.50  |- skos__prefLabel mesh__D045422 Continuous Positive Airway Pressure
% 219.35/219.50  |- mesh__historyNote mesh__D045422 2004   
% 219.35/219.50  |- skos__altLabel mesh__D045422 nCPAP Ventilation
% 219.35/219.50  |- skos__broader mesh__D045422smesh__D011175
% 219.35/219.50  |- skos__scopeNote mesh__D045422
% 219.35/219.50       A technique of respiratory therapy, in either spontaneously breathing or mechanically ventilated patients, in which airway pressure is maintained above atmospheric pressure throughout the respiratory cycle by pressurization of the ventilatory circuit. %28%On-Line Medical Dictionary %5B%Internet%5D%. Newcastle upon Tyne%28%UK%29%: The University Dept. of Medical Oncology: The CancerWEB Project; c1997-2003 %5B%cited 2003 Apr 17%5D%. Available from: http://cancerweb.ncl.ac.uk/omd/%29%%A%    
% 219.35/219.50  |- skos__altLabel mesh__D045422 APRV Ventilation Mode
% 219.35/219.50  |- skos__broader mesh__D012248smesh__D015003
% 219.35/219.50  |- skos__scopeNote mesh__D012248
% 219.35/219.50       A red yeast-like mitosporic fungal genus generally regarded as nonpathogenic. It is cultured from numerous sources in human patients.%A%    
% 219.35/219.50  |- mesh__dateRevised mesh__D012248 2005-06-30
% 219.35/219.50  |- mesh__dateCreated mesh__D012248 1974-12-12
% 219.35/219.50  |- skos__prefLabel mesh__D012248 Rhodotorula
% 219.35/219.50  |- mesh__recordMaintainer mesh__D012248 SYSTEM
% 219.35/219.50  |- mesh__historyNote mesh__D012248 91%28%75%29%   
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D012248 2006
% 219.35/219.50  |- rdf__type mesh__D012248sskos__Concept
% 219.35/219.50  |- mesh__recordAuthorizer mesh__D012248 sjn
% 219.35/219.50  |- skos__broader mesh__D012248smesh__D003904
% 219.35/219.50  |- mesh__dateEstablished mesh__D012248 1991-01-01
% 219.35/219.50  |- mesh__publicMeSHNote mesh__D012248
% 219.35/219.50       91; see HYPHOMYCETES 1986-90, see MONILIALES 1975-85   
% 219.35/219.50  |- mesh__recordOriginator mesh__D012248 NLM
% 219.35/219.50  |- mesh__publicMeSHNote mesh__D017731 94   
% 219.35/219.50  |- mesh__historyNote mesh__D017731 94   
% 219.35/219.50  |- skos__hiddenLabel mesh__D017731 Papuloses, Lymphomatoid
% 219.35/219.50  |- skos__prefLabel mesh__D017731 Lymphomatoid Papulosis
% 219.35/219.50  |- mesh__recordMaintainer mesh__D017731 KEV
% 219.35/219.50  |- skos__broader mesh__D017731smesh__D017514
% 219.35/219.50  |- mesh__dateRevised mesh__D017731 1995-05-24
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D017731 1997
% 219.35/219.50  |- skos__historyNote mesh__D017731 Skin Neoplasms %28%1968-1993%29%
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D017731 2004
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D017731 1999
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D017731 2002
% 219.35/219.50  |- rdf__type mesh__D017731sskos__Concept
% 219.35/219.50  |- skos__historyNote mesh__D017731 Skin Diseases %28%1968-1993%29%
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D017731 2006
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D017731 1996
% 219.35/219.50  |- skos__hiddenLabel mesh__D017731 Lymphomatoid Papuloses
% 219.35/219.50  |- skos__hiddenLabel mesh__D017731 Papulosis, Lymphomatoid
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D017731 2003
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D017731 1998
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D017731 2001
% 219.35/219.50  |- mesh__recordOriginator mesh__D017731 AGS
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D017731 2005
% 219.35/219.50  |- mesh__dateCreated mesh__D017731 1992-12-28
% 219.35/219.50  |- mesh__dateEstablished mesh__D017731 1994-01-01
% 219.35/219.50  |- skos__annotation mesh__D017731
% 219.35/219.50       a precancerous form of pityriasis lichenoides   
% 219.35/219.50  |- skos__scopeNote mesh__D017731
% 219.35/219.50       Clinically benign, histologically malignant, recurrent cutaneous eruption characterized by an infiltration of large atypical cells surrounded by inflammatory cells. The atypical cells resemble Reed-Sternberg cells of Hodgkin%27%s disease or the malignant cells of cutaneous T-cell lymphoma. In some cases, lymphomatoid papulosis progresses to lymphomatous conditions including mycosis fungoides, Hodgkin%27%s disease, cutaneous T-cell lymphoma, or Ki-1 lymphoma.%A%    
% 219.35/219.50  |- mesh__recordAuthorizer mesh__D017731 PLS
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D017731 2000
% 219.35/219.50  |- skos__broader mesh__D017731smesh__D011230
% 219.35/219.50  |- skos__prefLabel mesh__D031402 Alstroemeria
% 219.35/219.50  |- skos__altLabel mesh__D031402 Lily, Peruvian
% 219.35/219.50  |- skos__broader mesh__D031402smesh__D019668
% 219.35/219.50  |- mesh__dateEstablished mesh__D031402 2003-01-01
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D031402 2004
% 219.35/219.50  |- skos__scopeNote mesh__D031402
% 219.35/219.50       A plant genus of the family LILIACEAE. Members contain allergens, tuliposide A and tulipalin A.%A%    
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D031402 2006
% 219.35/219.50  |- mesh__dateCreated mesh__D031402 2002-07-02
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D031402 2003
% 219.35/219.50  |- mesh__publicMeSHNote mesh__D031402 2003   
% 219.35/219.50  |- skos__annotation mesh__D031402
% 219.35/219.50       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D031402 2005
% 219.35/219.50  |- rdf__type mesh__D031402sskos__Concept
% 219.35/219.50  |- mesh__historyNote mesh__D031402 2003   
% 219.35/219.50  |- skos__broader mesh__D003711smesh__D009422
% 219.35/219.50  |- skos__altLabel mesh__D003711 Demyelinating Disorders
% 219.35/219.50  |- mesh__dateCreated mesh__D003711 1999-01-01
% 219.35/219.50  |- mesh__publicMeSHNote mesh__D003711 79; was DEMYELINATION 1963-78   
% 219.35/219.50  |- skos__prefLabel mesh__D003711 Demyelinating Diseases
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D003711 2006
% 219.35/219.50  |- skos__scopeNote mesh__D003711
% 219.35/219.50       Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.%A%    
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D003711 2002
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D003711 2000A
% 219.35/219.50  |- mesh__recordOriginator mesh__D003711 NLM
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D003711 2005
% 219.35/219.50  |- rdf__type mesh__D003711sskos__Concept
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D003711 2001
% 219.35/219.50  |- mesh__onlineNote mesh__D003711
% 219.35/219.50       use DEMYELINATING DISEASES to search DEMYELINATION 1966-78%A%  
% 219.35/219.50  |- skos__hiddenLabel mesh__D003711 Demyelinating Disease
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D003711 2004
% 219.35/219.50  |- mesh__recordMaintainer mesh__D003711 ags
% 219.35/219.50  |- skos__hiddenLabel mesh__D003711 Demyelinations
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D003711 2000
% 219.35/219.50  |- skos__hiddenLabel mesh__D003711 Demyelinating Disorder
% 219.35/219.50  |- mesh__recordAuthorizer mesh__D003711 ags
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D003711 2003
% 219.35/219.50  |- mesh__historyNote mesh__D003711 79; was DEMYELINATION 1963-78   
% 219.35/219.50  |- mesh__dateRevised mesh__D003711 1999-11-24
% 219.35/219.50  |- mesh__recordMaintainer mesh__D016639 PXP
% 219.35/219.50  |- skos__broader mesh__D016639smesh__D013508
% 219.35/219.50  |- skos__scopeNote mesh__D016639
% 219.35/219.50       Plastic surgery of the sclera. This procedure is used frequently to prevent blindness and poor vision in children with myopia.%A%    
% 219.35/219.50  |- mesh__historyNote mesh__D016639 92   
% 219.35/219.50  |- skos__hiddenLabel mesh__D016639 Scleroplasties
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D016639 2002
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D016639 2004
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D016639 1999
% 219.35/219.50  |- skos__prefLabel mesh__D016639 Scleroplasty
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D016639 2003
% 219.35/219.50  |- mesh__recordOriginator mesh__D016639 PXP
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D016639 1998
% 219.35/219.50  |- skos__broader mesh__D016639smesh__D019651
% 219.35/219.50  |- skos__historyNote mesh__D016639 Sclera/surgery %28%1972-1991%29%
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D016639 2001
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D016639 2006
% 219.35/219.50  |- skos__annotation mesh__D016639
% 219.35/219.50       do not use /util except by MeSH definition   
% 219.35/219.50  |- mesh__dateEstablished mesh__D016639 1992-01-01
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D016639 2000
% 219.35/219.50  |- rdf__type mesh__D016639sskos__Concept
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D016639 2005
% 219.35/219.50  |- mesh__dateCreated mesh__D016639 1991-01-25
% 219.35/219.50  |- mesh__publicMeSHNote mesh__D016639 92   
% 219.35/219.50  |- mesh__dateRevised mesh__D016639 1997-06-20
% 219.35/219.50  |- mesh__recordAuthorizer mesh__D016639 SJN
% 219.35/219.50  |- skos__historyNote mesh__D016639 Myopia/surgery %28%1972-1991%29%
% 219.35/219.50  |- skos__broader mesh__D027361smesh__D027321
% 219.35/219.50  |- mesh__recordOriginator mesh__D027361 jmp
% 219.35/219.50  |- mesh__dateEstablished mesh__D027361 2002-01-01
% 219.35/219.50  |- mesh__dateRevised mesh__D027361 2005-06-30
% 219.35/219.50  |- mesh__historyNote mesh__D027361 2002;   
% 219.35/219.50  |- skos__prefLabel mesh__D027361 Organic Anion Transporters
% 219.35/219.50  |- skos__historyNote mesh__D027361 Ion Pumps %28%1994-2001%29%
% 219.35/219.50  |- skos__hiddenLabel mesh__D027361 Anion Transporters, Organic
% 219.35/219.50  |- skos__altLabel mesh__D027361 OATP Proteins
% 219.35/219.50  |- mesh__recordAuthorizer mesh__D027361 sjn
% 219.35/219.50  |- mesh__recordMaintainer mesh__D027361 SYSTEM
% 219.35/219.50  |- mesh__activeMeSHYear mesh__D027361 2006
% 219.35/219.50  |- skos__hiddenLabel mesh__D027361 Transporters, OATP
% 219.35/219.50  |- skos__hiddenLabel mesh__D027361 Transport Proteins, OAT
% 219.35/219.50  |- skos__altLabel mesh__D027361 OAT Transport Proteins
% 219.35/219.50  |- rdf__type mesh__D027361sskos__Concept
% 219.35/219.50  |- mesh__dateCreated mesh__D027361 2001-07-25
% 219.35/219.50  |- mesh__publicMeSHNote mesh__D027361 2002   
% 219.35/219.51  |- skos__scopeNote mesh__D027361
% 219.35/219.51       Proteins involved in the transport of organic anions. They play an important role in the elimination of a variety of endogenous substances, xenobiotics and their metabolites from the body.%A%    
% 219.35/219.51  |- skos__hiddenLabel mesh__D027361 Transporters, Organic Anion
% 219.35/219.51  |- skos__altLabel mesh__D027361 OATP Transporters
% 219.35/219.51  |- skos__historyNote mesh__D027361 Carrier Proteins %28%1980-2001%29%
% 219.35/219.51  |- skos__annotation mesh__D027361
% 219.35/219.51       ANION TRANSPORT PROTEINS is also available   
% 219.35/219.51  |- skos__altLabel mesh__D027361 Membrane Transport Proteins, Organic Anion
% 219.35/219.51  |- mesh__dateRevised mesh__D002619 2003-07-09
% 219.35/219.51  |- rdf__type mesh__D002619sskos__Concept
% 219.35/219.51  |- skos__historyNote mesh__D002619 Chemical Warfare %28%1966-1967%29%
% 219.35/219.51  |- mesh__dateEstablished mesh__D002619 1968-01-01
% 219.35/219.51  |- mesh__recordMaintainer mesh__D002619 ssb
% 219.35/219.51  |- skos__altLabel mesh__D002619 Warfare Agents, Chemical
% 219.35/219.51  |- skos__scopeNote mesh__D002619
% 219.35/219.51       Chemicals that are used to cause the disturbance, disease, or death of humans during war.%A%    
% 219.35/219.51  |- skos__altLabel mesh__D002619 Agents, Chemical Warfare
% 219.35/219.51  |- skos__prefLabel mesh__D002619 Chemical Warfare Agents
% 219.35/219.51  |- mesh__recordOriginator mesh__D002619 NLM
% 219.35/219.51  |- mesh__recordAuthorizer mesh__D002619 sjn
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D002619 2006
% 219.35/219.51  |- mesh__dateCreated mesh__D002619 1999-01-01
% 219.35/219.51  |- mesh__historyNote mesh__D002619 68   
% 219.35/219.51  |- skos__broader mesh__D002619smesh__D011042
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D002619 2005
% 219.35/219.51  |- skos__related mesh__D002619smesh__D013665
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D002619 2004
% 219.35/219.51  |- skos__historyNote mesh__D002619 Gases %28%1966-1967%29%
% 219.35/219.51  |- mesh__publicMeSHNote mesh__D002619 68   
% 219.35/219.51  |- mesh__dateRevised mesh__D013341 2001-07-25
% 219.35/219.51  |- skos__altLabel mesh__D013341 Encephalofacial Hemangiomatosis Syndrome
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341 Angiomatosis, Meningo-Oculo-Facial
% 219.35/219.51  |- skos__altLabel mesh__D013341 Sturge-Weber-Krabbe Syndrome
% 219.35/219.51  |- mesh__onlineNote mesh__D013341
% 219.35/219.51       search ANGIOMATOSIS 1966-74; use STURGE-WEBER SYNDROME to search DIMITRI DISEASE 1989-93%A%  
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341 Syndrome, Sturge-Weber
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341 Syndrome, Sturge-Weber-Dimitri
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341 Sturge Weber Krabbe Syndrome
% 219.35/219.51  |- mesh__dateCreated mesh__D013341 1999-01-01
% 219.35/219.51  |- skos__broader mesh__D013341smesh__D000798
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341 Syndrome, Sturge
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D013341 2006
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341 Angiomatoses, Meningo-Oculo-Facial
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341 Meningo Oculo Facial Angiomatosis
% 219.35/219.51  |- skos__altLabel mesh__D013341 Sturge-Kalischer-Weber Syndrome
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341 Syndrome, Sturge-Weber-Krabbe
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341
% 219.35/219.51       Syndromes, Encephalofacial Hemangiomatosis
% 219.35/219.51  |- mesh__dateEstablished mesh__D013341 1991-01-01
% 219.35/219.51  |- skos__scopeNote mesh__D013341
% 219.35/219.51       A congenital syndrome characterized by a port-wine nevus covering portions of the face and cranium %28%in the distribution of the ophthalmic division of the TRIGEMINAL NERVE%29% and angiomas of the meninges and choroid. Clinical manifestations include the onset of focal SEIZURES, progressive hemiparesis, GLAUCOMA, hemianopsia, and cognitive deficits in the first decade of life. By age two years, skull radiographs reveal %22%tramline calcifications%22% of the margins of the occipital and parietal lobes. Pathologically cortical neurons are replaced by glial tissue that undergoes calcification. %28%From Adams et al., Principles of Neurology, 6th ed, pp1018-9%29%%A%    
% 219.35/219.51  |- skos__altLabel mesh__D013341 Neuroretinoangiomatosis
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341
% 219.35/219.51       Encephalofacial Hemangiomatosis Syndromes
% 219.35/219.51  |- mesh__recordAuthorizer mesh__D013341 sjn
% 219.35/219.51  |- skos__broader mesh__D013341smesh__D006391
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341 Phakomatosis, Sturge Weber
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D013341 2005
% 219.35/219.51  |- skos__altLabel mesh__D013341
% 219.35/219.51       Meningofacial Angiomatosis-Cerebral Calcification Syndrome
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341 Sturge Weber Syndrome
% 219.35/219.51  |- mesh__recordMaintainer mesh__D013341 nns
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341
% 219.35/219.51       Syndrome, Encephalofacial Hemangiomatosis
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341 Syndrome, Sturge%27%s
% 219.35/219.51  |- skos__altLabel mesh__D013341 Sturge%27%s Syndrome
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D013341 2004
% 219.35/219.51  |- mesh__historyNote mesh__D013341
% 219.35/219.51       91%28%75%29%; was see under ANGIOMATOSIS 1975-90; DIMITRI DISEASE was see STURGE-WEBER SYNDROME 1989-93%A%  
% 219.35/219.51  |- skos__altLabel mesh__D013341 Sturge-Weber-Dimitri Syndrome
% 219.35/219.51  |- skos__altLabel mesh__D013341 Sturge Disease
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341 Syndrome, Sturge-Kalischer-Weber
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341 Sturge Kalischer Weber Syndrome
% 219.35/219.51  |- skos__broader mesh__D013341smesh__D009386
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D013341 2003
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341 Neuroretinoangiomatoses
% 219.35/219.51  |- skos__altLabel mesh__D013341 Angiomatosis Oculoorbital-Thalamic Syndrome
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341 Sturge Weber Dimitri Syndrome
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341
% 219.35/219.51       Meningofacial Angiomatosis Cerebral Calcification Syndrome
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341 Meningo-Oculo-Facial Angiomatoses
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341
% 219.35/219.51       Hemangiomatosis Syndrome, Encephalofacial
% 219.35/219.51  |- rdf__type mesh__D013341sskos__Concept
% 219.35/219.51  |- skos__prefLabel mesh__D013341 Sturge-Weber Syndrome
% 219.35/219.51  |- skos__altLabel mesh__D013341 Sturge Syndrome
% 219.35/219.51  |- skos__broader mesh__D013341smesh__D020752
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341
% 219.35/219.51       Hemangiomatosis Syndromes, Encephalofacial
% 219.35/219.51  |- skos__altLabel mesh__D013341 Meningo-Oculo-Facial Angiomatosis
% 219.35/219.51  |- mesh__recordOriginator mesh__D013341 NLM
% 219.35/219.51  |- mesh__publicMeSHNote mesh__D013341
% 219.35/219.51       91; was see under ANGIOMATOSIS 1975-90; DIMITRI DISEASE was see STURGE-WEBER SYNDROME 1989-93%A%  
% 219.35/219.51  |- skos__altLabel mesh__D013341 Phakomatosis, Sturge-Weber
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D013341 2002
% 219.35/219.51  |- skos__hiddenLabel mesh__D013341 Sturge-Weber Phakomatosis
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D007304 1996
% 219.35/219.51  |- mesh__publicMeSHNote mesh__D007304
% 219.35/219.51       63; POLYHEDROSIS VIRUSES was heading 1978-90; was see under INSECT VIRUSES 1975-77%A%  
% 219.35/219.51  |- skos__hiddenLabel mesh__D007304 Virus, Insect
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D007304 2000
% 219.35/219.51  |- mesh__historyNote mesh__D007304
% 219.35/219.51       63; POLYHEDROSIS VIRUSES was heading 1978-90; was see under INSECT VIRUSES 1973-77 %28%Prov 1973-74%29%%A%  
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D007304 2006
% 219.35/219.51  |- skos__scopeNote mesh__D007304
% 219.35/219.51       Viruses infecting insects, the largest family being BACULOVIRIDAE.%A%    
% 219.35/219.51  |- mesh__recordAuthorizer mesh__D007304 PLS
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D007304 2004
% 219.35/219.51  |- skos__annotation mesh__D007304
% 219.35/219.51       IM; coord with specific insect /virol %28%IM%29%   
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D007304 2005
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D007304 2002
% 219.35/219.51  |- mesh__onlineNote mesh__D007304
% 219.35/219.51       use INSECT VIRUSES to search POLYHEDROSIS VIRUSES 1973-90 %28%as Prov 1973-74%29%%A%  
% 219.35/219.51  |- skos__broader mesh__D007304smesh__D014780
% 219.35/219.51  |- skos__prefLabel mesh__D007304 Insect Viruses
% 219.35/219.51  |- mesh__recordOriginator mesh__D007304 NLM
% 219.35/219.51  |- skos__hiddenLabel mesh__D007304 Viruses, Insect
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D007304 2003
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D007304 1999
% 219.35/219.51  |- mesh__recordMaintainer mesh__D007304 TGC
% 219.35/219.51  |- skos__hiddenLabel mesh__D007304 Insect Virus
% 219.35/219.51  |- rdf__type mesh__D007304sskos__Concept
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D007304 1997
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D007304 1998
% 219.35/219.51  |- mesh__dateRevised mesh__D007304 1995-03-13
% 219.35/219.51  |- mesh__dateCreated mesh__D007304 1999-01-01
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D007304 2001
% 219.35/219.51  |- mesh__dateCreated mesh__D045423 2003-07-09
% 219.35/219.51  |- mesh__recordAuthorizer mesh__D045423 jls
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D045423 2005
% 219.35/219.51  |- mesh__publicMeSHNote mesh__D045423 2004   
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D045423 2005A
% 219.35/219.51  |- rdf__type mesh__D045423sskos__Concept
% 219.35/219.51  |- mesh__recordOriginator mesh__D045423 lkt
% 219.35/219.51  |- skos__scopeNote mesh__D045423
% 219.35/219.51       Very small encapsulated gas bubbles %28%diameters of micrometers%29% that can be used in diagnostic and therapeutic applications. Upon exposure to sufficiently intense ultrasound, microbubbles will cavitate, rupture, disappear, release gas content, etc. Such characteristics of the microbubbles can be used to enhance diagnostic tests, dissolve blood clots, and deliver drugs or genes for therapy.%A%    
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D045423 2006
% 219.35/219.51  |- skos__hiddenLabel mesh__D045423 Microbubble
% 219.35/219.51  |- mesh__dateEstablished mesh__D045423 2004-01-01
% 219.35/219.51  |- mesh__recordMaintainer mesh__D045423 jls
% 219.35/219.51  |- skos__altLabel mesh__D045423 Ultrasound Contrast Medium, Microbubbles
% 219.35/219.51  |- mesh__dateRevised mesh__D045423 2004-07-28
% 219.35/219.51  |- skos__prefLabel mesh__D045423 Microbubbles
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D045423 2004
% 219.35/219.51  |- skos__historyNote mesh__D045423 Acoustics %28%1973-2003%29%
% 219.35/219.51  |- mesh__historyNote mesh__D045423 2004   
% 219.35/219.51  |- skos__related mesh__D045423smesh__D008863
% 219.35/219.51  |- skos__historyNote mesh__D045423 Contrast Media %28%1973-2003%29%
% 219.35/219.51  |- skos__broader mesh__D045423smesh__D004864
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D012249 2005
% 219.35/219.51  |- mesh__recordMaintainer mesh__D012249 TAP
% 219.35/219.51  |- skos__scopeNote mesh__D012249
% 219.35/219.51       That part of the brain stem constituting the MEDULLA OBLONGATA %28%myelencephalon%29% and PONS %28%metencephalon%29%.%A%    
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D012249 1993
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D012249 1999
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D012249 2002
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D012249 2006
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D012249 1994
% 219.35/219.51  |- skos__historyNote mesh__D012249 Brain %28%1966-1986%29%
% 219.35/219.51  |- mesh__publicMeSHNote mesh__D012249 87   
% 219.35/219.51  |- rdf__type mesh__D012249sskos__Concept
% 219.35/219.51  |- mesh__historyNote mesh__D012249 87   
% 219.35/219.51  |- skos__hiddenLabel mesh__D012249 Hindbrains
% 219.35/219.51  |- mesh__recordAuthorizer mesh__D012249 PLS
% 219.35/219.51  |- skos__annotation mesh__D012249
% 219.35/219.51       includes the MEDULLA OBLONGATA %28%myelencephalon%29% %26% PONS %28%metencephalon%29%%A%  
% 219.35/219.51  |- skos__hiddenLabel mesh__D012249 Brains, Hind
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D012249 1996
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D012249 1995
% 219.35/219.51  |- skos__prefLabel mesh__D012249 Rhombencephalon
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D012249 2003
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D012249 1997
% 219.35/219.51  |- skos__broader mesh__D012249smesh__D001933
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D012249 2000
% 219.35/219.51  |- skos__hiddenLabel mesh__D012249 Hind Brains
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D012249 2004
% 219.35/219.51  |- skos__historyNote mesh__D012249 Brain Stem %28%1966-1986%29%
% 219.35/219.51  |- skos__hiddenLabel mesh__D012249 Brain, Hind
% 219.35/219.51  |- skos__hiddenLabel mesh__D012249 Rhombencephalons
% 219.35/219.51  |- skos__altLabel mesh__D012249 Hindbrain
% 219.35/219.51  |- skos__altLabel mesh__D012249 Hind Brain
% 219.35/219.51  |- mesh__dateRevised mesh__D012249 1992-05-18
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D012249 1998
% 219.35/219.51  |- mesh__dateEstablished mesh__D012249 1987-01-01
% 219.35/219.51  |- mesh__dateCreated mesh__D012249 1986-03-28
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D012249 2001
% 219.35/219.51  |- mesh__recordOriginator mesh__D012249 RC
% 219.35/219.51  |- skos__historyNote mesh__D017732 Ambulances %28%1966-1993%29%
% 219.35/219.51  |- skos__broader mesh__D017732smesh__D000401
% 219.35/219.51  |- mesh__dateEstablished mesh__D017732 1994-01-01
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D017732 2001
% 219.35/219.51  |- skos__prefLabel mesh__D017732 Air Ambulances
% 219.35/219.51  |- skos__hiddenLabel mesh__D017732 Helicopters, Emergency
% 219.35/219.51  |- mesh__historyNote mesh__D017732 94   
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D017732 2003
% 219.35/219.51  |- skos__hiddenLabel mesh__D017732 Helicopter, Emergency
% 219.35/219.51  |- skos__broader mesh__D017732smesh__D000552
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D017732 2005
% 219.35/219.51  |- skos__scopeNote mesh__D017732
% 219.35/219.51       Fixed-wing aircraft or helicopters equipped for air transport of patients.%A%    
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D017732 2004
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D017732 1999
% 219.35/219.51  |- rdf__type mesh__D017732sskos__Concept
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D017732 2002
% 219.35/219.51  |- skos__hiddenLabel mesh__D017732 Emergency Helicopter
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D017732 2006
% 219.35/219.51  |- skos__altLabel mesh__D017732 Ambulances, Air
% 219.35/219.51  |- mesh__publicMeSHNote mesh__D017732 94   
% 219.35/219.51  |- mesh__recordOriginator mesh__D017732 JLS
% 219.35/219.51  |- skos__hiddenLabel mesh__D017732 Ambulances, Helicopter
% 219.35/219.51  |- skos__hiddenLabel mesh__D017732 Ambulance, Helicopter
% 219.35/219.51  |- skos__annotation mesh__D017732 airplanes %26% helicopters   
% 219.35/219.51  |- mesh__dateCreated mesh__D017732 1992-12-28
% 219.35/219.51  |- skos__hiddenLabel mesh__D017732 Air Ambulance
% 219.35/219.51  |- mesh__recordAuthorizer mesh__D017732 SJN
% 219.35/219.51  |- skos__historyNote mesh__D017732 Aircraft %28%1966-1993%29%
% 219.35/219.51  |- skos__hiddenLabel mesh__D017732 Helicopter Ambulance
% 219.35/219.51  |- mesh__recordMaintainer mesh__D017732 JLS
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D017732 2000
% 219.35/219.51  |- mesh__dateRevised mesh__D017732 1998-06-10
% 219.35/219.51  |- skos__hiddenLabel mesh__D017732 Ambulance, Air
% 219.35/219.51  |- skos__broader mesh__D031403smesh__D019668
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D031403 2004
% 219.35/219.51  |- mesh__historyNote mesh__D031403 2003   
% 219.35/219.51  |- skos__altLabel mesh__D031403 Anemarrhenae
% 219.35/219.51  |- skos__prefLabel mesh__D031403 Anemarrhena
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D031403 2006
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D031403 2003
% 219.35/219.51  |- mesh__publicMeSHNote mesh__D031403 2003   
% 219.35/219.51  |- skos__annotation mesh__D031403
% 219.35/219.51       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.35/219.51  |- mesh__dateEstablished mesh__D031403 2003-01-01
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D031403 2005
% 219.35/219.51  |- rdf__type mesh__D031403sskos__Concept
% 219.35/219.51  |- skos__scopeNote mesh__D031403
% 219.35/219.51       A plant genus of the family LILIACEAE. Members contain anemarans %28%POLYSACCHARIDES%29%, hinokiresinol, mangiferin %28%a xanthone%29%, and timosaponin %28%a steroidal saponin%29%.%A%    
% 219.35/219.51  |- mesh__dateCreated mesh__D031403 2002-07-02
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D003712 2005
% 219.35/219.51  |- rdf__type mesh__D003712sskos__Concept
% 219.35/219.51  |- skos__broader mesh__D003712smesh__D009474
% 219.35/219.51  |- mesh__dateEstablished mesh__D003712 1965-01-01
% 219.35/219.51  |- mesh__historyNote mesh__D003712 65%28%64%29%   
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D003712 2004
% 219.35/219.51  |- mesh__recordAuthorizer mesh__D003712 sjn
% 219.35/219.51  |- mesh__dateRevised mesh__D003712 2000-06-22
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D003712 2003
% 219.35/219.51  |- skos__prefLabel mesh__D003712 Dendrites
% 219.35/219.51  |- mesh__publicMeSHNote mesh__D003712 65   
% 219.35/219.51  |- mesh__dateCreated mesh__D003712 1999-01-01
% 219.35/219.51  |- mesh__recordMaintainer mesh__D003712 KEV
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D003712 2002
% 219.35/219.51  |- mesh__recordOriginator mesh__D003712 NLM
% 219.35/219.51  |- skos__broader mesh__D003712smesh__D022081
% 219.35/219.51  |- skos__hiddenLabel mesh__D003712 Dendrite
% 219.35/219.51  |- skos__annotation mesh__D003712 do not confuse with DENDRITIC CELLS   
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D003712 2006
% 219.35/219.51  |- skos__scopeNote mesh__D003712
% 219.35/219.51       Extensions of the nerve cell body. They are short and branched and receive stimuli from other NEURONS.%A%    
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D003712 2001
% 219.35/219.51  |- skos__historyNote mesh__D027362 Carrier Proteins %28%1997-2001%29%
% 219.35/219.51  |- skos__altLabel mesh__D027362 OAT1 Protein
% 219.35/219.51  |- skos__prefLabel mesh__D027362 Organic Anion Transport Protein 1
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D027362 2005
% 219.35/219.51  |- skos__hiddenLabel mesh__D027362 p Aminohippurate Transporter
% 219.35/219.51  |- skos__altLabel mesh__D027362 PAH Transporter
% 219.35/219.51  |- mesh__recordOriginator mesh__D027362 jmp
% 219.35/219.51  |- mesh__historyNote mesh__D027362
% 219.35/219.51       2002; for OAT1 PROTEIN, P-AMINOHIPPURATE TRANSPORTER %26% RENAL PAN TRANSPORTER use ANION TRANSPORT PROTEINS 2000-2001%A%  
% 219.35/219.51  |- skos__scopeNote mesh__D027362
% 219.35/219.51       A polyspecific transporter for organic cations found primarily in the kidney. It mediates the coupled exchange of alpha-ketoglutarate with organic ions such as P-AMINOHIPPURIC ACID.%A%    
% 219.35/219.51  |- skos__altLabel mesh__D027362
% 219.35/219.51       Solute Carrier Family 22 %28%Organic Anion Transporter%29%, Member 6
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D027362 2006
% 219.35/219.51  |- skos__broader mesh__D027362smesh__D017920
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D027362 2002
% 219.35/219.51  |- rdf__type mesh__D027362sskos__Concept
% 219.35/219.51  |- skos__hiddenLabel mesh__D027362 Transporter, SLC22A6
% 219.35/219.51  |- mesh__recordMaintainer mesh__D027362 jmp
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D027362 2003
% 219.35/219.51  |- skos__hiddenLabel mesh__D027362 Transporter, p-Aminohippurate
% 219.35/219.51  |- mesh__recordAuthorizer mesh__D027362 sjn
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D027362 2004
% 219.35/219.51  |- mesh__publicMeSHNote mesh__D027362
% 219.35/219.51       2002; OAT1 PROTEIN, P-AMINOHIPPURATE TRANSPORTER %26% RENAL PAN TRANSPORTER were indexed under CARRIER PROTEINS 2000-2001%A%  
% 219.35/219.51  |- skos__altLabel mesh__D027362 p-Aminohippurate Transporter
% 219.35/219.51  |- skos__altLabel mesh__D027362 SLC22A6 Transporter
% 219.35/219.51  |- skos__altLabel mesh__D027362 Renal PAN transporter
% 219.35/219.51  |- skos__broader mesh__D027362smesh__D029362
% 219.35/219.51  |- mesh__dateEstablished mesh__D027362 2002-01-01
% 219.35/219.51  |- skos__historyNote mesh__D027362 Membrane Proteins %28%1997-2001%29%
% 219.35/219.51  |- skos__hiddenLabel mesh__D027362 PAN transporter, Renal
% 219.35/219.51  |- mesh__dateCreated mesh__D027362 2001-07-25
% 219.35/219.51  |- skos__scopeNote mesh__D013342
% 219.35/219.51       A disturbance in the normal fluency and time patterning of speech that is inappropriate for the individual%27%s age. This disturbance is characterized by frequent repetitions or prolongations of sounds or syllables. Various other types of speech dysfluencies may also be involved including interjections, broken words, audible or silent blocking, circumlocutions, words produced with an excess of physical tension, and monosyllabic whole word repetitions. Stuttering may occur as a developmental condition in childhood or as an acquired disorder which may be associated with BRAIN INFARCTIONS and other BRAIN DISEASES. %28%From DSM-IV, 1994%29%%A%    
% 219.35/219.51  |- skos__hiddenLabel mesh__D013342 Adult Stuttering
% 219.35/219.51  |- skos__hiddenLabel mesh__D013342 Developmental Stuttering
% 219.35/219.51  |- mesh__dateRevised mesh__D013342 1999-11-03
% 219.35/219.51  |- skos__hiddenLabel mesh__D013342 Acquired Stuttering
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D013342 2000
% 219.35/219.51  |- mesh__recordOriginator mesh__D013342 NLM
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D013342 2003
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D013342 2001
% 219.35/219.51  |- rdf__type mesh__D013342sskos__Concept
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D013342 2005
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D013342 2004
% 219.35/219.51  |- mesh__dateCreated mesh__D013342 1999-01-01
% 219.35/219.51  |- skos__hiddenLabel mesh__D013342 Childhood Stuttering
% 219.35/219.51  |- skos__prefLabel mesh__D013342 Stuttering
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D013342 2006
% 219.35/219.51  |- mesh__recordMaintainer mesh__D013342 KEV
% 219.35/219.51  |- skos__broader mesh__D013342smesh__D013064
% 219.35/219.51  |- mesh__recordAuthorizer mesh__D013342 sjn
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D013342 2002
% 219.35/219.51  |- mesh__recordMaintainer mesh__D007305 ssb
% 219.35/219.51  |- mesh__recordOriginator mesh__D007305 NLM
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D007305 2005
% 219.35/219.51  |- mesh__recordAuthorizer mesh__D007305 sjn
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D007305 2006
% 219.35/219.51  |- skos__hiddenLabel mesh__D007305 Resistances, Insecticide
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D007305 2004
% 219.35/219.51  |- mesh__dateEstablished mesh__D007305 1967-01-01
% 219.35/219.51  |- skos__prefLabel mesh__D007305 Insecticide Resistance
% 219.35/219.51  |- mesh__dateCreated mesh__D007305 1999-01-01
% 219.35/219.51  |- skos__annotation mesh__D007305
% 219.35/219.51       IM when general; NIM when with specific insecticide %28%IM%29% %26% specific insect %28%IM%29%%A%  
% 219.35/219.51  |- skos__scopeNote mesh__D007305
% 219.35/219.51       The development by insects of resistance to insecticides.%A%    
% 219.35/219.51  |- mesh__publicMeSHNote mesh__D007305 67   
% 219.35/219.51  |- skos__hiddenLabel mesh__D007305 Insecticide Resistances
% 219.35/219.51  |- mesh__dateRevised mesh__D007305 2003-07-09
% 219.35/219.51  |- skos__broader mesh__D007305smesh__D004351
% 219.35/219.51  |- rdf__type mesh__D007305sskos__Concept
% 219.35/219.51  |- mesh__historyNote mesh__D007305
% 219.35/219.51       67; was INSECTICIDES RESISTANCE 1964-66 %28%Prov%29%   
% 219.35/219.51  |- mesh__onlineNote mesh__D007305
% 219.35/219.51       use INSECTICIDE RESISTANCE to search INSECTICIDES RESISTANCE 1966 %28%as Prov%29%%A%  
% 219.35/219.51  |- skos__hiddenLabel mesh__D007305 Resistance, Insecticide
% 219.35/219.51  |- mesh__historyNote mesh__D045424 2004   
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D045424 2005
% 219.35/219.51  |- skos__altLabel mesh__D045424 Extracts, Complex
% 219.35/219.51  |- mesh__publicMeSHNote mesh__D045424 2004   
% 219.35/219.51  |- rdf__type mesh__D045424sskos__Concept
% 219.35/219.51  |- skos__altLabel mesh__D045424 Extracts, Crude
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D045424 2006
% 219.35/219.51  |- skos__prefLabel mesh__D045424 Complex Mixtures
% 219.35/219.51  |- skos__scopeNote mesh__D045424
% 219.35/219.51       Mixtures of many components in inexact proportions, usually natural, such as PLANT EXTRACTS; VENOMS; and MANURE. These are distinguished from DRUG COMBINATIONS which have only a few components in definite proportions.%A%    
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D045424 2004
% 219.35/219.51  |- skos__altLabel mesh__D045424 Mixtures, Complex
% 219.35/219.51  |- mesh__runningHead mesh__D045424 D20 - COMPLEX MIXTURES   
% 219.35/219.51  |- skos__annotation mesh__D045424 GEN only   
% 219.35/219.51  |- mesh__dateEstablished mesh__D045424 2004-01-01
% 219.35/219.51  |- skos__altLabel mesh__D045424 Crude Extracts
% 219.35/219.51  |- mesh__dateCreated mesh__D045424 2003-07-09
% 219.35/219.51  |- skos__related mesh__D045424smesh__D004338
% 219.35/219.51  |- mesh__historyNote mesh__D017733 94   
% 219.35/219.51  |- skos__hiddenLabel mesh__D017733 Oral Hairy Leukoplakias
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D017733 2003
% 219.35/219.51  |- mesh__recordMaintainer mesh__D017733 AGS
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D017733 2000
% 219.35/219.51  |- mesh__dateRevised mesh__D017733 1998-06-10
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D017733 2005
% 219.35/219.51  |- skos__hiddenLabel mesh__D017733 Leukoplakia, Oral Hairy
% 219.35/219.51  |- skos__hiddenLabel mesh__D017733 Hairy Leukoplakia
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D017733 2004
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D017733 1999
% 219.35/219.51  |- mesh__dateEstablished mesh__D017733 1994-01-01
% 219.35/219.51  |- skos__hiddenLabel mesh__D017733 Leukoplakias, Oral Hairy
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D017733 2001
% 219.35/219.51  |- rdf__type mesh__D017733sskos__Concept
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D017733 2006
% 219.35/219.51  |- skos__altLabel mesh__D017733 Oral Hairy Leukoplakia
% 219.35/219.51  |- skos__scopeNote mesh__D017733
% 219.35/219.51       Epithelial hyperplasia of the oral mucosa associated with Epstein-Barr virus %28%HERPESVIRUS 4, HUMAN%29% and found almost exclusively in persons with HIV infection. The lesion consists of a white patch that is often corrugated or hairy.%A%    
% 219.35/219.51  |- skos__altLabel mesh__D017733 Leukoplakia, Hairy, Oral
% 219.35/219.51  |- mesh__dateCreated mesh__D017733 1992-12-28
% 219.35/219.51  |- skos__broader mesh__D017733smesh__D020031
% 219.35/219.51  |- skos__hiddenLabel mesh__D017733 Hairy Leukoplakias, Oral
% 219.35/219.51  |- skos__annotation mesh__D017733
% 219.35/219.51       a form of oral leukoplakia seen in HIV infect; do not confuse with TONGUE, HAIRY%A%  
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D017733 2002
% 219.35/219.51  |- skos__hiddenLabel mesh__D017733 Hairy Leukoplakia, Oral
% 219.35/219.51  |- mesh__publicMeSHNote mesh__D017733 94   
% 219.35/219.51  |- skos__hiddenLabel mesh__D017733 Leukoplakias, Hairy
% 219.35/219.51  |- skos__hiddenLabel mesh__D017733 Hairy Leukoplakias
% 219.35/219.51  |- skos__broader mesh__D017733smesh__D007972
% 219.35/219.51  |- mesh__recordOriginator mesh__D017733 AGS
% 219.35/219.51  |- mesh__recordAuthorizer mesh__D017733 SJN
% 219.35/219.51  |- skos__historyNote mesh__D017733 Leukoplakia, Oral %28%1985-1993%29%
% 219.35/219.51  |- skos__prefLabel mesh__D017733 Leukoplakia, Hairy
% 219.35/219.51  |- skos__altLabel mesh__D031404 Camas
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D031404 2004
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D031404 2005
% 219.35/219.51  |- skos__prefLabel mesh__D031404 Camassia
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D031404 2006
% 219.35/219.51  |- mesh__publicMeSHNote mesh__D031404 2003   
% 219.35/219.51  |- skos__annotation mesh__D031404
% 219.35/219.51       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.35/219.51  |- mesh__dateCreated mesh__D031404 2002-07-03
% 219.35/219.51  |- mesh__historyNote mesh__D031404 2003   
% 219.35/219.51  |- rdf__type mesh__D031404sskos__Concept
% 219.35/219.51  |- skos__broader mesh__D031404smesh__D019668
% 219.35/219.51  |- mesh__dateEstablished mesh__D031404 2003-01-01
% 219.35/219.51  |- skos__scopeNote mesh__D031404
% 219.35/219.51       A plant genus of the family LILIACEAE that contains steroidal SAPONINS and should not be confused with Death Camas %28%ZIGADENUS%29%.%A%    
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D031404 2003
% 219.35/219.51  |- mesh__dateRevised mesh__D003713 2004-07-19
% 219.35/219.51  |- skos__broader mesh__D003713smesh__D000938
% 219.35/219.51  |- skos__scopeNote mesh__D003713
% 219.35/219.51       Immunocompetent cells of the lymphoid and hemopoietic systems and SKIN, and possessing branching morphology. They function morphologically and phenotypically by processing ANTIGENS or presenting them to T-CELLS, thereby stimulating cellular immunity %28%IMMUNITY, CELLULAR%29%. When found in the skin they are called LANGERHANS CELLS; when found in the lymph nodes, they are called interdigitating cells.%A%    
% 219.35/219.51  |- skos__historyNote mesh__D003713 Skin %28%1966-1986%29%
% 219.35/219.51  |- skos__hiddenLabel mesh__D003713 Cell, Dendritic
% 219.35/219.51  |- skos__historyNote mesh__D003713 Lymph Nodes %28%1975-1986%29%
% 219.35/219.51  |- mesh__recordMaintainer mesh__D003713 ags
% 219.35/219.51  |- mesh__historyNote mesh__D003713 87   
% 219.35/219.51  |- skos__hiddenLabel mesh__D003713 Interdigitating Dendritic Cells
% 219.35/219.51  |- skos__hiddenLabel mesh__D003713 Cells, Interdigitating Dendritic
% 219.35/219.51  |- skos__hiddenLabel mesh__D003713 Cell, Interdigitating Dendritic
% 219.35/219.51  |- skos__hiddenLabel mesh__D003713 Cells, Dendritic
% 219.35/219.51  |- skos__historyNote mesh__D003713
% 219.35/219.51       Antigen-Presenting Cells %28%1985-1986%29%
% 219.35/219.51  |- mesh__recordAuthorizer mesh__D003713 sjn
% 219.35/219.51  |- skos__historyNote mesh__D003713 Epidermis %28%1978-1986%29%
% 219.35/219.51  |- skos__broader mesh__D003713smesh__D004847
% 219.35/219.51  |- mesh__dateCreated mesh__D003713 1986-06-19
% 219.35/219.51  |- skos__hiddenLabel mesh__D003713 Dendritic Cell, Interdigitating
% 219.35/219.51  |- skos__prefLabel mesh__D003713 Dendritic Cells
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D003713 2006
% 219.35/219.51  |- skos__annotation mesh__D003713
% 219.35/219.51       do not confuse with DENDRITES; DENDRITIC CELLS, FOLLICULAR is also available%A%  
% 219.35/219.51  |- mesh__dateEstablished mesh__D003713 1987-01-01
% 219.35/219.51  |- skos__hiddenLabel mesh__D003713 Interdigitating Dendritic Cell
% 219.35/219.51  |- mesh__recordOriginator mesh__D003713 SCD
% 219.35/219.51  |- rdf__type mesh__D003713sskos__Concept
% 219.35/219.51  |- skos__altLabel mesh__D003713 Dendritic Cells, Interdigitating
% 219.35/219.51  |- skos__historyNote mesh__D003713 Langerhans Cells %28%1969-1986%29%
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D003713 2005
% 219.35/219.51  |- skos__hiddenLabel mesh__D003713 Dendritic Cell
% 219.35/219.51  |- mesh__publicMeSHNote mesh__D003713 87   
% 219.35/219.51  |- mesh__recordAuthorizer mesh__D013343 sjn
% 219.35/219.51  |- mesh__historyNote mesh__D013343 68   
% 219.35/219.51  |- mesh__activeMeSHYear mesh__D013343 2002
% 219.35/219.51  |- mesh__recordMaintainer mesh__D013343 adp
% 219.35/219.51  |- skos__annotation mesh__D013343
% 219.35/219.51       STYRENE and POLYSTYRENES are also available   
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D013343 2003
% 219.35/219.52  |- rdf__type mesh__D013343sskos__Concept
% 219.35/219.52  |- skos__scopeNote mesh__D013343
% 219.35/219.52       Derivatives and polymers of styrene. They are used in the manufacturing of synthetic rubber, plastics, and resins. Some of the polymers form the skeletal structures for ion exchange resin beads.%A%    
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D013343 2005
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D013343 2004
% 219.35/219.52  |- mesh__dateCreated mesh__D013343 1999-01-01
% 219.35/219.52  |- skos__prefLabel mesh__D013343 Styrenes
% 219.35/219.52  |- skos__broader mesh__D013343smesh__D001597
% 219.35/219.52  |- mesh__dateRevised mesh__D013343 1999-11-03
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D013343 2006
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D013343 2000
% 219.35/219.52  |- mesh__recordOriginator mesh__D013343 NLM
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D013343 2001
% 219.35/219.52  |- mesh__publicMeSHNote mesh__D013343 68   
% 219.35/219.52  |- mesh__dateEstablished mesh__D013343 1968-01-01
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D007306 2006
% 219.35/219.52  |- mesh__recordMaintainer mesh__D007306 ssb
% 219.35/219.52  |- mesh__dateRevised mesh__D007306 2004-07-07
% 219.35/219.52  |- mesh__recordOriginator mesh__D007306 NLM
% 219.35/219.52  |- skos__prefLabel mesh__D007306 Insecticides
% 219.35/219.52  |- mesh__recordAuthorizer mesh__D007306 sjn
% 219.35/219.52  |- mesh__dateCreated mesh__D007306 1999-01-01
% 219.35/219.52  |- skos__related mesh__D007306smesh__D002800
% 219.35/219.52  |- skos__broader mesh__D007306smesh__D010575
% 219.35/219.52  |- rdf__type mesh__D007306sskos__Concept
% 219.35/219.52  |- skos__scopeNote mesh__D007306
% 219.35/219.52       Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics.%A%    
% 219.35/219.52  |- skos__annotation mesh__D007306
% 219.35/219.52       for use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; may be used also with ticks even though ticks are not insects%A%  
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D007306 2005
% 219.35/219.52  |- mesh__recordOriginator mesh__D017734 JLS
% 219.35/219.52  |- skos__hiddenLabel mesh__D017734 Extrahepatic Bile Ducts
% 219.35/219.52  |- skos__prefLabel mesh__D017734 Bile Ducts, Extrahepatic
% 219.35/219.52  |- skos__hiddenLabel mesh__D017734 Ducts, Extrahepatic Bile
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017734 2002
% 219.35/219.52  |- mesh__recordMaintainer mesh__D017734 MSR
% 219.35/219.52  |- mesh__publicMeSHNote mesh__D017734 94   
% 219.35/219.52  |- mesh__dateCreated mesh__D017734 1993-06-15
% 219.35/219.52  |- mesh__recordAuthorizer mesh__D017734 SJN
% 219.35/219.52  |- skos__broader mesh__D017734smesh__D001652
% 219.35/219.52  |- skos__hiddenLabel mesh__D017734 Duct, Extrahepatic Bile
% 219.35/219.52  |- skos__hiddenLabel mesh__D017734 Biliary System, Extrahepatic
% 219.35/219.52  |- skos__hiddenLabel mesh__D017734 Bile Duct, Extrahepatic
% 219.35/219.52  |- mesh__dateEstablished mesh__D017734 1994-01-01
% 219.35/219.52  |- skos__annotation mesh__D017734
% 219.35/219.52       do not confuse with BILE DUCTS, INTRAHEPATIC; do not confuse with HEPATIC DUCT, COMMON, the external junction of right %26% left hepatic ducts; diseases: coord IM with BILE DUCT DISEASES %28%IM%29% but note BILE DUCT OBSTRUCTION, EXTRAHEPATIC; neopl: coord IM with BILE DUCT NEOPLASMS %28%IM%29%; inflammation: coord IM with CHOLANGITIS %28%IM%29%%A%  
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017734 2000
% 219.35/219.52  |- mesh__dateRevised mesh__D017734 1998-06-10
% 219.35/219.52  |- mesh__historyNote mesh__D017734 94   
% 219.35/219.52  |- skos__hiddenLabel mesh__D017734 System, Extrahepatic Biliary
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017734 2003
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017734 2001
% 219.35/219.52  |- skos__historyNote mesh__D017734 Common Bile Duct %28%1966-1993%29%
% 219.35/219.52  |- skos__altLabel mesh__D017734 Extrahepatic Biliary System
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017734 2005
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017734 2004
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017734 1999
% 219.35/219.52  |- skos__hiddenLabel mesh__D017734 Extrahepatic Bile Duct
% 219.35/219.52  |- rdf__type mesh__D017734sskos__Concept
% 219.35/219.52  |- skos__hiddenLabel mesh__D017734 Systems, Extrahepatic Biliary
% 219.35/219.52  |- skos__hiddenLabel mesh__D017734 Extrahepatic Biliary Systems
% 219.35/219.52  |- skos__hiddenLabel mesh__D017734 Biliary Systems, Extrahepatic
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017734 2006
% 219.35/219.52  |- skos__historyNote mesh__D017734 Hepatic Duct, Common %28%1966-1993%29%
% 219.35/219.52  |- skos__scopeNote mesh__D017734
% 219.35/219.52       Passages external to the liver for the conveyance of bile. These include the COMMON BILE DUCT and the common hepatic duct %28%HEPATIC DUCT, COMMON%29%.%A%    
% 219.35/219.52  |- skos__broader mesh__D011985Q000819smesh__D011985
% 219.35/219.52  |- mesh__preferredCombination mesh__D011985Q000819smesh__D017366
% 219.35/219.52  |- rdf__type mesh__D011985Q000819smesh__CompoundConcept
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D031405 2006
% 219.35/219.52  |- mesh__publicMeSHNote mesh__D031405 2003   
% 219.35/219.52  |- skos__annotation mesh__D031405
% 219.35/219.52       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.35/219.52  |- rdf__type mesh__D031405sskos__Concept
% 219.35/219.52  |- skos__broader mesh__D031405smesh__D019668
% 219.35/219.52  |- skos__altLabel mesh__D031405 Lily-of-the-Valley
% 219.35/219.52  |- skos__prefLabel mesh__D031405 Convallaria
% 219.35/219.52  |- mesh__dateCreated mesh__D031405 2002-07-03
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D031405 2003
% 219.35/219.52  |- mesh__historyNote mesh__D031405 2003   
% 219.35/219.52  |- mesh__dateEstablished mesh__D031405 2003-01-01
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D031405 2004
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D031405 2005
% 219.35/219.52  |- skos__scopeNote mesh__D031405
% 219.35/219.52       A plant genus of the family LILIACEAE that contains CARDIAC GLYCOSIDES.%A%    
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003714 2002
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003714 1998
% 219.35/219.52  |- mesh__dateEstablished mesh__D003714 1965-01-01
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003714 2004
% 219.35/219.52  |- skos__broader mesh__D003714smesh__D019635
% 219.35/219.52  |- mesh__dateRevised mesh__D003714 1997-06-20
% 219.35/219.52  |- skos__annotation mesh__D003714
% 219.35/219.52       GEN or unspecified; prefer specifics; coord with specific nerve /surg or /physiol or specific organ /innerv but MUSCLE DENERVATION is also available for coord with specific muscle; NIM when a study technique; do not use /util except by MeSH definition%A%  
% 219.35/219.52  |- mesh__dateCreated mesh__D003714 1999-01-01
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003714 1999
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003714 2000
% 219.35/219.52  |- mesh__recordAuthorizer mesh__D003714 SJN
% 219.35/219.52  |- mesh__recordOriginator mesh__D003714 NLM
% 219.35/219.52  |- skos__prefLabel mesh__D003714 Denervation
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003714 2005
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003714 2001
% 219.35/219.52  |- mesh__recordMaintainer mesh__D003714 PXP
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003714 2006
% 219.35/219.52  |- skos__scopeNote mesh__D003714
% 219.35/219.52       The resection or removal of the nerve to an organ or part. %28%Dorland, 28th ed%29%%A%    
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003714 2003
% 219.35/219.52  |- mesh__publicMeSHNote mesh__D003714 65   
% 219.35/219.52  |- mesh__historyNote mesh__D003714 65%28%64%29%   
% 219.35/219.52  |- rdf__type mesh__D003714sskos__Concept
% 219.35/219.52  |- skos__hiddenLabel mesh__D003714 Denervations
% 219.35/219.52  |- skos__altLabel mesh__D013344 SSPE
% 219.35/219.52  |- mesh__recordAuthorizer mesh__D013344 sjn
% 219.35/219.52  |- skos__altLabel mesh__D013344 Measles Inclusion Body Encephalitis
% 219.35/219.52  |- skos__hiddenLabel mesh__D013344 Subacute Sclerosing Panencephalitides
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D013344 2003
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D013344 2002
% 219.35/219.52  |- skos__broader mesh__D013344smesh__D012897
% 219.35/219.52  |- skos__altLabel mesh__D013344 Leukoencephalitis, Van Bogaert%27%s
% 219.35/219.52  |- skos__broader mesh__D013344smesh__D008457
% 219.35/219.52  |- mesh__publicMeSHNote mesh__D013344
% 219.35/219.52       71; VAN BOGAERT%27%S LEUKOENCEPHALITIS was see under SUBACUTE SCLEROSING PANENCEPHALITIS 1971-78; was see under CEREBRAL SCLEROSIS, DIFFUSE 1963-70%A%  
% 219.35/219.52  |- skos__broader mesh__D013344smesh__D018792
% 219.35/219.52  |- skos__hiddenLabel mesh__D013344 Van Bogaerts Leukoencephalitis
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D013344 2004
% 219.35/219.52  |- skos__altLabel mesh__D013344 Panencephalitis, Subacute Sclerosing
% 219.35/219.52  |- mesh__dateRevised mesh__D013344 2001-08-03
% 219.35/219.52  |- skos__hiddenLabel mesh__D013344 Panencephalitides, Subacute Sclerosing
% 219.35/219.52  |- skos__altLabel mesh__D013344 Inclusion Body Encephalitis, Measles
% 219.35/219.52  |- skos__hiddenLabel mesh__D013344 Leukoencephalitis, Van Bogaerts
% 219.35/219.52  |- skos__hiddenLabel mesh__D013344 Sclerosing Panencephalitides, Subacute
% 219.35/219.52  |- rdf__type mesh__D013344sskos__Concept
% 219.35/219.52  |- skos__altLabel mesh__D013344 Encephaltis, Inclusion Body, Measles
% 219.35/219.52  |- skos__hiddenLabel mesh__D013344 Leukoencephalitides, Subacute Sclerosing
% 219.35/219.52  |- skos__altLabel mesh__D013344 Sclerosing Leukoencephalitis, Subacute
% 219.35/219.52  |- mesh__onlineNote mesh__D013344
% 219.35/219.52       use SUBACUTE SCLEROSING PANENCEPHALITIS to search VAN BOGAERT%27%S LEUKOENCEPHALITIS 1971-78; use CEREBRAL SCLEROSIS, DIFFUSE 1966-70%A%  
% 219.35/219.52  |- skos__hiddenLabel mesh__D013344 Subacute Sclerosing Leukoencephalitides
% 219.35/219.52  |- mesh__recordOriginator mesh__D013344 NLM
% 219.35/219.52  |- mesh__recordMaintainer mesh__D013344 sjn
% 219.35/219.52  |- mesh__dateCreated mesh__D013344 1999-01-01
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D013344 2005
% 219.35/219.52  |- mesh__dateEstablished mesh__D013344 1971-01-01
% 219.35/219.52  |- mesh__historyNote mesh__D013344
% 219.35/219.52       71; VAN BOGAERT%27%S LEUKOENCEPHALITIS was see under SUBACUTE SCLEROSING PANENCEPHALITIS 1971-78; was see under CEREBRAL SCLEROSIS, DIFFUSE 1963-70%A%  
% 219.35/219.52  |- skos__hiddenLabel mesh__D013344 Leukoencephalitis, Van Bogaert
% 219.35/219.52  |- skos__altLabel mesh__D013344 Sclerosing Panencephalitis, Subacute
% 219.35/219.52  |- skos__altLabel mesh__D013344 Leukoencephalitis, Subacute Sclerosing
% 219.35/219.52  |- skos__hiddenLabel mesh__D013344 Subacute Sclerosing Leukoencephalitis
% 219.35/219.52  |- skos__altLabel mesh__D013344 Van Bogaert%27%s Leukoencephalitis
% 219.35/219.52  |- skos__hiddenLabel mesh__D013344 Van Bogaert Leukoencephalitis
% 219.35/219.52  |- skos__historyNote mesh__D013344
% 219.35/219.52       Cerebral Sclerosis, Diffuse %28%1966-1970%29%
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D013344 2006
% 219.35/219.52  |- skos__prefLabel mesh__D013344 Subacute Sclerosing Panencephalitis
% 219.35/219.52  |- skos__scopeNote mesh__D013344
% 219.35/219.52       A rare, slowly progressive encephalitis caused by chronic infection with the MEASLES VIRUS. The condition occurs primarily in children and young adults, approximately 2-8 years after the initial infection. A gradual decline in intellectual abilities and behavioral alterations are followed by progressive MYOCLONUS; MUSCLE SPASTICITY; SEIZURES; DEMENTIA; autonomic dysfunction; and ATAXIA. DEATH usually occurs 1-3 years after disease onset. Pathologic features include perivascular cuffing, eosinophilic cytoplasmic inclusions, neurophagia, and fibrous gliosis. It is caused by the SSPE virus, which is a defective variant of MEASLES VIRUS. %28%From Adams et al., Principles of Neurology, 6th ed, pp767-8%29%%A%    
% 219.35/219.52  |- skos__hiddenLabel mesh__D013344 Sclerosing Leukoencephalitides, Subacute
% 219.35/219.52  |- skos__related mesh__D017735smesh__D014775
% 219.35/219.52  |- mesh__recordMaintainer mesh__D017735 PXP
% 219.35/219.52  |- skos__hiddenLabel mesh__D017735 Latency, Virus
% 219.35/219.52  |- skos__broader mesh__D017735smesh__D018406
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017735 2002
% 219.35/219.52  |- skos__scopeNote mesh__D017735
% 219.35/219.52       The ability of a pathogenic virus to lie dormant within a cell %28%latent infection%29%. In eukaryotes, subsequent activation and viral replication is thought to be caused by extracellular stimulation of cellular transcription factors. Latency in bacteriophage is maintained by the expression of virally encoded repressors.%A%    
% 219.35/219.52  |- skos__hiddenLabel mesh__D017735 Latencies, Viral
% 219.35/219.52  |- skos__hiddenLabel mesh__D017735 Latency, Viral
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017735 1996
% 219.35/219.52  |- mesh__publicMeSHNote mesh__D017735 94   
% 219.35/219.52  |- mesh__dateRevised mesh__D017735 1994-02-08
% 219.35/219.52  |- skos__annotation mesh__D017735
% 219.35/219.52       coord with specific virus /physiol %28%IM or NIM%29%   
% 219.35/219.52  |- mesh__historyNote mesh__D017735 94   
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017735 2003
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017735 1998
% 219.35/219.52  |- skos__prefLabel mesh__D017735 Virus Latency
% 219.35/219.52  |- skos__historyNote mesh__D017735 Virus Replication %28%1968-1993%29%
% 219.35/219.52  |- skos__historyNote mesh__D017735 Virus Activation %28%1980-1993%29%
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017735 2005
% 219.35/219.52  |- mesh__recordOriginator mesh__D017735 AGS
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017735 1997
% 219.35/219.52  |- skos__altLabel mesh__D017735 Viral Latency
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017735 2004
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017735 1999
% 219.35/219.52  |- mesh__dateEstablished mesh__D017735 1994-01-01
% 219.35/219.52  |- mesh__recordAuthorizer mesh__D017735 PLS
% 219.35/219.52  |- rdf__type mesh__D017735sskos__Concept
% 219.35/219.52  |- skos__hiddenLabel mesh__D017735 Viral Latencies
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017735 2006
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017735 2000
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017735 1995
% 219.35/219.52  |- skos__hiddenLabel mesh__D017735 Latencies, Virus
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017735 2001
% 219.35/219.52  |- skos__hiddenLabel mesh__D017735 Virus Latencies
% 219.35/219.52  |- mesh__dateCreated mesh__D017735 1992-12-28
% 219.35/219.52  |- mesh__dateEstablished mesh__D031406 2003-01-01
% 219.35/219.52  |- skos__broader mesh__D031406smesh__D019668
% 219.35/219.52  |- mesh__historyNote mesh__D031406 2003   
% 219.35/219.52  |- rdf__type mesh__D031406sskos__Concept
% 219.35/219.52  |- mesh__dateCreated mesh__D031406 2002-07-03
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D031406 2003
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D031406 2005
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D031406 2004
% 219.35/219.52  |- skos__scopeNote mesh__D031406
% 219.35/219.52       A plant genus of the family LILIACEAE that contains spirostanol %26% furostanol SAPONINS.%A%    
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D031406 2006
% 219.35/219.52  |- mesh__publicMeSHNote mesh__D031406 2003   
% 219.35/219.52  |- skos__annotation mesh__D031406
% 219.35/219.52       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.35/219.52  |- skos__prefLabel mesh__D031406 Cordyline
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003715 2002
% 219.35/219.52  |- mesh__dateRevised mesh__D003715 1997-06-20
% 219.35/219.52  |- skos__altLabel mesh__D003715 Dengue Fever
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003715 2005
% 219.35/219.52  |- skos__prefLabel mesh__D003715 Dengue
% 219.35/219.52  |- skos__broader mesh__D003715smesh__D018177
% 219.35/219.52  |- skos__broader mesh__D003715smesh__D001102
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003715 2006
% 219.35/219.52  |- skos__hiddenLabel mesh__D003715 Fever, Dengue
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003715 2000
% 219.35/219.52  |- mesh__recordAuthorizer mesh__D003715 SJN
% 219.35/219.52  |- mesh__recordOriginator mesh__D003715 NLM
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003715 2003
% 219.35/219.52  |- rdf__type mesh__D003715sskos__Concept
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003715 2001
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003715 2004
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003715 1998
% 219.35/219.52  |- skos__scopeNote mesh__D003715
% 219.35/219.52       An acute infectious, eruptive, febrile disease caused by four antigenically related but distinct serotypes of the DENGUE VIRUS. It is transmitted by the bite of infected Aedes mosquitoes, especially A. aegypti. Classical dengue %28%dengue fever%29% is self-limiting and characterized by fever, myalgia, headache, and rash. DENGUE HEMORRHAGIC FEVER is a more virulent form of dengue virus infection and a separate clinical entity. %28%From Dorland, 28th ed%29%%A%    
% 219.35/219.52  |- mesh__recordMaintainer mesh__D003715 AGS
% 219.35/219.52  |- mesh__dateCreated mesh__D003715 1999-01-01
% 219.35/219.52  |- skos__broader mesh__D003715smesh__D006482
% 219.35/219.52  |- skos__annotation mesh__D003715
% 219.35/219.52       a hemorrhagic fever caused by a flavivirus but note DENGUE HEMORRHAGIC FEVER%A%  
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003715 1999
% 219.35/219.52  |- skos__hiddenLabel mesh__D008400 Xrays, Mass Chest
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D008400 2003
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D008400 2001
% 219.35/219.52  |- mesh__dateRevised mesh__D008400 1997-06-20
% 219.35/219.52  |- mesh__dateCreated mesh__D008400 1999-01-01
% 219.35/219.52  |- mesh__recordOriginator mesh__D008400 NLM
% 219.35/219.52  |- mesh__recordMaintainer mesh__D008400 PXP
% 219.35/219.52  |- skos__broader mesh__D008400smesh__D013902
% 219.35/219.52  |- rdf__type mesh__D008400sskos__Concept
% 219.35/219.52  |- skos__prefLabel mesh__D008400 Mass Chest X-Ray
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D008400 2004
% 219.35/219.52  |- skos__broader mesh__D008400smesh__D003948
% 219.35/219.52  |- skos__broader mesh__D008400smesh__D008403
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D008400 1998
% 219.35/219.52  |- skos__hiddenLabel mesh__D008400 X-Ray, Mass Chest
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D008400 2002
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D008400 2005
% 219.35/219.52  |- skos__hiddenLabel mesh__D008400 Mass Chest X-Rays
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D008400 1999
% 219.35/219.52  |- skos__hiddenLabel mesh__D008400 X-Rays, Mass Chest
% 219.35/219.52  |- mesh__recordAuthorizer mesh__D008400 SJN
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D008400 2006
% 219.35/219.52  |- skos__altLabel mesh__D008400 Mass Chest Xray
% 219.35/219.52  |- skos__scopeNote mesh__D008400
% 219.35/219.52       X-ray screening of large groups of persons for diseases of the lung and heart by means of radiography of the chest.%A%    
% 219.35/219.52  |- skos__annotation mesh__D008400
% 219.35/219.52       see note under RADIOGRAPHY, THORACIC; do not use /util except by MeSH definition%A%  
% 219.35/219.52  |- skos__hiddenLabel mesh__D008400 Mass Chest Xrays
% 219.35/219.52  |- skos__hiddenLabel mesh__D008400 Mass Chest X Ray
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D008400 2000
% 219.35/219.52  |- skos__hiddenLabel mesh__D008400 Xray, Mass Chest
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Hemorrhages, Subarachnoid
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D013345 2003
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Hemorrhages, Aneurysmal Subarachnoid
% 219.35/219.52  |- skos__broader mesh__D013345smesh__D020300
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Subarachnoid Hemorrhage, Perinatal
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 SAHs %28%Subarachnoid Hemorrhage%29%
% 219.35/219.52  |- mesh__recordAuthorizer mesh__D013345 sjn
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Intracranial Subarachnoid Hemorrhages
% 219.35/219.52  |- skos__prefLabel mesh__D013345 Subarachnoid Hemorrhage
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D013345 2002
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D013345 2004
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Hemorrhage, Spontaneous Subarachnoid
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Hemorrhage, Perinatal Subarachnoid
% 219.35/219.52  |- mesh__dateRevised mesh__D013345 1999-11-03
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Hemorrhage, Aneurysmal Subarachnoid
% 219.35/219.52  |- skos__altLabel mesh__D013345 Hemorrhage, Subarachnoid
% 219.35/219.52  |- rdf__type mesh__D013345sskos__Concept
% 219.35/219.52  |- skos__scopeNote mesh__D013345
% 219.35/219.52       Hemorrhage within the intracranial or spinal subarachnoid space, most often resulting from INTRACRANIAL ANEURYSM rupture or CRANIOCEREBRAL TRAUMA %28%see also SUBARACHNOID HEMORRHAGE, TRAUMATIC%29%. Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurologic deficits, intraocular subhyaloid hemorrhages, and a reduced level of consciousness which may progress to coma or death. Spasm of intracranial arteries %28%see VASOSPASM, INTRACRANIAL%29% frequently accompanies this condition and may lead to BRAIN ISCHEMIA or CEREBRAL INFARCTION. %28%From N Engl J Med 1997 Jan 2;336%28%1%29%:28-40%29%%A%    
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Spontaneous Subarachnoid Hemorrhage
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Spontaneous Subarachnoid Hemorrhages
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Subarachnoid Hemorrhages, Aneurysmal
% 219.35/219.52  |- mesh__dateCreated mesh__D013345 1999-01-01
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Subarachnoid Hemorrhages, Perinatal
% 219.35/219.52  |- mesh__recordOriginator mesh__D013345 NLM
% 219.35/219.52  |- mesh__recordMaintainer mesh__D013345 sjn
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Hemorrhage, Intracranial Subarachnoid
% 219.35/219.52  |- skos__altLabel mesh__D013345 SAH %28%Subarachnoid Hemorrhage%29%
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Aneurysmal Subarachnoid Hemorrhages
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D013345 2005
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Aneurysmal Subarachnoid Hemorrhage
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Hemorrhages, Perinatal Subarachnoid
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Subarachnoid Hemorrhages, Spontaneous
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Subarachnoid Hemorrhages, Intracranial
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Hemorrhages, Intracranial Subarachnoid
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D013345 2006
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D013345 2001
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Hemorrhages, Spontaneous Subarachnoid
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Subarachnoid Hemorrhages
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Perinatal Subarachnoid Hemorrhages
% 219.35/219.52  |- skos__hiddenLabel mesh__D013345 Intracranial Subarachnoid Hemorrhage
% 219.35/219.52  |- mesh__historyNote mesh__D018030 94   
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D018030 2001
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D018030 2006
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D018030 1997
% 219.35/219.52  |- skos__annotation mesh__D018030
% 219.35/219.52       inorganic; GEN or unspecified; prefer specifics; DF: SILVER CPDS%A%  
% 219.35/219.52  |- skos__hiddenLabel mesh__D018030 Compounds, Silver
% 219.35/219.52  |- skos__historyNote mesh__D018030 Silver %28%1966-1993%29%
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D018030 2000
% 219.35/219.52  |- mesh__dateEstablished mesh__D018030 1994-01-01
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D018030 2005
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D018030 1996
% 219.35/219.52  |- rdf__type mesh__D018030sskos__Concept
% 219.35/219.52  |- mesh__publicMeSHNote mesh__D018030 94   
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D018030 1999
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D018030 2002
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D018030 2004
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D018030 1995
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D018030 1998
% 219.35/219.52  |- skos__prefLabel mesh__D018030 Silver Compounds
% 219.35/219.52  |- skos__scopeNote mesh__D018030
% 219.35/219.52       Inorganic compounds that contain silver as an integral part of the molecule.%A%    
% 219.35/219.52  |- skos__broader mesh__D018030smesh__D007287
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D018030 2003
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D018030 1994
% 219.35/219.52  |- mesh__dateCreated mesh__D018030 1993-06-21
% 219.35/219.52  |- mesh__dateCreated mesh__D004010 1974-11-19
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D004010 2006
% 219.35/219.52  |- skos__altLabel mesh__D004010 Kelthane
% 219.35/219.52  |- skos__prefLabel mesh__D004010 Dicofol
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D004010 2005
% 219.35/219.52  |- skos__scopeNote mesh__D004010 An organochlorine insecticide.     
% 219.35/219.52  |- mesh__recordAuthorizer mesh__D004010 sjn
% 219.35/219.52  |- skos__historyNote mesh__D004010 Alcohol, Ethyl %28%1973-1974%29%
% 219.35/219.52  |- mesh__recordOriginator mesh__D004010 MEG
% 219.35/219.52  |- mesh__dateRevised mesh__D004010 2004-07-07
% 219.35/219.52  |- skos__broader mesh__D004010smesh__D002722
% 219.35/219.52  |- mesh__publicMeSHNote mesh__D004010
% 219.35/219.52       91; was see under INSECTICIDES, ORGANOCHLORINE 1975-90   
% 219.35/219.52  |- skos__historyNote mesh__D004010
% 219.35/219.52       Insecticides, Organochlorine %28%1973-1974%29%
% 219.35/219.52  |- rdf__type mesh__D004010sskos__Concept
% 219.35/219.52  |- mesh__recordMaintainer mesh__D004010 ssb
% 219.35/219.52  |- skos__annotation mesh__D004010 TN 111 for eff on insects   
% 219.35/219.52  |- mesh__historyNote mesh__D004010
% 219.35/219.52       91%28%75%29%; was see under INSECTICIDES, ORGANOCHLORINE 1975-90%A%  
% 219.35/219.52  |- mesh__dateEstablished mesh__D004010 1991-01-01
% 219.35/219.52  |- skos__hiddenLabel mesh__D017736 Ion Selective Electrodes
% 219.35/219.52  |- skos__prefLabel mesh__D017736 Ion-Selective Electrodes
% 219.35/219.52  |- skos__hiddenLabel mesh__D017736 Ion-Sensitive Electrode
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017736 1996
% 219.35/219.52  |- skos__historyNote mesh__D017736 Electrodes %28%1966-1993%29%
% 219.35/219.52  |- skos__hiddenLabel mesh__D017736 Ion Sensitive Electrodes
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017736 2002
% 219.35/219.52  |- skos__hiddenLabel mesh__D017736 Electrode, Ion-Selective
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017736 1998
% 219.35/219.52  |- mesh__publicMeSHNote mesh__D017736 94   
% 219.35/219.52  |- skos__hiddenLabel mesh__D017736 Ion-Selective Electrode
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017736 1997
% 219.35/219.52  |- mesh__historyNote mesh__D017736 94   
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017736 2003
% 219.35/219.52  |- skos__broader mesh__D017736smesh__D004566
% 219.35/219.52  |- rdf__type mesh__D017736sskos__Concept
% 219.35/219.52  |- skos__scopeNote mesh__D017736
% 219.35/219.52       Electrodes which can be used to measure the concentration of particular ions in cells, tissues, or solutions.%A%    
% 219.35/219.52  |- skos__hiddenLabel mesh__D017736 Electrodes, Ion Selective
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017736 2000
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017736 1999
% 219.35/219.52  |- mesh__dateEstablished mesh__D017736 1994-01-01
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017736 2005
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017736 2004
% 219.35/219.52  |- skos__altLabel mesh__D017736 Ion-Sensitive Electrodes
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017736 1994
% 219.35/219.52  |- skos__annotation mesh__D017736
% 219.35/219.52       designed to measure specific ion concentrations in cells, tissue or solutions%A%  
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017736 2001
% 219.35/219.52  |- skos__hiddenLabel mesh__D017736 Electrodes, Ion-Sensitive
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017736 2006
% 219.35/219.52  |- mesh__dateCreated mesh__D017736 1992-12-28
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D017736 1995
% 219.35/219.52  |- skos__altLabel mesh__D017736 Electrodes, Ion-Selective
% 219.35/219.52  |- skos__hiddenLabel mesh__D017736 Electrode, Ion-Sensitive
% 219.35/219.52  |- mesh__recordAuthorizer mesh__D031407 sjn
% 219.35/219.52  |- mesh__recordOriginator mesh__D031407 ssb
% 219.35/219.52  |- mesh__recordMaintainer mesh__D031407 ssb
% 219.35/219.52  |- mesh__dateRevised mesh__D031407 2003-07-09
% 219.35/219.52  |- mesh__dateEstablished mesh__D031407 2003-01-01
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D031407 2005
% 219.35/219.52  |- mesh__historyNote mesh__D031407 2003   
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D031407 2004
% 219.35/219.52  |- mesh__dateCreated mesh__D031407 2002-07-03
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D031407 2006
% 219.35/219.52  |- mesh__publicMeSHNote mesh__D031407 2003   
% 219.35/219.52  |- skos__scopeNote mesh__D031407
% 219.35/219.52       A plant genus of the family LILIACEAE that contains ALKALOIDS.%A%    
% 219.35/219.52  |- skos__annotation mesh__D031407
% 219.35/219.52       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.35/219.52  |- skos__prefLabel mesh__D031407 Crinum
% 219.35/219.52  |- skos__broader mesh__D031407smesh__D019668
% 219.35/219.52  |- rdf__type mesh__D031407sskos__Concept
% 219.35/219.52  |- mesh__recordOriginator mesh__D003716 NLM
% 219.35/219.52  |- skos__altLabel mesh__D003716 Breakbone Fever Virus
% 219.35/219.52  |- skos__hiddenLabel mesh__D003716 Breakbone Fever Viruses
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003716 2006
% 219.35/219.52  |- mesh__publicMeSHNote mesh__D003716
% 219.35/219.52       66; was see under ARBOVIRUS 1965, was see under ARBORVIRUSES 1963-64%A%  
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003716 2001
% 219.35/219.52  |- skos__scopeNote mesh__D003716
% 219.35/219.52       A species of the genus FLAVIVIRUS which causes an acute febrile and sometimes hemorrhagic disease in man. Dengue is mosquito-borne and four serotypes are known.%A%    
% 219.35/219.52  |- skos__hiddenLabel mesh__D003716 Viruses, Breakbone Fever
% 219.35/219.52  |- skos__hiddenLabel mesh__D003716 Virus, Dengue
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003716 2003
% 219.35/219.52  |- rdf__type mesh__D003716sskos__Concept
% 219.35/219.52  |- skos__hiddenLabel mesh__D003716 Viruses, Dengue
% 219.35/219.52  |- skos__prefLabel mesh__D003716 Dengue Virus
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003716 2004
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003716 1998
% 219.35/219.52  |- skos__annotation mesh__D003716
% 219.35/219.52       a species of Flavivirus; infection = DENGUE or DENGUE HEMORRHAGIC FEVER%A%  
% 219.35/219.52  |- skos__hiddenLabel mesh__D003716 Fever Virus, Breakbone
% 219.35/219.52  |- mesh__dateCreated mesh__D003716 1999-01-01
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003716 2002
% 219.35/219.52  |- mesh__activeMeSHYear mesh__D003716 1999
% 219.35/219.52  |- skos__broader mesh__D003716smesh__D005416
% 219.35/219.52  |- mesh__dateRevised mesh__D003716 1997-06-20
% 219.35/219.52  |- mesh__recordMaintainer mesh__D003716 AGS
% 219.35/219.52  |- mesh__dateEstablished mesh__D003716 1966-01-01
% 219.35/219.52  |- skos__hiddenLabel mesh__D003716 Dengue Viruses
% 219.35/219.53  |- mesh__historyNote mesh__D003716
% 219.35/219.53       66; was see under ARBOVIRUS 1965, was see under ARBORVIRUSES 1963-64%A%  
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003716 2000
% 219.35/219.53  |- mesh__recordAuthorizer mesh__D003716 SJN
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003716 2005
% 219.35/219.53  |- skos__hiddenLabel mesh__D003716 Virus, Breakbone Fever
% 219.35/219.53  |- skos__hiddenLabel mesh__D003716 Fever Viruses, Breakbone
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401 Chromatography-Mass Spectrometries, Gas
% 219.35/219.53  |- mesh__recordMaintainer mesh__D008401 lkt
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401
% 219.35/219.53       Gas-Liquid Chromatography-Mass Spectrometries
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401
% 219.35/219.53       Chromatography-Mass Spectrometry, Gas-Liquid
% 219.35/219.53  |- mesh__dateRevised mesh__D008401 2002-07-03
% 219.35/219.53  |- skos__scopeNote mesh__D008401
% 219.35/219.53       A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds.%A%    
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D008401 2006
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401
% 219.35/219.53       Spectrometry, Gas-Liquid Chromatography-Mass
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401
% 219.35/219.53       Spectrum Analysis, Mass Gas Chromatography
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401 Gas Chromatography-Mass Spectrometries
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401 Chromatography, Mass Spectrometry-Gas
% 219.35/219.53  |- skos__altLabel mesh__D008401 Chromatography, Mass
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D008401 2005
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401 Chromatographies, Mass Spectrometry-Gas
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401 Chromatographies, Gas-Mass Spectrometry
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401
% 219.35/219.53       Spectrometries, Gas-Liquid Chromatography-Mass
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401 Spectrometries, Mass-Gas Chromatography
% 219.35/219.53  |- skos__altLabel mesh__D008401 Spectrometry, Mass-Gas Chromatography
% 219.35/219.53  |- skos__altLabel mesh__D008401 Gas-Liquid Chromatography-Mass Spectrometry
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401 Spectrometry-Gas Chromatography, Mass
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401 Mass Spectrometry Gas Chromatography
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401
% 219.35/219.53       Gas Liquid Chromatography Mass Spectrometry
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401 Gas Chromatography Mass Spectrometry
% 219.35/219.53  |- skos__altLabel mesh__D008401 Chromatography, Gas-Mass Spectrometry
% 219.35/219.53  |- mesh__recordAuthorizer mesh__D008401 sjn
% 219.35/219.53  |- skos__altLabel mesh__D008401 Mass Spectrometry-Gas Chromatography
% 219.35/219.53  |- skos__altLabel mesh__D008401
% 219.35/219.53       Chromatography, Gas-Liquid-Mass Spectrometry
% 219.35/219.53  |- mesh__historyNote mesh__D008401
% 219.35/219.53       77%28%76%29%; was see under CHROMATOGRAPHY, GAS 1976   
% 219.35/219.53  |- skos__altLabel mesh__D008401 Spectrum Analysis, Mass-Gas Chromatography
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401 Spectrometry, Mass Gas Chromatography
% 219.35/219.53  |- skos__altLabel mesh__D008401 Gas Chromatography-Mass Spectrometry
% 219.35/219.53  |- skos__prefLabel mesh__D008401 Mass Fragmentography
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401 Mass Fragmentographies
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401 Fragmentographies, Mass
% 219.35/219.53  |- skos__broader mesh__D008401smesh__D002849
% 219.35/219.53  |- skos__historyNote mesh__D008401 Chromatography, Gas %28%1966-1976%29%
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401 Spectrometry-Gas Chromatographies, Mass
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D008401 2004
% 219.35/219.53  |- mesh__dateEstablished mesh__D008401 1977-01-01
% 219.35/219.53  |- mesh__dateCreated mesh__D008401 1975-07-25
% 219.35/219.53  |- skos__broader mesh__D008401smesh__D013058
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401
% 219.35/219.53       Chromatography, Gas Liquid Mass Spectrometry
% 219.35/219.53  |- mesh__publicMeSHNote mesh__D008401
% 219.35/219.53       77; was see under CHROMATOGRAPHY, GAS 1976   
% 219.35/219.53  |- mesh__recordOriginator mesh__D008401 JW
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401 Chromatography-Mass Spectrometry, Gas
% 219.35/219.53  |- rdf__type mesh__D008401sskos__Concept
% 219.35/219.53  |- skos__annotation mesh__D008401
% 219.35/219.53       a type of gas chromatogr %26% spectrum anal; NIM; DF: GCMS or MASS FRAGMENTOGR%A%  
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401 Chromatography, Gas Mass Spectrometry
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401
% 219.35/219.53       Chromatographies, Gas-Liquid-Mass Spectrometry
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D008401 2003
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401 Chromatographies, Mass
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401 Mass Chromatographies
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401 Spectrometries, Gas Chromatography-Mass
% 219.35/219.53  |- skos__altLabel mesh__D008401 Fragmentography, Mass
% 219.35/219.53  |- skos__historyNote mesh__D008401
% 219.35/219.53       Spectrum Analysis, Mass %28%1971-1976%29%
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401
% 219.35/219.53       Chromatography-Mass Spectrometries, Gas-Liquid
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401 Spectrometry, Gas Chromatography-Mass
% 219.35/219.53  |- skos__hiddenLabel mesh__D008401 Mass Spectrometry-Gas Chromatographies
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D013346 1999
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D013346 2003
% 219.35/219.53  |- skos__hiddenLabel mesh__D013346 Subarachnoid Spaces
% 219.35/219.53  |- skos__hiddenLabel mesh__D013346 Space, Subarachnoid
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D013346 2000
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D013346 1995
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D013346 2006
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D013346 1998
% 219.35/219.53  |- mesh__dateCreated mesh__D013346 1999-01-01
% 219.35/219.53  |- skos__broader mesh__D013346smesh__D001099
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D013346 1994
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D013346 2005
% 219.35/219.53  |- mesh__recordMaintainer mesh__D013346 TAP
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D013346 2002
% 219.35/219.53  |- mesh__recordAuthorizer mesh__D013346 PLS
% 219.35/219.53  |- skos__prefLabel mesh__D013346 Subarachnoid Space
% 219.35/219.53  |- mesh__dateRevised mesh__D013346 1992-05-18
% 219.35/219.53  |- mesh__recordOriginator mesh__D013346 NLM
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D013346 1997
% 219.35/219.53  |- skos__hiddenLabel mesh__D013346 Spaces, Subarachnoid
% 219.35/219.53  |- skos__annotation mesh__D013346
% 219.35/219.53       NIM: usually locational so few qualif apply   
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D013346 1993
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D013346 2004
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D013346 1996
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D013346 2001
% 219.35/219.53  |- rdf__type mesh__D013346sskos__Concept
% 219.35/219.53  |- skos__altLabel mesh__D018031 Connexin43
% 219.35/219.53  |- skos__altLabel mesh__D018031 Cx43
% 219.35/219.53  |- mesh__onlineNote mesh__D018031
% 219.35/219.53       use CONNEXINS %28%NM%29% to search CONNEXIN 43 1991-93   
% 219.35/219.53  |- skos__hiddenLabel mesh__D018031 43, Connexin
% 219.35/219.53  |- mesh__dateEstablished mesh__D018031 1994-01-01
% 219.35/219.53  |- mesh__recordOriginator mesh__D018031 RAZ
% 219.35/219.53  |- skos__scopeNote mesh__D018031
% 219.35/219.53       A 43-kDa peptide which is a member of the connexin family of gap junction proteins. Connexin 43 is a product of a gene in the alpha class of connexin genes %28%the alpha-1 gene%29%. It was first isolated from mammalian heart, but is widespread in the body including the brain.%A%    
% 219.35/219.53  |- mesh__dateCreated mesh__D018031 1993-06-18
% 219.35/219.53  |- mesh__publicMeSHNote mesh__D018031
% 219.35/219.53       94; CONNEXIN 43 was indexed under MEMBRANE PROTEINS 1987-93%A%  
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D018031 2006
% 219.35/219.53  |- mesh__dateRevised mesh__D018031 2004-07-07
% 219.35/219.53  |- skos__prefLabel mesh__D018031 Connexin 43
% 219.35/219.53  |- skos__broader mesh__D018031smesh__D017630
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D018031 2005
% 219.35/219.53  |- mesh__recordAuthorizer mesh__D018031 sjn
% 219.35/219.53  |- mesh__historyNote mesh__D018031
% 219.35/219.53       94; CONNEXIN 43 was %28%SY%29% to GAP JUNCTION PROTEIN 1991-93   
% 219.35/219.53  |- mesh__recordMaintainer mesh__D018031 jmp
% 219.35/219.53  |- skos__historyNote mesh__D018031 Membrane Proteins %28%1987-1993%29%
% 219.35/219.53  |- rdf__type mesh__D018031sskos__Concept
% 219.35/219.53  |- skos__hiddenLabel mesh__D004011 Dicrocoeliases
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D004011 2005
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D004011 2004
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D004011 1994
% 219.35/219.53  |- mesh__publicMeSHNote mesh__D004011 68   
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D004011 2003
% 219.35/219.53  |- mesh__historyNote mesh__D004011 68   
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D004011 2001
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D004011 1999
% 219.35/219.53  |- skos__prefLabel mesh__D004011 Dicrocoeliasis
% 219.35/219.53  |- skos__historyNote mesh__D004011 Trematode Infections %28%1966-1967%29%
% 219.35/219.53  |- skos__broader mesh__D004011smesh__D014201
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D004011 1998
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D004011 1997
% 219.35/219.53  |- mesh__recordMaintainer mesh__D004011 JLS
% 219.35/219.53  |- mesh__dateRevised mesh__D004011 1993-06-04
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D004011 2000
% 219.35/219.53  |- mesh__dateCreated mesh__D004011 1999-01-01
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D004011 1996
% 219.35/219.53  |- mesh__dateEstablished mesh__D004011 1968-01-01
% 219.35/219.53  |- mesh__recordAuthorizer mesh__D004011 PLS
% 219.35/219.53  |- rdf__type mesh__D004011sskos__Concept
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D004011 2006
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D004011 2002
% 219.35/219.53  |- skos__scopeNote mesh__D004011
% 219.35/219.53       Infection with flukes of the genus Dicrocoelium.     
% 219.35/219.53  |- mesh__recordOriginator mesh__D004011 NLM
% 219.35/219.53  |- skos__annotation mesh__D004011 trematode infect   
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D004011 1995
% 219.35/219.53  |- mesh__dateCreated mesh__D017737 1993-06-03
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D017737 2006
% 219.35/219.53  |- skos__historyNote mesh__D017737 Macrophages %28%1966-1993%29%
% 219.35/219.53  |- skos__hiddenLabel mesh__D017737 Macrophage, Peritoneal
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D017737 2005
% 219.35/219.53  |- skos__scopeNote mesh__D017737
% 219.35/219.53       Mononuclear phagocytes derived from bone marrow precursors but resident in the peritoneum.%A%    
% 219.35/219.53  |- skos__prefLabel mesh__D017737 Macrophages, Peritoneal
% 219.35/219.53  |- skos__altLabel mesh__D017737 Peritoneal Macrophages
% 219.35/219.53  |- skos__historyNote mesh__D017737 Peritoneum %28%1966-1971%29%
% 219.35/219.53  |- skos__hiddenLabel mesh__D017737 Peritoneal Macrophage
% 219.35/219.53  |- mesh__historyNote mesh__D017737 94   
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D017737 2004
% 219.35/219.53  |- skos__historyNote mesh__D017737 Peritoneal Cavity %28%1967-1993%29%
% 219.35/219.53  |- mesh__publicMeSHNote mesh__D017737 94   
% 219.35/219.53  |- rdf__type mesh__D017737sskos__Concept
% 219.35/219.53  |- mesh__dateEstablished mesh__D017737 1994-01-01
% 219.35/219.53  |- skos__broader mesh__D017737smesh__D008264
% 219.35/219.53  |- skos__annotation mesh__D017737 A 11 qualif   
% 219.35/219.53  |- mesh__dateRevised mesh__D017737 2003-07-09
% 219.35/219.53  |- rdf__type mesh__D031408sskos__Concept
% 219.35/219.53  |- skos__broader mesh__D031408smesh__D019668
% 219.35/219.53  |- mesh__dateEstablished mesh__D031408 2003-01-01
% 219.35/219.53  |- skos__prefLabel mesh__D031408 Curculigo
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D031408 2004
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D031408 2003
% 219.35/219.53  |- skos__scopeNote mesh__D031408
% 219.35/219.53       A plant genus of the family LILIACEAE that contains curculin and cycloartane saponins.%A%    
% 219.35/219.53  |- skos__annotation mesh__D031408
% 219.35/219.53       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.35/219.53  |- mesh__historyNote mesh__D031408 2003   
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D031408 2006
% 219.35/219.53  |- mesh__publicMeSHNote mesh__D031408 2003   
% 219.35/219.53  |- mesh__dateCreated mesh__D031408 2002-07-03
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D031408 2005
% 219.35/219.53  |- skos__hiddenLabel mesh__D003717 Denials %28%Psychology%29%
% 219.35/219.53  |- rdf__type mesh__D003717sskos__Concept
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003717 2003
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003717 2000
% 219.35/219.53  |- mesh__recordAuthorizer mesh__D003717 SJN
% 219.35/219.53  |- mesh__recordOriginator mesh__D003717 NLM
% 219.35/219.53  |- skos__altLabel mesh__D003717 Denial
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003717 2004
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003717 1998
% 219.35/219.53  |- skos__scopeNote mesh__D003717
% 219.35/219.53       Refusal to admit the truth or reality of a situation or experience.%A%    
% 219.35/219.53  |- skos__broader mesh__D003717smesh__D003674
% 219.35/219.53  |- mesh__dateCreated mesh__D003717 1974-11-11
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003717 2001
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003717 1999
% 219.35/219.53  |- skos__prefLabel mesh__D003717 Denial %28%Psychology%29%
% 219.35/219.53  |- skos__historyNote mesh__D003717 Defense Mechanisms %28%1966-1974%29%
% 219.35/219.53  |- mesh__publicMeSHNote mesh__D003717 75   
% 219.35/219.53  |- mesh__historyNote mesh__D003717 75   
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003717 2005
% 219.35/219.53  |- mesh__recordMaintainer mesh__D003717 JLS
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003717 2002
% 219.35/219.53  |- mesh__dateRevised mesh__D003717 1997-06-20
% 219.35/219.53  |- skos__annotation mesh__D003717 no qualif; DF: DENIAL   
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003717 2006
% 219.35/219.53  |- mesh__dateEstablished mesh__D003717 1975-09-01
% 219.35/219.53  |- skos__annotation mesh__D008402
% 219.35/219.53       IM with general reference to NEWSPAPERS; PERIODICALS; RADIO; TELEVISION; MOTION PICTURES; etc., as mass media; do not use as routine coord with the specific: coord only when specific is discussed as a mass medium, as %22%magazines as mass media%22%%A%  
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D008402 2005
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D008402 2004
% 219.35/219.53  |- skos__historyNote mesh__D008402 Radio %28%1966-1979%29%
% 219.35/219.53  |- mesh__historyNote mesh__D008402 80   
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D008402 2003
% 219.35/219.53  |- mesh__dateRevised mesh__D008402 2001-07-25
% 219.35/219.53  |- rdf__type mesh__D008402sskos__Concept
% 219.35/219.53  |- mesh__dateEstablished mesh__D008402 1980-01-01
% 219.35/219.53  |- skos__historyNote mesh__D008402 Television %28%1966-1979%29%
% 219.35/219.53  |- skos__scopeNote mesh__D008402
% 219.35/219.53       Instruments or technological means of communication that reach large numbers of people with a common message: press, radio, television, etc.%A%    
% 219.35/219.53  |- skos__historyNote mesh__D008402 Periodicals %28%1966-1979%29%
% 219.35/219.53  |- skos__hiddenLabel mesh__D008402 Media, Broadcast
% 219.35/219.53  |- skos__prefLabel mesh__D008402 Mass Media
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D008402 2002
% 219.35/219.53  |- skos__broader mesh__D008402smesh__D003146
% 219.35/219.53  |- mesh__recordMaintainer mesh__D008402 mdb
% 219.35/219.53  |- mesh__recordOriginator mesh__D008402 EC
% 219.35/219.53  |- skos__historyNote mesh__D008402 Newspapers %28%1966-1979%29%
% 219.35/219.53  |- mesh__recordAuthorizer mesh__D008402 sjn
% 219.35/219.53  |- skos__hiddenLabel mesh__D008402 Media, Printed
% 219.35/219.53  |- mesh__publicMeSHNote mesh__D008402 80   
% 219.35/219.53  |- mesh__dateCreated mesh__D008402 1979-02-21
% 219.35/219.53  |- skos__hiddenLabel mesh__D008402 Media, Folk
% 219.35/219.53  |- skos__hiddenLabel mesh__D008402 Media, Mass
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D008402 2006
% 219.35/219.53  |- skos__historyNote mesh__D008402 Communication %28%1966-1979%29%
% 219.35/219.53  |- mesh__onlineNote mesh__D013347
% 219.35/219.53       use SUBCELLULAR FRACTIONS to search HOMOGENATES 1966   
% 219.35/219.53  |- mesh__dateEstablished mesh__D013347 1972-01-01
% 219.35/219.53  |- mesh__dateCreated mesh__D013347 1999-01-01
% 219.35/219.53  |- mesh__dateRevised mesh__D013347 2004-07-07
% 219.35/219.53  |- skos__broader mesh__D013347smesh__D022082
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D013347 2006
% 219.35/219.53  |- skos__historyNote mesh__D013347 Cytology %28%1966-1971%29%
% 219.35/219.53  |- mesh__recordOriginator mesh__D013347 NLM
% 219.35/219.53  |- skos__scopeNote mesh__D013347
% 219.35/219.53       Components of a cell produced by various separation techniques which, though they disrupt the delicate anatomy of a cell, preserve the structure and physiology of its functioning constituents for biochemical and ultrastructural analysis. %28%From Alberts et al., Molecular Biology of the Cell, 2d ed, p163%29%%A%    
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D013347 2005
% 219.35/219.53  |- mesh__publicMeSHNote mesh__D013347 72   
% 219.35/219.53  |- mesh__historyNote mesh__D013347 72; HOMOGENATES was Prov 1964-66   
% 219.35/219.53  |- skos__hiddenLabel mesh__D013347 Fractions, Subcellular
% 219.35/219.53  |- skos__hiddenLabel mesh__D013347 Fraction, Subcellular
% 219.35/219.53  |- skos__related mesh__D013347smesh__D002458
% 219.35/219.53  |- skos__prefLabel mesh__D013347 Subcellular Fractions
% 219.35/219.53  |- rdf__type mesh__D013347sskos__Concept
% 219.35/219.53  |- skos__annotation mesh__D013347 NIM; A 11 qualif except /cytol   
% 219.35/219.53  |- mesh__recordMaintainer mesh__D013347 nns
% 219.35/219.53  |- skos__hiddenLabel mesh__D013347 Subcellular Fraction
% 219.35/219.53  |- mesh__recordAuthorizer mesh__D013347 sjn
% 219.35/219.53  |- skos__historyNote mesh__D013347 Microsomes %28%1966-1971%29%
% 219.35/219.53  |- skos__broader mesh__D014780Q000502smesh__D014780
% 219.35/219.53  |- mesh__preferredCombination mesh__D014780Q000502smesh__D018406
% 219.35/219.53  |- rdf__type mesh__D014780Q000502smesh__CompoundConcept
% 219.35/219.53  |- rdf__type mesh__D018830sskos__Concept
% 219.35/219.53  |- skos__hiddenLabel mesh__D018830 E coli Adhesin
% 219.35/219.53  |- skos__annotation mesh__D018830 bact antigens; DF: ADHESINS E COLI   
% 219.35/219.53  |- mesh__recordOriginator mesh__D018830 AGS
% 219.35/219.53  |- skos__scopeNote mesh__D018830
% 219.35/219.53       Thin, filamentous protein structures, including proteinaceous capsular antigens %28%fimbrial antigens%29%, that mediate adhesion of E. coli to surfaces and play a role in pathogenesis. They have a high affinity for various epithelial cells.%A%    
% 219.35/219.53  |- mesh__publicMeSHNote mesh__D018830
% 219.35/219.53       95; ADHESIN, E COLI was indexed under ANTIGENS, BACTERIAL 1982-94, BACTERIAL OUTER MEMBRANE PROTEINS 1985-94, %26% BACTERIAL PROTEINS 1982-88%A%  
% 219.35/219.53  |- skos__hiddenLabel mesh__D018830 Escherichia coli Adhesin
% 219.35/219.53  |- skos__historyNote mesh__D018830
% 219.35/219.53       Bacterial Outer Membrane Proteins %28%1985-1994%29%
% 219.35/219.53  |- mesh__dateCreated mesh__D018830 1994-05-31
% 219.35/219.53  |- skos__broader mesh__D018830smesh__D018829
% 219.35/219.53  |- mesh__recordMaintainer mesh__D018830 ssb
% 219.35/219.53  |- mesh__onlineNote mesh__D018830
% 219.35/219.53       use ADHESINS, ESCHERICHIA COLI %28%NM%29% to search ADHESIN, E COLI 1982-94%A%  
% 219.35/219.53  |- skos__historyNote mesh__D018830 Antigens, Bacterial %28%1982-1994%29%
% 219.35/219.53  |- skos__altLabel mesh__D018830 Adhesin, Escherichia coli
% 219.35/219.53  |- mesh__historyNote mesh__D018830
% 219.35/219.53       95; was ADHESIN, E COLI %28%NM%29% 1982-94   
% 219.35/219.53  |- mesh__recordAuthorizer mesh__D018830 sjn
% 219.35/219.53  |- skos__altLabel mesh__D018830 Adhesin, E coli
% 219.35/219.53  |- skos__broader mesh__D018830smesh__D029968
% 219.35/219.53  |- mesh__dateRevised mesh__D018830 2005-06-30
% 219.35/219.53  |- skos__historyNote mesh__D018830 Bacterial Proteins %28%1982-1988%29%
% 219.35/219.53  |- mesh__dateEstablished mesh__D018830 1995-01-01
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D018830 2006
% 219.35/219.53  |- skos__prefLabel mesh__D018830 Adhesins, Escherichia coli
% 219.35/219.53  |- skos__altLabel mesh__D018830 Escherichia coli Adhesins
% 219.35/219.53  |- mesh__dateEstablished mesh__D032501 2003-01-01
% 219.35/219.53  |- rdf__type mesh__D032501sskos__Concept
% 219.35/219.53  |- skos__scopeNote mesh__D032501
% 219.35/219.53       A plant genus of the family LYCOPODIACEAE. Members contain huperzine, one of the CHOLINESTERASE INHIBITORS.%A%    
% 219.35/219.53  |- skos__prefLabel mesh__D032501 Huperzia
% 219.35/219.53  |- skos__annotation mesh__D032501
% 219.35/219.53       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.35/219.53  |- mesh__publicMeSHNote mesh__D032501 2003   
% 219.35/219.53  |- mesh__dateCreated mesh__D032501 2002-07-03
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D032501 2004
% 219.35/219.53  |- mesh__historyNote mesh__D032501 2003   
% 219.35/219.53  |- skos__broader mesh__D032501smesh__D029542
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D032501 2003
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D032501 2006
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D032501 2005
% 219.35/219.53  |- skos__hiddenLabel mesh__D004810 Three Day Sickness
% 219.35/219.53  |- mesh__dateCreated mesh__D004810 1999-01-01
% 219.35/219.53  |- mesh__recordMaintainer mesh__D004810 ags
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D004810 2005
% 219.35/219.53  |- skos__broader mesh__D004810smesh__D018353
% 219.35/219.53  |- skos__broader mesh__D004810smesh__D002418
% 219.35/219.53  |- mesh__dateEstablished mesh__D004810 1970-01-01
% 219.35/219.53  |- mesh__recordOriginator mesh__D004810 NLM
% 219.35/219.53  |- mesh__publicMeSHNote mesh__D004810 70   
% 219.35/219.53  |- rdf__type mesh__D004810sskos__Concept
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D004810 2004
% 219.35/219.53  |- skos__hiddenLabel mesh__D004810 Sickness, Three-Day
% 219.35/219.53  |- skos__hiddenLabel mesh__D004810 Fever, Ephemeral
% 219.35/219.53  |- mesh__dateRevised mesh__D004810 2003-07-30
% 219.35/219.53  |- mesh__historyNote mesh__D004810 70   
% 219.35/219.53  |- skos__annotation mesh__D004810
% 219.35/219.53       caused by an Ephemerovirus; animal only; check tag ANIMALS; don%27%t forget also CATTLE %28%NIM%29% but do not index under CATTLE DISEASES%A%  
% 219.35/219.53  |- skos__prefLabel mesh__D004810 Ephemeral Fever
% 219.35/219.53  |- skos__altLabel mesh__D004810 Three-Day Sickness
% 219.35/219.53  |- skos__historyNote mesh__D004810 Cattle Diseases %28%1966-1969%29%
% 219.35/219.53  |- mesh__recordAuthorizer mesh__D004810 sjn
% 219.35/219.53  |- skos__scopeNote mesh__D004810
% 219.35/219.53       An Ephemerovirus infection of cattle caused by bovine ephemeral fever virus %28%EPHEMERAL FEVER VIRUS, BOVINE%29%. It is characterized by respiratory symptoms, increased oropharyngeal secretions and lacrimation, joint pains, tremor, and stiffness.%A%    
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D004810 2006
% 219.35/219.53  |- skos__historyNote mesh__D004810 Arbovirus Infections %28%1966-1969%29%
% 219.35/219.53  |- mesh__recordAuthorizer mesh__D004012 sjn
% 219.35/219.53  |- mesh__dateCreated mesh__D004012 1981-05-15
% 219.35/219.53  |- mesh__recordOriginator mesh__D004012 EC
% 219.35/219.53  |- skos__historyNote mesh__D004012 Trematoda %28%1966-1997%29%
% 219.35/219.53  |- rdf__type mesh__D004012sskos__Concept
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D004012 2006
% 219.35/219.53  |- skos__annotation mesh__D004012
% 219.35/219.53       a family of trematodes; infection: coord IM with TREMATODE INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D004012 2005
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D004012 2004
% 219.35/219.53  |- skos__broader mesh__D004012smesh__D014200
% 219.35/219.53  |- mesh__dateEstablished mesh__D004012 1998-01-01
% 219.35/219.53  |- skos__scopeNote mesh__D004012
% 219.35/219.53       A family of flattened, translucent flukes %28%TREMATODA%29% occurring in the gut, gallbladder, bile ducts, liver or pancreatic ducts of amphibians, reptiles, birds, and mammals. %28%Noble et al., Parasitology: the Biology of Animal Parasites, 6th ed, p188%29%%A%    
% 219.35/219.53  |- mesh__historyNote mesh__D004012 98; use explode 1982-97   
% 219.35/219.53  |- skos__prefLabel mesh__D004012 Dicrocoeliidae
% 219.35/219.53  |- mesh__dateRevised mesh__D004012 2003-07-09
% 219.35/219.53  |- mesh__recordMaintainer mesh__D004012 ags
% 219.35/219.53  |- mesh__publicMeSHNote mesh__D004012 98   
% 219.35/219.53  |- mesh__publicMeSHNote mesh__D017738 94   
% 219.35/219.53  |- mesh__dateEstablished mesh__D017738 1994-01-01
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D017738 2005
% 219.35/219.53  |- skos__prefLabel mesh__D017738 Alkanesulfonic Acids
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D017738 1994
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D017738 1997
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D017738 2002
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D017738 1996
% 219.35/219.53  |- mesh__dateCreated mesh__D017738 1993-06-04
% 219.35/219.53  |- mesh__historyNote mesh__D017738 94   
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D017738 2004
% 219.35/219.53  |- rdf__type mesh__D017738sskos__Concept
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D017738 2001
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D017738 1999
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D017738 2003
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D017738 2000
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D017738 1998
% 219.35/219.53  |- skos__broader mesh__D017738smesh__D013451
% 219.35/219.53  |- skos__historyNote mesh__D017738 Sulfonic Acids %28%1966-1993%29%
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D017738 2006
% 219.35/219.53  |- skos__hiddenLabel mesh__D017738 Acids, Alkanesulfonic
% 219.35/219.53  |- skos__broader mesh__D017738smesh__D000473
% 219.35/219.53  |- skos__scopeNote mesh__D017738
% 219.35/219.53       Sulfonic acid derivatives that are substituted with an aliphatic hydrocarbon group.%A%    
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D017738 1995
% 219.35/219.53  |- mesh__dateCreated mesh__D031409 2002-07-03
% 219.35/219.53  |- mesh__recordOriginator mesh__D031409 ssb
% 219.35/219.53  |- mesh__recordAuthorizer mesh__D031409 ags
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D031409 2004
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D031409 2003
% 219.35/219.53  |- mesh__dateEstablished mesh__D031409 2003-01-01
% 219.35/219.53  |- skos__annotation mesh__D031409
% 219.35/219.53       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D031409 2006A
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D031409 2006
% 219.35/219.53  |- mesh__dateRevised mesh__D031409 2005-07-22
% 219.35/219.53  |- mesh__publicMeSHNote mesh__D031409 2003   
% 219.35/219.53  |- skos__prefLabel mesh__D031409 Dracaena
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D031409 2005
% 219.35/219.53  |- skos__scopeNote mesh__D031409
% 219.35/219.53       A plant genus of the family LILIACEAE. The common name of %22%dragon%27%s blood%22% is also used for CROTON and Daemonorops %28%ARECACEAE%29%.%A%    
% 219.35/219.53  |- mesh__historyNote mesh__D031409 2003   
% 219.35/219.53  |- rdf__type mesh__D031409sskos__Concept
% 219.35/219.53  |- skos__broader mesh__D031409smesh__D019668
% 219.35/219.53  |- mesh__recordMaintainer mesh__D031409 ags
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003718 2001
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003718 2006
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003718 2000
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003718 2004
% 219.35/219.53  |- mesh__dateRevised mesh__D003718 1999-12-01
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003718 2000A
% 219.35/219.53  |- skos__prefLabel mesh__D003718 Denmark
% 219.35/219.53  |- rdf__type mesh__D003718sskos__Concept
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003718 2005
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003718 2003
% 219.35/219.53  |- skos__broader mesh__D003718smesh__D012537
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003718 1995
% 219.35/219.53  |- mesh__recordMaintainer mesh__D003718 ags
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003718 2002
% 219.35/219.53  |- mesh__recordAuthorizer mesh__D003718 ags
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003718 1993
% 219.35/219.53  |- mesh__recordOriginator mesh__D003718 NLM
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003718 1999
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003718 1997
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003718 1994
% 219.35/219.53  |- mesh__dateCreated mesh__D003718 1999-01-01
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003718 1992
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003718 1998
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D003718 1996
% 219.35/219.53  |- mesh__dateEstablished mesh__D014440 1991-01-01
% 219.35/219.53  |- rdf__type mesh__D014440sskos__Concept
% 219.35/219.53  |- skos__altLabel mesh__D014440 Tyrocidines
% 219.35/219.53  |- skos__historyNote mesh__D014440 Tyrothricin %28%1966-1974%29%
% 219.35/219.53  |- mesh__recordMaintainer mesh__D014440 ssb
% 219.35/219.53  |- mesh__historyNote mesh__D014440
% 219.35/219.53       94; was TYROCIDINES 1975-93 %28%see under TYROTHRICIN 1975-90%29%%A%  
% 219.35/219.53  |- mesh__publicMeSHNote mesh__D014440
% 219.35/219.53       94; was TYROCIDINES 1975-93 %28%see under TYROTHRICIN 1975-90%29%%A%  
% 219.35/219.53  |- mesh__dateCreated mesh__D014440 1974-11-19
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D014440 2004
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D014440 2006
% 219.35/219.53  |- mesh__onlineNote mesh__D014440
% 219.35/219.53       use TYROCIDINE to search TYROCIDINES 1975-93   
% 219.35/219.53  |- mesh__activeMeSHYear mesh__D014440 2005
% 219.35/219.54  |- skos__prefLabel mesh__D014440 Tyrocidine
% 219.35/219.54  |- skos__scopeNote mesh__D014440
% 219.35/219.54       An antibiotic mixture produced by Bacillus brevis which may be separated into three components, tyrocidines A, B, and C. It is the major constituent %28%40-60 per cent%29% of tyrothricin, gramicidin accounting for the remaining 10-20 per cent active material. It is a topical antimicrobial agent, that is very toxic parenterally.%A%    
% 219.35/219.54  |- mesh__recordAuthorizer mesh__D014440 sjn
% 219.35/219.54  |- mesh__recordOriginator mesh__D014440 NLM
% 219.35/219.54  |- mesh__dateRevised mesh__D014440 2003-07-09
% 219.35/219.54  |- skos__historyNote mesh__D014440 Peptides, Cyclic %28%1974%29%
% 219.35/219.54  |- skos__broader mesh__D014440smesh__D014449
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D008403 2003
% 219.35/219.54  |- rdf__type mesh__D008403sskos__Concept
% 219.35/219.54  |- skos__hiddenLabel mesh__D008403 Mass Screenings
% 219.35/219.54  |- mesh__dateCreated mesh__D008403 1999-01-01
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D008403 2001
% 219.35/219.54  |- skos__broader mesh__D008403smesh__D003954
% 219.35/219.54  |- skos__broader mesh__D008403smesh__D015980
% 219.35/219.54  |- skos__prefLabel mesh__D008403 Mass Screening
% 219.35/219.54  |- mesh__onlineNote mesh__D008403
% 219.35/219.54       use MASS SCREENING to search MASS SCREENING TECHNICS 1966-67%A%  
% 219.35/219.54  |- mesh__publicMeSHNote mesh__D008403
% 219.35/219.54       68; was MASS SCREENING TECHNICS 1963-67   
% 219.35/219.54  |- skos__hiddenLabel mesh__D008403 Screenings
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D008403 2000
% 219.35/219.54  |- mesh__historyNote mesh__D008403
% 219.35/219.54       68; was MASS SCREENING TECHNICS 1963-67   
% 219.35/219.54  |- skos__scopeNote mesh__D008403
% 219.35/219.54       Organized periodic procedures performed on large groups of people for the purpose of detecting disease.%A%    
% 219.35/219.54  |- skos__annotation mesh__D008403
% 219.35/219.54       coord with disease/diag or /epidemiol or /prev   
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D008403 2006
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D008403 2002
% 219.35/219.54  |- skos__broader mesh__D008403smesh__D019937
% 219.35/219.54  |- skos__broader mesh__D008403smesh__D006306
% 219.35/219.54  |- skos__related mesh__D008403smesh__D012680
% 219.35/219.54  |- skos__hiddenLabel mesh__D008403 Screenings, Mass
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D008403 2005
% 219.35/219.54  |- mesh__recordAuthorizer mesh__D008403 sjn
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D008403 2004
% 219.35/219.54  |- mesh__recordMaintainer mesh__D008403 kle
% 219.35/219.54  |- skos__hiddenLabel mesh__D008403 Screening, Mass
% 219.35/219.54  |- mesh__dateEstablished mesh__D008403 1968-01-01
% 219.35/219.54  |- mesh__recordOriginator mesh__D008403 NLM
% 219.35/219.54  |- mesh__dateRevised mesh__D008403 1999-11-03
% 219.35/219.54  |- skos__altLabel mesh__D000420 Salbutamol
% 219.35/219.54  |- skos__scopeNote mesh__D000420
% 219.35/219.54       A racemic mixture with a 1:1 ratio of the r-isomer, levalbuterol, and s-albuterol. It is a short-acting beta2-adrenergic agonist with its main clinical use in ASTHMA.%A%    
% 219.35/219.54  |- mesh__historyNote mesh__D000420 74   
% 219.35/219.54  |- rdf__type mesh__D000420sskos__Concept
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D000420 2006
% 219.35/219.54  |- mesh__recordOriginator mesh__D000420 NLM
% 219.35/219.54  |- mesh__recordAuthorizer mesh__D000420 sjn
% 219.35/219.54  |- mesh__recordMaintainer mesh__D000420 lkw
% 219.35/219.54  |- skos__prefLabel mesh__D000420 Albuterol
% 219.35/219.54  |- mesh__dateEstablished mesh__D000420 1974-01-01
% 219.35/219.54  |- skos__broader mesh__D000420smesh__D004983
% 219.35/219.54  |- skos__hiddenLabel mesh__D000420 Hydrochloride, Levalbuterol
% 219.35/219.54  |- mesh__dateCreated mesh__D000420 1999-01-01
% 219.35/219.54  |- mesh__publicMeSHNote mesh__D000420 74   
% 219.35/219.54  |- mesh__dateRevised mesh__D000420 2005-06-30
% 219.35/219.54  |- skos__broader mesh__D000420smesh__D010627
% 219.35/219.54  |- skos__altLabel mesh__D000420
% 219.35/219.54       2-t-Butylamino-1-%28%4-hydroxy-3-hydroxy-3-hydroxymethyl%29%phenylethanol
% 219.35/219.54  |- skos__scopeNote mesh__D013348
% 219.35/219.54       Artery arising from the brachiocephalic trunk on the right side and from the arch of the aorta on the left side. It distributes to the neck, thoracic wall, spinal cord, brain, meninges, and upper limb.%A%    
% 219.35/219.54  |- skos__hiddenLabel mesh__D013348 Artery, Subclavian
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D013348 2001
% 219.35/219.54  |- skos__hiddenLabel mesh__D013348 Subclavian Arteries
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D013348 1995
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D013348 2006
% 219.35/219.54  |- skos__broader mesh__D013348smesh__D001158
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D013348 2000
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D013348 1994
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D013348 2005
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D013348 1997
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D013348 1996
% 219.35/219.54  |- mesh__dateRevised mesh__D013348 1992-05-18
% 219.35/219.54  |- mesh__recordMaintainer mesh__D013348 TAP
% 219.35/219.54  |- skos__hiddenLabel mesh__D013348 Arteries, Subclavian
% 219.35/219.54  |- rdf__type mesh__D013348sskos__Concept
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D013348 2002
% 219.35/219.54  |- mesh__recordAuthorizer mesh__D013348 PLS
% 219.35/219.54  |- mesh__recordOriginator mesh__D013348 NLM
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D013348 1993
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D013348 2004
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D013348 1999
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D013348 2003
% 219.35/219.54  |- mesh__dateCreated mesh__D013348 1999-01-01
% 219.35/219.54  |- skos__prefLabel mesh__D013348 Subclavian Artery
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D013348 1998
% 219.35/219.54  |- skos__annotation mesh__D032502
% 219.35/219.54       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.35/219.54  |- mesh__publicMeSHNote mesh__D032502 2003   
% 219.35/219.54  |- mesh__dateEstablished mesh__D032502 2003-01-01
% 219.35/219.54  |- skos__scopeNote mesh__D032502
% 219.35/219.54       A plant genus of the family LYCOPODIACEAE. Members contain ALKALOIDS. Lycopodium oil is obtained from L. clavatum.%A%    
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D032502 2004
% 219.35/219.54  |- skos__broader mesh__D032502smesh__D029542
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D032502 2006
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D032502 2003
% 219.35/219.54  |- mesh__dateCreated mesh__D032502 2002-07-03
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D032502 2005
% 219.35/219.54  |- rdf__type mesh__D032502sskos__Concept
% 219.35/219.54  |- skos__prefLabel mesh__D032502 Lycopodium
% 219.35/219.54  |- mesh__historyNote mesh__D032502 2003   
% 219.35/219.54  |- skos__hiddenLabel mesh__D018033 Antibodies, Bispecific Monoclonal
% 219.35/219.54  |- skos__hiddenLabel mesh__D018033 Antibodies, Bifunctional
% 219.35/219.54  |- skos__related mesh__D018033smesh__D000922
% 219.35/219.54  |- skos__altLabel mesh__D018033 Bispecific Antibodies
% 219.35/219.54  |- mesh__dateCreated mesh__D018033 1993-06-04
% 219.35/219.54  |- skos__broader mesh__D018033smesh__D000906
% 219.35/219.54  |- skos__historyNote mesh__D018033 specific Antibodies %28%1985-1993%29%
% 219.35/219.54  |- skos__related mesh__D018033smesh__D016499
% 219.35/219.54  |- skos__prefLabel mesh__D018033 Antibodies, Bispecific
% 219.35/219.54  |- mesh__historyNote mesh__D018033 94   
% 219.35/219.54  |- skos__historyNote mesh__D018033 Antibodies %28%1985-1993%29%
% 219.35/219.54  |- mesh__recordAuthorizer mesh__D018033 sjn
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D018033 2006
% 219.35/219.54  |- mesh__publicMeSHNote mesh__D018033 94   
% 219.35/219.54  |- mesh__recordMaintainer mesh__D018033 ssb
% 219.35/219.54  |- skos__scopeNote mesh__D018033
% 219.35/219.54       Antibodies, often monoclonal, in which the two antigen-binding sites are specific for separate ANTIGENIC DETERMINANTS. They are artificial antibodies produced by chemical crosslinking, fusion of HYBRIDOMA cells, or by molecular genetic techniques. They function as the main mediators of targeted cellular cytotoxicity and have been shown to be efficient in the targeting of drugs, toxins, radiolabeled haptens, and effector cells to diseased tissue, primarily tumors.%A%    
% 219.35/219.54  |- skos__annotation mesh__D018033
% 219.35/219.54       do not coordinate with ANTIBODY FORMATION for /biosyn   
% 219.35/219.54  |- mesh__recordOriginator mesh__D018033 AGS
% 219.35/219.54  |- skos__altLabel mesh__D018033 Bifunctional Antibodies
% 219.35/219.54  |- rdf__type mesh__D018033sskos__Concept
% 219.35/219.54  |- skos__hiddenLabel mesh__D018033 Monoclonal Antibodies, Bispecific
% 219.35/219.54  |- mesh__dateEstablished mesh__D018033 1994-01-01
% 219.35/219.54  |- mesh__dateRevised mesh__D018033 2005-06-30
% 219.35/219.54  |- skos__broader mesh__D010050smesh__D003940
% 219.35/219.54  |- mesh__publicMeSHNote mesh__D010050 75   
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D010050 1999
% 219.35/219.54  |- skos__broader mesh__D010050smesh__D003944
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D010050 2002
% 219.35/219.54  |- mesh__recordMaintainer mesh__D010050 PXP
% 219.35/219.54  |- skos__historyNote mesh__D010050 Ovarian Diseases %28%1966-1974%29%
% 219.35/219.54  |- mesh__recordAuthorizer mesh__D010050 SJN
% 219.35/219.54  |- rdf__type mesh__D010050sskos__Concept
% 219.35/219.54  |- skos__annotation mesh__D010050 NIM   
% 219.35/219.54  |- mesh__dateCreated mesh__D010050 1974-11-19
% 219.35/219.54  |- mesh__dateEstablished mesh__D010050 1975-09-01
% 219.35/219.54  |- skos__hiddenLabel mesh__D010050 Function Test, Ovarian
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D010050 2003
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D010050 2005
% 219.35/219.54  |- mesh__dateRevised mesh__D010050 1997-06-20
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D010050 2000
% 219.35/219.54  |- skos__hiddenLabel mesh__D010050 Function Tests, Ovarian
% 219.35/219.54  |- skos__historyNote mesh__D010050 Ovary %28%1966-1974%29%
% 219.35/219.54  |- skos__hiddenLabel mesh__D010050 Tests, Ovarian Function
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D010050 2004
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D010050 2001
% 219.35/219.54  |- skos__prefLabel mesh__D010050 Ovarian Function Tests
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D010050 2006
% 219.35/219.54  |- mesh__recordOriginator mesh__D010050 NLM
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D010050 1998
% 219.35/219.54  |- skos__hiddenLabel mesh__D010050 Ovarian Function Test
% 219.35/219.54  |- mesh__historyNote mesh__D010050 75   
% 219.35/219.54  |- skos__scopeNote mesh__D010050
% 219.35/219.54       Methods used for assessment of ovarian function.     
% 219.35/219.54  |- skos__hiddenLabel mesh__D010050 Test, Ovarian Function
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D004811 2006
% 219.35/219.54  |- mesh__dateEstablished mesh__D004811 1991-01-01
% 219.35/219.54  |- mesh__recordOriginator mesh__D004811 NLM
% 219.35/219.54  |- skos__scopeNote mesh__D004811
% 219.35/219.54       A chlorinated epoxy compound used as an industrial solvent. It is a strong skin irritant and carcinogen.%A%    
% 219.35/219.54  |- skos__historyNote mesh__D004811 Ethers, Cyclic %28%1969-1974%29%
% 219.35/219.54  |- mesh__dateRevised mesh__D004811 2004-07-07
% 219.35/219.54  |- rdf__type mesh__D004811sskos__Concept
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D004811 2005
% 219.35/219.54  |- skos__broader mesh__D004811smesh__D004852
% 219.35/219.54  |- mesh__historyNote mesh__D004811
% 219.35/219.54       91%28%75%29%; was see under CHLOROHYDRINS 1975-90   
% 219.35/219.54  |- mesh__dateCreated mesh__D004811 1974-11-14
% 219.35/219.54  |- mesh__recordMaintainer mesh__D004811 ssb
% 219.35/219.54  |- mesh__publicMeSHNote mesh__D004811
% 219.35/219.54       91; was see under CHLOROHYDRINS 1975-90   
% 219.35/219.54  |- skos__historyNote mesh__D004811 Chlorine %28%1973-1974%29%
% 219.35/219.54  |- mesh__recordAuthorizer mesh__D004811 sjn
% 219.35/219.54  |- skos__historyNote mesh__D004811 Propane %28%1973-1974%29%
% 219.35/219.54  |- skos__prefLabel mesh__D004811 Epichlorohydrin
% 219.35/219.54  |- skos__altLabel mesh__D004811 Epichlorhydrin
% 219.35/219.54  |- skos__prefLabel mesh__D004013 Dicrocoelium
% 219.35/219.54  |- mesh__dateCreated mesh__D004013 1999-01-01
% 219.35/219.54  |- rdf__type mesh__D004013sskos__Concept
% 219.35/219.54  |- mesh__recordAuthorizer mesh__D004013 sjn
% 219.35/219.54  |- skos__annotation mesh__D004013
% 219.35/219.54       infection = DICROCOELIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D004013 2006
% 219.35/219.54  |- skos__altLabel mesh__D004013 Dicrocoelium dendriticum
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D004013 2005
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D004013 2004
% 219.35/219.54  |- mesh__recordOriginator mesh__D004013 NLM
% 219.35/219.54  |- mesh__dateRevised mesh__D004013 2003-07-09
% 219.35/219.54  |- mesh__recordMaintainer mesh__D004013 ags
% 219.35/219.54  |- skos__broader mesh__D004013smesh__D004012
% 219.35/219.54  |- skos__scopeNote mesh__D004013
% 219.35/219.54       A genus of trematode liver flukes of the family Dicrocoeliidae which includes the species dendriticum and hospes. It occurs in the biliary passages or liver of many vertebrates including man. The intermediate hosts are mainly mollusks but occasionally ants.%A%    
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D017739 2001
% 219.35/219.54  |- mesh__historyNote mesh__D017739 94   
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D017739 2004
% 219.35/219.54  |- skos__scopeNote mesh__D017739
% 219.35/219.54       Organic sulfonic acid derivatives which contain an aromatic hydrocarbon radical.%A%    
% 219.35/219.54  |- rdf__type mesh__D017739sskos__Concept
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D017739 2000
% 219.35/219.54  |- skos__hiddenLabel mesh__D017739 Acids, Arylsulfonic
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D017739 1999
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D017739 2003
% 219.35/219.54  |- mesh__dateEstablished mesh__D017739 1994-01-01
% 219.35/219.54  |- skos__historyNote mesh__D017739 Sulfonic Acids %28%1966-1993%29%
% 219.35/219.54  |- mesh__publicMeSHNote mesh__D017739 94   
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D017739 1998
% 219.35/219.54  |- skos__prefLabel mesh__D017739 Arylsulfonic Acids
% 219.35/219.54  |- skos__broader mesh__D017739smesh__D013451
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D017739 2006
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D017739 1995
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D017739 2002
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D017739 2005
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D017739 1994
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D017739 1997
% 219.35/219.54  |- mesh__dateCreated mesh__D017739 1993-06-04
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D017739 1996
% 219.35/219.54  |- skos__annotation mesh__D028461
% 219.35/219.54       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.35/219.54  |- mesh__recordAuthorizer mesh__D028461 sjn
% 219.35/219.54  |- rdf__type mesh__D028461sskos__Concept
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D028461 2006
% 219.35/219.54  |- skos__broader mesh__D028461smesh__D019684
% 219.35/219.54  |- skos__historyNote mesh__D028461 Plants, Medicinal %28%1971-2001%29%
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D028461 2003
% 219.35/219.54  |- mesh__publicMeSHNote mesh__D028461 2002   
% 219.35/219.54  |- mesh__dateEstablished mesh__D028461 2002-01-01
% 219.35/219.54  |- skos__prefLabel mesh__D028461 Zygophyllaceae
% 219.35/219.54  |- skos__scopeNote mesh__D028461
% 219.35/219.54       A plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida which is a small family of small trees and shrubs growing in arid and warm regions.%A%    
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D028461 2004
% 219.35/219.54  |- mesh__dateRevised mesh__D028461 2002-07-03
% 219.35/219.54  |- mesh__recordOriginator mesh__D028461 ssb
% 219.35/219.54  |- mesh__recordMaintainer mesh__D028461 ssb
% 219.35/219.54  |- mesh__historyNote mesh__D028461 2002   
% 219.35/219.54  |- mesh__dateCreated mesh__D028461 2001-07-25
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D028461 2005
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D003719 2005
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D003719 2004
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D003719 2001
% 219.35/219.54  |- skos__hiddenLabel mesh__D003719 in Dente, Dens
% 219.35/219.54  |- rdf__type mesh__D003719sskos__Concept
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D003719 2003
% 219.35/219.54  |- skos__annotation mesh__D003719
% 219.35/219.54       a tooth abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 219.35/219.54  |- mesh__recordMaintainer mesh__D003719 kle
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D003719 2000
% 219.35/219.54  |- mesh__historyNote mesh__D003719
% 219.35/219.54       91%28%75%29%; was see under TOOTH ABNORMALITIES 1975-90   
% 219.35/219.54  |- mesh__recordAuthorizer mesh__D003719 sjn
% 219.35/219.54  |- mesh__onlineNote mesh__D003719 search TOOTH ABNORMALITIES 1966-74   
% 219.35/219.54  |- skos__hiddenLabel mesh__D003719 Dentes, Dens in
% 219.35/219.54  |- skos__prefLabel mesh__D003719 Dens in Dente
% 219.35/219.54  |- mesh__dateRevised mesh__D003719 1999-11-03
% 219.35/219.54  |- mesh__dateEstablished mesh__D003719 1991-01-01
% 219.35/219.54  |- mesh__dateCreated mesh__D003719 1999-01-01
% 219.35/219.54  |- skos__hiddenLabel mesh__D003719 Dente, Dens in
% 219.35/219.54  |- skos__broader mesh__D003719smesh__D014071
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D003719 2002
% 219.35/219.54  |- skos__hiddenLabel mesh__D003719 in Dentes, Dens
% 219.35/219.54  |- mesh__recordOriginator mesh__D003719 NLM
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D003719 2006
% 219.35/219.54  |- skos__hiddenLabel mesh__D003719 Dens in Dentes
% 219.35/219.54  |- skos__scopeNote mesh__D003719
% 219.35/219.54       Anomaly of the tooth, found chiefly in upper lateral incisors. It is characterized by invagination of the enamel at the incisal edge.%A%    
% 219.35/219.54  |- mesh__publicMeSHNote mesh__D003719
% 219.35/219.54       91; was see under TOOTH ABNORMALITIES 1975-90   
% 219.35/219.54  |- mesh__publicMeSHNote mesh__D014441
% 219.35/219.54       91; was see under IODOBENZENES 1975-90   
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D014441 2001
% 219.35/219.54  |- rdf__type mesh__D014441sskos__Concept
% 219.35/219.54  |- mesh__recordOriginator mesh__D014441 NLM
% 219.35/219.54  |- mesh__recordAuthorizer mesh__D014441 sjn
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D014441 2003
% 219.35/219.54  |- mesh__historyNote mesh__D014441
% 219.35/219.54       91%28%75%29%; was see under IODOBENZENES 1975-90   
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D014441 2005
% 219.35/219.54  |- mesh__dateRevised mesh__D014441 2000-06-22
% 219.35/219.54  |- skos__altLabel mesh__D014441 Tyropanoate Sodium
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D014441 2004
% 219.35/219.54  |- skos__scopeNote mesh__D014441
% 219.35/219.54       A diagnostic aid as a radiopaque medium in cholecystography.%A%    
% 219.35/219.54  |- skos__hiddenLabel mesh__D014441 Sodium, Tyropanoate
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D014441 2002
% 219.35/219.54  |- skos__hiddenLabel mesh__D014441 WIN 88512
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D014441 2006
% 219.35/219.54  |- mesh__dateEstablished mesh__D014441 1991-01-01
% 219.35/219.54  |- mesh__dateCreated mesh__D014441 1974-11-19
% 219.35/219.54  |- mesh__recordMaintainer mesh__D014441 CCR
% 219.35/219.54  |- skos__broader mesh__D014441smesh__D007462
% 219.35/219.54  |- skos__hiddenLabel mesh__D014441 Tyropanoate, Sodium
% 219.35/219.54  |- skos__annotation mesh__D014441 D25-26 qualif   
% 219.35/219.54  |- skos__historyNote mesh__D014441 Iodobenzoates %28%1974%29%
% 219.35/219.54  |- skos__hiddenLabel mesh__D014441 WIN88512
% 219.35/219.54  |- skos__prefLabel mesh__D014441 Tyropanoate
% 219.35/219.54  |- skos__historyNote mesh__D014441 Butyrates %28%1974%29%
% 219.35/219.54  |- skos__prefLabel mesh__D008404 Massachusetts
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D008404 2002
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D008404 1999
% 219.35/219.54  |- skos__broader mesh__D008404smesh__D009511
% 219.35/219.54  |- skos__annotation mesh__D008404 BOSTON is also available   
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D008404 2006
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D008404 1998
% 219.35/219.54  |- mesh__recordOriginator mesh__D008404 NLM
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D008404 2004
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D008404 2005
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D008404 2001
% 219.35/219.54  |- mesh__recordAuthorizer mesh__D008404 SJN
% 219.35/219.54  |- rdf__type mesh__D008404sskos__Concept
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D008404 2003
% 219.35/219.54  |- mesh__dateCreated mesh__D008404 1999-01-01
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D008404 2000
% 219.35/219.54  |- mesh__dateRevised mesh__D008404 1997-06-20
% 219.35/219.54  |- mesh__recordMaintainer mesh__D008404 PXP
% 219.35/219.54  |- mesh__historyNote mesh__D000421 1976 %28%1963%29%   
% 219.35/219.54  |- skos__scopeNote mesh__D000421
% 219.35/219.54       A genus of gram-negative, aerobic, motile bacteria that occur in water and soil. Some are common inhabitants of the intestinal tract of vertebrates. These bacteria occasionally cause opportunistic infections in humans.%A%    
% 219.35/219.54  |- mesh__dateRevised mesh__D000421 2005-07-01
% 219.35/219.54  |- mesh__recordOriginator mesh__D000421 NLM
% 219.35/219.54  |- skos__broader mesh__D000421smesh__D042401
% 219.35/219.54  |- mesh__dateCreated mesh__D000421 1999-01-01
% 219.35/219.54  |- mesh__publicMeSHNote mesh__D000421 1976; see ACHROMOBACTER 1963-1975   
% 219.35/219.54  |- mesh__recordMaintainer mesh__D000421 sjn
% 219.35/219.54  |- skos__annotation mesh__D000421
% 219.35/219.54       ALCALIGENES EUTROPHA see WAUTERSIA EUTROPHA is available; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 219.35/219.54  |- mesh__recordAuthorizer mesh__D000421 sjn
% 219.35/219.54  |- skos__prefLabel mesh__D000421 Alcaligenes
% 219.35/219.54  |- rdf__type mesh__D000421sskos__Concept
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D000421 2006
% 219.35/219.54  |- skos__prefLabel mesh__D013349 Subclavian Steal Syndrome
% 219.35/219.54  |- skos__hiddenLabel mesh__D013349 Artery Stenosis, Subclavian
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D013349 2004
% 219.35/219.54  |- skos__hiddenLabel mesh__D013349 Insufficiency Syndrome, Brachial-Basilar
% 219.35/219.54  |- skos__hiddenLabel mesh__D013349
% 219.35/219.54       Syndromes, Brachial-Basilar Insufficiency
% 219.35/219.54  |- mesh__historyNote mesh__D013349 1965%28%1964%29%   
% 219.35/219.54  |- skos__hiddenLabel mesh__D013349 Stenosis, Subclavian Artery
% 219.35/219.54  |- skos__hiddenLabel mesh__D013349 Steal Syndrome, Basilar
% 219.35/219.54  |- skos__altLabel mesh__D013349 Basilar Steal Syndrome
% 219.35/219.54  |- rdf__type mesh__D013349sskos__Concept
% 219.35/219.54  |- skos__hiddenLabel mesh__D013349 Steal, Subclavian
% 219.35/219.54  |- mesh__dateRevised mesh__D013349 2002-07-02
% 219.35/219.54  |- skos__hiddenLabel mesh__D013349 Syndrome, Brachial-Basilar Insufficiency
% 219.35/219.54  |- skos__altLabel mesh__D013349 Brachial-Basilar Insufficiency Syndrome
% 219.35/219.54  |- skos__broader mesh__D013349smesh__D014715
% 219.35/219.54  |- skos__hiddenLabel mesh__D013349 Steal Syndromes, Subclavian
% 219.35/219.54  |- skos__hiddenLabel mesh__D013349 Artery Stenoses, Subclavian
% 219.35/219.54  |- mesh__recordOriginator mesh__D013349 NLM
% 219.35/219.54  |- skos__hiddenLabel mesh__D013349 Steal Syndromes, Basilar
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D013349 2003
% 219.35/219.54  |- mesh__publicMeSHNote mesh__D013349 1965   
% 219.35/219.54  |- mesh__dateEstablished mesh__D013349 1965-01-01
% 219.35/219.54  |- skos__hiddenLabel mesh__D013349
% 219.35/219.54       Insufficiency Syndromes, Brachial-Basilar
% 219.35/219.54  |- skos__hiddenLabel mesh__D013349 Phenomenon, Subclavian Steal
% 219.35/219.54  |- skos__hiddenLabel mesh__D013349 Stenoses, Subclavian Artery
% 219.35/219.54  |- skos__scopeNote mesh__D013349
% 219.35/219.54       A clinically significant reduction in blood supply to the BRAIN STEM and CEREBELLUM %28%i.e., VERTEBROBASILAR INSUFFICIENCY%29% resulting from reversal of blood flow through the VERTEBRAL ARTERY from occlusion or stenosis of the proximal subclavian or brachiocephalic artery. Common symptoms include VERTIGO; SYNCOPE; and INTERMITTENT CLAUDICATION of the involved upper extremity. Subclavian steal may also occur in asymptomatic individuals. %28%From J Cardiovasc Surg 1994;35%28%1%29%:11-4; Acta Neurol Scand 1994;90%28%3%29%:174-8%29%%A%    
% 219.35/219.54  |- skos__hiddenLabel mesh__D013349 Basilar Steal Syndromes
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D013349 2006
% 219.35/219.54  |- skos__hiddenLabel mesh__D013349 Steal Syndrome, Subclavian
% 219.35/219.54  |- skos__hiddenLabel mesh__D013349 Subclavian Artery Stenoses
% 219.35/219.54  |- skos__altLabel mesh__D013349 Subclavian Artery Stenosis
% 219.35/219.54  |- mesh__recordMaintainer mesh__D013349 lkt
% 219.35/219.54  |- mesh__dateCreated mesh__D013349 1999-01-01
% 219.35/219.54  |- skos__hiddenLabel mesh__D013349 Subclavian Carotid Artery Steal Syndrome
% 219.35/219.54  |- skos__hiddenLabel mesh__D013349 Brachial Basilar Insufficiency Syndrome
% 219.35/219.54  |- skos__hiddenLabel mesh__D013349 Subclavian Steal Syndromes
% 219.35/219.54  |- skos__hiddenLabel mesh__D013349 Steal Phenomenon, Subclavian
% 219.35/219.54  |- mesh__recordAuthorizer mesh__D013349 sjn
% 219.35/219.54  |- skos__hiddenLabel mesh__D013349 Brachial-Basilar Insufficiency Syndromes
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D013349 2005
% 219.35/219.54  |- skos__altLabel mesh__D013349 Subclavian Steal Phenomenon
% 219.35/219.54  |- mesh__dateEstablished mesh__D018832 1995-01-01
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D018832 2006
% 219.35/219.54  |- mesh__recordAuthorizer mesh__D018832 sjn
% 219.35/219.54  |- skos__historyNote mesh__D018832 Proteins %28%1987-1994%29%
% 219.35/219.54  |- skos__related mesh__D018832smesh__D006360
% 219.35/219.54  |- skos__historyNote mesh__D018832 Heat-Shock Proteins %28%1987-1994%29%
% 219.35/219.54  |- rdf__type mesh__D018832sskos__Concept
% 219.35/219.54  |- skos__scopeNote mesh__D018832
% 219.35/219.54       A family of cellular proteins that mediate the correct assembly or disassembly of other polypeptides, and in some cases their assembly into oligomeric structures, but which are not components of those final structures. It is believed that chaperone proteins assist polypeptides to self-assemble by inhibiting alternative assembly pathways that produce nonfunctional structures. Some classes of molecular chaperones are the nucleoplasmins, the CHAPERONINS, the HEAT-SHOCK PROTEINS 70, and the HSP90 HEAT-SHOCK PROTEINS.%A%    
% 219.35/219.54  |- mesh__recordMaintainer mesh__D018832 sjn
% 219.35/219.54  |- skos__broader mesh__D018832smesh__D011506
% 219.35/219.54  |- mesh__dateRevised mesh__D018832 2005-07-01
% 219.35/219.54  |- skos__prefLabel mesh__D018832 Molecular Chaperones
% 219.35/219.54  |- mesh__publicMeSHNote mesh__D018832 95   
% 219.35/219.54  |- skos__altLabel mesh__D018832 Chaperone, Molecular
% 219.35/219.54  |- skos__altLabel mesh__D018832 Chaperones, Molecular
% 219.35/219.54  |- skos__annotation mesh__D018832
% 219.35/219.54       a class of proteins; GEN or unspecified; prefer specifics; DF: MOL CHAPERONES%A%  
% 219.35/219.54  |- mesh__historyNote mesh__D018832 95   
% 219.35/219.54  |- mesh__dateCreated mesh__D018832 1994-05-31
% 219.35/219.54  |- skos__altLabel mesh__D018832 Molecular Chaperone
% 219.35/219.54  |- mesh__recordOriginator mesh__D018832 PXP
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D032503 2004
% 219.35/219.54  |- mesh__recordAuthorizer mesh__D032503 jls
% 219.35/219.54  |- mesh__dateCreated mesh__D032503 2002-07-03
% 219.35/219.54  |- skos__prefLabel mesh__D032503 Selaginellaceae
% 219.35/219.54  |- mesh__dateRevised mesh__D032503 2004-08-02
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D032503 2006
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D032503 2003
% 219.35/219.54  |- mesh__historyNote mesh__D032503 2003   
% 219.35/219.54  |- skos__altLabel mesh__D032503 Moss, Spike
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D032503 2005
% 219.35/219.54  |- rdf__type mesh__D032503sskos__Concept
% 219.35/219.54  |- mesh__dateEstablished mesh__D032503 2003-01-01
% 219.35/219.54  |- skos__altLabel mesh__D032503 Spikemoss
% 219.35/219.54  |- mesh__recordOriginator mesh__D032503 ssb
% 219.35/219.54  |- mesh__recordMaintainer mesh__D032503 jls
% 219.35/219.54  |- skos__altLabel mesh__D032503 Fern, Rainbow
% 219.35/219.54  |- skos__broader mesh__D032503smesh__D019669
% 219.35/219.54  |- skos__annotation mesh__D032503
% 219.35/219.54       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.35/219.54  |- mesh__publicMeSHNote mesh__D032503 2003   
% 219.35/219.54  |- skos__scopeNote mesh__D032503
% 219.35/219.54       A plant family of the order Selaginellales, class Lycopodiopsida, division Lycopodiophyta, subkingdom Tracheobionta. Members contain bilobetin. The rarely used common name of resurrection plant is mainly used with CRATEROSTIGMA.%A%    
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D032503 2005A
% 219.35/219.54  |- mesh__dateEstablished mesh__D018034 1994-01-01
% 219.35/219.54  |- skos__historyNote mesh__D018034 Olfactory Mucosa %28%1972-1993%29%
% 219.35/219.54  |- skos__prefLabel mesh__D018034 Olfactory Receptor Neurons
% 219.35/219.54  |- mesh__dateRevised mesh__D018034 2005-06-30
% 219.35/219.54  |- skos__broader mesh__D018034smesh__D002628
% 219.35/219.54  |- skos__hiddenLabel mesh__D018034 Olfactory Receptor Neuron
% 219.35/219.54  |- skos__altLabel mesh__D018034 Neurons, Olfactory Receptor
% 219.35/219.54  |- mesh__historyNote mesh__D018034 94   
% 219.35/219.54  |- mesh__recordMaintainer mesh__D018034 lkt
% 219.35/219.54  |- mesh__activeMeSHYear mesh__D018034 2006
% 219.35/219.54  |- mesh__recordOriginator mesh__D018034 RAZ
% 219.35/219.54  |- skos__related mesh__D018034smesh__D018035
% 219.35/219.54  |- skos__annotation mesh__D018034 DF: OLFACTORY RECEPT NEURONS   
% 219.35/219.54  |- skos__hiddenLabel mesh__D018034 Receptor Neuron, Olfactory
% 219.35/219.54  |- skos__scopeNote mesh__D018034
% 219.35/219.54       Neurons in the OLFACTORY EPITHELIUM with proteins %28%RECEPTORS, ODORANT%29% that bind, and thus detect, odorants. These neurons send their DENDRITES to the surface of the epithelium with the odorant receptors residing in the apical non-motile cilia. Their unmyelinated AXONS synapse in the OLFACTORY BULB of the BRAIN.%A%    
% 219.35/219.54  |- rdf__type mesh__D018034sskos__Concept
% 219.35/219.54  |- skos__historyNote mesh__D018034 Nasal Mucosa %28%1966-1971%29%
% 219.35/219.54  |- skos__historyNote mesh__D018034 Receptors, Sensory %28%1966-1993%29%
% 219.35/219.55  |- mesh__recordAuthorizer mesh__D018034 sjn
% 219.35/219.55  |- mesh__dateCreated mesh__D018034 1993-06-28
% 219.35/219.55  |- skos__broader mesh__D018034smesh__D009475
% 219.35/219.55  |- mesh__publicMeSHNote mesh__D018034 94   
% 219.35/219.55  |- skos__broader mesh__D018034smesh__D009831
% 219.35/219.55  |- skos__hiddenLabel mesh__D018034 Neuron, Olfactory Receptor
% 219.35/219.55  |- skos__hiddenLabel mesh__D018034 Receptor Neurons, Olfactory
% 219.35/219.55  |- skos__related mesh__D010051smesh__D011553
% 219.35/219.55  |- skos__altLabel mesh__D010051 Cancer of Ovary
% 219.35/219.55  |- skos__broader mesh__D010051smesh__D004701
% 219.35/219.55  |- skos__hiddenLabel mesh__D010051 Cancers, Ovarian
% 219.35/219.55  |- skos__scopeNote mesh__D010051
% 219.35/219.55       Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.%A%    
% 219.35/219.55  |- skos__hiddenLabel mesh__D010051 Ovarian Cancers
% 219.35/219.55  |- skos__hiddenLabel mesh__D010051 Neoplasm, Ovary
% 219.35/219.55  |- skos__hiddenLabel mesh__D010051 Neoplasm, Ovarian
% 219.35/219.55  |- skos__hiddenLabel mesh__D010051 Cancer, Ovarian
% 219.35/219.55  |- skos__annotation mesh__D010051
% 219.35/219.55       coordinate IM with histologic type of neoplasm %28%IM%29%   
% 219.35/219.55  |- mesh__recordOriginator mesh__D010051 NLM
% 219.35/219.55  |- skos__prefLabel mesh__D010051 Ovarian Neoplasms
% 219.35/219.55  |- skos__altLabel mesh__D010051 Cancer of the Ovary
% 219.35/219.55  |- mesh__dateCreated mesh__D010051 1999-01-01
% 219.35/219.55  |- mesh__dateRevised mesh__D010051 2005-06-30
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D010051 2006
% 219.35/219.55  |- skos__hiddenLabel mesh__D010051 Neoplasms, Ovary
% 219.35/219.55  |- skos__hiddenLabel mesh__D010051 Ovarian Neoplasm
% 219.35/219.55  |- mesh__recordMaintainer mesh__D010051 lkt
% 219.35/219.55  |- skos__related mesh__D010051smesh__D007725
% 219.35/219.55  |- skos__hiddenLabel mesh__D010051 Cancer, Ovary
% 219.35/219.55  |- skos__altLabel mesh__D010051 Ovarian Cancer
% 219.35/219.55  |- skos__hiddenLabel mesh__D010051 Ovary Cancers
% 219.35/219.55  |- skos__broader mesh__D010051smesh__D010049
% 219.35/219.55  |- skos__hiddenLabel mesh__D010051 Cancers, Ovary
% 219.35/219.55  |- rdf__type mesh__D010051sskos__Concept
% 219.35/219.55  |- skos__hiddenLabel mesh__D010051 Ovary Neoplasm
% 219.35/219.55  |- skos__altLabel mesh__D010051 Ovary Neoplasms
% 219.35/219.55  |- skos__altLabel mesh__D010051 Neoplasms, Ovarian
% 219.35/219.55  |- mesh__recordAuthorizer mesh__D010051 sjn
% 219.35/219.55  |- skos__broader mesh__D010051smesh__D005833
% 219.35/219.55  |- skos__hiddenLabel mesh__D004812 Methods, Epidemiological
% 219.35/219.55  |- rdf__type mesh__D004812sskos__Concept
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004812 2005
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004812 1998
% 219.35/219.55  |- skos__altLabel mesh__D004812 Epidemiologic Method
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004812 2001
% 219.35/219.55  |- skos__altLabel mesh__D004812 Epidemiological Methods
% 219.35/219.55  |- mesh__historyNote mesh__D004812 67%28%65%29%   
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004812 2004
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004812 2000
% 219.35/219.55  |- mesh__recordMaintainer mesh__D004812 TGC
% 219.35/219.55  |- mesh__recordOriginator mesh__D004812 NLM
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004812 2003
% 219.35/219.55  |- skos__broader mesh__D004812smesh__D008919
% 219.35/219.55  |- mesh__onlineNote mesh__D004812
% 219.35/219.55       pre-explosion = EPIDEMIOLOGIC METHODS %28%PX%29%   
% 219.35/219.55  |- skos__prefLabel mesh__D004812 Epidemiologic Methods
% 219.35/219.55  |- skos__broader mesh__D004812smesh__D011634
% 219.35/219.55  |- skos__altLabel mesh__D004812 Methods, Epidemiologic
% 219.35/219.55  |- skos__annotation mesh__D004812
% 219.35/219.55       IM GEN only; coord NIM with disease /epidemiol %28%IM%29%; specify geog if pertinent; DF: EPIDEMIOL METHODS%A%  
% 219.35/219.55  |- mesh__dateCreated mesh__D004812 1999-01-01
% 219.35/219.55  |- mesh__recordAuthorizer mesh__D004812 SJN
% 219.35/219.55  |- skos__hiddenLabel mesh__D004812 Method, Epidemiologic
% 219.35/219.55  |- mesh__dateEstablished mesh__D004812 1967-01-01
% 219.35/219.55  |- mesh__dateRevised mesh__D004812 1997-06-20
% 219.35/219.55  |- skos__hiddenLabel mesh__D004812 Epidemiological Method
% 219.35/219.55  |- skos__hiddenLabel mesh__D004812 Method, Epidemiological
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004812 2006
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004812 1999
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004812 2002
% 219.35/219.55  |- mesh__publicMeSHNote mesh__D004812 67   
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004014 2005
% 219.35/219.55  |- skos__prefLabel mesh__D004014 Dictionaries
% 219.35/219.55  |- mesh__dateRevised mesh__D004014 1999-12-01
% 219.35/219.55  |- rdf__type mesh__D004014sskos__Concept
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004014 2000
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004014 2003
% 219.35/219.55  |- skos__broader mesh__D004014smesh__D012013
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004014 2006
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004014 2001
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004014 2004
% 219.35/219.55  |- mesh__recordMaintainer mesh__D004014 ags
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004014 2002
% 219.35/219.55  |- mesh__recordAuthorizer mesh__D004014 ags
% 219.35/219.55  |- mesh__dateCreated mesh__D004014 1999-01-01
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004014 2000A
% 219.35/219.55  |- skos__annotation mesh__D004014
% 219.35/219.55       IM for dictionaries as a subject; do not confuse with Publication Type DICTIONARY; for articles listing terms %26% definitions in a specific subject or field, index under specific subject %28%IM%29% + DICTIONARY %28%PT%29%; no qualif; policy %26% relation to lang: Manual 33.14%A%  
% 219.35/219.55  |- mesh__recordOriginator mesh__D004014 NLM
% 219.35/219.55  |- mesh__dateEstablished mesh__D042931 2004-01-01
% 219.35/219.55  |- skos__broader mesh__D042931smesh__D000445
% 219.35/219.55  |- skos__prefLabel mesh__D042931 Aldehyde Oxidase
% 219.35/219.55  |- skos__hiddenLabel mesh__D042931 Oxidase, Aldehyde
% 219.35/219.55  |- mesh__recordOriginator mesh__D042931 AKE
% 219.35/219.55  |- mesh__historyNote mesh__D042931
% 219.35/219.55       2004; use ALDEHYDE OXIDASE %28%NM%29% 1980-2003   
% 219.35/219.55  |- mesh__recordAuthorizer mesh__D042931 sjn
% 219.35/219.55  |- mesh__recordMaintainer mesh__D042931 jmp
% 219.35/219.55  |- skos__scopeNote mesh__D042931
% 219.35/219.55       An aldehyde oxidoreductase expressed predominantly in the LIVER; LUNGS; and KIDNEY. It catalyzes the oxidation of a variety of organic aldehydes and N-heterocyclic compounds to CARBOXYLIC ACIDS, and also oxidizes QUINOLINE and PYRIDINE derivatives. The enzyme utilizes molybdenum cofactor and FAD as cofactors.%A%    
% 219.35/219.55  |- mesh__dateCreated mesh__D042931 2003-07-09
% 219.35/219.55  |- rdf__type mesh__D042931sskos__Concept
% 219.35/219.55  |- mesh__publicMeSHNote mesh__D042931
% 219.35/219.55       2004; ALDEHYDE OXIDASE was indexed under ALDEHYDE OXIDOREDUCTASES 1979-2003%A%  
% 219.35/219.55  |- skos__historyNote mesh__D042931 Oxidoreductases %28%1979-2003%29%
% 219.35/219.55  |- mesh__dateRevised mesh__D042931 2005-06-30
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D042931 2006
% 219.35/219.55  |- skos__broader mesh__D028462smesh__D019662
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D028462 2006A
% 219.35/219.55  |- skos__scopeNote mesh__D028462
% 219.35/219.55       A plant genus of the family CUCURBITACEAE, order Violales, subclass Dilleniidae best known for cucumber %28%CUCUMIS SATIVUS%29% and cantaloupe %28%CUCUMIS MELO%29%.  Watermelon is a different genus, CITRULLUS. Bitter melon may refer to MOMORDICA or this genus.%A%    
% 219.35/219.55  |- mesh__dateEstablished mesh__D028462 2002-01-01
% 219.35/219.55  |- skos__prefLabel mesh__D028462 Cucumis
% 219.35/219.55  |- mesh__dateCreated mesh__D028462 2001-07-25
% 219.35/219.55  |- mesh__recordOriginator mesh__D028462 ssb
% 219.35/219.55  |- skos__historyNote mesh__D028462 Cucurbitaceae %28%1996-2001%29%
% 219.35/219.55  |- mesh__dateRevised mesh__D028462 2005-07-12
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D028462 2005
% 219.35/219.55  |- mesh__publicMeSHNote mesh__D028462 2002; see CUCURBITACEAE 1996-2001   
% 219.35/219.55  |- rdf__type mesh__D028462sskos__Concept
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D028462 2006
% 219.35/219.55  |- mesh__recordMaintainer mesh__D028462 ags
% 219.35/219.55  |- mesh__recordAuthorizer mesh__D028462 ags
% 219.35/219.55  |- skos__annotation mesh__D028462
% 219.35/219.55       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.35/219.55  |- mesh__historyNote mesh__D028462 2002; use CUCURBITACEAE 1996-2001   
% 219.35/219.55  |- skos__broader mesh__D005704Q000530smesh__D005704
% 219.35/219.55  |- mesh__preferredCombination mesh__D005704Q000530smesh__D002765
% 219.35/219.55  |- rdf__type mesh__D005704Q000530smesh__CompoundConcept
% 219.35/219.55  |- skos__broader mesh__D014442smesh__D004156
% 219.35/219.55  |- skos__historyNote mesh__D014442 Diphenol Oxidases %28%1968-1976%29%
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D014442 2005
% 219.35/219.55  |- mesh__publicMeSHNote mesh__D014442
% 219.35/219.55       92; was TYROSINASE 1977-91 %28%see under DIPHENOL OXIDASES 1977-90%29%; TYROSINASE was see DIPHENOL OXIDASES 1975-76, see under DIPHENOL OXIDASES 1968-74 %26% see TYROSINE DECARBOXYLASE 1963-67; DOPA OXIDASE was heading 1991, was see under DIPHENOL OXIDASES 1968-72 %26% 1975-90, was see under TYROSINE DECARBOXYLASE 1963-67%A%  
% 219.35/219.55  |- skos__altLabel mesh__D014442 Phenol Oxidase
% 219.35/219.55  |- skos__altLabel mesh__D014442 Tyrosinase
% 219.35/219.55  |- skos__hiddenLabel mesh__D014442 Oxidase, Dopa
% 219.35/219.55  |- mesh__dateCreated mesh__D014442 1976-04-19
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D014442 2006
% 219.35/219.55  |- mesh__dateEstablished mesh__D014442 1991-01-01
% 219.35/219.55  |- skos__related mesh__D014442smesh__D000417
% 219.35/219.55  |- mesh__recordMaintainer mesh__D014442 ssb
% 219.35/219.55  |- mesh__recordAuthorizer mesh__D014442 sjn
% 219.35/219.55  |- skos__historyNote mesh__D014442 Tyrosine Decarboxylase %28%1966-1967%29%
% 219.35/219.55  |- skos__annotation mesh__D014442 /defic: consider also ALBINISM   
% 219.35/219.55  |- skos__hiddenLabel mesh__D014442 Oxidase, Phenol
% 219.35/219.55  |- skos__altLabel mesh__D014442 Phenoloxidase
% 219.35/219.55  |- skos__altLabel mesh__D014442 Cresolase
% 219.35/219.55  |- mesh__recordOriginator mesh__D014442 RLS
% 219.35/219.55  |- skos__hiddenLabel mesh__D014442 Monooxygenase, Monophenol
% 219.35/219.55  |- skos__scopeNote mesh__D014442
% 219.35/219.55       An enzyme of the oxidoreductase class that catalyzes the reaction between L-tyrosine, L-dopa, and oxygen to yield L-dopa, dopaquinone, and water. It is a copper protein that acts also on catechols, catalyzing some of the same reactions as CATECHOL OXIDASE. EC 1.14.18.1.%A%    
% 219.35/219.55  |- mesh__dateRevised mesh__D014442 2004-07-07
% 219.35/219.55  |- skos__altLabel mesh__D014442 Dopa Oxidase
% 219.35/219.55  |- rdf__type mesh__D014442sskos__Concept
% 219.35/219.55  |- mesh__onlineNote mesh__D014442
% 219.35/219.55       use MONOPHENOL MONOOXYGENASE to search TYROSINASE 1977-91, use CATECHOL OXIDASE 1968-76 %26% use TYROSINE DECARBOXYLASE 1966-67; use CATECHOL OXIDASE to search DOPA OXIDASE 1968-75 %28%as Prov 1973-74%29%, use TYROSINE DECARBOXYLASE 1963-67%A%  
% 219.35/219.55  |- mesh__historyNote mesh__D014442
% 219.35/219.55       92; was TYROSINASE 1977-91 %28%see under DIPHENOL OXIDASES 1977-90%29%; TYROSINASE was see DIPHENOL OXIDASES 1975-76, see under DIPHENOL OXIDASES 1968-74 %26% see TYROSINE DECARBOXYLASE 1963-67; DOPA OXIDASE was heading 1973-91 %28%see under DIPHENOL OXIDASES 1968-90 %28%Prov 1973-74%29%%29%, was see under TYROSINE DECARBOXYLASE 1963-67%A%  
% 219.35/219.55  |- skos__prefLabel mesh__D014442 Monophenol Monooxygenase
% 219.35/219.55  |- mesh__recordMaintainer mesh__D008405 lkt
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D008405 2006
% 219.35/219.55  |- skos__broader mesh__D008405smesh__D026201
% 219.35/219.55  |- skos__prefLabel mesh__D008405 Massage
% 219.35/219.55  |- mesh__recordAuthorizer mesh__D008405 sjn
% 219.35/219.55  |- rdf__type mesh__D008405sskos__Concept
% 219.35/219.55  |- skos__altLabel mesh__D008405 Therapy, Zone
% 219.35/219.55  |- mesh__dateCreated mesh__D008405 1999-01-01
% 219.35/219.55  |- mesh__recordOriginator mesh__D008405 NLM
% 219.35/219.55  |- skos__scopeNote mesh__D008405
% 219.35/219.55       Group of systematic and scientific manipulations of body tissues best performed with the hands for the purpose of affecting the nervous and muscular systems and the general circulation.%A%    
% 219.35/219.55  |- skos__annotation mesh__D008405
% 219.35/219.55       do not confuse X ref REFLEXOLOGY with REFLEXOTHERAPY; do not confuse with THERAPEUTIC TOUCH;%A%  
% 219.35/219.55  |- skos__hiddenLabel mesh__D008405 Massage, Craniosacral
% 219.35/219.55  |- mesh__dateRevised mesh__D008405 2005-06-30
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D000422 2006
% 219.35/219.55  |- skos__hiddenLabel mesh__D000422 Alchemies
% 219.35/219.55  |- mesh__recordOriginator mesh__D000422 NLM
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D000422 2005
% 219.35/219.55  |- mesh__dateCreated mesh__D000422 1999-01-01
% 219.35/219.55  |- mesh__recordMaintainer mesh__D000422 jls
% 219.35/219.55  |- skos__annotation mesh__D000422 no qualif   
% 219.35/219.55  |- mesh__recordAuthorizer mesh__D000422 sjn
% 219.35/219.55  |- mesh__dateRevised mesh__D000422 2004-07-07
% 219.35/219.55  |- skos__broader mesh__D000422smesh__D006664
% 219.35/219.55  |- skos__prefLabel mesh__D000422 Alchemy
% 219.35/219.55  |- rdf__type mesh__D000422sskos__Concept
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D018833 2006
% 219.35/219.55  |- skos__historyNote mesh__D018833 Proteins %28%1989-1994%29%
% 219.35/219.55  |- skos__scopeNote mesh__D018833
% 219.35/219.55       A class of sequence-related MOLECULAR CHAPERONES found in bacteria, mitochondria, and plastids. Chaperonins are abundant constitutive proteins that increase in amount after stresses such as heat shock, bacterial infection of macrophages, and an increase in the cellular content of unfolded proteins. Bacterial chaperonins are major immunogens in human bacterial infections because of their accumulation during the stress of infection. Two members of this class of chaperones are CHAPERONIN 10 and CHAPERONIN 60.%A%    
% 219.35/219.55  |- mesh__publicMeSHNote mesh__D018833
% 219.35/219.55       95; CHAPERONIN FAMILY was indexed under PROTEINS 1989-94   
% 219.35/219.55  |- skos__annotation mesh__D018833
% 219.35/219.55       a class of molecular chaperones; GEN or unspecified; prefer specifics%A%  
% 219.35/219.55  |- mesh__onlineNote mesh__D018833
% 219.35/219.55       use CHAPERONINS %28%NM%29% to search CHAPERONIN FAMILY 1989-94   
% 219.35/219.55  |- mesh__recordMaintainer mesh__D018833 SYSTEM
% 219.35/219.55  |- skos__broader mesh__D018833smesh__D018832
% 219.35/219.55  |- mesh__recordOriginator mesh__D018833 PXP
% 219.35/219.55  |- rdf__type mesh__D018833sskos__Concept
% 219.35/219.55  |- mesh__recordAuthorizer mesh__D018833 sjn
% 219.35/219.55  |- mesh__dateRevised mesh__D018833 2005-06-30
% 219.35/219.55  |- skos__prefLabel mesh__D018833 Chaperonins
% 219.35/219.55  |- mesh__dateEstablished mesh__D018833 1995-01-01
% 219.35/219.55  |- mesh__historyNote mesh__D018833
% 219.35/219.55       95; was CHAPERONIN FAMILY %28%NM%29% 1989-94   
% 219.35/219.55  |- skos__hiddenLabel mesh__D018833 Family, Chaperonin
% 219.35/219.55  |- skos__altLabel mesh__D018833 Chaperonin Family
% 219.35/219.55  |- skos__historyNote mesh__D018833 Heat-Shock Proteins %28%1989-1994%29%
% 219.35/219.55  |- mesh__dateCreated mesh__D018833 1994-05-31
% 219.35/219.55  |- skos__broader mesh__D018833smesh__D006360
% 219.35/219.55  |- skos__historyNote mesh__D010850 Virus Diseases %28%1966-1979%29%
% 219.35/219.55  |- mesh__recordAuthorizer mesh__D010850 PLS
% 219.35/219.55  |- skos__broader mesh__D010850smesh__D012327
% 219.35/219.55  |- mesh__dateCreated mesh__D010850 1999-01-01
% 219.35/219.55  |- skos__annotation mesh__D010850 GEN or unspecified; prefer specifics   
% 219.35/219.55  |- rdf__type mesh__D010850sskos__Concept
% 219.35/219.55  |- mesh__historyNote mesh__D010850
% 219.35/219.55       94; was PICORNAVIRUS INFECTIONS 1980-93; was PICORNAVIRUS INFECTIONS %28%NON MESH%29% before 1980%A%  
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D010850 1994
% 219.35/219.55  |- skos__hiddenLabel mesh__D010850 Picornaviridae Infection
% 219.35/219.55  |- skos__altLabel mesh__D010850 Infections, Picornaviridae
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D010850 2000
% 219.35/219.55  |- mesh__dateRevised mesh__D010850 1993-06-04
% 219.35/219.55  |- mesh__recordMaintainer mesh__D010850 AGS
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D010850 1998
% 219.35/219.55  |- skos__altLabel mesh__D010850 Picornavirus Infections
% 219.35/219.55  |- skos__hiddenLabel mesh__D010850 Picornavirus Infection
% 219.35/219.55  |- mesh__recordOriginator mesh__D010850 NLM
% 219.35/219.55  |- mesh__onlineNote mesh__D010850
% 219.35/219.55       use PICORNAVIRIDAE INFECTIONS to search PICORNAVIRUS INFECTIONS 1980-93%A%  
% 219.35/219.55  |- skos__hiddenLabel mesh__D010850 Infection, Picornaviridae
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D010850 1995
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D010850 1996
% 219.35/219.55  |- skos__prefLabel mesh__D010850 Picornaviridae Infections
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D010850 2005
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D010850 2001
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D010850 2003
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D010850 1999
% 219.35/219.55  |- skos__historyNote mesh__D010850 Picornaviridae %28%1966-1979%29%
% 219.35/219.55  |- mesh__publicMeSHNote mesh__D010850
% 219.35/219.55       94; was PICORNAVIRUS INFECTIONS 1980-93   
% 219.35/219.55  |- skos__scopeNote mesh__D010850
% 219.35/219.55       Virus diseases caused by the PICORNAVIRIDAE.     
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D010850 1997
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D010850 2006
% 219.35/219.55  |- skos__hiddenLabel mesh__D010850 Infection, Picornavirus
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D010850 2002
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D010850 2004
% 219.35/219.55  |- mesh__dateEstablished mesh__D010850 1980-01-01
% 219.35/219.55  |- skos__altLabel mesh__D010850 Infections, Picornavirus
% 219.35/219.55  |- skos__hiddenLabel mesh__D018035 Receptor, Odorant
% 219.35/219.55  |- skos__altLabel mesh__D018035 Odorant Receptor
% 219.35/219.55  |- mesh__recordAuthorizer mesh__D018035 sjn
% 219.35/219.55  |- mesh__publicMeSHNote mesh__D018035
% 219.35/219.55       94; ODORANT RECEPTOR was indexed under CARRIER PROTEINS 1993%A%  
% 219.35/219.55  |- rdf__type mesh__D018035sskos__Concept
% 219.35/219.55  |- skos__broader mesh__D018035smesh__D043562
% 219.35/219.55  |- mesh__dateEstablished mesh__D018035 1994-01-01
% 219.35/219.55  |- skos__annotation mesh__D018035
% 219.35/219.55       receptors on cilia of olfactory receptor neurons; DF: RECEPT ODORANT%A%  
% 219.35/219.55  |- skos__hiddenLabel mesh__D018035 Odorant Receptor Proteins
% 219.35/219.55  |- mesh__dateCreated mesh__D018035 1993-06-28
% 219.35/219.55  |- skos__altLabel mesh__D018035 Olfactory Receptor Proteins
% 219.35/219.55  |- skos__broader mesh__D018035smesh__D011956
% 219.35/219.55  |- mesh__dateRevised mesh__D018035 2005-06-30
% 219.35/219.55  |- skos__scopeNote mesh__D018035
% 219.35/219.55       Proteins, usually projecting from the cilia of olfactory receptor neurons, that specifically bind odorant molecules and trigger responses in the neurons. The large number of different odorant receptors appears to arise from several gene families or subfamilies rather than from DNA rearrangement.%A%    
% 219.35/219.55  |- skos__hiddenLabel mesh__D018035 Proteins, Olfactory Receptor
% 219.35/219.55  |- mesh__recordMaintainer mesh__D018035 SYSTEM
% 219.35/219.55  |- skos__hiddenLabel mesh__D018035 Protein, Olfactory Receptor
% 219.35/219.55  |- skos__hiddenLabel mesh__D018035 Receptor Protein, Odor
% 219.35/219.55  |- skos__hiddenLabel mesh__D018035 Proteins, Odorant Receptor
% 219.35/219.55  |- skos__altLabel mesh__D018035 Receptor Proteins, Odorant
% 219.35/219.55  |- skos__hiddenLabel mesh__D018035 Protein, Odor Receptor
% 219.35/219.55  |- mesh__recordOriginator mesh__D018035 RAZ
% 219.35/219.55  |- skos__altLabel mesh__D018035 Odor Receptor Protein
% 219.35/219.55  |- skos__hiddenLabel mesh__D018035 Receptor Protein, Olfactory
% 219.35/219.55  |- skos__altLabel mesh__D018035 Olfactory Receptor Protein
% 219.35/219.55  |- skos__prefLabel mesh__D018035 Receptors, Odorant
% 219.35/219.55  |- skos__altLabel mesh__D018035 Odorant Receptors
% 219.35/219.55  |- skos__historyNote mesh__D018035 Membrane Proteins %28%1990-1993%29%
% 219.35/219.55  |- mesh__onlineNote mesh__D018035
% 219.35/219.55       use ODORANT-BINDING PROTEIN %28%NM%29% to search ODORANT RECEPTOR 1993%A%  
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D018035 2006
% 219.35/219.55  |- mesh__historyNote mesh__D018035
% 219.35/219.55       94; ODORANT RECEPTORS was ODORANT RECEPTOR %28%SY%29% to ODORANT-BINDING PROTEIN %28%NM%29% 1993%A%  
% 219.35/219.55  |- skos__altLabel mesh__D018035 Receptor Proteins, Olfactory
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D010052 2005
% 219.35/219.55  |- skos__altLabel mesh__D010052 Bilaterial Ovariectomy
% 219.35/219.55  |- skos__scopeNote mesh__D010052
% 219.35/219.55       The surgical removal of one or both ovaries.     
% 219.35/219.55  |- skos__hiddenLabel mesh__D010052 Ovariectomies
% 219.35/219.55  |- skos__hiddenLabel mesh__D010052 Bilaterial Ovariectomies
% 219.35/219.55  |- skos__altLabel mesh__D010052 Oophorectomy
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D010052 2004
% 219.35/219.55  |- skos__hiddenLabel mesh__D010052 Ovariectomy, Bilaterial
% 219.35/219.55  |- mesh__recordAuthorizer mesh__D010052 sjn
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D010052 2006
% 219.35/219.55  |- mesh__dateEstablished mesh__D010052 1986-01-01
% 219.35/219.55  |- mesh__dateCreated mesh__D010052 1985-06-07
% 219.35/219.55  |- skos__prefLabel mesh__D010052 Ovariectomy
% 219.35/219.55  |- mesh__dateRevised mesh__D010052 2000-06-22
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D010052 2001
% 219.35/219.55  |- skos__hiddenLabel mesh__D010052 Ovariectomies, Bilaterial
% 219.35/219.55  |- mesh__historyNote mesh__D010052 86   
% 219.35/219.55  |- skos__broader mesh__D010052smesh__D013509
% 219.35/219.55  |- skos__hiddenLabel mesh__D010052 Oophorectomies
% 219.35/219.55  |- skos__broader mesh__D010052smesh__D002369
% 219.35/219.55  |- mesh__recordOriginator mesh__D010052 SH
% 219.35/219.55  |- rdf__type mesh__D010052sskos__Concept
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D010052 2002
% 219.35/219.55  |- mesh__recordMaintainer mesh__D010052 ags
% 219.35/219.55  |- mesh__publicMeSHNote mesh__D010052 86   
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D010052 2003
% 219.35/219.55  |- skos__historyNote mesh__D010052 Castration %28%1966-1985%29%
% 219.35/219.55  |- skos__broader mesh__D004813smesh__D008511
% 219.35/219.55  |- skos__scopeNote mesh__D004813
% 219.35/219.55       Field of medicine concerned with the determination of causes, incidence, and characteristic behavior of disease outbreaks affecting human populations. It includes the interrelationships of host, agent, and environment as related to the distribution and control of disease.%A%    
% 219.35/219.55  |- skos__annotation mesh__D004813
% 219.35/219.55       SPEC only: SPEC qualif; prefer /epidemiol with diseases: Manual 19.7+, 19.8.31; do not confuse with TOPOGRAPHY, MEDICAL: epidemiol emphasizes disease outbreaks %26% disease-related conditions, topography emphasizes geography-related events; DF: EPIDEMIOL%A%  
% 219.35/219.55  |- mesh__recordAuthorizer mesh__D004813 sjn
% 219.35/219.55  |- mesh__dateCreated mesh__D004813 1999-01-01
% 219.35/219.55  |- mesh__dateRevised mesh__D004813 2004-07-13
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004813 2006
% 219.35/219.55  |- skos__prefLabel mesh__D004813 Epidemiology
% 219.35/219.55  |- rdf__type mesh__D004813sskos__Concept
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004813 2005
% 219.35/219.55  |- mesh__recordOriginator mesh__D004813 NLM
% 219.35/219.55  |- mesh__recordMaintainer mesh__D004813 sjn
% 219.35/219.55  |- skos__broader mesh__D005528Q000002smesh__D005528
% 219.35/219.55  |- mesh__preferredCombination mesh__D005528Q000002smesh__D005532
% 219.35/219.55  |- rdf__type mesh__D005528Q000002smesh__CompoundConcept
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004015 2006
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004015 2003
% 219.35/219.55  |- skos__annotation mesh__D004015
% 219.35/219.55       IM for chem dictionaries as a subject; for article listing chemical terms %26% definitions, index under specific subject %28%IM%29% + DICTIONARIES, CHEMICAL %28%NIM%29% + DICTIONARY %28%PT%29%; no qualif; Manual 33.14; DF: DICTIONARIES CHEM%A%  
% 219.35/219.55  |- mesh__recordOriginator mesh__D004015 NLM
% 219.35/219.55  |- skos__prefLabel mesh__D004015 Dictionaries, Chemical
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004015 2004
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004015 2000
% 219.35/219.55  |- mesh__dateCreated mesh__D004015 1999-01-01
% 219.35/219.55  |- skos__altLabel mesh__D004015 Dictionary, Chemical
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004015 2001
% 219.35/219.55  |- skos__altLabel mesh__D004015 Chemical Dictionaries
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004015 2002
% 219.35/219.55  |- mesh__recordAuthorizer mesh__D004015 sjn
% 219.35/219.55  |- mesh__recordMaintainer mesh__D004015 kle
% 219.35/219.55  |- rdf__type mesh__D004015sskos__Concept
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D004015 2005
% 219.35/219.55  |- skos__altLabel mesh__D004015 Chemical Dictionary
% 219.35/219.55  |- skos__broader mesh__D004015smesh__D004014
% 219.35/219.55  |- mesh__dateRevised mesh__D004015 1999-11-03
% 219.35/219.55  |- mesh__historyNote mesh__D028463 2002   
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D028463 2005
% 219.35/219.55  |- mesh__dateCreated mesh__D028463 2001-07-25
% 219.35/219.55  |- rdf__type mesh__D028463sskos__Concept
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D028463 2006
% 219.35/219.55  |- skos__broader mesh__D028463smesh__D028462
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D028463 2002
% 219.35/219.55  |- skos__prefLabel mesh__D028463 Cucumis melo
% 219.35/219.55  |- mesh__publicMeSHNote mesh__D028463 2002   
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D028463 2003
% 219.35/219.55  |- skos__historyNote mesh__D028463 Melons %28%1995-2001%29%
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D028463 2004
% 219.35/219.55  |- skos__annotation mesh__D028463
% 219.35/219.55       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.35/219.55  |- mesh__dateEstablished mesh__D028463 2002-01-01
% 219.35/219.55  |- skos__scopeNote mesh__D028463
% 219.35/219.55       A plant species of the family CUCURBITACEAE, order Violales, subclass Dilleniidae known for the melon fruits with reticulated %28%net%29% surface including cantaloupes, honeydew, casaba, and Persian melons.%A%    
% 219.35/219.55  |- skos__scopeNote mesh__D020480
% 219.35/219.55       Works consisting of jokes and facetiae relating to a subject.%A%    
% 219.35/219.55  |- skos__prefLabel mesh__D020480 Humor %5B%Publication Type%5D%
% 219.35/219.55  |- skos__broader mesh__D020480smesh__D052180
% 219.35/219.55  |- skos__altLabel mesh__D020480 Humor %28%PT%29%
% 219.35/219.55  |- skos__altLabel mesh__D020480 Humor %28%Pub Type%29%
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D020480 2006
% 219.35/219.55  |- mesh__recordMaintainer mesh__D020480 jls
% 219.35/219.55  |- skos__related mesh__D020480smesh__D020465
% 219.35/219.55  |- mesh__recordOriginator mesh__D020480 JLS
% 219.35/219.55  |- mesh__historyNote mesh__D020480 1999   
% 219.35/219.55  |- mesh__dateRevised mesh__D020480 2005-06-30
% 219.35/219.55  |- rdf__type mesh__D020480sskos__Concept
% 219.35/219.55  |- mesh__dateCreated mesh__D020480 1998-06-03
% 219.35/219.55  |- mesh__dateEstablished mesh__D020480 1999-01-01
% 219.35/219.55  |- mesh__recordAuthorizer mesh__D020480 sjn
% 219.35/219.55  |- skos__broader mesh__D017536Q000293smesh__D017536
% 219.35/219.55  |- mesh__preferredCombination mesh__D017536Q000293smesh__D020212
% 219.35/219.55  |- rdf__type mesh__D017536Q000293smesh__CompoundConcept
% 219.35/219.55  |- skos__altLabel mesh__D014443 Tyrosine, L-isomer
% 219.35/219.55  |- skos__hiddenLabel mesh__D014443 L Tyrosine
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D014443 2002
% 219.35/219.55  |- skos__prefLabel mesh__D014443 Tyrosine
% 219.35/219.55  |- skos__scopeNote mesh__D014443
% 219.35/219.55       A non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin.%A%    
% 219.35/219.55  |- skos__hiddenLabel mesh__D014443 para Tyrosine
% 219.35/219.55  |- mesh__dateRevised mesh__D014443 2005-07-13
% 219.35/219.55  |- mesh__recordMaintainer mesh__D014443 ags
% 219.35/219.55  |- skos__broader mesh__D014443smesh__D024322
% 219.35/219.55  |- skos__altLabel mesh__D014443 para-Tyrosine
% 219.35/219.55  |- mesh__recordAuthorizer mesh__D014443 ags
% 219.35/219.55  |- skos__annotation mesh__D014443 /blood: consider also TYROSINEMIAS   
% 219.35/219.55  |- mesh__dateCreated mesh__D014443 1999-01-01
% 219.35/219.55  |- rdf__type mesh__D014443sskos__Concept
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D014443 2003
% 219.35/219.55  |- skos__hiddenLabel mesh__D014443 Tyrosine, L isomer
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D014443 2005
% 219.35/219.55  |- mesh__recordOriginator mesh__D014443 NLM
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D014443 2004
% 219.35/219.55  |- skos__altLabel mesh__D014443 L-Tyrosine
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D014443 2006A
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D014443 2006
% 219.35/219.55  |- skos__hiddenLabel mesh__D008406 Masseter Muscles
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D008406 2006
% 219.35/219.55  |- mesh__dateCreated mesh__D008406 1979-03-12
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D008406 2003
% 219.35/219.55  |- mesh__dateRevised mesh__D008406 2001-07-25
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D008406 2004
% 219.35/219.55  |- skos__prefLabel mesh__D008406 Masseter Muscle
% 219.35/219.55  |- mesh__dateEstablished mesh__D008406 1991-01-01
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D008406 2002
% 219.35/219.55  |- skos__scopeNote mesh__D008406
% 219.35/219.55       A masticatory muscle whose action is closing the jaws.     
% 219.35/219.55  |- mesh__publicMeSHNote mesh__D008406
% 219.35/219.55       91; was see under MASTICATORY MUSCLES 1980-90   
% 219.35/219.55  |- rdf__type mesh__D008406sskos__Concept
% 219.35/219.55  |- skos__historyNote mesh__D008406 Muscles %28%1966-1979%29%
% 219.35/219.55  |- skos__broader mesh__D008406smesh__D008410
% 219.35/219.55  |- mesh__historyNote mesh__D008406
% 219.35/219.55       91%28%80%29%; was see under MASTICATORY MUSCLES 1980-90   
% 219.35/219.55  |- skos__annotation mesh__D008406
% 219.35/219.55       /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 219.35/219.55  |- skos__hiddenLabel mesh__D008406 Muscle, Masseter
% 219.35/219.55  |- skos__hiddenLabel mesh__D008406 Muscles, Masseter
% 219.35/219.55  |- mesh__recordAuthorizer mesh__D008406 sjn
% 219.35/219.55  |- skos__historyNote mesh__D008406 Masticatory Muscles %28%1966-1979%29%
% 219.35/219.55  |- mesh__recordMaintainer mesh__D008406 nns
% 219.35/219.55  |- mesh__activeMeSHYear mesh__D008406 2005
% 219.35/219.56  |- mesh__recordOriginator mesh__D008406 SMH
% 219.35/219.56  |- skos__prefLabel mesh__D000423 Alcian Blue
% 219.35/219.56  |- skos__hiddenLabel mesh__D000423 8GX, Alcian Blue
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D000423 2006
% 219.35/219.56  |- mesh__recordMaintainer mesh__D000423 NLM
% 219.35/219.56  |- mesh__dateRevised mesh__D000423 2005-07-06
% 219.35/219.56  |- skos__altLabel mesh__D000423 Alcian Blue 8GS
% 219.35/219.56  |- skos__hiddenLabel mesh__D000423 Blue, Alcian
% 219.35/219.56  |- mesh__publicMeSHNote mesh__D000423 91; was see under INDOLES 1975-90   
% 219.35/219.56  |- skos__annotation mesh__D000423 D25-26 qualif   
% 219.35/219.56  |- mesh__historyNote mesh__D000423
% 219.35/219.56       91%28%75%29%; was see under INDOLES 1975-90   
% 219.35/219.56  |- mesh__dateEstablished mesh__D000423 1991-01-01
% 219.35/219.56  |- mesh__dateCreated mesh__D000423 1974-11-19
% 219.35/219.56  |- skos__broader mesh__D000423smesh__D007211
% 219.35/219.56  |- skos__altLabel mesh__D000423 Alcian Blue 8GX
% 219.35/219.56  |- skos__hiddenLabel mesh__D000423 Blue 8GX, Alcian
% 219.35/219.56  |- mesh__recordOriginator mesh__D000423 NLM
% 219.35/219.56  |- skos__historyNote mesh__D000423 Indoles %28%1973-1974%29%
% 219.35/219.56  |- skos__hiddenLabel mesh__D000423 8GS, Alcian Blue
% 219.35/219.56  |- mesh__recordAuthorizer mesh__D000423 NLM
% 219.35/219.56  |- skos__scopeNote mesh__D000423
% 219.35/219.56       A copper-containing dye used as a gelling agent for lubricants, for staining of bacteria and for the dyeing of histiocytes and fibroblasts in vivo.%A%    
% 219.35/219.56  |- rdf__type mesh__D000423sskos__Concept
% 219.35/219.56  |- skos__historyNote mesh__D000423 Onium Compounds %28%1974%29%
% 219.35/219.56  |- skos__hiddenLabel mesh__D000423 Blue 8GS, Alcian
% 219.35/219.56  |- skos__hiddenLabel mesh__D018834 Protein, hsp60
% 219.35/219.56  |- skos__historyNote mesh__D018834 Heat-Shock Proteins %28%1989-1994%29%
% 219.35/219.56  |- skos__historyNote mesh__D018834 Bacterial Proteins %28%1989-1994%29%
% 219.35/219.56  |- mesh__dateCreated mesh__D018834 1994-05-31
% 219.35/219.56  |- mesh__recordOriginator mesh__D018834 PXP
% 219.35/219.56  |- rdf__type mesh__D018834sskos__Concept
% 219.35/219.56  |- mesh__publicMeSHNote mesh__D018834
% 219.35/219.56       95; CHAPERONIN 60 was indexed under BACTERIAL PROTEINS %26% HEAT-SHOCK PROTEINS 1989-94; HEAT-SHOCK PROTEIN 60 was indexed under HEAT-SHOCK PROTEINS 1993-94; HSP60 PROTEIN was indexed under HEAT-SHOCK PROTEINS 1989-94%A%  
% 219.35/219.56  |- skos__altLabel mesh__D018834 cpn60
% 219.35/219.56  |- skos__broader mesh__D018834smesh__D018833
% 219.35/219.56  |- mesh__recordMaintainer mesh__D018834 ags
% 219.35/219.56  |- skos__prefLabel mesh__D018834 Chaperonin 60
% 219.35/219.56  |- skos__altLabel mesh__D018834 hsp60 Family
% 219.35/219.56  |- mesh__historyNote mesh__D018834
% 219.35/219.56       95; was SY to GROEL STRESS PROTEIN %28%NM%29% 1989-94; HEAT-SHOCK PROTEINS 60 was HEAT-SHOCK PROTEIN 60 %28%NM%29% 1993-94; HSP60 FAMILY was HSP60 PROTEIN %28%SY%29% to MITOCHONDRIAL ASSEMBLY FACTOR HSP60 %28%NM%29% 1989-94%A%  
% 219.35/219.56  |- skos__altLabel mesh__D018834 Heat-Shock Proteins 60
% 219.35/219.56  |- skos__hiddenLabel mesh__D018834 Family, hsp60
% 219.35/219.56  |- skos__hiddenLabel mesh__D018834 Heat Shock Protein 60
% 219.35/219.56  |- skos__altLabel mesh__D018834 cpn 060
% 219.35/219.56  |- skos__annotation mesh__D018834
% 219.35/219.56       from bacteria, plastids or mitochondria; DF: note short X ref%A%  
% 219.35/219.56  |- mesh__recordAuthorizer mesh__D018834 sjn
% 219.35/219.56  |- skos__scopeNote mesh__D018834
% 219.35/219.56       Members of the chaperonin heat-shock protein family. Chaperonin 60 purified from bacteria, plastids, or mitochondria is an oligomeric protein with a distinctive structure of fourteen subunits, arranged in two rings of seven subunits each.%A%    
% 219.35/219.56  |- skos__altLabel mesh__D018834 Heat-Shock Protein 60
% 219.35/219.56  |- mesh__onlineNote mesh__D018834
% 219.35/219.56       use GROEL PROTEIN %28%NM%29% to search CHAPERONIN 60 1989-94; use CHAPERONIN 60 %28%NM%29% to search HEAT-SHOCK PROTEINS 60 1993-94 %26% HSP60 FAMILY 1989-94%A%  
% 219.35/219.56  |- skos__hiddenLabel mesh__D018834 Heat Shock Proteins 60
% 219.35/219.56  |- mesh__dateRevised mesh__D018834 2005-06-30
% 219.35/219.56  |- mesh__dateEstablished mesh__D018834 1995-01-01
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D018834 2006
% 219.35/219.56  |- skos__altLabel mesh__D018834 hsp60 Protein
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010851 2002
% 219.35/219.56  |- rdf__type mesh__D010851sskos__Concept
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010851 1994
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010851 1998
% 219.35/219.56  |- mesh__recordAuthorizer mesh__D010851 PLS
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010851 1995
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010851 1996
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010851 2005
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010851 1993
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010851 2003
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010851 1999
% 219.35/219.56  |- mesh__dateRevised mesh__D010851 1992-05-19
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010851 1997
% 219.35/219.56  |- mesh__recordMaintainer mesh__D010851 TAP
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010851 2006
% 219.35/219.56  |- skos__prefLabel mesh__D010851 Picrates
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010851 2000
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010851 2004
% 219.35/219.56  |- mesh__recordOriginator mesh__D010851 NLM
% 219.35/219.56  |- skos__broader mesh__D010851smesh__D009596
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010851 2001
% 219.35/219.56  |- mesh__dateCreated mesh__D010851 1999-01-01
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D018036 2002
% 219.35/219.56  |- rdf__type mesh__D018036sskos__Concept
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D018036 1994
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D018036 1999
% 219.35/219.56  |- skos__broader mesh__D018036smesh__D007287
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D018036 2003
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D018036 1995
% 219.35/219.56  |- mesh__publicMeSHNote mesh__D018036 94   
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D018036 2004
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D018036 2005
% 219.35/219.56  |- mesh__dateEstablished mesh__D018036 1994-01-01
% 219.35/219.56  |- skos__scopeNote mesh__D018036
% 219.35/219.56       Inorganic compounds that contain selenium as an integral part of the molecule.%A%    
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D018036 1996
% 219.35/219.56  |- skos__hiddenLabel mesh__D018036 Compounds, Selenium
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D018036 2006
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D018036 2000
% 219.35/219.56  |- mesh__historyNote mesh__D018036 94   
% 219.35/219.56  |- mesh__dateCreated mesh__D018036 1993-06-21
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D018036 1997
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D018036 2001
% 219.35/219.56  |- skos__historyNote mesh__D018036 Selenium %28%1966-1993%29%
% 219.35/219.56  |- skos__prefLabel mesh__D018036 Selenium Compounds
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D018036 1998
% 219.35/219.56  |- skos__annotation mesh__D018036
% 219.35/219.56       inorganic; GEN or unspecified; prefer specifics; DF: SELENIUM CPDS%A%  
% 219.35/219.56  |- skos__scopeNote mesh__D010053
% 219.35/219.56       The reproductive organ %28%GONADS%29% in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells %28%OOGENESIS%29%; and the endocrine cells %28%GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS%29% for the production of ESTROGENS and PROGESTERONE.%A%    
% 219.35/219.56  |- skos__altLabel mesh__D010053 Ovaries
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010053 2004
% 219.35/219.56  |- mesh__considerAlso mesh__D010053
% 219.35/219.56       consider also terms at OOPHOR- and THEC-   
% 219.35/219.56  |- skos__annotation mesh__D010053
% 219.35/219.56       OVARY, PLANT is also available; /surg permitted but is probably OVARIECTOMY; /abnorm: agenesis or dysgenesis: coord OVARY /abnorm %28%IM%29% with GONADAL DYSGENESIS %28%IM%29%; /cytol: consider also THECA CELLS; inflammation = OOPHORITIS; polycystic ovary, sclerocystic ovary = POLYCYSTIC OVARY SYNDROME%A%  
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010053 2006
% 219.35/219.56  |- mesh__dateCreated mesh__D010053 1999-01-01
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010053 2006A
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010053 2005
% 219.35/219.56  |- skos__related mesh__D010053smesh__D010052
% 219.35/219.56  |- skos__broader mesh__D010053smesh__D000290
% 219.35/219.56  |- skos__prefLabel mesh__D010053 Ovary
% 219.35/219.56  |- mesh__recordOriginator mesh__D010053 NLM
% 219.35/219.56  |- mesh__dateRevised mesh__D010053 2005-07-15
% 219.35/219.56  |- mesh__recordMaintainer mesh__D010053 ags
% 219.35/219.56  |- mesh__recordAuthorizer mesh__D010053 ags
% 219.35/219.56  |- rdf__type mesh__D010053sskos__Concept
% 219.35/219.56  |- skos__broader mesh__D010053smesh__D006066
% 219.35/219.56  |- skos__hiddenLabel mesh__D004814 Cysts, Pilar
% 219.35/219.56  |- skos__hiddenLabel mesh__D004814 Pilar Cysts
% 219.35/219.56  |- skos__prefLabel mesh__D004814 Epidermal Cyst
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004814 1996
% 219.35/219.56  |- skos__broader mesh__D004814smesh__D003560
% 219.35/219.56  |- mesh__recordMaintainer mesh__D004814 PLS
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004814 2004
% 219.35/219.56  |- mesh__onlineNote mesh__D004814
% 219.35/219.56       use EPIDERMAL CYST to search SEBACEOUS CYST 1966-83   
% 219.35/219.56  |- mesh__dateEstablished mesh__D004814 1972-01-01
% 219.35/219.56  |- skos__annotation mesh__D004814
% 219.35/219.56       non-neoplastic; coord IM with organ/diseases term %28%IM%29%; /blood supply /chem /secret /ultrastruct permitted%A%  
% 219.35/219.56  |- skos__hiddenLabel mesh__D004814 Epidermoid Cysts
% 219.35/219.56  |- skos__hiddenLabel mesh__D004814 Cyst, Pilar
% 219.35/219.56  |- skos__scopeNote mesh__D004814
% 219.35/219.56       Intradermal or subcutaneous saclike structure, the wall of which is stratified epithelium containing keratohyalin granules.%A%    
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004814 1997
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004814 2005
% 219.35/219.56  |- mesh__dateRevised mesh__D004814 1991-06-18
% 219.35/219.56  |- skos__hiddenLabel mesh__D004814 Cyst, Epidermal
% 219.35/219.56  |- skos__hiddenLabel mesh__D004814 Cysts, Epidermoid
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004814 2000
% 219.35/219.56  |- skos__altLabel mesh__D004814 Epidermoid Cyst
% 219.35/219.56  |- skos__hiddenLabel mesh__D004814 Epidermal Cysts
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004814 1998
% 219.35/219.56  |- skos__hiddenLabel mesh__D004814 Cyst, Epidermoid
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004814 2006
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004814 1992
% 219.35/219.56  |- skos__hiddenLabel mesh__D004814 Cysts, Sebaceous
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004814 2001
% 219.35/219.56  |- skos__altLabel mesh__D004814 Sebaceous Cyst
% 219.35/219.56  |- skos__hiddenLabel mesh__D004814 Cysts, Epidermal
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004814 1994
% 219.35/219.56  |- skos__hiddenLabel mesh__D004814 Cyst, Sebaceous
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004814 1999
% 219.35/219.56  |- mesh__publicMeSHNote mesh__D004814
% 219.35/219.56       72; SEBACEOUS CYST was heading 1963-83   
% 219.35/219.56  |- rdf__type mesh__D004814sskos__Concept
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004814 1993
% 219.35/219.56  |- mesh__historyNote mesh__D004814
% 219.35/219.56       72%28%65%29%; SEBACEOUS CYST was heading 1963-83   
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004814 2002
% 219.35/219.56  |- mesh__recordOriginator mesh__D004814 NLM
% 219.35/219.56  |- mesh__dateCreated mesh__D004814 1999-01-01
% 219.35/219.56  |- mesh__recordAuthorizer mesh__D004814 PLS
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004814 2003
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004814 1995
% 219.35/219.56  |- skos__hiddenLabel mesh__D004814 Sebaceous Cysts
% 219.35/219.56  |- skos__hiddenLabel mesh__D004016 Dictionary, Classical
% 219.35/219.56  |- skos__annotation mesh__D004016
% 219.35/219.56       IM for classical dictionaries as a subject; articles dealing with subjects found in classical dictionaries are unusual: index under specific subject %28%IM%29% + DICTIONARIES, CLASSICAL %28%NIM%29% + DICTIONARY %28%PT%29%; no qualif%A%  
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004016 2002
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004016 1999
% 219.35/219.56  |- mesh__recordMaintainer mesh__D004016 TGC
% 219.35/219.56  |- skos__hiddenLabel mesh__D004016 Classical Dictionary
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004016 1996
% 219.35/219.56  |- skos__hiddenLabel mesh__D004016 Classical Dictionaries
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004016 1997
% 219.35/219.56  |- skos__prefLabel mesh__D004016 Dictionaries, Classical
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004016 2005
% 219.35/219.56  |- rdf__type mesh__D004016sskos__Concept
% 219.35/219.56  |- skos__broader mesh__D004016smesh__D004014
% 219.35/219.56  |- mesh__recordOriginator mesh__D004016 NLM
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004016 1994
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004016 2006
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004016 2003
% 219.35/219.56  |- mesh__dateRevised mesh__D004016 1991-06-26
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004016 1995
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004016 2000
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004016 1992
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004016 2004
% 219.35/219.56  |- mesh__recordAuthorizer mesh__D004016 PLS
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004016 2001
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004016 1998
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004016 1993
% 219.35/219.56  |- mesh__dateCreated mesh__D004016 1999-01-01
% 219.35/219.56  |- skos__annotation mesh__D028464
% 219.35/219.56       do not confuse with Squash %28%Sport%29% = RACQUET SPORTS; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D028464 2003
% 219.35/219.56  |- mesh__recordAuthorizer mesh__D028464 sjn
% 219.35/219.56  |- mesh__recordOriginator mesh__D028464 ssb
% 219.35/219.56  |- mesh__recordMaintainer mesh__D028464 ssb
% 219.35/219.56  |- mesh__dateEstablished mesh__D028464 2002-01-01
% 219.35/219.56  |- mesh__publicMeSHNote mesh__D028464
% 219.35/219.56       2002; for PUMPKINS %26% SQUASHES see CUCURBITACEAE 1998-2001%A%  
% 219.35/219.56  |- mesh__dateRevised mesh__D028464 2002-07-03
% 219.35/219.56  |- mesh__dateCreated mesh__D028464 2001-07-25
% 219.35/219.56  |- skos__broader mesh__D028464smesh__D019662
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D028464 2006
% 219.35/219.56  |- mesh__historyNote mesh__D028464
% 219.35/219.56       2002; for PUMPKINS %26% SQUASHES use CUCURBITACEAE 1998-2001%A%  
% 219.35/219.56  |- rdf__type mesh__D028464sskos__Concept
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D028464 2005
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D028464 2004
% 219.35/219.56  |- skos__prefLabel mesh__D028464 Cucurbita
% 219.35/219.56  |- skos__scopeNote mesh__D028464
% 219.35/219.56       A plant genus of the family CUCURBITACEAE, order Violales, subclass Dilleniidae, which includes pumpkin, gourd and squash.%A%    
% 219.35/219.56  |- skos__historyNote mesh__D028464 Cucurbitaceae %28%1998-2001%29%
% 219.35/219.56  |- skos__related mesh__D020481smesh__D020504
% 219.35/219.56  |- skos__altLabel mesh__D020481 Indexes %28%PT%29%
% 219.35/219.56  |- mesh__dateEstablished mesh__D020481 1999-01-01
% 219.35/219.56  |- mesh__recordAuthorizer mesh__D020481 sjn
% 219.35/219.56  |- skos__scopeNote mesh__D020481
% 219.35/219.56       Works providing an analytical subject approach to materials in a field of knowledge.%A%    
% 219.35/219.56  |- skos__related mesh__D020481smesh__D016417
% 219.35/219.56  |- skos__related mesh__D020481smesh__D020507
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D020481 2006
% 219.35/219.56  |- mesh__recordOriginator mesh__D020481 JLS
% 219.35/219.56  |- mesh__historyNote mesh__D020481 1999   
% 219.35/219.56  |- rdf__type mesh__D020481sskos__Concept
% 219.35/219.56  |- mesh__dateCreated mesh__D020481 1998-06-03
% 219.35/219.56  |- skos__prefLabel mesh__D020481 Indexes %5B%Publication Type%5D%
% 219.35/219.56  |- skos__related mesh__D020481smesh__D016453
% 219.35/219.56  |- mesh__recordMaintainer mesh__D020481 jls
% 219.35/219.56  |- skos__broader mesh__D020481smesh__D052180
% 219.35/219.56  |- mesh__dateRevised mesh__D020481 2005-06-30
% 219.35/219.56  |- mesh__recordAuthorizer mesh__D014444 sjn
% 219.35/219.56  |- mesh__recordMaintainer mesh__D014444 ssb
% 219.35/219.56  |- mesh__recordOriginator mesh__D014444 NLM
% 219.35/219.56  |- mesh__dateRevised mesh__D014444 2003-07-09
% 219.35/219.56  |- mesh__publicMeSHNote mesh__D014444
% 219.35/219.56       95; was TYROSINE AMINOTRANSFERASE 1964-94   
% 219.35/219.56  |- skos__broader mesh__D014444smesh__D000637
% 219.35/219.56  |- mesh__dateEstablished mesh__D014444 1968-01-01
% 219.35/219.56  |- skos__scopeNote mesh__D014444
% 219.35/219.56       An enzyme that catalyzes the conversion of L-TYROSINE and 2-oxoglutarate to 4-hydroxyphenylpyruvate and L-GLUTAMATE. It is a pyridoxal-phosphate protein. L-PHENYLALANINE is hydroxylated to L-tyrosine. The mitochondrial enzyme may be identical with ASPARTATE AMINOTRANSFERASES %28%EC 2.6.1.1.%29%. Deficiency of this enzyme may cause type II Tyrosinemia %28%see TYROSINEMIAS%29%. EC 2.6.1.5.%A%    
% 219.35/219.56  |- mesh__dateCreated mesh__D014444 1999-01-01
% 219.35/219.56  |- rdf__type mesh__D014444sskos__Concept
% 219.35/219.56  |- skos__annotation mesh__D014444 /defic: consider also TYROSINEMIAS   
% 219.35/219.56  |- skos__altLabel mesh__D014444 Tyrosine Aminotransferase
% 219.35/219.56  |- skos__hiddenLabel mesh__D014444 Transaminase, Tyrosine
% 219.35/219.56  |- skos__prefLabel mesh__D014444 Tyrosine Transaminase
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D014444 2005
% 219.35/219.56  |- mesh__historyNote mesh__D014444
% 219.35/219.56       95; was TYROSINE AMINOTRANSFERASE 1964-94 %28%Prov 1964-68%29%   
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D014444 2004
% 219.35/219.56  |- mesh__onlineNote mesh__D014444
% 219.35/219.56       use TYROSINE TRANSAMINASE to search TYROSINE AMINOTRANSFERASE 1966-94 %28%as Prov 1966-68%29%%A%  
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D014444 2006
% 219.35/219.56  |- skos__hiddenLabel mesh__D014444 Aminotransferase, Tyrosine
% 219.35/219.56  |- skos__related mesh__D014444smesh__D020176
% 219.35/219.56  |- mesh__recordAuthorizer mesh__D008407 sjn
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D008407 2004
% 219.35/219.56  |- skos__scopeNote mesh__D008407
% 219.35/219.56       Granulated cells that are found in almost all tissues, most abundantly in the skin and the gastrointestinal tract. Like the BASOPHILS, mast cells contain large amounts of HISTAMINE and HEPARIN. Unlike basophils, mast cells normally remain in the tissues and do not circulate in the blood. Mast cells, derived from the bone marrow stem cells, are regulated by the STEM CELL FACTOR.%A%    
% 219.35/219.56  |- mesh__recordOriginator mesh__D008407 NLM
% 219.35/219.56  |- rdf__type mesh__D008407sskos__Concept
% 219.35/219.56  |- skos__hiddenLabel mesh__D008407 Tissue Basophil
% 219.35/219.56  |- skos__hiddenLabel mesh__D008407 Cells, Mast
% 219.35/219.56  |- mesh__dateRevised mesh__D008407 2002-07-02
% 219.35/219.56  |- skos__prefLabel mesh__D008407 Mast Cells
% 219.35/219.56  |- skos__broader mesh__D008407smesh__D007107
% 219.35/219.56  |- skos__annotation mesh__D008407
% 219.35/219.56       MAST-CELL DISEASE see MASTOCYTOSIS is available   
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D008407 2005
% 219.35/219.56  |- skos__altLabel mesh__D008407 Basophils, Tissue
% 219.35/219.56  |- skos__hiddenLabel mesh__D008407 Tissue Basophils
% 219.35/219.56  |- skos__hiddenLabel mesh__D008407 Basophil, Tissue
% 219.35/219.56  |- mesh__recordMaintainer mesh__D008407 lkt
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D008407 2006
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D008407 2003
% 219.35/219.56  |- mesh__dateCreated mesh__D008407 1999-01-01
% 219.35/219.56  |- skos__hiddenLabel mesh__D008407 Cell, Mast
% 219.35/219.56  |- skos__broader mesh__D008407smesh__D003239
% 219.35/219.56  |- skos__hiddenLabel mesh__D008407 Mast Cell
% 219.35/219.56  |- mesh__publicMeSHNote mesh__D018835
% 219.35/219.56       95; CHAPERONIN 10 was indexed under HEAT-SHOCK PROTEINS 1989-94; HEAT-SHOCK PROTEIN 10 was indexed under HEAT-SHOCK PROTEINS 1993-94%A%  
% 219.35/219.56  |- mesh__dateEstablished mesh__D018835 1995-01-01
% 219.35/219.56  |- mesh__recordMaintainer mesh__D018835 ags
% 219.35/219.56  |- mesh__recordAuthorizer mesh__D018835 sjn
% 219.35/219.56  |- mesh__dateRevised mesh__D018835 2005-06-30
% 219.35/219.56  |- mesh__historyNote mesh__D018835
% 219.35/219.56       95; CHAPERONIN 10 was SY to GROES STRESS PROTEIN %28%NM%29% 1989-94; HEAT-SHOCK PROTEINS 10 was HEAT-SHOCK PROTEIN 10 %28%NM%29% 1993-94%A%  
% 219.35/219.56  |- skos__prefLabel mesh__D018835 Chaperonin 10
% 219.35/219.56  |- skos__annotation mesh__D018835
% 219.35/219.56       from bacteria, plastids or mitochondria; DF: note short X ref%A%  
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D018835 2006
% 219.35/219.56  |- skos__hiddenLabel mesh__D018835 Family, hsp10
% 219.35/219.56  |- mesh__onlineNote mesh__D018835
% 219.35/219.56       use GROES PROTEIN %28%NM%29% to search CHAPERONIN 10 1989-94; use CHAPERONIN 10 %28%NM%29% to search HEAT-SHOCK PROTEINS 10 1993-94%A%  
% 219.35/219.56  |- skos__hiddenLabel mesh__D018835 Heat Shock Protein 10
% 219.35/219.56  |- skos__historyNote mesh__D018835 Heat-Shock Proteins %28%1989-1994%29%
% 219.35/219.56  |- mesh__dateCreated mesh__D018835 1994-05-31
% 219.35/219.56  |- skos__altLabel mesh__D018835 hsp10 Protein
% 219.35/219.56  |- skos__altLabel mesh__D018835 hsp10 Family
% 219.35/219.56  |- skos__altLabel mesh__D018835 cpn 10
% 219.35/219.56  |- skos__scopeNote mesh__D018835
% 219.35/219.56       Members of the chaperonin heat-shock protein family. Chaperonin 10 purified from bacteria, plastids, or mitochondria occurs as an oligomer of seven identical subunits arranged in a single ring.%A%    
% 219.35/219.56  |- skos__hiddenLabel mesh__D018835 Heat Shock Proteins 10
% 219.35/219.56  |- skos__altLabel mesh__D018835 Heat-Shock Protein 10
% 219.35/219.56  |- skos__altLabel mesh__D018835 Heat-Shock Proteins 10
% 219.35/219.56  |- rdf__type mesh__D018835sskos__Concept
% 219.35/219.56  |- skos__broader mesh__D018835smesh__D018833
% 219.35/219.56  |- skos__hiddenLabel mesh__D018835 Protein, hsp10
% 219.35/219.56  |- skos__altLabel mesh__D018835 cpn10
% 219.35/219.56  |- mesh__recordOriginator mesh__D018835 PXP
% 219.35/219.56  |- mesh__recordOriginator mesh__D010852 NLM
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010852 2006
% 219.35/219.56  |- skos__broader mesh__D010852smesh__D005960
% 219.35/219.56  |- mesh__dateRevised mesh__D010852 2004-07-07
% 219.35/219.56  |- mesh__recordAuthorizer mesh__D010852 sjn
% 219.35/219.56  |- mesh__dateCreated mesh__D010852 1999-01-01
% 219.35/219.56  |- skos__scopeNote mesh__D010852
% 219.35/219.56       A noncompetitive antagonist at GABA-A receptors and thus a convulsant. Picrotoxin blocks the GAMMA-AMINOBUTYRIC ACID-activated chloride ionophore. Although it is most often used as a research tool, it has been used as a CNS stimulant and an antidote in poisoning by CNS depressants, especially the barbiturates.%A%    
% 219.35/219.56  |- rdf__type mesh__D010852sskos__Concept
% 219.35/219.56  |- mesh__recordMaintainer mesh__D010852 ssb
% 219.35/219.56  |- skos__prefLabel mesh__D010852 Picrotoxin
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010852 2005
% 219.35/219.56  |- mesh__recordOriginator mesh__D010054 NLM
% 219.35/219.56  |- skos__scopeNote mesh__D010054
% 219.35/219.56       A scale comprising 18 symptom constructs chosen to represent relatively independent dimensions of manifest psychopathology. The initial intended use was to provide more efficient assessment of treatment response in clinical psychopharmacology research; however, the scale was readily adapted to other uses. %28%From Hersen, M. and Bellack, A.S., Dictionary of Behavioral Assessment Techniques, p. 87%29%%A%    
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010054 2003
% 219.35/219.56  |- mesh__dateEstablished mesh__D010054 1991-01-01
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010054 1997
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010054 2001
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010054 2006
% 219.35/219.56  |- skos__annotation mesh__D010054 DF: BPRS   
% 219.35/219.56  |- mesh__dateCreated mesh__D010054 1999-01-01
% 219.35/219.56  |- skos__broader mesh__D010054smesh__D011569
% 219.35/219.56  |- skos__altLabel mesh__D010054
% 219.35/219.56       Overall and Gorham Brief Psychiatric Rating Scale
% 219.35/219.56  |- skos__altLabel mesh__D010054
% 219.35/219.56       Overall-Gorham Brief Psychiatric Rating Scale
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010054 1996
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010054 2000
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010054 2005
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010054 1999
% 219.35/219.56  |- mesh__dateRevised mesh__D010054 1994-01-25
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010054 1995
% 219.35/219.56  |- mesh__publicMeSHNote mesh__D010054
% 219.35/219.56       95; OVERALL AND GORHAM BRIEF PSYCHIATRIC RATING SCALE was heading 1975-94 %28%see under PSYCHIATRIC STATUS RATING SCALES 1975-90%29%%A%  
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010054 1998
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010054 2002
% 219.35/219.56  |- rdf__type mesh__D010054sskos__Concept
% 219.35/219.56  |- mesh__recordAuthorizer mesh__D010054 PLS
% 219.35/219.56  |- mesh__onlineNote mesh__D010054
% 219.35/219.56       use BRIEF PSYCHIATRIC RATING SCALE to search OVERALL AND GORHAM BRIEF PSYCHIATRIC RATING SCALE 1975-94; use PSYCHIATRIC STATUS RATING SCALES 1969-74%A%  
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D010054 2004
% 219.35/219.56  |- mesh__historyNote mesh__D010054
% 219.35/219.56       95; OVERALL AND GORHAM BRIEF PSYCHIATRIC RATING SCALE was heading 1975-94 %28%see under PSYCHIATRIC STATUS RATING SCALES 1975-90%29%%A%  
% 219.35/219.56  |- skos__prefLabel mesh__D010054 Brief Psychiatric Rating Scale
% 219.35/219.56  |- skos__hiddenLabel mesh__D010054
% 219.35/219.56       Overall Gorham Brief Psychiatric Rating Scale
% 219.35/219.56  |- mesh__recordMaintainer mesh__D010054 PLS
% 219.35/219.56  |- skos__related mesh__D004815smesh__D005765
% 219.35/219.56  |- skos__related mesh__D004815smesh__D000897
% 219.35/219.56  |- skos__historyNote mesh__D004815
% 219.35/219.56       Gastrointestinal Hormones %28%1966-1974%29%
% 219.35/219.56  |- skos__hiddenLabel mesh__D004815 Growth Factor-Urogastrone, Epidermal
% 219.35/219.56  |- skos__prefLabel mesh__D004815 Epidermal Growth Factor
% 219.35/219.56  |- mesh__dateRevised mesh__D004815 2005-06-30
% 219.35/219.56  |- skos__altLabel mesh__D004815 Urogastrone
% 219.35/219.56  |- mesh__recordMaintainer mesh__D004815 ssb
% 219.35/219.56  |- skos__altLabel mesh__D004815 beta-Urogastrone
% 219.35/219.56  |- mesh__dateCreated mesh__D004815 1976-04-16
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004815 2006
% 219.35/219.56  |- skos__altLabel mesh__D004815 EGF
% 219.35/219.56  |- rdf__type mesh__D004815sskos__Concept
% 219.35/219.56  |- skos__scopeNote mesh__D004815
% 219.35/219.56       A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. EPIDERMAL GROWTH FACTOR exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and epithelial cells.%A%    
% 219.35/219.56  |- skos__hiddenLabel mesh__D004815 Growth Factor, Epidermal
% 219.35/219.56  |- mesh__historyNote mesh__D004815
% 219.35/219.56       2000%28%1982%29%; use PEPTIDES 1977-1981; for UROGASTRONE use GASTROINTESTINAL HORMONES 1963-1981%A%  
% 219.35/219.56  |- skos__altLabel mesh__D004815 Human Urinary Gastric Inhibitor
% 219.35/219.56  |- skos__broader mesh__D004815smesh__D006133
% 219.35/219.56  |- skos__hiddenLabel mesh__D004815 Growth Factors, Epidermal
% 219.35/219.56  |- skos__historyNote mesh__D004815 Growth Substances %28%1966-1976%29%
% 219.35/219.56  |- skos__altLabel mesh__D004815 Epidermal Growth Factor-Urogastrone
% 219.35/219.56  |- mesh__recordOriginator mesh__D004815 SH
% 219.35/219.56  |- skos__broader mesh__D004815smesh__D036341
% 219.35/219.56  |- mesh__publicMeSHNote mesh__D004815
% 219.35/219.56       2000; see EPIDERMAL GROWTH FACTOR-UROGASTRONE 1982-1999, see PEPTIDES 1977-1981; for UROGASTRONE see GASTROINTESTINAL HORMONES 1963-1981%A%  
% 219.35/219.56  |- skos__altLabel mesh__D004815 Epidermal Growth Factors
% 219.35/219.56  |- mesh__recordAuthorizer mesh__D004815 sjn
% 219.35/219.56  |- skos__broader mesh__D004815smesh__D005768
% 219.35/219.56  |- skos__historyNote mesh__D004815 Peptides %28%1966-1976%29%
% 219.35/219.56  |- skos__related mesh__D004815smesh__D011958
% 219.35/219.56  |- mesh__dateEstablished mesh__D004815 1982-01-01
% 219.35/219.56  |- skos__hiddenLabel mesh__D004815 beta Urogastrone
% 219.35/219.56  |- skos__annotation mesh__D004017
% 219.35/219.56       IM for dent dictionaries as a subject; for article listing dent terms %26% definitions, index under specific subject %28%IM%29% + DICTIONARIES, DENTAL %28%NIM%29% + DICTIONARY %28%PT%29%; no qualif; Manual 33.14; DF: DICTIONARIES DENT%A%  
% 219.35/219.56  |- skos__prefLabel mesh__D004017 Dictionaries, Dental
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004017 2001
% 219.35/219.56  |- skos__broader mesh__D004017smesh__D004014
% 219.35/219.56  |- rdf__type mesh__D004017sskos__Concept
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004017 2005
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004017 2002
% 219.35/219.56  |- skos__altLabel mesh__D004017 Dental Dictionary
% 219.35/219.56  |- mesh__dateRevised mesh__D004017 1999-11-03
% 219.35/219.56  |- mesh__recordAuthorizer mesh__D004017 sjn
% 219.35/219.56  |- mesh__recordMaintainer mesh__D004017 kle
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004017 2006
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004017 2003
% 219.35/219.56  |- skos__altLabel mesh__D004017 Dictionary, Dental
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004017 2004
% 219.35/219.56  |- mesh__recordOriginator mesh__D004017 NLM
% 219.35/219.56  |- mesh__dateCreated mesh__D004017 1999-01-01
% 219.35/219.56  |- skos__altLabel mesh__D004017 Dental Dictionaries
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D004017 2000
% 219.35/219.56  |- skos__prefLabel mesh__D009500 Neutralization Tests
% 219.35/219.56  |- skos__scopeNote mesh__D009500
% 219.35/219.56       Titration of an antiserum by testing a series of dilutions of virus or immune serum to a given end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology %28%CPE%29% or the dilution at which 50%25% of test animals injected with serum-virus mixtures show infectivity %28%ID50%29% or die %28%LD50%29%.%A%    
% 219.35/219.56  |- mesh__recordAuthorizer mesh__D009500 sjn
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D009500 2003
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D009500 2004
% 219.35/219.56  |- skos__broader mesh__D009500smesh__D017186
% 219.35/219.56  |- skos__hiddenLabel mesh__D009500 Test, Neutralization
% 219.35/219.56  |- mesh__dateRevised mesh__D009500 2002-07-03
% 219.35/219.56  |- skos__annotation mesh__D009500
% 219.35/219.56       a titrimetric technique used in serodiag; NIM   
% 219.35/219.56  |- mesh__dateCreated mesh__D009500 1999-01-01
% 219.35/219.56  |- rdf__type mesh__D009500sskos__Concept
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D009500 2005
% 219.35/219.56  |- skos__broader mesh__D009500smesh__D012698
% 219.35/219.56  |- skos__hiddenLabel mesh__D009500 Neutralization Test
% 219.35/219.56  |- mesh__recordOriginator mesh__D009500 NLM
% 219.35/219.56  |- mesh__recordMaintainer mesh__D009500 lkt
% 219.35/219.56  |- mesh__activeMeSHYear mesh__D009500 2006
% 219.35/219.56  |- skos__hiddenLabel mesh__D009500 Tests, Neutralization
% 219.35/219.56  |- mesh__recordMaintainer mesh__D020482 jls
% 219.35/219.56  |- mesh__recordOriginator mesh__D020482 JLS
% 219.35/219.56  |- rdf__type mesh__D020482sskos__Concept
% 219.35/219.56  |- mesh__dateCreated mesh__D020482 1998-06-03
% 219.35/219.56  |- skos__related mesh__D020482smesh__D020496
% 219.35/219.56  |- mesh__dateEstablished mesh__D020482 1999-01-01
% 219.35/219.56  |- mesh__historyNote mesh__D020482 1999   
% 219.35/219.57  |- mesh__dateRevised mesh__D020482 2005-06-30
% 219.35/219.57  |- skos__altLabel mesh__D020482 Juvenile Literature %28%PT%29%
% 219.35/219.57  |- mesh__recordAuthorizer mesh__D020482 sjn
% 219.35/219.57  |- skos__scopeNote mesh__D020482
% 219.35/219.57       Works produced for children through age 15 or through the ninth grade.%A%    
% 219.35/219.57  |- skos__prefLabel mesh__D020482
% 219.35/219.57       Juvenile Literature %5B%Publication Type%5D%
% 219.35/219.57  |- skos__broader mesh__D020482smesh__D020496
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D020482 2006
% 219.35/219.57  |- mesh__recordMaintainer mesh__D014445 ssb
% 219.35/219.57  |- mesh__dateRevised mesh__D014445 2003-07-09
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D014445 2005
% 219.35/219.57  |- skos__prefLabel mesh__D014445 Tyrosine Decarboxylase
% 219.35/219.57  |- mesh__recordAuthorizer mesh__D014445 sjn
% 219.35/219.57  |- mesh__recordOriginator mesh__D014445 NLM
% 219.35/219.57  |- skos__broader mesh__D014445smesh__D002262
% 219.35/219.57  |- skos__scopeNote mesh__D014445
% 219.35/219.57       A pyridoxal-phosphate protein that catalyzes the conversion of L-tyrosine to tyramine and carbon dioxide. The bacterial enzyme also acts on 3-hydroxytyrosine and, more slowly, on 3-hydroxyphenylalanine. %28%From Enzyme Nomenclature, 1992%29% EC 4.1.1.25.%A%    
% 219.35/219.57  |- skos__hiddenLabel mesh__D014445 Decarboxylase, Tyrosine
% 219.35/219.57  |- rdf__type mesh__D014445sskos__Concept
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D014445 2004
% 219.35/219.57  |- mesh__dateCreated mesh__D014445 1999-01-01
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D014445 2006
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D008408 2006
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D008408 2000
% 219.35/219.57  |- rdf__type mesh__D008408sskos__Concept
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D008408 2004
% 219.35/219.57  |- mesh__dateRevised mesh__D008408 1996-06-10
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D008408 2001
% 219.35/219.57  |- skos__hiddenLabel mesh__D008408 Mammectomies
% 219.35/219.57  |- skos__hiddenLabel mesh__D008408 Mastectomies
% 219.35/219.57  |- skos__broader mesh__D008408smesh__D013514
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D008408 1998
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D008408 2002
% 219.35/219.57  |- mesh__recordAuthorizer mesh__D008408 PLS
% 219.35/219.57  |- skos__annotation mesh__D008408
% 219.35/219.57       GEN or unspecified; prefer specifics; do not use /util except by MeSH definition%A%  
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D008408 1999
% 219.35/219.57  |- mesh__recordMaintainer mesh__D008408 TGC
% 219.35/219.57  |- skos__prefLabel mesh__D008408 Mastectomy
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D008408 1997
% 219.35/219.57  |- skos__altLabel mesh__D008408 Mammectomy
% 219.35/219.57  |- mesh__dateCreated mesh__D008408 1999-01-01
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D008408 2005
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D008408 2003
% 219.35/219.57  |- mesh__recordOriginator mesh__D008408 NLM
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D000425 2003
% 219.35/219.57  |- rdf__type mesh__D000425sskos__Concept
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Alcohol Induced Amnestic Syndrome
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Korsakoff Syndromes, Alcoholic
% 219.35/219.57  |- skos__prefLabel mesh__D000425 Alcohol Amnestic Disorder
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Syndrome, Alcohol-Induced Amnestic
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Psychoses, Alcohol-Induced Amnestic
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Syndrome, Alcohol-Induced Dysmnesic
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Alcohol-Induced Dysmnesic Psychoses
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D000425 2001
% 219.35/219.57  |- skos__altLabel mesh__D000425
% 219.35/219.57       Alcohol-Induced Persisting Amnestic Disorder
% 219.35/219.57  |- skos__scopeNote mesh__D000425
% 219.35/219.57       A mental disorder associated with chronic ethanol abuse %28%ALCOHOLISM%29% and nutritional deficiencies characterized by short term memory loss, confabulations, and disturbances of attention. %28%Adams et al., Principles of Neurology, 6th ed, p1139%29%%A%    
% 219.35/219.57  |- skos__altLabel mesh__D000425 Alcohol Amnestic Syndrome
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Alcohol-Induced Korsakoff Syndromes
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D000425 2006
% 219.35/219.57  |- skos__altLabel mesh__D000425 Alcohol-Induced Amnestic Psychosis
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Korsakoff Syndrome, Alcoholic
% 219.35/219.57  |- skos__broader mesh__D000425smesh__D019973
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Psychosis, Alcohol-Induced Dysmnesic
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Psychosis, Alcohol-Induced Amnestic
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Amnestic Disorder, Alcohol
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Amnestic Psychosis, Alcohol Induced
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Syndromes, Alcohol Amnestic
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Syndromes, Alcohol-Induced Amnestic
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Psychoses, Alcohol-Induced Dysmnesic
% 219.35/219.57  |- skos__altLabel mesh__D000425 Amnestic Psychosis, Alcohol-Induced
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Syndromes, Alcohol-Induced Dysmnesic
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Dysmnesic Syndrome, Alcohol-Induced
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D000425 2000
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Syndromes, Alcoholic Korsakoff
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Alcohol-Induced Amnestic Syndromes
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D000425 2005
% 219.35/219.57  |- skos__broader mesh__D000425smesh__D000647
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Alcohol-Induced Dysmnesic Syndromes
% 219.35/219.57  |- mesh__recordAuthorizer mesh__D000425 sjn
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Amnestic Syndromes, Alcohol
% 219.35/219.57  |- skos__broader mesh__D000425smesh__D020268
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Amnestic Disorders, Alcohol
% 219.35/219.57  |- skos__altLabel mesh__D000425 Alcoholic Korsakoff Syndrome
% 219.35/219.57  |- mesh__dateRevised mesh__D000425 1999-11-03
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Alcohol Induced Dysmnesic Syndrome
% 219.35/219.57  |- mesh__publicMeSHNote mesh__D000425
% 219.35/219.57       81; was KORSAKOFF%27%S SYNDROME 1963-80   
% 219.35/219.57  |- mesh__recordOriginator mesh__D000425 NLM
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Dysmnesic Syndromes, Alcohol-Induced
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Syndrome, Alcoholic Korsakoff
% 219.35/219.57  |- skos__altLabel mesh__D000425 Alcohol-Induced Amnestic Syndrome
% 219.35/219.57  |- mesh__recordMaintainer mesh__D000425 KEV
% 219.35/219.57  |- skos__altLabel mesh__D000425 Alcohol-Induced Dysmnesic Syndrome
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Korsakoff Syndrome, Alcohol-Induced
% 219.35/219.57  |- mesh__dateCreated mesh__D000425 1999-01-01
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Syndrome, Alcohol Amnestic
% 219.35/219.57  |- mesh__onlineNote mesh__D000425
% 219.35/219.57       use ALCOHOL AMNESTIC DISORDER to search KORSAKOFF%27%S SYNDROME 1966-80%A%  
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Alcohol Induced Amnestic Psychosis
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Alcohol-Induced Amnestic Psychoses
% 219.35/219.57  |- skos__altLabel mesh__D000425 Alcohol-Induced Korsakoff Syndrome
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Alcoholic Korsakoff Syndromes
% 219.35/219.57  |- skos__altLabel mesh__D000425 Alcohol-Induced Dysmnesic Psychosis
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Alcohol Induced Korsakoff Syndrome
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Korsakoff Syndromes, Alcohol-Induced
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D000425 2004
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Dysmnesic Psychoses, Alcohol-Induced
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D000425 2002
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Amnestic Syndrome, Alcohol-Induced
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Amnestic Syndrome, Alcohol
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425
% 219.35/219.57       Alcohol Induced Persisting Amnestic Disorder
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Alcohol Amnestic Disorders
% 219.35/219.57  |- mesh__historyNote mesh__D000425
% 219.35/219.57       81; was KORSAKOFF%27%S SYNDROME 1963-80   
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Dysmnesic Psychosis, Alcohol-Induced
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Alcohol Amnestic Syndromes
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Syndromes, Alcohol-Induced Korsakoff
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Amnestic Syndromes, Alcohol-Induced
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Syndrome, Alcohol-Induced Korsakoff
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Alcohol Induced Dysmnesic Psychosis
% 219.35/219.57  |- skos__hiddenLabel mesh__D000425 Amnestic Psychoses, Alcohol-Induced
% 219.35/219.57  |- skos__prefLabel mesh__D005110 Extracellular Space
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D005110 2006
% 219.35/219.57  |- skos__hiddenLabel mesh__D005110 Extracellular Spaces
% 219.35/219.57  |- skos__hiddenLabel mesh__D005110 Space, Extracellular
% 219.35/219.57  |- skos__hiddenLabel mesh__D005110 Space, Intercellular
% 219.35/219.57  |- mesh__recordMaintainer mesh__D005110 nns
% 219.35/219.57  |- skos__hiddenLabel mesh__D005110 Spaces, Intercellular
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D005110 2004
% 219.35/219.57  |- skos__hiddenLabel mesh__D005110 Spaces, Extracellular
% 219.35/219.57  |- mesh__recordAuthorizer mesh__D005110 sjn
% 219.35/219.57  |- rdf__type mesh__D005110sskos__Concept
% 219.35/219.57  |- skos__hiddenLabel mesh__D005110 Intercellular Spaces
% 219.35/219.57  |- skos__scopeNote mesh__D005110
% 219.35/219.57       Interstitial space between cells, occupied by INTERSTITIAL FLUID as well as amorphous and fibrous substances. For organisms with a CELL WALL, the extracellular space includes everything outside of the CELL MEMBRANE including the PERIPLASM and the cell wall.%A%    
% 219.35/219.57  |- mesh__recordOriginator mesh__D005110 NLM
% 219.35/219.57  |- mesh__dateEstablished mesh__D005110 1966-01-01
% 219.35/219.57  |- mesh__historyNote mesh__D005110 1966%28%1964%29%   
% 219.35/219.57  |- skos__altLabel mesh__D005110 Intercellular Space
% 219.35/219.57  |- mesh__publicMeSHNote mesh__D005110 1966   
% 219.35/219.57  |- skos__broader mesh__D005110smesh__D022082
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D005110 2005
% 219.35/219.57  |- mesh__dateCreated mesh__D005110 1999-01-01
% 219.35/219.57  |- mesh__dateRevised mesh__D005110 2003-07-09
% 219.35/219.57  |- mesh__dateCreated mesh__D018836 1994-06-01
% 219.35/219.57  |- mesh__dateEstablished mesh__D018836 1995-01-01
% 219.35/219.57  |- mesh__recordOriginator mesh__D018836 TPW
% 219.35/219.57  |- skos__hiddenLabel mesh__D018836 Mediators, Inflammation
% 219.35/219.57  |- mesh__dateRevised mesh__D018836 2005-06-30
% 219.35/219.57  |- mesh__historyNote mesh__D018836 95   
% 219.35/219.57  |- skos__broader mesh__D018836smesh__D001685
% 219.35/219.57  |- mesh__recordMaintainer mesh__D018836 ssb
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D018836 2006
% 219.35/219.57  |- rdf__type mesh__D018836sskos__Concept
% 219.35/219.57  |- mesh__publicMeSHNote mesh__D018836 95   
% 219.35/219.57  |- skos__altLabel mesh__D018836 Mediators of Inflammation
% 219.35/219.57  |- skos__prefLabel mesh__D018836 Inflammation Mediators
% 219.35/219.57  |- skos__annotation mesh__D018836
% 219.35/219.57       do not confuse with ANTI-INFLAMMATORY AGENTS; DF: INFLAMM MEDIATORS%A%  
% 219.35/219.57  |- mesh__recordAuthorizer mesh__D018836 sjn
% 219.35/219.57  |- skos__scopeNote mesh__D018836
% 219.35/219.57       The endogenous compounds that mediate inflammation %28%AUTACOIDS%29% and related exogenous compounds including the synthetic prostaglandins %28%PROSTAGLANDINS, SYNTHETIC%29%.%A%    
% 219.35/219.57  |- skos__broader mesh__D010853smesh__D006241
% 219.35/219.57  |- mesh__historyNote mesh__D010853 65   
% 219.35/219.57  |- mesh__dateRevised mesh__D010853 2005-06-30
% 219.35/219.57  |- mesh__recordOriginator mesh__D010853 NLM
% 219.35/219.57  |- skos__altLabel mesh__D010853 2,4,6-Trinitro-1-chlorobenzene
% 219.35/219.57  |- skos__scopeNote mesh__D010853
% 219.35/219.57       A hapten that generates suppressor cells capable of down-regulating the efferent phase of trinitrophenol-specific contact hypersensitivity. %28%Arthritis Rheum 1991 Feb;34%28%2%29%:180%29%.%A%    
% 219.35/219.57  |- skos__altLabel mesh__D010853 Trinitrochlorobenzene
% 219.35/219.57  |- mesh__publicMeSHNote mesh__D010853 65   
% 219.35/219.57  |- mesh__dateCreated mesh__D010853 1999-01-01
% 219.35/219.57  |- skos__hiddenLabel mesh__D010853 Chloride, Picryl
% 219.35/219.57  |- skos__altLabel mesh__D010853 1-Chloro-2,4,6-trinitrobenzene
% 219.35/219.57  |- rdf__type mesh__D010853sskos__Concept
% 219.35/219.57  |- skos__prefLabel mesh__D010853 Picryl Chloride
% 219.35/219.57  |- mesh__dateEstablished mesh__D010853 1965-01-01
% 219.35/219.57  |- mesh__recordAuthorizer mesh__D010853 sjn
% 219.35/219.57  |- skos__broader mesh__D010853smesh__D006843
% 219.35/219.57  |- skos__broader mesh__D010853smesh__D014301
% 219.35/219.57  |- mesh__recordMaintainer mesh__D010853 ssb
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D010853 2006
% 219.35/219.57  |- mesh__onlineNote mesh__D018038
% 219.35/219.57       use SODIUM SELENITE %28%NM%29% to search SODIUM SELENITE 1980-93%A%  
% 219.35/219.57  |- rdf__type mesh__D018038sskos__Concept
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D018038 2004
% 219.35/219.57  |- skos__hiddenLabel mesh__D018038 Selenite, Sodium
% 219.35/219.57  |- mesh__historyNote mesh__D018038
% 219.35/219.57       94; was SODIUM SELENITE %28%NM%29% 1992-93; was SY to SELENIOUS ACID %28%NM%29% 1980-91%A%  
% 219.35/219.57  |- skos__hiddenLabel mesh__D018038 mono Na salt of Sodium Selenite
% 219.35/219.57  |- mesh__recordOriginator mesh__D018038 TPW
% 219.35/219.57  |- skos__scopeNote mesh__D018038
% 219.35/219.57       Selenious acid, disodium salt. It is used therapeutically to supply the trace element selenium.%A%    
% 219.35/219.57  |- mesh__dateRevised mesh__D018038 2003-07-25
% 219.35/219.57  |- skos__annotation mesh__D018038
% 219.35/219.57       a selenium cpd: do not confuse X ref SELENITE with the selenite which is a form of CALCIUM SULFATE%A%  
% 219.35/219.57  |- mesh__publicMeSHNote mesh__D018038
% 219.35/219.57       94; SODIUM SELENITE was indexed under SELENIUM 1992-93   
% 219.35/219.57  |- mesh__dateEstablished mesh__D018038 1994-01-01
% 219.35/219.57  |- mesh__dateCreated mesh__D018038 1993-06-17
% 219.35/219.57  |- mesh__recordMaintainer mesh__D018038 ssb
% 219.35/219.57  |- skos__historyNote mesh__D018038 Selenium %28%1966-1993%29%
% 219.35/219.57  |- skos__hiddenLabel mesh__D018038 Sodium Selenite pentahydrate
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D018038 2006
% 219.35/219.57  |- skos__hiddenLabel mesh__D018038 Selenite pentahydrate, Sodium
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D018038 2005
% 219.35/219.57  |- skos__broader mesh__D018038smesh__D017670
% 219.35/219.57  |- skos__hiddenLabel mesh__D018038
% 219.35/219.57       diselenious acid, di Na salt of Sodium Selenite
% 219.35/219.57  |- skos__broader mesh__D018038smesh__D018036
% 219.35/219.57  |- mesh__recordAuthorizer mesh__D018038 sjn
% 219.35/219.57  |- skos__prefLabel mesh__D018038 Sodium Selenite
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D004816 2006
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D004816 1999
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D004816 2000
% 219.35/219.57  |- skos__altLabel mesh__D004816 Scalded Skin Syndrome, Nonstaphylococcal
% 219.35/219.57  |- rdf__type mesh__D004816sskos__Concept
% 219.35/219.57  |- skos__hiddenLabel mesh__D004816 Syndrome, Lyell%27%s
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D004816 2003
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D004816 1996
% 219.35/219.57  |- mesh__recordMaintainer mesh__D004816 TAP
% 219.35/219.57  |- skos__hiddenLabel mesh__D004816 Necrolyses, Toxic Epidermal
% 219.35/219.57  |- skos__scopeNote mesh__D004816
% 219.35/219.57       An exfoliative disease of skin seen primarily in adults and characterized by flaccid bullae and spreading erythema so that the skin has the appearance of being scalded. It results primarily from a toxic reaction to various drugs, but occasionally occurs as a result of infection, neoplastic conditions, or other exposure.%A%    
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D004816 2001
% 219.35/219.57  |- mesh__historyNote mesh__D004816 65%28%64%29%   
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D004816 2004
% 219.35/219.57  |- mesh__recordAuthorizer mesh__D004816 PLS
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D004816 1997
% 219.35/219.57  |- skos__hiddenLabel mesh__D004816 Lyells Syndrome
% 219.35/219.57  |- skos__hiddenLabel mesh__D004816 Toxic Epidermal Necrolyses
% 219.35/219.57  |- skos__annotation mesh__D004816
% 219.35/219.57       a toxic reaction to drugs; do not confuse X ref NONSTAPHYLOCOCCAL SCALDED SKIN SYNDROME with STAPHYLOCOCCAL SCALDED SKIN SYNDROME%A%  
% 219.35/219.57  |- skos__hiddenLabel mesh__D004816 Necrolysis, Toxic Epidermal
% 219.35/219.57  |- mesh__publicMeSHNote mesh__D004816 65   
% 219.35/219.57  |- mesh__dateCreated mesh__D004816 1999-01-01
% 219.35/219.57  |- mesh__recordOriginator mesh__D004816 NLM
% 219.35/219.57  |- mesh__dateEstablished mesh__D004816 1965-01-01
% 219.35/219.57  |- skos__altLabel mesh__D004816 Nonstaphylococcal Scalded Skin Syndrome
% 219.35/219.57  |- skos__altLabel mesh__D004816 Lyell%27%s Syndrome
% 219.35/219.57  |- mesh__dateRevised mesh__D004816 1993-06-02
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D004816 2002
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D004816 1994
% 219.35/219.57  |- skos__broader mesh__D004816smesh__D003875
% 219.35/219.57  |- skos__hiddenLabel mesh__D004816 Lyell Syndrome
% 219.35/219.57  |- skos__altLabel mesh__D004816 Toxic Epidermal Necrolysis
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D004816 2005
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D004816 1998
% 219.35/219.57  |- skos__hiddenLabel mesh__D004816 Epidermal Necrolyses, Toxic
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D004816 1995
% 219.35/219.57  |- skos__prefLabel mesh__D004816 Epidermal Necrolysis, Toxic
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D004018 2002
% 219.35/219.57  |- mesh__recordMaintainer mesh__D004018 kle
% 219.35/219.57  |- skos__broader mesh__D004018smesh__D004014
% 219.35/219.57  |- skos__broader mesh__D004018smesh__D012014
% 219.35/219.57  |- skos__prefLabel mesh__D004018 Dictionaries, Medical
% 219.35/219.57  |- mesh__recordOriginator mesh__D004018 NLM
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D004018 2001
% 219.35/219.57  |- skos__altLabel mesh__D004018 Dictionary, Medical
% 219.35/219.57  |- rdf__type mesh__D004018sskos__Concept
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D004018 2000
% 219.35/219.57  |- mesh__dateCreated mesh__D004018 1999-01-01
% 219.35/219.57  |- skos__altLabel mesh__D004018 Medical Dictionaries
% 219.35/219.57  |- skos__altLabel mesh__D004018 Medical Dictionary
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D004018 2004
% 219.35/219.57  |- skos__annotation mesh__D004018
% 219.35/219.57       IM for med dictionaries as a subject; for article listing med terms %26% definitions, index under specific subject %28%IM%29% + DICTIONARY %28%PT%29%; no qualif; Manual 33.14; no qualif; DF: DICTIONARIES MED%A%  
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D004018 2006
% 219.35/219.57  |- mesh__recordAuthorizer mesh__D004018 sjn
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D004018 2003
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D004018 2005
% 219.35/219.57  |- mesh__dateRevised mesh__D004018 1999-11-03
% 219.35/219.57  |- skos__scopeNote mesh__D009501
% 219.35/219.57       Activation analysis in which the specimen is bombarded with neutrons. Identification is made by measuring the resulting radioisotopes. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 219.35/219.57  |- mesh__recordMaintainer mesh__D009501 lkt
% 219.35/219.57  |- mesh__historyNote mesh__D009501
% 219.35/219.57       91%28%75%29%; was see under ACTIVATION ANALYSIS 1975-90   
% 219.35/219.57  |- skos__altLabel mesh__D009501 Activation Analysis, Neutron
% 219.35/219.57  |- mesh__dateRevised mesh__D009501 2002-07-02
% 219.35/219.57  |- mesh__recordOriginator mesh__D009501 NLM
% 219.35/219.57  |- skos__broader mesh__D009501smesh__D000201
% 219.35/219.57  |- rdf__type mesh__D009501sskos__Concept
% 219.35/219.57  |- skos__hiddenLabel mesh__D009501 Neutron Activation Analyses
% 219.35/219.57  |- mesh__dateCreated mesh__D009501 1999-01-01
% 219.35/219.57  |- mesh__publicMeSHNote mesh__D009501
% 219.35/219.57       91; was see under ACTIVATION ANALYSIS 1975-90   
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D009501 2005
% 219.35/219.57  |- skos__hiddenLabel mesh__D009501 Analyses, Neutron Activation
% 219.35/219.57  |- skos__hiddenLabel mesh__D009501 Activation Analyses, Neutron
% 219.35/219.57  |- mesh__recordAuthorizer mesh__D009501 sjn
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D009501 2006
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D009501 2003
% 219.35/219.57  |- mesh__onlineNote mesh__D009501 search ACTIVATION ANALYSIS 1967-74   
% 219.35/219.57  |- skos__altLabel mesh__D009501 Analysis, Neutron Activation
% 219.35/219.57  |- mesh__dateEstablished mesh__D009501 1991-01-01
% 219.35/219.57  |- skos__annotation mesh__D009501
% 219.35/219.57       an anal chem technique; NIM; DF: NEUTRON ACTIVATION ANAL   
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D009501 2004
% 219.35/219.57  |- skos__prefLabel mesh__D009501 Neutron Activation Analysis
% 219.35/219.57  |- skos__hiddenLabel mesh__D014446 Hydroxylase, Tyrosine
% 219.35/219.57  |- mesh__publicMeSHNote mesh__D014446
% 219.35/219.57       95; was TYROSINE HYDROXYLASE 1971-94   
% 219.35/219.57  |- skos__scopeNote mesh__D014446
% 219.35/219.57       An enzyme that catalyzes the conversion of L-tyrosine, tetrahydrobiopterin, and oxygen to 3,4-dihydroxy-L-phenylalanine, dihydrobiopterin, and water. EC 1.14.16.2.%A%    
% 219.35/219.57  |- mesh__recordMaintainer mesh__D014446 ssb
% 219.35/219.57  |- mesh__dateEstablished mesh__D014446 1973-01-01
% 219.35/219.57  |- rdf__type mesh__D014446sskos__Concept
% 219.35/219.57  |- skos__altLabel mesh__D014446 Tyrosine Hydroxylase
% 219.35/219.57  |- mesh__dateRevised mesh__D014446 2004-07-07
% 219.35/219.57  |- skos__historyNote mesh__D014446 Hydroxylases %28%1966-1970%29%
% 219.35/219.57  |- mesh__dateCreated mesh__D014446 1999-01-01
% 219.35/219.57  |- skos__broader mesh__D014446smesh__D019159
% 219.35/219.57  |- mesh__onlineNote mesh__D014446
% 219.35/219.57       use TYROSINE 3-MONOOXYGENASE to search TYROSINE HYDROXYLASE 1971-94 %28%as Prov 1971-73%29%%A%  
% 219.35/219.57  |- skos__broader mesh__D014446smesh__D006899
% 219.35/219.57  |- mesh__recordAuthorizer mesh__D014446 sjn
% 219.35/219.57  |- mesh__recordOriginator mesh__D014446 NLM
% 219.35/219.57  |- skos__hiddenLabel mesh__D014446 Tyrosine 3 Monooxygenase
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D014446 2006
% 219.35/219.57  |- skos__hiddenLabel mesh__D014446 3-Monooxygenase, Tyrosine
% 219.35/219.57  |- mesh__historyNote mesh__D014446
% 219.35/219.57       95; was TYROSINE HYDROXYLASE 1971-94 %28%Prov 1971-73%29%   
% 219.35/219.57  |- skos__prefLabel mesh__D014446 Tyrosine 3-Monooxygenase
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D014446 2005
% 219.35/219.57  |- skos__broader mesh__D008409smesh__D004068
% 219.35/219.57  |- mesh__recordAuthorizer mesh__D008409 sjn
% 219.35/219.57  |- skos__prefLabel mesh__D008409 Mastication
% 219.35/219.57  |- mesh__dateRevised mesh__D008409 2000-06-22
% 219.35/219.57  |- mesh__recordOriginator mesh__D008409 NLM
% 219.35/219.57  |- mesh__dateCreated mesh__D008409 1999-01-01
% 219.35/219.57  |- mesh__recordMaintainer mesh__D008409 adp
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D008409 2005
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D008409 2003
% 219.35/219.57  |- skos__altLabel mesh__D008409 Chewing
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D008409 2006
% 219.35/219.57  |- skos__scopeNote mesh__D008409
% 219.35/219.57       The act and process of chewing and grinding food in the mouth.%A%    
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D008409 2001
% 219.35/219.57  |- rdf__type mesh__D008409sskos__Concept
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D008409 2004
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D008409 2002
% 219.35/219.57  |- skos__annotation mesh__D000426
% 219.35/219.57       a specific enzyme; do not confuse with ALCOHOL OXIDOREDUCTASES%A%  
% 219.35/219.57  |- skos__broader mesh__D000426smesh__D000429
% 219.35/219.57  |- mesh__recordOriginator mesh__D000426 RLS
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D000426 2005A
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D000426 2005
% 219.35/219.57  |- mesh__recordMaintainer mesh__D000426 jls
% 219.35/219.57  |- skos__historyNote mesh__D000426
% 219.35/219.57       Alcohol Oxidoreductases %28%1966-1986%29%
% 219.35/219.57  |- skos__hiddenLabel mesh__D000426 Dehydrogenase, Alcohol
% 219.35/219.57  |- mesh__dateRevised mesh__D000426 2004-08-03
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D000426 2006
% 219.35/219.57  |- skos__hiddenLabel mesh__D000426 Oxidoreductase, Alcohol-NAD+
% 219.35/219.57  |- skos__hiddenLabel mesh__D000426 Alcohol Dehydrogenase, Yeast
% 219.35/219.57  |- mesh__publicMeSHNote mesh__D000426 87   
% 219.35/219.57  |- mesh__historyNote mesh__D000426 87   
% 219.35/219.57  |- skos__altLabel mesh__D000426 Alcohol Dehydrogenase %28%NAD+%29%
% 219.35/219.57  |- mesh__dateCreated mesh__D000426 1986-04-09
% 219.35/219.57  |- skos__altLabel mesh__D000426 Alcohol-NAD+ Oxidoreductase
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D000426 2004
% 219.35/219.57  |- skos__scopeNote mesh__D000426
% 219.35/219.57       A zinc-containing enzyme which oxidizes primary and secondary alcohols or hemiacetals in the presence of NAD. In alcoholic fermentation, it catalyzes the final step of reducing an aldehyde to an alcohol in the presence of NADH and hydrogen.%A%    
% 219.35/219.57  |- mesh__dateEstablished mesh__D000426 1987-01-01
% 219.35/219.57  |- skos__hiddenLabel mesh__D000426 Alcohol NAD+ Oxidoreductase
% 219.35/219.57  |- skos__prefLabel mesh__D000426 Alcohol Dehydrogenase
% 219.35/219.57  |- skos__hiddenLabel mesh__D000426 Dehydrogenase, Yeast Alcohol
% 219.35/219.57  |- rdf__type mesh__D000426sskos__Concept
% 219.35/219.57  |- mesh__recordAuthorizer mesh__D000426 jls
% 219.35/219.57  |- skos__altLabel mesh__D019131
% 219.35/219.57       Social Security Administration, United States
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D019131 2006
% 219.35/219.57  |- skos__historyNote mesh__D019131 Social Security %28%1966-1995%29%
% 219.35/219.57  |- mesh__dateEstablished mesh__D019131 1996-01-01
% 219.35/219.57  |- rdf__type mesh__D019131sskos__Concept
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D019131 2005
% 219.35/219.57  |- mesh__dateRevised mesh__D019131 2004-07-13
% 219.35/219.57  |- mesh__recordOriginator mesh__D019131 JLS
% 219.35/219.57  |- mesh__recordMaintainer mesh__D019131 sjn
% 219.35/219.57  |- mesh__historyNote mesh__D019131 96   
% 219.35/219.57  |- skos__prefLabel mesh__D019131
% 219.35/219.57       United States Social Security Administration
% 219.35/219.57  |- skos__annotation mesh__D019131
% 219.35/219.57       add UNITED STATES %28%NIM%29%; research support by this agency is checked as OTHER US GOVT SUPPORT; DF: SSA      CATALOG: use NAF entry%A%  
% 219.35/219.57  |- mesh__recordAuthorizer mesh__D019131 sjn
% 219.35/219.57  |- mesh__dateCreated mesh__D019131 1995-06-05
% 219.35/219.57  |- mesh__publicMeSHNote mesh__D019131 96   
% 219.35/219.57  |- skos__altLabel mesh__D019131 Social Security Administration %28%U.S.%29%
% 219.35/219.57  |- skos__broader mesh__D019131smesh__D006077
% 219.35/219.57  |- skos__altLabel mesh__D019131 Social Security Administration
% 219.35/219.57  |- skos__scopeNote mesh__D019131
% 219.35/219.57       The Social Security Administration administers a national program of contributory social insurance whereby employees, employers, and the self-employed pay contributions that are pooled in special trust funds. When earnings are reduced because of retirement, death, or disability, monthly benefits are paid to partially replace lost earnings. Part of the contributions go into a separate hospital insurance trust fund for workers when they become 65 to provide help with medical expenses. Other programs include the supplemental social security income program for the aged, blind, and disabled and the Old Age Survivors and Disability Insurance Program. SSA became an independent agency March 31, 1995. It had previously been part of the Department of Health, Education, and Welfare, later the Department of Health and Human Services. %28%From United States Government Manual, 1994-95%29%%A%    
% 219.35/219.57  |- skos__altLabel mesh__D005111 Extranuclear Inheritance
% 219.35/219.57  |- mesh__recordOriginator mesh__D005111 NLM
% 219.35/219.57  |- skos__hiddenLabel mesh__D005111 Inheritance, Extrachromosomal
% 219.35/219.57  |- skos__broader mesh__D005111smesh__D040582
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D005111 2006
% 219.35/219.57  |- skos__related mesh__D005111smesh__D004272
% 219.35/219.57  |- mesh__dateCreated mesh__D005111 1999-01-01
% 219.35/219.57  |- mesh__recordMaintainer mesh__D005111 nns
% 219.35/219.57  |- skos__prefLabel mesh__D005111 Extrachromosomal Inheritance
% 219.35/219.57  |- skos__hiddenLabel mesh__D005111 Inheritance, Cytoplasmic
% 219.35/219.57  |- mesh__publicMeSHNote mesh__D005111 68   
% 219.35/219.57  |- mesh__dateRevised mesh__D005111 2005-06-30
% 219.35/219.57  |- skos__scopeNote mesh__D005111
% 219.35/219.57       Vertical transmission of hereditary characters by DNA from cytoplasmic organelles such as MITOCHONDRIA; CHLOROPLASTS; and PLASTIDS, or from PLASMIDS or viral episomal DNA.%A%    
% 219.35/219.57  |- mesh__dateEstablished mesh__D005111 1968-01-01
% 219.35/219.57  |- skos__historyNote mesh__D005111 Genetics %28%1966-1967%29%
% 219.35/219.57  |- rdf__type mesh__D005111sskos__Concept
% 219.35/219.57  |- mesh__historyNote mesh__D005111 68   
% 219.35/219.57  |- skos__related mesh__D005111smesh__D018742
% 219.35/219.57  |- mesh__recordAuthorizer mesh__D005111 sjn
% 219.35/219.57  |- skos__hiddenLabel mesh__D005111 Inheritance, Extranuclear
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D046528 2006
% 219.35/219.57  |- skos__historyNote mesh__D046528 Chimera %28%1966-2004%29%
% 219.35/219.57  |- skos__historyNote mesh__D046528
% 219.35/219.57       Transplantation Chimera %28%1966-2004%29%
% 219.35/219.57  |- skos__scopeNote mesh__D046528
% 219.35/219.57       The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from different individuals. This contrasts with MOSAICISM in which the different cell populations are derived from a single individual.%A%    
% 219.35/219.57  |- mesh__publicMeSHNote mesh__D046528 2005   
% 219.35/219.57  |- mesh__activeMeSHYear mesh__D046528 2005
% 219.35/219.57  |- skos__broader mesh__D046528smesh__D002869
% 219.35/219.57  |- mesh__recordAuthorizer mesh__D046528 sjn
% 219.35/219.57  |- skos__related mesh__D046528smesh__D002678
% 219.35/219.57  |- skos__prefLabel mesh__D046528 Chimerism
% 219.35/219.57  |- mesh__recordMaintainer mesh__D046528 ags
% 219.35/219.57  |- mesh__historyNote mesh__D046528 2005   
% 219.35/219.57  |- skos__related mesh__D046528smesh__D009030
% 219.35/219.57  |- rdf__type mesh__D046528sskos__Concept
% 219.35/219.57  |- mesh__recordOriginator mesh__D046528 ags
% 219.35/219.57  |- mesh__dateEstablished mesh__D046528 2005-01-01
% 219.35/219.57  |- mesh__dateCreated mesh__D046528 2004-07-07
% 219.35/219.57  |- skos__broader mesh__D018837smesh__D018835
% 219.35/219.57  |- mesh__recordAuthorizer mesh__D018837 sjn
% 219.35/219.57  |- skos__prefLabel mesh__D018837 GroES Protein
% 219.35/219.58  |- mesh__onlineNote mesh__D018837
% 219.35/219.58       use GROES PROTEIN %28%NM%29% to search GROES STRESS PROTEIN 1989-94%A%  
% 219.35/219.58  |- mesh__dateEstablished mesh__D018837 1995-01-01
% 219.35/219.58  |- skos__hiddenLabel mesh__D018837 Stress Protein, GroES
% 219.35/219.58  |- mesh__publicMeSHNote mesh__D018837
% 219.35/219.58       95; GROES STRESS PROTEIN was indexed under BACTERIAL PROTEINS %26% HEAT-SHOCK PROTEINS 1989-94%A%  
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D018837 2006
% 219.35/219.58  |- skos__hiddenLabel mesh__D018837 Protein, GroES Stress
% 219.35/219.58  |- mesh__dateRevised mesh__D018837 2005-06-30
% 219.35/219.58  |- rdf__type mesh__D018837sskos__Concept
% 219.35/219.58  |- skos__altLabel mesh__D018837 GroES Stress Protein
% 219.35/219.58  |- mesh__historyNote mesh__D018837
% 219.35/219.58       95; was GROES STRESS PROTEIN %28%NM%29% 1989-94   
% 219.35/219.58  |- skos__scopeNote mesh__D018837
% 219.35/219.58       A chaperonin 10 heat-shock protein isolated from Escherichia coli.%A%    
% 219.35/219.58  |- skos__historyNote mesh__D018837 Bacterial Proteins %28%1989-1994%29%
% 219.35/219.58  |- mesh__recordOriginator mesh__D018837 PXP
% 219.35/219.58  |- skos__historyNote mesh__D018837 Heat-Shock Proteins %28%1989-1994%29%
% 219.35/219.58  |- skos__altLabel mesh__D018837 Chaperonin 10 %28%GroES%29%
% 219.35/219.58  |- skos__broader mesh__D018837smesh__D001426
% 219.35/219.58  |- skos__hiddenLabel mesh__D018837 Protein, GroES
% 219.35/219.58  |- mesh__dateCreated mesh__D018837 1994-05-31
% 219.35/219.58  |- mesh__recordMaintainer mesh__D018837 SYSTEM
% 219.35/219.58  |- skos__annotation mesh__D018837
% 219.35/219.58       a chaperonin; spell in titles %26% translations with uppercase G %26% ES: GroES%A%  
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010854 1999
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010854 1996
% 219.35/219.58  |- skos__broader mesh__D010854smesh__D009181
% 219.35/219.58  |- mesh__dateCreated mesh__D010854 1999-01-01
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010854 2006
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010854 2003
% 219.35/219.58  |- skos__prefLabel mesh__D010854 Piedra
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010854 1998
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010854 2002
% 219.35/219.58  |- skos__scopeNote mesh__D010854
% 219.35/219.58       Either of two diseases resulting from fungal infection of the hair shafts. Black piedra occurs mainly in and on the hairs of the scalp and is caused by Piedraia hortae; white piedra occurs in and on the hairs of the scalp, beard, moustache and genital areas and is caused by Trichosporon beigelii.%A%    
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010854 2005
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010854 1995
% 219.35/219.58  |- mesh__dateEstablished mesh__D010854 1991-01-01
% 219.35/219.58  |- mesh__dateRevised mesh__D010854 1993-06-02
% 219.35/219.58  |- mesh__publicMeSHNote mesh__D010854 91; was see under MYCOSES 1975-90   
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010854 2001
% 219.35/219.58  |- mesh__recordMaintainer mesh__D010854 TAP
% 219.35/219.58  |- mesh__historyNote mesh__D010854
% 219.35/219.58       91%28%75%29%; was see under MYCOSES 1975-90   
% 219.35/219.58  |- mesh__onlineNote mesh__D010854 search MYCOSES 1966-74   
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010854 1994
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010854 2000
% 219.35/219.58  |- mesh__recordOriginator mesh__D010854 NLM
% 219.35/219.58  |- rdf__type mesh__D010854sskos__Concept
% 219.35/219.58  |- skos__hiddenLabel mesh__D010854 Piedras
% 219.35/219.58  |- skos__annotation mesh__D010854
% 219.35/219.58       fungus dis of hair shaft: see MeSH definition   
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010854 1997
% 219.35/219.58  |- mesh__recordAuthorizer mesh__D010854 PLS
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010854 2004
% 219.35/219.58  |- skos__hiddenLabel mesh__D018039 Tachykinins Receptors
% 219.35/219.58  |- mesh__recordOriginator mesh__D018039 RAZ
% 219.35/219.58  |- skos__historyNote mesh__D018039 Receptors, Drug %28%1968-1982%29%
% 219.35/219.58  |- skos__scopeNote mesh__D018039
% 219.35/219.58       Cell surface proteins that bind tachykinins with high affinity and trigger intracellular changes influencing the behavior of cells. Three classes of tachykinin receptors have been characterized, the NK-1; NK-2; and NK-3; which prefer, respectively, substance P, neurokinin A %28%substance K, neurokinin alpha, neuromedin L%29%, and neurokinin B %28%neurokinin beta, neuromedin K%29%.%A%    
% 219.35/219.58  |- mesh__dateCreated mesh__D018039 1993-06-21
% 219.35/219.58  |- skos__broader mesh__D018039smesh__D018013
% 219.35/219.58  |- skos__historyNote mesh__D018039
% 219.35/219.58       Receptors, Cell Surface %28%1981-1984%29%
% 219.35/219.58  |- skos__altLabel mesh__D018039 Tachykinin Receptors
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D018039 2006
% 219.35/219.58  |- mesh__recordAuthorizer mesh__D018039 sjn
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D018039 2002
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D018039 2005
% 219.35/219.58  |- skos__historyNote mesh__D018039
% 219.35/219.58       Receptors, Neurotransmitter %28%1985-1993%29%
% 219.35/219.58  |- skos__altLabel mesh__D018039 Receptors, Tachykinins
% 219.35/219.58  |- skos__annotation mesh__D018039 DF: RECEPT TACHYKININ   
% 219.35/219.58  |- mesh__recordMaintainer mesh__D018039 mdb
% 219.35/219.58  |- skos__prefLabel mesh__D018039 Receptors, Tachykinin
% 219.35/219.58  |- mesh__dateEstablished mesh__D018039 1994-01-01
% 219.35/219.58  |- mesh__historyNote mesh__D018039
% 219.35/219.58       94; was TACHYKININ RECEPTOR %28%NM%29% 1984-93   
% 219.35/219.58  |- rdf__type mesh__D018039sskos__Concept
% 219.35/219.58  |- mesh__publicMeSHNote mesh__D018039
% 219.35/219.58       94; TACHYKININ RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1985-93 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1984%A%  
% 219.35/219.58  |- skos__altLabel mesh__D018039 Tachykinin Receptor
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D018039 2004
% 219.35/219.58  |- mesh__onlineNote mesh__D018039
% 219.35/219.58       use RECEPTORS, TACHYKININ %28%NM%29% to search TACHYKININ RECEPTOR 1984-93%A%  
% 219.35/219.58  |- skos__hiddenLabel mesh__D018039 Receptor, Tachykinin
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D018039 2003
% 219.35/219.58  |- mesh__dateRevised mesh__D018039 2001-07-25
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010056 2000
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010056 1995
% 219.35/219.58  |- mesh__dateEstablished mesh__D010056 1967-01-01
% 219.35/219.58  |- rdf__type mesh__D010056sskos__Concept
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010056 1998
% 219.35/219.58  |- mesh__historyNote mesh__D010056 67%28%64%29%   
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010056 1994
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010056 2004
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010056 2002
% 219.35/219.58  |- skos__broader mesh__D010056smesh__D007858
% 219.35/219.58  |- mesh__publicMeSHNote mesh__D010056 67   
% 219.35/219.58  |- mesh__recordAuthorizer mesh__D010056 PLS
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010056 2003
% 219.35/219.58  |- mesh__dateRevised mesh__D010056 1992-05-15
% 219.35/219.58  |- mesh__recordMaintainer mesh__D010056 TAP
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010056 1997
% 219.35/219.58  |- skos__scopeNote mesh__D010056
% 219.35/219.58       Learning in which practice proceeds beyond the point where the act can just be performed with the required degree of excellence.%A%    
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010056 2006
% 219.35/219.58  |- mesh__recordOriginator mesh__D010056 NLM
% 219.35/219.58  |- skos__prefLabel mesh__D010056 Overlearning
% 219.35/219.58  |- mesh__dateCreated mesh__D010056 1999-01-01
% 219.35/219.58  |- skos__hiddenLabel mesh__D010056 Overlearnings
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010056 1993
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010056 2001
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010056 1996
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010056 2005
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010056 1999
% 219.35/219.58  |- mesh__recordMaintainer mesh__D004817 nns
% 219.35/219.58  |- skos__historyNote mesh__D004817 Skin %28%1966-1977%29%
% 219.35/219.58  |- mesh__historyNote mesh__D004817 78   
% 219.35/219.58  |- mesh__dateEstablished mesh__D004817 1978-01-01
% 219.35/219.58  |- mesh__publicMeSHNote mesh__D004817 78   
% 219.35/219.58  |- mesh__recordAuthorizer mesh__D004817 sjn
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D004817 2005
% 219.35/219.58  |- skos__broader mesh__D004817smesh__D004848
% 219.35/219.58  |- skos__scopeNote mesh__D004817
% 219.35/219.58       The external, nonvascular layer of the skin. It is made up, from within outward, of five layers of EPITHELIUM: %28%1%29% basal layer %28%stratum basale epidermidis%29%; %28%2%29% spinous layer %28%stratum spinosum epidermidis%29%; %28%3%29% granular layer %28%stratum granulosum epidermidis%29%; %28%4%29% clear layer %28%stratum lucidum epidermidis%29%; and %28%5%29% horny layer %28%stratum corneum epidermidis%29%.%A%    
% 219.35/219.58  |- skos__prefLabel mesh__D004817 Epidermis
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D004817 2006
% 219.35/219.58  |- mesh__recordOriginator mesh__D004817 SMH
% 219.35/219.58  |- mesh__dateRevised mesh__D004817 2002-07-03
% 219.35/219.58  |- skos__broader mesh__D004817smesh__D012867
% 219.35/219.58  |- mesh__dateCreated mesh__D004817 1977-03-01
% 219.35/219.58  |- rdf__type mesh__D004817sskos__Concept
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D004817 2003
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D004817 2004
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D004019 2002
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D004019 2005
% 219.35/219.58  |- skos__altLabel mesh__D004019 Dictionaries, Pharmaceutical
% 219.35/219.58  |- mesh__recordOriginator mesh__D004019 NLM
% 219.35/219.58  |- skos__altLabel mesh__D004019 Dictionary, Pharmacy
% 219.35/219.58  |- mesh__recordAuthorizer mesh__D004019 ags
% 219.35/219.58  |- skos__altLabel mesh__D004019 Pharmacy Dictionary
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D004019 2001
% 219.35/219.58  |- rdf__type mesh__D004019sskos__Concept
% 219.35/219.58  |- skos__altLabel mesh__D004019 Pharmaceutical Dictionaries
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D004019 2000
% 219.35/219.58  |- mesh__dateCreated mesh__D004019 1999-01-01
% 219.35/219.58  |- skos__altLabel mesh__D004019 Pharmaceutic Dictionaries
% 219.35/219.58  |- mesh__dateRevised mesh__D004019 2005-07-13
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D004019 2006A
% 219.35/219.58  |- skos__prefLabel mesh__D004019 Dictionaries, Pharmaceutic
% 219.35/219.58  |- skos__altLabel mesh__D004019 Dictionary, Pharmaceutic
% 219.35/219.58  |- skos__altLabel mesh__D004019 Pharmaceutical Dictionary
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D004019 2004
% 219.35/219.58  |- mesh__recordMaintainer mesh__D004019 ags
% 219.35/219.58  |- skos__altLabel mesh__D004019 Pharmacy Dictionaries
% 219.35/219.58  |- skos__altLabel mesh__D004019 Dictionaries, Pharmacy
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D004019 2003
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D004019 2006
% 219.35/219.58  |- skos__annotation mesh__D004019
% 219.35/219.58       IM for pharm dictionaries as a subject; for article listing pharm terms %26% definitions, index under specific subject %28%IM%29% + DICTIONARIES, PHARMACEUTIC %28%NIM%29% + DICTIONARY %28%PT%29%; no qualif; Manual 33.14; DF: DICTIONARIES PHARM%A%  
% 219.35/219.58  |- skos__broader mesh__D004019smesh__D004014
% 219.35/219.58  |- skos__altLabel mesh__D004019 Pharmaceutic Dictionary
% 219.35/219.58  |- skos__altLabel mesh__D004019 Dictionary, Pharmaceutical
% 219.35/219.58  |- mesh__recordAuthorizer mesh__D009502 PLS
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D009502 1998
% 219.35/219.58  |- rdf__type mesh__D009502sskos__Concept
% 219.35/219.58  |- mesh__dateCreated mesh__D009502 1999-01-01
% 219.35/219.58  |- skos__scopeNote mesh__D009502
% 219.35/219.58       Electrically neutral elementary particles found in all atomic nuclei except light hydrogen; the mass is equal to that of the proton and electron combined and they are unstable when isolated from the nucleus, undergoing beta decay. Slow, thermal, epithermal, and fast neutrons refer to the energy levels with which the neutrons are ejected from heavier nuclei during their decay.%A%    
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D009502 2005
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D009502 1999
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D009502 2006
% 219.35/219.58  |- mesh__recordOriginator mesh__D009502 NLM
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D009502 2002
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D009502 1996
% 219.35/219.58  |- mesh__recordMaintainer mesh__D009502 TGC
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D009502 2003
% 219.35/219.58  |- skos__prefLabel mesh__D009502 Neutrons
% 219.35/219.58  |- skos__broader mesh__D009502smesh__D004601
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D009502 1997
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D009502 1994
% 219.35/219.58  |- skos__hiddenLabel mesh__D009502 Neutron
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D009502 2004
% 219.35/219.58  |- mesh__dateRevised mesh__D009502 1993-06-02
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D009502 2000
% 219.35/219.58  |- skos__annotation mesh__D009502
% 219.35/219.58       elementary particles; IM; FAST NEUTRONS is available   
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D009502 1995
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D009502 2001
% 219.35/219.58  |- mesh__recordAuthorizer mesh__D020484 sjn
% 219.35/219.58  |- mesh__dateEstablished mesh__D020484 1999-01-01
% 219.35/219.58  |- mesh__dateCreated mesh__D020484 1998-06-08
% 219.35/219.58  |- skos__broader mesh__D020484smesh__D052180
% 219.35/219.58  |- skos__altLabel mesh__D020484 Laboratory Manuals %28%PT%29%
% 219.35/219.58  |- mesh__recordMaintainer mesh__D020484 jls
% 219.35/219.58  |- skos__related mesh__D020484smesh__D020479
% 219.35/219.58  |- skos__scopeNote mesh__D020484
% 219.35/219.58       Works containing concise background information and directions for activities, including conducting experiments or diagnostic tests in the laboratory.%A%    
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D020484 2006
% 219.35/219.58  |- skos__altLabel mesh__D020484 Experiments %28%Publication Type%29%
% 219.35/219.58  |- mesh__recordOriginator mesh__D020484 JLS
% 219.35/219.58  |- mesh__historyNote mesh__D020484 1999   
% 219.35/219.58  |- mesh__dateRevised mesh__D020484 2005-06-30
% 219.35/219.58  |- skos__prefLabel mesh__D020484
% 219.35/219.58       Laboratory Manuals %5B%Publication Type%5D%
% 219.35/219.58  |- rdf__type mesh__D020484sskos__Concept
% 219.35/219.58  |- mesh__dateRevised mesh__D014447 2003-07-09
% 219.35/219.58  |- mesh__dateEstablished mesh__D014447 1991-01-01
% 219.35/219.58  |- skos__hiddenLabel mesh__D014447 beta Tyrosinase
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D014447 2005
% 219.35/219.58  |- skos__altLabel mesh__D014447 beta-Tyrosinase
% 219.35/219.58  |- mesh__recordMaintainer mesh__D014447 ssb
% 219.35/219.58  |- mesh__historyNote mesh__D014447
% 219.35/219.58       91%28%75%29%; was see under LYASES 1975-90   
% 219.35/219.58  |- rdf__type mesh__D014447sskos__Concept
% 219.35/219.58  |- mesh__dateCreated mesh__D014447 1974-11-19
% 219.35/219.58  |- skos__hiddenLabel mesh__D014447 Tyrosine Phenol Lyase
% 219.35/219.58  |- mesh__recordOriginator mesh__D014447 NLM
% 219.35/219.58  |- mesh__recordAuthorizer mesh__D014447 sjn
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D014447 2004
% 219.35/219.58  |- skos__scopeNote mesh__D014447
% 219.35/219.58       An enzyme that catalyzes the cleavage of tyrosine to phenol, pyruvate, and ammonia. It is a pyridoxal phosphate protein. The enzyme also forms pyruvate from D-tyrosine, L-cysteine, S-methyl-L-cysteine, L-serine, and D-serine, although at a slower rate. EC 4.1.99.2.%A%    
% 219.35/219.58  |- skos__historyNote mesh__D014447 Tyrosine %28%1972-1974%29%
% 219.35/219.58  |- skos__prefLabel mesh__D014447 Tyrosine Phenol-Lyase
% 219.35/219.58  |- skos__hiddenLabel mesh__D014447 Phenol-Lyase, Tyrosine
% 219.35/219.58  |- skos__historyNote mesh__D014447 Phenols %28%1974%29%
% 219.35/219.58  |- skos__historyNote mesh__D014447 Lyases %28%1972-1974%29%
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D014447 2006
% 219.35/219.58  |- skos__broader mesh__D014447smesh__D019755
% 219.35/219.58  |- mesh__publicMeSHNote mesh__D014447 91; was see under LYASES 1975-90   
% 219.35/219.58  |- mesh__dateEstablished mesh__D019930 1998-01-01
% 219.35/219.58  |- skos__broader mesh__D019930smesh__D019931
% 219.35/219.58  |- skos__hiddenLabel mesh__D019930 Mandibular Prosthesis Implantations
% 219.35/219.58  |- skos__historyNote mesh__D019930 Prostheses and Implants %28%1966%29%
% 219.35/219.58  |- skos__scopeNote mesh__D019930
% 219.35/219.58       Surgical insertion of an appliance for the replacement of areas of the mandible.%A%    
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D019930 2002
% 219.35/219.58  |- skos__historyNote mesh__D019930 Mandibular Prosthesis %28%1967-1997%29%
% 219.35/219.58  |- rdf__type mesh__D019930sskos__Concept
% 219.35/219.58  |- skos__related mesh__D019930smesh__D008341
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D019930 1999
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D019930 2001
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D019930 1998
% 219.35/219.58  |- mesh__historyNote mesh__D019930 98   
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D019930 2000
% 219.35/219.58  |- mesh__dateCreated mesh__D019930 1997-06-20
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D019930 2004
% 219.35/219.58  |- skos__prefLabel mesh__D019930 Mandibular Prosthesis Implantation
% 219.35/219.58  |- skos__hiddenLabel mesh__D019930 Prosthesis Implantation, Mandibular
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D019930 2006
% 219.35/219.58  |- mesh__publicMeSHNote mesh__D019930 98   
% 219.35/219.58  |- skos__hiddenLabel mesh__D019930 Implantations, Mandibular Prosthesis
% 219.35/219.58  |- skos__hiddenLabel mesh__D019930 Implantation, Mandibular Prosthesis
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D019930 2003
% 219.35/219.58  |- skos__hiddenLabel mesh__D019930 Prosthesis Implantations, Mandibular
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D019930 2005
% 219.35/219.58  |- mesh__recordOriginator mesh__D033601 ags
% 219.35/219.58  |- skos__historyNote mesh__D033601 Actinomycetales %28%1971-2002%29%
% 219.35/219.58  |- mesh__dateEstablished mesh__D033601 2003-01-01
% 219.35/219.58  |- mesh__recordAuthorizer mesh__D033601 sjn
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D033601 2006
% 219.35/219.58  |- mesh__dateCreated mesh__D033601 2002-07-03
% 219.35/219.58  |- skos__annotation mesh__D033601
% 219.35/219.58       infection: coord IM with ACTINOMYCETALES INFECTIONS %28%IM%29%   
% 219.35/219.58  |- skos__altLabel mesh__D033601 Gordona
% 219.35/219.58  |- rdf__type mesh__D033601sskos__Concept
% 219.35/219.58  |- skos__scopeNote mesh__D033601
% 219.35/219.58       A genus of gram-positive BACTERIA in the family Gordoniaceae, isolated from soil and from sputa of patients with chest disorders. It is also used for biotransformation of natural products.%A%    
% 219.35/219.58  |- mesh__dateRevised mesh__D033601 2005-06-30
% 219.35/219.58  |- mesh__historyNote mesh__D033601 2003   
% 219.35/219.58  |- mesh__publicMeSHNote mesh__D033601 2003   
% 219.35/219.58  |- mesh__recordMaintainer mesh__D033601 SYSTEM
% 219.35/219.58  |- skos__broader mesh__D033601smesh__D000192
% 219.35/219.58  |- skos__prefLabel mesh__D033601 Gordonia Bacterium
% 219.35/219.58  |- mesh__recordAuthorizer mesh__D000427 sjn
% 219.35/219.58  |- mesh__recordMaintainer mesh__D000427 ssb
% 219.35/219.58  |- rdf__type mesh__D000427sskos__Concept
% 219.35/219.58  |- skos__scopeNote mesh__D000427
% 219.35/219.58       Substances interfering with the metabolism of ethyl alcohol, causing unpleasant side effects thought to discourage the drinking of alcoholic beverages. Alcohol deterrents are used in the treatment of alcoholism.%A%    
% 219.35/219.58  |- skos__annotation mesh__D000427 consider also ALCOHOLISM /drug ther   
% 219.35/219.58  |- mesh__dateCreated mesh__D000427 1999-01-01
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D000427 2006
% 219.35/219.58  |- mesh__dateRevised mesh__D000427 2005-06-30
% 219.35/219.58  |- skos__broader mesh__D000427smesh__D002491
% 219.35/219.58  |- skos__hiddenLabel mesh__D000427 Deterrents, Alcohol
% 219.35/219.58  |- mesh__recordOriginator mesh__D000427 NLM
% 219.35/219.58  |- skos__prefLabel mesh__D000427 Alcohol Deterrents
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D005910 2001
% 219.35/219.58  |- mesh__recordOriginator mesh__D005910 NLM
% 219.35/219.58  |- skos__hiddenLabel mesh__D005910 Mixed Gliomas
% 219.35/219.58  |- skos__prefLabel mesh__D005910 Glioma
% 219.35/219.58  |- skos__hiddenLabel mesh__D005910 Tumor, Glial Cell
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D005910 2002
% 219.35/219.58  |- rdf__type mesh__D005910sskos__Concept
% 219.35/219.58  |- skos__scopeNote mesh__D005910
% 219.35/219.58       Benign and malignant central nervous system neoplasms derived from glial cells %28%i.e., astrocytes, oligodendrocytes, and ependymocytes%29%. Astrocytes may give rise to astrocytomas %28%ASTROCYTOMA%29% or glioblastoma multiforme %28%see GLIOBLASTOMA%29%. Oligodendrocytes give rise to oligodendrogliomas %28%OLIGODENDROGLIOMA%29% and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. %28%From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21%29%%A%    
% 219.35/219.58  |- skos__hiddenLabel mesh__D005910 Glioma, Mixed
% 219.35/219.58  |- skos__hiddenLabel mesh__D005910 Glioma, Malignant
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D005910 2003
% 219.35/219.58  |- skos__annotation mesh__D005910
% 219.35/219.58       coord IM with precoord CNS/neopl term + site %28%IM%29%; GLIOMA, SUBEPENDYMAL is available; for sarcomatous GLIOMA use GLIOSARCOMA; for GLIOMA, RETINAL see RETINOBLASTOMA%A%  
% 219.35/219.58  |- skos__hiddenLabel mesh__D005910 Gliomas, Malignant
% 219.35/219.58  |- mesh__dateRevised mesh__D005910 2005-07-13
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D005910 2004
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D005910 2006A
% 219.35/219.58  |- skos__hiddenLabel mesh__D005910 Glial Cell Tumor
% 219.35/219.58  |- skos__hiddenLabel mesh__D005910 Malignant Gliomas
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D005910 2005
% 219.35/219.58  |- skos__hiddenLabel mesh__D005910 Tumors, Glial Cell
% 219.35/219.58  |- mesh__recordAuthorizer mesh__D005910 ags
% 219.35/219.58  |- mesh__recordMaintainer mesh__D005910 ags
% 219.35/219.58  |- skos__hiddenLabel mesh__D005910 Gliomas, Mixed
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D005910 2006
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D005910 2000
% 219.35/219.58  |- skos__broader mesh__D005910smesh__D018302
% 219.35/219.58  |- mesh__dateCreated mesh__D005910 1999-01-01
% 219.35/219.58  |- skos__hiddenLabel mesh__D005910 Gliomas
% 219.35/219.58  |- skos__altLabel mesh__D005910 Glial Cell Tumors
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D005112 2006
% 219.35/219.58  |- mesh__dateEstablished mesh__D005112 1967-01-01
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D005112 2002
% 219.35/219.58  |- mesh__dateRevised mesh__D005112 1999-11-03
% 219.35/219.58  |- mesh__recordAuthorizer mesh__D005112 sjn
% 219.35/219.58  |- mesh__onlineNote mesh__D005112 search HEART, MECHANICAL 1966   
% 219.35/219.58  |- skos__scopeNote mesh__D005112
% 219.35/219.58       Diversion of blood flow through a circuit located outside the body but continuous with the bodily circulation.%A%    
% 219.35/219.58  |- mesh__dateCreated mesh__D005112 1999-01-01
% 219.35/219.58  |- skos__annotation mesh__D005112
% 219.35/219.58       %22%diversion of blood flow through a circuit located outside the body but continuous with the bodily circulation%22%; GEN %26% unspecified: prefer specifics; do not confuse with CARDIOPULMONARY BYPASS or ASSISTED CIRCULATION; do not use /util except by MeSH definition; DF: EXTRACORPOREAL CIRC%A%  
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D005112 2005
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D005112 2004
% 219.35/219.58  |- mesh__recordOriginator mesh__D005112 NLM
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D005112 2003
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D005112 2001
% 219.35/219.58  |- mesh__historyNote mesh__D005112
% 219.35/219.58       67; was see under HEART, MECHANICAL 1963-66   
% 219.35/219.58  |- skos__hiddenLabel mesh__D005112 Extracorporeal Circulations
% 219.35/219.58  |- skos__broader mesh__D005112smesh__D013514
% 219.35/219.58  |- rdf__type mesh__D005112sskos__Concept
% 219.35/219.58  |- skos__hiddenLabel mesh__D005112 Circulations, Extracorporeal
% 219.35/219.58  |- mesh__publicMeSHNote mesh__D005112
% 219.35/219.58       67; was see under HEART, MECHANICAL 1963-66   
% 219.35/219.58  |- mesh__recordMaintainer mesh__D005112 ndw
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D005112 2000
% 219.35/219.58  |- skos__historyNote mesh__D005112 Heart-Lung Machine %28%1966%29%
% 219.35/219.58  |- skos__altLabel mesh__D005112 Circulation, Extracorporeal
% 219.35/219.58  |- skos__prefLabel mesh__D005112 Extracorporeal Circulation
% 219.35/219.58  |- skos__altLabel mesh__D046529 Electron Microscopy, Transmission
% 219.35/219.58  |- skos__prefLabel mesh__D046529 Microscopy, Electron, Transmission
% 219.35/219.58  |- mesh__recordMaintainer mesh__D046529 nns
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D046529 2005
% 219.35/219.58  |- mesh__dateEstablished mesh__D046529 2005-01-01
% 219.35/219.58  |- skos__scopeNote mesh__D046529
% 219.35/219.58       Electron microscopy in which the ELECTRONS or their reaction products that pass down through the specimen are imaged below the plane of the specimen.%A%    
% 219.35/219.58  |- skos__hiddenLabel mesh__D046529 Microscopy, Transmission Electron
% 219.35/219.58  |- skos__altLabel mesh__D046529 Transmission Electron Microscopy
% 219.35/219.58  |- skos__annotation mesh__D046529 note specifics   
% 219.35/219.58  |- skos__altLabel mesh__D046529 Microscopy, Electron Diffraction
% 219.35/219.58  |- rdf__type mesh__D046529sskos__Concept
% 219.35/219.58  |- mesh__recordAuthorizer mesh__D046529 sjn
% 219.35/219.58  |- skos__hiddenLabel mesh__D046529 Diffraction Microscopy, Electron
% 219.35/219.58  |- mesh__publicMeSHNote mesh__D046529
% 219.35/219.58       2005; see MICROSCOPY, ELECTRON 1991-2004; for ELECTRON DIFFRACTION MICROSCOPY see MICROSCOPY, ELECTRON 2003-2004%A%  
% 219.35/219.58  |- skos__historyNote mesh__D046529 Microscopy, Electron %28%1967-2004%29%
% 219.35/219.58  |- mesh__dateCreated mesh__D046529 2004-07-07
% 219.35/219.58  |- mesh__historyNote mesh__D046529
% 219.35/219.58       2005; use MICROSCOPY, ELECTRON 1991-2004; for ELECTRON DIFFRACTION MICROSCOPY use MICROSCOPY, ELECTRON 2003-2004%A%  
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D046529 2006
% 219.35/219.58  |- mesh__recordOriginator mesh__D046529 nns
% 219.35/219.58  |- skos__broader mesh__D046529smesh__D008854
% 219.35/219.58  |- skos__scopeNote mesh__D018838
% 219.35/219.58       A chaperonin 60 heat-shock protein isolated from Escherichia coli.%A%    
% 219.35/219.58  |- mesh__onlineNote mesh__D018838
% 219.35/219.58       use GROEL PROTEIN %28%NM%29% to search GROEL STRESS PROTEIN 1989-94%A%  
% 219.35/219.58  |- skos__prefLabel mesh__D018838 GroEL Protein
% 219.35/219.58  |- skos__altLabel mesh__D018838 GroEL Stress Protein
% 219.35/219.58  |- mesh__recordMaintainer mesh__D018838 SYSTEM
% 219.35/219.58  |- mesh__publicMeSHNote mesh__D018838
% 219.35/219.58       95; GROEL STRESS PROTEIN was indexed under BACTERIAL PROTEINS %26% HEAT-SHOCK PROTEINS 1989-94%A%  
% 219.35/219.58  |- skos__annotation mesh__D018838
% 219.35/219.58       a chaperonin; spell in titles %26% translations with uppercase G %26% EL: GroEL%A%  
% 219.35/219.58  |- skos__historyNote mesh__D018838 Heat-Shock Proteins %28%1989-1994%29%
% 219.35/219.58  |- skos__historyNote mesh__D018838 Bacterial Proteins %28%1989-1994%29%
% 219.35/219.58  |- mesh__recordAuthorizer mesh__D018838 sjn
% 219.35/219.58  |- skos__altLabel mesh__D018838 Chaperonin 60 %28%GroEL%29%
% 219.35/219.58  |- mesh__historyNote mesh__D018838
% 219.35/219.58       95; was GROEL STRESS PROTEIN %28%NM%29% 1989-94   
% 219.35/219.58  |- skos__hiddenLabel mesh__D018838 Protein, GroEL
% 219.35/219.58  |- skos__hiddenLabel mesh__D018838 Protein, GroEL Stress
% 219.35/219.58  |- mesh__dateCreated mesh__D018838 1994-05-31
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D018838 2006
% 219.35/219.58  |- rdf__type mesh__D018838sskos__Concept
% 219.35/219.58  |- skos__broader mesh__D018838smesh__D001426
% 219.35/219.58  |- mesh__recordOriginator mesh__D018838 PXP
% 219.35/219.58  |- mesh__dateRevised mesh__D018838 2005-06-30
% 219.35/219.58  |- mesh__dateEstablished mesh__D018838 1995-01-01
% 219.35/219.58  |- skos__hiddenLabel mesh__D018838 Stress Protein, GroEL
% 219.35/219.58  |- skos__broader mesh__D018838smesh__D018834
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010855 2003
% 219.35/219.58  |- skos__broader mesh__D010855smesh__D007569
% 219.35/219.58  |- skos__hiddenLabel mesh__D010855 Robin Syndrome, Pierre
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010855 2005
% 219.35/219.58  |- mesh__recordAuthorizer mesh__D010855 sjn
% 219.35/219.58  |- mesh__recordMaintainer mesh__D010855 kle
% 219.35/219.58  |- skos__altLabel mesh__D010855 Pierre-Robin Syndrome
% 219.35/219.58  |- mesh__historyNote mesh__D010855 65%28%64%29%   
% 219.35/219.58  |- rdf__type mesh__D010855sskos__Concept
% 219.35/219.58  |- skos__annotation mesh__D010855
% 219.35/219.58       multiple oral abnorm; named for French dentist Pierre Robin: Robin is his surname; note: no hyphen; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010855 2002
% 219.35/219.58  |- mesh__publicMeSHNote mesh__D010855 65   
% 219.35/219.58  |- skos__hiddenLabel mesh__D010855 Syndrome, Pierre-Robin
% 219.35/219.58  |- skos__scopeNote mesh__D010855
% 219.35/219.58       An autosomal recessive disorder characterized by brachygnathia and cleft palate, often associated with glossoptosis, backward and upward displacement of the larynx, and angulation of the manubrium sterni. Cleft palate makes sucking and swallowing difficult, permitting easy access of fluids into the larynx. It may appear in several syndromes or as an isolated hypoplasia. %28%Dorland, 27th ed%29%%A%    
% 219.35/219.58  |- skos__hiddenLabel mesh__D010855 Syndrome, Pierre Robin
% 219.35/219.58  |- skos__prefLabel mesh__D010855 Pierre Robin Syndrome
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010855 2001
% 219.35/219.58  |- mesh__dateRevised mesh__D010855 1999-11-03
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010855 2004
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010855 2000
% 219.35/219.58  |- mesh__dateEstablished mesh__D010855 1965-01-01
% 219.35/219.58  |- mesh__recordOriginator mesh__D010855 NLM
% 219.35/219.58  |- mesh__dateCreated mesh__D010855 1999-01-01
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010855 2006
% 219.35/219.58  |- skos__hiddenLabel mesh__D010057 Oviduct
% 219.35/219.58  |- mesh__recordOriginator mesh__D010057 NLM
% 219.35/219.58  |- rdf__type mesh__D010057sskos__Concept
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010057 2003
% 219.35/219.58  |- skos__broader mesh__D010057smesh__D000825
% 219.35/219.58  |- skos__scopeNote mesh__D010057
% 219.35/219.58       Ducts that serve exclusively for the passage of eggs from the ovaries to the exterior of the body. In non-mammals, they are termed oviducts. In mammals, they are highly specialized and known as FALLOPIAN TUBES.%A%    
% 219.35/219.58  |- skos__prefLabel mesh__D010057 Oviducts
% 219.35/219.58  |- mesh__dateCreated mesh__D010057 1999-01-01
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010057 2004
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010057 2005
% 219.35/219.58  |- mesh__recordMaintainer mesh__D010057 lkt
% 219.35/219.58  |- mesh__dateRevised mesh__D010057 2002-07-03
% 219.35/219.58  |- mesh__activeMeSHYear mesh__D010057 2006
% 219.35/219.58  |- skos__annotation mesh__D010057
% 219.35/219.58       non-mammals only; mammals, use FALLOPIAN TUBES; disease probably GENITAL DISEASES, FEMALE + OVIDUCTS%A%  
% 219.35/219.58  |- mesh__recordAuthorizer mesh__D010057 sjn
% 219.35/219.58  |- skos__related mesh__D010057smesh__D005187
% 219.35/219.58  |- mesh__historyNote mesh__D004818 70   
% 219.35/219.58  |- skos__hiddenLabel mesh__D004818 Swine Exudative Dermatitis
% 219.35/219.58  |- mesh__recordOriginator mesh__D004818 NLM
% 219.35/219.58  |- skos__altLabel mesh__D004818 Greasy Pig Disease
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D004818 2005
% 219.35/219.59  |- skos__hiddenLabel mesh__D004818 Disease, Greasy Pig
% 219.35/219.59  |- skos__scopeNote mesh__D004818
% 219.35/219.59       An acute generalized dermatitis of pigs which occurs from 5 to 35 days of age, characterized by sudden onset, with morbidity of 10 to 90%25% and mortality of 5 to 90%25%. The lesions are caused by Staphylococcus hyos but the bacterial agent is unable to penetrate the intact skin. Abrasions on the feet and legs or lacerations on the body frequently precede infection. In acute cases, a vesicular-type virus may be the predisposing factor. The causative organism is inhibited by most antibiotics. %28%Merck Veterinary Manual, 5th ed%29%%A%    
% 219.35/219.59  |- mesh__publicMeSHNote mesh__D004818 70   
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D004818 2006
% 219.35/219.59  |- skos__altLabel mesh__D004818 Epidermitis, Exudative of Swine
% 219.35/219.59  |- rdf__type mesh__D004818sskos__Concept
% 219.35/219.59  |- skos__hiddenLabel mesh__D004818 Swine Exudative Dermatitides
% 219.35/219.59  |- skos__broader mesh__D004818smesh__D013553
% 219.35/219.59  |- mesh__recordAuthorizer mesh__D004818 sjn
% 219.35/219.59  |- skos__annotation mesh__D004818
% 219.35/219.59       don%27%t forget also SWINE %28%NIM%29% %26% check tag ANIMALS   
% 219.35/219.59  |- mesh__recordMaintainer mesh__D004818 ags
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D004818 2004
% 219.35/219.59  |- mesh__dateEstablished mesh__D004818 1970-01-01
% 219.35/219.59  |- skos__historyNote mesh__D004818 Swine Diseases %28%1966-1969%29%
% 219.35/219.59  |- mesh__dateCreated mesh__D004818 1999-01-01
% 219.35/219.59  |- skos__altLabel mesh__D004818 Exudative Dermatitis of Swine
% 219.35/219.59  |- mesh__dateRevised mesh__D004818 2003-07-30
% 219.35/219.59  |- skos__prefLabel mesh__D004818 Epidermitis, Exudative, of Swine
% 219.35/219.59  |- mesh__recordAuthorizer mesh__D009503 PLS
% 219.35/219.59  |- mesh__dateEstablished mesh__D009503 1991-01-01
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D009503 1995
% 219.35/219.59  |- mesh__historyNote mesh__D009503
% 219.35/219.59       91%28%75%29%; was see under AGRANULOCYTOSIS 1975-90   
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D009503 2002
% 219.35/219.59  |- rdf__type mesh__D009503sskos__Concept
% 219.35/219.59  |- mesh__recordMaintainer mesh__D009503 TGC
% 219.35/219.59  |- skos__scopeNote mesh__D009503
% 219.35/219.59       A decrease in the number of neutrophilic leukocytes in the blood. %28%Dorland, 27th ed%29%%A%    
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D009503 1994
% 219.35/219.59  |- mesh__dateCreated mesh__D009503 1999-01-01
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D009503 1999
% 219.35/219.59  |- skos__annotation mesh__D009503 decrease in no. of neutrophils   
% 219.35/219.59  |- mesh__dateRevised mesh__D009503 1993-06-02
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D009503 2006
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D009503 2001
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D009503 1998
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D009503 1997
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D009503 2005
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D009503 2004
% 219.35/219.59  |- mesh__publicMeSHNote mesh__D009503
% 219.35/219.59       91; was see under AGRANULOCYTOSIS 1975-90   
% 219.35/219.59  |- mesh__recordOriginator mesh__D009503 NLM
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D009503 1996
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D009503 2000
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D009503 2003
% 219.35/219.59  |- skos__prefLabel mesh__D009503 Neutropenia
% 219.35/219.59  |- skos__broader mesh__D009503smesh__D000380
% 219.35/219.59  |- skos__hiddenLabel mesh__D009503 Neutropenias
% 219.35/219.59  |- mesh__onlineNote mesh__D009503 search AGRANULOCYTOSIS 1966-74   
% 219.35/219.59  |- mesh__onlineNote mesh__D001520
% 219.35/219.59       pre-explosion = BEHAVIOR A%23%D BEHAVIOR MECHANISMS %28%PX%29%   
% 219.35/219.59  |- mesh__publicMeSHNote mesh__D001520 98   
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D001520 2003
% 219.35/219.59  |- mesh__dateEstablished mesh__D001520 1998-01-01
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D001520 2000
% 219.35/219.59  |- mesh__runningHead mesh__D001520 F1 - BEHAVIOR AND BEHAVIOR MECHANISMS   
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D001520 2006
% 219.35/219.59  |- mesh__recordMaintainer mesh__D001520 TGC
% 219.35/219.59  |- skos__historyNote mesh__D001520 Defense Mechanisms %28%1966-1997%29%
% 219.35/219.59  |- skos__prefLabel mesh__D001520 Behavior and Behavior Mechanisms
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D001520 1999
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D001520 2005
% 219.35/219.59  |- skos__scopeNote mesh__D001520
% 219.35/219.59       The observable response made to a situation and the unconscious processes underlying it.%A%    
% 219.35/219.59  |- mesh__recordAuthorizer mesh__D001520 SJN
% 219.35/219.59  |- mesh__historyNote mesh__D001520 98; use pre-explosion   
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D001520 2002
% 219.35/219.59  |- rdf__type mesh__D001520sskos__Concept
% 219.35/219.59  |- mesh__dateRevised mesh__D001520 1997-06-26
% 219.35/219.59  |- mesh__recordOriginator mesh__D001520 NLM
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D001520 2004
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D001520 1998
% 219.35/219.59  |- mesh__dateCreated mesh__D001520 1999-01-01
% 219.35/219.59  |- skos__historyNote mesh__D001520 Behavior %28%1966-1997%29%
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D001520 2001
% 219.35/219.59  |- skos__annotation mesh__D001520
% 219.35/219.59       not used for indexing      CATALOG: do not use   
% 219.35/219.59  |- skos__broader mesh__D020485smesh__D052180
% 219.35/219.59  |- mesh__dateRevised mesh__D020485 2005-06-30
% 219.35/219.59  |- mesh__recordAuthorizer mesh__D020485 sjn
% 219.35/219.59  |- mesh__dateEstablished mesh__D020485 1999-01-01
% 219.35/219.59  |- skos__altLabel mesh__D020485 Laws %28%Publication Type%29%
% 219.35/219.59  |- skos__scopeNote mesh__D020485
% 219.35/219.59       Works consisting of the text of proposed or enacted legislation that may be in the form of bills, laws, statutes, ordinances, or government regulations.%A%    
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D020485 2006
% 219.35/219.59  |- skos__annotation mesh__D020485
% 219.35/219.59       CATALOG: use when 20%25% or more of the content consists of the text of laws, statutes, ordinances, or government regulations.  Do not use for works that are merely discussion of law, etc%A%  
% 219.35/219.59  |- skos__related mesh__D020485smesh__D016418
% 219.35/219.59  |- mesh__dateCreated mesh__D020485 1998-06-10
% 219.35/219.59  |- mesh__recordMaintainer mesh__D020485 jls
% 219.35/219.59  |- mesh__historyNote mesh__D020485 1999   
% 219.35/219.59  |- mesh__recordOriginator mesh__D020485 JLS
% 219.35/219.59  |- rdf__type mesh__D020485sskos__Concept
% 219.35/219.59  |- skos__altLabel mesh__D020485 Legislation %28%PT%29%
% 219.35/219.59  |- skos__prefLabel mesh__D020485 Legislation %5B%Publication Type%5D%
% 219.35/219.59  |- skos__scopeNote mesh__D014448
% 219.35/219.59       An enzyme that activates tyrosine with its specific transfer RNA. EC 6.1.1.1.%A%    
% 219.35/219.59  |- skos__altLabel mesh__D014448 Tyrosyl T RNA Synthetase
% 219.35/219.59  |- skos__historyNote mesh__D014448 Tyrosine %28%1972-1974%29%
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D014448 2004
% 219.35/219.59  |- mesh__publicMeSHNote mesh__D014448
% 219.35/219.59       98; see TYROSYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A%  
% 219.35/219.59  |- mesh__historyNote mesh__D014448 98%28%75%29%   
% 219.35/219.59  |- skos__altLabel mesh__D014448 Tyrosyl-tRNA Synthetase
% 219.35/219.59  |- skos__historyNote mesh__D014448
% 219.35/219.59       Amino Acyl T RNA Synthetases %28%1972-1974%29%
% 219.35/219.59  |- skos__hiddenLabel mesh__D014448 Tyrosyl tRNA Synthetase
% 219.35/219.59  |- skos__broader mesh__D014448smesh__D000604
% 219.35/219.59  |- mesh__recordMaintainer mesh__D014448 ssb
% 219.35/219.59  |- skos__hiddenLabel mesh__D014448 Ligase, Tyrosine-tRNA
% 219.35/219.59  |- mesh__dateCreated mesh__D014448 1974-11-19
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D014448 2006
% 219.35/219.59  |- mesh__dateRevised mesh__D014448 2003-07-09
% 219.35/219.59  |- skos__hiddenLabel mesh__D014448 Ligase, Tyr-tRNA
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D014448 2005
% 219.35/219.59  |- skos__hiddenLabel mesh__D014448 Tyrosine tRNA Ligase
% 219.35/219.59  |- mesh__dateEstablished mesh__D014448 1991-01-01
% 219.35/219.59  |- mesh__recordOriginator mesh__D014448 NLM
% 219.35/219.59  |- skos__prefLabel mesh__D014448 Tyrosine-tRNA Ligase
% 219.35/219.59  |- mesh__recordAuthorizer mesh__D014448 sjn
% 219.35/219.59  |- rdf__type mesh__D014448sskos__Concept
% 219.35/219.59  |- skos__hiddenLabel mesh__D014448 Tyr tRNA Ligase
% 219.35/219.59  |- skos__altLabel mesh__D014448 Tyr-tRNA Ligase
% 219.35/219.59  |- skos__hiddenLabel mesh__D014448 Synthetase, Tyrosyl-tRNA
% 219.35/219.59  |- mesh__publicMeSHNote mesh__D019931 98   
% 219.35/219.59  |- rdf__type mesh__D019931sskos__Concept
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D019931 1999
% 219.35/219.59  |- skos__related mesh__D019931smesh__D008447
% 219.35/219.59  |- skos__hiddenLabel mesh__D019931 Implantations, Maxillofacial Prosthesis
% 219.35/219.59  |- skos__broader mesh__D019931smesh__D019647
% 219.35/219.59  |- mesh__dateEstablished mesh__D019931 1998-01-01
% 219.35/219.59  |- skos__historyNote mesh__D019931
% 219.35/219.59       Maxillofacial Prosthesis %28%1967-1997%29%
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D019931 1998
% 219.35/219.59  |- mesh__historyNote mesh__D019931 98   
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D019931 2002
% 219.35/219.59  |- skos__hiddenLabel mesh__D019931 Prosthesis Implantation, Maxillofacial
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D019931 2004
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D019931 2001
% 219.35/219.59  |- skos__prefLabel mesh__D019931 Maxillofacial Prosthesis Implantation
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D019931 2006
% 219.35/219.59  |- skos__hiddenLabel mesh__D019931 Implantation, Maxillofacial Prosthesis
% 219.35/219.59  |- skos__broader mesh__D019931smesh__D019919
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D019931 2003
% 219.35/219.59  |- skos__hiddenLabel mesh__D019931 Prosthesis Implantations, Maxillofacial
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D019931 2005
% 219.35/219.59  |- skos__scopeNote mesh__D019931
% 219.35/219.59       Surgical insertion of an appliance for the replacement of areas of the maxilla, mandible, and face. When only portions of the mandible are replaced, it is referred to as MANDIBULAR PROSTHESIS IMPLANTATION.%A%    
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D019931 2000
% 219.35/219.59  |- skos__historyNote mesh__D019931 Prostheses and Implants %28%1966%29%
% 219.35/219.59  |- mesh__dateCreated mesh__D019931 1997-06-20
% 219.35/219.59  |- skos__hiddenLabel mesh__D019931 Maxillofacial Prosthesis Implantations
% 219.35/219.59  |- skos__altLabel mesh__D000428 Drinking, Alcohol
% 219.35/219.59  |- mesh__historyNote mesh__D000428 69   
% 219.35/219.59  |- skos__scopeNote mesh__D000428
% 219.35/219.59       Behaviors associated with the ingesting of alcoholic beverages, including social drinking.%A%    
% 219.35/219.59  |- mesh__dateRevised mesh__D000428 2002-07-02
% 219.35/219.59  |- skos__related mesh__D000428smesh__D000437
% 219.35/219.59  |- mesh__recordAuthorizer mesh__D000428 sjn
% 219.35/219.59  |- mesh__dateCreated mesh__D000428 1999-01-01
% 219.35/219.59  |- mesh__dateEstablished mesh__D000428 1969-01-01
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D000428 2006
% 219.35/219.59  |- skos__historyNote mesh__D000428 Alcoholic Beverages %28%1966-1968%29%
% 219.35/219.59  |- mesh__recordMaintainer mesh__D000428 PXP
% 219.35/219.59  |- skos__prefLabel mesh__D000428 Alcohol Drinking
% 219.35/219.59  |- mesh__publicMeSHNote mesh__D000428 69   
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D000428 2004
% 219.35/219.59  |- skos__annotation mesh__D000428
% 219.35/219.59       drunkenness = ALCOHOLIC INTOXICATION but binge drinking %26% acute alcohol intox = ETHANOL /pois; chronic alcohol consumption = ALCOHOLISM; TEMPERANCE is available for %22%abstinence from alcohol%22% but do not confuse with alcohol withdrawal %28%see note under ALCOHOL WITHDRAWAL DELIRIUM %26% SUBSTANCE WITHDRAWAL SYNDROME%29%%A%  
% 219.35/219.59  |- skos__broader mesh__D000428smesh__D004327
% 219.35/219.59  |- skos__related mesh__D000428smesh__D013695
% 219.35/219.59  |- skos__altLabel mesh__D000428 Alcohol Consumption
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D000428 2005
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D000428 2003
% 219.35/219.59  |- skos__hiddenLabel mesh__D000428 Consumption, Alcohol
% 219.35/219.59  |- rdf__type mesh__D000428sskos__Concept
% 219.35/219.59  |- mesh__recordOriginator mesh__D000428 NLM
% 219.35/219.59  |- mesh__recordOriginator mesh__D011150 NLM
% 219.35/219.59  |- skos__scopeNote mesh__D011150
% 219.35/219.59       The continuation of the femoral artery coursing through the popliteal fossa; it divides into the anterior and posterior tibial arteries.%A%    
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D011150 1996
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D011150 1998
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D011150 1997
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D011150 1994
% 219.35/219.59  |- rdf__type mesh__D011150sskos__Concept
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D011150 1999
% 219.35/219.59  |- mesh__dateRevised mesh__D011150 1992-05-18
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D011150 2000
% 219.35/219.59  |- skos__broader mesh__D011150smesh__D001158
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D011150 1993
% 219.35/219.59  |- skos__hiddenLabel mesh__D011150 Artery, Popliteal
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D011150 2001
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D011150 1995
% 219.35/219.59  |- skos__hiddenLabel mesh__D011150 Arteries, Popliteal
% 219.35/219.59  |- skos__hiddenLabel mesh__D011150 Popliteal Arteries
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D011150 2003
% 219.35/219.59  |- mesh__recordMaintainer mesh__D011150 TAP
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D011150 2005
% 219.35/219.59  |- mesh__dateCreated mesh__D011150 1999-01-01
% 219.35/219.59  |- skos__prefLabel mesh__D011150 Popliteal Artery
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D011150 2004
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D011150 2002
% 219.35/219.59  |- mesh__recordAuthorizer mesh__D011150 PLS
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D011150 2006
% 219.35/219.59  |- skos__broader mesh__D005911smesh__D010335
% 219.35/219.59  |- skos__prefLabel mesh__D005911 Gliosis
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D005911 2006
% 219.35/219.59  |- mesh__dateEstablished mesh__D005911 1974-01-01
% 219.35/219.59  |- rdf__type mesh__D005911sskos__Concept
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D005911 2002
% 219.35/219.59  |- mesh__publicMeSHNote mesh__D005911 74   
% 219.35/219.59  |- mesh__dateRevised mesh__D005911 2001-07-25
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D005911 2003
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D005911 2004
% 219.35/219.59  |- skos__historyNote mesh__D005911 Neuroglia %28%1966-1968%29%
% 219.35/219.59  |- skos__scopeNote mesh__D005911
% 219.35/219.59       The production of a dense fibrous network of neuroglia; includes astrocytosis, which is a proliferation of astrocytes in the area of a degenerative lesion.%A%    
% 219.35/219.59  |- mesh__dateCreated mesh__D005911 1999-01-01
% 219.35/219.59  |- mesh__recordAuthorizer mesh__D005911 sjn
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D005911 2005
% 219.35/219.59  |- skos__historyNote mesh__D005911 appropriate heading/PA %28%1966-1968%29%
% 219.35/219.59  |- mesh__recordMaintainer mesh__D005911 ags
% 219.35/219.59  |- skos__hiddenLabel mesh__D005911 Glioses
% 219.35/219.59  |- mesh__historyNote mesh__D005911 74%28%69%29%   
% 219.35/219.59  |- mesh__recordOriginator mesh__D005911 NLM
% 219.35/219.59  |- skos__hiddenLabel mesh__D005113 Obstetrical Extraction
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D005113 2003
% 219.35/219.59  |- skos__annotation mesh__D005113
% 219.35/219.59       do not use /util except by MeSH definition   
% 219.35/219.59  |- mesh__dateRevised mesh__D005113 2002-07-03
% 219.35/219.59  |- skos__hiddenLabel mesh__D005113 Obstetric Extractions
% 219.35/219.59  |- skos__related mesh__D005113smesh__D009772
% 219.35/219.59  |- skos__hiddenLabel mesh__D005113 Obstetrical Extractions
% 219.35/219.59  |- skos__broader mesh__D005113smesh__D036861
% 219.35/219.59  |- rdf__type mesh__D005113sskos__Concept
% 219.35/219.59  |- skos__hiddenLabel mesh__D005113 Extractions, Obstetric
% 219.35/219.59  |- skos__scopeNote mesh__D005113
% 219.35/219.59       Extraction of the fetus by means of obstetrical instruments.%A%    
% 219.35/219.59  |- skos__prefLabel mesh__D005113 Extraction, Obstetrical
% 219.35/219.59  |- mesh__recordMaintainer mesh__D005113 PXP
% 219.35/219.59  |- mesh__recordAuthorizer mesh__D005113 sjn
% 219.35/219.59  |- mesh__recordOriginator mesh__D005113 NLM
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D005113 2006
% 219.35/219.59  |- mesh__dateCreated mesh__D005113 1999-01-01
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D005113 2005
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D005113 2004
% 219.35/219.59  |- skos__altLabel mesh__D005113 Extraction, Obstetric
% 219.35/219.59  |- skos__hiddenLabel mesh__D005113 Obstetric Extraction
% 219.35/219.59  |- skos__hiddenLabel mesh__D005113 Extractions, Obstetrical
% 219.35/219.59  |- rdf__type mesh__D010856sskos__Concept
% 219.35/219.59  |- mesh__dateRevised mesh__D010856 2004-07-13
% 219.35/219.59  |- skos__historyNote mesh__D010856 Birds %28%1966-1967%29%
% 219.35/219.59  |- skos__hiddenLabel mesh__D010856 Pigeons, Rock
% 219.35/219.59  |- skos__altLabel mesh__D010856 Domestic Pigeons
% 219.35/219.59  |- skos__hiddenLabel mesh__D010856 Rock Pigeon
% 219.35/219.59  |- skos__hiddenLabel mesh__D010856 Rock Dove
% 219.35/219.59  |- skos__hiddenLabel mesh__D010856 Pigeon
% 219.35/219.59  |- mesh__recordOriginator mesh__D010856 NLM
% 219.35/219.59  |- mesh__recordMaintainer mesh__D010856 sjn
% 219.35/219.59  |- skos__hiddenLabel mesh__D010856 Dove
% 219.35/219.59  |- skos__altLabel mesh__D010856 Rock Doves
% 219.35/219.59  |- skos__altLabel mesh__D010856 Rock Pigeons
% 219.35/219.59  |- skos__altLabel mesh__D010856 Pigeons
% 219.35/219.59  |- skos__prefLabel mesh__D010856 Columbidae
% 219.35/219.59  |- skos__hiddenLabel mesh__D010856 Doves, Rock
% 219.35/219.59  |- skos__hiddenLabel mesh__D010856 Pigeon, Domestic
% 219.35/219.59  |- skos__altLabel mesh__D010856 Doves
% 219.35/219.59  |- skos__hiddenLabel mesh__D010856 Pigeon, Feral
% 219.35/219.59  |- mesh__dateEstablished mesh__D010856 1968-01-01
% 219.35/219.59  |- skos__scopeNote mesh__D010856
% 219.35/219.59       Family in the order COLUMBIFORMES, comprised of pigeons or doves. They are BIRDS with short legs, stout bodies, small heads, and slender bills. Some sources call the smaller species doves and the larger pigeons, but the names are interchangeable.%A%    
% 219.35/219.59  |- skos__hiddenLabel mesh__D010856 Pigeons, Feral
% 219.35/219.59  |- skos__hiddenLabel mesh__D010856 Feral Pigeon
% 219.35/219.59  |- skos__historyNote mesh__D010856 Poultry %28%1966-1967%29%
% 219.35/219.59  |- mesh__dateCreated mesh__D010856 1999-01-01
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D010856 2006
% 219.35/219.59  |- skos__hiddenLabel mesh__D010856 Dove, Rock
% 219.35/219.59  |- skos__hiddenLabel mesh__D010856 Pigeon, Rock
% 219.35/219.59  |- skos__altLabel mesh__D010856 Feral Pigeons
% 219.35/219.59  |- mesh__recordAuthorizer mesh__D010856 sjn
% 219.35/219.59  |- skos__broader mesh__D010856smesh__D046092
% 219.35/219.59  |- skos__hiddenLabel mesh__D010856 Pigeons, Domestic
% 219.35/219.59  |- mesh__historyNote mesh__D010856 2005 %28%1968%29%   
% 219.35/219.59  |- mesh__publicMeSHNote mesh__D010856 2005; see PIGEONS 1968-2004   
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D010856 2005
% 219.35/219.59  |- skos__hiddenLabel mesh__D010856 Domestic Pigeon
% 219.35/219.59  |- mesh__publicMeSHNote mesh__D029561 2002   
% 219.35/219.59  |- mesh__dateRevised mesh__D029561 2002-07-03
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D029561 2005
% 219.35/219.59  |- mesh__dateCreated mesh__D029561 2001-07-25
% 219.35/219.59  |- mesh__recordAuthorizer mesh__D029561 sjn
% 219.35/219.59  |- skos__prefLabel mesh__D029561 Lythraceae
% 219.35/219.59  |- rdf__type mesh__D029561sskos__Concept
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D029561 2006
% 219.35/219.59  |- skos__scopeNote mesh__D029561
% 219.35/219.59       The loosestrife plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida.  Members are mainly herbs and many of them contain ALKALOIDS.%A%    
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D029561 2003
% 219.35/219.59  |- skos__annotation mesh__D029561
% 219.35/219.59       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.35/219.59  |- mesh__recordOriginator mesh__D029561 ssb
% 219.35/219.59  |- mesh__recordMaintainer mesh__D029561 ssb
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D029561 2004
% 219.35/219.59  |- skos__broader mesh__D029561smesh__D019684
% 219.35/219.59  |- mesh__historyNote mesh__D029561 2002   
% 219.35/219.59  |- mesh__dateEstablished mesh__D029561 2002-01-01
% 219.35/219.59  |- rdf__type mesh__D010058sskos__Concept
% 219.35/219.59  |- skos__annotation mesh__D010058
% 219.35/219.59       index ovipositor under specific insect only with /anat %28%IM%29% + OVIPOSITION %28%IM%29%%A%  
% 219.35/219.59  |- mesh__recordMaintainer mesh__D010058 ags
% 219.35/219.59  |- mesh__dateCreated mesh__D010058 1999-01-01
% 219.35/219.59  |- mesh__dateRevised mesh__D010058 2005-06-30
% 219.35/219.59  |- mesh__publicMeSHNote mesh__D010058 74   
% 219.35/219.59  |- skos__broader mesh__D010058smesh__D012098
% 219.35/219.59  |- mesh__historyNote mesh__D010058 74   
% 219.35/219.59  |- skos__related mesh__D010058smesh__D052287
% 219.35/219.59  |- skos__related mesh__D010058smesh__D052284
% 219.35/219.59  |- skos__scopeNote mesh__D010058
% 219.35/219.59       The process of laying or shedding fully developed eggs %28%OVA%29% from the female body. The term is usually used for certain INSECTS or FISHES with an organ called ovipositor where eggs are stored or deposited before expulsion from the body.%A%    
% 219.35/219.59  |- skos__hiddenLabel mesh__D010058 Ovipositions
% 219.35/219.59  |- mesh__recordAuthorizer mesh__D010058 sjn
% 219.35/219.59  |- mesh__dateEstablished mesh__D010058 1974-01-01
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D010058 2006
% 219.35/219.59  |- skos__prefLabel mesh__D010058 Oviposition
% 219.35/219.59  |- mesh__recordOriginator mesh__D010058 NLM
% 219.35/219.59  |- skos__historyNote mesh__D004819 Warts %28%1966-1986%29%
% 219.35/219.59  |- skos__historyNote mesh__D004819 Papillomaviruses %28%1978-1986%29%
% 219.35/219.59  |- mesh__recordOriginator mesh__D004819 RC
% 219.35/219.59  |- skos__hiddenLabel mesh__D004819 Lutz Lewandowsky Disease
% 219.35/219.59  |- mesh__recordAuthorizer mesh__D004819 sjn
% 219.35/219.59  |- mesh__dateRevised mesh__D004819 2004-07-13
% 219.35/219.59  |- skos__annotation mesh__D004819 a non-neoplastic tumor virus infect   
% 219.35/219.59  |- skos__hiddenLabel mesh__D004819 Lewandowsky Lutz Disease
% 219.35/219.59  |- mesh__historyNote mesh__D004819 87   
% 219.35/219.59  |- skos__historyNote mesh__D004819 Skin Neoplasms %28%1968-1986%29%
% 219.35/219.59  |- skos__prefLabel mesh__D004819 Epidermodysplasia Verruciformis
% 219.35/219.59  |- skos__broader mesh__D004819smesh__D014860
% 219.35/219.59  |- skos__historyNote mesh__D004819 Tumor Virus Infections %28%1972-1986%29%
% 219.35/219.59  |- skos__hiddenLabel mesh__D004819 Disease, Lutz-Lewandowsky
% 219.35/219.59  |- skos__historyNote mesh__D004819 Skin Diseases %28%1966-1986%29%
% 219.35/219.59  |- mesh__dateEstablished mesh__D004819 1987-01-01
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D004819 2006
% 219.35/219.59  |- mesh__publicMeSHNote mesh__D004819 87   
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D004819 2005
% 219.35/219.59  |- skos__altLabel mesh__D004819 Lutz-Lewandowsky Disease
% 219.35/219.59  |- rdf__type mesh__D004819sskos__Concept
% 219.35/219.59  |- skos__scopeNote mesh__D004819
% 219.35/219.59       An autosomal recessive trait with impaired cell-mediated immunity. About 15 human papillomaviruses are implicated in associated infection, four of which lead to skin neoplasms. The disease begins in childhood with red papules and later spreads over the body as gray or yellow scales.%A%    
% 219.35/219.59  |- mesh__recordMaintainer mesh__D004819 sjn
% 219.35/219.59  |- skos__altLabel mesh__D004819 Lewandowsky-Lutz Disease
% 219.35/219.59  |- skos__hiddenLabel mesh__D004819 Disease, Lewandowsky-Lutz
% 219.35/219.59  |- mesh__dateCreated mesh__D004819 1986-04-01
% 219.35/219.59  |- mesh__historyNote mesh__D015541 90   
% 219.35/219.59  |- skos__hiddenLabel mesh__D015541 Three-Wheeler Vehicle
% 219.35/219.59  |- skos__hiddenLabel mesh__D015541 All Terrain Vehicles
% 219.35/219.59  |- skos__hiddenLabel mesh__D015541 Vehicles, All-Terrain
% 219.35/219.59  |- mesh__dateEstablished mesh__D015541 1990-01-01
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D015541 2006
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D015541 2002
% 219.35/219.59  |- skos__hiddenLabel mesh__D015541 Dirt-Bike
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D015541 2003
% 219.35/219.59  |- skos__hiddenLabel mesh__D015541 Off-Road Motor Vehicle
% 219.35/219.59  |- skos__hiddenLabel mesh__D015541 Snowmobile
% 219.35/219.59  |- skos__hiddenLabel mesh__D015541 Three Wheeled Vehicles
% 219.35/219.59  |- mesh__dateRevised mesh__D015541 1995-05-31
% 219.35/219.59  |- mesh__recordOriginator mesh__D015541 AGS
% 219.35/219.59  |- mesh__dateCreated mesh__D015541 1989-06-19
% 219.35/219.59  |- skos__hiddenLabel mesh__D015541 Vehicles, Three-Wheeler
% 219.35/219.59  |- skos__historyNote mesh__D015541 Motorcycles %28%1966-1989%29%
% 219.35/219.59  |- rdf__type mesh__D015541sskos__Concept
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D015541 2004
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D015541 1998
% 219.35/219.59  |- mesh__recordAuthorizer mesh__D015541 PLS
% 219.35/219.59  |- skos__scopeNote mesh__D015541
% 219.35/219.59       Motorized, recreational vehicles used on non-public roads. They include all-terrain vehicles, dirt-bikes, minibikes, motorbikes, trailbikes, and snowmobiles. Excludes MOTORCYCLES, which are considered public road vehicles.%A%    
% 219.35/219.59  |- skos__annotation mesh__D015541
% 219.35/219.59       do not confuse with MOTORCYCLES which are public-road vehicles%A%  
% 219.35/219.59  |- skos__hiddenLabel mesh__D015541 Dirt Bikes
% 219.35/219.59  |- skos__hiddenLabel mesh__D015541 All-Terrain Vehicle
% 219.35/219.59  |- skos__altLabel mesh__D015541 Three-Wheeled Vehicles
% 219.35/219.59  |- skos__hiddenLabel mesh__D015541 Motorbike
% 219.35/219.59  |- skos__broader mesh__D015541smesh__D018986
% 219.35/219.59  |- skos__hiddenLabel mesh__D015541 Minibike
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D015541 1999
% 219.35/219.59  |- mesh__recordMaintainer mesh__D015541 JLS
% 219.35/219.59  |- skos__historyNote mesh__D015541 Automobiles %28%1966-1989%29%
% 219.35/219.59  |- skos__prefLabel mesh__D015541 Off-Road Motor Vehicles
% 219.35/219.59  |- mesh__activeMeSHYear mesh__D015541 1996
% 219.35/219.59  |- skos__hiddenLabel mesh__D015541 Vehicles, Three-Wheeled
% 219.35/219.59  |- skos__hiddenLabel mesh__D015541 Vehicle, Three-Wheeler
% 219.35/219.59  |- skos__altLabel mesh__D015541 Motor Vehicles, Off-Road
% 219.35/219.59  |- skos__hiddenLabel mesh__D015541 Three Wheeler Vehicles
% 219.35/219.59  |- skos__hiddenLabel mesh__D015541 Vehicle, Three-Wheeled
% 219.35/219.59  |- skos__hiddenLabel mesh__D015541 Vehicle, All-Terrain
% 219.35/219.59  |- mesh__publicMeSHNote mesh__D015541 90   
% 219.35/219.60  |- skos__hiddenLabel mesh__D015541 Three-Wheeled Vehicle
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D015541 2000
% 219.35/219.60  |- skos__hiddenLabel mesh__D015541 Motor Vehicles, Off Road
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D015541 1997
% 219.35/219.60  |- skos__hiddenLabel mesh__D015541 Motor Vehicle, Off-Road
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D015541 2005
% 219.35/219.60  |- skos__hiddenLabel mesh__D015541 Off Road Motor Vehicles
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D015541 2001
% 219.35/219.60  |- skos__hiddenLabel mesh__D009504 Cell, LE
% 219.35/219.60  |- mesh__recordOriginator mesh__D009504 NLM
% 219.35/219.60  |- rdf__type mesh__D009504sskos__Concept
% 219.35/219.60  |- skos__broader mesh__D009504smesh__D006098
% 219.35/219.60  |- skos__altLabel mesh__D009504 Polymorphonuclear Leukocytes
% 219.35/219.60  |- skos__hiddenLabel mesh__D009504 Cells, LE
% 219.35/219.60  |- mesh__dateCreated mesh__D009504 1999-01-01
% 219.35/219.60  |- mesh__recordAuthorizer mesh__D009504 sjn
% 219.35/219.60  |- mesh__recordMaintainer mesh__D009504 nns
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D009504 2006
% 219.35/219.60  |- mesh__dateEstablished mesh__D009504 1965-01-01
% 219.35/219.60  |- skos__broader mesh__D009504smesh__D010586
% 219.35/219.60  |- skos__hiddenLabel mesh__D009504 Neutrophil
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D009504 2004
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D009504 2005
% 219.35/219.60  |- mesh__historyNote mesh__D009504
% 219.35/219.60       65; LE CELLS was heading 1963-95 %28%Prov 1963-64%29%   
% 219.35/219.60  |- skos__hiddenLabel mesh__D009504 Leukocyte, Polymorphonuclear
% 219.35/219.60  |- skos__altLabel mesh__D009504 Leukocytes, Polymorphonuclear
% 219.35/219.60  |- skos__scopeNote mesh__D009504
% 219.35/219.60       Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes.%A%    
% 219.35/219.60  |- skos__hiddenLabel mesh__D009504 Polymorphonuclear Leukocyte
% 219.35/219.60  |- mesh__publicMeSHNote mesh__D009504 65; LE CELLS was heading 1965-95   
% 219.35/219.60  |- mesh__dateRevised mesh__D009504 2003-07-09
% 219.35/219.60  |- skos__hiddenLabel mesh__D009504 LE Cell
% 219.35/219.60  |- skos__annotation mesh__D009504
% 219.35/219.60       A 11 qualif; decrease in no. = NEUTROPENIA; neutrophil chemotaxis: coord NIM with CHEMOTAXIS, LEUKOCYTE %28%IM%29%; note X ref LE CELLS: do not coord with LUPUS ERYTHEMATOSUS, SYSTEMIC unless disease is particularly discussed %28%see note there%29%%A%  
% 219.35/219.60  |- skos__prefLabel mesh__D009504 Neutrophils
% 219.35/219.60  |- skos__hiddenLabel mesh__D001521 Behavior Therapies
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D001521 2006
% 219.35/219.60  |- skos__scopeNote mesh__D001521
% 219.35/219.60       The application of modern theories of learning and conditioning in the treatment of behavior disorders.%A%    
% 219.35/219.60  |- skos__hiddenLabel mesh__D001521 Therapies, Conditioning
% 219.35/219.60  |- skos__annotation mesh__D001521
% 219.35/219.60       a psychother technique; assertiveness training: coord IM with ASSERTIVENESS %28%IM%29%; DF: BEHAVIOR THER%A%  
% 219.35/219.60  |- mesh__recordOriginator mesh__D001521 NLM
% 219.35/219.60  |- mesh__dateEstablished mesh__D001521 1966-01-01
% 219.35/219.60  |- mesh__recordMaintainer mesh__D001521 jrf
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D001521 2005
% 219.35/219.60  |- skos__related mesh__D001521smesh__D032763
% 219.35/219.60  |- skos__hiddenLabel mesh__D001521 Conditioning Therapies
% 219.35/219.60  |- rdf__type mesh__D001521sskos__Concept
% 219.35/219.60  |- skos__altLabel mesh__D001521 Behavior Modification
% 219.35/219.60  |- mesh__dateCreated mesh__D001521 1999-01-01
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D001521 2004
% 219.35/219.60  |- skos__prefLabel mesh__D001521 Behavior Therapy
% 219.35/219.60  |- mesh__recordAuthorizer mesh__D001521 sjn
% 219.35/219.60  |- skos__hiddenLabel mesh__D001521 Behavior Modifications
% 219.35/219.60  |- mesh__onlineNote mesh__D001521
% 219.35/219.60       use BEHAVIOR THERAPY to search BEHAVIOR MODIFICATION 1974-78%A%  
% 219.35/219.60  |- skos__broader mesh__D001521smesh__D011613
% 219.35/219.60  |- skos__hiddenLabel mesh__D001521 Modification, Behavior
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D001521 2003
% 219.35/219.60  |- mesh__historyNote mesh__D001521
% 219.35/219.60       66%28%64%29%; BEHAVIOR MODIFICATION was see under BEHAVIOR THERAPY 1974-78%A%  
% 219.35/219.60  |- skos__altLabel mesh__D001521 Conditioning Therapy
% 219.35/219.60  |- mesh__publicMeSHNote mesh__D001521 66   
% 219.35/219.60  |- skos__altLabel mesh__D001521 Therapy, Behavior
% 219.35/219.60  |- skos__hiddenLabel mesh__D001521 Therapies, Behavior
% 219.35/219.60  |- skos__hiddenLabel mesh__D001521 Modifications, Behavior
% 219.35/219.60  |- mesh__dateRevised mesh__D001521 2002-07-02
% 219.35/219.60  |- skos__altLabel mesh__D001521 Therapy, Conditioning
% 219.35/219.60  |- mesh__dateEstablished mesh__D020486 1999-01-01
% 219.35/219.60  |- mesh__recordAuthorizer mesh__D020486 sjn
% 219.35/219.60  |- skos__broader mesh__D020486smesh__D052180
% 219.35/219.60  |- mesh__dateRevised mesh__D020486 2005-06-30
% 219.35/219.60  |- skos__scopeNote mesh__D020486
% 219.35/219.60       Works prepared by hand including handwritten or typescript drafts of pre-publication papers or works not otherwise reproduced in multiple copies.%A%    
% 219.35/219.60  |- mesh__recordMaintainer mesh__D020486 jls
% 219.35/219.60  |- skos__altLabel mesh__D020486 Manuscripts %28%PT%29%
% 219.35/219.60  |- rdf__type mesh__D020486sskos__Concept
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D020486 2006
% 219.35/219.60  |- skos__prefLabel mesh__D020486 Manuscripts %5B%Publication Type%5D%
% 219.35/219.60  |- mesh__dateCreated mesh__D020486 1998-06-03
% 219.35/219.60  |- mesh__recordOriginator mesh__D020486 JLS
% 219.35/219.60  |- mesh__historyNote mesh__D020486 1999   
% 219.35/219.60  |- mesh__recordOriginator mesh__D014449 NLM
% 219.35/219.60  |- mesh__recordAuthorizer mesh__D014449 sjn
% 219.35/219.60  |- skos__broader mesh__D014449smesh__D010455
% 219.35/219.60  |- mesh__recordMaintainer mesh__D014449 CCR
% 219.35/219.60  |- skos__altLabel mesh__D014449 Madaus brand of Tyrothricin
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D014449 2006
% 219.35/219.60  |- skos__scopeNote mesh__D014449
% 219.35/219.60       A polypeptide antibiotic mixture obtained from Bacillus brevis. It consists of a mixture of three tyrocidines %28%60%25%%29% and several gramicidins %28%20%25%%29% and is very toxic to blood, liver, kidneys, meninges, and the olfactory apparatus. It is used topically.%A%    
% 219.35/219.60  |- mesh__dateRevised mesh__D014449 2005-06-30
% 219.35/219.60  |- rdf__type mesh__D014449sskos__Concept
% 219.35/219.60  |- mesh__dateCreated mesh__D014449 1999-01-01
% 219.35/219.60  |- skos__prefLabel mesh__D014449 Tyrothricin
% 219.35/219.60  |- skos__altLabel mesh__D014449 Engelhard brand of Tyrothricin
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D000429 2005
% 219.35/219.60  |- skos__prefLabel mesh__D000429 Alcohol Oxidoreductases
% 219.35/219.60  |- skos__hiddenLabel mesh__D000429 Oxidoreductases, Alcohol
% 219.35/219.60  |- skos__broader mesh__D000429smesh__D010088
% 219.35/219.60  |- mesh__recordOriginator mesh__D000429 NLM
% 219.35/219.60  |- mesh__dateEstablished mesh__D000429 1964-01-01
% 219.35/219.60  |- mesh__publicMeSHNote mesh__D000429 64   
% 219.35/219.60  |- skos__scopeNote mesh__D000429
% 219.35/219.60       A subclass of enzymes which includes all dehydrogenases acting on primary and secondary alcohols as well as hemiacetals. They are further classified according to the acceptor which can be NAD+ or NADP+ %28%subclass 1.1.1%29%, cytochrome %28%1.1.2%29%, oxygen %28%1.1.3%29%, quinone %28%1.1.5%29%, or another acceptor %28%1.1.99%29%.%A%    
% 219.35/219.60  |- skos__altLabel mesh__D000429 Ketone Reductases
% 219.35/219.60  |- rdf__type mesh__D000429sskos__Concept
% 219.35/219.60  |- mesh__recordAuthorizer mesh__D000429 sjn
% 219.35/219.60  |- mesh__recordMaintainer mesh__D000429 ssb
% 219.35/219.60  |- skos__altLabel mesh__D000429 Carbonyl Reductases
% 219.35/219.60  |- mesh__historyNote mesh__D000429 64   
% 219.35/219.60  |- skos__hiddenLabel mesh__D000429 Reductases, Carbonyl
% 219.35/219.60  |- mesh__dateRevised mesh__D000429 2003-07-09
% 219.35/219.60  |- skos__hiddenLabel mesh__D000429 Reductases, Ketone
% 219.35/219.60  |- mesh__dateCreated mesh__D000429 1999-01-01
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D000429 2006
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D000429 2004
% 219.35/219.60  |- skos__hiddenLabel mesh__D011151 Popliteal Cysts
% 219.35/219.60  |- mesh__publicMeSHNote mesh__D011151
% 219.35/219.60       91; was see under SYNOVIAL CYST 1987-90   
% 219.35/219.60  |- rdf__type mesh__D011151sskos__Concept
% 219.35/219.60  |- skos__historyNote mesh__D011151 Knee Joint %28%1966-1986%29%
% 219.35/219.60  |- mesh__dateEstablished mesh__D011151 1991-01-01
% 219.35/219.60  |- skos__hiddenLabel mesh__D011151 Cysts, Baker
% 219.35/219.60  |- skos__annotation mesh__D011151 non-neoplastic   
% 219.35/219.60  |- mesh__dateRevised mesh__D011151 2003-07-09
% 219.35/219.60  |- mesh__dateCreated mesh__D011151 1986-06-23
% 219.35/219.60  |- skos__scopeNote mesh__D011151
% 219.35/219.60       A SYNOVIAL CYST located in the back of the knee, in the popliteal space arising from the semimembranous bursa or the knee joint.%A%    
% 219.35/219.60  |- mesh__historyNote mesh__D011151
% 219.35/219.60       91%28%87%29%; was see under SYNOVIAL CYST 1987-90   
% 219.35/219.60  |- skos__hiddenLabel mesh__D011151 Cyst, Popliteal
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D011151 2005
% 219.35/219.60  |- skos__prefLabel mesh__D011151 Popliteal Cyst
% 219.35/219.60  |- skos__hiddenLabel mesh__D011151 Cyst, Baker
% 219.35/219.60  |- skos__altLabel mesh__D011151 Baker%27%s Cyst
% 219.35/219.60  |- skos__historyNote mesh__D011151 Synovial Cyst %28%1966-1986%29%
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D011151 2004
% 219.35/219.60  |- skos__broader mesh__D011151smesh__D013581
% 219.35/219.60  |- skos__hiddenLabel mesh__D011151 Cysts, Popliteal
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D011151 2006
% 219.35/219.60  |- mesh__recordMaintainer mesh__D011151 lkt
% 219.35/219.60  |- mesh__recordAuthorizer mesh__D011151 sjn
% 219.35/219.60  |- mesh__recordOriginator mesh__D011151 VDK
% 219.35/219.60  |- skos__altLabel mesh__D011151 Baker Cyst
% 219.35/219.60  |- skos__hiddenLabel mesh__D011151 Baker Cysts
% 219.35/219.60  |- skos__scopeNote mesh__D005912
% 219.35/219.60       A fungal toxin produced by various species of Trichoderma, Gladiocladium fimbriatum, Aspergillus fumigatus, and Penicillium. It is used as an immunosuppressive agent.%A%    
% 219.35/219.60  |- skos__prefLabel mesh__D005912 Gliotoxin
% 219.35/219.60  |- mesh__publicMeSHNote mesh__D005912
% 219.35/219.60       96; was GLIOTOXINS 1981-95 %28%see under MYCOTOXINS 1981-90%29%; was GLIOTOXIN see under ANTIBIOTICS 1975-80%A%  
% 219.35/219.60  |- skos__historyNote mesh__D005912 Disulfides %28%1973-1974%29%
% 219.35/219.60  |- skos__historyNote mesh__D005912 Alkaloids %28%1969-1974%29%
% 219.35/219.60  |- mesh__recordAuthorizer mesh__D005912 sjn
% 219.35/219.60  |- skos__broader mesh__D005912smesh__D009183
% 219.35/219.60  |- skos__broader mesh__D005912smesh__D007211
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D005912 2006
% 219.35/219.60  |- mesh__recordOriginator mesh__D005912 NLM
% 219.35/219.60  |- skos__annotation mesh__D005912
% 219.35/219.60       /antag permitted but consider also ANTITOXINS;/biosyn permitted if by fungus%A%  
% 219.35/219.60  |- rdf__type mesh__D005912sskos__Concept
% 219.35/219.60  |- skos__altLabel mesh__D005912 Gliotoxins
% 219.35/219.60  |- skos__historyNote mesh__D005912 Indoles %28%1969-1974%29%
% 219.35/219.60  |- mesh__dateEstablished mesh__D005912 1991-01-01
% 219.35/219.60  |- mesh__recordMaintainer mesh__D005912 ssb
% 219.35/219.60  |- mesh__historyNote mesh__D005912
% 219.35/219.60       96; was GLIOTOXINS 1981-95 %28%see under MYCOTOXINS 1981-90%29%; was GLIOTOXIN see under ANTIBIOTICS 1975-80%A%  
% 219.35/219.60  |- mesh__dateRevised mesh__D005912 2005-06-30
% 219.35/219.60  |- mesh__dateCreated mesh__D005912 1974-11-19
% 219.35/219.60  |- skos__historyNote mesh__D005912 Piperazines %28%1972-1974%29%
% 219.35/219.60  |- skos__hiddenLabel mesh__D005114 Sex Behavior, Extramarital
% 219.35/219.60  |- rdf__type mesh__D005114sskos__Concept
% 219.35/219.60  |- skos__hiddenLabel mesh__D005114 Relation, Extramarital
% 219.35/219.60  |- skos__hiddenLabel mesh__D005114 Behavior, Extramarital Sex
% 219.35/219.60  |- skos__hiddenLabel mesh__D005114 Extramarital Relation
% 219.35/219.60  |- skos__prefLabel mesh__D005114 Extramarital Relations
% 219.35/219.60  |- skos__altLabel mesh__D005114 Adultery
% 219.35/219.60  |- mesh__dateCreated mesh__D005114 1974-11-11
% 219.35/219.60  |- skos__broader mesh__D005114smesh__D012725
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D005114 2006
% 219.35/219.60  |- skos__scopeNote mesh__D005114
% 219.35/219.60       Voluntary SEXUAL INTERCOURSE between a married person and someone other than the SPOUSE.%A%    
% 219.35/219.60  |- mesh__historyNote mesh__D005114
% 219.35/219.60       91%28%75%29%; was see under SEX BEHAVIOR 1975-90   
% 219.35/219.60  |- skos__annotation mesh__D005114 DF: EXTRAMARITAL RELAT   
% 219.35/219.60  |- mesh__dateRevised mesh__D005114 2004-07-07
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D005114 2005
% 219.35/219.60  |- mesh__dateEstablished mesh__D005114 1991-01-01
% 219.35/219.60  |- mesh__recordMaintainer mesh__D005114 lkt
% 219.35/219.60  |- mesh__recordAuthorizer mesh__D005114 sjn
% 219.35/219.60  |- mesh__recordOriginator mesh__D005114 NLM
% 219.35/219.60  |- skos__hiddenLabel mesh__D005114 Relations, Extramarital
% 219.35/219.60  |- mesh__publicMeSHNote mesh__D005114
% 219.35/219.60       91; was see under SEX BEHAVIOR 1975-90   
% 219.35/219.60  |- skos__hiddenLabel mesh__D010857 Eye Pigment Epithelium
% 219.35/219.60  |- skos__historyNote mesh__D010857 Retina %28%1966-1975%29%
% 219.35/219.60  |- mesh__recordOriginator mesh__D010857 SMH
% 219.35/219.60  |- skos__broader mesh__D010857smesh__D005123
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D010857 1997
% 219.35/219.60  |- mesh__historyNote mesh__D010857 76   
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D010857 2002
% 219.35/219.60  |- skos__historyNote mesh__D010857 Retinal Degeneration %28%1968-1975%29%
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D010857 2004
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D010857 1999
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D010857 1996
% 219.35/219.60  |- mesh__recordMaintainer mesh__D010857 TGC
% 219.35/219.60  |- skos__broader mesh__D010857smesh__D004848
% 219.35/219.60  |- mesh__dateEstablished mesh__D010857 1976-01-01
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D010857 2001
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D010857 2006
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D010857 1991
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D010857 2003
% 219.35/219.60  |- skos__historyNote mesh__D010857 Iris %28%1966-1975%29%
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D010857 1993
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D010857 2000
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D010857 1998
% 219.35/219.60  |- skos__scopeNote mesh__D010857
% 219.35/219.60       Epithelium in the retina, ciliary body, and iris containing pigment granules.%A%    
% 219.35/219.60  |- mesh__dateRevised mesh__D010857 1990-04-24
% 219.35/219.60  |- skos__historyNote mesh__D010857 Ciliary Body %28%1966-1975%29%
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D010857 2005
% 219.35/219.60  |- mesh__publicMeSHNote mesh__D010857 76   
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D010857 1995
% 219.35/219.60  |- skos__historyNote mesh__D010857 Retinal Diseases %28%1972-1975%29%
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D010857 1992
% 219.35/219.60  |- skos__altLabel mesh__D010857 Retinal Pigment Epithelium
% 219.35/219.60  |- mesh__recordAuthorizer mesh__D010857 PLS
% 219.35/219.60  |- mesh__dateCreated mesh__D010857 1975-07-25
% 219.35/219.60  |- skos__hiddenLabel mesh__D010857 Pigment Epithelium, Retinal
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D010857 1994
% 219.35/219.60  |- skos__prefLabel mesh__D010857 Pigment Epithelium of Eye
% 219.35/219.60  |- skos__annotation mesh__D010857
% 219.35/219.60       includes pigment epithelium of retina, ciliary body %26% iris; detachment = RETINAL DETACHMENT%A%  
% 219.35/219.60  |- rdf__type mesh__D010857sskos__Concept
% 219.35/219.60  |- skos__annotation mesh__D029562
% 219.35/219.60       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.35/219.60  |- skos__prefLabel mesh__D029562 Magnoliaceae
% 219.35/219.60  |- mesh__publicMeSHNote mesh__D029562 2002   
% 219.35/219.60  |- skos__broader mesh__D029562smesh__D019684
% 219.35/219.60  |- mesh__historyNote mesh__D029562 2002   
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D029562 2005
% 219.35/219.60  |- skos__scopeNote mesh__D029562
% 219.35/219.60       A plant family of the order Magnoliales, subclass Magnoliidae, class Magnoliopsida.  They are trees and shrubs having an elongated conelike floral axis with fragrant flowers that have six tepals %28%sepals and petals that are not distinctly different%29% and many spirally arranged stamens.%A%    
% 219.35/219.60  |- rdf__type mesh__D029562sskos__Concept
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D029562 2006
% 219.35/219.60  |- mesh__dateRevised mesh__D029562 2003-07-09
% 219.35/219.60  |- mesh__dateCreated mesh__D029562 2001-07-25
% 219.35/219.60  |- mesh__recordOriginator mesh__D029562 ssb
% 219.35/219.60  |- mesh__recordAuthorizer mesh__D029562 sjn
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D029562 2004
% 219.35/219.60  |- mesh__dateEstablished mesh__D029562 2002-01-01
% 219.35/219.60  |- mesh__recordMaintainer mesh__D029562 ssb
% 219.35/219.60  |- skos__broader mesh__D010059smesh__D009088
% 219.35/219.60  |- mesh__dateCreated mesh__D010059 1974-11-11
% 219.35/219.60  |- mesh__recordOriginator mesh__D010059 NLM
% 219.35/219.60  |- mesh__recordMaintainer mesh__D010059 SYSTEM
% 219.35/219.60  |- skos__historyNote mesh__D010059 Egg Proteins %28%1973-1974%29%
% 219.35/219.60  |- mesh__dateRevised mesh__D010059 2005-06-30
% 219.35/219.60  |- skos__prefLabel mesh__D010059 Ovomucin
% 219.35/219.60  |- skos__annotation mesh__D010059
% 219.35/219.60       a trypsin inhib; /drug eff /ultrastruct permitted   
% 219.35/219.60  |- mesh__historyNote mesh__D010059
% 219.35/219.60       91%28%75%29%; was see under EGG PROTEINS 1975-90   
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D010059 2006
% 219.35/219.60  |- rdf__type mesh__D010059sskos__Concept
% 219.35/219.60  |- mesh__dateEstablished mesh__D010059 1991-01-01
% 219.35/219.60  |- mesh__recordAuthorizer mesh__D010059 sjn
% 219.35/219.60  |- skos__broader mesh__D010059smesh__D015387
% 219.35/219.60  |- mesh__publicMeSHNote mesh__D010059
% 219.35/219.60       91; was see under EGG PROTEINS 1975-90   
% 219.35/219.60  |- skos__broader mesh__D010059smesh__D004527
% 219.35/219.60  |- skos__altLabel mesh__D010059 Ovomucoid
% 219.35/219.60  |- skos__scopeNote mesh__D010059
% 219.35/219.60       A heterogeneous mixture of glycoproteins responsible for the gel structure of egg white. It has trypsin-inhibiting activity.%A%    
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D009505 1998
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D009505 2004
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D009505 2005
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D009505 2001
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D009505 2003
% 219.35/219.60  |- skos__prefLabel mesh__D009505 Nevada
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D009505 2000
% 219.35/219.60  |- mesh__recordOriginator mesh__D009505 NLM
% 219.35/219.60  |- mesh__recordAuthorizer mesh__D009505 SJN
% 219.35/219.60  |- skos__broader mesh__D009505smesh__D015206
% 219.35/219.60  |- rdf__type mesh__D009505sskos__Concept
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D009505 2002
% 219.35/219.60  |- mesh__recordMaintainer mesh__D009505 PXP
% 219.35/219.60  |- mesh__dateCreated mesh__D009505 1999-01-01
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D009505 1999
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D009505 2006
% 219.35/219.60  |- mesh__dateRevised mesh__D009505 1997-06-20
% 219.35/219.60  |- mesh__dateEstablished mesh__D001522 1964-01-01
% 219.35/219.60  |- skos__hiddenLabel mesh__D001522 Animal Behaviors
% 219.35/219.60  |- skos__prefLabel mesh__D001522 Behavior, Animal
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D001522 2006
% 219.35/219.60  |- skos__scopeNote mesh__D001522
% 219.35/219.60       The observable response an animal makes to any situation.%A%    
% 219.35/219.60  |- rdf__type mesh__D001522sskos__Concept
% 219.35/219.60  |- mesh__dateCreated mesh__D001522 1999-01-01
% 219.35/219.60  |- mesh__historyNote mesh__D001522 64   
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D001522 2005
% 219.35/219.60  |- skos__annotation mesh__D001522 IM   
% 219.35/219.60  |- mesh__recordMaintainer mesh__D001522 lkt
% 219.35/219.60  |- skos__hiddenLabel mesh__D001522 Behaviors, Animal
% 219.35/219.60  |- mesh__recordAuthorizer mesh__D001522 sjn
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D001522 2004
% 219.35/219.60  |- skos__related mesh__D001522smesh__D007224
% 219.35/219.60  |- skos__hiddenLabel mesh__D001522 Animal Behavior
% 219.35/219.60  |- mesh__publicMeSHNote mesh__D001522 64   
% 219.35/219.60  |- skos__broader mesh__D001522smesh__D001519
% 219.35/219.60  |- mesh__dateRevised mesh__D001522 2003-07-09
% 219.35/219.60  |- mesh__recordOriginator mesh__D001522 NLM
% 219.35/219.60  |- skos__altLabel mesh__D019933 Ossicular Prosthesis Implantation
% 219.35/219.60  |- skos__prefLabel mesh__D019933 Ossicular Replacement
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D019933 2003
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D019933 2001
% 219.35/219.60  |- skos__scopeNote mesh__D019933
% 219.35/219.60       Surgical insertion of an implant to replace one or more of the ear ossicles.%A%    
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D019933 2005
% 219.35/219.60  |- skos__broader mesh__D019933smesh__D019919
% 219.35/219.60  |- skos__broader mesh__D019933smesh__D013506
% 219.35/219.60  |- skos__hiddenLabel mesh__D019933 Implantation, Ossicular Prosthesis
% 219.35/219.60  |- mesh__activeMeSHYear mesh__D019933 2000
% 219.35/219.60  |- skos__hiddenLabel mesh__D019933 Implantations, Ossicular Prosthesis
% 219.47/219.64  |- mesh__dateCreated mesh__D019933 1997-06-20
% 219.47/219.64  |- skos__altLabel mesh__D019933 Replacement, Ossicular
% 219.47/219.64  |- rdf__type mesh__D019933sskos__Concept
% 219.47/219.64  |- mesh__activeMeSHYear mesh__D019933 1999
% 219.47/219.64  |- skos__hiddenLabel mesh__D019933 Prosthesis Implantations, Ossicular
% 219.47/219.64  |- skos__hiddenLabel mesh__D019933 Ossicular Prosthesis Implantations
% 219.47/219.64  |- skos__historyNote mesh__D019933 Ossicular Prosthesis %28%1987-1997%29%
% 219.47/219.64  |- mesh__publicMeSHNote mesh__D019933 98   
% 219.47/219.64  |- mesh__dateEstablished mesh__D019933 1998-01-01
% 219.47/219.64  |- skos__historyNote mesh__D019933
% 219.47/219.64       Prostheses and Implants %28%1966-1986%29%
% 219.47/219.64  |- skos__hiddenLabel mesh__D019933 Prosthesis Implantation, Ossicular
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D019933 1998
% 219.47/219.65  |- mesh__historyNote mesh__D019933 98   
% 219.47/219.65  |- skos__hiddenLabel mesh__D019933 Replacements, Ossicular
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D019933 2004
% 219.47/219.65  |- skos__related mesh__D019933smesh__D009998
% 219.47/219.65  |- skos__hiddenLabel mesh__D019933 Ossicular Replacements
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D019933 2002
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D019933 2006
% 219.47/219.65  |- skos__altLabel mesh__D011950 ACh Receptors
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011950 2004
% 219.47/219.65  |- mesh__dateRevised mesh__D011950 1996-06-10
% 219.47/219.65  |- skos__prefLabel mesh__D011950 Receptors, Cholinergic
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011950 2005
% 219.47/219.65  |- skos__altLabel mesh__D011950 Cholinoceptive Sites
% 219.47/219.65  |- skos__altLabel mesh__D011950 Acetylcholine Receptors
% 219.47/219.65  |- mesh__dateEstablished mesh__D011950 1974-01-01
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011950 2003
% 219.47/219.65  |- skos__annotation mesh__D011950
% 219.47/219.65       /antag = NEUROMUSCULAR BLOCKING AGENTS or NEUROMUSCULAR DEPOLARIZING AGENTS; coord IM with specific cholinergic agent %28%IM%29%; DF: RECEPT CHOLINERGIC%A%  
% 219.47/219.65  |- skos__scopeNote mesh__D011950
% 219.47/219.65       Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology.%A%    
% 219.47/219.65  |- rdf__type mesh__D011950sskos__Concept
% 219.47/219.65  |- skos__altLabel mesh__D011950 Receptors, Acetylcholine
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011950 2001
% 219.47/219.65  |- mesh__dateCreated mesh__D011950 1999-01-01
% 219.47/219.65  |- mesh__publicMeSHNote mesh__D011950 74   
% 219.47/219.65  |- skos__altLabel mesh__D011950 Cholinergic Receptors
% 219.47/219.65  |- mesh__recordOriginator mesh__D011950 NLM
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011950 2000
% 219.47/219.65  |- skos__hiddenLabel mesh__D011950 Sites, Cholinoceptive
% 219.47/219.65  |- skos__broader mesh__D011950smesh__D017981
% 219.47/219.65  |- skos__altLabel mesh__D011950 Cholinoceptors
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011950 1999
% 219.47/219.65  |- mesh__recordMaintainer mesh__D011950 TGC
% 219.47/219.65  |- skos__historyNote mesh__D011950 Receptors, Drug %28%1966-1970%29%
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011950 1997
% 219.47/219.65  |- skos__historyNote mesh__D011950
% 219.47/219.65       specific agonist, tissue, or organ affected %28%1966-1970%29%
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011950 1998
% 219.47/219.65  |- mesh__historyNote mesh__D011950 74%28%71%29%   
% 219.47/219.65  |- mesh__recordAuthorizer mesh__D011950 PLS
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011950 2006
% 219.47/219.65  |- skos__altLabel mesh__D011950 Receptors, ACh
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011950 2002
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011152 2003
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011152 2001
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011152 2005
% 219.47/219.65  |- mesh__dateCreated mesh__D011152 1999-01-01
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011152 2004
% 219.47/219.65  |- mesh__recordMaintainer mesh__D011152 TAP
% 219.47/219.65  |- skos__scopeNote mesh__D011152
% 219.47/219.65       The vein formed by the union of the anterior and posterior tibial veins; it courses through the popliteal space and becomes the femoral vein.%A%    
% 219.47/219.65  |- skos__hiddenLabel mesh__D011152 Popliteal Veins
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011152 2006
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011152 1996
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011152 2002
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011152 1998
% 219.47/219.65  |- mesh__recordAuthorizer mesh__D011152 PLS
% 219.47/219.65  |- mesh__recordOriginator mesh__D011152 NLM
% 219.47/219.65  |- skos__hiddenLabel mesh__D011152 Veins, Popliteal
% 219.47/219.65  |- skos__broader mesh__D011152smesh__D014680
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011152 1997
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011152 1994
% 219.47/219.65  |- rdf__type mesh__D011152sskos__Concept
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011152 1999
% 219.47/219.65  |- mesh__dateRevised mesh__D011152 1992-05-18
% 219.47/219.65  |- skos__prefLabel mesh__D011152 Popliteal Vein
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011152 1993
% 219.47/219.65  |- skos__hiddenLabel mesh__D011152 Vein, Popliteal
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011152 1995
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011152 2000
% 219.47/219.65  |- skos__hiddenLabel mesh__D005913 K4024
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005913 2006
% 219.47/219.65  |- skos__altLabel mesh__D005913 Mindiab
% 219.47/219.65  |- skos__altLabel mesh__D005913 Lacer Brand of Glipizide
% 219.47/219.65  |- rdf__type mesh__D005913sskos__Concept
% 219.47/219.65  |- skos__historyNote mesh__D005913 Pyrazines %28%1971-1974%29%
% 219.47/219.65  |- skos__altLabel mesh__D005913 Glydiazinamide
% 219.47/219.65  |- skos__prefLabel mesh__D005913 Glipizide
% 219.47/219.65  |- mesh__dateCreated mesh__D005913 1974-11-11
% 219.47/219.65  |- skos__altLabel mesh__D005913 Pfizer Brand of Glipizide
% 219.47/219.65  |- skos__altLabel mesh__D005913 Pharmacia Brand of Glipizide
% 219.47/219.65  |- skos__historyNote mesh__D005913 Cyclohexanes %28%1971-1974%29%
% 219.47/219.65  |- mesh__publicMeSHNote mesh__D005913
% 219.47/219.65       91; was see under SULFONYLUREA COMPOUNDS 1975-90   
% 219.47/219.65  |- mesh__dateEstablished mesh__D005913 1991-01-01
% 219.47/219.65  |- mesh__recordAuthorizer mesh__D005913 sjn
% 219.47/219.65  |- skos__altLabel mesh__D005913 Kenfarma Brand of Glipizide
% 219.47/219.65  |- mesh__recordOriginator mesh__D005913 NLM
% 219.47/219.65  |- skos__altLabel mesh__D005913 Glidiazinamide
% 219.47/219.65  |- skos__altLabel mesh__D005913 Glibenese Brand of Glipizide
% 219.47/219.65  |- skos__scopeNote mesh__D005913
% 219.47/219.65       An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.%A%    
% 219.47/219.65  |- mesh__historyNote mesh__D005913
% 219.47/219.65       91%28%75%29%; was see under SULFONYLUREA COMPOUNDS 1975-90   
% 219.47/219.65  |- skos__altLabel mesh__D005913 Alphapharm Brand of Glipizide
% 219.47/219.65  |- mesh__recordMaintainer mesh__D005913 CCR
% 219.47/219.65  |- skos__altLabel mesh__D005913 Ozidia
% 219.47/219.65  |- skos__broader mesh__D005913smesh__D013453
% 219.47/219.65  |- skos__historyNote mesh__D005913 Sulfonylurea Compounds %28%1971-1974%29%
% 219.47/219.65  |- skos__altLabel mesh__D005913 Minodiab
% 219.47/219.65  |- skos__hiddenLabel mesh__D005913 K 4024
% 219.47/219.65  |- skos__altLabel mesh__D005913 Lilly Brand of Glipizide
% 219.47/219.65  |- skos__altLabel mesh__D005913 Glypidizine
% 219.47/219.65  |- mesh__dateRevised mesh__D005913 2005-06-30
% 219.47/219.65  |- skos__hiddenLabel mesh__D005115 Face Bows, Orthodontic
% 219.47/219.65  |- skos__hiddenLabel mesh__D005115 Orthodontic Chincap
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005115 1995
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005115 2000
% 219.47/219.65  |- skos__scopeNote mesh__D005115
% 219.47/219.65       Extraoral devices for applying force to the dentition in order to avoid some of the problems in anchorage control met with in intermaxillary traction and to apply force in directions not otherwise possible.%A%    
% 219.47/219.65  |- skos__hiddenLabel mesh__D005115 Headgears, Orthodontic
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005115 1998
% 219.47/219.65  |- skos__hiddenLabel mesh__D005115 Orthodontic Chincaps
% 219.47/219.65  |- skos__hiddenLabel mesh__D005115 Orthodontic Headgear
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005115 1993
% 219.47/219.65  |- rdf__type mesh__D005115sskos__Concept
% 219.47/219.65  |- skos__hiddenLabel mesh__D005115 Appliances, Extraoral Traction
% 219.47/219.65  |- skos__hiddenLabel mesh__D005115 Orthodontic Face Bow
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005115 1994
% 219.47/219.65  |- skos__prefLabel mesh__D005115 Extraoral Traction Appliances
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005115 2004
% 219.47/219.65  |- skos__hiddenLabel mesh__D005115 Orthodontic Face Bows
% 219.47/219.65  |- mesh__dateRevised mesh__D005115 1992-05-15
% 219.47/219.65  |- skos__hiddenLabel mesh__D005115 Orthodontic Headgears
% 219.47/219.65  |- mesh__recordOriginator mesh__D005115 SMH
% 219.47/219.65  |- skos__historyNote mesh__D005115
% 219.47/219.65       Orthodontic Appliances, Removable %28%1971-1976%29%
% 219.47/219.65  |- skos__hiddenLabel mesh__D005115 Traction Appliances, Extraoral
% 219.47/219.65  |- mesh__historyNote mesh__D005115
% 219.47/219.65       91%28%77%29%; was see under ORTHODONTIC APPLIANCES, REMOVABLE 1977-90%A%  
% 219.47/219.65  |- skos__hiddenLabel mesh__D005115 Chincaps, Orthodontic
% 219.47/219.65  |- skos__hiddenLabel mesh__D005115 Extraoral Traction Appliance
% 219.47/219.65  |- skos__hiddenLabel mesh__D005115 Bows, Orthodontic Face
% 219.47/219.65  |- mesh__recordAuthorizer mesh__D005115 PLS
% 219.47/219.65  |- mesh__publicMeSHNote mesh__D005115
% 219.47/219.65       91; was see under ORTHODONTIC APPLIANCES, REMOVABLE 1977-90%A%  
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005115 2003
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005115 2006
% 219.47/219.65  |- mesh__dateEstablished mesh__D005115 1991-01-01
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005115 2002
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005115 1997
% 219.47/219.65  |- mesh__dateCreated mesh__D005115 1976-04-13
% 219.47/219.65  |- skos__broader mesh__D005115smesh__D009968
% 219.47/219.65  |- skos__hiddenLabel mesh__D005115 Bow, Orthodontic Face
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005115 2005
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005115 2001
% 219.47/219.65  |- mesh__recordMaintainer mesh__D005115 TAP
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005115 1996
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005115 1999
% 219.47/219.65  |- skos__hiddenLabel mesh__D005115 Appliance, Extraoral Traction
% 219.47/219.65  |- skos__hiddenLabel mesh__D005115 Traction Appliance, Extraoral
% 219.47/219.65  |- skos__broader mesh__D010858smesh__D010808
% 219.47/219.65  |- mesh__dateCreated mesh__D010858 1999-01-01
% 219.47/219.65  |- mesh__recordMaintainer mesh__D010858 ags
% 219.47/219.65  |- mesh__dateRevised mesh__D010858 2005-07-27
% 219.47/219.65  |- skos__hiddenLabel mesh__D010858 Pigmentations
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D010858 2006
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D010858 2006A
% 219.47/219.65  |- skos__broader mesh__D010858smesh__D001686
% 219.47/219.65  |- skos__prefLabel mesh__D010858 Pigmentation
% 219.47/219.65  |- mesh__recordAuthorizer mesh__D010858 ags
% 219.47/219.65  |- skos__related mesh__D010858smesh__D012880
% 219.47/219.65  |- skos__annotation mesh__D010858
% 219.47/219.65       differentiate from COLOR in that PIGMENTATION is related to biological PIGMENTS%A%  
% 219.47/219.65  |- skos__scopeNote mesh__D010858
% 219.47/219.65       Coloration or discoloration of a part by a pigment.     
% 219.47/219.65  |- mesh__recordOriginator mesh__D010858 NLM
% 219.47/219.65  |- rdf__type mesh__D010858sskos__Concept
% 219.47/219.65  |- mesh__recordOriginator mesh__D029563 jmp
% 219.47/219.65  |- mesh__recordMaintainer mesh__D029563 ags
% 219.47/219.65  |- skos__broader mesh__D029563smesh__D018797
% 219.47/219.65  |- skos__hiddenLabel mesh__D029563 Importin alpha Export Receptor CAS
% 219.47/219.65  |- skos__altLabel mesh__D029563 CSE1L Protein
% 219.47/219.65  |- skos__broader mesh__D029563smesh__D029543
% 219.47/219.65  |- skos__altLabel mesh__D029563 CAPTS gene product
% 219.47/219.65  |- skos__scopeNote mesh__D029563
% 219.47/219.65       A nucleocytoplasmic transport protein that binds to ALPHA KARYOPHERINS and RAN GTP BINDING PROTEIN inside the CELL NUCLEUS and participates in their export into CYTOPLASM. It is also associated with the regulation of APOPTOSIS and microtubule assembly.%A%    
% 219.47/219.65  |- skos__altLabel mesh__D029563 Importin-alpha Export Receptor CAS
% 219.47/219.65  |- mesh__dateEstablished mesh__D029563 2002-01-01
% 219.47/219.65  |- skos__related mesh__D029563smesh__D017209
% 219.47/219.65  |- skos__prefLabel mesh__D029563 Cellular Apoptosis Susceptibility Protein
% 219.47/219.65  |- mesh__recordAuthorizer mesh__D029563 ags
% 219.47/219.65  |- mesh__publicMeSHNote mesh__D029563
% 219.47/219.65       2002; CELLULAR APOPTOSIS SUSCEPTABILITY PROTEIN was indexed under PROTEINS 1995-2001%A%  
% 219.47/219.65  |- mesh__historyNote mesh__D029563
% 219.47/219.65       2002; use CELLULAR APOPTOSIS SUSCEPTABILITY PROTEIN %28%NM%29% 1995-2001%A%  
% 219.47/219.65  |- mesh__dateRevised mesh__D029563 2005-07-07
% 219.47/219.65  |- rdf__type mesh__D029563sskos__Concept
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D029563 2006
% 219.47/219.65  |- skos__altLabel mesh__D029563 Chromosome Segregation 1 Like Protein
% 219.47/219.65  |- mesh__dateCreated mesh__D029563 2001-07-25
% 219.47/219.65  |- skos__hiddenLabel mesh__D029563 Export Factor, CAS
% 219.47/219.65  |- skos__altLabel mesh__D029563 CAS Export Factor
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D029563 2006A
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D009506 1996
% 219.47/219.65  |- skos__prefLabel mesh__D009506 Nevus
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D009506 2003
% 219.47/219.65  |- skos__annotation mesh__D009506
% 219.47/219.65       /blood supply /chem /secret /ultrastruct permitted; coord IM with SKIN NEOPLASMS %28%IM%29% + site %28%IM or NIM%29% if relevant; BASAL CELL NEVUS SYNDROME %26% DYSPLASTIC NEVUS SYNDROME are also available%A%  
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D009506 2001
% 219.47/219.65  |- rdf__type mesh__D009506sskos__Concept
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D009506 2000
% 219.47/219.65  |- mesh__recordOriginator mesh__D009506 NLM
% 219.47/219.65  |- mesh__dateCreated mesh__D009506 1999-01-01
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D009506 1999
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D009506 2006
% 219.47/219.65  |- mesh__dateRevised mesh__D009506 1995-06-08
% 219.47/219.65  |- mesh__recordAuthorizer mesh__D009506 PLS
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D009506 1997
% 219.47/219.65  |- mesh__recordMaintainer mesh__D009506 KEV
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D009506 1998
% 219.47/219.65  |- skos__broader mesh__D009506smesh__D018326
% 219.47/219.65  |- skos__scopeNote mesh__D009506
% 219.47/219.65       A circumscribed stable malformation of the skin and occasionally of the oral mucosa, which is not due to external causes and therefore presumed to be of hereditary origin. The excess %28%or deficiency%29% of tissue may involve epidermal, connective tissue, adnexal, nervous, or vascular elements. %28%Dorland, 27th ed%29%%A%    
% 219.47/219.65  |- skos__altLabel mesh__D009506 Nevi
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D009506 2004
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D009506 2005
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D009506 2002
% 219.47/219.65  |- skos__related mesh__D001523smesh__D028642
% 219.47/219.65  |- mesh__runningHead mesh__D001523 F3 - MENTAL DISORDERS   
% 219.47/219.65  |- rdf__type mesh__D001523sskos__Concept
% 219.47/219.65  |- mesh__dateCreated mesh__D001523 1999-01-01
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D001523 2005
% 219.47/219.65  |- mesh__recordOriginator mesh__D001523 NLM
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D001523 2002
% 219.47/219.65  |- mesh__dateEstablished mesh__D001523 1998-01-01
% 219.47/219.65  |- mesh__recordMaintainer mesh__D001523 con
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D001523 2004
% 219.47/219.65  |- skos__prefLabel mesh__D001523 Mental Disorders
% 219.47/219.65  |- skos__hiddenLabel mesh__D001523 Disorder, Mental
% 219.47/219.65  |- skos__altLabel mesh__D001523 Psychiatric Diagnosis
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D001523 2003
% 219.47/219.65  |- skos__scopeNote mesh__D001523
% 219.47/219.65       Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.%A%    
% 219.47/219.65  |- skos__hiddenLabel mesh__D001523 Disorders, Behavior
% 219.47/219.65  |- mesh__onlineNote mesh__D001523
% 219.47/219.65       pre-explosion = MENTAL DISORDERS %28%PX%29%   
% 219.47/219.65  |- mesh__recordAuthorizer mesh__D001523 sjn
% 219.47/219.65  |- mesh__historyNote mesh__D001523 use pre-explosion 1974-97   
% 219.47/219.65  |- skos__hiddenLabel mesh__D001523 Mental Disorder
% 219.47/219.65  |- skos__hiddenLabel mesh__D001523 Disorders, Mental
% 219.47/219.65  |- mesh__dateRevised mesh__D001523 2001-07-25
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D001523 2006
% 219.47/219.65  |- rdf__type mesh__D020488sskos__Concept
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D020488 2006
% 219.47/219.65  |- skos__annotation mesh__D020488
% 219.47/219.65       CATALOG: Use for background material on diseases and other topics written for a nursing audience, which do not include specific nursing procedures.  For works which  include nursing procedures, use instead an appropriate main heading qualified by the topical subheading nursing, or coordinate with the main heading NURSING CARE or another appropriate nursing term%A%  
% 219.47/219.65  |- skos__prefLabel mesh__D020488
% 219.47/219.65       Nurses%27% Instruction %5B%Publication Type%5D%
% 219.47/219.65  |- mesh__recordOriginator mesh__D020488 JLS
% 219.47/219.65  |- mesh__dateCreated mesh__D020488 1998-06-03
% 219.47/219.65  |- skos__broader mesh__D020488smesh__D019514
% 219.47/219.65  |- skos__scopeNote mesh__D020488
% 219.47/219.65       Works consisting of materials developed for a nursing audience.%A%    
% 219.47/219.65  |- skos__altLabel mesh__D020488 Nurses%27% Instruction %28%PT%29%
% 219.47/219.65  |- mesh__historyNote mesh__D020488 1999   
% 219.47/219.65  |- mesh__dateEstablished mesh__D020488 1999-01-01
% 219.47/219.65  |- skos__altLabel mesh__D020488 Nurses Instruction %28%PT%29%
% 219.47/219.65  |- mesh__recordAuthorizer mesh__D020488 sjn
% 219.47/219.65  |- mesh__dateRevised mesh__D020488 2005-06-30
% 219.47/219.65  |- mesh__recordMaintainer mesh__D020488 jls
% 219.47/219.65  |- mesh__publicMeSHNote mesh__D019934 98   
% 219.47/219.65  |- skos__hiddenLabel mesh__D019934 Ratio, International Normalized
% 219.47/219.65  |- skos__annotation mesh__D019934 note short X ref   
% 219.47/219.65  |- skos__hiddenLabel mesh__D019934 International Normalized Ratios
% 219.47/219.65  |- skos__hiddenLabel mesh__D019934 Ratios, International Normalized
% 219.47/219.65  |- skos__altLabel mesh__D019934 INR
% 219.47/219.65  |- skos__hiddenLabel mesh__D019934 Normalized Ratios, International
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D019934 1998
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D019934 2000
% 219.47/219.65  |- mesh__dateCreated mesh__D019934 1997-06-20
% 219.47/219.65  |- rdf__type mesh__D019934sskos__Concept
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D019934 1999
% 219.47/219.65  |- skos__hiddenLabel mesh__D019934 Normalized Ratio, International
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D019934 2001
% 219.47/219.65  |- skos__broader mesh__D019934smesh__D001780
% 219.47/219.65  |- skos__prefLabel mesh__D019934 International Normalized Ratio
% 219.47/219.65  |- skos__related mesh__D019934smesh__D001777
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D019934 2003
% 219.47/219.65  |- mesh__historyNote mesh__D019934 98   
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D019934 2005
% 219.47/219.65  |- mesh__dateEstablished mesh__D019934 1998-01-01
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D019934 2004
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D019934 2002
% 219.47/219.65  |- skos__scopeNote mesh__D019934
% 219.47/219.65       System established by the World Health Organization and the International Committee on Thrombosis and Hemostasis for monitoring and reporting blood coagulation tests. Under this system, results are standardized using the International Sensitivity Index for the particular test reagent/instrument combination used.%A%    
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D019934 2006
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011951 2004
% 219.47/219.65  |- skos__annotation mesh__D011951
% 219.47/219.65       GEN; prefer specific; DF: RECEPT COMPLEMENT   
% 219.47/219.65  |- mesh__dateRevised mesh__D011951 2003-07-09
% 219.47/219.65  |- mesh__dateCreated mesh__D011951 1979-05-24
% 219.47/219.65  |- rdf__type mesh__D011951sskos__Concept
% 219.47/219.65  |- skos__historyNote mesh__D011951 B Lymphocytes %28%1973-1979%29%
% 219.47/219.65  |- skos__historyNote mesh__D011951 Lymphocytes %28%1966-1979%29%
% 219.47/219.65  |- mesh__publicMeSHNote mesh__D011951 80   
% 219.47/219.65  |- skos__broader mesh__D011951smesh__D011971
% 219.47/219.65  |- skos__altLabel mesh__D011951 Complement Receptors
% 219.47/219.65  |- skos__scopeNote mesh__D011951
% 219.47/219.65       Molecules on the surface of some B-lymphocytes and macrophages, that recognize and combine with the C3b, C3d, C1q, and C4b components of complement.%A%    
% 219.47/219.65  |- skos__altLabel mesh__D011951 Complement Receptor
% 219.47/219.65  |- mesh__historyNote mesh__D011951 80   
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011951 2005
% 219.47/219.65  |- mesh__dateEstablished mesh__D011951 1980-01-01
% 219.47/219.65  |- mesh__recordMaintainer mesh__D011951 jmp
% 219.47/219.65  |- skos__hiddenLabel mesh__D011951 Receptor, Complement
% 219.47/219.65  |- mesh__recordAuthorizer mesh__D011951 sjn
% 219.47/219.65  |- skos__historyNote mesh__D011951 Complement %28%1966-1979%29%
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011951 2006
% 219.47/219.65  |- mesh__recordOriginator mesh__D011951 AEP
% 219.47/219.65  |- skos__prefLabel mesh__D011951 Receptors, Complement
% 219.47/219.65  |- skos__hiddenLabel mesh__D011153 Populations
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011153 2004
% 219.47/219.65  |- mesh__dateRevised mesh__D011153 2002-07-03
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011153 2006
% 219.47/219.65  |- skos__hiddenLabel mesh__D011153 Populations, School Age
% 219.47/219.65  |- mesh__recordAuthorizer mesh__D011153 sjn
% 219.47/219.65  |- skos__hiddenLabel mesh__D011153 School-Age Populations
% 219.47/219.65  |- rdf__type mesh__D011153sskos__Concept
% 219.47/219.65  |- skos__hiddenLabel mesh__D011153 Population, School-Age
% 219.47/219.65  |- skos__prefLabel mesh__D011153 Population
% 219.47/219.65  |- skos__hiddenLabel mesh__D011153 School Age Populations
% 219.47/219.65  |- skos__scopeNote mesh__D011153
% 219.47/219.65       The total number of individuals inhabiting a particular region or area.%A%    
% 219.47/219.65  |- skos__annotation mesh__D011153
% 219.47/219.65       IM human, NIM animal; /genet allowed; differentiate from DEMOGRAPHY %28%the statist study of population characteristics%29%%A%  
% 219.47/219.65  |- skos__hiddenLabel mesh__D011153 Populations, School-Age
% 219.47/219.65  |- skos__hiddenLabel mesh__D011153 Population, School Age
% 219.47/219.65  |- mesh__recordOriginator mesh__D011153 NLM
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011153 2003
% 219.47/219.65  |- skos__broader mesh__D011153smesh__D011154
% 219.47/219.65  |- mesh__recordMaintainer mesh__D011153 nns
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D011153 2005
% 219.47/219.65  |- skos__altLabel mesh__D011153 School-Age Population
% 219.47/219.65  |- mesh__dateCreated mesh__D011153 1999-01-01
% 219.47/219.65  |- skos__altLabel mesh__D005914 beta, delta-Globin
% 219.47/219.65  |- skos__hiddenLabel mesh__D005914 A gamma Globin
% 219.47/219.65  |- skos__hiddenLabel mesh__D005914 Globin, alpha-1
% 219.47/219.65  |- skos__hiddenLabel mesh__D005914 gamma Globin
% 219.47/219.65  |- mesh__dateCreated mesh__D005914 1999-01-01
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005914 2004
% 219.47/219.65  |- skos__hiddenLabel mesh__D005914 delta, beta Globin
% 219.47/219.65  |- skos__hiddenLabel mesh__D005914 beta-Globin delta
% 219.47/219.65  |- mesh__historyNote mesh__D005914 2001, 1965-1971%28%1972%29%   
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005914 2005
% 219.47/219.65  |- skos__altLabel mesh__D005914 p-Globin
% 219.47/219.65  |- mesh__recordOriginator mesh__D005914 NLM
% 219.47/219.65  |- skos__altLabel mesh__D005914 Globin
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005914 2005A
% 219.47/219.65  |- skos__hiddenLabel mesh__D005914 p Globin
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005914 2001
% 219.47/219.65  |- skos__hiddenLabel mesh__D005914 beta Globin
% 219.47/219.65  |- skos__hiddenLabel mesh__D005914 theta Globin
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005914 2006
% 219.47/219.65  |- skos__hiddenLabel mesh__D005914 delta-Globin beta
% 219.47/219.65  |- mesh__recordAuthorizer mesh__D005914 jls
% 219.47/219.65  |- skos__prefLabel mesh__D005914 Globins
% 219.47/219.65  |- skos__hiddenLabel mesh__D005914 delta Globin
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005914 2005B
% 219.47/219.65  |- skos__hiddenLabel mesh__D005914 beta 1 Globin
% 219.47/219.65  |- skos__hiddenLabel mesh__D005914 alpha 1 Globin
% 219.47/219.65  |- mesh__dateRevised mesh__D005914 2004-07-27
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005914 2002
% 219.47/219.65  |- rdf__type mesh__D005914sskos__Concept
% 219.47/219.65  |- mesh__dateEstablished mesh__D005914 1972-01-01
% 219.47/219.65  |- skos__hiddenLabel mesh__D005914 Globin, beta-1
% 219.47/219.65  |- skos__broader mesh__D005914smesh__D006454
% 219.47/219.65  |- mesh__recordMaintainer mesh__D005914 jls
% 219.47/219.65  |- skos__hiddenLabel mesh__D005914 gamma-Globin, A
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005914 2003
% 219.47/219.65  |- skos__hiddenLabel mesh__D005914 beta, delta Globin
% 219.47/219.65  |- mesh__publicMeSHNote mesh__D005914 2001; see GLOBIN 1972-2000   
% 219.47/219.65  |- skos__hiddenLabel mesh__D005914 alpha Globin
% 219.47/219.65  |- skos__hiddenLabel mesh__D005914 zeta Globin
% 219.47/219.65  |- skos__scopeNote mesh__D005914
% 219.47/219.65       The protein constituents of hemoglobin. The term is used for proteins attached to iron-porphyrin molecules such as hemoglobin and MYOGLOBIN proteins.%A%    
% 219.47/219.65  |- skos__hiddenLabel mesh__D005914 epsilon Globin
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005116 2005
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005116 1993
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005116 1998
% 219.47/219.65  |- skos__broader mesh__D005116smesh__D004525
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005116 2006
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005116 2003
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005116 1999
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005116 1996
% 219.47/219.65  |- skos__hiddenLabel mesh__D005116 Tracts, Extrapyramidal
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005116 2004
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005116 1997
% 219.47/219.65  |- mesh__recordOriginator mesh__D005116 NLM
% 219.47/219.65  |- mesh__dateRevised mesh__D005116 1992-05-15
% 219.47/219.65  |- mesh__recordAuthorizer mesh__D005116 PLS
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005116 2000
% 219.47/219.65  |- mesh__recordMaintainer mesh__D005116 TAP
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005116 2001
% 219.47/219.65  |- skos__hiddenLabel mesh__D005116 Extrapyramidal Tract
% 219.47/219.65  |- skos__broader mesh__D005116smesh__D013116
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005116 1994
% 219.47/219.65  |- skos__prefLabel mesh__D005116 Extrapyramidal Tracts
% 219.47/219.65  |- skos__hiddenLabel mesh__D005116 Tract, Extrapyramidal
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005116 2002
% 219.47/219.65  |- rdf__type mesh__D005116sskos__Concept
% 219.47/219.65  |- mesh__dateCreated mesh__D005116 1999-01-01
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D005116 1995
% 219.47/219.65  |- mesh__onlineNote mesh__D010859
% 219.47/219.65       use PIGMENTATION DISORDERS to search SCHAMBERG%27%S DISEASE 1966-85%A%  
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D010859 1999
% 219.47/219.65  |- skos__hiddenLabel mesh__D010859 Pigmentation Disorder
% 219.47/219.65  |- skos__altLabel mesh__D010859 Incontinentia Pigmenti Achromians
% 219.47/219.65  |- mesh__activeMeSHYear mesh__D010859 2004
% 219.47/219.65  |- skos__hiddenLabel mesh__D010859 Disease, Schamberg
% 219.47/219.66  |- mesh__recordOriginator mesh__D010859 NLM
% 219.47/219.66  |- mesh__dateRevised mesh__D010859 1997-06-20
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D010859 2006
% 219.47/219.66  |- mesh__historyNote mesh__D010859
% 219.47/219.66       SCHAMBERG%27%S DISEASE was see under PIGMENTATION DISORDERS 1965-85%A%  
% 219.47/219.66  |- skos__annotation mesh__D010859
% 219.47/219.66       do not restrict to skin despite category; do not confuse X ref INCONTINENTIA PIGMENTI ACHROMIANS with INCONTINENTIA PIGMENTI%A%  
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D010859 2002
% 219.47/219.66  |- mesh__publicMeSHNote mesh__D010859
% 219.47/219.66       SCHAMBERG%27%S DISEASE was see under PIGMENTATION DISORDERS 1965-85%A%  
% 219.47/219.66  |- skos__broader mesh__D010859smesh__D012871
% 219.47/219.66  |- skos__hiddenLabel mesh__D010859 Disease, Schamberg%27%s
% 219.47/219.66  |- mesh__recordAuthorizer mesh__D010859 SJN
% 219.47/219.66  |- skos__altLabel mesh__D010859 Schamberg%27%s Disease
% 219.47/219.66  |- skos__prefLabel mesh__D010859 Pigmentation Disorders
% 219.47/219.66  |- skos__hiddenLabel mesh__D010859 Disorders, Pigmentation
% 219.47/219.66  |- skos__hiddenLabel mesh__D010859 Syndrome, Ito
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D010859 2000
% 219.47/219.66  |- rdf__type mesh__D010859sskos__Concept
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D010859 1998
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D010859 2003
% 219.47/219.66  |- mesh__dateCreated mesh__D010859 1999-01-01
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D010859 2001
% 219.47/219.66  |- skos__hiddenLabel mesh__D010859 Disorder, Pigmentation
% 219.47/219.66  |- mesh__recordMaintainer mesh__D010859 TGC
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D010859 2005
% 219.47/219.66  |- skos__hiddenLabel mesh__D010859 Schambergs Disease
% 219.47/219.66  |- skos__hiddenLabel mesh__D021581 Transport, Nucleocytoplasmic
% 219.47/219.66  |- mesh__recordAuthorizer mesh__D021581 sjn
% 219.47/219.66  |- skos__altLabel mesh__D021581 Nucleocytoplasmic Transport
% 219.47/219.66  |- skos__scopeNote mesh__D021581
% 219.47/219.66       Gated transport mechanisms by which proteins or RNA are moved across the NUCLEAR MEMBRANE.%A%    
% 219.47/219.66  |- mesh__historyNote mesh__D021581 2001   
% 219.47/219.66  |- mesh__recordMaintainer mesh__D021581 nns
% 219.47/219.66  |- skos__related mesh__D021581smesh__D029543
% 219.47/219.66  |- skos__hiddenLabel mesh__D021581 Export, Nuclear
% 219.47/219.66  |- skos__related mesh__D021581smesh__D019913
% 219.47/219.66  |- skos__related mesh__D021581smesh__D049790
% 219.47/219.66  |- skos__historyNote mesh__D021581 Cell Nucleus/ME %28%1982-2000%29%
% 219.47/219.66  |- skos__prefLabel mesh__D021581 Active Transport, Cell Nucleus
% 219.47/219.66  |- skos__hiddenLabel mesh__D021581 Nucleo cytoplasmic Transport
% 219.47/219.66  |- skos__hiddenLabel mesh__D021581 Import, Nuclear
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D021581 2006
% 219.47/219.66  |- rdf__type mesh__D021581sskos__Concept
% 219.47/219.66  |- mesh__dateEstablished mesh__D021581 2001-01-01
% 219.47/219.66  |- skos__broader mesh__D021581smesh__D001693
% 219.47/219.66  |- skos__hiddenLabel mesh__D021581 Transports, Nucleo-cytoplasmic
% 219.47/219.66  |- skos__annotation mesh__D021581
% 219.47/219.66       IM general only; coordinate NIM with CELL NUCLEUS /metab %28%IM%29% + substance /metab %28%IM%29%%A%  
% 219.47/219.66  |- skos__related mesh__D021581smesh__D028884
% 219.47/219.66  |- skos__hiddenLabel mesh__D021581 Transport, Nuclear
% 219.47/219.66  |- skos__altLabel mesh__D021581 Nucleo-cytoplasmic Transport
% 219.47/219.66  |- mesh__dateRevised mesh__D021581 2005-06-30
% 219.47/219.66  |- mesh__recordOriginator mesh__D021581 nns
% 219.47/219.66  |- mesh__publicMeSHNote mesh__D021581 2001   
% 219.47/219.66  |- skos__historyNote mesh__D021581 Biological Transport %28%1982-2000%29%
% 219.47/219.66  |- skos__hiddenLabel mesh__D021581 Transport, Nucleo-cytoplasmic
% 219.47/219.66  |- mesh__dateCreated mesh__D021581 2000-07-05
% 219.47/219.66  |- skos__altLabel mesh__D021581 Nuclear Transport
% 219.47/219.66  |- skos__broader mesh__D021581smesh__D021381
% 219.47/219.66  |- mesh__recordOriginator mesh__D015544 RLS
% 219.47/219.66  |- mesh__recordMaintainer mesh__D015544 ssb
% 219.47/219.66  |- mesh__historyNote mesh__D015544 90   
% 219.47/219.66  |- mesh__dateRevised mesh__D015544 2004-07-07
% 219.47/219.66  |- mesh__dateEstablished mesh__D015544 1990-01-01
% 219.47/219.66  |- skos__altLabel mesh__D015544 Myo-Inositol 1,4,5-Trisphosphate
% 219.47/219.66  |- skos__broader mesh__D015544smesh__D007295
% 219.47/219.66  |- rdf__type mesh__D015544sskos__Concept
% 219.47/219.66  |- skos__altLabel mesh__D015544 Inositol 1,4,5-Triphosphate
% 219.47/219.66  |- mesh__recordAuthorizer mesh__D015544 sjn
% 219.47/219.66  |- skos__prefLabel mesh__D015544 Inositol 1,4,5-Trisphosphate
% 219.47/219.66  |- mesh__dateCreated mesh__D015544 1989-07-05
% 219.47/219.66  |- skos__altLabel mesh__D015544 1,4,5-IP3
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D015544 2005
% 219.47/219.66  |- mesh__publicMeSHNote mesh__D015544 90   
% 219.47/219.66  |- skos__altLabel mesh__D015544 Myoinositol 1,4,5-Triphosphate
% 219.47/219.66  |- skos__altLabel mesh__D015544 1,4,5-InsP3
% 219.47/219.66  |- skos__historyNote mesh__D015544 Sugar Phosphates %28%1974-1977%29%
% 219.47/219.66  |- skos__historyNote mesh__D015544 Inositol Phosphates %28%1978-1989%29%
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D015544 2006
% 219.47/219.66  |- skos__scopeNote mesh__D015544
% 219.47/219.66       Intracellular messenger formed by the action of phospholipase C on phosphatidylinositol 4,5-bisphosphate, which is one of the phospholipids that make up the cell membrane. Inositol 1,4,5-trisphosphate is released into the cytoplasm where it releases calcium ions from internal stores within the cell%27%s endoplasmic reticulum. These calcium ions stimulate the activity of B kinase or calmodulin.%A%    
% 219.47/219.66  |- mesh__recordOriginator mesh__D009507 VDK
% 219.47/219.66  |- mesh__recordAuthorizer mesh__D009507 sjn
% 219.47/219.66  |- skos__scopeNote mesh__D009507
% 219.47/219.66       A macular lesion on the side of the FACE, involving the CONJUNCTIVA and EYELIDS, as well as the adjacent facial skin, SCLERA; OCULOMOTOR MUSCLES; and PERIOSTEUM. Histological features vary from those of a MONGOLIAN SPOT to those of a BLUE NEVUS.%A%    
% 219.47/219.66  |- skos__historyNote mesh__D009507 Nevus, Pigmented %28%1966-1986%29%
% 219.47/219.66  |- skos__altLabel mesh__D009507 Ota%27%s Nevus
% 219.47/219.66  |- mesh__recordMaintainer mesh__D009507 ags
% 219.47/219.66  |- skos__historyNote mesh__D009507 Nevus %28%1966-1986%29%
% 219.47/219.66  |- rdf__type mesh__D009507sskos__Concept
% 219.47/219.66  |- skos__annotation mesh__D009507
% 219.47/219.66       /blood supply /chem /secret /ultrastruct permitted; coord IM with SKIN NEOPLASMS %28%IM%29% + site %28%IM or NIM%29% if relevant%A%  
% 219.47/219.66  |- mesh__historyNote mesh__D009507
% 219.47/219.66       91%28%87%29%; was see under NEVUS, PIGMENTED 1987-90   
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D009507 2005
% 219.47/219.66  |- skos__hiddenLabel mesh__D009507 Otas Nevus
% 219.47/219.66  |- mesh__publicMeSHNote mesh__D009507
% 219.47/219.66       91; was see under NEVUS, PIGMENTED 1987-90   
% 219.47/219.66  |- skos__broader mesh__D009507smesh__D009508
% 219.47/219.66  |- skos__prefLabel mesh__D009507 Nevus of Ota
% 219.47/219.66  |- skos__hiddenLabel mesh__D009507 Nevus, Ota%27%s
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D009507 2006
% 219.47/219.66  |- skos__hiddenLabel mesh__D009507 Ota Nevus
% 219.47/219.66  |- mesh__dateEstablished mesh__D009507 1991-01-01
% 219.47/219.66  |- mesh__dateRevised mesh__D009507 2004-07-07
% 219.47/219.66  |- mesh__dateCreated mesh__D009507 1986-04-18
% 219.47/219.66  |- rdf__type mesh__D001524sskos__Concept
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D001524 2003
% 219.47/219.66  |- mesh__dateEstablished mesh__D001524 1983-01-01
% 219.47/219.66  |- skos__hiddenLabel mesh__D001524 Psychologies, Health
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D001524 2004
% 219.47/219.66  |- mesh__publicMeSHNote mesh__D001524 83   
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D001524 2002
% 219.47/219.66  |- skos__prefLabel mesh__D001524 Behavioral Medicine
% 219.47/219.66  |- mesh__recordOriginator mesh__D001524 EC
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D001524 1997
% 219.47/219.66  |- skos__hiddenLabel mesh__D001524 Health Psychologies
% 219.47/219.66  |- skos__annotation mesh__D001524 SPEC: SPEC qualif; DF: BEHAVIORAL MED   
% 219.47/219.66  |- mesh__dateCreated mesh__D001524 1982-04-28
% 219.47/219.66  |- skos__altLabel mesh__D001524 Medicine, Behavioral
% 219.47/219.66  |- mesh__dateRevised mesh__D001524 1996-06-10
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D001524 2000
% 219.47/219.66  |- skos__broader mesh__D001524smesh__D008511
% 219.47/219.66  |- mesh__historyNote mesh__D001524 83   
% 219.47/219.66  |- skos__broader mesh__D001524smesh__D001525
% 219.47/219.66  |- skos__altLabel mesh__D001524 Psychology, Health
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D001524 2005
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D001524 1998
% 219.47/219.66  |- skos__scopeNote mesh__D001524
% 219.47/219.66       The interdisciplinary field concerned with the development and integration of behavioral and biomedical science, knowledge, and techniques relevant to health and illness and the application of this knowledge and these techniques to prevention, diagnosis, treatment, and rehabilitation.%A%    
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D001524 2001
% 219.47/219.66  |- mesh__recordAuthorizer mesh__D001524 PLS
% 219.47/219.66  |- mesh__recordMaintainer mesh__D001524 JLS
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D001524 2006
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D001524 1999
% 219.47/219.66  |- skos__scopeNote mesh__D020489
% 219.47/219.66       Works consisting of brief statements of the principal elements of a subject, usually arranged by heads and subheads.%A%    
% 219.47/219.66  |- mesh__recordAuthorizer mesh__D020489 sjn
% 219.47/219.66  |- mesh__dateEstablished mesh__D020489 1999-01-01
% 219.47/219.66  |- mesh__recordMaintainer mesh__D020489 jls
% 219.47/219.66  |- skos__prefLabel mesh__D020489 Outlines %5B%Publication Type%5D%
% 219.47/219.66  |- mesh__dateRevised mesh__D020489 2005-06-30
% 219.47/219.66  |- mesh__dateCreated mesh__D020489 1998-06-03
% 219.47/219.66  |- rdf__type mesh__D020489sskos__Concept
% 219.47/219.66  |- mesh__historyNote mesh__D020489 1999   
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D020489 2006
% 219.47/219.66  |- mesh__recordOriginator mesh__D020489 JLS
% 219.47/219.66  |- skos__altLabel mesh__D020489 Outlines %28%PT%29%
% 219.47/219.66  |- skos__broader mesh__D020489smesh__D052180
% 219.47/219.66  |- mesh__dateEstablished mesh__D019935 1998-01-01
% 219.47/219.66  |- skos__historyNote mesh__D019935 Penis/surgery %28%1966-1989%29%
% 219.47/219.66  |- skos__hiddenLabel mesh__D019935 Implantations, Penile
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D019935 1998
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D019935 2002
% 219.47/219.66  |- mesh__publicMeSHNote mesh__D019935 98   
% 219.47/219.66  |- rdf__type mesh__D019935sskos__Concept
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D019935 1999
% 219.47/219.66  |- skos__historyNote mesh__D019935 Penile Prosthesis %28%1990-1997%29%
% 219.47/219.66  |- skos__scopeNote mesh__D019935
% 219.47/219.66       Surgical insertion of cylindric hydraulic devices for the treatment of organic impotence.%A%    
% 219.47/219.66  |- skos__hiddenLabel mesh__D019935 Implantations, Penile Prosthesis
% 219.47/219.66  |- skos__prefLabel mesh__D019935 Penile Implantation
% 219.47/219.66  |- skos__altLabel mesh__D019935 Penile Prosthesis Implantation
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D019935 2003
% 219.47/219.66  |- mesh__historyNote mesh__D019935 98   
% 219.47/219.66  |- skos__broader mesh__D019935smesh__D013521
% 219.47/219.66  |- skos__hiddenLabel mesh__D019935 Prosthesis Implantation, Penile
% 219.47/219.66  |- skos__hiddenLabel mesh__D019935 Penile Implantations
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D019935 2000
% 219.47/219.66  |- skos__hiddenLabel mesh__D019935 Penile Prosthesis Implantations
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D019935 2005
% 219.47/219.66  |- mesh__dateCreated mesh__D019935 1997-06-20
% 219.47/219.66  |- skos__hiddenLabel mesh__D019935 Implantation, Penile Prosthesis
% 219.47/219.66  |- skos__related mesh__D019935smesh__D015917
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D019935 2004
% 219.47/219.66  |- skos__historyNote mesh__D019935
% 219.47/219.66       Prostheses and Implants %28%1966-1989%29%
% 219.47/219.66  |- skos__hiddenLabel mesh__D019935 Implantation, Penile
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D019935 2001
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D019935 2006
% 219.47/219.66  |- skos__hiddenLabel mesh__D019935 Prosthesis Implantations, Penile
% 219.47/219.66  |- skos__broader mesh__D019935smesh__D019919
% 219.47/219.66  |- mesh__publicMeSHNote mesh__D011952
% 219.47/219.66       80; was see under RECEPTORS, DRUG 1977-79   
% 219.47/219.66  |- mesh__dateRevised mesh__D011952 2003-07-09
% 219.47/219.66  |- mesh__recordAuthorizer mesh__D011952 sjn
% 219.47/219.66  |- rdf__type mesh__D011952sskos__Concept
% 219.47/219.66  |- skos__historyNote mesh__D011952 Concanavalin A %28%1971-1976%29%
% 219.47/219.66  |- skos__scopeNote mesh__D011952
% 219.47/219.66       Glycoprotein moieties on the surfaces of cell membranes that bind concanavalin A selectively; the number and location of the sites depends on the type and condition of the cell.%A%    
% 219.47/219.66  |- skos__altLabel mesh__D011952 Concanavalin A Receptor
% 219.47/219.66  |- mesh__dateCreated mesh__D011952 1976-05-03
% 219.47/219.66  |- skos__historyNote mesh__D011952 Receptors, Drug %28%1968-1976%29%
% 219.47/219.66  |- skos__historyNote mesh__D011952 Lectins %28%1966-1970%29%
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D011952 2005
% 219.47/219.66  |- skos__altLabel mesh__D011952 Receptor, Concanavalin A
% 219.47/219.66  |- mesh__dateEstablished mesh__D011952 1980-01-01
% 219.47/219.66  |- mesh__recordMaintainer mesh__D011952 jmp
% 219.47/219.66  |- skos__prefLabel mesh__D011952 Receptors, Concanavalin A
% 219.47/219.66  |- skos__broader mesh__D011952smesh__D011975
% 219.47/219.66  |- mesh__historyNote mesh__D011952
% 219.47/219.66       80%28%77%29%; was see under RECEPTORS, DRUG 1977-79   
% 219.47/219.66  |- skos__altLabel mesh__D011952 Concanavalin A Receptors
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D011952 2006
% 219.47/219.66  |- skos__annotation mesh__D011952
% 219.47/219.66       coord IM with specific concanavalin %28%IM%29%; DF: RECEPT CON A%A%  
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D011952 2004
% 219.47/219.66  |- mesh__recordOriginator mesh__D011952 SH
% 219.47/219.66  |- skos__altLabel mesh__D011952 Concanavalin A Binding Sites
% 219.47/219.66  |- mesh__recordAuthorizer mesh__D011154 SJN
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D011154 2003
% 219.47/219.66  |- mesh__publicMeSHNote mesh__D011154 98   
% 219.47/219.66  |- skos__hiddenLabel mesh__D011154 Population, Low Fertility
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D011154 2002
% 219.47/219.66  |- skos__altLabel mesh__D011154 Biologic Characteristic
% 219.47/219.66  |- skos__hiddenLabel mesh__D011154 Populations, Low Fertility
% 219.47/219.66  |- skos__hiddenLabel mesh__D011154 Risk, Population at
% 219.47/219.66  |- mesh__runningHead mesh__D011154
% 219.47/219.66       N1 - HEALTH CARE-POPULATION CHARACTERISTICS   
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D011154 2004
% 219.47/219.66  |- skos__hiddenLabel mesh__D011154 Characteristic, Population
% 219.47/219.66  |- skos__hiddenLabel mesh__D011154 Characteristics, Biologic
% 219.47/219.66  |- skos__annotation mesh__D011154 not used for indexing   
% 219.47/219.66  |- skos__altLabel mesh__D011154 Biological Characteristics
% 219.47/219.66  |- mesh__recordMaintainer mesh__D011154 MSR
% 219.47/219.66  |- skos__altLabel mesh__D011154 Characteristic, Biologic
% 219.47/219.66  |- mesh__historyNote mesh__D011154 98; use explode 1970-97   
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D011154 1999
% 219.47/219.66  |- mesh__dateEstablished mesh__D011154 1998-01-01
% 219.47/219.66  |- skos__hiddenLabel mesh__D011154 Biologic Characteristics
% 219.47/219.66  |- skos__hiddenLabel mesh__D011154 Characteristics, Population
% 219.47/219.66  |- mesh__dateCreated mesh__D011154 1999-01-01
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D011154 2000
% 219.47/219.66  |- skos__historyNote mesh__D011154 Population %28%1971-1997%29%
% 219.47/219.66  |- skos__hiddenLabel mesh__D011154 Risk, Populations at
% 219.47/219.66  |- skos__scopeNote mesh__D011154
% 219.47/219.66       Qualities and characterization of various types of populations within a social or geographic group, with emphasis on demography, health status, and socioeconomic factors.%A%    
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D011154 2005
% 219.47/219.66  |- mesh__dateRevised mesh__D011154 1998-06-10
% 219.47/219.66  |- skos__hiddenLabel mesh__D011154 Population Characteristic
% 219.47/219.66  |- skos__hiddenLabel mesh__D011154 Characteristic, Biological
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D011154 2001
% 219.47/219.66  |- skos__hiddenLabel mesh__D011154 Low Fertility Populations
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D011154 2006
% 219.47/219.66  |- skos__altLabel mesh__D011154 Populations at Risk
% 219.47/219.66  |- skos__prefLabel mesh__D011154 Population Characteristics
% 219.47/219.66  |- mesh__recordOriginator mesh__D011154 NLM
% 219.47/219.66  |- rdf__type mesh__D011154sskos__Concept
% 219.47/219.66  |- skos__hiddenLabel mesh__D011154 Biological Characteristic
% 219.47/219.66  |- skos__hiddenLabel mesh__D011154 Statistics, Population
% 219.47/219.66  |- skos__hiddenLabel mesh__D011154 Heterogeneity, Population
% 219.47/219.66  |- mesh__dateRevised mesh__D005915 2004-07-07
% 219.47/219.66  |- skos__altLabel mesh__D005915 Lacto-N-tetraosylceramide
% 219.47/219.66  |- mesh__dateCreated mesh__D005915 1978-05-16
% 219.47/219.66  |- skos__altLabel mesh__D005915 Lacto-N-neotetraosylceramide
% 219.47/219.66  |- mesh__publicMeSHNote mesh__D005915
% 219.47/219.66       91; was see under GLYCOSPHINGOLIPIDS 1979-90   
% 219.47/219.66  |- mesh__historyNote mesh__D005915
% 219.47/219.66       91%28%79%29%; was see under GLYCOSPHINGOLIPIDS 1979-90   
% 219.47/219.66  |- skos__altLabel mesh__D005915 Lactoneotetraosylceramide
% 219.47/219.66  |- skos__hiddenLabel mesh__D005915 Lacto N tetraosylceramide
% 219.47/219.66  |- mesh__recordMaintainer mesh__D005915 ssb
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D005915 2006
% 219.47/219.66  |- mesh__recordOriginator mesh__D005915 RLS
% 219.47/219.66  |- skos__hiddenLabel mesh__D005915 Lacto N neotetraosylceramide
% 219.47/219.66  |- skos__historyNote mesh__D005915 Glycosphingolipids %28%1975-1978%29%
% 219.47/219.66  |- rdf__type mesh__D005915sskos__Concept
% 219.47/219.66  |- skos__historyNote mesh__D005915 Cerebrosides %28%1972-1978%29%
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D005915 2005
% 219.47/219.66  |- skos__annotation mesh__D005915 /biosyn /physiol permitted   
% 219.47/219.66  |- skos__prefLabel mesh__D005915 Globosides
% 219.47/219.66  |- skos__broader mesh__D005915smesh__D002518
% 219.47/219.66  |- skos__scopeNote mesh__D005915
% 219.47/219.66       Glycosphingolipids containing N-acetylglucosamine %28%paragloboside%29% or N-acetylgalactosamine %28%globoside%29%. Globoside is the P antigen on erythrocytes and paragloboside is an intermediate in the biosynthesis of erythrocyte blood group ABH and P 1 glycosphingolipid antigens. The accumulation of globoside in tissue, due to a defect in hexosaminidases A and B, is the cause of Sandhoff disease.%A%    
% 219.47/219.66  |- mesh__dateEstablished mesh__D005915 1991-01-01
% 219.47/219.66  |- skos__historyNote mesh__D005915 Glycolipids %28%1966-1978%29%
% 219.47/219.66  |- mesh__recordAuthorizer mesh__D005915 sjn
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D005117 2004
% 219.47/219.66  |- skos__hiddenLabel mesh__D005117 Extrasystoles
% 219.47/219.66  |- skos__hiddenLabel mesh__D005117 Premature Cardiac Complices
% 219.47/219.66  |- skos__altLabel mesh__D005117 Extrasystole
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D005117 2001
% 219.47/219.66  |- skos__hiddenLabel mesh__D005117 Cardiac Premature Complices
% 219.47/219.66  |- skos__hiddenLabel mesh__D005117 Cardiac Premature Complex
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D005117 2002
% 219.47/219.66  |- skos__hiddenLabel mesh__D005117 Complices, Cardiac Premature
% 219.47/219.66  |- skos__altLabel mesh__D005117 Premature Beats
% 219.47/219.66  |- skos__altLabel mesh__D005117 Cardiac Complex, Premature
% 219.47/219.66  |- skos__prefLabel mesh__D005117 Cardiac Complexes, Premature
% 219.47/219.66  |- rdf__type mesh__D005117sskos__Concept
% 219.47/219.66  |- skos__hiddenLabel mesh__D005117 Complex, Premature Cardiac
% 219.47/219.66  |- skos__hiddenLabel mesh__D005117 Complexes, Premature Cardiac
% 219.47/219.66  |- skos__annotation mesh__D005117
% 219.47/219.66       GEN or unspecified: atrial = ATRIAL PREMATURE COMPLEXES %26% ventric = VENTRICULAR PREMATURE COMPLEXES%A%  
% 219.47/219.66  |- mesh__dateCreated mesh__D005117 1999-01-01
% 219.47/219.66  |- skos__hiddenLabel mesh__D005117 Cardiac Complices, Premature
% 219.47/219.66  |- skos__hiddenLabel mesh__D005117 Complices, Premature Cardiac
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D005117 2005
% 219.47/219.66  |- mesh__dateRevised mesh__D005117 1999-11-08
% 219.47/219.66  |- skos__broader mesh__D005117smesh__D001145
% 219.47/219.66  |- mesh__recordAuthorizer mesh__D005117 sjn
% 219.47/219.66  |- mesh__publicMeSHNote mesh__D005117
% 219.47/219.66       96; was EXTRASYSTOLE 1963-95; PREMATURE BEATS was PREMATURE BEAT 1985-95%A%  
% 219.47/219.66  |- skos__hiddenLabel mesh__D005117 Beats, Premature
% 219.47/219.66  |- skos__hiddenLabel mesh__D005117 Premature Beat
% 219.47/219.66  |- skos__altLabel mesh__D005117 Premature Cardiac Complex
% 219.47/219.66  |- skos__scopeNote mesh__D005117
% 219.47/219.66       A premature contraction of the heart that is initiated somewhere other than the sinoatrial node.%A%    
% 219.47/219.66  |- skos__hiddenLabel mesh__D005117 Premature Complex, Cardiac
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D005117 2006
% 219.47/219.66  |- mesh__recordOriginator mesh__D005117 NLM
% 219.47/219.66  |- skos__hiddenLabel mesh__D005117 Premature Complices, Cardiac
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D005117 2003
% 219.47/219.66  |- skos__hiddenLabel mesh__D005117 Beat, Premature
% 219.47/219.66  |- skos__altLabel mesh__D005117 Premature Cardiac Complexes
% 219.47/219.66  |- mesh__historyNote mesh__D005117
% 219.47/219.66       96; was EXTRASYSTOLE 1963-95; PREMATURE BEATS was PREMATURE BEAT 1985-95%A%  
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D005117 2000
% 219.47/219.66  |- skos__altLabel mesh__D005117 Complex, Cardiac Premature
% 219.47/219.66  |- mesh__recordMaintainer mesh__D005117 adp
% 219.47/219.66  |- skos__broader mesh__D012194Q000037smesh__D012194
% 219.47/219.66  |- mesh__preferredCombination mesh__D012194Q000037smesh__D018894
% 219.47/219.66  |- rdf__type mesh__D012194Q000037smesh__CompoundConcept
% 219.47/219.66  |- mesh__dateEstablished mesh__D015545 1990-01-01
% 219.47/219.66  |- skos__historyNote mesh__D015545 Adjuvants, Immunologic %28%1966-1989%29%
% 219.47/219.66  |- mesh__recordOriginator mesh__D015545 RLS
% 219.47/219.66  |- rdf__type mesh__D015545sskos__Concept
% 219.47/219.66  |- skos__historyNote mesh__D015545 Antineoplastic Agents %28%1966-1989%29%
% 219.47/219.66  |- skos__altLabel mesh__D015545 Response Modifiers, Biological
% 219.47/219.66  |- mesh__dateRevised mesh__D015545 2005-06-30
% 219.47/219.66  |- mesh__recordMaintainer mesh__D015545 ssb
% 219.47/219.66  |- skos__annotation mesh__D015545
% 219.47/219.66       /ther use; coordinate IM with disease /drug ther %28%IM%29% + specific chemical /ther use %28%IM%29%%A%  
% 219.47/219.66  |- mesh__dateCreated mesh__D015545 1989-08-31
% 219.47/219.66  |- skos__altLabel mesh__D015545 Biomodulators
% 219.47/219.66  |- mesh__historyNote mesh__D015545 90   
% 219.47/219.66  |- mesh__publicMeSHNote mesh__D015545 90   
% 219.47/219.66  |- skos__related mesh__D015545smesh__D007166
% 219.47/219.66  |- skos__broader mesh__D015545smesh__D007155
% 219.47/219.66  |- skos__related mesh__D015545smesh__D000970
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D015545 2006
% 219.47/219.66  |- skos__scopeNote mesh__D015545
% 219.47/219.66       Biological or synthetic agents that are capable of eliciting specific and/or non-specific effects on immune responsiveness, thereby ultimately leading to an improvement in overall health of the patient. These agents can be further subcategorized into those that facilitate a normal immune response, those that stimulate the immune response, those that are capable of inducing noncytotoxic immunosuppression, and those that increase the ability of the host to tolerate damage by the cytotoxic modalities of the treatment.%A%    
% 219.47/219.66  |- skos__altLabel mesh__D015545 Modifiers, Biological Response
% 219.47/219.66  |- mesh__recordAuthorizer mesh__D015545 sjn
% 219.47/219.66  |- skos__prefLabel mesh__D015545 Biological Response Modifiers
% 219.47/219.66  |- skos__historyNote mesh__D015545
% 219.47/219.66       Immunosuppressive Agents %28%1966-1989%29%
% 219.47/219.66  |- skos__altLabel mesh__D009508 Nevi, Melanocytic
% 219.47/219.66  |- skos__altLabel mesh__D009508 Nevus, Halo
% 219.47/219.66  |- skos__altLabel mesh__D009508 Nevi, Pigmented
% 219.47/219.66  |- mesh__dateCreated mesh__D009508 1999-01-01
% 219.47/219.66  |- skos__broader mesh__D009508smesh__D009506
% 219.47/219.66  |- skos__altLabel mesh__D009508 Nevi, Halo
% 219.47/219.66  |- skos__hiddenLabel mesh__D009508 Melanocytic Nevi
% 219.47/219.66  |- skos__hiddenLabel mesh__D009508 Pigmented Nevus
% 219.47/219.66  |- rdf__type mesh__D009508sskos__Concept
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D009508 1998
% 219.47/219.66  |- skos__prefLabel mesh__D009508 Nevus, Pigmented
% 219.47/219.66  |- skos__scopeNote mesh__D009508
% 219.47/219.66       A nevus containing melanin. The term is usually restricted to nevocytic nevi %28%round or oval collections of melanin-containing nevus cells occurring at the dermoepidermal junction of the skin or in the dermis proper%29% or moles, but may be applied to other pigmented nevi. %28%From Dorland, 27th ed%29%%A%    
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D009508 1996
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D009508 2000
% 219.47/219.66  |- skos__hiddenLabel mesh__D009508 Pigmented Nevi
% 219.47/219.66  |- mesh__dateRevised mesh__D009508 1995-06-08
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D009508 1999
% 219.47/219.66  |- skos__annotation mesh__D009508
% 219.47/219.66       /blood supply /chem /secret /ultrastruct permitted; coord IM with SKIN NEOPLASMS %28%IM%29% + site %28%IM or NIM%29% if relevant%A%  
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D009508 2005
% 219.47/219.66  |- mesh__recordAuthorizer mesh__D009508 PLS
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D009508 1997
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D009508 2001
% 219.47/219.66  |- skos__hiddenLabel mesh__D009508 Halo Nevi
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D009508 2003
% 219.47/219.66  |- skos__hiddenLabel mesh__D009508 Halo Nevus
% 219.47/219.66  |- mesh__recordMaintainer mesh__D009508 KEV
% 219.47/219.66  |- mesh__recordOriginator mesh__D009508 NLM
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D009508 2006
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D009508 2002
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D009508 2004
% 219.47/219.66  |- skos__hiddenLabel mesh__D009508 Melanocytic Nevus
% 219.47/219.66  |- skos__altLabel mesh__D009508 Nevus, Melanocytic
% 219.47/219.66  |- mesh__historyNote mesh__D001525 69   
% 219.47/219.66  |- skos__hiddenLabel mesh__D001525 Behavioral Science
% 219.47/219.66  |- mesh__recordAuthorizer mesh__D001525 sjn
% 219.47/219.66  |- mesh__dateEstablished mesh__D001525 1969-01-01
% 219.47/219.66  |- skos__historyNote mesh__D001525 specific discipline
% 219.47/219.66  |- skos__scopeNote mesh__D001525
% 219.47/219.66       Disciplines concerned with the study of human and animal behavior.%A%    
% 219.47/219.66  |- skos__hiddenLabel mesh__D001525 Science, Behavioral
% 219.47/219.66  |- skos__annotation mesh__D001525 SPEC: SPEC qualif   
% 219.47/219.66  |- skos__broader mesh__D001525smesh__D004191
% 219.47/219.66  |- skos__historyNote mesh__D001525 Behavior %28%1966-1969%29%
% 219.47/219.66  |- mesh__dateCreated mesh__D001525 1999-01-01
% 219.47/219.66  |- mesh__dateRevised mesh__D001525 2004-07-13
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D001525 2005
% 219.47/219.66  |- mesh__publicMeSHNote mesh__D001525 69   
% 219.47/219.66  |- skos__prefLabel mesh__D001525 Behavioral Sciences
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D001525 2006
% 219.47/219.66  |- mesh__recordOriginator mesh__D001525 NLM
% 219.47/219.66  |- rdf__type mesh__D001525sskos__Concept
% 219.47/219.66  |- mesh__recordMaintainer mesh__D001525 sjn
% 219.47/219.66  |- skos__hiddenLabel mesh__D001525 Sciences, Behavioral
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D006210 2005
% 219.47/219.66  |- skos__annotation mesh__D006210
% 219.47/219.66       a form of craniofacial dysostosis with other abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 219.47/219.66  |- skos__hiddenLabel mesh__D006210 Syndrome, Hallermann-Streiff
% 219.47/219.66  |- skos__hiddenLabel mesh__D006210 Hallermann Streiff Syndrome
% 219.47/219.66  |- mesh__recordMaintainer mesh__D006210 kle
% 219.47/219.66  |- skos__broader mesh__D006210smesh__D003394
% 219.47/219.66  |- skos__altLabel mesh__D006210 Hallermann-Streiff Syndrome
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D006210 2006
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D006210 2000
% 219.47/219.66  |- skos__hiddenLabel mesh__D006210 Syndrome, Hallermann%27%s
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D006210 2003
% 219.47/219.66  |- mesh__dateRevised mesh__D006210 1999-11-03
% 219.47/219.66  |- skos__hiddenLabel mesh__D006210 Hallermann Syndrome
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D006210 2001
% 219.47/219.66  |- mesh__recordAuthorizer mesh__D006210 sjn
% 219.47/219.66  |- mesh__activeMeSHYear mesh__D006210 2004
% 219.47/219.66  |- rdf__type mesh__D006210sskos__Concept
% 219.47/219.66  |- skos__hiddenLabel mesh__D006210 Hallermanns Syndrome
% 219.47/219.66  |- skos__prefLabel mesh__D006210 Hallermann%27%s Syndrome
% 219.47/219.66  |- mesh__dateEstablished mesh__D006210 1991-01-01
% 219.47/219.67  |- mesh__publicMeSHNote mesh__D006210
% 219.47/219.67       91; was see under CRANIOFACIAL DYSOSTOSIS 1985-90; was see under MANDIBULOFACIAL DYSOSTOSIS 1965-84%A%  
% 219.47/219.67  |- mesh__dateCreated mesh__D006210 1999-01-01
% 219.47/219.67  |- mesh__historyNote mesh__D006210
% 219.47/219.67       91%28%65%29%; was see under CRANIOFACIAL DYSOSTOSIS 1985-90; was see under MANDIBULOFACIAL DYSOSTOSIS 1965-84%A%  
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D006210 2002
% 219.47/219.67  |- skos__scopeNote mesh__D006210
% 219.47/219.67       An oculomandibulofacial syndrome principally characterized by dyscephaly %28%usually brachycephaly%29%, parrot nose, mandibular hypoplasia, proportionate nanism, hypotrichosis, bilateral congenital cataracts, and microphthalmia. %28%Dorland, 27th ed%29%%A%    
% 219.47/219.67  |- mesh__recordOriginator mesh__D006210 NLM
% 219.47/219.67  |- mesh__publicMeSHNote mesh__D019936 98   
% 219.47/219.67  |- rdf__type mesh__D019936sskos__Concept
% 219.47/219.67  |- skos__scopeNote mesh__D019936
% 219.47/219.67       Live microbial DIETARY SUPPLEMENTS which beneficially affect the host animal by improving its intestinal microbial balance. Antibiotics and other related compounds are not included in this definition. In humans, lactobacilli are commonly used as probiotics, either as single species or in mixed culture with other bacteria. Other genera that have been used are bifidobacteria and streptococci. %28%J. Nutr. 1995;125:1401-12%29%%A%    
% 219.47/219.67  |- skos__annotation mesh__D019936 coordinate with specific microorganism   
% 219.47/219.67  |- mesh__dateRevised mesh__D019936 2002-07-03
% 219.47/219.67  |- skos__hiddenLabel mesh__D019936 Probiotic
% 219.47/219.67  |- mesh__historyNote mesh__D019936 98   
% 219.47/219.67  |- skos__broader mesh__D019936smesh__D019587
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D019936 2003
% 219.47/219.67  |- mesh__dateCreated mesh__D019936 1997-06-20
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D019936 2005
% 219.47/219.67  |- skos__prefLabel mesh__D019936 Probiotics
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D019936 2004
% 219.47/219.67  |- mesh__dateEstablished mesh__D019936 1998-01-01
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D019936 2006
% 219.47/219.67  |- skos__prefLabel mesh__D011953 Receptors, Cyclic AMP
% 219.47/219.67  |- skos__related mesh__D011953smesh__D002373
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D011953 2005
% 219.47/219.67  |- mesh__historyNote mesh__D011953 77   
% 219.47/219.67  |- skos__altLabel mesh__D011953 cAMP Receptors
% 219.47/219.67  |- mesh__publicMeSHNote mesh__D011953 77   
% 219.47/219.67  |- skos__historyNote mesh__D011953
% 219.47/219.67       Adenosine Cyclic Monophosphate %28%1968-1976%29%
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D011953 2006
% 219.47/219.67  |- mesh__recordMaintainer mesh__D011953 jmp
% 219.47/219.67  |- mesh__dateEstablished mesh__D011953 1977-01-01
% 219.47/219.67  |- mesh__recordAuthorizer mesh__D011953 sjn
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D011953 2004
% 219.47/219.67  |- skos__altLabel mesh__D011953 cAMP Receptor
% 219.47/219.67  |- skos__altLabel mesh__D011953 Receptors, cAMP
% 219.47/219.67  |- skos__altLabel mesh__D011953 Cyclic AMP Receptor
% 219.47/219.67  |- skos__scopeNote mesh__D011953
% 219.47/219.67       Cell surface proteins that bind cyclic AMP with high affinity and trigger intracellular changes which influence the behavior of cells. The best characterized cyclic AMP receptors are those of the slime mold Dictyostelium discoideum. The transcription regulator CYCLIC AMP RECEPTOR PROTEIN of prokaryotes is not included nor are the eukaryotic cytoplasmic cyclic AMP receptor proteins which are the regulatory subunits of CYCLIC AMP-DEPENDENT PROTEIN KINASES.%A%    
% 219.47/219.67  |- skos__historyNote mesh__D011953
% 219.47/219.67       Receptors, Endogenous Substances %28%1973-1976%29%
% 219.47/219.67  |- skos__hiddenLabel mesh__D011953 Receptor, cAMP
% 219.47/219.67  |- mesh__recordOriginator mesh__D011953 SH
% 219.47/219.67  |- skos__hiddenLabel mesh__D011953 Receptor, Cyclic AMP
% 219.47/219.67  |- skos__related mesh__D011953smesh__D017868
% 219.47/219.67  |- skos__annotation mesh__D011953
% 219.47/219.67       coord IM with specific cyclic AMP cpd %28%IM%29%; DF: note short X ref%A%  
% 219.47/219.67  |- mesh__dateRevised mesh__D011953 2003-07-09
% 219.47/219.67  |- rdf__type mesh__D011953sskos__Concept
% 219.47/219.67  |- skos__historyNote mesh__D011953 Adenine Nucleotides %28%1966-1967%29%
% 219.47/219.67  |- skos__broader mesh__D011953smesh__D011983
% 219.47/219.67  |- skos__historyNote mesh__D011953 Receptors, Drug %28%1968-1976%29%
% 219.47/219.67  |- skos__altLabel mesh__D011953 Cyclic AMP Receptors
% 219.47/219.67  |- mesh__dateCreated mesh__D011953 1976-05-03
% 219.47/219.67  |- mesh__dateRevised mesh__D019138 2005-06-30
% 219.47/219.67  |- mesh__historyNote mesh__D019138 96   
% 219.47/219.67  |- skos__annotation mesh__D019138
% 219.47/219.67       antibodies inhibiting reaction between antigen and other antibodies or sensitized T-lymphocytes: not for any antibody reaction to an antigen %28% = ANTIBODIES or specific antibody%29%; do not coordinate with ANTIBODY FORMATION for /biosyn%A%  
% 219.47/219.67  |- skos__altLabel mesh__D019138 Antibodies, Enhancing
% 219.47/219.67  |- skos__scopeNote mesh__D019138
% 219.47/219.67       Antibodies that inhibit the reaction between ANTIGEN and other antibodies or sensitized T-LYMPHOCYTES %28%e.g., antibodies of the IMMUNOGLOBULIN G class that compete with IGE antibodies for antigen, thereby blocking an allergic response%29%. Blocking antibodies that bind tumors and prevent destruction of tumor cells by CYTOTOXIC T-LYMPHOCYTES have also been called enhancing antibodies. %28%Rosen et al., Dictionary of Immunology, 1989%29%%A%    
% 219.47/219.67  |- mesh__dateCreated mesh__D019138 1995-06-06
% 219.47/219.67  |- mesh__publicMeSHNote mesh__D019138 96   
% 219.47/219.67  |- mesh__recordOriginator mesh__D019138 AGS
% 219.47/219.67  |- mesh__dateEstablished mesh__D019138 1996-01-01
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D019138 2006
% 219.47/219.67  |- skos__prefLabel mesh__D019138 Antibodies, Blocking
% 219.47/219.67  |- mesh__recordMaintainer mesh__D019138 ssb
% 219.47/219.67  |- skos__broader mesh__D019138smesh__D000906
% 219.47/219.67  |- rdf__type mesh__D019138sskos__Concept
% 219.47/219.67  |- mesh__recordAuthorizer mesh__D019138 sjn
% 219.47/219.67  |- skos__altLabel mesh__D019138 Blocking Antibodies
% 219.47/219.67  |- mesh__recordAuthorizer mesh__D011155 NLM
% 219.47/219.67  |- mesh__publicMeSHNote mesh__D011155 68   
% 219.47/219.67  |- skos__scopeNote mesh__D011155
% 219.47/219.67       Includes mechanisms or programs which control the numbers of individuals in a population of humans or animals.%A%    
% 219.47/219.67  |- mesh__dateCreated mesh__D011155 1999-01-01
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D011155 2006
% 219.47/219.67  |- skos__hiddenLabel mesh__D011155 Programs, Population
% 219.47/219.67  |- skos__hiddenLabel mesh__D011155 Program, Population
% 219.47/219.67  |- skos__related mesh__D011155smesh__D016656
% 219.47/219.67  |- skos__related mesh__D011155smesh__D013245
% 219.47/219.67  |- mesh__dateRevised mesh__D011155 2003-07-30
% 219.47/219.67  |- skos__hiddenLabel mesh__D011155 Population Program
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D011155 2005
% 219.47/219.67  |- skos__hiddenLabel mesh__D011155 Population Controls
% 219.47/219.67  |- mesh__recordOriginator mesh__D011155 NLM
% 219.47/219.67  |- rdf__type mesh__D011155sskos__Concept
% 219.47/219.67  |- skos__hiddenLabel mesh__D011155 Control, Population
% 219.47/219.67  |- skos__broader mesh__D011155smesh__D011157
% 219.47/219.67  |- skos__related mesh__D011155smesh__D003267
% 219.47/219.67  |- skos__historyNote mesh__D011155 Abortion, Legal %28%1966-1967%29%
% 219.47/219.67  |- skos__prefLabel mesh__D011155 Population Control
% 219.47/219.67  |- skos__annotation mesh__D011155
% 219.47/219.67       IM human, NIM animal; specify geog; a broad plane: differentiate from FAMILY PLANNING, a personal level%A%  
% 219.47/219.67  |- skos__historyNote mesh__D011155 Sterilization, Sexual %28%1966-1967%29%
% 219.47/219.67  |- skos__hiddenLabel mesh__D011155 Effectiveness, Demographic
% 219.47/219.67  |- skos__related mesh__D011155smesh__D005193
% 219.47/219.67  |- skos__related mesh__D011155smesh__D000029
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D011155 2004
% 219.47/219.67  |- skos__hiddenLabel mesh__D011155 Controls, Population
% 219.47/219.67  |- mesh__dateEstablished mesh__D011155 1968-01-01
% 219.47/219.67  |- skos__historyNote mesh__D011155 Population %28%1966-1967%29%
% 219.47/219.67  |- skos__historyNote mesh__D011155 Family Planning %28%1966-1967%29%
% 219.47/219.67  |- mesh__historyNote mesh__D011155 68   
% 219.47/219.67  |- mesh__recordMaintainer mesh__D011155 SYSTEM
% 219.47/219.67  |- mesh__recordMaintainer mesh__D005916 SYSTEM
% 219.47/219.67  |- mesh__recordAuthorizer mesh__D005916 sjn
% 219.47/219.67  |- mesh__dateCreated mesh__D005916 1999-01-01
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D005916 2006
% 219.47/219.67  |- mesh__recordOriginator mesh__D005916 NLM
% 219.47/219.67  |- rdf__type mesh__D005916sskos__Concept
% 219.47/219.67  |- skos__annotation mesh__D005916
% 219.47/219.67       GEN; permeability globulins: index under SERUM GLOBULINS; EUGLOBULINS %26% PSEUDOGLOBULINS are see refs to SERUM GLOBULINS; do not confuse with GLOBULINS, IMMUNE see IMMUNOGLOBULINS, INTRAVENOUS%A%  
% 219.47/219.67  |- skos__prefLabel mesh__D005916 Globulins
% 219.47/219.67  |- skos__broader mesh__D005916smesh__D011506
% 219.47/219.67  |- mesh__dateRevised mesh__D005916 2005-06-30
% 219.47/219.67  |- mesh__recordOriginator mesh__D005118 NLM
% 219.47/219.67  |- mesh__dateRevised mesh__D005118 2001-07-25
% 219.47/219.67  |- mesh__recordMaintainer mesh__D005118 mdb
% 219.47/219.67  |- rdf__type mesh__D005118sskos__Concept
% 219.47/219.67  |- skos__hiddenLabel mesh__D005118 Spaces %28%Astronomy%29%
% 219.47/219.67  |- mesh__dateCreated mesh__D005118 1999-01-01
% 219.47/219.67  |- skos__related mesh__D005118smesh__D016083
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D005118 2005
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D005118 2002
% 219.47/219.67  |- skos__broader mesh__D005118smesh__D004777
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D005118 2006
% 219.47/219.67  |- skos__related mesh__D005118smesh__D016082
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D005118 2003
% 219.47/219.67  |- skos__hiddenLabel mesh__D005118 Extraterrestrial Environments
% 219.47/219.67  |- skos__altLabel mesh__D005118 Environment, Extraterrestrial
% 219.47/219.67  |- skos__prefLabel mesh__D005118 Extraterrestrial Environment
% 219.47/219.67  |- skos__hiddenLabel mesh__D005118 Environments, Extraterrestrial
% 219.47/219.67  |- skos__scopeNote mesh__D005118
% 219.47/219.67       The environment outside the earth or its atmosphere. The environment may refer to a closed cabin %28%such as a space shuttle or space station%29% or to space itself, the moon, or other planets.%A%    
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D005118 2004
% 219.47/219.67  |- skos__related mesh__D005118smesh__D016081
% 219.47/219.67  |- mesh__recordAuthorizer mesh__D005118 sjn
% 219.47/219.67  |- skos__annotation mesh__D005118
% 219.47/219.67       no qualif; space itself or the SOLAR SYSTEM; PLANETS other than Earth; DF: EXTRATERRESTRIAL ENVIR%A%  
% 219.47/219.67  |- mesh__recordOriginator mesh__D009509 NLM
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D009509 2002
% 219.47/219.67  |- rdf__type mesh__D009509sskos__Concept
% 219.47/219.67  |- mesh__recordMaintainer mesh__D009509 mdb
% 219.47/219.67  |- skos__annotation mesh__D009509 a province of eastern Canada   
% 219.47/219.67  |- mesh__recordAuthorizer mesh__D009509 sjn
% 219.47/219.67  |- skos__broader mesh__D009509smesh__D002170
% 219.47/219.67  |- mesh__dateRevised mesh__D009509 2001-07-25
% 219.47/219.67  |- skos__prefLabel mesh__D009509 New Brunswick
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D009509 2005
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D009509 2003
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D009509 2006
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D009509 2004
% 219.47/219.67  |- skos__scopeNote mesh__D009509
% 219.47/219.67       A province of eastern Canada, one of the Maritime Provinces with NOVA SCOTIA; PRINCE EDWARD ISLAND; and sometimes NEWFOUNDLAND. Its capital is Fredericton. It was named in honor of King George III, of the House of Hanover, also called Brunswick. %28%From Webster%27%s New Geographical Dictionary, 1988, p828 %26% Room, Brewer%27%s Dictionary of Names, 1992, p375%29%%A%    
% 219.47/219.67  |- mesh__dateCreated mesh__D009509 1999-01-01
% 219.47/219.67  |- mesh__dateCreated mesh__D001526 1999-01-01
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D001526 2005
% 219.47/219.67  |- mesh__recordOriginator mesh__D001526 NLM
% 219.47/219.67  |- skos__hiddenLabel mesh__D001526 Behavioral Symptom
% 219.47/219.67  |- mesh__historyNote mesh__D001526 98; use explode 1970-97   
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D001526 2006
% 219.47/219.67  |- rdf__type mesh__D001526sskos__Concept
% 219.47/219.67  |- skos__broader mesh__D001526smesh__D001519
% 219.47/219.67  |- mesh__recordMaintainer mesh__D001526 jls
% 219.47/219.67  |- mesh__publicMeSHNote mesh__D001526 98   
% 219.47/219.67  |- skos__hiddenLabel mesh__D001526 Symptoms, Behavioral
% 219.47/219.67  |- mesh__recordAuthorizer mesh__D001526 sjn
% 219.47/219.67  |- skos__prefLabel mesh__D001526 Behavioral Symptoms
% 219.47/219.67  |- skos__hiddenLabel mesh__D001526 Symptom, Behavioral
% 219.47/219.67  |- mesh__dateRevised mesh__D001526 2004-07-19
% 219.47/219.67  |- skos__annotation mesh__D001526
% 219.47/219.67       GEN or unspecified; prefer specifics; do not confuse with BEHAVIOR: read MeSH definitions%A%  
% 219.47/219.67  |- skos__scopeNote mesh__D001526
% 219.47/219.67       Observable manifestations of impaired psychological functioning.%A%    
% 219.47/219.67  |- mesh__dateEstablished mesh__D001526 1998-01-01
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D006211 2002
% 219.47/219.67  |- skos__hiddenLabel mesh__D006211 Degenerations, Pigmentary Pallidal
% 219.47/219.67  |- mesh__recordMaintainer mesh__D006211 nns
% 219.47/219.67  |- mesh__historyNote mesh__D006211 1991%28%1965%29%   
% 219.47/219.67  |- skos__hiddenLabel mesh__D006211 Degeneration, Pigmentary Pallidal
% 219.47/219.67  |- skos__altLabel mesh__D006211 Pigmentary Pallidal Atrophy
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D006211 2003
% 219.47/219.67  |- skos__scopeNote mesh__D006211
% 219.47/219.67       A rare autosomal recessive degenerative disorder which usually presents in late childhood or adolescence. Clinical manifestations include progressive MUSCLE SPASTICITY; hyperreflexia; MUSCLE RIGIDITY; DYSTONIA; DYSARTHRIA; and intellectual deterioration which progresses to severe dementia over several years. Pathologic examination reveals neuronal atrophy in the globus pallidus and iron deposition in blood vessels and perivascular spaces. %28%From Adams et al., Principles of Neurology, 6th ed, p972; Davis %26% Robertson, Textbook of Neuropathology, 2nd ed, pp972-929%29%%A%    
% 219.47/219.67  |- mesh__recordOriginator mesh__D006211 NLM
% 219.47/219.67  |- skos__hiddenLabel mesh__D006211 Pigmentary Pallidal Atrophies
% 219.47/219.67  |- skos__broader mesh__D006211smesh__D001480
% 219.47/219.67  |- skos__broader mesh__D006211smesh__D020271
% 219.47/219.67  |- skos__hiddenLabel mesh__D006211 Hallervorden Spatz Disease
% 219.47/219.67  |- skos__altLabel mesh__D006211 Hallervorden-Spatz Disease
% 219.47/219.67  |- skos__hiddenLabel mesh__D006211 Atrophies, Pigmentary Pallidal
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D006211 2004
% 219.47/219.67  |- rdf__type mesh__D006211sskos__Concept
% 219.47/219.67  |- skos__altLabel mesh__D006211 Pigmentary Pallidal Degeneration
% 219.47/219.67  |- skos__hiddenLabel mesh__D006211 Pallidal Atrophy, Pigmentary
% 219.47/219.67  |- mesh__dateRevised mesh__D006211 2001-07-25
% 219.47/219.67  |- mesh__publicMeSHNote mesh__D006211
% 219.47/219.67       1991; see BASAL GANGLIA DISEASES 1979-1990, see BRAIN DISEASES 1975-78%A%  
% 219.47/219.67  |- skos__hiddenLabel mesh__D006211 Pallidal Atrophies, Pigmentary
% 219.47/219.67  |- skos__annotation mesh__D006211 DF: HALLERVORDEN SPATZ DIS   
% 219.47/219.67  |- mesh__dateEstablished mesh__D006211 1991-01-01
% 219.47/219.67  |- skos__hiddenLabel mesh__D006211 Atrophy, Pigmentary Pallidal
% 219.47/219.67  |- skos__broader mesh__D006211smesh__D009069
% 219.47/219.67  |- mesh__dateCreated mesh__D006211 1999-01-01
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D006211 2005
% 219.47/219.67  |- mesh__recordAuthorizer mesh__D006211 sjn
% 219.47/219.67  |- skos__broader mesh__D006211smesh__D019150
% 219.47/219.67  |- skos__hiddenLabel mesh__D006211 Hallervorden Spatz Syndrome
% 219.47/219.67  |- skos__hiddenLabel mesh__D006211 Pigmentary Pallidal Degenerations
% 219.47/219.67  |- skos__prefLabel mesh__D006211 Hallervorden-Spatz Syndrome
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D006211 2006
% 219.47/219.67  |- skos__hiddenLabel mesh__D006211 Pallidal Degenerations, Pigmentary
% 219.47/219.67  |- skos__broader mesh__D047628smesh__D011960
% 219.47/219.67  |- mesh__dateEstablished mesh__D047628 2005-01-01
% 219.47/219.67  |- skos__prefLabel mesh__D047628 Estrogen Receptor alpha
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D047628 2006
% 219.47/219.67  |- skos__scopeNote mesh__D047628
% 219.47/219.67       One of the ESTROGEN RECEPTORS that has marked affinity for ESTRADIOL. Its expression and function differs from, and in some ways opposes, ESTROGEN RECEPTOR BETA.%A%    
% 219.47/219.67  |- skos__hiddenLabel mesh__D047628 alpha, Estradiol Receptor
% 219.47/219.67  |- mesh__historyNote mesh__D047628 2005%28%1997%29%   
% 219.47/219.67  |- mesh__recordMaintainer mesh__D047628 ssb
% 219.47/219.67  |- mesh__recordOriginator mesh__D047628 ssb
% 219.47/219.67  |- rdf__type mesh__D047628sskos__Concept
% 219.47/219.67  |- mesh__publicMeSHNote mesh__D047628
% 219.47/219.67       2005; ESTROGEN RECEPTOR ALPHA was indexed under RECEPTORS, ESTROGEN 1997-2004%A%  
% 219.47/219.67  |- skos__altLabel mesh__D047628 Receptor alpha, Estrogen
% 219.47/219.67  |- skos__historyNote mesh__D047628 Receptors, Estrogen %28%1997-2004%29%
% 219.47/219.67  |- skos__altLabel mesh__D047628 Estrogen Receptors alpha
% 219.47/219.67  |- skos__altLabel mesh__D047628 ERalpha
% 219.47/219.67  |- mesh__dateCreated mesh__D047628 2004-07-07
% 219.47/219.67  |- skos__altLabel mesh__D047628 Estradiol Receptor alpha
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D047628 2005
% 219.47/219.67  |- skos__hiddenLabel mesh__D047628 Receptor alpha, Estradiol
% 219.47/219.67  |- mesh__recordAuthorizer mesh__D047628 sjn
% 219.47/219.67  |- skos__scopeNote mesh__D019937
% 219.47/219.67       Methods, procedures, and tests performed to diagnose disease, disordered function, or disability.%A%    
% 219.47/219.67  |- mesh__dateEstablished mesh__D019937 1998-01-01
% 219.47/219.67  |- mesh__dateRevised mesh__D019937 2005-06-30
% 219.47/219.67  |- skos__broader mesh__D019937smesh__D003933
% 219.47/219.67  |- skos__historyNote mesh__D019937 Diagnosis %28%1966-1997%29%
% 219.47/219.67  |- skos__related mesh__D019937smesh__D012680
% 219.47/219.67  |- skos__annotation mesh__D019937 general: prefer specifics   
% 219.47/219.67  |- skos__altLabel mesh__D019937 Technics and Procedures, Diagnostic
% 219.47/219.67  |- mesh__recordOriginator mesh__D019937 PXP
% 219.47/219.67  |- mesh__publicMeSHNote mesh__D019937 98   
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D019937 2006
% 219.47/219.67  |- mesh__recordAuthorizer mesh__D019937 sjn
% 219.47/219.67  |- rdf__type mesh__D019937sskos__Concept
% 219.47/219.67  |- skos__altLabel mesh__D019937 Techniques and Procedures, Diagnostic
% 219.47/219.67  |- skos__prefLabel mesh__D019937 Diagnostic Techniques and Procedures
% 219.47/219.67  |- mesh__recordMaintainer mesh__D019937 ssb
% 219.47/219.67  |- mesh__historyNote mesh__D019937 98   
% 219.47/219.67  |- mesh__dateCreated mesh__D019937 1997-06-20
% 219.47/219.67  |- skos__altLabel mesh__D019937 Diagnostic Technics and Procedures
% 219.47/219.67  |- mesh__publicMeSHNote mesh__D011954 77   
% 219.47/219.67  |- skos__scopeNote mesh__D011954
% 219.47/219.67       Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells.%A%    
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D011954 2006
% 219.47/219.67  |- skos__historyNote mesh__D011954 Receptors, Drug %28%1968-1976%29%
% 219.47/219.67  |- mesh__recordMaintainer mesh__D011954 jmp
% 219.47/219.67  |- skos__historyNote mesh__D011954 Receptors, Adrenergic %28%1973-1976%29%
% 219.47/219.67  |- skos__altLabel mesh__D011954 Dopamine Receptor
% 219.47/219.67  |- mesh__historyNote mesh__D011954 77   
% 219.47/219.67  |- mesh__recordOriginator mesh__D011954 SH
% 219.47/219.67  |- skos__altLabel mesh__D011954 Dopamine Receptors
% 219.47/219.67  |- rdf__type mesh__D011954sskos__Concept
% 219.47/219.67  |- skos__hiddenLabel mesh__D011954 Receptor, Dopamine
% 219.47/219.67  |- mesh__dateEstablished mesh__D011954 1977-01-01
% 219.47/219.67  |- mesh__recordAuthorizer mesh__D011954 sjn
% 219.47/219.67  |- skos__historyNote mesh__D011954 Dopamine %28%1966-1976%29%
% 219.47/219.67  |- mesh__dateCreated mesh__D011954 1976-05-03
% 219.47/219.67  |- skos__annotation mesh__D011954
% 219.47/219.67       coord IM with specific dopamine agent %28%IM%29%; DF: RECEPT DOPAMINE%A%  
% 219.47/219.67  |- mesh__dateRevised mesh__D011954 2005-06-30
% 219.47/219.67  |- skos__broader mesh__D011954smesh__D017983
% 219.47/219.67  |- skos__prefLabel mesh__D011954 Receptors, Dopamine
% 219.47/219.67  |- mesh__dateRevised mesh__D019139 2002-07-03
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D019139 2004
% 219.47/219.67  |- mesh__recordAuthorizer mesh__D019139 sjn
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D019139 2003
% 219.47/219.67  |- mesh__dateCreated mesh__D019139 1995-06-05
% 219.47/219.67  |- skos__broader mesh__D019139smesh__D007109
% 219.47/219.67  |- mesh__recordMaintainer mesh__D019139 ags
% 219.47/219.67  |- skos__hiddenLabel mesh__D019139 Tumor Immune Escape
% 219.47/219.67  |- skos__related mesh__D019139smesh__D007108
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D019139 2006
% 219.47/219.67  |- skos__prefLabel mesh__D019139 Tumor Escape
% 219.47/219.67  |- mesh__publicMeSHNote mesh__D019139 96   
% 219.47/219.67  |- rdf__type mesh__D019139sskos__Concept
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D019139 2005
% 219.47/219.67  |- mesh__recordOriginator mesh__D019139 AGS
% 219.47/219.67  |- mesh__dateEstablished mesh__D019139 1996-01-01
% 219.47/219.67  |- mesh__historyNote mesh__D019139 96   
% 219.47/219.67  |- skos__altLabel mesh__D019139 Immune Escape, Tumor
% 219.47/219.67  |- skos__scopeNote mesh__D019139
% 219.47/219.67       The ability of tumors to evade destruction by the IMMUNE SYSTEM. Theories concerning possible mechanisms by which this takes place involve both cellular immunity %28%IMMUNITY, CELLULAR%29% and humoral immunity %28%ANTIBODY FORMATION%29%, and also costimulatory pathways related to CD28 antigens %28%ANTIGENS, CD28%29% and CD80 antigens %28%ANTIGENS, CD80%29%.%A%    
% 219.47/219.67  |- skos__related mesh__D019139smesh__D016525
% 219.47/219.67  |- skos__broader mesh__D011156smesh__D003710
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D011156 2002
% 219.47/219.67  |- rdf__type mesh__D011156sskos__Concept
% 219.47/219.67  |- mesh__dateRevised mesh__D011156 1999-11-03
% 219.47/219.67  |- skos__annotation mesh__D011156
% 219.47/219.67       IM human, NIM animal; no qualif; specify geog   
% 219.47/219.67  |- skos__hiddenLabel mesh__D011156 Population Densities
% 219.47/219.67  |- skos__scopeNote mesh__D011156
% 219.47/219.67       Number of individuals in a population relative to space.%A%    
% 219.47/219.67  |- mesh__recordAuthorizer mesh__D011156 sjn
% 219.47/219.67  |- mesh__historyNote mesh__D011156 68   
% 219.47/219.67  |- mesh__recordMaintainer mesh__D011156 kle
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D011156 2004
% 219.47/219.67  |- mesh__dateEstablished mesh__D011156 1968-01-01
% 219.47/219.67  |- skos__historyNote mesh__D011156 Population %28%1966-1967%29%
% 219.47/219.67  |- skos__historyNote mesh__D011156 Demography %28%1966-1967%29%
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D011156 2001
% 219.47/219.67  |- skos__hiddenLabel mesh__D011156 Density, Population
% 219.47/219.67  |- skos__prefLabel mesh__D011156 Population Density
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D011156 2003
% 219.47/219.67  |- mesh__publicMeSHNote mesh__D011156 68   
% 219.47/219.67  |- skos__related mesh__D011156smesh__D003441
% 219.47/219.67  |- skos__hiddenLabel mesh__D011156 Densities, Population
% 219.47/219.67  |- mesh__dateCreated mesh__D011156 1999-01-01
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D011156 2000
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D011156 2006
% 219.47/219.67  |- mesh__recordOriginator mesh__D011156 NLM
% 219.47/219.67  |- skos__related mesh__D011156smesh__D012934
% 219.47/219.67  |- skos__hiddenLabel mesh__D011156 Population Sizes
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D011156 2005
% 219.47/219.67  |- skos__broader mesh__D005917smesh__D003342
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D005917 2005
% 219.47/219.67  |- mesh__dateCreated mesh__D005917 1999-01-01
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D005917 2006
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D005917 2000
% 219.47/219.67  |- rdf__type mesh__D005917sskos__Concept
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D005917 2003
% 219.47/219.67  |- skos__annotation mesh__D005917
% 219.47/219.67       medial globus pallidus in non-primates = ENTOPEDUNCULAR NUCLEUS%A%  
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D005917 2001
% 219.47/219.67  |- skos__prefLabel mesh__D005917 Globus Pallidus
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D005917 2004
% 219.47/219.67  |- mesh__recordAuthorizer mesh__D005917 sjn
% 219.47/219.67  |- mesh__dateRevised mesh__D005917 1999-11-03
% 219.47/219.67  |- skos__related mesh__D005917smesh__D020392
% 219.47/219.67  |- mesh__recordOriginator mesh__D005917 NLM
% 219.47/219.67  |- mesh__recordMaintainer mesh__D005917 nns
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D005917 2002
% 219.47/219.67  |- skos__scopeNote mesh__D005917
% 219.47/219.67       The representation of the phylogenetically oldest part of the corpus striatum called the paleostriatum. It forms the smaller, more medial part of the lentiform nucleus.%A%    
% 219.47/219.67  |- mesh__dateCreated mesh__D005119 1980-04-02
% 219.47/219.67  |- mesh__recordOriginator mesh__D005119 AEP
% 219.47/219.67  |- mesh__historyNote mesh__D005119
% 219.47/219.67       85; was EXTRAVASATION OF CONTRAST MEDIA 1981-84   
% 219.47/219.67  |- skos__annotation mesh__D005119 DF: EXTRAVASATION   
% 219.47/219.67  |- rdf__type mesh__D005119sskos__Concept
% 219.47/219.67  |- mesh__dateEstablished mesh__D005119 1981-01-01
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D005119 2001
% 219.47/219.67  |- skos__historyNote mesh__D005119 Contrast Media %28%1966-1980%29%
% 219.47/219.67  |- skos__hiddenLabel mesh__D005119 Contrast Media Extravasation
% 219.47/219.67  |- mesh__recordMaintainer mesh__D005119 KEV
% 219.47/219.67  |- skos__scopeNote mesh__D005119
% 219.47/219.67       The escape of diagnostic or therapeutic material from the vessel into which it is introduced into the surrounding tissue or body cavity.%A%    
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D005119 2002
% 219.47/219.67  |- skos__prefLabel mesh__D005119
% 219.47/219.67       Extravasation of Diagnostic and Therapeutic Materials
% 219.47/219.67  |- skos__broader mesh__D005119smesh__D010335
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D005119 2005
% 219.47/219.67  |- mesh__onlineNote mesh__D005119
% 219.47/219.67       use EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS to search EXTRAVASATION OF CONTRAST MEDIA 1981-84%A%  
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D005119 2003
% 219.47/219.67  |- skos__historyNote mesh__D005119
% 219.47/219.67       specific organ or disease/radiography %28%1967-1980%29%
% 219.47/219.67  |- mesh__recordAuthorizer mesh__D005119 sjn
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D005119 2006
% 219.47/219.67  |- skos__altLabel mesh__D005119
% 219.47/219.67       Extravasation of Diagnostic, Therapeutic Materials
% 219.47/219.67  |- mesh__dateRevised mesh__D005119 1999-11-08
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D005119 2004
% 219.47/219.67  |- skos__broader mesh__D005119smesh__D014947
% 219.47/219.67  |- mesh__publicMeSHNote mesh__D005119
% 219.47/219.67       85; was EXTRAVASATION OF CONTRAST MEDIA 1981-84   
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D005119 2000
% 219.47/219.67  |- mesh__dateEstablished mesh__D034701 2003-01-01
% 219.47/219.67  |- skos__hiddenLabel mesh__D034701 Mastocytoses, Skin
% 219.47/219.67  |- mesh__dateRevised mesh__D034701 2004-07-28
% 219.47/219.67  |- skos__hiddenLabel mesh__D034701 Skin Mastocytoses
% 219.47/219.67  |- skos__hiddenLabel mesh__D034701 Cutaneous Mastocytoses, Diffuse
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D034701 2004
% 219.47/219.67  |- skos__hiddenLabel mesh__D034701 Bullous Mastocytoses
% 219.47/219.67  |- skos__altLabel mesh__D034701 Cutaneous Mastocytosis
% 219.47/219.67  |- skos__altLabel mesh__D034701 Skin Mastocytosis
% 219.47/219.67  |- skos__hiddenLabel mesh__D034701 Bullous Mastocytosis
% 219.47/219.67  |- skos__prefLabel mesh__D034701 Mastocytosis, Cutaneous
% 219.47/219.67  |- mesh__recordOriginator mesh__D034701 lkt
% 219.47/219.67  |- skos__hiddenLabel mesh__D034701 Cutaneous Mastocytoses
% 219.47/219.67  |- mesh__dateCreated mesh__D034701 2002-07-02
% 219.47/219.67  |- mesh__historyNote mesh__D034701
% 219.47/219.67       2003; for MASTOCYTOSIS, BULLOUS use URTICARIA PIGMENTOSA 1987-2002; for MASTOCYTOSIS, DIFFUSE CUTANEOUS use URTICARIA PIGMENTOSA 1987-2002%A%  
% 219.47/219.67  |- skos__hiddenLabel mesh__D034701 Mastocytoses, Bullous
% 219.47/219.67  |- skos__hiddenLabel mesh__D034701 Mastocytosis, Skin
% 219.47/219.67  |- mesh__recordMaintainer mesh__D034701 jls
% 219.47/219.67  |- skos__hiddenLabel mesh__D034701 Mastocytoses, Cutaneous
% 219.47/219.67  |- mesh__recordAuthorizer mesh__D034701 jls
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D034701 2005A
% 219.47/219.67  |- skos__hiddenLabel mesh__D034701 Cutaneous Mastocytosis, Diffuse
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D034701 2005
% 219.47/219.67  |- skos__historyNote mesh__D034701 Urticaria Pigmentosa %28%1965-2002%29%
% 219.47/219.67  |- skos__scopeNote mesh__D034701
% 219.47/219.67       Skin lesions due to abnormal infiltration of MAST CELLS. Cutaneous mastocytosis is confined to the skin without the involvement of other tissues or organs, and is mostly found in children.%A%    
% 219.47/219.67  |- mesh__publicMeSHNote mesh__D034701
% 219.47/219.67       2003; for MASTOCYTOSIS, BULLOUS see URTICARIA PIGMENTOSA 1987-2002; for MASTOCYTOSIS, DIFFUSE CUTANEOUS see URTICARIA PIGMENTOSA 1987-2002%A%  
% 219.47/219.67  |- skos__broader mesh__D034701smesh__D008415
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D034701 2003
% 219.47/219.67  |- skos__annotation mesh__D034701
% 219.47/219.67       MACULOPAPULAR CUTANEOUS MASTOCYTOSIS see URTICARIA PIGMENTOSA is also available%A%  
% 219.47/219.67  |- rdf__type mesh__D034701sskos__Concept
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D034701 2006
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D001527 1995
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D001527 2002
% 219.47/219.67  |- skos__annotation mesh__D001527
% 219.47/219.67       a school of psychology: do not confuse with BEHAVIOR; only /hist%A%  
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D001527 2006
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D001527 1999
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D001527 1992
% 219.47/219.67  |- skos__prefLabel mesh__D001527 Behaviorism
% 219.47/219.67  |- skos__broader mesh__D001527smesh__D011582
% 219.47/219.67  |- rdf__type mesh__D001527sskos__Concept
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D001527 2003
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D001527 1993
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D001527 1996
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D001527 2000
% 219.47/219.67  |- mesh__recordMaintainer mesh__D001527 TGC
% 219.47/219.67  |- mesh__recordOriginator mesh__D001527 NLM
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D001527 1990
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D001527 2004
% 219.47/219.67  |- mesh__activeMeSHYear mesh__D001527 1997
% 219.47/219.67  |- mesh__recordAuthorizer mesh__D001527 PLS
% 219.47/219.67  |- mesh__dateRevised mesh__D001527 1989-04-27
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D001527 2001
% 219.47/219.68  |- skos__scopeNote mesh__D001527
% 219.47/219.68       A psychologic theory developed by James B. Watson concerned with studying and measuring behaviors that are observable.%A%    
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D001527 1994
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D001527 1991
% 219.47/219.68  |- skos__hiddenLabel mesh__D001527 Behaviorisms
% 219.47/219.68  |- mesh__dateCreated mesh__D001527 1999-01-01
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D001527 2005
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D001527 1998
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hallucination, Somatic
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Auditory Hallucination
% 219.47/219.68  |- mesh__recordMaintainer mesh__D006212 KEV
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Organic Hallucination
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hallucination, Auditory
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Olfactory Hallucinations
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Reflex Hallucinations
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hallucination, Mood Congruent
% 219.47/219.68  |- skos__scopeNote mesh__D006212
% 219.47/219.68       Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.%A%    
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D006212 2001
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Kinesthetic Hallucination
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hallucination, Gustatory
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Gustatory Hallucinations
% 219.47/219.68  |- skos__prefLabel mesh__D006212 Hallucinations
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Sensory Hallucinations
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Dissociative Hallucination
% 219.47/219.68  |- skos__broader mesh__D006212smesh__D010468
% 219.47/219.68  |- mesh__recordAuthorizer mesh__D006212 sjn
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Dissociative Hallucinations
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hypnagogic Hallucinations
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hallucination, Kinesthetic
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Tactile Hallucinations
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hallucination, Hypnagogic
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Verbal Auditory Hallucination
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hallucination, Visual
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Auditory Hallucination, Verbal
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hallucination, Organic
% 219.47/219.68  |- mesh__dateCreated mesh__D006212 1999-01-01
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Mood Incongruent Hallucinations
% 219.47/219.68  |- skos__annotation mesh__D006212 /chem ind: consider also HALLUCINOGENS   
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Body Sensation Hallucination
% 219.47/219.68  |- skos__related mesh__D006212smesh__D006213
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D006212 2003
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Somatic Hallucination
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Visual Hallucination
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Auditory Hallucinations
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D006212 2002
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hallucination, Tactile
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Body Sensation Hallucinations
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Sensory Hallucination
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hallucination, Sensory
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Verbal Auditory Hallucinations
% 219.47/219.68  |- mesh__dateRevised mesh__D006212 1999-11-03
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hallucination, Elementary
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D006212 2004
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D006212 2005
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Tactile Hallucination
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Elementary Hallucination
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Mood Congruent Hallucinations
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hallucination, Reflex
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hallucination, Hypnapompic
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Kinesthetic Hallucinations
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hypnagogic Hallucination
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Elementary Hallucinations
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hallucination, Verbal Auditory
% 219.47/219.68  |- mesh__recordOriginator mesh__D006212 NLM
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hypnapompic Hallucination
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Mood Incongruent Hallucination
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hallucination, Mood Incongruent
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Visual Hallucinations
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Somatic Hallucinations
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Reflex Hallucination
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Mood Congruent Hallucination
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Gustatory Hallucination
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hallucination, Olfactory
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hypnapompic Hallucinations
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Auditory Hallucinations, Verbal
% 219.47/219.68  |- rdf__type mesh__D006212sskos__Concept
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D006212 2006
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hallucination
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D006212 2000
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Hallucination, Dissociative
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Olfactory Hallucination
% 219.47/219.68  |- skos__hiddenLabel mesh__D006212 Organic Hallucinations
% 219.47/219.68  |- skos__historyNote mesh__D047629 Receptors, Estrogen %28%1997-2004%29%
% 219.47/219.68  |- mesh__recordMaintainer mesh__D047629 ssb
% 219.47/219.68  |- skos__altLabel mesh__D047629 Receptor beta, Estrogen
% 219.47/219.68  |- skos__broader mesh__D047629smesh__D011960
% 219.47/219.68  |- mesh__publicMeSHNote mesh__D047629
% 219.47/219.68       2005; ESTROGEN RECEPTOR BETA was indexed under RECEPTORS, ESTROGEN 1997-2004%A%  
% 219.47/219.68  |- mesh__dateCreated mesh__D047629 2004-07-07
% 219.47/219.68  |- mesh__dateEstablished mesh__D047629 2005-01-01
% 219.47/219.68  |- skos__altLabel mesh__D047629 Estrogen Receptors beta
% 219.47/219.68  |- mesh__recordOriginator mesh__D047629 ssb
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D047629 2006
% 219.47/219.68  |- mesh__recordAuthorizer mesh__D047629 sjn
% 219.47/219.68  |- rdf__type mesh__D047629sskos__Concept
% 219.47/219.68  |- skos__prefLabel mesh__D047629 Estrogen Receptor beta
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D047629 2005
% 219.47/219.68  |- skos__scopeNote mesh__D047629
% 219.47/219.68       One of the ESTROGEN RECEPTORS that has greater affinity for ISOFLAVONES than ESTROGEN RECEPTOR ALPHA does. There is great sequence homology with ER alpha in the DNA-binding domain but not in the ligand binding and hinge domains.%A%    
% 219.47/219.68  |- skos__altLabel mesh__D047629 ERbeta
% 219.47/219.68  |- mesh__historyNote mesh__D047629 2005%28%1997%29%   
% 219.47/219.68  |- skos__altLabel mesh__D019938 Proto-Oncogene Protein bcl-1
% 219.47/219.68  |- skos__hiddenLabel mesh__D019938 bcl 1 Proto Oncogene Products
% 219.47/219.68  |- skos__hiddenLabel mesh__D019938 Proto Oncogene Products bcl 1
% 219.47/219.68  |- skos__hiddenLabel mesh__D019938 c-bcl-1, Proto-Oncogene Proteins
% 219.47/219.68  |- skos__hiddenLabel mesh__D019938 bcl-1, Proto-Oncogene Protein
% 219.47/219.68  |- skos__hiddenLabel mesh__D019938 Proto Oncogene Protein bcl 1
% 219.47/219.68  |- mesh__recordMaintainer mesh__D019938 ssb
% 219.47/219.68  |- skos__hiddenLabel mesh__D019938 Proto Oncogene Proteins c bcl 1
% 219.47/219.68  |- skos__hiddenLabel mesh__D019938 Proto-Oncogene Proteins, bcl-1
% 219.47/219.68  |- skos__historyNote mesh__D019938 Cyclins %28%1991-1997%29%
% 219.47/219.68  |- mesh__dateCreated mesh__D019938 1997-06-20
% 219.47/219.68  |- skos__prefLabel mesh__D019938 Cyclin D1
% 219.47/219.68  |- mesh__dateEstablished mesh__D019938 1998-01-01
% 219.47/219.68  |- mesh__dateRevised mesh__D019938 2005-06-30
% 219.47/219.68  |- skos__broader mesh__D019938smesh__D016213
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D019938 2006
% 219.47/219.68  |- skos__scopeNote mesh__D019938
% 219.47/219.68       Protein encoded by the bcl-1 gene which plays a critical role in regulating the cell cycle. Overexpression of cyclin D1 is the result of bcl-1 rearrangement, a t%28%11;14%29% translocation, and is implicated in various neoplasms.%A%    
% 219.47/219.68  |- skos__related mesh__D019938smesh__D020522
% 219.47/219.68  |- skos__historyNote mesh__D019938
% 219.47/219.68       Proto-Oncogene Proteins %28%1990-1997%29%
% 219.47/219.68  |- skos__hiddenLabel mesh__D019938 c bcl 1 Proteins
% 219.47/219.68  |- skos__altLabel mesh__D019938 bcl-1 Proto-Oncogene Products
% 219.47/219.68  |- skos__broader mesh__D019938smesh__D011518
% 219.47/219.68  |- rdf__type mesh__D019938sskos__Concept
% 219.47/219.68  |- skos__hiddenLabel mesh__D019938 bcl1 Proto Oncogene Proteins
% 219.47/219.68  |- skos__historyNote mesh__D019938 Oncogene Proteins %28%1991-1997%29%
% 219.47/219.68  |- skos__altLabel mesh__D019938 bcl-1 Proto-Oncogene Proteins
% 219.47/219.68  |- skos__altLabel mesh__D019938 CCND1 Protein
% 219.47/219.68  |- mesh__publicMeSHNote mesh__D019938
% 219.47/219.68       98; PRAD1 PROTEIN %28%now CYCLIN D1%29% was indexed under CYCLINS %26% ONCOGENE PROTEINS 1991-97; PROTO-ONCOGENE PROTEIN BCL-1 %28%now CYCLIN D1%29% was indexed under PROTO-ONCOGENE PROTEINS 1990-97%A%  
% 219.47/219.68  |- skos__altLabel mesh__D019938 c-bcl-1 Proteins
% 219.47/219.68  |- skos__hiddenLabel mesh__D019938 bcl 1 Proto Oncogene Proteins
% 219.47/219.68  |- mesh__historyNote mesh__D019938 98; use CYCLIN D1 %28%NM%29% 1990-97   
% 219.47/219.68  |- skos__altLabel mesh__D019938 bcl1 Proto-Oncogene Proteins
% 219.47/219.68  |- mesh__recordAuthorizer mesh__D019938 sjn
% 219.47/219.68  |- mesh__recordOriginator mesh__D019938 AGS
% 219.47/219.68  |- skos__altLabel mesh__D019938 Proto-Oncogene Proteins c-bcl-1
% 219.47/219.68  |- skos__altLabel mesh__D019938 Proto-Oncogene Products bcl-1
% 219.47/219.68  |- skos__altLabel mesh__D019938 PRAD1 Protein
% 219.47/219.68  |- skos__hiddenLabel mesh__D019938 Proto-Oncogene Proteins, bcl1
% 219.47/219.68  |- skos__hiddenLabel mesh__D019938 Proto-Oncogene Products, bcl-1
% 219.47/219.68  |- mesh__dateCreated mesh__D011955 1999-01-01
% 219.47/219.68  |- mesh__historyNote mesh__D011955 68   
% 219.47/219.68  |- skos__prefLabel mesh__D011955 Receptors, Drug
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D011955 2004
% 219.47/219.68  |- mesh__dateRevised mesh__D011955 1995-06-08
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D011955 1999
% 219.47/219.68  |- mesh__dateEstablished mesh__D011955 1968-01-01
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D011955 1996
% 219.47/219.68  |- skos__broader mesh__D011955smesh__D011506
% 219.47/219.68  |- skos__historyNote mesh__D011955 Pharmacology %28%1966-1967%29%
% 219.47/219.68  |- mesh__publicMeSHNote mesh__D011955 68   
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D011955 2006
% 219.47/219.68  |- mesh__recordMaintainer mesh__D011955 KEV
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D011955 2003
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D011955 1998
% 219.47/219.68  |- skos__annotation mesh__D011955
% 219.47/219.68       do not confuse with CHEMORECEPTORS: TN 160; coord IM with specific drug or chemical %28%IM%29%; DF: RECEPT DRUG%A%  
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D011955 2002
% 219.47/219.68  |- skos__scopeNote mesh__D011955
% 219.47/219.68       Proteins that bind specific drugs with high affinity and trigger intracellular changes influencing the behavior of cells. Drug receptors are generally thought to be receptors for some endogenous substance not otherwise specified.%A%    
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D011955 2005
% 219.47/219.68  |- rdf__type mesh__D011955sskos__Concept
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D011955 2001
% 219.47/219.68  |- mesh__recordAuthorizer mesh__D011955 PLS
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D011955 2000
% 219.47/219.68  |- skos__altLabel mesh__D011955 Drug Receptor
% 219.47/219.68  |- skos__altLabel mesh__D011955 Drug Receptors
% 219.47/219.68  |- skos__hiddenLabel mesh__D011955 Receptor, Drug
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D011955 1997
% 219.47/219.68  |- mesh__recordOriginator mesh__D011955 NLM
% 219.47/219.68  |- mesh__recordMaintainer mesh__D011157 kle
% 219.47/219.68  |- rdf__type mesh__D011157sskos__Concept
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Decreases, Population
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Theories, Population
% 219.47/219.68  |- mesh__dateEstablished mesh__D011157 1976-01-01
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Population, Optimum
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Variables, Intermediate
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D011157 2002
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Populations, Stationary
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Population, Stable
% 219.47/219.68  |- skos__related mesh__D011157smesh__D005828
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D011157 2003
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Replacement, Population
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Pressure, Population
% 219.47/219.68  |- mesh__historyNote mesh__D011157 76; was NON MESH before 1976   
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Population Pressures
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Transition, Demographic
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Dynamics, Population
% 219.47/219.68  |- mesh__recordOriginator mesh__D011157 EC
% 219.47/219.68  |- skos__scopeNote mesh__D011157
% 219.47/219.68       The pattern of any process, or the interrelationship of phenomena, which affects growth or change within a population.%A%    
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D011157 2004
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Variable, Intermediate
% 219.47/219.68  |- mesh__publicMeSHNote mesh__D011157 76   
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Stable Populations
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Intermediate Variable
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D011157 2000
% 219.47/219.68  |- skos__prefLabel mesh__D011157 Population Dynamics
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Population Replacements
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Population Decreases
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Population, Stationary
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Populations, Stable
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Stationary Populations
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Demographic Transitions
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Aging, Demographic
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Pressures, Population
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D011157 2005
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D011157 2001
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Decrease, Population
% 219.47/219.68  |- skos__annotation mesh__D011157
% 219.47/219.68       IM human, NIM animal; no qualif; specify geog   
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Replacements, Population
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Theory, Population
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Optimum Populations
% 219.47/219.68  |- skos__broader mesh__D011157smesh__D003710
% 219.47/219.68  |- mesh__dateCreated mesh__D011157 1975-07-25
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Transitions, Demographic
% 219.47/219.68  |- mesh__recordAuthorizer mesh__D011157 sjn
% 219.47/219.68  |- mesh__dateRevised mesh__D011157 1999-11-03
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Population Theories
% 219.47/219.68  |- skos__hiddenLabel mesh__D011157 Populations, Optimum
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D011157 2006
% 219.47/219.68  |- skos__related mesh__D005918smesh__D010236
% 219.47/219.68  |- mesh__onlineNote mesh__D005918
% 219.47/219.68       use GLOMUS TUMOR to search GLOMANGIOMA 1966-93   
% 219.47/219.68  |- skos__scopeNote mesh__D005918
% 219.47/219.68       A blue-red, extremely painful vascular neoplasm involving a glomeriform arteriovenous anastomosis %28%glomus body%29%, which may be found anywhere in the skin, most often in the distal portion of the fingers and toes, especially beneath the nail. It is composed of specialized pericytes %28%sometimes termed glomus cells%29%, usually in single encapsulated nodular masses which may be several millimeters in diameter %28%From Stedman, 27th ed%29%. CHEMODECTOMA, a tumor of NEURAL CREST origin, is also sometimes called a glomus tumor.%A%    
% 219.47/219.68  |- mesh__recordOriginator mesh__D005918 NLM
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D005918 2004
% 219.47/219.68  |- skos__hiddenLabel mesh__D005918 Tumor, Glomus
% 219.47/219.68  |- mesh__dateRevised mesh__D005918 2003-07-09
% 219.47/219.68  |- mesh__recordMaintainer mesh__D005918 ags
% 219.47/219.68  |- skos__prefLabel mesh__D005918 Glomus Tumor
% 219.47/219.68  |- skos__annotation mesh__D005918
% 219.47/219.68       coord IM with precoord organ/neopl term %28%IM%29%   
% 219.47/219.68  |- skos__hiddenLabel mesh__D005918 Glomangiomas
% 219.47/219.68  |- mesh__historyNote mesh__D005918 94; was GLOMANGIOMA 1963-93   
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D005918 2005
% 219.47/219.68  |- mesh__dateCreated mesh__D005918 1999-01-01
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D005918 2006
% 219.47/219.68  |- skos__hiddenLabel mesh__D005918 Glomus Tumors
% 219.47/219.68  |- mesh__publicMeSHNote mesh__D005918 94; was GLOMANGIOMA 1963-93   
% 219.47/219.68  |- skos__hiddenLabel mesh__D005918 Tumors, Glomus
% 219.47/219.68  |- rdf__type mesh__D005918sskos__Concept
% 219.47/219.68  |- mesh__recordAuthorizer mesh__D005918 sjn
% 219.47/219.68  |- skos__broader mesh__D005918smesh__D009383
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D016640 2006
% 219.47/219.68  |- skos__historyNote mesh__D016640 Pregnancy in Diabetes %28%1966-1991%29%
% 219.47/219.68  |- mesh__dateRevised mesh__D016640 2005-06-30
% 219.47/219.68  |- skos__broader mesh__D016640smesh__D003920
% 219.47/219.68  |- mesh__recordAuthorizer mesh__D016640 sjn
% 219.47/219.68  |- skos__hiddenLabel mesh__D016640 Pregnancy-Induced Diabetes
% 219.47/219.68  |- skos__hiddenLabel mesh__D016640 Gestational Diabetes Mellitus
% 219.47/219.68  |- skos__annotation mesh__D016640
% 219.47/219.68       refers to DIABETES MELLITUS, not DIABETES INSIPIDUS; do not confuse with PREGNANCY IN DIABETICS where a diabetic becomes pregnant%A%  
% 219.47/219.68  |- mesh__publicMeSHNote mesh__D016640 92   
% 219.47/219.68  |- mesh__dateEstablished mesh__D016640 1992-01-01
% 219.47/219.68  |- skos__broader mesh__D016640smesh__D011248
% 219.47/219.68  |- mesh__recordOriginator mesh__D016640 TGC
% 219.47/219.68  |- mesh__dateCreated mesh__D016640 1991-01-25
% 219.47/219.68  |- skos__hiddenLabel mesh__D016640 Diabetes, Pregnancy Induced
% 219.47/219.68  |- skos__related mesh__D016640smesh__D011254
% 219.47/219.68  |- mesh__historyNote mesh__D016640 92   
% 219.47/219.68  |- rdf__type mesh__D016640sskos__Concept
% 219.47/219.68  |- skos__scopeNote mesh__D016640
% 219.47/219.68       Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant %28%PREGNANCY IN DIABETICS%29%. Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA.%A%    
% 219.47/219.68  |- skos__prefLabel mesh__D016640 Diabetes, Gestational
% 219.47/219.68  |- skos__altLabel mesh__D016640 Diabetes Mellitus, Gestational
% 219.47/219.68  |- skos__altLabel mesh__D016640 Diabetes, Pregnancy-Induced
% 219.47/219.68  |- mesh__recordMaintainer mesh__D016640 lkt
% 219.47/219.68  |- skos__altLabel mesh__D016640 Gestational Diabetes
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D002620 2001
% 219.47/219.68  |- mesh__dateRevised mesh__D002620 1997-06-26
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D002620 2005
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D002620 2000
% 219.47/219.68  |- mesh__runningHead mesh__D002620
% 219.47/219.68       G12 - CHEMICAL AND PHARMACOLOGIC PHENOMENA   
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D002620 1999
% 219.47/219.68  |- mesh__recordOriginator mesh__D002620 NLM
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D002620 2004
% 219.47/219.68  |- mesh__dateCreated mesh__D002620 1999-01-01
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D002620 1998
% 219.47/219.68  |- mesh__historyNote mesh__D002620 98; use explode   
% 219.47/219.68  |- mesh__recordAuthorizer mesh__D002620 SJN
% 219.47/219.68  |- skos__scopeNote mesh__D002620
% 219.47/219.68       Chemical, pharmacologic, and metabolic action and interaction of drugs.%A%    
% 219.47/219.68  |- mesh__publicMeSHNote mesh__D002620 98   
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D002620 2003
% 219.47/219.68  |- rdf__type mesh__D002620sskos__Concept
% 219.47/219.68  |- skos__prefLabel mesh__D002620 Chemical and Pharmacologic Phenomena
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D002620 2002
% 219.47/219.68  |- mesh__recordMaintainer mesh__D002620 TGC
% 219.47/219.68  |- skos__annotation mesh__D002620
% 219.47/219.68       not used for indexing; DF: CHEM PHARMACOL PHENOMENA      CATALOG: do not use%A%  
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D002620 2006
% 219.47/219.68  |- mesh__dateEstablished mesh__D002620 1998-01-01
% 219.47/219.68  |- skos__hiddenLabel mesh__D034702 FUS RNA Binding Protein
% 219.47/219.68  |- skos__altLabel mesh__D034702 Fusion Protein in Myxoid Liposarcoma
% 219.47/219.68  |- skos__prefLabel mesh__D034702 RNA-Binding Protein FUS
% 219.47/219.68  |- skos__altLabel mesh__D034702 hnRNP P2
% 219.47/219.68  |- skos__broader mesh__D034702smesh__D011518
% 219.47/219.68  |- skos__altLabel mesh__D034702 FUS Protein
% 219.47/219.68  |- mesh__dateCreated mesh__D034702 2002-07-03
% 219.47/219.68  |- mesh__dateEstablished mesh__D034702 2003-01-01
% 219.47/219.68  |- skos__altLabel mesh__D034702 POMp75 Protein
% 219.47/219.68  |- skos__altLabel mesh__D034702 TLS Protein
% 219.47/219.68  |- skos__broader mesh__D034702smesh__D034441
% 219.47/219.68  |- mesh__publicMeSHNote mesh__D034702
% 219.47/219.68       2003; FUS PROTEIN %26% HNRNP P2 were indexed under RIBONUCLEOPROTEINS 1996-2002; TLS PROTEIN was indexed under 1993-2002 RIBONUCLEOPROTEINS%A%  
% 219.47/219.68  |- skos__altLabel mesh__D034702 Translocated in Liposarcoma Protein
% 219.47/219.68  |- mesh__historyNote mesh__D034702
% 219.47/219.68       2003; for FUS PROTEIN %26% HNRNP P2 use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 1996-2002; for TLS PROTEIN use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 1993-2002;%A%  
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D034702 2005
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D034702 2003
% 219.47/219.68  |- skos__altLabel mesh__D034702 FUS RNA-Binding Protein
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D034702 2006
% 219.47/219.68  |- rdf__type mesh__D034702sskos__Concept
% 219.47/219.68  |- skos__hiddenLabel mesh__D034702 RNA-Binding Protein, FUS
% 219.47/219.68  |- skos__historyNote mesh__D034702 Ribonucleoproteins %28%1996-2002%29%
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D034702 2004
% 219.47/219.68  |- skos__hiddenLabel mesh__D034702 RNA Binding Protein FUS
% 219.47/219.68  |- skos__scopeNote mesh__D034702
% 219.47/219.68       A multifunctional heterogeneous-nuclear ribonucleoprotein that may play a role in homologous DNA pairing and recombination. The N-terminal portion of protein is a potent transcriptional activator, while the C terminus is required for RNA binding. The name FUS refers to the fact that genetic recombination events result in fusion oncogene proteins %28%ONCOGENE PROTEINS, FUSION%29% that contain the N-terminal region of this protein. These fusion proteins have been found in myxoid liposarcoma %28%LIPOSARCOMA, MYXOID%29% and acute myeloid leukemia.%A%    
% 219.47/219.68  |- skos__broader mesh__D001528smesh__D014657
% 219.47/219.68  |- skos__altLabel mesh__D001528 Triple-Symptom Complex
% 219.47/219.68  |- skos__broader mesh__D001528smesh__D014606
% 219.47/219.68  |- skos__annotation mesh__D001528
% 219.47/219.68       in translations spell Beh%C3%%A7%et%27%s, not Behcet%27%s   
% 219.47/219.68  |- skos__hiddenLabel mesh__D001528 Behcets Syndrome
% 219.47/219.68  |- mesh__dateCreated mesh__D001528 1999-01-01
% 219.47/219.68  |- skos__broader mesh__D001528smesh__D009059
% 219.47/219.68  |- mesh__dateRevised mesh__D001528 2005-08-01
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D001528 2006
% 219.47/219.68  |- mesh__recordAuthorizer mesh__D001528 ags
% 219.47/219.68  |- rdf__type mesh__D001528sskos__Concept
% 219.47/219.68  |- skos__prefLabel mesh__D001528 Behcet Syndrome
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D001528 2004
% 219.47/219.68  |- skos__altLabel mesh__D001528 Behcet Disease
% 219.47/219.68  |- skos__broader mesh__D001528smesh__D017445
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D001528 2005
% 219.47/219.68  |- mesh__publicMeSHNote mesh__D001528
% 219.47/219.68       2003; see BEHCET%27%S SYNDROME 1963-2002   
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D001528 2003
% 219.47/219.68  |- mesh__recordOriginator mesh__D001528 NLM
% 219.47/219.68  |- mesh__historyNote mesh__D001528 2003 %28%1963%29%   
% 219.47/219.68  |- skos__scopeNote mesh__D001528
% 219.47/219.68       Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.%A%    
% 219.47/219.68  |- mesh__recordMaintainer mesh__D001528 ags
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D001528 2006A
% 219.47/219.68  |- skos__hiddenLabel mesh__D001528 Triple Symptom Complex
% 219.47/219.68  |- skos__altLabel mesh__D001528 Behcet%27%s Syndrome
% 219.47/219.68  |- mesh__publicMeSHNote mesh__D012250
% 219.47/219.68       2004; see RHUBARB 1991-2003, see PLANTS, MEDICINAL 1978-1990, see RHUBARB 1963-1977%A%  
% 219.47/219.68  |- rdf__type mesh__D012250sskos__Concept
% 219.47/219.68  |- mesh__dateEstablished mesh__D012250 1964-01-01
% 219.47/219.68  |- skos__annotation mesh__D012250
% 219.47/219.68       X ref RHEUM RHAPONTICUM: RHAPONTICUM see LEUZEA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.47/219.68  |- skos__broader mesh__D012250smesh__D014675
% 219.47/219.68  |- mesh__recordOriginator mesh__D012250 NLM
% 219.47/219.68  |- skos__hiddenLabel mesh__D012250 rhaponticum, Rheum
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D012250 2004
% 219.47/219.68  |- mesh__dateCreated mesh__D012250 1999-01-01
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D012250 2006
% 219.47/219.68  |- mesh__recordMaintainer mesh__D012250 ssb
% 219.47/219.68  |- mesh__recordAuthorizer mesh__D012250 sjn
% 219.47/219.68  |- mesh__dateRevised mesh__D012250 2003-07-09
% 219.47/219.68  |- skos__scopeNote mesh__D012250
% 219.47/219.68       A plant genus of the family POLYGONACEAE. Members contain chrysophanic acid, rhein, EMODIN, and other anthraquinones. The roots were formerly used as purgatives.%A%    
% 219.47/219.68  |- mesh__historyNote mesh__D012250 2004%28%1963%29%   
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D012250 2005
% 219.47/219.68  |- skos__prefLabel mesh__D012250 Rheum
% 219.47/219.68  |- skos__broader mesh__D012250smesh__D019664
% 219.47/219.68  |- skos__hiddenLabel mesh__D006213 Substances, Hallucinogenic
% 219.47/219.68  |- skos__annotation mesh__D006213
% 219.47/219.68       GEN or unspecified; prefer specifics; consider also HALLUCINATIONS /chem ind%A%  
% 219.47/219.68  |- skos__altLabel mesh__D006213 Psychedelic Agents
% 219.47/219.68  |- skos__altLabel mesh__D006213 Hallucinogenic Drugs
% 219.47/219.68  |- skos__hiddenLabel mesh__D006213 Agents, Psychedelic
% 219.47/219.68  |- skos__broader mesh__D006213smesh__D011619
% 219.47/219.68  |- skos__scopeNote mesh__D006213
% 219.47/219.68       Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise.%A%    
% 219.47/219.68  |- mesh__dateRevised mesh__D006213 2005-06-30
% 219.47/219.68  |- skos__related mesh__D006213smesh__D006212
% 219.47/219.68  |- mesh__recordAuthorizer mesh__D006213 sjn
% 219.47/219.68  |- rdf__type mesh__D006213sskos__Concept
% 219.47/219.68  |- skos__prefLabel mesh__D006213 Hallucinogens
% 219.47/219.68  |- skos__altLabel mesh__D006213 Hallucinogenic Substances
% 219.47/219.68  |- skos__hiddenLabel mesh__D006213 Agents, Hallucinogenic
% 219.47/219.68  |- skos__altLabel mesh__D006213 Hallucinogenic Agents
% 219.47/219.68  |- skos__broader mesh__D006213smesh__D045505
% 219.47/219.68  |- skos__broader mesh__D006213smesh__D002491
% 219.47/219.68  |- mesh__recordOriginator mesh__D006213 NLM
% 219.47/219.68  |- mesh__dateCreated mesh__D006213 1999-01-01
% 219.47/219.68  |- skos__altLabel mesh__D006213 Psychotomimetic Agents
% 219.47/219.68  |- skos__altLabel mesh__D006213 Psychedelics
% 219.47/219.68  |- skos__hiddenLabel mesh__D006213 Drugs, Hallucinogenic
% 219.47/219.68  |- mesh__recordMaintainer mesh__D006213 ssb
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D006213 2006
% 219.47/219.68  |- skos__hiddenLabel mesh__D006213 Agents, Psychotomimetic
% 219.47/219.68  |- skos__broader mesh__D006321Q000648smesh__D006321
% 219.47/219.68  |- mesh__preferredCombination mesh__D006321Q000648smesh__D009206Q000648
% 219.47/219.68  |- rdf__type mesh__D006321Q000648smesh__CompoundConcept
% 219.47/219.68  |- mesh__recordMaintainer mesh__D011956 jmp
% 219.47/219.68  |- skos__altLabel mesh__D011956 Receptors, Endogenous Substances
% 219.47/219.68  |- mesh__publicMeSHNote mesh__D011956
% 219.47/219.68       94; was RECEPTORS, ENDOGENOUS SUBSTANCES 1983-93; was RECEPTORS, HORMONE 1973-82; CELL RECEPTORS %26% RECEPTORS, BIOLOGIC were see RECEPTORS, ENDOGENOUS SUBSTANCES 1985-93; HORMONE RECEPTORS was see RECEPTORS, ENDOGENOUS SUBSTANCES 1975-93%A%  
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D011956 2006
% 219.47/219.68  |- mesh__recordOriginator mesh__D011956 NLM
% 219.47/219.68  |- mesh__recordAuthorizer mesh__D011956 sjn
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D011956 2003
% 219.47/219.68  |- skos__prefLabel mesh__D011956 Receptors, Cell Surface
% 219.47/219.68  |- mesh__onlineNote mesh__D011956
% 219.47/219.68       use RECEPTORS, CELL SURFACE to search RECEPTORS, ENDOGENOUS SUBSTANCES 1983-93, CELL RECEPTORS 1985-93, HORMONE RECEPTORS 1975-93, RECEPTORS BIOLOGICAL 1985-93, %26% RECEPTORS, HORMONE 1973-93%A%  
% 219.47/219.68  |- skos__historyNote mesh__D011956 Receptors, Drug %28%1968-1972%29%
% 219.47/219.68  |- mesh__dateEstablished mesh__D011956 1973-01-01
% 219.47/219.68  |- mesh__activeMeSHYear mesh__D011956 2005
% 219.47/219.68  |- skos__annotation mesh__D011956
% 219.47/219.68       GEN: prefer specifics; coord IM with specific endogenous substance %28%IM%29%; for hormone receptors in general coord HORMONES %28%IM%29% + RECEPTORS, CELL SURFACE %28%IM%29% or RECEPTORS, CYTOPLASMIC AND NUCLEAR %28%IM%29%, for receptors of specific hormones, coord specific hormone or hormone group %28%IM%29% + precoord hormone receptor %28%e.g., RECEPTORS, ALDOSTERONE%29% %28%IM%29% or precoord hormone-group receptor %28%e.g., RECEPTORS, GLUCOCORTICOID%29% %28%IM%29%; DF: RECEPT CELL SURFACE%A%  
% 219.47/219.68  |- skos__scopeNote mesh__D011956
% 219.47/219.68       Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell %28%From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5%29%. Cell surface receptors, unlike enzymes, do not chemically alter their ligands.%A%    
% 219.47/219.68  |- mesh__dateRevised mesh__D011956 2000-06-22
% 219.47/219.68  |- rdf__type mesh__D011956sskos__Concept
% 219.47/219.68  |- skos__broader mesh__D011956smesh__D008565
% 219.47/219.68  |- mesh__historyNote mesh__D011956
% 219.47/219.68       94; was RECEPTORS, ENDOGENOUS SUBSTANCES 1983-93; was RECEPTORS, HORMONE 1973-82; CELL RECEPTORS %26% RECEPTORS, BIOLOGIC were see RECEPTORS, ENDOGENOUS SUBSTANCES 1985-93; HORMONE RECEPTORS was see RECEPTORS, ENDOGENOUS SUBSTANCES 1975-93%A%  
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D011956 2002
% 219.47/219.69  |- skos__altLabel mesh__D011956 Cell Surface Hormone Receptors
% 219.47/219.69  |- mesh__dateCreated mesh__D011956 1999-01-01
% 219.47/219.69  |- skos__altLabel mesh__D011956 Cell Surface Receptors
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D011956 2001
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D011956 2004
% 219.47/219.69  |- mesh__recordMaintainer mesh__D011158 kle
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D011158 2006
% 219.47/219.69  |- skos__hiddenLabel mesh__D011158 Growth, Population
% 219.47/219.69  |- skos__hiddenLabel mesh__D011158 Growth Estimations, Population
% 219.47/219.69  |- skos__prefLabel mesh__D011158 Population Growth
% 219.47/219.69  |- mesh__dateEstablished mesh__D011158 1968-01-01
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D011158 2002
% 219.47/219.69  |- skos__hiddenLabel mesh__D011158 Baby Busts
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D011158 2003
% 219.47/219.69  |- skos__hiddenLabel mesh__D011158 Population Growth Estimations
% 219.47/219.69  |- skos__hiddenLabel mesh__D011158 Increases, Natural
% 219.47/219.69  |- skos__hiddenLabel mesh__D011158 Natural Increases
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D011158 2004
% 219.47/219.69  |- skos__hiddenLabel mesh__D011158 Trends, Past
% 219.47/219.69  |- skos__hiddenLabel mesh__D011158 Estimations, Population Growth
% 219.47/219.69  |- skos__hiddenLabel mesh__D011158 Baby Booms
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D011158 2000
% 219.47/219.69  |- skos__hiddenLabel mesh__D011158 Increase, Natural
% 219.47/219.69  |- skos__historyNote mesh__D011158 Population %28%1966-1967%29%
% 219.47/219.69  |- skos__hiddenLabel mesh__D011158 Explosion, Population
% 219.47/219.69  |- skos__broader mesh__D011158smesh__D011157
% 219.47/219.69  |- mesh__dateCreated mesh__D011158 1999-01-01
% 219.47/219.69  |- skos__hiddenLabel mesh__D011158 Trend, Past
% 219.47/219.69  |- skos__scopeNote mesh__D011158
% 219.47/219.69       Increase, over a specific period of time, in the number of individuals living in a country or region.%A%    
% 219.47/219.69  |- mesh__publicMeSHNote mesh__D011158
% 219.47/219.69       68; POPULATION EXPLOSION was see under POPULATION GROWTH 1968-78%A%  
% 219.47/219.69  |- mesh__historyNote mesh__D011158
% 219.47/219.69       68; POPULATION EXPLOSION was see under POPULATION GROWTH 1968-78%A%  
% 219.47/219.69  |- skos__historyNote mesh__D011158 Demography %28%1966-1967%29%
% 219.47/219.69  |- skos__hiddenLabel mesh__D011158 Populations, High Fertility
% 219.47/219.69  |- skos__hiddenLabel mesh__D011158 Past Trend
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D011158 2001
% 219.47/219.69  |- skos__annotation mesh__D011158
% 219.47/219.69       IM human, NIM animal; no qualif; specify geog   
% 219.47/219.69  |- skos__hiddenLabel mesh__D011158 Growth Estimation, Population
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D011158 2005
% 219.47/219.69  |- skos__hiddenLabel mesh__D011158 Population, High Fertility
% 219.47/219.69  |- mesh__recordOriginator mesh__D011158 NLM
% 219.47/219.69  |- mesh__onlineNote mesh__D011158
% 219.47/219.69       use POPULATION GROWTH to search POPULATION EXPLOSION 1968-78%A%  
% 219.47/219.69  |- skos__hiddenLabel mesh__D011158 High Fertility Populations
% 219.47/219.69  |- mesh__recordAuthorizer mesh__D011158 sjn
% 219.47/219.69  |- skos__hiddenLabel mesh__D011158 Explosions, Population
% 219.47/219.69  |- skos__hiddenLabel mesh__D011158 Population Explosions
% 219.47/219.69  |- mesh__dateRevised mesh__D011158 1999-11-03
% 219.47/219.69  |- rdf__type mesh__D011158sskos__Concept
% 219.47/219.69  |- skos__hiddenLabel mesh__D011158 Estimation, Population Growth
% 219.47/219.69  |- mesh__dateEstablished mesh__D005919 1966-01-01
% 219.47/219.69  |- skos__broader mesh__D005919smesh__D007677
% 219.47/219.69  |- skos__hiddenLabel mesh__D005919 Rate, Glomerular Filtration
% 219.47/219.69  |- mesh__recordAuthorizer mesh__D005919 sjn
% 219.47/219.69  |- skos__prefLabel mesh__D005919 Glomerular Filtration Rate
% 219.47/219.69  |- mesh__historyNote mesh__D005919 66%28%65%29%   
% 219.47/219.69  |- mesh__recordOriginator mesh__D005919 NLM
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D005919 2005
% 219.47/219.69  |- skos__broader mesh__D005919smesh__D014553
% 219.47/219.69  |- mesh__recordMaintainer mesh__D005919 lkt
% 219.47/219.69  |- skos__hiddenLabel mesh__D005919 Rates, Glomerular Filtration
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D005919 2006
% 219.47/219.69  |- skos__scopeNote mesh__D005919
% 219.47/219.69       The volume of water filtered out of plasma through glomerular capillary walls into Bowman%27%s capsules per unit of time. It is considered to be equivalent to INULIN clearance.%A%    
% 219.47/219.69  |- mesh__publicMeSHNote mesh__D005919 66   
% 219.47/219.69  |- mesh__dateCreated mesh__D005919 1999-01-01
% 219.47/219.69  |- skos__hiddenLabel mesh__D005919 Glomerular Filtration Rates
% 219.47/219.69  |- skos__hiddenLabel mesh__D005919 Filtration Rate, Glomerular
% 219.47/219.69  |- rdf__type mesh__D005919sskos__Concept
% 219.47/219.69  |- mesh__dateRevised mesh__D005919 2004-07-07
% 219.47/219.69  |- skos__hiddenLabel mesh__D005919 Filtration Rates, Glomerular
% 219.47/219.69  |- mesh__recordMaintainer mesh__D002621 kle
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002621 2002
% 219.47/219.69  |- skos__related mesh__D002621smesh__D001923
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002621 2004
% 219.47/219.69  |- skos__related mesh__D002621smesh__D000422
% 219.47/219.69  |- mesh__dateCreated mesh__D002621 1999-01-01
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002621 2001
% 219.47/219.69  |- skos__prefLabel mesh__D002621 Chemistry
% 219.47/219.69  |- mesh__dateRevised mesh__D002621 1999-11-03
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002621 2003
% 219.47/219.69  |- mesh__recordAuthorizer mesh__D002621 sjn
% 219.47/219.69  |- rdf__type mesh__D002621sskos__Concept
% 219.47/219.69  |- mesh__recordOriginator mesh__D002621 NLM
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002621 2000
% 219.47/219.69  |- skos__annotation mesh__D002621
% 219.47/219.69       SPEC only: prefer /chem: Manual l9.7+, 19.8.15, 19.10+; SPEC qualif; as IM: Manual 29.6; DF: CHEM%A%  
% 219.47/219.69  |- skos__related mesh__D002621smesh__D009448
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002621 2006
% 219.47/219.69  |- skos__altLabel mesh__D002621 Ingredients and Chemicals
% 219.47/219.69  |- skos__broader mesh__D002621smesh__D010811
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002621 2005
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D015549 2001
% 219.47/219.69  |- skos__broader mesh__D015549smesh__D007159
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D015549 2004
% 219.47/219.69  |- mesh__dateCreated mesh__D015549 1989-04-07
% 219.47/219.69  |- mesh__dateRevised mesh__D015549 1997-06-20
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D015549 2000
% 219.47/219.69  |- skos__scopeNote mesh__D015549
% 219.47/219.69       An in vitro test used in the diagnosis of allergies including drug hypersensitivity. The allergen is added to the patient%27%s white blood cells and the subsequent histamine release is measured.%A%    
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D015549 2003
% 219.47/219.69  |- skos__annotation mesh__D015549
% 219.47/219.69       do not use /util except by MeSH definition   
% 219.47/219.69  |- mesh__recordAuthorizer mesh__D015549 SJN
% 219.47/219.69  |- skos__historyNote mesh__D015549 Basophils %28%1966-1989%29%
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D015549 2006
% 219.47/219.69  |- mesh__publicMeSHNote mesh__D015549
% 219.47/219.69       91; was see under IMMUNOLOGIC TESTS 1990   
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D015549 2002
% 219.47/219.69  |- skos__hiddenLabel mesh__D015549 Basophil Degranulation Tests
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D015549 2005
% 219.47/219.69  |- skos__prefLabel mesh__D015549 Basophil Degranulation Test
% 219.47/219.69  |- skos__hiddenLabel mesh__D015549 Degranulation Tests, Basophil
% 219.47/219.69  |- skos__hiddenLabel mesh__D015549 Degranulation Test, Basophil
% 219.47/219.69  |- mesh__historyNote mesh__D015549
% 219.47/219.69       91%28%90%29%; was see under IMMUNOLOGIC TESTS 1990   
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D015549 1999
% 219.47/219.69  |- rdf__type mesh__D015549sskos__Concept
% 219.47/219.69  |- mesh__recordMaintainer mesh__D015549 PXP
% 219.47/219.69  |- mesh__dateEstablished mesh__D015549 1991-01-01
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D015549 1998
% 219.47/219.69  |- mesh__recordOriginator mesh__D015549 AGS
% 219.47/219.69  |- mesh__onlineNote mesh__D012251
% 219.47/219.69       use TOXICODENDRON to search RHUS 1966-92   
% 219.47/219.69  |- rdf__type mesh__D012251sskos__Concept
% 219.47/219.69  |- skos__broader mesh__D012251smesh__D027926
% 219.47/219.69  |- mesh__recordAuthorizer mesh__D012251 sjn
% 219.47/219.69  |- skos__altLabel mesh__D012251 Sumac, Poison
% 219.47/219.69  |- mesh__dateCreated mesh__D012251 1999-01-01
% 219.47/219.69  |- skos__prefLabel mesh__D012251 Toxicodendron
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D012251 2003
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D012251 2005
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D012251 2004
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D012251 2002
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D012251 2006
% 219.47/219.69  |- skos__annotation mesh__D012251
% 219.47/219.69       DERMATITIS, TOXICODENDRON is available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.47/219.69  |- mesh__dateRevised mesh__D012251 2001-07-25
% 219.47/219.69  |- mesh__publicMeSHNote mesh__D012251
% 219.47/219.69       93; was RHUS 1963-92; TOXICODENDRON was see RHUS 1966-92   
% 219.47/219.69  |- mesh__recordMaintainer mesh__D012251 ssb
% 219.47/219.69  |- skos__altLabel mesh__D012251 Oak, Poison
% 219.47/219.69  |- mesh__recordOriginator mesh__D012251 NLM
% 219.47/219.69  |- mesh__historyNote mesh__D012251
% 219.47/219.69       93; was RHUS 1963-92; TOXICODENDRON was see RHUS 1986-92   
% 219.47/219.69  |- skos__altLabel mesh__D012251 Ivy, Poison
% 219.47/219.69  |- skos__scopeNote mesh__D012251
% 219.47/219.69       A genus %28%formerly part of Rhus genus%29% of shrubs, vines, or trees that yields a highly allergenic oleoresin which causes a severe contact dermatitis %28%DERMATITIS, TOXICODENDRON%29%. The most toxic species are Toxicodendron vernix %28%poison sumac%29%, T. diversilobum %28%poison oak%29%, and T. radicans %28%poison ivy%29%. T. vernicifera yields a useful varnish from which certain enzymes %28%laccases%29% are obtained.%A%    
% 219.47/219.69  |- skos__related mesh__D012251smesh__D011040
% 219.47/219.69  |- rdf__type mesh__D006214sskos__Concept
% 219.47/219.69  |- mesh__recordOriginator mesh__D006214 NLM
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D006214 2003A
% 219.47/219.69  |- mesh__dateRevised mesh__D006214 2002-10-23
% 219.47/219.69  |- skos__annotation mesh__D006214 primates only   
% 219.47/219.69  |- mesh__dateCreated mesh__D006214 1999-01-01
% 219.47/219.69  |- skos__broader mesh__D006214smesh__D014034
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D006214 2006
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D006214 2005
% 219.47/219.69  |- mesh__recordAuthorizer mesh__D006214 sjn
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D006214 2004
% 219.47/219.69  |- mesh__recordMaintainer mesh__D006214 sjn
% 219.47/219.69  |- skos__prefLabel mesh__D006214 Hallux
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D006214 2003
% 219.47/219.69  |- mesh__dateEstablished mesh__D011957 1977-01-01
% 219.47/219.69  |- skos__altLabel mesh__D011957 Enkephalin Receptors
% 219.47/219.69  |- skos__altLabel mesh__D011957 Receptors, Opiate
% 219.47/219.69  |- mesh__recordOriginator mesh__D011957 SH
% 219.47/219.69  |- mesh__historyNote mesh__D011957
% 219.47/219.69       94; was RECEPTORS, ENDORPHIN 1980-93; was RECEPTORS, NARCOTIC 1977-79%A%  
% 219.47/219.69  |- skos__altLabel mesh__D011957 Normorphine Receptors
% 219.47/219.69  |- rdf__type mesh__D011957sskos__Concept
% 219.47/219.69  |- skos__hiddenLabel mesh__D011957 beta Endorphin Receptor
% 219.47/219.69  |- skos__broader mesh__D011957smesh__D018013
% 219.47/219.69  |- skos__annotation mesh__D011957
% 219.47/219.69       coord IM with specific opioid %28%IM%29%; DF: RECEPT OPIOID   
% 219.47/219.69  |- skos__hiddenLabel mesh__D011957 Receptor, Enkephalin
% 219.47/219.69  |- mesh__dateCreated mesh__D011957 1976-05-03
% 219.47/219.69  |- skos__altLabel mesh__D011957 Narcotic Receptors
% 219.47/219.69  |- skos__hiddenLabel mesh__D011957 Receptors, beta Endorphin
% 219.47/219.69  |- mesh__recordMaintainer mesh__D011957 jmp
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D011957 2005
% 219.47/219.69  |- skos__hiddenLabel mesh__D011957 Receptor, Endorphin
% 219.47/219.69  |- skos__altLabel mesh__D011957 Opioid Receptor
% 219.47/219.69  |- skos__hiddenLabel mesh__D011957 beta-Endorphin Receptors
% 219.47/219.69  |- skos__hiddenLabel mesh__D011957 Receptor, beta-Endorphin
% 219.47/219.69  |- skos__altLabel mesh__D011957 Receptors, beta-Endorphin
% 219.47/219.69  |- skos__historyNote mesh__D011957 Receptors, Drug %28%1966-1976%29%
% 219.47/219.69  |- skos__hiddenLabel mesh__D011957 Receptor, Opioid
% 219.47/219.69  |- skos__altLabel mesh__D011957 Opioid Receptors
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D011957 2006
% 219.47/219.69  |- skos__hiddenLabel mesh__D011957 Receptor, Opiate
% 219.47/219.69  |- skos__altLabel mesh__D011957 Receptors, Enkephalin
% 219.47/219.69  |- skos__broader mesh__D011957smesh__D043562
% 219.47/219.69  |- mesh__onlineNote mesh__D011957
% 219.47/219.69       use RECEPTORS, OPIOID to search RECEPTORS, ENDORPHIN 1980-93 %26% RECEPTORS, NARCOTIC 1977-79%A%  
% 219.47/219.69  |- mesh__publicMeSHNote mesh__D011957
% 219.47/219.69       94; was RECEPTORS, ENDORPHIN 1980-93; was RECEPTORS, NARCOTIC 1977-79%A%  
% 219.47/219.69  |- skos__altLabel mesh__D011957 Opiate Receptor
% 219.47/219.69  |- skos__altLabel mesh__D011957 Endorphin Receptor
% 219.47/219.69  |- mesh__dateRevised mesh__D011957 2003-07-09
% 219.47/219.69  |- skos__scopeNote mesh__D011957
% 219.47/219.69       Cell membrane proteins that bind opioids and trigger intracellular changes which influence the behavior of cells. The endogenous ligands for opioid receptors in mammals include three families of peptides, the enkephalins, endorphins, and dynorphins. The receptor classes include mu, delta, and kappa receptors. Sigma receptors bind several psychoactive substances, including certain opioids, but their endogenous ligands are not known.%A%    
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D011957 2004
% 219.47/219.69  |- skos__prefLabel mesh__D011957 Receptors, Opioid
% 219.47/219.69  |- skos__altLabel mesh__D011957 Opiate Receptors
% 219.47/219.69  |- skos__altLabel mesh__D011957 Endorphin Receptors
% 219.47/219.69  |- mesh__recordAuthorizer mesh__D011957 sjn
% 219.47/219.69  |- skos__historyNote mesh__D011957 Narcotics %28%1966-1976%29%
% 219.47/219.69  |- mesh__dateCreated mesh__D011159 1999-01-01
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D011159 2001
% 219.47/219.69  |- mesh__dateRevised mesh__D011159 1999-11-03
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D011159 2003
% 219.47/219.69  |- mesh__dateEstablished mesh__D011159 1967-01-01
% 219.47/219.69  |- skos__annotation mesh__D011159 IM human, NIM animal; specify geog   
% 219.47/219.69  |- mesh__recordOriginator mesh__D011159 NLM
% 219.47/219.69  |- skos__altLabel mesh__D011159 Public Health Surveillance
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D011159 2002
% 219.47/219.69  |- skos__prefLabel mesh__D011159 Population Surveillance
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D011159 2004
% 219.47/219.69  |- skos__hiddenLabel mesh__D011159 Surveillance, Public Health
% 219.47/219.69  |- skos__scopeNote mesh__D011159
% 219.47/219.69       Ongoing scrutiny of a population %28%general population, study population, target population, etc.%29%, generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy.%A%    
% 219.47/219.69  |- skos__hiddenLabel mesh__D011159 Surveillance, Population
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D011159 2005
% 219.47/219.69  |- mesh__publicMeSHNote mesh__D011159 67   
% 219.47/219.69  |- mesh__historyNote mesh__D011159 67%28%65%29%   
% 219.47/219.69  |- skos__broader mesh__D011159smesh__D015980
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D011159 2006
% 219.47/219.69  |- mesh__recordAuthorizer mesh__D011159 sjn
% 219.47/219.69  |- rdf__type mesh__D011159sskos__Concept
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D011159 2000
% 219.47/219.69  |- skos__broader mesh__D011159smesh__D006306
% 219.47/219.69  |- mesh__recordMaintainer mesh__D011159 kle
% 219.47/219.69  |- mesh__historyNote mesh__D016642 92; was BUPROPION %28%NM%29% 1978-91   
% 219.47/219.69  |- skos__altLabel mesh__D016642
% 219.47/219.69       Glaxo Wellcome Brand 1 of Bupropion Hydrochloride
% 219.47/219.69  |- skos__prefLabel mesh__D016642 Bupropion
% 219.47/219.69  |- skos__broader mesh__D016642smesh__D011427
% 219.47/219.69  |- skos__altLabel mesh__D016642
% 219.47/219.69       GlaxoSmithKline Brand 1 of Bupropion Hydrochloride
% 219.47/219.69  |- skos__related mesh__D016642smesh__D016540
% 219.47/219.69  |- mesh__publicMeSHNote mesh__D016642
% 219.47/219.69       92; BUPROPION was indexed under PROPIOPHENONES 1978-91   
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D016642 2006
% 219.47/219.69  |- skos__altLabel mesh__D016642 Esteve Brand of Bupropion Hydrochloride
% 219.47/219.69  |- skos__historyNote mesh__D016642 Propiophenones %28%1966-1991%29%
% 219.47/219.69  |- skos__annotation mesh__D016642 do not confuse with Zyban fungicide   
% 219.47/219.69  |- skos__altLabel mesh__D016642
% 219.47/219.69       Glaxo Wellcome Brand 2 of Bupropion Hydrochloride
% 219.47/219.69  |- mesh__onlineNote mesh__D016642
% 219.47/219.69       use BUPROPION %28%NM%29% to search BUPROPION 1980-91   
% 219.47/219.69  |- mesh__dateCreated mesh__D016642 1991-01-24
% 219.47/219.69  |- mesh__dateRevised mesh__D016642 2005-06-30
% 219.47/219.69  |- skos__altLabel mesh__D016642
% 219.47/219.69       GlaxoSmithKline Brand 2 of Bupropion Hydrochloride
% 219.47/219.69  |- mesh__recordMaintainer mesh__D016642 CCR
% 219.47/219.69  |- mesh__dateEstablished mesh__D016642 1992-01-01
% 219.47/219.69  |- mesh__recordAuthorizer mesh__D016642 sjn
% 219.47/219.69  |- skos__historyNote mesh__D016642 Antidepressive Agents %28%1966-1991%29%
% 219.47/219.69  |- skos__altLabel mesh__D016642 Amfebutamone
% 219.47/219.69  |- skos__altLabel mesh__D016642
% 219.47/219.69       %28%+-%29%-1-%28%3-Chlorophenyl%29%-2-%28%%28%1,1-dimethylethyl%29%amino%29%-1-propanone
% 219.47/219.69  |- skos__scopeNote mesh__D016642
% 219.47/219.69       A unicyclic, aminoketone antidepressant. The mechanism of its therapeutic actions is not well understood, but it does appear to block dopamine uptake. The hydrochloride is available as an aid to smoking cessation treatment.%A%    
% 219.47/219.69  |- mesh__recordOriginator mesh__D016642 RLS
% 219.47/219.69  |- rdf__type mesh__D016642sskos__Concept
% 219.47/219.69  |- skos__altLabel mesh__D016642
% 219.47/219.69       Glaxo Wellcome Brand 3 of Bupropion Hydrochloride
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002622 1994
% 219.47/219.69  |- mesh__dateCreated mesh__D002622 1999-01-01
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002622 2005
% 219.47/219.69  |- skos__prefLabel mesh__D002622 Chemistry, Agricultural
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002622 2001
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002622 1998
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002622 1993
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002622 2004
% 219.47/219.69  |- mesh__recordOriginator mesh__D002622 NLM
% 219.47/219.69  |- rdf__type mesh__D002622sskos__Concept
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002622 2000
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002622 1997
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002622 1992
% 219.47/219.69  |- skos__hiddenLabel mesh__D002622 Agricultural Chemistries
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002622 2003
% 219.47/219.69  |- skos__annotation mesh__D002622
% 219.47/219.69       SPEC: SPEC qualif; as coord, NIM with no qualif; Manual 29.7%A%  
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002622 1996
% 219.47/219.69  |- mesh__dateRevised mesh__D002622 1991-01-08
% 219.47/219.69  |- mesh__recordAuthorizer mesh__D002622 PLS
% 219.47/219.69  |- skos__hiddenLabel mesh__D002622 Chemistries, Agricultural
% 219.47/219.69  |- skos__broader mesh__D002622smesh__D002621
% 219.47/219.69  |- mesh__recordMaintainer mesh__D002622 TGC
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002622 1995
% 219.47/219.69  |- skos__altLabel mesh__D002622 Agricultural Chemistry
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002622 2006
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002622 2002
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D002622 1999
% 219.47/219.69  |- mesh__dateCreated mesh__D040741 2002-07-03
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D040741 2003
% 219.47/219.69  |- mesh__historyNote mesh__D040741
% 219.47/219.69       2003; use GENETICS, POPULATION 1998-2002   
% 219.47/219.69  |- mesh__dateEstablished mesh__D040741 2003-01-01
% 219.47/219.69  |- skos__related mesh__D040741smesh__D006823
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D040741 2006
% 219.47/219.69  |- rdf__type mesh__D040741sskos__Concept
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D040741 2005
% 219.47/219.69  |- skos__prefLabel mesh__D040741 Genetic Load
% 219.47/219.69  |- mesh__publicMeSHNote mesh__D040741
% 219.47/219.69       2003; see GENETICS, POPULATION 1998-2002   
% 219.47/219.69  |- skos__scopeNote mesh__D040741
% 219.47/219.69       The relative amount by which the average fitness of a POPULATION is lowered, due to the presence of GENES that decrease survival, compared to the GENOTYPE  with maximum or optimal fitness. %28%From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A%    
% 219.47/219.69  |- skos__altLabel mesh__D040741 Load, Genetic
% 219.47/219.69  |- skos__broader mesh__D040741smesh__D040341
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D040741 2004
% 219.47/219.69  |- mesh__dateRevised mesh__D012252 2005-06-30
% 219.47/219.69  |- mesh__recordOriginator mesh__D012252 NLM
% 219.47/219.69  |- skos__historyNote mesh__D012252 Contraception %28%1966-1974%29%
% 219.47/219.69  |- skos__hiddenLabel mesh__D012252 Family Planning, Natural
% 219.47/219.69  |- mesh__historyNote mesh__D012252
% 219.47/219.69       2004 %28%1975%29%; for NATURAL FAMILY PLANNING use FAMILY PLANNING 1988-2003%A%  
% 219.47/219.69  |- mesh__publicMeSHNote mesh__D012252
% 219.47/219.69       2004; see RHYTHM METHOD 1975-2003; for NATURAL FAMILY PLANNING see FAMILY PLANNING 1988-2003%A%  
% 219.47/219.69  |- skos__hiddenLabel mesh__D012252 Abstinence, Periodic
% 219.47/219.69  |- skos__prefLabel mesh__D012252 Natural Family Planning Methods
% 219.47/219.69  |- mesh__recordAuthorizer mesh__D012252 sjn
% 219.47/219.69  |- skos__altLabel mesh__D012252 Symptothermal Method of Family Planning
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D012252 2006
% 219.47/219.69  |- skos__scopeNote mesh__D012252
% 219.47/219.69       A class of natural contraceptive methods in which SEXUAL ABSTINENCE is practiced a few days before and after the estimated day of ovulation, during the fertile phase. Methods for determining the fertile period or OVULATION DETECTION are based on various physiological indicators, such as circulating hormones, changes in cervical mucus %28%CERVIX MUCUS%29%, and the basal body temperature.%A%    
% 219.47/219.69  |- skos__related mesh__D012252smesh__D046910
% 219.47/219.69  |- skos__altLabel mesh__D012252 Periodic Abstinence
% 219.47/219.69  |- rdf__type mesh__D012252sskos__Concept
% 219.47/219.69  |- mesh__dateEstablished mesh__D012252 1975-09-01
% 219.47/219.69  |- mesh__recordMaintainer mesh__D012252 lkt
% 219.47/219.69  |- skos__broader mesh__D012252smesh__D003267
% 219.47/219.69  |- mesh__dateCreated mesh__D012252 1974-11-19
% 219.47/219.69  |- skos__altLabel mesh__D012252 Natural Family Planning
% 219.47/219.69  |- skos__hiddenLabel mesh__D006215 Bunions
% 219.47/219.69  |- skos__annotation mesh__D006215
% 219.47/219.69       do not confuse BUNION with TAILOR%27%S BUNION   
% 219.47/219.69  |- mesh__dateCreated mesh__D006215 1999-01-01
% 219.47/219.69  |- skos__hiddenLabel mesh__D006215 Primus Varus, Metatarsus
% 219.47/219.69  |- skos__related mesh__D006215smesh__D050489
% 219.47/219.69  |- skos__broader mesh__D006215smesh__D005530
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D006215 2006
% 219.47/219.69  |- mesh__recordOriginator mesh__D006215 NLM
% 219.47/219.69  |- mesh__publicMeSHNote mesh__D006215 1967   
% 219.47/219.69  |- mesh__recordMaintainer mesh__D006215 ags
% 219.47/219.69  |- skos__prefLabel mesh__D006215 Hallux Valgus
% 219.47/219.69  |- skos__altLabel mesh__D006215 Hallux Abductovalgus
% 219.47/219.69  |- mesh__dateEstablished mesh__D006215 1967-01-01
% 219.47/219.69  |- mesh__historyNote mesh__D006215 1967%28%1963%29%   
% 219.47/219.69  |- skos__hiddenLabel mesh__D006215 Varus, Metatarsus Primus
% 219.47/219.69  |- rdf__type mesh__D006215sskos__Concept
% 219.47/219.69  |- mesh__dateRevised mesh__D006215 2005-06-30
% 219.47/219.69  |- skos__scopeNote mesh__D006215
% 219.47/219.69       Lateral displacement of the great toe %28%HALLUX%29%, producing deformity of the first METATARSOPHALANGEAL JOINT with callous, bursa, or bunion formation over the bony prominence.%A%    
% 219.47/219.69  |- mesh__recordAuthorizer mesh__D006215 sjn
% 219.47/219.69  |- skos__hiddenLabel mesh__D011958
% 219.47/219.69       Epidermal Growth Factor Receptor Protein Tyrosine Kinase
% 219.47/219.69  |- skos__altLabel mesh__D011958 Receptor, EGF
% 219.47/219.69  |- mesh__recordAuthorizer mesh__D011958 sjn
% 219.47/219.69  |- mesh__dateRevised mesh__D011958 2005-06-30
% 219.47/219.69  |- skos__hiddenLabel mesh__D011958
% 219.47/219.69       Receptor, Transforming Growth Factor alpha
% 219.47/219.69  |- skos__altLabel mesh__D011958 TGF-alpha Receptor
% 219.47/219.69  |- rdf__type mesh__D011958sskos__Concept
% 219.47/219.69  |- skos__altLabel mesh__D011958 erbB-1 Proto-Oncogene Protein
% 219.47/219.69  |- mesh__dateCreated mesh__D011958 1986-03-31
% 219.47/219.69  |- skos__altLabel mesh__D011958 Receptor, Transforming-Growth Factor alpha
% 219.47/219.69  |- mesh__historyNote mesh__D011958
% 219.47/219.69       2000%28%1987%29%; for EPIDERMAL GROWTH FACTOR RECEPTOR PROTEIN-TYROSINE KINASE use RECEPTOR, EPIDERMAL GROWTH FACTOR 1994-1999%A%  
% 219.47/219.69  |- skos__hiddenLabel mesh__D011958 erbB 1 Proto Oncogene Protein
% 219.47/219.69  |- skos__hiddenLabel mesh__D011958 c erbB 1 Protein
% 219.47/219.69  |- skos__altLabel mesh__D011958 Epidermal Growth Factor Receptor
% 219.47/219.69  |- skos__altLabel mesh__D011958 Epidermal Growth Factor Receptor Kinase
% 219.47/219.69  |- skos__altLabel mesh__D011958 EGF Receptor
% 219.47/219.69  |- skos__altLabel mesh__D011958 Receptors, Epidermal Growth Factor
% 219.47/219.69  |- mesh__recordMaintainer mesh__D011958 jmp
% 219.47/219.69  |- skos__hiddenLabel mesh__D011958 Receptor, TGF alpha
% 219.47/219.69  |- mesh__publicMeSHNote mesh__D011958
% 219.47/219.69       2000; see RECEPTORS, EPIDERMAL GROWTH FACTOR-UROGASTRONE 1978-1999; for EPIDERMAL GROWTH FACTOR RECEPTOR PROTEIN-TYROSINE KINASE see EPIDERMAL GROWTH FACTOR RECEPTOR PROTEIN-TYROSINE KINASE 1994-1999%A%  
% 219.47/219.69  |- skos__altLabel mesh__D011958 Transforming Growth Factor alpha Receptor
% 219.47/219.69  |- skos__altLabel mesh__D011958
% 219.47/219.69       Epidermal Growth Factor Receptor Protein-Tyrosine Kinase
% 219.47/219.69  |- skos__altLabel mesh__D011958 c-erbB-1 Protein
% 219.47/219.69  |- skos__historyNote mesh__D011958
% 219.47/219.69       Epidermal Growth Factors %28%1977-1981%29%
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D011958 2006
% 219.47/219.69  |- skos__altLabel mesh__D011958 Receptor, TGF-alpha
% 219.47/219.69  |- skos__hiddenLabel mesh__D011958 Proto-Oncogene Protein, erbB-1
% 219.47/219.69  |- skos__hiddenLabel mesh__D011958
% 219.47/219.69       Receptors, Epidermal Growth Factor Urogastrone
% 219.47/219.69  |- skos__scopeNote mesh__D011958
% 219.47/219.69       A cell surface receptor involved in regulation of cell growth and differentiation. It is specific for EPIDERMAL GROWTH FACTOR and EGF related peptides including TRANSFORMING GROWTH FACTOR ALPHA, amphiregulin, and heparin-binding EGF-like growth factor. The binding of ligand to the receptor causes activation of its intrinsic tyrosine kinase activity and rapid internalization of the receptor-ligand complex into the cell.%A%    
% 219.47/219.69  |- skos__annotation mesh__D011958 DF: RECEPT EGF   
% 219.47/219.69  |- skos__broader mesh__D011958smesh__D011964
% 219.47/219.69  |- skos__altLabel mesh__D011958
% 219.47/219.69       Receptors, Epidermal Growth Factor-Urogastrone
% 219.47/219.69  |- skos__altLabel mesh__D011958 Receptor, Urogastrone
% 219.47/219.69  |- skos__altLabel mesh__D011958 Urogastrone Receptor
% 219.47/219.69  |- skos__historyNote mesh__D011958
% 219.47/219.69       Receptors, Cell Surface %28%1973-1986%29%
% 219.47/219.69  |- skos__prefLabel mesh__D011958 Receptor, Epidermal Growth Factor
% 219.47/219.69  |- mesh__dateEstablished mesh__D011958 1987-01-01
% 219.47/219.69  |- skos__broader mesh__D011958smesh__D020794
% 219.47/219.69  |- skos__broader mesh__D011958smesh__D017978
% 219.47/219.69  |- skos__historyNote mesh__D011958 Urogastrone %28%1966-1981%29%
% 219.47/219.69  |- skos__historyNote mesh__D011958
% 219.47/219.69       Epidermal Growth Factor-Urogastrone %28%1982-1986%29%
% 219.47/219.69  |- mesh__recordOriginator mesh__D011958 SH
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D016643 2003
% 219.47/219.69  |- skos__historyNote mesh__D016643 Cattle Diseases %28%1988-1991%29%
% 219.47/219.69  |- skos__broader mesh__D016643smesh__D017096
% 219.47/219.69  |- skos__hiddenLabel mesh__D016643 Mad Cow Diseases
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D016643 2005
% 219.47/219.69  |- skos__altLabel mesh__D016643 Spongiform Encephalopathy, Bovine
% 219.47/219.69  |- skos__hiddenLabel mesh__D016643
% 219.47/219.69       BSEs %28%Bovine Spongiform Encephalopathy%29%
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D016643 2004
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D016643 2002
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D016643 2006
% 219.47/219.69  |- mesh__dateCreated mesh__D016643 1991-01-25
% 219.47/219.69  |- mesh__recordMaintainer mesh__D016643 ags
% 219.47/219.69  |- skos__scopeNote mesh__D016643
% 219.47/219.69       A transmissible spongiform encephalopathy of cattle associated with abnormal prion proteins in the brain. Affected animals develop excitability and salivation followed by ATAXIA. This disorder has been associated with consumption of SCRAPIE infected ruminant derived protein. This condition may be transmitted to humans, where it is referred to as variant or new variant CREUTZFELDT-JAKOB SYNDROME. %28%Vet Rec 1998 Jul 25;143%28%41%29%:101-5%29%%A%    
% 219.47/219.69  |- skos__broader mesh__D016643smesh__D002418
% 219.47/219.69  |- skos__altLabel mesh__D016643 Bovine Spongiform Encephalopathy
% 219.47/219.69  |- skos__annotation mesh__D016643
% 219.47/219.69       if transmitted to man, coord IM %28%with probably /transm%29% with specific brain or other neurol dis in text %28%IM%29%; if transmitted to another species of animal, coord IM %28%with probably /transm%29% with animal/dis precoord %28%IM%29% + specific animal IM or NIM; DF ENCEPH BOVINE SPONGIFORM%A%  
% 219.47/219.69  |- mesh__recordOriginator mesh__D016643 AGS
% 219.47/219.69  |- mesh__recordAuthorizer mesh__D016643 ags
% 219.47/219.69  |- skos__historyNote mesh__D016643
% 219.47/219.69       Brain Diseases/veterinary %28%1988-1991%29%
% 219.47/219.69  |- skos__altLabel mesh__D016643 Mad Cow Disease
% 219.47/219.69  |- mesh__publicMeSHNote mesh__D016643 1992   
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D016643 2000
% 219.47/219.69  |- skos__prefLabel mesh__D016643 Encephalopathy, Bovine Spongiform
% 219.47/219.69  |- mesh__historyNote mesh__D016643 1992   
% 219.47/219.69  |- skos__altLabel mesh__D016643 Encephalitis, Bovine Spongiform
% 219.47/219.69  |- skos__hiddenLabel mesh__D016643 Bovine Spongiform Encephalitis
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D016643 2000A
% 219.47/219.69  |- mesh__dateRevised mesh__D016643 1999-12-08
% 219.47/219.69  |- rdf__type mesh__D016643sskos__Concept
% 219.47/219.69  |- mesh__activeMeSHYear mesh__D016643 2001
% 219.47/219.70  |- skos__altLabel mesh__D016643
% 219.47/219.70       BSE %28%Bovine Spongiform Encephalopathy%29%
% 219.47/219.70  |- mesh__dateEstablished mesh__D016643 1992-01-01
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002623 2003
% 219.47/219.70  |- skos__altLabel mesh__D002623 Chemistry, Analytic
% 219.47/219.70  |- skos__prefLabel mesh__D002623 Chemistry, Analytical
% 219.47/219.70  |- skos__related mesh__D002623smesh__D002624
% 219.47/219.70  |- skos__hiddenLabel mesh__D002623 Analytic Chemistry
% 219.47/219.70  |- mesh__dateRevised mesh__D002623 1997-06-20
% 219.47/219.70  |- skos__related mesh__D002623smesh__D001322
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002623 2002
% 219.47/219.70  |- skos__broader mesh__D002623smesh__D002621
% 219.47/219.70  |- skos__annotation mesh__D002623
% 219.47/219.70       SPEC: TN 37; never use as substitute for or reinforcement of /anal: Manual 19.7+, 19.10+, 29.8; as SPEC, SPEC qualif; do not use as NIM coord with specific substance; DF: CHEM ANAL%A%  
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002623 2006
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002623 2001
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002623 1999
% 219.47/219.70  |- mesh__recordMaintainer mesh__D002623 TGC
% 219.47/219.70  |- skos__scopeNote mesh__D002623
% 219.47/219.70       The branch of chemistry dealing with detection %28%qualitative%29% and determination %28%quantitative%29% of substances. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 219.47/219.70  |- skos__altLabel mesh__D002623 Analytical Chemistry
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002623 2005
% 219.47/219.70  |- mesh__dateCreated mesh__D002623 1999-01-01
% 219.47/219.70  |- mesh__recordOriginator mesh__D002623 NLM
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002623 2000
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002623 1998
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002623 2004
% 219.47/219.70  |- mesh__onlineNote mesh__D002623
% 219.47/219.70       pre-explosion = CHEMISTRY, ANALYTICAL %28%PX%29%   
% 219.47/219.70  |- skos__broader mesh__D002623smesh__D008919
% 219.47/219.70  |- rdf__type mesh__D002623sskos__Concept
% 219.47/219.70  |- mesh__recordAuthorizer mesh__D002623 SJN
% 219.47/219.70  |- skos__broader mesh__D012253smesh__D050723
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D012253 2006
% 219.47/219.70  |- skos__hiddenLabel mesh__D012253 Rib Fracture
% 219.47/219.70  |- skos__broader mesh__D012253smesh__D013898
% 219.47/219.70  |- mesh__recordMaintainer mesh__D012253 ssb
% 219.47/219.70  |- mesh__dateRevised mesh__D012253 2005-06-30
% 219.47/219.70  |- rdf__type mesh__D012253sskos__Concept
% 219.47/219.70  |- skos__prefLabel mesh__D012253 Rib Fractures
% 219.47/219.70  |- mesh__recordOriginator mesh__D012253 NLM
% 219.47/219.70  |- skos__hiddenLabel mesh__D012253 Fracture, Rib
% 219.47/219.70  |- skos__hiddenLabel mesh__D012253 Fractures, Rib
% 219.47/219.70  |- mesh__dateCreated mesh__D012253 1999-01-01
% 219.47/219.70  |- mesh__recordAuthorizer mesh__D012253 sjn
% 219.47/219.70  |- mesh__recordAuthorizer mesh__D006216 ags
% 219.47/219.70  |- skos__broader mesh__D006216smesh__D016931
% 219.47/219.70  |- mesh__dateCreated mesh__D006216 1975-07-25
% 219.47/219.70  |- skos__prefLabel mesh__D006216 Halobacteriaceae
% 219.47/219.70  |- mesh__dateRevised mesh__D006216 2005-07-15
% 219.47/219.70  |- mesh__recordMaintainer mesh__D006216 ags
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D006216 2006
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D006216 2006A
% 219.47/219.70  |- mesh__publicMeSHNote mesh__D006216 76   
% 219.47/219.70  |- skos__scopeNote mesh__D006216
% 219.47/219.70       A family of extremely halophilic archaea found in environments with high salt concentrations, such as salt lakes, evaporated brines, or salted fish. Halobacteriaceae are either obligate aerobes or facultative anaerobes and are divided into six genera: HALOARCULA; HALOBACTERIUM; HALOCOCCUS; HALOFERAX; NATRONOBACTERIUM; and NATRONOCOCCUS.%A%    
% 219.47/219.70  |- skos__annotation mesh__D006216
% 219.47/219.70       a family of Halobacteriales %22%found in environments with high salt concentrations%22%%A%  
% 219.47/219.70  |- skos__historyNote mesh__D006216 Pseudomonadaceae %28%1975%29%
% 219.47/219.70  |- mesh__dateEstablished mesh__D006216 1976-01-01
% 219.47/219.70  |- mesh__historyNote mesh__D006216 76   
% 219.47/219.70  |- rdf__type mesh__D006216sskos__Concept
% 219.47/219.70  |- mesh__recordOriginator mesh__D006216 JW
% 219.47/219.70  |- skos__historyNote mesh__D006216 Bacteria %28%1966-1974%29%
% 219.47/219.70  |- skos__historyNote mesh__D011959 Receptors, Drug %28%1968-1984%29%
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D011959 1996
% 219.47/219.70  |- skos__historyNote mesh__D011959 Pharmacology %28%1966-1967%29%
% 219.47/219.70  |- skos__altLabel mesh__D011959 Estradiol Receptor
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D011959 1998
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D011959 2003
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D011959 1997
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D011959 2002
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D011959 2005
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D011959 1999
% 219.47/219.70  |- skos__scopeNote mesh__D011959
% 219.47/219.70       Cytoplasmic proteins that bind estradiol, migrate to the nucleus, and regulate DNA transcription.%A%    
% 219.47/219.70  |- skos__historyNote mesh__D011959 Estradiol %28%1966-1984%29%
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D011959 2004
% 219.47/219.70  |- skos__annotation mesh__D011959 DF: RECEPT ESTRADIOL   
% 219.47/219.70  |- mesh__dateRevised mesh__D011959 1995-06-08
% 219.47/219.70  |- skos__hiddenLabel mesh__D011959 Receptor, Estradiol
% 219.47/219.70  |- skos__altLabel mesh__D011959 Estradiol Receptors
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D011959 2006
% 219.47/219.70  |- skos__prefLabel mesh__D011959 Receptors, Estradiol
% 219.47/219.70  |- mesh__recordMaintainer mesh__D011959 KEV
% 219.47/219.70  |- skos__historyNote mesh__D011959
% 219.47/219.70       Receptors, Endogenous Substances %28%1973-1976%29%
% 219.47/219.70  |- mesh__publicMeSHNote mesh__D011959
% 219.47/219.70       89; was see under RECEPTORS, ESTROGEN 1985-88   
% 219.47/219.70  |- mesh__recordAuthorizer mesh__D011959 PLS
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D011959 2000
% 219.47/219.70  |- mesh__dateEstablished mesh__D011959 1989-01-01
% 219.47/219.70  |- mesh__recordOriginator mesh__D011959 SH
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D011959 2001
% 219.47/219.70  |- skos__broader mesh__D011959smesh__D011960
% 219.47/219.70  |- skos__historyNote mesh__D011959 Receptors, Estrogen %28%1977-1984%29%
% 219.47/219.70  |- mesh__dateCreated mesh__D011959 1984-05-24
% 219.47/219.70  |- mesh__historyNote mesh__D011959
% 219.47/219.70       89%28%85%29%; was see under RECEPTORS, ESTROGEN 1985-88   
% 219.47/219.70  |- rdf__type mesh__D011959sskos__Concept
% 219.47/219.70  |- skos__prefLabel mesh__D022681
% 219.47/219.70       Diphtheria-Tetanus-acellular Pertussis Vaccines
% 219.47/219.70  |- skos__scopeNote mesh__D022681
% 219.47/219.70       Combined  vaccines consisting of DIPHTHERIA TOXOID; TETANUS TOXOID; and an acellular form of PERTUSSIS VACCINE. At least five different purified antigens of B. pertussis have been used in various combinations in these vaccines.%A%    
% 219.47/219.70  |- skos__altLabel mesh__D022681 DTaP Vaccines
% 219.47/219.70  |- skos__hiddenLabel mesh__D022681
% 219.47/219.70       Pertussis Vaccines, Diphtheria-Tetanus-acellular
% 219.47/219.70  |- skos__broader mesh__D022681smesh__D004168
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D022681 2006
% 219.47/219.70  |- skos__broader mesh__D022681smesh__D001428
% 219.47/219.70  |- skos__hiddenLabel mesh__D022681 ACELIMUNE
% 219.47/219.70  |- mesh__dateRevised mesh__D022681 2005-06-30
% 219.47/219.70  |- mesh__recordAuthorizer mesh__D022681 sjn
% 219.47/219.70  |- skos__hiddenLabel mesh__D022681
% 219.47/219.70       Diphtheria Tetanus acellular Pertussis Vaccines
% 219.47/219.70  |- skos__broader mesh__D022681smesh__D017778
% 219.47/219.70  |- skos__altLabel mesh__D022681 DTaP Vaccine
% 219.47/219.70  |- skos__historyNote mesh__D022681
% 219.47/219.70       Diphtheria-Tetanus-Pertussis Vaccine %28%1996-2000%29%
% 219.47/219.70  |- skos__broader mesh__D022681smesh__D010567
% 219.47/219.70  |- rdf__type mesh__D022681sskos__Concept
% 219.47/219.70  |- skos__broader mesh__D022681smesh__D013745
% 219.47/219.70  |- mesh__dateEstablished mesh__D022681 2001-01-01
% 219.47/219.70  |- skos__annotation mesh__D022681
% 219.47/219.70       DIPHTHERIA-TETANUS VACCINE and DIPHTHERIA-TETANUS-PERTUSSIS VACCINE are also available%A%  
% 219.47/219.70  |- skos__hiddenLabel mesh__D022681 ACEL IMUNE
% 219.47/219.70  |- skos__hiddenLabel mesh__D022681 Vaccine, DTaP
% 219.47/219.70  |- mesh__historyNote mesh__D022681
% 219.47/219.70       2001; use DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES %28%NM%29% to search DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINE 1997-2000%A%  
% 219.47/219.70  |- mesh__recordOriginator mesh__D022681 ags
% 219.47/219.70  |- mesh__recordMaintainer mesh__D022681 ssb
% 219.47/219.70  |- mesh__publicMeSHNote mesh__D022681
% 219.47/219.70       2001; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINE was indexed under DIPHTHERIA-TETANUS-PERTUSSIS VACCINE 1997-2000%A%  
% 219.47/219.70  |- mesh__dateCreated mesh__D022681 2000-06-28
% 219.47/219.70  |- skos__broader mesh__D022681smesh__D022282
% 219.47/219.70  |- skos__hiddenLabel mesh__D022681
% 219.47/219.70       Vaccines, Diphtheria-Tetanus-acellular Pertussis
% 219.47/219.70  |- skos__hiddenLabel mesh__D022681 Vaccines, DTaP
% 219.47/219.70  |- skos__historyNote mesh__D016644
% 219.47/219.70       Carotene/analogs %26% derivatives %28%1975-1991%29%
% 219.47/219.70  |- skos__altLabel mesh__D016644 Canthaxanthine
% 219.47/219.70  |- mesh__dateEstablished mesh__D016644 1992-01-01
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D016644 2006
% 219.47/219.70  |- skos__prefLabel mesh__D016644 Canthaxanthin
% 219.47/219.70  |- mesh__dateRevised mesh__D016644 2005-06-30
% 219.47/219.70  |- mesh__publicMeSHNote mesh__D016644
% 219.47/219.70       92; CANTHAXANTHIN was indexed under CAROTENE/analogs %26% derivatives 1978-91%A%  
% 219.47/219.70  |- mesh__recordAuthorizer mesh__D016644 sjn
% 219.47/219.70  |- mesh__recordMaintainer mesh__D016644 ssb
% 219.47/219.70  |- skos__scopeNote mesh__D016644
% 219.47/219.70       A trans-carotenoid pigment widely distributed in nature. The compound is used as an oral suntanning agent and as a food and drug coloring agent. Oral ingestion of the compound causes canthaxanthin retinopathy.%A%    
% 219.47/219.70  |- skos__historyNote mesh__D016644 Antioxidants %28%1966-1991%29%
% 219.47/219.70  |- mesh__dateCreated mesh__D016644 1991-01-24
% 219.47/219.70  |- skos__broader mesh__D016644smesh__D024341
% 219.47/219.70  |- mesh__historyNote mesh__D016644
% 219.47/219.70       92; was CANTHAXANTHIN %28%NM%29% 1978-91   
% 219.47/219.70  |- mesh__onlineNote mesh__D016644
% 219.47/219.70       use CANTHAXANTHIN %28%NM%29% to search CANTHAXANTHIN 1980-91   
% 219.47/219.70  |- rdf__type mesh__D016644sskos__Concept
% 219.47/219.70  |- mesh__recordOriginator mesh__D016644 RLS
% 219.47/219.70  |- skos__broader mesh__D001237Q000151smesh__D001237
% 219.47/219.70  |- mesh__preferredCombination mesh__D001237Q000151smesh__D001238
% 219.47/219.70  |- rdf__type mesh__D001237Q000151smesh__CompoundConcept
% 219.47/219.70  |- skos__scopeNote mesh__D002624
% 219.47/219.70       The specialty of analytical chemistry applied to assays of physiologically important substances found in blood, urine, tissues, and other biological fluids for the purpose of aiding the physician in making a diagnosis or following therapy.%A%    
% 219.47/219.70  |- skos__broader mesh__D002624smesh__D002621
% 219.47/219.70  |- mesh__recordAuthorizer mesh__D002624 SJN
% 219.47/219.70  |- mesh__historyNote mesh__D002624 67%28%66%29%   
% 219.47/219.70  |- skos__annotation mesh__D002624
% 219.47/219.70       SPEC: TN 37; SPEC qualif; do not use as NIM coord; DF: CLIN CHEM%A%  
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002624 2006
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002624 1999
% 219.47/219.70  |- skos__altLabel mesh__D002624 Clinical Chemistry
% 219.47/219.70  |- mesh__dateCreated mesh__D002624 1999-01-01
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002624 2005
% 219.47/219.70  |- mesh__dateRevised mesh__D002624 1997-06-20
% 219.47/219.70  |- skos__related mesh__D002624smesh__D019963
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002624 1998
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002624 2002
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002624 2004
% 219.47/219.70  |- rdf__type mesh__D002624sskos__Concept
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002624 2001
% 219.47/219.70  |- mesh__recordMaintainer mesh__D002624 PXP
% 219.47/219.70  |- skos__prefLabel mesh__D002624 Chemistry, Clinical
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002624 2003
% 219.47/219.70  |- mesh__publicMeSHNote mesh__D002624 67   
% 219.47/219.70  |- mesh__recordOriginator mesh__D002624 NLM
% 219.47/219.70  |- mesh__dateEstablished mesh__D002624 1967-01-01
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002624 2000
% 219.47/219.70  |- mesh__recordAuthorizer mesh__D012254 sjn
% 219.47/219.70  |- mesh__historyNote mesh__D012254
% 219.47/219.70       91%28%78%29%; was see under RIBONUCLEOSIDES 1978-90; was VIRAZOLE see under RIBONUCLEOSIDES 1975-77; VIRAZOLE was see RIBAVIRIN 1978-91%A%  
% 219.47/219.70  |- skos__historyNote mesh__D012254 Ribonucleosides %28%1973-1974%29%
% 219.47/219.70  |- skos__altLabel mesh__D012254 Dermatech Brand of Ribavirin
% 219.47/219.70  |- skos__altLabel mesh__D012254 Grossman Brand of Ribavirin
% 219.47/219.70  |- skos__hiddenLabel mesh__D012254 ICN1229
% 219.47/219.70  |- skos__hiddenLabel mesh__D012254 ICN 1229
% 219.47/219.70  |- skos__altLabel mesh__D012254 ICN Brand of Ribavirin
% 219.47/219.70  |- rdf__type mesh__D012254sskos__Concept
% 219.47/219.70  |- skos__broader mesh__D012254smesh__D012263
% 219.47/219.70  |- skos__historyNote mesh__D012254 Nucleosides %28%1966-1972%29%
% 219.47/219.70  |- mesh__dateCreated mesh__D012254 1974-11-19
% 219.47/219.70  |- skos__scopeNote mesh__D012254
% 219.47/219.70       A nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses.%A%    
% 219.47/219.70  |- skos__altLabel mesh__D012254 Ribamidyl
% 219.47/219.70  |- skos__altLabel mesh__D012254 Essex Brand of Ribavirin
% 219.47/219.70  |- skos__historyNote mesh__D012254 Triazoles %28%1966-1974%29%
% 219.47/219.70  |- skos__altLabel mesh__D012254 Ribamidil
% 219.47/219.70  |- skos__historyNote mesh__D012254 Amides %28%1966-1974%29%
% 219.47/219.70  |- skos__altLabel mesh__D012254 Pharmacia Brand of Ribavirin
% 219.47/219.70  |- mesh__dateRevised mesh__D012254 2005-06-30
% 219.47/219.70  |- skos__altLabel mesh__D012254
% 219.47/219.70       Three Rivers Pharmaceuticals Brand of Ribavirin
% 219.47/219.70  |- skos__hiddenLabel mesh__D012254 Schering Plough Brand of Ribavirin
% 219.47/219.70  |- mesh__recordOriginator mesh__D012254 NLM
% 219.47/219.70  |- mesh__onlineNote mesh__D012254
% 219.47/219.70       use RIBAVIRIN to search VIRAZOLE 1975-91   
% 219.47/219.70  |- skos__altLabel mesh__D012254 Tribavirin
% 219.47/219.70  |- mesh__recordMaintainer mesh__D012254 jmp
% 219.47/219.70  |- skos__altLabel mesh__D012254 Ribovirin
% 219.47/219.70  |- skos__altLabel mesh__D012254 Schering-Plough Brand of Ribavirin
% 219.47/219.70  |- mesh__publicMeSHNote mesh__D012254
% 219.47/219.70       91; was see under RIBONUCLEOSIDES 1978-90; was VIRAZOLE see under RIBONUCLEOSIDES 1975-77; VIRAZOLE was see RIBAVIRIN 1978-91%A%  
% 219.47/219.70  |- skos__altLabel mesh__D012254 Vilona
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D012254 2006
% 219.47/219.70  |- mesh__dateEstablished mesh__D012254 1991-01-01
% 219.47/219.70  |- skos__prefLabel mesh__D012254 Ribavirin
% 219.47/219.70  |- skos__scopeNote mesh__D006217
% 219.47/219.70       A genus of HALOBACTERIACEAE whose growth requires a high concentration of salt. Binary fission is by constriction.%A%    
% 219.47/219.70  |- skos__broader mesh__D006217smesh__D006216
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D006217 2006
% 219.47/219.70  |- mesh__recordMaintainer mesh__D006217 SYSTEM
% 219.47/219.70  |- skos__prefLabel mesh__D006217 Halobacterium
% 219.47/219.70  |- mesh__dateRevised mesh__D006217 2005-06-30
% 219.47/219.70  |- mesh__recordAuthorizer mesh__D006217 sjn
% 219.47/219.70  |- skos__annotation mesh__D006217
% 219.47/219.70       a genus of Halobacteriaceae found in salt waters %26% brines; DF: HALOBACT%A%  
% 219.47/219.70  |- rdf__type mesh__D006217sskos__Concept
% 219.47/219.70  |- mesh__dateCreated mesh__D006217 1999-01-01
% 219.47/219.70  |- mesh__recordOriginator mesh__D006217 NLM
% 219.47/219.70  |- skos__altLabel mesh__D016645 Monkey, Night
% 219.47/219.70  |- skos__broader mesh__D016645smesh__D002427
% 219.47/219.70  |- mesh__recordMaintainer mesh__D016645 ags
% 219.47/219.70  |- skos__altLabel mesh__D016645 Owl Monkey
% 219.47/219.70  |- mesh__dateCreated mesh__D016645 1991-01-24
% 219.47/219.70  |- skos__hiddenLabel mesh__D016645 Night Monkeys
% 219.47/219.70  |- rdf__type mesh__D016645sskos__Concept
% 219.47/219.70  |- mesh__dateEstablished mesh__D016645 1992-01-01
% 219.47/219.70  |- mesh__recordOriginator mesh__D016645 MXR
% 219.47/219.70  |- skos__altLabel mesh__D016645 Monkey, Owl
% 219.47/219.70  |- skos__prefLabel mesh__D016645 Aotinae
% 219.47/219.70  |- skos__scopeNote mesh__D016645
% 219.47/219.70       A subfamily of the New World monkeys, CEBIDAE, inhabiting the forests of South and Central America. The Aotinae are also referred to as night monkeys or owl monkeys. There are two species occurring in this subfamily: Aotus azarae %28%Southern night monkeys%29% and AOTUS TRIVIRGATUS %28%Northern night monkeys%29%.%A%    
% 219.47/219.70  |- skos__hiddenLabel mesh__D016645 Owl Monkeys
% 219.47/219.70  |- skos__altLabel mesh__D016645 Douroucouli
% 219.47/219.70  |- mesh__dateRevised mesh__D016645 2005-06-30
% 219.47/219.70  |- mesh__recordAuthorizer mesh__D016645 sjn
% 219.47/219.70  |- mesh__onlineNote mesh__D016645
% 219.47/219.70       use AOTINAE to search DOUROUCOULI, MONKEY, NIGHT %26% MONKEY, OWL 1981-91; use AOTUS TRIVIRGATUS to search NIGHT MONKEYS 1975-80%A%  
% 219.47/219.70  |- skos__altLabel mesh__D016645 Night Monkey
% 219.47/219.70  |- mesh__publicMeSHNote mesh__D016645
% 219.47/219.70       92; DOUROUCOULI was see AOTUS TRIVIRGATUS 1981-91; MONKEY, NIGHT was see AOTUS TRIVIRGATUS 1981-91, was NIGHT MONKEYS see under MONKEYS 1975-80; MONKEY, OWL was see AOTUS TRIVIRGATUS 1981-91%A%  
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D016645 2006
% 219.47/219.70  |- skos__hiddenLabel mesh__D016645 Monkeys, Owl
% 219.47/219.70  |- mesh__historyNote mesh__D016645
% 219.47/219.70       92; DOUROUCOULI was see AOTUS TRIVIRGATUS 1981-91; MONKEY, NIGHT was see AOTUS TRIVIRGATUS 1981-91, was NIGHT MONKEYS see under MONKEYS 1975-80; MONKEY, OWL was see AOTUS TRIVIRGATUS 1981-91%A%  
% 219.47/219.70  |- skos__hiddenLabel mesh__D016645 Monkeys, Night
% 219.47/219.70  |- skos__annotation mesh__D016645
% 219.47/219.70       New World monkeys; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 219.47/219.70  |- skos__prefLabel mesh__D002625 Chemistry, Organic
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002625 1994
% 219.47/219.70  |- mesh__recordMaintainer mesh__D002625 TAP
% 219.47/219.70  |- mesh__dateCreated mesh__D002625 1999-01-01
% 219.47/219.70  |- mesh__dateRevised mesh__D002625 1992-06-25
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002625 2005
% 219.47/219.70  |- mesh__dateEstablished mesh__D002625 1966-01-01
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002625 2001
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002625 1998
% 219.47/219.70  |- mesh__recordAuthorizer mesh__D002625 PLS
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002625 1995
% 219.47/219.70  |- mesh__recordOriginator mesh__D002625 NLM
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002625 2006
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002625 1999
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002625 2003
% 219.47/219.70  |- skos__annotation mesh__D002625
% 219.47/219.70       SPEC: TN 37; do not use as NIM coord for chemistry or chem struct of an organic chemical %28% = /chem %29%; as SPEC, qualif permitted; when not to use: Manual 29.9; DF: CHEM ORG%A%  
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002625 1996
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002625 1993
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002625 2002
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002625 2004
% 219.47/219.70  |- mesh__publicMeSHNote mesh__D002625 66   
% 219.47/219.70  |- rdf__type mesh__D002625sskos__Concept
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002625 1997
% 219.47/219.70  |- skos__broader mesh__D002625smesh__D002621
% 219.47/219.70  |- skos__altLabel mesh__D002625 Organic Chemistry
% 219.47/219.70  |- mesh__historyNote mesh__D002625 66   
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D002625 2000
% 219.47/219.70  |- skos__broader mesh__D035001smesh__D034982
% 219.47/219.70  |- skos__altLabel mesh__D035001 Host Factor Q
% 219.47/219.70  |- skos__historyNote mesh__D035001 Carrier Proteins %28%1994-2002%29%
% 219.47/219.70  |- skos__scopeNote mesh__D035001
% 219.47/219.70       An integration host factor that was originally identified as a bacterial protein required for the integration of bacteriophage Q beta %28%ALLOLEVIVIRUS%29%. Its cellular function may be to regulate mRNA stability and processing in that it binds tightly to poly%28%A%29% RNA and interferes with ribosome binding.%A%    
% 219.47/219.70  |- skos__altLabel mesh__D035001 Host Factor 1
% 219.47/219.70  |- skos__prefLabel mesh__D035001 Host Factor 1 Protein
% 219.47/219.70  |- skos__broader mesh__D035001smesh__D016601
% 219.47/219.70  |- mesh__dateCreated mesh__D035001 2002-07-03
% 219.47/219.70  |- rdf__type mesh__D035001sskos__Concept
% 219.47/219.70  |- mesh__recordAuthorizer mesh__D035001 jls
% 219.47/219.70  |- skos__altLabel mesh__D035001 hfq Gene Product
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D035001 2003
% 219.47/219.70  |- mesh__historyNote mesh__D035001
% 219.47/219.70       2003; for HFQ GENE PRODUCT %26% HOST FACTOR 1 use INTEGRATION HOST FACTORS %28%NM%29% 1994-2002%A%  
% 219.47/219.70  |- mesh__recordOriginator mesh__D035001 jmp
% 219.47/219.70  |- mesh__activeMeSHYear mesh__D035001 2005
% 219.47/219.70  |- mesh__dateEstablished mesh__D035001 2003-01-01
% 219.47/219.70  |- mesh__dateRevised mesh__D035001 2004-07-28
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D035001 2005A
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D035001 2004
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D035001 2006
% 219.56/219.70  |- mesh__recordMaintainer mesh__D035001 jls
% 219.56/219.70  |- mesh__publicMeSHNote mesh__D035001
% 219.56/219.70       2003; HFQ GENE PRODUCT %26% HOST FACTOR 1 were indexed under CARRIER PROTEINS 1994-2002%A%  
% 219.56/219.70  |- skos__broader mesh__D009206Q000276smesh__D009206
% 219.56/219.70  |- rdf__type mesh__D009206Q000276smesh__CompoundConcept
% 219.56/219.70  |- skos__prefLabel mesh__D012255 Ribitol
% 219.56/219.70  |- skos__scopeNote mesh__D012255
% 219.56/219.70       A sugar alcohol formed by the reduction of ribose.     
% 219.56/219.70  |- skos__broader mesh__D012255smesh__D013402
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D012255 2006
% 219.56/219.70  |- skos__altLabel mesh__D012255 Adonitol
% 219.56/219.70  |- mesh__recordOriginator mesh__D012255 RLS
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D012255 2005
% 219.56/219.70  |- mesh__dateEstablished mesh__D012255 1991-01-01
% 219.56/219.70  |- mesh__recordAuthorizer mesh__D012255 sjn
% 219.56/219.70  |- mesh__historyNote mesh__D012255
% 219.56/219.70       91%28%78%29%; was see under SUGAR ALCOHOLS 1978-90   
% 219.56/219.70  |- mesh__dateRevised mesh__D012255 2004-07-07
% 219.56/219.70  |- rdf__type mesh__D012255sskos__Concept
% 219.56/219.70  |- mesh__publicMeSHNote mesh__D012255
% 219.56/219.70       91; was see under SUGAR ALCOHOLS 1978-90   
% 219.56/219.70  |- skos__historyNote mesh__D012255 Sugar Alcohols %28%1972-1977%29%
% 219.56/219.70  |- mesh__recordMaintainer mesh__D012255 ssb
% 219.56/219.70  |- mesh__dateCreated mesh__D012255 1977-04-15
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D006218 2001
% 219.56/219.70  |- skos__historyNote mesh__D006218 Antilipemic Agents %28%1966-1972%29%
% 219.56/219.70  |- skos__scopeNote mesh__D006218
% 219.56/219.70       An antihyperlipoproteinemic agent and uricosuric agent.%A%    
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D006218 2002
% 219.56/219.70  |- rdf__type mesh__D006218sskos__Concept
% 219.56/219.70  |- skos__hiddenLabel mesh__D006218 MK 185
% 219.56/219.70  |- mesh__dateCreated mesh__D006218 1999-01-01
% 219.56/219.70  |- skos__hiddenLabel mesh__D006218 MK185
% 219.56/219.70  |- mesh__recordOriginator mesh__D006218 NLM
% 219.56/219.70  |- skos__historyNote mesh__D006218 Glycolates %28%1966-1972%29%
% 219.56/219.70  |- mesh__dateEstablished mesh__D006218 1991-01-01
% 219.56/219.70  |- mesh__dateRevised mesh__D006218 2000-06-22
% 219.56/219.70  |- skos__historyNote mesh__D006218
% 219.56/219.70       Anticholesteremic Agents %28%1966-1972%29%
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D006218 2005
% 219.56/219.70  |- mesh__publicMeSHNote mesh__D006218
% 219.56/219.70       91; was see under GLYCOLATES 1973-90   
% 219.56/219.70  |- mesh__historyNote mesh__D006218
% 219.56/219.70       91%28%73%29%; was see under GLYCOLATES 1973-90   
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D006218 2006
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D006218 2003
% 219.56/219.70  |- skos__broader mesh__D006218smesh__D006016
% 219.56/219.70  |- skos__prefLabel mesh__D006218 Halofenate
% 219.56/219.70  |- mesh__recordAuthorizer mesh__D006218 sjn
% 219.56/219.70  |- mesh__recordMaintainer mesh__D006218 CCR
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D006218 2004
% 219.56/219.70  |- rdf__type mesh__D016646sskos__Concept
% 219.56/219.70  |- skos__annotation mesh__D016646
% 219.56/219.70       New World monkeys; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 219.56/219.70  |- mesh__historyNote mesh__D016646 92   
% 219.56/219.70  |- mesh__publicMeSHNote mesh__D016646 92   
% 219.56/219.70  |- skos__broader mesh__D016646smesh__D002427
% 219.56/219.70  |- mesh__recordOriginator mesh__D016646 MXR
% 219.56/219.70  |- skos__prefLabel mesh__D016646 Cebinae
% 219.56/219.70  |- mesh__dateEstablished mesh__D016646 1992-01-01
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D016646 2006
% 219.56/219.70  |- skos__scopeNote mesh__D016646
% 219.56/219.70       A subfamily of New World monkeys in the family CEBIDAE. They inhabit the forests of South and Central America and comprise members of the genus CEBUS.%A%    
% 219.56/219.70  |- mesh__dateRevised mesh__D016646 2005-06-30
% 219.56/219.70  |- mesh__recordMaintainer mesh__D016646 ags
% 219.56/219.70  |- mesh__dateCreated mesh__D016646 1991-01-24
% 219.56/219.70  |- mesh__recordAuthorizer mesh__D016646 sjn
% 219.56/219.70  |- skos__annotation mesh__D002626
% 219.56/219.70       SPEC qualif; as NIM coord, no qualif; Manual 29.7; do not confuse X ref DRUG FORMULATION with DRUG COMPOUNDING; DF: CHEM PHARM%A%  
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D002626 2006
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D002626 2000
% 219.56/219.70  |- skos__hiddenLabel mesh__D002626 Drug Formulations
% 219.56/219.70  |- skos__prefLabel mesh__D002626 Chemistry, Pharmaceutical
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D002626 1999
% 219.56/219.70  |- skos__related mesh__D002626smesh__D004339
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D002626 2003
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D002626 2001
% 219.56/219.70  |- mesh__recordAuthorizer mesh__D002626 SJN
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D002626 2004
% 219.56/219.70  |- rdf__type mesh__D002626sskos__Concept
% 219.56/219.70  |- skos__altLabel mesh__D002626 Pharmaceutical Chemistry
% 219.56/219.70  |- mesh__recordOriginator mesh__D002626 NLM
% 219.56/219.70  |- skos__altLabel mesh__D002626 Pharmaceutic Chemistry
% 219.56/219.70  |- skos__altLabel mesh__D002626 Chemistry, Pharmaceutic
% 219.56/219.70  |- skos__broader mesh__D002626smesh__D002621
% 219.56/219.70  |- skos__hiddenLabel mesh__D002626 Formulations, Drug
% 219.56/219.70  |- skos__scopeNote mesh__D002626
% 219.56/219.70       Chemistry that deals with the composition and preparation of substances used in treatment of patients or diagnostic studies. %28%Dorland, 27th ed%29%%A%    
% 219.56/219.70  |- mesh__dateRevised mesh__D002626 1997-06-20
% 219.56/219.70  |- skos__hiddenLabel mesh__D002626 Formulation, Drug
% 219.56/219.70  |- skos__related mesh__D002626smesh__D001702
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D002626 2002
% 219.56/219.70  |- mesh__dateCreated mesh__D002626 1999-01-01
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D002626 2005
% 219.56/219.70  |- mesh__recordMaintainer mesh__D002626 TGC
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D002626 1998
% 219.56/219.70  |- skos__prefLabel mesh__D035002 Lower Extremity
% 219.56/219.70  |- skos__scopeNote mesh__D035002
% 219.56/219.70       The region of the lower limb in animals, extending from the gluteal region to the FOOT, and including the BUTTOCKS; HIP; and LEG.%A%    
% 219.56/219.70  |- skos__annotation mesh__D035002
% 219.56/219.70       prefer specifics; Manual 21.58: table of human, primate %26% non-primate extremities%A%  
% 219.56/219.70  |- rdf__type mesh__D035002sskos__Concept
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D035002 2003
% 219.56/219.70  |- skos__broader mesh__D035002smesh__D005121
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D035002 2005
% 219.56/219.70  |- skos__hiddenLabel mesh__D035002 Extremities, Lower
% 219.56/219.70  |- skos__hiddenLabel mesh__D035002 Lower Limbs
% 219.56/219.70  |- skos__altLabel mesh__D035002 Membrum inferius
% 219.56/219.70  |- skos__altLabel mesh__D035002 Lower Limb
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D035002 2004
% 219.56/219.70  |- mesh__dateCreated mesh__D035002 2002-07-03
% 219.56/219.70  |- skos__hiddenLabel mesh__D035002 Limbs, Lower
% 219.56/219.70  |- mesh__activeMeSHYear mesh__D035002 2006
% 219.56/219.70  |- skos__hiddenLabel mesh__D035002 Lower Extremities
% 219.56/219.70  |- mesh__publicMeSHNote mesh__D035002 2003; see LEG 1987-2002   
% 219.56/219.70  |- skos__historyNote mesh__D035002 Leg %28%1964-2002%29%
% 219.56/219.70  |- skos__altLabel mesh__D035002 Extremity, Lower
% 219.56/219.70  |- skos__hiddenLabel mesh__D035002 Limb, Lower
% 219.56/219.70  |- mesh__dateEstablished mesh__D035002 2003-01-01
% 219.56/219.70  |- mesh__historyNote mesh__D035002 2003; use LEG 1987-2002   
% 219.56/219.70  |- skos__historyNote mesh__D048728
% 219.56/219.70       Protein-Serine-Threonine Kinases %28%1994-2004%29%
% 219.56/219.70  |- skos__hiddenLabel mesh__D048728 Protein Kinase, MEKK-1
% 219.56/219.70  |- mesh__dateCreated mesh__D048728 2004-07-07
% 219.56/219.70  |- skos__hiddenLabel mesh__D048728 MEKK 1 Protein Kinase
% 219.56/219.70  |- skos__altLabel mesh__D048728 MEKK-1 Protein Kinase
% 219.56/219.70  |- skos__altLabel mesh__D048728 MAP3K1 Protein
% 219.56/219.71  |- mesh__recordOriginator mesh__D048728 jmp
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D048728 2005
% 219.56/219.71  |- rdf__type mesh__D048728sskos__Concept
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D048728 2006
% 219.56/219.71  |- skos__scopeNote mesh__D048728
% 219.56/219.71       A 195-kDa MAP kinase kinase kinase with broad specificity for MAP KINASE KINASES. It is found localized in the CYTOSKELETON and can activate a variety of MAP kinase-dependent pathways.%A%    
% 219.56/219.71  |- skos__hiddenLabel mesh__D048728
% 219.56/219.71       Mitogen Activated Protein Kinase Kinase Kinase 1
% 219.56/219.71  |- skos__altLabel mesh__D048728 MEKK1 Protein Kinase
% 219.56/219.71  |- skos__altLabel mesh__D048728 MEK Kinase 1
% 219.56/219.71  |- skos__altLabel mesh__D048728
% 219.56/219.71       Mitogen-Activated Protein Kinase Kinase Kinase 1
% 219.56/219.71  |- mesh__historyNote mesh__D048728 2005%28%1994%29%   
% 219.56/219.71  |- mesh__recordAuthorizer mesh__D048728 sjn
% 219.56/219.71  |- skos__prefLabel mesh__D048728 MAP Kinase Kinase Kinase 1
% 219.56/219.71  |- mesh__dateEstablished mesh__D048728 2005-01-01
% 219.56/219.71  |- skos__historyNote mesh__D048728
% 219.56/219.71       Mitogen-Activated Protein Kinase Kinase Kinases %28%2004%29%
% 219.56/219.71  |- mesh__publicMeSHNote mesh__D048728
% 219.56/219.71       2005; MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 1 was indexed under MAP KINASE KINASE KINASES 2004 %26% under PROTEIN-SERINE-THREONINE KINASES 1994-2004%A%  
% 219.56/219.71  |- skos__altLabel mesh__D048728 MAP ERK Kinase Kinase 1
% 219.56/219.71  |- skos__altLabel mesh__D048728 MEKK1 Protein
% 219.56/219.71  |- mesh__recordMaintainer mesh__D048728 jmp
% 219.56/219.71  |- skos__broader mesh__D048728smesh__D020930
% 219.56/219.71  |- skos__altLabel mesh__D012256 Vitamin B 2
% 219.56/219.71  |- mesh__dateRevised mesh__D012256 2005-06-30
% 219.56/219.71  |- skos__broader mesh__D012256smesh__D005415
% 219.56/219.71  |- rdf__type mesh__D012256sskos__Concept
% 219.56/219.71  |- mesh__recordOriginator mesh__D012256 NLM
% 219.56/219.71  |- skos__altLabel mesh__D012256 Vitamin G
% 219.56/219.71  |- skos__prefLabel mesh__D012256 Riboflavin
% 219.56/219.71  |- mesh__recordAuthorizer mesh__D012256 sjn
% 219.56/219.71  |- mesh__dateCreated mesh__D012256 1999-01-01
% 219.56/219.71  |- mesh__recordMaintainer mesh__D012256 ssb
% 219.56/219.71  |- skos__scopeNote mesh__D012256
% 219.56/219.71       Nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables. The richest natural source is yeast. It occurs in the free form only in the retina of the eye, in whey, and in urine; its principal forms in tissues and cells are as FLAVIN MONONUCLEOTIDE and FLAVIN-ADENINE DINUCLEOTIDE.%A%    
% 219.56/219.71  |- skos__altLabel mesh__D012256 Vitamin B2
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D012256 2006
% 219.56/219.71  |- skos__prefLabel mesh__D031410 Fritillaria
% 219.56/219.71  |- skos__scopeNote mesh__D031410
% 219.56/219.71       A plant genus of the family LILIACEAE. Members of this genus produce imperialine, a steroidal alkaloid which acts at muscarinic receptors.%A%    
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D031410 2005
% 219.56/219.71  |- skos__altLabel mesh__D031410 Fritillary
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D031410 2003
% 219.56/219.71  |- skos__annotation mesh__D031410
% 219.56/219.71       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D031410 2006
% 219.56/219.71  |- mesh__publicMeSHNote mesh__D031410 2003   
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D031410 2004
% 219.56/219.71  |- mesh__dateEstablished mesh__D031410 2003-01-01
% 219.56/219.71  |- skos__broader mesh__D031410smesh__D019668
% 219.56/219.71  |- mesh__historyNote mesh__D031410 2003   
% 219.56/219.71  |- mesh__dateCreated mesh__D031410 2002-07-03
% 219.56/219.71  |- rdf__type mesh__D031410sskos__Concept
% 219.56/219.71  |- skos__altLabel mesh__D006219 Group 17 Elements
% 219.56/219.71  |- rdf__type mesh__D006219sskos__Concept
% 219.56/219.71  |- mesh__dateCreated mesh__D006219 1999-01-01
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D006219 2002
% 219.56/219.71  |- mesh__recordOriginator mesh__D006219 NLM
% 219.56/219.71  |- skos__scopeNote mesh__D006219
% 219.56/219.71       A family of nonmetallic, generally electronegative, elements that form group 17 %28%formerly group VIIa%29% of the periodic table.%A%    
% 219.56/219.71  |- skos__hiddenLabel mesh__D006219 Elements, Group 17
% 219.56/219.71  |- skos__broader mesh__D006219smesh__D004602
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D006219 2005
% 219.56/219.71  |- mesh__recordAuthorizer mesh__D006219 sjn
% 219.56/219.71  |- mesh__recordMaintainer mesh__D006219 jmp
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D006219 2003
% 219.56/219.71  |- skos__prefLabel mesh__D006219 Halogens
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D006219 2006
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D006219 2004
% 219.56/219.71  |- mesh__dateRevised mesh__D006219 2001-07-25
% 219.56/219.71  |- mesh__dateCreated mesh__D016647 1991-01-24
% 219.56/219.71  |- rdf__type mesh__D016647sskos__Concept
% 219.56/219.71  |- skos__hiddenLabel mesh__D016647 Marmosets, Goeldis
% 219.56/219.71  |- skos__scopeNote mesh__D016647
% 219.56/219.71       A genus in the family CALLITRICHIDAE, comprising a single species with the common name Goeldi%27%s monkey.%A%    
% 219.56/219.71  |- mesh__recordOriginator mesh__D016647 MXR
% 219.56/219.71  |- mesh__publicMeSHNote mesh__D016647
% 219.56/219.71       2006;  see CALLIMICONINAE 1992-2005, see CALLITHRICIDAE 1981-1991, see MONKEYS 1975-1980%A%  
% 219.56/219.71  |- skos__altLabel mesh__D016647 Marmosets, Goeldi%27%s
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D016647 2006A
% 219.56/219.71  |- skos__hiddenLabel mesh__D016647 Monkey, Goeldi%27%s
% 219.56/219.71  |- skos__hiddenLabel mesh__D016647 Goeldis Monkey
% 219.56/219.71  |- skos__prefLabel mesh__D016647 Callimico
% 219.56/219.71  |- skos__annotation mesh__D016647
% 219.56/219.71       diseases: coordinate IM with MONKEY DISEASES %28%IM%29%   
% 219.56/219.71  |- mesh__dateEstablished mesh__D016647 1992-01-01
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D016647 2006
% 219.56/219.71  |- mesh__recordAuthorizer mesh__D016647 ags
% 219.56/219.71  |- skos__hiddenLabel mesh__D016647 Marmosets, Goeldi
% 219.56/219.71  |- skos__hiddenLabel mesh__D016647 Goeldi Monkey
% 219.56/219.71  |- mesh__dateRevised mesh__D016647 2005-07-11
% 219.56/219.71  |- mesh__recordMaintainer mesh__D016647 ags
% 219.56/219.71  |- mesh__historyNote mesh__D016647
% 219.56/219.71       2006 %28%1975%29%;  see CALLITHRICIDAE 1981-1991   
% 219.56/219.71  |- skos__broader mesh__D016647smesh__D002143
% 219.56/219.71  |- skos__hiddenLabel mesh__D016647 Callimicos
% 219.56/219.71  |- skos__hiddenLabel mesh__D016647 Goeldi%27%s Marmosets
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D035801 2005
% 219.56/219.71  |- skos__prefLabel mesh__D035801 Amomum
% 219.56/219.71  |- mesh__historyNote mesh__D035801 2003   
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D035801 2003
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D035801 2006
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D035801 2004
% 219.56/219.71  |- mesh__dateEstablished mesh__D035801 2003-01-01
% 219.56/219.71  |- skos__broader mesh__D035801smesh__D030521
% 219.56/219.71  |- skos__annotation mesh__D035801
% 219.56/219.71       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.56/219.71  |- mesh__publicMeSHNote mesh__D035801 2003   
% 219.56/219.71  |- rdf__type mesh__D035801sskos__Concept
% 219.56/219.71  |- skos__scopeNote mesh__D035801
% 219.56/219.71       A plant genus of the family ZINGIBERACEAE. Members contain aculeatin D, beta-sitosterol, and STIGMASTEROL. Some members have been reclassified to ELETTARIA and other ZINGIBERACEAE.%A%    
% 219.56/219.71  |- mesh__dateCreated mesh__D035801 2002-07-02
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D002627 2004
% 219.56/219.71  |- mesh__dateEstablished mesh__D002627 1965-01-01
% 219.56/219.71  |- rdf__type mesh__D002627sskos__Concept
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D002627 1997
% 219.56/219.71  |- skos__annotation mesh__D002627
% 219.56/219.71       SPEC: SPEC qualif; as NIM coord, no qualif; Manual 29.7   
% 219.56/219.71  |- mesh__dateRevised mesh__D002627 1992-05-07
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D002627 2002
% 219.56/219.71  |- skos__broader mesh__D002627smesh__D002621
% 219.56/219.71  |- mesh__publicMeSHNote mesh__D002627 65   
% 219.56/219.71  |- skos__prefLabel mesh__D002627 Chemistry, Physical
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D002627 1994
% 219.56/219.71  |- mesh__dateCreated mesh__D002627 1999-01-01
% 219.56/219.71  |- skos__altLabel mesh__D002627 Physical Chemistry
% 219.56/219.71  |- mesh__historyNote mesh__D002627 65   
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D002627 2000
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D002627 2005
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D002627 1998
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D002627 1995
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D002627 2006
% 219.56/219.71  |- mesh__recordMaintainer mesh__D002627 TAP
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D002627 2001
% 219.56/219.71  |- mesh__recordAuthorizer mesh__D002627 PLS
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D002627 1999
% 219.56/219.71  |- skos__hiddenLabel mesh__D002627 Physical Chemistries
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D002627 2003
% 219.56/219.71  |- mesh__recordOriginator mesh__D002627 NLM
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D002627 1996
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D002627 1993
% 219.56/219.71  |- skos__hiddenLabel mesh__D002627 Chemistries, Physical
% 219.56/219.71  |- skos__hiddenLabel mesh__D007312 Small Madagascar Hedgehogs
% 219.56/219.71  |- skos__broader mesh__D007312smesh__D008322
% 219.56/219.71  |- skos__annotation mesh__D007312
% 219.56/219.71       do not confuse with ANTEATERS see XENARTHRA   
% 219.56/219.71  |- mesh__recordAuthorizer mesh__D007312 sjn
% 219.56/219.71  |- skos__hiddenLabel mesh__D007312 Tenrecs, Lesser Hedgehog
% 219.56/219.71  |- skos__altLabel mesh__D007312 Lesser Hedgehog Tenrec
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D007312 2004
% 219.56/219.71  |- rdf__type mesh__D007312sskos__Concept
% 219.56/219.71  |- skos__hiddenLabel mesh__D007312 Madagascar Hedgehogs, Small
% 219.56/219.71  |- skos__hiddenLabel mesh__D007312 Lesser Hedgehog Tenrecs
% 219.56/219.71  |- skos__prefLabel mesh__D007312 Insectivora
% 219.56/219.71  |- skos__hiddenLabel mesh__D007312 Hedgehog, Small Madagascar
% 219.56/219.71  |- mesh__recordOriginator mesh__D007312 NLM
% 219.56/219.71  |- skos__scopeNote mesh__D007312
% 219.56/219.71       An order of insect eating MAMMALS including MOLES; SHREWS; HEDGEHOGS and tenrecs.%A%    
% 219.56/219.71  |- skos__hiddenLabel mesh__D007312 Madagascar Hedgehog, Small
% 219.56/219.71  |- skos__hiddenLabel mesh__D007312 Hedgehog Tenrecs, Lesser
% 219.56/219.71  |- skos__altLabel mesh__D007312 Small Madagascar Hedgehog
% 219.56/219.71  |- mesh__dateCreated mesh__D007312 1999-01-01
% 219.56/219.71  |- mesh__recordMaintainer mesh__D007312 ags
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D007312 2005
% 219.56/219.71  |- skos__hiddenLabel mesh__D007312 Hedgehogs, Small Madagascar
% 219.56/219.71  |- mesh__dateRevised mesh__D007312 2003-07-09
% 219.56/219.71  |- skos__hiddenLabel mesh__D007312 Tenrec, Lesser Hedgehog
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D007312 2006
% 219.56/219.71  |- skos__hiddenLabel mesh__D007312 Hedgehog Tenrec, Lesser
% 219.56/219.71  |- skos__scopeNote mesh__D048729
% 219.56/219.71       A group of 6-alkyl SALICYLIC ACIDS that are found in ANACARDIUM and known for causing CONTACT DERMATITIS.%A%    
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D048729 2005
% 219.56/219.71  |- rdf__type mesh__D048729sskos__Concept
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D048729 2006
% 219.56/219.71  |- mesh__recordOriginator mesh__D048729 ssb
% 219.56/219.71  |- mesh__historyNote mesh__D048729 2005   
% 219.56/219.71  |- skos__broader mesh__D048729smesh__D012461
% 219.56/219.71  |- skos__prefLabel mesh__D048729 Anacardic Acids
% 219.56/219.71  |- skos__altLabel mesh__D048729 Salicylic Acids, 6-Alkyl
% 219.56/219.71  |- skos__hiddenLabel mesh__D048729 Salicylic Acids, 6 Alkyl
% 219.56/219.71  |- mesh__publicMeSHNote mesh__D048729 2005   
% 219.56/219.71  |- skos__hiddenLabel mesh__D048729 Acids, Anacardic
% 219.56/219.71  |- mesh__recordAuthorizer mesh__D048729 sjn
% 219.56/219.71  |- mesh__dateEstablished mesh__D048729 2005-01-01
% 219.56/219.71  |- mesh__dateCreated mesh__D048729 2004-07-07
% 219.56/219.71  |- mesh__recordMaintainer mesh__D048729 ssb
% 219.56/219.71  |- skos__historyNote mesh__D048729 Salicylic Acids %28%1990-2004%29%
% 219.56/219.71  |- mesh__recordAuthorizer mesh__D012257 sjn
% 219.56/219.71  |- skos__hiddenLabel mesh__D012257 Riboflavin Deficiencies
% 219.56/219.71  |- skos__broader mesh__D012257smesh__D014804
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D012257 2004
% 219.56/219.71  |- mesh__recordMaintainer mesh__D012257 lkt
% 219.56/219.71  |- mesh__dateCreated mesh__D012257 1999-01-01
% 219.56/219.71  |- mesh__dateRevised mesh__D012257 2003-07-09
% 219.56/219.71  |- skos__annotation mesh__D012257 a vitamin B defic   
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D012257 2006
% 219.56/219.71  |- skos__scopeNote mesh__D012257
% 219.56/219.71       A dietary deficiency of riboflavin causing a syndrome chiefly marked by cheilitis, angular stomatitis, glossitis associated with a purplish red or magenta-colored tongue that may show fissures, corneal vascularization, dyssebacia, and anemia. %28%Dorland, 27th ed%29%%A%    
% 219.56/219.71  |- mesh__recordOriginator mesh__D012257 NLM
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D012257 2005
% 219.56/219.71  |- rdf__type mesh__D012257sskos__Concept
% 219.56/219.71  |- skos__altLabel mesh__D012257 Deficiency, Riboflavin
% 219.56/219.71  |- skos__prefLabel mesh__D012257 Riboflavin Deficiency
% 219.56/219.71  |- skos__hiddenLabel mesh__D012257 Deficiencies, Riboflavin
% 219.56/219.71  |- skos__prefLabel mesh__D003720 Densitometry
% 219.56/219.71  |- mesh__recordMaintainer mesh__D003720 lkt
% 219.56/219.71  |- skos__hiddenLabel mesh__D003720 Densitometries
% 219.56/219.71  |- rdf__type mesh__D003720sskos__Concept
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D003720 2003
% 219.56/219.71  |- mesh__dateCreated mesh__D003720 1999-01-01
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D003720 2004
% 219.56/219.71  |- mesh__recordOriginator mesh__D003720 NLM
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D003720 2005
% 219.56/219.71  |- mesh__dateRevised mesh__D003720 2002-07-03
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D003720 2006
% 219.56/219.71  |- mesh__dateEstablished mesh__D003720 1967-01-01
% 219.56/219.71  |- skos__broader mesh__D003720smesh__D010783
% 219.56/219.71  |- mesh__historyNote mesh__D003720 67%28%64%29%   
% 219.56/219.71  |- skos__annotation mesh__D003720
% 219.56/219.71       NIM; tomodensitometry seen in foreign lit is probably TOMOGRAPHY, X-RAY COMPUTED %26% if so use %22%x-ray computed tomography%22% in translations %26% not %22%tomodensitometry%22%%A%  
% 219.56/219.71  |- mesh__publicMeSHNote mesh__D003720 67   
% 219.56/219.71  |- mesh__recordAuthorizer mesh__D003720 sjn
% 219.56/219.71  |- skos__broader mesh__D050376smesh__D016025
% 219.56/219.71  |- skos__historyNote mesh__D050376
% 219.56/219.71       Tendons, Para-Articular %28%1991-2005%29%
% 219.56/219.71  |- skos__hiddenLabel mesh__D050376 Grafts, Bone-Patellar Tendon-Bone
% 219.56/219.71  |- mesh__dateCreated mesh__D050376 2005-06-30
% 219.56/219.71  |- mesh__historyNote mesh__D050376 2006   
% 219.56/219.71  |- skos__hiddenLabel mesh__D050376 Bone-Patellar Tendon-Bone Grafts
% 219.56/219.71  |- skos__scopeNote mesh__D050376
% 219.56/219.71       Fixation of the ANTERIOR CRUCIATE LIGAMENT, during surgical reconstruction, by the use of a bone- patellar tendon autograft.%A%    
% 219.56/219.71  |- mesh__recordMaintainer mesh__D050376 ags
% 219.56/219.71  |- mesh__recordAuthorizer mesh__D050376 sjn
% 219.56/219.71  |- mesh__recordOriginator mesh__D050376 ags
% 219.56/219.71  |- mesh__dateEstablished mesh__D050376 2006-01-01
% 219.56/219.71  |- skos__hiddenLabel mesh__D050376 Bone Patellar Tendon Bone Graft
% 219.56/219.71  |- skos__prefLabel mesh__D050376 Bone-Patellar Tendon-Bone Graft
% 219.56/219.71  |- skos__hiddenLabel mesh__D050376 Graft, Bone-Patellar Tendon-Bone
% 219.56/219.71  |- mesh__publicMeSHNote mesh__D050376 2006   
% 219.56/219.71  |- rdf__type mesh__D050376sskos__Concept
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D050376 2006
% 219.56/219.71  |- skos__historyNote mesh__D050376 Bone Transplantation %28%1991-2005%29%
% 219.56/219.71  |- mesh__recordOriginator mesh__D016648 MXR
% 219.56/219.71  |- mesh__recordAuthorizer mesh__D016648 sjn
% 219.56/219.71  |- mesh__dateCreated mesh__D016648 1991-01-25
% 219.56/219.71  |- rdf__type mesh__D016648sskos__Concept
% 219.56/219.71  |- mesh__dateRevised mesh__D016648 2005-06-30
% 219.56/219.71  |- skos__broader mesh__D016648smesh__D002427
% 219.56/219.71  |- mesh__historyNote mesh__D016648 92   
% 219.56/219.71  |- mesh__publicMeSHNote mesh__D016648 92   
% 219.56/219.71  |- skos__annotation mesh__D016648
% 219.56/219.71       New World monkeys; IM; qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 219.56/219.71  |- mesh__dateEstablished mesh__D016648 1992-01-01
% 219.56/219.71  |- skos__scopeNote mesh__D016648
% 219.56/219.71       A subfamily of CEBIDAE inhabiting the forests of Central and South America. This subfamily of New World monkeys consists of one genus, the SAIMIRI or squirrel monkeys.%A%    
% 219.56/219.71  |- skos__prefLabel mesh__D016648 Saimirinae
% 219.56/219.71  |- mesh__recordMaintainer mesh__D016648 ags
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D016648 2006
% 219.56/219.71  |- skos__historyNote mesh__D041041 Citrobacter %28%1973-2002%29%
% 219.56/219.71  |- skos__scopeNote mesh__D041041
% 219.56/219.71       A species of gram-negative enterobacteria found in WATER; SEWAGE; SOIL; and FOOD. It can be present in any clinical specimen as an opportunistic pathogen.%A%    
% 219.56/219.71  |- mesh__dateEstablished mesh__D041041 2003-01-01
% 219.56/219.71  |- rdf__type mesh__D041041sskos__Concept
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D041041 2006
% 219.56/219.71  |- mesh__historyNote mesh__D041041 2003   
% 219.56/219.71  |- skos__broader mesh__D041041smesh__D002954
% 219.56/219.71  |- mesh__dateCreated mesh__D041041 2002-07-03
% 219.56/219.71  |- skos__annotation mesh__D041041
% 219.56/219.71       infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 219.56/219.71  |- mesh__recordOriginator mesh__D041041 ags
% 219.56/219.71  |- skos__prefLabel mesh__D041041 Citrobacter koseri
% 219.56/219.71  |- mesh__publicMeSHNote mesh__D041041 2003   
% 219.56/219.71  |- mesh__recordAuthorizer mesh__D041041 sjn
% 219.56/219.71  |- mesh__recordMaintainer mesh__D041041 SYSTEM
% 219.56/219.71  |- mesh__dateRevised mesh__D041041 2005-06-30
% 219.56/219.71  |- skos__altLabel mesh__D041041 Citrobacter diversus
% 219.56/219.71  |- mesh__recordAuthorizer mesh__D002628 sjn
% 219.56/219.71  |- skos__annotation mesh__D002628
% 219.56/219.71       note category; do not confuse with RECEPTORS, DRUG; DF: CHEMORECEPT%A%  
% 219.56/219.71  |- mesh__recordOriginator mesh__D002628 NLM
% 219.56/219.71  |- mesh__onlineNote mesh__D002628 search RECEPTORS, SENSORY 1966-67   
% 219.56/219.71  |- mesh__dateRevised mesh__D002628 2003-07-09
% 219.56/219.71  |- mesh__dateCreated mesh__D002628 1999-01-01
% 219.56/219.71  |- skos__prefLabel mesh__D002628 Chemoreceptors
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D002628 2005
% 219.56/219.71  |- mesh__recordMaintainer mesh__D002628 jmp
% 219.56/219.71  |- mesh__historyNote mesh__D002628
% 219.56/219.71       68; was see under RECEPTORS, NEURAL 1963-67   
% 219.56/219.71  |- skos__hiddenLabel mesh__D002628 Chemoreceptor
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D002628 2006
% 219.56/219.71  |- skos__scopeNote mesh__D002628
% 219.56/219.71       Cells specialized to detect chemical substances and relay that information centrally in the nervous system. Chemoreceptors may monitor external stimuli, as in TASTE and OLFACTION, or internal stimuli, such as the concentrations of OXYGEN and CARBON DIOXIDE in the blood.%A%    
% 219.56/219.71  |- skos__broader mesh__D002628smesh__D011984
% 219.56/219.71  |- mesh__publicMeSHNote mesh__D002628
% 219.56/219.71       68; was see under RECEPTORS, NEURAL 1963-67   
% 219.56/219.71  |- mesh__dateEstablished mesh__D002628 1968-01-01
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D002628 2004
% 219.56/219.71  |- skos__historyNote mesh__D002628 Receptors, Sensory %28%1966-1967%29%
% 219.56/219.71  |- rdf__type mesh__D002628sskos__Concept
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D013350 1993
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D013350 2000
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D013350 1995
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D013350 2006
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D013350 1998
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D013350 2003
% 219.56/219.71  |- skos__prefLabel mesh__D013350 Subclavian Vein
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D013350 1994
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D013350 2005
% 219.56/219.71  |- mesh__dateCreated mesh__D013350 1999-01-01
% 219.56/219.71  |- skos__hiddenLabel mesh__D013350 Vein, Subclavian
% 219.56/219.71  |- skos__hiddenLabel mesh__D013350 Subclavian Veins
% 219.56/219.71  |- mesh__recordAuthorizer mesh__D013350 PLS
% 219.56/219.71  |- skos__scopeNote mesh__D013350
% 219.56/219.71       The continuation of the axillary vein which follows the subclavian artery and then joins the internal jugular vein to form the brachiocephalic vein.%A%    
% 219.56/219.71  |- mesh__recordMaintainer mesh__D013350 TAP
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D013350 2002
% 219.56/219.71  |- mesh__dateRevised mesh__D013350 1992-05-18
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D013350 2001
% 219.56/219.71  |- mesh__recordOriginator mesh__D013350 NLM
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D013350 1997
% 219.56/219.71  |- skos__broader mesh__D013350smesh__D014680
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D013350 1999
% 219.56/219.71  |- rdf__type mesh__D013350sskos__Concept
% 219.56/219.71  |- skos__hiddenLabel mesh__D013350 Veins, Subclavian
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D013350 2004
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D013350 1996
% 219.56/219.71  |- mesh__recordOriginator mesh__D007313 NLM
% 219.56/219.71  |- mesh__dateCreated mesh__D007313 1999-01-01
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D007313 2006
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D007313 2006A
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D007313 2005
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D007313 2004
% 219.56/219.71  |- skos__annotation mesh__D007313
% 219.56/219.71       GEN: prefer specifics; /microbiol /parasitol /virol permitted; /drug eff: TN 111%A%  
% 219.56/219.71  |- skos__prefLabel mesh__D007313 Insects
% 219.56/219.71  |- skos__broader mesh__D007313smesh__D001181
% 219.56/219.71  |- rdf__type mesh__D007313sskos__Concept
% 219.56/219.71  |- mesh__recordAuthorizer mesh__D007313 ags
% 219.56/219.71  |- mesh__recordMaintainer mesh__D007313 ags
% 219.56/219.71  |- skos__scopeNote mesh__D007313
% 219.56/219.71       Insects are a class, Insecta, of Arthropoda whose members are characterized by division into three parts: head, thorax, and abdomen. They are the dominant group of animals on earth, several hundred thousand different kinds having been described. They have lived on earth for about 350 million years, as compared with less than 2 million for man. While insects are often commercially valuable and useful as scavengers, many species are harmful, causing enormous losses in agriculture and storage. Three orders, HEMIPTERA; DIPTERA; and Siphonaptera; are of medical interest in that they cause disease in man and animal. %28%From Dorland, 27th ed; Borror et al., An Introduction to the Study of Insects, 4th ed, p1%29%%A%    
% 219.56/219.71  |- mesh__dateRevised mesh__D007313 2005-07-15
% 219.56/219.71  |- mesh__recordMaintainer mesh__D012258 ssb
% 219.56/219.71  |- skos__broader mesh__D012258smesh__D019883
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D012258 2004
% 219.56/219.71  |- skos__hiddenLabel mesh__D012258 Synthase, Riboflavin
% 219.56/219.71  |- skos__prefLabel mesh__D012258 Riboflavin Synthase
% 219.56/219.71  |- skos__historyNote mesh__D012258 Transferases %28%1973-1974%29%
% 219.56/219.71  |- skos__scopeNote mesh__D012258
% 219.56/219.71       An enzyme that catalyzes the formation of riboflavin from two molecules of 6,7-dimethyl-8-ribityllumazine, utilizing a four-carbon fragment from one molecule which is transferred to the second molecule. EC 2.5.1.9.%A%    
% 219.56/219.71  |- mesh__recordOriginator mesh__D012258 NLM
% 219.56/219.71  |- mesh__dateRevised mesh__D012258 2003-07-09
% 219.56/219.71  |- mesh__dateCreated mesh__D012258 1974-11-19
% 219.56/219.71  |- skos__historyNote mesh__D012258 Pteridines %28%1973-1974%29%
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D012258 2006
% 219.56/219.71  |- rdf__type mesh__D012258sskos__Concept
% 219.56/219.71  |- mesh__dateEstablished mesh__D012258 1991-01-01
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D012258 2005
% 219.56/219.71  |- mesh__recordAuthorizer mesh__D012258 sjn
% 219.56/219.71  |- mesh__historyNote mesh__D012258
% 219.56/219.71       91%28%75%29%; was see under TRANSFERASES 1975-90   
% 219.56/219.71  |- mesh__publicMeSHNote mesh__D012258
% 219.56/219.71       91; was see under TRANSFERASES 1975-90   
% 219.56/219.71  |- mesh__publicMeSHNote mesh__D017741 94   
% 219.56/219.71  |- skos__prefLabel mesh__D017741 Survivors
% 219.56/219.71  |- skos__scopeNote mesh__D017741
% 219.56/219.71       Persons who have experienced a prolonged survival after serious disease or who continue to live with a usually life-threatening condition as well as family members, significant others, or individuals surviving traumatic life events.%A%    
% 219.56/219.71  |- skos__broader mesh__D017741smesh__D010361
% 219.56/219.71  |- mesh__recordMaintainer mesh__D017741 JLS
% 219.56/219.71  |- skos__broader mesh__D017741smesh__D009272
% 219.56/219.71  |- mesh__historyNote mesh__D017741 94   
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D017741 2002
% 219.56/219.71  |- skos__hiddenLabel mesh__D017741 Long-Term Survivor
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D017741 2004
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D017741 2001
% 219.56/219.71  |- skos__hiddenLabel mesh__D017741 Survivor
% 219.56/219.71  |- skos__hiddenLabel mesh__D017741 Long Term Survivors
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D017741 2006
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D017741 1999
% 219.56/219.71  |- rdf__type mesh__D017741sskos__Concept
% 219.56/219.71  |- mesh__recordOriginator mesh__D017741 JLS
% 219.56/219.71  |- skos__hiddenLabel mesh__D017741 Survivors, Long-Term
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D017741 2003
% 219.56/219.71  |- mesh__recordAuthorizer mesh__D017741 SJN
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D017741 2005
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D017741 1998
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D017741 2000
% 219.56/219.71  |- skos__hiddenLabel mesh__D017741 Survivor, Long-Term
% 219.56/219.71  |- mesh__dateRevised mesh__D017741 1997-06-20
% 219.56/219.71  |- mesh__dateEstablished mesh__D017741 1994-01-01
% 219.56/219.71  |- mesh__dateCreated mesh__D017741 1992-12-28
% 219.56/219.71  |- skos__hiddenLabel mesh__D003721 Radiographic Absorptiometry, Dual Energy
% 219.56/219.71  |- skos__hiddenLabel mesh__D003721 Absorptiometry, Dual Energy X Ray
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D003721 2005
% 219.56/219.71  |- skos__historyNote mesh__D003721 Photometry %28%1966%29%
% 219.56/219.71  |- skos__altLabel mesh__D003721 Densitometry, Xray
% 219.56/219.71  |- mesh__publicMeSHNote mesh__D003721 67   
% 219.56/219.71  |- skos__altLabel mesh__D003721 X-Ray Absorptiometry, Dual-Energy
% 219.56/219.71  |- skos__annotation mesh__D003721
% 219.56/219.71       NIM; %22%tomodensitometry%22% seen in foreign lit = probably TOMOGRAPHY, X-RAY COMPUTED: see note under DENSITOMETRY%A%  
% 219.56/219.71  |- skos__hiddenLabel mesh__D003721 Densitometry, X Ray
% 219.56/219.71  |- skos__broader mesh__D003721smesh__D003720
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D003721 2004
% 219.56/219.71  |- skos__prefLabel mesh__D003721 Densitometry, X-Ray
% 219.56/219.71  |- skos__altLabel mesh__D003721 Absorptiometry, Dual-Energy Radiographic
% 219.56/219.71  |- skos__hiddenLabel mesh__D003721 Absorptiometry, Dual Energy Radiographic
% 219.56/219.71  |- skos__altLabel mesh__D003721 Dual-Energy Radiographic Absorptiometry
% 219.56/219.71  |- rdf__type mesh__D003721sskos__Concept
% 219.56/219.71  |- mesh__recordAuthorizer mesh__D003721 sjn
% 219.56/219.71  |- mesh__dateRevised mesh__D003721 2002-07-02
% 219.56/219.71  |- skos__hiddenLabel mesh__D003721 Xray Densitometry
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D003721 2003
% 219.56/219.71  |- skos__hiddenLabel mesh__D003721 Dual Energy Radiographic Absorptiometry
% 219.56/219.71  |- mesh__historyNote mesh__D003721 67   
% 219.56/219.71  |- skos__altLabel mesh__D003721 Absorptiometry, Dual-Energy X-Ray
% 219.56/219.71  |- skos__hiddenLabel mesh__D003721 X-Ray Densitometry
% 219.56/219.71  |- mesh__recordMaintainer mesh__D003721 lkt
% 219.56/219.71  |- skos__hiddenLabel mesh__D003721 Dual Energy X Ray Absorptiometry
% 219.56/219.71  |- skos__hiddenLabel mesh__D003721 X Ray Absorptiometry, Dual Energy
% 219.56/219.71  |- mesh__recordOriginator mesh__D003721 NLM
% 219.56/219.71  |- mesh__activeMeSHYear mesh__D003721 2006
% 219.56/219.71  |- mesh__dateEstablished mesh__D003721 1967-01-01
% 219.56/219.71  |- skos__broader mesh__D003721smesh__D011859
% 219.56/219.71  |- skos__altLabel mesh__D003721 Photodensitometry
% 219.56/219.71  |- mesh__dateCreated mesh__D003721 1999-01-01
% 219.56/219.71  |- skos__scopeNote mesh__D003721
% 219.56/219.71       Measurement of the degree of darkening of X-ray film by means of a photocell which measures light transmission through the film.%A%    
% 219.56/219.71  |- skos__hiddenLabel mesh__D050377 Time, Cold Ischemic
% 219.56/219.71  |- skos__scopeNote mesh__D050377
% 219.56/219.71       The chilling of a tissue or organ during decreased BLOOD perfusion or in the absence of blood supply. Cold ischemia time during ORGAN TRANSPLANTATION begins when the organ is cooled with a cold perfusion solution after ORGAN PROCUREMENT surgery, and ends after the tissue reaches physiological temperature during implantation procedures. WARM ISCHEMIA TIME starts then and ends with completion of SURGICAL ANASTOMOSIS.%A%    
% 219.56/219.71  |- skos__hiddenLabel mesh__D050377 Cold Ischemia Times
% 219.56/219.72  |- skos__altLabel mesh__D050377 Cold Ischemic Time
% 219.56/219.72  |- mesh__dateEstablished mesh__D050377 2006-01-01
% 219.56/219.72  |- skos__hiddenLabel mesh__D050377 Cold Ischemias
% 219.56/219.72  |- skos__hiddenLabel mesh__D050377 Ischemic Time, Cold
% 219.56/219.72  |- skos__hiddenLabel mesh__D050377 Ischemia Time, Cold
% 219.56/219.72  |- skos__hiddenLabel mesh__D050377 Cold Ischemic Times
% 219.56/219.72  |- skos__hiddenLabel mesh__D050377 Ischemias, Cold
% 219.56/219.72  |- skos__historyNote mesh__D050377 Ischemia %28%1976-2005%29%
% 219.56/219.72  |- mesh__dateCreated mesh__D050377 2005-06-30
% 219.56/219.72  |- mesh__historyNote mesh__D050377 2006   
% 219.56/219.72  |- skos__hiddenLabel mesh__D050377 Time, Cold Ischemia
% 219.56/219.72  |- skos__hiddenLabel mesh__D050377 Ischemia Times, Cold
% 219.56/219.72  |- mesh__recordAuthorizer mesh__D050377 sjn
% 219.56/219.72  |- mesh__recordOriginator mesh__D050377 nns
% 219.56/219.72  |- skos__broader mesh__D050377smesh__D014021
% 219.56/219.72  |- skos__prefLabel mesh__D050377 Cold Ischemia
% 219.56/219.72  |- skos__hiddenLabel mesh__D050377 Times, Cold Ischemic
% 219.56/219.72  |- skos__related mesh__D050377smesh__D052096
% 219.56/219.72  |- mesh__publicMeSHNote mesh__D050377 2006   
% 219.56/219.72  |- skos__broader mesh__D050377smesh__D014180
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D050377 2006
% 219.56/219.72  |- rdf__type mesh__D050377sskos__Concept
% 219.56/219.72  |- skos__hiddenLabel mesh__D050377 Ischemia, Cold
% 219.56/219.72  |- mesh__recordMaintainer mesh__D050377 nns
% 219.56/219.72  |- skos__hiddenLabel mesh__D050377 Times, Cold Ischemia
% 219.56/219.72  |- skos__related mesh__D050377smesh__D007511
% 219.56/219.72  |- skos__hiddenLabel mesh__D050377 Ischemic Times, Cold
% 219.56/219.72  |- rdf__type mesh__D016649sskos__Concept
% 219.56/219.72  |- skos__hiddenLabel mesh__D016649 Ovary Syndrome, Gonadotropin-Resistant
% 219.56/219.72  |- skos__hiddenLabel mesh__D016649 Resistant Ovary Syndromes
% 219.56/219.72  |- skos__prefLabel mesh__D016649 Ovarian Failure, Premature
% 219.56/219.72  |- mesh__publicMeSHNote mesh__D016649 1992   
% 219.56/219.72  |- skos__hiddenLabel mesh__D016649 Gonadotropin Resistant Ovary Syndrome
% 219.56/219.72  |- skos__scopeNote mesh__D016649
% 219.56/219.72       Cessation of ovarian function after MENARCHE but before the age of 40, without or with OVARIAN FOLLICLE depletion. It is characterized by the presence of OLIGOMENORRHEA or AMENORRHEA, elevated GONADOTROPINS, and low ESTRADIOL levels. It is a state of female HYPERGONADOTROPIC HYPOGONADISM. Etiologies include genetic defects, autoimmune processes, chemotherapy, radiation, and infections.%A%    
% 219.56/219.72  |- skos__related mesh__D016649smesh__D008594
% 219.56/219.72  |- mesh__recordOriginator mesh__D016649 AGS
% 219.56/219.72  |- mesh__recordMaintainer mesh__D016649 lkt
% 219.56/219.72  |- skos__altLabel mesh__D016649 Premature Ovarian Failure
% 219.56/219.72  |- skos__historyNote mesh__D016649 Menopause, Premature %28%1975-1991%29%
% 219.56/219.72  |- skos__hiddenLabel mesh__D016649 Ovarian Failures, Premature
% 219.56/219.72  |- mesh__historyNote mesh__D016649 1992   
% 219.56/219.72  |- mesh__recordAuthorizer mesh__D016649 sjn
% 219.56/219.72  |- skos__hiddenLabel mesh__D016649 Gonadotropin-Resistant Ovary Syndromes
% 219.56/219.72  |- skos__historyNote mesh__D016649 Ovarian Diseases %28%1966-1991%29%
% 219.56/219.72  |- mesh__dateRevised mesh__D016649 2005-06-30
% 219.56/219.72  |- skos__broader mesh__D016649smesh__D010049
% 219.56/219.72  |- skos__hiddenLabel mesh__D016649 Premature Ovarian Failures
% 219.56/219.72  |- mesh__dateCreated mesh__D016649 1991-05-30
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D016649 2006
% 219.56/219.72  |- skos__hiddenLabel mesh__D016649 Ovary Syndromes, Gonadotropin-Resistant
% 219.56/219.72  |- skos__altLabel mesh__D016649 Resistant Ovary Syndrome
% 219.56/219.72  |- skos__hiddenLabel mesh__D016649 Ovary Syndromes, Resistant
% 219.56/219.72  |- mesh__dateEstablished mesh__D016649 1992-01-01
% 219.56/219.72  |- skos__hiddenLabel mesh__D016649 Ovary Syndrome, Resistant
% 219.56/219.72  |- rdf__type mesh__D002629sskos__Concept
% 219.56/219.72  |- mesh__recordMaintainer mesh__D002629 ssb
% 219.56/219.72  |- mesh__dateRevised mesh__D002629 2003-07-09
% 219.56/219.72  |- mesh__recordAuthorizer mesh__D002629 sjn
% 219.56/219.72  |- skos__broader mesh__D002629smesh__D010575
% 219.56/219.72  |- mesh__historyNote mesh__D002629 72%28%66%29%   
% 219.56/219.72  |- skos__prefLabel mesh__D002629 Chemosterilants
% 219.56/219.72  |- mesh__recordOriginator mesh__D002629 NLM
% 219.56/219.72  |- skos__scopeNote mesh__D002629
% 219.56/219.72       Compounds that cause reproductive sterility in organisms. They are sometimes used to control pest populations by sterilizing males within the population.%A%    
% 219.56/219.72  |- mesh__dateCreated mesh__D002629 1999-01-01
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D002629 2006
% 219.56/219.72  |- mesh__dateEstablished mesh__D002629 1972-01-01
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D002629 2004
% 219.56/219.72  |- mesh__publicMeSHNote mesh__D002629 72   
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D002629 2005
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013351 1994
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013351 2005
% 219.56/219.72  |- skos__prefLabel mesh__D013351 Subcommissural Organ
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013351 2000
% 219.56/219.72  |- mesh__publicMeSHNote mesh__D013351
% 219.56/219.72       91; was see under NEUROSECRETORY SYSTEMS 1977-90   
% 219.56/219.72  |- mesh__recordOriginator mesh__D013351 MM
% 219.56/219.72  |- skos__hiddenLabel mesh__D013351 Organ, Subcommissural
% 219.56/219.72  |- skos__hiddenLabel mesh__D013351 Organs, Subcommissural
% 219.56/219.72  |- mesh__dateRevised mesh__D013351 1992-05-18
% 219.56/219.72  |- mesh__dateCreated mesh__D013351 1976-04-27
% 219.56/219.72  |- skos__broader mesh__D013351smesh__D009490
% 219.56/219.72  |- skos__scopeNote mesh__D013351
% 219.56/219.72       An ependymal derivative located at the junction of the third ventricle and the cerebral aqueduct, secreting somatostatin.%A%    
% 219.56/219.72  |- mesh__dateEstablished mesh__D013351 1991-01-01
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013351 1997
% 219.56/219.72  |- skos__historyNote mesh__D013351 Neurosecretory Systems %28%1970-1976%29%
% 219.56/219.72  |- mesh__recordAuthorizer mesh__D013351 PLS
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013351 1999
% 219.56/219.72  |- rdf__type mesh__D013351sskos__Concept
% 219.56/219.72  |- skos__hiddenLabel mesh__D013351 Subcommissural Organs
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013351 2004
% 219.56/219.72  |- mesh__recordMaintainer mesh__D013351 TAP
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013351 1996
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013351 1993
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013351 2002
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013351 1995
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013351 2006
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013351 1998
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013351 2003
% 219.56/219.72  |- mesh__historyNote mesh__D013351
% 219.56/219.72       91%28%77%29%; was see under NEUROSECRETORY SYSTEMS 1977-90   
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013351 2001
% 219.56/219.72  |- mesh__recordMaintainer mesh__D007314 lkt
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D007314 2005
% 219.56/219.72  |- mesh__recordOriginator mesh__D007314 NLM
% 219.56/219.72  |- skos__prefLabel mesh__D007314 Insemination
% 219.56/219.72  |- skos__hiddenLabel mesh__D007314 Inseminations
% 219.56/219.72  |- rdf__type mesh__D007314sskos__Concept
% 219.56/219.72  |- skos__scopeNote mesh__D007314
% 219.56/219.72       The deposit of SEMEN or SPERMATOZOA into the VAGINA to facilitate FERTILIZATION.%A%    
% 219.56/219.72  |- skos__broader mesh__D007314smesh__D012098
% 219.56/219.72  |- mesh__dateRevised mesh__D007314 2004-07-07
% 219.56/219.72  |- mesh__recordAuthorizer mesh__D007314 sjn
% 219.56/219.72  |- mesh__dateCreated mesh__D007314 1999-01-01
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D007314 2006
% 219.56/219.72  |- skos__prefLabel mesh__D012259 Ribonuclease, Pancreatic
% 219.56/219.72  |- skos__hiddenLabel mesh__D012259 RNase, Pancreatic
% 219.56/219.72  |- skos__hiddenLabel mesh__D012259 Pancreatic Ribonuclease
% 219.56/219.72  |- skos__historyNote mesh__D012259 Ribonucleases %28%1979-1982%29%
% 219.56/219.72  |- mesh__recordAuthorizer mesh__D012259 sjn
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D012259 2004
% 219.56/219.72  |- skos__historyNote mesh__D012259 Endonucleases %28%1979-1982%29%
% 219.56/219.72  |- mesh__recordMaintainer mesh__D012259 ssb
% 219.56/219.72  |- skos__broader mesh__D012259smesh__D004722
% 219.56/219.72  |- mesh__dateRevised mesh__D012259 2003-07-09
% 219.56/219.72  |- mesh__historyNote mesh__D012259 84   
% 219.56/219.72  |- mesh__publicMeSHNote mesh__D012259 84   
% 219.56/219.72  |- rdf__type mesh__D012259sskos__Concept
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D012259 2006
% 219.56/219.72  |- skos__altLabel mesh__D012259 Ribonuclease %28%Pancreatic%29%
% 219.56/219.72  |- skos__altLabel mesh__D012259 Pancreatic RNase
% 219.56/219.72  |- skos__altLabel mesh__D012259 Ribonuclease A
% 219.56/219.72  |- mesh__dateEstablished mesh__D012259 1984-01-01
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D012259 2005
% 219.56/219.72  |- skos__altLabel mesh__D012259 RNase A
% 219.56/219.72  |- skos__scopeNote mesh__D012259
% 219.56/219.72       An enzyme that catalyzes the endonucleolytic cleavage of pancreatic ribonucleic acids to 3%27%-phosphomono- and oligonucleotides ending in cytidylic or uridylic acids with 2%27%,3%27%-cyclic phosphate intermediates. EC 3.1.27.5.%A%    
% 219.56/219.72  |- skos__altLabel mesh__D012259 Ribonuclease I
% 219.56/219.72  |- mesh__dateCreated mesh__D012259 1983-03-17
% 219.56/219.72  |- skos__historyNote mesh__D012259 Endoribonucleases %28%1982-1983%29%
% 219.56/219.72  |- skos__altLabel mesh__D012259 RNase I
% 219.56/219.72  |- mesh__recordOriginator mesh__D012259 RLS
% 219.56/219.72  |- mesh__dateRevised mesh__D017742 1999-11-03
% 219.56/219.72  |- mesh__dateEstablished mesh__D017742 1994-01-01
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D017742 2004
% 219.56/219.72  |- mesh__recordAuthorizer mesh__D017742 sjn
% 219.56/219.72  |- skos__broader mesh__D017742smesh__D003729
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D017742 2000
% 219.56/219.72  |- rdf__type mesh__D017742sskos__Concept
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D017742 2006
% 219.56/219.72  |- skos__altLabel mesh__D017742 Chronically Ill, Dentistry
% 219.56/219.72  |- mesh__recordOriginator mesh__D017742 JLS
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D017742 2003
% 219.56/219.72  |- skos__altLabel mesh__D017742 Chronically Ill, Dental Care
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D017742 2005
% 219.56/219.72  |- skos__hiddenLabel mesh__D017742 Dentistry Chronically Ill
% 219.56/219.72  |- mesh__publicMeSHNote mesh__D017742 94   
% 219.56/219.72  |- mesh__dateCreated mesh__D017742 1992-12-28
% 219.56/219.72  |- skos__prefLabel mesh__D017742 Dental Care for Chronically Ill
% 219.56/219.72  |- skos__annotation mesh__D017742
% 219.56/219.72       = professional care by a professional; DF: DENT CARE CHRONIC ILL%A%  
% 219.56/219.72  |- skos__historyNote mesh__D017742
% 219.56/219.72       Dental Care for Disabled %28%1980-1993%29%
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D017742 2002
% 219.56/219.72  |- skos__scopeNote mesh__D017742
% 219.56/219.72       Dental care for patients with chronic diseases. These diseases include chronic cardiovascular, endocrinologic, hematologic, immunologic, neoplastic, and renal diseases. The concept does not include dental care for the mentally or physically disabled which is DENTAL CARE FOR DISABLED.%A%    
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D017742 2001
% 219.56/219.72  |- mesh__recordMaintainer mesh__D017742 kle
% 219.56/219.72  |- mesh__historyNote mesh__D017742 94   
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003722 2000
% 219.56/219.72  |- skos__altLabel mesh__D003722 Dental Alloy
% 219.56/219.72  |- mesh__recordMaintainer mesh__D003722 TAP
% 219.56/219.72  |- mesh__dateRevised mesh__D003722 1992-05-22
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003722 1996
% 219.56/219.72  |- skos__altLabel mesh__D003722 Alloy, Dental
% 219.56/219.72  |- skos__historyNote mesh__D003722 Dental Materials %28%1966-1972%29%
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003722 2005
% 219.56/219.72  |- rdf__type mesh__D003722sskos__Concept
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003722 2004
% 219.56/219.72  |- skos__historyNote mesh__D003722 Alloys %28%1966-1972%29%
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003722 1995
% 219.56/219.72  |- skos__scopeNote mesh__D003722
% 219.56/219.72       A mixture of metallic elements or compounds with other metallic or metalloid elements in varying proportions for use in restorative or prosthetic dentistry.%A%    
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003722 2003
% 219.56/219.72  |- mesh__recordAuthorizer mesh__D003722 PLS
% 219.56/219.72  |- skos__altLabel mesh__D003722 Alloys, Dental
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003722 1999
% 219.56/219.72  |- skos__broader mesh__D003722smesh__D003764
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003722 1994
% 219.56/219.72  |- mesh__recordOriginator mesh__D003722 NLM
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003722 2002
% 219.56/219.72  |- skos__prefLabel mesh__D003722 Dental Alloys
% 219.56/219.72  |- skos__annotation mesh__D003722 D25-26 qualif; DF: DENT ALLOYS   
% 219.56/219.72  |- mesh__dateEstablished mesh__D003722 1973-01-01
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003722 1993
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003722 1998
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003722 2001
% 219.56/219.72  |- mesh__dateCreated mesh__D003722 1999-01-01
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003722 1997
% 219.56/219.72  |- mesh__publicMeSHNote mesh__D003722 73   
% 219.56/219.72  |- mesh__historyNote mesh__D003722 73   
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003722 2006
% 219.56/219.72  |- skos__hiddenLabel mesh__D050378 Regulatory T-Lymphocyte
% 219.56/219.72  |- skos__hiddenLabel mesh__D050378 Tr1 Cell
% 219.56/219.72  |- skos__hiddenLabel mesh__D050378 Suppressor Cell
% 219.56/219.72  |- skos__prefLabel mesh__D050378 T-Lymphocytes, Regulatory
% 219.56/219.72  |- mesh__recordOriginator mesh__D050378 ags
% 219.56/219.72  |- skos__hiddenLabel mesh__D050378 T Cells, Regulatory
% 219.56/219.72  |- skos__hiddenLabel mesh__D050378 Cells, Treg
% 219.56/219.72  |- skos__hiddenLabel mesh__D050378 Cells, Th3
% 219.56/219.72  |- skos__altLabel mesh__D050378 Regulatory T-Lymphocytes
% 219.56/219.72  |- mesh__dateEstablished mesh__D050378 2006-01-01
% 219.56/219.72  |- skos__scopeNote mesh__D050378
% 219.56/219.72       CD4-positive T cells that inhibit immunopathology or autoimmune disease in vivo. These include naturally occurring CD4+CD25+ Treg cells, IL-10 secreting Tr1 cells, and Th3 cells.%A%    
% 219.56/219.72  |- skos__hiddenLabel mesh__D050378 Regulatory T Cells
% 219.56/219.72  |- mesh__historyNote mesh__D050378
% 219.56/219.72       2006, 1985-1994; use T-LYMPHOCYTES 1995-2005   
% 219.56/219.72  |- skos__hiddenLabel mesh__D050378 Cells, Tr1
% 219.56/219.72  |- skos__broader mesh__D050378smesh__D015496
% 219.56/219.72  |- skos__hiddenLabel mesh__D050378 Cell, Tr1
% 219.56/219.72  |- skos__altLabel mesh__D050378 T-Cells, Regulatory
% 219.56/219.72  |- skos__hiddenLabel mesh__D050378 Cell, Th3
% 219.56/219.72  |- skos__hiddenLabel mesh__D050378 T Lymphocytes, Regulatory
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D050378 2006
% 219.56/219.72  |- rdf__type mesh__D050378sskos__Concept
% 219.56/219.72  |- mesh__dateCreated mesh__D050378 2005-06-30
% 219.56/219.72  |- skos__hiddenLabel mesh__D050378 T-Lymphocyte, Regulatory
% 219.56/219.72  |- skos__altLabel mesh__D050378 Suppressor Cells
% 219.56/219.72  |- skos__hiddenLabel mesh__D050378 Regulatory T Lymphocytes
% 219.56/219.72  |- mesh__recordAuthorizer mesh__D050378 sjn
% 219.56/219.72  |- skos__hiddenLabel mesh__D050378 Treg Cell
% 219.56/219.72  |- skos__hiddenLabel mesh__D050378 Cell, Treg
% 219.56/219.72  |- skos__altLabel mesh__D050378 Regulatory T-Cells
% 219.56/219.72  |- mesh__recordMaintainer mesh__D050378 ags
% 219.56/219.72  |- mesh__publicMeSHNote mesh__D050378
% 219.56/219.72       2006, 1985-1994; see T-LYMPHOCYTES 1995-2005; for SUPPRESSOR CELLS, see T-LYMPHOCYTES, SUPPRESSOR-EFFECTOR 1993-2005%A%  
% 219.56/219.72  |- skos__hiddenLabel mesh__D050378 Th3 Cell
% 219.56/219.72  |- mesh__publicMeSHNote mesh__D041841
% 219.56/219.72       2004; for NITROBACTERACEAE see NITROBACTERACEAE 1975-2003%A%  
% 219.56/219.72  |- skos__broader mesh__D041841smesh__D016946
% 219.56/219.72  |- skos__scopeNote mesh__D041841
% 219.56/219.72       A proposed family of bacteria belonging to the alpha-2 subgroup of PROTEOBACTERIA.%A%    
% 219.56/219.72  |- mesh__dateEstablished mesh__D041841 2004-01-01
% 219.56/219.72  |- mesh__dateCreated mesh__D041841 2003-07-09
% 219.56/219.72  |- mesh__recordAuthorizer mesh__D041841 sjn
% 219.56/219.72  |- mesh__recordMaintainer mesh__D041841 SYSTEM
% 219.56/219.72  |- rdf__type mesh__D041841sskos__Concept
% 219.56/219.72  |- mesh__historyNote mesh__D041841 2004   
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D041841 2006
% 219.56/219.72  |- mesh__dateRevised mesh__D041841 2005-06-30
% 219.56/219.72  |- mesh__recordOriginator mesh__D041841 ags
% 219.56/219.72  |- skos__prefLabel mesh__D041841 Bradyrhizobiaceae
% 219.56/219.72  |- skos__broader mesh__D041841smesh__D020561
% 219.56/219.72  |- mesh__dateEstablished mesh__D013352 1991-01-01
% 219.56/219.72  |- skos__scopeNote mesh__D013352
% 219.56/219.72       Presence of air or gas in the subcutaneous tissues of the body.%A%    
% 219.56/219.72  |- skos__prefLabel mesh__D013352 Subcutaneous Emphysema
% 219.56/219.72  |- mesh__recordOriginator mesh__D013352 VDK
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013352 2000
% 219.56/219.72  |- mesh__historyNote mesh__D013352
% 219.56/219.72       91%28%77%29%; was see under EMPHYSEMA 1977-90   
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013352 2001
% 219.56/219.72  |- mesh__dateRevised mesh__D013352 1999-11-03
% 219.56/219.72  |- skos__hiddenLabel mesh__D013352 Subcutaneous Emphysemas
% 219.56/219.72  |- mesh__publicMeSHNote mesh__D013352
% 219.56/219.72       91; was see under EMPHYSEMA 1977-90   
% 219.56/219.72  |- skos__altLabel mesh__D013352 Emphysema, Subcutaneous
% 219.56/219.72  |- skos__broader mesh__D013352smesh__D004646
% 219.56/219.72  |- skos__historyNote mesh__D013352 Emphysema %28%1966-1976%29%
% 219.56/219.72  |- mesh__dateCreated mesh__D013352 1976-04-27
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013352 2003
% 219.56/219.72  |- skos__hiddenLabel mesh__D013352 Emphysemas, Subcutaneous
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013352 2005
% 219.56/219.72  |- rdf__type mesh__D013352sskos__Concept
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013352 2004
% 219.56/219.72  |- mesh__recordAuthorizer mesh__D013352 sjn
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013352 2002
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013352 2006
% 219.56/219.72  |- mesh__recordMaintainer mesh__D013352 KEV
% 219.56/219.72  |- rdf__type mesh__D007315sskos__Concept
% 219.56/219.72  |- skos__broader mesh__D007315smesh__D027724
% 219.56/219.72  |- skos__related mesh__D007315smesh__D005307
% 219.56/219.72  |- skos__hiddenLabel mesh__D007315 Artificial Inseminations
% 219.56/219.72  |- skos__annotation mesh__D007315 GEN or unspecified; prefer specifics   
% 219.56/219.72  |- skos__related mesh__D007315smesh__D012662
% 219.56/219.72  |- skos__related mesh__D007315smesh__D013074
% 219.56/219.72  |- mesh__recordAuthorizer mesh__D007315 sjn
% 219.56/219.72  |- skos__hiddenLabel mesh__D007315 Eutelegeneses
% 219.56/219.72  |- mesh__recordMaintainer mesh__D007315 lkt
% 219.56/219.72  |- mesh__dateCreated mesh__D007315 1999-01-01
% 219.56/219.72  |- mesh__dateRevised mesh__D007315 2005-06-30
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D007315 2006
% 219.56/219.72  |- skos__broader mesh__D007315smesh__D007314
% 219.56/219.72  |- skos__hiddenLabel mesh__D007315 Inseminations, Artificial
% 219.56/219.72  |- skos__broader mesh__D007315smesh__D012099
% 219.56/219.72  |- mesh__recordOriginator mesh__D007315 NLM
% 219.56/219.72  |- skos__prefLabel mesh__D007315 Insemination, Artificial
% 219.56/219.72  |- skos__altLabel mesh__D007315 Eutelegenesis
% 219.56/219.72  |- skos__scopeNote mesh__D007315
% 219.56/219.72       Artificial introduction of SEMEN or SPERMATOZOA into the VAGINA to facilitate FERTILIZATION.%A%    
% 219.56/219.72  |- skos__altLabel mesh__D007315 Artificial Insemination
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D017743 1999
% 219.56/219.72  |- rdf__type mesh__D017743sskos__Concept
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D017743 2003
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D017743 1996
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D017743 1995
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D017743 2001
% 219.56/219.72  |- skos__hiddenLabel mesh__D017743 Reusability, Equipment
% 219.56/219.72  |- skos__hiddenLabel mesh__D017743 Reuse, Equipment
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D017743 2005
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D017743 1998
% 219.56/219.72  |- mesh__dateCreated mesh__D017743 1992-12-28
% 219.56/219.72  |- mesh__dateEstablished mesh__D017743 1994-01-01
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D017743 1994
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D017743 2000
% 219.56/219.72  |- skos__prefLabel mesh__D017743 Equipment Reuse
% 219.56/219.72  |- skos__hiddenLabel mesh__D017743 Recycling, Product
% 219.56/219.72  |- skos__broader mesh__D017743smesh__D008919
% 219.56/219.72  |- mesh__publicMeSHNote mesh__D017743 94   
% 219.56/219.72  |- skos__broader mesh__D017743smesh__D011634
% 219.56/219.72  |- skos__hiddenLabel mesh__D017743 Equipment Recycling
% 219.56/219.72  |- mesh__historyNote mesh__D017743 94   
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D017743 2004
% 219.56/219.72  |- skos__altLabel mesh__D017743 Recycling, Equipment
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D017743 1997
% 219.56/219.72  |- skos__annotation mesh__D017743
% 219.56/219.72       NIM; coord with specific equip %28%IM%29% or specific techn /instrum %28%IM%29%%A%  
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D017743 2002
% 219.56/219.72  |- skos__scopeNote mesh__D017743
% 219.56/219.72       Further or repeated use of equipment, instruments, devices, or materials. It includes additional use regardless of the original intent of the producer as to disposability or durability. It does not include the repeated use of fluids or solutions.%A%    
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D017743 2006
% 219.56/219.72  |- rdf__type mesh__D003723sskos__Concept
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003723 2001
% 219.56/219.72  |- skos__altLabel mesh__D003723 Dental Amalgams
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003723 2004
% 219.56/219.72  |- skos__scopeNote mesh__D003723
% 219.56/219.72       An alloy used in restorative dentistry that contains mercury, silver, tin, copper, and possibly zinc.%A%    
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003723 2000
% 219.56/219.72  |- mesh__recordMaintainer mesh__D003723 MXR
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003723 1995
% 219.56/219.72  |- skos__annotation mesh__D003723 D25-26 qualif; DF: DENT AMALGAM   
% 219.56/219.72  |- skos__prefLabel mesh__D003723 Dental Amalgam
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003723 2003
% 219.56/219.72  |- skos__altLabel mesh__D003723 Amalgam, Dental
% 219.56/219.72  |- skos__altLabel mesh__D003723 Amalgams, Dental
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003723 1999
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003723 1994
% 219.56/219.72  |- mesh__dateEstablished mesh__D003723 1965-01-01
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003723 1993
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003723 1998
% 219.56/219.72  |- mesh__dateCreated mesh__D003723 1999-01-01
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003723 1997
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003723 1992
% 219.56/219.72  |- mesh__recordAuthorizer mesh__D003723 PLS
% 219.56/219.72  |- mesh__historyNote mesh__D003723 65   
% 219.56/219.72  |- mesh__publicMeSHNote mesh__D003723 65   
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003723 2006
% 219.56/219.72  |- skos__broader mesh__D003723smesh__D003722
% 219.56/219.72  |- mesh__dateRevised mesh__D003723 1991-05-30
% 219.56/219.72  |- mesh__recordOriginator mesh__D003723 NLM
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003723 2002
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003723 1996
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D003723 2005
% 219.56/219.72  |- mesh__dateCreated mesh__D050379 2005-06-30
% 219.56/219.72  |- skos__historyNote mesh__D050379 Arteriosclerosis %28%1966-2005%29%
% 219.56/219.72  |- rdf__type mesh__D050379sskos__Concept
% 219.56/219.72  |- mesh__recordMaintainer mesh__D050379 lkt
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D050379 2006
% 219.56/219.72  |- mesh__recordAuthorizer mesh__D050379 sjn
% 219.56/219.72  |- skos__prefLabel mesh__D050379 Arteriolosclerosis
% 219.56/219.72  |- mesh__publicMeSHNote mesh__D050379
% 219.56/219.72       2006; see ARTERIOSCLEROSIS 2001-2005   
% 219.56/219.72  |- skos__broader mesh__D050379smesh__D001161
% 219.56/219.72  |- skos__annotation mesh__D050379 do not confuse with ARTERIOSCLEROSIS   
% 219.56/219.72  |- mesh__dateEstablished mesh__D050379 2006-01-01
% 219.56/219.72  |- skos__hiddenLabel mesh__D050379 Arterioloscleroses
% 219.56/219.72  |- mesh__recordOriginator mesh__D050379 lkt
% 219.56/219.72  |- skos__scopeNote mesh__D050379
% 219.56/219.72       Thickening of the walls of small ARTERIES or ARTERIOLES due to cell proliferation or HYALINE deposition.%A%    
% 219.56/219.72  |- mesh__historyNote mesh__D050379 2006; use ARTERIOSCLEROSIS 2001-2005   
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013353 2002
% 219.56/219.72  |- skos__hiddenLabel mesh__D013353 Effusion, Subdural
% 219.56/219.72  |- skos__scopeNote mesh__D013353
% 219.56/219.72       Leakage and accumulation of CEREBROSPINAL FLUID in the subdural space which may be associated with an infectious process; CRANIOCEREBRAL TRAUMA; BRAIN NEOPLASMS; INTRACRANIAL HYPOTENSION; and other conditions.%A%    
% 219.56/219.72  |- skos__broader mesh__D013353smesh__D001927
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013353 2000A
% 219.56/219.72  |- skos__altLabel mesh__D013353 Cerebrospinal Fluid Leakage, Subdural
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013353 2003
% 219.56/219.72  |- skos__altLabel mesh__D013353 Subdural Cerebrospinal Fluid Effusion
% 219.56/219.72  |- skos__altLabel mesh__D013353 Subdural Cerebrospinal Fluid Leakage
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013353 2005
% 219.56/219.72  |- mesh__recordAuthorizer mesh__D013353 ags
% 219.56/219.72  |- skos__historyNote mesh__D013353
% 219.56/219.72       Meningitis/complications %28%1966-1971%29%
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013353 2000
% 219.56/219.72  |- rdf__type mesh__D013353sskos__Concept
% 219.56/219.72  |- skos__annotation mesh__D013353
% 219.56/219.72       Coord IM with specific infection %28%IM%29%   
% 219.56/219.72  |- skos__broader mesh__D013353smesh__D020819
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013353 2004
% 219.56/219.72  |- skos__prefLabel mesh__D013353 Subdural Effusion
% 219.56/219.72  |- mesh__recordOriginator mesh__D013353 NLM
% 219.56/219.72  |- mesh__dateCreated mesh__D013353 1999-01-01
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013353 2001
% 219.56/219.72  |- skos__hiddenLabel mesh__D013353 Subdural Hygroma
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D013353 2006
% 219.56/219.72  |- skos__altLabel mesh__D013353 Cerebrospinal Fluid Effusion, Subdural
% 219.56/219.72  |- mesh__publicMeSHNote mesh__D013353 1991; see MENINGITIS 1972-1990   
% 219.56/219.72  |- mesh__dateRevised mesh__D013353 1999-12-08
% 219.56/219.72  |- skos__historyNote mesh__D013353
% 219.56/219.72       specific meningitis/complications %28%1966-1971%29%
% 219.56/219.72  |- skos__related mesh__D013353smesh__D008581
% 219.56/219.72  |- mesh__recordMaintainer mesh__D013353 ags
% 219.56/219.72  |- mesh__historyNote mesh__D013353 1991%28%1972%29%   
% 219.56/219.72  |- mesh__dateEstablished mesh__D013353 1991-01-01
% 219.56/219.72  |- mesh__publicMeSHNote mesh__D007316
% 219.56/219.72       91; was see under INSEMINATION, ARTIFICIAL 1975-90   
% 219.56/219.72  |- skos__hiddenLabel mesh__D007316 Donor Artificial Insemination
% 219.56/219.72  |- skos__annotation mesh__D007316
% 219.56/219.72       human only: semen other than husband%27%s; DF: INSEMINATION ARTIFICIAL HETEROL%A%  
% 219.56/219.72  |- mesh__dateCreated mesh__D007316 1974-11-19
% 219.56/219.72  |- skos__prefLabel mesh__D007316 Insemination, Artificial, Heterologous
% 219.56/219.72  |- skos__altLabel mesh__D007316 AID
% 219.56/219.72  |- mesh__activeMeSHYear mesh__D007316 2006
% 219.56/219.72  |- mesh__recordAuthorizer mesh__D007316 sjn
% 219.56/219.72  |- mesh__recordMaintainer mesh__D007316 lkt
% 219.56/219.72  |- skos__altLabel mesh__D007316 Heterologous Insemination
% 219.56/219.73  |- skos__altLabel mesh__D007316 Insemination, Artificial, Human Donor
% 219.56/219.73  |- skos__broader mesh__D007316smesh__D007315
% 219.56/219.73  |- mesh__historyNote mesh__D007316
% 219.56/219.73       91%28%75%29%; was see under INSEMINATION, ARTIFICIAL 1975-90   
% 219.56/219.73  |- mesh__dateRevised mesh__D007316 2005-06-30
% 219.56/219.73  |- skos__hiddenLabel mesh__D007316 Insemination, Donor Artificial
% 219.56/219.73  |- skos__altLabel mesh__D007316 Insemination, Heterologous
% 219.56/219.73  |- rdf__type mesh__D007316sskos__Concept
% 219.56/219.73  |- mesh__recordOriginator mesh__D007316 NLM
% 219.56/219.73  |- mesh__dateEstablished mesh__D007316 1991-01-01
% 219.56/219.73  |- skos__altLabel mesh__D007316 Artificial Insemination, Donor
% 219.56/219.73  |- skos__scopeNote mesh__D007316
% 219.56/219.73       Human artificial insemination in which the semen used is that of a man other than the woman%27%s husband.%A%    
% 219.56/219.73  |- mesh__recordAuthorizer mesh__D051472 sjn
% 219.56/219.73  |- mesh__dateCreated mesh__D051472 2005-06-30
% 219.56/219.73  |- mesh__recordOriginator mesh__D051472 ags
% 219.56/219.73  |- skos__historyNote mesh__D051472 Cartilage %28%1967-2005%29%
% 219.56/219.73  |- skos__hiddenLabel mesh__D051472 Cartilage, Elastic
% 219.56/219.73  |- rdf__type mesh__D051472sskos__Concept
% 219.56/219.73  |- skos__scopeNote mesh__D051472
% 219.56/219.73       A type of CARTILAGE whose matrix contains ELASTIC FIBERS and elastic lamellae, in addition to the normal components of HYALINE CARTILAGE matrix. Elastic cartilage is found in the EXTERNAL EAR; EUSTACHIAN TUBE; EPIGLOTTIS; and LARYNX.%A%    
% 219.56/219.73  |- mesh__publicMeSHNote mesh__D051472 2006   
% 219.56/219.73  |- skos__annotation mesh__D051472 ELASTIC TISSUE is also available   
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D051472 2006
% 219.56/219.73  |- mesh__historyNote mesh__D051472 2006   
% 219.56/219.73  |- skos__hiddenLabel mesh__D051472 Cartilages, Elastic
% 219.56/219.73  |- mesh__recordMaintainer mesh__D051472 ags
% 219.56/219.73  |- skos__hiddenLabel mesh__D051472 Elastic Cartilages
% 219.56/219.73  |- skos__historyNote mesh__D051472 Cartilage, Articular %28%1986-2005%29%
% 219.56/219.73  |- skos__broader mesh__D051472smesh__D002356
% 219.56/219.73  |- mesh__dateEstablished mesh__D051472 2006-01-01
% 219.56/219.73  |- skos__prefLabel mesh__D051472 Elastic Cartilage
% 219.56/219.73  |- skos__scopeNote mesh__D023781
% 219.56/219.73       Family of small, surface-dwelling fish that inhabit fresh and brackish waters, and coastal marine areas.%A%    
% 219.56/219.73  |- mesh__dateRevised mesh__D023781 2003-07-09
% 219.56/219.73  |- mesh__dateEstablished mesh__D023781 2002-01-01
% 219.56/219.73  |- skos__broader mesh__D023781smesh__D003532
% 219.56/219.73  |- skos__altLabel mesh__D023781 Killifish, Gulf
% 219.56/219.73  |- skos__altLabel mesh__D023781 Fundulus heteroclitus
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D023781 2004
% 219.56/219.73  |- skos__annotation mesh__D023781
% 219.56/219.73       do not confuse X ref TOPMINNOWS with gila topminnows in the family Poeciliidae = CYPRINODONTIFORMES; do not confuse X refs KILLIFISH %28%Fundulus heteroclitus%29%, GULF KILLIFISH %28%Fundulus grandis%29%, or ATLANTIC KILLIFISH  with KILLIFISHES or with JAPANESE KILLIFISH see ORYZIAS; killifish unspecified goes under KILLIFISHES%A%  
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D023781 2005
% 219.56/219.73  |- mesh__publicMeSHNote mesh__D023781 2002   
% 219.56/219.73  |- mesh__historyNote mesh__D023781 2002   
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D023781 2006
% 219.56/219.73  |- skos__hiddenLabel mesh__D023781 Mummichogs
% 219.56/219.73  |- skos__altLabel mesh__D023781 Topminnows
% 219.56/219.73  |- skos__altLabel mesh__D023781 Mummichog
% 219.56/219.73  |- skos__altLabel mesh__D023781 Fundulus grandis
% 219.56/219.73  |- rdf__type mesh__D023781sskos__Concept
% 219.56/219.73  |- skos__historyNote mesh__D023781 Killifish %28%1976-2001%29%
% 219.56/219.73  |- mesh__dateCreated mesh__D023781 2001-07-25
% 219.56/219.73  |- skos__prefLabel mesh__D023781 Fundulidae
% 219.56/219.73  |- skos__altLabel mesh__D023781 Atlantic Killifish
% 219.56/219.73  |- rdf__type mesh__D017744sskos__Concept
% 219.56/219.73  |- mesh__publicMeSHNote mesh__D017744 94   
% 219.56/219.73  |- mesh__recordOriginator mesh__D017744 JLS
% 219.56/219.73  |- skos__hiddenLabel mesh__D017744 Disposal, Specimen
% 219.56/219.73  |- skos__historyNote mesh__D017744 Refuse Disposal %28%1966-1993%29%
% 219.56/219.73  |- skos__altLabel mesh__D017744 Waste Disposal, Biological
% 219.56/219.73  |- skos__altLabel mesh__D017744 Biologic Waste Disposal
% 219.56/219.73  |- skos__hiddenLabel mesh__D017744 Waste Disposal, Biologic
% 219.56/219.73  |- skos__prefLabel mesh__D017744 Medical Waste Disposal
% 219.56/219.73  |- skos__altLabel mesh__D017744 Disposal, Infectious Waste
% 219.56/219.73  |- mesh__dateRevised mesh__D017744 2005-06-30
% 219.56/219.73  |- skos__altLabel mesh__D017744 Disposal, Biological Waste
% 219.56/219.73  |- skos__hiddenLabel mesh__D017744 Disposal, Biologic Waste
% 219.56/219.73  |- skos__scopeNote mesh__D017744
% 219.56/219.73       Management, removal, and elimination of biologic, infectious, pathologic, and dental waste. The concept includes blood, mucus, tissue removed at surgery or autopsy, soiled surgical dressings, and other materials requiring special control and handling. Disposal may take place where the waste is generated or elsewhere.%A%    
% 219.56/219.73  |- skos__altLabel mesh__D017744 Disposal, Medical Waste
% 219.56/219.73  |- mesh__dateEstablished mesh__D017744 1994-01-01
% 219.56/219.73  |- skos__altLabel mesh__D017744 Pathological Waste Disposal
% 219.56/219.73  |- skos__annotation mesh__D017744
% 219.56/219.73       disposal of dental waste: coord IM with DENTAL WASTE %28%IM%29%%A%  
% 219.56/219.73  |- skos__broader mesh__D017744smesh__D012037
% 219.56/219.73  |- skos__altLabel mesh__D017744 Infectious Waste Disposal
% 219.56/219.73  |- mesh__recordAuthorizer mesh__D017744 sjn
% 219.56/219.73  |- skos__historyNote mesh__D017744 Medical Waste %28%1991-1993%29%
% 219.56/219.73  |- mesh__historyNote mesh__D017744 94   
% 219.56/219.73  |- skos__historyNote mesh__D017744 Waste Products %28%1978-1990%29%
% 219.56/219.73  |- mesh__recordMaintainer mesh__D017744 ssb
% 219.56/219.73  |- skos__altLabel mesh__D017744 Waste Disposal, Medical
% 219.56/219.73  |- skos__broader mesh__D017744smesh__D008506
% 219.56/219.73  |- skos__altLabel mesh__D017744 Disposal, Pathological Waste
% 219.56/219.73  |- mesh__dateCreated mesh__D017744 1993-06-04
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D017744 2006
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003724 1999
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003724 1994
% 219.56/219.73  |- mesh__recordAuthorizer mesh__D003724 PLS
% 219.56/219.73  |- skos__altLabel mesh__D003724 Dental Arches
% 219.56/219.73  |- skos__altLabel mesh__D003724 Arch, Dental
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003724 1993
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003724 1998
% 219.56/219.73  |- mesh__dateRevised mesh__D003724 1992-05-18
% 219.56/219.73  |- mesh__recordOriginator mesh__D003724 NLM
% 219.56/219.73  |- mesh__dateCreated mesh__D003724 1999-01-01
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003724 2002
% 219.56/219.73  |- skos__altLabel mesh__D003724 Arches, Dental
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003724 1997
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003724 2006
% 219.56/219.73  |- mesh__recordMaintainer mesh__D003724 TGC
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003724 2001
% 219.56/219.73  |- mesh__dateEstablished mesh__D003724 1966-01-01
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003724 1996
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003724 2005
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003724 2000
% 219.56/219.73  |- rdf__type mesh__D003724sskos__Concept
% 219.56/219.73  |- skos__prefLabel mesh__D003724 Dental Arch
% 219.56/219.73  |- mesh__historyNote mesh__D003724 66   
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003724 2004
% 219.56/219.73  |- mesh__publicMeSHNote mesh__D003724 66   
% 219.56/219.73  |- skos__broader mesh__D003724smesh__D007568
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003724 1995
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003724 2003
% 219.56/219.73  |- skos__annotation mesh__D003724 DF: DENT ARCH   
% 219.56/219.73  |- skos__scopeNote mesh__D049028
% 219.56/219.73       A macromolecular complex of proteins that includes DYSTROPHIN and DYSTROPHIN-ASSOCIATED PROTEINS. It plays a structural role in the linking the CYTOSKELETON to the EXTRACELLULAR MATRIX.%A%    
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D049028 2006A
% 219.56/219.73  |- mesh__historyNote mesh__D049028 2005   
% 219.56/219.73  |- mesh__recordAuthorizer mesh__D049028 ags
% 219.56/219.73  |- mesh__dateEstablished mesh__D049028 2005-01-01
% 219.56/219.73  |- mesh__dateRevised mesh__D049028 2005-07-13
% 219.56/219.73  |- skos__prefLabel mesh__D049028 Dystrophin-Associated Protein Complex
% 219.56/219.73  |- mesh__dateCreated mesh__D049028 2004-07-07
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D049028 2006
% 219.56/219.73  |- mesh__recordOriginator mesh__D049028 jmp
% 219.56/219.73  |- rdf__type mesh__D049028sskos__Concept
% 219.56/219.73  |- skos__hiddenLabel mesh__D049028 Dystrophin Associated Protein Complex
% 219.56/219.73  |- mesh__recordMaintainer mesh__D049028 ags
% 219.56/219.73  |- mesh__publicMeSHNote mesh__D049028 2005   
% 219.56/219.73  |- skos__broader mesh__D049028smesh__D046912
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013354 2001
% 219.56/219.73  |- mesh__recordAuthorizer mesh__D013354 ags
% 219.56/219.73  |- skos__altLabel mesh__D013354 Subdural Empyema
% 219.56/219.73  |- mesh__historyNote mesh__D013354 1995%28%1984%29%   
% 219.56/219.73  |- mesh__recordOriginator mesh__D013354 RC
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013354 2005
% 219.56/219.73  |- rdf__type mesh__D013354sskos__Concept
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013354 2004
% 219.56/219.73  |- skos__annotation mesh__D013354
% 219.56/219.73       coord IM with specific infection %28%IM%29% and specific CNS infection term %28%IM%29%%A%  
% 219.56/219.73  |- skos__hiddenLabel mesh__D013354 Subdural Empyemas
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013354 2006
% 219.56/219.73  |- mesh__dateCreated mesh__D013354 1983-04-21
% 219.56/219.73  |- skos__broader mesh__D013354smesh__D020819
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013354 2002
% 219.56/219.73  |- skos__related mesh__D013354smesh__D001922
% 219.56/219.73  |- skos__broader mesh__D013354smesh__D004653
% 219.56/219.73  |- skos__broader mesh__D013354smesh__D002494
% 219.56/219.73  |- mesh__recordMaintainer mesh__D013354 ags
% 219.56/219.73  |- skos__scopeNote mesh__D013354
% 219.56/219.73       An intracranial or rarely intraspinal suppurative process invading the space between the inner surface of the DURA MATER and the outer surface of the ARACHNOID. Bacteria and other pathogenic organisms may gain entrance to the subdural space from the FRONTAL SINUS; ETHMOID SINUS; middle ear %28%EAR, MIDDLE%29%; MASTOID; or as the result of CRANIOCEREBRAL TRAUMA or NEUROSURGICAL PROCEDURES. This condition may be associated with intracranial sinus thrombosis %28%SINUS THROMBOSIS, INTRACRANIAL%29%. Circumscribed collections of purulent material in the subdural space are referred to as subdural abscesses. %28%From Adams et al., Principles of Neurology, 6th ed, p709%29%%A%    
% 219.56/219.73  |- mesh__dateEstablished mesh__D013354 1984-01-01
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013354 2000A
% 219.56/219.73  |- skos__historyNote mesh__D013354 Brain Abscess %28%1966-1983%29%
% 219.56/219.73  |- skos__prefLabel mesh__D013354 Empyema, Subdural
% 219.56/219.73  |- skos__broader mesh__D013354smesh__D020806
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013354 2000
% 219.56/219.73  |- mesh__publicMeSHNote mesh__D013354
% 219.56/219.73       1995; see SUBDURAL EMPYEMA 1984-94; for EMPYEMA, SUBDURAL see SUBDURAL EMPYEMA 1984-94%A%  
% 219.56/219.73  |- mesh__dateRevised mesh__D013354 1999-12-08
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013354 2003
% 219.56/219.73  |- mesh__recordMaintainer mesh__D007317 lkt
% 219.56/219.73  |- mesh__dateRevised mesh__D007317 2005-06-30
% 219.56/219.73  |- skos__altLabel mesh__D007317 Insemination, Artificial, Husband
% 219.56/219.73  |- mesh__recordOriginator mesh__D007317 NLM
% 219.56/219.73  |- mesh__dateEstablished mesh__D007317 1991-01-01
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D007317 2006
% 219.56/219.73  |- mesh__dateCreated mesh__D007317 1974-11-19
% 219.56/219.73  |- skos__scopeNote mesh__D007317
% 219.56/219.73       Human artificial insemination in which the husband%27%s semen is used.%A%    
% 219.56/219.73  |- skos__altLabel mesh__D007317 AIH
% 219.56/219.73  |- skos__altLabel mesh__D007317 Homologous Insemination
% 219.56/219.73  |- skos__broader mesh__D007317smesh__D007315
% 219.56/219.73  |- skos__hiddenLabel mesh__D007317 Insemination, Husband Artificial
% 219.56/219.73  |- mesh__publicMeSHNote mesh__D007317
% 219.56/219.73       91; was see under INSEMINATION, ARTIFICIAL 1975-90   
% 219.56/219.73  |- skos__annotation mesh__D007317
% 219.56/219.73       human only; use of husband%27%s semen; DF: INSEMINATION ARTIFICIAL HOMOL%A%  
% 219.56/219.73  |- skos__altLabel mesh__D007317 Insemination, Homologous
% 219.56/219.73  |- skos__hiddenLabel mesh__D007317 Husband Artificial Insemination
% 219.56/219.73  |- skos__altLabel mesh__D007317 Artificial Insemination, Husband
% 219.56/219.73  |- rdf__type mesh__D007317sskos__Concept
% 219.56/219.73  |- skos__prefLabel mesh__D007317 Insemination, Artificial, Homologous
% 219.56/219.73  |- mesh__recordAuthorizer mesh__D007317 sjn
% 219.56/219.73  |- mesh__historyNote mesh__D007317
% 219.56/219.73       91%28%75%29%; was see under INSEMINATION, ARTIFICIAL 1975-90   
% 219.56/219.73  |- mesh__dateEstablished mesh__D051473 2006-01-01
% 219.56/219.73  |- rdf__type mesh__D051473sskos__Concept
% 219.56/219.73  |- skos__scopeNote mesh__D051473
% 219.56/219.73       A family of high molecular weight Maf transcription factors that contain distinct activation domains.%A%    
% 219.56/219.73  |- mesh__dateCreated mesh__D051473 2005-06-30
% 219.56/219.73  |- mesh__publicMeSHNote mesh__D051473 2006   
% 219.56/219.73  |- mesh__historyNote mesh__D051473 2006   
% 219.56/219.73  |- mesh__recordOriginator mesh__D051473 DRC
% 219.56/219.73  |- skos__prefLabel mesh__D051473 Maf Transcription Factors, Large
% 219.56/219.73  |- skos__broader mesh__D051473smesh__D050977
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D051473 2006
% 219.56/219.73  |- skos__altLabel mesh__D051473 Large Maf Transcription Factors
% 219.56/219.73  |- mesh__recordMaintainer mesh__D051473 DRC
% 219.56/219.73  |- mesh__recordAuthorizer mesh__D051473 sjn
% 219.56/219.73  |- mesh__dateRevised mesh__D017745 1994-02-28
% 219.56/219.73  |- skos__altLabel mesh__D017745 Thermal Destruction
% 219.56/219.73  |- mesh__dateCreated mesh__D017745 1992-12-28
% 219.56/219.73  |- skos__hiddenLabel mesh__D017745 Destructions, Thermal
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D017745 2002
% 219.56/219.73  |- mesh__publicMeSHNote mesh__D017745 94   
% 219.56/219.73  |- skos__hiddenLabel mesh__D017745 Thermal Destructions
% 219.56/219.73  |- skos__prefLabel mesh__D017745 Incineration
% 219.56/219.73  |- skos__scopeNote mesh__D017745
% 219.56/219.73       High temperature destruction of waste by burning with subsequent reduction to ashes or conversion to an inert mass.%A%    
% 219.56/219.73  |- skos__historyNote mesh__D017745 Refuse Disposal %28%1966-1993%29%
% 219.56/219.73  |- skos__broader mesh__D017745smesh__D012037
% 219.56/219.73  |- mesh__recordMaintainer mesh__D017745 JLS
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D017745 2003
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D017745 1996
% 219.56/219.73  |- mesh__recordAuthorizer mesh__D017745 PLS
% 219.56/219.73  |- mesh__historyNote mesh__D017745 94   
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D017745 2000
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D017745 2005
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D017745 1998
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D017745 2004
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D017745 1997
% 219.56/219.73  |- mesh__dateEstablished mesh__D017745 1994-01-01
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D017745 2001
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D017745 2006
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D017745 1999
% 219.56/219.73  |- rdf__type mesh__D017745sskos__Concept
% 219.56/219.73  |- mesh__recordOriginator mesh__D017745 JLS
% 219.56/219.73  |- skos__annotation mesh__D017745 restrict to waste disposal   
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D017745 1995
% 219.56/219.73  |- skos__hiddenLabel mesh__D017745 Destruction, Thermal
% 219.56/219.73  |- skos__hiddenLabel mesh__D017745 Incinerations
% 219.56/219.73  |- skos__broader mesh__D003725smesh__D003748
% 219.56/219.73  |- mesh__recordOriginator mesh__D003725 SMH
% 219.56/219.73  |- mesh__dateEstablished mesh__D003725 1991-01-01
% 219.56/219.73  |- skos__altLabel mesh__D003725 Articulators, Dental
% 219.56/219.73  |- skos__annotation mesh__D003725 DF: DENT ARTICULATORS   
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003725 1997
% 219.56/219.73  |- skos__historyNote mesh__D003725 Dental Equipment %28%1966-1976%29%
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003725 2006
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003725 1996
% 219.56/219.73  |- mesh__recordAuthorizer mesh__D003725 PLS
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003725 2005
% 219.56/219.73  |- rdf__type mesh__D003725sskos__Concept
% 219.56/219.73  |- skos__hiddenLabel mesh__D003725 Articulator
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003725 2002
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003725 2004
% 219.56/219.73  |- mesh__onlineNote mesh__D003725
% 219.56/219.73       use DENTAL EQUIPMENT to search ARTICULATORS, DENTAL 1969-74%A%  
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003725 2001
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003725 1995
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003725 2003
% 219.56/219.73  |- skos__altLabel mesh__D003725 Dental Articulator
% 219.56/219.73  |- skos__altLabel mesh__D003725 Articulator, Dental
% 219.56/219.73  |- mesh__publicMeSHNote mesh__D003725
% 219.56/219.73       91; was see under DENTAL EQUIPMENT 1977-90; was ARTICULATORS, DENTAL see under DENTAL EQUIPMENT 1969-74%A%  
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003725 2000
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003725 1999
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003725 1994
% 219.56/219.73  |- mesh__recordMaintainer mesh__D003725 TAP
% 219.56/219.73  |- skos__scopeNote mesh__D003725
% 219.56/219.73       Mechanical devices that simulate the temporomandibular joints and jaws to which maxillary and mandibular casts are attached. The entire assembly attempts to reproduce the movements of the mandible and the various tooth-to-tooth relationships that accompany those movements.%A%    
% 219.56/219.73  |- mesh__dateRevised mesh__D003725 1992-05-14
% 219.56/219.73  |- mesh__historyNote mesh__D003725
% 219.56/219.73       91%28%77%29%; was see under DENTAL EQUIPMENT 1977-90; was ARTICULATORS, DENTAL see under DENTAL EQUIPMENT 1969-74%A%  
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003725 1998
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D003725 1993
% 219.56/219.73  |- mesh__dateCreated mesh__D003725 1976-04-13
% 219.56/219.73  |- skos__prefLabel mesh__D003725 Dental Articulators
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D036101 2006
% 219.56/219.73  |- skos__prefLabel mesh__D036101 Cord Blood Stem Cell Transplantation
% 219.56/219.73  |- skos__scopeNote mesh__D036101
% 219.56/219.73       Transplantation of STEM CELLS collected from the fetal blood remaining in the UMBILICAL CORD and the PLACENTA after delivery. Included are the HEMATOPOIETIC STEM CELLS.%A%    
% 219.56/219.73  |- mesh__dateEstablished mesh__D036101 2003-01-01
% 219.56/219.73  |- mesh__historyNote mesh__D036101 2003   
% 219.56/219.73  |- mesh__publicMeSHNote mesh__D036101 2003   
% 219.56/219.73  |- rdf__type mesh__D036101sskos__Concept
% 219.56/219.73  |- skos__altLabel mesh__D036101
% 219.56/219.73       Umbilical Cord Blood Stem Cell Transplantation
% 219.56/219.73  |- skos__historyNote mesh__D036101
% 219.56/219.73       Hematopoietic Stem Cell Transplantation %28%1993-2002%29%
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D036101 2003
% 219.56/219.73  |- mesh__dateCreated mesh__D036101 2002-07-03
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D036101 2005
% 219.56/219.73  |- skos__broader mesh__D036101smesh__D033581
% 219.56/219.73  |- skos__altLabel mesh__D036101 Placental Blood Stem Cell Transplantation
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D036101 2004
% 219.56/219.73  |- mesh__recordOriginator mesh__D008410 NLM
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D008410 2003
% 219.56/219.73  |- skos__annotation mesh__D008410
% 219.56/219.73       GEN: prefer specific; /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 219.56/219.73  |- mesh__dateCreated mesh__D008410 1999-01-01
% 219.56/219.73  |- rdf__type mesh__D008410sskos__Concept
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D008410 2004
% 219.56/219.73  |- skos__hiddenLabel mesh__D008410 Muscles, Masticatory
% 219.56/219.73  |- skos__scopeNote mesh__D008410
% 219.56/219.73       Muscles arising in the zygomatic arch that close the jaw. Their nerve supply is masseteric from the mandibular division of the trigeminal nerve. %28%From Stedman, 25th ed%29%%A%    
% 219.56/219.73  |- skos__hiddenLabel mesh__D008410 Muscle, Masticatory
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D008410 2002
% 219.56/219.73  |- skos__broader mesh__D008410smesh__D018482
% 219.56/219.73  |- mesh__recordMaintainer mesh__D008410 nns
% 219.56/219.73  |- skos__hiddenLabel mesh__D008410 Masticatory Muscle
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D008410 2005
% 219.56/219.73  |- skos__prefLabel mesh__D008410 Masticatory Muscles
% 219.56/219.73  |- mesh__recordAuthorizer mesh__D008410 sjn
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D008410 2006
% 219.56/219.73  |- mesh__dateRevised mesh__D008410 2001-07-25
% 219.56/219.73  |- skos__broader mesh__D008410smesh__D013284
% 219.56/219.73  |- skos__hiddenLabel mesh__D049029 Dystrophin Associated Proteins
% 219.56/219.73  |- mesh__recordMaintainer mesh__D049029 SYSTEM
% 219.56/219.73  |- mesh__recordAuthorizer mesh__D049029 sjn
% 219.56/219.73  |- mesh__historyNote mesh__D049029 2005   
% 219.56/219.73  |- mesh__dateCreated mesh__D049029 2004-07-07
% 219.56/219.73  |- skos__broader mesh__D049029smesh__D008565
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D049029 2006
% 219.56/219.73  |- rdf__type mesh__D049029sskos__Concept
% 219.56/219.73  |- mesh__dateEstablished mesh__D049029 2005-01-01
% 219.56/219.73  |- skos__broader mesh__D049029smesh__D009124
% 219.56/219.73  |- skos__scopeNote mesh__D049029
% 219.56/219.73       A group of proteins that associate with DYSTROPHIN at the CELL MEMBRANE to form the DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX.%A%    
% 219.56/219.73  |- skos__prefLabel mesh__D049029 Dystrophin-Associated Proteins
% 219.56/219.73  |- skos__broader mesh__D049029smesh__D003598
% 219.56/219.73  |- mesh__publicMeSHNote mesh__D049029 2005   
% 219.56/219.73  |- mesh__recordOriginator mesh__D049029 jmp
% 219.56/219.73  |- mesh__dateRevised mesh__D049029 2005-06-30
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013355 1995
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013355 2006
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013355 2000
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013355 2001
% 219.56/219.73  |- mesh__recordOriginator mesh__D013355 NLM
% 219.56/219.73  |- skos__prefLabel mesh__D013355 Subdural Space
% 219.56/219.73  |- skos__annotation mesh__D013355
% 219.56/219.73       NIM: usually locational so few qualif apply   
% 219.56/219.73  |- mesh__dateRevised mesh__D013355 1992-05-18
% 219.56/219.73  |- mesh__dateEstablished mesh__D013355 1991-01-01
% 219.56/219.73  |- skos__hiddenLabel mesh__D013355 Spaces, Subdural
% 219.56/219.73  |- mesh__publicMeSHNote mesh__D013355 91; was see under MENINGES 1972-90   
% 219.56/219.73  |- skos__broader mesh__D013355smesh__D004388
% 219.56/219.73  |- mesh__recordAuthorizer mesh__D013355 PLS
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013355 2002
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013355 1996
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013355 1998
% 219.56/219.73  |- mesh__historyNote mesh__D013355
% 219.56/219.73       91%28%72%29%; was see under MENINGES 1972-90   
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013355 2003
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013355 1997
% 219.56/219.73  |- rdf__type mesh__D013355sskos__Concept
% 219.56/219.73  |- skos__hiddenLabel mesh__D013355 Subdural Spaces
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013355 1994
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013355 2005
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013355 1999
% 219.56/219.73  |- skos__historyNote mesh__D013355 Meninges %28%1966-1971%29%
% 219.56/219.73  |- skos__hiddenLabel mesh__D013355 Space, Subdural
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013355 2004
% 219.56/219.73  |- mesh__dateCreated mesh__D013355 1999-01-01
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D013355 1993
% 219.56/219.73  |- mesh__recordMaintainer mesh__D013355 TAP
% 219.56/219.73  |- skos__broader mesh__D007318smesh__D004493
% 219.56/219.73  |- skos__altLabel mesh__D007318 Training, Inservice
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D007318 1999
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D007318 2006
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D007318 1996
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D007318 2003
% 219.56/219.73  |- skos__hiddenLabel mesh__D007318 Program, Employee Orientation
% 219.56/219.73  |- skos__historyNote mesh__D007318 Education, Continuing %28%1966%29%
% 219.56/219.73  |- skos__altLabel mesh__D007318 On-the-Job Training
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D007318 1997
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D007318 2004
% 219.56/219.73  |- mesh__historyNote mesh__D007318 70%28%67%29%   
% 219.56/219.73  |- skos__hiddenLabel mesh__D007318 On the Job Training
% 219.56/219.73  |- skos__hiddenLabel mesh__D007318 Training, On-the-Job
% 219.56/219.73  |- mesh__recordOriginator mesh__D007318 NLM
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D007318 2000
% 219.56/219.73  |- skos__prefLabel mesh__D007318 Inservice Training
% 219.56/219.73  |- skos__scopeNote mesh__D007318
% 219.56/219.73       On the job training programs for personnel carried out within an institution or agency. It includes orientation programs.%A%    
% 219.56/219.73  |- rdf__type mesh__D007318sskos__Concept
% 219.56/219.73  |- skos__annotation mesh__D007318 DF: INSERV TRAINING   
% 219.56/219.73  |- skos__hiddenLabel mesh__D007318 Programs, Employee Orientation
% 219.56/219.73  |- skos__altLabel mesh__D007318 Employee Orientation Programs
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D007318 2001
% 219.56/219.73  |- skos__hiddenLabel mesh__D007318 Employee Orientation Program
% 219.56/219.73  |- mesh__dateCreated mesh__D007318 1999-01-01
% 219.56/219.73  |- mesh__dateEstablished mesh__D007318 1970-01-01
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D007318 2002
% 219.56/219.73  |- mesh__dateRevised mesh__D007318 1995-05-22
% 219.56/219.73  |- mesh__recordMaintainer mesh__D007318 KEV
% 219.56/219.73  |- skos__hiddenLabel mesh__D007318 Orientation Program, Employee
% 219.56/219.73  |- mesh__publicMeSHNote mesh__D007318 70   
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D007318 1998
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D007318 2005
% 219.56/219.73  |- mesh__recordAuthorizer mesh__D007318 PLS
% 219.56/219.73  |- skos__altLabel mesh__D018040 Neurokinin-1 Receptors
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D018040 1999
% 219.56/219.73  |- skos__altLabel mesh__D018040 Receptors, SP-P
% 219.56/219.73  |- mesh__publicMeSHNote mesh__D018040
% 219.56/219.73       94; SUBSTANCE P RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1985-93 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1981-84%A%  
% 219.56/219.73  |- skos__altLabel mesh__D018040 NK-1 Receptor
% 219.56/219.73  |- skos__historyNote mesh__D018040
% 219.56/219.73       Receptors, Cell Surface %28%1981-1984%29%
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D018040 2002
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D018040 2003
% 219.56/219.73  |- mesh__dateRevised mesh__D018040 1997-06-20
% 219.56/219.73  |- skos__hiddenLabel mesh__D018040 SP P Receptors
% 219.56/219.73  |- skos__hiddenLabel mesh__D018040 Receptor, Substance P
% 219.56/219.73  |- skos__altLabel mesh__D018040 Receptors, Substance P
% 219.56/219.73  |- mesh__recordAuthorizer mesh__D018040 SJN
% 219.56/219.73  |- skos__altLabel mesh__D018040 SP-P Receptors
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D018040 1998
% 219.56/219.73  |- skos__altLabel mesh__D018040 Neurokinin-1 Receptor
% 219.56/219.73  |- skos__hiddenLabel mesh__D018040 Receptors, Neurokinin 1
% 219.56/219.73  |- skos__altLabel mesh__D018040 SP-P Receptor
% 219.56/219.73  |- skos__altLabel mesh__D018040 NK-1 Receptors
% 219.56/219.73  |- skos__prefLabel mesh__D018040 Receptors, Neurokinin-1
% 219.56/219.73  |- skos__annotation mesh__D018040
% 219.56/219.73       tachykinin receptors; DF: RECEPT NEUROKININ 1   
% 219.56/219.73  |- skos__hiddenLabel mesh__D018040 Receptors, NK 1
% 219.56/219.73  |- skos__hiddenLabel mesh__D018040 Receptor, SP-P
% 219.56/219.73  |- skos__historyNote mesh__D018040 Receptors, Drug %28%1968-1993%29%
% 219.56/219.73  |- skos__hiddenLabel mesh__D018040 P Receptors, Substance
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D018040 2001
% 219.56/219.73  |- skos__hiddenLabel mesh__D018040 Receptor, Neurokinin-1
% 219.56/219.73  |- mesh__onlineNote mesh__D018040
% 219.56/219.73       use RECEPTORS, NEUROKININ-1 %28%NM%29% to search SUBSTANCE P RECEPTOR 1981-93%A%  
% 219.56/219.73  |- mesh__dateCreated mesh__D018040 1993-06-21
% 219.56/219.73  |- skos__hiddenLabel mesh__D018040 NK 1 Receptor
% 219.56/219.73  |- skos__hiddenLabel mesh__D018040 Receptors, SP P
% 219.56/219.73  |- skos__altLabel mesh__D018040 Receptors, NK-1
% 219.56/219.73  |- skos__hiddenLabel mesh__D018040 P Receptor, Substance
% 219.56/219.73  |- mesh__recordOriginator mesh__D018040 RAZ
% 219.56/219.73  |- skos__scopeNote mesh__D018040
% 219.56/219.73       A class of cell surface receptors for tachykinins with a preference for substance P. Neurokinin-1 %28%NK-1%29% receptors have been cloned and are members of the G protein coupled receptor superfamily. They are found on many cell types including central and peripheral neurons, smooth muscle cells, acinar cells, endothelial cells, fibroblasts, and immune cells.%A%    
% 219.56/219.73  |- mesh__recordMaintainer mesh__D018040 NDW
% 219.56/219.73  |- skos__hiddenLabel mesh__D018040 Neurokinin 1 Receptors
% 219.56/219.73  |- mesh__dateEstablished mesh__D018040 1994-01-01
% 219.56/219.73  |- skos__hiddenLabel mesh__D018040 Receptor, NK-1
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D018040 2006
% 219.56/219.73  |- mesh__activeMeSHYear mesh__D018040 2000
% 219.56/219.73  |- skos__hiddenLabel mesh__D018040 NK 1 Receptors
% 219.56/219.73  |- mesh__historyNote mesh__D018040
% 219.56/219.73       94; was SUBSTANCE P RECEPTOR %28%NM%29% 1981-93; NK-1 RECEPTOR %26% NEUROKININ-1 RECEPTOR were SY to SUBSTANCE K RECEPTOR 1986-93; NK-1 RECEPTOR SITE was SY to TACHYKININ RECEPTOR 1989-93%A%  
% 219.56/219.73  |- skos__hiddenLabel mesh__D018040 Neurokinin 1 Receptor
% 219.56/219.73  |- skos__broader mesh__D018040smesh__D018039
% 219.56/219.74  |- rdf__type mesh__D018040sskos__Concept
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D018040 2005
% 219.56/219.74  |- skos__historyNote mesh__D018040
% 219.56/219.74       Receptors, Neurotransmitter %28%1985-1993%29%
% 219.56/219.74  |- skos__altLabel mesh__D018040 Substance P Receptors
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D018040 2004
% 219.56/219.74  |- skos__hiddenLabel mesh__D018040 SP P Receptor
% 219.56/219.74  |- skos__altLabel mesh__D018040 Substance P Receptor
% 219.56/219.74  |- mesh__dateRevised mesh__D051474 2005-07-21
% 219.56/219.74  |- mesh__recordAuthorizer mesh__D051474 ags
% 219.56/219.74  |- mesh__publicMeSHNote mesh__D051474 2006   
% 219.56/219.74  |- mesh__recordMaintainer mesh__D051474 ags
% 219.56/219.74  |- mesh__dateCreated mesh__D051474 2005-06-30
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D051474 2006A
% 219.56/219.74  |- rdf__type mesh__D051474sskos__Concept
% 219.56/219.74  |- skos__historyNote mesh__D051474 Neuralgia %28%1968-2005%29%
% 219.56/219.74  |- mesh__recordOriginator mesh__D051474 ags
% 219.56/219.74  |- mesh__dateEstablished mesh__D051474 2006-01-01
% 219.56/219.74  |- skos__historyNote mesh__D051474 Herpes Zoster %28%1968-2005%29%
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D051474 2006
% 219.56/219.74  |- skos__altLabel mesh__D051474 Postherpetic Neuralgia
% 219.56/219.74  |- mesh__historyNote mesh__D051474 2006   
% 219.56/219.74  |- skos__scopeNote mesh__D051474
% 219.56/219.74       Pain in nerves, frequently involving facial SKIN, resulting from the activation the latent varicella-zoster virus %28%HERPESVIRUS 3, HUMAN%29%. The two forms of the condition preceding the pain are HERPES ZOSTER OPTICUS; and HERPES ZOSTER OPHTHALMICUS. Following the healing of the rashes and blisters, the pain sometimes persists.%A%    
% 219.56/219.74  |- skos__related mesh__D051474smesh__D006562
% 219.56/219.74  |- skos__prefLabel mesh__D051474 Neuralgia, Postherpetic
% 219.56/219.74  |- skos__broader mesh__D051474smesh__D009437
% 219.56/219.74  |- mesh__recordMaintainer mesh__D004020 kle
% 219.56/219.74  |- rdf__type mesh__D004020sskos__Concept
% 219.56/219.74  |- skos__hiddenLabel mesh__D004020 Polyglot Dictionaries
% 219.56/219.74  |- mesh__recordAuthorizer mesh__D004020 sjn
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D004020 2002
% 219.56/219.74  |- mesh__dateRevised mesh__D004020 1999-11-03
% 219.56/219.74  |- skos__broader mesh__D004020smesh__D004014
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D004020 2005
% 219.56/219.74  |- skos__hiddenLabel mesh__D004020 Polyglot Dictionary
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D004020 2006
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D004020 2000
% 219.56/219.74  |- mesh__recordOriginator mesh__D004020 NLM
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D004020 2003
% 219.56/219.74  |- skos__annotation mesh__D004020
% 219.56/219.74       IM for polyglot dictionaries as a subject; for article listing terms %26% definitions in different languages, index under specific subject %28%IM%29% + DICTIONARIES, POLYGLOT %28%NIM%29% + DICTIONARY %28%PT%29%; no qualif%A%  
% 219.56/219.74  |- skos__hiddenLabel mesh__D004020 Dictionary, Polyglot
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D004020 2001
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D004020 2004
% 219.56/219.74  |- mesh__dateCreated mesh__D004020 1999-01-01
% 219.56/219.74  |- skos__prefLabel mesh__D004020 Dictionaries, Polyglot
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D017746 2000
% 219.56/219.74  |- skos__annotation mesh__D017746
% 219.56/219.74       coord IM with specific joint %28%IM%29% or bone %28%IM%29% if no joint term is available%A%  
% 219.56/219.74  |- skos__altLabel mesh__D017746 Synovial Capsule
% 219.56/219.74  |- skos__hiddenLabel mesh__D017746 Capsules, Joint
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D017746 2003
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D017746 2001
% 219.56/219.74  |- mesh__historyNote mesh__D017746 94   
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D017746 2005
% 219.56/219.74  |- mesh__recordMaintainer mesh__D017746 KEV
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D017746 2004
% 219.56/219.74  |- mesh__dateRevised mesh__D017746 1999-11-03
% 219.56/219.74  |- mesh__recordAuthorizer mesh__D017746 sjn
% 219.56/219.74  |- skos__broader mesh__D017746smesh__D007596
% 219.56/219.74  |- skos__historyNote mesh__D017746 Joints %28%1966-1993%29%
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D017746 2006
% 219.56/219.74  |- rdf__type mesh__D017746sskos__Concept
% 219.56/219.74  |- skos__hiddenLabel mesh__D017746 Capsule, Joint
% 219.56/219.74  |- mesh__recordOriginator mesh__D017746 JLS
% 219.56/219.74  |- skos__hiddenLabel mesh__D017746 Capsules, Synovial
% 219.56/219.74  |- skos__altLabel mesh__D017746 Articular Capsule
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D017746 2002
% 219.56/219.74  |- skos__prefLabel mesh__D017746 Joint Capsule
% 219.56/219.74  |- mesh__publicMeSHNote mesh__D017746 94   
% 219.56/219.74  |- mesh__dateCreated mesh__D017746 1992-12-28
% 219.56/219.74  |- skos__hiddenLabel mesh__D017746 Synovial Capsules
% 219.56/219.74  |- skos__hiddenLabel mesh__D017746 Joint Capsules
% 219.56/219.74  |- skos__hiddenLabel mesh__D017746 Capsule, Synovial
% 219.56/219.74  |- skos__hiddenLabel mesh__D017746 Articular Capsules
% 219.56/219.74  |- skos__hiddenLabel mesh__D017746 Capsules, Articular
% 219.56/219.74  |- skos__scopeNote mesh__D017746
% 219.56/219.74       The sac enclosing a joint. It is composed of an outer fibrous articular capsule and an inner SYNOVIAL MEMBRANE.%A%    
% 219.56/219.74  |- mesh__dateEstablished mesh__D017746 1994-01-01
% 219.56/219.74  |- skos__hiddenLabel mesh__D017746 Capsule, Articular
% 219.56/219.74  |- skos__altLabel mesh__D017746 Capsula Articularis
% 219.56/219.74  |- mesh__recordMaintainer mesh__D003726 TGC
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003726 2001
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003726 2006
% 219.56/219.74  |- skos__annotation mesh__D003726
% 219.56/219.74       assist a dentist or hygienist; DENTAL AUXILIARIES is also available; DF: DENT ASSISTANTS%A%  
% 219.56/219.74  |- skos__altLabel mesh__D003726 Dental Assistant
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003726 2003
% 219.56/219.74  |- skos__altLabel mesh__D003726 Dental Nurses
% 219.56/219.74  |- rdf__type mesh__D003726sskos__Concept
% 219.56/219.74  |- skos__altLabel mesh__D003726 Nurses, Dental
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003726 2002
% 219.56/219.74  |- skos__broader mesh__D003726smesh__D003727
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003726 2004
% 219.56/219.74  |- skos__hiddenLabel mesh__D003726 Dental Nurse
% 219.56/219.74  |- mesh__dateRevised mesh__D003726 1997-06-20
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003726 1998
% 219.56/219.74  |- mesh__dateCreated mesh__D003726 1999-01-01
% 219.56/219.74  |- skos__altLabel mesh__D003726 Assistants, Dental
% 219.56/219.74  |- skos__scopeNote mesh__D003726
% 219.56/219.74       Individuals who assist the dentist or the dental hygienist.%A%    
% 219.56/219.74  |- skos__altLabel mesh__D003726 Assistant, Dental
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003726 1999
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003726 2000
% 219.56/219.74  |- skos__prefLabel mesh__D003726 Dental Assistants
% 219.56/219.74  |- mesh__recordAuthorizer mesh__D003726 SJN
% 219.56/219.74  |- mesh__recordOriginator mesh__D003726 NLM
% 219.56/219.74  |- skos__hiddenLabel mesh__D003726 Nurse, Dental
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003726 2005
% 219.56/219.74  |- rdf__type mesh__D036102sskos__Concept
% 219.56/219.74  |- mesh__dateCreated mesh__D036102 2002-07-03
% 219.56/219.74  |- mesh__publicMeSHNote mesh__D036102
% 219.56/219.74       2003; see HEMATOPOIETIC STEM CELL TRANSPLANTATION 1995-2002%A%  
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D036102 2003
% 219.56/219.74  |- skos__historyNote mesh__D036102
% 219.56/219.74       Hematopoietic Stem Cells/transplantation %28%1986-1994%29%
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D036102 2005
% 219.56/219.74  |- mesh__dateEstablished mesh__D036102 2003-01-01
% 219.56/219.74  |- skos__broader mesh__D036102smesh__D033581
% 219.56/219.74  |- mesh__historyNote mesh__D036102
% 219.56/219.74       2003; use HEMATOPOIETIC STEM CELL TRANSPLANTATION 1995-2002%A%  
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D036102 2004
% 219.56/219.74  |- skos__altLabel mesh__D036102 Peripheral Stem Cell Transplantation
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D036102 2006
% 219.56/219.74  |- skos__altLabel mesh__D036102 Transplantation, Peripheral Stem Cell
% 219.56/219.74  |- skos__prefLabel mesh__D036102 Peripheral Blood Stem Cell Transplantation
% 219.56/219.74  |- skos__altLabel mesh__D036102 Stem Cell Transplantation, Peripheral
% 219.56/219.74  |- skos__scopeNote mesh__D036102
% 219.56/219.74       Transplantation of stem cells collected from the peripheral blood. It is a less invasive alternative to direct marrow harvesting of hematopoietic stem cells. Enrichment of stem cells in peripheral blood can be achieved by inducing mobilization of stem cells from the BONE MARROW.%A%    
% 219.56/219.74  |- skos__historyNote mesh__D036102
% 219.56/219.74       Hematopoietic Stem Cell Transplantation %28%1995-2002%29%
% 219.56/219.74  |- skos__broader mesh__D004194Q000532smesh__D004194
% 219.56/219.74  |- mesh__preferredCombination mesh__D004194Q000532smesh__D011878
% 219.56/219.74  |- rdf__type mesh__D004194Q000532smesh__CompoundConcept
% 219.56/219.74  |- mesh__publicMeSHNote mesh__D008411 99; see MASTIGOMYCOTINA 1986-98   
% 219.56/219.74  |- mesh__historyNote mesh__D008411 99%28%86%29%   
% 219.56/219.74  |- mesh__dateEstablished mesh__D008411 1986-01-01
% 219.56/219.74  |- mesh__recordAuthorizer mesh__D008411 sjn
% 219.56/219.74  |- rdf__type mesh__D008411sskos__Concept
% 219.56/219.74  |- skos__scopeNote mesh__D008411
% 219.56/219.74       A phylum of fungi that was formerly considered a subdivision of Phycomycetes. They are the only fungi that produce motile cells at some stage in their life cycle. Most are saprobes but they also contain examples of plant, animal and fungal pathogens.%A%    
% 219.56/219.74  |- skos__historyNote mesh__D008411 Phycomyces %28%1966-1985%29%
% 219.56/219.74  |- skos__altLabel mesh__D008411 Mastigomycotina
% 219.56/219.74  |- skos__broader mesh__D008411smesh__D005658
% 219.56/219.74  |- mesh__recordOriginator mesh__D008411 RC
% 219.56/219.74  |- mesh__recordMaintainer mesh__D008411 SYSTEM
% 219.56/219.74  |- skos__prefLabel mesh__D008411 Chytridiomycota
% 219.56/219.74  |- mesh__dateCreated mesh__D008411 1985-02-12
% 219.56/219.74  |- mesh__dateRevised mesh__D008411 2005-06-30
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D008411 2006
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013356 1996
% 219.56/219.74  |- mesh__historyNote mesh__D013356
% 219.56/219.74       91%28%77%29%; was see under NEUROSECRETORY SYSTEMS 1977-90   
% 219.56/219.74  |- skos__historyNote mesh__D013356 Neurosecretory Systems %28%1970-1976%29%
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013356 2000
% 219.56/219.74  |- rdf__type mesh__D013356sskos__Concept
% 219.56/219.74  |- skos__scopeNote mesh__D013356
% 219.56/219.74       A structure, situated close to the intraventricular foramen, which induces drinking behavior after stimulation with angiotensin II.%A%    
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013356 1999
% 219.56/219.74  |- skos__hiddenLabel mesh__D013356 Organs, Subfornical
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013356 2003
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013356 1995
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013356 2006
% 219.56/219.74  |- mesh__recordOriginator mesh__D013356 MM
% 219.56/219.74  |- skos__prefLabel mesh__D013356 Subfornical Organ
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013356 1998
% 219.56/219.74  |- mesh__recordMaintainer mesh__D013356 TAP
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013356 2002
% 219.56/219.74  |- skos__hiddenLabel mesh__D013356 Subfornical Organs
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013356 1994
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013356 2005
% 219.56/219.74  |- mesh__recordAuthorizer mesh__D013356 PLS
% 219.56/219.74  |- skos__broader mesh__D013356smesh__D009490
% 219.56/219.74  |- mesh__publicMeSHNote mesh__D013356
% 219.56/219.74       91; was see under NEUROSECRETORY SYSTEMS 1977-90   
% 219.56/219.74  |- skos__hiddenLabel mesh__D013356 Organ, Subfornical
% 219.56/219.74  |- mesh__dateRevised mesh__D013356 1992-05-18
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013356 1997
% 219.56/219.74  |- mesh__dateEstablished mesh__D013356 1991-01-01
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013356 2001
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013356 2004
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013356 1993
% 219.56/219.74  |- mesh__dateCreated mesh__D013356 1976-04-27
% 219.56/219.74  |- skos__prefLabel mesh__D007319 Sleep Initiation and Maintenance Disorders
% 219.56/219.74  |- skos__hiddenLabel mesh__D007319 Insomnias
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D007319 2005
% 219.56/219.74  |- skos__hiddenLabel mesh__D007319 Insomnia Disorders
% 219.56/219.74  |- skos__altLabel mesh__D007319
% 219.56/219.74       Disorders of Initiating and Maintaining Sleep
% 219.56/219.74  |- skos__hiddenLabel mesh__D007319 Insomnia, Secondary
% 219.56/219.74  |- skos__altLabel mesh__D007319
% 219.56/219.74       DIMS %28%Disorders of Initiating and Maintaining Sleep%29%
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D007319 2003
% 219.56/219.74  |- mesh__recordOriginator mesh__D007319 NLM
% 219.56/219.74  |- skos__annotation mesh__D007319
% 219.56/219.74       do not confuse with SLEEP DEPRIVATION, being deprived of sleep or prevented from sleeping; usually chronic so do not coord with CHRONIC DISEASE%A%  
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D007319 2006
% 219.56/219.74  |- mesh__historyNote mesh__D007319 2000%28%1966%29%   
% 219.56/219.74  |- skos__hiddenLabel mesh__D007319 Insomnia, Transient
% 219.56/219.74  |- skos__hiddenLabel mesh__D007319 Insomnia, Primary
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D007319 2004
% 219.56/219.74  |- rdf__type mesh__D007319sskos__Concept
% 219.56/219.74  |- skos__hiddenLabel mesh__D007319 Insomnia, Psychophysiological
% 219.56/219.74  |- skos__altLabel mesh__D007319 Insomnia Disorder
% 219.56/219.74  |- mesh__dateCreated mesh__D007319 1999-01-01
% 219.56/219.74  |- skos__hiddenLabel mesh__D007319 Dysfunctions, Sleep Initiation
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D007319 2001
% 219.56/219.74  |- skos__hiddenLabel mesh__D007319 Insomnia, Nonorganic
% 219.56/219.74  |- skos__hiddenLabel mesh__D007319 Awakening, Early
% 219.56/219.74  |- skos__altLabel mesh__D007319 Insomnia
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D007319 2002
% 219.56/219.74  |- mesh__recordMaintainer mesh__D007319 ags
% 219.56/219.74  |- mesh__publicMeSHNote mesh__D007319 2000; see INSOMNIA 1966-1999   
% 219.56/219.74  |- skos__hiddenLabel mesh__D007319 Insomnia, Rebound
% 219.56/219.74  |- mesh__recordAuthorizer mesh__D007319 sjn
% 219.56/219.74  |- mesh__dateRevised mesh__D007319 2000-06-21
% 219.56/219.74  |- skos__hiddenLabel mesh__D007319 Insomnia, Chronic
% 219.56/219.74  |- skos__scopeNote mesh__D007319
% 219.56/219.74       Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.%A%    
% 219.56/219.74  |- skos__broader mesh__D007319smesh__D020919
% 219.56/219.74  |- skos__hiddenLabel mesh__D007319 Sleep Initiation Dysfunctions
% 219.56/219.74  |- skos__hiddenLabel mesh__D007319 Dysfunction, Sleep Initiation
% 219.56/219.74  |- skos__altLabel mesh__D018041 Receptors, Substance K
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D018041 2005
% 219.56/219.74  |- mesh__recordAuthorizer mesh__D018041 sjn
% 219.56/219.74  |- skos__historyNote mesh__D018041
% 219.56/219.74       Receptors, Neurotransmitter %28%1985-1993%29%
% 219.56/219.74  |- mesh__dateRevised mesh__D018041 2001-07-25
% 219.56/219.74  |- skos__altLabel mesh__D018041 SP-K Receptors
% 219.56/219.74  |- skos__altLabel mesh__D018041 Receptors, NK-2
% 219.56/219.74  |- skos__hiddenLabel mesh__D018041 Receptors, Neurokinin A
% 219.56/219.74  |- mesh__recordOriginator mesh__D018041 RAZ
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D018041 2006
% 219.56/219.74  |- skos__altLabel mesh__D018041 Neurokinin A Receptors
% 219.56/219.74  |- skos__hiddenLabel mesh__D018041 NK 2 Receptors
% 219.56/219.74  |- skos__broader mesh__D018041smesh__D018039
% 219.56/219.74  |- rdf__type mesh__D018041sskos__Concept
% 219.56/219.74  |- skos__altLabel mesh__D018041 NK-2 Receptors
% 219.56/219.74  |- skos__hiddenLabel mesh__D018041 Receptors, SP-K
% 219.56/219.74  |- mesh__dateCreated mesh__D018041 1993-06-21
% 219.56/219.74  |- skos__hiddenLabel mesh__D018041 Neurokinin 2 Receptor
% 219.56/219.74  |- skos__altLabel mesh__D018041 Neurokinin-2 Receptor
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D018041 2003
% 219.56/219.74  |- skos__altLabel mesh__D018041 Neurokinin-2 Receptors
% 219.56/219.74  |- skos__hiddenLabel mesh__D018041 Receptor, Neurokinin-2
% 219.56/219.74  |- skos__hiddenLabel mesh__D018041 Receptor, SP-K
% 219.56/219.74  |- skos__hiddenLabel mesh__D018041 SP K Receptor
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D018041 2002
% 219.56/219.74  |- skos__altLabel mesh__D018041 NK-2 Receptor
% 219.56/219.74  |- skos__hiddenLabel mesh__D018041 Receptor, Substance K
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D018041 2004
% 219.56/219.74  |- mesh__publicMeSHNote mesh__D018041
% 219.56/219.74       94; SUBSTANCE K RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1984-93%A%  
% 219.56/219.74  |- mesh__dateEstablished mesh__D018041 1994-01-01
% 219.56/219.74  |- skos__hiddenLabel mesh__D018041 Receptor, NK-2
% 219.56/219.74  |- skos__hiddenLabel mesh__D018041 SP K Receptors
% 219.56/219.74  |- skos__altLabel mesh__D018041 NK-2 Receptor Site
% 219.56/219.74  |- skos__hiddenLabel mesh__D018041 Neurokinin 2 Receptors
% 219.56/219.74  |- skos__hiddenLabel mesh__D018041 Receptor Site, NK-2
% 219.56/219.74  |- skos__hiddenLabel mesh__D018041 Receptors, Neurokinin 2
% 219.56/219.74  |- mesh__recordMaintainer mesh__D018041 mdb
% 219.56/219.74  |- skos__altLabel mesh__D018041 SP-K Receptor
% 219.56/219.74  |- skos__altLabel mesh__D018041 Substance K Receptors
% 219.56/219.74  |- skos__hiddenLabel mesh__D018041 A Receptors, Neurokinin
% 219.56/219.74  |- mesh__onlineNote mesh__D018041
% 219.56/219.74       use RECEPTORS, NEUROKININ-2 %28%NM%29% to search SUBSTANCE K RECEPTOR 1984-93%A%  
% 219.56/219.74  |- mesh__historyNote mesh__D018041
% 219.56/219.74       94; was SUBSTANCE K RECEPTOR %28%NM%29% 1984-93; NK-2 RECEPTOR SITE was SY to TACHYKININ RECEPTOR 1989-93%A%  
% 219.56/219.74  |- skos__prefLabel mesh__D018041 Receptors, Neurokinin-2
% 219.56/219.74  |- skos__scopeNote mesh__D018041
% 219.56/219.74       A class of cell surface receptors for tachykinins that prefers neurokinin A; %28%NKA, substance K, neurokinin alpha, neuromedin L%29%, neuropeptide K; %28%NPK%29%; or neuropeptide gamma over other tachykinins. Neurokinin-2 %28%NK-2%29% receptors have been cloned and are similar to other G-protein coupled receptors.%A%    
% 219.56/219.74  |- skos__hiddenLabel mesh__D018041 NK 2 Receptor Site
% 219.56/219.74  |- skos__hiddenLabel mesh__D018041 Receptors, NK 2
% 219.56/219.74  |- skos__annotation mesh__D018041
% 219.56/219.74       tachykinin receptors; DF: RECEPT NEUROKININ 2   
% 219.56/219.74  |- skos__altLabel mesh__D018041 Substance K Receptor
% 219.56/219.74  |- skos__hiddenLabel mesh__D018041 NK 2 Receptor
% 219.56/219.74  |- skos__annotation mesh__D004021
% 219.56/219.74       a genus of nematodes; infection = DICTYOCAULUS INFECTIONS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 219.56/219.74  |- mesh__dateCreated mesh__D004021 1974-12-12
% 219.56/219.74  |- skos__broader mesh__D004021smesh__D014251
% 219.56/219.74  |- mesh__dateRevised mesh__D004021 2003-07-09
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D004021 2005
% 219.56/219.74  |- mesh__publicMeSHNote mesh__D004021
% 219.56/219.74       91; was see under TRICHOSTRONGYLOIDEA 1986-90; was see under METASTRONGYLOIDEA 1975-85%A%  
% 219.56/219.74  |- mesh__historyNote mesh__D004021
% 219.56/219.74       91%28%75%29%; was see under TRICHOSTRONGYLOIDEA 1986-90; was see under METASTRONGYLOIDEA 1975-85%A%  
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D004021 2006
% 219.56/219.74  |- mesh__recordAuthorizer mesh__D004021 sjn
% 219.56/219.74  |- skos__scopeNote mesh__D004021
% 219.56/219.74       Nematodes parasitic in the bronchi of herbivorous animals.%A%    
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D004021 2004
% 219.56/219.74  |- skos__prefLabel mesh__D004021 Dictyocaulus
% 219.56/219.74  |- mesh__dateEstablished mesh__D004021 1991-01-01
% 219.56/219.74  |- mesh__recordOriginator mesh__D004021 NLM
% 219.56/219.74  |- mesh__recordMaintainer mesh__D004021 ags
% 219.56/219.74  |- rdf__type mesh__D004021sskos__Concept
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D017747 2001
% 219.56/219.74  |- skos__scopeNote mesh__D017747
% 219.56/219.74       Marine fish and shellfish used as food or suitable for food. %28%Webster, 3d ed%29% SHELLFISH and FISH PRODUCTS are more specific types of SEAFOOD.%A%    
% 219.56/219.74  |- skos__altLabel mesh__D017747 Sea-Food
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D017747 1998
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D017747 2003
% 219.56/219.74  |- mesh__historyNote mesh__D017747 94   
% 219.56/219.74  |- rdf__type mesh__D017747sskos__Concept
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D017747 2005
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D017747 1999
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D017747 2004
% 219.56/219.74  |- skos__prefLabel mesh__D017747 Seafood
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D017747 2002
% 219.56/219.74  |- mesh__recordMaintainer mesh__D017747 JLS
% 219.56/219.74  |- skos__broader mesh__D017747smesh__D008460
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D017747 2006
% 219.56/219.74  |- mesh__recordOriginator mesh__D017747 JLS
% 219.56/219.74  |- skos__hiddenLabel mesh__D017747 Sea-Foods
% 219.56/219.74  |- skos__hiddenLabel mesh__D017747 Sea Food
% 219.56/219.74  |- mesh__publicMeSHNote mesh__D017747 94   
% 219.56/219.74  |- mesh__dateCreated mesh__D017747 1992-12-28
% 219.56/219.74  |- mesh__recordAuthorizer mesh__D017747 SJN
% 219.56/219.74  |- skos__annotation mesh__D017747
% 219.56/219.74       %22%marine fish %26% shellfish used as food%22%; coord IM with specific fish or shellfish %28%IM%29%%A%  
% 219.56/219.74  |- skos__hiddenLabel mesh__D017747 Seafoods
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D017747 2000
% 219.56/219.74  |- mesh__dateRevised mesh__D017747 1997-06-20
% 219.56/219.74  |- mesh__dateEstablished mesh__D017747 1994-01-01
% 219.56/219.74  |- skos__annotation mesh__D036901
% 219.56/219.74       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.56/219.74  |- skos__altLabel mesh__D036901 Butterbur
% 219.56/219.74  |- skos__broader mesh__D036901smesh__D019659
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D036901 2005
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D036901 2003
% 219.56/219.74  |- mesh__dateEstablished mesh__D036901 2003-01-01
% 219.56/219.74  |- skos__altLabel mesh__D036901 Coltsfoot, Sweet
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D036901 2006
% 219.56/219.74  |- mesh__historyNote mesh__D036901 2003   
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D036901 2004
% 219.56/219.74  |- mesh__publicMeSHNote mesh__D036901 2003   
% 219.56/219.74  |- skos__prefLabel mesh__D036901 Petasites
% 219.56/219.74  |- mesh__dateCreated mesh__D036901 2002-07-02
% 219.56/219.74  |- rdf__type mesh__D036901sskos__Concept
% 219.56/219.74  |- skos__scopeNote mesh__D036901
% 219.56/219.74       A plant genus of the family ASTERACEAE. Members contain SESQUITERPENES. The common name of sweet coltsfoot is similar to the common name for TUSSILAGO.%A%    
% 219.56/219.74  |- skos__scopeNote mesh__D003727
% 219.56/219.74       Personnel whose work is prescribed and supervised by the dentist.%A%    
% 219.56/219.74  |- skos__altLabel mesh__D003727 Dental Auxiliary
% 219.56/219.74  |- mesh__recordOriginator mesh__D003727 NLM
% 219.56/219.74  |- mesh__historyNote mesh__D003727
% 219.56/219.74       78; was ALLIED DENTAL PERSONNEL %28%NON MESH%29% before 1978   
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003727 2003
% 219.56/219.74  |- rdf__type mesh__D003727sskos__Concept
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003727 1994
% 219.56/219.74  |- mesh__recordMaintainer mesh__D003727 PLS
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003727 2001
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003727 2004
% 219.56/219.74  |- skos__broader mesh__D003727smesh__D000488
% 219.56/219.74  |- skos__altLabel mesh__D003727 Dental Receptionists
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003727 1998
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003727 1995
% 219.56/219.74  |- mesh__dateCreated mesh__D003727 1999-01-01
% 219.56/219.74  |- mesh__dateEstablished mesh__D003727 1978-01-01
% 219.56/219.74  |- skos__altLabel mesh__D003727 Receptionists, Dental
% 219.56/219.74  |- skos__prefLabel mesh__D003727 Dental Auxiliaries
% 219.56/219.74  |- skos__altLabel mesh__D003727 Auxiliary, Dental
% 219.56/219.74  |- mesh__recordAuthorizer mesh__D003727 PLS
% 219.56/219.74  |- skos__annotation mesh__D003727 DF: DENT AUXILIARIES   
% 219.56/219.74  |- mesh__dateRevised mesh__D003727 1992-05-14
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003727 1999
% 219.56/219.74  |- skos__historyNote mesh__D003727
% 219.56/219.74       Allied Health Personnel %28%1971-1977%29%
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003727 2002
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003727 1993
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003727 1996
% 219.56/219.74  |- skos__historyNote mesh__D003727 Dental Assistants %28%1966-1977%29%
% 219.56/219.74  |- skos__altLabel mesh__D003727 Receptionist, Dental
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003727 2005
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003727 1997
% 219.56/219.74  |- skos__altLabel mesh__D003727 Auxiliaries, Dental
% 219.56/219.74  |- mesh__publicMeSHNote mesh__D003727 78   
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003727 2006
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D003727 2000
% 219.56/219.74  |- skos__hiddenLabel mesh__D036103 Nanotechnologies
% 219.56/219.74  |- skos__broader mesh__D036103smesh__D010811
% 219.56/219.74  |- skos__scopeNote mesh__D036103
% 219.56/219.74       The development and use of techniques to study physical phenomena and construct structures in the nanoscale size range or smaller.%A%    
% 219.56/219.74  |- mesh__recordAuthorizer mesh__D036103 sjn
% 219.56/219.74  |- skos__broader mesh__D036103smesh__D008904
% 219.56/219.74  |- skos__prefLabel mesh__D036103 Nanotechnology
% 219.56/219.74  |- skos__related mesh__D036103smesh__D008832
% 219.56/219.74  |- mesh__publicMeSHNote mesh__D036103 2002   
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D036103 2006
% 219.56/219.74  |- skos__related mesh__D036103smesh__D049329
% 219.56/219.74  |- skos__historyNote mesh__D036103 Microchemistry %28%1991-2001%29%
% 219.56/219.74  |- mesh__dateEstablished mesh__D036103 2002-01-03
% 219.56/219.74  |- mesh__dateCreated mesh__D036103 2002-01-03
% 219.56/219.74  |- mesh__recordOriginator mesh__D036103 sjn
% 219.56/219.74  |- mesh__dateRevised mesh__D036103 2005-06-30
% 219.56/219.74  |- skos__historyNote mesh__D036103 Miniaturization %28%1994-2001%29%
% 219.56/219.74  |- skos__related mesh__D036103smesh__D046208
% 219.56/219.74  |- mesh__recordMaintainer mesh__D036103 ags
% 219.56/219.74  |- mesh__historyNote mesh__D036103 2002   
% 219.56/219.74  |- rdf__type mesh__D036103sskos__Concept
% 219.56/219.74  |- mesh__publicMeSHNote mesh__D008412
% 219.56/219.74       ZOOFLAGELLATA was see MASTIGOPHORA 1976-91; ZOOMASTIGINA was see MASTIGOPHORA 1986-91, was see under MASTIGOPHORA 1966-85%A%  
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D008412 2005
% 219.56/219.74  |- skos__altLabel mesh__D008412 Flagellata
% 219.56/219.74  |- mesh__recordAuthorizer mesh__D008412 ags
% 219.56/219.74  |- mesh__recordMaintainer mesh__D008412 ags
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D008412 2006A
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D008412 2006
% 219.56/219.74  |- mesh__historyNote mesh__D008412
% 219.56/219.74       ZOOFLAGELLATA was see MASTIGOPHORA 1976-91; ZOOMASTIGINA was see MASTIGOPHORA 1986-91, was see under MASTIGOPHORA 1966-85%A%  
% 219.56/219.74  |- skos__annotation mesh__D008412
% 219.56/219.74       a subphylum of protozoa; infection = MASTIGOPHORA INFECTIONS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 219.56/219.74  |- skos__prefLabel mesh__D008412 Mastigophora
% 219.56/219.74  |- skos__broader mesh__D008412smesh__D016820
% 219.56/219.74  |- mesh__dateCreated mesh__D008412 1999-01-01
% 219.56/219.74  |- skos__scopeNote mesh__D008412
% 219.56/219.74       A subphylum of flagellate protozoa. It contains two classes: PHYTOMASTIGOPHOREA and ZOOMASTIGOPHORA.%A%    
% 219.56/219.74  |- mesh__recordOriginator mesh__D008412 NLM
% 219.56/219.74  |- mesh__dateRevised mesh__D008412 2005-07-27
% 219.56/219.74  |- rdf__type mesh__D008412sskos__Concept
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D008412 2004
% 219.56/219.74  |- mesh__onlineNote mesh__D008412
% 219.56/219.74       use MASTIGOPHORA to search ZOOFLAGELLATA 1976-91 %26% ZOOMASTIGINA 1966-91%A%  
% 219.56/219.74  |- skos__prefLabel mesh__D013357 Subgingival Curettage
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013357 2001
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013357 1995
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013357 2006
% 219.56/219.74  |- skos__broader mesh__D013357smesh__D010517
% 219.56/219.74  |- skos__annotation mesh__D013357
% 219.56/219.74       do not use /util except by MeSH definition   
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013357 1998
% 219.56/219.74  |- mesh__dateCreated mesh__D013357 1999-01-01
% 219.56/219.74  |- mesh__recordMaintainer mesh__D013357 MXR
% 219.56/219.74  |- skos__hiddenLabel mesh__D013357 Gingival Curettages
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013357 2000
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013357 1994
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013357 2005
% 219.56/219.74  |- skos__hiddenLabel mesh__D013357 Subgingival Curettages
% 219.56/219.74  |- mesh__dateRevised mesh__D013357 1991-04-29
% 219.56/219.74  |- skos__hiddenLabel mesh__D013357 Curettages, Gingival
% 219.56/219.74  |- skos__altLabel mesh__D013357 Gingival Curettage
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013357 1997
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013357 2002
% 219.56/219.74  |- skos__hiddenLabel mesh__D013357 Curettage, Gingival
% 219.56/219.74  |- mesh__historyNote mesh__D013357 65   
% 219.56/219.74  |- mesh__recordAuthorizer mesh__D013357 PLS
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013357 2004
% 219.56/219.74  |- mesh__activeMeSHYear mesh__D013357 1993
% 219.56/219.75  |- mesh__recordOriginator mesh__D013357 NLM
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D013357 1996
% 219.56/219.75  |- mesh__dateEstablished mesh__D013357 1965-01-01
% 219.56/219.75  |- skos__scopeNote mesh__D013357
% 219.56/219.75       Removal of degenerated and necrotic epithelium and underlying connective tissue of a periodontal pocket in an effort to convert a chronic ulcerated wound to an acute surgical wound, thereby insuring wound healing and attachment or epithelial adhesion, and shrinkage of the marginal gingiva. The term is sometimes used in connection with smoothing of a root surface or ROOT PLANING. %28%Jablonski; Illustrated Dictionary of Dentistry, 1982%29%%A%    
% 219.56/219.75  |- rdf__type mesh__D013357sskos__Concept
% 219.56/219.75  |- skos__hiddenLabel mesh__D013357 Curettages, Subgingival
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D013357 1999
% 219.56/219.75  |- skos__hiddenLabel mesh__D013357 Curettage, Subgingival
% 219.56/219.75  |- mesh__publicMeSHNote mesh__D013357 65   
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D013357 2003
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D013357 1992
% 219.56/219.75  |- skos__scopeNote mesh__D018840
% 219.56/219.75       A class of MOLECULAR CHAPERONES found in both prokaryotes and in several compartments of eukaryotic cells. These proteins can interact with polypeptides during a variety of assembly processes in such a way as to prevent the formation of nonfunctional structures.%A%    
% 219.56/219.75  |- skos__altLabel mesh__D018840 Heat-Shock Proteins 70
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D018840 2006
% 219.56/219.75  |- skos__hiddenLabel mesh__D018840 Heat Shock Proteins 70
% 219.56/219.75  |- skos__hiddenLabel mesh__D018840 HSP70 Heat Shock Proteins
% 219.56/219.75  |- mesh__dateCreated mesh__D018840 1994-05-31
% 219.56/219.75  |- mesh__recordAuthorizer mesh__D018840 sjn
% 219.56/219.75  |- skos__broader mesh__D018840smesh__D018832
% 219.56/219.75  |- rdf__type mesh__D018840sskos__Concept
% 219.56/219.75  |- mesh__publicMeSHNote mesh__D018840
% 219.56/219.75       2006; see HEAT SHOCK PROTEINS 70 1995-2005, see HEAT-SHOCK PROTEINS 1990-1994; MITOCHONDRIAL HEAT SHOCK PROTEIN 70 was indexed under HEAT SHOCK PROTEINS 70 1996-2005%A%  
% 219.56/219.75  |- skos__altLabel mesh__D018840 Heat-Shock Protein 70
% 219.56/219.75  |- mesh__dateRevised mesh__D018840 2005-06-30
% 219.56/219.75  |- skos__prefLabel mesh__D018840 HSP70 Heat-Shock Proteins
% 219.56/219.75  |- skos__hiddenLabel mesh__D018840 Heat-Shock Proteins, HSP70
% 219.56/219.75  |- mesh__dateEstablished mesh__D018840 1995-01-01
% 219.56/219.75  |- skos__hiddenLabel mesh__D018840 Heat Shock Protein 70
% 219.56/219.75  |- skos__altLabel mesh__D018840 Heat Shock 70 kDa Protein
% 219.56/219.75  |- mesh__historyNote mesh__D018840
% 219.56/219.75       2006%28%1990%29%; use HEAT-SHOCK PROTEINS 1990-1994   
% 219.56/219.75  |- skos__broader mesh__D018840smesh__D006360
% 219.56/219.75  |- mesh__recordOriginator mesh__D018840 PXP
% 219.56/219.75  |- mesh__recordMaintainer mesh__D018840 jmp
% 219.56/219.75  |- skos__historyNote mesh__D018042
% 219.56/219.75       Receptors, Neurotransmitter %28%1987-1993%29%
% 219.56/219.75  |- skos__hiddenLabel mesh__D018042 B Receptors, Neurokinin
% 219.56/219.75  |- skos__hiddenLabel mesh__D018042 NK 3 Receptor
% 219.56/219.75  |- skos__hiddenLabel mesh__D018042 NK 3 Receptors
% 219.56/219.75  |- skos__altLabel mesh__D018042 NK-3 Receptor
% 219.56/219.75  |- skos__altLabel mesh__D018042 Receptors, Neuromedin K
% 219.56/219.75  |- skos__hiddenLabel mesh__D018042 Receptor, Neurokinin-3
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D018042 2006
% 219.56/219.75  |- skos__hiddenLabel mesh__D018042 Receptors, NK 3
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D018042 2001
% 219.56/219.75  |- skos__broader mesh__D018042smesh__D018039
% 219.56/219.75  |- rdf__type mesh__D018042sskos__Concept
% 219.56/219.75  |- skos__altLabel mesh__D018042 Neurokinin-3 Receptor
% 219.56/219.75  |- mesh__recordOriginator mesh__D018042 RAZ
% 219.56/219.75  |- skos__scopeNote mesh__D018042
% 219.56/219.75       A class of cell surface receptors for tachykinins that prefers neurokinin B %28%neurokinin beta, neuromedin K%29% over other tachykinins. Neurokinin-3 %28%NK-3%29% receptors have been cloned and are members of the G-protein coupled receptor superfamily. They have been found in the central nervous system and in peripheral tissues.%A%    
% 219.56/219.75  |- skos__hiddenLabel mesh__D018042 Neurokinin 3 Receptors
% 219.56/219.75  |- skos__hiddenLabel mesh__D018042 Receptor, Neuromedin K
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D018042 1998
% 219.56/219.75  |- mesh__dateCreated mesh__D018042 1993-06-30
% 219.56/219.75  |- skos__hiddenLabel mesh__D018042 K Receptors, Neuromedin
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D018042 2003
% 219.56/219.75  |- skos__altLabel mesh__D018042 Receptors, NK-3
% 219.56/219.75  |- mesh__dateRevised mesh__D018042 1997-06-20
% 219.56/219.75  |- skos__prefLabel mesh__D018042 Receptors, Neurokinin-3
% 219.56/219.75  |- skos__hiddenLabel mesh__D018042 Receptors, Neurokinin 3
% 219.56/219.75  |- mesh__historyNote mesh__D018042
% 219.56/219.75       94; was NEUROMEDIN K RECEPTOR %28%NM%29% 1987-93; NK-3 RECEPTOR SITE was SY to TACHYKININ RECEPTOR 1989-93%A%  
% 219.56/219.75  |- mesh__recordAuthorizer mesh__D018042 SJN
% 219.56/219.75  |- skos__hiddenLabel mesh__D018042 Receptor, NK-3
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D018042 1999
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D018042 2002
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D018042 2004
% 219.56/219.75  |- skos__annotation mesh__D018042
% 219.56/219.75       tachykinin receptors; DF: RECEPT NEUROKININ 3   
% 219.56/219.75  |- skos__altLabel mesh__D018042 Neuromedin K Receptor
% 219.56/219.75  |- skos__altLabel mesh__D018042 Neurokinin B Receptors
% 219.56/219.75  |- mesh__dateEstablished mesh__D018042 1994-01-01
% 219.56/219.75  |- skos__altLabel mesh__D018042 NK-3 Receptors
% 219.56/219.75  |- skos__hiddenLabel mesh__D018042 Neurokinin 3 Receptor
% 219.56/219.75  |- skos__hiddenLabel mesh__D018042 Neuromedin K Receptors
% 219.56/219.75  |- skos__altLabel mesh__D018042 Neurokinin-3 Receptors
% 219.56/219.75  |- mesh__recordMaintainer mesh__D018042 NDW
% 219.56/219.75  |- skos__hiddenLabel mesh__D018042 Receptors, Neurokinin B
% 219.56/219.75  |- mesh__onlineNote mesh__D018042
% 219.56/219.75       use RECEPTORS, NEUROKININ-3 to search NEUROMEDIN K RECEPTOR 1987-93%A%  
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D018042 2005
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D018042 2000
% 219.56/219.75  |- mesh__publicMeSHNote mesh__D018042
% 219.56/219.75       94; NEUROMEDIN K RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1987-93%A%  
% 219.56/219.75  |- skos__broader mesh__D004820smesh__D012868
% 219.56/219.75  |- skos__broader mesh__D004820smesh__D012872
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D004820 2004
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D004820 2005
% 219.56/219.75  |- mesh__recordOriginator mesh__D004820 NLM
% 219.56/219.75  |- skos__prefLabel mesh__D004820 Epidermolysis Bullosa
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D004820 2002
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D004820 2006
% 219.56/219.75  |- mesh__recordMaintainer mesh__D004820 nns
% 219.56/219.75  |- skos__altLabel mesh__D004820 Acantholysis Bullosa
% 219.56/219.75  |- skos__scopeNote mesh__D004820
% 219.56/219.75       Group of genetically determined disorders characterized by the blistering of skin and mucosae. There are four major forms: acquired, simple, junctional, and dystrophic. Each of the latter three has several varieties.%A%    
% 219.56/219.75  |- mesh__recordAuthorizer mesh__D004820 sjn
% 219.56/219.75  |- rdf__type mesh__D004820sskos__Concept
% 219.56/219.75  |- mesh__dateRevised mesh__D004820 2001-07-25
% 219.56/219.75  |- skos__annotation mesh__D004820
% 219.56/219.75       vesiculobullous skin dis; GEN only: prefer specifics; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 219.56/219.75  |- skos__broader mesh__D004820smesh__D012873
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D004820 2003
% 219.56/219.75  |- mesh__dateCreated mesh__D004820 1999-01-01
% 219.56/219.75  |- mesh__recordMaintainer mesh__D004022 ags
% 219.56/219.75  |- skos__altLabel mesh__D004022 Dictyocauliasis
% 219.56/219.75  |- skos__annotation mesh__D004022
% 219.56/219.75       nematode infect; usually animal; check tag ANIMALS   
% 219.56/219.75  |- skos__hiddenLabel mesh__D004022 Dictyocaulus Infection
% 219.56/219.75  |- mesh__dateCreated mesh__D004022 1999-01-01
% 219.56/219.75  |- skos__broader mesh__D004022smesh__D014252
% 219.56/219.75  |- mesh__onlineNote mesh__D004022
% 219.56/219.75       use DICTYOCAULUS INFECTIONS to search DICTYOCAULUS INFECTION 1982-92 %26% DICTYOCAULIASIS 1968-81%A%  
% 219.56/219.75  |- mesh__dateEstablished mesh__D004022 1968-01-01
% 219.56/219.75  |- skos__hiddenLabel mesh__D004022 Dictyocauliases
% 219.56/219.75  |- rdf__type mesh__D004022sskos__Concept
% 219.56/219.75  |- mesh__publicMeSHNote mesh__D004022
% 219.56/219.75       93; was DICTYOCAULUS INFECTION 1982-92; was DICTYOCAULIASIS 1968-81%A%  
% 219.56/219.75  |- mesh__dateRevised mesh__D004022 2003-07-30
% 219.56/219.75  |- mesh__historyNote mesh__D004022
% 219.56/219.75       93; was DICTYOCAULUS INFECTION 1982-92; was DICTYOCAULIASIS 1968-81%A%  
% 219.56/219.75  |- mesh__recordOriginator mesh__D004022 NLM
% 219.56/219.75  |- skos__altLabel mesh__D004022 Infections, Dictyocaulus
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D004022 2006
% 219.56/219.75  |- skos__broader mesh__D004022smesh__D006374
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D004022 2005
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D004022 2004
% 219.56/219.75  |- skos__scopeNote mesh__D004022
% 219.56/219.75       Infection with nematodes of the genus DICTYOCAULUS. In deer, cattle, sheep, and horses the bronchi are the site of infestation.%A%    
% 219.56/219.75  |- skos__historyNote mesh__D004022 Nematode Infections %28%1966-1967%29%
% 219.56/219.75  |- mesh__recordAuthorizer mesh__D004022 sjn
% 219.56/219.75  |- skos__hiddenLabel mesh__D004022 Infection, Dictyocaulus
% 219.56/219.75  |- skos__prefLabel mesh__D004022 Dictyocaulus Infections
% 219.56/219.75  |- mesh__historyNote mesh__D017748 94   
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D017748 2000
% 219.56/219.75  |- rdf__type mesh__D017748sskos__Concept
% 219.56/219.75  |- skos__broader mesh__D017748smesh__D006804
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D017748 2005
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D017748 2004
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D017748 1999
% 219.56/219.75  |- mesh__dateEstablished mesh__D017748 1994-01-01
% 219.56/219.75  |- mesh__dateRevised mesh__D017748 1997-06-20
% 219.56/219.75  |- skos__hiddenLabel mesh__D017748 Management, Time
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D017748 2001
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D017748 2006
% 219.56/219.75  |- mesh__recordOriginator mesh__D017748 JLS
% 219.56/219.75  |- mesh__dateCreated mesh__D017748 1992-12-28
% 219.56/219.75  |- skos__prefLabel mesh__D017748 Time Management
% 219.56/219.75  |- skos__broader mesh__D017748smesh__D009934
% 219.56/219.75  |- skos__scopeNote mesh__D017748
% 219.56/219.75       Planning and control of time to improve efficiency and effectiveness.%A%    
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D017748 2002
% 219.56/219.75  |- mesh__recordMaintainer mesh__D017748 JLS
% 219.56/219.75  |- skos__hiddenLabel mesh__D017748 Managements, Time
% 219.56/219.75  |- mesh__publicMeSHNote mesh__D017748 94   
% 219.56/219.75  |- skos__hiddenLabel mesh__D017748 Time Managements
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D017748 1998
% 219.56/219.75  |- mesh__recordAuthorizer mesh__D017748 SJN
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D017748 2003
% 219.56/219.75  |- skos__broader mesh__D017748smesh__D011590
% 219.56/219.75  |- skos__scopeNote mesh__D036902
% 219.56/219.75       A plant genus of the family APOCYNACEAE. Members contain voacangine and other INDOLES.%A%    
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D036902 2005
% 219.56/219.75  |- skos__broader mesh__D036902smesh__D029062
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D036902 2003
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D036902 2006
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D036902 2004
% 219.56/219.75  |- mesh__dateCreated mesh__D036902 2002-07-03
% 219.56/219.75  |- mesh__publicMeSHNote mesh__D036902 2003   
% 219.56/219.75  |- skos__prefLabel mesh__D036902 Voacanga
% 219.56/219.75  |- rdf__type mesh__D036902sskos__Concept
% 219.56/219.75  |- mesh__dateEstablished mesh__D036902 2003-01-01
% 219.56/219.75  |- mesh__historyNote mesh__D036902 2003   
% 219.56/219.75  |- skos__annotation mesh__D036902
% 219.56/219.75       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.56/219.75  |- mesh__recordAuthorizer mesh__D003728 sjn
% 219.56/219.75  |- mesh__dateRevised mesh__D003728 1999-11-08
% 219.56/219.75  |- mesh__dateCreated mesh__D003728 1999-01-01
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D003728 2002
% 219.56/219.75  |- mesh__dateEstablished mesh__D003728 1964-01-01
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D003728 2000
% 219.56/219.75  |- skos__scopeNote mesh__D003728
% 219.56/219.75       Abnormal concretion or calcified deposit that forms around the teeth or dental prostheses.%A%    
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D003728 2005
% 219.56/219.75  |- mesh__recordOriginator mesh__D003728 NLM
% 219.56/219.75  |- mesh__historyNote mesh__D003728 64; was in Cat C only 1964-74   
% 219.56/219.75  |- mesh__recordMaintainer mesh__D003728 KEV
% 219.56/219.75  |- skos__broader mesh__D003728smesh__D003741
% 219.56/219.75  |- skos__broader mesh__D003728smesh__D002137
% 219.56/219.75  |- skos__related mesh__D003728smesh__D003777
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D003728 2006
% 219.56/219.75  |- skos__annotation mesh__D003728
% 219.56/219.75       note categories; from Cat A /chem /ultrastruct permitted; DF: DENT CALCULUS%A%  
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D003728 2001
% 219.56/219.75  |- skos__altLabel mesh__D003728 Calculus, Dental
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D003728 2003
% 219.56/219.75  |- rdf__type mesh__D003728sskos__Concept
% 219.56/219.75  |- skos__altLabel mesh__D003728 Tartar
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D003728 2004
% 219.56/219.75  |- skos__prefLabel mesh__D003728 Dental Calculus
% 219.56/219.75  |- mesh__publicMeSHNote mesh__D003728 64   
% 219.56/219.75  |- mesh__dateEstablished mesh__D014450 1987-01-01
% 219.56/219.75  |- skos__broader mesh__D014450smesh__D017494
% 219.56/219.75  |- skos__hiddenLabel mesh__D014450 Ubiquinol Cytochrome c Reductase
% 219.56/219.75  |- skos__altLabel mesh__D014450 Cytochrome b-c2 Oxidoreductase
% 219.56/219.75  |- mesh__dateCreated mesh__D014450 1986-06-12
% 219.56/219.75  |- skos__hiddenLabel mesh__D014450 Ubihydroquinone Cytochrome c Reductase
% 219.56/219.75  |- skos__broader mesh__D014450smesh__D013384
% 219.56/219.75  |- mesh__recordOriginator mesh__D014450 RLS
% 219.56/219.75  |- skos__hiddenLabel mesh__D014450 Coenzyme QH2 Cytochrome c Reductase
% 219.56/219.75  |- mesh__historyNote mesh__D014450
% 219.56/219.75       2004%28%1994%29%; for CORE I PROTEIN, UBIQUINOL-CYTOCHROME C REDUCTASE %26% CORE II PROTEIN, UBIQUINOL-CYTOCHROME C REDUCTASE use ELECTRON TRANSPORT COMPLEX III %28%NM%29% 1991-2004%A%  
% 219.56/219.75  |- skos__scopeNote mesh__D014450
% 219.56/219.75       A multisubunit enzyme complex that contains CYTOCHROME B GROUP; CYTOCHROME C1; and iron-sulfur centers. It catalyzes the oxidation of ubiquinol to UBIQUINONE, and transfers the electrons to CYTOCHROME C. In MITOCHONDRIA the redox reaction is coupled to the transport of PROTONS across the inner mitochondrial membrane.%A%    
% 219.56/219.75  |- skos__altLabel mesh__D014450 Dihydroubiquinone-Cytochrome-c Reductase
% 219.56/219.75  |- skos__broader mesh__D014450smesh__D007506
% 219.56/219.75  |- skos__altLabel mesh__D014450 Core I Protein, UCCreductase
% 219.56/219.75  |- skos__altLabel mesh__D014450 QH%28%2%29%-Cytochrome-c Reductase
% 219.56/219.75  |- mesh__publicMeSHNote mesh__D014450
% 219.56/219.75       2004; see UBIQUINOL-CYTOCHROME-C REDUCTASE 1994-2003, see UBIQUINOL-CYTOCHROME C REDUCTASE 1987-1993; CORE I PROTEIN, UBIQUINOL-CYTOCHROME C REDUCTASE %26% CORE II PROTEIN, UBIQUINOL-CYTOCHROME C REDUCTASE were indexed under NUCLEAR PROTEINS 1991-2003%A%  
% 219.56/219.75  |- skos__historyNote mesh__D014450 Multienzyme Complexes %28%1973-1986%29%
% 219.56/219.75  |- skos__hiddenLabel mesh__D014450 Dihydroubiquinone Cytochrome c Reductase
% 219.56/219.75  |- rdf__type mesh__D014450sskos__Concept
% 219.56/219.75  |- skos__historyNote mesh__D014450 Cytochrome Reductases %28%1974-1979%29%
% 219.56/219.75  |- skos__altLabel mesh__D014450
% 219.56/219.75       QH%28%2%29%-Ferricytochrome-c Oxidoreductase
% 219.56/219.75  |- mesh__recordAuthorizer mesh__D014450 sjn
% 219.56/219.75  |- skos__altLabel mesh__D014450 Ubiquinol-Cytochrome-c Reductase
% 219.56/219.75  |- skos__hiddenLabel mesh__D014450
% 219.56/219.75       Core II Protein, Ubiquinol Cytochrome c Reductase
% 219.56/219.75  |- skos__historyNote mesh__D014450 Quinone Reductases %28%1975-1986%29%
% 219.56/219.75  |- skos__altLabel mesh__D014450 Complex III
% 219.56/219.75  |- skos__altLabel mesh__D014450 Core II Protein, UCCreductase
% 219.56/219.75  |- skos__altLabel mesh__D014450 Coenzyme QH2-Cytochrome-c Reductase
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D014450 2005
% 219.56/219.75  |- skos__altLabel mesh__D014450 Coenzyme Q-Cytochrome-c Reductase
% 219.56/219.75  |- mesh__dateRevised mesh__D014450 2004-07-07
% 219.56/219.75  |- skos__hiddenLabel mesh__D014450
% 219.56/219.75       Core I Protein, Ubiquinol Cytochrome c Reductase
% 219.56/219.75  |- skos__prefLabel mesh__D014450 Electron Transport Complex III
% 219.56/219.75  |- mesh__recordMaintainer mesh__D014450 jmp
% 219.56/219.75  |- skos__altLabel mesh__D014450 Cytochrome bc1 Complex
% 219.56/219.75  |- skos__altLabel mesh__D014450 Ubiquinone-Cytochrome b-c2 Oxidoreductase
% 219.56/219.75  |- skos__hiddenLabel mesh__D014450 Reductase, Ubiquinol-Cytochrome c
% 219.56/219.75  |- skos__hiddenLabel mesh__D014450
% 219.56/219.75       Ubiquinone Cytochrome b c2 Oxidoreductase
% 219.56/219.75  |- skos__hiddenLabel mesh__D014450 Cytochrome b c2 Oxidoreductase
% 219.56/219.75  |- skos__historyNote mesh__D014450 Oxidoreductases %28%1966-1973%29%
% 219.56/219.75  |- skos__hiddenLabel mesh__D014450 Coenzyme Q Cytochrome c Reductase
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D014450 2006
% 219.56/219.75  |- skos__altLabel mesh__D014450 Ubiquinol-Cytochrome c Reductase
% 219.56/219.75  |- skos__altLabel mesh__D014450 Ubihydroquinone-Cytochrome-c Reductase
% 219.56/219.75  |- skos__altLabel mesh__D036104 EphA2 Receptor Tyrosine Kinase
% 219.56/219.75  |- skos__prefLabel mesh__D036104 Receptor, EphA2
% 219.56/219.75  |- mesh__dateRevised mesh__D036104 2005-06-30
% 219.56/219.75  |- rdf__type mesh__D036104sskos__Concept
% 219.56/219.75  |- skos__altLabel mesh__D036104 Epithelial Cell Kinase Protein
% 219.56/219.75  |- skos__scopeNote mesh__D036104
% 219.56/219.75       An Eph family receptor found abundantly in tissues of epithelial origin. It is expressed in a diverse array of tissues during embryonic development, suggesting that it may play a role in embryogenesis. In adult tissues high levels of the receptor are expressed in the LUNG; SKIN; SMALL INTESTINE and OVARY.%A%    
% 219.56/219.75  |- skos__broader mesh__D036104smesh__D036081
% 219.56/219.75  |- mesh__publicMeSHNote mesh__D036104
% 219.56/219.75       2003; EPHA2 PROTEIN %28%now RECEPTOR, EPHA2%29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 2001-2002 %26% MEMBRANE PROTEINS 1990-2000%A%  
% 219.56/219.75  |- mesh__recordAuthorizer mesh__D036104 sjn
% 219.56/219.75  |- skos__altLabel mesh__D036104 EphA2-Tyrosine Kinase
% 219.56/219.75  |- skos__historyNote mesh__D036104 Membrane Proteins %28%1990-2002%29%
% 219.56/219.75  |- mesh__dateEstablished mesh__D036104 2003-01-01
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D036104 2006
% 219.56/219.75  |- skos__altLabel mesh__D036104 EphA2 Receptor
% 219.56/219.75  |- mesh__historyNote mesh__D036104
% 219.56/219.75       2003; use RECEPTOR, EPHA2  %28%NM%29% 1990-2002   
% 219.56/219.75  |- skos__hiddenLabel mesh__D036104 Mammary Derived Tyrosine Kinase 2
% 219.56/219.75  |- mesh__dateCreated mesh__D036104 2002-07-03
% 219.56/219.75  |- skos__hiddenLabel mesh__D036104 EphA2 Tyrosine Kinase
% 219.56/219.75  |- skos__altLabel mesh__D036104 EphA2 Protein
% 219.56/219.75  |- skos__historyNote mesh__D036104
% 219.56/219.75       Receptor Protein-Tyrosine Kinases %28%1999-2002%29%
% 219.56/219.75  |- skos__altLabel mesh__D036104 Mammary-Derived Tyrosine Kinase 2
% 219.56/219.75  |- mesh__recordOriginator mesh__D036104 jmp
% 219.56/219.75  |- mesh__recordMaintainer mesh__D036104 jmp
% 219.56/219.75  |- skos__broader mesh__D004194Q000534smesh__D004194
% 219.56/219.75  |- mesh__preferredCombination mesh__D004194Q000534smesh__D012046
% 219.56/219.75  |- rdf__type mesh__D004194Q000534smesh__CompoundConcept
% 219.56/219.75  |- mesh__historyNote mesh__D008413 1966   
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D008413 2006
% 219.56/219.75  |- skos__prefLabel mesh__D008413 Mastitis
% 219.56/219.75  |- skos__broader mesh__D008413smesh__D011644
% 219.56/219.75  |- mesh__dateCreated mesh__D008413 1999-01-01
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D008413 2006A
% 219.56/219.75  |- rdf__type mesh__D008413sskos__Concept
% 219.56/219.75  |- skos__annotation mesh__D008413
% 219.56/219.75       CHRONIC CYSTIC MASTITIS see FIBROCYSTIC BREAST DISEASE is also available; MASTITIS, BOVINE is also available%A%  
% 219.56/219.75  |- mesh__publicMeSHNote mesh__D008413 1966   
% 219.56/219.75  |- mesh__dateRevised mesh__D008413 2005-07-19
% 219.56/219.75  |- skos__scopeNote mesh__D008413
% 219.56/219.75       INFLAMMATION of the BREAST, or MAMMARY GLAND.     
% 219.56/219.75  |- mesh__recordOriginator mesh__D008413 NLM
% 219.56/219.75  |- skos__broader mesh__D008413smesh__D001941
% 219.56/219.75  |- mesh__recordMaintainer mesh__D008413 ags
% 219.56/219.75  |- mesh__recordAuthorizer mesh__D008413 ags
% 219.56/219.75  |- mesh__recordOriginator mesh__D000430 NLM
% 219.56/219.75  |- skos__altLabel mesh__D000430
% 219.56/219.75       Delirium Tremens, Alcohol Withdrawal Induced
% 219.56/219.75  |- skos__broader mesh__D000430smesh__D013375
% 219.56/219.75  |- mesh__onlineNote mesh__D000430
% 219.56/219.75       use ALCOHOL WITHDRAWAL DELIRIUM to search DELIRIUM TREMENS 1975-80 %26% use PSYCHOSES, ALCOHOLIC 1966-74%A%  
% 219.56/219.75  |- skos__hiddenLabel mesh__D000430 Hallucinosis, Alcohol Withdrawal
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D000430 2006
% 219.56/219.75  |- skos__hiddenLabel mesh__D000430
% 219.56/219.75       Alcohol Withdrawal Induced Delirium Tremens
% 219.56/219.75  |- rdf__type mesh__D000430sskos__Concept
% 219.56/219.75  |- skos__prefLabel mesh__D000430 Alcohol Withdrawal Delirium
% 219.56/219.75  |- mesh__recordAuthorizer mesh__D000430 sjn
% 219.56/219.75  |- mesh__dateEstablished mesh__D000430 1991-01-01
% 219.56/219.75  |- skos__altLabel mesh__D000430 Alcohol Withdrawal-Induced Delirium Tremens
% 219.56/219.75  |- skos__altLabel mesh__D000430
% 219.56/219.75       Alcohol Withdrawal Associated Autonomic Hyperactivity
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D000430 2005
% 219.56/219.75  |- mesh__publicMeSHNote mesh__D000430
% 219.56/219.75       91; was see under PSYCHOSES, ALCOHOLIC 1981-90; was DELIRIUM TREMENS see under PSYCHOSES, ALCOHOLIC 1963-80%A%  
% 219.56/219.75  |- mesh__dateRevised mesh__D000430 2003-07-09
% 219.56/219.75  |- skos__annotation mesh__D000430
% 219.56/219.75       note X ref; do not confuse with %22%alcohol withdrawal syndrome%22% %28% = SUBSTANCE WITHDRAWAL SYNDROME %28%IM%29% + ETHANOL /adv eff %28%IM%29%%29%; ALCOHOL WITHDRAWAL SEIZURES is available%A%  
% 219.56/219.75  |- mesh__recordMaintainer mesh__D000430 lkt
% 219.56/219.75  |- skos__broader mesh__D000430smesh__D019973
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D000430 2004
% 219.56/219.75  |- mesh__dateCreated mesh__D000430 1999-01-01
% 219.56/219.75  |- skos__broader mesh__D000430smesh__D020268
% 219.56/219.75  |- skos__altLabel mesh__D000430 Delirium Tremens
% 219.56/219.75  |- skos__scopeNote mesh__D000430
% 219.56/219.75       An acute organic mental disorder induced by cessation or reduction in chronic alcohol consumption. Clinical characteristics include CONFUSION; DELUSIONS; vivid HALLUCINATIONS; TREMOR; agitation; insomnia; and signs of autonomic hyperactivity %28%e.g., elevated blood pressure and heart rate, dilated pupils, and diaphoresis%29%. This condition may occasionally be fatal. It was formerly called delirium tremens. %28%From Adams et al., Principles of Neurology, 6th ed, p1175%29%%A%    
% 219.56/219.75  |- skos__hiddenLabel mesh__D000430 Delirium, Alcohol Withdrawal
% 219.56/219.75  |- mesh__historyNote mesh__D000430
% 219.56/219.75       91%28%81%29%; was see under PSYCHOSES, ALCOHOLIC 1981-90; was DELIRIUM TREMENS see under PSYCHOSES, ALCOHOLIC 1963-80%A%  
% 219.56/219.75  |- mesh__recordAuthorizer mesh__D013358 sjn
% 219.56/219.75  |- skos__scopeNote mesh__D013358
% 219.56/219.75       Terms or expressions which provide the major means of access by subject to the bibliographic unit.%A%    
% 219.56/219.75  |- skos__hiddenLabel mesh__D013358 Descriptor
% 219.56/219.75  |- mesh__dateRevised mesh__D013358 2002-07-03
% 219.56/219.75  |- skos__annotation mesh__D013358
% 219.56/219.75       no qualif; VOCABULARY, CONTROLLED is also available   
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D013358 2006
% 219.56/219.75  |- skos__prefLabel mesh__D013358 Subject Headings
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D013358 2005
% 219.56/219.75  |- skos__hiddenLabel mesh__D013358 Subject Heading
% 219.56/219.75  |- mesh__recordMaintainer mesh__D013358 TGC
% 219.56/219.75  |- skos__broader mesh__D013358smesh__D018875
% 219.56/219.75  |- mesh__recordOriginator mesh__D013358 NLM
% 219.56/219.75  |- skos__hiddenLabel mesh__D013358 Headings, Subject
% 219.56/219.75  |- rdf__type mesh__D013358sskos__Concept
% 219.56/219.75  |- skos__hiddenLabel mesh__D013358 Heading, Subject
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D013358 2004
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D013358 2003
% 219.56/219.75  |- mesh__dateCreated mesh__D013358 1999-01-01
% 219.56/219.75  |- mesh__recordMaintainer mesh__D018841 jmp
% 219.56/219.75  |- skos__broader mesh__D018841smesh__D018832
% 219.56/219.75  |- mesh__recordOriginator mesh__D018841 PXP
% 219.56/219.75  |- skos__historyNote mesh__D018841 Heat-Shock Proteins %28%1986-1994%29%
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D018841 2006
% 219.56/219.75  |- skos__altLabel mesh__D018841 Heat-Shock Proteins 90
% 219.56/219.75  |- mesh__publicMeSHNote mesh__D018841
% 219.56/219.75       2006; see HEAT-SHOCK PROTEINS 90 1995-2005, see HEAT-SHOCK PROTEINS 1990-1994%A%  
% 219.56/219.75  |- skos__broader mesh__D018841smesh__D006360
% 219.56/219.75  |- skos__scopeNote mesh__D018841
% 219.56/219.75       A class of MOLECULAR CHAPERONES whose members act in the mechanism of SIGNAL TRANSDUCTION by STEROID RECEPTORS.%A%    
% 219.56/219.75  |- skos__hiddenLabel mesh__D018841 HSP90 Heat Shock Proteins
% 219.56/219.75  |- mesh__historyNote mesh__D018841
% 219.56/219.75       2006%28%1994%29%; use HEAT-SHOCK PROTEINS 1990-1994   
% 219.56/219.75  |- mesh__dateCreated mesh__D018841 1994-05-27
% 219.56/219.75  |- rdf__type mesh__D018841sskos__Concept
% 219.56/219.75  |- mesh__recordAuthorizer mesh__D018841 sjn
% 219.56/219.75  |- skos__prefLabel mesh__D018841 HSP90 Heat-Shock Proteins
% 219.56/219.75  |- skos__hiddenLabel mesh__D018841 Heat-Shock Proteins, HSP90
% 219.56/219.75  |- mesh__dateRevised mesh__D018841 2005-06-30
% 219.56/219.75  |- mesh__dateEstablished mesh__D018841 1995-01-01
% 219.56/219.75  |- skos__hiddenLabel mesh__D018841 Heat Shock Proteins 90
% 219.56/219.75  |- mesh__onlineNote mesh__D018043
% 219.56/219.75       use RECEPTORS, CORTICOTROPIN %28%NM%29% to search CORTICOTROPIN RECEPTOR 1981-93%A%  
% 219.56/219.75  |- skos__hiddenLabel mesh__D018043 Hormone Receptors, Adrenocorticotropic
% 219.56/219.75  |- skos__altLabel mesh__D018043 Receptors, Adrenocorticotropic Hormone
% 219.56/219.75  |- skos__historyNote mesh__D018043
% 219.56/219.75       Receptors, Pituitary Hormone %28%1987-1993%29%
% 219.56/219.75  |- skos__scopeNote mesh__D018043
% 219.56/219.75       Cell surface receptors that bind CORTICOTROPIN; %28%ACTH, adrenocorticotropic hormone%29% with high affinity and trigger intracellular changes. Pharmacology suggests there may be multiple ACTH receptors. An ACTH receptor has been cloned and belongs to a subfamily of G-protein-coupled receptors. In addition to the adrenal cortex, ACTH receptors are found in the brain and immune systems.%A%    
% 219.56/219.75  |- mesh__recordMaintainer mesh__D018043 mdb
% 219.56/219.75  |- skos__hiddenLabel mesh__D018043 Hormone Receptor, Adrenocorticotropic
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D018043 2006
% 219.56/219.75  |- skos__altLabel mesh__D018043 Adrenocorticotropic Hormone Receptors
% 219.56/219.75  |- mesh__publicMeSHNote mesh__D018043
% 219.56/219.75       94; CORTICOTROPIN RECEPTOR was indexed under RECEPTORS, PITUITARY HORMONE 1987-93 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1981-86%A%  
% 219.56/219.75  |- mesh__historyNote mesh__D018043
% 219.56/219.75       94; was CORTICOTROPIN RECEPTOR %28%NM%29% 1981-93; CORTICOTROPIN RECEPTORS %26% ACTH RECEPTORS were SYs 1983-93%A%  
% 219.56/219.75  |- rdf__type mesh__D018043sskos__Concept
% 219.56/219.75  |- skos__altLabel mesh__D018043 Adrenocorticotropic Hormone Receptor
% 219.56/219.75  |- mesh__recordAuthorizer mesh__D018043 sjn
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D018043 2005
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D018043 2002
% 219.56/219.75  |- skos__altLabel mesh__D018043 ACTH Receptors
% 219.56/219.75  |- skos__prefLabel mesh__D018043 Receptors, Corticotropin
% 219.56/219.75  |- mesh__dateRevised mesh__D018043 2001-07-25
% 219.56/219.75  |- skos__altLabel mesh__D018043 Corticotropin Receptors
% 219.56/219.75  |- skos__altLabel mesh__D018043 Receptors, ACTH
% 219.56/219.75  |- skos__altLabel mesh__D018043 Corticotropin Receptor
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D018043 2004
% 219.56/219.75  |- skos__altLabel mesh__D018043 ACTH Receptor
% 219.56/219.75  |- skos__annotation mesh__D018043 DF: RECEPT ACTH   
% 219.56/219.75  |- skos__broader mesh__D018043smesh__D018013
% 219.56/219.75  |- skos__hiddenLabel mesh__D018043 Receptor, Adrenocorticotropic Hormone
% 219.56/219.75  |- mesh__dateCreated mesh__D018043 1993-06-14
% 219.56/219.75  |- mesh__recordOriginator mesh__D018043 RAZ
% 219.56/219.75  |- skos__historyNote mesh__D018043
% 219.56/219.75       Receptors, Cell Surface %28%1981-1986%29%
% 219.56/219.75  |- skos__hiddenLabel mesh__D018043 Receptor, Corticotropin
% 219.56/219.75  |- skos__hiddenLabel mesh__D018043 Receptor, ACTH
% 219.56/219.75  |- mesh__dateEstablished mesh__D018043 1994-01-01
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D018043 2003
% 219.56/219.75  |- skos__broader mesh__D018043smesh__D011979
% 219.56/219.75  |- mesh__dateRevised mesh__D010060 2004-07-07
% 219.56/219.75  |- skos__broader mesh__D010060smesh__D008597
% 219.56/219.75  |- mesh__recordAuthorizer mesh__D010060 sjn
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D010060 2006
% 219.56/219.75  |- skos__prefLabel mesh__D010060 Ovulation
% 219.56/219.75  |- mesh__dateCreated mesh__D010060 1999-01-01
% 219.56/219.75  |- mesh__recordOriginator mesh__D010060 NLM
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D010060 2005
% 219.56/219.75  |- skos__hiddenLabel mesh__D010060 Ovulations
% 219.56/219.75  |- skos__scopeNote mesh__D010060
% 219.56/219.75       The discharge of an OVUM from a rupturing Graafian follicle. Ovulation is regulated by a surge release of LUTEINIZING HORMONE.%A%    
% 219.56/219.75  |- mesh__recordMaintainer mesh__D010060 lkt
% 219.56/219.75  |- rdf__type mesh__D010060sskos__Concept
% 219.56/219.75  |- mesh__recordMaintainer mesh__D004821 SYSTEM
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D004821 2006
% 219.56/219.75  |- skos__broader mesh__D004821smesh__D003904
% 219.56/219.75  |- mesh__recordOriginator mesh__D004821 NLM
% 219.56/219.75  |- skos__annotation mesh__D004821 infection = EPIDERMOPHYTOSIS see TINEA   
% 219.56/219.75  |- rdf__type mesh__D004821sskos__Concept
% 219.56/219.75  |- mesh__dateCreated mesh__D004821 1999-01-01
% 219.56/219.75  |- skos__prefLabel mesh__D004821 Epidermophyton
% 219.56/219.75  |- skos__scopeNote mesh__D004821
% 219.56/219.75       A fungal genus which grows in the epidermis and is the cause of TINEA.%A%    
% 219.56/219.75  |- mesh__recordAuthorizer mesh__D004821 sjn
% 219.56/219.75  |- mesh__dateRevised mesh__D004821 2005-06-30
% 219.56/219.75  |- mesh__publicMeSHNote mesh__D004023 79; see MYXOMYCETES 1975-78   
% 219.56/219.75  |- rdf__type mesh__D004023sskos__Concept
% 219.56/219.75  |- skos__historyNote mesh__D004023 Myxomycetes %28%1966-1974%29%
% 219.56/219.75  |- mesh__recordAuthorizer mesh__D004023 sjn
% 219.56/219.75  |- skos__annotation mesh__D004023 a genus of protozoa   
% 219.56/219.75  |- skos__broader mesh__D004023smesh__D016837
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D004023 2006
% 219.56/219.75  |- mesh__dateEstablished mesh__D004023 1979-01-01
% 219.56/219.75  |- skos__scopeNote mesh__D004023
% 219.56/219.75       A genus of protozoa, formerly also considered a fungus. Its natural habitat is decaying forest leaves, where it feeds on bacteria. D. discoideum is the best-known species and is widely used in biomedical research.%A%    
% 219.56/219.75  |- mesh__historyNote mesh__D004023 79%28%75%29%   
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D004023 2005
% 219.56/219.75  |- mesh__activeMeSHYear mesh__D004023 2004
% 219.56/219.75  |- mesh__recordOriginator mesh__D004023 NLM
% 219.56/219.75  |- skos__prefLabel mesh__D004023 Dictyostelium
% 219.56/219.75  |- mesh__recordMaintainer mesh__D004023 ags
% 219.56/219.75  |- mesh__dateRevised mesh__D004023 2003-07-09
% 219.56/219.75  |- mesh__dateCreated mesh__D004023 1974-12-12
% 219.56/219.75  |- mesh__recordAuthorizer mesh__D017749 PLS
% 219.56/219.76  |- skos__scopeNote mesh__D017749
% 219.56/219.76       The application of industrial management practice to systematically maintain and improve organization-wide performance. Effectiveness and success are determined and assessed by quantitative quality measures.%A%    
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D017749 2000
% 219.56/219.76  |- skos__broader mesh__D017749smesh__D009934
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D017749 1996
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D017749 2004
% 219.56/219.76  |- skos__hiddenLabel mesh__D017749 Management, Total Quality
% 219.56/219.76  |- mesh__historyNote mesh__D017749 94   
% 219.56/219.76  |- mesh__publicMeSHNote mesh__D017749 94   
% 219.56/219.76  |- rdf__type mesh__D017749sskos__Concept
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D017749 2003
% 219.56/219.76  |- mesh__dateCreated mesh__D017749 1993-05-05
% 219.56/219.76  |- mesh__dateEstablished mesh__D017749 1994-01-01
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D017749 1999
% 219.56/219.76  |- mesh__recordMaintainer mesh__D017749 TGC
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D017749 2002
% 219.56/219.76  |- skos__hiddenLabel mesh__D017749 Management, Continuous Quality
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D017749 1998
% 219.56/219.76  |- skos__altLabel mesh__D017749 Continuous Quality Management
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D017749 2006
% 219.56/219.76  |- mesh__recordOriginator mesh__D017749 JLS
% 219.56/219.76  |- mesh__dateRevised mesh__D017749 1994-05-05
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D017749 1995
% 219.56/219.76  |- skos__historyNote mesh__D017749
% 219.56/219.76       Quality Assurance, Health Care %28%1989-1993%29%
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D017749 2005
% 219.56/219.76  |- skos__prefLabel mesh__D017749 Total Quality Management
% 219.56/219.76  |- skos__related mesh__D017749smesh__D011786
% 219.56/219.76  |- skos__annotation mesh__D017749 not restricted to health care; DF: TQM   
% 219.56/219.76  |- skos__broader mesh__D017749smesh__D011785
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D017749 2001
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D017749 1997
% 219.56/219.76  |- skos__prefLabel mesh__D036903 Aspalathus
% 219.56/219.76  |- skos__broader mesh__D036903smesh__D007887
% 219.56/219.76  |- mesh__historyNote mesh__D036903 2003   
% 219.56/219.76  |- mesh__dateCreated mesh__D036903 2002-07-02
% 219.56/219.76  |- rdf__type mesh__D036903sskos__Concept
% 219.56/219.76  |- skos__altLabel mesh__D036903 Rooibos
% 219.56/219.76  |- skos__annotation mesh__D036903
% 219.56/219.76       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D036903 2005
% 219.56/219.76  |- skos__scopeNote mesh__D036903
% 219.56/219.76       A plant genus of the family FABACEAE. It is the source of an herbal tea that is commonly consumed in South Africa. Members contain aspalathin and other polyphenols %28%PHENOLS%29%.%A%    
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D036903 2003
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D036903 2006
% 219.56/219.76  |- mesh__dateEstablished mesh__D036903 2003-01-01
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D036903 2004
% 219.56/219.76  |- mesh__publicMeSHNote mesh__D036903 2003   
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D003729 2005
% 219.56/219.76  |- mesh__recordAuthorizer mesh__D003729 sjn
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D003729 2002
% 219.56/219.76  |- mesh__dateRevised mesh__D003729 1999-11-03
% 219.56/219.76  |- mesh__recordMaintainer mesh__D003729 kle
% 219.56/219.76  |- mesh__historyNote mesh__D003729 73   
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D003729 2006
% 219.56/219.76  |- skos__scopeNote mesh__D003729
% 219.56/219.76       The total of dental diagnostic, preventive, and restorative services provided to meet the needs of a patient %28%from Illustrated Dictionary of Dentistry, 1982%29%.%A%    
% 219.56/219.76  |- mesh__dateEstablished mesh__D003729 1973-01-01
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D003729 2003
% 219.56/219.76  |- rdf__type mesh__D003729sskos__Concept
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D003729 2000
% 219.56/219.76  |- mesh__recordOriginator mesh__D003729 NLM
% 219.56/219.76  |- skos__annotation mesh__D003729
% 219.56/219.76       = professional care by a professional; ORAL HYGIENE = personal care by the subject himself; do not confuse with DENTISTRY: DENTISTRY is the dentist %26% the profession, DENTAL CARE is the patient %26% the care given him; GEN only: do not confuse with TOOTH DISEASES; DF: DENT CARE%A%  
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D003729 2004
% 219.56/219.76  |- skos__prefLabel mesh__D003729 Dental Care
% 219.56/219.76  |- skos__related mesh__D003729smesh__D003190
% 219.56/219.76  |- skos__broader mesh__D003729smesh__D003813
% 219.56/219.76  |- mesh__dateCreated mesh__D003729 1999-01-01
% 219.56/219.76  |- skos__broader mesh__D003729smesh__D003752
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D003729 2001
% 219.56/219.76  |- skos__altLabel mesh__D003729 Care, Dental
% 219.56/219.76  |- mesh__publicMeSHNote mesh__D003729 73   
% 219.56/219.76  |- skos__altLabel mesh__D014451 Coenzyme Q
% 219.56/219.76  |- skos__scopeNote mesh__D014451
% 219.56/219.76       A lipid-soluble benzoquinone which is involved in electron transport in mitochondrial preparations. The compound occurs in the majority of aerobic organisms, from bacteria to higher plants and animals.%A%    
% 219.56/219.76  |- mesh__recordOriginator mesh__D014451 NLM
% 219.56/219.76  |- mesh__recordAuthorizer mesh__D014451 sjn
% 219.56/219.76  |- skos__prefLabel mesh__D014451 Ubiquinone
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D014451 2004
% 219.56/219.76  |- mesh__dateCreated mesh__D014451 1999-01-01
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D014451 2006
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D014451 2005
% 219.56/219.76  |- mesh__recordMaintainer mesh__D014451 ssb
% 219.56/219.76  |- mesh__dateRevised mesh__D014451 2003-07-09
% 219.56/219.76  |- skos__broader mesh__D014451smesh__D003067
% 219.56/219.76  |- skos__broader mesh__D014451smesh__D016227
% 219.56/219.76  |- rdf__type mesh__D014451sskos__Concept
% 219.56/219.76  |- mesh__recordAuthorizer mesh__D008414 sjn
% 219.56/219.76  |- skos__annotation mesh__D008414
% 219.56/219.76       don%27%t forget also CATTLE %28%NIM%29% %26% check tags ANIMALS %26% FEMALE%A%  
% 219.56/219.76  |- mesh__recordOriginator mesh__D008414 NLM
% 219.56/219.76  |- skos__broader mesh__D008414smesh__D002418
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D008414 2006
% 219.56/219.76  |- skos__hiddenLabel mesh__D008414 Bovine Mastitis
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D008414 2005
% 219.56/219.76  |- mesh__dateRevised mesh__D008414 2004-07-07
% 219.56/219.76  |- skos__scopeNote mesh__D008414 INFLAMMATION of the UDDER in cows.     
% 219.56/219.76  |- rdf__type mesh__D008414sskos__Concept
% 219.56/219.76  |- mesh__dateCreated mesh__D008414 1999-01-01
% 219.56/219.76  |- skos__hiddenLabel mesh__D008414 Mastitides, Bovine
% 219.56/219.76  |- skos__hiddenLabel mesh__D008414 Bovine Mastitides
% 219.56/219.76  |- mesh__recordMaintainer mesh__D008414 lkt
% 219.56/219.76  |- skos__prefLabel mesh__D008414 Mastitis, Bovine
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D000431 2006
% 219.56/219.76  |- rdf__type mesh__D000431sskos__Concept
% 219.56/219.76  |- mesh__historyNote mesh__D000431 98%28%63%29%   
% 219.56/219.76  |- skos__hiddenLabel mesh__D000431 Alcohol, Absolute
% 219.56/219.76  |- skos__broader mesh__D000431smesh__D000438
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D000431 2005
% 219.56/219.76  |- mesh__recordAuthorizer mesh__D000431 SJN
% 219.56/219.76  |- mesh__recordOriginator mesh__D000431 NLM
% 219.56/219.76  |- mesh__dateRevised mesh__D000431 1997-06-20
% 219.56/219.76  |- skos__altLabel mesh__D000431 Alcohol, Ethyl
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D000431 2002
% 219.56/219.76  |- skos__annotation mesh__D000431
% 219.56/219.76       for %22%alcohol%22% unspecified; /antag: consider also ALCOHOL DETERRENTS; ethanol production by organisms = /metab; /pois: for acute alcohol pois, acute alcoholic intox, binge drinking, but ALCOHOLIC INTOXICATION is available for drunkenness %26% ALCOHOLISM for chronic alcohol intox; consider also ALCOHOLIC BEVERAGES; hypophysectomy by alcohol injection = HYPOPHYSECTOMY, CHEMICAL %26% do not index under ETHANOL unless particularly discussed; %22%abstinence from alcohol%22% = TEMPERANCE%A%  
% 219.56/219.76  |- skos__altLabel mesh__D000431 Grain Alcohol
% 219.56/219.76  |- skos__hiddenLabel mesh__D000431 Alcohol, Grain
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D000431 2004
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D000431 2001
% 219.56/219.76  |- mesh__dateCreated mesh__D000431 1999-01-01
% 219.56/219.76  |- skos__prefLabel mesh__D000431 Ethanol
% 219.56/219.76  |- mesh__publicMeSHNote mesh__D000431 98; see ALCOHOL, ETHYL 1963-97   
% 219.56/219.76  |- skos__related mesh__D000431smesh__D000434
% 219.56/219.76  |- skos__hiddenLabel mesh__D000431 Ethyl Alcohol
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D000431 2003
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D000431 1999
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D000431 2000
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D000431 1998
% 219.56/219.76  |- skos__scopeNote mesh__D000431
% 219.56/219.76       A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES.%A%    
% 219.56/219.76  |- mesh__recordMaintainer mesh__D000431 ADP
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D013359 2005
% 219.56/219.76  |- mesh__recordOriginator mesh__D013359 NLM
% 219.56/219.76  |- mesh__recordAuthorizer mesh__D013359 SJN
% 219.56/219.76  |- skos__scopeNote mesh__D013359
% 219.56/219.76       A defense mechanism through which unacceptable impulses and instinctive urges are diverted into personally and socially acceptable channels; e.g., aggression may be diverted through sports activities.%A%    
% 219.56/219.76  |- skos__historyNote mesh__D013359 Psychoanalytic Theory %28%1966-1967%29%
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D013359 2001
% 219.56/219.76  |- rdf__type mesh__D013359sskos__Concept
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D013359 2004
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D013359 1999
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D013359 2000
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D013359 2003
% 219.56/219.76  |- mesh__dateCreated mesh__D013359 1999-01-01
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D013359 1998
% 219.56/219.76  |- mesh__historyNote mesh__D013359 68   
% 219.56/219.76  |- mesh__dateRevised mesh__D013359 1997-06-20
% 219.56/219.76  |- mesh__dateEstablished mesh__D013359 1968-01-01
% 219.56/219.76  |- skos__annotation mesh__D013359 no qualif   
% 219.56/219.76  |- skos__prefLabel mesh__D013359 Sublimation
% 219.56/219.76  |- mesh__recordMaintainer mesh__D013359 JLS
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D013359 2006
% 219.56/219.76  |- skos__broader mesh__D013359smesh__D003674
% 219.56/219.76  |- mesh__publicMeSHNote mesh__D013359 68   
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D013359 2002
% 219.56/219.76  |- mesh__historyNote mesh__D024081 2002; use COLLAGEN 1990-2001   
% 219.56/219.76  |- skos__altLabel mesh__D024081 Collagen alpha3%28%IX%29%
% 219.56/219.76  |- skos__prefLabel mesh__D024081 Collagen Type IX
% 219.56/219.76  |- mesh__dateRevised mesh__D024081 2004-07-07
% 219.56/219.76  |- skos__altLabel mesh__D024081 Collagen alpha1%28%IX%29%
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D024081 2005
% 219.56/219.76  |- skos__hiddenLabel mesh__D024081 Type IX, Procollagen
% 219.56/219.76  |- skos__hiddenLabel mesh__D024081 Collagen, Type IX
% 219.56/219.76  |- skos__hiddenLabel mesh__D024081 Collagen Type IX, alpha1 Chain
% 219.56/219.76  |- skos__altLabel mesh__D024081 Collagen alpha2%28%IX%29%
% 219.56/219.76  |- mesh__recordOriginator mesh__D024081 jmp
% 219.56/219.76  |- mesh__dateCreated mesh__D024081 2001-07-25
% 219.56/219.76  |- rdf__type mesh__D024081sskos__Concept
% 219.56/219.76  |- mesh__publicMeSHNote mesh__D024081 2002; see COLLAGEN 1990-2001   
% 219.56/219.76  |- skos__hiddenLabel mesh__D024081 Collagen Type IX, alpha2 Chain
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D024081 2006
% 219.56/219.76  |- mesh__recordMaintainer mesh__D024081 jmp
% 219.56/219.76  |- skos__broader mesh__D024081smesh__D024021
% 219.56/219.76  |- skos__altLabel mesh__D024081 Type IX Procollagen
% 219.56/219.76  |- skos__altLabel mesh__D024081 Collagen Type-IX, alpha2 Chain
% 219.56/219.76  |- mesh__recordAuthorizer mesh__D024081 sjn
% 219.56/219.76  |- skos__altLabel mesh__D024081 Type IX Collagen
% 219.56/219.76  |- skos__scopeNote mesh__D024081
% 219.56/219.76       A fibril-associated collagen usually found crosslinked to the surface of COLLAGEN TYPE II fibrils.  It is a heterotrimer containing alpha1%28%IX%29%, alpha2%28%IX%29% and alpha3%28%IX%29% subunits.%A%    
% 219.56/219.76  |- skos__altLabel mesh__D024081 Collagen Type-IX, alpha3 Chain
% 219.56/219.76  |- skos__altLabel mesh__D024081 Collagen Type-IX, alpha1 Chain
% 219.56/219.76  |- skos__hiddenLabel mesh__D024081 Collagen Type IX, alpha3 Chain
% 219.56/219.76  |- skos__historyNote mesh__D024081 Collagen %28%1990-2001%29%
% 219.56/219.76  |- mesh__dateEstablished mesh__D024081 2002-01-01
% 219.56/219.76  |- skos__hiddenLabel mesh__D024081 Procollagen, Type IX
% 219.56/219.76  |- skos__annotation mesh__D024081
% 219.56/219.76       precursors: coord IM with PROCOLLAGEN %28%IM%29%   
% 219.56/219.76  |- rdf__type mesh__D010061sskos__Concept
% 219.56/219.76  |- skos__scopeNote mesh__D010061
% 219.56/219.76       Method to determine the occurrence of OVULATION by direct or indirect means. Indirect methods examine the effects of PROGESTERONE on cervical mucus %28%CERVIX MUCUS%29%, or basal body temperature. Direct ovulation detection, generally used in fertility treatment, involves analyses of circulating hormones in blood and ULTRASONOGRAPHY.%A%    
% 219.56/219.76  |- skos__hiddenLabel mesh__D010061 Ovulation Detections
% 219.56/219.76  |- skos__prefLabel mesh__D010061 Ovulation Detection
% 219.56/219.76  |- skos__hiddenLabel mesh__D010061
% 219.56/219.76       Ovulation Detection, Sympto Thermal Method
% 219.56/219.76  |- mesh__dateEstablished mesh__D010061 1975-09-01
% 219.56/219.76  |- mesh__recordOriginator mesh__D010061 NLM
% 219.56/219.76  |- skos__broader mesh__D010061smesh__D012099
% 219.56/219.76  |- mesh__dateRevised mesh__D010061 2005-06-30
% 219.56/219.76  |- mesh__publicMeSHNote mesh__D010061 75   
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D010061 2006
% 219.56/219.76  |- skos__broader mesh__D010061smesh__D010050
% 219.56/219.76  |- mesh__recordMaintainer mesh__D010061 lkt
% 219.56/219.76  |- mesh__historyNote mesh__D010061 75   
% 219.56/219.76  |- skos__related mesh__D010061smesh__D044384
% 219.56/219.76  |- mesh__dateCreated mesh__D010061 1974-11-19
% 219.56/219.76  |- skos__historyNote mesh__D010061 Ovulation %28%1966-1974%29%
% 219.56/219.76  |- skos__hiddenLabel mesh__D010061 Detection, Ovulation
% 219.56/219.76  |- mesh__recordAuthorizer mesh__D010061 sjn
% 219.56/219.76  |- mesh__dateRevised mesh__D004822 2005-06-30
% 219.56/219.76  |- skos__broader mesh__D004822smesh__D005837
% 219.56/219.76  |- skos__scopeNote mesh__D004822
% 219.56/219.76       The convoluted cordlike structure attached to the posterior of the TESTIS. Epididymis consists of the head %28%caput%29%, the body %28%corpus%29%, and the tail %28%cauda%29%. A network of ducts leaving the testis joins into a common epididymal tubule proper which provides the transport, storage, and maturation of SPERMATOZOA.%A%    
% 219.56/219.76  |- mesh__recordOriginator mesh__D004822 NLM
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D004822 2006
% 219.56/219.76  |- skos__annotation mesh__D004822
% 219.56/219.76       NIM when used in fat-pad tissue studies; diseases: coordinate IM with GENITAL DISEASES, MALE %28%IM%29%; inflammation = EPIDIDYMITIS%A%  
% 219.56/219.76  |- skos__prefLabel mesh__D004822 Epididymis
% 219.56/219.76  |- mesh__recordMaintainer mesh__D004822 lkt
% 219.56/219.76  |- rdf__type mesh__D004822sskos__Concept
% 219.56/219.76  |- mesh__dateCreated mesh__D004822 1999-01-01
% 219.56/219.76  |- mesh__recordAuthorizer mesh__D004822 sjn
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D051478 2006
% 219.56/219.76  |- mesh__historyNote mesh__D051478 2006   
% 219.56/219.76  |- skos__hiddenLabel mesh__D051478 Fibrocartilage, Triangular
% 219.56/219.76  |- skos__hiddenLabel mesh__D051478 Fibrocartilages, Triangular
% 219.56/219.76  |- skos__broader mesh__D051478smesh__D014955
% 219.56/219.76  |- skos__hiddenLabel mesh__D051478 Complex, Triangular Fibrocartilage
% 219.56/219.76  |- skos__historyNote mesh__D051478 Cartilage, Articular %28%1969-2005%29%
% 219.56/219.76  |- mesh__publicMeSHNote mesh__D051478 2006   
% 219.56/219.76  |- mesh__dateCreated mesh__D051478 2005-06-30
% 219.56/219.76  |- mesh__dateRevised mesh__D051478 2005-07-11
% 219.56/219.76  |- skos__scopeNote mesh__D051478
% 219.56/219.76       Fibrocartilage that makes up the triangular fibrocartilage complex which is found in the WRIST JOINT.%A%    
% 219.56/219.76  |- mesh__recordMaintainer mesh__D051478 ags
% 219.56/219.76  |- skos__broader mesh__D051478smesh__D051445
% 219.56/219.76  |- skos__prefLabel mesh__D051478 Triangular Fibrocartilage
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D051478 2006A
% 219.56/219.76  |- rdf__type mesh__D051478sskos__Concept
% 219.56/219.76  |- mesh__recordOriginator mesh__D051478 ags
% 219.56/219.76  |- mesh__dateEstablished mesh__D051478 2006-01-01
% 219.56/219.76  |- skos__hiddenLabel mesh__D051478 Triangular Fibrocartilages
% 219.56/219.76  |- mesh__recordAuthorizer mesh__D051478 ags
% 219.56/219.76  |- skos__hiddenLabel mesh__D051478 Fibrocartilage Complex, Triangular
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D004024 2005
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D004024 2004
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D004024 1999
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D004024 2001
% 219.56/219.76  |- skos__altLabel mesh__D004024 DCCD
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D004024 2003
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D004024 1998
% 219.56/219.76  |- skos__broader mesh__D004024smesh__D002234
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D004024 1997
% 219.56/219.76  |- mesh__recordAuthorizer mesh__D004024 PLS
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D004024 2000
% 219.56/219.76  |- skos__annotation mesh__D004024 DF: note short X ref   
% 219.56/219.76  |- mesh__dateCreated mesh__D004024 1999-01-01
% 219.56/219.76  |- mesh__historyNote mesh__D004024
% 219.56/219.76       91%28%73%29%; was see under CARBODIIMIDES 1973-90   
% 219.56/219.76  |- skos__scopeNote mesh__D004024
% 219.56/219.76       A carbodiimide that is used as a chemical intermediate and coupling agent in peptide synthesis. %28%From Hawley%27%s Condensed Chemical Dictionary, 12th ed%29%%A%    
% 219.56/219.76  |- rdf__type mesh__D004024sskos__Concept
% 219.56/219.76  |- mesh__dateRevised mesh__D004024 1996-06-10
% 219.56/219.76  |- mesh__recordMaintainer mesh__D004024 TPW
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D004024 2002
% 219.56/219.76  |- skos__prefLabel mesh__D004024 Dicyclohexylcarbodiimide
% 219.56/219.76  |- mesh__dateEstablished mesh__D004024 1991-01-01
% 219.56/219.76  |- mesh__recordOriginator mesh__D004024 NLM
% 219.56/219.76  |- mesh__publicMeSHNote mesh__D004024
% 219.56/219.76       91; was see under CARBODIIMIDES 1973-90   
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D004024 2006
% 219.56/219.76  |- mesh__dateEstablished mesh__D036904 2003-01-01
% 219.56/219.76  |- skos__hiddenLabel mesh__D036904 Rolling, Leucocyte
% 219.56/219.76  |- skos__hiddenLabel mesh__D036904 Rolling, Leukocyte
% 219.56/219.76  |- mesh__recordOriginator mesh__D036904 ags
% 219.56/219.76  |- skos__altLabel mesh__D036904 Leucocyte Rolling
% 219.56/219.76  |- mesh__historyNote mesh__D036904 2003   
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D036904 2005A
% 219.56/219.76  |- mesh__recordMaintainer mesh__D036904 jls
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D036904 2005
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D036904 2003
% 219.56/219.76  |- skos__broader mesh__D036904smesh__D002634
% 219.56/219.76  |- mesh__dateRevised mesh__D036904 2004-07-28
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D036904 2006
% 219.56/219.76  |- skos__historyNote mesh__D036904 Cell Adhesion %28%1991-2002%29%
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D036904 2004
% 219.56/219.76  |- mesh__publicMeSHNote mesh__D036904 2003   
% 219.56/219.76  |- skos__historyNote mesh__D036904 Cell Movement %28%1991-2002%29%
% 219.56/219.76  |- mesh__recordAuthorizer mesh__D036904 jls
% 219.56/219.76  |- skos__scopeNote mesh__D036904
% 219.56/219.76       Movement of tethered, spherical LEUKOCYTES along the endothelial surface of the microvasculature. The tethering and rolling involves interaction with SELECTINS and other adhesion molecules in both the ENDOTHELIUM and leukocyte. The rolling leukocyte then becomes activated by CHEMOKINES, flattens out, and firmly adheres to the endothelial surface in preparation for transmigration through the interendothelial cell junction. %28%From Abbas, Cellular and Molecular Immunology, 3rd ed%29%%A%    
% 219.56/219.76  |- mesh__dateCreated mesh__D036904 2002-07-03
% 219.56/219.76  |- rdf__type mesh__D036904sskos__Concept
% 219.56/219.76  |- skos__prefLabel mesh__D036904 Leukocyte Rolling
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D014452 2006
% 219.56/219.76  |- skos__scopeNote mesh__D014452
% 219.56/219.76       A family of proteins that are structurally-related to Ubiquitin. Ubiquitins and ubiquitin-like proteins participate in diverse cellular functions, such as protein degradation and HEAT-SHOCK RESPONSE, by conjugation to other proteins.%A%    
% 219.56/219.76  |- skos__historyNote mesh__D014452
% 219.56/219.76       Chromosomal Proteins, Non-Histone %28%1977-1984%29%
% 219.56/219.76  |- skos__hiddenLabel mesh__D014452 Ubiquitin Like Proteins
% 219.56/219.76  |- skos__hiddenLabel mesh__D014452 Proteins, Ubiquitin-Like
% 219.56/219.76  |- skos__historyNote mesh__D014452 Peptides %28%1975-1980%29%
% 219.56/219.76  |- skos__historyNote mesh__D014452 Nucleoproteins %28%1966-1977%29%
% 219.56/219.76  |- mesh__publicMeSHNote mesh__D014452
% 219.56/219.76       2002; see UBIQUITIN 1987-2001, see HIGH MOBILITY GROUP PROTEINS 1985-1986; for HIGH MOBILITY PROTEIN 20 %26% HMG-20 see UBIQUITIN 1985-1993%A%  
% 219.56/219.76  |- mesh__recordAuthorizer mesh__D014452 sjn
% 219.56/219.76  |- mesh__recordOriginator mesh__D014452 RLS
% 219.56/219.76  |- skos__prefLabel mesh__D014452 Ubiquitins
% 219.56/219.76  |- mesh__dateRevised mesh__D014452 2005-06-30
% 219.56/219.76  |- rdf__type mesh__D014452sskos__Concept
% 219.56/219.76  |- skos__broader mesh__D014452smesh__D011506
% 219.56/219.76  |- mesh__recordMaintainer mesh__D014452 SYSTEM
% 219.56/219.76  |- mesh__historyNote mesh__D014452 2002%28%1985%29%;   
% 219.56/219.76  |- mesh__dateEstablished mesh__D014452 1987-01-01
% 219.56/219.76  |- mesh__dateCreated mesh__D014452 1984-05-30
% 219.56/219.76  |- skos__annotation mesh__D014452 UBIQUITIN is available   
% 219.56/219.76  |- skos__hiddenLabel mesh__D008415 Mastocytoses
% 219.56/219.76  |- mesh__recordMaintainer mesh__D008415 lkt
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D008415 2006
% 219.56/219.76  |- skos__historyNote mesh__D008415 Urticaria Pigmentosa %28%1966-1986%29%
% 219.56/219.76  |- skos__broader mesh__D008415smesh__D012871
% 219.56/219.76  |- mesh__dateRevised mesh__D008415 2002-07-03
% 219.56/219.76  |- skos__prefLabel mesh__D008415 Mastocytosis
% 219.56/219.76  |- skos__hiddenLabel mesh__D008415 Mast-Cell Diseases
% 219.56/219.76  |- mesh__dateCreated mesh__D008415 1986-04-07
% 219.56/219.76  |- mesh__recordAuthorizer mesh__D008415 sjn
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D008415 2004
% 219.56/219.76  |- mesh__recordOriginator mesh__D008415 RC
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D008415 2005
% 219.56/219.76  |- skos__broader mesh__D008415smesh__D009372
% 219.56/219.76  |- skos__hiddenLabel mesh__D008415 Mast Cell Disease
% 219.56/219.76  |- rdf__type mesh__D008415sskos__Concept
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D008415 2003
% 219.56/219.76  |- mesh__onlineNote mesh__D008415
% 219.56/219.76       use URTICARIA PIGMENTOSA to search MASTOCYTOSIS 1975-86   
% 219.56/219.76  |- mesh__dateEstablished mesh__D008415 1987-01-01
% 219.56/219.76  |- skos__hiddenLabel mesh__D008415 Disease, Mast-Cell
% 219.56/219.76  |- mesh__publicMeSHNote mesh__D008415
% 219.56/219.76       87; was see URTICARIA PIGMENTOSA 1975-86   
% 219.56/219.76  |- skos__scopeNote mesh__D008415
% 219.56/219.76       A heterogenous group of disorders characterized by the abnormal increase of MAST CELLS in only the skin  %28%MASTOCYTOSIS, CUTANEOUS%29%, in extracutaneous tissues involving multiple organs %28%MASTOCYTOSIS, SYSTEMIC%29%, or in solid tumors %28%MASTOCYTOMAS%29%.%A%    
% 219.56/219.76  |- skos__annotation mesh__D008415 GEN or unspecified; prefer specifics   
% 219.56/219.76  |- skos__hiddenLabel mesh__D008415 Diseases, Mast-Cell
% 219.56/219.76  |- skos__altLabel mesh__D008415 Mast-Cell Disease
% 219.56/219.76  |- mesh__historyNote mesh__D008415
% 219.56/219.76       87; was see URTICARIA PIGMENTOSA 1975-86   
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D000432 2004
% 219.56/219.76  |- skos__hiddenLabel mesh__D000432 Methyl Alcohol
% 219.56/219.76  |- skos__altLabel mesh__D000432 Alcohol, Methyl
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D000432 2000
% 219.56/219.76  |- mesh__historyNote mesh__D000432 98;   
% 219.56/219.76  |- mesh__dateCreated mesh__D000432 1999-01-01
% 219.56/219.76  |- skos__scopeNote mesh__D000432
% 219.56/219.76       A colorless, flammable liquid used in the manufacture of FORMALDEHYDE and ACETIC ACID, in chemical synthesis, antifreeze, and as a solvent. Ingestion of methanol is toxic and may cause blindness.%A%    
% 219.56/219.76  |- skos__hiddenLabel mesh__D000432 Alcohol, Wood
% 219.56/219.76  |- skos__annotation mesh__D000432 for wood alcohol   
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D000432 2003
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D000432 1999
% 219.56/219.76  |- skos__hiddenLabel mesh__D000432 Methoxide, Sodium
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D000432 1998
% 219.56/219.76  |- skos__broader mesh__D000432smesh__D000438
% 219.56/219.76  |- skos__altLabel mesh__D000432 Carbinol
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D000432 2006
% 219.56/219.76  |- mesh__publicMeSHNote mesh__D000432 98; see ALCOHOL, METHYL 1966-97   
% 219.56/219.76  |- mesh__dateRevised mesh__D000432 1997-06-20
% 219.56/219.76  |- mesh__recordOriginator mesh__D000432 NLM
% 219.56/219.76  |- mesh__recordAuthorizer mesh__D000432 SJN
% 219.56/219.76  |- rdf__type mesh__D000432sskos__Concept
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D000432 2002
% 219.56/219.76  |- skos__prefLabel mesh__D000432 Methanol
% 219.56/219.76  |- mesh__recordMaintainer mesh__D000432 ADP
% 219.56/219.76  |- skos__altLabel mesh__D000432 Wood Alcohol
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D000432 2005
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D000432 2001
% 219.56/219.76  |- skos__broader mesh__D002552Q000530smesh__D002552
% 219.56/219.76  |- mesh__preferredCombination mesh__D002552Q000530smesh__D014695
% 219.56/219.76  |- rdf__type mesh__D002552Q000530smesh__CompoundConcept
% 219.56/219.76  |- mesh__recordAuthorizer mesh__D024082 sjn
% 219.56/219.76  |- mesh__publicMeSHNote mesh__D024082 2002; see COLLAGEN 1992-2001   
% 219.56/219.76  |- skos__broader mesh__D024082smesh__D024021
% 219.56/219.76  |- skos__historyNote mesh__D024082 Collagen %28%1987-2001%29%
% 219.56/219.76  |- skos__hiddenLabel mesh__D024082 Procollagen, Type XII
% 219.56/219.76  |- skos__hiddenLabel mesh__D024082 Collagen, Type XII
% 219.56/219.76  |- skos__altLabel mesh__D024082 Collagen Type XII, alpha1 Chain
% 219.56/219.76  |- mesh__recordMaintainer mesh__D024082 jmp
% 219.56/219.76  |- skos__altLabel mesh__D024082 Type XII Collagen
% 219.56/219.76  |- skos__altLabel mesh__D024082 Collagen alpha1%28%XII%29%
% 219.56/219.76  |- skos__scopeNote mesh__D024082
% 219.56/219.76       A fibril-associated collagen found in many tissues bearing high tensile stress, such as TENDONS and LIGAMENTS. It is comprised of a trimer of three identical alpha1%28%XII%29% chains.%A%    
% 219.56/219.76  |- skos__annotation mesh__D024082
% 219.56/219.76       precursors: coord IM with PROCOLLAGEN %28%IM%29%   
% 219.56/219.76  |- mesh__dateCreated mesh__D024082 2001-07-25
% 219.56/219.76  |- mesh__dateRevised mesh__D024082 2004-07-07
% 219.56/219.76  |- mesh__recordOriginator mesh__D024082 jmp
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D024082 2005
% 219.56/219.76  |- mesh__dateEstablished mesh__D024082 2002-01-01
% 219.56/219.76  |- rdf__type mesh__D024082sskos__Concept
% 219.56/219.76  |- skos__altLabel mesh__D024082 Type XII Procollagen
% 219.56/219.76  |- mesh__historyNote mesh__D024082 2002; use COLLAGEN 1992-2001   
% 219.56/219.76  |- skos__prefLabel mesh__D024082 Collagen Type XII
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D024082 2006
% 219.56/219.76  |- skos__hiddenLabel mesh__D024082 Type XII, Procollagen
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D018843 2006A
% 219.56/219.76  |- skos__broader mesh__D018843smesh__D015022
% 219.56/219.76  |- skos__broader mesh__D018843smesh__D005061
% 219.56/219.76  |- mesh__dateRevised mesh__D018843 2005-07-19
% 219.56/219.76  |- rdf__type mesh__D018843sskos__Concept
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D018843 1997
% 219.56/219.76  |- mesh__historyNote mesh__D018843
% 219.56/219.76       95; MACEDONIA %28%YUGOSLAVIA%29% was see YUGOSLAVIA 1994   
% 219.56/219.76  |- mesh__dateCreated mesh__D018843 1994-05-31
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D018843 2002
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D018843 1999
% 219.56/219.76  |- mesh__dateEstablished mesh__D018843 1995-01-01
% 219.56/219.76  |- skos__annotation mesh__D018843
% 219.56/219.76       note X refs: do not confuse with MACEDONIA %28%GREECE%29% see GREECE%A%  
% 219.56/219.76  |- skos__altLabel mesh__D018843 The Former Yugoslav Republic of Macedonia
% 219.56/219.76  |- mesh__recordMaintainer mesh__D018843 ags
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D018843 1996
% 219.56/219.76  |- skos__altLabel mesh__D018843 Former Yugoslav Republic of Macedonia
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D018843 2001
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D018843 1998
% 219.56/219.76  |- mesh__onlineNote mesh__D018843
% 219.56/219.76       use YUGOSLAVIA to search MACEDONIA %28%YUGOSLAVIA%29% 1994   
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D018843 2004
% 219.56/219.76  |- skos__altLabel mesh__D018843 Macedonia %28%Yugoslavia%29%
% 219.56/219.76  |- mesh__recordOriginator mesh__D018843 TGC
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D018843 2000
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D018843 2006
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D018843 2003
% 219.56/219.76  |- skos__altLabel mesh__D018843 Macedonia, Former Yugoslave Republic of
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D018843 2005
% 219.56/219.76  |- mesh__recordAuthorizer mesh__D018843 ags
% 219.56/219.76  |- skos__scopeNote mesh__D018843
% 219.56/219.76       Formerly a constituent republic of Yugoslavia, comprising the Yugoslav section of the region of Macedonia. It was made a constituent republic in the 1946 constitution. It became independent on 8 February 1994 and was recognized as The Former Yugoslav Republic of Macedonia by the United States Board on Geographic Names 16 February 1994.%A%    
% 219.56/219.76  |- skos__prefLabel mesh__D018843 Macedonia %28%Republic%29%
% 219.56/219.76  |- skos__scopeNote mesh__D010860
% 219.56/219.76       Any normal or abnormal coloring matter in PLANTS; ANIMALS or micro-organisms.%A%    
% 219.56/219.76  |- mesh__activeMeSHYear mesh__D010860 2006
% 219.56/219.76  |- mesh__recordAuthorizer mesh__D010860 sjn
% 219.56/219.76  |- mesh__dateCreated mesh__D010860 1999-01-01
% 219.56/219.77  |- skos__related mesh__D010860smesh__D010858
% 219.56/219.77  |- mesh__historyNote mesh__D010860 2006%28%1963%29%   
% 219.56/219.77  |- skos__broader mesh__D010860smesh__D001685
% 219.56/219.77  |- skos__hiddenLabel mesh__D010860 Biological Pigments
% 219.56/219.77  |- skos__prefLabel mesh__D010860 Pigments, Biological
% 219.56/219.77  |- mesh__recordMaintainer mesh__D010860 sjn
% 219.56/219.77  |- mesh__publicMeSHNote mesh__D010860 2006; see PIGMENTS 1963-2005   
% 219.56/219.77  |- mesh__recordOriginator mesh__D010860 NLM
% 219.56/219.77  |- mesh__dateRevised mesh__D010860 2005-07-01
% 219.56/219.77  |- skos__annotation mesh__D010860 differentiate from COLORING AGENTS   
% 219.56/219.77  |- rdf__type mesh__D010860sskos__Concept
% 219.56/219.77  |- mesh__dateRevised mesh__D018045 2003-07-09
% 219.56/219.77  |- skos__hiddenLabel mesh__D018045 Receptor, Oxytocin
% 219.56/219.77  |- rdf__type mesh__D018045sskos__Concept
% 219.56/219.77  |- skos__scopeNote mesh__D018045
% 219.56/219.77       Cell surface proteins that bind oxytocin with high affinity and trigger intracellular changes which influence the behavior of cells. Oxytocin receptors in the uterus and the mammary glands mediate the hormone%27%s stimulation of contraction and milk ejection. The presence of oxytocin and oxytocin receptors in neurons of the brain probably reflects an additional role as a neurotransmitter.%A%    
% 219.56/219.77  |- mesh__dateCreated mesh__D018045 1993-06-21
% 219.56/219.77  |- skos__historyNote mesh__D018045
% 219.56/219.77       Receptors, Cell Surface %28%1981-1984%29%
% 219.56/219.77  |- skos__annotation mesh__D018045 DF: RECEPT OXYTOCIN   
% 219.56/219.77  |- skos__altLabel mesh__D018045 Oxytocin Receptors
% 219.56/219.77  |- mesh__dateEstablished mesh__D018045 1994-01-01
% 219.56/219.77  |- mesh__publicMeSHNote mesh__D018045
% 219.56/219.77       94; OXYTOCIN RECEPTOR was indexed under RECEPTORS, ANGIOTENSIN 1985-93 %26% RECEPTORS, ENDOGENOUS SUBSTANCES %28%1981-84%29%%A%  
% 219.56/219.77  |- skos__historyNote mesh__D018045 Receptors, Angiotensin %28%1985-1993%29%
% 219.56/219.77  |- mesh__recordOriginator mesh__D018045 RAZ
% 219.56/219.77  |- skos__broader mesh__D018045smesh__D043562
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D018045 2004
% 219.56/219.77  |- skos__broader mesh__D018045smesh__D011979
% 219.56/219.77  |- skos__prefLabel mesh__D018045 Receptors, Oxytocin
% 219.56/219.77  |- skos__altLabel mesh__D018045 Oxytocin Receptor
% 219.56/219.77  |- skos__broader mesh__D018045smesh__D018013
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D018045 2005
% 219.56/219.77  |- mesh__recordMaintainer mesh__D018045 jmp
% 219.56/219.77  |- mesh__onlineNote mesh__D018045
% 219.56/219.77       use RECEPTORS, OXYTOCIN %28%NM%29% to search OXYTOCIN RECEPTOR 1981-93%A%  
% 219.56/219.77  |- mesh__historyNote mesh__D018045
% 219.56/219.77       94; was OXYTOCIN RECEPTOR %28%NM%29% 1981-93   
% 219.56/219.77  |- mesh__recordAuthorizer mesh__D018045 sjn
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D018045 2006
% 219.56/219.77  |- mesh__dateCreated mesh__D010062 1977-03-01
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D010062 2005
% 219.56/219.77  |- mesh__recordAuthorizer mesh__D010062 sjn
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D010062 2004
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D010062 2006
% 219.56/219.77  |- skos__prefLabel mesh__D010062 Ovulation Induction
% 219.56/219.77  |- skos__historyNote mesh__D010062 Ovulation %28%1966-1977%29%
% 219.56/219.77  |- skos__broader mesh__D010062smesh__D027724
% 219.56/219.77  |- skos__historyNote mesh__D010062 Anovulation %28%1975-1977%29%
% 219.56/219.77  |- mesh__historyNote mesh__D010062 1978   
% 219.56/219.77  |- skos__hiddenLabel mesh__D010062 Stimulations, Ovarian
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D010062 2002
% 219.56/219.77  |- mesh__publicMeSHNote mesh__D010062 1978   
% 219.56/219.77  |- mesh__dateEstablished mesh__D010062 1978-01-01
% 219.56/219.77  |- skos__related mesh__D010062smesh__D016471
% 219.56/219.77  |- mesh__dateRevised mesh__D010062 2001-07-25
% 219.56/219.77  |- mesh__recordOriginator mesh__D010062 SMH
% 219.56/219.77  |- skos__scopeNote mesh__D010062
% 219.56/219.77       Techniques for the artifical induction of ovulation, the rupture of the follicle and release of the ovum.%A%    
% 219.56/219.77  |- mesh__recordMaintainer mesh__D010062 lkt
% 219.56/219.77  |- skos__hiddenLabel mesh__D010062 Ovarian Stimulations
% 219.56/219.77  |- rdf__type mesh__D010062sskos__Concept
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D010062 2003
% 219.56/219.77  |- skos__hiddenLabel mesh__D010062 Stimulation, Ovarian
% 219.56/219.77  |- mesh__recordMaintainer mesh__D004823 lkt
% 219.56/219.77  |- mesh__recordAuthorizer mesh__D004823 sjn
% 219.56/219.77  |- skos__broader mesh__D004823smesh__D005832
% 219.56/219.77  |- mesh__dateCreated mesh__D004823 1999-01-01
% 219.56/219.77  |- mesh__dateRevised mesh__D004823 2005-06-30
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D004823 2006
% 219.56/219.77  |- mesh__recordOriginator mesh__D004823 NLM
% 219.56/219.77  |- rdf__type mesh__D004823sskos__Concept
% 219.56/219.77  |- skos__scopeNote mesh__D004823
% 219.56/219.77       Inflammation of the EPIDIDYMIS. Its clinical features include enlarged epididymis, a swollen SCROTUM; PAIN; PYURIA; and FEVER. It is usually related to infections in the URINARY TRACT, which likely spread to the EPIDIDYMIS through either the VAS DEFERENS or the lymphatics of the SPERMATIC CORD.%A%    
% 219.56/219.77  |- skos__hiddenLabel mesh__D004823 Epididymitides
% 219.56/219.77  |- skos__prefLabel mesh__D004823 Epididymitis
% 219.56/219.77  |- skos__prefLabel mesh__D051479 Plant Infertility
% 219.56/219.77  |- mesh__publicMeSHNote mesh__D051479 2006   
% 219.56/219.77  |- mesh__historyNote mesh__D051479 2006   
% 219.56/219.77  |- rdf__type mesh__D051479sskos__Concept
% 219.56/219.77  |- skos__altLabel mesh__D051479 Reproductive Sterility in Plants
% 219.56/219.77  |- mesh__recordOriginator mesh__D051479 nns
% 219.56/219.77  |- mesh__dateCreated mesh__D051479 2005-06-30
% 219.56/219.77  |- mesh__recordMaintainer mesh__D051479 nns
% 219.56/219.77  |- skos__altLabel mesh__D051479 Sterility, Reproductive, Plants
% 219.56/219.77  |- skos__altLabel mesh__D051479 Reproductive Sterility, Plants
% 219.56/219.77  |- mesh__recordAuthorizer mesh__D051479 sjn
% 219.56/219.77  |- skos__broader mesh__D051479smesh__D018521
% 219.56/219.77  |- skos__altLabel mesh__D051479 Infertility, Plant
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D051479 2006
% 219.56/219.77  |- skos__scopeNote mesh__D051479
% 219.56/219.77       The failure of PLANTS to complete fertilization and obtain seed %28%SEEDS%29% as a result of defective POLLEN or ovules, or other aberrations. %28%Dict. of Plant Genet. and Mol. Biol., 1998%29%%A%    
% 219.56/219.77  |- mesh__dateEstablished mesh__D051479 2006-01-01
% 219.56/219.77  |- skos__altLabel mesh__D004025 Ortega Brand of Dicyclomine Hydrochloride
% 219.56/219.77  |- mesh__dateRevised mesh__D004025 2005-06-30
% 219.56/219.77  |- skos__hiddenLabel mesh__D004025 Di Cyclonex
% 219.56/219.77  |- skos__hiddenLabel mesh__D004025 Hydrochloride, Dicyclomine
% 219.56/219.77  |- skos__hiddenLabel mesh__D004025 Di Spaz
% 219.56/219.77  |- skos__altLabel mesh__D004025 Vortech Brand of Dicyclomine Hydrochloride
% 219.56/219.77  |- skos__historyNote mesh__D004025 Diethylamines %28%1974-1975%29%
% 219.56/219.77  |- skos__altLabel mesh__D004025
% 219.56/219.77       Aventis Behring Brand of Dicyclomine Hydrochloride
% 219.56/219.77  |- skos__broader mesh__D004025smesh__D003510
% 219.56/219.77  |- skos__altLabel mesh__D004025 Dicycloverin
% 219.56/219.77  |- skos__altLabel mesh__D004025 Atlantis Brand of Dicyclomine Hydrochloride
% 219.56/219.77  |- skos__prefLabel mesh__D004025 Dicyclomine
% 219.56/219.77  |- mesh__historyNote mesh__D004025
% 219.56/219.77       91%28%76%29%; was see under CYCLOHEXANECARBOXYLIC ACIDS 1976-90%A%  
% 219.56/219.77  |- rdf__type mesh__D004025sskos__Concept
% 219.56/219.77  |- skos__scopeNote mesh__D004025
% 219.56/219.77       A muscarinic antagonist used as an antispasmodic and in urinary incontinence. It has little effect on glandular secretion or the cardiovascular system. It does have some local anesthetic properties and is used in gastrointestinal, biliary, and urinary tract spasms.%A%    
% 219.56/219.77  |- skos__altLabel mesh__D004025 Sigma Brand of Dicyclomine Hydrochloride
% 219.56/219.77  |- skos__altLabel mesh__D004025 Florizel Brand of Dicyclomine Hydrochloride
% 219.56/219.77  |- skos__altLabel mesh__D004025 Pasadena Brand of Dicyclomine Hydrochloride
% 219.56/219.77  |- mesh__dateEstablished mesh__D004025 1991-01-01
% 219.56/219.77  |- skos__altLabel mesh__D004025 Hauck Brand of Dicyclomine Hydrochloride
% 219.56/219.77  |- mesh__recordOriginator mesh__D004025 SH
% 219.56/219.77  |- mesh__recordAuthorizer mesh__D004025 sjn
% 219.56/219.77  |- mesh__dateCreated mesh__D004025 1975-07-23
% 219.56/219.77  |- mesh__recordMaintainer mesh__D004025 CCR
% 219.56/219.77  |- skos__historyNote mesh__D004025
% 219.56/219.77       Cyclohexanecarboxylic Acids %28%1968-1975%29%
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D004025 2006
% 219.56/219.77  |- skos__hiddenLabel mesh__D004025 OR Tyl
% 219.56/219.77  |- skos__altLabel mesh__D004025 Hoechst Brand of Dicyclomine Hydrochloride
% 219.56/219.77  |- skos__altLabel mesh__D004025 Aventis Brand of Dicyclomine Hydrochloride
% 219.56/219.77  |- skos__broader mesh__D004025smesh__D003509
% 219.56/219.77  |- skos__altLabel mesh__D004025 Vangard Brand of Dicyclomine Hydrochloride
% 219.56/219.77  |- skos__altLabel mesh__D004025 Riva Brand of Dicyclomine Hydrochloride
% 219.56/219.77  |- mesh__publicMeSHNote mesh__D004025
% 219.56/219.77       91; was see under CYCLOHEXANECARBOXYLIC ACIDS 1976-90   
% 219.56/219.77  |- skos__historyNote mesh__D004025 Cyclohexanes %28%1972-1975%29%
% 219.56/219.77  |- skos__historyNote mesh__D042942 Ketone Oxidoreductases %28%1982-2003%29%
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D042942 2006
% 219.56/219.77  |- mesh__historyNote mesh__D042942
% 219.56/219.77       2004; use 3-METHYL-2-OXBUTANOATE DEHYDROGENASE %28%LIPOAMIDE%29% %28%NM%29% 1973-2003%A%  
% 219.56/219.77  |- mesh__dateRevised mesh__D042942 2005-06-30
% 219.56/219.77  |- mesh__dateEstablished mesh__D042942 2004-01-01
% 219.56/219.77  |- skos__hiddenLabel mesh__D042942 Decarboxylase, BCKA
% 219.56/219.77  |- skos__related mesh__D042942smesh__D008375
% 219.56/219.77  |- skos__hiddenLabel mesh__D042942 Oxo-Acid Dehydrogenase, Branched-Chain
% 219.56/219.77  |- skos__hiddenLabel mesh__D042942 2 Oxoisocaproate Dehydrogenase
% 219.56/219.77  |- skos__hiddenLabel mesh__D042942 Acid Dehydrogenase, Alpha-Keto
% 219.56/219.77  |- skos__historyNote mesh__D042942 Carboxy-Lyases %28%1974-1979%29%
% 219.56/219.77  |- skos__altLabel mesh__D042942 Branched-Chain Keto Acid Dehydrogenase
% 219.56/219.77  |- skos__altLabel mesh__D042942 BCKA Decarboxylase
% 219.56/219.77  |- skos__hiddenLabel mesh__D042942 Branched Chain Oxo Acid Dehydrogenase
% 219.56/219.77  |- mesh__recordOriginator mesh__D042942 AKE
% 219.56/219.77  |- skos__prefLabel mesh__D042942
% 219.56/219.77       3-Methyl-2-Oxobutanoate Dehydrogenase %28%Lipoamide%29%
% 219.56/219.77  |- skos__hiddenLabel mesh__D042942 Branched Chain 2 Oxo Acid Dehydrogenase
% 219.56/219.77  |- skos__hiddenLabel mesh__D042942 Dehydrogenase, 2-Oxoisocaproate
% 219.56/219.77  |- skos__historyNote mesh__D042942 Multienzyme Complexes %28%1982-2003%29%
% 219.56/219.77  |- skos__altLabel mesh__D042942 Branched-Chain 2-Oxo Acid Dehydrogenase
% 219.56/219.77  |- skos__hiddenLabel mesh__D042942
% 219.56/219.77       Branched Chain Alpha Keto Acid Decarboxylase
% 219.56/219.77  |- skos__altLabel mesh__D042942
% 219.56/219.77       Branched Chain Alpha-Keto Acid Decarboxylase
% 219.56/219.77  |- mesh__recordMaintainer mesh__D042942 jmp
% 219.56/219.77  |- mesh__dateCreated mesh__D042942 2003-07-09
% 219.56/219.77  |- mesh__publicMeSHNote mesh__D042942
% 219.56/219.77       2004; 2-OXOISOVALERATE DEHYDROGENASE %28%LIPOAMIDE%29% %28%now 3-METHYL-2-OXBUTANOATE DEHYDROGENASE %28%LIPOAMIDE%29%%29% was indexed under KETONE OXIDOREDUCTASES %26% MULTIENZYME COMPLEXES 1982-2003, under AMINO ACIDS, BRANCH-CHAIN 1979-1981, under KETO ACIDS 1973-1981, under CARBOXY-LYASES 1974-1979%A%  
% 219.56/219.77  |- skos__scopeNote mesh__D042942
% 219.56/219.77       A ketone oxidoreductase that catalyzes the overall conversion of alpha-keto acids to ACYL-CoA and CO2. The enzyme requires THIAMINE DIPHOSPHATE as a cofactor. Defects in genes that code for subunits of the enzyme are a cause of MAPLE SYRUP URINE DISEASE. The enzyme was formerly classified  as EC 1.2.4.3.%A%    
% 219.56/219.77  |- mesh__recordAuthorizer mesh__D042942 sjn
% 219.56/219.77  |- skos__altLabel mesh__D042942 Branched Chain Ketoacid Dehydrogenase
% 219.56/219.77  |- skos__hiddenLabel mesh__D042942 Dehydrogenase, Branched-Chain Oxo-Acid
% 219.56/219.77  |- skos__altLabel mesh__D042942 Branched-Chain Oxo-Acid Dehydrogenase
% 219.56/219.77  |- rdf__type mesh__D042942sskos__Concept
% 219.56/219.77  |- skos__altLabel mesh__D042942
% 219.56/219.77       2-Oxoisovalerate Dehydrogenase %28%Lipoamide%29%
% 219.56/219.77  |- skos__broader mesh__D042942smesh__D007658
% 219.56/219.77  |- skos__altLabel mesh__D042942 Alpha-Keto Acid Dehydrogenase
% 219.56/219.77  |- skos__historyNote mesh__D042942 Keto Acids %28%1973-1981%29%
% 219.56/219.77  |- skos__hiddenLabel mesh__D042942 Branched Chain Keto Acid Dehydrogenase
% 219.56/219.77  |- skos__historyNote mesh__D042942
% 219.56/219.77       Amino Acids, Branched Chain %28%1979-1981%29%
% 219.56/219.77  |- skos__hiddenLabel mesh__D042942 Alpha Keto Acid Dehydrogenase
% 219.56/219.77  |- skos__hiddenLabel mesh__D042942 Dehydrogenase, Alpha-Keto Acid
% 219.56/219.77  |- skos__altLabel mesh__D042942 2-Oxoisocaproate Dehydrogenase
% 219.56/219.77  |- skos__broader mesh__D020490smesh__D052180
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D020490 2006
% 219.56/219.77  |- mesh__dateCreated mesh__D020490 1998-06-03
% 219.56/219.77  |- rdf__type mesh__D020490sskos__Concept
% 219.56/219.77  |- mesh__recordMaintainer mesh__D020490 jls
% 219.56/219.77  |- skos__prefLabel mesh__D020490 Patents %5B%Publication Type%5D%
% 219.56/219.77  |- mesh__historyNote mesh__D020490 1999   
% 219.56/219.77  |- mesh__dateEstablished mesh__D020490 1999-01-01
% 219.56/219.77  |- skos__altLabel mesh__D020490 Patents %28%PT%29%
% 219.56/219.77  |- mesh__recordAuthorizer mesh__D020490 sjn
% 219.56/219.77  |- mesh__recordOriginator mesh__D020490 JLS
% 219.56/219.77  |- mesh__dateRevised mesh__D020490 2005-06-30
% 219.56/219.77  |- skos__scopeNote mesh__D020490
% 219.56/219.77       Works consisting of documents granted by a government giving exclusive rights to an inventor or assignee to manufacture, use, or sell an invention for a certain number of years.%A%    
% 219.56/219.77  |- mesh__publicMeSHNote mesh__D036905 2003   
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D036905 2005
% 219.56/219.77  |- skos__broader mesh__D036905smesh__D027821
% 219.56/219.77  |- rdf__type mesh__D036905sskos__Concept
% 219.56/219.77  |- mesh__historyNote mesh__D036905 2003   
% 219.56/219.77  |- skos__prefLabel mesh__D036905 Dictamnus
% 219.56/219.77  |- mesh__dateEstablished mesh__D036905 2003-01-01
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D036905 2004
% 219.56/219.77  |- skos__annotation mesh__D036905
% 219.56/219.77       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.56/219.77  |- mesh__dateCreated mesh__D036905 2002-07-03
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D036905 2006
% 219.56/219.77  |- skos__scopeNote mesh__D036905
% 219.56/219.77       A plant genus of the family RUTACEAE. Members contain eudesmane type SESQUITERPENES; COUMARINS, and obacunone %28%a limonoid%29%.%A%    
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D036905 2003
% 219.56/219.77  |- skos__hiddenLabel mesh__D014453
% 219.56/219.77       7 Hydroxycoumarin UDP Glucuronyltransferase
% 219.56/219.77  |- skos__hiddenLabel mesh__D014453 UDP-Glucuronosyltransferase, Estrogen
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D014453 2005
% 219.56/219.77  |- skos__hiddenLabel mesh__D014453 Glucuronosyltransferase, UDP
% 219.56/219.77  |- skos__hiddenLabel mesh__D014453
% 219.56/219.77       17 beta Hydroxysteroid UDP Glucuronosyltransferase
% 219.56/219.77  |- mesh__onlineNote mesh__D014453
% 219.56/219.77       use GLUCURONOSYLTRANSFERASE to search UDP GLUCURONOSYLTRANSFERASE 1973-91 %28%as Prov 1973-74%29%%A%  
% 219.56/219.77  |- skos__hiddenLabel mesh__D014453
% 219.56/219.77       UDP-Glucuronosyltransferase, Androsterone
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D014453 2004
% 219.56/219.77  |- skos__hiddenLabel mesh__D014453 Androsterone UDP Glucuronosyltransferase
% 219.56/219.77  |- skos__hiddenLabel mesh__D014453 Bilirubin UDP Glucuronyltransferase
% 219.56/219.77  |- skos__annotation mesh__D014453
% 219.56/219.77       /defic: consider also CRIGLER-NAJJAR SYNDROME %26% coord with BILIRUBIN /metab %28%NIM%29%%A%  
% 219.56/219.77  |- skos__hiddenLabel mesh__D014453
% 219.56/219.77       p Nitrophenyl UDP Glucuronosyltransferase
% 219.56/219.77  |- skos__hiddenLabel mesh__D014453 UDP-Glucuronyltransferase, Bilirubin
% 219.56/219.77  |- skos__broader mesh__D014453smesh__D006602
% 219.56/219.77  |- mesh__publicMeSHNote mesh__D014453
% 219.56/219.77       92; was UDP GLUCURONOSYLTRANSFERASE 1975-91 %28%see under HEXOSYLTRANSFERASES 1975-76%29%%A%  
% 219.56/219.77  |- mesh__recordAuthorizer mesh__D014453 sjn
% 219.56/219.77  |- mesh__historyNote mesh__D014453
% 219.56/219.77       92; was UDP GLUCURONOSYLTRANSFERASE 1973-91 %28%see under HEXOSYLTRANSFERASES 1975-76, Prov 1973-74%29%%A%  
% 219.56/219.77  |- skos__hiddenLabel mesh__D014453
% 219.56/219.77       UDP Glucuronyltransferase, 7-Hydroxycoumarin
% 219.56/219.77  |- rdf__type mesh__D014453sskos__Concept
% 219.56/219.77  |- skos__hiddenLabel mesh__D014453 Transferase, UDP Glucuronyl
% 219.56/219.77  |- skos__historyNote mesh__D014453 Transferases %28%1966-1971%29%
% 219.56/219.77  |- mesh__dateEstablished mesh__D014453 1977-01-01
% 219.56/219.77  |- skos__hiddenLabel mesh__D014453
% 219.56/219.77       Glucuronyltransferase, 7-Hydroxycoumarin UDP
% 219.56/219.77  |- skos__altLabel mesh__D014453 UDP Glucuronyl Transferase
% 219.56/219.77  |- mesh__recordMaintainer mesh__D014453 ssb
% 219.56/219.77  |- skos__hiddenLabel mesh__D014453 Estrogen UDP Glucuronosyltransferase
% 219.56/219.77  |- skos__hiddenLabel mesh__D014453
% 219.56/219.77       UDP Glucuronic Acid 3 O beta D Galactosyl D Galactose Glucuronosyltransferase
% 219.56/219.77  |- skos__altLabel mesh__D014453 Glucuronic Transferase
% 219.56/219.77  |- mesh__dateCreated mesh__D014453 1999-01-01
% 219.56/219.77  |- skos__hiddenLabel mesh__D014453 Glucuronyl Transferase, UDP
% 219.56/219.77  |- skos__hiddenLabel mesh__D014453
% 219.56/219.77       UDP-Glucuronosyltransferase, p-Nitrophenyl
% 219.56/219.77  |- skos__altLabel mesh__D014453 Glucuronyltransferase
% 219.56/219.77  |- skos__scopeNote mesh__D014453
% 219.56/219.77       A family of enzymes accepting a wide range of substrates, including phenols, alcohols, amines, and fatty acids. They function as drug-metabolizing enzymes that catalyze the conjugation of UDPglucuronic acid to a variety of endogenous and exogenous compounds. EC 2.4.1.17.%A%    
% 219.56/219.77  |- skos__hiddenLabel mesh__D014453 Glucuronyltransferase, Morphine
% 219.56/219.77  |- skos__altLabel mesh__D014453 UDP Glucuronosyltransferase
% 219.56/219.77  |- mesh__dateRevised mesh__D014453 2003-07-09
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D014453 2006
% 219.56/219.77  |- skos__hiddenLabel mesh__D014453
% 219.56/219.77       4 Nitrophenol UDP Glucuronosyltransferase
% 219.56/219.77  |- skos__hiddenLabel mesh__D014453 Glucuronyltransferase, Estrone
% 219.56/219.77  |- skos__prefLabel mesh__D014453 Glucuronosyltransferase
% 219.56/219.77  |- skos__historyNote mesh__D014453 Hexosyltransferases %28%1972-1973%29%
% 219.56/219.77  |- skos__hiddenLabel mesh__D014453
% 219.56/219.77       UDP-Glucuronosyltransferase, 17 beta-Hydroxysteroid
% 219.56/219.77  |- skos__hiddenLabel mesh__D014453 Transferase, Glucuronic
% 219.56/219.77  |- mesh__recordOriginator mesh__D014453 NLM
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D008416 2001
% 219.56/219.77  |- mesh__recordAuthorizer mesh__D008416 MED
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D008416 1991
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D008416 2003
% 219.56/219.77  |- rdf__type mesh__D008416sskos__Concept
% 219.56/219.77  |- mesh__dateCreated mesh__D008416 1999-01-01
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D008416 2000
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D008416 1995
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D008416 1993
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D008416 1994
% 219.56/219.77  |- skos__annotation mesh__D008416
% 219.56/219.77       inflammation = MASTOIDITIS; fractures: coord MASTOID /inj %28%IM%29% + SKULL FRACTURES %28%IM%29%%A%  
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D008416 1990
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D008416 2002
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D008416 1999
% 219.56/219.77  |- skos__hiddenLabel mesh__D008416 Mastoids
% 219.56/219.77  |- skos__broader mesh__D008416smesh__D013701
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D008416 1992
% 219.56/219.77  |- skos__prefLabel mesh__D008416 Mastoid
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D008416 2006
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D008416 1997
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D008416 1998
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D008416 1989
% 219.56/219.77  |- mesh__dateRevised mesh__D008416 1982-04-29
% 219.56/219.77  |- mesh__recordOriginator mesh__D008416 NLM
% 219.56/219.77  |- mesh__recordMaintainer mesh__D008416 RRC
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D008416 2004
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D008416 2005
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D008416 1996
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D000433 2004
% 219.56/219.77  |- skos__hiddenLabel mesh__D000433 1 Propanol
% 219.56/219.77  |- mesh__publicMeSHNote mesh__D000433 98; see ALCOHOL, PROPYL 1963-97   
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D000433 1999
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D000433 2003
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D000433 1998
% 219.56/219.77  |- mesh__recordOriginator mesh__D000433 NLM
% 219.56/219.77  |- mesh__recordAuthorizer mesh__D000433 SJN
% 219.56/219.77  |- mesh__historyNote mesh__D000433 98%28%63%29%   
% 219.56/219.77  |- mesh__dateRevised mesh__D000433 1997-06-20
% 219.56/219.77  |- rdf__type mesh__D000433sskos__Concept
% 219.56/219.77  |- skos__altLabel mesh__D000433 Alcohol, Propyl
% 219.56/219.77  |- skos__broader mesh__D000433smesh__D020005
% 219.56/219.77  |- skos__altLabel mesh__D000433 n-Propanol
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D000433 2002
% 219.56/219.77  |- skos__prefLabel mesh__D000433 1-Propanol
% 219.56/219.77  |- skos__scopeNote mesh__D000433
% 219.56/219.77       A colorless liquid made by oxidation of aliphatic hydrocarbons that is used as a solvent and chemical intermediate.%A%    
% 219.56/219.77  |- skos__hiddenLabel mesh__D000433 Propyl Alcohol
% 219.56/219.77  |- skos__hiddenLabel mesh__D000433 n Propanol
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D000433 2006
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D000433 2001
% 219.56/219.77  |- mesh__recordMaintainer mesh__D000433 ADP
% 219.56/219.77  |- skos__altLabel mesh__D000433 Propanol
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D000433 2005
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D000433 2000
% 219.56/219.77  |- mesh__dateCreated mesh__D000433 1999-01-01
% 219.56/219.77  |- skos__scopeNote mesh__D024881
% 219.56/219.77       The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids %28%R FACTORS%29%.%A%    
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D024881 2006
% 219.56/219.77  |- mesh__dateCreated mesh__D024881 2001-07-25
% 219.56/219.77  |- skos__altLabel mesh__D024881 Antibacterial Drug Resistance
% 219.56/219.77  |- mesh__publicMeSHNote mesh__D024881 2002   
% 219.56/219.77  |- skos__prefLabel mesh__D024881 Drug Resistance, Bacterial
% 219.56/219.77  |- rdf__type mesh__D024881sskos__Concept
% 219.56/219.77  |- mesh__historyNote mesh__D024881 2002   
% 219.56/219.77  |- mesh__recordOriginator mesh__D024881 lkt
% 219.56/219.77  |- mesh__recordMaintainer mesh__D024881 ssb
% 219.56/219.77  |- skos__annotation mesh__D024881 GEN or unspecified; prefer specifics   
% 219.56/219.77  |- mesh__dateEstablished mesh__D024881 2002-01-01
% 219.56/219.77  |- skos__broader mesh__D024881smesh__D004352
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D024881 2004
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D024881 2005
% 219.56/219.77  |- skos__historyNote mesh__D024881
% 219.56/219.77       Drug Resistance, Microbial %28%1968-2001%29%
% 219.56/219.77  |- mesh__recordAuthorizer mesh__D024881 sjn
% 219.56/219.77  |- mesh__dateRevised mesh__D024881 2003-07-09
% 219.56/219.77  |- skos__broader mesh__D018844smesh__D038461
% 219.56/219.77  |- skos__hiddenLabel mesh__D018844 Cyclin Dependent Kinases
% 219.56/219.77  |- skos__altLabel mesh__D018844 Cyclin-Dependent Protein Kinases
% 219.56/219.77  |- mesh__publicMeSHNote mesh__D018844 95   
% 219.56/219.77  |- mesh__recordOriginator mesh__D018844 AGS
% 219.56/219.77  |- mesh__historyNote mesh__D018844 95   
% 219.56/219.77  |- skos__prefLabel mesh__D018844 Cyclin-Dependent Kinases
% 219.56/219.77  |- mesh__dateCreated mesh__D018844 1994-05-31
% 219.56/219.77  |- skos__broader mesh__D018844smesh__D017346
% 219.56/219.77  |- mesh__recordMaintainer mesh__D018844 jmp
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D018844 2006
% 219.56/219.77  |- mesh__recordAuthorizer mesh__D018844 sjn
% 219.56/219.77  |- mesh__dateEstablished mesh__D018844 1995-01-01
% 219.56/219.77  |- skos__broader mesh__D018844smesh__D018797
% 219.56/219.77  |- skos__historyNote mesh__D018844 Protein Kinases %28%1992-1994%29%
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D018844 2005
% 219.56/219.77  |- skos__altLabel mesh__D018844 cdk Proteins
% 219.56/219.77  |- skos__hiddenLabel mesh__D018844 Cyclin Dependent Protein Kinases
% 219.56/219.77  |- skos__broader mesh__D018844smesh__D047908
% 219.56/219.77  |- rdf__type mesh__D018844sskos__Concept
% 219.56/219.77  |- skos__scopeNote mesh__D018844
% 219.56/219.77       Protein kinases that control cell cycle progression in all eukaryotes and require physical association with CYCLINS to achieve full enzymatic activity. Cyclin-dependent kinases are regulated by phosphorylation and dephosphorylation events.%A%    
% 219.56/219.77  |- mesh__dateRevised mesh__D018844 2004-07-07
% 219.56/219.77  |- mesh__recordAuthorizer mesh__D010861 sjn
% 219.56/219.77  |- skos__hiddenLabel mesh__D010861 Fimbria, Common
% 219.56/219.77  |- skos__broader mesh__D010861smesh__D022081
% 219.56/219.77  |- skos__hiddenLabel mesh__D010861 Fimbriae, Common
% 219.56/219.77  |- skos__altLabel mesh__D010861 Pilus, Bacterial
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D010861 2006
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D010861 2002
% 219.56/219.77  |- skos__altLabel mesh__D010861 Common Pilus
% 219.56/219.77  |- mesh__publicMeSHNote mesh__D010861
% 219.56/219.77       95; was PILI, BACTERIAL 1980-94; FIMBRIAE, BACTERIAL was see PILI, BACTERIAL 1980-94%A%  
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D010861 2004
% 219.56/219.77  |- skos__altLabel mesh__D010861 Pili, Common
% 219.56/219.77  |- mesh__recordMaintainer mesh__D010861 nns
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D010861 2005
% 219.56/219.77  |- skos__related mesh__D010861smesh__D018829
% 219.56/219.77  |- skos__altLabel mesh__D010861 Pili, Bacterial
% 219.56/219.77  |- skos__altLabel mesh__D010861 Bacterial Fimbriae
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D010861 2003
% 219.56/219.77  |- skos__scopeNote mesh__D010861
% 219.56/219.77       Thin, hairlike appendages, 1 to 20 microns in length and often occurring in large numbers, present on the cells of gram-negative bacteria, particularly Enterobacteriaceae and Neisseria. Unlike flagella, they do not possess motility, but being protein %28%pilin%29% in nature, they possess antigenic and hemagglutinating properties. They are of medical importance because some fimbriae mediate the attachment of bacteria to cells via adhesins %28%ADHESINS, BACTERIAL%29%. Bacterial fimbriae refer to common pili, to be distinguished from the preferred use of %22%pili%22%, which is confined to sex pili %28%PILI, SEX%29%.%A%    
% 219.56/219.77  |- skos__annotation mesh__D010861
% 219.56/219.77       appendages of gram-neg bact; coord IM with specific bacterium %28%IM or NIM%29% if pertinent; A 11 qualif except /cytol; /genet permitted; DF: FIMBRIAE BACT%A%  
% 219.56/219.77  |- skos__altLabel mesh__D010861 Fimbria, Bacterial
% 219.56/219.77  |- skos__altLabel mesh__D010861 Common Fimbriae
% 219.56/219.77  |- skos__altLabel mesh__D010861 Common Fimbria
% 219.56/219.77  |- mesh__dateEstablished mesh__D010861 1980-01-01
% 219.56/219.77  |- skos__hiddenLabel mesh__D010861 Pilus, Common
% 219.56/219.77  |- skos__altLabel mesh__D010861 Bacterial Pili
% 219.56/219.77  |- skos__historyNote mesh__D010861 Bacterial Proteins %28%1966-1979%29%
% 219.56/219.77  |- mesh__dateCreated mesh__D010861 1979-01-04
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D010861 2001
% 219.56/219.77  |- skos__prefLabel mesh__D010861 Fimbriae, Bacterial
% 219.56/219.77  |- mesh__recordOriginator mesh__D010861 AEP
% 219.56/219.77  |- rdf__type mesh__D010861sskos__Concept
% 219.56/219.77  |- mesh__dateRevised mesh__D010861 2000-06-23
% 219.56/219.77  |- skos__historyNote mesh__D010861 Cell Wall %28%1966-1979%29%
% 219.56/219.77  |- skos__historyNote mesh__D010861 specific bacterium %28%1966-1979%29%
% 219.56/219.77  |- skos__altLabel mesh__D010861 Common Pili
% 219.56/219.77  |- skos__altLabel mesh__D010861 Bacterial Fimbria
% 219.56/219.77  |- mesh__historyNote mesh__D010861
% 219.56/219.77       95; was PILI, BACTERIAL 1980-94; FIMBRIAE, BACTERIAL was see PILI, BACTERIAL 1980-94%A%  
% 219.56/219.77  |- mesh__historyNote mesh__D018046
% 219.56/219.77       94; was PROTEIN C INHIBITOR %28%NM%29% 1981-93; PAI-3 was see PLASMINOGEN INACTIVATORS 1990-93%A%  
% 219.56/219.77  |- skos__altLabel mesh__D018046 Type 3 Plasminogen Activator Inhibitor
% 219.56/219.77  |- mesh__dateRevised mesh__D018046 1999-11-09
% 219.56/219.77  |- mesh__recordMaintainer mesh__D018046 KEV
% 219.56/219.77  |- skos__altLabel mesh__D018046 Plasminogen Activator Inhibitor, Type 3
% 219.56/219.77  |- skos__altLabel mesh__D018046 Activated Protein C Inhibitor
% 219.56/219.77  |- mesh__dateCreated mesh__D018046 1993-06-04
% 219.56/219.77  |- skos__historyNote mesh__D018046 Blood Proteins %28%1981-1993%29%
% 219.56/219.77  |- skos__altLabel mesh__D018046 PAI-3
% 219.56/219.77  |- mesh__recordAuthorizer mesh__D018046 sjn
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D018046 2003
% 219.56/219.77  |- skos__scopeNote mesh__D018046
% 219.56/219.77       A member of the serpin family of proteins that is found in plasma and urine. It is dependent on heparin and able to inhibit activated protein C, thrombin, kallikrein, and other SERINE ENDOPEPTIDASES.%A%    
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D018046 2004
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D018046 2000
% 219.56/219.77  |- mesh__dateEstablished mesh__D018046 1994-01-01
% 219.56/219.77  |- skos__prefLabel mesh__D018046 Protein C Inhibitor
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D018046 2005
% 219.56/219.77  |- skos__historyNote mesh__D018046
% 219.56/219.77       Plasminogen Inactivators %28%1990-1993%29%
% 219.56/219.77  |- skos__altLabel mesh__D018046 Plasminogen Activator Inhibitor 3
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D018046 2001
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D018046 2006
% 219.56/219.77  |- mesh__publicMeSHNote mesh__D018046
% 219.56/219.77       94; PROTEIN C INHIBITOR was indexed under PLASMINOGEN INACTIVATORS 1992-93 %26% BLOOD PROTEINS 1981-92; PAI-3 was see PLASMINOGEN INACTIVATORS 1990-93%A%  
% 219.56/219.77  |- skos__hiddenLabel mesh__D018046 Inhibitor, Protein C
% 219.56/219.77  |- rdf__type mesh__D018046sskos__Concept
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D018046 2002
% 219.56/219.77  |- skos__broader mesh__D018046smesh__D015849
% 219.56/219.77  |- skos__annotation mesh__D018046
% 219.56/219.77       a plasminogen inactivator %26% serine proteinase inhib; DF: PROTEIN C INHIB%A%  
% 219.56/219.77  |- skos__altLabel mesh__D018046 Protein C Inhibitor, Activated
% 219.56/219.77  |- mesh__recordOriginator mesh__D018046 TPW
% 219.56/219.77  |- mesh__onlineNote mesh__D018046
% 219.56/219.77       use PROTEIN C INHIBITOR %28%NM%29% to search PROTEIN C INHIBITOR 1981-93; use PLASMINOGEN INACTIVATORS to search PAI-3 1990-93%A%  
% 219.56/219.77  |- skos__broader mesh__D010063smesh__D005854
% 219.56/219.77  |- skos__related mesh__D010063smesh__D006080
% 219.56/219.77  |- skos__hiddenLabel mesh__D010063 Unfertilized Egg
% 219.56/219.77  |- mesh__dateRevised mesh__D010063 2002-07-03
% 219.56/219.77  |- skos__hiddenLabel mesh__D010063 Eggs, Unfertilized
% 219.56/219.77  |- rdf__type mesh__D010063sskos__Concept
% 219.56/219.77  |- skos__broader mesh__D010063smesh__D004628
% 219.56/219.77  |- mesh__recordAuthorizer mesh__D010063 sjn
% 219.56/219.77  |- skos__altLabel mesh__D010063 Ova
% 219.56/219.77  |- skos__hiddenLabel mesh__D010063 Unfertilized Eggs
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D010063 2003
% 219.56/219.77  |- mesh__activeMeSHYear mesh__D010063 2005
% 219.56/219.78  |- skos__scopeNote mesh__D010063
% 219.56/219.78       A mature haploid female germ cell extruded from the OVARY at OVULATION.%A%    
% 219.56/219.78  |- skos__altLabel mesh__D010063 Egg
% 219.56/219.78  |- skos__prefLabel mesh__D010063 Ovum
% 219.56/219.78  |- mesh__recordOriginator mesh__D010063 NLM
% 219.56/219.78  |- skos__annotation mesh__D010063
% 219.56/219.78       differentiate from EGGS %28%Cat J2%29%; /transpl is not implantation %28% = OVUM IMPLANTATION%29%%A%  
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D010063 2004
% 219.56/219.78  |- mesh__dateCreated mesh__D010063 1999-01-01
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D010063 2006
% 219.56/219.78  |- skos__altLabel mesh__D010063 Egg, Unfertilized
% 219.56/219.78  |- mesh__recordMaintainer mesh__D010063 lkt
% 219.56/219.78  |- mesh__considerAlso mesh__D010063 consider also terms at OO-   
% 219.56/219.78  |- mesh__publicMeSHNote mesh__D004824
% 219.56/219.78       91; was see under SPINAL CANAL 1979-90   
% 219.56/219.78  |- skos__historyNote mesh__D004824 Spinal Cord %28%1966-1978%29%
% 219.56/219.78  |- mesh__recordAuthorizer mesh__D004824 PLS
% 219.56/219.78  |- skos__hiddenLabel mesh__D004824 Spaces, Epidural
% 219.56/219.78  |- skos__hiddenLabel mesh__D004824 Epidural Spaces
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004824 1995
% 219.56/219.78  |- skos__historyNote mesh__D004824 Meninges %28%1966-1978%29%
% 219.56/219.78  |- skos__broader mesh__D004824smesh__D013115
% 219.56/219.78  |- skos__historyNote mesh__D004824 Spinal Canal %28%1966-1978%29%
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004824 2006
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004824 1999
% 219.56/219.78  |- mesh__dateEstablished mesh__D004824 1991-01-01
% 219.56/219.78  |- mesh__dateCreated mesh__D004824 1978-05-22
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004824 1994
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004824 2002
% 219.56/219.78  |- mesh__dateRevised mesh__D004824 1992-05-15
% 219.56/219.78  |- rdf__type mesh__D004824sskos__Concept
% 219.56/219.78  |- skos__hiddenLabel mesh__D004824 Space, Epidural
% 219.56/219.78  |- mesh__recordMaintainer mesh__D004824 TAP
% 219.56/219.78  |- mesh__historyNote mesh__D004824
% 219.56/219.78       91%28%79%29%; was see under SPINAL CANAL 1979-90   
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004824 2005
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004824 1998
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004824 1993
% 219.56/219.78  |- skos__annotation mesh__D004824
% 219.56/219.78       NIM: usually locational so few qualif apply   
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004824 2001
% 219.56/219.78  |- skos__prefLabel mesh__D004824 Epidural Space
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004824 2004
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004824 1997
% 219.56/219.78  |- mesh__recordOriginator mesh__D004824 RC
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004824 2000
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004824 2003
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004824 1996
% 219.56/219.78  |- skos__scopeNote mesh__D004824
% 219.56/219.78       Space between the dura mater and the walls of the vertebral canal.%A%    
% 219.56/219.78  |- skos__historyNote mesh__D004824 Dura Mater %28%1966-1978%29%
% 219.56/219.78  |- skos__broader mesh__D004026smesh__D006843
% 219.56/219.78  |- skos__hiddenLabel mesh__D004026 Alvit 55
% 219.56/219.78  |- mesh__recordAuthorizer mesh__D004026 sjn
% 219.56/219.78  |- mesh__dateRevised mesh__D004026 2000-06-21
% 219.56/219.78  |- mesh__recordMaintainer mesh__D004026 CCR
% 219.56/219.78  |- rdf__type mesh__D004026sskos__Concept
% 219.56/219.78  |- skos__hiddenLabel mesh__D004026 Alvit55
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004026 2005
% 219.56/219.78  |- mesh__recordOriginator mesh__D004026 NLM
% 219.56/219.78  |- skos__prefLabel mesh__D004026 Dieldrin
% 219.56/219.78  |- skos__scopeNote mesh__D004026
% 219.56/219.78       An organochlorine insecticide whose use has been cancelled or suspended in the United States. It has been used to control locusts, tropical disease vectors, in termite control by direct soil injection, and non-food seed and plant treatment. %28%From HSDB%29%%A%    
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004026 2006
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004026 2003
% 219.56/219.78  |- skos__annotation mesh__D004026 TN 111 for eff on insects   
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004026 2001
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004026 2004
% 219.56/219.78  |- mesh__dateCreated mesh__D004026 1999-01-01
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004026 2002
% 219.56/219.78  |- mesh__recordMaintainer mesh__D042943 jmp
% 219.56/219.78  |- mesh__dateCreated mesh__D042943 2003-07-09
% 219.56/219.78  |- rdf__type mesh__D042943sskos__Concept
% 219.56/219.78  |- mesh__publicMeSHNote mesh__D042943
% 219.56/219.78       2004; DIHYDROURACIL DEHYDROGENASE %28%NADP%29% was indexed under OXIDOREDUCTASES 1983-2003; %26% under URACIL 1979%A%  
% 219.56/219.78  |- mesh__historyNote mesh__D042943
% 219.56/219.78       2004; use DIHYDROURACIL DEHYDROGENASE %28%NADP%29% %28%NM%29% 1980-2003%A%  
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D042943 2006
% 219.56/219.78  |- mesh__dateRevised mesh__D042943 2005-06-30
% 219.56/219.78  |- mesh__dateEstablished mesh__D042943 2004-01-01
% 219.56/219.78  |- skos__altLabel mesh__D042943 Dihydropyrimidine Dehydrogenase
% 219.56/219.78  |- skos__prefLabel mesh__D042943 Dihydrouracil Dehydrogenase %28%NADP%29%
% 219.56/219.78  |- mesh__recordOriginator mesh__D042943 AKE
% 219.56/219.78  |- skos__scopeNote mesh__D042943
% 219.56/219.78       An oxidoreductase involved in pyrimidine base degradation. It catalyzes the catabolism of THYMINE; URACIL and the chemotherapeutic drug, 5-FLUOROURACIL.%A%    
% 219.56/219.78  |- skos__historyNote mesh__D042943 Uracil %28%1979%29%
% 219.56/219.78  |- skos__broader mesh__D042943smesh__D044925
% 219.56/219.78  |- skos__historyNote mesh__D042943 Oxidoreductases %28%1980-2003%29%
% 219.56/219.78  |- skos__hiddenLabel mesh__D042943 Dehydrogenase, Dihydropyrimidine
% 219.56/219.78  |- skos__altLabel mesh__D042943 Dihydrothymine Dehydrogenase %28%NADP%29%
% 219.56/219.78  |- mesh__recordAuthorizer mesh__D042943 sjn
% 219.56/219.78  |- skos__broader mesh__D014454smesh__D000351
% 219.56/219.78  |- mesh__dateRevised mesh__D014454 1995-02-21
% 219.56/219.78  |- skos__prefLabel mesh__D014454 Uganda
% 219.56/219.78  |- skos__scopeNote mesh__D014454
% 219.56/219.78       A republic in eastern Africa, south of SUDAN and east of KENYA. Its capital is Kampala. In 1894 it was formally proclaimed a British protectorate but became independent in 1966. Its name is Swahili, u, land + Ganda, the name of its indigenous people, the land of the Ganda. The origin of their name is unknown. %28%From Webster%27%s New Geographical Dictionary, 1992, p1244 %26% Room, Brewer%27%s Dictionary of Names, 1992, p562%29%%A%    
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D014454 2002
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D014454 1996
% 219.56/219.78  |- mesh__dateCreated mesh__D014454 1999-01-01
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D014454 1998
% 219.56/219.78  |- rdf__type mesh__D014454sskos__Concept
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D014454 1997
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D014454 2003
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D014454 1999
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D014454 2000
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D014454 2005
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D014454 2004
% 219.56/219.78  |- mesh__recordAuthorizer mesh__D014454 PLS
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D014454 2001
% 219.56/219.78  |- skos__annotation mesh__D014454 a republic in eastern Africa   
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D014454 2006
% 219.56/219.78  |- mesh__recordOriginator mesh__D014454 NLM
% 219.56/219.78  |- mesh__recordMaintainer mesh__D014454 TGC
% 219.56/219.78  |- mesh__recordOriginator mesh__D008417 NLM
% 219.56/219.78  |- skos__prefLabel mesh__D008417 Mastoiditis
% 219.56/219.78  |- mesh__recordMaintainer mesh__D008417 KEV
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D008417 2001
% 219.56/219.78  |- skos__broader mesh__D008417smesh__D010033
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D008417 2000
% 219.56/219.78  |- skos__hiddenLabel mesh__D008417 Mastoiditides
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D008417 2006
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D008417 2004
% 219.56/219.78  |- skos__related mesh__D008417smesh__D020227
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D008417 2005
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D008417 2002
% 219.56/219.78  |- skos__scopeNote mesh__D008417
% 219.56/219.78       Inflammation of the cavity and air cells in the mastoid part of the temporal bone.%A%    
% 219.56/219.78  |- mesh__recordAuthorizer mesh__D008417 sjn
% 219.56/219.78  |- mesh__dateRevised mesh__D008417 1999-11-03
% 219.56/219.78  |- rdf__type mesh__D008417sskos__Concept
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D008417 2003
% 219.56/219.78  |- mesh__dateCreated mesh__D008417 1999-01-01
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D000434 2001
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D000434 2003
% 219.56/219.78  |- mesh__recordMaintainer mesh__D000434 adp
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D000434 2000
% 219.56/219.78  |- mesh__dateRevised mesh__D000434 1999-11-03
% 219.56/219.78  |- rdf__type mesh__D000434sskos__Concept
% 219.56/219.78  |- skos__hiddenLabel mesh__D000434 Beverage, Alcoholic
% 219.56/219.78  |- skos__prefLabel mesh__D000434 Alcoholic Beverages
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D000434 2006
% 219.56/219.78  |- skos__hiddenLabel mesh__D000434 Beverages, Alcoholic
% 219.56/219.78  |- mesh__recordOriginator mesh__D000434 NLM
% 219.56/219.78  |- skos__broader mesh__D000434smesh__D001628
% 219.56/219.78  |- skos__hiddenLabel mesh__D000434 Alcoholic Beverage
% 219.56/219.78  |- skos__scopeNote mesh__D000434 Drinkable liquids containing ETHANOL.     
% 219.56/219.78  |- skos__annotation mesh__D000434
% 219.56/219.78       GEN; BEER %26% WINE are available; chronic consumption of alcoholic bev = ALCOHOLISM%A%  
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D000434 2005
% 219.56/219.78  |- mesh__dateCreated mesh__D000434 1999-01-01
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D000434 2002
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D000434 2004
% 219.56/219.78  |- mesh__recordAuthorizer mesh__D000434 sjn
% 219.56/219.78  |- mesh__recordMaintainer mesh__D024882 ssb
% 219.56/219.78  |- skos__hiddenLabel mesh__D024882 Antiviral Drug Resistances
% 219.56/219.78  |- rdf__type mesh__D024882sskos__Concept
% 219.56/219.78  |- skos__prefLabel mesh__D024882 Drug Resistance, Viral
% 219.56/219.78  |- skos__altLabel mesh__D024882 Antiviral Drug Resistance
% 219.56/219.78  |- mesh__recordAuthorizer mesh__D024882 sjn
% 219.56/219.78  |- mesh__recordOriginator mesh__D024882 lkt
% 219.56/219.78  |- skos__historyNote mesh__D024882
% 219.56/219.78       Drug Resistance, Microbial %28%1968-2001%29%
% 219.56/219.78  |- skos__broader mesh__D024882smesh__D004352
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D024882 2004
% 219.56/219.78  |- skos__scopeNote mesh__D024882
% 219.56/219.78       The ability of viruses to resist or to become tolerant to chemotherapeutic agents or antiviral agents. This resistance is acquired through gene mutation.%A%    
% 219.56/219.78  |- mesh__dateEstablished mesh__D024882 2002-01-01
% 219.56/219.78  |- skos__hiddenLabel mesh__D024882 Drug Resistances, Viral
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D024882 2005
% 219.56/219.78  |- mesh__dateCreated mesh__D024882 2001-07-25
% 219.56/219.78  |- mesh__dateRevised mesh__D024882 2003-07-09
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D024882 2006
% 219.56/219.78  |- mesh__historyNote mesh__D024882 2002   
% 219.56/219.78  |- mesh__publicMeSHNote mesh__D024882 2002   
% 219.56/219.78  |- mesh__dateRevised mesh__D018845 2005-06-30
% 219.56/219.78  |- mesh__dateEstablished mesh__D018845 1995-01-01
% 219.56/219.78  |- mesh__publicMeSHNote mesh__D018845
% 219.56/219.78       95; CD11 ANTIGENS was indexed under ANTIGENS, CD 1990-94 %26% ANTIGENS, DIFFERENTIATION 1988-91%A%  
% 219.56/219.78  |- skos__altLabel mesh__D018845 CD11 Antigen
% 219.56/219.78  |- mesh__onlineNote mesh__D018845
% 219.56/219.78       use ANTIGENS, CD11 %28%NM%29% to search CD11 ANTIGENS 1988-94   
% 219.56/219.78  |- skos__scopeNote mesh__D018845
% 219.56/219.78       A group of three different alpha chains %28%CD11a, CD11b, CD11c%29% that are associated with an invariant CD18 beta chain %28%ANTIGENS, CD18%29%. The three resulting leukocyte-adhesion molecules %28%RECEPTORS, LEUKOCYTE ADHESION%29% are LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MACROPHAGE-1 ANTIGEN; and ANTIGEN, P150,95.%A%    
% 219.56/219.78  |- mesh__recordOriginator mesh__D018845 AGS
% 219.56/219.78  |- mesh__dateCreated mesh__D018845 1994-05-31
% 219.56/219.78  |- mesh__historyNote mesh__D018845
% 219.56/219.78       95; was CD11 ANTIGENS %28%NM%29% 1988-94   
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D018845 2006
% 219.56/219.78  |- skos__historyNote mesh__D018845 Antigens, CD %28%1990-1994%29%
% 219.56/219.78  |- mesh__recordMaintainer mesh__D018845 ssb
% 219.56/219.78  |- skos__historyNote mesh__D018845
% 219.56/219.78       Antigens, Differentiation %28%1988-1991%29%
% 219.56/219.78  |- skos__broader mesh__D018845smesh__D015703
% 219.56/219.78  |- skos__altLabel mesh__D018845 CD11 Antigens
% 219.56/219.78  |- rdf__type mesh__D018845sskos__Concept
% 219.56/219.78  |- skos__prefLabel mesh__D018845 Antigens, CD11
% 219.56/219.78  |- skos__annotation mesh__D018845 a group of differentiation antigens   
% 219.56/219.78  |- mesh__recordAuthorizer mesh__D018845 sjn
% 219.56/219.78  |- skos__scopeNote mesh__D010862
% 219.56/219.78       A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.%A%    
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D010862 2005
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D010862 2003
% 219.56/219.78  |- skos__altLabel mesh__D010862
% 219.56/219.78       Pilocarpine Mononitrate, %28%3S-cis%29%-Isomer
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D010862 2006
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D010862 2002
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D010862 2004
% 219.56/219.78  |- mesh__recordMaintainer mesh__D010862 CCR
% 219.56/219.78  |- mesh__recordAuthorizer mesh__D010862 sjn
% 219.56/219.78  |- mesh__dateRevised mesh__D010862 2001-07-25
% 219.56/219.78  |- skos__broader mesh__D010862smesh__D000470
% 219.56/219.78  |- mesh__dateCreated mesh__D010862 1999-01-01
% 219.56/219.78  |- skos__hiddenLabel mesh__D010862 Hydrochloride, Pilocarpine
% 219.56/219.78  |- skos__annotation mesh__D010862 /biosyn permitted if by plant   
% 219.56/219.78  |- skos__prefLabel mesh__D010862 Pilocarpine
% 219.56/219.78  |- rdf__type mesh__D010862sskos__Concept
% 219.56/219.78  |- skos__altLabel mesh__D010862
% 219.56/219.78       Pilocarpine, Monohydrochloride, %28%3S-cis%29%-Isomer
% 219.56/219.78  |- skos__hiddenLabel mesh__D010862 Nitrate, Pilocarpine
% 219.56/219.78  |- mesh__recordOriginator mesh__D010862 NLM
% 219.56/219.78  |- skos__altLabel mesh__D018047 P1 Purinoceptor
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D018047 2004
% 219.56/219.78  |- mesh__historyNote mesh__D018047
% 219.56/219.78       94; ADENOSINE RECEPTORS was see RECEPTORS, PURINERGIC 1987-93; RECEPTORS, ADENOSINE was see RECEPTORS, PURINERGIC 1993%A%  
% 219.56/219.78  |- skos__hiddenLabel mesh__D018047 Receptor, Adenosine
% 219.56/219.78  |- skos__hiddenLabel mesh__D018047 P1 Receptors, Purinergic
% 219.56/219.78  |- skos__hiddenLabel mesh__D018047 P1 Receptor, Purinergic
% 219.56/219.78  |- skos__hiddenLabel mesh__D018047 Purinoceptors, P1
% 219.56/219.78  |- mesh__recordOriginator mesh__D018047 RAZ
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D018047 2005
% 219.56/219.78  |- skos__historyNote mesh__D018047 Receptors, Purinergic %28%1987-1993%29%
% 219.56/219.78  |- skos__scopeNote mesh__D018047
% 219.56/219.78       A class of cell surface receptors that prefers ADENOSINE to other endogenous purines. Purinergic P1 receptors are widespread in the body including the cardiovascular, respiratory, immune, and nervous systems. There are at least two pharmacologically distinguishable types %28%A1 and A2, or Ri and Ra%29%. The methylxanthines, e.g., CAFFEINE, bind to these receptors, but also have other unrelated effects.%A%    
% 219.56/219.78  |- skos__hiddenLabel mesh__D018047 Purinergic P1 Receptor
% 219.56/219.78  |- skos__historyNote mesh__D018047
% 219.56/219.78       Receptors, Cell Surface %28%1979-1993%29%
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D018047 2006
% 219.56/219.78  |- mesh__dateRevised mesh__D018047 2003-07-09
% 219.56/219.78  |- skos__annotation mesh__D018047 GEN; prefer specifics   
% 219.56/219.78  |- skos__altLabel mesh__D018047 Adenosine Receptors
% 219.56/219.78  |- mesh__publicMeSHNote mesh__D018047
% 219.56/219.78       94; ADENOSINE RECEPTORS, was see RECEPTORS, PURINERGIC 1987-93; RECEPTORS, ADENOSINE was see RECEPTORS, PURINERGIC 1993%A%  
% 219.56/219.78  |- mesh__recordMaintainer mesh__D018047 jmp
% 219.56/219.78  |- skos__altLabel mesh__D018047 Adenosine Receptor
% 219.56/219.78  |- rdf__type mesh__D018047sskos__Concept
% 219.56/219.78  |- skos__altLabel mesh__D018047 Purinergic P1 Receptors
% 219.56/219.78  |- mesh__recordAuthorizer mesh__D018047 sjn
% 219.56/219.78  |- skos__prefLabel mesh__D018047 Receptors, Purinergic P1
% 219.56/219.78  |- skos__altLabel mesh__D018047 P1 Purinoceptors
% 219.56/219.78  |- mesh__dateEstablished mesh__D018047 1994-01-01
% 219.56/219.78  |- skos__altLabel mesh__D018047 Receptor, Purinergic P1
% 219.56/219.78  |- skos__broader mesh__D018047smesh__D011983
% 219.56/219.78  |- mesh__onlineNote mesh__D018047
% 219.56/219.78       use RECEPTORS, PURINERGIC to search ADENOSINE RECEPTORS 1987-93 %26% RECEPTORS, ADENOSINE 1993%A%  
% 219.56/219.78  |- skos__hiddenLabel mesh__D018047 Purinoceptor, P1
% 219.56/219.78  |- mesh__dateCreated mesh__D018047 1993-06-21
% 219.56/219.78  |- skos__altLabel mesh__D018047 Receptors, Adenosine
% 219.56/219.78  |- skos__hiddenLabel mesh__D010064 Ovum Implantations
% 219.56/219.78  |- skos__hiddenLabel mesh__D010064 Blastocyst Implantations
% 219.56/219.78  |- mesh__publicMeSHNote mesh__D010064
% 219.56/219.78       2003; see OVUM IMPLANTATION 1985-2002; for OVUM IMPLANTATION see NIDATION 1967-1984%A%  
% 219.56/219.78  |- skos__hiddenLabel mesh__D010064 Implantations, Embryo
% 219.56/219.78  |- mesh__dateEstablished mesh__D010064 1967-01-01
% 219.56/219.78  |- skos__hiddenLabel mesh__D010064 Implantations, Ovum
% 219.56/219.78  |- mesh__dateRevised mesh__D010064 2004-07-07
% 219.56/219.78  |- mesh__recordMaintainer mesh__D010064 lkt
% 219.56/219.78  |- skos__hiddenLabel mesh__D010064 Implantations, Blastocyst
% 219.56/219.78  |- rdf__type mesh__D010064sskos__Concept
% 219.56/219.78  |- skos__hiddenLabel mesh__D010064 Implantation, Ovum
% 219.56/219.78  |- skos__altLabel mesh__D010064 Ovum Implantation
% 219.56/219.78  |- skos__scopeNote mesh__D010064
% 219.56/219.78       Endometrial implantation of EMBRYO at the  BLASTOCYST stage.%A%    
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D010064 2005
% 219.56/219.78  |- skos__altLabel mesh__D010064 Nidation
% 219.56/219.78  |- skos__hiddenLabel mesh__D010064 Embryo Implantations
% 219.56/219.78  |- skos__altLabel mesh__D010064 Implantation, Blastocyst
% 219.56/219.78  |- skos__hiddenLabel mesh__D010064 Nidations
% 219.56/219.78  |- mesh__dateCreated mesh__D010064 1999-01-01
% 219.56/219.78  |- mesh__historyNote mesh__D010064
% 219.56/219.78       2003 %28%1985%29%; for OVUM IMPLANTATION use NIDATION 1965-1984 %28%Prov 1965-1966%29%%A%  
% 219.56/219.78  |- skos__hiddenLabel mesh__D010064 Decidual Cell Reactions
% 219.56/219.78  |- skos__hiddenLabel mesh__D010064 Implantation, Embryo
% 219.56/219.78  |- mesh__recordAuthorizer mesh__D010064 sjn
% 219.56/219.78  |- skos__prefLabel mesh__D010064 Embryo Implantation
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D010064 2006
% 219.56/219.78  |- skos__annotation mesh__D010064
% 219.56/219.78       don%27%t forget also available are PREIMPLANTATION PHASE %26% POSTIMPLANTATION PHASE%A%  
% 219.56/219.78  |- skos__altLabel mesh__D010064 Blastocyst Implantation
% 219.56/219.78  |- skos__broader mesh__D010064smesh__D047108
% 219.56/219.78  |- mesh__recordOriginator mesh__D010064 NLM
% 219.56/219.78  |- skos__prefLabel mesh__D004825 Epiglottis
% 219.56/219.78  |- mesh__dateRevised mesh__D004825 2005-06-30
% 219.56/219.78  |- rdf__type mesh__D004825sskos__Concept
% 219.56/219.78  |- mesh__recordOriginator mesh__D004825 NLM
% 219.56/219.78  |- mesh__recordMaintainer mesh__D004825 ags
% 219.56/219.78  |- skos__annotation mesh__D004825 inflammation = EPIGLOTTITIS   
% 219.56/219.78  |- mesh__recordAuthorizer mesh__D004825 sjn
% 219.56/219.78  |- mesh__dateCreated mesh__D004825 1999-01-01
% 219.56/219.78  |- skos__scopeNote mesh__D004825
% 219.56/219.78       Thin leaf-shaped cartilage, covered with mucous membrane, at the root of the tongue, which folds back over the entrance to the larynx, covering it, during the act of swallowing.%A%    
% 219.56/219.78  |- skos__broader mesh__D004825smesh__D007817
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004825 2006
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D037201 2005
% 219.56/219.78  |- skos__historyNote mesh__D037201
% 219.56/219.78       Follicle Stimulating Hormone %28%1963-2002%29%
% 219.56/219.78  |- mesh__historyNote mesh__D037201
% 219.56/219.78       2003; use FOLLICLE STIMULATING HORMONE, BETA SUBUNIT %28%NM%29% 1983-2002%A%  
% 219.56/219.78  |- skos__altLabel mesh__D037201 Follitropin, beta Subunit
% 219.56/219.78  |- skos__altLabel mesh__D037201 Follitropin-beta
% 219.56/219.78  |- skos__altLabel mesh__D037201 FSH-beta
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D037201 2006
% 219.56/219.78  |- skos__hiddenLabel mesh__D037201 FSH beta
% 219.56/219.78  |- skos__altLabel mesh__D037201
% 219.56/219.78       Follicle Stimulating Hormone, beta Polypeptide Chain
% 219.56/219.78  |- mesh__publicMeSHNote mesh__D037201
% 219.56/219.78       2003; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT was indexed under FOLLICLE STIMULATING HORMONE 2002; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT was indexed under FSH 1963-2001%A%  
% 219.56/219.78  |- mesh__dateRevised mesh__D037201 2004-07-07
% 219.56/219.78  |- mesh__dateCreated mesh__D037201 2002-07-03
% 219.56/219.78  |- skos__altLabel mesh__D037201 Follicle-Stimulating Hormone, beta Subunit
% 219.56/219.78  |- rdf__type mesh__D037201sskos__Concept
% 219.56/219.78  |- mesh__recordOriginator mesh__D037201 lkt
% 219.56/219.78  |- skos__broader mesh__D037201smesh__D005640
% 219.56/219.78  |- skos__hiddenLabel mesh__D037201 Follitropin beta
% 219.56/219.78  |- mesh__recordAuthorizer mesh__D037201 sjn
% 219.56/219.78  |- skos__altLabel mesh__D037201 FSH, beta Chain
% 219.56/219.78  |- skos__scopeNote mesh__D037201
% 219.56/219.78       The beta subunit of follicle stimulating hormone. It is a 15-kDa glycopolypeptide. Full biological activity of FSH requires the non-covalently bound heterodimers of an alpha and a beta subunit. Mutation of the FSHB gene causes delayed puberty, or infertility.%A%    
% 219.56/219.78  |- mesh__recordMaintainer mesh__D037201 jmp
% 219.56/219.78  |- skos__altLabel mesh__D037201 Follitropin, beta Chain
% 219.56/219.78  |- skos__altLabel mesh__D037201 FSH, beta Subunit
% 219.56/219.78  |- skos__prefLabel mesh__D037201 Follicle Stimulating Hormone, beta Subunit
% 219.56/219.78  |- mesh__dateEstablished mesh__D037201 2003-01-01
% 219.56/219.78  |- skos__prefLabel mesh__D004027 Diencephalon
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004027 2002
% 219.56/219.78  |- rdf__type mesh__D004027sskos__Concept
% 219.56/219.78  |- mesh__recordAuthorizer mesh__D004027 sjn
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004027 2005
% 219.56/219.78  |- mesh__dateRevised mesh__D004027 2001-07-25
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004027 2006
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004027 2003
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D004027 2004
% 219.56/219.78  |- mesh__dateCreated mesh__D004027 1999-01-01
% 219.56/219.78  |- mesh__recordOriginator mesh__D004027 NLM
% 219.56/219.78  |- skos__broader mesh__D004027smesh__D016548
% 219.56/219.78  |- skos__scopeNote mesh__D004027
% 219.56/219.78       The paired caudal parts of the prosencephalon from which the THALAMUS; HYPOTHALAMUS; EPITHALAMUS; and SUBTHALAMUS are derived.%A%    
% 219.56/219.78  |- mesh__recordMaintainer mesh__D004027 mdb
% 219.56/219.78  |- skos__annotation mesh__D009510 an island group in Melanesia   
% 219.56/219.78  |- mesh__dateCreated mesh__D009510 1974-11-11
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D009510 2002
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D009510 2003
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D009510 1996
% 219.56/219.78  |- skos__prefLabel mesh__D009510 New Caledonia
% 219.56/219.78  |- rdf__type mesh__D009510sskos__Concept
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D009510 2001
% 219.56/219.78  |- mesh__dateEstablished mesh__D009510 1975-01-01
% 219.56/219.78  |- skos__broader mesh__D009510smesh__D008542
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D009510 2000
% 219.56/219.78  |- skos__scopeNote mesh__D009510
% 219.56/219.78       A group of islands in Melanesia constituting a French overseas territory. The group includes New Caledonia %28%the main island%29%, Ile des Pins, Loyalty Island, and several other islet groups. The capital is Noumea. It was discovered by Captain Cook in 1774 and visited by various navigators, explorers, and traders from 1792 to 1840. Occupied by the French in 1853, it was set up as a penal colony 1864-94. In 1946 it was made a French overseas territory. It was named by Captain Cook with the 5th and 6th century A.D. Latin name for Scotland, Caledonia. %28%From Webster%27%s New Geographical Dictionary, 1988, p830 %26% Room, Brewer%27%s Dictionary of Names, 1992, p375%29%%A%    
% 219.56/219.78  |- mesh__historyNote mesh__D009510 75   
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D009510 2006
% 219.56/219.78  |- mesh__recordAuthorizer mesh__D009510 PLS
% 219.56/219.78  |- mesh__recordOriginator mesh__D009510 NLM
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D009510 1999
% 219.56/219.78  |- mesh__dateRevised mesh__D009510 1995-06-08
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D009510 2005
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D009510 1998
% 219.56/219.78  |- mesh__recordMaintainer mesh__D009510 TGC
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D009510 2004
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D009510 1997
% 219.56/219.78  |- mesh__dateCreated mesh__D042944 2003-07-09
% 219.56/219.78  |- skos__altLabel mesh__D042944 4-Ene Steroid 5 alpha-Reductase
% 219.56/219.78  |- mesh__dateEstablished mesh__D042944 2004-01-01
% 219.56/219.78  |- skos__prefLabel mesh__D042944 Cholestenone 5 alpha-Reductase
% 219.56/219.78  |- skos__broader mesh__D042944smesh__D044925
% 219.56/219.78  |- mesh__recordOriginator mesh__D042944 AKE
% 219.56/219.78  |- rdf__type mesh__D042944sskos__Concept
% 219.56/219.78  |- mesh__recordAuthorizer mesh__D042944 sjn
% 219.56/219.78  |- skos__historyNote mesh__D042944 Oxidoreductases %28%1983-2003%29%
% 219.56/219.78  |- skos__hiddenLabel mesh__D042944 5 alpha-Reductase, Cholestenone
% 219.56/219.78  |- mesh__activeMeSHYear mesh__D042944 2006
% 219.56/219.78  |- skos__scopeNote mesh__D042944
% 219.56/219.78       An oxidoreductase that catalyzes the conversion of compounds that contain 5-alpha-cholestan-3-one into the cholest-4-en-3-one derivative.  It plays an important role in the conversion of TESTOSTERONE into DIHYDROTESTOSTERONE and PROGESTERONE into DIHYDROPROGESTERONE.%A%    
% 219.56/219.78  |- skos__historyNote mesh__D042944 Cholestenones %28%1970-1982%29%
% 219.56/219.78  |- mesh__historyNote mesh__D042944
% 219.56/219.78       2004; use CHOLESTENONE 5 ALPHA-REDUCTASE %28%NM%29% 1980-2003   
% 219.56/219.78  |- mesh__publicMeSHNote mesh__D042944
% 219.56/219.78       2004; CHOLESTENONE 5 ALPHA-REDUCTASE was indexed under OXIDOREDUCTASES 1983-2003 %26% under CHOLESTENONES 1970-1982%A%  
% 219.56/219.78  |- skos__hiddenLabel mesh__D042944 4 Ene Steroid 5 alpha Reductase
% 219.56/219.78  |- skos__hiddenLabel mesh__D042944 5 alpha Reductase
% 219.64/219.78  |- skos__hiddenLabel mesh__D042944 Cholestenone 5 alpha Reductase
% 219.64/219.78  |- mesh__recordMaintainer mesh__D042944 jmp
% 219.64/219.78  |- skos__hiddenLabel mesh__D042944 alpha-Reductase, Cholestenone 5
% 219.64/219.78  |- mesh__dateRevised mesh__D042944 2005-06-30
% 219.64/219.78  |- skos__altLabel mesh__D042944 5 alpha-Reductase
% 219.64/219.78  |- mesh__recordMaintainer mesh__D020492 jls
% 219.64/219.78  |- mesh__activeMeSHYear mesh__D020492 2006
% 219.64/219.78  |- rdf__type mesh__D020492sskos__Concept
% 219.64/219.78  |- mesh__recordOriginator mesh__D020492 JLS
% 219.64/219.78  |- mesh__recordAuthorizer mesh__D020492 sjn
% 219.64/219.78  |- mesh__dateEstablished mesh__D020492 1999-01-01
% 219.64/219.78  |- mesh__dateCreated mesh__D020492 1998-06-03
% 219.64/219.78  |- skos__prefLabel mesh__D020492 Periodicals %5B%Publication Type%5D%
% 219.64/219.78  |- mesh__dateRevised mesh__D020492 2005-06-30
% 219.64/219.78  |- mesh__historyNote mesh__D020492 1999   
% 219.64/219.78  |- skos__broader mesh__D020492smesh__D052180
% 219.64/219.78  |- skos__altLabel mesh__D020492 Periodicals %28%PT%29%
% 219.64/219.78  |- skos__scopeNote mesh__D020492
% 219.64/219.78       Publications intended to be issued on an ongoing basis, generally more frequently than annually, containing separate articles, stories, or writings.%A%    
% 219.64/219.78  |- mesh__activeMeSHYear mesh__D014455 2000
% 219.64/219.78  |- mesh__dateCreated mesh__D014455 1999-01-01
% 219.64/219.78  |- mesh__activeMeSHYear mesh__D014455 1998
% 219.64/219.78  |- rdf__type mesh__D014455sskos__Concept
% 219.64/219.78  |- mesh__dateRevised mesh__D014455 1994-03-17
% 219.64/219.78  |- mesh__activeMeSHYear mesh__D014455 1997
% 219.64/219.78  |- mesh__recordAuthorizer mesh__D014455 PLS
% 219.64/219.78  |- mesh__activeMeSHYear mesh__D014455 2003
% 219.64/219.78  |- mesh__activeMeSHYear mesh__D014455 2001
% 219.64/219.78  |- mesh__activeMeSHYear mesh__D014455 1999
% 219.64/219.78  |- mesh__activeMeSHYear mesh__D014455 2005
% 219.64/219.78  |- mesh__recordOriginator mesh__D014455 NLM
% 219.64/219.78  |- mesh__activeMeSHYear mesh__D014455 2004
% 219.64/219.78  |- mesh__activeMeSHYear mesh__D014455 1995
% 219.64/219.78  |- skos__broader mesh__D014455smesh__D005061
% 219.64/219.78  |- mesh__activeMeSHYear mesh__D014455 2006
% 219.64/219.78  |- skos__annotation mesh__D014455
% 219.64/219.78       no change in English spelling in pre-Soviet, Soviet or post- Soviet translations%A%  
% 219.64/219.78  |- skos__broader mesh__D014455smesh__D017517
% 219.64/219.78  |- skos__broader mesh__D014455smesh__D014586
% 219.64/219.78  |- mesh__activeMeSHYear mesh__D014455 2002
% 219.64/219.78  |- mesh__recordMaintainer mesh__D014455 PLS
% 219.64/219.78  |- skos__prefLabel mesh__D014455 Ukraine
% 219.64/219.78  |- mesh__activeMeSHYear mesh__D014455 1996
% 219.64/219.78  |- mesh__recordMaintainer mesh__D008418 lkt
% 219.64/219.78  |- mesh__recordAuthorizer mesh__D008418 sjn
% 219.64/219.78  |- mesh__activeMeSHYear mesh__D008418 2005
% 219.64/219.78  |- mesh__dateRevised mesh__D008418 2004-07-07
% 219.64/219.78  |- mesh__recordOriginator mesh__D008418 NLM
% 219.64/219.78  |- skos__broader mesh__D008418smesh__D012725
% 219.64/219.78  |- mesh__activeMeSHYear mesh__D008418 2006
% 219.64/219.78  |- skos__annotation mesh__D008418 human %26% animal   
% 219.64/219.78  |- mesh__dateCreated mesh__D008418 1999-01-01
% 219.64/219.78  |- skos__prefLabel mesh__D008418 Masturbation
% 219.64/219.78  |- skos__scopeNote mesh__D008418
% 219.64/219.78       Sexual stimulation or gratification of the self.     
% 219.64/219.79  |- rdf__type mesh__D008418sskos__Concept
% 219.64/219.79  |- skos__hiddenLabel mesh__D008418 Masturbations
% 219.64/219.79  |- mesh__recordOriginator mesh__D000435 NLM
% 219.64/219.79  |- skos__hiddenLabel mesh__D000435 Drunkennesses
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D000435 2000
% 219.64/219.79  |- skos__annotation mesh__D000435 human %26% animal   
% 219.64/219.79  |- rdf__type mesh__D000435sskos__Concept
% 219.64/219.79  |- skos__scopeNote mesh__D000435
% 219.64/219.79       An acute brain syndrome which results from the excessive ingestion of ETHANOL or ALCOHOLIC BEVERAGES.%A%    
% 219.64/219.79  |- skos__broader mesh__D000435smesh__D019973
% 219.64/219.79  |- mesh__recordAuthorizer mesh__D000435 sjn
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D000435 2005
% 219.64/219.79  |- mesh__dateCreated mesh__D000435 1999-01-01
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D000435 2001
% 219.64/219.79  |- skos__prefLabel mesh__D000435 Alcoholic Intoxication
% 219.64/219.79  |- mesh__recordMaintainer mesh__D000435 adp
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D000435 2006
% 219.64/219.79  |- skos__altLabel mesh__D000435 Drunkenness
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D000435 2003
% 219.64/219.79  |- skos__altLabel mesh__D000435 Intoxication, Alcoholic
% 219.64/219.79  |- mesh__dateRevised mesh__D000435 1999-11-08
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D000435 2002
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D000435 2004
% 219.64/219.79  |- mesh__onlineNote mesh__D019140
% 219.64/219.79       use PEDIATRIC DENTISTRY to search DENTISTRY FOR CHILDREN 1995%A%  
% 219.64/219.79  |- mesh__dateEstablished mesh__D019140 1996-01-01
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D019140 2000
% 219.64/219.79  |- skos__historyNote mesh__D019140 Pediatric Dentistry %28%1966-1995%29%
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D019140 2003
% 219.64/219.79  |- mesh__historyNote mesh__D019140
% 219.64/219.79       96; DENTISTRY FOR CHILDREN was see PEDIATRIC DENTISTRY 1995%A%  
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D019140 2001
% 219.64/219.79  |- mesh__recordAuthorizer mesh__D019140 sjn
% 219.64/219.79  |- skos__prefLabel mesh__D019140 Dental Care for Children
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D019140 2005
% 219.64/219.79  |- skos__annotation mesh__D019140
% 219.64/219.79       = professional care by a professional; do not confuse with PEDIATRIC DENTISTRY, the specialty; check tag CHILD; DF: DENT CARE CHILDREN%A%  
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D019140 2004
% 219.64/219.79  |- mesh__recordMaintainer mesh__D019140 kle
% 219.64/219.79  |- skos__scopeNote mesh__D019140
% 219.64/219.79       The giving of attention to the special dental needs of children, including the prevention of tooth diseases and instruction in dental hygiene and dental health. The dental care may include the services provided by dental specialists.%A%    
% 219.64/219.79  |- skos__hiddenLabel mesh__D019140 Children, Dentistry for
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D019140 2006
% 219.64/219.79  |- mesh__recordOriginator mesh__D019140 TGC
% 219.64/219.79  |- rdf__type mesh__D019140sskos__Concept
% 219.64/219.79  |- mesh__dateRevised mesh__D019140 1999-11-03
% 219.64/219.79  |- mesh__publicMeSHNote mesh__D019140
% 219.64/219.79       96; DENTISTRY FOR CHILDREN was see PEDIATRIC DENTISTRY 1995%A%  
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D019140 2002
% 219.64/219.79  |- skos__broader mesh__D019140smesh__D003729
% 219.64/219.79  |- mesh__dateCreated mesh__D019140 1995-06-08
% 219.64/219.79  |- skos__altLabel mesh__D019140 Dentistry for Children
% 219.64/219.79  |- mesh__dateCreated mesh__D005120 1999-01-01
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D005120 2002
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D005120 1998
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D005120 2006
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D005120 1999
% 219.64/219.79  |- skos__historyNote mesh__D005120 Psychoanalytic Theory %28%1966-1967%29%
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D005120 2003
% 219.64/219.79  |- skos__annotation mesh__D005120 no qualif; DF: EXTRAVERSION   
% 219.64/219.79  |- mesh__dateEstablished mesh__D005120 1968-01-01
% 219.64/219.79  |- mesh__recordAuthorizer mesh__D005120 PLS
% 219.64/219.79  |- mesh__historyNote mesh__D005120
% 219.64/219.79       78; was EXTROVERSION %28%PSYCHOLOGY%29% 1968-77   
% 219.64/219.79  |- skos__hiddenLabel mesh__D005120 Extraversions %28%Psychology%29%
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D005120 2000
% 219.64/219.79  |- mesh__dateRevised mesh__D005120 1993-06-04
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D005120 1996
% 219.64/219.79  |- skos__hiddenLabel mesh__D005120 Extroversions %28%Psychology%29%
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D005120 2004
% 219.64/219.79  |- skos__broader mesh__D005120smesh__D010553
% 219.64/219.79  |- skos__altLabel mesh__D005120 Extroversion
% 219.64/219.79  |- mesh__publicMeSHNote mesh__D005120
% 219.64/219.79       78; was EXTROVERSION %28%PSYCHOLOGY%29% 1968-77   
% 219.64/219.79  |- mesh__recordOriginator mesh__D005120 NLM
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D005120 1997
% 219.64/219.79  |- mesh__onlineNote mesh__D005120
% 219.64/219.79       use EXTRAVERSION %28%PSYCHOLOGY%29% to search EXTROVERSION %28%PSYCHOLOGY%29% 1968-77%A%  
% 219.64/219.79  |- skos__altLabel mesh__D005120 Extraversion
% 219.64/219.79  |- skos__historyNote mesh__D005120 Personality %28%1966-1967%29%
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D005120 2001
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D005120 1994
% 219.64/219.79  |- rdf__type mesh__D005120sskos__Concept
% 219.64/219.79  |- skos__broader mesh__D005120smesh__D011574
% 219.64/219.79  |- skos__prefLabel mesh__D005120 Extraversion %28%Psychology%29%
% 219.64/219.79  |- skos__altLabel mesh__D005120 Extroversion %28%Psychology%29%
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D005120 1995
% 219.64/219.79  |- mesh__recordMaintainer mesh__D005120 JLS
% 219.64/219.79  |- skos__scopeNote mesh__D005120
% 219.64/219.79       A state in which attention is largely directed outward from the self.%A%    
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D005120 2005
% 219.64/219.79  |- skos__scopeNote mesh__D018846
% 219.64/219.79       Endogenous amino acids released by neurons as excitatory neurotransmitters. Glutamic acid is the most common excitatory neurotransmitter in the brain. Aspartic acid has been regarded as an excitatory transmitter for many years, but the extent of its role as a transmitter is unclear.%A%    
% 219.64/219.79  |- mesh__recordOriginator mesh__D018846 RAZ
% 219.64/219.79  |- skos__altLabel mesh__D018846 Amino Acids, Excitatory
% 219.64/219.79  |- skos__hiddenLabel mesh__D018846 Acid, Excitatory Amino
% 219.64/219.79  |- skos__prefLabel mesh__D018846 Excitatory Amino Acids
% 219.64/219.79  |- mesh__recordAuthorizer mesh__D018846 sjn
% 219.64/219.79  |- mesh__historyNote mesh__D018846 95   
% 219.64/219.79  |- skos__related mesh__D018846smesh__D017470
% 219.64/219.79  |- mesh__dateRevised mesh__D018846 2005-06-30
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D018846 2006
% 219.64/219.79  |- mesh__dateEstablished mesh__D018846 1995-01-01
% 219.64/219.79  |- skos__annotation mesh__D018846
% 219.64/219.79       endogenous: do not confuse with EXCITATORY AMINO ACID AGENTS which are exogenous; GEN or unspecified; prefer specifics; DF: EXCITATORY AA%A%  
% 219.64/219.79  |- skos__broader mesh__D018846smesh__D000596
% 219.64/219.79  |- skos__hiddenLabel mesh__D018846 Amino Acid, Excitatory
% 219.64/219.79  |- rdf__type mesh__D018846sskos__Concept
% 219.64/219.79  |- skos__historyNote mesh__D018846 Amino Acids %28%1966-1994%29%
% 219.64/219.79  |- skos__hiddenLabel mesh__D018846 Acids, Excitatory Amino
% 219.64/219.79  |- mesh__recordMaintainer mesh__D018846 ssb
% 219.64/219.79  |- mesh__dateCreated mesh__D018846 1994-06-03
% 219.64/219.79  |- mesh__publicMeSHNote mesh__D018846 95   
% 219.64/219.79  |- skos__altLabel mesh__D018846 Excitatory Amino Acid
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D010863 1997
% 219.64/219.79  |- mesh__recordMaintainer mesh__D010863 TAP
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D010863 2006
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D010863 2000
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D010863 2004
% 219.64/219.79  |- mesh__recordOriginator mesh__D010863 NLM
% 219.64/219.79  |- skos__prefLabel mesh__D010863 Piloerection
% 219.64/219.79  |- skos__scopeNote mesh__D010863
% 219.64/219.79       Involuntary erection or bristling of hairs.     
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D010863 2001
% 219.64/219.79  |- mesh__historyNote mesh__D010863
% 219.64/219.79       91%28%72%29%; was see under REFLEX 1972-90   
% 219.64/219.79  |- skos__historyNote mesh__D010863 Hair %28%1966-1971%29%
% 219.64/219.79  |- mesh__publicMeSHNote mesh__D010863 91; was see under REFLEX 1972-90   
% 219.64/219.79  |- mesh__dateCreated mesh__D010863 1999-01-01
% 219.64/219.79  |- skos__historyNote mesh__D010863 Reflex %28%1966-1971%29%
% 219.64/219.79  |- skos__hiddenLabel mesh__D010863 Piloerections
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D010863 2002
% 219.64/219.79  |- rdf__type mesh__D010863sskos__Concept
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D010863 1994
% 219.64/219.79  |- skos__broader mesh__D010863smesh__D012879
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D010863 1998
% 219.64/219.79  |- skos__broader mesh__D010863smesh__D012018
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D010863 1995
% 219.64/219.79  |- mesh__recordAuthorizer mesh__D010863 PLS
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D010863 1996
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D010863 2005
% 219.64/219.79  |- mesh__dateRevised mesh__D010863 1992-05-18
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D010863 1993
% 219.64/219.79  |- mesh__dateEstablished mesh__D010863 1991-01-01
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D010863 2003
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D010863 1999
% 219.64/219.79  |- mesh__dateEstablished mesh__D018048 1994-01-01
% 219.64/219.79  |- skos__broader mesh__D018048smesh__D011983
% 219.64/219.79  |- skos__hiddenLabel mesh__D018048 Purinoceptors, P2
% 219.64/219.79  |- skos__altLabel mesh__D018048 P2 Purinoceptors
% 219.64/219.79  |- skos__altLabel mesh__D018048 ATP Receptors
% 219.64/219.79  |- mesh__dateRevised mesh__D018048 2003-07-09
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D018048 2006
% 219.64/219.79  |- skos__annotation mesh__D018048 DF: note short X ref   
% 219.64/219.79  |- mesh__onlineNote mesh__D018048
% 219.64/219.79       use RECEPTORS, PURINERGIC to search ADP RECEPTORS %26% ATP RECEPTORS 1987-93 %26% RECEPTORS, ADP %26% RECEPTORS ATP 1993%A%  
% 219.64/219.79  |- mesh__historyNote mesh__D018048
% 219.64/219.79       94; ADP RECEPTORS %26% ATP RECEPTORS were see RECEPTORS, PURINERGIC 1987-93; RECEPTORS, ADP %26% RECEPTORS, ATP were see RECEPTORS, PURINERGIC 1993%A%  
% 219.64/219.79  |- skos__altLabel mesh__D018048 ADP Receptor
% 219.64/219.79  |- mesh__recordMaintainer mesh__D018048 jmp
% 219.64/219.79  |- mesh__recordOriginator mesh__D018048 RAZ
% 219.64/219.79  |- skos__historyNote mesh__D018048 Receptors, Purinergic %28%1987-1993%29%
% 219.64/219.79  |- rdf__type mesh__D018048sskos__Concept
% 219.64/219.79  |- skos__hiddenLabel mesh__D018048 Receptor, ATP
% 219.64/219.79  |- skos__hiddenLabel mesh__D018048 P2 Receptor, Purinergic
% 219.64/219.79  |- skos__hiddenLabel mesh__D018048 Purinoceptor, P2
% 219.64/219.79  |- skos__altLabel mesh__D018048 Purinergic P2 Receptors
% 219.64/219.79  |- skos__altLabel mesh__D018048 ADP Receptors
% 219.64/219.79  |- skos__prefLabel mesh__D018048 Receptors, Purinergic P2
% 219.64/219.79  |- skos__historyNote mesh__D018048
% 219.64/219.79       Receptors, Cell Surface %28%1979-1993%29%
% 219.64/219.79  |- skos__hiddenLabel mesh__D018048 P2 Receptors, Purinergic
% 219.64/219.79  |- mesh__dateCreated mesh__D018048 1993-06-30
% 219.64/219.79  |- mesh__publicMeSHNote mesh__D018048
% 219.64/219.79       94; ADP RECEPTORS %26% ATP RECEPTORS were see RECEPTORS, PURINERGIC 1987-93; RECEPTORS, ADP %26% RECEPTORS, ATP were see RECEPTORS, PURINERGIC 1993%A%  
% 219.64/219.79  |- skos__scopeNote mesh__D018048
% 219.64/219.79       A class of cell surface receptors for purines that prefer ATP or ADP over adenosine. P2 purinergic receptors are widespread in the periphery and in the central and peripheral nervous system. Subtypes have been proposed, usually designated P2 x, y, z, and t. P2x receptors may mediate fast synaptic transmission by ATP. The ADP-preferring P2t receptors in platelets stimulate aggregation.%A%    
% 219.64/219.79  |- skos__altLabel mesh__D018048 Receptor, Purinergic P2
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D018048 2004
% 219.64/219.79  |- mesh__recordAuthorizer mesh__D018048 sjn
% 219.64/219.79  |- skos__hiddenLabel mesh__D018048 Purinergic P2 Receptor
% 219.64/219.79  |- skos__altLabel mesh__D018048 P2 Purinoceptor
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D018048 2005
% 219.64/219.79  |- skos__hiddenLabel mesh__D018048 Receptor, ADP
% 219.64/219.79  |- skos__altLabel mesh__D018048 ATP Receptor
% 219.64/219.79  |- skos__hiddenLabel mesh__D010065 Delayed Nidation
% 219.64/219.79  |- skos__altLabel mesh__D010065 Delayed Embryo Implantation
% 219.64/219.79  |- mesh__recordAuthorizer mesh__D010065 sjn
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D010065 2005
% 219.64/219.79  |- skos__scopeNote mesh__D010065
% 219.64/219.79       Delay in the attachment and implantation of BLASTOCYST to the uterine ENDOMETRIUM. The blastocyst remains unattached beyond the normal duration thus delaying embryonic development.%A%    
% 219.64/219.79  |- skos__altLabel mesh__D010065 Blastocyst Implantation Inhibition
% 219.64/219.79  |- mesh__publicMeSHNote mesh__D010065
% 219.64/219.79       2003; see OVUM IMPLANTATION, DELAYED 1991-2002, see OVUM IMPLANTATION 1985-1990, see NIDATION 1975-1984; for NIDATION, DELAYED see OVUM IMPLANTATION 1985-1990, see NIDATION 1975-1984%A%  
% 219.64/219.79  |- skos__hiddenLabel mesh__D010065 Delayed Ovum Implantations
% 219.64/219.79  |- skos__hiddenLabel mesh__D010065 Delayed Ovum Implantation
% 219.64/219.79  |- mesh__historyNote mesh__D010065
% 219.64/219.79       2003 %28%1991%29%; for OVUM IMPLANTATION, DELAYED use OVUM IMPLANTATION 1985-1990, NIDATION 1975-1984; for NIDATION, DELAYED use OVUM IMPLANTATION, DELAYED 1985-1990, NIDATION 1975-1984%A%  
% 219.64/219.79  |- skos__prefLabel mesh__D010065 Embryo Implantation, Delayed
% 219.64/219.79  |- skos__hiddenLabel mesh__D010065 Delayed Embryo Implantations
% 219.64/219.79  |- skos__hiddenLabel mesh__D010065 Blastocyst Implantations, Delayed
% 219.64/219.79  |- mesh__recordOriginator mesh__D010065 NLM
% 219.64/219.79  |- skos__hiddenLabel mesh__D010065 Implantation Suppression, Blastocyst
% 219.64/219.79  |- skos__altLabel mesh__D010065 Nidation, Delayed
% 219.64/219.79  |- rdf__type mesh__D010065sskos__Concept
% 219.64/219.79  |- skos__hiddenLabel mesh__D010065 Embryo Implantations, Delayed
% 219.64/219.79  |- skos__hiddenLabel mesh__D010065 Delayed Blastocyst Implantation
% 219.64/219.79  |- mesh__dateRevised mesh__D010065 2004-07-07
% 219.64/219.79  |- skos__altLabel mesh__D010065 Embryo Implantation Suppression
% 219.64/219.79  |- skos__hiddenLabel mesh__D010065 Ovum Implantations, Delayed
% 219.64/219.79  |- skos__altLabel mesh__D010065 Blastocyst Implantation, Delayed
% 219.64/219.79  |- skos__altLabel mesh__D010065 Implantation, Ovum, Delayed
% 219.64/219.79  |- skos__hiddenLabel mesh__D010065 Delayed Blastocyst Implantations
% 219.64/219.79  |- skos__broader mesh__D010065smesh__D010064
% 219.64/219.79  |- skos__altLabel mesh__D010065 Ovum Implantation, Delayed
% 219.64/219.79  |- skos__hiddenLabel mesh__D010065 Delayed Nidations
% 219.64/219.79  |- skos__hiddenLabel mesh__D010065 Implantation Suppression, Embryo
% 219.64/219.79  |- mesh__recordMaintainer mesh__D010065 lkt
% 219.64/219.79  |- mesh__dateEstablished mesh__D010065 1991-01-01
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D010065 2006
% 219.64/219.79  |- mesh__onlineNote mesh__D010065
% 219.64/219.79       use OVUM IMPLANTATION, DELAYED to search NIDATION, DELAYED 1975-84%A%  
% 219.64/219.79  |- skos__hiddenLabel mesh__D010065 Implantation Inhibition, Blastocyst
% 219.64/219.79  |- skos__altLabel mesh__D010065 Blastocyst Implantation Suppression
% 219.64/219.79  |- skos__hiddenLabel mesh__D010065 Nidations, Delayed
% 219.64/219.79  |- mesh__dateCreated mesh__D010065 1974-11-11
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D004826 2002
% 219.64/219.79  |- skos__hiddenLabel mesh__D004826 Epiglottitides
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D004826 2004
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D004826 1997
% 219.64/219.79  |- mesh__historyNote mesh__D004826
% 219.64/219.79       91%28%84%29%; was see under LARYNGITIS 1984-90   
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D004826 2001
% 219.64/219.79  |- mesh__publicMeSHNote mesh__D004826
% 219.64/219.79       91; was see under LARYNGITIS 1984-90   
% 219.64/219.79  |- mesh__recordOriginator mesh__D004826 VDK
% 219.64/219.79  |- skos__prefLabel mesh__D004826 Epiglottitis
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D004826 2003
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D004826 1996
% 219.64/219.79  |- mesh__dateRevised mesh__D004826 1993-05-27
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D004826 2000
% 219.64/219.79  |- mesh__recordMaintainer mesh__D004826 TGC
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D004826 1995
% 219.64/219.79  |- skos__historyNote mesh__D004826 Laryngitis %28%1966-1983%29%
% 219.64/219.79  |- mesh__dateCreated mesh__D004826 1983-05-31
% 219.64/219.79  |- skos__scopeNote mesh__D004826 Inflammation of the epiglottis.     
% 219.64/219.79  |- mesh__recordAuthorizer mesh__D004826 PLS
% 219.64/219.79  |- skos__broader mesh__D004826smesh__D007827
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D004826 2006
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D004826 1999
% 219.64/219.79  |- skos__annotation mesh__D004826 inflamm of epiglottis   
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D004826 1994
% 219.64/219.79  |- rdf__type mesh__D004826sskos__Concept
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D004826 2005
% 219.64/219.79  |- mesh__dateEstablished mesh__D004826 1991-01-01
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D004826 1998
% 219.64/219.79  |- mesh__dateRevised mesh__D004028 2005-06-30
% 219.64/219.79  |- skos__altLabel mesh__D004028 Ortho Brand of Dienestrol
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D004028 2006
% 219.64/219.79  |- mesh__dateCreated mesh__D004028 1974-11-11
% 219.64/219.79  |- mesh__recordOriginator mesh__D004028 NLM
% 219.64/219.79  |- skos__scopeNote mesh__D004028
% 219.64/219.79       A synthetic, non-steroidal estrogen structurally related to stilbestrol. It is used, usually as the cream, in the treatment of menopausal and postmenopausal symptoms.%A%    
% 219.64/219.79  |- skos__altLabel mesh__D004028 Janssen Brand of Dienestrol
% 219.64/219.79  |- skos__prefLabel mesh__D004028 Dienestrol
% 219.64/219.79  |- skos__broader mesh__D004028smesh__D010636
% 219.64/219.79  |- mesh__publicMeSHNote mesh__D004028 91; was see under PHENOLS 1975-90   
% 219.64/219.79  |- skos__historyNote mesh__D004028 Phenols %28%1969-1974%29%
% 219.64/219.79  |- mesh__dateEstablished mesh__D004028 1991-01-01
% 219.64/219.79  |- mesh__recordAuthorizer mesh__D004028 sjn
% 219.64/219.79  |- mesh__recordMaintainer mesh__D004028 CCR
% 219.64/219.79  |- skos__historyNote mesh__D004028 Alkadienes %28%1974%29%
% 219.64/219.79  |- rdf__type mesh__D004028sskos__Concept
% 219.64/219.79  |- skos__altLabel mesh__D004028
% 219.64/219.79       4,4%27%-%28%Diethylideneethylene%29%diphenol
% 219.64/219.79  |- mesh__historyNote mesh__D004028
% 219.64/219.79       91%28%75%29%; was see under PHENOLS 1975-90   
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D009511 2004
% 219.64/219.79  |- skos__altLabel mesh__D009511 Northeastern United States
% 219.64/219.79  |- mesh__recordOriginator mesh__D009511 NLM
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D009511 2002
% 219.64/219.79  |- mesh__dateRevised mesh__D009511 1997-06-20
% 219.64/219.79  |- mesh__dateCreated mesh__D009511 1999-01-01
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D009511 2005
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D009511 1998
% 219.64/219.79  |- rdf__type mesh__D009511sskos__Concept
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D009511 2000
% 219.64/219.79  |- mesh__historyNote mesh__D009511 75   
% 219.64/219.79  |- skos__scopeNote mesh__D009511
% 219.64/219.79       The geographic area of New England in general and when the specific state or states are not indicated. States usually included in this region are Maine, New Hampshire, Vermont, Massachusetts, Connecticut, and Rhode Island.%A%    
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D009511 2006
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D009511 1999
% 219.64/219.79  |- skos__prefLabel mesh__D009511 New England
% 219.64/219.79  |- mesh__recordAuthorizer mesh__D009511 SJN
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D009511 2001
% 219.64/219.79  |- skos__annotation mesh__D009511
% 219.64/219.79       includes Conn, Maine, Mass, NH, RI, %26% Vt; specify as needed but use NEW ENGLAND when text uses the term      CATALOG: use for 4 or more states%A%  
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D009511 2003
% 219.64/219.79  |- mesh__dateEstablished mesh__D009511 1975-01-01
% 219.64/219.79  |- skos__broader mesh__D009511smesh__D014481
% 219.64/219.79  |- mesh__recordMaintainer mesh__D009511 PXP
% 219.64/219.79  |- skos__scopeNote mesh__D020493
% 219.64/219.79       Works consisting of accounts of personal experience in relation to a particular field or of participation in related activities or autobiographical accounts.%A%    
% 219.64/219.79  |- skos__annotation mesh__D020493
% 219.64/219.79       CATALOG: Use for single as well as for collections of autobiographical  accounts and  personal reminiscences.  Do not use the main heading  AUTOBIOGRAPHY, which is used only for works about AUTOBIOGRAPHY%A%  
% 219.64/219.79  |- skos__altLabel mesh__D020493 Personal Narratives %28%PT%29%
% 219.64/219.79  |- mesh__recordOriginator mesh__D020493 JLS
% 219.64/219.79  |- mesh__dateCreated mesh__D020493 1998-06-03
% 219.64/219.79  |- skos__broader mesh__D020493smesh__D019215
% 219.64/219.79  |- mesh__historyNote mesh__D020493 1999   
% 219.64/219.79  |- mesh__recordMaintainer mesh__D020493 jls
% 219.64/219.79  |- mesh__recordAuthorizer mesh__D020493 sjn
% 219.64/219.79  |- mesh__dateEstablished mesh__D020493 1999-01-01
% 219.64/219.79  |- mesh__dateRevised mesh__D020493 2005-06-30
% 219.64/219.79  |- skos__related mesh__D020493smesh__D019215
% 219.64/219.79  |- skos__prefLabel mesh__D020493
% 219.64/219.79       Personal Narratives %5B%Publication Type%5D%
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D020493 2006
% 219.64/219.79  |- rdf__type mesh__D020493sskos__Concept
% 219.64/219.79  |- mesh__recordAuthorizer mesh__D047630 sjn
% 219.64/219.79  |- skos__broader mesh__D047630smesh__D010456
% 219.64/219.79  |- rdf__type mesh__D047630sskos__Concept
% 219.64/219.79  |- mesh__historyNote mesh__D047630 2005   
% 219.64/219.79  |- skos__prefLabel mesh__D047630 Depsipeptides
% 219.64/219.79  |- mesh__dateCreated mesh__D047630 2004-07-07
% 219.64/219.79  |- mesh__dateEstablished mesh__D047630 2005-01-01
% 219.64/219.79  |- skos__altLabel mesh__D047630 Cyclodepsipeptides
% 219.64/219.79  |- skos__hiddenLabel mesh__D047630 Cyclic Depsipeptides
% 219.64/219.79  |- skos__scopeNote mesh__D047630
% 219.64/219.79       Compounds consisting of chains of AMINO ACIDS alternating with CARBOXYLIC ACIDS via ester and amide linkages. They are commonly cyclized.%A%    
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D047630 2005
% 219.64/219.79  |- mesh__recordOriginator mesh__D047630 ssb
% 219.64/219.79  |- skos__historyNote mesh__D047630 Peptides, Cyclic %28%1971-2004%29%
% 219.64/219.79  |- mesh__publicMeSHNote mesh__D047630 2005   
% 219.64/219.79  |- mesh__recordMaintainer mesh__D047630 ssb
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D047630 2006
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D014456 2005
% 219.64/219.79  |- skos__prefLabel mesh__D014456 Ulcer
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D014456 2004
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D014456 2006
% 219.64/219.79  |- skos__hiddenLabel mesh__D014456 Ulcers
% 219.64/219.79  |- mesh__recordMaintainer mesh__D014456 lkt
% 219.64/219.79  |- skos__annotation mesh__D014456
% 219.64/219.79       coord IM with organ/dis precoord %28%IM%29% but note specific precoord ulcer terms; RODENT ULCER see CARCINOMA, BASAL CELL is available; stress ulcer: index under PEPTIC ULCER or specific %28%IM%29% + STRESS or STRESS, PSYCHOLOGICAL %28%IM%29%%A%  
% 219.64/219.79  |- mesh__recordOriginator mesh__D014456 NLM
% 219.64/219.79  |- mesh__recordAuthorizer mesh__D014456 sjn
% 219.64/219.79  |- mesh__dateRevised mesh__D014456 2002-07-03
% 219.64/219.79  |- skos__broader mesh__D014456smesh__D010335
% 219.64/219.79  |- skos__scopeNote mesh__D014456
% 219.64/219.79       A lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue.%A%    
% 219.64/219.79  |- mesh__dateCreated mesh__D014456 1999-01-01
% 219.64/219.79  |- rdf__type mesh__D014456sskos__Concept
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D014456 2003
% 219.64/219.79  |- mesh__recordMaintainer mesh__D008419 ssb
% 219.64/219.79  |- skos__annotation mesh__D008419
% 219.64/219.79       prefer the more specific PHYTOTHERAPY or HOMEOPATHY; coord IM with specific substance IM; for use in therapy coord /ther use %28%IM%29% with substance /ther use %28%IM%29% if permitted + disease /*drug ther %28%IM%29%; do not capitalize Chinese names of various substances in titles or translations%A%  
% 219.64/219.79  |- skos__hiddenLabel mesh__D008419 Medica, Materia
% 219.64/219.79  |- mesh__recordAuthorizer mesh__D008419 sjn
% 219.64/219.79  |- mesh__historyNote mesh__D008419 88   
% 219.64/219.79  |- skos__historyNote mesh__D008419 Drugs %28%1966-1987%29%
% 219.64/219.79  |- skos__scopeNote mesh__D008419
% 219.64/219.79       Materials or substances used in the composition of traditional medical remedies. The use of this term in MeSH was formerly restricted to historical articles or those concerned with traditional medicine, but it can also refer to homeopathic remedies. Nosodes are specific types of homeopathic remedies prepared from causal agents or disease products.%A%    
% 219.64/219.79  |- skos__historyNote mesh__D008419 Medicine, Arabic %28%1966-1987%29%
% 219.64/219.79  |- skos__related mesh__D008419smesh__D010936
% 219.64/219.79  |- skos__historyNote mesh__D008419 Medicine, Traditional %28%1966-1987%29%
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D008419 2005
% 219.64/219.79  |- mesh__dateRevised mesh__D008419 2003-07-09
% 219.64/219.79  |- skos__historyNote mesh__D008419 Medicine, Ayurvedic %28%1966-1987%29%
% 219.64/219.79  |- mesh__recordOriginator mesh__D008419 RLS
% 219.64/219.79  |- mesh__dateCreated mesh__D008419 1987-03-23
% 219.64/219.79  |- skos__historyNote mesh__D008419
% 219.64/219.79       Medicine, Chinese Traditional %28%1975-1987%29%
% 219.64/219.79  |- skos__historyNote mesh__D008419
% 219.64/219.79       Medicine, Oriental Traditional %28%1966-1987%29%
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D008419 2006
% 219.64/219.79  |- rdf__type mesh__D008419sskos__Concept
% 219.64/219.79  |- skos__hiddenLabel mesh__D008419 Remedies, Homeopathic
% 219.64/219.79  |- skos__historyNote mesh__D008419 Folklore %28%1968-1987%29%
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D008419 2004
% 219.64/219.79  |- skos__historyNote mesh__D008419 Medicine, Herbal %28%1966-1987%29%
% 219.64/219.79  |- skos__prefLabel mesh__D008419 Materia Medica
% 219.64/219.79  |- mesh__dateEstablished mesh__D008419 1988-01-01
% 219.64/219.79  |- skos__related mesh__D008419smesh__D008517
% 219.64/219.79  |- skos__related mesh__D008419smesh__D008519
% 219.64/219.79  |- skos__related mesh__D008419smesh__D006705
% 219.64/219.79  |- mesh__publicMeSHNote mesh__D008419 88   
% 219.64/219.79  |- skos__broader mesh__D008419smesh__D004364
% 219.64/219.79  |- skos__broader mesh__D000436smesh__D012657
% 219.64/219.79  |- rdf__type mesh__D000436sskos__Concept
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D000436 2002
% 219.64/219.79  |- mesh__historyNote mesh__D000436 74   
% 219.64/219.79  |- mesh__dateRevised mesh__D000436 1992-03-25
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D000436 1997
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D000436 2005
% 219.64/219.79  |- mesh__dateCreated mesh__D000436 1999-01-01
% 219.64/219.79  |- mesh__recordOriginator mesh__D000436 NLM
% 219.64/219.79  |- mesh__recordMaintainer mesh__D000436 TAP
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D000436 2006
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D000436 2000
% 219.64/219.79  |- skos__prefLabel mesh__D000436 Alcoholics Anonymous
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D000436 1994
% 219.64/219.79  |- mesh__dateEstablished mesh__D000436 1974-01-01
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D000436 2003
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D000436 1998
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D000436 2001
% 219.64/219.79  |- skos__scopeNote mesh__D000436
% 219.64/219.79       An organization of self-proclaimed alcoholics who meet frequently to reinforce their practice of abstinence.%A%    
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D000436 1995
% 219.64/219.79  |- mesh__recordAuthorizer mesh__D000436 PLS
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D000436 2004
% 219.64/219.79  |- mesh__publicMeSHNote mesh__D000436 74   
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D000436 1999
% 219.64/219.79  |- skos__annotation mesh__D000436 IM      CATALOG: use NAF Entry   
% 219.64/219.79  |- skos__hiddenLabel mesh__D000436 Anonymous, Alcoholics
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D000436 1996
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D000436 1993
% 219.64/219.79  |- mesh__dateCreated mesh__D019141 1995-05-26
% 219.64/219.79  |- skos__scopeNote mesh__D019141
% 219.64/219.79       Drugs used for their effects on the respiratory system.%A%    
% 219.64/219.79  |- mesh__dateEstablished mesh__D019141 1996-01-01
% 219.64/219.79  |- skos__hiddenLabel mesh__D019141 Stimulants, Respiratory
% 219.64/219.79  |- skos__historyNote mesh__D019141
% 219.64/219.79       Respiration/drug effects %28%1968-1995%29%
% 219.64/219.79  |- mesh__activeMeSHYear mesh__D019141 2006
% 219.64/219.79  |- rdf__type mesh__D019141sskos__Concept
% 219.64/219.80  |- mesh__recordAuthorizer mesh__D019141 sjn
% 219.64/219.80  |- skos__broader mesh__D019141smesh__D045506
% 219.64/219.80  |- mesh__dateRevised mesh__D019141 2005-06-30
% 219.64/219.80  |- mesh__recordMaintainer mesh__D019141 ssb
% 219.64/219.80  |- mesh__publicMeSHNote mesh__D019141 96   
% 219.64/219.80  |- mesh__historyNote mesh__D019141 96   
% 219.64/219.80  |- mesh__recordOriginator mesh__D019141 JRT
% 219.64/219.80  |- skos__hiddenLabel mesh__D019141 Agents, Respiratory System
% 219.64/219.80  |- skos__prefLabel mesh__D019141 Respiratory System Agents
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D005121 2001
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D005121 2004
% 219.64/219.80  |- rdf__type mesh__D005121sskos__Concept
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D005121 2002
% 219.64/219.80  |- skos__hiddenLabel mesh__D005121 Extremity
% 219.64/219.80  |- skos__annotation mesh__D005121
% 219.64/219.80       TN 75: extremities of animals; TN 117: joints of animals %26% table of human, primate %26% non-primate extremities%A%  
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D005121 2005
% 219.64/219.80  |- mesh__dateCreated mesh__D005121 1999-01-01
% 219.64/219.80  |- skos__altLabel mesh__D005121 Limbs
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D005121 2006
% 219.64/219.80  |- mesh__recordAuthorizer mesh__D005121 sjn
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D005121 2000
% 219.64/219.80  |- skos__hiddenLabel mesh__D005121 Limb
% 219.64/219.80  |- skos__broader mesh__D005121smesh__D001829
% 219.64/219.80  |- mesh__dateRevised mesh__D005121 1999-11-08
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D005121 2003
% 219.64/219.80  |- mesh__recordOriginator mesh__D005121 NLM
% 219.64/219.80  |- skos__prefLabel mesh__D005121 Extremities
% 219.64/219.80  |- mesh__recordMaintainer mesh__D005121 kle
% 219.64/219.80  |- mesh__recordAuthorizer mesh__D018847 sjn
% 219.64/219.80  |- mesh__dateCreated mesh__D018847 1994-06-16
% 219.64/219.80  |- skos__historyNote mesh__D018847 Endorphins %28%1978-1994%29%
% 219.64/219.80  |- mesh__recordOriginator mesh__D018847 RAZ
% 219.64/219.80  |- skos__prefLabel mesh__D018847 Opioid Peptides
% 219.64/219.80  |- skos__altLabel mesh__D018847 Opiate Peptides
% 219.64/219.80  |- skos__hiddenLabel mesh__D018847 Peptides, Opioid
% 219.64/219.80  |- mesh__dateRevised mesh__D018847 2005-06-30
% 219.64/219.80  |- skos__broader mesh__D018847smesh__D010455
% 219.64/219.80  |- mesh__dateEstablished mesh__D018847 1995-01-01
% 219.64/219.80  |- skos__hiddenLabel mesh__D018847 Peptide, Opioid
% 219.64/219.80  |- skos__scopeNote mesh__D018847
% 219.64/219.80       The endogenous peptides with opiate-like activity. The three major classes currently recognized are the ENKEPHALINS, the DYNORPHINS, and the ENDORPHINS. Each of these families derives from different precursors, proenkephalin, prodynorphin, and PRO-OPIOMELANOCORTIN, respectively. There are also at least three classes of OPIOID RECEPTORS, but the peptide families do not map to the receptors in a simple way.%A%    
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D018847 2006
% 219.64/219.80  |- rdf__type mesh__D018847sskos__Concept
% 219.64/219.80  |- mesh__recordMaintainer mesh__D018847 ssb
% 219.64/219.80  |- skos__altLabel mesh__D018847 Opioid Peptide
% 219.64/219.80  |- skos__broader mesh__D018847smesh__D009479
% 219.64/219.80  |- skos__related mesh__D018847smesh__D011957
% 219.64/219.80  |- mesh__historyNote mesh__D018847
% 219.64/219.80       95; OPIOID PEPTIDES was see ENDORPHINS 1982-94; OPIATES, ENDOGENOUS was see ENDORPHINS 1980-94%A%  
% 219.64/219.80  |- skos__altLabel mesh__D018847 Endogenous Opiates
% 219.64/219.80  |- skos__hiddenLabel mesh__D018847 Peptides, Opiate
% 219.64/219.80  |- mesh__onlineNote mesh__D018847
% 219.64/219.80       use ENDORPHINS to search OPIOID PEPTIDES 1982-94 %26% OPIATES, ENDOGENOUS 1980-94%A%  
% 219.64/219.80  |- mesh__publicMeSHNote mesh__D018847
% 219.64/219.80       95; OPIOID PEPTIDES was see ENDORPHINS 1982-94; OPIATES,  ENDOGENOUS was see ENDORPHINS 1980-94%A%  
% 219.64/219.80  |- mesh__recordAuthorizer mesh__D010864 sjn
% 219.64/219.80  |- mesh__dateCreated mesh__D010864 1999-01-01
% 219.64/219.80  |- skos__annotation mesh__D010864
% 219.64/219.80       non-neoplastic; a hair-containing cyst or sinus usually in the coccygeal region: no organ coord needed; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; /blood supply /chem /secret /ultrastruct permitted%A%  
% 219.64/219.80  |- rdf__type mesh__D010864sskos__Concept
% 219.64/219.80  |- mesh__historyNote mesh__D010864
% 219.64/219.80       97; was PILONIDAL CYST 1963-96; PILONIDAL SINUS was see PILONIDAL CYST 1978-96%A%  
% 219.64/219.80  |- skos__hiddenLabel mesh__D010864 Cyst, Pilonidal
% 219.64/219.80  |- mesh__dateRevised mesh__D010864 1999-11-03
% 219.64/219.80  |- skos__scopeNote mesh__D010864
% 219.64/219.80       A hair-containing cyst or sinus, occurring chiefly in the coccygeal region.%A%    
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010864 2005
% 219.64/219.80  |- skos__prefLabel mesh__D010864 Pilonidal Sinus
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010864 2000
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010864 2003
% 219.64/219.80  |- mesh__recordOriginator mesh__D010864 NLM
% 219.64/219.80  |- skos__hiddenLabel mesh__D010864 Cysts, Pilonidal
% 219.64/219.80  |- mesh__recordMaintainer mesh__D010864 kle
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010864 2006
% 219.64/219.80  |- skos__hiddenLabel mesh__D010864 Pilonidal Cysts
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010864 2001
% 219.64/219.80  |- skos__altLabel mesh__D010864 Pilonidal Cyst
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010864 2004
% 219.64/219.80  |- skos__hiddenLabel mesh__D010864 Sinus, Pilonidal
% 219.64/219.80  |- skos__broader mesh__D010864smesh__D003560
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010864 2002
% 219.64/219.80  |- mesh__publicMeSHNote mesh__D010864
% 219.64/219.80       97; was PILONIDAL CYST 1963-96; PILONIDAL SINUS was see PILONIDAL CYST 1978-96%A%  
% 219.64/219.80  |- skos__hiddenLabel mesh__D018049 LCM Lassa Complex Viruses
% 219.64/219.80  |- skos__altLabel mesh__D018049
% 219.64/219.80       Lymphocytic Choriomeningitis-Lassa Complex Viruses
% 219.64/219.80  |- skos__hiddenLabel mesh__D018049
% 219.64/219.80       Lymphocytic Choriomeningitis Lassa Complex Viruses
% 219.64/219.80  |- skos__altLabel mesh__D018049 LCM-Lassa Complex Viruses
% 219.64/219.80  |- mesh__dateRevised mesh__D018049 2001-07-25
% 219.64/219.80  |- skos__scopeNote mesh__D018049
% 219.64/219.80       One of two groups of viruses in the ARENAVIRUS genus and considered part of the Old World complex. It includes LASSA VIRUS and LYMPHOCYTIC CHORIOMENINGITIS VIRUS, although the latter has worldwide distribution now.%A%    
% 219.64/219.80  |- mesh__recordAuthorizer mesh__D018049 sjn
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D018049 2002
% 219.64/219.80  |- mesh__recordOriginator mesh__D018049 AGS
% 219.64/219.80  |- skos__broader mesh__D018049smesh__D018050
% 219.64/219.80  |- mesh__dateCreated mesh__D018049 1993-06-30
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D018049 2006
% 219.64/219.80  |- mesh__publicMeSHNote mesh__D018049
% 219.64/219.80       2002; see LCM-LASSA COMPLEX VIRUSES 1994-2001   
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D018049 2005
% 219.64/219.80  |- mesh__recordMaintainer mesh__D018049 ags
% 219.64/219.80  |- rdf__type mesh__D018049sskos__Concept
% 219.64/219.80  |- skos__altLabel mesh__D018049 Old World Arenaviruses
% 219.64/219.80  |- skos__prefLabel mesh__D018049 Arenaviruses, Old World
% 219.64/219.80  |- mesh__historyNote mesh__D018049 2002 %28%1994%29%   
% 219.64/219.80  |- mesh__dateEstablished mesh__D018049 1994-01-01
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D018049 2004
% 219.64/219.80  |- skos__annotation mesh__D018049
% 219.64/219.80       infection: coord IM with ARENAVIRIDAE INFECTIONS %28%IM%29%   
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D018049 2003
% 219.64/219.80  |- mesh__recordMaintainer mesh__D010066 lkt
% 219.64/219.80  |- mesh__onlineNote mesh__D010066 search OVUM 1974   
% 219.64/219.80  |- mesh__historyNote mesh__D010066
% 219.64/219.80       76%28%75%29%; was see under OVUM 1974-75   
% 219.64/219.80  |- mesh__recordAuthorizer mesh__D010066 sjn
% 219.64/219.80  |- rdf__type mesh__D010066sskos__Concept
% 219.64/219.80  |- mesh__dateEstablished mesh__D010066 1976-01-01
% 219.64/219.80  |- mesh__dateRevised mesh__D010066 2004-07-07
% 219.64/219.80  |- skos__prefLabel mesh__D010066 Ovum Transport
% 219.64/219.80  |- skos__historyNote mesh__D010066 Ovum %28%1966-1974%29%
% 219.64/219.80  |- skos__broader mesh__D010066smesh__D005306
% 219.64/219.80  |- mesh__recordOriginator mesh__D010066 NLM
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010066 2006
% 219.64/219.80  |- skos__broader mesh__D010066smesh__D002465
% 219.64/219.80  |- mesh__publicMeSHNote mesh__D010066 76; was see under OVUM 1974-75   
% 219.64/219.80  |- mesh__dateCreated mesh__D010066 1974-11-11
% 219.64/219.80  |- skos__scopeNote mesh__D010066
% 219.64/219.80       Transport of the OVUM or fertilized ovum %28%ZYGOTE%29% from the mammalian oviduct %28%FALLOPIAN TUBES%29% to the site of EMBRYO IMPLANTATION in the UTERUS.%A%    
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010066 2005
% 219.64/219.80  |- skos__hiddenLabel mesh__D004827 Epilepsies, Cryptogenic
% 219.64/219.80  |- skos__hiddenLabel mesh__D004827 Seizures, Single
% 219.64/219.80  |- skos__broader mesh__D004827smesh__D001927
% 219.64/219.80  |- skos__hiddenLabel mesh__D004827 Single Seizures
% 219.64/219.80  |- skos__hiddenLabel mesh__D004827 Epileptic Seizure
% 219.64/219.80  |- skos__hiddenLabel mesh__D004827 Epilepsy, Awakening
% 219.64/219.80  |- mesh__dateCreated mesh__D004827 1999-01-01
% 219.64/219.80  |- skos__altLabel mesh__D004827 Seizures, Epileptic
% 219.64/219.80  |- skos__scopeNote mesh__D004827
% 219.64/219.80       A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: %28%1%29% clinical features of the seizure episodes %28%e.g., motor seizure%29%, %28%2%29% etiology %28%e.g., post-traumatic%29%, %28%3%29% anatomic site of seizure origin %28%e.g., frontal lobe seizure%29%, %28%4%29% tendency to spread to other structures in the brain, and %28%5%29% temporal patterns %28%e.g., nocturnal epilepsy%29%. %28%From Adams et al., Principles of Neurology, 6th ed, p313%29%%A%    
% 219.64/219.80  |- mesh__recordMaintainer mesh__D004827 lkt
% 219.64/219.80  |- skos__annotation mesh__D004827 GEN or unspecified; prefer specifics   
% 219.64/219.80  |- mesh__recordAuthorizer mesh__D004827 sjn
% 219.64/219.80  |- mesh__dateRevised mesh__D004827 2004-07-07
% 219.64/219.80  |- skos__related mesh__D004827smesh__D012640
% 219.64/219.80  |- skos__altLabel mesh__D004827 Seizure Disorder
% 219.64/219.80  |- skos__hiddenLabel mesh__D004827 Seizure, Single
% 219.64/219.80  |- skos__prefLabel mesh__D004827 Epilepsy
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D004827 2005
% 219.64/219.80  |- skos__altLabel mesh__D004827 Epileptic Seizures
% 219.64/219.80  |- skos__hiddenLabel mesh__D004827 Cryptogenic Epilepsy
% 219.64/219.80  |- skos__hiddenLabel mesh__D004827 Auras
% 219.64/219.80  |- skos__hiddenLabel mesh__D004827 Seizure, Epileptic
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D004827 2006
% 219.64/219.80  |- skos__hiddenLabel mesh__D004827 Seizure Disorders
% 219.64/219.80  |- skos__hiddenLabel mesh__D004827 Epilepsies
% 219.64/219.80  |- mesh__recordOriginator mesh__D004827 NLM
% 219.64/219.80  |- skos__hiddenLabel mesh__D004827 Cryptogenic Epilepsies
% 219.64/219.80  |- rdf__type mesh__D004827sskos__Concept
% 219.64/219.80  |- mesh__dateCreated mesh__D004029 1999-01-01
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D004029 2004
% 219.64/219.80  |- skos__broader mesh__D004029smesh__D016834
% 219.64/219.80  |- mesh__recordOriginator mesh__D004029 NLM
% 219.64/219.80  |- skos__prefLabel mesh__D004029 Dientamoeba
% 219.64/219.80  |- mesh__dateRevised mesh__D004029 2003-07-09
% 219.64/219.80  |- skos__scopeNote mesh__D004029
% 219.64/219.80       A genus of minute protozoa that are characterized by the preponderance of binucleate over uninucleate forms, the presence of several distinct granules in the karyosome, and the lack of a cystic stage. It is parasitic in the large intestine of humans and certain monkeys.%A%    
% 219.64/219.80  |- mesh__recordMaintainer mesh__D004029 ags
% 219.64/219.80  |- rdf__type mesh__D004029sskos__Concept
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D004029 2005
% 219.64/219.80  |- mesh__recordAuthorizer mesh__D004029 sjn
% 219.64/219.80  |- skos__annotation mesh__D004029
% 219.64/219.80       infection = DIENTAMOEBIASIS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D004029 2006
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D009512 1995
% 219.64/219.80  |- mesh__dateCreated mesh__D009512 1999-01-01
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D009512 2005
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D009512 1998
% 219.64/219.80  |- rdf__type mesh__D009512sskos__Concept
% 219.64/219.80  |- mesh__recordOriginator mesh__D009512 NLM
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D009512 2002
% 219.64/219.80  |- mesh__recordMaintainer mesh__D009512 PLS
% 219.64/219.80  |- mesh__dateRevised mesh__D009512 1993-04-22
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D009512 2006
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D009512 1999
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D009512 2003
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D009512 1996
% 219.64/219.80  |- skos__broader mesh__D009512smesh__D017516
% 219.64/219.80  |- skos__scopeNote mesh__D009512
% 219.64/219.80       Originally an island of the Malay Archipelago, the second largest island in the world. It divided, West New Guinea becoming part of Indonesia and East New Guinea becoming Papua New Guinea.%A%    
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D009512 2000
% 219.64/219.80  |- skos__annotation mesh__D009512
% 219.64/219.80       East New Guinea is a part of Papua New Guinea %26% West New Guinea is part of Indonesia%A%  
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D009512 2004
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D009512 2001
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D009512 1997
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D009512 1994
% 219.64/219.80  |- mesh__recordAuthorizer mesh__D009512 PLS
% 219.64/219.80  |- skos__prefLabel mesh__D009512 New Guinea
% 219.64/219.80  |- mesh__dateRevised mesh__D020494 2005-06-30
% 219.64/219.80  |- skos__scopeNote mesh__D020494
% 219.64/219.80       Works consisting of common terms, phrases, idioms, and typical conversations, e.g., between health professional and patients. These are often intended for use by non-native speakers of a language.%A%    
% 219.64/219.80  |- mesh__historyNote mesh__D020494 1999   
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D020494 2006
% 219.64/219.80  |- mesh__recordMaintainer mesh__D020494 jls
% 219.64/219.80  |- rdf__type mesh__D020494sskos__Concept
% 219.64/219.80  |- skos__broader mesh__D020494smesh__D016437
% 219.64/219.80  |- mesh__dateEstablished mesh__D020494 1999-01-01
% 219.64/219.80  |- skos__prefLabel mesh__D020494 Phrases %5B%Publication Type%5D%
% 219.64/219.80  |- mesh__recordOriginator mesh__D020494 JLS
% 219.64/219.80  |- mesh__dateCreated mesh__D020494 1998-06-03
% 219.64/219.80  |- skos__altLabel mesh__D020494 Phrases %28%PT%29%
% 219.64/219.80  |- mesh__recordAuthorizer mesh__D020494 sjn
% 219.64/219.80  |- skos__annotation mesh__D014457 fracture = ULNA FRACTURES   
% 219.64/219.80  |- skos__broader mesh__D014457smesh__D050280
% 219.64/219.80  |- rdf__type mesh__D014457sskos__Concept
% 219.64/219.80  |- mesh__dateCreated mesh__D014457 1999-01-01
% 219.64/219.80  |- mesh__dateRevised mesh__D014457 2005-06-30
% 219.64/219.80  |- skos__hiddenLabel mesh__D014457 Ulnas
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D014457 2006
% 219.64/219.80  |- mesh__recordMaintainer mesh__D014457 ags
% 219.64/219.80  |- mesh__recordOriginator mesh__D014457 NLM
% 219.64/219.80  |- mesh__recordAuthorizer mesh__D014457 sjn
% 219.64/219.80  |- skos__prefLabel mesh__D014457 Ulna
% 219.64/219.80  |- skos__altLabel mesh__D019940 Genes, PRAD1
% 219.64/219.80  |- skos__hiddenLabel mesh__D019940 PRAD1 Genes
% 219.64/219.80  |- mesh__recordAuthorizer mesh__D019940 sjn
% 219.64/219.80  |- skos__hiddenLabel mesh__D019940 Gene, c-bcl-1
% 219.64/219.80  |- skos__broader mesh__D019940smesh__D011519
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D019940 2006
% 219.64/219.80  |- skos__hiddenLabel mesh__D019940 Gene, PRAD1
% 219.64/219.80  |- rdf__type mesh__D019940sskos__Concept
% 219.64/219.80  |- skos__historyNote mesh__D019940 Proto-Oncogenes %28%1990-1997%29%
% 219.64/219.80  |- mesh__dateCreated mesh__D019940 1997-06-20
% 219.64/219.80  |- skos__hiddenLabel mesh__D019940 Proto-Oncogene, c-bcl-1
% 219.64/219.80  |- skos__hiddenLabel mesh__D019940 bcl-1 Gene
% 219.64/219.80  |- mesh__dateEstablished mesh__D019940 1998-01-01
% 219.64/219.80  |- skos__altLabel mesh__D019940 c-bcl-1 Proto-Oncogenes
% 219.64/219.80  |- skos__hiddenLabel mesh__D019940 c bcl 1 Genes
% 219.64/219.80  |- skos__related mesh__D019940smesh__D020522
% 219.64/219.80  |- skos__hiddenLabel mesh__D019940 c-bcl-1 Gene
% 219.64/219.80  |- skos__related mesh__D019940smesh__D019938
% 219.64/219.80  |- skos__hiddenLabel mesh__D019940 bcl 1 Genes
% 219.64/219.80  |- skos__prefLabel mesh__D019940 Genes, bcl-1
% 219.64/219.80  |- skos__scopeNote mesh__D019940
% 219.64/219.80       The B-cell leukemia/lymphoma-1 genes, associated with various neoplasms when overexpressed. Overexpression results from the t%28%11;14%29% translocation, which is characteristic of mantle zone-derived B-cell lymphomas. The human c-bcl-1 gene is located at 11q13 on the long arm of chromosome 11.%A%    
% 219.64/219.80  |- skos__hiddenLabel mesh__D019940 Gene, Cyclin D1
% 219.64/219.80  |- skos__altLabel mesh__D019940 bcl-1 Genes
% 219.64/219.80  |- skos__hiddenLabel mesh__D019940 Genes, c-bcl-1
% 219.64/219.80  |- skos__hiddenLabel mesh__D019940 Proto-Oncogenes, c-bcl-1
% 219.64/219.80  |- skos__altLabel mesh__D019940 Cyclin D1 Genes
% 219.64/219.80  |- skos__hiddenLabel mesh__D019940 Cyclin D1 Gene
% 219.64/219.80  |- skos__hiddenLabel mesh__D019940 c-bcl-1 Proto-Oncogene
% 219.64/219.80  |- mesh__historyNote mesh__D019940 98   
% 219.64/219.80  |- mesh__publicMeSHNote mesh__D019940 98   
% 219.64/219.80  |- skos__historyNote mesh__D019940 Oncogenes %28%1988-1997%29%
% 219.64/219.80  |- skos__altLabel mesh__D019940 Genes, Cyclin D1
% 219.64/219.80  |- mesh__recordOriginator mesh__D019940 AGS
% 219.64/219.80  |- mesh__recordMaintainer mesh__D019940 nns
% 219.64/219.80  |- skos__annotation mesh__D019940 bcl stands for %22%B-Cell Leukemia%22%   
% 219.64/219.80  |- skos__hiddenLabel mesh__D019940 c bcl 1 Proto Oncogenes
% 219.64/219.80  |- skos__hiddenLabel mesh__D019940 PRAD1 Gene
% 219.64/219.80  |- mesh__dateRevised mesh__D019940 2005-06-30
% 219.64/219.80  |- skos__hiddenLabel mesh__D019940 Genes, bcl 1
% 219.64/219.80  |- skos__hiddenLabel mesh__D019940 Gene, bcl-1
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D000437 2003
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D000437 2004
% 219.64/219.80  |- skos__related mesh__D000437smesh__D000436
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D000437 2002
% 219.64/219.80  |- skos__related mesh__D000437smesh__D013695
% 219.64/219.80  |- skos__hiddenLabel mesh__D000437 Intoxication, Chronic Alcoholic
% 219.64/219.80  |- mesh__recordMaintainer mesh__D000437 mdb
% 219.64/219.80  |- skos__annotation mesh__D000437
% 219.64/219.80       human %26% animal; do not coord with CHRONIC DISEASE: alcoholism is presumed to be chronic; differentiate from ALCOHOLIC INTOXICATION, being drunk, not chronic; acute alcoholic intox %26% binge drinking is ETHANOL /pois; /drug ther: consider also ALCOHOL DETERRENTS; consider also LIVER DISEASES, ALCOHOLIC %26% its specifics FATTY LIVER, ALCOHOLIC; HEPATITIS, ALCOHOLIC %26% LIVER CIRRHOSIS, ALCOHOLIC; also PANCREATITIS, ALCOHOLIC; also CARDIOMYOPATHY, ALCOHOLIC; PSYCHOSES, ALCOHOLIC %26% FETAL ALCOHOL SYNDROME; index other compl of alcoholism under ALCOHOLISM /compl %28%IM%29% + disease /etiol not /chem ind %28%IM%29%; abstinence from alcohol in alcoholism: coord with TEMPERANCE %28%NIM%29%; available is SKID ROW ALCOHOLICS see HOMELESS PERSONS but see note there%A%  
% 219.64/219.80  |- skos__prefLabel mesh__D000437 Alcoholism
% 219.64/219.80  |- skos__scopeNote mesh__D000437
% 219.64/219.80       A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. %28%Morse %26% Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4%29%%A%    
% 219.64/219.80  |- skos__altLabel mesh__D000437 Alcoholic Intoxication, Chronic
% 219.64/219.80  |- mesh__recordOriginator mesh__D000437 NLM
% 219.64/219.80  |- rdf__type mesh__D000437sskos__Concept
% 219.64/219.80  |- skos__broader mesh__D000437smesh__D019973
% 219.64/219.80  |- skos__related mesh__D000437smesh__D011604
% 219.64/219.80  |- mesh__dateCreated mesh__D000437 1999-01-01
% 219.64/219.80  |- skos__hiddenLabel mesh__D000437 Abuse, Alcohol
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D000437 2005
% 219.64/219.80  |- skos__hiddenLabel mesh__D000437 Chronic Alcoholic Intoxication
% 219.64/219.80  |- skos__related mesh__D000437smesh__D000427
% 219.64/219.80  |- skos__related mesh__D000437smesh__D005310
% 219.64/219.80  |- mesh__dateRevised mesh__D000437 2001-07-25
% 219.64/219.80  |- mesh__recordAuthorizer mesh__D000437 sjn
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D000437 2006
% 219.64/219.80  |- skos__broader mesh__D019142smesh__D006482
% 219.64/219.80  |- mesh__recordAuthorizer mesh__D019142 ags
% 219.64/219.80  |- mesh__historyNote mesh__D019142 96   
% 219.64/219.80  |- skos__altLabel mesh__D019142 Ebola Hemorrhagic Fever
% 219.64/219.80  |- mesh__publicMeSHNote mesh__D019142 96   
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D019142 2004
% 219.64/219.80  |- mesh__dateEstablished mesh__D019142 1996-01-01
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D019142 2006A
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D019142 2003
% 219.64/219.80  |- mesh__dateCreated mesh__D019142 1995-06-05
% 219.64/219.80  |- skos__historyNote mesh__D019142
% 219.64/219.80       Hemorrhagic Fevers, Viral %28%1978-1995%29%
% 219.64/219.80  |- skos__annotation mesh__D019142
% 219.64/219.80       caused by Ebola virus, a species of Filovirus   
% 219.64/219.80  |- mesh__dateRevised mesh__D019142 2005-07-13
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D019142 2006
% 219.64/219.80  |- mesh__recordOriginator mesh__D019142 AGS
% 219.64/219.80  |- rdf__type mesh__D019142sskos__Concept
% 219.64/219.80  |- skos__prefLabel mesh__D019142 Hemorrhagic Fever, Ebola
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D019142 2002
% 219.64/219.80  |- mesh__recordMaintainer mesh__D019142 ags
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D019142 2005
% 219.64/219.80  |- skos__scopeNote mesh__D019142
% 219.64/219.80       A highly fatal, acute hemorrhagic fever, clinically very similar to MARBURG VIRUS DISEASE, caused by EBOLA-LIKE VIRUSES, first occurring in the Sudan and adjacent northwestern %28%what was then%29% Zaire. The natural reservoir and mode of transmission of the virus are unknown, but secondary infection is by direct contact with infected blood and other body secretions. %28%From Dorland, 28th ed%29%%A%    
% 219.64/219.80  |- skos__broader mesh__D019142smesh__D018702
% 219.64/219.80  |- skos__altLabel mesh__D019142 Ebola Virus Disease
% 219.64/219.80  |- mesh__recordOriginator mesh__D005920 EC
% 219.64/219.80  |- mesh__dateRevised mesh__D005920 2005-06-30
% 219.64/219.80  |- mesh__dateCreated mesh__D005920 1983-06-06
% 219.64/219.80  |- rdf__type mesh__D005920sskos__Concept
% 219.64/219.80  |- skos__altLabel mesh__D005920 Mesangium, Glomerular
% 219.64/219.80  |- mesh__recordMaintainer mesh__D005920 nns
% 219.64/219.80  |- mesh__dateEstablished mesh__D005920 1984-01-01
% 219.64/219.80  |- skos__hiddenLabel mesh__D005920 Extracellular Matrices, Mesangial
% 219.64/219.80  |- skos__hiddenLabel mesh__D005920 Matrix, Mesangial Extracellular
% 219.64/219.80  |- skos__hiddenLabel mesh__D005920 Extracellular Matrix, Mesangial
% 219.64/219.80  |- skos__hiddenLabel mesh__D005920 Glomerular Mesangiums
% 219.64/219.80  |- mesh__historyNote mesh__D005920 84   
% 219.64/219.80  |- skos__scopeNote mesh__D005920
% 219.64/219.80       The thin membranous structure supporting the adjoining glomerular capillaries. It is composed of GLOMERULAR MESANGIAL CELLS and their EXTRACELLULAR MATRIX.%A%    
% 219.64/219.80  |- skos__hiddenLabel mesh__D005920 Mesangial Extracellular Matrices
% 219.64/219.80  |- skos__hiddenLabel mesh__D005920 Matrices, Mesangial Extracellular
% 219.64/219.80  |- mesh__recordAuthorizer mesh__D005920 sjn
% 219.64/219.80  |- skos__broader mesh__D005920smesh__D050527
% 219.64/219.80  |- skos__hiddenLabel mesh__D005920 Mesangiums, Glomerular
% 219.64/219.80  |- mesh__publicMeSHNote mesh__D005920 84   
% 219.64/219.80  |- skos__historyNote mesh__D005920 Kidney Glomerulus %28%1966-1983%29%
% 219.64/219.80  |- skos__prefLabel mesh__D005920 Glomerular Mesangium
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D005920 2006
% 219.64/219.80  |- mesh__recordAuthorizer mesh__D005122 sjn
% 219.64/219.80  |- mesh__recordOriginator mesh__D005122 NLM
% 219.64/219.80  |- skos__prefLabel mesh__D005122 Exudates and Transudates
% 219.64/219.80  |- rdf__type mesh__D005122sskos__Concept
% 219.64/219.80  |- mesh__dateRevised mesh__D005122 2004-07-13
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D005122 2005
% 219.64/219.80  |- skos__annotation mesh__D005122
% 219.64/219.80        breast cyst fluid =  FIBROCYSTIC BREAST DISEASE %28%IM%29% + EXUDATES AND TRANSUDATES with pertinent qualif %28%NIM%29%; DF: EXUDATES%A%  
% 219.64/219.80  |- skos__altLabel mesh__D005122 Transudates and Exudates
% 219.64/219.80  |- skos__related mesh__D005122smesh__D049291
% 219.64/219.80  |- mesh__dateCreated mesh__D005122 1999-01-01
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D005122 2006
% 219.64/219.80  |- skos__related mesh__D005122smesh__D010490
% 219.64/219.80  |- skos__hiddenLabel mesh__D005122 Exudate
% 219.64/219.80  |- skos__hiddenLabel mesh__D005122 Transudate
% 219.64/219.80  |- mesh__recordMaintainer mesh__D005122 sjn
% 219.64/219.80  |- skos__broader mesh__D005122smesh__D005441
% 219.64/219.80  |- skos__related mesh__D005122smesh__D001202
% 219.64/219.80  |- skos__related mesh__D005122smesh__D010996
% 219.64/219.80  |- skos__scopeNote mesh__D005122
% 219.64/219.80       Exudates are fluids, CELLS, or other cellular substances that are slowly discharged from BLOOD VESSELS usually from inflamed tissues. Transudates are fluids that pass through a membrane or squeeze through tissue or into the EXTRACELLULAR SPACE of TISSUES. Transudates are thin and watery and contain few cells or PROTEINS.%A%    
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D018848 2006
% 219.64/219.80  |- skos__altLabel mesh__D018848 Controlled Clinical Trial %28%PT%29%
% 219.64/219.80  |- mesh__recordMaintainer mesh__D018848 jls
% 219.64/219.80  |- rdf__type mesh__D018848sskos__Concept
% 219.64/219.80  |- mesh__dateEstablished mesh__D018848 1996-01-01
% 219.64/219.80  |- skos__altLabel mesh__D018848 Controlled Clinical Trial
% 219.64/219.80  |- skos__annotation mesh__D018848
% 219.64/219.80       publication type only; controlled clinical trials as a  subject are indexed under the main heading CONTROLLED CLINICAL TRIALS; Manual 26.26; RANDOMIZED CONTROLLED TRIAL %5B%Publication Type%5D% is also available;  CATALOG: Do not use%A%  
% 219.64/219.80  |- skos__scopeNote mesh__D018848
% 219.64/219.80       Work consisting of a clinical trial involving one or more test treatments, at least one control treatment, specified outcome measures for evaluating the studied intervention, and a bias-free method for assigning patients to the test treatment. The treatment may be drugs, devices, or procedures studied for diagnostic, therapeutic, or prophylactic effectiveness. Control measures include placebos, active medicine, no-treatment, dosage forms and regimens, historical comparisons, etc. When randomization using mathematical techniques, such as the use of a random numbers table, is employed to assign patients to test or control treatments, the trial is characterized as a RANDOMIZED CONTROLLED TRIAL %5B%PUBLICATION TYPE%5D%.%A%    
% 219.64/219.80  |- mesh__recordAuthorizer mesh__D018848 sjn
% 219.64/219.80  |- mesh__historyNote mesh__D018848 1995   
% 219.64/219.80  |- mesh__recordOriginator mesh__D018848 PLS
% 219.64/219.80  |- mesh__dateRevised mesh__D018848 2005-06-30
% 219.64/219.80  |- skos__prefLabel mesh__D018848
% 219.64/219.80       Controlled Clinical Trial %5B%Publication Type%5D%
% 219.64/219.80  |- mesh__dateCreated mesh__D018848 1995-06-23
% 219.64/219.80  |- skos__broader mesh__D018848smesh__D016430
% 219.64/219.80  |- skos__altLabel mesh__D010865 Pilot Study
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010865 2002
% 219.64/219.80  |- skos__hiddenLabel mesh__D010865 Study, Pilot
% 219.64/219.80  |- mesh__recordAuthorizer mesh__D010865 sjn
% 219.64/219.80  |- skos__hiddenLabel mesh__D010865 Projects, Pilot
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010865 2005
% 219.64/219.80  |- skos__prefLabel mesh__D010865 Pilot Projects
% 219.64/219.80  |- skos__historyNote mesh__D010865 Research %28%1966-1970%29%
% 219.64/219.80  |- mesh__dateRevised mesh__D010865 2001-07-25
% 219.64/219.80  |- skos__annotation mesh__D010865
% 219.64/219.80       IM GEN only; coord NIM with specific subject %28%IM%29%; no qualif; specify geog if pertinent%A%  
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010865 2003
% 219.64/219.80  |- skos__scopeNote mesh__D010865
% 219.64/219.80       Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work.%A%    
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010865 2006
% 219.64/219.80  |- mesh__dateEstablished mesh__D010865 1974-01-01
% 219.64/219.80  |- skos__broader mesh__D010865smesh__D016020
% 219.64/219.80  |- skos__hiddenLabel mesh__D010865 Pilot Project
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010865 2004
% 219.64/219.80  |- skos__hiddenLabel mesh__D010865 Project, Pilot
% 219.64/219.80  |- mesh__historyNote mesh__D010865 74%28%71%29%   
% 219.64/219.80  |- mesh__dateCreated mesh__D010865 1999-01-01
% 219.64/219.80  |- mesh__recordOriginator mesh__D010865 NLM
% 219.64/219.80  |- mesh__recordMaintainer mesh__D010865 ags
% 219.64/219.80  |- skos__hiddenLabel mesh__D010865 Studies, Pilot
% 219.64/219.80  |- skos__broader mesh__D010865smesh__D012106
% 219.64/219.80  |- mesh__publicMeSHNote mesh__D010865 74   
% 219.64/219.80  |- skos__altLabel mesh__D010865 Pilot Studies
% 219.64/219.80  |- rdf__type mesh__D010865sskos__Concept
% 219.64/219.80  |- skos__broader mesh__D010067smesh__D009934
% 219.64/219.80  |- mesh__recordAuthorizer mesh__D010067 SJN
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010067 2001
% 219.64/219.80  |- mesh__publicMeSHNote mesh__D010067 68   
% 219.64/219.80  |- mesh__historyNote mesh__D010067 68   
% 219.64/219.80  |- skos__annotation mesh__D010067 med or non-med contexts   
% 219.64/219.80  |- mesh__dateRevised mesh__D010067 1998-06-10
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010067 2003
% 219.64/219.80  |- skos__broader mesh__D010067smesh__D007603
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010067 2000
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010067 2006
% 219.64/219.80  |- mesh__dateCreated mesh__D010067 1999-01-01
% 219.64/219.80  |- skos__hiddenLabel mesh__D010067 Property Right
% 219.64/219.80  |- skos__scopeNote mesh__D010067
% 219.64/219.80       The legal relation between an entity %28%individual, group, corporation, or-profit, secular, government%29% and an object. The object may be corporeal, such as equipment, or completely a creature of law, such as a patent; it may be movable, such as an animal, or immovable, such as a building.%A%    
% 219.64/219.80  |- mesh__recordMaintainer mesh__D010067 JLS
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010067 2005
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010067 1999
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010067 2002
% 219.64/219.80  |- skos__related mesh__D010067smesh__D018973
% 219.64/219.80  |- mesh__dateEstablished mesh__D010067 1968-01-01
% 219.64/219.80  |- rdf__type mesh__D010067sskos__Concept
% 219.64/219.80  |- skos__historyNote mesh__D010067
% 219.64/219.80       Hospital Administration %28%1966-1967%29%
% 219.64/219.80  |- skos__related mesh__D010067smesh__D020443
% 219.64/219.80  |- skos__hiddenLabel mesh__D010067 Rights, Property
% 219.64/219.80  |- skos__prefLabel mesh__D010067 Ownership
% 219.64/219.80  |- mesh__recordOriginator mesh__D010067 NLM
% 219.64/219.80  |- mesh__activeMeSHYear mesh__D010067 2004
% 219.64/219.80  |- skos__altLabel mesh__D004828 Digestive Epilepsy
% 219.64/219.80  |- mesh__dateEstablished mesh__D004828 1977-01-01
% 219.64/219.80  |- skos__hiddenLabel mesh__D004828 Gelastic Epilepsies
% 219.64/219.80  |- skos__hiddenLabel mesh__D004828 Seizure, Subclinical
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Epilepsies, Occipital Lobe
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Epilepsies, Rhinencephalic
% 219.64/219.81  |- skos__altLabel mesh__D004828 Benign Occipital Epilepsy, Childhood
% 219.64/219.81  |- skos__historyNote mesh__D004828 Jacksonian Seizure %28%1966-1976%29%
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Seizures, Simple Partial
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D004828 2005
% 219.64/219.81  |- mesh__publicMeSHNote mesh__D004828
% 219.64/219.81       2000; see EPILEPSY, PARTIAL 1966-1999, see EPILEPSY, FOCAL 1977-1991; for EPILEPSY, ABDOMINAL see EPILEPSY, TEMPORAL LOBE, 1975-1999; for EPILEPSY, PARTIAL see EPILEPSY, FOCAL 1977-1991; for EPILEPSY, FOCAL see JACKSONIAN SEIZURE 1970-1976; for JACKSONIAN SEIZURE see JACKSONIAN SEIZURE 1963-1991%A%  
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Focal Epilepsies
% 219.64/219.81  |- skos__altLabel mesh__D004828 Epilepsy, Localization-Related
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Epilepsies, Digestive
% 219.64/219.81  |- skos__prefLabel mesh__D004828 Epilepsies, Partial
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Seizures, Uncinate
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Focal Epilepsy
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Seizure Disorders, Focal
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Epilepsies, Localization-Related
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Localization-Related Epilepsies
% 219.64/219.81  |- skos__altLabel mesh__D004828 Childhood Benign Focal Epilepsy
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Abdominal Epilepsies
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Epilepsies, Abdominal
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Lobe Epilepsy, Occipital
% 219.64/219.81  |- skos__altLabel mesh__D004828 Epilepsy, Partial
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Epilepsies, Gelastic
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Occipital Lobe Epilepsies
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Amygdalo-Hippocampal Epilepsies
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Digestive Epilepsies
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Epilepsies, Simple Partial
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Subclinical Seizures
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Localization-Related Epilepsy
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Simple Partial Epilepsies
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Epilepsies, Amygdalo-Hippocampal
% 219.64/219.81  |- skos__scopeNote mesh__D004828
% 219.64/219.81       Conditions characterized by recurrent paroxysmal neuronal discharges which arise from a focal region of the brain. Partial seizures are divided into simple and complex, depending on whether consciousness is unaltered %28%simple partial seizure%29% or disturbed %28%complex partial seizure%29%. Both types may feature a wide variety of motor, sensory, and autonomic symptoms. Partial seizures may be classified by associated clinical features or anatomic location of the seizure focus. A secondary generalized seizure refers to a partial seizure that spreads to involve the brain diffusely. %28%From Adams et al., Principles of Neurology, 6th ed, pp317%29%%A%    
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Partial Epilepsies
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Seizure Disorders, Partial
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D004828 2004
% 219.64/219.81  |- skos__altLabel mesh__D004828 Focal Seizure Disorder
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Partial Epilepsies, Simple
% 219.64/219.81  |- skos__altLabel mesh__D004828 Epilepsy, Focal
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Partial Seizure Disorders
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Disorders, Focal Seizure
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Epilepsy, Abdominal
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Seizures, Subclinical
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Rhinencephalic Epilepsies
% 219.64/219.81  |- mesh__recordAuthorizer mesh__D004828 sjn
% 219.64/219.81  |- mesh__dateCreated mesh__D004828 1976-05-05
% 219.64/219.81  |- mesh__dateRevised mesh__D004828 2002-07-02
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D004828 2003
% 219.64/219.81  |- mesh__recordMaintainer mesh__D004828 lkt
% 219.64/219.81  |- skos__altLabel mesh__D004828
% 219.64/219.81       Partial Seizures, Simple, Consciousness Preserved
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Epilepsies, Focal
% 219.64/219.81  |- mesh__historyNote mesh__D004828
% 219.64/219.81       2000%28%1966%29%; for EPILEPSY, ABDOMINAL use EPILEPSY, TEMPORAL LOBE 1975-1999%A%  
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Seizure, Uncinate
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Partial Seizures, Simple
% 219.64/219.81  |- skos__altLabel mesh__D004828 Seizure Disorder, Focal
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Disorders, Partial Seizure
% 219.64/219.81  |- rdf__type mesh__D004828sskos__Concept
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Focal Seizure Disorders
% 219.64/219.81  |- mesh__recordOriginator mesh__D004828 MM
% 219.64/219.81  |- skos__hiddenLabel mesh__D004828 Partial Epilepsy
% 219.64/219.81  |- skos__broader mesh__D004828smesh__D004827
% 219.64/219.81  |- skos__altLabel mesh__D004828 Seizure Disorder, Partial
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D004828 2006
% 219.64/219.81  |- skos__altLabel mesh__D004828 Partial Seizure Disorder
% 219.64/219.81  |- mesh__dateCreated mesh__D015550 1989-03-29
% 219.64/219.81  |- mesh__dateEstablished mesh__D015550 1990-01-01
% 219.64/219.81  |- mesh__recordMaintainer mesh__D015550 nns
% 219.64/219.81  |- mesh__dateRevised mesh__D015550 2000-06-22
% 219.64/219.81  |- mesh__historyNote mesh__D015550 90   
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D015550 2002
% 219.64/219.81  |- mesh__recordAuthorizer mesh__D015550 sjn
% 219.64/219.81  |- skos__related mesh__D015550smesh__D005089
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D015550 2001
% 219.64/219.81  |- skos__annotation mesh__D015550
% 219.64/219.81       IM; coord with specific cell /physiol %28%IM%29%   
% 219.64/219.81  |- skos__broader mesh__D015550smesh__D005089
% 219.64/219.81  |- mesh__publicMeSHNote mesh__D015550 90   
% 219.64/219.81  |- rdf__type mesh__D015550sskos__Concept
% 219.64/219.81  |- mesh__recordOriginator mesh__D015550 AGS
% 219.64/219.81  |- skos__scopeNote mesh__D015550
% 219.64/219.81       The process of losing secretory granules %28%SECRETORY VESICLES%29%. This occurs, for example, in mast cells, basophils, neutrophils, eosinophils, and platelets when secretory products are released from the granules by EXOCYTOSIS.%A%    
% 219.64/219.81  |- skos__hiddenLabel mesh__D015550 Degranulation, Cell
% 219.64/219.81  |- skos__related mesh__D015550smesh__D022142
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D015550 2004
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D015550 2006
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D015550 2003
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D015550 2005
% 219.64/219.81  |- skos__prefLabel mesh__D015550 Cell Degranulation
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D009513 1999
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D009513 2000
% 219.64/219.81  |- mesh__recordAuthorizer mesh__D009513 SJN
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D009513 2003
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D009513 2001
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D009513 2004
% 219.64/219.81  |- skos__prefLabel mesh__D009513 New Hampshire
% 219.64/219.81  |- mesh__recordMaintainer mesh__D009513 PXP
% 219.64/219.81  |- skos__broader mesh__D009513smesh__D009511
% 219.64/219.81  |- mesh__recordOriginator mesh__D009513 NLM
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D009513 2002
% 219.64/219.81  |- mesh__dateRevised mesh__D009513 1997-06-20
% 219.64/219.81  |- rdf__type mesh__D009513sskos__Concept
% 219.64/219.81  |- mesh__dateCreated mesh__D009513 1999-01-01
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D009513 2005
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D009513 1998
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D009513 2006
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D001530 2001
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D001530 1994
% 219.64/219.81  |- mesh__dateRevised mesh__D001530 1991-11-02
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D001530 1999
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D001530 2002
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D001530 1995
% 219.64/219.81  |- mesh__recordMaintainer mesh__D001530 PLS
% 219.64/219.81  |- rdf__type mesh__D001530sskos__Concept
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D001530 2003
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D001530 1990
% 219.64/219.81  |- skos__broader mesh__D001530smesh__D005060
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D001530 2004
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D001530 1996
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D001530 1991
% 219.64/219.81  |- mesh__recordAuthorizer mesh__D001530 PLS
% 219.64/219.81  |- mesh__dateCreated mesh__D001530 1999-01-01
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D001530 2005
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D001530 1989
% 219.64/219.81  |- mesh__recordOriginator mesh__D001530 NLM
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D001530 1997
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D001530 1992
% 219.64/219.81  |- skos__prefLabel mesh__D001530 Belgium
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D001530 2006
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D001530 2000
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D001530 1998
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D001530 1993
% 219.64/219.81  |- mesh__recordAuthorizer mesh__D020495 sjn
% 219.64/219.81  |- mesh__dateRevised mesh__D020495 2005-06-30
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D020495 2006
% 219.64/219.81  |- rdf__type mesh__D020495sskos__Concept
% 219.64/219.81  |- skos__altLabel mesh__D020495 Pictorial Works %28%PT%29%
% 219.64/219.81  |- mesh__recordOriginator mesh__D020495 JLS
% 219.64/219.81  |- skos__scopeNote mesh__D020495
% 219.64/219.81       Works consisting exclusively or mainly of pictures but not technical drawings.%A%    
% 219.64/219.81  |- mesh__dateCreated mesh__D020495 1998-06-03
% 219.64/219.81  |- mesh__recordMaintainer mesh__D020495 jls
% 219.64/219.81  |- skos__broader mesh__D020495smesh__D019489
% 219.64/219.81  |- skos__prefLabel mesh__D020495 Pictorial Works %5B%Publication Type%5D%
% 219.64/219.81  |- skos__broader mesh__D020495smesh__D052180
% 219.64/219.81  |- skos__related mesh__D020495smesh__D019492
% 219.64/219.81  |- mesh__historyNote mesh__D020495 1999   
% 219.64/219.81  |- mesh__dateEstablished mesh__D020495 1999-01-01
% 219.64/219.81  |- mesh__publicMeSHNote mesh__D014458 73   
% 219.64/219.81  |- mesh__dateCreated mesh__D014458 1999-01-01
% 219.64/219.81  |- skos__historyNote mesh__D014458 Fractures %28%1966-1972%29%
% 219.64/219.81  |- skos__scopeNote mesh__D014458
% 219.64/219.81       Fractures of the larger bone of the forearm.     
% 219.64/219.81  |- skos__historyNote mesh__D014458 Ulna %28%1966-1972%29%
% 219.64/219.81  |- mesh__historyNote mesh__D014458 73   
% 219.64/219.81  |- mesh__dateRevised mesh__D014458 2005-06-30
% 219.64/219.81  |- skos__hiddenLabel mesh__D014458 Fractures, Ulna
% 219.64/219.81  |- mesh__recordMaintainer mesh__D014458 ssb
% 219.64/219.81  |- skos__broader mesh__D014458smesh__D050723
% 219.64/219.81  |- skos__historyNote mesh__D014458 Forearm Injuries %28%1966-1972%29%
% 219.64/219.81  |- skos__hiddenLabel mesh__D014458 Fracture, Ulna
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D014458 2006
% 219.64/219.81  |- mesh__recordOriginator mesh__D014458 NLM
% 219.64/219.81  |- mesh__recordAuthorizer mesh__D014458 sjn
% 219.64/219.81  |- skos__hiddenLabel mesh__D014458 Ulna Fracture
% 219.64/219.81  |- mesh__dateEstablished mesh__D014458 1973-01-01
% 219.64/219.81  |- skos__prefLabel mesh__D014458 Ulna Fractures
% 219.64/219.81  |- skos__broader mesh__D014458smesh__D005543
% 219.64/219.81  |- rdf__type mesh__D014458sskos__Concept
% 219.64/219.81  |- skos__altLabel mesh__D019941 CDKN2 Protein
% 219.64/219.81  |- mesh__recordOriginator mesh__D019941 AGS
% 219.64/219.81  |- skos__altLabel mesh__D019941 INK4A Protein
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D019941 2006
% 219.64/219.81  |- skos__altLabel mesh__D019941 Cdk4-Associated Protein p16
% 219.64/219.81  |- skos__hiddenLabel mesh__D019941 Protein, INK4A
% 219.64/219.81  |- skos__hiddenLabel mesh__D019941 Cyclin Dependent Kinase Inhibitor p16
% 219.64/219.81  |- mesh__recordAuthorizer mesh__D019941 sjn
% 219.64/219.81  |- mesh__dateRevised mesh__D019941 2005-07-01
% 219.64/219.81  |- mesh__publicMeSHNote mesh__D019941
% 219.64/219.81       1998; see PROTEIN P16; CDK4-ASSOCIATED PROTEIN P16 was indexed under CARRIER PROTEINS 1994-1997; P16%28%INK4A%29% was indexed under CARRIER PROTEINS 2000-2001%A%  
% 219.64/219.81  |- mesh__recordMaintainer mesh__D019941 sjn
% 219.64/219.81  |- mesh__dateEstablished mesh__D019941 1998-01-01
% 219.64/219.81  |- skos__hiddenLabel mesh__D019941 Cyclin Dependent Kinase Inhibitor 2A
% 219.64/219.81  |- skos__altLabel mesh__D019941 p16INK4 Protein
% 219.64/219.81  |- skos__broader mesh__D019941smesh__D050756
% 219.64/219.81  |- rdf__type mesh__D019941sskos__Concept
% 219.64/219.81  |- skos__related mesh__D019941smesh__D019942
% 219.64/219.81  |- skos__altLabel mesh__D019941 CDKN2A Protein
% 219.64/219.81  |- mesh__dateCreated mesh__D019941 1997-06-20
% 219.64/219.81  |- skos__related mesh__D019941smesh__D025803
% 219.64/219.81  |- skos__altLabel mesh__D019941 p16INK4A Protein
% 219.64/219.81  |- skos__historyNote mesh__D019941 Carrier Proteins %28%1994-1997%29%
% 219.64/219.81  |- skos__hiddenLabel mesh__D019941 Cdk4 Associated Protein p16
% 219.64/219.81  |- skos__scopeNote mesh__D019941
% 219.64/219.81       A product of the p16 tumor suppressor gene %28%GENES, P16%29%. It is also called INK4 or INK4A because it is the prototype member of the INK4 CYCLIN-DEPENDENT KINASE INHIBITORS. This protein is produced from the alpha mRNA transcript of the p16 gene. The other gene product, produced from the alternatively spliced beta transcript, is TUMOR SUPPRESSOR PROTEIN P14ARF.  Both p16 gene products have tumor suppressor functions.%A%    
% 219.64/219.81  |- skos__hiddenLabel mesh__D019941 Multiple Tumor Suppressor 1
% 219.64/219.81  |- skos__altLabel mesh__D019941 p16%28%INK4A%29%
% 219.64/219.81  |- skos__altLabel mesh__D019941 Multiple Tumor Suppressor-1
% 219.64/219.81  |- skos__altLabel mesh__D019941 Cyclin-Dependent Kinase Inhibitor-2A
% 219.64/219.81  |- skos__altLabel mesh__D019941 MTS1 Protein
% 219.64/219.81  |- mesh__historyNote mesh__D019941 2006%28%1994%29%   
% 219.64/219.81  |- skos__prefLabel mesh__D019941 Cyclin-Dependent Kinase Inhibitor p16
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D019143 2004
% 219.64/219.81  |- mesh__dateRevised mesh__D019143 2002-07-03
% 219.64/219.81  |- mesh__recordAuthorizer mesh__D019143 sjn
% 219.64/219.81  |- skos__prefLabel mesh__D019143 Evolution, Molecular
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D019143 2003
% 219.64/219.81  |- mesh__dateCreated mesh__D019143 1995-06-05
% 219.64/219.81  |- skos__broader mesh__D019143smesh__D005075
% 219.64/219.81  |- mesh__publicMeSHNote mesh__D019143 96   
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D019143 2006
% 219.64/219.81  |- mesh__dateEstablished mesh__D019143 1996-01-01
% 219.64/219.81  |- rdf__type mesh__D019143sskos__Concept
% 219.64/219.81  |- skos__altLabel mesh__D019143 Molecular Evolution
% 219.64/219.81  |- skos__historyNote mesh__D019143 Evolution %28%1966-1995%29%
% 219.64/219.81  |- skos__annotation mesh__D019143
% 219.64/219.81       %22%evolution at the molec level of DNA seq and proteins%22%; DF: EVOLUTION MOL%A%  
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D019143 2005
% 219.64/219.81  |- mesh__recordMaintainer mesh__D019143 TGC
% 219.64/219.81  |- mesh__recordOriginator mesh__D019143 PXP
% 219.64/219.81  |- mesh__historyNote mesh__D019143 96   
% 219.64/219.81  |- skos__related mesh__D019143smesh__D019020
% 219.64/219.81  |- skos__scopeNote mesh__D019143
% 219.64/219.81       Evolution at the molecular level of DNA sequences and proteins. %28%Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A%    
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D000438 1998
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D000438 2004
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D000438 1999
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D000438 2001
% 219.64/219.81  |- skos__prefLabel mesh__D000438 Alcohols
% 219.64/219.81  |- mesh__recordAuthorizer mesh__D000438 SJN
% 219.64/219.81  |- mesh__dateRevised mesh__D000438 1997-06-20
% 219.64/219.81  |- rdf__type mesh__D000438sskos__Concept
% 219.64/219.81  |- skos__scopeNote mesh__D000438
% 219.64/219.81       Alkyl compounds containing a hydroxyl group. They are classified according to relation of the carbon atom: primary alcohols, R-CH2OH; secondary alcohols, R2-CHOH; tertiary alcohols, R3-COH. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 219.64/219.81  |- mesh__dateCreated mesh__D000438 1999-01-01
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D000438 2005
% 219.64/219.81  |- skos__annotation mesh__D000438
% 219.64/219.81       do not use for %22%alcohol%22% %28% = ETHANOL%29%; diols = GLYCOLS; hypophysectomy by alcohol %28%ethanol%29% injection = HYPOPHYSECTOMY, CHEMICAL %26% do not index under ETHANOL unless particularly discussed%A%  
% 219.64/219.81  |- skos__broader mesh__D000438smesh__D009930
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D000438 2002
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D000438 2006
% 219.64/219.81  |- mesh__recordMaintainer mesh__D000438 ADP
% 219.64/219.81  |- mesh__recordOriginator mesh__D000438 NLM
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D000438 2003
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D000438 2000
% 219.64/219.81  |- skos__historyNote mesh__D011160
% 219.64/219.81       Antibiotics, Antineoplastic %28%1967-1972%29%
% 219.64/219.81  |- mesh__recordMaintainer mesh__D011160 ssb
% 219.64/219.81  |- skos__altLabel mesh__D011160 Methylmitomycin C
% 219.64/219.81  |- mesh__recordAuthorizer mesh__D011160 sjn
% 219.64/219.81  |- mesh__dateEstablished mesh__D011160 1973-01-01
% 219.64/219.81  |- mesh__dateRevised mesh__D011160 2004-07-07
% 219.64/219.81  |- mesh__publicMeSHNote mesh__D011160
% 219.64/219.81       91; was see under MITOMYCINS 1982-90; was heading 1973-81%A%  
% 219.64/219.81  |- skos__scopeNote mesh__D011160
% 219.64/219.81       Toxic antibiotic of the mitomycin group, obtained from MITOMYCIN and also from Streptomyces ardus and other species. It is proposed as an antineoplastic agent, with some antibiotic properties.%A%    
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D011160 2006
% 219.64/219.81  |- mesh__dateCreated mesh__D011160 1999-01-01
% 219.64/219.81  |- mesh__recordOriginator mesh__D011160 NLM
% 219.64/219.81  |- skos__prefLabel mesh__D011160 Porfiromycin
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D011160 2005
% 219.64/219.81  |- skos__broader mesh__D011160smesh__D008937
% 219.64/219.81  |- rdf__type mesh__D011160sskos__Concept
% 219.64/219.81  |- mesh__historyNote mesh__D011160
% 219.64/219.81       91%28%82%29%73; was see under MITOMYCINS 1982-90; was heading 1973-81%A%  
% 219.64/219.81  |- mesh__recordMaintainer mesh__D005921 TGC
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D005921 2003
% 219.64/219.81  |- mesh__dateRevised mesh__D005921 1996-06-10
% 219.64/219.81  |- mesh__recordAuthorizer mesh__D005921 PLS
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D005921 2000
% 219.64/219.81  |- skos__hiddenLabel mesh__D005921 Disease, Bright
% 219.64/219.81  |- skos__scopeNote mesh__D005921
% 219.64/219.81       Glomerular disease characterized by an inflammatory reaction, with leukocyte infiltration and cellular proliferation of the glomeruli, or that appears to be the result of immune glomerular injury.%A%    
% 219.64/219.81  |- mesh__publicMeSHNote mesh__D005921
% 219.64/219.81       BRIGHT DISEASE was BRIGHT%27%S DISEASE see NEPHRITIS 1963-78%A%  
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D005921 2004
% 219.64/219.81  |- skos__prefLabel mesh__D005921 Glomerulonephritis
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D005921 2001
% 219.64/219.81  |- skos__hiddenLabel mesh__D005921 Nephritis, Heymann
% 219.64/219.81  |- skos__hiddenLabel mesh__D005921 Glomerulonephritides
% 219.64/219.81  |- skos__altLabel mesh__D005921 Bright Disease
% 219.64/219.81  |- mesh__onlineNote mesh__D005921
% 219.64/219.81       search BRIGHT DISEASE under NEPHRITIS 1966-78   
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D005921 1997
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D005921 2005
% 219.64/219.81  |- skos__annotation mesh__D005921
% 219.64/219.81       %22%minimal lesion glomerulonephritis%22% = GLOMERULOSCLEROSIS, FOCAL%A%  
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D005921 2002
% 219.64/219.81  |- mesh__recordOriginator mesh__D005921 NLM
% 219.64/219.81  |- skos__related mesh__D005921smesh__D007676
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D005921 1998
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D005921 2006
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D005921 1999
% 219.64/219.81  |- mesh__dateCreated mesh__D005921 1999-01-01
% 219.64/219.81  |- skos__broader mesh__D005921smesh__D009393
% 219.64/219.81  |- rdf__type mesh__D005921sskos__Concept
% 219.64/219.81  |- skos__altLabel mesh__D005921 Heymann Nephritis
% 219.64/219.81  |- mesh__historyNote mesh__D005921
% 219.64/219.81       BRIGHT DISEASE was BRIGHT%27%S DISEASE see NEPHRITIS 1963-78%A%  
% 219.64/219.81  |- skos__related mesh__D005123smesh__D005132
% 219.64/219.81  |- mesh__recordMaintainer mesh__D005123 ags
% 219.64/219.81  |- mesh__considerAlso mesh__D005123
% 219.64/219.81       consider also terms at OCUL-, OPHTHALM-, OPT-, and VIS-   
% 219.64/219.81  |- skos__related mesh__D005123smesh__D012029
% 219.64/219.81  |- mesh__recordAuthorizer mesh__D005123 sjn
% 219.64/219.81  |- rdf__type mesh__D005123sskos__Concept
% 219.64/219.81  |- skos__prefLabel mesh__D005123 Eye
% 219.64/219.81  |- skos__broader mesh__D005123smesh__D012679
% 219.64/219.81  |- mesh__recordOriginator mesh__D005123 NLM
% 219.64/219.81  |- skos__annotation mesh__D005123
% 219.64/219.81       inflamm of eye = ENDOPHTHALMITIS %28%but see note there%29% or better -ITIS specifics in C11%A%  
% 219.64/219.81  |- skos__related mesh__D005123smesh__D007429
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D005123 2006
% 219.64/219.81  |- skos__hiddenLabel mesh__D005123 Eyes
% 219.64/219.81  |- mesh__dateCreated mesh__D005123 1999-01-01
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D005123 2005
% 219.64/219.81  |- skos__related mesh__D005123smesh__D014785
% 219.64/219.81  |- mesh__dateRevised mesh__D005123 2004-07-07
% 219.64/219.81  |- skos__broader mesh__D005123smesh__D005145
% 219.64/219.81  |- skos__broader mesh__D011978Q000037smesh__D011978
% 219.64/219.81  |- mesh__preferredCombination mesh__D011978Q000037smesh__D018733
% 219.64/219.81  |- rdf__type mesh__D011978Q000037smesh__CompoundConcept
% 219.64/219.81  |- skos__hiddenLabel mesh__D018849 Trials, Controlled Clinical
% 219.64/219.81  |- skos__scopeNote mesh__D018849
% 219.64/219.81       Clinical trials involving one or more test treatments, at least one control treatment, specified outcome measures for evaluating the studied intervention, and a bias-free method for assigning patients to the test treatment. The treatment may be drugs, devices, or procedures studied for diagnostic, therapeutic, or prophylactic effectiveness. Control measures include placebos, active medicines, no-treatment, dosage forms and regimens, historical comparisons, etc. When randomization using mathematical techniques, such as the use of a random numbers table, is employed to assign patients to test or control treatments, the trials are characterized as RANDOMIZED CONTROLLED TRIALS.%A%    
% 219.64/219.81  |- skos__historyNote mesh__D018849 Clinical Trials %28%1980-1994%29%
% 219.64/219.81  |- skos__broader mesh__D018849smesh__D002986
% 219.64/219.81  |- mesh__recordMaintainer mesh__D018849 jls
% 219.64/219.81  |- skos__annotation mesh__D018849
% 219.64/219.81       human %26% vet animals only; IM for articles %26% books about controlled clin trials as a method in med research: do not confuse with Publication Type CONTROLLED CLINICAL TRIAL; do not interpret trial design: use term of author; if in doubt, read MeSH definitions; available also are CONTROLLED CLINICAL TRIALS, RANDOMIZED %26% CLINICAL TRIALS, RANDOMIZED see RANDOMIZED CONTROLLED TRIALS; DF: CONTROLLED CLIN TRIALS%A%  
% 219.64/219.81  |- skos__prefLabel mesh__D018849 Controlled Clinical Trials
% 219.64/219.81  |- mesh__recordAuthorizer mesh__D018849 sjn
% 219.64/219.81  |- mesh__dateCreated mesh__D018849 1994-06-30
% 219.64/219.81  |- skos__altLabel mesh__D018849 Clinical Trials, Controlled
% 219.64/219.81  |- mesh__dateEstablished mesh__D018849 1995-01-01
% 219.64/219.81  |- mesh__historyNote mesh__D018849
% 219.64/219.81       1995; was see CLINICAL TRIALS 1980-1994   
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D018849 2006
% 219.64/219.81  |- mesh__publicMeSHNote mesh__D018849
% 219.64/219.81       95; was see CLINICAL TRIALS 1980-94   
% 219.64/219.81  |- mesh__recordOriginator mesh__D018849 TGC
% 219.64/219.81  |- rdf__type mesh__D018849sskos__Concept
% 219.64/219.81  |- skos__related mesh__D018849smesh__D035061
% 219.64/219.81  |- mesh__dateRevised mesh__D018849 2005-06-30
% 219.64/219.81  |- skos__annotation mesh__D010866
% 219.64/219.81       do not use /biosyn unless by living matter   
% 219.64/219.81  |- rdf__type mesh__D010866sskos__Concept
% 219.64/219.81  |- skos__scopeNote mesh__D010866
% 219.64/219.81       Amphoteric macrolide antifungal antibiotic from Streptomyces natalensis or S. chattanoogensis. It is used for a variety of fungal infections, mainly topically.%A%    
% 219.64/219.81  |- mesh__recordOriginator mesh__D010866 NLM
% 219.64/219.81  |- skos__altLabel mesh__D010866 Tennecetin
% 219.64/219.81  |- mesh__recordMaintainer mesh__D010866 ssb
% 219.64/219.81  |- mesh__onlineNote mesh__D010866
% 219.64/219.81       use NATAMYCIN to search PIMARICIN 1966-89   
% 219.64/219.81  |- skos__prefLabel mesh__D010866 Natamycin
% 219.64/219.81  |- mesh__recordAuthorizer mesh__D010866 sjn
% 219.64/219.81  |- mesh__publicMeSHNote mesh__D010866 90; was PIMARICIN 1973-89   
% 219.64/219.81  |- skos__altLabel mesh__D010866 Pimaricin
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D010866 2006
% 219.64/219.81  |- skos__broader mesh__D010866smesh__D018942
% 219.64/219.81  |- mesh__dateEstablished mesh__D010866 1973-01-01
% 219.64/219.81  |- mesh__dateRevised mesh__D010866 2004-07-07
% 219.64/219.81  |- mesh__dateCreated mesh__D010866 1999-01-01
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D010866 2005
% 219.64/219.81  |- mesh__historyNote mesh__D010866 90%28%66%29%; was PIMARICIN 1966-89   
% 219.64/219.81  |- skos__hiddenLabel mesh__D010068 Sodium, Oxacillin
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D010068 2006
% 219.64/219.81  |- mesh__dateCreated mesh__D010068 1999-01-01
% 219.64/219.81  |- mesh__recordOriginator mesh__D010068 NLM
% 219.64/219.81  |- skos__altLabel mesh__D010068 Sodium Oxacillin
% 219.64/219.81  |- skos__altLabel mesh__D010068 Oxazocilline
% 219.64/219.81  |- mesh__publicMeSHNote mesh__D010068 66   
% 219.64/219.81  |- mesh__recordMaintainer mesh__D010068 ssb
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D010068 2005
% 219.64/219.81  |- skos__altLabel mesh__D010068 Oxacillin, Monosodium Salt, Anhydrous
% 219.64/219.81  |- skos__prefLabel mesh__D010068 Oxacillin
% 219.64/219.81  |- rdf__type mesh__D010068sskos__Concept
% 219.64/219.81  |- mesh__dateRevised mesh__D010068 2004-07-07
% 219.64/219.81  |- skos__hiddenLabel mesh__D010068 Methylphenylisoxazolyl Penicillin
% 219.64/219.81  |- skos__altLabel mesh__D010068 Penicillin, Methylphenylisoxazolyl
% 219.64/219.81  |- mesh__recordAuthorizer mesh__D010068 sjn
% 219.64/219.81  |- mesh__historyNote mesh__D010068 66%28%64%29%   
% 219.64/219.81  |- skos__broader mesh__D010068smesh__D010406
% 219.64/219.81  |- mesh__dateEstablished mesh__D010068 1966-01-01
% 219.64/219.81  |- skos__scopeNote mesh__D010068
% 219.64/219.81       An antibiotic similar to FLUCLOXACILLIN used in resistant staphylococci infections.%A%    
% 219.64/219.81  |- skos__hiddenLabel mesh__D010068 Oxacillin, Sodium
% 219.64/219.81  |- rdf__type mesh__D004829sskos__Concept
% 219.64/219.81  |- skos__hiddenLabel mesh__D004829 Generalized Seizure Disorders
% 219.64/219.81  |- mesh__dateCreated mesh__D004829 1976-04-27
% 219.64/219.81  |- skos__hiddenLabel mesh__D004829 Epilepsies, Generalized Convulsive
% 219.64/219.81  |- skos__altLabel mesh__D004829 Seizure Disorder, Generalized
% 219.64/219.81  |- skos__hiddenLabel mesh__D004829 Generalized Epilepsy
% 219.64/219.81  |- skos__hiddenLabel mesh__D004829 Tonic Epilepsies
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D004829 2006
% 219.64/219.81  |- mesh__dateRevised mesh__D004829 2001-07-25
% 219.64/219.81  |- skos__altLabel mesh__D004829 Convulsive Seizure Disorder, Generalized
% 219.64/219.81  |- skos__altLabel mesh__D004829 Seizure Disorder, Generalized Nonconvulsive
% 219.64/219.81  |- mesh__publicMeSHNote mesh__D004829 1992   
% 219.64/219.81  |- skos__hiddenLabel mesh__D004829 Akinetic Epilepsy
% 219.64/219.81  |- skos__hiddenLabel mesh__D004829 Generalized Seizure Disorder
% 219.64/219.81  |- skos__altLabel mesh__D004829 Generalized Convulsive Epilepsy
% 219.64/219.81  |- skos__historyNote mesh__D004829 Epilepsy %28%1966-1991%29%
% 219.64/219.81  |- skos__annotation mesh__D004829
% 219.64/219.81       %22%generalized%22% as opposed to %22%focal%22% or partial %28% = EPILEPSIES, PARTIAL%29%; prefer specific indentions; note X ref EPILEPSY, TONIC: do not confuse with EPILEPSY, TONIC-CLONIC%A%  
% 219.64/219.81  |- skos__altLabel mesh__D004829 Seizure Disorder, Generalized Onset
% 219.64/219.81  |- skos__hiddenLabel mesh__D004829 Epilepsies, Tonic
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D004829 2005
% 219.64/219.81  |- skos__altLabel mesh__D004829 Generalized Seizure Disorder, Nonconvulsive
% 219.64/219.81  |- skos__hiddenLabel mesh__D004829 Convulsive Epilepsies, Generalized
% 219.64/219.81  |- skos__hiddenLabel mesh__D004829 Generalized Epilepsy, Symptomatic
% 219.64/219.81  |- skos__altLabel mesh__D004829 Seizure Disorder, Generalized, Convulsive
% 219.64/219.81  |- skos__hiddenLabel mesh__D004829 Epilepsies, Atonic
% 219.64/219.81  |- skos__altLabel mesh__D004829 Generalized Seizure Disorder, Convulsive
% 219.64/219.81  |- mesh__recordAuthorizer mesh__D004829 sjn
% 219.64/219.81  |- skos__altLabel mesh__D004829 Nonconvulsive Seizure Disorder, Generalized
% 219.64/219.81  |- skos__hiddenLabel mesh__D004829 Atonic Epilepsy
% 219.64/219.81  |- skos__altLabel mesh__D004829 Generalized Onset Seizure Disorder
% 219.64/219.81  |- skos__hiddenLabel mesh__D004829 Seizure Disorders, Generalized
% 219.64/219.81  |- skos__altLabel mesh__D004829 Seizure Disorder, Nonconvulsive Generalized
% 219.64/219.81  |- skos__hiddenLabel mesh__D004829 Generalized Epilepsies
% 219.64/219.81  |- skos__prefLabel mesh__D004829 Epilepsy, Generalized
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D004829 2004
% 219.64/219.81  |- skos__altLabel mesh__D004829 Nonconvulsive Generalized Seizure Disorder
% 219.64/219.81  |- skos__hiddenLabel mesh__D004829 Tonic Epilepsy
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D004829 2002
% 219.64/219.81  |- mesh__recordMaintainer mesh__D004829 ags
% 219.64/219.81  |- skos__scopeNote mesh__D004829
% 219.64/219.81       Recurrent conditions characterized by epileptic seizures which arise diffusely and simultaneously from both hemispheres of the brain. Classification is generally based upon motor manifestations of the seizure %28%e.g., convulsive, nonconvulsive, akinetic, atonic, etc.%29% or etiology %28%e.g., idiopathic, cryptogenic, and symptomatic%29%. %28%From Mayo Clin Proc, 1996 Apr;71%28%4%29%:405-14%29%%A%    
% 219.64/219.81  |- skos__broader mesh__D004829smesh__D004827
% 219.64/219.81  |- mesh__dateEstablished mesh__D004829 1992-01-01
% 219.64/219.81  |- skos__hiddenLabel mesh__D004829 Convulsive Epilepsy, Generalized
% 219.64/219.81  |- mesh__activeMeSHYear mesh__D004829 2003
% 219.64/219.81  |- skos__hiddenLabel mesh__D004829 Epilepsies, Generalized
% 219.64/219.81  |- mesh__historyNote mesh__D004829
% 219.64/219.81       1992; was EPILEPSY, GENERALIZED %28%NON MESH%29% 1977-1991   
% 219.64/219.81  |- skos__hiddenLabel mesh__D004829 Nonconvulsive Epilepsy, Generalized
% 219.64/219.81  |- skos__hiddenLabel mesh__D004829 Akinetic Epilepsies
% 219.64/219.82  |- skos__altLabel mesh__D004829 Generalized Nonconvulsive Epilepsy
% 219.64/219.82  |- skos__hiddenLabel mesh__D004829 Epilepsy, Generalized Convulsive
% 219.64/219.82  |- skos__hiddenLabel mesh__D004829 Epilepsy, Symptomatic Generalized
% 219.64/219.82  |- mesh__recordOriginator mesh__D004829 MM
% 219.64/219.82  |- skos__hiddenLabel mesh__D004829 Generalized Convulsive Epilepsies
% 219.64/219.82  |- skos__hiddenLabel mesh__D004829 Epilepsies, Akinetic
% 219.64/219.82  |- skos__hiddenLabel mesh__D004829 Atonic Epilepsies
% 219.64/219.82  |- skos__altLabel mesh__D004829 Seizure Disorder, Convulsive, Generalized
% 219.64/219.82  |- skos__hiddenLabel mesh__D004829 Epilepsy, Generalized Nonconvulsive
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D015551 1999
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D015551 1996
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D015551 1998
% 219.64/219.82  |- skos__related mesh__D015551smesh__D001323
% 219.64/219.82  |- mesh__publicMeSHNote mesh__D015551 90   
% 219.64/219.82  |- skos__historyNote mesh__D015551 Autoimmune Diseases %28%1966-1989%29%
% 219.64/219.82  |- rdf__type mesh__D015551sskos__Concept
% 219.64/219.82  |- mesh__historyNote mesh__D015551 90   
% 219.64/219.82  |- mesh__recordAuthorizer mesh__D015551 PLS
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D015551 2002
% 219.64/219.82  |- mesh__dateRevised mesh__D015551 1995-02-22
% 219.64/219.82  |- skos__prefLabel mesh__D015551 Autoimmunity
% 219.64/219.82  |- skos__hiddenLabel mesh__D015551 Autoimmune Responses
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D015551 2004
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D015551 2001
% 219.64/219.82  |- mesh__dateCreated mesh__D015551 1989-05-02
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D015551 2006
% 219.64/219.82  |- skos__broader mesh__D015551smesh__D007109
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D015551 2003
% 219.64/219.82  |- mesh__recordMaintainer mesh__D015551 AGS
% 219.64/219.82  |- skos__hiddenLabel mesh__D015551 Autoimmunities
% 219.64/219.82  |- mesh__recordOriginator mesh__D015551 AGS
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D015551 2005
% 219.64/219.82  |- skos__related mesh__D015551smesh__D001327
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D015551 2000
% 219.64/219.82  |- mesh__dateEstablished mesh__D015551 1990-01-01
% 219.64/219.82  |- skos__scopeNote mesh__D015551
% 219.64/219.82       Process whereby the immune system reacts against the body%27%s own tissues. Autoimmunity may produce or be caused by AUTOIMMUNE DISEASES.%A%    
% 219.64/219.82  |- skos__historyNote mesh__D015551 Autoantibodies %28%1966-1989%29%
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D015551 1997
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D009514 2003
% 219.64/219.82  |- mesh__recordMaintainer mesh__D009514 TGC
% 219.64/219.82  |- skos__annotation mesh__D009514
% 219.64/219.82       an island group in Melanesia; X ref NEW HEBRIDES was its former name%A%  
% 219.64/219.82  |- skos__scopeNote mesh__D009514
% 219.64/219.82       A republic consisting of an island group in Melanesia, in the southwest Pacific Ocean. Its capital is Port-Vila. It was called New Hebrides until 1980. It was discovered in 1606 by the Portuguese, forgotten for 160 years, then visited by Bougainville in 1768 and Captain Cook in 1774. It was under joint British and French administration from 1906 until it became independent in 1980 under the name of Vanuatu. The name is native, meaning our land. %28%From Webster%27%s New Geographical Dictionary, 1988, p833 %26% Room, Brewer%27%s Dictionary of Names, 1992, p570%29%%A%    
% 219.64/219.82  |- skos__broader mesh__D009514smesh__D008542
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D009514 2004
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D009514 2000
% 219.64/219.82  |- mesh__onlineNote mesh__D009514
% 219.64/219.82       use VANUATU to search NEW HEBRIDES 1975-89   
% 219.64/219.82  |- skos__altLabel mesh__D009514 New Hebrides
% 219.64/219.82  |- mesh__recordAuthorizer mesh__D009514 SJN
% 219.64/219.82  |- skos__prefLabel mesh__D009514 Vanuatu
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D009514 2001
% 219.64/219.82  |- mesh__dateEstablished mesh__D009514 1975-01-01
% 219.64/219.82  |- rdf__type mesh__D009514sskos__Concept
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D009514 2005
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D009514 1998
% 219.64/219.82  |- mesh__historyNote mesh__D009514 90; was NEW HEBRIDES 1975-89   
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D009514 2006
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D009514 1999
% 219.64/219.82  |- mesh__dateCreated mesh__D009514 1974-11-11
% 219.64/219.82  |- mesh__recordOriginator mesh__D009514 NLM
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D009514 2002
% 219.64/219.82  |- mesh__dateRevised mesh__D009514 1997-06-20
% 219.64/219.82  |- skos__altLabel mesh__D001531 British Honduras
% 219.64/219.82  |- mesh__recordMaintainer mesh__D001531 PLS
% 219.64/219.82  |- mesh__recordOriginator mesh__D001531 NLM
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D001531 2006
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D001531 1994
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D001531 2001
% 219.64/219.82  |- skos__prefLabel mesh__D001531 Belize
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D001531 1999
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D001531 2005
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D001531 1993
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D001531 2000
% 219.64/219.82  |- mesh__onlineNote mesh__D001531
% 219.64/219.82       use BELIZE to search BRITISH HONDURAS 1966-77   
% 219.64/219.82  |- rdf__type mesh__D001531sskos__Concept
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D001531 2004
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D001531 1998
% 219.64/219.82  |- mesh__dateCreated mesh__D001531 1999-01-01
% 219.64/219.82  |- skos__broader mesh__D001531smesh__D002489
% 219.64/219.82  |- mesh__historyNote mesh__D001531 78; was BRITISH HONDURAS 1966-77   
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D001531 1992
% 219.64/219.82  |- mesh__recordAuthorizer mesh__D001531 PLS
% 219.64/219.82  |- mesh__dateRevised mesh__D001531 1991-11-12
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D001531 1997
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D001531 2003
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D001531 1996
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D001531 1995
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D001531 2002
% 219.64/219.82  |- skos__altLabel mesh__D020496 Patient Education %28%Publication Type%29%
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D020496 2006
% 219.64/219.82  |- skos__related mesh__D020496smesh__D020482
% 219.64/219.82  |- skos__altLabel mesh__D020496 Health Education %28%PT%29%
% 219.64/219.82  |- rdf__type mesh__D020496sskos__Concept
% 219.64/219.82  |- skos__altLabel mesh__D020496
% 219.64/219.82       Consumer Health Information %28%Publication Type%29%
% 219.64/219.82  |- skos__altLabel mesh__D020496 Consumer Health Information %28%PT%29%
% 219.64/219.82  |- mesh__recordAuthorizer mesh__D020496 sjn
% 219.64/219.82  |- mesh__dateEstablished mesh__D020496 1999-01-01
% 219.64/219.82  |- mesh__recordOriginator mesh__D020496 JLS
% 219.64/219.82  |- mesh__dateCreated mesh__D020496 1998-06-03
% 219.64/219.82  |- mesh__dateRevised mesh__D020496 2005-06-30
% 219.64/219.82  |- mesh__historyNote mesh__D020496 99   
% 219.64/219.82  |- mesh__onlineNote mesh__D020496
% 219.64/219.82       search policy: Online Manual; use: main heading AND POPULAR WORKS %28%PT%29%%A%  
% 219.64/219.82  |- skos__broader mesh__D020496smesh__D052180
% 219.64/219.82  |- skos__altLabel mesh__D020496 Popular Works %28%PT%29%
% 219.64/219.82  |- skos__scopeNote mesh__D020496
% 219.64/219.82       Works written for non-professional or lay audiences.     
% 219.64/219.82  |- mesh__recordMaintainer mesh__D020496 jls
% 219.64/219.82  |- skos__prefLabel mesh__D020496 Popular Works %5B%Publication Type%5D%
% 219.64/219.82  |- skos__altLabel mesh__D020496 Consumer Information %28%PT%29%
% 219.64/219.82  |- skos__hiddenLabel mesh__D014459 Nerve, Ulnar
% 219.64/219.82  |- skos__hiddenLabel mesh__D014459 Ulnar Nerves
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D014459 2001
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D014459 2003
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D014459 2000
% 219.64/219.82  |- skos__prefLabel mesh__D014459 Ulnar Nerve
% 219.64/219.82  |- skos__annotation mesh__D014459
% 219.64/219.82       dis = ULNAR NEUROPATHY; neopl = ULNAR NEUROPATHY %28%IM%29% + PERIPHERAL NERVOUS SYSTEM NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D014459 2006
% 219.64/219.82  |- skos__scopeNote mesh__D014459
% 219.64/219.82       A major nerve of the upper extremity. In humans, the fibers of the ulnar nerve originate in the lower cervical and upper thoracic spinal cord %28%usually C7 to T1%29%, travel via the medial cord of the brachial plexus, and supply sensory and motor innervation to parts of the hand and forearm.%A%    
% 219.64/219.82  |- skos__broader mesh__D014459smesh__D001917
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D014459 2005
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D014459 2002
% 219.64/219.82  |- rdf__type mesh__D014459sskos__Concept
% 219.64/219.82  |- mesh__dateCreated mesh__D014459 1999-01-01
% 219.64/219.82  |- mesh__dateRevised mesh__D014459 1999-11-03
% 219.64/219.82  |- mesh__recordOriginator mesh__D014459 NLM
% 219.64/219.82  |- skos__hiddenLabel mesh__D014459 Nerves, Ulnar
% 219.64/219.82  |- mesh__recordMaintainer mesh__D014459 KEV
% 219.64/219.82  |- mesh__recordAuthorizer mesh__D014459 sjn
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D014459 2004
% 219.64/219.82  |- skos__historyNote mesh__D025181
% 219.64/219.82       Phosphotransferases %28%Phosphate Group Acceptor%29% %28%1994-2001%29%
% 219.64/219.82  |- mesh__recordAuthorizer mesh__D025181 ags
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D025181 2006A
% 219.64/219.82  |- skos__historyNote mesh__D025181 Adenosine Triphosphate %28%1972-1976%29%
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D025181 2005
% 219.64/219.82  |- mesh__dateRevised mesh__D025181 2005-07-07
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D025181 2006
% 219.64/219.82  |- skos__scopeNote mesh__D025181
% 219.64/219.82       Multisubunit enzyme complexes that synthesize ADENOSINE TRIPHOSPHATE from energy sources such as ions traveling through channels.%A%    
% 219.64/219.82  |- mesh__dateEstablished mesh__D025181 2002-01-01
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D025181 2006B
% 219.64/219.82  |- mesh__recordOriginator mesh__D025181 jmp
% 219.64/219.82  |- skos__altLabel mesh__D025181 ADP Kinases
% 219.64/219.82  |- mesh__publicMeSHNote mesh__D025181
% 219.64/219.82       2002; ATP SYNTHETASE COMPLEX was indexed under MULTIENZYME COMPLEXES 1980-2001, PHOSPHOTRANSFERASES %28%PHOSPHATE GROUP ACCEPTOR%29% 1994-2001, PHOSPHOTRANSFERASES, ATP 1977-1993, PHOSPHOTRANSFERASES 1972-1976 %26% ATP 1972-1976%A%  
% 219.64/219.82  |- rdf__type mesh__D025181sskos__Concept
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D025181 2004
% 219.64/219.82  |- skos__historyNote mesh__D025181 Phosphotransferases %28%1977-1993%29%
% 219.64/219.82  |- skos__altLabel mesh__D025181 ATP-ADP Kinase
% 219.64/219.82  |- skos__altLabel mesh__D025181 ATP Synthetase Complex
% 219.64/219.82  |- skos__altLabel mesh__D025181 ADP Kinase
% 219.64/219.82  |- mesh__dateCreated mesh__D025181 2001-07-25
% 219.64/219.82  |- skos__hiddenLabel mesh__D025181 ATP ADP Kinase
% 219.64/219.82  |- mesh__historyNote mesh__D025181
% 219.64/219.82       2002; use ATP SYNTHETASE COMPLEXES %28%NM%29% 1980-2001   
% 219.64/219.82  |- skos__historyNote mesh__D025181 Multienzyme Complexes %28%1980-2001%29%
% 219.64/219.82  |- skos__broader mesh__D025181smesh__D017856
% 219.64/219.82  |- skos__prefLabel mesh__D025181 ATP Synthetase Complexes
% 219.64/219.82  |- mesh__recordMaintainer mesh__D025181 ags
% 219.64/219.82  |- mesh__historyNote mesh__D019942 98   
% 219.64/219.82  |- skos__scopeNote mesh__D019942
% 219.64/219.82       Tumor suppressor genes located on human chromosome 9 in the region 9p21. This gene is either deleted or mutated in a wide range of malignancies. %28%From Segen, Current Med Talk, 1995%29% Two alternatively spliced gene products are encoded by p16: CYCLIN-DEPENDENT KINASE INHIBITOR P16 and TUMOR SUPPRESSOR PROTEIN P14ARF.%A%    
% 219.64/219.82  |- skos__hiddenLabel mesh__D019942 CDKN2 Gene
% 219.64/219.82  |- mesh__recordMaintainer mesh__D019942 sjn
% 219.64/219.82  |- skos__altLabel mesh__D019942 Genes, CDKN2A
% 219.64/219.82  |- skos__hiddenLabel mesh__D019942 p16INK4A Gene
% 219.64/219.82  |- skos__related mesh__D019942smesh__D025803
% 219.64/219.82  |- skos__hiddenLabel mesh__D019942 CDKN2A Gene
% 219.64/219.82  |- skos__hiddenLabel mesh__D019942 p16 Gene
% 219.64/219.82  |- skos__altLabel mesh__D019942 Genes, p16INK4A
% 219.64/219.82  |- mesh__dateRevised mesh__D019942 2005-07-01
% 219.64/219.82  |- skos__altLabel mesh__D019942 Genes, p16INK4
% 219.64/219.82  |- skos__related mesh__D019942smesh__D019941
% 219.64/219.82  |- skos__hiddenLabel mesh__D019942 MTS1 Gene
% 219.64/219.82  |- skos__hiddenLabel mesh__D019942 CDKN2A Genes
% 219.64/219.82  |- skos__altLabel mesh__D019942 Genes, CDKN2
% 219.64/219.82  |- skos__altLabel mesh__D019942 CDKN2 Genes
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D019942 2006
% 219.64/219.82  |- skos__broader mesh__D019942smesh__D016147
% 219.64/219.82  |- skos__hiddenLabel mesh__D019942 p16INK4A Genes
% 219.64/219.82  |- mesh__publicMeSHNote mesh__D019942 98   
% 219.64/219.82  |- skos__altLabel mesh__D019942 p16INK4 Genes
% 219.64/219.82  |- skos__historyNote mesh__D019942
% 219.64/219.82       Genes, Suppressor, Tumor %28%1994-1997%29%
% 219.64/219.82  |- mesh__dateEstablished mesh__D019942 1998-01-01
% 219.64/219.82  |- mesh__recordAuthorizer mesh__D019942 sjn
% 219.64/219.82  |- rdf__type mesh__D019942sskos__Concept
% 219.64/219.82  |- skos__hiddenLabel mesh__D019942 p16INK4 Gene
% 219.64/219.82  |- skos__altLabel mesh__D019942 p16 Genes
% 219.64/219.82  |- skos__altLabel mesh__D019942 MTS1 Genes
% 219.64/219.82  |- skos__prefLabel mesh__D019942 Genes, p16
% 219.64/219.82  |- mesh__recordOriginator mesh__D019942 AGS
% 219.64/219.82  |- skos__altLabel mesh__D019942 Genes, MTS1
% 219.64/219.82  |- mesh__dateCreated mesh__D019942 1997-06-20
% 219.64/219.82  |- skos__historyNote mesh__D000439 Alcohols %28%1966-1971%29%
% 219.64/219.82  |- skos__broader mesh__D000439smesh__D005233
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D000439 2004
% 219.64/219.82  |- mesh__dateEstablished mesh__D000439 1974-01-01
% 219.64/219.82  |- skos__hiddenLabel mesh__D000439 Alcohols, Pentyl
% 219.64/219.82  |- skos__altLabel mesh__D000439 Pentyl Alcohols
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D000439 2005
% 219.64/219.82  |- mesh__recordOriginator mesh__D000439 NLM
% 219.64/219.82  |- skos__scopeNote mesh__D000439
% 219.64/219.82       Isomeric forms and derivatives of pentanol %28%C5H11OH%29%.     
% 219.64/219.82  |- mesh__historyNote mesh__D000439 98%28%72%29%   
% 219.64/219.82  |- skos__prefLabel mesh__D000439 Pentanols
% 219.64/219.82  |- mesh__recordMaintainer mesh__D000439 ssb
% 219.64/219.82  |- mesh__recordAuthorizer mesh__D000439 sjn
% 219.64/219.82  |- skos__altLabel mesh__D000439 Hydroxypentanes
% 219.64/219.82  |- rdf__type mesh__D000439sskos__Concept
% 219.64/219.82  |- skos__altLabel mesh__D000439 Alcohols, Amyl
% 219.64/219.82  |- skos__hiddenLabel mesh__D000439 Amyl Alcohols
% 219.64/219.82  |- mesh__dateCreated mesh__D000439 1999-01-01
% 219.64/219.82  |- skos__altLabel mesh__D000439 Methylbutanols
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D000439 2006
% 219.64/219.82  |- mesh__dateRevised mesh__D000439 2003-07-09
% 219.64/219.82  |- mesh__publicMeSHNote mesh__D000439 98; see ALCOHOLS, AMYL 1974-97   
% 219.64/219.82  |- mesh__recordOriginator mesh__D011161 NLM
% 219.64/219.82  |- mesh__recordMaintainer mesh__D011161 ags
% 219.64/219.82  |- skos__altLabel mesh__D011161 Sponge %28%Zoology%29%
% 219.64/219.82  |- mesh__dateRevised mesh__D011161 2004-07-07
% 219.64/219.82  |- skos__broader mesh__D011161smesh__D007448
% 219.64/219.82  |- skos__prefLabel mesh__D011161 Porifera
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D011161 2006
% 219.64/219.82  |- skos__scopeNote mesh__D011161
% 219.64/219.82       The phylum of sponges which are sessile, suspension-feeding, multicellular animals that utilize flagellated cells called choanocytes to circulate water. Most are hermaphroditic. They are probably an early evolutionary side branch that gave rise to no other group of animals. Except for about 150 freshwater species, sponges are marine animals. They are a source of ALKALOIDS; STEROLS; and other complex molecules useful in medicine and biological research.%A%    
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D011161 2005
% 219.64/219.82  |- mesh__recordAuthorizer mesh__D011161 sjn
% 219.64/219.82  |- mesh__dateCreated mesh__D011161 1999-01-01
% 219.64/219.82  |- skos__altLabel mesh__D011161 Sponges
% 219.64/219.82  |- skos__altLabel mesh__D011161 Sponges %28%Zoology%29%
% 219.64/219.82  |- rdf__type mesh__D011161sskos__Concept
% 219.64/219.82  |- mesh__dateCreated mesh__D005922 1984-04-12
% 219.64/219.82  |- skos__altLabel mesh__D005922 Nephropathy, IGA
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D005922 2003
% 219.64/219.82  |- mesh__recordAuthorizer mesh__D005922 sjn
% 219.64/219.82  |- skos__hiddenLabel mesh__D005922 IGA Glomerulonephritides
% 219.64/219.82  |- skos__broader mesh__D005922smesh__D001327
% 219.64/219.82  |- skos__annotation mesh__D005922
% 219.64/219.82       IGA deposits in the mesangium; do not confuse X ref BERGER%27%S DISEASE with BUERGER%27%S DISEASE see THROMBOANGIITIS OBLITERANS%A%  
% 219.64/219.82  |- mesh__publicMeSHNote mesh__D005922 85   
% 219.64/219.82  |- mesh__recordOriginator mesh__D005922 EC
% 219.64/219.82  |- skos__hiddenLabel mesh__D005922 Bergers Disease
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D005922 2004
% 219.64/219.82  |- skos__historyNote mesh__D005922
% 219.64/219.82       Glomerulonephritis/immunology %28%1966-1984%29%
% 219.64/219.82  |- skos__hiddenLabel mesh__D005922 Disease, Berger
% 219.64/219.82  |- mesh__dateEstablished mesh__D005922 1985-01-01
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D005922 2002
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D005922 2005
% 219.64/219.82  |- mesh__historyNote mesh__D005922 85   
% 219.64/219.82  |- skos__historyNote mesh__D005922 IGA/immunology %28%1973-1984%29%
% 219.64/219.82  |- skos__hiddenLabel mesh__D005922 Glomerulonephritides, IGA
% 219.64/219.82  |- skos__altLabel mesh__D005922 Berger Disease
% 219.64/219.82  |- skos__broader mesh__D005922smesh__D005921
% 219.64/219.82  |- mesh__recordMaintainer mesh__D005922 sjn
% 219.64/219.82  |- skos__altLabel mesh__D005922 IGA Nephropathy
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D005922 2006
% 219.64/219.82  |- rdf__type mesh__D005922sskos__Concept
% 219.64/219.82  |- skos__hiddenLabel mesh__D005922 Disease, Berger%27%s
% 219.64/219.82  |- skos__altLabel mesh__D005922 IGA Glomerulonephritis
% 219.64/219.82  |- skos__prefLabel mesh__D005922 Glomerulonephritis, IGA
% 219.64/219.82  |- skos__hiddenLabel mesh__D005922 IGA Nephropathies
% 219.64/219.82  |- skos__altLabel mesh__D005922 Berger%27%s Disease
% 219.64/219.82  |- skos__hiddenLabel mesh__D005922 Nephropathies, IGA
% 219.64/219.82  |- mesh__dateRevised mesh__D005922 2001-08-05
% 219.64/219.82  |- skos__scopeNote mesh__D005922
% 219.64/219.82       Chronic form of glomerulonephritis characterized by recurring hematuria with only slight proteinuria and by deposits of IMMUNOGLOBULIN A in the mesangial areas of the renal glomeruli. It usually occurs in young males.%A%    
% 219.64/219.82  |- skos__hiddenLabel mesh__D005124 Abnormality, Eye
% 219.64/219.82  |- rdf__type mesh__D005124sskos__Concept
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D005124 2000
% 219.64/219.82  |- skos__broader mesh__D005124smesh__D005128
% 219.64/219.82  |- skos__scopeNote mesh__D005124
% 219.64/219.82       Congenital absence of or defects in structures of the eye; may also be hereditary.%A%    
% 219.64/219.82  |- skos__hiddenLabel mesh__D005124 Eye Abnormality
% 219.64/219.82  |- skos__annotation mesh__D005124
% 219.64/219.82       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; these are structural abnorm: EYE DISEASES, HEREDITARY is also available%A%  
% 219.64/219.82  |- mesh__dateEstablished mesh__D005124 1990-01-01
% 219.64/219.82  |- mesh__historyNote mesh__D005124 90; was NON MESH 1977-89   
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D005124 2006
% 219.64/219.82  |- mesh__publicMeSHNote mesh__D005124 90   
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D005124 2002
% 219.64/219.82  |- mesh__recordAuthorizer mesh__D005124 sjn
% 219.64/219.82  |- mesh__dateRevised mesh__D005124 1999-11-03
% 219.64/219.82  |- mesh__dateCreated mesh__D005124 1999-01-01
% 219.64/219.82  |- skos__prefLabel mesh__D005124 Eye Abnormalities
% 219.64/219.82  |- skos__historyNote mesh__D005124 Eye/abnormalities %28%1977-1989%29%
% 219.64/219.82  |- mesh__recordMaintainer mesh__D005124 kle
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D005124 2005
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D005124 2004
% 219.64/219.82  |- mesh__recordOriginator mesh__D005124 NLM
% 219.64/219.82  |- skos__hiddenLabel mesh__D005124 Abnormalities, Eye
% 219.64/219.82  |- skos__historyNote mesh__D005124
% 219.64/219.82       specific eye heading/abnormalities %28%1977-1989%29%
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D005124 2003
% 219.64/219.82  |- skos__broader mesh__D005124smesh__D000013
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D005124 2001
% 219.64/219.82  |- mesh__dateRevised mesh__D010867 1995-05-18
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D010867 2002
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D010867 1997
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D010867 2001
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D010867 2004
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D010867 2000
% 219.64/219.82  |- skos__broader mesh__D010867smesh__D003998
% 219.64/219.82  |- skos__scopeNote mesh__D010867
% 219.64/219.82       A group of compounds that are derivatives of heptanedioic acid with the general formula R-C7H11O4.%A%    
% 219.64/219.82  |- skos__hiddenLabel mesh__D010867 Acid, Pimelic
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D010867 2006
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D010867 1999
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D010867 1996
% 219.64/219.82  |- mesh__publicMeSHNote mesh__D010867 75; was PIMELIC ACID 1963-74   
% 219.64/219.82  |- mesh__onlineNote mesh__D010867
% 219.64/219.82       use PIMELIC ACIDS to search PIMELIC ACID 1966-74   
% 219.64/219.82  |- mesh__recordOriginator mesh__D010867 NLM
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D010867 2003
% 219.64/219.82  |- mesh__dateCreated mesh__D010867 1999-01-01
% 219.64/219.82  |- mesh__recordMaintainer mesh__D010867 KEV
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D010867 1998
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D010867 2005
% 219.64/219.82  |- mesh__recordAuthorizer mesh__D010867 PLS
% 219.64/219.82  |- skos__prefLabel mesh__D010867 Pimelic Acids
% 219.64/219.82  |- skos__hiddenLabel mesh__D010867 Acids, Pimelic
% 219.64/219.82  |- rdf__type mesh__D010867sskos__Concept
% 219.64/219.82  |- mesh__historyNote mesh__D010867 75; was PIMELIC ACID 1963-74   
% 219.64/219.82  |- mesh__recordMaintainer mesh__D043243 nns
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D043243 2006
% 219.64/219.82  |- mesh__dateEstablished mesh__D043243 2004-01-01
% 219.64/219.82  |- skos__prefLabel mesh__D043243 DNA Sequence, Unstable
% 219.64/219.82  |- skos__hiddenLabel mesh__D043243 DNA Sequences, Unstable
% 219.64/219.82  |- mesh__publicMeSHNote mesh__D043243
% 219.64/219.82       2004%28%1998%29%; see TRINUCLEOTIDE REPEAT EXPANSION 1999-2003   
% 219.64/219.82  |- skos__related mesh__D043243smesh__D042822
% 219.64/219.82  |- skos__scopeNote mesh__D043243
% 219.64/219.82       A region of DNA that is highly polymorphic and is prone to strand breaks, rearrangements or other MUTATIONS because of the nature of its sequence. These regions often harbor palindromic, or repetitive sequences %28%REPETITIVE SEQUENCES, NUCLEIC ACID%29%. Variability in stability of the DNA sequence is seen at CHROMOSOME FRAGILE SITES.%A%    
% 219.64/219.82  |- rdf__type mesh__D043243sskos__Concept
% 219.64/219.82  |- skos__hiddenLabel mesh__D043243 Sequences, Unstable DNA
% 219.64/219.82  |- skos__altLabel mesh__D043243 Unstable DNA Sequence
% 219.64/219.82  |- mesh__dateRevised mesh__D043243 2005-06-30
% 219.64/219.82  |- mesh__recordAuthorizer mesh__D043243 sjn
% 219.64/219.82  |- skos__hiddenLabel mesh__D043243 Sequence, Unstable DNA
% 219.64/219.82  |- mesh__historyNote mesh__D043243
% 219.64/219.82       2004 %28%1998%29%; use TRINUCLEOTIDE REPEAT EXPANSION 1998-2003%A%  
% 219.64/219.82  |- skos__altLabel mesh__D043243 Unstable DNA Sequences
% 219.64/219.82  |- mesh__dateCreated mesh__D043243 2003-07-09
% 219.64/219.82  |- mesh__recordOriginator mesh__D043243 nns
% 219.64/219.82  |- skos__broader mesh__D043243smesh__D040481
% 219.64/219.82  |- skos__related mesh__D043243smesh__D002873
% 219.64/219.82  |- skos__broader mesh__D010069smesh__D010080
% 219.64/219.82  |- rdf__type mesh__D010069sskos__Concept
% 219.64/219.82  |- skos__prefLabel mesh__D010069 Oxadiazoles
% 219.64/219.82  |- mesh__recordOriginator mesh__D010069 NLM
% 219.64/219.82  |- mesh__recordMaintainer mesh__D010069 ssb
% 219.64/219.82  |- mesh__recordAuthorizer mesh__D010069 sjn
% 219.64/219.82  |- mesh__dateRevised mesh__D010069 2005-06-30
% 219.64/219.82  |- mesh__dateCreated mesh__D010069 1999-01-01
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D010069 2006
% 219.64/219.82  |- mesh__publicMeSHNote mesh__D015552 90   
% 219.64/219.82  |- skos__hiddenLabel mesh__D015552 Intralesional Injection
% 219.64/219.82  |- mesh__recordOriginator mesh__D015552 AGS
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D015552 2004
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D015552 2000
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D015552 2006
% 219.64/219.82  |- mesh__dateRevised mesh__D015552 1997-06-20
% 219.64/219.82  |- skos__annotation mesh__D015552
% 219.64/219.82       must be %22%directly into localized lesions%22%; NIM; do not use /util except by MeSH definition; DF: INJECT INTRALESIONAL%A%  
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D015552 2003
% 219.64/219.82  |- mesh__recordMaintainer mesh__D015552 TGC
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D015552 2005
% 219.64/219.82  |- skos__prefLabel mesh__D015552 Injections, Intralesional
% 219.64/219.82  |- skos__hiddenLabel mesh__D015552 Injection, Intralesional
% 219.64/219.82  |- skos__altLabel mesh__D015552 Intralesional Injections
% 219.64/219.82  |- mesh__recordAuthorizer mesh__D015552 SJN
% 219.64/219.82  |- mesh__historyNote mesh__D015552 90   
% 219.64/219.82  |- skos__scopeNote mesh__D015552
% 219.64/219.82       Injections introduced directly into localized lesions.     
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D015552 1999
% 219.64/219.82  |- mesh__dateEstablished mesh__D015552 1990-01-01
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D015552 2002
% 219.64/219.82  |- skos__historyNote mesh__D015552 Injections %28%1966-1989%29%
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D015552 1998
% 219.64/219.82  |- rdf__type mesh__D015552sskos__Concept
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D015552 2001
% 219.64/219.82  |- mesh__dateCreated mesh__D015552 1989-04-07
% 219.64/219.82  |- skos__broader mesh__D015552smesh__D007267
% 219.64/219.82  |- skos__broader mesh__D009515smesh__D008873
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D009515 2001
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D009515 2004
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D009515 2005
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D009515 1998
% 219.64/219.82  |- mesh__recordOriginator mesh__D009515 NLM
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D009515 2000
% 219.64/219.82  |- mesh__recordAuthorizer mesh__D009515 SJN
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D009515 2003
% 219.64/219.82  |- skos__prefLabel mesh__D009515 New Jersey
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D009515 2002
% 219.64/219.82  |- mesh__recordMaintainer mesh__D009515 PXP
% 219.64/219.82  |- rdf__type mesh__D009515sskos__Concept
% 219.64/219.82  |- mesh__dateRevised mesh__D009515 1997-06-20
% 219.64/219.82  |- mesh__dateCreated mesh__D009515 1999-01-01
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D009515 2006
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D009515 1999
% 219.64/219.82  |- mesh__dateRevised mesh__D001532 2002-07-02
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D001532 2005
% 219.64/219.82  |- skos__altLabel mesh__D001532 Belladonna
% 219.64/219.82  |- rdf__type mesh__D001532sskos__Concept
% 219.64/219.82  |- mesh__recordOriginator mesh__D001532 NLM
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D001532 2004
% 219.64/219.82  |- mesh__dateCreated mesh__D001532 1999-01-01
% 219.64/219.82  |- mesh__recordMaintainer mesh__D001532 ssb
% 219.64/219.82  |- mesh__publicMeSHNote mesh__D001532
% 219.64/219.82       2003; see BELLADONA 1991-2003, see PLANTS, TOXIC 1986-1990, see BELLADONA 1963-1985%A%  
% 219.64/219.82  |- mesh__dateEstablished mesh__D001532 1991-01-01
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D001532 2003
% 219.64/219.82  |- skos__prefLabel mesh__D001532 Atropa belladonna
% 219.64/219.82  |- skos__annotation mesh__D001532
% 219.64/219.82       BLACK NIGHTSHADE see SOLANUM NIGRUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.64/219.82  |- mesh__recordAuthorizer mesh__D001532 sjn
% 219.64/219.82  |- skos__broader mesh__D001532smesh__D032282
% 219.64/219.82  |- skos__related mesh__D001532smesh__D001533
% 219.64/219.82  |- mesh__historyNote mesh__D001532 2003%28%1963%29%   
% 219.64/219.82  |- skos__scopeNote mesh__D001532
% 219.64/219.82       A plant species of the genus ATROPA, family SOLANACEAE that contains ATROPINE;  SCOPOLAMINE; BELLADONNA ALKALOIDS and other SOLANACEOUS ALKALOIDS.  Some species in this genus are called deadly nightshade which is also a common name for SOLANUM.%A%    
% 219.64/219.82  |- mesh__activeMeSHYear mesh__D001532 2006
% 219.64/219.82  |- skos__scopeNote mesh__D020497
% 219.64/219.82       Works consisting of collections of practice questions and drills, generally for instructional or review use.%A%    
% 219.64/219.82  |- skos__broader mesh__D020497smesh__D019514
% 219.64/219.82  |- skos__related mesh__D020497smesh__D020475
% 219.64/219.82  |- rdf__type mesh__D020497sskos__Concept
% 219.64/219.83  |- skos__prefLabel mesh__D020497
% 219.64/219.83       Problems and Exercises %5B%Publication Type%5D%
% 219.64/219.83  |- mesh__recordAuthorizer mesh__D020497 sjn
% 219.64/219.83  |- mesh__dateEstablished mesh__D020497 1999-01-01
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D020497 2006
% 219.64/219.83  |- mesh__dateCreated mesh__D020497 1998-06-03
% 219.64/219.83  |- mesh__dateRevised mesh__D020497 2005-06-30
% 219.64/219.83  |- mesh__recordOriginator mesh__D020497 JLS
% 219.64/219.83  |- mesh__recordMaintainer mesh__D020497 jls
% 219.64/219.83  |- mesh__historyNote mesh__D020497 1999   
% 219.64/219.83  |- skos__altLabel mesh__D020497 Problems and Exercises %28%PT%29%
% 219.64/219.83  |- skos__altLabel mesh__D020497 Problems Exercises %28%PT%29%
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D019943 2001
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D019943 2006
% 219.64/219.83  |- skos__hiddenLabel mesh__D019943 Substitution, Amino Acid
% 219.64/219.83  |- mesh__dateCreated mesh__D019943 1997-06-20
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D019943 2003
% 219.64/219.83  |- skos__hiddenLabel mesh__D019943 Amino Acid Substitutions
% 219.64/219.83  |- skos__broader mesh__D019943smesh__D001669
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D019943 2000
% 219.64/219.83  |- mesh__recordOriginator mesh__D019943 NDW
% 219.64/219.83  |- skos__historyNote mesh__D019943 Amino Acid Sequence %28%1966-1997%29%
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D019943 2005
% 219.64/219.83  |- skos__broader mesh__D019943smesh__D015202
% 219.64/219.83  |- rdf__type mesh__D019943sskos__Concept
% 219.64/219.83  |- skos__scopeNote mesh__D019943
% 219.64/219.83       The naturally occurring or experimentally induced replacement of one or more amino acids in a protein with another. If a functionally equivalent amino acid is substituted, the protein may retain wild-type activity. Substitution may also diminish or eliminate protein function. Experimentally induced substitution is often used to study enzyme activities and binding site properties.%A%    
% 219.64/219.83  |- skos__related mesh__D019943smesh__D020125
% 219.64/219.83  |- skos__related mesh__D019943smesh__D016297
% 219.64/219.83  |- mesh__recordAuthorizer mesh__D019943 SJN
% 219.64/219.83  |- mesh__publicMeSHNote mesh__D019943 98   
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D019943 1999
% 219.64/219.83  |- skos__hiddenLabel mesh__D019943 Substitutions, Amino Acid
% 219.64/219.83  |- mesh__dateEstablished mesh__D019943 1998-01-01
% 219.64/219.83  |- skos__prefLabel mesh__D019943 Amino Acid Substitution
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D019943 2002
% 219.64/219.83  |- mesh__historyNote mesh__D019943 98   
% 219.64/219.83  |- mesh__recordMaintainer mesh__D019943 NDW
% 219.64/219.83  |- mesh__dateRevised mesh__D019943 1998-06-10
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D019943 2004
% 219.64/219.83  |- skos__hiddenLabel mesh__D011960 Nuclear Receptor, Estrogen
% 219.64/219.83  |- mesh__recordOriginator mesh__D011960 SH
% 219.64/219.83  |- rdf__type mesh__D011960sskos__Concept
% 219.64/219.83  |- skos__altLabel mesh__D011960 Estrogen Receptors Type I
% 219.64/219.83  |- skos__altLabel mesh__D011960 Estrogen Receptor Type I
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D011960 2002
% 219.64/219.83  |- skos__altLabel mesh__D011960 Receptor, Estrogen Nuclear
% 219.64/219.83  |- mesh__dateCreated mesh__D011960 1976-05-03
% 219.64/219.83  |- mesh__recordAuthorizer mesh__D011960 PLS
% 219.64/219.83  |- mesh__recordMaintainer mesh__D011960 KEV
% 219.64/219.83  |- skos__historyNote mesh__D011960
% 219.64/219.83       Receptors, Endogenous Substances %28%1973-1976%29%
% 219.64/219.83  |- skos__historyNote mesh__D011960 Receptors, Drug %28%1968-1976%29%
% 219.64/219.83  |- skos__altLabel mesh__D011960 Estrogen Receptors Type II
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D011960 2006
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D011960 1999
% 219.64/219.83  |- skos__altLabel mesh__D011960 Estrogen Receptors
% 219.64/219.83  |- skos__historyNote mesh__D011960 Estrogens %28%1966-1976%29%
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D011960 2004
% 219.64/219.83  |- mesh__historyNote mesh__D011960 77   
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D011960 1997
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D011960 2005
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D011960 1998
% 219.64/219.83  |- skos__prefLabel mesh__D011960 Receptors, Estrogen
% 219.64/219.83  |- skos__scopeNote mesh__D011960
% 219.64/219.83       Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important.%A%    
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D011960 2001
% 219.64/219.83  |- mesh__publicMeSHNote mesh__D011960 77   
% 219.64/219.83  |- skos__annotation mesh__D011960
% 219.64/219.83       coord IM with specific estrogen %28%IM%29%; DF: RECEPT ESTROGEN%A%  
% 219.64/219.83  |- skos__broader mesh__D011960smesh__D011987
% 219.64/219.83  |- mesh__dateRevised mesh__D011960 1995-06-08
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D011960 2003
% 219.64/219.83  |- mesh__dateEstablished mesh__D011960 1977-01-01
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D011960 1996
% 219.64/219.83  |- skos__altLabel mesh__D011960 Estrogen Receptor Type II
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D011960 2000
% 219.64/219.83  |- skos__hiddenLabel mesh__D019145 Rehabilitation Nursings
% 219.64/219.83  |- mesh__publicMeSHNote mesh__D019145 97   
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D019145 2005
% 219.64/219.83  |- skos__prefLabel mesh__D019145 Rehabilitation Nursing
% 219.64/219.83  |- mesh__dateCreated mesh__D019145 1996-06-13
% 219.64/219.83  |- mesh__recordOriginator mesh__D019145 JLS
% 219.64/219.83  |- mesh__recordMaintainer mesh__D019145 sjn
% 219.64/219.83  |- skos__broader mesh__D019145smesh__D009732
% 219.64/219.83  |- mesh__dateRevised mesh__D019145 2004-07-13
% 219.64/219.83  |- skos__historyNote mesh__D019145 Rehabilitation/nursing %28%1993-1996%29%
% 219.64/219.83  |- skos__hiddenLabel mesh__D019145 Nursings, Rehabilitation
% 219.64/219.83  |- skos__historyNote mesh__D019145 Specialties, Nursing %28%1993-1996%29%
% 219.64/219.83  |- skos__annotation mesh__D019145 SPEC; SPEC qualif; DF: REHABIL NURS   
% 219.64/219.83  |- mesh__dateEstablished mesh__D019145 1997-01-01
% 219.64/219.83  |- mesh__recordAuthorizer mesh__D019145 sjn
% 219.64/219.83  |- skos__scopeNote mesh__D019145
% 219.64/219.83       The diagnosis and treatment of human responses of individuals and groups to actual or potential health problems with the characteristics of altered functional ability and altered life-style. %28%American Nurses Association %26% Association of Rehabilitation Nurses. Standards of Rehabilitation Nursing Practice, 1986, p.2%29%%A%    
% 219.64/219.83  |- skos__altLabel mesh__D019145 Nursing, Rehabilitation
% 219.64/219.83  |- mesh__historyNote mesh__D019145 97   
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D019145 2006
% 219.64/219.83  |- skos__broader mesh__D019145smesh__D013041
% 219.64/219.83  |- rdf__type mesh__D019145sskos__Concept
% 219.64/219.83  |- mesh__recordAuthorizer mesh__D011162 sjn
% 219.64/219.83  |- skos__prefLabel mesh__D011162 Porphobilinogen
% 219.64/219.83  |- mesh__dateCreated mesh__D011162 1999-01-01
% 219.64/219.83  |- mesh__publicMeSHNote mesh__D011162 74   
% 219.64/219.83  |- mesh__historyNote mesh__D011162 74%28%72%29%   
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D011162 2006
% 219.64/219.83  |- mesh__recordOriginator mesh__D011162 NLM
% 219.64/219.83  |- mesh__recordMaintainer mesh__D011162 ssb
% 219.64/219.83  |- skos__annotation mesh__D011162 /biosyn /physiol permitted   
% 219.64/219.83  |- skos__historyNote mesh__D011162 Pyrroles %28%1966-1971%29%
% 219.64/219.83  |- mesh__dateEstablished mesh__D011162 1974-01-01
% 219.64/219.83  |- skos__broader mesh__D011162smesh__D011758
% 219.64/219.83  |- rdf__type mesh__D011162sskos__Concept
% 219.64/219.83  |- mesh__dateRevised mesh__D011162 2005-06-30
% 219.64/219.83  |- skos__historyNote mesh__D011162 Porphyrins %28%1966-1971%29%
% 219.64/219.83  |- skos__hiddenLabel mesh__D005923 Focal Glomeruloscleroses
% 219.64/219.83  |- mesh__dateCreated mesh__D005923 1976-05-19
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005923 1997
% 219.64/219.83  |- skos__hiddenLabel mesh__D005923 Glomerulonephritides, Focal Sclerosing
% 219.64/219.83  |- skos__hiddenLabel mesh__D005923 Hyalinoses, Segmental
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005923 2004
% 219.64/219.83  |- mesh__recordMaintainer mesh__D005923 TAP
% 219.64/219.83  |- mesh__dateRevised mesh__D005923 1993-06-02
% 219.64/219.83  |- mesh__recordAuthorizer mesh__D005923 PLS
% 219.64/219.83  |- mesh__publicMeSHNote mesh__D005923
% 219.64/219.83       91; was see under GLOMERULONEPHRITIS 1977-90   
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005923 2000
% 219.64/219.83  |- skos__altLabel mesh__D005923 Glomerulonephritis, Focal Sclerosing
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005923 1998
% 219.64/219.83  |- skos__hiddenLabel mesh__D005923 Focal Glomerulosclerosis
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005923 2005
% 219.64/219.83  |- skos__historyNote mesh__D005923 Kidney Glomerulus %28%1966-1976%29%
% 219.64/219.83  |- skos__broader mesh__D005923smesh__D005921
% 219.64/219.83  |- mesh__historyNote mesh__D005923
% 219.64/219.83       91%28%77%29%; was see under GLOMERULONEPHRITIS 1977-90   
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005923 2001
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005923 1999
% 219.64/219.83  |- skos__annotation mesh__D005923 a form of glomerulonephritis   
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005923 2006
% 219.64/219.83  |- rdf__type mesh__D005923sskos__Concept
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005923 1994
% 219.64/219.83  |- skos__hiddenLabel mesh__D005923 Sclerosing Glomerulonephritides, Focal
% 219.64/219.83  |- skos__hiddenLabel mesh__D005923 Segmental Hyalinoses
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005923 2002
% 219.64/219.83  |- skos__hiddenLabel mesh__D005923 Focal Sclerosing Glomerulonephritis
% 219.64/219.83  |- skos__scopeNote mesh__D005923
% 219.64/219.83       Glomerular disease characterized by focal and segmental areas of glomerular sclerosis, usually commencing in the juxtamedullary glomeruli and gradually spreading to involve other parts of the kidney, with eventual kidney failure.%A%    
% 219.64/219.83  |- skos__hiddenLabel mesh__D005923 Focal Sclerosing Glomerulonephritides
% 219.64/219.83  |- mesh__dateEstablished mesh__D005923 1991-01-01
% 219.64/219.83  |- skos__prefLabel mesh__D005923 Glomerulosclerosis, Focal
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005923 1995
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005923 1996
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005923 2003
% 219.64/219.83  |- skos__hiddenLabel mesh__D005923 Segmental Hyalinosis
% 219.64/219.83  |- mesh__recordOriginator mesh__D005923 SMH
% 219.64/219.83  |- skos__hiddenLabel mesh__D005923 Glomeruloscleroses, Focal
% 219.64/219.83  |- skos__hiddenLabel mesh__D005923 Sclerosing Glomerulonephritis, Focal
% 219.64/219.83  |- skos__prefLabel mesh__D005125 Eye Banks
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005125 1994
% 219.64/219.83  |- skos__scopeNote mesh__D005125
% 219.64/219.83       Centers for storing various parts of the eye for future use.%A%    
% 219.64/219.83  |- mesh__recordOriginator mesh__D005125 NLM
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005125 2006
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005125 1999
% 219.64/219.83  |- mesh__historyNote mesh__D005125
% 219.64/219.83       91%28%75%29%; was see under TISSUE BANKS 1975-90   
% 219.64/219.83  |- skos__hiddenLabel mesh__D005125 Banks, Eye
% 219.64/219.83  |- mesh__dateCreated mesh__D005125 1999-01-01
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005125 2005
% 219.64/219.83  |- mesh__recordMaintainer mesh__D005125 JLS
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005125 2004
% 219.64/219.83  |- mesh__dateEstablished mesh__D005125 1991-01-01
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005125 2001
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005125 1998
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005125 1997
% 219.64/219.83  |- mesh__onlineNote mesh__D005125 search TISSUE BANKS 1966-74   
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005125 2003
% 219.64/219.83  |- mesh__dateRevised mesh__D005125 1993-06-04
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005125 1996
% 219.64/219.83  |- mesh__recordAuthorizer mesh__D005125 PLS
% 219.64/219.83  |- skos__hiddenLabel mesh__D005125 Eye Bank
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005125 2000
% 219.64/219.83  |- rdf__type mesh__D005125sskos__Concept
% 219.64/219.83  |- skos__hiddenLabel mesh__D005125 Bank, Eye
% 219.64/219.83  |- mesh__publicMeSHNote mesh__D005125
% 219.64/219.83       91; was see under TISSUE BANKS 1975-90   
% 219.64/219.83  |- skos__broader mesh__D005125smesh__D014015
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005125 1995
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005125 2002
% 219.64/219.83  |- skos__historyNote mesh__D010868 Benzimidazoles %28%1966-1972%29%
% 219.64/219.83  |- mesh__recordMaintainer mesh__D010868 lkw
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D010868 2006
% 219.64/219.83  |- mesh__recordAuthorizer mesh__D010868 sjn
% 219.64/219.83  |- mesh__dateEstablished mesh__D010868 1973-01-01
% 219.64/219.83  |- skos__broader mesh__D010868smesh__D001562
% 219.64/219.83  |- mesh__dateCreated mesh__D010868 1999-01-01
% 219.64/219.83  |- mesh__publicMeSHNote mesh__D010868 73   
% 219.64/219.83  |- skos__altLabel mesh__D010868 Janssen Brand of Pimozide
% 219.64/219.83  |- skos__altLabel mesh__D010868 Orap forte
% 219.64/219.83  |- rdf__type mesh__D010868sskos__Concept
% 219.64/219.83  |- skos__altLabel mesh__D010868 Pharmascience Brand of Pimozide
% 219.64/219.83  |- mesh__dateRevised mesh__D010868 2005-06-30
% 219.64/219.83  |- skos__historyNote mesh__D010868 Tranquilizing Agents %28%1966-1972%29%
% 219.64/219.83  |- mesh__historyNote mesh__D010868 73   
% 219.64/219.83  |- mesh__recordOriginator mesh__D010868 NLM
% 219.64/219.83  |- skos__scopeNote mesh__D010868
% 219.64/219.83       A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to HALOPERIDOL for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. %28%From AMA Drug Evaluations Annual, 1994, p403%29%%A%    
% 219.64/219.83  |- skos__prefLabel mesh__D010868 Pimozide
% 219.64/219.83  |- skos__altLabel mesh__D010868 ASTA Medica Brand of Pimozide
% 219.64/219.83  |- skos__hiddenLabel mesh__D010868 R6238
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D043244 2006
% 219.64/219.83  |- skos__hiddenLabel mesh__D043244 Enzyme, Dicer
% 219.64/219.83  |- skos__historyNote mesh__D043244 Endoribonucleases %28%1980-2003%29%
% 219.64/219.83  |- mesh__publicMeSHNote mesh__D043244
% 219.64/219.83       2004; RIBONUCLEASE III was indexed under ENDORIBONUCLEASES 1983-2003, under ENDONUCLEASE %26% RIBONUCLEASE 1979-1982%A%  
% 219.64/219.83  |- skos__historyNote mesh__D043244 Endonucleases %28%1979-1982%29%
% 219.64/219.83  |- rdf__type mesh__D043244sskos__Concept
% 219.64/219.83  |- mesh__recordMaintainer mesh__D043244 AKE
% 219.64/219.83  |- skos__historyNote mesh__D043244 Ribonuclease %28%1979-1982%29%
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D043244 2004
% 219.64/219.83  |- mesh__historyNote mesh__D043244
% 219.64/219.83       2004; use RIBONUCLEASE III %28%NM%29% 1980-2003   
% 219.64/219.83  |- mesh__dateEstablished mesh__D043244 2004-01-01
% 219.64/219.83  |- skos__broader mesh__D043244smesh__D004722
% 219.64/219.83  |- skos__altLabel mesh__D043244 Ribonuclease D
% 219.64/219.83  |- skos__scopeNote mesh__D043244
% 219.64/219.83       An endoribonuclease that is specific for double-stranded RNA. It plays a role in POST-TRANSCRIPTIONAL RNA PROCESSING of pre-RIBOSOMAL RNA and a variety of other RNA structures that contain double-stranded regions.%A%    
% 219.64/219.83  |- skos__altLabel mesh__D043244 RNase III
% 219.64/219.83  |- mesh__dateCreated mesh__D043244 2003-07-09
% 219.64/219.83  |- skos__prefLabel mesh__D043244 Ribonuclease III
% 219.64/219.83  |- mesh__recordOriginator mesh__D043244 AKE
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D043244 2005
% 219.64/219.83  |- skos__altLabel mesh__D043244 RNase D
% 219.64/219.83  |- mesh__recordAuthorizer mesh__D043244 sjn
% 219.64/219.83  |- skos__broader mesh__D005823Q000379smesh__D005823
% 219.64/219.83  |- mesh__preferredCombination mesh__D005823Q000379smesh__D005821
% 219.64/219.83  |- rdf__type mesh__D005823Q000379smesh__CompoundConcept
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D009516 1998
% 219.64/219.83  |- mesh__dateRevised mesh__D009516 1997-06-20
% 219.64/219.83  |- skos__prefLabel mesh__D009516 New Mexico
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D009516 2003
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D009516 2001
% 219.64/219.83  |- mesh__recordOriginator mesh__D009516 NLM
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D009516 2000
% 219.64/219.83  |- mesh__recordAuthorizer mesh__D009516 SJN
% 219.64/219.83  |- rdf__type mesh__D009516sskos__Concept
% 219.64/219.83  |- skos__broader mesh__D009516smesh__D015206
% 219.64/219.83  |- mesh__dateCreated mesh__D009516 1999-01-01
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D009516 2006
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D009516 1999
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D009516 2002
% 219.64/219.83  |- mesh__recordMaintainer mesh__D009516 PXP
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D009516 2004
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D009516 2005
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D001533 2006
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D001533 1999
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D001533 1994
% 219.64/219.83  |- mesh__historyNote mesh__D001533
% 219.64/219.83       76%28%75%29%; was see under BELLADONNA 1975-76, was see under TROPANES 1969-74%A%  
% 219.64/219.83  |- mesh__recordOriginator mesh__D001533 NLM
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D001533 2002
% 219.64/219.83  |- rdf__type mesh__D001533sskos__Concept
% 219.64/219.83  |- mesh__dateCreated mesh__D001533 1999-01-01
% 219.64/219.83  |- mesh__recordMaintainer mesh__D001533 TAP
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D001533 2005
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D001533 1998
% 219.64/219.83  |- mesh__dateEstablished mesh__D001533 1976-01-01
% 219.64/219.83  |- mesh__publicMeSHNote mesh__D001533
% 219.64/219.83       76; was see under BELLADONNA 1975-76, was see under TROPANES 1969-74%A%  
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D001533 1993
% 219.64/219.83  |- skos__prefLabel mesh__D001533 Belladonna Alkaloids
% 219.64/219.83  |- skos__scopeNote mesh__D001533
% 219.64/219.83       Alkaloids obtained from various plants, especially the deadly nightshade %28%Atropa belladonna%29%, variety acuminata; atropine, hyoscyamine and scopolamine are classical, specific antimuscarinic agents with many pharmacologic actions; used mainly as antispasmodics.%A%    
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D001533 2001
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D001533 2004
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D001533 1997
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D001533 2000
% 219.64/219.83  |- skos__hiddenLabel mesh__D001533 Alkaloids, Belladonna
% 219.64/219.83  |- skos__broader mesh__D001533smesh__D014326
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D001533 2003
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D001533 1996
% 219.64/219.83  |- skos__historyNote mesh__D001533 Belladonna %28%1968-1974%29%
% 219.64/219.83  |- mesh__recordAuthorizer mesh__D001533 PLS
% 219.64/219.83  |- mesh__onlineNote mesh__D001533 search TROPANES 1969-74   
% 219.64/219.83  |- mesh__dateRevised mesh__D001533 1992-05-08
% 219.64/219.83  |- skos__historyNote mesh__D001533 Tropanes %28%1968-1974%29%
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D001533 1995
% 219.64/219.83  |- skos__broader mesh__D001533smesh__D012991
% 219.64/219.83  |- rdf__type mesh__D020498sskos__Concept
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D020498 2006
% 219.64/219.83  |- skos__altLabel mesh__D020498 Programmed Instruction %28%PT%29%
% 219.64/219.83  |- skos__prefLabel mesh__D020498
% 219.64/219.83       Programmed Instruction %5B%Publication Type%5D%
% 219.64/219.83  |- mesh__dateCreated mesh__D020498 1998-06-03
% 219.64/219.83  |- mesh__recordOriginator mesh__D020498 JLS
% 219.64/219.83  |- mesh__recordAuthorizer mesh__D020498 sjn
% 219.64/219.83  |- mesh__dateEstablished mesh__D020498 1999-01-01
% 219.64/219.83  |- skos__scopeNote mesh__D020498
% 219.64/219.83       Works consisting of sequenced self-correction texts.     
% 219.64/219.83  |- mesh__historyNote mesh__D020498 1999   
% 219.64/219.83  |- skos__broader mesh__D020498smesh__D019514
% 219.64/219.83  |- mesh__dateRevised mesh__D020498 2005-06-30
% 219.64/219.83  |- mesh__recordMaintainer mesh__D020498 jls
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D025981 2005
% 219.64/219.83  |- skos__historyNote mesh__D025981 Hip/injuries %28%1966-2001%29%
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D025981 2006
% 219.64/219.83  |- skos__historyNote mesh__D025981 Femoral Neck Fractures %28%1966-2001%29%
% 219.64/219.83  |- rdf__type mesh__D025981sskos__Concept
% 219.64/219.83  |- mesh__dateCreated mesh__D025981 2001-07-25
% 219.64/219.83  |- skos__scopeNote mesh__D025981
% 219.64/219.83       General or unspecified injuries involving the hip.     
% 219.64/219.83  |- skos__historyNote mesh__D025981 Hip Fractures %28%1978-2001%29%
% 219.64/219.83  |- mesh__historyNote mesh__D025981 2002   
% 219.64/219.83  |- skos__altLabel mesh__D025981 Injuries, Hip
% 219.64/219.83  |- skos__broader mesh__D025981smesh__D014947
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D025981 2003
% 219.64/219.83  |- mesh__publicMeSHNote mesh__D025981 2002   
% 219.64/219.83  |- skos__prefLabel mesh__D025981 Hip Injuries
% 219.64/219.83  |- mesh__dateEstablished mesh__D025981 2002-01-01
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D025981 2004
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D025981 2002
% 219.64/219.83  |- rdf__type mesh__D011961sskos__Concept
% 219.64/219.83  |- mesh__dateRevised mesh__D011961 2003-07-09
% 219.64/219.83  |- skos__hiddenLabel mesh__D011961 Receptor, Fc
% 219.64/219.83  |- skos__historyNote mesh__D011961 B Lymphocytes %28%1973-1979%29%
% 219.64/219.83  |- skos__historyNote mesh__D011961 Lymphocytes %28%1966-1979%29%
% 219.64/219.83  |- skos__annotation mesh__D011961 DF: RECEPT FC   
% 219.64/219.83  |- skos__broader mesh__D011961smesh__D011971
% 219.64/219.83  |- skos__altLabel mesh__D011961 Fc Receptor
% 219.64/219.83  |- skos__prefLabel mesh__D011961 Receptors, Fc
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D011961 2006
% 219.64/219.83  |- mesh__recordMaintainer mesh__D011961 jmp
% 219.64/219.83  |- mesh__historyNote mesh__D011961 80   
% 219.64/219.83  |- skos__historyNote mesh__D011961
% 219.64/219.83       Binding Sites, Antibody %28%1973-1979%29%
% 219.64/219.83  |- mesh__recordAuthorizer mesh__D011961 sjn
% 219.64/219.83  |- mesh__publicMeSHNote mesh__D011961 80   
% 219.64/219.83  |- mesh__dateEstablished mesh__D011961 1980-01-01
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D011961 2004
% 219.64/219.83  |- skos__historyNote mesh__D011961 Immunoglobulins, Fc %28%1973-1979%29%
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D011961 2005
% 219.64/219.83  |- mesh__recordOriginator mesh__D011961 AEP
% 219.64/219.83  |- skos__altLabel mesh__D011961 Fc Receptors
% 219.64/219.83  |- mesh__dateCreated mesh__D011961 1979-05-24
% 219.64/219.83  |- skos__scopeNote mesh__D011961
% 219.64/219.83       Molecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognize and combine with the Fc %28%crystallizable%29% portion of immunoglobulin molecules.%A%    
% 219.64/219.83  |- mesh__dateRevised mesh__D019146 2004-07-07
% 219.64/219.83  |- skos__historyNote mesh__D019146
% 219.64/219.83       Computer-Assisted Instruction %28%1993-1996%29%
% 219.64/219.83  |- mesh__recordOriginator mesh__D019146 JLS
% 219.64/219.83  |- mesh__dateCreated mesh__D019146 1996-06-13
% 219.64/219.83  |- mesh__recordAuthorizer mesh__D019146 sjn
% 219.64/219.83  |- skos__broader mesh__D019146smesh__D012984
% 219.64/219.83  |- skos__altLabel mesh__D019146 Hypermedium
% 219.64/219.83  |- skos__prefLabel mesh__D019146 Hypermedia
% 219.64/219.83  |- mesh__dateEstablished mesh__D019146 1997-01-01
% 219.64/219.83  |- mesh__publicMeSHNote mesh__D019146 97   
% 219.64/219.83  |- mesh__recordMaintainer mesh__D019146 jls
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D019146 2005
% 219.64/219.83  |- skos__annotation mesh__D019146 a type of computer software   
% 219.64/219.83  |- mesh__historyNote mesh__D019146 97   
% 219.64/219.83  |- skos__scopeNote mesh__D019146
% 219.64/219.83       Computerized compilations of information units %28%text, sound, graphics, and/or video%29% interconnected by logical nonlinear linkages that enable users to follow optimal paths through the material and also the systems used to create and display this information. %28%From Thesaurus of ERIC Descriptors, 1994%29%%A%    
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D019146 2006
% 219.64/219.83  |- rdf__type mesh__D019146sskos__Concept
% 219.64/219.83  |- skos__prefLabel mesh__D011163 Hydroxymethylbilane Synthase
% 219.64/219.83  |- skos__altLabel mesh__D011163 Porphobilinogen Deaminase
% 219.64/219.83  |- mesh__recordMaintainer mesh__D011163 jmp
% 219.64/219.83  |- skos__altLabel mesh__D011163 Porphobilinogen Ammonia-Lyase
% 219.64/219.83  |- mesh__dateRevised mesh__D011163 2005-06-30
% 219.64/219.83  |- skos__broader mesh__D011163smesh__D019883
% 219.64/219.83  |- skos__hiddenLabel mesh__D011163 Synthase, Hydroxymethylbilane
% 219.64/219.83  |- mesh__recordAuthorizer mesh__D011163 sjn
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D011163 2006
% 219.64/219.83  |- skos__hiddenLabel mesh__D011163 Porphobilinogen Ammonia Lyase
% 219.64/219.83  |- skos__scopeNote mesh__D011163
% 219.64/219.83       An enzyme that catalyzes the tetrapolymerization of the monopyrrole PORPHOBILINOGEN into the hydroxymethylbilane preuroporphyrinogen %28%UROPORPHYRINOGENS%29% in several discrete steps. It is the third enzyme in the 8-enzyme biosynthetic pathway of HEME. In humans, deficiency in this enzyme encoded by HMBS %28%or PBGD%29% gene results in a form of neurological porphyria %28%PORPHYRIA, ACUTE INTERMITTENT%29%. This enzyme was formerly listed as EC 4.3.1.8%A%    
% 219.64/219.83  |- skos__hiddenLabel mesh__D011163 Synthetase, Pre-uroporphyrinogen
% 219.64/219.83  |- skos__altLabel mesh__D011163 Uroporphyrinogen I Synthase
% 219.64/219.83  |- skos__altLabel mesh__D011163 Preuroporphyrinogen Synthetase
% 219.64/219.83  |- skos__related mesh__D011163smesh__D011164
% 219.64/219.83  |- skos__hiddenLabel mesh__D011163 Synthetase, Preuroporphyrinogen
% 219.64/219.83  |- skos__hiddenLabel mesh__D011163 Synthase, Uroporphyrinogen I
% 219.64/219.83  |- skos__hiddenLabel mesh__D011163 Synthetase, Hydroxymethylbilane
% 219.64/219.83  |- rdf__type mesh__D011163sskos__Concept
% 219.64/219.83  |- mesh__recordOriginator mesh__D011163 NLM
% 219.64/219.83  |- skos__hiddenLabel mesh__D011163 Deaminase, Porphobilinogen
% 219.64/219.83  |- skos__hiddenLabel mesh__D011163 Ammonia-Lyase, Porphobilinogen
% 219.64/219.83  |- mesh__dateEstablished mesh__D011163 1991-01-01
% 219.64/219.83  |- skos__altLabel mesh__D011163 Hydroxymethylbilane Synthetase
% 219.64/219.83  |- skos__historyNote mesh__D011163 Ammonia-Lyases %28%1973-1974%29%
% 219.64/219.83  |- skos__altLabel mesh__D011163 Pre-uroporphyrinogen Synthetase
% 219.64/219.83  |- mesh__historyNote mesh__D011163 98%28%75%29%   
% 219.64/219.83  |- mesh__dateCreated mesh__D011163 1974-11-19
% 219.64/219.83  |- mesh__publicMeSHNote mesh__D011163
% 219.64/219.83       98; see PORPHOBILINOGEN DEAMINASE 1991-97, see AMMONIA-LYASES 1975-90%A%  
% 219.64/219.83  |- skos__hiddenLabel mesh__D011163 Pre uroporphyrinogen Synthetase
% 219.64/219.83  |- skos__historyNote mesh__D011163 Porphobilinogen %28%1973-1974%29%
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005924 1997
% 219.64/219.83  |- skos__hiddenLabel mesh__D005924 Jugulare, Glomus
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005924 2004
% 219.64/219.83  |- skos__annotation mesh__D005924 a nonchromaffin paraganglion   
% 219.64/219.83  |- mesh__dateEstablished mesh__D005924 1991-01-01
% 219.64/219.83  |- mesh__recordAuthorizer mesh__D005924 PLS
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005924 1996
% 219.64/219.83  |- skos__prefLabel mesh__D005924 Glomus Jugulare
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005924 2003
% 219.64/219.83  |- mesh__dateCreated mesh__D005924 1999-01-01
% 219.64/219.83  |- skos__scopeNote mesh__D005924
% 219.64/219.83       A nonchromaffin paraganglion located in the wall of the jugular bulb. The most common tumors of the middle ear arise from this tissue. %28%Lockard, Desk Reference for Neuroscience, 1992, p114%29%%A%    
% 219.64/219.83  |- mesh__publicMeSHNote mesh__D005924
% 219.64/219.83       91; was see under PARAGANGLIA, NONCHROMAFFIN 1975-90   
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005924 2002
% 219.64/219.83  |- mesh__recordMaintainer mesh__D005924 TAP
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005924 2001
% 219.64/219.83  |- rdf__type mesh__D005924sskos__Concept
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005924 1999
% 219.64/219.83  |- mesh__dateRevised mesh__D005924 1995-06-08
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005924 2006
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005924 2000
% 219.64/219.83  |- mesh__onlineNote mesh__D005924
% 219.64/219.83       search PARAGANGLIA, NONCHROMAFFIN 1966-74   
% 219.64/219.83  |- mesh__historyNote mesh__D005924
% 219.64/219.83       91%28%75%29%; was see under PARAGANGLIA, NONCHROMAFFIN 1975-90   
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005924 1998
% 219.64/219.83  |- skos__broader mesh__D005924smesh__D010234
% 219.64/219.83  |- mesh__recordOriginator mesh__D005924 NLM
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005924 2005
% 219.64/219.83  |- mesh__dateCreated mesh__D005126 1999-01-01
% 219.64/219.83  |- skos__hiddenLabel mesh__D005126 Burns, Eye
% 219.64/219.83  |- mesh__dateRevised mesh__D005126 1999-11-03
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005126 2004
% 219.64/219.83  |- skos__prefLabel mesh__D005126 Eye Burns
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005126 2005
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005126 2002
% 219.64/219.83  |- mesh__recordMaintainer mesh__D005126 PXP
% 219.64/219.83  |- mesh__recordAuthorizer mesh__D005126 sjn
% 219.64/219.83  |- skos__scopeNote mesh__D005126
% 219.64/219.83       Injury to any part of the eye by extreme heat, chemical agents, or ultraviolet radiation.%A%    
% 219.64/219.83  |- mesh__activeMeSHYear mesh__D005126 2003
% 219.64/219.84  |- skos__hiddenLabel mesh__D005126 Burn, Eye
% 219.64/219.84  |- skos__hiddenLabel mesh__D005126 Eye Burn
% 219.64/219.84  |- mesh__recordOriginator mesh__D005126 NLM
% 219.64/219.84  |- skos__broader mesh__D005126smesh__D002056
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D005126 2001
% 219.64/219.84  |- rdf__type mesh__D005126sskos__Concept
% 219.64/219.84  |- skos__broader mesh__D005126smesh__D005131
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D005126 2000
% 219.64/219.84  |- skos__annotation mesh__D005126
% 219.64/219.84       chem burns of eye = EYE BURNS /chem ind %28%IM%29% + BURNS, CHEMICAL %28%IM%29%%A%  
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D005126 2006
% 219.64/219.84  |- mesh__dateCreated mesh__D010869 1999-01-01
% 219.64/219.84  |- mesh__recordOriginator mesh__D010869 NLM
% 219.64/219.84  |- mesh__recordMaintainer mesh__D010869 ssb
% 219.64/219.84  |- skos__prefLabel mesh__D010869 Pindolol
% 219.64/219.84  |- rdf__type mesh__D010869sskos__Concept
% 219.64/219.84  |- mesh__recordAuthorizer mesh__D010869 sjn
% 219.64/219.84  |- mesh__publicMeSHNote mesh__D010869 73   
% 219.64/219.84  |- mesh__dateEstablished mesh__D010869 1973-01-01
% 219.64/219.84  |- skos__scopeNote mesh__D010869
% 219.64/219.84       A moderately lipophilic beta blocker %28%ADRENERGIC BETA-ANTAGONISTS%29%. It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. %28%From Martindale, The Extra Pharmocopoeia, 30th ed, p638%29%%A%    
% 219.64/219.84  |- mesh__historyNote mesh__D010869 73   
% 219.64/219.84  |- skos__historyNote mesh__D010869 Sympatholytics %28%1966-1972%29%
% 219.64/219.84  |- skos__altLabel mesh__D010869 Prindolol
% 219.64/219.84  |- skos__broader mesh__D010869smesh__D011412
% 219.64/219.84  |- skos__hiddenLabel mesh__D010869 LB 46
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D010869 2006
% 219.64/219.84  |- mesh__dateRevised mesh__D010869 2005-06-30
% 219.64/219.84  |- skos__hiddenLabel mesh__D010869 LB46
% 219.64/219.84  |- skos__broader mesh__D010869smesh__D050198
% 219.64/219.84  |- mesh__recordOriginator mesh__D009517 EC
% 219.64/219.84  |- mesh__historyNote mesh__D009517 88   
% 219.64/219.84  |- mesh__recordAuthorizer mesh__D009517 PLS
% 219.64/219.84  |- rdf__type mesh__D009517sskos__Concept
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D009517 2002
% 219.64/219.84  |- mesh__dateEstablished mesh__D009517 1988-01-01
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D009517 2006
% 219.64/219.84  |- skos__annotation mesh__D009517 a state of Australia   
% 219.64/219.84  |- mesh__recordMaintainer mesh__D009517 TGC
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D009517 1999
% 219.64/219.84  |- skos__prefLabel mesh__D009517 New South Wales
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D009517 2004
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D009517 1997
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D009517 2005
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D009517 1998
% 219.64/219.84  |- mesh__dateCreated mesh__D009517 1987-03-14
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D009517 2001
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D009517 2003
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D009517 1996
% 219.64/219.84  |- skos__broader mesh__D009517smesh__D001315
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D009517 2000
% 219.64/219.84  |- skos__scopeNote mesh__D009517
% 219.64/219.84       A state in southeastern Australia. Its capital is Sydney. It was discovered by Captain Cook in 1770 and first settled at Botany Bay by marines and convicts in 1788. It was named by Captain Cook who thought its coastline resembled that of South Wales. %28%From Webster%27%s New Geographical Dictionary, 1988, p840 %26% Room, Brewer%27%s Dictionary of Names, 1992, p377%29%%A%    
% 219.64/219.84  |- mesh__dateRevised mesh__D009517 1995-02-21
% 219.64/219.84  |- skos__historyNote mesh__D009517 Australia %28%1966-1987%29%
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D001534 2004
% 219.64/219.84  |- skos__scopeNote mesh__D001534
% 219.64/219.84       A CNS stimulant that is used to induce convulsions in experimental animals. It has also been used as a respiratory stimulant and in the treatment of barbiturate overdose.%A%    
% 219.64/219.84  |- skos__altLabel mesh__D001534 Methetharimide
% 219.64/219.84  |- skos__altLabel mesh__D001534 Ethylmethylglutarimide
% 219.64/219.84  |- mesh__dateRevised mesh__D001534 2001-07-25
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D001534 2003
% 219.64/219.84  |- mesh__publicMeSHNote mesh__D001534
% 219.64/219.84       ETHYLMETHYLGLUTARIMIDE was see under ANALEPTICS 1963   
% 219.64/219.84  |- skos__prefLabel mesh__D001534 Bemegride
% 219.64/219.84  |- mesh__recordOriginator mesh__D001534 NLM
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D001534 2002
% 219.64/219.84  |- mesh__recordMaintainer mesh__D001534 ssb
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D001534 2006
% 219.64/219.84  |- rdf__type mesh__D001534sskos__Concept
% 219.64/219.84  |- mesh__dateCreated mesh__D001534 1999-01-01
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D001534 2005
% 219.64/219.84  |- mesh__recordAuthorizer mesh__D001534 sjn
% 219.64/219.84  |- mesh__historyNote mesh__D001534
% 219.64/219.84       ETHYLMETHYLGLUTARIMIDE was see under ANALEPTICS 1963   
% 219.64/219.84  |- skos__broader mesh__D001534smesh__D011728
% 219.64/219.84  |- skos__broader mesh__D007568Q000002smesh__D007568
% 219.64/219.84  |- mesh__preferredCombination mesh__D007568Q000002smesh__D007569
% 219.64/219.84  |- rdf__type mesh__D007568Q000002smesh__CompoundConcept
% 219.64/219.84  |- skos__altLabel mesh__D011962 Follicle-Stimulating Hormone Receptors
% 219.64/219.84  |- skos__scopeNote mesh__D011962
% 219.64/219.84       Cell surface proteins that bind FOLLICLE STIMULATING HORMONE with high affinity and trigger intracellular changes influencing the behavior of cells.%A%    
% 219.64/219.84  |- skos__hiddenLabel mesh__D011962 Follicle Stimulating Hormone Receptor
% 219.64/219.84  |- mesh__onlineNote mesh__D011962
% 219.64/219.84       use RECEPTORS, FSH to search FOLLITROPIN RECEPTORS 1987-92%A%  
% 219.64/219.84  |- skos__altLabel mesh__D011962 Receptors, Follicle-Stimulating Hormone
% 219.64/219.84  |- skos__altLabel mesh__D011962 FSH Receptors
% 219.64/219.84  |- skos__annotation mesh__D011962 DF: RECEPT FSH   
% 219.64/219.84  |- skos__altLabel mesh__D011962 Follicle-Stimulating Hormone Receptor
% 219.64/219.84  |- mesh__historyNote mesh__D011962
% 219.64/219.84       87; FOLLITROPIN RECEPTORS was see RECEPTORS, FSH 1987-92   
% 219.64/219.84  |- skos__hiddenLabel mesh__D011962 Hormone Receptor, Follicle-Stimulating
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D011962 2006
% 219.64/219.84  |- mesh__recordMaintainer mesh__D011962 jmp
% 219.64/219.84  |- skos__broader mesh__D011962smesh__D011967
% 219.64/219.84  |- mesh__publicMeSHNote mesh__D011962
% 219.64/219.84       87; FOLLITROPIN RECEPTORS was see RECEPTORS, FSH 1987-92   
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D011962 2004
% 219.64/219.84  |- skos__hiddenLabel mesh__D011962 Receptor, FSH
% 219.64/219.84  |- skos__altLabel mesh__D011962 FSH Receptor
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D011962 2005
% 219.64/219.84  |- skos__prefLabel mesh__D011962 Receptors, FSH
% 219.64/219.84  |- mesh__dateEstablished mesh__D011962 1987-01-01
% 219.64/219.84  |- skos__hiddenLabel mesh__D011962 Follicle Stimulating Hormone Receptors
% 219.64/219.84  |- skos__historyNote mesh__D011962 FSH %28%1966-1986%29%
% 219.64/219.84  |- skos__hiddenLabel mesh__D011962 Receptor, Follicle-Stimulating Hormone
% 219.64/219.84  |- mesh__recordOriginator mesh__D011962 SH
% 219.64/219.84  |- skos__broader mesh__D011962smesh__D018013
% 219.64/219.84  |- rdf__type mesh__D011962sskos__Concept
% 219.64/219.84  |- mesh__dateRevised mesh__D011962 2003-07-09
% 219.64/219.84  |- skos__hiddenLabel mesh__D011962 Receptors, Follicle Stimulating Hormone
% 219.64/219.84  |- skos__hiddenLabel mesh__D011962 Hormone Receptors, Follicle-Stimulating
% 219.64/219.84  |- skos__broader mesh__D011962smesh__D043562
% 219.64/219.84  |- mesh__recordAuthorizer mesh__D011962 sjn
% 219.64/219.84  |- skos__historyNote mesh__D011962
% 219.64/219.84       Receptors, Endogenous Substances %28%1973-1986%29%
% 219.64/219.84  |- mesh__dateCreated mesh__D011962 1986-03-31
% 219.64/219.84  |- skos__hiddenLabel mesh__D019147 Organ, Vomeronasal
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D019147 2003
% 219.64/219.84  |- skos__hiddenLabel mesh__D019147 Organum Vomeronasales
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D019147 1999
% 219.64/219.84  |- skos__hiddenLabel mesh__D019147 System, Vomeronasal
% 219.64/219.84  |- mesh__dateCreated mesh__D019147 1996-06-10
% 219.64/219.84  |- skos__hiddenLabel mesh__D019147 Organ, Jacobson%27%s
% 219.64/219.84  |- skos__altLabel mesh__D019147 Organum Vomeronasale
% 219.64/219.84  |- skos__hiddenLabel mesh__D019147 Vomeronasal Organs
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D019147 2004
% 219.64/219.84  |- skos__annotation mesh__D019147 in the nasal cavity within the septum   
% 219.64/219.84  |- skos__hiddenLabel mesh__D019147 Nerve, Vomeronasal
% 219.64/219.84  |- skos__hiddenLabel mesh__D019147 Jacobsons Organ
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D019147 2005
% 219.64/219.84  |- skos__hiddenLabel mesh__D019147 Vomeronasale, Organum
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D019147 2000
% 219.64/219.84  |- mesh__dateEstablished mesh__D019147 1997-01-01
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D019147 2001
% 219.64/219.84  |- skos__broader mesh__D019147smesh__D009666
% 219.64/219.84  |- skos__hiddenLabel mesh__D019147 Vomeronasal Nerves
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D019147 2006
% 219.64/219.84  |- skos__hiddenLabel mesh__D019147 Vomeronasal Systems
% 219.64/219.84  |- skos__hiddenLabel mesh__D019147 Systems, Vomeronasal
% 219.64/219.84  |- skos__altLabel mesh__D019147 Jacobson%27%s Organ
% 219.64/219.84  |- mesh__historyNote mesh__D019147 97   
% 219.64/219.84  |- skos__scopeNote mesh__D019147
% 219.64/219.84       A specialized part of the olfactory system located anteriorly in the nasal cavity within the nasal septum. Chemosensitive cells of the vomeronasal organ project via the vomeronasal nerve to the accessory olfactory bulb. The primary function of this organ appears to be in sensing pheromones which regulate reproductive and other social behaviors. While the structure has been thought absent in higher primate adults, data now suggests it may be present in adult humans.%A%    
% 219.64/219.84  |- mesh__publicMeSHNote mesh__D019147 97   
% 219.64/219.84  |- skos__broader mesh__D019147smesh__D009300
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D019147 2002
% 219.64/219.84  |- skos__hiddenLabel mesh__D019147 Jacobson Organ
% 219.64/219.84  |- skos__prefLabel mesh__D019147 Vomeronasal Organ
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D019147 1997
% 219.64/219.84  |- rdf__type mesh__D019147sskos__Concept
% 219.64/219.84  |- skos__hiddenLabel mesh__D019147 Nerves, Vomeronasal
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D019147 1998
% 219.64/219.84  |- skos__hiddenLabel mesh__D019147 Organs, Vomeronasal
% 219.64/219.84  |- mesh__recordOriginator mesh__D011164 NLM
% 219.64/219.84  |- skos__related mesh__D011164smesh__D000623
% 219.64/219.84  |- rdf__type mesh__D011164sskos__Concept
% 219.64/219.84  |- skos__broader mesh__D011164smesh__D012875
% 219.64/219.84  |- mesh__dateRevised mesh__D011164 2004-07-07
% 219.64/219.84  |- skos__annotation mesh__D011164 GEN or unspecified: prefer specifics   
% 219.64/219.84  |- skos__prefLabel mesh__D011164 Porphyrias
% 219.64/219.84  |- mesh__recordMaintainer mesh__D011164 lkt
% 219.64/219.84  |- skos__altLabel mesh__D011164 Porphyria
% 219.64/219.84  |- skos__scopeNote mesh__D011164
% 219.64/219.84       A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological %28%acute%29% or cutaneous %28%skin lesions%29%. Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.%A%    
% 219.64/219.84  |- mesh__publicMeSHNote mesh__D011164 2005; see PORPHYRIA 1963-2004   
% 219.64/219.84  |- skos__related mesh__D011164smesh__D011163
% 219.64/219.84  |- mesh__recordAuthorizer mesh__D011164 sjn
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D011164 2005
% 219.64/219.84  |- mesh__dateCreated mesh__D011164 1999-01-01
% 219.64/219.84  |- mesh__historyNote mesh__D011164 2005 %28%1963%29%   
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D011164 2006
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D005925 2003
% 219.64/219.84  |- mesh__dateCreated mesh__D005925 1999-01-01
% 219.64/219.84  |- mesh__recordOriginator mesh__D005925 NLM
% 219.64/219.84  |- skos__hiddenLabel mesh__D005925 Glomus Jugulare Tumors
% 219.64/219.84  |- skos__annotation mesh__D005925
% 219.64/219.84       /blood supply /chem /second /secret /ultrastruct permitted; organ/neopl %26% histol coords not necessary%A%  
% 219.64/219.84  |- skos__hiddenLabel mesh__D005925 Jugulare Tumors, Glomus
% 219.64/219.84  |- skos__prefLabel mesh__D005925 Glomus Jugulare Tumor
% 219.64/219.84  |- skos__scopeNote mesh__D005925
% 219.64/219.84       A paraganglioma involving the glomus jugulare, a microscopic collection of chemoreceptor tissue in the adventitia of the bulb of the jugular vein. It may cause paralysis of the vocal cords, attacks of dizziness, blackouts, and nystagmus. It is not resectable but radiation therapy is effective. It regresses slowly, but permanent control is regularly achieved. %28%From Dorland, 27th ed; Stedman, 25th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, pp1603-4%29%%A%    
% 219.64/219.84  |- mesh__recordAuthorizer mesh__D005925 PLS
% 219.64/219.84  |- mesh__onlineNote mesh__D005925
% 219.64/219.84       search PARAGANGLIOMA, NONCHROMAFFIN 1968-74   
% 219.64/219.84  |- skos__broader mesh__D005925smesh__D010236
% 219.64/219.84  |- mesh__recordMaintainer mesh__D005925 KEV
% 219.64/219.84  |- skos__hiddenLabel mesh__D005925 Tumors, Glomus Jugulare
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D005925 1999
% 219.64/219.84  |- mesh__dateRevised mesh__D005925 1995-06-08
% 219.64/219.84  |- rdf__type mesh__D005925sskos__Concept
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D005925 2006
% 219.64/219.84  |- mesh__publicMeSHNote mesh__D005925
% 219.64/219.84       91; was see under PARAGANGLIOMA, NONCHROMAFFIN 1975-90   
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D005925 2002
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D005925 1998
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D005925 2005
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D005925 2001
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D005925 1997
% 219.64/219.84  |- skos__hiddenLabel mesh__D005925 Jugulare Tumor, Glomus
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D005925 2004
% 219.64/219.84  |- mesh__historyNote mesh__D005925
% 219.64/219.84       91%28%75%29%; was see under PARAGANGLIOMA, NONCHROMAFFIN 1975-90%A%  
% 219.64/219.84  |- skos__hiddenLabel mesh__D005925 Tumor, Glomus Jugulare
% 219.64/219.84  |- mesh__dateEstablished mesh__D005925 1991-01-01
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D005925 2000
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D005925 1996
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D038301 2004
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D038301 2006
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D038301 2003
% 219.64/219.84  |- skos__related mesh__D038301smesh__D000998
% 219.64/219.84  |- mesh__historyNote mesh__D038301 2003   
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D038301 2005
% 219.64/219.84  |- skos__broader mesh__D038301smesh__D008828
% 219.64/219.84  |- mesh__publicMeSHNote mesh__D038301 2003   
% 219.64/219.84  |- skos__scopeNote mesh__D038301
% 219.64/219.84       Inactivation of viruses by non-immune related techniques. They include extremes of pH, HEAT treatment, ultraviolet radiation, IONIZING RADIATION; DESICCATION; ANTISEPTICS; DISINFECTANTS; organic solvents, and DETERGENTS.%A%    
% 219.64/219.84  |- mesh__dateEstablished mesh__D038301 2003-01-01
% 219.64/219.84  |- skos__prefLabel mesh__D038301 Virus Inactivation
% 219.64/219.84  |- skos__broader mesh__D038301smesh__D018406
% 219.64/219.84  |- skos__hiddenLabel mesh__D038301 Inactivation, Viral
% 219.64/219.84  |- skos__hiddenLabel mesh__D038301 Inactivation, Virus
% 219.64/219.84  |- skos__altLabel mesh__D038301 Viral Inactivation
% 219.64/219.84  |- rdf__type mesh__D038301sskos__Concept
% 219.64/219.84  |- mesh__dateCreated mesh__D038301 2002-07-03
% 219.64/219.84  |- skos__prefLabel mesh__D005127 Eye Color
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D005127 2004
% 219.64/219.84  |- skos__annotation mesh__D005127
% 219.64/219.84       = color of iris, not the color of the eye as in disease   
% 219.64/219.84  |- skos__historyNote mesh__D005127 Pigmentation %28%1966-1975%29%
% 219.64/219.84  |- mesh__dateEstablished mesh__D005127 1976-01-01
% 219.64/219.84  |- skos__historyNote mesh__D005127 Eye %28%1966-1975%29%
% 219.64/219.84  |- mesh__dateCreated mesh__D005127 1975-07-25
% 219.64/219.84  |- skos__broader mesh__D005127smesh__D010858
% 219.64/219.84  |- skos__scopeNote mesh__D005127 Color of the iris.     
% 219.64/219.84  |- mesh__recordOriginator mesh__D005127 SMH
% 219.64/219.84  |- mesh__publicMeSHNote mesh__D005127 76   
% 219.64/219.84  |- mesh__recordAuthorizer mesh__D005127 sjn
% 219.64/219.84  |- skos__hiddenLabel mesh__D005127 Color, Eye
% 219.64/219.84  |- mesh__dateRevised mesh__D005127 2003-07-09
% 219.64/219.84  |- rdf__type mesh__D005127sskos__Concept
% 219.64/219.84  |- skos__hiddenLabel mesh__D005127 Eye Colors
% 219.64/219.84  |- skos__broader mesh__D005127smesh__D043722
% 219.64/219.84  |- mesh__historyNote mesh__D005127 76   
% 219.64/219.84  |- skos__hiddenLabel mesh__D005127 Colors, Eye
% 219.64/219.84  |- mesh__recordMaintainer mesh__D005127 nns
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D005127 2005
% 219.64/219.84  |- skos__historyNote mesh__D005127 Iris %28%1966-1975%29% or
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D005127 2006
% 219.64/219.84  |- skos__historyNote mesh__D005127 Color %28%1966-1975%29% or
% 219.64/219.84  |- mesh__recordOriginator mesh__D009518 NLM
% 219.64/219.84  |- mesh__dateCreated mesh__D009518 1999-01-01
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D009518 2000
% 219.64/219.84  |- skos__broader mesh__D009518smesh__D008873
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D009518 2006
% 219.64/219.84  |- mesh__recordAuthorizer mesh__D009518 SJN
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D009518 1999
% 219.64/219.84  |- skos__broader mesh__D009518smesh__D001061
% 219.64/219.84  |- skos__prefLabel mesh__D009518 New York
% 219.64/219.84  |- skos__annotation mesh__D009518
% 219.64/219.84       = state; NEW YORK CITY is also available   
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D009518 2004
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D009518 2005
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D009518 1998
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D009518 2002
% 219.64/219.84  |- mesh__recordMaintainer mesh__D009518 PXP
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D009518 2003
% 219.64/219.84  |- mesh__dateRevised mesh__D009518 1997-06-20
% 219.64/219.84  |- skos__broader mesh__D009518smesh__D006114
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D009518 2001
% 219.64/219.84  |- rdf__type mesh__D009518sskos__Concept
% 219.64/219.84  |- skos__altLabel mesh__D001535
% 219.64/219.84       Smith %26% Nephew Brand of Benactyzine Hydrochloride
% 219.64/219.84  |- mesh__recordAuthorizer mesh__D001535 sjn
% 219.64/219.84  |- mesh__recordMaintainer mesh__D001535 mdb
% 219.64/219.84  |- skos__prefLabel mesh__D001535 Benactyzine
% 219.64/219.84  |- mesh__dateRevised mesh__D001535 2004-07-07
% 219.64/219.84  |- skos__scopeNote mesh__D001535
% 219.64/219.84       A centrally acting muscarinic antagonist. Benactyzine has been used in the treatment of depression and is used in research to investigate the role of cholinergic systems on behavior.%A%    
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D001535 2006
% 219.64/219.84  |- skos__altLabel mesh__D001535 Amizil
% 219.64/219.84  |- rdf__type mesh__D001535sskos__Concept
% 219.64/219.84  |- mesh__dateCreated mesh__D001535 1999-01-01
% 219.64/219.84  |- skos__broader mesh__D001535smesh__D001561
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D001535 2005
% 219.64/219.84  |- mesh__recordOriginator mesh__D001535 NLM
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D006220 2005
% 219.64/219.84  |- skos__broader mesh__D006220smesh__D002090
% 219.64/219.84  |- mesh__activeMeSHYear mesh__D006220 2006
% 219.64/219.84  |- mesh__recordMaintainer mesh__D006220 ssb
% 219.73/219.88  |- mesh__recordAuthorizer mesh__D006220 sjn
% 219.73/219.88  |- skos__scopeNote mesh__D006220
% 219.73/219.88       A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME %28%a drug of choice%29% and occasionally as adjunctive therapy in MENTAL RETARDATION and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. %28%From AMA Drug Evaluations Annual, 1994, p279%29%%A%    
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D006220 2004
% 219.73/219.88  |- rdf__type mesh__D006220sskos__Concept
% 219.73/219.88  |- skos__prefLabel mesh__D006220 Haloperidol
% 219.73/219.88  |- mesh__recordOriginator mesh__D006220 NLM
% 219.73/219.88  |- mesh__dateCreated mesh__D006220 1999-01-01
% 219.73/219.88  |- mesh__dateRevised mesh__D006220 2003-07-09
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D019946 2001
% 219.73/219.88  |- skos__scopeNote mesh__D019946
% 219.73/219.88       A clear, colorless, viscous organic solvent and diluent used in pharmaceutical preparations.%A%    
% 219.73/219.88  |- skos__historyNote mesh__D019946 Propylene Glycols %28%1972-1997%29%
% 219.73/219.88  |- skos__annotation mesh__D019946 PROPYLENE GLYCOLS is also available   
% 219.73/219.88  |- mesh__recordOriginator mesh__D019946 ADP
% 219.73/219.88  |- mesh__dateRevised mesh__D019946 2000-06-22
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D019946 2003
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D019946 2005
% 219.73/219.88  |- mesh__dateEstablished mesh__D019946 1998-01-01
% 219.73/219.88  |- skos__hiddenLabel mesh__D019946 Monohydrate, Propylene Glycol
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D019946 2004
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D019946 2002
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D019946 2006
% 219.73/219.88  |- skos__altLabel mesh__D019946 Propan-1,2-Diol
% 219.73/219.88  |- skos__broader mesh__D019946smesh__D011409
% 219.73/219.88  |- mesh__publicMeSHNote mesh__D019946
% 219.73/219.88       98; PROPYLENE GLYCOL was indexed under PROPANEDIOLS 1972-97%A%  
% 219.73/219.88  |- mesh__recordAuthorizer mesh__D019946 sjn
% 219.73/219.88  |- mesh__historyNote mesh__D019946
% 219.73/219.88       98; use PROPYLENE GLYCOL %28%NM%29% 1980-97   
% 219.73/219.88  |- mesh__recordMaintainer mesh__D019946 CCR
% 219.73/219.88  |- skos__hiddenLabel mesh__D019946 1,2 Propanediol
% 219.73/219.88  |- mesh__dateCreated mesh__D019946 1997-06-20
% 219.73/219.88  |- rdf__type mesh__D019946sskos__Concept
% 219.73/219.88  |- skos__altLabel mesh__D019946 1,2-Propanediol
% 219.73/219.88  |- skos__hiddenLabel mesh__D019946 Glycol, Propylene
% 219.73/219.88  |- skos__prefLabel mesh__D019946 Propylene Glycol
% 219.73/219.88  |- skos__broader mesh__D017419Q000737smesh__D017419
% 219.73/219.88  |- mesh__preferredCombination mesh__D017419Q000737smesh__D011188Q000737
% 219.73/219.88  |- rdf__type mesh__D017419Q000737smesh__CompoundConcept
% 219.73/219.88  |- mesh__historyNote mesh__D011963
% 219.73/219.88       94; was RECEPTORS, GABA-BENZODIAZEPINE 1985-93   
% 219.73/219.88  |- skos__annotation mesh__D011963 DF: RECEPT GABA A   
% 219.73/219.88  |- skos__broader mesh__D011963smesh__D018079
% 219.73/219.88  |- skos__altLabel mesh__D011963 Diazepam Receptors
% 219.73/219.88  |- skos__hiddenLabel mesh__D011963 Receptor, GABA-A
% 219.73/219.88  |- rdf__type mesh__D011963sskos__Concept
% 219.73/219.88  |- mesh__recordMaintainer mesh__D011963 sjn
% 219.73/219.88  |- skos__historyNote mesh__D011963 Receptors, Drug %28%1968-1984%29%
% 219.73/219.88  |- skos__altLabel mesh__D011963 Diazepam Receptor
% 219.73/219.88  |- mesh__onlineNote mesh__D011963
% 219.73/219.88       use RECEPTORS, GABA-A to search RECEPTORS, GABA-BENZODIAZEPINE 1985-93%A%  
% 219.73/219.88  |- skos__altLabel mesh__D011963 Receptors, Benzodiazepine-GABA
% 219.73/219.88  |- skos__hiddenLabel mesh__D011963 Receptor, Benzodiazepine
% 219.73/219.88  |- skos__hiddenLabel mesh__D011963 Receptor, Diazepam
% 219.73/219.88  |- skos__hiddenLabel mesh__D011963 Benzodiazepine GABA Receptor
% 219.73/219.88  |- skos__hiddenLabel mesh__D011963 Receptor, Benzodiazepine-GABA
% 219.73/219.88  |- skos__hiddenLabel mesh__D011963 Receptor, Muscimol
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D011963 2004
% 219.73/219.88  |- skos__altLabel mesh__D011963 Muscimol Receptor
% 219.73/219.88  |- skos__scopeNote mesh__D011963
% 219.73/219.88       Cell surface proteins which bind GAMMA-AMINOBUTYRIC ACID and control an integral membrane chloride channel. GABA-A receptors are the most prevalent inhibitory neurotransmitter receptors in the brain. Several isoforms have been cloned, and they belong to a superfamily which includes nicotinic receptors, glycine receptors, and 5HT-3 receptors. Most GABA-A receptors have separate modulatory sites sensitive to benzodiazepines and to barbiturates.%A%    
% 219.73/219.88  |- skos__hiddenLabel mesh__D011963 GABA Benzodiazepine Receptors
% 219.73/219.88  |- skos__altLabel mesh__D011963 GABA%28%A%29% Receptor
% 219.73/219.88  |- skos__prefLabel mesh__D011963 Receptors, GABA-A
% 219.73/219.88  |- skos__hiddenLabel mesh__D011963 Receptors, GABA Benzodiazepine
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D011963 2003
% 219.73/219.88  |- skos__historyNote mesh__D011963
% 219.73/219.88       Receptors, Endogenous Substances %28%1973-1984%29%
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D011963 2002
% 219.73/219.88  |- skos__hiddenLabel mesh__D011963 Receptors, GABA A
% 219.73/219.88  |- skos__altLabel mesh__D011963 Benzodiazepine-Gaba Receptors
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D011963 2006
% 219.73/219.88  |- skos__hiddenLabel mesh__D011963 GABA A Receptors
% 219.73/219.88  |- mesh__dateCreated mesh__D011963 1984-05-31
% 219.73/219.88  |- skos__hiddenLabel mesh__D011963 GABA Benzodiazepine Receptor
% 219.73/219.88  |- skos__altLabel mesh__D011963 Receptors, Muscimol
% 219.73/219.88  |- mesh__recordAuthorizer mesh__D011963 sjn
% 219.73/219.88  |- skos__historyNote mesh__D011963 Aminobutyric Acids %28%1966-1978%29%
% 219.73/219.88  |- skos__hiddenLabel mesh__D011963 Receptors, Benzodiazepine GABA
% 219.73/219.88  |- skos__altLabel mesh__D011963 Muscimol Receptors
% 219.73/219.88  |- skos__altLabel mesh__D011963 GABA-A Receptor
% 219.73/219.88  |- skos__altLabel mesh__D011963 Receptors, Diazepam
% 219.73/219.88  |- mesh__dateRevised mesh__D011963 2001-08-03
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D011963 2005
% 219.73/219.88  |- mesh__publicMeSHNote mesh__D011963
% 219.73/219.88       94; was RECEPTORS, GABA-BENZODIAZEPINE 1985-93   
% 219.73/219.88  |- skos__hiddenLabel mesh__D011963 Benzodiazepine Gaba Receptors
% 219.73/219.88  |- skos__altLabel mesh__D011963 GABA-Benzodiazepine Receptors
% 219.73/219.88  |- skos__altLabel mesh__D011963 Benzodiazepine Receptors
% 219.73/219.88  |- skos__altLabel mesh__D011963 Receptors, GABA-Benzodiazepine
% 219.73/219.88  |- skos__historyNote mesh__D011963 GABA %28%1979-1984%29%
% 219.73/219.88  |- skos__hiddenLabel mesh__D011963 Receptor, GABA-Benzodiazepine
% 219.73/219.88  |- skos__altLabel mesh__D011963 Receptors, Benzodiazepine
% 219.73/219.88  |- skos__altLabel mesh__D011963 GABA-A Receptors
% 219.73/219.88  |- mesh__dateEstablished mesh__D011963 1985-01-01
% 219.73/219.88  |- skos__altLabel mesh__D011963 GABA-Benzodiazepine Receptor
% 219.73/219.88  |- mesh__recordOriginator mesh__D011963 SH
% 219.73/219.88  |- skos__altLabel mesh__D011963 Benzodiazepine-GABA Receptor
% 219.73/219.88  |- skos__hiddenLabel mesh__D011963 GABA A Receptor
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D019148 2005
% 219.73/219.88  |- mesh__publicMeSHNote mesh__D019148 97   
% 219.73/219.88  |- skos__historyNote mesh__D019148
% 219.73/219.88       Neuromuscular Junction/drug effects %28%1966-1996%29%
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D019148 2002
% 219.73/219.88  |- skos__broader mesh__D019148smesh__D000760
% 219.73/219.88  |- skos__prefLabel mesh__D019148 Neuromuscular Blockade
% 219.73/219.88  |- skos__altLabel mesh__D019148 Neuromuscular Block
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D019148 2006
% 219.73/219.88  |- mesh__recordOriginator mesh__D019148 RAZ
% 219.73/219.88  |- mesh__dateRevised mesh__D019148 2001-07-25
% 219.73/219.88  |- mesh__historyNote mesh__D019148 97   
% 219.73/219.88  |- rdf__type mesh__D019148sskos__Concept
% 219.73/219.88  |- mesh__recordMaintainer mesh__D019148 lkt
% 219.73/219.88  |- mesh__dateCreated mesh__D019148 1996-06-10
% 219.73/219.88  |- skos__annotation mesh__D019148
% 219.73/219.88       to produce muscle relaxation during surg %26% in various exper procedures; differentiate from NERVE BLOCK: read MeSH definitions%A%  
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D019148 2003
% 219.73/219.88  |- mesh__dateEstablished mesh__D019148 1997-01-01
% 219.73/219.88  |- skos__hiddenLabel mesh__D019148 Block, Neuromuscular
% 219.73/219.88  |- skos__related mesh__D019148smesh__D009466
% 219.73/219.88  |- mesh__recordAuthorizer mesh__D019148 sjn
% 219.73/219.88  |- skos__historyNote mesh__D019148
% 219.73/219.88       Neuromuscular Blocking Agents %28%1966-1996%29%
% 219.73/219.88  |- skos__broader mesh__D019148smesh__D008919
% 219.73/219.88  |- skos__hiddenLabel mesh__D019148 Blockade, Neuromuscular
% 219.73/219.88  |- skos__scopeNote mesh__D019148
% 219.73/219.88       The intentional interruption of transmission at the NEUROMUSCULAR JUNCTION by external agents, usually neuromuscular blocking agents. It is distinguished from NERVE BLOCK in which nerve conduction %28%NEURAL CONDUCTION%29% is interrupted rather than neuromuscular transmission. Neuromuscular blockade is commonly used to produce MUSCLE RELAXATION as an adjunct to anesthesia during surgery and other medical procedures. It is also often used as an experimental manipulation in basic research. It is not strictly speaking anesthesia but is grouped here with anesthetic techniques. The failure of neuromuscular transmission as a result of pathological processes is not included here.%A%    
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D019148 2004
% 219.73/219.88  |- rdf__type mesh__D011165sskos__Concept
% 219.73/219.88  |- skos__broader mesh__D011165smesh__D011166
% 219.73/219.88  |- mesh__dateCreated mesh__D011165 1974-11-19
% 219.73/219.88  |- mesh__recordMaintainer mesh__D011165 ssb
% 219.73/219.88  |- mesh__recordOriginator mesh__D011165 NLM
% 219.73/219.88  |- skos__prefLabel mesh__D011165 Porphyrinogens
% 219.73/219.88  |- skos__annotation mesh__D011165 pigments; porphyrin precursors   
% 219.73/219.88  |- mesh__publicMeSHNote mesh__D011165 76; was see under PORPHYRINS 1975   
% 219.73/219.88  |- skos__scopeNote mesh__D011165
% 219.73/219.88       Colorless reduced precursors of porphyrins in which the pyrrole rings are linked by methylene %28%-CH2-%29% bridges.%A%    
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D011165 2006
% 219.73/219.88  |- mesh__dateRevised mesh__D011165 2005-06-30
% 219.73/219.88  |- skos__historyNote mesh__D011165 Porphyrins %28%1968-1974%29%
% 219.73/219.88  |- mesh__recordAuthorizer mesh__D011165 sjn
% 219.73/219.88  |- mesh__historyNote mesh__D011165
% 219.73/219.88       76%28%75%29%; was see under PORPHYRINS 1975   
% 219.73/219.88  |- mesh__dateEstablished mesh__D011165 1976-01-01
% 219.73/219.88  |- mesh__dateRevised mesh__D005926 1999-11-24
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D005926 2006
% 219.73/219.88  |- rdf__type mesh__D005926sskos__Concept
% 219.73/219.88  |- mesh__onlineNote mesh__D005926
% 219.73/219.88       use GLOSSALGIA to search GLOSSODYNIA 1966-68   
% 219.73/219.88  |- skos__broader mesh__D005926smesh__D014060
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D005926 2001
% 219.73/219.88  |- mesh__historyNote mesh__D005926
% 219.73/219.88       65; GLOSSODYNIA was see under GLOSSALGIA 1965-68   
% 219.73/219.88  |- mesh__dateEstablished mesh__D005926 1965-01-01
% 219.73/219.88  |- skos__hiddenLabel mesh__D005926 Glossalgias
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D005926 2000
% 219.73/219.88  |- mesh__publicMeSHNote mesh__D005926 65   
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D005926 2005
% 219.73/219.88  |- mesh__recordMaintainer mesh__D005926 ags
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D005926 2004
% 219.73/219.88  |- mesh__recordOriginator mesh__D005926 NLM
% 219.73/219.88  |- skos__hiddenLabel mesh__D005926 Glossodynias
% 219.73/219.88  |- skos__scopeNote mesh__D005926
% 219.73/219.88       Painful sensations in the tongue, including a sensation of burning.%A%    
% 219.73/219.88  |- mesh__dateCreated mesh__D005926 1999-01-01
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D005926 2003
% 219.73/219.88  |- skos__prefLabel mesh__D005926 Glossalgia
% 219.73/219.88  |- mesh__recordAuthorizer mesh__D005926 ags
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D005926 2000A
% 219.73/219.88  |- skos__hiddenLabel mesh__D005926 Glossopyroses
% 219.73/219.88  |- skos__altLabel mesh__D005926 Glossodynia
% 219.73/219.88  |- skos__broader mesh__D005926smesh__D010146
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D005926 2002
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D005128 2000
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D005128 2001
% 219.73/219.88  |- skos__related mesh__D005128smesh__D005132
% 219.73/219.88  |- skos__prefLabel mesh__D005128 Eye Diseases
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D005128 2002
% 219.73/219.88  |- rdf__type mesh__D005128sskos__Concept
% 219.73/219.88  |- mesh__dateCreated mesh__D005128 1999-01-01
% 219.73/219.88  |- skos__hiddenLabel mesh__D005128 Eye Disease
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D005128 2005
% 219.73/219.88  |- mesh__historyNote mesh__D005128
% 219.73/219.88       65; was see under OPHTHALMOLOGY 1963-64   
% 219.73/219.88  |- mesh__publicMeSHNote mesh__D005128
% 219.73/219.88       65; was see under OPHTHALMOLOGY 1963-64   
% 219.73/219.88  |- skos__hiddenLabel mesh__D005128 Diseases, Eye
% 219.73/219.88  |- mesh__activeMeSHYear mesh__D005128 2006
% 219.73/219.89  |- skos__hiddenLabel mesh__D005128 Disease, Eye
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D005128 2003
% 219.73/219.89  |- mesh__dateEstablished mesh__D005128 1965-01-01
% 219.73/219.89  |- mesh__recordAuthorizer mesh__D005128 sjn
% 219.73/219.89  |- mesh__runningHead mesh__D005128 C11 - DISEASES-OCULAR   
% 219.73/219.89  |- mesh__dateRevised mesh__D005128 1999-11-03
% 219.73/219.89  |- mesh__recordMaintainer mesh__D005128 kle
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D005128 2004
% 219.73/219.89  |- mesh__recordOriginator mesh__D005128 NLM
% 219.73/219.89  |- skos__annotation mesh__D005128
% 219.73/219.89       GEN; coord IM with specific part of eye %28%IM%29%; /diag: consider also DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL%A%  
% 219.73/219.89  |- mesh__recordMaintainer mesh__D048730 jmp
% 219.73/219.89  |- mesh__dateCreated mesh__D048730 2004-07-07
% 219.73/219.89  |- skos__prefLabel mesh__D048730 MAP Kinase Kinase Kinase 2
% 219.73/219.89  |- skos__broader mesh__D048730smesh__D020930
% 219.73/219.89  |- skos__scopeNote mesh__D048730
% 219.73/219.89       A 70-kDa MAP kinase kinase kinase with specificity for MAP KINASE KINASE 5. It is activated during the cellular response to GROWTH FACTORS, oxidative stress, and hyperosmotic conditions.%A%    
% 219.73/219.89  |- skos__hiddenLabel mesh__D048730 Protein Kinase, MEKK-2
% 219.73/219.89  |- skos__hiddenLabel mesh__D048730 Protein Kinase, MEKK2
% 219.73/219.89  |- mesh__dateEstablished mesh__D048730 2005-01-01
% 219.73/219.89  |- skos__altLabel mesh__D048730 MEKK2 Protein Kinase
% 219.73/219.89  |- skos__historyNote mesh__D048730
% 219.73/219.89       MAP Kinase Kinase Kinases %28%1999-2004%29%
% 219.73/219.89  |- skos__hiddenLabel mesh__D048730 MEKK 2 Protein Kinase
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D048730 2005
% 219.73/219.89  |- skos__altLabel mesh__D048730 MEKK2 Protein
% 219.73/219.89  |- mesh__recordAuthorizer mesh__D048730 sjn
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D048730 2006
% 219.73/219.89  |- mesh__recordOriginator mesh__D048730 jmp
% 219.73/219.89  |- mesh__publicMeSHNote mesh__D048730
% 219.73/219.89       2005; MAP KINASE KINASE KINASE 2 was indexed under MAP KINASE KINASE KINASES 1999-2004%A%  
% 219.73/219.89  |- skos__altLabel mesh__D048730 MAP3K2 Protein Kinase
% 219.73/219.89  |- rdf__type mesh__D048730sskos__Concept
% 219.73/219.89  |- skos__altLabel mesh__D048730 MEK Kinase 2
% 219.73/219.89  |- skos__hiddenLabel mesh__D048730 Protein Kinase, MAP3K2
% 219.73/219.89  |- skos__altLabel mesh__D048730 MEKK-2 Protein Kinase
% 219.73/219.89  |- mesh__historyNote mesh__D048730 2005%28%1999%29%   
% 219.73/219.89  |- mesh__recordAuthorizer mesh__D009519 SJN
% 219.73/219.89  |- skos__broader mesh__D009519smesh__D009518
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D009519 1999
% 219.73/219.89  |- skos__broader mesh__D009519smesh__D002947
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D009519 1998
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D009519 2006
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D009519 2002
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D009519 2004
% 219.73/219.89  |- skos__prefLabel mesh__D009519 New York City
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D009519 2005
% 219.73/219.89  |- mesh__dateRevised mesh__D009519 1997-06-20
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D009519 2003
% 219.73/219.89  |- mesh__dateEstablished mesh__D009519 1970-01-01
% 219.73/219.89  |- mesh__recordMaintainer mesh__D009519 PXP
% 219.73/219.89  |- mesh__dateCreated mesh__D009519 1975-03-24
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D009519 2001
% 219.73/219.89  |- rdf__type mesh__D009519sskos__Concept
% 219.73/219.89  |- mesh__recordOriginator mesh__D009519 CAB
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D009519 2000
% 219.73/219.89  |- skos__broader mesh__D001536smesh__D010266
% 219.73/219.89  |- mesh__recordOriginator mesh__D001536 NLM
% 219.73/219.89  |- mesh__dateRevised mesh__D001536 2005-06-30
% 219.73/219.89  |- mesh__dateCreated mesh__D001536 1999-01-01
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D001536 2006
% 219.73/219.89  |- mesh__recordAuthorizer mesh__D001536 sjn
% 219.73/219.89  |- rdf__type mesh__D001536sskos__Concept
% 219.73/219.89  |- skos__scopeNote mesh__D001536
% 219.73/219.89       An abnormal protein with unusual thermosolubility characteristics that is found in the urine of patients with MULTIPLE MYELOMA.%A%    
% 219.73/219.89  |- mesh__recordMaintainer mesh__D001536 ssb
% 219.73/219.89  |- skos__prefLabel mesh__D001536 Bence Jones Protein
% 219.73/219.89  |- skos__hiddenLabel mesh__D001536 Jones Protein, Bence
% 219.73/219.89  |- skos__hiddenLabel mesh__D001536 Protein, Bence Jones
% 219.73/219.89  |- skos__scopeNote mesh__D006221
% 219.73/219.89       A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. %28%From AMA Drug Evaluations Annual, 1994, p178%29%%A%    
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D006221 2006
% 219.73/219.89  |- skos__altLabel mesh__D006221 1,1,1-Trifluoro-2-Chloro-2-Bromoethane
% 219.73/219.89  |- skos__prefLabel mesh__D006221 Halothane
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D006221 2003
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D006221 2004
% 219.73/219.89  |- rdf__type mesh__D006221sskos__Concept
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D006221 2001
% 219.73/219.89  |- mesh__recordAuthorizer mesh__D006221 sjn
% 219.73/219.89  |- mesh__historyNote mesh__D006221
% 219.73/219.89       BROMCHLORTRIFLUORETHANE was see HALOTHANE 1978-94   
% 219.73/219.89  |- mesh__dateCreated mesh__D006221 1999-01-01
% 219.73/219.89  |- mesh__recordMaintainer mesh__D006221 CCR
% 219.73/219.89  |- mesh__dateRevised mesh__D006221 2000-06-22
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D006221 2005
% 219.73/219.89  |- mesh__onlineNote mesh__D006221
% 219.73/219.89       use HALOTHANE to search BROMCHLORTRIFLUORETHANE 1978-94   
% 219.73/219.89  |- skos__broader mesh__D006221smesh__D006846
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D006221 2002
% 219.73/219.89  |- mesh__publicMeSHNote mesh__D006221
% 219.73/219.89       BROMCHLORTRIFLUORETHANE was see HALOTHANE 1978-94   
% 219.73/219.89  |- mesh__recordOriginator mesh__D006221 NLM
% 219.73/219.89  |- skos__historyNote mesh__D019947 Antigens, CD %28%1989-1997%29%
% 219.73/219.89  |- skos__hiddenLabel mesh__D019947 IL 6 Receptors
% 219.73/219.89  |- skos__annotation mesh__D019947 DF: RECEPT IL 6   
% 219.73/219.89  |- skos__hiddenLabel mesh__D019947 IL 6 Receptor
% 219.73/219.89  |- mesh__dateEstablished mesh__D019947 1998-01-01
% 219.73/219.89  |- skos__historyNote mesh__D019947 Receptors, Interleukin %28%1994-1997%29%
% 219.73/219.89  |- skos__altLabel mesh__D019947 Interleukin 6 Receptor
% 219.73/219.89  |- skos__hiddenLabel mesh__D019947 Receptor, IL6
% 219.73/219.89  |- skos__hiddenLabel mesh__D019947 Receptor, IL-6
% 219.73/219.89  |- skos__altLabel mesh__D019947 IL-6 Receptors
% 219.73/219.89  |- skos__hiddenLabel mesh__D019947 Receptors, Interleukin 6
% 219.73/219.89  |- mesh__publicMeSHNote mesh__D019947
% 219.73/219.89       98; INTERLEUKIN 6 RECEPTOR %28%now RECEPTORS, INTERLEUKIN-6%29% was indexed under RECEPTORS, INTERLEUKIN 1994-97, ANTIGENS, CD 1989-97, %26% RECEPTORS, IMMUNOLOGIC 1988-93%A%  
% 219.73/219.89  |- skos__hiddenLabel mesh__D019947 Receptors, IL6
% 219.73/219.89  |- skos__hiddenLabel mesh__D019947 6 Receptor, Interleukin
% 219.73/219.89  |- skos__altLabel mesh__D019947 Antigens, CD126
% 219.73/219.89  |- skos__prefLabel mesh__D019947 Receptors, Interleukin-6
% 219.73/219.89  |- mesh__recordAuthorizer mesh__D019947 sjn
% 219.73/219.89  |- skos__broader mesh__D019947smesh__D015703
% 219.73/219.89  |- mesh__historyNote mesh__D019947
% 219.73/219.89       98; use RECEPTORS, INTERLEUKIN-6 %28%NM%29% 1988-97   
% 219.73/219.89  |- skos__hiddenLabel mesh__D019947 Receptor, Interleukin 6
% 219.73/219.89  |- skos__altLabel mesh__D019947 IL6 Receptors
% 219.73/219.89  |- mesh__recordOriginator mesh__D019947 AGS
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D019947 2006
% 219.73/219.89  |- skos__hiddenLabel mesh__D019947 Receptor, CD126
% 219.73/219.89  |- rdf__type mesh__D019947sskos__Concept
% 219.73/219.89  |- skos__hiddenLabel mesh__D019947 Interleukin 6 Receptors
% 219.73/219.89  |- skos__altLabel mesh__D019947 Interleukin-6 Receptors
% 219.73/219.89  |- skos__altLabel mesh__D019947 IL-6 Receptor
% 219.73/219.89  |- skos__scopeNote mesh__D019947
% 219.73/219.89       Receptors present on T cells, mitogen-activated B cells, peripheral monocytes, and some macrophage- and B cell-derived tumor cell types. The receptor is a strongly glycosylated protein of 80 kDa and a length of 468 amino acids. %28%Ibelgaufts, Dictionary of Cytokines, 1995%29%%A%    
% 219.73/219.89  |- mesh__dateCreated mesh__D019947 1997-06-20
% 219.73/219.89  |- mesh__recordMaintainer mesh__D019947 ssb
% 219.73/219.89  |- skos__broader mesh__D019947smesh__D018123
% 219.73/219.89  |- skos__hiddenLabel mesh__D019947 Receptors, IL 6
% 219.73/219.89  |- mesh__dateRevised mesh__D019947 2005-06-30
% 219.73/219.89  |- skos__historyNote mesh__D019947 Receptors, Immunologic %28%1988-1993%29%
% 219.73/219.89  |- skos__altLabel mesh__D019947 CD126 Antigens
% 219.73/219.89  |- skos__altLabel mesh__D019947 CD126 Receptor
% 219.73/219.89  |- skos__altLabel mesh__D019947 Receptors, IL-6
% 219.73/219.89  |- skos__altLabel mesh__D019947 IL6 Receptor
% 219.73/219.89  |- rdf__type mesh__D011964sskos__Concept
% 219.73/219.89  |- mesh__recordMaintainer mesh__D011964 KEV
% 219.73/219.89  |- skos__altLabel mesh__D011964 Receptors, Intestinal Hormone
% 219.73/219.89  |- mesh__dateCreated mesh__D011964 1986-03-31
% 219.73/219.89  |- skos__hiddenLabel mesh__D011964 Gastrointestinal Peptides Receptors
% 219.73/219.89  |- skos__hiddenLabel mesh__D011964 Hormone Receptors, Intestinal
% 219.73/219.89  |- skos__annotation mesh__D011964
% 219.73/219.89       GEN: prefer specifics;  coord IM with specific hormone %28%IM%29%; DF: RECEPT GASTROINTESTINAL HORMONE%A%  
% 219.73/219.89  |- skos__altLabel mesh__D011964 Intestinal Hormone Receptors
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D011964 1999
% 219.73/219.89  |- mesh__dateRevised mesh__D011964 1997-06-20
% 219.73/219.89  |- skos__hiddenLabel mesh__D011964 Hormones Receptors, Gastrointestinal
% 219.73/219.89  |- skos__altLabel mesh__D011964 Receptors, Gastrointestinal Peptides
% 219.73/219.89  |- skos__altLabel mesh__D011964 Intestinal Hormone Receptor
% 219.73/219.89  |- skos__prefLabel mesh__D011964 Receptors, Gastrointestinal Hormone
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D011964 2004
% 219.73/219.89  |- skos__historyNote mesh__D011964
% 219.73/219.89       Gastrointestinal Hormones %28%1966-1986%29%
% 219.73/219.89  |- skos__altLabel mesh__D011964 Gastrointestinal Hormone Receptor
% 219.73/219.89  |- skos__hiddenLabel mesh__D011964 Hormone Receptor, Gastrointestinal
% 219.73/219.89  |- mesh__historyNote mesh__D011964 87   
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D011964 1998
% 219.73/219.89  |- skos__altLabel mesh__D011964 Receptors, Gastrointestinal Hormones
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D011964 2003
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D011964 2006
% 219.73/219.89  |- skos__scopeNote mesh__D011964
% 219.73/219.89       Cell surface proteins that bind gastrointestinal hormones with high affinity and trigger intracellular changes influencing the behavior of cells. Most gastrointestinal hormones also act as neurotransmitters so these receptors are also present in the central and peripheral nervous systems.%A%    
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D011964 2002
% 219.73/219.89  |- mesh__publicMeSHNote mesh__D011964 87   
% 219.73/219.89  |- skos__historyNote mesh__D011964
% 219.73/219.89       Receptors, Endogenous Substances %28%1973-1986%29%
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D011964 2005
% 219.73/219.89  |- skos__hiddenLabel mesh__D011964 Peptides Receptors, Gastrointestinal
% 219.73/219.89  |- skos__hiddenLabel mesh__D011964 Gastrointestinal Hormones Receptors
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D011964 2001
% 219.73/219.89  |- skos__hiddenLabel mesh__D011964 Receptor, Gastrointestinal Hormone
% 219.73/219.89  |- mesh__dateEstablished mesh__D011964 1987-01-01
% 219.73/219.89  |- skos__broader mesh__D011964smesh__D018000
% 219.73/219.89  |- skos__hiddenLabel mesh__D011964 Hormone Receptors, Gastrointestinal
% 219.73/219.89  |- skos__hiddenLabel mesh__D011964 Hormone Receptor, Intestinal
% 219.73/219.89  |- mesh__recordAuthorizer mesh__D011964 SJN
% 219.73/219.89  |- skos__altLabel mesh__D011964 Gastrointestinal Hormone Receptors
% 219.73/219.89  |- mesh__recordOriginator mesh__D011964 SH
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D011964 2000
% 219.73/219.89  |- skos__hiddenLabel mesh__D011964 Receptor, Intestinal Hormone
% 219.73/219.89  |- skos__annotation mesh__D019149
% 219.73/219.89       for generating products from biol systems   
% 219.73/219.89  |- mesh__recordAuthorizer mesh__D019149 sjn
% 219.73/219.89  |- mesh__activeMeSHYear mesh__D019149 2006
% 219.75/219.89  |- skos__broader mesh__D019149smesh__D001709
% 219.75/219.89  |- mesh__historyNote mesh__D019149 97   
% 219.75/219.89  |- skos__broader mesh__D019149smesh__D004864
% 219.75/219.89  |- skos__scopeNote mesh__D019149
% 219.75/219.89       Tools or devices for generating products using the synthetic or chemical conversion capacity of a biological system. They can be classical fermentors, cell culture perfusion systems, or enzyme bioreactors. For production of proteins or enzymes, recombinant microorganisms such as bacteria, mammalian cells, or insect or plant cells are usually chosen.%A%    
% 219.75/219.89  |- rdf__type mesh__D019149sskos__Concept
% 219.75/219.89  |- skos__related mesh__D019149smesh__D011994
% 219.75/219.89  |- mesh__recordOriginator mesh__D019149 AGS
% 219.75/219.89  |- mesh__publicMeSHNote mesh__D019149 97   
% 219.75/219.89  |- skos__prefLabel mesh__D019149 Bioreactors
% 219.75/219.89  |- skos__historyNote mesh__D019149 Biotechnology %28%1987-1996%29%
% 219.75/219.89  |- mesh__dateRevised mesh__D019149 2004-07-13
% 219.75/219.89  |- skos__related mesh__D019149smesh__D005285
% 219.75/219.89  |- mesh__dateCreated mesh__D019149 1996-02-12
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D019149 2005
% 219.75/219.89  |- skos__hiddenLabel mesh__D019149 Bioreactor
% 219.75/219.89  |- mesh__recordMaintainer mesh__D019149 sjn
% 219.75/219.89  |- mesh__dateEstablished mesh__D019149 1997-01-01
% 219.75/219.89  |- skos__prefLabel mesh__D011166 Porphyrins
% 219.75/219.89  |- mesh__dateRevised mesh__D011166 2005-06-30
% 219.75/219.89  |- skos__broader mesh__D011166smesh__D045725
% 219.75/219.89  |- mesh__recordAuthorizer mesh__D011166 sjn
% 219.75/219.89  |- rdf__type mesh__D011166sskos__Concept
% 219.75/219.89  |- skos__broader mesh__D011166smesh__D010860
% 219.75/219.89  |- mesh__recordMaintainer mesh__D011166 ssb
% 219.75/219.89  |- skos__annotation mesh__D011166
% 219.75/219.89       pigments; iron porphyrins = HEME or HEMIN, magnesium porphyrins = CHLOROPHYLL%A%  
% 219.75/219.89  |- skos__related mesh__D011166smesh__D011162
% 219.75/219.89  |- mesh__recordOriginator mesh__D011166 NLM
% 219.75/219.89  |- skos__scopeNote mesh__D011166
% 219.75/219.89       A group of compounds containing the porphin structure, four pyrrole rings connected by methine bridges in a cyclic configuration to which a variety of side chains are attached. The nature of the side chain is indicated by a prefix, as uroporphyrin, hematoporphyrin, etc. The porphyrins, in combination with iron, form the heme component in biologically significant compounds such as hemoglobin and myoglobin.%A%    
% 219.75/219.89  |- mesh__dateCreated mesh__D011166 1999-01-01
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D011166 2006
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D005927 1998
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D005927 2005
% 219.75/219.89  |- skos__prefLabel mesh__D005927 Glossectomy
% 219.75/219.89  |- skos__annotation mesh__D005927
% 219.75/219.89       do not use /util except by MeSH definition   
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D005927 2002
% 219.75/219.89  |- skos__scopeNote mesh__D005927
% 219.75/219.89       Partial or total surgical excision of the tongue. %28%Dorland, 28th ed%29%%A%    
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D005927 2004
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D005927 2001
% 219.75/219.89  |- mesh__dateCreated mesh__D005927 1999-01-01
% 219.75/219.89  |- skos__hiddenLabel mesh__D005927 Glossectomies
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D005927 2003
% 219.75/219.89  |- mesh__dateEstablished mesh__D005927 1965-01-01
% 219.75/219.89  |- mesh__recordAuthorizer mesh__D005927 SJN
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D005927 2000
% 219.75/219.89  |- mesh__historyNote mesh__D005927 65   
% 219.75/219.89  |- mesh__publicMeSHNote mesh__D005927 65   
% 219.75/219.89  |- skos__broader mesh__D005927smesh__D019647
% 219.75/219.89  |- mesh__recordMaintainer mesh__D005927 PXP
% 219.75/219.89  |- mesh__recordOriginator mesh__D005927 NLM
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D005927 1999
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D005927 2006
% 219.75/219.89  |- rdf__type mesh__D005927sskos__Concept
% 219.75/219.89  |- mesh__dateRevised mesh__D005927 1997-06-20
% 219.75/219.89  |- rdf__type mesh__D005129sskos__Concept
% 219.75/219.89  |- mesh__dateCreated mesh__D005129 1999-01-01
% 219.75/219.89  |- mesh__dateRevised mesh__D005129 1999-11-03
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D005129 2005
% 219.75/219.89  |- mesh__recordAuthorizer mesh__D005129 sjn
% 219.75/219.89  |- skos__broader mesh__D005129smesh__D005547
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D005129 2006
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D005129 2003
% 219.75/219.89  |- mesh__recordOriginator mesh__D005129 NLM
% 219.75/219.89  |- skos__hiddenLabel mesh__D005129 Foreign Bodies, Eye
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D005129 2000
% 219.75/219.89  |- skos__hiddenLabel mesh__D005129 Foreign Body, Eye
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D005129 2004
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D005129 2001
% 219.75/219.89  |- skos__prefLabel mesh__D005129 Eye Foreign Bodies
% 219.75/219.89  |- skos__broader mesh__D005129smesh__D005131
% 219.75/219.89  |- mesh__recordMaintainer mesh__D005129 PXP
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D005129 2002
% 219.75/219.89  |- skos__hiddenLabel mesh__D005129 Eye Foreign Body
% 219.75/219.89  |- mesh__recordMaintainer mesh__D001537 ssb
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D001537 2005
% 219.75/219.89  |- skos__altLabel mesh__D001537
% 219.75/219.89       Andreu Brand of Bencyclane acefyllinate and fumarate
% 219.75/219.89  |- skos__historyNote mesh__D001537 Cycloheptanes %28%1971-1974%29%
% 219.75/219.89  |- mesh__dateEstablished mesh__D001537 1991-01-01
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D001537 2006
% 219.75/219.89  |- skos__hiddenLabel mesh__D001537 compositu, Dilangio
% 219.75/219.89  |- rdf__type mesh__D001537sskos__Concept
% 219.75/219.89  |- skos__historyNote mesh__D001537 Benzyl Compounds %28%1972-1974%29%
% 219.75/219.89  |- mesh__dateCreated mesh__D001537 1974-11-19
% 219.75/219.89  |- mesh__recordOriginator mesh__D001537 NLM
% 219.75/219.89  |- skos__scopeNote mesh__D001537
% 219.75/219.89       A vasodilator agent found to be effective in a variety of peripheral circulation disorders. It has various other potentially useful pharmacological effects. Its mechanism may involve block of calcium channels.%A%    
% 219.75/219.89  |- skos__hiddenLabel mesh__D001537 Fumarate, Bencyclane
% 219.75/219.89  |- skos__altLabel mesh__D001537 Elmuquimica Brand of Bencyclane Fumarate
% 219.75/219.89  |- skos__historyNote mesh__D001537 Dimethylamines %28%1974%29%
% 219.75/219.89  |- mesh__publicMeSHNote mesh__D001537
% 219.75/219.89       91; was see under CYCLOHEPTANES 1975-90   
% 219.75/219.89  |- mesh__dateRevised mesh__D001537 2004-07-07
% 219.75/219.89  |- mesh__recordAuthorizer mesh__D001537 sjn
% 219.75/219.89  |- skos__prefLabel mesh__D001537 Bencyclane
% 219.75/219.89  |- mesh__historyNote mesh__D001537
% 219.75/219.89       91%28%75%29%; was see under CYCLOHEPTANES 1975-90   
% 219.75/219.89  |- skos__broader mesh__D001537smesh__D003508
% 219.75/219.89  |- skos__altLabel mesh__D001537 Rovi Brand of Bencyclane Fumarate
% 219.75/219.89  |- skos__altLabel mesh__D001537 Thiemann Brand of Bencyclane Fumarate
% 219.75/219.89  |- mesh__dateRevised mesh__D006222 1996-06-10
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D006222 2004
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D006222 1999
% 219.75/219.89  |- skos__broader mesh__D006222smesh__D009369
% 219.75/219.89  |- rdf__type mesh__D006222sskos__Concept
% 219.75/219.89  |- skos__scopeNote mesh__D006222
% 219.75/219.89       A focal malformation resembling a neoplasm, composed of an overgrowth of mature cells and tissues that normally occur in the affected area.%A%    
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D006222 2002
% 219.75/219.89  |- mesh__dateCreated mesh__D006222 1999-01-01
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D006222 2005
% 219.75/219.89  |- skos__annotation mesh__D006222
% 219.75/219.89       non-neoplastic; coord IM with precoord organ/diseases term %28%IM%29%%A%  
% 219.75/219.89  |- mesh__recordOriginator mesh__D006222 NLM
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D006222 1997
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D006222 2006
% 219.75/219.89  |- skos__prefLabel mesh__D006222 Hamartoma
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D006222 2000
% 219.75/219.89  |- skos__hiddenLabel mesh__D006222 Hamartomas
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D006222 2003
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D006222 2001
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D006222 1998
% 219.75/219.89  |- mesh__recordMaintainer mesh__D006222 TGC
% 219.75/219.89  |- mesh__recordAuthorizer mesh__D006222 PLS
% 219.75/219.89  |- skos__altLabel mesh__D019948 IL-4 Receptor
% 219.75/219.89  |- skos__altLabel mesh__D019948 Interleukin 4 Receptor
% 219.75/219.89  |- skos__altLabel mesh__D019948 IL4 Receptor
% 219.75/219.89  |- mesh__recordAuthorizer mesh__D019948 sjn
% 219.75/219.89  |- mesh__recordOriginator mesh__D019948 AGS
% 219.75/219.89  |- mesh__publicMeSHNote mesh__D019948
% 219.75/219.89       98; B CELL-ACTIVATING FACTOR RECEPTOR %28%now RECEPTORS, INTERLEUKIN-4%29% was indexed under RECEPTORS, INTERLEUKIN 1994-97, ANTIGENS, CD 1990-97, %26% RECEPTORS, MITOGEN 1986-94%A%  
% 219.75/219.89  |- skos__hiddenLabel mesh__D019948 Receptor, B Cell Activating Factor
% 219.75/219.89  |- skos__altLabel mesh__D019948 Receptor, B Cell-Activating Factor
% 219.75/219.89  |- skos__altLabel mesh__D019948 IL4 Receptors
% 219.75/219.89  |- skos__annotation mesh__D019948 DF: RECEPT IL 4   
% 219.75/219.89  |- mesh__historyNote mesh__D019948
% 219.75/219.89       98; use RECEPTORS, INTERLEUKIN-4 %28%NM%29% 1986-97   
% 219.75/219.89  |- skos__broader mesh__D019948smesh__D015703
% 219.75/219.89  |- skos__altLabel mesh__D019948 B Cell-Activating Factor Receptor
% 219.75/219.89  |- skos__hiddenLabel mesh__D019948 Receptor, IL-4
% 219.75/219.89  |- skos__altLabel mesh__D019948 Receptors, IL-4
% 219.75/219.89  |- skos__altLabel mesh__D019948 IL-4 Receptors
% 219.75/219.89  |- skos__historyNote mesh__D019948 Receptors, Mitogen %28%1986-1994%29%
% 219.75/219.89  |- rdf__type mesh__D019948sskos__Concept
% 219.75/219.89  |- skos__historyNote mesh__D019948 Antigens, CD %28%1990-1997%29%
% 219.75/219.89  |- skos__hiddenLabel mesh__D019948 Interleukin 4 Receptors
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D019948 2006
% 219.75/219.89  |- mesh__dateCreated mesh__D019948 1997-06-20
% 219.75/219.89  |- skos__altLabel mesh__D019948 CD124 Antigens
% 219.75/219.89  |- skos__broader mesh__D019948smesh__D018123
% 219.75/219.89  |- skos__hiddenLabel mesh__D019948 Receptor, IL4
% 219.75/219.89  |- skos__historyNote mesh__D019948 Receptors, Interleukin %28%1994-1997%29%
% 219.75/219.89  |- skos__prefLabel mesh__D019948 Receptors, Interleukin-4
% 219.75/219.89  |- skos__hiddenLabel mesh__D019948 IL 4 Receptor
% 219.75/219.89  |- skos__hiddenLabel mesh__D019948 Receptors, Interleukin 4
% 219.75/219.89  |- skos__hiddenLabel mesh__D019948 IL 4 Receptors
% 219.75/219.89  |- skos__altLabel mesh__D019948 CD124 Antigen
% 219.75/219.89  |- mesh__dateEstablished mesh__D019948 1998-01-01
% 219.75/219.89  |- skos__hiddenLabel mesh__D019948 Receptor, Interleukin 4
% 219.75/219.89  |- skos__scopeNote mesh__D019948
% 219.75/219.89       Receptors present on a wide variety of hematopoietic and non-hematopoietic cell types and various human tumors. Two forms of the receptor have been described, soluble and membrane-bound. Low affinity and high affinity receptors for IL-4 have been reported.%A%    
% 219.75/219.89  |- mesh__recordMaintainer mesh__D019948 ssb
% 219.75/219.89  |- skos__hiddenLabel mesh__D019948 Receptors, IL 4
% 219.75/219.89  |- skos__altLabel mesh__D019948 Antigens, CD124
% 219.75/219.89  |- skos__altLabel mesh__D019948 CDw124 Antigen
% 219.75/219.89  |- skos__hiddenLabel mesh__D019948 B Cell Activating Factor Receptor
% 219.75/219.89  |- skos__altLabel mesh__D019948 Interleukin-4 Receptors
% 219.75/219.89  |- skos__hiddenLabel mesh__D019948 Receptors, IL4
% 219.75/219.89  |- mesh__dateRevised mesh__D019948 2005-06-30
% 219.75/219.89  |- mesh__historyNote mesh__D011965
% 219.75/219.89       86%28%77%29%; was see under RECEPTORS, STEROID 1977-85   
% 219.75/219.89  |- mesh__recordAuthorizer mesh__D011965 PLS
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D011965 2002
% 219.75/219.89  |- skos__prefLabel mesh__D011965 Receptors, Glucocorticoid
% 219.75/219.89  |- skos__historyNote mesh__D011965
% 219.75/219.89       Receptors, Endogenous Substances %28%1973-1976%29%
% 219.75/219.89  |- mesh__recordOriginator mesh__D011965 SH
% 219.75/219.89  |- rdf__type mesh__D011965sskos__Concept
% 219.75/219.89  |- skos__broader mesh__D011965smesh__D011987
% 219.75/219.89  |- skos__annotation mesh__D011965
% 219.75/219.89       coord IM with specific glucocorticoid %28%IM%29%; DF: RECEPT GLUCOCORTICOID%A%  
% 219.75/219.89  |- skos__altLabel mesh__D011965 Corticoid II Receptor
% 219.75/219.89  |- skos__historyNote mesh__D011965 Glucocorticoids %28%1967-1976%29%
% 219.75/219.89  |- skos__hiddenLabel mesh__D011965 Glucocorticoids Receptors
% 219.75/219.89  |- skos__historyNote mesh__D011965 Receptors, Drug %28%1968-1976%29%
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D011965 1998
% 219.75/219.89  |- skos__altLabel mesh__D011965 Receptors, Glucocorticoids
% 219.75/219.89  |- skos__scopeNote mesh__D011965
% 219.75/219.89       Cytoplasmic proteins that specifically bind glucocorticoids and mediate their cellular effects. The glucocorticoid receptor-glucocorticoid complex acts in the nucleus to induce transcription of DNA. Glucocorticoids were named for their actions on blood glucose concentration, but they have equally important effects on protein and fat metabolism. Cortisol is the most important example.%A%    
% 219.75/219.89  |- skos__altLabel mesh__D011965 Glucocorticoid Receptors
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D011965 1996
% 219.75/219.89  |- skos__hiddenLabel mesh__D011965 Receptor, Glucocorticoid
% 219.75/219.89  |- mesh__recordMaintainer mesh__D011965 KEV
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D011965 2000
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D011965 1999
% 219.75/219.89  |- skos__altLabel mesh__D011965 Corticoid Type II Receptors
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D011965 2005
% 219.75/219.89  |- skos__altLabel mesh__D011965 Glucocorticoid Receptor
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D011965 1997
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D011965 2003
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D011965 2006
% 219.75/219.89  |- mesh__dateCreated mesh__D011965 1976-05-05
% 219.75/219.89  |- skos__hiddenLabel mesh__D011965 Corticoid II Receptors
% 219.75/219.89  |- skos__altLabel mesh__D011965 Receptors, Corticoid II
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D011965 2004
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D011965 2001
% 219.75/219.89  |- mesh__dateRevised mesh__D011965 1995-06-08
% 219.75/219.89  |- mesh__publicMeSHNote mesh__D011965
% 219.75/219.89       86; was see under RECEPTORS, STEROID 1977-85   
% 219.75/219.89  |- mesh__dateEstablished mesh__D011965 1986-01-01
% 219.75/219.89  |- skos__hiddenLabel mesh__D011965 Receptor, Corticoid II
% 219.75/219.89  |- skos__hiddenLabel mesh__D011167 Anastomosis, Portacaval
% 219.75/219.89  |- rdf__type mesh__D011167sskos__Concept
% 219.75/219.89  |- mesh__historyNote mesh__D011167
% 219.75/219.89       81; was PORTACAVAL ANASTOMOSIS 1963-80; ECK FISTULA was see under PORTACAVAL ANASTOMOSIS 1974-80%A%  
% 219.75/219.89  |- skos__hiddenLabel mesh__D011167 Surgical Portacaval Shunts
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D011167 1999
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D011167 2002
% 219.75/219.89  |- skos__prefLabel mesh__D011167 Portacaval Shunt, Surgical
% 219.75/219.89  |- skos__altLabel mesh__D011167 Portacaval Shunt
% 219.75/219.89  |- skos__altLabel mesh__D011167 Surgical Portacaval Shunt
% 219.75/219.89  |- skos__scopeNote mesh__D011167
% 219.75/219.89       Surgical portasystemic shunt between the portal vein and inferior vena cava.%A%    
% 219.75/219.89  |- skos__hiddenLabel mesh__D011167 Shunts, Portacaval
% 219.75/219.89  |- skos__hiddenLabel mesh__D011167 Portacaval Anastomoses
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D011167 2004
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D011167 1998
% 219.75/219.89  |- skos__altLabel mesh__D011167 Eck Fistula
% 219.75/219.89  |- mesh__publicMeSHNote mesh__D011167
% 219.75/219.89       81; was PORTACAVAL ANASTOMOSIS 1963-80   
% 219.75/219.89  |- skos__annotation mesh__D011167
% 219.75/219.89       do not use /util except by MeSH definition; DF: PORTACAVAL SHUNT%A%  
% 219.75/219.89  |- mesh__recordAuthorizer mesh__D011167 SJN
% 219.75/219.89  |- mesh__activeMeSHYear mesh__D011167 2003
% 219.75/219.89  |- skos__hiddenLabel mesh__D011167 Portacaval Shunts, Surgical
% 219.75/219.89  |- skos__hiddenLabel mesh__D011167 Anastomoses, Portacaval
% 219.75/219.89  |- skos__hiddenLabel mesh__D011167 Portacaval Shunts
% 219.75/219.89  |- mesh__dateCreated mesh__D011167 1999-01-01
% 219.75/219.90  |- mesh__recordMaintainer mesh__D011167 PXP
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D011167 2001
% 219.75/219.90  |- skos__hiddenLabel mesh__D011167 Shunts, Surgical Portacaval
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D011167 2006
% 219.75/219.90  |- skos__altLabel mesh__D011167 Shunt, Surgical Portacaval
% 219.75/219.90  |- skos__hiddenLabel mesh__D011167 Shunt, Portacaval
% 219.75/219.90  |- skos__hiddenLabel mesh__D011167 Fistula, Eck
% 219.75/219.90  |- skos__broader mesh__D011167smesh__D011170
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D011167 2000
% 219.75/219.90  |- mesh__recordOriginator mesh__D011167 NLM
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D011167 2005
% 219.75/219.90  |- skos__altLabel mesh__D011167 Portacaval Anastomosis
% 219.75/219.90  |- mesh__onlineNote mesh__D011167
% 219.75/219.90       use PORTACAVAL SHUNT, SURGICAL to search PORTACAVAL ANASTOMOSIS 1966-80 %26% ECK FISTULA 1974-80%A%  
% 219.75/219.90  |- mesh__dateRevised mesh__D011167 1997-06-20
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D005928 1996
% 219.75/219.90  |- mesh__dateCreated mesh__D005928 1999-01-01
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D005928 2003
% 219.75/219.90  |- mesh__recordOriginator mesh__D005928 NLM
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D005928 1997
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D005928 2002
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D005928 2004
% 219.75/219.90  |- skos__annotation mesh__D005928 inflamm of the tongue   
% 219.75/219.90  |- skos__scopeNote mesh__D005928 Inflammation of the tongue.     
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D005928 2000
% 219.75/219.90  |- skos__broader mesh__D005928smesh__D014060
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D005928 1994
% 219.75/219.90  |- skos__hiddenLabel mesh__D005928 Glossitides
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D005928 1998
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D005928 1995
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D005928 2005
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D005928 2001
% 219.75/219.90  |- skos__prefLabel mesh__D005928 Glossitis
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D005928 1999
% 219.75/219.90  |- rdf__type mesh__D005928sskos__Concept
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D005928 2006
% 219.75/219.90  |- mesh__dateRevised mesh__D005928 1993-05-28
% 219.75/219.90  |- mesh__recordMaintainer mesh__D005928 TGC
% 219.75/219.90  |- mesh__recordAuthorizer mesh__D005928 PLS
% 219.75/219.90  |- rdf__type mesh__D016650sskos__Concept
% 219.75/219.90  |- mesh__recordAuthorizer mesh__D016650 sjn
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D016650 2001
% 219.75/219.90  |- mesh__onlineNote mesh__D016650
% 219.75/219.90       use FLUORESCEIN-5-ISOTHIOCYANATE %28%NM%29% to search FLUORESCEIN-5-ISOTHIOCYANATE 1979-91%A%  
% 219.75/219.90  |- skos__hiddenLabel mesh__D016650
% 219.75/219.90       Fluorescein 5 isothiocyanate Hydrochloride
% 219.75/219.90  |- mesh__dateRevised mesh__D016650 2000-06-22
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D016650 2005
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D016650 2002
% 219.75/219.90  |- mesh__dateCreated mesh__D016650 1991-07-12
% 219.75/219.90  |- skos__broader mesh__D016650smesh__D005452
% 219.75/219.90  |- skos__scopeNote mesh__D016650
% 219.75/219.90       Fluorescent probe capable of being conjugated to tissue and proteins. It is used as a label in fluorescent antibody staining procedures as well as protein- and amino acid-binding techniques.%A%    
% 219.75/219.90  |- skos__hiddenLabel mesh__D016650
% 219.75/219.90       Hydrochloride, Fluorescein-5-isothiocyanate
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D016650 2003
% 219.75/219.90  |- skos__broader mesh__D016650smesh__D017879
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D016650 2006
% 219.75/219.90  |- mesh__recordOriginator mesh__D016650 RLS
% 219.75/219.90  |- skos__hiddenLabel mesh__D016650 Fluorescein 5 isothiocyanate
% 219.75/219.90  |- mesh__recordMaintainer mesh__D016650 CCR
% 219.75/219.90  |- skos__historyNote mesh__D016650 Thiocyanates %28%1966-1991%29%
% 219.75/219.90  |- mesh__publicMeSHNote mesh__D016650
% 219.75/219.90       92; FLUORESCEIN-5-ISOTHIOCYANATE was indexed under FLUORESCEINS %26% THIOCYANATES 1978-91%A%  
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D016650 2004
% 219.75/219.90  |- mesh__historyNote mesh__D016650
% 219.75/219.90       92; was FLUORESCEIN-5-ISOTHIOCYANATE %28%NM%29% 1978-91   
% 219.75/219.90  |- skos__annotation mesh__D016650 DF: note short X ref   
% 219.75/219.90  |- mesh__dateEstablished mesh__D016650 1992-01-01
% 219.75/219.90  |- skos__altLabel mesh__D016650 FITC
% 219.75/219.90  |- skos__altLabel mesh__D016650 5-Isothiocyanatofluorescein
% 219.75/219.90  |- skos__hiddenLabel mesh__D016650 5 Isothiocyanatofluorescein
% 219.75/219.90  |- skos__prefLabel mesh__D016650 Fluorescein-5-isothiocyanate
% 219.75/219.90  |- skos__historyNote mesh__D016650 Fluoresceins %28%1966-1991%29%
% 219.75/219.90  |- mesh__historyNote mesh__D030321 2002   
% 219.75/219.90  |- skos__related mesh__D030321smesh__D016162
% 219.75/219.90  |- skos__broader mesh__D030321smesh__D009396
% 219.75/219.90  |- skos__hiddenLabel mesh__D030321 Syndrome, Denys-Drash
% 219.75/219.90  |- skos__hiddenLabel mesh__D030321 Denys Drash Syndrome
% 219.75/219.90  |- rdf__type mesh__D030321sskos__Concept
% 219.75/219.90  |- mesh__recordAuthorizer mesh__D030321 sjn
% 219.75/219.90  |- skos__historyNote mesh__D030321 Pseudohermaphroditism %28%1991-2001%29%
% 219.75/219.90  |- skos__altLabel mesh__D030321 Wilms Tumor And Pseudohermaphroditism
% 219.75/219.90  |- skos__scopeNote mesh__D030321
% 219.75/219.90       A rare syndrome characterized by UROGENITAL ABNORMALITIES; GONADAL DYSGENESIS; PSEUDOHERMAPHRODITISM; and WILMS TUMOR. It is caused by a mutation in the Wilms tumor suppressor gene %28%GENES, WILMS TUMOR%29% on chromosome 11.%A%    
% 219.75/219.90  |- mesh__recordOriginator mesh__D030321 nns
% 219.75/219.90  |- mesh__recordMaintainer mesh__D030321 lkt
% 219.75/219.90  |- mesh__dateCreated mesh__D030321 2001-08-03
% 219.75/219.90  |- skos__historyNote mesh__D030321 Nephroblastoma %28%1991-2001%29%
% 219.75/219.90  |- skos__prefLabel mesh__D030321 Denys-Drash Syndrome
% 219.75/219.90  |- mesh__dateEstablished mesh__D030321 2002-01-01
% 219.75/219.90  |- mesh__publicMeSHNote mesh__D030321 2002   
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D030321 2006
% 219.75/219.90  |- skos__broader mesh__D030321smesh__D011545
% 219.75/219.90  |- mesh__dateRevised mesh__D030321 2005-06-30
% 219.75/219.90  |- mesh__recordAuthorizer mesh__D002630 sjn
% 219.75/219.90  |- skos__annotation mesh__D002630 /biosyn /physiol permitted   
% 219.75/219.90  |- mesh__onlineNote mesh__D002630
% 219.75/219.90       use CHEMOTACTIC FACTORS to search PEPTIDES, CHEMOTACTIC 1984-90%A%  
% 219.75/219.90  |- skos__historyNote mesh__D002630 Chemotaxis, Leukocyte %28%1977-1979%29%
% 219.75/219.90  |- mesh__dateCreated mesh__D002630 1979-04-30
% 219.75/219.90  |- skos__broader mesh__D002630smesh__D001685
% 219.75/219.90  |- mesh__recordOriginator mesh__D002630 SH
% 219.75/219.90  |- mesh__publicMeSHNote mesh__D002630
% 219.75/219.90       80; PEPTIDES, CHEMOTACTIC was see CHEMOTACTIC FACTORS 1984-90%A%  
% 219.75/219.90  |- skos__altLabel mesh__D002630 Cytotaxins
% 219.75/219.90  |- mesh__historyNote mesh__D002630
% 219.75/219.90       80; PEPTIDES, CHEMOTACTIC was see CHEMOTACTIC FACTORS 1984-90%A%  
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D002630 2006
% 219.75/219.90  |- mesh__dateRevised mesh__D002630 2005-06-30
% 219.75/219.90  |- skos__altLabel mesh__D002630 Chemoattractants
% 219.75/219.90  |- mesh__dateEstablished mesh__D002630 1980-01-01
% 219.75/219.90  |- skos__historyNote mesh__D002630 Chemotaxis %28%1966-1979%29%
% 219.75/219.90  |- skos__scopeNote mesh__D002630
% 219.75/219.90       Chemical substances that attract or repel cells or organisms. The concept denotes especially those factors released as a result of tissue injury, invasion, or immunologic activity, that attract leukocytes, macrophages, or other cells to the site of infection or insult.%A%    
% 219.75/219.90  |- skos__prefLabel mesh__D002630 Chemotactic Factors
% 219.75/219.90  |- skos__related mesh__D002630smesh__D010675
% 219.75/219.90  |- skos__altLabel mesh__D002630 Chemotaxins
% 219.75/219.90  |- mesh__recordMaintainer mesh__D002630 ssb
% 219.75/219.90  |- rdf__type mesh__D002630sskos__Concept
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D001538 1996
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D001538 1993
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D001538 2004
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D001538 1997
% 219.75/219.90  |- mesh__dateRevised mesh__D001538 1992-05-26
% 219.75/219.90  |- skos__prefLabel mesh__D001538 Bender-Gestalt Test
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D001538 2002
% 219.75/219.90  |- skos__hiddenLabel mesh__D001538 Bender Gestalt Test
% 219.75/219.90  |- skos__scopeNote mesh__D001538
% 219.75/219.90       A psychological test consisting of nine geometric designs on cards. The subject is asked to redraw them from memory after each one is presented individually.%A%    
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D001538 1994
% 219.75/219.90  |- mesh__dateCreated mesh__D001538 1999-01-01
% 219.75/219.90  |- skos__broader mesh__D001538smesh__D010556
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D001538 2000
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D001538 2005
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D001538 1998
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D001538 1995
% 219.75/219.90  |- mesh__recordOriginator mesh__D001538 NLM
% 219.75/219.90  |- mesh__recordMaintainer mesh__D001538 TAP
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D001538 2006
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D001538 1999
% 219.75/219.90  |- mesh__recordAuthorizer mesh__D001538 PLS
% 219.75/219.90  |- skos__hiddenLabel mesh__D001538 Test, Bender-Gestalt
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D001538 2001
% 219.75/219.90  |- skos__altLabel mesh__D001538 Bender Visual Motor Gestalt Test
% 219.75/219.90  |- rdf__type mesh__D001538sskos__Concept
% 219.75/219.90  |- skos__broader mesh__D001538smesh__D009483
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D001538 2003
% 219.75/219.90  |- mesh__dateRevised mesh__D012260 2003-07-09
% 219.75/219.90  |- skos__hiddenLabel mesh__D012260 Ribonuclease, Acid
% 219.75/219.90  |- rdf__type mesh__D012260sskos__Concept
% 219.75/219.90  |- skos__hiddenLabel mesh__D012260 RNA Nucleases
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D012260 2005
% 219.75/219.90  |- skos__scopeNote mesh__D012260
% 219.75/219.90       Enzymes that catalyze the hydrolysis of ester bonds within RNA. EC 3.1.-.%A%    
% 219.75/219.90  |- skos__altLabel mesh__D012260 Nucleases, RNA
% 219.75/219.90  |- mesh__historyNote mesh__D012260 83; was RIBONUCLEASE 1963-82   
% 219.75/219.90  |- skos__prefLabel mesh__D012260 Ribonucleases
% 219.75/219.90  |- mesh__publicMeSHNote mesh__D012260 83; was RIBONUCLEASE 1963-82   
% 219.75/219.90  |- mesh__recordOriginator mesh__D012260 NLM
% 219.75/219.90  |- skos__broader mesh__D012260smesh__D004950
% 219.75/219.90  |- skos__altLabel mesh__D012260 RNase
% 219.75/219.90  |- mesh__recordMaintainer mesh__D012260 ssb
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D012260 2004
% 219.75/219.90  |- mesh__recordAuthorizer mesh__D012260 sjn
% 219.75/219.90  |- mesh__onlineNote mesh__D012260
% 219.75/219.90       use RIBONUCLEASES to search RIBONUCLEASE 1986-82   
% 219.75/219.90  |- mesh__dateCreated mesh__D012260 1999-01-01
% 219.75/219.90  |- skos__hiddenLabel mesh__D012260 Ribonuclease, Alkaline
% 219.75/219.90  |- skos__altLabel mesh__D012260 Ribonuclease
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D012260 2006
% 219.75/219.90  |- mesh__historyNote mesh__D006223
% 219.75/219.90       91%28%87%29%; was see under NEOPLASMS, MULTIPLE PRIMARY 1987-90%A%  
% 219.75/219.90  |- skos__hiddenLabel mesh__D006223 Disease, Cowden
% 219.75/219.90  |- skos__altLabel mesh__D006223 Cowden%27%s Disease
% 219.75/219.90  |- mesh__dateEstablished mesh__D006223 1991-01-01
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D006223 2005
% 219.75/219.90  |- skos__broader mesh__D006223smesh__D009386
% 219.75/219.90  |- mesh__recordAuthorizer mesh__D006223 sjn
% 219.75/219.90  |- skos__broader mesh__D006223smesh__D006222
% 219.75/219.90  |- skos__historyNote mesh__D006223 Hamartoma %28%1966-1986%29%
% 219.75/219.90  |- skos__hiddenLabel mesh__D006223 Disease, Cowden%27%s
% 219.75/219.90  |- skos__hiddenLabel mesh__D006223 Syndrome, Multiple Hamartoma
% 219.75/219.90  |- skos__altLabel mesh__D006223 Multiple Hamartoma Syndrome
% 219.75/219.90  |- skos__hiddenLabel mesh__D006223 Cowdens Disease
% 219.75/219.90  |- mesh__publicMeSHNote mesh__D006223
% 219.75/219.90       91; was see under NEOPLASMS, MULTIPLE PRIMARY 1987-90   
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D006223 2006
% 219.75/219.90  |- skos__annotation mesh__D006223
% 219.75/219.90       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D006223 2002
% 219.75/219.90  |- skos__prefLabel mesh__D006223 Hamartoma Syndrome, Multiple
% 219.75/219.90  |- mesh__recordMaintainer mesh__D006223 nns
% 219.75/219.90  |- mesh__recordOriginator mesh__D006223 VDK
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D006223 2003
% 219.75/219.90  |- skos__scopeNote mesh__D006223
% 219.75/219.90       A hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Papules of the face and oral mucosa are the most characteristic lesion. Other changes occur in the skin, in the thyroid, the breast, the gastrointestinal system, and the nervous system.%A%    
% 219.75/219.90  |- skos__historyNote mesh__D006223
% 219.75/219.90       Neoplasms, Multiple Primary %28%1966-1986%29%
% 219.75/219.90  |- skos__altLabel mesh__D006223 Cowden Disease
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D006223 2004
% 219.75/219.90  |- mesh__dateCreated mesh__D006223 1986-06-23
% 219.75/219.90  |- mesh__dateRevised mesh__D006223 2001-07-25
% 219.75/219.90  |- skos__broader mesh__D006223smesh__D009378
% 219.75/219.90  |- rdf__type mesh__D006223sskos__Concept
% 219.75/219.90  |- skos__altLabel mesh__D011966 Receptor, LHRH
% 219.75/219.90  |- skos__hiddenLabel mesh__D011966 Receptor, Gonadotropin-Releasing Hormone
% 219.75/219.90  |- mesh__recordOriginator mesh__D011966 SH
% 219.75/219.90  |- skos__scopeNote mesh__D011966
% 219.75/219.90       Receptors with a 6-kDa protein on the surfaces of cells that secrete LUTEINIZING HORMONE or FOLLICLE STIMULATING HORMONE, usually in the adenohypophysis. LUTEINIZING HORMONE RH binds to these receptors, is endocytosed with the receptor and, in the cell, triggers the release of LUTEINIZING HORMONE or FOLLICLE STIMULATING HORMONE by the cell. These receptors are also found in rat gonads. INHIBINS prevent the binding of GnRH to its receptors.%A%    
% 219.75/219.90  |- skos__annotation mesh__D011966 DF: RECEPT LHRH   
% 219.75/219.90  |- rdf__type mesh__D011966sskos__Concept
% 219.75/219.90  |- skos__related mesh__D011966smesh__D007265
% 219.75/219.90  |- mesh__recordAuthorizer mesh__D011966 jls
% 219.75/219.90  |- skos__hiddenLabel mesh__D011966 Gonadotropin Releasing Hormone Receptor
% 219.75/219.90  |- skos__prefLabel mesh__D011966 Receptors, LHRH
% 219.75/219.90  |- skos__altLabel mesh__D011966 LHRH Receptor
% 219.75/219.90  |- skos__hiddenLabel mesh__D011966 Receptor, GnRH
% 219.75/219.90  |- mesh__dateCreated mesh__D011966 1986-03-25
% 219.75/219.90  |- mesh__onlineNote mesh__D011966
% 219.75/219.90       use RECEPTORS, LHRH to search RECEPTORS, GONADORELIN 1992-93 %26% RECEPTORS, GONADOLIBERIN %26% FOLIBERIN RECEPTORS 1987-91%A%  
% 219.75/219.90  |- skos__altLabel mesh__D011966 Gonadotropin-Releasing Hormone Receptor
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D011966 2005A
% 219.75/219.90  |- skos__hiddenLabel mesh__D011966
% 219.75/219.90       Follicle Stimulating Hormone Releasing Hormone Receptors
% 219.75/219.90  |- skos__altLabel mesh__D011966 Receptors, Luliberin
% 219.75/219.90  |- mesh__dateRevised mesh__D011966 2004-08-02
% 219.75/219.90  |- mesh__publicMeSHNote mesh__D011966
% 219.75/219.90       94; was RECEPTORS, GONADORELIN 1992-93; was RECEPTORS, GONADOLIBERIN 1987-91; FOLIBERIN RECEPTORS was see RECEPTORS, GONADOLIBERIN 1987-91%A%  
% 219.75/219.90  |- skos__hiddenLabel mesh__D011966
% 219.75/219.90       Releasing-Hormone Receptors, Gonadotropin
% 219.75/219.90  |- skos__altLabel mesh__D011966 Gonadorelin Receptors
% 219.75/219.90  |- skos__altLabel mesh__D011966 Gonadorelin Receptor
% 219.75/219.90  |- skos__hiddenLabel mesh__D011966 Hormone Receptor, Gonadotropin-Releasing
% 219.75/219.90  |- skos__related mesh__D011966smesh__D007987
% 219.75/219.90  |- skos__historyNote mesh__D011966
% 219.75/219.90       LH-FSH Releasing Hormone %28%1974-1986%29%
% 219.75/219.90  |- skos__broader mesh__D011966smesh__D043562
% 219.75/219.90  |- skos__broader mesh__D011966smesh__D018013
% 219.75/219.90  |- skos__hiddenLabel mesh__D011966 Receptor, Gonadorelin
% 219.75/219.90  |- skos__altLabel mesh__D011966 Luliberin Receptors
% 219.75/219.90  |- mesh__historyNote mesh__D011966
% 219.75/219.90       94; was RECEPTORS, GONADORELIN 1992-93; was RECEPTORS, GONADOLIBERIN 1987-91; FOLIBERIN RECEPTORS was see RECEPTORS, GONADOLIBERIN 1987-91%A%  
% 219.75/219.90  |- skos__altLabel mesh__D011966
% 219.75/219.90       Luteinizing Hormone Releasing-Hormone Receptor
% 219.75/219.90  |- mesh__recordMaintainer mesh__D011966 jls
% 219.75/219.90  |- skos__altLabel mesh__D011966
% 219.75/219.90       Follicle Stimulating Hormone-Releasing Hormone Receptors
% 219.75/219.90  |- skos__broader mesh__D011966smesh__D018017
% 219.75/219.90  |- skos__altLabel mesh__D011966 LHRH Receptors
% 219.75/219.90  |- skos__altLabel mesh__D011966
% 219.75/219.90       Luteinizing Hormone Releasing Hormone Receptors
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D011966 2006
% 219.75/219.90  |- skos__altLabel mesh__D011966 Receptors, Gonadotropin Releasing-Hormone
% 219.75/219.90  |- skos__altLabel mesh__D011966 LHFSHRH Receptors
% 219.75/219.90  |- skos__altLabel mesh__D011966 GnRH Receptor
% 219.75/219.90  |- skos__hiddenLabel mesh__D011966
% 219.75/219.90       Receptors, Gonadotropin Releasing Hormone
% 219.75/219.90  |- skos__altLabel mesh__D011966 Receptors, Gonadoliberin
% 219.75/219.90  |- skos__altLabel mesh__D011966 Receptors, Gonadorelin
% 219.75/219.90  |- skos__historyNote mesh__D011966
% 219.75/219.90       Receptors, Endogenous Substances %28%1973-1986%29%
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D011966 2005
% 219.75/219.90  |- skos__altLabel mesh__D011966 Gonadotropin Releasing-Hormone Receptors
% 219.75/219.90  |- skos__altLabel mesh__D011966 Gonadoliberin Receptors
% 219.75/219.90  |- skos__altLabel mesh__D011966 GnRH Receptors
% 219.75/219.90  |- skos__hiddenLabel mesh__D011966 Gonadotropin Releasing Hormone Receptors
% 219.75/219.90  |- mesh__dateEstablished mesh__D011966 1987-01-01
% 219.75/219.90  |- skos__altLabel mesh__D011966 Receptors, GnRH
% 219.75/219.90  |- skos__hiddenLabel mesh__D011966
% 219.75/219.90       Luteinizing Hormone Releasing Hormone Receptor
% 219.75/219.90  |- skos__altLabel mesh__D011966 Receptors, LHFSHRH
% 219.75/219.90  |- mesh__publicMeSHNote mesh__D044342
% 219.75/219.90       2004; see NUTRITION DISORDERS 1975-2003   
% 219.75/219.90  |- skos__broader mesh__D044342smesh__D009748
% 219.75/219.90  |- skos__historyNote mesh__D044342 Nutrition Disorders %28%1964-2003%29%
% 219.75/219.90  |- mesh__dateEstablished mesh__D044342 2004-01-01
% 219.75/219.90  |- skos__prefLabel mesh__D044342 Malnutrition
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D044342 2006
% 219.75/219.90  |- skos__altLabel mesh__D044342 Undernutrition
% 219.75/219.90  |- mesh__dateCreated mesh__D044342 2003-07-09
% 219.75/219.90  |- rdf__type mesh__D044342sskos__Concept
% 219.75/219.90  |- skos__altLabel mesh__D044342 Nutritional Deficiency
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D044342 2005
% 219.75/219.90  |- mesh__historyNote mesh__D044342
% 219.75/219.90       2004; use NUTRITION DISORDERS 1975-2003   
% 219.75/219.90  |- skos__scopeNote mesh__D044342
% 219.75/219.90       An imbalanced nutritional status resulted from insufficient intake of nutrients to meet normal physiological requirement.%A%    
% 219.75/219.90  |- skos__hiddenLabel mesh__D044342 Nutritional Deficiencies
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D044342 2004
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D011168 2001
% 219.75/219.90  |- mesh__recordMaintainer mesh__D011168 TAP
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D011168 1994
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D011168 2003
% 219.75/219.90  |- mesh__dateCreated mesh__D011168 1999-01-01
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D011168 2000
% 219.75/219.90  |- mesh__recordOriginator mesh__D011168 NLM
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D011168 2006
% 219.75/219.90  |- skos__scopeNote mesh__D011168
% 219.75/219.90       A system of vessels in which blood, after passing through one capillary bed, is conveyed through a second set of capillaries before it returns to the systemic circulation. It pertains especially to the hepatic portal system.%A%    
% 219.75/219.90  |- skos__related mesh__D011168smesh__D011172
% 219.75/219.90  |- skos__prefLabel mesh__D011168 Portal System
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D011168 1997
% 219.75/219.90  |- skos__hiddenLabel mesh__D011168 Portal Systems
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D011168 2005
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D011168 1993
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D011168 2002
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D011168 1996
% 219.75/219.90  |- rdf__type mesh__D011168sskos__Concept
% 219.75/219.90  |- skos__hiddenLabel mesh__D011168 Systems, Portal
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D011168 1999
% 219.75/219.90  |- skos__broader mesh__D011168smesh__D014680
% 219.75/219.90  |- skos__hiddenLabel mesh__D011168 System, Portal
% 219.75/219.90  |- mesh__recordAuthorizer mesh__D011168 PLS
% 219.75/219.90  |- mesh__dateRevised mesh__D011168 1992-05-18
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D011168 1995
% 219.75/219.90  |- skos__related mesh__D011168smesh__D008102
% 219.75/219.90  |- skos__annotation mesh__D011168 /radiogr: consider also PORTOGRAPHY   
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D011168 2004
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D011168 1998
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D005929 2001
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D005929 2004
% 219.75/219.90  |- mesh__recordAuthorizer mesh__D005929 sjn
% 219.75/219.90  |- skos__hiddenLabel mesh__D005929 Benign Migratory Glossitis
% 219.75/219.90  |- skos__hiddenLabel mesh__D005929 Migratory Glossitis, Benign
% 219.75/219.90  |- mesh__recordMaintainer mesh__D005929 adp
% 219.75/219.90  |- skos__altLabel mesh__D005929 Tongue, Geographic
% 219.75/219.90  |- mesh__dateEstablished mesh__D005929 1965-01-01
% 219.75/219.90  |- mesh__recordOriginator mesh__D005929 NLM
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D005929 2002
% 219.75/219.90  |- skos__altLabel mesh__D005929 Glossitis Areata Exfoliativa
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D005929 2005
% 219.75/219.90  |- skos__scopeNote mesh__D005929
% 219.75/219.90       An idiopathic disorder characterized by the loss of filiform papillae leaving reddened areas of circinate macules bound by a white band. The lesions heal, then others erupt.%A%    
% 219.75/219.90  |- rdf__type mesh__D005929sskos__Concept
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D005929 2006
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D005929 2000
% 219.75/219.90  |- mesh__publicMeSHNote mesh__D005929 65   
% 219.75/219.90  |- mesh__dateCreated mesh__D005929 1999-01-01
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D005929 2003
% 219.75/219.90  |- skos__broader mesh__D005929smesh__D005928
% 219.75/219.90  |- skos__altLabel mesh__D005929 Geographic Tongue
% 219.75/219.90  |- mesh__historyNote mesh__D005929 65   
% 219.75/219.90  |- skos__prefLabel mesh__D005929 Glossitis, Benign Migratory
% 219.75/219.90  |- mesh__dateRevised mesh__D005929 1999-11-08
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D016651 2002
% 219.75/219.90  |- skos__hiddenLabel mesh__D016651 NSC 16895
% 219.75/219.90  |- skos__hiddenLabel mesh__D016651 Carbonate, Dilithium
% 219.75/219.90  |- skos__altLabel mesh__D016651 Dilithium Carbonate
% 219.75/219.90  |- rdf__type mesh__D016651sskos__Concept
% 219.75/219.90  |- mesh__dateCreated mesh__D016651 1991-01-25
% 219.75/219.90  |- skos__historyNote mesh__D016651 Tranquilizing Agents %28%1966-1991%29%
% 219.75/219.90  |- skos__scopeNote mesh__D016651
% 219.75/219.90       A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems.%A%    
% 219.75/219.90  |- mesh__onlineNote mesh__D016651
% 219.75/219.90       use LITHIUM CARBONATE %28%NM%29% to search LITHIUM CARBONATE 1977-91%A%  
% 219.75/219.90  |- mesh__dateRevised mesh__D016651 2001-07-25
% 219.75/219.90  |- skos__hiddenLabel mesh__D016651 Quilinorm retard
% 219.75/219.90  |- skos__hiddenLabel mesh__D016651 CP 15,467 61
% 219.75/219.90  |- mesh__recordAuthorizer mesh__D016651 sjn
% 219.75/219.90  |- mesh__publicMeSHNote mesh__D016651
% 219.75/219.90       92; LITHIUM CARBONATE was indexed under LITHIUM 1969-91   
% 219.75/219.90  |- skos__hiddenLabel mesh__D016651 Quilinormretard
% 219.75/219.90  |- skos__historyNote mesh__D016651 Lithium %28%1966-1991%29%
% 219.75/219.90  |- skos__broader mesh__D016651smesh__D018020
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D016651 2004
% 219.75/219.90  |- skos__hiddenLabel mesh__D016651 CP15,46761
% 219.75/219.90  |- skos__hiddenLabel mesh__D016651 NSC16895
% 219.75/219.90  |- skos__hiddenLabel mesh__D016651 Carbonate, Lithium
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D016651 2006
% 219.75/219.90  |- skos__prefLabel mesh__D016651 Lithium Carbonate
% 219.75/219.90  |- mesh__recordOriginator mesh__D016651 RLS
% 219.75/219.90  |- mesh__dateEstablished mesh__D016651 1992-01-01
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D016651 2003
% 219.75/219.90  |- mesh__historyNote mesh__D016651
% 219.75/219.90       92; was LITHIUM CARBONATE %28%NM%29% 1969-91   
% 219.75/219.90  |- mesh__recordMaintainer mesh__D016651 ssb
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D016651 2005
% 219.75/219.90  |- skos__broader mesh__D016651smesh__D002254
% 219.75/219.90  |- skos__hiddenLabel mesh__D016651 Bicarbonate, Lithium
% 219.75/219.90  |- skos__historyNote mesh__D002631 Eosinophils %28%1966-1979%29%
% 219.75/219.90  |- mesh__recordMaintainer mesh__D002631 ssb
% 219.75/219.90  |- mesh__dateEstablished mesh__D002631 1991-01-01
% 219.75/219.90  |- skos__hiddenLabel mesh__D002631 Chemotaxins, Eosinophil
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D002631 2006
% 219.75/219.90  |- skos__hiddenLabel mesh__D002631 Factors, Eosinophil Chemotactic
% 219.75/219.90  |- mesh__recordAuthorizer mesh__D002631 sjn
% 219.75/219.90  |- skos__historyNote mesh__D002631 Chemotaxis, Leukocyte %28%1977-1979%29%
% 219.75/219.90  |- skos__altLabel mesh__D002631 Eosinophil Chemotaxins
% 219.75/219.90  |- skos__annotation mesh__D002631
% 219.75/219.90       chemotactic substances attracting eosinophils, not liberated by eosinophils; /biosyn /physiol permitted; DF: ECF A%A%  
% 219.75/219.90  |- skos__broader mesh__D002631smesh__D002630
% 219.75/219.90  |- mesh__historyNote mesh__D002631
% 219.75/219.90       91%28%80%29%; was see under CHEMOTACTIC FACTORS 1980-90   
% 219.75/219.90  |- mesh__dateRevised mesh__D002631 2005-06-30
% 219.75/219.90  |- skos__altLabel mesh__D002631 Eosinophil Chemotactic Factors
% 219.75/219.90  |- skos__historyNote mesh__D002631 Chemotaxis %28%1966-1979%29%
% 219.75/219.90  |- skos__prefLabel mesh__D002631 Chemotactic Factors, Eosinophil
% 219.75/219.90  |- rdf__type mesh__D002631sskos__Concept
% 219.75/219.90  |- mesh__publicMeSHNote mesh__D002631
% 219.75/219.90       91; was see under CHEMOTACTIC FACTORS 1980-90   
% 219.75/219.90  |- mesh__dateCreated mesh__D002631 1979-04-30
% 219.75/219.90  |- mesh__recordOriginator mesh__D002631 SH
% 219.75/219.90  |- skos__scopeNote mesh__D002631
% 219.75/219.90       Cytotaxins liberated from normal or invading cells that specifically attract eosinophils; they may be complement fragments, lymphokines, neutrophil products, histamine or other; the best known is the tetrapeptide ECF-A, released mainly by mast cells.%A%    
% 219.75/219.90  |- skos__altLabel mesh__D026281 DEFA Protein
% 219.75/219.90  |- rdf__type mesh__D026281sskos__Concept
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D026281 2005
% 219.75/219.90  |- skos__historyNote mesh__D026281 Homeodomain Proteins %28%1997-2001%29%
% 219.75/219.90  |- skos__broader mesh__D026281smesh__D026161
% 219.75/219.90  |- mesh__historyNote mesh__D026281
% 219.75/219.90       2002; use DEFICIENS PROTEIN %28%NM%29% 1996-2001   
% 219.75/219.90  |- skos__annotation mesh__D026281
% 219.75/219.90       DEFICIENS-AGAMOUS-LIKE PROTEINS see MADS DOMAIN PROTEINS is also available%A%  
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D026281 2004
% 219.75/219.90  |- skos__scopeNote mesh__D026281
% 219.75/219.90       DEFICIENS is a homeotic gene involved in the genetic control of Antirrhinum majus flower development. Its protein is one of the four founder proteins that structurally define the superfamily of MADS DOMAIN PROTEINS.%A%    
% 219.75/219.90  |- mesh__dateCreated mesh__D026281 2001-07-25
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D026281 2002
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D026281 2003
% 219.75/219.90  |- skos__prefLabel mesh__D026281 DEFICIENS Protein
% 219.75/219.90  |- skos__broader mesh__D026281smesh__D010940
% 219.75/219.90  |- mesh__publicMeSHNote mesh__D026281
% 219.75/219.90       2002; DEFICIENS PROTEIN was indexed under HOMEODOMAIN PROTEINS 1996-2001%A%  
% 219.75/219.90  |- mesh__dateEstablished mesh__D026281 2002-01-01
% 219.75/219.90  |- mesh__activeMeSHYear mesh__D026281 2006
% 219.75/219.90  |- skos__broader mesh__D001539smesh__D001581
% 219.75/219.90  |- skos__altLabel mesh__D001539
% 219.75/219.90       Schaper %26% Br%C3%%BC%mmer Brand of Bendroflumethiazide
% 219.75/219.90  |- skos__altLabel mesh__D001539 Bendrofluazide
% 219.75/219.90  |- skos__altLabel mesh__D001539 Knoll Brand of Bendroflumethiazide
% 219.75/219.90  |- skos__hiddenLabel mesh__D001539 Bendroflumethiazide Berk Brand
% 219.75/219.90  |- skos__altLabel mesh__D001539 DDSA Brand of Bendroflumethiazide
% 219.75/219.90  |- skos__altLabel mesh__D001539 Apothecon Brand of Bendroflumethiazide
% 219.75/219.90  |- skos__hiddenLabel mesh__D001539 Neo NaClex
% 219.75/219.90  |- mesh__recordAuthorizer mesh__D001539 sjn
% 219.75/219.90  |- skos__altLabel mesh__D001539
% 219.75/219.90       Bristol-Myers Squibb Brand of Bendroflumethiazide
% 219.75/219.90  |- skos__altLabel mesh__D001539 Protea Brand of Bendroflumethiazide
% 219.75/219.90  |- skos__altLabel mesh__D001539 Goldshield Brand of Bendroflumethiazide
% 219.75/219.90  |- mesh__dateCreated mesh__D001539 1999-01-01
% 219.75/219.90  |- skos__hiddenLabel mesh__D001539 NeoNaClex
% 219.75/219.90  |- skos__hiddenLabel mesh__D001539 Bendroflumethiazide Protea Brand
% 219.75/219.90  |- skos__hiddenLabel mesh__D001539 Bendroflumethiazide Leo Brand
% 219.75/219.90  |- skos__altLabel mesh__D001539 Benzide-M
% 219.75/219.90  |- skos__prefLabel mesh__D001539 Bendroflumethiazide
% 219.75/219.90  |- skos__hiddenLabel mesh__D001539 Bendroflumethiazide DDSA Brand
% 219.75/219.90  |- skos__altLabel mesh__D001539 Berk Brand of Bendroflumethiazide
% 219.75/219.90  |- mesh__recordMaintainer mesh__D001539 ssb
% 219.75/219.91  |- mesh__activeMeSHYear mesh__D001539 2006
% 219.75/219.91  |- rdf__type mesh__D001539sskos__Concept
% 219.75/219.91  |- skos__hiddenLabel mesh__D001539 Benzide M
% 219.75/219.91  |- skos__hiddenLabel mesh__D001539 Bendroflumethiazide Knoll Brand
% 219.75/219.91  |- skos__altLabel mesh__D001539 Naturine
% 219.75/219.91  |- skos__hiddenLabel mesh__D001539 Bendroflumethiazide Apothecon Brand
% 219.75/219.91  |- skos__scopeNote mesh__D001539
% 219.75/219.91       A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p810%29%%A%    
% 219.75/219.91  |- skos__altLabel mesh__D001539 Pluryl
% 219.75/219.91  |- skos__hiddenLabel mesh__D001539
% 219.75/219.91       Bristol Myers Squibb Brand of Bendroflumethiazide
% 219.75/219.91  |- skos__hiddenLabel mesh__D001539 BenzideM
% 219.75/219.91  |- skos__altLabel mesh__D001539 Leo Brand of Bendroflumethiazide
% 219.75/219.91  |- mesh__dateRevised mesh__D001539 2005-06-30
% 219.75/219.91  |- mesh__recordOriginator mesh__D001539 NLM
% 219.75/219.91  |- skos__hiddenLabel mesh__D001539 Bendroflumethiazide Goldshield Brand
% 219.75/219.91  |- mesh__recordAuthorizer mesh__D012261 sjn
% 219.75/219.91  |- mesh__dateCreated mesh__D012261 1975-07-25
% 219.75/219.91  |- mesh__dateEstablished mesh__D012261 1984-01-01
% 219.75/219.91  |- skos__historyNote mesh__D012261 specific RNA%28%1966-1975%29%
% 219.75/219.91  |- mesh__historyNote mesh__D012261
% 219.75/219.91       84%28%76%29%; was see under NUCLEOPROTEINS 1976-83   
% 219.75/219.91  |- mesh__publicMeSHNote mesh__D012261
% 219.75/219.91       84; was see under NUCLEOPROTEINS 1976-83   
% 219.75/219.91  |- skos__prefLabel mesh__D012261 Ribonucleoproteins
% 219.75/219.91  |- mesh__activeMeSHYear mesh__D012261 2006
% 219.75/219.91  |- mesh__recordOriginator mesh__D012261 RLS
% 219.75/219.91  |- skos__historyNote mesh__D012261 RNA %28%1966-1975%29%
% 219.75/219.91  |- mesh__dateRevised mesh__D012261 2005-06-30
% 219.75/219.91  |- skos__historyNote mesh__D012261 Nucleoproteins %28%1966-1975%29%
% 219.75/219.91  |- rdf__type mesh__D012261sskos__Concept
% 219.75/219.91  |- skos__altLabel mesh__D012261 Ribonucleoprotein
% 219.75/219.91  |- skos__scopeNote mesh__D012261
% 219.75/219.91       Complexes of RNA-binding proteins with ribonucleic acids %28%RNA%29%.%A%    
% 219.75/219.91  |- skos__broader mesh__D012261smesh__D016601
% 219.75/219.91  |- mesh__recordMaintainer mesh__D012261 SYSTEM
% 219.75/219.91  |- mesh__recordOriginator mesh__D006224 NLM
% 219.75/219.91  |- skos__altLabel mesh__D006224 Hamsters
% 219.75/219.91  |- mesh__publicMeSHNote mesh__D006224
% 219.75/219.91       2006; for CRICETUS see HAMSTERS 1966-1981   
% 219.75/219.91  |- skos__broader mesh__D006224smesh__D009115
% 219.75/219.91  |- rdf__type mesh__D006224sskos__Concept
% 219.75/219.91  |- skos__prefLabel mesh__D006224 Cricetinae
% 219.75/219.91  |- skos__scopeNote mesh__D006224
% 219.75/219.91       A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS.%A%    
% 219.75/219.91  |- mesh__dateCreated mesh__D006224 1999-01-01
% 219.75/219.91  |- mesh__dateRevised mesh__D006224 2005-06-30
% 219.75/219.91  |- mesh__recordMaintainer mesh__D006224 ags
% 219.75/219.91  |- mesh__recordAuthorizer mesh__D006224 sjn
% 219.75/219.91  |- mesh__activeMeSHYear mesh__D006224 2006
% 219.75/219.91  |- skos__annotation mesh__D006224
% 219.75/219.91       check tag: NIM no qualifiers for HAMSTERS or any CRICETINAE%A%  
% 219.75/219.91  |- mesh__historyNote mesh__D006224 2006 %28%1963%29%   
% 219.75/219.91  |- skos__hiddenLabel mesh__D006224 Hamster
% 219.75/219.91  |- skos__altLabel mesh__D050380 Monckeberg%27%s Medial Calcific Sclerosis
% 219.75/219.91  |- mesh__dateEstablished mesh__D050380 2006-01-01
% 219.75/219.91  |- skos__altLabel mesh__D050380 Medial Calcific Sclerosis
% 219.75/219.91  |- skos__hiddenLabel mesh__D050380 Scleroses, Medial Calcific
% 219.75/219.91  |- skos__hiddenLabel mesh__D050380 Calcific Sclerosis, Medial
% 219.75/219.91  |- skos__historyNote mesh__D050380 Arteriosclerosis %28%1999-2005%29%
% 219.75/219.91  |- mesh__publicMeSHNote mesh__D050380
% 219.75/219.91       2006; see ARTERIOSCLEROSIS 2001-2005   
% 219.75/219.91  |- skos__broader mesh__D050380smesh__D001161
% 219.75/219.91  |- skos__hiddenLabel mesh__D050380 Calcific Scleroses, Medial
% 219.75/219.91  |- mesh__activeMeSHYear mesh__D050380 2006
% 219.75/219.91  |- skos__hiddenLabel mesh__D050380 Sclerosis, Medial Calcific
% 219.75/219.91  |- skos__altLabel mesh__D050380 Sclerosis, Monckeberg Medial Calcific
% 219.75/219.91  |- skos__hiddenLabel mesh__D050380 Medial Calcific Scleroses
% 219.75/219.91  |- mesh__historyNote mesh__D050380 2006; use ARTERIOSCLEROSIS 2001-2005   
% 219.75/219.91  |- mesh__recordOriginator mesh__D050380 lkt
% 219.75/219.91  |- rdf__type mesh__D050380sskos__Concept
% 219.75/219.91  |- skos__scopeNote mesh__D050380
% 219.75/219.91       Thickening and loss of elasticity of the walls of muscular ARTERIES due to calcification of the TUNICA MEDIA, the concentric layers of helically arranged SMOOTH MUSCLE CELLS.%A%    
% 219.75/219.91  |- mesh__recordMaintainer mesh__D050380 lkt
% 219.75/219.91  |- mesh__dateCreated mesh__D050380 2005-06-30
% 219.75/219.91  |- mesh__recordAuthorizer mesh__D050380 sjn
% 219.75/219.91  |- skos__prefLabel mesh__D050380 Monckeberg Medial Calcific Sclerosis
% 219.75/219.91  |- mesh__activeMeSHYear mesh__D011967 2002
% 219.75/219.91  |- skos__hiddenLabel mesh__D011967 Gonadotropin Receptor, Pituitary
% 219.75/219.91  |- skos__broader mesh__D011967smesh__D011979
% 219.75/219.91  |- mesh__activeMeSHYear mesh__D011967 2005
% 219.75/219.91  |- skos__hiddenLabel mesh__D011967 Gonadotropin Receptors, Pituitary
% 219.75/219.91  |- skos__altLabel mesh__D011967 Pituitary Gonadotropin Receptors
% 219.75/219.91  |- skos__altLabel mesh__D011967 Receptors, Pituitary Gonadotropin
% 219.75/219.91  |- mesh__recordOriginator mesh__D011967 SH
% 219.75/219.91  |- rdf__type mesh__D011967sskos__Concept
% 219.75/219.91  |- mesh__dateCreated mesh__D011967 1986-03-25
% 219.75/219.91  |- skos__prefLabel mesh__D011967 Receptors, Gonadotropin
% 219.75/219.91  |- skos__altLabel mesh__D011967 Menotropin Receptors
% 219.75/219.91  |- skos__historyNote mesh__D011967
% 219.75/219.91       Receptors, Endogenous Substances %28%1973-1986%29%
% 219.75/219.91  |- skos__historyNote mesh__D011967
% 219.75/219.91       Gonadotropins, Pituitary %28%1966-1986%29%
% 219.75/219.91  |- skos__hiddenLabel mesh__D011967 Gonadotropins Receptors
% 219.75/219.91  |- mesh__recordAuthorizer mesh__D011967 sjn
% 219.75/219.91  |- skos__altLabel mesh__D011967 Pituitary Gonadotropin Receptor
% 219.75/219.91  |- skos__hiddenLabel mesh__D011967 Receptor, Pituitary Gonadotropin
% 219.75/219.91  |- skos__altLabel mesh__D011967 Gonadotropin Receptors
% 219.75/219.91  |- mesh__recordMaintainer mesh__D011967 sjn
% 219.75/219.91  |- mesh__publicMeSHNote mesh__D011967 87   
% 219.75/219.91  |- skos__historyNote mesh__D011967
% 219.75/219.91       Gonadotropins, Chorionic %28%1966-1986%29%
% 219.75/219.91  |- skos__annotation mesh__D011967
% 219.75/219.91       GEN; prefer specifics; DF: RECEPT GONADOTROPIN   
% 219.75/219.91  |- mesh__activeMeSHYear mesh__D011967 2004
% 219.75/219.91  |- mesh__dateEstablished mesh__D011967 1987-01-01
% 219.75/219.91  |- mesh__historyNote mesh__D011967 87   
% 219.75/219.91  |- mesh__activeMeSHYear mesh__D011967 2006
% 219.75/219.91  |- mesh__activeMeSHYear mesh__D011967 2003
% 219.75/219.91  |- mesh__dateRevised mesh__D011967 2001-08-03
% 219.75/219.91  |- skos__scopeNote mesh__D011967
% 219.75/219.91       Those protein complexes or molecular sites on the surfaces of gonadal and other sensitive cells that bind gonadotropins and thereby modify the functions of those cells; hCG, LH, and FOLLICLE STIMULATING HORMONE are the major specific gonadotropins.%A%    
% 219.75/219.91  |- skos__hiddenLabel mesh__D011967 Receptor, Gonadotopin
% 219.75/219.91  |- skos__altLabel mesh__D011967 Receptors, Gonadotropins
% 219.75/219.91  |- skos__altLabel mesh__D011967 Gonadotopin Receptor
% 219.75/219.91  |- skos__scopeNote mesh__D044343
% 219.75/219.91       An imbalanced nutritional status resulted from excessive intake of nutrients. Generally, overnutrition generates an energy imbalance between food consumption and energy expenditure leading to disorders such as OBESITY.%A%    
% 219.75/219.91  |- mesh__activeMeSHYear mesh__D044343 2006
% 219.75/219.91  |- mesh__historyNote mesh__D044343 2004   
% 219.76/219.91  |- mesh__dateCreated mesh__D044343 2003-07-09
% 219.76/219.91  |- rdf__type mesh__D044343sskos__Concept
% 219.76/219.91  |- skos__prefLabel mesh__D044343 Overnutrition
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D044343 2005
% 219.76/219.91  |- mesh__publicMeSHNote mesh__D044343 2004   
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D044343 2004
% 219.76/219.91  |- mesh__dateEstablished mesh__D044343 2004-01-01
% 219.76/219.91  |- skos__broader mesh__D044343smesh__D009748
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D011169 1995
% 219.76/219.91  |- mesh__dateCreated mesh__D011169 1999-01-01
% 219.76/219.91  |- mesh__recordOriginator mesh__D011169 NLM
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D011169 2000
% 219.76/219.91  |- skos__hiddenLabel mesh__D011169 Vein, Portal
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D011169 2003
% 219.76/219.91  |- skos__annotation mesh__D011169
% 219.76/219.91       /radiogr permitted but PORTOGRAPHY is more likely   
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D011169 1994
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D011169 1997
% 219.76/219.91  |- skos__prefLabel mesh__D011169 Portal Vein
% 219.76/219.91  |- skos__broader mesh__D011169smesh__D011168
% 219.76/219.91  |- skos__hiddenLabel mesh__D011169 Veins, Portal
% 219.76/219.91  |- skos__related mesh__D011169smesh__D011172
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D011169 1996
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D011169 2006
% 219.76/219.91  |- rdf__type mesh__D011169sskos__Concept
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D011169 2002
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D011169 2005
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D011169 1993
% 219.76/219.91  |- skos__scopeNote mesh__D011169
% 219.76/219.91       A short thick vein formed by union of the superior mesenteric vein and the splenic vein.%A%    
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D011169 1999
% 219.76/219.91  |- mesh__recordAuthorizer mesh__D011169 PLS
% 219.76/219.91  |- skos__hiddenLabel mesh__D011169 Portal Veins
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D011169 1998
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D011169 2001
% 219.76/219.91  |- mesh__dateRevised mesh__D011169 1992-05-18
% 219.76/219.91  |- mesh__recordMaintainer mesh__D011169 TAP
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D011169 2004
% 219.76/219.91  |- mesh__historyNote mesh__D002632
% 219.76/219.91       91%28%80%29%; was see under CHEMOTACTIC FACTORS 1980-90   
% 219.76/219.91  |- skos__altLabel mesh__D002632 Macrophage Chemotaxins
% 219.76/219.91  |- skos__historyNote mesh__D002632 Chemotaxis, Leukocyte %28%1977-1979%29%
% 219.76/219.91  |- mesh__recordMaintainer mesh__D002632 ssb
% 219.76/219.91  |- skos__hiddenLabel mesh__D002632 Chemotaxins, Macrophage
% 219.76/219.91  |- mesh__dateCreated mesh__D002632 1979-04-30
% 219.76/219.91  |- mesh__recordOriginator mesh__D002632 SH
% 219.76/219.91  |- skos__broader mesh__D002632smesh__D002630
% 219.76/219.91  |- skos__hiddenLabel mesh__D002632 Factors, Macrophage Chemotactic
% 219.76/219.91  |- skos__historyNote mesh__D002632 Chemotaxis %28%1966-1979%29%
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D002632 2006
% 219.76/219.91  |- skos__historyNote mesh__D002632 Macrophages %28%1966-1979%29%
% 219.76/219.91  |- skos__altLabel mesh__D002632 Macrophage Chemotactic Factors
% 219.76/219.91  |- mesh__dateEstablished mesh__D002632 1991-01-01
% 219.76/219.91  |- mesh__publicMeSHNote mesh__D002632
% 219.76/219.91       91; was see under CHEMOTACTIC FACTORS 1980-90   
% 219.76/219.91  |- mesh__recordAuthorizer mesh__D002632 sjn
% 219.76/219.91  |- skos__scopeNote mesh__D002632
% 219.76/219.91       Cytotaxins liberated from normal or invading cells that specifically attract macrophages. They may be lymphokines, products of antigen, antibody and complement interactions or other.%A%    
% 219.76/219.91  |- skos__annotation mesh__D002632
% 219.76/219.91       chemotactic substances attracting macrophages, not liberated by macrophages; /biosyn /physiol permitted%A%  
% 219.76/219.91  |- rdf__type mesh__D002632sskos__Concept
% 219.76/219.91  |- skos__prefLabel mesh__D002632 Chemotactic Factors, Macrophage
% 219.76/219.91  |- mesh__dateRevised mesh__D002632 2005-06-30
% 219.76/219.91  |- mesh__recordOriginator mesh__D012262 NLM
% 219.76/219.91  |- mesh__recordMaintainer mesh__D012262 jmp
% 219.76/219.91  |- skos__prefLabel mesh__D012262 Ribonucleoside Diphosphate Reductase
% 219.76/219.91  |- mesh__dateCreated mesh__D012262 1999-01-01
% 219.76/219.91  |- skos__hiddenLabel mesh__D012262 Reductase, Ribonucleoside Diphosphate
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D012262 2006
% 219.76/219.91  |- mesh__recordAuthorizer mesh__D012262 sjn
% 219.76/219.91  |- skos__hiddenLabel mesh__D012262 Diphosphate Reductase, Ribonucleoside
% 219.76/219.91  |- mesh__publicMeSHNote mesh__D012262
% 219.76/219.91       91; was see under RIBONUCLEOTIDE REDUCTASES 1975-90   
% 219.76/219.91  |- mesh__onlineNote mesh__D012262 search RIBONUCLEOTIDE REDUCTASES 1974   
% 219.76/219.91  |- skos__scopeNote mesh__D012262
% 219.76/219.91       An enzyme of the oxidoreductase class that catalyzes the formation of 2%27%-deoxyribonucleotides from the corresponding ribonucleotides using NADPH as the ultimate electron donor. The deoxyribonucleoside diphosphates are used in DNA synthesis. %28%From Dorland, 27th ed%29% EC 1.17.4.1.%A%    
% 219.76/219.91  |- rdf__type mesh__D012262sskos__Concept
% 219.76/219.91  |- mesh__dateEstablished mesh__D012262 1991-01-01
% 219.76/219.91  |- skos__hiddenLabel mesh__D012262 Reductase, UDP
% 219.76/219.91  |- mesh__historyNote mesh__D012262
% 219.76/219.91       91%28%75%29%; was see under RIBONUCLEOTIDE REDUCTASES 1975-90   
% 219.76/219.91  |- skos__broader mesh__D012262smesh__D012264
% 219.76/219.91  |- mesh__dateRevised mesh__D012262 2005-06-30
% 219.76/219.91  |- mesh__recordOriginator mesh__D006225 NLM
% 219.76/219.91  |- skos__hiddenLabel mesh__D006225 Hands
% 219.76/219.91  |- mesh__dateRevised mesh__D006225 2002-07-03
% 219.76/219.91  |- mesh__dateCreated mesh__D006225 1999-01-01
% 219.76/219.91  |- mesh__onlineNote mesh__D006225
% 219.76/219.91       use HAND /AB %26% HAND DEFORMITIES, ACQUIRED to search HAND DEFORMITY 1966-70; in searching non-acquired hand abnormalities consider HAND DEFORMITIES, ACQUIRED 1966-72%A%  
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D006225 2006
% 219.76/219.91  |- skos__prefLabel mesh__D006225 Hand
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D006225 2005
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D006225 2004
% 219.76/219.91  |- mesh__publicMeSHNote mesh__D006225
% 219.76/219.91       HAND DEFORMITIES was heading 1966-70   
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D006225 2003
% 219.76/219.91  |- mesh__recordAuthorizer mesh__D006225 sjn
% 219.76/219.91  |- skos__annotation mesh__D006225
% 219.76/219.91       primates only; /inj = HAND INJURIES; skin dis of hand = HAND DERMATOSES: see note there%A%  
% 219.76/219.91  |- mesh__recordMaintainer mesh__D006225 TPW
% 219.76/219.91  |- rdf__type mesh__D006225sskos__Concept
% 219.76/219.91  |- mesh__historyNote mesh__D006225 HAND DEFORMITIES was heading 1966-70   
% 219.76/219.91  |- skos__broader mesh__D006225smesh__D034941
% 219.76/219.91  |- mesh__dateRevised mesh__D011968 2005-06-30
% 219.76/219.91  |- rdf__type mesh__D011968sskos__Concept
% 219.76/219.91  |- skos__historyNote mesh__D011968 Histamine %28%1970-1976%29%
% 219.76/219.91  |- skos__prefLabel mesh__D011968 Receptors, Histamine
% 219.76/219.91  |- skos__annotation mesh__D011968
% 219.76/219.91       GEN or unspecified; prefer specifics; coord IM with specific histamine cpd %28%IM%29%; DF: RECEPT HISTAMINE%A%  
% 219.76/219.91  |- mesh__dateEstablished mesh__D011968 1977-01-01
% 219.76/219.91  |- skos__hiddenLabel mesh__D011968 Binding Sites, Histamine
% 219.76/219.91  |- mesh__dateCreated mesh__D011968 1976-05-03
% 219.76/219.91  |- skos__historyNote mesh__D011968 Receptors, Drug %28%1970-1976%29%
% 219.76/219.91  |- skos__historyNote mesh__D011968
% 219.76/219.91       Receptors, Endogenous Substances %28%1973-1976%29%
% 219.76/219.91  |- mesh__recordMaintainer mesh__D011968 jmp
% 219.76/219.91  |- skos__scopeNote mesh__D011968
% 219.76/219.91       Cell-surface proteins that bind histamine and trigger intracellular changes influencing the behavior of cells. Histamine receptors are widespread in the central nervous system and in peripheral tissues. Three types have been recognized and designated H1, H2, and H3. They differ in pharmacology, distribution, and mode of action.%A%    
% 219.76/219.91  |- skos__hiddenLabel mesh__D011968 Receptor, Histamine
% 219.76/219.91  |- mesh__historyNote mesh__D011968 77   
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D011968 2006
% 219.76/219.91  |- mesh__recordAuthorizer mesh__D011968 sjn
% 219.76/219.91  |- mesh__publicMeSHNote mesh__D011968 77   
% 219.76/219.91  |- skos__altLabel mesh__D011968 Histamine Receptors
% 219.76/219.91  |- skos__hiddenLabel mesh__D011968 Sites, Histamine Binding
% 219.76/219.91  |- skos__broader mesh__D011968smesh__D017982
% 219.76/219.91  |- mesh__recordOriginator mesh__D011968 SH
% 219.76/219.91  |- skos__altLabel mesh__D011968 Histamine Receptor
% 219.76/219.91  |- skos__broader mesh__D015632Q000506smesh__D015632
% 219.76/219.91  |- mesh__preferredCombination mesh__D015632Q000506smesh__D020267
% 219.76/219.91  |- rdf__type mesh__D015632Q000506smesh__CompoundConcept
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D002633 2003
% 219.76/219.91  |- mesh__recordMaintainer mesh__D002633 mdb
% 219.76/219.91  |- mesh__dateEstablished mesh__D002633 1970-01-01
% 219.76/219.91  |- skos__related mesh__D002633smesh__D002630
% 219.76/219.91  |- skos__scopeNote mesh__D002633
% 219.76/219.91       The movement of cells or organisms toward or away from a substance in response to its concentration gradient.%A%    
% 219.76/219.91  |- skos__broader mesh__D002633smesh__D002465
% 219.76/219.91  |- mesh__recordAuthorizer mesh__D002633 sjn
% 219.76/219.91  |- mesh__dateRevised mesh__D002633 2002-07-03
% 219.76/219.91  |- mesh__historyNote mesh__D002633 70%28%65%29%   
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D002633 2006
% 219.76/219.91  |- skos__related mesh__D002633smesh__D002628
% 219.76/219.91  |- mesh__publicMeSHNote mesh__D002633 70   
% 219.76/219.91  |- mesh__recordOriginator mesh__D002633 NLM
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D002633 2005
% 219.76/219.91  |- rdf__type mesh__D002633sskos__Concept
% 219.76/219.91  |- mesh__dateCreated mesh__D002633 1999-01-01
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D002633 2004
% 219.76/219.91  |- skos__prefLabel mesh__D002633 Chemotaxis
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D012263 2005
% 219.76/219.91  |- mesh__publicMeSHNote mesh__D012263 73   
% 219.76/219.91  |- mesh__historyNote mesh__D012263 73%28%71%29%   
% 219.76/219.91  |- mesh__dateEstablished mesh__D012263 1973-01-01
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D012263 2004
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D012263 2002
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D012263 2006
% 219.76/219.91  |- skos__prefLabel mesh__D012263 Ribonucleosides
% 219.76/219.91  |- mesh__recordAuthorizer mesh__D012263 SJN
% 219.76/219.91  |- mesh__dateRevised mesh__D012263 1997-06-20
% 219.76/219.91  |- skos__historyNote mesh__D012263 specific nucleoside %28%1966-1970%29%
% 219.76/219.91  |- mesh__recordOriginator mesh__D012263 NLM
% 219.76/219.91  |- rdf__type mesh__D012263sskos__Concept
% 219.76/219.91  |- skos__historyNote mesh__D012263 Nucleosides %28%1966-1970%29%
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D012263 2000
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D012263 1998
% 219.76/219.91  |- skos__scopeNote mesh__D012263
% 219.76/219.91       Nucleosides in which the purine or pyrimidine base is combined with ribose. %28%Dorland, 28th ed%29%%A%    
% 219.76/219.91  |- skos__broader mesh__D012263smesh__D009705
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D012263 2001
% 219.76/219.91  |- skos__annotation mesh__D012263 deoxy or desoxy = DEOXYRIBONUCLEOSIDES   
% 219.76/219.91  |- mesh__dateCreated mesh__D012263 1999-01-01
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D012263 1999
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D012263 2003
% 219.76/219.91  |- mesh__recordMaintainer mesh__D012263 TGC
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D006226 2006
% 219.76/219.91  |- mesh__recordOriginator mesh__D006226 EC
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D006226 2004
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D006226 2005
% 219.76/219.91  |- mesh__dateCreated mesh__D006226 1987-04-30
% 219.76/219.91  |- skos__prefLabel mesh__D006226 Hand Deformities
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D006226 2001
% 219.76/219.91  |- skos__hiddenLabel mesh__D006226 Deformity, Hand
% 219.76/219.91  |- skos__scopeNote mesh__D006226
% 219.76/219.91       Alterations or deviations from normal shape or size which result in a disfigurement of the hand.%A%    
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D006226 2003
% 219.76/219.91  |- skos__hiddenLabel mesh__D006226 Hand Deformity
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D006226 1999
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D006226 2000
% 219.76/219.91  |- mesh__publicMeSHNote mesh__D006226 88   
% 219.76/219.91  |- rdf__type mesh__D006226sskos__Concept
% 219.76/219.91  |- mesh__recordMaintainer mesh__D006226 TPW
% 219.76/219.91  |- mesh__dateEstablished mesh__D006226 1988-01-01
% 219.76/219.91  |- skos__hiddenLabel mesh__D006226 Deformities, Hand
% 219.76/219.91  |- mesh__historyNote mesh__D006226 88   
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D006226 1998
% 219.76/219.91  |- skos__broader mesh__D006226smesh__D009140
% 219.76/219.91  |- mesh__recordAuthorizer mesh__D006226 SJN
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D006226 2002
% 219.76/219.91  |- skos__annotation mesh__D006226
% 219.76/219.91       GEN or unspecified only; prefer specifics   
% 219.76/219.91  |- mesh__dateRevised mesh__D006226 1997-06-20
% 219.76/219.91  |- skos__altLabel mesh__D011969 Histamine H1 Receptor
% 219.76/219.91  |- mesh__publicMeSHNote mesh__D011969
% 219.76/219.91       89; was see under RECEPTORS, HISTAMINE 1977-88   
% 219.76/219.91  |- mesh__recordAuthorizer mesh__D011969 sjn
% 219.76/219.91  |- skos__altLabel mesh__D011969 H1 Receptors
% 219.76/219.91  |- skos__scopeNote mesh__D011969
% 219.76/219.91       A class of histamine receptors discriminated by their pharmacology and mode of action. Most histamine H1 receptors operate through the inositol phosphate/diacylglycerol second messenger system. Among the many responses mediated by these receptors are smooth muscle contraction, increased vascular permeability, hormone release, and cerebral glyconeogenesis. %28%From Biochem Soc Trans 1992 Feb;20%28%1%29%:122-5%29%%A%    
% 219.76/219.91  |- skos__hiddenLabel mesh__D011969 H1 Receptor, Histamine
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D011969 2006
% 219.76/219.91  |- skos__hiddenLabel mesh__D011969 H1 Receptors, Histamine
% 219.76/219.91  |- skos__broader mesh__D011969smesh__D043562
% 219.76/219.91  |- skos__historyNote mesh__D011969 Histamine %28%1966-1976%29%
% 219.76/219.91  |- mesh__recordMaintainer mesh__D011969 jmp
% 219.76/219.91  |- skos__broader mesh__D011969smesh__D011968
% 219.76/219.91  |- mesh__dateRevised mesh__D011969 2005-06-30
% 219.76/219.91  |- mesh__dateEstablished mesh__D011969 1989-01-01
% 219.76/219.91  |- skos__hiddenLabel mesh__D011969 Receptor, Histamine H1
% 219.76/219.91  |- mesh__dateCreated mesh__D011969 1976-05-05
% 219.76/219.91  |- mesh__recordOriginator mesh__D011969 SH
% 219.76/219.91  |- skos__altLabel mesh__D011969 Receptors, H1
% 219.76/219.91  |- skos__annotation mesh__D011969
% 219.76/219.91       receptors for only the classical %22%antihistaminics%22%; DF: RECEPT H1%A%  
% 219.76/219.91  |- skos__altLabel mesh__D011969 Histamine H1 Receptors
% 219.76/219.91  |- rdf__type mesh__D011969sskos__Concept
% 219.76/219.91  |- mesh__historyNote mesh__D011969
% 219.76/219.91       89%28%77%29%; was see under RECEPTORS, HISTAMINE 1977-88   
% 219.76/219.91  |- skos__prefLabel mesh__D011969 Receptors, Histamine H1
% 219.76/219.91  |- skos__historyNote mesh__D011969 Receptors, Drug %28%1970-1976%29%
% 219.76/219.91  |- skos__hiddenLabel mesh__D044345 Triester Hydrolases, Phosphoric
% 219.76/219.91  |- skos__historyNote mesh__D044345 Esterases %28%1980-2003%29%
% 219.76/219.91  |- mesh__dateCreated mesh__D044345 2003-07-09
% 219.76/219.91  |- mesh__dateEstablished mesh__D044345 2004-01-01
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D044345 2006
% 219.76/219.91  |- skos__altLabel mesh__D044345 Phosphotriesterase
% 219.76/219.91  |- mesh__publicMeSHNote mesh__D044345
% 219.76/219.91       2004; PHOSPHOTRIESTERASE was indexed under ESTERASES 1994-2003; PHOSPHORIC MONOESTER HYRDOLASES 1990-1993; PHOSPHOMONOESTERASES 1982-1989%A%  
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D044345 2005
% 219.76/219.91  |- skos__prefLabel mesh__D044345 Phosphoric Triester Hydrolases
% 219.76/219.91  |- mesh__activeMeSHYear mesh__D044345 2004
% 219.76/219.91  |- skos__scopeNote mesh__D044345
% 219.76/219.91       A class of enzymes that catalyze the hydrolysis of one of the three ester bonds in a phosphotriester-containing compound.%A%    
% 219.76/219.91  |- mesh__historyNote mesh__D044345
% 219.76/219.91       2004; for PHOSPHOTRIESTERASE use ARYLDIALKYLPHOSPHATASE %28%NM%29% 1980 - 2003%A%  
% 219.76/219.91  |- skos__hiddenLabel mesh__D044345 Hydrolases, Phosphoric Triester
% 219.76/219.91  |- skos__broader mesh__D044345smesh__D004950
% 219.76/219.91  |- rdf__type mesh__D044345sskos__Concept
% 219.76/219.91  |- mesh__dateRevised mesh__D016654 2005-06-30
% 219.76/219.91  |- mesh__dateCreated mesh__D016654 1991-06-21
% 219.76/219.91  |- skos__hiddenLabel mesh__D016654 RAG-1 Gene
% 219.76/219.91  |- mesh__recordOriginator mesh__D016654 AGS
% 219.76/219.91  |- skos__altLabel mesh__D016654 Recombination-Activating Gene-1
% 219.76/219.91  |- mesh__recordAuthorizer mesh__D016654 sjn
% 219.76/219.91  |- mesh__publicMeSHNote mesh__D016654 92   
% 219.76/219.91  |- rdf__type mesh__D016654sskos__Concept
% 219.76/219.91  |- skos__hiddenLabel mesh__D016654 Recombination Activating Genes 1
% 219.76/219.91  |- skos__hiddenLabel mesh__D016654 Gene, RAG-1
% 219.76/219.91  |- mesh__dateEstablished mesh__D016654 1992-01-01
% 219.76/219.91  |- skos__altLabel mesh__D016654 RAG-1 Genes
% 219.76/219.91  |- mesh__recordMaintainer mesh__D016654 nns
% 219.77/219.91  |- mesh__historyNote mesh__D016654 92   
% 219.77/219.91  |- skos__broader mesh__D016654smesh__D005796
% 219.77/219.91  |- skos__annotation mesh__D016654
% 219.77/219.91       RAG stands for %22%Recombination-Activating Gene%22%   
% 219.77/219.91  |- skos__altLabel mesh__D016654 Recombination-Activating Genes-1
% 219.77/219.91  |- skos__hiddenLabel mesh__D016654 RAG 1 Genes
% 219.77/219.91  |- skos__hiddenLabel mesh__D016654 Genes, RAG 1
% 219.77/219.91  |- skos__hiddenLabel mesh__D016654 Recombination Activating Gene 1
% 219.77/219.91  |- mesh__activeMeSHYear mesh__D016654 2006
% 219.77/219.91  |- skos__scopeNote mesh__D016654
% 219.77/219.91       Genes involved in activating the enzyme VDJ recombinase. RAG-1 is located on chromosome 11 in humans %28%chromosome 2 in mice%29% and is expressed exclusively in maturing lymphocytes.%A%    
% 219.77/219.91  |- skos__prefLabel mesh__D016654 Genes, RAG-1
% 219.77/219.91  |- skos__altLabel mesh__D049030 Cranin
% 219.77/219.91  |- skos__hiddenLabel mesh__D049030 Dystrophin Associated Glycoprotein 1
% 219.77/219.91  |- rdf__type mesh__D049030sskos__Concept
% 219.77/219.91  |- mesh__activeMeSHYear mesh__D049030 2006
% 219.77/219.91  |- mesh__recordMaintainer mesh__D049030 ags
% 219.77/219.91  |- skos__altLabel mesh__D049030 Dystroglycan
% 219.77/219.91  |- mesh__recordOriginator mesh__D049030 jmp
% 219.77/219.91  |- skos__related mesh__D049030smesh__D049028
% 219.77/219.91  |- mesh__activeMeSHYear mesh__D049030 2006A
% 219.77/219.91  |- skos__hiddenLabel mesh__D049030 alpha Dystroglycan
% 219.77/219.91  |- mesh__dateRevised mesh__D049030 2005-07-27
% 219.77/219.91  |- mesh__publicMeSHNote mesh__D049030
% 219.77/219.91       2005; DYSTROGLYCANS was indexed under CYTOSKELETAL PROTEINS and MEMBRANE GLYCOPROTEINS 1992-2004%A%  
% 219.77/219.91  |- skos__broader mesh__D049030smesh__D049029
% 219.77/219.91  |- skos__altLabel mesh__D049030 dystroglycan 1
% 219.77/219.91  |- mesh__historyNote mesh__D049030 2005%28%1992%29%   
% 219.77/219.91  |- mesh__dateEstablished mesh__D049030 2005-01-01
% 219.77/219.91  |- mesh__dateCreated mesh__D049030 2004-07-08
% 219.77/219.91  |- skos__prefLabel mesh__D049030 Dystroglycans
% 219.77/219.91  |- mesh__recordAuthorizer mesh__D049030 ags
% 219.77/219.91  |- mesh__activeMeSHYear mesh__D049030 2006B
% 219.77/219.91  |- skos__historyNote mesh__D049030 Membrane Glycoproteins %28%1992-2004%29%
% 219.77/219.91  |- skos__historyNote mesh__D049030 Cytoskeletal Proteins %28%1992-2004%29%
% 219.77/219.91  |- skos__scopeNote mesh__D049030
% 219.77/219.91       Dystrophin-associated proteins that play role in the formation of a transmembrane link between laminin-2 and DYSTROPHIN. Both the alpha and the beta subtypes of dystroglycan originate via POST-TRANSLATIONAL PROTEIN PROCESSING of a single precursor protein.%A%    
% 219.77/219.91  |- skos__hiddenLabel mesh__D049030 beta Dystroglycan
% 219.77/219.91  |- skos__prefLabel mesh__D002634 Chemotaxis, Leukocyte
% 219.77/219.91  |- mesh__activeMeSHYear mesh__D002634 1996
% 219.77/219.91  |- skos__hiddenLabel mesh__D002634 Leukocyte Chemotaxis
% 219.77/219.91  |- skos__broader mesh__D002634smesh__D002633
% 219.77/219.91  |- skos__annotation mesh__D002634
% 219.77/219.91       coord IM with specific type of leukocyte %28%IM%29%   
% 219.77/219.91  |- skos__scopeNote mesh__D002634
% 219.77/219.91       The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction.%A%    
% 219.77/219.91  |- mesh__dateEstablished mesh__D002634 1977-01-01
% 219.77/219.92  |- mesh__recordAuthorizer mesh__D002634 PLS
% 219.77/219.92  |- mesh__recordMaintainer mesh__D002634 TGC
% 219.77/219.92  |- mesh__dateRevised mesh__D002634 1995-03-13
% 219.77/219.92  |- skos__historyNote mesh__D002634 Chemotaxis %28%1966-1976%29%
% 219.77/219.92  |- mesh__recordOriginator mesh__D002634 MM
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D002634 2006
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D002634 2002
% 219.77/219.92  |- mesh__publicMeSHNote mesh__D002634 77   
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D002634 2005
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D002634 1999
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D002634 2001
% 219.77/219.92  |- mesh__historyNote mesh__D002634 77   
% 219.77/219.92  |- rdf__type mesh__D002634sskos__Concept
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D002634 2004
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D002634 1998
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D002634 2000
% 219.77/219.92  |- mesh__dateCreated mesh__D002634 1976-05-19
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D002634 2003
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D002634 1997
% 219.77/219.92  |- skos__altLabel mesh__D002634 Leukotaxis
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D012264 2006
% 219.77/219.92  |- skos__hiddenLabel mesh__D012264 Reductase, Ribonucleotide
% 219.77/219.92  |- rdf__type mesh__D012264sskos__Concept
% 219.77/219.92  |- skos__hiddenLabel mesh__D012264 Reductases, Ribonucleotide
% 219.77/219.92  |- skos__prefLabel mesh__D012264 Ribonucleotide Reductases
% 219.77/219.92  |- mesh__dateRevised mesh__D012264 2005-06-30
% 219.77/219.92  |- skos__broader mesh__D012264smesh__D010088
% 219.77/219.92  |- mesh__recordOriginator mesh__D012264 NLM
% 219.77/219.92  |- mesh__dateCreated mesh__D012264 1999-01-01
% 219.77/219.92  |- mesh__publicMeSHNote mesh__D012264 74   
% 219.77/219.92  |- mesh__recordMaintainer mesh__D012264 jmp
% 219.77/219.92  |- mesh__dateEstablished mesh__D012264 1974-01-01
% 219.77/219.92  |- skos__altLabel mesh__D012264 Ribonucleotide Reductase
% 219.77/219.92  |- mesh__historyNote mesh__D012264 74   
% 219.77/219.92  |- mesh__recordAuthorizer mesh__D012264 sjn
% 219.77/219.92  |- skos__altLabel mesh__D039401 Pregnancy Nutrition
% 219.77/219.92  |- mesh__recordMaintainer mesh__D039401 lkt
% 219.77/219.92  |- mesh__historyNote mesh__D039401 2003   
% 219.77/219.92  |- skos__annotation mesh__D039401 check tags FEMALE %26% PREGNANCY   
% 219.77/219.92  |- skos__prefLabel mesh__D039401 Prenatal Nutrition
% 219.77/219.92  |- mesh__dateRevised mesh__D039401 2004-07-07
% 219.77/219.92  |- skos__scopeNote mesh__D039401 Nutrition of FEMALE during PREGNANCY.     
% 219.77/219.92  |- skos__broader mesh__D039401smesh__D011247
% 219.77/219.92  |- mesh__dateEstablished mesh__D039401 2003-01-01
% 219.77/219.92  |- skos__hiddenLabel mesh__D039401 Nutrition, Prenatal
% 219.77/219.92  |- mesh__recordAuthorizer mesh__D039401 sjn
% 219.77/219.92  |- skos__altLabel mesh__D039401 Nutrition During Pregnancy
% 219.77/219.92  |- mesh__dateCreated mesh__D039401 2002-07-03
% 219.77/219.92  |- rdf__type mesh__D039401sskos__Concept
% 219.77/219.92  |- mesh__recordOriginator mesh__D039401 ssb
% 219.77/219.92  |- skos__related mesh__D039401smesh__D011295
% 219.77/219.92  |- skos__broader mesh__D039401smesh__D039382
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D039401 2006
% 219.77/219.92  |- skos__historyNote mesh__D039401 Nutrition %28%1979-2002%29%
% 219.77/219.92  |- skos__hiddenLabel mesh__D039401 Nutrition, Pregnancy
% 219.77/219.92  |- mesh__publicMeSHNote mesh__D039401 2003   
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D039401 2005
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D006227 2004
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D006227 2005
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D006227 2002
% 219.77/219.92  |- skos__hiddenLabel mesh__D006227 Deformity, Acquired Hand
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D006227 1993
% 219.77/219.92  |- skos__prefLabel mesh__D006227 Hand Deformities, Acquired
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D006227 1994
% 219.77/219.92  |- mesh__dateEstablished mesh__D006227 1971-01-01
% 219.77/219.92  |- mesh__historyNote mesh__D006227 71; was HAND DEFORMITIES 1963-70   
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D006227 2003
% 219.77/219.92  |- skos__hiddenLabel mesh__D006227 Acquired Hand Deformities
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D006227 1999
% 219.77/219.92  |- mesh__dateRevised mesh__D006227 1992-05-20
% 219.77/219.92  |- skos__broader mesh__D006227smesh__D006226
% 219.77/219.92  |- rdf__type mesh__D006227sskos__Concept
% 219.77/219.92  |- skos__annotation mesh__D006227 deformity of bone, joint, muscle, etc.   
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D006227 1997
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D006227 1998
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D006227 2001
% 219.77/219.92  |- mesh__publicMeSHNote mesh__D006227 71; was HAND DEFORMITIES 1963-70   
% 219.77/219.92  |- skos__hiddenLabel mesh__D006227 Deformities, Acquired Hand
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D006227 1996
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D006227 2000
% 219.77/219.92  |- mesh__dateCreated mesh__D006227 1999-01-01
% 219.77/219.92  |- skos__hiddenLabel mesh__D006227 Hand Deformity, Acquired
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D006227 2006
% 219.77/219.92  |- mesh__recordMaintainer mesh__D006227 TGC
% 219.77/219.92  |- mesh__recordOriginator mesh__D006227 NLM
% 219.77/219.92  |- skos__hiddenLabel mesh__D006227 Acquired Hand Deformity
% 219.77/219.92  |- mesh__onlineNote mesh__D006227
% 219.77/219.92       use HAND /AB %26% HAND DEFORMITIES, ACQUIRED to search HAND DEFORMITIES 1966-70%A%  
% 219.77/219.92  |- mesh__recordAuthorizer mesh__D006227 PLS
% 219.77/219.92  |- skos__scopeNote mesh__D006227
% 219.77/219.92       Deformities of the hand, or a part of the hand, acquired after birth as the result of injury or disease.%A%    
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D006227 1995
% 219.77/219.92  |- skos__hiddenLabel mesh__D044346 Receptors, Serotonin 1D
% 219.77/219.92  |- mesh__dateCreated mesh__D044346 2003-07-09
% 219.77/219.92  |- mesh__recordAuthorizer mesh__D044346 sjn
% 219.77/219.92  |- skos__broader mesh__D044346smesh__D017660
% 219.77/219.92  |- skos__hiddenLabel mesh__D044346 5 HT1D Receptor
% 219.77/219.92  |- skos__altLabel mesh__D044346 Receptor, Serotonin 1Dalpha
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D044346 2006
% 219.77/219.92  |- skos__hiddenLabel mesh__D044346 5 Hydroxytryptamine1D Receptor
% 219.77/219.92  |- skos__altLabel mesh__D044346 5-HT1D Receptor
% 219.77/219.92  |- skos__historyNote mesh__D044346 Receptors, Serotonin %28%1996-2003%29%
% 219.77/219.92  |- skos__altLabel mesh__D044346 Serotonin 1Dalpha Receptors
% 219.77/219.92  |- skos__altLabel mesh__D044346 5-HT1Dalpha Receptor
% 219.77/219.92  |- skos__scopeNote mesh__D044346
% 219.77/219.92       A serotonin receptor subtype that is localized to the CAUDATE NUCLEUS; PUTAMEN; the NUCLEUS ACCUMBENS; the HIPPOCAMPUS, and the RAPHE NUCLEI. It plays a role as a terminal autoreceptor that regulates the rate of SEROTONIN release from nerve endings. This serotonin receptor subtype is closely related to and has similar drug binding properties as the 5-HT1B RECEPTOR, but is expressed at low levels. It is particularly sensitive to the agonist SUMATRIPTAN and may be involved in mediating the drug%27%s antimigrane effect.%A%    
% 219.77/219.92  |- skos__altLabel mesh__D044346 Serotonin 1D Receptor
% 219.77/219.92  |- mesh__recordMaintainer mesh__D044346 jmp
% 219.77/219.92  |- skos__altLabel mesh__D044346 Receptor, Serotonin 1D
% 219.77/219.92  |- skos__altLabel mesh__D044346 5-Hydroxytryptamine1D Receptor
% 219.77/219.92  |- skos__hiddenLabel mesh__D044346 Receptor, 5-HT1D
% 219.77/219.92  |- skos__altLabel mesh__D044346 Serotonin 1D Receptors
% 219.77/219.92  |- skos__altLabel mesh__D044346 Serotonin 1D Alpha Receptor
% 219.77/219.92  |- skos__prefLabel mesh__D044346 Receptor, Serotonin, 5-HT1D
% 219.77/219.92  |- mesh__publicMeSHNote mesh__D044346
% 219.77/219.92       2004; SEROTONIN 1D RECEPTOR %28%now RECEPTOR, SEROTONIN, 5-HT1D%29% was indexed under RECEPTORS, SEROTONIN 1996-2003; SEROTONIN 1DALPHA RECEPTOR was indexed under RECEPTORS, SEROTONIN 1997-2003;%A%  
% 219.77/219.92  |- skos__broader mesh__D044346smesh__D044263
% 219.77/219.92  |- skos__hiddenLabel mesh__D044346 Receptor, 5-Hydroxytryptamine1D
% 219.77/219.92  |- mesh__dateEstablished mesh__D044346 2004-01-01
% 219.77/219.92  |- mesh__dateRevised mesh__D044346 2005-06-30
% 219.77/219.92  |- mesh__historyNote mesh__D044346
% 219.77/219.92       2004; use RECEPTOR, SEROTONIN, 5-HT1D %28%NM%29% 1996-2003   
% 219.77/219.92  |- skos__altLabel mesh__D044346 Serotonin 1Dalpha Receptor
% 219.77/219.92  |- skos__altLabel mesh__D044346 5-HT%28%1D%29% Receptor
% 219.77/219.92  |- mesh__recordOriginator mesh__D044346 jmp
% 219.77/219.92  |- rdf__type mesh__D044346sskos__Concept
% 219.77/219.92  |- skos__historyNote mesh__D016655 Retroviridae Proteins %28%1985-1991%29%
% 219.77/219.92  |- skos__hiddenLabel mesh__D016655 p24, HIV Protein
% 219.77/219.92  |- skos__broader mesh__D016655smesh__D015683
% 219.77/219.92  |- skos__altLabel mesh__D016655 HIV Major Core Protein p24
% 219.77/219.92  |- mesh__recordOriginator mesh__D016655 AGS
% 219.77/219.92  |- mesh__recordMaintainer mesh__D016655 DRC
% 219.77/219.92  |- skos__historyNote mesh__D016655 Antigens, Viral %28%1985-1991%29%
% 219.77/219.92  |- skos__historyNote mesh__D016655 HIV Antigens %28%1988-1991%29%
% 219.77/219.92  |- skos__prefLabel mesh__D016655 HIV Core Protein p24
% 219.77/219.92  |- mesh__dateCreated mesh__D016655 1991-07-12
% 219.77/219.92  |- rdf__type mesh__D016655sskos__Concept
% 219.77/219.92  |- skos__broader mesh__D016655smesh__D015488
% 219.77/219.92  |- skos__altLabel mesh__D016655 gag Protein p24, HIV
% 219.77/219.92  |- mesh__dateRevised mesh__D016655 2005-06-30
% 219.77/219.92  |- skos__altLabel mesh__D016655 HTLV-III p24
% 219.77/219.92  |- skos__altLabel mesh__D016655 HIV Protein p24
% 219.77/219.92  |- skos__historyNote mesh__D016655 Gene Products, gag %28%1989-1991%29%
% 219.77/219.92  |- skos__historyNote mesh__D016655 Viral Core Proteins %28%1985-1991%29%
% 219.77/219.92  |- mesh__dateEstablished mesh__D016655 1992-01-01
% 219.77/219.92  |- skos__hiddenLabel mesh__D016655 HTLV III p24
% 219.77/219.92  |- mesh__recordAuthorizer mesh__D016655 sjn
% 219.77/219.92  |- mesh__onlineNote mesh__D016655
% 219.77/219.92       use HIV CORE PROTEIN P24 %28%NM%29% to search HIV MAJOR CORE PROTEIN P24 %28%NM%29% 1987-91%A%  
% 219.77/219.92  |- skos__hiddenLabel mesh__D016655 p24 Antigen, HIV
% 219.77/219.92  |- skos__annotation mesh__D016655 /drug eff /ultrastruct permitted   
% 219.77/219.92  |- skos__scopeNote mesh__D016655
% 219.77/219.92       A major core protein of the human immunodeficiency virus encoded by the HIV gag gene. HIV-seropositive individuals mount a significant immune response to p24 and thus detection of antibodies to p24 is one basis for determining HIV infection by ELISA and Western blot assays. The protein is also being investigated as a potential HIV immunogen in vaccines.%A%    
% 219.77/219.92  |- skos__altLabel mesh__D016655 HIV gag Gene Product p24
% 219.77/219.92  |- skos__hiddenLabel mesh__D016655 p24, HTLV-III
% 219.77/219.92  |- skos__altLabel mesh__D016655 HIV-1 Core Protein p24
% 219.77/219.92  |- mesh__publicMeSHNote mesh__D016655
% 219.77/219.92       92; HIV MAJOR CORE PROTEIN P24 was indexed under GENE PRODUCTS, GAG %26% VIRAL CORE PROTEINS 1990-91 %26% under RETROVIRIDAE PROTEINS 1987-89%A%  
% 219.77/219.92  |- skos__altLabel mesh__D016655 p24%28%HIV%29%
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D016655 2006
% 219.77/219.92  |- skos__altLabel mesh__D016655 HIV p24 Antigen
% 219.77/219.92  |- mesh__historyNote mesh__D016655
% 219.77/219.92       92; was HIV MAJOR CORE PROTEIN P24 %28%NM%29% 1987-91   
% 219.77/219.92  |- skos__hiddenLabel mesh__D049031 delta Sarcoglycan
% 219.77/219.92  |- skos__altLabel mesh__D049031 Adhalin
% 219.77/219.92  |- skos__altLabel mesh__D049031 43-kDa Dystrophin-Associated Glycoprotein
% 219.77/219.92  |- mesh__dateCreated mesh__D049031 2004-07-07
% 219.77/219.92  |- skos__broader mesh__D049031smesh__D008562
% 219.77/219.92  |- mesh__historyNote mesh__D049031 2005%28%1993%29%   
% 219.77/219.92  |- skos__hiddenLabel mesh__D049031
% 219.77/219.92       Glycoprotein, 43-kDa Dystrophin-Associated
% 219.77/219.92  |- skos__hiddenLabel mesh__D049031 epsilon Sarcoglycan
% 219.77/219.92  |- mesh__dateRevised mesh__D049031 2005-06-30
% 219.77/219.92  |- skos__hiddenLabel mesh__D049031 beta Sarcoglycan
% 219.77/219.92  |- skos__prefLabel mesh__D049031 Sarcoglycans
% 219.77/219.92  |- mesh__recordOriginator mesh__D049031 jmp
% 219.77/219.92  |- skos__hiddenLabel mesh__D049031
% 219.77/219.92       43 kDa Dystrophin Associated Glycoprotein
% 219.77/219.92  |- skos__broader mesh__D049031smesh__D049029
% 219.77/219.92  |- skos__hiddenLabel mesh__D049031
% 219.77/219.92       50 kDa Dystrophin Associated glycoprotein
% 219.77/219.92  |- skos__hiddenLabel mesh__D049031
% 219.77/219.92       Dystrophin-Associated Glycoprotein, 43-kDa
% 219.77/219.92  |- mesh__recordMaintainer mesh__D049031 SYSTEM
% 219.77/219.92  |- skos__hiddenLabel mesh__D049031 gamma Sarcoglycan
% 219.77/219.92  |- skos__related mesh__D049031smesh__D049288
% 219.77/219.92  |- skos__hiddenLabel mesh__D049031
% 219.77/219.92       glycoprotein, 50-kDa Dystrophin-Associated
% 219.77/219.92  |- skos__scopeNote mesh__D049031
% 219.77/219.92       A family of transmembrane dystrophin-associated proteins that plays a role in the membrane association of the DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX. Mutations abolishing the expression of sarcoglycans result in LIMB-GIRDLE MUSCULAR DYSTROPHY.%A%    
% 219.77/219.92  |- skos__altLabel mesh__D049031 50-kDa Dystrophin-Associated glycoprotein
% 219.77/219.92  |- mesh__recordAuthorizer mesh__D049031 sjn
% 219.77/219.92  |- skos__hiddenLabel mesh__D049031
% 219.77/219.92       Dystrophin-Associated glycoprotein, 50-kDa
% 219.77/219.92  |- skos__hiddenLabel mesh__D049031 alpha Sarcoglycan
% 219.77/219.92  |- mesh__dateEstablished mesh__D049031 2005-01-01
% 219.77/219.92  |- rdf__type mesh__D049031sskos__Concept
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D049031 2006
% 219.77/219.92  |- skos__historyNote mesh__D049031 Membrane Proteins %28%1993-2004%29%
% 219.77/219.92  |- skos__historyNote mesh__D049031 Cytoskeletal Proteins %28%1993-2004%29%
% 219.77/219.92  |- mesh__publicMeSHNote mesh__D049031
% 219.77/219.92       2005; ADHALIN was indexed under CYTOSKELETAL PROTEINS %26% MEMBRANE GLYCOPROTEINS 1993-2004; DELTA-SARCOGLYCAN was indexed under CYTOSKELETAL PROTEINS %26% MEMBRANE GLYCOPROTEINS 1996-2004; EPSILON-SARCOGLYCAN was indexed under CYTOSKELETAL PROTEINS %26% MEMBRANE GLYCOPROTEINS 1998-2004; GAMMA-SARCOGLYCAN was indexed under CYTOSKELETAL PROTEINS %26% MEMBRANE GLYCOPROTEINS 1994-2004%A%  
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D002635 2006
% 219.77/219.92  |- mesh__publicMeSHNote mesh__D002635 74   
% 219.77/219.92  |- skos__hiddenLabel mesh__D002635 Acid, Chenique
% 219.77/219.92  |- mesh__recordAuthorizer mesh__D002635 sjn
% 219.77/219.92  |- skos__broader mesh__D002635smesh__D003840
% 219.77/219.92  |- rdf__type mesh__D002635sskos__Concept
% 219.77/219.92  |- skos__hiddenLabel mesh__D002635 Acid, Chenic
% 219.77/219.92  |- skos__altLabel mesh__D002635 Henohol
% 219.77/219.92  |- skos__annotation mesh__D002635
% 219.77/219.92       a bile acid; /biosyn /physiol permitted   
% 219.77/219.92  |- skos__altLabel mesh__D002635 Gallodesoxycholic Acid
% 219.77/219.92  |- mesh__dateEstablished mesh__D002635 1974-01-01
% 219.77/219.92  |- skos__altLabel mesh__D002635 Tramedico Brand of Chenodeoxycholic Acid
% 219.77/219.92  |- skos__altLabel mesh__D002635 Chenophalk
% 219.77/219.92  |- mesh__recordOriginator mesh__D002635 NLM
% 219.77/219.92  |- skos__altLabel mesh__D002635 Chenodiol
% 219.77/219.92  |- skos__historyNote mesh__D002635 Bile Acids and Salts %28%1966-1972%29%
% 219.77/219.92  |- skos__altLabel mesh__D002635 Chenic Acid
% 219.77/219.92  |- mesh__dateCreated mesh__D002635 1999-01-01
% 219.77/219.92  |- skos__hiddenLabel mesh__D002635 Acid, Gallodesoxycholic
% 219.77/219.92  |- skos__prefLabel mesh__D002635 Chenodeoxycholic Acid
% 219.77/219.92  |- skos__altLabel mesh__D002635 Falk Brand of Chenodeoxycholic Acid
% 219.77/219.92  |- mesh__recordMaintainer mesh__D002635 lkw
% 219.77/219.92  |- skos__altLabel mesh__D002635 Estedi Brand of Chenodeoxycholic Acid
% 219.77/219.92  |- skos__altLabel mesh__D002635 Solvay Brand of Chenodeoxycholic Acid
% 219.77/219.92  |- skos__altLabel mesh__D002635 Zambon Brand of Chenodeoxycholic Acid
% 219.77/219.92  |- mesh__dateRevised mesh__D002635 2005-06-30
% 219.77/219.92  |- mesh__historyNote mesh__D002635 74%28%73%29%   
% 219.77/219.92  |- skos__scopeNote mesh__D002635
% 219.77/219.92       A bile acid, usually conjugated with either glycine or taurine. It acts as a detergent to solubilize fats for intestinal absorption and is reabsorbed by the small intestine. It is used as cholagogue, a choleretic laxative, and to prevent or dissolve gallstones.%A%    
% 219.77/219.92  |- skos__hiddenLabel mesh__D002635 Chenodeoxycholate, Sodium
% 219.77/219.92  |- skos__hiddenLabel mesh__D002635 Acid, Chenodeoxycholic
% 219.77/219.92  |- skos__altLabel mesh__D002635 Antigen Brand of Chenodeoxycholic Acid
% 219.77/219.92  |- skos__altLabel mesh__D002635 Chenique Acid
% 219.77/219.92  |- mesh__dateCreated mesh__D007320 1974-12-12
% 219.77/219.92  |- mesh__dateRevised mesh__D007320 2003-07-09
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D007320 2006
% 219.77/219.92  |- skos__prefLabel mesh__D007320 Inspiratory Capacity
% 219.77/219.92  |- mesh__recordAuthorizer mesh__D007320 sjn
% 219.77/219.92  |- skos__hiddenLabel mesh__D007320 Inspiratory Capacities
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D007320 2005
% 219.77/219.92  |- skos__hiddenLabel mesh__D007320 Capacities, Inspiratory
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D007320 2004
% 219.77/219.92  |- rdf__type mesh__D007320sskos__Concept
% 219.77/219.92  |- skos__broader mesh__D007320smesh__D014797
% 219.77/219.92  |- mesh__dateEstablished mesh__D007320 1991-01-01
% 219.77/219.92  |- mesh__publicMeSHNote mesh__D007320
% 219.77/219.92       91; was see under LUNG VOLUME MEASUREMENTS 1975-90   
% 219.77/219.92  |- skos__hiddenLabel mesh__D007320 Capacity, Inspiratory
% 219.77/219.92  |- mesh__historyNote mesh__D007320
% 219.77/219.92       91%28%75%29%; was see under LUNG VOLUME MEASUREMENTS 1975-90   
% 219.77/219.92  |- skos__scopeNote mesh__D007320
% 219.77/219.92       The maximum volume of air that can be inspired after reaching the end of a normal, quiet expiration. It is the sum of the TIDAL VOLUME and the INSPIRATORY RESERVE VOLUME. Common abbreviation is IC.%A%    
% 219.77/219.92  |- mesh__recordOriginator mesh__D007320 NLM
% 219.77/219.92  |- skos__annotation mesh__D007320
% 219.77/219.92       NIM; in texts as IC; DF: INSPIRATORY CAPAC   
% 219.77/219.92  |- mesh__recordMaintainer mesh__D007320 nns
% 219.77/219.92  |- mesh__recordOriginator mesh__D012265 NLM
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D012265 1998
% 219.77/219.92  |- skos__broader mesh__D012265smesh__D009711
% 219.77/219.92  |- skos__scopeNote mesh__D012265
% 219.77/219.92       Nucleotides in which the purine or pyrimidine base is combined with ribose. %28%Dorland, 28th ed%29%%A%    
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D012265 2000
% 219.77/219.92  |- mesh__dateCreated mesh__D012265 1999-01-01
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D012265 1999
% 219.77/219.92  |- skos__prefLabel mesh__D012265 Ribonucleotides
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D012265 2003
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D012265 2001
% 219.77/219.92  |- skos__annotation mesh__D012265 deoxy or desoxy = DEOXYRIBONUCLEOTIDES   
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D012265 2005
% 219.77/219.92  |- skos__hiddenLabel mesh__D012265 Phosphates, Ribonucleoside
% 219.77/219.92  |- mesh__dateEstablished mesh__D012265 1973-01-01
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D012265 2004
% 219.77/219.92  |- mesh__recordMaintainer mesh__D012265 TGC
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D012265 2006
% 219.77/219.92  |- mesh__publicMeSHNote mesh__D012265 73   
% 219.77/219.92  |- mesh__historyNote mesh__D012265 73%28%71%29%   
% 219.77/219.92  |- skos__historyNote mesh__D012265 Nucleotides %28%1966-1970%29%
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D012265 2002
% 219.77/219.92  |- skos__altLabel mesh__D012265 Ribonucleoside Phosphates
% 219.77/219.92  |- mesh__recordAuthorizer mesh__D012265 SJN
% 219.77/219.92  |- mesh__dateRevised mesh__D012265 1997-06-20
% 219.77/219.92  |- skos__historyNote mesh__D012265 specific nucleotide %28%1966-1970%29%
% 219.77/219.92  |- rdf__type mesh__D012265sskos__Concept
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D006228 2004
% 219.77/219.92  |- skos__broader mesh__D006228smesh__D017880
% 219.77/219.92  |- skos__altLabel mesh__D006228 Deformities, Congenital Hand
% 219.77/219.92  |- skos__altLabel mesh__D006228 Congenital Hand Deformities
% 219.77/219.92  |- skos__altLabel mesh__D006228 Deformity, Congenital Hand
% 219.77/219.92  |- mesh__historyNote mesh__D006228 88   
% 219.77/219.92  |- mesh__dateRevised mesh__D006228 2002-07-03
% 219.77/219.92  |- skos__broader mesh__D006228smesh__D006226
% 219.77/219.92  |- rdf__type mesh__D006228sskos__Concept
% 219.77/219.92  |- mesh__publicMeSHNote mesh__D006228 88   
% 219.77/219.92  |- skos__altLabel mesh__D006228 Congenital Hand Deformity
% 219.77/219.92  |- mesh__recordMaintainer mesh__D006228 kle
% 219.77/219.92  |- mesh__recordOriginator mesh__D006228 EC
% 219.77/219.92  |- mesh__dateCreated mesh__D006228 1987-04-30
% 219.77/219.92  |- skos__broader mesh__D006228smesh__D038062
% 219.77/219.92  |- skos__altLabel mesh__D006228 Hand Deformity, Congenital
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D006228 2005
% 219.77/219.92  |- skos__scopeNote mesh__D006228
% 219.77/219.92       Alterations or deviations from normal shape or size which result in a disfigurement of the hand occurring at or before birth.%A%    
% 219.77/219.92  |- mesh__recordAuthorizer mesh__D006228 sjn
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D006228 2006
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D006228 2003
% 219.77/219.92  |- skos__prefLabel mesh__D006228 Hand Deformities, Congenital
% 219.77/219.92  |- skos__annotation mesh__D006228
% 219.77/219.92       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 219.77/219.92  |- mesh__dateEstablished mesh__D006228 1988-01-01
% 219.77/219.92  |- skos__prefLabel mesh__D044347 Sexology
% 219.77/219.92  |- skos__historyNote mesh__D044347 Sex Disorders %28%1966-2003%29%
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D044347 2004
% 219.77/219.92  |- skos__broader mesh__D044347smesh__D001525
% 219.77/219.92  |- mesh__historyNote mesh__D044347 2004; use SEX 1991-2003   
% 219.77/219.92  |- skos__scopeNote mesh__D044347
% 219.77/219.92       This discipline concerns the study of SEXUALITY, and the application of sexual knowledge such as sexual attitudes, psychology, and SEXUAL BEHAVIOR. Scope of application generally includes educational %28%SEX EDUCATION%29%, clinical %28%SEX COUNSELING%29%, and other settings.%A%    
% 219.77/219.92  |- skos__historyNote mesh__D044347 Sex Education %28%1968-2003%29%
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D044347 2005
% 219.77/219.92  |- rdf__type mesh__D044347sskos__Concept
% 219.77/219.92  |- mesh__publicMeSHNote mesh__D044347 2004; see SEX 1991-2003   
% 219.77/219.92  |- mesh__dateCreated mesh__D044347 2003-07-09
% 219.77/219.92  |- mesh__dateEstablished mesh__D044347 2004-01-01
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D044347 2006
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D049830 2006
% 219.77/219.92  |- mesh__recordMaintainer mesh__D049830 ags
% 219.77/219.92  |- skos__historyNote mesh__D049830 Mollusca %28%1965-2005%29%
% 219.77/219.92  |- skos__scopeNote mesh__D049830
% 219.77/219.92       A class in the phylum MOLLUSCA comprised of SQUID; CUTTLEFISH; OCTOPUS; and NAUTILUS. These marine animals are the most highly organized of all the mollusks.%A%    
% 219.77/219.92  |- mesh__recordOriginator mesh__D049830 ags
% 219.77/219.92  |- rdf__type mesh__D049830sskos__Concept
% 219.77/219.92  |- mesh__historyNote mesh__D049830 2006   
% 219.77/219.92  |- mesh__dateEstablished mesh__D049830 2006-01-01
% 219.77/219.92  |- mesh__recordAuthorizer mesh__D049830 sjn
% 219.77/219.92  |- skos__prefLabel mesh__D049830 Cephalopoda
% 219.77/219.92  |- skos__altLabel mesh__D049830 Cephalopods
% 219.77/219.92  |- skos__broader mesh__D049830smesh__D008974
% 219.77/219.92  |- mesh__dateCreated mesh__D049830 2005-06-30
% 219.77/219.92  |- mesh__publicMeSHNote mesh__D049830 2006   
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D016656 2003
% 219.77/219.92  |- skos__hiddenLabel mesh__D016656 Policies, Family
% 219.77/219.92  |- skos__hiddenLabel mesh__D016656 Policies, Antinatalist
% 219.77/219.92  |- skos__hiddenLabel mesh__D016656 Policy, Pronatalist
% 219.77/219.92  |- skos__hiddenLabel mesh__D016656 Antinatalist Policies
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D016656 2002
% 219.77/219.92  |- skos__hiddenLabel mesh__D016656 Pronatalist Policies
% 219.77/219.92  |- skos__hiddenLabel mesh__D016656 Policy, One Child
% 219.77/219.92  |- mesh__recordMaintainer mesh__D016656 kle
% 219.77/219.92  |- skos__historyNote mesh__D016656 Public Policy %28%1978-1991%29%
% 219.77/219.92  |- mesh__dateCreated mesh__D016656 1991-02-11
% 219.77/219.92  |- skos__hiddenLabel mesh__D016656 Family Planning Policies
% 219.77/219.92  |- skos__scopeNote mesh__D016656
% 219.77/219.92       A course or method of action selected, usually by a government, to guide and determine present and future decisions on population control by limiting the number of children or controlling fertility, notably through family planning and contraception within the nuclear family.%A%    
% 219.77/219.92  |- mesh__dateRevised mesh__D016656 1999-11-03
% 219.77/219.92  |- skos__broader mesh__D016656smesh__D011640
% 219.77/219.92  |- skos__prefLabel mesh__D016656 Family Planning Policy
% 219.77/219.92  |- skos__hiddenLabel mesh__D016656 Policy, Family Planning
% 219.77/219.92  |- skos__hiddenLabel mesh__D016656 Policies, Family Planning
% 219.77/219.92  |- skos__historyNote mesh__D016656 Family Planning %28%1968-1991%29%
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D016656 2006
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D016656 2001
% 219.77/219.92  |- skos__hiddenLabel mesh__D016656 Policies, One Child
% 219.77/219.92  |- mesh__publicMeSHNote mesh__D016656 92   
% 219.77/219.92  |- mesh__recordAuthorizer mesh__D016656 sjn
% 219.77/219.92  |- mesh__dateEstablished mesh__D016656 1992-01-01
% 219.77/219.92  |- skos__hiddenLabel mesh__D016656 Policies, One-Child
% 219.77/219.92  |- skos__hiddenLabel mesh__D016656 Policy, Family
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D016656 2005
% 219.77/219.92  |- skos__hiddenLabel mesh__D016656 Policy, Antinatalist
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D016656 2000
% 219.77/219.92  |- mesh__historyNote mesh__D016656 92   
% 219.77/219.92  |- skos__hiddenLabel mesh__D016656 One Child Policies
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D016656 2004
% 219.77/219.92  |- skos__hiddenLabel mesh__D016656 Policies, Pronatalist
% 219.77/219.92  |- mesh__recordOriginator mesh__D016656 TGC
% 219.77/219.92  |- rdf__type mesh__D016656sskos__Concept
% 219.77/219.92  |- skos__hiddenLabel mesh__D016656 Policy, One-Child
% 219.77/219.92  |- skos__altLabel mesh__D016656 One Child Policy
% 219.77/219.92  |- skos__hiddenLabel mesh__D016656 One-Child Policies
% 219.77/219.92  |- skos__annotation mesh__D016656
% 219.77/219.92       by government: for planning on family or personal level index under FAMILY PLANNING; specify state or country%A%  
% 219.77/219.92  |- skos__hiddenLabel mesh__D016656 Family Policies
% 219.77/219.92  |- mesh__recordMaintainer mesh__D002636 nns
% 219.77/219.92  |- skos__broader mesh__D002636smesh__D030342
% 219.77/219.92  |- rdf__type mesh__D002636sskos__Concept
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D002636 2002
% 219.77/219.92  |- mesh__dateCreated mesh__D002636 1999-01-01
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D002636 2004
% 219.77/219.92  |- skos__broader mesh__D002636smesh__D007571
% 219.77/219.92  |- mesh__publicMeSHNote mesh__D002636 65   
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D002636 2003
% 219.77/219.92  |- mesh__recordAuthorizer mesh__D002636 sjn
% 219.77/219.92  |- mesh__recordOriginator mesh__D002636 NLM
% 219.77/219.92  |- skos__prefLabel mesh__D002636 Cherubism
% 219.77/219.92  |- mesh__dateRevised mesh__D002636 2001-07-25
% 219.77/219.92  |- mesh__dateEstablished mesh__D002636 1965-01-01
% 219.77/219.92  |- skos__broader mesh__D002636smesh__D005357
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D002636 2006
% 219.77/219.92  |- skos__broader mesh__D002636smesh__D019767
% 219.77/219.92  |- mesh__historyNote mesh__D002636 65   
% 219.77/219.92  |- skos__scopeNote mesh__D002636
% 219.77/219.92       A fibro-osseous hereditary disease of the jaws. The swollen jaws and raised eyes give a cherubic appearance; multiple radiolucencies are evident upon radiographic examination.%A%    
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D002636 2005
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D007321 2005
% 219.77/219.92  |- mesh__dateEstablished mesh__D007321 1991-01-01
% 219.77/219.92  |- skos__hiddenLabel mesh__D007321 Reserve Volumes, Inspiratory
% 219.77/219.92  |- mesh__recordMaintainer mesh__D007321 nns
% 219.77/219.92  |- mesh__dateCreated mesh__D007321 1974-12-12
% 219.77/219.92  |- mesh__dateRevised mesh__D007321 2003-07-09
% 219.77/219.92  |- mesh__activeMeSHYear mesh__D007321 2006
% 219.77/219.92  |- skos__hiddenLabel mesh__D007321 Reserve Volume, Inspiratory
% 219.77/219.92  |- mesh__recordOriginator mesh__D007321 NLM
% 219.77/219.92  |- mesh__publicMeSHNote mesh__D007321
% 219.77/219.92       91; was see under LUNG VOLUME MEASUREMENTS 1975-90   
% 219.77/219.93  |- skos__broader mesh__D007321smesh__D007320
% 219.77/219.93  |- skos__hiddenLabel mesh__D007321 Volumes, Inspiratory Reserve
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D007321 2004
% 219.77/219.93  |- mesh__historyNote mesh__D007321
% 219.77/219.93       91%28%75%29%; was see under LUNG VOLUME MEASUREMENTS 1975-90   
% 219.77/219.93  |- skos__prefLabel mesh__D007321 Inspiratory Reserve Volume
% 219.77/219.93  |- rdf__type mesh__D007321sskos__Concept
% 219.77/219.93  |- skos__annotation mesh__D007321 NIM; in texts as IRV   
% 219.77/219.93  |- skos__hiddenLabel mesh__D007321 Inspiratory Reserve Volumes
% 219.77/219.93  |- skos__scopeNote mesh__D007321
% 219.77/219.93       The extra volume of air that can be inspired with maximal effort after reaching the end of a normal, quiet inspiration. Common abbreviation is IRV.%A%    
% 219.77/219.93  |- skos__hiddenLabel mesh__D007321 Volume, Inspiratory Reserve
% 219.77/219.93  |- mesh__recordAuthorizer mesh__D007321 sjn
% 219.77/219.93  |- mesh__recordMaintainer mesh__D012266 ssb
% 219.77/219.93  |- skos__scopeNote mesh__D012266
% 219.77/219.93       A pentose active in biological systems usually in its D-form.%A%    
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D012266 2005
% 219.77/219.93  |- mesh__recordOriginator mesh__D012266 NLM
% 219.77/219.93  |- skos__broader mesh__D012266smesh__D010429
% 219.77/219.93  |- skos__altLabel mesh__D012266 D-Ribose
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D012266 2006
% 219.77/219.93  |- skos__hiddenLabel mesh__D012266 D Ribose
% 219.77/219.93  |- mesh__recordAuthorizer mesh__D012266 sjn
% 219.77/219.93  |- mesh__dateRevised mesh__D012266 2004-07-07
% 219.77/219.93  |- skos__prefLabel mesh__D012266 Ribose
% 219.77/219.93  |- rdf__type mesh__D012266sskos__Concept
% 219.77/219.93  |- mesh__dateCreated mesh__D012266 1999-01-01
% 219.77/219.93  |- skos__altLabel mesh__D006229 Hand Dermatosis
% 219.77/219.93  |- skos__broader mesh__D006229smesh__D012871
% 219.77/219.93  |- rdf__type mesh__D006229sskos__Concept
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D006229 1999
% 219.77/219.93  |- skos__hiddenLabel mesh__D006229 Dermatoses, Hand
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D006229 1996
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D006229 2001
% 219.77/219.93  |- mesh__recordAuthorizer mesh__D006229 PLS
% 219.77/219.93  |- mesh__dateCreated mesh__D006229 1999-01-01
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D006229 1997
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D006229 2002
% 219.77/219.93  |- skos__prefLabel mesh__D006229 Hand Dermatoses
% 219.77/219.93  |- mesh__recordOriginator mesh__D006229 NLM
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D006229 2005
% 219.77/219.93  |- mesh__recordMaintainer mesh__D006229 PLS
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D006229 1994
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D006229 2006
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D006229 2003
% 219.77/219.93  |- skos__annotation mesh__D006229
% 219.77/219.93       GEN %26% as coord for specific skin diseases of the hand but not as coord for neoplasms on the hand %28%use neopl coords %28%IM%29% with HAND %28%IM%29%%29%; consider synonym for dermatitis of hand %26% do not add DERMATITIS unless one of the specific DERMATITIS terms in MeSH%A%  
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D006229 1995
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D006229 2004
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D006229 1993
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D006229 1998
% 219.77/219.93  |- skos__hiddenLabel mesh__D006229 Dermatosis, Hand
% 219.77/219.93  |- mesh__dateRevised mesh__D006229 1992-05-20
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D006229 2000
% 219.77/219.93  |- skos__hiddenLabel mesh__D044348 Serotonin 2 Receptors
% 219.77/219.93  |- skos__altLabel mesh__D044348 Serotonin S2 Receptors
% 219.77/219.93  |- skos__hiddenLabel mesh__D044348 Serotonin 5 HT2 Receptors
% 219.77/219.93  |- mesh__dateEstablished mesh__D044348 2004-01-01
% 219.77/219.93  |- skos__altLabel mesh__D044348 Serotonin 5-HT2 Receptors
% 219.77/219.93  |- skos__hiddenLabel mesh__D044348 5 HT 2 Receptors
% 219.77/219.93  |- mesh__dateRevised mesh__D044348 2005-06-30
% 219.77/219.93  |- skos__altLabel mesh__D044348 Serotonin Receptors, 5-HT2
% 219.77/219.93  |- rdf__type mesh__D044348sskos__Concept
% 219.77/219.93  |- skos__hiddenLabel mesh__D044348 5-HT2 Serotonin Receptors
% 219.77/219.93  |- skos__altLabel mesh__D044348 Receptors, Serotonin-2
% 219.77/219.93  |- skos__hiddenLabel mesh__D044348 S2 Receptors, Serotonin
% 219.77/219.93  |- skos__hiddenLabel mesh__D044348 Receptors, Serotonin 2
% 219.77/219.93  |- skos__hiddenLabel mesh__D044348 Receptors, 5-HT2 Serotonin
% 219.77/219.93  |- mesh__dateCreated mesh__D044348 2003-07-09
% 219.77/219.93  |- mesh__recordOriginator mesh__D044348 jmp
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D044348 2006
% 219.77/219.93  |- skos__altLabel mesh__D044348 Receptors, Serotonin S2
% 219.77/219.93  |- skos__hiddenLabel mesh__D044348 Receptors, 5 HT 2
% 219.77/219.93  |- skos__historyNote mesh__D044348 Receptors, Serotonin %28%1983-2003%29%
% 219.77/219.93  |- mesh__historyNote mesh__D044348
% 219.77/219.93       2004; use RECEPTORS, SEROTONIN 1989-2003   
% 219.77/219.93  |- mesh__recordAuthorizer mesh__D044348 sjn
% 219.77/219.93  |- skos__altLabel mesh__D044348 5-HT-2 Receptors
% 219.77/219.93  |- skos__altLabel mesh__D044348 Serotonin-2 Receptors
% 219.77/219.93  |- skos__hiddenLabel mesh__D044348 Receptors, Serotonin 5-HT2
% 219.77/219.93  |- skos__scopeNote mesh__D044348
% 219.77/219.93       A subclass of G-protein coupled SEROTONIN receptors that couple preferentialy to the GQ-G11 G-PROTEINS resulting in increased intracellular levels of INOSITOL PHOSPHATES and free CALCIUM.%A%    
% 219.77/219.93  |- skos__prefLabel mesh__D044348 Receptors, Serotonin, 5-HT2
% 219.77/219.93  |- mesh__publicMeSHNote mesh__D044348
% 219.77/219.93       2004; see RECEPTORS, SEROTONIN 1989-2003   
% 219.77/219.93  |- skos__hiddenLabel mesh__D044348 Serotonin Receptors, 5 HT2
% 219.77/219.93  |- skos__altLabel mesh__D044348 Receptors, 5-HT-2
% 219.77/219.93  |- skos__broader mesh__D044348smesh__D011985
% 219.77/219.93  |- skos__hiddenLabel mesh__D044348 5-HT2 Receptors, Serotonin
% 219.77/219.93  |- mesh__recordMaintainer mesh__D044348 jmp
% 219.77/219.93  |- mesh__recordMaintainer mesh__D049831 ags
% 219.77/219.93  |- skos__historyNote mesh__D049831 Octopus %28%1972-2005%29%
% 219.77/219.93  |- skos__prefLabel mesh__D049831 Octopodiformes
% 219.77/219.93  |- mesh__dateCreated mesh__D049831 2005-06-30
% 219.77/219.93  |- rdf__type mesh__D049831sskos__Concept
% 219.77/219.93  |- skos__scopeNote mesh__D049831
% 219.77/219.93       A superorder in the class CEPHALOPODA, consisting of the orders Octopoda %28%octopus%29% with over 200 species and Vampyromorpha with a single species. The latter is a phylogenetic relic but holds the key to the origins of Octopoda.%A%    
% 219.77/219.93  |- skos__annotation mesh__D049831 OCTOPUS as animal and food   
% 219.77/219.93  |- skos__broader mesh__D049831smesh__D049830
% 219.77/219.93  |- skos__historyNote mesh__D049831 Mollusca %28%1965-1972%29%
% 219.77/219.93  |- skos__altLabel mesh__D049831 Octopus
% 219.77/219.93  |- mesh__recordOriginator mesh__D049831 ags
% 219.77/219.93  |- mesh__historyNote mesh__D049831 2006   
% 219.77/219.93  |- mesh__dateEstablished mesh__D049831 2006-01-01
% 219.77/219.93  |- mesh__recordAuthorizer mesh__D049831 sjn
% 219.77/219.93  |- skos__altLabel mesh__D049831 Octopuses
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D049831 2006
% 219.77/219.93  |- mesh__publicMeSHNote mesh__D049831
% 219.77/219.93       2006; for OCTOPODA see OCTOPUS 1973-2005   
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D016657 2003
% 219.77/219.93  |- skos__altLabel mesh__D016657 Amyloid Angiopathy, Cerebral
% 219.77/219.93  |- mesh__historyNote mesh__D016657 1992   
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D016657 2005
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D016657 2004
% 219.77/219.93  |- skos__broader mesh__D016657smesh__D000686
% 219.77/219.93  |- skos__hiddenLabel mesh__D016657 Angiopathy, Congophilic
% 219.77/219.93  |- mesh__recordOriginator mesh__D016657 PXP
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D016657 2006
% 219.77/219.93  |- skos__prefLabel mesh__D016657 Cerebral Amyloid Angiopathy
% 219.77/219.93  |- skos__altLabel mesh__D016657 Congophilic Angiopathy
% 219.77/219.93  |- skos__hiddenLabel mesh__D016657 Congophilic Angiopathies
% 219.77/219.93  |- mesh__recordMaintainer mesh__D016657 ags
% 219.77/219.93  |- mesh__dateRevised mesh__D016657 2005-07-08
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D016657 2002
% 219.77/219.93  |- mesh__recordAuthorizer mesh__D016657 ags
% 219.77/219.93  |- mesh__publicMeSHNote mesh__D016657 1992   
% 219.77/219.93  |- skos__scopeNote mesh__D016657
% 219.77/219.93       A heterogeneous group of disorders that includes sporadic and familial forms, characterized clinically by cerebral ischemia %28%see BRAIN ISCHEMIA%29%; CEREBRAL INFARCTION; and CEREBRAL HEMORRHAGE. Pathologically the condition is marked by the deposition of AMYLOID in the walls of small blood vessels in the cerebral cortex and meninges. The sporadic form is associated with lobar cerebral hemorrhage in the elderly and ALZHEIMER DISEASE. %28%From Neuropathol Appl Neurobiol 1996 Jun;22%28%3%29%:216-227; Adams et al., Principles of Neurology, 6th ed, p852%29%%A%    
% 219.77/219.93  |- skos__historyNote mesh__D016657
% 219.77/219.93       Cerebrovascular Disorders %28%1974-1991%29%
% 219.77/219.93  |- skos__historyNote mesh__D016657 Amyloidosis %28%1974-1991%29%
% 219.77/219.93  |- mesh__dateCreated mesh__D016657 1991-01-24
% 219.77/219.93  |- rdf__type mesh__D016657sskos__Concept
% 219.77/219.93  |- skos__hiddenLabel mesh__D016657 Cerebral Amyloid Angiopathies
% 219.77/219.93  |- skos__annotation mesh__D016657
% 219.77/219.93       /genet:consider also CEREBRAL AMYLOID ANGIOPATHY, FAMILIAL%A%  
% 219.77/219.93  |- skos__broader mesh__D016657smesh__D002539
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D016657 2006A
% 219.77/219.93  |- skos__hiddenLabel mesh__D016657 Angiopathy, Cerebral Amyloid
% 219.77/219.93  |- mesh__dateEstablished mesh__D016657 1992-01-01
% 219.77/219.93  |- skos__broader mesh__D016099Q000295smesh__D016099
% 219.77/219.93  |- mesh__preferredCombination mesh__D016099Q000295smesh__D020776
% 219.77/219.93  |- rdf__type mesh__D016099Q000295smesh__CompoundConcept
% 219.77/219.93  |- skos__hiddenLabel mesh__D049033 Membrane, Chorioallantoic
% 219.77/219.93  |- skos__broader mesh__D049033smesh__D004625
% 219.77/219.93  |- skos__scopeNote mesh__D049033
% 219.77/219.93       A highly vascularized extra-embryonic membrane, formed by the fusion of the CHORION and the ALLANTOIS. It is mostly found in BIRDS and REPTILES. It serves as a model for studying tumor or cell biology, such as angiogenesis and TISSUE TRANSPLANTATION.%A%    
% 219.77/219.93  |- skos__broader mesh__D049033smesh__D005321
% 219.77/219.93  |- rdf__type mesh__D049033sskos__Concept
% 219.77/219.93  |- skos__hiddenLabel mesh__D049033 Chorioallantoic Membranes
% 219.77/219.93  |- mesh__dateEstablished mesh__D049033 2005-01-01
% 219.77/219.93  |- skos__prefLabel mesh__D049033 Chorioallantoic Membrane
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D049033 2006
% 219.77/219.93  |- mesh__recordMaintainer mesh__D049033 lkt
% 219.77/219.93  |- mesh__recordAuthorizer mesh__D049033 sjn
% 219.77/219.93  |- mesh__recordOriginator mesh__D049033 lkt
% 219.77/219.93  |- mesh__historyNote mesh__D049033 2005   
% 219.77/219.93  |- skos__related mesh__D049033smesh__D002823
% 219.77/219.93  |- mesh__publicMeSHNote mesh__D049033 2005   
% 219.77/219.93  |- mesh__dateCreated mesh__D049033 2004-07-07
% 219.77/219.93  |- skos__related mesh__D049033smesh__D000482
% 219.77/219.93  |- skos__hiddenLabel mesh__D049033 Membranes, Chorioallantoic
% 219.77/219.93  |- skos__historyNote mesh__D049033 Fetal Membranes %28%1965-2004%29%
% 219.77/219.93  |- mesh__dateRevised mesh__D049033 2005-06-30
% 219.77/219.93  |- rdf__type mesh__D002637sskos__Concept
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D002637 2002
% 219.77/219.93  |- mesh__dateCreated mesh__D002637 1986-03-26
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D002637 2004
% 219.77/219.93  |- skos__hiddenLabel mesh__D002637 Pains, Chest
% 219.77/219.93  |- skos__broader mesh__D002637smesh__D010146
% 219.77/219.93  |- skos__scopeNote mesh__D002637
% 219.77/219.93       Pressure, burning, or numbness in the chest.     
% 219.77/219.93  |- skos__prefLabel mesh__D002637 Chest Pain
% 219.77/219.93  |- skos__hiddenLabel mesh__D002637 Pain, Chest
% 219.77/219.93  |- mesh__publicMeSHNote mesh__D002637 87   
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D002637 2000
% 219.77/219.93  |- mesh__dateRevised mesh__D002637 1999-11-05
% 219.77/219.93  |- mesh__recordOriginator mesh__D002637 VDK
% 219.77/219.93  |- mesh__recordMaintainer mesh__D002637 KEV
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D002637 2005
% 219.77/219.93  |- mesh__historyNote mesh__D002637 87   
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D002637 2001
% 219.77/219.93  |- mesh__recordAuthorizer mesh__D002637 sjn
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D002637 2006
% 219.77/219.93  |- skos__hiddenLabel mesh__D002637 Chest Pains
% 219.77/219.93  |- mesh__dateEstablished mesh__D002637 1987-01-01
% 219.77/219.93  |- skos__historyNote mesh__D002637 Thorax %28%1966-1986%29%
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D002637 2003
% 219.77/219.93  |- skos__annotation mesh__D002637 cardiac = probably ANGINA PECTORIS   
% 219.77/219.93  |- skos__historyNote mesh__D002637 Pain %28%1966-1986%29%
% 219.77/219.93  |- skos__related mesh__D002637smesh__D000787
% 219.77/219.93  |- mesh__dateRevised mesh__D007322 1991-05-14
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D007322 2006
% 219.77/219.93  |- skos__hiddenLabel mesh__D007322 Instillations, Drug
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D007322 1993
% 219.77/219.93  |- skos__annotation mesh__D007322
% 219.77/219.93       NIM but only if discussed: do not index here routinely for every instilled drug; read MeSH definition; no qualif%A%  
% 219.77/219.93  |- skos__prefLabel mesh__D007322 Instillation, Drug
% 219.77/219.93  |- skos__scopeNote mesh__D007322
% 219.77/219.93       The administration of therapeutic agents drop by drop, as eye drops, ear drops, or nose drops. It is also administered into a body space or cavity through a catheter. It differs from irrigation in that the irrigate is removed within minutes, but the instillate is left in place.%A%    
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D007322 1996
% 219.77/219.93  |- mesh__recordMaintainer mesh__D007322 TGC
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D007322 2003
% 219.77/219.93  |- skos__broader mesh__D007322smesh__D004333
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D007322 2000
% 219.77/219.93  |- mesh__historyNote mesh__D007322 87   
% 219.77/219.93  |- mesh__publicMeSHNote mesh__D007322 87   
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D007322 2004
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D007322 1997
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D007322 1994
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D007322 2001
% 219.77/219.93  |- mesh__recordOriginator mesh__D007322 SH
% 219.77/219.93  |- rdf__type mesh__D007322sskos__Concept
% 219.77/219.93  |- skos__hiddenLabel mesh__D007322 Drug Instillations
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D007322 1995
% 219.77/219.93  |- mesh__dateCreated mesh__D007322 1986-06-19
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D007322 1998
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D007322 2005
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D007322 1992
% 219.77/219.93  |- mesh__recordAuthorizer mesh__D007322 PLS
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D007322 2002
% 219.77/219.93  |- skos__altLabel mesh__D007322 Drug Instillation
% 219.77/219.93  |- mesh__dateEstablished mesh__D007322 1987-01-01
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D007322 1999
% 219.77/219.93  |- mesh__recordMaintainer mesh__D012267 ssb
% 219.77/219.93  |- skos__broader mesh__D012267smesh__D010428
% 219.77/219.93  |- mesh__publicMeSHNote mesh__D012267
% 219.77/219.93       91; was see under PENTOSEPHOSPHATES 1975-90   
% 219.77/219.93  |- skos__historyNote mesh__D012267 Pentosephosphates %28%1968-1974%29%
% 219.77/219.93  |- mesh__recordOriginator mesh__D012267 NLM
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D012267 2006
% 219.77/219.93  |- skos__prefLabel mesh__D012267 Ribosemonophosphates
% 219.77/219.93  |- mesh__historyNote mesh__D012267
% 219.77/219.93       91%28%75%29%; was see under PENTOSEPHOSPHATES 1975-90   
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D012267 2005
% 219.77/219.93  |- mesh__dateCreated mesh__D012267 1974-11-19
% 219.77/219.93  |- mesh__dateEstablished mesh__D012267 1991-01-01
% 219.77/219.93  |- skos__scopeNote mesh__D012267
% 219.77/219.93       Ribose substituted in the 1-, 3-, or 5-position by a phosphoric acid moiety.%A%    
% 219.77/219.93  |- mesh__recordAuthorizer mesh__D012267 sjn
% 219.77/219.93  |- rdf__type mesh__D012267sskos__Concept
% 219.77/219.93  |- skos__historyNote mesh__D012267 Ribose %28%1968-1974%29%
% 219.77/219.93  |- mesh__dateRevised mesh__D012267 2004-07-07
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Animal Technologist, Laboratory
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Assistants, Animal Care
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Technologist, Laboratory Animal
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Technician, Animal
% 219.77/219.93  |- skos__altLabel mesh__D017750 Animal Care Assistants
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Care Technician, Animal
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Animal Technician
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Animal Technologists, Laboratory
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D017750 2004
% 219.77/219.93  |- mesh__recordAuthorizer mesh__D017750 SJN
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D017750 2002
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D017750 1999
% 219.77/219.93  |- mesh__recordOriginator mesh__D017750 JLS
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Assistant, Veterinary
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Technician, Animal Care
% 219.77/219.93  |- mesh__dateEstablished mesh__D017750 1994-01-01
% 219.77/219.93  |- skos__altLabel mesh__D017750 Nurses, Veterinary
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Technologists, Laboratory Animal
% 219.77/219.93  |- mesh__dateCreated mesh__D017750 1992-12-28
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D017750 2003
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Assistant, Animal Care
% 219.77/219.93  |- skos__altLabel mesh__D017750 Technicians, Veterinary
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D017750 2006
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D017750 2001
% 219.77/219.93  |- skos__broader mesh__D017750smesh__D000488
% 219.77/219.93  |- mesh__publicMeSHNote mesh__D017750 94   
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Veterinary Nurse
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Nurse, Veterinary
% 219.77/219.93  |- skos__altLabel mesh__D017750 Animal Care Technicians
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D017750 2005
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Care Technicians, Animal
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D017750 2000
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Veterinary Assistant
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Care Assistant, Animal
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Veterinary Technician
% 219.77/219.93  |- skos__historyNote mesh__D017750 Veterinary Medicine %28%1966-1993%29%
% 219.77/219.93  |- skos__altLabel mesh__D017750 Veterinary Assistants
% 219.77/219.93  |- skos__altLabel mesh__D017750 Assistants, Veterinary
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Animal Care Technician
% 219.77/219.93  |- skos__prefLabel mesh__D017750 Animal Technicians
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Care Assistants, Animal
% 219.77/219.93  |- mesh__recordMaintainer mesh__D017750 NDW
% 219.77/219.93  |- skos__annotation mesh__D017750 X ref VETERINARY NURSES is British   
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Technicians, Animal
% 219.77/219.93  |- skos__altLabel mesh__D017750 Veterinary Technicians
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Laboratory Animal Technologist
% 219.77/219.93  |- mesh__historyNote mesh__D017750 94   
% 219.77/219.93  |- rdf__type mesh__D017750sskos__Concept
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Technicians, Animal Care
% 219.77/219.93  |- skos__scopeNote mesh__D017750
% 219.77/219.93       Assistants to a veterinarian, biological or biomedical researcher, or other scientist who are engaged in the care and management of animals, and who are trained in basic principles of animal life processes and routine laboratory and animal health care procedures. %28%Facts on File Dictionary of Health Care Management, 1988%29%%A%    
% 219.77/219.93  |- skos__altLabel mesh__D017750 Veterinary Nurses
% 219.77/219.93  |- mesh__dateRevised mesh__D017750 1998-06-10
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Animal Care Assistant
% 219.77/219.93  |- skos__hiddenLabel mesh__D017750 Technician, Veterinary
% 219.77/219.93  |- mesh__dateEstablished mesh__D031421 2003-01-01
% 219.77/219.93  |- skos__scopeNote mesh__D031421
% 219.77/219.93       A plant genus of the family LILIACEAE. Members contain steroidal saponins.%A%    
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D031421 2005
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D031421 2003
% 219.77/219.93  |- skos__annotation mesh__D031421
% 219.77/219.93       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D031421 2006
% 219.77/219.93  |- mesh__publicMeSHNote mesh__D031421 2003   
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D031421 2004
% 219.77/219.93  |- skos__broader mesh__D031421smesh__D019668
% 219.77/219.93  |- skos__altLabel mesh__D031421 Daylily
% 219.77/219.93  |- skos__prefLabel mesh__D031421 Hemerocallis
% 219.77/219.93  |- rdf__type mesh__D031421sskos__Concept
% 219.77/219.93  |- mesh__historyNote mesh__D031421 2003   
% 219.77/219.93  |- mesh__dateCreated mesh__D031421 2002-07-03
% 219.77/219.93  |- skos__broader mesh__D011985Q000037smesh__D011985
% 219.77/219.93  |- mesh__preferredCombination mesh__D011985Q000037smesh__D012702
% 219.77/219.93  |- rdf__type mesh__D011985Q000037smesh__CompoundConcept
% 219.77/219.93  |- mesh__publicMeSHNote mesh__D003730
% 219.77/219.93       93; was DENTAL CARE FOR HANDICAPPED 1980-92   
% 219.77/219.93  |- skos__annotation mesh__D003730
% 219.77/219.93       = professional care by a professional; disability can refer to emotional, mental or physical dis; DF: DENT CARE DISABLED%A%  
% 219.77/219.93  |- mesh__dateCreated mesh__D003730 1979-04-25
% 219.77/219.93  |- mesh__recordMaintainer mesh__D003730 nns
% 219.77/219.93  |- skos__related mesh__D003730smesh__D017742
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D003730 2003
% 219.77/219.93  |- mesh__dateEstablished mesh__D003730 1980-01-01
% 219.77/219.93  |- skos__historyNote mesh__D003730
% 219.77/219.93       specific mouth or tooth disease %28%1966-1979%29%
% 219.77/219.93  |- rdf__type mesh__D003730sskos__Concept
% 219.77/219.93  |- skos__altLabel mesh__D003730 Dentistry for Handicapped
% 219.77/219.93  |- mesh__dateRevised mesh__D003730 2001-07-25
% 219.77/219.93  |- skos__broader mesh__D003730smesh__D003729
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D003730 2004
% 219.77/219.93  |- skos__hiddenLabel mesh__D003730 Disabled, Dentistry for
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D003730 2005
% 219.77/219.93  |- skos__prefLabel mesh__D003730 Dental Care for Disabled
% 219.77/219.93  |- mesh__onlineNote mesh__D003730
% 219.77/219.93       93; use DENTAL CARE FOR DISABLED to search DENTAL CARE FOR HANDICAPPED 1980-92%A%  
% 219.77/219.93  |- skos__hiddenLabel mesh__D003730 Handicapped, Dentistry for
% 219.77/219.93  |- mesh__historyNote mesh__D003730
% 219.77/219.93       93; was DENTAL CARE FOR HANDICAPPED 1980-92   
% 219.77/219.93  |- skos__historyNote mesh__D003730 Handicapped %28%1966-1979%29%
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D003730 2006
% 219.77/219.93  |- mesh__recordOriginator mesh__D003730 SMH
% 219.77/219.93  |- skos__historyNote mesh__D003730 Dental Care %28%1973-1979%29%
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D003730 2002
% 219.77/219.93  |- skos__historyNote mesh__D003730 specific disability %28%1966-1979%29%
% 219.77/219.93  |- mesh__recordAuthorizer mesh__D003730 sjn
% 219.77/219.93  |- skos__scopeNote mesh__D003730
% 219.77/219.93       Dental care for the emotionally, mentally, or physically disabled patient. It does not include dental care for the chronically ill %28% = DENTAL CARE FOR CHRONICALLY ILL%29%.%A%    
% 219.77/219.93  |- skos__altLabel mesh__D003730 Dental Care for Handicapped
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D044349 2005
% 219.77/219.93  |- rdf__type mesh__D044349sskos__Concept
% 219.77/219.93  |- mesh__dateEstablished mesh__D044349 2004-01-01
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D044349 2006
% 219.77/219.93  |- mesh__dateCreated mesh__D044349 2003-07-09
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D044349 2004
% 219.77/219.93  |- skos__broader mesh__D044349smesh__D005842
% 219.77/219.93  |- mesh__historyNote mesh__D044349 2004   
% 219.77/219.93  |- skos__scopeNote mesh__D044349
% 219.77/219.93       The islands of the central and South Pacific, including Micronesia, Melanesia, Polynesia, and traditionally Australasia. %28%Random House Dictionary, 2d ed%29%%A%    
% 219.77/219.93  |- skos__prefLabel mesh__D044349 Oceania
% 219.77/219.93  |- mesh__historyNote mesh__D049832
% 219.77/219.93       2006; for CUTTLEFISH use MOLLUSCA 1995-2005   
% 219.77/219.93  |- mesh__publicMeSHNote mesh__D049832
% 219.77/219.93       2006; for CUTTLEFISH see MOLLUSCA 1995-2005; for SQUID see SQUID 1973-2005;%A%  
% 219.77/219.93  |- mesh__recordAuthorizer mesh__D049832 sjn
% 219.77/219.93  |- mesh__dateCreated mesh__D049832 2005-06-30
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D049832 2006
% 219.77/219.93  |- skos__prefLabel mesh__D049832 Decapodiformes
% 219.77/219.93  |- skos__scopeNote mesh__D049832
% 219.77/219.93       A superorder of CEPHALOPODS comprised of squid, cuttlefish, and their relatives. Their distinguishing feature is the modification of their fourth pair of arms into tentacles, resulting in 10 limbs.%A%    
% 219.77/219.93  |- skos__annotation mesh__D049832
% 219.77/219.93       SQUID as animal %26% food; squid giant axon: coordinate NIM with AXONS %28%IM%29%%A%  
% 219.77/219.93  |- mesh__recordMaintainer mesh__D049832 ags
% 219.77/219.93  |- rdf__type mesh__D049832sskos__Concept
% 219.77/219.93  |- skos__altLabel mesh__D049832 Cuttlefish
% 219.77/219.93  |- mesh__dateEstablished mesh__D049832 2006-01-01
% 219.77/219.93  |- skos__broader mesh__D049832smesh__D049830
% 219.77/219.93  |- mesh__recordOriginator mesh__D049832 ags
% 219.77/219.93  |- mesh__recordMaintainer mesh__D016658 nns
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D016658 2003
% 219.77/219.93  |- mesh__historyNote mesh__D016658 92   
% 219.77/219.93  |- mesh__recordAuthorizer mesh__D016658 sjn
% 219.77/219.93  |- mesh__dateEstablished mesh__D016658 1992-01-01
% 219.77/219.93  |- skos__annotation mesh__D016658
% 219.77/219.93       IM for anat %26% site of dis; NIM in studies on muscle tissue %26% fibers; infection = probably PSOAS ABSCESS; /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D016658 2005
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D016658 2004
% 219.77/219.93  |- skos__broader mesh__D016658smesh__D018482
% 219.77/219.93  |- mesh__recordOriginator mesh__D016658 TGC
% 219.77/219.93  |- skos__hiddenLabel mesh__D016658 Psoas Muscle
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D016658 2002
% 219.77/219.93  |- mesh__publicMeSHNote mesh__D016658 92   
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D016658 2006
% 219.77/219.93  |- skos__hiddenLabel mesh__D016658 Muscle, Psoas
% 219.77/219.93  |- rdf__type mesh__D016658sskos__Concept
% 219.77/219.93  |- mesh__dateCreated mesh__D016658 1991-02-11
% 219.77/219.93  |- skos__prefLabel mesh__D016658 Psoas Muscles
% 219.77/219.93  |- skos__historyNote mesh__D016658 Muscles %28%1968-1991%29%
% 219.77/219.93  |- skos__scopeNote mesh__D016658
% 219.77/219.93       A powerful flexor of the thigh at the hip joint %28%psoas major%29% and a weak flexor of the trunk and lumbar spinal column %28%psoas minor%29%. Psoas is derived from the Greek %22%psoa%22%, the plural meaning %22%muscles of the loin%22%. It is a common site of infection manifesting as abscess %28%PSOAS ABSCESS%29%. The psoas muscles and their fibers are also used frequently in experiments in muscle physiology.%A%    
% 219.77/219.93  |- skos__hiddenLabel mesh__D016658 Muscles, Psoas
% 219.77/219.93  |- mesh__dateRevised mesh__D016658 2001-07-25
% 219.77/219.93  |- mesh__recordOriginator mesh__D002638 NLM
% 219.77/219.93  |- skos__annotation mesh__D002638
% 219.77/219.93       as a confection or as vehicle for admin of med substances%A%  
% 219.77/219.93  |- mesh__dateRevised mesh__D002638 1997-06-20
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D002638 2002
% 219.77/219.93  |- skos__hiddenLabel mesh__D002638 Gum, Chewing
% 219.77/219.93  |- skos__prefLabel mesh__D002638 Chewing Gum
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D002638 2005
% 219.77/219.93  |- skos__broader mesh__D002638smesh__D002182
% 219.77/219.93  |- skos__scopeNote mesh__D002638
% 219.77/219.93       A preparation of chicle, sometimes mixed with other plastic substances, sweetened and flavored. It is masticated usually for pleasure as a candy substitute but it sometimes acts as a vehicle for the administration of medication.%A%    
% 219.77/219.93  |- mesh__dateCreated mesh__D002638 1999-01-01
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D002638 2006
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D002638 1998
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D002638 2000
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D002638 2003
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D002638 1999
% 219.77/219.93  |- mesh__recordAuthorizer mesh__D002638 SJN
% 219.77/219.93  |- rdf__type mesh__D002638sskos__Concept
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D002638 2001
% 219.77/219.93  |- skos__hiddenLabel mesh__D002638 Chewing Gums
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D002638 2004
% 219.77/219.93  |- skos__hiddenLabel mesh__D002638 Gums, Chewing
% 219.77/219.93  |- mesh__recordMaintainer mesh__D002638 JLS
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D013360 2004
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D013360 1993
% 219.77/219.93  |- skos__scopeNote mesh__D013360
% 219.77/219.93       Stimulation at an intensity below that where a differentiated response can be elicited.%A%    
% 219.77/219.93  |- mesh__onlineNote mesh__D013360
% 219.77/219.93       use SUBLIMINAL STIMULATION to search SUBLIMINAL PERCEPTION 1969-78%A%  
% 219.77/219.93  |- skos__hiddenLabel mesh__D013360 Subliminal Stimulations
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D013360 1999
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D013360 1996
% 219.77/219.93  |- skos__prefLabel mesh__D013360 Subliminal Stimulation
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D013360 2006
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D013360 2003
% 219.77/219.93  |- mesh__dateEstablished mesh__D013360 1969-01-01
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D013360 1995
% 219.77/219.93  |- skos__annotation mesh__D013360 no qualif   
% 219.77/219.93  |- mesh__activeMeSHYear mesh__D013360 1992
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D013360 1998
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D013360 2005
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D013360 1994
% 219.77/219.94  |- mesh__recordAuthorizer mesh__D013360 PLS
% 219.77/219.94  |- skos__hiddenLabel mesh__D013360 Subliminal Perceptions
% 219.77/219.94  |- mesh__dateCreated mesh__D013360 1999-01-01
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D013360 2002
% 219.77/219.94  |- skos__hiddenLabel mesh__D013360 Stimulations, Subliminal
% 219.77/219.94  |- mesh__recordMaintainer mesh__D013360 TGC
% 219.77/219.94  |- skos__hiddenLabel mesh__D013360 Perceptions, Subliminal
% 219.77/219.94  |- skos__hiddenLabel mesh__D013360 Perception, Subliminal
% 219.77/219.94  |- mesh__historyNote mesh__D013360
% 219.77/219.94       69%28%64%29%; SUBLIMINAL PERCEPTION was see under SUBLIMINAL STIMULATION 1969-78%A%  
% 219.77/219.94  |- mesh__recordOriginator mesh__D013360 NLM
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D013360 2001
% 219.77/219.94  |- mesh__publicMeSHNote mesh__D013360 69   
% 219.77/219.94  |- rdf__type mesh__D013360sskos__Concept
% 219.77/219.94  |- skos__broader mesh__D013360smesh__D012684
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D013360 2000
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D013360 1997
% 219.77/219.94  |- skos__hiddenLabel mesh__D013360 Stimulation, Subliminal
% 219.77/219.94  |- mesh__dateRevised mesh__D013360 1991-06-11
% 219.77/219.94  |- mesh__publicMeSHNote mesh__D007323
% 219.77/219.94       FIXED ACTION PATTERN was see under BEHAVIOR, ANIMAL 1968-78%A%  
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007323 1997
% 219.77/219.94  |- skos__hiddenLabel mesh__D007323 Fixed Action Patterns
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007323 2004
% 219.77/219.94  |- rdf__type mesh__D007323sskos__Concept
% 219.77/219.94  |- skos__prefLabel mesh__D007323 Instinct
% 219.77/219.94  |- skos__altLabel mesh__D007323 Innate Behavior
% 219.77/219.94  |- skos__hiddenLabel mesh__D007323 Behaviors, Innate
% 219.77/219.94  |- mesh__recordAuthorizer mesh__D007323 PLS
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007323 2002
% 219.77/219.94  |- mesh__historyNote mesh__D007323
% 219.77/219.94       FIXED ACTION PATTERN was see under BEHAVIOR, ANIMAL 1968-78; INNATE BEHAVIOR was see under INSTINCT 1968-78%A%  
% 219.77/219.94  |- skos__hiddenLabel mesh__D007323 Behavior, Innate
% 219.77/219.94  |- mesh__onlineNote mesh__D007323
% 219.77/219.94       to search FIXED ACTION PATTERN use INSTINCT 1975-78 %26% BEHAVIOR, ANIMAL 1968-74; use INSTINCT to search INNATE BEHAVIOR 1968-78%A%  
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007323 1998
% 219.77/219.94  |- mesh__dateCreated mesh__D007323 1999-01-01
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007323 2005
% 219.77/219.94  |- skos__broader mesh__D007323smesh__D009042
% 219.77/219.94  |- mesh__dateRevised mesh__D007323 1995-05-18
% 219.77/219.94  |- skos__hiddenLabel mesh__D007323 Innate Behaviors
% 219.77/219.94  |- mesh__recordMaintainer mesh__D007323 TAP
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007323 1999
% 219.77/219.94  |- skos__annotation mesh__D007323 human %26% animal; no qualif   
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007323 2006
% 219.77/219.94  |- skos__scopeNote mesh__D007323
% 219.77/219.94       Stereotyped patterns of response, characteristic of a given species, that have been phylogenetically adapted to a specific type of situation.%A%    
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007323 2000
% 219.77/219.94  |- skos__related mesh__D007323smesh__D007989
% 219.77/219.94  |- skos__hiddenLabel mesh__D007323 Instincts
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007323 1996
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007323 2003
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007323 2001
% 219.77/219.94  |- skos__hiddenLabel mesh__D007323 Patterns, Fixed Action
% 219.77/219.94  |- mesh__recordOriginator mesh__D007323 NLM
% 219.77/219.94  |- skos__hiddenLabel mesh__D007323 Pattern, Fixed Action
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D045442 2006
% 219.77/219.94  |- skos__hiddenLabel mesh__D045442 Performance Test, Rotarod
% 219.77/219.94  |- rdf__type mesh__D045442sskos__Concept
% 219.77/219.94  |- mesh__dateEstablished mesh__D045442 2004-01-01
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D045442 2005
% 219.77/219.94  |- skos__scopeNote mesh__D045442
% 219.77/219.94       A performance test based on forced MOTOR ACTIVITY on a rotating rod, usually by a rodent. Parameters include the riding time %28%seconds%29% or endurance. Test is used to evaluate balance and coordination of the subjects, particular in experimental animal models for neurological disorders and drug effects.%A%    
% 219.77/219.94  |- skos__hiddenLabel mesh__D045442 Test, Rotarod
% 219.77/219.94  |- skos__altLabel mesh__D045442 Rotarod Assay
% 219.77/219.94  |- skos__historyNote mesh__D045442 Motor Skills %28%1967-2003%29%
% 219.77/219.94  |- skos__altLabel mesh__D045442 Rotarod Method
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D045442 2004
% 219.77/219.94  |- mesh__historyNote mesh__D045442 2004   
% 219.77/219.94  |- skos__altLabel mesh__D045442 Rotarod Test
% 219.77/219.94  |- mesh__dateCreated mesh__D045442 2003-07-09
% 219.77/219.94  |- skos__hiddenLabel mesh__D045442 Assay, Rotarod
% 219.77/219.94  |- skos__broader mesh__D045442smesh__D032761
% 219.77/219.94  |- skos__prefLabel mesh__D045442 Rotarod Performance Test
% 219.77/219.94  |- mesh__publicMeSHNote mesh__D045442 2004   
% 219.77/219.94  |- skos__historyNote mesh__D045442 Motor Activity %28%1968-2003%29%
% 219.77/219.94  |- skos__historyNote mesh__D012268 Phosphotransferases, ATP %28%1974%29%
% 219.77/219.94  |- skos__historyNote mesh__D012268 Pentosephosphates %28%1974%29%
% 219.77/219.94  |- skos__prefLabel mesh__D012268 Ribose-Phosphate Pyrophosphokinase
% 219.77/219.94  |- skos__altLabel mesh__D012268 PRPP Synthetase
% 219.77/219.94  |- mesh__dateCreated mesh__D012268 1974-11-19
% 219.77/219.94  |- skos__altLabel mesh__D012268
% 219.77/219.94       5-Phospho-alpha-D-Ribose 1-Diphosphate Synthetase
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D012268 2004
% 219.77/219.94  |- mesh__recordAuthorizer mesh__D012268 sjn
% 219.77/219.94  |- skos__hiddenLabel mesh__D012268
% 219.77/219.94       Synthetase, 5-Phospho-alpha-D-Ribose 1-Diphosphate
% 219.77/219.94  |- mesh__onlineNote mesh__D012268
% 219.77/219.94       use RIBOSE-PHOSPHATE PYROPHOSPHOKINASE to search RIBOSEPHOSPHATE PYROPHOSPHOKINASE 1975-93%A%  
% 219.77/219.94  |- skos__broader mesh__D012268smesh__D017854
% 219.77/219.94  |- skos__hiddenLabel mesh__D012268
% 219.77/219.94       1-Diphosphate Synthetase, 5-Phospho-alpha-D-Ribose
% 219.77/219.94  |- skos__hiddenLabel mesh__D012268 Synthetase, Phosphoribosyl Pyrophosphate
% 219.77/219.94  |- skos__hiddenLabel mesh__D012268 Ribose Phosphate Pyrophosphokinase
% 219.77/219.94  |- skos__historyNote mesh__D012268 Pyrophosphoric Acids %28%1974%29%
% 219.77/219.94  |- mesh__recordMaintainer mesh__D012268 ssb
% 219.77/219.94  |- mesh__dateRevised mesh__D012268 2003-07-09
% 219.77/219.94  |- skos__hiddenLabel mesh__D012268 Pyrophosphokinase, Ribosephosphate
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D012268 2006
% 219.77/219.94  |- skos__scopeNote mesh__D012268
% 219.77/219.94       An enzyme that catalyzes the formation of phosphoribosyl pyrophosphate from ATP and ribose-5-phosphate. EC 2.7.6.1.%A%    
% 219.77/219.94  |- skos__hiddenLabel mesh__D012268
% 219.77/219.94       5 Phospho alpha D Ribose 1 Diphosphate Synthetase
% 219.77/219.94  |- mesh__publicMeSHNote mesh__D012268
% 219.77/219.94       94; was RIBOSEPHOSPHATE PYROPHOSPHOKINASE 1975-93 %28%see under PHOSPHOTRANSFERASES, ATP 1975-90%29%%A%  
% 219.77/219.94  |- skos__hiddenLabel mesh__D012268 Pyrophosphate Synthetase, Phosphoribosyl
% 219.77/219.94  |- skos__altLabel mesh__D012268 PRibPP Synthetase
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D012268 2005
% 219.77/219.94  |- mesh__dateEstablished mesh__D012268 1991-01-01
% 219.77/219.94  |- skos__altLabel mesh__D012268 Phosphoribosyl Pyrophosphate Synthetase
% 219.77/219.94  |- mesh__historyNote mesh__D012268
% 219.77/219.94       94; was RIBOSEPHOSPHATE PYROPHOSPHOKINASE 1975-93 %28%see under PHOSPHOTRANSFERASES, ATP 1975-90%29%%A%  
% 219.77/219.94  |- rdf__type mesh__D012268sskos__Concept
% 219.77/219.94  |- mesh__recordOriginator mesh__D012268 NLM
% 219.77/219.94  |- skos__hiddenLabel mesh__D012268 Synthetase, PRPP
% 219.77/219.94  |- skos__annotation mesh__D012268 DF: note short X ref   
% 219.77/219.94  |- skos__altLabel mesh__D012268 Ribosephosphate Pyrophosphokinase
% 219.77/219.94  |- skos__hiddenLabel mesh__D012268 Pyrophosphokinase, Ribose-Phosphate
% 219.77/219.94  |- mesh__recordAuthorizer mesh__D017751 PLS
% 219.77/219.94  |- skos__prefLabel mesh__D017751 Safety Management
% 219.77/219.94  |- mesh__recordMaintainer mesh__D017751 JLS
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D017751 2003
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D017751 1996
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D017751 2006
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D017751 1999
% 219.77/219.94  |- rdf__type mesh__D017751sskos__Concept
% 219.77/219.94  |- skos__scopeNote mesh__D017751
% 219.77/219.94       The development of systems to prevent accidents, injuries, and other adverse occurrences in an institutional setting. The concept includes prevention or reduction of adverse events or incidents involving employees, patients, or facilities. Examples include plans to reduce injuries from falls or plans for fire safety to promote a safe institutional environment.%A%    
% 219.77/219.94  |- skos__historyNote mesh__D017751 Risk Management %28%1966-1993%29%
% 219.77/219.94  |- skos__hiddenLabel mesh__D017751 Surveillance Program, Hazard
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D017751 2004
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D017751 1997
% 219.77/219.94  |- skos__hiddenLabel mesh__D017751 Control, Hazard
% 219.77/219.94  |- skos__hiddenLabel mesh__D017751 Hazard Controls
% 219.77/219.94  |- mesh__publicMeSHNote mesh__D017751 94   
% 219.77/219.94  |- skos__broader mesh__D017751smesh__D012449
% 219.77/219.94  |- skos__hiddenLabel mesh__D017751 Surveillance Programs, Hazard
% 219.77/219.94  |- mesh__dateEstablished mesh__D017751 1994-01-01
% 219.77/219.94  |- mesh__dateRevised mesh__D017751 1994-06-01
% 219.77/219.94  |- skos__hiddenLabel mesh__D017751 Program, Hazard Surveillance
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D017751 2000
% 219.77/219.94  |- mesh__recordOriginator mesh__D017751 JLS
% 219.77/219.94  |- mesh__dateCreated mesh__D017751 1992-12-28
% 219.77/219.94  |- skos__broader mesh__D017751smesh__D012308
% 219.77/219.94  |- skos__broader mesh__D017751smesh__D009934
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D017751 2001
% 219.77/219.94  |- skos__hiddenLabel mesh__D017751 Programs, Hazard Surveillance
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D017751 1995
% 219.77/219.94  |- skos__hiddenLabel mesh__D017751 Hazard Surveillance Programs
% 219.77/219.94  |- mesh__historyNote mesh__D017751 94   
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D017751 2005
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D017751 1998
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D017751 2002
% 219.77/219.94  |- skos__hiddenLabel mesh__D017751 Management, Safety
% 219.77/219.94  |- skos__hiddenLabel mesh__D017751 Management, Hazard
% 219.77/219.94  |- skos__historyNote mesh__D017751 Safety %28%1966-1993%29%
% 219.77/219.94  |- skos__annotation mesh__D031422
% 219.77/219.94       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D031422 2006
% 219.77/219.94  |- skos__broader mesh__D031422smesh__D019668
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D031422 2004
% 219.77/219.94  |- mesh__publicMeSHNote mesh__D031422 2003   
% 219.77/219.94  |- mesh__dateEstablished mesh__D031422 2003-01-01
% 219.77/219.94  |- mesh__historyNote mesh__D031422 2003   
% 219.77/219.94  |- mesh__dateCreated mesh__D031422 2002-07-03
% 219.77/219.94  |- rdf__type mesh__D031422sskos__Concept
% 219.77/219.94  |- skos__scopeNote mesh__D031422
% 219.77/219.94       A plant genus of the family LILIACEAE. Members contain steroidal saponins.%A%    
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D031422 2005
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D031422 2003
% 219.77/219.94  |- skos__prefLabel mesh__D031422 Hosta
% 219.77/219.94  |- skos__scopeNote mesh__D003731
% 219.77/219.94       Localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation. If left unchecked, the cavity may penetrate the enamel and dentin and reach the pulp. The three most prominent theories used to explain the etiology of the disease are that acids produced by bacteria lead to decalcification; that micro-organisms destroy the enamel protein; or that keratolytic micro-organisms produce chelates that lead to decalcification.%A%    
% 219.77/219.94  |- skos__related mesh__D003731smesh__D002326
% 219.77/219.94  |- skos__altLabel mesh__D003731 Dental Decay
% 219.77/219.94  |- skos__altLabel mesh__D003731 Dental White Spots
% 219.77/219.94  |- skos__broader mesh__D003731smesh__D017001
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D003731 2005
% 219.77/219.94  |- mesh__publicMeSHNote mesh__D003731
% 219.77/219.94       DENTAL CARIES CONTROL was heading 1965-66   
% 219.77/219.94  |- skos__related mesh__D003731smesh__D017213
% 219.77/219.94  |- skos__hiddenLabel mesh__D003731 White Spot
% 219.77/219.94  |- skos__altLabel mesh__D003731 White Spot, Dental
% 219.77/219.94  |- skos__prefLabel mesh__D003731 Dental Caries
% 219.77/219.94  |- mesh__recordAuthorizer mesh__D003731 sjn
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D003731 2006
% 219.77/219.94  |- mesh__historyNote mesh__D003731
% 219.77/219.94       DENTAL CARIES CONTROL was heading 1965-66   
% 219.77/219.94  |- skos__altLabel mesh__D003731 White Spots, Dental
% 219.77/219.94  |- skos__annotation mesh__D003731
% 219.77/219.94       /drug ther: consider also CARIOSTATIC AGENTS; /etiol: consider also CARIOGENIC AGENTS %26% DIET, CARIOGENIC; /epidemiol: consider also DMF INDEX; DF: DENT CARIES%A%  
% 219.77/219.94  |- mesh__dateRevised mesh__D003731 2004-07-19
% 219.77/219.94  |- skos__related mesh__D003731smesh__D017001
% 219.77/219.94  |- skos__altLabel mesh__D003731 Decay, Dental
% 219.77/219.94  |- skos__hiddenLabel mesh__D003731 Spot, White
% 219.77/219.94  |- mesh__onlineNote mesh__D003731
% 219.77/219.94       use DENTAL CARIES to search DENTAL CARIES CONTROL 1966   
% 219.77/219.94  |- skos__related mesh__D003731smesh__D004037
% 219.77/219.94  |- mesh__recordOriginator mesh__D003731 NLM
% 219.77/219.94  |- skos__related mesh__D003731smesh__D002327
% 219.77/219.94  |- skos__altLabel mesh__D003731 Caries, Dental
% 219.77/219.94  |- skos__hiddenLabel mesh__D003731 Spots, White
% 219.77/219.94  |- mesh__dateCreated mesh__D003731 1999-01-01
% 219.77/219.94  |- rdf__type mesh__D003731sskos__Concept
% 219.77/219.94  |- mesh__recordMaintainer mesh__D003731 jls
% 219.77/219.94  |- skos__altLabel mesh__D003731 White Spots
% 219.77/219.94  |- mesh__dateEstablished mesh__D049833 2006-01-01
% 219.77/219.94  |- mesh__publicMeSHNote mesh__D049833 2006   
% 219.77/219.94  |- mesh__recordOriginator mesh__D049833 ags
% 219.77/219.94  |- mesh__historyNote mesh__D049833 2006   
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D049833 2006
% 219.77/219.94  |- skos__broader mesh__D049833smesh__D049832
% 219.77/219.94  |- mesh__recordAuthorizer mesh__D049833 sjn
% 219.77/219.94  |- skos__scopeNote mesh__D049833
% 219.77/219.94       A genus of cuttlefish in the family Sepiidae. They live in tropical, subtropical and temperate waters in most oceans.%A%    
% 219.77/219.94  |- mesh__recordMaintainer mesh__D049833 ags
% 219.77/219.94  |- rdf__type mesh__D049833sskos__Concept
% 219.77/219.94  |- mesh__dateCreated mesh__D049833 2005-06-30
% 219.77/219.94  |- skos__prefLabel mesh__D049833 Sepia
% 219.77/219.94  |- skos__historyNote mesh__D049833 Mollusca %28%1965-2005%29%
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D016659 2005
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D016659 2004
% 219.77/219.94  |- skos__broader mesh__D016659smesh__D000038
% 219.77/219.94  |- mesh__recordMaintainer mesh__D016659 lkt
% 219.77/219.94  |- skos__annotation mesh__D016659 for coord read note on ABSCESS   
% 219.77/219.94  |- skos__historyNote mesh__D016659 Muscular Diseases %28%1968-1991%29%
% 219.77/219.94  |- skos__hiddenLabel mesh__D016659 Abscesses, Pyogenic Iliopsoas
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D016659 2006
% 219.77/219.94  |- skos__hiddenLabel mesh__D016659 Abscess, Iliopsoas
% 219.77/219.94  |- skos__hiddenLabel mesh__D016659 Abscesses, Iliopsoas
% 219.77/219.94  |- mesh__recordAuthorizer mesh__D016659 sjn
% 219.77/219.94  |- mesh__dateEstablished mesh__D016659 1992-01-01
% 219.77/219.94  |- rdf__type mesh__D016659sskos__Concept
% 219.77/219.94  |- skos__hiddenLabel mesh__D016659 Pyogenic Iliopsoas Abscesses
% 219.77/219.94  |- skos__hiddenLabel mesh__D016659 Abscess, Pyogenic Iliopsoas
% 219.77/219.94  |- mesh__recordOriginator mesh__D016659 TGC
% 219.77/219.94  |- skos__altLabel mesh__D016659 Abscess, Psoas
% 219.77/219.94  |- mesh__publicMeSHNote mesh__D016659 92   
% 219.77/219.94  |- skos__hiddenLabel mesh__D016659 Abscesses, Psoas
% 219.77/219.94  |- skos__hiddenLabel mesh__D016659 Psoas Abscesses
% 219.77/219.94  |- skos__hiddenLabel mesh__D016659 Iliopsoas Abscesses, Pyogenic
% 219.77/219.94  |- skos__altLabel mesh__D016659 Pyogenic Iliopsoas Abscess
% 219.77/219.94  |- skos__altLabel mesh__D016659 Iliopsoas Abscess
% 219.77/219.94  |- skos__hiddenLabel mesh__D016659 Iliopsoas Abscess, Pyogenic
% 219.77/219.94  |- skos__scopeNote mesh__D016659
% 219.77/219.94       Abscess of the PSOAS MUSCLES resulting usually from disease of the lumbar vertebrae, with the pus descending into the muscle sheath. The infection is most commonly tuberculous or staphylococcal.%A%    
% 219.77/219.94  |- skos__historyNote mesh__D016659 Abscess %28%1968-1991%29%
% 219.77/219.94  |- skos__hiddenLabel mesh__D016659 Iliopsoas Abscesses
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D016659 2003
% 219.77/219.94  |- mesh__dateCreated mesh__D016659 1991-02-11
% 219.77/219.94  |- mesh__historyNote mesh__D016659 92   
% 219.77/219.94  |- skos__prefLabel mesh__D016659 Psoas Abscess
% 219.77/219.94  |- mesh__dateRevised mesh__D016659 2002-07-02
% 219.77/219.94  |- skos__hiddenLabel mesh__D027381 LST 1 Transport Protein
% 219.77/219.94  |- mesh__recordMaintainer mesh__D027381 sjn
% 219.77/219.94  |- skos__scopeNote mesh__D027381
% 219.77/219.94       An organic anion transporter found in human liver. It is capable of transporting a variety organic anions and mediates sodium-independent uptake of bile in the liver.%A%    
% 219.77/219.94  |- mesh__publicMeSHNote mesh__D027381
% 219.77/219.94       2002; LIVER-SPECIFIC ORGANIC ANION TRANSPORTER, LST-1 was indexed under CARRIER PROTEINS 1999-2001; OATP2 %26% OATP2 PROTEIN were indexed under CARRIER PROTEINS 2000-2001%A%  
% 219.77/219.94  |- skos__hiddenLabel mesh__D027381
% 219.77/219.94       Liver Specific Organic Anion Transporter, LST 1
% 219.77/219.94  |- skos__altLabel mesh__D027381 SLC21A6 Transporter
% 219.77/219.94  |- mesh__recordAuthorizer mesh__D027381 sjn
% 219.77/219.94  |- mesh__historyNote mesh__D027381
% 219.77/219.94       2002; for LIVER-SPECIFIC ORGANIC ANION TRANSPORTER, LST-1 use ANION TRANSPORT PROTEINS %28%NM%29% 1999-2001; for OATP2 %26% OATP2 PROTEIN use ANION TRANSPORT PROTEINS %28%NM%29% 2000-2001%A%  
% 219.77/219.94  |- skos__altLabel mesh__D027381 LST-1 Transport Protein
% 219.77/219.94  |- skos__prefLabel mesh__D027381 Organic Anion Transport Polypeptide C
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D027381 2006
% 219.77/219.94  |- mesh__dateEstablished mesh__D027381 2002-01-01
% 219.77/219.94  |- skos__altLabel mesh__D027381
% 219.77/219.94       Solute Carrier Family-21%28%Organic Anion Transporter%29%, Member 6 Protein
% 219.77/219.94  |- skos__hiddenLabel mesh__D027381 Human Oatp2 Protein
% 219.77/219.94  |- skos__hiddenLabel mesh__D027381 Transporter, SLC21A6
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D027381 2005
% 219.77/219.94  |- skos__altLabel mesh__D027381
% 219.77/219.94       Organic Anion Transport Polypeptide 2, Human
% 219.77/219.94  |- skos__historyNote mesh__D027381 Carrier Proteins %28%1999-2001%29%
% 219.77/219.94  |- skos__altLabel mesh__D027381
% 219.77/219.94       Liver-Specific Organic Anion Transporter, LST-1
% 219.77/219.94  |- rdf__type mesh__D027381sskos__Concept
% 219.77/219.94  |- skos__altLabel mesh__D027381 Oatp-C Transport Protein
% 219.77/219.94  |- skos__altLabel mesh__D027381 Oatp2 Protein, Human
% 219.77/219.94  |- mesh__dateRevised mesh__D027381 2004-07-13
% 219.77/219.94  |- skos__hiddenLabel mesh__D027381 Transport Protein, Oatp-C
% 219.77/219.94  |- skos__hiddenLabel mesh__D027381 Transport Protein, LST-1
% 219.77/219.94  |- skos__hiddenLabel mesh__D027381 Oatp C Transport Protein
% 219.77/219.94  |- mesh__recordOriginator mesh__D027381 jmp
% 219.77/219.94  |- mesh__dateCreated mesh__D027381 2001-07-25
% 219.77/219.94  |- skos__altLabel mesh__D027381 OATP2, Human
% 219.77/219.94  |- skos__broader mesh__D027381smesh__D029362
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D002639 2005
% 219.77/219.94  |- mesh__dateCreated mesh__D002639 1999-01-01
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D002639 2006
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D002639 2001
% 219.77/219.94  |- mesh__dateRevised mesh__D002639 1999-11-08
% 219.77/219.94  |- mesh__recordAuthorizer mesh__D002639 sjn
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D002639 2003
% 219.77/219.94  |- skos__broader mesh__D002639smesh__D012120
% 219.77/219.94  |- rdf__type mesh__D002639sskos__Concept
% 219.77/219.94  |- skos__hiddenLabel mesh__D002639 Respiration, Cheyne-Stokes
% 219.77/219.94  |- skos__prefLabel mesh__D002639 Cheyne-Stokes Respiration
% 219.77/219.94  |- mesh__recordOriginator mesh__D002639 NLM
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D002639 2004
% 219.77/219.94  |- mesh__publicMeSHNote mesh__D002639
% 219.77/219.94       91; was see under RESPIRATION DISORDERS 1977-90; was see under RESPIRATION 1966-76%A%  
% 219.77/219.94  |- skos__hiddenLabel mesh__D002639 Cheyne Stokes Respiration
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D002639 2002
% 219.77/219.94  |- mesh__dateEstablished mesh__D002639 1991-01-01
% 219.77/219.94  |- skos__broader mesh__D002639smesh__D012818
% 219.77/219.94  |- skos__scopeNote mesh__D002639
% 219.77/219.94       An abnormal pattern of breathing characterized by alternating periods of apnea and deep, rapid breathing. The cycle begins with slow, shallow breaths that gradually increase in depth and rate and is then followed by a period of apnea. The period of apnea can last 5 to 30 seconds, then the cycle repeats every 45 seconds to 3 minutes.%A%    
% 219.77/219.94  |- mesh__onlineNote mesh__D002639
% 219.77/219.94       use RESPIRATION to search CHEYNE-STOKES RESPIRATION 1966-76%A%  
% 219.77/219.94  |- mesh__historyNote mesh__D002639
% 219.77/219.94       91%28%66%29%; was see under RESPIRATION DISORDERS 1977-90; was see under RESPIRATION 1966-76%A%  
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D002639 2000
% 219.77/219.94  |- mesh__recordMaintainer mesh__D002639 adp
% 219.77/219.94  |- skos__annotation mesh__D013361
% 219.77/219.94       diseases: coord IM with SALIVARY GLAND DISEASES %28%NIM%29%   
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D013361 2005
% 219.77/219.94  |- mesh__recordMaintainer mesh__D013361 lkt
% 219.77/219.94  |- mesh__recordAuthorizer mesh__D013361 sjn
% 219.77/219.94  |- mesh__dateCreated mesh__D013361 1999-01-01
% 219.77/219.94  |- mesh__dateRevised mesh__D013361 2003-07-09
% 219.77/219.94  |- rdf__type mesh__D013361sskos__Concept
% 219.77/219.94  |- skos__hiddenLabel mesh__D013361 Sublingual Glands
% 219.77/219.94  |- skos__broader mesh__D013361smesh__D012469
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D013361 2004
% 219.77/219.94  |- skos__prefLabel mesh__D013361 Sublingual Gland
% 219.77/219.94  |- skos__hiddenLabel mesh__D013361 Gland, Sublingual
% 219.77/219.94  |- skos__hiddenLabel mesh__D013361 Glands, Sublingual
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D013361 2006
% 219.77/219.94  |- mesh__recordOriginator mesh__D013361 NLM
% 219.77/219.94  |- skos__broader mesh__D007324smesh__D009934
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007324 2001
% 219.77/219.94  |- skos__altLabel mesh__D007324 Management Teams, Institutional
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007324 1995
% 219.77/219.94  |- skos__hiddenLabel mesh__D007324 Teams, Institutional Management
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007324 1998
% 219.77/219.94  |- skos__hiddenLabel mesh__D007324 Management Team, Institutional
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007324 2005
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007324 1999
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007324 2006
% 219.77/219.94  |- mesh__publicMeSHNote mesh__D007324
% 219.77/219.94       91; was see under ORGANIZATION AND ADMINISTRATION 1983-90%A%  
% 219.77/219.94  |- skos__prefLabel mesh__D007324 Institutional Management Teams
% 219.77/219.94  |- mesh__recordAuthorizer mesh__D007324 PLS
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007324 2002
% 219.77/219.94  |- mesh__dateEstablished mesh__D007324 1991-01-01
% 219.77/219.94  |- skos__hiddenLabel mesh__D007324 Institutional Management Team
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007324 1996
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007324 2003
% 219.77/219.94  |- mesh__dateRevised mesh__D007324 1994-05-05
% 219.77/219.94  |- skos__hiddenLabel mesh__D007324 Team, Institutional Management
% 219.77/219.94  |- mesh__recordOriginator mesh__D007324 EC
% 219.77/219.94  |- skos__annotation mesh__D007324
% 219.77/219.94       IM; toward integration of various institutional functions: do not confuse with PATIENT CARE TEAM %28%directed to personal care%29%%A%  
% 219.77/219.94  |- mesh__recordMaintainer mesh__D007324 TGC
% 219.77/219.94  |- skos__scopeNote mesh__D007324
% 219.77/219.94       Administrator-selected management groups who are responsible for making decisions pertaining to the provision of integrated direction for various institutional functions.%A%    
% 219.77/219.94  |- mesh__historyNote mesh__D007324
% 219.77/219.94       91%28%83%29%; was see under ORGANIZATION AND ADMINISTRATION 1983-90%A%  
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007324 1997
% 219.77/219.94  |- mesh__dateCreated mesh__D007324 1982-04-28
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007324 2004
% 219.77/219.94  |- rdf__type mesh__D007324sskos__Concept
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D007324 2000
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D051480 2006A
% 219.77/219.94  |- mesh__dateEstablished mesh__D051480 2006-01-01
% 219.77/219.94  |- skos__altLabel mesh__D051480 Acute Kidney Insufficiency
% 219.77/219.94  |- skos__hiddenLabel mesh__D051480 Renal Insufficiencies, Acute
% 219.77/219.94  |- mesh__historyNote mesh__D051480
% 219.77/219.94       2006; use KIDNEY FAILURE, ACUTE 1993-2005   
% 219.77/219.94  |- mesh__dateCreated mesh__D051480 2005-06-30
% 219.77/219.94  |- skos__scopeNote mesh__D051480
% 219.77/219.94       Conditions in which the function of KIDNEYS deteriorates suddenly in a matter of days or even hours. It is characterized by the sudden drop in GLOMERULAR FILTRATION RATE; %28%GMR%29%. The most severe stage is when the GFR drops below 15 ml per min %28%ACUTE KIDNEY FAILURE%29%.%A%    
% 219.77/219.94  |- skos__hiddenLabel mesh__D051480 Acute Kidney Insufficiencies
% 219.77/219.94  |- skos__altLabel mesh__D051480 Acute Renal Insufficiency
% 219.77/219.94  |- skos__broader mesh__D051480smesh__D051437
% 219.77/219.94  |- skos__hiddenLabel mesh__D051480 Kidney Insufficiencies, Acute
% 219.77/219.94  |- rdf__type mesh__D051480sskos__Concept
% 219.77/219.94  |- skos__prefLabel mesh__D051480 Renal Insufficiency, Acute
% 219.77/219.94  |- mesh__recordOriginator mesh__D051480 lkt
% 219.77/219.94  |- mesh__dateRevised mesh__D051480 2005-07-15
% 219.77/219.94  |- mesh__recordAuthorizer mesh__D051480 ags
% 219.77/219.94  |- mesh__publicMeSHNote mesh__D051480
% 219.77/219.94       2006; see KIDNEY FAILURE, ACUTE 1993-2005   
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D051480 2006
% 219.77/219.94  |- skos__altLabel mesh__D051480 Kidney Insufficiency, Acute
% 219.77/219.94  |- skos__hiddenLabel mesh__D051480 Acute Renal Insufficiencies
% 219.77/219.94  |- mesh__recordMaintainer mesh__D051480 ags
% 219.77/219.94  |- skos__altLabel mesh__D012269 Ribosomal Protein
% 219.77/219.94  |- mesh__dateEstablished mesh__D012269 1975-09-01
% 219.77/219.94  |- skos__annotation mesh__D012269 /biosyn /drug eff /physiol permitted   
% 219.77/219.94  |- skos__prefLabel mesh__D012269 Ribosomal Proteins
% 219.77/219.94  |- mesh__publicMeSHNote mesh__D012269 75   
% 219.77/219.94  |- mesh__dateCreated mesh__D012269 1974-11-11
% 219.77/219.94  |- skos__broader mesh__D012269smesh__D011506
% 219.77/219.94  |- skos__altLabel mesh__D012269 Proteins, Ribosomal
% 219.77/219.94  |- skos__scopeNote mesh__D012269
% 219.77/219.94       Proteins found in ribosomes. They are believed to have a catalytic function in reconstituting biologically active ribosomal subunits.%A%    
% 219.77/219.94  |- mesh__historyNote mesh__D012269 75   
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D012269 2006
% 219.77/219.94  |- rdf__type mesh__D012269sskos__Concept
% 219.77/219.94  |- mesh__recordOriginator mesh__D012269 NLM
% 219.77/219.94  |- mesh__dateRevised mesh__D012269 2005-06-30
% 219.77/219.94  |- skos__historyNote mesh__D012269 Ribosomes %28%1966-1974%29%
% 219.77/219.94  |- skos__historyNote mesh__D012269 Proteins %28%1966-1974%29%
% 219.77/219.94  |- mesh__recordMaintainer mesh__D012269 SYSTEM
% 219.77/219.94  |- skos__hiddenLabel mesh__D012269 Protein, Ribosomal
% 219.77/219.94  |- mesh__recordAuthorizer mesh__D012269 sjn
% 219.77/219.94  |- skos__broader mesh__D017752smesh__D004777
% 219.77/219.94  |- mesh__recordAuthorizer mesh__D017752 sjn
% 219.77/219.94  |- mesh__historyNote mesh__D017752 94   
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D017752 2000
% 219.77/219.94  |- mesh__dateRevised mesh__D017752 1999-11-03
% 219.77/219.94  |- skos__annotation mesh__D017752
% 219.77/219.94       specify geog if pertinent; no qualif; DF: GREENHOUSE EFF   
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D017752 2004
% 219.77/219.94  |- mesh__dateEstablished mesh__D017752 1994-01-01
% 219.77/219.94  |- skos__scopeNote mesh__D017752
% 219.77/219.94       The effect of global warming and the resulting increase in world temperatures. The predicted health effects of such long-term climatic change include increased incidence of respiratory, water-borne, and vector-borne diseases.%A%    
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D017752 2006
% 219.77/219.94  |- mesh__publicMeSHNote mesh__D017752 94   
% 219.77/219.94  |- mesh__recordOriginator mesh__D017752 JLS
% 219.77/219.94  |- rdf__type mesh__D017752sskos__Concept
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D017752 2003
% 219.77/219.94  |- skos__prefLabel mesh__D017752 Greenhouse Effect
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D017752 2005
% 219.77/219.94  |- skos__hiddenLabel mesh__D017752 Warming, Global
% 219.77/219.94  |- skos__hiddenLabel mesh__D017752 Effect, Greenhouse
% 219.77/219.94  |- mesh__dateCreated mesh__D017752 1992-12-28
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D017752 2002
% 219.77/219.94  |- skos__broader mesh__D017752smesh__D002980
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D017752 2001
% 219.77/219.94  |- mesh__recordMaintainer mesh__D017752 kle
% 219.77/219.94  |- skos__historyNote mesh__D017752 Climate %28%1966-1993%29%
% 219.77/219.94  |- rdf__type mesh__D031423sskos__Concept
% 219.77/219.94  |- skos__annotation mesh__D031423
% 219.77/219.94       HYACINTH, WATER see EICHHORNIA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.77/219.94  |- mesh__dateEstablished mesh__D031423 2003-01-01
% 219.77/219.94  |- mesh__historyNote mesh__D031423 2003   
% 219.77/219.94  |- skos__scopeNote mesh__D031423
% 219.77/219.94       A plant genus of the family LILIACEAE. Do not confuse with water hyacinth %28%EICHHORNIA%29%.%A%    
% 219.77/219.94  |- mesh__dateCreated mesh__D031423 2002-07-03
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D031423 2005
% 219.77/219.94  |- mesh__activeMeSHYear mesh__D031423 2003
% 219.77/219.94  |- skos__prefLabel mesh__D031423 Hyacinthus
% 219.77/219.95  |- skos__altLabel mesh__D031423 Hyacinth
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D031423 2006
% 219.77/219.95  |- skos__broader mesh__D031423smesh__D019668
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D031423 2004
% 219.77/219.95  |- mesh__publicMeSHNote mesh__D031423 2003   
% 219.77/219.95  |- mesh__historyNote mesh__D003732 72%28%70%29%   
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003732 1995
% 219.77/219.95  |- mesh__dateRevised mesh__D003732 1992-05-14
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003732 2006
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003732 2000
% 219.77/219.95  |- mesh__recordAuthorizer mesh__D003732 PLS
% 219.77/219.95  |- skos__historyNote mesh__D003732
% 219.77/219.95       Dental Caries Susceptibility %28%1966-1969%29%
% 219.77/219.95  |- mesh__recordMaintainer mesh__D003732 TAP
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003732 2001
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003732 1996
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003732 2002
% 219.77/219.95  |- skos__annotation mesh__D003732 DF: DENT CARIES ACTIVITY TESTS   
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003732 1997
% 219.77/219.95  |- skos__prefLabel mesh__D003732 Dental Caries Activity Tests
% 219.77/219.95  |- skos__historyNote mesh__D003732 Diagnosis, Oral %28%1966-1979%29%
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003732 2003
% 219.77/219.95  |- mesh__dateCreated mesh__D003732 1999-01-01
% 219.77/219.95  |- rdf__type mesh__D003732sskos__Concept
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003732 1998
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003732 1993
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003732 2004
% 219.77/219.95  |- mesh__dateEstablished mesh__D003732 1972-01-01
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003732 1994
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003732 1999
% 219.77/219.95  |- mesh__publicMeSHNote mesh__D003732 72   
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003732 2005
% 219.77/219.95  |- mesh__recordOriginator mesh__D003732 NLM
% 219.77/219.95  |- skos__broader mesh__D003732smesh__D003945
% 219.77/219.95  |- skos__historyNote mesh__D049834 Squid %28%1972-2005%29%
% 219.77/219.95  |- mesh__recordOriginator mesh__D049834 ags
% 219.77/219.95  |- mesh__publicMeSHNote mesh__D049834 2006   
% 219.77/219.95  |- mesh__dateEstablished mesh__D049834 2006-01-01
% 219.77/219.95  |- mesh__historyNote mesh__D049834 2006   
% 219.77/219.95  |- skos__scopeNote mesh__D049834
% 219.77/219.95       A genus of SQUID in the family Loliginidae, superorder DECAPODIFORMES, with a spindle-shaped body. They are well-studied, common inshore squids of the Atlantic and eastern Pacific Oceans, but their various species are taxonomically unresolved.%A%    
% 219.77/219.95  |- mesh__recordAuthorizer mesh__D049834 sjn
% 219.77/219.95  |- skos__broader mesh__D049834smesh__D049832
% 219.77/219.95  |- rdf__type mesh__D049834sskos__Concept
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D049834 2006
% 219.77/219.95  |- mesh__recordMaintainer mesh__D049834 ags
% 219.77/219.95  |- skos__historyNote mesh__D049834 Mollusca %28%1965-1972%29%
% 219.77/219.95  |- skos__prefLabel mesh__D049834 Loligo
% 219.77/219.95  |- mesh__dateCreated mesh__D049834 2005-06-30
% 219.77/219.95  |- skos__broader mesh__D027382smesh__D004267
% 219.77/219.95  |- skos__broader mesh__D027382smesh__D014712
% 219.77/219.95  |- mesh__dateCreated mesh__D027382 2001-07-25
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D027382 2006
% 219.77/219.95  |- mesh__dateEstablished mesh__D027382 2002-01-01
% 219.77/219.95  |- skos__annotation mesh__D027382
% 219.77/219.95       infection = POLYOMAVIRUS INFECTIONS + TUMOR VIRUS INFECTIONS%A%  
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D027382 2005
% 219.77/219.95  |- mesh__publicMeSHNote mesh__D027382 2002   
% 219.77/219.95  |- rdf__type mesh__D027382sskos__Concept
% 219.77/219.95  |- skos__scopeNote mesh__D027382
% 219.77/219.95       A family of small, non-enveloped DNA viruses, infecting mainly MAMMALS, and containing a single genus: POLYOMAVIRUS.%A%    
% 219.77/219.95  |- skos__broader mesh__D027382smesh__D004263
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D027382 2004
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D027382 2002
% 219.77/219.95  |- mesh__historyNote mesh__D027382 2002   
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D027382 2003
% 219.77/219.95  |- skos__prefLabel mesh__D027382 Polyomaviridae
% 219.77/219.95  |- mesh__dateRevised mesh__D013362 1995-06-08
% 219.77/219.95  |- skos__historyNote mesh__D013362
% 219.77/219.95       Salivary Gland Neoplasms %28%1966-1985%29%
% 219.77/219.95  |- mesh__recordOriginator mesh__D013362 VDK
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013362 2002
% 219.77/219.95  |- skos__hiddenLabel mesh__D013362 Gland Neoplasm, Sublingual
% 219.77/219.95  |- mesh__recordAuthorizer mesh__D013362 PLS
% 219.77/219.95  |- skos__hiddenLabel mesh__D013362 Sublingual Gland Neoplasm
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013362 2001
% 219.77/219.95  |- rdf__type mesh__D013362sskos__Concept
% 219.77/219.95  |- mesh__publicMeSHNote mesh__D013362
% 219.77/219.95       91; was see under SALIVARY GLAND NEOPLASMS 1986-90   
% 219.77/219.95  |- skos__annotation mesh__D013362
% 219.77/219.95       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%  
% 219.77/219.95  |- mesh__dateEstablished mesh__D013362 1991-01-01
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013362 1997
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013362 2004
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013362 1999
% 219.77/219.95  |- skos__hiddenLabel mesh__D013362 Gland Neoplasms, Sublingual
% 219.77/219.95  |- skos__hiddenLabel mesh__D013362 Neoplasms, Sublingual Gland
% 219.77/219.95  |- skos__scopeNote mesh__D013362 Neoplasms of the sublingual glands.     
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013362 2000
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013362 1996
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013362 2006
% 219.77/219.95  |- mesh__dateCreated mesh__D013362 1985-03-11
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013362 2003
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013362 1998
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013362 2005
% 219.77/219.95  |- mesh__recordMaintainer mesh__D013362 KEV
% 219.77/219.95  |- skos__prefLabel mesh__D013362 Sublingual Gland Neoplasms
% 219.77/219.95  |- mesh__historyNote mesh__D013362
% 219.77/219.95       91%28%86%29%; was see under SALIVARY GLAND NEOPLASMS 1986-90   
% 219.77/219.95  |- skos__broader mesh__D013362smesh__D012468
% 219.77/219.95  |- skos__hiddenLabel mesh__D013362 Neoplasm, Sublingual Gland
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007325 2003
% 219.77/219.95  |- mesh__dateEstablished mesh__D007325 1968-01-01
% 219.77/219.95  |- rdf__type mesh__D007325sskos__Concept
% 219.77/219.95  |- skos__hiddenLabel mesh__D007325 Practice, Institutional
% 219.77/219.95  |- skos__scopeNote mesh__D007325
% 219.77/219.95       Professional practice as an employee or contractee of a health care institution.%A%    
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007325 2002
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007325 1995
% 219.77/219.95  |- mesh__publicMeSHNote mesh__D007325 68   
% 219.77/219.95  |- mesh__recordAuthorizer mesh__D007325 PLS
% 219.77/219.95  |- mesh__recordOriginator mesh__D007325 NLM
% 219.77/219.95  |- skos__prefLabel mesh__D007325 Institutional Practice
% 219.77/219.95  |- mesh__dateCreated mesh__D007325 1999-01-01
% 219.77/219.95  |- mesh__recordMaintainer mesh__D007325 TGC
% 219.77/219.95  |- skos__hiddenLabel mesh__D007325 Institutional Practices
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007325 1999
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007325 2006
% 219.77/219.95  |- skos__broader mesh__D007325smesh__D011364
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007325 2001
% 219.77/219.95  |- skos__hiddenLabel mesh__D007325 Practices, Institutional
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007325 1998
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007325 2005
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007325 1997
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007325 2004
% 219.77/219.95  |- skos__historyNote mesh__D007325
% 219.77/219.95       Medical Staff, Hospital %28%1966-1967%29%
% 219.77/219.95  |- mesh__dateRevised mesh__D007325 1994-05-05
% 219.77/219.95  |- mesh__historyNote mesh__D007325 68   
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007325 2000
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007325 1996
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D017753 2004
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D017753 2006
% 219.77/219.95  |- mesh__recordOriginator mesh__D017753 JLS
% 219.77/219.95  |- rdf__type mesh__D017753sskos__Concept
% 219.77/219.95  |- skos__hiddenLabel mesh__D017753 Systems, Ecologic
% 219.77/219.95  |- skos__altLabel mesh__D017753 System, Ecological
% 219.77/219.95  |- mesh__recordAuthorizer mesh__D017753 sjn
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D017753 2005
% 219.77/219.95  |- mesh__historyNote mesh__D017753 94; was see ECOLOGY 1993   
% 219.77/219.95  |- mesh__dateRevised mesh__D017753 2003-07-09
% 219.77/219.95  |- skos__hiddenLabel mesh__D017753 Ecosystems
% 219.77/219.95  |- skos__altLabel mesh__D017753 Ecologic System
% 219.77/219.95  |- skos__related mesh__D017753smesh__D004463
% 219.77/219.95  |- skos__altLabel mesh__D017753 Ecological System
% 219.77/219.95  |- mesh__dateCreated mesh__D017753 1992-12-28
% 219.77/219.95  |- skos__altLabel mesh__D017753 Ecologic Systems
% 219.77/219.95  |- mesh__dateEstablished mesh__D017753 1994-01-01
% 219.77/219.95  |- mesh__onlineNote mesh__D017753 use ECOLOGY to search ECOSYSTEM 1993   
% 219.77/219.95  |- mesh__publicMeSHNote mesh__D017753 94; was see ECOLOGY 1993   
% 219.77/219.95  |- skos__prefLabel mesh__D017753 Ecosystem
% 219.77/219.95  |- mesh__recordMaintainer mesh__D017753 nns
% 219.77/219.95  |- skos__scopeNote mesh__D017753
% 219.77/219.95       A functional system which includes the organisms of a natural community together with their environment. %28%McGraw Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 219.77/219.95  |- skos__broader mesh__D017753smesh__D004777
% 219.77/219.95  |- skos__annotation mesh__D017753
% 219.77/219.95       ECOLOGY is the science, ECOSYSTEM is the interrelat of organisms within the science; specify geog if pertinent%A%  
% 219.77/219.95  |- skos__altLabel mesh__D017753 Systems, Ecological
% 219.77/219.95  |- skos__hiddenLabel mesh__D017753 System, Ecologic
% 219.77/219.95  |- skos__hiddenLabel mesh__D017753 Ecological Systems
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D031424 2006
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D031424 2003
% 219.77/219.95  |- mesh__publicMeSHNote mesh__D031424 2003   
% 219.77/219.95  |- skos__prefLabel mesh__D031424 Liriope Plant
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D031424 2005
% 219.77/219.95  |- mesh__dateCreated mesh__D031424 2002-07-03
% 219.77/219.95  |- mesh__historyNote mesh__D031424 2003   
% 219.77/219.95  |- skos__annotation mesh__D031424
% 219.77/219.95       for the sea organism hydrozoa, LIRIOPE TETRAPHYLLA see CNIDARIA is available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.77/219.95  |- rdf__type mesh__D031424sskos__Concept
% 219.77/219.95  |- skos__scopeNote mesh__D031424
% 219.77/219.95       A plant genus of the family LILIACEAE. Members contain ruscogenin. Do not confuse with the Liriope jellyfish %28%CNIDARIA%29%.%A%    
% 219.77/219.95  |- skos__broader mesh__D031424smesh__D019668
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D031424 2004
% 219.77/219.95  |- skos__altLabel mesh__D031424 Lilyturf
% 219.77/219.95  |- mesh__dateEstablished mesh__D031424 2003-01-01
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003733 2005
% 219.77/219.95  |- mesh__publicMeSHNote mesh__D003733 65   
% 219.77/219.95  |- skos__altLabel mesh__D003733 Caries Susceptibility, Dental
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003733 2001
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003733 2006
% 219.77/219.95  |- skos__annotation mesh__D003733 DF: DENT CARIES SUSCEPTIBILITY   
% 219.77/219.95  |- mesh__dateRevised mesh__D003733 1997-06-20
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003733 2002
% 219.77/219.95  |- mesh__dateCreated mesh__D003733 1999-01-01
% 219.77/219.95  |- rdf__type mesh__D003733sskos__Concept
% 219.77/219.95  |- mesh__recordMaintainer mesh__D003733 TGC
% 219.77/219.95  |- mesh__recordAuthorizer mesh__D003733 SJN
% 219.77/219.95  |- mesh__historyNote mesh__D003733 65   
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003733 2003
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003733 1998
% 219.77/219.95  |- skos__altLabel mesh__D003733 Resistance, Dental Caries
% 219.77/219.95  |- skos__altLabel mesh__D003733 Susceptibility, Dental Caries
% 219.77/219.95  |- mesh__dateEstablished mesh__D003733 1965-01-01
% 219.77/219.95  |- skos__prefLabel mesh__D003733 Dental Caries Susceptibility
% 219.77/219.95  |- mesh__recordOriginator mesh__D003733 NLM
% 219.77/219.95  |- skos__altLabel mesh__D003733 Dental Caries Resistance
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003733 2004
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003733 1999
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003733 2000
% 219.77/219.95  |- skos__broader mesh__D003733smesh__D009063
% 219.77/219.95  |- mesh__historyNote mesh__D027383 2002   
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D027383 2006
% 219.77/219.95  |- skos__broader mesh__D027383smesh__D014712
% 219.77/219.95  |- mesh__dateCreated mesh__D027383 2001-07-25
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D027383 2003
% 219.77/219.95  |- mesh__publicMeSHNote mesh__D027383 2002   
% 219.77/219.95  |- rdf__type mesh__D027383sskos__Concept
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D027383 2004
% 219.77/219.95  |- mesh__dateEstablished mesh__D027383 2002-01-01
% 219.77/219.95  |- skos__broader mesh__D027383smesh__D004263
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D027383 2002
% 219.77/219.95  |- skos__broader mesh__D027383smesh__D004267
% 219.77/219.95  |- skos__scopeNote mesh__D027383
% 219.77/219.95       A family of small, non-enveloped DNA viruses infecting MAMMALS. There is one genus: PAPILLOMAVIRUS.%A%    
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D027383 2005
% 219.77/219.95  |- skos__prefLabel mesh__D027383 Papillomaviridae
% 219.77/219.95  |- mesh__dateRevised mesh__D013363 2003-07-09
% 219.77/219.95  |- skos__hiddenLabel mesh__D013363 Glands, Submandibular
% 219.77/219.95  |- rdf__type mesh__D013363sskos__Concept
% 219.77/219.95  |- skos__altLabel mesh__D013363 Submaxillary Gland
% 219.77/219.95  |- skos__hiddenLabel mesh__D013363 Submandibular Glands
% 219.77/219.95  |- skos__hiddenLabel mesh__D013363 Gland, Submandibular
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013363 2004
% 219.77/219.95  |- skos__hiddenLabel mesh__D013363 Glands, Submaxillary
% 219.77/219.95  |- skos__broader mesh__D013363smesh__D012469
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013363 2006
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013363 2005
% 219.77/219.95  |- mesh__recordMaintainer mesh__D013363 lkt
% 219.77/219.95  |- mesh__recordOriginator mesh__D013363 NLM
% 219.77/219.95  |- skos__hiddenLabel mesh__D013363 Submaxillary Glands
% 219.77/219.95  |- skos__hiddenLabel mesh__D013363 Gland, Submaxillary
% 219.77/219.95  |- skos__prefLabel mesh__D013363 Submandibular Gland
% 219.77/219.95  |- mesh__dateCreated mesh__D013363 1999-01-01
% 219.77/219.95  |- mesh__recordAuthorizer mesh__D013363 sjn
% 219.77/219.95  |- skos__scopeNote mesh__D013363
% 219.77/219.95       One of two salivary glands in the neck, located in the space bound by the two bellies of the digastric muscle and the angle of the mandible. It discharges through the submandibular duct. The secretory units are predominantly serous although a few mucous alveoli, some with serous demilunes, occur. %28%Stedman, 25th ed%29%%A%    
% 219.77/219.95  |- mesh__publicMeSHNote mesh__D007326 79   
% 219.77/219.95  |- skos__hiddenLabel mesh__D007326 Person, Institutionalized
% 219.77/219.95  |- skos__related mesh__D007326smesh__D003688
% 219.77/219.95  |- skos__related mesh__D007326smesh__D006760
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007326 2000
% 219.77/219.95  |- mesh__recordMaintainer mesh__D007326 PXP
% 219.77/219.95  |- mesh__dateEstablished mesh__D007326 1979-01-01
% 219.77/219.95  |- skos__annotation mesh__D007326
% 219.77/219.95       coord IM with type of institution %28%IM%29% if pertinent; institutionalization of mentally ill: consider also COMMITMENT OF MENTALLY ILL%A%  
% 219.77/219.95  |- skos__hiddenLabel mesh__D007326 Institutionalizations
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007326 2006
% 219.77/219.95  |- mesh__recordAuthorizer mesh__D007326 SJN
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007326 1999
% 219.77/219.95  |- skos__prefLabel mesh__D007326 Institutionalization
% 219.77/219.95  |- mesh__historyNote mesh__D007326 79   
% 219.77/219.95  |- mesh__dateRevised mesh__D007326 1997-06-20
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007326 2002
% 219.77/219.95  |- skos__scopeNote mesh__D007326
% 219.77/219.95       The caring for individuals in institutions and their adaptation to routines characteristic of the institutional environment, and/or their loss of adaptation to life outside the institution.%A%    
% 219.77/219.95  |- skos__hiddenLabel mesh__D007326 Institutionalized Person
% 219.77/219.95  |- skos__broader mesh__D007326smesh__D005791
% 219.77/219.95  |- mesh__dateCreated mesh__D007326 1978-05-16
% 219.77/219.95  |- skos__hiddenLabel mesh__D007326 Persons, Institutionalized
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007326 2004
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007326 1998
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007326 2005
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007326 2003
% 219.77/219.95  |- mesh__recordOriginator mesh__D007326 EC
% 219.77/219.95  |- rdf__type mesh__D007326sskos__Concept
% 219.77/219.95  |- skos__related mesh__D007326smesh__D002674
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007326 2001
% 219.77/219.95  |- skos__altLabel mesh__D017754 Purchasing, Hospital, Group
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D017754 2003
% 219.77/219.95  |- skos__historyNote mesh__D017754
% 219.77/219.95       Hospital Shared Services %28%1972-1993%29%
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D017754 1997
% 219.77/219.95  |- skos__hiddenLabel mesh__D017754 Purchasing, Group
% 219.77/219.95  |- skos__related mesh__D017754smesh__D011682
% 219.77/219.95  |- skos__prefLabel mesh__D017754 Group Purchasing
% 219.77/219.95  |- skos__altLabel mesh__D017754 Joint Purchasing
% 219.77/219.95  |- skos__broader mesh__D017754smesh__D005376
% 219.77/219.95  |- skos__altLabel mesh__D017754 Joint Purchasing, Hospital
% 219.77/219.95  |- rdf__type mesh__D017754sskos__Concept
% 219.77/219.95  |- skos__broader mesh__D017754smesh__D011682
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D017754 2004
% 219.77/219.95  |- skos__altLabel mesh__D017754 Hospital Shared Purchasing
% 219.77/219.95  |- skos__altLabel mesh__D017754 Purchasing, Hospital, Shared
% 219.77/219.95  |- mesh__dateRevised mesh__D017754 1993-09-16
% 219.77/219.95  |- mesh__dateCreated mesh__D017754 1992-12-28
% 219.77/219.95  |- mesh__recordMaintainer mesh__D017754 PLS
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D017754 2000
% 219.77/219.95  |- skos__historyNote mesh__D017754 Purchasing, Hospital %28%1978-1993%29%
% 219.77/219.95  |- mesh__recordOriginator mesh__D017754 JLS
% 219.77/219.95  |- mesh__historyNote mesh__D017754 94   
% 219.77/219.95  |- skos__hiddenLabel mesh__D017754 Purchasing, Shared
% 219.77/219.95  |- skos__annotation mesh__D017754 not restricted to hosp purchasing   
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D017754 1998
% 219.77/219.95  |- skos__scopeNote mesh__D017754
% 219.77/219.95       A shared service which combines the purchasing power of individual organizations or facilities in order to obtain lower prices for equipment and supplies. %28%From Health Care Terms, 2nd ed%29%%A%    
% 219.77/219.95  |- skos__hiddenLabel mesh__D017754 Purchasing, Joint
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D017754 1995
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D017754 2001
% 219.77/219.95  |- skos__altLabel mesh__D017754 Group Purchasing, Hospital
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D017754 2005
% 219.77/219.95  |- skos__altLabel mesh__D017754 Shared Purchasing
% 219.77/219.95  |- mesh__dateEstablished mesh__D017754 1994-01-01
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D017754 1999
% 219.77/219.95  |- mesh__recordAuthorizer mesh__D017754 NLM
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D017754 1996
% 219.77/219.95  |- skos__altLabel mesh__D017754 Hospital Joint Purchasing
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D017754 2002
% 219.77/219.95  |- mesh__publicMeSHNote mesh__D017754 94   
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D017754 2006
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D031425 2005
% 219.77/219.95  |- mesh__dateEstablished mesh__D031425 2003-01-01
% 219.77/219.95  |- rdf__type mesh__D031425sskos__Concept
% 219.77/219.95  |- skos__prefLabel mesh__D031425 Plasmodesmata
% 219.77/219.95  |- skos__broader mesh__D031425smesh__D007365
% 219.77/219.95  |- skos__scopeNote mesh__D031425
% 219.77/219.95       Membrane-like channels of cytoplasm connecting adjacent plant cells. Plasmodesmata connect through pores in the CELL WALL and associate with the CYTOSKELETON machinery. They are essential for intercellular transport and communication.%A%    
% 219.77/219.95  |- mesh__dateCreated mesh__D031425 2002-07-03
% 219.77/219.95  |- mesh__historyNote mesh__D031425 2003   
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D031425 2004
% 219.77/219.95  |- skos__historyNote mesh__D031425 Cell Wall %28%1967-2002%29%
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D031425 2006
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D031425 2003
% 219.77/219.95  |- mesh__publicMeSHNote mesh__D031425 2003   
% 219.77/219.95  |- skos__annotation mesh__D003734
% 219.77/219.95       material from which a casting mold is made; D25-26 qualif; DF: DENT CASTING INVESTMENT%A%  
% 219.77/219.95  |- skos__altLabel mesh__D003734 Casting Investments, Dental
% 219.77/219.95  |- mesh__publicMeSHNote mesh__D003734 65   
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003734 1999
% 219.77/219.95  |- skos__broader mesh__D003734smesh__D003764
% 219.77/219.95  |- skos__altLabel mesh__D003734 Investments, Dental Casting
% 219.77/219.95  |- skos__prefLabel mesh__D003734 Dental Casting Investment
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003734 2002
% 219.77/219.95  |- mesh__recordOriginator mesh__D003734 NLM
% 219.77/219.95  |- skos__scopeNote mesh__D003734
% 219.77/219.95       Material from which the casting mold is made in the fabrication of gold or cobalt-chromium castings. %28%Boucher%27%s Clinical Dental Terminology, 4th ed, p168%29%%A%    
% 219.77/219.95  |- skos__altLabel mesh__D003734 Investment, Dental Casting
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003734 1998
% 219.77/219.95  |- skos__altLabel mesh__D003734 Dental Casting Investments
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003734 2001
% 219.77/219.95  |- mesh__recordMaintainer mesh__D003734 TGC
% 219.77/219.95  |- mesh__dateCreated mesh__D003734 1999-01-01
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003734 1997
% 219.77/219.95  |- mesh__historyNote mesh__D003734 65   
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003734 2006
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003734 2000
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003734 1996
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003734 2005
% 219.77/219.95  |- mesh__dateRevised mesh__D003734 1995-03-16
% 219.77/219.95  |- rdf__type mesh__D003734sskos__Concept
% 219.77/219.95  |- mesh__dateEstablished mesh__D003734 1965-01-01
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003734 2004
% 219.77/219.95  |- skos__altLabel mesh__D003734 Casting Investment, Dental
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D003734 2003
% 219.77/219.95  |- mesh__recordAuthorizer mesh__D003734 PLS
% 219.77/219.95  |- skos__hiddenLabel mesh__D027384 Oncogene Proteins v raf
% 219.77/219.95  |- skos__hiddenLabel mesh__D027384 v-raf, Oncogene Proteins
% 219.77/219.95  |- mesh__recordAuthorizer mesh__D027384 sjn
% 219.77/219.95  |- rdf__type mesh__D027384sskos__Concept
% 219.77/219.95  |- skos__scopeNote mesh__D027384
% 219.77/219.95       A family of transforming proteins isolated from retroviruses such as MOUSE SARCOMA VIRUSES. They are viral-derived members of the raf-kinase family of serine-theonine kinases.%A%    
% 219.77/219.95  |- skos__hiddenLabel mesh__D027384 Kinases, v-raf
% 219.77/219.95  |- skos__hiddenLabel mesh__D027384 Protein mil, Oncogene
% 219.77/219.95  |- skos__broader mesh__D027384smesh__D048490
% 219.77/219.95  |- skos__hiddenLabel mesh__D027384 mil, Oncogene Protein
% 219.77/219.95  |- skos__hiddenLabel mesh__D027384 v-mil, Oncogene Proteins
% 219.77/219.95  |- skos__broader mesh__D027384smesh__D015682
% 219.77/219.95  |- skos__altLabel mesh__D027384 Protein v-mil
% 219.77/219.95  |- mesh__dateCreated mesh__D027384 2001-07-25
% 219.77/219.95  |- skos__hiddenLabel mesh__D027384 v mil Protein
% 219.77/219.95  |- mesh__dateEstablished mesh__D027384 2002-01-01
% 219.77/219.95  |- skos__altLabel mesh__D027384 Oncogene Protein mil
% 219.77/219.95  |- skos__hiddenLabel mesh__D027384 v raf Kinases
% 219.77/219.95  |- skos__hiddenLabel mesh__D027384 v-mil, Protein
% 219.77/219.95  |- mesh__historyNote mesh__D027384
% 219.77/219.95       2002; for ONCOGENE PROTEIN MIL use ONCOGENE PROTEINS V-RAF %28%NM%29% 1986-2001%A%  
% 219.77/219.95  |- mesh__recordMaintainer mesh__D027384 SYSTEM
% 219.77/219.95  |- skos__historyNote mesh__D027384
% 219.77/219.95       Retroviridae Proteins, Oncogenic %28%1989-2001%29%
% 219.77/219.95  |- skos__hiddenLabel mesh__D027384 Oncogene Proteins v mil
% 219.77/219.95  |- mesh__recordOriginator mesh__D027384 nns
% 219.77/219.95  |- skos__prefLabel mesh__D027384 Oncogene Proteins v-raf
% 219.77/219.95  |- skos__altLabel mesh__D027384 v-raf Kinases
% 219.77/219.95  |- mesh__dateRevised mesh__D027384 2005-06-30
% 219.77/219.95  |- skos__historyNote mesh__D027384 Retroviridae Proteins %28%1986-1989%29%
% 219.77/219.95  |- skos__altLabel mesh__D027384 v-mil Protein
% 219.77/219.95  |- mesh__publicMeSHNote mesh__D027384
% 219.77/219.95       2002; ONCOGENE PROTEIN MIL was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-2001 and RETROVIRIDAE PROTEINS 1986-1989%A%  
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D027384 2006
% 219.77/219.95  |- skos__hiddenLabel mesh__D027384 Proteins v-raf, Oncogene
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013364 2003
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013364 1998
% 219.77/219.95  |- rdf__type mesh__D013364sskos__Concept
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013364 1992
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013364 2005
% 219.77/219.95  |- skos__hiddenLabel mesh__D013364 Submandibular Gland Disease
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013364 1997
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013364 1994
% 219.77/219.95  |- mesh__recordOriginator mesh__D013364 RC
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013364 2004
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013364 1999
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013364 1993
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013364 2002
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013364 2006
% 219.77/219.95  |- mesh__recordAuthorizer mesh__D013364 PLS
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013364 1991
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013364 1995
% 219.77/219.95  |- mesh__dateCreated mesh__D013364 1980-04-09
% 219.77/219.95  |- mesh__historyNote mesh__D013364
% 219.77/219.95       91%28%81%29%; was see under SALIVARY GLAND DISEASES 1981-90   
% 219.77/219.95  |- mesh__dateEstablished mesh__D013364 1991-01-01
% 219.77/219.95  |- skos__broader mesh__D013364smesh__D012466
% 219.77/219.95  |- skos__historyNote mesh__D013364 Submandibular Gland %28%1966-1980%29%
% 219.77/219.95  |- mesh__dateRevised mesh__D013364 1990-04-13
% 219.77/219.95  |- skos__hiddenLabel mesh__D013364 Disease, Submandibular Gland
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013364 2000
% 219.77/219.95  |- skos__prefLabel mesh__D013364 Submandibular Gland Diseases
% 219.77/219.95  |- mesh__publicMeSHNote mesh__D013364
% 219.77/219.95       91; was see under SALIVARY GLAND DISEASES 1981-90   
% 219.77/219.95  |- mesh__recordMaintainer mesh__D013364 NLM
% 219.77/219.95  |- skos__hiddenLabel mesh__D013364 Gland Diseases, Submandibular
% 219.77/219.95  |- skos__hiddenLabel mesh__D013364 Gland Disease, Submandibular
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013364 2001
% 219.77/219.95  |- skos__hiddenLabel mesh__D013364 Diseases, Submandibular Gland
% 219.77/219.95  |- skos__historyNote mesh__D013364
% 219.77/219.95       Salivary Gland Diseases %28%1966-1980%29%
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D013364 1996
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007327 1999
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007327 2006
% 219.77/219.95  |- skos__prefLabel mesh__D007327 Insufflation
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007327 2004
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007327 1998
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007327 2005
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007327 2001
% 219.77/219.95  |- mesh__publicMeSHNote mesh__D007327 87   
% 219.77/219.95  |- mesh__activeMeSHYear mesh__D007327 2003
% 219.77/219.96  |- skos__annotation mesh__D007327
% 219.77/219.96       for air %26% other gases, powders, etc., do not use /util except by MeSH definition; for specific insufflation procedures consider other terms under PNEUMO-%A%  
% 219.77/219.96  |- skos__scopeNote mesh__D007327
% 219.77/219.96       The act of blowing a powder, vapor, or gas into any body cavity for experimental, diagnostic, or therapeutic purposes.%A%    
% 219.77/219.96  |- rdf__type mesh__D007327sskos__Concept
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D007327 2000
% 219.77/219.96  |- mesh__recordOriginator mesh__D007327 SH
% 219.77/219.96  |- skos__broader mesh__D007327smesh__D013812
% 219.77/219.96  |- mesh__dateEstablished mesh__D007327 1987-01-01
% 219.77/219.96  |- mesh__recordMaintainer mesh__D007327 PXP
% 219.77/219.96  |- skos__broader mesh__D007327smesh__D019937
% 219.77/219.96  |- skos__hiddenLabel mesh__D007327 Insufflations
% 219.77/219.96  |- mesh__recordAuthorizer mesh__D007327 SJN
% 219.77/219.96  |- mesh__dateRevised mesh__D007327 1997-06-20
% 219.77/219.96  |- mesh__historyNote mesh__D007327 87   
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D007327 2002
% 219.77/219.96  |- mesh__dateCreated mesh__D007327 1986-06-20
% 219.77/219.96  |- skos__broader mesh__D013234Q000637smesh__D013234
% 219.77/219.96  |- mesh__preferredCombination mesh__D013234Q000637smesh__D033581
% 219.77/219.96  |- rdf__type mesh__D013234Q000637smesh__CompoundConcept
% 219.77/219.96  |- skos__scopeNote mesh__D017755
% 219.77/219.96       The fitting and adjusting of artificial parts of the body. %28%From Stedman%27%s, 26th ed%29%%A%    
% 219.77/219.96  |- mesh__dateRevised mesh__D017755 1997-06-20
% 219.77/219.96  |- skos__broader mesh__D017755smesh__D008919
% 219.77/219.96  |- mesh__publicMeSHNote mesh__D017755 94   
% 219.77/219.96  |- mesh__historyNote mesh__D017755 94   
% 219.77/219.96  |- skos__hiddenLabel mesh__D017755 Prosthesis Fittings
% 219.77/219.96  |- skos__hiddenLabel mesh__D017755 Fittings, Prosthesis
% 219.77/219.96  |- mesh__recordMaintainer mesh__D017755 PXP
% 219.77/219.96  |- skos__hiddenLabel mesh__D017755 Prosthesis Adjustments
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017755 2004
% 219.77/219.96  |- skos__hiddenLabel mesh__D017755 Adjustments, Prosthesis
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017755 2002
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017755 2006
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017755 1999
% 219.77/219.96  |- skos__hiddenLabel mesh__D017755 Fitting, Prosthesis
% 219.77/219.96  |- rdf__type mesh__D017755sskos__Concept
% 219.77/219.96  |- mesh__recordOriginator mesh__D017755 JLS
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017755 2003
% 219.77/219.96  |- skos__hiddenLabel mesh__D017755 Adjustment, Prosthesis
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017755 2001
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017755 2005
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017755 1998
% 219.77/219.96  |- skos__prefLabel mesh__D017755 Prosthesis Fitting
% 219.77/219.96  |- mesh__dateCreated mesh__D017755 1992-12-28
% 219.77/219.96  |- mesh__recordAuthorizer mesh__D017755 SJN
% 219.77/219.96  |- skos__annotation mesh__D017755
% 219.77/219.96       NIM; coord with specific prosthesis with no qualif %28%IM%29%   
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017755 2000
% 219.77/219.96  |- mesh__dateEstablished mesh__D017755 1994-01-01
% 219.77/219.96  |- mesh__historyNote mesh__D031426 2003   
% 219.77/219.96  |- skos__scopeNote mesh__D031426
% 219.77/219.96       A plant genus of the family LILIACEAE. Members contain radiatine, vittatine, haemanthamine, lycorenine, dihydrolycorine, lycorine, lycoricidinol and lycoricidine.%A%    
% 219.77/219.96  |- skos__broader mesh__D031426smesh__D019668
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D031426 2004
% 219.77/219.96  |- mesh__dateEstablished mesh__D031426 2003-01-01
% 219.77/219.96  |- skos__prefLabel mesh__D031426 Lycoris
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D031426 2006
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D031426 2003
% 219.77/219.96  |- mesh__publicMeSHNote mesh__D031426 2003   
% 219.77/219.96  |- skos__annotation mesh__D031426
% 219.77/219.96       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D031426 2005
% 219.77/219.96  |- rdf__type mesh__D031426sskos__Concept
% 219.77/219.96  |- mesh__dateCreated mesh__D031426 2002-07-03
% 219.77/219.96  |- mesh__dateEstablished mesh__D003735 1965-01-01
% 219.77/219.96  |- mesh__recordMaintainer mesh__D003735 kle
% 219.77/219.96  |- skos__altLabel mesh__D003735 Technic, Dental Casting
% 219.77/219.96  |- skos__scopeNote mesh__D003735
% 219.77/219.96       The process of producing a form or impression made of metal or plaster using a mold.%A%    
% 219.77/219.96  |- mesh__dateCreated mesh__D003735 1999-01-01
% 219.77/219.96  |- mesh__dateRevised mesh__D003735 1999-11-03
% 219.77/219.96  |- skos__broader mesh__D003735smesh__D013674
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D003735 2006
% 219.77/219.96  |- skos__altLabel mesh__D003735 Technics, Dental Casting
% 219.77/219.96  |- mesh__recordOriginator mesh__D003735 NLM
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D003735 2002
% 219.77/219.96  |- skos__broader mesh__D003735smesh__D011476
% 219.77/219.96  |- skos__altLabel mesh__D003735 Casting Techniques, Dental
% 219.77/219.96  |- skos__altLabel mesh__D003735 Casting Technique, Dental
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D003735 2005
% 219.77/219.96  |- rdf__type mesh__D003735sskos__Concept
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D003735 2001
% 219.77/219.96  |- skos__annotation mesh__D003735 DF: DENT CASTING TECHNIQUE   
% 219.77/219.96  |- skos__altLabel mesh__D003735 Dental Casting Techniques
% 219.77/219.96  |- mesh__onlineNote mesh__D003735
% 219.77/219.96       use DENTAL CASTING TECHNIQUE to search DENTAL CASTING TECHNIC 1966-90%A%  
% 219.77/219.96  |- skos__altLabel mesh__D003735 Dental Casting Technic
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D003735 2004
% 219.77/219.96  |- skos__altLabel mesh__D003735 Casting Technic, Dental
% 219.77/219.96  |- skos__altLabel mesh__D003735 Dental Casting Technics
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D003735 2000
% 219.77/219.96  |- mesh__publicMeSHNote mesh__D003735
% 219.77/219.96       91; was DENTAL CASTING TECHNIC 1965-90   
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D003735 2003
% 219.77/219.96  |- skos__altLabel mesh__D003735 Techniques, Dental Casting
% 219.77/219.96  |- skos__altLabel mesh__D003735 Casting Technics, Dental
% 219.77/219.96  |- skos__prefLabel mesh__D003735 Dental Casting Technique
% 219.77/219.96  |- mesh__recordAuthorizer mesh__D003735 sjn
% 219.77/219.96  |- skos__altLabel mesh__D003735 Technique, Dental Casting
% 219.77/219.96  |- mesh__historyNote mesh__D003735
% 219.77/219.96       91; was DENTAL CASTING TECHNIC 1965-90   
% 219.77/219.96  |- mesh__recordOriginator mesh__D008420 NLM
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D008420 2000
% 219.77/219.96  |- mesh__publicMeSHNote mesh__D008420 98   
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D008420 2003
% 219.77/219.96  |- skos__annotation mesh__D008420
% 219.77/219.96       GEN or unspecified; prefer specifics; TN 124   
% 219.77/219.96  |- mesh__dateRevised mesh__D008420 1997-06-20
% 219.77/219.96  |- skos__prefLabel mesh__D008420 Manufactured Materials
% 219.77/219.96  |- mesh__dateCreated mesh__D008420 1999-01-01
% 219.77/219.96  |- skos__hiddenLabel mesh__D008420 Material, Manufactured
% 219.77/219.96  |- mesh__dateEstablished mesh__D008420 1998-01-01
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D008420 1999
% 219.77/219.96  |- skos__scopeNote mesh__D008420
% 219.77/219.96       Substances and materials manufactured for use in various technologies and industries and for domestic use.%A%    
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D008420 2006
% 219.77/219.96  |- mesh__recordMaintainer mesh__D008420 TGC
% 219.77/219.96  |- skos__broader mesh__D008420smesh__D013676
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D008420 2002
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D008420 1998
% 219.77/219.96  |- mesh__recordAuthorizer mesh__D008420 SJN
% 219.77/219.96  |- rdf__type mesh__D008420sskos__Concept
% 219.77/219.96  |- skos__hiddenLabel mesh__D008420 Manufactured Material
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D008420 2005
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D008420 2001
% 219.77/219.96  |- mesh__historyNote mesh__D008420 98; use explode 1967-97   
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D008420 2004
% 219.77/219.96  |- skos__hiddenLabel mesh__D008420 Materials, Manufactured
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013365 2004
% 219.77/219.96  |- mesh__historyNote mesh__D013365
% 219.77/219.96       91%28%81%29%; was see under SALIVARY GLAND NEOPLASMS 1981-90   
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013365 1999
% 219.77/219.96  |- mesh__recordOriginator mesh__D013365 RC
% 219.77/219.96  |- skos__hiddenLabel mesh__D013365 Neoplasm, Submandibular Gland
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013365 2001
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013365 2006
% 219.77/219.96  |- skos__hiddenLabel mesh__D013365 Gland Neoplasm, Submandibular
% 219.77/219.96  |- skos__prefLabel mesh__D013365 Submandibular Gland Neoplasms
% 219.77/219.96  |- mesh__recordMaintainer mesh__D013365 KEV
% 219.77/219.96  |- mesh__dateCreated mesh__D013365 1980-04-09
% 219.77/219.96  |- mesh__dateEstablished mesh__D013365 1991-01-01
% 219.77/219.96  |- skos__historyNote mesh__D013365 Submandibular Gland %28%1966-1980%29%
% 219.77/219.96  |- skos__broader mesh__D013365smesh__D013364
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013365 2002
% 219.77/219.96  |- mesh__recordAuthorizer mesh__D013365 PLS
% 219.77/219.96  |- mesh__dateRevised mesh__D013365 1995-06-08
% 219.77/219.96  |- skos__hiddenLabel mesh__D013365 Submandibular Gland Neoplasm
% 219.77/219.96  |- skos__historyNote mesh__D013365
% 219.77/219.96       Salivary Gland Neoplasms %28%1966-1980%29%
% 219.77/219.96  |- skos__broader mesh__D013365smesh__D012468
% 219.77/219.96  |- skos__annotation mesh__D013365
% 219.77/219.96       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%  
% 219.77/219.96  |- skos__hiddenLabel mesh__D013365 Neoplasms, Submandibular Gland
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013365 1996
% 219.77/219.96  |- skos__hiddenLabel mesh__D013365 Gland Neoplasms, Submandibular
% 219.77/219.96  |- mesh__publicMeSHNote mesh__D013365
% 219.77/219.96       91; was see under SALIVARY GLAND NEOPLASMS 1981-90   
% 219.77/219.96  |- rdf__type mesh__D013365sskos__Concept
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013365 2003
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013365 1998
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013365 2000
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013365 1997
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013365 2005
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D007328 2004
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D007328 2005
% 219.77/219.96  |- skos__broader mesh__D007328smesh__D036361
% 219.77/219.96  |- skos__hiddenLabel mesh__D007328 Insulin, Type I
% 219.77/219.96  |- skos__hiddenLabel mesh__D007328 Insulin, Type II
% 219.77/219.96  |- skos__related mesh__D007328smesh__D009632
% 219.77/219.96  |- rdf__type mesh__D007328sskos__Concept
% 219.77/219.96  |- skos__altLabel mesh__D007328 Insulin, Regular
% 219.77/219.96  |- mesh__recordOriginator mesh__D007328 NLM
% 219.77/219.96  |- skos__prefLabel mesh__D007328 Insulin
% 219.77/219.96  |- mesh__dateRevised mesh__D007328 2003-07-09
% 219.77/219.96  |- skos__annotation mesh__D007328
% 219.77/219.96       /biosyn /physiol permitted; /admin: consider also INSULIN INFUSION SYSTEMS; /blood: consider also HYPERINSULINEMIA %28%excessively high blood insulin levels%29% but do not confuse with HYPERINSULINISM %28%excessive secretion of insulin by pancreas%29%; /immunology: consider also INSULIN ANTIBODIES; /ther use: if by INSULIN INFUSION SYSTEMS use INSULIN INFUSION SYSTEMS %26% not also INSULIN /ther use; precursor = PROINSULIN%A%  
% 219.77/219.96  |- skos__related mesh__D007328smesh__D011972
% 219.77/219.96  |- skos__hiddenLabel mesh__D007328 Insulin, Sodium
% 219.77/219.96  |- skos__related mesh__D007328smesh__D006946
% 219.77/219.96  |- mesh__dateCreated mesh__D007328 1999-01-01
% 219.77/219.96  |- skos__hiddenLabel mesh__D007328 Globin Zinc Insulin
% 219.77/219.96  |- skos__hiddenLabel mesh__D007328 Regular Insulin
% 219.77/219.96  |- skos__related mesh__D007328smesh__D011384
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D007328 2006
% 219.77/219.96  |- skos__broader mesh__D007328smesh__D010187
% 219.77/219.96  |- mesh__recordAuthorizer mesh__D007328 sjn
% 219.77/219.96  |- mesh__recordMaintainer mesh__D007328 lkt
% 219.77/219.96  |- skos__scopeNote mesh__D007328
% 219.77/219.96       A protein hormone secreted by beta cells of the pancreas. Insulin plays a major role in the regulation of glucose metabolism, generally promoting the cellular utilization of glucose. It is also an important regulator of protein and lipid metabolism. Insulin is used as a drug to control insulin-dependent diabetes mellitus.%A%    
% 219.77/219.96  |- mesh__dateCreated mesh__D018050 1993-06-04
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D018050 2002
% 219.77/219.96  |- mesh__recordOriginator mesh__D018050 AGS
% 219.77/219.96  |- mesh__recordMaintainer mesh__D018050 sjn
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D018050 2003
% 219.77/219.96  |- skos__scopeNote mesh__D018050
% 219.77/219.96       The only genus in the family ARENAVIRIDAE. It contains two groups ARENAVIRUSES, OLD WORLD and ARENAVIRUSES, NEW WORLD, which are distinguished by antigenic relationships and geographic distribution.%A%    
% 219.77/219.96  |- mesh__recordAuthorizer mesh__D018050 sjn
% 219.77/219.96  |- mesh__historyNote mesh__D018050 94   
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D018050 2005
% 219.77/219.96  |- mesh__dateEstablished mesh__D018050 1994-01-01
% 219.77/219.96  |- skos__broader mesh__D018050smesh__D001116
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D018050 2004
% 219.77/219.96  |- skos__annotation mesh__D018050
% 219.77/219.96       a genus of the family Arenaviridae; infection = ARENAVIRIDAE INFECTIONS%A%  
% 219.77/219.96  |- mesh__publicMeSHNote mesh__D018050 94   
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D018050 2006
% 219.77/219.96  |- skos__hiddenLabel mesh__D018050 Arenaviruses
% 219.77/219.96  |- rdf__type mesh__D018050sskos__Concept
% 219.77/219.96  |- skos__prefLabel mesh__D018050 Arenavirus
% 219.77/219.96  |- mesh__dateRevised mesh__D018050 2001-08-03
% 219.77/219.96  |- skos__broader mesh__D004030smesh__D007411
% 219.77/219.96  |- skos__hiddenLabel mesh__D004030 Dientamoebiases
% 219.77/219.96  |- mesh__recordAuthorizer mesh__D004030 sjn
% 219.77/219.96  |- skos__prefLabel mesh__D004030 Dientamoebiasis
% 219.77/219.96  |- mesh__onlineNote mesh__D004030
% 219.77/219.96       use AMEBIASIS to search DIENTAMOEBIASIS 1967-74   
% 219.77/219.96  |- rdf__type mesh__D004030sskos__Concept
% 219.77/219.96  |- mesh__dateRevised mesh__D004030 2003-07-09
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D004030 2005
% 219.77/219.96  |- skos__broader mesh__D004030smesh__D016772
% 219.77/219.96  |- mesh__publicMeSHNote mesh__D004030
% 219.77/219.96       91; was see under PROTOZOAN INFECTIONS 1990; was see under AMEBIASIS 1967-89%A%  
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D004030 2006
% 219.77/219.96  |- mesh__recordOriginator mesh__D004030 NLM
% 219.77/219.96  |- mesh__historyNote mesh__D004030
% 219.77/219.96       91%28%75%29%; was see under PROTOZOAN INFECTIONS 1990; was see under AMEBIASIS 1967-89%A%  
% 219.77/219.96  |- mesh__recordMaintainer mesh__D004030 lkt
% 219.77/219.96  |- mesh__dateEstablished mesh__D004030 1991-01-01
% 219.77/219.96  |- skos__scopeNote mesh__D004030
% 219.77/219.96       Gastrointestinal infection with PROTOZOA of the genus DIENTAMOEBA.%A%    
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D004030 2004
% 219.77/219.96  |- mesh__dateCreated mesh__D004030 1999-01-01
% 219.77/219.96  |- skos__scopeNote mesh__D017756
% 219.77/219.96       Cultivation of natural faunal resources of water. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017756 2001
% 219.77/219.96  |- mesh__dateEstablished mesh__D017756 1994-01-01
% 219.77/219.96  |- skos__altLabel mesh__D017756 Aquiculture
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017756 2003
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017756 1996
% 219.77/219.96  |- mesh__historyNote mesh__D017756 94   
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017756 2005
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017756 1998
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017756 2004
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017756 1997
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017756 2002
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017756 1994
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017756 2006
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017756 1999
% 219.77/219.96  |- rdf__type mesh__D017756sskos__Concept
% 219.77/219.96  |- mesh__publicMeSHNote mesh__D017756 94   
% 219.77/219.96  |- skos__historyNote mesh__D017756 Fisheries %28%1966-1993%29%
% 219.77/219.96  |- skos__broader mesh__D017756smesh__D000383
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017756 1995
% 219.77/219.96  |- skos__hiddenLabel mesh__D017756 Aquacultures
% 219.77/219.96  |- skos__hiddenLabel mesh__D017756 Aquicultures
% 219.77/219.96  |- skos__prefLabel mesh__D017756 Aquaculture
% 219.77/219.96  |- mesh__dateCreated mesh__D017756 1992-12-28
% 219.77/219.96  |- skos__annotation mesh__D017756 restrict to fauna in waters   
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D017756 2000
% 219.77/219.96  |- skos__broader mesh__D031427smesh__D019668
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D031427 2004
% 219.77/219.96  |- mesh__dateCreated mesh__D031427 2002-07-03
% 219.77/219.96  |- mesh__historyNote mesh__D031427 2003   
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D031427 2006
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D031427 2003
% 219.77/219.96  |- skos__prefLabel mesh__D031427 Narcissus
% 219.77/219.96  |- mesh__publicMeSHNote mesh__D031427 2003   
% 219.77/219.96  |- skos__annotation mesh__D031427
% 219.77/219.96       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D031427 2005
% 219.77/219.96  |- mesh__dateEstablished mesh__D031427 2003-01-01
% 219.77/219.96  |- skos__altLabel mesh__D031427 Daffodil
% 219.77/219.96  |- rdf__type mesh__D031427sskos__Concept
% 219.77/219.96  |- skos__scopeNote mesh__D031427
% 219.77/219.96       A plant genus of the family LILIACEAE. Members contain ungiminorine and LECTINS.%A%    
% 219.77/219.96  |- skos__altLabel mesh__D003736 Cavity Linings, Dental
% 219.77/219.96  |- skos__altLabel mesh__D003736 Linings, Dental Cavity
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D003736 1994
% 219.77/219.96  |- skos__hiddenLabel mesh__D003736 Liner, Dental Cavity
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D003736 1999
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D003736 2004
% 219.77/219.96  |- mesh__recordAuthorizer mesh__D003736 PLS
% 219.77/219.96  |- skos__altLabel mesh__D003736 Lining, Dental Cavity
% 219.77/219.96  |- mesh__historyNote mesh__D003736 65   
% 219.77/219.96  |- skos__altLabel mesh__D003736 Cavity Lining Varnishes
% 219.77/219.96  |- skos__altLabel mesh__D003736 Cavity Lining Varnish
% 219.77/219.96  |- skos__altLabel mesh__D003736 Dental Cavity Liners
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D003736 1995
% 219.77/219.96  |- skos__hiddenLabel mesh__D003736 Varnishes, Cavity
% 219.77/219.96  |- skos__altLabel mesh__D003736 Cavity Lining, Dental
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D003736 2000
% 219.77/219.96  |- skos__altLabel mesh__D003736 Cavity Varnishes
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D003736 2005
% 219.77/219.96  |- mesh__publicMeSHNote mesh__D003736 65   
% 219.77/219.96  |- skos__hiddenLabel mesh__D003736 Cavity Varnish
% 219.77/219.96  |- skos__annotation mesh__D003736 DF: DENT CAVITY LINING   
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D003736 1996
% 219.77/219.96  |- skos__altLabel mesh__D003736 Liners, Dental Cavity
% 219.77/219.96  |- skos__hiddenLabel mesh__D003736 Cavity Liners, Dental
% 219.77/219.96  |- skos__altLabel mesh__D003736 Dental Cavity Liner
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D003736 2001
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D003736 2006
% 219.77/219.96  |- mesh__dateRevised mesh__D003736 1992-05-14
% 219.77/219.96  |- skos__prefLabel mesh__D003736 Dental Cavity Lining
% 219.77/219.96  |- skos__broader mesh__D003736smesh__D003814
% 219.77/219.96  |- mesh__dateEstablished mesh__D003736 1965-01-01
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D003736 1997
% 219.77/219.96  |- mesh__recordOriginator mesh__D003736 NLM
% 219.77/219.96  |- skos__hiddenLabel mesh__D003736 Varnish, Cavity Lining
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D003736 2002
% 219.77/219.96  |- skos__hiddenLabel mesh__D003736 Varnishes, Cavity Lining
% 219.77/219.96  |- rdf__type mesh__D003736sskos__Concept
% 219.77/219.96  |- mesh__dateCreated mesh__D003736 1999-01-01
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D003736 1993
% 219.77/219.96  |- skos__scopeNote mesh__D003736
% 219.77/219.96       An inner coating, as of varnish or other protective substance, to cover the dental cavity wall. It is usually a resinous film-forming agent dissolved in a volatile solvent, or a suspension of calcium hydroxide in a solution of a synthetic resin. The lining seals the dentinal tubules and protects the pulp before a restoration is inserted. %28%Jablonski, Illustrated Dictionary of Dentistry, 1982%29%%A%    
% 219.77/219.96  |- mesh__recordMaintainer mesh__D003736 PLS
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D003736 1998
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D003736 2003
% 219.77/219.96  |- skos__related mesh__D003736smesh__D002126
% 219.77/219.96  |- skos__altLabel mesh__D003736 Dental Cavity Linings
% 219.77/219.96  |- skos__altLabel mesh__D008421 Storerooms
% 219.77/219.96  |- skos__altLabel mesh__D008421 Hospital Materials Management
% 219.77/219.96  |- skos__scopeNote mesh__D008421
% 219.77/219.96       The management of all procurement, distribution, and storage of equipment and supplies, as well as logistics management including laundry, processing of reusables, etc.%A%    
% 219.77/219.96  |- mesh__dateRevised mesh__D008421 1996-06-10
% 219.77/219.96  |- mesh__publicMeSHNote mesh__D008421
% 219.77/219.96       78; was HOSPITAL MATERIALS MANAGEMENT see under HOSPITAL ADMINISTRATION 1976-77%A%  
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D008421 2001
% 219.77/219.96  |- skos__broader mesh__D008421smesh__D006739
% 219.77/219.96  |- skos__hiddenLabel mesh__D008421 Material Managements, Hospital
% 219.77/219.96  |- skos__hiddenLabel mesh__D008421 Hospital Material Managements
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D008421 2000
% 219.77/219.96  |- skos__altLabel mesh__D008421 Management, Hospital Material
% 219.77/219.96  |- mesh__recordMaintainer mesh__D008421 KEV
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D008421 1999
% 219.77/219.96  |- mesh__dateEstablished mesh__D008421 1978-01-01
% 219.77/219.96  |- skos__hiddenLabel mesh__D008421 Material Management, Hospital
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D008421 2006
% 219.77/219.96  |- skos__hiddenLabel mesh__D008421 Managements, Hospital Material
% 219.77/219.96  |- mesh__historyNote mesh__D008421
% 219.77/219.96       78; was HOSPITAL MATERIALS MANAGEMENT see under HOSPITAL ADMINISTRATION 1976-77%A%  
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D008421 1998
% 219.77/219.96  |- mesh__dateCreated mesh__D008421 1975-07-25
% 219.77/219.96  |- skos__prefLabel mesh__D008421 Materials Management, Hospital
% 219.77/219.96  |- rdf__type mesh__D008421sskos__Concept
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D008421 2005
% 219.77/219.96  |- mesh__onlineNote mesh__D008421
% 219.77/219.96       use MATERIALS MANAGEMENT, HOSPITAL to search HOSPITAL MATERIALS MANAGEMENT 1976-77%A%  
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D008421 1997
% 219.77/219.96  |- skos__altLabel mesh__D008421 Management, Hospital Materials
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D008421 2004
% 219.77/219.96  |- mesh__recordAuthorizer mesh__D008421 PLS
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D008421 2002
% 219.77/219.96  |- mesh__recordOriginator mesh__D008421 EC
% 219.77/219.96  |- skos__hiddenLabel mesh__D008421 Hospital Material Management
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D008421 2003
% 219.77/219.96  |- skos__altLabel mesh__D013366 Medicine, Submarine
% 219.77/219.96  |- mesh__recordMaintainer mesh__D013366 JLS
% 219.77/219.96  |- skos__related mesh__D013366smesh__D018504
% 219.77/219.96  |- skos__annotation mesh__D013366
% 219.77/219.96       SPEC: SPEC qualif; for med %26% physiol aspects of activities of submarine personnel; Manual 28.8; DIVING is also available; DF: SUBMARINE MED%A%  
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013366 2000
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013366 1996
% 219.77/219.96  |- rdf__type mesh__D013366sskos__Concept
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013366 2003
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013366 1998
% 219.77/219.96  |- mesh__dateRevised mesh__D013366 1994-06-30
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013366 2001
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013366 1997
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013366 2005
% 219.77/219.96  |- mesh__recordOriginator mesh__D013366 NLM
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013366 2004
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013366 1999
% 219.77/219.96  |- skos__prefLabel mesh__D013366 Submarine Medicine
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013366 2006
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013366 1995
% 219.77/219.96  |- mesh__dateCreated mesh__D013366 1999-01-01
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D013366 2002
% 219.77/219.96  |- skos__broader mesh__D013366smesh__D009326
% 219.77/219.96  |- mesh__recordAuthorizer mesh__D013366 PLS
% 219.77/219.96  |- skos__scopeNote mesh__D013366
% 219.77/219.96       The field of medicine concerned with conditions affecting the health of people in submarines or sealabs.%A%    
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D007329 2004
% 219.77/219.96  |- skos__broader mesh__D007329smesh__D006727
% 219.77/219.96  |- mesh__historyNote mesh__D007329 78   
% 219.77/219.96  |- skos__historyNote mesh__D007329 Insulin %28%1966-1977%29%
% 219.77/219.96  |- mesh__recordAuthorizer mesh__D007329 sjn
% 219.77/219.96  |- rdf__type mesh__D007329sskos__Concept
% 219.77/219.96  |- mesh__recordMaintainer mesh__D007329 ssb
% 219.77/219.96  |- skos__hiddenLabel mesh__D007329 Antagonists, Insulin
% 219.77/219.96  |- mesh__publicMeSHNote mesh__D007329 78   
% 219.77/219.96  |- mesh__dateCreated mesh__D007329 1977-05-17
% 219.77/219.96  |- mesh__dateEstablished mesh__D007329 1978-01-01
% 219.77/219.96  |- mesh__dateRevised mesh__D007329 2003-07-09
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D007329 2005
% 219.77/219.96  |- skos__scopeNote mesh__D007329
% 219.77/219.96       Compounds which inhibit or antagonize the biosynthesis or action of insulin.%A%    
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D007329 2006
% 219.77/219.96  |- skos__prefLabel mesh__D007329 Insulin Antagonists
% 219.77/219.96  |- skos__annotation mesh__D007329 DF: INSULIN ANTAG   
% 219.77/219.96  |- mesh__recordOriginator mesh__D007329 RLS
% 219.77/219.96  |- skos__broader mesh__D018051smesh__D006477
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D018051 2005
% 219.77/219.96  |- skos__altLabel mesh__D018051 Hemorrhagic Fever Virus, Argentinian
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D018051 2004
% 219.77/219.96  |- mesh__recordMaintainer mesh__D018051 ags
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D018051 2006
% 219.77/219.96  |- skos__annotation mesh__D018051
% 219.77/219.96       infection: coord IM with ARENAVIRIDAE INFECTIONS %28%IM%29%   
% 219.77/219.96  |- mesh__dateCreated mesh__D018051 1993-06-25
% 219.77/219.96  |- mesh__dateRevised mesh__D018051 2001-07-25
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D018051 2002
% 219.77/219.96  |- rdf__type mesh__D018051sskos__Concept
% 219.77/219.96  |- mesh__recordOriginator mesh__D018051 AGS
% 219.77/219.96  |- mesh__onlineNote mesh__D018051
% 219.77/219.96       use TACARIBE COMPLEX VIRUSES to search JUNIN VIRUS 1975-93 %26% HEMORRHAGIC FEVER VIRUS, ARGENTINIAN 1977-93%A%  
% 219.77/219.96  |- mesh__historyNote mesh__D018051
% 219.77/219.96       94; was see HEMORRHAGIC FEVER VIRUSES, AMERICAN 1975-93; HEMORRHAGIC FEVER VIRUS, ARGENTINIAN was see HEMORRHAGIC FEVER VIRUSES, AMERICAN 1977-93%A%  
% 219.77/219.96  |- mesh__dateEstablished mesh__D018051 1994-01-01
% 219.77/219.96  |- skos__scopeNote mesh__D018051
% 219.77/219.96       A species of ARENAVIRUS, part of the New World Arenaviruses %28%ARENAVIRUSES, NEW WORLD%29%, causing Argentinian hemorrhagic fever. The disease is characterized by congestion, edema, generalized lymphadenopathy and hemorrhagic necrosis and is sometimes fatal.%A%    
% 219.77/219.96  |- mesh__recordAuthorizer mesh__D018051 sjn
% 219.77/219.96  |- skos__prefLabel mesh__D018051 Junin virus
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D018051 2003
% 219.77/219.96  |- skos__historyNote mesh__D018051
% 219.77/219.96       Tacaribe Complex Viruses %28%1976-1993%29%
% 219.77/219.96  |- mesh__publicMeSHNote mesh__D018051
% 219.77/219.96       94; was see HEMORRHAGIC FEVER VIRUSES, AMERICAN 1975-93; HEMORRHAGIC FEVER VIRUS, ARGENTINIAN was see HEMORRHAGIC FEVER VIRUSES, AMERICAN 1977-93%A%  
% 219.77/219.96  |- mesh__recordMaintainer mesh__D004031 lkt
% 219.77/219.96  |- skos__annotation mesh__D004031 non-primate mammals only   
% 219.77/219.96  |- rdf__type mesh__D004031sskos__Concept
% 219.77/219.96  |- skos__broader mesh__D004031smesh__D030762
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D004031 2005
% 219.77/219.96  |- mesh__recordAuthorizer mesh__D004031 sjn
% 219.77/219.96  |- mesh__activeMeSHYear mesh__D004031 2006
% 219.77/219.96  |- mesh__publicMeSHNote mesh__D004031 91; was see under ESTRUS 1975-90   
% 219.77/219.96  |- mesh__dateCreated mesh__D004031 1974-11-11
% 219.77/219.97  |- mesh__dateEstablished mesh__D004031 1991-01-01
% 219.77/219.97  |- mesh__historyNote mesh__D004031
% 219.77/219.97       91%28%75%29%; was see under ESTRUS 1975-90   
% 219.77/219.97  |- skos__prefLabel mesh__D004031 Diestrus
% 219.77/219.97  |- mesh__recordOriginator mesh__D004031 NLM
% 219.77/219.97  |- mesh__dateRevised mesh__D004031 2004-07-07
% 219.77/219.97  |- skos__scopeNote mesh__D004031
% 219.77/219.97       A phase of the ESTROUS CYCLES that follows METESTRUS. Diestrus is a period of sexual quiescence separating phases of ESTRUS in polyestrous animals.%A%    
% 219.77/219.97  |- skos__hiddenLabel mesh__D017757 Transmission, Professional Patient
% 219.77/219.97  |- skos__historyNote mesh__D017757
% 219.77/219.97       specific health profession %28%1974-1993%29%
% 219.77/219.97  |- skos__altLabel mesh__D017757 Professional-to-Patient Transmission
% 219.77/219.97  |- skos__hiddenLabel mesh__D017757
% 219.77/219.97       Disease Transmission, Professional Patient
% 219.77/219.97  |- skos__altLabel mesh__D017757 Physician-Patient Transmission
% 219.77/219.97  |- skos__hiddenLabel mesh__D017757
% 219.77/219.97       Disease Transmission, Professional to Patient
% 219.77/219.97  |- skos__altLabel mesh__D017757 Transmission, Healthcare Worker-Patient
% 219.77/219.97  |- skos__related mesh__D017757smesh__D017848
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D017757 2003
% 219.77/219.97  |- skos__broader mesh__D017757smesh__D018446
% 219.77/219.97  |- skos__hiddenLabel mesh__D017757 Worker-Patient Transmission, Healthcare
% 219.77/219.97  |- mesh__recordOriginator mesh__D017757 JLS
% 219.77/219.97  |- mesh__historyNote mesh__D017757 94   
% 219.77/219.97  |- skos__historyNote mesh__D017757
% 219.77/219.97       specific disease/transmission %28%1974-1993%29%
% 219.77/219.97  |- skos__prefLabel mesh__D017757
% 219.77/219.97       Disease Transmission, Professional-to-Patient
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D017757 2002
% 219.77/219.97  |- skos__hiddenLabel mesh__D017757 Transmission, Health Care Worker Patient
% 219.77/219.97  |- skos__altLabel mesh__D017757
% 219.77/219.97       Professional-to-Patient Disease Transmission
% 219.77/219.97  |- mesh__recordAuthorizer mesh__D017757 SJN
% 219.77/219.97  |- skos__hiddenLabel mesh__D017757 Dentist Patient Transmission
% 219.77/219.97  |- skos__hiddenLabel mesh__D017757 Physician Patient Transmission
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D017757 1999
% 219.77/219.97  |- skos__scopeNote mesh__D017757
% 219.77/219.97       The transmission of infectious disease or pathogens from health professional or health care worker to patients. It includes transmission via direct or indirect exposure to bacterial, fungal, parasitic, or viral agents.%A%    
% 219.77/219.97  |- mesh__dateRevised mesh__D017757 1997-06-20
% 219.77/219.97  |- mesh__recordMaintainer mesh__D017757 TPW
% 219.77/219.97  |- skos__altLabel mesh__D017757 Healthcare Worker-Patient Transmission
% 219.77/219.97  |- skos__annotation mesh__D017757
% 219.77/219.97       coord IM with disease /transm %28%IM%29% + professional or profession %28%including DENTISTS or DENTISTRY%29% with no qualif %28%IM%29%; do not confuse with DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; DF: DIS TRANSM PROF PATIENT or PROF PATIENT TRANSM%A%  
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D017757 2006
% 219.77/219.97  |- skos__altLabel mesh__D017757 Transmission, Professional-to-Patient
% 219.77/219.97  |- skos__hiddenLabel mesh__D017757 Professional to Patient Transmission
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D017757 2001
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D017757 1998
% 219.77/219.97  |- skos__hiddenLabel mesh__D017757
% 219.77/219.97       Transmission, Professional-Patient Disease
% 219.77/219.97  |- skos__altLabel mesh__D017757 Health Care Worker-Patient Transmission
% 219.77/219.97  |- skos__hiddenLabel mesh__D017757 Transmission, Dentist Patient
% 219.77/219.97  |- skos__hiddenLabel mesh__D017757 Transmission, Professional to Patient
% 219.77/219.97  |- mesh__dateCreated mesh__D017757 1993-06-15
% 219.77/219.97  |- skos__hiddenLabel mesh__D017757
% 219.77/219.97       Professional to Patient Disease Transmission
% 219.77/219.97  |- skos__hiddenLabel mesh__D017757 Transmission, Physician Patient
% 219.77/219.97  |- skos__hiddenLabel mesh__D017757
% 219.77/219.97       Transmission, Professional-to-Patient Disease
% 219.77/219.97  |- skos__historyNote mesh__D017757
% 219.77/219.97       specific health professional %28%1974-1993%29%
% 219.77/219.97  |- skos__altLabel mesh__D017757 Dentist-Patient Transmission
% 219.77/219.97  |- skos__hiddenLabel mesh__D017757
% 219.77/219.97       Professional-Patient Disease Transmission
% 219.77/219.97  |- rdf__type mesh__D017757sskos__Concept
% 219.77/219.97  |- skos__altLabel mesh__D017757 Transmission, Professional-Patient
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D017757 2005
% 219.77/219.97  |- skos__hiddenLabel mesh__D017757 Professional-Patient Transmission
% 219.77/219.97  |- skos__hiddenLabel mesh__D017757 Healthcare Worker Patient Transmission
% 219.77/219.97  |- skos__altLabel mesh__D017757 Transmission, Health Care Worker-Patient
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D017757 2000
% 219.77/219.97  |- skos__altLabel mesh__D017757 Disease Transmission, Professional-Patient
% 219.77/219.97  |- skos__hiddenLabel mesh__D017757 Transmission, Healthcare Worker Patient
% 219.77/219.97  |- skos__hiddenLabel mesh__D017757 Health Care Worker Patient Transmission
% 219.77/219.97  |- mesh__publicMeSHNote mesh__D017757 94   
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D017757 2004
% 219.77/219.97  |- mesh__dateEstablished mesh__D017757 1994-01-01
% 219.77/219.97  |- skos__scopeNote mesh__D003737
% 219.77/219.97       An operation in which carious material is removed from teeth and biomechanically correct forms are established in the teeth to receive and retain restorations. A constant requirement is provision for prevention of failure of the restoration through recurrence of decay or inadequate resistance to applied stresses. %28%Boucher%27%s Clinical Dental Terminology, 4th ed, p239-40%29%%A%    
% 219.77/219.97  |- skos__altLabel mesh__D003737 Dental Cavity Preparations
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D003737 2001
% 219.77/219.97  |- skos__prefLabel mesh__D003737 Dental Cavity Preparation
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D003737 2003
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D003737 1999
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D003737 2000
% 219.77/219.97  |- skos__altLabel mesh__D003737 Cavity Preparations, Dental
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D003737 1998
% 219.77/219.97  |- mesh__dateCreated mesh__D003737 1999-01-01
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D003737 1997
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D003737 2006
% 219.77/219.97  |- mesh__recordMaintainer mesh__D003737 TGC
% 219.77/219.97  |- skos__annotation mesh__D003737
% 219.77/219.97       restrict to fillings %26% inlays; for other prep procedures TOOTH PREPARATION, PROSTHODONTIC %26% ROOT CANAL PREPARATION are available; DF: DENT CAVITY PREPARATION%A%  
% 219.77/219.97  |- mesh__recordAuthorizer mesh__D003737 PLS
% 219.77/219.97  |- skos__altLabel mesh__D003737 Cavity Preparation, Dental
% 219.77/219.97  |- skos__altLabel mesh__D003737 Preparations, Dental Cavity
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D003737 2005
% 219.77/219.97  |- skos__broader mesh__D003737smesh__D019246
% 219.77/219.97  |- rdf__type mesh__D003737sskos__Concept
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D003737 2002
% 219.77/219.97  |- skos__altLabel mesh__D003737 Preparation, Dental Cavity
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D003737 2004
% 219.77/219.97  |- mesh__dateRevised mesh__D003737 1996-06-10
% 219.77/219.97  |- mesh__recordOriginator mesh__D003737 NLM
% 219.77/219.97  |- skos__hiddenLabel mesh__D008422 Testings, Biocompatibility
% 219.77/219.97  |- skos__hiddenLabel mesh__D008422 Materials Testing, Hemocompatible
% 219.77/219.97  |- mesh__recordMaintainer mesh__D008422 nns
% 219.77/219.97  |- skos__prefLabel mesh__D008422 Materials Testing
% 219.77/219.97  |- skos__related mesh__D008422smesh__D018056
% 219.77/219.97  |- skos__related mesh__D008422smesh__D001672
% 219.77/219.97  |- mesh__historyNote mesh__D008422 87   
% 219.77/219.97  |- mesh__dateCreated mesh__D008422 1986-06-20
% 219.77/219.97  |- mesh__recordOriginator mesh__D008422 SH
% 219.77/219.97  |- skos__hiddenLabel mesh__D008422 Testings, Hemocompatibility
% 219.77/219.97  |- mesh__recordAuthorizer mesh__D008422 sjn
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D008422 2006
% 219.77/219.97  |- skos__annotation mesh__D008422
% 219.77/219.97       do not confuse HEMOCOMPATIBILITY TESTING with HISTOCOMPATIBILITY TESTING%A%  
% 219.77/219.97  |- skos__historyNote mesh__D008422 Stress, Mechanical %28%1971-1986%29%
% 219.77/219.97  |- skos__hiddenLabel mesh__D008422 Hemocompatibility Testings
% 219.77/219.97  |- mesh__dateEstablished mesh__D008422 1987-01-01
% 219.77/219.97  |- skos__broader mesh__D008422smesh__D008919
% 219.77/219.97  |- skos__altLabel mesh__D008422 Testing, Hemocompatible Materials
% 219.77/219.97  |- skos__hiddenLabel mesh__D008422 Hemocompatible Materials Testing
% 219.77/219.97  |- rdf__type mesh__D008422sskos__Concept
% 219.77/219.97  |- mesh__publicMeSHNote mesh__D008422 87   
% 219.77/219.97  |- skos__hiddenLabel mesh__D008422 Testing, Hemocompatibility
% 219.77/219.97  |- skos__hiddenLabel mesh__D008422 Testing, Materials
% 219.77/219.97  |- skos__hiddenLabel mesh__D008422 Materials Testing, Biocompatible
% 219.77/219.97  |- skos__hiddenLabel mesh__D008422 Testing, Biocompatibility
% 219.77/219.97  |- skos__altLabel mesh__D008422 Biocompatible Materials Testing
% 219.77/219.97  |- mesh__dateRevised mesh__D008422 2005-06-30
% 219.77/219.97  |- skos__altLabel mesh__D008422 Biocompatibility Testing
% 219.77/219.97  |- skos__historyNote mesh__D008422
% 219.77/219.97       Biocompatible Materials %28%1972-1986%29%
% 219.77/219.97  |- skos__scopeNote mesh__D008422
% 219.77/219.97       The testing of materials and devices, especially those used for PROSTHESES AND IMPLANTS; SUTURES; TISSUE ADHESIVES; etc., for hardness, strength, durability, safety, efficacy, and biocompatibility.%A%    
% 219.77/219.97  |- mesh__recordAuthorizer mesh__D013367 sjn
% 219.77/219.97  |- skos__historyNote mesh__D013367 specific mitochondria heading
% 219.77/219.97  |- mesh__historyNote mesh__D013367
% 219.77/219.97       85%28%79%29%; was see under MITOCHONDRIA 1979-84   
% 219.77/219.97  |- skos__scopeNote mesh__D013367
% 219.77/219.97       The various filaments, granules, tubules or other inclusions within mitochondria.%A%    
% 219.77/219.97  |- rdf__type mesh__D013367sskos__Concept
% 219.77/219.97  |- skos__historyNote mesh__D013367 Mitochondria %28%1966-1978%29%
% 219.77/219.97  |- mesh__dateRevised mesh__D013367 2003-07-09
% 219.77/219.97  |- mesh__dateEstablished mesh__D013367 1985-01-01
% 219.77/219.97  |- mesh__recordMaintainer mesh__D013367 nns
% 219.77/219.97  |- skos__prefLabel mesh__D013367 Submitochondrial Particles
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D013367 2005
% 219.77/219.97  |- skos__hiddenLabel mesh__D013367 Submitochondrial Particle
% 219.77/219.97  |- skos__annotation mesh__D013367
% 219.77/219.97       A 11 qualif except /cytol; /genet permitted; coord IM with specific precoord mitochondria term %28%IM or NIM%29% if pertinent%A%  
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D013367 2004
% 219.77/219.97  |- mesh__recordOriginator mesh__D013367 VDK
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D013367 2006
% 219.77/219.97  |- mesh__publicMeSHNote mesh__D013367
% 219.77/219.97       85; was see under MITOCHONDRIA 1979-84   
% 219.77/219.97  |- skos__hiddenLabel mesh__D013367 Particles, Submitochondrial
% 219.77/219.97  |- skos__broader mesh__D013367smesh__D008928
% 219.77/219.97  |- mesh__dateCreated mesh__D013367 1978-03-10
% 219.77/219.97  |- skos__hiddenLabel mesh__D013367 Particle, Submitochondrial
% 219.77/219.97  |- skos__broader mesh__D032521smesh__D007109
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D032521 2004
% 219.77/219.97  |- rdf__type mesh__D032521sskos__Concept
% 219.77/219.97  |- mesh__dateEstablished mesh__D032521 2003-01-01
% 219.77/219.97  |- skos__annotation mesh__D032521 human %26% animal   
% 219.77/219.97  |- skos__prefLabel mesh__D032521 Immunity, Herd
% 219.77/219.97  |- skos__altLabel mesh__D032521 Herd Immunity
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D032521 2005
% 219.77/219.97  |- mesh__publicMeSHNote mesh__D032521 2003   
% 219.77/219.97  |- mesh__historyNote mesh__D032521 2003   
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D032521 2003
% 219.77/219.97  |- skos__scopeNote mesh__D032521
% 219.77/219.97       The non-susceptibility to infection of a large group of individuals in a population. A variety of factors can be responsible for herd immunity and this gives rise to the different definitions used in the literature. Most commonly, herd immunity refers to the case when, if most of the population is immune, infection of a single individual will not cause an epidemic. Also, in such immunized populations, susceptible individuals are not likely to become infected.  Herd immunity can also refer to the case when unprotected individuals fail to contract a disease because the infecting organism has been banished from the population.%A%    
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D032521 2006
% 219.77/219.97  |- mesh__dateCreated mesh__D032521 2002-07-03
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D018052 2006
% 219.77/219.97  |- mesh__publicMeSHNote mesh__D018052 94   
% 219.77/219.97  |- rdf__type mesh__D018052sskos__Concept
% 219.77/219.97  |- skos__historyNote mesh__D018052
% 219.77/219.97       Tacaribe Complex Viruses %28%1979-1993%29%
% 219.77/219.97  |- skos__historyNote mesh__D018052 RNA Viruses %28%1971-1975%29%
% 219.77/219.97  |- skos__annotation mesh__D018052
% 219.77/219.97       infection: coord IM with ARENAVIRIDAE INFECTIONS %28%IM%29%   
% 219.77/219.97  |- mesh__dateRevised mesh__D018052 2001-07-25
% 219.77/219.97  |- skos__prefLabel mesh__D018052 Pichinde virus
% 219.77/219.97  |- skos__scopeNote mesh__D018052
% 219.77/219.97       A species of ARENAVIRUS, one of the New World Arenaviruses %28%ARENAVIRUSES, NEW WORLD%29%, causing a fatal infection in the cricetine rodent Oryzomys albigularis. Asymptomatic laboratory infection in humans has been reported.%A%    
% 219.77/219.97  |- mesh__dateCreated mesh__D018052 1993-06-04
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D018052 2002
% 219.77/219.97  |- skos__historyNote mesh__D018052 Arenaviridae %28%1979-1993%29%
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D018052 2003
% 219.77/219.97  |- mesh__recordOriginator mesh__D018052 AGS
% 219.77/219.97  |- mesh__historyNote mesh__D018052 94   
% 219.77/219.97  |- skos__broader mesh__D018052smesh__D006477
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D018052 2005
% 219.77/219.97  |- mesh__dateEstablished mesh__D018052 1994-01-01
% 219.77/219.97  |- mesh__recordMaintainer mesh__D018052 ags
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D018052 2004
% 219.77/219.97  |- mesh__recordAuthorizer mesh__D018052 sjn
% 219.77/219.97  |- skos__altLabel mesh__D004830 Epilepsy, Tonic-Clonic, Cryptogenic
% 219.77/219.97  |- skos__altLabel mesh__D004830 Major Motor Seizure Disorder
% 219.77/219.97  |- mesh__historyNote mesh__D004830 1992%28%1963%29%   
% 219.77/219.97  |- skos__altLabel mesh__D004830 Seizure Disorder, Grand Mal
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D004830 2001
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Grand Mal Epilepsy
% 219.77/219.97  |- skos__scopeNote mesh__D004830
% 219.77/219.97       A generalized seizure disorder characterized by recurrent major motor seizures. The initial brief tonic phase is marked by trunk flexion followed by diffuse extension of the trunk and extremities. The clonic phase features rhythmic flexor contractions of the trunk and limbs, pupillary dilation, elevations of blood pressure and pulse, urinary incontinence, and tongue biting. This is followed by a profound state of depressed consciousness %28%post-ictal state%29% which gradually improves over minutes to hours. The disorder may be cryptogenic, familial, or symptomatic %28%caused by an identified disease process%29%. %28%From Adams et al., Principles of Neurology, 6th ed, p329%29%%A%    
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Syndrome, Tonic-Clonic Seizure
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Seizure Disorders, Tonic-Clonic
% 219.77/219.97  |- skos__altLabel mesh__D004830 Tonic Clonic Convulsions
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Cryptogenic Tonic Clonic Epilepsy
% 219.77/219.97  |- mesh__dateCreated mesh__D004830 1999-01-01
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Convulsion Syndromes, Tonic-Clonic
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Seizure Syndromes, Tonic-Clonic
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Tonic-Clonic Epilepsy, Symptomatic
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D004830 2006
% 219.77/219.97  |- skos__altLabel mesh__D004830 Tonic-Clonic Convulsion Disorder
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Grand Mal Convulsions
% 219.77/219.97  |- skos__altLabel mesh__D004830 Familial Tonic-Clonic Epilepsy
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Major Epilepsies
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Tonic-Clonic Convulsion Syndromes
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Seizure Disorder, Tonic-Clonic
% 219.77/219.97  |- skos__altLabel mesh__D004830 Seizure Disorder, Tonic Clonic
% 219.77/219.97  |- skos__altLabel mesh__D004830 Tonic-Clonic Convulsion Syndrome
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Tonic-Clonic Epilepsy
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Disorder, Tonic-Clonic Convulsion
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Epilepsies, Symptomatic Tonic-Clonic
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Tonic-Clonic Epilepsies
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Convulsion Disorder, Tonic-Clonic
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Symptomatic Tonic-Clonic Epilepsies
% 219.77/219.97  |- skos__altLabel mesh__D004830 Convulsions, Grand Mal
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Tonic-Clonic Seizure Disorders
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D004830 2000
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Major Epilepsy
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D004830 2000B
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Epilepsies, Tonic-Clonic
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Syndromes, Tonic-Clonic Seizure
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Tonic Clonic Convulsion Syndrome
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Disorders, Tonic-Clonic Seizure
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Tonic-Clonic Seizure Syndromes
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Tonic Clonic Seizure Disorder
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D004830 2005
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Disorder, Tonic-Clonic Seizure
% 219.77/219.97  |- skos__altLabel mesh__D004830 Symptomatic Tonic-Clonic Epilepsy
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Epilepsies, Cryptogenic Tonic-Clonic
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Grand Mal Convulsion
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Familial Tonic Clonic Epilepsy
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Cryptogenic Tonic-Clonic Epilepsies
% 219.77/219.97  |- skos__annotation mesh__D004830
% 219.77/219.97       do not confuse with EPILEPSY, TONIC see EPILEPSY, GENERALIZED%A%  
% 219.77/219.97  |- skos__altLabel mesh__D004830 Tonic-Clonic Seizure Syndrome
% 219.77/219.97  |- skos__altLabel mesh__D004830 Epilepsy, Major
% 219.77/219.97  |- mesh__recordOriginator mesh__D004830 NLM
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Convulsions, Tonic Clonic
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Epilepsy, Symptomatic Tonic-Clonic
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D004830 2000A
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Epilepsies, Familial Tonic-Clonic
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Syndrome, Tonic-Clonic Convulsion
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Convulsion Disorders, Tonic-Clonic
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Epilepsy, Cryptogenic Tonic-Clonic
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Tonic Clonic Seizure Syndrome
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Convulsion Syndrome, Tonic-Clonic
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Convulsion, Grand Mal
% 219.77/219.97  |- mesh__publicMeSHNote mesh__D004830
% 219.77/219.97       1992; see EPILEPSY, GRAND MAL 1963-1991   
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D004830 2004
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Tonic-Clonic Epilepsy, Familial
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Convulsion, Tonic Clonic
% 219.77/219.97  |- skos__prefLabel mesh__D004830 Epilepsy, Tonic-Clonic
% 219.77/219.97  |- mesh__dateRevised mesh__D004830 2005-07-30
% 219.77/219.97  |- skos__broader mesh__D004830smesh__D004829
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Disorders, Tonic-Clonic Convulsion
% 219.77/219.97  |- mesh__recordAuthorizer mesh__D004830 jls
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Tonic Clonic Convulsion Disorder
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Tonic-Clonic Epilepsy, Cryptogenic
% 219.77/219.97  |- skos__altLabel mesh__D004830 Seizure Disorder, Major Motor
% 219.77/219.97  |- skos__altLabel mesh__D004830 Tonic-Clonic Seizure Disorder
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Tonic Clonic Convulsion
% 219.77/219.97  |- skos__altLabel mesh__D004830 Grand Mal Seizure Disorder
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Epilepsy, Tonic Clonic
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D004830 2003
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Tonic-Clonic Epilepsies, Familial
% 219.77/219.97  |- rdf__type mesh__D004830sskos__Concept
% 219.77/219.97  |- mesh__recordMaintainer mesh__D004830 jls
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Tonic-Clonic Epilepsies, Cryptogenic
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Syndromes, Tonic-Clonic Convulsion
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Epilepsy, Familial Tonic-Clonic
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Symptomatic Tonic Clonic Epilepsy
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D004830 2002
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D004830 2006A
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Tonic-Clonic Epilepsies, Symptomatic
% 219.77/219.97  |- skos__altLabel mesh__D004830 Epilepsy, Grand Mal
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Seizure Syndrome, Tonic-Clonic
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Tonic-Clonic Convulsion Disorders
% 219.77/219.97  |- skos__hiddenLabel mesh__D004830 Familial Tonic-Clonic Epilepsies
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D004032 2006
% 219.77/219.97  |- skos__prefLabel mesh__D004032 Diet
% 219.77/219.97  |- skos__related mesh__D004032smesh__D003296
% 219.77/219.97  |- skos__broader mesh__D004032smesh__D009747
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D004032 2003
% 219.77/219.97  |- mesh__recordOriginator mesh__D004032 NLM
% 219.77/219.97  |- skos__scopeNote mesh__D004032
% 219.77/219.97       Regular course of eating and drinking adopted by a person or animal. This does not include DIET THERAPY, a specific diet prescribed in the treatment of a disease.%A%    
% 219.77/219.97  |- skos__hiddenLabel mesh__D004032 Diets
% 219.77/219.97  |- skos__broader mesh__D004032smesh__D008919
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D004032 2004
% 219.77/219.97  |- mesh__dateCreated mesh__D004032 1999-01-01
% 219.77/219.97  |- mesh__recordMaintainer mesh__D004032 mdb
% 219.77/219.97  |- rdf__type mesh__D004032sskos__Concept
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D004032 2002
% 219.77/219.97  |- mesh__recordAuthorizer mesh__D004032 sjn
% 219.77/219.97  |- mesh__dateRevised mesh__D004032 2001-07-25
% 219.77/219.97  |- skos__annotation mesh__D004032
% 219.77/219.97       what a person usually eats: do not confuse with DIET THERAPY, what a physician prescribes to treat a condition; GEN or unspecified; prefer specific diets; /trends: do not confuse with DIET FADS; differentiation among food %26% diet headings: Manual 31.5; in vet journals consider also ANIMAL FEED; SILAGE; ANIMAL NUTRITION; etc.; TN 50: animal diet; consider also DIABETIC DIET%A%  
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D004032 2005
% 219.77/219.97  |- skos__altLabel mesh__D017758
% 219.77/219.97       Patient-to-Professional Disease Transmission
% 219.77/219.97  |- skos__scopeNote mesh__D017758
% 219.77/219.97       The transmission of infectious disease or pathogens from patients to health professionals or health care workers. It includes transmission via direct or indirect exposure to bacterial, fungal, parasitic, or viral agents.%A%    
% 219.77/219.97  |- skos__historyNote mesh__D017758
% 219.77/219.97       specific health profession %28%1974-1993%29%
% 219.77/219.97  |- skos__broader mesh__D017758smesh__D018446
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D017758 2003
% 219.77/219.97  |- mesh__dateRevised mesh__D017758 1996-06-10
% 219.77/219.97  |- skos__related mesh__D017758smesh__D017848
% 219.77/219.97  |- mesh__recordOriginator mesh__D017758 JLS
% 219.77/219.97  |- mesh__historyNote mesh__D017758 94   
% 219.77/219.97  |- skos__hiddenLabel mesh__D017758
% 219.77/219.97       Disease Transmission, Patient to Professional
% 219.77/219.97  |- skos__historyNote mesh__D017758
% 219.77/219.97       specific disease/transmission %28%1974-1993%29%
% 219.77/219.97  |- skos__hiddenLabel mesh__D017758
% 219.77/219.97       Disease Transmission, Patient Professional
% 219.77/219.97  |- skos__hiddenLabel mesh__D017758 Transmission, Patient to Professional
% 219.77/219.97  |- skos__altLabel mesh__D017758 Transmission, Patient-to-Professional
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D017758 2002
% 219.77/219.97  |- skos__hiddenLabel mesh__D017758 Transmission, Patient Professional
% 219.77/219.97  |- skos__altLabel mesh__D017758 Transmission, Patient-Professional
% 219.77/219.97  |- skos__historyNote mesh__D017758 Occupational Diseases %28%1966-1993%29%
% 219.77/219.97  |- skos__hiddenLabel mesh__D017758
% 219.77/219.97       Patient-Professional Disease Transmission
% 219.77/219.97  |- skos__annotation mesh__D017758
% 219.77/219.97       coord IM with disease /transm %28%IM%29% + professional or profession with no qualif %28%IM%29%; do not confuse with DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; DF: DIS TRANSM PATIENT PROF or PATIENT PROF TRANSM%A%  
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D017758 1999
% 219.77/219.97  |- skos__altLabel mesh__D017758 Disease Transmission, Patient-Professional
% 219.77/219.97  |- mesh__recordAuthorizer mesh__D017758 PLS
% 219.77/219.97  |- mesh__recordMaintainer mesh__D017758 TGC
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D017758 2001
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D017758 1998
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D017758 2006
% 219.77/219.97  |- mesh__dateCreated mesh__D017758 1993-06-15
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D017758 1997
% 219.77/219.97  |- skos__historyNote mesh__D017758
% 219.77/219.97       specific health professional %28%1974-1993%29%
% 219.77/219.97  |- rdf__type mesh__D017758sskos__Concept
% 219.77/219.97  |- skos__hiddenLabel mesh__D017758 Patient to Professional Transmission
% 219.77/219.97  |- skos__prefLabel mesh__D017758
% 219.77/219.97       Disease Transmission, Patient-to-Professional
% 219.77/219.97  |- skos__hiddenLabel mesh__D017758
% 219.77/219.97       Patient to Professional Disease Transmission
% 219.77/219.97  |- skos__hiddenLabel mesh__D017758 Patient-Professional Transmission
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D017758 2000
% 219.77/219.97  |- skos__altLabel mesh__D017758 Patient-to-Professional Transmission
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D017758 2005
% 219.77/219.97  |- mesh__publicMeSHNote mesh__D017758 94   
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D017758 2004
% 219.77/219.97  |- mesh__dateEstablished mesh__D017758 1994-01-01
% 219.77/219.97  |- mesh__dateCreated mesh__D003738 1999-01-01
% 219.77/219.97  |- mesh__recordOriginator mesh__D003738 NLM
% 219.77/219.97  |- skos__altLabel mesh__D003738 Luting Agents
% 219.77/219.97  |- mesh__publicMeSHNote mesh__D003738
% 219.77/219.97       72; was CEMENT, DENTAL see under DENTAL MATERIALS 1963-64%A%  
% 219.77/219.97  |- skos__altLabel mesh__D003738 Cements, Dental
% 219.77/219.97  |- skos__altLabel mesh__D003738 Cement, Dental
% 219.77/219.97  |- mesh__recordMaintainer mesh__D003738 jls
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D003738 2005
% 219.77/219.97  |- skos__historyNote mesh__D003738 Cementation %28%1966-1970%29%
% 219.77/219.97  |- skos__prefLabel mesh__D003738 Dental Cements
% 219.77/219.97  |- skos__annotation mesh__D003738
% 219.77/219.97       IM; coord with specific material if pertinent %28%IM%29%; do not confuse with DENTAL CEMENTUM %28%Cat A%29% or denture adhesives %28% = DENTURE RETENTION + ADHESIVES%29%; DF: DENT CEMENTS%A%  
% 219.77/219.97  |- mesh__dateEstablished mesh__D003738 1972-01-01
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D003738 2006
% 219.77/219.97  |- mesh__dateRevised mesh__D003738 2004-07-19
% 219.77/219.97  |- skos__scopeNote mesh__D003738
% 219.77/219.97       Substances used as bonding or luting agents in restorative dentistry, root canal therapy, prosthodontics, and orthodontics.%A%    
% 219.77/219.97  |- skos__broader mesh__D003738smesh__D003764
% 219.77/219.97  |- mesh__historyNote mesh__D003738
% 219.77/219.97       72%28%71%29%; was CEMENT, DENTAL see under DENTAL MATERIALS 1963-64%A%  
% 219.77/219.97  |- mesh__recordAuthorizer mesh__D003738 sjn
% 219.77/219.97  |- rdf__type mesh__D003738sskos__Concept
% 219.77/219.97  |- skos__altLabel mesh__D003738 Dental Cement
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D014460 1997
% 219.77/219.97  |- skos__related mesh__D014460smesh__D002116
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D014460 2003
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D014460 2006
% 219.77/219.97  |- mesh__recordAuthorizer mesh__D014460 PLS
% 219.77/219.97  |- mesh__dateRevised mesh__D014460 1995-03-13
% 219.77/219.97  |- mesh__dateEstablished mesh__D014460 1973-01-01
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D014460 2004
% 219.77/219.97  |- skos__hiddenLabel mesh__D014460 Ultimobranchial Bodies
% 219.77/219.97  |- mesh__dateCreated mesh__D014460 1999-01-01
% 219.77/219.97  |- mesh__historyNote mesh__D014460 73   
% 219.77/219.97  |- skos__historyNote mesh__D014460 Thyroid Gland %28%1966-1972%29%
% 219.77/219.97  |- skos__prefLabel mesh__D014460 Ultimobranchial Body
% 219.77/219.97  |- skos__hiddenLabel mesh__D014460 Body, Ultimobranchial
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D014460 2000
% 219.77/219.97  |- mesh__recordOriginator mesh__D014460 NLM
% 219.77/219.97  |- skos__annotation mesh__D014460
% 219.77/219.97       embryonic structure in animals; /embryol permitted but consider other qualif%A%  
% 219.77/219.97  |- rdf__type mesh__D014460sskos__Concept
% 219.77/219.97  |- skos__broader mesh__D014460smesh__D000825
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D014460 1998
% 219.77/219.97  |- mesh__recordMaintainer mesh__D014460 TGC
% 219.77/219.97  |- skos__historyNote mesh__D014460 Calcitonin %28%1966-1972%29%
% 219.77/219.97  |- skos__hiddenLabel mesh__D014460 Bodies, Ultimobranchial
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D014460 2001
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D014460 1996
% 219.77/219.97  |- mesh__publicMeSHNote mesh__D014460 73   
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D014460 1999
% 219.77/219.97  |- skos__scopeNote mesh__D014460
% 219.77/219.97       A diverticulum from the fourth pharyngeal pouch of an embryo, regarded by some as a rudimentary fifth pharyngeal pouch and by others as a lateral thyroid primordium. The ultimobranchial bodies of lower vertebrates contain large amounts of calcitonin. In mammals the bodies fuse with the thyroid gland and are thought to develop into the parafollicular cells. %28%Stedman, 25th ed%29%%A%    
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D014460 2005
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D014460 2002
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D008423 2006
% 219.77/219.97  |- mesh__publicMeSHNote mesh__D008423 67   
% 219.77/219.97  |- mesh__dateRevised mesh__D008423 2004-07-07
% 219.77/219.97  |- mesh__dateEstablished mesh__D008423 1967-01-01
% 219.77/219.97  |- skos__prefLabel mesh__D008423 Maternal Age
% 219.77/219.97  |- skos__annotation mesh__D008423 relation to PREGNANCY: Manual 28.16.4   
% 219.77/219.97  |- rdf__type mesh__D008423sskos__Concept
% 219.77/219.97  |- mesh__recordMaintainer mesh__D008423 lkt
% 219.77/219.97  |- mesh__recordAuthorizer mesh__D008423 sjn
% 219.77/219.97  |- mesh__dateCreated mesh__D008423 1999-01-01
% 219.77/219.97  |- skos__broader mesh__D008423smesh__D011247
% 219.77/219.97  |- skos__broader mesh__D008423smesh__D000367
% 219.77/219.97  |- skos__hiddenLabel mesh__D008423 Maternal Ages
% 219.77/219.97  |- mesh__recordOriginator mesh__D008423 NLM
% 219.77/219.97  |- mesh__historyNote mesh__D008423 67%28%65%29%   
% 219.77/219.97  |- skos__hiddenLabel mesh__D008423 Ages, Maternal
% 219.77/219.97  |- skos__hiddenLabel mesh__D008423 Age, Maternal
% 219.77/219.97  |- skos__scopeNote mesh__D008423 The age of the mother in PREGNANCY.     
% 219.77/219.97  |- skos__broader mesh__D008423smesh__D012098
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D008423 2005
% 219.77/219.97  |- mesh__dateEstablished mesh__D000440 1974-01-01
% 219.77/219.97  |- skos__annotation mesh__D000440
% 219.77/219.97       1-BUTANOL and TERT-BUTYL ALCOHOL also available   
% 219.77/219.97  |- mesh__recordAuthorizer mesh__D000440 sjn
% 219.77/219.97  |- mesh__publicMeSHNote mesh__D000440 98; see ALCOHOLS, BUTYL 1972-97   
% 219.77/219.97  |- skos__altLabel mesh__D000440 Alcohols, Butyl
% 219.77/219.97  |- skos__altLabel mesh__D000440 Butylhydroxides
% 219.77/219.97  |- mesh__activeMeSHYear mesh__D000440 2004
% 219.77/219.98  |- mesh__recordMaintainer mesh__D000440 ssb
% 219.77/219.98  |- skos__prefLabel mesh__D000440 Butanols
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D000440 2005
% 219.77/219.98  |- mesh__dateCreated mesh__D000440 1999-01-01
% 219.77/219.98  |- mesh__historyNote mesh__D000440 98%28%72%29%   
% 219.77/219.98  |- skos__broader mesh__D000440smesh__D005233
% 219.77/219.98  |- skos__historyNote mesh__D000440 Alcohols %28%1966-1971%29%
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D000440 2006
% 219.77/219.98  |- mesh__dateRevised mesh__D000440 2003-07-09
% 219.77/219.98  |- rdf__type mesh__D000440sskos__Concept
% 219.77/219.98  |- skos__hiddenLabel mesh__D000440 Butyl Alcohols
% 219.77/219.98  |- skos__scopeNote mesh__D000440
% 219.77/219.98       Isomeric forms and derivatives of butanol %28%C4H9OH%29%.     
% 219.77/219.98  |- mesh__recordOriginator mesh__D000440 NLM
% 219.77/219.98  |- skos__altLabel mesh__D000440 Hydroxybutanes
% 219.77/219.98  |- skos__broader mesh__D011460Q000031smesh__D011460
% 219.77/219.98  |- mesh__preferredCombination mesh__D011460Q000031smesh__D011461
% 219.77/219.98  |- rdf__type mesh__D011460Q000031smesh__CompoundConcept
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D013368 1994
% 219.77/219.98  |- mesh__recordMaintainer mesh__D013368 RAZ
% 219.77/219.98  |- mesh__recordAuthorizer mesh__D013368 PLS
% 219.77/219.98  |- mesh__recordOriginator mesh__D013368 NLM
% 219.77/219.98  |- skos__prefLabel mesh__D013368 Submucous Plexus
% 219.77/219.98  |- mesh__dateEstablished mesh__D013368 1965-01-01
% 219.77/219.98  |- skos__broader mesh__D013368smesh__D017776
% 219.77/219.98  |- mesh__publicMeSHNote mesh__D013368 65   
% 219.77/219.98  |- skos__hiddenLabel mesh__D013368 Plexus, Submucous
% 219.77/219.98  |- skos__hiddenLabel mesh__D013368 Meissner Plexus
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D013368 2001
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D013368 1997
% 219.77/219.98  |- mesh__historyNote mesh__D013368 65   
% 219.77/219.98  |- skos__scopeNote mesh__D013368
% 219.77/219.98       One of two ganglionated neural networks which together form the enteric nervous system. The submucous %28%Meissner%27%s%29% plexus is in the connective tissue of the submucosa. Its neurons innervate the epithelium, blood vessels, endocrine cells, other submucosal ganglia, and myenteric ganglia, and play an important role in regulating ion and water transport. %28%From FASEB J 1989;3:127-38%29%%A%    
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D013368 2004
% 219.77/219.98  |- rdf__type mesh__D013368sskos__Concept
% 219.77/219.98  |- skos__altLabel mesh__D013368 Submucosal Plexus
% 219.77/219.98  |- skos__altLabel mesh__D013368 Meissner%27%s Plexus
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D013368 2000
% 219.77/219.98  |- skos__annotation mesh__D013368
% 219.77/219.98       a neural network of the enteric nerv syst   
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D013368 1996
% 219.77/219.98  |- mesh__dateRevised mesh__D013368 1993-06-21
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D013368 2003
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D013368 1999
% 219.77/219.98  |- skos__hiddenLabel mesh__D013368 Meissners Plexus
% 219.77/219.98  |- skos__hiddenLabel mesh__D013368 Plexus, Meissner%27%s
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D013368 2006
% 219.77/219.98  |- skos__hiddenLabel mesh__D013368 Plexus, Submucosal
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D013368 1995
% 219.77/219.98  |- skos__broader mesh__D013368smesh__D017615
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D013368 2002
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D013368 1998
% 219.77/219.98  |- mesh__dateCreated mesh__D013368 1999-01-01
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D013368 2005
% 219.77/219.98  |- mesh__recordOriginator mesh__D018053 TPW
% 219.77/219.98  |- mesh__dateEstablished mesh__D018053 1994-01-01
% 219.77/219.98  |- skos__broader mesh__D018053smesh__D000838
% 219.77/219.98  |- skos__prefLabel mesh__D018053 Arsenites
% 219.77/219.98  |- mesh__recordMaintainer mesh__D018053 jls
% 219.77/219.98  |- mesh__recordAuthorizer mesh__D018053 sjn
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D018053 2006
% 219.77/219.98  |- skos__scopeNote mesh__D018053
% 219.77/219.98       Inorganic salts or organic esters of arsenious acid.     
% 219.77/219.98  |- skos__broader mesh__D018053smesh__D001152
% 219.77/219.98  |- skos__annotation mesh__D018053 do not confuse with ARSENATES   
% 219.77/219.98  |- rdf__type mesh__D018053sskos__Concept
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D018053 2005
% 219.77/219.98  |- mesh__dateRevised mesh__D018053 2004-07-19
% 219.77/219.98  |- mesh__publicMeSHNote mesh__D018053 94   
% 219.77/219.98  |- mesh__dateCreated mesh__D018053 1993-06-04
% 219.77/219.98  |- skos__historyNote mesh__D018053 Arsenic %28%1966-1993%29%
% 219.77/219.98  |- mesh__historyNote mesh__D018053 94   
% 219.77/219.98  |- skos__hiddenLabel mesh__D010070 Oxalate, Iron
% 219.77/219.98  |- skos__hiddenLabel mesh__D010070 Oxalate, Diammonium
% 219.77/219.98  |- skos__altLabel mesh__D010070 Monohydrogen Monopotassium Oxalate
% 219.77/219.98  |- skos__hiddenLabel mesh__D010070 Oxalate, Dilithium
% 219.77/219.98  |- skos__hiddenLabel mesh__D010070 Oxalate, Chromium
% 219.77/219.98  |- skos__hiddenLabel mesh__D010070 Oxalate, Monoammonium
% 219.77/219.98  |- mesh__recordMaintainer mesh__D010070 jmp
% 219.77/219.98  |- skos__altLabel mesh__D010070 Ferric Oxalate
% 219.77/219.98  |- mesh__recordAuthorizer mesh__D010070 sjn
% 219.77/219.98  |- skos__prefLabel mesh__D010070 Oxalates
% 219.77/219.98  |- skos__hiddenLabel mesh__D010070 Oxalate, Monosodium
% 219.77/219.98  |- skos__hiddenLabel mesh__D010070 Oxalate, Magnesium
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D010070 2002
% 219.77/219.98  |- skos__related mesh__D010070smesh__D006960
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D010070 2004
% 219.77/219.98  |- skos__hiddenLabel mesh__D010070 Oxalate, Sodium
% 219.77/219.98  |- skos__hiddenLabel mesh__D010070 Oxalate, Dipotassium
% 219.77/219.98  |- mesh__dateRevised mesh__D010070 2001-07-25
% 219.77/219.98  |- skos__scopeNote mesh__D010070 Salts and esters of OXALIC ACID.     
% 219.77/219.98  |- skos__hiddenLabel mesh__D010070 Oxalate, Aluminum
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D010070 2006
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D010070 2003
% 219.77/219.98  |- skos__hiddenLabel mesh__D010070 Oxalate, Potassium Chromium
% 219.77/219.98  |- mesh__recordOriginator mesh__D010070 NLM
% 219.77/219.98  |- skos__altLabel mesh__D010070 Magnesium Oxalate
% 219.77/219.98  |- skos__hiddenLabel mesh__D010070 Oxalate, Potassium
% 219.77/219.98  |- skos__broader mesh__D010070smesh__D019815
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D010070 2005
% 219.77/219.98  |- skos__hiddenLabel mesh__D010070 Oxalate, Monohydrogen Monopotassium
% 219.77/219.98  |- skos__annotation mesh__D010070
% 219.77/219.98       /urine: HYPEROXALURIA %26% HYPEROXALURIA, PRIMARY are also available; CALCIUM OXALATE is also available%A%  
% 219.77/219.98  |- skos__hiddenLabel mesh__D010070 Oxalate, Ferric
% 219.77/219.98  |- skos__hiddenLabel mesh__D010070 Oxalate, Disodium
% 219.77/219.98  |- rdf__type mesh__D010070sskos__Concept
% 219.77/219.98  |- mesh__dateCreated mesh__D010070 1999-01-01
% 219.77/219.98  |- skos__related mesh__D010070smesh__D006959
% 219.77/219.98  |- skos__hiddenLabel mesh__D010070 Oxalate, Monopotassium
% 219.77/219.98  |- skos__historyNote mesh__D004831 Epilepsy %28%1966-1976%29%
% 219.77/219.98  |- mesh__dateEstablished mesh__D004831 1977-01-01
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Seizure Disorders, Myoclonic
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Astatic Epilepsy, Myoclonic
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Myoclonic Astatic Epilepsies
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Absence Epilepsies, Myoclonic
% 219.77/219.98  |- skos__altLabel mesh__D004831 Myoclonic Epilepsy, Severe Infantile
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Myoclonus Epilepsy
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Astatic Epilepsies, Myoclonic
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Epilepsy, Myoclonic Absence
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Epilepsy, Symptomatic Myoclonic
% 219.77/219.98  |- skos__historyNote mesh__D004831 Myoclonus %28%1966-1976%29%
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D004831 2006
% 219.77/219.98  |- mesh__dateCreated mesh__D004831 1976-04-27
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D004831 2001
% 219.77/219.98  |- mesh__recordOriginator mesh__D004831 MM
% 219.77/219.98  |- skos__scopeNote mesh__D004831
% 219.77/219.98       A clinically diverse group of epilepsy syndromes characterized either by myoclonic seizures or by myoclonus in association with other seizure types. Myoclonic epilepsy syndromes are divided into three subtypes based on etiology: familial, cryptogenic, and symptomatic %28%i.e., occurring secondary to known disease processes such as infections, hypoxic-ischemic injuries, trauma, etc.%29%.%A%    
% 219.77/219.98  |- skos__altLabel mesh__D004831 Myoclonic Seizure Disorder
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Epilepsies, Myoclonic Absence
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Epilepsy, Myoclonic Astatic
% 219.77/219.98  |- skos__altLabel mesh__D004831 Myoclonic Epilepsy, Benign Infantile
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Myoclonic Epilepsies, Idiopathic
% 219.77/219.98  |- skos__altLabel mesh__D004831 Severe Myoclonic Epilepsy, Infantile
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Myoclonic Absence Epilepsies
% 219.77/219.98  |- skos__broader mesh__D004831smesh__D004827
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Cryptogenic Myoclonic Epilepsies
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Epilepsies, Idiopathic Myoclonic
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Myoclonic Epilepsies, Cryptogenic
% 219.77/219.98  |- skos__prefLabel mesh__D004831 Epilepsies, Myoclonic
% 219.77/219.98  |- skos__altLabel mesh__D004831 Epilepsy, Myoclonic, Early Childhood
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D004831 2005
% 219.77/219.98  |- skos__altLabel mesh__D004831 Myoclonic Epilepsy, Early Childhood
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D004831 2000
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Epilepsy, Cryptogenic Myoclonic
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Myoclonic Epilepsy, Idiopathic
% 219.77/219.98  |- skos__altLabel mesh__D004831 Encephalopathy, Myoclonic
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Symptomatic Myoclonic Epilepsies
% 219.77/219.98  |- skos__altLabel mesh__D004831 Epilepsy, Myoclonic, Infantile, Benign
% 219.77/219.98  |- mesh__publicMeSHNote mesh__D004831
% 219.77/219.98       2000; see EPILEPSY, MYOCLONIC 1992-1999; see EPILEPSY, MYOCLONUS 1977-1991%A%  
% 219.77/219.98  |- skos__altLabel mesh__D004831 Severe Infantile Myoclonic Epilepsy
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Disorders, Myoclonic Seizure
% 219.77/219.98  |- mesh__recordMaintainer mesh__D004831 KEV
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D004831 2004
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Myoclonic Epilepsy, Cryptogenic
% 219.77/219.98  |- skos__altLabel mesh__D004831 Myoclonic Epilepsy, Infantile, Benign
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Seizure Disorder, Myoclonic
% 219.77/219.98  |- skos__altLabel mesh__D004831 Epilepsy, Myoclonus
% 219.77/219.98  |- skos__altLabel mesh__D004831 Myoclonic Epilepsy, Infantile, Severe
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Idiopathic Myoclonic Epilepsies
% 219.77/219.98  |- mesh__historyNote mesh__D004831
% 219.77/219.98       2000%28%1992%29% was EPILEPSY, MYOCLONUS 1977-1991   
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Encephalopathies, Myoclonic
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Myoclonic Encephalopathies
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Myoclonus Epilepsies
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Epilepsy, Myoclonic
% 219.77/219.98  |- mesh__recordAuthorizer mesh__D004831 sjn
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Epilepsies, Symptomatic Myoclonic
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D004831 2003
% 219.77/219.98  |- rdf__type mesh__D004831sskos__Concept
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Epilepsies, Myoclonic Astatic
% 219.77/219.98  |- skos__altLabel mesh__D004831 Myoclonic Epilepsy
% 219.77/219.98  |- skos__altLabel mesh__D004831 Infantile Severe Myoclonic Epilepsy
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Myoclonic Epilepsies, Symptomatic
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Disorder, Myoclonic Seizure
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Epilepsy, Idiopathic Myoclonic
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Epilepsies, Cryptogenic Myoclonic
% 219.77/219.98  |- skos__altLabel mesh__D004831 Cryptogenic Myoclonic Epilepsy
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Absence Epilepsy, Myoclonic
% 219.77/219.98  |- skos__altLabel mesh__D004831 Epilepsy, Early Childhood, Myoclonic
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D004831 2002
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Myoclonic Epilepsies
% 219.77/219.98  |- skos__altLabel mesh__D004831 Early Childhood, Myoclonic Epilepsy
% 219.77/219.98  |- mesh__dateRevised mesh__D004831 1999-11-04
% 219.77/219.98  |- skos__hiddenLabel mesh__D004831 Myoclonic Seizure Disorders
% 219.77/219.98  |- mesh__recordAuthorizer mesh__D004033 sjn
% 219.77/219.98  |- skos__broader mesh__D004033smesh__D004035
% 219.77/219.98  |- skos__hiddenLabel mesh__D004033 Fads, Food
% 219.77/219.98  |- skos__broader mesh__D004033smesh__D006802
% 219.77/219.98  |- skos__scopeNote mesh__D004033
% 219.77/219.98       Diets which become fashionable, but which are not necessarily nutritious.%28%Lehninger 1982, page 484%29%%A%    
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D004033 2004
% 219.77/219.98  |- mesh__dateCreated mesh__D004033 1999-01-01
% 219.77/219.98  |- skos__hiddenLabel mesh__D004033 Fad, Food
% 219.77/219.98  |- skos__prefLabel mesh__D004033 Diet Fads
% 219.77/219.98  |- mesh__recordMaintainer mesh__D004033 lkt
% 219.77/219.98  |- mesh__recordOriginator mesh__D004033 NLM
% 219.77/219.98  |- mesh__dateRevised mesh__D004033 2003-07-09
% 219.77/219.98  |- rdf__type mesh__D004033sskos__Concept
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D004033 2005
% 219.77/219.98  |- skos__hiddenLabel mesh__D004033 Diet Fad
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D004033 2006
% 219.77/219.98  |- skos__hiddenLabel mesh__D004033 Food Fad
% 219.77/219.98  |- skos__hiddenLabel mesh__D004033 Fad, Diet
% 219.77/219.98  |- skos__hiddenLabel mesh__D004033 Fads, Diet
% 219.77/219.98  |- skos__broader mesh__D004813Q000379smesh__D004813
% 219.77/219.98  |- mesh__preferredCombination mesh__D004813Q000379smesh__D004812
% 219.77/219.98  |- rdf__type mesh__D004813Q000379smesh__CompoundConcept
% 219.77/219.98  |- skos__hiddenLabel mesh__D017759 Crossunited Fractures
% 219.77/219.98  |- skos__altLabel mesh__D017759 Fractures, Abnormal Union
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D017759 2006
% 219.77/219.98  |- skos__hiddenLabel mesh__D017759 Malunited Fracture
% 219.77/219.98  |- skos__hiddenLabel mesh__D017759 Fracture, Malunited
% 219.77/219.98  |- mesh__recordOriginator mesh__D017759 JLS
% 219.77/219.98  |- skos__hiddenLabel mesh__D017759 Crossunited Fracture
% 219.77/219.98  |- mesh__dateCreated mesh__D017759 1992-12-28
% 219.77/219.98  |- mesh__publicMeSHNote mesh__D017759 94   
% 219.77/219.98  |- mesh__dateEstablished mesh__D017759 1994-01-01
% 219.77/219.98  |- skos__hiddenLabel mesh__D017759 Fracture, Abnormal Union
% 219.77/219.98  |- skos__hiddenLabel mesh__D017759 Malunited Fractures
% 219.77/219.98  |- mesh__dateRevised mesh__D017759 2005-06-30
% 219.77/219.98  |- mesh__recordAuthorizer mesh__D017759 sjn
% 219.77/219.98  |- mesh__historyNote mesh__D017759 94   
% 219.77/219.98  |- skos__broader mesh__D017759smesh__D050723
% 219.77/219.98  |- mesh__recordMaintainer mesh__D017759 ssb
% 219.77/219.98  |- rdf__type mesh__D017759sskos__Concept
% 219.77/219.98  |- skos__annotation mesh__D017759
% 219.77/219.98       faulty union of a fract; do not confuse with FRACTURES, UNUNITED; IM; coord with specific organ/inj or precoord organ/fract term %28%IM%29%%A%  
% 219.77/219.98  |- skos__scopeNote mesh__D017759
% 219.77/219.98       Union of the fragments of a fractured bone in a faulty or abnormal position. If two bones parallel to one another unite by osseous tissue, the result is a crossunion. %28%From Manual of Orthopaedic Terminology, 4th ed%29%%A%    
% 219.77/219.98  |- skos__hiddenLabel mesh__D017759 Fracture, Crossunited
% 219.77/219.98  |- skos__prefLabel mesh__D017759 Fractures, Malunited
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D028481 2005
% 219.77/219.98  |- skos__annotation mesh__D028481
% 219.77/219.98       X ref SPURGE: restrict to EUPHORBIA; SPURGE, JAPANESE see PACHYSANDRA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D028481 2004
% 219.77/219.98  |- mesh__publicMeSHNote mesh__D028481
% 219.77/219.98       2002; for SPURGE see EUPHORBIACEAE 1998-2001   
% 219.77/219.98  |- skos__historyNote mesh__D028481 Euphorbiaceae %28%1998-2001%29%
% 219.77/219.98  |- mesh__historyNote mesh__D028481
% 219.77/219.98       2002; for SPURGE use EUPHORBIACEAE 1998-2001   
% 219.77/219.98  |- skos__broader mesh__D028481smesh__D019665
% 219.77/219.98  |- mesh__dateEstablished mesh__D028481 2002-01-01
% 219.77/219.98  |- skos__prefLabel mesh__D028481 Euphorbia
% 219.77/219.98  |- mesh__recordOriginator mesh__D028481 ssb
% 219.77/219.98  |- mesh__dateRevised mesh__D028481 2003-07-09
% 219.77/219.98  |- mesh__recordMaintainer mesh__D028481 ssb
% 219.77/219.98  |- mesh__recordAuthorizer mesh__D028481 sjn
% 219.77/219.98  |- skos__scopeNote mesh__D028481
% 219.77/219.98       A large plant genus of the family EUPHORBIACEAE, order Euphorbiales, subclass Rosidae. They have a milky sap and a female flower consisting of a single pistil, surrounded by numerous male flowers of one stamen each. Euphorbia hirta is rarely called milkweed but that name is normally used for ASCLEPIAS.%A%    
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D028481 2006
% 219.77/219.98  |- rdf__type mesh__D028481sskos__Concept
% 219.77/219.98  |- mesh__dateCreated mesh__D028481 2001-07-25
% 219.77/219.98  |- skos__broader mesh__D003739smesh__D010519
% 219.77/219.98  |- skos__altLabel mesh__D003739 Cementum
% 219.77/219.98  |- mesh__recordAuthorizer mesh__D003739 sjn
% 219.77/219.98  |- skos__annotation mesh__D003739
% 219.77/219.98       do not confuse with DENTAL CEMENTS %28%Cat D%29%; DF: DENT CEMENTUM%A%  
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D003739 2005
% 219.77/219.98  |- skos__broader mesh__D003739smesh__D019589
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D003739 2006
% 219.77/219.98  |- skos__altLabel mesh__D003739 Cementum, Dental
% 219.77/219.98  |- mesh__recordMaintainer mesh__D003739 lkt
% 219.77/219.98  |- mesh__recordOriginator mesh__D003739 NLM
% 219.77/219.98  |- skos__altLabel mesh__D003739 Cementoblast
% 219.77/219.98  |- skos__related mesh__D003739smesh__D025021
% 219.77/219.98  |- skos__scopeNote mesh__D003739
% 219.77/219.98       The bonelike rigid connective tissue covering the root of a tooth from the cementoenamel junction to the apex and lining the apex of the root canal, also assisting in tooth support by serving as attachment structures for the periodontal ligament. %28%Jablonski, Dictionary of Dentistry, 1992%29%%A%    
% 219.77/219.98  |- rdf__type mesh__D003739sskos__Concept
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D003739 2004
% 219.77/219.98  |- skos__prefLabel mesh__D003739 Dental Cementum
% 219.77/219.98  |- mesh__dateCreated mesh__D003739 1999-01-01
% 219.77/219.98  |- mesh__dateRevised mesh__D003739 2003-07-09
% 219.77/219.98  |- mesh__recordAuthorizer mesh__D014461 sjn
% 219.77/219.98  |- mesh__recordMaintainer mesh__D014461 lkt
% 219.77/219.98  |- rdf__type mesh__D014461sskos__Concept
% 219.77/219.98  |- mesh__dateRevised mesh__D014461 2002-07-03
% 219.77/219.98  |- skos__broader mesh__D014461smesh__D002623
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D014461 2004
% 219.77/219.98  |- mesh__dateCreated mesh__D014461 1999-01-01
% 219.77/219.98  |- skos__annotation mesh__D014461
% 219.77/219.98       an anal chem technique; GEN or unspecified; prefer specifics; NIM%A%  
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D014461 2006
% 219.77/219.98  |- skos__scopeNote mesh__D014461
% 219.77/219.98       Centrifugation with a centrifuge that develops centrifugal fields of more than 100,000 times gravity. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D014461 2003
% 219.77/219.98  |- skos__broader mesh__D014461smesh__D002498
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D014461 2005
% 219.77/219.98  |- mesh__historyNote mesh__D014461 65   
% 219.77/219.98  |- skos__prefLabel mesh__D014461 Ultracentrifugation
% 219.77/219.98  |- mesh__publicMeSHNote mesh__D014461 65   
% 219.77/219.98  |- mesh__dateEstablished mesh__D014461 1965-01-01
% 219.77/219.98  |- mesh__recordOriginator mesh__D014461 NLM
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D000441 2004
% 219.77/219.98  |- skos__scopeNote mesh__D000441
% 219.77/219.98       Isomeric forms and derivatives of hexanol %28%C6H11OH%29%.     
% 219.77/219.98  |- mesh__recordOriginator mesh__D000441 NLM
% 219.77/219.98  |- skos__prefLabel mesh__D000441 Hexanols
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D000441 2005
% 219.77/219.98  |- mesh__dateEstablished mesh__D000441 1974-01-01
% 219.77/219.98  |- mesh__dateCreated mesh__D000441 1999-01-01
% 219.77/219.98  |- skos__broader mesh__D000441smesh__D005233
% 219.77/219.98  |- mesh__recordAuthorizer mesh__D000441 sjn
% 219.77/219.98  |- mesh__publicMeSHNote mesh__D000441 98; see ALCOHOLS, HEXYL 1974-97   
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D000441 2006
% 219.77/219.98  |- mesh__dateRevised mesh__D000441 2003-07-09
% 219.77/219.98  |- skos__hiddenLabel mesh__D000441 Hexyl Alcohols
% 219.77/219.98  |- rdf__type mesh__D000441sskos__Concept
% 219.77/219.98  |- mesh__recordMaintainer mesh__D000441 ssb
% 219.77/219.98  |- mesh__historyNote mesh__D000441 98%28%72%29%   
% 219.77/219.98  |- skos__altLabel mesh__D000441 Hydroxyhexanes
% 219.77/219.98  |- skos__broader mesh__D000441smesh__D000438
% 219.77/219.98  |- skos__altLabel mesh__D000441 Alcohols, Hexyl
% 219.77/219.98  |- mesh__recordOriginator mesh__D013369 NLM
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D013369 2005
% 219.77/219.98  |- skos__altLabel mesh__D013369 Abscess, Subphrenic
% 219.77/219.98  |- skos__altLabel mesh__D013369 Subdiaphragmatic Abscess
% 219.77/219.98  |- skos__hiddenLabel mesh__D013369 Subphrenic Abscesses
% 219.77/219.98  |- skos__hiddenLabel mesh__D013369 Subdiaphragmatic Abscesses
% 219.77/219.98  |- skos__altLabel mesh__D013369 Abscess, Subdiaphragmatic
% 219.77/219.98  |- mesh__recordAuthorizer mesh__D013369 sjn
% 219.77/219.98  |- rdf__type mesh__D013369sskos__Concept
% 219.77/219.98  |- mesh__recordMaintainer mesh__D013369 lkt
% 219.77/219.98  |- skos__broader mesh__D013369smesh__D010538
% 219.77/219.98  |- mesh__dateRevised mesh__D013369 2004-07-07
% 219.77/219.98  |- skos__hiddenLabel mesh__D013369 Abscesses, Subdiaphragmatic
% 219.77/219.98  |- skos__annotation mesh__D013369
% 219.77/219.98       coordinate IM with specific organism/infection term %28%IM%29% but not with BACTERIAL INFECTIONS for unspecified bacterial abscess%A%  
% 219.77/219.98  |- mesh__dateCreated mesh__D013369 1999-01-01
% 219.77/219.98  |- skos__scopeNote mesh__D013369
% 219.77/219.98       Accumulation of purulent EXUDATES beneath the DIAPHRAGM, also known as upper abdominal abscess. It is usually associated with PERITONITIS or postoperative infections.%A%    
% 219.77/219.98  |- skos__prefLabel mesh__D013369 Subphrenic Abscess
% 219.77/219.98  |- skos__broader mesh__D013369smesh__D018784
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D013369 2006
% 219.77/219.98  |- skos__hiddenLabel mesh__D013369 Abscesses, Subphrenic
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D018054 2006
% 219.77/219.98  |- skos__altLabel mesh__D018054 Hydrogen Bromide
% 219.77/219.98  |- rdf__type mesh__D018054sskos__Concept
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D018054 2005
% 219.77/219.98  |- mesh__recordOriginator mesh__D018054 TPW
% 219.77/219.98  |- mesh__dateEstablished mesh__D018054 1994-01-01
% 219.77/219.98  |- skos__prefLabel mesh__D018054 Hydrobromic Acid
% 219.77/219.98  |- skos__scopeNote mesh__D018054
% 219.77/219.98       Hydrobromic acid %28%HBr%29%. A solution of hydrogen bromide gas in water.%A%    
% 219.77/219.98  |- skos__hiddenLabel mesh__D018054 Acid, Hydrobromic
% 219.77/219.98  |- skos__hiddenLabel mesh__D018054 Bromide, Hydrogen
% 219.77/219.98  |- mesh__recordAuthorizer mesh__D018054 sjn
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D018054 2002
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D018054 2004
% 219.77/219.98  |- mesh__historyNote mesh__D018054
% 219.77/219.98       94; was HYDROBROMIC ACID %28%NM%29% 1974-93   
% 219.77/219.98  |- mesh__dateRevised mesh__D018054 2001-07-25
% 219.77/219.98  |- mesh__publicMeSHNote mesh__D018054
% 219.77/219.98       94; HYDROBROMIC ACID was indexed under ACIDS 1983-93 %26% BROMIDES 1974-82%A%  
% 219.77/219.98  |- mesh__dateCreated mesh__D018054 1993-06-04
% 219.77/219.98  |- skos__historyNote mesh__D018054 Acids %28%1983-1993%29%
% 219.77/219.98  |- skos__historyNote mesh__D018054 Bromides %28%1974-1982%29%
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D018054 2003
% 219.77/219.98  |- mesh__recordMaintainer mesh__D018054 ssb
% 219.77/219.98  |- skos__broader mesh__D018054smesh__D000148
% 219.77/219.98  |- mesh__onlineNote mesh__D018054
% 219.77/219.98       use HYDROBROMIC ACID %28%NM%29% to search HYDROBROMIC ACID 1980-93%A%  
% 219.77/219.98  |- skos__broader mesh__D018054smesh__D017605
% 219.77/219.98  |- skos__altLabel mesh__D010071 Oxosuccinates
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D010071 2004
% 219.77/219.98  |- mesh__recordMaintainer mesh__D010071 ADP
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D010071 2000
% 219.77/219.98  |- mesh__recordOriginator mesh__D010071 NLM
% 219.77/219.98  |- skos__altLabel mesh__D010071 Ketosuccinates
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D010071 2006
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D010071 2003
% 219.77/219.98  |- mesh__publicMeSHNote mesh__D010071 66   
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D010071 2005
% 219.77/219.98  |- mesh__dateRevised mesh__D010071 1998-06-10
% 219.77/219.98  |- rdf__type mesh__D010071sskos__Concept
% 219.77/219.98  |- mesh__dateCreated mesh__D010071 1999-01-01
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D010071 1999
% 219.77/219.98  |- skos__annotation mesh__D010071 OXALOACETATE is available.   
% 219.77/219.98  |- mesh__dateEstablished mesh__D010071 1966-01-01
% 219.77/219.98  |- mesh__historyNote mesh__D010071 66%28%64%29%   
% 219.77/219.98  |- mesh__recordAuthorizer mesh__D010071 SJN
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D010071 2002
% 219.77/219.98  |- skos__broader mesh__D010071smesh__D020351
% 219.77/219.98  |- skos__prefLabel mesh__D010071 Oxaloacetates
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D010071 2001
% 219.77/219.98  |- skos__scopeNote mesh__D010071 Salts and esters of oxaloacetic acid.     
% 219.77/219.98  |- skos__altLabel mesh__D004832 Absence Seizures
% 219.77/219.98  |- skos__hiddenLabel mesh__D004832 Pykno-Epilepsies
% 219.77/219.98  |- skos__hiddenLabel mesh__D004832 Juvenile Absence Epilepsies
% 219.77/219.98  |- skos__hiddenLabel mesh__D004832 Seizure, Atonic Absence
% 219.77/219.98  |- skos__hiddenLabel mesh__D004832 Absence Epilepsy, Childhood
% 219.77/219.98  |- mesh__dateCreated mesh__D004832 1999-01-01
% 219.77/219.98  |- skos__hiddenLabel mesh__D004832 Absence Epilepsies, Juvenile
% 219.77/219.98  |- skos__hiddenLabel mesh__D004832 Absence Epilepsy
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D004832 2006
% 219.77/219.98  |- mesh__dateRevised mesh__D004832 2004-07-26
% 219.77/219.98  |- skos__altLabel mesh__D004832 Absence Seizure Disorder
% 219.77/219.98  |- skos__hiddenLabel mesh__D004832 Epilepsies, Childhood Absence
% 219.77/219.98  |- skos__annotation mesh__D004832
% 219.77/219.98       note X ref PETIT MAL EPILEPSY: do not confuse with PETIT MAL STATUS see STATUS EPILEPTICUS%A%  
% 219.77/219.98  |- skos__hiddenLabel mesh__D004832 Seizure, Absence
% 219.77/219.98  |- skos__hiddenLabel mesh__D004832 Petit Mal Epilepsies
% 219.77/219.98  |- skos__hiddenLabel mesh__D004832 Atonic Absence Seizure
% 219.77/219.98  |- skos__hiddenLabel mesh__D004832 Absence Seizure
% 219.77/219.98  |- mesh__recordOriginator mesh__D004832 NLM
% 219.77/219.98  |- skos__hiddenLabel mesh__D004832 Epilepsy, Childhood Absence
% 219.77/219.98  |- skos__hiddenLabel mesh__D004832 Pyknolepsies
% 219.77/219.98  |- skos__altLabel mesh__D004832 Epilepsy, Minor
% 219.77/219.98  |- skos__hiddenLabel mesh__D004832 Minor Epilepsies
% 219.77/219.98  |- skos__hiddenLabel mesh__D004832 Absence Seizure Disorders
% 219.77/219.98  |- skos__hiddenLabel mesh__D004832 Minor Epilepsy
% 219.77/219.98  |- skos__hiddenLabel mesh__D004832 Childhood Absence Epilepsies
% 219.77/219.98  |- mesh__activeMeSHYear mesh__D004832 2005
% 219.77/219.98  |- skos__hiddenLabel mesh__D004832 Seizure Disorders, Absence
% 219.77/219.98  |- skos__broader mesh__D004832smesh__D004829
% 219.77/219.98  |- skos__hiddenLabel mesh__D004832 Absence Seizures, Atonic
% 219.77/219.98  |- skos__hiddenLabel mesh__D004832 Absence Epilepsies, Childhood
% 219.77/219.98  |- mesh__recordAuthorizer mesh__D004832 jls
% 219.77/219.98  |- skos__altLabel mesh__D004832 Petit Mal Convulsion
% 219.77/219.98  |- skos__altLabel mesh__D004832 Pykno-Epilepsy
% 219.77/219.98  |- skos__altLabel mesh__D004832 Petit Mal Epilepsy
% 219.77/219.99  |- skos__hiddenLabel mesh__D004832 Pykno Epilepsy
% 219.77/219.99  |- skos__hiddenLabel mesh__D004832 Epilepsy, Juvenile Absence
% 219.77/219.99  |- skos__hiddenLabel mesh__D004832 Absence Epilepsy, Juvenile
% 219.77/219.99  |- skos__altLabel mesh__D004832 Juvenile Absence Epilepsy
% 219.77/219.99  |- skos__altLabel mesh__D004832 Childhood Absence Epilepsy
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D004832 2005A
% 219.77/219.99  |- skos__hiddenLabel mesh__D004832 Absence Seizure, Atonic
% 219.77/219.99  |- skos__altLabel mesh__D004832 Epilepsy, Petit Mal
% 219.77/219.99  |- mesh__historyNote mesh__D004832
% 219.77/219.99       1992; was EPILEPSY, PETIT MAL 1963-1991   
% 219.77/219.99  |- skos__altLabel mesh__D004832 Pyknolepsy
% 219.77/219.99  |- skos__scopeNote mesh__D004832
% 219.77/219.99       A childhood seizure disorder characterized by rhythmic electrical brain discharges of generalized onset. Clinical features include a sudden cessation of ongoing activity usually without loss of postural tone. Rhythmic blinking of the eyelids or lip smacking frequently accompanies the SEIZURES. The usual duration is 5-10 seconds, and multiple episodes may occur daily. Juvenile absence epilepsy is characterized by the juvenile onset of absence seizures and an increased incidence of myoclonus and tonic-clonic seizures. %28%Menkes, Textbook of Child Neurology, 5th ed, p736%29%%A%    
% 219.77/219.99  |- skos__hiddenLabel mesh__D004832 Seizures, Atonic Absence
% 219.77/219.99  |- skos__prefLabel mesh__D004832 Epilepsy, Absence
% 219.77/219.99  |- skos__hiddenLabel mesh__D004832 Petit Mal, Akinetic
% 219.77/219.99  |- skos__hiddenLabel mesh__D004832 Epilepsies, Juvenile Absence
% 219.77/219.99  |- skos__hiddenLabel mesh__D004832 Convulsion, Petit Mal
% 219.77/219.99  |- mesh__publicMeSHNote mesh__D004832
% 219.77/219.99       1992; was EPILEPSY, PETIT MAL 1963-1991   
% 219.77/219.99  |- skos__altLabel mesh__D004832 Seizure Disorder, Absence
% 219.77/219.99  |- rdf__type mesh__D004832sskos__Concept
% 219.77/219.99  |- mesh__recordMaintainer mesh__D004832 jls
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D004034 2006
% 219.77/219.99  |- skos__hiddenLabel mesh__D004034 Survey, Diet
% 219.77/219.99  |- skos__annotation mesh__D004034
% 219.77/219.99       no qualif; TN 97: caution against word %22%survey%22%   
% 219.77/219.99  |- mesh__historyNote mesh__D004034
% 219.77/219.99       91%28%75%29%; was see under NUTRITION SURVEYS 1975-90   
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D004034 2005
% 219.77/219.99  |- skos__scopeNote mesh__D004034
% 219.77/219.99       Systematic collections of factual data pertaining to the diet of a human population within a given geographic area.%A%    
% 219.77/219.99  |- skos__broader mesh__D004034smesh__D009749
% 219.77/219.99  |- mesh__recordMaintainer mesh__D004034 sjn
% 219.77/219.99  |- mesh__recordAuthorizer mesh__D004034 sjn
% 219.77/219.99  |- mesh__dateRevised mesh__D004034 2004-07-13
% 219.77/219.99  |- skos__hiddenLabel mesh__D004034 Diet Survey
% 219.77/219.99  |- mesh__publicMeSHNote mesh__D004034
% 219.77/219.99       91; was see under NUTRITION SURVEYS 1975-90   
% 219.77/219.99  |- mesh__dateCreated mesh__D004034 1999-01-01
% 219.77/219.99  |- skos__prefLabel mesh__D004034 Diet Surveys
% 219.77/219.99  |- skos__hiddenLabel mesh__D004034 Surveys, Diet
% 219.77/219.99  |- mesh__dateEstablished mesh__D004034 1991-01-01
% 219.77/219.99  |- rdf__type mesh__D004034sskos__Concept
% 219.77/219.99  |- mesh__recordOriginator mesh__D004034 NLM
% 219.77/219.99  |- mesh__onlineNote mesh__D004034
% 219.77/219.99       use NUTRITION SURVEYS to search DIET SURVEYS 1966-74   
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D028482 2003
% 219.77/219.99  |- skos__broader mesh__D028482smesh__D019665
% 219.77/219.99  |- mesh__recordAuthorizer mesh__D028482 sjn
% 219.77/219.99  |- mesh__publicMeSHNote mesh__D028482
% 219.77/219.99       2002; for RUBBER TREE see EUPHORBIACEAE 1998-2001   
% 219.77/219.99  |- skos__prefLabel mesh__D028482 Hevea
% 219.77/219.99  |- mesh__dateEstablished mesh__D028482 2002-01-01
% 219.77/219.99  |- skos__annotation mesh__D028482
% 219.77/219.99       do not confuse with FICUS which is sometimes called rubberplant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.77/219.99  |- skos__related mesh__D028482smesh__D012408
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D028482 2006
% 219.77/219.99  |- skos__historyNote mesh__D028482 Euphorbiaceae %28%1998-2001%29%
% 219.77/219.99  |- mesh__recordOriginator mesh__D028482 ssb
% 219.77/219.99  |- skos__scopeNote mesh__D028482
% 219.77/219.99       A plant genus of the family EUPHORBIACEAE, order Euphorbiales, subclass Rosidae.  Commercial natural RUBBER is mainly obtained from Hevea brasiliensis but also from some other plants.%A%    
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D028482 2002
% 219.77/219.99  |- rdf__type mesh__D028482sskos__Concept
% 219.77/219.99  |- mesh__dateCreated mesh__D028482 2001-08-03
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D028482 2005
% 219.77/219.99  |- mesh__recordMaintainer mesh__D028482 jls
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D028482 2004
% 219.77/219.99  |- mesh__historyNote mesh__D028482
% 219.77/219.99       2002; for RUBBER TREE use EUPHORBIACEAE 1998-2001   
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D014462 2004
% 219.77/219.99  |- skos__historyNote mesh__D014462 Filtration %28%1970-1972%29%
% 219.77/219.99  |- skos__broader mesh__D014462smesh__D005374
% 219.77/219.99  |- mesh__dateCreated mesh__D014462 1999-01-01
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D014462 2006
% 219.77/219.99  |- mesh__publicMeSHNote mesh__D014462 73   
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D014462 2003
% 219.77/219.99  |- mesh__recordOriginator mesh__D014462 NLM
% 219.77/219.99  |- mesh__recordAuthorizer mesh__D014462 sjn
% 219.77/219.99  |- mesh__recordMaintainer mesh__D014462 lkt
% 219.77/219.99  |- mesh__historyNote mesh__D014462 73   
% 219.77/219.99  |- mesh__dateRevised mesh__D014462 2002-07-03
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D014462 2005
% 219.77/219.99  |- skos__broader mesh__D014462smesh__D005112
% 219.77/219.99  |- skos__annotation mesh__D014462
% 219.77/219.99       NIM; ultrafilt of blood is indexed under HEMOFILTRATION or HEMODIAFILTRATION if combined with hemodialysis%A%  
% 219.77/219.99  |- skos__scopeNote mesh__D014462
% 219.77/219.99       The separation of particles from a suspension by passage through a filter with very fine pores. In ultrafiltration the separation is accomplished by convective transport; in DIALYSIS separation relies instead upon differential diffusion. Ultrafiltration occurs naturally and is a laboratory procedure. Artificial ultrafiltration of the blood is referred to as HEMOFILTRATION or HEMODIAFILTRATION %28%if combined with HEMODIALYSIS%29%.%A%    
% 219.77/219.99  |- skos__related mesh__D014462smesh__D008851
% 219.77/219.99  |- mesh__dateEstablished mesh__D014462 1973-01-01
% 219.77/219.99  |- skos__prefLabel mesh__D014462 Ultrafiltration
% 219.77/219.99  |- rdf__type mesh__D014462sskos__Concept
% 219.77/219.99  |- skos__related mesh__D014462smesh__D006440
% 219.77/219.99  |- skos__hiddenLabel mesh__D008425 Pattern, Maternal Care
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008425 2004
% 219.77/219.99  |- mesh__dateCreated mesh__D008425 1999-01-01
% 219.77/219.99  |- skos__hiddenLabel mesh__D008425 Care Pattern, Maternal
% 219.77/219.99  |- skos__prefLabel mesh__D008425 Maternal Behavior
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008425 2000
% 219.77/219.99  |- skos__annotation mesh__D008425
% 219.77/219.99       human %26% animal; /drug eff permitted only if the drug affects the mother%27%s behavior: do not use for eff of a drug on the offspring after admin of drug to pregn mother%A%  
% 219.77/219.99  |- skos__hiddenLabel mesh__D008425 Care Patterns, Maternal
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008425 2001
% 219.77/219.99  |- skos__altLabel mesh__D008425 Maternal Patterns of Care
% 219.77/219.99  |- mesh__publicMeSHNote mesh__D008425 68   
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008425 1998
% 219.77/219.99  |- mesh__dateRevised mesh__D008425 1997-06-20
% 219.77/219.99  |- skos__hiddenLabel mesh__D008425 Patterns, Maternal Care
% 219.77/219.99  |- mesh__historyNote mesh__D008425 68   
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008425 2005
% 219.77/219.99  |- mesh__recordOriginator mesh__D008425 NLM
% 219.77/219.99  |- skos__hiddenLabel mesh__D008425 Behaviors, Maternal
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008425 1999
% 219.77/219.99  |- skos__historyNote mesh__D008425 Behavior, Animal %28%1966-1967%29%
% 219.77/219.99  |- mesh__recordMaintainer mesh__D008425 JLS
% 219.77/219.99  |- mesh__dateEstablished mesh__D008425 1968-01-01
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008425 2006
% 219.77/219.99  |- skos__scopeNote mesh__D008425
% 219.77/219.99       The behavior patterns associated with or characteristic of a mother.%A%    
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008425 2002
% 219.77/219.99  |- skos__hiddenLabel mesh__D008425 Maternal Care Pattern
% 219.77/219.99  |- skos__hiddenLabel mesh__D008425 Behavior, Maternal
% 219.77/219.99  |- skos__hiddenLabel mesh__D008425 Maternal Behaviors
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008425 2003
% 219.77/219.99  |- mesh__recordAuthorizer mesh__D008425 SJN
% 219.77/219.99  |- rdf__type mesh__D008425sskos__Concept
% 219.77/219.99  |- skos__broader mesh__D008425smesh__D005195
% 219.77/219.99  |- skos__historyNote mesh__D008425 Parent-Child Relations %28%1966-1967%29%
% 219.77/219.99  |- skos__hiddenLabel mesh__D000442 Octyl Alcohols
% 219.77/219.99  |- mesh__dateEstablished mesh__D000442 1974-01-01
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D000442 2004
% 219.77/219.99  |- skos__altLabel mesh__D000442 Alcohols, Octyl
% 219.77/219.99  |- skos__annotation mesh__D000442 1-OCTANOL is also available   
% 219.77/219.99  |- mesh__dateCreated mesh__D000442 1999-01-01
% 219.77/219.99  |- skos__broader mesh__D000442smesh__D005233
% 219.77/219.99  |- mesh__recordOriginator mesh__D000442 NLM
% 219.77/219.99  |- mesh__historyNote mesh__D000442 98%28%72%29%   
% 219.77/219.99  |- mesh__recordMaintainer mesh__D000442 ssb
% 219.77/219.99  |- skos__altLabel mesh__D000442 Hydroxyoctanes
% 219.77/219.99  |- skos__prefLabel mesh__D000442 Octanols
% 219.77/219.99  |- skos__scopeNote mesh__D000442
% 219.77/219.99       Isomeric forms and derivatives of octanol %28%C8H17OH%29%.     
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D000442 2006
% 219.77/219.99  |- skos__altLabel mesh__D000442 Octylic Alcohols
% 219.77/219.99  |- rdf__type mesh__D000442sskos__Concept
% 219.77/219.99  |- mesh__recordAuthorizer mesh__D000442 sjn
% 219.77/219.99  |- mesh__publicMeSHNote mesh__D000442 98; see ALCOHOLS, OCTYL 1974-97   
% 219.77/219.99  |- skos__hiddenLabel mesh__D000442 Alcohols, Octylic
% 219.77/219.99  |- skos__altLabel mesh__D000442 Heptylcarbinols
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D000442 2005
% 219.77/219.99  |- mesh__dateRevised mesh__D000442 2003-07-09
% 219.77/219.99  |- mesh__recordAuthorizer mesh__D010870 sjn
% 219.77/219.99  |- skos__hiddenLabel mesh__D010870 Pineal Glands
% 219.77/219.99  |- skos__altLabel mesh__D010870 Pineal Body
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D010870 2006
% 219.77/219.99  |- skos__altLabel mesh__D010870 Epiphysis Cerebri
% 219.77/219.99  |- skos__broader mesh__D010870smesh__D004702
% 219.77/219.99  |- skos__broader mesh__D010870smesh__D009490
% 219.77/219.99  |- skos__hiddenLabel mesh__D010870 Glands, Pineal
% 219.77/219.99  |- skos__prefLabel mesh__D010870 Pineal Gland
% 219.77/219.99  |- mesh__recordMaintainer mesh__D010870 lkt
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D010870 2004
% 219.77/219.99  |- mesh__dateCreated mesh__D010870 1999-01-01
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D010870 2005
% 219.77/219.99  |- mesh__dateRevised mesh__D010870 2002-07-02
% 219.77/219.99  |- skos__hiddenLabel mesh__D010870 Gland, Pineal
% 219.77/219.99  |- skos__hiddenLabel mesh__D010870 Bodies, Pineal
% 219.77/219.99  |- skos__hiddenLabel mesh__D010870 Cerebri, Epiphysis
% 219.77/219.99  |- skos__hiddenLabel mesh__D010870 Body, Pineal
% 219.77/219.99  |- skos__annotation mesh__D010870
% 219.77/219.99       neopl: do not consider PINEALOMA a synonym: coord PINEAL GLAND %28%IM%29% with BRAIN NEOPLASMS %28%IM%29% + histol type of type %28%IM%29%%A%  
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D010870 2003
% 219.77/219.99  |- mesh__recordOriginator mesh__D010870 NLM
% 219.77/219.99  |- skos__scopeNote mesh__D010870
% 219.77/219.99       A light-sensitive neuroendocrine organ attached to the roof of the THIRD VENTRICLE of the brain. The pineal gland secretes MELATONIN, other biogenic amines, and neuropeptides.%A%    
% 219.77/219.99  |- skos__hiddenLabel mesh__D010870 Pineal Bodies
% 219.77/219.99  |- rdf__type mesh__D010870sskos__Concept
% 219.77/219.99  |- skos__broader mesh__D010870smesh__D019261
% 219.77/219.99  |- skos__altLabel mesh__D018055 Eicosanoid Receptors
% 219.77/219.99  |- skos__scopeNote mesh__D018055
% 219.77/219.99       Cell surface proteins that bind eicosanoids with high affinity and trigger intracellular changes influencing the behavior of cells. Among the eicosanoid receptors are receptors for the prostaglandins, thromboxanes, and leukotrienes.%A%    
% 219.77/219.99  |- skos__altLabel mesh__D018055 Eicosanoid Receptor
% 219.77/219.99  |- skos__prefLabel mesh__D018055 Receptors, Eicosanoid
% 219.77/219.99  |- mesh__dateCreated mesh__D018055 1993-06-21
% 219.77/219.99  |- mesh__publicMeSHNote mesh__D018055 94   
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D018055 2004
% 219.77/219.99  |- skos__historyNote mesh__D018055
% 219.77/219.99       Receptors, Cell Surface %28%1983-1993%29%
% 219.77/219.99  |- skos__altLabel mesh__D018055 Receptor, Eicosanoids
% 219.77/219.99  |- skos__annotation mesh__D018055
% 219.77/219.99       GEN; prefer specifics; DF: RECEPT EICOSANOID   
% 219.77/219.99  |- mesh__historyNote mesh__D018055 94   
% 219.77/219.99  |- mesh__recordOriginator mesh__D018055 RAZ
% 219.77/219.99  |- skos__historyNote mesh__D018055
% 219.77/219.99       Receptors, Prostaglandin %28%1977-1993%29%
% 219.77/219.99  |- mesh__dateEstablished mesh__D018055 1994-01-01
% 219.77/219.99  |- skos__broader mesh__D018055smesh__D011956
% 219.77/219.99  |- skos__hiddenLabel mesh__D018055 Eicosanoids Receptor
% 219.77/219.99  |- skos__broader mesh__D018055smesh__D043562
% 219.77/219.99  |- skos__hiddenLabel mesh__D018055 Receptor, Eicosanoid
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D018055 2006
% 219.77/219.99  |- mesh__dateRevised mesh__D018055 2003-07-09
% 219.77/219.99  |- mesh__recordMaintainer mesh__D018055 jmp
% 219.77/219.99  |- rdf__type mesh__D018055sskos__Concept
% 219.77/219.99  |- mesh__recordAuthorizer mesh__D018055 sjn
% 219.77/219.99  |- skos__historyNote mesh__D018055 Receptors, Thromboxane %28%1993%29%
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D018055 2005
% 219.77/219.99  |- mesh__dateCreated mesh__D010072 1974-11-19
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D010072 2003
% 219.77/219.99  |- skos__scopeNote mesh__D010072
% 219.77/219.99       Amino-substituted glyoxylic acid derivative.     
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D010072 2001
% 219.77/219.99  |- skos__historyNote mesh__D010072 Glyoxylates %28%1972-1974%29%
% 219.77/219.99  |- skos__hiddenLabel mesh__D010072 Acid, Oxalamic
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D010072 2005
% 219.77/219.99  |- mesh__dateEstablished mesh__D010072 1991-01-01
% 219.77/219.99  |- mesh__recordMaintainer mesh__D010072 TAP
% 219.77/219.99  |- skos__historyNote mesh__D010072 Amino Acids %28%1972-1974%29%
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D010072 1997
% 219.77/219.99  |- skos__broader mesh__D010072smesh__D006038
% 219.77/219.99  |- mesh__publicMeSHNote mesh__D010072
% 219.77/219.99       91; was see under AMINO ACIDS 1975-90   
% 219.77/219.99  |- skos__hiddenLabel mesh__D010072 Acid, Oxamic
% 219.77/219.99  |- skos__altLabel mesh__D010072 Oxamidic Acid
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D010072 2000
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D010072 1999
% 219.77/219.99  |- mesh__recordOriginator mesh__D010072 NLM
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D010072 1993
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D010072 1996
% 219.77/219.99  |- rdf__type mesh__D010072sskos__Concept
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D010072 1995
% 219.77/219.99  |- skos__hiddenLabel mesh__D010072 Acid, Oxamidic
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D010072 1998
% 219.77/219.99  |- mesh__dateRevised mesh__D010072 1992-05-19
% 219.77/219.99  |- skos__broader mesh__D010072smesh__D000596
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D010072 1994
% 219.77/219.99  |- skos__hiddenLabel mesh__D010072 Acid, Aminooxoacetic
% 219.77/219.99  |- skos__prefLabel mesh__D010072 Oxamic Acid
% 219.77/219.99  |- mesh__historyNote mesh__D010072
% 219.77/219.99       91%28%75%29%; was see under AMINO ACIDS 1975-90   
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D010072 2004
% 219.77/219.99  |- skos__altLabel mesh__D010072 Aminooxoacetic Acid
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D010072 2002
% 219.77/219.99  |- mesh__recordAuthorizer mesh__D010072 PLS
% 219.77/219.99  |- skos__altLabel mesh__D010072 Oxalamic Acid
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D010072 2006
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D004833 2006
% 219.77/219.99  |- skos__hiddenLabel mesh__D004833 Temporal Lobe Epilepsies
% 219.77/219.99  |- skos__hiddenLabel mesh__D004833 Temporal Lobe Epilepsy
% 219.77/219.99  |- mesh__dateCreated mesh__D004833 1999-01-01
% 219.77/219.99  |- rdf__type mesh__D004833sskos__Concept
% 219.77/219.99  |- skos__hiddenLabel mesh__D004833 Epilepsies, Temporal Lobe
% 219.77/219.99  |- skos__prefLabel mesh__D004833 Epilepsy, Temporal Lobe
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D004833 2003
% 219.77/219.99  |- skos__hiddenLabel mesh__D004833 Uncinate Epilepsy
% 219.77/219.99  |- mesh__recordOriginator mesh__D004833 NLM
% 219.77/219.99  |- skos__hiddenLabel mesh__D004833 Lateral Temporal Epilepsies
% 219.77/219.99  |- mesh__historyNote mesh__D004833 1964   
% 219.77/219.99  |- mesh__publicMeSHNote mesh__D004833 1964   
% 219.77/219.99  |- skos__hiddenLabel mesh__D004833 Epilepsies, Uncinate
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D004833 2004
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D004833 2005A
% 219.77/219.99  |- mesh__recordMaintainer mesh__D004833 jls
% 219.77/219.99  |- skos__hiddenLabel mesh__D004833 Uncinate Epilepsies
% 219.77/219.99  |- skos__hiddenLabel mesh__D004833 Lateral Temporal Epilepsy
% 219.77/219.99  |- skos__altLabel mesh__D004833 Childhood Benign Psychomotor Epilepsy
% 219.77/219.99  |- skos__broader mesh__D004833smesh__D004828
% 219.77/219.99  |- skos__related mesh__D004833smesh__D038481
% 219.77/219.99  |- skos__altLabel mesh__D004833 Benign Psychomotor Epilepsy, Childhood
% 219.77/219.99  |- mesh__dateRevised mesh__D004833 2004-07-26
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D004833 2005
% 219.77/219.99  |- mesh__recordAuthorizer mesh__D004833 jls
% 219.77/219.99  |- skos__scopeNote mesh__D004833
% 219.77/219.99       A localization-related %28%focal%29% form of epilepsy characterized by recurrent seizures that arise from foci within the temporal lobe, most commonly from its mesial aspect. A wide variety of psychic phenomena may be associated, including illusions, hallucinations, dyscognitive states, and affective experiences. The majority of complex partial seizures %28%see EPILEPSY, COMPLEX PARTIAL%29% originate from the temporal lobes. Temporal lobe seizures may be classified by etiology as cryptogenic, familial, or symptomatic %28%i.e., related to an identified disease process or lesion%29%. %28%From Adams et al., Principles of Neurology, 6th ed, p321%29%%A%    
% 219.77/219.99  |- skos__hiddenLabel mesh__D004833 Epilepsies, Lateral Temporal
% 219.77/219.99  |- mesh__dateEstablished mesh__D004833 1964-01-01
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D004035 2005
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D004035 2004
% 219.77/219.99  |- mesh__recordOriginator mesh__D004035 NLM
% 219.77/219.99  |- skos__scopeNote mesh__D004035
% 219.77/219.99       By adjusting the quantity and quality of food intake to improve health status of an individual. This term does not include the methods of food intake %28%NUTRITIONAL SUPPORT%29%.%A%    
% 219.77/219.99  |- skos__hiddenLabel mesh__D004035 Therapies, Diet
% 219.77/219.99  |- mesh__recordMaintainer mesh__D004035 lkt
% 219.77/219.99  |- skos__annotation mesh__D004035
% 219.77/219.99       GEN only: prefer /diet ther with disease term: Manual 19.7+, 19.8.24; DF: DIET THER%A%  
% 219.77/219.99  |- mesh__dateRevised mesh__D004035 2003-07-09
% 219.77/219.99  |- mesh__dateCreated mesh__D004035 1999-01-01
% 219.77/219.99  |- skos__hiddenLabel mesh__D004035 Diet Therapies
% 219.77/219.99  |- rdf__type mesh__D004035sskos__Concept
% 219.77/219.99  |- mesh__recordAuthorizer mesh__D004035 sjn
% 219.77/219.99  |- skos__prefLabel mesh__D004035 Diet Therapy
% 219.77/219.99  |- skos__broader mesh__D004035smesh__D044623
% 219.77/219.99  |- skos__altLabel mesh__D004035 Therapy, Diet
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D004035 2006
% 219.77/219.99  |- skos__broader mesh__D028483smesh__D019660
% 219.77/219.99  |- mesh__dateRevised mesh__D028483 2005-06-30
% 219.77/219.99  |- mesh__dateEstablished mesh__D028483 2002-01-01
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D028483 2006
% 219.77/219.99  |- mesh__recordOriginator mesh__D028483 ssb
% 219.77/219.99  |- skos__annotation mesh__D028483
% 219.77/219.99       coordinate with specific PLANT COMPONENTS term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.77/219.99  |- mesh__historyNote mesh__D028483
% 219.77/219.99       2002; for OKRA use MALVACEAE 1996-2001   
% 219.77/219.99  |- rdf__type mesh__D028483sskos__Concept
% 219.77/219.99  |- mesh__recordMaintainer mesh__D028483 ssb
% 219.77/219.99  |- mesh__recordAuthorizer mesh__D028483 sjn
% 219.77/219.99  |- skos__historyNote mesh__D028483 Malvaceae %28%1996-2001%29%
% 219.77/219.99  |- skos__scopeNote mesh__D028483
% 219.77/219.99       A plant genus of the family MALVACEAE, order Malvales, subclass Dilleniidae best known for okra.%A%    
% 219.77/219.99  |- mesh__dateCreated mesh__D028483 2001-07-25
% 219.77/219.99  |- mesh__publicMeSHNote mesh__D028483
% 219.77/219.99       2002; for OKRA see MALVACEAE 1996-2001   
% 219.77/219.99  |- skos__prefLabel mesh__D028483 Abelmoschus
% 219.77/219.99  |- skos__broader mesh__D008607Q000193smesh__D008607
% 219.77/219.99  |- mesh__preferredCombination mesh__D008607Q000193smesh__D004495
% 219.77/219.99  |- rdf__type mesh__D008607Q000193smesh__CompoundConcept
% 219.77/219.99  |- skos__hiddenLabel mesh__D014463 Imagings, Ultrasonic
% 219.77/219.99  |- skos__scopeNote mesh__D014463
% 219.77/219.99       The visualization of deep structures of the body by recording the reflections of echoes of pulses of ultrasonic waves directed into the tissues. Use of ultrasound for imaging or diagnostic purposes employs frequencies ranging from 1.6 to 10 megahertz.%A%    
% 219.77/219.99  |- skos__altLabel mesh__D014463 Ultrasonic Diagnosis
% 219.77/219.99  |- skos__altLabel mesh__D014463 Echography
% 219.77/219.99  |- skos__related mesh__D014463smesh__D019412
% 219.77/219.99  |- skos__altLabel mesh__D014463 Computer Echotomography
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D014463 2002
% 219.77/219.99  |- skos__altLabel mesh__D014463 Ultrasonic Imaging
% 219.77/219.99  |- skos__hiddenLabel mesh__D014463 Echotomographies
% 219.77/219.99  |- skos__hiddenLabel mesh__D014463 Ultrasonic Imagings
% 219.77/219.99  |- rdf__type mesh__D014463sskos__Concept
% 219.77/219.99  |- mesh__publicMeSHNote mesh__D014463
% 219.77/219.99       91; was ULTRASONIC DIAGNOSIS 1985-90   
% 219.77/219.99  |- skos__altLabel mesh__D014463 Ultrasonic Tomography
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D014463 2001
% 219.77/219.99  |- skos__hiddenLabel mesh__D014463 Imaging, Ultrasonic
% 219.77/219.99  |- skos__hiddenLabel mesh__D014463 Ultrasonic Diagnoses
% 219.77/219.99  |- skos__prefLabel mesh__D014463 Ultrasonography
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D014463 1999
% 219.77/219.99  |- skos__hiddenLabel mesh__D014463 Diagnoses, Ultrasonic
% 219.77/219.99  |- mesh__recordOriginator mesh__D014463 NLM
% 219.77/219.99  |- skos__broader mesh__D014463smesh__D003952
% 219.77/219.99  |- mesh__onlineNote mesh__D014463
% 219.77/219.99       use ULTRASONOGRAPHY to search ULTRASONIC DIAGNOSIS 1985-90; use ULTRASONICS/DU to search DIAGNOSIS, ULTRASONIC 1974-84%A%  
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D014463 2004
% 219.77/219.99  |- skos__altLabel mesh__D014463 Echotomography
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D014463 1998
% 219.77/219.99  |- skos__annotation mesh__D014463
% 219.77/219.99       GEN only; prefer /ultrasonogr with organs %26% diseases: Manual 19.7+, 19.8.77; ultrasonic or sonographic imaging of organs is organ /ultrasonogr; X ref ECHOTOMOGRAPHY is seen in foreign lit: if so, use %22%ultrasonography%22% or %22%ultrasonic diagnosis%22% or %22%ultrasonic imaging%22% in translations %26% not %22%echotomography%22%; ECHOCARDIOGRAPHY %26% ECHOCARDIOGRAPHY, DOPPLER %26% ECHOENCEPHALOGRAPHY are also available; DF: ULTRASONOGR%A%  
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D014463 2000
% 219.77/219.99  |- mesh__dateCreated mesh__D014463 1999-01-01
% 219.77/219.99  |- mesh__historyNote mesh__D014463
% 219.77/219.99       91; was ULTRASONIC DIAGNOSIS 1985-90; was DIAGNOSIS, ULTRASONIC %28%NON MESH%29% 1974-84%A%  
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D014463 2006
% 219.77/219.99  |- mesh__recordAuthorizer mesh__D014463 SJN
% 219.77/219.99  |- mesh__dateEstablished mesh__D014463 1985-01-01
% 219.77/219.99  |- mesh__dateRevised mesh__D014463 1997-06-20
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D014463 2003
% 219.77/219.99  |- mesh__recordMaintainer mesh__D014463 PXP
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D014463 2005
% 219.77/219.99  |- skos__hiddenLabel mesh__D008426 Maternal Deprivations
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008426 2005
% 219.77/219.99  |- rdf__type mesh__D008426sskos__Concept
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008426 2000
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008426 1996
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008426 2003
% 219.77/219.99  |- skos__annotation mesh__D008426 human %26% animal   
% 219.77/219.99  |- skos__hiddenLabel mesh__D008426 Deprivation, Maternal
% 219.77/219.99  |- mesh__recordMaintainer mesh__D008426 TAP
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008426 1995
% 219.77/219.99  |- mesh__dateCreated mesh__D008426 1999-01-01
% 219.77/219.99  |- mesh__dateRevised mesh__D008426 1992-05-14
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008426 2002
% 219.77/219.99  |- skos__scopeNote mesh__D008426
% 219.77/219.99       Prolonged separation of the offspring from the mother.     
% 219.77/219.99  |- mesh__publicMeSHNote mesh__D008426 69   
% 219.77/219.99  |- skos__hiddenLabel mesh__D008426 Deprivations, Maternal
% 219.77/219.99  |- skos__broader mesh__D008426smesh__D005195
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008426 1993
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008426 1994
% 219.77/219.99  |- mesh__historyNote mesh__D008426 69%28%66%29%   
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008426 1999
% 219.77/219.99  |- mesh__recordAuthorizer mesh__D008426 PLS
% 219.77/219.99  |- skos__prefLabel mesh__D008426 Maternal Deprivation
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008426 2006
% 219.77/219.99  |- mesh__recordOriginator mesh__D008426 NLM
% 219.77/219.99  |- mesh__dateEstablished mesh__D008426 1969-01-01
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008426 2001
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008426 1997
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008426 1998
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D008426 2004
% 219.77/219.99  |- mesh__onlineNote mesh__D000443
% 219.77/219.99       use ALCURONIUM to search ALLOFERIN 1978-93   
% 219.77/219.99  |- mesh__publicMeSHNote mesh__D000443
% 219.77/219.99       91; was see under TOXIFERINE 1975-90; ALLOFERIN was see ALCURONIUM 1978-93%A%  
% 219.77/219.99  |- mesh__historyNote mesh__D000443
% 219.77/219.99       91%28%75%29%; was see under TOXIFERINE 1975-90; ALLOFERIN was see ALCURONIUM 1978-93%A%  
% 219.77/219.99  |- skos__altLabel mesh__D000443 Allnortoxiferine
% 219.77/219.99  |- skos__historyNote mesh__D000443 Toxiferine %28%1972-1974%29%
% 219.77/219.99  |- skos__prefLabel mesh__D000443 Alcuronium
% 219.77/219.99  |- skos__altLabel mesh__D000443 N,N%27%-Diallylnortoxiferinium Dichloride
% 219.77/219.99  |- mesh__dateRevised mesh__D000443 2005-06-30
% 219.77/219.99  |- skos__altLabel mesh__D000443 Diallylnortoxiferine
% 219.77/219.99  |- skos__scopeNote mesh__D000443
% 219.77/219.99       A non-depolarizing skeletal muscle relaxant similar to TUBOCURARINE. It is used as an anesthesia adjuvant.%A%    
% 219.77/219.99  |- skos__altLabel mesh__D000443 Alcuronium Dichloride
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D000443 2006
% 219.77/219.99  |- rdf__type mesh__D000443sskos__Concept
% 219.77/219.99  |- mesh__dateEstablished mesh__D000443 1991-01-01
% 219.77/219.99  |- skos__hiddenLabel mesh__D000443 Dichloride, Alcuronium
% 219.77/219.99  |- mesh__recordOriginator mesh__D000443 NLM
% 219.77/219.99  |- mesh__recordMaintainer mesh__D000443 ssb
% 219.77/219.99  |- skos__broader mesh__D000443smesh__D014117
% 219.77/219.99  |- skos__hiddenLabel mesh__D000443
% 219.77/219.99       Dichloride, N,N%27%-Diallylnortoxiferinium
% 219.77/219.99  |- skos__historyNote mesh__D000443 Allyl Compounds %28%1972-1974%29%
% 219.77/219.99  |- mesh__recordAuthorizer mesh__D000443 sjn
% 219.77/219.99  |- mesh__dateCreated mesh__D000443 1974-11-19
% 219.77/219.99  |- rdf__type mesh__D018854sskos__Concept
% 219.77/219.99  |- skos__broader mesh__D018854smesh__D007348
% 219.77/219.99  |- mesh__historyNote mesh__D018854 96   
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D018854 1997
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D018854 1999
% 219.77/219.99  |- skos__annotation mesh__D018854
% 219.77/219.99       restrict to health insurance; do not confuse with MANAGED CARE PROGRAMS%A%  
% 219.77/219.99  |- skos__historyNote mesh__D018854 Managed Care Programs %28%1992-1995%29%
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D018854 2002
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D018854 1996
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D018854 1998
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D018854 2004
% 219.77/219.99  |- skos__hiddenLabel mesh__D018854 Accountable Health Plan
% 219.77/219.99  |- skos__hiddenLabel mesh__D018854 Health Plan, Accountable
% 219.77/219.99  |- skos__altLabel mesh__D018854 Accountable Health Plans
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D018854 2001
% 219.77/219.99  |- skos__historyNote mesh__D018854 Economic Competition %28%1992-1995%29%
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D018854 2006
% 219.77/219.99  |- skos__prefLabel mesh__D018854 Managed Competition
% 219.77/219.99  |- mesh__publicMeSHNote mesh__D018854 96   
% 219.77/219.99  |- skos__scopeNote mesh__D018854
% 219.77/219.99       A strategy for purchasing health care in a manner which will obtain maximum value for the price for the purchasers of the health care and the recipients. The concept was developed primarily by Alain Enthoven of Stanford University and promulgated by the Jackson Hole Group. The strategy depends on sponsors for groups of the population to be insured. The sponsor, in some cases a health alliance, acts as an intermediary between the group and competing provider groups %28%accountable health plans%29%. The competition is price-based among annual premiums for a defined, standardized benefit package. %28%From Slee and Slee, Health Care Reform Terms, 1993%29%%A%    
% 219.77/219.99  |- skos__hiddenLabel mesh__D018854 Plan, Accountable Health
% 219.77/219.99  |- skos__altLabel mesh__D018854 Competition, Managed
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D018854 2003
% 219.77/219.99  |- skos__historyNote mesh__D018854 Insurance, Health %28%1992-1995%29%
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D018854 2000
% 219.77/219.99  |- skos__hiddenLabel mesh__D018854 Plans, Accountable Health
% 219.77/219.99  |- mesh__activeMeSHYear mesh__D018854 2005
% 219.77/219.99  |- mesh__dateEstablished mesh__D018854 1996-01-01
% 219.77/219.99  |- mesh__dateCreated mesh__D018854 1995-06-05
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D010871 2005
% 219.77/220.00  |- skos__hiddenLabel mesh__D010871 Tumors, Pineal Parenchymal
% 219.77/220.00  |- skos__hiddenLabel mesh__D010871 Pineocytoma-Pineoblastoma, Mixed
% 219.77/220.00  |- skos__altLabel mesh__D010871 Pineal Parenchymal Tumors
% 219.77/220.00  |- mesh__recordMaintainer mesh__D010871 ags
% 219.77/220.00  |- mesh__recordOriginator mesh__D010871 NLM
% 219.77/220.00  |- skos__hiddenLabel mesh__D010871 Pinealomas
% 219.77/220.00  |- skos__hiddenLabel mesh__D010871 Pineoblastomas
% 219.77/220.00  |- skos__broader mesh__D010871smesh__D018302
% 219.77/220.00  |- skos__annotation mesh__D010871
% 219.77/220.00       coord IM with  BRAIN NEOPLASMS + PINEAL GLAND %28%IM%29%   
% 219.77/220.00  |- mesh__dateRevised mesh__D010871 2004-07-07
% 219.77/220.00  |- skos__hiddenLabel mesh__D010871 Tumors, Pineal
% 219.77/220.00  |- skos__hiddenLabel mesh__D010871 Tumor, Pineal
% 219.77/220.00  |- skos__prefLabel mesh__D010871 Pinealoma
% 219.77/220.00  |- mesh__recordAuthorizer mesh__D010871 sjn
% 219.77/220.00  |- skos__hiddenLabel mesh__D010871 Pineal Neoplasm
% 219.77/220.00  |- rdf__type mesh__D010871sskos__Concept
% 219.77/220.00  |- skos__hiddenLabel mesh__D010871 Pineocytomas
% 219.77/220.00  |- skos__hiddenLabel mesh__D010871 Neoplasm, Pineal
% 219.77/220.00  |- skos__hiddenLabel mesh__D010871 Pineal Tumor
% 219.77/220.00  |- skos__altLabel mesh__D010871 Pineocytoma
% 219.77/220.00  |- skos__altLabel mesh__D010871 Pineal Neoplasms
% 219.77/220.00  |- skos__altLabel mesh__D010871 Neoplasms, Pineal
% 219.77/220.00  |- skos__hiddenLabel mesh__D010871 Mixed Pineocytoma-Pineoblastomas
% 219.77/220.00  |- skos__hiddenLabel mesh__D010871 Pineocytoma-Pineoblastomas, Mixed
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D010871 2006
% 219.77/220.00  |- skos__altLabel mesh__D010871 Pineal Tumors
% 219.77/220.00  |- skos__hiddenLabel mesh__D010871 Pinealocytomas
% 219.77/220.00  |- skos__hiddenLabel mesh__D010871 Mixed Pineocytoma Pineoblastoma
% 219.77/220.00  |- skos__broader mesh__D010871smesh__D001932
% 219.77/220.00  |- skos__hiddenLabel mesh__D010871 Pineal Parenchymal Tumor
% 219.77/220.00  |- skos__hiddenLabel mesh__D010871 Tumor, Pineal Parenchymal
% 219.77/220.00  |- skos__scopeNote mesh__D010871
% 219.77/220.00       Neoplasms which originate from pineal parenchymal cells that tend to enlarge the gland and be locally invasive. The two major forms are pineocytoma and the more malignant pineoblastoma. Pineocytomas have moderate cellularity and tend to form rosette patterns. Pineoblastomas are highly cellular tumors containing small, poorly differentiated cells. These tumors occasionally seed the neuroaxis or cause obstructive HYDROCEPHALUS or Parinaud%27%s syndrome. GERMINOMA; CARCINOMA, EMBRYONAL; GLIOMA; and other neoplasms may arise in the pineal region with germinoma being the most common pineal region tumor. %28%From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2064; Adams et al., Principles of Neurology, 6th ed, p670%29%%A%    
% 219.77/220.00  |- mesh__dateCreated mesh__D010871 1999-01-01
% 219.77/220.00  |- mesh__recordOriginator mesh__D018056 TGC
% 219.77/220.00  |- skos__altLabel mesh__D018056 Hemorrheology
% 219.77/220.00  |- skos__historyNote mesh__D018056 Rheology %28%1966-1993%29%
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D018056 2004
% 219.77/220.00  |- mesh__recordAuthorizer mesh__D018056 sjn
% 219.77/220.00  |- mesh__recordMaintainer mesh__D018056 nns
% 219.77/220.00  |- skos__related mesh__D018056smesh__D004907
% 219.77/220.00  |- skos__related mesh__D018056smesh__D004903
% 219.77/220.00  |- mesh__historyNote mesh__D018056 94   
% 219.77/220.00  |- mesh__publicMeSHNote mesh__D018056 94   
% 219.77/220.00  |- skos__prefLabel mesh__D018056 Hemorheology
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D018056 2006
% 219.77/220.00  |- mesh__dateRevised mesh__D018056 2003-07-09
% 219.77/220.00  |- mesh__dateCreated mesh__D018056 1993-06-02
% 219.77/220.00  |- skos__historyNote mesh__D018056 Blood Viscosity %28%1966-1993%29%
% 219.77/220.00  |- rdf__type mesh__D018056sskos__Concept
% 219.77/220.00  |- skos__annotation mesh__D018056 DF: HEMORHEOL   
% 219.77/220.00  |- skos__broader mesh__D018056smesh__D001703
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D018056 2005
% 219.77/220.00  |- mesh__dateEstablished mesh__D018056 1994-01-01
% 219.77/220.00  |- skos__broader mesh__D018056smesh__D012212
% 219.77/220.00  |- skos__related mesh__D018056smesh__D001809
% 219.77/220.00  |- skos__historyNote mesh__D018056
% 219.77/220.00       Erythrocyte Deformability %28%1985-1993%29%
% 219.77/220.00  |- skos__scopeNote mesh__D018056
% 219.77/220.00       The study of the flow of BLOOD in relation to the pressures, flow, volumes, and resistances in BLOOD VESSELS; in macroscopic, microscopic, and submicroscopic dimensions.%A%    
% 219.77/220.00  |- mesh__publicMeSHNote mesh__D010073
% 219.77/220.00       91; was see under NITROQUINOLINES 1975-90   
% 219.77/220.00  |- skos__hiddenLabel mesh__D010073 UK 4271
% 219.77/220.00  |- skos__broader mesh__D010073smesh__D006912
% 219.77/220.00  |- mesh__dateCreated mesh__D010073 1974-11-19
% 219.77/220.00  |- skos__hiddenLabel mesh__D010073 UK4271
% 219.77/220.00  |- skos__historyNote mesh__D010073 Quinolines %28%1973-1974%29%
% 219.77/220.00  |- mesh__recordAuthorizer mesh__D010073 sjn
% 219.77/220.00  |- rdf__type mesh__D010073sskos__Concept
% 219.77/220.00  |- mesh__recordMaintainer mesh__D010073 TWD
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D010073 2001
% 219.77/220.00  |- mesh__historyNote mesh__D010073
% 219.77/220.00       91%28%75%29%; was see under NITROQUINOLINES 1975-90   
% 219.77/220.00  |- mesh__dateEstablished mesh__D010073 1991-01-01
% 219.77/220.00  |- skos__historyNote mesh__D010073 Nitro Compounds %28%1973-1974%29%
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D010073 2003
% 219.77/220.00  |- skos__altLabel mesh__D010073 Oxaminiquine
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D010073 2005
% 219.77/220.00  |- mesh__recordOriginator mesh__D010073 NLM
% 219.77/220.00  |- skos__prefLabel mesh__D010073 Oxamniquine
% 219.77/220.00  |- skos__scopeNote mesh__D010073
% 219.77/220.00       An anthelmintic with schistosomicidal activity against Schistosoma mansoni, but not against other Schistosoma spp. Oxamniquine causes worms to shift from the mesenteric veins to the liver where the male worms are retained; the female worms return to the mesentery, but can no longer release eggs. %28%From Martidale, The Extra Pharmacopoeia, 31st ed, p121%29%%A%    
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D010073 2004
% 219.77/220.00  |- skos__broader mesh__D010073smesh__D009600
% 219.77/220.00  |- skos__historyNote mesh__D010073 Propylamines %28%1973-1974%29%
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D010073 2002
% 219.77/220.00  |- mesh__dateRevised mesh__D010073 2000-06-22
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D010073 2006
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004834 2001
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Disorder, Post-Traumatic Seizure
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Seizure, Early Post-Traumatic
% 219.77/220.00  |- mesh__recordMaintainer mesh__D004834 sjn
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Post-Traumatic Epilepsies
% 219.77/220.00  |- skos__scopeNote mesh__D004834
% 219.77/220.00       Recurrent seizures causally related to CRANIOCEREBRAL TRAUMA. Seizure onset may be immediate but is typically delayed for several days after the injury and may not occur for up to two years. The majority of seizures have a focal onset that correlates clinically with the site of brain injury. Cerebral cortex injuries caused by a penetrating foreign object %28%CRANIOCEREBRAL TRAUMA, PENETRATING%29% are more likely than closed head injuries %28%HEAD INJURIES, CLOSED%29% to be associated with epilepsy. Concussive convulsions are nonepileptic phenomena that occur immediately after head injury and are characterized by tonic and clonic movements. %28%From Rev Neurol 1998 Feb;26%28%150%29%:256-261; Sports Med 1998 Feb;25%28%2%29%:131-6%29%%A%    
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Post Traumatic Seizure Disorder
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Convulsion, Concussive
% 219.77/220.00  |- mesh__dateCreated mesh__D004834 1999-01-01
% 219.77/220.00  |- skos__broader mesh__D004834smesh__D004827
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Concussive Convulsions
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Epilepsies, Traumatic
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004834 2006
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Seizure, Late Post-Traumatic
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Seizure Disorder, Post Traumatic
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Seizure Disorders, Post-Traumatic
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Seizures, Late Post-Traumatic
% 219.77/220.00  |- skos__altLabel mesh__D004834 Seizure Disorder, Post-Traumatic
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Early Post Traumatic Seizures
% 219.77/220.00  |- mesh__recordOriginator mesh__D004834 NLM
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Post-Traumatic Seizures, Early
% 219.77/220.00  |- skos__broader mesh__D004834smesh__D001930
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Early Post-Traumatic Seizure
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Late Post Traumatic Seizures
% 219.77/220.00  |- mesh__publicMeSHNote mesh__D004834
% 219.77/220.00       1992; was EPILEPSY, TRAUMATIC 1963-1991   
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004834 2005
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Seizures, Early Post-Traumatic
% 219.77/220.00  |- skos__prefLabel mesh__D004834 Epilepsy, Post-Traumatic
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Traumatic Epilepsy
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Post-Traumatic Seizure Disorders
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Post-Traumatic Seizures, Late
% 219.77/220.00  |- mesh__recordAuthorizer mesh__D004834 sjn
% 219.77/220.00  |- skos__altLabel mesh__D004834 Post-Traumatic Seizure Disorder
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Epilepsies, Post-Traumatic
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Post-Traumatic Seizure, Late
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Impact Seizures
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Traumatic Epilepsies
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004834 2004
% 219.77/220.00  |- mesh__historyNote mesh__D004834
% 219.77/220.00       1992; was EPILEPSY, TRAUMATIC 1963-1991   
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Convulsions, Concussive
% 219.77/220.00  |- skos__annotation mesh__D004834
% 219.77/220.00       coord IM with specific type of epilepsy %28%IM or NIM%29%   
% 219.77/220.00  |- skos__altLabel mesh__D004834 Epilepsy, Traumatic
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Disorders, Post-Traumatic Seizure
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Post-Traumatic Epilepsy
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004834 2002
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Epilepsy, Post Traumatic
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Late Post-Traumatic Seizure
% 219.77/220.00  |- mesh__dateRevised mesh__D004834 1999-12-03
% 219.77/220.00  |- rdf__type mesh__D004834sskos__Concept
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004834 2003
% 219.77/220.00  |- skos__hiddenLabel mesh__D004834 Post-Traumatic Seizure, Early
% 219.77/220.00  |- skos__prefLabel mesh__D004036 Diet, Atherogenic
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004036 1996
% 219.77/220.00  |- mesh__dateCreated mesh__D004036 1999-01-01
% 219.77/220.00  |- skos__annotation mesh__D004036 no qualif   
% 219.77/220.00  |- skos__broader mesh__D004036smesh__D004032
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004036 1991
% 219.77/220.00  |- skos__hiddenLabel mesh__D004036 Atherogenic Diets
% 219.77/220.00  |- rdf__type mesh__D004036sskos__Concept
% 219.77/220.00  |- mesh__recordMaintainer mesh__D004036 PLS
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004036 2002
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004036 1995
% 219.77/220.00  |- skos__hiddenLabel mesh__D004036 Diets, Atherogenic
% 219.77/220.00  |- skos__related mesh__D004036smesh__D002791
% 219.77/220.00  |- mesh__recordOriginator mesh__D004036 NLM
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004036 2006
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004036 1994
% 219.77/220.00  |- skos__historyNote mesh__D004036 Diet %28%1966%29%
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004036 1993
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004036 1990
% 219.77/220.00  |- mesh__publicMeSHNote mesh__D004036 67   
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004036 2005
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004036 2004
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004036 2001
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004036 1999
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004036 1992
% 219.77/220.00  |- mesh__dateEstablished mesh__D004036 1967-01-01
% 219.77/220.00  |- skos__hiddenLabel mesh__D004036 Atherogenic Diet
% 219.77/220.00  |- mesh__historyNote mesh__D004036 67   
% 219.77/220.00  |- skos__historyNote mesh__D004036 Arteriosclerosis %28%1966%29%
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004036 2003
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004036 1998
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004036 1997
% 219.77/220.00  |- mesh__recordAuthorizer mesh__D004036 PLS
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D004036 2000
% 219.77/220.00  |- mesh__dateRevised mesh__D004036 1989-10-06
% 219.77/220.00  |- skos__hiddenLabel mesh__D014464 Ultrasonic Therapies
% 219.77/220.00  |- mesh__dateRevised mesh__D014464 2005-06-30
% 219.77/220.00  |- skos__altLabel mesh__D014464 Therapy, Ultrasonic
% 219.77/220.00  |- rdf__type mesh__D014464sskos__Concept
% 219.77/220.00  |- skos__prefLabel mesh__D014464 Ultrasonic Therapy
% 219.77/220.00  |- mesh__dateCreated mesh__D014464 1999-01-01
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D014464 2006
% 219.77/220.00  |- mesh__recordMaintainer mesh__D014464 lkt
% 219.77/220.00  |- skos__broader mesh__D014464smesh__D003972
% 219.77/220.00  |- skos__annotation mesh__D014464
% 219.77/220.00       do not use /util except by MeSH definition; coord with dis /ther, not dis /radiother%A%  
% 219.77/220.00  |- skos__hiddenLabel mesh__D014464 Therapies, Ultrasonic
% 219.77/220.00  |- mesh__recordOriginator mesh__D014464 NLM
% 219.77/220.00  |- skos__scopeNote mesh__D014464
% 219.77/220.00       The use of focused, high-frequency sound waves to produce local hyperthermia in certain diseased or injured parts of the body or to destroy the diseased tissue.%A%    
% 219.77/220.00  |- mesh__recordAuthorizer mesh__D014464 sjn
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D008427 2003
% 219.77/220.00  |- mesh__recordOriginator mesh__D008427 NLM
% 219.77/220.00  |- mesh__dateCreated mesh__D008427 1999-01-01
% 219.77/220.00  |- skos__annotation mesh__D008427
% 219.77/220.00       specify geog; check also tags HUMAN; FEMALE %26% PREGNANCY; DF: MATERNAL HEALTH SERV%A%  
% 219.77/220.00  |- mesh__publicMeSHNote mesh__D008427 68   
% 219.77/220.00  |- skos__scopeNote mesh__D008427
% 219.77/220.00       Organized services to provide health care to expectant and nursing mothers.%A%    
% 219.77/220.00  |- skos__broader mesh__D008427smesh__D034121
% 219.77/220.00  |- skos__altLabel mesh__D008427 Services, Maternal Health
% 219.77/220.00  |- skos__altLabel mesh__D008427 Health Services, Maternal
% 219.77/220.00  |- skos__hiddenLabel mesh__D008427 Maternal Health Service
% 219.77/220.00  |- skos__hiddenLabel mesh__D008427 Service, Maternal Health
% 219.77/220.00  |- skos__prefLabel mesh__D008427 Maternal Health Services
% 219.77/220.00  |- skos__historyNote mesh__D008427 Prenatal Care %28%1966-1967%29%
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D008427 2006
% 219.77/220.00  |- skos__broader mesh__D008427smesh__D003153
% 219.77/220.00  |- skos__historyNote mesh__D008427 Maternal Welfare %28%1966-1967%29%
% 219.77/220.00  |- mesh__recordMaintainer mesh__D008427 lkt
% 219.77/220.00  |- mesh__dateRevised mesh__D008427 2002-07-03
% 219.77/220.00  |- mesh__recordAuthorizer mesh__D008427 sjn
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D008427 2004
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D008427 2005
% 219.77/220.00  |- rdf__type mesh__D008427sskos__Concept
% 219.77/220.00  |- skos__hiddenLabel mesh__D008427 Health Service, Maternal
% 219.77/220.00  |- mesh__historyNote mesh__D008427 68   
% 219.77/220.00  |- mesh__dateEstablished mesh__D008427 1968-01-01
% 219.77/220.00  |- skos__historyNote mesh__D000444
% 219.77/220.00       Aldehyde Oxidoreductases %28%1980-1984%29%
% 219.77/220.00  |- skos__scopeNote mesh__D000444
% 219.77/220.00       An enzyme that oxidizes an aldehyde in the presence of NAD+ and water to an acid and NADH. EC 1.2.1.3. Before 1978, it was classified as EC 1.1.1.70.%A%    
% 219.77/220.00  |- skos__hiddenLabel mesh__D000444 Aldehyde NAD Oxidoreductase
% 219.77/220.00  |- mesh__recordMaintainer mesh__D000444 jmp
% 219.77/220.00  |- skos__hiddenLabel mesh__D000444 Dehydrogenase E2, Aldehyde
% 219.77/220.00  |- skos__prefLabel mesh__D000444 Aldehyde Dehydrogenase
% 219.77/220.00  |- mesh__dateRevised mesh__D000444 2005-06-30
% 219.77/220.00  |- rdf__type mesh__D000444sskos__Concept
% 219.77/220.00  |- skos__hiddenLabel mesh__D000444 Dehydrogenase, D-Glucuronolactone
% 219.77/220.00  |- mesh__recordOriginator mesh__D000444 RLS
% 219.77/220.00  |- skos__hiddenLabel mesh__D000444 Dehydrogenase E1, Aldehyde
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D000444 2006
% 219.77/220.00  |- skos__hiddenLabel mesh__D000444 E2, Aldehyde Dehydrogenase
% 219.77/220.00  |- skos__historyNote mesh__D000444
% 219.77/220.00       Alcohol Oxidoreductases %28%1974-1979%29%
% 219.77/220.00  |- skos__hiddenLabel mesh__D000444 D Glucuronolactone Dehydrogenase
% 219.77/220.00  |- skos__hiddenLabel mesh__D000444 Oxidoreductase, Aldehyde-NAD
% 219.77/220.00  |- skos__broader mesh__D000444smesh__D000445
% 219.77/220.00  |- skos__hiddenLabel mesh__D000444 E1, Aldehyde Dehydrogenase
% 219.77/220.00  |- skos__altLabel mesh__D000444 Aldehyde-NAD Oxidoreductase
% 219.77/220.00  |- skos__hiddenLabel mesh__D000444 Dehydrogenase, Aldehyde
% 219.77/220.00  |- mesh__dateCreated mesh__D000444 1984-04-11
% 219.77/220.00  |- mesh__recordAuthorizer mesh__D000444 sjn
% 219.77/220.00  |- mesh__publicMeSHNote mesh__D000444 85   
% 219.77/220.00  |- mesh__historyNote mesh__D000444 85   
% 219.77/220.00  |- mesh__dateEstablished mesh__D000444 1985-01-01
% 219.77/220.00  |- skos__broader mesh__D004364Q000331smesh__D004364
% 219.77/220.00  |- mesh__preferredCombination mesh__D004364Q000331smesh__D007880
% 219.77/220.00  |- rdf__type mesh__D004364Q000331smesh__CompoundConcept
% 219.77/220.00  |- skos__annotation mesh__D018855
% 219.77/220.00       a type of organized health-care financing   
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D018855 1998
% 219.77/220.00  |- mesh__dateEstablished mesh__D018855 1996-01-01
% 219.77/220.00  |- skos__broader mesh__D018855smesh__D005381
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D018855 2004
% 219.77/220.00  |- skos__hiddenLabel mesh__D018855 Single-Payer Systems
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D018855 2000
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D018855 2006
% 219.77/220.00  |- skos__scopeNote mesh__D018855
% 219.77/220.00       An approach to health care financing with only one source of money for paying health care providers. The scope may be national %28%the Canadian System%29%, state-wide, or community-based. The payer may be a governmental unit or other entity such as an insurance company. The proposed advantages include administrative simplicity for patients and providers, and resulting significant savings in overhead costs. %28%From Slee and Slee, Health Care Reform Terms, 1993, p106%29%%A%    
% 219.77/220.00  |- skos__hiddenLabel mesh__D018855 System, Single-Payer
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D018855 2003
% 219.77/220.00  |- skos__historyNote mesh__D018855 Insurance, Health %28%1992-1995%29%
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D018855 2005
% 219.77/220.00  |- skos__hiddenLabel mesh__D018855 Plans, Single-Payer
% 219.77/220.00  |- mesh__dateCreated mesh__D018855 1995-06-05
% 219.77/220.00  |- skos__broader mesh__D018855smesh__D009313
% 219.77/220.00  |- rdf__type mesh__D018855sskos__Concept
% 219.77/220.00  |- skos__broader mesh__D018855smesh__D007348
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D018855 2002
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D018855 1997
% 219.77/220.00  |- mesh__historyNote mesh__D018855 96   
% 219.77/220.00  |- skos__hiddenLabel mesh__D018855 Single Payer Plan
% 219.77/220.00  |- skos__hiddenLabel mesh__D018855 Single-Payer Plans
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D018855 1999
% 219.77/220.00  |- skos__hiddenLabel mesh__D018855 Plan, Single-Payer
% 219.77/220.00  |- skos__hiddenLabel mesh__D018855 Systems, Single-Payer
% 219.77/220.00  |- skos__hiddenLabel mesh__D018855 Single Payer System
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D018855 2001
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D018855 1996
% 219.77/220.00  |- skos__prefLabel mesh__D018855 Single-Payer System
% 219.77/220.00  |- mesh__publicMeSHNote mesh__D018855 96   
% 219.77/220.00  |- skos__prefLabel mesh__D010872 Pinnipedia
% 219.77/220.00  |- mesh__activeMeSHYear mesh__D010872 2005
% 219.77/220.00  |- mesh__recordMaintainer mesh__D010872 ags
% 219.77/220.00  |- skos__altLabel mesh__D010872 Pinnipeds
% 219.77/220.00  |- mesh__recordAuthorizer mesh__D010872 sjn
% 219.77/220.00  |- skos__historyNote mesh__D010872 Carnivora %28%1966-1967%29%
% 219.86/220.00  |- mesh__dateRevised mesh__D010872 2004-07-07
% 219.86/220.00  |- rdf__type mesh__D010872sskos__Concept
% 219.86/220.00  |- mesh__historyNote mesh__D010872 68   
% 219.86/220.00  |- skos__annotation mesh__D010872 GEN or unspecified; prefer specifics   
% 219.86/220.00  |- mesh__publicMeSHNote mesh__D010872 68   
% 219.86/220.00  |- skos__hiddenLabel mesh__D010872 Pinniped
% 219.86/220.00  |- mesh__dateCreated mesh__D010872 1999-01-01
% 219.86/220.00  |- skos__broader mesh__D010872smesh__D002335
% 219.86/220.00  |- mesh__dateEstablished mesh__D010872 1968-01-01
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D010872 2006
% 219.86/220.00  |- skos__scopeNote mesh__D010872
% 219.86/220.00       The suborder of aquatic CARNIVORA comprising the WALRUSES; FUR SEALS; SEA LIONS; and EARLESS SEALS. They have fusiform bodies with very short tails and are found on all sea coasts. The offspring are born on land.%A%    
% 219.86/220.00  |- mesh__recordOriginator mesh__D010872 NLM
% 219.86/220.00  |- mesh__dateRevised mesh__D018057 2005-06-30
% 219.86/220.00  |- mesh__historyNote mesh__D018057 94   
% 219.86/220.00  |- skos__hiddenLabel mesh__D018057 Wastes, Dental
% 219.86/220.00  |- skos__prefLabel mesh__D018057 Dental Waste
% 219.86/220.00  |- mesh__dateCreated mesh__D018057 1993-06-04
% 219.86/220.00  |- skos__broader mesh__D018057smesh__D008506
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D018057 2006
% 219.86/220.00  |- mesh__recordAuthorizer mesh__D018057 sjn
% 219.86/220.00  |- mesh__recordMaintainer mesh__D018057 ssb
% 219.86/220.00  |- skos__scopeNote mesh__D018057
% 219.86/220.00       Any waste product generated by a dental office, surgery, clinic, or laboratory including amalgams, saliva, and rinse water.%A%    
% 219.86/220.00  |- rdf__type mesh__D018057sskos__Concept
% 219.86/220.00  |- skos__hiddenLabel mesh__D018057 Dental Wastes
% 219.86/220.00  |- mesh__recordOriginator mesh__D018057 JLS
% 219.86/220.00  |- skos__altLabel mesh__D018057 Waste, Dental
% 219.86/220.00  |- mesh__publicMeSHNote mesh__D018057 94   
% 219.86/220.00  |- skos__historyNote mesh__D018057 Waste Products %28%1976-1993%29%
% 219.86/220.00  |- mesh__dateEstablished mesh__D018057 1994-01-01
% 219.86/220.00  |- skos__annotation mesh__D018057
% 219.86/220.00       includes saliva, rinse, amalgams, etc.; disposal of dent waste: coord IM with MEDICAL WASTE DISPOSAL %28%IM%29%%A%  
% 219.86/220.00  |- skos__hiddenLabel mesh__D010074 SC 11585
% 219.86/220.00  |- mesh__onlineNote mesh__D010074
% 219.86/220.00       use OXANDROLONE to search ANAVAR 1966-93   
% 219.86/220.00  |- skos__scopeNote mesh__D010074
% 219.86/220.00       A synthetic hormone with anabolic and androgenic properties.%A%    
% 219.86/220.00  |- rdf__type mesh__D010074sskos__Concept
% 219.86/220.00  |- skos__hiddenLabel mesh__D010074 SC11585
% 219.86/220.00  |- mesh__recordMaintainer mesh__D010074 lkt
% 219.86/220.00  |- mesh__dateRevised mesh__D010074 2003-07-09
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D010074 2005
% 219.86/220.00  |- mesh__recordAuthorizer mesh__D010074 sjn
% 219.86/220.00  |- skos__prefLabel mesh__D010074 Oxandrolone
% 219.86/220.00  |- skos__broader mesh__D010074smesh__D000732
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D010074 2004
% 219.86/220.00  |- mesh__publicMeSHNote mesh__D010074
% 219.86/220.00       65; ANAVAR was see OXANDROLONE 1965-93   
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D010074 2006
% 219.86/220.00  |- mesh__historyNote mesh__D010074
% 219.86/220.00       65%28%64%29%; ANAVAR was see OXANDROLONE 1965-93   
% 219.86/220.00  |- mesh__dateCreated mesh__D010074 1999-01-01
% 219.86/220.00  |- mesh__dateEstablished mesh__D010074 1965-01-01
% 219.86/220.00  |- mesh__recordOriginator mesh__D010074 NLM
% 219.86/220.00  |- mesh__dateRevised mesh__D004037 1989-04-28
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D004037 1995
% 219.86/220.00  |- mesh__historyNote mesh__D004037 73%28%72%29%   
% 219.86/220.00  |- mesh__recordAuthorizer mesh__D004037 PLS
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D004037 2000
% 219.86/220.00  |- skos__historyNote mesh__D004037 Diet %28%1966-1971%29%
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D004037 2006
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D004037 1993
% 219.86/220.00  |- skos__hiddenLabel mesh__D004037 Diets, Cariogenic
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D004037 1994
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D004037 1991
% 219.86/220.00  |- skos__prefLabel mesh__D004037 Diet, Cariogenic
% 219.86/220.00  |- mesh__publicMeSHNote mesh__D004037 73   
% 219.86/220.00  |- skos__broader mesh__D004037smesh__D004032
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D004037 2004
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D004037 2005
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D004037 1999
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D004037 2002
% 219.86/220.00  |- skos__hiddenLabel mesh__D004037 Cariogenic Diet
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D004037 1992
% 219.86/220.00  |- skos__hiddenLabel mesh__D004037 Cariogenic Diets
% 219.86/220.00  |- mesh__recordMaintainer mesh__D004037 TGC
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D004037 2003
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D004037 1997
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D004037 1998
% 219.86/220.00  |- skos__historyNote mesh__D004037 Dental Caries %28%1966-1971%29%
% 219.86/220.00  |- mesh__recordOriginator mesh__D004037 NLM
% 219.86/220.00  |- mesh__dateEstablished mesh__D004037 1973-01-01
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D004037 1990
% 219.86/220.00  |- mesh__dateCreated mesh__D004037 1999-01-01
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D004037 1996
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D004037 2001
% 219.86/220.00  |- skos__annotation mesh__D004037 no qualif   
% 219.86/220.00  |- rdf__type mesh__D004037sskos__Concept
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D009520 2004
% 219.86/220.00  |- mesh__recordAuthorizer mesh__D009520 jls
% 219.86/220.00  |- rdf__type mesh__D009520sskos__Concept
% 219.86/220.00  |- skos__prefLabel mesh__D009520 New Zealand
% 219.86/220.00  |- mesh__recordMaintainer mesh__D009520 jls
% 219.86/220.00  |- skos__scopeNote mesh__D009520
% 219.86/220.00       A group of islands in the southwest Pacific. Its capital is Wellington. It was discovered by the Dutch explorer Abel Tasman in 1642 and circumnavigated by Cook in 1769. Colonized in 1840 by the New Zealand Company, it became a British crown colony in 1840 until 1907 when colonial status was terminated. New Zealand is a partly anglicized form of the original Dutch name Nieuw Zeeland, new sea land, possibly with reference to the Dutch province of Zeeland. %28%From Webster%27%s New Geographical Dictionary, 1988, p842 %26% Room, Brewer%27%s Dictionary of Names, 1992, p378%29%%A%    
% 219.86/220.00  |- mesh__recordOriginator mesh__D009520 NLM
% 219.86/220.00  |- skos__broader mesh__D009520smesh__D010139
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D009520 2005A
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D009520 2006
% 219.86/220.00  |- mesh__dateCreated mesh__D009520 1999-01-01
% 219.86/220.00  |- skos__annotation mesh__D009520
% 219.86/220.00       Maori are Polynesians native to New Zealand; Australasia refers to Australia, New Zealand or both: check text%A%  
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D009520 2006A
% 219.86/220.00  |- mesh__dateRevised mesh__D009520 2005-09-28
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D009520 2005
% 219.86/220.00  |- skos__broader mesh__D009520smesh__D044362
% 219.86/220.00  |- skos__prefLabel mesh__D014465 Ultrasonics
% 219.86/220.00  |- mesh__dateCreated mesh__D014465 1999-01-01
% 219.86/220.00  |- mesh__dateRevised mesh__D014465 2004-07-07
% 219.86/220.00  |- mesh__recordAuthorizer mesh__D014465 sjn
% 219.86/220.00  |- rdf__type mesh__D014465sskos__Concept
% 219.86/220.00  |- skos__scopeNote mesh__D014465
% 219.86/220.00       A subfield of acoustics dealing in the radio frequency range higher than SOUND waves %28%beyond 20 kilohertz%29%, but usually restricted to frequencies above 500,000 Hertz. Ultrasonic radiation is used therapeutically %28%DIATHERMY and ULTRASONIC THERAPY%29% to generate HEAT and to selectively destroy tissues.  It is also used in diagnostics, for example, ULTRASONOGRAPHY; ECHOENCEPHALOGRAPHY; and ECHOCARDIOGRAPHY, to visually display echoes received from irradiated tissues.%A%    
% 219.86/220.00  |- mesh__recordOriginator mesh__D014465 NLM
% 219.86/220.00  |- skos__broader mesh__D014465smesh__D000162
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D014465 2005
% 219.86/220.00  |- skos__hiddenLabel mesh__D014465 Ultrasonic
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D014465 2006
% 219.86/220.00  |- skos__annotation mesh__D014465
% 219.86/220.00       /adv eff permitted but consider also ULTRASONOGRAPHY /adv eff %26% ULTRASONIC THERAPY /adv eff; ultrasonic or sonographic imaging of organs is organ /ultrasonogr%A%  
% 219.86/220.00  |- skos__altLabel mesh__D014465 Shockwaves, Ultrasonic
% 219.86/220.00  |- skos__hiddenLabel mesh__D014465 Ultrasound, Doppler
% 219.86/220.00  |- mesh__recordMaintainer mesh__D014465 nns
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D008428 2002
% 219.86/220.00  |- skos__broader mesh__D008428smesh__D009026
% 219.86/220.00  |- mesh__dateRevised mesh__D008428 1999-11-03
% 219.86/220.00  |- mesh__recordAuthorizer mesh__D008428 sjn
% 219.86/220.00  |- skos__prefLabel mesh__D008428 Maternal Mortality
% 219.86/220.00  |- mesh__activeMeSHYear mesh__D008428 2006
% 219.86/220.01  |- skos__altLabel mesh__D008428 Mortality, Maternal
% 219.86/220.01  |- mesh__recordMaintainer mesh__D008428 kle
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D008428 2004
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D008428 2005
% 219.86/220.01  |- mesh__recordOriginator mesh__D008428 NLM
% 219.86/220.01  |- skos__hiddenLabel mesh__D008428 Maternal Mortalities
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D008428 2001
% 219.86/220.01  |- rdf__type mesh__D008428sskos__Concept
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D008428 2003
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D008428 2000
% 219.86/220.01  |- skos__annotation mesh__D008428
% 219.86/220.01       a largely statistical concept, not for individual maternal deaths; IM GEN only; coord NIM with disease /mortal %28%IM%29%; specify geog if pertinent%A%  
% 219.86/220.01  |- skos__scopeNote mesh__D008428
% 219.86/220.01       Maternal deaths resulting from complications of pregnancy and childbirth in a given population.%A%    
% 219.86/220.01  |- mesh__dateCreated mesh__D008428 1999-01-01
% 219.86/220.01  |- skos__hiddenLabel mesh__D008428 Mortalities, Maternal
% 219.86/220.01  |- rdf__type mesh__D000445sskos__Concept
% 219.86/220.01  |- mesh__recordMaintainer mesh__D000445 jmp
% 219.86/220.01  |- mesh__recordAuthorizer mesh__D000445 sjn
% 219.86/220.01  |- skos__prefLabel mesh__D000445 Aldehyde Oxidoreductases
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D000445 2006
% 219.86/220.01  |- skos__broader mesh__D000445smesh__D050837
% 219.86/220.01  |- mesh__dateEstablished mesh__D000445 1973-01-01
% 219.86/220.01  |- skos__historyNote mesh__D000445 Oxidoreductases %28%1966-1972%29%
% 219.86/220.01  |- mesh__dateCreated mesh__D000445 1999-01-01
% 219.86/220.01  |- skos__hiddenLabel mesh__D000445 Oxidoreductases, Aldehyde
% 219.86/220.01  |- skos__scopeNote mesh__D000445
% 219.86/220.01       Oxidoreductases that are specific for ALDEHYDES.     
% 219.86/220.01  |- mesh__dateRevised mesh__D000445 2005-06-30
% 219.86/220.01  |- mesh__publicMeSHNote mesh__D000445 73   
% 219.86/220.01  |- mesh__historyNote mesh__D000445 73   
% 219.86/220.01  |- mesh__recordOriginator mesh__D000445 NLM
% 219.86/220.01  |- skos__hiddenLabel mesh__D019150 Seitelbergers Disease
% 219.86/220.01  |- skos__hiddenLabel mesh__D019150 Juvenile Neuroaxonal Dystrophies
% 219.86/220.01  |- skos__altLabel mesh__D019150 Seitelberger%27%s Disease
% 219.86/220.01  |- skos__broader mesh__D019150smesh__D001927
% 219.86/220.01  |- skos__prefLabel mesh__D019150 Neuroaxonal Dystrophies
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D019150 2001
% 219.86/220.01  |- mesh__recordOriginator mesh__D019150 RAZ
% 219.86/220.01  |- skos__hiddenLabel mesh__D019150 Dystrophies, Juvenile Neuroaxonal
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D019150 2006
% 219.86/220.01  |- skos__hiddenLabel mesh__D019150 Neuroaxonal Dystrophy
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D019150 2000
% 219.86/220.01  |- rdf__type mesh__D019150sskos__Concept
% 219.86/220.01  |- skos__hiddenLabel mesh__D019150 Infantile Neuroaxonal Dystrophies
% 219.86/220.01  |- skos__hiddenLabel mesh__D019150 Dystrophy, Juvenile Neuroaxonal
% 219.86/220.01  |- mesh__recordAuthorizer mesh__D019150 ags
% 219.86/220.01  |- skos__hiddenLabel mesh__D019150 Neuroaxonal Dystrophies, Adult
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D019150 2005
% 219.86/220.01  |- skos__hiddenLabel mesh__D019150 Dystrophy, Infantile Neuroaxonal
% 219.86/220.01  |- skos__hiddenLabel mesh__D019150 Adult Neuroaxonal Dystrophies
% 219.86/220.01  |- mesh__dateRevised mesh__D019150 1999-12-13
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D019150 2004
% 219.86/220.01  |- skos__hiddenLabel mesh__D019150 Neuroaxonal Dystrophies, Juvenile
% 219.86/220.01  |- skos__hiddenLabel mesh__D019150 Dystrophy, Neuroaxonal
% 219.86/220.01  |- mesh__recordMaintainer mesh__D019150 ags
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D019150 2000A
% 219.86/220.01  |- skos__altLabel mesh__D019150 Neuroaxonal Dystrophy, Adult
% 219.86/220.01  |- skos__scopeNote mesh__D019150
% 219.86/220.01       A nonspecific term referring both to the pathologic finding of swelling of distal portions of axons in the brain and to disorders which feature this finding. Neuroaxonal dystrophy is seen in various genetic diseases, vitamin deficiencies, and aging. Infantile neuroaxonal dystrophy is an autosomal recessive disease characterized by arrested psychomotor development at 6 months to 2 years of age, ataxia, brain stem dysfunction, and quadriparesis. Juvenile and adult forms also occur. Pathologic findings include brain atrophy and widespread accumulation of axonal spheroids throughout the neuroaxis, peripheral nerves, and dental pulp. %28%From Davis %26% Robertson, Textbook of Neuropathology, 2nd ed, p927%29%%A%    
% 219.86/220.01  |- skos__hiddenLabel mesh__D019150 Disease, Seitelberger%27%s
% 219.86/220.01  |- mesh__dateEstablished mesh__D019150 1997-01-01
% 219.86/220.01  |- skos__hiddenLabel mesh__D019150 Dystrophies, Infantile Neuroaxonal
% 219.86/220.01  |- skos__hiddenLabel mesh__D019150 Dystrophies, Neuroaxonal
% 219.86/220.01  |- skos__altLabel mesh__D019150 Neuroaxonal Dystrophy, Infantile
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D019150 2003
% 219.86/220.01  |- skos__hiddenLabel mesh__D019150 Dystrophies, Adult Neuroaxonal
% 219.86/220.01  |- skos__hiddenLabel mesh__D019150 Dystrophy, Adult Neuroaxonal
% 219.86/220.01  |- mesh__dateCreated mesh__D019150 1996-06-10
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D019150 2002
% 219.86/220.01  |- mesh__publicMeSHNote mesh__D019150 1997   
% 219.86/220.01  |- skos__hiddenLabel mesh__D019150 Seitelberger Disease
% 219.86/220.01  |- skos__altLabel mesh__D019150 Neuroaxonal Dystrophy, Late Infantile
% 219.86/220.01  |- mesh__historyNote mesh__D019150 1997   
% 219.86/220.01  |- skos__hiddenLabel mesh__D019150 Neuroaxonal Dystrophies, Infantile
% 219.86/220.01  |- skos__altLabel mesh__D019150 Neuroaxonal Dystrophy, Juvenile
% 219.86/220.01  |- skos__historyNote mesh__D005130 Hemorrhage %28%1966-1986%29%
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D005130 2005
% 219.86/220.01  |- skos__broader mesh__D005130smesh__D006470
% 219.86/220.01  |- skos__historyNote mesh__D005130 Eye Diseases %28%1966-1986%29%
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D005130 2004
% 219.86/220.01  |- skos__historyNote mesh__D005130 Eye or specifics %28%1966-1986%29%
% 219.86/220.01  |- mesh__recordAuthorizer mesh__D005130 sjn
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D005130 2002
% 219.86/220.01  |- rdf__type mesh__D005130sskos__Concept
% 219.86/220.01  |- skos__scopeNote mesh__D005130
% 219.86/220.01       Intraocular hemorrhage from the vessels of various tissues of the eye.%A%    
% 219.86/220.01  |- skos__altLabel mesh__D005130 Hemophthalmos
% 219.86/220.01  |- mesh__recordOriginator mesh__D005130 RC
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D005130 2003
% 219.86/220.01  |- skos__altLabel mesh__D005130 Hemorrhage, Eye
% 219.86/220.01  |- skos__annotation mesh__D005130
% 219.86/220.01       GEN or unspecified; hemorrh of eye tissue: do not confuse with RETROBULBAR HEMORRHAGE, hemorrh within the orbital cavity behind the eyeball; CHOROIDAL HEMORRHAGE; HYPHEMA; RETINAL HEMORRHAGE %26% VITREOUS HEMORRHAGE are also available%A%  
% 219.86/220.01  |- mesh__dateCreated mesh__D005130 1986-04-08
% 219.86/220.01  |- mesh__dateEstablished mesh__D005130 1987-01-01
% 219.86/220.01  |- mesh__historyNote mesh__D005130 87   
% 219.86/220.01  |- skos__hiddenLabel mesh__D005130 Eye Hemorrhages
% 219.86/220.01  |- mesh__publicMeSHNote mesh__D005130 87   
% 219.86/220.01  |- mesh__dateRevised mesh__D005130 2001-07-25
% 219.86/220.01  |- skos__prefLabel mesh__D005130 Eye Hemorrhage
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D005130 2006
% 219.86/220.01  |- skos__broader mesh__D005130smesh__D005128
% 219.86/220.01  |- mesh__recordMaintainer mesh__D005130 mdb
% 219.86/220.01  |- skos__broader mesh__D005130smesh__D005132
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018856 2006
% 219.86/220.01  |- skos__hiddenLabel mesh__D018856 Cystitides, Interstitial
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018856 2003
% 219.86/220.01  |- skos__altLabel mesh__D018856 Interstitial Cystitis
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018856 2001
% 219.86/220.01  |- skos__prefLabel mesh__D018856 Cystitis, Interstitial
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018856 2005
% 219.86/220.01  |- mesh__publicMeSHNote mesh__D018856 96   
% 219.86/220.01  |- mesh__dateEstablished mesh__D018856 1996-01-01
% 219.86/220.01  |- skos__hiddenLabel mesh__D018856 Interstitial Cystitides
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018856 2000
% 219.86/220.01  |- mesh__dateCreated mesh__D018856 1994-12-27
% 219.86/220.01  |- rdf__type mesh__D018856sskos__Concept
% 219.86/220.01  |- skos__hiddenLabel mesh__D018856 Chronic Interstitial Cystitides
% 219.86/220.01  |- skos__hiddenLabel mesh__D018856 Cystitides, Chronic Interstitial
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018856 1997
% 219.86/220.01  |- mesh__historyNote mesh__D018856 96   
% 219.86/220.01  |- skos__scopeNote mesh__D018856
% 219.86/220.01       A condition of the bladder occurring predominantly in women, with an inflammatory lesion, usually in the vertex, and involving the entire thickness of the wall, appearing as a small patch of brownish red mucosa, surrounded by a network of radiating vessels. The lesions, known as Fenwick-Hunner or Hunner ulcers, may heal superficially, and are notoriously difficult to detect. Typically, there is urinary frequency and pain on bladder filling and at the end of micturition. It is also called chronic interstitial cystitis. %28%Dorland, 27th ed%29%%A%    
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018856 1999
% 219.86/220.01  |- skos__annotation mesh__D018856
% 219.86/220.01       note X ref: usually chronic so do not coord with CHRONIC DISEASE%A%  
% 219.86/220.01  |- skos__broader mesh__D018856smesh__D003556
% 219.86/220.01  |- skos__hiddenLabel mesh__D018856 Interstitial Cystitis, Chronic
% 219.86/220.01  |- skos__hiddenLabel mesh__D018856 Interstitial Cystitides, Chronic
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018856 1996
% 219.86/220.01  |- skos__historyNote mesh__D018856 Cystitis %28%1966-1995%29%
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018856 1998
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018856 2004
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018856 2002
% 219.86/220.01  |- skos__hiddenLabel mesh__D018856 Chronic Interstitial Cystitis
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010873 2003
% 219.86/220.01  |- mesh__publicMeSHNote mesh__D010873 66   
% 219.86/220.01  |- rdf__type mesh__D010873sskos__Concept
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010873 2001
% 219.86/220.01  |- mesh__recordOriginator mesh__D010873 NLM
% 219.86/220.01  |- mesh__recordAuthorizer mesh__D010873 PLS
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010873 2000
% 219.86/220.01  |- mesh__dateEstablished mesh__D010873 1966-01-01
% 219.86/220.01  |- mesh__historyNote mesh__D010873 66%28%64%29%   
% 219.86/220.01  |- skos__hiddenLabel mesh__D010873 Pinocytoses
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010873 1995
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010873 1993
% 219.86/220.01  |- mesh__dateCreated mesh__D010873 1999-01-01
% 219.86/220.01  |- skos__prefLabel mesh__D010873 Pinocytosis
% 219.86/220.01  |- skos__broader mesh__D010873smesh__D004705
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010873 1999
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010873 1994
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010873 2006
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010873 2002
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010873 1997
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010873 2004
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010873 1998
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010873 2005
% 219.86/220.01  |- mesh__dateRevised mesh__D010873 1992-05-18
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010873 1996
% 219.86/220.01  |- skos__scopeNote mesh__D010873
% 219.86/220.01       The engulfing of liquids by cells by a process of invagination and closure of the cell membrane to form fluid-filled vacuoles.%A%    
% 219.86/220.01  |- mesh__recordMaintainer mesh__D010873 TAP
% 219.86/220.01  |- mesh__publicMeSHNote mesh__D018058 94   
% 219.86/220.01  |- mesh__historyNote mesh__D018058 94   
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018058 2000
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018058 1997
% 219.86/220.01  |- mesh__dateEstablished mesh__D018058 1994-01-01
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018058 2001
% 219.86/220.01  |- skos__altLabel mesh__D018058 Tympanic Membrane Rupture
% 219.86/220.01  |- skos__hiddenLabel mesh__D018058 Tympanic Membrane Ruptures
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018058 1998
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018058 2006
% 219.86/220.01  |- skos__prefLabel mesh__D018058 Tympanic Membrane Perforation
% 219.86/220.01  |- skos__hiddenLabel mesh__D018058 Perforations, Tympanic Membrane
% 219.86/220.01  |- skos__hiddenLabel mesh__D018058 Membrane Ruptures, Tympanic
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018058 2002
% 219.86/220.01  |- skos__hiddenLabel mesh__D018058 Ruptures, Tympanic Membrane
% 219.86/220.01  |- skos__broader mesh__D018058smesh__D004427
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018058 1999
% 219.86/220.01  |- skos__broader mesh__D018058smesh__D014947
% 219.86/220.01  |- rdf__type mesh__D018058sskos__Concept
% 219.86/220.01  |- skos__scopeNote mesh__D018058
% 219.86/220.01       An opening in the tympanic membrane usually caused by trauma. There are four general categories: compression injuries %28%the most common and usually the result of a blow to the ear%29%; instrumentation injuries %28%the second most common, usually inadvertent, caused often by cotton swabs or bobby-pins%29%; burn-slag injuries %28%frequently seen in industry, from hot metal from machines or welding%29%; and blast injuries %28%usually seen during war or as a result of terrorist bombing%29%. In the absence of infection, most traumatic tympanic membrane perforations heal spontaneously. Persistent perforation is usually a manifestation of tubotympanitis, an inflammation of the eustachian tube and tympanic cavity %28%middle ear%29%. %28%From Paparella, Shumrick, Gluckman, and Meyerhoff: Otolaryngology, vol. II, 3d ed, pp1363-65%29%%A%    
% 219.86/220.01  |- mesh__recordMaintainer mesh__D018058 TAP
% 219.86/220.01  |- skos__hiddenLabel mesh__D018058 Rupture, Tympanic Membrane
% 219.86/220.01  |- skos__historyNote mesh__D018058
% 219.86/220.01       Tympanic Membrane/injuries %28%1966-1993%29%
% 219.86/220.01  |- skos__hiddenLabel mesh__D018058 Perforation, Tympanic Membrane
% 219.86/220.01  |- skos__annotation mesh__D018058 perf of eardrum; usually traumatic   
% 219.86/220.01  |- skos__hiddenLabel mesh__D018058 Membrane Rupture, Tympanic
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018058 2003
% 219.86/220.01  |- mesh__recordOriginator mesh__D018058 TGC
% 219.86/220.01  |- skos__hiddenLabel mesh__D018058 Tympanic Membrane Perforations
% 219.86/220.01  |- mesh__dateCreated mesh__D018058 1993-06-03
% 219.86/220.01  |- skos__hiddenLabel mesh__D018058 Membrane Perforations, Tympanic
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018058 1996
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018058 2004
% 219.86/220.01  |- skos__hiddenLabel mesh__D018058 Membrane Perforation, Tympanic
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D018058 2005
% 219.86/220.01  |- mesh__dateRevised mesh__D018058 1995-06-08
% 219.86/220.01  |- mesh__recordAuthorizer mesh__D018058 PLS
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010075 2003
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010075 2001
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010075 2005
% 219.86/220.01  |- mesh__recordMaintainer mesh__D010075 TAP
% 219.86/220.01  |- mesh__dateEstablished mesh__D010075 1991-01-01
% 219.86/220.01  |- mesh__publicMeSHNote mesh__D010075
% 219.86/220.01       91; was see under HETEROCYCLIC COMPOUNDS 1971-90   
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010075 2004
% 219.86/220.01  |- mesh__recordOriginator mesh__D010075 NLM
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010075 2006
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010075 1996
% 219.86/220.01  |- mesh__historyNote mesh__D010075
% 219.86/220.01       91%28%71%29%; was see under HETEROCYCLIC COMPOUNDS 1971-90   
% 219.86/220.01  |- mesh__dateCreated mesh__D010075 1999-01-01
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010075 1998
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010075 2002
% 219.86/220.01  |- mesh__recordAuthorizer mesh__D010075 PLS
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010075 1997
% 219.86/220.01  |- skos__altLabel mesh__D010075 Oxathins
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010075 1994
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010075 1999
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010075 1993
% 219.86/220.01  |- rdf__type mesh__D010075sskos__Concept
% 219.86/220.01  |- skos__broader mesh__D010075smesh__D006573
% 219.86/220.01  |- skos__historyNote mesh__D010075 Heterocyclic Compounds %28%1966-1970%29%
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010075 1995
% 219.86/220.01  |- skos__prefLabel mesh__D010075 Oxathiins
% 219.86/220.01  |- mesh__dateRevised mesh__D010075 1992-05-19
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D010075 2000
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D004836 2005
% 219.86/220.01  |- rdf__type mesh__D004836sskos__Concept
% 219.86/220.01  |- mesh__dateRevised mesh__D004836 2003-07-09
% 219.86/220.01  |- skos__historyNote mesh__D004836 Hydroxysteroids %28%1972-1974%29%
% 219.86/220.01  |- skos__historyNote mesh__D004836 Methyl Ethers %28%1972-1974%29%
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D004836 2004
% 219.86/220.01  |- mesh__publicMeSHNote mesh__D004836 91; was see under ESTRENES 1975-90   
% 219.86/220.01  |- mesh__recordOriginator mesh__D004836 NLM
% 219.86/220.01  |- skos__broader mesh__D004836smesh__D004963
% 219.86/220.01  |- mesh__dateCreated mesh__D004836 1974-11-11
% 219.86/220.01  |- skos__scopeNote mesh__D004836
% 219.86/220.01       A synthetic steroid with estrogenic activity.     
% 219.86/220.01  |- skos__historyNote mesh__D004836 Estranes %28%1972-1974%29%
% 219.86/220.01  |- skos__prefLabel mesh__D004836 Epimestrol
% 219.86/220.01  |- mesh__historyNote mesh__D004836
% 219.86/220.01       91%28%75%29%; was see under ESTRENES 1975-90   
% 219.86/220.01  |- mesh__recordMaintainer mesh__D004836 lkt
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D004836 2006
% 219.86/220.01  |- mesh__recordAuthorizer mesh__D004836 sjn
% 219.86/220.01  |- mesh__dateEstablished mesh__D004836 1991-01-01
% 219.86/220.01  |- skos__prefLabel mesh__D004038 Diet, Reducing
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D004038 2005
% 219.86/220.01  |- mesh__recordOriginator mesh__D004038 NLM
% 219.86/220.01  |- skos__broader mesh__D004038smesh__D004035
% 219.86/220.01  |- skos__hiddenLabel mesh__D004038 Reducing Diets
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D004038 2006
% 219.86/220.01  |- mesh__recordMaintainer mesh__D004038 lkt
% 219.86/220.01  |- mesh__dateCreated mesh__D004038 1999-01-01
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D004038 2004
% 219.86/220.01  |- mesh__recordAuthorizer mesh__D004038 sjn
% 219.86/220.01  |- skos__annotation mesh__D004038
% 219.86/220.01       coord IM with specific dis /diet ther %28%IM%29%   
% 219.86/220.01  |- skos__hiddenLabel mesh__D004038 Diets, Reducing
% 219.86/220.01  |- mesh__dateRevised mesh__D004038 2003-07-09
% 219.86/220.01  |- rdf__type mesh__D004038sskos__Concept
% 219.86/220.01  |- skos__hiddenLabel mesh__D004038 Reducing Diet
% 219.86/220.01  |- skos__annotation mesh__D009521
% 219.86/220.01       don%27%t forget also BIRDS %28%NIM%29% or POULTRY %28%NIM%29% or specific bird or fowl %28%IM%29% %26% check tag ANIMALS%A%  
% 219.86/220.01  |- rdf__type mesh__D009521sskos__Concept
% 219.86/220.01  |- skos__broader mesh__D009521smesh__D045463
% 219.86/220.01  |- mesh__recordAuthorizer mesh__D009521 ags
% 219.86/220.01  |- mesh__recordMaintainer mesh__D009521 ags
% 219.86/220.01  |- skos__prefLabel mesh__D009521 Newcastle Disease
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D009521 2006A
% 219.86/220.01  |- skos__hiddenLabel mesh__D009521 Disease, Newcastle
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D009521 2006
% 219.86/220.01  |- skos__scopeNote mesh__D009521
% 219.86/220.01       An acute febrile, contagious, viral disease of birds caused by an AVULAVIRUS called NEWCASTLE DISEASE VIRUS. It is characterized by respiratory and nervous symptoms in fowl and is transmissible to man causing a severe, but transient conjunctivitis.%A%    
% 219.86/220.01  |- mesh__dateCreated mesh__D009521 1999-01-01
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D009521 2005
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D009521 2004
% 219.86/220.01  |- skos__broader mesh__D009521smesh__D001715
% 219.86/220.01  |- mesh__dateRevised mesh__D009521 2005-07-08
% 219.86/220.01  |- mesh__recordOriginator mesh__D009521 NLM
% 219.86/220.01  |- rdf__type mesh__D014466sskos__Concept
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D014466 2003
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D014466 1994
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D014466 1999
% 219.86/220.01  |- mesh__recordMaintainer mesh__D014466 TAP
% 219.86/220.01  |- skos__hiddenLabel mesh__D014466 Rays, Ultraviolet
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D014466 2000
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D014466 2005
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D014466 1993
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D014466 2004
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D014466 1995
% 219.86/220.01  |- mesh__recordAuthorizer mesh__D014466 PLS
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D014466 2001
% 219.86/220.01  |- mesh__dateRevised mesh__D014466 1992-05-18
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D014466 2006
% 219.86/220.01  |- skos__broader mesh__D014466smesh__D011840
% 219.86/220.01  |- skos__broader mesh__D014466smesh__D013472
% 219.86/220.01  |- mesh__recordOriginator mesh__D014466 NLM
% 219.86/220.01  |- skos__altLabel mesh__D014466 Actinic Rays
% 219.86/220.01  |- skos__hiddenLabel mesh__D014466 Ray, Actinic
% 219.86/220.01  |- skos__scopeNote mesh__D014466
% 219.86/220.01       That portion of the electromagnetic spectrum immediately below the visible range and extending into the x-ray frequencies. The longer wavelengths %28%near-UV or biotic or vital rays%29% are necessary for the endogenous synthesis of vitamin D and are also called antirachitic rays; the shorter, ionizing wavelengths %28%far-UV or abiotic or extravital rays%29% are viricidal, bactericidal, mutagenic, and carcinogenic and are used as disinfectants.%A%    
% 219.86/220.01  |- skos__hiddenLabel mesh__D014466 Rays, Actinic
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D014466 2002
% 219.86/220.01  |- skos__hiddenLabel mesh__D014466 Ray, Ultraviolet
% 219.86/220.01  |- skos__prefLabel mesh__D014466 Ultraviolet Rays
% 219.86/220.01  |- skos__hiddenLabel mesh__D014466 Ultraviolet Ray
% 219.86/220.01  |- skos__hiddenLabel mesh__D014466 Actinic Ray
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D014466 1996
% 219.86/220.01  |- mesh__dateCreated mesh__D014466 1999-01-01
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D014466 1998
% 219.86/220.01  |- skos__annotation mesh__D014466
% 219.86/220.01       non-ionizing but short-wave UV is ionizing; black light goes here or under INFRARED RAYS depending on text but unspecified, index here%A%  
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D014466 1997
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D008429 2006
% 219.86/220.01  |- skos__hiddenLabel mesh__D008429 Welfare, Maternal
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D008429 2004
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D008429 2005
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D008429 2002
% 219.86/220.01  |- rdf__type mesh__D008429sskos__Concept
% 219.86/220.01  |- mesh__dateRevised mesh__D008429 1999-11-03
% 219.86/220.01  |- mesh__recordAuthorizer mesh__D008429 sjn
% 219.86/220.01  |- skos__prefLabel mesh__D008429 Maternal Welfare
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D008429 2003
% 219.86/220.01  |- mesh__recordMaintainer mesh__D008429 kle
% 219.86/220.01  |- mesh__dateCreated mesh__D008429 1999-01-01
% 219.86/220.01  |- skos__hiddenLabel mesh__D008429 Health, Maternal
% 219.86/220.01  |- mesh__recordOriginator mesh__D008429 NLM
% 219.86/220.01  |- skos__related mesh__D008429smesh__D008427
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D008429 2001
% 219.86/220.01  |- skos__scopeNote mesh__D008429
% 219.86/220.01       Organized efforts by communities or organizations to improve the health and well-being of the mother.%A%    
% 219.86/220.01  |- skos__broader mesh__D008429smesh__D012946
% 219.86/220.01  |- skos__annotation mesh__D008429 specify geog   
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D008429 2000
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D000446 2006
% 219.86/220.01  |- mesh__recordOriginator mesh__D000446 NLM
% 219.86/220.01  |- mesh__recordMaintainer mesh__D000446 ssb
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D000446 2005
% 219.86/220.01  |- mesh__dateCreated mesh__D000446 1999-01-01
% 219.86/220.01  |- mesh__dateRevised mesh__D000446 2003-07-09
% 219.86/220.01  |- skos__scopeNote mesh__D000446
% 219.86/220.01       Enzymes that catalyze a reverse aldol condensation. A molecule containing a hydroxyl group and a carbonyl group is cleaved at a C-C bond to produce two smaller molecules %28%ALDEHYDES or KETONES%29%. EC 4.1.2.%A%    
% 219.86/220.01  |- skos__altLabel mesh__D000446 Aldolases
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D000446 2004
% 219.86/220.01  |- mesh__recordAuthorizer mesh__D000446 sjn
% 219.86/220.01  |- skos__hiddenLabel mesh__D000446 Aldehyde Lyases
% 219.86/220.01  |- rdf__type mesh__D000446sskos__Concept
% 219.86/220.01  |- skos__broader mesh__D000446smesh__D019755
% 219.86/220.01  |- skos__prefLabel mesh__D000446 Aldehyde-Lyases
% 219.86/220.01  |- skos__hiddenLabel mesh__D019151 Library, Random Peptide
% 219.86/220.01  |- skos__historyNote mesh__D019151 Amino Acid Sequence %28%1990-1996%29%
% 219.86/220.01  |- skos__hiddenLabel mesh__D019151 Random Peptide Libraries
% 219.86/220.01  |- skos__hiddenLabel mesh__D019151 Libraries, Random Peptide
% 219.86/220.01  |- skos__prefLabel mesh__D019151 Peptide Library
% 219.86/220.01  |- skos__hiddenLabel mesh__D019151 Peptide Libraries, Synthetic
% 219.86/220.01  |- mesh__dateCreated mesh__D019151 1996-02-12
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D019151 2003
% 219.86/220.01  |- skos__altLabel mesh__D019151 Peptide Phage Display Library
% 219.86/220.01  |- skos__hiddenLabel mesh__D019151 Peptide Libraries, Random
% 219.86/220.01  |- skos__broader mesh__D019151smesh__D000595
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D019151 2005
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D019151 2004
% 219.86/220.01  |- skos__hiddenLabel mesh__D019151 Library, Peptide
% 219.86/220.01  |- skos__hiddenLabel mesh__D019151 Peptide Libraries
% 219.86/220.01  |- rdf__type mesh__D019151sskos__Concept
% 219.86/220.01  |- skos__hiddenLabel mesh__D019151 Peptide Library, Synthetic
% 219.86/220.01  |- skos__hiddenLabel mesh__D019151 Libraries, Peptide
% 219.86/220.01  |- mesh__recordAuthorizer mesh__D019151 sjn
% 219.86/220.01  |- mesh__historyNote mesh__D019151 97   
% 219.86/220.01  |- skos__hiddenLabel mesh__D019151 Peptide Library, Random
% 219.86/220.01  |- skos__altLabel mesh__D019151 Phage Display Library, Peptide
% 219.86/220.01  |- mesh__dateEstablished mesh__D019151 1997-01-01
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D019151 2006
% 219.86/220.01  |- skos__broader mesh__D019151smesh__D015723
% 219.86/220.01  |- mesh__dateRevised mesh__D019151 2002-07-03
% 219.86/220.01  |- skos__scopeNote mesh__D019151
% 219.86/220.01       A collection of cloned peptides, or chemically synthesized peptides, frequently consisting of all possible combinations of amino acids making up an n-amino acid peptide.%A%    
% 219.86/220.01  |- skos__hiddenLabel mesh__D019151 Libraries, Synthetic Peptide
% 219.86/220.01  |- skos__broader mesh__D019151smesh__D010455
% 219.86/220.01  |- skos__hiddenLabel mesh__D019151 Synthetic Peptide Libraries
% 219.86/220.01  |- skos__historyNote mesh__D019151 Peptides %28%1990-1996%29%
% 219.86/220.01  |- skos__related mesh__D019151smesh__D020650
% 219.86/220.01  |- mesh__recordMaintainer mesh__D019151 nns
% 219.86/220.01  |- skos__hiddenLabel mesh__D019151 Library, Synthetic Peptide
% 219.86/220.01  |- mesh__publicMeSHNote mesh__D019151 97   
% 219.86/220.01  |- mesh__recordOriginator mesh__D019151 AGS
% 219.86/220.01  |- mesh__recordMaintainer mesh__D005131 PXP
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D005131 2004
% 219.86/220.01  |- skos__hiddenLabel mesh__D005131 Injury, Eye
% 219.86/220.01  |- rdf__type mesh__D005131sskos__Concept
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D005131 2002
% 219.86/220.01  |- skos__broader mesh__D005131smesh__D005151
% 219.86/220.01  |- skos__annotation mesh__D005131
% 219.86/220.01       GEN or unspecified; consider also /inj with specific parts of eye; EYE INJURIES, PENETRATING %26% EYE BURNS are also available%A%  
% 219.86/220.01  |- skos__altLabel mesh__D005131 Injuries, Eye
% 219.86/220.01  |- mesh__recordAuthorizer mesh__D005131 sjn
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D005131 2000
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D005131 2005
% 219.86/220.01  |- skos__prefLabel mesh__D005131 Eye Injuries
% 219.86/220.01  |- mesh__dateRevised mesh__D005131 1999-11-03
% 219.86/220.01  |- skos__scopeNote mesh__D005131
% 219.86/220.01       Damage or trauma inflicted to the eye by external means. The concept includes both surface injuries and intraocular injuries.%A%    
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D005131 2006
% 219.86/220.01  |- mesh__dateCreated mesh__D005131 1999-01-01
% 219.86/220.01  |- mesh__activeMeSHYear mesh__D005131 2001
% 219.86/220.01  |- mesh__recordOriginator mesh__D005131 NLM
% 219.86/220.02  |- skos__hiddenLabel mesh__D005131 Eye Injury
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D005131 2003
% 219.86/220.02  |- skos__historyNote mesh__D046548 Pubic Symphysis %28%1966-2003%29%
% 219.86/220.02  |- skos__hiddenLabel mesh__D046548 Diastasis, Symphysis Pubis
% 219.86/220.02  |- skos__hiddenLabel mesh__D046548 Symphysis Pubis Diastases
% 219.86/220.02  |- skos__hiddenLabel mesh__D046548 Symphysis Pubis, Diastasis
% 219.86/220.02  |- skos__broader mesh__D046548smesh__D011644
% 219.86/220.02  |- mesh__dateCreated mesh__D046548 2004-07-07
% 219.86/220.02  |- mesh__recordAuthorizer mesh__D046548 sjn
% 219.86/220.02  |- skos__hiddenLabel mesh__D046548 Diastases, Pubic Symphysis
% 219.86/220.02  |- mesh__dateRevised mesh__D046548 2005-06-30
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D046548 2006
% 219.86/220.02  |- mesh__dateEstablished mesh__D046548 2005-01-01
% 219.86/220.02  |- mesh__publicMeSHNote mesh__D046548 2005   
% 219.86/220.02  |- skos__hiddenLabel mesh__D046548 Pubic Symphysis Diastases
% 219.86/220.02  |- skos__historyNote mesh__D046548 Dislocations %28%1963-2004%29%
% 219.86/220.02  |- skos__scopeNote mesh__D046548
% 219.86/220.02       Separation of the PUBIC SYMPHYSIS. It is an uncommon complication of CHILDBIRTH causing postpartum PAIN, but it can also arise from other causes.%A%    
% 219.86/220.02  |- skos__hiddenLabel mesh__D046548 Diastasis, Pubic Symphysis
% 219.86/220.02  |- mesh__historyNote mesh__D046548 2005   
% 219.86/220.02  |- skos__hiddenLabel mesh__D046548 Diastases, Symphysis Pubis
% 219.86/220.02  |- skos__altLabel mesh__D046548 Diastasis Symphysis Pubis
% 219.86/220.02  |- mesh__recordOriginator mesh__D046548 ags
% 219.86/220.02  |- skos__broader mesh__D046548smesh__D004204
% 219.86/220.02  |- skos__prefLabel mesh__D046548 Pubic Symphysis Diastasis
% 219.86/220.02  |- mesh__recordMaintainer mesh__D046548 lkt
% 219.86/220.02  |- rdf__type mesh__D046548sskos__Concept
% 219.86/220.02  |- skos__altLabel mesh__D046548 Symphysis Pubis Diastasis
% 219.86/220.02  |- skos__hiddenLabel mesh__D018857 Food Container
% 219.86/220.02  |- skos__historyNote mesh__D018857 Food Technology %28%1975-1995%29%
% 219.86/220.02  |- skos__altLabel mesh__D018857 Packaging, Food
% 219.86/220.02  |- skos__scopeNote mesh__D018857
% 219.86/220.02       Containers, packaging, and packaging materials for processed and raw foods and beverages. It includes packaging intended to be used for storage and also used for preparation of foods such as microwave food containers versus COOKING AND EATING UTENSILS. Packaging materials may be intended for food contact or designated non-contact, for example, shipping containers. FOOD LABELING is also available.%A%    
% 219.86/220.02  |- skos__broader mesh__D018857smesh__D005524
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D018857 2000
% 219.86/220.02  |- rdf__type mesh__D018857sskos__Concept
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D018857 1998
% 219.86/220.02  |- mesh__dateEstablished mesh__D018857 1996-01-01
% 219.86/220.02  |- skos__broader mesh__D018857smesh__D019064
% 219.86/220.02  |- mesh__recordOriginator mesh__D018857 JLS
% 219.86/220.02  |- mesh__dateRevised mesh__D018857 1997-06-20
% 219.86/220.02  |- skos__broader mesh__D018857smesh__D005511
% 219.86/220.02  |- mesh__historyNote mesh__D018857 96   
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D018857 2001
% 219.86/220.02  |- mesh__publicMeSHNote mesh__D018857 96   
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D018857 1999
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D018857 2003
% 219.86/220.02  |- mesh__recordAuthorizer mesh__D018857 SJN
% 219.86/220.02  |- skos__annotation mesh__D018857
% 219.86/220.02       includes containers, packaging methods, packaging materials; IM; coord with specific food %28%IM%29%; FOOD LABELING is also available%A%  
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D018857 2005
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D018857 2004
% 219.86/220.02  |- mesh__recordMaintainer mesh__D018857 JLS
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D018857 2002
% 219.86/220.02  |- skos__prefLabel mesh__D018857 Food Packaging
% 219.86/220.02  |- mesh__dateCreated mesh__D018857 1995-06-05
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D018857 2006
% 219.86/220.02  |- rdf__type mesh__D010874sskos__Concept
% 219.86/220.02  |- mesh__dateRevised mesh__D010874 1994-02-08
% 219.86/220.02  |- skos__annotation mesh__D010874 a nonvenereal treponemal skin infect   
% 219.86/220.02  |- skos__broader mesh__D010874smesh__D014211
% 219.86/220.02  |- mesh__recordAuthorizer mesh__D010874 PLS
% 219.86/220.02  |- mesh__dateCreated mesh__D010874 1999-01-01
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D010874 2000
% 219.86/220.02  |- skos__scopeNote mesh__D010874
% 219.86/220.02       An infectious disease of the skin caused by Treponema carateum that occurs only in the western hemisphere. Age of onset is between 10 and 20 years of age. This condition is characterized by marked changes in the skin color and is believed to be transmitted by direct person-to-person contact.%A%    
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D010874 1998
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D010874 2005
% 219.86/220.02  |- mesh__recordMaintainer mesh__D010874 PXP
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D010874 1995
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D010874 1996
% 219.86/220.02  |- skos__prefLabel mesh__D010874 Pinta
% 219.86/220.02  |- mesh__recordOriginator mesh__D010874 NLM
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D010874 2001
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D010874 2003
% 219.86/220.02  |- skos__broader mesh__D010874smesh__D017192
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D010874 1999
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D010874 2006
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D010874 1997
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D010874 2002
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D010874 2004
% 219.86/220.02  |- mesh__publicMeSHNote mesh__D018059 94; BIRNAVIRUS was heading 1994-96   
% 219.86/220.02  |- skos__prefLabel mesh__D018059 Birnaviridae
% 219.86/220.02  |- mesh__dateCreated mesh__D018059 1993-06-04
% 219.86/220.02  |- mesh__historyNote mesh__D018059 94; BIRNAVIRUS was heading 1994-96   
% 219.86/220.02  |- mesh__onlineNote mesh__D018059
% 219.86/220.02       use BIRNAVIRIDAE to search BIRNAVIRUS 1994-96   
% 219.86/220.02  |- rdf__type mesh__D018059sskos__Concept
% 219.86/220.02  |- mesh__recordAuthorizer mesh__D018059 sjn
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D018059 2003
% 219.86/220.02  |- mesh__dateEstablished mesh__D018059 1994-01-01
% 219.86/220.02  |- skos__historyNote mesh__D018059 Reoviridae %28%1990-1993%29%
% 219.86/220.02  |- mesh__recordMaintainer mesh__D018059 mdb
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D018059 2004
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D018059 2005
% 219.86/220.02  |- skos__scopeNote mesh__D018059
% 219.86/220.02       A family of bisegmented, double-stranded RNA viruses causing infection in fish, mollusks, fowl, and Drosophila. There are three genera: AQUABIRNAVIRUS; AVIBIRNAVIRUS; and ENTOMOBIRNAVIRUS. Horizontal and vertical transmission occurs for all viruses.%A%    
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D018059 2002
% 219.86/220.02  |- skos__broader mesh__D018059smesh__D012328
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D018059 2006
% 219.86/220.02  |- mesh__recordOriginator mesh__D018059 AGS
% 219.86/220.02  |- skos__annotation mesh__D018059
% 219.86/220.02       a family of RNA viruses; from BIsegmental RNA viruses; infection = BIRNAVIRIDAE INFECTIONS%A%  
% 219.86/220.02  |- mesh__dateRevised mesh__D018059 2001-07-25
% 219.86/220.02  |- skos__prefLabel mesh__D010076 Oxazepam
% 219.86/220.02  |- mesh__historyNote mesh__D010076 68%28%65%29%   
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D010076 2004
% 219.86/220.02  |- mesh__publicMeSHNote mesh__D010076 68   
% 219.86/220.02  |- mesh__recordAuthorizer mesh__D010076 sjn
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D010076 2006
% 219.86/220.02  |- mesh__dateCreated mesh__D010076 1999-01-01
% 219.86/220.02  |- mesh__dateEstablished mesh__D010076 1968-01-01
% 219.86/220.02  |- skos__scopeNote mesh__D010076
% 219.86/220.02       A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia.%A%    
% 219.86/220.02  |- mesh__recordOriginator mesh__D010076 NLM
% 219.86/220.02  |- rdf__type mesh__D010076sskos__Concept
% 219.86/220.02  |- mesh__dateRevised mesh__D010076 2003-07-09
% 219.86/220.02  |- mesh__recordMaintainer mesh__D010076 ssb
% 219.86/220.02  |- skos__broader mesh__D010076smesh__D001570
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D010076 2005
% 219.86/220.02  |- skos__broader mesh__D004837smesh__D004983
% 219.86/220.02  |- skos__hiddenLabel mesh__D004837 Hydrochloride, Adrenaline
% 219.86/220.02  |- mesh__recordAuthorizer mesh__D004837 sjn
% 219.86/220.02  |- skos__altLabel mesh__D004837 Epinephrine Hydrogen Tartrate
% 219.86/220.02  |- mesh__dateCreated mesh__D004837 1999-01-01
% 219.86/220.02  |- skos__scopeNote mesh__D004837
% 219.86/220.02       The active sympathomimetic hormone from the adrenal medulla in most species. It stimulates both the alpha- and beta- adrenergic systems, causes systemic vasoconstriction and gastrointestinal relaxation, stimulates the heart, and dilates bronchi and cerebral vessels. It is used in asthma and cardiac failure and to delay absorption of local anesthetics.%A%    
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D004837 2006
% 219.86/220.02  |- skos__altLabel mesh__D004837
% 219.86/220.02       4-%28%1-Hydroxy-2-%28%methylamino%29%ethyl%29%-1,2-benzenediol
% 219.86/220.02  |- skos__related mesh__D004837smesh__D011941
% 219.86/220.02  |- mesh__dateRevised mesh__D004837 2005-06-30
% 219.86/220.02  |- skos__hiddenLabel mesh__D004837 Epinephrine, Racemic
% 219.86/220.02  |- skos__broader mesh__D004837smesh__D002395
% 219.86/220.02  |- skos__altLabel mesh__D004837 Adrenaline
% 219.86/220.02  |- skos__prefLabel mesh__D004837 Epinephrine
% 219.86/220.02  |- rdf__type mesh__D004837sskos__Concept
% 219.86/220.02  |- skos__altLabel mesh__D004837 Epinephrine Bitartrate
% 219.86/220.02  |- mesh__recordOriginator mesh__D004837 NLM
% 219.86/220.02  |- skos__altLabel mesh__D004837 Racemic Epinephrine
% 219.86/220.02  |- mesh__recordMaintainer mesh__D004837 ssb
% 219.86/220.02  |- skos__annotation mesh__D004837 /biosyn /physiol permitted   
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D004039 2006
% 219.86/220.02  |- skos__altLabel mesh__D004039 Diet, Low-Salt
% 219.86/220.02  |- mesh__onlineNote mesh__D004039
% 219.86/220.02       use DIET, SODIUM-RESTRICTED to search DIET, SALT-FREE 1966-79%A%  
% 219.86/220.02  |- skos__altLabel mesh__D004039 Diet, Low-Sodium
% 219.86/220.02  |- mesh__historyNote mesh__D004039 80; was DIET, SALT-FREE 1963-79   
% 219.86/220.02  |- skos__hiddenLabel mesh__D004039 Low-Sodium Diet
% 219.86/220.02  |- skos__hiddenLabel mesh__D004039 Diets, Low-Sodium
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D004039 2004
% 219.86/220.02  |- mesh__dateCreated mesh__D004039 1999-01-01
% 219.86/220.02  |- skos__hiddenLabel mesh__D004039 Sodium-Restricted Diets
% 219.86/220.02  |- mesh__recordOriginator mesh__D004039 NLM
% 219.86/220.02  |- skos__hiddenLabel mesh__D004039 Diet, Low Sodium
% 219.86/220.02  |- skos__annotation mesh__D004039
% 219.86/220.02       coord IM with specific dis /diet ther %28%IM%29%   
% 219.86/220.02  |- skos__prefLabel mesh__D004039 Diet, Sodium-Restricted
% 219.86/220.02  |- skos__hiddenLabel mesh__D004039 Diet, Salt Free
% 219.86/220.02  |- skos__hiddenLabel mesh__D004039 Diet, Sodium Restricted
% 219.86/220.02  |- mesh__recordMaintainer mesh__D004039 lkt
% 219.86/220.02  |- mesh__publicMeSHNote mesh__D004039 80; was DIET, SALT-FREE 1963-79   
% 219.86/220.02  |- skos__scopeNote mesh__D004039
% 219.86/220.02       A diet which contains very little sodium chloride. It is prescribed by some for hypertension and for edematous states. %28%Dorland, 27th ed%29%%A%    
% 219.86/220.02  |- skos__hiddenLabel mesh__D004039 Salt-Free Diet
% 219.86/220.02  |- skos__hiddenLabel mesh__D004039 Diets, Sodium-Restricted
% 219.86/220.02  |- skos__hiddenLabel mesh__D004039 Low-Salt Diets
% 219.86/220.02  |- mesh__dateRevised mesh__D004039 2003-07-09
% 219.86/220.02  |- skos__hiddenLabel mesh__D004039 Low-Salt Diet
% 219.86/220.02  |- skos__hiddenLabel mesh__D004039 Salt-Free Diets
% 219.86/220.02  |- skos__hiddenLabel mesh__D004039 Diets, Low-Salt
% 219.86/220.02  |- rdf__type mesh__D004039sskos__Concept
% 219.86/220.02  |- mesh__recordAuthorizer mesh__D004039 sjn
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D004039 2005
% 219.86/220.02  |- skos__hiddenLabel mesh__D004039 Diet, Low Salt
% 219.86/220.02  |- skos__hiddenLabel mesh__D004039 Sodium-Restricted Diet
% 219.86/220.02  |- skos__hiddenLabel mesh__D004039 Low-Sodium Diets
% 219.86/220.02  |- skos__hiddenLabel mesh__D004039 Diets, Salt-Free
% 219.86/220.02  |- skos__broader mesh__D004039smesh__D004035
% 219.86/220.02  |- mesh__onlineNote mesh__D009522
% 219.86/220.02       use NEWCASTLE DISEASE VIRUS to search AVIAN PARAMYXOVIRUS TYPE 1 1994-96 %26% PARAMYXOVIRUS TYPE 1, AVIAN 1994-96%A%  
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D009522 2006
% 219.86/220.02  |- skos__broader mesh__D009522smesh__D018109
% 219.86/220.02  |- mesh__recordOriginator mesh__D009522 NLM
% 219.86/220.02  |- mesh__dateCreated mesh__D009522 1999-01-01
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D009522 2005
% 219.86/220.02  |- mesh__recordAuthorizer mesh__D009522 sjn
% 219.86/220.02  |- skos__annotation mesh__D009522 infection = NEWCASTLE DISEASE   
% 219.86/220.02  |- skos__prefLabel mesh__D009522 Newcastle disease virus
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D009522 2004
% 219.86/220.02  |- skos__scopeNote mesh__D009522
% 219.86/220.02       The most well known avian paramyxovirus in the genus AVULAVIRUS and the cause of a highly infectious pneumoencephalitis in fowl. It is also reported to cause CONJUNCTIVITIS in humans. Transmission is by droplet inhalation or ingestion of contaminated water or food.%A%    
% 219.86/220.02  |- skos__altLabel mesh__D009522 Paramyxovirus 1, Avian
% 219.86/220.02  |- mesh__publicMeSHNote mesh__D009522
% 219.86/220.02       63; AVIAN PARAMYXOVIRUS 1 was AVIAN PARAMYXOVIRUS TYPE 1 1994-96; PARAMYXOVIRUS 1, AVIAN was PARAMYXOVIRUS TYPE 1, AVIAN 1994-96%A%  
% 219.86/220.02  |- skos__altLabel mesh__D009522 Avian Paramyxovirus 1
% 219.86/220.02  |- mesh__dateRevised mesh__D009522 2003-07-09
% 219.86/220.02  |- mesh__historyNote mesh__D009522
% 219.86/220.02       63; AVIAN PARAMYXOVIRUS 1 was AVIAN PARAMYXOVIRUS TYPE 1 1994-96; PARAMYXOVIRUS 1, AVIAN was PARAMYXOVIRUS TYPE 1, AVIAN 1994-96%A%  
% 219.86/220.02  |- rdf__type mesh__D009522sskos__Concept
% 219.86/220.02  |- mesh__recordMaintainer mesh__D009522 ags
% 219.86/220.02  |- skos__scopeNote mesh__D014467
% 219.86/220.02       The use of ultraviolet electromagnetic radiation in the treatment of disease, usually of the skin. This is the part of the sun%27%s spectrum that causes sunburn and tanning. Ultraviolet A, used in PUVA, is closer to visible light and less damaging than Ultraviolet B, which is ionizing.%A%    
% 219.86/220.02  |- mesh__dateRevised mesh__D014467 2005-06-30
% 219.86/220.02  |- skos__prefLabel mesh__D014467 Ultraviolet Therapy
% 219.86/220.02  |- mesh__publicMeSHNote mesh__D014467 65   
% 219.86/220.02  |- skos__annotation mesh__D014467
% 219.86/220.02       non-ionizing but short-wave UV is ionizing; do not use /util except by MeSH definition; coord with dis /radiother, not dis /ther; do not index here for ultraviolet ther in PUVA THERAPY unless particularly discussed%A%  
% 219.86/220.02  |- skos__hiddenLabel mesh__D014467 Therapies, Ultraviolet
% 219.86/220.02  |- skos__related mesh__D014467smesh__D010778
% 219.86/220.02  |- skos__hiddenLabel mesh__D014467 Ultraviolet Therapies
% 219.86/220.02  |- mesh__dateEstablished mesh__D014467 1965-01-01
% 219.86/220.02  |- mesh__dateCreated mesh__D014467 1999-01-01
% 219.86/220.02  |- rdf__type mesh__D014467sskos__Concept
% 219.86/220.02  |- skos__altLabel mesh__D014467 Therapy, Ultraviolet
% 219.86/220.02  |- mesh__recordMaintainer mesh__D014467 lkt
% 219.86/220.02  |- skos__broader mesh__D014467smesh__D010789
% 219.86/220.02  |- mesh__recordAuthorizer mesh__D014467 sjn
% 219.86/220.02  |- skos__altLabel mesh__D014467 Actinotherapy
% 219.86/220.02  |- mesh__recordOriginator mesh__D014467 NLM
% 219.86/220.02  |- mesh__historyNote mesh__D014467 65   
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D014467 2006
% 219.86/220.02  |- skos__hiddenLabel mesh__D014467 Actinotherapies
% 219.86/220.02  |- skos__hiddenLabel mesh__D019950 MAPK2 Mitogen Activated Protein Kinase
% 219.86/220.02  |- skos__altLabel mesh__D019950 ERK2 Brain Kinase PK40
% 219.86/220.02  |- skos__altLabel mesh__D019950 p42%28%Mapk%29%
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D019950 2005
% 219.86/220.02  |- mesh__dateEstablished mesh__D019950 1998-01-01
% 219.86/220.02  |- mesh__recordMaintainer mesh__D019950 jmp
% 219.86/220.02  |- skos__prefLabel mesh__D019950 Mitogen-Activated Protein Kinase 1
% 219.86/220.02  |- skos__scopeNote mesh__D019950
% 219.86/220.02       A proline-directed serine/threonine protein kinase which mediates signal transduction from the cell surface to the nucleus. Activation of the enzyme by phosphorylation leads to its translocation into the nucleus where it acts upon specific transcription factors. p40 MAPK and p41 MAPK are isoforms.%A%    
% 219.86/220.02  |- mesh__dateRevised mesh__D019950 2004-07-07
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D019950 2006
% 219.86/220.02  |- skos__altLabel mesh__D019950 MAP Kinase 2
% 219.86/220.02  |- skos__hiddenLabel mesh__D019950 p40 Mitogen Activated Protein Kinase
% 219.86/220.02  |- mesh__publicMeSHNote mesh__D019950
% 219.86/220.02       2000; see P42 MAP KINASE 2000-2004, see P42%28%MAPK%29% KINASE 1998-1999; P42%28%MAPK%29% KINASE was indexed under CALMODULIN-DEPENDENT PROTEIN KINASES 1994-1997, PROTEIN-TYROSINE KINASE 1992-1997, PROTEIN-SERINE-THREONINE KINASES 1993-1995 %26% PROTEIN KINASES 1992; ERK2 BRAIN KINASE PK40 was indexed under PROTEIN-SERINE-THREONINE KINASES 1995-1999; ERK2 was indexed under CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1998-1999, CALMODULIN-DEPENDENT KINASES 1994-1997, PROTEIN-SERINE-THREONINE KINASES 1992-1993 %26% PROTEIN KINASES 1992; ERK2 MBP-KINASE was indexed under CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1998-1999 %26% CALMODULIN-DEPENDENT KINASES 1994-1997%A%  
% 219.86/220.02  |- skos__altLabel mesh__D019950 MAPK2 Mitogen-Activated Protein Kinase
% 219.86/220.02  |- skos__altLabel mesh__D019950 p42%28%Mapk%29% Kinase
% 219.86/220.02  |- skos__altLabel mesh__D019950 p42 MAPK
% 219.86/220.02  |- skos__altLabel mesh__D019950 Extracellular Signal-Regulated Kinase 2
% 219.86/220.02  |- skos__annotation mesh__D019950
% 219.86/220.02       Don%27%t confuse MAP Kinase 2 with MAP KINASE KINASES referred to as MAP2 Kinases%A%  
% 219.86/220.02  |- mesh__dateCreated mesh__D019950 1997-07-02
% 219.86/220.02  |- skos__hiddenLabel mesh__D019950 MAP Kinase, p42
% 219.86/220.02  |- skos__altLabel mesh__D019950 p42%28%Mitogen-Activated Protein Kinase%29%
% 219.86/220.02  |- skos__hiddenLabel mesh__D019950 Mitogen Activated Protein Kinase 2
% 219.86/220.02  |- skos__altLabel mesh__D019950 p42 MAP Kinase
% 219.86/220.02  |- skos__historyNote mesh__D019950
% 219.86/220.02       Protein-Tyrosine Kinase %28%1992-1997%29%
% 219.86/220.02  |- skos__historyNote mesh__D019950
% 219.86/220.02       Protein-Serine-Threonine Kinases %28%1993-1995%29%
% 219.86/220.02  |- skos__historyNote mesh__D019950 Protein Kinases %28%1992%29%
% 219.86/220.02  |- skos__hiddenLabel mesh__D019950 Extracellular Signal Regulated Kinase 2
% 219.86/220.02  |- skos__altLabel mesh__D019950 MAPK1 Mitogen-Activated Protein Kinase
% 219.86/220.02  |- rdf__type mesh__D019950sskos__Concept
% 219.86/220.02  |- mesh__historyNote mesh__D019950 2005%28%1992%29%   
% 219.86/220.02  |- skos__hiddenLabel mesh__D019950 Mitogen Activated Protein Kinase 1
% 219.86/220.02  |- skos__hiddenLabel mesh__D019950 p41 Mitogen Activated Protein Kinase
% 219.86/220.02  |- skos__altLabel mesh__D019950 p41 MAPK
% 219.86/220.02  |- skos__altLabel mesh__D019950 Mitogen-Activated Protein Kinase 2
% 219.86/220.02  |- mesh__recordAuthorizer mesh__D019950 sjn
% 219.86/220.02  |- skos__broader mesh__D019950smesh__D048049
% 219.86/220.02  |- skos__historyNote mesh__D019950
% 219.86/220.02       Ca%28%2+%29%-Calmodulin Dependent Protein Kinase %28%1994-1997%29%
% 219.86/220.02  |- skos__hiddenLabel mesh__D019950 MAPK1 Mitogen Activated Protein Kinase
% 219.86/220.02  |- mesh__recordOriginator mesh__D019950 KEV
% 219.86/220.02  |- mesh__dateCreated mesh__D033621 2002-07-02
% 219.86/220.02  |- skos__broader mesh__D033621smesh__D004175
% 219.86/220.02  |- skos__altLabel mesh__D033621 Bactrocera tryoni
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D033621 2006
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D033621 2004
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D033621 2005
% 219.86/220.02  |- skos__altLabel mesh__D033621 Trypetidae
% 219.86/220.02  |- rdf__type mesh__D033621sskos__Concept
% 219.86/220.02  |- skos__scopeNote mesh__D033621
% 219.86/220.02       A large family of fruit flies in the order DIPTERA, comprising over 4,500 species in about 100 genera. They have patterned wings and brightly colored bodies and are found predominantly in the tropical latitudes.%A%    
% 219.86/220.02  |- skos__historyNote mesh__D033621 Diptera %28%1967-2002%29%
% 219.86/220.02  |- mesh__dateRevised mesh__D033621 2003-07-09
% 219.86/220.02  |- mesh__dateEstablished mesh__D033621 2003-01-01
% 219.86/220.02  |- skos__altLabel mesh__D033621 Anastrepha suspensa
% 219.86/220.02  |- mesh__historyNote mesh__D033621 2003   
% 219.86/220.02  |- mesh__publicMeSHNote mesh__D033621 2003   
% 219.86/220.02  |- skos__altLabel mesh__D033621 Anastrepha ludens
% 219.86/220.02  |- skos__prefLabel mesh__D033621 Tephritidae
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D000447 2006
% 219.86/220.02  |- mesh__dateRevised mesh__D000447 2000-06-21
% 219.86/220.02  |- skos__scopeNote mesh__D000447
% 219.86/220.02       Organic compounds containing a carbonyl group in the form -CHO.%A%    
% 219.86/220.02  |- mesh__recordMaintainer mesh__D000447 adp
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D000447 2003
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D000447 2002
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D000447 2004
% 219.86/220.02  |- mesh__recordOriginator mesh__D000447 NLM
% 219.86/220.02  |- rdf__type mesh__D000447sskos__Concept
% 219.86/220.02  |- mesh__recordAuthorizer mesh__D000447 sjn
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D000447 2005
% 219.86/220.02  |- skos__broader mesh__D000447smesh__D009930
% 219.86/220.02  |- mesh__dateCreated mesh__D000447 1999-01-01
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D000447 2001
% 219.86/220.02  |- skos__prefLabel mesh__D000447 Aldehydes
% 219.86/220.02  |- mesh__historyNote mesh__D019152 97   
% 219.86/220.02  |- rdf__type mesh__D019152sskos__Concept
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D019152 2006
% 219.86/220.02  |- skos__scopeNote mesh__D019152
% 219.86/220.02       A procedure in which fluid is withdrawn from a body cavity via a trocar and cannula, needle, or other hollow instrument.%A%    
% 219.86/220.02  |- mesh__recordOriginator mesh__D019152 TGC
% 219.86/220.02  |- mesh__publicMeSHNote mesh__D019152 97   
% 219.86/220.02  |- mesh__dateRevised mesh__D019152 1999-11-03
% 219.86/220.02  |- skos__broader mesh__D019152smesh__D013514
% 219.86/220.02  |- skos__prefLabel mesh__D019152 Paracentesis
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D019152 2002
% 219.86/220.02  |- skos__historyNote mesh__D019152 Drainage %28%1966-1996%29%
% 219.86/220.02  |- skos__broader mesh__D019152smesh__D011677
% 219.86/220.02  |- skos__historyNote mesh__D019152 Punctures %28%1966-1996%29%
% 219.86/220.02  |- skos__historyNote mesh__D019152 Suction %28%1977-1996%29%
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D019152 2000
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D019152 2003
% 219.86/220.02  |- mesh__dateEstablished mesh__D019152 1997-01-01
% 219.86/220.02  |- mesh__dateCreated mesh__D019152 1996-02-12
% 219.86/220.02  |- skos__hiddenLabel mesh__D019152 Paracenteses
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D019152 2001
% 219.86/220.02  |- mesh__recordAuthorizer mesh__D019152 sjn
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D019152 2005
% 219.86/220.02  |- mesh__recordMaintainer mesh__D019152 KEV
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D019152 2004
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D005930 2000
% 219.86/220.02  |- skos__hiddenLabel mesh__D005930 Nerve, Ninth Cranial
% 219.86/220.02  |- mesh__recordOriginator mesh__D005930 NLM
% 219.86/220.02  |- skos__hiddenLabel mesh__D005930 Nerve IX, Cranial
% 219.86/220.02  |- skos__hiddenLabel mesh__D005930 Nerves, Ninth Cranial
% 219.86/220.02  |- skos__hiddenLabel mesh__D005930 Cranial Nerve IXs
% 219.86/220.02  |- skos__hiddenLabel mesh__D005930 Cranial Nerves, Ninth
% 219.86/220.02  |- skos__scopeNote mesh__D005930
% 219.86/220.02       The 9th cranial nerve. The glossopharyngeal nerve is a mixed motor and sensory nerve; it conveys somatic and autonomic efferents as well as general, special, and visceral afferents. Among the connections are motor fibers to the stylopharyngeus muscle, parasympathetic fibers to the parotid glands, general and taste afferents from the posterior third of the tongue, the nasopharynx, and the palate, and afferents from baroreceptors and chemoreceptors of the carotid sinus.%A%    
% 219.86/220.02  |- skos__hiddenLabel mesh__D005930 Cranial Nerve, Ninth
% 219.86/220.02  |- mesh__dateCreated mesh__D005930 1999-01-01
% 219.86/220.02  |- mesh__dateRevised mesh__D005930 1999-11-03
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D005930 2004
% 219.86/220.02  |- skos__hiddenLabel mesh__D005930 Glossopharyngeal Nerves
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D005930 2002
% 219.86/220.02  |- skos__hiddenLabel mesh__D005930 Nerve, Glossopharyngeal
% 219.86/220.02  |- skos__hiddenLabel mesh__D005930 IXs, Cranial Nerve
% 219.86/220.02  |- skos__hiddenLabel mesh__D005930 IX, Cranial Nerve
% 219.86/220.02  |- skos__altLabel mesh__D005930 Cranial Nerve IX
% 219.86/220.02  |- skos__hiddenLabel mesh__D005930 Nerve IXs, Cranial
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D005930 2003
% 219.86/220.02  |- mesh__recordMaintainer mesh__D005930 ags
% 219.86/220.02  |- skos__prefLabel mesh__D005930 Glossopharyngeal Nerve
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D005930 2006
% 219.86/220.02  |- mesh__recordAuthorizer mesh__D005930 sjn
% 219.86/220.02  |- skos__annotation mesh__D005930
% 219.86/220.02       neopl = GLOSSOPHARYNGEAL NERVE DISEASES %28%IM%29% + CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D005930 2001
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D005930 2005
% 219.86/220.02  |- skos__hiddenLabel mesh__D005930 Ninth Cranial Nerves
% 219.86/220.02  |- skos__broader mesh__D005930smesh__D003391
% 219.86/220.02  |- rdf__type mesh__D005930sskos__Concept
% 219.86/220.02  |- skos__hiddenLabel mesh__D005930 Nerves, Glossopharyngeal
% 219.86/220.02  |- skos__altLabel mesh__D005930 Ninth Cranial Nerve
% 219.86/220.02  |- skos__prefLabel mesh__D005132 Eye Manifestations
% 219.86/220.02  |- rdf__type mesh__D005132sskos__Concept
% 219.86/220.02  |- skos__hiddenLabel mesh__D005132 Manifestation, Eye
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D005132 2001
% 219.86/220.02  |- mesh__recordOriginator mesh__D005132 NLM
% 219.86/220.02  |- skos__annotation mesh__D005132
% 219.86/220.02       not used for indexing since 1989; prior to 1989 used for eye manifest of non-eye diseases%A%  
% 219.86/220.02  |- skos__broader mesh__D005132smesh__D005128
% 219.86/220.02  |- mesh__recordMaintainer mesh__D005132 JLS
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D005132 2005
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D005132 2002
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D005132 2006
% 219.86/220.02  |- mesh__dateCreated mesh__D005132 1999-01-01
% 219.86/220.02  |- skos__hiddenLabel mesh__D005132 Manifestations, Eye
% 219.86/220.02  |- skos__broader mesh__D005132smesh__D012816
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D005132 2003
% 219.86/220.02  |- skos__scopeNote mesh__D005132
% 219.86/220.02       Ocular disorders attendant upon non-ocular disease or injury.%A%    
% 219.86/220.02  |- mesh__recordAuthorizer mesh__D005132 sjn
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D005132 2000
% 219.86/220.02  |- skos__hiddenLabel mesh__D005132 Eye Manifestation
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D005132 2004
% 219.86/220.02  |- mesh__dateRevised mesh__D005132 1999-11-03
% 219.86/220.02  |- skos__historyNote mesh__D046549 Recombinant Proteins %28%1997-2004%29%
% 219.86/220.02  |- mesh__publicMeSHNote mesh__D046549 2005   
% 219.86/220.02  |- skos__prefLabel mesh__D046549 Plantibodies
% 219.86/220.02  |- skos__historyNote mesh__D046549 Antibodies %28%1997-2004%29%
% 219.86/220.02  |- skos__altLabel mesh__D046549 Plant Antibodies, Recombinant
% 219.86/220.02  |- skos__hiddenLabel mesh__D046549 Plant-Derived Antibodies
% 219.86/220.02  |- skos__scopeNote mesh__D046549
% 219.86/220.02       Recombinant antibodies produced in TRANSGENIC PLANTS. The plants serve as BIOREACTORS to produce the antibodies for medical use or industrial processes.%A%    
% 219.86/220.02  |- mesh__recordAuthorizer mesh__D046549 sjn
% 219.86/220.02  |- mesh__dateRevised mesh__D046549 2005-06-30
% 219.86/220.02  |- mesh__dateEstablished mesh__D046549 2005-01-01
% 219.86/220.02  |- skos__hiddenLabel mesh__D046549 Recombinant Plant Antibodies
% 219.86/220.02  |- skos__broader mesh__D046549smesh__D000906
% 219.86/220.02  |- skos__related mesh__D046549smesh__D030821
% 219.86/220.02  |- rdf__type mesh__D046549sskos__Concept
% 219.86/220.02  |- mesh__historyNote mesh__D046549 2005   
% 219.86/220.02  |- skos__hiddenLabel mesh__D046549 Antibodies, Recombinant Plant
% 219.86/220.02  |- mesh__recordOriginator mesh__D046549 ags
% 219.86/220.02  |- mesh__dateCreated mesh__D046549 2004-07-07
% 219.86/220.02  |- skos__hiddenLabel mesh__D046549 Antibodies, Plant Derived
% 219.86/220.02  |- mesh__recordMaintainer mesh__D046549 ssb
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D046549 2006
% 219.86/220.02  |- skos__altLabel mesh__D046549 Antibodies, Plant-Derived
% 219.86/220.02  |- skos__prefLabel mesh__D018858 Germinal Center
% 219.86/220.02  |- mesh__dateRevised mesh__D018858 2003-07-09
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D018858 2006
% 219.86/220.02  |- skos__historyNote mesh__D018858 B-Lymphocytes %28%1976-1995%29%
% 219.86/220.02  |- skos__broader mesh__D018858smesh__D008221
% 219.86/220.02  |- skos__hiddenLabel mesh__D018858 Germinal Centers
% 219.86/220.02  |- mesh__recordAuthorizer mesh__D018858 sjn
% 219.86/220.02  |- rdf__type mesh__D018858sskos__Concept
% 219.86/220.02  |- mesh__dateEstablished mesh__D018858 1996-01-01
% 219.86/220.02  |- skos__historyNote mesh__D018858 Lymphocytes %28%1968-1995%29%
% 219.86/220.02  |- skos__broader mesh__D018858smesh__D008198
% 219.86/220.02  |- skos__scopeNote mesh__D018858
% 219.86/220.02       The activated center of a lymphoid follicle in secondary lymphoid tissue where B-LYMPHOCYTES are stimulated by antigens and helper T cells %28%T-LYMPHOCYTES, HELPER-INDUCER%29% are stimulated to generate memory cells.%A%    
% 219.86/220.02  |- skos__historyNote mesh__D018858 Lymph Nodes %28%1968-1995%29%
% 219.86/220.02  |- mesh__historyNote mesh__D018858 96   
% 219.86/220.02  |- skos__hiddenLabel mesh__D018858 Center, Germinal
% 219.86/220.02  |- mesh__publicMeSHNote mesh__D018858 96   
% 219.86/220.02  |- mesh__recordOriginator mesh__D018858 TGC
% 219.86/220.02  |- skos__historyNote mesh__D018858 Lymphoid Tissue %28%1966-1995%29%
% 219.86/220.02  |- mesh__recordMaintainer mesh__D018858 jmp
% 219.86/220.02  |- skos__hiddenLabel mesh__D018858 Centers, Germinal
% 219.86/220.02  |- mesh__dateCreated mesh__D018858 1994-12-27
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D018858 2005
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D018858 2004
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D010875 2002
% 219.86/220.02  |- mesh__dateCreated mesh__D010875 1999-01-01
% 219.86/220.02  |- mesh__dateEstablished mesh__D010875 1968-01-01
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D010875 1994
% 219.86/220.02  |- mesh__historyNote mesh__D010875 68   
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D010875 1998
% 219.86/220.02  |- mesh__publicMeSHNote mesh__D010875 68   
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D010875 2005
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D010875 1995
% 219.86/220.02  |- mesh__activeMeSHYear mesh__D010875 1996
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010875 2003
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010875 1993
% 219.86/220.03  |- mesh__dateRevised mesh__D010875 1992-05-19
% 219.86/220.03  |- mesh__recordAuthorizer mesh__D010875 PLS
% 219.86/220.03  |- skos__prefLabel mesh__D010875 Pipecolic Acids
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010875 1999
% 219.86/220.03  |- skos__broader mesh__D010875smesh__D010880
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010875 2006
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010875 2000
% 219.86/220.03  |- mesh__recordMaintainer mesh__D010875 TAP
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010875 1997
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010875 2004
% 219.86/220.03  |- skos__hiddenLabel mesh__D010875 Acids, Pipecolic
% 219.86/220.03  |- mesh__recordOriginator mesh__D010875 NLM
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010875 2001
% 219.86/220.03  |- skos__broader mesh__D010875smesh__D000147
% 219.86/220.03  |- rdf__type mesh__D010875sskos__Concept
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010077 2004
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010077 1994
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010077 2000
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010077 2003
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010077 2006
% 219.86/220.03  |- mesh__dateEstablished mesh__D010077 1991-01-01
% 219.86/220.03  |- skos__broader mesh__D010077smesh__D001381
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010077 1997
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010077 2002
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010077 1993
% 219.86/220.03  |- mesh__dateCreated mesh__D010077 1999-01-01
% 219.86/220.03  |- mesh__publicMeSHNote mesh__D010077 91; was see under AZEPINES 1975-90   
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010077 2005
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010077 1996
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010077 1999
% 219.86/220.03  |- mesh__recordAuthorizer mesh__D010077 PLS
% 219.86/220.03  |- rdf__type mesh__D010077sskos__Concept
% 219.86/220.03  |- mesh__recordMaintainer mesh__D010077 TAP
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010077 1995
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010077 2001
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010077 1998
% 219.86/220.03  |- skos__prefLabel mesh__D010077 Oxazepines
% 219.86/220.03  |- mesh__dateRevised mesh__D010077 1992-05-19
% 219.86/220.03  |- mesh__historyNote mesh__D010077
% 219.86/220.03       91%28%75%29%; was see under AZEPINES 1975-90   
% 219.86/220.03  |- mesh__onlineNote mesh__D010077 search AZEPINES 1974   
% 219.86/220.03  |- mesh__recordOriginator mesh__D010077 NLM
% 219.86/220.03  |- mesh__dateCreated mesh__D004838 1999-01-01
% 219.86/220.03  |- skos__annotation mesh__D004838
% 219.86/220.03       IM GEN or unspecified; NIM with specific long bone IM; DIAPHYSES %28%shaft of long bones%29% is also available%A%  
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004838 2006
% 219.86/220.03  |- skos__altLabel mesh__D004838 Epiphysis
% 219.86/220.03  |- skos__scopeNote mesh__D004838
% 219.86/220.03       The head of a long bone that is separated from the shaft by the epiphyseal plate until bone growth stops. At that time, the plate disappears and the head and shaft are united.%A%    
% 219.86/220.03  |- mesh__recordMaintainer mesh__D004838 KEV
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004838 2005
% 219.86/220.03  |- mesh__recordAuthorizer mesh__D004838 sjn
% 219.86/220.03  |- rdf__type mesh__D004838sskos__Concept
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004838 2002
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004838 2004
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004838 2001
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004838 2003
% 219.86/220.03  |- skos__broader mesh__D004838smesh__D001842
% 219.86/220.03  |- mesh__dateRevised mesh__D004838 1999-11-05
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004838 2000
% 219.86/220.03  |- skos__prefLabel mesh__D004838 Epiphyses
% 219.86/220.03  |- mesh__recordOriginator mesh__D004838 NLM
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D009523 2006
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D009523 1999
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D009523 2001
% 219.86/220.03  |- mesh__recordMaintainer mesh__D009523 TGC
% 219.86/220.03  |- mesh__recordAuthorizer mesh__D009523 PLS
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D009523 2003
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D009523 1996
% 219.86/220.03  |- skos__prefLabel mesh__D009523 Newfoundland
% 219.86/220.03  |- skos__broader mesh__D009523smesh__D002170
% 219.86/220.03  |- skos__scopeNote mesh__D009523
% 219.86/220.03       An island in the Atlantic Ocean, off the east coast of Canada, constituting with Labrador on the mainland, a province of Canada. The name describing a land just discovered was recorded by John Cabot in 1497. %28%From Webster%27%s New Geographical Dictionary, 1988, p831 %26% Room, Brewer%27%s Dictionary of Names, 1992, p376%29%%A%    
% 219.86/220.03  |- mesh__dateRevised mesh__D009523 1995-02-21
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D009523 2004
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D009523 1997
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D009523 2002
% 219.86/220.03  |- mesh__recordOriginator mesh__D009523 NLM
% 219.86/220.03  |- skos__annotation mesh__D009523 a province of Canada   
% 219.86/220.03  |- mesh__dateCreated mesh__D009523 1999-01-01
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D009523 2005
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D009523 1998
% 219.86/220.03  |- rdf__type mesh__D009523sskos__Concept
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D009523 2000
% 219.86/220.03  |- mesh__dateEstablished mesh__D014468 1977-01-01
% 219.86/220.03  |- skos__hiddenLabel mesh__D014468 7 Hydroxycoumarins
% 219.86/220.03  |- skos__historyNote mesh__D014468 Coumarins %28%1969-1976%29%
% 219.86/220.03  |- mesh__dateRevised mesh__D014468 2005-06-30
% 219.86/220.03  |- rdf__type mesh__D014468sskos__Concept
% 219.86/220.03  |- skos__annotation mesh__D014468 /biosyn permitted if by plant   
% 219.86/220.03  |- skos__broader mesh__D014468smesh__D003374
% 219.86/220.03  |- skos__altLabel mesh__D014468 7-Hydroxycoumarins
% 219.86/220.03  |- mesh__dateCreated mesh__D014468 1976-04-13
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D014468 2006
% 219.86/220.03  |- skos__scopeNote mesh__D014468
% 219.86/220.03       7-Hydroxycoumarins. Substances present in many plants, especially umbelliferae. Umbelliferones are used in sunscreen preparations and may be mutagenic. Their derivatives are used in liver therapy, as reagents, plant growth factors, sunscreens, insecticides, parasiticides, choleretics, spasmolytics, etc.%A%    
% 219.86/220.03  |- mesh__historyNote mesh__D014468 77   
% 219.86/220.03  |- mesh__publicMeSHNote mesh__D014468
% 219.86/220.03       77; HYMECROMONE %26% SCOPOLETIN were see under COUMARINS 1975-76%A%  
% 219.86/220.03  |- skos__prefLabel mesh__D014468 Umbelliferones
% 219.86/220.03  |- mesh__recordMaintainer mesh__D014468 ssb
% 219.86/220.03  |- mesh__recordAuthorizer mesh__D014468 sjn
% 219.86/220.03  |- mesh__recordOriginator mesh__D014468 SH
% 219.86/220.03  |- skos__broader mesh__D019951smesh__D004259
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D019951 2006
% 219.86/220.03  |- skos__hiddenLabel mesh__D019951 IV, DNA Polymerase
% 219.86/220.03  |- mesh__publicMeSHNote mesh__D019951 98; see DNA POLYMERASE I 1981-97   
% 219.86/220.03  |- mesh__historyNote mesh__D019951 98; use DNA POLYMERASE I 1981-97   
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D019951 2004
% 219.86/220.03  |- mesh__dateRevised mesh__D019951 2003-07-09
% 219.86/220.03  |- mesh__dateEstablished mesh__D019951 1998-01-01
% 219.86/220.03  |- mesh__dateCreated mesh__D019951 1997-06-25
% 219.86/220.03  |- rdf__type mesh__D019951sskos__Concept
% 219.86/220.03  |- skos__altLabel mesh__D019951 DNA Polymerase IV
% 219.86/220.03  |- skos__hiddenLabel mesh__D019951 Polymerase beta, DNA
% 219.86/220.03  |- skos__prefLabel mesh__D019951 DNA Polymerase beta
% 219.86/220.03  |- skos__hiddenLabel mesh__D019951 Polymerase IV, DNA
% 219.86/220.03  |- skos__scopeNote mesh__D019951
% 219.86/220.03       A DNA repair enzyme that catalyzes DNA synthesis during base excision DNA repair. EC 2.7.7.7.%A%    
% 219.86/220.03  |- skos__historyNote mesh__D019951 DNA Polymerase I %28%1981-1997%29%
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D019951 2005
% 219.86/220.03  |- mesh__historyNote mesh__D033622 2003   
% 219.86/220.03  |- skos__altLabel mesh__D033622 Fruit Fly, Mediterranean
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D033622 2006
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D033622 2004
% 219.86/220.03  |- rdf__type mesh__D033622sskos__Concept
% 219.86/220.03  |- skos__scopeNote mesh__D033622
% 219.86/220.03       A species of fruit fly originating in sub-Saharan Africa but widely distributed worldwide. One of the most destructive fruit pests, its larvae feed and develop on many different fruits and some vegetables.%A%    
% 219.86/220.03  |- skos__prefLabel mesh__D033622 Ceratitis capitata
% 219.86/220.03  |- skos__altLabel mesh__D033622 Mediterranean Fruit Fly
% 219.86/220.03  |- mesh__dateRevised mesh__D033622 2003-07-09
% 219.86/220.03  |- mesh__publicMeSHNote mesh__D033622 2003   
% 219.86/220.03  |- mesh__dateCreated mesh__D033622 2002-07-03
% 219.86/220.03  |- mesh__dateEstablished mesh__D033622 2003-01-01
% 219.86/220.03  |- skos__altLabel mesh__D033622 Medfly
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D033622 2005
% 219.86/220.03  |- skos__broader mesh__D033622smesh__D033621
% 219.86/220.03  |- skos__hiddenLabel mesh__D000448 ENT27,093
% 219.86/220.03  |- skos__historyNote mesh__D000448 Insecticides %28%1966-1971%29%
% 219.86/220.03  |- mesh__historyNote mesh__D000448
% 219.86/220.03       91%28%72%29%; was see under INSECTICIDES, CARBAMATE 1972-90   
% 219.86/220.03  |- mesh__dateEstablished mesh__D000448 1991-01-01
% 219.86/220.03  |- mesh__publicMeSHNote mesh__D000448
% 219.86/220.03       91; was see under INSECTICIDES, CARBAMATE 1972-90   
% 219.86/220.03  |- skos__scopeNote mesh__D000448
% 219.86/220.03       Carbamate derivative used as an insecticide, acaricide, and nematocide.%A%    
% 219.86/220.03  |- skos__hiddenLabel mesh__D000448 ENT 27,093
% 219.86/220.03  |- skos__broader mesh__D000448smesh__D002219
% 219.86/220.03  |- skos__hiddenLabel mesh__D000448 UC 21,149
% 219.86/220.03  |- mesh__recordMaintainer mesh__D000448 ssb
% 219.86/220.03  |- skos__hiddenLabel mesh__D000448 UC21149
% 219.86/220.03  |- mesh__dateRevised mesh__D000448 2005-06-30
% 219.86/220.03  |- rdf__type mesh__D000448sskos__Concept
% 219.86/220.03  |- skos__hiddenLabel mesh__D000448 UC21,149
% 219.86/220.03  |- skos__historyNote mesh__D000448 Carbamates %28%1966-1971%29%
% 219.86/220.03  |- mesh__dateCreated mesh__D000448 1999-01-01
% 219.86/220.03  |- mesh__recordOriginator mesh__D000448 NLM
% 219.86/220.03  |- skos__altLabel mesh__D000448 UC-21149
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D000448 2006
% 219.86/220.03  |- skos__prefLabel mesh__D000448 Aldicarb
% 219.86/220.03  |- skos__hiddenLabel mesh__D000448 UC 21149
% 219.86/220.03  |- mesh__recordAuthorizer mesh__D000448 sjn
% 219.86/220.03  |- skos__historyNote mesh__D011170
% 219.86/220.03       Esophageal and Gastric Varices/surgery %28%1966-1980%29%
% 219.86/220.03  |- skos__altLabel mesh__D011170 Shunt, Surgical Portosystemic
% 219.86/220.03  |- skos__historyNote mesh__D011170
% 219.86/220.03       specific portal system vein/surgery %28%1966-1980%29%
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D011170 2004
% 219.86/220.03  |- skos__scopeNote mesh__D011170
% 219.86/220.03       Surgical venous shunt between the portal and systemic circulation to effect decompression of the portal circulation. It is performed primarily in the treatment of bleeding esophageal varices resulting from portal hypertension. Types of shunt include portacaval, splenorenal, mesocaval, splenocaval, left gastric-caval %28%coronary-caval%29%, portarenal, umbilicorenal, and umbilicocaval.%A%    
% 219.86/220.03  |- skos__hiddenLabel mesh__D011170 Shunt, Portosystemic
% 219.86/220.03  |- skos__prefLabel mesh__D011170 Portasystemic Shunt, Surgical
% 219.86/220.03  |- skos__hiddenLabel mesh__D011170 Portasystemic Shunts, Surgical
% 219.86/220.03  |- rdf__type mesh__D011170sskos__Concept
% 219.86/220.03  |- mesh__recordMaintainer mesh__D011170 PXP
% 219.86/220.03  |- skos__altLabel mesh__D011170 Surgical Portosystemic Shunt
% 219.86/220.03  |- skos__hiddenLabel mesh__D011170 Shunts, Surgical Portasystemic
% 219.86/220.03  |- skos__historyNote mesh__D011170
% 219.86/220.03       Portacaval Shunt, Surgical %28%1966-1980%29%
% 219.86/220.03  |- skos__altLabel mesh__D011170 Surgical Portasystemic Shunt
% 219.86/220.03  |- mesh__recordAuthorizer mesh__D011170 SJN
% 219.86/220.03  |- skos__hiddenLabel mesh__D011170 Shunts, Portasystemic
% 219.86/220.03  |- mesh__recordOriginator mesh__D011170 SMH
% 219.86/220.03  |- skos__hiddenLabel mesh__D011170 Surgical Portosystemic Shunts
% 219.86/220.03  |- skos__hiddenLabel mesh__D011170 Portosystemic Shunts
% 219.86/220.03  |- skos__historyNote mesh__D011170
% 219.86/220.03       Hypertension, Portal/surgery %28%1966-1980%29%
% 219.86/220.03  |- mesh__dateCreated mesh__D011170 1980-03-25
% 219.86/220.03  |- skos__hiddenLabel mesh__D011170 Shunt, Portasystemic
% 219.86/220.03  |- mesh__historyNote mesh__D011170 81   
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D011170 2000
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D011170 1998
% 219.86/220.03  |- skos__altLabel mesh__D011170 Portosystemic Shunt
% 219.86/220.03  |- skos__broader mesh__D011170smesh__D000714
% 219.86/220.03  |- skos__hiddenLabel mesh__D011170 Portasystemic Shunts
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D011170 2005
% 219.86/220.03  |- skos__annotation mesh__D011170
% 219.86/220.03       GEN or unspecified; prefer specifics; see MeSH definition for types; do not use /util except by MeSH definition; DF: PORTASYSTEMIC SHUNT%A%  
% 219.86/220.03  |- skos__hiddenLabel mesh__D011170 Surgical Portasystemic Shunts
% 219.86/220.03  |- skos__hiddenLabel mesh__D011170 Shunts, Portosystemic
% 219.86/220.03  |- mesh__dateEstablished mesh__D011170 1981-01-01
% 219.86/220.03  |- mesh__dateRevised mesh__D011170 1997-06-20
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D011170 1999
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D011170 2001
% 219.86/220.03  |- mesh__publicMeSHNote mesh__D011170 81   
% 219.86/220.03  |- skos__altLabel mesh__D011170 Portosystemic Shunt, Surgical
% 219.86/220.03  |- skos__historyNote mesh__D011170 Portal System/surgery %28%1966-1980%29%
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D011170 2006
% 219.86/220.03  |- skos__hiddenLabel mesh__D011170 Shunts, Surgical Portosystemic
% 219.86/220.03  |- skos__altLabel mesh__D011170 Shunt, Surgical Portasystemic
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D011170 2003
% 219.86/220.03  |- skos__hiddenLabel mesh__D011170 Portosystemic Shunts, Surgical
% 219.86/220.03  |- skos__broader mesh__D011170smesh__D014656
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D011170 2002
% 219.86/220.03  |- skos__altLabel mesh__D011170 Portasystemic Shunt
% 219.86/220.03  |- mesh__recordAuthorizer mesh__D005931 sjn
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D005931 2003
% 219.86/220.03  |- skos__scopeNote mesh__D005931
% 219.86/220.03       The vocal apparatus of the larynx, consisting of the true vocal cords %28%plica vocalis%29% and the opening between them %28%rima glottidis%29%.%A%    
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D005931 2004
% 219.86/220.03  |- mesh__recordMaintainer mesh__D005931 mdb
% 219.86/220.03  |- mesh__recordOriginator mesh__D005931 NLM
% 219.86/220.03  |- skos__broader mesh__D005931smesh__D007830
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D005931 2005
% 219.86/220.03  |- skos__annotation mesh__D005931
% 219.86/220.03       glottitis: coord NIM with LARYNGITIS %28%IM%29%; stenosis = LARYNGOSTENOSIS%A%  
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D005931 2006
% 219.86/220.03  |- mesh__dateRevised mesh__D005931 2002-07-03
% 219.86/220.03  |- skos__prefLabel mesh__D005931 Glottis
% 219.86/220.03  |- mesh__dateCreated mesh__D005931 1999-01-01
% 219.86/220.03  |- rdf__type mesh__D005931sskos__Concept
% 219.86/220.03  |- skos__related mesh__D005133smesh__D004585
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D005133 2006A
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D005133 2006
% 219.86/220.03  |- skos__broader mesh__D005133smesh__D043723
% 219.86/220.03  |- skos__related mesh__D005133smesh__D012895
% 219.86/220.03  |- skos__annotation mesh__D005133
% 219.86/220.03       nystagmography may go here but consider also ELECTRONYSTAGMOGRAPHY%A%  
% 219.86/220.03  |- mesh__dateCreated mesh__D005133 1999-01-01
% 219.86/220.03  |- mesh__dateRevised mesh__D005133 2005-07-22
% 219.86/220.03  |- skos__related mesh__D005133smesh__D009759
% 219.86/220.03  |- skos__broader mesh__D005133smesh__D003941
% 219.86/220.03  |- skos__hiddenLabel mesh__D005133 Eye Movement
% 219.86/220.03  |- skos__hiddenLabel mesh__D005133 Movements, Eye
% 219.86/220.03  |- mesh__recordAuthorizer mesh__D005133 ags
% 219.86/220.03  |- mesh__recordOriginator mesh__D005133 NLM
% 219.86/220.03  |- skos__hiddenLabel mesh__D005133 Movement, Eye
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D005133 2004
% 219.86/220.03  |- skos__broader mesh__D005133smesh__D009068
% 219.86/220.03  |- skos__scopeNote mesh__D005133
% 219.86/220.03       Voluntary or reflex-controlled movements of the eye.     
% 219.86/220.03  |- rdf__type mesh__D005133sskos__Concept
% 219.86/220.03  |- mesh__recordMaintainer mesh__D005133 ags
% 219.86/220.03  |- skos__prefLabel mesh__D005133 Eye Movements
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D005133 2005
% 219.86/220.03  |- skos__related mesh__D018859smesh__D005499
% 219.86/220.03  |- rdf__type mesh__D018859sskos__Concept
% 219.86/220.03  |- skos__hiddenLabel mesh__D018859 Follicles, Hair
% 219.86/220.03  |- mesh__historyNote mesh__D018859 96   
% 219.86/220.03  |- mesh__dateRevised mesh__D018859 2002-07-03
% 219.86/220.03  |- skos__hiddenLabel mesh__D018859 Hair Follicles
% 219.86/220.03  |- skos__prefLabel mesh__D018859 Hair Follicle
% 219.86/220.03  |- skos__hiddenLabel mesh__D018859 Follicle, Hair
% 219.86/220.03  |- mesh__recordAuthorizer mesh__D018859 sjn
% 219.86/220.03  |- skos__broader mesh__D018859smesh__D004817
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D018859 2003
% 219.86/220.03  |- skos__scopeNote mesh__D018859
% 219.86/220.03       A tube-like invagination of the EPIDERMIS from which the hair shaft develops and into which SEBACEOUS GLANDS open. The hair follicle is lined by a cellular inner and outer root sheath of epidermal origin and is invested with a fibrous sheath derived from the dermis. %28%Stedman, 26th ed%29% Follicles of very long hairs extend into the subcutaneous layer of tissue under the SKIN.%A%    
% 219.86/220.03  |- mesh__dateEstablished mesh__D018859 1996-01-01
% 219.86/220.03  |- mesh__dateCreated mesh__D018859 1994-12-27
% 219.86/220.03  |- mesh__recordMaintainer mesh__D018859 nns
% 219.86/220.03  |- mesh__publicMeSHNote mesh__D018859 96   
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D018859 2005
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D018859 2004
% 219.86/220.03  |- skos__broader mesh__D018859smesh__D006197
% 219.86/220.03  |- mesh__recordOriginator mesh__D018859 TGC
% 219.86/220.03  |- skos__historyNote mesh__D018859 Hair %28%1966-1995%29%
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D018859 2006
% 219.86/220.03  |- skos__annotation mesh__D018859
% 219.86/220.03       dis = HAIR FOLLICLE %28%IM%29% + HAIR DISEASES %28%NIM%29%; inflammation = FOLLICULITIS%A%  
% 219.86/220.03  |- mesh__publicMeSHNote mesh__D010876
% 219.86/220.03       91; was see under NICOTINIC ACIDS 1979-90   
% 219.86/220.03  |- mesh__dateCreated mesh__D010876 1977-12-09
% 219.86/220.03  |- skos__broader mesh__D010876smesh__D010879
% 219.86/220.03  |- skos__altLabel mesh__D010876 Almirall Brand of Pipemidic Acid
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010876 2006
% 219.86/220.03  |- skos__altLabel mesh__D010876 Aventis Brand of Pipemidic Acid
% 219.86/220.03  |- skos__hiddenLabel mesh__D010876 Acid, Piperamic
% 219.86/220.03  |- skos__prefLabel mesh__D010876 Pipemidic Acid
% 219.86/220.03  |- mesh__dateEstablished mesh__D010876 1991-01-01
% 219.86/220.03  |- skos__altLabel mesh__D010876 Tedec Meiji Brand of Pipemidic Acid
% 219.86/220.03  |- skos__scopeNote mesh__D010876
% 219.86/220.03       Antimicrobial against Gram negative and some Gram positive bacteria. It is protein bound and concentrated in bile and urine and used for gastrointestinal, biliary, and urinary infections.%A%    
% 219.86/220.03  |- skos__broader mesh__D010876smesh__D009539
% 219.86/220.03  |- skos__hiddenLabel mesh__D010876 Acid, Pipemidic
% 219.86/220.03  |- skos__altLabel mesh__D010876 Madaus Brand of Pipemidic Acid
% 219.86/220.03  |- skos__altLabel mesh__D010876 AF Brand of Pipemidic Acid
% 219.86/220.03  |- mesh__recordAuthorizer mesh__D010876 sjn
% 219.86/220.03  |- skos__historyNote mesh__D010876 Nalidixic Acid %28%1966-1975%29%
% 219.86/220.03  |- rdf__type mesh__D010876sskos__Concept
% 219.86/220.03  |- skos__altLabel mesh__D010876 Piperamic Acid
% 219.86/220.03  |- mesh__historyNote mesh__D010876
% 219.86/220.03       91%28%79%29%; was see under NICOTINIC ACIDS 1979-90   
% 219.86/220.03  |- mesh__recordOriginator mesh__D010876 SH
% 219.86/220.03  |- mesh__recordMaintainer mesh__D010876 lkw
% 219.86/220.03  |- skos__altLabel mesh__D010876
% 219.86/220.03       Rh%C3%%B4%ne-Poulenc Brand of Pipemidic Acid
% 219.86/220.03  |- skos__historyNote mesh__D010876 Piperazines %28%1966-1970%29%
% 219.86/220.03  |- mesh__dateRevised mesh__D010876 2005-06-30
% 219.86/220.03  |- skos__historyNote mesh__D010876 Nicotinic Acids %28%1976-1978%29%
% 219.86/220.03  |- skos__altLabel mesh__D010876 Nuril
% 219.86/220.03  |- skos__scopeNote mesh__D029581
% 219.86/220.03       A plant family of the order Polygalales, subclass Rosidae class, Magnoliopsida that are mostly shrubs and small trees. Many of the members contain indole alkaloids.%A%    
% 219.86/220.03  |- rdf__type mesh__D029581sskos__Concept
% 219.86/220.03  |- mesh__recordAuthorizer mesh__D029581 sjn
% 219.86/220.03  |- mesh__publicMeSHNote mesh__D029581 2002   
% 219.86/220.03  |- mesh__dateRevised mesh__D029581 2002-07-03
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D029581 2006
% 219.86/220.03  |- mesh__dateCreated mesh__D029581 2001-07-25
% 219.86/220.03  |- skos__broader mesh__D029581smesh__D019684
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D029581 2005
% 219.86/220.03  |- skos__annotation mesh__D029581
% 219.86/220.03       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D029581 2004
% 219.86/220.03  |- mesh__historyNote mesh__D029581 2002   
% 219.86/220.03  |- skos__prefLabel mesh__D029581 Malpighiaceae
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D029581 2003
% 219.86/220.03  |- mesh__recordOriginator mesh__D029581 ssb
% 219.86/220.03  |- mesh__dateEstablished mesh__D029581 2002-01-01
% 219.86/220.03  |- mesh__recordMaintainer mesh__D029581 ssb
% 219.86/220.03  |- skos__scopeNote mesh__D010078
% 219.86/220.03       Six-membered heterocycles containing an oxygen and a nitrogen.%A%    
% 219.86/220.03  |- skos__broader mesh__D010078smesh__D006573
% 219.86/220.03  |- mesh__recordMaintainer mesh__D010078 ssb
% 219.86/220.03  |- mesh__recordOriginator mesh__D010078 NLM
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010078 2006
% 219.86/220.03  |- mesh__dateCreated mesh__D010078 1999-01-01
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D010078 2005
% 219.86/220.03  |- rdf__type mesh__D010078sskos__Concept
% 219.86/220.03  |- mesh__dateRevised mesh__D010078 2004-07-07
% 219.86/220.03  |- mesh__recordAuthorizer mesh__D010078 sjn
% 219.86/220.03  |- skos__prefLabel mesh__D010078 Oxazines
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004839 1994
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004839 2005
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004839 2001
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004839 1998
% 219.86/220.03  |- mesh__recordAuthorizer mesh__D004839 PLS
% 219.86/220.03  |- skos__broader mesh__D004839smesh__D001847
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004839 1995
% 219.86/220.03  |- skos__hiddenLabel mesh__D004839 Epiphysiolyses
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004839 2006
% 219.86/220.03  |- mesh__dateEstablished mesh__D004839 1967-01-01
% 219.86/220.03  |- mesh__recordOriginator mesh__D004839 NLM
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004839 1999
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004839 1992
% 219.86/220.03  |- mesh__historyNote mesh__D004839 67   
% 219.86/220.03  |- skos__historyNote mesh__D004839 Bone Diseases %28%1966%29%
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004839 2003
% 219.86/220.03  |- rdf__type mesh__D004839sskos__Concept
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004839 1993
% 219.86/220.03  |- mesh__publicMeSHNote mesh__D004839 67   
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004839 1996
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004839 2002
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004839 2004
% 219.86/220.03  |- skos__hiddenLabel mesh__D004839 Slipped Epiphyses
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004839 1997
% 219.86/220.03  |- mesh__dateCreated mesh__D004839 1999-01-01
% 219.86/220.03  |- mesh__recordMaintainer mesh__D004839 TGC
% 219.86/220.03  |- skos__historyNote mesh__D004839 Epiphyses %28%1966%29%
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D004839 2000
% 219.86/220.03  |- mesh__dateRevised mesh__D004839 1991-06-18
% 219.86/220.03  |- skos__altLabel mesh__D004839 Epiphysiolysis
% 219.86/220.03  |- skos__prefLabel mesh__D004839 Epiphyses, Slipped
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D009524 2003
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D009524 2000
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D009524 2004
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D009524 2001
% 219.86/220.03  |- skos__prefLabel mesh__D009524 Newspapers
% 219.86/220.03  |- mesh__recordAuthorizer mesh__D009524 SJN
% 219.86/220.03  |- skos__hiddenLabel mesh__D009524 Newspaper
% 219.86/220.03  |- mesh__recordMaintainer mesh__D009524 TPW
% 219.86/220.03  |- skos__broader mesh__D009524smesh__D012693
% 219.86/220.03  |- skos__annotation mesh__D009524
% 219.86/220.03       med newspapers: do not coord with MEDICINE; do not confuse with NEWSLETTERS see PERIODICALS; do not confuse with Publication Types NEWS or NEWSPAPER ARTICLE%A%  
% 219.86/220.03  |- mesh__dateCreated mesh__D009524 1999-01-01
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D009524 2005
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D009524 1998
% 219.86/220.03  |- rdf__type mesh__D009524sskos__Concept
% 219.86/220.03  |- mesh__recordOriginator mesh__D009524 NLM
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D009524 2002
% 219.86/220.03  |- mesh__dateRevised mesh__D009524 1997-06-20
% 219.86/220.03  |- skos__scopeNote mesh__D009524
% 219.86/220.03       Publications printed and distributed daily, weekly, or at some other regular and usually short interval, containing news, articles of opinion %28%as editorials and letters%29%, features, advertising, and announcements of current interest. %28%Webster%27%s 3d ed%29%%A%    
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D009524 2006
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D009524 1999
% 219.86/220.03  |- rdf__type mesh__D001541sskos__Concept
% 219.86/220.03  |- skos__broader mesh__D001541smesh__D000354
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D001541 2003
% 219.86/220.03  |- skos__scopeNote mesh__D001541
% 219.86/220.03       A republic in western Africa, south of NIGER and between TOGO and NIGERIA. Its capital is Porto-Novo. It was formerly called Dahomey. In the 17th century it was a kingdom in the southern area of Africa. Coastal footholds were established by the French who deposed the ruler by 1892. It was made a French colony in 1894 and gained independence in 1960. Benin comes from the name of the indigenous inhabitants, the Bini, now more closely linked with southern Nigeria %28%Benin City, a town there%29%. Bini may be related to the Arabic bani, sons. %28%From Webster%27%s New Geographical Dictionary, 1988, p136, 310 %26% Room, Brewer%27%s Dictionary of Names, 1992, p60%29%%A%    
% 219.86/220.03  |- mesh__recordMaintainer mesh__D001541 TGC
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D001541 2000
% 219.86/220.03  |- mesh__onlineNote mesh__D001541 use BENIN to search DAHOMEY 1966-79   
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D001541 2004
% 219.86/220.03  |- mesh__recordAuthorizer mesh__D001541 SJN
% 219.86/220.03  |- mesh__historyNote mesh__D001541 80; was DAHOMEY 1966-79   
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D001541 2001
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D001541 2005
% 219.86/220.03  |- mesh__dateCreated mesh__D001541 1999-01-01
% 219.86/220.03  |- skos__prefLabel mesh__D001541 Benin
% 219.86/220.03  |- mesh__dateRevised mesh__D001541 1997-06-20
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D001541 2002
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D001541 2006
% 219.86/220.03  |- skos__altLabel mesh__D001541 Dahomey
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D001541 1998
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D001541 1999
% 219.86/220.03  |- skos__annotation mesh__D001541
% 219.86/220.03       a republic in western Africa; X ref DAHOMEY was its former name%A%  
% 219.86/220.03  |- mesh__recordOriginator mesh__D001541 NLM
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D014469 1996
% 219.86/220.03  |- skos__historyNote mesh__D014469 Umbilical Cord/BS %28%1966-1967%29%
% 219.86/220.03  |- skos__broader mesh__D014469smesh__D014470
% 219.86/220.03  |- mesh__dateCreated mesh__D014469 1999-01-01
% 219.86/220.03  |- skos__hiddenLabel mesh__D014469 Artery, Umbilical
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D014469 1998
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D014469 2002
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D014469 1997
% 219.86/220.03  |- rdf__type mesh__D014469sskos__Concept
% 219.86/220.03  |- mesh__dateEstablished mesh__D014469 1968-01-01
% 219.86/220.03  |- skos__scopeNote mesh__D014469
% 219.86/220.03       Either of a pair of arteries originating from the internal iliac artery and passing through the umbilical cord to carry blood from the fetus to the placenta.%A%    
% 219.86/220.03  |- skos__broader mesh__D014469smesh__D001158
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D014469 1999
% 219.86/220.03  |- mesh__historyNote mesh__D014469 68%28%64%29%   
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D014469 2003
% 219.86/220.03  |- skos__hiddenLabel mesh__D014469 Umbilical Artery
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D014469 2000
% 219.86/220.03  |- mesh__activeMeSHYear mesh__D014469 1994
% 219.86/220.03  |- mesh__recordMaintainer mesh__D014469 TAP
% 219.86/220.03  |- skos__hiddenLabel mesh__D014469 Arteries, Umbilical
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D014469 1993
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D014469 2005
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D014469 2004
% 219.86/220.04  |- mesh__recordAuthorizer mesh__D014469 PLS
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D014469 2001
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D014469 1995
% 219.86/220.04  |- mesh__dateRevised mesh__D014469 1992-05-18
% 219.86/220.04  |- mesh__recordOriginator mesh__D014469 NLM
% 219.86/220.04  |- skos__prefLabel mesh__D014469 Umbilical Arteries
% 219.86/220.04  |- mesh__publicMeSHNote mesh__D014469 68   
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D014469 2006
% 219.86/220.04  |- rdf__type mesh__D019952sskos__Concept
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D019952 1998
% 219.86/220.04  |- skos__scopeNote mesh__D019952
% 219.86/220.04       Those psychiatric disorders usually first diagnosed in infancy, childhood, or adolescence. These disorders can also be first diagnosed during other life stages.%A%    
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D019952 2002
% 219.86/220.04  |- skos__annotation mesh__D019952
% 219.86/220.04       Not used for indexing; do not use for diagnosis of a specific disorder in a child DF: MENTAL DIS DIAG CHILD      CATALOG: do not use%A%  
% 219.86/220.04  |- skos__broader mesh__D019952smesh__D001523
% 219.86/220.04  |- skos__prefLabel mesh__D019952 Mental Disorders Diagnosed in Childhood
% 219.86/220.04  |- skos__hiddenLabel mesh__D019952 Mental Disorder, Child
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D019952 1999
% 219.86/220.04  |- skos__hiddenLabel mesh__D019952 Child Mental Disorder
% 219.86/220.04  |- mesh__historyNote mesh__D019952 98   
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D019952 2005
% 219.86/220.04  |- skos__hiddenLabel mesh__D019952 Mental Disorders, Child
% 219.86/220.04  |- mesh__dateEstablished mesh__D019952 1998-01-01
% 219.86/220.04  |- skos__altLabel mesh__D019952
% 219.86/220.04       Disorders Usually Diagnosed in Infancy, Childhood or Adolescence
% 219.86/220.04  |- skos__hiddenLabel mesh__D019952 Disorders, Child Mental
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D019952 2003
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D019952 2006
% 219.86/220.04  |- skos__hiddenLabel mesh__D019952 Disorder, Child Mental
% 219.86/220.04  |- mesh__publicMeSHNote mesh__D019952 98   
% 219.86/220.04  |- mesh__dateCreated mesh__D019952 1997-06-20
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D019952 2000
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D019952 2004
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D019952 2001
% 219.86/220.04  |- skos__scopeNote mesh__D019154
% 219.86/220.04       The excision of in-frame internal protein sequences %28%INTEINS%29% of a precursor protein, coupled with ligation of the flanking sequences %28%EXTEINS%29%. Protein splicing is an autocatalytic reaction and results in the production of two proteins from a single primary translation product: the intein and the mature protein.%A%    
% 219.86/220.04  |- skos__historyNote mesh__D019154
% 219.86/220.04       Protein Processing, Post-Translational %28%1990-1996%29%
% 219.86/220.04  |- mesh__historyNote mesh__D019154 97   
% 219.86/220.04  |- rdf__type mesh__D019154sskos__Concept
% 219.86/220.04  |- mesh__dateCreated mesh__D019154 1996-02-12
% 219.86/220.04  |- skos__related mesh__D019154smesh__D047669
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D019154 2006
% 219.86/220.04  |- mesh__recordOriginator mesh__D019154 AGS
% 219.86/220.04  |- skos__broader mesh__D019154smesh__D011499
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D019154 2005
% 219.86/220.04  |- mesh__recordMaintainer mesh__D019154 nns
% 219.86/220.04  |- skos__hiddenLabel mesh__D019154 Splicing, Protein
% 219.86/220.04  |- mesh__recordAuthorizer mesh__D019154 sjn
% 219.86/220.04  |- skos__hiddenLabel mesh__D019154 Splicings, Protein
% 219.86/220.04  |- mesh__dateRevised mesh__D019154 2004-07-07
% 219.86/220.04  |- skos__hiddenLabel mesh__D019154 Protein Splicings
% 219.86/220.04  |- skos__related mesh__D019154smesh__D047668
% 219.86/220.04  |- skos__prefLabel mesh__D019154 Protein Splicing
% 219.86/220.04  |- mesh__dateEstablished mesh__D019154 1997-01-01
% 219.86/220.04  |- mesh__publicMeSHNote mesh__D019154 97   
% 219.86/220.04  |- mesh__dateEstablished mesh__D000449 1991-01-01
% 219.86/220.04  |- skos__hiddenLabel mesh__D000449 Reductase, Aldose
% 219.86/220.04  |- mesh__dateCreated mesh__D000449 1975-07-23
% 219.86/220.04  |- skos__historyNote mesh__D000449 Sugar Alcohols %28%1972-1975%29%
% 219.86/220.04  |- skos__hiddenLabel mesh__D000449 Reductase, Xylose
% 219.86/220.04  |- rdf__type mesh__D000449sskos__Concept
% 219.86/220.04  |- skos__broader mesh__D000449smesh__D013401
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D000449 2005
% 219.86/220.04  |- skos__hiddenLabel mesh__D000449 Reductase, Aldehyde
% 219.86/220.04  |- skos__prefLabel mesh__D000449 Aldehyde Reductase
% 219.86/220.04  |- mesh__recordAuthorizer mesh__D000449 sjn
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D000449 2006
% 219.86/220.04  |- skos__scopeNote mesh__D000449
% 219.86/220.04       An enzyme that catalyzes reversibly the oxidation of an aldose to an alditol. It possesses broad specificity for many aldoses. EC 1.1.1.21.%A%    
% 219.86/220.04  |- skos__historyNote mesh__D000449
% 219.86/220.04       Alcohol Oxidoreductases %28%1972-1975%29%
% 219.86/220.04  |- skos__hiddenLabel mesh__D000449 Reductase Ia, Aldose
% 219.86/220.04  |- mesh__publicMeSHNote mesh__D000449
% 219.86/220.04       92; was ALDOSE REDUCTASE 1976-91 %28%see under SUGAR ALCOHOL DEHYDROGENASES 1978-90, see under ALCOHOL OXIDOREDUCTASES 1976-77%29%%A%  
% 219.86/220.04  |- mesh__dateRevised mesh__D000449 2003-07-09
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D000449 2004
% 219.86/220.04  |- mesh__onlineNote mesh__D000449
% 219.86/220.04       use ALDEHYDE REDUCTASE to search ALDOSE REDUCTASE 1976-91%A%  
% 219.86/220.04  |- skos__hiddenLabel mesh__D000449 Reductase Ib, Aldose
% 219.86/220.04  |- mesh__recordMaintainer mesh__D000449 ssb
% 219.86/220.04  |- mesh__historyNote mesh__D000449
% 219.86/220.04       92; was ALDOSE REDUCTASE 1976-91 %28%see under SUGAR ALCOHOL DEHYDROGENASES 1978-90, see under ALCOHOL OXIDOREDUCTASES 1976-77%29%%A%  
% 219.86/220.04  |- skos__hiddenLabel mesh__D000449 Reductase, Erythrose
% 219.86/220.04  |- mesh__recordOriginator mesh__D000449 RLS
% 219.86/220.04  |- skos__altLabel mesh__D000449 Aldose Reductase
% 219.86/220.04  |- skos__historyNote mesh__D011171 Duodenum/surgery %28%1971-1987%29%
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D011171 1999
% 219.86/220.04  |- skos__annotation mesh__D011171
% 219.86/220.04       do not use /util except by MeSH definition; DF: PORTOENTEROSTOMY%A%  
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D011171 1998
% 219.86/220.04  |- skos__historyNote mesh__D011171 Liver/surgery %28%1971-1987%29%
% 219.86/220.04  |- skos__altLabel mesh__D011171 Hepatic Portoenterostomy
% 219.86/220.04  |- skos__historyNote mesh__D011171 Biliary Atresia/surgery %28%1987%29%
% 219.86/220.04  |- mesh__recordOriginator mesh__D011171 SCD
% 219.86/220.04  |- skos__hiddenLabel mesh__D011171 Hepatic Portoenterostomies
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D011171 2002
% 219.86/220.04  |- skos__broader mesh__D011171smesh__D000714
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D011171 2004
% 219.86/220.04  |- mesh__recordAuthorizer mesh__D011171 SJN
% 219.86/220.04  |- skos__historyNote mesh__D011171 Jejunum/surgery %28%1971-1987%29%
% 219.86/220.04  |- skos__broader mesh__D011171smesh__D001662
% 219.86/220.04  |- mesh__dateEstablished mesh__D011171 1988-01-01
% 219.86/220.04  |- mesh__recordMaintainer mesh__D011171 PXP
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D011171 2001
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D011171 2006
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D011171 2003
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D011171 2000
% 219.86/220.04  |- skos__prefLabel mesh__D011171 Portoenterostomy, Hepatic
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D011171 2005
% 219.86/220.04  |- mesh__historyNote mesh__D011171 88   
% 219.86/220.04  |- mesh__dateRevised mesh__D011171 1997-06-20
% 219.86/220.04  |- rdf__type mesh__D011171sskos__Concept
% 219.86/220.04  |- skos__historyNote mesh__D011171 Bile Ducts/surgery %28%1971-1987%29%
% 219.86/220.04  |- mesh__dateCreated mesh__D011171 1987-03-20
% 219.86/220.04  |- skos__scopeNote mesh__D011171
% 219.86/220.04       Operation for biliary atresia by anastomosis of the bile ducts into the jejunum or duodenum.%A%    
% 219.86/220.04  |- mesh__publicMeSHNote mesh__D011171 88   
% 219.86/220.04  |- skos__hiddenLabel mesh__D011171 Portoenterostomies, Hepatic
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005932 2004
% 219.86/220.04  |- skos__prefLabel mesh__D005932 Gloves, Surgical
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005932 2000
% 219.86/220.04  |- mesh__dateRevised mesh__D005932 1997-06-20
% 219.86/220.04  |- skos__annotation mesh__D005932
% 219.86/220.04       do not use /util except by MeSH definition: DF: GLOVES SURG%A%  
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005932 2005
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005932 2001
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005932 1998
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005932 2006
% 219.86/220.04  |- skos__hiddenLabel mesh__D005932 Surgical Glove
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005932 2002
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005932 1999
% 219.86/220.04  |- skos__altLabel mesh__D005932 Surgical Gloves
% 219.86/220.04  |- skos__scopeNote mesh__D005932
% 219.86/220.04       Gloves, usually rubber, worn by surgeons, examining physicians, dentists, and other health personnel for the mutual protection of personnel and patient.%A%    
% 219.86/220.04  |- skos__hiddenLabel mesh__D005932 Glove, Surgical
% 219.86/220.04  |- mesh__recordOriginator mesh__D005932 NLM
% 219.86/220.04  |- mesh__dateCreated mesh__D005932 1999-01-01
% 219.86/220.04  |- rdf__type mesh__D005932sskos__Concept
% 219.86/220.04  |- mesh__recordAuthorizer mesh__D005932 SJN
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005932 2003
% 219.86/220.04  |- mesh__recordMaintainer mesh__D005932 JLS
% 219.86/220.04  |- skos__broader mesh__D005932smesh__D017575
% 219.86/220.04  |- skos__hiddenLabel mesh__D005134 Eye Cancers
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005134 2002
% 219.86/220.04  |- mesh__dateCreated mesh__D005134 1999-01-01
% 219.86/220.04  |- mesh__recordMaintainer mesh__D005134 nns
% 219.86/220.04  |- skos__annotation mesh__D005134
% 219.86/220.04       coord IM with specific site in eye %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005134 2003
% 219.86/220.04  |- skos__hiddenLabel mesh__D005134 Cancer, Eye
% 219.86/220.04  |- skos__scopeNote mesh__D005134 Tumors or cancer of the EYE.     
% 219.86/220.04  |- skos__broader mesh__D005134smesh__D009371
% 219.86/220.04  |- skos__hiddenLabel mesh__D005134 Eye Neoplasm
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005134 2004
% 219.86/220.04  |- mesh__recordAuthorizer mesh__D005134 sjn
% 219.86/220.04  |- skos__hiddenLabel mesh__D005134 Cancers, Eye
% 219.86/220.04  |- rdf__type mesh__D005134sskos__Concept
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005134 2001
% 219.86/220.04  |- skos__broader mesh__D005134smesh__D005128
% 219.86/220.04  |- skos__hiddenLabel mesh__D005134 Neoplasm, Eye
% 219.86/220.04  |- skos__altLabel mesh__D005134 Eye Cancer
% 219.86/220.04  |- skos__altLabel mesh__D005134 Neoplasms, Eye
% 219.86/220.04  |- skos__altLabel mesh__D005134 Cancer of the Eye
% 219.86/220.04  |- mesh__dateRevised mesh__D005134 2000-06-22
% 219.86/220.04  |- mesh__recordOriginator mesh__D005134 NLM
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005134 2005
% 219.86/220.04  |- skos__prefLabel mesh__D005134 Eye Neoplasms
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005134 2006
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D029582 2006
% 219.86/220.04  |- skos__annotation mesh__D029582
% 219.86/220.04       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.86/220.04  |- mesh__recordMaintainer mesh__D029582 ssb
% 219.86/220.04  |- mesh__dateRevised mesh__D029582 2003-07-09
% 219.86/220.04  |- skos__scopeNote mesh__D029582
% 219.86/220.04       The mahogany plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida.%A%    
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D029582 2005
% 219.86/220.04  |- mesh__recordAuthorizer mesh__D029582 sjn
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D029582 2004
% 219.86/220.04  |- mesh__dateCreated mesh__D029582 2001-07-25
% 219.86/220.04  |- skos__broader mesh__D029582smesh__D019684
% 219.86/220.04  |- mesh__recordOriginator mesh__D029582 ssb
% 219.86/220.04  |- mesh__dateEstablished mesh__D029582 2002-01-01
% 219.86/220.04  |- mesh__historyNote mesh__D029582 2002   
% 219.86/220.04  |- skos__prefLabel mesh__D029582 Meliaceae
% 219.86/220.04  |- rdf__type mesh__D029582sskos__Concept
% 219.86/220.04  |- mesh__publicMeSHNote mesh__D029582 2002   
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D010079 2005
% 219.86/220.04  |- mesh__dateEstablished mesh__D010079 1975-09-01
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D010079 1996
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D010079 2002
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D010079 1999
% 219.86/220.04  |- rdf__type mesh__D010079sskos__Concept
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D010079 1995
% 219.86/220.04  |- skos__scopeNote mesh__D010079
% 219.86/220.04       One ring heterocyclic compounds defined by C6H7NO. Permitted are any degree of hydrogenation, any substituents and any ortho-fused or ortho-peri-fused ring systems.%A%    
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D010079 1998
% 219.86/220.04  |- mesh__recordAuthorizer mesh__D010079 PLS
% 219.86/220.04  |- mesh__dateRevised mesh__D010079 1992-05-19
% 219.86/220.04  |- skos__historyNote mesh__D010079 Azocines %28%1966-1974%29%
% 219.86/220.04  |- skos__broader mesh__D010079smesh__D001392
% 219.86/220.04  |- mesh__recordMaintainer mesh__D010079 TAP
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D010079 2004
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D010079 1994
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D010079 2001
% 219.86/220.04  |- mesh__recordOriginator mesh__D010079 NLM
% 219.86/220.04  |- skos__prefLabel mesh__D010079 Oxazocines
% 219.86/220.04  |- mesh__historyNote mesh__D010079 75   
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D010079 2003
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D010079 2000
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D010079 2006
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D010079 1997
% 219.86/220.04  |- mesh__publicMeSHNote mesh__D010079 75   
% 219.86/220.04  |- mesh__dateCreated mesh__D010079 1974-11-11
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D010079 1993
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Acid, 3-Pyridinecarboxylic
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Nico 400
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Salt, Niacin Lithium
% 219.86/220.04  |- skos__altLabel mesh__D009525 3-Pyridinecarboxylic Acid
% 219.86/220.04  |- mesh__recordOriginator mesh__D009525 RLS
% 219.86/220.04  |- skos__prefLabel mesh__D009525 Niacin
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Zinc Salt, Niacin
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Aluminum Salt, Niacin
% 219.86/220.04  |- mesh__historyNote mesh__D009525
% 219.86/220.04       83; was see NICOTINIC ACIDS 1975-82 %26% NICOTINIC ACID 1963-74%A%  
% 219.86/220.04  |- skos__annotation mesh__D009525
% 219.86/220.04       /defic: consider also PELLAGRA; /ther use: coordinate disease with /drug ther, not /diet ther%A%  
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Salt, Niacin Sodium
% 219.86/220.04  |- mesh__recordAuthorizer mesh__D009525 sjn
% 219.86/220.04  |- mesh__publicMeSHNote mesh__D009525
% 219.86/220.04       83; was see NICOTINIC ACIDS 1975-82 %26% NICOTINIC ACID 1963-74%A%  
% 219.86/220.04  |- skos__historyNote mesh__D009525 Nicotinic Acids %28%1966-1982%29%
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Calcium Salt, Niacin
% 219.86/220.04  |- skos__scopeNote mesh__D009525
% 219.86/220.04       A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.%A%    
% 219.86/220.04  |- mesh__dateEstablished mesh__D009525 1983-01-01
% 219.86/220.04  |- skos__broader mesh__D009525smesh__D009539
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Nico400
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Nicotinate, Lithium
% 219.86/220.04  |- skos__altLabel mesh__D009525 Nicotinic Acid
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D009525 2006
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Salt, Niacin Magnesium
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Hydrochloride, Niacin
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Potassium Salt, Niacin
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Tosylate, Niacin
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Salt, Niacin Zinc
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Salt, Niacin Aluminum
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Ammonium Salt, Niacin
% 219.86/220.04  |- rdf__type mesh__D009525sskos__Concept
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Lithium Salt, Niacin
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Acid, Nicotinic
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Magnesium Salt, Niacin
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Salt, Niacin Ammonium
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 3 Pyridinecarboxylic Acid
% 219.86/220.04  |- mesh__recordMaintainer mesh__D009525 ssb
% 219.86/220.04  |- mesh__dateCreated mesh__D009525 1982-05-06
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Tartrate, Niacin
% 219.86/220.04  |- mesh__dateRevised mesh__D009525 2005-06-30
% 219.86/220.04  |- mesh__onlineNote mesh__D009525 search NICOTINIC ACIDS 1966-82   
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Sodium Salt, Niacin
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Salt, Niacin Calcium
% 219.86/220.04  |- skos__hiddenLabel mesh__D009525 Salt, Niacin Potassium
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D001542 2004
% 219.86/220.04  |- skos__prefLabel mesh__D001542 Benomyl
% 219.86/220.04  |- skos__historyNote mesh__D001542 Benzimidazoles %28%1972-1974%29%
% 219.86/220.04  |- mesh__recordOriginator mesh__D001542 NLM
% 219.86/220.04  |- mesh__historyNote mesh__D001542
% 219.86/220.04       91%28%75%29%; was see under CARBAMATES 1975-90   
% 219.86/220.04  |- skos__scopeNote mesh__D001542
% 219.86/220.04       A systemic agricultural fungicide used for control of certain fungal diseases of stone fruit.%A%    
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D001542 2005
% 219.86/220.04  |- mesh__publicMeSHNote mesh__D001542
% 219.86/220.04       91; was see under CARBAMATES 1975-90   
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D001542 2006
% 219.86/220.04  |- mesh__recordMaintainer mesh__D001542 CCR
% 219.86/220.04  |- skos__broader mesh__D001542smesh__D002219
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D001542 2001
% 219.86/220.04  |- mesh__recordAuthorizer mesh__D001542 sjn
% 219.86/220.04  |- skos__broader mesh__D001542smesh__D001562
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D001542 2002
% 219.86/220.04  |- mesh__dateCreated mesh__D001542 1974-11-11
% 219.86/220.04  |- rdf__type mesh__D001542sskos__Concept
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D001542 2003
% 219.86/220.04  |- skos__altLabel mesh__D001542 Fundasol
% 219.86/220.04  |- mesh__dateEstablished mesh__D001542 1991-01-01
% 219.86/220.04  |- skos__historyNote mesh__D001542 Carbamates %28%1972-1974%29%
% 219.86/220.04  |- mesh__dateRevised mesh__D001542 2000-06-22
% 219.86/220.04  |- skos__scopeNote mesh__D011970
% 219.86/220.04       A class of histamine receptors discriminated by their pharmacology and mode of action. Histamine H2 receptors act via G-proteins to stimulate adenylate cyclase. Among the many responses mediated by these receptors are gastric acid secretion, smooth muscle relaxation, inotropic and chronotropic effects on heart muscle, and inhibition of lymphocyte function. %28%From Biochem Soc Trans 1992 Feb;20%28%1%29%:122-5%29%%A%    
% 219.86/220.04  |- skos__historyNote mesh__D011970 Receptors, Drug %28%1970-1976%29%
% 219.86/220.04  |- mesh__recordOriginator mesh__D011970 SH
% 219.86/220.04  |- skos__broader mesh__D011970smesh__D043562
% 219.86/220.04  |- skos__altLabel mesh__D011970 Receptors, H2
% 219.86/220.04  |- rdf__type mesh__D011970sskos__Concept
% 219.86/220.04  |- skos__altLabel mesh__D011970 Histamine H2 Receptors
% 219.86/220.04  |- skos__altLabel mesh__D011970 H2 Receptors
% 219.86/220.04  |- skos__broader mesh__D011970smesh__D011968
% 219.86/220.04  |- mesh__historyNote mesh__D011970
% 219.86/220.04       87%28%77%29%; was see under RECEPTORS, HISTAMINE 1977-86   
% 219.86/220.04  |- skos__historyNote mesh__D011970 Histamine %28%1966-1976%29%
% 219.86/220.04  |- mesh__recordMaintainer mesh__D011970 jmp
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D011970 2006
% 219.86/220.04  |- skos__prefLabel mesh__D011970 Receptors, Histamine H2
% 219.86/220.04  |- skos__hiddenLabel mesh__D011970 H2 Receptors, Histamine
% 219.86/220.04  |- mesh__dateEstablished mesh__D011970 1987-01-01
% 219.86/220.04  |- skos__annotation mesh__D011970
% 219.86/220.04       receptors for the non-classical antihistaminics %28%HISTAMINE H2 ANTAGONISTS%29%; DF: RECEPT H2%A%  
% 219.86/220.04  |- mesh__recordAuthorizer mesh__D011970 sjn
% 219.86/220.04  |- mesh__dateCreated mesh__D011970 1976-05-05
% 219.86/220.04  |- mesh__dateRevised mesh__D011970 2005-06-30
% 219.86/220.04  |- mesh__publicMeSHNote mesh__D011970
% 219.86/220.04       87; was see under RECEPTORS, HISTAMINE 1977-86   
% 219.86/220.04  |- mesh__publicMeSHNote mesh__D019155 97   
% 219.86/220.04  |- skos__annotation mesh__D019155
% 219.86/220.04       GEN or unspecified; prefer specific drug /ther use with required animal dis precoords with /drug ther%A%  
% 219.86/220.04  |- skos__prefLabel mesh__D019155 Veterinary Drugs
% 219.86/220.04  |- skos__altLabel mesh__D019155 Pharmaceuticals, Veterinary
% 219.86/220.04  |- mesh__recordMaintainer mesh__D019155 sjn
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D019155 2005
% 219.86/220.04  |- skos__altLabel mesh__D019155 Veterinary Pharmaceuticals
% 219.86/220.04  |- mesh__dateRevised mesh__D019155 2004-07-13
% 219.86/220.04  |- mesh__recordOriginator mesh__D019155 TGC
% 219.86/220.04  |- skos__altLabel mesh__D019155 Drug, Veterinary
% 219.86/220.04  |- skos__altLabel mesh__D019155 Drugs, Veterinary
% 219.86/220.04  |- skos__broader mesh__D019155smesh__D004364
% 219.86/220.04  |- mesh__recordAuthorizer mesh__D019155 sjn
% 219.86/220.04  |- skos__altLabel mesh__D019155 Veterinary Drug
% 219.86/220.04  |- skos__scopeNote mesh__D019155
% 219.86/220.04       Drugs used by veterinarians in the treatment of animal diseases. The veterinarian%27%s pharmacological armamentarium is the counterpart of drugs treating human diseases, with dosage and administration adjusted to the size, weight, disease, and idiosyncrasies of the species. In the United States most drugs are subject to federal regulations with special reference to the safety of drugs and residues in edible animal products.%A%    
% 219.86/220.04  |- mesh__historyNote mesh__D019155 97   
% 219.86/220.04  |- rdf__type mesh__D019155sskos__Concept
% 219.86/220.04  |- mesh__dateCreated mesh__D019155 1996-02-12
% 219.86/220.04  |- mesh__dateEstablished mesh__D019155 1997-01-01
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D019155 2006
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D011172 2004
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D011172 2000
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D011172 2006
% 219.86/220.04  |- skos__broader mesh__D011172smesh__D003938
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D011172 2003
% 219.86/220.04  |- mesh__publicMeSHNote mesh__D011172 86; was SPLENOPORTOGRAPHY 1963-85   
% 219.86/220.04  |- skos__annotation mesh__D011172
% 219.86/220.04       NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: PORTOGR%A%  
% 219.86/220.04  |- mesh__dateRevised mesh__D011172 1997-06-20
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D011172 2005
% 219.86/220.04  |- skos__broader mesh__D011172smesh__D011860
% 219.86/220.04  |- mesh__dateCreated mesh__D011172 1999-01-01
% 219.86/220.04  |- skos__hiddenLabel mesh__D011172 Portographies
% 219.86/220.04  |- mesh__onlineNote mesh__D011172
% 219.86/220.04       use PORTOGRAPHY to search SPLENOPORTOGRAPHY 1966-85   
% 219.86/220.04  |- mesh__recordOriginator mesh__D011172 NLM
% 219.86/220.04  |- skos__hiddenLabel mesh__D011172 Splenoportographies
% 219.86/220.04  |- mesh__historyNote mesh__D011172 86; was SPLENOPORTOGRAPHY 1963-85   
% 219.86/220.04  |- skos__scopeNote mesh__D011172
% 219.86/220.04       Examination of the portal circulation by the use of X-ray films after injection of radiopaque material.%A%    
% 219.86/220.04  |- rdf__type mesh__D011172sskos__Concept
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D011172 1999
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D011172 2002
% 219.86/220.04  |- skos__prefLabel mesh__D011172 Portography
% 219.86/220.04  |- skos__broader mesh__D011172smesh__D000792
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D011172 1998
% 219.86/220.04  |- mesh__recordAuthorizer mesh__D011172 SJN
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D011172 2001
% 219.86/220.04  |- mesh__recordMaintainer mesh__D011172 PXP
% 219.86/220.04  |- skos__annotation mesh__D005135
% 219.86/220.04       for physical protection: do not confuse with EYEGLASSES which is for improvement of vision%A%  
% 219.86/220.04  |- skos__hiddenLabel mesh__D005135 Protective Device, Eye
% 219.86/220.04  |- mesh__recordOriginator mesh__D005135 NLM
% 219.86/220.04  |- mesh__publicMeSHNote mesh__D005135 91; see PROTECTIVE DEVICES 1975-90   
% 219.86/220.04  |- skos__hiddenLabel mesh__D005135 Glasses, Nonprescription Sun
% 219.86/220.04  |- mesh__dateCreated mesh__D005135 1974-12-12
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005135 2006
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005135 2001
% 219.86/220.04  |- skos__altLabel mesh__D005135 Safety Glasses
% 219.86/220.04  |- skos__broader mesh__D005135smesh__D011482
% 219.86/220.04  |- mesh__dateEstablished mesh__D005135 1991-01-01
% 219.86/220.04  |- skos__hiddenLabel mesh__D005135 Protective Devices, Eye
% 219.86/220.04  |- skos__hiddenLabel mesh__D005135 Lenses, Safety
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005135 1999
% 219.86/220.04  |- mesh__historyNote mesh__D005135 91%28%75%29%   
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005135 2005
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005135 2004
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005135 2000
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005135 1998
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005135 2003
% 219.86/220.04  |- skos__prefLabel mesh__D005135 Eye Protective Devices
% 219.86/220.04  |- skos__hiddenLabel mesh__D005135 Device, Eye Protective
% 219.86/220.04  |- skos__hiddenLabel mesh__D005135 Devices, Eye Protective
% 219.86/220.04  |- skos__hiddenLabel mesh__D005135 Eye Protective Device
% 219.86/220.04  |- mesh__recordMaintainer mesh__D005135 PXP
% 219.86/220.04  |- rdf__type mesh__D005135sskos__Concept
% 219.86/220.04  |- mesh__recordAuthorizer mesh__D005135 SJN
% 219.86/220.04  |- skos__hiddenLabel mesh__D005135 Glasse, Nonprescription Sun
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D005135 2002
% 219.86/220.04  |- skos__hiddenLabel mesh__D005135 Glasses, Safety
% 219.86/220.04  |- skos__hiddenLabel mesh__D005135 Nonprescription Sun Glasses
% 219.86/220.04  |- skos__scopeNote mesh__D005135
% 219.86/220.04       Personal devices for protection of the eyes from impact, flying objects, glare, liquids, or injurious radiation.%A%    
% 219.86/220.04  |- mesh__dateRevised mesh__D005135 1997-06-20
% 219.86/220.04  |- mesh__recordAuthorizer mesh__D010878 sjn
% 219.86/220.04  |- skos__altLabel mesh__D010878 Pipril
% 219.86/220.04  |- skos__hiddenLabel mesh__D010878 Cl227193
% 219.86/220.04  |- skos__hiddenLabel mesh__D010878 Piperacillin ratiopharm
% 219.86/220.04  |- skos__altLabel mesh__D010878 T-1220
% 219.86/220.04  |- skos__hiddenLabel mesh__D010878 AB Piperacillin
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D010878 2006
% 219.86/220.04  |- mesh__recordMaintainer mesh__D010878 lkw
% 219.86/220.04  |- skos__altLabel mesh__D010878 Piperacillin curasan
% 219.86/220.04  |- skos__altLabel mesh__D010878 AHP Brand of Piperacillin Sodium
% 219.86/220.04  |- skos__altLabel mesh__D010878 curasan Brand of Piperacillin Sodium
% 219.86/220.04  |- mesh__historyNote mesh__D010878 84   
% 219.86/220.04  |- mesh__publicMeSHNote mesh__D010878 84   
% 219.86/220.04  |- skos__broader mesh__D010878smesh__D000667
% 219.86/220.04  |- skos__altLabel mesh__D010878 Piperacillin Monosodium Salt
% 219.86/220.04  |- skos__prefLabel mesh__D010878 Piperacillin
% 219.86/220.04  |- skos__scopeNote mesh__D010878
% 219.86/220.04       Semisynthetic, broad-spectrum, AMPICILLIN derived ureidopenicillin antibiotic proposed for PSEUDOMONAS infections. It is also used in combination with other antibiotics.%A%    
% 219.86/220.04  |- mesh__dateRevised mesh__D010878 2005-06-30
% 219.86/220.04  |- skos__altLabel mesh__D010878 Wyeth Brand of Piperacillin Sodium
% 219.86/220.04  |- skos__altLabel mesh__D010878 Hexal Brand of Piperacillin Sodium
% 219.86/220.04  |- rdf__type mesh__D010878sskos__Concept
% 219.86/220.04  |- skos__hiddenLabel mesh__D010878 Salt, Piperacillin Monosodium
% 219.86/220.04  |- mesh__recordOriginator mesh__D010878 SH
% 219.86/220.04  |- skos__hiddenLabel mesh__D010878 Cl 227193
% 219.86/220.04  |- skos__altLabel mesh__D010878 Pipercillin
% 219.86/220.04  |- skos__hiddenLabel mesh__D010878 Pipera hameln
% 219.86/220.04  |- skos__hiddenLabel mesh__D010878 T 1220
% 219.86/220.04  |- skos__hiddenLabel mesh__D010878 Sodium, Piperacillin
% 219.86/220.04  |- skos__altLabel mesh__D010878 Astrapin Brand of Piperacillin Sodium
% 219.86/220.04  |- skos__altLabel mesh__D010878 Fresenius Brand of Piperacillin Sodium
% 219.86/220.04  |- skos__altLabel mesh__D010878 ratiopharm Brand of Piperacillin Sodium
% 219.86/220.04  |- skos__hiddenLabel mesh__D010878 Monosodium Salt, Piperacillin
% 219.86/220.04  |- mesh__dateCreated mesh__D010878 1983-03-11
% 219.86/220.04  |- skos__historyNote mesh__D010878 Penicillins %28%1966-1983%29%
% 219.86/220.04  |- skos__altLabel mesh__D010878 Lederle Brand of Pipracillin Sodium
% 219.86/220.04  |- mesh__dateEstablished mesh__D010878 1984-01-01
% 219.86/220.04  |- skos__annotation mesh__D029583
% 219.86/220.04       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.86/220.04  |- mesh__historyNote mesh__D029583 2002   
% 219.86/220.04  |- mesh__activeMeSHYear mesh__D029583 2003
% 219.86/220.04  |- mesh__recordOriginator mesh__D029583 ssb
% 219.86/220.05  |- skos__prefLabel mesh__D029583 Menispermaceae
% 219.86/220.05  |- mesh__dateEstablished mesh__D029583 2002-01-01
% 219.86/220.05  |- skos__scopeNote mesh__D029583
% 219.86/220.05       A plant family of the order Ranunculales, subclass Magnoliidae, class Magnoliopsida. Members are mostly vines and shrubs and they contain isoquinoline alkaloids, some of which have been used as arrow poisons.%A%    
% 219.86/220.05  |- mesh__recordMaintainer mesh__D029583 ssb
% 219.86/220.05  |- rdf__type mesh__D029583sskos__Concept
% 219.86/220.05  |- mesh__publicMeSHNote mesh__D029583 2002   
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D029583 2006
% 219.86/220.05  |- mesh__recordAuthorizer mesh__D029583 sjn
% 219.86/220.05  |- skos__broader mesh__D029583smesh__D019684
% 219.86/220.05  |- mesh__dateRevised mesh__D029583 2002-07-03
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D029583 2005
% 219.86/220.05  |- mesh__dateCreated mesh__D029583 2001-07-25
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D029583 2004
% 219.86/220.05  |- mesh__dateCreated mesh__D009526 1999-01-01
% 219.86/220.05  |- skos__scopeNote mesh__D009526
% 219.86/220.05       An MAO inhibitor that is used as an antidepressive agent.%A%    
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009526 2005
% 219.86/220.05  |- rdf__type mesh__D009526sskos__Concept
% 219.86/220.05  |- mesh__dateRevised mesh__D009526 2000-06-22
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009526 2006
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009526 2002
% 219.86/220.05  |- mesh__recordOriginator mesh__D009526 NLM
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009526 2003
% 219.86/220.05  |- mesh__recordMaintainer mesh__D009526 TWD
% 219.86/220.05  |- mesh__recordAuthorizer mesh__D009526 sjn
% 219.86/220.05  |- skos__prefLabel mesh__D009526 Nialamide
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009526 2004
% 219.86/220.05  |- skos__broader mesh__D009526smesh__D007539
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009526 2001
% 219.86/220.05  |- skos__altLabel mesh__D019954 Cognitive Symptoms
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D019954 2002
% 219.86/220.05  |- mesh__publicMeSHNote mesh__D019954
% 219.86/220.05       2000; see COGNITIVE SYMPTOMS 1998-1999   
% 219.86/220.05  |- skos__hiddenLabel mesh__D019954 Symptoms, Cognitive
% 219.86/220.05  |- skos__altLabel mesh__D019954 Neurobehavioral Signs and Symptoms
% 219.86/220.05  |- rdf__type mesh__D019954sskos__Concept
% 219.86/220.05  |- skos__prefLabel mesh__D019954 Neurobehavioral Manifestations
% 219.86/220.05  |- mesh__recordOriginator mesh__D019954 JLS
% 219.86/220.05  |- mesh__historyNote mesh__D019954 2000%28%1998%29%   
% 219.86/220.05  |- skos__hiddenLabel mesh__D019954 Neurobehavioral Manifestation
% 219.86/220.05  |- skos__hiddenLabel mesh__D019954 Symptom, Cognitive
% 219.86/220.05  |- skos__altLabel mesh__D019954 Cognitive Manifestations
% 219.86/220.05  |- mesh__dateRevised mesh__D019954 2001-07-25
% 219.86/220.05  |- skos__hiddenLabel mesh__D019954 Manifestations, Neurobehavioral
% 219.86/220.05  |- mesh__dateCreated mesh__D019954 1997-06-20
% 219.86/220.05  |- skos__annotation mesh__D019954 not used for indexing   
% 219.86/220.05  |- skos__hiddenLabel mesh__D019954 Manifestations, Cognitive
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D019954 2004
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D019954 2006
% 219.86/220.05  |- skos__altLabel mesh__D019954 Signs and Symptoms, Neurobehavioral
% 219.86/220.05  |- skos__broader mesh__D019954smesh__D001520
% 219.86/220.05  |- skos__scopeNote mesh__D019954
% 219.86/220.05       Signs and symptoms of higher cortical dysfunction caused by organic conditions. These include certain behavioral alterations and impairments of skills involved in the acquisition, processing, and utilization of knowledge or information.%A%    
% 219.86/220.05  |- skos__hiddenLabel mesh__D019954 Cognitive Symptom
% 219.86/220.05  |- skos__hiddenLabel mesh__D019954 Cognitive Manifestation
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D019954 2003
% 219.86/220.05  |- skos__hiddenLabel mesh__D019954 Manifestation, Neurobehavioral
% 219.86/220.05  |- skos__hiddenLabel mesh__D019954 Manifestation, Cognitive
% 219.86/220.05  |- mesh__recordAuthorizer mesh__D019954 sjn
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D019954 2005
% 219.86/220.05  |- skos__broader mesh__D019954smesh__D009461
% 219.86/220.05  |- mesh__dateEstablished mesh__D019954 1998-01-01
% 219.86/220.05  |- mesh__recordMaintainer mesh__D019954 nns
% 219.86/220.05  |- rdf__type mesh__D011971sskos__Concept
% 219.86/220.05  |- skos__related mesh__D011971smesh__D007155
% 219.86/220.05  |- mesh__dateCreated mesh__D011971 1979-05-24
% 219.86/220.05  |- skos__altLabel mesh__D011971 Immunologic Receptor
% 219.86/220.05  |- skos__historyNote mesh__D011971
% 219.86/220.05       Binding Sites, Antibody %28%1973-1979%29%
% 219.86/220.05  |- skos__altLabel mesh__D011971 Immunologic Receptors
% 219.86/220.05  |- skos__historyNote mesh__D011971 Macrophages %28%1966-1979%29%
% 219.86/220.05  |- skos__historyNote mesh__D011971 B Lymphocytes %28%1973-1979%29%
% 219.86/220.05  |- mesh__recordMaintainer mesh__D011971 jmp
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011971 2006
% 219.86/220.05  |- skos__prefLabel mesh__D011971 Receptors, Immunologic
% 219.86/220.05  |- skos__hiddenLabel mesh__D011971 Receptor, Immunologic
% 219.86/220.05  |- mesh__historyNote mesh__D011971 80   
% 219.86/220.05  |- skos__broader mesh__D011971smesh__D011956
% 219.86/220.05  |- skos__altLabel mesh__D011971 Immunological Receptors
% 219.86/220.05  |- skos__historyNote mesh__D011971 Lymphocytes %28%1966-1979%29%
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011971 2004
% 219.86/220.05  |- mesh__dateEstablished mesh__D011971 1980-01-01
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011971 2005
% 219.86/220.05  |- mesh__publicMeSHNote mesh__D011971 80   
% 219.86/220.05  |- skos__hiddenLabel mesh__D011971 Receptors, Immunological
% 219.86/220.05  |- mesh__dateRevised mesh__D011971 2003-07-09
% 219.86/220.05  |- mesh__recordOriginator mesh__D011971 AEP
% 219.86/220.05  |- skos__historyNote mesh__D011971 T Lymphocytes %28%1973-1979%29%
% 219.86/220.05  |- mesh__recordAuthorizer mesh__D011971 sjn
% 219.86/220.05  |- skos__annotation mesh__D011971
% 219.86/220.05       GEN; prefer specifics; DF: RECEPT IMMUNOL   
% 219.86/220.05  |- skos__scopeNote mesh__D011971
% 219.86/220.05       Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere.%A%    
% 219.86/220.05  |- skos__annotation mesh__D019156
% 219.86/220.05       no qualif; includes X refs PERSIAN GULF %26% RED SEA but do not index Persian Gulf War here %28% = WAR + MIDDLE EAST%29%%A%  
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D019156 2004
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D019156 1999
% 219.86/220.05  |- mesh__dateEstablished mesh__D019156 1997-01-01
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D019156 2001
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D019156 2003
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D019156 1998
% 219.86/220.05  |- skos__broader mesh__D019156smesh__D009792
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D019156 2000
% 219.86/220.05  |- skos__prefLabel mesh__D019156 Indian Ocean
% 219.86/220.05  |- mesh__historyNote mesh__D019156 97   
% 219.86/220.05  |- rdf__type mesh__D019156sskos__Concept
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D019156 2006
% 219.86/220.05  |- skos__scopeNote mesh__D019156
% 219.86/220.05       A body of water covering approximately one-fifth of the total ocean area of the earth, extending amidst Africa in the west, Australia in the east, Asia in the north, and Antarctica in the south. Including the Red Sea and the Persian Gulf, it constitutes the third largest ocean after the ATLANTIC OCEAN and the PACIFIC OCEAN. %28%New Encyclopaedia Britannica Micropaedia, 15th ed, 1990, p289%29%%A%    
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D019156 1997
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D019156 2005
% 219.86/220.05  |- mesh__dateCreated mesh__D019156 1996-06-10
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D019156 2002
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011173 2003
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011173 2001
% 219.86/220.05  |- skos__annotation mesh__D011173
% 219.86/220.05       as IM, Manual 32.14; as NIM, Manual 32.14.1; TN 154: use and quality; portrait may be a painting, a drawing, a photograph, a bust, etc.; may be of an individual or of a group; do not confuse with Publication Type PORTRAITS%A%  
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011173 2005
% 219.86/220.05  |- mesh__recordAuthorizer mesh__D011173 sjn
% 219.86/220.05  |- mesh__dateCreated mesh__D011173 1999-01-01
% 219.86/220.05  |- mesh__recordMaintainer mesh__D011173 kle
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011173 2000
% 219.86/220.05  |- rdf__type mesh__D011173sskos__Concept
% 219.86/220.05  |- mesh__recordOriginator mesh__D011173 NLM
% 219.86/220.05  |- skos__scopeNote mesh__D011173
% 219.86/220.05       Graphic representations, especially of the face, of real persons, usually posed, living or dead. %28%From Thesaurus for Graphic Materials II, p540, 1995%29%%A%    
% 219.86/220.05  |- skos__broader mesh__D011173smesh__D001154
% 219.86/220.05  |- skos__hiddenLabel mesh__D011173 Portrait
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011173 2004
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011173 2002
% 219.86/220.05  |- mesh__dateRevised mesh__D011173 1999-11-03
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011173 2006
% 219.86/220.05  |- skos__prefLabel mesh__D011173 Portraits
% 219.86/220.05  |- mesh__dateEstablished mesh__D005934 1963-01-01
% 219.86/220.05  |- skos__hiddenLabel mesh__D005934 HG Factor
% 219.86/220.05  |- mesh__dateCreated mesh__D005934 1999-01-01
% 219.86/220.05  |- mesh__recordMaintainer mesh__D005934 sjn
% 219.86/220.05  |- skos__broader mesh__D005934smesh__D052336
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D005934 2006
% 219.86/220.05  |- rdf__type mesh__D005934sskos__Concept
% 219.86/220.05  |- skos__hiddenLabel mesh__D005934 Hyperglycemic Glycogenolytic Factor
% 219.86/220.05  |- mesh__dateRevised mesh__D005934 2005-07-01
% 219.86/220.05  |- skos__altLabel mesh__D005934 HG-Factor
% 219.86/220.05  |- mesh__recordAuthorizer mesh__D005934 sjn
% 219.86/220.05  |- skos__annotation mesh__D005934
% 219.86/220.05       do not confuse with ENTEROGLUCAGONS secreted by the intestine%A%  
% 219.86/220.05  |- skos__altLabel mesh__D005934 Glukagon
% 219.86/220.05  |- skos__scopeNote mesh__D005934
% 219.86/220.05       A pancreatic peptide hormone of about 29 amino acids secreted by PANCREATIC ALPHA CELLS. It has an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. %28%From Gilman et al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 9th ed, p1511%29%%A%    
% 219.86/220.05  |- skos__altLabel mesh__D005934 Hyperglycemic-Glycogenolytic Factor
% 219.86/220.05  |- skos__altLabel mesh__D005934 Glucagon %28%1-29%29%
% 219.86/220.05  |- mesh__recordOriginator mesh__D005934 NLM
% 219.86/220.05  |- skos__prefLabel mesh__D005934 Glucagon
% 219.86/220.05  |- skos__related mesh__D005934smesh__D018027
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D005136 2006
% 219.86/220.05  |- mesh__recordMaintainer mesh__D005136 SYSTEM
% 219.86/220.05  |- skos__hiddenLabel mesh__D005136 Proteins, Eye
% 219.86/220.05  |- mesh__recordAuthorizer mesh__D005136 sjn
% 219.86/220.05  |- skos__annotation mesh__D005136
% 219.86/220.05       IM; coord with specific protein %28%IM%29% %26% specific part of eye %28%IM%29%; /biosyn /drug eff /physiol permitted%A%  
% 219.86/220.05  |- mesh__dateCreated mesh__D005136 1999-01-01
% 219.86/220.05  |- skos__prefLabel mesh__D005136 Eye Proteins
% 219.86/220.05  |- mesh__recordOriginator mesh__D005136 NLM
% 219.86/220.05  |- skos__broader mesh__D005136smesh__D011506
% 219.86/220.05  |- rdf__type mesh__D005136sskos__Concept
% 219.86/220.05  |- mesh__dateRevised mesh__D005136 2005-06-30
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D010879 1993
% 219.86/220.05  |- mesh__dateCreated mesh__D010879 1999-01-01
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D010879 1998
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D010879 2005
% 219.86/220.05  |- mesh__recordAuthorizer mesh__D010879 PLS
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D010879 1995
% 219.86/220.05  |- mesh__dateRevised mesh__D010879 1992-05-19
% 219.86/220.05  |- rdf__type mesh__D010879sskos__Concept
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D010879 1994
% 219.86/220.05  |- skos__broader mesh__D010879smesh__D006573
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D010879 2002
% 219.86/220.05  |- skos__prefLabel mesh__D010879 Piperazines
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D010879 1997
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D010879 2001
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D010879 2004
% 219.86/220.05  |- mesh__recordMaintainer mesh__D010879 TAP
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D010879 2000
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D010879 1999
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D010879 1996
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D010879 2006
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D010879 2003
% 219.86/220.05  |- mesh__recordOriginator mesh__D010879 NLM
% 219.86/220.05  |- mesh__dateRevised mesh__D029584 2005-06-30
% 219.86/220.05  |- mesh__dateCreated mesh__D029584 2001-07-25
% 219.86/220.05  |- skos__scopeNote mesh__D029584
% 219.86/220.05       Proteins secreted by the prostate gland. The major secretory proteins from the human prostate gland include PROSTATE-SPECIFIC ANTIGEN, prostate-specific acid phosphatase, prostate-specific membrane antigen, and prostate-specific protein-94.%A%    
% 219.86/220.05  |- mesh__dateEstablished mesh__D029584 2002-01-01
% 219.86/220.05  |- skos__prefLabel mesh__D029584 Prostatic Secretory Proteins
% 219.86/220.05  |- rdf__type mesh__D029584sskos__Concept
% 219.86/220.05  |- mesh__publicMeSHNote mesh__D029584 2002   
% 219.86/220.05  |- mesh__historyNote mesh__D029584 2002   
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D029584 2006
% 219.86/220.05  |- mesh__recordOriginator mesh__D029584 lkt
% 219.86/220.05  |- skos__historyNote mesh__D029584 Antigens %28%1979-1986%29%
% 219.86/220.05  |- skos__hiddenLabel mesh__D029584 Secretory Proteins, Prostatic
% 219.86/220.05  |- skos__historyNote mesh__D029584 Inhibin %28%1984-2001%29%
% 219.86/220.05  |- mesh__recordMaintainer mesh__D029584 SYSTEM
% 219.86/220.05  |- skos__historyNote mesh__D029584
% 219.86/220.05       Prostate-Specific Antigen %28%1987-2001%29%
% 219.86/220.05  |- mesh__recordAuthorizer mesh__D029584 sjn
% 219.86/220.05  |- skos__broader mesh__D029584smesh__D029589
% 219.86/220.05  |- skos__hiddenLabel mesh__D029584 Proteins, Prostatic Secretory
% 219.86/220.05  |- mesh__recordMaintainer mesh__D009527 PLS
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009527 2002
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009527 1995
% 219.86/220.05  |- mesh__dateRevised mesh__D009527 1993-06-03
% 219.86/220.05  |- rdf__type mesh__D009527sskos__Concept
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009527 1994
% 219.86/220.05  |- mesh__dateCreated mesh__D009527 1999-01-01
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009527 2006
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009527 1999
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009527 2001
% 219.86/220.05  |- skos__broader mesh__D009527smesh__D002489
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009527 2004
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009527 1997
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009527 2005
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009527 1998
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009527 2000
% 219.86/220.05  |- mesh__recordOriginator mesh__D009527 NLM
% 219.86/220.05  |- skos__prefLabel mesh__D009527 Nicaragua
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009527 2003
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009527 1996
% 219.86/220.05  |- mesh__recordAuthorizer mesh__D009527 PLS
% 219.86/220.05  |- mesh__historyNote mesh__D001544 66   
% 219.86/220.05  |- skos__hiddenLabel mesh__D001544 Benperidolneuraxpharm
% 219.86/220.05  |- skos__hiddenLabel mesh__D001544 Benperidol Bayer Brand
% 219.86/220.05  |- skos__hiddenLabel mesh__D001544 Benperidol neuraxpharm Brand
% 219.86/220.05  |- skos__hiddenLabel mesh__D001544 Benperidol Janssen Brand
% 219.86/220.05  |- mesh__recordOriginator mesh__D001544 NLM
% 219.86/220.05  |- mesh__recordMaintainer mesh__D001544 mdb
% 219.86/220.05  |- skos__hiddenLabel mesh__D001544 Benperidol neuraxpharm
% 219.86/220.05  |- skos__altLabel mesh__D001544 Bayer Brand of Benperidol
% 219.86/220.05  |- skos__broader mesh__D001544smesh__D002090
% 219.86/220.05  |- mesh__publicMeSHNote mesh__D001544 66   
% 219.86/220.05  |- mesh__dateRevised mesh__D001544 2004-07-07
% 219.86/220.05  |- skos__altLabel mesh__D001544 Frenactil
% 219.86/220.05  |- skos__altLabel mesh__D001544 neuraxpharm Brand of Benperidol
% 219.86/220.05  |- mesh__dateEstablished mesh__D001544 1966-01-01
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D001544 2006
% 219.86/220.05  |- skos__scopeNote mesh__D001544
% 219.86/220.05       A butyrophenone with general properties similar to those of HALOPERIDOL. It has been used in the treatment of aberrant sexual behavior. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p567%29%%A%    
% 219.86/220.05  |- mesh__recordAuthorizer mesh__D001544 sjn
% 219.86/220.05  |- skos__altLabel mesh__D001544 Janssen Brand of Benperidol
% 219.86/220.05  |- mesh__dateCreated mesh__D001544 1999-01-01
% 219.86/220.05  |- rdf__type mesh__D001544sskos__Concept
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D001544 2005
% 219.86/220.05  |- skos__prefLabel mesh__D001544 Benperidol
% 219.86/220.05  |- mesh__publicMeSHNote mesh__D019955 98   
% 219.86/220.05  |- skos__related mesh__D019955smesh__D000987
% 219.86/220.05  |- mesh__recordAuthorizer mesh__D019955 sjn
% 219.86/220.05  |- skos__annotation mesh__D019955 onset before age 18   
% 219.86/220.05  |- mesh__dateEstablished mesh__D019955 1998-01-01
% 219.86/220.05  |- mesh__historyNote mesh__D019955 98   
% 219.86/220.05  |- skos__hiddenLabel mesh__D019955 Conduct Disorders
% 219.86/220.05  |- skos__scopeNote mesh__D019955
% 219.86/220.05       A repetitive and persistent pattern of behavior in which the basic rights of others or major age-appropriate societal norms or rules are violated. These behaviors include aggressive conduct that causes or threatens physical harm to other people or animals, nonaggressive conduct that causes property loss or damage, deceitfulness or theft, and serious violations of rules. The onset is before age 18. %28%From DSM-IV, 1994%29%%A%    
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D019955 2006
% 219.86/220.05  |- mesh__dateCreated mesh__D019955 1997-06-20
% 219.86/220.05  |- mesh__dateRevised mesh__D019955 2004-07-19
% 219.86/220.05  |- mesh__recordMaintainer mesh__D019955 jls
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D019955 2005
% 219.86/220.05  |- skos__prefLabel mesh__D019955 Conduct Disorder
% 219.86/220.05  |- rdf__type mesh__D019955sskos__Concept
% 219.86/220.05  |- skos__broader mesh__D019955smesh__D019958
% 219.86/220.05  |- mesh__recordOriginator mesh__D019955 JLS
% 219.86/220.05  |- mesh__dateEstablished mesh__D011972 1977-01-01
% 219.86/220.05  |- skos__broader mesh__D011972smesh__D020794
% 219.86/220.05  |- mesh__dateRevised mesh__D011972 2005-06-30
% 219.86/220.05  |- mesh__dateCreated mesh__D011972 1976-05-03
% 219.86/220.05  |- skos__altLabel mesh__D011972 Insulin Receptor beta Chain
% 219.86/220.05  |- skos__altLabel mesh__D011972 Insulin Receptor alpha Chain
% 219.86/220.05  |- skos__altLabel mesh__D011972 Insulin Receptor Protein-Tyrosine Kinase
% 219.86/220.05  |- mesh__recordMaintainer mesh__D011972 jmp
% 219.86/220.05  |- mesh__publicMeSHNote mesh__D011972
% 219.86/220.05       2000; for INSULIN RECEPTOR PROTEIN-TYROSINE KINASE see INSULIN RECEPTOR PROTEIN-TYROSINE KINASE 1994-1999; INSULIN-DEPENDENT PROTEIN TYROSINE KINASE was indexed under PROTEIN-TYROSINE KINASE 1986-1993 %26% PROTEIN KINASES 1983-1985%A%  
% 219.86/220.05  |- mesh__historyNote mesh__D011972
% 219.86/220.05       2000%28%1977%29%; for INSULIN RECEPTOR PROTEIN-TYROSINE KINASE use RECEPTOR, INSULIN %28%NM%29% 1983-1993%A%  
% 219.86/220.05  |- skos__hiddenLabel mesh__D011972 Insulin Receptors
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011972 2006
% 219.86/220.05  |- skos__historyNote mesh__D011972
% 219.86/220.05       Receptors, Endogenous Substances %28%1973-1976%29%
% 219.86/220.05  |- skos__prefLabel mesh__D011972 Receptor, Insulin
% 219.86/220.05  |- skos__historyNote mesh__D011972 Receptors, Drug %28%1968-1976%29%
% 219.86/220.05  |- skos__altLabel mesh__D011972 Insulin Receptor
% 219.86/220.05  |- mesh__recordAuthorizer mesh__D011972 sjn
% 219.86/220.05  |- mesh__recordOriginator mesh__D011972 SH
% 219.86/220.05  |- skos__scopeNote mesh__D011972
% 219.86/220.05       A cell surface receptor for INSULIN. It is comprised of a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precusor protein. The receptor contains an intrinsic tyrosine kinase domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the LIVER; MUSCLE; and ADIPOSE TISSUE.%A%    
% 219.86/220.05  |- skos__altLabel mesh__D011972 Insulin-Dependent Tyrosine Protein Kinase
% 219.86/220.05  |- skos__altLabel mesh__D011972 Receptors, Insulin
% 219.86/220.05  |- skos__broader mesh__D011972smesh__D018026
% 219.86/220.05  |- rdf__type mesh__D011972sskos__Concept
% 219.86/220.05  |- skos__historyNote mesh__D011972 Insulin %28%1966-1976%29%
% 219.86/220.05  |- skos__hiddenLabel mesh__D011972 Insulin Receptor Protein Tyrosine Kinase
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D019157 2003
% 219.86/220.05  |- skos__hiddenLabel mesh__D019157 Preconditioning, Myocardial
% 219.86/220.05  |- mesh__recordAuthorizer mesh__D019157 sjn
% 219.86/220.05  |- skos__hiddenLabel mesh__D019157 Myocardial Ischemic Preconditioning
% 219.86/220.05  |- rdf__type mesh__D019157sskos__Concept
% 219.86/220.05  |- skos__scopeNote mesh__D019157
% 219.86/220.05       Exposure of myocardial tissue to brief, repeated periods of vascular occlusion in order to render the myocardium resistant to the deleterious effects of ISCHEMIA or REPERFUSION. The period of pre-exposure and the number of times the tissue is exposed to ischemia and reperfusion vary, the average being 3 to 5 minutes.%A%    
% 219.86/220.05  |- mesh__historyNote mesh__D019157 97   
% 219.86/220.05  |- mesh__dateEstablished mesh__D019157 1997-01-01
% 219.86/220.05  |- mesh__dateCreated mesh__D019157 1996-02-12
% 219.86/220.05  |- mesh__dateRevised mesh__D019157 2002-07-03
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D019157 2006
% 219.86/220.05  |- skos__hiddenLabel mesh__D019157 Preconditioning, Myocardial Ischemic
% 219.86/220.05  |- skos__prefLabel mesh__D019157 Ischemic Preconditioning, Myocardial
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D019157 2005
% 219.86/220.05  |- mesh__publicMeSHNote mesh__D019157 97   
% 219.86/220.05  |- skos__broader mesh__D019157smesh__D019194
% 219.86/220.05  |- skos__annotation mesh__D019157
% 219.86/220.05       do not coordinate with MYOCARDIAL ISCHEMIA or MYOCARDIAL REPERFUSION unless particularly discussed%A%  
% 219.86/220.05  |- mesh__recordOriginator mesh__D019157 TGC
% 219.86/220.05  |- skos__altLabel mesh__D019157 Myocardial Preconditioning
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D019157 2004
% 219.86/220.05  |- mesh__recordMaintainer mesh__D019157 nns
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011174 1996
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011174 1998
% 219.86/220.05  |- skos__prefLabel mesh__D011174 Portugal
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011174 1997
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011174 1994
% 219.86/220.05  |- rdf__type mesh__D011174sskos__Concept
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011174 2000
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011174 1999
% 219.86/220.05  |- mesh__recordMaintainer mesh__D011174 PLS
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011174 2001
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011174 1995
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011174 2003
% 219.86/220.05  |- mesh__dateRevised mesh__D011174 1993-06-03
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011174 2005
% 219.86/220.05  |- mesh__dateCreated mesh__D011174 1999-01-01
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011174 2004
% 219.86/220.05  |- skos__broader mesh__D011174smesh__D005060
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011174 2002
% 219.86/220.05  |- mesh__recordAuthorizer mesh__D011174 PLS
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D011174 2006
% 219.86/220.05  |- mesh__recordOriginator mesh__D011174 NLM
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D005935 2006
% 219.86/220.05  |- mesh__publicMeSHNote mesh__D005935
% 219.86/220.05       91; was see under ISLET CELL TUMOR 1982-90; was see ISLET CELL TUMOR 1981%A%  
% 219.86/220.05  |- rdf__type mesh__D005935sskos__Concept
% 219.86/220.05  |- skos__hiddenLabel mesh__D005935 alpha Cell Tumor
% 219.86/220.05  |- skos__broader mesh__D005935smesh__D018273
% 219.86/220.05  |- skos__historyNote mesh__D005935 Islet Cell Tumor %28%1966-1981%29%
% 219.86/220.05  |- skos__prefLabel mesh__D005935 Glucagonoma
% 219.86/220.05  |- skos__altLabel mesh__D005935 alpha-Cell Tumor
% 219.86/220.05  |- mesh__recordMaintainer mesh__D005935 lkt
% 219.86/220.05  |- mesh__historyNote mesh__D005935
% 219.86/220.05       91%28%82%29%; was see under ISLET CELL TUMOR 1982-90; was see ISLET CELL TUMOR 1981%A%  
% 219.86/220.05  |- skos__hiddenLabel mesh__D005935 alpha-Cell Adenomas
% 219.86/220.05  |- skos__hiddenLabel mesh__D005935 Tumor, alpha-Cell
% 219.86/220.05  |- mesh__dateCreated mesh__D005935 1981-05-20
% 219.86/220.05  |- skos__hiddenLabel mesh__D005935 Adenoma, alpha Cell
% 219.86/220.05  |- mesh__dateEstablished mesh__D005935 1991-01-01
% 219.86/220.05  |- skos__altLabel mesh__D005935 Adenoma, alpha-Cell
% 219.86/220.05  |- skos__annotation mesh__D005935
% 219.86/220.05       coord IM with PANCREATIC NEOPLASMS %28%IM%29%   
% 219.86/220.05  |- skos__hiddenLabel mesh__D005935 alpha-Cell Adenoma
% 219.86/220.05  |- mesh__dateRevised mesh__D005935 2004-07-07
% 219.86/220.05  |- mesh__recordOriginator mesh__D005935 VDK
% 219.86/220.05  |- skos__hiddenLabel mesh__D005935 Glucagonomas
% 219.86/220.05  |- skos__hiddenLabel mesh__D005935 Tumors, alpha-Cell
% 219.86/220.05  |- skos__hiddenLabel mesh__D005935 alpha-Cell Tumors
% 219.86/220.05  |- skos__hiddenLabel mesh__D005935 Adenomas, alpha-Cell
% 219.86/220.05  |- mesh__recordAuthorizer mesh__D005935 sjn
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D005935 2005
% 219.86/220.05  |- mesh__onlineNote mesh__D005935 search ISLET CELL TUMOR 1981   
% 219.86/220.05  |- skos__scopeNote mesh__D005935
% 219.86/220.05       An almost always malignant GLUCAGON-secreting tumor derived from the PANCREATIC ALPHA CELLS. It is characterized by a distinctive migratory ERYTHEMA; WEIGHT LOSS; STOMATITIS; GLOSSITIS; DIABETES MELLITUS; hypoaminoacidemia; and normochromic normocytic ANEMIA.%A%    
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D005137 2003
% 219.86/220.05  |- skos__hiddenLabel mesh__D005137 Prosthesis, Ocular
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D005137 2000
% 219.86/220.05  |- rdf__type mesh__D005137sskos__Concept
% 219.86/220.05  |- skos__altLabel mesh__D005137 Artificial Eye
% 219.86/220.05  |- skos__scopeNote mesh__D005137
% 219.86/220.05       A ready-made or custom-made prosthesis of glass or plastic shaped and colored to resemble the anterior portion of a normal eye and used for cosmetic reasons. It is attached to the anterior portion of an orbital implant %28%ORBITAL IMPLANTS%29% which is placed in the socket of an enucleated or eviscerated eye. %28%From Dorland, 28th ed%29%%A%    
% 219.86/220.05  |- skos__prefLabel mesh__D005137 Eye, Artificial
% 219.86/220.05  |- mesh__recordAuthorizer mesh__D005137 SJN
% 219.86/220.05  |- skos__broader mesh__D005137smesh__D019736
% 219.86/220.05  |- skos__hiddenLabel mesh__D005137 Prostheses, Ocular
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D005137 2002
% 219.86/220.05  |- skos__hiddenLabel mesh__D005137 Ocular Prostheses
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D005137 2006
% 219.86/220.05  |- skos__hiddenLabel mesh__D005137 Artificial Eyes
% 219.86/220.05  |- mesh__recordMaintainer mesh__D005137 NDW
% 219.86/220.05  |- skos__related mesh__D005137smesh__D020273
% 219.86/220.05  |- skos__hiddenLabel mesh__D005137 Eyes, Artificial
% 219.86/220.05  |- skos__altLabel mesh__D005137 Ocular Prosthesis
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D005137 1999
% 219.86/220.05  |- mesh__recordOriginator mesh__D005137 NLM
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D005137 2004
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D005137 2005
% 219.86/220.05  |- mesh__dateCreated mesh__D005137 1999-01-01
% 219.86/220.05  |- mesh__dateRevised mesh__D005137 1998-06-10
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D005137 2001
% 219.86/220.05  |- skos__broader mesh__D029585smesh__D019684
% 219.86/220.05  |- mesh__dateCreated mesh__D029585 2001-07-25
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D029585 2005
% 219.86/220.05  |- rdf__type mesh__D029585sskos__Concept
% 219.86/220.05  |- mesh__recordAuthorizer mesh__D029585 sjn
% 219.86/220.05  |- mesh__publicMeSHNote mesh__D029585 2002   
% 219.86/220.05  |- mesh__dateRevised mesh__D029585 2002-07-03
% 219.86/220.05  |- skos__scopeNote mesh__D029585
% 219.86/220.05       A plant family of the order Laurales, subclass Magnoliidae, class Magnoliopsida.%A%    
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D029585 2006
% 219.86/220.05  |- skos__annotation mesh__D029585
% 219.86/220.05       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.86/220.05  |- mesh__recordOriginator mesh__D029585 ssb
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D029585 2003
% 219.86/220.05  |- mesh__dateEstablished mesh__D029585 2002-01-01
% 219.86/220.05  |- mesh__recordMaintainer mesh__D029585 ssb
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D029585 2004
% 219.86/220.05  |- mesh__historyNote mesh__D029585 2002   
% 219.86/220.05  |- skos__prefLabel mesh__D029585 Monimiaceae
% 219.86/220.05  |- mesh__dateRevised mesh__D009528 2000-06-22
% 219.86/220.05  |- rdf__type mesh__D009528sskos__Concept
% 219.86/220.05  |- skos__prefLabel mesh__D009528 Nicarbazin
% 219.86/220.05  |- mesh__recordAuthorizer mesh__D009528 sjn
% 219.86/220.05  |- mesh__dateCreated mesh__D009528 1974-11-19
% 219.86/220.05  |- skos__broader mesh__D009528smesh__D002224
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009528 2006
% 219.86/220.05  |- skos__historyNote mesh__D009528 Carbanilides %28%1974%29%
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009528 2002
% 219.86/220.05  |- mesh__historyNote mesh__D009528
% 219.86/220.05       91%28%75%29%; was see under CARBANILIDES 1975-90   
% 219.86/220.05  |- skos__scopeNote mesh__D009528
% 219.86/220.05       An equimolar complex of 4,4%27%-Dinitrocarbanilide and 2-Hydroxy-4,6-dimethylpyrimidine. A coccidiostat for poultry.%A%    
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009528 2004
% 219.86/220.05  |- mesh__activeMeSHYear mesh__D009528 2005
% 219.86/220.06  |- skos__altLabel mesh__D009528 Nicarbazine
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D009528 2003
% 219.86/220.06  |- mesh__recordMaintainer mesh__D009528 CCR
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D009528 2001
% 219.86/220.06  |- skos__historyNote mesh__D009528 Pyrimidines %28%1969-1974%29%
% 219.86/220.06  |- mesh__dateEstablished mesh__D009528 1991-01-01
% 219.86/220.06  |- mesh__publicMeSHNote mesh__D009528
% 219.86/220.06       91; was see under CARBANILIDES 1975-90   
% 219.86/220.06  |- skos__broader mesh__D009528smesh__D011743
% 219.86/220.06  |- mesh__recordOriginator mesh__D009528 NLM
% 219.86/220.06  |- mesh__recordAuthorizer mesh__D001545 sjn
% 219.86/220.06  |- skos__altLabel mesh__D001545 Seryltrihydroxy Benzylhydrazine
% 219.86/220.06  |- skos__hiddenLabel mesh__D001545 Ro 4 4602
% 219.86/220.06  |- skos__historyNote mesh__D001545 Benzene Derivatives %28%1968-1971%29%
% 219.86/220.06  |- skos__altLabel mesh__D001545 Serazide
% 219.86/220.06  |- skos__scopeNote mesh__D001545
% 219.86/220.06       An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone.%A%    
% 219.86/220.06  |- skos__broader mesh__D001545smesh__D006834
% 219.86/220.06  |- mesh__publicMeSHNote mesh__D001545
% 219.86/220.06       91; was see under HYDRAZINES 1979-90; was SERYLTRIHYDROXY BENZYLHYDRAZINE see under HYDRAZINES 1975-78%A%  
% 219.86/220.06  |- mesh__dateRevised mesh__D001545 2004-07-07
% 219.86/220.06  |- skos__historyNote mesh__D001545 Benzene %28%1966-1967%29%
% 219.86/220.06  |- skos__prefLabel mesh__D001545 Benserazide
% 219.86/220.06  |- skos__historyNote mesh__D001545 Benzyl Compounds %28%1972%29%
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D001545 2006
% 219.86/220.06  |- mesh__recordOriginator mesh__D001545 NLM
% 219.86/220.06  |- skos__altLabel mesh__D001545 Seryltrihydroxybenzylhydrazine
% 219.86/220.06  |- skos__hiddenLabel mesh__D001545 Ro 44602
% 219.86/220.06  |- mesh__recordMaintainer mesh__D001545 jmp
% 219.86/220.06  |- mesh__dateCreated mesh__D001545 1999-01-01
% 219.86/220.06  |- rdf__type mesh__D001545sskos__Concept
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D001545 2005
% 219.86/220.06  |- skos__historyNote mesh__D001545 Hydrazines %28%1966-1972%29%
% 219.86/220.06  |- skos__historyNote mesh__D001545 Serine %28%1966-1972%29%
% 219.86/220.06  |- skos__hiddenLabel mesh__D001545 Benzylhydrazine, Seryltrihydroxy
% 219.86/220.06  |- mesh__historyNote mesh__D001545
% 219.86/220.06       91%28%79%29%; was see under HYDRAZINES 1979-90; was SERYLTRIHYDROXY BENZYLHYDRAZINE see under HYDRAZINES 1973-78 %28%Prov 1973-74%29%%A%  
% 219.86/220.06  |- mesh__onlineNote mesh__D001545
% 219.86/220.06       use BENSERAZIDE to search SERYLTRIHYDROXY BENZYLHYDRAZINE 1973-78 %28%as Prov 73-74%29%%A%  
% 219.86/220.06  |- skos__altLabel mesh__D001545
% 219.86/220.06       DL-Serine 2-%28%%28%2,3,4-trihydroxyphenyl%29%methyl%29%hydrazide
% 219.86/220.06  |- mesh__dateEstablished mesh__D001545 1991-01-01
% 219.86/220.06  |- skos__related mesh__D006230smesh__D014954
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D006230 2005
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D006230 2001
% 219.86/220.06  |- skos__scopeNote mesh__D006230
% 219.86/220.06       General or unspecified injuries to the hand.     
% 219.86/220.06  |- skos__hiddenLabel mesh__D006230 Hand Injury
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D006230 2004
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D006230 2000
% 219.86/220.06  |- skos__broader mesh__D006230smesh__D014947
% 219.86/220.06  |- rdf__type mesh__D006230sskos__Concept
% 219.86/220.06  |- skos__hiddenLabel mesh__D006230 Injury, Hand
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D006230 1999
% 219.86/220.06  |- skos__annotation mesh__D006230
% 219.86/220.06       consider also METACARPUS /inj; FINGER INJURIES is also available%A%  
% 219.86/220.06  |- skos__altLabel mesh__D006230 Injuries, Hand
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D006230 2003
% 219.86/220.06  |- mesh__recordMaintainer mesh__D006230 TPW
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D006230 1998
% 219.86/220.06  |- mesh__recordAuthorizer mesh__D006230 SJN
% 219.86/220.06  |- skos__prefLabel mesh__D006230 Hand Injuries
% 219.86/220.06  |- mesh__recordOriginator mesh__D006230 NLM
% 219.86/220.06  |- mesh__dateRevised mesh__D006230 1997-06-20
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D006230 2006
% 219.86/220.06  |- mesh__dateCreated mesh__D006230 1999-01-01
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D006230 2002
% 219.86/220.06  |- skos__related mesh__D019956smesh__D013239
% 219.86/220.06  |- skos__scopeNote mesh__D019956
% 219.86/220.06       Motor behavior that is repetitive, often seemingly driven, and nonfunctional. This behavior markedly interferes with normal activities or results in severe bodily self-injury. The behavior is not due to the direct physiological effects of a substance or a general medical condition. %28%DSM-IV, 1994%29%%A%    
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D019956 2004
% 219.86/220.06  |- mesh__dateCreated mesh__D019956 1997-06-20
% 219.86/220.06  |- mesh__recordMaintainer mesh__D019956 JLS
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D019956 2000
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D019956 2006
% 219.86/220.06  |- mesh__historyNote mesh__D019956
% 219.86/220.06       98; for HEAD BANGING %26% BODY ROCKING use STEREOTYPED BEHAVIOR 1981-97%A%  
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D019956 2003
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D019956 2005
% 219.86/220.06  |- mesh__dateRevised mesh__D019956 1998-06-11
% 219.86/220.06  |- mesh__dateEstablished mesh__D019956 1998-01-01
% 219.86/220.06  |- skos__prefLabel mesh__D019956 Stereotypic Movement Disorder
% 219.86/220.06  |- mesh__publicMeSHNote mesh__D019956
% 219.86/220.06       98; for HEAD BANGING %26% BODY ROCKING see STEREOTYPED BEHAVIOR 1981-97%A%  
% 219.86/220.06  |- mesh__recordAuthorizer mesh__D019956 SJN
% 219.86/220.06  |- skos__broader mesh__D019956smesh__D019952
% 219.86/220.06  |- rdf__type mesh__D019956sskos__Concept
% 219.86/220.06  |- mesh__recordOriginator mesh__D019956 JLS
% 219.86/220.06  |- skos__altLabel mesh__D019956 Movement Disorder, Stereotypic
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D019956 2002
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D019956 1999
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D019956 2001
% 219.86/220.06  |- skos__hiddenLabel mesh__D019956 Stereotypic Movement Disorders
% 219.86/220.06  |- skos__hiddenLabel mesh__D011973 Receptor, LDL
% 219.86/220.06  |- skos__altLabel mesh__D011973 Receptors, Lipoprotein, LDL
% 219.86/220.06  |- skos__broader mesh__D011973smesh__D018110
% 219.86/220.06  |- skos__altLabel mesh__D011973 LDL Receptors, Lipoprotein
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D011973 2006
% 219.86/220.06  |- mesh__recordAuthorizer mesh__D011973 sjn
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D011973 2005
% 219.86/220.06  |- skos__scopeNote mesh__D011973
% 219.86/220.06       Receptors on the plasma membrane of nonhepatic cells that specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1, receptors do not bind to LDL; 2, there is reduced binding of LDL; and 3, there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking.%A%    
% 219.86/220.06  |- skos__altLabel mesh__D011973 Receptors, Low Density Lipoprotein
% 219.86/220.06  |- mesh__recordOriginator mesh__D011973 RLS
% 219.86/220.06  |- skos__hiddenLabel mesh__D011973 Receptors, Lipoprotein LDL
% 219.86/220.06  |- mesh__publicMeSHNote mesh__D011973
% 219.86/220.06       85; LIPOPROTEINS, LDL RECEPTORS was see RECEPTORS, LDL 1985-92%A%  
% 219.86/220.06  |- mesh__dateCreated mesh__D011973 1984-05-25
% 219.86/220.06  |- skos__annotation mesh__D011973 DF: RECEPT LDL   
% 219.86/220.06  |- skos__altLabel mesh__D011973 LDL Receptors
% 219.86/220.06  |- mesh__historyNote mesh__D011973
% 219.86/220.06       85; LIPOPROTEINS, LDL RECEPTORS was see RECEPTORS, LDL 1985-92%A%  
% 219.86/220.06  |- mesh__dateRevised mesh__D011973 2004-07-07
% 219.86/220.06  |- mesh__recordMaintainer mesh__D011973 wdj
% 219.86/220.06  |- rdf__type mesh__D011973sskos__Concept
% 219.86/220.06  |- skos__altLabel mesh__D011973 LDL Receptor
% 219.86/220.06  |- skos__altLabel mesh__D011973 Low Density Lipoprotein Receptor
% 219.86/220.06  |- mesh__onlineNote mesh__D011973
% 219.86/220.06       use RECEPTORS, LDL to search LIPOPROTEINS, LDL RECEPTORS 1985-92%A%  
% 219.86/220.06  |- skos__altLabel mesh__D011973 Lipoprotein LDL Receptors
% 219.86/220.06  |- skos__historyNote mesh__D011973 Lipoproteins, LDL %28%1972-1984%29%
% 219.86/220.06  |- skos__altLabel mesh__D011973 Low Density Lipoprotein Receptors
% 219.86/220.06  |- skos__prefLabel mesh__D011973 Receptors, LDL
% 219.86/220.06  |- mesh__dateEstablished mesh__D011973 1985-01-01
% 219.86/220.06  |- skos__historyNote mesh__D011973
% 219.86/220.06       Receptors, Endogenous Substances %28%1973-1984%29%
% 219.86/220.06  |- mesh__recordMaintainer mesh__D019158 ssb
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D019158 2005
% 219.86/220.06  |- skos__hiddenLabel mesh__D019158 Acid, Sialic
% 219.86/220.06  |- skos__prefLabel mesh__D019158 N-Acetylneuraminic Acid
% 219.86/220.06  |- skos__historyNote mesh__D019158 Sialic Acids %28%1981-1996%29%
% 219.86/220.06  |- skos__hiddenLabel mesh__D019158 Acid, N-Acetylneuraminic
% 219.86/220.06  |- mesh__historyNote mesh__D019158
% 219.86/220.06       97; was N-ACETYLNEURAMINIC ACID %28%NM%29% 1981-96   
% 219.86/220.06  |- skos__scopeNote mesh__D019158
% 219.86/220.06       An N-acyl derivative of neuraminic acid. N-acetylneuraminic acid occurs in many polysaccharides, glycoproteins, and glycolipids in animals and bacteria. %28%From Dorland, 28th ed, p1518%29%%A%    
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D019158 2006
% 219.86/220.06  |- mesh__dateCreated mesh__D019158 1996-06-10
% 219.86/220.06  |- skos__altLabel mesh__D019158 Sialic Acid
% 219.86/220.06  |- skos__hiddenLabel mesh__D019158 N Acetylneuraminic Acid
% 219.86/220.06  |- rdf__type mesh__D019158sskos__Concept
% 219.86/220.06  |- mesh__dateRevised mesh__D019158 2004-07-07
% 219.86/220.06  |- skos__broader mesh__D019158smesh__D012794
% 219.86/220.06  |- mesh__onlineNote mesh__D019158
% 219.86/220.06       use N-ACETYLNEURAMINIC ACID %28%NM%29% to search N-ACETYLNEURAMINIC ACID 1981-96%A%  
% 219.86/220.06  |- mesh__recordAuthorizer mesh__D019158 sjn
% 219.86/220.06  |- mesh__recordOriginator mesh__D019158 TPW
% 219.86/220.06  |- skos__annotation mesh__D019158
% 219.86/220.06       do not confuse with N-ACETYLNEURAMINIC ACIDS see SIALIC ACIDS; do not confuse X ref SIALIC ACID with SIALIC ACIDS%A%  
% 219.86/220.06  |- mesh__publicMeSHNote mesh__D019158
% 219.86/220.06       97; N-ACETYLNEURAMINIC ACID was indexed under SIALIC ACIDS 1981-96%A%  
% 219.86/220.06  |- mesh__dateEstablished mesh__D019158 1997-01-01
% 219.86/220.06  |- skos__annotation mesh__D011175
% 219.86/220.06       note category: a type of artif resp; do not confuse with POSITIVE-PRESSURE RESPIRATION, INTRINSIC, a type of resp insuff %28%Cat C%29%; do not use /util except by MeSH definition; DF: note short X ref%A%  
% 219.86/220.06  |- skos__hiddenLabel mesh__D011175 Pressures, Positive End-Expiratory
% 219.86/220.06  |- skos__hiddenLabel mesh__D011175 End-Expiratory Pressure, Positive
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D011175 2002
% 219.86/220.06  |- mesh__recordMaintainer mesh__D011175 TGC
% 219.86/220.06  |- rdf__type mesh__D011175sskos__Concept
% 219.86/220.06  |- mesh__publicMeSHNote mesh__D011175
% 219.86/220.06       91; was POSITIVE PRESSURE RESPIRATION 1979-90; was heading 1963-78%A%  
% 219.86/220.06  |- mesh__recordOriginator mesh__D011175 NLM
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D011175 1999
% 219.86/220.06  |- skos__altLabel mesh__D011175 PEEP
% 219.86/220.06  |- mesh__recordAuthorizer mesh__D011175 SJN
% 219.86/220.06  |- skos__prefLabel mesh__D011175 Positive-Pressure Respiration
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D011175 2003
% 219.86/220.06  |- skos__broader mesh__D011175smesh__D012121
% 219.86/220.06  |- skos__hiddenLabel mesh__D011175 End-Expiratory Pressures, Positive
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D011175 2005
% 219.86/220.06  |- mesh__historyNote mesh__D011175
% 219.86/220.06       91; was POSITIVE PRESSURE RESPIRATION 1979-90; was heading 1963-78%A%  
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D011175 2000
% 219.86/220.06  |- mesh__dateCreated mesh__D011175 1999-01-01
% 219.86/220.06  |- skos__hiddenLabel mesh__D011175 Positive End-Expiratory Pressures
% 219.86/220.06  |- skos__hiddenLabel mesh__D011175 Positive End Expiratory Pressure
% 219.86/220.06  |- skos__hiddenLabel mesh__D011175 Positive-Pressure Respirations
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D011175 2004
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D011175 2001
% 219.86/220.06  |- skos__scopeNote mesh__D011175
% 219.86/220.06       A method of mechanical ventilation in which pressure is maintained to increase the volume of gas remaining in the lungs at the end of expiration, thus reducing the shunting of blood through the lungs and improving gas exchange.%A%    
% 219.86/220.06  |- mesh__dateRevised mesh__D011175 1997-06-20
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D011175 2006
% 219.86/220.06  |- skos__hiddenLabel mesh__D011175 Positive Pressure Respiration
% 219.86/220.06  |- skos__hiddenLabel mesh__D011175 Respirations, Positive-Pressure
% 219.86/220.06  |- skos__hiddenLabel mesh__D011175 Respiration, Positive-Pressure
% 219.86/220.06  |- skos__altLabel mesh__D011175 Positive End-Expiratory Pressure
% 219.86/220.06  |- mesh__onlineNote mesh__D011175
% 219.86/220.06       use POSITIVE-PRESSURE RESPIRATION to search POSITIVE PRESSURE RESPIRATION 1979-90%A%  
% 219.86/220.06  |- skos__hiddenLabel mesh__D011175 Pressure, Positive End-Expiratory
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D011175 1998
% 219.86/220.06  |- mesh__publicMeSHNote mesh__D005936 79   
% 219.86/220.06  |- skos__altLabel mesh__D005936 Polyglucoses
% 219.86/220.06  |- skos__broader mesh__D005936smesh__D011134
% 219.86/220.06  |- skos__historyNote mesh__D005936 Polysaccharides %28%1966-1978%29%
% 219.86/220.06  |- mesh__recordAuthorizer mesh__D005936 sjn
% 219.86/220.06  |- skos__prefLabel mesh__D005936 Glucans
% 219.86/220.06  |- skos__hiddenLabel mesh__D005936 Polymer, Glucose
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D005936 2006
% 219.86/220.06  |- rdf__type mesh__D005936sskos__Concept
% 219.86/220.06  |- mesh__recordMaintainer mesh__D005936 jmp
% 219.86/220.06  |- mesh__dateEstablished mesh__D005936 1979-01-01
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D005936 2005
% 219.86/220.06  |- mesh__dateCreated mesh__D005936 1977-12-15
% 219.86/220.06  |- skos__scopeNote mesh__D005936
% 219.86/220.06       Polysaccharides composed of repeating glucose units. They can consist of branched or unbranched chains in any linkages.%A%    
% 219.86/220.06  |- skos__broader mesh__D005936smesh__D001704
% 219.86/220.06  |- skos__altLabel mesh__D005936 Glucose Polymer
% 219.86/220.06  |- mesh__historyNote mesh__D005936 79   
% 219.86/220.06  |- skos__historyNote mesh__D005936 Glucose %28%1966-1978%29%
% 219.86/220.06  |- mesh__recordOriginator mesh__D005936 RLS
% 219.86/220.06  |- mesh__dateRevised mesh__D005936 2004-07-07
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D005138 2006
% 219.86/220.06  |- skos__broader mesh__D005138smesh__D005123
% 219.86/220.06  |- mesh__dateRevised mesh__D005138 2002-07-03
% 219.86/220.06  |- skos__prefLabel mesh__D005138 Eyebrows
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D005138 2004
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D005138 2005
% 219.86/220.06  |- mesh__dateCreated mesh__D005138 1999-01-01
% 219.86/220.06  |- mesh__recordAuthorizer mesh__D005138 sjn
% 219.86/220.06  |- skos__scopeNote mesh__D005138
% 219.86/220.06       Curved rows of HAIR located on the upper edges of the eye sockets.%A%    
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D005138 2003
% 219.86/220.06  |- skos__broader mesh__D005138smesh__D006197
% 219.86/220.06  |- rdf__type mesh__D005138sskos__Concept
% 219.86/220.06  |- skos__hiddenLabel mesh__D005138 Eyebrow
% 219.86/220.06  |- mesh__recordOriginator mesh__D005138 NLM
% 219.86/220.06  |- mesh__recordMaintainer mesh__D005138 nns
% 219.86/220.06  |- mesh__publicMeSHNote mesh__D029586 2002   
% 219.86/220.06  |- rdf__type mesh__D029586sskos__Concept
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D029586 2006
% 219.86/220.06  |- mesh__dateRevised mesh__D029586 2003-07-09
% 219.86/220.06  |- mesh__recordOriginator mesh__D029586 ssb
% 219.86/220.06  |- mesh__dateCreated mesh__D029586 2001-07-25
% 219.86/220.06  |- skos__broader mesh__D029586smesh__D019684
% 219.86/220.06  |- mesh__dateEstablished mesh__D029586 2002-01-01
% 219.86/220.06  |- skos__prefLabel mesh__D029586 Moraceae
% 219.86/220.06  |- mesh__recordAuthorizer mesh__D029586 sjn
% 219.86/220.06  |- skos__annotation mesh__D029586
% 219.86/220.06       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D029586 2004
% 219.86/220.06  |- skos__scopeNote mesh__D029586
% 219.86/220.06       The mulberry plant family of the order Urticales, subclass Hamamelidae, class Magnoliopsida.  They have milky latex and small, petalless male or female flowers.%A%    
% 219.86/220.06  |- mesh__historyNote mesh__D029586 2002   
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D029586 2005
% 219.86/220.06  |- mesh__recordMaintainer mesh__D029586 ssb
% 219.86/220.06  |- skos__scopeNote mesh__D009529
% 219.86/220.06       A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.%A%    
% 219.86/220.06  |- skos__hiddenLabel mesh__D009529 Y93
% 219.86/220.06  |- skos__altLabel mesh__D009529
% 219.86/220.06       Ratiopharm Brand of Nicardipine Hydrochloride
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D009529 2005
% 219.86/220.06  |- skos__altLabel mesh__D009529
% 219.86/220.06       Farma Lepori Brand of Nicardipine Hydrochloride
% 219.86/220.06  |- skos__altLabel mesh__D009529 Seid Brand of Nicardipine
% 219.86/220.06  |- skos__historyNote mesh__D009529 Pyridines %28%1966-1974%29%
% 219.86/220.06  |- skos__hiddenLabel mesh__D009529 Nicardipine Seid Brand
% 219.86/220.06  |- skos__altLabel mesh__D009529
% 219.86/220.06       Yamanouchi Brand 3 of Nicardipine Hydrochloride
% 219.86/220.06  |- skos__altLabel mesh__D009529 Antagonil
% 219.86/220.06  |- mesh__historyNote mesh__D009529 87   
% 219.86/220.06  |- skos__altLabel mesh__D009529
% 219.86/220.06       Yamanouchi Brand 1 of Nicardipine Hydrochloride
% 219.86/220.06  |- mesh__dateCreated mesh__D009529 1986-06-02
% 219.86/220.06  |- skos__altLabel mesh__D009529 Syntex Brand of Nicardipine Hydrochloride
% 219.86/220.06  |- skos__historyNote mesh__D009529
% 219.86/220.06       Nifedipine/analogs %26% derivatives %28%1975-1986%29%
% 219.86/220.06  |- skos__altLabel mesh__D009529
% 219.86/220.06       ESP Pharma Brand of Nicardipine Hydrochloride
% 219.86/220.06  |- mesh__dateRevised mesh__D009529 2004-07-07
% 219.86/220.06  |- mesh__recordMaintainer mesh__D009529 lkw
% 219.86/220.06  |- skos__hiddenLabel mesh__D009529 Y 93
% 219.86/220.06  |- skos__altLabel mesh__D009529 Roche Brand of Nicardipine Hydrochloride
% 219.86/220.06  |- skos__altLabel mesh__D009529 Novartis Brand of Nicardipine Hydrochloride
% 219.86/220.06  |- mesh__recordAuthorizer mesh__D009529 sjn
% 219.86/220.06  |- mesh__dateEstablished mesh__D009529 1987-01-01
% 219.86/220.06  |- mesh__publicMeSHNote mesh__D009529 87   
% 219.86/220.06  |- rdf__type mesh__D009529sskos__Concept
% 219.86/220.06  |- skos__altLabel mesh__D009529
% 219.86/220.06       Tedec Meiji Brand of Nicardipine Hydrochloride
% 219.86/220.06  |- skos__altLabel mesh__D009529 UCB Brand of Nicardipine Hydrochloride
% 219.86/220.06  |- skos__altLabel mesh__D009529 Vasonase
% 219.86/220.06  |- skos__prefLabel mesh__D009529 Nicardipine
% 219.86/220.06  |- skos__hiddenLabel mesh__D009529 LA, Nicardipine
% 219.86/220.06  |- skos__altLabel mesh__D009529
% 219.86/220.06       Yamanouchi Brand 2 of Nicardipine Hydrochloride
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D009529 2006
% 219.86/220.06  |- mesh__recordOriginator mesh__D009529 RLS
% 219.86/220.06  |- skos__broader mesh__D009529smesh__D004095
% 219.86/220.06  |- skos__hiddenLabel mesh__D009529 Hydrochloride, Nicardipine
% 219.86/220.06  |- skos__altLabel mesh__D009529 Solvay Brand of Nicardipine Hydrochloride
% 219.86/220.06  |- skos__altLabel mesh__D009529 Almirall Brand of Nicardipine Hydrochloride
% 219.86/220.06  |- skos__broader mesh__D001546smesh__D000538
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D001546 2002
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D001546 2006
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D001546 2001
% 219.86/220.06  |- rdf__type mesh__D001546sskos__Concept
% 219.86/220.06  |- mesh__dateCreated mesh__D001546 1999-01-01
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D001546 2005
% 219.86/220.06  |- skos__prefLabel mesh__D001546 Bentonite
% 219.86/220.06  |- mesh__recordAuthorizer mesh__D001546 sjn
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D001546 2004
% 219.86/220.06  |- skos__altLabel mesh__D001546 Montmorillonite
% 219.86/220.06  |- mesh__onlineNote mesh__D001546
% 219.86/220.06       use ALUMINUM SILICATES to search BENTONITE 1966-72   
% 219.86/220.06  |- skos__historyNote mesh__D001546 Aluminum Silicates %28%1966-1972%29%
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D001546 2003
% 219.86/220.06  |- mesh__dateRevised mesh__D001546 2000-06-22
% 219.86/220.06  |- mesh__recordMaintainer mesh__D001546 adp
% 219.86/220.06  |- mesh__dateEstablished mesh__D001546 1973-01-01
% 219.86/220.06  |- skos__scopeNote mesh__D001546
% 219.86/220.06       A colloidal, hydrated aluminum silicate that swells 12 times its dry size when added to water.%A%    
% 219.86/220.06  |- mesh__historyNote mesh__D001546
% 219.86/220.06       73; was see ALUMINUM SILICATES 1963-72; MONTMORILLONITE was MONTMORRILLONITE 1977-93%A%  
% 219.86/220.06  |- mesh__publicMeSHNote mesh__D001546
% 219.86/220.06       73; was see ALUMINUM SILICATES 1963-72; MONTMORILLONITE was MONTMORRILLONITE 1977-93%A%  
% 219.86/220.06  |- mesh__recordOriginator mesh__D001546 NLM
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D020700 2001
% 219.86/220.06  |- mesh__dateEstablished mesh__D020700 2000-01-01
% 219.86/220.06  |- skos__broader mesh__D020700smesh__D020776
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D020700 2000
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D020700 2004
% 219.86/220.06  |- skos__altLabel mesh__D020700 Proctoscope
% 219.86/220.06  |- skos__historyNote mesh__D020700 Proctoscopy %28%1979-1999%29%
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D020700 2003
% 219.86/220.06  |- rdf__type mesh__D020700sskos__Concept
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D020700 2002
% 219.86/220.06  |- skos__historyNote mesh__D020700
% 219.86/220.06       Proctoscopy/instrumentation %28%1966-1999%29%
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D020700 2006
% 219.86/220.06  |- mesh__publicMeSHNote mesh__D020700
% 219.86/220.06       2000; for PROCTOSCOPE see PROCTOSCOPY 1979-1999   
% 219.86/220.06  |- mesh__historyNote mesh__D020700
% 219.86/220.06       2000; for PROCTOSCOPE use PROCTOSCOPY 1979-1999   
% 219.86/220.06  |- mesh__dateCreated mesh__D020700 1999-11-03
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D020700 2005
% 219.86/220.06  |- skos__prefLabel mesh__D020700 Proctoscopes
% 219.86/220.06  |- skos__scopeNote mesh__D020700
% 219.86/220.06       Endoscopes for visual examination of the rectum and anus.%A%    
% 219.86/220.06  |- skos__historyNote mesh__D047648 Menopause %28%1982-2004%29%
% 219.86/220.06  |- rdf__type mesh__D047648sskos__Concept
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D047648 2005
% 219.86/220.06  |- mesh__dateCreated mesh__D047648 2004-07-07
% 219.86/220.06  |- mesh__dateEstablished mesh__D047648 2005-01-01
% 219.86/220.06  |- skos__broader mesh__D047648smesh__D008593
% 219.86/220.06  |- skos__historyNote mesh__D047648 Climacteric %28%1980-2004%29%
% 219.86/220.06  |- mesh__recordOriginator mesh__D047648 lkt
% 219.86/220.06  |- mesh__recordMaintainer mesh__D047648 lkt
% 219.86/220.06  |- skos__prefLabel mesh__D047648 Perimenopause
% 219.86/220.06  |- skos__scopeNote mesh__D047648
% 219.86/220.06       The transitional period before and after MENOPAUSE. Perimenopausal symptoms are associated with irregular MENSTRUAL CYCLE and widely fluctuated hormone levels. They may appear 6 years before menopause and subside 2 to 5 years after menopause.%A%    
% 219.86/220.06  |- mesh__recordAuthorizer mesh__D047648 sjn
% 219.86/220.06  |- mesh__historyNote mesh__D047648
% 219.86/220.06       2005; use CLIMACTERIC 2002-2004, use PREMENOPAUSE 1995-2001%A%  
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D047648 2006
% 219.86/220.06  |- mesh__publicMeSHNote mesh__D047648
% 219.86/220.06       2005; see CLIMACTERIC 2002-2004, see PREMENOPAUSE 1995-2001%A%  
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D019957 2003
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D019957 2001
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D019957 2005
% 219.86/220.06  |- mesh__dateCreated mesh__D019957 1997-06-20
% 219.86/220.06  |- skos__broader mesh__D019957smesh__D019952
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D019957 2000
% 219.86/220.06  |- rdf__type mesh__D019957sskos__Concept
% 219.86/220.06  |- skos__hiddenLabel mesh__D019957 Developmental Coordination Disorders
% 219.86/220.06  |- skos__hiddenLabel mesh__D019957 Coordination Disorder, Developmental
% 219.86/220.06  |- skos__prefLabel mesh__D019957 Motor Skills Disorders
% 219.86/220.06  |- skos__scopeNote mesh__D019957
% 219.86/220.06       Marked impairments in the development of motor coordination such that the impairment interferes with activities of daily living. %28%From DSM-IV, 1994%29%%A%    
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D019957 1999
% 219.86/220.06  |- mesh__dateEstablished mesh__D019957 1998-01-01
% 219.86/220.06  |- mesh__publicMeSHNote mesh__D019957 98   
% 219.86/220.06  |- mesh__historyNote mesh__D019957 98   
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D019957 1998
% 219.86/220.06  |- skos__hiddenLabel mesh__D019957 Motor Skills Disorder
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D019957 2004
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D019957 2002
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D019957 2006
% 219.86/220.06  |- skos__altLabel mesh__D011974
% 219.86/220.06       Receptors, Interstitial Cell Stimulating Hormone
% 219.86/220.06  |- skos__annotation mesh__D011974 DF: RECEPT LH   
% 219.86/220.06  |- skos__altLabel mesh__D011974 Receptors, hCG
% 219.86/220.06  |- skos__hiddenLabel mesh__D011974 Hormone Receptors, Luteinizing
% 219.86/220.06  |- skos__altLabel mesh__D011974 hCG Receptors
% 219.86/220.06  |- skos__scopeNote mesh__D011974
% 219.86/220.06       Those protein complexes or molecular sites on the surfaces and cytoplasm of gonadal cells that bind luteinizing or chorionic gonadotropic hormones and thereby cause the gonadal cells to synthesize and secrete sex steroids. The hormone-receptor complex is internalized from the plasma membrane and initiates steroid synthesis.%A%    
% 219.86/220.06  |- skos__hiddenLabel mesh__D011974 Receptor, Luteinizing Hormone
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D011974 2004
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D011974 2005
% 219.86/220.06  |- skos__altLabel mesh__D011974 LH-hCG Receptors
% 219.86/220.06  |- skos__altLabel mesh__D011974 ICSH Receptors
% 219.86/220.06  |- skos__altLabel mesh__D011974 Receptors, Human Chorionic Gonadotropin
% 219.86/220.06  |- skos__hiddenLabel mesh__D011974 Receptor, Chorionic Gonadotropin
% 219.86/220.06  |- skos__altLabel mesh__D011974 Receptors, Chorionic Gonadotropin
% 219.86/220.06  |- skos__altLabel mesh__D011974 Receptors, Lutropin
% 219.86/220.06  |- skos__prefLabel mesh__D011974 Receptors, LH
% 219.86/220.06  |- skos__altLabel mesh__D011974 Luteinizing Hormone Receptor
% 219.86/220.06  |- mesh__recordAuthorizer mesh__D011974 sjn
% 219.86/220.06  |- skos__broader mesh__D011974smesh__D011967
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D011974 2006
% 219.86/220.06  |- skos__hiddenLabel mesh__D011974 LH hCG Receptors
% 219.86/220.06  |- skos__broader mesh__D011974smesh__D043562
% 219.86/220.06  |- skos__hiddenLabel mesh__D011974 Receptor, hCG
% 219.86/220.06  |- skos__altLabel mesh__D011974 Receptors, ICSH
% 219.86/220.06  |- skos__hiddenLabel mesh__D011974 Receptors, LH hCG
% 219.86/220.06  |- skos__altLabel mesh__D011974 Chorionic Gonadotropin Receptors
% 219.86/220.06  |- skos__altLabel mesh__D011974
% 219.86/220.06       Receptors, Interstitial Cell-Stimulating Hormone
% 219.86/220.06  |- skos__altLabel mesh__D011974 LH Receptors
% 219.86/220.06  |- skos__hiddenLabel mesh__D011974 Gonadotropin Receptor, Chorionic
% 219.86/220.06  |- skos__historyNote mesh__D011974
% 219.86/220.06       Receptors, Endogenous Substances %28%1973-1986%29%
% 219.86/220.06  |- rdf__type mesh__D011974sskos__Concept
% 219.86/220.06  |- mesh__historyNote mesh__D011974
% 219.86/220.06       87; CHORIONIC GONADOTROPIN RECEPTORS was see RECEPTORS, GONADOTROPIN 1986-93%A%  
% 219.86/220.06  |- skos__hiddenLabel mesh__D011974 Receptor, LH
% 219.86/220.06  |- skos__historyNote mesh__D011974
% 219.86/220.06       Gonadotropins, Chorionic %28%1966-1986%29%
% 219.86/220.06  |- mesh__onlineNote mesh__D011974
% 219.86/220.06       use RECEPTORS, GONADOTROPIN to search CHORIONIC GONADOTROPIN RECEPTORS 1986-93%A%  
% 219.86/220.06  |- skos__hiddenLabel mesh__D011974 Hormone Receptor, Luteinizing
% 219.86/220.06  |- mesh__dateCreated mesh__D011974 1986-03-31
% 219.86/220.06  |- skos__altLabel mesh__D011974 Human Chorionic Gonadotropin Receptor
% 219.86/220.06  |- mesh__publicMeSHNote mesh__D011974
% 219.86/220.06       87; CHORIONIC GONADOTROPIN RECEPTORS was see RECEPTORS, GONADOTROPIN 1986-93%A%  
% 219.86/220.06  |- skos__hiddenLabel mesh__D011974 Gonadotropin Receptors, Chorionic
% 219.86/220.06  |- mesh__dateRevised mesh__D011974 2003-07-09
% 219.86/220.06  |- mesh__dateEstablished mesh__D011974 1987-01-01
% 219.86/220.06  |- skos__altLabel mesh__D011974 Receptors, Luteinizing Hormone
% 219.86/220.06  |- skos__altLabel mesh__D011974 hCG Receptor
% 219.86/220.06  |- skos__altLabel mesh__D011974 Human Chorionic Gonadotropin Receptors
% 219.86/220.06  |- skos__altLabel mesh__D011974 Lutropin Receptors
% 219.86/220.06  |- skos__altLabel mesh__D011974 Receptors, LH-hCG
% 219.86/220.06  |- skos__altLabel mesh__D011974 LH Receptor
% 219.86/220.06  |- mesh__recordMaintainer mesh__D011974 jmp
% 219.86/220.06  |- skos__altLabel mesh__D011974 Luteinizing Hormone Receptors
% 219.86/220.06  |- mesh__recordOriginator mesh__D011974 SH
% 219.86/220.06  |- skos__altLabel mesh__D011974 Chorionic Gonadotropin Receptor
% 219.86/220.06  |- skos__broader mesh__D011974smesh__D018013
% 219.86/220.06  |- mesh__onlineNote mesh__D019159
% 219.86/220.06       use NONHEME IRON PROTEINS %28%NM%29% to search NON-HEME IRON PROTEINS 1980-96%A%  
% 219.86/220.06  |- mesh__recordOriginator mesh__D019159 TPW
% 219.86/220.06  |- skos__hiddenLabel mesh__D019159 Iron Proteins, Non Heme
% 219.86/220.06  |- skos__hiddenLabel mesh__D019159 Proteins, Nonheme Iron
% 219.86/220.06  |- mesh__dateEstablished mesh__D019159 1997-01-01
% 219.86/220.06  |- mesh__activeMeSHYear mesh__D019159 2006
% 219.86/220.06  |- skos__historyNote mesh__D019159 Metalloproteins %28%1983-1996%29%
% 219.86/220.06  |- rdf__type mesh__D019159sskos__Concept
% 219.86/220.06  |- skos__altLabel mesh__D019159 Iron Proteins, Non-Heme
% 219.86/220.06  |- skos__historyNote mesh__D019159 Iron %28%1978-1982%29%
% 219.86/220.06  |- mesh__recordMaintainer mesh__D019159 SYSTEM
% 219.86/220.06  |- skos__broader mesh__D019159smesh__D033862
% 219.86/220.06  |- skos__annotation mesh__D019159 GEN or unspecified; prefer specifics   
% 219.86/220.06  |- skos__altLabel mesh__D019159 Non-Heme Iron Proteins
% 219.86/220.06  |- mesh__dateCreated mesh__D019159 1996-06-10
% 219.86/220.06  |- skos__hiddenLabel mesh__D019159 Iron Proteins, Nonheme
% 219.86/220.06  |- mesh__historyNote mesh__D019159
% 219.86/220.06       97; was NON-HEME IRON PROTEINS %28%NM%29% 1978-96   
% 219.86/220.06  |- skos__scopeNote mesh__D019159
% 219.86/220.06       Proteins, usually acting in oxidation-reduction reactions, containing iron but no porphyrin groups. %28%Lehninger, Principles of Biochemistry, 1993, pG-10%29%%A%    
% 219.86/220.06  |- skos__hiddenLabel mesh__D019159 Proteins, Non-Heme Iron
% 219.86/220.06  |- skos__hiddenLabel mesh__D019159 Non Heme Iron Proteins
% 219.86/220.06  |- mesh__publicMeSHNote mesh__D019159
% 219.86/220.06       97; NON-HEME IRON PROTEINS was indexed under METALLOPROTEINS 1983-96 %26% IRON 1978-82%A%  
% 219.86/220.06  |- mesh__dateRevised mesh__D019159 2005-06-30
% 219.86/220.06  |- mesh__recordAuthorizer mesh__D019159 sjn
% 219.86/220.07  |- skos__prefLabel mesh__D019159 Nonheme Iron Proteins
% 219.86/220.07  |- skos__scopeNote mesh__D011176
% 219.86/220.07       Use of a metal casting, usually with a post in the pulp or root canal, designed to support and retain an artificial crown.%A%    
% 219.86/220.07  |- skos__annotation mesh__D011176
% 219.86/220.07       do not use /util except by MeSH definition; DF: POST TECHNIQUE%A%  
% 219.86/220.07  |- skos__hiddenLabel mesh__D011176 Techniques, Post
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D011176 2003
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D011176 2001
% 219.86/220.07  |- mesh__dateRevised mesh__D011176 1997-06-20
% 219.86/220.07  |- skos__hiddenLabel mesh__D011176 Post Techniques
% 219.86/220.07  |- skos__hiddenLabel mesh__D011176 Post Technics
% 219.86/220.07  |- mesh__publicMeSHNote mesh__D011176
% 219.86/220.07       91; was POST AND CORE TECHNIC see under CROWNS 1975-90   
% 219.86/220.07  |- mesh__dateCreated mesh__D011176 1999-01-01
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D011176 2005
% 219.86/220.07  |- skos__hiddenLabel mesh__D011176 Technics, Post-Core
% 219.86/220.07  |- skos__hiddenLabel mesh__D011176 Technics, Post
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D011176 2004
% 219.86/220.07  |- mesh__historyNote mesh__D011176
% 219.86/220.07       91%28%75%29%; was POST AND CORE TECHNIC see under CROWNS 1975-90%A%  
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D011176 2006
% 219.86/220.07  |- skos__hiddenLabel mesh__D011176 Technique, Post
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D011176 2002
% 219.86/220.07  |- skos__hiddenLabel mesh__D011176 Post-Core Technics
% 219.86/220.07  |- mesh__onlineNote mesh__D011176
% 219.86/220.07       use POST AND CORE TECHNIQUE to search POST AND CORE TECHNIC 1975-90; search CROWNS 1974%A%  
% 219.86/220.07  |- skos__altLabel mesh__D011176 Dental Dowels
% 219.86/220.07  |- mesh__recordOriginator mesh__D011176 NLM
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D011176 1998
% 219.86/220.07  |- skos__hiddenLabel mesh__D011176 Technic, Post-Core
% 219.86/220.07  |- mesh__recordAuthorizer mesh__D011176 SJN
% 219.86/220.07  |- skos__altLabel mesh__D011176 Post-Core Technic
% 219.86/220.07  |- skos__altLabel mesh__D011176 Post Technic
% 219.86/220.07  |- skos__broader mesh__D011176smesh__D003442
% 219.86/220.07  |- rdf__type mesh__D011176sskos__Concept
% 219.86/220.07  |- skos__altLabel mesh__D011176 Post and Core Technic
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D011176 1999
% 219.86/220.07  |- skos__prefLabel mesh__D011176 Post and Core Technique
% 219.86/220.07  |- skos__altLabel mesh__D011176 Dowels, Dental
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D011176 2000
% 219.86/220.07  |- mesh__recordMaintainer mesh__D011176 TGC
% 219.86/220.07  |- skos__altLabel mesh__D011176 Dowel, Dental
% 219.86/220.07  |- skos__hiddenLabel mesh__D011176 Technic, Post
% 219.86/220.07  |- mesh__dateEstablished mesh__D011176 1991-01-01
% 219.86/220.07  |- skos__broader mesh__D005937smesh__D013400
% 219.86/220.07  |- rdf__type mesh__D005937sskos__Concept
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D005937 2005
% 219.86/220.07  |- mesh__historyNote mesh__D005937
% 219.86/220.07       91%28%76%29%; was see under SUGAR ACIDS 1976-90   
% 219.86/220.07  |- skos__hiddenLabel mesh__D005937 L Gularic Acid
% 219.86/220.07  |- skos__altLabel mesh__D005937 D-Glucaric Acid
% 219.86/220.07  |- skos__hiddenLabel mesh__D005937 Acid, Levo-Gularic
% 219.86/220.07  |- mesh__recordAuthorizer mesh__D005937 sjn
% 219.86/220.07  |- skos__hiddenLabel mesh__D005937 Glucarate, Calcium
% 219.86/220.07  |- skos__hiddenLabel mesh__D005937 D Glucaric Acid
% 219.86/220.07  |- skos__hiddenLabel mesh__D005937 Acid, Tetrahydroxyadipic
% 219.86/220.07  |- mesh__dateEstablished mesh__D005937 1991-01-01
% 219.86/220.07  |- skos__hiddenLabel mesh__D005937 Levo Gularic Acid
% 219.86/220.07  |- skos__historyNote mesh__D005937 Sugar Acids %28%1974%29%
% 219.86/220.07  |- skos__hiddenLabel mesh__D005937 Acid, Glucaric
% 219.86/220.07  |- mesh__dateRevised mesh__D005937 2004-07-07
% 219.86/220.07  |- skos__altLabel mesh__D005937 Glucosaccharic Acid
% 219.86/220.07  |- skos__prefLabel mesh__D005937 Glucaric Acid
% 219.86/220.07  |- skos__historyNote mesh__D005937 Adipic Acids %28%1970-1975%29%
% 219.86/220.07  |- skos__hiddenLabel mesh__D005937 Acid, Glucosaccharic
% 219.86/220.07  |- skos__scopeNote mesh__D005937
% 219.86/220.07       A sugar acid derived from D-glucose in which both the aldehydic carbon atom and the carbon atom bearing the primary hydroxyl group are oxidized to carboxylic acid groups.%A%    
% 219.86/220.07  |- mesh__dateCreated mesh__D005937 1975-07-25
% 219.86/220.07  |- skos__hiddenLabel mesh__D005937 Acid, D-Glucaric
% 219.86/220.07  |- mesh__recordMaintainer mesh__D005937 ssb
% 219.86/220.07  |- skos__hiddenLabel mesh__D005937 Acid, L-Gularic
% 219.86/220.07  |- mesh__publicMeSHNote mesh__D005937
% 219.86/220.07       91; was see under SUGAR ACIDS 1976-90   
% 219.86/220.07  |- skos__altLabel mesh__D005937 Tetrahydroxyadipic Acid
% 219.86/220.07  |- skos__altLabel mesh__D005937 L-Gularic Acid
% 219.86/220.07  |- mesh__recordOriginator mesh__D005937 RLS
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D005937 2006
% 219.86/220.07  |- skos__scopeNote mesh__D005139
% 219.86/220.07       A pair of ophthalmic lenses in a frame or mounting which is supported by the nose and ears. The purpose is to aid or improve vision. It does not include goggles or nonprescription sun glasses for which EYE PROTECTIVE DEVICES is available.%A%    
% 219.86/220.07  |- skos__hiddenLabel mesh__D005139 Glasses, Prescription Sun
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D005139 2005
% 219.86/220.07  |- skos__altLabel mesh__D005139 Spectacles
% 219.86/220.07  |- mesh__dateCreated mesh__D005139 1999-01-01
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D005139 2000
% 219.86/220.07  |- mesh__recordOriginator mesh__D005139 NLM
% 219.86/220.07  |- skos__altLabel mesh__D005139 Glasses
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D005139 1998
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D005139 2006
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D005139 2003
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D005139 2001
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D005139 1999
% 219.86/220.07  |- skos__hiddenLabel mesh__D005139 Prescription Sun Glasses
% 219.86/220.07  |- mesh__recordMaintainer mesh__D005139 PXP
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D005139 2004
% 219.86/220.07  |- mesh__recordAuthorizer mesh__D005139 SJN
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D005139 2002
% 219.86/220.07  |- skos__broader mesh__D005139smesh__D007909
% 219.86/220.07  |- skos__prefLabel mesh__D005139 Eyeglasses
% 219.86/220.07  |- mesh__dateRevised mesh__D005139 1997-06-20
% 219.86/220.07  |- skos__annotation mesh__D005139
% 219.86/220.07       prescription lenses to aid vision: do not confuse with EYE PROTECTIVE DEVICES%A%  
% 219.86/220.07  |- rdf__type mesh__D005139sskos__Concept
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D029587 2003
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D029587 2004
% 219.86/220.07  |- skos__annotation mesh__D029587
% 219.86/220.07       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.86/220.07  |- mesh__dateEstablished mesh__D029587 2002-01-01
% 219.86/220.07  |- mesh__historyNote mesh__D029587 2002   
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D029587 2002
% 219.86/220.07  |- skos__scopeNote mesh__D029587
% 219.86/220.07       A plant genus of the family Moringaceae, order Capparales, subclass Dilleniidae, class Magnoliopsida.%A%    
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D029587 2005
% 219.86/220.07  |- skos__broader mesh__D029587smesh__D019684
% 219.86/220.07  |- mesh__publicMeSHNote mesh__D029587 2002   
% 219.86/220.07  |- mesh__dateCreated mesh__D029587 2001-07-25
% 219.86/220.07  |- rdf__type mesh__D029587sskos__Concept
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D029587 2006
% 219.86/220.07  |- skos__prefLabel mesh__D029587 Moringa
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D034721 2003
% 219.86/220.07  |- skos__broader mesh__D034721smesh__D008415
% 219.86/220.07  |- skos__scopeNote mesh__D034721
% 219.86/220.07       A group of disorders caused by the abnormal proliferation of MAST CELLS in a variety of extracutaneous tissues including bone marrow, liver, spleen, lymph nodes, and gastrointestinal tract. Systemic mastocytosis is commonly seen in adults. These diseases are categorized on the basis of clinical features, pathologic findings, and prognosis.%A%    
% 219.86/220.07  |- skos__historyNote mesh__D034721 Mast Cells %28%1965-2002%29%
% 219.86/220.07  |- skos__hiddenLabel mesh__D034721 Systemic Mastocytosis, Indolent
% 219.86/220.07  |- mesh__publicMeSHNote mesh__D034721 2003   
% 219.86/220.07  |- skos__hiddenLabel mesh__D034721 Systemic Mastocytosis
% 219.86/220.07  |- mesh__recordOriginator mesh__D034721 lkt
% 219.86/220.07  |- mesh__historyNote mesh__D034721 2003   
% 219.86/220.07  |- mesh__dateEstablished mesh__D034721 2003-01-01
% 219.86/220.07  |- skos__hiddenLabel mesh__D034721 Systemic Mast Cell Disease
% 219.86/220.07  |- skos__hiddenLabel mesh__D034721 Systemic Mastocytosis, Aggressive
% 219.86/220.07  |- skos__hiddenLabel mesh__D034721 Mastocytoses, Aggressive Systemic
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D034721 2005A
% 219.86/220.07  |- mesh__recordAuthorizer mesh__D034721 jls
% 219.86/220.07  |- skos__hiddenLabel mesh__D034721 Mast-Cell Diseases, Systemic
% 219.86/220.07  |- skos__hiddenLabel mesh__D034721 Systemic Mastocytoses
% 219.86/220.07  |- skos__prefLabel mesh__D034721 Mastocytosis, Systemic
% 219.86/220.07  |- mesh__dateCreated mesh__D034721 2002-07-02
% 219.86/220.07  |- skos__hiddenLabel mesh__D034721 Mastocytosis, Indolent Systemic
% 219.86/220.07  |- skos__hiddenLabel mesh__D034721 Mastocytosis, Aggressive Systemic
% 219.86/220.07  |- skos__hiddenLabel mesh__D034721 Aggressive Systemic Mastocytoses
% 219.86/220.07  |- skos__hiddenLabel mesh__D034721 Mastocytoses, Indolent Systemic
% 219.86/220.07  |- skos__altLabel mesh__D034721 Systemic Mast-Cell Disease
% 219.86/220.07  |- skos__hiddenLabel mesh__D034721 Systemic Mast-Cell Diseases
% 219.86/220.07  |- mesh__recordMaintainer mesh__D034721 jls
% 219.86/220.07  |- skos__historyNote mesh__D034721 Bone Marrow Diseases %28%1965-2002%29%
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D034721 2006
% 219.86/220.07  |- rdf__type mesh__D034721sskos__Concept
% 219.86/220.07  |- skos__hiddenLabel mesh__D034721 Systemic Mastocytoses, Aggressive
% 219.86/220.07  |- skos__hiddenLabel mesh__D034721 Systemic Mastocytoses, Indolent
% 219.86/220.07  |- skos__hiddenLabel mesh__D034721 Mast-Cell Disease, Systemic
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D034721 2004
% 219.86/220.07  |- skos__hiddenLabel mesh__D034721 Indolent Systemic Mastocytoses
% 219.86/220.07  |- mesh__dateRevised mesh__D034721 2004-07-28
% 219.86/220.07  |- skos__hiddenLabel mesh__D034721 Mastocytoses, Systemic
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D034721 2005
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D001547 1999
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D001547 1994
% 219.86/220.07  |- rdf__type mesh__D001547sskos__Concept
% 219.86/220.07  |- mesh__dateCreated mesh__D001547 1999-01-01
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D001547 2005
% 219.86/220.07  |- mesh__publicMeSHNote mesh__D001547 74   
% 219.86/220.07  |- mesh__recordOriginator mesh__D001547 NLM
% 219.86/220.07  |- skos__historyNote mesh__D001547 Aldehydes %28%1966-1971%29%
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D001547 1993
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D001547 1998
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D001547 2002
% 219.86/220.07  |- mesh__recordMaintainer mesh__D001547 TGC
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D001547 2004
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D001547 1997
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D001547 2001
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D001547 2003
% 219.86/220.07  |- skos__prefLabel mesh__D001547 Benzaldehydes
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D001547 1996
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D001547 2000
% 219.86/220.07  |- mesh__historyNote mesh__D001547 74%28%72%29%   
% 219.86/220.07  |- mesh__dateRevised mesh__D001547 1992-05-08
% 219.86/220.07  |- mesh__recordAuthorizer mesh__D001547 PLS
% 219.86/220.07  |- skos__broader mesh__D001547smesh__D000447
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D001547 1995
% 219.86/220.07  |- mesh__dateEstablished mesh__D001547 1974-01-01
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D001547 2006
% 219.86/220.07  |- mesh__recordAuthorizer mesh__D020701 sjn
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D020701 2004
% 219.86/220.07  |- mesh__publicMeSHNote mesh__D020701 2000   
% 219.86/220.07  |- skos__historyNote mesh__D020701
% 219.86/220.07       Esophagoscopy/instrumentation %28%1966-1999%29%
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D020701 2003
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D020701 2001
% 219.86/220.07  |- skos__hiddenLabel mesh__D020701 Esophagoscope
% 219.86/220.07  |- mesh__dateRevised mesh__D020701 2000-06-22
% 219.86/220.07  |- skos__broader mesh__D020701smesh__D020776
% 219.86/220.07  |- skos__scopeNote mesh__D020701
% 219.86/220.07       Endoscopes for examining the interior of the esophagus.%A%    
% 219.86/220.07  |- rdf__type mesh__D020701sskos__Concept
% 219.86/220.07  |- mesh__recordMaintainer mesh__D020701 sjn
% 219.86/220.07  |- mesh__historyNote mesh__D020701 2000   
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D020701 2006
% 219.86/220.07  |- skos__historyNote mesh__D020701 Endoscopes %28%1998-1999%29%
% 219.86/220.07  |- skos__prefLabel mesh__D020701 Esophagoscopes
% 219.86/220.07  |- mesh__recordOriginator mesh__D020701 nns
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D020701 2005
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D020701 2002
% 219.86/220.07  |- mesh__dateEstablished mesh__D020701 2000-01-01
% 219.86/220.07  |- mesh__dateCreated mesh__D020701 1999-11-03
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D006232 2004
% 219.86/220.07  |- skos__scopeNote mesh__D006232
% 219.86/220.07       A mild, highly infectious viral disease of children, characterized by vesicular lesions in the mouth and on the hands and feet. It is caused by coxsackieviruses A.%A%    
% 219.86/220.07  |- mesh__recordOriginator mesh__D006232 GHR
% 219.86/220.07  |- skos__prefLabel mesh__D006232 Hand, Foot and Mouth Disease
% 219.86/220.07  |- rdf__type mesh__D006232sskos__Concept
% 219.86/220.07  |- skos__broader mesh__D006232smesh__D003384
% 219.86/220.07  |- mesh__dateEstablished mesh__D006232 1991-01-01
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D006232 2002
% 219.86/220.07  |- skos__annotation mesh__D006232
% 219.86/220.07       do not confuse with FOOT-AND-MOUTH DISEASE caused by a picornavirus; DF: HAND FOOT MOUTH DIS%A%  
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D006232 2005
% 219.86/220.07  |- mesh__historyNote mesh__D006232
% 219.86/220.07       91%28%75%29%; was see under COXSACKIEVIRUS INFECTIONS 1979-90; was see under COXSACKIE VIRUS INFECTIONS 1970-78%A%  
% 219.86/220.07  |- mesh__recordMaintainer mesh__D006232 ags
% 219.86/220.07  |- mesh__dateRevised mesh__D006232 2001-07-25
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D006232 2006
% 219.86/220.07  |- mesh__recordAuthorizer mesh__D006232 sjn
% 219.86/220.07  |- skos__altLabel mesh__D006232 Hand, Foot, Mouth Disease
% 219.86/220.07  |- mesh__publicMeSHNote mesh__D006232
% 219.86/220.07       91; was see under COXSACKIEVIRUS INFECTIONS 1979-90; was see under COXSACKIE VIRUS INFECTIONS 1970-78%A%  
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D006232 2003
% 219.86/220.07  |- mesh__onlineNote mesh__D006232
% 219.86/220.07       search COXSACKIEVIRUS INFECTIONS 1970-74   
% 219.86/220.07  |- mesh__dateCreated mesh__D006232 1978-02-22
% 219.86/220.07  |- rdf__type mesh__D047649sskos__Concept
% 219.86/220.07  |- mesh__recordMaintainer mesh__D047649 lkt
% 219.86/220.07  |- mesh__recordAuthorizer mesh__D047649 sjn
% 219.86/220.07  |- skos__scopeNote mesh__D047649
% 219.86/220.07       An endocrine state in men, characterized by a significant decline in the production of TESTOSTERONE; DEHYDROEPIANDROSTERONE; and other hormones such as HUMAN GROWTH HORMONE. Andropause symptoms are related to the lack of androgens including DEPRESSION, sexual dysfunction, and OSTEOPOROSIS. Andropause may  also result from hormonal ablation therapy for malignant diseases.%A%    
% 219.86/220.07  |- skos__historyNote mesh__D047649 Aged %28%1965-2004%29%
% 219.86/220.07  |- mesh__historyNote mesh__D047649 2005   
% 219.86/220.07  |- skos__prefLabel mesh__D047649 Andropause
% 219.86/220.07  |- mesh__dateEstablished mesh__D047649 2005-01-01
% 219.86/220.07  |- mesh__recordOriginator mesh__D047649 lkt
% 219.86/220.07  |- skos__historyNote mesh__D047649 Climacteric %28%1965-2004%29%
% 219.86/220.07  |- mesh__publicMeSHNote mesh__D047649 2005   
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D047649 2005
% 219.86/220.07  |- mesh__dateCreated mesh__D047649 2004-07-07
% 219.86/220.07  |- skos__broader mesh__D047649smesh__D002979
% 219.86/220.07  |- skos__altLabel mesh__D047649 Change of Life, Male
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D047649 2006
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D019958 2001
% 219.86/220.07  |- skos__annotation mesh__D019958 DF:DISRUPTIVE BEHAVIOR DIS   
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D019958 2003
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D019958 2006
% 219.86/220.07  |- skos__broader mesh__D019958smesh__D019952
% 219.86/220.07  |- skos__hiddenLabel mesh__D019958 Behavior Disorder, Disruptive
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D019958 2000
% 219.86/220.07  |- rdf__type mesh__D019958sskos__Concept
% 219.86/220.07  |- mesh__dateCreated mesh__D019958 1997-06-20
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D019958 2005
% 219.86/220.07  |- mesh__dateEstablished mesh__D019958 1998-01-01
% 219.86/220.07  |- mesh__publicMeSHNote mesh__D019958 98   
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D019958 1999
% 219.86/220.07  |- mesh__historyNote mesh__D019958 98   
% 219.86/220.07  |- skos__prefLabel mesh__D019958
% 219.86/220.07       Attention Deficit and Disruptive Behavior Disorders
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D019958 1998
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D019958 2002
% 219.86/220.07  |- skos__hiddenLabel mesh__D019958 Defiant Disorder, Oppositional
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D019958 2004
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D011975 2004
% 219.86/220.07  |- mesh__dateCreated mesh__D011975 1979-05-24
% 219.86/220.07  |- skos__historyNote mesh__D011975 B Lymphocytes %28%1973-1979%29%
% 219.86/220.07  |- mesh__dateRevised mesh__D011975 2003-07-09
% 219.86/220.07  |- rdf__type mesh__D011975sskos__Concept
% 219.86/220.07  |- skos__prefLabel mesh__D011975 Receptors, Mitogen
% 219.86/220.07  |- skos__historyNote mesh__D011975 Lymphocytes %28%1966-1979%29%
% 219.86/220.07  |- skos__historyNote mesh__D011975 T Lymphocytes %28%1973-1979%29%
% 219.86/220.07  |- skos__broader mesh__D011975smesh__D011971
% 219.86/220.07  |- skos__altLabel mesh__D011975 Mitogen Receptors
% 219.86/220.07  |- mesh__publicMeSHNote mesh__D011975 80   
% 219.86/220.07  |- skos__annotation mesh__D011975 DF: RECEPT MITOGEN   
% 219.86/220.07  |- skos__hiddenLabel mesh__D011975 Receptor, Mitogen
% 219.86/220.07  |- mesh__historyNote mesh__D011975 80   
% 219.86/220.07  |- skos__scopeNote mesh__D011975
% 219.86/220.07       Glycoprotein molecules on the surface of B- and T-lymphocytes, that react with molecules of antilymphocyte sera, lectins, and other agents which induce blast transformation of lymphocytes.%A%    
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D011975 2005
% 219.86/220.07  |- skos__altLabel mesh__D011975 Lectin Receptors
% 219.86/220.07  |- mesh__recordMaintainer mesh__D011975 jmp
% 219.86/220.07  |- mesh__dateEstablished mesh__D011975 1980-01-01
% 219.86/220.07  |- mesh__recordAuthorizer mesh__D011975 sjn
% 219.86/220.07  |- skos__historyNote mesh__D011975 Mitogens %28%1972-1979%29%
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D011975 2006
% 219.86/220.07  |- skos__altLabel mesh__D011975 Mitogen Receptor
% 219.86/220.07  |- mesh__recordOriginator mesh__D011975 AEP
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D011177 2004
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D011177 2006
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D011177 2000
% 219.86/220.07  |- mesh__dateRevised mesh__D011177 1999-11-03
% 219.86/220.07  |- skos__broader mesh__D011177smesh__D006078
% 219.86/220.07  |- skos__hiddenLabel mesh__D011177 Mail Order
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D011177 2001
% 219.86/220.07  |- mesh__recordAuthorizer mesh__D011177 sjn
% 219.86/220.07  |- skos__hiddenLabel mesh__D011177 Services, Postal
% 219.86/220.07  |- skos__hiddenLabel mesh__D011177 Postal Services
% 219.86/220.07  |- skos__hiddenLabel mesh__D011177 Mails
% 219.86/220.07  |- skos__prefLabel mesh__D011177 Postal Service
% 219.86/220.07  |- mesh__recordMaintainer mesh__D011177 kle
% 219.86/220.07  |- skos__scopeNote mesh__D011177
% 219.86/220.07       The functions and activities carried out by the U.S. Postal Service, foreign postal services, and private postal services such as Federal Express.%A%    
% 219.86/220.07  |- rdf__type mesh__D011177sskos__Concept
% 219.86/220.07  |- skos__annotation mesh__D011177 specify geog; DF: POSTAL SERV   
% 219.86/220.07  |- skos__hiddenLabel mesh__D011177 Mail Distributions
% 219.86/220.07  |- skos__hiddenLabel mesh__D011177 Distribution, Mail
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D011177 2002
% 219.86/220.07  |- skos__hiddenLabel mesh__D011177 Distributions, Mail
% 219.86/220.07  |- mesh__recordOriginator mesh__D011177 NLM
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D011177 2003
% 219.86/220.07  |- skos__hiddenLabel mesh__D011177 Mail-Orders
% 219.86/220.07  |- mesh__dateCreated mesh__D011177 1999-01-01
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D011177 2005
% 219.86/220.07  |- skos__altLabel mesh__D011177 Service, Postal
% 219.86/220.07  |- mesh__dateRevised mesh__D005938 2003-07-09
% 219.86/220.07  |- skos__annotation mesh__D005938 GEN: avoid: prefer specifics;   
% 219.86/220.07  |- mesh__recordOriginator mesh__D005938 NLM
% 219.86/220.07  |- mesh__dateCreated mesh__D005938 1999-01-01
% 219.86/220.07  |- mesh__recordMaintainer mesh__D005938 ssb
% 219.86/220.07  |- skos__scopeNote mesh__D005938
% 219.86/220.07       A group of CORTICOSTEROIDS that affect carbohydrate metabolism %28%GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR%29%, inhibit CORTICOTROPIN secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system.%A%    
% 219.86/220.07  |- skos__related mesh__D005938smesh__D011965
% 219.86/220.07  |- skos__prefLabel mesh__D005938 Glucocorticoids
% 219.86/220.07  |- mesh__dateEstablished mesh__D005938 1967-01-01
% 219.86/220.07  |- skos__historyNote mesh__D005938 Adrenal Cortex Hormones %28%1966%29%
% 219.86/220.07  |- skos__broader mesh__D005938smesh__D006728
% 219.86/220.07  |- mesh__historyNote mesh__D005938 67   
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D005938 2006
% 219.86/220.07  |- rdf__type mesh__D005938sskos__Concept
% 219.86/220.07  |- mesh__publicMeSHNote mesh__D005938 67   
% 219.86/220.07  |- mesh__recordAuthorizer mesh__D005938 sjn
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D005938 2005
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D005938 2004
% 219.86/220.07  |- skos__hiddenLabel mesh__D016660 Diaphorase, DT
% 219.86/220.07  |- mesh__dateRevised mesh__D016660 2003-07-09
% 219.86/220.07  |- skos__prefLabel mesh__D016660
% 219.86/220.07       NAD%28%P%29%H Dehydrogenase %28%Quinone%29%
% 219.86/220.07  |- skos__scopeNote mesh__D016660
% 219.86/220.07       A flavoprotein that reversibly catalyzes the oxidation of NADH or NADPH by various quinones and oxidation-reduction dyes. The enzyme is inhibited by dicoumarol, capsaicin, and caffeine. EC 1.6.99.2.%A%    
% 219.86/220.07  |- skos__hiddenLabel mesh__D016660 Reductase, Menadione
% 219.86/220.07  |- mesh__dateCreated mesh__D016660 1991-07-12
% 219.86/220.07  |- mesh__historyNote mesh__D016660
% 219.86/220.07       92; was NAD%28%P%29%H DEHYDROGENASE %28%QUINONE%29% %28%NM%29% 1973-91   
% 219.86/220.07  |- mesh__onlineNote mesh__D016660
% 219.86/220.07       use NAD%28%P%29%H DEHYDROGENASE %28%QUINONE%29% %28%NM%29% to search NAD%28%P%29%H DEHYDROGENASE %28%QUINONE%29% 1980-91%A%  
% 219.86/220.07  |- mesh__publicMeSHNote mesh__D016660
% 219.86/220.07       92; NAD%28%P%29%H DEHYDROGENASE %28%QUINONE%29% was indexed under OXIDOREDUCTASES 1973, under NADH, NADPH OXIDOREDUCTASES 1974-79 %26% under QUINONE REDUCTASES 1980-91%A%  
% 219.86/220.07  |- skos__historyNote mesh__D016660
% 219.86/220.07       NADH, NADPH Oxidoreductases %28%1975-1979%29%
% 219.86/220.07  |- skos__altLabel mesh__D016660 Quinone Reductase
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D016660 2005
% 219.86/220.07  |- skos__hiddenLabel mesh__D016660 Reductase, Vitamin K
% 219.86/220.07  |- skos__broader mesh__D016660smesh__D011808
% 219.86/220.07  |- skos__altLabel mesh__D016660 Menadione Reductase
% 219.86/220.07  |- mesh__recordOriginator mesh__D016660 RLS
% 219.86/220.07  |- skos__historyNote mesh__D016660 Oxidoreductases %28%1966-1974%29%
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D016660 2006
% 219.86/220.07  |- mesh__recordMaintainer mesh__D016660 ssb
% 219.86/220.07  |- skos__altLabel mesh__D016660 Phylloquinone Reductase
% 219.86/220.07  |- skos__hiddenLabel mesh__D016660 Reductase, Phylloquinone
% 219.86/220.07  |- skos__hiddenLabel mesh__D016660 Reductase, Quinone
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D016660 2004
% 219.86/220.07  |- skos__altLabel mesh__D016660 DT Diaphorase
% 219.86/220.07  |- rdf__type mesh__D016660sskos__Concept
% 219.86/220.07  |- mesh__recordAuthorizer mesh__D016660 sjn
% 219.86/220.07  |- mesh__dateEstablished mesh__D016660 1992-01-01
% 219.86/220.07  |- mesh__historyNote mesh__D002640 65%28%64%29%   
% 219.86/220.07  |- mesh__dateEstablished mesh__D002640 1965-01-01
% 219.86/220.07  |- skos__hiddenLabel mesh__D002640 Disease, Frommel
% 219.86/220.07  |- rdf__type mesh__D002640sskos__Concept
% 219.86/220.07  |- skos__hiddenLabel mesh__D002640 Chiari Frommel Syndrome
% 219.86/220.07  |- mesh__recordOriginator mesh__D002640 NLM
% 219.86/220.07  |- mesh__publicMeSHNote mesh__D002640 65   
% 219.86/220.07  |- skos__altLabel mesh__D002640 Frommel%27%s Disease
% 219.86/220.07  |- mesh__dateRevised mesh__D002640 2005-06-30
% 219.86/220.07  |- skos__hiddenLabel mesh__D002640 Disease, Frommel%27%s
% 219.86/220.07  |- skos__altLabel mesh__D002640 Frommel Disease
% 219.86/220.07  |- mesh__dateCreated mesh__D002640 1999-01-01
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D002640 2006
% 219.86/220.07  |- skos__prefLabel mesh__D002640 Chiari-Frommel Syndrome
% 219.86/220.07  |- skos__scopeNote mesh__D002640
% 219.86/220.07       A POSTPARTUM condition consists of persistent lactation %28%GALACTORRHEA%29% and AMENORRHEA in patients not BREAST FEEDING.%A%    
% 219.86/220.07  |- skos__broader mesh__D002640smesh__D005687
% 219.86/220.07  |- mesh__recordMaintainer mesh__D002640 lkt
% 219.86/220.07  |- mesh__recordAuthorizer mesh__D002640 sjn
% 219.86/220.07  |- skos__hiddenLabel mesh__D002640 Syndrome, Chiari-Frommel
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D029588 2004
% 219.86/220.07  |- mesh__dateEstablished mesh__D029588 2002-01-01
% 219.86/220.07  |- mesh__recordAuthorizer mesh__D029588 sjn
% 219.86/220.07  |- skos__altLabel mesh__D029588 Drumsticktree
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D029588 2005
% 219.86/220.07  |- skos__prefLabel mesh__D029588 Moringa oleifera
% 219.86/220.07  |- skos__scopeNote mesh__D029588
% 219.86/220.07       A plant species of the family Moringaceae, order Capparales, subclass Dilleniidae.  It is a source of niaziminin and hypotensive thiocarbamate glycosides.%A%    
% 219.86/220.07  |- mesh__publicMeSHNote mesh__D029588 2002   
% 219.86/220.07  |- mesh__historyNote mesh__D029588 2002   
% 219.86/220.07  |- rdf__type mesh__D029588sskos__Concept
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D029588 2006
% 219.86/220.07  |- mesh__recordMaintainer mesh__D029588 jls
% 219.86/220.07  |- skos__annotation mesh__D029588
% 219.86/220.07       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D029588 2002
% 219.86/220.07  |- skos__broader mesh__D029588smesh__D029587
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D029588 2003
% 219.86/220.07  |- mesh__dateCreated mesh__D029588 2001-08-03
% 219.86/220.07  |- mesh__recordOriginator mesh__D029588 ssb
% 219.86/220.07  |- mesh__dateCreated mesh__D034722 2002-07-03
% 219.86/220.07  |- skos__altLabel mesh__D034722 hnRNP U
% 219.86/220.07  |- mesh__publicMeSHNote mesh__D034722
% 219.86/220.07       2003; HNRNP U PROTEIN was indexed under RIBONUCLEOPROTEINS 1992-2002, GRIP120 %26%  SCAFFOLD ATTACHMENT FACTOR A %28%SAF-A%29% were indexed under RIBONUCLEOPROTEINS 1998-2002%A%  
% 219.86/220.07  |- skos__altLabel mesh__D034722 GRIP120
% 219.86/220.07  |- skos__annotation mesh__D034722 see SCR for specific hnRNP entries   
% 219.86/220.07  |- skos__hiddenLabel mesh__D034722
% 219.86/220.07       Ribonucleoprotein U, Heterogeneous-Nuclear
% 219.86/220.07  |- skos__prefLabel mesh__D034722 Heterogeneous-Nuclear Ribonucleoprotein U
% 219.86/220.07  |- skos__scopeNote mesh__D034722
% 219.86/220.07       A heterogeneous-nuclear ribonucleoprotein found associated with the NUCLEAR MATRIX.%A%    
% 219.86/220.07  |- skos__broader mesh__D034722smesh__D034441
% 219.86/220.07  |- skos__altLabel mesh__D034722
% 219.86/220.07       Glucocorticoid Receptor Interacting Protein 120
% 219.86/220.07  |- mesh__dateEstablished mesh__D034722 2003-01-01
% 219.86/220.07  |- skos__historyNote mesh__D034722 Ribonucleoproteins %28%1992-2002%29%
% 219.86/220.07  |- skos__altLabel mesh__D034722 Scaffold Attachment Factor A %28%SAF-A%29%
% 219.86/220.07  |- mesh__recordMaintainer mesh__D034722 jmp
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D034722 2006
% 219.86/220.07  |- rdf__type mesh__D034722sskos__Concept
% 219.86/220.07  |- mesh__historyNote mesh__D034722
% 219.86/220.07       2003; for HNRNP U PROTEIN use HETEROGENEOUS-NUCLEAR RIBONUCLEAR PROTEINS 1992-2002, for GRIP120 %26% SCAFFOLD ATTACHMENT FACTOR A %28%SAF-A%29% use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 1998-2002%A%  
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D034722 2004
% 219.86/220.07  |- skos__broader mesh__D034722smesh__D034521
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D034722 2005
% 219.86/220.07  |- skos__hiddenLabel mesh__D034722
% 219.86/220.07       Heterogeneous Nuclear Ribonucleoprotein U
% 219.86/220.07  |- mesh__activeMeSHYear mesh__D034722 2003
% 219.86/220.07  |- mesh__recordOriginator mesh__D034722 jmp
% 219.86/220.08  |- mesh__recordAuthorizer mesh__D034722 sjn
% 219.86/220.08  |- rdf__type mesh__D001548sskos__Concept
% 219.86/220.08  |- skos__broader mesh__D001548smesh__D000644
% 219.86/220.08  |- mesh__dateEstablished mesh__D001548 1968-01-01
% 219.86/220.08  |- mesh__recordMaintainer mesh__D001548 ssb
% 219.86/220.08  |- mesh__onlineNote mesh__D001548
% 219.86/220.08       use BENZALKONIUM COMPOUNDS to search BENZALKONIUM 1981-83 %26% BENZALKONIUM CHLORIDE 1966-80 %28%as Prov 1966-67%29%%A%  
% 219.86/220.08  |- skos__hiddenLabel mesh__D001548 BTC2125
% 219.86/220.08  |- skos__annotation mesh__D001548 D25-26 qualif   
% 219.86/220.08  |- mesh__publicMeSHNote mesh__D001548
% 219.86/220.08       84; was BENZALKONIUM 1981-83, was BENZALKONIUM CHLORIDE 1968-80, was BENZALKONIUM CHLORIDE see under ANTI-INFECTIVE AGENTS, LOCAL 1967, was BENZALKONIUM CHLORIDE see under ANTISEPTICS, QUATERNARY AMMONIUM 1964-66, was BENZALKONIUM see under ANTISEPTICS, QUATERNARY AMMONIUM 1963%A%  
% 219.86/220.08  |- mesh__recordOriginator mesh__D001548 NLM
% 219.86/220.08  |- mesh__dateRevised mesh__D001548 2005-06-30
% 219.86/220.08  |- skos__prefLabel mesh__D001548 Benzalkonium Compounds
% 219.86/220.08  |- mesh__dateCreated mesh__D001548 1999-01-01
% 219.86/220.08  |- skos__hiddenLabel mesh__D001548 Chloride, Alkyldimethylbenzylammonium
% 219.86/220.08  |- skos__broader mesh__D001548smesh__D050339
% 219.86/220.08  |- mesh__historyNote mesh__D001548
% 219.86/220.08       84; was BENZALKONIUM 1981-83, was BENZALKONIUM CHLORIDE 1964-80 %28%Prov 1964-67%29% see under ANTI-INFECTIVE AGENTS, LOCAL 1967, was  BENZALKONIUM CHLORIDE see under ANTISEPTICS, QUATERNARY AMMONIUM 1964-66, was BENZALKONIUM see under ANTISEPTICS, QUATERNARY AMMONIUM 1963%A%  
% 219.86/220.08  |- skos__hiddenLabel mesh__D001548 Chloride, Benzalkonium
% 219.86/220.08  |- skos__hiddenLabel mesh__D001548 BTC 2125
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D001548 2006
% 219.86/220.08  |- skos__hiddenLabel mesh__D001548 Compounds, Benzalkonium
% 219.86/220.08  |- skos__scopeNote mesh__D001548
% 219.86/220.08       A mixture of alkylbenzyldimethylammonium compounds. It is a bactericidal quaternary ammonium detergent used topically in medicaments, deodorants, mouthwashes, as a surgical antiseptic, and as a as preservative and emulsifier in drugs and cosmetics.%A%    
% 219.86/220.08  |- mesh__recordAuthorizer mesh__D001548 sjn
% 219.86/220.08  |- skos__prefLabel mesh__D012270 Ribosomes
% 219.86/220.08  |- mesh__historyNote mesh__D012270 65%28%64%29%   
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D012270 2005
% 219.86/220.08  |- mesh__recordMaintainer mesh__D012270 nns
% 219.86/220.08  |- mesh__dateRevised mesh__D012270 2003-07-09
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D012270 2006
% 219.86/220.08  |- mesh__recordOriginator mesh__D012270 NLM
% 219.86/220.08  |- skos__related mesh__D012270smesh__D012335
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D012270 2004
% 219.86/220.08  |- skos__related mesh__D012270smesh__D012269
% 219.86/220.08  |- rdf__type mesh__D012270sskos__Concept
% 219.86/220.08  |- mesh__publicMeSHNote mesh__D012270 65   
% 219.86/220.08  |- mesh__dateCreated mesh__D012270 1999-01-01
% 219.86/220.08  |- mesh__recordAuthorizer mesh__D012270 sjn
% 219.86/220.08  |- skos__hiddenLabel mesh__D012270 Ribosome
% 219.86/220.08  |- skos__related mesh__D012270smesh__D004275
% 219.86/220.08  |- skos__broader mesh__D012270smesh__D015388
% 219.86/220.08  |- mesh__dateEstablished mesh__D012270 1965-01-01
% 219.86/220.08  |- skos__annotation mesh__D012270
% 219.86/220.08       A 11 qualif except /cytol; /genet permitted   
% 219.86/220.08  |- skos__scopeNote mesh__D012270
% 219.86/220.08       A class of multicomponent structures found in all cells, in mitochondria, and chloroplasts. They have roles both in the genetic translation of transcripts and in the manufacture and secretion of the proteins. %28%From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A%    
% 219.86/220.08  |- mesh__historyNote mesh__D020702 2000   
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D020702 2006
% 219.86/220.08  |- skos__scopeNote mesh__D020702
% 219.86/220.08       Endoscopes for examining the interior of the uterus.     
% 219.86/220.08  |- mesh__dateCreated mesh__D020702 1999-11-03
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D020702 2002
% 219.86/220.08  |- skos__historyNote mesh__D020702
% 219.86/220.08       Hysteroscopy/instrumentation %28%1990-1999%29%
% 219.86/220.08  |- skos__prefLabel mesh__D020702 Hysteroscopes
% 219.86/220.08  |- skos__altLabel mesh__D020702 Uteroscopes
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D020702 2005
% 219.86/220.08  |- mesh__publicMeSHNote mesh__D020702 2000   
% 219.86/220.08  |- skos__altLabel mesh__D020702 Hysteroscope
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D020702 2001
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D020702 2004
% 219.86/220.08  |- mesh__dateEstablished mesh__D020702 2000-01-01
% 219.86/220.08  |- skos__hiddenLabel mesh__D020702 Uteroscope
% 219.86/220.08  |- skos__broader mesh__D020702smesh__D019723
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D020702 2000
% 219.86/220.08  |- skos__historyNote mesh__D020702
% 219.86/220.08       Endoscopy/instrumentation %28%1979-1989%29%
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D020702 2003
% 219.86/220.08  |- skos__historyNote mesh__D020702 Endoscopes %28%1998-1999%29%
% 219.86/220.08  |- rdf__type mesh__D020702sskos__Concept
% 219.86/220.08  |- rdf__type mesh__D006233sskos__Concept
% 219.86/220.08  |- skos__hiddenLabel mesh__D006233 Person, Disabled
% 219.86/220.08  |- mesh__recordAuthorizer mesh__D006233 sjn
% 219.86/220.08  |- mesh__dateCreated mesh__D006233 1999-01-01
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D006233 2005
% 219.86/220.08  |- skos__altLabel mesh__D006233 People with Disabilities
% 219.86/220.08  |- skos__related mesh__D006233smesh__D018479
% 219.86/220.08  |- skos__related mesh__D006233smesh__D003730
% 219.86/220.08  |- skos__hiddenLabel mesh__D006233 Handicapped, Physically
% 219.86/220.08  |- skos__hiddenLabel mesh__D006233 Disabilities, Persons with
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D006233 2002
% 219.86/220.08  |- skos__hiddenLabel mesh__D006233 People with Disability
% 219.86/220.08  |- skos__hiddenLabel mesh__D006233 Disabled, Physically
% 219.86/220.08  |- skos__altLabel mesh__D006233 Physically Disabled
% 219.86/220.08  |- skos__altLabel mesh__D006233 Persons with Disabilities
% 219.86/220.08  |- mesh__historyNote mesh__D006233 98%28%63%29%   
% 219.86/220.08  |- mesh__publicMeSHNote mesh__D006233
% 219.86/220.08       98; see DISABLED 1993-97; see HANDICAPPED 1963-92   
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D006233 2006
% 219.86/220.08  |- skos__annotation mesh__D006233
% 219.86/220.08       as GEN or unspecified includes both physical %26% mental disability; prefer specifics %28%VISUALLY IMPAIRED PERSONS; HEARING IMPAIRED PERSONS; MENTALLY DISABLED PERSONS%29% emotionally disabled = MENTAL DISORDERS or specific; /educ permitted but is probably EDUCATION, SPECIAL or MAINSTREAMING %28%EDUCATION%29%; /rehabil permitted; DF: DISABLED%A%  
% 219.86/220.08  |- skos__hiddenLabel mesh__D006233 Disabilities, People with
% 219.86/220.08  |- mesh__recordOriginator mesh__D006233 NLM
% 219.86/220.08  |- skos__related mesh__D006233smesh__D008282
% 219.86/220.08  |- skos__hiddenLabel mesh__D006233 Persons, Disabled
% 219.86/220.08  |- skos__related mesh__D006233smesh__D016832
% 219.86/220.08  |- mesh__recordMaintainer mesh__D006233 jls
% 219.86/220.08  |- skos__scopeNote mesh__D006233
% 219.86/220.08       Persons with physical or mental disabilities that affect or limit their activities of daily living and that may require special accommodations.%A%    
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D006233 2003
% 219.86/220.08  |- skos__hiddenLabel mesh__D006233 Persons with Disability
% 219.86/220.08  |- skos__related mesh__D006233smesh__D012656
% 219.86/220.08  |- skos__related mesh__D006233smesh__D012046
% 219.86/220.08  |- mesh__dateRevised mesh__D006233 2001-07-25
% 219.86/220.08  |- skos__related mesh__D006233smesh__D004519
% 219.86/220.08  |- skos__hiddenLabel mesh__D006233 Disability, Persons with
% 219.86/220.08  |- skos__broader mesh__D006233smesh__D009272
% 219.86/220.08  |- skos__altLabel mesh__D006233 Handicapped
% 219.86/220.08  |- skos__hiddenLabel mesh__D006233 Disabled Person
% 219.86/220.08  |- skos__prefLabel mesh__D006233 Disabled Persons
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D006233 2004
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D019959 2006
% 219.86/220.08  |- skos__broader mesh__D019959smesh__D019952
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D019959 2000
% 219.86/220.08  |- rdf__type mesh__D019959sskos__Concept
% 219.86/220.08  |- mesh__dateCreated mesh__D019959 1997-06-20
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D019959 1998
% 219.86/220.08  |- skos__hiddenLabel mesh__D019959 Disorder, Rumination
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D019959 2001
% 219.86/220.08  |- skos__scopeNote mesh__D019959
% 219.86/220.08       Mental disorders related to feeding and eating that are usually diagnosed in infancy or early childhood.%A%    
% 219.86/220.08  |- skos__hiddenLabel mesh__D019959 Rumination Disorder
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D019959 1999
% 219.86/220.08  |- skos__prefLabel mesh__D019959 Feeding and Eating Disorders of Childhood
% 219.86/220.08  |- mesh__historyNote mesh__D019959 98   
% 219.86/220.08  |- skos__annotation mesh__D019959 DF: FEEDING EATING DIS CHILD   
% 219.86/220.08  |- mesh__dateEstablished mesh__D019959 1998-01-01
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D019959 2003
% 219.86/220.08  |- skos__altLabel mesh__D019959 Childhood Eating and Feeding Disorders
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D019959 2002
% 219.86/220.08  |- mesh__publicMeSHNote mesh__D019959 98   
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D019959 2005
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D019959 2004
% 219.86/220.08  |- mesh__dateEstablished mesh__D011976 1984-01-01
% 219.86/220.08  |- mesh__recordOriginator mesh__D011976 SH
% 219.86/220.08  |- skos__prefLabel mesh__D011976 Receptors, Muscarinic
% 219.86/220.08  |- rdf__type mesh__D011976sskos__Concept
% 219.86/220.08  |- mesh__publicMeSHNote mesh__D011976
% 219.86/220.08       84; was see under RECEPTORS, CHOLINERGIC 1977-83   
% 219.86/220.08  |- skos__hiddenLabel mesh__D011976 Acetylcholine Receptor, Muscarinic
% 219.86/220.08  |- mesh__dateRevised mesh__D011976 2003-07-09
% 219.86/220.08  |- skos__hiddenLabel mesh__D011976 Acetylcholine Receptors, Muscarinic
% 219.86/220.08  |- skos__altLabel mesh__D011976 Muscarinic Acetylcholine Receptors
% 219.86/220.08  |- skos__broader mesh__D011976smesh__D011950
% 219.86/220.08  |- skos__annotation mesh__D011976 GEN or unspecified; prefer specifics   
% 219.86/220.08  |- skos__historyNote mesh__D011976 Receptors, Cholinergic %28%1971-1976%29%
% 219.86/220.08  |- mesh__dateCreated mesh__D011976 1976-05-03
% 219.86/220.08  |- skos__altLabel mesh__D011976 Muscarinic Receptors
% 219.86/220.08  |- skos__altLabel mesh__D011976 Muscarinic Receptor
% 219.86/220.08  |- skos__historyNote mesh__D011976 Receptors, Drug %28%1968-1976%29%
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D011976 2005
% 219.86/220.08  |- mesh__recordMaintainer mesh__D011976 jmp
% 219.86/220.08  |- mesh__historyNote mesh__D011976
% 219.86/220.08       84%28%77%29%; was see under RECEPTORS, CHOLINERGIC 1977-83   
% 219.86/220.08  |- skos__historyNote mesh__D011976 Parasympathomimetics %28%1966-1976%29%
% 219.86/220.08  |- skos__hiddenLabel mesh__D011976 Receptors, Muscarinic Acetylcholine
% 219.86/220.08  |- mesh__activeMeSHYear mesh__D011976 2006
% 219.86/220.08  |- skos__hiddenLabel mesh__D011976 Receptor, Muscarinic Acetylcholine
% 219.86/220.08  |- skos__altLabel mesh__D011976 Muscarinic Acetylcholine Receptor
% 219.86/220.08  |- skos__historyNote mesh__D011976 Acetylcholine %28%1966-1976%29%
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D011976 2004
% 219.94/220.12  |- skos__scopeNote mesh__D011976
% 219.94/220.12       One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes %28%usually M1, M2, M3....%29% that are characterized by their cellular actions, pharmacology, and molecular biology.%A%    
% 219.94/220.12  |- skos__broader mesh__D011976smesh__D043562
% 219.94/220.12  |- skos__hiddenLabel mesh__D011976 Receptor, Muscarinic
% 219.94/220.12  |- mesh__recordAuthorizer mesh__D011976 sjn
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D011178 2004
% 219.94/220.12  |- skos__hiddenLabel mesh__D011178 Postgastrectomy Syndrome
% 219.94/220.12  |- skos__broader mesh__D011178smesh__D011183
% 219.94/220.12  |- mesh__recordOriginator mesh__D011178 NLM
% 219.94/220.12  |- mesh__dateCreated mesh__D011178 1999-01-01
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D011178 2006
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D011178 2005
% 219.94/220.12  |- skos__scopeNote mesh__D011178
% 219.94/220.12       Sequelae of gastrectomy from the second week after operation on. Include recurrent or anastomotic ulcer, postprandial syndromes %28%DUMPING SYNDROME and late postprandial hypoglycemia%29%, disordered bowel action, and nutritional deficiencies.%A%    
% 219.94/220.12  |- skos__hiddenLabel mesh__D011178 Syndromes, Postgastrectomy
% 219.94/220.12  |- skos__broader mesh__D011178smesh__D013272
% 219.94/220.12  |- mesh__recordAuthorizer mesh__D011178 sjn
% 219.94/220.12  |- mesh__recordMaintainer mesh__D011178 lkt
% 219.94/220.12  |- rdf__type mesh__D011178sskos__Concept
% 219.94/220.12  |- skos__hiddenLabel mesh__D011178 Syndrome, Postgastrectomy
% 219.94/220.12  |- mesh__dateRevised mesh__D011178 2003-07-09
% 219.94/220.12  |- skos__prefLabel mesh__D011178 Postgastrectomy Syndromes
% 219.94/220.12  |- skos__scopeNote mesh__D016661
% 219.94/220.12       A subfamily of CEBIDAE inhabiting the forests of Central and South America. The genus ALOUATTA, or howler monkeys, belongs to this subfamily of New World monkeys.%A%    
% 219.94/220.12  |- mesh__dateEstablished mesh__D016661 1992-01-01
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D016661 2006
% 219.94/220.12  |- mesh__dateRevised mesh__D016661 2005-06-30
% 219.94/220.12  |- skos__annotation mesh__D016661
% 219.94/220.12       New World monkeys; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 219.94/220.12  |- mesh__recordOriginator mesh__D016661 MXR
% 219.94/220.12  |- skos__broader mesh__D016661smesh__D002427
% 219.94/220.12  |- mesh__dateCreated mesh__D016661 1991-01-24
% 219.94/220.12  |- mesh__recordAuthorizer mesh__D016661 sjn
% 219.94/220.12  |- skos__prefLabel mesh__D016661 Alouattinae
% 219.94/220.12  |- rdf__type mesh__D016661sskos__Concept
% 219.94/220.12  |- mesh__historyNote mesh__D016661 92   
% 219.94/220.12  |- mesh__recordMaintainer mesh__D016661 ags
% 219.94/220.12  |- mesh__publicMeSHNote mesh__D016661 92   
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002641 2000
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002641 2005
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002641 2006
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002641 2001
% 219.94/220.12  |- mesh__dateCreated mesh__D002641 1999-01-01
% 219.94/220.12  |- mesh__dateRevised mesh__D002641 1997-06-20
% 219.94/220.12  |- mesh__recordOriginator mesh__D002641 NLM
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002641 2002
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002641 1998
% 219.94/220.12  |- mesh__recordMaintainer mesh__D002641 PXP
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002641 1999
% 219.94/220.12  |- skos__prefLabel mesh__D002641 Chicago
% 219.94/220.12  |- skos__broader mesh__D002641smesh__D002947
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002641 2003
% 219.94/220.12  |- mesh__recordAuthorizer mesh__D002641 SJN
% 219.94/220.12  |- rdf__type mesh__D002641sskos__Concept
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002641 2004
% 219.94/220.12  |- skos__broader mesh__D002641smesh__D007087
% 219.94/220.12  |- skos__scopeNote mesh__D029589
% 219.94/220.12       Proteins found in SEMEN. Major seminal plasma proteins are secretory proteins from the male sex accessory glands, such as the SEMINAL VESICLES and the PROSTATE. They include the seminal vesicle-specific antigen, an ejaculate clotting protein; and the PROSTATE-SPECIFIC ANTIGEN, a protease and an esterase.%A%    
% 219.94/220.12  |- skos__historyNote mesh__D029589 Plasma Proteins %28%1979-1980%29%
% 219.94/220.12  |- mesh__historyNote mesh__D029589
% 219.94/220.12       2002; use SEMINAL PLASMA PROTEINS %28%NM%29% 1979-2001   
% 219.94/220.12  |- skos__prefLabel mesh__D029589 Seminal Plasma Proteins
% 219.94/220.12  |- mesh__publicMeSHNote mesh__D029589
% 219.94/220.12       2002; SEMINAL PLASMA PROTEINS was indexed under PROTEINS 1979-2001%A%  
% 219.94/220.12  |- mesh__dateEstablished mesh__D029589 2002-01-01
% 219.94/220.12  |- mesh__recordAuthorizer mesh__D029589 sjn
% 219.94/220.12  |- skos__broader mesh__D029589smesh__D011506
% 219.94/220.12  |- mesh__dateRevised mesh__D029589 2005-06-30
% 219.94/220.12  |- rdf__type mesh__D029589sskos__Concept
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D029589 2006
% 219.94/220.12  |- skos__historyNote mesh__D029589 Proteins %28%1980-2001%29%
% 219.94/220.12  |- mesh__recordOriginator mesh__D029589 lkt
% 219.94/220.12  |- mesh__recordMaintainer mesh__D029589 SYSTEM
% 219.94/220.12  |- mesh__dateCreated mesh__D029589 2001-07-25
% 219.94/220.12  |- skos__related mesh__D034723smesh__D033182
% 219.94/220.12  |- skos__historyNote mesh__D034723 Ethics, Medical %28%1997-2002%29%
% 219.94/220.12  |- skos__scopeNote mesh__D034723
% 219.94/220.12       In ethics, a technical term which refers to two types of consequences which may be produced by a single action, namely, intended consequences and unintended side effects.%A%    
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D034723 2005
% 219.94/220.12  |- skos__prefLabel mesh__D034723 Double Effect
% 219.94/220.12  |- mesh__dateCreated mesh__D034723 2002-07-03
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D034723 2003
% 219.94/220.12  |- skos__hiddenLabel mesh__D034723 Effect, Double
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D034723 2006
% 219.94/220.12  |- rdf__type mesh__D034723sskos__Concept
% 219.94/220.12  |- mesh__dateEstablished mesh__D034723 2003-01-01
% 219.94/220.12  |- mesh__historyNote mesh__D034723 2003; use ETHICS 2002   
% 219.94/220.12  |- mesh__publicMeSHNote mesh__D034723 2003; see ETHICS 2002   
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D034723 2004
% 219.94/220.12  |- skos__broader mesh__D034723smesh__D004989
% 219.94/220.12  |- skos__historyNote mesh__D034723 Ethics %28%1979-2002%29%
% 219.94/220.12  |- mesh__historyNote mesh__D001549
% 219.94/220.12       73; TRIMETHOBENZAMIDE was heading 1963-84   
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D001549 2004
% 219.94/220.12  |- skos__scopeNote mesh__D001549 BENZOIC ACID amides.     
% 219.94/220.12  |- skos__historyNote mesh__D001549 Amides %28%1966-1972%29%
% 219.94/220.12  |- mesh__onlineNote mesh__D001549
% 219.94/220.12       use BENZAMIDES to search TRIMETHOBENZAMIDE 1966-84   
% 219.94/220.12  |- mesh__publicMeSHNote mesh__D001549
% 219.94/220.12       73; TRIMETHOBENZAMIDE was heading 1963-84   
% 219.94/220.12  |- mesh__recordAuthorizer mesh__D001549 SJN
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D001549 2002
% 219.94/220.12  |- skos__historyNote mesh__D001549 Benzoates %28%1966-1972%29%
% 219.94/220.12  |- mesh__dateCreated mesh__D001549 1999-01-01
% 219.94/220.12  |- mesh__recordMaintainer mesh__D001549 ADP
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D001549 2005
% 219.94/220.12  |- mesh__dateEstablished mesh__D001549 1973-01-01
% 219.94/220.12  |- skos__broader mesh__D001549smesh__D020185
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D001549 2006
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D001549 2000
% 219.94/220.12  |- skos__prefLabel mesh__D001549 Benzamides
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D001549 1999
% 219.94/220.12  |- mesh__recordOriginator mesh__D001549 NLM
% 219.94/220.12  |- mesh__dateRevised mesh__D001549 1998-06-10
% 219.94/220.12  |- rdf__type mesh__D001549sskos__Concept
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D001549 2003
% 219.94/220.12  |- skos__broader mesh__D001549smesh__D000577
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D001549 2001
% 219.94/220.12  |- mesh__dateCreated mesh__D012271 1974-11-19
% 219.94/220.12  |- mesh__dateRevised mesh__D012271 2004-07-07
% 219.94/220.12  |- skos__hiddenLabel mesh__D012271 SF 733
% 219.94/220.12  |- skos__broader mesh__D012271smesh__D009355
% 219.94/220.12  |- skos__hiddenLabel mesh__D012271 SF733
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D012271 2006
% 219.94/220.12  |- mesh__publicMeSHNote mesh__D012271
% 219.94/220.12       91; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1975-90   
% 219.94/220.12  |- mesh__recordOriginator mesh__D012271 NLM
% 219.94/220.12  |- skos__historyNote mesh__D012271 Antibiotics %28%1972-1974%29%
% 219.94/220.12  |- mesh__dateEstablished mesh__D012271 1991-01-01
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D012271 2005
% 219.94/220.12  |- rdf__type mesh__D012271sskos__Concept
% 219.94/220.12  |- mesh__historyNote mesh__D012271
% 219.94/220.12       91%28%75%29%; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1975-90%A%  
% 219.94/220.12  |- mesh__recordMaintainer mesh__D012271 ssb
% 219.94/220.12  |- skos__prefLabel mesh__D012271 Ribostamycin
% 219.94/220.12  |- skos__scopeNote mesh__D012271
% 219.94/220.12       A broad-spectrum antimicrobial isolated from Streptomyces ribosifidicus.%A%    
% 219.94/220.12  |- skos__historyNote mesh__D012271 Aminoglycosides %28%1974%29%
% 219.94/220.12  |- mesh__recordAuthorizer mesh__D012271 sjn
% 219.94/220.12  |- skos__hiddenLabel mesh__D020703 ras GTPase Activating Proteins
% 219.94/220.12  |- skos__hiddenLabel mesh__D020703 ras GAPs
% 219.94/220.12  |- skos__historyNote mesh__D020703 Proteins %28%1995-1999%29%
% 219.94/220.12  |- skos__prefLabel mesh__D020703 ras GTPase-Activating Proteins
% 219.94/220.12  |- skos__hiddenLabel mesh__D020703 ras GAP
% 219.94/220.12  |- mesh__publicMeSHNote mesh__D020703
% 219.94/220.12       2000; RAS-GAP was indexed under PROTEINS 1995-1999   
% 219.94/220.12  |- mesh__dateCreated mesh__D020703 1999-11-03
% 219.94/220.12  |- mesh__dateEstablished mesh__D020703 2000-01-01
% 219.94/220.12  |- skos__hiddenLabel mesh__D020703 GTPase-Activating Proteins, ras
% 219.94/220.12  |- skos__broader mesh__D020703smesh__D020690
% 219.94/220.12  |- mesh__recordMaintainer mesh__D020703 SYSTEM
% 219.94/220.12  |- skos__altLabel mesh__D020703 ras-GAP
% 219.94/220.12  |- skos__scopeNote mesh__D020703
% 219.94/220.12       PROTEINS that specifically activate the GTP-phosphohydrolase activity of RAS PROTEINS.%A%    
% 219.94/220.12  |- mesh__recordAuthorizer mesh__D020703 sjn
% 219.94/220.12  |- mesh__historyNote mesh__D020703
% 219.94/220.12       2000; for RAS-GAP use RAS GTPASE-ACTIVATING PROTEINS %28%NM%29% 1995-1999%A%  
% 219.94/220.12  |- mesh__dateRevised mesh__D020703 2005-06-30
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D020703 2006
% 219.94/220.12  |- rdf__type mesh__D020703sskos__Concept
% 219.94/220.12  |- skos__altLabel mesh__D020703 ras-GAPs
% 219.94/220.12  |- mesh__recordOriginator mesh__D020703 jmp
% 219.94/220.12  |- mesh__dateRevised mesh__D006234 1993-05-28
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006234 2006
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006234 2000
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006234 1995
% 219.94/220.12  |- mesh__publicMeSHNote mesh__D006234 65   
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006234 2003
% 219.94/220.12  |- skos__altLabel mesh__D006234 Handling
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006234 2001
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006234 1998
% 219.94/220.12  |- mesh__recordMaintainer mesh__D006234 TGC
% 219.94/220.12  |- mesh__recordAuthorizer mesh__D006234 PLS
% 219.94/220.12  |- skos__scopeNote mesh__D006234
% 219.94/220.12       Physical manipulation of animals and humans to induce a behavioral or other psychological reaction. In experimental psychology, the animal is handled to induce a stress situation or to study the effects of %22%gentling%22% or %22%mothering%22%.%A%    
% 219.94/220.12  |- skos__broader mesh__D006234smesh__D009042
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006234 2004
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006234 1999
% 219.94/220.12  |- rdf__type mesh__D006234sskos__Concept
% 219.94/220.12  |- skos__annotation mesh__D006234
% 219.94/220.12       human %26% animal; no qualif; DF: HANDLING   
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006234 1996
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006234 2002
% 219.94/220.12  |- skos__hiddenLabel mesh__D006234 Handlings %28%Psychology%29%
% 219.94/220.12  |- mesh__dateCreated mesh__D006234 1999-01-01
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006234 2005
% 219.94/220.12  |- mesh__dateEstablished mesh__D006234 1965-01-01
% 219.94/220.12  |- mesh__recordOriginator mesh__D006234 NLM
% 219.94/220.12  |- mesh__historyNote mesh__D006234 65%28%64%29%   
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006234 1997
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006234 1994
% 219.94/220.12  |- skos__prefLabel mesh__D006234 Handling %28%Psychology%29%
% 219.94/220.12  |- skos__broader mesh__D016662smesh__D039361
% 219.94/220.12  |- skos__hiddenLabel mesh__D016662 Provirus Integrations
% 219.94/220.12  |- mesh__publicMeSHNote mesh__D016662 92   
% 219.94/220.12  |- mesh__recordOriginator mesh__D016662 AGS
% 219.94/220.12  |- skos__hiddenLabel mesh__D016662 Integrations, Virus
% 219.94/220.12  |- skos__broader mesh__D016662smesh__D018406
% 219.94/220.12  |- skos__scopeNote mesh__D016662
% 219.94/220.12       Insertion of viral DNA into host-cell DNA. This includes integration of phage DNA into bacterial DNA; %28%LYSOGENY%29%; to form a PROPHAGE or integration of retroviral DNA into cellular DNA to form a PROVIRUS.%A%    
% 219.94/220.12  |- skos__hiddenLabel mesh__D016662 Virus Integrations
% 219.94/220.12  |- mesh__dateRevised mesh__D016662 2005-07-13
% 219.94/220.12  |- skos__prefLabel mesh__D016662 Virus Integration
% 219.94/220.12  |- mesh__dateEstablished mesh__D016662 1992-01-01
% 219.94/220.12  |- rdf__type mesh__D016662sskos__Concept
% 219.94/220.12  |- skos__hiddenLabel mesh__D016662 Integrations, Provirus
% 219.94/220.12  |- skos__related mesh__D016662smesh__D011533
% 219.94/220.12  |- mesh__historyNote mesh__D016662 92   
% 219.94/220.12  |- mesh__recordMaintainer mesh__D016662 ags
% 219.94/220.12  |- skos__altLabel mesh__D016662 Integration, Virus
% 219.94/220.12  |- skos__altLabel mesh__D016662 Provirus Integration
% 219.94/220.12  |- mesh__recordAuthorizer mesh__D016662 ags
% 219.94/220.12  |- skos__historyNote mesh__D016662 Proviruses %28%1988-1991%29%
% 219.94/220.12  |- skos__historyNote mesh__D016662 DNA, Viral %28%1966-1991%29%
% 219.94/220.12  |- skos__related mesh__D016662smesh__D001287
% 219.94/220.12  |- skos__related mesh__D016662smesh__D019426
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D016662 2006A
% 219.94/220.12  |- mesh__dateCreated mesh__D016662 1991-01-25
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D016662 2006
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002642 1998
% 219.94/220.12  |- mesh__dateRevised mesh__D002642 1989-07-13
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002642 1993
% 219.94/220.12  |- skos__prefLabel mesh__D002642 Chick Embryo
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002642 1990
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002642 1994
% 219.94/220.12  |- skos__altLabel mesh__D002642 Embryo, Chick
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002642 1999
% 219.94/220.12  |- skos__broader mesh__D002642smesh__D004625
% 219.94/220.12  |- mesh__recordMaintainer mesh__D002642 PLS
% 219.94/220.12  |- mesh__publicMeSHNote mesh__D002642 64   
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002642 1991
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002642 2003
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002642 1995
% 219.94/220.12  |- mesh__recordAuthorizer mesh__D002642 PLS
% 219.94/220.12  |- skos__hiddenLabel mesh__D002642 Chick Embryos
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002642 2000
% 219.94/220.12  |- rdf__type mesh__D002642sskos__Concept
% 219.94/220.12  |- skos__annotation mesh__D002642
% 219.94/220.12       check tag: no qualif; when IM, /abnorm /growth /inj permitted as well as usual Cat A qualif; chick embryo heart = CHICK EMBRYO + HEART /embryol %28%not FETAL HEART%29%; /transpl permitted for chick embryo transfer: do not use EMBRYO TRANSFER since this is mammalian only%A%  
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002642 2004
% 219.94/220.12  |- mesh__dateEstablished mesh__D002642 1964-01-01
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002642 2001
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002642 2005
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002642 1996
% 219.94/220.12  |- mesh__recordOriginator mesh__D002642 NLM
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002642 2002
% 219.94/220.12  |- skos__hiddenLabel mesh__D002642 Embryos, Chick
% 219.94/220.12  |- mesh__historyNote mesh__D002642 64   
% 219.94/220.12  |- mesh__dateCreated mesh__D002642 1999-01-01
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002642 2006
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002642 1997
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D002642 1992
% 219.94/220.12  |- skos__broader mesh__D009206Q000293smesh__D009206
% 219.94/220.12  |- mesh__preferredCombination mesh__D009206Q000293smesh__D006335
% 219.94/220.12  |- rdf__type mesh__D009206Q000293smesh__CompoundConcept
% 219.94/220.12  |- skos__hiddenLabel mesh__D040761 Devices, Biomimetic
% 219.94/220.12  |- mesh__historyNote mesh__D040761 2003   
% 219.94/220.12  |- mesh__dateCreated mesh__D040761 2002-07-02
% 219.94/220.12  |- skos__related mesh__D040761smesh__D001672
% 219.94/220.12  |- skos__hiddenLabel mesh__D040761 Materials, Biomimetic
% 219.94/220.12  |- mesh__publicMeSHNote mesh__D040761 2003   
% 219.94/220.12  |- skos__hiddenLabel mesh__D040761 Biomimetic Material
% 219.94/220.12  |- skos__hiddenLabel mesh__D040761 Biomimetic Device
% 219.94/220.12  |- skos__broader mesh__D040761smesh__D008420
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D040761 2003
% 219.94/220.12  |- skos__hiddenLabel mesh__D040761 Material, Biomimetic
% 219.94/220.12  |- skos__scopeNote mesh__D040761
% 219.94/220.12       Materials fabricated by BIOMIMETICS techniques, i.e., based on natural processes found in biological systems.%A%    
% 219.94/220.12  |- skos__annotation mesh__D040761
% 219.94/220.12       do not confuse with BIOMATERIALS see BIOCOMPATIBLE MATERIALS%A%  
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D040761 2005
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D040761 2004
% 219.94/220.12  |- skos__hiddenLabel mesh__D040761 Device, Biomimetic
% 219.94/220.12  |- skos__prefLabel mesh__D040761 Biomimetic Materials
% 219.94/220.12  |- rdf__type mesh__D040761sskos__Concept
% 219.94/220.12  |- mesh__dateEstablished mesh__D040761 2003-01-01
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D040761 2006
% 219.94/220.12  |- skos__broader mesh__D012272smesh__D013909
% 219.94/220.12  |- skos__annotation mesh__D012272
% 219.94/220.12       /inj permitted: do not coord with THORACIC INJURIES but note RIB FRACTURES is available%A%  
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D012272 1999
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D012272 2002
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D012272 1993
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D012272 1996
% 219.94/220.12  |- mesh__recordMaintainer mesh__D012272 TGC
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D012272 1995
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D012272 1998
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D012272 2004
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D012272 2001
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D012272 1992
% 219.94/220.12  |- mesh__dateCreated mesh__D012272 1999-01-01
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D012272 2006
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D012272 1994
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D012272 2003
% 219.94/220.12  |- mesh__recordAuthorizer mesh__D012272 PLS
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D012272 2005
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D012272 2000
% 219.94/220.12  |- skos__hiddenLabel mesh__D012272 Rib
% 219.94/220.12  |- skos__related mesh__D012272smesh__D013991
% 219.94/220.12  |- rdf__type mesh__D012272sskos__Concept
% 219.94/220.12  |- skos__prefLabel mesh__D012272 Ribs
% 219.94/220.12  |- mesh__recordOriginator mesh__D012272 NLM
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D012272 1997
% 219.94/220.12  |- mesh__dateRevised mesh__D012272 1991-01-03
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D020704 2000
% 219.94/220.12  |- skos__prefLabel mesh__D020704 Laryngoscopes
% 219.94/220.12  |- skos__broader mesh__D020704smesh__D019723
% 219.94/220.12  |- skos__scopeNote mesh__D020704
% 219.94/220.12       Endoscopes for examining the interior of the larynx.     
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D020704 2001
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D020704 2003
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D020704 2002
% 219.94/220.12  |- skos__historyNote mesh__D020704 Endoscopes %28%1998-1999%29%
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D020704 2004
% 219.94/220.12  |- mesh__historyNote mesh__D020704 2000   
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D020704 2005
% 219.94/220.12  |- skos__hiddenLabel mesh__D020704 Laryngoscope
% 219.94/220.12  |- mesh__publicMeSHNote mesh__D020704 2000   
% 219.94/220.12  |- skos__historyNote mesh__D020704
% 219.94/220.12       Laryngoscopy/instrumentation %28%1966-1999%29%
% 219.94/220.12  |- rdf__type mesh__D020704sskos__Concept
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D020704 2006
% 219.94/220.12  |- mesh__dateEstablished mesh__D020704 2000-01-01
% 219.94/220.12  |- mesh__dateCreated mesh__D020704 1999-11-03
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006235 1995
% 219.94/220.12  |- skos__hiddenLabel mesh__D006235 Surgical Scrubs
% 219.94/220.12  |- mesh__historyNote mesh__D006235 82   
% 219.94/220.12  |- skos__historyNote mesh__D006235 Sterilization %28%1966-1974%29%
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006235 2003
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006235 1998
% 219.94/220.12  |- mesh__recordOriginator mesh__D006235 EC
% 219.94/220.12  |- mesh__dateCreated mesh__D006235 1981-03-02
% 219.94/220.12  |- skos__scopeNote mesh__D006235
% 219.94/220.12       The act of cleansing the hands with water or other liquid, with or without the inclusion of soap or other detergent, for the purpose of removing soil or microorganisms.%A%    
% 219.94/220.12  |- skos__prefLabel mesh__D006235 Handwashing
% 219.94/220.12  |- mesh__dateRevised mesh__D006235 1992-05-15
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006235 2004
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006235 1999
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006235 2000
% 219.94/220.12  |- rdf__type mesh__D006235sskos__Concept
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006235 1993
% 219.94/220.12  |- skos__historyNote mesh__D006235 Disinfection %28%1975-1981%29%
% 219.94/220.12  |- skos__altLabel mesh__D006235 Hand Disinfection
% 219.94/220.12  |- skos__hiddenLabel mesh__D006235 Scrubs, Surgical
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006235 2001
% 219.94/220.12  |- mesh__dateEstablished mesh__D006235 1982-01-01
% 219.94/220.12  |- skos__historyNote mesh__D006235
% 219.94/220.12       Cross Infection/prevention %26% control %28%1966-1981%29%
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006235 1996
% 219.94/220.12  |- mesh__recordAuthorizer mesh__D006235 PLS
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006235 2005
% 219.94/220.12  |- skos__broader mesh__D006235smesh__D003140
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006235 1997
% 219.94/220.12  |- mesh__activeMeSHYear mesh__D006235 1994
% 219.94/220.12  |- skos__altLabel mesh__D006235 Surgical Scrub
% 219.94/220.12  |- mesh__publicMeSHNote mesh__D006235 82   
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006235 2006
% 219.94/220.13  |- mesh__recordMaintainer mesh__D006235 TAP
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006235 2002
% 219.94/220.13  |- skos__broader mesh__D002477Q000637smesh__D002477
% 219.94/220.13  |- mesh__preferredCombination mesh__D002477Q000637smesh__D017690
% 219.94/220.13  |- rdf__type mesh__D002477Q000637smesh__CompoundConcept
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011978 1997
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011978 2003
% 219.94/220.13  |- mesh__historyNote mesh__D011978
% 219.94/220.13       84%28%77%29%; was see under RECEPTORS, CHOLINERGIC 1977-83   
% 219.94/220.13  |- skos__hiddenLabel mesh__D011978 Acetylcholine Receptors, Nicotinic
% 219.94/220.13  |- skos__altLabel mesh__D011978 Nicotinic Receptor
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011978 2006
% 219.94/220.13  |- skos__historyNote mesh__D011978 Receptors, Drug %28%1968-1976%29%
% 219.94/220.13  |- skos__scopeNote mesh__D011978
% 219.94/220.13       One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for nicotine over muscarine. They are generally divided into muscle-type and neuronal-type %28%previously ganglionic%29% based on pharmacology, molecular biology, and biophysical properties of the channels.%A%    
% 219.94/220.13  |- skos__altLabel mesh__D011978 Nicotinic Receptors
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011978 2004
% 219.94/220.13  |- skos__historyNote mesh__D011978 Nicotine %28%1974-1976%29%
% 219.94/220.13  |- skos__hiddenLabel mesh__D011978 Receptor, Nicotinic
% 219.94/220.13  |- mesh__recordMaintainer mesh__D011978 TPW
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011978 2000
% 219.94/220.13  |- skos__historyNote mesh__D011978 Acetylcholine %28%1966-1976%29%
% 219.94/220.13  |- skos__hiddenLabel mesh__D011978 Receptors, Nicotinic Acetylcholine
% 219.94/220.13  |- mesh__dateEstablished mesh__D011978 1984-01-01
% 219.94/220.13  |- mesh__recordOriginator mesh__D011978 SH
% 219.94/220.13  |- skos__prefLabel mesh__D011978 Receptors, Nicotinic
% 219.94/220.13  |- skos__hiddenLabel mesh__D011978 Acetylcholine Receptor, Nicotinic
% 219.94/220.13  |- mesh__dateRevised mesh__D011978 1995-03-24
% 219.94/220.13  |- rdf__type mesh__D011978sskos__Concept
% 219.94/220.13  |- mesh__publicMeSHNote mesh__D011978
% 219.94/220.13       84; was see under RECEPTORS, CHOLINERGIC 1977-83   
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011978 2001
% 219.94/220.13  |- skos__altLabel mesh__D011978 Nicotinic Acetylcholine Receptors
% 219.94/220.13  |- mesh__recordAuthorizer mesh__D011978 PLS
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011978 2002
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011978 1998
% 219.94/220.13  |- skos__historyNote mesh__D011978 Receptors, Cholinergic %28%1971-1976%29%
% 219.94/220.13  |- mesh__dateCreated mesh__D011978 1976-05-03
% 219.94/220.13  |- skos__altLabel mesh__D011978 Nicotinic Acetylcholine Receptor
% 219.94/220.13  |- skos__broader mesh__D011978smesh__D011950
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011978 1996
% 219.94/220.13  |- skos__hiddenLabel mesh__D011978 Receptor, Nicotinic Acetylcholine
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011978 1999
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011978 2005
% 219.94/220.13  |- skos__annotation mesh__D011978
% 219.94/220.13       coord IM with specific nicotinic agent %28%IM%29%; DF: RECEPT NICOTINIC%A%  
% 219.94/220.13  |- mesh__publicMeSHNote mesh__D016663 92   
% 219.94/220.13  |- mesh__recordMaintainer mesh__D016663 ags
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D016663 2006
% 219.94/220.13  |- skos__prefLabel mesh__D016663 Cercopithecinae
% 219.94/220.13  |- mesh__dateEstablished mesh__D016663 1992-01-01
% 219.94/220.13  |- skos__annotation mesh__D016663
% 219.94/220.13       a subfamily of Old World monkeys: do not confuse with CERCOPITHECIDAE, the family; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 219.94/220.13  |- mesh__recordOriginator mesh__D016663 MXR
% 219.94/220.13  |- mesh__dateCreated mesh__D016663 1991-01-24
% 219.94/220.13  |- rdf__type mesh__D016663sskos__Concept
% 219.94/220.13  |- mesh__dateRevised mesh__D016663 2005-06-30
% 219.94/220.13  |- mesh__historyNote mesh__D016663 92   
% 219.94/220.13  |- skos__broader mesh__D016663smesh__D002520
% 219.94/220.13  |- mesh__recordAuthorizer mesh__D016663 sjn
% 219.94/220.13  |- skos__scopeNote mesh__D016663
% 219.94/220.13       A subfamily of the Old World monkeys, CERCOPITHECIDAE. They inhabit the forests and savannas of Africa. This subfamily contains the following genera: CERCOCEBUS; CERCOPITHECUS; ERYTHROCEBUS; MACACA; PAPIO; and THEROPITHECUS.%A%    
% 219.94/220.13  |- skos__broader mesh__D009206Q000294smesh__D009206
% 219.94/220.13  |- mesh__preferredCombination mesh__D009206Q000294smesh__D006321Q000294
% 219.94/220.13  |- rdf__type mesh__D009206Q000294smesh__CompoundConcept
% 219.94/220.13  |- mesh__dateRevised mesh__D012273 2003-07-09
% 219.94/220.13  |- skos__hiddenLabel mesh__D012273 Protein, Fraction 1
% 219.94/220.13  |- skos__hiddenLabel mesh__D012273
% 219.94/220.13       Carboxylase-Oxygenase, Ribulose-1,5-Biphosphate
% 219.94/220.13  |- mesh__recordOriginator mesh__D012273 NLM
% 219.94/220.13  |- mesh__recordMaintainer mesh__D012273 ssb
% 219.94/220.13  |- skos__hiddenLabel mesh__D012273 Carboxylase-Oxygenase, 1,5-Biphosphate
% 219.94/220.13  |- mesh__publicMeSHNote mesh__D012273
% 219.94/220.13       98; see RIBULOSEBIPHOSPHATE CARBOXYLASE 1984-97, see CARBOXY-LYASES 1975-83%A%  
% 219.94/220.13  |- rdf__type mesh__D012273sskos__Concept
% 219.94/220.13  |- skos__scopeNote mesh__D012273
% 219.94/220.13       A copper protein that catalyzes the formation of 2 moles of 3-phosphoglycerate from ribulose 1,5-biphosphate in the presence of carbon dioxide. It utilizes oxygen instead of carbon dioxide to form 2-phosphoglycollate and 3-phosphoglycerate. EC 4.1.1.39.%A%    
% 219.94/220.13  |- skos__hiddenLabel mesh__D012273 Carboxylase, Ribulose Bisphosphate
% 219.94/220.13  |- skos__hiddenLabel mesh__D012273 Carboxylase, Ribulose Diphosphate
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D012273 2005
% 219.94/220.13  |- mesh__dateCreated mesh__D012273 1974-11-11
% 219.94/220.13  |- skos__altLabel mesh__D012273 Ribulosebiphosphate Carboxylase
% 219.94/220.13  |- skos__altLabel mesh__D012273 Ribulose Bisphosphate Carboxylase
% 219.94/220.13  |- skos__hiddenLabel mesh__D012273
% 219.94/220.13       Ribulose Biphosphate Carboxylase Oxygenase
% 219.94/220.13  |- skos__prefLabel mesh__D012273 Ribulose-Bisphosphate Carboxylase
% 219.94/220.13  |- skos__hiddenLabel mesh__D012273 1,5 Biphosphate Carboxylase Oxygenase
% 219.94/220.13  |- skos__hiddenLabel mesh__D012273 Carboxylase, Ribulose-Bisphosphate
% 219.94/220.13  |- skos__historyNote mesh__D012273 Pentosephosphates %28%1973-1974%29%
% 219.94/220.13  |- skos__hiddenLabel mesh__D012273 Ribulose 1,5 Biphosphate Carboxylase
% 219.94/220.13  |- mesh__historyNote mesh__D012273 98%28%75%29%   
% 219.94/220.13  |- skos__hiddenLabel mesh__D012273 Carboxylase, Ribulosebiphosphate
% 219.94/220.13  |- skos__altLabel mesh__D012273 Rubisco
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D012273 2006
% 219.94/220.13  |- skos__historyNote mesh__D012273 Carboxy-Lyases %28%1973-1974%29%
% 219.94/220.13  |- skos__hiddenLabel mesh__D012273 Bisphosphate Carboxylase, Ribulose
% 219.94/220.13  |- skos__hiddenLabel mesh__D012273
% 219.94/220.13       Carboxylase-Oxygenase, Ribulose Biphosphate
% 219.94/220.13  |- skos__altLabel mesh__D012273 1,5-Biphosphate Carboxylase-Oxygenase
% 219.94/220.13  |- skos__altLabel mesh__D012273 Carboxydismutase
% 219.94/220.13  |- skos__hiddenLabel mesh__D012273 Diphosphate Carboxylase, Ribulose
% 219.94/220.13  |- skos__historyNote mesh__D012273
% 219.94/220.13       Organophosphorus Compounds %28%1973-1974%29%
% 219.94/220.13  |- skos__hiddenLabel mesh__D012273 1 Protein, Fraction
% 219.94/220.13  |- skos__hiddenLabel mesh__D012273
% 219.94/220.13       Ribulose 1,5 Biphosphate Carboxylase Oxygenase
% 219.94/220.13  |- skos__altLabel mesh__D012273 Fraction 1 Protein
% 219.94/220.13  |- skos__hiddenLabel mesh__D012273 Carboxylase, Ribulose Biphosphate
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D012273 2004
% 219.94/220.13  |- mesh__recordAuthorizer mesh__D012273 sjn
% 219.94/220.13  |- skos__altLabel mesh__D012273 Ribulose Diphosphate Carboxylase
% 219.94/220.13  |- skos__altLabel mesh__D012273 Ribulose-1,5-Biphosphate Carboxylase
% 219.94/220.13  |- skos__altLabel mesh__D012273
% 219.94/220.13       Ribulose-1,5-Biphosphate Carboxylase-Oxygenase
% 219.94/220.13  |- skos__altLabel mesh__D012273 Ribulose Biphosphate Carboxylase-Oxygenase
% 219.94/220.13  |- skos__hiddenLabel mesh__D012273 Carboxylase, Ribulose-1,5-Biphosphate
% 219.94/220.13  |- skos__hiddenLabel mesh__D012273
% 219.94/220.13       Biphosphate Carboxylase-Oxygenase, Ribulose
% 219.94/220.13  |- skos__altLabel mesh__D012273 Ribulose Biphosphate Carboxylase
% 219.94/220.13  |- mesh__dateEstablished mesh__D012273 1984-01-01
% 219.94/220.13  |- skos__broader mesh__D012273smesh__D002262
% 219.94/220.13  |- skos__hiddenLabel mesh__D012273 Biphosphate Carboxylase, Ribulose
% 219.94/220.13  |- skos__historyNote mesh__D012273 Glyceric Acids %28%1973-1974%29%
% 219.94/220.13  |- mesh__dateCreated mesh__D006236 1999-01-01
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006236 2006
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006236 2001
% 219.94/220.13  |- mesh__dateRevised mesh__D006236 1989-04-28
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006236 1995
% 219.94/220.13  |- skos__annotation mesh__D006236
% 219.94/220.13       no qualif; handwriting %22%disorders%22% goes here with no coord for disord%A%  
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006236 1990
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006236 2005
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006236 2004
% 219.94/220.13  |- skos__related mesh__D006236smesh__D000381
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006236 1994
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006236 2000
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006236 1993
% 219.94/220.13  |- skos__hiddenLabel mesh__D006236 Handwritings
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006236 2003
% 219.94/220.13  |- mesh__recordOriginator mesh__D006236 NLM
% 219.94/220.13  |- skos__prefLabel mesh__D006236 Handwriting
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006236 1999
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006236 1992
% 219.94/220.13  |- mesh__recordAuthorizer mesh__D006236 PLS
% 219.94/220.13  |- rdf__type mesh__D006236sskos__Concept
% 219.94/220.13  |- skos__broader mesh__D006236smesh__D014956
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006236 1998
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006236 2002
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006236 1997
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006236 1991
% 219.94/220.13  |- mesh__recordMaintainer mesh__D006236 TGC
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006236 1996
% 219.94/220.13  |- skos__broader mesh__D006505Q000139smesh__D006505
% 219.94/220.13  |- mesh__preferredCombination mesh__D006505Q000139smesh__D006523
% 219.94/220.13  |- rdf__type mesh__D006505Q000139smesh__CompoundConcept
% 219.94/220.13  |- mesh__recordMaintainer mesh__D011979 KEV
% 219.94/220.13  |- skos__broader mesh__D011979smesh__D018000
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011979 1998
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011979 2004
% 219.94/220.13  |- skos__annotation mesh__D011979
% 219.94/220.13       GEN: prefer specifics; coord IM with specific pituit hormone %28%IM%29%; DF: RECEPT PITUITARY HORMONE%A%  
% 219.94/220.13  |- mesh__dateRevised mesh__D011979 1995-06-08
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011979 2006
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011979 2003
% 219.94/220.13  |- mesh__recordOriginator mesh__D011979 SH
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011979 2002
% 219.94/220.13  |- skos__historyNote mesh__D011979 Pituitary Hormones %28%1972-1986%29%
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011979 2005
% 219.94/220.13  |- mesh__recordAuthorizer mesh__D011979 PLS
% 219.94/220.13  |- rdf__type mesh__D011979sskos__Concept
% 219.94/220.13  |- skos__historyNote mesh__D011979
% 219.94/220.13       Receptors, Endogenous Substances %28%1973-1986%29%
% 219.94/220.13  |- mesh__historyNote mesh__D011979 87   
% 219.94/220.13  |- skos__hiddenLabel mesh__D011979 Pituitary Hormones Receptors
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011979 2001
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011979 1997
% 219.94/220.13  |- skos__altLabel mesh__D011979 Pituitary Hormone Receptors
% 219.94/220.13  |- skos__historyNote mesh__D011979
% 219.94/220.13       Pituitary Hormones, Anterior %28%1966-1986%29%
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011979 2000
% 219.94/220.13  |- skos__prefLabel mesh__D011979 Receptors, Pituitary Hormone
% 219.94/220.13  |- mesh__publicMeSHNote mesh__D011979 87   
% 219.94/220.13  |- skos__altLabel mesh__D011979 Receptors, Pituitary Hormones
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011979 1999
% 219.94/220.13  |- mesh__dateCreated mesh__D011979 1986-03-31
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D011979 1996
% 219.94/220.13  |- skos__scopeNote mesh__D011979
% 219.94/220.13       Cell surface proteins that bind pituitary hormones with high affinity and trigger intracellular changes influencing the behavior of cells. Since many pituitary hormones are also released by neurons as neurotransmitters, these receptors are also found in the nervous system.%A%    
% 219.94/220.13  |- skos__historyNote mesh__D011979
% 219.94/220.13       Pituitary Hormones, Posterior %28%1966-1986%29%
% 219.94/220.13  |- mesh__dateEstablished mesh__D011979 1987-01-01
% 219.94/220.13  |- skos__altLabel mesh__D016664 Lophocebus
% 219.94/220.13  |- skos__altLabel mesh__D016664 Mangabeys
% 219.94/220.13  |- mesh__recordAuthorizer mesh__D016664 sjn
% 219.94/220.13  |- mesh__publicMeSHNote mesh__D016664 92   
% 219.94/220.13  |- mesh__recordOriginator mesh__D016664 MXR
% 219.94/220.13  |- skos__hiddenLabel mesh__D016664 Mangabey
% 219.94/220.13  |- mesh__dateCreated mesh__D016664 1991-01-24
% 219.94/220.13  |- rdf__type mesh__D016664sskos__Concept
% 219.94/220.13  |- mesh__dateEstablished mesh__D016664 1992-01-01
% 219.94/220.13  |- skos__broader mesh__D016664smesh__D016663
% 219.94/220.13  |- mesh__historyNote mesh__D016664 92   
% 219.94/220.13  |- skos__prefLabel mesh__D016664 Cercocebus
% 219.94/220.13  |- skos__annotation mesh__D016664
% 219.94/220.13       Old World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 219.94/220.13  |- mesh__recordMaintainer mesh__D016664 ags
% 219.94/220.13  |- skos__scopeNote mesh__D016664
% 219.94/220.13       A genus of the subfamily CERCOPITHECINAE inhabiting the African forests. They are also known as mangabeys.%A%    
% 219.94/220.13  |- mesh__dateRevised mesh__D016664 2005-06-30
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D016664 2006
% 219.94/220.13  |- skos__annotation mesh__D002644 caused by a herpesvirus   
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D002644 1994
% 219.94/220.13  |- rdf__type mesh__D002644sskos__Concept
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D002644 2003
% 219.94/220.13  |- skos__prefLabel mesh__D002644 Chickenpox
% 219.94/220.13  |- skos__altLabel mesh__D002644 Varicella
% 219.94/220.13  |- skos__scopeNote mesh__D002644
% 219.94/220.13       A highly contagious infectious disease caused by the varicella-zoster virus %28%HERPESVIRUS 3, HUMAN%29%. It usually affects children, is spread by direct contact or respiratory route via droplet nuclei, and is characterized by the appearance on the skin and mucous membranes of successive crops of typical pruritic vesicular lesions that are easily broken and become scabbed. Chickenpox is relatively benign in children, but may be complicated by pneumonia and encephalitis in adults. %28%From Dorland, 27th ed%29%%A%    
% 219.94/220.13  |- skos__altLabel mesh__D002644 Chicken Pox
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D002644 1995
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D002644 1996
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D002644 2004
% 219.94/220.13  |- skos__broader mesh__D002644smesh__D006566
% 219.94/220.13  |- mesh__recordAuthorizer mesh__D002644 PLS
% 219.94/220.13  |- mesh__dateCreated mesh__D002644 1999-01-01
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D002644 2000
% 219.94/220.13  |- mesh__dateRevised mesh__D002644 1993-05-26
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D002644 1997
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D002644 2005
% 219.94/220.13  |- mesh__recordMaintainer mesh__D002644 PLS
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D002644 2001
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D002644 1998
% 219.94/220.13  |- mesh__recordOriginator mesh__D002644 NLM
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D002644 2006
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D002644 2002
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D002644 1999
% 219.94/220.13  |- rdf__type mesh__D012274sskos__Concept
% 219.94/220.13  |- mesh__recordOriginator mesh__D012274 RLS
% 219.94/220.13  |- mesh__historyNote mesh__D012274
% 219.94/220.13       91%28%75%29%; was see under PENTOSEPHOSPHATES 1975-90   
% 219.94/220.13  |- mesh__dateEstablished mesh__D012274 1991-01-01
% 219.94/220.13  |- skos__historyNote mesh__D012274 Pentosephosphates %28%1973-1974%29%
% 219.94/220.13  |- mesh__dateRevised mesh__D012274 2004-07-07
% 219.94/220.13  |- mesh__dateCreated mesh__D012274 1976-06-28
% 219.94/220.13  |- skos__historyNote mesh__D012274 Ketoses %28%1974%29%
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D012274 2006
% 219.94/220.13  |- skos__prefLabel mesh__D012274 Ribulosephosphates
% 219.94/220.13  |- mesh__recordMaintainer mesh__D012274 ssb
% 219.94/220.13  |- mesh__publicMeSHNote mesh__D012274
% 219.94/220.13       91; was see under PENTOSEPHOSPHATES 1975-90   
% 219.94/220.13  |- mesh__recordAuthorizer mesh__D012274 sjn
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D012274 2005
% 219.94/220.13  |- skos__broader mesh__D012274smesh__D010428
% 219.94/220.13  |- skos__scopeNote mesh__D012274
% 219.94/220.13       Ribulose substituted by one or more phosphoric acid moieties.%A%    
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D020706 2005
% 219.94/220.13  |- mesh__recordOriginator mesh__D020706 nns
% 219.94/220.13  |- mesh__historyNote mesh__D020706 2000; use ENDOSCOPES 1998-1999   
% 219.94/220.13  |- rdf__type mesh__D020706sskos__Concept
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D020706 2006
% 219.94/220.13  |- skos__prefLabel mesh__D020706 Laparoscopes
% 219.94/220.13  |- mesh__dateCreated mesh__D020706 1999-11-03
% 219.94/220.13  |- skos__altLabel mesh__D020706 Laparoscope
% 219.94/220.13  |- skos__altLabel mesh__D020706 Celioscopes
% 219.94/220.13  |- mesh__dateEstablished mesh__D020706 2000-01-01
% 219.94/220.13  |- mesh__dateRevised mesh__D020706 2002-07-03
% 219.94/220.13  |- skos__broader mesh__D020706smesh__D019723
% 219.94/220.13  |- mesh__recordMaintainer mesh__D020706 lkt
% 219.94/220.13  |- skos__altLabel mesh__D020706 Peritoneoscopes
% 219.94/220.13  |- mesh__recordAuthorizer mesh__D020706 sjn
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D020706 2003
% 219.94/220.13  |- skos__hiddenLabel mesh__D020706 Celioscope
% 219.94/220.13  |- skos__scopeNote mesh__D020706
% 219.94/220.13       ENDOSCOPES for examining the abdominal and pelvic organs in the peritoneal cavity.%A%    
% 219.94/220.13  |- skos__historyNote mesh__D020706
% 219.94/220.13       Laparoscopy/instrumentation %28%1966-1999%29%
% 219.94/220.13  |- skos__hiddenLabel mesh__D020706 Peritoneoscope
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D020706 2004
% 219.94/220.13  |- mesh__publicMeSHNote mesh__D020706 2000; see ENDOSCOPES 1998-1999   
% 219.94/220.13  |- skos__historyNote mesh__D020706 Endoscopes %28%1998-1999%29%
% 219.94/220.13  |- mesh__dateCreated mesh__D016665 1991-01-24
% 219.94/220.13  |- rdf__type mesh__D016665sskos__Concept
% 219.94/220.13  |- mesh__recordOriginator mesh__D016665 MXR
% 219.94/220.13  |- mesh__historyNote mesh__D016665 92   
% 219.94/220.13  |- skos__broader mesh__D016665smesh__D016664
% 219.94/220.13  |- skos__hiddenLabel mesh__D016665 Mangabeys, Sooty
% 219.94/220.13  |- mesh__dateRevised mesh__D016665 2005-06-30
% 219.94/220.13  |- skos__scopeNote mesh__D016665
% 219.94/220.13       A species of Old World monkeys from the genera CERCOCEBUS that is important in AIDS research. They may be naturally or experimentally infected with the simian immunodeficiency virus. They inhabit African forests from Sierra Leone to the Congo Republic.%A%    
% 219.94/220.13  |- skos__annotation mesh__D016665
% 219.94/220.13       Old World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 219.94/220.13  |- skos__altLabel mesh__D016665 Sooty Mangabey
% 219.94/220.13  |- mesh__recordAuthorizer mesh__D016665 sjn
% 219.94/220.13  |- skos__prefLabel mesh__D016665 Cercocebus atys
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D016665 2006
% 219.94/220.13  |- mesh__publicMeSHNote mesh__D016665 92   
% 219.94/220.13  |- skos__altLabel mesh__D016665 Mangabey, Sooty
% 219.94/220.13  |- mesh__dateEstablished mesh__D016665 1992-01-01
% 219.94/220.13  |- mesh__recordMaintainer mesh__D016665 ags
% 219.94/220.13  |- skos__hiddenLabel mesh__D016665 Sooty Mangabeys
% 219.94/220.13  |- mesh__recordAuthorizer mesh__D002645 sjn
% 219.94/220.13  |- skos__altLabel mesh__D002645 Gallus gallus domesticus
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D002645 2006
% 219.94/220.13  |- skos__broader mesh__D002645smesh__D046094
% 219.94/220.13  |- mesh__recordOriginator mesh__D002645 NLM
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D002645 2005
% 219.94/220.13  |- skos__broader mesh__D002645smesh__D011200
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D002645 2005A
% 219.94/220.13  |- mesh__recordMaintainer mesh__D002645 sjn
% 219.94/220.13  |- mesh__dateCreated mesh__D002645 1999-01-01
% 219.94/220.13  |- rdf__type mesh__D002645sskos__Concept
% 219.94/220.13  |- mesh__publicMeSHNote mesh__D002645 68   
% 219.94/220.13  |- skos__annotation mesh__D002645
% 219.94/220.13       diseases: coord IM with POULTRY DISEASES %28%IM%29%; canned chicken: coord IM with FOOD PRESERVATION%A%  
% 219.94/220.13  |- skos__hiddenLabel mesh__D002645 Chicken
% 219.94/220.13  |- skos__prefLabel mesh__D002645 Chickens
% 219.94/220.13  |- mesh__dateRevised mesh__D002645 2004-10-20
% 219.94/220.13  |- skos__scopeNote mesh__D002645
% 219.94/220.13       Common name for the species Gallus gallus, the domestic fowl, in the family Phasianidae, order GALLIFORMES. It is descended from the red jungle fowl of SOUTHEAST ASIA.%A%    
% 219.94/220.13  |- skos__altLabel mesh__D002645 Gallus gallus
% 219.94/220.13  |- mesh__dateEstablished mesh__D002645 1968-01-01
% 219.94/220.13  |- skos__historyNote mesh__D002645 Poultry %28%1966-1967%29%
% 219.94/220.13  |- skos__altLabel mesh__D002645 Gallus domesticus
% 219.94/220.13  |- mesh__historyNote mesh__D002645 68   
% 219.94/220.13  |- mesh__dateEstablished mesh__D035021 2003-01-01
% 219.94/220.13  |- mesh__publicMeSHNote mesh__D035021
% 219.94/220.13       2003; INVERSION STIMULATION FACTOR were indexed under CARRIER PROTEINS 1994-2002;%A%  
% 219.94/220.13  |- skos__altLabel mesh__D035021
% 219.94/220.13       HIN Recombinational Enhancer Binding Protein
% 219.94/220.13  |- mesh__recordMaintainer mesh__D035021 jmp
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D035021 2006
% 219.94/220.13  |- skos__scopeNote mesh__D035021
% 219.94/220.13       A highly abundant DNA binding protein whose expression is strongly correlated with the growth phase of bacteria. The protein plays a role in regulating DNA topology and activation of RIBOSOMAL RNA transcription. It was originally identified as a factor required for inversion stimulation by the Hin recombinase of SALMONELLA and Gin site-specific recombinase of BACTERIOPHAGE MU.%A%    
% 219.94/220.13  |- mesh__historyNote mesh__D035021
% 219.94/220.13       2003; for INVERSION STIMULATION FACTOR use INTEGRATION HOST FACTOR %28%NM%29% 1994-2002%A%  
% 219.94/220.13  |- mesh__recordAuthorizer mesh__D035021 sjn
% 219.94/220.13  |- mesh__dateRevised mesh__D035021 2004-07-07
% 219.94/220.13  |- skos__prefLabel mesh__D035021 Factor For Inversion Stimulation Protein
% 219.94/220.13  |- mesh__dateCreated mesh__D035021 2002-07-03
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D035021 2005
% 219.94/220.13  |- skos__broader mesh__D035021smesh__D001426
% 219.94/220.13  |- skos__historyNote mesh__D035021 Carrier Proteins %28%1994-2002%29%
% 219.94/220.13  |- mesh__recordOriginator mesh__D035021 jmp
% 219.94/220.13  |- rdf__type mesh__D035021sskos__Concept
% 219.94/220.13  |- skos__broader mesh__D035021smesh__D004268
% 219.94/220.13  |- skos__altLabel mesh__D035021 Inversion Stimulation Factor
% 219.94/220.13  |- skos__hiddenLabel mesh__D007330 Antibodies, Insulin
% 219.94/220.13  |- skos__scopeNote mesh__D007330 Antibodies specific to INSULIN.     
% 219.94/220.13  |- mesh__recordAuthorizer mesh__D007330 sjn
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D007330 2006
% 219.94/220.13  |- mesh__dateCreated mesh__D007330 1999-01-01
% 219.94/220.13  |- skos__broader mesh__D007330smesh__D000906
% 219.94/220.13  |- mesh__recordMaintainer mesh__D007330 ssb
% 219.94/220.13  |- mesh__dateRevised mesh__D007330 2005-06-30
% 219.94/220.13  |- skos__prefLabel mesh__D007330 Insulin Antibodies
% 219.94/220.13  |- rdf__type mesh__D007330sskos__Concept
% 219.94/220.13  |- mesh__recordOriginator mesh__D007330 NLM
% 219.94/220.13  |- rdf__type mesh__D012275sskos__Concept
% 219.94/220.13  |- skos__prefLabel mesh__D012275 Oryza sativa
% 219.94/220.13  |- mesh__dateRevised mesh__D012275 2002-07-31
% 219.94/220.13  |- mesh__recordAuthorizer mesh__D012275 sjn
% 219.94/220.13  |- skos__annotation mesh__D012275
% 219.94/220.13       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29; %22%yusho pois%22%: index under ORYZA SATIVA  /pois %28%IM%29% + PLANT OILS /pois %28%IM%29% + POLYCHLOROBIPHENYL COMPOUNDS /pois %28%IM%29% + FOOD CONTAMINATION %28%IM%29%%A%  
% 219.94/220.13  |- mesh__dateCreated mesh__D012275 1999-01-01
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D012275 2003
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D012275 2005
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D012275 2004
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D012275 2006
% 219.94/220.13  |- skos__scopeNote mesh__D012275
% 219.94/220.13       Annual cereal grass of the family POACEAE and its edible starchy grain, rice, which is the staple food of roughly one-half of the world%27%s population.%A%    
% 219.94/220.13  |- mesh__recordMaintainer mesh__D012275 sjn
% 219.94/220.13  |- skos__broader mesh__D012275smesh__D002523
% 219.94/220.13  |- mesh__recordOriginator mesh__D012275 NLM
% 219.94/220.13  |- skos__broader mesh__D012275smesh__D006109
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D020707 2002
% 219.94/220.13  |- skos__scopeNote mesh__D020707
% 219.94/220.13       Endoscopes for examining tissue of the anterior superior mediastinum.%A%    
% 219.94/220.13  |- skos__historyNote mesh__D020707
% 219.94/220.13       Mediastinoscopy/instrumentation %28%1974-1999%29%
% 219.94/220.13  |- mesh__dateEstablished mesh__D020707 2000-01-01
% 219.94/220.13  |- skos__historyNote mesh__D020707 Endoscopes %28%1998-1999%29%
% 219.94/220.13  |- skos__broader mesh__D020707smesh__D019723
% 219.94/220.13  |- mesh__publicMeSHNote mesh__D020707 2000   
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D020707 2003
% 219.94/220.13  |- mesh__dateCreated mesh__D020707 1999-11-03
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D020707 2004
% 219.94/220.13  |- mesh__historyNote mesh__D020707 2000   
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D020707 2000
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D020707 2005
% 219.94/220.13  |- skos__hiddenLabel mesh__D020707 Mediastinoscope
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D020707 2001
% 219.94/220.13  |- skos__prefLabel mesh__D020707 Mediastinoscopes
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D020707 2006
% 219.94/220.13  |- rdf__type mesh__D020707sskos__Concept
% 219.94/220.13  |- skos__hiddenLabel mesh__D006238 Cells, Haploid
% 219.94/220.13  |- mesh__publicMeSHNote mesh__D006238 68   
% 219.94/220.13  |- rdf__type mesh__D006238sskos__Concept
% 219.94/220.13  |- mesh__recordOriginator mesh__D006238 NLM
% 219.94/220.13  |- skos__prefLabel mesh__D006238 Haploidy
% 219.94/220.13  |- skos__hiddenLabel mesh__D006238 Haploidies
% 219.94/220.13  |- skos__annotation mesh__D006238 no qualif   
% 219.94/220.13  |- skos__scopeNote mesh__D006238
% 219.94/220.13       The chromosomal constitution of cells, in which each type of CHROMOSOME is represented once. Symbol: N.%A%    
% 219.94/220.13  |- skos__hiddenLabel mesh__D006238 Cell, Haploid
% 219.94/220.13  |- mesh__dateCreated mesh__D006238 1999-01-01
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006238 2006
% 219.94/220.13  |- skos__altLabel mesh__D006238 Haploid
% 219.94/220.13  |- skos__historyNote mesh__D006238 Chromosomes %28%1966-1967%29%
% 219.94/220.13  |- mesh__recordAuthorizer mesh__D006238 sjn
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006238 2004
% 219.94/220.13  |- mesh__recordMaintainer mesh__D006238 nns
% 219.94/220.13  |- mesh__historyNote mesh__D006238 68   
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D006238 2005
% 219.94/220.13  |- skos__broader mesh__D006238smesh__D011003
% 219.94/220.13  |- mesh__dateEstablished mesh__D006238 1968-01-01
% 219.94/220.13  |- skos__hiddenLabel mesh__D006238 Haploids
% 219.94/220.13  |- skos__hiddenLabel mesh__D006238 Haploid Cells
% 219.94/220.13  |- mesh__dateRevised mesh__D006238 2003-07-09
% 219.94/220.13  |- skos__hiddenLabel mesh__D016666 Novo Fluvoxamine
% 219.94/220.13  |- mesh__dateCreated mesh__D016666 1991-01-25
% 219.94/220.13  |- skos__altLabel mesh__D016666 Arrow Brand of Fluvoxamine Maleate
% 219.94/220.13  |- skos__altLabel mesh__D016666 Merck dura Brand of Fluvoxamine Maleate
% 219.94/220.13  |- skos__altLabel mesh__D016666 Fevarin
% 219.94/220.13  |- skos__altLabel mesh__D016666 Stadapharm Brand of Fluvoxamine Maleate
% 219.94/220.13  |- skos__hiddenLabel mesh__D016666 Nu Fluvoxamine
% 219.94/220.13  |- skos__altLabel mesh__D016666 ratio-Fluvoxamine
% 219.94/220.13  |- mesh__dateRevised mesh__D016666 2005-06-30
% 219.94/220.13  |- skos__altLabel mesh__D016666 Aliud Brand of Fluvoxamine Maleate
% 219.94/220.13  |- skos__altLabel mesh__D016666 Dumirox
% 219.94/220.13  |- skos__hiddenLabel mesh__D016666 Fluvoxamin neuraxpharm
% 219.94/220.13  |- skos__altLabel mesh__D016666 Solvay Brand of Fluvoxamine Maleate
% 219.94/220.13  |- mesh__onlineNote mesh__D016666
% 219.94/220.13       use FLUVOXAMINE %28%NM%29% to search FLUVOXAMINE 1980-91   
% 219.94/220.13  |- mesh__recordAuthorizer mesh__D016666 sjn
% 219.94/220.13  |- skos__broader mesh__D016666smesh__D010091
% 219.94/220.13  |- skos__altLabel mesh__D016666 betapharm Brand of Fluvoxamine Maleate
% 219.94/220.13  |- skos__scopeNote mesh__D016666
% 219.94/220.13       A selective serotonin reuptake inhibitor. It is effective in the treatment of depression, obsessive-compulsive disorders, anxiety, panic disorders, and alcohol amnestic disorders.%A%    
% 219.94/220.13  |- mesh__historyNote mesh__D016666
% 219.94/220.13       92; was FLUVOXAMINE %28%NM%29% 1978-91   
% 219.94/220.13  |- skos__hiddenLabel mesh__D016666 DU23000
% 219.94/220.13  |- skos__altLabel mesh__D016666 Pharmascience Brand of Fluvoxamine Maleate
% 219.94/220.13  |- rdf__type mesh__D016666sskos__Concept
% 219.94/220.13  |- skos__altLabel mesh__D016666 Pharmacia Brand of Fluvoxamine Maleate
% 219.94/220.13  |- mesh__activeMeSHYear mesh__D016666 2006
% 219.94/220.13  |- skos__historyNote mesh__D016666 Serotonin Antagonists %28%1978-1991%29%
% 219.94/220.13  |- skos__altLabel mesh__D016666 Ratiopharm Brand of Fluvoxamine Maleate
% 219.94/220.13  |- mesh__publicMeSHNote mesh__D016666
% 219.94/220.13       92; FLUVOXAMINE was indexed under OXIMES 1978-91   
% 219.94/220.14  |- skos__historyNote mesh__D016666 Antidepressive Agents %28%1979-1991%29%
% 219.94/220.14  |- skos__altLabel mesh__D016666 Nu-Pharm Brand of Fluvoxamine Maleate
% 219.94/220.14  |- skos__altLabel mesh__D016666 Novopharm Brand of Fluvoxamine Maleate
% 219.94/220.14  |- skos__altLabel mesh__D016666 Declimed Brand of Fluvoxamine Maleate
% 219.94/220.14  |- skos__altLabel mesh__D016666 neuraxpharm Brand of Fluvoxamine Maleate
% 219.94/220.14  |- skos__altLabel mesh__D016666 Floxyfral
% 219.94/220.14  |- skos__historyNote mesh__D016666 Oximes %28%1966-1991%29%
% 219.94/220.14  |- skos__hiddenLabel mesh__D016666 Nu Pharm Brand of Fluvoxamine Maleate
% 219.94/220.14  |- skos__altLabel mesh__D016666 Geminis Brand of Fluvoxamine Maleate
% 219.94/220.14  |- skos__altLabel mesh__D016666 Faverin
% 219.94/220.14  |- skos__hiddenLabel mesh__D016666 Fluvoxamin ratiopharm
% 219.94/220.14  |- mesh__recordMaintainer mesh__D016666 CCR
% 219.94/220.14  |- skos__hiddenLabel mesh__D016666 Geminis, Fluvoxamina
% 219.94/220.14  |- mesh__dateEstablished mesh__D016666 1992-01-01
% 219.94/220.14  |- skos__hiddenLabel mesh__D016666 PMS Fluvoxamine
% 219.94/220.14  |- skos__hiddenLabel mesh__D016666 DU 23000
% 219.94/220.14  |- skos__altLabel mesh__D016666 Eurim Brand of Fluvoxamine Maleate
% 219.94/220.14  |- skos__prefLabel mesh__D016666 Fluvoxamine
% 219.94/220.14  |- skos__hiddenLabel mesh__D016666 ratio Fluvoxamine
% 219.94/220.14  |- mesh__recordOriginator mesh__D016666 RLS
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D002646 2005
% 219.94/220.14  |- rdf__type mesh__D002646sskos__Concept
% 219.94/220.14  |- mesh__dateCreated mesh__D002646 1999-01-01
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D002646 2004
% 219.94/220.14  |- mesh__recordAuthorizer mesh__D002646 sjn
% 219.94/220.14  |- mesh__historyNote mesh__D002646 66%28%64%29%   
% 219.94/220.14  |- mesh__publicMeSHNote mesh__D002646 66   
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D002646 2003
% 219.94/220.14  |- mesh__dateEstablished mesh__D002646 1966-01-01
% 219.94/220.14  |- mesh__recordOriginator mesh__D002646 NLM
% 219.94/220.14  |- mesh__dateRevised mesh__D002646 2001-07-25
% 219.94/220.14  |- skos__annotation mesh__D002646
% 219.94/220.14       infection: coord IM with ALPHAVIRUS INFECTIONS %28%IM%29%   
% 219.94/220.14  |- mesh__recordMaintainer mesh__D002646 ags
% 219.94/220.14  |- skos__broader mesh__D002646smesh__D000524
% 219.94/220.14  |- skos__prefLabel mesh__D002646 Chikungunya virus
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D002646 2006
% 219.94/220.14  |- skos__scopeNote mesh__D002646
% 219.94/220.14       A species of ALPHAVIRUS causing an acute dengue-like fever.%A%    
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D002646 2002
% 219.94/220.14  |- mesh__dateRevised mesh__D007331 2003-07-09
% 219.94/220.14  |- skos__scopeNote mesh__D007331
% 219.94/220.14       Severe HYPOGLYCEMIA induced by a large dose of exogenous INSULIN resulting in a COMA or profound state of unconsciousness from which the individual cannot be aroused.%A%    
% 219.94/220.14  |- mesh__recordOriginator mesh__D007331 NLM
% 219.94/220.14  |- mesh__historyNote mesh__D007331
% 219.94/220.14       91%28%64%29%; was see under HYPOGLYCEMIA 1964-90   
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D007331 2005
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D007331 2004
% 219.94/220.14  |- skos__related mesh__D007331smesh__D003295
% 219.94/220.14  |- rdf__type mesh__D007331sskos__Concept
% 219.94/220.14  |- skos__hiddenLabel mesh__D007331 Coma, Insulin
% 219.94/220.14  |- mesh__dateEstablished mesh__D007331 1991-01-01
% 219.94/220.14  |- mesh__recordAuthorizer mesh__D007331 sjn
% 219.94/220.14  |- skos__broader mesh__D007331smesh__D003128
% 219.94/220.14  |- mesh__recordMaintainer mesh__D007331 lkt
% 219.94/220.14  |- mesh__publicMeSHNote mesh__D007331
% 219.94/220.14       91; was see under HYPOGLYCEMIA 1964-90   
% 219.94/220.14  |- skos__hiddenLabel mesh__D007331 Shock, Insulin
% 219.94/220.14  |- skos__prefLabel mesh__D007331 Insulin Coma
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D007331 2006
% 219.94/220.14  |- skos__broader mesh__D007331smesh__D007003
% 219.94/220.14  |- mesh__dateCreated mesh__D007331 1999-01-01
% 219.94/220.14  |- skos__scopeNote mesh__D048748
% 219.94/220.14       A 70-kDa MAPK kinase kinase with specificity for MAP KINASE KINASE 5.%A%    
% 219.94/220.14  |- mesh__recordOriginator mesh__D048748 jmp
% 219.94/220.14  |- mesh__historyNote mesh__D048748 2005%28%1999%29%   
% 219.94/220.14  |- rdf__type mesh__D048748sskos__Concept
% 219.94/220.14  |- skos__hiddenLabel mesh__D048748 Protein Kinase, MEKK3
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D048748 2006
% 219.94/220.14  |- skos__altLabel mesh__D048748 MAP3K3 Protein Kinase
% 219.94/220.14  |- skos__altLabel mesh__D048748 MAPK-ERK Kinase Kinase 3
% 219.94/220.14  |- mesh__publicMeSHNote mesh__D048748
% 219.94/220.14       2005; MAP KINASE KINASE KINASE 3 was indexed under MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASES 1999-2004%A%  
% 219.94/220.14  |- mesh__dateCreated mesh__D048748 2004-07-07
% 219.94/220.14  |- skos__prefLabel mesh__D048748 MAP Kinase Kinase Kinase 3
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D048748 2005
% 219.94/220.14  |- skos__hiddenLabel mesh__D048748
% 219.94/220.14       Mitogen Activated Protein Kinase Kinase Kinase 3
% 219.94/220.14  |- skos__hiddenLabel mesh__D048748 MAPK ERK Kinase Kinase 3
% 219.94/220.14  |- skos__altLabel mesh__D048748 MEKK3 Protein Kinase
% 219.94/220.14  |- mesh__recordAuthorizer mesh__D048748 sjn
% 219.94/220.14  |- skos__historyNote mesh__D048748
% 219.94/220.14       Mitogen-Activated Protein Kinase Kinase Kinases %28%1997-2004%29%
% 219.94/220.14  |- mesh__recordMaintainer mesh__D048748 jmp
% 219.94/220.14  |- skos__hiddenLabel mesh__D048748 Protein Kinase, MAP3K3
% 219.94/220.14  |- skos__altLabel mesh__D048748 ERK Kinase Kinase 3
% 219.94/220.14  |- skos__altLabel mesh__D048748
% 219.94/220.14       Mitogen-Activated Protein Kinase Kinase Kinase 3
% 219.94/220.14  |- mesh__dateEstablished mesh__D048748 2005-01-01
% 219.94/220.14  |- skos__altLabel mesh__D048748 MEK Kinase 3
% 219.94/220.14  |- skos__broader mesh__D048748smesh__D020930
% 219.94/220.14  |- skos__altLabel mesh__D012276 RCA 60
% 219.94/220.14  |- skos__altLabel mesh__D012276 RCA60
% 219.94/220.14  |- skos__altLabel mesh__D012276 Lectin, Ricinus
% 219.94/220.14  |- mesh__dateRevised mesh__D012276 2005-06-30
% 219.94/220.14  |- mesh__dateCreated mesh__D012276 1999-01-01
% 219.94/220.14  |- skos__altLabel mesh__D012276 Castor Bean Lectin
% 219.94/220.14  |- mesh__recordOriginator mesh__D012276 NLM
% 219.94/220.14  |- mesh__dateEstablished mesh__D012276 1978-01-01
% 219.94/220.14  |- skos__annotation mesh__D012276 /antag: consider also ANTITOXINS   
% 219.94/220.14  |- skos__hiddenLabel mesh__D012276 A Chain, Ricin
% 219.94/220.14  |- mesh__recordAuthorizer mesh__D012276 sjn
% 219.94/220.14  |- skos__hiddenLabel mesh__D012276 B Chain, Ricin
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D012276 2006
% 219.94/220.14  |- mesh__historyNote mesh__D012276
% 219.94/220.14       78%28%64%29%; was see under PLANT PROTEINS 1975-77   
% 219.94/220.14  |- mesh__publicMeSHNote mesh__D012276
% 219.94/220.14       78; was see under PLANT PROTEINS 1975-77   
% 219.94/220.14  |- skos__altLabel mesh__D012276 Lectin, Castor Bean
% 219.94/220.14  |- skos__prefLabel mesh__D012276 Ricin
% 219.94/220.14  |- skos__broader mesh__D012276smesh__D037121
% 219.94/220.14  |- skos__altLabel mesh__D012276 Ricinus Toxin
% 219.94/220.14  |- rdf__type mesh__D012276sskos__Concept
% 219.94/220.14  |- skos__broader mesh__D012276smesh__D000418
% 219.94/220.14  |- mesh__recordMaintainer mesh__D012276 ssb
% 219.94/220.14  |- skos__hiddenLabel mesh__D012276 Ricinus Lectin
% 219.94/220.14  |- skos__scopeNote mesh__D012276
% 219.94/220.14       A protein phytotoxin from the seeds of Ricinus communis, the castor oil plant. It agglutinates cells, is proteolytic, and causes lethal inflammation and hemorrhage if taken internally.%A%    
% 219.94/220.14  |- skos__hiddenLabel mesh__D012276 Toxin, Ricinus
% 219.94/220.14  |- mesh__publicMeSHNote mesh__D020708 2000   
% 219.94/220.14  |- mesh__historyNote mesh__D020708 2000   
% 219.94/220.14  |- skos__hiddenLabel mesh__D020708 Thoracoscope
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D020708 2001
% 219.94/220.14  |- skos__altLabel mesh__D020708 Pleuroscopes
% 219.94/220.14  |- rdf__type mesh__D020708sskos__Concept
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D020708 2006
% 219.94/220.14  |- skos__prefLabel mesh__D020708 Thoracoscopes
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D020708 2000
% 219.94/220.14  |- mesh__dateEstablished mesh__D020708 2000-01-01
% 219.94/220.14  |- skos__broader mesh__D020708smesh__D019723
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D020708 2005
% 219.94/220.14  |- mesh__dateCreated mesh__D020708 1999-11-05
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D020708 2004
% 219.94/220.14  |- skos__hiddenLabel mesh__D020708 Pleuroscope
% 219.94/220.14  |- skos__historyNote mesh__D020708 Endoscopes %28%1998-1999%29%
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D020708 2003
% 219.94/220.14  |- skos__historyNote mesh__D020708
% 219.94/220.14       Thoracoscopy/instrumentation %28%1966-1999%29%
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D020708 2002
% 219.94/220.14  |- skos__scopeNote mesh__D020708
% 219.94/220.14       Endoscopes for examining the pleural cavity.     
% 219.94/220.14  |- mesh__dateCreated mesh__D006239 1986-06-18
% 219.94/220.14  |- skos__historyNote mesh__D006239 Genotype %28%1968-1986%29%
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D006239 2006
% 219.94/220.14  |- mesh__dateRevised mesh__D006239 2002-07-03
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D006239 2004
% 219.94/220.14  |- mesh__recordOriginator mesh__D006239 SCD
% 219.94/220.14  |- skos__hiddenLabel mesh__D006239 Haplotype
% 219.94/220.14  |- skos__historyNote mesh__D006239 Haploidy %28%1968-1986%29%
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D006239 2005
% 219.94/220.14  |- skos__historyNote mesh__D006239
% 219.94/220.14       specific histocompatibility antigen %28%1975-1986%29%
% 219.94/220.14  |- skos__prefLabel mesh__D006239 Haplotypes
% 219.94/220.14  |- skos__broader mesh__D006239smesh__D005838
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D006239 2003
% 219.94/220.14  |- mesh__historyNote mesh__D006239 87   
% 219.94/220.14  |- rdf__type mesh__D006239sskos__Concept
% 219.94/220.14  |- skos__scopeNote mesh__D006239
% 219.94/220.14       The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX.%A%    
% 219.94/220.14  |- mesh__recordMaintainer mesh__D006239 nns
% 219.94/220.14  |- mesh__recordAuthorizer mesh__D006239 sjn
% 219.94/220.14  |- mesh__publicMeSHNote mesh__D006239 87   
% 219.94/220.14  |- mesh__dateEstablished mesh__D006239 1987-01-01
% 219.94/220.14  |- mesh__historyNote mesh__D016667 92   
% 219.94/220.14  |- mesh__dateEstablished mesh__D016667 1992-01-01
% 219.94/220.14  |- mesh__recordMaintainer mesh__D016667 ssb
% 219.94/220.14  |- mesh__recordAuthorizer mesh__D016667 sjn
% 219.94/220.14  |- mesh__recordOriginator mesh__D016667 PXP
% 219.94/220.14  |- skos__annotation mesh__D016667 DF: BACT CAPSULES   
% 219.94/220.14  |- mesh__publicMeSHNote mesh__D016667 92   
% 219.94/220.14  |- skos__altLabel mesh__D016667 Capsules, Bacterial
% 219.94/220.14  |- skos__altLabel mesh__D016667 Bacterial Capsule
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D016667 2006
% 219.94/220.14  |- skos__prefLabel mesh__D016667 Bacterial Capsules
% 219.94/220.14  |- skos__broader mesh__D016667smesh__D001426
% 219.94/220.14  |- skos__historyNote mesh__D016667
% 219.94/220.14       Polysaccharides, Bacterial %28%1966-1991%29%
% 219.94/220.14  |- skos__scopeNote mesh__D016667
% 219.94/220.14       An envelope of loose gel surrounding a bacterial cell which is associated with the virulence of pathogenic bacteria. Some capsules have a well-defined border, whereas others form a slime layer that trails off into the medium. Most capsules consist of relatively simple polysaccharides but there are some bacteria whose capsules are made of polypeptides.%A%    
% 219.94/220.14  |- skos__broader mesh__D016667smesh__D011135
% 219.94/220.14  |- mesh__dateCreated mesh__D016667 1991-01-24
% 219.94/220.14  |- rdf__type mesh__D016667sskos__Concept
% 219.94/220.14  |- skos__altLabel mesh__D016667 Capsule, Bacterial
% 219.94/220.14  |- mesh__dateRevised mesh__D016667 2005-06-30
% 219.94/220.14  |- mesh__recordAuthorizer mesh__D002647 PLS
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D002647 1996
% 219.94/220.14  |- mesh__publicMeSHNote mesh__D002647
% 219.94/220.14       91; was see under FROSTBITE 1975-90   
% 219.94/220.14  |- skos__broader mesh__D002647smesh__D005627
% 219.94/220.14  |- skos__prefLabel mesh__D002647 Chilblains
% 219.94/220.14  |- mesh__dateRevised mesh__D002647 1993-06-02
% 219.94/220.14  |- mesh__historyNote mesh__D002647
% 219.94/220.14       91%28%75%29%; was see under FROSTBITE 1975-90   
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D002647 2002
% 219.94/220.14  |- skos__annotation mesh__D002647 a form of frostbite   
% 219.94/220.14  |- mesh__dateEstablished mesh__D002647 1991-01-01
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D002647 2006
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D002647 2001
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D002647 1995
% 219.94/220.14  |- mesh__recordMaintainer mesh__D002647 TAP
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D002647 2005
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D002647 1999
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D002647 2000
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D002647 1994
% 219.94/220.14  |- rdf__type mesh__D002647sskos__Concept
% 219.94/220.14  |- mesh__recordOriginator mesh__D002647 NLM
% 219.94/220.14  |- mesh__dateCreated mesh__D002647 1999-01-01
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D002647 2004
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D002647 1998
% 219.94/220.14  |- skos__hiddenLabel mesh__D002647 Chilblain
% 219.94/220.14  |- mesh__onlineNote mesh__D002647 search FROSTBITE 1966-74   
% 219.94/220.14  |- skos__scopeNote mesh__D002647
% 219.94/220.14       Recurrent localized itching, swelling and painful erythema on the fingers, toes or ears, produced by exposure to cold. It is also called pernio.%A%    
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D002647 2003
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D002647 1997
% 219.94/220.14  |- mesh__publicMeSHNote mesh__D021801 2001   
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D021801 2004
% 219.94/220.14  |- skos__scopeNote mesh__D021801
% 219.94/220.14       The joint that occurs between facets of the interior and superior articular processes of adjacent vertebra.%A%    
% 219.94/220.14  |- mesh__dateCreated mesh__D021801 2000-06-22
% 219.94/220.14  |- rdf__type mesh__D021801sskos__Concept
% 219.94/220.14  |- skos__broader mesh__D021801smesh__D007596
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D021801 2003
% 219.94/220.14  |- skos__historyNote mesh__D021801 Joints %28%1966-2000%29%
% 219.94/220.14  |- mesh__dateEstablished mesh__D021801 2001-01-01
% 219.94/220.14  |- skos__hiddenLabel mesh__D021801 Joints, Zygapophyseal
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D021801 2002
% 219.94/220.14  |- skos__hiddenLabel mesh__D021801 Joint, Zygapophyseal
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D021801 2006
% 219.94/220.14  |- skos__prefLabel mesh__D021801 Zygapophyseal Joint
% 219.94/220.14  |- mesh__historyNote mesh__D021801 2001   
% 219.94/220.14  |- skos__hiddenLabel mesh__D021801 Joints, Facet
% 219.94/220.14  |- skos__altLabel mesh__D021801 Facet Joint
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D021801 2005
% 219.94/220.14  |- skos__hiddenLabel mesh__D021801 Zygapophyseal Joints
% 219.94/220.14  |- skos__hiddenLabel mesh__D021801 Joint, Facet
% 219.94/220.14  |- skos__hiddenLabel mesh__D021801 Facet Joints
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D021801 2001
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D007332 2004
% 219.94/220.14  |- skos__broader mesh__D007332smesh__D007260
% 219.94/220.14  |- rdf__type mesh__D007332sskos__Concept
% 219.94/220.14  |- skos__altLabel mesh__D007332 Pump, Programmable Implantable Insulin
% 219.94/220.14  |- mesh__publicMeSHNote mesh__D007332 82   
% 219.94/220.14  |- skos__hiddenLabel mesh__D007332 beta Cells, Artificial
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D007332 2005
% 219.94/220.14  |- skos__altLabel mesh__D007332 Insulin Pump, Programmable Implantable
% 219.94/220.14  |- skos__broader mesh__D007332smesh__D016503
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D007332 2000
% 219.94/220.14  |- skos__historyNote mesh__D007332 Islands of Langerhans %28%1973-1981%29%
% 219.94/220.14  |- skos__hiddenLabel mesh__D007332 Artificial beta Cell
% 219.94/220.14  |- skos__hiddenLabel mesh__D007332 Artificial Endocrine Pancreas
% 219.94/220.14  |- skos__historyNote mesh__D007332 Pancreas %28%1973-1981%29%
% 219.94/220.14  |- skos__hiddenLabel mesh__D007332 System, Insulin Infusion
% 219.94/220.14  |- skos__hiddenLabel mesh__D007332 Infusion System, Insulin
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D007332 2006
% 219.94/220.14  |- mesh__dateEstablished mesh__D007332 1982-01-01
% 219.94/220.14  |- skos__historyNote mesh__D007332 Infusions, Parenteral %28%1973-1981%29%
% 219.94/220.14  |- skos__altLabel mesh__D007332 Programmable Implantable Insulin Pump
% 219.94/220.14  |- skos__hiddenLabel mesh__D007332 Cells, Artificial beta
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D007332 2001
% 219.94/220.14  |- skos__hiddenLabel mesh__D007332 Insulin Infusion System
% 219.94/220.14  |- skos__annotation mesh__D007332
% 219.94/220.14       do not use /util except by MeSH definition; does not include conventional insulin injections %28% = INSULIN /admin + specific injection term%29%; permitted as IM coord with DIABETES MELLITUS %26% specifics instead of INSULIN /ther use; for implantable insulin infusion devices coord IM with INFUSION PUMPS, IMPLANTABLE %28%NIM%29%; insulin patches do not go here: index INSULIN /admin %28%IM%29% + ADMINISTRATION, CUTANEOUS %28%NIM%29%%A%  
% 219.94/220.14  |- skos__hiddenLabel mesh__D007332 Endocrine Pancreas, Artificial
% 219.94/220.14  |- skos__historyNote mesh__D007332 Artificial Organs %28%1973-1981%29%
% 219.94/220.14  |- skos__hiddenLabel mesh__D007332 Infusion Systems, Insulin
% 219.94/220.14  |- skos__scopeNote mesh__D007332
% 219.94/220.14       Portable or implantable devices for infusion of insulin. Includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor.%A%    
% 219.94/220.14  |- mesh__dateRevised mesh__D007332 1999-11-05
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D007332 2002
% 219.94/220.14  |- skos__hiddenLabel mesh__D007332 Artificial beta Cells
% 219.94/220.14  |- mesh__recordMaintainer mesh__D007332 TGC
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D007332 2003
% 219.94/220.14  |- mesh__historyNote mesh__D007332 82   
% 219.94/220.14  |- skos__historyNote mesh__D007332 Insulin %28%1973-1981%29%
% 219.94/220.14  |- mesh__recordAuthorizer mesh__D007332 sjn
% 219.94/220.14  |- skos__hiddenLabel mesh__D007332 Systems, Insulin Infusion
% 219.94/220.14  |- mesh__recordOriginator mesh__D007332 SMH
% 219.94/220.14  |- skos__hiddenLabel mesh__D007332 Cell, Artificial beta
% 219.94/220.14  |- mesh__dateCreated mesh__D007332 1981-02-26
% 219.94/220.14  |- skos__prefLabel mesh__D007332 Insulin Infusion Systems
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D048749 2006
% 219.94/220.14  |- skos__historyNote mesh__D048749 Cell Division %28%1965-2004%29%
% 219.94/220.14  |- mesh__dateEstablished mesh__D048749 2005-01-01
% 219.94/220.14  |- rdf__type mesh__D048749sskos__Concept
% 219.94/220.14  |- skos__prefLabel mesh__D048749 Cytokinesis
% 219.94/220.14  |- mesh__historyNote mesh__D048749 2005; use CELL DIVISION 1985-2004   
% 219.94/220.14  |- mesh__dateCreated mesh__D048749 2004-07-07
% 219.94/220.14  |- skos__broader mesh__D048749smesh__D002455
% 219.94/220.14  |- skos__annotation mesh__D048749
% 219.94/220.14       permitted with microorganisms; do not confuse CYTOKINESIS with CELL MOVEMENT or CYTOPLASMIC STREAMING%A%  
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D048749 2005
% 219.94/220.14  |- mesh__dateRevised mesh__D048749 2004-08-06
% 219.94/220.14  |- skos__hiddenLabel mesh__D048749 Cytokineses
% 219.94/220.14  |- skos__hiddenLabel mesh__D048749 Cytoplasmic Divisions
% 219.94/220.14  |- skos__scopeNote mesh__D048749
% 219.94/220.14       The process by which the CYTOPLASM of a cell is divided.%A%    
% 219.94/220.14  |- mesh__recordOriginator mesh__D048749 nns
% 219.94/220.14  |- skos__altLabel mesh__D048749 Cytoplasmic Division
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D048749 2005A
% 219.94/220.14  |- skos__hiddenLabel mesh__D048749 Divisions, Cytoplasmic
% 219.94/220.14  |- mesh__recordMaintainer mesh__D048749 jls
% 219.94/220.14  |- mesh__publicMeSHNote mesh__D048749 2005; see CELL DIVISION 1985-2004   
% 219.94/220.14  |- skos__hiddenLabel mesh__D048749 Division, Cytoplasmic
% 219.94/220.14  |- mesh__recordAuthorizer mesh__D048749 jls
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D012277 2006
% 219.94/220.14  |- mesh__dateEstablished mesh__D012277 1991-01-01
% 219.94/220.14  |- mesh__publicMeSHNote mesh__D012277
% 219.94/220.14       91; was see under OLEIC ACIDS 1988-90, was see under FATTY ACIDS, UNSATURATED 1975-87; was RICINOLEIC ACID see under FATTY ACIDS 1963-74; SODIUM RICINOLEATE was see under FATTY ACIDS, UNSATURATED 1975-80, was see under SCLEROSING SOLUTIONS 1963-74%A%  
% 219.94/220.14  |- mesh__dateRevised mesh__D012277 2003-07-09
% 219.94/220.14  |- mesh__recordMaintainer mesh__D012277 ssb
% 219.94/220.14  |- skos__prefLabel mesh__D012277 Ricinoleic Acids
% 219.94/220.14  |- rdf__type mesh__D012277sskos__Concept
% 219.94/220.14  |- mesh__recordOriginator mesh__D012277 NLM
% 219.94/220.14  |- mesh__onlineNote mesh__D012277
% 219.94/220.14       use FATTY ACIDS to search RICINOLEIC ACID 1966-74; use RICINOLEIC ACIDS to search SODIUM RICINOLEATE 1975-80, use SCLEROSING SOLUTIONS 1966-74%A%  
% 219.94/220.14  |- mesh__dateCreated mesh__D012277 1999-01-01
% 219.94/220.14  |- mesh__historyNote mesh__D012277
% 219.94/220.14       91%28%75%29%; was see under OLEIC ACIDS 1988-90, was see under FATTY ACIDS, UNSATURATED 1975-87; was RICINOLEIC ACID see under FATTY ACIDS 1963-74; SODIUM RICINOLEATE was see under FATTY ACIDS, UNSATURATED 1975-80, was see under SCLEROSING SOLUTIONS 1963-74%A%  
% 219.94/220.14  |- mesh__recordAuthorizer mesh__D012277 sjn
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D012277 2005
% 219.94/220.14  |- skos__broader mesh__D012277smesh__D009829
% 219.94/220.14  |- skos__hiddenLabel mesh__D012277 Acids, Ricinoleic
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D012277 2004
% 219.94/220.14  |- rdf__type mesh__D020709sskos__Concept
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D020709 2006
% 219.94/220.14  |- skos__historyNote mesh__D020709 Endoscopes %28%1998-1999%29%
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D020709 2002
% 219.94/220.14  |- mesh__dateEstablished mesh__D020709 2000-01-01
% 219.94/220.14  |- skos__broader mesh__D020709smesh__D019723
% 219.94/220.14  |- mesh__publicMeSHNote mesh__D020709 2000   
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D020709 2005
% 219.94/220.14  |- skos__historyNote mesh__D020709
% 219.94/220.14       Ureteroscopy/instrumentation %28%1995-1999%29%
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D020709 2001
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D020709 2004
% 219.94/220.14  |- skos__scopeNote mesh__D020709
% 219.94/220.14       Endoscopes for examining the interior of the ureter.     
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D020709 2000
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D020709 2003
% 219.94/220.14  |- skos__prefLabel mesh__D020709 Ureteroscopes
% 219.94/220.14  |- skos__hiddenLabel mesh__D020709 Ureteroscope
% 219.94/220.14  |- mesh__dateCreated mesh__D020709 1999-11-03
% 219.94/220.14  |- mesh__historyNote mesh__D020709 2000   
% 219.94/220.14  |- skos__hiddenLabel mesh__D017760 Bone Misalignments
% 219.94/220.14  |- skos__hiddenLabel mesh__D017760 Malposition, Bone
% 219.94/220.14  |- skos__hiddenLabel mesh__D017760 Malalignment, Bone
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D017760 1995
% 219.94/220.14  |- skos__hiddenLabel mesh__D017760 Bone Malalignments
% 219.94/220.14  |- mesh__historyNote mesh__D017760 94   
% 219.94/220.14  |- mesh__publicMeSHNote mesh__D017760 94   
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D017760 2005
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D017760 2000
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D017760 1998
% 219.94/220.14  |- skos__hiddenLabel mesh__D017760 Bone Malpositions
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D017760 2003
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D017760 1996
% 219.94/220.14  |- rdf__type mesh__D017760sskos__Concept
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D017760 2006
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D017760 1999
% 219.94/220.14  |- mesh__dateEstablished mesh__D017760 1994-01-01
% 219.94/220.14  |- skos__prefLabel mesh__D017760 Bone Malalignment
% 219.94/220.14  |- skos__broader mesh__D017760smesh__D001847
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D017760 2004
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D017760 2001
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D017760 1997
% 219.94/220.14  |- skos__altLabel mesh__D017760 Bone Misalignment
% 219.94/220.14  |- skos__scopeNote mesh__D017760
% 219.94/220.14       Displacement of bones out of line in relation to joints. It may be congenital or traumatic in origin.%A%    
% 219.94/220.14  |- skos__annotation mesh__D017760 congen or traum   
% 219.94/220.14  |- skos__altLabel mesh__D017760 Bone Malposition
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D017760 2002
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D017760 1994
% 219.94/220.14  |- skos__hiddenLabel mesh__D017760 Misalignment, Bone
% 219.94/220.14  |- mesh__dateCreated mesh__D017760 1992-12-28
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D003740 1995
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D003740 1998
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D003740 2003
% 219.94/220.14  |- mesh__dateRevised mesh__D003740 1992-05-14
% 219.94/220.14  |- skos__altLabel mesh__D003740 Clinic, Dental
% 219.94/220.14  |- skos__altLabel mesh__D003740 Clinics, Dental
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D003740 2006
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D003740 1994
% 219.94/220.14  |- skos__annotation mesh__D003740 DF: DENT CLINICS   
% 219.94/220.14  |- mesh__dateCreated mesh__D003740 1999-01-01
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D003740 2001
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D003740 2005
% 219.94/220.14  |- skos__altLabel mesh__D003740 Dental Clinic
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D003740 1997
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D003740 2000
% 219.94/220.14  |- mesh__historyNote mesh__D003740 65   
% 219.94/220.14  |- mesh__recordOriginator mesh__D003740 NLM
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D003740 1993
% 219.94/220.14  |- skos__broader mesh__D003740smesh__D003749
% 219.94/220.14  |- mesh__dateEstablished mesh__D003740 1965-01-01
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D003740 1996
% 219.94/220.14  |- skos__prefLabel mesh__D003740 Dental Clinics
% 219.94/220.14  |- rdf__type mesh__D003740sskos__Concept
% 219.94/220.14  |- mesh__publicMeSHNote mesh__D003740 65   
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D003740 1999
% 219.94/220.14  |- mesh__recordAuthorizer mesh__D003740 PLS
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D003740 2004
% 219.94/220.14  |- mesh__recordMaintainer mesh__D003740 TGC
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D003740 2002
% 219.94/220.14  |- skos__scopeNote mesh__D003740
% 219.94/220.14       Facilities where dental care is provided to patients.     
% 219.94/220.14  |- skos__broader mesh__D050396smesh__D050051
% 219.94/220.14  |- skos__broader mesh__D050396smesh__D015220
% 219.94/220.14  |- mesh__recordAuthorizer mesh__D050396 sjn
% 219.94/220.14  |- skos__hiddenLabel mesh__D050396 Channels, TRPP Cation
% 219.94/220.14  |- mesh__recordOriginator mesh__D050396 ssb
% 219.94/220.14  |- skos__historyNote mesh__D050396
% 219.94/220.14       Polycystic Kidney Diseases %28%1995-2005%29%
% 219.94/220.14  |- mesh__dateEstablished mesh__D050396 2006-01-01
% 219.94/220.14  |- mesh__activeMeSHYear mesh__D050396 2006
% 219.94/220.14  |- mesh__dateCreated mesh__D050396 2005-06-30
% 219.94/220.14  |- rdf__type mesh__D050396sskos__Concept
% 219.94/220.14  |- skos__prefLabel mesh__D050396 TRPP Cation Channels
% 219.94/220.14  |- skos__altLabel mesh__D050396 Polycystins
% 219.94/220.14  |- skos__hiddenLabel mesh__D050396 Cation Channels, TRPP
% 219.94/220.14  |- skos__annotation mesh__D050396
% 219.94/220.14       do not confuse with polycysteine%5B%nm%5D%   
% 219.94/220.14  |- skos__scopeNote mesh__D050396
% 219.94/220.14       A subgroup of TRP cation channels that are widely expressed in various cell types. Defects are associated with POLYCYSTIC KIDNEY DISEASES.%A%    
% 219.94/220.14  |- mesh__publicMeSHNote mesh__D050396 2006   
% 219.94/220.14  |- mesh__recordMaintainer mesh__D050396 ssb
% 219.94/220.14  |- mesh__historyNote mesh__D050396 2006   
% 219.94/220.14  |- skos__scopeNote mesh__D041061
% 219.94/220.14       Species of gram-negative bacteria in the family ANAPLASMATACEAE, causing EHRLICHIOSIS in DOGS. The most common vector is the brown dog tick. It can also cause disease in humans.%A%    
% 219.94/220.14  |- mesh__dateEstablished mesh__D041061 2003-01-01
% 219.94/220.14  |- mesh__publicMeSHNote mesh__D041061 2003   
% 219.94/220.14  |- mesh__recordMaintainer mesh__D041061 SYSTEM
% 219.94/220.14  |- mesh__recordOriginator mesh__D041061 ags
% 219.94/220.14  |- mesh__recordAuthorizer mesh__D041061 sjn
% 219.94/220.14  |- skos__broader mesh__D041061smesh__D004536
% 219.94/220.14  |- mesh__historyNote mesh__D041061 2003   
% 219.94/220.14  |- mesh__dateRevised mesh__D041061 2005-06-30
% 219.94/220.14  |- skos__historyNote mesh__D041061 Ehrlichia %28%1969-2002%29%
% 219.94/220.15  |- mesh__dateCreated mesh__D041061 2002-07-03
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D041061 2006
% 219.94/220.15  |- rdf__type mesh__D041061sskos__Concept
% 219.94/220.15  |- skos__prefLabel mesh__D041061 Ehrlichia canis
% 219.94/220.15  |- skos__annotation mesh__D041061
% 219.94/220.15       infection: coord IM with EHRLICHIOSIS %28%IM%29%   
% 219.94/220.15  |- mesh__recordOriginator mesh__D002648 NLM
% 219.94/220.15  |- skos__related mesh__D002648smesh__D009863
% 219.94/220.15  |- skos__related mesh__D002648smesh__D033242
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D002648 2006
% 219.94/220.15  |- skos__scopeNote mesh__D002648
% 219.94/220.15       A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.%A%    
% 219.94/220.15  |- skos__altLabel mesh__D002648 Children
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D002648 2005
% 219.94/220.15  |- mesh__dateCreated mesh__D002648 1999-01-01
% 219.94/220.15  |- rdf__type mesh__D002648sskos__Concept
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D002648 2004
% 219.94/220.15  |- skos__broader mesh__D002648smesh__D009273
% 219.94/220.15  |- skos__prefLabel mesh__D002648 Child
% 219.94/220.15  |- skos__annotation mesh__D002648
% 219.94/220.15       age 6-12 yr; IM only as psychol %26% sociol or social entity: Manual 18.5.11; no qualif; /psychol = CHILD PSYCHOLOGY %28%Manual 34.9.4%29% but consider also CHILD BEHAVIOR %26% other specifics; NIM as check tag: Manual 18.5+; as student: Manual 34.16%A%  
% 219.94/220.15  |- mesh__recordMaintainer mesh__D002648 hjn
% 219.94/220.15  |- mesh__recordAuthorizer mesh__D002648 sjn
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D002648 2003
% 219.94/220.15  |- mesh__dateRevised mesh__D002648 2002-07-03
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D013370 2002
% 219.94/220.15  |- skos__prefLabel mesh__D013370 Subrenal Capsule Assay
% 219.94/220.15  |- mesh__dateRevised mesh__D013370 2000-06-21
% 219.94/220.15  |- rdf__type mesh__D013370sskos__Concept
% 219.94/220.15  |- skos__hiddenLabel mesh__D013370 Assays, Subrenal Capsule
% 219.94/220.15  |- mesh__publicMeSHNote mesh__D013370 88   
% 219.94/220.15  |- skos__broader mesh__D013370smesh__D023041
% 219.94/220.15  |- skos__scopeNote mesh__D013370
% 219.94/220.15       In vivo method of screening investigative anticancer drugs and biologic response modifiers for individual cancer patients. Fresh tumor tissue is implanted under the kidney capsule of immunocompetent mice or rats; gross and histological assessments follow several days after tumor treatment in situ.%A%    
% 219.94/220.15  |- skos__historyNote mesh__D013370
% 219.94/220.15       Transplantation, Heterologous %28%1983-1987%29%
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D013370 2005
% 219.94/220.15  |- mesh__recordOriginator mesh__D013370 SCD
% 219.94/220.15  |- mesh__historyNote mesh__D013370 88   
% 219.94/220.15  |- skos__hiddenLabel mesh__D013370 Assay, Subrenal Capsule
% 219.94/220.15  |- skos__historyNote mesh__D013370 Tumor Stem Cell Assay %28%1984-1987%29%
% 219.94/220.15  |- skos__historyNote mesh__D013370
% 219.94/220.15       Neoplasm Transplantation %28%1979-1987%29%
% 219.94/220.15  |- mesh__recordMaintainer mesh__D013370 nns
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D013370 2003
% 219.94/220.15  |- skos__hiddenLabel mesh__D013370 Subrenal Capsule Assays
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D013370 2006
% 219.94/220.15  |- skos__historyNote mesh__D013370 Drug Screening %28%1979-1987%29%
% 219.94/220.15  |- mesh__dateCreated mesh__D013370 1987-05-08
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D013370 2004
% 219.94/220.15  |- skos__altLabel mesh__D013370 Subrenal Capsule Xenograft Assay
% 219.94/220.15  |- skos__annotation mesh__D013370 DF: SRCA   
% 219.94/220.15  |- mesh__dateEstablished mesh__D013370 1988-01-01
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D013370 2001
% 219.94/220.15  |- mesh__recordAuthorizer mesh__D013370 sjn
% 219.94/220.15  |- skos__broader mesh__D034941Q000002smesh__D034941
% 219.94/220.15  |- mesh__preferredCombination mesh__D034941Q000002smesh__D038062
% 219.94/220.15  |- rdf__type mesh__D034941Q000002smesh__CompoundConcept
% 219.94/220.15  |- mesh__dateEstablished mesh__D007333 1967-01-01
% 219.94/220.15  |- rdf__type mesh__D007333sskos__Concept
% 219.94/220.15  |- skos__scopeNote mesh__D007333
% 219.94/220.15       Diminished effectiveness of INSULIN in lowering blood sugar levels: Requiring the use of 200 units or more of insulin per day to prevent hyperglycemia or ketosis. It is usually due to insulin binding by antibodies %28%INSULIN ANTIBODIES%29%, but abnormalities in insulin receptors %28%RECEPTOR, INSULIN%29% on cell surfaces also occur. It is associated with obesity, ketoacidosis, infection, and certain rare conditions. %28%from Stedman, 25th ed%29%%A%    
% 219.94/220.15  |- mesh__historyNote mesh__D007333 67%28%64%29%   
% 219.94/220.15  |- mesh__recordAuthorizer mesh__D007333 sjn
% 219.94/220.15  |- mesh__dateCreated mesh__D007333 1999-01-01
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D007333 2005
% 219.94/220.15  |- skos__prefLabel mesh__D007333 Insulin Resistance
% 219.94/220.15  |- mesh__dateRevised mesh__D007333 2004-07-13
% 219.94/220.15  |- skos__annotation mesh__D007333
% 219.94/220.15       for insulin resistance syndrome X use METABOLIC SYNDROME X%A%  
% 219.94/220.15  |- mesh__recordMaintainer mesh__D007333 sjn
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D007333 2006
% 219.94/220.15  |- skos__broader mesh__D007333smesh__D006946
% 219.94/220.15  |- skos__broader mesh__D007333smesh__D004351
% 219.94/220.15  |- mesh__recordOriginator mesh__D007333 NLM
% 219.94/220.15  |- skos__hiddenLabel mesh__D007333 Resistance, Insulin
% 219.94/220.15  |- mesh__publicMeSHNote mesh__D007333 67   
% 219.94/220.15  |- skos__prefLabel mesh__D012278 Ricinus
% 219.94/220.15  |- rdf__type mesh__D012278sskos__Concept
% 219.94/220.15  |- skos__broader mesh__D012278smesh__D019665
% 219.94/220.15  |- mesh__publicMeSHNote mesh__D012278
% 219.94/220.15       2002; for CASTOR OIL PLANT see EUPHORBIACEAE 1998-2001   
% 219.94/220.15  |- mesh__historyNote mesh__D012278
% 219.94/220.15       2002; for CASTOR OIL PLANT use EUPHORBIACEAE 1998-2001   
% 219.94/220.15  |- skos__related mesh__D012278smesh__D002368
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D012278 2002
% 219.94/220.15  |- mesh__dateCreated mesh__D012278 1999-01-01
% 219.94/220.15  |- mesh__recordMaintainer mesh__D012278 ssb
% 219.94/220.15  |- skos__related mesh__D012278smesh__D012276
% 219.94/220.15  |- mesh__dateRevised mesh__D012278 2001-07-25
% 219.94/220.15  |- skos__altLabel mesh__D012278 Castor Oil Plant
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D012278 2003
% 219.94/220.15  |- mesh__recordOriginator mesh__D012278 NLM
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D012278 2005
% 219.94/220.15  |- skos__scopeNote mesh__D012278
% 219.94/220.15       A plant genus of the family EUPHORBIACEAE, order Euphorbiales, subclass Rosidae. The seed of Ricinus communis L. is the CASTOR BEAN which is the source of CASTOR OIL; RICIN; and other lectins.%A%    
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D012278 2004
% 219.94/220.15  |- skos__annotation mesh__D012278
% 219.94/220.15       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D012278 2006
% 219.94/220.15  |- mesh__recordAuthorizer mesh__D012278 sjn
% 219.94/220.15  |- mesh__dateCreated mesh__D003741 1999-01-01
% 219.94/220.15  |- skos__broader mesh__D003741smesh__D005441
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003741 1995
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003741 2005
% 219.94/220.15  |- mesh__recordOriginator mesh__D003741 NLM
% 219.94/220.15  |- mesh__publicMeSHNote mesh__D003741
% 219.94/220.15       65; MATERIA ALBA was heading 1965-86   
% 219.94/220.15  |- skos__altLabel mesh__D003741 Deposit, Dental
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003741 2006
% 219.94/220.15  |- mesh__dateEstablished mesh__D003741 1965-01-01
% 219.94/220.15  |- skos__broader mesh__D003741smesh__D014076
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003741 1996
% 219.94/220.15  |- skos__prefLabel mesh__D003741 Dental Deposits
% 219.94/220.15  |- mesh__historyNote mesh__D003741
% 219.94/220.15       65; was in Cat C only 1965-74; MATERIA ALBA was heading 1965-86%A%  
% 219.94/220.15  |- skos__annotation mesh__D003741
% 219.94/220.15       note categories; from Cat A /chem /ultrastruct permitted; tartar = DENTAL CALCULUS; DF: DENT DEPOSITS%A%  
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003741 1997
% 219.94/220.15  |- mesh__dateRevised mesh__D003741 1992-05-14
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003741 2000
% 219.94/220.15  |- skos__altLabel mesh__D003741 Deposits, Dental
% 219.94/220.15  |- skos__altLabel mesh__D003741 Dental Deposit
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003741 1993
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003741 1998
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003741 2003
% 219.94/220.15  |- mesh__recordMaintainer mesh__D003741 TGC
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003741 2001
% 219.94/220.15  |- mesh__onlineNote mesh__D003741
% 219.94/220.15       use DENTAL DEPOSITS to search MATERIA ALBA 1966-86   
% 219.94/220.15  |- rdf__type mesh__D003741sskos__Concept
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003741 1994
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003741 1999
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003741 2004
% 219.94/220.15  |- mesh__recordAuthorizer mesh__D003741 PLS
% 219.94/220.15  |- skos__altLabel mesh__D003741 Materia Alba
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003741 2002
% 219.94/220.15  |- skos__hiddenLabel mesh__D050397 Intensity-Modulated Radiotherapy
% 219.94/220.15  |- skos__prefLabel mesh__D050397 Radiotherapy, Intensity-Modulated
% 219.94/220.15  |- mesh__historyNote mesh__D050397 2006   
% 219.94/220.15  |- skos__broader mesh__D050397smesh__D020266
% 219.94/220.15  |- skos__scopeNote mesh__D050397
% 219.94/220.15       CONFORMAL RADIOTHERAPY that combines several intensity-modulated beams to provide improved dose homogeneity and highly conformal dose distributions.%A%    
% 219.94/220.15  |- mesh__dateCreated mesh__D050397 2005-06-30
% 219.94/220.15  |- mesh__recordAuthorizer mesh__D050397 sjn
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D050397 2006
% 219.94/220.15  |- skos__historyNote mesh__D050397
% 219.94/220.15       Radiotherapy, Conformal %28%1999-2005%29%
% 219.94/220.15  |- mesh__publicMeSHNote mesh__D050397 2006   
% 219.94/220.15  |- skos__hiddenLabel mesh__D050397 Radiotherapies, Intensity-Modulated
% 219.94/220.15  |- rdf__type mesh__D050397sskos__Concept
% 219.94/220.15  |- mesh__recordOriginator mesh__D050397 ags
% 219.94/220.15  |- skos__hiddenLabel mesh__D050397 Intensity-Modulated Radiotherapies
% 219.94/220.15  |- skos__hiddenLabel mesh__D050397 Radiotherapy, Intensity Modulated
% 219.94/220.15  |- mesh__dateEstablished mesh__D050397 2006-01-01
% 219.94/220.15  |- mesh__recordMaintainer mesh__D050397 ags
% 219.94/220.15  |- mesh__recordAuthorizer mesh__D016669 sjn
% 219.94/220.15  |- mesh__recordMaintainer mesh__D016669 ags
% 219.94/220.15  |- mesh__dateRevised mesh__D016669 2005-06-30
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D016669 2006
% 219.94/220.15  |- mesh__recordOriginator mesh__D016669 MXR
% 219.94/220.15  |- skos__annotation mesh__D016669
% 219.94/220.15       Old World monkey; NIM when exper animal; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 219.94/220.15  |- mesh__dateEstablished mesh__D016669 1992-01-01
% 219.94/220.15  |- skos__broader mesh__D016669smesh__D016663
% 219.94/220.15  |- rdf__type mesh__D016669sskos__Concept
% 219.94/220.15  |- skos__prefLabel mesh__D016669 Erythrocebus
% 219.94/220.15  |- mesh__dateCreated mesh__D016669 1991-01-25
% 219.94/220.15  |- mesh__publicMeSHNote mesh__D016669 92   
% 219.94/220.15  |- skos__scopeNote mesh__D016669
% 219.94/220.15       a genus of Old World monkeys of the family CERCOPITHECINAE that inhabit the forests and savannas of Africa. It contains only one species, ERYTHROCEBUS PATAS, also known as the patas monkey or red monkey.%A%    
% 219.94/220.15  |- mesh__historyNote mesh__D016669 92   
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D002649 2005
% 219.94/220.15  |- skos__hiddenLabel mesh__D002649 Child Abuses
% 219.94/220.15  |- skos__hiddenLabel mesh__D002649 Abuse, Child
% 219.94/220.15  |- mesh__dateCreated mesh__D002649 1999-01-01
% 219.94/220.15  |- mesh__recordAuthorizer mesh__D002649 sjn
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D002649 2006
% 219.94/220.15  |- mesh__recordMaintainer mesh__D002649 lkt
% 219.94/220.15  |- skos__hiddenLabel mesh__D002649 Neglect, Child
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D002649 2003
% 219.94/220.15  |- skos__annotation mesh__D002649 check also tag CHILD or specific   
% 219.94/220.15  |- mesh__recordOriginator mesh__D002649 NLM
% 219.94/220.15  |- skos__prefLabel mesh__D002649 Child Abuse
% 219.94/220.15  |- mesh__dateRevised mesh__D002649 2002-07-02
% 219.94/220.15  |- skos__broader mesh__D002649smesh__D002669
% 219.94/220.15  |- rdf__type mesh__D002649sskos__Concept
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D002649 2004
% 219.94/220.15  |- skos__related mesh__D002649smesh__D038642
% 219.94/220.15  |- mesh__publicMeSHNote mesh__D002649 65   
% 219.94/220.15  |- mesh__dateEstablished mesh__D002649 1965-01-01
% 219.94/220.15  |- skos__scopeNote mesh__D002649
% 219.94/220.15       Abuse of children in a family, institutional, or other setting. %28%APA, Thesaurus of Psychological Index Terms, 1994%29%%A%    
% 219.94/220.15  |- mesh__historyNote mesh__D002649 65%28%64%29%   
% 219.94/220.15  |- skos__hiddenLabel mesh__D002649 Abuses, Child
% 219.94/220.15  |- skos__broader mesh__D002649smesh__D017579
% 219.94/220.15  |- skos__historyNote mesh__D007334 Peptides %28%1966-1985%29%
% 219.94/220.15  |- rdf__type mesh__D007334sskos__Concept
% 219.94/220.15  |- mesh__recordOriginator mesh__D007334 RLS
% 219.94/220.15  |- mesh__historyNote mesh__D007334
% 219.94/220.15       91%28%86%29%; was see under SOMATOMEDINS 1986-90   
% 219.94/220.15  |- skos__altLabel mesh__D007334 Insulin Like Growth Factor I
% 219.94/220.15  |- mesh__publicMeSHNote mesh__D007334
% 219.94/220.15       91; was see under SOMATOMEDINS 1986-90   
% 219.94/220.15  |- skos__altLabel mesh__D007334 IGF-I
% 219.94/220.15  |- skos__hiddenLabel mesh__D007334 Insulin Like Somatomedin Peptide I
% 219.94/220.15  |- skos__altLabel mesh__D007334 IGF-I-SmC
% 219.94/220.15  |- skos__scopeNote mesh__D007334
% 219.94/220.15       A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor.%A%    
% 219.94/220.15  |- mesh__recordMaintainer mesh__D007334 ssb
% 219.94/220.15  |- skos__historyNote mesh__D007334 Sulfation Factor %28%1971-1972%29%
% 219.94/220.15  |- mesh__dateCreated mesh__D007334 1985-04-25
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D007334 2006
% 219.94/220.15  |- mesh__dateEstablished mesh__D007334 1991-01-01
% 219.94/220.15  |- skos__historyNote mesh__D007334 Insulin %28%1966-1985%29%
% 219.94/220.15  |- skos__altLabel mesh__D007334 Somatomedin C
% 219.94/220.15  |- skos__altLabel mesh__D007334 Insulin-Like Somatomedin Peptide I
% 219.94/220.15  |- mesh__recordAuthorizer mesh__D007334 sjn
% 219.94/220.15  |- skos__historyNote mesh__D007334 Growth Substances %28%1966-1985%29%
% 219.94/220.15  |- skos__related mesh__D007334smesh__D017526
% 219.94/220.15  |- skos__broader mesh__D007334smesh__D013002
% 219.94/220.15  |- skos__historyNote mesh__D007334 Somatomedins %28%1973-1985%29%
% 219.94/220.15  |- skos__altLabel mesh__D007334 IGF-1
% 219.94/220.15  |- skos__prefLabel mesh__D007334 Insulin-Like Growth Factor I
% 219.94/220.15  |- mesh__dateRevised mesh__D007334 2005-06-30
% 219.94/220.15  |- skos__broader mesh__D012279smesh__D014808
% 219.94/220.15  |- skos__prefLabel mesh__D012279 Rickets
% 219.94/220.15  |- skos__broader mesh__D012279smesh__D001851
% 219.94/220.15  |- mesh__recordOriginator mesh__D012279 NLM
% 219.94/220.15  |- skos__annotation mesh__D012279
% 219.94/220.15       consider also VITAMIN D DEFICIENCY %26% note next entry   
% 219.94/220.15  |- mesh__dateRevised mesh__D012279 2003-07-09
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D012279 2006
% 219.94/220.15  |- skos__scopeNote mesh__D012279
% 219.94/220.15       A condition caused by deficiency of VITAMIN D, especially in infancy and childhood, with disturbance of normal ossification. The disease is marked by bending and distortion of the bones under muscular action, by the formation of nodular enlargements on the ends and sides of the bones, by delayed closure of the fontanels, pain in the muscles, and sweating of the head. Vitamin D and sunlight together with an adequate diet are curative, provided that the parathyroid glands are functioning properly. %28%Dorland, 27th ed%29%%A%    
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D012279 2005
% 219.94/220.15  |- mesh__recordAuthorizer mesh__D012279 sjn
% 219.94/220.15  |- skos__broader mesh__D012279smesh__D002128
% 219.94/220.15  |- rdf__type mesh__D012279sskos__Concept
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D012279 2004
% 219.94/220.15  |- skos__hiddenLabel mesh__D012279 Rachitides
% 219.94/220.15  |- mesh__recordMaintainer mesh__D012279 lkt
% 219.94/220.15  |- mesh__dateCreated mesh__D012279 1999-01-01
% 219.94/220.15  |- skos__prefLabel mesh__D017762 Nadroparin
% 219.94/220.15  |- skos__hiddenLabel mesh__D017762 LMF CY 216
% 219.94/220.15  |- skos__hiddenLabel mesh__D017762 LMF CY216
% 219.94/220.15  |- skos__hiddenLabel mesh__D017762 Calcium, Nadroparin
% 219.94/220.15  |- skos__hiddenLabel mesh__D017762 CY216
% 219.94/220.15  |- skos__altLabel mesh__D017762 Nadroparine
% 219.94/220.15  |- mesh__historyNote mesh__D017762 94   
% 219.94/220.15  |- skos__altLabel mesh__D017762 Fraxiparine
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D017762 2005
% 219.94/220.15  |- skos__historyNote mesh__D017762
% 219.94/220.15       Heparin, Low-Molecular-Weight %28%1988-1993%29%
% 219.94/220.15  |- mesh__publicMeSHNote mesh__D017762 94   
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D017762 2006
% 219.94/220.15  |- skos__annotation mesh__D017762 a low-molec weight heparin fraction   
% 219.94/220.15  |- mesh__recordMaintainer mesh__D017762 ssb
% 219.94/220.15  |- skos__scopeNote mesh__D017762
% 219.94/220.15       A heparin fraction with a mean molecular weight of 4500 daltons. It is isolated from porcine mucosal heparin and used as an antithrombotic agent. %28%From Merck Index, 11th ed%29%%A%    
% 219.94/220.15  |- mesh__dateEstablished mesh__D017762 1994-01-01
% 219.94/220.15  |- rdf__type mesh__D017762sskos__Concept
% 219.94/220.15  |- skos__broader mesh__D017762smesh__D006495
% 219.94/220.15  |- skos__historyNote mesh__D017762
% 219.94/220.15       Heparin/analogs %26% derivatives %28%1987%29%
% 219.94/220.15  |- mesh__recordOriginator mesh__D017762 TPW
% 219.94/220.15  |- skos__altLabel mesh__D017762 Nadroparin Calcium
% 219.94/220.15  |- skos__altLabel mesh__D017762 CY-216
% 219.94/220.15  |- mesh__dateRevised mesh__D017762 2004-07-07
% 219.94/220.15  |- mesh__recordAuthorizer mesh__D017762 sjn
% 219.94/220.15  |- mesh__dateCreated mesh__D017762 1993-06-04
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003742 2001
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003742 2006
% 219.94/220.15  |- skos__broader mesh__D003742smesh__D003748
% 219.94/220.15  |- mesh__recordAuthorizer mesh__D003742 PLS
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003742 2002
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003742 1996
% 219.94/220.15  |- skos__historyNote mesh__D003742 Dental Prophylaxis %28%1966-1971%29%
% 219.94/220.15  |- mesh__recordOriginator mesh__D003742 NLM
% 219.94/220.15  |- mesh__dateRevised mesh__D003742 1994-04-20
% 219.94/220.15  |- skos__related mesh__D003742smesh__D014099
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003742 1997
% 219.94/220.15  |- mesh__historyNote mesh__D003742 72   
% 219.94/220.15  |- skos__altLabel mesh__D003742 Home Care Dental Devices
% 219.94/220.15  |- skos__annotation mesh__D003742 DF: DENT DEVICES HOME CARE   
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003742 1998
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003742 2003
% 219.94/220.15  |- rdf__type mesh__D003742sskos__Concept
% 219.94/220.15  |- skos__scopeNote mesh__D003742
% 219.94/220.15       Devices used in the home by persons to maintain dental and periodontal health. The devices include toothbrushes, dental flosses, water irrigators, gingival stimulators, etc.%A%    
% 219.94/220.15  |- skos__historyNote mesh__D003742 Oral Health %28%1966-1971%29%
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003742 1999
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003742 2004
% 219.94/220.15  |- mesh__recordMaintainer mesh__D003742 PLS
% 219.94/220.15  |- mesh__publicMeSHNote mesh__D003742 72   
% 219.94/220.15  |- mesh__dateCreated mesh__D003742 1999-01-01
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003742 1995
% 219.94/220.15  |- skos__altLabel mesh__D003742 Dental Floss
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003742 2000
% 219.94/220.15  |- skos__broader mesh__D003742smesh__D009910
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003742 2005
% 219.94/220.15  |- skos__prefLabel mesh__D003742 Dental Devices, Home Care
% 219.94/220.15  |- mesh__dateEstablished mesh__D003742 1972-01-01
% 219.94/220.15  |- mesh__historyNote mesh__D050398
% 219.94/220.15       2006, 1963-1964; use AMELOBLASTOMA 1965-2005   
% 219.94/220.15  |- mesh__dateEstablished mesh__D050398 2006-01-01
% 219.94/220.15  |- skos__prefLabel mesh__D050398 Adamantinoma
% 219.94/220.15  |- skos__historyNote mesh__D050398 Ameloblastoma %28%1965-2005%29%
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D050398 2006
% 219.94/220.15  |- skos__scopeNote mesh__D050398
% 219.94/220.15       A locally aggressive, osteolytic neoplasm of the long bones, probably of epithelial origin and most often involving the TIBIA.%A%    
% 219.94/220.15  |- rdf__type mesh__D050398sskos__Concept
% 219.94/220.15  |- mesh__dateCreated mesh__D050398 2005-06-30
% 219.94/220.15  |- skos__hiddenLabel mesh__D050398 Adamantinomas
% 219.94/220.15  |- mesh__recordAuthorizer mesh__D050398 sjn
% 219.94/220.15  |- mesh__publicMeSHNote mesh__D050398
% 219.94/220.15       2006, 1963-1964; see AMELOBLASTOMA 1965-2005   
% 219.94/220.15  |- mesh__recordMaintainer mesh__D050398 ags
% 219.94/220.15  |- skos__broader mesh__D050398smesh__D001859
% 219.94/220.15  |- mesh__recordOriginator mesh__D050398 ags
% 219.94/220.15  |- mesh__recordAuthorizer mesh__D041861 sjn
% 219.94/220.15  |- skos__prefLabel mesh__D041861 Chloroflexus
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D041861 2006
% 219.94/220.15  |- skos__broader mesh__D041861smesh__D041862
% 219.94/220.15  |- mesh__publicMeSHNote mesh__D041861 2004   
% 219.94/220.15  |- mesh__dateRevised mesh__D041861 2005-06-30
% 219.94/220.15  |- mesh__historyNote mesh__D041861 2004   
% 219.94/220.15  |- mesh__recordOriginator mesh__D041861 ags
% 219.94/220.15  |- mesh__recordMaintainer mesh__D041861 SYSTEM
% 219.94/220.15  |- skos__historyNote mesh__D041861 Bacteria %28%1974-2003%29%
% 219.94/220.15  |- skos__broader mesh__D041861smesh__D006090
% 219.94/220.15  |- skos__scopeNote mesh__D041861
% 219.94/220.15       A genus of green nonsulfur bacteria in the family Chloroflexaceae. They are photosynthetic, thermophilic, filamentous gliding bacteria found in hot springs.%A%    
% 219.94/220.15  |- skos__historyNote mesh__D041861 Chlorobi %28%1996-2003%29%
% 219.94/220.15  |- mesh__dateEstablished mesh__D041861 2004-01-01
% 219.94/220.15  |- rdf__type mesh__D041861sskos__Concept
% 219.94/220.15  |- mesh__dateCreated mesh__D041861 2003-07-09
% 219.94/220.15  |- mesh__historyNote mesh__D007335 1991%28%1986%29%   
% 219.94/220.15  |- skos__altLabel mesh__D007335 Somatomedin A
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D007335 2006
% 219.94/220.15  |- mesh__dateCreated mesh__D007335 1985-04-25
% 219.94/220.15  |- skos__hiddenLabel mesh__D007335 Multiplication Stimulating Activity
% 219.94/220.15  |- mesh__publicMeSHNote mesh__D007335
% 219.94/220.15       1991; see SOMATOMEDINS 1986-1990; SOMATOMEDIN A was indexed under INSULIN-LIKE GROWTH FACTOR II 1980-2004%A%  
% 219.94/220.15  |- skos__related mesh__D007335smesh__D017526
% 219.94/220.15  |- skos__broader mesh__D007335smesh__D013002
% 219.94/220.15  |- mesh__recordOriginator mesh__D007335 RLS
% 219.94/220.15  |- skos__historyNote mesh__D007335 Sulfation Factor %28%1971-1972%29%
% 219.94/220.15  |- skos__altLabel mesh__D007335 IGF-2
% 219.94/220.15  |- mesh__dateEstablished mesh__D007335 1991-01-01
% 219.94/220.15  |- mesh__dateRevised mesh__D007335 2005-06-30
% 219.94/220.15  |- skos__altLabel mesh__D007335 Insulin-Like Somatomedin Peptide II
% 219.94/220.15  |- skos__altLabel mesh__D007335 Multiplication-Stimulating Factor
% 219.94/220.15  |- skos__historyNote mesh__D007335 Somatomedins %28%1973-1985%29%
% 219.94/220.15  |- skos__altLabel mesh__D007335 Insulin Like Growth Factor II
% 219.94/220.15  |- rdf__type mesh__D007335sskos__Concept
% 219.94/220.15  |- skos__related mesh__D007335smesh__D017527
% 219.94/220.15  |- skos__scopeNote mesh__D007335
% 219.94/220.15       A well-characterized neutral peptide believed to be secreted by the LIVER and to circulate in the BLOOD. It has growth-regulating, insulin-like and mitogenic activities. The growth factor has a major, but not absolute, dependence on SOMATOTROPIN. It is believed to be a major fetal growth factor in contrast to INSULIN-LIKE GROWTH FACTOR I, which is a major growth factor in adults.%A%    
% 219.94/220.15  |- skos__historyNote mesh__D007335 Peptides %28%1966-1985%29%
% 219.94/220.15  |- skos__hiddenLabel mesh__D007335 Multiplication Stimulating Factor
% 219.94/220.15  |- skos__prefLabel mesh__D007335 Insulin-Like Growth Factor II
% 219.94/220.15  |- skos__altLabel mesh__D007335 Multiplication-Stimulating Activity
% 219.94/220.15  |- skos__hiddenLabel mesh__D007335 Insulin Like Somatomedin Peptide II
% 219.94/220.15  |- skos__historyNote mesh__D007335 Blood Proteins %28%1966-1985%29%
% 219.94/220.15  |- mesh__recordMaintainer mesh__D007335 ssb
% 219.94/220.15  |- skos__historyNote mesh__D007335 Growth Substances %28%1966-1985%29%
% 219.94/220.15  |- skos__altLabel mesh__D007335 IGF-II
% 219.94/220.15  |- skos__altLabel mesh__D007335 Somatomedin MSA
% 219.94/220.15  |- skos__hiddenLabel mesh__D007335 Factor, Multiplication-Stimulating
% 219.94/220.15  |- skos__historyNote mesh__D007335 Insulin %28%1966-1985%29%
% 219.94/220.15  |- mesh__recordAuthorizer mesh__D007335 sjn
% 219.94/220.15  |- mesh__dateEstablished mesh__D017763 1994-01-01
% 219.94/220.15  |- skos__broader mesh__D017763smesh__D003714
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D017763 2000
% 219.94/220.15  |- mesh__publicMeSHNote mesh__D017763
% 219.94/220.15       94; DENERVATION, AUTONOMIC was see SYMPATHECTOMY 1989-93   
% 219.94/220.15  |- mesh__onlineNote mesh__D017763
% 219.94/220.15       use SYMPATHECTOMY to search DENERVATION, AUTONOMIC 1989-93%A%  
% 219.94/220.15  |- skos__annotation mesh__D017763
% 219.94/220.15       do not use /util except by MeSH definition; coord IM with specific nerve /surg or plexus /surg %28%IM or NIM%29%%A%  
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D017763 2001
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D017763 2005
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D017763 1998
% 219.94/220.15  |- skos__hiddenLabel mesh__D017763 Denervations, Autonomic
% 219.94/220.15  |- mesh__recordOriginator mesh__D017763 RAZ
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D017763 2002
% 219.94/220.15  |- mesh__recordAuthorizer mesh__D017763 SJN
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D017763 2006
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D017763 2003
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D017763 1999
% 219.94/220.15  |- mesh__recordMaintainer mesh__D017763 PXP
% 219.94/220.15  |- rdf__type mesh__D017763sskos__Concept
% 219.94/220.15  |- skos__scopeNote mesh__D017763
% 219.94/220.15       The removal or interruption of some part of the autonomic nervous system for therapeutic or research purposes.%A%    
% 219.94/220.15  |- mesh__dateRevised mesh__D017763 1997-06-20
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D017763 2004
% 219.94/220.15  |- mesh__dateCreated mesh__D017763 1993-06-18
% 219.94/220.15  |- skos__historyNote mesh__D017763 Sympathectomy %28%1989-1993%29%
% 219.94/220.15  |- skos__prefLabel mesh__D017763 Autonomic Denervation
% 219.94/220.15  |- mesh__historyNote mesh__D017763
% 219.94/220.15       94; DENERVATION, AUTONOMIC was see SYMPATHECTOMY 1989-93   
% 219.94/220.15  |- skos__altLabel mesh__D017763 Denervation, Autonomic
% 219.94/220.15  |- skos__historyNote mesh__D017763 Denervation %28%1966-1993%29%
% 219.94/220.15  |- skos__hiddenLabel mesh__D017763 Autonomic Denervations
% 219.94/220.15  |- skos__hiddenLabel mesh__D003743 Cuticles, Enamel
% 219.94/220.15  |- skos__altLabel mesh__D003743 Dental Enamels
% 219.94/220.15  |- skos__prefLabel mesh__D003743 Dental Enamel
% 219.94/220.15  |- rdf__type mesh__D003743sskos__Concept
% 219.94/220.15  |- mesh__recordAuthorizer mesh__D003743 sjn
% 219.94/220.15  |- skos__altLabel mesh__D003743 Enamel, Dental
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003743 2004
% 219.94/220.15  |- skos__hiddenLabel mesh__D003743 Enamel Cuticles
% 219.94/220.15  |- skos__annotation mesh__D003743
% 219.94/220.15       /embryol: consider also AMELOGENESIS; DF: DENT ENAMEL   
% 219.94/220.15  |- mesh__dateCreated mesh__D003743 1999-01-01
% 219.94/220.15  |- mesh__recordMaintainer mesh__D003743 lkt
% 219.94/220.15  |- skos__hiddenLabel mesh__D003743 Enamels
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003743 2005
% 219.94/220.15  |- skos__altLabel mesh__D003743 Enamels, Dental
% 219.94/220.15  |- mesh__onlineNote mesh__D003743
% 219.94/220.15       use DENTAL ENAMEL to search NASMYTH%27%S MEMBRANE 1975-96   
% 219.94/220.15  |- skos__broader mesh__D003743smesh__D019589
% 219.94/220.15  |- mesh__activeMeSHYear mesh__D003743 2006
% 219.94/220.15  |- mesh__recordOriginator mesh__D003743 NLM
% 219.94/220.15  |- mesh__dateRevised mesh__D003743 2003-07-09
% 219.94/220.15  |- skos__hiddenLabel mesh__D003743 Cuticle, Enamel
% 219.94/220.15  |- mesh__publicMeSHNote mesh__D003743
% 219.94/220.15       ENAMEL CUTICLE was heading 1965-96; NASMYTH%27%S MEMBRANE was see ENAMEL CUTICLE 1975-96%A%  
% 219.94/220.15  |- skos__related mesh__D003743smesh__D000566
% 219.94/220.15  |- skos__scopeNote mesh__D003743
% 219.94/220.15       A hard thin translucent layer of calcified substance which envelops and protects the dentin of the crown of the tooth. It is the hardest substance in the body and is almost entirely composed of calcium salts. Under the microscope, it is composed of thin rods %28%enamel prisms%29% held together by cementing substance, and surrounded by an enamel sheath. %28%From Jablonski, Dictionary of Dentistry, 1992, p286%29%%A%    
% 219.94/220.15  |- skos__altLabel mesh__D003743 Enamel
% 219.94/220.15  |- mesh__historyNote mesh__D003743
% 219.94/220.15       ENAMEL CUTICLE was heading 1965-96; NASMYTH%27%S MEMBRANE was see ENAMEL CUTICLE 1975-96%A%  
% 219.94/220.15  |- skos__related mesh__D003743smesh__D000565
% 219.94/220.15  |- mesh__dateEstablished mesh__D041862 2004-01-01
% 219.94/220.15  |- mesh__publicMeSHNote mesh__D041862
% 219.94/220.15       2004; for CHLOROFLEXACEAE see GREEN SULFUR BACTERIA 1997-2003%A%  
% 219.94/220.15  |- mesh__historyNote mesh__D041862
% 219.94/220.15       2004; for CHLOROFLEXACEAE use CHLOROBI 1997-2003   
% 219.94/220.15  |- skos__altLabel mesh__D041862 Bacteria, Green Non-Sulfur
% 219.94/220.15  |- skos__scopeNote mesh__D041862
% 219.94/220.15       Phylum of green nonsulfur bacteria including the family Chloroflexaceae, among others.%A%    
% 219.94/220.15  |- mesh__recordAuthorizer mesh__D041862 sjn
% 219.94/220.15  |- skos__altLabel mesh__D041862 Bacteria, Green Nonsulfur
% 219.94/220.15  |- skos__broader mesh__D041862smesh__D001419
% 219.94/220.15  |- skos__prefLabel mesh__D041862 Chloroflexi
% 219.94/220.16  |- mesh__recordMaintainer mesh__D041862 SYSTEM
% 219.94/220.16  |- skos__altLabel mesh__D041862 Green Non-Sulfur Bacteria
% 219.94/220.16  |- mesh__dateRevised mesh__D041862 2005-06-30
% 219.94/220.16  |- rdf__type mesh__D041862sskos__Concept
% 219.94/220.16  |- mesh__recordOriginator mesh__D041862 ags
% 219.94/220.16  |- mesh__dateCreated mesh__D041862 2003-07-09
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D041862 2006
% 219.94/220.16  |- skos__altLabel mesh__D041862 Green Nonsulfur Bacteria
% 219.94/220.16  |- skos__broader mesh__D013373smesh__D015320
% 219.94/220.16  |- skos__hiddenLabel mesh__D013373 P, Substance
% 219.94/220.16  |- skos__hiddenLabel mesh__D013373 Substance P, Hypothalamic
% 219.94/220.16  |- rdf__type mesh__D013373sskos__Concept
% 219.94/220.16  |- skos__hiddenLabel mesh__D013373 P, Hypothalamic Substance
% 219.94/220.16  |- mesh__recordMaintainer mesh__D013373 ssb
% 219.94/220.16  |- mesh__dateRevised mesh__D013373 2005-06-30
% 219.94/220.16  |- skos__hiddenLabel mesh__D013373 Substance P, Euler-Gaddum
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D013373 2006
% 219.94/220.16  |- mesh__dateEstablished mesh__D013373 1973-01-01
% 219.94/220.16  |- mesh__publicMeSHNote mesh__D013373
% 219.94/220.16       73; was see under PEPTIDES 1963-72; EULER-GADDUM SUBSTANCE P was see SUBSTANCE P 1973-92; HYPOTHALAMIC SUBSTANCE P was see SUBSTANCE P 1977-92%A%  
% 219.94/220.16  |- mesh__recordOriginator mesh__D013373 NLM
% 219.94/220.16  |- skos__prefLabel mesh__D013373 Substance P
% 219.94/220.16  |- skos__hiddenLabel mesh__D013373 Euler Gaddum Substance P
% 219.94/220.16  |- skos__altLabel mesh__D013373 SP%28%1-11%29%
% 219.94/220.16  |- mesh__historyNote mesh__D013373
% 219.94/220.16       73%28%65%29%; was see under PEPTIDES 1963-72; EULER-GADDUM SUBSTANCE P was see SUBSTANCE P 1973-92; HYPOTHALAMIC SUBSTANCE P was see SUBSTANCE P 1977-92%A%  
% 219.94/220.16  |- mesh__recordAuthorizer mesh__D013373 sjn
% 219.94/220.16  |- skos__scopeNote mesh__D013373
% 219.94/220.16       An eleven-amino acid neurotransmitter that appears in both the central and peripheral nervous systems. It is involved in transmission of PAIN, causes rapid contractions of the gastrointestinal smooth muscle, and modulates inflammatory and immune responses.%A%    
% 219.94/220.16  |- mesh__onlineNote mesh__D013373
% 219.94/220.16       use SUBSTANCE P to search EULER-GADDUM SUBSTANCE P 1973-92 %26% HYPOTHALAMIC SUBSTANCE P 1977-92%A%  
% 219.94/220.16  |- skos__related mesh__D013373smesh__D018040
% 219.94/220.16  |- mesh__dateCreated mesh__D013373 1999-01-01
% 219.94/220.16  |- skos__hiddenLabel mesh__D013373 P, Euler-Gaddum Substance
% 219.94/220.16  |- skos__altLabel mesh__D013373 Euler-Gaddum Substance P
% 219.94/220.16  |- skos__altLabel mesh__D007336 Insulin, NPH, Human
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D007336 2003
% 219.94/220.16  |- skos__altLabel mesh__D007336 Protamine Hagedorn Insulin
% 219.94/220.16  |- skos__altLabel mesh__D007336 Insulin, Isophane, Beef-Pork
% 219.94/220.16  |- skos__prefLabel mesh__D007336 Insulin, Isophane
% 219.94/220.16  |- skos__altLabel mesh__D007336 Insulin, NPH, Beef-Pork
% 219.94/220.16  |- mesh__recordAuthorizer mesh__D007336 sjn
% 219.94/220.16  |- skos__hiddenLabel mesh__D007336 Insulin, Beef Isophane
% 219.94/220.16  |- skos__altLabel mesh__D007336 NPH Insulin
% 219.94/220.16  |- skos__altLabel mesh__D007336 NPH Insulin, Beef
% 219.94/220.16  |- skos__altLabel mesh__D007336 Isophane Insulin, Regular
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D007336 2004
% 219.94/220.16  |- skos__altLabel mesh__D007336 Insulin, NPH, Pork
% 219.94/220.16  |- skos__hiddenLabel mesh__D007336 Hagedorn Insulin, Protamine
% 219.94/220.16  |- rdf__type mesh__D007336sskos__Concept
% 219.94/220.16  |- skos__altLabel mesh__D007336 Insulin, Isophane, Pork
% 219.94/220.16  |- skos__hiddenLabel mesh__D007336 Human Isophane Insulin
% 219.94/220.16  |- skos__hiddenLabel mesh__D007336 Beef Isophane Insulin
% 219.94/220.16  |- skos__hiddenLabel mesh__D007336 Isophane Insulin, Beef Pork
% 219.94/220.16  |- skos__hiddenLabel mesh__D007336 Beef NPH Insulin
% 219.94/220.16  |- skos__scopeNote mesh__D007336
% 219.94/220.16       A modified form of insulin that contains protamine and zinc.  Isophane insulin is an intermediate-acting INSULIN with time of onset of 2 hours and duration of 24 hours.%A%    
% 219.94/220.16  |- skos__altLabel mesh__D007336 Insulin, NPH, Beef
% 219.94/220.16  |- mesh__recordOriginator mesh__D007336 NLM
% 219.94/220.16  |- skos__altLabel mesh__D007336 Insulin, NPH
% 219.94/220.16  |- skos__hiddenLabel mesh__D007336 Beef-Pork Isophane Insulin
% 219.94/220.16  |- mesh__dateCreated mesh__D007336 1999-01-01
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D007336 2005
% 219.94/220.16  |- mesh__dateRevised mesh__D007336 2002-07-02
% 219.94/220.16  |- skos__hiddenLabel mesh__D007336 Pork Isophane Insulin
% 219.94/220.16  |- mesh__recordMaintainer mesh__D007336 adp
% 219.94/220.16  |- skos__hiddenLabel mesh__D007336 Regular Isophane Insulin
% 219.94/220.16  |- skos__hiddenLabel mesh__D007336 Isophane Insulin
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D007336 2006
% 219.94/220.16  |- skos__broader mesh__D007336smesh__D007328
% 219.94/220.16  |- skos__hiddenLabel mesh__D007336 Insulin, Protamine Hagedorn
% 219.94/220.16  |- mesh__publicMeSHNote mesh__D017764 94   
% 219.94/220.16  |- skos__annotation mesh__D017764
% 219.94/220.16       do not use /util except by MeSH definition; coord IM with specific nerve /surg or plexus /surg %28%IM or NIM%29%%A%  
% 219.94/220.16  |- mesh__dateRevised mesh__D017764 1997-06-20
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D017764 1999
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D017764 2000
% 219.94/220.16  |- skos__altLabel mesh__D017764 Parasympathetic Denervation
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D017764 2004
% 219.94/220.16  |- rdf__type mesh__D017764sskos__Concept
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D017764 1998
% 219.94/220.16  |- skos__altLabel mesh__D017764 Denervation, Parasympathetic
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D017764 2006
% 219.94/220.16  |- skos__hiddenLabel mesh__D017764 Parasympathetic Denervations
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D017764 2003
% 219.94/220.16  |- skos__hiddenLabel mesh__D017764 Denervations, Parasympathetic
% 219.94/220.16  |- mesh__recordOriginator mesh__D017764 RAZ
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D017764 2005
% 219.94/220.16  |- skos__prefLabel mesh__D017764 Parasympathectomy
% 219.94/220.16  |- mesh__recordAuthorizer mesh__D017764 SJN
% 219.94/220.16  |- skos__hiddenLabel mesh__D017764 Parasympathectomies
% 219.94/220.16  |- skos__broader mesh__D017764smesh__D017763
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D017764 2002
% 219.94/220.16  |- mesh__dateEstablished mesh__D017764 1994-01-01
% 219.94/220.16  |- mesh__dateCreated mesh__D017764 1993-06-18
% 219.94/220.16  |- mesh__historyNote mesh__D017764 94   
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D017764 2001
% 219.94/220.16  |- skos__scopeNote mesh__D017764
% 219.94/220.16       The removal or interruption of some part of the parasympathetic nervous system for therapeutic or research purposes.%A%    
% 219.94/220.16  |- mesh__recordMaintainer mesh__D017764 PXP
% 219.94/220.16  |- skos__altLabel mesh__D003744 Enamel Hypoplasia, Dental
% 219.94/220.16  |- skos__annotation mesh__D003744
% 219.94/220.16       a congen or acquired tooth abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: DENT ENAMEL HYPOPLASIA%A%  
% 219.94/220.16  |- rdf__type mesh__D003744sskos__Concept
% 219.94/220.16  |- mesh__publicMeSHNote mesh__D003744 66; was ENAMEL HYPOPLASIA 1965   
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D003744 2000
% 219.94/220.16  |- mesh__recordAuthorizer mesh__D003744 sjn
% 219.94/220.16  |- skos__prefLabel mesh__D003744 Dental Enamel Hypoplasia
% 219.94/220.16  |- skos__hiddenLabel mesh__D003744 Enamel, Hypoplastic
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D003744 2003
% 219.94/220.16  |- mesh__dateRevised mesh__D003744 1999-11-03
% 219.94/220.16  |- skos__altLabel mesh__D003744 Enamel Agenesis
% 219.94/220.16  |- mesh__historyNote mesh__D003744 66; was ENAMEL HYPOPLASIA 1965   
% 219.94/220.16  |- mesh__dateEstablished mesh__D003744 1966-01-01
% 219.94/220.16  |- mesh__dateCreated mesh__D003744 1999-01-01
% 219.94/220.16  |- skos__altLabel mesh__D003744 Hypoplastic Enamel
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D003744 2001
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D003744 2004
% 219.94/220.16  |- skos__hiddenLabel mesh__D003744 Ageneses, Enamel
% 219.94/220.16  |- skos__scopeNote mesh__D003744
% 219.94/220.16       A form of AMELOGENESIS IMPERFECTA characterized by incomplete formation of the dental enamel and transmitted as an X-linked or autosomal dominant trait. It is also associated with vitamin A, C, or D deficiency, infectious disease, prematurity, birth injury, Rh incompatibility, trauma, or local infection. Small grooves, pits, and fissures are seen in mild cases, deep horizontal rows of pits in severe cases, or absence of enamel in extreme cases. %28%Dorland, 27th ed%29%%A%    
% 219.94/220.16  |- mesh__recordOriginator mesh__D003744 NLM
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D003744 2002
% 219.94/220.16  |- skos__altLabel mesh__D003744 Hypoplasia, Dental Enamel
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D003744 2005
% 219.94/220.16  |- mesh__recordMaintainer mesh__D003744 kle
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D003744 2006
% 219.94/220.16  |- skos__hiddenLabel mesh__D003744 Agenesis, Enamel
% 219.94/220.16  |- skos__broader mesh__D003744smesh__D000567
% 219.94/220.16  |- skos__hiddenLabel mesh__D003744 Enamel Ageneses
% 219.94/220.16  |- skos__broader mesh__D010450Q000037smesh__D010450
% 219.94/220.16  |- mesh__preferredCombination mesh__D010450Q000037smesh__D011480
% 219.94/220.16  |- rdf__type mesh__D010450Q000037smesh__CompoundConcept
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D003745 1999
% 219.94/220.16  |- mesh__dateCreated mesh__D003745 1999-01-01
% 219.94/220.16  |- skos__broader mesh__D003745smesh__D014088
% 219.94/220.16  |- mesh__onlineNote mesh__D003745 search TOOTH PERMEABILITY 1966-74   
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D003745 2004
% 219.94/220.16  |- skos__altLabel mesh__D003745 Permeability, Dental Enamel
% 219.94/220.16  |- skos__altLabel mesh__D003745 Enamel Permeability, Dental
% 219.94/220.16  |- mesh__publicMeSHNote mesh__D003745
% 219.94/220.16       91; was see under TOOTH PERMEABILITY 1975-90   
% 219.94/220.16  |- mesh__dateRevised mesh__D003745 1996-06-10
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D003745 2000
% 219.94/220.16  |- skos__prefLabel mesh__D003745 Dental Enamel Permeability
% 219.94/220.16  |- mesh__recordMaintainer mesh__D003745 TGC
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D003745 2005
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D003745 2001
% 219.94/220.16  |- mesh__recordAuthorizer mesh__D003745 PLS
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D003745 2006
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D003745 1997
% 219.94/220.16  |- skos__scopeNote mesh__D003745
% 219.94/220.16       The property of dental enamel to permit passage of light, heat, gases, liquids, metabolites, mineral ions and other substances. It does not include the penetration of the dental enamel by microorganisms.%A%    
% 219.94/220.16  |- mesh__dateEstablished mesh__D003745 1991-01-01
% 219.94/220.16  |- mesh__recordOriginator mesh__D003745 NLM
% 219.94/220.16  |- mesh__historyNote mesh__D003745
% 219.94/220.16       91%28%75%29%; was see under TOOTH PERMEABILITY 1975-90   
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D003745 2002
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D003745 1998
% 219.94/220.16  |- skos__annotation mesh__D003745
% 219.94/220.16       coord IM with substance /pharmacokin %28%IM%29%; DF: DENT ENAMEL PERMEABILITY%A%  
% 219.94/220.16  |- rdf__type mesh__D003745sskos__Concept
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D003745 2003
% 219.94/220.16  |- mesh__publicMeSHNote mesh__D036121
% 219.94/220.16       2003; CEK4 RECEPTOR PROTEIN-TYROSINE KINASE %28%now RECEPTOR, EPHA3 %29% were indexed under RECEPTOR PROTEIN TYROSINE KINASES 1999-2002,  EPHA3 PROTEIN was indexed under RECEPTOR PROTEIN TYROSINE KINASES 1999-2002%A%  
% 219.94/220.16  |- skos__broader mesh__D036121smesh__D036081
% 219.94/220.16  |- skos__hiddenLabel mesh__D036121 Eph Receptor, Cek4
% 219.94/220.16  |- skos__altLabel mesh__D036121 EphA3 Protein
% 219.94/220.16  |- mesh__recordMaintainer mesh__D036121 jmp
% 219.94/220.16  |- rdf__type mesh__D036121sskos__Concept
% 219.94/220.16  |- skos__annotation mesh__D036121 see SCR for species specific terms   
% 219.94/220.16  |- mesh__dateEstablished mesh__D036121 2003-01-01
% 219.94/220.16  |- skos__hiddenLabel mesh__D036121 Cek4, Eph Receptor
% 219.94/220.16  |- skos__altLabel mesh__D036121 EphA3 Receptor
% 219.94/220.16  |- mesh__recordAuthorizer mesh__D036121 sjn
% 219.94/220.16  |- skos__prefLabel mesh__D036121 Receptor, EphA3
% 219.94/220.16  |- mesh__dateCreated mesh__D036121 2002-07-03
% 219.94/220.16  |- skos__hiddenLabel mesh__D036121 Cek4 Receptor Protein Tyrosine Kinase
% 219.94/220.16  |- skos__historyNote mesh__D036121
% 219.94/220.16       Receptor Protein-Tyrosine Kinases %28%1998-2002%29%
% 219.94/220.16  |- mesh__recordOriginator mesh__D036121 jmp
% 219.94/220.16  |- skos__scopeNote mesh__D036121
% 219.94/220.16       An eph family receptor that is found primarily in adult BRAIN and variety of tissues in the developing embryo tissues. During embryonic development high levels of EphA3 receptor expression is seen in the nervous system and coincides with neuronal cell migration, suggesting a role for this protein in axonal pathfinding.%A%    
% 219.94/220.16  |- skos__altLabel mesh__D036121 Eph Receptor Cek4
% 219.94/220.16  |- mesh__dateRevised mesh__D036121 2005-06-30
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D036121 2006
% 219.94/220.16  |- skos__altLabel mesh__D036121 Cek4 Receptor Protein-Tyrosine Kinase
% 219.94/220.16  |- skos__altLabel mesh__D036121 Cek4 Eph Receptor
% 219.94/220.16  |- mesh__historyNote mesh__D036121
% 219.94/220.16       2003; use RECEPTOR, EPHA3 %28%NM%29% 1999-2002, for EPHA3 PROTEIN  use  RECEPTOR, EPHA5 %28%NM%29% 1999-2002%A%  
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D008430 2004
% 219.94/220.16  |- skos__hiddenLabel mesh__D008430 Health Service, Maternal-Child
% 219.94/220.16  |- skos__hiddenLabel mesh__D008430 Health Center, Maternal-Child
% 219.94/220.16  |- skos__scopeNote mesh__D008430
% 219.94/220.16       Facilities which administer the delivery of health care services to mothers and children.%A%    
% 219.94/220.16  |- skos__altLabel mesh__D008430 Maternal-Child Health Services
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D008430 1996
% 219.94/220.16  |- skos__hiddenLabel mesh__D008430 Centers, Maternal-Child Health
% 219.94/220.16  |- skos__hiddenLabel mesh__D008430 Services, Maternal-Child Health
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D008430 2003
% 219.94/220.16  |- mesh__dateEstablished mesh__D008430 1991-01-01
% 219.94/220.16  |- skos__hiddenLabel mesh__D008430 Service, Maternal-Child Health
% 219.94/220.16  |- skos__broader mesh__D008430smesh__D000554
% 219.94/220.16  |- skos__hiddenLabel mesh__D008430 Maternal Child Health Services
% 219.94/220.16  |- mesh__dateRevised mesh__D008430 1995-05-22
% 219.94/220.16  |- mesh__recordAuthorizer mesh__D008430 PLS
% 219.94/220.16  |- skos__historyNote mesh__D008430
% 219.94/220.16       Maternal Health Services %28%1968-1978%29%
% 219.94/220.16  |- skos__hiddenLabel mesh__D008430 Maternal Child Health Centers
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D008430 2002
% 219.94/220.16  |- skos__hiddenLabel mesh__D008430 Health Centers, Maternal-Child
% 219.94/220.16  |- mesh__recordMaintainer mesh__D008430 KEV
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D008430 1999
% 219.94/220.16  |- skos__historyNote mesh__D008430 Child Health Services %28%1968-1978%29%
% 219.94/220.16  |- skos__hiddenLabel mesh__D008430 Maternal-Child Health Center
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D008430 2006
% 219.94/220.16  |- mesh__historyNote mesh__D008430
% 219.94/220.16       91%28%79%29%; was see under HEALTH FACILITIES 1979-90   
% 219.94/220.16  |- skos__hiddenLabel mesh__D008430 Center, Maternal-Child Health
% 219.94/220.16  |- mesh__dateCreated mesh__D008430 1978-05-17
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D008430 2001
% 219.94/220.16  |- mesh__publicMeSHNote mesh__D008430
% 219.94/220.16       91; was see under HEALTH FACILITIES 1979-90   
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D008430 1998
% 219.94/220.16  |- skos__hiddenLabel mesh__D008430 Maternal-Child Health Service
% 219.94/220.16  |- mesh__recordOriginator mesh__D008430 EC
% 219.94/220.16  |- skos__hiddenLabel mesh__D008430 Health Services, Maternal Child
% 219.94/220.16  |- skos__annotation mesh__D008430 check also tag CHILD or specific   
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D008430 2000
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D008430 2005
% 219.94/220.16  |- skos__prefLabel mesh__D008430 Maternal-Child Health Centers
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D008430 1997
% 219.94/220.16  |- rdf__type mesh__D008430sskos__Concept
% 219.94/220.16  |- skos__hiddenLabel mesh__D022101 MTOCs
% 219.94/220.16  |- skos__annotation mesh__D022101 DF: MTOC   
% 219.94/220.16  |- mesh__historyNote mesh__D022101 2001; use CENTROSOME 1993-2000   
% 219.94/220.16  |- skos__historyNote mesh__D022101 Microtubules %28%1973-2000%29%
% 219.94/220.16  |- mesh__publicMeSHNote mesh__D022101 2001; see CENTROSOME 1993-2000   
% 219.94/220.16  |- mesh__dateCreated mesh__D022101 2000-07-06
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D022101 2006
% 219.94/220.16  |- mesh__recordAuthorizer mesh__D022101 sjn
% 219.94/220.16  |- mesh__dateEstablished mesh__D022101 2001-01-01
% 219.94/220.16  |- mesh__recordMaintainer mesh__D022101 nns
% 219.94/220.16  |- rdf__type mesh__D022101sskos__Concept
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D022101 2005
% 219.94/220.16  |- mesh__recordOriginator mesh__D022101 nns
% 219.94/220.16  |- skos__broader mesh__D022101smesh__D003599
% 219.94/220.16  |- mesh__dateRevised mesh__D022101 2003-07-09
% 219.94/220.16  |- skos__hiddenLabel mesh__D022101 Microtubule-Organizing Centers
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D022101 2004
% 219.94/220.16  |- skos__prefLabel mesh__D022101 Microtubule-Organizing Center
% 219.94/220.16  |- skos__hiddenLabel mesh__D022101 Microtubule Organizing Center
% 219.94/220.16  |- skos__scopeNote mesh__D022101
% 219.94/220.16       An amorphous region of electron dense material in the cytoplasm from which the MICROTUBULES polymerization is nucleated. The pericentriolar region of the CENTROSOME which surrounds the CENTRIOLES is an example.%A%    
% 219.94/220.16  |- skos__altLabel mesh__D022101 MTOC
% 219.94/220.16  |- mesh__publicMeSHNote mesh__D049049 2005   
% 219.94/220.16  |- skos__altLabel mesh__D049049 Human Pheromones
% 219.94/220.16  |- skos__hiddenLabel mesh__D049049 Chemosignals, Human
% 219.94/220.16  |- mesh__recordAuthorizer mesh__D049049 sjn
% 219.94/220.16  |- mesh__dateRevised mesh__D049049 2005-06-30
% 219.94/220.16  |- mesh__recordOriginator mesh__D049049 lkt
% 219.94/220.16  |- mesh__historyNote mesh__D049049 2005   
% 219.94/220.16  |- mesh__dateCreated mesh__D049049 2004-07-07
% 219.94/220.16  |- skos__altLabel mesh__D049049 Human Chemosignals
% 219.94/220.16  |- skos__scopeNote mesh__D049049
% 219.94/220.16       Chemical substances excreted by humans that elicit behavior or physiological responses from other humans. Perception of these chemical signals may be olfactory or by contact.%A%    
% 219.94/220.16  |- mesh__dateEstablished mesh__D049049 2005-01-01
% 219.94/220.16  |- rdf__type mesh__D049049sskos__Concept
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D049049 2006
% 219.94/220.16  |- skos__broader mesh__D049049smesh__D010675
% 219.94/220.16  |- mesh__recordMaintainer mesh__D049049 ssb
% 219.94/220.16  |- skos__prefLabel mesh__D049049 Pheromones, Human
% 219.94/220.16  |- skos__historyNote mesh__D049049 Pheromones %28%1971-2004%29%
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D013375 2005
% 219.94/220.16  |- mesh__publicMeSHNote mesh__D013375
% 219.94/220.16       81; was DRUG WITHDRAWAL SYMPTOMS 1967-80   
% 219.94/220.16  |- mesh__dateEstablished mesh__D013375 1967-01-01
% 219.94/220.16  |- mesh__recordOriginator mesh__D013375 NLM
% 219.94/220.16  |- mesh__historyNote mesh__D013375
% 219.94/220.16       81; was DRUG WITHDRAWAL SYMPTOMS 1964-80 %28%Prov 1964-66%29%   
% 219.94/220.16  |- skos__hiddenLabel mesh__D013375 Withdrawal Syndromes, Substance
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D013375 2000
% 219.94/220.16  |- skos__scopeNote mesh__D013375
% 219.94/220.16       Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.%A%    
% 219.94/220.16  |- mesh__dateCreated mesh__D013375 1999-01-01
% 219.94/220.16  |- skos__hiddenLabel mesh__D013375 Withdrawal Symptoms, Drug
% 219.94/220.16  |- skos__broader mesh__D013375smesh__D019966
% 219.94/220.16  |- mesh__recordAuthorizer mesh__D013375 sjn
% 219.94/220.16  |- skos__hiddenLabel mesh__D013375 Substance Withdrawal Syndromes
% 219.94/220.16  |- skos__hiddenLabel mesh__D013375 Withdrawal Symptom, Drug
% 219.94/220.16  |- skos__hiddenLabel mesh__D013375 Symptoms, Withdrawal
% 219.94/220.16  |- skos__hiddenLabel mesh__D013375 Drug Withdrawal Symptom
% 219.94/220.16  |- skos__hiddenLabel mesh__D013375 Symptoms, Drug Withdrawal
% 219.94/220.16  |- skos__hiddenLabel mesh__D013375 Withdrawal Symptom
% 219.94/220.16  |- rdf__type mesh__D013375sskos__Concept
% 219.94/220.16  |- skos__hiddenLabel mesh__D013375 Syndrome, Substance Withdrawal
% 219.94/220.16  |- skos__hiddenLabel mesh__D013375 Syndromes, Substance Withdrawal
% 219.94/220.16  |- skos__prefLabel mesh__D013375 Substance Withdrawal Syndrome
% 219.94/220.16  |- mesh__onlineNote mesh__D013375
% 219.94/220.16       use SUBSTANCE WITHDRAWAL SYNDROME to search DRUG WITHDRAWAL SYMPTOMS 1966-80 %28%as Prov 1966%29%%A%  
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D013375 2004
% 219.94/220.16  |- skos__hiddenLabel mesh__D013375 Symptom, Withdrawal
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D013375 2002
% 219.94/220.16  |- mesh__dateRevised mesh__D013375 1999-11-03
% 219.94/220.16  |- skos__hiddenLabel mesh__D013375 Withdrawal Syndrome, Substance
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D013375 2006
% 219.94/220.16  |- skos__annotation mesh__D013375
% 219.94/220.16       includes withdrawal from addictive drugs or other substances, administered drugs, smoking %26% alcohol %28%but DELIRIUM TREMENS see ALCOHOL WITHDRAWAL DELIRIUM is also available%29%; do not use /compl for the symptom; coord IM with specific substance /adv eff %28%IM%29% + specific dis or symptom following withdrawal /chem ind %28%IM%29%, e.g., hypertension after propranolol withdrawal = SUBSTANCE WITHDRAWAL SYNDROME %28%IM%29% + PROPRANOLOL /adv eff %28%IM%29% + HYPERTENSION /chem ind %28%IM%29%; babies born to addicted mothers %26% developing withdraw symp = NEONATAL ABSTINENCE SYNDROME: see note there%A%  
% 219.94/220.16  |- mesh__recordMaintainer mesh__D013375 adp
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D013375 2003
% 219.94/220.16  |- skos__hiddenLabel mesh__D013375 Symptom, Drug Withdrawal
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D013375 2001
% 219.94/220.16  |- mesh__recordAuthorizer mesh__D004040 sjn
% 219.94/220.16  |- rdf__type mesh__D004040sskos__Concept
% 219.94/220.16  |- mesh__dateCreated mesh__D004040 1999-01-01
% 219.94/220.16  |- skos__scopeNote mesh__D004040
% 219.94/220.16       Carbohydrates present in food comprising digestible sugars and starches and indigestible cellulose and other dietary fibers. The former are the major source of energy. The sugars are in beet and cane sugar, fruits, honey, sweet corn, corn syrup, milk and milk products, etc.; the starches are in cereal grains, legumes %28%FABACEAE%29%, tubers, etc. %28%From Claudio %26% Lagua, Nutrition and Diet Therapy Dictionary, 3d ed, p32, p277%29%%A%    
% 219.94/220.16  |- mesh__dateEstablished mesh__D004040 1964-01-01
% 219.94/220.16  |- mesh__dateRevised mesh__D004040 2004-07-07
% 219.94/220.16  |- mesh__recordMaintainer mesh__D004040 ssb
% 219.94/220.16  |- mesh__historyNote mesh__D004040 64   
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D004040 2006
% 219.94/220.16  |- mesh__recordOriginator mesh__D004040 NLM
% 219.94/220.16  |- mesh__publicMeSHNote mesh__D004040 64   
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D004040 2005
% 219.94/220.16  |- skos__prefLabel mesh__D004040 Dietary Carbohydrates
% 219.94/220.16  |- skos__annotation mesh__D004040
% 219.94/220.16       /adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with specific dis /diet ther; low-carbohydrate diet: use /admin%A%  
% 219.94/220.16  |- skos__altLabel mesh__D004040 Carbohydrates, Dietary
% 219.94/220.16  |- skos__broader mesh__D004040smesh__D002241
% 219.94/220.16  |- skos__broader mesh__D017766smesh__D006867
% 219.94/220.16  |- skos__historyNote mesh__D017766 Hydrolases %28%1966-1993%29%
% 219.94/220.16  |- mesh__dateEstablished mesh__D017766 1994-01-01
% 219.94/220.16  |- mesh__historyNote mesh__D017766 94   
% 219.94/220.16  |- mesh__dateCreated mesh__D017766 1993-02-16
% 219.94/220.16  |- skos__hiddenLabel mesh__D017766 Anhydride Hydrolases, Acid
% 219.94/220.16  |- mesh__dateRevised mesh__D017766 2003-07-09
% 219.94/220.16  |- skos__hiddenLabel mesh__D017766 Hydrolases, Acid Anhydride
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D017766 2004
% 219.94/220.16  |- skos__scopeNote mesh__D017766
% 219.94/220.16       A group of enzymes that catalyze the hydrolysis of diphosphate bonds in compounds such as nucleoside di- and tri-phosphates, and sulfonyl-containing anhydrides such as adenylylsulfate. %28%Enzyme Nomenclature, 1992%29% EC 3.6.%A%    
% 219.94/220.16  |- mesh__publicMeSHNote mesh__D017766 94   
% 219.94/220.16  |- rdf__type mesh__D017766sskos__Concept
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D017766 2006
% 219.94/220.16  |- skos__prefLabel mesh__D017766 Acid Anhydride Hydrolases
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D017766 2005
% 219.94/220.16  |- mesh__recordOriginator mesh__D003746 NLM
% 219.94/220.16  |- rdf__type mesh__D003746sskos__Concept
% 219.94/220.16  |- mesh__historyNote mesh__D003746 65   
% 219.94/220.16  |- skos__altLabel mesh__D003746 Enamel Proteins, Dental
% 219.94/220.16  |- skos__annotation mesh__D003746
% 219.94/220.16       coord IM with specific protein %28%IM%29%; DF: DENT ENAMEL PROTEINS%A%  
% 219.94/220.16  |- mesh__publicMeSHNote mesh__D003746 65   
% 219.94/220.16  |- skos__prefLabel mesh__D003746 Dental Enamel Proteins
% 219.94/220.16  |- skos__altLabel mesh__D003746 Proteins, Dental Enamel
% 219.94/220.16  |- skos__broader mesh__D003746smesh__D011506
% 219.94/220.16  |- mesh__recordAuthorizer mesh__D003746 sjn
% 219.94/220.16  |- skos__scopeNote mesh__D003746
% 219.94/220.16       The proteins that are part of the dental enamel matrix.%A%    
% 219.94/220.16  |- mesh__dateEstablished mesh__D003746 1965-01-01
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D003746 2006
% 219.94/220.16  |- mesh__recordMaintainer mesh__D003746 SYSTEM
% 219.94/220.16  |- mesh__dateCreated mesh__D003746 1999-01-01
% 219.94/220.16  |- mesh__dateRevised mesh__D003746 2005-06-30
% 219.94/220.16  |- mesh__historyNote mesh__D036122
% 219.94/220.16       2003; use RECEPTOR, EPHA4 %28%NM%29% 1999-2002   
% 219.94/220.16  |- mesh__recordMaintainer mesh__D036122 jmp
% 219.94/220.16  |- mesh__recordOriginator mesh__D036122 jmp
% 219.94/220.16  |- mesh__dateRevised mesh__D036122 2005-06-30
% 219.94/220.16  |- skos__altLabel mesh__D036122 EphA4 Receptor
% 219.94/220.16  |- skos__hiddenLabel mesh__D036122 Sek 1 Receptor Tyrosine Kinase
% 219.94/220.16  |- skos__broader mesh__D036122smesh__D036081
% 219.94/220.16  |- skos__hiddenLabel mesh__D036122 Eph A4 Receptor Tyrosine Kinase
% 219.94/220.16  |- skos__altLabel mesh__D036122 Eph-A4 Receptor Tyrosine Kinase
% 219.94/220.16  |- skos__historyNote mesh__D036122
% 219.94/220.16       Receptor Protein-Tyrosine Kinases %28%1994-2002%29%
% 219.94/220.16  |- skos__historyNote mesh__D036122 Fetal Proteins %28%1999-2002%29%
% 219.94/220.16  |- skos__altLabel mesh__D036122 Sek-1 Receptor Tyrosine Kinase
% 219.94/220.16  |- skos__altLabel mesh__D036122 Ephrin Receptor A4
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D036122 2006
% 219.94/220.16  |- skos__prefLabel mesh__D036122 Receptor, EphA4
% 219.94/220.16  |- mesh__dateEstablished mesh__D036122 2003-01-01
% 219.94/220.16  |- skos__scopeNote mesh__D036122
% 219.94/220.16       An eph family receptor found in variety of tissues including BRAIN. During embryogenesis, EphA4 receptor exhibits a diverse spatial and temporal pattern of expression suggesting its role in multiple developmental processes.%A%    
% 219.94/220.16  |- skos__hiddenLabel mesh__D036122 Cek 8 Kinase
% 219.94/220.16  |- skos__altLabel mesh__D036122 EphA4 Protein
% 219.94/220.16  |- skos__historyNote mesh__D036122 Neuropeptides %28%1999-2002%29%
% 219.94/220.16  |- skos__altLabel mesh__D036122 Cek-8 Kinase
% 219.94/220.16  |- mesh__recordAuthorizer mesh__D036122 sjn
% 219.94/220.16  |- skos__altLabel mesh__D036122 Receptor Tyrosine Kinase Eph-A4
% 219.94/220.16  |- rdf__type mesh__D036122sskos__Concept
% 219.94/220.16  |- skos__hiddenLabel mesh__D036122 Receptor Tyrosine Kinase Eph A4
% 219.94/220.16  |- mesh__publicMeSHNote mesh__D036122
% 219.94/220.16       2003; EPHA4 RECEPTOR TYROSINE KINASE %28%now RECEPTOR, EPHA4%29% was indexed under FETAL PROTEINS %26% RECEPTOR PROTEIN-TYROSINE KINASES 1999-2002;  CEK8 PROTEIN %28%now RECEPTOR, EPHA4%29% was indexed under NEUROPEPTIDES %26% RECEPTOR PROTEIN-TYROSINE KINASES 1999-2002%A%  
% 219.94/220.16  |- mesh__dateCreated mesh__D036122 2002-07-03
% 219.94/220.16  |- skos__scopeNote mesh__D008431
% 219.94/220.16       Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission.%A%    
% 219.94/220.16  |- mesh__recordOriginator mesh__D008431 NLM
% 219.94/220.16  |- mesh__dateCreated mesh__D008431 1999-01-01
% 219.94/220.16  |- skos__altLabel mesh__D008431 Transplacental Exposure
% 219.94/220.16  |- skos__broader mesh__D008431smesh__D011247
% 219.94/220.16  |- skos__annotation mesh__D008431
% 219.94/220.16       check the tags FEMALE %26% PREGNANCY; note that FETOMATERNAL TRANSFUSION %28%Cat C%29% %26% IMMUNITY, MATERNALLY-ACQUIRED %28%Cat G%29% exist%A%  
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D008431 2006
% 219.94/220.16  |- skos__related mesh__D008431smesh__D000014
% 219.94/220.16  |- skos__hiddenLabel mesh__D008431 Exposure, Transplacental
% 219.94/220.16  |- skos__hiddenLabel mesh__D008431 Exchange, Maternal-Fetal
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D008431 2005
% 219.94/220.16  |- rdf__type mesh__D008431sskos__Concept
% 219.94/220.16  |- mesh__recordMaintainer mesh__D008431 lkt
% 219.94/220.16  |- mesh__recordAuthorizer mesh__D008431 sjn
% 219.94/220.16  |- mesh__dateRevised mesh__D008431 2004-07-07
% 219.94/220.16  |- skos__prefLabel mesh__D008431 Maternal-Fetal Exchange
% 219.94/220.16  |- skos__related mesh__D008431smesh__D033261
% 219.94/220.16  |- skos__hiddenLabel mesh__D008431 Maternal Fetal Exchange
% 219.94/220.16  |- mesh__dateEstablished mesh__D013376 1991-01-01
% 219.94/220.16  |- skos__hiddenLabel mesh__D013376 Gelatinosa, Substantia
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D013376 2000
% 219.94/220.16  |- skos__scopeNote mesh__D013376
% 219.94/220.16       Gelatinous-appearing material in the dorsal horn of the spinal cord, consisting chiefly of Golgi type II neurons and some larger nerve cells.%A%    
% 219.94/220.16  |- mesh__historyNote mesh__D013376
% 219.94/220.16       91%28%75%29%%28%64-67%29%; was see under SPINAL CORD 1964-90 %28%Prov 1964-67%29%%A%  
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D013376 2001
% 219.94/220.16  |- mesh__dateRevised mesh__D013376 1999-11-03
% 219.94/220.16  |- skos__broader mesh__D013376smesh__D020671
% 219.94/220.16  |- mesh__recordOriginator mesh__D013376 NLM
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D013376 2003
% 219.94/220.16  |- rdf__type mesh__D013376sskos__Concept
% 219.94/220.16  |- mesh__onlineNote mesh__D013376
% 219.94/220.16       use SPINAL CORD to search SUBSTANTIA GELATINOSA 1966-74 %28%as Prov 1966-67%29%%A%  
% 219.94/220.16  |- mesh__publicMeSHNote mesh__D013376
% 219.94/220.16       91; was see under SPINAL CORD 1968-90   
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D013376 2005
% 219.94/220.16  |- skos__hiddenLabel mesh__D013376 Substantia Gelatinosas
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D013376 2004
% 219.94/220.16  |- mesh__recordAuthorizer mesh__D013376 sjn
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D013376 2002
% 219.94/220.16  |- mesh__activeMeSHYear mesh__D013376 2006
% 219.94/220.16  |- mesh__dateCreated mesh__D013376 1999-01-01
% 219.94/220.16  |- skos__hiddenLabel mesh__D013376 Gelatinosas, Substantia
% 219.94/220.16  |- mesh__recordMaintainer mesh__D013376 ags
% 219.94/220.16  |- skos__prefLabel mesh__D013376 Substantia Gelatinosa
% 219.94/220.17  |- rdf__type mesh__D007339sskos__Concept
% 219.94/220.17  |- skos__hiddenLabel mesh__D007339 Protease, Insulin
% 219.94/220.17  |- skos__scopeNote mesh__D007339
% 219.94/220.17       An enzyme the catalyzes the degradation of insulin, glucagon and other polypeptides. It is inhibited by bacitracin, chelating agents EDTA and 1,10-phenanthroline, and by thiol-blocking reagents such as N-ethylmaleimide, but not phosphoramidon. %28%Eur J Biochem 1994;223:1-5%29% EC 3.4.24.56.%A%    
% 219.94/220.17  |- mesh__dateEstablished mesh__D007339 1991-01-01
% 219.94/220.17  |- mesh__recordAuthorizer mesh__D007339 sjn
% 219.94/220.17  |- skos__altLabel mesh__D007339 Insulin-Degrading Enzyme
% 219.94/220.17  |- skos__altLabel mesh__D007339 Insulinase
% 219.94/220.17  |- mesh__dateRevised mesh__D007339 2003-07-09
% 219.94/220.17  |- skos__altLabel mesh__D007339 Insulin Proteinase
% 219.94/220.17  |- mesh__dateCreated mesh__D007339 1999-01-01
% 219.94/220.17  |- mesh__publicMeSHNote mesh__D007339
% 219.94/220.17       97; was INSULINASE 1963-96 %28%see under PEPTIDE HYDROLASES 1975-90, see under PEPTIDE PEPTIDOHYDROLASES 1963-74%29%%A%  
% 219.94/220.17  |- skos__hiddenLabel mesh__D007339 Proteinase, Insulin
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D007339 2006
% 219.94/220.17  |- mesh__historyNote mesh__D007339
% 219.94/220.17       97; was INSULINASE 1963-96 %28%see under PEPTIDE HYDROLASES 1975-90, see under ENDOPEPTIDASES 1963-74%29%%A%  
% 219.94/220.17  |- skos__altLabel mesh__D007339 Insulin Protease
% 219.94/220.17  |- mesh__recordOriginator mesh__D007339 NLM
% 219.94/220.17  |- skos__broader mesh__D007339smesh__D008666
% 219.94/220.17  |- skos__hiddenLabel mesh__D007339 Enzyme, Insulin-Degrading
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D007339 2004
% 219.94/220.17  |- skos__prefLabel mesh__D007339 Insulysin
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D007339 2005
% 219.94/220.17  |- mesh__onlineNote mesh__D007339 search ENDOPEPTIDASES 1966-74   
% 219.94/220.17  |- skos__hiddenLabel mesh__D007339 Insulin Degrading Enzyme
% 219.94/220.17  |- mesh__recordMaintainer mesh__D007339 jmp
% 219.94/220.17  |- mesh__recordMaintainer mesh__D018061 ags
% 219.94/220.17  |- mesh__historyNote mesh__D018061 94   
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D018061 2005
% 219.94/220.17  |- skos__historyNote mesh__D018061 RNA Viruses %28%1969-1993%29%
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D018061 2004
% 219.94/220.17  |- mesh__dateRevised mesh__D018061 2001-07-25
% 219.94/220.17  |- mesh__dateCreated mesh__D018061 1993-06-04
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D018061 2002
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D018061 2006
% 219.94/220.17  |- skos__broader mesh__D018061smesh__D019201
% 219.94/220.17  |- skos__annotation mesh__D018061
% 219.94/220.17       infection: coord IM with BIRNAVIRIDAE INFECTIONS %28%IM%29%; DF: note short X ref%A%  
% 219.94/220.17  |- mesh__recordOriginator mesh__D018061 AGS
% 219.94/220.17  |- rdf__type mesh__D018061sskos__Concept
% 219.94/220.17  |- skos__scopeNote mesh__D018061
% 219.94/220.17       The type species of AQUABIRNAVIRUS, causing infectious pancreatic necrosis in salmonid fish and other freshwater and marine animals including mollusks.%A%    
% 219.94/220.17  |- mesh__recordAuthorizer mesh__D018061 sjn
% 219.94/220.17  |- skos__prefLabel mesh__D018061 Infectious pancreatic necrosis virus
% 219.94/220.17  |- skos__altLabel mesh__D018061 IPNV
% 219.94/220.17  |- skos__altLabel mesh__D018061 Pancreatic Necrosis Virus, Infectious
% 219.94/220.17  |- mesh__dateEstablished mesh__D018061 1994-01-01
% 219.94/220.17  |- mesh__publicMeSHNote mesh__D018061 94   
% 219.94/220.17  |- skos__historyNote mesh__D018061 Reoviridae %28%1969-1993%29%
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D018061 2003
% 219.94/220.17  |- mesh__historyNote mesh__D004041 64   
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D004041 2006
% 219.94/220.17  |- mesh__recordAuthorizer mesh__D004041 sjn
% 219.94/220.17  |- mesh__dateEstablished mesh__D004041 1964-01-01
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D004041 2005
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D004041 2004
% 219.94/220.17  |- mesh__recordMaintainer mesh__D004041 ssb
% 219.94/220.17  |- skos__altLabel mesh__D004041 Fats, Dietary
% 219.94/220.17  |- skos__hiddenLabel mesh__D004041 Ghees
% 219.94/220.17  |- skos__prefLabel mesh__D004041 Dietary Fats
% 219.94/220.17  |- mesh__recordOriginator mesh__D004041 NLM
% 219.94/220.17  |- mesh__publicMeSHNote mesh__D004041 64   
% 219.94/220.17  |- skos__annotation mesh__D004041
% 219.94/220.17       /adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with specific disease /diet ther%A%  
% 219.94/220.17  |- rdf__type mesh__D004041sskos__Concept
% 219.94/220.17  |- mesh__dateCreated mesh__D004041 1999-01-01
% 219.94/220.17  |- skos__broader mesh__D004041smesh__D005502
% 219.94/220.17  |- skos__broader mesh__D004041smesh__D005223
% 219.94/220.17  |- skos__hiddenLabel mesh__D004041 Dietary Fat
% 219.94/220.17  |- skos__hiddenLabel mesh__D004041 Fat, Dietary
% 219.94/220.17  |- skos__scopeNote mesh__D004041
% 219.94/220.17       Fats present in food, especially in animal products such as meat, meat products, butter, ghee. They are present in lower amounts in nuts, seeds, and avocados.%A%    
% 219.94/220.17  |- mesh__dateRevised mesh__D004041 2003-07-09
% 219.94/220.17  |- mesh__dateCreated mesh__D017767 1992-12-28
% 219.94/220.17  |- skos__annotation mesh__D017767
% 219.94/220.17       not restricted to exterm of Jews by Nazis but when so used, spell in titles %26% translations with uppercase H: Holocaust%A%  
% 219.94/220.17  |- mesh__historyNote mesh__D017767 94   
% 219.94/220.17  |- mesh__recordOriginator mesh__D017767 JLS
% 219.94/220.17  |- mesh__dateRevised mesh__D017767 2001-07-25
% 219.94/220.17  |- skos__related mesh__D017767smesh__D003209
% 219.94/220.17  |- mesh__recordAuthorizer mesh__D017767 sjn
% 219.94/220.17  |- mesh__dateEstablished mesh__D017767 1994-01-01
% 219.94/220.17  |- skos__broader mesh__D017767smesh__D014858
% 219.94/220.17  |- mesh__recordMaintainer mesh__D017767 tjk
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D017767 2004
% 219.94/220.17  |- rdf__type mesh__D017767sskos__Concept
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D017767 2002
% 219.94/220.17  |- skos__scopeNote mesh__D017767
% 219.94/220.17       A massive slaughter, especially the systematic mass extermination of European Jews in Nazi concentration camps prior to and during World War II.%A%    
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D017767 2006
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D017767 2003
% 219.94/220.17  |- skos__related mesh__D017767smesh__D028683
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D017767 2005
% 219.94/220.17  |- skos__prefLabel mesh__D017767 Holocaust
% 219.94/220.17  |- mesh__publicMeSHNote mesh__D017767 94   
% 219.94/220.17  |- skos__hiddenLabel mesh__D017767 Holocausts
% 219.94/220.17  |- skos__altLabel mesh__D036921 Marcela
% 219.94/220.17  |- skos__broader mesh__D036921smesh__D019659
% 219.94/220.17  |- mesh__historyNote mesh__D036921 2003   
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D036921 2006
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D036921 2004
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D036921 2005
% 219.94/220.17  |- mesh__publicMeSHNote mesh__D036921 2003   
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D036921 2003
% 219.94/220.17  |- mesh__dateEstablished mesh__D036921 2003-01-01
% 219.94/220.17  |- rdf__type mesh__D036921sskos__Concept
% 219.94/220.17  |- skos__prefLabel mesh__D036921 Achyrocline
% 219.94/220.17  |- mesh__dateCreated mesh__D036921 2002-07-02
% 219.94/220.17  |- skos__scopeNote mesh__D036921
% 219.94/220.17       A plant genus of the family ASTERACEAE. Members contain TERPENES and achyrofuran, a prenylated dibenzofuran %28%BENZOFURANS%29%.%A%    
% 219.94/220.17  |- skos__annotation mesh__D036921
% 219.94/220.17       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 219.94/220.17  |- mesh__dateEstablished mesh__D003747 1965-01-01
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003747 2000
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003747 1999
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003747 1994
% 219.94/220.17  |- mesh__dateRevised mesh__D003747 1992-05-14
% 219.94/220.17  |- skos__broader mesh__D003747smesh__D009063
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003747 2003
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003747 1993
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003747 1998
% 219.94/220.17  |- mesh__recordOriginator mesh__D003747 NLM
% 219.94/220.17  |- skos__annotation mesh__D003747 DF: DENT ENAMEL SOLUBILITY   
% 219.94/220.17  |- mesh__recordMaintainer mesh__D003747 TAP
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003747 1997
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003747 1996
% 219.94/220.17  |- skos__altLabel mesh__D003747 Enamel Solubility, Dental
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003747 2006
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003747 2002
% 219.94/220.17  |- mesh__dateCreated mesh__D003747 1999-01-01
% 219.94/220.17  |- mesh__publicMeSHNote mesh__D003747 65   
% 219.94/220.17  |- skos__prefLabel mesh__D003747 Dental Enamel Solubility
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003747 2005
% 219.94/220.17  |- mesh__recordAuthorizer mesh__D003747 PLS
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003747 2001
% 219.94/220.17  |- rdf__type mesh__D003747sskos__Concept
% 219.94/220.17  |- skos__altLabel mesh__D003747 Solubility, Dental Enamel
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003747 1995
% 219.94/220.17  |- mesh__historyNote mesh__D003747 65   
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003747 2004
% 219.94/220.17  |- mesh__recordAuthorizer mesh__D036123 sjn
% 219.94/220.17  |- skos__altLabel mesh__D036123 EphA5 Receptor
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D036123 2006
% 219.94/220.17  |- skos__scopeNote mesh__D036123
% 219.94/220.17       An eph family receptor found primarily in differentiated neuronal tissues. Several isoforms of EphA5 receptor occur due to multiple alternative RNA splicing. The protein is prominently expressed in the NEURONS of the LIMBIC SYSTEM during development and throughout adult life, suggesting its role in the plasticity of limbic structure and function.%A%    
% 219.94/220.17  |- skos__hiddenLabel mesh__D036123 Brain Specific Kinase
% 219.94/220.17  |- mesh__recordOriginator mesh__D036123 jmp
% 219.94/220.17  |- mesh__dateRevised mesh__D036123 2005-06-30
% 219.94/220.17  |- skos__altLabel mesh__D036123 bsk Tyrosine Kinase
% 219.94/220.17  |- skos__broader mesh__D036123smesh__D036081
% 219.94/220.17  |- skos__altLabel mesh__D036123 Brain-Specific Kinase
% 219.94/220.17  |- skos__altLabel mesh__D036123 EphA5 Protein
% 219.94/220.17  |- skos__historyNote mesh__D036123
% 219.94/220.17       Receptor Protein-Tyrosine Kinases %28%1994-2002%29%
% 219.94/220.17  |- skos__hiddenLabel mesh__D036123 Tyrosine Kinase, bsk
% 219.94/220.17  |- mesh__historyNote mesh__D036123
% 219.94/220.17       2003; use RECEPTOR, EPHA5 %28%NM%29% 1994-2002   
% 219.94/220.17  |- rdf__type mesh__D036123sskos__Concept
% 219.94/220.17  |- mesh__dateCreated mesh__D036123 2002-07-02
% 219.94/220.17  |- mesh__dateEstablished mesh__D036123 2003-01-01
% 219.94/220.17  |- mesh__recordMaintainer mesh__D036123 jmp
% 219.94/220.17  |- mesh__publicMeSHNote mesh__D036123
% 219.94/220.17       2003; BRAIN-SPECIFIC KINASE %26% CEK7 PROTEIN %28%now RECEPTOR, EPHA5%29% were indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1994-2002; EPHA5 PROTEIN %28%now RECEPTOR, EPHA5 %29% were indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1998-2002%A%  
% 219.94/220.17  |- skos__prefLabel mesh__D036123 Receptor, EphA5
% 219.94/220.17  |- skos__altLabel mesh__D008432 Mathematic Computing
% 219.94/220.17  |- skos__hiddenLabel mesh__D008432 Computings, Mathematical
% 219.94/220.17  |- skos__hiddenLabel mesh__D008432 Computings, Mathematic
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D008432 2006
% 219.94/220.17  |- mesh__dateEstablished mesh__D008432 1987-01-01
% 219.94/220.17  |- skos__annotation mesh__D008432 IM; no qualif   
% 219.94/220.17  |- mesh__recordAuthorizer mesh__D008432 sjn
% 219.94/220.17  |- skos__hiddenLabel mesh__D008432 Statistical Computings
% 219.94/220.17  |- skos__hiddenLabel mesh__D008432 Computing, Mathematical
% 219.94/220.17  |- mesh__recordOriginator mesh__D008432 EC
% 219.94/220.17  |- mesh__historyNote mesh__D008432 87   
% 219.94/220.17  |- skos__hiddenLabel mesh__D008432 Computing, Mathematic
% 219.94/220.17  |- skos__scopeNote mesh__D008432
% 219.94/220.17       Computer-assisted interpretation and analysis of various mathematical functions related to a particular problem.%A%    
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D008432 2005
% 219.94/220.17  |- mesh__recordMaintainer mesh__D008432 jls
% 219.94/220.17  |- rdf__type mesh__D008432sskos__Concept
% 219.94/220.17  |- mesh__dateRevised mesh__D008432 2004-07-07
% 219.94/220.17  |- skos__broader mesh__D008432smesh__D008433
% 219.94/220.17  |- skos__hiddenLabel mesh__D008432 Computings, Statistical
% 219.94/220.17  |- mesh__dateCreated mesh__D008432 1986-06-18
% 219.94/220.17  |- skos__broader mesh__D008432smesh__D003205
% 219.94/220.17  |- skos__hiddenLabel mesh__D008432 Mathematical Computings
% 219.94/220.17  |- skos__prefLabel mesh__D008432 Mathematical Computing
% 219.94/220.17  |- skos__altLabel mesh__D008432 Computing, Statistical
% 219.94/220.17  |- skos__hiddenLabel mesh__D008432 Mathematic Computings
% 219.94/220.17  |- mesh__publicMeSHNote mesh__D008432 87   
% 219.94/220.17  |- skos__broader mesh__D013377smesh__D008032
% 219.94/220.17  |- mesh__dateCreated mesh__D013377 1983-06-15
% 219.94/220.17  |- mesh__publicMeSHNote mesh__D013377
% 219.94/220.17       91; was see under BASAL GANGLIA 1984-90   
% 219.94/220.17  |- skos__historyNote mesh__D013377 Globus Pallidus %28%1966-1983%29%
% 219.94/220.17  |- skos__historyNote mesh__D013377 Basal Ganglia %28%1982-1983%29%
% 219.94/220.17  |- mesh__historyNote mesh__D013377
% 219.94/220.17       91%28%84%29%; was see under BASAL GANGLIA 1984-90   
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D013377 2003
% 219.94/220.17  |- rdf__type mesh__D013377sskos__Concept
% 219.94/220.17  |- skos__scopeNote mesh__D013377
% 219.94/220.17       Tissue in the base of the forebrain inferior to the anterior perforated substance, and anterior to the GLOBUS PALLIDUS and ansa lenticularis. It contains the BASAL NUCLEUS OF MEYNERT.%A%    
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D013377 2000
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D013377 2005
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D013377 2004
% 219.94/220.17  |- skos__prefLabel mesh__D013377 Substantia Innominata
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D013377 2001
% 219.94/220.17  |- mesh__recordOriginator mesh__D013377 RC
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D013377 2006
% 219.94/220.17  |- mesh__dateRevised mesh__D013377 1999-11-03
% 219.94/220.17  |- skos__historyNote mesh__D013377 Telencephalon %28%1966-1983%29%
% 219.94/220.17  |- skos__hiddenLabel mesh__D013377 Innominata, Substantia
% 219.94/220.17  |- mesh__recordMaintainer mesh__D013377 ags
% 219.94/220.17  |- mesh__dateEstablished mesh__D013377 1991-01-01
% 219.94/220.17  |- skos__broader mesh__D013377smesh__D001479
% 219.94/220.17  |- skos__historyNote mesh__D013377 Brain %28%1966-1983%29%
% 219.94/220.17  |- mesh__recordAuthorizer mesh__D013377 sjn
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D013377 2002
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D018860 2004
% 219.94/220.17  |- mesh__recordMaintainer mesh__D018860 ags
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D018860 2000A
% 219.94/220.17  |- skos__hiddenLabel mesh__D018860 Sneddon Champion Syndrome
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D018860 2005
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D018860 2002
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D018860 2003
% 219.94/220.17  |- rdf__type mesh__D018860sskos__Concept
% 219.94/220.17  |- skos__prefLabel mesh__D018860 Sneddon Syndrome
% 219.94/220.17  |- skos__hiddenLabel mesh__D018860 Syndrome, Sneddon
% 219.94/220.17  |- skos__historyNote mesh__D018860
% 219.94/220.17       Skin Diseases, Vascular %28%1993-1995%29%
% 219.94/220.17  |- skos__historyNote mesh__D018860 Skin %28%1979-1983%29%
% 219.94/220.17  |- skos__broader mesh__D018860smesh__D017445
% 219.94/220.17  |- skos__annotation mesh__D018860
% 219.94/220.17       do not confuse with SNEDDON-WILKINSON DISEASE see SKIN DISEASES, VESICULOBULLOUS%A%  
% 219.94/220.17  |- mesh__publicMeSHNote mesh__D018860 1996   
% 219.94/220.17  |- skos__broader mesh__D018860smesh__D002561
% 219.94/220.17  |- skos__altLabel mesh__D018860 Livedo Reticularis, Systemic Involvement
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D018860 2001
% 219.94/220.17  |- mesh__recordAuthorizer mesh__D018860 ags
% 219.94/220.17  |- mesh__dateRevised mesh__D018860 1999-12-13
% 219.94/220.17  |- skos__scopeNote mesh__D018860
% 219.94/220.17       A systemic non-inflammatory arteriopathy primarily of middle-aged females characterized by the association of livedo reticularis, multiple thrombotic CEREBRAL INFARCTION; CORONARY DISEASE, and HYPERTENSION. Elevation of antiphospholipid antibody titers %28%see also ANTIPHOSPHOLIPID SYNDROME%29%, cardiac valvulopathy, ISCHEMIC ATTACK, TRANSIENT; SEIZURES; DEMENTIA; and chronic ischemia of the extremities may also occur. Pathologic examination of affected arteries reveals non-inflammatory adventitial fibrosis, thrombosis, and changes in the media. %28%From Jablonski, Dictionary of Syndromes %26% Eponymic Diseases, 2d ed; Adams et al., Principles of Neurology, 6th ed, p861; Arch Neurol 1997 Jan;54%28%1%29%:53-60%29%%A%    
% 219.94/220.17  |- mesh__recordOriginator mesh__D018860 TGC
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D018860 2000
% 219.94/220.17  |- skos__altLabel mesh__D018860 Sneddon-Champion Syndrome
% 219.94/220.17  |- skos__hiddenLabel mesh__D018860 Syndrome, Sneddon-Champion
% 219.94/220.17  |- mesh__historyNote mesh__D018860 1996   
% 219.94/220.17  |- skos__historyNote mesh__D018860
% 219.94/220.17       Cerebrovascular Disorders %28%1983-1995%29%
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D018860 2006
% 219.94/220.17  |- mesh__dateEstablished mesh__D018860 1996-01-01
% 219.94/220.17  |- mesh__dateCreated mesh__D018860 1994-12-27
% 219.94/220.17  |- skos__prefLabel mesh__D018062 La Crosse virus
% 219.94/220.17  |- skos__historyNote mesh__D018062
% 219.94/220.17       California Group Viruses %28%1975-1993%29%
% 219.94/220.17  |- skos__scopeNote mesh__D018062
% 219.94/220.17       A serotype of the species California encephalitis virus %28%ENCEPHALITIS VIRUS, CALIFORNIA%29%, in the genus ORTHOBUNYAVIRUS, causing human MENINGOENCEPHALITIS. This is the agent most responsible for California encephalitis %28%ENCEPHALITIS, CALIFORNIA%29%, the most prevalent mosquito-borne disease recognized in the United States.%A%    
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D018062 2006
% 219.94/220.17  |- mesh__onlineNote mesh__D018062
% 219.94/220.17       use CALIFORNIA GROUP VIRUSES to search LA CROSSE VIRUS 1976-93%A%  
% 219.94/220.17  |- rdf__type mesh__D018062sskos__Concept
% 219.94/220.17  |- mesh__dateRevised mesh__D018062 2004-07-13
% 219.94/220.17  |- skos__related mesh__D018062smesh__D004670
% 219.94/220.17  |- mesh__dateCreated mesh__D018062 1993-06-04
% 219.94/220.17  |- skos__historyNote mesh__D018062 Encephalitis Viruses %28%1972-1974%29%
% 219.94/220.17  |- skos__altLabel mesh__D018062 LaCrosse Virus
% 219.94/220.17  |- skos__annotation mesh__D018062
% 219.94/220.17       infection: coord IM with ENCEPHALITIS, CALIFORNIA %28%IM%29%; DF: LAC VIRUS%A%  
% 219.94/220.17  |- mesh__recordOriginator mesh__D018062 AGS
% 219.94/220.17  |- mesh__historyNote mesh__D018062
% 219.94/220.17       94; was see CALIFORNIA GROUP VIRUSES 1976-93   
% 219.94/220.17  |- mesh__recordAuthorizer mesh__D018062 sjn
% 219.94/220.17  |- mesh__recordMaintainer mesh__D018062 sjn
% 219.94/220.17  |- skos__broader mesh__D018062smesh__D002141
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D018062 2005
% 219.94/220.17  |- mesh__publicMeSHNote mesh__D018062
% 219.94/220.17       94; was see CALIFORNIA GROUP VIRUSES 1976-93   
% 219.94/220.17  |- mesh__dateEstablished mesh__D018062 1994-01-01
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D004840 2006
% 219.94/220.17  |- skos__historyNote mesh__D004840 Pyrazoles %28%1972-1975%29%
% 219.94/220.17  |- skos__scopeNote mesh__D004840
% 219.94/220.17       4-Methoxy-2-%28%5-methoxy-3-methylpyrazol-1-yl%29%-6-methylpyrimidine. A pyrimidinyl pyrazole with antipyretic, analgesic, and anti-inflammatory activity.%A%    
% 219.94/220.17  |- mesh__publicMeSHNote mesh__D004840
% 219.94/220.17       91; was see under PYRAZOLES 1976-90   
% 219.94/220.17  |- skos__altLabel mesh__D004840 Methopyrimazole
% 219.94/220.17  |- mesh__recordAuthorizer mesh__D004840 sjn
% 219.94/220.17  |- skos__prefLabel mesh__D004840 Epirizole
% 219.94/220.17  |- mesh__dateRevised mesh__D004840 2005-06-30
% 219.94/220.17  |- mesh__historyNote mesh__D004840
% 219.94/220.17       91%28%76%29%; was see under PYRAZOLES 1976-90   
% 219.94/220.17  |- skos__altLabel mesh__D004840 Mepirizole
% 219.94/220.17  |- rdf__type mesh__D004840sskos__Concept
% 219.94/220.17  |- skos__annotation mesh__D004840 a non-steroidal anti-inflamm agent   
% 219.94/220.17  |- mesh__dateEstablished mesh__D004840 1991-01-01
% 219.94/220.17  |- skos__historyNote mesh__D004840 Pyrimidines %28%1972-1975%29%
% 219.94/220.17  |- skos__broader mesh__D004840smesh__D011743
% 219.94/220.17  |- skos__broader mesh__D004840smesh__D011720
% 219.94/220.17  |- mesh__dateCreated mesh__D004840 1975-07-23
% 219.94/220.17  |- mesh__recordMaintainer mesh__D004840 ssb
% 219.94/220.17  |- mesh__recordOriginator mesh__D004840 SH
% 219.94/220.17  |- skos__broader mesh__D051496smesh__D020794
% 219.94/220.17  |- mesh__recordMaintainer mesh__D051496 DRC
% 219.94/220.17  |- skos__altLabel mesh__D051496 FGFR1 Tyrosine Kinase
% 219.94/220.17  |- skos__altLabel mesh__D051496 Fibroblast Growth Factor Receptor 1
% 219.94/220.17  |- mesh__recordOriginator mesh__D051496 DRC
% 219.94/220.17  |- skos__prefLabel mesh__D051496 Receptor, Fibroblast Growth Factor, Type 1
% 219.94/220.17  |- skos__altLabel mesh__D051496 fms-Like Tyrosine Kinase-2
% 219.94/220.17  |- skos__broader mesh__D051496smesh__D017468
% 219.94/220.17  |- mesh__dateEstablished mesh__D051496 2006-01-01
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D051496 2006
% 219.94/220.17  |- skos__altLabel mesh__D051496 FGFR1 Protein
% 219.94/220.17  |- mesh__historyNote mesh__D051496 2006%28%1992%29%   
% 219.94/220.17  |- skos__scopeNote mesh__D051496
% 219.94/220.17       A fibroblast growth factor receptor with specificity for FIBROBLAST GROWTH FACTORS; HEPARAN SULFATE PROTEOGLYCAN; and NEURONAL CELL ADHESION MOLECULES. Several variants of the receptor exist due to multiple ALTERNATIVE SPLICING of its mRNA. Fibroblast growth factor receptor 1 is a tyrosine kinase that transmits signals through the MAP KINASE SIGNALING SYSTEM.%A%    
% 219.94/220.17  |- mesh__recordAuthorizer mesh__D051496 sjn
% 219.94/220.17  |- skos__hiddenLabel mesh__D051496 fms Like Tyrosine Kinase 2
% 219.94/220.17  |- rdf__type mesh__D051496sskos__Concept
% 219.94/220.17  |- mesh__dateCreated mesh__D051496 2005-06-30
% 219.94/220.17  |- mesh__publicMeSHNote mesh__D051496
% 219.94/220.17       2006; FIBROBLAST GROWTH FACTOR RECEPTOR 1 was indexed under RECEPTORS, FIBROBLAST GROWTH FACTOR %26% RECEPTOR PROTEIN-TYROSINE KINASES 1994-2005, %26% under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993%A%  
% 219.94/220.17  |- mesh__dateCreated mesh__D004042 1986-06-03
% 219.94/220.17  |- skos__hiddenLabel mesh__D004042 Dietary Oil
% 219.94/220.17  |- skos__hiddenLabel mesh__D004042 Dietary Fat, Unsaturated
% 219.94/220.17  |- skos__scopeNote mesh__D004042
% 219.94/220.17       Unsaturated fats or oils used in foods or as a food.     
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D004042 2006
% 219.94/220.17  |- skos__hiddenLabel mesh__D004042 Fats, Unsaturated Dietary
% 219.94/220.17  |- mesh__historyNote mesh__D004042 87   
% 219.94/220.17  |- skos__historyNote mesh__D004042 Dietary Fats %28%1966-1986%29%
% 219.94/220.17  |- mesh__recordOriginator mesh__D004042 RLS
% 219.94/220.17  |- skos__hiddenLabel mesh__D004042 Fat, Unsaturated Dietary
% 219.94/220.17  |- skos__prefLabel mesh__D004042 Dietary Fats, Unsaturated
% 219.94/220.17  |- skos__historyNote mesh__D004042 Oils %28%1966-1986%29%
% 219.94/220.17  |- skos__altLabel mesh__D004042 Unsaturated Dietary Fats
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D004042 2004
% 219.94/220.17  |- mesh__recordMaintainer mesh__D004042 ssb
% 219.94/220.17  |- skos__hiddenLabel mesh__D004042 Oil, Dietary
% 219.94/220.17  |- skos__annotation mesh__D004042
% 219.94/220.17       /adv eff: coord with disease /etiol, not /chem /ind; /ther use: coord with specific disease /diet ther%A%  
% 219.94/220.17  |- mesh__recordAuthorizer mesh__D004042 sjn
% 219.94/220.17  |- skos__hiddenLabel mesh__D004042 Unsaturated Dietary Fat
% 219.94/220.17  |- mesh__publicMeSHNote mesh__D004042 87   
% 219.94/220.17  |- skos__broader mesh__D004042smesh__D004041
% 219.94/220.17  |- rdf__type mesh__D004042sskos__Concept
% 219.94/220.17  |- skos__hiddenLabel mesh__D004042 Oils, Dietary
% 219.94/220.17  |- mesh__dateEstablished mesh__D004042 1987-01-01
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D004042 2005
% 219.94/220.17  |- mesh__dateRevised mesh__D004042 2003-07-09
% 219.94/220.17  |- skos__scopeNote mesh__D017768
% 219.94/220.17       Synthetic material used for the treatment of burns and other conditions involving large-scale loss of skin. It often consists of an outer %28%epidermal%29% layer of silicone and an inner %28%dermal%29% layer of collagen and chondroitin 6-sulfate. The dermal layer elicits new growth and vascular invasion and the outer layer is later removed and replaced by a graft.%A%    
% 219.94/220.17  |- skos__hiddenLabel mesh__D017768 Substitute, Skin
% 219.94/220.17  |- mesh__dateCreated mesh__D017768 1992-12-28
% 219.94/220.17  |- skos__annotation mesh__D017768
% 219.94/220.17       to stimulate new skin growth before replacement by graft   
% 219.94/220.17  |- skos__hiddenLabel mesh__D017768 Substitutes, Skin
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D017768 1996
% 219.94/220.17  |- skos__hiddenLabel mesh__D017768 Skin Substitute
% 219.94/220.17  |- mesh__historyNote mesh__D017768 94   
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D017768 2001
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D017768 1998
% 219.94/220.17  |- skos__broader mesh__D017768smesh__D001187
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D017768 1997
% 219.94/220.17  |- skos__historyNote mesh__D017768 Artificial Organs %28%1966-1993%29%
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D017768 2003
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D017768 1994
% 219.94/220.17  |- mesh__publicMeSHNote mesh__D017768 94   
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D017768 1999
% 219.94/220.17  |- skos__hiddenLabel mesh__D017768 Skins, Artificial
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D017768 2005
% 219.94/220.17  |- skos__altLabel mesh__D017768 Artificial Skin
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D017768 2004
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D017768 1995
% 219.94/220.17  |- rdf__type mesh__D017768sskos__Concept
% 219.94/220.17  |- skos__prefLabel mesh__D017768 Skin, Artificial
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D017768 2002
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D017768 2006
% 219.94/220.17  |- skos__hiddenLabel mesh__D017768 Artificial Skins
% 219.94/220.17  |- mesh__dateEstablished mesh__D017768 1994-01-01
% 219.94/220.17  |- skos__historyNote mesh__D017768 Skin %28%1966-1993%29%
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D017768 2000
% 219.94/220.17  |- mesh__publicMeSHNote mesh__D042161 2004   
% 219.94/220.17  |- skos__scopeNote mesh__D042161
% 219.94/220.17       A species of gram-negative bacteria functioning as a nitrogen inoculum for dry beans, especially species in the genus PHASEOLUS.%A%    
% 219.94/220.17  |- skos__historyNote mesh__D042161 Rhizobium %28%1969-2003%29%
% 219.94/220.17  |- mesh__recordOriginator mesh__D042161 ags
% 219.94/220.17  |- rdf__type mesh__D042161sskos__Concept
% 219.94/220.17  |- skos__prefLabel mesh__D042161 Rhizobium phaseoli
% 219.94/220.17  |- mesh__dateRevised mesh__D042161 2005-06-30
% 219.94/220.17  |- skos__broader mesh__D042161smesh__D012231
% 219.94/220.17  |- mesh__recordMaintainer mesh__D042161 SYSTEM
% 219.94/220.17  |- mesh__recordAuthorizer mesh__D042161 sjn
% 219.94/220.17  |- mesh__dateEstablished mesh__D042161 2004-01-01
% 219.94/220.17  |- mesh__historyNote mesh__D042161 2004   
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D042161 2006
% 219.94/220.17  |- mesh__dateCreated mesh__D042161 2003-07-09
% 219.94/220.17  |- mesh__dateRevised mesh__D003748 1996-06-10
% 219.94/220.17  |- skos__broader mesh__D003748smesh__D004864
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003748 2002
% 219.94/220.17  |- mesh__publicMeSHNote mesh__D003748 65   
% 219.94/220.17  |- mesh__recordAuthorizer mesh__D003748 PLS
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003748 2006
% 219.94/220.17  |- mesh__dateEstablished mesh__D003748 1965-01-01
% 219.94/220.17  |- mesh__recordMaintainer mesh__D003748 JLS
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003748 2001
% 219.94/220.17  |- mesh__dateCreated mesh__D003748 1999-01-01
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003748 2000
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003748 2005
% 219.94/220.17  |- rdf__type mesh__D003748sskos__Concept
% 219.94/220.17  |- skos__hiddenLabel mesh__D003748 Equipments, Dental
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003748 2004
% 219.94/220.17  |- mesh__historyNote mesh__D003748 65   
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003748 1999
% 219.94/220.17  |- skos__altLabel mesh__D003748 Equipment, Dental
% 219.94/220.17  |- skos__hiddenLabel mesh__D003748 Dental Equipments
% 219.94/220.17  |- mesh__recordOriginator mesh__D003748 NLM
% 219.94/220.17  |- skos__broader mesh__D003748smesh__D003813
% 219.94/220.17  |- skos__scopeNote mesh__D003748
% 219.94/220.17       The nonexpendable items used by the dentist or dental staff in the performance of professional duties. %28%From Boucher%27%s Clinical Dental Terminology, 4th ed, p106%29%%A%    
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003748 2003
% 219.94/220.17  |- skos__annotation mesh__D003748
% 219.94/220.17       for the dent professional, not the patient; differentiate from DENTAL INSTRUMENTS on basis of size %28%instrum are holdable in the hand%29%; DF: DENT EQUIPMENT%A%  
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003748 1998
% 219.94/220.17  |- skos__prefLabel mesh__D003748 Dental Equipment
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D003748 1997
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D014470 2005
% 219.94/220.17  |- mesh__recordAuthorizer mesh__D014470 PLS
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D014470 1997
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D014470 2003
% 219.94/220.17  |- skos__hiddenLabel mesh__D014470 Cords, Umbilical
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D014470 2006
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D014470 2004
% 219.94/220.17  |- skos__broader mesh__D014470smesh__D004622
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D014470 2000
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D014470 1994
% 219.94/220.17  |- mesh__dateCreated mesh__D014470 1999-01-01
% 219.94/220.17  |- skos__annotation mesh__D014470
% 219.94/220.17       cord blood = UMBILICAL CORD BLOOD see FETAL BLOOD   
% 219.94/220.17  |- mesh__recordOriginator mesh__D014470 NLM
% 219.94/220.17  |- skos__prefLabel mesh__D014470 Umbilical Cord
% 219.94/220.17  |- mesh__activeMeSHYear mesh__D014470 1995
% 219.94/220.17  |- mesh__recordMaintainer mesh__D014470 TGC
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D014470 2001
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D014470 1993
% 219.94/220.18  |- skos__hiddenLabel mesh__D014470 Cord, Umbilical
% 219.94/220.18  |- rdf__type mesh__D014470sskos__Concept
% 219.94/220.18  |- skos__scopeNote mesh__D014470
% 219.94/220.18       The flexible structure, giving passage to the umbilical arteries and vein, which connects the embryo or fetus to the placenta.%A%    
% 219.94/220.18  |- skos__hiddenLabel mesh__D014470 Umbilical Cords
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D014470 1998
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D014470 2002
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D014470 1996
% 219.94/220.18  |- mesh__dateRevised mesh__D014470 1992-05-18
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D014470 1999
% 219.94/220.18  |- skos__broader mesh__D036124smesh__D036081
% 219.94/220.18  |- mesh__historyNote mesh__D036124
% 219.94/220.18       2003; use RECEPTOR, EPHA6 %28%NM%29% 1994-2002, for EPHA6 PROTEIN use EPHA7 RECEPTOR 1994-2002%A%  
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D036124 2006
% 219.94/220.18  |- skos__prefLabel mesh__D036124 Receptor, EphA6
% 219.94/220.18  |- mesh__recordAuthorizer mesh__D036124 sjn
% 219.94/220.18  |- mesh__publicMeSHNote mesh__D036124
% 219.94/220.18       2003; EHK-2 PROTEIN %28%now RECEPTOR, EPHA6%29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1994-2002, EPHA6 PROTEIN was indexed under RECEPTOR PROTEIN TYROSINE KINASES 1994-2002%A%  
% 219.94/220.18  |- mesh__dateCreated mesh__D036124 2002-07-03
% 219.94/220.18  |- skos__scopeNote mesh__D036124
% 219.94/220.18       An eph family receptor that is found in a variety of neuronal regions of the BRAIN. In contrast to the other proteins in this class, it is expressed at higher levels in adult tissues than in embryonic tissues.%A%    
% 219.94/220.18  |- skos__historyNote mesh__D036124
% 219.94/220.18       Receptor Protein-Tyrosine Kinases %28%1994-2002%29%
% 219.94/220.18  |- rdf__type mesh__D036124sskos__Concept
% 219.94/220.18  |- skos__altLabel mesh__D036124 EphA6 Receptor
% 219.94/220.18  |- mesh__recordMaintainer mesh__D036124 jmp
% 219.94/220.18  |- mesh__recordOriginator mesh__D036124 jmp
% 219.94/220.18  |- mesh__dateRevised mesh__D036124 2005-06-30
% 219.94/220.18  |- skos__altLabel mesh__D036124 ehk-2 Protein
% 219.94/220.18  |- skos__hiddenLabel mesh__D036124 ehk 2 Protein
% 219.94/220.18  |- skos__altLabel mesh__D036124 EphA6 Protein
% 219.94/220.18  |- mesh__dateEstablished mesh__D036124 2003-01-01
% 219.94/220.18  |- mesh__dateEstablished mesh__D022902 2000-03-31
% 219.94/220.18  |- skos__prefLabel mesh__D022902 Unpublished Works %5B%Publication Type%5D%
% 219.94/220.18  |- skos__scopeNote mesh__D022902
% 219.94/220.18       Works that have not been formally published.     
% 219.94/220.18  |- skos__altLabel mesh__D022902 Unpublished Documents %28%PT%29%
% 219.94/220.18  |- mesh__recordOriginator mesh__D022902 jls
% 219.94/220.18  |- rdf__type mesh__D022902sskos__Concept
% 219.94/220.18  |- mesh__recordAuthorizer mesh__D022902 sjn
% 219.94/220.18  |- mesh__dateRevised mesh__D022902 2005-06-30
% 219.94/220.18  |- skos__broader mesh__D022902smesh__D052180
% 219.94/220.18  |- mesh__recordMaintainer mesh__D022902 jls
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D022902 2006
% 219.94/220.18  |- skos__annotation mesh__D022902 used by special data producers only   
% 219.94/220.18  |- mesh__dateCreated mesh__D022902 2000-03-31
% 219.94/220.18  |- mesh__historyNote mesh__D022902 2000   
% 219.94/220.18  |- skos__altLabel mesh__D022902 Unpublished Works %28%PT%29%
% 219.94/220.18  |- mesh__dateRevised mesh__D008433 1992-05-14
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D008433 2005
% 219.94/220.18  |- skos__annotation mesh__D008433
% 219.94/220.18       NIM; includes arithmetic, geometry, calculus; differentiate from STATISTICS%A%  
% 219.94/220.18  |- rdf__type mesh__D008433sskos__Concept
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D008433 1997
% 219.94/220.18  |- mesh__recordMaintainer mesh__D008433 TAP
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D008433 2004
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D008433 2002
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D008433 1996
% 219.94/220.18  |- mesh__recordAuthorizer mesh__D008433 PLS
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D008433 1995
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D008433 2003
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D008433 2001
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D008433 1994
% 219.94/220.18  |- mesh__dateCreated mesh__D008433 1999-01-01
% 219.94/220.18  |- mesh__recordOriginator mesh__D008433 NLM
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D008433 2000
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D008433 1999
% 219.94/220.18  |- skos__prefLabel mesh__D008433 Mathematics
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D008433 2006
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D008433 1993
% 219.94/220.18  |- skos__broader mesh__D008433smesh__D010811
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D008433 1998
% 219.94/220.18  |- skos__hiddenLabel mesh__D008433 Mathematic
% 219.94/220.18  |- skos__related mesh__D000450smesh__D006929
% 219.94/220.18  |- mesh__recordAuthorizer mesh__D000450 sjn
% 219.94/220.18  |- mesh__recordMaintainer mesh__D000450 ssb
% 219.94/220.18  |- skos__related mesh__D000450smesh__D012084
% 219.94/220.18  |- skos__prefLabel mesh__D000450 Aldosterone
% 219.94/220.18  |- skos__annotation mesh__D000450
% 219.94/220.18       /biosyn /physiol permitted; /defic: consider also HYPOALDOSTERONISM; PSEUDOHYPOALDOSTERONISM is also available; consider also RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM see RENIN-ANGIOTENSIN SYSTEM %26% do not index under ALDOSTERONE unless particularly discussed%A%  
% 219.94/220.18  |- skos__related mesh__D000450smesh__D006994
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D000450 2004
% 219.94/220.18  |- skos__scopeNote mesh__D000450
% 219.94/220.18       A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium.%A%    
% 219.94/220.18  |- mesh__dateCreated mesh__D000450 1999-01-01
% 219.94/220.18  |- skos__related mesh__D000450smesh__D017458
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D000450 2005
% 219.94/220.18  |- skos__broader mesh__D000450smesh__D015062
% 219.94/220.18  |- rdf__type mesh__D000450sskos__Concept
% 219.94/220.18  |- skos__broader mesh__D000450smesh__D011282
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D000450 2006
% 219.94/220.18  |- skos__related mesh__D000450smesh__D011546
% 219.94/220.18  |- mesh__dateRevised mesh__D000450 2003-07-09
% 219.94/220.18  |- mesh__recordOriginator mesh__D000450 NLM
% 219.94/220.18  |- skos__broader mesh__D013378smesh__D008636
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D013378 1997
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D013378 2005
% 219.94/220.18  |- skos__hiddenLabel mesh__D013378 Nigra, Substantia
% 219.94/220.18  |- mesh__recordOriginator mesh__D013378 NLM
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D013378 1994
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D013378 2004
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D013378 1999
% 219.94/220.18  |- skos__hiddenLabel mesh__D013378 Nigras, Substantia
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D013378 2006
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D013378 1993
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D013378 1995
% 219.94/220.18  |- mesh__dateCreated mesh__D013378 1999-01-01
% 219.94/220.18  |- skos__hiddenLabel mesh__D013378 Substantia Nigras
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D013378 2002
% 219.94/220.18  |- mesh__recordAuthorizer mesh__D013378 PLS
% 219.94/220.18  |- mesh__dateRevised mesh__D013378 1992-05-18
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D013378 2000
% 219.94/220.18  |- mesh__recordMaintainer mesh__D013378 TAP
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D013378 1996
% 219.94/220.18  |- rdf__type mesh__D013378sskos__Concept
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D013378 2003
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D013378 1998
% 219.94/220.18  |- skos__prefLabel mesh__D013378 Substantia Nigra
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D013378 2001
% 219.94/220.18  |- skos__altLabel mesh__D018063 Korean Hemorrhagic Fever Virus
% 219.94/220.18  |- skos__prefLabel mesh__D018063 Hantaan virus
% 219.94/220.18  |- mesh__recordOriginator mesh__D018063 AGS
% 219.94/220.18  |- skos__hiddenLabel mesh__D018063 Nephroso-Nephritis Viruses, Hemorrhagic
% 219.94/220.18  |- mesh__dateEstablished mesh__D018063 1994-01-01
% 219.94/220.18  |- mesh__recordAuthorizer mesh__D018063 sjn
% 219.94/220.18  |- skos__annotation mesh__D018063
% 219.94/220.18       infection: coord IM with HEMORRHAGIC FEVER WITH RENAL SYNDROME %28%IM%29%%A%  
% 219.94/220.18  |- skos__hiddenLabel mesh__D018063 Hemorrhagic Nephroso Nephritis Virus
% 219.94/220.18  |- skos__altLabel mesh__D018063 Hemorrhagic Nephroso-Nephritis Virus
% 219.94/220.18  |- skos__altLabel mesh__D018063 Hemorrhagic Fever Virus, Korean
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D018063 2003
% 219.94/220.18  |- skos__altLabel mesh__D018063 HFRS Virus
% 219.94/220.18  |- skos__scopeNote mesh__D018063
% 219.94/220.18       The type species of the genus HANTAVIRUS infecting the rodent Apodemus agrarius and humans who come in contact with it. It causes syndromes of hemorrhagic fever associated with vascular and especially renal pathology.%A%    
% 219.94/220.18  |- skos__hiddenLabel mesh__D018063 HFRS Viruses
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D018063 2005
% 219.94/220.18  |- mesh__historyNote mesh__D018063
% 219.94/220.18       94; was see HANTAVIRUS 1992-93, was see HEMORRHAGIC FEVER VIRUS, EPIDEMIC 1987-91; HEMORRHAGIC FEVER RENAL SYNDROME VIRUS was HEMORRHAGIC FEVER WITH RENAL SYNDROME VIRUS see HANTAVIRUS 1987-94; HFRS VIRUS was see HANTAVIRUS 1987-94; HEMORRHAGIC FEVER VIRUS, EPIDEMIC was see HANTAVIRUS 1992-94, was heading 1977-91 %28%see under RNA VIRUSES 1978-86, see under ARBOVIRUSES 1977%29%, was EPIDEMIC HEMORRHAGIC FEVER VIRUS see under ARBOVIRUSES 1975-76, see under ARBOVIRUS 1965-74, %26% see under ARBOVIRUSES 1963-64; HEMORRHAGIC FEVER VIRUS, KOREAN was see HANTAVIRUS 1977-94; HEMORRHAGIC NEPHROSO-NEPHRITIS VIRUS was see HANTAVIRUS 1976-94%A%  
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D018063 2004
% 219.94/220.18  |- mesh__recordMaintainer mesh__D018063 ags
% 219.94/220.18  |- skos__altLabel mesh__D018063 Hemorrhagic Fever Virus, Epidemic
% 219.94/220.18  |- mesh__publicMeSHNote mesh__D018063
% 219.94/220.18       94; was see HANTAVIRUS 1992-93, was see HEMORRHAGIC FEVER VIRUS, EPIDEMIC 1987-91; HEMORRHAGIC FEVER RENAL SYNDROME VIRUS was HEMORRHAGIC FEVER WITH RENAL SYNDROME VIRUS see HANTAVIRUS 1987-94; HFRS VIRUS was see HANTAVIRUS 1987-94; HEMORRHAGIC FEVER VIRUS, EPIDEMIC was see HANTAVIRUS 1992-94, was heading 1977-91 %28%see under RNA VIRUSES 1978-86, see under ARBOVIRUSES 1977%29%, was EPIDEMIC HEMORRHAGIC FEVER VIRUS see under ARBOVIRUSES 1975-76, see under ARBOVIRUS 1965-74, %26% see under ARBOVIRUSES 1963-64; HEMORRHAGIC FEVER VIRUS, KOREAN was see HANTAVIRUS 1977-94; HEMORRHAGIC NEPHROSO-NEPHRITIS VIRUS was see HANTAVIRUS 1976-94%A%  
% 219.94/220.18  |- mesh__onlineNote mesh__D018063
% 219.94/220.18       use HANTAVIRUS to search HEMORRHAGIC FEVER WITH RENAL SYNDROME VIRUS %26% HFRS VIRUS 1987-94, HANTAAN VIRUS 1987-93, HEMORRHAGIC FEVER VIRUS, EPIDEMIC 1977-91, %26% EPIDEMIC HEMORRHAGIC FEVER VIRUS 1975-76; use ARBOVIRUSES 1966-74%A%  
% 219.94/220.18  |- skos__broader mesh__D018063smesh__D006476
% 219.94/220.18  |- skos__hiddenLabel mesh__D018063 Nephroso-Nephritis Virus, Hemorrhagic
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D018063 2006
% 219.94/220.18  |- mesh__dateRevised mesh__D018063 2001-07-25
% 219.94/220.18  |- skos__hiddenLabel mesh__D018063 Hemorrhagic Nephroso-Nephritis Viruses
% 219.94/220.18  |- mesh__dateCreated mesh__D018063 1993-06-04
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D018063 2002
% 219.94/220.18  |- rdf__type mesh__D018063sskos__Concept
% 219.94/220.18  |- skos__altLabel mesh__D018063 Epidemic Hemorrhagic Fever Virus
% 219.94/220.18  |- skos__scopeNote mesh__D010080
% 219.94/220.18       Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions.%A%    
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D010080 2006
% 219.94/220.18  |- skos__hiddenLabel mesh__D010080 1,3 Oxazolium 5 Oxides
% 219.94/220.18  |- mesh__recordAuthorizer mesh__D010080 sjn
% 219.94/220.18  |- mesh__publicMeSHNote mesh__D010080
% 219.94/220.18       TRIMETHADIONE was see under ANTICONVULSANTS 1963-74   
% 219.94/220.18  |- skos__broader mesh__D010080smesh__D001393
% 219.94/220.18  |- rdf__type mesh__D010080sskos__Concept
% 219.94/220.18  |- skos__altLabel mesh__D010080 1,3-Oxazolium-5-Oxides
% 219.94/220.18  |- mesh__dateRevised mesh__D010080 2005-06-30
% 219.94/220.18  |- skos__prefLabel mesh__D010080 Oxazoles
% 219.94/220.18  |- mesh__recordOriginator mesh__D010080 NLM
% 219.94/220.18  |- mesh__recordMaintainer mesh__D010080 ssb
% 219.94/220.18  |- mesh__dateCreated mesh__D010080 1999-01-01
% 219.94/220.18  |- skos__annotation mesh__D010080 includes oxazolines, oxazolidines   
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D004841 2005
% 219.94/220.18  |- mesh__recordOriginator mesh__D004841 NLM
% 219.94/220.18  |- skos__prefLabel mesh__D004841 Episiotomy
% 219.94/220.18  |- mesh__recordMaintainer mesh__D004841 PXP
% 219.94/220.18  |- skos__broader mesh__D004841smesh__D036861
% 219.94/220.18  |- skos__annotation mesh__D004841
% 219.94/220.18       do not use /util except by MeSH definition   
% 219.94/220.18  |- skos__hiddenLabel mesh__D004841 Episiotomies
% 219.94/220.18  |- rdf__type mesh__D004841sskos__Concept
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D004841 2004
% 219.94/220.18  |- mesh__dateRevised mesh__D004841 2002-07-03
% 219.94/220.18  |- mesh__recordAuthorizer mesh__D004841 sjn
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D004841 2003
% 219.94/220.18  |- mesh__dateCreated mesh__D004841 1999-01-01
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D004841 2006
% 219.94/220.18  |- skos__scopeNote mesh__D004841
% 219.94/220.18       An incision of the posterior vaginal wall and a portion of the pudenda which enlarges the vaginal introitus to facilitate delivery and prevent lacerations.%A%    
% 219.94/220.18  |- skos__altLabel mesh__D051497
% 219.94/220.18       BEK Fibroblast Growth Factor Receptor Kinase
% 219.94/220.18  |- mesh__dateCreated mesh__D051497 2005-06-30
% 219.94/220.18  |- skos__altLabel mesh__D051497 Fibroblast Growth Factor Receptor 2
% 219.94/220.18  |- skos__scopeNote mesh__D051497
% 219.94/220.18       A fibroblast growth factor receptor that is found in two isoforms. One receptor isoform is found in the MESENCHYME and is activated by FIBROBLAST GROWTH FACTOR 2. A second isoform of fibroblast growth factor receptor 2 is found mainly in EPITHELIAL CELLS and is activated by FIBROBLAST GROWTH FACTOR 7 and FIBROBLAST GROWTH FACTOR 10. Mutation of the gene for fibroblast growth factor receptor 2 can result in APERT SYNDROME.%A%    
% 219.94/220.18  |- skos__altLabel mesh__D051497 BEK Protein Tyrosine Kinase
% 219.94/220.18  |- skos__broader mesh__D051497smesh__D017468
% 219.94/220.18  |- skos__broader mesh__D051497smesh__D020794
% 219.94/220.18  |- mesh__publicMeSHNote mesh__D051497
% 219.94/220.18       2006; FIBROBLAST GROWTH FACTOR RECEPTOR 2 was indexed under RECEPTORS, FIBROBLAST GROWTH FACTOR %26% RECEPTOR PROTEIN-TYROSINE KINASE 2004-2005, %26% under PROTEIN-TYROSINE KINASE 1999-2003%A%  
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D051497 2006
% 219.94/220.18  |- skos__prefLabel mesh__D051497 Receptor, Fibroblast Growth Factor, Type 2
% 219.94/220.18  |- mesh__recordMaintainer mesh__D051497 DRC
% 219.94/220.18  |- skos__related mesh__D051497smesh__D000168
% 219.94/220.18  |- skos__altLabel mesh__D051497 FGFR2c
% 219.94/220.18  |- skos__altLabel mesh__D051497 FGFR2 Protein
% 219.94/220.18  |- skos__altLabel mesh__D051497 BEK Fibroblast Growth Factor Receptor
% 219.94/220.18  |- rdf__type mesh__D051497sskos__Concept
% 219.94/220.18  |- skos__altLabel mesh__D051497 Receptor, Fibroblast Growth Factor 2b
% 219.94/220.18  |- mesh__dateEstablished mesh__D051497 2006-01-01
% 219.94/220.18  |- mesh__historyNote mesh__D051497 2006%28%1999%29%   
% 219.94/220.18  |- skos__altLabel mesh__D051497 Fibroblast Growth Factor Receptors 2b
% 219.94/220.18  |- skos__altLabel mesh__D051497 Bek Fgf Receptor Kinase
% 219.94/220.18  |- skos__altLabel mesh__D051497 Receptor, Fibroblast Growth Factor 2c
% 219.94/220.18  |- skos__altLabel mesh__D051497 Fibroblast Growth Factor Receptors 2
% 219.94/220.18  |- skos__altLabel mesh__D051497
% 219.94/220.18       Bek-Related Fibroblast Growth Factor-Receptor-1
% 219.94/220.18  |- skos__hiddenLabel mesh__D051497
% 219.94/220.18       Bek Related Fibroblast Growth Factor Receptor 1
% 219.94/220.18  |- skos__altLabel mesh__D051497 FGFR2b
% 219.94/220.18  |- mesh__recordAuthorizer mesh__D051497 sjn
% 219.94/220.18  |- mesh__recordOriginator mesh__D051497 DRC
% 219.94/220.18  |- skos__hiddenLabel mesh__D004043 Roughages
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D004043 1998
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D004043 2003
% 219.94/220.18  |- skos__altLabel mesh__D004043 Fiber, Dietary
% 219.94/220.18  |- skos__hiddenLabel mesh__D004043 Brans, Wheat
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D004043 2000
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D004043 1999
% 219.94/220.18  |- skos__broader mesh__D004043smesh__D005502
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D004043 2004
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D004043 2001
% 219.94/220.18  |- skos__prefLabel mesh__D004043 Dietary Fiber
% 219.94/220.18  |- mesh__dateCreated mesh__D004043 1976-04-27
% 219.94/220.18  |- skos__annotation mesh__D004043
% 219.94/220.18       /adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with specific dis /diet ther; /defic permitted; low- or high-fiber diet: use /admin%A%  
% 219.94/220.18  |- skos__hiddenLabel mesh__D004043 Bran, Wheat
% 219.94/220.18  |- skos__hiddenLabel mesh__D004043 Wheat Brans
% 219.94/220.18  |- skos__hiddenLabel mesh__D004043 Fibers, Dietary
% 219.94/220.18  |- rdf__type mesh__D004043sskos__Concept
% 219.94/220.18  |- mesh__recordOriginator mesh__D004043 VDK
% 219.94/220.18  |- mesh__dateEstablished mesh__D004043 1982-01-01
% 219.94/220.18  |- mesh__dateRevised mesh__D004043 1997-06-20
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D004043 2005
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D004043 2002
% 219.94/220.18  |- mesh__historyNote mesh__D004043
% 219.94/220.18       82%28%77%29%; was see under CELLULOSE 1977-81   
% 219.94/220.18  |- mesh__publicMeSHNote mesh__D004043
% 219.94/220.18       82; was see under CELLULOSE 1977-81   
% 219.94/220.18  |- skos__scopeNote mesh__D004043
% 219.94/220.18       The remnants of plant cell walls that are resistant to digestion by the alimentary enzymes of man. It comprises various polysaccharides and lignins.%A%    
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D004043 2006
% 219.94/220.18  |- skos__hiddenLabel mesh__D004043 Dietary Fibers
% 219.94/220.18  |- mesh__recordAuthorizer mesh__D004043 SJN
% 219.94/220.18  |- mesh__recordMaintainer mesh__D004043 JLS
% 219.94/220.18  |- skos__hiddenLabel mesh__D017769 Nerve Entrapment, Ulnar
% 219.94/220.18  |- skos__hiddenLabel mesh__D017769 Entrapment, Ulnar Nerve
% 219.94/220.18  |- skos__altLabel mesh__D017769 Entrapment Syndrome, Ulnar Nerve
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D017769 2001
% 219.94/220.18  |- mesh__recordMaintainer mesh__D017769 KEV
% 219.94/220.18  |- skos__hiddenLabel mesh__D017769 Syndrome, Guyon
% 219.94/220.18  |- skos__hiddenLabel mesh__D017769 Guyon Syndromes
% 219.94/220.18  |- skos__broader mesh__D017769smesh__D009408
% 219.94/220.18  |- mesh__historyNote mesh__D017769 2000%28%1994%29%   
% 219.94/220.18  |- skos__hiddenLabel mesh__D017769 Compression, Ulnar Nerve
% 219.94/220.18  |- skos__historyNote mesh__D017769 Ulnar Nerve %28%1966-1993%29%
% 219.94/220.18  |- skos__hiddenLabel mesh__D017769 Ulnar Nerve Compressions
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D017769 2003
% 219.94/220.18  |- skos__broader mesh__D017769smesh__D020424
% 219.94/220.18  |- skos__altLabel mesh__D017769 Ulnar Nerve Entrapment at the Wrist
% 219.94/220.18  |- rdf__type mesh__D017769sskos__Concept
% 219.94/220.18  |- skos__broader mesh__D017769smesh__D012090
% 219.94/220.18  |- mesh__dateRevised mesh__D017769 1999-11-04
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D017769 2002
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D017769 2005
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D017769 2004
% 219.94/220.18  |- mesh__recordAuthorizer mesh__D017769 sjn
% 219.94/220.18  |- mesh__dateCreated mesh__D017769 1993-06-21
% 219.94/220.18  |- mesh__dateEstablished mesh__D017769 1994-01-01
% 219.94/220.18  |- mesh__publicMeSHNote mesh__D017769
% 219.94/220.18       2000; see ULNAR NERVE COMPRESSION SYNDROME 1994-1999   
% 219.94/220.18  |- skos__altLabel mesh__D017769 Ulnar Nerve Compression
% 219.94/220.18  |- skos__hiddenLabel mesh__D017769 Syndromes, Guyon
% 219.94/220.18  |- skos__altLabel mesh__D017769 External Compression Syndrome, Ulnar Nerve
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D017769 2006
% 219.94/220.18  |- skos__hiddenLabel mesh__D017769 Entrapments, Ulnar Nerve
% 219.94/220.18  |- skos__hiddenLabel mesh__D017769 Nerve Compression, Ulnar
% 219.94/220.18  |- mesh__recordOriginator mesh__D017769 RAZ
% 219.94/220.18  |- skos__prefLabel mesh__D017769 Ulnar Nerve Compression Syndromes
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D017769 2000
% 219.94/220.18  |- skos__hiddenLabel mesh__D017769 Ulnar Nerve Entrapments
% 219.94/220.18  |- skos__historyNote mesh__D017769
% 219.94/220.18       Nerve Compression Syndromes %28%1968-1993%29%
% 219.94/220.18  |- skos__altLabel mesh__D017769 Ulnar Nerve Entrapment
% 219.94/220.18  |- skos__scopeNote mesh__D017769
% 219.94/220.18       Ulnar neuropathies caused by mechanical compression of the nerve at any location from its origin at the BRACHIAL PLEXUS to its terminations in the hand. Common sites of compression include the retroepicondylar groove, cubital tunnel at the elbow %28%CUBITAL TUNNEL SYNDROME%29%, and Guyon%27%s canal at the wrist. Clinical features depend on the site of injury, but may include weakness or paralysis of wrist flexion, finger flexion, and ulnar innervated intrinsic hand muscles, and impaired sensation over the ulnar aspect of the hand, fifth finger, and ulnar half of the ring finger. %28%Joynt, Clinical Neurology, 1995, Ch51, p43%29%%A%    
% 219.94/220.18  |- rdf__type mesh__D042162sskos__Concept
% 219.94/220.18  |- skos__broader mesh__D042162smesh__D012231
% 219.94/220.18  |- mesh__recordMaintainer mesh__D042162 SYSTEM
% 219.94/220.18  |- skos__historyNote mesh__D042162 Rhizobium %28%1991-2003%29%
% 219.94/220.18  |- mesh__recordOriginator mesh__D042162 ags
% 219.94/220.18  |- mesh__dateRevised mesh__D042162 2005-06-30
% 219.94/220.18  |- mesh__recordAuthorizer mesh__D042162 sjn
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D042162 2006
% 219.94/220.18  |- mesh__dateCreated mesh__D042162 2003-07-09
% 219.94/220.18  |- skos__scopeNote mesh__D042162
% 219.94/220.18       A species of gram-negative bacteria and an nitrogen inoculum that displays a high intrinsic tolerance to acidity.%A%    
% 219.94/220.18  |- mesh__dateEstablished mesh__D042162 2004-01-01
% 219.94/220.18  |- skos__prefLabel mesh__D042162 Rhizobium tropici
% 219.94/220.18  |- mesh__publicMeSHNote mesh__D042162 2004   
% 219.94/220.18  |- mesh__historyNote mesh__D042162 2004   
% 219.94/220.18  |- mesh__dateEstablished mesh__D003749 1972-01-01
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D003749 1996
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D003749 2006
% 219.94/220.18  |- skos__annotation mesh__D003749 DF: DENT FACILITIES   
% 219.94/220.18  |- mesh__dateCreated mesh__D003749 1999-01-01
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D003749 2005
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D003749 2002
% 219.94/220.18  |- rdf__type mesh__D003749sskos__Concept
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D003749 1995
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D003749 2004
% 219.94/220.18  |- mesh__recordAuthorizer mesh__D003749 PLS
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D003749 1999
% 219.94/220.18  |- mesh__recordMaintainer mesh__D003749 TGC
% 219.94/220.18  |- mesh__historyNote mesh__D003749 72   
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D003749 2001
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D003749 1994
% 219.94/220.18  |- skos__historyNote mesh__D003749 Health Facilities %28%1968-1971%29%
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D003749 2003
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D003749 2000
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D003749 1993
% 219.94/220.18  |- skos__prefLabel mesh__D003749 Dental Facilities
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D003749 1998
% 219.94/220.18  |- skos__broader mesh__D003749smesh__D006268
% 219.94/220.18  |- skos__altLabel mesh__D003749 Dental Facility
% 219.94/220.18  |- mesh__dateRevised mesh__D003749 1992-05-14
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D003749 1997
% 219.94/220.18  |- mesh__publicMeSHNote mesh__D003749 72   
% 219.94/220.18  |- mesh__recordOriginator mesh__D003749 NLM
% 219.94/220.18  |- skos__scopeNote mesh__D003749
% 219.94/220.18       Use for material on dental facilities in general or for which there is no specific heading.%A%    
% 219.94/220.18  |- skos__altLabel mesh__D003749 Facility, Dental
% 219.94/220.18  |- skos__altLabel mesh__D003749 Facilities, Dental
% 219.94/220.18  |- skos__scopeNote mesh__D014471
% 219.94/220.18       Veins which carry oxygenated, nutrient-rich blood from the placenta and which are obliterated in the first few days after birth.%A%    
% 219.94/220.18  |- mesh__dateCreated mesh__D014471 1999-01-01
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D014471 2001
% 219.94/220.18  |- mesh__historyNote mesh__D014471
% 219.94/220.18       68; was UMBILICAL VEIN 1964-67 %28%Prov%29%   
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D014471 2002
% 219.94/220.18  |- mesh__dateEstablished mesh__D014471 1968-01-01
% 219.94/220.18  |- mesh__publicMeSHNote mesh__D014471 68   
% 219.94/220.18  |- rdf__type mesh__D014471sskos__Concept
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D014471 1998
% 219.94/220.18  |- mesh__recordAuthorizer mesh__D014471 PLS
% 219.94/220.18  |- skos__prefLabel mesh__D014471 Umbilical Veins
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D014471 1996
% 219.94/220.18  |- skos__broader mesh__D014471smesh__D011168
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D014471 1999
% 219.94/220.18  |- mesh__onlineNote mesh__D014471
% 219.94/220.18       use UMBILICAL VEINS to search UMBILICAL VEIN 1966-67 %28%as Prov%29%%A%  
% 219.94/220.18  |- mesh__recordMaintainer mesh__D014471 TAP
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D014471 2005
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D014471 1997
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D014471 2003
% 219.94/220.18  |- skos__hiddenLabel mesh__D014471 Veins, Umbilical
% 219.94/220.18  |- skos__hiddenLabel mesh__D014471 Vein, Umbilical
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D014471 2006
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D014471 2000
% 219.94/220.18  |- mesh__recordOriginator mesh__D014471 NLM
% 219.94/220.18  |- mesh__dateRevised mesh__D014471 1995-05-18
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D014471 2004
% 219.94/220.18  |- skos__hiddenLabel mesh__D014471 Umbilical Vein
% 219.94/220.18  |- skos__broader mesh__D014471smesh__D014470
% 219.94/220.18  |- mesh__dateCreated mesh__D022903 2000-03-31
% 219.94/220.18  |- mesh__recordOriginator mesh__D022903 jls
% 219.94/220.18  |- rdf__type mesh__D022903sskos__Concept
% 219.94/220.18  |- skos__broader mesh__D022903smesh__D052180
% 219.94/220.18  |- skos__scopeNote mesh__D022903
% 219.94/220.18       Works consisting of documents issued by local, regional, or national governments or by their agencies or subdivisions.%A%    
% 219.94/220.18  |- skos__altLabel mesh__D022903 Government Publication %28%PT%29%
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D022903 2006
% 219.94/220.18  |- skos__prefLabel mesh__D022903
% 219.94/220.18       Government Publications %5B%Publication Type%5D%
% 219.94/220.18  |- skos__altLabel mesh__D022903 Government Documents %28%PT%29%
% 219.94/220.18  |- mesh__dateEstablished mesh__D022903 2000-03-31
% 219.94/220.18  |- mesh__recordAuthorizer mesh__D022903 sjn
% 219.94/220.18  |- skos__annotation mesh__D022903 used by collaborating partners only   
% 219.94/220.18  |- skos__altLabel mesh__D022903 Government Publications %28%PT%29%
% 219.94/220.18  |- mesh__historyNote mesh__D022903 2000   
% 219.94/220.18  |- mesh__dateRevised mesh__D022903 2005-06-30
% 219.94/220.18  |- mesh__recordMaintainer mesh__D022903 jls
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D008434 1996
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D008434 2003
% 219.94/220.18  |- mesh__recordOriginator mesh__D008434 NLM
% 219.94/220.18  |- skos__scopeNote mesh__D008434
% 219.94/220.18       Devices which provide an artificial temporary wall, or matrix, used in filling a prepared cavity.%A%    
% 219.94/220.18  |- mesh__dateEstablished mesh__D008434 1991-01-01
% 219.94/220.18  |- rdf__type mesh__D008434sskos__Concept
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D008434 1997
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D008434 1994
% 219.94/220.18  |- skos__hiddenLabel mesh__D008434 Matrix Band
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D008434 2004
% 219.94/220.18  |- mesh__dateCreated mesh__D008434 1999-01-01
% 219.94/220.18  |- skos__hiddenLabel mesh__D008434 Band, Matrix
% 219.94/220.18  |- mesh__onlineNote mesh__D008434
% 219.94/220.18       use DENTAL MATERIALS to search MATRIX BAND 1969-74; use MATRIX BANDS 1975-79%A%  
% 219.94/220.18  |- mesh__activeMeSHYear mesh__D008434 2002
% 219.94/220.19  |- mesh__recordAuthorizer mesh__D008434 PLS
% 219.94/220.19  |- mesh__dateRevised mesh__D008434 1992-05-14
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D008434 1995
% 219.94/220.19  |- skos__prefLabel mesh__D008434 Matrix Bands
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D008434 1998
% 219.94/220.19  |- mesh__publicMeSHNote mesh__D008434
% 219.94/220.19       91; was see under DENTAL INSTRUMENTS 1980-90; was MATRIX BAND see under DENTAL MATERIALS 1969-79%A%  
% 219.94/220.19  |- mesh__recordMaintainer mesh__D008434 TAP
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D008434 2005
% 219.94/220.19  |- skos__broader mesh__D008434smesh__D003762
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D008434 1999
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D008434 2000
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D008434 2006
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D008434 1993
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D008434 2001
% 219.94/220.19  |- mesh__historyNote mesh__D008434
% 219.94/220.19       91%28%80%29%; was see under DENTAL INSTRUMENTS 1980-90; was MATRIX BAND see under DENTAL MATERIALS 1969-79%A%  
% 219.94/220.19  |- skos__hiddenLabel mesh__D008434 Bands, Matrix
% 219.94/220.19  |- mesh__onlineNote mesh__D000451
% 219.94/220.19       search ALDOSTERONE /AI 1968-77 %26% ALDOSTERONE 1966-67   
% 219.94/220.19  |- mesh__recordOriginator mesh__D000451 RLS
% 219.94/220.19  |- mesh__dateCreated mesh__D000451 1977-05-17
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D000451 2004
% 219.94/220.19  |- mesh__publicMeSHNote mesh__D000451 78,63-67   
% 219.94/220.19  |- mesh__recordAuthorizer mesh__D000451 sjn
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D000451 2005
% 219.94/220.19  |- mesh__recordMaintainer mesh__D000451 ssb
% 219.94/220.19  |- skos__annotation mesh__D000451 DF: ALDOSTERONE ANTAG   
% 219.94/220.19  |- mesh__dateEstablished mesh__D000451 1978-01-01
% 219.94/220.19  |- rdf__type mesh__D000451sskos__Concept
% 219.94/220.19  |- skos__historyNote mesh__D000451 Aldosterone %28%1966-1977%29%
% 219.94/220.19  |- skos__broader mesh__D000451smesh__D006727
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D000451 2006
% 219.94/220.19  |- skos__scopeNote mesh__D000451
% 219.94/220.19       Compounds which inhibit or antagonize the biosynthesis or actions of aldosterone.%A%    
% 219.94/220.19  |- mesh__historyNote mesh__D000451 78,63-67   
% 219.94/220.19  |- mesh__dateRevised mesh__D000451 2003-07-09
% 219.94/220.19  |- skos__hiddenLabel mesh__D000451 Antagonists, Aldosterone
% 219.94/220.19  |- skos__prefLabel mesh__D000451 Aldosterone Antagonists
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D013379 2000
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D013379 1993
% 219.94/220.19  |- mesh__publicMeSHNote mesh__D013379 78   
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D013379 1995
% 219.94/220.19  |- skos__hiddenLabel mesh__D013379 Specificities, Substrate
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D013379 2001
% 219.94/220.19  |- mesh__dateCreated mesh__D013379 1977-04-27
% 219.94/220.19  |- mesh__historyNote mesh__D013379 78   
% 219.94/220.19  |- mesh__dateRevised mesh__D013379 1992-05-18
% 219.94/220.19  |- skos__annotation mesh__D013379
% 219.94/220.19       almost never IM; coord NIM with specific enzyme or catalytic molecule %28%IM%29%%A%  
% 219.94/220.19  |- skos__hiddenLabel mesh__D013379 Substrate Specificities
% 219.94/220.19  |- skos__prefLabel mesh__D013379 Substrate Specificity
% 219.94/220.19  |- skos__scopeNote mesh__D013379
% 219.94/220.19       A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts.%A%    
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D013379 2002
% 219.94/220.19  |- mesh__recordAuthorizer mesh__D013379 PLS
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D013379 1996
% 219.94/220.19  |- skos__broader mesh__D013379smesh__D001669
% 219.94/220.19  |- rdf__type mesh__D013379sskos__Concept
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D013379 2003
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D013379 1998
% 219.94/220.19  |- skos__hiddenLabel mesh__D013379 Specificity, Substrate
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D013379 1997
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D013379 2005
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D013379 2004
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D013379 1994
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D013379 1999
% 219.94/220.19  |- mesh__recordMaintainer mesh__D013379 AGS
% 219.94/220.19  |- mesh__recordOriginator mesh__D013379 VDK
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D013379 2006
% 219.94/220.19  |- mesh__dateEstablished mesh__D013379 1978-01-01
% 219.94/220.19  |- mesh__recordAuthorizer mesh__D018862 jls
% 219.94/220.19  |- skos__related mesh__D018862smesh__D015266
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D018862 2001
% 219.94/220.19  |- rdf__type mesh__D018862sskos__Concept
% 219.94/220.19  |- skos__prefLabel mesh__D018862 Merkel Cells
% 219.94/220.19  |- skos__scopeNote mesh__D018862
% 219.94/220.19       Modified epidermal cells located in the stratum basale. They are found mostly in areas where sensory perception is acute, such as the fingertips. Merkel cells are closely associated with an expanded terminal bulb of an afferent myelinated nerve fiber. Do not confuse with Merkel%27%s corpuscle which is a combination of a neuron and an epidermal cell.%A%    
% 219.94/220.19  |- mesh__onlineNote mesh__D018862
% 219.94/220.19       use MECHANORECEPTORS to search MERKEL%27%S RECEPTOR 1994-95   
% 219.94/220.19  |- skos__hiddenLabel mesh__D018862 Merkels Receptor
% 219.94/220.19  |- mesh__dateEstablished mesh__D018862 1996-01-01
% 219.94/220.19  |- skos__hiddenLabel mesh__D018862 Receptors, Merkels
% 219.94/220.19  |- skos__hiddenLabel mesh__D018862 Receptors, Merkel
% 219.94/220.19  |- skos__hiddenLabel mesh__D018862 Cells, Merkel
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D018862 2002
% 219.94/220.19  |- skos__altLabel mesh__D018862 Receptor, Merkel
% 219.94/220.19  |- mesh__publicMeSHNote mesh__D018862
% 219.94/220.19       96; MERKEL%27%S RECEPTOR was see MECHANORECEPTORS 1994-95   
% 219.94/220.19  |- mesh__recordOriginator mesh__D018862 TGC
% 219.94/220.19  |- skos__hiddenLabel mesh__D018862 Merkel%27%s Receptors
% 219.94/220.19  |- skos__altLabel mesh__D018862 Receptors, Merkel%27%s
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D018862 2005
% 219.94/220.19  |- skos__altLabel mesh__D018862 Merkel%27%s Receptor
% 219.94/220.19  |- mesh__historyNote mesh__D018862
% 219.94/220.19       96; MERKEL%27%S RECEPTOR was see MECHANORECEPTORS 1994-95   
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D018862 2005A
% 219.94/220.19  |- skos__broader mesh__D018862smesh__D004847
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D018862 2003
% 219.94/220.19  |- skos__hiddenLabel mesh__D018862 Merkel Receptor
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D018862 2006
% 219.94/220.19  |- skos__altLabel mesh__D018862 Merkel Receptors
% 219.94/220.19  |- skos__broader mesh__D018862smesh__D008465
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D018862 2004
% 219.94/220.19  |- mesh__dateCreated mesh__D018862 1995-06-08
% 219.94/220.19  |- mesh__recordMaintainer mesh__D018862 jls
% 219.94/220.19  |- skos__hiddenLabel mesh__D018862 Receptor, Merkel%27%s
% 219.94/220.19  |- mesh__dateRevised mesh__D018862 2004-07-28
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D018862 2000
% 219.94/220.19  |- skos__historyNote mesh__D010081 Oxazoles %28%1974%29%
% 219.94/220.19  |- mesh__dateCreated mesh__D010081 1974-11-19
% 219.94/220.19  |- mesh__recordOriginator mesh__D010081 NLM
% 219.94/220.19  |- skos__prefLabel mesh__D010081 Oxazolone
% 219.94/220.19  |- mesh__dateEstablished mesh__D010081 1991-01-01
% 219.94/220.19  |- mesh__publicMeSHNote mesh__D010081 91; was see under OXAZOLES 1975-90   
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D010081 2006
% 219.94/220.19  |- skos__hiddenLabel mesh__D010081 4 Ethoxymethylene 2 phenyloxazolone
% 219.94/220.19  |- skos__altLabel mesh__D010081
% 219.94/220.19       2-Phenyl-4-%28%ethoxymethylene%29%oxazol-5-one
% 219.94/220.19  |- mesh__recordAuthorizer mesh__D010081 sjn
% 219.94/220.19  |- mesh__historyNote mesh__D010081
% 219.94/220.19       91%28%75%29%; was see under OXAZOLES 1975-90   
% 219.94/220.19  |- rdf__type mesh__D010081sskos__Concept
% 219.94/220.19  |- skos__broader mesh__D010081smesh__D010080
% 219.94/220.19  |- skos__historyNote mesh__D010081 Ethyl Ethers %28%1974%29%
% 219.94/220.19  |- mesh__recordMaintainer mesh__D010081 ssb
% 219.94/220.19  |- skos__altLabel mesh__D010081 4-Ethoxymethylene-2-phenyloxazolone
% 219.94/220.19  |- skos__scopeNote mesh__D010081
% 219.94/220.19       Immunologic adjuvant and sensitizing agent.     
% 219.94/220.19  |- mesh__dateRevised mesh__D010081 2005-06-30
% 219.94/220.19  |- mesh__recordAuthorizer mesh__D004842 sjn
% 219.94/220.19  |- mesh__dateRevised mesh__D004842 2005-06-30
% 219.94/220.19  |- skos__broader mesh__D004842smesh__D014564
% 219.94/220.19  |- mesh__dateCreated mesh__D004842 1999-01-01
% 219.94/220.19  |- rdf__type mesh__D004842sskos__Concept
% 219.94/220.19  |- skos__broader mesh__D004842smesh__D014522
% 219.94/220.19  |- mesh__recordOriginator mesh__D004842 NLM
% 219.94/220.19  |- skos__scopeNote mesh__D004842
% 219.94/220.19       A birth defect due to malformation of the URETHRA in which the urethral opening is above its normal location. In the male, the malformed urethra generally opens on the top or the side of the PENIS, but the urethra can also be open the entire length of the penis. In the female, the malformed urethral opening is often between the CLITORIS and the labia, or in the ABDOMEN.%A%    
% 219.94/220.19  |- mesh__recordMaintainer mesh__D004842 lkt
% 219.94/220.19  |- skos__prefLabel mesh__D004842 Epispadias
% 219.94/220.19  |- skos__hiddenLabel mesh__D004842 Epispadia
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D004842 2006
% 219.94/220.19  |- skos__altLabel mesh__D051498 FGFR3 Protein
% 219.94/220.19  |- skos__scopeNote mesh__D051498
% 219.94/220.19       A fibroblast growth factor receptor that regulates CHONDROCYTE growth and CELL DIFFERENTIATION. Mutations in the gene for fibroblast growth factor receptor 3 have been associated with ACHONDROPLASIA; THANATOPHORIC DYSPLASIA and NEOPLASTIC CELL TRANSFORMATION.%A%    
% 219.94/220.19  |- mesh__dateEstablished mesh__D051498 2006-01-01
% 219.94/220.19  |- mesh__publicMeSHNote mesh__D051498
% 219.94/220.19       2006; FIBROBLAST GROWTH FACTOR RECEPTOR 3 was indexed under RECEPTORS, FIBROBLAST GROWTH FACTOR %26% RECEPTOR PROTEIN-TYROSINE KINASES 1993-2005, %26% under RECEPTORS, ENDOGENOUS SUBSTANCES 1992%A%  
% 219.94/220.19  |- mesh__recordAuthorizer mesh__D051498 sjn
% 219.94/220.19  |- skos__prefLabel mesh__D051498 Receptor, Fibroblast Growth Factor, Type 3
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D051498 2006
% 219.94/220.19  |- mesh__recordMaintainer mesh__D051498 DRC
% 219.94/220.19  |- skos__broader mesh__D051498smesh__D011518
% 219.94/220.19  |- mesh__historyNote mesh__D051498 2006%28%1992%29%   
% 219.94/220.19  |- skos__altLabel mesh__D051498 Fibroblast Growth Factor Receptor 3
% 219.94/220.19  |- skos__broader mesh__D051498smesh__D017468
% 219.94/220.19  |- skos__altLabel mesh__D051498 Receptor 3, Fibroblast Growth Factor
% 219.94/220.19  |- skos__altLabel mesh__D051498 Fibroblast Growth Factor Receptors 3
% 219.94/220.19  |- mesh__recordOriginator mesh__D051498 DRC
% 219.94/220.19  |- skos__broader mesh__D051498smesh__D020794
% 219.94/220.19  |- rdf__type mesh__D051498sskos__Concept
% 219.94/220.19  |- mesh__dateCreated mesh__D051498 2005-06-30
% 219.94/220.19  |- mesh__recordAuthorizer mesh__D004044 ags
% 219.94/220.19  |- skos__broader mesh__D004044smesh__D011506
% 219.94/220.19  |- mesh__recordMaintainer mesh__D004044 ags
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D004044 2005
% 219.94/220.19  |- skos__altLabel mesh__D004044 Proteins, Dietary
% 219.94/220.19  |- rdf__type mesh__D004044sskos__Concept
% 219.94/220.19  |- mesh__dateRevised mesh__D004044 2005-07-13
% 219.94/220.19  |- skos__prefLabel mesh__D004044 Dietary Proteins
% 219.94/220.19  |- skos__scopeNote mesh__D004044
% 219.94/220.19       Proteins obtained from foods. They are the main source of the essential amino acids.%A%    
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D004044 2006
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D004044 2006A
% 219.94/220.19  |- mesh__recordOriginator mesh__D004044 NLM
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D004044 2003
% 219.94/220.19  |- skos__related mesh__D004044smesh__D011488
% 219.94/220.19  |- skos__annotation mesh__D004044
% 219.94/220.19       /adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with specific dis /diet ther; high-protein diet: use /admin; EGG PROTEINS; MILK PROTEINS; %26% VEGETABLE PROTEINS and specifics are also available; for dietary plant proteins see note on PLANT PROTEINS%A%  
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D004044 2004
% 219.94/220.19  |- mesh__dateCreated mesh__D004044 1999-01-01
% 219.94/220.19  |- mesh__recordAuthorizer mesh__D042163 sjn
% 219.94/220.19  |- mesh__recordMaintainer mesh__D042163 SYSTEM
% 219.94/220.19  |- rdf__type mesh__D042163sskos__Concept
% 219.94/220.19  |- mesh__historyNote mesh__D042163 2004   
% 219.94/220.19  |- skos__historyNote mesh__D042163 Rhizobium %28%1993-2003%29%
% 219.94/220.19  |- skos__scopeNote mesh__D042163
% 219.94/220.19       A species of gram-negative bacteria and nitrogen innoculant of PHASEOLUS VULGARIS.%A%    
% 219.94/220.19  |- skos__prefLabel mesh__D042163 Rhizobium etli
% 219.94/220.19  |- mesh__dateEstablished mesh__D042163 2004-01-01
% 219.94/220.19  |- mesh__publicMeSHNote mesh__D042163 2004   
% 219.94/220.19  |- mesh__dateCreated mesh__D042163 2003-07-09
% 219.94/220.19  |- skos__broader mesh__D042163smesh__D012231
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D042163 2006
% 219.94/220.19  |- mesh__recordOriginator mesh__D042163 ags
% 219.94/220.19  |- mesh__dateRevised mesh__D042163 2005-06-30
% 219.94/220.19  |- mesh__recordOriginator mesh__D014472 NLM
% 219.94/220.19  |- mesh__recordAuthorizer mesh__D014472 sjn
% 219.94/220.19  |- rdf__type mesh__D014472sskos__Concept
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D014472 2005
% 219.94/220.19  |- mesh__considerAlso mesh__D014472
% 219.94/220.19       consider also terms at OMPHALO- %28%navel%29%   
% 219.94/220.19  |- mesh__dateRevised mesh__D014472 2004-07-07
% 219.94/220.19  |- skos__broader mesh__D014472smesh__D000005
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D014472 2006
% 219.94/220.19  |- skos__prefLabel mesh__D014472 Umbilicus
% 219.94/220.19  |- mesh__dateCreated mesh__D014472 1999-01-01
% 219.94/220.19  |- mesh__recordMaintainer mesh__D014472 lkt
% 219.94/220.19  |- skos__scopeNote mesh__D014472
% 219.94/220.19       The pit in the center of the ABDOMINAL WALL marking the point where the UMBILICAL CORD entered in the FETUS.%A%    
% 219.94/220.19  |- skos__annotation mesh__D008435
% 219.94/220.19       a republic in western Africa; do not confuse with the ancient country Mauretania%A%  
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D008435 2000
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D008435 1997
% 219.94/220.19  |- skos__broader mesh__D008435smesh__D000354
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D008435 2004
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D008435 2001
% 219.94/220.19  |- mesh__dateCreated mesh__D008435 1974-11-11
% 219.94/220.19  |- skos__prefLabel mesh__D008435 Mauritania
% 219.94/220.19  |- mesh__historyNote mesh__D008435 75   
% 219.94/220.19  |- mesh__dateEstablished mesh__D008435 1975-01-01
% 219.94/220.19  |- mesh__recordOriginator mesh__D008435 NLM
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D008435 1998
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D008435 2005
% 219.94/220.19  |- mesh__recordMaintainer mesh__D008435 TGC
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D008435 2002
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D008435 1999
% 219.94/220.19  |- mesh__recordAuthorizer mesh__D008435 PLS
% 219.94/220.19  |- mesh__dateRevised mesh__D008435 1995-02-21
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D008435 2006
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D008435 1996
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D008435 2003
% 219.94/220.19  |- skos__scopeNote mesh__D008435
% 219.94/220.19       A republic in western Africa, southwest of ALGERIA and west of MALI. Its capital is Nouakchott. Its coast was opened by the Portuguese in the 15th century. Although recognized as in the French sphere from 1817, it did not become a French colony until 1921. It gained independence in 1960. Mauritania takes its name from the Moors, either from the Greek mauros, dark, with reference to their skin or from the Punic mahurim or mauharin, western, with reference to the geographical area of North Africa that they occupied. It should not be confused with the ancient country of Mauretania in northern Africa, although both share a common derivation for their names. %28%From Webster%27%s New Geographical Dictionary, 1988, p742 %26% Room, Brewer%27%s Dictionary of Names, 1992, p361%29%%A%    
% 219.94/220.19  |- rdf__type mesh__D008435sskos__Concept
% 219.94/220.19  |- mesh__dateEstablished mesh__D000452 1973-01-01
% 219.94/220.19  |- rdf__type mesh__D000452sskos__Concept
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D000452 2006
% 219.94/220.19  |- skos__broader mesh__D000452smesh__D006843
% 219.94/220.19  |- skos__historyNote mesh__D000452
% 219.94/220.19       Hydrocarbons, Halogenated %28%1966-1970%29%
% 219.94/220.19  |- skos__scopeNote mesh__D000452
% 219.94/220.19       A highly poisonous substance that was formerly used as an insecticide. The manufacture and use has been discontinued in the U.S. %28%From Merck Index, 11th ed%29%%A%    
% 219.94/220.19  |- mesh__publicMeSHNote mesh__D000452 73   
% 219.94/220.19  |- skos__historyNote mesh__D000452 Insecticides %28%1966-1970%29%
% 219.94/220.19  |- mesh__recordOriginator mesh__D000452 NLM
% 219.94/220.19  |- mesh__recordAuthorizer mesh__D000452 sjn
% 219.94/220.19  |- mesh__historyNote mesh__D000452 73%28%71%29%   
% 219.94/220.19  |- skos__annotation mesh__D000452 TN 111 for eff on insects   
% 219.94/220.19  |- mesh__dateRevised mesh__D000452 2004-07-07
% 219.94/220.19  |- mesh__recordMaintainer mesh__D000452 ssb
% 219.94/220.19  |- mesh__dateCreated mesh__D000452 1999-01-01
% 219.94/220.19  |- skos__prefLabel mesh__D000452 Aldrin
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D000452 2005
% 219.94/220.19  |- mesh__dateRevised mesh__D010880 2004-07-07
% 219.94/220.19  |- mesh__publicMeSHNote mesh__D010880 AZACYCLONOL was heading 1963-84   
% 219.94/220.19  |- skos__prefLabel mesh__D010880 Piperidines
% 219.94/220.19  |- skos__scopeNote mesh__D010880 A family of hexahydropyridines.     
% 219.94/220.19  |- skos__related mesh__D010880smesh__D011725
% 219.94/220.19  |- rdf__type mesh__D010880sskos__Concept
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D010880 2005
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D010880 2006
% 219.94/220.19  |- mesh__dateCreated mesh__D010880 1999-01-01
% 219.94/220.19  |- mesh__recordOriginator mesh__D010880 NLM
% 219.94/220.19  |- mesh__historyNote mesh__D010880 AZACYCLONOL was heading 1963-84   
% 219.94/220.19  |- skos__broader mesh__D010880smesh__D006573
% 219.94/220.19  |- mesh__recordAuthorizer mesh__D010880 sjn
% 219.94/220.19  |- mesh__recordMaintainer mesh__D010880 ssb
% 219.94/220.19  |- mesh__onlineNote mesh__D010880
% 219.94/220.19       use PIPERIDINES to search AZACYCLONOL 1966-84   
% 219.94/220.19  |- skos__altLabel mesh__D010082 Oxepenes
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D010082 2006
% 219.94/220.19  |- mesh__historyNote mesh__D010082 68   
% 219.94/220.19  |- skos__altLabel mesh__D010082 Oxepin
% 219.94/220.19  |- mesh__recordOriginator mesh__D010082 NLM
% 219.94/220.19  |- skos__broader mesh__D010082smesh__D004988
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D010082 2005
% 219.94/220.19  |- mesh__dateCreated mesh__D010082 1999-01-01
% 219.94/220.19  |- rdf__type mesh__D010082sskos__Concept
% 219.94/220.19  |- skos__scopeNote mesh__D010082
% 219.94/220.19       Compounds based on a 7-membered heterocyclic ring including an oxygen. They can be considered a medium ring ether. A natural source is the MONTANOA plant genus. Some dibenzo-dioxepins, called depsidones, are found in GARCINIA plants.%A%    
% 219.94/220.19  |- skos__prefLabel mesh__D010082 Oxepins
% 219.94/220.19  |- mesh__dateEstablished mesh__D010082 1968-01-01
% 219.94/220.19  |- mesh__dateRevised mesh__D010082 2004-07-07
% 219.94/220.19  |- mesh__recordAuthorizer mesh__D010082 sjn
% 219.94/220.19  |- skos__altLabel mesh__D010082 Oxepene
% 219.94/220.19  |- mesh__publicMeSHNote mesh__D010082 68   
% 219.94/220.19  |- skos__broader mesh__D010082smesh__D006573
% 219.94/220.19  |- mesh__recordMaintainer mesh__D010082 ssb
% 219.94/220.19  |- mesh__dateEstablished mesh__D004843 1979-01-01
% 219.94/220.19  |- mesh__recordMaintainer mesh__D004843 jls
% 219.94/220.19  |- mesh__historyNote mesh__D004843 79   
% 219.94/220.19  |- rdf__type mesh__D004843sskos__Concept
% 219.94/220.19  |- skos__historyNote mesh__D004843 Genetics %28%1966-1967%29%
% 219.94/220.19  |- skos__historyNote mesh__D004843 Genes, Dominant %28%1968-1978%29%
% 219.94/220.19  |- skos__hiddenLabel mesh__D004843 Gene, Hypostatic
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D004843 2004
% 219.94/220.19  |- skos__historyNote mesh__D004843 Phenotype %28%1968-1978%29%
% 219.94/220.19  |- skos__hiddenLabel mesh__D004843 Interaction Deviations
% 219.94/220.19  |- mesh__dateCreated mesh__D004843 1978-01-27
% 219.94/220.19  |- skos__hiddenLabel mesh__D004843 Hypostatic Gene
% 219.94/220.19  |- mesh__publicMeSHNote mesh__D004843 79   
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D004843 2005
% 219.94/220.19  |- skos__altLabel mesh__D004843 Hypostases, Genetic
% 219.94/220.19  |- mesh__recordOriginator mesh__D004843 AEP
% 219.94/220.19  |- skos__hiddenLabel mesh__D004843 Hypostatic Genes
% 219.94/220.19  |- skos__broader mesh__D004843smesh__D005786
% 219.94/220.19  |- skos__hiddenLabel mesh__D004843 Epistatic Gene
% 219.94/220.19  |- skos__hiddenLabel mesh__D004843 Deviations, Epistatic
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D004843 2006
% 219.94/220.19  |- skos__hiddenLabel mesh__D004843 Gene, Epistatic
% 219.94/220.19  |- skos__hiddenLabel mesh__D004843 Epistatic Genes
% 219.94/220.19  |- skos__hiddenLabel mesh__D004843 Deviations, Interaction
% 219.94/220.19  |- skos__hiddenLabel mesh__D004843 Deviation, Interaction
% 219.94/220.19  |- skos__altLabel mesh__D004843 Interaction Deviation
% 219.94/220.19  |- skos__altLabel mesh__D004843 Genetic Hypostasis
% 219.94/220.19  |- skos__altLabel mesh__D004843 Genetic Hypostases
% 219.94/220.19  |- skos__altLabel mesh__D004843 Genetic Epistasis
% 219.94/220.19  |- skos__altLabel mesh__D004843 Genetic Epistases
% 219.94/220.19  |- mesh__recordAuthorizer mesh__D004843 jls
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D004843 2005A
% 219.94/220.19  |- skos__hiddenLabel mesh__D004843 Epistatic Deviations
% 219.94/220.19  |- skos__scopeNote mesh__D004843
% 219.94/220.19       A gene interaction whereby the expression of one gene interfers with or masks the expression of a different gene or genes. Genes whose expression interfers with or masks the effects of other genes are said to be epistatic to the effected genes. Genes whose expression is effected %28%blocked or masked%29% are hypostatic to the interfering genes.%A%    
% 219.94/220.19  |- skos__altLabel mesh__D004843 Deviation, Epistatic
% 219.94/220.19  |- skos__altLabel mesh__D004843 Hypostasis, Genetic
% 219.94/220.19  |- skos__altLabel mesh__D004843 Epistatic Deviation
% 219.94/220.19  |- mesh__dateRevised mesh__D004843 2004-07-26
% 219.94/220.19  |- skos__prefLabel mesh__D004843 Epistasis, Genetic
% 219.94/220.19  |- skos__broader mesh__D051499smesh__D020794
% 219.94/220.19  |- skos__altLabel mesh__D051499 Receptor 4, Fibroblast Growth Factor
% 219.94/220.19  |- mesh__dateCreated mesh__D051499 2005-06-30
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D051499 2006
% 219.94/220.19  |- mesh__publicMeSHNote mesh__D051499
% 219.94/220.19       2006; FIBROBLAST GROWTH FACTOR RECEPTOR 4 was indexed under RECEPTORS, FIBROBLAST GROWTH FACTOR 1993-2005, %26% under RECEPTORS, ENDOGENOUS SUBSTANCES 1992%A%  
% 219.94/220.19  |- skos__altLabel mesh__D051499 Fibroblast Growth Factor Receptors 4
% 219.94/220.19  |- skos__altLabel mesh__D051499 Fibroblast Growth Factor Receptor 4
% 219.94/220.19  |- mesh__dateEstablished mesh__D051499 2006-01-01
% 219.94/220.19  |- mesh__recordAuthorizer mesh__D051499 sjn
% 219.94/220.19  |- skos__broader mesh__D051499smesh__D017468
% 219.94/220.19  |- rdf__type mesh__D051499sskos__Concept
% 219.94/220.19  |- mesh__recordOriginator mesh__D051499 DRC
% 219.94/220.19  |- mesh__recordMaintainer mesh__D051499 DRC
% 219.94/220.19  |- skos__scopeNote mesh__D051499
% 219.94/220.19       A fibroblast growth factor receptor that is mainly expressed in LUNG; KIDNEY; PANCREAS; and SPLEEN. It also plays an important role in SKELETAL MUSCLE development and can contribute to NEOPLASTIC CELL TRANSFORMATION.%A%    
% 219.94/220.19  |- mesh__historyNote mesh__D051499 2006%28%1992%29%   
% 219.94/220.19  |- skos__prefLabel mesh__D051499 Receptor, Fibroblast Growth Factor, Type 4
% 219.94/220.19  |- skos__hiddenLabel mesh__D004045 Dietary Service
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D004045 1997
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D004045 2005
% 219.94/220.19  |- rdf__type mesh__D004045sskos__Concept
% 219.94/220.19  |- mesh__historyNote mesh__D004045 68   
% 219.94/220.19  |- skos__annotation mesh__D004045
% 219.94/220.19       emphasis on nutrition: differentiate from FOOD SERVICES, mere preparation %26% distribution of %22%ready-to-eat food%22%; DF: DIETARY SERV%A%  
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D004045 2006
% 219.94/220.19  |- skos__prefLabel mesh__D004045 Dietary Services
% 219.94/220.19  |- skos__historyNote mesh__D004045 Food Service, Hospital %28%1966-1967%29%
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D004045 1998
% 219.94/220.19  |- skos__altLabel mesh__D004045 Services, Dietary
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D004045 2002
% 219.94/220.19  |- skos__scopeNote mesh__D004045
% 219.94/220.19       Services provided by dietitians or nutritionists to meet the nutritional needs of individuals, including consultation with other professional personnel.%A%    
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D004045 2003
% 219.94/220.19  |- mesh__dateEstablished mesh__D004045 1968-01-01
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D004045 1999
% 219.94/220.19  |- mesh__dateRevised mesh__D004045 1995-05-22
% 219.94/220.19  |- mesh__recordMaintainer mesh__D004045 KEV
% 219.94/220.19  |- skos__historyNote mesh__D004045 Dietetics %28%1966-1967%29%
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D004045 2004
% 219.94/220.19  |- mesh__dateCreated mesh__D004045 1999-01-01
% 219.94/220.19  |- mesh__publicMeSHNote mesh__D004045 68   
% 219.94/220.19  |- mesh__recordAuthorizer mesh__D004045 PLS
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D004045 1996
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D004045 2000
% 219.94/220.19  |- skos__broader mesh__D004045smesh__D006296
% 219.94/220.19  |- mesh__recordOriginator mesh__D004045 NLM
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D004045 2001
% 219.94/220.19  |- skos__hiddenLabel mesh__D004045 Service, Dietary
% 219.94/220.19  |- skos__hiddenLabel mesh__D042962 Fatty Acyl CoA Oxidase
% 219.94/220.19  |- skos__altLabel mesh__D042962 Fatty Acid Acyl-CoA Oxidase
% 219.94/220.19  |- mesh__dateCreated mesh__D042962 2003-07-09
% 219.94/220.19  |- rdf__type mesh__D042962sskos__Concept
% 219.94/220.19  |- mesh__dateRevised mesh__D042962 2005-06-30
% 219.94/220.19  |- skos__historyNote mesh__D042962 Oxidoreductases %28%1982-2003%29%
% 219.94/220.19  |- mesh__recordOriginator mesh__D042962 AKE
% 219.94/220.19  |- mesh__activeMeSHYear mesh__D042962 2006
% 219.94/220.19  |- skos__hiddenLabel mesh__D042962 Acyl CoA Oxidase
% 219.94/220.19  |- skos__hiddenLabel mesh__D042962 Acyl-CoA Oxidase, Fatty
% 219.94/220.19  |- skos__altLabel mesh__D042962 Fatty Acyl-Coenzyme A Oxidase
% 219.94/220.19  |- skos__broader mesh__D042962smesh__D044944
% 219.94/220.19  |- skos__hiddenLabel mesh__D042962 Oxidase, Acyl-CoA
% 219.94/220.19  |- skos__prefLabel mesh__D042962 Acyl-CoA Oxidase
% 219.94/220.19  |- mesh__recordAuthorizer mesh__D042962 sjn
% 219.94/220.19  |- mesh__publicMeSHNote mesh__D042962
% 219.94/220.19       2004; ACYL-COA OXIDASE was indexed under OXIDOREDUCTASES 1982-2003, under ACYL COENZYME A 1980-1981 %26% under PEROXIDASES 1980%A%  
% 219.94/220.19  |- skos__altLabel mesh__D042962 Acyl Coenzyme A Oxidase
% 219.94/220.19  |- skos__historyNote mesh__D042962 Acyl Coenzyme A %28%1980-1981%29%
% 219.94/220.19  |- mesh__historyNote mesh__D042962
% 219.94/220.19       2004; use ACYL-COA OXIDASE %28%NM%29% 1979-2003   
% 219.94/220.19  |- mesh__recordMaintainer mesh__D042962 jmp
% 219.94/220.19  |- skos__hiddenLabel mesh__D042962 Fatty Acyl Coenzyme A Oxidase
% 219.94/220.19  |- skos__altLabel mesh__D042962 Fatty Acyl-CoA Oxidase
% 219.94/220.19  |- skos__historyNote mesh__D042962 Peroxidases %28%1980%29%
% 219.94/220.19  |- skos__hiddenLabel mesh__D042962 Oxidase, Fatty Acyl-CoA
% 219.94/220.19  |- skos__broader mesh__D042962smesh__D005420
% 219.94/220.20  |- skos__scopeNote mesh__D042962
% 219.94/220.20       An enzyme that catalyzes the first and rate-determining steps of peroxisomal beta-oxidation of fatty acids. It acts on COENZYME A derivatives of fatty acids with chain lengths from 8 to 18, using FLAVIN-ADENINE DINUCLEOTIDE as a cofactor.%A%    
% 219.94/220.20  |- mesh__dateEstablished mesh__D042962 2004-01-01
% 219.94/220.20  |- skos__hiddenLabel mesh__D042962 Fatty Acid Acyl CoA Oxidase
% 219.94/220.20  |- mesh__activeMeSHYear mesh__D014473 2002
% 219.94/220.20  |- skos__broader mesh__D014473smesh__D011574
% 219.94/220.20  |- mesh__activeMeSHYear mesh__D014473 1997
% 219.94/220.20  |- skos__scopeNote mesh__D014473
% 219.94/220.20       Those forces and content of the mind which are not ordinarily available to conscious awareness or to immediate recall.%A%    
% 219.94/220.20  |- mesh__activeMeSHYear mesh__D014473 2001
% 219.94/220.20  |- mesh__activeMeSHYear mesh__D014473 1999
% 219.94/220.20  |- rdf__type mesh__D014473sskos__Concept
% 219.94/220.20  |- mesh__activeMeSHYear mesh__D014473 1993
% 219.94/220.20  |- mesh__activeMeSHYear mesh__D014473 1996
% 219.94/220.20  |- skos__annotation mesh__D014473
% 219.94/220.20       no qualif; %22%the unconscious%22% or unconscious behavior: do not confuse with UNCONSCIOUSNESS, the physiol loss of consciousness; DF: UNCONSCIOUS%A%  
% 219.94/220.20  |- mesh__activeMeSHYear mesh__D014473 1995
% 219.94/220.20  |- mesh__activeMeSHYear mesh__D014473 1998
% 219.94/220.20  |- skos__altLabel mesh__D014473 Unconscious
% 219.94/220.20  |- skos__broader mesh__D014473smesh__D010553
% 219.94/220.20  |- mesh__activeMeSHYear mesh__D014473 1992
% 219.94/220.20  |- mesh__recordAuthorizer mesh__D014473 PLS
% 219.94/220.20  |- mesh__activeMeSHYear mesh__D014473 2000
% 219.94/220.20  |- mesh__recordOriginator mesh__D014473 NLM
% 219.94/220.20  |- mesh__dateCreated mesh__D014473 1999-01-01
% 219.94/220.20  |- mesh__historyNote mesh__D014473 69; was SUBCONSCIOUS 1963-68   
% 219.94/220.20  |- mesh__dateRevised mesh__D014473 1991-06-11
% 219.94/220.20  |- mesh__activeMeSHYear mesh__D014473 1994
% 219.94/220.20  |- mesh__activeMeSHYear mesh__D014473 2004
% 219.94/220.20  |- mesh__onlineNote mesh__D014473
% 219.94/220.20       use UNCONSCIOUS %28%PSYCHOLOGY%29% to search SUBCONSCIOUS 1966-68%A%  
% 219.94/220.20  |- skos__prefLabel mesh__D014473 Unconscious %28%Psychology%29%
% 219.94/220.20  |- mesh__activeMeSHYear mesh__D014473 2006
% 219.94/220.20  |- mesh__recordMaintainer mesh__D014473 PLS
% 219.94/220.20  |- mesh__activeMeSHYear mesh__D014473 2003
% 219.94/220.20  |- mesh__dateEstablished mesh__D014473 1969-01-01
% 219.94/220.20  |- mesh__publicMeSHNote mesh__D014473 69; was SUBCONSCIOUS 1963-68   
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D014473 2005
% 220.06/220.20  |- mesh__dateRevised mesh__D008436 2004-07-28
% 220.06/220.20  |- mesh__recordAuthorizer mesh__D008436 jls
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008436 2005
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008436 2005A
% 220.06/220.20  |- mesh__recordMaintainer mesh__D008436 jls
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008436 1999
% 220.06/220.20  |- skos__broader mesh__D008436smesh__D007195
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008436 2006
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008436 2000
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008436 1996
% 220.06/220.20  |- skos__annotation mesh__D008436 one of the Indian Ocean Islands   
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008436 2003
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008436 2001
% 220.06/220.20  |- mesh__dateEstablished mesh__D008436 1975-01-01
% 220.06/220.20  |- rdf__type mesh__D008436sskos__Concept
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008436 1997
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008436 2004
% 220.06/220.20  |- mesh__recordOriginator mesh__D008436 NLM
% 220.06/220.20  |- skos__scopeNote mesh__D008436
% 220.06/220.20       One of the Indian Ocean Islands, east of Madagascar. Its capital is Port Louis. It was discovered by the Portuguese in 1505, occupied by the Dutch 1598-1710, held by the French 1715-1810 when the British captured it, formally ceded to the British in 1814, and became independent in 1968. It was named by the Dutch in honor of Maurice of Nassau, Prince of Orange %28%1567-1625%29%. %28%From Webster%27%s New Geographical Dictionary, 1988, p742 %26% Room, Brewer%27%s Dictionary of Names, 1992, p341%29%%A%    
% 220.06/220.20  |- skos__prefLabel mesh__D008436 Mauritius
% 220.06/220.20  |- mesh__dateCreated mesh__D008436 1974-11-11
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008436 2002
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008436 1998
% 220.06/220.20  |- mesh__historyNote mesh__D000453 71   
% 220.06/220.20  |- skos__historyNote mesh__D000453 Virus Diseases %28%1966-1970%29%
% 220.06/220.20  |- mesh__recordMaintainer mesh__D000453 ags
% 220.06/220.20  |- skos__related mesh__D000453smesh__D002609
% 220.06/220.20  |- skos__hiddenLabel mesh__D000453 Disease, Aleutian Mink
% 220.06/220.20  |- skos__broader mesh__D000453smesh__D000820
% 220.06/220.20  |- skos__altLabel mesh__D000453 Aleutian Disease of Mink
% 220.06/220.20  |- skos__broader mesh__D000453smesh__D002609
% 220.06/220.20  |- skos__historyNote mesh__D000453 Carnivora %28%1966-1967%29%
% 220.06/220.20  |- skos__hiddenLabel mesh__D000453 Mink Disease, Aleutian
% 220.06/220.20  |- skos__broader mesh__D000453smesh__D010322
% 220.06/220.20  |- skos__prefLabel mesh__D000453 Aleutian Mink Disease
% 220.06/220.20  |- skos__scopeNote mesh__D000453
% 220.06/220.20       A slow progressive disease of mink caused by the ALEUTIAN MINK DISEASE VIRUS. It is characterized by poor reproduction, weight loss, autoimmunity, hypergammaglobulinemia, increased susceptibility to bacterial infections, and death from renal failure. The disease occurs in all color types, but mink which are homozygous recessive for the Aleutian gene for light coat color are particularly susceptible.%A%    
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D000453 2004
% 220.06/220.20  |- mesh__dateEstablished mesh__D000453 1971-01-01
% 220.06/220.20  |- mesh__dateCreated mesh__D000453 1999-01-01
% 220.06/220.20  |- skos__annotation mesh__D000453
% 220.06/220.20       caused by a parvovirus; don%27%t forget also MINK %28%NIM%29% %26% check tag ANIMALS%A%  
% 220.06/220.20  |- mesh__recordOriginator mesh__D000453 NLM
% 220.06/220.20  |- skos__broader mesh__D000453smesh__D012897
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D000453 2005
% 220.06/220.20  |- skos__historyNote mesh__D000453 Mink %28%1968-1970%29%
% 220.06/220.20  |- mesh__recordAuthorizer mesh__D000453 sjn
% 220.06/220.20  |- rdf__type mesh__D000453sskos__Concept
% 220.06/220.20  |- mesh__publicMeSHNote mesh__D000453 71   
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D000453 2006
% 220.06/220.20  |- mesh__dateRevised mesh__D000453 2003-07-30
% 220.06/220.20  |- mesh__publicMeSHNote mesh__D018864 96   
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D018864 2003
% 220.06/220.20  |- mesh__recordOriginator mesh__D018864 JLS
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D018864 2006
% 220.06/220.20  |- skos__scopeNote mesh__D018864
% 220.06/220.20       Coexistence of numerous distinct ethnic, racial, religious, or cultural groups within one social unit, organization, or population. %28%From American Heritage Dictionary, 2d college ed., 1982, p955%29%%A%    
% 220.06/220.20  |- skos__hiddenLabel mesh__D018864 Pluralisms
% 220.06/220.20  |- skos__annotation mesh__D018864
% 220.06/220.20       IM; coord with specific ethnic, racial, religious or other cultural aspect %28%IM%29%; specify geog if pertinent%A%  
% 220.06/220.20  |- skos__prefLabel mesh__D018864 Cultural Diversity
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D018864 2004
% 220.06/220.20  |- mesh__dateCreated mesh__D018864 1995-06-05
% 220.06/220.20  |- skos__hiddenLabel mesh__D018864 Diversity, Cultural
% 220.06/220.20  |- mesh__recordMaintainer mesh__D018864 jrf
% 220.06/220.20  |- mesh__recordAuthorizer mesh__D018864 sjn
% 220.06/220.20  |- rdf__type mesh__D018864sskos__Concept
% 220.06/220.20  |- skos__related mesh__D018864smesh__D028781
% 220.06/220.20  |- mesh__historyNote mesh__D018864 96   
% 220.06/220.20  |- skos__historyNote mesh__D018864 Culture %28%1975-1995%29%
% 220.06/220.20  |- skos__broader mesh__D018864smesh__D003469
% 220.06/220.20  |- skos__hiddenLabel mesh__D018864 Diversities, Cultural
% 220.06/220.20  |- mesh__dateEstablished mesh__D018864 1996-01-01
% 220.06/220.20  |- mesh__dateRevised mesh__D018864 2001-07-25
% 220.06/220.20  |- skos__hiddenLabel mesh__D018864 Pluralism, Cultural
% 220.06/220.20  |- skos__hiddenLabel mesh__D018864 Cultural Diversities
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D018864 2005
% 220.06/220.20  |- skos__hiddenLabel mesh__D018864 Multiculturalisms
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D018864 2002
% 220.06/220.20  |- skos__altLabel mesh__D018864 Multiculturalism
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D010881 1999
% 220.06/220.20  |- mesh__recordAuthorizer mesh__D010881 PLS
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D010881 2005
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D010881 2004
% 220.06/220.20  |- mesh__dateCreated mesh__D010881 1999-01-01
% 220.06/220.20  |- mesh__recordOriginator mesh__D010881 NLM
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D010881 2000
% 220.06/220.20  |- skos__historyNote mesh__D010881 Piperidines %28%1966-1970%29%
% 220.06/220.20  |- mesh__publicMeSHNote mesh__D010881
% 220.06/220.20       91; was see under PIPERIDINES 1971-90   
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D010881 1997
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D010881 1998
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D010881 2003
% 220.06/220.20  |- skos__broader mesh__D010881smesh__D010880
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D010881 1996
% 220.06/220.20  |- mesh__dateEstablished mesh__D010881 1991-01-01
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D010881 2002
% 220.06/220.20  |- mesh__historyNote mesh__D010881
% 220.06/220.20       91%28%71%29%; was see under PIPERIDINES 1971-90   
% 220.06/220.20  |- rdf__type mesh__D010881sskos__Concept
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D010881 1995
% 220.06/220.20  |- skos__prefLabel mesh__D010881 Piperidones
% 220.06/220.20  |- mesh__recordMaintainer mesh__D010881 TAP
% 220.06/220.20  |- mesh__dateRevised mesh__D010881 1992-05-19
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D010881 2006
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D010881 1993
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D010881 1994
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D010881 2001
% 220.06/220.20  |- mesh__dateCreated mesh__D018066 1993-06-15
% 220.06/220.20  |- skos__scopeNote mesh__D018066
% 220.06/220.20       A species in the genus PHLEBOVIRUS of the family BUNYAVIRIDAE, infecting vertebrates and vectored by ticks. It has not been associated with human disease though antibodies have been isolated from human sera.%A%    
% 220.06/220.20  |- mesh__recordOriginator mesh__D018066 AGS
% 220.06/220.20  |- skos__historyNote mesh__D018066 Phlebovirus %28%1992%29%
% 220.06/220.20  |- mesh__recordMaintainer mesh__D018066 sjn
% 220.06/220.20  |- skos__annotation mesh__D018066
% 220.06/220.20       infection: coord IM with BUNYAVIRIDAE INFECTIONS %28%IM%29%   
% 220.06/220.20  |- skos__historyNote mesh__D018066 Arboviruses %28%1968-1980%29%
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D018066 2006
% 220.06/220.20  |- skos__broader mesh__D018066smesh__D016856
% 220.06/220.20  |- mesh__publicMeSHNote mesh__D018066
% 220.06/220.20       2002; see UUKUNIEMI GROUP VIRUSES 1994-2001   
% 220.06/220.20  |- skos__prefLabel mesh__D018066 Uukuniemi virus
% 220.06/220.20  |- skos__altLabel mesh__D018066 Uukuniemi Group Viruses
% 220.06/220.20  |- mesh__dateRevised mesh__D018066 2004-07-13
% 220.06/220.20  |- mesh__historyNote mesh__D018066 2002 %28%1994%29%   
% 220.06/220.20  |- rdf__type mesh__D018066sskos__Concept
% 220.06/220.20  |- skos__historyNote mesh__D018066 Bunyaviridae %28%1981-1993%29%
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D018066 2005
% 220.06/220.20  |- mesh__dateEstablished mesh__D018066 1994-01-01
% 220.06/220.20  |- mesh__recordAuthorizer mesh__D018066 sjn
% 220.06/220.20  |- mesh__dateCreated mesh__D010083 1999-01-01
% 220.06/220.20  |- rdf__type mesh__D010083sskos__Concept
% 220.06/220.20  |- mesh__recordAuthorizer mesh__D010083 sjn
% 220.06/220.20  |- skos__broader mesh__D010083smesh__D000394
% 220.06/220.20  |- mesh__dateRevised mesh__D010083 2003-07-09
% 220.06/220.20  |- skos__historyNote mesh__D010083 Photochemistry %28%1971-1974%29%
% 220.06/220.20  |- skos__broader mesh__D010083smesh__D016877
% 220.06/220.20  |- mesh__recordMaintainer mesh__D010083 ssb
% 220.06/220.20  |- skos__hiddenLabel mesh__D010083 Photochemical Oxidants
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D010083 2004
% 220.06/220.20  |- skos__prefLabel mesh__D010083 Oxidants, Photochemical
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D010083 2006
% 220.06/220.20  |- mesh__recordOriginator mesh__D010083 NLM
% 220.06/220.20  |- mesh__historyNote mesh__D010083 75   
% 220.06/220.20  |- mesh__publicMeSHNote mesh__D010083 75   
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D010083 2005
% 220.06/220.20  |- skos__scopeNote mesh__D010083
% 220.06/220.20       Compounds that accept electrons in an oxidation-reduction reaction. The reaction is induced by or accelerated by exposure to electromagnetic radiation in the spectrum of visible or ultraviolet light.%A%    
% 220.06/220.20  |- skos__historyNote mesh__D010083 Oxidation-Reduction %28%1966-1974%29%
% 220.06/220.20  |- mesh__dateEstablished mesh__D010083 1975-09-01
% 220.06/220.20  |- skos__hiddenLabel mesh__D004844 Nose Bleeds
% 220.06/220.20  |- mesh__dateCreated mesh__D004844 1999-01-01
% 220.06/220.20  |- skos__broader mesh__D004844smesh__D009668
% 220.06/220.20  |- rdf__type mesh__D004844sskos__Concept
% 220.06/220.20  |- mesh__recordAuthorizer mesh__D004844 sjn
% 220.06/220.20  |- skos__broader mesh__D004844smesh__D006470
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004844 2003
% 220.06/220.20  |- mesh__dateRevised mesh__D004844 1999-11-03
% 220.06/220.20  |- skos__altLabel mesh__D004844 Nose Bleed
% 220.06/220.20  |- skos__prefLabel mesh__D004844 Epistaxis
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004844 2000
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004844 2004
% 220.06/220.20  |- skos__scopeNote mesh__D004844 Bleeding from the nose.     
% 220.06/220.20  |- skos__altLabel mesh__D004844 Nosebleed
% 220.06/220.20  |- mesh__recordOriginator mesh__D004844 NLM
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004844 2001
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004844 2005
% 220.06/220.20  |- mesh__recordMaintainer mesh__D004844 KEV
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004844 2002
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004844 2006
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004046 1997
% 220.06/220.20  |- skos__broader mesh__D004046smesh__D006281
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004046 1991
% 220.06/220.20  |- mesh__dateCreated mesh__D004046 1999-01-01
% 220.06/220.20  |- mesh__dateRevised mesh__D004046 1989-10-06
% 220.06/220.20  |- skos__scopeNote mesh__D004046 The study and regulation of the diet.     
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004046 2002
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004046 1996
% 220.06/220.20  |- mesh__recordOriginator mesh__D004046 NLM
% 220.06/220.20  |- rdf__type mesh__D004046sskos__Concept
% 220.06/220.20  |- mesh__recordMaintainer mesh__D004046 PLS
% 220.06/220.20  |- skos__related mesh__D004046smesh__D004045
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004046 1995
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004046 1990
% 220.06/220.20  |- skos__prefLabel mesh__D004046 Dietetics
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004046 2006
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004046 2001
% 220.06/220.20  |- skos__related mesh__D004046smesh__D005521
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004046 1993
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004046 1994
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004046 2005
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004046 2004
% 220.06/220.20  |- skos__annotation mesh__D004046
% 220.06/220.20       SPEC: SPEC qualif; principles of nutrition applied to feeding persons or groups of persons%A%  
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004046 1992
% 220.06/220.20  |- mesh__recordAuthorizer mesh__D004046 PLS
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004046 1999
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004046 2000
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004046 2003
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D004046 1998
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D042963 2006
% 220.06/220.20  |- skos__altLabel mesh__D042963 Succinate-Quinone Oxidoreductase
% 220.06/220.20  |- skos__historyNote mesh__D042963 Succinates %28%1973-1979%29%
% 220.06/220.20  |- mesh__dateEstablished mesh__D042963 2004-01-01
% 220.06/220.20  |- skos__altLabel mesh__D042963 Succinate-Ubiquinone Reductase
% 220.06/220.20  |- skos__historyNote mesh__D042963 Ubiquinone %28%1972-1978%29%
% 220.06/220.20  |- skos__hiddenLabel mesh__D042963 Succinate Coenzyme Q Reductase
% 220.06/220.20  |- skos__broader mesh__D042963smesh__D013384
% 220.06/220.20  |- skos__broader mesh__D042963smesh__D007506
% 220.06/220.20  |- skos__broader mesh__D042963smesh__D044925
% 220.06/220.20  |- skos__altLabel mesh__D042963 Succinate-Q Oxidoreductase
% 220.06/220.20  |- skos__hiddenLabel mesh__D042963 Succinate Ubiquinone Reductase
% 220.06/220.20  |- skos__altLabel mesh__D042963 Succinate Dehydrogenase-CoQ Reductase
% 220.06/220.20  |- skos__hiddenLabel mesh__D042963 Succinate Ubiquinone Oxidoreductase
% 220.06/220.20  |- mesh__dateRevised mesh__D042963 2005-06-30
% 220.06/220.20  |- skos__hiddenLabel mesh__D042963 Succinate Quinone Oxidoreductase
% 220.06/220.20  |- skos__hiddenLabel mesh__D042963 Oxidoreductase, Succinate-Quinone
% 220.06/220.20  |- mesh__recordOriginator mesh__D042963 AKE
% 220.06/220.20  |- skos__altLabel mesh__D042963 Succinate-Ubiquinone Oxidoreductase
% 220.06/220.20  |- skos__altLabel mesh__D042963 Succinate-Coenzyme Q Reductase
% 220.06/220.20  |- mesh__recordMaintainer mesh__D042963 jmp
% 220.06/220.20  |- mesh__historyNote mesh__D042963
% 220.06/220.20       2004; use ELECTRON TRANSPORT COMPLEX II %28%NM%29% 1980-2003; for SUCCINATE-Q OXIDOREDUCTASE use SUCCINATE DEHYDROGENASE 1980-2003%A%  
% 220.06/220.20  |- skos__hiddenLabel mesh__D042963 Succinate Q Oxidoreductase
% 220.06/220.20  |- skos__broader mesh__D042963smesh__D044927
% 220.06/220.20  |- mesh__publicMeSHNote mesh__D042963
% 220.06/220.20       2004; SUCCINATE DEHYDROGENASE %28%UBIQUINONE%29% was indexed under MULTIENZYME COMPLEXES, OXIDOREDUCTASES %26% SUCCINATE DEHYDROGENASE 1972-2003; for SUCCINATE-Q OXIDOREDUCTASE see SUCCINATE DEHYDROGENASE 1980-2003%A%  
% 220.06/220.20  |- skos__hiddenLabel mesh__D042963 Succinate Dehydrogenase CoQ Reductase
% 220.06/220.20  |- mesh__recordAuthorizer mesh__D042963 sjn
% 220.06/220.20  |- skos__hiddenLabel mesh__D042963 Oxidoreductase, Succinate-Q
% 220.06/220.20  |- skos__hiddenLabel mesh__D042963
% 220.06/220.20       Succinate Dehydrogenase Coenzyme Q Reductase
% 220.06/220.20  |- skos__historyNote mesh__D042963
% 220.06/220.20       Succinate Dehydrogenase %28%1980-2003%29%
% 220.06/220.20  |- skos__scopeNote mesh__D042963
% 220.06/220.20       A flavoprotein oxidase complex that contains iron-sulfur centers. It catalyzes the oxidation of SUCCINATE to FUMARATE and couples the reaction to the reduction of UBIQUINONE to ubiquinol.%A%    
% 220.06/220.20  |- rdf__type mesh__D042963sskos__Concept
% 220.06/220.20  |- skos__hiddenLabel mesh__D042963 Oxidoreductase, Succinate-Ubiquinone
% 220.06/220.20  |- skos__prefLabel mesh__D042963 Electron Transport Complex II
% 220.06/220.20  |- mesh__dateCreated mesh__D042963 2003-07-09
% 220.06/220.20  |- skos__hiddenLabel mesh__D042963 Dehydrogenase-CoQ Reductase, Succinate
% 220.06/220.20  |- skos__altLabel mesh__D042963 Succinate Dehydrogenase %28%Ubiquinone%29%
% 220.06/220.20  |- skos__hiddenLabel mesh__D042963 Reductase, Succinate Dehydrogenase-CoQ
% 220.06/220.20  |- skos__altLabel mesh__D042963
% 220.06/220.20       Succinate Dehydrogenase-Coenzyme Q Reductase
% 220.06/220.20  |- mesh__dateRevised mesh__D014474 2001-07-25
% 220.06/220.20  |- rdf__type mesh__D014474sskos__Concept
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D014474 2002
% 220.06/220.20  |- skos__scopeNote mesh__D014474
% 220.06/220.20       Loss of the ability to maintain awareness of self and environment combined with markedly reduced responsiveness to environmental stimuli. %28%From Adams et al., Principles of Neurology, 6th ed, pp344-5%29%%A%    
% 220.06/220.20  |- mesh__dateCreated mesh__D014474 1999-01-01
% 220.06/220.20  |- skos__prefLabel mesh__D014474 Unconsciousness
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D014474 2004
% 220.06/220.20  |- skos__altLabel mesh__D014474 Unconscious State
% 220.06/220.20  |- skos__broader mesh__D014474smesh__D003244
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D014474 2006
% 220.06/220.20  |- skos__hiddenLabel mesh__D014474 State, Unconscious
% 220.06/220.20  |- skos__hiddenLabel mesh__D014474 Loss of Consciousness
% 220.06/220.20  |- mesh__recordAuthorizer mesh__D014474 sjn
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D014474 2003
% 220.06/220.20  |- mesh__recordOriginator mesh__D014474 NLM
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D014474 2005
% 220.06/220.20  |- skos__annotation mesh__D014474
% 220.06/220.20       do not confuse with UNCONSCIOUS %28%PSYCHOLOGY%29%, unconscious behavior or %22%the unconscious%22% in psychol%A%  
% 220.06/220.20  |- skos__altLabel mesh__D014474 Consciousness, Loss of
% 220.06/220.20  |- skos__related mesh__D014474smesh__D013575
% 220.06/220.20  |- skos__hiddenLabel mesh__D014474 Unconscious States
% 220.06/220.20  |- mesh__recordMaintainer mesh__D014474 ags
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008437 2006
% 220.06/220.20  |- mesh__dateRevised mesh__D008437 1991-06-20
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008437 1993
% 220.06/220.20  |- mesh__recordMaintainer mesh__D008437 TGC
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008437 2002
% 220.06/220.20  |- mesh__recordAuthorizer mesh__D008437 PLS
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008437 1996
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008437 2003
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008437 1997
% 220.06/220.20  |- rdf__type mesh__D008437sskos__Concept
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008437 1994
% 220.06/220.20  |- skos__hiddenLabel mesh__D008437 Maxillas
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008437 2004
% 220.06/220.20  |- mesh__dateCreated mesh__D008437 1999-01-01
% 220.06/220.20  |- skos__related mesh__D008437smesh__D008445
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008437 2000
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008437 1995
% 220.06/220.20  |- skos__broader mesh__D008437smesh__D007568
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008437 2001
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008437 1998
% 220.06/220.20  |- skos__annotation mesh__D008437
% 220.06/220.20       the upper jaw only; check text for loose use of %22%maxillary%22% to mean %22%jaw%22%, not precisely MAXILLA; /blood supply: consider also MAXILLARY ARTERY; /growth: consider also MAXILLOFACIAL DEVELOPMENT; /inj: consider also MAXILLOFACIAL INJURIES; /innerv: consider also MAXILLARY NERVE%A%  
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008437 2005
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008437 1992
% 220.06/220.20  |- skos__prefLabel mesh__D008437 Maxilla
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D008437 1999
% 220.06/220.20  |- mesh__recordOriginator mesh__D008437 NLM
% 220.06/220.20  |- mesh__dateEstablished mesh__D000454 1991-01-01
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D000454 1997
% 220.06/220.20  |- mesh__historyNote mesh__D000454
% 220.06/220.20       97,75-93; was ALEUTIAN MINK DISEASE PARVOVIRUS 1994-96; was see under PARVOVIRIDAE 1986-90, see under VERTEBRATE VIRUSES, UNCLASSIFIED 1975-85%A%  
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D000454 2002
% 220.06/220.20  |- skos__altLabel mesh__D000454 Aleutian Mink Disease Parvovirus
% 220.06/220.20  |- rdf__type mesh__D000454sskos__Concept
% 220.06/220.20  |- mesh__recordOriginator mesh__D000454 NLM
% 220.06/220.20  |- mesh__recordMaintainer mesh__D000454 AGS
% 220.06/220.20  |- mesh__dateRevised mesh__D000454 1996-06-10
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D000454 2006
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D000454 2001
% 220.06/220.20  |- skos__scopeNote mesh__D000454
% 220.06/220.20       A species of PARVOVIRUS that causes a disease in mink, mainly those homozygous for the recessive Aleutian gene which determines a desirable coat color.%A%    
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D000454 2005
% 220.06/220.20  |- skos__altLabel mesh__D000454 Aleutian Disease Virus
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D000454 2000
% 220.06/220.20  |- skos__prefLabel mesh__D000454 Aleutian Mink Disease Virus
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D000454 2004
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D000454 1999
% 220.06/220.20  |- mesh__recordAuthorizer mesh__D000454 PLS
% 220.06/220.20  |- skos__broader mesh__D000454smesh__D017992
% 220.06/220.20  |- mesh__publicMeSHNote mesh__D000454
% 220.06/220.20       97,75-93; was ALEUTIAN MINK DISEASE PARVOVIRUS 1994-96; was see under PARVOVIRIDAE 1986-90, see under VERTEBRATE VIRUSES, UNCLASSIFIED 1975-85%A%  
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D000454 1998
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D000454 2003
% 220.06/220.20  |- skos__annotation mesh__D000454
% 220.06/220.20       a species of Parvovirus; infection = ALEUTIAN MINK DISEASE: see note there; DF: ALEUTIAN MINK DIS PARVOVIRUS%A%  
% 220.06/220.20  |- mesh__dateCreated mesh__D000454 1974-11-19
% 220.06/220.20  |- mesh__dateRevised mesh__D018865 1999-11-03
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D018865 2000
% 220.06/220.20  |- mesh__recordOriginator mesh__D018865 TGC
% 220.06/220.20  |- mesh__dateEstablished mesh__D018865 1996-01-01
% 220.06/220.20  |- skos__scopeNote mesh__D018865
% 220.06/220.20       The study of laws, theories, and hypotheses through a systematic examination of pertinent facts and their interpretation in the field of dentistry. %28%From Jablonski, Illustrated Dictionary of Dentistry, 1982, p674%29%%A%    
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D018865 2004
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D018865 2006
% 220.06/220.20  |- skos__historyNote mesh__D018865 Research %28%1966-1995%29%
% 220.06/220.20  |- skos__broader mesh__D018865smesh__D003813
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D018865 2003
% 220.06/220.20  |- skos__annotation mesh__D018865
% 220.06/220.20       dent research as a field; avoid since most dental articles indexed contribute to %22%dental research%22%; IM general only on dent research as a field; NIM for status or progress of research in a special dent field or subject %28%IM%29%; /methods: consider also RESEARCH DESIGN; DF: DENT RESEARCH%A%  
% 220.06/220.20  |- skos__historyNote mesh__D018865 Dentistry %28%1966-1995%29%
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D018865 2005
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D018865 2002
% 220.06/220.20  |- mesh__dateCreated mesh__D018865 1994-12-27
% 220.06/220.20  |- mesh__recordAuthorizer mesh__D018865 sjn
% 220.06/220.20  |- mesh__recordMaintainer mesh__D018865 kle
% 220.06/220.20  |- rdf__type mesh__D018865sskos__Concept
% 220.06/220.20  |- skos__altLabel mesh__D018865 Research, Dental
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D018865 2001
% 220.06/220.20  |- mesh__historyNote mesh__D018865 96   
% 220.06/220.20  |- skos__prefLabel mesh__D018865 Dental Research
% 220.06/220.20  |- mesh__publicMeSHNote mesh__D018865 96   
% 220.06/220.20  |- skos__broader mesh__D010882smesh__D052117
% 220.06/220.20  |- mesh__recordMaintainer mesh__D010882 ssb
% 220.06/220.20  |- mesh__publicMeSHNote mesh__D010882 74   
% 220.06/220.20  |- mesh__historyNote mesh__D010882 74%28%72%29%   
% 220.06/220.20  |- mesh__dateEstablished mesh__D010882 1974-01-01
% 220.06/220.20  |- mesh__recordOriginator mesh__D010882 NLM
% 220.06/220.20  |- skos__prefLabel mesh__D010882 Piperonyl Butoxide
% 220.06/220.20  |- rdf__type mesh__D010882sskos__Concept
% 220.06/220.20  |- skos__historyNote mesh__D010882 Pesticides %28%1966-1971%29%
% 220.06/220.20  |- mesh__recordAuthorizer mesh__D010882 sjn
% 220.06/220.20  |- skos__historyNote mesh__D010882 Insecticides %28%1966-1971%29%
% 220.06/220.20  |- skos__hiddenLabel mesh__D010882 Butoxide, Piperonyl
% 220.06/220.20  |- skos__historyNote mesh__D010882 Dioxoles %28%1968-1971%29%
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D010882 2006
% 220.06/220.20  |- skos__scopeNote mesh__D010882
% 220.06/220.20       An insecticide synergist, especially for pyrethroids and ROTENONE.%A%    
% 220.06/220.20  |- mesh__dateRevised mesh__D010882 2005-06-30
% 220.06/220.20  |- mesh__dateCreated mesh__D010882 1999-01-01
% 220.06/220.20  |- mesh__dateEstablished mesh__D018067 1994-01-01
% 220.06/220.20  |- mesh__recordMaintainer mesh__D018067 ags
% 220.06/220.20  |- mesh__activeMeSHYear mesh__D018067 2006
% 220.06/220.21  |- mesh__recordAuthorizer mesh__D018067 sjn
% 220.06/220.21  |- rdf__type mesh__D018067sskos__Concept
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D018067 2005
% 220.06/220.21  |- skos__broader mesh__D018067smesh__D012328
% 220.06/220.21  |- skos__scopeNote mesh__D018067
% 220.06/220.21       A family of RNA viruses, many of which cause disease in humans and domestic animals. There are three genera FLAVIVIRUS; PESTIVIRUS; and HEPACIVIRUS, as well as several unassigned species.%A%    
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D018067 2002
% 220.06/220.21  |- skos__historyNote mesh__D018067 Flavivirus %28%1985-1993%29%
% 220.06/220.21  |- mesh__dateRevised mesh__D018067 2001-07-25
% 220.06/220.21  |- mesh__dateCreated mesh__D018067 1993-06-04
% 220.06/220.21  |- mesh__recordOriginator mesh__D018067 AGS
% 220.06/220.21  |- mesh__publicMeSHNote mesh__D018067 94   
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D018067 2004
% 220.06/220.21  |- skos__annotation mesh__D018067 infection = FLAVIVIRIDAE INFECTIONS   
% 220.06/220.21  |- skos__prefLabel mesh__D018067 Flaviviridae
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D018067 2003
% 220.06/220.21  |- mesh__historyNote mesh__D018067 94   
% 220.06/220.21  |- skos__annotation mesh__D010084
% 220.06/220.21       IM for general only; NIM with no qualif with specific drug IM%A%  
% 220.06/220.21  |- mesh__dateRevised mesh__D010084 1996-06-13
% 220.06/220.21  |- mesh__recordMaintainer mesh__D010084 TGC
% 220.06/220.21  |- skos__altLabel mesh__D010084 Redox
% 220.06/220.21  |- skos__hiddenLabel mesh__D010084 Oxidation Reduction
% 220.06/220.21  |- skos__related mesh__D010084smesh__D000975
% 220.06/220.21  |- skos__scopeNote mesh__D010084
% 220.06/220.21       A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs %28%Lehninger, Principles of Biochemistry, 1982, p471%29%.%A%    
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D010084 2004
% 220.06/220.21  |- skos__related mesh__D010084smesh__D016877
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D010084 2002
% 220.06/220.21  |- skos__prefLabel mesh__D010084 Oxidation-Reduction
% 220.06/220.21  |- mesh__recordAuthorizer mesh__D010084 PLS
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D010084 2006
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D010084 2003
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D010084 2001
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D010084 2005
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D010084 1997
% 220.06/220.21  |- skos__broader mesh__D010084smesh__D004734
% 220.06/220.21  |- skos__broader mesh__D010084smesh__D002627
% 220.06/220.21  |- skos__related mesh__D010084smesh__D019163
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D010084 1999
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D010084 2000
% 220.06/220.21  |- mesh__recordOriginator mesh__D010084 NLM
% 220.06/220.21  |- mesh__dateCreated mesh__D010084 1999-01-01
% 220.06/220.21  |- rdf__type mesh__D010084sskos__Concept
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D010084 1998
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D004845 2004
% 220.06/220.21  |- skos__historyNote mesh__D004845 Testosterone %28%1969-1974%29%
% 220.06/220.21  |- mesh__recordMaintainer mesh__D004845 lkt
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D004845 2005
% 220.06/220.21  |- skos__hiddenLabel mesh__D004845 17 alpha Testosterone
% 220.06/220.21  |- mesh__dateEstablished mesh__D004845 1991-01-01
% 220.06/220.21  |- skos__scopeNote mesh__D004845
% 220.06/220.21       The 17-alpha isomer of TESTOSTERONE, derived from PREGNENOLONE via the delta5-steroid pathway, and via 5-androstene-3-beta,17-alpha-diol. Epitestosterone acts as an antiandrogen in various target tissues. The ratio between testosterone/epitestosterone is used to monitor anabolic drug abuse.%A%    
% 220.06/220.21  |- mesh__historyNote mesh__D004845
% 220.06/220.21       91%28%75%29%; was see under TESTOSTERONE 1975-90   
% 220.06/220.21  |- mesh__dateRevised mesh__D004845 2003-07-09
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D004845 2006
% 220.06/220.21  |- mesh__recordAuthorizer mesh__D004845 sjn
% 220.06/220.21  |- mesh__dateCreated mesh__D004845 1974-11-11
% 220.06/220.21  |- skos__altLabel mesh__D004845 17-alpha-Testosterone
% 220.06/220.21  |- rdf__type mesh__D004845sskos__Concept
% 220.06/220.21  |- mesh__publicMeSHNote mesh__D004845
% 220.06/220.21       91; was see under TESTOSTERONE 1975-90   
% 220.06/220.21  |- skos__broader mesh__D004845smesh__D013739
% 220.06/220.21  |- skos__prefLabel mesh__D004845 Epitestosterone
% 220.06/220.21  |- mesh__recordOriginator mesh__D004845 NLM
% 220.06/220.21  |- skos__historyNote mesh__D004047 Formic Acids %28%1974%29%
% 220.06/220.21  |- mesh__recordAuthorizer mesh__D004047 sjn
% 220.06/220.21  |- rdf__type mesh__D004047sskos__Concept
% 220.06/220.21  |- skos__historyNote mesh__D004047 Esters %28%1974%29%
% 220.06/220.21  |- mesh__dateEstablished mesh__D004047 1991-01-01
% 220.06/220.21  |- skos__prefLabel mesh__D004047 Diethyl Pyrocarbonate
% 220.06/220.21  |- skos__altLabel mesh__D004047 Diethyl Oxydiformate
% 220.06/220.21  |- skos__altLabel mesh__D004047 Ethoxyformic Anhydride
% 220.06/220.21  |- skos__hiddenLabel mesh__D004047 Anhydride, Ethoxyformic
% 220.06/220.21  |- skos__broader mesh__D004047smesh__D005563
% 220.06/220.21  |- skos__altLabel mesh__D004047 Pyrocarbonic Acid Diethyl Ester
% 220.06/220.21  |- mesh__recordMaintainer mesh__D004047 CCR
% 220.06/220.21  |- skos__hiddenLabel mesh__D004047 Dicarbonate, Diethyl
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D004047 2006
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D004047 2002
% 220.06/220.21  |- skos__altLabel mesh__D004047 Diethyl Dicarbonate
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D004047 2005
% 220.06/220.21  |- mesh__recordOriginator mesh__D004047 NLM
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D004047 2004
% 220.06/220.21  |- mesh__publicMeSHNote mesh__D004047 91; was see under FORMATES 1975-90   
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D004047 2003
% 220.06/220.21  |- mesh__dateCreated mesh__D004047 1974-11-27
% 220.06/220.21  |- mesh__dateRevised mesh__D004047 2000-06-21
% 220.06/220.21  |- skos__hiddenLabel mesh__D004047 Oxydiformate, Diethyl
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D004047 2001
% 220.06/220.21  |- skos__altLabel mesh__D004047 Diethylpyrocarbonate
% 220.06/220.21  |- mesh__historyNote mesh__D004047
% 220.06/220.21       91%28%75%29%; was see under FORMATES 1975-90   
% 220.06/220.21  |- skos__scopeNote mesh__D004047
% 220.06/220.21       Preservative for wines, soft drinks, and fruit juices and a gentle esterifying agent.%A%    
% 220.06/220.21  |- skos__hiddenLabel mesh__D004047 Pyrocarbonate, Diethyl
% 220.06/220.21  |- skos__altLabel mesh__D009530 Reig Jofre Brand of Nicergoline
% 220.06/220.21  |- skos__altLabel mesh__D009530 Nimergoline
% 220.06/220.21  |- mesh__recordMaintainer mesh__D009530 lkw
% 220.06/220.21  |- skos__altLabel mesh__D009530 neuraxpharm Brand of Nicergoline
% 220.06/220.21  |- mesh__historyNote mesh__D009530
% 220.06/220.21       91%28%75%29%; was see under ERGOLINES 1975-90   
% 220.06/220.21  |- skos__altLabel mesh__D009530 Aventis Brand of Nicergoline
% 220.06/220.21  |- skos__altLabel mesh__D009530 Pharmacia Brand of Nicergoline
% 220.06/220.21  |- skos__altLabel mesh__D009530 Krewel Brand of Nicergoline
% 220.06/220.21  |- mesh__activeMeSHYear mesh__D009530 2006
% 220.06/220.21  |- skos__hiddenLabel mesh__D009530 Nicergoline Teva Brand
% 220.06/220.21  |- mesh__dateEstablished mesh__D009530 1991-01-01
% 220.06/220.21  |- mesh__publicMeSHNote mesh__D009530
% 220.06/220.21       91; was see under ERGOLINES 1975-90   
% 220.06/220.21  |- skos__altLabel mesh__D009530 Hormosan Brand of Nicergoline
% 220.06/220.21  |- skos__hiddenLabel mesh__D009530 Circo Maren
% 220.06/220.21  |- skos__hiddenLabel mesh__D009530 Nicergolin ratiopharm
% 220.06/220.21  |- skos__altLabel mesh__D009530 ct-Arzneimittel Brand of Nicergoline
% 220.06/220.21  |- skos__prefLabel mesh__D009530 Nicergoline
% 220.06/220.21  |- skos__altLabel mesh__D009530 betapharm Brand of Nicergoline
% 220.06/220.21  |- skos__altLabel mesh__D009530 Kenfarma Brand of Nicergoline
% 220.06/220.21  |- skos__historyNote mesh__D009530 Ergolines %28%1972-1974%29%
% 220.06/220.21  |- skos__hiddenLabel mesh__D009530 Nicergoline Hexal Brand
% 220.06/220.21  |- skos__historyNote mesh__D009530 Nicotinic Acids %28%1972-1974%29%
% 220.06/220.21  |- mesh__recordOriginator mesh__D009530 NLM
% 220.06/220.21  |- skos__altLabel mesh__D009530 Nicotergoline
% 220.06/220.21  |- skos__altLabel mesh__D009530 ratiopharm Brand of Nicergoline
% 220.06/220.21  |- mesh__recordAuthorizer mesh__D009530 sjn
% 220.06/220.21  |- skos__broader mesh__D009530smesh__D004873
% 220.06/220.21  |- skos__hiddenLabel mesh__D009530 Nicergolin TEVA
% 220.06/220.21  |- skos__hiddenLabel mesh__D009530 Nicergolin neuraxpharm
% 220.07/220.21  |- skos__hiddenLabel mesh__D009530 ct Arzneimittel Brand of Nicergoline
% 220.07/220.21  |- rdf__type mesh__D009530sskos__Concept
% 220.07/220.21  |- mesh__dateCreated mesh__D009530 1974-11-11
% 220.07/220.21  |- skos__altLabel mesh__D009530 Lindopharm Brand of Nicergoline
% 220.07/220.21  |- skos__scopeNote mesh__D009530
% 220.07/220.21       An ergot derivative that has been used as a cerebral vasodilator and in peripheral vascular disease. It has been suggested to ameliorate cognitive deficits in cerebrovascular disease.%A%    
% 220.07/220.21  |- skos__altLabel mesh__D009530 Dexcel Brand of Nicergoline
% 220.07/220.21  |- skos__altLabel mesh__D009530 Teva Brand of Nicergoline
% 220.07/220.21  |- skos__altLabel mesh__D009530 Hexal Brand of Nicergoline
% 220.07/220.21  |- mesh__dateRevised mesh__D009530 2004-07-07
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D009530 2005
% 220.07/220.21  |- mesh__dateRevised mesh__D023201 2005-06-30
% 220.07/220.21  |- skos__broader mesh__D023201smesh__D008562
% 220.07/220.21  |- mesh__dateCreated mesh__D023201 2000-06-23
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D023201 2006
% 220.07/220.21  |- skos__altLabel mesh__D023201 gp39 Antigen, T-Cell
% 220.07/220.21  |- skos__altLabel mesh__D023201 CD154 Antigen
% 220.07/220.21  |- skos__altLabel mesh__D023201 Antigen, CD154
% 220.07/220.21  |- rdf__type mesh__D023201sskos__Concept
% 220.07/220.21  |- mesh__historyNote mesh__D023201
% 220.07/220.21       2001; use CD40 LIGAND %28%NM%29% to search CD40L 1992-2000   
% 220.07/220.21  |- mesh__publicMeSHNote mesh__D023201
% 220.07/220.21       2001; CD40L was indexed under MEMBRANE GLYCOPROTEINS 1992-2000%A%  
% 220.07/220.21  |- skos__altLabel mesh__D023201 T-BAM
% 220.07/220.21  |- skos__broader mesh__D023201smesh__D015703
% 220.07/220.21  |- skos__hiddenLabel mesh__D023201 T-Cell gp39 Antigen
% 220.07/220.21  |- mesh__recordMaintainer mesh__D023201 ssb
% 220.07/220.21  |- skos__hiddenLabel mesh__D023201 gp39 Antigen, T Cell
% 220.07/220.21  |- skos__altLabel mesh__D023201 T-B Cell Activating Molecule
% 220.07/220.21  |- skos__hiddenLabel mesh__D023201 T BAM
% 220.07/220.21  |- skos__historyNote mesh__D023201 Membrane Glycoproteins %28%1992-2000%29%
% 220.07/220.21  |- mesh__dateEstablished mesh__D023201 2001-01-01
% 220.07/220.21  |- mesh__recordOriginator mesh__D023201 ags
% 220.07/220.21  |- skos__altLabel mesh__D023201 CD40L
% 220.07/220.21  |- mesh__recordAuthorizer mesh__D023201 sjn
% 220.07/220.21  |- skos__related mesh__D023201smesh__D019013
% 220.07/220.21  |- skos__prefLabel mesh__D023201 CD40 Ligand
% 220.07/220.21  |- skos__scopeNote mesh__D023201
% 220.07/220.21       Membrane glycoprotein and differentiation antigen expressed on the surface of T-cells.  It binds to CD40; %28%ANTIGENS, CD40%29% on B-cells, inducing B-cell proliferation. Mutation in this protein causes X-linked hyper-IMMUNOGLOBULIN M syndrome %28%HYPERGAMMAGLOBULINEMIA%29%.%A%    
% 220.07/220.21  |- skos__altLabel mesh__D023201 CD154 Antigens
% 220.07/220.21  |- skos__altLabel mesh__D023201 Antigens, CD154
% 220.07/220.21  |- skos__hiddenLabel mesh__D042964 Acyl CoA Dehydrogenase
% 220.07/220.21  |- mesh__publicMeSHNote mesh__D042964
% 220.07/220.21       2004; ACYL-COA DEHYDROGENASE was indexed under FATTY ACID DESATURASES 1982-2003%A%  
% 220.07/220.21  |- skos__altLabel mesh__D042964 Octanoyl-CoA Dehydrogenase
% 220.07/220.21  |- skos__prefLabel mesh__D042964 Acyl-CoA Dehydrogenase
% 220.07/220.21  |- mesh__recordMaintainer mesh__D042964 jmp
% 220.07/220.21  |- skos__hiddenLabel mesh__D042964 Acyl-CoA Dehydrogenase, Medium-Chain
% 220.07/220.21  |- skos__hiddenLabel mesh__D042964
% 220.07/220.21       Medium Chain Acyl Coenzyme A Dehydrogenase
% 220.07/220.21  |- mesh__recordAuthorizer mesh__D042964 sjn
% 220.07/220.21  |- skos__altLabel mesh__D042964 Medium Chain Acyl-CoA Dehydrogenase
% 220.07/220.21  |- skos__hiddenLabel mesh__D042964 Acyl coenzyme A Dehydrogenase
% 220.07/220.21  |- mesh__dateCreated mesh__D042964 2003-07-09
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D042964 2006
% 220.07/220.21  |- skos__altLabel mesh__D042964 MCACA-Dehydrogenase
% 220.07/220.21  |- skos__altLabel mesh__D042964 Palmitoyl-CoA Dehydrogenase
% 220.07/220.21  |- rdf__type mesh__D042964sskos__Concept
% 220.07/220.21  |- skos__altLabel mesh__D042964 Medium-Chain Acyl-Coenzyme A Dehydrogenase
% 220.07/220.21  |- skos__hiddenLabel mesh__D042964 Dehydrogenase, Octanoyl-CoA
% 220.07/220.21  |- skos__hiddenLabel mesh__D042964 Octanoyl CoA Dehydrogenase
% 220.07/220.21  |- skos__altLabel mesh__D042964 Acyl-coenzyme A Dehydrogenase
% 220.07/220.21  |- skos__annotation mesh__D042964
% 220.07/220.21       ACYL-COA DEHYDROGENASES and ACYL-COA DEHYDROGENASE, LONG-CHAIN are also available%A%  
% 220.07/220.21  |- mesh__historyNote mesh__D042964
% 220.07/220.21       2004; use ACYL-COA DEHYDROGENASE %28%NM%29% 1980-2003   
% 220.07/220.21  |- skos__broader mesh__D042964smesh__D044944
% 220.07/220.21  |- skos__hiddenLabel mesh__D042964 Dehydrogenase, Medium-Chain Acyl-CoA
% 220.07/220.21  |- skos__broader mesh__D042964smesh__D005420
% 220.07/220.21  |- skos__hiddenLabel mesh__D042964 Dehydrogenase, Acyl-coenzyme A
% 220.07/220.21  |- skos__hiddenLabel mesh__D042964 Fatty acyl CoA Dehydrogenase
% 220.07/220.21  |- skos__hiddenLabel mesh__D042964 Medium Chain Acyl CoA Dehydrogenase
% 220.07/220.21  |- mesh__recordOriginator mesh__D042964 AKE
% 220.07/220.21  |- skos__hiddenLabel mesh__D042964 Dehydrogenase, Acyl-CoA
% 220.07/220.21  |- skos__historyNote mesh__D042964 Fatty Acid Desaturases %28%1982-2003%29%
% 220.07/220.21  |- mesh__dateEstablished mesh__D042964 2004-01-01
% 220.07/220.21  |- skos__hiddenLabel mesh__D042964 Dehydrogenase, Fatty-acyl CoA
% 220.07/220.21  |- skos__hiddenLabel mesh__D042964 MCACA Dehydrogenase
% 220.07/220.21  |- skos__altLabel mesh__D042964 Fatty-acyl CoA Dehydrogenase
% 220.07/220.21  |- skos__hiddenLabel mesh__D042964 Palmitoyl CoA Dehydrogenase
% 220.07/220.21  |- skos__scopeNote mesh__D042964
% 220.07/220.21       A flavoprotein oxidoreductase that has specificity for medium-chain fatty acids. It forms a complex with ELECTRON TRANSFERRING FLAVOPROTEINS and conveys reducing equivalents to UBIQUINONE.%A%    
% 220.07/220.21  |- skos__hiddenLabel mesh__D042964 Dehydrogenase, Palmitoyl-CoA
% 220.07/220.21  |- skos__altLabel mesh__D042964 Medium-Chain Acyl-CoA Dehydrogenase
% 220.07/220.21  |- mesh__dateRevised mesh__D042964 2005-06-30
% 220.07/220.21  |- skos__hiddenLabel mesh__D042964 CoA Dehydrogenase, Fatty-acyl
% 220.07/220.21  |- skos__historyNote mesh__D014475
% 220.07/220.21       Oxidoreductases/antagonists %26% inhibitors %28%1968%29%
% 220.07/220.21  |- mesh__dateCreated mesh__D014475 1999-01-01
% 220.07/220.21  |- mesh__historyNote mesh__D014475 72%28%69%29%   
% 220.07/220.21  |- mesh__recordAuthorizer mesh__D014475 sjn
% 220.07/220.21  |- skos__historyNote mesh__D014475
% 220.07/220.21       Oxidative Phosphorylation/drug effects %28%1966-1968%29%
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D014475 2004
% 220.07/220.21  |- mesh__recordOriginator mesh__D014475 NLM
% 220.07/220.21  |- skos__hiddenLabel mesh__D014475 Agents, Uncoupling
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D014475 2006
% 220.07/220.21  |- skos__related mesh__D014475smesh__D007476
% 220.07/220.21  |- skos__prefLabel mesh__D014475 Uncoupling Agents
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D014475 2005
% 220.07/220.21  |- mesh__recordMaintainer mesh__D014475 ssb
% 220.07/220.21  |- skos__broader mesh__D014475smesh__D004791
% 220.07/220.21  |- mesh__publicMeSHNote mesh__D014475
% 220.07/220.21       72; DIO-9 was see under ANTIBIOTICS 1975-81   
% 220.07/220.21  |- mesh__dateRevised mesh__D014475 2003-07-09
% 220.07/220.21  |- rdf__type mesh__D014475sskos__Concept
% 220.07/220.21  |- skos__scopeNote mesh__D014475
% 220.07/220.21       Chemical agents that uncouple oxidation from phosphorylation in the metabolic cycle so that ATP synthesis does not occur. Included here are those IONOPHORES that disrupt electron transfer by short-circuiting the proton gradient across mitochondrial membranes.%A%    
% 220.07/220.21  |- mesh__dateEstablished mesh__D014475 1972-01-01
% 220.07/220.21  |- skos__annotation mesh__D014475 enzyme inhib   
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D008438 1993
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D008438 1994
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D008438 1999
% 220.07/220.21  |- mesh__recordAuthorizer mesh__D008438 PLS
% 220.07/220.21  |- skos__hiddenLabel mesh__D008438 Artery, Maxillary
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D008438 2006
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D008438 2001
% 220.07/220.21  |- mesh__recordOriginator mesh__D008438 NLM
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D008438 1997
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D008438 1998
% 220.07/220.21  |- skos__hiddenLabel mesh__D008438 Arteries, Maxillary
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D008438 2004
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D008438 2005
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D008438 2000
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D008438 1996
% 220.07/220.21  |- rdf__type mesh__D008438sskos__Concept
% 220.07/220.21  |- skos__hiddenLabel mesh__D008438 Maxillary Arteries
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D008438 2003
% 220.07/220.21  |- skos__broader mesh__D008438smesh__D001158
% 220.07/220.21  |- skos__scopeNote mesh__D008438
% 220.07/220.21       A branch of the external carotid artery which distributes to the deep structures of the face %28%internal maxillary%29% and to the side of the face and nose %28%external maxillary%29%.%A%    
% 220.07/220.21  |- skos__prefLabel mesh__D008438 Maxillary Artery
% 220.07/220.21  |- mesh__recordMaintainer mesh__D008438 TAP
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D008438 1995
% 220.07/220.21  |- mesh__dateCreated mesh__D008438 1999-01-01
% 220.07/220.21  |- mesh__dateRevised mesh__D008438 1992-05-14
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D008438 2002
% 220.07/220.21  |- mesh__dateRevised mesh__D000455 2002-07-31
% 220.07/220.21  |- skos__broader mesh__D000455smesh__D000821
% 220.07/220.21  |- mesh__recordAuthorizer mesh__D000455 sjn
% 220.07/220.21  |- skos__prefLabel mesh__D000455 Medicago sativa
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D000455 2006
% 220.07/220.21  |- skos__scopeNote mesh__D000455
% 220.07/220.21       A plant species of the family FABACEAE widely cultivated for animal feed.%A%    
% 220.07/220.21  |- mesh__dateCreated mesh__D000455 1999-01-01
% 220.07/220.21  |- skos__broader mesh__D000455smesh__D029902
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D000455 2005
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D000455 2004
% 220.07/220.21  |- skos__historyNote mesh__D000455 Alfalfa %28%1963-2001%29%
% 220.07/220.21  |- skos__annotation mesh__D000455
% 220.07/220.21       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.07/220.21  |- skos__altLabel mesh__D000455 Lucerne
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D000455 2003
% 220.07/220.21  |- skos__altLabel mesh__D000455 Alfalfa
% 220.07/220.21  |- mesh__recordMaintainer mesh__D000455 ssb
% 220.07/220.21  |- mesh__historyNote mesh__D000455 2002%28%1963%29%   
% 220.07/220.21  |- mesh__publicMeSHNote mesh__D000455 2002; see ALFALFA 1963-2001   
% 220.07/220.21  |- mesh__recordOriginator mesh__D000455 NLM
% 220.07/220.21  |- rdf__type mesh__D000455sskos__Concept
% 220.07/220.21  |- rdf__type mesh__D019160sskos__Concept
% 220.07/220.21  |- mesh__dateCreated mesh__D019160 1996-02-12
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D019160 2005
% 220.07/220.21  |- skos__annotation mesh__D019160
% 220.07/220.21       ultrasonogr of hollow organs: endo- = within, not with endoscopy; coord IM with organ or dis /ultrasonogr; do not index under ENDOSCOPY or specific endoscopic technique unless also discussed in article; DF: ENDOSONOGR%A%  
% 220.07/220.21  |- skos__hiddenLabel mesh__D019160 Echo-Endoscopies
% 220.07/220.21  |- skos__broader mesh__D019160smesh__D014463
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D019160 2002
% 220.07/220.21  |- skos__altLabel mesh__D019160 Ultrasonic Endoscopy
% 220.07/220.21  |- skos__altLabel mesh__D019160 Endoscopic Ultrasonography
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D019160 1999
% 220.07/220.21  |- mesh__dateEstablished mesh__D019160 1997-01-01
% 220.07/220.21  |- skos__hiddenLabel mesh__D019160 Endoscopic Ultrasonographies
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D019160 2006
% 220.07/220.21  |- skos__altLabel mesh__D019160 Echo-Endoscopy
% 220.07/220.21  |- skos__historyNote mesh__D019160 Endoscopy %28%1984-1996%29%
% 220.07/220.21  |- skos__scopeNote mesh__D019160
% 220.07/220.21       Ultrasonography of internal organs using an ultrasound transducer sometimes mounted on a fiberoptic endoscope. In endosonography the transducer converts electronic signals into acoustic pulses or continuous waves and acts also as a receiver to detect reflected pulses from within the organ. An audiovisual-electronic interface converts the detected or processed echo signals, which pass through the electronics of the instrument, into a form that the technologist can evaluate. The procedure should not be confused with ENDOSCOPY which employs a special instrument called an endoscope. The %22%endo-%22% of endosonography refers to the examination of tissue within hollow organs, with reference to the usual ultrasonography procedure which is performed externally or transcutaneously.%A%    
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D019160 2003
% 220.07/220.21  |- skos__hiddenLabel mesh__D019160 Ultrasonographies, Endoscopic
% 220.07/220.21  |- mesh__publicMeSHNote mesh__D019160 97   
% 220.07/220.21  |- mesh__historyNote mesh__D019160 97   
% 220.07/220.21  |- skos__historyNote mesh__D019160
% 220.07/220.21       specific endoscopic technique %28%1984-1996%29%
% 220.07/220.21  |- mesh__recordMaintainer mesh__D019160 PXP
% 220.07/220.21  |- skos__prefLabel mesh__D019160 Endosonography
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D019160 2004
% 220.07/220.21  |- mesh__dateRevised mesh__D019160 1997-06-20
% 220.07/220.21  |- mesh__recordAuthorizer mesh__D019160 SJN
% 220.07/220.21  |- skos__hiddenLabel mesh__D019160 Endoscopies, Echo
% 220.07/220.21  |- skos__hiddenLabel mesh__D019160 Echo Endoscopy
% 220.07/220.21  |- skos__altLabel mesh__D019160 Endoscopy, Echo
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D019160 2000
% 220.07/220.21  |- skos__historyNote mesh__D019160 Ultrasonography %28%1984-1996%29%
% 220.07/220.21  |- skos__hiddenLabel mesh__D019160 Echo Endoscopies
% 220.07/220.21  |- skos__altLabel mesh__D019160 Endoscopy, Ultrasonic
% 220.07/220.21  |- skos__historyNote mesh__D019160 Ultrasonics %28%1983-1984%29%
% 220.07/220.21  |- mesh__recordOriginator mesh__D019160 TGC
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D019160 2001
% 220.07/220.21  |- skos__hiddenLabel mesh__D019160 Ultrasonic Endoscopies
% 220.07/220.21  |- skos__hiddenLabel mesh__D019160 Endosonographies
% 220.07/220.21  |- skos__hiddenLabel mesh__D019160 Endoscopies, Ultrasonic
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D019160 1998
% 220.07/220.21  |- mesh__dateRevised mesh__D005140 2002-07-03
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D005140 2005
% 220.07/220.21  |- mesh__recordAuthorizer mesh__D005140 sjn
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D005140 2004
% 220.07/220.21  |- mesh__dateCreated mesh__D005140 1999-01-01
% 220.07/220.21  |- skos__broader mesh__D005140smesh__D006197
% 220.07/220.21  |- rdf__type mesh__D005140sskos__Concept
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D005140 2003
% 220.07/220.21  |- mesh__recordOriginator mesh__D005140 NLM
% 220.07/220.21  |- skos__prefLabel mesh__D005140 Eyelashes
% 220.07/220.21  |- skos__scopeNote mesh__D005140
% 220.07/220.21       The hairs which project from the edges of the EYELIDS.     
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D005140 2006
% 220.07/220.21  |- mesh__recordMaintainer mesh__D005140 TGC
% 220.07/220.21  |- skos__broader mesh__D005140smesh__D005143
% 220.07/220.21  |- skos__prefLabel mesh__D010883 Piperoxan
% 220.07/220.21  |- mesh__recordMaintainer mesh__D010883 ssb
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D010883 2003
% 220.07/220.21  |- mesh__onlineNote mesh__D010883 search SYMPATHOLYTICS 1966-74   
% 220.07/220.21  |- mesh__dateEstablished mesh__D010883 1991-01-01
% 220.07/220.21  |- mesh__dateCreated mesh__D010883 1976-04-13
% 220.07/220.21  |- skos__hiddenLabel mesh__D010883 933, Forneau
% 220.07/220.21  |- skos__broader mesh__D010883smesh__D010880
% 220.07/220.21  |- rdf__type mesh__D010883sskos__Concept
% 220.07/220.21  |- mesh__recordOriginator mesh__D010883 SH
% 220.07/220.21  |- skos__altLabel mesh__D010883 Piperoxane
% 220.07/220.21  |- mesh__recordAuthorizer mesh__D010883 sjn
% 220.07/220.21  |- skos__altLabel mesh__D010883 Benodaine
% 220.07/220.21  |- skos__historyNote mesh__D010883 Dioxins %28%1973-1974%29%
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D010883 2002
% 220.07/220.21  |- skos__historyNote mesh__D010883 Dioxanes %28%1975%29%
% 220.07/220.21  |- mesh__publicMeSHNote mesh__D010883
% 220.07/220.21       91; was see under PIPERIDINES 1975-90; was see under SYMPATHOLYTICS 1963-74%A%  
% 220.07/220.21  |- skos__scopeNote mesh__D010883
% 220.07/220.21       A benzodioxane alpha-adrenergic blocking agent with considerable stimulatory action. It has been used to diagnose PHEOCHROMOCYTOMA and as an antihypertensive agent.%A%    
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D010883 2006
% 220.07/220.21  |- mesh__dateRevised mesh__D010883 2001-07-25
% 220.07/220.21  |- skos__historyNote mesh__D010883 Piperidines %28%1970-1976%29%
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D010883 2004
% 220.07/220.21  |- mesh__historyNote mesh__D010883
% 220.07/220.21       91%28%77%29%; was see under PIPERIDINES 1975-90; was see under SYMPATHOLYTICS 1963-74%A%  
% 220.07/220.21  |- skos__historyNote mesh__D010883 Sympatholytics %28%1966-1974%29%
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D010883 2005
% 220.07/220.21  |- skos__annotation mesh__D018068
% 220.07/220.21       infection: coord IM with ENCEPHALITIS, ARBOVIRUS %28%IM%29%; DF: ENCEPH VIRUS MURRAY VALLEY%A%  
% 220.07/220.21  |- rdf__type mesh__D018068sskos__Concept
% 220.07/220.21  |- mesh__onlineNote mesh__D018068
% 220.07/220.21       use FLAVIVIRUS to search MURRAY VALLEY ENCEPHALITIS VIRUS 1981-93; use ENCEPHALITIS VIRUSES 1977-80; use ARBOVIRUSES 1975-76%A%  
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D018068 2005
% 220.07/220.21  |- skos__broader mesh__D018068smesh__D018349
% 220.07/220.21  |- mesh__dateEstablished mesh__D018068 1994-01-01
% 220.07/220.21  |- mesh__publicMeSHNote mesh__D018068
% 220.07/220.21       94; was MURRAY VALLEY ENCEPHALITIS VIRUS see FLAVIVIRUSES 1981-93, see ENCEPHALITIS VIRUSES 1977-80, see ARBOVIRUSES 1975-76%A%  
% 220.07/220.21  |- skos__scopeNote mesh__D018068
% 220.07/220.21       A species of FLAVIVIRUS, one of the Japanese encephalitis virus group %28%ENCEPHALITIS VIRUSES, JAPANESE%29%, found in Australia and New Guinea. It causes a fulminating viremia resembling Japanese encephalitis %28%ENCEPHALITIS, JAPANESE%29%.%A%    
% 220.07/220.21  |- skos__prefLabel mesh__D018068 Encephalitis Virus, Murray Valley
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D018068 2004
% 220.07/220.21  |- mesh__recordAuthorizer mesh__D018068 sjn
% 220.07/220.21  |- skos__altLabel mesh__D018068 Murray Valley encephalitis virus
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D018068 2002
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D018068 2003
% 220.07/220.21  |- mesh__dateRevised mesh__D018068 2001-07-25
% 220.07/220.21  |- mesh__dateCreated mesh__D018068 1993-06-04
% 220.07/220.21  |- mesh__recordMaintainer mesh__D018068 ags
% 220.07/220.21  |- mesh__recordOriginator mesh__D018068 AGS
% 220.07/220.21  |- mesh__historyNote mesh__D018068
% 220.07/220.21       94; was MURRAY VALLEY ENCEPHALITIS VIRUS see FLAVIVIRUSES 1981-93, see ENCEPHALITIS VIRUSES 1977-80, see ARBOVIRUSES 1975-76%A%  
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D018068 2006
% 220.07/220.21  |- skos__hiddenLabel mesh__D010085 Phosphorylations, Oxidative
% 220.07/220.21  |- skos__broader mesh__D010085smesh__D004734
% 220.07/220.21  |- skos__altLabel mesh__D010085 Phosphorylation, Oxidative
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D010085 2003
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D010085 2005
% 220.07/220.21  |- mesh__recordOriginator mesh__D010085 NLM
% 220.07/220.21  |- mesh__recordMaintainer mesh__D010085 PXP
% 220.07/220.21  |- mesh__publicMeSHNote mesh__D010085
% 220.07/220.21       66; was see under ENERGY METABOLISM 1963-65   
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D010085 2004
% 220.07/220.21  |- mesh__historyNote mesh__D010085
% 220.07/220.21       66; was see under ENERGY METABOLISM 1963-65   
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D010085 2002
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D010085 2006
% 220.07/220.21  |- skos__hiddenLabel mesh__D010085 Oxidative Phosphorylations
% 220.07/220.21  |- skos__prefLabel mesh__D010085 Oxidative Phosphorylation
% 220.07/220.21  |- mesh__recordAuthorizer mesh__D010085 SJN
% 220.07/220.21  |- skos__annotation mesh__D010085 DF: OX PHOS   
% 220.07/220.21  |- mesh__dateCreated mesh__D010085 1999-01-01
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D010085 1998
% 220.07/220.21  |- mesh__dateEstablished mesh__D010085 1966-01-01
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D010085 1999
% 220.07/220.21  |- mesh__activeMeSHYear mesh__D010085 2000
% 220.07/220.21  |- skos__scopeNote mesh__D010085
% 220.07/220.21       Electron transfer through the cytochrome system liberating free energy which is transformed into high-energy phosphate bonds.%A%    
% 220.07/220.21  |- rdf__type mesh__D010085sskos__Concept
% 220.07/220.21  |- mesh__dateRevised mesh__D010085 1997-06-20
% 220.07/220.21  |- skos__related mesh__D010085smesh__D014475
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D010085 2001
% 220.07/220.22  |- skos__broader mesh__D010085smesh__D010766
% 220.07/220.22  |- skos__hiddenLabel mesh__D004846 Epithelial Attachments
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D004846 2005
% 220.07/220.22  |- skos__hiddenLabel mesh__D004846 Attachment, Epithelial
% 220.07/220.22  |- skos__altLabel mesh__D004846 Junctional Epithelium
% 220.07/220.22  |- mesh__recordOriginator mesh__D004846 NLM
% 220.07/220.22  |- mesh__dateEstablished mesh__D004846 1991-01-01
% 220.07/220.22  |- mesh__dateRevised mesh__D004846 2003-07-09
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D004846 2006
% 220.07/220.22  |- skos__annotation mesh__D004846
% 220.07/220.22       do not confuse with %22%periodontal attachment%22% as in PERIODONTAL ATTACHMENT LOSS%A%  
% 220.07/220.22  |- mesh__onlineNote mesh__D004846 search PERIODONTIUM 1969-74   
% 220.07/220.22  |- mesh__recordMaintainer mesh__D004846 lkt
% 220.07/220.22  |- mesh__historyNote mesh__D004846
% 220.07/220.22       91%28%75%29%; was see under PERIODONTIUM 1975-90   
% 220.07/220.22  |- skos__altLabel mesh__D004846 Epithelium, Junctional
% 220.07/220.22  |- mesh__dateCreated mesh__D004846 1999-01-01
% 220.07/220.22  |- rdf__type mesh__D004846sskos__Concept
% 220.07/220.22  |- skos__broader mesh__D004846smesh__D010519
% 220.07/220.22  |- mesh__recordAuthorizer mesh__D004846 sjn
% 220.07/220.22  |- skos__hiddenLabel mesh__D004846 Attachments, Epithelial
% 220.07/220.22  |- mesh__publicMeSHNote mesh__D004846
% 220.07/220.22       91; was see under PERIODONTIUM 1975-90   
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D004846 2004
% 220.07/220.22  |- skos__prefLabel mesh__D004846 Epithelial Attachment
% 220.07/220.22  |- rdf__type mesh__D037222sskos__Concept
% 220.07/220.22  |- skos__broader mesh__D037222smesh__D037181
% 220.07/220.22  |- mesh__publicMeSHNote mesh__D037222
% 220.07/220.22       2003; COLLECTIN %28%now COLLECTINS%29% was indexed under CARRIER PROTEINS 1980-2002%A%  
% 220.07/220.22  |- skos__historyNote mesh__D037222 Carrier Proteins %28%1980-2002%29%
% 220.07/220.22  |- mesh__recordMaintainer mesh__D037222 ssb
% 220.07/220.22  |- mesh__dateEstablished mesh__D037222 2003-01-01
% 220.07/220.22  |- mesh__dateCreated mesh__D037222 2002-07-03
% 220.07/220.22  |- skos__altLabel mesh__D037222 Collectin
% 220.07/220.22  |- mesh__recordAuthorizer mesh__D037222 sjn
% 220.07/220.22  |- skos__scopeNote mesh__D037222
% 220.07/220.22       A class of C-type lectins that target the carbohydrate structures found on invading pathogens. Binding of collectins to microorganisms results in their agglutination and enhanced clearance. Collectins form trimers that may assemble into larger oligomers. Each collectin polypeptide chain consists of four regions: a relatively short N-terminal region, a collagen-like region, an alpha-helical coiled-coil region, and carbohydrate-binding region.%A%    
% 220.07/220.22  |- mesh__dateRevised mesh__D037222 2005-06-30
% 220.07/220.22  |- skos__altLabel mesh__D037222 Collagenous Lectins
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D037222 2006
% 220.07/220.22  |- mesh__historyNote mesh__D037222
% 220.07/220.22       2003; use COLLECTINS %28%NM%29% 1980-2002   
% 220.07/220.22  |- skos__prefLabel mesh__D037222 Collectins
% 220.07/220.22  |- skos__hiddenLabel mesh__D037222 Lectins, Collagenous
% 220.07/220.22  |- mesh__recordOriginator mesh__D037222 jmp
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D004048 1993
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D004048 1994
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D004048 2004
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D004048 2005
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D004048 2001
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D004048 1999
% 220.07/220.22  |- skos__broader mesh__D004048smesh__D005021
% 220.07/220.22  |- skos__prefLabel mesh__D004048 Diethylamines
% 220.07/220.22  |- mesh__historyNote mesh__D004048 74   
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D004048 2003
% 220.07/220.22  |- mesh__recordMaintainer mesh__D004048 TGC
% 220.07/220.22  |- mesh__recordAuthorizer mesh__D004048 PLS
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D004048 1997
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D004048 2000
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D004048 1998
% 220.07/220.22  |- mesh__dateCreated mesh__D004048 1999-01-01
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D004048 1996
% 220.07/220.22  |- rdf__type mesh__D004048sskos__Concept
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D004048 2002
% 220.07/220.22  |- mesh__dateEstablished mesh__D004048 1974-01-01
% 220.07/220.22  |- mesh__dateRevised mesh__D004048 1992-05-13
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D004048 1995
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D004048 2006
% 220.07/220.22  |- mesh__recordOriginator mesh__D004048 NLM
% 220.07/220.22  |- mesh__publicMeSHNote mesh__D004048 74   
% 220.07/220.22  |- rdf__type mesh__D009531sskos__Concept
% 220.07/220.22  |- mesh__recordAuthorizer mesh__D009531 sjn
% 220.07/220.22  |- skos__altLabel mesh__D009531 Pentaerythritoltetranicotinate
% 220.07/220.22  |- mesh__dateRevised mesh__D009531 2000-06-22
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D009531 2002
% 220.07/220.22  |- skos__historyNote mesh__D009531 Nicotinic Acids %28%1971-1976%29%
% 220.07/220.22  |- skos__hiddenLabel mesh__D009531 Tetrahydrochloride, Niceritrol
% 220.07/220.22  |- skos__broader mesh__D009531smesh__D009539
% 220.07/220.22  |- skos__historyNote mesh__D009531 Propanediols %28%1971-1976%29%
% 220.07/220.22  |- skos__hiddenLabel mesh__D009531 Tetranicotinate, Pentaerythritol
% 220.07/220.22  |- skos__scopeNote mesh__D009531
% 220.07/220.22       An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.%A%    
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D009531 2006
% 220.07/220.22  |- mesh__recordMaintainer mesh__D009531 TWD
% 220.07/220.22  |- skos__altLabel mesh__D009531 Pentaerythritol Tetranicotinate
% 220.07/220.22  |- mesh__publicMeSHNote mesh__D009531
% 220.07/220.22       91; was see under NICOTINIC ACIDS 1977-90   
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D009531 2001
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D009531 2005
% 220.07/220.22  |- skos__prefLabel mesh__D009531 Niceritrol
% 220.07/220.22  |- mesh__recordOriginator mesh__D009531 RLS
% 220.07/220.22  |- mesh__dateEstablished mesh__D009531 1991-01-01
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D009531 2004
% 220.07/220.22  |- mesh__historyNote mesh__D009531
% 220.07/220.22       91%28%77%29%; was see under NICOTINIC ACIDS 1977-90   
% 220.07/220.22  |- mesh__dateCreated mesh__D009531 1976-04-13
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D009531 2003
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D042965 2006
% 220.07/220.22  |- skos__altLabel mesh__D042965 Methylene-THF Reductase %28%NADPH%29%
% 220.07/220.22  |- skos__historyNote mesh__D042965 Amine Oxidoreductases %28%1986-2003%29%
% 220.07/220.22  |- mesh__dateEstablished mesh__D042965 2004-01-01
% 220.07/220.22  |- skos__hiddenLabel mesh__D042965 Tetrahydrofolate Reductase, Methylene
% 220.07/220.22  |- mesh__recordOriginator mesh__D042965 AKE
% 220.07/220.22  |- skos__broader mesh__D042965smesh__D000587
% 220.07/220.22  |- mesh__recordAuthorizer mesh__D042965 sjn
% 220.07/220.22  |- skos__altLabel mesh__D042965
% 220.07/220.22       5,10-Methylenetetrahydrofolate Reductase %28%NADPH%29%
% 220.07/220.22  |- mesh__recordMaintainer mesh__D042965 jmp
% 220.07/220.22  |- mesh__historyNote mesh__D042965
% 220.07/220.22       2004; use METHYLENETETRAHYDROFOLATE REDUCTASE %28%NADPH2%29% %28%NM%29% 1986-2003%A%  
% 220.07/220.22  |- skos__altLabel mesh__D042965
% 220.07/220.22       Methylenetetrahydrofolate Reductase %28%NADPH%29%
% 220.07/220.22  |- skos__altLabel mesh__D042965 Methylene Tetrahydrofolate Reductase
% 220.07/220.22  |- skos__scopeNote mesh__D042965
% 220.07/220.22       A flavoprotein amine oxidoreductase that catalyzes the reversible conversion of 5-METHYLTETRAHYDROFOLATE to 5,10-METHYLENETETRAHYDROFOLATE. This enzyme was formerly classified as EC 1.1.1.171.%A%    
% 220.07/220.22  |- mesh__dateCreated mesh__D042965 2003-07-09
% 220.07/220.22  |- skos__broader mesh__D042965smesh__D005420
% 220.07/220.22  |- skos__altLabel mesh__D042965 Methylenetetrahydrofolate Reductase
% 220.07/220.22  |- mesh__publicMeSHNote mesh__D042965
% 220.07/220.22       2004; METHYLENE-THF-REDUCTASE %28%NADPH%29% was indexed under AMINE OXIDOREDUCTASES 1986-2003%A%  
% 220.07/220.22  |- skos__prefLabel mesh__D042965
% 220.07/220.22       Methylenetetrahydrofolate Reductase %28%NADPH2%29%
% 220.07/220.22  |- rdf__type mesh__D042965sskos__Concept
% 220.07/220.22  |- mesh__dateRevised mesh__D042965 2005-06-30
% 220.07/220.22  |- mesh__historyNote mesh__D014476 75; was UNDECYLENIC ACID 1963-74   
% 220.07/220.22  |- skos__prefLabel mesh__D014476 Undecylenic Acids
% 220.07/220.22  |- skos__hiddenLabel mesh__D014476 Acids, Undecylenic
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D014476 2005
% 220.07/220.22  |- mesh__recordAuthorizer mesh__D014476 sjn
% 220.07/220.22  |- mesh__recordOriginator mesh__D014476 NLM
% 220.07/220.22  |- skos__scopeNote mesh__D014476
% 220.07/220.22       Salts and derivatives of undecylenic acid.     
% 220.07/220.22  |- mesh__dateRevised mesh__D014476 2003-07-09
% 220.07/220.22  |- mesh__publicMeSHNote mesh__D014476 75; was UNDECYLENIC ACID 1963-74   
% 220.07/220.22  |- rdf__type mesh__D014476sskos__Concept
% 220.07/220.22  |- mesh__recordMaintainer mesh__D014476 ssb
% 220.07/220.22  |- mesh__dateCreated mesh__D014476 1999-01-01
% 220.07/220.22  |- skos__hiddenLabel mesh__D014476 Acid, Undecylenic
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D014476 2004
% 220.07/220.22  |- mesh__onlineNote mesh__D014476
% 220.07/220.22       use UNDECYLENIC ACIDS to search UNDECYLENIC ACID 1966-74   
% 220.07/220.22  |- skos__broader mesh__D014476smesh__D005229
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D014476 2006
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D008439 1999
% 220.07/220.22  |- skos__historyNote mesh__D008439 Maxilla %28%1966%29%
% 220.07/220.22  |- skos__annotation mesh__D008439
% 220.07/220.22       must be of the MAXILLA, not for %22%jaws%22% %28% = JAW DISEASES%29%   
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D008439 1992
% 220.07/220.22  |- skos__hiddenLabel mesh__D008439 Maxillary Disease
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D008439 2006
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D008439 2002
% 220.07/220.22  |- mesh__recordAuthorizer mesh__D008439 NLM
% 220.07/220.22  |- skos__hiddenLabel mesh__D008439 Disease, Maxillary
% 220.07/220.22  |- mesh__publicMeSHNote mesh__D008439 67   
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D008439 1997
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D008439 1998
% 220.07/220.22  |- mesh__dateRevised mesh__D008439 1990-05-29
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D008439 2004
% 220.07/220.22  |- mesh__dateEstablished mesh__D008439 1967-01-01
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D008439 2005
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D008439 1996
% 220.07/220.22  |- rdf__type mesh__D008439sskos__Concept
% 220.07/220.22  |- skos__prefLabel mesh__D008439 Maxillary Diseases
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D008439 2003
% 220.07/220.22  |- mesh__recordOriginator mesh__D008439 NLM
% 220.07/220.22  |- skos__broader mesh__D008439smesh__D007571
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D008439 2001
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D008439 1995
% 220.07/220.22  |- mesh__dateCreated mesh__D008439 1999-01-01
% 220.07/220.22  |- skos__hiddenLabel mesh__D008439 Diseases, Maxillary
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D008439 1991
% 220.07/220.22  |- skos__historyNote mesh__D008439 Bone Diseases %28%1966%29%
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D008439 2000
% 220.07/220.22  |- mesh__historyNote mesh__D008439 67   
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D008439 1993
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D008439 1994
% 220.07/220.22  |- mesh__recordMaintainer mesh__D008439 PLS
% 220.07/220.22  |- skos__altLabel mesh__D000456 Alga
% 220.07/220.22  |- mesh__recordMaintainer mesh__D000456 SYSTEM
% 220.07/220.22  |- mesh__dateRevised mesh__D000456 2005-06-30
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D000456 2006
% 220.07/220.22  |- mesh__recordOriginator mesh__D000456 NLM
% 220.07/220.22  |- mesh__dateCreated mesh__D000456 1999-01-01
% 220.07/220.22  |- mesh__recordAuthorizer mesh__D000456 sjn
% 220.07/220.22  |- mesh__runningHead mesh__D000456 B2 - ORGANISMS-ALGAE   
% 220.07/220.22  |- skos__annotation mesh__D000456 GEN or unspecified; prefer specifics   
% 220.07/220.22  |- skos__prefLabel mesh__D000456 Algae
% 220.07/220.22  |- skos__scopeNote mesh__D000456
% 220.07/220.22       A major group of polyphyletic organisms of extremely varied morphology and physiology, mostly photosynthetic, but distinguished from plants by their complex form of sexual reproduction. They are freshwater and marine, terrestrial and subterranean; some are neustonic %28%living at the interface of water and the atmosphere%29%. They live in various protozoa and within other plants. They live also in soil and on soil surfaces, on long-persistent snows, and in Antarctic rocks. Thermophilic algae inhabit hot springs. %28%From Webster, 3d ed; from Bold %26% Wynne, Introduction to the Algae, 2d ed, pp1-6%29%%A%    
% 220.07/220.22  |- rdf__type mesh__D000456sskos__Concept
% 220.07/220.22  |- mesh__dateRevised mesh__D019161 2005-08-01
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D019161 2004
% 220.07/220.22  |- skos__hiddenLabel mesh__D019161 Inhibitors, HMG CoA Reductase
% 220.07/220.22  |- skos__altLabel mesh__D019161 Inhibitors, HMG-CoA Reductase
% 220.07/220.22  |- mesh__historyNote mesh__D019161 98   
% 220.07/220.22  |- skos__altLabel mesh__D019161 HMG-CoA Reductase Inhibitors
% 220.07/220.22  |- skos__historyNote mesh__D019161
% 220.07/220.22       Hydroxymethylglutaryl CoA Reductases/antagonists %26% inhibitors %28%1976-1996%29%
% 220.07/220.22  |- skos__hiddenLabel mesh__D019161 HMG-CoA Statins
% 220.07/220.22  |- skos__scopeNote mesh__D019161
% 220.07/220.22       Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis.%A%    
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D019161 2006
% 220.07/220.22  |- mesh__dateEstablished mesh__D019161 1997-01-01
% 220.07/220.22  |- rdf__type mesh__D019161sskos__Concept
% 220.07/220.22  |- mesh__recordOriginator mesh__D019161 TPW
% 220.07/220.22  |- skos__hiddenLabel mesh__D019161 Statins, HMG CoA
% 220.07/220.22  |- skos__hiddenLabel mesh__D019161 HMG CoA Reductase Inhibitors
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D019161 2005
% 220.07/220.22  |- skos__related mesh__D019161smesh__D006903
% 220.07/220.22  |- mesh__publicMeSHNote mesh__D019161
% 220.07/220.22       98; see HMG-COA REDUCTASE INHIBITORS 1997; for HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS see HMG-COA REDUCTASE INHIBITORS 1997%A%  
% 220.07/220.22  |- skos__hiddenLabel mesh__D019161
% 220.07/220.22       Reductase Inhibitors, Hydroxymethylglutaryl-CoA
% 220.07/220.22  |- skos__hiddenLabel mesh__D019161
% 220.07/220.22       Inhibitors, Hydroxymethylglutaryl-CoA Reductase
% 220.07/220.22  |- skos__hiddenLabel mesh__D019161 Reductase Inhibitors, HMG-CoA
% 220.07/220.22  |- skos__hiddenLabel mesh__D019161
% 220.07/220.22       Inhibitors, Hydroxymethylglutaryl Coenzyme A
% 220.07/220.22  |- mesh__recordMaintainer mesh__D019161 ags
% 220.07/220.22  |- mesh__recordAuthorizer mesh__D019161 ags
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D019161 2006A
% 220.07/220.22  |- skos__hiddenLabel mesh__D019161 Inhibitors, Hydroxymethylglutaryl CoA
% 220.07/220.22  |- skos__historyNote mesh__D019161 Enzyme Inhibitors %28%1976-1996%29%
% 220.07/220.22  |- skos__hiddenLabel mesh__D019161
% 220.07/220.22       Hydroxymethylglutaryl CoA Reductase Inhibitors
% 220.07/220.22  |- skos__altLabel mesh__D019161
% 220.07/220.22       Inhibitors, Hydroxymethylglutaryl-Coenzyme A
% 220.07/220.22  |- skos__hiddenLabel mesh__D019161 Hydroxymethylglutaryl-CoA Inhibitors
% 220.07/220.22  |- skos__annotation mesh__D019161
% 220.07/220.22       X ref STATINS, HMG-COA: do not confuse with statin protein in SCR%A%  
% 220.07/220.22  |- skos__broader mesh__D019161smesh__D004791
% 220.07/220.22  |- skos__prefLabel mesh__D019161
% 220.07/220.22       Hydroxymethylglutaryl-CoA Reductase Inhibitors
% 220.07/220.22  |- skos__altLabel mesh__D019161 Statins, HMG-CoA
% 220.07/220.22  |- skos__hiddenLabel mesh__D019161
% 220.07/220.22       Hydroxymethylglutaryl-Coenzyme A Inhibitors
% 220.07/220.22  |- skos__altLabel mesh__D019161 Inhibitors, Hydroxymethylglutaryl-CoA
% 220.07/220.22  |- mesh__dateCreated mesh__D019161 1996-06-10
% 220.07/220.22  |- skos__broader mesh__D019161smesh__D000924
% 220.07/220.22  |- mesh__historyNote mesh__D005141 70   
% 220.07/220.22  |- rdf__type mesh__D005141sskos__Concept
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D005141 2003
% 220.07/220.22  |- mesh__dateRevised mesh__D005141 1990-05-29
% 220.07/220.22  |- skos__prefLabel mesh__D005141 Eyelid Diseases
% 220.07/220.22  |- skos__hiddenLabel mesh__D005141 Eyelid Disease
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D005141 1996
% 220.07/220.22  |- skos__annotation mesh__D005141
% 220.07/220.22       GEN; many specifics are available; inflamm dis = BLEPHARITIS%A%  
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D005141 1995
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D005141 1991
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D005141 2006
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D005141 1994
% 220.07/220.22  |- skos__broader mesh__D005141smesh__D005128
% 220.07/220.22  |- mesh__recordAuthorizer mesh__D005141 NLM
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D005141 2002
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D005141 1993
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D005141 1999
% 220.07/220.22  |- skos__historyNote mesh__D005141 Skin Diseases %28%1966-1969%29%
% 220.07/220.22  |- skos__historyNote mesh__D005141 Eye Diseases %28%1966-1969%29%
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D005141 2005
% 220.07/220.22  |- mesh__recordMaintainer mesh__D005141 PLS
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D005141 2001
% 220.07/220.22  |- skos__historyNote mesh__D005141 Eyelids %28%1966-1969%29%
% 220.07/220.22  |- skos__hiddenLabel mesh__D005141 Diseases, Eyelid
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D005141 2004
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D005141 1998
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D005141 1992
% 220.07/220.22  |- mesh__recordOriginator mesh__D005141 NLM
% 220.07/220.22  |- mesh__publicMeSHNote mesh__D005141 70   
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D005141 2000
% 220.07/220.22  |- mesh__dateCreated mesh__D005141 1999-01-01
% 220.07/220.22  |- mesh__dateEstablished mesh__D005141 1970-01-01
% 220.07/220.22  |- skos__hiddenLabel mesh__D005141 Disease, Eyelid
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D005141 1997
% 220.07/220.22  |- skos__broader mesh__D012480Q000662smesh__D012480
% 220.07/220.22  |- mesh__preferredCombination mesh__D012480Q000662smesh__D012481
% 220.07/220.22  |- rdf__type mesh__D012480Q000662smesh__CompoundConcept
% 220.07/220.22  |- mesh__publicMeSHNote mesh__D010884 81   
% 220.07/220.22  |- skos__annotation mesh__D010884
% 220.07/220.22       tongueless frogs; NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 220.07/220.22  |- mesh__dateRevised mesh__D010884 2003-07-09
% 220.07/220.22  |- skos__broader mesh__D010884smesh__D001001
% 220.07/220.22  |- mesh__historyNote mesh__D010884 81   
% 220.07/220.22  |- mesh__dateCreated mesh__D010884 1980-05-12
% 220.07/220.22  |- skos__prefLabel mesh__D010884 Pipidae
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D010884 2006
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D010884 2004
% 220.07/220.22  |- skos__scopeNote mesh__D010884
% 220.07/220.22       A family of the order Anura, distinguished by the lack of a tongue. It includes four living genera of aquatic %22%toads%22%. Two of the most familiar pipids are the popularly called Surinam %22%toad%22% %28%Pipa pipa%29% and XENOPUS LAEVIS.%A%    
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D010884 2005
% 220.07/220.22  |- mesh__recordMaintainer mesh__D010884 ags
% 220.07/220.22  |- mesh__recordAuthorizer mesh__D010884 sjn
% 220.07/220.22  |- mesh__dateEstablished mesh__D010884 1981-01-01
% 220.07/220.22  |- rdf__type mesh__D010884sskos__Concept
% 220.07/220.22  |- mesh__recordOriginator mesh__D010884 EC
% 220.07/220.22  |- mesh__recordAuthorizer mesh__D018069 sjn
% 220.07/220.22  |- skos__broader mesh__D018069smesh__D012665
% 220.07/220.22  |- skos__hiddenLabel mesh__D018069 Hair Cell, Vestibular
% 220.07/220.22  |- rdf__type mesh__D018069sskos__Concept
% 220.07/220.22  |- mesh__dateCreated mesh__D018069 1993-06-18
% 220.07/220.22  |- mesh__publicMeSHNote mesh__D018069 94   
% 220.07/220.22  |- skos__annotation mesh__D018069
% 220.07/220.22       mechanoreceptors in the ear; see note on HAIR CELLS   
% 220.07/220.22  |- skos__broader mesh__D018069smesh__D006198
% 220.07/220.22  |- mesh__dateEstablished mesh__D018069 1994-01-01
% 220.07/220.22  |- skos__altLabel mesh__D018069 Vestibular Hair Cells
% 220.07/220.22  |- mesh__recordOriginator mesh__D018069 RAZ
% 220.07/220.22  |- skos__broader mesh__D018069smesh__D008267
% 220.07/220.22  |- skos__hiddenLabel mesh__D018069 Cells, Vestibular Hair
% 220.07/220.22  |- mesh__recordMaintainer mesh__D018069 ags
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D018069 2005
% 220.07/220.22  |- skos__hiddenLabel mesh__D018069 Cell, Vestibular Hair
% 220.07/220.22  |- mesh__historyNote mesh__D018069 94   
% 220.07/220.22  |- skos__historyNote mesh__D018069 Mechanoreceptors %28%1977-1979%29%
% 220.07/220.22  |- skos__scopeNote mesh__D018069
% 220.07/220.22       Mechanoreceptors located in the acoustic maculae and the semicircular canals that mediate the sense of balance, movement, and head position. The vestibular hair cells are connected to accessory structures in such a way that movements of the head displace their stereocilia. This influences the membrane potential of the cells which relay information about movements via the vestibular part of the VESTIBULOCOCHLEAR NERVE to the brain stem.%A%    
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D018069 2006
% 220.07/220.22  |- skos__historyNote mesh__D018069 Hair Cells %28%1980-1993%29%
% 220.07/220.22  |- skos__hiddenLabel mesh__D018069 Vestibular Hair Cell
% 220.07/220.22  |- mesh__dateRevised mesh__D018069 2004-07-07
% 220.07/220.22  |- skos__prefLabel mesh__D018069 Hair Cells, Vestibular
% 220.07/220.22  |- mesh__recordAuthorizer mesh__D010086 sjn
% 220.07/220.22  |- skos__prefLabel mesh__D010086 Oxidative Phosphorylation Coupling Factors
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D010086 2006
% 220.07/220.22  |- mesh__dateCreated mesh__D010086 1999-01-01
% 220.07/220.22  |- mesh__publicMeSHNote mesh__D010086 74   
% 220.07/220.22  |- mesh__dateRevised mesh__D010086 2005-06-30
% 220.07/220.22  |- mesh__recordOriginator mesh__D010086 NLM
% 220.07/220.22  |- skos__historyNote mesh__D010086
% 220.07/220.22       Oxidative Phosphorylation %28%1966-1971%29%
% 220.07/220.22  |- mesh__historyNote mesh__D010086 74%28%72%29%   
% 220.07/220.22  |- rdf__type mesh__D010086sskos__Concept
% 220.07/220.22  |- mesh__dateEstablished mesh__D010086 1974-01-01
% 220.07/220.22  |- skos__broader mesh__D010086smesh__D011506
% 220.07/220.22  |- mesh__recordMaintainer mesh__D010086 SYSTEM
% 220.07/220.22  |- skos__annotation mesh__D010086 DF: OX PHOS COUPLING FACTORS   
% 220.07/220.22  |- skos__annotation mesh__D004847
% 220.07/220.22       coordinate with specific tissue type if pertinent; do not confuse with EPITHELIOID CELLS %28%type of macrophage%29%%A%  
% 220.07/220.22  |- mesh__recordMaintainer mesh__D004847 sjn
% 220.07/220.22  |- mesh__dateEstablished mesh__D004847 1998-01-01
% 220.07/220.22  |- mesh__recordAuthorizer mesh__D004847 sjn
% 220.07/220.22  |- mesh__dateRevised mesh__D004847 2005-07-01
% 220.07/220.22  |- skos__broader mesh__D004847smesh__D002477
% 220.07/220.22  |- skos__scopeNote mesh__D004847
% 220.07/220.22       Cells that line the inner and outer surfaces of the body by forming cellular layers %28%EPITHELIUM%29% or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others %28%CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM%29% from mesoderm.%A%    
% 220.07/220.22  |- skos__prefLabel mesh__D004847 Epithelial Cells
% 220.07/220.22  |- mesh__dateCreated mesh__D004847 1999-01-01
% 220.07/220.22  |- mesh__historyNote mesh__D004847 98, 65-77; use explode 1978-97   
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D004847 2006
% 220.07/220.22  |- skos__hiddenLabel mesh__D004847 Cells, Epithelial
% 220.07/220.22  |- mesh__recordOriginator mesh__D004847 NLM
% 220.07/220.22  |- skos__historyNote mesh__D004847 Epithelial Cells %28%1966-1977%29%
% 220.07/220.22  |- skos__hiddenLabel mesh__D004847 Epithelial Cell
% 220.07/220.22  |- mesh__publicMeSHNote mesh__D004847 98, 72-77   
% 220.07/220.22  |- rdf__type mesh__D004847sskos__Concept
% 220.07/220.22  |- skos__hiddenLabel mesh__D004847 Cell, Epithelial
% 220.07/220.22  |- skos__historyNote mesh__D004847 Epithelium/cytology %28%1978-1997%29%
% 220.07/220.22  |- skos__scopeNote mesh__D004049
% 220.07/220.22       An anthelmintic used primarily as the citrate in the treatment of filariasis, particularly infestations with Wucheria bancrofti or Loa loa.%A%    
% 220.07/220.22  |- mesh__dateRevised mesh__D004049 2005-06-30
% 220.07/220.22  |- mesh__recordOriginator mesh__D004049 NLM
% 220.07/220.22  |- mesh__recordMaintainer mesh__D004049 exl
% 220.07/220.22  |- skos__altLabel mesh__D004049 Carbamazine
% 220.07/220.22  |- mesh__dateCreated mesh__D004049 1999-01-01
% 220.07/220.22  |- skos__broader mesh__D004049smesh__D002219
% 220.07/220.22  |- skos__hiddenLabel mesh__D004049 Citrate, Diethylcarbamazine
% 220.07/220.22  |- rdf__type mesh__D004049sskos__Concept
% 220.07/220.22  |- skos__prefLabel mesh__D004049 Diethylcarbamazine
% 220.07/220.22  |- skos__hiddenLabel mesh__D004049 Monohydrochloride, Diethylcarbamazine
% 220.07/220.22  |- skos__hiddenLabel mesh__D004049 Maleate, Diethylcarbamazine
% 220.07/220.22  |- skos__annotation mesh__D004049
% 220.07/220.22       do not confuse X ref CARBAMAZINE with CARBAMAZEPINE   
% 220.07/220.22  |- skos__altLabel mesh__D004049 Aventis Brand of Diethylcarbamazine Citrate
% 220.07/220.22  |- mesh__recordAuthorizer mesh__D004049 sjn
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D004049 2006
% 220.07/220.22  |- skos__broader mesh__D004049smesh__D010879
% 220.07/220.22  |- skos__scopeNote mesh__D009532
% 220.07/220.22       A trace element with the atomic symbol Ni, atomic number 28, and atomic weight 58.69. It is a cofactor of the enzyme UREASE.%A%    
% 220.07/220.22  |- mesh__dateCreated mesh__D009532 1999-01-01
% 220.07/220.22  |- mesh__recordOriginator mesh__D009532 NLM
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D009532 2006
% 220.07/220.22  |- mesh__recordAuthorizer mesh__D009532 sjn
% 220.07/220.22  |- skos__prefLabel mesh__D009532 Nickel
% 220.07/220.22  |- skos__annotation mesh__D009532
% 220.07/220.22       Ni-58; Ni-60-62, 64 = NICKEL %28%IM%29% + ISOTOPES %28%NIM%29%; Ni-56, 57, 59, 63, 65-67 = NICKEL %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 220.07/220.22  |- mesh__dateRevised mesh__D009532 2005-06-30
% 220.07/220.22  |- skos__broader mesh__D009532smesh__D019216
% 220.07/220.22  |- rdf__type mesh__D009532sskos__Concept
% 220.07/220.22  |- mesh__recordMaintainer mesh__D009532 ssb
% 220.07/220.22  |- skos__broader mesh__D009532smesh__D028561
% 220.07/220.22  |- skos__altLabel mesh__D042966 NADH-Ferrihemoglobin Reductase
% 220.07/220.22  |- skos__altLabel mesh__D042966 NADH Cytochrome B5 Reductase
% 220.07/220.22  |- skos__hiddenLabel mesh__D042966 Methemoglobin Reductase, NADH
% 220.07/220.22  |- skos__historyNote mesh__D042966
% 220.07/220.22       NADH, NADPH Oxidoreductases %28%1975-1990%29%
% 220.07/220.22  |- skos__hiddenLabel mesh__D042966 Reductase, NADH Methemoglobin
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D042966 2004
% 220.07/220.22  |- skos__hiddenLabel mesh__D042966 Reductase, Methemoglobin
% 220.07/220.22  |- skos__altLabel mesh__D042966 NADH-Cytochrome B5 Reductase
% 220.07/220.22  |- skos__prefLabel mesh__D042966 Cytochrome-B%28%5%29% Reductase
% 220.07/220.22  |- mesh__dateCreated mesh__D042966 2003-07-09
% 220.07/220.22  |- skos__broader mesh__D042966smesh__D005420
% 220.07/220.22  |- mesh__dateEstablished mesh__D042966 2004-01-01
% 220.07/220.22  |- skos__historyNote mesh__D042966 Oxidoreductases %28%1973-1974%29%
% 220.07/220.22  |- mesh__recordOriginator mesh__D042966 AKE
% 220.07/220.22  |- rdf__type mesh__D042966sskos__Concept
% 220.07/220.22  |- skos__hiddenLabel mesh__D042966 Reductase, NADH-Ferrihemoglobin
% 220.07/220.22  |- skos__scopeNote mesh__D042966
% 220.07/220.22       A FLAVOPROTEIN oxidoreductase that occurs both as a soluble enzyme and a membrane-bound enzyme due to ALTERNATIVE SPLICING of a single mRNA. The soluble form is present mainly in ERYTHROCYTES and is involved in the reduction of METHEMOGLOBIN. The membrane-bound form of the enzyme is found primarily in the ENDOPLASMIC RETICULUM and outer mitochondrial membrane, where it participates in the desaturation of FATTY ACIDS; CHOLESTEROL biosynthesis and drug metabolism. A deficiency in the enzyme can result in METHEMOGLOBINEMIA.%A%    
% 220.07/220.22  |- mesh__publicMeSHNote mesh__D042966
% 220.07/220.22       2004; CYTOCHROME B%28%5%29%REDUCTASE was indexed under CYTOCHROME REDUCTASES 1975-2003 %26% under OXIDOREDUCTASES 1973-1974; for METHEMOGLOBIN REDUCTASE see METHEMOGLOBIN REDUCTASE 1991-2003, see NADH, NADPH OXIDOREDUCTASES 1975-1990%A%  
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D042966 2006
% 220.07/220.22  |- mesh__recordAuthorizer mesh__D042966 sjn
% 220.07/220.22  |- skos__altLabel mesh__D042966 NADH Methemoglobin Reductase
% 220.07/220.22  |- mesh__historyNote mesh__D042966
% 220.07/220.22       2004; use CYTOCHROME B%28%5%29% REDUCTASE %28%NM%29% 1980-2003   
% 220.07/220.22  |- skos__historyNote mesh__D042966 Cytochrome Reductases %28%1975-2003%29%
% 220.07/220.22  |- skos__annotation mesh__D042966
% 220.07/220.22       /defic: consider also METHEMOGLOBINEMIA   
% 220.07/220.22  |- mesh__recordMaintainer mesh__D042966 AKE
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D042966 2005
% 220.07/220.22  |- skos__broader mesh__D042966smesh__D003579
% 220.07/220.22  |- skos__hiddenLabel mesh__D042966 NADH Ferrihemoglobin Reductase
% 220.07/220.22  |- skos__hiddenLabel mesh__D042966 B5 Reductase, NADH-Cytochrome
% 220.07/220.22  |- skos__scopeNote mesh__D014477
% 220.07/220.22       Performance, usually in school work, poorer than that predicted from aptitude and/or intelligence testing.%A%    
% 220.07/220.22  |- mesh__recordMaintainer mesh__D014477 TGC
% 220.07/220.22  |- mesh__publicMeSHNote mesh__D014477 68   
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D014477 1990
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D014477 1996
% 220.07/220.22  |- mesh__dateEstablished mesh__D014477 1968-01-01
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D014477 1998
% 220.07/220.22  |- mesh__dateRevised mesh__D014477 1989-05-16
% 220.07/220.22  |- mesh__recordAuthorizer mesh__D014477 PLS
% 220.07/220.22  |- skos__broader mesh__D014477smesh__D011588
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D014477 2000
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D014477 1992
% 220.07/220.22  |- skos__hiddenLabel mesh__D014477 Underachievements
% 220.07/220.22  |- mesh__dateCreated mesh__D014477 1999-01-01
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D014477 1997
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D014477 1999
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D014477 1994
% 220.07/220.22  |- mesh__historyNote mesh__D014477 68   
% 220.07/220.22  |- skos__prefLabel mesh__D014477 Underachievement
% 220.07/220.22  |- rdf__type mesh__D014477sskos__Concept
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D014477 2001
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D014477 1993
% 220.07/220.22  |- skos__historyNote mesh__D014477 Learning Disorders %28%1966-1967%29%
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D014477 1991
% 220.07/220.22  |- mesh__activeMeSHYear mesh__D014477 1995
% 220.07/220.22  |- skos__annotation mesh__D014477 no qualif   
% 220.07/220.23  |- mesh__activeMeSHYear mesh__D014477 2003
% 220.07/220.23  |- mesh__activeMeSHYear mesh__D014477 2005
% 220.07/220.23  |- mesh__recordOriginator mesh__D014477 NLM
% 220.07/220.23  |- mesh__activeMeSHYear mesh__D014477 2004
% 220.07/220.23  |- mesh__activeMeSHYear mesh__D014477 2002
% 220.07/220.23  |- mesh__activeMeSHYear mesh__D014477 2006
% 220.07/220.23  |- mesh__publicMeSHNote mesh__D019960 98   
% 220.07/220.23  |- mesh__activeMeSHYear mesh__D019960 2006
% 220.07/220.23  |- skos__hiddenLabel mesh__D019960 Disorders, Elimination
% 220.07/220.23  |- mesh__activeMeSHYear mesh__D019960 2004
% 220.07/220.23  |- mesh__dateEstablished mesh__D019960 1998-01-01
% 220.07/220.23  |- mesh__activeMeSHYear mesh__D019960 2005
% 220.07/220.23  |- rdf__type mesh__D019960sskos__Concept
% 220.07/220.23  |- mesh__activeMeSHYear mesh__D019960 2001
% 220.07/220.23  |- skos__hiddenLabel mesh__D019960 Elimination Disorder
% 220.07/220.23  |- mesh__activeMeSHYear mesh__D019960 2003
% 220.07/220.23  |- skos__scopeNote mesh__D019960
% 220.07/220.23       Excretory-related psychiatric disorders usually diagnosed in infancy or childhood.%A%    
% 220.07/220.23  |- mesh__activeMeSHYear mesh__D019960 2000
% 220.07/220.23  |- mesh__dateCreated mesh__D019960 1997-06-20
% 220.07/220.23  |- mesh__activeMeSHYear mesh__D019960 1999
% 220.07/220.23  |- mesh__historyNote mesh__D019960 98   
% 220.07/220.23  |- skos__broader mesh__D019960smesh__D019952
% 220.07/220.23  |- skos__hiddenLabel mesh__D019960 Disorder, Elimination
% 220.07/220.23  |- mesh__activeMeSHYear mesh__D019960 1998
% 220.07/220.23  |- mesh__activeMeSHYear mesh__D019960 2002
% 220.07/220.23  |- skos__prefLabel mesh__D019960 Elimination Disorders
% 220.07/220.23  |- mesh__publicMeSHNote mesh__D019162 97   
% 220.07/220.23  |- mesh__historyNote mesh__D019162 97   
% 220.07/220.23  |- mesh__activeMeSHYear mesh__D019162 2006
% 220.07/220.23  |- rdf__type mesh__D019162sskos__Concept
% 220.07/220.23  |- mesh__dateCreated mesh__D019162 1996-06-10
% 220.07/220.23  |- skos__prefLabel mesh__D019162 Anesthetics, Combined
% 220.07/220.23  |- skos__annotation mesh__D019162
% 220.07/220.23       coordinate IM with specific anesthetics %28%IM%29% using the same qualifiers%A%  
% 220.07/220.23  |- skos__broader mesh__D019162smesh__D000777
% 220.07/220.23  |- skos__scopeNote mesh__D019162
% 220.07/220.23       The use of two or more chemicals simultaneously or sequentially to induce anesthesia. The drugs need not be in the same dosage form.%A%    
% 220.07/220.23  |- skos__historyNote mesh__D019162 Anesthetics %28%1970-1996%29%
% 220.07/220.23  |- skos__hiddenLabel mesh__D019162 Combined Anesthetics
% 220.07/220.23  |- mesh__recordAuthorizer mesh__D019162 sjn
% 220.07/220.23  |- mesh__dateRevised mesh__D019162 2005-06-30
% 220.07/220.23  |- mesh__dateEstablished mesh__D019162 1997-01-01
% 220.07/220.23  |- mesh__recordOriginator mesh__D019162 TPW
% 220.07/220.23  |- mesh__recordMaintainer mesh__D019162 ssb
% 220.07/220.23  |- mesh__activeMeSHYear mesh__D005142 2001
% 220.07/220.23  |- skos__broader mesh__D005142smesh__D005141
% 220.07/220.23  |- skos__hiddenLabel mesh__D005142 Neoplasms, Eyelid
% 220.07/220.23  |- mesh__recordOriginator mesh__D005142 NLM
% 220.07/220.23  |- mesh__publicMeSHNote mesh__D005142 70   
% 220.09/220.23  |- mesh__dateEstablished mesh__D005142 1970-01-01
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D005142 2006
% 220.09/220.23  |- skos__hiddenLabel mesh__D005142 Eyelid Neoplasm
% 220.09/220.23  |- skos__scopeNote mesh__D005142 Tumors of cancer of the EYELIDS.     
% 220.09/220.23  |- skos__annotation mesh__D005142
% 220.09/220.23       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%  
% 220.09/220.23  |- skos__historyNote mesh__D005142 Facial Neoplasms %28%1966-1969%29%
% 220.09/220.23  |- skos__historyNote mesh__D005142 Eye Neoplasms %28%1966-1969%29%
% 220.09/220.23  |- mesh__dateRevised mesh__D005142 2000-06-22
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D005142 2005
% 220.09/220.23  |- skos__historyNote mesh__D005142 Eyelids %28%1966-1969%29%
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D005142 2004
% 220.09/220.23  |- skos__hiddenLabel mesh__D005142 Neoplasm, Eyelid
% 220.09/220.23  |- skos__broader mesh__D005142smesh__D005153
% 220.09/220.23  |- mesh__dateCreated mesh__D005142 1999-01-01
% 220.09/220.23  |- mesh__recordAuthorizer mesh__D005142 sjn
% 220.09/220.23  |- skos__prefLabel mesh__D005142 Eyelid Neoplasms
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D005142 2002
% 220.09/220.23  |- skos__broader mesh__D005142smesh__D005134
% 220.09/220.23  |- mesh__historyNote mesh__D005142 70   
% 220.09/220.23  |- rdf__type mesh__D005142sskos__Concept
% 220.09/220.23  |- skos__historyNote mesh__D005142 Skin Neoplasms %28%1966-1969%29%
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D005142 2003
% 220.09/220.23  |- mesh__recordMaintainer mesh__D005142 nns
% 220.09/220.23  |- skos__historyNote mesh__D018868
% 220.09/220.23       Workers%27% Compensation %28%1993-1995%29%
% 220.09/220.23  |- skos__prefLabel mesh__D018868 Insurance, Disability
% 220.09/220.23  |- skos__historyNote mesh__D018868 Insurance %28%1966-1995%29%
% 220.09/220.23  |- mesh__historyNote mesh__D018868 96   
% 220.09/220.23  |- mesh__dateCreated mesh__D018868 1995-06-06
% 220.09/220.23  |- skos__altLabel mesh__D018868 Disability Insurance
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D018868 2004
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D018868 2002
% 220.09/220.23  |- skos__historyNote mesh__D018868 Social Security %28%1966-1995%29%
% 220.09/220.23  |- skos__broader mesh__D018868smesh__D007341
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D018868 2006
% 220.09/220.23  |- skos__annotation mesh__D018868
% 220.09/220.23       IM; coord with specific disability if pertinent %28%IM%29%; specific geog if possible%A%  
% 220.09/220.23  |- mesh__recordAuthorizer mesh__D018868 sjn
% 220.09/220.23  |- mesh__recordMaintainer mesh__D018868 kle
% 220.09/220.23  |- skos__scopeNote mesh__D018868
% 220.09/220.23       Insurance designed to compensate persons who lose wages because of illness or injury; insurance providing periodic payments that partially replace lost wages, salary, or other income when the insured is unable to work because of illness, injury, or disease. Individual and group disability insurance are two types of such coverage. %28%From Facts on File Dictionary of Health Care Management, 1988, p207%29%%A%    
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D018868 2003
% 220.09/220.23  |- mesh__dateRevised mesh__D018868 1999-11-03
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D018868 2001
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D018868 2005
% 220.09/220.23  |- mesh__publicMeSHNote mesh__D018868 96   
% 220.09/220.23  |- mesh__dateEstablished mesh__D018868 1996-01-01
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D018868 2000
% 220.09/220.23  |- rdf__type mesh__D018868sskos__Concept
% 220.09/220.23  |- mesh__recordOriginator mesh__D018868 JLS
% 220.09/220.23  |- mesh__dateCreated mesh__D010885 1999-01-01
% 220.09/220.23  |- skos__historyNote mesh__D010885 Antineoplastic Agents %28%1966%29%
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D010885 2006
% 220.09/220.23  |- mesh__dateEstablished mesh__D010885 1973-01-01
% 220.09/220.23  |- mesh__publicMeSHNote mesh__D010885 73   
% 220.09/220.23  |- skos__historyNote mesh__D010885 Bromine %28%1966%29%
% 220.09/220.23  |- mesh__dateRevised mesh__D010885 2005-06-30
% 220.09/220.23  |- skos__prefLabel mesh__D010885 Pipobroman
% 220.09/220.23  |- skos__scopeNote mesh__D010885
% 220.09/220.23       An antineoplastic agent that acts by alkylation.     
% 220.09/220.23  |- skos__historyNote mesh__D010885 Propionates %28%1966%29%
% 220.09/220.23  |- mesh__recordMaintainer mesh__D010885 lkw
% 220.09/220.23  |- rdf__type mesh__D010885sskos__Concept
% 220.09/220.23  |- mesh__recordOriginator mesh__D010885 NLM
% 220.09/220.23  |- skos__historyNote mesh__D010885 Piperazines %28%1966%29%
% 220.09/220.23  |- skos__broader mesh__D010885smesh__D010879
% 220.09/220.23  |- mesh__historyNote mesh__D010885 73%28%67%29%   
% 220.09/220.23  |- mesh__recordAuthorizer mesh__D010885 sjn
% 220.09/220.23  |- skos__altLabel mesh__D010885 Abbott Brand of Pipobroman
% 220.09/220.23  |- mesh__recordOriginator mesh__D029590 ssb
% 220.09/220.23  |- rdf__type mesh__D029590sskos__Concept
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D029590 2006
% 220.09/220.23  |- mesh__historyNote mesh__D029590 2002   
% 220.09/220.23  |- mesh__dateCreated mesh__D029590 2001-07-25
% 220.09/220.23  |- skos__prefLabel mesh__D029590 Myricaceae
% 220.09/220.23  |- skos__scopeNote mesh__D029590
% 220.09/220.23       A plant family of the order Myricales, subclass Hamamelidae, class Magnoliopsida. They are trees and shrubs having aromatic leaves that often have yellow glandular dots on the surface. Single-seeded fruits are often covered with waxy granules, bumps, or layers. The flowers are small, greenish, and inconspicuous.%A%    
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D029590 2003
% 220.09/220.23  |- mesh__publicMeSHNote mesh__D029590 2002   
% 220.09/220.23  |- skos__altLabel mesh__D029590 Fern, Sweet
% 220.09/220.23  |- mesh__recordAuthorizer mesh__D029590 sjn
% 220.09/220.23  |- mesh__dateRevised mesh__D029590 2002-07-03
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D029590 2004
% 220.09/220.23  |- mesh__recordMaintainer mesh__D029590 ssb
% 220.09/220.23  |- mesh__dateEstablished mesh__D029590 2002-01-01
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D029590 2005
% 220.09/220.23  |- skos__annotation mesh__D029590
% 220.09/220.23       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.09/220.23  |- skos__broader mesh__D029590smesh__D019684
% 220.09/220.23  |- skos__broader mesh__D003813Q000191smesh__D003813
% 220.09/220.23  |- mesh__preferredCombination mesh__D003813Q000191smesh__D004468
% 220.09/220.23  |- rdf__type mesh__D003813Q000191smesh__CompoundConcept
% 220.09/220.23  |- mesh__recordAuthorizer mesh__D010087 PLS
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D010087 1998
% 220.09/220.23  |- mesh__publicMeSHNote mesh__D010087 66   
% 220.09/220.23  |- mesh__historyNote mesh__D010087 66   
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D010087 1997
% 220.09/220.23  |- mesh__recordMaintainer mesh__D010087 TPW
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D010087 1994
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D010087 1999
% 220.09/220.23  |- skos__scopeNote mesh__D010087
% 220.09/220.23       Binary compounds of oxygen containing the anion O%28%2-%29%. The anion combines with metals to form alkaline oxides and non-metals to form acidic oxides.%A%    
% 220.09/220.23  |- rdf__type mesh__D010087sskos__Concept
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D010087 1995
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D010087 2000
% 220.09/220.23  |- skos__broader mesh__D010087smesh__D017601
% 220.09/220.23  |- skos__related mesh__D010087smesh__D003499
% 220.09/220.23  |- skos__related mesh__D010087smesh__D003497
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D010087 2003
% 220.09/220.23  |- mesh__dateRevised mesh__D010087 1993-06-04
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D010087 2001
% 220.09/220.23  |- skos__related mesh__D010087smesh__D003498
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D010087 2005
% 220.09/220.23  |- skos__prefLabel mesh__D010087 Oxides
% 220.09/220.23  |- skos__broader mesh__D010087smesh__D000838
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D010087 2004
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D010087 2006
% 220.09/220.23  |- mesh__recordOriginator mesh__D010087 NLM
% 220.09/220.23  |- mesh__dateCreated mesh__D010087 1999-01-01
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D010087 1996
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D010087 2002
% 220.09/220.23  |- mesh__dateEstablished mesh__D010087 1966-01-01
% 220.09/220.23  |- skos__broader mesh__D004848smesh__D014024
% 220.09/220.23  |- mesh__dateCreated mesh__D004848 1999-01-01
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D004848 2006
% 220.09/220.23  |- skos__scopeNote mesh__D004848
% 220.09/220.23       One or more layers of EPITHELIAL CELLS, supported by the basal lamina, which covers the inner or outer surfaces of the body.%A%    
% 220.09/220.23  |- mesh__recordAuthorizer mesh__D004848 sjn
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D004848 2002
% 220.09/220.23  |- mesh__recordMaintainer mesh__D004848 KEV
% 220.09/220.23  |- skos__annotation mesh__D004848 usually NIM with specific organ IM   
% 220.09/220.23  |- mesh__dateRevised mesh__D004848 1999-11-03
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D004848 2005
% 220.09/220.23  |- rdf__type mesh__D004848sskos__Concept
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D004848 2001
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D004848 2004
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D004848 2000
% 220.09/220.23  |- mesh__recordOriginator mesh__D004848 NLM
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D004848 2003
% 220.09/220.23  |- skos__prefLabel mesh__D004848 Epithelium
% 220.09/220.23  |- mesh__dateCreated mesh__D015570 1989-05-26
% 220.09/220.23  |- skos__altLabel mesh__D015570 Turimycin A5
% 220.09/220.23  |- skos__historyNote mesh__D015570 Antibiotics %28%1966-1980%29%
% 220.09/220.23  |- mesh__dateRevised mesh__D015570 2004-07-07
% 220.09/220.23  |- mesh__recordOriginator mesh__D015570 RLS
% 220.09/220.23  |- skos__broader mesh__D015570smesh__D018942
% 220.09/220.23  |- skos__scopeNote mesh__D015570
% 220.09/220.23       A macrolide antibiotic from Streptomyces narbonensis. The drug has antimicrobial activity against a wide spectrum of pathogens.%A%    
% 220.09/220.23  |- skos__altLabel mesh__D015570 Kitasamycin A3
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D015570 2005
% 220.09/220.23  |- mesh__historyNote mesh__D015570
% 220.09/220.23       90; was see LEUCOMYCINS 1981-89; was see under ANTIBIOTICS 1975-80%A%  
% 220.09/220.23  |- mesh__publicMeSHNote mesh__D015570
% 220.09/220.23       90; was see LEUCOMYCINS 1981-89; was see under ANTIBIOTICS 1975-80%A%  
% 220.09/220.23  |- mesh__recordMaintainer mesh__D015570 ssb
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D015570 2006
% 220.09/220.23  |- skos__altLabel mesh__D015570 Leucomycin A3
% 220.09/220.23  |- skos__annotation mesh__D015570
% 220.09/220.23       do not use /biosyn unless by living matter   
% 220.09/220.23  |- skos__hiddenLabel mesh__D015570 EN 141
% 220.09/220.23  |- mesh__dateEstablished mesh__D015570 1990-01-01
% 220.09/220.23  |- mesh__onlineNote mesh__D015570
% 220.09/220.23       use ANTIBIOTICS to search JOSAMYCIN 1975-80; use LEUCOMYCINS 1981-89%A%  
% 220.09/220.23  |- skos__historyNote mesh__D015570 Leucomycins %28%1981-1989%29%
% 220.09/220.23  |- skos__prefLabel mesh__D015570 Josamycin
% 220.09/220.23  |- rdf__type mesh__D015570sskos__Concept
% 220.09/220.23  |- skos__altLabel mesh__D015570 Josamycine
% 220.09/220.23  |- skos__hiddenLabel mesh__D015570 EN141
% 220.09/220.23  |- mesh__recordAuthorizer mesh__D015570 sjn
% 220.09/220.23  |- skos__broader mesh__D009533smesh__D001713
% 220.09/220.23  |- mesh__publicMeSHNote mesh__D009533
% 220.09/220.23       91; was see under NITROPHENOLS 1975-90   
% 220.09/220.23  |- mesh__historyNote mesh__D009533
% 220.09/220.23       91%28%75%29%; was see under NITROPHENOLS 1975-90   
% 220.09/220.23  |- skos__altLabel mesh__D009533 Distolone
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D009533 2004
% 220.09/220.23  |- mesh__dateCreated mesh__D009533 1974-11-19
% 220.09/220.23  |- skos__broader mesh__D009533smesh__D009596
% 220.09/220.23  |- mesh__dateEstablished mesh__D009533 1991-01-01
% 220.09/220.23  |- skos__hiddenLabel mesh__D009533 9015, Bayer
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D009533 2003
% 220.09/220.23  |- skos__historyNote mesh__D009533 Biphenyl Compounds %28%1972-1974%29%
% 220.09/220.23  |- rdf__type mesh__D009533sskos__Concept
% 220.09/220.23  |- skos__altLabel mesh__D009533 Niclofan
% 220.09/220.23  |- mesh__recordOriginator mesh__D009533 NLM
% 220.09/220.23  |- skos__scopeNote mesh__D009533
% 220.09/220.23       Proposed fasciolacide. Synonyms: Dertil; Bilevon; Bay 9015.%A%    
% 220.09/220.23  |- skos__hiddenLabel mesh__D009533 3625, Bayer
% 220.09/220.23  |- mesh__recordAuthorizer mesh__D009533 sjn
% 220.09/220.23  |- skos__altLabel mesh__D009533 Menichlopholan
% 220.09/220.23  |- mesh__dateRevised mesh__D009533 2000-06-22
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D009533 2006
% 220.09/220.23  |- skos__hiddenLabel mesh__D009533 R, Bilevon
% 220.09/220.23  |- skos__historyNote mesh__D009533 Nitrophenols %28%1972-1974%29%
% 220.09/220.23  |- mesh__recordMaintainer mesh__D009533 jmp
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D009533 2002
% 220.09/220.23  |- skos__prefLabel mesh__D009533 Niclofolan
% 220.09/220.23  |- skos__hiddenLabel mesh__D009533 M, Bilevon
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D009533 2005
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D009533 2001
% 220.09/220.23  |- skos__historyNote mesh__D001550 Benzene Derivatives %28%1972-1974%29%
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D001550 2000
% 220.09/220.23  |- skos__annotation mesh__D001550 peptidase inhib   
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D001550 1995
% 220.09/220.23  |- mesh__historyNote mesh__D001550
% 220.09/220.23       91%28%75%29%; was see under AMIDINES 1975-90   
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D001550 1998
% 220.09/220.23  |- rdf__type mesh__D001550sskos__Concept
% 220.09/220.23  |- mesh__dateCreated mesh__D001550 1974-11-19
% 220.09/220.23  |- skos__prefLabel mesh__D001550 Benzamidines
% 220.09/220.23  |- mesh__recordMaintainer mesh__D001550 TGC
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D001550 1994
% 220.09/220.23  |- skos__historyNote mesh__D001550 Amidines %28%1972-1974%29%
% 220.09/220.23  |- skos__scopeNote mesh__D001550
% 220.09/220.23       Amidines substituted with a benzene group. Benzamidine and its derivatives are known as peptidase inhibitors.%A%    
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D001550 2004
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D001550 2002
% 220.09/220.23  |- mesh__recordOriginator mesh__D001550 NLM
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D001550 2003
% 220.09/220.23  |- mesh__dateEstablished mesh__D001550 1991-01-01
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D001550 1997
% 220.09/220.23  |- mesh__publicMeSHNote mesh__D001550 91; was see under AMIDINES 1975-90   
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D001550 2006
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D001550 2001
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D001550 1996
% 220.09/220.23  |- mesh__recordAuthorizer mesh__D001550 PLS
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D001550 1993
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D001550 2005
% 220.09/220.23  |- mesh__dateRevised mesh__D001550 1992-05-08
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D001550 1999
% 220.09/220.23  |- skos__broader mesh__D001550smesh__D000578
% 220.09/220.23  |- skos__altLabel mesh__D042967 NADH-Coenzyme Q Reductase
% 220.09/220.23  |- mesh__recordMaintainer mesh__D042967 jmp
% 220.09/220.23  |- mesh__historyNote mesh__D042967
% 220.09/220.23       2004; for NADH DEHYDROGENASE %28%UBIQUINONE%29% use ELECTRON TRANSPORT COMPLEX I %28%NM%29% 1992-2003; for NADH DEHYDROGENASE COMPLEX 1 use NADH DEHYDROGENASE 1989-2003; for UBIQUINONE REDUCTASE use NAD%28%P%29%H DEHYDROGENASE %28%QUINONE%29% 1992-1999%A%  
% 220.09/220.23  |- skos__hiddenLabel mesh__D042967
% 220.09/220.23       Rotenone Sensitive Mitochondrial NADH Ubiquinone Oxidoreductase
% 220.09/220.23  |- skos__altLabel mesh__D042967 Complex I Dehydrogenase
% 220.09/220.23  |- skos__scopeNote mesh__D042967
% 220.09/220.23       A flavoprotein and iron sulfur-containing oxidoreductase complex that catalyzes the conversion of UBIQUINONE to ubiquinol. In MITOCHONDRIA the complex also couples its reaction to the transport of PROTONS across the internal mitochondrial membrane. The NADH DEHYDROGENASE component of the complex can be isolated and is listed as EC 1.6.99.3.%A%    
% 220.09/220.23  |- skos__altLabel mesh__D042967 NADH Q1 Oxidoreductase
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D042967 2005
% 220.09/220.23  |- skos__hiddenLabel mesh__D042967 Reductase, NADH-Ubiquinone
% 220.09/220.23  |- mesh__recordAuthorizer mesh__D042967 sjn
% 220.09/220.23  |- skos__altLabel mesh__D042967 NADH DH I
% 220.09/220.23  |- skos__hiddenLabel mesh__D042967 NADH Coenzyme Q Reductase
% 220.09/220.23  |- skos__altLabel mesh__D042967 NADH-CoQ Reductase
% 220.09/220.23  |- mesh__dateCreated mesh__D042967 2003-07-09
% 220.09/220.23  |- skos__broader mesh__D042967smesh__D007506
% 220.09/220.23  |- skos__altLabel mesh__D042967 Respiratory Complex I
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D042967 2006
% 220.09/220.23  |- skos__altLabel mesh__D042967 NADH-Ubiquinone Oxidoreductase
% 220.09/220.23  |- rdf__type mesh__D042967sskos__Concept
% 220.09/220.23  |- skos__hiddenLabel mesh__D042967 NADH Ubiquinone Oxidoreductase
% 220.09/220.23  |- mesh__publicMeSHNote mesh__D042967
% 220.09/220.23       2004; NADH DEHYDROGENASE %28%UBIQUINONE%29% was indexed under NADH, NADPH OXIDOREDUCTASES 1992-2003; for NADH DEHYDROGENASE use NADH DEHYDROGENASE 1990-2003; for UBIQUINONE REDUCTASE see NAD%28%P%29%H DEHYDROGENASE %28%QUINONE%29% 1992-1999%A%  
% 220.09/220.23  |- skos__historyNote mesh__D042967
% 220.09/220.23       NADH, NADPH Oxidoreductases %28%1992-2003%29%
% 220.09/220.23  |- skos__hiddenLabel mesh__D042967 Oxidoreductase, NADH-Ubiquinone
% 220.09/220.23  |- skos__hiddenLabel mesh__D042967 Oxidoreductase, NADH Q1
% 220.09/220.23  |- skos__altLabel mesh__D042967
% 220.09/220.23       Rotenone-Sensitive Mitochondrial NADH-Ubiquinone Oxidoreductase
% 220.09/220.23  |- skos__altLabel mesh__D042967 Ubiquinone Reductase
% 220.09/220.23  |- skos__hiddenLabel mesh__D042967 Dehydrogenase, Complex I
% 220.09/220.23  |- skos__altLabel mesh__D042967 NADH Dehydrogenase Complex 1
% 220.09/220.23  |- skos__broader mesh__D042967smesh__D009247
% 220.09/220.23  |- skos__hiddenLabel mesh__D042967 NADH CoQ Reductase
% 220.09/220.23  |- mesh__recordOriginator mesh__D042967 AKE
% 220.09/220.23  |- mesh__dateRevised mesh__D042967 2004-07-07
% 220.09/220.23  |- skos__altLabel mesh__D042967 NADH-Ubiquinone Reductase
% 220.09/220.23  |- skos__altLabel mesh__D042967 NADH Dehydrogenase I
% 220.09/220.23  |- skos__historyNote mesh__D042967 Cytochrome Reductases %28%1983-2003%29%
% 220.09/220.23  |- skos__broader mesh__D042967smesh__D044927
% 220.09/220.23  |- mesh__dateEstablished mesh__D042967 2004-01-01
% 220.09/220.23  |- skos__prefLabel mesh__D042967 Electron Transport Complex I
% 220.09/220.23  |- skos__broader mesh__D042967smesh__D017494
% 220.09/220.23  |- skos__broader mesh__D042967smesh__D009097
% 220.09/220.23  |- skos__hiddenLabel mesh__D042967 NADH Ubiquinone Reductase
% 220.09/220.23  |- mesh__recordOriginator mesh__D014478 NLM
% 220.09/220.23  |- skos__prefLabel mesh__D014478 Unemployment
% 220.09/220.23  |- skos__broader mesh__D014478smesh__D004651
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D014478 1996
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D014478 2002
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D014478 1998
% 220.09/220.23  |- mesh__dateCreated mesh__D014478 1999-01-01
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D014478 1997
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D014478 1999
% 220.09/220.23  |- rdf__type mesh__D014478sskos__Concept
% 220.09/220.23  |- mesh__recordMaintainer mesh__D014478 KEV
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D014478 2003
% 220.09/220.23  |- mesh__recordAuthorizer mesh__D014478 PLS
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D014478 2000
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D014478 2005
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D014478 2004
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D014478 2001
% 220.09/220.23  |- mesh__dateRevised mesh__D014478 1995-05-23
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D014478 2006
% 220.09/220.23  |- skos__scopeNote mesh__D014478
% 220.09/220.23       The state of not being engaged in a gainful occupation.%A%    
% 220.09/220.23  |- mesh__historyNote mesh__D019163 97   
% 220.09/220.23  |- rdf__type mesh__D019163sskos__Concept
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D019163 2006
% 220.09/220.23  |- mesh__dateRevised mesh__D019163 2003-07-09
% 220.09/220.23  |- mesh__dateEstablished mesh__D019163 1997-01-01
% 220.09/220.23  |- mesh__recordOriginator mesh__D019163 TPW
% 220.09/220.23  |- skos__scopeNote mesh__D019163
% 220.09/220.23       Materials that add an electron to an element or compound, that is, decrease the positiveness of its valence. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%    
% 220.09/220.23  |- mesh__recordMaintainer mesh__D019163 ssb
% 220.09/220.23  |- skos__prefLabel mesh__D019163 Reducing Agents
% 220.09/220.23  |- skos__hiddenLabel mesh__D019163 Agents, Reducing
% 220.09/220.23  |- skos__altLabel mesh__D019163 Reductants
% 220.09/220.23  |- mesh__publicMeSHNote mesh__D019163 97   
% 220.09/220.23  |- skos__historyNote mesh__D019163 Oxidation-Reduction %28%1967-1996%29%
% 220.09/220.23  |- skos__annotation mesh__D019163
% 220.09/220.23       %22%reducing%22% refers to oxidation-reduction, not body weight or obesity; D25-26 qualif%A%  
% 220.09/220.23  |- mesh__dateCreated mesh__D019163 1996-06-10
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D019163 2005
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D019163 2004
% 220.09/220.23  |- skos__broader mesh__D019163smesh__D007202
% 220.09/220.23  |- mesh__recordAuthorizer mesh__D019163 sjn
% 220.09/220.23  |- skos__annotation mesh__D000458
% 220.09/220.23       general or unspecified; prefer specifics; do not confuse X ref CYANOPHYCEAE with CYANOPHORA%A%  
% 220.09/220.23  |- skos__altLabel mesh__D000458 Cyanophyceae
% 220.09/220.23  |- skos__scopeNote mesh__D000458
% 220.09/220.23       A phylum of oxygenic photosynthetic bacteria comprised of unicellular to multicellular bacteria possessing CHLOROPHYLL a and carrying out oxygenic PHOTOSYNTHESIS. Cyanobacteria are the only known organisms capable of fixing both CARBON DIOXIDE %28%in the presence of light%29% and NITROGEN. Cell morphology can include nitrogen-fixing heterocysts and/or resting cells called akinetes. Formerly called blue-green algae, cyanobacteria were traditionally treated as ALGAE.%A%    
% 220.09/220.23  |- skos__altLabel mesh__D000458 Algae, Blue-Green
% 220.09/220.23  |- mesh__publicMeSHNote mesh__D000458
% 220.09/220.23       92; was ALGAE, BLUE-GREEN 1970-91; CYANOBACTERIA was see ALGAE, BLUE-GREEN 1978-91; CYANOPHYTA was see ALGAE, BLUE-GREEN 1970-91%A%  
% 220.09/220.23  |- skos__altLabel mesh__D000458 Bacteria, Blue Green
% 220.09/220.23  |- rdf__type mesh__D000458sskos__Concept
% 220.09/220.23  |- mesh__dateEstablished mesh__D000458 1970-01-01
% 220.09/220.23  |- skos__altLabel mesh__D000458 Blue-Green Algae
% 220.09/220.23  |- skos__broader mesh__D000458smesh__D001419
% 220.09/220.23  |- skos__historyNote mesh__D000458 Algae %28%1966-1969%29%
% 220.09/220.23  |- skos__altLabel mesh__D000458 Blue-Green Bacteria
% 220.09/220.23  |- mesh__onlineNote mesh__D000458
% 220.09/220.23       use CYANOBACTERIA to search ALGAE, BLUE-GREEN %26% CYANOPHYTA 1970-91%A%  
% 220.09/220.23  |- skos__broader mesh__D000458smesh__D019688
% 220.09/220.23  |- skos__prefLabel mesh__D000458 Cyanobacteria
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D000458 2006
% 220.09/220.23  |- skos__related mesh__D000458smesh__D010839
% 220.09/220.23  |- mesh__historyNote mesh__D000458
% 220.09/220.23       92; was ALGAE, BLUE-GREEN 1970-91; CYANOBACTERIA was see ALGAE, BLUE-GREEN 1978-91; CYANOPHYTA was see ALGAE, BLUE-GREEN 1970-91%A%  
% 220.09/220.23  |- mesh__dateCreated mesh__D000458 1999-01-01
% 220.09/220.23  |- skos__altLabel mesh__D000458 Blue Green Algae
% 220.09/220.23  |- mesh__recordMaintainer mesh__D000458 SYSTEM
% 220.09/220.23  |- skos__altLabel mesh__D000458 Algae, Blue Green
% 220.09/220.23  |- mesh__dateRevised mesh__D000458 2005-06-30
% 220.09/220.23  |- mesh__recordOriginator mesh__D000458 NLM
% 220.09/220.23  |- skos__altLabel mesh__D000458 Bacteria, Blue-Green
% 220.09/220.23  |- skos__altLabel mesh__D000458 Blue Green Bacteria
% 220.09/220.23  |- mesh__recordAuthorizer mesh__D000458 sjn
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D011180 2005
% 220.09/220.23  |- skos__prefLabel mesh__D011180 Postmortem Changes
% 220.09/220.23  |- skos__hiddenLabel mesh__D011180 Change, Postmortem
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D011180 2003
% 220.09/220.23  |- mesh__recordAuthorizer mesh__D011180 sjn
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D011180 2006
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D011180 2000
% 220.09/220.23  |- mesh__dateRevised mesh__D011180 1999-11-08
% 220.09/220.23  |- mesh__recordMaintainer mesh__D011180 KEV
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D011180 2004
% 220.09/220.23  |- skos__historyNote mesh__D011180 Death %28%1966-1969%29%
% 220.09/220.23  |- mesh__onlineNote mesh__D011180
% 220.09/220.23       use POSTMORTEM CHANGES to search ADIPOCERE, ALGOR MORTIS, CRUOR, LIVOR MORTIS %26% MUMMIFICATION 1970-78%A%  
% 220.09/220.23  |- skos__scopeNote mesh__D011180
% 220.09/220.23       Physiological changes that occur in bodies after death.%A%    
% 220.09/220.23  |- skos__broader mesh__D011180smesh__D002102
% 220.09/220.23  |- mesh__dateEstablished mesh__D011180 1970-01-01
% 220.09/220.23  |- mesh__activeMeSHYear mesh__D011180 2001
% 220.09/220.23  |- mesh__publicMeSHNote mesh__D011180 70   
% 220.09/220.23  |- rdf__type mesh__D011180sskos__Concept
% 220.09/220.23  |- skos__hiddenLabel mesh__D011180 Changes, Postmortem
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D011180 2002
% 220.09/220.24  |- mesh__recordOriginator mesh__D011180 NLM
% 220.09/220.24  |- mesh__dateCreated mesh__D011180 1999-01-01
% 220.09/220.24  |- skos__annotation mesh__D011180
% 220.09/220.24       do not use for routine postmortem pathol %28% = /pathol%29%   
% 220.09/220.24  |- mesh__historyNote mesh__D011180
% 220.09/220.24       70; ADIPOCERE, ALGOR MORTIS, CRUOR, LIVOR MORTIS %26% MUMMIFICATION were see under POSTMORTEM CHANGES 1970-78%A%  
% 220.09/220.24  |- skos__hiddenLabel mesh__D011180 Postmortem Change
% 220.09/220.24  |- skos__prefLabel mesh__D005941 Glucokinase
% 220.09/220.24  |- skos__broader mesh__D005941smesh__D017853
% 220.09/220.24  |- mesh__recordMaintainer mesh__D005941 ssb
% 220.09/220.24  |- skos__scopeNote mesh__D005941
% 220.09/220.24       A group of enzymes that catalyzes the conversion of ATP and D-glucose to ADP and D-glucose 6-phosphate. They are found in invertebrates and microorganisms, and are highly specific for glucose. %28%Enzyme Nomenclature, 1992%29% EC 2.7.1.2.%A%    
% 220.09/220.24  |- mesh__recordOriginator mesh__D005941 NLM
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D005941 2006
% 220.09/220.24  |- mesh__dateEstablished mesh__D005941 1965-01-01
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D005941 2005
% 220.09/220.24  |- mesh__dateRevised mesh__D005941 2003-07-09
% 220.09/220.24  |- mesh__historyNote mesh__D005941 65; was see under HEXOKINASE 1963-64   
% 220.09/220.24  |- rdf__type mesh__D005941sskos__Concept
% 220.09/220.24  |- mesh__publicMeSHNote mesh__D005941
% 220.09/220.24       65; was see under HEXOKINASE 1963-64   
% 220.09/220.24  |- mesh__dateCreated mesh__D005941 1999-01-01
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D005941 2004
% 220.09/220.24  |- mesh__recordAuthorizer mesh__D005941 sjn
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D005143 2000
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D005143 2005
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D005143 1998
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D005143 2006
% 220.09/220.24  |- mesh__dateCreated mesh__D005143 1999-01-01
% 220.09/220.24  |- mesh__recordMaintainer mesh__D005143 TGC
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D005143 2001
% 220.09/220.24  |- skos__prefLabel mesh__D005143 Eyelids
% 220.09/220.24  |- mesh__recordOriginator mesh__D005143 NLM
% 220.09/220.24  |- mesh__recordAuthorizer mesh__D005143 SJN
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D005143 1999
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D005143 2003
% 220.09/220.24  |- skos__hiddenLabel mesh__D005143 Eyelid
% 220.09/220.24  |- skos__broader mesh__D005143smesh__D005123
% 220.09/220.24  |- skos__related mesh__D005143smesh__D009541
% 220.09/220.24  |- mesh__dateRevised mesh__D005143 1997-06-20
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D005143 2004
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D005143 2002
% 220.09/220.24  |- rdf__type mesh__D005143sskos__Concept
% 220.09/220.24  |- skos__annotation mesh__D005143
% 220.09/220.24       inflammation = BLEPHARITIS; plasty = BLEPHAROPLASTY; ptosis = BLEPHAROPTOSIS; spasm = BLEPHAROSPASM%A%  
% 220.09/220.24  |- mesh__considerAlso mesh__D005143 consider also terms at BLEPHAR-   
% 220.09/220.24  |- skos__related mesh__D018869smesh__D006360
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D018869 1996
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D018869 1999
% 220.09/220.24  |- skos__scopeNote mesh__D018869
% 220.09/220.24       A constellation of responses that occur when an organism is exposed to excessive heat and other environmental stresses. Responses include synthesis of some proteins, repression of other proteins, and expression of new proteins. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 220.09/220.24  |- skos__hiddenLabel mesh__D018869 Heat Shock Reaction
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D018869 1998
% 220.09/220.24  |- skos__annotation mesh__D018869 a form of homeostasis   
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D018869 2002
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D018869 2004
% 220.09/220.24  |- skos__altLabel mesh__D018869 Heat-Shock Reaction
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D018869 2001
% 220.09/220.24  |- skos__hiddenLabel mesh__D018869 Heat-Shock Responses
% 220.09/220.24  |- skos__hiddenLabel mesh__D018869 Heat Shock Response
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D018869 2003
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D018869 2006
% 220.09/220.24  |- mesh__publicMeSHNote mesh__D018869 96   
% 220.09/220.24  |- mesh__dateEstablished mesh__D018869 1996-01-01
% 220.09/220.24  |- skos__broader mesh__D018869smesh__D006706
% 220.09/220.24  |- mesh__dateCreated mesh__D018869 1994-12-27
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D018869 2000
% 220.09/220.24  |- skos__hiddenLabel mesh__D018869 Heat-Shock Reactions
% 220.09/220.24  |- skos__prefLabel mesh__D018869 Heat-Shock Response
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D018869 2005
% 220.09/220.24  |- rdf__type mesh__D018869sskos__Concept
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D018869 1997
% 220.09/220.24  |- mesh__historyNote mesh__D018869 96   
% 220.09/220.24  |- mesh__recordAuthorizer mesh__D029591 sjn
% 220.09/220.24  |- mesh__publicMeSHNote mesh__D029591 2002   
% 220.09/220.24  |- skos__broader mesh__D029591smesh__D019684
% 220.09/220.24  |- mesh__recordMaintainer mesh__D029591 ssb
% 220.09/220.24  |- skos__scopeNote mesh__D029591
% 220.09/220.24       A plant family of the order Primulales, subclass Dilleniidae, class Magnoliopsida.%A%    
% 220.09/220.24  |- skos__annotation mesh__D029591
% 220.09/220.24       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D029591 2004
% 220.09/220.24  |- skos__prefLabel mesh__D029591 Myrsinaceae
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D029591 2005
% 220.09/220.24  |- mesh__historyNote mesh__D029591 2002   
% 220.09/220.24  |- mesh__dateCreated mesh__D029591 2001-07-25
% 220.09/220.24  |- mesh__dateRevised mesh__D029591 2003-07-09
% 220.09/220.24  |- rdf__type mesh__D029591sskos__Concept
% 220.09/220.24  |- mesh__dateEstablished mesh__D029591 2002-01-01
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D029591 2006
% 220.09/220.24  |- mesh__recordOriginator mesh__D029591 ssb
% 220.09/220.24  |- skos__historyNote mesh__D043262 Endoribonucleases %28%1983-2003%29%
% 220.09/220.24  |- rdf__type mesh__D043262sskos__Concept
% 220.09/220.24  |- mesh__historyNote mesh__D043262
% 220.09/220.24       2004; use RIBONUCLEASE P %28%NM%29% 1980-2003   
% 220.09/220.24  |- skos__historyNote mesh__D043262 RNA, Catalytic %28%1991-2003%29%
% 220.09/220.24  |- mesh__recordMaintainer mesh__D043262 jmp
% 220.09/220.24  |- skos__prefLabel mesh__D043262 Ribonuclease P
% 220.09/220.24  |- mesh__recordAuthorizer mesh__D043262 sjn
% 220.09/220.24  |- skos__historyNote mesh__D043262 Endonucleases %28%1979-2003%29%
% 220.09/220.24  |- skos__altLabel mesh__D043262 RNase P
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D043262 2004
% 220.09/220.24  |- skos__altLabel mesh__D043262 RNA Catalytic Subunit, Ribonuclease P
% 220.09/220.24  |- mesh__dateEstablished mesh__D043262 2004-01-01
% 220.09/220.24  |- mesh__publicMeSHNote mesh__D043262
% 220.09/220.24       2004; RIBONUCLEASE P was indexed under ENDORIBONUCLEASES 1983-2003, under RNA, CATALYTIC 1991-2003, under ENDONUCLEASES 1981-1982, %26% under RIBONUCLEASES 1979-1982%A%  
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D043262 2005
% 220.09/220.24  |- mesh__recordOriginator mesh__D043262 AKE
% 220.09/220.24  |- skos__broader mesh__D043262smesh__D016337
% 220.09/220.24  |- mesh__dateCreated mesh__D043262 2003-07-09
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D043262 2006
% 220.09/220.24  |- skos__broader mesh__D043262smesh__D012261
% 220.09/220.24  |- skos__broader mesh__D043262smesh__D004722
% 220.09/220.24  |- skos__scopeNote mesh__D043262
% 220.09/220.24       An RNA-containing enzyme that plays an essential role in tRNA processing by catalyzing the endonucleolytic cleavage of TRANSFER RNA precursors. It removes the extra 5%27%-nucleotides from tRNA precursors to generate mature tRNA molecules.%A%    
% 220.09/220.24  |- mesh__recordOriginator mesh__D010088 NLM
% 220.09/220.24  |- rdf__type mesh__D010088sskos__Concept
% 220.09/220.24  |- skos__altLabel mesh__D010088 Oxidases
% 220.09/220.24  |- mesh__historyNote mesh__D010088
% 220.09/220.24       DEHYDROGENASES %26% OXIDASES were headings 1963   
% 220.09/220.24  |- skos__altLabel mesh__D010088 Dehydrogenases
% 220.09/220.24  |- mesh__dateRevised mesh__D010088 2003-07-09
% 220.09/220.24  |- mesh__publicMeSHNote mesh__D010088
% 220.09/220.24       DEHYDROGENASES %26% OXIDASES were headings 1963   
% 220.09/220.24  |- mesh__recordMaintainer mesh__D010088 ssb
% 220.09/220.24  |- skos__altLabel mesh__D010088 Reductase
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D010088 2005
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D010088 2004
% 220.09/220.24  |- skos__broader mesh__D010088smesh__D004798
% 220.09/220.24  |- skos__altLabel mesh__D010088 Reductases
% 220.09/220.24  |- mesh__recordAuthorizer mesh__D010088 sjn
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D010088 2006
% 220.09/220.24  |- skos__scopeNote mesh__D010088
% 220.09/220.24       The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. %28%Enzyme Nomenclature, 1992, p9%29%%A%    
% 220.09/220.24  |- mesh__dateCreated mesh__D010088 1999-01-01
% 220.09/220.24  |- skos__altLabel mesh__D010088 Dehydrogenase
% 220.09/220.24  |- skos__annotation mesh__D010088
% 220.09/220.24       X refs OXIDASES; REDUCTASES %26% DEHYDROGENASES are GEN only: see Tree D8 under OXIDOREDUCTASES for all indentions %26% choose the most specific%A%  
% 220.09/220.24  |- skos__prefLabel mesh__D010088 Oxidoreductases
% 220.09/220.24  |- skos__broader mesh__D004849smesh__D009946
% 220.09/220.24  |- mesh__dateRevised mesh__D004849 2005-06-30
% 220.09/220.24  |- rdf__type mesh__D004849sskos__Concept
% 220.09/220.24  |- mesh__dateEstablished mesh__D004849 1991-01-01
% 220.09/220.24  |- mesh__recordOriginator mesh__D004849 NLM
% 220.09/220.24  |- skos__hiddenLabel mesh__D004849 EPN300
% 220.09/220.24  |- skos__altLabel mesh__D004849
% 220.09/220.24       O-Ethyl-O-%28%4-nitrophenyl%29%phenylphosphonothioate
% 220.09/220.24  |- mesh__publicMeSHNote mesh__D004849
% 220.09/220.24       2001; see EPN 1991-2000 %26% INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-1990%A%  
% 220.09/220.24  |- skos__annotation mesh__D004849 DF: EPN300   
% 220.09/220.24  |- mesh__recordMaintainer mesh__D004849 ssb
% 220.09/220.24  |- skos__scopeNote mesh__D004849
% 220.09/220.24       An organothiophosphorus cholinesterase inhibitor that is used as an insecticide and as a acaricide.%A%    
% 220.09/220.24  |- skos__hiddenLabel mesh__D004849 EPN 300
% 220.09/220.24  |- mesh__recordAuthorizer mesh__D004849 sjn
% 220.09/220.24  |- mesh__dateCreated mesh__D004849 1999-01-01
% 220.09/220.24  |- skos__hiddenLabel mesh__D004849 ENT 17,798
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D004849 2006
% 220.09/220.24  |- skos__prefLabel mesh__D004849
% 220.09/220.24       Phenylphosphonothioic Acid, 2-Ethyl 2-%28%4-Nitrophenyl%29% Ester
% 220.09/220.24  |- skos__hiddenLabel mesh__D004849 ENT17,798
% 220.09/220.24  |- skos__historyNote mesh__D004849 Insecticides %28%1966-1971%29%
% 220.09/220.24  |- mesh__historyNote mesh__D004849 2001%28%1972%29%;   
% 220.09/220.24  |- mesh__recordOriginator mesh__D015571 PXP
% 220.09/220.24  |- mesh__recordMaintainer mesh__D015571 nns
% 220.09/220.24  |- skos__broader mesh__D015571smesh__D006080
% 220.09/220.24  |- skos__historyNote mesh__D015571 Graafian Follicle %28%1966-1989%29%
% 220.09/220.24  |- skos__hiddenLabel mesh__D015571 Fluid, Follicular
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D015571 2006
% 220.09/220.24  |- mesh__recordAuthorizer mesh__D015571 sjn
% 220.09/220.24  |- skos__historyNote mesh__D015571 Body Fluids %28%1966-1989%29%
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D015571 2004
% 220.09/220.24  |- skos__scopeNote mesh__D015571
% 220.09/220.24       The fluid surrounding the OVUM and GRANULOSA CELLS in the Graafian follicle %28%OVARIAN FOLLICLE%29%. The follicular fluid contains sex steroids, glycoprotein hormones, plasma proteins, mucopolysaccharides, and enzymes.%A%    
% 220.09/220.24  |- mesh__dateCreated mesh__D015571 1989-04-07
% 220.09/220.24  |- skos__hiddenLabel mesh__D015571 Folliculi, Liquor
% 220.09/220.24  |- mesh__dateEstablished mesh__D015571 1990-01-01
% 220.09/220.24  |- skos__hiddenLabel mesh__D015571 Follicular Fluids
% 220.09/220.24  |- skos__altLabel mesh__D015571 Liquor Folliculi
% 220.09/220.24  |- skos__altLabel mesh__D015571 Antral Fluid, Ovarian Follicle
% 220.09/220.24  |- skos__prefLabel mesh__D015571 Follicular Fluid
% 220.09/220.24  |- mesh__publicMeSHNote mesh__D015571 90   
% 220.09/220.24  |- rdf__type mesh__D015571sskos__Concept
% 220.09/220.24  |- mesh__historyNote mesh__D015571 90   
% 220.09/220.24  |- mesh__dateRevised mesh__D015571 2003-07-09
% 220.09/220.24  |- skos__broader mesh__D015571smesh__D045604
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D015571 2005
% 220.09/220.24  |- mesh__dateEstablished mesh__D009534 1973-01-01
% 220.09/220.24  |- skos__broader mesh__D009534smesh__D012458
% 220.09/220.24  |- rdf__type mesh__D009534sskos__Concept
% 220.09/220.24  |- skos__altLabel mesh__D009534 Phenasal
% 220.09/220.24  |- skos__scopeNote mesh__D009534
% 220.09/220.24       An antihelmintic that is active against most tapeworms. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p48%29%%A%    
% 220.09/220.24  |- skos__altLabel mesh__D009534 Aventis Brand of Niclosamide
% 220.09/220.24  |- mesh__historyNote mesh__D009534
% 220.09/220.24       78; was YOMESAN 1963-77 %28%Prov 1963-72%29%; YOMESAN was see NICLOSAMIDE 1978-96; CLONITRALIDE was %28%NM%29% 1975-96%A%  
% 220.09/220.24  |- mesh__dateCreated mesh__D009534 1999-01-01
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D009534 2006
% 220.09/220.24  |- mesh__dateRevised mesh__D009534 2004-07-07
% 220.09/220.24  |- skos__altLabel mesh__D009534 Bayer Brand of Niclosamide
% 220.09/220.24  |- mesh__publicMeSHNote mesh__D009534
% 220.09/220.24       78; was YOMESAN 1973-77; YOMESAN was see NICLOSAMIDE 1978-96; CLONITRALIDE was indexed under NICLOSAMIDE/analogs %26% derivatives 1983-96 %26% ETHANOLAMINES 1975-82%A%  
% 220.09/220.24  |- mesh__onlineNote mesh__D009534
% 220.09/220.24       use NICLOSAMIDE to search YOMESAN 1966-77 %28%as Prov 1966-72%29%%A%  
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D009534 2005
% 220.09/220.24  |- mesh__recordOriginator mesh__D009534 NLM
% 220.09/220.24  |- skos__prefLabel mesh__D009534 Niclosamide
% 220.09/220.24  |- mesh__recordMaintainer mesh__D009534 lkw
% 220.09/220.24  |- mesh__recordAuthorizer mesh__D009534 sjn
% 220.09/220.24  |- skos__prefLabel mesh__D001551 Benz%28%a%29%Anthracenes
% 220.09/220.24  |- rdf__type mesh__D001551sskos__Concept
% 220.09/220.24  |- skos__broader mesh__D001551smesh__D011084
% 220.09/220.24  |- mesh__recordAuthorizer mesh__D001551 sjn
% 220.09/220.24  |- mesh__publicMeSHNote mesh__D001551
% 220.09/220.24       2005; see BENZANTHRACENES 1963-2005   
% 220.09/220.24  |- mesh__recordMaintainer mesh__D001551 ssb
% 220.09/220.24  |- mesh__dateCreated mesh__D001551 1999-01-01
% 220.09/220.24  |- skos__altLabel mesh__D001551 Naphthanthracenes
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D001551 2006
% 220.09/220.24  |- mesh__dateRevised mesh__D001551 2005-06-30
% 220.09/220.24  |- mesh__historyNote mesh__D001551 2005%28%1963%29%   
% 220.09/220.24  |- skos__scopeNote mesh__D001551
% 220.09/220.24       Four fused benzyl rings with three linear and one angular, that can be viewed as a benzyl-phenanthrenes. Compare with NAPHTHACENES which are four linear rings.%A%    
% 220.09/220.24  |- mesh__recordOriginator mesh__D001551 NLM
% 220.09/220.24  |- skos__altLabel mesh__D001551 Benz%28%b%29%Phenanthrenes
% 220.09/220.24  |- skos__scopeNote mesh__D014479
% 220.09/220.24       A federation of seven states on the southeast portion of the Arabian peninsula: Abu Dhabi, Ajman, Dubai, Fujairah, Ras al-Khaimah, Sharjah and Umm al-Qaiwain. In 1820 a treaty of peace was concluded between Great Britain and native rulers. During the 19th century the rulers agreed to suppression of the slave trade and restriction of foreign relations to Great Britain. The Trucial Council was established in 1952 and defense treaties with Great Britain terminated. In 1971 an independent six-member federation was formed, with Ras al-Khaimah joining the federation in 1972. %28%From Webster%27%s New Geographical Dictionary, 1988, p1250%29%%A%    
% 220.09/220.24  |- mesh__dateCreated mesh__D014479 1974-11-11
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D014479 2003
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D014479 2001
% 220.09/220.24  |- mesh__onlineNote mesh__D014479
% 220.09/220.24       use UNITED ARAB EMIRATES to search TRUCIAL STATES 1975-80%A%  
% 220.09/220.24  |- skos__annotation mesh__D014479
% 220.09/220.24       7 states on the southeast Arabian peninsula   
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D014479 2005
% 220.09/220.24  |- mesh__dateRevised mesh__D014479 1996-06-10
% 220.09/220.24  |- skos__prefLabel mesh__D014479 United Arab Emirates
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D014479 2004
% 220.09/220.24  |- skos__altLabel mesh__D014479 Trucial States
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D014479 2006
% 220.09/220.24  |- mesh__recordOriginator mesh__D014479 NLM
% 220.09/220.24  |- mesh__historyNote mesh__D014479 81; was TRUCIAL STATES 1975-80   
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D014479 2002
% 220.09/220.24  |- mesh__dateEstablished mesh__D014479 1975-01-01
% 220.09/220.24  |- mesh__recordMaintainer mesh__D014479 TGC
% 220.09/220.24  |- skos__broader mesh__D014479smesh__D008877
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D014479 1998
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D014479 1997
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D014479 1999
% 220.09/220.24  |- rdf__type mesh__D014479sskos__Concept
% 220.09/220.24  |- mesh__recordAuthorizer mesh__D014479 PLS
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D014479 2000
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D019962 2004
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D019962 2002
% 220.09/220.24  |- skos__hiddenLabel mesh__D019962 Disorders, Reactive Attachment
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D019962 1998
% 220.09/220.24  |- rdf__type mesh__D019962sskos__Concept
% 220.09/220.24  |- skos__scopeNote mesh__D019962
% 220.09/220.24       Markedly disturbed and developmentally inappropriate social relatedness that begins before age 5 and is associated with grossly pathological child care. The child may persistently fail to initiate and respond to social interactions in a developmentally appropriate way %28%inhibited type%29% or there may be a pattern of diffuse attachments with nondiscriminate sociability %28%disinhibited type%29%. %28%From DSM-IV, 1994%29%%A%    
% 220.09/220.24  |- skos__prefLabel mesh__D019962 Reactive Attachment Disorder
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D019962 1999
% 220.09/220.24  |- mesh__historyNote mesh__D019962 98   
% 220.09/220.24  |- skos__hiddenLabel mesh__D019962 Reactive Attachment Disorders
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D019962 2005
% 220.09/220.24  |- skos__hiddenLabel mesh__D019962 Attachment Disorder, Reactive
% 220.09/220.24  |- mesh__dateEstablished mesh__D019962 1998-01-01
% 220.09/220.24  |- mesh__publicMeSHNote mesh__D019962 98   
% 220.09/220.24  |- skos__hiddenLabel mesh__D019962 Attachment Disorders, Reactive
% 220.09/220.24  |- mesh__dateCreated mesh__D019962 1997-06-20
% 220.09/220.24  |- skos__broader mesh__D019962smesh__D019952
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D019962 2000
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D019962 2003
% 220.09/220.24  |- skos__hiddenLabel mesh__D019962 Disorder, Reactive Attachment
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D019962 2006
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D019962 2001
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D019164 1998
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D019164 1997
% 220.09/220.24  |- skos__hiddenLabel mesh__D019164 Liver, Bioartificial
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D019164 2000
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D019164 1999
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D019164 2003
% 220.09/220.24  |- mesh__dateEstablished mesh__D019164 1997-01-01
% 220.09/220.24  |- mesh__dateCreated mesh__D019164 1996-02-12
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D019164 2001
% 220.09/220.24  |- skos__prefLabel mesh__D019164 Liver, Artificial
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D019164 2005
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D019164 2004
% 220.09/220.24  |- skos__altLabel mesh__D019164 Bioartificial Liver
% 220.09/220.24  |- skos__hiddenLabel mesh__D019164 Livers, Bioartificial
% 220.09/220.24  |- skos__hiddenLabel mesh__D019164 Livers, Artificial
% 220.09/220.24  |- mesh__historyNote mesh__D019164 97   
% 220.09/220.24  |- skos__broader mesh__D019164smesh__D001187
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D019164 2006
% 220.09/220.24  |- rdf__type mesh__D019164sskos__Concept
% 220.09/220.24  |- mesh__publicMeSHNote mesh__D019164 97   
% 220.09/220.24  |- skos__altLabel mesh__D019164 Artificial Liver
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D019164 2002
% 220.09/220.24  |- skos__hiddenLabel mesh__D019164 Artificial Livers
% 220.09/220.24  |- skos__historyNote mesh__D019164 Artificial Organs %28%1972-1996%29%
% 220.09/220.24  |- skos__scopeNote mesh__D019164
% 220.09/220.24       Devices for simulating the activities of the liver. They often consist of a hybrid between both biological and artificial materials.%A%    
% 220.09/220.24  |- skos__hiddenLabel mesh__D019164 Bioartificial Livers
% 220.09/220.24  |- skos__broader mesh__D000459smesh__D000456
% 220.09/220.24  |- skos__scopeNote mesh__D000459
% 220.09/220.24       Predominantly marine algae of the division Phaeophyta, having CHROMATOPHORES containing carotenoid PIGMENTS, BIOLOGICAL. ALGINATES and phlorotannins occur widely in all major orders. They are considered the most highly evolved algae because of their well-developed multicellular organization and structural complexity.%A%    
% 220.09/220.24  |- rdf__type mesh__D000459sskos__Concept
% 220.09/220.24  |- mesh__dateCreated mesh__D000459 1999-01-01
% 220.09/220.24  |- mesh__recordOriginator mesh__D000459 NLM
% 220.09/220.24  |- mesh__dateRevised mesh__D000459 2005-07-01
% 220.09/220.24  |- skos__altLabel mesh__D000459 Brown Algae
% 220.09/220.24  |- mesh__recordAuthorizer mesh__D000459 sjn
% 220.09/220.24  |- skos__annotation mesh__D000459 GEN or unspecified; prefer specifics   
% 220.09/220.24  |- mesh__recordMaintainer mesh__D000459 sjn
% 220.09/220.24  |- mesh__publicMeSHNote mesh__D000459 91; was see under ALGAE 1971-90   
% 220.09/220.24  |- mesh__historyNote mesh__D000459
% 220.09/220.24       91%28%71%29%; was see under ALGAE 1971-90   
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D000459 2006
% 220.09/220.24  |- skos__prefLabel mesh__D000459 Algae, Brown
% 220.09/220.24  |- skos__altLabel mesh__D000459 Phaeophyceae
% 220.09/220.24  |- skos__altLabel mesh__D000459 Phaeophyta
% 220.09/220.24  |- mesh__dateEstablished mesh__D000459 1991-01-01
% 220.09/220.24  |- skos__historyNote mesh__D000459 Algae %28%1966-1970%29%
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D011181 2006
% 220.09/220.24  |- skos__hiddenLabel mesh__D011181 Program, Postpartum
% 220.09/220.24  |- mesh__dateRevised mesh__D011181 1997-06-20
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D011181 2004
% 220.09/220.24  |- mesh__dateEstablished mesh__D011181 1971-01-01
% 220.09/220.24  |- skos__prefLabel mesh__D011181 Postnatal Care
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D011181 1998
% 220.09/220.24  |- mesh__recordMaintainer mesh__D011181 PXP
% 220.09/220.24  |- rdf__type mesh__D011181sskos__Concept
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D011181 2000
% 220.09/220.24  |- skos__broader mesh__D011181smesh__D005791
% 220.09/220.24  |- skos__hiddenLabel mesh__D011181 Programs, Postpartum
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D011181 1999
% 220.09/220.24  |- skos__hiddenLabel mesh__D011181 Care, Postnatal
% 220.09/220.24  |- mesh__dateCreated mesh__D011181 1999-01-01
% 220.09/220.24  |- skos__scopeNote mesh__D011181
% 220.09/220.24       The care provided a woman following the birth of a child.%A%    
% 220.09/220.24  |- mesh__recordAuthorizer mesh__D011181 SJN
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D011181 2001
% 220.09/220.24  |- mesh__publicMeSHNote mesh__D011181 71   
% 220.09/220.24  |- skos__hiddenLabel mesh__D011181 Postpartum Program
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D011181 2005
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D011181 2002
% 220.09/220.24  |- mesh__recordOriginator mesh__D011181 NLM
% 220.09/220.24  |- skos__historyNote mesh__D011181 Puerperium %28%1966-1970%29%
% 220.09/220.24  |- mesh__historyNote mesh__D011181 71   
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D011181 2003
% 220.09/220.24  |- skos__broader mesh__D011181smesh__D008427
% 220.09/220.24  |- mesh__dateRevised mesh__D005942 2004-07-07
% 220.09/220.24  |- skos__annotation mesh__D005942 do not confuse with GLUCURONATES   
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D005942 2006
% 220.09/220.24  |- mesh__recordAuthorizer mesh__D005942 sjn
% 220.09/220.24  |- mesh__recordMaintainer mesh__D005942 ssb
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D005942 2005
% 220.09/220.24  |- mesh__recordOriginator mesh__D005942 NLM
% 220.09/220.24  |- rdf__type mesh__D005942sskos__Concept
% 220.09/220.24  |- skos__prefLabel mesh__D005942 Gluconates
% 220.09/220.24  |- mesh__dateCreated mesh__D005942 1999-01-01
% 220.09/220.24  |- skos__broader mesh__D005942smesh__D013400
% 220.09/220.24  |- skos__hiddenLabel mesh__D005942 Gluconate, Copper
% 220.09/220.24  |- skos__altLabel mesh__D005144 Sex Factor F
% 220.09/220.24  |- skos__hiddenLabel mesh__D005144 Factor Fs, Sex
% 220.09/220.24  |- mesh__publicMeSHNote mesh__D005144
% 220.09/220.24       78; was see under CONJUGATION, GENETIC 1975-77; SEX FACTOR, BACTERIAL was SEX FACTORS, BACTERIAL see under PLASMIDS 1978-83%A%  
% 220.09/220.24  |- skos__hiddenLabel mesh__D005144 Fs, Sex Factor
% 220.09/220.24  |- rdf__type mesh__D005144sskos__Concept
% 220.09/220.24  |- mesh__historyNote mesh__D005144
% 220.09/220.24       78%28%75%29%; was see under CONJUGATION, GENETIC 1975-77; SEX FACTOR, BACTERIAL was SEX FACTORS, BACTERIAL see under PLASMIDS 1978-83%A%  
% 220.09/220.24  |- skos__hiddenLabel mesh__D005144 Bacterial Fertility Factor
% 220.09/220.24  |- mesh__recordAuthorizer mesh__D005144 sjn
% 220.09/220.24  |- skos__hiddenLabel mesh__D005144 Bacterial Fertility Factors
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D005144 2006
% 220.09/220.24  |- skos__hiddenLabel mesh__D005144 Sex Factor Fs
% 220.09/220.24  |- skos__prefLabel mesh__D005144 F Factor
% 220.09/220.24  |- skos__altLabel mesh__D005144 F Plasmid
% 220.09/220.24  |- mesh__dateEstablished mesh__D005144 1978-01-01
% 220.09/220.24  |- skos__hiddenLabel mesh__D005144 Transfer Factor, Resistance
% 220.09/220.24  |- skos__hiddenLabel mesh__D005144 F Factors
% 220.09/220.24  |- skos__hiddenLabel mesh__D005144 Factors, Resistance Transfer
% 220.09/220.24  |- skos__hiddenLabel mesh__D005144 Factors, F
% 220.09/220.24  |- skos__hiddenLabel mesh__D005144 Factor, F
% 220.09/220.24  |- skos__historyNote mesh__D005144 Conjugation, Genetic %28%1968-1974%29%
% 220.09/220.24  |- skos__altLabel mesh__D005144 Fertility Factor, Bacterial
% 220.09/220.24  |- skos__altLabel mesh__D005144 Bacterial Sex Factor
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D005144 2005
% 220.09/220.24  |- skos__hiddenLabel mesh__D005144 Factors, Bacterial Fertility
% 220.09/220.24  |- skos__related mesh__D005144smesh__D018933
% 220.09/220.24  |- skos__altLabel mesh__D005144 Resistance Transfer Factor
% 220.09/220.24  |- skos__altLabel mesh__D005144 Factors, Bacterial Sex
% 220.09/220.24  |- skos__altLabel mesh__D005144 Sex Factor, Bacterial
% 220.09/220.24  |- skos__altLabel mesh__D005144 Factor, Bacterial Sex
% 220.09/220.24  |- skos__hiddenLabel mesh__D005144 Factor, Resistance Transfer
% 220.09/220.24  |- mesh__onlineNote mesh__D005144
% 220.09/220.24       use F FACTOR to search SEX FACTORS, BACTERIAL 1978-83   
% 220.09/220.24  |- skos__scopeNote mesh__D005144
% 220.09/220.24       A plasmid whose presence in the cell, either extrachromosomal or integrated into the BACTERIAL CHROMOSOME, determines the %22%sex%22% of the bacterium, host chromosome mobilization, transfer via conjugation %28%CONJUGATION, GENETIC%29% of genetic material, and the formation of SEX PILI.%A%    
% 220.09/220.24  |- skos__altLabel mesh__D005144 F Plasmids
% 220.09/220.24  |- skos__altLabel mesh__D005144 Bacterial Sex Factors
% 220.09/220.24  |- skos__hiddenLabel mesh__D005144 Factor, Bacterial Fertility
% 220.09/220.24  |- skos__altLabel mesh__D005144 Sex Factors, Bacterial
% 220.09/220.24  |- mesh__dateCreated mesh__D005144 1974-11-11
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D005144 2004
% 220.09/220.24  |- mesh__recordOriginator mesh__D005144 NLM
% 220.09/220.24  |- skos__hiddenLabel mesh__D005144 Fertility Factors, Bacterial
% 220.09/220.24  |- skos__historyNote mesh__D005144 Genetics %28%1966-1967%29%
% 220.09/220.24  |- skos__hiddenLabel mesh__D005144 F, Sex Factor
% 220.09/220.24  |- skos__hiddenLabel mesh__D005144 Factor F, Sex
% 220.09/220.24  |- skos__hiddenLabel mesh__D005144 Plasmids, F
% 220.09/220.24  |- mesh__recordMaintainer mesh__D005144 nns
% 220.09/220.24  |- skos__hiddenLabel mesh__D005144 Transfer Factors, Resistance
% 220.09/220.24  |- skos__hiddenLabel mesh__D005144 Plasmid, F
% 220.09/220.24  |- skos__broader mesh__D005144smesh__D010957
% 220.09/220.24  |- skos__hiddenLabel mesh__D005144 Resistance Transfer Factors
% 220.09/220.24  |- mesh__dateRevised mesh__D005144 2003-07-09
% 220.09/220.24  |- skos__hiddenLabel mesh__D043263 Phosphatase, Myosin-Light-Chain
% 220.09/220.24  |- skos__hiddenLabel mesh__D043263 Phosphatase, Myosin
% 220.09/220.24  |- mesh__recordMaintainer mesh__D043263 AKE
% 220.09/220.24  |- skos__altLabel mesh__D043263 Smooth Muscle MBP
% 220.09/220.24  |- skos__historyNote mesh__D043263
% 220.09/220.24       Phosphoprotein Phosphatase %28%1980-2003%29%
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D043263 2004
% 220.09/220.24  |- skos__hiddenLabel mesh__D043263 Smooth Muscle Phosphatase II
% 220.09/220.24  |- skos__prefLabel mesh__D043263 Myosin-Light-Chain Phosphatase
% 220.09/220.24  |- mesh__recordAuthorizer mesh__D043263 sjn
% 220.09/220.24  |- skos__altLabel mesh__D043263 Myosin Phosphatase
% 220.09/220.24  |- mesh__activeMeSHYear mesh__D043263 2005
% 220.09/220.24  |- skos__altLabel mesh__D043263 Myosin Light Chain Phosphatase
% 220.09/220.24  |- skos__hiddenLabel mesh__D043263 Muscle Phosphatase-II, Smooth
% 220.09/220.25  |- mesh__historyNote mesh__D043263
% 220.09/220.25       2004; use MYOSIN-LIGHT-CHAIN PHOSPHATASE %28%NM%29% 1980-2003   
% 220.09/220.25  |- mesh__dateCreated mesh__D043263 2003-07-09
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D043263 2006
% 220.09/220.25  |- mesh__publicMeSHNote mesh__D043263
% 220.09/220.25       2004; MYOSIN-LIGHT CHAIN PHOSPHATASE was indexed under PHOSPHOPROTEIN PHOSPHATASE 1980-2003%A%  
% 220.09/220.25  |- skos__altLabel mesh__D043263 Calponin Phosphatase
% 220.09/220.25  |- mesh__dateEstablished mesh__D043263 2004-01-01
% 220.09/220.25  |- skos__hiddenLabel mesh__D043263 Smooth Muscle Phosphatase I
% 220.09/220.25  |- skos__hiddenLabel mesh__D043263 Phosphatase, Calponin
% 220.09/220.25  |- rdf__type mesh__D043263sskos__Concept
% 220.09/220.25  |- mesh__recordOriginator mesh__D043263 AKE
% 220.09/220.25  |- skos__broader mesh__D043263smesh__D010749
% 220.09/220.25  |- skos__hiddenLabel mesh__D043263 Phosphatase-II, Smooth Muscle
% 220.09/220.25  |- skos__hiddenLabel mesh__D043263 Smooth Muscle Myosin bound Phosphatase
% 220.09/220.25  |- skos__scopeNote mesh__D043263
% 220.09/220.25       A phosphoprotein phosphatase that is specific for MYOSIN LIGHT CHAINS. It is composed of three subunits, which include a catalytic subunit, a myosin binding subunit, and a third subunit of unknown function.%A%    
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D029592 2004
% 220.09/220.25  |- skos__scopeNote mesh__D029592
% 220.09/220.25       A plant family of the order Scrophulariales subclass Asteridae, class Magnoliopsida.  The leaves are usually opposite and the flowers usually have four sepals, four petals, two stamens, and two fused carpels that form a single superior ovary.%A%    
% 220.09/220.25  |- mesh__recordAuthorizer mesh__D029592 sjn
% 220.09/220.25  |- skos__annotation mesh__D029592
% 220.09/220.25       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D029592 2005
% 220.09/220.25  |- skos__broader mesh__D029592smesh__D019684
% 220.09/220.25  |- mesh__recordMaintainer mesh__D029592 ssb
% 220.09/220.25  |- mesh__dateRevised mesh__D029592 2003-07-09
% 220.09/220.25  |- rdf__type mesh__D029592sskos__Concept
% 220.09/220.25  |- mesh__dateEstablished mesh__D029592 2002-01-01
% 220.09/220.25  |- skos__prefLabel mesh__D029592 Oleaceae
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D029592 2006
% 220.09/220.25  |- mesh__recordOriginator mesh__D029592 ssb
% 220.09/220.25  |- mesh__historyNote mesh__D029592 2002   
% 220.09/220.25  |- mesh__dateCreated mesh__D029592 2001-07-25
% 220.09/220.25  |- mesh__publicMeSHNote mesh__D029592 2002   
% 220.09/220.25  |- skos__broader mesh__D003813Q000193smesh__D003813
% 220.09/220.25  |- mesh__preferredCombination mesh__D003813Q000193smesh__D004497
% 220.09/220.25  |- rdf__type mesh__D003813Q000193smesh__CompoundConcept
% 220.09/220.25  |- mesh__recordAuthorizer mesh__D010089 sjn
% 220.09/220.25  |- skos__hiddenLabel mesh__D010089 N-Demethylating Oxidoreductases
% 220.09/220.25  |- skos__prefLabel mesh__D010089 Oxidoreductases, N-Demethylating
% 220.09/220.25  |- mesh__dateCreated mesh__D010089 1999-01-01
% 220.09/220.25  |- skos__altLabel mesh__D010089 N-Demethylases
% 220.09/220.25  |- skos__hiddenLabel mesh__D010089 Demethylating Oxidoreductases, N
% 220.09/220.25  |- rdf__type mesh__D010089sskos__Concept
% 220.09/220.25  |- mesh__dateRevised mesh__D010089 2005-06-30
% 220.09/220.25  |- skos__hiddenLabel mesh__D010089 N Demethylases
% 220.09/220.25  |- skos__historyNote mesh__D010089 Oxidoreductases %28%1966-1972%29%
% 220.09/220.25  |- mesh__recordOriginator mesh__D010089 NLM
% 220.09/220.25  |- skos__altLabel mesh__D010089 Oxidoreductases, N Demethylating
% 220.09/220.25  |- mesh__recordMaintainer mesh__D010089 jmp
% 220.09/220.25  |- mesh__publicMeSHNote mesh__D010089 73   
% 220.09/220.25  |- skos__hiddenLabel mesh__D010089 N Demethylating Oxidoreductases
% 220.09/220.25  |- mesh__dateEstablished mesh__D010089 1973-01-01
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D010089 2006
% 220.09/220.25  |- mesh__historyNote mesh__D010089 73   
% 220.09/220.25  |- skos__broader mesh__D010089smesh__D000587
% 220.09/220.25  |- mesh__publicMeSHNote mesh__D015572
% 220.09/220.25       90; was see LEUCOMYCINS 1981-89; was heading 1963-80   
% 220.09/220.25  |- skos__scopeNote mesh__D015572
% 220.09/220.25       A macrolide antibiotic produced by Streptomyces ambofaciens. The drug is effective against gram-positive aerobic pathogens, N. gonorrhoeae, and staphylococci. It is used to treat infections caused by bacteria and Toxoplasma gondii.%A%    
% 220.09/220.25  |- skos__altLabel mesh__D015572
% 220.09/220.25       Rh%C3%%B4%ne-Poulenc Rorer Brand of Spiramycin
% 220.09/220.25  |- skos__altLabel mesh__D015572 Gr%C3%%BC%nenthal Brand of Spiramycin
% 220.09/220.25  |- skos__hiddenLabel mesh__D015572 IL5902
% 220.09/220.25  |- mesh__dateEstablished mesh__D015572 1990-01-01
% 220.09/220.25  |- skos__broader mesh__D015572smesh__D007933
% 220.09/220.25  |- mesh__recordMaintainer mesh__D015572 CCR
% 220.09/220.25  |- mesh__dateRevised mesh__D015572 2005-06-30
% 220.09/220.25  |- skos__historyNote mesh__D015572 Leucomycins %28%1981-1989%29%
% 220.09/220.25  |- rdf__type mesh__D015572sskos__Concept
% 220.09/220.25  |- skos__hiddenLabel mesh__D015572 IL 5902
% 220.09/220.25  |- mesh__recordOriginator mesh__D015572 RLS
% 220.09/220.25  |- skos__altLabel mesh__D015572 Spiramycine
% 220.09/220.25  |- skos__altLabel mesh__D015572 Selectomycin
% 220.09/220.25  |- skos__prefLabel mesh__D015572 Spiramycin
% 220.09/220.25  |- mesh__historyNote mesh__D015572
% 220.09/220.25       90; was see LEUCOMYCINS 1981-89; was heading 1963-80   
% 220.09/220.25  |- skos__hiddenLabel mesh__D015572 NSC64393
% 220.09/220.25  |- mesh__recordAuthorizer mesh__D015572 sjn
% 220.09/220.25  |- skos__hiddenLabel mesh__D015572 NSC 55926
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D015572 2006
% 220.09/220.25  |- skos__altLabel mesh__D015572 Teofarma Brand of Spiramycin
% 220.09/220.25  |- skos__altLabel mesh__D015572 Aventis Brand of Spiramycin
% 220.09/220.25  |- skos__hiddenLabel mesh__D015572 NSC55926
% 220.09/220.25  |- skos__annotation mesh__D015572
% 220.09/220.25       do not use /biosyn unless by living matter   
% 220.09/220.25  |- mesh__dateCreated mesh__D015572 1989-05-25
% 220.09/220.25  |- mesh__onlineNote mesh__D015572
% 220.09/220.25       use LEUCOMYCINS to search SPIRAMYCIN 1981-89   
% 220.09/220.25  |- skos__hiddenLabel mesh__D015572 NSC 64393
% 220.09/220.25  |- skos__historyNote mesh__D009535 Nicotinamide %28%1972-1974%29%
% 220.09/220.25  |- skos__prefLabel mesh__D009535 Nicotinamidase
% 220.09/220.25  |- mesh__publicMeSHNote mesh__D009535
% 220.09/220.25       91; was see under AMIDOHYDROLASES 1975-90   
% 220.09/220.25  |- mesh__recordOriginator mesh__D009535 NLM
% 220.09/220.25  |- skos__altLabel mesh__D009535 Nicotinamide Amidohydrolase
% 220.09/220.25  |- mesh__historyNote mesh__D009535
% 220.09/220.25       91%28%75%29%; was see under AMIDOHYDROLASES 1975-90   
% 220.09/220.25  |- skos__scopeNote mesh__D009535
% 220.09/220.25       An enzyme that catalyzes the hydrolysis of nicotinamide to nicotinate and ammonia. EC 3.5.1.19.%A%    
% 220.09/220.25  |- skos__historyNote mesh__D009535 Amidohydrolases %28%1972-1974%29%
% 220.09/220.25  |- rdf__type mesh__D009535sskos__Concept
% 220.09/220.25  |- mesh__dateRevised mesh__D009535 2003-07-09
% 220.09/220.25  |- mesh__recordAuthorizer mesh__D009535 sjn
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D009535 2005
% 220.09/220.25  |- skos__altLabel mesh__D009535 Nicotinamide Deamidase
% 220.09/220.25  |- skos__hiddenLabel mesh__D009535 Amidohydrolase, Nicotinamide
% 220.09/220.25  |- mesh__dateEstablished mesh__D009535 1991-01-01
% 220.09/220.25  |- skos__hiddenLabel mesh__D009535 Deamidase, Nicotinamide
% 220.09/220.25  |- mesh__recordMaintainer mesh__D009535 ssb
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D009535 2006
% 220.09/220.25  |- mesh__dateCreated mesh__D009535 1974-11-19
% 220.09/220.25  |- skos__broader mesh__D009535smesh__D000581
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D009535 2004
% 220.09/220.25  |- skos__related mesh__D001552smesh__D001381
% 220.09/220.25  |- mesh__recordOriginator mesh__D001552 NLM
% 220.09/220.25  |- skos__scopeNote mesh__D001552
% 220.09/220.25       Compounds with BENZENE fused to AZEPINES.     
% 220.09/220.25  |- mesh__publicMeSHNote mesh__D001552 68   
% 220.09/220.25  |- mesh__dateCreated mesh__D001552 1999-01-01
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D001552 2005
% 220.09/220.25  |- mesh__dateRevised mesh__D001552 2004-07-07
% 220.09/220.25  |- skos__prefLabel mesh__D001552 Benzazepines
% 220.09/220.25  |- mesh__historyNote mesh__D001552 68   
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D001552 2006
% 220.09/220.25  |- mesh__recordAuthorizer mesh__D001552 sjn
% 220.09/220.25  |- mesh__recordMaintainer mesh__D001552 ssb
% 220.09/220.25  |- mesh__dateEstablished mesh__D001552 1968-01-01
% 220.09/220.25  |- skos__related mesh__D001552smesh__D003984
% 220.09/220.25  |- skos__broader mesh__D001552smesh__D006574
% 220.09/220.25  |- rdf__type mesh__D001552sskos__Concept
% 220.09/220.25  |- rdf__type mesh__D019963sskos__Concept
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D019963 2001
% 220.09/220.25  |- skos__broader mesh__D019963smesh__D003942
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D019963 1999
% 220.09/220.25  |- skos__related mesh__D019963smesh__D002624
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D019963 2002
% 220.09/220.25  |- mesh__historyNote mesh__D019963 98   
% 220.09/220.25  |- skos__altLabel mesh__D019963 Chemistry Test, Clinical
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D019963 2005
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D019963 2003
% 220.09/220.25  |- skos__altLabel mesh__D019963 Test, Clinical Chemistry
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D019963 2006
% 220.09/220.25  |- skos__scopeNote mesh__D019963
% 220.09/220.25       Laboratory tests demonstrating the presence of physiologically significant substances in the blood, urine, tissue, and body fluids with application to the diagnosis or therapy of disease.%A%    
% 220.09/220.25  |- skos__altLabel mesh__D019963 Chemistry Tests, Clinical
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D019963 2004
% 220.09/220.25  |- mesh__dateEstablished mesh__D019963 1998-01-01
% 220.09/220.25  |- mesh__publicMeSHNote mesh__D019963 98   
% 220.09/220.25  |- skos__historyNote mesh__D019963 Chemistry, Clinical %28%1966-1997%29%
% 220.09/220.25  |- skos__altLabel mesh__D019963 Clinical Chemistry Test
% 220.09/220.25  |- skos__annotation mesh__D019963
% 220.09/220.25       GEN or unspecified; prefer specifics; NIM; DF: CLIN CHEM TESTS%A%  
% 220.09/220.25  |- mesh__dateCreated mesh__D019963 1997-06-20
% 220.09/220.25  |- skos__prefLabel mesh__D019963 Clinical Chemistry Tests
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D019963 2000
% 220.09/220.25  |- skos__altLabel mesh__D019963 Tests, Clinical Chemistry
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D019963 1998
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011980 2006
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011980 1996
% 220.09/220.25  |- skos__prefLabel mesh__D011980 Receptors, Progesterone
% 220.09/220.25  |- skos__historyNote mesh__D011980
% 220.09/220.25       Receptors, Endogenous Substances %28%1973-1976%29%
% 220.09/220.25  |- skos__hiddenLabel mesh__D011980 Receptor, Progesterone
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011980 2000
% 220.09/220.25  |- mesh__dateCreated mesh__D011980 1976-05-03
% 220.09/220.25  |- mesh__dateEstablished mesh__D011980 1977-01-01
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011980 1997
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011980 2003
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011980 2001
% 220.09/220.25  |- mesh__publicMeSHNote mesh__D011980 77   
% 220.09/220.25  |- mesh__recordOriginator mesh__D011980 SH
% 220.09/220.25  |- mesh__recordAuthorizer mesh__D011980 PLS
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011980 2004
% 220.09/220.25  |- skos__historyNote mesh__D011980 Progesterone %28%1966-1976%29%
% 220.09/220.25  |- rdf__type mesh__D011980sskos__Concept
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011980 1998
% 220.09/220.25  |- skos__altLabel mesh__D011980 Progestin Receptors
% 220.09/220.25  |- skos__scopeNote mesh__D011980
% 220.09/220.25       Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives.%A%    
% 220.09/220.25  |- skos__altLabel mesh__D011980 Receptors, Progestin
% 220.09/220.25  |- skos__altLabel mesh__D011980 Progesterone Receptor
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011980 2002
% 220.09/220.25  |- mesh__dateRevised mesh__D011980 1995-06-08
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011980 1999
% 220.09/220.25  |- mesh__historyNote mesh__D011980 77   
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011980 2005
% 220.09/220.25  |- skos__historyNote mesh__D011980 Receptors, Drug %28%1968-1976%29%
% 220.09/220.25  |- skos__annotation mesh__D011980
% 220.09/220.25       coord IM with specific progesterone %28%IM%29%; DF: RECEPT PROGESTERONE%A%  
% 220.09/220.25  |- skos__broader mesh__D011980smesh__D011987
% 220.09/220.25  |- skos__altLabel mesh__D011980 Progesterone Receptors
% 220.09/220.25  |- mesh__recordMaintainer mesh__D011980 KEV
% 220.09/220.25  |- skos__scopeNote mesh__D011182
% 220.09/220.25       The period of care beginning when the patient is removed from surgery and aimed at meeting the patient%27%s psychological and physical needs directly after surgery. %28%From Dictionary of Health Services Management, 2d ed%29%%A%    
% 220.09/220.25  |- skos__prefLabel mesh__D011182 Postoperative Care
% 220.09/220.25  |- skos__annotation mesh__D011182 DF: POSTOP CARE   
% 220.09/220.25  |- skos__related mesh__D011182smesh__D026741
% 220.09/220.25  |- rdf__type mesh__D011182sskos__Concept
% 220.09/220.25  |- mesh__dateCreated mesh__D011182 1999-01-01
% 220.09/220.25  |- skos__broader mesh__D011182smesh__D019990
% 220.09/220.25  |- skos__hiddenLabel mesh__D011182 Postoperative Procedure
% 220.09/220.25  |- skos__broader mesh__D011182smesh__D013514
% 220.09/220.25  |- mesh__recordMaintainer mesh__D011182 NLM
% 220.09/220.25  |- skos__altLabel mesh__D011182 Procedures, Postoperative
% 220.09/220.25  |- skos__hiddenLabel mesh__D011182 Procedure, Postoperative
% 220.09/220.25  |- mesh__recordAuthorizer mesh__D011182 NLM
% 220.09/220.25  |- mesh__dateRevised mesh__D011182 2005-07-06
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011182 2006
% 220.09/220.25  |- mesh__recordOriginator mesh__D011182 NLM
% 220.09/220.25  |- skos__altLabel mesh__D011182 Care, Postoperative
% 220.09/220.25  |- skos__scopeNote mesh__D005943
% 220.09/220.25       Biosynthesis of GLUCOSE from nonhexose or non-carbohydrate precursors, such as LACTATE; PYRUVATE; ALANINE; and GLYCEROL.%A%    
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D005943 2006
% 220.09/220.25  |- mesh__publicMeSHNote mesh__D005943 67   
% 220.09/220.25  |- mesh__dateCreated mesh__D005943 1999-01-01
% 220.09/220.25  |- skos__broader mesh__D005943smesh__D050260
% 220.09/220.25  |- rdf__type mesh__D005943sskos__Concept
% 220.09/220.25  |- mesh__recordAuthorizer mesh__D005943 sjn
% 220.09/220.25  |- skos__prefLabel mesh__D005943 Gluconeogenesis
% 220.09/220.25  |- mesh__recordOriginator mesh__D005943 NLM
% 220.09/220.25  |- mesh__dateRevised mesh__D005943 2005-06-30
% 220.09/220.25  |- mesh__dateEstablished mesh__D005943 1967-01-01
% 220.09/220.25  |- mesh__historyNote mesh__D005943 67%28%65%29%   
% 220.09/220.25  |- mesh__recordMaintainer mesh__D005943 lkt
% 220.09/220.25  |- mesh__recordOriginator mesh__D005145 NLM
% 220.09/220.25  |- skos__annotation mesh__D005145
% 220.09/220.25       usually NIM as site; soft parts = FACE, bones = FACIAL BONES or specifics; /abnorm permitted but FACIAL BONES /abnorm is more likely; facial fractures: see note on FACIAL BONES; craniofacial dysmorphism %26% craniofacial fibrous dysplasia %26% long face syndrome: see note also on FACIAL BONES%A%  
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D005145 2004
% 220.09/220.25  |- skos__broader mesh__D005145smesh__D006257
% 220.09/220.25  |- skos__hiddenLabel mesh__D005145 Faces
% 220.09/220.25  |- rdf__type mesh__D005145sskos__Concept
% 220.09/220.25  |- skos__scopeNote mesh__D005145
% 220.09/220.25       The anterior portion of the head that includes the skin, muscles, and structures of the forehead, eyes, nose, mouth, cheeks, and jaw.%A%    
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D005145 2002
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D005145 2005
% 220.09/220.25  |- mesh__dateRevised mesh__D005145 1999-11-03
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D005145 2006
% 220.09/220.25  |- mesh__dateCreated mesh__D005145 1999-01-01
% 220.09/220.25  |- mesh__recordAuthorizer mesh__D005145 sjn
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D005145 2000
% 220.09/220.25  |- mesh__recordMaintainer mesh__D005145 KEV
% 220.09/220.25  |- skos__prefLabel mesh__D005145 Face
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D005145 2003
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D005145 2001
% 220.09/220.25  |- skos__altLabel mesh__D029593 Jervell and Lange-Nielsen Syndrome
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D029593 2004
% 220.09/220.25  |- skos__historyNote mesh__D029593 Long QT Syndrome %28%1986-2001%29%
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D029593 2003
% 220.09/220.25  |- skos__prefLabel mesh__D029593 Jervell-Lange Nielsen Syndrome
% 220.09/220.25  |- skos__hiddenLabel mesh__D029593 Jervell Lange Nielsen Syndrome
% 220.09/220.25  |- mesh__dateEstablished mesh__D029593 2002-01-01
% 220.09/220.25  |- mesh__historyNote mesh__D029593 2002; use LONG QT SYNDROME 1986-2001   
% 220.09/220.25  |- skos__broader mesh__D029593smesh__D008133
% 220.09/220.25  |- skos__hiddenLabel mesh__D029593 Nielsen Syndrome, Jervell-Lange
% 220.09/220.25  |- skos__broader mesh__D029593smesh__D030342
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D029593 2002
% 220.09/220.25  |- rdf__type mesh__D029593sskos__Concept
% 220.09/220.25  |- skos__hiddenLabel mesh__D029593 Jervell and Lange Nielsen Syndrome
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D029593 2006
% 220.09/220.25  |- skos__scopeNote mesh__D029593
% 220.09/220.25       An autosomal recessive syndrome of abnormal cardioelectrophysiology, combining LONG QT SYNDROME with deafness.%A%    
% 220.09/220.25  |- mesh__dateCreated mesh__D029593 2001-07-25
% 220.09/220.25  |- skos__historyNote mesh__D029593 Deafness %28%1969-1985%29%
% 220.09/220.25  |- mesh__publicMeSHNote mesh__D029593
% 220.09/220.25       2002; see LONG QT SYNDROME 1986-2001   
% 220.09/220.25  |- skos__hiddenLabel mesh__D029593 Syndrome, Jervell-Lange Nielsen
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D029593 2005
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D043264 2005
% 220.09/220.25  |- mesh__recordMaintainer mesh__D043264 jmp
% 220.09/220.25  |- rdf__type mesh__D043264sskos__Concept
% 220.09/220.25  |- skos__hiddenLabel mesh__D043264 5%27% Nucleotidephosphodiesterase
% 220.09/220.25  |- skos__altLabel mesh__D043264 Alkaline Phosphodiesterase
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D043264 2004
% 220.09/220.25  |- skos__scopeNote mesh__D043264
% 220.09/220.25       A phosphoric diester hydrolase that removes 5%27%-nucleotides from the 3%27%-hydroxy termini of 3%27%-hydroxy-terminated OLIGONUCLEOTIDES. It has low activity towards POLYNUCLEOTIDES and the presence of 3%27%-phosphate terminus on the substrate may inhibit hydrolysis.%A%    
% 220.09/220.25  |- skos__hiddenLabel mesh__D043264 Phosphodiesterase, Alkaline
% 220.09/220.25  |- skos__broader mesh__D043264smesh__D010727
% 220.09/220.25  |- skos__prefLabel mesh__D043264 Phosphodiesterase I
% 220.09/220.25  |- skos__hiddenLabel mesh__D043264
% 220.09/220.25       Diester Phosphohydrolase, Orthophosphoric
% 220.09/220.25  |- skos__hiddenLabel mesh__D043264 Phosphodiesterase I, Alkaline
% 220.09/220.25  |- skos__hiddenLabel mesh__D043264
% 220.09/220.25       Phosphohydrolase, Orthophosphoric Diester
% 220.09/220.25  |- skos__altLabel mesh__D043264 Orthophosphoric Diester Phosphohydrolase
% 220.09/220.25  |- skos__altLabel mesh__D043264 Oligonucleate 5%27%-Nucleotidohydrolase
% 220.09/220.25  |- mesh__dateEstablished mesh__D043264 2004-01-01
% 220.09/220.25  |- mesh__dateCreated mesh__D043264 2003-07-09
% 220.09/220.25  |- skos__hiddenLabel mesh__D043264 Oligonucleate 5%27% Nucleotidohydrolase
% 220.09/220.25  |- mesh__historyNote mesh__D043264
% 220.09/220.25       2004; use PHOSPHODIESTERASE I %28%NM%29% 1980-2003   
% 220.09/220.25  |- skos__historyNote mesh__D043264
% 220.09/220.25       Phosphoric Diester Hydrolases %28%1978-2003%29%
% 220.09/220.25  |- mesh__recordAuthorizer mesh__D043264 sjn
% 220.09/220.25  |- skos__altLabel mesh__D043264 Alkaline Phosphodiesterase I
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D043264 2006
% 220.09/220.25  |- mesh__publicMeSHNote mesh__D043264
% 220.09/220.25       2004; PHOSPHODIESTERASE I was indexed under PHOSPHORIC DIESTER HYDROLASES 1981-2003, under NUCLEOTIDES 1978-1980%A%  
% 220.09/220.25  |- skos__altLabel mesh__D043264 5%27%-Nucleotidephosphodiesterase
% 220.09/220.25  |- skos__hiddenLabel mesh__D043264 5%27% Exonuclease
% 220.09/220.25  |- mesh__recordOriginator mesh__D043264 AKE
% 220.09/220.25  |- skos__altLabel mesh__D043264 5%27%-Exonuclease
% 220.09/220.25  |- skos__hiddenLabel mesh__D009536 Niacinamide Merck Brand
% 220.09/220.25  |- rdf__type mesh__D009536sskos__Concept
% 220.09/220.25  |- skos__hiddenLabel mesh__D009536 B 3, Vitamin
% 220.09/220.25  |- skos__annotation mesh__D009536
% 220.09/220.25       /defic: consider also PELLAGRA; /ther use: coordinate disease with /drug ther, not /diet ther%A%  
% 220.09/220.25  |- skos__scopeNote mesh__D009536
% 220.09/220.25       An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and PELLAGRA. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake.%A%    
% 220.09/220.25  |- skos__prefLabel mesh__D009536 Niacinamide
% 220.09/220.25  |- skos__hiddenLabel mesh__D009536 Jenapharm, Nicotins%C3%%A4%ureamid
% 220.09/220.25  |- mesh__publicMeSHNote mesh__D009536
% 220.09/220.25       93; was NICOTINAMIDE 1963-92; NIACINAMIDE was see NICOTINAMIDE 1963-92%A%  
% 220.09/220.25  |- skos__altLabel mesh__D009536 Vitamin B3
% 220.09/220.25  |- skos__hiddenLabel mesh__D009536 3 Pyridinecarboxamide
% 220.09/220.25  |- skos__altLabel mesh__D009536 Vitamin B 3
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D009536 2006
% 220.09/220.25  |- mesh__recordOriginator mesh__D009536 NLM
% 220.09/220.25  |- skos__altLabel mesh__D009536 Nicotinamide
% 220.09/220.25  |- skos__broader mesh__D009536smesh__D009539
% 220.09/220.25  |- mesh__recordAuthorizer mesh__D009536 sjn
% 220.09/220.25  |- skos__hiddenLabel mesh__D009536 B3, Vitamin
% 220.09/220.25  |- skos__altLabel mesh__D009536 Astra Brand of Niacinamide
% 220.09/220.25  |- skos__altLabel mesh__D009536 Merck Brand of Niacinamide
% 220.09/220.25  |- skos__hiddenLabel mesh__D009536 Niacinamide Jenapharm Brand
% 220.09/220.25  |- skos__altLabel mesh__D009536 3-Pyridinecarboxamide
% 220.09/220.25  |- mesh__historyNote mesh__D009536
% 220.09/220.25       93; was NICOTINAMIDE 1963-92; NIACINAMIDE was see NICOTINAMIDE 1963-92%A%  
% 220.09/220.25  |- skos__hiddenLabel mesh__D009536 Niacinamide Astra Brand
% 220.09/220.25  |- skos__altLabel mesh__D009536 Jenapharm Brand of Niacinamide
% 220.09/220.25  |- mesh__recordMaintainer mesh__D009536 ssb
% 220.09/220.25  |- skos__hiddenLabel mesh__D009536 Niacinamide Pharmagenix Brand
% 220.09/220.25  |- skos__altLabel mesh__D009536 Vitamin PP
% 220.09/220.25  |- mesh__dateRevised mesh__D009536 2005-06-30
% 220.09/220.25  |- mesh__onlineNote mesh__D009536
% 220.09/220.25       use NIACINAMIDE to search NICOTINAMIDE 1966-92   
% 220.09/220.25  |- mesh__dateCreated mesh__D009536 1999-01-01
% 220.09/220.25  |- skos__altLabel mesh__D009536 Pharmagenix Brand of Niacinamide
% 220.09/220.25  |- skos__historyNote mesh__D001553 Benzofurans %28%1971-1974%29%
% 220.09/220.25  |- skos__altLabel mesh__D001553 Aliud Brand of Benzbromarone
% 220.09/220.25  |- skos__hiddenLabel mesh__D001553 Benzbromaron ratiopharm
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D001553 2006
% 220.09/220.25  |- skos__hiddenLabel mesh__D001553 Benzbromarone Heumann Brand
% 220.09/220.25  |- skos__altLabel mesh__D001553 Urinorm
% 220.09/220.25  |- mesh__recordMaintainer mesh__D001553 mdb
% 220.09/220.25  |- skos__hiddenLabel mesh__D001553 Benzbromaronratiopharm
% 220.09/220.25  |- skos__altLabel mesh__D001553 Sanofi Winthrop Brand of Benzbromarone
% 220.09/220.25  |- skos__hiddenLabel mesh__D001553 Benzbromarone Sanfer Brand
% 220.09/220.25  |- skos__hiddenLabel mesh__D001553 Benzbromarone ratiopharm Brand
% 220.09/220.25  |- skos__altLabel mesh__D001553 Heumann Brand of Benzbromarone
% 220.09/220.25  |- skos__hiddenLabel mesh__D001553 Benzbromarone Aliud Brand
% 220.09/220.25  |- mesh__recordOriginator mesh__D001553 NLM
% 220.09/220.25  |- skos__altLabel mesh__D001553 Sanfer Brand of Benzbromarone
% 220.09/220.25  |- rdf__type mesh__D001553sskos__Concept
% 220.09/220.25  |- skos__historyNote mesh__D001553 Bromine %28%1973-1974%29%
% 220.09/220.25  |- skos__historyNote mesh__D001553 Benzoates %28%1971-1974%29%
% 220.09/220.25  |- skos__altLabel mesh__D001553 Benzbromaron
% 220.09/220.25  |- mesh__publicMeSHNote mesh__D001553
% 220.09/220.25       91; was see under BENZOFURANS 1975-90   
% 220.09/220.25  |- mesh__dateEstablished mesh__D001553 1991-01-01
% 220.09/220.25  |- mesh__historyNote mesh__D001553
% 220.09/220.25       91%28%75%29%; was see under BENZOFURANS 1975-90   
% 220.09/220.25  |- skos__prefLabel mesh__D001553 Benzbromarone
% 220.09/220.25  |- skos__scopeNote mesh__D001553
% 220.09/220.25       Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.%A%    
% 220.09/220.25  |- skos__broader mesh__D001553smesh__D001572
% 220.09/220.25  |- skos__hiddenLabel mesh__D001553 AL, Benzbromaron
% 220.09/220.25  |- mesh__dateCreated mesh__D001553 1974-11-19
% 220.09/220.25  |- skos__altLabel mesh__D001553 ratiopharm Brand of Benzbromarone
% 220.09/220.25  |- mesh__recordAuthorizer mesh__D001553 sjn
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D001553 2005
% 220.09/220.25  |- mesh__dateRevised mesh__D001553 2004-07-07
% 220.09/220.25  |- skos__hiddenLabel mesh__D019964 Disorders, Mood
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D019964 2005
% 220.09/220.25  |- mesh__dateEstablished mesh__D019964 1998-01-01
% 220.09/220.25  |- skos__annotation mesh__D019964
% 220.09/220.25       human only; do not confuse with AFFECTIVE SYMPTOMS: read MeSH definitions %26% follow text%A%  
% 220.09/220.25  |- skos__hiddenLabel mesh__D019964 Disorder, Affective
% 220.09/220.25  |- skos__hiddenLabel mesh__D019964 Disorder, Mood
% 220.09/220.25  |- skos__scopeNote mesh__D019964
% 220.09/220.25       Those disorders that have a disturbance in mood as their predominant feature.%A%    
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D019964 2003
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D019964 2006
% 220.09/220.25  |- mesh__dateCreated mesh__D019964 1997-06-20
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D019964 2000
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D019964 2004
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D019964 2001
% 220.09/220.25  |- skos__altLabel mesh__D019964 Affective Disorders
% 220.09/220.25  |- rdf__type mesh__D019964sskos__Concept
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D019964 1998
% 220.09/220.25  |- skos__hiddenLabel mesh__D019964 Mood Disorder
% 220.09/220.25  |- skos__prefLabel mesh__D019964 Mood Disorders
% 220.09/220.25  |- skos__hiddenLabel mesh__D019964 Disorders, Affective
% 220.09/220.25  |- skos__hiddenLabel mesh__D019964 Affective Disorder
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D019964 2002
% 220.09/220.25  |- skos__broader mesh__D019964smesh__D001523
% 220.09/220.25  |- mesh__historyNote mesh__D019964 98%28%81%29%   
% 220.09/220.25  |- mesh__publicMeSHNote mesh__D019964
% 220.09/220.25       98; see AFFECTIVE DISORDERS 1981-97   
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D019964 1999
% 220.09/220.25  |- mesh__historyNote mesh__D011981 87   
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011981 1997
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011981 2003
% 220.09/220.25  |- skos__historyNote mesh__D011981
% 220.09/220.25       Receptors, Endogenous Substances %28%1973-1986%29%
% 220.09/220.25  |- mesh__recordOriginator mesh__D011981 SH
% 220.09/220.25  |- mesh__dateEstablished mesh__D011981 1987-01-01
% 220.09/220.25  |- skos__historyNote mesh__D011981 Prolactin %28%1966-1986%29%
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011981 2004
% 220.09/220.25  |- skos__prefLabel mesh__D011981 Receptors, Prolactin
% 220.09/220.25  |- skos__annotation mesh__D011981 DF: RECEPT PRL   
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011981 2000
% 220.09/220.25  |- rdf__type mesh__D011981sskos__Concept
% 220.09/220.25  |- mesh__dateCreated mesh__D011981 1986-03-31
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011981 1998
% 220.09/220.25  |- skos__altLabel mesh__D011981 PRL Receptors
% 220.09/220.25  |- skos__altLabel mesh__D011981 Receptors, PRL
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011981 2001
% 220.09/220.25  |- mesh__dateRevised mesh__D011981 1995-06-08
% 220.09/220.25  |- mesh__recordAuthorizer mesh__D011981 PLS
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011981 1999
% 220.09/220.25  |- skos__altLabel mesh__D011981 Prolactin Receptors
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011981 2005
% 220.09/220.25  |- skos__scopeNote mesh__D011981
% 220.09/220.25       Labile proteins on or in prolactin-sensitive cells that bind prolactin initiating the cells%27% physiological response to that hormone. Mammary casein synthesis is one of the responses. The receptors are also found in placenta, liver, testes, kidneys, ovaries, and other organs and bind and respond to certain other hormones and their analogs and antagonists. This receptor is related to the growth hormone receptor.%A%    
% 220.09/220.25  |- skos__broader mesh__D011981smesh__D018013
% 220.09/220.25  |- skos__altLabel mesh__D011981 Prolactin Receptor
% 220.09/220.25  |- mesh__recordMaintainer mesh__D011981 KEV
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011981 2006
% 220.09/220.25  |- mesh__publicMeSHNote mesh__D011981 87   
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011981 1996
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011981 2002
% 220.09/220.25  |- skos__hiddenLabel mesh__D011981 Receptor, Prolactin
% 220.09/220.25  |- skos__broader mesh__D011981smesh__D011967
% 220.09/220.25  |- mesh__dateCreated mesh__D011183 1999-01-01
% 220.09/220.25  |- rdf__type mesh__D011183sskos__Concept
% 220.09/220.25  |- mesh__publicMeSHNote mesh__D011183 64   
% 220.09/220.25  |- mesh__historyNote mesh__D011183 64   
% 220.09/220.25  |- mesh__recordOriginator mesh__D011183 NLM
% 220.09/220.25  |- skos__scopeNote mesh__D011183
% 220.09/220.25       Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.%A%    
% 220.09/220.25  |- skos__hiddenLabel mesh__D011183 Complications, Postoperative
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011183 2002
% 220.09/220.25  |- mesh__dateEstablished mesh__D011183 1964-01-01
% 220.09/220.25  |- skos__prefLabel mesh__D011183 Postoperative Complications
% 220.09/220.25  |- skos__annotation mesh__D011183
% 220.09/220.25       few qualif apply; IM; coord with specific postop compl %28%IM%29%; not restricted to immediate postop period; differentiate from Cat E4 terms with /adv eff: Manual 23.18+; DF: POSTOP COMPL%A%  
% 220.09/220.25  |- mesh__activeMeSHYear mesh__D011183 2004
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011183 2001
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011183 2006
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011183 2003
% 220.09/220.26  |- skos__broader mesh__D011183smesh__D010335
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011183 2005
% 220.09/220.26  |- mesh__recordAuthorizer mesh__D011183 sjn
% 220.09/220.26  |- skos__hiddenLabel mesh__D011183 Postoperative Complication
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011183 2000
% 220.09/220.26  |- mesh__dateRevised mesh__D011183 1999-11-08
% 220.09/220.26  |- mesh__recordMaintainer mesh__D011183 KEV
% 220.09/220.26  |- skos__altLabel mesh__D011183 Complication, Postoperative
% 220.09/220.26  |- mesh__dateCreated mesh__D005944 1999-01-01
% 220.09/220.26  |- skos__prefLabel mesh__D005944 Glucosamine
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D005944 2006
% 220.09/220.26  |- mesh__recordMaintainer mesh__D005944 CCR
% 220.09/220.26  |- rdf__type mesh__D005944sskos__Concept
% 220.09/220.26  |- skos__hiddenLabel mesh__D005944 2 Amino 2 Deoxyglucose
% 220.09/220.26  |- mesh__recordAuthorizer mesh__D005944 sjn
% 220.09/220.26  |- skos__hiddenLabel mesh__D005944 Sulfate, Glucosamine
% 220.09/220.26  |- skos__altLabel mesh__D005944 Dona S
% 220.09/220.26  |- mesh__recordOriginator mesh__D005944 NLM
% 220.09/220.26  |- skos__altLabel mesh__D005944
% 220.09/220.26       Fides Ecopharma Brand of Glucosamine Sulfate
% 220.09/220.26  |- skos__broader mesh__D005944smesh__D006595
% 220.09/220.26  |- skos__altLabel mesh__D005944 Opfermann Brand of Glucosamine Sulfate
% 220.09/220.26  |- skos__altLabel mesh__D005944 2-Amino-2-Deoxyglucose
% 220.09/220.26  |- mesh__dateRevised mesh__D005944 2005-06-30
% 220.09/220.26  |- skos__altLabel mesh__D005944 Rottapharm Brand of Glucosamine Sulfate
% 220.09/220.26  |- mesh__dateRevised mesh__D005146 1999-11-08
% 220.09/220.26  |- skos__annotation mesh__D005146
% 220.09/220.26       if congen use /congen; do not confuse with FACIAL HEMIATROPHY; since asymmetry is lateral, long face syndrome does not go here: index under FACIAL BONES /abnorm %28%IM%29% + MALOCCLUSION or specific type %28%IM%29% + SYNDROME %28%NIM%29%%A%  
% 220.09/220.26  |- rdf__type mesh__D005146sskos__Concept
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D005146 2001
% 220.09/220.26  |- mesh__dateEstablished mesh__D005146 1977-01-01
% 220.09/220.26  |- mesh__historyNote mesh__D005146 77   
% 220.09/220.26  |- skos__hiddenLabel mesh__D005146 Asymmetries, Facial
% 220.09/220.26  |- skos__broader mesh__D005146smesh__D020763
% 220.09/220.26  |- skos__hiddenLabel mesh__D005146 Asymmetry, Facial
% 220.09/220.26  |- skos__hiddenLabel mesh__D005146 Facial Asymmetries
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D005146 2005
% 220.09/220.26  |- mesh__publicMeSHNote mesh__D005146 77   
% 220.09/220.26  |- skos__scopeNote mesh__D005146
% 220.09/220.26       Congenital or acquired asymmetry of the face.     
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D005146 2006
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D005146 2002
% 220.09/220.26  |- mesh__recordMaintainer mesh__D005146 KEV
% 220.09/220.26  |- skos__historyNote mesh__D005146 Face %28%1966-1976%29%
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D005146 2003
% 220.09/220.26  |- mesh__dateCreated mesh__D005146 1976-04-16
% 220.09/220.26  |- skos__related mesh__D005146smesh__D019066
% 220.09/220.26  |- skos__prefLabel mesh__D005146 Facial Asymmetry
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D005146 2004
% 220.09/220.26  |- skos__altLabel mesh__D005146 Hemifacial Microsomia
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D005146 2000
% 220.09/220.26  |- mesh__recordOriginator mesh__D005146 MM
% 220.09/220.26  |- mesh__recordAuthorizer mesh__D005146 sjn
% 220.09/220.26  |- skos__hiddenLabel mesh__D010889 Memo Puren
% 220.09/220.26  |- skos__altLabel mesh__D010889 Hexal Brand of Piracetam
% 220.09/220.26  |- skos__hiddenLabel mesh__D010889 UCB 6215
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D010889 2006
% 220.09/220.26  |- skos__altLabel mesh__D010889 Alpharma Brand of Piracetam
% 220.09/220.26  |- skos__altLabel mesh__D010889 Nootropyl
% 220.09/220.26  |- skos__altLabel mesh__D010889 Hormona Brand of Piracetam
% 220.09/220.26  |- skos__altLabel mesh__D010889 Holsten Brand of Piracetam
% 220.09/220.26  |- skos__altLabel mesh__D010889 Normabra%C3%%AF%n
% 220.09/220.26  |- skos__altLabel mesh__D010889 TAD Brand of Piracetam
% 220.09/220.26  |- mesh__dateRevised mesh__D010889 2005-06-30
% 220.09/220.26  |- skos__hiddenLabel mesh__D010889 Piracetam RPh
% 220.09/220.26  |- skos__altLabel mesh__D010889 Vedim Brand of Piracetam
% 220.09/220.26  |- skos__altLabel mesh__D010889 UCB Brand of Piracetam
% 220.09/220.26  |- skos__broader mesh__D010889smesh__D000081
% 220.09/220.26  |- mesh__dateEstablished mesh__D010889 1991-01-01
% 220.09/220.26  |- skos__altLabel mesh__D010889 Rodleben Brand of Piracetam
% 220.09/220.26  |- skos__altLabel mesh__D010889 Almirall Brand of Piracetam
% 220.09/220.26  |- mesh__recordOriginator mesh__D010889 NLM
% 220.09/220.26  |- skos__prefLabel mesh__D010889 Piracetam
% 220.09/220.26  |- skos__altLabel mesh__D010889 Pfizer Brand of Piracetam
% 220.09/220.26  |- skos__altLabel mesh__D010889 AbZ Brand of Piracetam
% 220.09/220.26  |- skos__altLabel mesh__D010889 Piracetam-RPh
% 220.09/220.26  |- mesh__recordAuthorizer mesh__D010889 sjn
% 220.09/220.26  |- skos__altLabel mesh__D010889 2-Pyrrolidone-N-Acetamide
% 220.09/220.26  |- skos__altLabel mesh__D010889 Merckle Brand of Piracetam
% 220.09/220.26  |- skos__altLabel mesh__D010889 Pyramem
% 220.09/220.26  |- skos__altLabel mesh__D010889 Nootrop
% 220.09/220.26  |- skos__altLabel mesh__D010889 Pyracetam
% 220.09/220.26  |- skos__scopeNote mesh__D010889
% 220.09/220.26       A compound suggested to be both a nootropic and a neuroprotective agent.%A%    
% 220.09/220.26  |- mesh__publicMeSHNote mesh__D010889
% 220.09/220.26       91; was see under PYRROLIDINONES 1975-90   
% 220.09/220.26  |- mesh__recordMaintainer mesh__D010889 lkw
% 220.09/220.26  |- skos__altLabel mesh__D010889 Sanofi Synthelabo Brand of Piracetam
% 220.09/220.26  |- skos__broader mesh__D010889smesh__D011760
% 220.09/220.26  |- skos__altLabel mesh__D010889 Pirazetam
% 220.09/220.26  |- mesh__dateCreated mesh__D010889 1974-11-11
% 220.09/220.26  |- skos__historyNote mesh__D010889 Pyrrolidinones %28%1971-1974%29%
% 220.09/220.26  |- skos__altLabel mesh__D010889 Azupharma Brand of Piracetam
% 220.09/220.26  |- rdf__type mesh__D010889sskos__Concept
% 220.09/220.26  |- skos__altLabel mesh__D010889 Riemser Brand of Piracetam
% 220.09/220.26  |- mesh__historyNote mesh__D010889
% 220.09/220.26       91%28%75%29%; was see under PYRROLIDINONES 1975-90   
% 220.09/220.26  |- skos__hiddenLabel mesh__D010889 UCB6215
% 220.09/220.26  |- skos__historyNote mesh__D010889 Acetamides %28%1973-1974%29%
% 220.09/220.26  |- mesh__recordOriginator mesh__D029594 ssb
% 220.09/220.26  |- skos__scopeNote mesh__D029594
% 220.09/220.26       The evening primrose plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. Flower parts are mostly in fours and the ovary is inferior.%A%    
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D029594 2003
% 220.09/220.26  |- mesh__dateEstablished mesh__D029594 2002-01-01
% 220.09/220.26  |- mesh__historyNote mesh__D029594 2002   
% 220.09/220.26  |- mesh__publicMeSHNote mesh__D029594 2002   
% 220.09/220.26  |- rdf__type mesh__D029594sskos__Concept
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D029594 2006
% 220.09/220.26  |- skos__annotation mesh__D029594
% 220.09/220.26       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.09/220.26  |- mesh__recordMaintainer mesh__D029594 ssb
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D029594 2005
% 220.09/220.26  |- skos__prefLabel mesh__D029594 Onagraceae
% 220.09/220.26  |- mesh__recordAuthorizer mesh__D029594 sjn
% 220.09/220.26  |- mesh__dateRevised mesh__D029594 2002-07-03
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D029594 2004
% 220.09/220.26  |- skos__broader mesh__D029594smesh__D019684
% 220.09/220.26  |- mesh__dateCreated mesh__D029594 2001-07-25
% 220.09/220.26  |- skos__hiddenLabel mesh__D043265
% 220.09/220.26       Phosphodiesterase, Monophosphatidylinositol
% 220.09/220.26  |- mesh__publicMeSHNote mesh__D043265
% 220.09/220.26       2004; 1-PHOSPHATYDYLINOSITOL-GLYCAN-SPECIFIC PHOSPHOLIPASE C %28%now PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE%29% was indexed under PHOSPHOLIPASE C 1998-2003; under PHOSPHORIC DIESTER HYDROLASES 1976-1997 %26% under PHOSPHATIDYLINOSITOLS 1977-1982%A%  
% 220.09/220.26  |- skos__historyNote mesh__D043265 Phospholipase C %28%1998-2003%29%
% 220.09/220.26  |- mesh__recordMaintainer mesh__D043265 AKE
% 220.09/220.26  |- skos__altLabel mesh__D043265 Phosphoinositide Phosphodiesterase C
% 220.09/220.26  |- skos__prefLabel mesh__D043265 Phosphatidylinositol Diacylglycerol-Lyase
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D043265 2006
% 220.09/220.26  |- mesh__dateEstablished mesh__D043265 2004-01-01
% 220.09/220.26  |- skos__hiddenLabel mesh__D043265 Phospholipase C, PtdIns-Glycan
% 220.09/220.26  |- skos__historyNote mesh__D043265
% 220.09/220.26       Phosphoric Diester Hydrolases %28%1976-1997%29%
% 220.09/220.26  |- skos__hiddenLabel mesh__D043265
% 220.09/220.26       Phospholipase C, Phosphatidylinositol-Specific
% 220.09/220.26  |- skos__altLabel mesh__D043265 Phosphoinositide Phospholipase C
% 220.09/220.26  |- skos__broader mesh__D043265smesh__D010738
% 220.09/220.26  |- skos__hiddenLabel mesh__D043265 Phospholipase C, Phosphoinositide
% 220.09/220.26  |- skos__altLabel mesh__D043265 GPI-PLC
% 220.09/220.26  |- mesh__recordOriginator mesh__D043265 AKE
% 220.09/220.26  |- skos__hiddenLabel mesh__D043265
% 220.09/220.26       Phosphatidylinositol Specific Phospholipase C
% 220.09/220.26  |- skos__annotation mesh__D043265
% 220.09/220.26       note X refs: PHOSPHOLIPASE C is also available   
% 220.09/220.26  |- skos__hiddenLabel mesh__D043265
% 220.09/220.26       Phosphatidylinositol Glycan Specific Phospholipase C
% 220.09/220.26  |- skos__scopeNote mesh__D043265
% 220.09/220.26       A phosphorus-oxygen lyase found primarily in BACTERIA. The enzyme catalyzes the cleavage of a phosphoester linkage in 1-phosphatidyl-1D-myo-inositol to form 1D-myo-inositol 1,2-cyclic phosphate and diacylglycerol. The enzyme was formerly classified as a phosphoric diester hydrolase %28%EC 3.1.4.10%29% and is often referred to as a PHOSPHOLIPASE C. However it is now known that a cyclic phosphate is the final product of this enzyme and that water does not enter into the reaction.%A%    
% 220.09/220.26  |- skos__hiddenLabel mesh__D043265
% 220.09/220.26       Glycosylphosphatidylinositol Specific Phospholipase C
% 220.09/220.26  |- skos__hiddenLabel mesh__D043265
% 220.09/220.26       Phosphatidylinositol Diacylglycerol Lyase
% 220.09/220.26  |- mesh__recordAuthorizer mesh__D043265 sjn
% 220.09/220.26  |- skos__hiddenLabel mesh__D043265
% 220.09/220.26       Phospholipase C, Glycosylphosphatidylinositol-Specific
% 220.09/220.26  |- skos__altLabel mesh__D043265 Phosphoinositol Specific Phospholipase C
% 220.09/220.26  |- skos__altLabel mesh__D043265 1-Phosphatidylinositol Phosphodiesterase
% 220.09/220.26  |- skos__historyNote mesh__D043265 Phosphatidylinositols %28%1977-1982%29%
% 220.09/220.26  |- skos__hiddenLabel mesh__D043265
% 220.09/220.26       Phospholipase C, Phosphatidylinositol-Glycan-Specific
% 220.09/220.26  |- mesh__historyNote mesh__D043265
% 220.09/220.26       2004; use PHOSPHOTIDYLINOSITOL DIACYLGLYCEROL-LYASE %28%NM%29% 1980-2003%A%  
% 220.09/220.26  |- skos__altLabel mesh__D043265 PtdIns-Glycan Phospholipase C
% 220.09/220.26  |- skos__hiddenLabel mesh__D043265 Phosphodiesterase C, Phosphoinositide
% 220.09/220.26  |- skos__hiddenLabel mesh__D043265
% 220.09/220.26       Diacylglycerol-Lyase, Phosphatidylinositol
% 220.09/220.26  |- skos__altLabel mesh__D043265 Phosphoinositide Selective Phospholipase C
% 220.09/220.26  |- skos__altLabel mesh__D043265 Monophosphatidylinositol Phosphodiesterase
% 220.09/220.26  |- skos__hiddenLabel mesh__D043265
% 220.09/220.26       C, Glycosylphosphatidylinositol-Specific Phospholipase
% 220.09/220.26  |- skos__broader mesh__D043265smesh__D019761
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D043265 2004
% 220.09/220.26  |- skos__altLabel mesh__D043265
% 220.09/220.26       Glycosylphosphatidylinositol-Specific Phospholipase C
% 220.09/220.26  |- skos__hiddenLabel mesh__D043265 PtdIns Glycan Phospholipase C
% 220.09/220.26  |- skos__hiddenLabel mesh__D043265
% 220.09/220.26       Phosphodiesterase, 1-Phosphatidylinositol
% 220.09/220.26  |- mesh__dateCreated mesh__D043265 2003-07-09
% 220.09/220.26  |- rdf__type mesh__D043265sskos__Concept
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D043265 2005
% 220.09/220.26  |- skos__altLabel mesh__D043265
% 220.09/220.26       Phosphatidylinositol-Specific Phospholipase C
% 220.09/220.26  |- skos__hiddenLabel mesh__D043265 1 Phosphatidylinositol Phosphodiesterase
% 220.09/220.26  |- mesh__publicMeSHNote mesh__D009537 77   
% 220.09/220.26  |- skos__annotation mesh__D009537 /biosyn /physiol permitted; DF: NMN   
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D009537 2000
% 220.09/220.26  |- mesh__historyNote mesh__D009537 77%28%72%29%   
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D009537 1997
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D009537 2003
% 220.09/220.26  |- mesh__recordAuthorizer mesh__D009537 NLM
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D009537 1994
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D009537 2001
% 220.09/220.26  |- mesh__recordMaintainer mesh__D009537 PLS
% 220.09/220.26  |- skos__broader mesh__D009537smesh__D012265
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D009537 2004
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D009537 1995
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D009537 1998
% 220.09/220.26  |- mesh__dateCreated mesh__D009537 1999-01-01
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D009537 1992
% 220.09/220.26  |- mesh__dateEstablished mesh__D009537 1977-01-01
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D009537 2002
% 220.09/220.26  |- rdf__type mesh__D009537sskos__Concept
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D009537 1999
% 220.09/220.26  |- skos__historyNote mesh__D009537 Ribonucleotides %28%1966-1972%29%
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D009537 1993
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D009537 2005
% 220.09/220.26  |- mesh__recordOriginator mesh__D009537 NLM
% 220.09/220.26  |- mesh__dateRevised mesh__D009537 1990-05-30
% 220.09/220.26  |- skos__historyNote mesh__D009537 Nicotinamide %28%1966-1972%29%
% 220.09/220.26  |- skos__hiddenLabel mesh__D009537 Mononucleotide, Nicotinamide
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D009537 2006
% 220.09/220.26  |- skos__scopeNote mesh__D009537
% 220.09/220.26       3-Carbamoyl-1-beta-D-ribofuranosyl pyridinium hydroxide-5%27%phosphate, inner salt. A nucleotide in which the nitrogenous base, nicotinamide, is in beta-N-glycosidic linkage with the C-1 position of D-ribose. Synonyms: Nicotinamide Ribonucleotide; NMN.%A%    
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D009537 1996
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D009537 1991
% 220.09/220.26  |- skos__prefLabel mesh__D009537 Nicotinamide Mononucleotide
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D001554 2001
% 220.09/220.26  |- skos__prefLabel mesh__D001554 Benzene
% 220.09/220.26  |- skos__annotation mesh__D001554 do not confuse with BENZIL or BENZAL   
% 220.09/220.26  |- mesh__recordMaintainer mesh__D001554 jls
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D001554 2002
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D001554 2006A
% 220.09/220.26  |- skos__scopeNote mesh__D001554
% 220.09/220.26       Toxic, volatile, flammable liquid hydrocarbon byproduct of coal distillation. It is used as an industrial solvent in paints, varnishes, lacquer thinners, gasoline, etc. Benzene causes central nervous system damage acutely and bone marrow damage chronically and is carcinogenic. It was formerly used as parasiticide.%A%    
% 220.09/220.26  |- rdf__type mesh__D001554sskos__Concept
% 220.09/220.26  |- skos__altLabel mesh__D001554 Benzol
% 220.09/220.26  |- mesh__recordAuthorizer mesh__D001554 jls
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D001554 2003
% 220.09/220.26  |- skos__altLabel mesh__D001554 Cyclohexatriene
% 220.09/220.26  |- skos__broader mesh__D001554smesh__D006841
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D001554 2004
% 220.09/220.26  |- mesh__dateCreated mesh__D001554 1999-01-01
% 220.09/220.26  |- mesh__recordOriginator mesh__D001554 NLM
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D001554 2005
% 220.09/220.26  |- mesh__dateRevised mesh__D001554 2005-07-30
% 220.09/220.26  |- skos__altLabel mesh__D001554 Benzole
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D001554 2006
% 220.09/220.26  |- skos__broader mesh__D019965smesh__D001523
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D019965 2003
% 220.09/220.26  |- mesh__recordAuthorizer mesh__D019965 sjn
% 220.09/220.26  |- skos__hiddenLabel mesh__D019965 Disorders, Organic Mental
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D019965 2004
% 220.09/220.26  |- mesh__dateEstablished mesh__D019965 1998-01-01
% 220.09/220.26  |- skos__hiddenLabel mesh__D019965 Mental Disorder, Organic
% 220.09/220.26  |- skos__altLabel mesh__D019965 Clerambault Syndrome
% 220.09/220.26  |- rdf__type mesh__D019965sskos__Concept
% 220.09/220.26  |- skos__scopeNote mesh__D019965
% 220.09/220.26       Cognitive disorders including delirium, dementia, and other cognitive disorders. These may be the result of substance use, trauma, or other causes.%A%    
% 220.09/220.26  |- skos__altLabel mesh__D019965 Mental Disorders, Organic
% 220.09/220.26  |- skos__prefLabel mesh__D019965
% 220.09/220.26       Delirium, Dementia, Amnestic, Cognitive Disorders
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D019965 2000
% 220.09/220.26  |- mesh__publicMeSHNote mesh__D019965
% 220.09/220.26       98; see ORGANIC MENTAL DISORDERS 1981-97; see MENTAL DISORDERS 1969-80; see PSYCHOSES, ORGANIC 1996-80; see PSYCHOSES, TRAUMATIC 1963-78; see ORGANIC MENTAL DISORDERS, PSYCHOTIC%A%  
% 220.09/220.26  |- mesh__historyNote mesh__D019965
% 220.09/220.26       98%28%63%29% for NON PSYCHOTIC BRAIN SYNDROME use MENTAL DISORDERS 1969-74%A%  
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D019965 2001
% 220.09/220.26  |- skos__hiddenLabel mesh__D019965 Organic Mental Disorder
% 220.09/220.26  |- skos__altLabel mesh__D019965 Organic Mental Disorders
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D019965 2005
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D019965 2002
% 220.09/220.26  |- mesh__dateRevised mesh__D019965 1999-11-03
% 220.09/220.26  |- mesh__dateCreated mesh__D019965 1997-07-07
% 220.09/220.26  |- skos__hiddenLabel mesh__D019965 Traumatic Psychoses
% 220.09/220.26  |- mesh__recordMaintainer mesh__D019965 KEV
% 220.09/220.26  |- skos__altLabel mesh__D019965 Nonpsychotic Organic Brain Syndrome
% 220.09/220.26  |- mesh__recordOriginator mesh__D019965 JLS
% 220.09/220.26  |- skos__annotation mesh__D019965
% 220.09/220.26       avoid, prefer specifics, but use for see refs; DF: ORG MENTAL DIS%A%  
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D019965 2006
% 220.09/220.26  |- mesh__dateEstablished mesh__D011982 1987-01-01
% 220.09/220.26  |- skos__prefLabel mesh__D011982 Receptors, Prostaglandin
% 220.09/220.26  |- mesh__publicMeSHNote mesh__D011982
% 220.09/220.26       87; was see under RECEPTORS, ENDOGENOUS SUBSTANCES 1977-86%A%  
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011982 2006
% 220.09/220.26  |- mesh__dateCreated mesh__D011982 1976-05-03
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011982 2004
% 220.09/220.26  |- mesh__recordAuthorizer mesh__D011982 sjn
% 220.09/220.26  |- skos__hiddenLabel mesh__D011982 Prostaglandins Receptors
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011982 2005
% 220.09/220.26  |- mesh__recordOriginator mesh__D011982 SH
% 220.09/220.26  |- skos__annotation mesh__D011982
% 220.09/220.26       coord IM with specific natural or synthetic prostaglandin %28%IM%29%; RECEPTORS, PROSTAGLANDIN E is available; DF: RECEPT PG%A%  
% 220.09/220.26  |- skos__altLabel mesh__D011982 Prostaglandin Receptors
% 220.09/220.26  |- mesh__dateRevised mesh__D011982 2003-07-09
% 220.09/220.26  |- mesh__historyNote mesh__D011982
% 220.09/220.26       87%28%77%29%; was see under RECEPTORS, ENDOGENOUS SUBSTANCES 1977-86%A%  
% 220.09/220.26  |- skos__altLabel mesh__D011982 Receptor, Prostaglandin
% 220.09/220.26  |- rdf__type mesh__D011982sskos__Concept
% 220.09/220.26  |- skos__altLabel mesh__D011982 Receptors, Prostaglandins
% 220.09/220.26  |- skos__altLabel mesh__D011982 Prostaglandin Receptor
% 220.09/220.26  |- skos__scopeNote mesh__D011982
% 220.09/220.26       Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin D2 %28%DP receptors%29%, prostaglandin E2 %28%EP1, EP2, and EP3 receptors%29%, prostaglandin F2-alpha %28%FP receptors%29%, and prostacyclin %28%IP receptors%29%.%A%    
% 220.09/220.26  |- mesh__recordMaintainer mesh__D011982 jmp
% 220.09/220.26  |- skos__historyNote mesh__D011982 Receptors, Drug %28%1968-1976%29%
% 220.09/220.26  |- skos__historyNote mesh__D011982 Prostaglandins %28%1966-1976%29%
% 220.09/220.26  |- skos__broader mesh__D011982smesh__D018055
% 220.09/220.26  |- mesh__recordAuthorizer mesh__D019167 sjn
% 220.09/220.26  |- mesh__dateRevised mesh__D019167 2005-06-30
% 220.09/220.26  |- skos__annotation mesh__D019167
% 220.09/220.26       GEN or unspecified; prefer specifics; consider also APPETITE /drug eff%A%  
% 220.09/220.26  |- skos__historyNote mesh__D019167 Anorexia %28%1968-1974%29%
% 220.09/220.26  |- mesh__recordOriginator mesh__D019167 TPW
% 220.09/220.26  |- skos__hiddenLabel mesh__D019167 Appetite Stimulating Drugs
% 220.09/220.26  |- mesh__historyNote mesh__D019167 97   
% 220.09/220.26  |- skos__hiddenLabel mesh__D019167 Stimulants, Appetite
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D019167 2006
% 220.09/220.26  |- rdf__type mesh__D019167sskos__Concept
% 220.09/220.26  |- mesh__dateEstablished mesh__D019167 1997-01-01
% 220.09/220.26  |- skos__altLabel mesh__D019167 Appetite-Stimulating Drugs
% 220.09/220.26  |- mesh__publicMeSHNote mesh__D019167 97   
% 220.09/220.26  |- skos__prefLabel mesh__D019167 Appetite Stimulants
% 220.09/220.26  |- skos__scopeNote mesh__D019167
% 220.09/220.26       Agents that are used to stimulate appetite. These drugs are frequently used to treat anorexia associated with cancer and AIDS.%A%    
% 220.09/220.26  |- skos__broader mesh__D019167smesh__D000697
% 220.09/220.26  |- skos__hiddenLabel mesh__D019167 Drugs, Appetite-Stimulating
% 220.09/220.26  |- mesh__recordMaintainer mesh__D019167 ssb
% 220.09/220.26  |- skos__historyNote mesh__D019167 Anorexia/drug therapy %28%1975-1996%29%
% 220.09/220.26  |- mesh__dateCreated mesh__D019167 1996-06-10
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011184 1997
% 220.09/220.26  |- mesh__recordOriginator mesh__D011184 VDK
% 220.09/220.26  |- mesh__historyNote mesh__D011184
% 220.09/220.26       86%28%79%29%; was see under SURGERY, OPERATIVE 1979-85, was in Cat E %26% H 1979-81%A%  
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011184 1999
% 220.09/220.26  |- skos__scopeNote mesh__D011184
% 220.09/220.26       The period following a surgical operation.     
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011184 2004
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011184 1993
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011184 1996
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011184 2000
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011184 2006
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011184 1995
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011184 1998
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011184 2003
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011184 1992
% 220.09/220.26  |- mesh__dateCreated mesh__D011184 1978-05-19
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011184 2005
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011184 1994
% 220.09/220.26  |- mesh__recordMaintainer mesh__D011184 TGC
% 220.09/220.26  |- skos__hiddenLabel mesh__D011184 Period, Postoperative
% 220.09/220.26  |- mesh__dateEstablished mesh__D011184 1986-01-01
% 220.09/220.26  |- mesh__recordAuthorizer mesh__D011184 PLS
% 220.09/220.26  |- mesh__dateRevised mesh__D011184 1989-05-16
% 220.09/220.26  |- rdf__type mesh__D011184sskos__Concept
% 220.09/220.26  |- skos__hiddenLabel mesh__D011184 Periods, Postoperative
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011184 2002
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011184 1991
% 220.09/220.26  |- skos__annotation mesh__D011184
% 220.09/220.26       almost never IM; no qualif; DF: POSTOP PERIOD   
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011184 2001
% 220.09/220.26  |- mesh__publicMeSHNote mesh__D011184
% 220.09/220.26       86; was see under SURGERY, OPERATIVE 1979-85   
% 220.09/220.26  |- skos__prefLabel mesh__D011184 Postoperative Period
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D011184 1990
% 220.09/220.26  |- skos__hiddenLabel mesh__D011184 Postoperative Periods
% 220.09/220.26  |- skos__broader mesh__D011184smesh__D013514
% 220.09/220.26  |- skos__hiddenLabel mesh__D005945
% 220.09/220.26       Ketol-Isomerase, 2-Amino-2-Deoxy-D-Glucose-6-Phosphate
% 220.09/220.26  |- skos__hiddenLabel mesh__D005945 Glutamine Fructose 6 P Aminotransferase
% 220.09/220.26  |- skos__altLabel mesh__D005945 Glucosamine Synthetase
% 220.09/220.26  |- skos__prefLabel mesh__D005945
% 220.09/220.26       Glutamine-Fructose-6-Phosphate Transaminase %28%Isomerizing%29%
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D005945 2004
% 220.09/220.26  |- skos__altLabel mesh__D005945 Glucosamine 6-Phosphate Synthetase
% 220.09/220.26  |- mesh__historyNote mesh__D005945 98%28%75%29%   
% 220.09/220.26  |- skos__altLabel mesh__D005945
% 220.09/220.26       Glucosaminephosphate Isomerase %28%Glutamine-Forming%29%
% 220.09/220.26  |- skos__altLabel mesh__D005945
% 220.09/220.26       Glucosaminephosphate Isomerase %28%Glutamine Forming%29%
% 220.09/220.26  |- mesh__recordAuthorizer mesh__D005945 sjn
% 220.09/220.26  |- mesh__dateCreated mesh__D005945 1974-11-19
% 220.09/220.26  |- skos__hiddenLabel mesh__D005945 Glucosamine 6 Phosphate Synthase
% 220.09/220.26  |- skos__altLabel mesh__D005945 Glutamine-Fructose-6-P Aminotransferase
% 220.09/220.26  |- skos__historyNote mesh__D005945 Carbohydrate Isomerases %28%1974%29%
% 220.09/220.26  |- mesh__recordMaintainer mesh__D005945 ssb
% 220.09/220.26  |- rdf__type mesh__D005945sskos__Concept
% 220.09/220.26  |- skos__historyNote mesh__D005945 Glutamine %28%1970-1974%29%
% 220.09/220.26  |- skos__hiddenLabel mesh__D005945 6-Phosphate Synthetase, Glucosamine
% 220.09/220.26  |- skos__hiddenLabel mesh__D005945
% 220.09/220.26       Aminotransferase, Glutamine-Fructose-6-Phosphate
% 220.09/220.26  |- skos__altLabel mesh__D005945 Glucosamine-6-Phosphate Synthase
% 220.09/220.26  |- mesh__publicMeSHNote mesh__D005945
% 220.09/220.26       98; see GLUCOSAMINEPHOSPHATE ISOMERASE %28%GLUTAMINE-FORMING%29% 1991-97; see AMINOTRANSFERASES 1975-90%A%  
% 220.09/220.26  |- skos__hiddenLabel mesh__D005945 Synthase, Glucosamine-6-Phosphate
% 220.09/220.26  |- skos__scopeNote mesh__D005945
% 220.09/220.26       An enzyme that catalyzes the synthesis of fructose-6-phosphate plus glutamine from glutamate plus glucosamine-6-phosphate. EC 2.6.1.16.%A%    
% 220.09/220.26  |- skos__hiddenLabel mesh__D005945
% 220.09/220.26       2 Amino 2 Deoxy D Glucose 6 Phosphate Ketol Isomerase
% 220.09/220.26  |- skos__hiddenLabel mesh__D005945 Synthetase, Glucosamine
% 220.09/220.26  |- skos__annotation mesh__D005945 DF: note short X ref   
% 220.09/220.26  |- skos__historyNote mesh__D005945 Fructosephosphates %28%1972-1974%29%
% 220.09/220.26  |- skos__historyNote mesh__D005945 Aminotransferases %28%1970-1974%29%
% 220.09/220.26  |- skos__hiddenLabel mesh__D005945
% 220.09/220.26       Glutamine Fructose 6 Phosphate Aminotransferase
% 220.09/220.26  |- skos__altLabel mesh__D005945
% 220.09/220.26       Glutamine-Fructose-6-Phosphate Aminotransferase
% 220.09/220.26  |- skos__hiddenLabel mesh__D005945 Synthetase, Glucosamine 6-Phosphate
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D005945 2006
% 220.09/220.26  |- mesh__recordOriginator mesh__D005945 NLM
% 220.09/220.26  |- skos__hiddenLabel mesh__D005945 Aminotransferase, Hexosephosphate
% 220.09/220.26  |- mesh__dateRevised mesh__D005945 2003-07-09
% 220.09/220.26  |- skos__hiddenLabel mesh__D005945 Aminotransferase, Glutamine-Fructose-6-P
% 220.09/220.26  |- skos__altLabel mesh__D005945 Hexosephosphate Aminotransferase
% 220.09/220.26  |- skos__historyNote mesh__D005945 Glucosamine %28%1974%29%
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D005945 2005
% 220.09/220.26  |- skos__broader mesh__D005945smesh__D000637
% 220.09/220.26  |- skos__altLabel mesh__D005945
% 220.09/220.26       2-Amino-2-Deoxy-D-Glucose-6-Phosphate Ketol-Isomerase
% 220.09/220.26  |- skos__hiddenLabel mesh__D005945 Glucosamine 6 Phosphate Synthetase
% 220.09/220.26  |- mesh__dateEstablished mesh__D005945 1991-01-01
% 220.09/220.26  |- skos__historyNote mesh__D038321 Blood Glucose %28%1981-2002%29%
% 220.09/220.26  |- skos__scopeNote mesh__D038321
% 220.09/220.26       A numerical system of measuring the rate of BLOOD GLUCOSE generation by a particular food item as compared to a reference item, such as glucose = 100. Foods with higher glycemic index numbers create greater blood sugar swings. These numbers do not correspond to calories or amounts of food intake but rather, depend on the rates of digestion and absorption of these food items.%A%    
% 220.09/220.26  |- mesh__dateCreated mesh__D038321 2002-07-03
% 220.09/220.26  |- skos__historyNote mesh__D038321 Dietary Carbohydrates %28%1981-2002%29%
% 220.09/220.26  |- skos__prefLabel mesh__D038321 Glycemic Index
% 220.09/220.26  |- rdf__type mesh__D038321sskos__Concept
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D038321 2005
% 220.09/220.26  |- mesh__dateEstablished mesh__D038321 2003-01-01
% 220.09/220.26  |- skos__altLabel mesh__D038321 Glycemic Index Number
% 220.09/220.26  |- skos__hiddenLabel mesh__D038321 Glycemic Index Numbers
% 220.09/220.26  |- skos__broader mesh__D038321smesh__D009753
% 220.09/220.26  |- mesh__historyNote mesh__D038321 2003   
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D038321 2003
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D038321 2006
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D038321 2004
% 220.09/220.26  |- skos__hiddenLabel mesh__D038321 Glycemic Indices
% 220.09/220.26  |- skos__related mesh__D038321smesh__D001786
% 220.09/220.26  |- mesh__publicMeSHNote mesh__D038321 2003   
% 220.09/220.26  |- mesh__dateRevised mesh__D005147 2002-07-02
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D005147 2003
% 220.09/220.26  |- skos__prefLabel mesh__D005147 Facial Bones
% 220.09/220.26  |- skos__broader mesh__D005147smesh__D012886
% 220.09/220.26  |- mesh__recordMaintainer mesh__D005147 ags
% 220.09/220.26  |- rdf__type mesh__D005147sskos__Concept
% 220.09/220.26  |- skos__scopeNote mesh__D005147
% 220.09/220.26       The facial skeleton, consisting of bones situated between the cranial base and the mandibular region. While some consider the facial bones to comprise the hyoid %28%HYOID BONE%29%, palatine %28%HARD PALATE%29%, and zygomatic %28%ZYGOMA%29% bones, MANDIBLE, and MAXILLA, others include also the lacrimal and nasal bones, inferior nasal concha, and vomer but exclude the hyoid bone. %28%Jablonski, Dictionary of Dentistry, 1992, p113%29%%A%    
% 220.09/220.26  |- mesh__recordAuthorizer mesh__D005147 sjn
% 220.09/220.26  |- skos__hiddenLabel mesh__D005147 Bones, Facial
% 220.09/220.26  |- skos__hiddenLabel mesh__D005147 Facial Bone
% 220.09/220.26  |- skos__annotation mesh__D005147
% 220.09/220.26       consider specifics; do not confuse with FACE %28%locational %26% soft tissue%29% or its specifics; /abnorm: consider also CRANIOFACIAL ABNORMALITIES; fractures: coord FACIAL BONES /inj %28%IM%29% + SKULL FRACTURES %28%IM%29%; neopl: coord IM + SKULL NEOPLASMS; craniofacial dysmorphism: index under CRANIOFACIAL ABNORMALITIES; craniofacial dysplasia or craniofacial fibrous dysplasia: index under FACIAL BONES %28%IM%29% + SKULL %28%IM%29% + FIBROUS DYSPLASIA, POLYOSTOTIC %28%IM%29%%A%  
% 220.09/220.26  |- mesh__recordOriginator mesh__D005147 NLM
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D005147 2006
% 220.09/220.26  |- skos__hiddenLabel mesh__D005147 Bone, Facial
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D005147 2005
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D005147 2004
% 220.09/220.26  |- mesh__dateCreated mesh__D005147 1999-01-01
% 220.09/220.26  |- mesh__publicMeSHNote mesh__D024301 2002   
% 220.09/220.26  |- skos__broader mesh__D024301smesh__D019441
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D024301 2003
% 220.09/220.26  |- mesh__activeMeSHYear mesh__D024301 2004
% 220.09/220.27  |- skos__altLabel mesh__D024301 Bark, Tree
% 220.09/220.27  |- mesh__historyNote mesh__D024301 2002   
% 220.09/220.27  |- mesh__dateCreated mesh__D024301 2001-07-25
% 220.09/220.27  |- mesh__dateEstablished mesh__D024301 2002-01-01
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D024301 2005
% 220.09/220.27  |- skos__scopeNote mesh__D024301
% 220.09/220.27       The outer layer of the woody parts of plants.     
% 220.09/220.27  |- rdf__type mesh__D024301sskos__Concept
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D024301 2006
% 220.09/220.27  |- skos__altLabel mesh__D024301 Bark, Plant
% 220.09/220.27  |- mesh__dateRevised mesh__D024301 2002-07-02
% 220.09/220.27  |- skos__prefLabel mesh__D024301 Plant Bark
% 220.09/220.27  |- mesh__publicMeSHNote mesh__D029595 2002   
% 220.09/220.27  |- rdf__type mesh__D029595sskos__Concept
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D029595 2006
% 220.09/220.27  |- skos__annotation mesh__D029595
% 220.09/220.27       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.09/220.27  |- skos__broader mesh__D029595smesh__D019684
% 220.09/220.27  |- mesh__recordAuthorizer mesh__D029595 sjn
% 220.09/220.27  |- skos__scopeNote mesh__D029595
% 220.09/220.27       A plant family of the order Orchidales, subclass Liliidae, class Liliopsida %28%monocotyledons%29%.  All orchids have the same bilaterally symmetrical flower structure, with three sepals, but the flowers vary greatly in color and shape.%A%    
% 220.09/220.27  |- mesh__dateRevised mesh__D029595 2003-07-09
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D029595 2005
% 220.09/220.27  |- mesh__dateCreated mesh__D029595 2001-07-25
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D029595 2004
% 220.09/220.27  |- mesh__historyNote mesh__D029595 2002   
% 220.09/220.27  |- skos__prefLabel mesh__D029595 Orchidaceae
% 220.09/220.27  |- mesh__recordOriginator mesh__D029595 ssb
% 220.09/220.27  |- mesh__recordMaintainer mesh__D029595 ssb
% 220.09/220.27  |- mesh__dateEstablished mesh__D029595 2002-01-01
% 220.09/220.27  |- skos__altLabel mesh__D043266 Steroid Sulphatase
% 220.09/220.27  |- rdf__type mesh__D043266sskos__Concept
% 220.09/220.27  |- mesh__recordAuthorizer mesh__D043266 jls
% 220.09/220.27  |- skos__hiddenLabel mesh__D043266
% 220.09/220.27       Sulfate Sulfatase, Dehydroepiandrosterone
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D043266 2005
% 220.09/220.27  |- skos__hiddenLabel mesh__D043266 Steryl Sulfatase
% 220.09/220.27  |- skos__altLabel mesh__D043266 3 Beta-Hydroxysteroid Sulfate Sulfatase
% 220.09/220.27  |- mesh__dateEstablished mesh__D043266 2004-01-01
% 220.09/220.27  |- skos__hiddenLabel mesh__D043266 Sulfohydrolase, Estrone Sulfate
% 220.09/220.27  |- skos__altLabel mesh__D043266 Arylsulfatase C
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D043266 2006
% 220.09/220.27  |- skos__prefLabel mesh__D043266 Steryl-Sulfatase
% 220.09/220.27  |- skos__hiddenLabel mesh__D043266 Sulfatase, DHEA
% 220.09/220.27  |- skos__scopeNote mesh__D043266
% 220.09/220.27       An arylsulfatase with high specificity towards sulfated steroids. Defects in this enzyme are the cause of ICHTHYOSIS, X-LINKED.%A%    
% 220.09/220.27  |- skos__hiddenLabel mesh__D043266 3 Beta Hydroxysteroid Sulfate Sulfatase
% 220.09/220.27  |- skos__altLabel mesh__D043266 Sterylsulfatase
% 220.09/220.27  |- skos__hiddenLabel mesh__D043266 Sulfatase, Steroid
% 220.09/220.27  |- skos__altLabel mesh__D043266 Steroid Sulfatase
% 220.09/220.27  |- mesh__recordOriginator mesh__D043266 AKE
% 220.09/220.27  |- skos__historyNote mesh__D043266 Arylsulfatases %28%1997-2003%29%
% 220.09/220.27  |- skos__hiddenLabel mesh__D043266 Sulfate Sulfohydrolase, Estrone
% 220.09/220.27  |- skos__altLabel mesh__D043266 Estrone Sulfate Sulfatase
% 220.09/220.27  |- skos__altLabel mesh__D043266 Dehydroepiandrosterone Sulfate Sulfatase
% 220.09/220.27  |- skos__altLabel mesh__D043266 Steroid Sulfohydrolase
% 220.09/220.27  |- skos__hiddenLabel mesh__D043266 Sulfohydrolase, Steroid
% 220.09/220.27  |- skos__hiddenLabel mesh__D043266 Sulphatase, Steroid
% 220.09/220.27  |- skos__hiddenLabel mesh__D043266 Sulfate Sulfatase, Estrone
% 220.09/220.27  |- skos__broader mesh__D043266smesh__D001192
% 220.09/220.27  |- mesh__recordMaintainer mesh__D043266 jls
% 220.09/220.27  |- skos__altLabel mesh__D043266 Cholesterol Sulfatase
% 220.09/220.27  |- skos__hiddenLabel mesh__D043266 Sulfate Sulfatase, Cholesterol
% 220.09/220.27  |- skos__hiddenLabel mesh__D043266
% 220.09/220.27       Sulfatase, Dehydroepiandrosterone Sulfate
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D043266 2005A
% 220.09/220.27  |- mesh__publicMeSHNote mesh__D043266
% 220.09/220.27       2004; STERYL-SULFATASE was indexed under ARYLSULFATASES 1976-2003%A%  
% 220.09/220.27  |- skos__hiddenLabel mesh__D043266 Sulfatase, Estrone Sulfate
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D043266 2004
% 220.09/220.27  |- skos__altLabel mesh__D043266 DHEA Sulfatase
% 220.09/220.27  |- skos__altLabel mesh__D043266 Arylsulphatase C
% 220.09/220.27  |- skos__altLabel mesh__D043266 Sterol Sulfatase
% 220.09/220.27  |- skos__altLabel mesh__D043266 Estrone Sulfate Sulfohydrolase
% 220.09/220.27  |- mesh__dateRevised mesh__D043266 2004-08-02
% 220.09/220.27  |- skos__hiddenLabel mesh__D043266 Sulfatase, Sterol
% 220.09/220.27  |- skos__hiddenLabel mesh__D043266 Sulfatase, Cholesterol Sulfate
% 220.09/220.27  |- skos__hiddenLabel mesh__D043266 Sulfatase, Cholesterol
% 220.09/220.27  |- mesh__historyNote mesh__D043266
% 220.09/220.27       2004; use STERYL-SULFATASE %28%NM%29% 1980-2003   
% 220.09/220.27  |- mesh__dateCreated mesh__D043266 2003-07-09
% 220.09/220.27  |- skos__altLabel mesh__D043266 Cholesterol Sulfate Sulfatase
% 220.09/220.27  |- skos__hiddenLabel mesh__D015575 RU965
% 220.09/220.27  |- skos__altLabel mesh__D015575 Merck dura Brand of Roxithromycin
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D015575 2006
% 220.09/220.27  |- skos__hiddenLabel mesh__D015575 RU28965
% 220.09/220.27  |- skos__altLabel mesh__D015575 betapharm Brand of Roxithromycin
% 220.09/220.27  |- mesh__dateRevised mesh__D015575 2005-06-30
% 220.09/220.27  |- skos__altLabel mesh__D015575 Hoechst Brand of Roxithromycin
% 220.09/220.27  |- skos__altLabel mesh__D015575 Alpharma Brand of Roxithromycin
% 220.09/220.27  |- skos__altLabel mesh__D015575 Faes Brand of Roxithromycin
% 220.09/220.27  |- mesh__recordOriginator mesh__D015575 RLS
% 220.09/220.27  |- skos__altLabel mesh__D015575 Roxi-paed 1A Pharma
% 220.09/220.27  |- skos__altLabel mesh__D015575 RU-28965
% 220.09/220.27  |- skos__scopeNote mesh__D015575
% 220.09/220.27       Semisynthetic derivative of erythromycin. It is concentrated by human phagocytes and is bioactive intracellularly. While the drug is active against a wide spectrum of pathogens, it is particularly effective in the treatment of respiratory and genital tract infections.%A%    
% 220.09/220.27  |- mesh__dateEstablished mesh__D015575 1990-01-01
% 220.09/220.27  |- mesh__historyNote mesh__D015575 90; was see LEUCOMYCINS 1981-89   
% 220.09/220.27  |- skos__altLabel mesh__D015575 Knoll Brand of Roxithromycin
% 220.09/220.27  |- skos__altLabel mesh__D015575 Lichtenstein Brand of Roxithromycin
% 220.09/220.27  |- skos__altLabel mesh__D015575 Aventis Brand of Roxithromycin
% 220.09/220.27  |- skos__hiddenLabel mesh__D015575 Roxithromycin Hexal Brand
% 220.09/220.27  |- skos__altLabel mesh__D015575 Pfizer Brand of Roxithromycin
% 220.09/220.27  |- rdf__type mesh__D015575sskos__Concept
% 220.09/220.27  |- skos__altLabel mesh__D015575 Sigma Brand of Roxithromycin
% 220.09/220.27  |- skos__altLabel mesh__D015575 Infectoroxit
% 220.09/220.27  |- skos__altLabel mesh__D015575 Infectopharm Brand of Roxithromycin
% 220.09/220.27  |- skos__historyNote mesh__D015575 Leucomycins %28%1981-1989%29%
% 220.09/220.27  |- mesh__onlineNote mesh__D015575
% 220.09/220.27       use LEUCOMYCINS to search ROXITHROMYCIN 1981-89   
% 220.09/220.27  |- mesh__dateCreated mesh__D015575 1989-05-26
% 220.09/220.27  |- skos__altLabel mesh__D015575 Gr%C3%%BC%nenthal Brand of Roxithromycin
% 220.09/220.27  |- skos__altLabel mesh__D015575 1A Brand of Roxithromycin
% 220.09/220.27  |- mesh__recordMaintainer mesh__D015575 lkw
% 220.09/220.27  |- skos__altLabel mesh__D015575 Wolff Brand of Roxithromycin
% 220.09/220.27  |- skos__broader mesh__D015575smesh__D004917
% 220.09/220.27  |- skos__prefLabel mesh__D015575 Roxithromycin
% 220.09/220.27  |- skos__altLabel mesh__D015575 Basics Brand of Roxithromycin
% 220.09/220.27  |- skos__altLabel mesh__D015575 Rulid
% 220.09/220.27  |- skos__altLabel mesh__D015575 MIP Brand of Roxithromycin
% 220.09/220.27  |- skos__altLabel mesh__D015575 Hexal Brand of Roxithromycin
% 220.09/220.27  |- mesh__recordAuthorizer mesh__D015575 sjn
% 220.09/220.27  |- skos__altLabel mesh__D015575 RU-965
% 220.09/220.27  |- skos__altLabel mesh__D015575 Medeva Brand of Roxithromycin
% 220.09/220.27  |- skos__altLabel mesh__D015575 ct-Arzneimittel Brand of Roxithromycin
% 220.09/220.27  |- skos__altLabel mesh__D015575 MTW Brand of Roxithromycin
% 220.09/220.27  |- skos__altLabel mesh__D015575 TAD Brand of Roxithromycin
% 220.09/220.27  |- skos__altLabel mesh__D015575 Juta Brand of Roxithromycin
% 220.09/220.27  |- mesh__publicMeSHNote mesh__D015575 90; was see LEUCOMYCINS 1981-89   
% 220.09/220.27  |- skos__altLabel mesh__D015575 W%C3%%B6%rwag Brand of Roxithromycin
% 220.09/220.27  |- skos__prefLabel mesh__D009538 Nicotine
% 220.09/220.27  |- skos__scopeNote mesh__D009538
% 220.09/220.27       Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke.%A%    
% 220.09/220.27  |- mesh__recordAuthorizer mesh__D009538 sjn
% 220.09/220.27  |- mesh__recordMaintainer mesh__D009538 TWD
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D009538 2004
% 220.09/220.27  |- skos__broader mesh__D009538smesh__D012991
% 220.09/220.27  |- mesh__dateRevised mesh__D009538 2000-06-22
% 220.09/220.27  |- mesh__dateCreated mesh__D009538 1999-01-01
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D009538 2001
% 220.09/220.27  |- rdf__type mesh__D009538sskos__Concept
% 220.09/220.27  |- skos__hiddenLabel mesh__D009538 Bitartrate, Nicotine
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D009538 2005
% 220.09/220.27  |- skos__broader mesh__D009538smesh__D011725
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D009538 2006
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D009538 2002
% 220.09/220.27  |- skos__annotation mesh__D009538 /biosyn permitted if by plant   
% 220.09/220.27  |- skos__hiddenLabel mesh__D009538 Tartrate, Nicotine
% 220.09/220.27  |- mesh__recordOriginator mesh__D009538 NLM
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D009538 2003
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D001555 2006
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D001555 1993
% 220.09/220.27  |- mesh__historyNote mesh__D001555 68   
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D001555 1999
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D001555 2002
% 220.09/220.27  |- skos__prefLabel mesh__D001555 Benzene Derivatives
% 220.09/220.27  |- rdf__type mesh__D001555sskos__Concept
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D001555 1994
% 220.09/220.27  |- skos__broader mesh__D001555smesh__D006841
% 220.09/220.27  |- mesh__dateEstablished mesh__D001555 1968-01-01
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D001555 2003
% 220.09/220.27  |- skos__historyNote mesh__D001555 Benzene %28%1966-1967%29%
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D001555 1996
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D001555 1995
% 220.09/220.27  |- mesh__recordAuthorizer mesh__D001555 PLS
% 220.09/220.27  |- mesh__recordOriginator mesh__D001555 NLM
% 220.09/220.27  |- mesh__dateCreated mesh__D001555 1999-01-01
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D001555 2004
% 220.09/220.27  |- skos__hiddenLabel mesh__D001555 Derivatives, Benzene
% 220.09/220.27  |- mesh__recordMaintainer mesh__D001555 TGC
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D001555 1997
% 220.09/220.27  |- mesh__publicMeSHNote mesh__D001555 68   
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D001555 2000
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D001555 2005
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D001555 1998
% 220.09/220.27  |- mesh__dateRevised mesh__D001555 1992-05-08
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D001555 2001
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D006240 1992
% 220.09/220.27  |- mesh__publicMeSHNote mesh__D006240 74   
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D006240 1998
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D006240 2006
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D006240 1997
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D006240 2001
% 220.09/220.27  |- skos__scopeNote mesh__D006240
% 220.09/220.27       Highly pleasant emotion characterized by outward manifestations of gratification; joy.%A%    
% 220.09/220.27  |- skos__annotation mesh__D006240 no qualif; includes %22%joy%22%   
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D006240 2000
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D006240 2005
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D006240 1991
% 220.09/220.27  |- mesh__recordMaintainer mesh__D006240 TGC
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D006240 1996
% 220.09/220.27  |- skos__historyNote mesh__D006240 Emotions %28%1966-1969%29%
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D006240 2004
% 220.09/220.27  |- mesh__dateCreated mesh__D006240 1999-01-01
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D006240 1995
% 220.09/220.27  |- skos__broader mesh__D006240smesh__D004644
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D006240 1990
% 220.09/220.27  |- skos__hiddenLabel mesh__D006240 Happinesses
% 220.09/220.27  |- mesh__historyNote mesh__D006240 74%28%70%29%   
% 220.09/220.27  |- rdf__type mesh__D006240sskos__Concept
% 220.09/220.27  |- mesh__dateRevised mesh__D006240 1989-04-28
% 220.09/220.27  |- skos__prefLabel mesh__D006240 Happiness
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D006240 2003
% 220.09/220.27  |- mesh__recordOriginator mesh__D006240 NLM
% 220.09/220.27  |- mesh__dateEstablished mesh__D006240 1974-01-01
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D006240 1994
% 220.09/220.27  |- mesh__recordAuthorizer mesh__D006240 PLS
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D006240 1993
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D006240 1999
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D006240 2002
% 220.09/220.27  |- skos__related mesh__D019966smesh__D013287
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D019966 2003
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D019966 2002
% 220.09/220.27  |- mesh__recordMaintainer mesh__D019966 lkt
% 220.09/220.27  |- skos__hiddenLabel mesh__D019966 Dependence, Substance
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D019966 2004
% 220.09/220.27  |- skos__broader mesh__D019966smesh__D001523
% 220.09/220.27  |- skos__hiddenLabel mesh__D019966 Substance Use Disorder
% 220.09/220.27  |- mesh__publicMeSHNote mesh__D019966
% 220.09/220.27       98; see ORGANIC MENTAL DISORDERS, SUBSTANCE-INDUCED 1981-97; see SUBSTANCE ABUSE 1981-97; see DRUG ABUSE 1968-80; see DRUG ADDICTION 1963-75%A%  
% 220.09/220.27  |- skos__prefLabel mesh__D019966 Substance-Related Disorders
% 220.09/220.27  |- skos__hiddenLabel mesh__D019966 Abuse, Drug
% 220.09/220.27  |- rdf__type mesh__D019966sskos__Concept
% 220.09/220.27  |- skos__hiddenLabel mesh__D019966 Drug Use Disorder
% 220.09/220.27  |- skos__related mesh__D019966smesh__D015198
% 220.09/220.27  |- skos__related mesh__D019966smesh__D017004
% 220.09/220.27  |- skos__hiddenLabel mesh__D019966 Sniffing, Glue
% 220.09/220.27  |- skos__hiddenLabel mesh__D019966 Abuses, Substance
% 220.09/220.27  |- skos__hiddenLabel mesh__D019966 Abuse, Substance
% 220.09/220.27  |- skos__hiddenLabel mesh__D019966 Disorder, Drug Use
% 220.09/220.27  |- skos__related mesh__D019966smesh__D004335
% 220.09/220.27  |- skos__hiddenLabel mesh__D019966
% 220.09/220.27       Organic Mental Disorders, Substance Induced
% 220.09/220.27  |- skos__hiddenLabel mesh__D019966 Addiction, Drug
% 220.09/220.27  |- skos__hiddenLabel mesh__D019966 Usage, Drug
% 220.09/220.27  |- skos__related mesh__D019966smesh__D019973
% 220.09/220.27  |- skos__hiddenLabel mesh__D019966 Substance Abuses
% 220.09/220.27  |- mesh__recordAuthorizer mesh__D019966 sjn
% 220.09/220.27  |- mesh__dateRevised mesh__D019966 2001-07-25
% 220.09/220.27  |- skos__hiddenLabel mesh__D019966 Disorder, Substance Use
% 220.09/220.27  |- skos__related mesh__D019966smesh__D011604
% 220.09/220.27  |- skos__broader mesh__D019966smesh__D007280
% 220.09/220.27  |- skos__hiddenLabel mesh__D019966 Habituation, Drug
% 220.09/220.27  |- mesh__historyNote mesh__D019966 98%28%63%29%   
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D019966 2005
% 220.09/220.27  |- mesh__dateEstablished mesh__D019966 1998-01-01
% 220.09/220.27  |- skos__hiddenLabel mesh__D019966 Addiction, Substance
% 220.09/220.27  |- skos__hiddenLabel mesh__D019966 Dependence, Drug
% 220.09/220.27  |- mesh__recordOriginator mesh__D019966 JLS
% 220.09/220.27  |- mesh__dateCreated mesh__D019966 1997-06-20
% 220.09/220.27  |- skos__annotation mesh__D019966
% 220.09/220.27       consider also PSYCHOSES, SUBSTANCE-INDUCED or PSYCHOSES, ALCOHOLIC; /diag: consider SUBSTANCE ABUSE DETECTION%A%  
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D019966 2006
% 220.09/220.27  |- skos__altLabel mesh__D019966 Substance Addiction
% 220.09/220.27  |- skos__scopeNote mesh__D019966
% 220.09/220.27       Disorders related to substance abuse, the side effects of a medication, toxin exposure, and ALCOHOL-RELATED DISORDERS.%A%    
% 220.09/220.27  |- mesh__recordAuthorizer mesh__D011983 sjn
% 220.09/220.27  |- skos__altLabel mesh__D011983 Purinoceptors
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D011983 2006
% 220.09/220.27  |- mesh__recordOriginator mesh__D011983 SH
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D011983 2004
% 220.09/220.27  |- skos__altLabel mesh__D011983 Receptors, Purine
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D011983 2005
% 220.09/220.27  |- skos__scopeNote mesh__D011983
% 220.09/220.27       Cell surface proteins that bind PURINES with high affinity and trigger intracellular changes which influence the behavior of cells. The best characterized classes of purinergic receptors in mammals are the P1 receptors, which prefer ADENOSINE, and the P2 receptors, which prefer ATP or ADP.%A%    
% 220.09/220.27  |- mesh__publicMeSHNote mesh__D011983
% 220.09/220.27       87; CAFFEINE RECEPTORS, METHYLXANTHINE RECEPTORS, %26% THEOPHYLLINE RECEPTORS were see RECEPTORS, PURINERGIC 1987-93; RECEPTORS, CAFFEINE %26% RECEPTORS, THEOPHYLLINE were see RECEPTORS, PURINERGIC  1993%A%  
% 220.09/220.27  |- skos__historyNote mesh__D011983
% 220.09/220.27       Receptors, Endogenous Substances %28%1973-1986%29%
% 220.09/220.27  |- rdf__type mesh__D011983sskos__Concept
% 220.09/220.27  |- mesh__historyNote mesh__D011983
% 220.09/220.27       87; CAFFEINE RECEPTORS, METHYLXANTHINE RECEPTORS, %26% THEOPHYLLINE RECEPTORS were see RECEPTORS, PURINERGIC 1987-93; RECEPTORS, CAFFEINE %26% RECEPTORS, THEOPHYLLINE were see RECEPTORS, PURINERGIC 1993%A%  
% 220.09/220.27  |- skos__hiddenLabel mesh__D011983 Receptor, Purine
% 220.09/220.27  |- skos__historyNote mesh__D011983 Adenosine %28%1966-1986%29%
% 220.09/220.27  |- mesh__dateRevised mesh__D011983 2003-07-09
% 220.09/220.27  |- skos__broader mesh__D011983smesh__D011956
% 220.09/220.27  |- skos__broader mesh__D011983smesh__D017981
% 220.09/220.27  |- mesh__onlineNote mesh__D011983
% 220.09/220.27       use RECEPTORS, PURINERGIC to search CAFFEINE RECEPTORS, METHYLXANTHINE RECEPTORS, %26% THEOPHYLLINE RECEPTORS 1987-93, %26% RECEPTORS, CAFFEINE %26% RECEPTORS, THEOPHYLLINE 1993%A%  
% 220.09/220.27  |- mesh__dateCreated mesh__D011983 1986-03-31
% 220.09/220.27  |- skos__historyNote mesh__D011983 Purines %28%1966-1986%29%
% 220.09/220.27  |- skos__prefLabel mesh__D011983 Receptors, Purinergic
% 220.09/220.27  |- mesh__dateEstablished mesh__D011983 1987-01-01
% 220.09/220.27  |- skos__altLabel mesh__D011983 Receptors, Methyladenine
% 220.09/220.27  |- skos__altLabel mesh__D011983 Purinergic Receptors
% 220.09/220.27  |- mesh__recordMaintainer mesh__D011983 jmp
% 220.09/220.27  |- skos__altLabel mesh__D011983 Purine Receptors
% 220.09/220.27  |- skos__altLabel mesh__D011983 Purinoceptor
% 220.09/220.27  |- skos__annotation mesh__D011983
% 220.09/220.27       GEN; prefer specifics; DF: RECEPT PURINE   
% 220.09/220.27  |- skos__altLabel mesh__D011983 Purine Receptor
% 220.09/220.27  |- skos__broader mesh__D011983smesh__D043562
% 220.09/220.27  |- mesh__historyNote mesh__D019168 97   
% 220.09/220.27  |- mesh__recordAuthorizer mesh__D019168 SJN
% 220.09/220.27  |- rdf__type mesh__D019168sskos__Concept
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D019168 2006
% 220.09/220.27  |- skos__scopeNote mesh__D019168
% 220.09/220.27       A type of surgical portasystemic shunt to reduce portal hypertension with associated complications of esophageal varices and ascites. It is performed percutaneously through the jugular vein and involves the creation of an intrahepatic shunt between the hepatic vein and portal vein. The channel is maintained by a metallic stent. The procedure can be performed in patients who have failed sclerotherapy and is an additional option to the surgical techniques of portocaval, mesocaval, and splenorenal shunts. It takes one to three hours to perform. %28%JAMA 1995;273%28%23%29%:1824-30%29%%A%    
% 220.09/220.27  |- skos__broader mesh__D019168smesh__D011170
% 220.09/220.27  |- skos__altLabel mesh__D019168 TIPSS
% 220.09/220.27  |- mesh__recordOriginator mesh__D019168 TGC
% 220.09/220.27  |- skos__altLabel mesh__D019168
% 220.09/220.27       Transjugular Intrahepatic Portasystemic Shunt
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D019168 2005
% 220.09/220.27  |- skos__altLabel mesh__D019168
% 220.09/220.27       Portosystemic Shunt, Transjugular Intrahepatic
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D019168 2002
% 220.09/220.27  |- skos__annotation mesh__D019168
% 220.09/220.27       do not use /util except by MeSH definition; DF: TIPS or TIPSS%A%  
% 220.09/220.27  |- skos__historyNote mesh__D019168
% 220.09/220.27       Portasystemic Shunt, Surgical %28%1987-1996%29%
% 220.09/220.27  |- skos__altLabel mesh__D019168
% 220.09/220.27       Shunt, Transjugular Intrahepatic Portosystemic
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D019168 2004
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D019168 1999
% 220.09/220.27  |- mesh__dateCreated mesh__D019168 1996-06-20
% 220.09/220.27  |- mesh__dateRevised mesh__D019168 1997-06-20
% 220.09/220.27  |- mesh__dateEstablished mesh__D019168 1997-01-01
% 220.09/220.27  |- skos__prefLabel mesh__D019168
% 220.09/220.27       Portasystemic Shunt, Transjugular Intrahepatic
% 220.09/220.27  |- skos__altLabel mesh__D019168
% 220.09/220.27       Shunt, Transjugular Intrahepatic Portasystemic
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D019168 2001
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D019168 2003
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D019168 1998
% 220.09/220.27  |- mesh__recordMaintainer mesh__D019168 PXP
% 220.09/220.27  |- mesh__publicMeSHNote mesh__D019168 97   
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D019168 2000
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D011185 2006
% 220.09/220.27  |- skos__hiddenLabel mesh__D011185 Postcommissurotomy Syndromes
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D011185 2003
% 220.09/220.27  |- skos__hiddenLabel mesh__D011185 Syndromes, Postpericardiotomy
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D011185 2001
% 220.09/220.27  |- mesh__dateRevised mesh__D011185 1999-11-03
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D011185 2005
% 220.09/220.27  |- mesh__publicMeSHNote mesh__D011185
% 220.09/220.27       91; was see under HEART DISEASES 1965-90   
% 220.09/220.27  |- mesh__historyNote mesh__D011185
% 220.09/220.27       91%28%65%29%; was see under HEART DISEASES 1965-90   
% 220.09/220.27  |- mesh__recordMaintainer mesh__D011185 TGC
% 220.09/220.27  |- skos__broader mesh__D011185smesh__D011183
% 220.09/220.27  |- mesh__recordAuthorizer mesh__D011185 sjn
% 220.09/220.27  |- skos__broader mesh__D011185smesh__D006331
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D011185 2000
% 220.09/220.27  |- rdf__type mesh__D011185sskos__Concept
% 220.09/220.27  |- skos__scopeNote mesh__D011185
% 220.09/220.27       A febrile illness associated with pericardial and sometimes pleuropulmonary reaction that often follows extensive pericardiotomy.%A%    
% 220.09/220.27  |- skos__prefLabel mesh__D011185 Postpericardiotomy Syndrome
% 220.09/220.27  |- skos__hiddenLabel mesh__D011185 Syndrome, Postcommissurotomy
% 220.09/220.27  |- mesh__dateCreated mesh__D011185 1999-01-01
% 220.09/220.27  |- skos__hiddenLabel mesh__D011185 Syndrome, Postpericardiotomy
% 220.09/220.27  |- mesh__dateEstablished mesh__D011185 1991-01-01
% 220.09/220.27  |- mesh__recordOriginator mesh__D011185 NLM
% 220.09/220.27  |- skos__hiddenLabel mesh__D011185 Syndromes, Postcommissurotomy
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D011185 2004
% 220.09/220.27  |- skos__hiddenLabel mesh__D011185 Postpericardiotomy Syndromes
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D011185 2002
% 220.09/220.27  |- mesh__historyNote mesh__D005148
% 220.09/220.27       FAVRE-RACOUCHOT SYNDROME was heading 1964-96 %28%see under SKIN DISEASES 1964-90%29%; NODULAR ELASTOIDOSIS was see FAVRE-RACOUCHOT SYNDROME 1992-96%A%  
% 220.09/220.27  |- skos__hiddenLabel mesh__D005148 Nodular Elastoidoses
% 220.09/220.27  |- skos__hiddenLabel mesh__D005148 Elastoses, Nodular
% 220.09/220.27  |- rdf__type mesh__D005148sskos__Concept
% 220.09/220.27  |- skos__annotation mesh__D005148
% 220.09/220.27       consider synonym for dermatitis of face %26% do not add DERMATITIS unless one of the specific DERMATITIS terms in MeSH; does not include neopl of face %28% = FACIAL NEOPLASMS%29%%A%  
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D005148 2000
% 220.09/220.27  |- skos__hiddenLabel mesh__D005148 Elastoidoses, Nodular
% 220.09/220.27  |- skos__hiddenLabel mesh__D005148 Dermatosis, Facial
% 220.09/220.27  |- skos__altLabel mesh__D005148 Facial Dermatosis
% 220.09/220.27  |- mesh__recordMaintainer mesh__D005148 TGC
% 220.09/220.27  |- mesh__publicMeSHNote mesh__D005148
% 220.09/220.27       FAVRE-RACOUCHOT SYNDROME was heading 1964-96 %28%see under SKIN DISEASES 1964-90%29%; NODULAR ELASTOIDOSIS was see FAVRE-RACOUCHOT SYNDROME 1992-96%A%  
% 220.09/220.27  |- skos__hiddenLabel mesh__D005148 Nodular Elastoses
% 220.09/220.27  |- skos__hiddenLabel mesh__D005148 Syndrome, Favre-Racouchot
% 220.09/220.27  |- skos__broader mesh__D005148smesh__D012871
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D005148 2006
% 220.09/220.27  |- mesh__recordAuthorizer mesh__D005148 SJN
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D005148 2002
% 220.09/220.27  |- skos__hiddenLabel mesh__D005148 Elastoidosis, Nodular
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D005148 1999
% 220.09/220.27  |- mesh__dateRevised mesh__D005148 1997-06-20
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D005148 2004
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D005148 2005
% 220.09/220.27  |- mesh__dateCreated mesh__D005148 1999-01-01
% 220.09/220.27  |- skos__prefLabel mesh__D005148 Facial Dermatoses
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D005148 1998
% 220.09/220.27  |- skos__hiddenLabel mesh__D005148 Dermatoses, Facial
% 220.09/220.27  |- skos__altLabel mesh__D005148 Nodular Elastosis
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D005148 2003
% 220.09/220.27  |- skos__hiddenLabel mesh__D005148 Favre Racouchot Syndrome
% 220.09/220.27  |- mesh__recordOriginator mesh__D005148 NLM
% 220.09/220.27  |- skos__hiddenLabel mesh__D005148 Elastosis, Nodular
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D005148 2001
% 220.09/220.27  |- mesh__recordMaintainer mesh__D029596 ssb
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D029596 2005
% 220.09/220.27  |- skos__scopeNote mesh__D029596
% 220.09/220.27       A plant genus of the family Paeoniaceae, order Dilleniales, subclass Dilleniidae, class Magnoliopsida. These perennial herbs are up to 2 m %28%6%27%%29% tall.  Leaves are alternate and are divided into three lobes, each lobe being further divided into three smaller lobes. The large flowers are symmetrical, bisexual, have 5 sepals, 5 petals %28%sometimes 10%29%, and many stamens.%A%    
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D029596 2004
% 220.09/220.27  |- skos__broader mesh__D029596smesh__D019684
% 220.09/220.27  |- mesh__recordAuthorizer mesh__D029596 sjn
% 220.09/220.27  |- mesh__dateRevised mesh__D029596 2002-07-03
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D029596 2003
% 220.09/220.27  |- skos__prefLabel mesh__D029596 Paeonia
% 220.09/220.27  |- mesh__dateCreated mesh__D029596 2001-07-25
% 220.09/220.27  |- mesh__recordOriginator mesh__D029596 ssb
% 220.09/220.27  |- mesh__dateEstablished mesh__D029596 2002-01-01
% 220.09/220.27  |- mesh__publicMeSHNote mesh__D029596 2002   
% 220.09/220.27  |- rdf__type mesh__D029596sskos__Concept
% 220.09/220.27  |- mesh__historyNote mesh__D029596 2002   
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D029596 2006
% 220.09/220.27  |- skos__annotation mesh__D029596
% 220.09/220.27       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.09/220.27  |- skos__altLabel mesh__D048750 Karyokinesis
% 220.09/220.27  |- skos__historyNote mesh__D048750 Mitosis %28%1965-2004%29%
% 220.09/220.27  |- mesh__recordMaintainer mesh__D048750 nns
% 220.09/220.27  |- mesh__recordOriginator mesh__D048750 nns
% 220.09/220.27  |- skos__hiddenLabel mesh__D048750 Nuclear Divisions
% 220.09/220.27  |- skos__hiddenLabel mesh__D048750 Division, Nuclear
% 220.09/220.27  |- skos__altLabel mesh__D048750 Nuclear Division
% 220.09/220.27  |- mesh__publicMeSHNote mesh__D048750
% 220.09/220.27       2005; for KARYOKINESIS see MITOSIS 1981-2004   
% 220.09/220.27  |- mesh__dateCreated mesh__D048750 2004-07-07
% 220.09/220.27  |- skos__hiddenLabel mesh__D048750 Divisions, Cell Nucleus
% 220.09/220.27  |- skos__broader mesh__D048750smesh__D002455
% 220.09/220.27  |- mesh__recordAuthorizer mesh__D048750 sjn
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D048750 2006
% 220.09/220.27  |- mesh__dateEstablished mesh__D048750 2005-01-01
% 220.09/220.27  |- mesh__historyNote mesh__D048750
% 220.09/220.27       2005; for KARYOKINESIS use MITOSIS 1981-2004   
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D048750 2005
% 220.09/220.27  |- skos__scopeNote mesh__D048750
% 220.09/220.27       The process by which the CELL NUCLEUS is divided.     
% 220.09/220.27  |- rdf__type mesh__D048750sskos__Concept
% 220.09/220.27  |- skos__historyNote mesh__D048750 Cell Division %28%1965-2004%29%
% 220.09/220.27  |- skos__hiddenLabel mesh__D048750 Nucleus Division, Cell
% 220.09/220.27  |- skos__hiddenLabel mesh__D048750 Divisions, Nuclear
% 220.09/220.27  |- skos__prefLabel mesh__D048750 Cell Nucleus Division
% 220.09/220.27  |- skos__hiddenLabel mesh__D048750 Cell Nucleus Divisions
% 220.09/220.27  |- skos__historyNote mesh__D048750 Cell Nucleus %28%1965-2004%29%
% 220.09/220.27  |- skos__hiddenLabel mesh__D048750 Nucleus Divisions, Cell
% 220.09/220.27  |- skos__hiddenLabel mesh__D048750 Division, Cell Nucleus
% 220.09/220.27  |- skos__annotation mesh__D048750
% 220.09/220.27       1st phase = PROPHASE, 2d phase = METAPHASE, 3d phase = ANAPHASE, final phase = TELOPHASE%A%  
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D015576 2004
% 220.09/220.27  |- mesh__publicMeSHNote mesh__D015576 90   
% 220.09/220.27  |- skos__hiddenLabel mesh__D015576 Hypertrophy, Bone
% 220.09/220.27  |- skos__historyNote mesh__D015576 Hypertrophy %28%1966-1989%29%
% 220.09/220.27  |- mesh__activeMeSHYear mesh__D015576 2000
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D015576 2006
% 220.09/220.28  |- skos__hiddenLabel mesh__D015576 Hyperostoses
% 220.09/220.28  |- mesh__recordOriginator mesh__D015576 AGS
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D015576 2003
% 220.09/220.28  |- mesh__recordMaintainer mesh__D015576 KEV
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D015576 2005
% 220.09/220.28  |- skos__historyNote mesh__D015576 Bone and Bones %28%1966-1989%29%
% 220.09/220.28  |- skos__historyNote mesh__D015576 Exostoses %28%1966-1989%29%
% 220.09/220.28  |- skos__scopeNote mesh__D015576
% 220.09/220.28       Increase in the mass of bone per unit volume.     
% 220.09/220.28  |- skos__historyNote mesh__D015576 Osteochondrodysplasias %28%1985-1989%29%
% 220.09/220.28  |- skos__hiddenLabel mesh__D015576 Bone Hypertrophies
% 220.09/220.28  |- mesh__historyNote mesh__D015576 90   
% 220.09/220.28  |- skos__prefLabel mesh__D015576 Hyperostosis
% 220.09/220.28  |- skos__altLabel mesh__D015576 Bone Hypertrophy
% 220.09/220.28  |- skos__historyNote mesh__D015576
% 220.09/220.28       Bone Diseases, Developmental %28%1970-1989%29%
% 220.09/220.28  |- skos__historyNote mesh__D015576 Exostoses, Multiple %28%1966-1989%29%
% 220.09/220.28  |- skos__historyNote mesh__D015576 Bone Diseases %28%1966-1989%29%
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D015576 2002
% 220.09/220.28  |- mesh__dateEstablished mesh__D015576 1990-01-01
% 220.09/220.28  |- mesh__recordAuthorizer mesh__D015576 sjn
% 220.09/220.28  |- rdf__type mesh__D015576sskos__Concept
% 220.09/220.28  |- mesh__dateCreated mesh__D015576 1989-04-07
% 220.09/220.28  |- skos__hiddenLabel mesh__D015576 Hypertrophies, Bone
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D015576 2001
% 220.09/220.28  |- skos__broader mesh__D015576smesh__D001847
% 220.09/220.28  |- skos__historyNote mesh__D015576
% 220.09/220.28       Spondylitis, Ankylosing %28%1966-1989%29%
% 220.09/220.28  |- mesh__dateRevised mesh__D015576 1999-11-03
% 220.09/220.28  |- skos__broader mesh__D009539smesh__D011725
% 220.09/220.28  |- skos__broader mesh__D009539smesh__D000147
% 220.09/220.28  |- skos__prefLabel mesh__D009539 Nicotinic Acids
% 220.09/220.28  |- skos__scopeNote mesh__D009539
% 220.09/220.28       2-, 3-, or 4-Pyridinecarboxylic acids. Pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position. The 3-carboxy derivative %28%NIACIN%29% is active as a vitamin.%A%    
% 220.09/220.28  |- mesh__recordMaintainer mesh__D009539 ssb
% 220.09/220.28  |- mesh__recordOriginator mesh__D009539 NLM
% 220.09/220.28  |- mesh__historyNote mesh__D009539 75; was NICOTINIC ACID 1963-74   
% 220.09/220.28  |- mesh__recordAuthorizer mesh__D009539 sjn
% 220.09/220.28  |- mesh__onlineNote mesh__D009539
% 220.09/220.28       use NICOTINIC ACIDS to search NICOTINIC ACID 1966-74   
% 220.09/220.28  |- mesh__publicMeSHNote mesh__D009539 75; was NICOTINIC ACID 1963-74   
% 220.09/220.28  |- rdf__type mesh__D009539sskos__Concept
% 220.09/220.28  |- skos__hiddenLabel mesh__D009539 Acids, Nicotinic
% 220.09/220.28  |- mesh__dateCreated mesh__D009539 1999-01-01
% 220.09/220.28  |- skos__annotation mesh__D009539
% 220.09/220.28       /defic: consider also PELLAGRA; /ther use: coordinate disease with /drug ther, not /diet ther%A%  
% 220.09/220.28  |- mesh__dateRevised mesh__D009539 2005-06-30
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D009539 2006
% 220.09/220.28  |- mesh__recordMaintainer mesh__D001556 ssb
% 220.09/220.28  |- skos__altLabel mesh__D001556 Chinoin Brand of Lindane
% 220.09/220.28  |- skos__altLabel mesh__D001556 gamma-Benzene Hexachloride
% 220.09/220.28  |- skos__altLabel mesh__D001556 gamma-Hexachlorocyclohexane
% 220.09/220.28  |- skos__hiddenLabel mesh__D001556 PMS Lindane
% 220.09/220.28  |- skos__altLabel mesh__D001556 Hexachlorocyclohexane
% 220.09/220.28  |- skos__altLabel mesh__D001556 Pharmascience Brand of Lindane
% 220.09/220.28  |- skos__hiddenLabel mesh__D001556 gamma Benzene Hexachloride
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D001556 2006
% 220.09/220.28  |- skos__hiddenLabel mesh__D001556 PMSLindane
% 220.09/220.28  |- skos__hiddenLabel mesh__D001556 Hexachloride, gamma-Benzene
% 220.09/220.28  |- skos__altLabel mesh__D001556 Infectopharm Brand of Lindane
% 220.09/220.28  |- mesh__recordAuthorizer mesh__D001556 sjn
% 220.09/220.28  |- mesh__dateCreated mesh__D001556 1999-01-01
% 220.09/220.28  |- skos__broader mesh__D001556smesh__D006843
% 220.09/220.28  |- skos__hiddenLabel mesh__D001556 gamma Hexachlorocyclohexane
% 220.09/220.28  |- rdf__type mesh__D001556sskos__Concept
% 220.09/220.28  |- mesh__publicMeSHNote mesh__D001556
% 220.09/220.28       96; was BENZENE HEXACHLORIDE 1963-95; LINDANE was see BENZENE HEXACHLORIDE 1963-95%A%  
% 220.09/220.28  |- skos__annotation mesh__D001556
% 220.09/220.28       do not confuse X ref BENZENE HEXACHLORIDE with HEXACHLOROBENZENE%A%  
% 220.09/220.28  |- mesh__historyNote mesh__D001556
% 220.09/220.28       96; was BENZENE HEXACHLORIDE 1963-95; LINDANE was see BENZENE HEXACHLORIDE 1963-95%A%  
% 220.09/220.28  |- skos__hiddenLabel mesh__D001556 Insecticide, BHC
% 220.09/220.28  |- skos__hiddenLabel mesh__D001556 Gamma 666
% 220.09/220.28  |- skos__altLabel mesh__D001556 Stiefel Brand of Lindane
% 220.09/220.28  |- skos__hiddenLabel mesh__D001556 Gamma666
% 220.09/220.28  |- skos__altLabel mesh__D001556 Benzene Hexachloride
% 220.09/220.28  |- skos__scopeNote mesh__D001556
% 220.09/220.28       An organochlorine insecticide that has been used as a pediculicide and a scabicide. It has been shown to cause cancer.%A%    
% 220.09/220.28  |- mesh__recordOriginator mesh__D001556 NLM
% 220.09/220.28  |- skos__prefLabel mesh__D001556 Lindane
% 220.09/220.28  |- skos__altLabel mesh__D001556 Scabene
% 220.09/220.28  |- mesh__dateRevised mesh__D001556 2005-06-30
% 220.09/220.28  |- skos__hiddenLabel mesh__D001556 Hexachloride, Benzene
% 220.09/220.28  |- skos__altLabel mesh__D001556 Hexachlorane
% 220.09/220.28  |- skos__broader mesh__D012697Q000037smesh__D012697
% 220.09/220.28  |- mesh__preferredCombination mesh__D012697Q000037smesh__D015842
% 220.09/220.28  |- rdf__type mesh__D012697Q000037smesh__CompoundConcept
% 220.09/220.28  |- skos__prefLabel mesh__D020710 RGS Proteins
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D020710 2006
% 220.09/220.28  |- mesh__recordOriginator mesh__D020710 jmp
% 220.09/220.28  |- skos__altLabel mesh__D020710 RGS Protein %28%G-Protein Signaling%29%
% 220.09/220.28  |- mesh__publicMeSHNote mesh__D020710
% 220.09/220.28       2000; RGS PROTEIN %28%G-PROTEIN SIGNALING%29% was indexed under PROTEINS 1997-1999%A%  
% 220.09/220.28  |- skos__annotation mesh__D020710
% 220.09/220.28       do not confuse with GTP-BINDING PROTEIN REGULATORS; not the same as RGS tripeptide%A%  
% 220.09/220.28  |- mesh__historyNote mesh__D020710
% 220.09/220.28       2000; for RGS PROTEIN %28%G-PROTEIN SIGNALING%29% use GTPASE-ACTIVATING PROTEINS %28%NM%29% 1997-1999%A%  
% 220.09/220.28  |- skos__scopeNote mesh__D020710
% 220.09/220.28       A large family of evolutionarily conserved proteins that function as negative regulators of HETEROTRIMERIC GTP-BINDING PROTEINS. RGS PROTEINS act by increasing the GTPase activity of the G alpha subunit of a heterotrimeric GTP-binding protein, causing it to revert to its inactive %28%GDP-bound%29% form.%A%    
% 220.09/220.28  |- mesh__dateCreated mesh__D020710 1999-11-03
% 220.09/220.28  |- skos__altLabel mesh__D020710 Regulators of G-Protein Signaling Proteins
% 220.09/220.28  |- skos__hiddenLabel mesh__D020710
% 220.09/220.28       Regulators of G Protein Signaling Proteins
% 220.09/220.28  |- mesh__recordMaintainer mesh__D020710 SYSTEM
% 220.09/220.28  |- mesh__dateEstablished mesh__D020710 2000-01-01
% 220.09/220.28  |- mesh__recordAuthorizer mesh__D020710 sjn
% 220.09/220.28  |- skos__historyNote mesh__D020710 Proteins %28%1989-1999%29%
% 220.09/220.28  |- rdf__type mesh__D020710sskos__Concept
% 220.09/220.28  |- skos__broader mesh__D020710smesh__D020690
% 220.09/220.28  |- mesh__dateRevised mesh__D020710 2005-06-30
% 220.09/220.28  |- skos__broader mesh__D006241smesh__D000939
% 220.09/220.28  |- mesh__historyNote mesh__D006241 65%28%64%29%   
% 220.09/220.28  |- mesh__dateCreated mesh__D006241 1999-01-01
% 220.09/220.28  |- skos__hiddenLabel mesh__D006241 Agents, Contact-Sensitizing
% 220.09/220.28  |- mesh__publicMeSHNote mesh__D006241 65   
% 220.09/220.28  |- skos__prefLabel mesh__D006241 Haptens
% 220.09/220.28  |- rdf__type mesh__D006241sskos__Concept
% 220.09/220.28  |- skos__hiddenLabel mesh__D006241 Contact Sensitizing Agents
% 220.09/220.28  |- mesh__recordMaintainer mesh__D006241 ssb
% 220.09/220.28  |- mesh__dateRevised mesh__D006241 2005-06-30
% 220.09/220.28  |- mesh__dateEstablished mesh__D006241 1965-01-01
% 220.09/220.28  |- skos__scopeNote mesh__D006241
% 220.09/220.28       Small antigenic determinants capable of eliciting an immune response only when coupled to a carrier. Haptens bind to antibodies but by themselves cannot elicit an antibody response.%A%    
% 220.09/220.28  |- mesh__recordAuthorizer mesh__D006241 sjn
% 220.09/220.28  |- mesh__recordOriginator mesh__D006241 NLM
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D006241 2006
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D019967 2001
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D019967 2006
% 220.09/220.28  |- skos__annotation mesh__D019967
% 220.09/220.28       not used for indexing      CATALOG: do not use   
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D019967 2003
% 220.09/220.28  |- skos__broader mesh__D019967smesh__D001523
% 220.09/220.28  |- skos__scopeNote mesh__D019967
% 220.09/220.28       Marked disorders of thought %28%delusions, hallucinations, or other thought disorder accompanied by disordered affect or behavior%29%, and deterioration from a previous level of functioning.%A%    
% 220.09/220.28  |- mesh__dateCreated mesh__D019967 1997-06-20
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D019967 2000
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D019967 2005
% 220.09/220.28  |- skos__prefLabel mesh__D019967
% 220.09/220.28       Schizophrenia and Disorders with Psychotic Features
% 220.09/220.28  |- rdf__type mesh__D019967sskos__Concept
% 220.09/220.28  |- mesh__publicMeSHNote mesh__D019967 98   
% 220.09/220.28  |- mesh__dateEstablished mesh__D019967 1998-01-01
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D019967 1999
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D019967 2002
% 220.09/220.28  |- mesh__historyNote mesh__D019967 98   
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D019967 1998
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D019967 2004
% 220.09/220.28  |- skos__broader mesh__D019342Q000031smesh__D019342
% 220.09/220.28  |- mesh__preferredCombination mesh__D019342Q000031smesh__D000088
% 220.09/220.28  |- rdf__type mesh__D019342Q000031smesh__CompoundConcept
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011984 2006
% 220.09/220.28  |- skos__prefLabel mesh__D011984 Receptors, Sensory
% 220.09/220.28  |- skos__hiddenLabel mesh__D011984 Nerve Ending, Sensory
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011984 2004
% 220.09/220.28  |- mesh__publicMeSHNote mesh__D011984 77; was RECEPTORS, NEURAL 1963-76   
% 220.09/220.28  |- skos__altLabel mesh__D011984 Receptors, Neural
% 220.09/220.28  |- skos__hiddenLabel mesh__D011984 Receptor, Sensory
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011984 2005
% 220.09/220.28  |- mesh__historyNote mesh__D011984 77; was RECEPTORS, NEURAL 1963-76   
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011984 2001
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011984 2003
% 220.09/220.28  |- skos__hiddenLabel mesh__D011984 Sensory Nerve Endings
% 220.09/220.28  |- mesh__dateCreated mesh__D011984 1999-01-01
% 220.09/220.28  |- rdf__type mesh__D011984sskos__Concept
% 220.09/220.28  |- skos__altLabel mesh__D011984 Sensory Receptors
% 220.09/220.28  |- skos__hiddenLabel mesh__D011984 Neuroreceptor
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011984 2000
% 220.09/220.28  |- mesh__recordOriginator mesh__D011984 NLM
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011984 1995
% 220.09/220.28  |- skos__annotation mesh__D011984 DF: RECEPT SENSORY   
% 220.09/220.28  |- skos__broader mesh__D011984smesh__D009411
% 220.09/220.28  |- skos__scopeNote mesh__D011984
% 220.09/220.28       Specialized neurons or parts of neurons which transduce sensory information and relay it centrally. Included are receptors for stimuli outside the body %28%exteroceptors%29% as well as receptors for stimuli from within the body itself %28%interoceptors and proprioceptors%29%. Sensory receptors may include accessory structures which condition %28%e.g., filter%29% the input received by the receptor neurons themselves.%A%    
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011984 1999
% 220.09/220.28  |- skos__hiddenLabel mesh__D011984 Sensory Receptor
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011984 1994
% 220.09/220.28  |- mesh__recordAuthorizer mesh__D011984 PLS
% 220.09/220.28  |- skos__hiddenLabel mesh__D011984 Receptor, Neural
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011984 1997
% 220.09/220.28  |- mesh__onlineNote mesh__D011984
% 220.09/220.28       use RECEPTORS, SENSORY to search RECEPTORS, NEURAL 1966-76%A%  
% 220.09/220.28  |- skos__altLabel mesh__D011984 Neuroreceptors
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011984 1998
% 220.09/220.28  |- mesh__recordMaintainer mesh__D011984 RAZ
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011984 2002
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011984 1996
% 220.09/220.28  |- skos__altLabel mesh__D011984 Neural Receptors
% 220.09/220.28  |- skos__hiddenLabel mesh__D011984 Neural Receptor
% 220.09/220.28  |- skos__hiddenLabel mesh__D011984 Sensory Nerve Ending
% 220.09/220.28  |- mesh__dateRevised mesh__D011984 1993-06-21
% 220.09/220.28  |- skos__broader mesh__D019169smesh__D013601
% 220.09/220.28  |- skos__historyNote mesh__D019169 Cells, Cultured %28%1982-1996%29%
% 220.09/220.28  |- mesh__publicMeSHNote mesh__D019169 97   
% 220.09/220.28  |- skos__scopeNote mesh__D019169
% 220.09/220.28       A CELL LINE derived from human T-CELL LEUKEMIA and used to determine the mechanism of differential susceptibility to anti-cancer drugs and radiation.%A%    
% 220.09/220.28  |- skos__broader mesh__D019169smesh__D045744
% 220.09/220.28  |- mesh__dateRevised mesh__D019169 2004-07-13
% 220.09/220.28  |- skos__historyNote mesh__D019169 Cell Line %28%1981-1996%29%
% 220.09/220.28  |- skos__hiddenLabel mesh__D019169 Cells, Jurkat
% 220.09/220.28  |- mesh__recordOriginator mesh__D019169 AGS
% 220.09/220.28  |- skos__hiddenLabel mesh__D019169 Cell, Jurkat
% 220.09/220.28  |- skos__prefLabel mesh__D019169 Jurkat Cells
% 220.09/220.28  |- skos__hiddenLabel mesh__D019169 Jurkat Cell
% 220.09/220.28  |- mesh__recordAuthorizer mesh__D019169 sjn
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D019169 2006
% 220.09/220.28  |- mesh__dateEstablished mesh__D019169 1997-01-01
% 220.09/220.28  |- skos__annotation mesh__D019169
% 220.09/220.28       almost always NIM with no subheadings; check HUMAN;do not routinely add LEUKEMIA, T-CELL%A%  
% 220.09/220.28  |- mesh__historyNote mesh__D019169 97   
% 220.09/220.28  |- mesh__dateCreated mesh__D019169 1996-06-13
% 220.09/220.28  |- rdf__type mesh__D019169sskos__Concept
% 220.09/220.28  |- mesh__recordMaintainer mesh__D019169 sjn
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D019169 2005
% 220.09/220.28  |- skos__hiddenLabel mesh__D011186 Syndrome, Postphlebitic
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011186 2000
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011186 1996
% 220.09/220.28  |- skos__hiddenLabel mesh__D011186 Ulcer, Postphlebitic
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011186 2005
% 220.09/220.28  |- mesh__historyNote mesh__D011186 87   
% 220.09/220.28  |- mesh__publicMeSHNote mesh__D011186 87   
% 220.09/220.28  |- skos__altLabel mesh__D011186 Postphlebitic Disease
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011186 2004
% 220.09/220.28  |- skos__hiddenLabel mesh__D011186 Postphlebitic Ulcers
% 220.09/220.28  |- rdf__type mesh__D011186sskos__Concept
% 220.09/220.28  |- skos__hiddenLabel mesh__D011186 Diseases, Postphlebitic
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011186 2003
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011186 1995
% 220.09/220.28  |- skos__broader mesh__D011186smesh__D010689
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011186 2002
% 220.09/220.28  |- skos__scopeNote mesh__D011186
% 220.09/220.28       Post-thrombotic complications, including destruction of the valves of the deep veins and communication veins of the leg, and obliteration of the thrombosed veins rather than recanalization, resulting in chronic venous insufficiency, marked by edema, stasis dermatitis, and ulceration of the leg.%A%    
% 220.09/220.28  |- skos__annotation mesh__D011186
% 220.09/220.28       post-thrombotic venous insuff of the legs   
% 220.09/220.28  |- skos__hiddenLabel mesh__D011186 Syndromes, Postphlebitic
% 220.09/220.28  |- mesh__dateRevised mesh__D011186 1993-06-02
% 220.09/220.28  |- skos__hiddenLabel mesh__D011186 Postphlebitic Syndromes
% 220.09/220.28  |- skos__hiddenLabel mesh__D011186 Ulcers, Postphlebitic
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011186 1999
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011186 1994
% 220.09/220.28  |- skos__broader mesh__D011186smesh__D014689
% 220.09/220.28  |- mesh__recordOriginator mesh__D011186 VDK
% 220.09/220.28  |- mesh__dateEstablished mesh__D011186 1987-01-01
% 220.09/220.28  |- skos__prefLabel mesh__D011186 Postphlebitic Syndrome
% 220.09/220.28  |- skos__historyNote mesh__D011186 Varicose Ulcer %28%1966-1986%29%
% 220.09/220.28  |- skos__historyNote mesh__D011186 Phlebitis %28%1966-1986%29%
% 220.09/220.28  |- skos__hiddenLabel mesh__D011186 Disease, Postphlebitic
% 220.09/220.28  |- skos__historyNote mesh__D011186 Thrombophlebitis %28%1966-1986%29%
% 220.09/220.28  |- mesh__recordAuthorizer mesh__D011186 PLS
% 220.09/220.28  |- skos__historyNote mesh__D011186 Venous Insufficiency %28%1973-1986%29%
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011186 2001
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011186 1998
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011186 1997
% 220.09/220.28  |- mesh__dateCreated mesh__D011186 1986-03-26
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D011186 2006
% 220.09/220.28  |- mesh__recordMaintainer mesh__D011186 TAP
% 220.09/220.28  |- skos__hiddenLabel mesh__D011186 Postphlebitic Diseases
% 220.09/220.28  |- mesh__historyNote mesh__D005947
% 220.09/220.28       /metabolism was GLUCOSE METABOLISM 1965; GLUCOSE INJECTION was heading 1963-66%A%  
% 220.09/220.28  |- mesh__recordMaintainer mesh__D005947 ssb
% 220.09/220.28  |- skos__altLabel mesh__D005947 L-Glucose
% 220.09/220.28  |- skos__hiddenLabel mesh__D005947 L Glucose
% 220.09/220.28  |- skos__altLabel mesh__D005947 Dextrose
% 220.09/220.28  |- mesh__recordAuthorizer mesh__D005947 sjn
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D005947 2005
% 220.09/220.28  |- skos__prefLabel mesh__D005947 Glucose
% 220.09/220.28  |- mesh__dateCreated mesh__D005947 1999-01-01
% 220.09/220.28  |- skos__related mesh__D005947smesh__D006029
% 220.09/220.28  |- skos__broader mesh__D005947smesh__D006601
% 220.09/220.28  |- skos__related mesh__D005947smesh__D006943
% 220.09/220.28  |- mesh__recordOriginator mesh__D005947 NLM
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D005947 2006
% 220.09/220.28  |- rdf__type mesh__D005947sskos__Concept
% 220.09/220.28  |- skos__hiddenLabel mesh__D005947 D Glucose
% 220.09/220.28  |- skos__altLabel mesh__D005947 D-Glucose
% 220.09/220.28  |- skos__related mesh__D005947smesh__D001786
% 220.09/220.28  |- mesh__onlineNote mesh__D005947
% 220.09/220.28       use GLUCOSE to search GLUCOSE INJECTION 1966   
% 220.09/220.28  |- skos__related mesh__D005947smesh__D007003
% 220.09/220.28  |- mesh__publicMeSHNote mesh__D005947
% 220.09/220.28       /metabolism was GLUCOSE METABOLISM 1965; GLUCOSE INJECTION was heading 1963-66%A%  
% 220.09/220.28  |- skos__scopeNote mesh__D005947
% 220.09/220.28       A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement.%A%    
% 220.09/220.28  |- skos__hiddenLabel mesh__D005947 Monohydrate, Glucose
% 220.09/220.28  |- skos__annotation mesh__D005947
% 220.09/220.28       /blood = BLOOD GLUCOSE but consider also HYPERGLYCEMIA %26% HYPOGLYCEMIA; /defic: consider also HYPOGLYCEMIA%A%  
% 220.09/220.28  |- mesh__dateRevised mesh__D005947 2004-07-07
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D005149 2006
% 220.09/220.28  |- skos__broader mesh__D005149smesh__D009633
% 220.09/220.28  |- skos__hiddenLabel mesh__D005149 Facial Expressions
% 220.09/220.28  |- skos__prefLabel mesh__D005149 Facial Expression
% 220.09/220.28  |- skos__hiddenLabel mesh__D005149 Expression, Facial
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D005149 2004
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D005149 2005
% 220.09/220.28  |- mesh__recordOriginator mesh__D005149 NLM
% 220.09/220.28  |- mesh__dateCreated mesh__D005149 1999-01-01
% 220.09/220.28  |- skos__broader mesh__D005149smesh__D010808
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D005149 2003
% 220.09/220.28  |- skos__scopeNote mesh__D005149
% 220.09/220.28       Observable changes of expression in the face in response to emotional stimuli.%A%    
% 220.09/220.28  |- rdf__type mesh__D005149sskos__Concept
% 220.09/220.28  |- skos__annotation mesh__D005149
% 220.09/220.28       human %26% animal; a psychol response: do not confuse with FACIES, phys appearance characteristic of various dis; no qualif%A%  
% 220.09/220.28  |- mesh__dateRevised mesh__D005149 2002-07-03
% 220.09/220.28  |- mesh__recordMaintainer mesh__D005149 PXP
% 220.09/220.28  |- skos__hiddenLabel mesh__D005149 Expressions, Facial
% 220.09/220.28  |- mesh__recordAuthorizer mesh__D005149 sjn
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D029597 2003
% 220.09/220.28  |- skos__scopeNote mesh__D029597
% 220.09/220.28       An autosomal dominant LONG QT SYNDROME, without deafness.%A%    
% 220.09/220.28  |- mesh__publicMeSHNote mesh__D029597
% 220.09/220.28       2002; see LONG QT SYNDROME 1986-2001   
% 220.09/220.28  |- skos__altLabel mesh__D029597 Ward-Romano Syndrome
% 220.09/220.28  |- mesh__dateEstablished mesh__D029597 2002-01-01
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D029597 2004
% 220.09/220.28  |- skos__broader mesh__D029597smesh__D030342
% 220.09/220.28  |- skos__hiddenLabel mesh__D029597 Ward Romano Syndrome
% 220.09/220.28  |- skos__hiddenLabel mesh__D029597 Romano Ward Syndrome
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D029597 2002
% 220.09/220.28  |- skos__prefLabel mesh__D029597 Romano-Ward Syndrome
% 220.09/220.28  |- skos__broader mesh__D029597smesh__D008133
% 220.09/220.28  |- mesh__historyNote mesh__D029597 2002; use LONG QT SYNDROME 1986-2001   
% 220.09/220.28  |- mesh__dateCreated mesh__D029597 2001-07-25
% 220.09/220.28  |- skos__hiddenLabel mesh__D029597 Syndrome, Ward-Romano
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D029597 2005
% 220.09/220.28  |- skos__historyNote mesh__D029597 Long QT Syndrome %28%1985-2001%29%
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D029597 2006
% 220.09/220.28  |- rdf__type mesh__D029597sskos__Concept
% 220.09/220.28  |- skos__hiddenLabel mesh__D029597 Syndrome, Romano-Ward
% 220.09/220.28  |- skos__altLabel mesh__D029597 Long QT Syndrome 1
% 220.09/220.28  |- skos__annotation mesh__D015577 DF: GERIATRIC ASSESS   
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D015577 2003
% 220.09/220.28  |- mesh__dateCreated mesh__D015577 1989-06-20
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D015577 2005
% 220.09/220.28  |- skos__historyNote mesh__D015577 Aged %28%1966-1989%29%
% 220.09/220.28  |- skos__scopeNote mesh__D015577
% 220.09/220.28       Evaluation of the level of physical, physiological, or mental functioning in the older population group.%A%    
% 220.09/220.28  |- skos__historyNote mesh__D015577
% 220.09/220.28       Health Services for the Aged %28%1980-1989%29%
% 220.09/220.28  |- mesh__recordMaintainer mesh__D015577 lkt
% 220.09/220.28  |- skos__altLabel mesh__D015577 Assessment, Geriatric
% 220.09/220.28  |- skos__prefLabel mesh__D015577 Geriatric Assessment
% 220.09/220.28  |- mesh__recordOriginator mesh__D015577 EGC
% 220.09/220.28  |- mesh__dateEstablished mesh__D015577 1990-01-01
% 220.09/220.28  |- skos__historyNote mesh__D015577 Health Status %28%1980-1989%29%
% 220.09/220.28  |- skos__broader mesh__D015577smesh__D006304
% 220.09/220.28  |- skos__broader mesh__D015577smesh__D003625
% 220.09/220.28  |- rdf__type mesh__D015577sskos__Concept
% 220.09/220.28  |- mesh__historyNote mesh__D015577 90   
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D015577 2004
% 220.09/220.28  |- mesh__publicMeSHNote mesh__D015577 90   
% 220.09/220.28  |- mesh__dateRevised mesh__D015577 2002-07-02
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D015577 2006
% 220.09/220.28  |- skos__hiddenLabel mesh__D015577 Assessments, Geriatric
% 220.09/220.28  |- mesh__recordAuthorizer mesh__D015577 sjn
% 220.09/220.28  |- skos__hiddenLabel mesh__D015577 Geriatric Assessments
% 220.09/220.28  |- mesh__dateEstablished mesh__D001557 1974-01-01
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D001557 2006
% 220.09/220.28  |- mesh__recordOriginator mesh__D001557 NLM
% 220.09/220.28  |- mesh__publicMeSHNote mesh__D001557 74   
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D001557 2002
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D001557 1999
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D001557 1994
% 220.09/220.28  |- mesh__dateCreated mesh__D001557 1999-01-01
% 220.09/220.28  |- mesh__dateRevised mesh__D001557 1993-06-04
% 220.09/220.28  |- rdf__type mesh__D001557sskos__Concept
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D001557 2005
% 220.09/220.28  |- mesh__recordMaintainer mesh__D001557 TPW
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D001557 2001
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D001557 1998
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D001557 2004
% 220.09/220.28  |- skos__broader mesh__D001557smesh__D001555
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D001557 2000
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D001557 1997
% 220.09/220.28  |- skos__scopeNote mesh__D001557
% 220.09/220.28       Organic salts and esters of benzenesulfonic acid.     
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D001557 2003
% 220.09/220.28  |- skos__prefLabel mesh__D001557 Benzenesulfonates
% 220.09/220.28  |- mesh__historyNote mesh__D001557 74   
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D001557 1996
% 220.09/220.28  |- mesh__recordAuthorizer mesh__D001557 PLS
% 220.09/220.28  |- skos__broader mesh__D001557smesh__D001190
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D001557 1995
% 220.09/220.28  |- skos__prefLabel mesh__D020711 Threshold Limit Values
% 220.09/220.28  |- skos__hiddenLabel mesh__D020711 TLV BLV
% 220.09/220.28  |- mesh__publicMeSHNote mesh__D020711
% 220.09/220.28       2000; see MAXIMUM PERMISSIBLE EXPOSURE LEVEL 1976-1999; for TLV see MAXIMUM PERMISSIBLE EXPOSURE LEVEL 1976-1999%A%  
% 220.09/220.28  |- skos__annotation mesh__D020711 DF: STEL   
% 220.09/220.28  |- skos__broader mesh__D020711smesh__D007878
% 220.09/220.28  |- mesh__dateCreated mesh__D020711 1999-11-09
% 220.09/220.28  |- skos__hiddenLabel mesh__D020711 TLV-Ceilings
% 220.09/220.28  |- skos__hiddenLabel mesh__D020711 TLV-BLVs
% 220.09/220.28  |- skos__hiddenLabel mesh__D020711 TLV Ceiling
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D020711 2002
% 220.09/220.28  |- skos__broader mesh__D020711smesh__D016273
% 220.09/220.28  |- skos__altLabel mesh__D020711 TLV-STEL
% 220.09/220.28  |- skos__related mesh__D020711smesh__D008452
% 220.09/220.28  |- mesh__dateEstablished mesh__D020711 2000-01-01
% 220.09/220.28  |- skos__scopeNote mesh__D020711
% 220.09/220.28       Standards for limiting worker exposure to airborne contaminants. They are the maximum concentration in air at which it is believed that a particular substance will not produce adverse health effects with repeated daily exposure. It can be a time-weighted average %28%TLV-TWA%29%, a short-term value %28%TLV-STEL%29%, or an instantaneous value %28%TLV-Ceiling%29%. They are expressed either as parts per million %28%ppm%29% or milligram per cubic meter %28%mg/m3%29%.%A%    
% 220.09/220.28  |- skos__altLabel mesh__D020711 STEL
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D020711 2003
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D020711 2000
% 220.09/220.28  |- skos__hiddenLabel mesh__D020711 TLV-STELs
% 220.09/220.28  |- skos__hiddenLabel mesh__D020711 TLV STEL
% 220.09/220.28  |- rdf__type mesh__D020711sskos__Concept
% 220.09/220.28  |- mesh__historyNote mesh__D020711
% 220.09/220.28       2000; use MAXIMUM ALLOWABLE CONCENTRATION 1976-1999; for TLV use MAXIMUM ALLOWABLE CONCENTRATION 1976-1999%A%  
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D020711 2004
% 220.09/220.28  |- skos__hiddenLabel mesh__D020711 TLV-TWAs
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D020711 2005
% 220.09/220.28  |- skos__altLabel mesh__D020711 TLV-BLV
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D020711 2001
% 220.09/220.28  |- skos__altLabel mesh__D020711 TLV-TWA
% 220.09/220.28  |- skos__hiddenLabel mesh__D020711 TLV TWA
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D020711 2006
% 220.09/220.28  |- skos__hiddenLabel mesh__D020711 STELs
% 220.09/220.28  |- rdf__type mesh__D006242sskos__Concept
% 220.09/220.28  |- skos__scopeNote mesh__D006242
% 220.09/220.28       Plasma glycoproteins that form a stable complex with hemoglobin to aid the recycling of heme iron. They are encoded in man by a gene on the short arm of chromosome 16.%A%    
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D006242 2003
% 220.09/220.28  |- skos__prefLabel mesh__D006242 Haptoglobins
% 220.09/220.28  |- skos__broader mesh__D006242smesh__D009088
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D006242 1999
% 220.09/220.28  |- mesh__recordOriginator mesh__D006242 NLM
% 220.09/220.28  |- skos__annotation mesh__D006242 alpha-globulins; acute phase proteins   
% 220.09/220.28  |- mesh__recordAuthorizer mesh__D006242 PLS
% 220.09/220.28  |- mesh__recordMaintainer mesh__D006242 KEV
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D006242 1998
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D006242 2006
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D006242 2002
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D006242 1997
% 220.09/220.28  |- mesh__dateRevised mesh__D006242 1995-03-17
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D006242 2005
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D006242 2001
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D006242 1996
% 220.09/220.28  |- skos__altLabel mesh__D006242 Haptoglobin
% 220.09/220.28  |- mesh__activeMeSHYear mesh__D006242 2004
% 220.09/220.28  |- skos__broader mesh__D006242smesh__D000510
% 220.09/220.29  |- skos__broader mesh__D006242smesh__D000209
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D006242 2000
% 220.09/220.29  |- mesh__dateCreated mesh__D006242 1999-01-01
% 220.09/220.29  |- mesh__publicMeSHNote mesh__D019968 98   
% 220.09/220.29  |- rdf__type mesh__D019968sskos__Concept
% 220.09/220.29  |- mesh__recordOriginator mesh__D019968 JLS
% 220.09/220.29  |- mesh__recordAuthorizer mesh__D019968 jls
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D019968 2002
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D019968 1999
% 220.09/220.29  |- mesh__recordMaintainer mesh__D019968 jls
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D019968 2001
% 220.09/220.29  |- mesh__historyNote mesh__D019968 98   
% 220.09/220.29  |- mesh__dateRevised mesh__D019968 2004-08-02
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D019968 1998
% 220.09/220.29  |- skos__broader mesh__D019968smesh__D001523
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D019968 2004
% 220.09/220.29  |- skos__annotation mesh__D019968
% 220.09/220.29       GEN: avoid, prefer specifics; DF: SEX GENDER DIS   
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D019968 2006
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D019968 2000
% 220.09/220.29  |- mesh__dateCreated mesh__D019968 1997-06-20
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D019968 2005A
% 220.09/220.29  |- skos__prefLabel mesh__D019968 Sexual and Gender Disorders
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D019968 2005B
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D019968 2003
% 220.09/220.29  |- skos__scopeNote mesh__D019968
% 220.09/220.29       Mental disorders related to sexual dysfunction, paraphilias, and gender identity disorders.%A%    
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D019968 2005
% 220.09/220.29  |- mesh__dateEstablished mesh__D019968 1998-01-01
% 220.09/220.29  |- mesh__publicMeSHNote mesh__D011985 77   
% 220.09/220.29  |- skos__annotation mesh__D011985
% 220.09/220.29       GEN; prefer specifics; DF: RECEPT SEROTONIN   
% 220.09/220.29  |- skos__altLabel mesh__D011985 Receptors, 5-Hydroxytryptamine
% 220.09/220.29  |- skos__hiddenLabel mesh__D011985 5 HT Receptors
% 220.09/220.29  |- skos__altLabel mesh__D011985 5-HT Receptors
% 220.09/220.29  |- mesh__dateRevised mesh__D011985 2005-06-30
% 220.09/220.29  |- skos__hiddenLabel mesh__D011985 5 Hydroxytryptamine Receptors
% 220.09/220.29  |- skos__altLabel mesh__D011985 Serotonin Receptors
% 220.09/220.29  |- skos__altLabel mesh__D011985 Tryptamine Receptors
% 220.09/220.29  |- skos__broader mesh__D011985smesh__D043562
% 220.09/220.29  |- skos__altLabel mesh__D011985 5-Hydroxytryptamine Receptors
% 220.09/220.29  |- mesh__recordMaintainer mesh__D011985 jmp
% 220.09/220.29  |- mesh__dateCreated mesh__D011985 1976-05-03
% 220.09/220.29  |- mesh__dateEstablished mesh__D011985 1977-01-01
% 220.09/220.29  |- skos__historyNote mesh__D011985
% 220.09/220.29       Receptors, Endogenous Substances %28%1973-1976%29%
% 220.09/220.29  |- skos__historyNote mesh__D011985 Receptors, Drug %28%1968-1976%29%
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D011985 2006
% 220.09/220.29  |- skos__hiddenLabel mesh__D011985 Receptors, 5 Hydroxytryptamine
% 220.09/220.29  |- mesh__recordOriginator mesh__D011985 SH
% 220.09/220.29  |- skos__hiddenLabel mesh__D011985 Receptors, 5 HT
% 220.09/220.29  |- mesh__recordAuthorizer mesh__D011985 sjn
% 220.09/220.29  |- mesh__historyNote mesh__D011985 77   
% 220.09/220.29  |- skos__broader mesh__D011985smesh__D017982
% 220.09/220.29  |- skos__historyNote mesh__D011985 Serotonin %28%1966-1976%29%
% 220.09/220.29  |- rdf__type mesh__D011985sskos__Concept
% 220.09/220.29  |- skos__altLabel mesh__D011985 Receptors, 5-HT
% 220.09/220.29  |- skos__prefLabel mesh__D011985 Receptors, Serotonin
% 220.09/220.29  |- skos__scopeNote mesh__D011985
% 220.09/220.29       Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action.%A%    
% 220.09/220.29  |- skos__hiddenLabel mesh__D011187 Postures
% 220.09/220.29  |- rdf__type mesh__D011187sskos__Concept
% 220.09/220.29  |- mesh__dateRevised mesh__D011187 2003-07-09
% 220.09/220.29  |- mesh__recordMaintainer mesh__D011187 nns
% 220.09/220.29  |- mesh__recordOriginator mesh__D011187 NLM
% 220.09/220.29  |- skos__scopeNote mesh__D011187
% 220.09/220.29       The position of the limbs or the carriage of the body as a whole. %28%Stedman, 25th ed.%29%%A%    
% 220.09/220.29  |- skos__annotation mesh__D011187
% 220.09/220.29       the position of the body as a whole; PRONE POSITION %26% SUPINE POSITION are also available; HEAD-DOWN TILT is available for studies on this position in space flight, surg %26% physiol%A%  
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D011187 2005
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D011187 2004
% 220.09/220.29  |- skos__prefLabel mesh__D011187 Posture
% 220.09/220.29  |- skos__broader mesh__D011187smesh__D043703
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D011187 2006
% 220.09/220.29  |- skos__related mesh__D011187smesh__D007024
% 220.09/220.29  |- mesh__dateCreated mesh__D011187 1999-01-01
% 220.09/220.29  |- mesh__recordAuthorizer mesh__D011187 sjn
% 220.09/220.29  |- skos__related mesh__D011187smesh__D007697
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D005948 2004
% 220.09/220.29  |- mesh__recordMaintainer mesh__D005948 ssb
% 220.09/220.29  |- mesh__dateEstablished mesh__D005948 1991-01-01
% 220.09/220.29  |- mesh__dateRevised mesh__D005948 2003-07-09
% 220.09/220.29  |- skos__historyNote mesh__D005948
% 220.09/220.29       Alcohol Oxidoreductases %28%1966-1977%29%
% 220.09/220.29  |- skos__broader mesh__D005948smesh__D002237
% 220.09/220.29  |- mesh__recordOriginator mesh__D005948 RLS
% 220.09/220.29  |- skos__prefLabel mesh__D005948 Glucose Dehydrogenases
% 220.09/220.29  |- skos__hiddenLabel mesh__D005948 Oxidoreductases, Glucose
% 220.09/220.29  |- mesh__publicMeSHNote mesh__D005948
% 220.09/220.29       91; was see under CARBOHYDRATE DEHYDROGENASES 1978-90   
% 220.09/220.29  |- mesh__recordAuthorizer mesh__D005948 sjn
% 220.09/220.29  |- skos__scopeNote mesh__D005948
% 220.09/220.29       D-Glucose:1-oxidoreductases. Catalyzes the oxidation of D-glucose to D-glucono-gamma-lactone and reduced acceptor. Any acceptor except molecular oxygen is permitted. Includes EC 1.1.1.47; EC 1.1.1.118; EC 1.1.1.119 and EC 1.1.99.10.%A%    
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D005948 2006
% 220.09/220.29  |- rdf__type mesh__D005948sskos__Concept
% 220.09/220.29  |- skos__hiddenLabel mesh__D005948 Dehydrogenases, Glucose
% 220.09/220.29  |- skos__altLabel mesh__D005948 Glucose Oxidoreductases
% 220.09/220.29  |- mesh__historyNote mesh__D005948
% 220.09/220.29       91%28%78%29%; was see under CARBOHYDRATE DEHYDROGENASES 1978-90%A%  
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D005948 2005
% 220.09/220.29  |- mesh__dateCreated mesh__D005948 1977-05-17
% 220.09/220.29  |- skos__prefLabel mesh__D016670 Gabexate
% 220.09/220.29  |- mesh__onlineNote mesh__D016670
% 220.09/220.29       use GABEXATE %28%NM%29% to search GABEXATE 1979-91   
% 220.09/220.29  |- mesh__dateEstablished mesh__D016670 1992-01-01
% 220.09/220.29  |- skos__historyNote mesh__D016670 Anticoagulants %28%1966-1991%29%
% 220.09/220.29  |- skos__hiddenLabel mesh__D016670 Mesilate, Gabexate
% 220.09/220.29  |- skos__hiddenLabel mesh__D016670 Methanesulfonate, Gabexate
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D016670 2006
% 220.09/220.29  |- mesh__recordOriginator mesh__D016670 RLS
% 220.09/220.29  |- mesh__recordMaintainer mesh__D016670 jmp
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D016670 2004
% 220.09/220.29  |- skos__altLabel mesh__D016670 Gabexate Mesylate
% 220.09/220.29  |- skos__hiddenLabel mesh__D016670
% 220.09/220.29       Gabexate Monomethanesulfonate, 14C Labeled Cpd
% 220.09/220.29  |- mesh__dateRevised mesh__D016670 2000-06-22
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D016670 2005
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D016670 2002
% 220.09/220.29  |- skos__hiddenLabel mesh__D016670 Mesylate, Gabexate
% 220.09/220.29  |- skos__historyNote mesh__D016670 Guanidines %28%1966-1991%29%
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D016670 2003
% 220.09/220.29  |- mesh__publicMeSHNote mesh__D016670
% 220.09/220.29       92; GABEXATE was indexed under GUANIDINES 1976-91   
% 220.09/220.29  |- rdf__type mesh__D016670sskos__Concept
% 220.09/220.29  |- skos__historyNote mesh__D016670
% 220.09/220.29       Serine Proteinase Inhibitors %28%1990-1991%29%
% 220.09/220.29  |- mesh__dateCreated mesh__D016670 1991-01-25
% 220.09/220.29  |- skos__historyNote mesh__D016670 Protease Inhibitors %28%1979-1989%29%
% 220.09/220.29  |- mesh__recordAuthorizer mesh__D016670 sjn
% 220.09/220.29  |- skos__broader mesh__D016670smesh__D006146
% 220.09/220.29  |- skos__hiddenLabel mesh__D016670 Monomethanesulfonate, Gabexate
% 220.09/220.29  |- skos__altLabel mesh__D016670 Gabexate Mesilate
% 220.09/220.29  |- mesh__historyNote mesh__D016670 92; was GABEXATE %28%NM%29% 1976-91   
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D016670 2001
% 220.09/220.29  |- skos__scopeNote mesh__D016670
% 220.09/220.29       A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation %28%DIC%29%, and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.%A%    
% 220.09/220.29  |- rdf__type mesh__D030341sskos__Concept
% 220.09/220.29  |- skos__scopeNote mesh__D030341
% 220.09/220.29       Infections with viruses of the order NIDOVIRALES. The concept includes ARTERIVIRUS INFECTIONS and CORONAVIRIDAE INFECTIONS.%A%    
% 220.09/220.29  |- mesh__dateCreated mesh__D030341 2001-07-25
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D030341 2006
% 220.09/220.29  |- skos__broader mesh__D030341smesh__D012327
% 220.09/220.29  |- mesh__publicMeSHNote mesh__D030341 2002   
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D030341 2004
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D030341 2005
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D030341 2002
% 220.09/220.29  |- skos__prefLabel mesh__D030341 Nidovirales Infections
% 220.09/220.29  |- skos__annotation mesh__D030341 GEN; prefer specifics   
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D030341 2003
% 220.09/220.29  |- mesh__historyNote mesh__D030341 2002   
% 220.09/220.29  |- mesh__dateEstablished mesh__D030341 2002-01-01
% 220.09/220.29  |- skos__annotation mesh__D002650
% 220.09/220.29       check also tag CHILD or specific; for adult survivors of child sexual abuse, check both tags CHILD or specific + relevant adult age%A%  
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D002650 2003
% 220.09/220.29  |- skos__altLabel mesh__D002650 Sexual Abuse, Child
% 220.09/220.29  |- skos__prefLabel mesh__D002650 Child Abuse, Sexual
% 220.09/220.29  |- mesh__dateCreated mesh__D002650 1986-03-25
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D002650 2000
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D002650 2006
% 220.09/220.29  |- mesh__recordOriginator mesh__D002650 EC
% 220.09/220.29  |- skos__hiddenLabel mesh__D002650 Abuse, Child Sexual
% 220.09/220.29  |- skos__broader mesh__D002650smesh__D012742
% 220.09/220.29  |- mesh__publicMeSHNote mesh__D002650 87   
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D002650 2005
% 220.09/220.29  |- skos__hiddenLabel mesh__D002650 Sexual Child Molestation
% 220.09/220.29  |- mesh__dateRevised mesh__D002650 1997-06-20
% 220.09/220.29  |- skos__altLabel mesh__D002650 Molestation, Sexual, Child
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D002650 2002
% 220.09/220.29  |- mesh__dateEstablished mesh__D002650 1987-01-01
% 220.09/220.29  |- skos__hiddenLabel mesh__D002650 Sexual Child Abuse
% 220.09/220.29  |- skos__historyNote mesh__D002650 Sex Offenses %28%1968-1986%29%
% 220.09/220.29  |- skos__hiddenLabel mesh__D002650 Child Sexual Abuse
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D002650 1999
% 220.09/220.29  |- skos__historyNote mesh__D002650 Child Abuse %28%1966-1986%29%
% 220.09/220.29  |- mesh__historyNote mesh__D002650 87   
% 220.09/220.29  |- mesh__recordMaintainer mesh__D002650 JLS
% 220.09/220.29  |- skos__scopeNote mesh__D002650
% 220.09/220.29       Sexual maltreatment of the child or minor.     
% 220.09/220.29  |- skos__altLabel mesh__D002650 Sexual Abuse of Child
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D002650 1998
% 220.09/220.29  |- skos__hiddenLabel mesh__D002650 Molestation, Sexual Child
% 220.09/220.29  |- rdf__type mesh__D002650sskos__Concept
% 220.09/220.29  |- skos__broader mesh__D002650smesh__D002649
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D002650 2004
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D002650 2001
% 220.09/220.29  |- mesh__recordAuthorizer mesh__D002650 SJN
% 220.09/220.29  |- skos__altLabel mesh__D002650 Child Molestation, Sexual
% 220.09/220.29  |- mesh__dateEstablished mesh__D029598 2002-01-01
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D029598 2004
% 220.09/220.29  |- skos__broader mesh__D029598smesh__D031683
% 220.09/220.29  |- skos__scopeNote mesh__D029598
% 220.09/220.29       A plant genus of the family Passifloraceae, order Violales, subclass Dilleniidae, class Magnoliopsida.  They are vines with ornamental flowers and edible fruit.%A%    
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D029598 2005
% 220.09/220.29  |- mesh__historyNote mesh__D029598 2002   
% 220.09/220.29  |- mesh__publicMeSHNote mesh__D029598 2002   
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D029598 2006
% 220.09/220.29  |- rdf__type mesh__D029598sskos__Concept
% 220.09/220.29  |- skos__annotation mesh__D029598
% 220.09/220.29       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.09/220.29  |- skos__prefLabel mesh__D029598 Passiflora
% 220.09/220.29  |- mesh__dateCreated mesh__D029598 2001-07-25
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D029598 2003
% 220.09/220.29  |- mesh__dateRevised mesh__D029598 2002-07-03
% 220.09/220.29  |- skos__scopeNote mesh__D001558
% 220.09/220.29       Bactericidal cationic quaternary ammonium surfactant used as a topical anti-infective agent. It is an ingredient in medicaments, deodorants, mouthwashes, etc., and is used to disinfect apparatus, etc., in the food processing and pharmaceutical industries, in surgery, and also as a preservative. The compound is toxic orally as a result of neuromuscular blockade.%A%    
% 220.09/220.29  |- skos__hiddenLabel mesh__D001558 Chloride, Benzethonium
% 220.09/220.29  |- skos__hiddenLabel mesh__D001558 Puri Clens
% 220.09/220.29  |- skos__historyNote mesh__D001558 Ammonium Compounds %28%1969-1974%29%
% 220.09/220.29  |- skos__hiddenLabel mesh__D001558 Magic, Formula
% 220.09/220.29  |- skos__altLabel mesh__D001558 Care-Tech Brand of Benzethonium Chloride
% 220.09/220.29  |- skos__historyNote mesh__D001558 Benzyl Compounds %28%1971-1974%29%
% 220.09/220.29  |- mesh__dateEstablished mesh__D001558 1991-01-01
% 220.09/220.29  |- mesh__publicMeSHNote mesh__D001558
% 220.09/220.29       91; was see under AMMONIUM COMPOUNDS 1981-90; was BENZETHONIUM CHLORIDE see under AMMONIUM COMPOUNDS 1975-80%A%  
% 220.09/220.29  |- mesh__historyNote mesh__D001558
% 220.09/220.29       91%28%81%29%; was see under AMMONIUM COMPOUNDS 1981-90; was BENZETHONIUM CHLORIDE see under AMMONIUM COMPOUNDS 1975-80%A%  
% 220.09/220.29  |- skos__broader mesh__D001558smesh__D000644
% 220.09/220.29  |- mesh__recordOriginator mesh__D001558 NLM
% 220.09/220.29  |- skos__altLabel mesh__D001558 Formula Magic
% 220.09/220.29  |- mesh__onlineNote mesh__D001558
% 220.09/220.29       use BENZETHONIUM to search BENZETHONIUM COMPOUNDS 1975-80%A%  
% 220.09/220.29  |- skos__hiddenLabel mesh__D001558 PuriClens
% 220.09/220.29  |- mesh__dateRevised mesh__D001558 2005-06-30
% 220.09/220.29  |- mesh__recordMaintainer mesh__D001558 ssb
% 220.09/220.29  |- skos__altLabel mesh__D001558 Bencetonium Chloride
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D001558 2006
% 220.09/220.29  |- skos__broader mesh__D001558smesh__D050339
% 220.09/220.29  |- skos__historyNote mesh__D001558 Phenyl Ethers %28%1974%29%
% 220.09/220.29  |- skos__hiddenLabel mesh__D001558 Chloride, Bencetonium
% 220.09/220.29  |- skos__hiddenLabel mesh__D001558 Care Tech Brand of Benzethonium Chloride
% 220.09/220.29  |- skos__altLabel mesh__D001558 Sween Brand of Benzethonium Chloride
% 220.09/220.29  |- mesh__dateCreated mesh__D001558 1974-11-19
% 220.09/220.29  |- skos__annotation mesh__D001558 D25-26 qualif   
% 220.09/220.29  |- rdf__type mesh__D001558sskos__Concept
% 220.09/220.29  |- skos__prefLabel mesh__D001558 Benzethonium
% 220.09/220.29  |- mesh__recordAuthorizer mesh__D001558 sjn
% 220.09/220.29  |- skos__hiddenLabel mesh__D020712 Fornix-Fimbrias
% 220.09/220.29  |- mesh__historyNote mesh__D020712 2000   
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D020712 2002
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D020712 2006
% 220.09/220.29  |- skos__hiddenLabel mesh__D020712 Fimbria Fornix
% 220.09/220.29  |- mesh__recordAuthorizer mesh__D020712 sjn
% 220.09/220.29  |- skos__scopeNote mesh__D020712
% 220.09/220.29       Heavily myelinated fiber bundle of the TELENCEPHALON projecting from the hippocampal formation to the HYPOTHALAMUS. Some authorities consider the fornix part of the LIMBIC SYSTEM. The fimbria starts as a flattened band of axons arising from the subiculum and HIPPOCAMPUS, which then thickens to form the fornix.%A%    
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D020712 2005
% 220.09/220.29  |- skos__altLabel mesh__D020712 Fornix-Fimbria
% 220.09/220.29  |- mesh__dateRevised mesh__D020712 2001-07-25
% 220.09/220.29  |- skos__hiddenLabel mesh__D020712 Fornices %28%Brain%29%
% 220.09/220.29  |- mesh__publicMeSHNote mesh__D020712 2000   
% 220.09/220.29  |- skos__hiddenLabel mesh__D020712 Fornix Fimbria
% 220.09/220.29  |- mesh__recordOriginator mesh__D020712 ags
% 220.09/220.29  |- mesh__dateCreated mesh__D020712 1999-11-08
% 220.09/220.29  |- mesh__dateEstablished mesh__D020712 2000-01-01
% 220.09/220.29  |- skos__historyNote mesh__D020712 Hippocampus %28%1966-1999%29%
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D020712 2004
% 220.09/220.29  |- mesh__recordMaintainer mesh__D020712 ags
% 220.09/220.29  |- skos__broader mesh__D020712smesh__D008032
% 220.09/220.29  |- skos__broader mesh__D020712smesh__D013687
% 220.09/220.29  |- rdf__type mesh__D020712sskos__Concept
% 220.09/220.29  |- skos__prefLabel mesh__D020712 Fornix %28%Brain%29%
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D020712 2003
% 220.09/220.29  |- skos__hiddenLabel mesh__D020712 Fimbrias %28%Brain%29%
% 220.09/220.29  |- skos__hiddenLabel mesh__D020712 Fimbria-Fornices
% 220.09/220.29  |- skos__broader mesh__D020148Q000031smesh__D020148
% 220.09/220.29  |- mesh__preferredCombination mesh__D020148Q000031smesh__D002088
% 220.09/220.29  |- rdf__type mesh__D020148Q000031smesh__CompoundConcept
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D006243 2001
% 220.09/220.29  |- mesh__onlineNote mesh__D006243 search LACRIMAL APPARATUS 1969-74   
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D006243 1999
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D006243 2000
% 220.09/220.29  |- mesh__dateRevised mesh__D006243 1994-04-16
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D006243 1998
% 220.09/220.29  |- skos__hiddenLabel mesh__D006243 Gland, Harderian
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D006243 2006
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D006243 1997
% 220.09/220.29  |- skos__annotation mesh__D006243 animal only; accessory lacrimal gland   
% 220.09/220.29  |- mesh__recordOriginator mesh__D006243 NLM
% 220.09/220.29  |- skos__broader mesh__D006243smesh__D000825
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D006243 2005
% 220.09/220.29  |- mesh__historyNote mesh__D006243
% 220.09/220.29       91%28%75%29%; was see under LACRIMAL APPARATUS 1975-90   
% 220.09/220.29  |- mesh__recordAuthorizer mesh__D006243 PLS
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D006243 1996
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D006243 2004
% 220.09/220.29  |- skos__scopeNote mesh__D006243
% 220.09/220.29       A sebaceous gland that, in some animals, acts as an accessory to the lacrimal gland. The harderian gland excretes fluid that facilitates movement of the third eyelid.%A%    
% 220.09/220.29  |- mesh__dateCreated mesh__D006243 1999-01-01
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D006243 1995
% 220.09/220.29  |- rdf__type mesh__D006243sskos__Concept
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D006243 2002
% 220.09/220.29  |- skos__prefLabel mesh__D006243 Harderian Gland
% 220.09/220.29  |- mesh__recordMaintainer mesh__D006243 PXP
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D006243 2003
% 220.09/220.29  |- mesh__publicMeSHNote mesh__D006243
% 220.09/220.29       91; was see under LACRIMAL APPARATUS 1975-90   
% 220.09/220.29  |- mesh__dateEstablished mesh__D006243 1991-01-01
% 220.09/220.29  |- skos__hiddenLabel mesh__D019969 Abuse, Amphetamine
% 220.09/220.29  |- skos__broader mesh__D019969smesh__D019966
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D019969 2002
% 220.09/220.29  |- mesh__recordOriginator mesh__D019969 JLS
% 220.09/220.29  |- mesh__historyNote mesh__D019969 98   
% 220.09/220.29  |- skos__hiddenLabel mesh__D019969 Disorders, Amphetamine-Related
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D019969 2001
% 220.09/220.29  |- skos__hiddenLabel mesh__D019969 Users, Amphetamine
% 220.09/220.29  |- mesh__recordMaintainer mesh__D019969 ags
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D019969 2000A
% 220.09/220.29  |- skos__prefLabel mesh__D019969 Amphetamine-Related Disorders
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D019969 2000
% 220.09/220.29  |- mesh__dateCreated mesh__D019969 1997-06-20
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D019969 2004
% 220.09/220.29  |- skos__scopeNote mesh__D019969
% 220.09/220.29       Disorders related or resulting from use of amphetamines.%A%    
% 220.09/220.29  |- skos__hiddenLabel mesh__D019969 Amphetamine User
% 220.09/220.29  |- mesh__dateEstablished mesh__D019969 1998-01-01
% 220.09/220.29  |- skos__hiddenLabel mesh__D019969 Dependence, Amphetamine
% 220.09/220.29  |- skos__hiddenLabel mesh__D019969 User, Amphetamine
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D019969 2003
% 220.09/220.29  |- mesh__dateRevised mesh__D019969 1999-12-28
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D019969 2006
% 220.09/220.29  |- skos__hiddenLabel mesh__D019969 Amphetamine Related Disorders
% 220.09/220.29  |- mesh__publicMeSHNote mesh__D019969 98   
% 220.09/220.29  |- skos__hiddenLabel mesh__D019969 Addiction, Amphetamine
% 220.09/220.29  |- mesh__recordAuthorizer mesh__D019969 ags
% 220.09/220.29  |- skos__hiddenLabel mesh__D019969 Disorder, Amphetamine-Related
% 220.09/220.29  |- rdf__type mesh__D019969sskos__Concept
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D019969 2005
% 220.09/220.29  |- skos__hiddenLabel mesh__D011986 Hormone Receptor, Growth
% 220.09/220.29  |- skos__altLabel mesh__D011986 Growth Hormone Receptor
% 220.09/220.29  |- skos__broader mesh__D011986smesh__D011979
% 220.09/220.29  |- skos__altLabel mesh__D011986 Somatotropin Receptors
% 220.09/220.29  |- skos__altLabel mesh__D011986 Receptors, Growth Hormone
% 220.09/220.29  |- mesh__publicMeSHNote mesh__D011986 87   
% 220.09/220.29  |- skos__annotation mesh__D011986 DF: RECEPT SOMATOTROPIN   
% 220.09/220.29  |- mesh__recordMaintainer mesh__D011986 jmp
% 220.09/220.29  |- skos__scopeNote mesh__D011986
% 220.09/220.29       Cell surface proteins that bind GROWTH HORMONE with high affinity and trigger intracellular changes influencing the behavior of cells. Activation of growth hormone receptors regulates amino acid transport through cell membranes, RNA translation to protein, DNA transcription, and protein and amino acid catabolism in many cell types. Many of these effects are mediated indirectly through stimulation of the release of somatomedins.%A%    
% 220.09/220.29  |- skos__altLabel mesh__D011986 Somatomammotropin Receptors
% 220.09/220.29  |- skos__hiddenLabel mesh__D011986 Hormone Receptors, Growth
% 220.09/220.29  |- skos__historyNote mesh__D011986 Somatotropin %28%1966-1986%29%
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D011986 2006
% 220.09/220.29  |- mesh__dateEstablished mesh__D011986 1987-01-01
% 220.09/220.29  |- mesh__recordOriginator mesh__D011986 SH
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D011986 2004
% 220.09/220.29  |- skos__altLabel mesh__D011986 Somatotropin Receptor
% 220.09/220.29  |- skos__altLabel mesh__D011986 Growth Hormone Receptors
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D011986 2005
% 220.09/220.29  |- skos__prefLabel mesh__D011986 Receptors, Somatotropin
% 220.09/220.29  |- mesh__historyNote mesh__D011986 87   
% 220.09/220.29  |- rdf__type mesh__D011986sskos__Concept
% 220.09/220.29  |- skos__historyNote mesh__D011986
% 220.09/220.29       Receptors, Endogenous Substances %28%1973-1986%29%
% 220.09/220.29  |- skos__altLabel mesh__D011986 Somatomammotropin Receptor
% 220.09/220.29  |- mesh__dateRevised mesh__D011986 2003-07-09
% 220.09/220.29  |- skos__broader mesh__D011986smesh__D018013
% 220.09/220.29  |- skos__altLabel mesh__D011986 Receptor, Growth Hormone
% 220.09/220.29  |- mesh__recordAuthorizer mesh__D011986 sjn
% 220.09/220.29  |- mesh__dateCreated mesh__D011986 1986-03-31
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D044362 2006
% 220.09/220.29  |- mesh__dateEstablished mesh__D044362 2004-01-01
% 220.09/220.29  |- rdf__type mesh__D044362sskos__Concept
% 220.09/220.29  |- mesh__dateCreated mesh__D044362 2003-07-09
% 220.09/220.29  |- skos__scopeNote mesh__D044362
% 220.09/220.29       Australia, New Zealand and neighboring islands in the South Pacific Ocean. %28%Random House Unabridged Dictionary, 2d ed.%29%%A%    
% 220.09/220.29  |- skos__broader mesh__D044362smesh__D044349
% 220.09/220.29  |- mesh__historyNote mesh__D044362 2004   
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D044362 2004
% 220.09/220.29  |- skos__prefLabel mesh__D044362 Australasia
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D044362 2005
% 220.09/220.29  |- mesh__recordAuthorizer mesh__D011188 SJN
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D011188 1998
% 220.09/220.29  |- skos__related mesh__D011188smesh__D011197
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D011188 2003
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D011188 2001
% 220.09/220.29  |- skos__annotation mesh__D011188
% 220.09/220.29       an alkali metal; K-39; /physiol permitted; /metab: consider also POTASSIUM CHANNELS %26% SODIUM-POTASSIUM PUMP; /blood: note see relateds; POTASSIUM, DIETARY is also available%A%  
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D011188 2005
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D011188 1999
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D011188 2004
% 220.09/220.29  |- skos__hiddenLabel mesh__D011188 Ion Level, Potassium
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D011188 2006
% 220.09/220.29  |- skos__related mesh__D011188smesh__D006947
% 220.09/220.29  |- mesh__dateCreated mesh__D011188 1999-01-01
% 220.09/220.29  |- skos__prefLabel mesh__D011188 Potassium
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D011188 2002
% 220.09/220.29  |- skos__related mesh__D011188smesh__D007008
% 220.09/220.29  |- skos__scopeNote mesh__D011188
% 220.09/220.29       An element that is in the alkali group of metals. It has an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte and it plays a significant role in the regulation of fluid volume and maintenance of the water-electrolyte balance.%A%    
% 220.09/220.29  |- mesh__recordMaintainer mesh__D011188 ADP
% 220.09/220.29  |- mesh__recordOriginator mesh__D011188 NLM
% 220.09/220.29  |- rdf__type mesh__D011188sskos__Concept
% 220.09/220.29  |- mesh__dateRevised mesh__D011188 1997-06-20
% 220.09/220.29  |- skos__broader mesh__D011188smesh__D008672
% 220.09/220.29  |- skos__related mesh__D011188smesh__D011194
% 220.09/220.29  |- skos__hiddenLabel mesh__D011188 Level, Potassium Ion
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D011188 2000
% 220.09/220.29  |- mesh__recordOriginator mesh__D005949 NLM
% 220.09/220.29  |- skos__scopeNote mesh__D005949
% 220.09/220.29       An enzyme of the oxidoreductase class that catalyzes the conversion of beta-D-glucose and oxygen to D-glucono-1,5-lactone and peroxide. It is a flavoprotein, highly specific for beta-D-glucose. The enzyme is produced by Penicillium notatum and other fungi and has antibacterial activity in the presence of glucose and oxygen. It is used to estimate glucose concentration in blood or urine samples through the formation of colored dyes by the hydrogen peroxide produced in the reaction. %28%From Enzyme Nomenclature, 1992%29% EC 1.1.3.4.%A%    
% 220.09/220.29  |- mesh__recordMaintainer mesh__D005949 ssb
% 220.09/220.29  |- mesh__publicMeSHNote mesh__D005949 64   
% 220.09/220.29  |- skos__prefLabel mesh__D005949 Glucose Oxidase
% 220.09/220.29  |- mesh__dateEstablished mesh__D005949 1964-01-01
% 220.09/220.29  |- mesh__historyNote mesh__D005949 64   
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D005949 2006
% 220.09/220.29  |- skos__broader mesh__D005949smesh__D000429
% 220.09/220.29  |- rdf__type mesh__D005949sskos__Concept
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D005949 2005
% 220.09/220.29  |- skos__altLabel mesh__D005949 Microcid
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D005949 2004
% 220.09/220.29  |- mesh__recordAuthorizer mesh__D005949 sjn
% 220.09/220.29  |- skos__hiddenLabel mesh__D005949 Oxidase, Glucose
% 220.09/220.29  |- mesh__dateRevised mesh__D005949 2003-07-09
% 220.09/220.29  |- mesh__dateCreated mesh__D005949 1999-01-01
% 220.09/220.29  |- mesh__dateRevised mesh__D016671 2005-06-30
% 220.09/220.29  |- mesh__recordOriginator mesh__D016671 MXR
% 220.09/220.29  |- skos__hiddenLabel mesh__D016671 Baboons, Gelada
% 220.09/220.29  |- skos__prefLabel mesh__D016671 Theropithecus
% 220.09/220.29  |- mesh__recordAuthorizer mesh__D016671 sjn
% 220.09/220.29  |- skos__altLabel mesh__D016671 Theropithecus gelada
% 220.09/220.29  |- mesh__dateCreated mesh__D016671 1991-01-25
% 220.09/220.29  |- mesh__activeMeSHYear mesh__D016671 2006
% 220.09/220.29  |- mesh__dateEstablished mesh__D016671 1992-01-01
% 220.09/220.29  |- skos__altLabel mesh__D016671 Gelada Baboon
% 220.09/220.29  |- skos__broader mesh__D016671smesh__D016663
% 220.09/220.29  |- skos__hiddenLabel mesh__D016671 gelada, Theropithecus
% 220.09/220.29  |- rdf__type mesh__D016671sskos__Concept
% 220.09/220.29  |- skos__hiddenLabel mesh__D016671 Gelada Baboons
% 220.09/220.29  |- mesh__recordMaintainer mesh__D016671 ags
% 220.09/220.29  |- skos__altLabel mesh__D016671 Baboon, Gelada
% 220.09/220.29  |- skos__scopeNote mesh__D016671
% 220.09/220.29       A genus of Old World monkeys of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, that inhabits the mountainous regions of Ethiopia. The genus consists of only one species, Theropithecus gelada.%A%    
% 220.09/220.29  |- skos__hiddenLabel mesh__D016671 Theropithecus geladas
% 220.09/220.29  |- skos__annotation mesh__D016671
% 220.09/220.29       Old World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 220.09/220.29  |- mesh__historyNote mesh__D016671
% 220.09/220.29       92; THEROPITHECUS GELADA was heading 1981-96 %28%see under CERCOPITHECIDAE 1981-90%29%; was GELADA see under MONKEYS 1975-80%A%  
% 220.09/220.29  |- skos__hiddenLabel mesh__D016671 geladas, Theropithecus
% 220.09/220.29  |- mesh__publicMeSHNote mesh__D016671
% 220.09/220.29       92; THEROPITHECUS GELADA was heading 1981-96 %28%see under CERCOPITHECIDAE 1981-90%29%; was GELADA see under MONKEYS 1975-80%A%  
% 220.09/220.29  |- skos__hiddenLabel mesh__D016671 Geladas
% 220.09/220.29  |- skos__hiddenLabel mesh__D030342 Inborn Genetic Disease
% 220.09/220.29  |- skos__hiddenLabel mesh__D030342 Diseases, Hereditary
% 220.09/220.29  |- mesh__dateCreated mesh__D030342 2001-07-25
% 220.09/220.30  |- skos__altLabel mesh__D030342 Hereditary Disease
% 220.09/220.30  |- skos__altLabel mesh__D030342 Inborn Genetic Diseases
% 220.09/220.30  |- mesh__dateRevised mesh__D030342 2002-07-03
% 220.09/220.30  |- skos__hiddenLabel mesh__D030342 Single-Gene Defect
% 220.09/220.30  |- skos__hiddenLabel mesh__D030342 Disease, Hereditary
% 220.09/220.30  |- skos__hiddenLabel mesh__D030342 Single Gene Defects
% 220.09/220.30  |- mesh__recordAuthorizer mesh__D030342 sjn
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D030342 2006
% 220.09/220.30  |- skos__hiddenLabel mesh__D030342 Defect, Single-Gene
% 220.09/220.30  |- skos__prefLabel mesh__D030342 Genetic Diseases, Inborn
% 220.09/220.30  |- skos__related mesh__D030342smesh__D005826
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D030342 2004
% 220.09/220.30  |- mesh__publicMeSHNote mesh__D030342
% 220.09/220.30       2002; for HEREDITARY DISEASES see HEREDITARY DISEASES 1968-2001%A%  
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D030342 2005
% 220.09/220.30  |- skos__hiddenLabel mesh__D030342 Diseases, Inborn Genetic
% 220.09/220.30  |- skos__hiddenLabel mesh__D030342 Defects, Single-Gene
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D030342 2003
% 220.09/220.30  |- skos__hiddenLabel mesh__D030342 Disease, Inborn Genetic
% 220.09/220.30  |- skos__hiddenLabel mesh__D030342 Genetic Disease, Inborn
% 220.09/220.30  |- mesh__recordOriginator mesh__D030342 nns
% 220.09/220.30  |- skos__broader mesh__D030342smesh__D009358
% 220.09/220.30  |- mesh__dateEstablished mesh__D030342 2002-01-01
% 220.09/220.30  |- skos__scopeNote mesh__D030342
% 220.09/220.30       Diseases that are caused by genetic mutations present during embryo or fetal development, although they may be observed later in life. The mutations may be inherited from a parent%27%s genome or they may be acquired in utero.%A%    
% 220.09/220.30  |- skos__annotation mesh__D030342
% 220.09/220.30       GEN only: prefer /genet with specific diseases; Manual 23.22+; Manual 19.8.34%A%  
% 220.09/220.30  |- rdf__type mesh__D030342sskos__Concept
% 220.09/220.30  |- mesh__recordMaintainer mesh__D030342 jmp
% 220.09/220.30  |- mesh__historyNote mesh__D030342 2002   
% 220.09/220.30  |- skos__scopeNote mesh__D002651
% 220.09/220.30       Promotion and protection of the rights of children; frequently through a legal process.%A%    
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D002651 1997
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D002651 2001
% 220.09/220.30  |- mesh__dateCreated mesh__D002651 1974-11-19
% 220.09/220.30  |- mesh__historyNote mesh__D002651 75   
% 220.09/220.30  |- skos__annotation mesh__D002651
% 220.09/220.30       rights of children; check also tag CHILD or specific   
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D002651 2005
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D002651 1993
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D002651 1991
% 220.09/220.30  |- mesh__recordOriginator mesh__D002651 NLM
% 220.09/220.30  |- mesh__dateEstablished mesh__D002651 1975-09-01
% 220.09/220.30  |- mesh__dateRevised mesh__D002651 1989-04-28
% 220.09/220.30  |- skos__hiddenLabel mesh__D002651 Advocacies, Child
% 220.09/220.30  |- mesh__recordAuthorizer mesh__D002651 PLS
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D002651 1996
% 220.09/220.30  |- mesh__recordMaintainer mesh__D002651 TGC
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D002651 2000
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D002651 1999
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D002651 1992
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D002651 1995
% 220.09/220.30  |- skos__broader mesh__D002651smesh__D006806
% 220.09/220.30  |- rdf__type mesh__D002651sskos__Concept
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D002651 1998
% 220.09/220.30  |- skos__prefLabel mesh__D002651 Child Advocacy
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D002651 2004
% 220.09/220.30  |- skos__hiddenLabel mesh__D002651 Advocacy, Child
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D002651 2002
% 220.09/220.30  |- skos__historyNote mesh__D002651 Child Welfare %28%1966-1974%29%
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D002651 1990
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D002651 1994
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D002651 2003
% 220.09/220.30  |- skos__hiddenLabel mesh__D002651 Child Advocacies
% 220.09/220.30  |- skos__broader mesh__D002651smesh__D002669
% 220.09/220.30  |- mesh__publicMeSHNote mesh__D002651 75   
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D002651 2006
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D001559 2000
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D001559 1996
% 220.09/220.30  |- mesh__historyNote mesh__D001559 75   
% 220.09/220.30  |- mesh__dateRevised mesh__D001559 1992-05-08
% 220.09/220.30  |- skos__annotation mesh__D001559 DF: BENZHYDRYL CPDS   
% 220.09/220.30  |- mesh__recordAuthorizer mesh__D001559 PLS
% 220.09/220.30  |- mesh__dateCreated mesh__D001559 1974-11-11
% 220.09/220.30  |- skos__hiddenLabel mesh__D001559 Compounds, Benzhydryl
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D001559 1995
% 220.09/220.30  |- skos__historyNote mesh__D001559 Benzene Derivatives %28%1968-1974%29%
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D001559 2006
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D001559 1999
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D001559 1994
% 220.09/220.30  |- mesh__publicMeSHNote mesh__D001559 75   
% 220.09/220.30  |- rdf__type mesh__D001559sskos__Concept
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D001559 2005
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D001559 2002
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D001559 1993
% 220.09/220.30  |- skos__prefLabel mesh__D001559 Benzhydryl Compounds
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D001559 1998
% 220.09/220.30  |- mesh__recordOriginator mesh__D001559 NLM
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D001559 2004
% 220.09/220.30  |- mesh__recordMaintainer mesh__D001559 TGC
% 220.09/220.30  |- skos__scopeNote mesh__D001559
% 220.09/220.30       Compounds which contain the methyl radical substituted with two benzene rings. Permitted are any substituents, but ring fusion to any of the benzene rings is not allowed.%A%    
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D001559 1997
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D001559 2001
% 220.09/220.30  |- skos__broader mesh__D001559smesh__D001555
% 220.09/220.30  |- mesh__dateEstablished mesh__D001559 1975-09-01
% 220.09/220.30  |- skos__altLabel mesh__D001559 Diphenylmethyl Compounds
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D001559 2003
% 220.09/220.30  |- skos__historyNote mesh__D001559 Benzyl Compounds %28%1972-1974%29%
% 220.09/220.30  |- skos__hiddenLabel mesh__D001559 Compounds, Diphenylmethyl
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D012281 2006
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D012281 2006A
% 220.09/220.30  |- skos__broader mesh__D012281smesh__D016996
% 220.09/220.30  |- skos__prefLabel mesh__D012281 Rickettsia
% 220.09/220.30  |- rdf__type mesh__D012281sskos__Concept
% 220.09/220.30  |- mesh__dateCreated mesh__D012281 1999-01-01
% 220.09/220.30  |- skos__scopeNote mesh__D012281
% 220.09/220.30       A genus of gram-negative, aerobic, rod-shaped bacteria often surrounded by a protein microcapsular layer and slime layer. The natural cycle of its organisms generally involves a vertebrate and an invertebrate host. Species of the genus are the etiological agents of human diseases, such as typhus.%A%    
% 220.09/220.30  |- mesh__recordOriginator mesh__D012281 NLM
% 220.09/220.30  |- mesh__dateRevised mesh__D012281 2005-07-22
% 220.09/220.30  |- skos__annotation mesh__D012281
% 220.09/220.30       classified with bacteria; infection = RICKETTSIA INFECTIONS or their specifics: see notes on species terms for various infections; Rickettsia quintana infection = TRENCH FEVER; RICKETTSIA TSUTSUGAMUSHI see ORIENTIA TSUTSUGAMUSHI is available%A%  
% 220.09/220.30  |- mesh__recordAuthorizer mesh__D012281 ags
% 220.09/220.30  |- mesh__recordMaintainer mesh__D012281 ags
% 220.09/220.30  |- mesh__dateRevised mesh__D020713 2003-07-09
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D020713 2005
% 220.09/220.30  |- skos__historyNote mesh__D020713
% 220.09/220.30       Drug Resistance, Microbial %28%1973-1999%29%
% 220.09/220.30  |- skos__prefLabel mesh__D020713 Vancomycin Resistance
% 220.09/220.30  |- mesh__recordOriginator mesh__D020713 ndw
% 220.09/220.30  |- mesh__dateEstablished mesh__D020713 2000-01-01
% 220.09/220.30  |- mesh__recordAuthorizer mesh__D020713 sjn
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D020713 2004
% 220.09/220.30  |- mesh__dateCreated mesh__D020713 1999-11-03
% 220.09/220.30  |- skos__scopeNote mesh__D020713
% 220.09/220.30       Nonsusceptibility of bacteria to the action of VANCOMYCIN, an inhibitor of cell wall synthesis.%A%    
% 220.09/220.30  |- mesh__publicMeSHNote mesh__D020713 2000   
% 220.09/220.30  |- rdf__type mesh__D020713sskos__Concept
% 220.09/220.30  |- mesh__historyNote mesh__D020713 2000   
% 220.09/220.30  |- mesh__recordMaintainer mesh__D020713 ssb
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D020713 2006
% 220.09/220.30  |- skos__broader mesh__D020713smesh__D024881
% 220.09/220.30  |- skos__historyNote mesh__D020713
% 220.09/220.30       Vancomycin/pharmacology %28%1973-1999%29%
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006244 1999
% 220.09/220.30  |- mesh__dateRevised mesh__D006244 1992-05-15
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006244 2005
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006244 1993
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006244 2000
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006244 1996
% 220.09/220.30  |- skos__annotation mesh__D006244 almost never IM   
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006244 2006
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006244 2001
% 220.09/220.30  |- mesh__dateCreated mesh__D006244 1999-01-01
% 220.09/220.30  |- skos__hiddenLabel mesh__D006244 Hardnesses
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006244 1997
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006244 1994
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006244 2003
% 220.09/220.30  |- skos__prefLabel mesh__D006244 Hardness
% 220.09/220.30  |- mesh__dateEstablished mesh__D006244 1965-01-01
% 220.09/220.30  |- mesh__historyNote mesh__D006244 65   
% 220.09/220.30  |- mesh__recordAuthorizer mesh__D006244 PLS
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006244 1995
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006244 2004
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006244 2002
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006244 1998
% 220.09/220.30  |- mesh__recordMaintainer mesh__D006244 TAP
% 220.09/220.30  |- rdf__type mesh__D006244sskos__Concept
% 220.09/220.30  |- mesh__recordOriginator mesh__D006244 NLM
% 220.09/220.30  |- skos__broader mesh__D006244smesh__D010825
% 220.09/220.30  |- mesh__publicMeSHNote mesh__D006244 65   
% 220.09/220.30  |- skos__historyNote mesh__D011987
% 220.09/220.30       Receptors, Cell Surface %28%1973-1976%29%
% 220.09/220.30  |- skos__altLabel mesh__D011987 Steroid Receptors
% 220.09/220.30  |- skos__altLabel mesh__D011987 Steroid Receptor
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D011987 1997
% 220.09/220.30  |- skos__annotation mesh__D011987
% 220.09/220.30       GEN; prefer specifics; coord IM with specific steroid %28%IM%29%; DF: RECEPT STEROID%A%  
% 220.09/220.30  |- skos__altLabel mesh__D011987 Receptors, Steroids
% 220.09/220.30  |- skos__broader mesh__D011987smesh__D018160
% 220.09/220.30  |- skos__scopeNote mesh__D011987
% 220.09/220.30       Proteins found usually in the cytoplasm or nucleus that specifically bind steroid hormones and trigger changes influencing the behavior of cells. The steroid receptor-steroid hormone complex regulates the transcription of specific genes.%A%    
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D011987 2005
% 220.09/220.30  |- mesh__publicMeSHNote mesh__D011987
% 220.09/220.30       77; RECEPTORS, CORTICOSTEROID was see RECEPTORS, GLUCOCORTICOID 1984-93; CORTICOSTEROID RECEPTORS was see RECEPTORS, GLUCOCORTICOID 1993%A%  
% 220.09/220.30  |- mesh__recordAuthorizer mesh__D011987 PLS
% 220.09/220.30  |- mesh__dateEstablished mesh__D011987 1977-01-01
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D011987 2001
% 220.09/220.30  |- skos__hiddenLabel mesh__D011987 Steroids Receptors
% 220.09/220.30  |- mesh__dateCreated mesh__D011987 1976-05-03
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D011987 2003
% 220.09/220.30  |- skos__hiddenLabel mesh__D011987 Receptor, Steroid
% 220.09/220.30  |- mesh__onlineNote mesh__D011987
% 220.09/220.30       use RECEPTORS, GLUCOCORTICOID to search RECEPTORS, CORTICOSTEROID 1984-93 %26% CORTICOSTEROID RECEPTORS 1993%A%  
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D011987 2006
% 220.09/220.30  |- skos__altLabel mesh__D011987 Corticosteroid Receptor
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D011987 2002
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D011987 2004
% 220.09/220.30  |- skos__historyNote mesh__D011987 Receptors, Drug %28%1968-1972%29%
% 220.09/220.30  |- mesh__recordOriginator mesh__D011987 SH
% 220.09/220.30  |- skos__hiddenLabel mesh__D011987 Receptor, Corticosteroid
% 220.09/220.30  |- mesh__dateRevised mesh__D011987 1995-06-08
% 220.09/220.30  |- skos__prefLabel mesh__D011987 Receptors, Steroid
% 220.09/220.30  |- rdf__type mesh__D011987sskos__Concept
% 220.09/220.30  |- skos__altLabel mesh__D011987 Corticosteroid Receptors
% 220.09/220.30  |- skos__historyNote mesh__D011987 Steroids %28%1966-1976%29%
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D011987 1998
% 220.09/220.30  |- mesh__historyNote mesh__D011987
% 220.09/220.30       77; RECEPTORS, CORTICOSTEROID was see RECEPTORS, GLUCOCORTICOID 1984-93; CORTICOSTEROID RECEPTORS was see RECEPTORS, GLUCOCORTICOID 1993%A%  
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D011987 1996
% 220.09/220.30  |- mesh__recordMaintainer mesh__D011987 KEV
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D011987 1999
% 220.09/220.30  |- skos__broader mesh__D011987smesh__D014157
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D011987 2000
% 220.09/220.30  |- mesh__recordOriginator mesh__D044363 lkt
% 220.09/220.30  |- mesh__historyNote mesh__D044363
% 220.09/220.30       2004; for FERTILITY CONTROL, POSTCOITAL use CONTRACEPTIVES, POSTCOITAL 1980-2003%A%  
% 220.09/220.30  |- skos__historyNote mesh__D044363 Contraceptive Agents %28%1968-2003%29%
% 220.09/220.30  |- mesh__recordMaintainer mesh__D044363 lkt
% 220.09/220.30  |- skos__related mesh__D044363smesh__D003281
% 220.09/220.30  |- skos__prefLabel mesh__D044363 Contraception, Postcoital
% 220.09/220.30  |- mesh__dateEstablished mesh__D044363 2004-01-01
% 220.09/220.30  |- mesh__recordAuthorizer mesh__D044363 sjn
% 220.09/220.30  |- skos__scopeNote mesh__D044363
% 220.09/220.30       Means of postcoital interception to avoid pregnancy, such as the administration of POSTCOITAL CONTRACEPTIVES or the morning-after pill to prevent FERTILIZATION of an egg or implantation of a fertilized egg %28%OVUM IMPLANTATION%29%.%A%    
% 220.09/220.30  |- skos__broader mesh__D044363smesh__D003267
% 220.09/220.30  |- skos__altLabel mesh__D044363 Fertility Control, Postcoital
% 220.09/220.30  |- skos__hiddenLabel mesh__D044363 Postcoital Contraception
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D044363 2006
% 220.09/220.30  |- mesh__publicMeSHNote mesh__D044363
% 220.09/220.30       2004; for FERTILITY CONTROL, POSTCOITAL see CONTRACEPTIVES, POSTCOITAL 1980-2003%A%  
% 220.09/220.30  |- mesh__dateRevised mesh__D044363 2005-06-30
% 220.09/220.30  |- rdf__type mesh__D044363sskos__Concept
% 220.09/220.30  |- skos__historyNote mesh__D044363
% 220.09/220.30       Contraceptives, Postcoital %28%1974-2003%29%
% 220.09/220.30  |- skos__hiddenLabel mesh__D044363 Postcoital Fertility Control
% 220.09/220.30  |- skos__annotation mesh__D044363
% 220.09/220.30       for postcoital douching use CONTRACEPTION, POSTCOITAL and VAGINAL DOUCHING%A%  
% 220.09/220.30  |- skos__hiddenLabel mesh__D044363 Control, Postcoital Fertility
% 220.09/220.30  |- mesh__dateCreated mesh__D044363 2003-07-09
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D011189 2005
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D011189 2004
% 220.09/220.30  |- skos__prefLabel mesh__D011189 Potassium Chloride
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D011189 2006
% 220.09/220.30  |- mesh__dateCreated mesh__D011189 1999-01-01
% 220.09/220.30  |- mesh__publicMeSHNote mesh__D011189 66   
% 220.09/220.30  |- mesh__recordMaintainer mesh__D011189 jmp
% 220.09/220.30  |- skos__broader mesh__D011189smesh__D002712
% 220.09/220.30  |- skos__scopeNote mesh__D011189
% 220.09/220.30       Potassium chloride. A white crystal or crystalline powder used as an electrolyte replenisher, in the treatment of hypokalemia, in buffer solutions, and in fertilizers and explosives.%A%    
% 220.09/220.30  |- mesh__recordAuthorizer mesh__D011189 sjn
% 220.09/220.30  |- skos__broader mesh__D011189smesh__D017680
% 220.09/220.30  |- rdf__type mesh__D011189sskos__Concept
% 220.09/220.30  |- mesh__historyNote mesh__D011189 66%28%64%29%   
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D011189 2002
% 220.09/220.30  |- skos__hiddenLabel mesh__D011189 Chloride, Potassium
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D011189 2003
% 220.09/220.30  |- mesh__dateEstablished mesh__D011189 1966-01-01
% 220.09/220.30  |- mesh__dateRevised mesh__D011189 2001-07-25
% 220.09/220.30  |- mesh__recordOriginator mesh__D011189 NLM
% 220.09/220.30  |- skos__altLabel mesh__D016672 Esophago-Pharyngeal Diverticulum
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Zenker Diverticula
% 220.09/220.30  |- skos__altLabel mesh__D016672 Pharyngoesophageal Pulsion Diverticula
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Diverticulum, Pharyngoesophageal Pulsion
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Diverticula, Pharyngoesophageal
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Pulsion Diverticulum, Pharyngoesophageal
% 220.09/220.30  |- mesh__recordAuthorizer mesh__D016672 sjn
% 220.09/220.30  |- skos__prefLabel mesh__D016672 Zenker Diverticulum
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Pulsion Diverticula, Pharyngoesophageal
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Zenkers Diverticulum
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Pharyngo Esophageal Diverticula
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D016672 2004
% 220.09/220.30  |- skos__altLabel mesh__D016672 Zenker%27%s Diverticulum
% 220.09/220.30  |- skos__altLabel mesh__D016672 Pharyngeal Diverticula
% 220.09/220.30  |- skos__scopeNote mesh__D016672
% 220.09/220.30       A DIVERTICULUM at the upper end of the ESOPHAGUS through the cricopharyngeal muscle at the junction of the PHARYNX and the esophagus.%A%    
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Diverticula, Zenker%27%s
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Pharyngo Esophageal Diverticulum
% 220.09/220.30  |- mesh__recordMaintainer mesh__D016672 lkt
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Diverticulum, Esophagopharyngeal
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Diverticula, Pharyngeal
% 220.09/220.30  |- skos__altLabel mesh__D016672 Pharyngoesophageal Diverticula
% 220.09/220.30  |- skos__altLabel mesh__D016672 Pharyngo-Esophageal Diverticulum
% 220.09/220.30  |- skos__altLabel mesh__D016672 Pharyngeal Diverticulum
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Diverticula, Esophago-Pharyngeal
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Zenkers Diverticula
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Esophago Pharyngeal Diverticula
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Diverticulum, Zenker
% 220.09/220.30  |- skos__historyNote mesh__D016672
% 220.09/220.30       Esophageal Diverticulum %28%1966-1991%29%
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Diverticula, Pharyngoesophageal Pulsion
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Diverticulum, Zenker%27%s
% 220.09/220.30  |- skos__annotation mesh__D016672
% 220.09/220.30       inflamm divertic or diverticulitis: coord IM with DIVERTICULITIS %28%IM%29%%A%  
% 220.09/220.30  |- skos__altLabel mesh__D016672 Zenker%27%s Diverticula
% 220.09/220.30  |- rdf__type mesh__D016672sskos__Concept
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D016672 2006
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Diverticulums, Esophagopharyngeal
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Diverticulum, Esophago-Pharyngeal
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Diverticulum, Pharyngoesophageal
% 220.09/220.30  |- mesh__publicMeSHNote mesh__D016672
% 220.09/220.30       2000; see ZENKER%27%s DIVERTICULUM 1992-1999; see ZENKER%27%s DIVERTICULUM 1992-1999%A%  
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D016672 2005
% 220.09/220.30  |- skos__broader mesh__D016672smesh__D004936
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Diverticula, Pharyngo-Esophageal
% 220.09/220.30  |- mesh__dateEstablished mesh__D016672 1992-01-01
% 220.09/220.30  |- mesh__historyNote mesh__D016672 2000%28%1992%29%   
% 220.09/220.30  |- skos__altLabel mesh__D016672 Pharyngoesophageal Diverticulum
% 220.09/220.30  |- skos__altLabel mesh__D016672 Esophago-Pharyngeal Diverticula
% 220.09/220.30  |- skos__altLabel mesh__D016672 Esophagopharyngeal Diverticulum
% 220.09/220.30  |- mesh__recordOriginator mesh__D016672 TGC
% 220.09/220.30  |- mesh__dateRevised mesh__D016672 2003-07-09
% 220.09/220.30  |- skos__altLabel mesh__D016672 Pharyngoesophageal Pulsion Diverticulum
% 220.09/220.30  |- mesh__dateCreated mesh__D016672 1991-02-11
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Esophago Pharyngeal Diverticulum
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Diverticulum, Pharyngo-Esophageal
% 220.09/220.30  |- skos__altLabel mesh__D016672 Pharyngo-Esophageal Diverticula
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Diverticulum, Pharyngeal
% 220.09/220.30  |- skos__hiddenLabel mesh__D016672 Esophagopharyngeal Diverticulums
% 220.09/220.30  |- skos__broader mesh__D002652smesh__D001519
% 220.09/220.30  |- mesh__recordMaintainer mesh__D002652 TGC
% 220.09/220.30  |- skos__historyNote mesh__D002652 Child Psychology %28%1966-1967%29%
% 220.09/220.30  |- mesh__historyNote mesh__D002652 68   
% 220.09/220.30  |- skos__altLabel mesh__D002652 Behavior, Child
% 220.09/220.30  |- mesh__dateEstablished mesh__D002652 1968-01-01
% 220.09/220.30  |- mesh__recordAuthorizer mesh__D002652 sjn
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D002652 2003
% 220.09/220.30  |- skos__prefLabel mesh__D002652 Child Behavior
% 220.09/220.30  |- skos__historyNote mesh__D002652 Behavior %28%1966-1967%29%
% 220.09/220.30  |- rdf__type mesh__D002652sskos__Concept
% 220.09/220.30  |- mesh__dateRevised mesh__D002652 2002-07-02
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D002652 2004
% 220.09/220.30  |- mesh__recordOriginator mesh__D002652 NLM
% 220.09/220.30  |- skos__scopeNote mesh__D002652
% 220.09/220.30       Any observable response or action of a child from 24 months through 12 years of age. For neonates or children younger than 24 months, INFANT BEHAVIOR is available.%A%    
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D002652 2005
% 220.09/220.30  |- skos__annotation mesh__D002652
% 220.09/220.30       check also tag CHILD or specific; INFANT BEHAVIOR is also available%A%  
% 220.09/220.30  |- mesh__publicMeSHNote mesh__D002652 68   
% 220.09/220.30  |- mesh__dateCreated mesh__D002652 1999-01-01
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D002652 2006
% 220.09/220.30  |- mesh__recordOriginator mesh__D012282 RC
% 220.09/220.30  |- skos__altLabel mesh__D012282 Infections, Rickettsia
% 220.09/220.30  |- rdf__type mesh__D012282sskos__Concept
% 220.09/220.30  |- mesh__recordAuthorizer mesh__D012282 sjn
% 220.09/220.30  |- mesh__dateEstablished mesh__D012282 1987-01-01
% 220.09/220.30  |- skos__broader mesh__D012282smesh__D012288
% 220.09/220.30  |- skos__prefLabel mesh__D012282 Rickettsia Infections
% 220.09/220.30  |- mesh__historyNote mesh__D012282 87   
% 220.09/220.30  |- mesh__publicMeSHNote mesh__D012282 87   
% 220.09/220.30  |- mesh__recordMaintainer mesh__D012282 ags
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D012282 2005
% 220.09/220.30  |- skos__hiddenLabel mesh__D012282 Infection, Rickettsia
% 220.09/220.30  |- skos__annotation mesh__D012282
% 220.09/220.30       gram-neg bact infect; GEN or unspecified; prefer specific infection as shown at the various RICKETTSIA species; infection by genus RICKETTSIA: do not confuse with RICKETTSIACEAE INFECTIONS %28%%22%infections with rickettsias of the Family RICKETTSIACEAE%22%%29%; Rickettsia conorii infection = BOUTONNEUSE FEVER; Rickettsia quintana infection = TRENCH FEVER%A%  
% 220.09/220.30  |- mesh__dateRevised mesh__D012282 2003-07-09
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D012282 2006
% 220.09/220.30  |- skos__hiddenLabel mesh__D012282 Rickettsia Infection
% 220.09/220.30  |- mesh__dateCreated mesh__D012282 1986-04-07
% 220.09/220.30  |- skos__historyNote mesh__D012282 Rickettsial Infections %28%1977-1986%29%
% 220.09/220.30  |- skos__scopeNote mesh__D012282 Infections by the genus RICKETTSIA.     
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D012282 2004
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D020714 2001
% 220.09/220.30  |- skos__scopeNote mesh__D020714
% 220.09/220.30       The highest dose of a biologically active agent given during a chronic study that will not reduce longevity from effects other than carcinogenicity. %28%from Lewis Dictionary of Toxicology, 1st ed%29%%A%    
% 220.09/220.30  |- skos__hiddenLabel mesh__D020714 Tolerated Dose, Maximum
% 220.09/220.30  |- mesh__recordOriginator mesh__D020714 adp
% 220.09/220.30  |- skos__broader mesh__D020714smesh__D018675
% 220.09/220.30  |- skos__broader mesh__D020714smesh__D002620
% 220.09/220.30  |- mesh__publicMeSHNote mesh__D020714 2000   
% 220.09/220.30  |- skos__hiddenLabel mesh__D020714 Doses, Maximally Tolerated
% 220.09/220.30  |- skos__hiddenLabel mesh__D020714 Tolerated Dose, Maximal
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D020714 2004
% 220.09/220.30  |- mesh__dateEstablished mesh__D020714 2000-01-01
% 220.09/220.30  |- mesh__dateRevised mesh__D020714 2000-06-22
% 220.09/220.30  |- skos__hiddenLabel mesh__D020714 Tolerated Doses, Maximally
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D020714 2003
% 220.09/220.30  |- skos__altLabel mesh__D020714 Maximal Tolerated Dose
% 220.09/220.30  |- skos__hiddenLabel mesh__D020714 Dose, Maximal Tolerated
% 220.09/220.30  |- rdf__type mesh__D020714sskos__Concept
% 220.09/220.30  |- skos__hiddenLabel mesh__D020714 Tolerated Dose, Maximally
% 220.09/220.30  |- skos__hiddenLabel mesh__D020714 Doses, Maximal Tolerated
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D020714 2006
% 220.09/220.30  |- mesh__historyNote mesh__D020714 2000   
% 220.09/220.30  |- skos__prefLabel mesh__D020714 Maximum Tolerated Dose
% 220.09/220.30  |- skos__hiddenLabel mesh__D020714 Dose, Maximum Tolerated
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D020714 2002
% 220.09/220.30  |- skos__hiddenLabel mesh__D020714 Tolerated Doses, Maximum
% 220.09/220.30  |- skos__altLabel mesh__D020714 Maximally Tolerated Dose
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D020714 2005
% 220.09/220.30  |- skos__hiddenLabel mesh__D020714 Dose, Maximally Tolerated
% 220.09/220.30  |- skos__hiddenLabel mesh__D020714 Tolerated Doses, Maximal
% 220.09/220.30  |- skos__hiddenLabel mesh__D020714 Doses, Maximum Tolerated
% 220.09/220.30  |- skos__hiddenLabel mesh__D020714 Maximum Tolerated Doses
% 220.09/220.30  |- mesh__recordAuthorizer mesh__D020714 sjn
% 220.09/220.30  |- mesh__dateCreated mesh__D020714 1999-11-04
% 220.09/220.30  |- skos__hiddenLabel mesh__D020714 Maximally Tolerated Doses
% 220.09/220.30  |- skos__hiddenLabel mesh__D020714 Maximal Tolerated Doses
% 220.09/220.30  |- mesh__recordMaintainer mesh__D020714 nns
% 220.09/220.30  |- skos__hiddenLabel mesh__D006245 Test, Hardness
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006245 1996
% 220.09/220.30  |- mesh__recordMaintainer mesh__D006245 TAP
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006245 2006
% 220.09/220.30  |- mesh__recordOriginator mesh__D006245 NLM
% 220.09/220.30  |- mesh__dateCreated mesh__D006245 1999-01-01
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006245 1997
% 220.09/220.30  |- mesh__dateRevised mesh__D006245 1992-05-15
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006245 1994
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006245 2003
% 220.09/220.30  |- skos__annotation mesh__D006245 NIM   
% 220.09/220.30  |- mesh__publicMeSHNote mesh__D006245 72   
% 220.09/220.30  |- mesh__historyNote mesh__D006245 72%28%64%29%   
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006245 2000
% 220.09/220.30  |- skos__broader mesh__D006245smesh__D008919
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006245 1995
% 220.09/220.30  |- skos__hiddenLabel mesh__D006245 Hardness Test
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006245 2004
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006245 2001
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006245 1998
% 220.09/220.30  |- rdf__type mesh__D006245sskos__Concept
% 220.09/220.30  |- mesh__dateEstablished mesh__D006245 1972-01-01
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006245 1999
% 220.09/220.30  |- mesh__recordAuthorizer mesh__D006245 PLS
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006245 2005
% 220.09/220.30  |- skos__prefLabel mesh__D006245 Hardness Tests
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006245 1993
% 220.09/220.30  |- skos__hiddenLabel mesh__D006245 Tests, Hardness
% 220.09/220.30  |- skos__broader mesh__D006245smesh__D006244
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D006245 2002
% 220.09/220.30  |- skos__historyNote mesh__D011988
% 220.09/220.30       Receptors, Endogenous Substances %28%1973-1986%29%
% 220.09/220.30  |- rdf__type mesh__D011988sskos__Concept
% 220.09/220.30  |- skos__altLabel mesh__D011988 Receptors, T3
% 220.09/220.30  |- skos__altLabel mesh__D011988 T3 Receptors
% 220.09/220.30  |- mesh__activeMeSHYear mesh__D011988 2005
% 220.09/220.30  |- skos__broader mesh__D011988smesh__D018160
% 220.09/220.30  |- mesh__dateRevised mesh__D011988 2002-07-03
% 220.09/220.30  |- skos__broader mesh__D011988smesh__D014157
% 220.09/220.30  |- skos__altLabel mesh__D011988 Thyroid Hormone Receptor
% 220.09/220.30  |- mesh__recordMaintainer mesh__D011988 lkt
% 220.09/220.30  |- skos__related mesh__D011988smesh__D018382
% 220.09/220.30  |- skos__altLabel mesh__D011988 T3 Receptor
% 220.09/220.30  |- mesh__onlineNote mesh__D011988
% 220.09/220.30       use RECEPTORS, THYROID HORMONE %28%NM%29% to search PROTO-ONCOGENE PROTEIN ERBA 1987-93%A%  
% 220.09/220.30  |- skos__broader mesh__D011988smesh__D011518
% 220.09/220.31  |- mesh__recordOriginator mesh__D011988 SH
% 220.09/220.31  |- skos__altLabel mesh__D011988 T4 Receptor
% 220.09/220.31  |- skos__altLabel mesh__D011988 MIT Receptors
% 220.09/220.31  |- skos__prefLabel mesh__D011988 Receptors, Thyroid Hormone
% 220.09/220.31  |- mesh__dateCreated mesh__D011988 1986-03-31
% 220.09/220.31  |- mesh__historyNote mesh__D011988
% 220.09/220.31       87; PROTO-ONCOGENE PROTEIN ERBA was %28%NM%29% 1987-93   
% 220.09/220.31  |- mesh__dateEstablished mesh__D011988 1987-01-01
% 220.09/220.31  |- skos__altLabel mesh__D011988 DIT Receptors
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D011988 2004
% 220.09/220.31  |- skos__altLabel mesh__D011988 T4 Receptors
% 220.09/220.31  |- skos__altLabel mesh__D011988 Thyroxine Receptors
% 220.09/220.31  |- skos__historyNote mesh__D011988 Triiodothyronine %28%1966-1986%29%
% 220.09/220.31  |- skos__altLabel mesh__D011988 Receptors, MIT
% 220.09/220.31  |- skos__altLabel mesh__D011988 Receptors, DIT
% 220.09/220.31  |- skos__scopeNote mesh__D011988
% 220.09/220.31       Specific high affinity binding proteins for THYROID HORMONES in target cells. They are usually found in the nucleus and regulate DNA transcription. These receptors are activated by hormones that leads to transcription, cell differentiation, and growth suppression. Thyroid hormone receptors are encoded by two genes %28%GENES, ERBA%29%: erbA-alpha and erbA-beta for alpha and beta thyroid hormone receptors, respectively.%A%    
% 220.09/220.31  |- skos__altLabel mesh__D011988 Monoiodotyrosine Receptors
% 220.09/220.31  |- skos__historyNote mesh__D011988 Thyroid Hormones %28%1966-1986%29%
% 220.09/220.31  |- skos__annotation mesh__D011988
% 220.09/220.31       coord IM with specific thyroid hormone %28%IM%29%; DF: RECEPT THYROID HORMONE%A%  
% 220.09/220.31  |- skos__altLabel mesh__D011988 Diiodotyrosine Receptors
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D011988 2003
% 220.09/220.31  |- skos__altLabel mesh__D011988 Thyroxine Receptor
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D011988 2006
% 220.09/220.31  |- skos__altLabel mesh__D011988 Receptors, T4
% 220.09/220.31  |- skos__altLabel mesh__D011988 Triiodothyronine Receptors
% 220.09/220.31  |- mesh__publicMeSHNote mesh__D011988
% 220.09/220.31       87; PROTO-ONCOGENE PROTEIN ERBA was indexed under PROTO-ONCOGENE PROTEINS 1987-93%A%  
% 220.09/220.31  |- skos__altLabel mesh__D011988 Thyroid Hormone Receptors
% 220.09/220.31  |- skos__altLabel mesh__D011988 Diiodotyrosine Receptor
% 220.09/220.31  |- skos__historyNote mesh__D011988 Thyroxine %28%1966-1986%29%
% 220.09/220.31  |- mesh__recordAuthorizer mesh__D011988 sjn
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D044364 2004
% 220.09/220.31  |- skos__prefLabel mesh__D044364 Vaginal Douching
% 220.09/220.31  |- mesh__publicMeSHNote mesh__D044364 2004   
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D044364 2005
% 220.09/220.31  |- mesh__historyNote mesh__D044364 2004   
% 220.09/220.31  |- skos__hiddenLabel mesh__D044364 Lavage, Vaginal
% 220.09/220.31  |- skos__hiddenLabel mesh__D044364 Irrigation, Vaginal
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D044364 2006
% 220.09/220.31  |- mesh__dateEstablished mesh__D044364 2004-01-01
% 220.09/220.31  |- rdf__type mesh__D044364sskos__Concept
% 220.09/220.31  |- skos__annotation mesh__D044364
% 220.09/220.31       for postcoital douching use CONTRACEPTION, POSTCOITAL and VAGINAL DOUCHING%A%  
% 220.09/220.31  |- skos__historyNote mesh__D044364 Vagina %28%1973-2003%29%
% 220.09/220.31  |- skos__altLabel mesh__D044364 Vaginal Lavage
% 220.09/220.31  |- skos__altLabel mesh__D044364 Vaginal Irrigation
% 220.09/220.31  |- skos__scopeNote mesh__D044364
% 220.09/220.31       The washing of the VAGINA cavity or surface with a solution. Agents or drugs can be added to the irrigation solution.%A%    
% 220.09/220.31  |- mesh__dateCreated mesh__D044364 2003-07-09
% 220.09/220.31  |- skos__broader mesh__D044364smesh__D007507
% 220.09/220.31  |- skos__historyNote mesh__D044364 Irrigation %28%1973-2003%29%
% 220.09/220.31  |- skos__hiddenLabel mesh__D044364 Douching, Vaginal
% 220.09/220.31  |- skos__scopeNote mesh__D016673
% 220.09/220.31       A subfamily of the Old World monkeys, CERCOPITHECIDAE, that inhabits the forests of Africa and Asia. The genera COLOBUS %28%Procolobus; colobus%29%, Nasalis %28%proboscis monkey%29%, Presbytis %28%Semnopithecus; leaf monkey%29%, Pygathrix %28%Rhinopithecus; snub-nosed monkey%29%, and Simias %28%pig-tailed langur%29% all belong to this subfamily.%A%    
% 220.09/220.31  |- rdf__type mesh__D016673sskos__Concept
% 220.09/220.31  |- skos__broader mesh__D016673smesh__D002520
% 220.09/220.31  |- mesh__historyNote mesh__D016673 92   
% 220.09/220.31  |- mesh__recordMaintainer mesh__D016673 ags
% 220.09/220.31  |- mesh__publicMeSHNote mesh__D016673 92   
% 220.09/220.31  |- mesh__dateEstablished mesh__D016673 1992-01-01
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D016673 2006
% 220.09/220.31  |- mesh__dateRevised mesh__D016673 2005-06-30
% 220.09/220.31  |- mesh__recordOriginator mesh__D016673 MXR
% 220.09/220.31  |- mesh__dateCreated mesh__D016673 1991-01-24
% 220.09/220.31  |- skos__annotation mesh__D016673
% 220.09/220.31       a subfamily of Old World monkeys; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 220.09/220.31  |- skos__prefLabel mesh__D016673 Colobinae
% 220.09/220.31  |- mesh__recordAuthorizer mesh__D016673 sjn
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002653 1998
% 220.09/220.31  |- skos__prefLabel mesh__D002653 Child Behavior Disorders
% 220.09/220.31  |- skos__hiddenLabel mesh__D002653 Behavior Disorders, Child
% 220.09/220.31  |- skos__annotation mesh__D002653 check also tag CHILD or specific   
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002653 1999
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002653 2003
% 220.09/220.31  |- mesh__recordAuthorizer mesh__D002653 SJN
% 220.09/220.31  |- rdf__type mesh__D002653sskos__Concept
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002653 2004
% 220.09/220.31  |- skos__scopeNote mesh__D002653
% 220.09/220.31       Disturbances considered to be pathological based on age and stage appropriateness, e.g., conduct disturbances and anaclitic depression. This concept does not include psychoneuroses, psychoses, or personality disorders with fixed patterns.%A%    
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002653 2000
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002653 2005
% 220.09/220.31  |- skos__broader mesh__D002653smesh__D019952
% 220.09/220.31  |- skos__hiddenLabel mesh__D002653 Disorders, Child Behavior
% 220.09/220.31  |- mesh__recordMaintainer mesh__D002653 JLS
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002653 2001
% 220.09/220.31  |- mesh__dateCreated mesh__D002653 1999-01-01
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002653 2006
% 220.09/220.31  |- mesh__dateRevised mesh__D002653 1997-06-20
% 220.09/220.31  |- mesh__recordOriginator mesh__D002653 NLM
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002653 2002
% 220.09/220.31  |- skos__scopeNote mesh__D012283
% 220.09/220.31       A species of gram-negative, aerobic bacteria that is the etiologic agent of epidemic typhus fever acquired through contact with lice %28%TYPHUS, EPIDEMIC LOUSE-BORNE%29% as well as Brill%27%s disease.%A%    
% 220.09/220.31  |- mesh__recordOriginator mesh__D012283 NLM
% 220.09/220.31  |- mesh__dateRevised mesh__D012283 2005-06-30
% 220.09/220.31  |- skos__broader mesh__D012283smesh__D012281
% 220.09/220.31  |- mesh__recordMaintainer mesh__D012283 SYSTEM
% 220.09/220.31  |- skos__annotation mesh__D012283
% 220.09/220.31       infection = TYPHUS, EPIDEMIC LOUSE-BORNE   
% 220.09/220.31  |- rdf__type mesh__D012283sskos__Concept
% 220.09/220.31  |- mesh__recordAuthorizer mesh__D012283 sjn
% 220.09/220.31  |- mesh__dateCreated mesh__D012283 1999-01-01
% 220.09/220.31  |- skos__prefLabel mesh__D012283 Rickettsia prowazekii
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D012283 2006
% 220.09/220.31  |- mesh__dateEstablished mesh__D006246 1991-01-01
% 220.09/220.31  |- skos__annotation mesh__D006246 do not confuse with HARMINE   
% 220.09/220.31  |- mesh__dateRevised mesh__D006246 2004-07-07
% 220.09/220.31  |- skos__altLabel mesh__D006246 Harmidine
% 220.09/220.31  |- rdf__type mesh__D006246sskos__Concept
% 220.09/220.31  |- skos__scopeNote mesh__D006246
% 220.09/220.31       A beta-carboline alkaloid isolated from seeds of PEGANUM.%A%    
% 220.09/220.31  |- skos__prefLabel mesh__D006246 Harmaline
% 220.09/220.31  |- mesh__recordAuthorizer mesh__D006246 sjn
% 220.09/220.31  |- skos__historyNote mesh__D006246 Alkaloids %28%1970-1974%29%
% 220.09/220.31  |- mesh__publicMeSHNote mesh__D006246
% 220.09/220.31       91; was see under ALKALOIDS 1975-90   
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D006246 2005
% 220.09/220.31  |- mesh__recordOriginator mesh__D006246 NLM
% 220.09/220.31  |- skos__broader mesh__D006246smesh__D026121
% 220.09/220.31  |- mesh__dateCreated mesh__D006246 1974-11-19
% 220.09/220.31  |- skos__historyNote mesh__D006246 Pyridines %28%1972-1974%29%
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D006246 2006
% 220.09/220.31  |- skos__altLabel mesh__D006246 Dihydroharmine
% 220.09/220.31  |- mesh__recordMaintainer mesh__D006246 ssb
% 220.09/220.31  |- skos__broader mesh__D006246smesh__D002243
% 220.09/220.31  |- mesh__historyNote mesh__D006246
% 220.09/220.31       91%28%75%29%; was see under ALKALOIDS 1975-90   
% 220.09/220.31  |- skos__historyNote mesh__D006246 Indoles %28%1970-1974%29%
% 220.09/220.31  |- skos__altLabel mesh__D011989 Thyrotropin Receptor
% 220.09/220.31  |- rdf__type mesh__D011989sskos__Concept
% 220.09/220.31  |- skos__historyNote mesh__D011989
% 220.09/220.31       Receptors, Endogenous Substances %28%1973-1986%29%
% 220.09/220.31  |- skos__scopeNote mesh__D011989
% 220.09/220.31       Cell surface proteins that bind pituitary THYROTROPIN %28%also named thyroid stimulating hormone or TSH%29% and trigger intracellular changes of the target cells. TSH receptors are present in the nervous system and on target cells in the thyroid gland. Autoantibodies to TSH receptors are implicated in thyroid diseases such as GRAVES DISEASE and Hashimoto disease %28%THYROIDITIS, AUTOIMMUNE%29%.%A%    
% 220.09/220.31  |- skos__annotation mesh__D011989 DF: RECEPT TSH   
% 220.09/220.31  |- skos__broader mesh__D011989smesh__D011979
% 220.09/220.31  |- skos__prefLabel mesh__D011989 Receptors, Thyrotropin
% 220.09/220.31  |- skos__hiddenLabel mesh__D011989 Receptor, Thyrotropin
% 220.09/220.31  |- mesh__recordMaintainer mesh__D011989 sjn
% 220.09/220.31  |- skos__altLabel mesh__D011989 TSH Receptor
% 220.09/220.31  |- mesh__dateCreated mesh__D011989 1986-03-31
% 220.09/220.31  |- skos__altLabel mesh__D011989 Thyroid Stimulating Hormone Receptor
% 220.09/220.31  |- mesh__dateEstablished mesh__D011989 1987-01-01
% 220.09/220.31  |- skos__altLabel mesh__D011989 TSH Receptors
% 220.09/220.31  |- skos__altLabel mesh__D011989 LATS Receptors
% 220.09/220.31  |- skos__altLabel mesh__D011989 Receptor, LATS Immunoglobulins
% 220.09/220.31  |- skos__historyNote mesh__D011989 Thyrotropin %28%1966-1986%29%
% 220.09/220.31  |- mesh__publicMeSHNote mesh__D011989
% 220.09/220.31       1987; for RECEPTORS, LONG ACTING THYROID STIMULATOR see RECEPTORS, THYROID HORMONE 1993-2002%A%  
% 220.09/220.31  |- mesh__historyNote mesh__D011989
% 220.09/220.31       1987; for RECEPTORS, LONG ACTING THYROID STIMULATOR use RECEPTORS, THYROID HORMONE 1993-2002%A%  
% 220.09/220.31  |- skos__altLabel mesh__D011989 Receptors, TSH
% 220.09/220.31  |- skos__altLabel mesh__D011989 Receptors, LATS
% 220.09/220.31  |- skos__altLabel mesh__D011989 Thyroid Stimulating Hormone Receptors
% 220.09/220.31  |- skos__altLabel mesh__D011989 Receptors, Thyroid Stimulating Hormone
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D011989 2006
% 220.09/220.31  |- mesh__dateRevised mesh__D011989 2005-07-01
% 220.09/220.31  |- mesh__recordAuthorizer mesh__D011989 sjn
% 220.09/220.31  |- skos__hiddenLabel mesh__D011989 Receptor, TSH
% 220.09/220.31  |- mesh__recordOriginator mesh__D011989 SH
% 220.09/220.31  |- skos__broader mesh__D011989smesh__D018013
% 220.09/220.31  |- skos__altLabel mesh__D011989 Thyrotropin Receptors
% 220.09/220.31  |- skos__hiddenLabel mesh__D011989
% 220.09/220.31       Receptors, Long Acting Thyroid Stimulator
% 220.09/220.31  |- skos__hiddenLabel mesh__D044365 G Protein, G12 Subunit
% 220.09/220.31  |- skos__altLabel mesh__D044365 G-Protein, G12 Subunit
% 220.09/220.31  |- skos__hiddenLabel mesh__D044365 G13 G Protein
% 220.09/220.31  |- skos__hiddenLabel mesh__D044365 G12 Subunit G-Protein
% 220.09/220.31  |- skos__hiddenLabel mesh__D044365 alpha Protein, G12
% 220.09/220.31  |- skos__altLabel mesh__D044365 G12 alpha Protein
% 220.09/220.31  |- skos__hiddenLabel mesh__D044365 alpha12 Protein, G
% 220.09/220.31  |- skos__hiddenLabel mesh__D044365 Subunit G-Protein, G12
% 220.09/220.31  |- skos__altLabel mesh__D044365 G-Protein, G12-G13 alpha Family
% 220.09/220.31  |- mesh__historyNote mesh__D044365
% 220.09/220.31       2004; use GTP-BINDING PROTEIN, G12-13 ALPHA SUBUNITS %28%NM%29% 1996-2003%A%  
% 220.09/220.31  |- mesh__recordOriginator mesh__D044365 jmp
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D044365 2006
% 220.09/220.31  |- skos__altLabel mesh__D044365 G13 Protein
% 220.09/220.31  |- skos__hiddenLabel mesh__D044365 GTP Binding Protein alpha Subunit, G12
% 220.09/220.31  |- skos__altLabel mesh__D044365 Galpha12 Protein
% 220.09/220.31  |- skos__scopeNote mesh__D044365
% 220.09/220.31       A ubiquitously expressed family of heterotrimeric GTP-binding protein alpha subunits that signal through interactions with a variety of second messengers as GTPASE-ACTIVATING PROTEINS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; and HEAT SHOCK PROTEINS. The G12-G13 part of the name is also spelled G12/G13.%A%    
% 220.09/220.31  |- skos__altLabel mesh__D044365 G alpha13 Protein
% 220.09/220.31  |- mesh__dateEstablished mesh__D044365 2004-01-01
% 220.09/220.31  |- rdf__type mesh__D044365sskos__Concept
% 220.09/220.31  |- mesh__dateRevised mesh__D044365 2004-07-07
% 220.09/220.31  |- mesh__publicMeSHNote mesh__D044365
% 220.09/220.31       2004; G ALPHA12 PROTEIN was indexed under HETEROTRIMERIC GTP-BINDING PROTEINS 2000-2003; G13 PROTEIN was indexed under DNA-BINDING PROTEINS 1996-2003; G%28%13%29% PROTEIN was indexed under HETEROTRIMERIC GTP-BINDING PROTEINS 2000-2003 %26% GTP-BINDING PROTEINS 1998-1999%A%  
% 220.09/220.31  |- skos__hiddenLabel mesh__D044365 alpha13 Protein, G
% 220.09/220.31  |- skos__altLabel mesh__D044365 G%28%13%29% Protein
% 220.09/220.31  |- skos__hiddenLabel mesh__D044365 G13 Subunit G-Protein
% 220.09/220.31  |- skos__altLabel mesh__D044365 G alpha12 Protein
% 220.09/220.31  |- mesh__recordMaintainer mesh__D044365 jmp
% 220.09/220.31  |- skos__hiddenLabel mesh__D044365 G Protein, G13 Subunit
% 220.09/220.31  |- skos__hiddenLabel mesh__D044365
% 220.09/220.31       GTP Binding Protein alpha Subunits, G12 G13
% 220.09/220.31  |- skos__altLabel mesh__D044365 G13 G-Protein
% 220.09/220.31  |- skos__prefLabel mesh__D044365
% 220.09/220.31       GTP-Binding Protein alpha Subunits, G12-G13
% 220.09/220.31  |- skos__hiddenLabel mesh__D044365 Protein, G12
% 220.09/220.31  |- skos__broader mesh__D044365smesh__D044385
% 220.09/220.31  |- mesh__recordAuthorizer mesh__D044365 sjn
% 220.09/220.31  |- skos__historyNote mesh__D044365 GTP-Binding Proteins %28%1991-2003%29%
% 220.09/220.31  |- skos__altLabel mesh__D044365 G-Protein, G13 Subunit
% 220.09/220.31  |- skos__altLabel mesh__D044365 Galpha13 Protein
% 220.09/220.31  |- skos__hiddenLabel mesh__D044365 G Protein, G12 G13 alpha Subunits
% 220.09/220.31  |- mesh__dateCreated mesh__D044365 2003-07-09
% 220.09/220.31  |- skos__altLabel mesh__D044365 G12 Protein
% 220.09/220.31  |- skos__hiddenLabel mesh__D044365 G Protein, G12 G13 alpha Family
% 220.09/220.31  |- skos__altLabel mesh__D044365 G-Protein, G12-G13 alpha Subunits
% 220.09/220.31  |- skos__hiddenLabel mesh__D044365 Subunit G-Protein, G13
% 220.09/220.31  |- skos__historyNote mesh__D044365
% 220.09/220.31       Heterotrimeric GTP-Binding Proteins %28%2000-2003%29%
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D044365 2005
% 220.09/220.31  |- skos__hiddenLabel mesh__D044365 G-Protein, G13
% 220.09/220.31  |- skos__hiddenLabel mesh__D044365 GTP Binding Protein alpha Subunit, G13
% 220.09/220.31  |- mesh__recordAuthorizer mesh__D016674 sjn
% 220.09/220.31  |- mesh__recordMaintainer mesh__D016674 ags
% 220.09/220.31  |- mesh__historyNote mesh__D016674 92   
% 220.09/220.31  |- skos__annotation mesh__D016674
% 220.09/220.31       a family with only one genus %28%HYLOBATES%29%: gibbon, not monkey %26% not ape; IM; qualif permitted; diseases: coord IM with specific dis /vet %28%IM%29%%A%  
% 220.09/220.31  |- mesh__dateCreated mesh__D016674 1991-01-25
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D016674 2006
% 220.09/220.31  |- mesh__recordOriginator mesh__D016674 MXR
% 220.09/220.31  |- skos__broader mesh__D016674smesh__D051079
% 220.09/220.31  |- skos__scopeNote mesh__D016674
% 220.09/220.31       A family of the suborder HAPLORHINI comprising only one genus, HYLOBATES %28%also called Nomascus or Symphalangus%29%.%A%    
% 220.09/220.31  |- mesh__publicMeSHNote mesh__D016674 92   
% 220.09/220.31  |- skos__historyNote mesh__D016674 Pongidae %28%1967-1991%29%
% 220.09/220.31  |- skos__prefLabel mesh__D016674 Hylobatidae
% 220.09/220.31  |- mesh__dateEstablished mesh__D016674 1992-01-01
% 220.09/220.31  |- mesh__dateRevised mesh__D016674 2005-06-30
% 220.09/220.31  |- rdf__type mesh__D016674sskos__Concept
% 220.09/220.31  |- rdf__type mesh__D002654sskos__Concept
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002654 2004
% 220.09/220.31  |- skos__hiddenLabel mesh__D002654 Support, Child
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002654 2001
% 220.09/220.31  |- skos__hiddenLabel mesh__D002654 Care, Child
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002654 2005
% 220.09/220.31  |- mesh__recordOriginator mesh__D002654 NLM
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002654 2002
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002654 1996
% 220.09/220.31  |- mesh__dateCreated mesh__D002654 1999-01-01
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002654 2006
% 220.09/220.31  |- mesh__dateRevised mesh__D002654 1992-05-07
% 220.09/220.31  |- skos__altLabel mesh__D002654 Puericulture
% 220.09/220.31  |- skos__annotation mesh__D002654
% 220.09/220.31       in home or institution; check also tag CHILD or specific   
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002654 1997
% 220.09/220.31  |- skos__related mesh__D002654smesh__D007224
% 220.09/220.31  |- skos__scopeNote mesh__D002654
% 220.09/220.31       Care of children in the home or institution.     
% 220.09/220.31  |- skos__related mesh__D002654smesh__D002668
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002654 1993
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002654 1998
% 220.09/220.31  |- mesh__recordMaintainer mesh__D002654 TGC
% 220.09/220.31  |- skos__prefLabel mesh__D002654 Child Care
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002654 1994
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002654 1999
% 220.09/220.31  |- skos__broader mesh__D002654smesh__D006296
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002654 2003
% 220.09/220.31  |- mesh__recordAuthorizer mesh__D002654 PLS
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002654 1995
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D002654 2000
% 220.09/220.31  |- mesh__recordMaintainer mesh__D012284 SYSTEM
% 220.09/220.31  |- rdf__type mesh__D012284sskos__Concept
% 220.09/220.31  |- skos__scopeNote mesh__D012284
% 220.09/220.31       A species of gram-negative, aerobic bacteria that is the etiologic agent of ROCKY MOUNTAIN SPOTTED FEVER. Its cells are slightly smaller and more uniform in size than those of RICKETTSIA PROWAZEKII.%A%    
% 220.09/220.31  |- mesh__recordOriginator mesh__D012284 NLM
% 220.09/220.31  |- mesh__dateRevised mesh__D012284 2005-06-30
% 220.09/220.31  |- skos__prefLabel mesh__D012284 Rickettsia rickettsii
% 220.09/220.31  |- skos__broader mesh__D012284smesh__D012281
% 220.09/220.31  |- mesh__recordAuthorizer mesh__D012284 sjn
% 220.09/220.31  |- mesh__dateCreated mesh__D012284 1999-01-01
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D012284 2006
% 220.09/220.31  |- skos__annotation mesh__D012284
% 220.09/220.31       infection = ROCKY MOUNTAIN SPOTTED FEVER   
% 220.09/220.31  |- skos__broader mesh__D039421smesh__D015703
% 220.09/220.31  |- mesh__dateEstablished mesh__D039421 2003-01-01
% 220.09/220.31  |- mesh__dateCreated mesh__D039421 2002-07-02
% 220.09/220.31  |- mesh__dateRevised mesh__D039421 2005-06-30
% 220.09/220.31  |- mesh__recordAuthorizer mesh__D039421 sjn
% 220.09/220.31  |- skos__hiddenLabel mesh__D039421 Glycoprotein Ia, Platelet
% 220.09/220.31  |- skos__hiddenLabel mesh__D039421 Antigen, CD49b
% 220.09/220.31  |- skos__hiddenLabel mesh__D039421 alpha Chain, VLA-2
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D039421 2006
% 220.09/220.31  |- skos__altLabel mesh__D039421 Antigens, CD49b
% 220.09/220.31  |- skos__hiddenLabel mesh__D039421 Chain, VLA-2 alpha
% 220.09/220.31  |- mesh__publicMeSHNote mesh__D039421
% 220.09/220.31       2003; INTEGRIN ALPHA2 was indexed under ANTIGENS, CD 1996-2002 %26% under INTEGRINS 1993-1995%A%  
% 220.09/220.31  |- skos__scopeNote mesh__D039421
% 220.09/220.31       An integrin alpha subunit that primarily combines with INTEGRIN BETA1 to form the INTEGRIN ALPHA2BETA1 heterodimer. It contains a domain which has homology to collagen-binding domains found in von Willebrand factor.%A%    
% 220.09/220.31  |- skos__hiddenLabel mesh__D039421 alpha2, Integrin
% 220.09/220.31  |- skos__altLabel mesh__D039421 VLA-2 alpha Chain
% 220.09/220.31  |- skos__altLabel mesh__D039421 Platelet Glycoprotein Ia
% 220.09/220.31  |- skos__altLabel mesh__D039421 GPIa
% 220.09/220.31  |- skos__altLabel mesh__D039421 CD49b Antigen
% 220.09/220.31  |- skos__hiddenLabel mesh__D039421 VLA 2 alpha Chain
% 220.09/220.31  |- skos__historyNote mesh__D039421 Antigens, CD %28%1996-2002%29%
% 220.09/220.31  |- mesh__recordOriginator mesh__D039421 MDJ
% 220.09/220.31  |- skos__historyNote mesh__D039421 Integrins %28%1993-1995%29%
% 220.09/220.31  |- mesh__recordMaintainer mesh__D039421 ssb
% 220.09/220.31  |- skos__hiddenLabel mesh__D039421 Integrin, alpha2
% 220.09/220.31  |- skos__altLabel mesh__D039421 CD49b Antigens
% 220.09/220.31  |- skos__prefLabel mesh__D039421 Integrin alpha2
% 220.09/220.31  |- skos__altLabel mesh__D039421 alpha2 Integrin
% 220.09/220.31  |- rdf__type mesh__D039421sskos__Concept
% 220.09/220.31  |- mesh__historyNote mesh__D039421
% 220.09/220.31       2003; use INTEGRIN ALPHA2 %28%NM%29% 1993-2002   
% 220.09/220.31  |- skos__broader mesh__D039421smesh__D039001
% 220.09/220.31  |- mesh__historyNote mesh__D006247
% 220.09/220.31       91%28%75%29%; was see under ALKALOIDS 1975-90   
% 220.09/220.31  |- rdf__type mesh__D006247sskos__Concept
% 220.09/220.31  |- skos__historyNote mesh__D006247 Indoles %28%1969-1974%29%
% 220.09/220.31  |- skos__annotation mesh__D006247
% 220.09/220.31       do not confuse with HARMIDINE or HARMALINE   
% 220.09/220.31  |- skos__historyNote mesh__D006247 Alkaloids %28%1969-1974%29%
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D006247 2005
% 220.09/220.31  |- skos__altLabel mesh__D006247 Yageine
% 220.09/220.31  |- skos__broader mesh__D006247smesh__D026121
% 220.09/220.31  |- mesh__recordAuthorizer mesh__D006247 sjn
% 220.09/220.31  |- skos__altLabel mesh__D006247 Banisterine
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D006247 2006
% 220.09/220.31  |- skos__broader mesh__D006247smesh__D002243
% 220.09/220.31  |- mesh__publicMeSHNote mesh__D006247
% 220.09/220.31       91; was see under ALKALOIDS 1975-90   
% 220.09/220.31  |- skos__historyNote mesh__D006247 Pyridines %28%1969-1974%29%
% 220.09/220.31  |- skos__prefLabel mesh__D006247 Harmine
% 220.09/220.31  |- skos__altLabel mesh__D006247 Leucoharmine
% 220.09/220.31  |- mesh__recordOriginator mesh__D006247 NLM
% 220.09/220.31  |- skos__scopeNote mesh__D006247
% 220.09/220.31       Alkaloid isolated from seeds of Peganum harmala L., Zygophyllaceae. It is identical to banisterine, or telepathine, from Banisteria caapi and is one of the active ingredients of hallucinogenic drinks made in the western Amazon region from related plants. It has no therapeutic use, but %28%as banisterine%29% was hailed as a cure for postencephalitic Parkinson disease in the 1920%27%s.%A%    
% 220.09/220.31  |- skos__altLabel mesh__D006247 Telepathine
% 220.09/220.31  |- mesh__dateCreated mesh__D006247 1974-11-19
% 220.09/220.31  |- mesh__dateEstablished mesh__D006247 1991-01-01
% 220.09/220.31  |- mesh__recordMaintainer mesh__D006247 ssb
% 220.09/220.31  |- mesh__dateRevised mesh__D006247 2004-07-07
% 220.09/220.31  |- mesh__dateCreated mesh__D025401 2001-07-25
% 220.09/220.31  |- skos__altLabel mesh__D025401 Stress Echocardiography
% 220.09/220.31  |- skos__hiddenLabel mesh__D025401 Stress Echocardiography, Dobutamine
% 220.09/220.31  |- skos__altLabel mesh__D025401 Dobutamine Stress Echocardiography
% 220.09/220.31  |- mesh__dateEstablished mesh__D025401 2002-01-01
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D025401 2005
% 220.09/220.31  |- mesh__publicMeSHNote mesh__D025401 2002   
% 220.09/220.31  |- skos__hiddenLabel mesh__D025401 Dobutamine Stress Echocardiographies
% 220.09/220.31  |- skos__prefLabel mesh__D025401 Echocardiography, Stress
% 220.09/220.31  |- rdf__type mesh__D025401sskos__Concept
% 220.09/220.31  |- skos__historyNote mesh__D025401 Echocardiography %28%1983-2001%29%
% 220.09/220.31  |- mesh__historyNote mesh__D025401 2002   
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D025401 2006
% 220.09/220.31  |- skos__scopeNote mesh__D025401
% 220.09/220.31       A method of recording heart motion and internal structures by combining ultrasonic imaging with exercise testing %28%EXERCISE TEST%29% or pharmacologic stress.%A%    
% 220.09/220.31  |- skos__historyNote mesh__D025401 Exercise Test %28%1983-2001%29%
% 220.09/220.31  |- skos__broader mesh__D025401smesh__D004452
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D025401 2002
% 220.09/220.31  |- skos__hiddenLabel mesh__D025401 Echocardiography, Dobutamine Stress
% 220.09/220.31  |- skos__hiddenLabel mesh__D025401 Echocardiographies, Stress
% 220.09/220.31  |- skos__hiddenLabel mesh__D025401 Stress Echocardiographies
% 220.09/220.31  |- skos__hiddenLabel mesh__D025401 Stress Echocardiographies, Dobutamine
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D025401 2003
% 220.09/220.31  |- skos__related mesh__D025401smesh__D005080
% 220.09/220.31  |- skos__hiddenLabel mesh__D025401 Echocardiographies, Dobutamine Stress
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D025401 2004
% 220.09/220.31  |- skos__hiddenLabel mesh__D044366 Temperatures, Freezing Point
% 220.09/220.31  |- mesh__recordAuthorizer mesh__D044366 sjn
% 220.09/220.31  |- skos__hiddenLabel mesh__D044366 Transition Temperatures
% 220.09/220.31  |- skos__related mesh__D044366smesh__D044367
% 220.09/220.31  |- skos__hiddenLabel mesh__D044366 Freezing Point Temperatures
% 220.09/220.31  |- skos__related mesh__D044366smesh__D003460
% 220.09/220.31  |- skos__hiddenLabel mesh__D044366 Temperature, Melting Point
% 220.09/220.31  |- skos__hiddenLabel mesh__D044366 Temperature, Boiling Point
% 220.09/220.31  |- skos__altLabel mesh__D044366 Temperature, Transition
% 220.09/220.31  |- skos__broader mesh__D044366smesh__D013696
% 220.09/220.31  |- skos__hiddenLabel mesh__D044366 Temperatures, Melting Point
% 220.09/220.31  |- skos__hiddenLabel mesh__D044366 Temperatures, Boiling Point
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D044366 2006
% 220.09/220.31  |- skos__hiddenLabel mesh__D044366 Boiling Point Temperatures
% 220.09/220.31  |- mesh__dateCreated mesh__D044366 2003-07-09
% 220.09/220.31  |- mesh__dateEstablished mesh__D044366 2004-01-01
% 220.09/220.31  |- mesh__dateRevised mesh__D044366 2004-07-07
% 220.09/220.31  |- rdf__type mesh__D044366sskos__Concept
% 220.09/220.31  |- skos__prefLabel mesh__D044366 Transition Temperature
% 220.09/220.31  |- skos__hiddenLabel mesh__D044366 Melting Point Temperatures
% 220.09/220.31  |- mesh__recordMaintainer mesh__D044366 nns
% 220.09/220.31  |- skos__scopeNote mesh__D044366
% 220.09/220.31       The temperature at which a substance changes from one state or conformation of matter to another.%A%    
% 220.09/220.31  |- mesh__activeMeSHYear mesh__D044366 2005
% 220.09/220.31  |- skos__related mesh__D044366smesh__D002151
% 220.09/220.31  |- skos__hiddenLabel mesh__D044366 Temperatures, Transition
% 220.09/220.31  |- mesh__publicMeSHNote mesh__D044366 2004   
% 220.09/220.31  |- mesh__historyNote mesh__D044366 2004   
% 220.09/220.31  |- skos__hiddenLabel mesh__D044366 Temperature, Freezing Point
% 220.17/220.31  |- mesh__recordOriginator mesh__D044366 nns
% 220.17/220.31  |- skos__hiddenLabel mesh__D016675 Scandentias
% 220.17/220.31  |- mesh__recordOriginator mesh__D016675 MXR
% 220.17/220.31  |- skos__scopeNote mesh__D016675
% 220.17/220.31       An order of the class MAMMALS that consists of one family, TUPAIIDAE %28%tree shrews%29%, 5 genera %28%one of which is TUPAIA%29%, and 16 species. Their recent distribution is from India to the Philippines, southern China to Java, Borneo, Sumatra, Bali, and other islands in those regions.%A%    
% 220.17/220.31  |- rdf__type mesh__D016675sskos__Concept
% 220.17/220.31  |- mesh__dateCreated mesh__D016675 1991-01-25
% 220.17/220.31  |- mesh__historyNote mesh__D016675 92   
% 220.17/220.31  |- skos__broader mesh__D016675smesh__D008322
% 220.17/220.31  |- mesh__recordAuthorizer mesh__D016675 sjn
% 220.17/220.31  |- skos__prefLabel mesh__D016675 Scandentia
% 220.17/220.31  |- mesh__dateRevised mesh__D016675 2003-07-09
% 220.17/220.31  |- mesh__publicMeSHNote mesh__D016675 92   
% 220.17/220.31  |- skos__annotation mesh__D016675
% 220.17/220.31       order of mammals consisting of a single family, TUPAIIDAE, the tree shrews; IM; qualif permitted%A%  
% 220.17/220.31  |- mesh__activeMeSHYear mesh__D016675 2004
% 220.17/220.31  |- mesh__recordMaintainer mesh__D016675 ags
% 220.17/220.31  |- mesh__activeMeSHYear mesh__D016675 2006
% 220.17/220.31  |- mesh__dateEstablished mesh__D016675 1992-01-01
% 220.17/220.31  |- mesh__activeMeSHYear mesh__D016675 2005
% 220.17/220.31  |- mesh__activeMeSHYear mesh__D002655 2001
% 220.17/220.31  |- skos__prefLabel mesh__D002655 Child Custody
% 220.17/220.31  |- mesh__activeMeSHYear mesh__D002655 2004
% 220.17/220.31  |- mesh__activeMeSHYear mesh__D002655 1995
% 220.17/220.31  |- mesh__activeMeSHYear mesh__D002655 1996
% 220.17/220.31  |- skos__hiddenLabel mesh__D002655 Child Custodies
% 220.17/220.31  |- mesh__dateCreated mesh__D002655 1987-02-27
% 220.17/220.31  |- mesh__dateEstablished mesh__D002655 1991-01-01
% 220.17/220.31  |- mesh__activeMeSHYear mesh__D002655 2002
% 220.17/220.31  |- mesh__activeMeSHYear mesh__D002655 2005
% 220.17/220.31  |- mesh__activeMeSHYear mesh__D002655 1997
% 220.17/220.31  |- skos__scopeNote mesh__D002655
% 220.17/220.31       The formally authorized guardianship or care of a child.%A%    
% 220.17/220.31  |- mesh__historyNote mesh__D002655
% 220.17/220.31       91%28%88%29%; was see under CHILD WELFARE 1988-90   
% 220.17/220.31  |- skos__historyNote mesh__D002655 Child Welfare %28%1966-1987%29%
% 220.17/220.31  |- mesh__dateRevised mesh__D002655 1992-05-07
% 220.17/220.31  |- mesh__activeMeSHYear mesh__D002655 2006
% 220.17/220.31  |- mesh__activeMeSHYear mesh__D002655 1998
% 220.17/220.31  |- skos__altLabel mesh__D002655 Custody, Child
% 220.17/220.31  |- skos__broader mesh__D002655smesh__D002669
% 220.17/220.31  |- mesh__activeMeSHYear mesh__D002655 1993
% 220.17/220.31  |- skos__annotation mesh__D002655 check also tag CHILD or specific   
% 220.17/220.31  |- mesh__recordAuthorizer mesh__D002655 PLS
% 220.17/220.31  |- mesh__activeMeSHYear mesh__D002655 1999
% 220.17/220.31  |- mesh__activeMeSHYear mesh__D002655 2000
% 220.17/220.32  |- rdf__type mesh__D002655sskos__Concept
% 220.17/220.32  |- mesh__recordMaintainer mesh__D002655 TGC
% 220.17/220.32  |- mesh__activeMeSHYear mesh__D002655 2003
% 220.17/220.32  |- mesh__activeMeSHYear mesh__D002655 1994
% 220.17/220.32  |- skos__hiddenLabel mesh__D002655 Custodies, Child
% 220.17/220.32  |- mesh__publicMeSHNote mesh__D002655
% 220.17/220.32       91; was see under CHILD WELFARE 1988-90   
% 220.17/220.32  |- mesh__recordOriginator mesh__D002655 EC
% 220.17/220.32  |- skos__hiddenLabel mesh__D007340 beta-Cell Adenomas
% 220.17/220.32  |- skos__altLabel mesh__D007340 Insuloma
% 220.17/220.32  |- skos__scopeNote mesh__D007340
% 220.17/220.32       A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.%A%    
% 220.17/220.32  |- skos__hiddenLabel mesh__D007340 Insulinomas
% 220.17/220.32  |- skos__broader mesh__D007340smesh__D007516
% 220.17/220.32  |- mesh__publicMeSHNote mesh__D007340
% 220.17/220.32       91; was see under ISLET CELL TUMOR 1982-90; was see ISLET CELL TUMOR 1979-81%A%  
% 220.17/220.32  |- skos__hiddenLabel mesh__D007340 Adenoma, beta Cell
% 220.17/220.32  |- skos__historyNote mesh__D007340 Islet Cell Tumor %28%1966-1981%29%
% 220.17/220.32  |- mesh__dateCreated mesh__D007340 1981-05-20
% 220.17/220.32  |- mesh__recordAuthorizer mesh__D007340 sjn
% 220.17/220.32  |- skos__hiddenLabel mesh__D007340 beta Cell Tumor
% 220.17/220.32  |- mesh__historyNote mesh__D007340
% 220.17/220.32       91%28%82%29%; was see under ISLET CELL TUMOR 1982-90; was see ISLET CELL TUMOR 1979-81%A%  
% 220.17/220.32  |- rdf__type mesh__D007340sskos__Concept
% 220.17/220.32  |- mesh__recordMaintainer mesh__D007340 lkt
% 220.17/220.32  |- skos__prefLabel mesh__D007340 Insulinoma
% 220.17/220.32  |- skos__hiddenLabel mesh__D007340 Adenomas, beta-Cell
% 220.17/220.32  |- skos__hiddenLabel mesh__D007340 beta-Cell Tumors
% 220.17/220.32  |- skos__altLabel mesh__D007340 Adenoma, beta-Cell
% 220.17/220.32  |- skos__annotation mesh__D007340
% 220.17/220.32       coord IM with PANCREATIC NEOPLASMS %28%IM%29%   
% 220.17/220.32  |- mesh__recordOriginator mesh__D007340 VDK
% 220.17/220.32  |- skos__hiddenLabel mesh__D007340 Tumor, beta-Cell
% 220.17/220.32  |- mesh__activeMeSHYear mesh__D007340 2005
% 220.17/220.32  |- mesh__dateRevised mesh__D007340 2004-07-07
% 220.17/220.32  |- mesh__onlineNote mesh__D007340 search ISLET CELL TUMOR 1979-81   
% 220.17/220.32  |- skos__hiddenLabel mesh__D007340 beta-Cell Adenoma
% 220.17/220.32  |- skos__altLabel mesh__D007340 beta-Cell Tumor
% 220.17/220.32  |- mesh__activeMeSHYear mesh__D007340 2006
% 220.17/220.32  |- skos__hiddenLabel mesh__D007340 Tumors, beta-Cell
% 220.17/220.32  |- skos__hiddenLabel mesh__D007340 Insulomas
% 220.17/220.32  |- mesh__dateEstablished mesh__D007340 1991-01-01
% 220.17/220.32  |- skos__scopeNote mesh__D012285
% 220.17/220.32       A gram-negative, rod-shaped to coccoid bacterium. It is the etiologic agent of SCRUB TYPHUS in humans and is transmitted by mites from rodent reservoirs.%A%    
% 220.17/220.32  |- mesh__recordAuthorizer mesh__D012285 sjn
% 220.17/220.32  |- mesh__historyNote mesh__D012285 99%28%66%29%   
% 220.17/220.32  |- mesh__dateCreated mesh__D012285 1999-01-01
% 220.17/220.32  |- mesh__activeMeSHYear mesh__D012285 2006
% 220.17/220.32  |- skos__altLabel mesh__D012285 Rickettsia tsutsugamushi
% 220.17/220.32  |- skos__prefLabel mesh__D012285 Orientia tsutsugamushi
% 220.17/220.32  |- mesh__recordOriginator mesh__D012285 NLM
% 220.17/220.32  |- mesh__dateRevised mesh__D012285 2005-06-30
% 220.17/220.32  |- rdf__type mesh__D012285sskos__Concept
% 220.17/220.32  |- mesh__recordMaintainer mesh__D012285 SYSTEM
% 220.17/220.32  |- skos__broader mesh__D012285smesh__D016996
% 220.17/220.32  |- skos__annotation mesh__D012285 infection = SCRUB TYPHUS   
% 220.17/220.32  |- mesh__publicMeSHNote mesh__D012285
% 220.17/220.32       99; see RICKETTSIA TSUTSUGAMUSHI 1966-98   
% 220.17/220.32  |- skos__hiddenLabel mesh__D020717 Eukaryotic Initiation Factor 2B
% 220.17/220.32  |- skos__hiddenLabel mesh__D020717 EIF2B gamma
% 220.17/220.32  |- skos__hiddenLabel mesh__D020717 EIF2B delta
% 220.17/220.32  |- skos__altLabel mesh__D020717 EIF-2B
% 220.17/220.32  |- mesh__recordMaintainer mesh__D020717 jmp
% 220.17/220.32  |- mesh__recordAuthorizer mesh__D020717 sjn
% 220.17/220.32  |- skos__altLabel mesh__D020717 EIF2B-delta
% 220.17/220.32  |- skos__broader mesh__D020717smesh__D039642
% 220.17/220.32  |- skos__hiddenLabel mesh__D020717
% 220.17/220.32       Eukaryotic Initiation Factor 2B, gamma Subunit
% 220.17/220.32  |- skos__altLabel mesh__D020717 EIF2B1
% 220.17/220.32  |- skos__altLabel mesh__D020717 EIF2B-gamma
% 220.17/220.32  |- mesh__dateRevised mesh__D020717 2004-07-07
% 220.17/220.32  |- skos__hiddenLabel mesh__D020717 Peptide Initiation Factor EIF 2B
% 220.17/220.32  |- skos__hiddenLabel mesh__D020717 EIF2B beta
% 220.17/220.32  |- mesh__dateCreated mesh__D020717 1999-11-05
% 220.17/220.32  |- skos__broader mesh__D020717smesh__D020662
% 220.17/220.32  |- skos__hiddenLabel mesh__D020717
% 220.17/220.32       Eukaryotic Initiation Factor 2B, epsilon Subunit
% 220.17/220.32  |- skos__hiddenLabel mesh__D020717 EIF2B epsilon
% 220.17/220.32  |- skos__altLabel mesh__D020717 Eukaryotic Peptide Initiation Factor-2B
% 220.17/220.32  |- skos__hiddenLabel mesh__D020717 EIF2B alpha
% 220.17/220.32  |- skos__hiddenLabel mesh__D020717
% 220.17/220.32       Eukaryotic Initiation Factor 2B, delta Subunit
% 220.17/220.32  |- skos__historyNote mesh__D020717 Proteins %28%1983-1999%29%
% 220.17/220.32  |- mesh__activeMeSHYear mesh__D020717 2006
% 220.17/220.32  |- mesh__historyNote mesh__D020717
% 220.17/220.32       2003%28%2000%29%; use EUKARYOTIC INITIATION FACTOR-2B %28%NM%29% 1992-1999%A%  
% 220.17/220.32  |- skos__altLabel mesh__D020717 EIF2B-beta
% 220.17/220.32  |- skos__hiddenLabel mesh__D020717
% 220.17/220.32       Eukaryotic Initiation Factor 2B, alpha Subunit
% 220.17/220.32  |- rdf__type mesh__D020717sskos__Concept
% 220.17/220.32  |- skos__hiddenLabel mesh__D020717
% 220.17/220.32       Eukaryotic Initiation Factor 2B, beta Subunit
% 220.17/220.32  |- mesh__dateEstablished mesh__D020717 2000-01-01
% 220.17/220.32  |- skos__altLabel mesh__D020717 EIF2B
% 220.17/220.32  |- skos__scopeNote mesh__D020717
% 220.17/220.32       A guanine nucleotide exchange factor that acts to restore EUKARYOTIC INITIATION FACTOR-2 to its GTP bound form.%A%    
% 220.17/220.32  |- skos__altLabel mesh__D020717 EIF2B-epsilon
% 220.17/220.32  |- mesh__activeMeSHYear mesh__D020717 2005
% 220.17/220.32  |- skos__hiddenLabel mesh__D020717 EIF 2B
% 220.17/220.32  |- skos__altLabel mesh__D020717 Peptide Initiation Factor EIF-2B
% 220.17/220.32  |- skos__altLabel mesh__D020717 EIF2B-alpha
% 220.17/220.32  |- skos__prefLabel mesh__D020717 Eukaryotic Initiation Factor-2B
% 220.17/220.32  |- mesh__recordOriginator mesh__D020717 jmp
% 220.17/220.32  |- skos__hiddenLabel mesh__D020717 Eukaryotic Peptide Initiation Factor 2B
% 220.17/220.35  |- mesh__publicMeSHNote mesh__D020717
% 220.17/220.35       2003; see EIF-2B 2000-2002; EIF-2B was indexed under PROTEINS 1992-1999%A%  
% 220.17/220.35  |- skos__hiddenLabel mesh__D039422 Fusion Regulatory Protein 2
% 220.17/220.35  |- mesh__activeMeSHYear mesh__D039422 2006
% 220.17/220.35  |- skos__broader mesh__D039422smesh__D039001
% 220.17/220.35  |- skos__broader mesh__D039422smesh__D015703
% 220.17/220.35  |- skos__hiddenLabel mesh__D039422 alpha3, Integrin
% 220.17/220.35  |- mesh__dateEstablished mesh__D039422 2003-01-01
% 220.17/220.35  |- mesh__dateCreated mesh__D039422 2002-07-02
% 220.17/220.35  |- mesh__dateRevised mesh__D039422 2005-06-30
% 220.17/220.35  |- mesh__recordAuthorizer mesh__D039422 sjn
% 220.17/220.35  |- skos__prefLabel mesh__D039422 Integrin alpha3
% 220.17/220.35  |- mesh__recordOriginator mesh__D039422 MDJ
% 220.17/220.35  |- skos__altLabel mesh__D039422 Fusion Regulatory Protein-2
% 220.17/220.35  |- skos__altLabel mesh__D039422 CD49c Antigen
% 220.17/220.35  |- skos__scopeNote mesh__D039422
% 220.17/220.35       An integrin alpha subunit that occurs as alternatively spliced isoforms. The isoforms are differentially expressed in specific cell types and at specific developmental stages. Integrin alpha3 combines with INTEGRIN BETA1 to form INTEGRIN ALPHA3BETA1 which is a heterodimer found primarily in epithelial cells.%A%    
% 220.17/220.35  |- skos__altLabel mesh__D039422 FRP-2
% 220.17/220.35  |- skos__historyNote mesh__D039422 Integrins %28%1995-2002%29%
% 220.17/220.35  |- skos__altLabel mesh__D039422 alpha%28%3%29% Integrin
% 220.17/220.35  |- rdf__type mesh__D039422sskos__Concept
% 220.17/220.35  |- mesh__historyNote mesh__D039422
% 220.17/220.35       2003; use INTEGRIN ALPHA3 %28%NM%29% 1995-2002   
% 220.17/220.35  |- skos__altLabel mesh__D039422 CD49c Antigens
% 220.17/220.35  |- skos__altLabel mesh__D039422 Antigens, CD49c
% 220.17/220.35  |- skos__hiddenLabel mesh__D039422 Antigen, CD49c
% 220.17/220.35  |- skos__historyNote mesh__D039422 Antigens, CD %28%1995-2002%29%
% 220.17/220.35  |- mesh__recordMaintainer mesh__D039422 ssb
% 220.17/220.35  |- mesh__publicMeSHNote mesh__D039422
% 220.17/220.35       2003; INTEGRIN ALPHA3 was indexed under INTEGRINS %26% ANTIGENS CD 1995-2002%A%  
% 220.17/220.35  |- skos__broader mesh__D006248smesh__D001552
% 220.17/220.35  |- skos__broader mesh__D006248smesh__D000470
% 220.17/220.35  |- skos__prefLabel mesh__D006248 Harringtonines
% 220.17/220.35  |- skos__broader mesh__D006248smesh__D006576
% 220.17/220.35  |- skos__scopeNote mesh__D006248
% 220.17/220.35       Tetracyclic spiro-BENZAZEPINES isolated from the seeds of CEPHALOTAXUS. They are esters of the alkaloid cephalotaxine and may be effective as antineoplastic agents.%A%    
% 220.17/220.35  |- skos__hiddenLabel mesh__D006248 Alkaloids, Cephalotaxine
% 220.17/220.35  |- mesh__dateEstablished mesh__D006248 1991-01-01
% 220.17/220.35  |- rdf__type mesh__D006248sskos__Concept
% 220.17/220.35  |- skos__altLabel mesh__D006248 Cephalotaxus Alkaloids
% 220.17/220.35  |- skos__historyNote mesh__D006248 Dioxoles %28%1972-1976%29%
% 220.17/220.35  |- mesh__historyNote mesh__D006248
% 220.17/220.35       91%28%77%29%; was see under ALKALOIDS 1977-90   
% 220.17/220.35  |- skos__historyNote mesh__D006248 Alkaloids %28%1972-1976%29%
% 220.17/220.35  |- skos__hiddenLabel mesh__D006248 Alkaloids, Cephalotaxus
% 220.17/220.35  |- skos__altLabel mesh__D006248 Cephalotaxine Alkaloids
% 220.17/220.35  |- mesh__publicMeSHNote mesh__D006248
% 220.17/220.35       91; was see under ALKALOIDS 1977-90   
% 220.17/220.35  |- mesh__dateCreated mesh__D006248 1976-04-13
% 220.17/220.35  |- mesh__activeMeSHYear mesh__D006248 2006
% 220.17/220.35  |- mesh__dateRevised mesh__D006248 2003-07-09
% 220.17/220.35  |- mesh__recordAuthorizer mesh__D006248 sjn
% 220.17/220.35  |- mesh__activeMeSHYear mesh__D006248 2004
% 220.17/220.35  |- mesh__recordOriginator mesh__D006248 SH
% 220.17/220.35  |- mesh__activeMeSHYear mesh__D006248 2005
% 220.17/220.35  |- mesh__recordMaintainer mesh__D006248 ssb
% 220.17/220.35  |- mesh__dateCreated mesh__D044367 2003-07-25
% 220.17/220.35  |- mesh__recordAuthorizer mesh__D044367 sjn
% 220.17/220.35  |- mesh__recordOriginator mesh__D044367 nns
% 220.17/220.35  |- skos__hiddenLabel mesh__D044367 Phase Transition, Gas-Liquid-Solid
% 220.17/220.35  |- skos__hiddenLabel mesh__D044367 Phase Transition, Sol-Gel
% 220.17/220.35  |- skos__broader mesh__D044367smesh__D010825
% 220.17/220.35  |- skos__related mesh__D044367smesh__D003460
% 220.17/220.35  |- skos__hiddenLabel mesh__D044367 Transitions, Sol-Gel Phase
% 220.17/220.35  |- skos__hiddenLabel mesh__D044367 Gas-Liquid-Solid Phase Transition
% 220.17/220.35  |- rdf__type mesh__D044367sskos__Concept
% 220.17/220.35  |- skos__annotation mesh__D044367
% 220.17/220.35       note X refs: restrict to physical chemical change; not for physiologic  phase transition%A%  
% 220.17/220.35  |- skos__related mesh__D044367smesh__D044366
% 220.17/220.35  |- skos__hiddenLabel mesh__D044367 Transition, Gas-Liquid-Solid Phase
% 220.17/220.35  |- mesh__recordMaintainer mesh__D044367 nns
% 220.17/220.35  |- skos__hiddenLabel mesh__D044367 Phase Transitions
% 220.17/220.35  |- mesh__activeMeSHYear mesh__D044367 2006
% 220.17/220.35  |- skos__hiddenLabel mesh__D044367 Phase Transitions, Gas-Liquid-Solid
% 220.17/220.35  |- mesh__dateEstablished mesh__D044367 2004-01-01
% 220.17/220.35  |- skos__hiddenLabel mesh__D044367 Transitions, Gas-Liquid-Solid Phase
% 220.17/220.35  |- skos__hiddenLabel mesh__D044367 Sol Gel Phase Transition
% 220.17/220.35  |- skos__hiddenLabel mesh__D044367 Gas Liquid Solid Phase Transitions
% 220.17/220.35  |- mesh__activeMeSHYear mesh__D044367 2005
% 220.17/220.35  |- skos__scopeNote mesh__D044367
% 220.17/220.35       A change of a substance from one form or state to another.%A%    
% 220.17/220.35  |- mesh__publicMeSHNote mesh__D044367 2004   
% 220.17/220.35  |- skos__related mesh__D044367smesh__D017186
% 220.17/220.35  |- skos__related mesh__D044367smesh__D011232
% 220.17/220.35  |- skos__broader mesh__D044367smesh__D002627
% 220.17/220.35  |- skos__hiddenLabel mesh__D044367 Transition, Sol-Gel Phase
% 220.17/220.35  |- skos__hiddenLabel mesh__D044367 Sol-Gel Phase Transitions
% 220.17/220.35  |- skos__hiddenLabel mesh__D044367 Phase Transitions, Sol-Gel
% 220.17/220.36  |- skos__prefLabel mesh__D044367 Phase Transition
% 220.17/220.36  |- mesh__historyNote mesh__D044367 2004   
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D044367 2004
% 220.17/220.36  |- mesh__recordMaintainer mesh__D049850 ags
% 220.17/220.36  |- skos__prefLabel mesh__D049850 Nautilus
% 220.17/220.36  |- skos__historyNote mesh__D049850 Mollusca %28%1967-2005%29%
% 220.17/220.36  |- mesh__recordOriginator mesh__D049850 ags
% 220.17/220.36  |- mesh__historyNote mesh__D049850 2006   
% 220.17/220.36  |- rdf__type mesh__D049850sskos__Concept
% 220.17/220.36  |- mesh__dateEstablished mesh__D049850 2006-01-01
% 220.17/220.36  |- skos__scopeNote mesh__D049850
% 220.17/220.36       The sole genus in the family Nautilidae, order Nautilida, comprised of CEPHALOPODS with spiral external shells that are separated into chambers.%A%    
% 220.17/220.36  |- skos__broader mesh__D049850smesh__D049830
% 220.17/220.36  |- mesh__recordAuthorizer mesh__D049850 sjn
% 220.17/220.36  |- mesh__dateCreated mesh__D049850 2005-06-30
% 220.17/220.36  |- mesh__publicMeSHNote mesh__D049850 2006   
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D049850 2006
% 220.17/220.36  |- mesh__recordMaintainer mesh__D016676 nns
% 220.17/220.36  |- skos__historyNote mesh__D016676 Macrophages %28%1966-1991%29%
% 220.17/220.36  |- skos__hiddenLabel mesh__D016676 Macrophage, Alveolar
% 220.17/220.36  |- mesh__historyNote mesh__D016676 92   
% 220.17/220.36  |- mesh__dateRevised mesh__D016676 2003-07-09
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D016676 2004
% 220.17/220.36  |- skos__altLabel mesh__D016676 Macrophages, Pulmonary
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D016676 2006
% 220.17/220.36  |- skos__altLabel mesh__D016676 Alveolar Macrophages
% 220.17/220.36  |- skos__altLabel mesh__D016676 Pulmonary Macrophage
% 220.17/220.36  |- skos__annotation mesh__D016676
% 220.17/220.36       alveolar refers to pulm alveoli; A 11 qualif   
% 220.17/220.36  |- mesh__recordAuthorizer mesh__D016676 sjn
% 220.17/220.36  |- skos__scopeNote mesh__D016676
% 220.17/220.36       Round, granular, mononuclear phagocytes found in the alveoli of the lungs. They ingest small inhaled particles resulting in degradation and presentation of the antigen to immunocompetent cells.%A%    
% 220.17/220.36  |- mesh__recordOriginator mesh__D016676 AGS
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D016676 2005
% 220.17/220.36  |- skos__altLabel mesh__D016676 Pulmonary Macrophages
% 220.17/220.36  |- skos__altLabel mesh__D016676 Macrophage, Pulmonary
% 220.17/220.36  |- mesh__publicMeSHNote mesh__D016676 92   
% 220.17/220.36  |- skos__historyNote mesh__D016676 Pulmonary Alveoli %28%1966-1991%29%
% 220.17/220.36  |- skos__broader mesh__D016676smesh__D008264
% 220.17/220.36  |- skos__hiddenLabel mesh__D016676 Alveolar Macrophage
% 220.17/220.36  |- skos__prefLabel mesh__D016676 Macrophages, Alveolar
% 220.17/220.36  |- mesh__dateEstablished mesh__D016676 1992-01-01
% 220.17/220.36  |- rdf__type mesh__D016676sskos__Concept
% 220.17/220.36  |- mesh__dateCreated mesh__D016676 1991-02-14
% 220.17/220.36  |- mesh__dateCreated mesh__D002656 1999-01-01
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D002656 2000
% 220.17/220.36  |- skos__historyNote mesh__D002656 Child Care %28%1966-1972%29%
% 220.17/220.36  |- skos__prefLabel mesh__D002656 Child Day Care Centers
% 220.17/220.36  |- skos__hiddenLabel mesh__D002656 Centers, Child Daycare
% 220.17/220.36  |- mesh__dateRevised mesh__D002656 1999-11-03
% 220.17/220.36  |- mesh__recordAuthorizer mesh__D002656 sjn
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D002656 2005
% 220.17/220.36  |- skos__scopeNote mesh__D002656
% 220.17/220.36       Facilities which provide care for pre-school and school-age children.%A%    
% 220.17/220.36  |- skos__related mesh__D002656smesh__D009724
% 220.17/220.36  |- skos__hiddenLabel mesh__D002656 Daycare Centers, Child
% 220.17/220.36  |- skos__hiddenLabel mesh__D002656 Center, Child Daycare
% 220.17/220.36  |- skos__altLabel mesh__D002656 Day Care Centers for Children
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D002656 2001
% 220.17/220.36  |- mesh__recordOriginator mesh__D002656 NLM
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D002656 2006
% 220.17/220.36  |- skos__hiddenLabel mesh__D002656 Daycare Center, Child
% 220.17/220.36  |- skos__hiddenLabel mesh__D002656 Child Daycare Center
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D002656 2002
% 220.17/220.36  |- mesh__historyNote mesh__D002656 73   
% 220.17/220.36  |- skos__historyNote mesh__D002656 Child Welfare %28%1966-1972%29%
% 220.17/220.36  |- mesh__recordMaintainer mesh__D002656 kle
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D002656 2003
% 220.17/220.36  |- rdf__type mesh__D002656sskos__Concept
% 220.17/220.36  |- mesh__publicMeSHNote mesh__D002656 73   
% 220.17/220.36  |- mesh__dateEstablished mesh__D002656 1973-01-01
% 220.17/220.36  |- skos__broader mesh__D002656smesh__D002669
% 220.17/220.36  |- skos__altLabel mesh__D002656 Daycare Centers for Children
% 220.17/220.36  |- skos__annotation mesh__D002656 check also tag CHILD or specific   
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D002656 2004
% 220.17/220.36  |- skos__altLabel mesh__D002656 Child Daycare Centers
% 220.17/220.36  |- mesh__dateRevised mesh__D007341 1999-11-03
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D007341 2006
% 220.17/220.36  |- mesh__dateCreated mesh__D007341 1999-01-01
% 220.17/220.36  |- skos__scopeNote mesh__D007341
% 220.17/220.36       Coverage by contract whereby one part indemnifies or guarantees another against loss by a specified contingency.%A%    
% 220.17/220.36  |- mesh__recordOriginator mesh__D007341 NLM
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D007341 2001
% 220.17/220.36  |- skos__annotation mesh__D007341 specify geog if possible   
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D007341 2000
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D007341 2005
% 220.17/220.36  |- skos__prefLabel mesh__D007341 Insurance
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D007341 2004
% 220.17/220.36  |- skos__hiddenLabel mesh__D007341 Insurances
% 220.17/220.36  |- rdf__type mesh__D007341sskos__Concept
% 220.17/220.36  |- mesh__recordMaintainer mesh__D007341 kle
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D007341 2003
% 220.17/220.36  |- mesh__recordAuthorizer mesh__D007341 sjn
% 220.17/220.36  |- skos__broader mesh__D007341smesh__D005381
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D007341 2002
% 220.17/220.36  |- mesh__dateRevised mesh__D012286 2005-06-30
% 220.17/220.36  |- mesh__recordOriginator mesh__D012286 FPG
% 220.17/220.36  |- mesh__dateCreated mesh__D012286 1999-01-01
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D012286 2006
% 220.17/220.36  |- mesh__recordAuthorizer mesh__D012286 sjn
% 220.17/220.36  |- skos__scopeNote mesh__D012286
% 220.17/220.36       The etiologic agent of murine typhus %28%see TYPHUS, ENDEMIC FLEA-BORNE%29%.%A%    
% 220.17/220.36  |- rdf__type mesh__D012286sskos__Concept
% 220.17/220.36  |- mesh__recordMaintainer mesh__D012286 SYSTEM
% 220.17/220.36  |- skos__annotation mesh__D012286 infection = TYPHUS, ENDEMIC FLEA-BORNE   
% 220.17/220.36  |- skos__broader mesh__D012286smesh__D012281
% 220.17/220.36  |- skos__prefLabel mesh__D012286 Rickettsia typhi
% 220.17/220.36  |- mesh__recordAuthorizer mesh__D020718 sjn
% 220.17/220.36  |- skos__historyNote mesh__D020718 Ribonucleoproteins %28%1982-1992%29%
% 220.17/220.36  |- mesh__recordMaintainer mesh__D020718 SYSTEM
% 220.17/220.36  |- skos__scopeNote mesh__D020718
% 220.17/220.36       Nucleolar RNA-protein complexes that function in pre-ribosomal RNA processing.%A%    
% 220.17/220.36  |- mesh__historyNote mesh__D020718 2000   
% 220.17/220.36  |- skos__historyNote mesh__D020718 Cell Nucleolus %28%1975-1999%29%
% 220.17/220.36  |- mesh__dateRevised mesh__D020718 2005-06-30
% 220.17/220.36  |- skos__altLabel mesh__D020718 Small Nucleolar Ribonucleoproteins
% 220.17/220.36  |- skos__altLabel mesh__D020718 snoRNP
% 220.17/220.36  |- rdf__type mesh__D020718sskos__Concept
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D020718 2006
% 220.17/220.36  |- mesh__recordOriginator mesh__D020718 nns
% 220.17/220.36  |- skos__prefLabel mesh__D020718 Ribonucleoproteins, Small Nucleolar
% 220.17/220.36  |- skos__historyNote mesh__D020718
% 220.17/220.36       Ribonucleoproteins, Small Nuclear %28%1993-1999%29%
% 220.17/220.36  |- skos__broader mesh__D020718smesh__D017411
% 220.17/220.36  |- mesh__publicMeSHNote mesh__D020718 2000   
% 220.17/220.36  |- mesh__dateCreated mesh__D020718 1999-11-03
% 220.17/220.36  |- mesh__dateEstablished mesh__D020718 2000-01-01
% 220.17/220.36  |- mesh__recordMaintainer mesh__D039423 ssb
% 220.17/220.36  |- mesh__recordOriginator mesh__D039423 MDJ
% 220.17/220.36  |- skos__altLabel mesh__D039423 alpha1 Integrin
% 220.17/220.36  |- mesh__historyNote mesh__D039423
% 220.17/220.36       2003; use INTEGRIN ALPHA1 %28%NM%29% 1994-2002   
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D039423 2006
% 220.17/220.36  |- mesh__dateCreated mesh__D039423 2002-07-02
% 220.17/220.36  |- skos__historyNote mesh__D039423 Antigens, CD %28%1996-2002%29%
% 220.17/220.36  |- skos__broader mesh__D039423smesh__D039001
% 220.17/220.36  |- skos__altLabel mesh__D039423 CD49a Antigens
% 220.17/220.36  |- skos__scopeNote mesh__D039423
% 220.17/220.36       An integrin alpha subunit that binds COLLAGEN and LAMININ though its I domain. It combines with INTEGRIN BETA1 to form the heterodimer INTEGRIN ALPHA1BETA1.%A%    
% 220.17/220.36  |- skos__hiddenLabel mesh__D039423 Integrin, alpha1
% 220.17/220.36  |- skos__hiddenLabel mesh__D039423 VLA 1 alpha Subunit
% 220.17/220.36  |- mesh__publicMeSHNote mesh__D039423
% 220.17/220.36       2003; INTEGRIN ALPHA1 was indexed under ANTIGENS, CD 1994-2002%A%  
% 220.17/220.36  |- skos__historyNote mesh__D039423 Integrins %28%1994-1995%29%
% 220.17/220.36  |- skos__altLabel mesh__D039423 Integrin alpha%28%1%29%
% 220.17/220.36  |- skos__altLabel mesh__D039423 VLA-1 alpha Subunit
% 220.17/220.36  |- skos__hiddenLabel mesh__D039423 alpha Subunit, VLA-1
% 220.17/220.36  |- mesh__dateEstablished mesh__D039423 2003-01-01
% 220.17/220.36  |- mesh__recordAuthorizer mesh__D039423 sjn
% 220.17/220.36  |- skos__altLabel mesh__D039423 Antigens, CD49a
% 220.17/220.36  |- mesh__dateRevised mesh__D039423 2005-06-30
% 220.17/220.36  |- skos__hiddenLabel mesh__D039423 Antigen, CD49a
% 220.17/220.36  |- skos__prefLabel mesh__D039423 Integrin alpha1
% 220.17/220.36  |- skos__broader mesh__D039423smesh__D015703
% 220.17/220.36  |- skos__altLabel mesh__D039423 CD49a Antigen
% 220.17/220.36  |- rdf__type mesh__D039423sskos__Concept
% 220.17/220.36  |- mesh__recordAuthorizer mesh__D006249 sjn
% 220.17/220.36  |- rdf__type mesh__D006249sskos__Concept
% 220.17/220.36  |- skos__annotation mesh__D006249
% 220.17/220.36       found in fresh water; infection: coord IM with AMEBIASIS %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 220.17/220.36  |- mesh__dateEstablished mesh__D006249 1972-01-01
% 220.17/220.36  |- mesh__recordOriginator mesh__D006249 NLM
% 220.17/220.36  |- mesh__historyNote mesh__D006249 72   
% 220.17/220.36  |- skos__prefLabel mesh__D006249 Hartmannella
% 220.17/220.36  |- skos__historyNote mesh__D006249 Sarcodina %28%1966-1971%29%
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D006249 2006
% 220.17/220.36  |- mesh__dateRevised mesh__D006249 2003-07-09
% 220.17/220.36  |- skos__scopeNote mesh__D006249
% 220.17/220.36       A genus of free-living amoebae found in fresh water. The cysts usually pass harmlessly through the intestinal tract of man and may thus be found in feces. Occasionally, these organisms cause respiratory tract infections or generalized fatal meningoencephalitis.%A%    
% 220.17/220.36  |- mesh__recordMaintainer mesh__D006249 ags
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D006249 2004
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D006249 2005
% 220.17/220.36  |- mesh__dateCreated mesh__D006249 1999-01-01
% 220.17/220.36  |- skos__broader mesh__D006249smesh__D016846
% 220.17/220.36  |- mesh__publicMeSHNote mesh__D006249 72   
% 220.17/220.36  |- skos__historyNote mesh__D006249 Amoeba %28%1966-1971%29%
% 220.17/220.36  |- mesh__dateCreated mesh__D049851 2005-06-30
% 220.17/220.36  |- rdf__type mesh__D049851sskos__Concept
% 220.17/220.36  |- mesh__recordOriginator mesh__D049851 ags
% 220.17/220.36  |- mesh__historyNote mesh__D049851 2006   
% 220.17/220.36  |- mesh__dateEstablished mesh__D049851 2006-01-01
% 220.17/220.36  |- skos__prefLabel mesh__D049851 Gastropoda
% 220.17/220.36  |- mesh__recordAuthorizer mesh__D049851 sjn
% 220.17/220.36  |- mesh__publicMeSHNote mesh__D049851 2006   
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D049851 2006
% 220.17/220.36  |- skos__historyNote mesh__D049851 Mollusca %28%1965-2005%29%
% 220.17/220.36  |- mesh__recordMaintainer mesh__D049851 ags
% 220.17/220.36  |- skos__broader mesh__D049851smesh__D008974
% 220.17/220.36  |- skos__scopeNote mesh__D049851
% 220.17/220.36       A class in the phylum MOLLUSCA comprised of SNAILS and slugs. The former have coiled external shells and the latter usually lack shells.%A%    
% 220.17/220.36  |- skos__altLabel mesh__D049851 Gastropods
% 220.17/220.36  |- skos__altLabel mesh__D016677
% 220.17/220.36       AstraZeneca Brand of Tocainide Hydrochloride
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D016677 2006
% 220.17/220.36  |- skos__scopeNote mesh__D016677
% 220.17/220.36       An antiarrhythmic agent which exerts a potential- and frequency-dependent block of sodium channels.%A%    
% 220.17/220.36  |- mesh__dateEstablished mesh__D016677 1992-01-01
% 220.17/220.36  |- skos__historyNote mesh__D016677
% 220.17/220.36       Lidocaine/analogs %26% derivatives %28%1982-1991%29%
% 220.17/220.36  |- mesh__recordOriginator mesh__D016677 RLS
% 220.17/220.36  |- skos__broader mesh__D016677smesh__D000813
% 220.17/220.36  |- skos__historyNote mesh__D016677 Anti-Arrhythmia Agents %28%1966-1991%29%
% 220.17/220.36  |- mesh__historyNote mesh__D016677 92; was TOCAINIDE %28%NM%29% 1974-91   
% 220.17/220.36  |- skos__altLabel mesh__D016677 Astra Brand of Tocainide Hydrochloride
% 220.17/220.36  |- rdf__type mesh__D016677sskos__Concept
% 220.17/220.36  |- skos__historyNote mesh__D016677 Anilides %28%1974-1981%29%
% 220.17/220.36  |- skos__hiddenLabel mesh__D016677 W36095
% 220.17/220.36  |- mesh__dateCreated mesh__D016677 1991-01-25
% 220.17/220.36  |- skos__altLabel mesh__D016677 Xylotocan
% 220.17/220.36  |- skos__hiddenLabel mesh__D016677 W 36095
% 220.17/220.36  |- mesh__dateRevised mesh__D016677 2005-06-30
% 220.17/220.36  |- skos__prefLabel mesh__D016677 Tocainide
% 220.17/220.36  |- mesh__onlineNote mesh__D016677
% 220.17/220.36       use TOCAINIDE %28%NM%29% to search TOCAINIDE 1979-91   
% 220.17/220.36  |- mesh__recordMaintainer mesh__D016677 CCR
% 220.17/220.36  |- mesh__publicMeSHNote mesh__D016677
% 220.17/220.36       92; TOCAINIDE was indexed under LIDOCAINE 1974 %26% under LIDOCAINE/analogs and derivatives 1975-91%A%  
% 220.17/220.36  |- skos__hiddenLabel mesh__D016677 Monohydrochloride, Tocainide
% 220.17/220.36  |- mesh__recordAuthorizer mesh__D016677 sjn
% 220.17/220.36  |- skos__historyNote mesh__D002657 Growth %28%1966-1967%29%
% 220.17/220.36  |- skos__hiddenLabel mesh__D002657 Development, Child
% 220.17/220.36  |- skos__prefLabel mesh__D002657 Child Development
% 220.17/220.36  |- skos__historyNote mesh__D002657 Behavior %28%1966-1967%29%
% 220.17/220.36  |- mesh__dateEstablished mesh__D002657 1968-01-01
% 220.17/220.36  |- skos__hiddenLabel mesh__D002657 Development, Infant
% 220.17/220.36  |- skos__broader mesh__D002657smesh__D006803
% 220.17/220.36  |- skos__related mesh__D002657smesh__D006128
% 220.17/220.36  |- mesh__recordAuthorizer mesh__D002657 sjn
% 220.17/220.36  |- skos__historyNote mesh__D002657 Child Psychology %28%1966-1967%29%
% 220.17/220.36  |- skos__related mesh__D002657smesh__D010553
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D002657 2006
% 220.17/220.36  |- mesh__historyNote mesh__D002657 68   
% 220.17/220.36  |- mesh__recordMaintainer mesh__D002657 lkt
% 220.17/220.36  |- mesh__dateRevised mesh__D002657 2004-07-07
% 220.17/220.36  |- mesh__recordOriginator mesh__D002657 NLM
% 220.17/220.36  |- skos__scopeNote mesh__D002657
% 220.17/220.36       The continuous sequential physiological and psychological maturing of an individual from birth up to but not including ADOLESCENCE.%A%    
% 220.17/220.36  |- skos__annotation mesh__D002657
% 220.17/220.36       includes infant and child but not adolescents; add the appropriate age check tag%A%  
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D002657 2005
% 220.17/220.36  |- skos__related mesh__D002657smesh__D009048
% 220.17/220.36  |- mesh__dateCreated mesh__D002657 1999-01-01
% 220.17/220.36  |- rdf__type mesh__D002657sskos__Concept
% 220.17/220.36  |- mesh__publicMeSHNote mesh__D002657 68   
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D007342 2005
% 220.17/220.36  |- mesh__recordMaintainer mesh__D007342 TGC
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D007342 2002
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D007342 1998
% 220.17/220.36  |- mesh__publicMeSHNote mesh__D007342 78   
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D007342 2004
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D007342 1997
% 220.17/220.36  |- mesh__dateCreated mesh__D007342 1977-05-11
% 220.17/220.36  |- rdf__type mesh__D007342sskos__Concept
% 220.17/220.36  |- skos__hiddenLabel mesh__D007342 Benefit, Insurance
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D007342 2001
% 220.17/220.36  |- skos__hiddenLabel mesh__D007342 Benefits, Insurance
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D007342 2003
% 220.17/220.36  |- skos__scopeNote mesh__D007342
% 220.17/220.36       Payments or services provided under stated circumstances under the terms of an insurance policy. In prepayment programs, benefits are the services the programs will provide at defined locations and to the extent needed.%A%    
% 220.17/220.36  |- skos__hiddenLabel mesh__D007342 Benefit, Health
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D007342 2000
% 220.17/220.36  |- skos__prefLabel mesh__D007342 Insurance Benefits
% 220.17/220.36  |- mesh__recordOriginator mesh__D007342 EC
% 220.17/220.36  |- skos__broader mesh__D007342smesh__D007341
% 220.17/220.36  |- skos__hiddenLabel mesh__D007342 Benefits, Health
% 220.17/220.36  |- skos__annotation mesh__D007342
% 220.17/220.36       coord IM with specific type of insurance %28%IM%29% + geog if pertinent%A%  
% 220.17/220.36  |- mesh__dateRevised mesh__D007342 1996-06-13
% 220.17/220.36  |- skos__historyNote mesh__D007342 Insurance %28%1966-1977%29%
% 220.17/220.36  |- skos__hiddenLabel mesh__D007342 Insurance Benefit
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D007342 2006
% 220.17/220.36  |- mesh__historyNote mesh__D007342 78   
% 220.17/220.36  |- skos__hiddenLabel mesh__D007342 Health Benefit
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D007342 1999
% 220.17/220.36  |- mesh__recordAuthorizer mesh__D007342 PLS
% 220.17/220.36  |- mesh__dateEstablished mesh__D007342 1978-01-01
% 220.17/220.36  |- skos__broader mesh__D012287smesh__D006090
% 220.17/220.36  |- mesh__recordMaintainer mesh__D012287 SYSTEM
% 220.17/220.36  |- mesh__dateEstablished mesh__D012287 1975-01-01
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D012287 2006
% 220.17/220.36  |- mesh__recordOriginator mesh__D012287 FPG
% 220.17/220.36  |- mesh__dateRevised mesh__D012287 2005-06-30
% 220.17/220.36  |- skos__annotation mesh__D012287
% 220.17/220.36       a family: do not confuse with RICKETTSIEAE, a tribe; infection = RICKETTSIACEAE INFECTIONS%A%  
% 220.17/220.36  |- skos__prefLabel mesh__D012287 Rickettsiaceae
% 220.17/220.36  |- skos__historyNote mesh__D012287 Bacteria %28%1966-1974%29%
% 220.17/220.36  |- rdf__type mesh__D012287sskos__Concept
% 220.17/220.36  |- mesh__recordAuthorizer mesh__D012287 sjn
% 220.17/220.36  |- mesh__publicMeSHNote mesh__D012287 1975   
% 220.17/220.36  |- skos__scopeNote mesh__D012287
% 220.17/220.36       A family of small, gram-negative organisms, often parasitic in humans and other animals, causing diseases that may be transmitted by invertebrate vectors.%A%    
% 220.17/220.36  |- skos__broader mesh__D012287smesh__D020561
% 220.17/220.36  |- mesh__dateCreated mesh__D012287 1976-05-25
% 220.17/220.36  |- mesh__historyNote mesh__D012287 1975   
% 220.17/220.36  |- skos__scopeNote mesh__D020719
% 220.17/220.36       Glycosides of GLUCURONIC ACID formed by the reaction of URIDINE DIPHOSPHATE GLUCURONIC ACID with certain endogenous and exogenous substances. Their formation is important for the detoxification of drugs, steroid excretion and BILIRUBIN metabolism to a more water-soluble compound that can be eliminated in the URINE and BILE.%A%    
% 220.17/220.36  |- mesh__publicMeSHNote mesh__D020719 2000; see GLUCURONATES 1977-1999   
% 220.17/220.36  |- mesh__dateCreated mesh__D020719 1999-11-08
% 220.17/220.36  |- mesh__recordOriginator mesh__D020719 adp
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D020719 2005
% 220.17/220.36  |- mesh__recordAuthorizer mesh__D020719 sjn
% 220.17/220.36  |- mesh__recordMaintainer mesh__D020719 ssb
% 220.17/220.36  |- rdf__type mesh__D020719sskos__Concept
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D020719 2006
% 220.17/220.36  |- mesh__dateRevised mesh__D020719 2004-07-07
% 220.17/220.36  |- skos__broader mesh__D020719smesh__D005965
% 220.17/220.36  |- mesh__dateEstablished mesh__D020719 2000-01-01
% 220.17/220.36  |- skos__related mesh__D020719smesh__D014535
% 220.17/220.36  |- mesh__historyNote mesh__D020719 2000; use GLUCURONATES 1977-1999   
% 220.17/220.36  |- skos__prefLabel mesh__D020719 Glucuronides
% 220.17/220.36  |- mesh__historyNote mesh__D017770 94   
% 220.17/220.36  |- mesh__dateRevised mesh__D017770 2003-07-09
% 220.17/220.36  |- mesh__recordAuthorizer mesh__D017770 sjn
% 220.17/220.36  |- mesh__recordMaintainer mesh__D017770 nns
% 220.17/220.36  |- mesh__publicMeSHNote mesh__D017770 94   
% 220.17/220.36  |- skos__broader mesh__D017770smesh__D001696
% 220.17/220.36  |- skos__scopeNote mesh__D017770
% 220.17/220.36       Moving or bringing something from a lower level to a higher one. The concept encompasses biomechanic stresses resulting from work done in transferring objects from one plane to another as well as the effects of varying techniques of patient handling and transfer.%A%    
% 220.17/220.36  |- mesh__dateCreated mesh__D017770 1992-12-28
% 220.17/220.36  |- mesh__dateEstablished mesh__D017770 1994-01-01
% 220.17/220.36  |- rdf__type mesh__D017770sskos__Concept
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D017770 2006
% 220.17/220.36  |- skos__prefLabel mesh__D017770 Lifting
% 220.17/220.36  |- skos__broader mesh__D017770smesh__D019563
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D017770 2004
% 220.17/220.36  |- skos__annotation mesh__D017770 by machines or humans   
% 220.17/220.36  |- mesh__recordOriginator mesh__D017770 JLS
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D017770 2005
% 220.17/220.36  |- mesh__dateCreated mesh__D031441 2002-07-03
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D031441 2003
% 220.17/220.36  |- skos__broader mesh__D031441smesh__D019668
% 220.17/220.36  |- mesh__dateEstablished mesh__D031441 2003-01-01
% 220.17/220.36  |- rdf__type mesh__D031441sskos__Concept
% 220.17/220.36  |- skos__altLabel mesh__D031441 Ophiopogon japonicus
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D031441 2006
% 220.17/220.36  |- skos__annotation mesh__D031441
% 220.17/220.36       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.17/220.36  |- mesh__publicMeSHNote mesh__D031441 2003   
% 220.17/220.36  |- skos__prefLabel mesh__D031441 Ophiopogon
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D031441 2004
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D031441 2005
% 220.17/220.36  |- skos__scopeNote mesh__D031441
% 220.17/220.36       A plant genus of the family LILIACEAE. Members contain steroidal glycosides and provide an ingredient of shengmaisan %28%DRUGS, CHINESE HERBAL%29%.%A%    
% 220.17/220.36  |- mesh__historyNote mesh__D031441 2003   
% 220.17/220.36  |- skos__broader mesh__D003750smesh__D003731
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D003750 1999
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D003750 1992
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D003750 2004
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D003750 1995
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D003750 1998
% 220.17/220.36  |- skos__historyNote mesh__D003750 Dental Caries %28%1966-1986%29%
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D003750 2003
% 220.17/220.36  |- mesh__historyNote mesh__D003750
% 220.17/220.36       91%28%87%29%; was see under DENTAL CARIES 1987-90   
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D003750 2001
% 220.17/220.36  |- skos__altLabel mesh__D003750 Fissures, Dental
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D003750 1994
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D003750 2006
% 220.17/220.36  |- skos__altLabel mesh__D003750 Dental Fissure
% 220.17/220.36  |- skos__prefLabel mesh__D003750 Dental Fissures
% 220.17/220.36  |- mesh__dateRevised mesh__D003750 1991-06-13
% 220.17/220.36  |- skos__annotation mesh__D003750
% 220.17/220.36       a degree of dent caries; DF: DENT FISSURES   
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D003750 2005
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D003750 2000
% 220.17/220.36  |- mesh__dateCreated mesh__D003750 1986-04-08
% 220.17/220.36  |- mesh__recordMaintainer mesh__D003750 MXR
% 220.17/220.36  |- skos__scopeNote mesh__D003750
% 220.17/220.36       Deep grooves or clefts in the surface of teeth equivalent to class 1 cavities in Black%27%s classification of dental caries.%A%    
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D003750 1997
% 220.17/220.36  |- mesh__recordOriginator mesh__D003750 RC
% 220.17/220.36  |- mesh__publicMeSHNote mesh__D003750
% 220.17/220.36       91; was see under DENTAL CARIES 1987-90   
% 220.17/220.36  |- skos__altLabel mesh__D003750 Fissure, Dental
% 220.17/220.36  |- mesh__recordAuthorizer mesh__D003750 PLS
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D003750 1996
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D003750 1993
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D003750 2002
% 220.17/220.36  |- mesh__dateEstablished mesh__D003750 1991-01-01
% 220.17/220.36  |- rdf__type mesh__D003750sskos__Concept
% 220.17/220.36  |- mesh__publicMeSHNote mesh__D049852 2006   
% 220.17/220.36  |- skos__historyNote mesh__D049852 Mollusca %28%1972-2005%29%
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D049852 2006
% 220.17/220.36  |- mesh__dateCreated mesh__D049852 2005-06-30
% 220.17/220.36  |- skos__scopeNote mesh__D049852
% 220.17/220.36       A genus of small, shell-less, marine mollusks in the family Clione, superorder GASTROPODA. These pteropod %28%possessing a foot developed into wing-like organ for swimming%29% sea slugs feed exclusively on another pteropod mollusk, Limacina.%A%    
% 220.17/220.36  |- mesh__recordMaintainer mesh__D049852 ags
% 220.17/220.36  |- mesh__dateEstablished mesh__D049852 2006-01-01
% 220.17/220.36  |- rdf__type mesh__D049852sskos__Concept
% 220.17/220.36  |- skos__broader mesh__D049852smesh__D049851
% 220.17/220.36  |- mesh__historyNote mesh__D049852 2006   
% 220.17/220.36  |- mesh__recordOriginator mesh__D049852 ags
% 220.17/220.36  |- skos__prefLabel mesh__D049852 Clione
% 220.17/220.36  |- mesh__recordAuthorizer mesh__D049852 sjn
% 220.17/220.36  |- skos__historyNote mesh__D016678 Base Sequence %28%1971-1991%29%
% 220.17/220.36  |- skos__scopeNote mesh__D016678
% 220.17/220.36       The genetic complement of an organism, including all of its GENES, as represented in its DNA, or in some cases, its RNA.%A%    
% 220.17/220.36  |- mesh__dateRevised mesh__D016678 2005-06-30
% 220.17/220.36  |- skos__broader mesh__D016678smesh__D040342
% 220.17/220.36  |- skos__historyNote mesh__D016678 Genomic Library %28%1990-1991%29%
% 220.17/220.36  |- skos__related mesh__D016678smesh__D023281
% 220.17/220.36  |- mesh__recordAuthorizer mesh__D016678 sjn
% 220.17/220.36  |- mesh__recordOriginator mesh__D016678 PXP
% 220.17/220.36  |- rdf__type mesh__D016678sskos__Concept
% 220.17/220.36  |- skos__annotation mesh__D016678
% 220.17/220.36       general or unspecified; prefer specifics; coordinate IM with animal /genet %28%IM%29% or organism /genet %28%IM%29%%A%  
% 220.17/220.36  |- mesh__dateEstablished mesh__D016678 1992-01-01
% 220.17/220.36  |- skos__related mesh__D016678smesh__D005796
% 220.17/220.36  |- skos__historyNote mesh__D016678 Genetic Code %28%1966-1970%29%
% 220.17/220.36  |- mesh__recordMaintainer mesh__D016678 nns
% 220.17/220.36  |- skos__prefLabel mesh__D016678 Genome
% 220.17/220.36  |- skos__hiddenLabel mesh__D016678 Genomes
% 220.17/220.36  |- mesh__historyNote mesh__D016678 92; was see GENOMIC LIBRARY 1990-91   
% 220.17/220.36  |- mesh__dateCreated mesh__D016678 1991-02-11
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D016678 2006
% 220.17/220.36  |- mesh__publicMeSHNote mesh__D016678
% 220.17/220.36       92; was see GENOMIC LIBRARY 1990-91   
% 220.17/220.36  |- mesh__onlineNote mesh__D016678
% 220.17/220.36       use GENOMIC LIBRARY to search GENOME 1990-91   
% 220.17/220.36  |- mesh__recordAuthorizer mesh__D002658 SJN
% 220.17/220.36  |- mesh__dateEstablished mesh__D002658 1968-01-01
% 220.17/220.36  |- skos__hiddenLabel mesh__D002658 Developmental Disability
% 220.17/220.36  |- mesh__publicMeSHNote mesh__D002658
% 220.17/220.36       96; was CHILD DEVELOPMENT DISORDERS 1981-95; was CHILD DEVELOPMENT DEVIATIONS 1968-80%A%  
% 220.17/220.36  |- skos__hiddenLabel mesh__D002658 Child Development Disorder
% 220.17/220.36  |- skos__altLabel mesh__D002658 Disabilities, Developmental
% 220.17/220.36  |- mesh__historyNote mesh__D002658
% 220.17/220.36       96; was CHILD DEVELOPMENT DISORDERS 1981-95; was CHILD DEVELOPMENT DEVIATIONS 1968-80%A%  
% 220.17/220.36  |- skos__prefLabel mesh__D002658 Developmental Disabilities
% 220.17/220.36  |- skos__historyNote mesh__D002658
% 220.17/220.36       Child Behavior Disorders %28%1966-1967%29%
% 220.17/220.36  |- skos__historyNote mesh__D002658 Child Psychology %28%1966-1967%29%
% 220.17/220.36  |- skos__hiddenLabel mesh__D002658 Development Deviation, Child
% 220.17/220.36  |- mesh__activeMeSHYear mesh__D002658 2006
% 220.17/220.36  |- skos__scopeNote mesh__D002658
% 220.17/220.36       Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. %28%From American Psychiatric Glossary, 6th ed%29%%A%    
% 220.17/220.37  |- skos__altLabel mesh__D002658 Development Disorders, Child
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D002658 2002
% 220.17/220.37  |- skos__broader mesh__D002658smesh__D019952
% 220.17/220.37  |- mesh__dateRevised mesh__D002658 1997-06-20
% 220.17/220.37  |- skos__hiddenLabel mesh__D002658 Development Deviations, Child
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D002658 2005
% 220.17/220.37  |- skos__altLabel mesh__D002658 Child Development Disorders
% 220.17/220.37  |- skos__hiddenLabel mesh__D002658 Deviation, Child Development
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D002658 2001
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D002658 1999
% 220.17/220.37  |- skos__altLabel mesh__D002658 Developmental Delay Disorders
% 220.17/220.37  |- mesh__dateCreated mesh__D002658 1999-01-01
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D002658 2004
% 220.17/220.37  |- rdf__type mesh__D002658sskos__Concept
% 220.17/220.37  |- skos__hiddenLabel mesh__D002658 Developmental Delay Disorder
% 220.17/220.37  |- mesh__recordMaintainer mesh__D002658 JLS
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D002658 2000
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D002658 1998
% 220.17/220.37  |- skos__hiddenLabel mesh__D002658 Development Disorder, Child
% 220.17/220.37  |- skos__hiddenLabel mesh__D002658 Child Development Deviation
% 220.17/220.37  |- mesh__recordOriginator mesh__D002658 NLM
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D002658 2003
% 220.17/220.37  |- skos__hiddenLabel mesh__D002658 Disability, Developmental
% 220.17/220.37  |- skos__annotation mesh__D002658 check also tag CHILD or specific   
% 220.17/220.37  |- skos__hiddenLabel mesh__D013380 Subtalar Joints
% 220.17/220.37  |- skos__broader mesh__D013380smesh__D013640
% 220.17/220.37  |- skos__prefLabel mesh__D013380 Subtalar Joint
% 220.17/220.37  |- rdf__type mesh__D013380sskos__Concept
% 220.17/220.37  |- mesh__historyNote mesh__D013380 88   
% 220.17/220.37  |- mesh__recordMaintainer mesh__D013380 TAP
% 220.17/220.37  |- skos__hiddenLabel mesh__D013380 Talocalcaneal Joints
% 220.17/220.37  |- mesh__publicMeSHNote mesh__D013380 88   
% 220.17/220.37  |- skos__hiddenLabel mesh__D013380 Joints, Talocalcaneal
% 220.17/220.37  |- skos__hiddenLabel mesh__D013380 Joint, Talocalcaneal
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D013380 2005
% 220.17/220.37  |- skos__hiddenLabel mesh__D013380 Joints, Subtalar
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D013380 2003
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D013380 2006
% 220.17/220.37  |- skos__hiddenLabel mesh__D013380 Joint, Subtalar
% 220.17/220.37  |- mesh__dateCreated mesh__D013380 1987-04-02
% 220.17/220.37  |- skos__scopeNote mesh__D013380
% 220.17/220.37       Formed by the articulation of the talus with the calcaneus.%A%    
% 220.17/220.37  |- mesh__recordOriginator mesh__D013380 EC
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D013380 2004
% 220.17/220.37  |- mesh__recordAuthorizer mesh__D013380 sjn
% 220.17/220.37  |- skos__annotation mesh__D013380 human %26% animal   
% 220.17/220.37  |- skos__altLabel mesh__D013380 Talocalcaneal Joint
% 220.17/220.37  |- mesh__dateRevised mesh__D013380 2002-07-03
% 220.17/220.37  |- mesh__dateEstablished mesh__D013380 1988-01-01
% 220.17/220.37  |- skos__scopeNote mesh__D007343
% 220.17/220.37       Organizations which assume the financial responsibility for the risks of policyholders.%A%    
% 220.17/220.37  |- skos__hiddenLabel mesh__D007343 Carrier, Insurance
% 220.17/220.37  |- mesh__historyNote mesh__D007343
% 220.17/220.37       91%28%Aug 77%29%; was see under INSURANCE 1977-90   
% 220.17/220.37  |- skos__hiddenLabel mesh__D007343 Insurer
% 220.17/220.37  |- mesh__recordMaintainer mesh__D007343 kle
% 220.17/220.37  |- mesh__recordAuthorizer mesh__D007343 sjn
% 220.17/220.37  |- mesh__publicMeSHNote mesh__D007343
% 220.17/220.37       91; was see under INSURANCE Aug 1977-90   
% 220.17/220.37  |- skos__hiddenLabel mesh__D007343 Carriers, Insurance
% 220.17/220.37  |- skos__altLabel mesh__D007343 Insurers
% 220.17/220.37  |- skos__hiddenLabel mesh__D007343 Insurance Carrier
% 220.17/220.37  |- mesh__dateRevised mesh__D007343 1999-11-03
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D007343 2006
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D007343 2002
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D007343 2005
% 220.17/220.37  |- mesh__recordOriginator mesh__D007343 EC
% 220.17/220.37  |- skos__broader mesh__D007343smesh__D007341
% 220.17/220.37  |- skos__annotation mesh__D007343 specify geog if possible   
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D007343 2001
% 220.17/220.37  |- mesh__dateCreated mesh__D007343 1977-05-12
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D007343 2004
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D007343 2000
% 220.17/220.37  |- skos__prefLabel mesh__D007343 Insurance Carriers
% 220.17/220.37  |- rdf__type mesh__D007343sskos__Concept
% 220.17/220.37  |- mesh__dateEstablished mesh__D007343 1991-01-01
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D007343 2003
% 220.17/220.37  |- skos__historyNote mesh__D045462 Nitric Oxide %28%1986-2003%29%
% 220.17/220.37  |- skos__prefLabel mesh__D045462 Endothelium-Dependent Relaxing Factors
% 220.17/220.37  |- skos__hiddenLabel mesh__D045462 Relaxing Factor, Endothelium-Derived
% 220.17/220.37  |- skos__hiddenLabel mesh__D045462 Endothelium Derived Relaxant Factor
% 220.17/220.37  |- skos__altLabel mesh__D045462 Endothelium-Dependent Relaxing Factor
% 220.17/220.37  |- skos__hiddenLabel mesh__D045462 Relaxing Factors, Endothelium-Dependent
% 220.17/220.37  |- mesh__recordOriginator mesh__D045462 lkt
% 220.17/220.37  |- mesh__historyNote mesh__D045462 2004; use NITRIC OXIDE 1990-2003   
% 220.17/220.37  |- skos__historyNote mesh__D045462 Vasodilator Agents %28%1984-2003%29%
% 220.17/220.37  |- skos__hiddenLabel mesh__D045462 Endothelium Dependent Vasodilators
% 220.17/220.37  |- mesh__dateRevised mesh__D045462 2005-06-30
% 220.17/220.37  |- skos__related mesh__D045462smesh__D009569
% 220.17/220.37  |- skos__hiddenLabel mesh__D045462 Endothelium Derived Relaxing Factor
% 220.17/220.37  |- skos__altLabel mesh__D045462 Endothelium-Derived Relaxant Factor
% 220.17/220.37  |- skos__hiddenLabel mesh__D045462 Neutrophil Derived Relaxant Factor
% 220.17/220.37  |- mesh__dateCreated mesh__D045462 2003-07-09
% 220.17/220.37  |- skos__hiddenLabel mesh__D045462 Vasodilators, Endothelium-Dependent
% 220.17/220.37  |- skos__hiddenLabel mesh__D045462 Relaxant Factor, Neutrophil-Derived
% 220.17/220.37  |- skos__hiddenLabel mesh__D045462 Endothelium Dependent Relaxing Factors
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D045462 2006
% 220.17/220.37  |- skos__broader mesh__D045462smesh__D014665
% 220.17/220.37  |- skos__hiddenLabel mesh__D045462 Factor, Neutrophil-Derived Relaxant
% 220.17/220.37  |- skos__altLabel mesh__D045462 Endothelium-Dependent Vasodilators
% 220.17/220.37  |- mesh__publicMeSHNote mesh__D045462 2004; see  NITRIC OXIDE 1990-2003   
% 220.17/220.37  |- rdf__type mesh__D045462sskos__Concept
% 220.17/220.37  |- skos__scopeNote mesh__D045462
% 220.17/220.37       Paracrine substances produced by the VASCULAR ENDOTHELIUM with VASCULAR SMOOTH MUSCLE relaxation %28%VASODILATION%29% activities. Several factors have been identified, including NITRIC OXIDE and PROSTACYCLIN.%A%    
% 220.17/220.37  |- skos__altLabel mesh__D045462 Endothelium-Derived Relaxing Factor
% 220.17/220.37  |- skos__historyNote mesh__D045462 Endothelium %28%1984-2003%29%
% 220.17/220.37  |- mesh__recordMaintainer mesh__D045462 ssb
% 220.17/220.37  |- mesh__dateEstablished mesh__D045462 2004-01-01
% 220.17/220.37  |- skos__hiddenLabel mesh__D045462 Relaxing Factor, Endothelium-Dependent
% 220.17/220.37  |- skos__hiddenLabel mesh__D045462 Relaxant Factor, Endothelium-Derived
% 220.17/220.37  |- mesh__recordAuthorizer mesh__D045462 sjn
% 220.17/220.37  |- skos__hiddenLabel mesh__D045462 Endothelium Dependent Relaxing Factor
% 220.17/220.37  |- mesh__publicMeSHNote mesh__D012288
% 220.17/220.37       77; NEORICKETTSIOSIS HELMINTHOECA was heading 1971-81; RICKETTSIALPOX was heading 1963-81%A%  
% 220.17/220.37  |- skos__hiddenLabel mesh__D012288 Infection, Rickettsiaceae
% 220.17/220.37  |- skos__altLabel mesh__D012288 Infections, Rickettsiaceae
% 220.17/220.37  |- mesh__recordMaintainer mesh__D012288 ags
% 220.17/220.37  |- mesh__dateRevised mesh__D012288 2003-07-09
% 220.17/220.37  |- skos__scopeNote mesh__D012288
% 220.17/220.37       Infections with bacteria of the family RICKETTSIACEAE.     
% 220.17/220.37  |- mesh__onlineNote mesh__D012288
% 220.17/220.37       use RICKETTSIACEAE INFECTIONS/veterinary to search NEORICKETTSIOSIS HELMINTHOECA 1971-81; use RICKETTSIACEAE INFECTIONS to search RICKETTSIALPOX 1966-81%A%  
% 220.17/220.37  |- rdf__type mesh__D012288sskos__Concept
% 220.17/220.37  |- skos__prefLabel mesh__D012288 Rickettsiaceae Infections
% 220.17/220.37  |- mesh__dateCreated mesh__D012288 1976-04-27
% 220.17/220.37  |- mesh__recordOriginator mesh__D012288 FPG
% 220.17/220.37  |- mesh__historyNote mesh__D012288
% 220.17/220.37       77; NEORICKETTSIOSIS HELMINTHOECA was heading 1971-81; RICKETTSIALPOX was heading 1963-81%A%  
% 220.17/220.37  |- mesh__dateEstablished mesh__D012288 1977-01-01
% 220.17/220.37  |- skos__broader mesh__D012288smesh__D016905
% 220.17/220.37  |- skos__hiddenLabel mesh__D012288 Rickettsiaceae Infection
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D012288 2005
% 220.17/220.37  |- skos__historyNote mesh__D012288 Rickettsial Diseases %28%1966-1976%29%
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D012288 2004
% 220.17/220.37  |- mesh__recordAuthorizer mesh__D012288 sjn
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D012288 2006
% 220.17/220.37  |- skos__annotation mesh__D012288
% 220.17/220.37       gram-neg bact %22%infections with rickettsias of the family RICKETTSIACEAE%22%: do not confuse with RICKETTSIA INFECTIONS %28%infection by genus RICKETTSIA%29%%A%  
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D031442 2005
% 220.17/220.37  |- mesh__dateCreated mesh__D031442 2002-07-03
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D031442 2003
% 220.17/220.37  |- mesh__historyNote mesh__D031442 2003   
% 220.17/220.37  |- rdf__type mesh__D031442sskos__Concept
% 220.17/220.37  |- skos__prefLabel mesh__D031442 Ornithogalum
% 220.17/220.37  |- skos__broader mesh__D031442smesh__D019668
% 220.17/220.37  |- skos__scopeNote mesh__D031442
% 220.17/220.37       A plant genus of the family LILIACEAE that contains cholestane glycosides %28%CHOLESTANES%29%.%A%    
% 220.17/220.37  |- mesh__dateEstablished mesh__D031442 2003-01-01
% 220.17/220.37  |- skos__annotation mesh__D031442
% 220.17/220.37       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D031442 2006
% 220.17/220.37  |- skos__altLabel mesh__D031442 Star of Bethlehem
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D031442 2004
% 220.17/220.37  |- mesh__publicMeSHNote mesh__D031442 2003   
% 220.17/220.37  |- mesh__recordOriginator mesh__D003751 NLM
% 220.17/220.37  |- mesh__dateCreated mesh__D003751 1999-01-01
% 220.17/220.37  |- skos__prefLabel mesh__D003751 Dental Fistula
% 220.17/220.37  |- skos__hiddenLabel mesh__D003751 Gingival Fistulas
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D003751 2005
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D003751 2002
% 220.17/220.37  |- mesh__historyNote mesh__D003751 70   
% 220.17/220.37  |- skos__historyNote mesh__D003751 Periapical Abscess %28%1966-1969%29%
% 220.17/220.37  |- skos__hiddenLabel mesh__D003751 Fistula, Gingival
% 220.17/220.37  |- mesh__dateRevised mesh__D003751 1999-11-08
% 220.17/220.37  |- mesh__recordMaintainer mesh__D003751 KEV
% 220.17/220.37  |- mesh__recordAuthorizer mesh__D003751 sjn
% 220.17/220.37  |- skos__scopeNote mesh__D003751
% 220.17/220.37       An abnormal passage in the oral cavity on the gingiva.     
% 220.17/220.37  |- rdf__type mesh__D003751sskos__Concept
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D003751 2004
% 220.17/220.37  |- mesh__publicMeSHNote mesh__D003751 70   
% 220.17/220.37  |- skos__altLabel mesh__D003751 Gingival Fistula
% 220.17/220.37  |- skos__altLabel mesh__D003751 Fistulas, Dental
% 220.17/220.37  |- skos__hiddenLabel mesh__D003751 Fistulas, Gingival
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D003751 2001
% 220.17/220.37  |- mesh__dateEstablished mesh__D003751 1970-01-01
% 220.17/220.37  |- skos__altLabel mesh__D003751 Fistula, Dental
% 220.17/220.37  |- skos__annotation mesh__D003751
% 220.17/220.37       fistula policy: Manual 23.19+; DF: DENT FISTULA   
% 220.17/220.37  |- skos__altLabel mesh__D003751 Dental Fistulas
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D003751 2003
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D003751 2000
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D003751 2006
% 220.17/220.37  |- skos__broader mesh__D003751smesh__D016155
% 220.17/220.37  |- mesh__publicMeSHNote mesh__D049853 2006   
% 220.17/220.37  |- skos__scopeNote mesh__D049853
% 220.17/220.37       A genus of side-gilled sea slugs in the family Pleurobranchidae, superorder GASTROPODA. They are opportunistic voracious feeders but prefer the sea anemone.%A%    
% 220.17/220.37  |- mesh__recordOriginator mesh__D049853 ags
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D049853 2006
% 220.17/220.37  |- mesh__recordAuthorizer mesh__D049853 sjn
% 220.17/220.37  |- skos__prefLabel mesh__D049853 Pleurobranchaea
% 220.17/220.37  |- mesh__recordMaintainer mesh__D049853 ags
% 220.17/220.37  |- rdf__type mesh__D049853sskos__Concept
% 220.17/220.37  |- skos__historyNote mesh__D049853 Mollusca %28%1972-2005%29%
% 220.17/220.37  |- skos__broader mesh__D049853smesh__D049851
% 220.17/220.37  |- mesh__dateCreated mesh__D049853 2005-06-30
% 220.17/220.37  |- mesh__dateEstablished mesh__D049853 2006-01-01
% 220.17/220.37  |- mesh__historyNote mesh__D049853 2006   
% 220.17/220.37  |- skos__hiddenLabel mesh__D016679 Genomes, Viral
% 220.17/220.37  |- mesh__dateCreated mesh__D016679 1991-02-11
% 220.17/220.37  |- skos__hiddenLabel mesh__D016679 Viral Genomes
% 220.17/220.37  |- skos__broader mesh__D016679smesh__D016678
% 220.17/220.37  |- skos__historyNote mesh__D016679 RNA, Viral %28%1966-1977%29%
% 220.17/220.37  |- skos__annotation mesh__D016679
% 220.17/220.37       coordinate IM with specific virus /genet %28%IM%29%   
% 220.17/220.37  |- rdf__type mesh__D016679sskos__Concept
% 220.17/220.37  |- mesh__dateRevised mesh__D016679 2005-06-30
% 220.17/220.37  |- skos__related mesh__D016679smesh__D005814
% 220.17/220.37  |- mesh__dateEstablished mesh__D016679 1992-01-01
% 220.17/220.37  |- mesh__recordAuthorizer mesh__D016679 sjn
% 220.17/220.37  |- skos__historyNote mesh__D016679 Genes, Viral %28%1978-1991%29%
% 220.17/220.37  |- mesh__recordMaintainer mesh__D016679 nns
% 220.17/220.37  |- mesh__historyNote mesh__D016679
% 220.17/220.37       92; was see GENES, VIRAL 1978-91; VIRAL GENOME was see GENES, VIRAL 1978-91%A%  
% 220.17/220.37  |- mesh__recordOriginator mesh__D016679 PXP
% 220.17/220.37  |- skos__prefLabel mesh__D016679 Genome, Viral
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D016679 2006
% 220.17/220.37  |- skos__historyNote mesh__D016679 DNA, Viral %28%1966-1977%29%
% 220.17/220.37  |- skos__scopeNote mesh__D016679
% 220.17/220.37       The complete genetic complement contained in a DNA or RNA molecule in a virus.%A%    
% 220.17/220.37  |- mesh__onlineNote mesh__D016679
% 220.17/220.37       use GENES, VIRAL to search GENOME, VIRAL %26% VIRAL GENOME 1978-91%A%  
% 220.17/220.37  |- skos__altLabel mesh__D016679 Viral Genome
% 220.17/220.37  |- mesh__publicMeSHNote mesh__D016679
% 220.17/220.37       92; was see GENES, VIRAL 1978-91; VIRAL GENOME was see GENES, VIRAL 1978-91%A%  
% 220.17/220.37  |- mesh__recordOriginator mesh__D002659 EC
% 220.17/220.37  |- skos__broader mesh__D002659smesh__D019952
% 220.17/220.37  |- mesh__historyNote mesh__D002659 81   
% 220.17/220.37  |- skos__hiddenLabel mesh__D002659 Development Disorders, Pervasive
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D002659 2000
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D002659 2005
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D002659 1999
% 220.17/220.37  |- skos__prefLabel mesh__D002659 Child Development Disorders, Pervasive
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D002659 2004
% 220.17/220.37  |- rdf__type mesh__D002659sskos__Concept
% 220.17/220.37  |- mesh__dateEstablished mesh__D002659 1981-01-01
% 220.17/220.37  |- mesh__recordAuthorizer mesh__D002659 SJN
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D002659 1998
% 220.17/220.37  |- skos__hiddenLabel mesh__D002659 Disorders, Pervasive Development
% 220.17/220.37  |- skos__scopeNote mesh__D002659
% 220.17/220.37       Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.%A%    
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D002659 2003
% 220.17/220.37  |- skos__hiddenLabel mesh__D002659 Disorder, Pervasive Development
% 220.17/220.37  |- skos__altLabel mesh__D002659 Pervasive Child Development Disorders
% 220.17/220.37  |- skos__hiddenLabel mesh__D002659 Pervasive Development Disorder
% 220.17/220.37  |- skos__hiddenLabel mesh__D002659 Development Disorder, Pervasive
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D002659 2002
% 220.17/220.37  |- mesh__dateRevised mesh__D002659 1997-06-20
% 220.17/220.37  |- mesh__dateCreated mesh__D002659 1980-05-21
% 220.17/220.37  |- mesh__publicMeSHNote mesh__D002659 81   
% 220.17/220.37  |- skos__annotation mesh__D002659
% 220.17/220.37       %22%pervasive%22% is a psychiatric diag: follow text; check also tag CHILD or specific%A%  
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D002659 2006
% 220.17/220.37  |- mesh__recordMaintainer mesh__D002659 JLS
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D002659 2001
% 220.17/220.37  |- mesh__recordAuthorizer mesh__D013381 sjn
% 220.17/220.37  |- skos__altLabel mesh__D013381 Subtilisin DY
% 220.17/220.37  |- skos__scopeNote mesh__D013381
% 220.17/220.37       A family of SERINE ENDOPEPTIDASES isolated from Bacillus subtilis. EC 3.4.21.-%A%    
% 220.17/220.37  |- skos__altLabel mesh__D013381 Subtilisin A
% 220.17/220.37  |- mesh__historyNote mesh__D013381 74%28%73%29%   
% 220.17/220.37  |- rdf__type mesh__D013381sskos__Concept
% 220.17/220.37  |- skos__hiddenLabel mesh__D013381 Subtilisin, Carlsberg
% 220.17/220.37  |- mesh__dateCreated mesh__D013381 1999-01-01
% 220.17/220.37  |- mesh__publicMeSHNote mesh__D013381 74   
% 220.17/220.37  |- skos__altLabel mesh__D013381 Subtilopeptidase A
% 220.17/220.37  |- skos__historyNote mesh__D013381
% 220.17/220.37       Peptide Peptidohydrolases %28%1966-1972%29%
% 220.17/220.37  |- skos__altLabel mesh__D013381 Subtilisin E
% 220.17/220.37  |- skos__altLabel mesh__D013381 Subtilisin GX
% 220.17/220.37  |- skos__hiddenLabel mesh__D013381 Alcalase, Novo
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D013381 2005
% 220.17/220.37  |- skos__altLabel mesh__D013381 Subtilisin Novo
% 220.17/220.37  |- skos__prefLabel mesh__D013381 Subtilisins
% 220.17/220.37  |- skos__broader mesh__D013381smesh__D012697
% 220.17/220.37  |- skos__altLabel mesh__D013381 Carlsberg Subtilisin
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D013381 2006
% 220.17/220.37  |- skos__altLabel mesh__D013381 Novo Alcalase
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D013381 2004
% 220.17/220.37  |- mesh__dateEstablished mesh__D013381 1974-01-01
% 220.17/220.37  |- skos__hiddenLabel mesh__D013381 AprA Subtilisin
% 220.17/220.37  |- mesh__recordOriginator mesh__D013381 NLM
% 220.17/220.37  |- skos__altLabel mesh__D013381 Alcalase
% 220.17/220.37  |- mesh__recordMaintainer mesh__D013381 ssb
% 220.17/220.37  |- skos__altLabel mesh__D013381 Nagarse
% 220.17/220.37  |- skos__annotation mesh__D013381 SUBTILISIN is available   
% 220.17/220.37  |- mesh__dateRevised mesh__D013381 2003-07-09
% 220.17/220.37  |- mesh__publicMeSHNote mesh__D007344
% 220.17/220.37       91; was see under INSURANCE Aug 1977-90   
% 220.17/220.37  |- skos__hiddenLabel mesh__D007344 Reporting, Insurance Claim
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D007344 2000
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D007344 2006
% 220.17/220.37  |- mesh__dateRevised mesh__D007344 1993-09-16
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D007344 1999
% 220.17/220.37  |- skos__prefLabel mesh__D007344 Insurance Claim Reporting
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D007344 2005
% 220.17/220.37  |- mesh__recordAuthorizer mesh__D007344 NLM
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D007344 1998
% 220.17/220.37  |- skos__hiddenLabel mesh__D007344 Claim Reporting, Insurance
% 220.17/220.37  |- skos__scopeNote mesh__D007344
% 220.17/220.37       The design, completion, and filing of forms with the insurer.%A%    
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D007344 2004
% 220.17/220.37  |- mesh__dateCreated mesh__D007344 1977-05-11
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D007344 2002
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D007344 1997
% 220.17/220.37  |- mesh__recordMaintainer mesh__D007344 PLS
% 220.17/220.37  |- rdf__type mesh__D007344sskos__Concept
% 220.17/220.37  |- mesh__historyNote mesh__D007344
% 220.17/220.37       91%28%Aug 77%29%; was see under INSURANCE 1977-90   
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D007344 2003
% 220.17/220.37  |- mesh__dateEstablished mesh__D007344 1991-01-01
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D007344 2001
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D007344 1996
% 220.17/220.37  |- skos__broader mesh__D007344smesh__D007341
% 220.17/220.37  |- mesh__recordOriginator mesh__D007344 EC
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D007344 1995
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D045463 2004
% 220.17/220.37  |- mesh__dateEstablished mesh__D045463 2004-01-01
% 220.17/220.37  |- skos__broader mesh__D045463smesh__D018184
% 220.17/220.37  |- skos__hiddenLabel mesh__D045463 Infection, Avulavirus
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D045463 2005
% 220.17/220.37  |- mesh__dateCreated mesh__D045463 2003-07-09
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D045463 2006
% 220.17/220.37  |- rdf__type mesh__D045463sskos__Concept
% 220.17/220.37  |- mesh__historyNote mesh__D045463 2004   
% 220.17/220.37  |- skos__hiddenLabel mesh__D045463 Avulavirus Infection
% 220.17/220.37  |- skos__scopeNote mesh__D045463
% 220.17/220.37       Infections with viruses of the genus AVULAVIRUS, family PARAMYXOVIRIDAE. This includes NEWCASTLE DISEASE and other infections of domestic fowl.%A%    
% 220.17/220.37  |- mesh__publicMeSHNote mesh__D045463 2004   
% 220.17/220.37  |- skos__prefLabel mesh__D045463 Avulavirus Infections
% 220.17/220.37  |- skos__hiddenLabel mesh__D045463 Infections, Avulavirus
% 220.17/220.37  |- skos__historyNote mesh__D017772 Amyloidosis %28%1967-1993%29%
% 220.17/220.37  |- skos__hiddenLabel mesh__D017772 Neuropathies, Secondary Amyloid
% 220.17/220.37  |- skos__prefLabel mesh__D017772 Amyloid Neuropathies
% 220.17/220.37  |- skos__hiddenLabel mesh__D017772 Amyloid Neuropathies, Secondary
% 220.17/220.37  |- skos__hiddenLabel mesh__D017772 Polyneuropathy, Amyloid
% 220.17/220.37  |- skos__hiddenLabel mesh__D017772 Polyneuropathies, Amyloid
% 220.17/220.37  |- skos__hiddenLabel mesh__D017772 Neuropathy, Amyloid
% 220.17/220.37  |- mesh__dateCreated mesh__D017772 1993-06-30
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D017772 2005
% 220.17/220.37  |- mesh__historyNote mesh__D017772 1994   
% 220.17/220.37  |- skos__historyNote mesh__D017772
% 220.17/220.37       Peripheral Nervous System Diseases %28%1967-1993%29%
% 220.17/220.37  |- mesh__recordMaintainer mesh__D017772 ags
% 220.17/220.37  |- skos__broader mesh__D017772smesh__D000686
% 220.17/220.37  |- rdf__type mesh__D017772sskos__Concept
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D017772 2006
% 220.17/220.37  |- skos__broader mesh__D017772smesh__D010523
% 220.17/220.37  |- skos__altLabel mesh__D017772 Neuropathies, Amyloid
% 220.17/220.37  |- skos__hiddenLabel mesh__D017772 Secondary Amyloid Neuropathies
% 220.17/220.37  |- skos__hiddenLabel mesh__D017772 Amyloid Polyneuropathy
% 220.17/220.37  |- skos__hiddenLabel mesh__D017772 Neuropathy, Secondary Amyloid
% 220.17/220.37  |- mesh__recordOriginator mesh__D017772 RAZ
% 220.17/220.37  |- mesh__dateRevised mesh__D017772 2004-07-07
% 220.17/220.37  |- skos__hiddenLabel mesh__D017772 Amyloid Neuropathy
% 220.17/220.37  |- skos__scopeNote mesh__D017772
% 220.17/220.37       Disorders of the peripheral nervous system associated with the deposition of AMYLOID in nerve tissue. Familial, primary %28%nonfamilial%29%, and secondary forms have been described. Some familial subtypes demonstrate an autosomal dominant pattern of inheritance. Clinical manifestations include sensory loss, mild weakness, autonomic dysfunction, and CARPAL TUNNEL SYNDROME. %28%Adams et al., Principles of Neurology, 6th ed, p1349%29%%A%    
% 220.17/220.37  |- mesh__publicMeSHNote mesh__D017772 1994   
% 220.17/220.37  |- skos__hiddenLabel mesh__D017772 Secondary Amyloid Neuropathy
% 220.17/220.37  |- mesh__recordAuthorizer mesh__D017772 sjn
% 220.17/220.37  |- skos__annotation mesh__D017772
% 220.17/220.37       coord IM with specific neurol dis %28%IM%29% or specific nerve %28%IM%29%; /genet: consider also AMYLOID NEUROPATHIES, FAMILIAL%A%  
% 220.17/220.37  |- skos__altLabel mesh__D017772 Amyloid Polyneuropathies
% 220.17/220.37  |- mesh__dateEstablished mesh__D017772 1994-01-01
% 220.17/220.37  |- rdf__type mesh__D031443sskos__Concept
% 220.17/220.37  |- mesh__dateCreated mesh__D031443 2002-07-02
% 220.17/220.37  |- skos__broader mesh__D031443smesh__D019668
% 220.17/220.37  |- skos__scopeNote mesh__D031443
% 220.17/220.37       A plant genus of the family LILIACEAE. This should not be confused with Broom or Scotch Broom %28%CYTISUS%29% or Desert Broom %28%BACCHARIS%29% or Spanish Broom %28%SPARTIUM%29% or Brome %28%BROMUS%29%.%A%    
% 220.17/220.37  |- mesh__historyNote mesh__D031443 2003   
% 220.17/220.37  |- skos__altLabel mesh__D031443 Butcher%27%s Broom
% 220.17/220.37  |- skos__prefLabel mesh__D031443 Ruscus
% 220.17/220.37  |- skos__annotation mesh__D031443
% 220.17/220.37       note X refs: several other Broom terms are also available; check text and MeSH; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.17/220.37  |- mesh__dateEstablished mesh__D031443 2003-01-01
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D031443 2006
% 220.17/220.37  |- skos__altLabel mesh__D031443 Broom, Butcher%27%s
% 220.17/220.37  |- mesh__publicMeSHNote mesh__D031443 2003   
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D031443 2004
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D031443 2005
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D031443 2003
% 220.17/220.37  |- skos__historyNote mesh__D003752
% 220.17/220.37       Dental Service, Hospital %28%1966-1977%29%
% 220.17/220.37  |- skos__historyNote mesh__D003752 Dental Care %28%1973-1977%29%
% 220.17/220.37  |- skos__annotation mesh__D003752 DF: DENT HEALTH SERV   
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D003752 2000
% 220.17/220.37  |- skos__hiddenLabel mesh__D003752 Health Service, Dental
% 220.17/220.37  |- skos__prefLabel mesh__D003752 Dental Health Services
% 220.17/220.37  |- skos__hiddenLabel mesh__D003752 Dental Health Service
% 220.17/220.37  |- skos__altLabel mesh__D003752 Services, Dental Health
% 220.17/220.37  |- mesh__recordMaintainer mesh__D003752 kle
% 220.17/220.37  |- skos__altLabel mesh__D003752 Health Services, Dental
% 220.17/220.37  |- rdf__type mesh__D003752sskos__Concept
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D003752 2004
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D003752 2002
% 220.17/220.37  |- skos__hiddenLabel mesh__D003752 Service, Dental Health
% 220.17/220.37  |- mesh__publicMeSHNote mesh__D003752 78   
% 220.17/220.37  |- mesh__dateRevised mesh__D003752 1999-11-03
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D003752 2003
% 220.17/220.37  |- mesh__recordOriginator mesh__D003752 EC
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D003752 2006
% 220.17/220.37  |- mesh__recordAuthorizer mesh__D003752 sjn
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D003752 2001
% 220.17/220.37  |- skos__broader mesh__D003752smesh__D006296
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D003752 2005
% 220.17/220.37  |- mesh__dateEstablished mesh__D003752 1978-01-01
% 220.17/220.37  |- mesh__dateCreated mesh__D003752 1977-05-19
% 220.17/220.37  |- mesh__historyNote mesh__D003752 78   
% 220.17/220.37  |- skos__scopeNote mesh__D003752
% 220.17/220.37       Services designed to promote, maintain, or restore dental health.%A%    
% 220.17/220.37  |- mesh__dateRevised mesh__D013382 1999-11-03
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D013382 2003
% 220.17/220.37  |- skos__hiddenLabel mesh__D013382 Technic, Subtraction
% 220.17/220.37  |- mesh__historyNote mesh__D013382
% 220.17/220.37       91%28%64%29%; was SUBTRACTION TECHNIC 1964-90 %28%Prov 1964-72%29%   
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D013382 2006
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D013382 2000
% 220.17/220.37  |- mesh__recordOriginator mesh__D013382 NLM
% 220.17/220.37  |- mesh__dateEstablished mesh__D013382 1973-01-01
% 220.17/220.37  |- skos__scopeNote mesh__D013382
% 220.17/220.37       Combination or superimposition of two images for demonstrating differences between them %28%e.g., radiograph with contrast vs. one without, radionuclide images using different radionuclides, radiograph vs. radionuclide image%29% and in the preparation of audiovisual materials %28%e.g., offsetting identical images, coloring of vessels in angiograms%29%.%A%    
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D013382 2004
% 220.17/220.37  |- skos__annotation mesh__D013382
% 220.17/220.37       do not use /util except by MeSH definition; coord IM with RADIOGRAPHY %28%NIM%29% or RADIONUCLIDE IMAGING %28%NIM%29% for general articles only: do not use these coords when using /radiogr or /radionuclide%A%  
% 220.17/220.37  |- skos__hiddenLabel mesh__D013382 Techniques, Subtraction
% 220.17/220.37  |- skos__hiddenLabel mesh__D013382 Subtraction Techniques
% 220.17/220.37  |- mesh__publicMeSHNote mesh__D013382
% 220.17/220.37       91; was SUBTRACTION TECHNIC 1973-90   
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D013382 2001
% 220.17/220.37  |- mesh__recordAuthorizer mesh__D013382 sjn
% 220.17/220.37  |- mesh__activeMeSHYear mesh__D013382 2002
% 220.17/220.37  |- skos__broader mesh__D013382smesh__D003952
% 220.17/220.37  |- mesh__recordMaintainer mesh__D013382 kle
% 220.17/220.37  |- rdf__type mesh__D013382sskos__Concept
% 220.17/220.37  |- skos__altLabel mesh__D013382 Subtraction Technic
% 220.17/220.37  |- skos__hiddenLabel mesh__D013382 Technique, Subtraction
% 220.17/220.37  |- mesh__dateCreated mesh__D013382 1999-01-01
% 220.17/220.38  |- mesh__onlineNote mesh__D013382
% 220.17/220.38       use SUBTRACTION TECHNIQUE to search SUBTRACTION TECHNIC 1966-90%A%  
% 220.17/220.38  |- skos__prefLabel mesh__D013382 Subtraction Technique
% 220.17/220.38  |- skos__hiddenLabel mesh__D013382 Subtraction Technics
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D013382 2005
% 220.17/220.38  |- skos__hiddenLabel mesh__D013382 Technics, Subtraction
% 220.17/220.38  |- skos__hiddenLabel mesh__D007345 Insurance Claim Reviews
% 220.17/220.38  |- mesh__recordOriginator mesh__D007345 EC
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007345 2005
% 220.17/220.38  |- mesh__publicMeSHNote mesh__D007345
% 220.17/220.38       91; was see under INSURANCE, HEALTH 1986-90   
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007345 1996
% 220.17/220.38  |- skos__altLabel mesh__D007345 Claims Review
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007345 2001
% 220.17/220.38  |- mesh__dateRevised mesh__D007345 1993-09-16
% 220.17/220.38  |- skos__altLabel mesh__D007345 Claims Analysis
% 220.17/220.38  |- rdf__type mesh__D007345sskos__Concept
% 220.17/220.38  |- skos__altLabel mesh__D007345 Review, Claims
% 220.17/220.38  |- mesh__dateEstablished mesh__D007345 1991-01-01
% 220.17/220.38  |- skos__hiddenLabel mesh__D007345 Reviews, Claims
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007345 1999
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007345 2000
% 220.17/220.38  |- skos__hiddenLabel mesh__D007345 Reviews, Insurance Claim
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007345 1995
% 220.17/220.38  |- skos__broader mesh__D007345smesh__D007341
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007345 2004
% 220.17/220.38  |- skos__hiddenLabel mesh__D007345 Analyses, Claims
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007345 1998
% 220.17/220.38  |- skos__altLabel mesh__D007345 Review, Insurance Claim
% 220.17/220.38  |- mesh__dateCreated mesh__D007345 1985-04-24
% 220.17/220.38  |- skos__hiddenLabel mesh__D007345 Insurance Audits
% 220.17/220.38  |- skos__hiddenLabel mesh__D007345 Claims Reviews
% 220.17/220.38  |- skos__altLabel mesh__D007345 Claim Review, Insurance
% 220.17/220.38  |- skos__hiddenLabel mesh__D007345 Claims Processing, Insurance
% 220.17/220.38  |- skos__altLabel mesh__D007345 Analysis, Claims
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007345 2003
% 220.17/220.38  |- skos__hiddenLabel mesh__D007345 Audit, Insurance
% 220.17/220.38  |- skos__historyNote mesh__D007345
% 220.17/220.38       Insurance, Health/utilization %28%1966-1985%29%
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007345 2002
% 220.17/220.38  |- mesh__recordMaintainer mesh__D007345 PLS
% 220.17/220.38  |- skos__historyNote mesh__D007345 Utilization Review %28%1968-1985%29%
% 220.17/220.38  |- skos__hiddenLabel mesh__D007345 Claims Analyses
% 220.17/220.38  |- skos__hiddenLabel mesh__D007345 Processing, Insurance Claims
% 220.17/220.38  |- skos__hiddenLabel mesh__D007345 Claim Reviews, Insurance
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007345 2006
% 220.17/220.38  |- mesh__historyNote mesh__D007345
% 220.17/220.38       91%28%86%29%; was see under INSURANCE, HEALTH 1986-90   
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007345 1997
% 220.17/220.38  |- skos__hiddenLabel mesh__D007345 Audits, Insurance
% 220.17/220.38  |- skos__historyNote mesh__D007345
% 220.17/220.38       Insurance, Hospitalization/utilization %28%1966-1985%29%
% 220.17/220.38  |- skos__prefLabel mesh__D007345 Insurance Claim Review
% 220.17/220.38  |- skos__scopeNote mesh__D007345
% 220.17/220.38       Review of claims by insurance companies to determine liability and amount of payment for various services. The review may also include determination of eligibility of the claimant or beneficiary or of the provider of the benefit; determination that the benefit is covered or not payable under another policy; or determination that the service was necessary and of reasonable cost and quality.%A%    
% 220.17/220.38  |- mesh__recordAuthorizer mesh__D007345 NLM
% 220.17/220.38  |- mesh__historyNote mesh__D045464 2004   
% 220.17/220.38  |- skos__hiddenLabel mesh__D045464 Henipavirus Infection
% 220.17/220.38  |- rdf__type mesh__D045464sskos__Concept
% 220.17/220.38  |- mesh__dateEstablished mesh__D045464 2004-01-01
% 220.17/220.38  |- skos__broader mesh__D045464smesh__D018184
% 220.17/220.38  |- skos__scopeNote mesh__D045464
% 220.17/220.38       Infections with viruses of the genus HENIPAVIRUS, family PARAMYXOVIRIDAE.%A%    
% 220.17/220.38  |- mesh__publicMeSHNote mesh__D045464 2004   
% 220.17/220.38  |- skos__prefLabel mesh__D045464 Henipavirus Infections
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D045464 2004
% 220.17/220.38  |- skos__hiddenLabel mesh__D045464 Infection, Henipavirus
% 220.17/220.38  |- skos__hiddenLabel mesh__D045464 Infections, Henipavirus
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D045464 2005
% 220.17/220.38  |- mesh__dateCreated mesh__D045464 2003-07-09
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D045464 2006
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D017773 2005
% 220.17/220.38  |- skos__historyNote mesh__D017773 Pelvis %28%1966-1993%29%
% 220.17/220.38  |- mesh__publicMeSHNote mesh__D017773 94   
% 220.17/220.38  |- mesh__dateEstablished mesh__D017773 1994-01-01
% 220.17/220.38  |- rdf__type mesh__D017773sskos__Concept
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D017773 2003
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D017773 2006
% 220.17/220.38  |- mesh__dateRevised mesh__D017773 2004-07-30
% 220.17/220.38  |- mesh__recordAuthorizer mesh__D017773 jls
% 220.17/220.38  |- skos__prefLabel mesh__D017773 Pelvic Floor
% 220.17/220.38  |- mesh__recordOriginator mesh__D017773 JLS
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D017773 2005A
% 220.17/220.38  |- skos__broader mesh__D017773smesh__D010388
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D017773 2004
% 220.17/220.38  |- skos__annotation mesh__D017773 NIM when merely locational   
% 220.17/220.38  |- skos__hiddenLabel mesh__D017773 Floor, Pelvic
% 220.17/220.38  |- skos__scopeNote mesh__D017773
% 220.17/220.38       Soft tissue formed mainly by the pelvic diaphragm, which is composed of the two levator ani and two coccygeus muscles. The pelvic diaphragm lies just below the pelvic aperture %28%outlet%29% and separates the pelvic cavity from the PERINEUM. It extends between the PUBIC BONE anteriorly and the COCCYX posteriorly.%A%    
% 220.17/220.38  |- skos__broader mesh__D017773smesh__D000009
% 220.17/220.38  |- mesh__historyNote mesh__D017773 94   
% 220.17/220.38  |- mesh__recordMaintainer mesh__D017773 jls
% 220.17/220.38  |- mesh__dateCreated mesh__D017773 1992-12-28
% 220.17/220.38  |- rdf__type mesh__D031444sskos__Concept
% 220.17/220.38  |- skos__prefLabel mesh__D031444 Sansevieria
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D031444 2005
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D031444 2003
% 220.17/220.38  |- skos__scopeNote mesh__D031444
% 220.17/220.38       A plant genus of the family LILIACEAE that contains steroidal saponins.%A%    
% 220.17/220.38  |- skos__annotation mesh__D031444
% 220.17/220.38       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D031444 2006
% 220.17/220.38  |- mesh__dateCreated mesh__D031444 2002-07-03
% 220.17/220.38  |- skos__broader mesh__D031444smesh__D019668
% 220.17/220.38  |- mesh__historyNote mesh__D031444 2003   
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D031444 2004
% 220.17/220.38  |- mesh__publicMeSHNote mesh__D031444 2003   
% 220.17/220.38  |- mesh__dateEstablished mesh__D031444 2003-01-01
% 220.17/220.38  |- skos__broader mesh__D003753smesh__D011636
% 220.17/220.38  |- skos__annotation mesh__D003753
% 220.17/220.38       no qualif; specify geog if pertinent; DF: DENT HEALTH SURVEYS%A%  
% 220.17/220.38  |- mesh__publicMeSHNote mesh__D003753 72   
% 220.17/220.38  |- skos__historyNote mesh__D003753 Health Surveys %28%1966-1971%29%
% 220.17/220.38  |- mesh__historyNote mesh__D003753 72   
% 220.17/220.38  |- mesh__dateRevised mesh__D003753 2004-07-13
% 220.17/220.38  |- mesh__recordAuthorizer mesh__D003753 sjn
% 220.17/220.38  |- skos__broader mesh__D003753smesh__D006306
% 220.17/220.38  |- skos__altLabel mesh__D003753 Health Survey, Dental
% 220.17/220.38  |- skos__prefLabel mesh__D003753 Dental Health Surveys
% 220.17/220.38  |- mesh__dateEstablished mesh__D003753 1972-01-01
% 220.17/220.38  |- rdf__type mesh__D003753sskos__Concept
% 220.17/220.38  |- mesh__recordMaintainer mesh__D003753 sjn
% 220.17/220.38  |- skos__scopeNote mesh__D003753
% 220.17/220.38       A systematic collection of factual data pertaining to dental or oral health and disease in a human population within a given geographic area.%A%    
% 220.17/220.38  |- mesh__dateCreated mesh__D003753 1999-01-01
% 220.17/220.38  |- skos__altLabel mesh__D003753 Surveys, Dental Health
% 220.17/220.38  |- skos__altLabel mesh__D003753 Dental Health Survey
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D003753 2005
% 220.17/220.38  |- mesh__recordOriginator mesh__D003753 NLM
% 220.17/220.38  |- skos__altLabel mesh__D003753 Survey, Dental Health
% 220.17/220.38  |- skos__altLabel mesh__D003753 Health Surveys, Dental
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D003753 2006
% 220.17/220.38  |- skos__broader mesh__D003753smesh__D003813
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D013383 2004
% 220.17/220.38  |- mesh__dateRevised mesh__D013383 1999-11-03
% 220.17/220.38  |- skos__altLabel mesh__D013383 Nonmetropolitan Population
% 220.17/220.38  |- mesh__recordOriginator mesh__D013383 EC
% 220.17/220.38  |- skos__annotation mesh__D013383
% 220.17/220.38       specify geog; SUBURBAN HEALTH %26% SUBURBAN HEALTH SERVICES are also available%A%  
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D013383 2000
% 220.17/220.38  |- mesh__publicMeSHNote mesh__D013383 80   
% 220.17/220.38  |- mesh__historyNote mesh__D013383 80   
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D013383 2001
% 220.17/220.38  |- skos__historyNote mesh__D013383 Urban Population %28%1968-1979%29%
% 220.17/220.38  |- skos__hiddenLabel mesh__D013383 Nonmetropolitan Populations
% 220.17/220.38  |- skos__hiddenLabel mesh__D013383 Population, Suburban
% 220.17/220.38  |- skos__hiddenLabel mesh__D013383 Population, Nonmetropolitan
% 220.17/220.38  |- rdf__type mesh__D013383sskos__Concept
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D013383 2005
% 220.17/220.38  |- skos__prefLabel mesh__D013383 Suburban Population
% 220.17/220.38  |- mesh__recordAuthorizer mesh__D013383 sjn
% 220.17/220.38  |- skos__scopeNote mesh__D013383
% 220.17/220.38       The inhabitants of peripheral or adjacent areas of a city or town.%A%    
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D013383 2002
% 220.17/220.38  |- skos__hiddenLabel mesh__D013383 Suburban Populations
% 220.17/220.38  |- skos__hiddenLabel mesh__D013383 Populations, Suburban
% 220.17/220.38  |- skos__hiddenLabel mesh__D013383 Populations, Nonmetropolitan
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D013383 2006
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D013383 2003
% 220.17/220.38  |- mesh__dateCreated mesh__D013383 1978-12-22
% 220.17/220.38  |- mesh__dateEstablished mesh__D013383 1980-01-01
% 220.17/220.38  |- mesh__recordMaintainer mesh__D013383 kle
% 220.17/220.38  |- skos__broader mesh__D013383smesh__D011153
% 220.17/220.38  |- mesh__recordAuthorizer mesh__D007346 sjn
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007346 2003
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007346 2000
% 220.17/220.38  |- mesh__dateRevised mesh__D007346 1999-11-03
% 220.17/220.38  |- skos__broader mesh__D007346smesh__D007348
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007346 2004
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007346 2001
% 220.17/220.38  |- mesh__recordOriginator mesh__D007346 NLM
% 220.17/220.38  |- rdf__type mesh__D007346sskos__Concept
% 220.17/220.38  |- skos__altLabel mesh__D007346 Accident Insurance
% 220.17/220.38  |- skos__hiddenLabel mesh__D007346 Accident Insurances
% 220.17/220.38  |- skos__annotation mesh__D007346 specify geog if possible   
% 220.17/220.38  |- mesh__dateCreated mesh__D007346 1999-01-01
% 220.17/220.38  |- skos__hiddenLabel mesh__D007346 Insurances, Accident
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007346 2005
% 220.17/220.38  |- skos__scopeNote mesh__D007346
% 220.17/220.38       Insurance providing coverage for physical injury suffered as a result of unavoidable circumstances.%A%    
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007346 2002
% 220.17/220.38  |- mesh__recordMaintainer mesh__D007346 kle
% 220.17/220.38  |- skos__prefLabel mesh__D007346 Insurance, Accident
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007346 2006
% 220.17/220.38  |- mesh__publicMeSHNote mesh__D045465 2004   
% 220.17/220.38  |- mesh__historyNote mesh__D045465 2004   
% 220.17/220.38  |- skos__prefLabel mesh__D045465 Corsiaceae
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D045465 2004
% 220.17/220.38  |- mesh__dateEstablished mesh__D045465 2004-01-01
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D045465 2005
% 220.17/220.38  |- skos__broader mesh__D045465smesh__D019684
% 220.17/220.38  |- skos__annotation mesh__D045465
% 220.17/220.38       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.17/220.38  |- mesh__dateCreated mesh__D045465 2003-07-09
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D045465 2006
% 220.17/220.38  |- skos__scopeNote mesh__D045465
% 220.17/220.38       A plant family of the order Liliales %28%or by some as Dioscoreales or Burmanniales%29%, subclass Liliidae, class Liliopsida %28%monocotyledons%29%. They are perennial saprophytic plants obtaining their carbon from FUNGI.%A%    
% 220.17/220.38  |- rdf__type mesh__D045465sskos__Concept
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D017774 2004
% 220.17/220.38  |- skos__historyNote mesh__D017774 Synapses/physiology %28%1977-1993%29%
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D017774 1994
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D017774 2001
% 220.17/220.38  |- mesh__dateCreated mesh__D017774 1993-06-18
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D017774 1995
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D017774 2002
% 220.17/220.38  |- skos__scopeNote mesh__D017774
% 220.17/220.38       A persistent increase in synaptic efficacy, usually induced by appropriate activation of the same synapses. The phenomenological properties of long-term potentiation suggest that it may be a cellular mechanism of learning and memory.%A%    
% 220.17/220.38  |- mesh__dateEstablished mesh__D017774 1994-01-01
% 220.17/220.38  |- mesh__historyNote mesh__D017774 94   
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D017774 1998
% 220.17/220.38  |- skos__hiddenLabel mesh__D017774 Potentiation, Long-Term
% 220.17/220.38  |- mesh__publicMeSHNote mesh__D017774 94   
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D017774 1996
% 220.17/220.38  |- skos__hiddenLabel mesh__D017774 Potentiations, Long-Term
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D017774 1999
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D017774 2005
% 220.17/220.38  |- skos__annotation mesh__D017774
% 220.17/220.38       note category: %22%a persistent increase in synaptic efficacy%22%; DF: LTP%A%  
% 220.17/220.38  |- skos__broader mesh__D017774smesh__D009473
% 220.17/220.38  |- skos__hiddenLabel mesh__D017774 Long-Term Potentiations
% 220.17/220.38  |- rdf__type mesh__D017774sskos__Concept
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D017774 1997
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D017774 2003
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D017774 2006
% 220.17/220.38  |- skos__hiddenLabel mesh__D017774 Long Term Potentiation
% 220.17/220.38  |- skos__prefLabel mesh__D017774 Long-Term Potentiation
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D017774 2000
% 220.17/220.38  |- mesh__dateEstablished mesh__D031445 2003-01-01
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D031445 2005
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D031445 2003
% 220.17/220.38  |- skos__annotation mesh__D031445
% 220.17/220.38       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D031445 2006
% 220.17/220.38  |- skos__broader mesh__D031445smesh__D019668
% 220.17/220.38  |- mesh__publicMeSHNote mesh__D031445 2003   
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D031445 2004
% 220.17/220.38  |- skos__prefLabel mesh__D031445 Scilla
% 220.17/220.38  |- skos__scopeNote mesh__D031445
% 220.17/220.38       A plant genus of the family LILIACEAE. Members contain the cardiotonic PROSCILLARIDIN. The common name of squill is also used for URGINEA.%A%    
% 220.17/220.38  |- rdf__type mesh__D031445sskos__Concept
% 220.17/220.38  |- mesh__dateCreated mesh__D031445 2002-07-03
% 220.17/220.38  |- mesh__historyNote mesh__D031445 2003   
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D003754 1998
% 220.17/220.38  |- mesh__recordMaintainer mesh__D003754 TGC
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D003754 2003
% 220.17/220.38  |- mesh__dateEstablished mesh__D003754 1965-01-01
% 220.17/220.38  |- skos__hiddenLabel mesh__D003754 Dental High-Speed Equipments
% 220.17/220.38  |- mesh__publicMeSHNote mesh__D003754
% 220.17/220.38       65; was DENTAL HIGH SPEED EQUIPMENT 1965-90   
% 220.17/220.38  |- rdf__type mesh__D003754sskos__Concept
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D003754 1999
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D003754 2004
% 220.17/220.38  |- skos__altLabel mesh__D003754 High Speed Dental Equipment
% 220.17/220.38  |- mesh__dateCreated mesh__D003754 1999-01-01
% 220.17/220.38  |- mesh__historyNote mesh__D003754
% 220.17/220.38       65; was DENTAL HIGH SPEED EQUIPMENT 1965-90   
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D003754 2000
% 220.17/220.38  |- mesh__dateRevised mesh__D003754 1996-06-10
% 220.17/220.38  |- skos__annotation mesh__D003754
% 220.17/220.38       note X ref DENTAL HANDPIECES: restrict to dent high-speed equip: do not confuse with DENTAL INSTRUMENTS; DF: DENT HIGH SPEED EQUIPMENT%A%  
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D003754 2005
% 220.17/220.38  |- mesh__onlineNote mesh__D003754
% 220.17/220.38       use DENTAL HIGH-SPEED EQUIPMENT to search DENTAL HIGH SPEED EQUIPMENT 1966-90%A%  
% 220.17/220.38  |- skos__hiddenLabel mesh__D003754 Equipments, Dental High-Speed
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D003754 2001
% 220.17/220.38  |- skos__altLabel mesh__D003754 Handpiece, Dental
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D003754 2006
% 220.17/220.38  |- skos__hiddenLabel mesh__D003754 High-Speed Equipment, Dental
% 220.17/220.38  |- skos__altLabel mesh__D003754 Dental Handpiece
% 220.17/220.38  |- mesh__recordAuthorizer mesh__D003754 PLS
% 220.17/220.38  |- skos__broader mesh__D003754smesh__D003748
% 220.17/220.38  |- skos__altLabel mesh__D003754 Dental Handpieces
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D003754 2002
% 220.17/220.38  |- mesh__recordOriginator mesh__D003754 NLM
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D003754 1997
% 220.17/220.38  |- skos__hiddenLabel mesh__D003754 Equipment, Dental High-Speed
% 220.17/220.38  |- skos__prefLabel mesh__D003754 Dental High-Speed Equipment
% 220.17/220.38  |- skos__hiddenLabel mesh__D003754 High-Speed Equipments, Dental
% 220.17/220.38  |- skos__hiddenLabel mesh__D003754 Dental High Speed Equipment
% 220.17/220.38  |- mesh__recordAuthorizer mesh__D013384 sjn
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D013384 2006
% 220.17/220.38  |- mesh__recordMaintainer mesh__D013384 jmp
% 220.17/220.38  |- mesh__historyNote mesh__D013384
% 220.17/220.38       91%28%75%29%; was see under OXIDOREDUCTASES 1975-90   
% 220.17/220.38  |- skos__broader mesh__D013384smesh__D045222
% 220.17/220.38  |- mesh__dateRevised mesh__D013384 2004-07-07
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D013384 2005
% 220.17/220.38  |- skos__scopeNote mesh__D013384
% 220.17/220.38       An electron transport chain complex that catalyzes the transfer of electrons from SUCCINATE to CYTOCHROME C. It includes ELECTRON TRANSPORT COMPLEX II and ELECTRON TRANSPORT COMPLEX III.%A%    
% 220.17/220.38  |- skos__broader mesh__D013384smesh__D010088
% 220.17/220.38  |- skos__altLabel mesh__D013384 Succinate Cytochrome c Reductase
% 220.17/220.38  |- skos__historyNote mesh__D013384 Cytochrome C %28%1973-1974%29%
% 220.17/220.38  |- skos__broader mesh__D013384smesh__D009097
% 220.17/220.38  |- mesh__dateCreated mesh__D013384 1974-11-19
% 220.17/220.38  |- skos__annotation mesh__D013384
% 220.17/220.38       spell in titles %26% translations with lowercase c: succinate cytochrome c oxidoreductase%A%  
% 220.17/220.38  |- mesh__recordOriginator mesh__D013384 NLM
% 220.17/220.38  |- skos__historyNote mesh__D013384 Succinates %28%1973-1974%29%
% 220.17/220.38  |- mesh__dateEstablished mesh__D013384 1991-01-01
% 220.17/220.38  |- skos__historyNote mesh__D013384 Oxidoreductases %28%1973-1974%29%
% 220.17/220.38  |- mesh__publicMeSHNote mesh__D013384
% 220.17/220.38       91; was see under OXIDOREDUCTASES 1975-90   
% 220.17/220.38  |- skos__prefLabel mesh__D013384 Succinate Cytochrome c Oxidoreductase
% 220.17/220.38  |- rdf__type mesh__D013384sskos__Concept
% 220.17/220.38  |- skos__broader mesh__D009206Q000502smesh__D009206
% 220.17/220.38  |- mesh__preferredCombination mesh__D009206Q000502smesh__D006321Q000502
% 220.17/220.38  |- rdf__type mesh__D009206Q000502smesh__CompoundConcept
% 220.17/220.38  |- skos__broader mesh__D007347smesh__D007348
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007347 2004
% 220.17/220.38  |- rdf__type mesh__D007347sskos__Concept
% 220.17/220.38  |- skos__altLabel mesh__D007347 Plans, Dental Care
% 220.17/220.38  |- skos__altLabel mesh__D007347 Dental Insurance
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007347 2002
% 220.17/220.38  |- mesh__recordMaintainer mesh__D007347 kle
% 220.17/220.38  |- skos__altLabel mesh__D007347 Care, Prepaid Dental
% 220.17/220.38  |- mesh__dateCreated mesh__D007347 1999-01-01
% 220.17/220.38  |- skos__prefLabel mesh__D007347 Insurance, Dental
% 220.17/220.38  |- mesh__historyNote mesh__D007347
% 220.17/220.38       DENTAL CARE PLANS was see under INSURANCE, DENTAL 1963-78; PREPAID DENTAL CARE was see under INSURANCE, DENTAL 1969-78%A%  
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007347 2005
% 220.17/220.38  |- skos__annotation mesh__D007347
% 220.17/220.38       specify geog if possible; DF: INSURANCE DENT   
% 220.17/220.38  |- mesh__recordAuthorizer mesh__D007347 sjn
% 220.17/220.38  |- skos__hiddenLabel mesh__D007347 Dental Care, Prepaid
% 220.17/220.38  |- mesh__dateRevised mesh__D007347 1999-11-03
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007347 2006
% 220.17/220.38  |- skos__altLabel mesh__D007347 Plan, Dental Care
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007347 2000
% 220.17/220.38  |- skos__altLabel mesh__D007347 Dental Care Plans
% 220.17/220.38  |- mesh__onlineNote mesh__D007347
% 220.17/220.38       use INSURANCE, DENTAL to search DENTAL CARE PLANS 1966-78 %26% PREPAID DENTAL CARE 1969-78%A%  
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007347 2003
% 220.17/220.38  |- skos__scopeNote mesh__D007347
% 220.17/220.38       Insurance providing coverage for dental care.     
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D007347 2001
% 220.17/220.38  |- skos__altLabel mesh__D007347 Dental Care Plan
% 220.17/220.38  |- mesh__recordOriginator mesh__D007347 NLM
% 220.17/220.38  |- rdf__type mesh__D026501sskos__Concept
% 220.17/220.38  |- skos__altLabel mesh__D026501 Southwestern Blot
% 220.17/220.38  |- skos__altLabel mesh__D026501 Southwestern Blotting
% 220.17/220.38  |- skos__historyNote mesh__D026501 DNA-Binding Proteins %28%1989-2001%29%
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D026501 2003
% 220.17/220.38  |- skos__scopeNote mesh__D026501
% 220.17/220.38       A method that is used to detect DNA-protein interactions. Proteins are separated by electrophoresis and blotted onto a nitrocellulose membrane similar to Western blotting %28%BLOTTING, WESTERN%29% but the proteins are identified when they bind labeled DNA PROBES %28%as with Southern blotting %28%BLOTTING, SOUTHERN%29%%29% instead of antibodies.%A%    
% 220.17/220.38  |- mesh__dateCreated mesh__D026501 2001-07-25
% 220.17/220.38  |- skos__broader mesh__D026501smesh__D015336
% 220.17/220.38  |- mesh__dateEstablished mesh__D026501 2002-01-01
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D026501 2004
% 220.17/220.38  |- skos__hiddenLabel mesh__D026501 Blots, Southwestern
% 220.17/220.38  |- skos__hiddenLabel mesh__D026501 Southwestern Blottings
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D026501 2002
% 220.17/220.38  |- mesh__historyNote mesh__D026501 2002   
% 220.17/220.38  |- skos__hiddenLabel mesh__D026501 Blottings, Southwestern
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D026501 2005
% 220.17/220.38  |- mesh__publicMeSHNote mesh__D026501 2002   
% 220.17/220.38  |- skos__historyNote mesh__D026501 Blotting, Western %28%1991-2001%29%
% 220.17/220.38  |- skos__hiddenLabel mesh__D026501 Southwestern Blots
% 220.17/220.38  |- mesh__activeMeSHYear mesh__D026501 2006
% 220.24/220.38  |- skos__historyNote mesh__D026501 Blotting, Southern %28%1989-2001%29%
% 220.24/220.38  |- skos__prefLabel mesh__D026501 Blotting, Southwestern
% 220.24/220.38  |- mesh__activeMeSHYear mesh__D045466 2006
% 220.24/220.38  |- skos__broader mesh__D045466smesh__D019684
% 220.24/220.38  |- rdf__type mesh__D045466sskos__Concept
% 220.24/220.38  |- skos__annotation mesh__D045466
% 220.24/220.38       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.24/220.38  |- mesh__activeMeSHYear mesh__D045466 2005
% 220.24/220.38  |- mesh__dateEstablished mesh__D045466 2004-01-01
% 220.24/220.38  |- skos__prefLabel mesh__D045466 Dilleniaceae
% 220.24/220.38  |- mesh__activeMeSHYear mesh__D045466 2004
% 220.24/220.38  |- skos__scopeNote mesh__D045466
% 220.24/220.38       A plant family of the order Dilleniales, subclass Dilleniidae, class Magnoliopsida.%A%    
% 220.24/220.38  |- mesh__historyNote mesh__D045466 2004   
% 220.24/220.38  |- mesh__dateCreated mesh__D045466 2003-07-09
% 220.24/220.38  |- mesh__publicMeSHNote mesh__D045466 2004   
% 220.24/220.38  |- mesh__activeMeSHYear mesh__D031446 2006
% 220.24/220.38  |- mesh__activeMeSHYear mesh__D031446 2004
% 220.24/220.38  |- skos__broader mesh__D031446smesh__D019668
% 220.24/220.38  |- mesh__publicMeSHNote mesh__D031446 2003   
% 220.24/220.38  |- mesh__dateCreated mesh__D031446 2002-07-03
% 220.24/220.38  |- mesh__dateEstablished mesh__D031446 2003-01-01
% 220.24/220.38  |- mesh__historyNote mesh__D031446 2003   
% 220.24/220.38  |- skos__prefLabel mesh__D031446 Trillium
% 220.24/220.38  |- rdf__type mesh__D031446sskos__Concept
% 220.24/220.38  |- skos__altLabel mesh__D031446 Wakerobin
% 220.24/220.38  |- mesh__activeMeSHYear mesh__D031446 2005
% 220.24/220.38  |- mesh__activeMeSHYear mesh__D031446 2003
% 220.24/220.38  |- skos__annotation mesh__D031446
% 220.24/220.38       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.24/220.38  |- skos__scopeNote mesh__D031446
% 220.24/220.38       A plant genus of the family LILIACEAE that is a short plant with a distinct whorl of 3 broad leaves.%A%    
% 220.24/220.38  |- mesh__activeMeSHYear mesh__D050600 2006A
% 220.24/220.38  |- skos__altLabel mesh__D050600 Receptor, SNAP
% 220.24/220.38  |- skos__historyNote mesh__D050600 Membrane Proteins %28%1994-2005%29%
% 220.24/220.38  |- skos__altLabel mesh__D050600 SNAP Receptor
% 220.24/220.38  |- skos__broader mesh__D050600smesh__D050576
% 220.24/220.38  |- skos__altLabel mesh__D050600 v-SNAREs
% 220.24/220.38  |- skos__altLabel mesh__D050600 NSF Attachment Protein Receptor
% 220.24/220.38  |- mesh__dateCreated mesh__D050600 2005-06-30
% 220.24/220.38  |- skos__altLabel mesh__D050600 tSNAREs
% 220.24/220.38  |- skos__altLabel mesh__D050600
% 220.24/220.38       Soluble N-ethylmaleimide-Sensitive-Factor Attachment Protein Receptor
% 220.24/220.38  |- skos__altLabel mesh__D050600 SNAP Receptors
% 220.24/220.38  |- skos__hiddenLabel mesh__D050600
% 220.24/220.38       Soluble N ethylmaleimide Sensitive Factor Attachment Protein Receptor
% 220.24/220.38  |- skos__hiddenLabel mesh__D050600 SNARE Proteins, Target
% 220.24/220.38  |- skos__broader mesh__D050600smesh__D033921
% 220.24/220.38  |- skos__altLabel mesh__D050600 Vesicular SNARE Proteins
% 220.24/220.38  |- mesh__recordMaintainer mesh__D050600 ags
% 220.24/220.38  |- mesh__publicMeSHNote mesh__D050600
% 220.24/220.38       2006; SNAP RECEPTOR %28%now SNARE PROTEINS%29% was indexed under MEMBRANE PROTEINS 1995-2003 and VESICULAR TRANSPORT PROTEINS 2004-2005%A%  
% 220.24/220.38  |- skos__altLabel mesh__D050600 t-SNARE
% 220.24/220.38  |- skos__historyNote mesh__D050600
% 220.24/220.38       Vesicular Transport Proteins %28%2004-2005%29%
% 220.24/220.38  |- skos__hiddenLabel mesh__D050600 SNARE Proteins, Vesicular
% 220.24/220.38  |- mesh__dateRevised mesh__D050600 2005-07-29
% 220.24/220.38  |- rdf__type mesh__D050600sskos__Concept
% 220.24/220.38  |- skos__hiddenLabel mesh__D050600 SNARE Proteins, Vesicle
% 220.24/220.38  |- skos__hiddenLabel mesh__D050600 v SNAREs
% 220.24/220.38  |- mesh__activeMeSHYear mesh__D050600 2006
% 220.24/220.38  |- skos__altLabel mesh__D050600 Target SNARE Proteins
% 220.24/220.38  |- skos__altLabel mesh__D050600 SNAREs
% 220.24/220.38  |- mesh__recordAuthorizer mesh__D050600 ags
% 220.24/220.38  |- mesh__recordOriginator mesh__D050600 nns
% 220.24/220.38  |- skos__altLabel mesh__D050600 v-SNARE
% 220.24/220.38  |- mesh__historyNote mesh__D050600 2006 %28%1995%29%   
% 220.24/220.38  |- mesh__dateEstablished mesh__D050600 2006-01-01
% 220.24/220.38  |- skos__prefLabel mesh__D050600 SNARE Proteins
% 220.24/220.38  |- skos__altLabel mesh__D050600 SNARE
% 220.24/220.38  |- skos__scopeNote mesh__D050600
% 220.24/220.38       A superfamily of small proteins which are involved in the MEMBRANE FUSION events, intracellular protein trafficking and secretory processes. They share a homologous SNARE motif. The SNARE proteins are divided into subfamilies: QA-SNARES; QB-SNARES; QC-SNARES; and R-SNARES. The formation of a SNARE complex %28%composed of one each of the four different types SNARE domains %28%Qa, Qb, Qc, and R%29%%29% mediates MEMBRANE FUSION. Following membrane fusion SNARE complexes are dissociated by the NSFs %28%N-ETHYLMALEIMIDE-SENSITIVE FACTORS%29%, in conjunction with SOLUBLE NSF ATTACHMENT PROTEIN, i.e., SNAPs %28%no relation to SNAP 25.%29%%A%    
% 220.24/220.38  |- skos__hiddenLabel mesh__D003755 Techniques, Dental High Speed
% 220.24/220.39  |- mesh__historyNote mesh__D003755
% 220.24/220.39       91; was DENTAL HIGH SPEED TECHNIC 1965-90   
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D003755 2004
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 High Speed Technics, Dental
% 220.24/220.39  |- skos__altLabel mesh__D003755 Dental Technique, High-Speed
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 Technique, Dental High Speed
% 220.24/220.39  |- skos__altLabel mesh__D003755 High-Speed Technic, Dental
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 Dental Technic, High Speed
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 Techniques, High Speed Dental
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 Dental High Speed Technic
% 220.24/220.39  |- mesh__recordMaintainer mesh__D003755 kle
% 220.24/220.39  |- mesh__dateCreated mesh__D003755 1999-01-01
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 High Speed Technique, Dental
% 220.24/220.39  |- skos__altLabel mesh__D003755 Technics, High-Speed Dental
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 Dental High Speed Technique
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 Dental High Speed Technics
% 220.24/220.39  |- skos__broader mesh__D003755smesh__D003813
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 Technics, Dental High Speed
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D003755 2003
% 220.24/220.39  |- skos__altLabel mesh__D003755 Techniques, High-Speed Dental
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 High Speed Technic, Dental
% 220.24/220.39  |- mesh__onlineNote mesh__D003755
% 220.24/220.39       use DENTAL HIGH-SPEED TECHNIQUE to search DENTAL HIGH SPEED TECHNIC 1966-90%A%  
% 220.24/220.39  |- mesh__dateRevised mesh__D003755 1999-11-03
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 High Speed Dental Technique
% 220.24/220.39  |- skos__altLabel mesh__D003755 Technique, High-Speed Dental
% 220.24/220.39  |- skos__altLabel mesh__D003755 Dental High-Speed Technics
% 220.24/220.39  |- skos__altLabel mesh__D003755 Dental Technics, High-Speed
% 220.24/220.39  |- skos__altLabel mesh__D003755 Technic, Dental High-Speed
% 220.24/220.39  |- skos__altLabel mesh__D003755 Dental Techniques, High-Speed
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D003755 2002
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 Dental High Speed Techniques
% 220.24/220.39  |- skos__altLabel mesh__D003755 High-Speed Techniques, Dental
% 220.24/220.39  |- skos__altLabel mesh__D003755 Technic, High-Speed Dental
% 220.24/220.39  |- rdf__type mesh__D003755sskos__Concept
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 High Speed Techniques, Dental
% 220.24/220.39  |- skos__altLabel mesh__D003755 Dental Technic, High-Speed
% 220.24/220.39  |- skos__altLabel mesh__D003755 High-Speed Technique, Dental
% 220.24/220.39  |- skos__altLabel mesh__D003755 Dental High-Speed Techniques
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D003755 2001
% 220.24/220.39  |- skos__altLabel mesh__D003755 Technics, Dental High-Speed
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 Technic, High Speed Dental
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D003755 2006
% 220.24/220.39  |- skos__altLabel mesh__D003755 High-Speed Dental Technique
% 220.24/220.39  |- mesh__recordAuthorizer mesh__D003755 sjn
% 220.24/220.39  |- skos__prefLabel mesh__D003755 Dental High-Speed Technique
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 Technique, High Speed Dental
% 220.24/220.39  |- skos__altLabel mesh__D003755 High-Speed Dental Technics
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 Dental Technics, High Speed
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 High Speed Dental Techniques
% 220.24/220.39  |- mesh__recordOriginator mesh__D003755 NLM
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 High Speed Dental Technics
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 Technics, High Speed Dental
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 Dental Technique, High Speed
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D003755 2000
% 220.24/220.39  |- skos__altLabel mesh__D003755 High-Speed Dental Technic
% 220.24/220.39  |- skos__altLabel mesh__D003755 High-Speed Dental Techniques
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D003755 2005
% 220.24/220.39  |- skos__altLabel mesh__D003755 Techniques, Dental High-Speed
% 220.24/220.39  |- mesh__publicMeSHNote mesh__D003755
% 220.24/220.39       91; was DENTAL HIGH SPEED TECHNIC 1965-90   
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 Technic, Dental High Speed
% 220.24/220.39  |- skos__annotation mesh__D003755 DF: DENT HIGH SPEED TECHNIQUE   
% 220.24/220.39  |- skos__altLabel mesh__D003755 Technique, Dental High-Speed
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 Dental Techniques, High Speed
% 220.24/220.39  |- skos__altLabel mesh__D003755 Dental High-Speed Technic
% 220.24/220.39  |- mesh__dateEstablished mesh__D003755 1965-01-01
% 220.24/220.39  |- skos__hiddenLabel mesh__D003755 High Speed Dental Technic
% 220.24/220.39  |- skos__altLabel mesh__D003755 High-Speed Technics, Dental
% 220.24/220.39  |- skos__hiddenLabel mesh__D008440 Fractures, Maxillary
% 220.24/220.39  |- skos__prefLabel mesh__D008440 Maxillary Fractures
% 220.24/220.39  |- mesh__dateRevised mesh__D008440 2005-06-30
% 220.24/220.39  |- skos__broader mesh__D008440smesh__D007572
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D008440 2006
% 220.24/220.39  |- mesh__dateCreated mesh__D008440 1999-01-01
% 220.24/220.39  |- skos__scopeNote mesh__D008440 Fractures of the upper jaw.     
% 220.24/220.39  |- rdf__type mesh__D008440sskos__Concept
% 220.24/220.39  |- skos__hiddenLabel mesh__D008440 Fracture, Maxillary
% 220.24/220.39  |- mesh__recordAuthorizer mesh__D008440 sjn
% 220.24/220.39  |- mesh__historyNote mesh__D008440 66   
% 220.24/220.39  |- mesh__recordOriginator mesh__D008440 NLM
% 220.24/220.39  |- mesh__publicMeSHNote mesh__D008440 66   
% 220.24/220.39  |- skos__annotation mesh__D008440
% 220.24/220.39       must be of the MAXILLA, not for %22%jaws%22% %28% = JAW FRACTURES%29%%A%  
% 220.24/220.39  |- mesh__recordMaintainer mesh__D008440 ssb
% 220.24/220.39  |- skos__hiddenLabel mesh__D008440 Maxillary Fracture
% 220.24/220.39  |- skos__altLabel mesh__D013385 Succinic Oxidase
% 220.24/220.39  |- skos__hiddenLabel mesh__D013385 Oxidase, Succinic
% 220.24/220.39  |- mesh__recordAuthorizer mesh__D013385 sjn
% 220.24/220.39  |- mesh__dateCreated mesh__D013385 1999-01-01
% 220.24/220.39  |- skos__altLabel mesh__D013385 Succinic Dehydrogenase
% 220.24/220.39  |- skos__prefLabel mesh__D013385 Succinate Dehydrogenase
% 220.24/220.39  |- skos__hiddenLabel mesh__D013385 Dehydrogenase, Succinate
% 220.24/220.39  |- skos__altLabel mesh__D013385 Fumarate Reductase
% 220.24/220.39  |- skos__scopeNote mesh__D013385
% 220.24/220.39       A flavoprotein containing oxidoreductase that catalyzes the dehdyrogenation of SUCCINATE to FUMARATE. In most eukaryotic organisms this enzyme is a component of mitochondrial electron transport complex II.%A%    
% 220.24/220.39  |- rdf__type mesh__D013385sskos__Concept
% 220.24/220.39  |- skos__hiddenLabel mesh__D013385 Reductase, Fumarate
% 220.24/220.39  |- skos__broader mesh__D013385smesh__D044925
% 220.24/220.39  |- skos__broader mesh__D013385smesh__D042963
% 220.24/220.39  |- mesh__dateRevised mesh__D013385 2005-06-30
% 220.24/220.39  |- mesh__recordMaintainer mesh__D013385 jmp
% 220.24/220.39  |- skos__hiddenLabel mesh__D013385 Dehydrogenase, Succinic
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D013385 2006
% 220.24/220.39  |- mesh__recordOriginator mesh__D013385 NLM
% 220.24/220.39  |- skos__broader mesh__D009206Q000503smesh__D009206
% 220.24/220.39  |- mesh__preferredCombination mesh__D009206Q000503smesh__D006321Q000503
% 220.24/220.39  |- rdf__type mesh__D009206Q000503smesh__CompoundConcept
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D007348 2001
% 220.24/220.39  |- skos__broader mesh__D007348smesh__D007341
% 220.24/220.39  |- skos__altLabel mesh__D007348 Health Insurance
% 220.24/220.39  |- mesh__dateCreated mesh__D007348 1999-01-01
% 220.24/220.39  |- mesh__recordOriginator mesh__D007348 NLM
% 220.24/220.39  |- skos__annotation mesh__D007348
% 220.24/220.39       specify geog if possible; CHAMPUS: index under HEALTH BENEFIT PLANS, EMPLOYEE%A%  
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D007348 2005
% 220.24/220.39  |- skos__related mesh__D007348smesh__D010818
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D007348 2006
% 220.24/220.39  |- skos__hiddenLabel mesh__D007348 Health Insurance, Group
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D007348 2002
% 220.24/220.39  |- mesh__recordMaintainer mesh__D007348 kle
% 220.24/220.39  |- skos__hiddenLabel mesh__D007348 Insurance, Group Health
% 220.24/220.39  |- skos__hiddenLabel mesh__D007348 Voluntary Health Insurance
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D007348 2003
% 220.24/220.39  |- mesh__recordAuthorizer mesh__D007348 sjn
% 220.24/220.39  |- skos__related mesh__D007348smesh__D017057
% 220.24/220.39  |- mesh__dateRevised mesh__D007348 1999-11-03
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D007348 2004
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D007348 2000
% 220.24/220.39  |- skos__hiddenLabel mesh__D007348 Insurance, Voluntary Health
% 220.24/220.39  |- rdf__type mesh__D007348sskos__Concept
% 220.24/220.39  |- skos__scopeNote mesh__D007348
% 220.24/220.39       Insurance providing coverage of medical, surgical, or hospital care in general or for which there is no specific heading.%A%    
% 220.24/220.39  |- skos__prefLabel mesh__D007348 Insurance, Health
% 220.24/220.39  |- mesh__recordAuthorizer mesh__D018070 sjn
% 220.24/220.39  |- skos__altLabel mesh__D018070 Biological Substance Bank
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D018070 2002
% 220.24/220.39  |- mesh__dateCreated mesh__D018070 1993-06-04
% 220.24/220.39  |- skos__altLabel mesh__D018070 Substance Banks, Biological
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D018070 2001
% 220.24/220.39  |- skos__altLabel mesh__D018070 Substance Bank, Biological
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D018070 2004
% 220.24/220.39  |- mesh__historyNote mesh__D018070 94   
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D018070 2000
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D018070 2006
% 220.24/220.39  |- mesh__publicMeSHNote mesh__D018070 94   
% 220.24/220.39  |- rdf__type mesh__D018070sskos__Concept
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D018070 2003
% 220.24/220.39  |- skos__prefLabel mesh__D018070 Biological Specimen Banks
% 220.24/220.39  |- skos__altLabel mesh__D018070 Banks, Biological Specimen
% 220.24/220.39  |- skos__altLabel mesh__D018070 Biological Substance Banks
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D018070 2005
% 220.24/220.39  |- skos__altLabel mesh__D018070 Bank, Biological Specimen
% 220.24/220.39  |- mesh__recordOriginator mesh__D018070 JLS
% 220.24/220.39  |- skos__altLabel mesh__D018070 Specimen Bank, Biological
% 220.24/220.39  |- skos__broader mesh__D018070smesh__D006268
% 220.24/220.39  |- mesh__dateRevised mesh__D018070 1999-11-03
% 220.24/220.39  |- mesh__recordMaintainer mesh__D018070 KEV
% 220.24/220.39  |- skos__scopeNote mesh__D018070
% 220.24/220.39       Facilities that collect, store, and distribute tissues, e.g., cell lines, microorganisms, blood, sperm, milk, breast tissue, for use by others. Other uses may include transplantation and comparison of diseased tissues in the identification of cancer.%A%    
% 220.24/220.39  |- mesh__dateEstablished mesh__D018070 1994-01-01
% 220.24/220.39  |- skos__altLabel mesh__D018070 Specimen Banks, Biological
% 220.24/220.39  |- skos__annotation mesh__D018070
% 220.24/220.39       human or animal material; GEN or unspecified; prefer specifics; American Type Culture Collection %28%ATCC%29% goes here; DF: BIOL SPECIMEN BANKS%A%  
% 220.24/220.39  |- skos__altLabel mesh__D018070 Biological Specimen Bank
% 220.24/220.39  |- skos__altLabel mesh__D018070 Banks, Biological Substance
% 220.24/220.39  |- skos__altLabel mesh__D018070 Bank, Biological Substance
% 220.24/220.39  |- skos__historyNote mesh__D026502 Receptors, Immunologic %28%1990-2001%29%
% 220.24/220.39  |- skos__hiddenLabel mesh__D026502 Low Density Lipoprotein Related Proteins
% 220.24/220.39  |- mesh__recordMaintainer mesh__D026502 SYSTEM
% 220.24/220.39  |- skos__hiddenLabel mesh__D026502 LDL Receptor Related Proteins
% 220.24/220.39  |- mesh__dateRevised mesh__D026502 2005-06-30
% 220.24/220.39  |- mesh__dateEstablished mesh__D026502 2002-01-01
% 220.24/220.39  |- mesh__recordOriginator mesh__D026502 jmp
% 220.24/220.39  |- skos__broader mesh__D026502smesh__D011506
% 220.24/220.39  |- skos__prefLabel mesh__D026502 LDL-Receptor Related Proteins
% 220.24/220.39  |- mesh__publicMeSHNote mesh__D026502 2002   
% 220.24/220.39  |- mesh__recordAuthorizer mesh__D026502 sjn
% 220.24/220.39  |- mesh__dateCreated mesh__D026502 2001-07-25
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D026502 2006
% 220.24/220.39  |- skos__altLabel mesh__D026502 Low Density Lipoprotein-Related Proteins
% 220.24/220.39  |- mesh__historyNote mesh__D026502 2002   
% 220.24/220.39  |- skos__broader mesh__D026502smesh__D011973
% 220.24/220.39  |- skos__scopeNote mesh__D026502
% 220.24/220.39       A family of proteins that share sequence similarity with the low density lipoprotein receptor %28%RECEPTORS, LDL%29%.%A%    
% 220.24/220.39  |- rdf__type mesh__D026502sskos__Concept
% 220.24/220.39  |- skos__annotation mesh__D004050 D25-26 qualif   
% 220.24/220.39  |- skos__hiddenLabel mesh__D004050 Bismuth Salt Ditiocarb
% 220.24/220.39  |- skos__altLabel mesh__D004050 Dithiocarb
% 220.24/220.39  |- rdf__type mesh__D004050sskos__Concept
% 220.24/220.39  |- mesh__dateEstablished mesh__D004050 1987-01-01
% 220.24/220.39  |- mesh__dateRevised mesh__D004050 2001-07-25
% 220.24/220.39  |- skos__hiddenLabel mesh__D004050 Ammonium Salt Ditiocarb
% 220.24/220.39  |- skos__altLabel mesh__D004050 Diethylcarbamodithioic Acid
% 220.24/220.39  |- skos__historyNote mesh__D004050 Thiocarbamates %28%1969-1974%29%
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D004050 2002
% 220.24/220.39  |- skos__hiddenLabel mesh__D004050 Diethyldithiocarbamate, Sodium
% 220.24/220.39  |- mesh__recordOriginator mesh__D004050 NLM
% 220.24/220.39  |- mesh__dateCreated mesh__D004050 1974-11-19
% 220.24/220.39  |- skos__hiddenLabel mesh__D004050 Sodium, Ditiocarb
% 220.24/220.39  |- skos__altLabel mesh__D004050 Ditiocarb, Sodium Salt
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D004050 2006
% 220.24/220.39  |- mesh__onlineNote mesh__D004050
% 220.24/220.39       use DITIOCARB to search DIETHYLDITHIOCARBAMATE 1973-93   
% 220.24/220.39  |- skos__hiddenLabel mesh__D004050 Diethyldithiocarbamate, Zinc
% 220.24/220.39  |- skos__broader mesh__D004050smesh__D013859
% 220.24/220.39  |- mesh__recordMaintainer mesh__D004050 lkt
% 220.24/220.39  |- skos__hiddenLabel mesh__D004050 Lead Salt Ditiocarb
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D004050 2005
% 220.24/220.39  |- skos__altLabel mesh__D004050 Thiocarb
% 220.24/220.39  |- skos__scopeNote mesh__D004050
% 220.24/220.39       A chelating agent that has been used to mobilize toxic metals from the tissues of man and experimental animals. It is the main metabolite of DISULFIRAM.%A%    
% 220.24/220.39  |- mesh__publicMeSHNote mesh__D004050
% 220.24/220.39       94; was DIETHYLDITHIOCARBAMATE 1973-93 %28%see under THIOCARBAMATES 1973-86%29%; DITIOCARB was see DIETHYLDITHIOCARBAMATE 1992-93%A%  
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D004050 2004
% 220.24/220.39  |- skos__altLabel mesh__D004050 Zinc Diethyldithiocarbamate
% 220.24/220.39  |- skos__hiddenLabel mesh__D004050 Potassium Salt Ditiocarb
% 220.24/220.39  |- mesh__historyNote mesh__D004050
% 220.24/220.39       94; was DIETHYLDITHIOCARBAMATE 1973-93 %28%see under THIOCARBAMATES 1973-86%29%; DITIOCARB was see DIETHYLDITHIOCARBAMATE 1992-93%A%  
% 220.24/220.39  |- skos__hiddenLabel mesh__D004050 Zinc Salt Ditiocarb
% 220.24/220.39  |- skos__hiddenLabel mesh__D004050 Sodium Salt Ditiocarb
% 220.24/220.39  |- skos__altLabel mesh__D004050 Diethyldithiocarbamic Acid
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D004050 2003
% 220.24/220.39  |- mesh__recordAuthorizer mesh__D004050 sjn
% 220.24/220.39  |- skos__altLabel mesh__D004050 Sodium Diethyldithiocarbamate
% 220.24/220.39  |- skos__prefLabel mesh__D004050 Ditiocarb
% 220.24/220.39  |- mesh__publicMeSHNote mesh__D045467 2004   
% 220.24/220.39  |- rdf__type mesh__D045467sskos__Concept
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D045467 2006
% 220.24/220.39  |- skos__annotation mesh__D045467
% 220.24/220.39       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.24/220.39  |- skos__broader mesh__D045467smesh__D019684
% 220.24/220.39  |- skos__prefLabel mesh__D045467 Elaeocarpaceae
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D045467 2005
% 220.24/220.39  |- skos__scopeNote mesh__D045467
% 220.24/220.39       A plant family of the order Malvales, subclass Dilleniidae, class Magnoliopsida.%A%    
% 220.24/220.39  |- mesh__dateEstablished mesh__D045467 2004-01-01
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D045467 2004
% 220.24/220.39  |- mesh__historyNote mesh__D045467 2004   
% 220.24/220.39  |- mesh__dateCreated mesh__D045467 2003-07-09
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D017776 2005
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D017776 2002
% 220.24/220.39  |- skos__hiddenLabel mesh__D017776 Nerves, Autonomic
% 220.24/220.39  |- mesh__dateEstablished mesh__D017776 1994-01-01
% 220.24/220.39  |- skos__prefLabel mesh__D017776 Autonomic Pathways
% 220.24/220.39  |- skos__hiddenLabel mesh__D017776 Autonomic Nerve
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D017776 2001
% 220.24/220.39  |- mesh__historyNote mesh__D017776 94   
% 220.24/220.39  |- mesh__dateCreated mesh__D017776 1993-06-18
% 220.24/220.39  |- skos__broader mesh__D017776smesh__D001341
% 220.24/220.39  |- skos__historyNote mesh__D017776
% 220.24/220.39       Autonomic Nervous System %28%1966-1993%29%
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D017776 1997
% 220.24/220.39  |- skos__hiddenLabel mesh__D017776 Pathways, Autonomic
% 220.24/220.39  |- mesh__publicMeSHNote mesh__D017776 94   
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D017776 1999
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D017776 2000
% 220.24/220.39  |- skos__hiddenLabel mesh__D017776 Autonomic Pathway
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D017776 2004
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D017776 1996
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D017776 1995
% 220.24/220.39  |- skos__hiddenLabel mesh__D017776 Nerve, Autonomic
% 220.24/220.39  |- skos__scopeNote mesh__D017776
% 220.24/220.39       Nerves and plexuses of the autonomic nervous system. The central nervous system structures which regulate the autonomic nervous system are not included.%A%    
% 220.24/220.39  |- rdf__type mesh__D017776sskos__Concept
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D017776 1998
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D017776 2006
% 220.24/220.39  |- skos__broader mesh__D017776smesh__D010525
% 220.24/220.39  |- skos__hiddenLabel mesh__D017776 Pathway, Autonomic
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D017776 2003
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D017776 1994
% 220.24/220.39  |- rdf__type mesh__D031447sskos__Concept
% 220.24/220.39  |- mesh__dateCreated mesh__D031447 2002-07-03
% 220.24/220.39  |- skos__prefLabel mesh__D031447 Tulipa
% 220.24/220.39  |- mesh__dateEstablished mesh__D031447 2003-01-01
% 220.24/220.39  |- mesh__historyNote mesh__D031447 2003   
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D031447 2005
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D031447 2003
% 220.24/220.39  |- skos__annotation mesh__D031447
% 220.24/220.39       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.24/220.39  |- skos__altLabel mesh__D031447 Tulip
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D031447 2006
% 220.24/220.39  |- skos__scopeNote mesh__D031447
% 220.24/220.39       A plant genus of the family LILIACEAE. Members contain tuliposides and tulipalins and have been associated with allergic contact dermatitis in florists.%A%    
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D031447 2004
% 220.24/220.39  |- skos__broader mesh__D031447smesh__D019668
% 220.24/220.39  |- mesh__publicMeSHNote mesh__D031447 2003   
% 220.24/220.39  |- skos__hiddenLabel mesh__D050601 L Kynurenine 3 Hydroxylase
% 220.24/220.39  |- skos__altLabel mesh__D050601 L-Kynurenine-3-Hydroxylase
% 220.24/220.39  |- mesh__dateEstablished mesh__D050601 2006-01-01
% 220.24/220.39  |- mesh__recordMaintainer mesh__D050601 ags
% 220.24/220.39  |- skos__hiddenLabel mesh__D050601 3-Hydroxylase, Kynurenine
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D050601 2006A
% 220.24/220.39  |- skos__hiddenLabel mesh__D050601 Hydroxylase, Kynurenine
% 220.24/220.39  |- mesh__dateCreated mesh__D050601 2005-06-30
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D050601 2006
% 220.24/220.39  |- mesh__historyNote mesh__D050601
% 220.24/220.39       2006%28%1980%29%; KYNURENINE 1973-1979   
% 220.24/220.39  |- rdf__type mesh__D050601sskos__Concept
% 220.24/220.39  |- skos__scopeNote mesh__D050601
% 220.24/220.39       An NADPH-dependent flavin monooxygenase that plays a key role in the catabolism of TRYPTOPHAN by catalyzing the HYDROXYLATION of KYNURENINE to 3-hydroxykynurenine. It was formerly characterized as EC 1.14.1.2 and  EC 1.99.1.5.%A%    
% 220.24/220.39  |- skos__hiddenLabel mesh__D050601 Kynurenine 3 Monooxygenase
% 220.24/220.39  |- skos__hiddenLabel mesh__D050601 Kynurenine 3 Hydroxylase
% 220.24/220.39  |- mesh__recordAuthorizer mesh__D050601 ags
% 220.24/220.39  |- skos__prefLabel mesh__D050601 Kynurenine 3-Monooxygenase
% 220.24/220.39  |- mesh__publicMeSHNote mesh__D050601
% 220.24/220.39       2006; KYNURENINE 3-MONOOXYGENASE was indexed under MIXED FUNCTION OXYGENASES 1981-2005, %26% under KYNURENINE 1973-1980%A%  
% 220.24/220.39  |- skos__altLabel mesh__D050601 Kynurenine 3-Hydroxylase
% 220.24/220.39  |- skos__broader mesh__D050601smesh__D006899
% 220.24/220.39  |- mesh__recordOriginator mesh__D050601 AKE
% 220.24/220.39  |- skos__altLabel mesh__D050601 Kynurenine Hydroxylase
% 220.24/220.39  |- skos__hiddenLabel mesh__D050601 3-Monooxygenase, Kynurenine
% 220.24/220.39  |- mesh__dateRevised mesh__D050601 2005-07-14
% 220.24/220.39  |- mesh__historyNote mesh__D003756 65   
% 220.24/220.39  |- mesh__recordOriginator mesh__D003756 NLM
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D003756 2002
% 220.24/220.39  |- skos__scopeNote mesh__D003756
% 220.24/220.39       Persons trained in an accredited school or dental college and licensed by the state in which they reside to provide dental prophylaxis under the direction of a licensed dentist.%A%    
% 220.24/220.39  |- mesh__dateEstablished mesh__D003756 1965-01-01
% 220.24/220.39  |- skos__altLabel mesh__D003756 Hygienists, Dental
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D003756 2005
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D003756 1995
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D003756 1996
% 220.24/220.39  |- skos__broader mesh__D003756smesh__D003727
% 220.24/220.39  |- mesh__recordMaintainer mesh__D003756 TAP
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D003756 2006
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D003756 1997
% 220.24/220.39  |- skos__annotation mesh__D003756
% 220.24/220.39       trained in accredited schools %26% licensed to practice DENTAL PROPHYLAXIS %28%see note there%29% under a licensed dentist; DF: DENT HYGIENISTS%A%  
% 220.24/220.39  |- skos__altLabel mesh__D003756 Dental Hygienist
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D003756 1998
% 220.24/220.39  |- mesh__dateRevised mesh__D003756 1992-05-14
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D003756 2000
% 220.24/220.39  |- skos__altLabel mesh__D003756 Hygienist, Dental
% 220.24/220.39  |- rdf__type mesh__D003756sskos__Concept
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D003756 2003
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D003756 1993
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D003756 1999
% 220.24/220.39  |- mesh__dateCreated mesh__D003756 1999-01-01
% 220.24/220.39  |- mesh__publicMeSHNote mesh__D003756 65   
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D003756 2001
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D003756 2004
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D003756 1994
% 220.24/220.39  |- mesh__recordAuthorizer mesh__D003756 PLS
% 220.24/220.39  |- skos__prefLabel mesh__D003756 Dental Hygienists
% 220.24/220.39  |- skos__broader mesh__D008441smesh__D007573
% 220.24/220.39  |- mesh__dateCreated mesh__D008441 1999-01-01
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D008441 2001
% 220.24/220.39  |- rdf__type mesh__D008441sskos__Concept
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D008441 2002
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D008441 2003
% 220.24/220.39  |- skos__prefLabel mesh__D008441 Maxillary Neoplasms
% 220.24/220.39  |- mesh__dateRevised mesh__D008441 2000-06-22
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D008441 2004
% 220.24/220.39  |- skos__hiddenLabel mesh__D008441 Neoplasms, Maxillary
% 220.24/220.39  |- skos__hiddenLabel mesh__D008441 Maxillary Neoplasm
% 220.24/220.39  |- mesh__recordMaintainer mesh__D008441 nns
% 220.24/220.39  |- skos__scopeNote mesh__D008441
% 220.24/220.39       Cancer or tumors of the MAXILLA or upper jaw.     
% 220.24/220.39  |- mesh__recordAuthorizer mesh__D008441 sjn
% 220.24/220.39  |- skos__broader mesh__D008441smesh__D008439
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D008441 2005
% 220.24/220.39  |- skos__hiddenLabel mesh__D008441 Neoplasm, Maxillary
% 220.24/220.39  |- skos__annotation mesh__D008441
% 220.24/220.39       must be of the MAXILLA, not for %22%jaws%22% %28% = JAW NEOPLASMS%29%; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%  
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D008441 2006
% 220.24/220.39  |- mesh__recordOriginator mesh__D008441 NLM
% 220.24/220.39  |- mesh__recordAuthorizer mesh__D013386 SJN
% 220.24/220.39  |- skos__scopeNote mesh__D013386
% 220.24/220.39       The salts and esters of SUCCINIC ACID and its derivatives.%A%    
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D013386 2002
% 220.24/220.39  |- skos__prefLabel mesh__D013386 Succinates
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D013386 2001
% 220.24/220.39  |- rdf__type mesh__D013386sskos__Concept
% 220.24/220.39  |- mesh__recordOriginator mesh__D013386 NLM
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D013386 2004
% 220.24/220.39  |- skos__broader mesh__D013386smesh__D019802
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D013386 2000
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D013386 1999
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D013386 2006
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D013386 2003
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D013386 1998
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D013386 2005
% 220.24/220.39  |- mesh__recordMaintainer mesh__D013386 KEV
% 220.24/220.39  |- mesh__dateRevised mesh__D013386 1997-06-20
% 220.24/220.39  |- mesh__dateCreated mesh__D013386 1999-01-01
% 220.24/220.39  |- skos__hiddenLabel mesh__D007349 Third Party Payments
% 220.24/220.39  |- mesh__recordAuthorizer mesh__D007349 sjn
% 220.24/220.39  |- skos__broader mesh__D007349smesh__D005381
% 220.24/220.39  |- skos__hiddenLabel mesh__D007349 Payment, Third-Party
% 220.24/220.39  |- skos__altLabel mesh__D007349 Third-Party Payments
% 220.24/220.39  |- rdf__type mesh__D007349sskos__Concept
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D007349 2002
% 220.24/220.39  |- skos__hiddenLabel mesh__D007349 Payer, Third-Party
% 220.24/220.39  |- skos__hiddenLabel mesh__D007349 Third Party Payers
% 220.24/220.39  |- skos__hiddenLabel mesh__D007349 Health Insurance Reimbursements
% 220.24/220.39  |- mesh__dateRevised mesh__D007349 1999-11-03
% 220.24/220.39  |- mesh__historyNote mesh__D007349
% 220.24/220.39       82 %28%Aug 77%29%; was see under INSURANCE, HEALTH Aug 77-81   
% 220.24/220.39  |- skos__hiddenLabel mesh__D007349 Third-Party Payment
% 220.24/220.39  |- skos__broader mesh__D007349smesh__D007348
% 220.24/220.39  |- skos__altLabel mesh__D007349 Reimbursement, Health Insurance
% 220.24/220.39  |- skos__scopeNote mesh__D007349
% 220.24/220.39       Payment by a third-party payer in a sum equal to the amount expended by a health care provider or facility for health services rendered to an insured or program beneficiary. %28%From Facts on File Dictionary of Health Care Management, 1988%29%%A%    
% 220.24/220.39  |- skos__hiddenLabel mesh__D007349 Third-Party Payer
% 220.24/220.39  |- skos__hiddenLabel mesh__D007349 Insurance Reimbursement, Health
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D007349 2006
% 220.24/220.39  |- mesh__recordOriginator mesh__D007349 EC
% 220.24/220.39  |- skos__hiddenLabel mesh__D007349 Payments, Third-Party
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D007349 2001
% 220.24/220.39  |- skos__hiddenLabel mesh__D007349 Payers, Third-Party
% 220.24/220.39  |- skos__altLabel mesh__D007349 Health Insurance Reimbursement
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D007349 2004
% 220.24/220.39  |- skos__annotation mesh__D007349 specify geog if possible   
% 220.24/220.39  |- mesh__activeMeSHYear mesh__D007349 2005
% 220.24/220.40  |- mesh__dateCreated mesh__D007349 1977-05-11
% 220.24/220.40  |- mesh__dateEstablished mesh__D007349 1982-01-01
% 220.24/220.40  |- mesh__recordMaintainer mesh__D007349 kle
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D007349 2000
% 220.24/220.40  |- skos__hiddenLabel mesh__D007349 Insurance Reimbursements, Health
% 220.24/220.40  |- skos__prefLabel mesh__D007349 Insurance, Health, Reimbursement
% 220.24/220.40  |- skos__hiddenLabel mesh__D007349 Reimbursements, Health Insurance
% 220.24/220.40  |- mesh__publicMeSHNote mesh__D007349
% 220.24/220.40       82; was indexed under INSURANCE, HEALTH Aug 77-81   
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D007349 2003
% 220.24/220.40  |- skos__prefLabel mesh__D018071 Polydnaviridae
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D018071 1997
% 220.24/220.40  |- mesh__dateEstablished mesh__D018071 1994-01-01
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D018071 2006
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D018071 1999
% 220.24/220.40  |- rdf__type mesh__D018071sskos__Concept
% 220.24/220.40  |- skos__hiddenLabel mesh__D018071 Viruses, Braconid
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D018071 2003
% 220.24/220.40  |- mesh__publicMeSHNote mesh__D018071
% 220.24/220.40       94; BRACONID VIRUSES was see BACULOVIRIDAE 1991-93   
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D018071 2005
% 220.24/220.40  |- skos__scopeNote mesh__D018071
% 220.24/220.40       A family of insect viruses isolated from endoparasitic hymenopteran insects belonging to the families Ichneumonidae and Braconidae. The two genera are Ichnovirus and Bracovirus.%A%    
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D018071 1998
% 220.24/220.40  |- skos__historyNote mesh__D018071 Insect Viruses %28%1984-1993%29%
% 220.24/220.40  |- mesh__historyNote mesh__D018071
% 220.24/220.40       94; BRACONID VIRUSES was see BACULOVIRIDAE 1991-93   
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D018071 2002
% 220.24/220.40  |- skos__broader mesh__D018071smesh__D007304
% 220.24/220.40  |- mesh__dateCreated mesh__D018071 1993-06-04
% 220.24/220.40  |- skos__broader mesh__D018071smesh__D004267
% 220.24/220.40  |- skos__hiddenLabel mesh__D018071 Braconid Virus
% 220.24/220.40  |- mesh__recordOriginator mesh__D018071 AGS
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D018071 2001
% 220.24/220.40  |- skos__annotation mesh__D018071
% 220.24/220.40       a family of insect viruses infecting hymenopterans; from POLY %28%several or many%29% DNA viruses; coord IM with specific insect /virol %28%IM%29%%A%  
% 220.24/220.40  |- skos__hiddenLabel mesh__D018071 Virus, Braconid
% 220.24/220.40  |- mesh__onlineNote mesh__D018071
% 220.24/220.40       use BACULOVIRIDAE to search BRACONID VIRUSES 1991-93   
% 220.24/220.40  |- mesh__recordMaintainer mesh__D018071 AGS
% 220.24/220.40  |- mesh__recordAuthorizer mesh__D018071 PLS
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D018071 2000
% 220.24/220.40  |- mesh__dateRevised mesh__D018071 1996-06-10
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D018071 2004
% 220.24/220.40  |- skos__broader mesh__D026503smesh__D026502
% 220.24/220.40  |- skos__altLabel mesh__D026503 ApoE Receptor
% 220.24/220.40  |- skos__historyNote mesh__D026503 Receptors, Immunologic %28%1981-2001%29%
% 220.24/220.40  |- skos__hiddenLabel mesh__D026503
% 220.24/220.40       Receptor-Related Protein-1, Low-Density-Lipoprotein
% 220.24/220.40  |- skos__hiddenLabel mesh__D026503 Receptor, ApoE
% 220.24/220.40  |- mesh__dateEstablished mesh__D026503 2002-01-01
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D026503 2003
% 220.24/220.40  |- skos__hiddenLabel mesh__D026503 alpha2 Macroglobulin Signaling Receptor
% 220.24/220.40  |- mesh__historyNote mesh__D026503
% 220.24/220.40       2002; for ALPHA-2-MACROGLOBULIN RECEPTOR %26% APOLIPOPROTEIN E RECEPTOR use LDL-RECEPTOR RELATED PROTEIN 1 %28%NM%29% 1981-2001%A%  
% 220.24/220.40  |- skos__prefLabel mesh__D026503 LDL-Receptor Related Protein 1
% 220.24/220.40  |- skos__altLabel mesh__D026503 Apo E Receptor
% 220.24/220.40  |- skos__related mesh__D026503smesh__D001057
% 220.24/220.40  |- skos__hiddenLabel mesh__D026503 alpha 2 Macroglobulin Receptor
% 220.24/220.40  |- mesh__recordOriginator mesh__D026503 jmp
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D026503 2004
% 220.24/220.40  |- skos__altLabel mesh__D026503 Receptor, Apo E
% 220.24/220.40  |- mesh__recordAuthorizer mesh__D026503 sjn
% 220.24/220.40  |- skos__annotation mesh__D026503 DF: RECEPT APO E   
% 220.24/220.40  |- skos__altLabel mesh__D026503 LDL-Receptor Related Protein
% 220.24/220.40  |- skos__historyNote mesh__D026503
% 220.24/220.40       Receptors, Endogenous Substances %28%1981-1993%29%
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D026503 2005
% 220.24/220.40  |- mesh__dateCreated mesh__D026503 2001-07-25
% 220.24/220.40  |- skos__altLabel mesh__D026503 Apolipoprotein E Receptor
% 220.24/220.40  |- skos__altLabel mesh__D026503 alpha-2-Macroglobulin Receptor
% 220.24/220.40  |- skos__hiddenLabel mesh__D026503 alpha-2 Macroglobulin Receptor
% 220.24/220.40  |- skos__altLabel mesh__D026503 Receptor, alpha-2 Macroglobulin
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D026503 2002
% 220.24/220.40  |- skos__altLabel mesh__D026503 alpha2-Macroglobulin Signaling Receptor
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D026503 2006
% 220.24/220.40  |- skos__hiddenLabel mesh__D026503 LDL Receptor Related Protein 1
% 220.24/220.40  |- skos__altLabel mesh__D026503
% 220.24/220.40       Low Density Lipoprotein Receptor-Related Protein
% 220.24/220.40  |- rdf__type mesh__D026503sskos__Concept
% 220.24/220.40  |- skos__scopeNote mesh__D026503
% 220.24/220.40       A LDL-receptor related protein involved in clearance of chylomicron remnants and of activated ALPHA-MACROGLOBULINS from plasma.%A%    
% 220.24/220.40  |- skos__historyNote mesh__D026503 Receptors, Lipoprotein %28%1994-2001%29%
% 220.24/220.40  |- skos__altLabel mesh__D026503 Receptor, Apolipoprotein E
% 220.24/220.40  |- skos__altLabel mesh__D026503
% 220.24/220.40       Low-Density-Lipoprotein Receptor-Related Protein-1
% 220.24/220.40  |- mesh__publicMeSHNote mesh__D026503
% 220.24/220.40       2002; ALPHA-2-MACROGLOBULIN RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1981-2000; APOLIPOPROTEIN E RECEPTOR was indexed under RECEPTORS, LIPOPROTEIN 1994-2001 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1981-1993%A%  
% 220.24/220.40  |- mesh__recordMaintainer mesh__D026503 jmp
% 220.24/220.40  |- skos__hiddenLabel mesh__D026503 LDL Receptor Related Protein
% 220.24/220.40  |- skos__broader mesh__D004051smesh__D010795
% 220.24/220.40  |- skos__hiddenLabel mesh__D004051 Di 2 Ethylhexylphthalate
% 220.24/220.40  |- skos__hiddenLabel mesh__D004051 Phthalate, Diethylhexyl
% 220.24/220.40  |- mesh__historyNote mesh__D004051
% 220.24/220.40       91%28%75%29%; was see under PHTHALIC ACIDS 1975-90   
% 220.24/220.40  |- mesh__recordAuthorizer mesh__D004051 sjn
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004051 2006
% 220.24/220.40  |- skos__altLabel mesh__D004051 DEHP
% 220.24/220.40  |- mesh__recordMaintainer mesh__D004051 ssb
% 220.24/220.40  |- mesh__publicMeSHNote mesh__D004051
% 220.24/220.40       91; was see under PHTHALIC ACIDS 1975-90   
% 220.24/220.40  |- skos__prefLabel mesh__D004051 Diethylhexyl Phthalate
% 220.24/220.40  |- skos__historyNote mesh__D004051 Phthalic Acids %28%1969-1974%29%
% 220.24/220.40  |- mesh__dateRevised mesh__D004051 2005-06-30
% 220.24/220.40  |- skos__hiddenLabel mesh__D004051 Phthalate, Dioctyl
% 220.24/220.40  |- skos__altLabel mesh__D004051 Di-2-Ethylhexylphthalate
% 220.24/220.40  |- mesh__recordOriginator mesh__D004051 NLM
% 220.24/220.40  |- skos__altLabel mesh__D004051 Bis%28%2-ethylhexyl%29%phthalate
% 220.24/220.40  |- skos__altLabel mesh__D004051 Dioctyl Phthalate
% 220.24/220.40  |- skos__scopeNote mesh__D004051
% 220.24/220.40       An ester of phthalic acid. It appears as a light-colored, odorless liquid and is used as a plasticizer for many resins and elastomers.%A%    
% 220.24/220.40  |- mesh__dateCreated mesh__D004051 1974-11-27
% 220.24/220.40  |- mesh__dateEstablished mesh__D004051 1991-01-01
% 220.24/220.40  |- skos__historyNote mesh__D004051 Esters %28%1974%29%
% 220.24/220.40  |- rdf__type mesh__D004051sskos__Concept
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D045468 2005
% 220.24/220.40  |- skos__prefLabel mesh__D045468 Polygonum cuspidatum
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D045468 2004
% 220.24/220.40  |- skos__altLabel mesh__D045468 Knotweed, Japanese
% 220.24/220.40  |- skos__broader mesh__D045468smesh__D028502
% 220.24/220.40  |- skos__altLabel mesh__D045468 Fallopia japonica
% 220.24/220.40  |- mesh__dateCreated mesh__D045468 2003-07-09
% 220.24/220.40  |- skos__scopeNote mesh__D045468
% 220.24/220.40       A plant species of the family POLYGONACEAE. Itadori tea is prepared from the root of this genus.%A%    
% 220.24/220.40  |- mesh__dateEstablished mesh__D045468 2004-01-01
% 220.24/220.40  |- skos__altLabel mesh__D045468 Japanese Knotweed
% 220.24/220.40  |- mesh__publicMeSHNote mesh__D045468 2004   
% 220.24/220.40  |- rdf__type mesh__D045468sskos__Concept
% 220.24/220.40  |- mesh__historyNote mesh__D045468 2004   
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D045468 2006
% 220.24/220.40  |- skos__annotation mesh__D045468
% 220.24/220.40       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.24/220.40  |- skos__broader mesh__D017777smesh__D010275
% 220.24/220.40  |- mesh__historyNote mesh__D017777 94   
% 220.24/220.40  |- mesh__dateCreated mesh__D017777 1993-06-18
% 220.24/220.40  |- skos__prefLabel mesh__D017777 Parasympathetic Fibers, Postganglionic
% 220.24/220.40  |- skos__hiddenLabel mesh__D017777 Fiber, Postganglionic Parasympathetic
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D017777 1997
% 220.24/220.40  |- skos__historyNote mesh__D017777
% 220.24/220.40       Autonomic Fibers, Postganglionic %28%1971-1993%29%
% 220.24/220.40  |- skos__hiddenLabel mesh__D017777 Postganglionic Parasympathetic Fiber
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D017777 2002
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D017777 1999
% 220.24/220.40  |- mesh__dateEstablished mesh__D017777 1994-01-01
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D017777 2004
% 220.24/220.40  |- skos__annotation mesh__D017777
% 220.24/220.40       do not confuse with SYMPATHETIC FIBERS, POSTGANGLIONIC   
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D017777 1996
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D017777 1995
% 220.24/220.40  |- skos__broader mesh__D017777smesh__D001338
% 220.24/220.40  |- rdf__type mesh__D017777sskos__Concept
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D017777 2001
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D017777 1998
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D017777 2006
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D017777 2003
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D017777 1994
% 220.24/220.40  |- skos__hiddenLabel mesh__D017777 Fibers, Postganglionic Parasympathetic
% 220.24/220.40  |- skos__hiddenLabel mesh__D017777 Postganglionic Parasympathetic Fibers
% 220.24/220.40  |- mesh__publicMeSHNote mesh__D017777 94   
% 220.24/220.40  |- skos__historyNote mesh__D017777 Ganglia, Autonomic %28%1966-1970%29%
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D017777 2000
% 220.24/220.40  |- skos__hiddenLabel mesh__D017777 Parasympathetic Fiber, Postganglionic
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D017777 2005
% 220.24/220.40  |- skos__scopeNote mesh__D017777
% 220.24/220.40       Nerve fibers which project from parasympathetic ganglia to synapses on target organs. Parasympathetic postganglionic fibers use acetylcholine as transmitter. They may also release peptide cotransmitters.%A%    
% 220.24/220.40  |- skos__broader mesh__D017777smesh__D002799
% 220.24/220.40  |- mesh__publicMeSHNote mesh__D031448 2003   
% 220.24/220.40  |- mesh__dateCreated mesh__D031448 2002-07-03
% 220.24/220.40  |- skos__annotation mesh__D031448
% 220.24/220.40       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.24/220.40  |- skos__prefLabel mesh__D031448 Urginea
% 220.24/220.40  |- skos__broader mesh__D031448smesh__D019668
% 220.24/220.40  |- mesh__historyNote mesh__D031448 2003   
% 220.24/220.40  |- skos__scopeNote mesh__D031448
% 220.24/220.40       A plant genus of the family LILIACEAE that contains bufadienolides %28%BUFANOLIDES%29%. The common name of squill is also used for SCILLA.%A%    
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D031448 2004
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D031448 2006
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D031448 2003
% 220.24/220.40  |- mesh__dateEstablished mesh__D031448 2003-01-01
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D031448 2005
% 220.24/220.40  |- rdf__type mesh__D031448sskos__Concept
% 220.24/220.40  |- mesh__recordOriginator mesh__D050602 AKE
% 220.24/220.40  |- rdf__type mesh__D050602sskos__Concept
% 220.24/220.40  |- skos__hiddenLabel mesh__D050602 Linoleic Acid Delta 6 Desaturase
% 220.24/220.40  |- skos__altLabel mesh__D050602 Fatty Acid Delta-6-Desaturase
% 220.24/220.40  |- skos__altLabel mesh__D050602 Linoleoyl CoA Desaturase
% 220.24/220.40  |- skos__hiddenLabel mesh__D050602 Desaturase, Linoleoyl-CoA
% 220.24/220.40  |- skos__hiddenLabel mesh__D050602 Fatty Acid Delta 6 Desaturase
% 220.24/220.40  |- mesh__historyNote mesh__D050602 2006%28%1981%29%   
% 220.24/220.40  |- skos__hiddenLabel mesh__D050602 Delta 6 FADTase
% 220.24/220.40  |- skos__altLabel mesh__D050602 Delta%28%6%29%-Desaturase
% 220.24/220.40  |- skos__altLabel mesh__D050602 Delta-6-FADTase
% 220.24/220.40  |- skos__altLabel mesh__D050602 Linoleic Acid Delta-6 Desaturase
% 220.24/220.40  |- skos__hiddenLabel mesh__D050602 Desaturase, Linoleoyl CoA
% 220.24/220.40  |- skos__scopeNote mesh__D050602
% 220.24/220.40       An enzyme that catalyzes the syn-dehydrogenation of linoleol-CoA gamma-linolenoyl-CoA. It was formerly characterized as EC 1.14.99.25.%A%    
% 220.24/220.40  |- skos__prefLabel mesh__D050602 Linoleoyl-CoA Desaturase
% 220.24/220.40  |- mesh__dateEstablished mesh__D050602 2006-01-01
% 220.24/220.40  |- mesh__recordMaintainer mesh__D050602 AKE
% 220.24/220.40  |- mesh__recordAuthorizer mesh__D050602 sjn
% 220.24/220.40  |- skos__altLabel mesh__D050602 Linoleoyl Coenzyme A Desaturase
% 220.24/220.40  |- skos__hiddenLabel mesh__D050602 Delta-6-Desaturase, Fatty Acid
% 220.24/220.40  |- skos__hiddenLabel mesh__D050602 Acid Delta-6-Desaturase, Fatty
% 220.24/220.40  |- skos__broader mesh__D050602smesh__D044943
% 220.24/220.40  |- skos__altLabel mesh__D050602 Delta-6 Fatty Acid Desaturase
% 220.24/220.40  |- skos__hiddenLabel mesh__D050602 Delta 6 Desaturase
% 220.24/220.40  |- skos__hiddenLabel mesh__D050602 Delta 6 Fatty Acid Desaturase
% 220.24/220.40  |- mesh__publicMeSHNote mesh__D050602
% 220.24/220.40       2006; LINOLEOYL-COA DESATURASE was indexed under FATTY ACID DESATURASES 1981-2005%A%  
% 220.24/220.40  |- mesh__dateCreated mesh__D050602 2005-06-30
% 220.24/220.40  |- skos__hiddenLabel mesh__D050602 CoA Desaturase, Linoleoyl
% 220.24/220.40  |- skos__altLabel mesh__D050602 Delta-6-Desaturase
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D050602 2006
% 220.24/220.40  |- skos__broader mesh__D003757smesh__D011476
% 220.24/220.40  |- mesh__publicMeSHNote mesh__D003757 65   
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D003757 2001
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D003757 2006
% 220.24/220.40  |- skos__broader mesh__D003757smesh__D019919
% 220.24/220.40  |- mesh__recordMaintainer mesh__D003757 PXP
% 220.24/220.40  |- mesh__recordOriginator mesh__D003757 NLM
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D003757 2002
% 220.24/220.40  |- mesh__dateEstablished mesh__D003757 1965-01-01
% 220.24/220.40  |- skos__altLabel mesh__D003757 Dental Prosthesis Implantation
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D003757 1998
% 220.24/220.40  |- rdf__type mesh__D003757sskos__Concept
% 220.24/220.40  |- skos__prefLabel mesh__D003757 Dental Implantation
% 220.24/220.40  |- skos__broader mesh__D003757smesh__D003813
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D003757 2003
% 220.24/220.40  |- skos__altLabel mesh__D003757 Implantation, Dental Prosthesis
% 220.24/220.40  |- mesh__recordAuthorizer mesh__D003757 SJN
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D003757 1999
% 220.24/220.40  |- mesh__dateCreated mesh__D003757 1999-01-01
% 220.24/220.40  |- mesh__dateRevised mesh__D003757 1997-06-20
% 220.24/220.40  |- skos__annotation mesh__D003757
% 220.24/220.40       GEN or unspecified; prefer specifics; implantation of a foreign material into jaw tissue %28%e.g., gingival or subperiosteal%29%, the procedure: do not confuse with DENTAL IMPLANTS, the implant itself; differentiate from TOOTH REPLANTATION %28%reinsertion of a tooth lost by trauma or deliberate extraction%29%; do not use /util except by MeSH definition; DF: DENT IMPLANTATION%A%  
% 220.24/220.40  |- skos__hiddenLabel mesh__D003757 Implantations, Dental Prosthesis
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D003757 2004
% 220.24/220.40  |- skos__altLabel mesh__D003757 Prosthesis Implantation, Dental
% 220.24/220.40  |- skos__altLabel mesh__D003757 Implantation, Dental
% 220.24/220.40  |- skos__scopeNote mesh__D003757
% 220.24/220.40       The grafting or inserting of a prosthetic device of alloplastic material into the oral tissue beneath the mucosal or periosteal layer or within the bone. Its purpose is to provide support and retention to a partial or complete denture.%A%    
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D003757 2000
% 220.24/220.40  |- mesh__historyNote mesh__D003757 65   
% 220.24/220.40  |- skos__hiddenLabel mesh__D003757 Dental Prosthesis Implantations
% 220.24/220.40  |- skos__related mesh__D003757smesh__D015921
% 220.24/220.40  |- skos__broader mesh__D003757smesh__D013516
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D003757 2005
% 220.24/220.40  |- skos__hiddenLabel mesh__D003757 Prosthesis Implantations, Dental
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D008442 2002
% 220.24/220.40  |- skos__annotation mesh__D008442
% 220.24/220.40       a branch of the trigeminal %28%5th cranial%29% nerve; dis: coord IM with CRANIAL NERVE DISEASES %28%IM%29%; neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 220.24/220.40  |- skos__hiddenLabel mesh__D008442 Superior Alveolar Nerve
% 220.24/220.40  |- mesh__dateRevised mesh__D008442 1998-06-10
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D008442 1999
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D008442 2006
% 220.24/220.40  |- mesh__recordAuthorizer mesh__D008442 SJN
% 220.24/220.40  |- skos__hiddenLabel mesh__D008442 Nerves, Maxillary
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D008442 2001
% 220.24/220.40  |- skos__broader mesh__D008442smesh__D014276
% 220.24/220.40  |- mesh__recordOriginator mesh__D008442 NLM
% 220.24/220.40  |- skos__scopeNote mesh__D008442
% 220.24/220.40       The intermediate sensory division of the trigeminal %28%5th cranial%29% nerve. The maxillary nerve carries general afferents from the intermediate region of the face including the lower eyelid, nose and upper lip, the maxillary teeth, and parts of the dura.%A%    
% 220.24/220.40  |- skos__hiddenLabel mesh__D008442 Nerves, Superior Alveolar
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D008442 2000
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D008442 2005
% 220.24/220.40  |- skos__hiddenLabel mesh__D008442 Maxillary Nerves
% 220.24/220.40  |- rdf__type mesh__D008442sskos__Concept
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D008442 2004
% 220.24/220.40  |- skos__hiddenLabel mesh__D008442 Nerve, Maxillary
% 220.24/220.40  |- skos__hiddenLabel mesh__D008442 Alveolar Nerves, Superior
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D008442 2003
% 220.24/220.40  |- skos__prefLabel mesh__D008442 Maxillary Nerve
% 220.24/220.40  |- mesh__recordMaintainer mesh__D008442 MSR
% 220.24/220.40  |- mesh__dateCreated mesh__D008442 1999-01-01
% 220.24/220.40  |- skos__hiddenLabel mesh__D008442 Nerve, Superior Alveolar
% 220.24/220.40  |- skos__hiddenLabel mesh__D008442 Superior Alveolar Nerves
% 220.24/220.40  |- skos__broader mesh__D013387smesh__D013386
% 220.24/220.40  |- skos__historyNote mesh__D013387 Succinates %28%1966-1978%29%
% 220.24/220.40  |- skos__broader mesh__D013387smesh__D000812
% 220.24/220.40  |- rdf__type mesh__D013387sskos__Concept
% 220.24/220.40  |- mesh__recordOriginator mesh__D013387 RLS
% 220.24/220.40  |- mesh__dateCreated mesh__D013387 1977-12-22
% 220.24/220.40  |- mesh__dateEstablished mesh__D013387 1991-01-01
% 220.24/220.40  |- mesh__recordAuthorizer mesh__D013387 SJN
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D013387 2004
% 220.24/220.40  |- skos__scopeNote mesh__D013387
% 220.24/220.40       A subclass of anhydrides with the general structure of dihydrofurandione. They can be substituted on any carbon atom. They modify and inhibit proteins and enzymes and are used in the acylation of amino- and hydroxyl groups.%A%    
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D013387 2002
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D013387 1999
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D013387 2006
% 220.24/220.40  |- mesh__historyNote mesh__D013387
% 220.24/220.40       91%28%79%29%; was see under SUCCINATES 1979-90   
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D013387 2003
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D013387 2001
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D013387 1998
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D013387 2005
% 220.24/220.40  |- mesh__recordMaintainer mesh__D013387 KEV
% 220.24/220.40  |- skos__historyNote mesh__D013387 Anhydrides %28%1966-1978%29%
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D013387 2000
% 220.24/220.40  |- skos__prefLabel mesh__D013387 Succinic Anhydrides
% 220.24/220.40  |- mesh__publicMeSHNote mesh__D013387
% 220.24/220.40       91; was see under SUCCINATES 1979-90   
% 220.24/220.40  |- skos__hiddenLabel mesh__D013387 Anhydrides, Succinic
% 220.24/220.40  |- mesh__dateRevised mesh__D013387 1997-06-20
% 220.24/220.40  |- mesh__recordAuthorizer mesh__D018870 sjn
% 220.24/220.40  |- mesh__dateEstablished mesh__D018870 1996-01-01
% 220.24/220.40  |- mesh__dateCreated mesh__D018870 1994-12-27
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D018870 2004
% 220.24/220.40  |- skos__annotation mesh__D018870
% 220.24/220.40       A 11 qualif except /cytol; /genet permitted; ENDOPLASMIC RETICULUM, SMOOTH is also available%A%  
% 220.24/220.40  |- skos__hiddenLabel mesh__D018870 Granular Endoplasmic Reticulum
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D018870 2005
% 220.24/220.40  |- skos__hiddenLabel mesh__D018870 Rough Endoplasmic Reticulum
% 220.24/220.40  |- skos__broader mesh__D018870smesh__D004721
% 220.24/220.40  |- skos__historyNote mesh__D018870 Endoplasmic Reticulum %28%1966-1995%29%
% 220.24/220.40  |- rdf__type mesh__D018870sskos__Concept
% 220.24/220.40  |- skos__broader mesh__D018870smesh__D011132
% 220.24/220.40  |- mesh__historyNote mesh__D018870 96   
% 220.24/220.40  |- mesh__dateRevised mesh__D018870 2003-07-09
% 220.24/220.40  |- skos__scopeNote mesh__D018870
% 220.24/220.40       A type of endoplasmic reticulum %28%ER%29% where polyribosomes are present on the cytoplasmic surfaces of the ER membranes. This form of ER is prominent in cells specialized for protein secretion and its principal function is to segregate proteins destined for export or intracellular utilization.%A%    
% 220.24/220.40  |- mesh__recordMaintainer mesh__D018870 nns
% 220.24/220.40  |- mesh__publicMeSHNote mesh__D018870 96   
% 220.24/220.40  |- skos__altLabel mesh__D018870 Endoplasmic Reticulum, Granular
% 220.24/220.40  |- skos__prefLabel mesh__D018870 Endoplasmic Reticulum, Rough
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D018870 2006
% 220.24/220.40  |- mesh__recordOriginator mesh__D018870 AGS
% 220.24/220.40  |- skos__hiddenLabel mesh__D032541 Vaccinations, Mass
% 220.24/220.40  |- skos__hiddenLabel mesh__D032541 Vaccination, Mass
% 220.24/220.40  |- mesh__publicMeSHNote mesh__D032541 2003   
% 220.24/220.40  |- skos__historyNote mesh__D032541 Immunization %28%1967-2002%29%
% 220.24/220.40  |- skos__prefLabel mesh__D032541 Mass Immunization
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D032541 2006
% 220.24/220.40  |- skos__scopeNote mesh__D032541
% 220.24/220.40       Administration of an antigen to large populations in order to produce an immune response to that antigen.%A%    
% 220.24/220.40  |- mesh__dateEstablished mesh__D032541 2003-01-01
% 220.24/220.40  |- skos__broader mesh__D032541smesh__D007114
% 220.24/220.40  |- skos__hiddenLabel mesh__D032541 Immunization, Mass
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D032541 2004
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D032541 2005
% 220.24/220.40  |- mesh__dateRevised mesh__D032541 2003-07-09
% 220.24/220.40  |- skos__hiddenLabel mesh__D032541 Immunizations, Mass
% 220.24/220.40  |- skos__hiddenLabel mesh__D032541 Mass Vaccinations
% 220.24/220.40  |- mesh__historyNote mesh__D032541 2003   
% 220.24/220.40  |- skos__broader mesh__D032541smesh__D017589
% 220.24/220.40  |- rdf__type mesh__D032541sskos__Concept
% 220.24/220.40  |- mesh__dateCreated mesh__D032541 2002-07-03
% 220.24/220.40  |- skos__hiddenLabel mesh__D032541 Mass Immunizations
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D018072 2005
% 220.24/220.40  |- skos__broader mesh__D018072smesh__D006198
% 220.24/220.40  |- mesh__recordOriginator mesh__D018072 RAZ
% 220.24/220.40  |- skos__historyNote mesh__D018072 Hair Cells %28%1980-1993%29%
% 220.24/220.40  |- mesh__dateEstablished mesh__D018072 1994-01-01
% 220.24/220.40  |- rdf__type mesh__D018072sskos__Concept
% 220.24/220.40  |- skos__scopeNote mesh__D018072
% 220.24/220.40       Mechanoreceptors in the organ of Corti. In mammals the outer hair cells are arranged in three rows which are further from the modiolus than the single row of inner hair cells. The motile properties of the outer hair cells may contribute actively to tuning the sensitivity and frequency selectivity of the cochlea.%A%    
% 220.24/220.40  |- mesh__dateCreated mesh__D018072 1993-06-29
% 220.24/220.40  |- skos__historyNote mesh__D018072 Organ of Corti %28%1966-1976%29%
% 220.24/220.40  |- skos__prefLabel mesh__D018072 Hair Cells, Outer
% 220.24/220.40  |- skos__hiddenLabel mesh__D018072 Outer Hair Cell
% 220.24/220.40  |- skos__hiddenLabel mesh__D018072 Hair Cell, Outer
% 220.24/220.40  |- mesh__dateRevised mesh__D018072 2004-07-07
% 220.24/220.40  |- skos__historyNote mesh__D018072 Mechanoreceptors %28%1977-1979%29%
% 220.24/220.40  |- mesh__historyNote mesh__D018072 94   
% 220.24/220.40  |- mesh__recordAuthorizer mesh__D018072 sjn
% 220.24/220.40  |- skos__hiddenLabel mesh__D018072 Cell, Outer Hair
% 220.24/220.40  |- mesh__recordMaintainer mesh__D018072 ags
% 220.24/220.40  |- skos__hiddenLabel mesh__D018072 Outer Hair Cells
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D018072 2006
% 220.24/220.40  |- skos__hiddenLabel mesh__D018072 Cells, Outer Hair
% 220.24/220.40  |- skos__annotation mesh__D018072 see note on HAIR CELLS   
% 220.24/220.40  |- mesh__publicMeSHNote mesh__D018072 94   
% 220.24/220.40  |- mesh__recordAuthorizer mesh__D004850 PLS
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004850 2000
% 220.24/220.40  |- skos__hiddenLabel mesh__D004850 Eponym
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004850 2003
% 220.24/220.40  |- mesh__dateRevised mesh__D004850 1989-04-28
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004850 2006
% 220.24/220.40  |- skos__annotation mesh__D004850 IM; no qualif   
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004850 1990
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004850 1997
% 220.24/220.40  |- mesh__dateCreated mesh__D004850 1999-01-01
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004850 2002
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004850 2005
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004850 1993
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004850 1996
% 220.24/220.40  |- skos__broader mesh__D004850smesh__D009275
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004850 1992
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004850 1999
% 220.24/220.40  |- rdf__type mesh__D004850sskos__Concept
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004850 1995
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004850 2001
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004850 1998
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004850 1991
% 220.24/220.40  |- mesh__recordMaintainer mesh__D004850 TGC
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004850 2004
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004850 1994
% 220.24/220.40  |- mesh__recordOriginator mesh__D004850 NLM
% 220.24/220.40  |- skos__prefLabel mesh__D004850 Eponyms
% 220.24/220.40  |- skos__altLabel mesh__D004052 N-Nitrosodiethylamine
% 220.24/220.40  |- mesh__recordOriginator mesh__D004052 NLM
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004052 2005
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004052 2001
% 220.24/220.40  |- skos__altLabel mesh__D004052 Nitrosodiethylamine
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004052 2004
% 220.24/220.40  |- skos__prefLabel mesh__D004052 Diethylnitrosamine
% 220.24/220.40  |- mesh__historyNote mesh__D004052
% 220.24/220.40       86%28%75%29%; was see under NITROSAMINES 1975-85   
% 220.24/220.40  |- skos__annotation mesh__D004052 D25-D26 qualif   
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004052 2003
% 220.24/220.40  |- mesh__dateCreated mesh__D004052 1974-11-11
% 220.24/220.40  |- mesh__recordAuthorizer mesh__D004052 sjn
% 220.24/220.40  |- rdf__type mesh__D004052sskos__Concept
% 220.24/220.40  |- skos__broader mesh__D004052smesh__D009602
% 220.24/220.40  |- mesh__recordMaintainer mesh__D004052 CCR
% 220.24/220.40  |- skos__historyNote mesh__D004052 Nitrosamines %28%1969-1974%29%
% 220.24/220.40  |- mesh__publicMeSHNote mesh__D004052
% 220.24/220.40       86; was see under NITROSAMINES 1975-85   
% 220.24/220.40  |- skos__scopeNote mesh__D004052
% 220.24/220.40       A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties.%A%    
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004052 2006
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D004052 2002
% 220.24/220.40  |- mesh__dateRevised mesh__D004052 2000-06-22
% 220.24/220.40  |- mesh__dateEstablished mesh__D004052 1986-01-01
% 220.24/220.40  |- skos__hiddenLabel mesh__D004052 N Nitrosodiethylamine
% 220.24/220.40  |- mesh__historyNote mesh__D045469 2004; use ROSALES 2003-2004   
% 220.24/220.40  |- mesh__dateCreated mesh__D045469 2003-07-09
% 220.24/220.40  |- mesh__publicMeSHNote mesh__D045469 2004; see ROSALES 2003-2004   
% 220.24/220.40  |- rdf__type mesh__D045469sskos__Concept
% 220.24/220.40  |- skos__annotation mesh__D045469
% 220.24/220.40       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D045469 2006
% 220.24/220.40  |- skos__prefLabel mesh__D045469 Chrysobalanaceae
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D045469 2005
% 220.24/220.40  |- skos__broader mesh__D045469smesh__D019685
% 220.24/220.40  |- mesh__dateEstablished mesh__D045469 2004-01-01
% 220.24/220.40  |- skos__scopeNote mesh__D045469
% 220.24/220.40       A plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida.%A%    
% 220.24/220.40  |- mesh__activeMeSHYear mesh__D045469 2004
% 220.24/220.41  |- skos__altLabel mesh__D017778 Vaccines, Combination
% 220.24/220.41  |- skos__scopeNote mesh__D017778
% 220.24/220.41       Two or more vaccines in a single dosage form.     
% 220.24/220.41  |- skos__annotation mesh__D017778
% 220.24/220.41       coord NIM with specific vaccines %28%IM%29%   
% 220.24/220.41  |- mesh__publicMeSHNote mesh__D017778 94   
% 220.24/220.41  |- rdf__type mesh__D017778sskos__Concept
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D017778 2006
% 220.24/220.41  |- skos__hiddenLabel mesh__D017778 Combination Vaccines
% 220.24/220.41  |- skos__hiddenLabel mesh__D017778 Combined Vaccines
% 220.24/220.41  |- skos__prefLabel mesh__D017778 Vaccines, Combined
% 220.24/220.41  |- mesh__recordAuthorizer mesh__D017778 sjn
% 220.24/220.41  |- skos__broader mesh__D017778smesh__D014612
% 220.24/220.41  |- mesh__recordMaintainer mesh__D017778 ssb
% 220.24/220.41  |- mesh__dateEstablished mesh__D017778 1994-01-01
% 220.24/220.41  |- mesh__dateCreated mesh__D017778 1992-12-28
% 220.24/220.41  |- mesh__historyNote mesh__D017778 94   
% 220.24/220.41  |- mesh__recordOriginator mesh__D017778 AGS
% 220.24/220.41  |- mesh__dateRevised mesh__D017778 2005-06-30
% 220.24/220.41  |- skos__altLabel mesh__D031449 Camas, Death
% 220.24/220.41  |- skos__scopeNote mesh__D031449
% 220.24/220.41       A plant genus of the family LILIACEAE that is fatally toxic to grazing animals. The name is similar to another plant called Camas %28%CAMASSIA%29%.%A%    
% 220.24/220.41  |- skos__annotation mesh__D031449
% 220.24/220.41       CAMAS see CAMASSIA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.24/220.41  |- skos__altLabel mesh__D031449 Death Camas
% 220.24/220.41  |- mesh__dateCreated mesh__D031449 2002-07-03
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D031449 2004
% 220.24/220.41  |- mesh__historyNote mesh__D031449 2003   
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D031449 2006
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D031449 2003
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D031449 2005
% 220.24/220.41  |- skos__altLabel mesh__D031449 Zygadenus
% 220.24/220.41  |- rdf__type mesh__D031449sskos__Concept
% 220.24/220.41  |- skos__prefLabel mesh__D031449 Zigadenus
% 220.24/220.41  |- mesh__publicMeSHNote mesh__D031449 2003   
% 220.24/220.41  |- mesh__dateEstablished mesh__D031449 2003-01-01
% 220.24/220.41  |- skos__broader mesh__D031449smesh__D019668
% 220.24/220.41  |- skos__hiddenLabel mesh__D050603 Epoxidase, Squalene
% 220.24/220.41  |- skos__altLabel mesh__D050603 Squalene Epoxidase
% 220.24/220.41  |- skos__hiddenLabel mesh__D050603 Monooxygenase, Squalene
% 220.24/220.41  |- skos__broader mesh__D050603smesh__D006899
% 220.24/220.41  |- mesh__recordOriginator mesh__D050603 AKE
% 220.24/220.41  |- mesh__historyNote mesh__D050603
% 220.24/220.41       2006%28%1980%29%; use ETHERS, CYCLIC 1970-1979   
% 220.24/220.41  |- mesh__recordMaintainer mesh__D050603 AKE
% 220.24/220.41  |- skos__altLabel mesh__D050603
% 220.24/220.41       Squalene Monooxygenase %28%2,3-Epoxidizing%29%
% 220.24/220.41  |- mesh__publicMeSHNote mesh__D050603
% 220.24/220.41       2006; SQUALENE MONOOXYGENASE was indexed under OXYGENASES 1981-2005 %26% ETHERS, CYCLIC 1970-1980%A%  
% 220.24/220.41  |- mesh__dateEstablished mesh__D050603 2006-01-01
% 220.24/220.41  |- mesh__recordAuthorizer mesh__D050603 sjn
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D050603 2006
% 220.24/220.41  |- rdf__type mesh__D050603sskos__Concept
% 220.24/220.41  |- skos__scopeNote mesh__D050603
% 220.24/220.41       The second enzyme in the committed pathway for CHOLESTEROL biosynthesis, this enzyme catalyzes the first oxygenation step in the biosynthesis of STEROLS and is thought to be a rate limiting enzyme in this pathway. Specifically, this enzyme catalyzes the conversion of SQUALENE to %28%S%29%-squalene-2,3-epoxide.%A%    
% 220.24/220.41  |- skos__prefLabel mesh__D050603 Squalene Monooxygenase
% 220.24/220.41  |- mesh__dateCreated mesh__D050603 2005-06-30
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D003758 2002
% 220.24/220.41  |- mesh__dateEstablished mesh__D003758 1977-01-01
% 220.24/220.41  |- skos__altLabel mesh__D003758 Implantation, Osseointegrated Dental
% 220.24/220.41  |- skos__prefLabel mesh__D003758 Dental Implantation, Endosseous
% 220.24/220.41  |- skos__annotation mesh__D003758
% 220.24/220.41       insertion of implant into the bone tissue of the jaw; DENTAL IMPLANTATION, ENDOSSEOUS, ENDODONTIC is also available; do not use /util except by MeSH definition; DF: DENT IMPLANT ENDOSS%A%  
% 220.24/220.41  |- mesh__recordOriginator mesh__D003758 SMH
% 220.24/220.41  |- skos__altLabel mesh__D003758 Dental Implantation, Osseointegrated
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D003758 2001
% 220.24/220.41  |- skos__broader mesh__D003758smesh__D003757
% 220.24/220.41  |- skos__altLabel mesh__D003758 Endosseous Dental Implantation
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D003758 2006
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D003758 2000
% 220.24/220.41  |- skos__altLabel mesh__D003758 Implantation, Endosseous Dental
% 220.24/220.41  |- skos__historyNote mesh__D003758 Dental Implantation %28%1966-1976%29%
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D003758 2005
% 220.24/220.41  |- mesh__recordAuthorizer mesh__D003758 SJN
% 220.24/220.41  |- mesh__dateRevised mesh__D003758 1997-06-20
% 220.24/220.41  |- rdf__type mesh__D003758sskos__Concept
% 220.24/220.41  |- skos__scopeNote mesh__D003758
% 220.24/220.41       Insertion of an implant into the bone of the mandible or maxilla. The implant has an exposed head which protrudes through the mucosa and is a prosthodontic abutment.%A%    
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D003758 2004
% 220.24/220.41  |- mesh__recordMaintainer mesh__D003758 PXP
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D003758 1999
% 220.24/220.41  |- skos__altLabel mesh__D003758 Endosseous Implantation
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D003758 2003
% 220.24/220.41  |- mesh__historyNote mesh__D003758 77   
% 220.24/220.41  |- mesh__publicMeSHNote mesh__D003758 77   
% 220.24/220.41  |- mesh__dateCreated mesh__D003758 1976-04-27
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D003758 1998
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D014480 1995
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D014480 2005
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D014480 2002
% 220.24/220.41  |- mesh__recordAuthorizer mesh__D014480 PLS
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D014480 2003
% 220.24/220.41  |- mesh__recordMaintainer mesh__D014480 NLM
% 220.24/220.41  |- rdf__type mesh__D014480sskos__Concept
% 220.24/220.41  |- skos__altLabel mesh__D014480 UN
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D014480 1999
% 220.24/220.41  |- mesh__publicMeSHNote mesh__D014480 80   
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D014480 1997
% 220.24/220.41  |- mesh__dateRevised mesh__D014480 1994-03-17
% 220.24/220.41  |- mesh__dateEstablished mesh__D014480 1980-01-01
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D014480 2001
% 220.24/220.41  |- skos__prefLabel mesh__D014480 United Nations
% 220.24/220.41  |- mesh__recordOriginator mesh__D014480 EC
% 220.24/220.41  |- skos__annotation mesh__D014480 IM      CATALOG: use NAF entry   
% 220.24/220.41  |- mesh__dateCreated mesh__D014480 1979-04-11
% 220.24/220.41  |- mesh__historyNote mesh__D014480 80   
% 220.24/220.41  |- skos__broader mesh__D014480smesh__D007390
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D014480 1998
% 220.24/220.41  |- skos__historyNote mesh__D014480 International Agencies %28%1966-1979%29%
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D014480 2000
% 220.24/220.41  |- skos__altLabel mesh__D014480 FAO, United Nations
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D014480 1996
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D014480 2006
% 220.24/220.41  |- skos__scopeNote mesh__D014480
% 220.24/220.41       An international organization whose members include most of the sovereign nations of the world with headquarters in New York City. The primary objectives of the organization are to maintain peace and security and to achieve international cooperation in solving international economic, social, cultural, or humanitarian problems.%A%    
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D014480 2004
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D008443 2006
% 220.24/220.41  |- skos__hiddenLabel mesh__D008443 Antrums, Maxillary
% 220.24/220.41  |- skos__hiddenLabel mesh__D008443 Maxillary Antrums
% 220.24/220.41  |- skos__hiddenLabel mesh__D008443 Antrum, Maxillary
% 220.24/220.41  |- skos__prefLabel mesh__D008443 Maxillary Sinus
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D008443 2005
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D008443 1998
% 220.24/220.41  |- mesh__dateRevised mesh__D008443 1994-05-12
% 220.24/220.41  |- mesh__recordAuthorizer mesh__D008443 PLS
% 220.24/220.41  |- skos__scopeNote mesh__D008443
% 220.24/220.41       One of the paired paranasal sinuses, located in the body of the maxilla, communicating with the middle meatus of the nasal cavity.%A%    
% 220.24/220.41  |- rdf__type mesh__D008443sskos__Concept
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D008443 2002
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D008443 1997
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D008443 2004
% 220.24/220.41  |- skos__hiddenLabel mesh__D008443 Sinus, Maxillary
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D008443 2001
% 220.24/220.41  |- skos__altLabel mesh__D008443 Antrum of Highmore
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D008443 1996
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D008443 2003
% 220.24/220.41  |- mesh__recordOriginator mesh__D008443 NLM
% 220.24/220.41  |- skos__hiddenLabel mesh__D008443 Highmore Antrum
% 220.24/220.41  |- skos__altLabel mesh__D008443 Maxillary Antrum
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D008443 2000
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D008443 1995
% 220.24/220.41  |- mesh__dateCreated mesh__D008443 1999-01-01
% 220.24/220.41  |- mesh__recordMaintainer mesh__D008443 PXP
% 220.24/220.41  |- skos__broader mesh__D008443smesh__D010256
% 220.24/220.41  |- skos__annotation mesh__D008443
% 220.24/220.41       inflammation or sinusitis = MAXILLARY SINUSITIS;  fractures: coord MAXILLARY SINUS /inj %28%IM%29% + MAXILLARY FRACTURES %28%IM%29%%A%  
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D008443 1999
% 220.24/220.41  |- skos__annotation mesh__D000460 GEN or unspecified; prefer specifics   
% 220.24/220.41  |- mesh__recordMaintainer mesh__D000460 SYSTEM
% 220.24/220.41  |- skos__scopeNote mesh__D000460
% 220.24/220.41       Algae of the division Chlorophyta, in which the green pigment of CHLOROPHYLL is not masked by other pigments. Green algae have over 7000 species and live in a variety of primarily aquatic habitats. Only about ten percent are marine species, most live in freshwater. They are more closely related to the green vascular land PLANTS than any other group of algae.%A%    
% 220.24/220.41  |- skos__related mesh__D000460smesh__D010839
% 220.24/220.41  |- skos__altLabel mesh__D000460 Chlorophyta
% 220.24/220.41  |- skos__altLabel mesh__D000460 Green Algae
% 220.24/220.41  |- rdf__type mesh__D000460sskos__Concept
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D000460 2006
% 220.24/220.41  |- mesh__publicMeSHNote mesh__D000460 70   
% 220.24/220.41  |- skos__broader mesh__D000460smesh__D000456
% 220.24/220.41  |- mesh__dateCreated mesh__D000460 1999-01-01
% 220.24/220.41  |- mesh__dateRevised mesh__D000460 2005-06-30
% 220.24/220.41  |- skos__historyNote mesh__D000460 Algae %28%1966-1969%29%
% 220.24/220.41  |- mesh__historyNote mesh__D000460 70   
% 220.24/220.41  |- mesh__dateEstablished mesh__D000460 1970-01-01
% 220.24/220.41  |- mesh__recordOriginator mesh__D000460 NLM
% 220.24/220.41  |- skos__prefLabel mesh__D000460 Algae, Green
% 220.24/220.41  |- mesh__recordAuthorizer mesh__D000460 sjn
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D013388 2003
% 220.24/220.41  |- mesh__publicMeSHNote mesh__D013388
% 220.24/220.41       74; PHENSUXIMIDE was heading 1973-84   
% 220.24/220.41  |- rdf__type mesh__D013388sskos__Concept
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D013388 1998
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D013388 2005
% 220.24/220.41  |- skos__historyNote mesh__D013388 Succinates %28%1966-1971%29%
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D013388 2004
% 220.24/220.41  |- mesh__recordAuthorizer mesh__D013388 SJN
% 220.24/220.41  |- skos__broader mesh__D013388smesh__D011760
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D013388 2002
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D013388 1999
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D013388 2006
% 220.24/220.41  |- skos__historyNote mesh__D013388 Pyrrolidinones %28%1966-1971%29%
% 220.24/220.41  |- mesh__historyNote mesh__D013388
% 220.24/220.41       74%28%72%29%; PHENSUXIMIDE was heading l963-84 %28%Prov l963-72%29%   
% 220.24/220.41  |- mesh__dateCreated mesh__D013388 1999-01-01
% 220.24/220.41  |- skos__prefLabel mesh__D013388 Succinimides
% 220.24/220.41  |- mesh__recordMaintainer mesh__D013388 KEV
% 220.24/220.41  |- skos__altLabel mesh__D013388 Butanimides
% 220.24/220.41  |- mesh__dateEstablished mesh__D013388 1974-01-01
% 220.24/220.41  |- skos__scopeNote mesh__D013388
% 220.24/220.41       A subclass of IMIDES with the general structure of pyrrolidinedione. They are prepared by the distillation of ammonium succinate. They are sweet-tasting compounds that are used as chemical intermediates and plant growth stimulants.%A%    
% 220.24/220.41  |- mesh__onlineNote mesh__D013388
% 220.24/220.41       use SUCCINIMIDES to search PHENSUXIMIDE 1966-84 %28%as Prov 1966-72%29%%A%  
% 220.24/220.41  |- skos__broader mesh__D013388smesh__D007094
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D013388 2000
% 220.24/220.41  |- skos__altLabel mesh__D013388 Pyrrolidinediones
% 220.24/220.41  |- skos__historyNote mesh__D013388 Pyrrolidines %28%1966-1971%29%
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D013388 2001
% 220.24/220.41  |- mesh__dateRevised mesh__D013388 1997-06-20
% 220.24/220.41  |- skos__related mesh__D013388smesh__D019822
% 220.24/220.41  |- mesh__recordOriginator mesh__D013388 NLM
% 220.24/220.41  |- mesh__recordMaintainer mesh__D018871 nns
% 220.24/220.41  |- mesh__historyNote mesh__D018871 96   
% 220.24/220.41  |- mesh__publicMeSHNote mesh__D018871 96   
% 220.24/220.41  |- mesh__dateEstablished mesh__D018871 1996-01-01
% 220.24/220.41  |- mesh__dateRevised mesh__D018871 2003-07-09
% 220.24/220.41  |- mesh__recordOriginator mesh__D018871 AGS
% 220.24/220.41  |- mesh__recordAuthorizer mesh__D018871 sjn
% 220.24/220.41  |- skos__altLabel mesh__D018871 Endoplasmic Reticulum, Agranular
% 220.24/220.41  |- skos__hiddenLabel mesh__D018871 Smooth Endoplasmic Reticulum
% 220.24/220.41  |- skos__hiddenLabel mesh__D018871 Agranular Endoplasmic Reticulum
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D018871 2006
% 220.24/220.41  |- skos__prefLabel mesh__D018871 Endoplasmic Reticulum, Smooth
% 220.24/220.41  |- mesh__dateCreated mesh__D018871 1994-12-27
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D018871 2004
% 220.24/220.41  |- skos__historyNote mesh__D018871 Endoplasmic Reticulum %28%1966-1995%29%
% 220.24/220.41  |- skos__scopeNote mesh__D018871
% 220.24/220.41       A type of endoplasmic reticulum lacking associated ribosomes on the membrane surface. It exhibits a wide range of specialized metabolic functions including supplying enzymes for steroid synthesis, detoxification, and glycogen breakdown. In muscle cells, smooth endoplasmic reticulum is called SARCOPLASMIC RETICULUM.%A%    
% 220.24/220.41  |- skos__annotation mesh__D018871
% 220.24/220.41       A 11 qualif except /cytol; /genet permitted; smooth endoplasmic reticulum in muscle = SARCOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM, ROUGH is also available%A%  
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D018871 2005
% 220.24/220.41  |- skos__broader mesh__D018871smesh__D004721
% 220.24/220.41  |- rdf__type mesh__D018871sskos__Concept
% 220.24/220.41  |- mesh__recordAuthorizer mesh__D018073 sjn
% 220.24/220.41  |- rdf__type mesh__D018073sskos__Concept
% 220.24/220.41  |- skos__hiddenLabel mesh__D018073 Vaccines, Haemophilus influenzae
% 220.24/220.41  |- skos__scopeNote mesh__D018073
% 220.24/220.41       Vaccines or candidate vaccines containing antigenic polysaccharides from Haemophilus influenzae and designed to prevent infection. The vaccine can contain the polysaccharides alone or more frequently polysaccharides conjugated to carrier molecules. It is also seen as a combined vaccine with diphtheria-tetanus-pertussis vaccine.%A%    
% 220.24/220.41  |- skos__hiddenLabel mesh__D018073 Vaccine, Haemophilus
% 220.24/220.41  |- mesh__dateEstablished mesh__D018073 1994-01-01
% 220.24/220.41  |- mesh__publicMeSHNote mesh__D018073 94   
% 220.24/220.41  |- skos__altLabel mesh__D018073 Haemophilus influenzae Vaccines
% 220.24/220.41  |- skos__historyNote mesh__D018073 Bacterial Vaccines %28%1975-1993%29%
% 220.24/220.41  |- skos__annotation mesh__D018073
% 220.24/220.41       note X ref HAEMOPHILUS INFLUENZAE VACCINES: restrict to vaccine against H. influenzae so do not coord with HAEMOPHILUS INFLUENZAE%A%  
% 220.24/220.41  |- mesh__historyNote mesh__D018073 94   
% 220.24/220.41  |- skos__hiddenLabel mesh__D018073 Vaccines, Haemophilus
% 220.24/220.41  |- skos__altLabel mesh__D018073 Haemophilus Vaccine
% 220.24/220.41  |- skos__broader mesh__D018073smesh__D001428
% 220.24/220.41  |- mesh__dateCreated mesh__D018073 1993-06-04
% 220.24/220.41  |- mesh__dateRevised mesh__D018073 2005-06-30
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D018073 2006
% 220.24/220.41  |- skos__altLabel mesh__D018073 Hemophilus Vaccines
% 220.24/220.41  |- mesh__recordMaintainer mesh__D018073 ssb
% 220.24/220.41  |- skos__hiddenLabel mesh__D018073 Vaccines, Hemophilus
% 220.24/220.41  |- mesh__recordOriginator mesh__D018073 AGS
% 220.24/220.41  |- skos__prefLabel mesh__D018073 Haemophilus Vaccines
% 220.24/220.41  |- skos__altLabel mesh__D010090 Oxidoreductases, O Demethylating
% 220.24/220.41  |- mesh__recordAuthorizer mesh__D010090 sjn
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D010090 2006
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D010090 2004
% 220.24/220.41  |- mesh__historyNote mesh__D010090
% 220.24/220.41       91%28%75%29%; was see under OXIDOREDUCTASES 1975-90   
% 220.24/220.41  |- skos__prefLabel mesh__D010090 Oxidoreductases, O-Demethylating
% 220.24/220.41  |- skos__broader mesh__D010090smesh__D010088
% 220.24/220.41  |- skos__hiddenLabel mesh__D010090 Demethylating Oxidoreductases, O
% 220.24/220.41  |- rdf__type mesh__D010090sskos__Concept
% 220.24/220.41  |- skos__scopeNote mesh__D010090
% 220.24/220.41       Drug metabolizing enzymes which oxidize methyl ethers. Usually found in liver microsomes.%A%    
% 220.24/220.41  |- mesh__recordOriginator mesh__D010090 NLM
% 220.24/220.41  |- skos__hiddenLabel mesh__D010090 O Demethylases
% 220.24/220.41  |- mesh__dateRevised mesh__D010090 2003-07-09
% 220.24/220.41  |- mesh__dateCreated mesh__D010090 1974-11-19
% 220.24/220.41  |- mesh__recordMaintainer mesh__D010090 ssb
% 220.24/220.41  |- mesh__dateEstablished mesh__D010090 1991-01-01
% 220.24/220.41  |- skos__hiddenLabel mesh__D010090 O Demethylating Oxidoreductases
% 220.24/220.41  |- skos__hiddenLabel mesh__D010090 O-Demethylating Oxidoreductases
% 220.24/220.41  |- skos__historyNote mesh__D010090 Oxidoreductases %28%1968-1974%29%
% 220.24/220.41  |- mesh__publicMeSHNote mesh__D010090
% 220.24/220.41       91; was see under OXIDOREDUCTASES 1975-90   
% 220.24/220.41  |- skos__altLabel mesh__D010090 O-Demethylases
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D010090 2005
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D004851 2006
% 220.24/220.41  |- skos__broader mesh__D004851smesh__D006867
% 220.24/220.41  |- skos__prefLabel mesh__D004851 Epoxide Hydrolases
% 220.24/220.41  |- skos__altLabel mesh__D004851 Epoxide Hydratases
% 220.24/220.41  |- mesh__dateEstablished mesh__D004851 1978-01-01
% 220.24/220.41  |- skos__hiddenLabel mesh__D004851 Acid Hydrase, 9,10-Epoxypalmitic
% 220.24/220.41  |- skos__altLabel mesh__D004851 Epoxide Hydrases
% 220.24/220.41  |- mesh__dateRevised mesh__D004851 2003-07-09
% 220.24/220.41  |- mesh__recordOriginator mesh__D004851 NLM
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D004851 2005
% 220.24/220.41  |- mesh__historyNote mesh__D004851
% 220.24/220.41       81; was EPOXIDE HYDRATASES 1975-80 %28%see under HYDRO-LYASES 1975-77%29%%A%  
% 220.24/220.41  |- rdf__type mesh__D004851sskos__Concept
% 220.24/220.41  |- skos__hiddenLabel mesh__D004851 Hydrase, 9,10-Epoxypalmitic Acid
% 220.24/220.41  |- skos__hiddenLabel mesh__D004851 Epoxide Hydrolase, Styrene
% 220.24/220.41  |- skos__hiddenLabel mesh__D004851 Hydratases, Epoxide
% 220.24/220.41  |- mesh__recordAuthorizer mesh__D004851 sjn
% 220.24/220.41  |- skos__scopeNote mesh__D004851
% 220.24/220.41       Enzymes that catalyze reversibly the formation of an epoxide or arene oxide from a glycol or aromatic diol, respectively. EC 3.3.2.3.%A%    
% 220.24/220.41  |- skos__hiddenLabel mesh__D004851 Hydrolases, Epoxide
% 220.24/220.41  |- skos__hiddenLabel mesh__D004851 Hydrolase, Microsomal Epoxide
% 220.24/220.41  |- mesh__publicMeSHNote mesh__D004851
% 220.24/220.41       81; was EPOXIDE HYDRATASES 1975-80 %28%see under HYDRO-LYASES 1975-77%29%%A%  
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D004851 2004
% 220.24/220.41  |- skos__hiddenLabel mesh__D004851 Epoxide Hydrolase, Microsomal
% 220.24/220.41  |- skos__hiddenLabel mesh__D004851 9,10 Epoxypalmitic Acid Hydrase
% 220.24/220.41  |- mesh__onlineNote mesh__D004851
% 220.24/220.41       use EPOXIDE HYDROLASES to search EPOXIDE HYDRATASES 1975-80%A%  
% 220.24/220.41  |- skos__historyNote mesh__D004851 Ethers, Cyclic %28%1966-1974%29%
% 220.24/220.41  |- skos__hiddenLabel mesh__D004851 Hydrolase, Styrene Epoxide
% 220.24/220.41  |- mesh__dateCreated mesh__D004851 1974-11-11
% 220.24/220.41  |- skos__hiddenLabel mesh__D004851 Hydrases, Epoxide
% 220.24/220.41  |- skos__historyNote mesh__D004851 Hydro-Lyases %28%1966-1974%29%
% 220.24/220.41  |- mesh__recordMaintainer mesh__D004851 ssb
% 220.24/220.41  |- skos__altLabel mesh__D004053 Medic Brand of Amfepramone Hydrochloride
% 220.24/220.41  |- skos__altLabel mesh__D004053 Hoechst Brand of Amfepramone Hydrochloride
% 220.24/220.41  |- skos__altLabel mesh__D004053 Temmler Brand of Amfepramone Hydrochloride
% 220.24/220.41  |- skos__altLabel mesh__D004053 Phepranon
% 220.24/220.41  |- skos__hiddenLabel mesh__D004053 Norex, Ifa
% 220.24/220.41  |- skos__altLabel mesh__D004053 Dietil-retard
% 220.24/220.41  |- mesh__recordOriginator mesh__D004053 NLM
% 220.24/220.41  |- skos__altLabel mesh__D004053 Nadeau Brand of Amfepramone Hydrochloride
% 220.24/220.41  |- skos__broader mesh__D004053smesh__D005021
% 220.24/220.41  |- skos__altLabel mesh__D004053 2-Diethylaminopropiophenone
% 220.24/220.41  |- skos__altLabel mesh__D004053
% 220.24/220.41       Marion Merrell Dow Brand of Amfepramone Hydrochloride
% 220.24/220.41  |- skos__altLabel mesh__D004053 Delgamer
% 220.24/220.41  |- mesh__dateCreated mesh__D004053 1999-01-01
% 220.24/220.41  |- rdf__type mesh__D004053sskos__Concept
% 220.24/220.41  |- skos__altLabel mesh__D004053
% 220.24/220.41       Investigacion Farmaceutica Brand of Amfepramone Hydrochloride
% 220.24/220.41  |- skos__altLabel mesh__D004053 Dexo Brand of Amfepramone Hydrochloride
% 220.24/220.41  |- skos__altLabel mesh__D004053
% 220.24/220.41       Th%C3%%A9%ranol Brand of Amfepramone Hydrochloride
% 220.24/220.41  |- skos__hiddenLabel mesh__D004053 Dietilretard
% 220.24/220.41  |- skos__altLabel mesh__D004053 Vortech Brand of Amfepramone Hydrochloride
% 220.24/220.41  |- skos__altLabel mesh__D004053 Crinex Brand of Amfepramone Hydrochloride
% 220.24/220.41  |- mesh__dateRevised mesh__D004053 2004-07-07
% 220.24/220.41  |- skos__hiddenLabel mesh__D004053 Hydrochloride, Diethylpropion
% 220.24/220.41  |- skos__altLabel mesh__D004053 Amfepramon
% 220.24/220.41  |- mesh__recordMaintainer mesh__D004053 mdb
% 220.24/220.41  |- skos__altLabel mesh__D004053
% 220.24/220.41       Artegodan Brand of Amfepramone Hydrochloride
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D004053 2006
% 220.24/220.41  |- skos__altLabel mesh__D004053
% 220.24/220.41       Marion Merrell Brand of Amfepramone Hydrochloride
% 220.24/220.41  |- skos__altLabel mesh__D004053 Medix Brand of Amfepramone Hydrochloride
% 220.24/220.41  |- skos__scopeNote mesh__D004053
% 220.24/220.41       A appetite depressant considered to produce less central nervous system disturbance than most drugs in this therapeutic category. It is also considered to be among the safest for patients with hypertension. %28%From AMA Drug Evaluations Annual, 1994, p2290%29%%A%    
% 220.24/220.41  |- mesh__recordAuthorizer mesh__D004053 sjn
% 220.24/220.41  |- skos__altLabel mesh__D004053 Amfepramone
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D004053 2005
% 220.24/220.41  |- skos__prefLabel mesh__D004053 Diethylpropion
% 220.24/220.41  |- skos__altLabel mesh__D004053 Uriach Brand of Amfepramone Hydrochloride
% 220.24/220.41  |- skos__altLabel mesh__D004053 Pro Doc Brand of Amfepramone Hydrochloride
% 220.24/220.41  |- skos__hiddenLabel mesh__D004053 Dietil retard
% 220.24/220.41  |- skos__altLabel mesh__D004053 3M Brand of Amfepramone Hydrochloride
% 220.24/220.41  |- skos__broader mesh__D001792Q000637smesh__D001792
% 220.24/220.41  |- mesh__preferredCombination mesh__D001792Q000637smesh__D017713
% 220.24/220.41  |- rdf__type mesh__D001792Q000637smesh__CompoundConcept
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D017779 2002
% 220.24/220.41  |- rdf__type mesh__D017779sskos__Concept
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D017779 1998
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D017779 2006
% 220.24/220.41  |- skos__hiddenLabel mesh__D017779 Sympathetic Fiber, Postganglionic
% 220.24/220.41  |- skos__broader mesh__D017779smesh__D000320
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D017779 2003
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D017779 1994
% 220.24/220.41  |- skos__broader mesh__D017779smesh__D001338
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D017779 2001
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D017779 2005
% 220.24/220.41  |- skos__prefLabel mesh__D017779 Sympathetic Fibers, Postganglionic
% 220.24/220.41  |- skos__scopeNote mesh__D017779
% 220.24/220.41       Nerve fibers which project from sympathetic ganglia to synapses on target organs. Sympathetic postganglionic fibers use norepinephrine as transmitter, except for those innervating eccrine sweat glands %28%and possibly some blood vessels%29% which use acetylcholine. They may also release peptide cotransmitters.%A%    
% 220.24/220.41  |- mesh__publicMeSHNote mesh__D017779 94   
% 220.24/220.41  |- skos__annotation mesh__D017779
% 220.24/220.41       do not confuse with PARASYMPATHETIC FIBERS, POSTGANGLIONIC%A%  
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D017779 2000
% 220.24/220.41  |- skos__historyNote mesh__D017779 Ganglia, Autonomic %28%1966-1970%29%
% 220.24/220.41  |- skos__hiddenLabel mesh__D017779 Fiber, Postganglionic Sympathetic
% 220.24/220.41  |- mesh__historyNote mesh__D017779 94   
% 220.24/220.41  |- mesh__dateCreated mesh__D017779 1993-06-21
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D017779 1997
% 220.24/220.41  |- skos__hiddenLabel mesh__D017779 Postganglionic Sympathetic Fiber
% 220.24/220.41  |- skos__hiddenLabel mesh__D017779 Fibers, Postganglionic Sympathetic
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D017779 1999
% 220.24/220.41  |- skos__hiddenLabel mesh__D017779 Postganglionic Sympathetic Fibers
% 220.24/220.41  |- mesh__dateEstablished mesh__D017779 1994-01-01
% 220.24/220.41  |- skos__historyNote mesh__D017779
% 220.24/220.41       Autonomic Fibers, Postganglionic %28%1971-1993%29%
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D017779 2004
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D017779 1996
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D017779 1995
% 220.24/220.41  |- rdf__type mesh__D050604sskos__Concept
% 220.24/220.41  |- mesh__recordAuthorizer mesh__D050604 sjn
% 220.24/220.41  |- skos__broader mesh__D050604smesh__D000445
% 220.24/220.41  |- mesh__dateEstablished mesh__D050604 2006-01-01
% 220.24/220.41  |- skos__hiddenLabel mesh__D050604 Succinate Semialadehyde Reductase, NADP
% 220.24/220.41  |- mesh__historyNote mesh__D050604 2006%28%1974%29%   
% 220.24/220.41  |- mesh__dateCreated mesh__D050604 2005-06-30
% 220.24/220.41  |- mesh__recordMaintainer mesh__D050604 AKE
% 220.24/220.41  |- skos__prefLabel mesh__D050604
% 220.24/220.41       Succinate-Semialdehyde Dehydrogenase %28%NADP+%29%
% 220.24/220.41  |- skos__hiddenLabel mesh__D050604 Reductase, NADP Succinate-Semialadehyde
% 220.24/220.41  |- mesh__publicMeSHNote mesh__D050604
% 220.24/220.41       2006; SUCCINATE-SEMIALDEHYDE DEHYDROGENASE %28%NADP+%29% was indexed under ALDEHYDE OXIDOREDUCTASES 1974-2005%A%  
% 220.24/220.41  |- mesh__recordOriginator mesh__D050604 AKE
% 220.24/220.41  |- skos__altLabel mesh__D050604
% 220.24/220.41       Succinate-Semialdehyde Dehydrogenase %28%NAD%28%P%29%+%29%
% 220.24/220.41  |- skos__hiddenLabel mesh__D050604 NADP Succinate-Semialadehyde Reductase
% 220.24/220.41  |- skos__scopeNote mesh__D050604
% 220.24/220.41       An enzyme that catalyzes the oxidation of succinate semialdehyde to SUCCINIC ACID. It plays a role in the metabolism of GLUTAMATE; TYROSINE; and butanoate.%A%    
% 220.24/220.41  |- skos__altLabel mesh__D050604 Succinate-Semialadehyde Reductase, NADP
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D050604 2006
% 220.24/220.41  |- skos__hiddenLabel mesh__D003759 Implantations, Endodontic Endosseous
% 220.24/220.41  |- skos__hiddenLabel mesh__D003759 Endosseous Implantations, Endodontic
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D003759 2006
% 220.24/220.41  |- mesh__dateEstablished mesh__D003759 1972-01-01
% 220.24/220.41  |- skos__annotation mesh__D003759
% 220.24/220.41       insertion of rod through root canal; do not use /util except by MeSH definition; DF: DENT IMPLANT ENDOSS ENDO%A%  
% 220.24/220.41  |- skos__hiddenLabel mesh__D003759 Stabilization, Endodontic
% 220.24/220.41  |- skos__hiddenLabel mesh__D003759 Implantation, Endodontic Endosseous
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D003759 2002
% 220.24/220.41  |- mesh__dateCreated mesh__D003759 1999-01-01
% 220.24/220.41  |- mesh__onlineNote mesh__D003759
% 220.24/220.41       use DENTAL IMPLANTATION, ENDOSSEOUS, ENDODONTIC to search ENDODONTIC ENDOSSEOUS IMPLANTATION 1971-76%A%  
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D003759 2005
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D003759 2001
% 220.24/220.41  |- skos__historyNote mesh__D003759 Root Canal Therapy %28%1966-1970%29%
% 220.24/220.41  |- rdf__type mesh__D003759sskos__Concept
% 220.24/220.41  |- mesh__activeMeSHYear mesh__D003759 2004
% 220.24/220.42  |- mesh__historyNote mesh__D003759
% 220.24/220.42       77; was ENDODONTIC ENDOSSEOUS IMPLANTATION 1971-76   
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D003759 2000
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D003759 1999
% 220.24/220.42  |- skos__altLabel mesh__D003759 Endosseous Implantation, Endodontic
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D003759 2003
% 220.24/220.42  |- skos__broader mesh__D003759smesh__D003758
% 220.24/220.42  |- skos__historyNote mesh__D003759 Dental Implantation %28%1966-1970%29%
% 220.24/220.42  |- skos__altLabel mesh__D003759 Endodontic Stabilization
% 220.24/220.42  |- mesh__recordAuthorizer mesh__D003759 SJN
% 220.24/220.42  |- skos__altLabel mesh__D003759 Endodontic Endosseous Implantation
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D003759 1998
% 220.24/220.42  |- mesh__dateRevised mesh__D003759 1997-06-20
% 220.24/220.42  |- skos__broader mesh__D003759smesh__D004708
% 220.24/220.42  |- skos__hiddenLabel mesh__D003759 Stabilizations, Endodontic
% 220.24/220.42  |- skos__hiddenLabel mesh__D003759 Endodontic Endosseous Implantations
% 220.24/220.42  |- mesh__recordOriginator mesh__D003759 NLM
% 220.24/220.42  |- skos__prefLabel mesh__D003759
% 220.24/220.42       Dental Implantation, Endosseous, Endodontic
% 220.24/220.42  |- skos__hiddenLabel mesh__D003759 Endodontic Stabilizations
% 220.24/220.42  |- mesh__publicMeSHNote mesh__D003759
% 220.24/220.42       77; was ENDODONTIC ENDOSSEOUS IMPLANTATION 1971-76   
% 220.24/220.42  |- skos__scopeNote mesh__D003759
% 220.24/220.42       Insertion of a tapered rod through the root canal into the periapical osseous structure to lengthen the existing root and provide individual tooth stabilization.%A%    
% 220.24/220.42  |- mesh__recordMaintainer mesh__D003759 PXP
% 220.24/220.42  |- mesh__dateCreated mesh__D014481 1999-01-01
% 220.24/220.42  |- skos__prefLabel mesh__D014481 United States
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D014481 2002
% 220.24/220.42  |- skos__broader mesh__D014481smesh__D009656
% 220.24/220.42  |- skos__annotation mesh__D014481
% 220.24/220.42       do not abbreviate; each state is available as a heading as are several cities; %22%American%22% in titles refers probably to UNITED STATES, not AMERICAS; with Amer organizations: Manual 36.16%A%  
% 220.24/220.42  |- mesh__recordMaintainer mesh__D014481 TGC
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D014481 1998
% 220.24/220.42  |- mesh__dateRevised mesh__D014481 1997-06-20
% 220.24/220.42  |- rdf__type mesh__D014481sskos__Concept
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D014481 1999
% 220.24/220.42  |- mesh__recordAuthorizer mesh__D014481 SJN
% 220.24/220.42  |- mesh__onlineNote mesh__D014481
% 220.24/220.42       pre-explosion = UNITED STATES %28%PX%29%   
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D014481 2000
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D014481 2005
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D014481 2003
% 220.24/220.42  |- mesh__recordOriginator mesh__D014481 NLM
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D014481 2006
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D014481 2004
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D014481 2001
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D008444 2004
% 220.24/220.42  |- mesh__publicMeSHNote mesh__D008444
% 220.24/220.42       91; was see under PARANASAL SINUS NEOPLASMS 1984-90   
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D008444 2000
% 220.24/220.42  |- skos__altLabel mesh__D008444 Neoplasms, Maxillary Sinus
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D008444 2003
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D008444 1996
% 220.24/220.42  |- mesh__historyNote mesh__D008444
% 220.24/220.42       91%28%84%29%; was see under PARANASAL SINUS NEOPLASMS 1984-90   
% 220.24/220.42  |- skos__prefLabel mesh__D008444 Maxillary Sinus Neoplasms
% 220.24/220.42  |- mesh__dateRevised mesh__D008444 1995-06-08
% 220.24/220.42  |- mesh__dateCreated mesh__D008444 1983-05-31
% 220.24/220.42  |- skos__hiddenLabel mesh__D008444 Neoplasm, Maxillary Sinus
% 220.24/220.42  |- skos__historyNote mesh__D008444
% 220.24/220.42       Paranasal Sinus Neoplasms %28%1966-1983%29%
% 220.24/220.42  |- skos__hiddenLabel mesh__D008444 Maxillary Sinus Neoplasm
% 220.24/220.42  |- mesh__dateEstablished mesh__D008444 1991-01-01
% 220.24/220.42  |- mesh__recordMaintainer mesh__D008444 KEV
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D008444 1999
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D008444 2006
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D008444 2002
% 220.24/220.42  |- skos__annotation mesh__D008444
% 220.24/220.42       coord IM with histol type of neopl %28%IM%29%; /blood supply /chem /second /secret /ultrastruct permitted%A%  
% 220.24/220.42  |- mesh__recordAuthorizer mesh__D008444 PLS
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D008444 1998
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D008444 2005
% 220.24/220.42  |- skos__hiddenLabel mesh__D008444 Sinus Neoplasms, Maxillary
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D008444 2001
% 220.24/220.42  |- skos__broader mesh__D008444smesh__D010255
% 220.24/220.42  |- skos__scopeNote mesh__D008444
% 220.24/220.42       Neoplasms or tumors of the maxillary sinus. The majority of paranasal sinus neoplasms arise here. They develop silently when confined to the sinus and produce symptoms on extension through the walls.%A%    
% 220.24/220.42  |- rdf__type mesh__D008444sskos__Concept
% 220.24/220.42  |- skos__hiddenLabel mesh__D008444 Sinus Neoplasm, Maxillary
% 220.24/220.42  |- mesh__recordOriginator mesh__D008444 VDK
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D008444 1997
% 220.24/220.42  |- mesh__recordOriginator mesh__D000461 NLM
% 220.24/220.42  |- skos__historyNote mesh__D000461 Algae %28%1966-1970%29%
% 220.24/220.42  |- mesh__recordAuthorizer mesh__D000461 sjn
% 220.24/220.42  |- skos__annotation mesh__D000461 GEN or unspecified; prefer specifics   
% 220.24/220.42  |- rdf__type mesh__D000461sskos__Concept
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D000461 2006
% 220.24/220.42  |- skos__scopeNote mesh__D000461
% 220.24/220.42       Algae of the division Rhodophyta, in which the red pigment %28%PHYCOERYTHRIN%29% predominates. However if this pigment is destroyed, the algae can appear purple, brown, green, or yellow. Two important substances found in the cell walls of red algae are AGAR and CARRAGEENAN. Red algae are thought to be closely related to the prokaryotic CYANOBACTERIA.%A%    
% 220.24/220.42  |- skos__prefLabel mesh__D000461 Algae, Red
% 220.24/220.42  |- mesh__dateCreated mesh__D000461 1999-01-01
% 220.24/220.42  |- skos__hiddenLabel mesh__D000461 Red Algae
% 220.24/220.42  |- mesh__publicMeSHNote mesh__D000461 74   
% 220.24/220.42  |- mesh__historyNote mesh__D000461 74%28%71%29%   
% 220.24/220.42  |- skos__broader mesh__D000461smesh__D000456
% 220.24/220.42  |- mesh__dateEstablished mesh__D000461 1974-01-01
% 220.24/220.42  |- mesh__dateRevised mesh__D000461 2005-06-30
% 220.24/220.42  |- skos__altLabel mesh__D000461 Rhodophyta
% 220.24/220.42  |- mesh__recordMaintainer mesh__D000461 SYSTEM
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D013389 2004
% 220.24/220.42  |- skos__altLabel mesh__D013389 Succinic Thiokinases
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D013389 2006
% 220.24/220.42  |- skos__hiddenLabel mesh__D013389 Succinate CoA Ligases
% 220.24/220.42  |- skos__broader mesh__D013389smesh__D003066
% 220.24/220.42  |- skos__historyNote mesh__D013389 Succinates %28%1973%29%
% 220.24/220.42  |- mesh__dateEstablished mesh__D013389 1991-01-01
% 220.24/220.42  |- skos__hiddenLabel mesh__D013389 Thiokinases, Succinic
% 220.24/220.42  |- mesh__recordAuthorizer mesh__D013389 sjn
% 220.24/220.42  |- mesh__dateCreated mesh__D013389 1975-07-25
% 220.24/220.42  |- mesh__recordMaintainer mesh__D013389 ssb
% 220.24/220.42  |- skos__altLabel mesh__D013389 Succinyl Coenzyme A Synthetases
% 220.24/220.42  |- skos__prefLabel mesh__D013389 Succinate-CoA Ligases
% 220.24/220.42  |- skos__historyNote mesh__D013389 Coenzyme A Synthetases %28%1973%29%
% 220.24/220.42  |- mesh__historyNote mesh__D013389 98%28%76%29%   
% 220.24/220.42  |- skos__scopeNote mesh__D013389
% 220.24/220.42       Enzymes that catalyze the first step leading to the oxidation of succinic acid by the reversible formation of succinyl-CoA from succinate and CoA with the concomitant cleavage of ATP to ADP %28%EC 6.2.1.5%29% or GTP to GDP %28%EC 6.2.1.4%29% and orthophosphate. Itaconate can act instead of succinate and ITP instead of GTP.EC 6.2.1.-.%A%    
% 220.24/220.42  |- mesh__publicMeSHNote mesh__D013389
% 220.24/220.42       98; see SUCCINYL COENZYME A SYNTHETASES 1991-97; see COENZYME A SYNTHETASES 1976-90%A%  
% 220.24/220.42  |- rdf__type mesh__D013389sskos__Concept
% 220.24/220.42  |- mesh__recordOriginator mesh__D013389 RLS
% 220.24/220.42  |- mesh__dateRevised mesh__D013389 2003-07-09
% 220.24/220.42  |- skos__hiddenLabel mesh__D013389 Synthetases, Succinyl CoA
% 220.24/220.42  |- skos__hiddenLabel mesh__D013389 Ligases, Succinate-CoA
% 220.24/220.42  |- skos__hiddenLabel mesh__D013389 CoA Synthetases, Succinyl
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D013389 2005
% 220.24/220.42  |- skos__altLabel mesh__D013389 Succinyl CoA Synthetases
% 220.24/220.42  |- mesh__dateRevised mesh__D018074 2005-06-30
% 220.24/220.42  |- mesh__recordMaintainer mesh__D018074 ssb
% 220.24/220.42  |- mesh__recordOriginator mesh__D018074 AGS
% 220.24/220.42  |- skos__annotation mesh__D018074
% 220.24/220.42       %22%induce antibody formation in people not responsive to polysaccharide alone%22%; semisynthetic vaccines; coord NIM with specific vaccine %28%IM%29%%A%  
% 220.24/220.42  |- mesh__recordAuthorizer mesh__D018074 sjn
% 220.24/220.42  |- skos__historyNote mesh__D018074
% 220.24/220.42       vaccine components/immunology %28%1984-1993%29%
% 220.24/220.42  |- mesh__historyNote mesh__D018074 94   
% 220.24/220.42  |- skos__broader mesh__D018074smesh__D014614
% 220.24/220.42  |- mesh__dateEstablished mesh__D018074 1994-01-01
% 220.24/220.42  |- mesh__publicMeSHNote mesh__D018074 94   
% 220.24/220.42  |- skos__historyNote mesh__D018074 Vaccines, Synthetic %28%1988-1993%29%
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D018074 2006
% 220.24/220.42  |- skos__prefLabel mesh__D018074 Vaccines, Conjugate
% 220.24/220.42  |- skos__scopeNote mesh__D018074
% 220.24/220.42       Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognized by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection.%A%    
% 220.24/220.42  |- rdf__type mesh__D018074sskos__Concept
% 220.24/220.42  |- skos__hiddenLabel mesh__D018074 Conjugate Vaccines
% 220.24/220.42  |- mesh__dateCreated mesh__D018074 1993-06-04
% 220.24/220.42  |- mesh__recordMaintainer mesh__D010091 ssb
% 220.24/220.42  |- rdf__type mesh__D010091sskos__Concept
% 220.24/220.42  |- mesh__dateRevised mesh__D010091 2002-07-18
% 220.24/220.42  |- skos__broader mesh__D010091smesh__D006898
% 220.24/220.42  |- mesh__dateCreated mesh__D010091 1999-01-01
% 220.24/220.42  |- mesh__recordAuthorizer mesh__D010091 sjn
% 220.24/220.42  |- skos__hiddenLabel mesh__D010091 Compounds, Hydroxyimino
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D010091 2005
% 220.24/220.42  |- skos__scopeNote mesh__D010091
% 220.24/220.42       Compounds that contain the radical R2C=N.OH derived from condensation of ALDEHYDES or KETONES with HYDROXYLAMINE. Members of this group are CHOLINESTERASE REACTIVATORS.%A%    
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D010091 2003
% 220.24/220.42  |- skos__altLabel mesh__D010091 Hydroxyimino Compounds
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D010091 2006
% 220.24/220.42  |- skos__prefLabel mesh__D010091 Oximes
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D010091 2004
% 220.24/220.42  |- mesh__recordOriginator mesh__D010091 NLM
% 220.24/220.42  |- skos__annotation mesh__D004852 DF: EPOXY CPDS   
% 220.24/220.42  |- mesh__dateRevised mesh__D004852 2004-07-07
% 220.24/220.42  |- rdf__type mesh__D004852sskos__Concept
% 220.24/220.42  |- mesh__dateEstablished mesh__D004852 1991-01-01
% 220.24/220.42  |- mesh__historyNote mesh__D004852
% 220.24/220.42       91%28%75%29%; was see under ETHERS, CYCLIC 1975-90   
% 220.24/220.42  |- mesh__recordMaintainer mesh__D004852 ssb
% 220.24/220.42  |- skos__altLabel mesh__D004852 Epoxides
% 220.24/220.42  |- mesh__recordOriginator mesh__D004852 NLM
% 220.24/220.42  |- mesh__publicMeSHNote mesh__D004852
% 220.24/220.42       91; was see under ETHERS, CYCLIC 1975-90   
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D004852 2006
% 220.24/220.42  |- skos__prefLabel mesh__D004852 Epoxy Compounds
% 220.24/220.42  |- mesh__dateCreated mesh__D004852 1999-01-01
% 220.24/220.42  |- skos__broader mesh__D004852smesh__D004988
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D004852 2005
% 220.24/220.42  |- mesh__onlineNote mesh__D004852 search ETHERS, CYCLIC 1966-74   
% 220.24/220.42  |- skos__hiddenLabel mesh__D004852 Compounds, Epoxy
% 220.24/220.42  |- mesh__recordAuthorizer mesh__D004852 sjn
% 220.24/220.42  |- mesh__recordAuthorizer mesh__D004054 sjn
% 220.24/220.42  |- rdf__type mesh__D004054sskos__Concept
% 220.24/220.42  |- skos__altLabel mesh__D004054 Shire Brand of Diethylstilbestrol
% 220.24/220.42  |- skos__altLabel mesh__D004054 APS Brand of Diethylstilbestrol
% 220.24/220.42  |- skos__annotation mesh__D004054 DF: DES   
% 220.24/220.42  |- skos__altLabel mesh__D004054 Stilbene Estrogen
% 220.24/220.42  |- mesh__dateRevised mesh__D004054 2005-06-30
% 220.24/220.42  |- skos__altLabel mesh__D004054 Co-Pharma Brand of Diethylstilbestrol
% 220.24/220.42  |- skos__scopeNote mesh__D004054
% 220.24/220.42       A synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders. It was also used formerly as a growth promoter in animals. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%, diethylstilbestrol has been listed as a known carcinogen. %28%Merck, 11th ed%29%%A%    
% 220.24/220.42  |- mesh__recordOriginator mesh__D004054 NLM
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D004054 2006
% 220.24/220.42  |- skos__broader mesh__D004054smesh__D013267
% 220.24/220.42  |- skos__altLabel mesh__D004054 Gerda Brand of Diethylstilbestrol
% 220.24/220.42  |- skos__prefLabel mesh__D004054 Diethylstilbestrol
% 220.24/220.42  |- skos__hiddenLabel mesh__D004054 Co Pharma Brand of Diethylstilbestrol
% 220.24/220.42  |- skos__hiddenLabel mesh__D004054 Estrogen, Stilbene
% 220.24/220.42  |- mesh__recordMaintainer mesh__D004054 exl
% 220.24/220.42  |- mesh__dateCreated mesh__D004054 1999-01-01
% 220.24/220.42  |- mesh__recordOriginator mesh__D050605 AKE
% 220.24/220.42  |- mesh__publicMeSHNote mesh__D050605
% 220.24/220.42       2006; MALONATE-SEMIALDEHYDE DEHYDROGENASE %28%ACETYLATING%29% was indexed under ALDEHYDE OXIDOREDUCTASES 1987-2005%A%  
% 220.24/220.42  |- skos__altLabel mesh__D050605
% 220.24/220.42       Malonate Semialdehyde Dehydrogenase %28%Acetylating%29%
% 220.24/220.42  |- skos__prefLabel mesh__D050605
% 220.24/220.42       Malonate-Semialdehyde Dehydrogenase %28%Acetylating%29%
% 220.24/220.42  |- mesh__recordAuthorizer mesh__D050605 sjn
% 220.24/220.42  |- skos__altLabel mesh__D050605
% 220.24/220.42       Malonic-Semialdehyde Dehydrogenase %28%Acylating%29%
% 220.24/220.42  |- mesh__recordMaintainer mesh__D050605 AKE
% 220.24/220.42  |- mesh__dateEstablished mesh__D050605 2006-01-01
% 220.24/220.42  |- skos__broader mesh__D050605smesh__D000445
% 220.24/220.42  |- skos__altLabel mesh__D050605 MSA Dehydrogenase
% 220.24/220.42  |- mesh__dateCreated mesh__D050605 2005-06-30
% 220.24/220.42  |- mesh__historyNote mesh__D050605 2006%28%1987%29%   
% 220.24/220.42  |- skos__scopeNote mesh__D050605
% 220.24/220.42       An enzyme that catalyzes the oxidation of 3-oxopropanoate %28%malonate semialdehyde%29% to acetyl COENZYME A. It plays a role in the metabolism of BETA-ALANINE.%A%    
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D050605 2006
% 220.24/220.42  |- rdf__type mesh__D050605sskos__Concept
% 220.24/220.42  |- skos__altLabel mesh__D014482
% 220.24/220.42       Substance Abuse and Mental Health Services Administration
% 220.24/220.42  |- mesh__dateEstablished mesh__D014482 1975-09-01
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D014482 1998
% 220.24/220.42  |- mesh__recordOriginator mesh__D014482 NLM
% 220.24/220.42  |- mesh__recordMaintainer mesh__D014482 PXP
% 220.24/220.42  |- rdf__type mesh__D014482sskos__Concept
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D014482 2001
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D014482 1999
% 220.24/220.42  |- mesh__publicMeSHNote mesh__D014482
% 220.24/220.42       94; was UNITED STATES ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1978-93; was ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1975-77, was UNITED STATES HEALTH SER AND MENTAL HEALTH AD 1973-74%A%  
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D014482 2002
% 220.24/220.42  |- mesh__onlineNote mesh__D014482
% 220.24/220.42       use UNITED STATES SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION to search UNITED STATES ALCOHOL, DRUG ABUSE AND MENTAL HEALTH ADMINISTRATION 1978-93, ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1975-77 %26% UNITED STATES HEALTH SER AND MENTAL HEALTH AD 1973-74%A%  
% 220.24/220.42  |- mesh__dateRevised mesh__D014482 1997-06-20
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D014482 2005
% 220.24/220.42  |- mesh__dateCreated mesh__D014482 1975-02-03
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D014482 2003
% 220.24/220.42  |- mesh__historyNote mesh__D014482
% 220.24/220.42       94; was UNITED STATES ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1978-93; was ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1975-77; was UNITED STATES HEALTH SER AND MENTAL HEALTH AD 1973-74%A%  
% 220.24/220.42  |- mesh__recordAuthorizer mesh__D014482 SJN
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D014482 2006
% 220.24/220.42  |- skos__annotation mesh__D014482
% 220.24/220.42       add UNITED STATES %28%NIM%29%; research support by this agency is checked as NIH/PHS SUP; DF: SAMHSA      CATALOG: use NAF entry%A%  
% 220.24/220.42  |- skos__altLabel mesh__D014482
% 220.24/220.42       Substance Abuse and Mental Health Services Administration %28%U.S.%29%
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D014482 2004
% 220.24/220.42  |- skos__broader mesh__D014482smesh__D014492
% 220.24/220.42  |- skos__prefLabel mesh__D014482
% 220.24/220.42       United States Substance Abuse and Mental Health Services Administration
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D014482 2000
% 220.24/220.42  |- skos__scopeNote mesh__D014482
% 220.24/220.42       An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to substance abuse and mental health. It is commonly referred to by the acronym SAMHSA. On 1 October 1992, the United States Alcohol, Drug Abuse, and Mental Health Administration %28%ADAMHA%29% became SAMHSA. %28%Telephone communication with SAMHSA 7 April 1992%29%%A%    
% 220.24/220.42  |- mesh__dateCreated mesh__D008445 1999-01-01
% 220.24/220.42  |- mesh__recordOriginator mesh__D008445 NLM
% 220.24/220.42  |- mesh__publicMeSHNote mesh__D008445 65   
% 220.24/220.42  |- skos__hiddenLabel mesh__D008445 Development, Maxillofacial
% 220.24/220.42  |- skos__prefLabel mesh__D008445 Maxillofacial Development
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D008445 2006
% 220.24/220.42  |- skos__hiddenLabel mesh__D008445 Developments, Maxillofacial
% 220.24/220.42  |- skos__related mesh__D008445smesh__D002508
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D008445 2005
% 220.24/220.42  |- skos__broader mesh__D008445smesh__D001846
% 220.24/220.42  |- skos__related mesh__D008445smesh__D014716
% 220.24/220.42  |- mesh__recordMaintainer mesh__D008445 lkt
% 220.24/220.42  |- skos__annotation mesh__D008445
% 220.24/220.42       long face syndrome does not go here: index under FACIAL BONES /abnorm %28%IM%29% + MALOCCLUSION or specific type %28%IM%29% + SYNDROME %28%NIM%29%%A%  
% 220.24/220.42  |- rdf__type mesh__D008445sskos__Concept
% 220.24/220.42  |- skos__hiddenLabel mesh__D008445 Maxillofacial Developments
% 220.24/220.42  |- mesh__dateRevised mesh__D008445 2004-07-07
% 220.24/220.42  |- skos__scopeNote mesh__D008445
% 220.24/220.42       The process of growth and differentiation of the jaws and face.%A%    
% 220.24/220.42  |- mesh__dateEstablished mesh__D008445 1965-01-01
% 220.24/220.42  |- mesh__recordAuthorizer mesh__D008445 sjn
% 220.24/220.42  |- mesh__historyNote mesh__D008445 65   
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D000462 2005
% 220.24/220.42  |- skos__annotation mesh__D000462 a country in northern Africa   
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D000462 1996
% 220.24/220.42  |- rdf__type mesh__D000462sskos__Concept
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D000462 2006
% 220.24/220.42  |- mesh__recordAuthorizer mesh__D000462 PLS
% 220.24/220.42  |- skos__broader mesh__D000462smesh__D000352
% 220.24/220.42  |- skos__scopeNote mesh__D000462
% 220.24/220.42       A country in northern Africa between MOROCCO and LIBYA. Its capital is Algiers. It was known to the Romans as Numidia. From 430 A.D. until 1942 it was successively in the hands of the Vandals, the Eastern Roman Empire, the Arabs, the Ottoman Empire, and the French, and gained independence in 1962. The country took its name from its capital, from the Arabic al %28%the%29% + jaza%27%ir %28%islands%29%, with reference to four islands lying off the coast at Algiers but joined to the mainland by 1525. %28%From Webster%27%s New Geographical Dictionary, 1988, p31 %26% Room, Brewer%27%s Dictionary of Names, 1992, p14%29%%A%    
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D000462 1997
% 220.24/220.42  |- mesh__recordOriginator mesh__D000462 NLM
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D000462 1998
% 220.24/220.42  |- mesh__dateRevised mesh__D000462 1995-05-23
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D000462 2000
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D000462 1999
% 220.24/220.42  |- mesh__recordMaintainer mesh__D000462 KEV
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D000462 2003
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D000462 2001
% 220.24/220.42  |- skos__prefLabel mesh__D000462 Algeria
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D000462 2004
% 220.24/220.42  |- mesh__dateCreated mesh__D000462 1999-01-01
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D000462 2002
% 220.24/220.42  |- mesh__recordAuthorizer mesh__D018873 sjn
% 220.24/220.42  |- skos__altLabel mesh__D018873 Live-Birth Pregnancy Rate
% 220.24/220.42  |- mesh__dateCreated mesh__D018873 1994-12-27
% 220.24/220.42  |- skos__prefLabel mesh__D018873 Pregnancy Rate
% 220.24/220.42  |- skos__historyNote mesh__D018873 Pregnancy %28%1967-1995%29%
% 220.24/220.42  |- skos__hiddenLabel mesh__D018873 Pregnancy Rates, Live-Birth
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D018873 2005
% 220.24/220.42  |- skos__scopeNote mesh__D018873
% 220.24/220.42       The ratio of the number of conceptions %28%CONCEPTION%29% including LIVE BIRTH; STILLBIRTH; and fetal losses, to the mean number of females of reproductive age in a population during a set time period.%A%    
% 220.24/220.42  |- skos__altLabel mesh__D018873 Rates, Pregnancy
% 220.24/220.42  |- skos__altLabel mesh__D018873 Rate, Pregnancy
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D018873 2006
% 220.24/220.42  |- skos__hiddenLabel mesh__D018873 Pregnancy Rate, Live Birth
% 220.24/220.42  |- skos__hiddenLabel mesh__D018873 Rates, Live-Birth Pregnancy
% 220.24/220.42  |- skos__broader mesh__D018873smesh__D014798
% 220.24/220.42  |- mesh__dateEstablished mesh__D018873 1996-01-01
% 220.24/220.42  |- skos__broader mesh__D018873smesh__D011247
% 220.24/220.42  |- mesh__recordOriginator mesh__D018873 TGC
% 220.24/220.42  |- skos__annotation mesh__D018873
% 220.24/220.42       check tags PREGNANCY %26% FEMALE; DF: PREGN RATE   
% 220.24/220.42  |- mesh__publicMeSHNote mesh__D018873 96   
% 220.24/220.42  |- skos__altLabel mesh__D018873 Pregnancy Rates
% 220.24/220.42  |- mesh__dateRevised mesh__D018873 2004-07-07
% 220.24/220.42  |- mesh__recordMaintainer mesh__D018873 lkt
% 220.24/220.42  |- rdf__type mesh__D018873sskos__Concept
% 220.24/220.42  |- skos__hiddenLabel mesh__D018873 Rate, Live-Birth Pregnancy
% 220.24/220.42  |- skos__hiddenLabel mesh__D018873 Live-Birth Pregnancy Rates
% 220.24/220.42  |- mesh__historyNote mesh__D018873 96   
% 220.24/220.42  |- skos__hiddenLabel mesh__D018873 Live Birth Pregnancy Rate
% 220.24/220.42  |- skos__broader mesh__D010890smesh__D001570
% 220.24/220.42  |- skos__altLabel mesh__D010890
% 220.24/220.42       ct-Arzneimittel Brand of Pirenzepine Dihydrochloride
% 220.24/220.42  |- mesh__dateCreated mesh__D010890 1986-04-09
% 220.24/220.42  |- mesh__dateRevised mesh__D010890 2005-06-30
% 220.24/220.42  |- skos__altLabel mesh__D010890 Pyrenzepine
% 220.24/220.42  |- skos__altLabel mesh__D010890
% 220.24/220.42       Boehringer Ingelheim Brand of Pirenzepine Dihydrochloride
% 220.24/220.42  |- skos__hiddenLabel mesh__D010890 LS519
% 220.24/220.42  |- skos__hiddenLabel mesh__D010890 Dihydrochloride, Pirenzepine
% 220.24/220.42  |- mesh__dateEstablished mesh__D010890 1987-01-01
% 220.24/220.42  |- skos__altLabel mesh__D010890 LS-519
% 220.24/220.42  |- skos__scopeNote mesh__D010890
% 220.24/220.42       An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.%A%    
% 220.24/220.42  |- rdf__type mesh__D010890sskos__Concept
% 220.24/220.42  |- skos__hiddenLabel mesh__D010890 LS 519
% 220.24/220.42  |- skos__hiddenLabel mesh__D010890 Pirenzepin ratiopharm
% 220.24/220.42  |- skos__altLabel mesh__D010890
% 220.24/220.42       Azupharma Brand of Pirenzepine Dihydrochloride
% 220.24/220.42  |- mesh__historyNote mesh__D010890 87   
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D010890 2006
% 220.24/220.42  |- mesh__recordOriginator mesh__D010890 RLS
% 220.24/220.42  |- skos__historyNote mesh__D010890 Azepines %28%1966-1973%29%
% 220.24/220.42  |- mesh__recordAuthorizer mesh__D010890 sjn
% 220.24/220.42  |- mesh__recordMaintainer mesh__D010890 lkw
% 220.24/220.42  |- skos__hiddenLabel mesh__D010890 Piren basan
% 220.24/220.42  |- skos__prefLabel mesh__D010890 Pirenzepine
% 220.24/220.42  |- skos__altLabel mesh__D010890 Pirenzepin
% 220.24/220.42  |- skos__historyNote mesh__D010890 Benzodiazepinones %28%1974-1986%29%
% 220.24/220.42  |- skos__altLabel mesh__D010890
% 220.24/220.42       Dolorgiet Brand of Pirenzepine Dihydrochloride
% 220.24/220.42  |- skos__altLabel mesh__D010890
% 220.24/220.42       ratiopharm Brand of Pirenzepine Dihydrochloride
% 220.24/220.42  |- skos__altLabel mesh__D010890
% 220.24/220.42       Sagitta Brand of Pirenzepine Dihydrochloride
% 220.24/220.42  |- mesh__publicMeSHNote mesh__D010890 87   
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D018075 2005
% 220.24/220.42  |- mesh__historyNote mesh__D018075
% 220.24/220.42       94; was COMPLEMENTARY RNA %28%NM%29% 1984-93   
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D018075 2004
% 220.24/220.42  |- mesh__publicMeSHNote mesh__D018075
% 220.24/220.42       94; COMPLEMENTARY RNA was indexed under RNA 1984-93   
% 220.24/220.42  |- skos__broader mesh__D018075smesh__D012313
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D018075 2006
% 220.24/220.42  |- skos__historyNote mesh__D018075 RNA %28%1974-1993%29%
% 220.24/220.42  |- skos__scopeNote mesh__D018075
% 220.24/220.42       Synthetic transcripts of a specific DNA molecule or fragment, made by an in vitro transcription system. This cRNA can be labeled with radioactive uracil and then used as a probe. %28%King %26% Stansfield, A Dictionary of Genetics, 4th ed%29%%A%    
% 220.24/220.42  |- mesh__recordMaintainer mesh__D018075 ssb
% 220.24/220.42  |- mesh__onlineNote mesh__D018075
% 220.24/220.42       use RNA, COMPLEMENTARY %28%NM%29% to search COMPLEMENTARY RNA 1984-93%A%  
% 220.24/220.42  |- rdf__type mesh__D018075sskos__Concept
% 220.24/220.42  |- skos__historyNote mesh__D018075 specific RNA %28%1974-1993%29%
% 220.24/220.42  |- mesh__dateCreated mesh__D018075 1993-06-03
% 220.24/220.42  |- mesh__dateRevised mesh__D018075 2003-07-09
% 220.24/220.42  |- mesh__recordOriginator mesh__D018075 PXP
% 220.24/220.42  |- skos__broader mesh__D018075smesh__D015347
% 220.24/220.42  |- mesh__recordAuthorizer mesh__D018075 sjn
% 220.24/220.42  |- skos__prefLabel mesh__D018075 RNA, Complementary
% 220.24/220.42  |- mesh__dateEstablished mesh__D018075 1994-01-01
% 220.24/220.42  |- skos__annotation mesh__D018075
% 220.24/220.42       IM; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 220.24/220.42  |- skos__altLabel mesh__D018075 Complementary RNA
% 220.24/220.42  |- skos__altLabel mesh__D018075 cRNA
% 220.24/220.42  |- skos__hiddenLabel mesh__D018075 Probes, cRNA
% 220.24/220.42  |- skos__broader mesh__D010092smesh__D006334
% 220.24/220.42  |- mesh__recordAuthorizer mesh__D010092 SJN
% 220.24/220.42  |- mesh__recordOriginator mesh__D010092 NLM
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D010092 2001
% 220.24/220.42  |- mesh__dateCreated mesh__D010092 1999-01-01
% 220.24/220.42  |- skos__hiddenLabel mesh__D010092 Oximetries, Pulse
% 220.24/220.42  |- skos__altLabel mesh__D010092 Pulse Oximetry
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D010092 2005
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D010092 2002
% 220.24/220.42  |- skos__hiddenLabel mesh__D010092 Oximetries
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D010092 2003
% 220.24/220.42  |- skos__annotation mesh__D010092
% 220.24/220.42       for measuremt of blood oxygen using an oximeter: not a synonym for %22%oxygen measuremt%22% %28% = OXYGEN /anal%29%%A%  
% 220.24/220.42  |- mesh__recordMaintainer mesh__D010092 PXP
% 220.24/220.42  |- mesh__dateRevised mesh__D010092 1997-06-20
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D010092 2006
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D010092 2004
% 220.24/220.42  |- skos__hiddenLabel mesh__D010092 Pulse Oximetries
% 220.24/220.42  |- skos__scopeNote mesh__D010092
% 220.24/220.42       The determination of oxygen-hemoglobin saturation of blood either by withdrawing a sample and passing it through a classical photoelectric oximeter or by electrodes attached to some translucent part of the body like finger, earlobe, or skin fold. It includes non-invasive oxygen monitoring by pulse oximetry.%A%    
% 220.24/220.42  |- skos__prefLabel mesh__D010092 Oximetry
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D010092 1998
% 220.24/220.42  |- rdf__type mesh__D010092sskos__Concept
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D010092 1999
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D010092 2000
% 220.24/220.42  |- skos__broader mesh__D010092smesh__D001784
% 220.24/220.42  |- skos__annotation mesh__D004853 D25-26 qualif   
% 220.24/220.42  |- mesh__recordMaintainer mesh__D004853 jmp
% 220.24/220.42  |- skos__broader mesh__D004853smesh__D012117
% 220.24/220.42  |- mesh__recordAuthorizer mesh__D004853 sjn
% 220.24/220.42  |- skos__scopeNote mesh__D004853
% 220.24/220.42       Organic compounds containing an epoxide group and characterized by strength and thermosetting properties. Epoxy resins are often used as dental materials.%A%    
% 220.24/220.42  |- skos__hiddenLabel mesh__D004853 Resins, Epoxy
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D004853 2006
% 220.24/220.42  |- mesh__dateCreated mesh__D004853 1999-01-01
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D004853 2005
% 220.24/220.42  |- mesh__recordOriginator mesh__D004853 NLM
% 220.24/220.42  |- skos__prefLabel mesh__D004853 Epoxy Resins
% 220.24/220.42  |- rdf__type mesh__D004853sskos__Concept
% 220.24/220.42  |- mesh__historyNote mesh__D004853 68%28%66%29%   
% 220.24/220.42  |- mesh__publicMeSHNote mesh__D004853 68   
% 220.24/220.42  |- mesh__dateRevised mesh__D004853 2004-07-07
% 220.24/220.42  |- mesh__dateEstablished mesh__D004853 1968-01-01
% 220.24/220.42  |- mesh__recordMaintainer mesh__D004055 lkt
% 220.24/220.42  |- skos__prefLabel mesh__D004055 Differential Thermal Analysis
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D004055 2005
% 220.24/220.42  |- rdf__type mesh__D004055sskos__Concept
% 220.24/220.42  |- mesh__historyNote mesh__D004055
% 220.24/220.42       91%28%77%29%; was see under CHEMISTRY, ANALYTICAL 1977-90   
% 220.24/220.42  |- skos__historyNote mesh__D004055 Thermodynamics %28%1966-1976%29%
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D004055 2006
% 220.24/220.42  |- mesh__recordAuthorizer mesh__D004055 sjn
% 220.24/220.42  |- skos__hiddenLabel mesh__D004055 Analyses, Differential Thermal
% 220.24/220.42  |- skos__altLabel mesh__D004055 Analysis, Differential Thermal
% 220.24/220.42  |- skos__altLabel mesh__D004055 Thermal Analysis, Differential
% 220.24/220.42  |- mesh__activeMeSHYear mesh__D004055 2003
% 220.24/220.42  |- skos__annotation mesh__D004055 NIM   
% 220.24/220.42  |- skos__hiddenLabel mesh__D004055 Differential Thermal Analyses
% 220.24/220.42  |- mesh__dateCreated mesh__D004055 1976-04-13
% 220.24/220.42  |- skos__broader mesh__D004055smesh__D002623
% 220.24/220.42  |- mesh__publicMeSHNote mesh__D004055
% 220.24/220.42       91; was see under CHEMISTRY, ANALYTICAL 1977-90   
% 220.24/220.42  |- skos__historyNote mesh__D004055 Heat %28%1966-1976%29%
% 220.24/220.43  |- mesh__dateEstablished mesh__D004055 1991-01-01
% 220.24/220.43  |- mesh__dateRevised mesh__D004055 2002-07-02
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D004055 2004
% 220.24/220.43  |- mesh__recordOriginator mesh__D004055 SMH
% 220.24/220.43  |- skos__historyNote mesh__D004055 Temperature %28%1966-1976%29%
% 220.24/220.43  |- skos__hiddenLabel mesh__D004055 Thermal Analyses, Differential
% 220.24/220.43  |- skos__scopeNote mesh__D004055
% 220.24/220.43       Technique by which phase transitions of chemical reactions can be followed by observation of the heat absorbed or liberated.%A%    
% 220.24/220.43  |- skos__broader mesh__D050606smesh__D012697
% 220.24/220.43  |- skos__altLabel mesh__D050606 MBP-Associated Serine Protease
% 220.24/220.43  |- mesh__recordMaintainer mesh__D050606 lkt
% 220.24/220.43  |- skos__annotation mesh__D050606 see SCR for organism-specific terms   
% 220.24/220.43  |- skos__prefLabel mesh__D050606
% 220.24/220.43       Mannose-Binding Protein-Associated Serine Proteases
% 220.24/220.43  |- skos__altLabel mesh__D050606 MASP Proteases
% 220.24/220.43  |- skos__altLabel mesh__D050606 MBL-Associated Serine Proteases
% 220.24/220.43  |- skos__hiddenLabel mesh__D050606
% 220.24/220.43       MBP Associated Serine Protease Related Protein
% 220.24/220.43  |- skos__hiddenLabel mesh__D050606 Serine Protease, MBP-Associated
% 220.24/220.43  |- mesh__historyNote mesh__D050606 2006 %28%1994%29%   
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D050606 2006
% 220.24/220.43  |- skos__hiddenLabel mesh__D050606 Protein, MASP-Related
% 220.24/220.43  |- skos__hiddenLabel mesh__D050606 Serine Proteases, MBL-Associated
% 220.24/220.43  |- skos__historyNote mesh__D050606 Serine Endopeptidases %28%1992-2005%29%
% 220.24/220.43  |- skos__hiddenLabel mesh__D050606 MBL Associated Serine Proteases
% 220.24/220.43  |- rdf__type mesh__D050606sskos__Concept
% 220.24/220.43  |- skos__historyNote mesh__D050606
% 220.24/220.43       Mannose-Binding Lectins %28%1992-2005%29%
% 220.24/220.43  |- skos__altLabel mesh__D050606
% 220.24/220.43       Mannose-Binding Protein-Associated Serine Protease
% 220.24/220.43  |- skos__altLabel mesh__D050606
% 220.24/220.43       MBP-Associated Serine Protease-Related Protein
% 220.24/220.43  |- mesh__dateEstablished mesh__D050606 2006-01-01
% 220.24/220.43  |- skos__altLabel mesh__D050606 MASPs
% 220.24/220.43  |- mesh__publicMeSHNote mesh__D050606
% 220.24/220.43       2006; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES was indexed under SERINE ENDOPEPTIDASES 1994-2005%A%  
% 220.24/220.43  |- skos__altLabel mesh__D050606 Mannan-Binding Lectin Serine Proteases
% 220.24/220.43  |- mesh__recordAuthorizer mesh__D050606 sjn
% 220.24/220.43  |- skos__broader mesh__D050606smesh__D050577
% 220.24/220.43  |- skos__hiddenLabel mesh__D050606 MBP Associated Serine Protease
% 220.24/220.43  |- skos__hiddenLabel mesh__D050606 MASP Related Protein
% 220.24/220.43  |- mesh__recordOriginator mesh__D050606 lkt
% 220.24/220.43  |- skos__hiddenLabel mesh__D050606 Mannan Binding Lectin Serine Proteases
% 220.24/220.43  |- mesh__dateCreated mesh__D050606 2005-06-30
% 220.24/220.43  |- skos__hiddenLabel mesh__D050606 Proteases, MASP
% 220.24/220.43  |- skos__hiddenLabel mesh__D050606
% 220.24/220.43       Mannose Binding Protein Associated Serine Protease
% 220.24/220.43  |- skos__scopeNote mesh__D050606
% 220.24/220.43       Serum serine proteases which participate in COMPLEMENT ACTIVATION. They are activated when complexed with the MANNOSE-BINDING LECTIN, therefore also known as Mannose-binding protein-Associated Serine Proteases %28%MASPs%29%. They cleave COMPLEMENT C4 and COMPLEMENT C2 to form C4b2a, the CLASSICAL PATHWAY C3 CONVERTASE.%A%    
% 220.24/220.43  |- skos__altLabel mesh__D014483
% 220.24/220.43       Department of Health and Human Services %28%U.S.%29%
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D014483 2005
% 220.24/220.43  |- mesh__publicMeSHNote mesh__D014483
% 220.24/220.43       82; was UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES 1981, was UNITED STATES DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE 1976-80%A%  
% 220.24/220.43  |- mesh__recordOriginator mesh__D014483 EC
% 220.24/220.43  |- mesh__dateCreated mesh__D014483 1975-07-23
% 220.24/220.43  |- mesh__onlineNote mesh__D014483
% 220.24/220.43       use UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES to search UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES 1981 %26% UNITED STATES DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE 1976-80%A%  
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D014483 2006
% 220.24/220.43  |- skos__altLabel mesh__D014483 Department of Health and Human Services
% 220.24/220.43  |- skos__historyNote mesh__D014483 Government Agencies %28%1968-1975%29%
% 220.24/220.43  |- mesh__recordAuthorizer mesh__D014483 sjn
% 220.24/220.43  |- mesh__recordMaintainer mesh__D014483 sjn
% 220.24/220.43  |- skos__broader mesh__D014483smesh__D006077
% 220.24/220.43  |- skos__altLabel mesh__D014483
% 220.24/220.43       United States Department of Health, Education and Welfare
% 220.24/220.43  |- skos__altLabel mesh__D014483
% 220.24/220.43       United States Department of Health and Human Services
% 220.24/220.43  |- mesh__dateEstablished mesh__D014483 1976-01-01
% 220.24/220.43  |- skos__prefLabel mesh__D014483
% 220.24/220.43       United States Dept. of Health and Human Services
% 220.24/220.43  |- mesh__dateRevised mesh__D014483 2004-07-13
% 220.24/220.43  |- skos__altLabel mesh__D014483
% 220.24/220.43       United States Department of Health, Human Services
% 220.24/220.43  |- skos__annotation mesh__D014483
% 220.24/220.43       add UNITED STATES %28%NIM%29%; research support by this agency is checked as OTHER US GOVT SUP; DF: HHS      CATALOG: use NAF entry%A%  
% 220.24/220.43  |- mesh__historyNote mesh__D014483
% 220.24/220.43       82; was UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES 1981, was UNITED STATES DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE 1976-80%A%  
% 220.24/220.43  |- skos__historyNote mesh__D014483 specific agency %28%1968-1975%29%
% 220.24/220.43  |- rdf__type mesh__D014483sskos__Concept
% 220.24/220.43  |- skos__scopeNote mesh__D014483
% 220.24/220.43       A department of the United States government concerned with administering those agencies and offices having programs pertaining to health and human services.%A%    
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D008446 2005
% 220.24/220.43  |- skos__hiddenLabel mesh__D008446 Maxillofacial Injury
% 220.24/220.43  |- skos__scopeNote mesh__D008446
% 220.24/220.43       General or unspecified injuries involving the face and jaw %28%either upper, lower, or both%29%.%A%    
% 220.24/220.43  |- skos__altLabel mesh__D008446 Injuries, Maxillofacial
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D008446 2000
% 220.24/220.43  |- mesh__publicMeSHNote mesh__D008446 65   
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D008446 2006
% 220.24/220.43  |- mesh__recordAuthorizer mesh__D008446 sjn
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D008446 2001
% 220.24/220.43  |- mesh__recordMaintainer mesh__D008446 PXP
% 220.24/220.43  |- mesh__dateRevised mesh__D008446 1999-11-03
% 220.24/220.43  |- skos__prefLabel mesh__D008446 Maxillofacial Injuries
% 220.24/220.43  |- mesh__dateEstablished mesh__D008446 1965-01-01
% 220.24/220.43  |- skos__broader mesh__D008446smesh__D005151
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D008446 2003
% 220.24/220.43  |- mesh__recordOriginator mesh__D008446 NLM
% 220.24/220.43  |- mesh__historyNote mesh__D008446 65   
% 220.24/220.43  |- skos__hiddenLabel mesh__D008446 Injury, Maxillofacial
% 220.24/220.43  |- skos__annotation mesh__D008446
% 220.24/220.43       GEN or unspecified %26% involving both a jaw %26% the face: not a substitute for MANDIBULAR INJURIES or MAXILLA /inj or FACIAL INJURIES or FACIAL BONES /inj%A%  
% 220.24/220.43  |- rdf__type mesh__D008446sskos__Concept
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D008446 2004
% 220.24/220.43  |- mesh__dateCreated mesh__D008446 1999-01-01
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D008446 2002
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D000463 2006
% 220.24/220.43  |- skos__prefLabel mesh__D000463 Algestone Acetophenide
% 220.24/220.43  |- mesh__publicMeSHNote mesh__D000463 74   
% 220.24/220.43  |- mesh__dateRevised mesh__D000463 2003-07-09
% 220.24/220.43  |- skos__hiddenLabel mesh__D000463 Acetophenide, Algestone
% 220.24/220.43  |- skos__hiddenLabel mesh__D000463 Acetophenide, Alphasone
% 220.24/220.43  |- skos__scopeNote mesh__D000463
% 220.24/220.43       A progesterone that has been used in ESTRUS SYNCHRONIZATION and has been evaluated as an injectable contraceptive in combination with estradiol enanthate. It is also used therapeutically as a topical anti-inflammatory and is applied topically in the treatment of ACNE.%A%    
% 220.24/220.43  |- mesh__historyNote mesh__D000463 74   
% 220.24/220.43  |- skos__broader mesh__D000463smesh__D000523
% 220.24/220.43  |- mesh__recordOriginator mesh__D000463 NLM
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D000463 2004
% 220.24/220.43  |- mesh__recordAuthorizer mesh__D000463 sjn
% 220.24/220.43  |- mesh__dateCreated mesh__D000463 1999-01-01
% 220.24/220.43  |- skos__hiddenLabel mesh__D000463 Acetophenide, Dihydroxyprogesterone
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D000463 2005
% 220.24/220.43  |- mesh__recordMaintainer mesh__D000463 lkt
% 220.24/220.43  |- skos__altLabel mesh__D000463 Dihydroxyprogesterone Acetophenide
% 220.24/220.43  |- skos__altLabel mesh__D000463 Alphasone Acetophenide
% 220.24/220.43  |- rdf__type mesh__D000463sskos__Concept
% 220.24/220.43  |- skos__hiddenLabel mesh__D018874 Spheroids, Multicellular
% 220.24/220.43  |- skos__hiddenLabel mesh__D018874 Cellular Spheroid
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D018874 2006
% 220.24/220.43  |- skos__hiddenLabel mesh__D018874 Multicellular Spheroid
% 220.24/220.43  |- skos__scopeNote mesh__D018874
% 220.24/220.43       Spherical, heterogeneous aggregates of proliferating, quiescent, and necrotic cells in culture that retain three-dimensional architecture and tissue-specific functions. The ability to form spheroids is a characteristic trait of CULTURED TUMOR CELLS derived from solid TUMORS. Cells from normal tissues can also form spheroids. They represent an in-vitro model for studies of the biology of both normal and malignant cells. %28%From Bjerkvig, Spheroid Culture in Cancer Research, 1992, p4%29%%A%    
% 220.24/220.43  |- skos__historyNote mesh__D018874 Tissue Culture %28%1966-1971%29%
% 220.24/220.43  |- mesh__publicMeSHNote mesh__D018874
% 220.24/220.43       2004%28%1996%29%; see SPHEROIDS 1996-2003   
% 220.24/220.43  |- skos__hiddenLabel mesh__D018874 Spheroid, Cellular
% 220.24/220.43  |- skos__historyNote mesh__D018874 Cells, Cultured %28%1972-1995%29%
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D018874 2004
% 220.24/220.43  |- skos__annotation mesh__D018874
% 220.24/220.43       do not confuse with %22%spheroid bodies%22% referring to axons in neuropathol; if tumor spheroids coordinate with TUMOR CELLS, CULTURED%A%  
% 220.24/220.43  |- skos__hiddenLabel mesh__D018874 Cellular Spheroids
% 220.24/220.43  |- skos__historyNote mesh__D018874 Tumor Cells, Cultured %28%1988-1995%29%
% 220.24/220.43  |- mesh__historyNote mesh__D018874 2004%28%1996%29%   
% 220.24/220.43  |- skos__prefLabel mesh__D018874 Spheroids, Cellular
% 220.24/220.43  |- rdf__type mesh__D018874sskos__Concept
% 220.24/220.43  |- mesh__dateEstablished mesh__D018874 1996-01-01
% 220.24/220.43  |- skos__hiddenLabel mesh__D018874 Spheroid, Multicellular
% 220.24/220.43  |- skos__broader mesh__D018874smesh__D002478
% 220.24/220.43  |- skos__altLabel mesh__D018874 Multicellular Spheroids
% 220.24/220.43  |- mesh__dateRevised mesh__D018874 2003-07-09
% 220.24/220.43  |- mesh__dateCreated mesh__D018874 1994-12-27
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D018874 2005
% 220.24/220.43  |- skos__scopeNote mesh__D010891
% 220.24/220.43       A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.%A%    
% 220.24/220.43  |- skos__hiddenLabel mesh__D010891 Piribedil Mono hydrochloride
% 220.24/220.43  |- skos__hiddenLabel mesh__D010891 ET 495
% 220.24/220.43  |- rdf__type mesh__D010891sskos__Concept
% 220.24/220.43  |- skos__prefLabel mesh__D010891 Piribedil
% 220.24/220.43  |- skos__historyNote mesh__D010891 Pyrimidines %28%1971-1974%29%
% 220.24/220.43  |- skos__hiddenLabel mesh__D010891 Mono-hydrochloride, Piribedil
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D010891 2005
% 220.24/220.43  |- mesh__dateCreated mesh__D010891 1974-11-19
% 220.24/220.43  |- mesh__recordMaintainer mesh__D010891 sjn
% 220.24/220.43  |- mesh__recordAuthorizer mesh__D010891 sjn
% 220.24/220.43  |- mesh__dateRevised mesh__D010891 2003-07-25
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D010891 2006
% 220.24/220.43  |- skos__hiddenLabel mesh__D010891 EU 4200
% 220.24/220.43  |- skos__hiddenLabel mesh__D010891 Mesylate, Piribedil
% 220.24/220.43  |- skos__hiddenLabel mesh__D010891 ET495
% 220.24/220.43  |- skos__historyNote mesh__D010891 Dioxoles %28%1971-1974%29%
% 220.24/220.43  |- skos__broader mesh__D010891smesh__D010879
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D010891 2004
% 220.24/220.43  |- skos__altLabel mesh__D010891 Piribendyl
% 220.24/220.43  |- mesh__historyNote mesh__D010891
% 220.24/220.43       91%28%75%29%; was see under PIPERAZINES 1975-90   
% 220.24/220.43  |- mesh__dateEstablished mesh__D010891 1991-01-01
% 220.24/220.43  |- skos__historyNote mesh__D010891 Piperazines %28%1971-1974%29%
% 220.24/220.43  |- skos__hiddenLabel mesh__D010891 Hydrochloride, Piribedil
% 220.24/220.43  |- skos__hiddenLabel mesh__D010891 EU4200
% 220.24/220.43  |- mesh__publicMeSHNote mesh__D010891
% 220.24/220.43       91; was see under PIPERAZINES 1975-90   
% 220.24/220.43  |- mesh__recordOriginator mesh__D010891 NLM
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D018076 2006
% 220.24/220.43  |- mesh__onlineNote mesh__D018076
% 220.24/220.43       use DNA to search COMPLEMENTARY DNA 1987-93   
% 220.24/220.43  |- rdf__type mesh__D018076sskos__Concept
% 220.24/220.43  |- skos__altLabel mesh__D018076 Complementary DNA
% 220.24/220.43  |- mesh__dateRevised mesh__D018076 2003-07-09
% 220.24/220.43  |- mesh__recordOriginator mesh__D018076 PXP
% 220.24/220.43  |- skos__annotation mesh__D018076 a single-stranded DNA   
% 220.24/220.43  |- mesh__historyNote mesh__D018076
% 220.24/220.43       94; COMPLEMENTARY DNA was see DNA 1987-93   
% 220.24/220.43  |- skos__broader mesh__D018076smesh__D015342
% 220.24/220.43  |- skos__historyNote mesh__D018076 DNA %28%1966-1993%29%
% 220.24/220.43  |- mesh__recordMaintainer mesh__D018076 ssb
% 220.24/220.43  |- skos__hiddenLabel mesh__D018076 Probes, cDNA
% 220.24/220.43  |- skos__broader mesh__D018076smesh__D004277
% 220.24/220.43  |- skos__scopeNote mesh__D018076
% 220.24/220.43       Single-stranded complementary DNA synthesized from an RNA template by the action of RNA-dependent DNA polymerase. cDNA %28%i.e., complementary DNA, not circular DNA, not C-DNA%29% is used in a variety of molecular cloning experiments as well as serving as a specific hybridization probe.%A%    
% 220.24/220.43  |- mesh__dateCreated mesh__D018076 1993-06-03
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D018076 2004
% 220.24/220.43  |- skos__prefLabel mesh__D018076 DNA, Complementary
% 220.24/220.43  |- mesh__recordAuthorizer mesh__D018076 sjn
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D018076 2005
% 220.24/220.43  |- skos__altLabel mesh__D018076 cDNA
% 220.24/220.43  |- mesh__dateEstablished mesh__D018076 1994-01-01
% 220.24/220.43  |- mesh__publicMeSHNote mesh__D018076
% 220.24/220.43       94; COMPLEMENTARY DNA was see DNA 1987-93   
% 220.24/220.43  |- mesh__recordAuthorizer mesh__D010093 sjn
% 220.24/220.43  |- skos__historyNote mesh__D010093 Quinolines %28%1966-1971%29%
% 220.24/220.43  |- mesh__dateCreated mesh__D010093 1999-01-01
% 220.24/220.43  |- rdf__type mesh__D010093sskos__Concept
% 220.24/220.43  |- mesh__recordMaintainer mesh__D010093 ssb
% 220.24/220.43  |- skos__prefLabel mesh__D010093 Oxolinic Acid
% 220.24/220.43  |- mesh__recordOriginator mesh__D010093 NLM
% 220.24/220.43  |- mesh__publicMeSHNote mesh__D010093 73   
% 220.24/220.43  |- skos__historyNote mesh__D010093
% 220.24/220.43       Anti-Infective Agents, Urinary %28%1966-1971%29%
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D010093 2004
% 220.24/220.43  |- mesh__dateRevised mesh__D010093 2003-07-09
% 220.24/220.43  |- mesh__historyNote mesh__D010093 73%28%72%29%   
% 220.24/220.43  |- skos__hiddenLabel mesh__D010093 Acid, Oxolinic
% 220.24/220.43  |- mesh__dateEstablished mesh__D010093 1973-01-01
% 220.24/220.43  |- skos__broader mesh__D010093smesh__D042462
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D010093 2006
% 220.24/220.43  |- skos__scopeNote mesh__D010093
% 220.24/220.43       Synthetic antimicrobial related to NALIDIXIC ACID and used in URINARY TRACT INFECTIONS.%A%    
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D010093 2005
% 220.24/220.43  |- skos__hiddenLabel mesh__D004854 Infectious Mononucleosis Viruses
% 220.24/220.43  |- skos__altLabel mesh__D004854 Epstein-Barr Virus
% 220.24/220.43  |- skos__hiddenLabel mesh__D004854 Herpesvirus, Burkitt
% 220.24/220.43  |- mesh__historyNote mesh__D004854
% 220.24/220.43       94; was EPSTEIN-BARR VIRUS 1978-93; was BURKITT%27%S LYMPHOMA VIRUS 1969-77 %28%Prov 1969-72%29%%A%  
% 220.24/220.43  |- mesh__onlineNote mesh__D004854
% 220.24/220.43       use HERPESVIRUS 4, HUMAN to search EPSTEIN-BARR VIRUS 1978-93 %26% BURKITT%27%S LYMPHOMA VIRUS 1969-77 %28%as Prov 1969-72%29%%A%  
% 220.24/220.43  |- skos__broader mesh__D004854smesh__D018143
% 220.24/220.43  |- mesh__dateCreated mesh__D004854 1999-01-01
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D004854 2003
% 220.24/220.43  |- skos__historyNote mesh__D004854 Herpesviridae %28%1966-1968%29%
% 220.24/220.43  |- skos__altLabel mesh__D004854 Burkitt Herpesvirus
% 220.24/220.43  |- skos__altLabel mesh__D004854 E-B Virus
% 220.24/220.43  |- skos__altLabel mesh__D004854 Human Herpesvirus 4
% 220.24/220.43  |- skos__prefLabel mesh__D004854 Herpesvirus 4, Human
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D004854 2002
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D004854 2006A
% 220.24/220.43  |- mesh__dateEstablished mesh__D004854 1973-01-01
% 220.24/220.43  |- skos__annotation mesh__D004854
% 220.24/220.43       infection = EPSTEIN-BARR VIRUS INFECTIONS or its indentions%A%  
% 220.24/220.43  |- mesh__recordMaintainer mesh__D004854 ags
% 220.24/220.43  |- mesh__dateRevised mesh__D004854 2005-07-19
% 220.24/220.43  |- skos__scopeNote mesh__D004854
% 220.24/220.43       The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia %28%LEUKOPLAKIA, HAIRY;%29%, BURKITT LYMPHOMA; and other malignancies.%A%    
% 220.24/220.43  |- mesh__recordOriginator mesh__D004854 NLM
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D004854 2006
% 220.24/220.43  |- skos__hiddenLabel mesh__D004854 Mononucleosis Viruses, Infectious
% 220.24/220.43  |- skos__hiddenLabel mesh__D004854 E B Virus
% 220.24/220.43  |- skos__altLabel mesh__D004854 EBV
% 220.24/220.43  |- mesh__recordAuthorizer mesh__D004854 ags
% 220.24/220.43  |- skos__hiddenLabel mesh__D004854 Burkitts Lymphoma Virus
% 220.24/220.43  |- skos__hiddenLabel mesh__D004854 Mononucleosis Virus, Infectious
% 220.24/220.43  |- skos__historyNote mesh__D004854
% 220.24/220.43       specific disease/microbiology %28%1966-1968%29%
% 220.24/220.43  |- skos__altLabel mesh__D004854 Burkitt Lymphoma Virus
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D004854 2005
% 220.24/220.43  |- skos__altLabel mesh__D004854 HHV-4
% 220.24/220.43  |- skos__altLabel mesh__D004854 Burkitt%27%s Lymphoma Virus
% 220.24/220.43  |- skos__altLabel mesh__D004854 Infectious Mononucleosis Virus
% 220.24/220.43  |- mesh__publicMeSHNote mesh__D004854
% 220.24/220.43       94; was EPSTEIN-BARR VIRUS 1978-93; was BURKITT%27%S LYMPHOMA VIRUS 1973-77%A%  
% 220.24/220.43  |- skos__hiddenLabel mesh__D004854 E-B Viruses
% 220.24/220.43  |- skos__related mesh__D004854smesh__D015673
% 220.24/220.43  |- skos__hiddenLabel mesh__D004854 Epstein Barr Virus
% 220.24/220.43  |- rdf__type mesh__D004854sskos__Concept
% 220.24/220.43  |- skos__hiddenLabel mesh__D004854 Lymphoma Virus, Burkitt
% 220.24/220.43  |- skos__altLabel mesh__D004854 Herpesvirus 4 %28%gamma%29%, Human
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D004854 2004
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D004056 1994
% 220.24/220.43  |- skos__hiddenLabel mesh__D004056 Limens, Difference
% 220.24/220.43  |- skos__historyNote mesh__D004056
% 220.24/220.43       appropriate perception or sensation heading
% 220.24/220.43  |- mesh__recordAuthorizer mesh__D004056 PLS
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D004056 2006
% 220.24/220.43  |- skos__annotation mesh__D004056 NIM; DF: DIFFER THRESHOLD   
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D004056 2001
% 220.24/220.43  |- skos__broader mesh__D004056smesh__D010465
% 220.24/220.43  |- mesh__dateCreated mesh__D004056 1999-01-01
% 220.24/220.43  |- skos__hiddenLabel mesh__D004056 Limen, Difference
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D004056 1997
% 220.24/220.43  |- skos__hiddenLabel mesh__D004056 Thresholds, Differential
% 220.24/220.43  |- mesh__dateRevised mesh__D004056 1992-05-14
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D004056 2005
% 220.24/220.43  |- rdf__type mesh__D004056sskos__Concept
% 220.24/220.43  |- skos__historyNote mesh__D004056 Psychophysics %28%1970-1971%29%
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D004056 2000
% 220.24/220.43  |- skos__hiddenLabel mesh__D004056 Weber Fechner Law
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D004056 1993
% 220.24/220.43  |- skos__scopeNote mesh__D004056
% 220.24/220.43       The smallest difference which can be discriminated between two stimuli or one which is barely above the threshold.%A%    
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D004056 1996
% 220.24/220.43  |- skos__prefLabel mesh__D004056 Differential Threshold
% 220.24/220.43  |- skos__hiddenLabel mesh__D004056 Differential Thresholds
% 220.24/220.43  |- skos__hiddenLabel mesh__D004056 Difference, Just-Noticeable
% 220.24/220.43  |- mesh__recordMaintainer mesh__D004056 TAP
% 220.24/220.43  |- skos__hiddenLabel mesh__D004056 Law, Weber-Fechner
% 220.24/220.43  |- mesh__dateEstablished mesh__D004056 1974-01-01
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D004056 1999
% 220.24/220.43  |- skos__hiddenLabel mesh__D004056 Just-Noticeable Differences
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D004056 2004
% 220.24/220.43  |- mesh__recordOriginator mesh__D004056 NLM
% 220.24/220.43  |- skos__hiddenLabel mesh__D004056 Difference Limens
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D004056 2002
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D004056 1995
% 220.24/220.43  |- skos__broader mesh__D004056smesh__D012684
% 220.24/220.43  |- skos__hiddenLabel mesh__D004056 Threshold, Differential
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D004056 1998
% 220.24/220.43  |- skos__altLabel mesh__D004056 Difference Limen
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D004056 2003
% 220.24/220.43  |- mesh__publicMeSHNote mesh__D004056 74   
% 220.24/220.43  |- skos__hiddenLabel mesh__D004056 Differences, Just-Noticeable
% 220.24/220.43  |- skos__hiddenLabel mesh__D004056 Just Noticeable Difference
% 220.24/220.43  |- mesh__historyNote mesh__D004056 74%28%72%29%   
% 220.24/220.43  |- skos__hiddenLabel mesh__D050607 Compounds, Organogold
% 220.24/220.43  |- mesh__publicMeSHNote mesh__D050607 2006   
% 220.24/220.43  |- skos__broader mesh__D050607smesh__D009942
% 220.24/220.43  |- mesh__dateCreated mesh__D050607 2005-06-30
% 220.24/220.43  |- mesh__recordMaintainer mesh__D050607 ssb
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D050607 2006
% 220.24/220.43  |- skos__related mesh__D050607smesh__D012971
% 220.24/220.43  |- rdf__type mesh__D050607sskos__Concept
% 220.24/220.43  |- mesh__recordOriginator mesh__D050607 ssb
% 220.24/220.43  |- skos__historyNote mesh__D050607 Gold %28%1974-2005%29%
% 220.24/220.43  |- skos__scopeNote mesh__D050607
% 220.24/220.43       Organic compounds that contain GOLD as an integral part of the molecule. Some are used as ANTIRHEUMATIC AGENTS. The term chrysotherapy derives from an ancient Greek term for gold.%A%    
% 220.24/220.43  |- skos__prefLabel mesh__D050607 Organogold Compounds
% 220.24/220.43  |- mesh__historyNote mesh__D050607 2006   
% 220.24/220.43  |- mesh__dateEstablished mesh__D050607 2006-01-01
% 220.24/220.43  |- mesh__recordAuthorizer mesh__D050607 sjn
% 220.24/220.43  |- mesh__historyNote mesh__D014484
% 220.24/220.43       91%28%82%29%; was see under GOVERNMENT AGENCIES 1982-90   
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D014484 2003
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D014484 2006
% 220.24/220.43  |- mesh__dateEstablished mesh__D014484 1991-01-01
% 220.24/220.43  |- mesh__dateRevised mesh__D014484 1997-06-20
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D014484 2004
% 220.24/220.43  |- mesh__dateCreated mesh__D014484 1981-02-26
% 220.24/220.43  |- mesh__recordAuthorizer mesh__D014484 SJN
% 220.24/220.43  |- skos__altLabel mesh__D014484
% 220.24/220.43       Environmental Protection Agency, United States
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D014484 1998
% 220.24/220.43  |- mesh__recordOriginator mesh__D014484 EC
% 220.24/220.43  |- skos__annotation mesh__D014484
% 220.24/220.43       add UNITED STATES %28%NIM%29%; research support by this agency is checked as OTHER US GOVT SUP; DF: EPA      CATALOG: use NAF entry%A%  
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D014484 2000
% 220.24/220.43  |- mesh__publicMeSHNote mesh__D014484
% 220.24/220.43       91; was see under GOVERNMENT AGENCIES 1982-90   
% 220.24/220.43  |- skos__historyNote mesh__D014484 Government Agencies %28%1968-1981%29%
% 220.24/220.43  |- skos__scopeNote mesh__D014484
% 220.24/220.43       An agency in the executive branch which endeavors to abate and control pollution in the areas of air, water, solid waste, noise, radiation, and toxic substances.%A%    
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D014484 1999
% 220.24/220.43  |- rdf__type mesh__D014484sskos__Concept
% 220.24/220.43  |- mesh__recordMaintainer mesh__D014484 PXP
% 220.24/220.43  |- skos__prefLabel mesh__D014484
% 220.24/220.43       United States Environmental Protection Agency
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D014484 2001
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D014484 2005
% 220.24/220.43  |- skos__broader mesh__D014484smesh__D006077
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D014484 2002
% 220.24/220.43  |- skos__altLabel mesh__D014484 Environmental Protection Agency
% 220.24/220.43  |- skos__altLabel mesh__D014484
% 220.24/220.43       Environmental Protection Agency %28%U.S.%29%
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D008447 2002
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D008447 1999
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D008447 2006
% 220.24/220.43  |- skos__related mesh__D008447smesh__D008341
% 220.24/220.43  |- mesh__publicMeSHNote mesh__D008447 67   
% 220.24/220.43  |- skos__scopeNote mesh__D008447
% 220.24/220.43       A prosthetic appliance for the replacement of areas of the maxilla, mandible, and face, missing as a result of deformity, disease, injury, or surgery. When the prosthesis replaces portions of the mandible only, it is referred to as MANDIBULAR PROSTHESIS.%A%    
% 220.24/220.43  |- skos__hiddenLabel mesh__D008447 Maxillary Prostheses
% 220.24/220.43  |- skos__annotation mesh__D008447
% 220.24/220.43       maxillo- here may be either jaw but MANDIBULAR PROSTHESIS is also available; not for outer ear replacements %28% = EAR, EXTERNAL %28%IM%29% + PROSTHESES AND IMPLANTS %28%IM%29% %29% or nose replacements %28% = NOSE %28%IM%29% + PROSTHESES AND IMPLANTS %28%IM%29% %29%%A%  
% 220.24/220.43  |- mesh__recordAuthorizer mesh__D008447 SJN
% 220.24/220.43  |- skos__hiddenLabel mesh__D008447 Prostheses, Maxillofacial
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D008447 2003
% 220.24/220.43  |- mesh__dateEstablished mesh__D008447 1967-01-01
% 220.24/220.43  |- skos__prefLabel mesh__D008447 Maxillofacial Prosthesis
% 220.24/220.43  |- skos__hiddenLabel mesh__D008447 Prosthesis, Maxillofacial
% 220.24/220.43  |- skos__related mesh__D008447smesh__D019931
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D008447 2000
% 220.24/220.43  |- rdf__type mesh__D008447sskos__Concept
% 220.24/220.43  |- skos__broader mesh__D008447smesh__D019736
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D008447 2004
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D008447 2001
% 220.24/220.43  |- mesh__dateCreated mesh__D008447 1999-01-01
% 220.24/220.43  |- skos__hiddenLabel mesh__D008447 Prosthesis, Maxillary
% 220.24/220.43  |- mesh__recordMaintainer mesh__D008447 PXP
% 220.24/220.43  |- mesh__historyNote mesh__D008447 67%28%66%29%   
% 220.24/220.43  |- mesh__dateRevised mesh__D008447 1997-06-20
% 220.24/220.43  |- mesh__recordOriginator mesh__D008447 NLM
% 220.24/220.43  |- skos__hiddenLabel mesh__D008447 Maxillofacial Prostheses
% 220.24/220.43  |- skos__hiddenLabel mesh__D008447 Prostheses, Maxillary
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D008447 1998
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D008447 2005
% 220.24/220.43  |- mesh__recordOriginator mesh__D000464 NLM
% 220.24/220.43  |- mesh__recordAuthorizer mesh__D000464 sjn
% 220.24/220.43  |- mesh__dateRevised mesh__D000464 2004-07-07
% 220.24/220.43  |- mesh__recordMaintainer mesh__D000464 ssb
% 220.24/220.43  |- skos__scopeNote mesh__D000464
% 220.24/220.43       Salts of alginic acid that are extracted from marine kelp and used to make dental impressions and as absorbent material for surgical dressings.%A%    
% 220.24/220.43  |- mesh__dateCreated mesh__D000464 1999-01-01
% 220.24/220.43  |- skos__broader mesh__D000464smesh__D011134
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D000464 2005
% 220.24/220.43  |- rdf__type mesh__D000464sskos__Concept
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D000464 2006
% 220.24/220.43  |- skos__prefLabel mesh__D000464 Alginates
% 220.24/220.43  |- skos__related mesh__D000464smesh__D003760
% 220.24/220.43  |- skos__annotation mesh__D000464 D25-26 qualif   
% 220.24/220.43  |- mesh__dateCreated mesh__D027601 2001-07-25
% 220.24/220.43  |- skos__hiddenLabel mesh__D027601 Polyomavirus Infection
% 220.24/220.43  |- mesh__historyNote mesh__D027601 2002   
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D027601 2005
% 220.24/220.43  |- skos__prefLabel mesh__D027601 Polyomavirus Infections
% 220.24/220.43  |- skos__broader mesh__D027601smesh__D004266
% 220.24/220.43  |- rdf__type mesh__D027601sskos__Concept
% 220.24/220.43  |- skos__historyNote mesh__D027601 DNA Virus Infections %28%1992-2001%29%
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D027601 2004
% 220.24/220.43  |- skos__scopeNote mesh__D027601
% 220.24/220.43       Infections with POLYOMAVIRUS, which are often cultured from the urine of kidney transplant patients. Excretion of BK VIRUS is associated with ureteral strictures and CYSTITIS, and that of JC VIRUS with progressive multifocal leukoencephalopathy %28%LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL%29%.%A%    
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D027601 2002
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D027601 2003
% 220.24/220.43  |- mesh__publicMeSHNote mesh__D027601 2002   
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D027601 2006
% 220.24/220.43  |- mesh__dateEstablished mesh__D027601 2002-01-01
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D018875 2006A
% 220.24/220.43  |- skos__altLabel mesh__D018875 Controlled Thesauri
% 220.24/220.43  |- mesh__recordAuthorizer mesh__D018875 ags
% 220.24/220.43  |- skos__hiddenLabel mesh__D018875 Thesauri, Controlled
% 220.24/220.43  |- mesh__dateRevised mesh__D018875 2005-07-11
% 220.24/220.43  |- rdf__type mesh__D018875sskos__Concept
% 220.24/220.43  |- mesh__recordOriginator mesh__D018875 TGC
% 220.24/220.43  |- mesh__historyNote mesh__D018875 96   
% 220.24/220.43  |- mesh__publicMeSHNote mesh__D018875 96   
% 220.24/220.43  |- skos__scopeNote mesh__D018875
% 220.24/220.43       A specified list of terms with a fixed and unalterable meaning, and from which a selection is made when CATALOGING; ABSTRACTING AND INDEXING; or searching BOOKS; JOURNALS; and other documents. The control is intended to avoid the scattering of related subjects under different headings %28%SUBJECT HEADINGS%29%. The list may be altered or extended only by the publisher or issuing agency. %28%From Harrod%27%s Librarians%27% Glossary, 7th ed, p163%29%%A%    
% 220.24/220.43  |- mesh__activeMeSHYear mesh__D018875 2005
% 220.24/220.44  |- skos__altLabel mesh__D018875 Controlled Vocabulary
% 220.24/220.44  |- skos__hiddenLabel mesh__D018875 Controlled Vocabularies
% 220.24/220.44  |- skos__hiddenLabel mesh__D018875 Vocabularies, Controlled
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D018875 2003
% 220.24/220.44  |- skos__altLabel mesh__D018875 Thesauri
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D018875 2006
% 220.24/220.44  |- skos__historyNote mesh__D018875 Subject Headings %28%1989-1995%29%
% 220.24/220.44  |- skos__broader mesh__D018875smesh__D004282
% 220.24/220.44  |- skos__hiddenLabel mesh__D018875 Thesaurus, Controlled
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D018875 2004
% 220.24/220.44  |- mesh__recordMaintainer mesh__D018875 ags
% 220.24/220.44  |- skos__prefLabel mesh__D018875 Vocabulary, Controlled
% 220.24/220.44  |- mesh__dateEstablished mesh__D018875 1996-01-01
% 220.24/220.44  |- mesh__dateCreated mesh__D018875 1995-06-05
% 220.24/220.44  |- skos__altLabel mesh__D010892 Piritramide
% 220.24/220.44  |- mesh__publicMeSHNote mesh__D010892
% 220.24/220.44       91; was see under ISONIPECOTIC ACIDS 1977-90   
% 220.24/220.44  |- skos__broader mesh__D010892smesh__D007540
% 220.24/220.44  |- skos__historyNote mesh__D010892 Piperidines %28%1971-1975%29%
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D010892 2006
% 220.24/220.44  |- skos__scopeNote mesh__D010892
% 220.24/220.44       A diphenylpropylamine with intense narcotic analgesic activity of long duration. It is a derivative of MEPERIDINE with similar activity and usage.%A%    
% 220.24/220.44  |- mesh__recordMaintainer mesh__D010892 lkw
% 220.24/220.44  |- skos__historyNote mesh__D010892 Isonipecotic Acids %28%1969-1976%29%
% 220.24/220.44  |- mesh__recordAuthorizer mesh__D010892 sjn
% 220.24/220.44  |- skos__altLabel mesh__D010892 Piritramid
% 220.24/220.44  |- mesh__historyNote mesh__D010892
% 220.24/220.44       91%28%77%29%; was see under ISONIPECOTIC ACIDS 1977-90   
% 220.24/220.44  |- mesh__dateEstablished mesh__D010892 1991-01-01
% 220.24/220.44  |- mesh__dateRevised mesh__D010892 2005-06-30
% 220.24/220.44  |- skos__historyNote mesh__D010892 Nitriles %28%1971-1976%29%
% 220.24/220.44  |- rdf__type mesh__D010892sskos__Concept
% 220.24/220.44  |- skos__altLabel mesh__D010892 Dipydolor
% 220.24/220.44  |- mesh__recordOriginator mesh__D010892 SH
% 220.24/220.44  |- skos__altLabel mesh__D010892 Janssen Brand of Pirinitramide
% 220.24/220.44  |- skos__prefLabel mesh__D010892 Pirinitramide
% 220.24/220.44  |- mesh__dateCreated mesh__D010892 1976-04-16
% 220.24/220.44  |- skos__hiddenLabel mesh__D051700 Transcription Factor, ATF3
% 220.24/220.44  |- mesh__dateEstablished mesh__D051700 2006-01-01
% 220.24/220.44  |- skos__altLabel mesh__D051700 ATF3 Transcription Factor
% 220.24/220.44  |- skos__altLabel mesh__D051700 Activating Transcription Factor-3
% 220.24/220.44  |- mesh__publicMeSHNote mesh__D051700
% 220.24/220.44       2006; ACTIVATING TRANSCRIPTION FACTOR 3 was indexed under TRANSCRIPTION FACTORS 1994-2005%A%  
% 220.24/220.44  |- mesh__historyNote mesh__D051700 2006%28%1994%29%   
% 220.24/220.44  |- rdf__type mesh__D051700sskos__Concept
% 220.24/220.44  |- mesh__recordOriginator mesh__D051700 DRC
% 220.24/220.44  |- skos__prefLabel mesh__D051700 Activating Transcription Factor 3
% 220.24/220.44  |- mesh__recordAuthorizer mesh__D051700 sjn
% 220.24/220.44  |- mesh__recordMaintainer mesh__D051700 DRC
% 220.24/220.44  |- skos__broader mesh__D051700smesh__D051696
% 220.24/220.44  |- skos__scopeNote mesh__D051700
% 220.24/220.44       An activating transcription factor that plays a key role in cellular responses to GENOTOXIC STRESS and OXIDATIVE STRESS.%A%    
% 220.24/220.44  |- mesh__dateCreated mesh__D051700 2005-06-30
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D051700 2006
% 220.24/220.44  |- skos__hiddenLabel mesh__D018077 SRS A Receptors
% 220.24/220.44  |- mesh__onlineNote mesh__D018077
% 220.24/220.44       use RECEPTORS, LEUKOTRIENE %28%NM%29% to search SRS-A RECEPTOR 1983-94%A%  
% 220.24/220.44  |- skos__altLabel mesh__D018077
% 220.24/220.44       Slow Reaction Substance of Anaphylaxis Receptors
% 220.24/220.44  |- skos__historyNote mesh__D018077
% 220.24/220.44       Receptors, Cell Surface %28%1982-1984%29%
% 220.24/220.44  |- skos__altLabel mesh__D018077
% 220.24/220.44       Slow Reacting Substance of Anaphylaxis Receptors
% 220.24/220.44  |- skos__altLabel mesh__D018077 SRS-A Receptor
% 220.24/220.44  |- mesh__historyNote mesh__D018077
% 220.24/220.44       94; was SRS-A RECEPTOR %28%NM%29% 1983-93   
% 220.24/220.44  |- skos__prefLabel mesh__D018077 Receptors, Leukotriene
% 220.24/220.44  |- mesh__dateEstablished mesh__D018077 1994-01-01
% 220.24/220.44  |- skos__broader mesh__D018077smesh__D018055
% 220.24/220.44  |- skos__altLabel mesh__D018077 Receptors, Leukotrienes
% 220.24/220.44  |- skos__historyNote mesh__D018077 Receptors, Immunologic %28%1990-1993%29%
% 220.24/220.44  |- skos__hiddenLabel mesh__D018077 Receptor, Leukotriene
% 220.24/220.44  |- skos__scopeNote mesh__D018077
% 220.24/220.44       Cell-surface receptors that bind LEUKOTRIENES with high affinity and trigger intracellular changes influencing the behavior of cells. The leukotriene receptor subtypes have been tentatively named according to their affinities for the endogenous leukotrienes LTB4; LTC4; LTD4; and LTE4.%A%    
% 220.24/220.44  |- mesh__recordAuthorizer mesh__D018077 sjn
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D018077 2006
% 220.24/220.44  |- skos__historyNote mesh__D018077
% 220.24/220.44       Receptors, Prostaglandin %28%1984-1989%29%
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D018077 2005
% 220.24/220.44  |- rdf__type mesh__D018077sskos__Concept
% 220.24/220.44  |- mesh__dateCreated mesh__D018077 1993-06-21
% 220.24/220.44  |- skos__altLabel mesh__D018077 Leukotriene Receptors
% 220.24/220.44  |- skos__altLabel mesh__D018077 Receptors, SRS-A
% 220.24/220.44  |- skos__altLabel mesh__D018077 Leukotriene Receptor
% 220.24/220.44  |- mesh__dateRevised mesh__D018077 2004-07-07
% 220.24/220.44  |- skos__hiddenLabel mesh__D018077 Receptor, SRS-A
% 220.24/220.44  |- mesh__recordMaintainer mesh__D018077 ssb
% 220.24/220.44  |- mesh__publicMeSHNote mesh__D018077
% 220.24/220.44       94; SRS-A RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1990-93, RECEPTORS, PROSTAGLANDIN 1984-89, %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1983-84%A%  
% 220.24/220.44  |- skos__hiddenLabel mesh__D018077 Leukotrienes Receptors
% 220.24/220.44  |- mesh__recordOriginator mesh__D018077 RAZ
% 220.24/220.44  |- skos__hiddenLabel mesh__D018077 Receptors, SRS A
% 220.24/220.44  |- skos__hiddenLabel mesh__D018077 SRS A Receptor
% 220.24/220.44  |- skos__annotation mesh__D018077
% 220.24/220.44       RECEPTORS, LEUKOTRIENE B4 is also available; DF: RECEPT LEUKOTRIENE%A%  
% 220.24/220.44  |- skos__prefLabel mesh__D010094 Oxonic Acid
% 220.24/220.44  |- rdf__type mesh__D010094sskos__Concept
% 220.24/220.44  |- skos__historyNote mesh__D010094 Triazines %28%1971-1974%29%
% 220.24/220.44  |- mesh__dateRevised mesh__D010094 2002-07-03
% 220.24/220.44  |- mesh__recordAuthorizer mesh__D010094 sjn
% 220.24/220.44  |- skos__broader mesh__D010094smesh__D014227
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D010094 2004
% 220.24/220.44  |- skos__altLabel mesh__D010094 Oteracil
% 220.24/220.44  |- mesh__historyNote mesh__D010094
% 220.24/220.44       91%28%75%29%; was see under TRIAZINES 1975-90   
% 220.24/220.44  |- mesh__recordMaintainer mesh__D010094 ssb
% 220.24/220.44  |- mesh__publicMeSHNote mesh__D010094
% 220.24/220.44       91; was see under TRIAZINES 1975-90   
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D010094 2006
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D010094 2003
% 220.24/220.44  |- mesh__dateEstablished mesh__D010094 1991-01-01
% 220.24/220.44  |- mesh__dateCreated mesh__D010094 1974-11-19
% 220.24/220.44  |- skos__scopeNote mesh__D010094 Antagonist of urate oxidase.     
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D010094 2005
% 220.24/220.44  |- mesh__recordOriginator mesh__D010094 NLM
% 220.24/220.44  |- skos__scopeNote mesh__D004855
% 220.24/220.44       An estrogenic steroid produced by HORSES. It has a total of five double bonds in the A- and B-ring. High concentration of equilenin is found in the URINE of pregnant mares.%A%    
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D004855 2004
% 220.24/220.44  |- skos__broader mesh__D004855smesh__D015068
% 220.24/220.44  |- skos__historyNote mesh__D004855 17-Ketosteroids %28%1969-1974%29%
% 220.24/220.44  |- mesh__historyNote mesh__D004855
% 220.24/220.44       91%28%75%29%; was see under 17-KETOSTEROIDS 1975-90   
% 220.24/220.44  |- skos__annotation mesh__D004855 do not confuse with EQUILIN   
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D004855 2005
% 220.24/220.44  |- mesh__dateEstablished mesh__D004855 1991-01-01
% 220.24/220.44  |- mesh__recordAuthorizer mesh__D004855 sjn
% 220.24/220.44  |- mesh__recordMaintainer mesh__D004855 lkt
% 220.24/220.44  |- skos__broader mesh__D004855smesh__D004963
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D004855 2006
% 220.24/220.44  |- mesh__dateRevised mesh__D004855 2003-07-09
% 220.24/220.44  |- rdf__type mesh__D004855sskos__Concept
% 220.24/220.44  |- mesh__dateCreated mesh__D004855 1974-11-11
% 220.24/220.44  |- mesh__publicMeSHNote mesh__D004855
% 220.24/220.44       91; was see under 17-KETOSTEROIDS 1975-90   
% 220.24/220.44  |- skos__broader mesh__D004855smesh__D045166
% 220.24/220.44  |- skos__historyNote mesh__D004855 Estranes %28%1973-1974%29%
% 220.24/220.44  |- skos__prefLabel mesh__D004855 Equilenin
% 220.24/220.44  |- skos__historyNote mesh__D004855 Hydroxysteroids %28%1974%29%
% 220.24/220.44  |- mesh__recordOriginator mesh__D004855 NLM
% 220.24/220.44  |- mesh__dateRevised mesh__D004057 1994-04-11
% 220.24/220.44  |- skos__annotation mesh__D004057 DF: DISH   
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D004057 1999
% 220.24/220.44  |- skos__hiddenLabel mesh__D004057 Vertebral Ankylosing Hyperostoses
% 220.24/220.44  |- skos__altLabel mesh__D004057 Forestier Disease
% 220.24/220.44  |- skos__historyNote mesh__D004057 Spinal Diseases %28%1966-1984%29%
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D004057 2004
% 220.24/220.44  |- skos__hiddenLabel mesh__D004057 Hyperostosis, Vertebral Ankylosing
% 220.24/220.44  |- mesh__recordAuthorizer mesh__D004057 PLS
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D004057 1996
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D004057 2000
% 220.24/220.44  |- skos__historyNote mesh__D004057
% 220.24/220.44       Spondylitis, Ankylosing %28%1966-1984%29%
% 220.24/220.44  |- skos__broader mesh__D004057smesh__D015576
% 220.24/220.44  |- mesh__dateEstablished mesh__D004057 1991-01-01
% 220.24/220.44  |- mesh__dateCreated mesh__D004057 1984-04-06
% 220.24/220.44  |- skos__altLabel mesh__D004057 Vertebral Ankylosing Hyperostosis
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D004057 2001
% 220.24/220.44  |- mesh__recordMaintainer mesh__D004057 TGC
% 220.24/220.44  |- skos__hiddenLabel mesh__D004057 Ankylosing Hyperostoses, Vertebral
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D004057 1997
% 220.24/220.44  |- skos__hiddenLabel mesh__D004057 Disease, Forestier
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D004057 2005
% 220.24/220.44  |- rdf__type mesh__D004057sskos__Concept
% 220.24/220.44  |- mesh__historyNote mesh__D004057
% 220.24/220.44       91%28%90%29%; was see under SPINAL OSTEOPHYTOSIS 1990; was DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS see under SPINAL OSTEOPHYTOSIS 1985-89%A%  
% 220.24/220.44  |- skos__hiddenLabel mesh__D004057 Hyperostoses, Vertebral Ankylosing
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D004057 1995
% 220.24/220.44  |- mesh__recordOriginator mesh__D004057 RC
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D004057 2006
% 220.24/220.44  |- skos__scopeNote mesh__D004057
% 220.24/220.44       A disease of elderly men characterized by large osteophytes that bridge vertebrae and ossification of ligaments and tendon insertions.%A%    
% 220.24/220.44  |- skos__broader mesh__D004057smesh__D013128
% 220.24/220.44  |- skos__historyNote mesh__D004057 Spinal Osteophytosis %28%1966-1984%29%
% 220.24/220.44  |- skos__hiddenLabel mesh__D004057 Ankylosing Hyperostosis, Vertebral
% 220.24/220.44  |- skos__altLabel mesh__D004057 Diffuse Idiopathic Skeletal Hyperostosis
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D004057 1998
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D004057 2002
% 220.24/220.44  |- skos__prefLabel mesh__D004057 Hyperostosis, Diffuse Idiopathic Skeletal
% 220.24/220.44  |- mesh__onlineNote mesh__D004057
% 220.24/220.44       use HYPEROSTOSIS, DIFFUSE IDIOPATHIC SKELETAL to search DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS 1985-89%A%  
% 220.24/220.44  |- mesh__publicMeSHNote mesh__D004057
% 220.24/220.44       91; was see under SPINAL OSTEOPHYTOSIS 1990; was DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS see under SPINAL OSTEOPHYTOSIS 1985-89%A%  
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D004057 2003
% 220.24/220.44  |- skos__prefLabel mesh__D009540 Nicotinyl Alcohol
% 220.24/220.44  |- skos__hiddenLabel mesh__D009540 3 Hydroxymethylpyridine
% 220.24/220.44  |- skos__altLabel mesh__D009540 Pyridylcarbinol
% 220.24/220.44  |- skos__altLabel mesh__D009540 Pyridine-3-Methanol
% 220.24/220.44  |- mesh__historyNote mesh__D009540
% 220.24/220.44       91%28%75%29%; was see under PYRIDINES 1975-90   
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D009540 2005
% 220.24/220.44  |- mesh__dateEstablished mesh__D009540 1991-01-01
% 220.24/220.44  |- skos__historyNote mesh__D009540 Alcohol, Methyl %28%1969-1974%29%
% 220.24/220.44  |- mesh__dateRevised mesh__D009540 2000-06-21
% 220.24/220.44  |- skos__altLabel mesh__D009540 3-Hydroxymethylpyridine
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D009540 2001
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D009540 2006
% 220.24/220.44  |- skos__scopeNote mesh__D009540
% 220.24/220.44       A direct-acting peripheral vasodilator that causes flushing and may decrease blood pressure. It is used in vasospasm and threatened gangrene.%A%    
% 220.24/220.44  |- skos__altLabel mesh__D009540 Nicotinic Alcohol
% 220.24/220.44  |- skos__hiddenLabel mesh__D009540 Pyridine 3 Methanol
% 220.24/220.44  |- mesh__publicMeSHNote mesh__D009540
% 220.24/220.44       91; was see under PYRIDINES 1975-90   
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D009540 2002
% 220.24/220.44  |- skos__hiddenLabel mesh__D009540 Alcohol, Nicotinic
% 220.24/220.44  |- skos__historyNote mesh__D009540 Pyridines %28%1969-1974%29%
% 220.24/220.44  |- mesh__recordOriginator mesh__D009540 NLM
% 220.24/220.44  |- skos__hiddenLabel mesh__D009540 Hydrofluoride, Nicomethanol
% 220.24/220.44  |- skos__altLabel mesh__D009540 beta-Pyridylcarbinol
% 220.24/220.44  |- mesh__recordAuthorizer mesh__D009540 sjn
% 220.24/220.44  |- mesh__dateCreated mesh__D009540 1974-11-19
% 220.24/220.44  |- skos__altLabel mesh__D009540 Ronicol
% 220.24/220.44  |- skos__broader mesh__D009540smesh__D011725
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D009540 2003
% 220.24/220.44  |- skos__hiddenLabel mesh__D009540 Alcohol, Nicotinyl
% 220.24/220.44  |- skos__broader mesh__D009540smesh__D000432
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D009540 2004
% 220.24/220.44  |- mesh__recordMaintainer mesh__D009540 CCR
% 220.24/220.44  |- rdf__type mesh__D009540sskos__Concept
% 220.24/220.44  |- skos__hiddenLabel mesh__D009540 beta Pyridylcarbinol
% 220.24/220.44  |- mesh__publicMeSHNote mesh__D050608
% 220.24/220.44       2006; SODIUM-PHOSPHATE COTRANSPROTER PROTEINS was indexed under SYMPORTERS 2002-2005 %26% under CARRIER PROTEINS 1987-2001%A%  
% 220.24/220.44  |- mesh__recordMaintainer mesh__D050608 ags
% 220.24/220.44  |- skos__historyNote mesh__D050608 Symporters %28%1987-2005%29%
% 220.24/220.44  |- skos__altLabel mesh__D050608 Sodium Phosphate Transporters
% 220.24/220.44  |- skos__scopeNote mesh__D050608
% 220.24/220.44       A family of symporters that facilitate sodium-dependent membrane transport of phosphate.%A%    
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D050608 2006
% 220.24/220.44  |- skos__hiddenLabel mesh__D050608 Sodium Phosphate Cotransporter
% 220.24/220.44  |- rdf__type mesh__D050608sskos__Concept
% 220.24/220.44  |- skos__hiddenLabel mesh__D050608 Symporters, Sodium-Phosphate
% 220.24/220.44  |- skos__altLabel mesh__D050608 Sodium Phosphate Transporter
% 220.24/220.44  |- mesh__dateEstablished mesh__D050608 2006-01-01
% 220.24/220.44  |- skos__altLabel mesh__D050608 Sodium-Phosphate Symporters
% 220.24/220.44  |- mesh__recordAuthorizer mesh__D050608 ags
% 220.24/220.44  |- skos__hiddenLabel mesh__D050608 Phosphate Transporter, Sodium
% 220.24/220.44  |- mesh__dateCreated mesh__D050608 2005-06-30
% 220.24/220.44  |- mesh__historyNote mesh__D050608 2006%28%1987%29%   
% 220.24/220.44  |- skos__broader mesh__D050608smesh__D027981
% 220.24/220.44  |- skos__prefLabel mesh__D050608 Sodium-Phosphate Cotransporter Proteins
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D050608 2006A
% 220.24/220.44  |- mesh__dateRevised mesh__D050608 2005-07-25
% 220.24/220.44  |- skos__hiddenLabel mesh__D050608 Cotransporter Proteins, Sodium-Phosphate
% 220.24/220.44  |- mesh__recordOriginator mesh__D050608 DRC
% 220.24/220.44  |- skos__hiddenLabel mesh__D050608 Phosphate Transporters, Sodium
% 220.24/220.44  |- skos__hiddenLabel mesh__D050608 Sodium Phosphate Cotransporter Proteins
% 220.24/220.44  |- skos__broader mesh__D050608smesh__D028061
% 220.24/220.44  |- skos__altLabel mesh__D050608 Sodium-Phosphate Cotransporter
% 220.24/220.44  |- skos__hiddenLabel mesh__D050608 Sodium Phosphate Symporters
% 220.24/220.44  |- skos__hiddenLabel mesh__D050608 Transporters, Sodium Phosphate
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D014485 1998
% 220.24/220.44  |- skos__broader mesh__D014485smesh__D006077
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D014485 2000
% 220.24/220.44  |- skos__annotation mesh__D014485
% 220.24/220.44       add UNITED STATES %28%NIM%29%; research support by this agency is checked as OTHER GOVT SUP; DF: FTC      CATALOG: use NAF entry%A%  
% 220.24/220.44  |- mesh__historyNote mesh__D014485
% 220.24/220.44       91%28%82%29%; was see under GOVERNMENT AGENCIES 1982-90   
% 220.24/220.44  |- mesh__recordMaintainer mesh__D014485 PXP
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D014485 2004
% 220.24/220.44  |- mesh__dateRevised mesh__D014485 1997-06-20
% 220.24/220.44  |- skos__prefLabel mesh__D014485 United States Federal Trade Commission
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D014485 2006
% 220.24/220.44  |- skos__altLabel mesh__D014485 Federal Trade Commission %28%U.S.%29%
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D014485 2003
% 220.24/220.44  |- mesh__recordAuthorizer mesh__D014485 SJN
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D014485 2005
% 220.24/220.44  |- mesh__dateCreated mesh__D014485 1981-02-26
% 220.24/220.44  |- mesh__dateEstablished mesh__D014485 1991-01-01
% 220.24/220.44  |- skos__historyNote mesh__D014485 Government Agencies %28%1968-1981%29%
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D014485 2002
% 220.24/220.44  |- skos__altLabel mesh__D014485 Federal Trade Commission
% 220.24/220.44  |- skos__scopeNote mesh__D014485
% 220.24/220.44       An independent administrative agency concerned with maintaining competitive free enterprise by prohibiting unfair methods of competition and unfair deceptive acts or practices.%A%    
% 220.24/220.44  |- mesh__publicMeSHNote mesh__D014485
% 220.24/220.44       91; was see under GOVERNMENT AGENCIES 1982-90   
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D014485 2001
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D014485 1999
% 220.24/220.44  |- mesh__recordOriginator mesh__D014485 EC
% 220.24/220.44  |- rdf__type mesh__D014485sskos__Concept
% 220.24/220.44  |- skos__altLabel mesh__D008448 Forced Expiratory Flow 0.2-1.2
% 220.24/220.44  |- mesh__dateRevised mesh__D008448 2003-07-09
% 220.24/220.44  |- mesh__dateCreated mesh__D008448 1974-12-12
% 220.24/220.44  |- rdf__type mesh__D008448sskos__Concept
% 220.24/220.44  |- skos__altLabel mesh__D008448 Flow Rate, Maximal Expiratory
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D008448 2004
% 220.24/220.44  |- mesh__recordOriginator mesh__D008448 NLM
% 220.24/220.44  |- mesh__dateEstablished mesh__D008448 1991-01-01
% 220.24/220.44  |- skos__annotation mesh__D008448
% 220.24/220.44       usually NIM; do not confuse with MAXIMAL MIDEXPIRATORY FLOW RATE; %28%MMFR%29%; DF: MEFR%A%  
% 220.24/220.44  |- skos__altLabel mesh__D008448 Forced Expiratory Flow 200-1200
% 220.24/220.44  |- mesh__recordMaintainer mesh__D008448 nns
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D008448 2005
% 220.24/220.44  |- skos__hiddenLabel mesh__D008448 Forced Expiratory Flow 0.2 1.2
% 220.24/220.44  |- skos__hiddenLabel mesh__D008448 Forced Expiratory Flow 200 1200
% 220.24/220.44  |- mesh__publicMeSHNote mesh__D008448
% 220.24/220.44       91; was see under FORCED EXPIRATORY FLOW RATES 1975-90   
% 220.24/220.44  |- skos__scopeNote mesh__D008448
% 220.24/220.44       The airflow rate measured during the first liter expired after the first 200 ml have been exhausted during a FORCED VITAL CAPACITY determination. Common abbreviations are MEFR, FEF 200-1200, and FEF 0.2-1.2.%A%    
% 220.24/220.44  |- skos__broader mesh__D008448smesh__D005540
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D008448 2006
% 220.24/220.44  |- skos__altLabel mesh__D008448 MEFR
% 220.24/220.44  |- skos__prefLabel mesh__D008448 Maximal Expiratory Flow Rate
% 220.24/220.44  |- mesh__historyNote mesh__D008448
% 220.24/220.44       91%28%75%29%; was see under FORCED EXPIRATORY FLOW RATES 1975-90%A%  
% 220.24/220.44  |- mesh__recordAuthorizer mesh__D008448 sjn
% 220.24/220.44  |- skos__hiddenLabel mesh__D000465 Algorithm
% 220.24/220.44  |- skos__prefLabel mesh__D000465 Algorithms
% 220.24/220.44  |- mesh__recordMaintainer mesh__D000465 jls
% 220.24/220.44  |- mesh__dateRevised mesh__D000465 2004-07-07
% 220.24/220.44  |- skos__broader mesh__D000465smesh__D012586
% 220.24/220.44  |- mesh__dateCreated mesh__D000465 1986-06-18
% 220.24/220.44  |- mesh__historyNote mesh__D000465 87   
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D000465 2005
% 220.24/220.44  |- mesh__recordAuthorizer mesh__D000465 sjn
% 220.24/220.44  |- rdf__type mesh__D000465sskos__Concept
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D000465 2006
% 220.24/220.44  |- mesh__publicMeSHNote mesh__D000465 87   
% 220.24/220.44  |- skos__scopeNote mesh__D000465
% 220.24/220.44       A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task.%A%    
% 220.24/220.44  |- skos__broader mesh__D000465smesh__D008433
% 220.24/220.44  |- mesh__recordOriginator mesh__D000465 EC
% 220.24/220.44  |- skos__broader mesh__D000465smesh__D003205
% 220.24/220.44  |- mesh__dateEstablished mesh__D000465 1987-01-01
% 220.24/220.44  |- mesh__recordAuthorizer mesh__D019170 sjn
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D019170 2000
% 220.24/220.44  |- mesh__recordMaintainer mesh__D019170 KEV
% 220.24/220.44  |- mesh__historyNote mesh__D019170 97   
% 220.24/220.44  |- mesh__publicMeSHNote mesh__D019170 97   
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D019170 2004
% 220.24/220.44  |- rdf__type mesh__D019170sskos__Concept
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D019170 2006
% 220.24/220.44  |- mesh__dateCreated mesh__D019170 1996-02-12
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D019170 2003
% 220.24/220.44  |- skos__prefLabel mesh__D019170 Somites
% 220.24/220.44  |- mesh__dateRevised mesh__D019170 1999-11-03
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D019170 2002
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D019170 2005
% 220.24/220.44  |- mesh__recordOriginator mesh__D019170 AGS
% 220.24/220.44  |- skos__scopeNote mesh__D019170
% 220.24/220.44       Paired, segmented masses of mesodermal tissue that form along the length of the neural tube during the early stage of embryonic development. They give rise to the vertebral column and other tissues including voluntary muscle, bone, connective tissue, and the dermal layers of the skin.%A%    
% 220.24/220.44  |- skos__broader mesh__D019170smesh__D008648
% 220.24/220.44  |- skos__historyNote mesh__D019170 Mesoderm %28%1966-1996%29%
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D019170 2001
% 220.24/220.44  |- mesh__dateEstablished mesh__D019170 1997-01-01
% 220.24/220.44  |- skos__hiddenLabel mesh__D019170 Somite
% 220.24/220.44  |- skos__historyNote mesh__D027602 Serum Response Factor %28%1988-2001%29%
% 220.24/220.44  |- skos__hiddenLabel mesh__D027602 Element, Serum Response
% 220.24/220.44  |- mesh__dateCreated mesh__D027602 2001-07-25
% 220.24/220.44  |- skos__broader mesh__D027602smesh__D020218
% 220.24/220.44  |- mesh__recordAuthorizer mesh__D027602 sjn
% 220.24/220.44  |- mesh__historyNote mesh__D027602
% 220.24/220.44       2002; use SERUM RESPONSE FACTOR %28%NM%29% 1988-2001   
% 220.24/220.44  |- rdf__type mesh__D027602sskos__Concept
% 220.24/220.44  |- skos__historyNote mesh__D027602 DNA-Binding Proteins %28%1987-2001%29%
% 220.24/220.44  |- skos__historyNote mesh__D027602 Response Elements %28%1999-2001%29%
% 220.24/220.44  |- mesh__dateEstablished mesh__D027602 2002-01-01
% 220.24/220.44  |- skos__historyNote mesh__D027602
% 220.24/220.44       Promoter Regions %28%Genetics%29% %28%1987-2001%29%
% 220.24/220.44  |- skos__scopeNote mesh__D027602
% 220.24/220.44       A DNA sequence that is found in the promoter region of many growth-related genes. The regulatory transcription factor SERUM RESPONSE FACTOR binds to and regulates the activity of genes containing this element.%A%    
% 220.24/220.44  |- skos__altLabel mesh__D027602 Response Elements, Serum
% 220.24/220.44  |- skos__hiddenLabel mesh__D027602 Elements, Serum Response
% 220.24/220.44  |- mesh__recordMaintainer mesh__D027602 nns
% 220.24/220.44  |- mesh__publicMeSHNote mesh__D027602
% 220.24/220.44       2002; SERUM RESPONSE ELEMENT was indexed under DNA-BINDING PROTEINS and NUCLEAR PROTEINS 1988-2001%A%  
% 220.24/220.44  |- mesh__dateRevised mesh__D027602 2005-06-30
% 220.24/220.44  |- skos__altLabel mesh__D027602 Serum Response Elements
% 220.24/220.44  |- mesh__recordOriginator mesh__D027602 nns
% 220.24/220.44  |- skos__prefLabel mesh__D027602 Serum Response Element
% 220.24/220.44  |- skos__altLabel mesh__D027602 Response Element, Serum
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D027602 2006
% 220.24/220.44  |- skos__altLabel mesh__D005150 Romberg Disease
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Parry Romberg Disease
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Atrophies, Progressive Hemifacial
% 220.24/220.44  |- mesh__recordOriginator mesh__D005150 NLM
% 220.24/220.44  |- rdf__type mesh__D005150sskos__Concept
% 220.24/220.44  |- mesh__recordAuthorizer mesh__D005150 sjn
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D005150 2002
% 220.24/220.44  |- skos__scopeNote mesh__D005150
% 220.24/220.44       A syndrome characterized by slowly progressive unilateral atrophy of facial subcutaneous fat, muscle tissue, skin, cartilage, and bone. The condition typically progresses over a period of 2-10 years and then stabilizes.%A%    
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D005150 2003
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Atrophy, Hemifacial
% 220.24/220.44  |- skos__altLabel mesh__D005150 Progressive Hemifacial Atrophy
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Romberg Facial Hemiatrophy
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Progressive Hemifacial Atrophies
% 220.24/220.44  |- skos__altLabel mesh__D005150 Romberg%27%s Disease
% 220.24/220.44  |- skos__altLabel mesh__D005150 Parry-Romberg Disease
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Facial Hemiatrophies
% 220.24/220.44  |- skos__altLabel mesh__D005150 Parry-Romberg Syndrome
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Facial Hemiatrophy, Progressive
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Hemiatrophies, Facial
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Rombergs Disease
% 220.24/220.44  |- mesh__publicMeSHNote mesh__D005150
% 220.24/220.44       for ROMBERG DISEASE see ROMBERG%27%S DISEASE 1963-97   
% 220.24/220.44  |- skos__broader mesh__D005150smesh__D005155
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Parry Romberg Syndrome
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Disease, Romberg
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Disease, Romberg%27%s
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Hemiatrophies, Progressive Facial
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D005150 2006
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Atrophies, Hemifacial
% 220.24/220.44  |- mesh__dateCreated mesh__D005150 1999-01-01
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Hemifacial Atrophies, Progressive
% 220.24/220.44  |- skos__annotation mesh__D005150
% 220.24/220.44       do not confuse with FACIAL ASYMMETRY; note HEMIFACIAL MICROSOMIA see FACIAL ASYMMETRY%A%  
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Hemifacial Atrophies
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D005150 2005
% 220.24/220.44  |- skos__altLabel mesh__D005150 Facial Hemiatrophy of Romberg
% 220.24/220.44  |- skos__altLabel mesh__D005150 Hemifacial Atrophy
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Progressive Facial Hemiatrophies
% 220.24/220.44  |- mesh__recordMaintainer mesh__D005150 sjn
% 220.24/220.44  |- skos__prefLabel mesh__D005150 Facial Hemiatrophy
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Syndrome, Parry-Romberg
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Disease, Parry-Romberg
% 220.24/220.44  |- mesh__dateRevised mesh__D005150 2001-08-13
% 220.24/220.44  |- skos__altLabel mesh__D005150 Progressive Facial Hemiatrophy
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Atrophy, Progressive Hemifacial
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D005150 2004
% 220.24/220.44  |- skos__broader mesh__D005150smesh__D009059
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Hemiatrophy, Progressive Facial
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Hemifacial Atrophy, Progressive
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Hemiatrophy, Facial
% 220.24/220.44  |- skos__hiddenLabel mesh__D005150 Facial Hemiatrophies, Progressive
% 220.24/220.44  |- rdf__type mesh__D018876sskos__Concept
% 220.24/220.44  |- skos__altLabel mesh__D018876 Environmental Illnesses
% 220.24/220.44  |- skos__annotation mesh__D018876
% 220.24/220.44       GEN or unspecified; prefer specifics; coord IM with specific disease %28%IM%29% or source of illness %28%IM%29%; also available are MULTIPLE CHEMICAL SENSITIVITY; PERSIAN GULF SYNDROME %26% SICK BUILDING SYNDROME; not for diseases caused by environmental pollution: index under specific dis %28%IM%29% + ENVIRONMENTAL POLLUTION %28%IM%29% or specific envir pollut %28%IM%29%; DF: ENVIR ILLNESS%A%  
% 220.24/220.44  |- mesh__historyNote mesh__D018876 96   
% 220.24/220.44  |- skos__altLabel mesh__D018876 Illnesses, Environmental
% 220.24/220.44  |- mesh__dateEstablished mesh__D018876 1996-01-01
% 220.24/220.44  |- mesh__dateRevised mesh__D018876 2001-07-25
% 220.24/220.44  |- mesh__dateCreated mesh__D018876 1995-05-19
% 220.24/220.44  |- mesh__recordMaintainer mesh__D018876 mdb
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D018876 2005
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D018876 2002
% 220.24/220.44  |- mesh__recordOriginator mesh__D018876 TGC
% 220.24/220.44  |- skos__altLabel mesh__D018876 Environmental Hypersensitivity
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D018876 2006
% 220.24/220.44  |- mesh__publicMeSHNote mesh__D018876 96   
% 220.24/220.44  |- mesh__activeMeSHYear mesh__D018876 2003
% 220.24/220.44  |- skos__broader mesh__D018876smesh__D007280
% 220.24/220.44  |- skos__altLabel mesh__D018876 Hypersensitivities, Environmental
% 220.24/220.44  |- skos__scopeNote mesh__D018876
% 220.24/220.44       A polysymptomatic condition believed by clinical ecologists to result from immune dysregulation induced by common foods, allergens, and chemicals, resulting in various physical and mental disorders. The medical community has remained largely skeptical of the existence of this %22%disease%22%, given the plethora of symptoms attributed to environmental illness, the lack of reproducible laboratory abnormalities, and the use of unproven therapies to treat the condition. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D018876 2004
% 220.24/220.45  |- skos__altLabel mesh__D018876 Hypersensitivity, Environmental
% 220.24/220.45  |- mesh__recordAuthorizer mesh__D018876 sjn
% 220.24/220.45  |- skos__prefLabel mesh__D018876 Environmental Illness
% 220.24/220.45  |- skos__altLabel mesh__D018876 Environmental Hypersensitivities
% 220.24/220.45  |- skos__broader mesh__D018876smesh__D006967
% 220.24/220.45  |- skos__altLabel mesh__D018876 Illness, Environmental
% 220.24/220.45  |- mesh__dateEstablished mesh__D010893 1991-01-01
% 220.24/220.45  |- rdf__type mesh__D010893sskos__Concept
% 220.24/220.45  |- mesh__recordOriginator mesh__D010893 SH
% 220.24/220.45  |- mesh__recordMaintainer mesh__D010893 TWD
% 220.24/220.45  |- skos__prefLabel mesh__D010893 Piromidic Acid
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D010893 2006
% 220.24/220.45  |- skos__scopeNote mesh__D010893
% 220.24/220.45       Antibacterial against mainly gram negative organisms. It is used for urinary tract and intestinal infections.%A%    
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D010893 2001
% 220.24/220.45  |- mesh__historyNote mesh__D010893
% 220.24/220.45       91%28%79%29%; was see under NICOTINIC ACIDS 1979-90   
% 220.24/220.45  |- skos__historyNote mesh__D010893 Pyrimidines %28%1966-1975%29%
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D010893 2004
% 220.24/220.45  |- mesh__publicMeSHNote mesh__D010893
% 220.24/220.45       91; was see under NICOTINIC ACIDS 1979-90   
% 220.24/220.45  |- mesh__dateCreated mesh__D010893 1977-12-09
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D010893 2005
% 220.24/220.45  |- skos__historyNote mesh__D010893 Pyrrolidines %28%1966-1978%29%
% 220.24/220.45  |- skos__historyNote mesh__D010893 Nicotinic Acids %28%1976-1978%29%
% 220.24/220.45  |- skos__broader mesh__D010893smesh__D009539
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D010893 2003
% 220.24/220.45  |- skos__hiddenLabel mesh__D010893 Acid, Piromidic
% 220.24/220.45  |- mesh__recordAuthorizer mesh__D010893 sjn
% 220.24/220.45  |- skos__historyNote mesh__D010893 Picolinic Acids %28%1968-1975%29%
% 220.24/220.45  |- mesh__dateRevised mesh__D010893 2000-06-21
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D010893 2002
% 220.24/220.45  |- skos__altLabel mesh__D051701 ATF4 Transcription Factor
% 220.24/220.45  |- mesh__dateCreated mesh__D051701 2005-06-30
% 220.24/220.45  |- skos__scopeNote mesh__D051701
% 220.24/220.45       An activating transcription factor that regulates the expression of a variety of GENES involved in amino acid metabolism and transport. It also interacts with HTLV-I TRANS-ACTIVATOR PROTEIN.%A%    
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D051701 2006A
% 220.24/220.45  |- mesh__publicMeSHNote mesh__D051701
% 220.24/220.45       2006; ACTIVATING TRANSCRIPTION FACTOR 4 was indexed under TRANSCRIPTION FACTORS 1991-2005%A%  
% 220.24/220.45  |- rdf__type mesh__D051701sskos__Concept
% 220.24/220.45  |- mesh__dateRevised mesh__D051701 2005-07-07
% 220.24/220.45  |- skos__prefLabel mesh__D051701 Activating Transcription Factor 4
% 220.24/220.45  |- skos__hiddenLabel mesh__D051701 Tax Responsive Enhancer Element B67
% 220.24/220.45  |- skos__altLabel mesh__D051701 Tax-Responsive Enhancer Element B67
% 220.24/220.45  |- mesh__recordAuthorizer mesh__D051701 ags
% 220.24/220.45  |- mesh__historyNote mesh__D051701 2006%28%1991%29%   
% 220.24/220.45  |- skos__hiddenLabel mesh__D051701 Transcription Factor, ATF4
% 220.24/220.45  |- mesh__dateEstablished mesh__D051701 2006-01-01
% 220.24/220.45  |- mesh__recordMaintainer mesh__D051701 ags
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D051701 2006
% 220.24/220.45  |- mesh__recordOriginator mesh__D051701 DRC
% 220.24/220.45  |- skos__broader mesh__D051701smesh__D051696
% 220.24/220.45  |- mesh__dateCreated mesh__D018078 1993-06-16
% 220.24/220.45  |- skos__hiddenLabel mesh__D018078 E Receptor, Prostaglandin
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D018078 2006
% 220.24/220.45  |- mesh__recordOriginator mesh__D018078 RAZ
% 220.24/220.45  |- skos__prefLabel mesh__D018078 Receptors, Prostaglandin E
% 220.24/220.45  |- mesh__dateRevised mesh__D018078 2003-07-09
% 220.24/220.45  |- skos__altLabel mesh__D018078 Prostaglandin E Receptor
% 220.24/220.45  |- skos__hiddenLabel mesh__D018078 E Receptors, Prostaglandin
% 220.24/220.45  |- skos__hiddenLabel mesh__D018078 Receptor, Prostaglandin E
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D018078 2005
% 220.24/220.45  |- rdf__type mesh__D018078sskos__Concept
% 220.24/220.45  |- mesh__publicMeSHNote mesh__D018078
% 220.24/220.45       94; PROSTAGLANDINS E RECEPTOR was indexed under RECEPTORS, PROSTAGLANDIN 1981-93%A%  
% 220.24/220.45  |- mesh__dateEstablished mesh__D018078 1994-01-01
% 220.24/220.45  |- skos__scopeNote mesh__D018078
% 220.24/220.45       Cell surface receptors which bind prostaglandins with a high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin E receptors prefer prostaglandin E2 to other endogenous prostaglandins. They are subdivided into EP1, EP2, and EP3 types based on their effects and their pharmacology.%A%    
% 220.24/220.45  |- mesh__recordAuthorizer mesh__D018078 sjn
% 220.24/220.45  |- skos__annotation mesh__D018078 DF: RECEPT PGE   
% 220.24/220.45  |- skos__historyNote mesh__D018078
% 220.24/220.45       Receptors, Prostaglandin %28%1981-1993%29%
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D018078 2004
% 220.24/220.45  |- mesh__historyNote mesh__D018078
% 220.24/220.45       94; PROSTAGLANDINS E RECEPTOR was %28%NM%29% 1981-93   
% 220.24/220.45  |- skos__altLabel mesh__D018078 PGE2 Receptors
% 220.24/220.45  |- skos__altLabel mesh__D018078 PGE Receptors
% 220.24/220.45  |- skos__altLabel mesh__D018078 PGE Receptor
% 220.24/220.45  |- skos__altLabel mesh__D018078 Prostaglandin E Receptors
% 220.24/220.45  |- mesh__onlineNote mesh__D018078
% 220.24/220.45       use RECEPTORS, PROSTAGLANDIN E %28%NM%29% to search PROSTAGLANDINS E RECEPTOR 1981-93%A%  
% 220.24/220.45  |- mesh__recordMaintainer mesh__D018078 jmp
% 220.24/220.45  |- skos__broader mesh__D018078smesh__D011982
% 220.24/220.45  |- mesh__recordMaintainer mesh__D010095 JRT
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D010095 2004
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D010095 2000
% 220.24/220.45  |- mesh__publicMeSHNote mesh__D010095 73   
% 220.24/220.45  |- mesh__recordOriginator mesh__D010095 NLM
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D010095 2006
% 220.24/220.45  |- mesh__dateEstablished mesh__D010095 1973-01-01
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D010095 2003
% 220.24/220.45  |- skos__historyNote mesh__D010095 Tremorine %28%1966-1971%29%
% 220.24/220.45  |- skos__altLabel mesh__D010095 Oxytremorine
% 220.24/220.45  |- skos__annotation mesh__D010095 a muscarinic agonist used in exper   
% 220.24/220.45  |- mesh__historyNote mesh__D010095 73%28%72%29%   
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D010095 2005
% 220.24/220.45  |- skos__broader mesh__D010095smesh__D011760
% 220.24/220.45  |- mesh__dateRevised mesh__D010095 1995-06-08
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D010095 1997
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D010095 1999
% 220.24/220.45  |- mesh__dateCreated mesh__D010095 1999-01-01
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D010095 1996
% 220.24/220.45  |- rdf__type mesh__D010095sskos__Concept
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D010095 2002
% 220.24/220.45  |- mesh__recordAuthorizer mesh__D010095 PLS
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D010095 1998
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D010095 2001
% 220.24/220.45  |- skos__prefLabel mesh__D010095 Oxotremorine
% 220.24/220.45  |- skos__scopeNote mesh__D010095
% 220.24/220.45       A non-hydrolyzed muscarinic agonist used as a research tool.%A%    
% 220.24/220.45  |- skos__scopeNote mesh__D004856
% 220.24/220.45       A state of the body being evenly balanced in POSTURE. The biomechanical responses of the MUSCULOSKELETAL SYSTEM during standing, walking, sitting, and other movements.%A%    
% 220.24/220.45  |- mesh__historyNote mesh__D004856 2004%28%1966%29%   
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D004856 2005
% 220.24/220.45  |- skos__broader mesh__D004856smesh__D011434
% 220.24/220.45  |- mesh__recordOriginator mesh__D004856 NLM
% 220.24/220.45  |- mesh__publicMeSHNote mesh__D004856
% 220.24/220.45       2004%28%1966%29%; see EQUILIBRIUM 1963-2003   
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D004856 2006
% 220.24/220.45  |- mesh__dateRevised mesh__D004856 2003-07-09
% 220.24/220.45  |- rdf__type mesh__D004856sskos__Concept
% 220.24/220.45  |- skos__hiddenLabel mesh__D004856 Equilibrium, Musculoskeletal
% 220.24/220.45  |- skos__prefLabel mesh__D004856 Musculoskeletal Equilibrium
% 220.24/220.45  |- skos__altLabel mesh__D004856 Postural Balance
% 220.24/220.45  |- skos__altLabel mesh__D004856 Balance, Postural
% 220.24/220.45  |- skos__hiddenLabel mesh__D004856 Equilibrium, Postural
% 220.24/220.45  |- skos__broader mesh__D004856smesh__D043703
% 220.24/220.45  |- skos__altLabel mesh__D004856 Postural Equilibrium
% 220.24/220.45  |- mesh__recordMaintainer mesh__D004856 nns
% 220.24/220.45  |- mesh__recordAuthorizer mesh__D004856 sjn
% 220.24/220.45  |- skos__annotation mesh__D004856
% 220.24/220.45       note category: equilibrium in chemical reactions  = CHEMISTRY; disord of equilibrium: coord IM with SENSATION DISORDERS %28%IM%29%%A%  
% 220.24/220.45  |- mesh__dateCreated mesh__D004856 1999-01-01
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D004856 2004
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D004058 2006
% 220.24/220.45  |- mesh__dateEstablished mesh__D004058 1970-01-01
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D004058 2001
% 220.24/220.45  |- skos__scopeNote mesh__D004058
% 220.24/220.45       The tendency of a gas or solute to pass from a point of higher pressure or concentration to a point of lower pressure or concentration and to distribute itself throughout the available space; a major mechanism of BIOLOGICAL TRANSPORT.%A%    
% 220.24/220.45  |- skos__broader mesh__D004058smesh__D001703
% 220.24/220.45  |- mesh__recordMaintainer mesh__D004058 TAP
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D004058 1994
% 220.24/220.45  |- mesh__publicMeSHNote mesh__D004058 70   
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D004058 1993
% 220.24/220.45  |- skos__historyNote mesh__D004058 Chemistry, Physical %28%1966-1967%29%
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D004058 2005
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D004058 2004
% 220.24/220.45  |- mesh__recordAuthorizer mesh__D004058 PLS
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D004058 1999
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D004058 2000
% 220.24/220.45  |- skos__hiddenLabel mesh__D004058 Diffusions
% 220.24/220.45  |- skos__broader mesh__D004058smesh__D001669
% 220.24/220.45  |- mesh__dateRevised mesh__D004058 1992-05-14
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D004058 2003
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D004058 1998
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D004058 1997
% 220.24/220.45  |- skos__annotation mesh__D004058 almost never IM   
% 220.24/220.45  |- skos__prefLabel mesh__D004058 Diffusion
% 220.24/220.45  |- mesh__dateCreated mesh__D004058 1999-01-01
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D004058 2002
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D004058 1996
% 220.24/220.45  |- skos__historyNote mesh__D004058 Biophysics %28%1966-1967%29%
% 220.24/220.45  |- mesh__recordOriginator mesh__D004058 NLM
% 220.24/220.45  |- rdf__type mesh__D004058sskos__Concept
% 220.24/220.45  |- mesh__historyNote mesh__D004058 70%28%68%29%   
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D004058 1995
% 220.24/220.45  |- skos__hiddenLabel mesh__D009541 Membranes, Nictitating
% 220.24/220.45  |- skos__hiddenLabel mesh__D009541 Eyelids, Third
% 220.24/220.45  |- mesh__dateCreated mesh__D009541 1999-01-01
% 220.24/220.45  |- skos__hiddenLabel mesh__D009541 Third Eyelids
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D009541 2003
% 220.24/220.45  |- skos__broader mesh__D009541smesh__D000825
% 220.24/220.45  |- mesh__dateRevised mesh__D009541 1999-11-03
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D009541 2000
% 220.24/220.45  |- skos__hiddenLabel mesh__D009541 Membrane, Nictitating
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D009541 2004
% 220.24/220.45  |- skos__scopeNote mesh__D009541
% 220.24/220.45       A fold of the mucous membrane of the CONJUNCTIVA in many animals. At rest, it is hidden in the medial canthus. It can extend to cover part or all of the cornea to help clean the CORNEA.%A%    
% 220.24/220.45  |- rdf__type mesh__D009541sskos__Concept
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D009541 2001
% 220.24/220.45  |- skos__hiddenLabel mesh__D009541 Eyelid, Third
% 220.24/220.45  |- skos__annotation mesh__D009541
% 220.24/220.45       ptosis of X ref THIRD EYELID: coord IM with EYELID DISEASES /vet %28%IM%29%, not BLEPHAROPTOSIS%A%  
% 220.24/220.45  |- skos__prefLabel mesh__D009541 Nictitating Membrane
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D009541 2005
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D009541 2002
% 220.24/220.45  |- skos__altLabel mesh__D009541 Third Eyelid
% 220.24/220.45  |- mesh__recordMaintainer mesh__D009541 KEV
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D009541 2006
% 220.24/220.45  |- mesh__recordOriginator mesh__D009541 NLM
% 220.24/220.45  |- mesh__recordAuthorizer mesh__D009541 sjn
% 220.24/220.45  |- skos__hiddenLabel mesh__D009541 Nictitating Membranes
% 220.24/220.45  |- skos__hiddenLabel mesh__D050609
% 220.24/220.45       Sodium Phosphate Symporter Proteins, Type I
% 220.24/220.45  |- skos__hiddenLabel mesh__D050609
% 220.24/220.45       Sodium Phosphate Cotransporter Proteins, Type I
% 220.24/220.45  |- rdf__type mesh__D050609sskos__Concept
% 220.24/220.45  |- skos__altLabel mesh__D050609 Sodium-Phosphate Symporters, Type I
% 220.24/220.45  |- skos__altLabel mesh__D050609
% 220.24/220.45       Type I Sodium-Phosphate Cotransporter Proteins
% 220.24/220.45  |- mesh__publicMeSHNote mesh__D050609
% 220.24/220.45       2006; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE I was indexed under SYMPORTERS 2004-2005%A%  
% 220.24/220.45  |- skos__altLabel mesh__D050609 Sodium-Phosphate Symporter Proteins, Type I
% 220.24/220.45  |- mesh__dateEstablished mesh__D050609 2006-01-01
% 220.24/220.45  |- skos__hiddenLabel mesh__D050609 Sodium Phosphate Symporters, Type I
% 220.24/220.45  |- mesh__recordAuthorizer mesh__D050609 sjn
% 220.24/220.45  |- skos__altLabel mesh__D050609 NaPi-1 Proteins
% 220.24/220.45  |- skos__hiddenLabel mesh__D050609 NaPi 1 Proteins
% 220.24/220.45  |- mesh__historyNote mesh__D050609 2006%28%2004%29%   
% 220.24/220.45  |- mesh__dateCreated mesh__D050609 2005-06-30
% 220.24/220.45  |- mesh__recordOriginator mesh__D050609 DRC
% 220.24/220.45  |- skos__altLabel mesh__D050609 Type I Na-Dependent Phosphate Cotransporter
% 220.24/220.45  |- mesh__recordMaintainer mesh__D050609 DRC
% 220.24/220.45  |- skos__hiddenLabel mesh__D050609
% 220.24/220.45       Type I Sodium Phosphate Cotransporter Proteins
% 220.24/220.45  |- skos__prefLabel mesh__D050609
% 220.24/220.45       Sodium-Phosphate Cotransporter Proteins, Type I
% 220.24/220.45  |- skos__broader mesh__D050609smesh__D050608
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D050609 2006
% 220.24/220.45  |- skos__scopeNote mesh__D050609
% 220.24/220.45       A family of sodium-phosphate cotransporter proteins that also transport organic ANIONS. They are low affinity phosphate transporters.%A%    
% 220.24/220.45  |- skos__hiddenLabel mesh__D050609
% 220.24/220.45       Type I Na Dependent Phosphate Cotransporter
% 220.24/220.45  |- skos__broader mesh__D011188Q000737smesh__D011188
% 220.24/220.45  |- rdf__type mesh__D011188Q000737smesh__CompoundConcept
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D014486 2004
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D014486 2001
% 220.24/220.45  |- mesh__historyNote mesh__D014486 66%28%64%29%   
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D014486 2006
% 220.24/220.45  |- skos__altLabel mesh__D014486 United States Food, Drug Administration
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D014486 2003
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D014486 2005
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D014486 2000
% 220.24/220.45  |- mesh__recordOriginator mesh__D014486 NLM
% 220.24/220.45  |- mesh__recordMaintainer mesh__D014486 PXP
% 220.24/220.45  |- mesh__dateRevised mesh__D014486 1997-06-20
% 220.24/220.45  |- skos__annotation mesh__D014486
% 220.24/220.45       add UNITED STATES %28%NIM%29%; research support by this agency is checked as NIH/PHS SUP; DF: FDA      CATALOG: use NAF entry%A%  
% 220.24/220.45  |- mesh__recordAuthorizer mesh__D014486 SJN
% 220.24/220.45  |- skos__altLabel mesh__D014486 Food and Drug Administration %28%U.S.%29%
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D014486 1999
% 220.24/220.45  |- skos__broader mesh__D014486smesh__D014492
% 220.24/220.45  |- mesh__dateEstablished mesh__D014486 1966-01-01
% 220.24/220.45  |- rdf__type mesh__D014486sskos__Concept
% 220.24/220.45  |- skos__altLabel mesh__D014486 Food and Drug Administration
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D014486 1998
% 220.24/220.45  |- mesh__publicMeSHNote mesh__D014486 66   
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D014486 2002
% 220.24/220.45  |- skos__scopeNote mesh__D014486
% 220.24/220.45       An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc.%A%    
% 220.24/220.45  |- mesh__dateCreated mesh__D014486 1999-01-01
% 220.24/220.45  |- skos__altLabel mesh__D014486 USFDA
% 220.24/220.45  |- skos__prefLabel mesh__D014486 United States Food and Drug Administration
% 220.24/220.45  |- mesh__dateEstablished mesh__D008449 1991-01-01
% 220.24/220.45  |- mesh__recordAuthorizer mesh__D008449 sjn
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D008449 2005
% 220.24/220.45  |- mesh__publicMeSHNote mesh__D008449
% 220.24/220.45       91; was see under FORCED EXPIRATORY FLOW RATES 1975-90   
% 220.24/220.45  |- mesh__recordOriginator mesh__D008449 NLM
% 220.24/220.45  |- skos__prefLabel mesh__D008449 Maximal Expiratory Flow-Volume Curves
% 220.24/220.45  |- skos__broader mesh__D008449smesh__D005540
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D008449 2006
% 220.24/220.45  |- skos__scopeNote mesh__D008449
% 220.24/220.45       Curves depicting MAXIMAL EXPIRATORY FLOW RATE, in liters/second, versus lung inflation, in liters or percentage of lung capacity, during a FORCED VITAL CAPACITY determination. Common abbreviation is MEFV.%A%    
% 220.24/220.45  |- skos__altLabel mesh__D008449 Maximal Expiratory Flow Volume Curves
% 220.24/220.45  |- mesh__historyNote mesh__D008449
% 220.24/220.45       91%28%75%29%; was see under FORCED EXPIRATORY FLOW RATES 1975-90%A%  
% 220.24/220.45  |- mesh__recordMaintainer mesh__D008449 nns
% 220.24/220.45  |- mesh__dateRevised mesh__D008449 2003-07-09
% 220.24/220.45  |- skos__annotation mesh__D008449
% 220.24/220.45       usually NIM; do not confuse with MAXIMAL EXPIRATORY FLOW RATE; %28%MEFR%29%; DF: MEFV%A%  
% 220.24/220.45  |- mesh__dateCreated mesh__D008449 1974-12-12
% 220.24/220.45  |- rdf__type mesh__D008449sskos__Concept
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D008449 2004
% 220.24/220.45  |- mesh__dateCreated mesh__D000466 1999-01-01
% 220.24/220.45  |- mesh__recordOriginator mesh__D000466 NLM
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D000466 2004
% 220.24/220.45  |- mesh__recordMaintainer mesh__D000466 TGC
% 220.24/220.45  |- skos__broader mesh__D000466smesh__D011090
% 220.24/220.45  |- skos__altLabel mesh__D000466 Diolefins
% 220.24/220.45  |- rdf__type mesh__D000466sskos__Concept
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D000466 2000
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D000466 2005
% 220.24/220.45  |- mesh__dateRevised mesh__D000466 1997-06-20
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D000466 2001
% 220.24/220.45  |- mesh__dateEstablished mesh__D000466 1974-01-01
% 220.24/220.45  |- mesh__publicMeSHNote mesh__D000466 74   
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D000466 2006
% 220.24/220.45  |- mesh__recordAuthorizer mesh__D000466 SJN
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D000466 1998
% 220.24/220.45  |- skos__prefLabel mesh__D000466 Alkadienes
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D000466 2002
% 220.24/220.45  |- skos__scopeNote mesh__D000466
% 220.24/220.45       Acyclic branched or unbranched hydrocarbons having two carbon-carbon double bonds.%A%    
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D000466 1999
% 220.24/220.45  |- mesh__historyNote mesh__D000466 74   
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D000466 2003
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D005151 2003
% 220.24/220.45  |- rdf__type mesh__D005151sskos__Concept
% 220.24/220.45  |- mesh__recordMaintainer mesh__D005151 PXP
% 220.24/220.45  |- mesh__recordAuthorizer mesh__D005151 sjn
% 220.24/220.45  |- skos__altLabel mesh__D005151 Injuries, Facial
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D005151 2002
% 220.24/220.45  |- mesh__dateRevised mesh__D005151 1999-11-03
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D005151 2006
% 220.24/220.45  |- skos__broader mesh__D005151smesh__D006259
% 220.24/220.45  |- skos__scopeNote mesh__D005151
% 220.24/220.45       General or unspecified injuries to the soft tissue or bony portions of the face.%A%    
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D005151 2001
% 220.24/220.45  |- mesh__recordOriginator mesh__D005151 NLM
% 220.24/220.45  |- skos__prefLabel mesh__D005151 Facial Injuries
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D005151 2000
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D005151 2005
% 220.24/220.45  |- skos__hiddenLabel mesh__D005151 Facial Injury
% 220.24/220.45  |- skos__annotation mesh__D005151
% 220.24/220.45       GEN or unspecified for soft tissue or bony portions of face; consider also /inj with FACIAL BONES or specific facial bones; fractures: see note on FACIAL BONES; TN 115: use of FACIAL INJURIES %26% jaw inj%A%  
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D005151 2004
% 220.24/220.45  |- mesh__dateCreated mesh__D005151 1999-01-01
% 220.24/220.45  |- skos__hiddenLabel mesh__D005151 Injury, Facial
% 220.24/220.45  |- mesh__publicMeSHNote mesh__D046568 2005   
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D046568 2005
% 220.24/220.45  |- mesh__recordMaintainer mesh__D046568 ags
% 220.24/220.45  |- skos__broader mesh__D046568smesh__D046569
% 220.24/220.45  |- mesh__historyNote mesh__D046568 2005   
% 220.24/220.45  |- skos__scopeNote mesh__D046568
% 220.24/220.45       Innervated clusters of NEUROEPITHELIAL CELLS found in the LUNGS. They act as airway OXYGEN sensors, releasing regulatory PEPTIDES and SEROTONIN in response to HYPOXIA.%A%    
% 220.24/220.45  |- mesh__dateCreated mesh__D046568 2004-07-07
% 220.24/220.45  |- mesh__dateEstablished mesh__D046568 2005-01-01
% 220.24/220.45  |- skos__prefLabel mesh__D046568 Neuroepithelial Bodies
% 220.24/220.45  |- mesh__recordOriginator mesh__D046568 ags
% 220.24/220.45  |- skos__hiddenLabel mesh__D046568 Bodies, Neuroepithelial
% 220.24/220.45  |- skos__historyNote mesh__D046568 Neurosecretory Systems %28%1982-2004%29%
% 220.24/220.45  |- rdf__type mesh__D046568sskos__Concept
% 220.24/220.45  |- skos__historyNote mesh__D046568 Epithelial Cells %28%1973-2004%29%
% 220.24/220.45  |- skos__hiddenLabel mesh__D046568 Body, Neuroepithelial
% 220.24/220.45  |- mesh__recordAuthorizer mesh__D046568 sjn
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D046568 2006
% 220.24/220.45  |- skos__hiddenLabel mesh__D046568 Neuroepithelial Body
% 220.24/220.45  |- skos__annotation mesh__D018877
% 220.24/220.45       coord IM with specific manifest if pertinent %28%IM%29%   
% 220.24/220.45  |- mesh__onlineNote mesh__D018877
% 220.24/220.45       use AIR POLLUTION, INDOOR to search SICK BUILDING SYNDROME 1992-95; use ENVIRONMENTAL EXPOSURE 1990-91%A%  
% 220.24/220.45  |- skos__historyNote mesh__D018877 Occupational Diseases %28%1984-1989%29%
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D018877 2002
% 220.24/220.45  |- rdf__type mesh__D018877sskos__Concept
% 220.24/220.45  |- mesh__recordAuthorizer mesh__D018877 sjn
% 220.24/220.45  |- mesh__recordMaintainer mesh__D018877 mdb
% 220.24/220.45  |- mesh__dateCreated mesh__D018877 1994-12-27
% 220.24/220.45  |- skos__historyNote mesh__D018877 Environmental Exposure %28%1990-1991%29%
% 220.24/220.45  |- skos__broader mesh__D018877smesh__D018876
% 220.24/220.45  |- skos__prefLabel mesh__D018877 Sick Building Syndrome
% 220.24/220.45  |- skos__hiddenLabel mesh__D018877 Syndrome, Sick Building
% 220.24/220.45  |- mesh__recordOriginator mesh__D018877 TGC
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D018877 2004
% 220.24/220.45  |- mesh__dateRevised mesh__D018877 2001-07-25
% 220.24/220.45  |- mesh__dateEstablished mesh__D018877 1996-01-01
% 220.24/220.45  |- skos__scopeNote mesh__D018877
% 220.24/220.45       A group of symptoms that are two- to three-fold more common in those who work in large, energy-efficient buildings, associated with an increased frequency of headaches, lethargy, and dry skin. Clinical manifestations include hypersensitivity pneumonitis %28%ALVEOLITIS, EXTRINSIC ALLERGIC%29%; allergic rhinitis %28%RHINITIS, ALLERGIC, PERENNIAL%29%; ASTHMA; infections, skin eruptions, and mucous membrane irritation syndromes. Current usage tends to be less restrictive with regard to the type of building and delineation of complaints. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D018877 2006
% 220.24/220.45  |- mesh__publicMeSHNote mesh__D018877
% 220.24/220.45       96; was see AIR POLLUTION, INDOOR 1992-95, was see ENVIRONMENTAL EXPOSURE 1990-91%A%  
% 220.24/220.45  |- skos__historyNote mesh__D018877 Air Pollution, Indoor %28%1992-1995%29%
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D018877 2003
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D018877 2005
% 220.24/220.45  |- mesh__historyNote mesh__D018877
% 220.24/220.45       96; was see AIR POLLUTION, INDOOR 1992-95, was see ENVIRONMENTAL EXPOSURE 1990-91%A%  
% 220.24/220.45  |- rdf__type mesh__D010894sskos__Concept
% 220.24/220.45  |- mesh__recordOriginator mesh__D010894 RLS
% 220.24/220.45  |- mesh__publicMeSHNote mesh__D010894 87   
% 220.24/220.45  |- mesh__dateRevised mesh__D010894 2005-06-30
% 220.24/220.45  |- skos__hiddenLabel mesh__D010894 CP16171
% 220.24/220.45  |- skos__historyNote mesh__D010894 Thiazines %28%1966-1986%29%
% 220.24/220.45  |- mesh__recordMaintainer mesh__D010894 ssb
% 220.24/220.45  |- mesh__dateEstablished mesh__D010894 1987-01-01
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D010894 2006
% 220.24/220.45  |- skos__broader mesh__D010894smesh__D013843
% 220.24/220.45  |- mesh__historyNote mesh__D010894 87   
% 220.24/220.45  |- skos__prefLabel mesh__D010894 Piroxicam
% 220.24/220.45  |- mesh__recordAuthorizer mesh__D010894 sjn
% 220.24/220.45  |- skos__scopeNote mesh__D010894
% 220.24/220.45       A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent %28%NSAID%29% that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.%A%    
% 220.24/220.45  |- skos__hiddenLabel mesh__D010894 CP 16171
% 220.24/220.45  |- mesh__dateCreated mesh__D010894 1986-06-02
% 220.24/220.45  |- skos__hiddenLabel mesh__D051702 Transcription Factor, ATF6
% 220.24/220.45  |- skos__broader mesh__D051702smesh__D051696
% 220.24/220.45  |- rdf__type mesh__D051702sskos__Concept
% 220.24/220.45  |- mesh__dateCreated mesh__D051702 2005-06-30
% 220.24/220.45  |- mesh__dateRevised mesh__D051702 2005-07-21
% 220.24/220.45  |- skos__altLabel mesh__D051702 ATF6 Transcription Factor
% 220.24/220.45  |- mesh__historyNote mesh__D051702 2006%28%1997%29%   
% 220.24/220.45  |- mesh__recordAuthorizer mesh__D051702 ags
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D051702 2006A
% 220.24/220.45  |- mesh__recordMaintainer mesh__D051702 ags
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D051702 2006
% 220.24/220.45  |- skos__prefLabel mesh__D051702 Activating Transcription Factor 6
% 220.24/220.45  |- mesh__recordOriginator mesh__D051702 DRC
% 220.24/220.45  |- mesh__publicMeSHNote mesh__D051702
% 220.24/220.45       2006; ACTIVATING TRANSCRIPTION FACTOR 6 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1997-2005%A%  
% 220.24/220.45  |- skos__broader mesh__D051702smesh__D047908
% 220.24/220.45  |- skos__scopeNote mesh__D051702
% 220.24/220.45       A BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR that is synthesized as a membrane-bound protein in the ENDOPLASMIC RETICULUM. In response to endoplasmic reticulum stress it translocates to the GOLGI APPARATUS. It is activated by PROTEASES and then moves to the CELL NUCLEUS to regulate GENETIC TRANSCRIPTION of GENES involved in the unfolded protein response.%A%    
% 220.24/220.45  |- mesh__dateEstablished mesh__D051702 2006-01-01
% 220.24/220.45  |- skos__hiddenLabel mesh__D018079 Receptor, gamma-Aminobutyric Acid
% 220.24/220.45  |- skos__altLabel mesh__D018079 gamma-Aminobutyric Acid Receptor
% 220.24/220.45  |- mesh__dateCreated mesh__D018079 1993-06-21
% 220.24/220.45  |- skos__annotation mesh__D018079 GEN; prefer specifics; DF: RECEPT GABA   
% 220.24/220.45  |- skos__historyNote mesh__D018079 GABA %28%1979-1984%29%
% 220.24/220.45  |- skos__hiddenLabel mesh__D018079 gamma Aminobutyric Acid Receptors
% 220.24/220.45  |- mesh__publicMeSHNote mesh__D018079
% 220.24/220.45       94; GABA RECEPTORS %26% RECEPTORS, GAMMA-AMINOBUTYRIC ACID were see RECEPTORS, GABA-BENZODIAZEPINE 1985-93%A%  
% 220.24/220.45  |- skos__altLabel mesh__D018079 Receptors, gamma-Aminobutyric Acid
% 220.24/220.45  |- skos__altLabel mesh__D018079 GABA Receptor
% 220.24/220.45  |- skos__related mesh__D018079smesh__D050485
% 220.24/220.45  |- skos__scopeNote mesh__D018079
% 220.24/220.45       Cell-surface proteins that bind GAMMA-AMINOBUTYRIC ACID with high affinity and trigger changes that influence the behavior of cells. GABA-A receptors control chloride channels formed by the receptor complex itself. They are blocked by bicuculline and usually have modulatory sites sensitive to benzodiazepines and barbiturates. GABA-B receptors act through G-proteins on several effector systems, are insensitive to bicuculline, and have a high affinity for L-baclofen.%A%    
% 220.24/220.45  |- skos__hiddenLabel mesh__D018079 Receptor, GABA
% 220.24/220.45  |- skos__hiddenLabel mesh__D018079 Receptors, gamma Aminobutyric Acid
% 220.24/220.45  |- skos__historyNote mesh__D018079 Receptors, GABA-A %28%1985-1993%29%
% 220.24/220.45  |- mesh__recordOriginator mesh__D018079 RAZ
% 220.24/220.45  |- skos__broader mesh__D018079smesh__D017459
% 220.24/220.45  |- skos__altLabel mesh__D018079 GABA Receptors
% 220.24/220.45  |- mesh__dateEstablished mesh__D018079 1994-01-01
% 220.24/220.45  |- mesh__dateRevised mesh__D018079 2005-06-30
% 220.24/220.45  |- skos__prefLabel mesh__D018079 Receptors, GABA
% 220.24/220.45  |- mesh__activeMeSHYear mesh__D018079 2006
% 220.24/220.45  |- skos__altLabel mesh__D018079 gamma-Aminobutyric Acid Receptors
% 220.24/220.45  |- mesh__recordMaintainer mesh__D018079 jmp
% 220.24/220.45  |- mesh__recordAuthorizer mesh__D018079 sjn
% 220.24/220.45  |- skos__hiddenLabel mesh__D018079 gamma Aminobutyric Acid Receptor
% 220.24/220.45  |- rdf__type mesh__D018079sskos__Concept
% 220.24/220.45  |- mesh__historyNote mesh__D018079
% 220.24/220.45       94; GABA RECEPTORS %26% RECEPTORS, GAMMA-AMINOBUTYRIC ACID were see RECEPTORS, GABA-BENZODIAZEPINE 1985-93%A%  
% 220.24/220.46  |- skos__historyNote mesh__D018079
% 220.24/220.46       Receptors, Cell Surface %28%1973-1984%29%
% 220.24/220.46  |- mesh__onlineNote mesh__D018079
% 220.24/220.46       use RECEPTORS, GABA-A to search GABA RECEPTORS %26% RECEPTORS, GAMMA-AMINOBUTYRIC ACID 1985-93%A%  
% 220.24/220.46  |- skos__historyNote mesh__D010096 Sympatholytics %28%1966-1971%29%
% 220.24/220.46  |- skos__prefLabel mesh__D010096 Oxprenolol
% 220.24/220.46  |- mesh__recordMaintainer mesh__D010096 ssb
% 220.24/220.46  |- skos__scopeNote mesh__D010096
% 220.24/220.46       A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.%A%    
% 220.24/220.46  |- mesh__recordOriginator mesh__D010096 NLM
% 220.24/220.46  |- mesh__publicMeSHNote mesh__D010096 73   
% 220.24/220.46  |- mesh__dateRevised mesh__D010096 2005-06-30
% 220.24/220.46  |- skos__hiddenLabel mesh__D010096 Trasicor, Slow
% 220.24/220.46  |- mesh__dateEstablished mesh__D010096 1973-01-01
% 220.24/220.46  |- mesh__dateCreated mesh__D010096 1999-01-01
% 220.24/220.46  |- rdf__type mesh__D010096sskos__Concept
% 220.24/220.46  |- mesh__historyNote mesh__D010096 73%28%72%29%   
% 220.24/220.46  |- skos__historyNote mesh__D010096 Amino Alcohols %28%1966-1971%29%
% 220.24/220.46  |- skos__hiddenLabel mesh__D010096 Hydrochloride, Oxprenolol
% 220.24/220.46  |- skos__altLabel mesh__D010096 Coretal
% 220.24/220.46  |- mesh__recordAuthorizer mesh__D010096 sjn
% 220.24/220.46  |- skos__broader mesh__D010096smesh__D050198
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D010096 2006
% 220.24/220.46  |- skos__broader mesh__D010096smesh__D011412
% 220.24/220.46  |- mesh__recordAuthorizer mesh__D004857 sjn
% 220.24/220.46  |- mesh__dateRevised mesh__D004857 2003-07-09
% 220.24/220.46  |- rdf__type mesh__D004857sskos__Concept
% 220.24/220.46  |- skos__prefLabel mesh__D004857 Equilin
% 220.24/220.46  |- mesh__dateCreated mesh__D004857 1974-11-11
% 220.24/220.46  |- skos__scopeNote mesh__D004857
% 220.24/220.46       An estrogenic steroid produced by HORSES. It has a total of four double bonds in the A- and B-ring. High concentration of euilin is found in the URINE of pregnant mares.%A%    
% 220.24/220.46  |- mesh__publicMeSHNote mesh__D004857
% 220.24/220.46       91; was see under 17-KETOSTEROIDS 1975-90   
% 220.24/220.46  |- skos__broader mesh__D004857smesh__D045166
% 220.24/220.46  |- skos__historyNote mesh__D004857 Estranes %28%1973-1974%29%
% 220.24/220.46  |- skos__historyNote mesh__D004857 Hydroxysteroids %28%1974%29%
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D004857 2004
% 220.24/220.46  |- mesh__recordOriginator mesh__D004857 NLM
% 220.24/220.46  |- skos__annotation mesh__D004857 do not confuse with EQUILENIN   
% 220.24/220.46  |- skos__broader mesh__D004857smesh__D015068
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D004857 2005
% 220.24/220.46  |- mesh__recordMaintainer mesh__D004857 lkt
% 220.24/220.46  |- skos__broader mesh__D004857smesh__D004963
% 220.24/220.46  |- skos__historyNote mesh__D004857 17-Ketosteroids %28%1969-1974%29%
% 220.24/220.46  |- mesh__historyNote mesh__D004857
% 220.24/220.46       91%28%75%29%; was see under 17-KETOSTEROIDS 1975-90   
% 220.24/220.46  |- mesh__dateEstablished mesh__D004857 1991-01-01
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D004857 2006
% 220.24/220.46  |- mesh__recordOriginator mesh__D004059 EC
% 220.24/220.46  |- mesh__recordMaintainer mesh__D004059 tjk
% 220.24/220.46  |- mesh__historyNote mesh__D004059
% 220.24/220.46       91%28%80%29%; was see under COMMUNICATION 1980-90   
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D004059 2003
% 220.24/220.46  |- skos__annotation mesh__D004059 no qualif   
% 220.24/220.46  |- skos__prefLabel mesh__D004059 Diffusion of Innovation
% 220.24/220.46  |- mesh__recordAuthorizer mesh__D004059 sjn
% 220.24/220.46  |- mesh__dateEstablished mesh__D004059 1991-01-01
% 220.24/220.46  |- skos__broader mesh__D004059smesh__D003142
% 220.24/220.46  |- rdf__type mesh__D004059sskos__Concept
% 220.24/220.46  |- mesh__dateCreated mesh__D004059 1979-05-31
% 220.24/220.46  |- skos__altLabel mesh__D004059 Innovation Diffusion
% 220.24/220.46  |- skos__related mesh__D004059smesh__D033181
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D004059 2006
% 220.24/220.46  |- mesh__dateRevised mesh__D004059 2002-07-03
% 220.24/220.46  |- mesh__publicMeSHNote mesh__D004059
% 220.24/220.46       91; was see under COMMUNICATION 1980-90   
% 220.24/220.46  |- skos__scopeNote mesh__D004059
% 220.24/220.46       The broad dissemination of new ideas, procedures, techniques, materials, and devices and the degree to which these are accepted and used.%A%    
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D004059 2004
% 220.24/220.46  |- skos__hiddenLabel mesh__D004059 Diffusion, Innovation
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D004059 2005
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542
% 220.24/220.46       Niemann Pick Disease, Acute Neurovisceral Form
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Niemann Pick Disease Type D
% 220.24/220.46  |- skos__related mesh__D009542smesh__D012618
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Deficiency Disease, Sphingomyelinase
% 220.24/220.46  |- skos__altLabel mesh__D009542 Ophthalmoplegia, Supraoptic Vertical
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Niemann-Pick Disease, Classical
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Niemann Pick%27%s Disease Type D
% 220.24/220.46  |- skos__related mesh__D009542smesh__D013108
% 220.24/220.46  |- skos__altLabel mesh__D009542 Neimann-Pick Disease
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Niemann Pick Disease, Type E
% 220.24/220.46  |- rdf__type mesh__D009542sskos__Concept
% 220.24/220.46  |- skos__altLabel mesh__D009542
% 220.24/220.46       Niemann-Pick Disease, Adult Non-Neuronopathic
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Neimann Pick Disease
% 220.24/220.46  |- skos__altLabel mesh__D009542 Niemann-Pick%27%s Disease Type A
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Niemann Pick Diseases
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D009542 2006
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Niemann Pick Disease, Neuronopathic Type
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Supraoptic Vertical Ophthalmoplegias
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Niemann Pick%27%s Disease Type E
% 220.24/220.46  |- skos__altLabel mesh__D009542 Classical Niemann-Pick Disease
% 220.24/220.46  |- skos__altLabel mesh__D009542 Niemann-Pick%27%s Disease Type E
% 220.24/220.46  |- skos__broader mesh__D009542smesh__D013106
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Vertical Ophthalmoplegias, Supraoptic
% 220.24/220.46  |- skos__altLabel mesh__D009542 Niemann-Pick%27%s Disease Type D
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Niemann Pick Disease Type A
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Sphingomyelinase Deficiency Diseases
% 220.24/220.46  |- skos__altLabel mesh__D009542
% 220.24/220.46       Niemann-Pick Disease, Non-Neuronopathic Type
% 220.24/220.46  |- skos__altLabel mesh__D009542 Niemann-Pick Disease, Nova Scotian
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542
% 220.24/220.46       Niemann Pick Disease, Adult Non Neuronopathic
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Niemann Pick Disease, Nova Scotian
% 220.24/220.46  |- skos__altLabel mesh__D009542 Lipidosis, Neuronal Cholesterol
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Neuronal Cholesterol Lipidoses
% 220.24/220.46  |- mesh__recordOriginator mesh__D009542 NLM
% 220.24/220.46  |- skos__prefLabel mesh__D009542 Niemann-Pick Diseases
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Cholesterol Lipidosis, Neuronal
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D009542 2005
% 220.24/220.46  |- skos__altLabel mesh__D009542 Supraoptic Vertical Ophthalmoplegia
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Cholesterol Lipidoses, Neuronal
% 220.24/220.46  |- skos__broader mesh__D009542smesh__D015616
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Niemann Pick%27%s Disease Type A
% 220.24/220.46  |- mesh__dateCreated mesh__D009542 1999-01-01
% 220.24/220.46  |- skos__altLabel mesh__D009542 Niemann-Pick%27%s Disease Type C
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Niemann Pick Disease Type B
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Ophthalmoplegias, Supraoptic Vertical
% 220.24/220.46  |- skos__scopeNote mesh__D009542
% 220.24/220.46       A group of diseases marked by autosomal recessive inheritance and accumulation of sphingomyelin in cells of the RETICULOENDOTHELIAL SYSTEM. They are divided into 5 subtypes: A-E. Type A %28%classic infantile form%29% is caused by a deficiency of SPHINGOMYELIN PHOSPHODIESTERASE and presents at age 6-12 months with progressive hepatosplenomegaly and neurologic deterioration. Type B %28%non-neuronopathic form%29% presents in childhood with hepatosplenomegaly and pulmonary infiltrates. Type C %28%chronic neuronopathic form%29% is caused by defective intracellular cholesterol transport and is divided into severe infantile, late infantile, juvenile, and neonatal hepatitis forms. Type D %28%Nova Scotian Variant%29% is phenotypically similar to type C. Type E is an adult non-neuronopathic form. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp101-4%29%%A%    
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Vertical Ophthalmoplegia, Supraoptic
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Niemann Pick%27%s Disease Type B
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D009542 2004
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Lipidoses, Neuronal Cholesterol
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542
% 220.24/220.46       Niemann Pick Disease, Acute Neuronopathic Form
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Deficiency Diseases, Sphingomyelinase
% 220.24/220.46  |- mesh__historyNote mesh__D009542 2000%28%1966%29%   
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Niemann Pick Disease, Type C
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Neuronal Cholesterol Lipidosis
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Disease, Sphingomyelinase Deficiency
% 220.24/220.46  |- skos__altLabel mesh__D009542 Niemann-Pick Disease, Neuronopathic Type
% 220.24/220.46  |- mesh__dateRevised mesh__D009542 2001-07-25
% 220.24/220.46  |- mesh__publicMeSHNote mesh__D009542
% 220.24/220.46       2000; see NIEMANN-PICK DISEASE 1966-1999   
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Classical Niemann Pick Disease
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D009542 2002
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Niemann Pick%27%s Disease Type C
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D009542 2003
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Niemann Pick Disease
% 220.24/220.46  |- mesh__recordMaintainer mesh__D009542 nns
% 220.24/220.46  |- skos__altLabel mesh__D009542 Niemann-Pick Disease
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542 Diseases, Sphingomyelinase Deficiency
% 220.24/220.46  |- skos__altLabel mesh__D009542
% 220.24/220.46       Niemann-Pick Disease, Acute Neurovisceral Form
% 220.24/220.46  |- mesh__recordAuthorizer mesh__D009542 sjn
% 220.24/220.46  |- skos__altLabel mesh__D009542 Niemann-Pick%27%s Disease Type B
% 220.24/220.46  |- skos__altLabel mesh__D009542
% 220.24/220.46       Niemann-Pick Disease, Acute Neuronopathic Form
% 220.24/220.46  |- skos__hiddenLabel mesh__D009542
% 220.24/220.46       Niemann Pick Disease, Non Neuronopathic Type
% 220.24/220.46  |- mesh__publicMeSHNote mesh__D014487
% 220.24/220.46       2002; see UNITED STATES HEALTH CARE FINANCING ADMINISTRATION 1992-2001; see UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES 1982-1990%A%  
% 220.24/220.46  |- mesh__recordMaintainer mesh__D014487 sjn
% 220.24/220.46  |- skos__altLabel mesh__D014487 Health Care Financing Administration
% 220.24/220.46  |- skos__altLabel mesh__D014487
% 220.24/220.46       Health Care Financing Administration %28%U.S.%29%
% 220.24/220.46  |- mesh__dateEstablished mesh__D014487 1991-01-01
% 220.24/220.46  |- skos__altLabel mesh__D014487
% 220.24/220.46       Centers for Medicare and Medicaid Services %28%U.S.%29%
% 220.24/220.46  |- skos__broader mesh__D014487smesh__D014483
% 220.24/220.46  |- mesh__recordOriginator mesh__D014487 EC
% 220.24/220.46  |- rdf__type mesh__D014487sskos__Concept
% 220.24/220.46  |- mesh__dateRevised mesh__D014487 2004-07-13
% 220.24/220.46  |- skos__prefLabel mesh__D014487
% 220.24/220.46       United States Centers for Medicare and Medicaid Services
% 220.24/220.46  |- skos__scopeNote mesh__D014487
% 220.24/220.46       A component of the Department of Health and Human Services to oversee and direct the Medicare and Medicaid programs and related Federal medical care quality control staffs. Name was changed effective June 14, 2001.%A%    
% 220.24/220.46  |- mesh__recordAuthorizer mesh__D014487 sjn
% 220.24/220.46  |- mesh__dateCreated mesh__D014487 1981-05-19
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D014487 2006
% 220.24/220.46  |- skos__annotation mesh__D014487
% 220.24/220.46       add UNITED STATES %28%NIM%29%; research support by this agency is checked as OTHER US GOVT SUP; DF: HCFA      CATALOG: use NAF entry%A%  
% 220.24/220.46  |- skos__altLabel mesh__D014487 Centers for Medicare and Medicaid Services
% 220.24/220.46  |- mesh__historyNote mesh__D014487 2002%28%1982%29%   
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D014487 2005
% 220.24/220.46  |- skos__altLabel mesh__D014487
% 220.24/220.46       United States Health Care Financing Administration
% 220.24/220.46  |- mesh__recordMaintainer mesh__D019970 adp
% 220.24/220.46  |- mesh__recordOriginator mesh__D019970 JLS
% 220.24/220.46  |- skos__prefLabel mesh__D019970 Cocaine-Related Disorders
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D019970 2006
% 220.24/220.46  |- skos__hiddenLabel mesh__D019970 Users, Cocaine
% 220.24/220.46  |- skos__broader mesh__D019970smesh__D019966
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D019970 2004
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D019970 2001
% 220.24/220.46  |- skos__hiddenLabel mesh__D019970 Cocaine Related Disorders
% 220.24/220.46  |- mesh__dateEstablished mesh__D019970 1998-01-01
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D019970 2000
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D019970 2005
% 220.24/220.46  |- skos__hiddenLabel mesh__D019970 Dependence, Cocaine
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D019970 2003
% 220.24/220.46  |- mesh__dateCreated mesh__D019970 1997-06-20
% 220.24/220.46  |- rdf__type mesh__D019970sskos__Concept
% 220.24/220.46  |- skos__hiddenLabel mesh__D019970 Cocaine-Related Disorder
% 220.24/220.46  |- mesh__recordAuthorizer mesh__D019970 sjn
% 220.24/220.46  |- mesh__dateRevised mesh__D019970 1999-11-03
% 220.24/220.46  |- skos__hiddenLabel mesh__D019970 Addiction, Cocaine
% 220.24/220.46  |- skos__hiddenLabel mesh__D019970 Dependences, Cocaine
% 220.24/220.46  |- skos__hiddenLabel mesh__D019970 Disorder, Cocaine-Related
% 220.24/220.46  |- skos__hiddenLabel mesh__D019970 User, Cocaine
% 220.24/220.46  |- skos__hiddenLabel mesh__D019970 Abuse, Cocaine
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D019970 2002
% 220.24/220.46  |- mesh__historyNote mesh__D019970 98   
% 220.24/220.46  |- skos__scopeNote mesh__D019970
% 220.24/220.46       Disorders related or resulting from use of cocaine.     
% 220.24/220.46  |- skos__hiddenLabel mesh__D019970 Cocaine User
% 220.24/220.46  |- skos__hiddenLabel mesh__D019970 Disorders, Cocaine-Related
% 220.24/220.46  |- mesh__publicMeSHNote mesh__D019970 98   
% 220.24/220.46  |- skos__annotation mesh__D033641
% 220.24/220.46       X ref PONGAMIA PINNATA: Pongamia unspecified: PONGAMIA see FABACEAE is available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D033641 2003
% 220.24/220.46  |- rdf__type mesh__D033641sskos__Concept
% 220.24/220.46  |- skos__altLabel mesh__D033641 Pongamia pinnata
% 220.24/220.46  |- mesh__dateCreated mesh__D033641 2002-07-03
% 220.24/220.46  |- skos__prefLabel mesh__D033641 Millettia
% 220.24/220.46  |- mesh__publicMeSHNote mesh__D033641 2003   
% 220.24/220.46  |- mesh__historyNote mesh__D033641 2003   
% 220.24/220.46  |- mesh__dateEstablished mesh__D033641 2003-01-01
% 220.24/220.46  |- skos__scopeNote mesh__D033641
% 220.24/220.46       A plant genus of the family FABACEAE. Members contain ISOFLAVONES, some of which show molluscicidal and schistosomicidal activity. Some species of Pongamia have been reclassified to this genus and some to DERRIS.%A%    
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D033641 2006
% 220.24/220.46  |- skos__broader mesh__D033641smesh__D007887
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D033641 2004
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D033641 2005
% 220.24/220.46  |- rdf__type mesh__D019172sskos__Concept
% 220.24/220.46  |- skos__hiddenLabel mesh__D019172 Transplantation Conditionings
% 220.24/220.46  |- mesh__publicMeSHNote mesh__D019172 97   
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D019172 2005
% 220.24/220.46  |- skos__broader mesh__D019172smesh__D007165
% 220.24/220.46  |- skos__prefLabel mesh__D019172 Transplantation Conditioning
% 220.24/220.46  |- mesh__recordAuthorizer mesh__D019172 ags
% 220.24/220.46  |- mesh__dateCreated mesh__D019172 1996-06-10
% 220.24/220.46  |- mesh__recordMaintainer mesh__D019172 ags
% 220.24/220.46  |- skos__hiddenLabel mesh__D019172 Conditionings, Transplantation
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D019172 2002
% 220.24/220.46  |- mesh__dateEstablished mesh__D019172 1997-01-01
% 220.24/220.46  |- mesh__recordOriginator mesh__D019172 AGS
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D019172 1999
% 220.24/220.46  |- skos__altLabel mesh__D019172 Conditioning, Transplantation
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D019172 2001
% 220.24/220.46  |- skos__scopeNote mesh__D019172
% 220.24/220.46       Preparative treatment of transplant recipient with various conditioning regimens including radiation, immune sera, chemotherapy, and/or immunosuppressive agents, prior to transplantation. Transplantation conditioning is very common before bone marrow transplantation.%A%    
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D019172 2004
% 220.24/220.46  |- mesh__dateRevised mesh__D019172 2005-07-15
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D019172 1998
% 220.24/220.46  |- skos__related mesh__D019172smesh__D014180
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D019172 2000
% 220.24/220.46  |- skos__annotation mesh__D019172
% 220.24/220.46       coord IM with organ /transpl %28%IM%29% or precoord organ/transpl term %28%IM%29% %28%e.g., bone marrow transpl conditioning: coord IM with BONE MARROW TRANSPLANTATION %28%IM%29%; hematopoietic stem cell transpl conditioning: coord IM with HEMATOPOIETIC STEM CELL TRANSPLANTATION %28%IM%29% %29%; myeloablative therapy or conditioning goes here; DF: TRANSPL CONDITIONING%A%  
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D019172 2006A
% 220.24/220.46  |- mesh__historyNote mesh__D019172 97   
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D019172 2003
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D019172 2006
% 220.24/220.46  |- mesh__dateEstablished mesh__D005950 1990-01-01
% 220.24/220.46  |- skos__hiddenLabel mesh__D005950 Glucose Hypertonic Solutions
% 220.24/220.46  |- skos__historyNote mesh__D005950 Hypertonic Solutions %28%1969-1974%29%
% 220.24/220.46  |- skos__annotation mesh__D005950
% 220.24/220.46       NIM: no qualif; when IM, use D25-26 qualif; DF: GLUCOSE SOL HYPERTONIC%A%  
% 220.24/220.46  |- mesh__recordMaintainer mesh__D005950 ssb
% 220.24/220.46  |- skos__hiddenLabel mesh__D005950 Solution, Glucose Hypertonic
% 220.24/220.46  |- skos__altLabel mesh__D005950 Hypertonic Solutions, Glucose
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D005950 2004
% 220.24/220.46  |- skos__altLabel mesh__D005950 Glucose Solutions, Hypertonic
% 220.24/220.46  |- mesh__historyNote mesh__D005950
% 220.24/220.46       90%28%75%29%; was see under GLUCOSE 1975-89   
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D005950 2006
% 220.24/220.46  |- skos__hiddenLabel mesh__D005950 Solution, Hypertonic Glucose
% 220.24/220.46  |- skos__scopeNote mesh__D005950
% 220.24/220.46       Solution that is usually 10 percent glucose but may be higher. An isotonic solution of glucose is 5 percent.%A%    
% 220.24/220.46  |- mesh__dateCreated mesh__D005950 1974-11-11
% 220.24/220.46  |- skos__altLabel mesh__D005950 Hypertonic Solution, Glucose
% 220.24/220.46  |- mesh__recordAuthorizer mesh__D005950 sjn
% 220.24/220.46  |- mesh__publicMeSHNote mesh__D005950 90; was see under GLUCOSE 1975-89   
% 220.24/220.46  |- rdf__type mesh__D005950sskos__Concept
% 220.24/220.46  |- mesh__dateRevised mesh__D005950 2003-07-09
% 220.24/220.46  |- skos__historyNote mesh__D005950 Glucose %28%1969-1974%29%
% 220.24/220.46  |- skos__altLabel mesh__D005950 Hypertonic Glucose Solution
% 220.24/220.46  |- skos__prefLabel mesh__D005950 Glucose Solution, Hypertonic
% 220.24/220.46  |- skos__hiddenLabel mesh__D005950 Glucose Hypertonic Solution
% 220.24/220.46  |- mesh__recordOriginator mesh__D005950 NLM
% 220.24/220.46  |- skos__broader mesh__D005950smesh__D006982
% 220.24/220.46  |- skos__hiddenLabel mesh__D005950 Solutions, Hypertonic Glucose
% 220.24/220.46  |- skos__hiddenLabel mesh__D005950 Solutions, Glucose Hypertonic
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D005950 2005
% 220.24/220.46  |- skos__hiddenLabel mesh__D005950 Hypertonic Glucose Solutions
% 220.24/220.46  |- mesh__dateRevised mesh__D005152 2001-07-25
% 220.24/220.46  |- skos__hiddenLabel mesh__D005152 Muscles, Facial
% 220.24/220.46  |- skos__hiddenLabel mesh__D005152 Muscle, Facial
% 220.24/220.46  |- skos__hiddenLabel mesh__D005152 Facial Muscle
% 220.24/220.46  |- skos__related mesh__D005152smesh__D020247
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D005152 2006
% 220.24/220.46  |- skos__hiddenLabel mesh__D005152 Muscles, Mimetic
% 220.24/220.46  |- mesh__publicMeSHNote mesh__D005152 65   
% 220.24/220.46  |- skos__hiddenLabel mesh__D005152 Muscle, Mimetic
% 220.24/220.46  |- skos__broader mesh__D005152smesh__D013284
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D005152 2005
% 220.24/220.46  |- mesh__recordAuthorizer mesh__D005152 sjn
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D005152 2002
% 220.24/220.46  |- skos__hiddenLabel mesh__D005152 Mimetic Muscle
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D005152 2004
% 220.24/220.46  |- mesh__dateEstablished mesh__D005152 1965-01-01
% 220.24/220.46  |- mesh__dateCreated mesh__D005152 1999-01-01
% 220.24/220.46  |- skos__broader mesh__D005152smesh__D018482
% 220.24/220.46  |- mesh__historyNote mesh__D005152 65   
% 220.24/220.46  |- skos__annotation mesh__D005152
% 220.24/220.46       /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D005152 2003
% 220.24/220.46  |- mesh__recordOriginator mesh__D005152 NLM
% 220.24/220.46  |- skos__prefLabel mesh__D005152 Facial Muscles
% 220.24/220.46  |- skos__scopeNote mesh__D005152
% 220.24/220.46       Muscles of facial expression or mimetic muscles that include the numerous muscles supplied by the facial nerve that are attached to and move the skin of the face. %28%From Stedman, 25th ed%29%%A%    
% 220.24/220.46  |- rdf__type mesh__D005152sskos__Concept
% 220.24/220.46  |- mesh__recordMaintainer mesh__D005152 nns
% 220.24/220.46  |- mesh__recordAuthorizer mesh__D046569 sjn
% 220.24/220.46  |- mesh__dateCreated mesh__D046569 2004-07-07
% 220.24/220.46  |- skos__broader mesh__D046569smesh__D008465
% 220.24/220.46  |- skos__related mesh__D046569smesh__D013650
% 220.24/220.46  |- skos__broader mesh__D046569smesh__D004847
% 220.24/220.46  |- rdf__type mesh__D046569sskos__Concept
% 220.24/220.46  |- mesh__historyNote mesh__D046569 2005   
% 220.24/220.46  |- skos__broader mesh__D046569smesh__D002628
% 220.24/220.46  |- skos__hiddenLabel mesh__D046569 Cells, Neuroepithelial
% 220.24/220.46  |- skos__hiddenLabel mesh__D046569 Neuroepithelial Cell
% 220.24/220.46  |- mesh__dateEstablished mesh__D046569 2005-01-01
% 220.24/220.46  |- skos__prefLabel mesh__D046569 Neuroepithelial Cells
% 220.24/220.46  |- mesh__recordOriginator mesh__D046569 ags
% 220.24/220.46  |- skos__hiddenLabel mesh__D046569 Cell, Neuroepithelial
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D046569 2006
% 220.24/220.46  |- skos__scopeNote mesh__D046569
% 220.24/220.46       Cells of epithelial origin possessing specialized sensory functions. They include cells that are found in the TASTE BUDS; OLFACTORY MUCOSA; cochlear HAIR CELLS; and NEUROEPITHELIAL BODIES.%A%    
% 220.24/220.46  |- skos__historyNote mesh__D046569 Neurons %28%1972-2004%29%
% 220.24/220.46  |- skos__related mesh__D046569smesh__D009831
% 220.24/220.46  |- mesh__publicMeSHNote mesh__D046569 2005   
% 220.24/220.46  |- mesh__recordMaintainer mesh__D046569 ags
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D046569 2005
% 220.24/220.46  |- skos__historyNote mesh__D046569 Epithelial Cells %28%1968-2004%29%
% 220.24/220.46  |- skos__hiddenLabel mesh__D018878 Buds, Limb
% 220.24/220.46  |- mesh__dateCreated mesh__D018878 1994-12-27
% 220.24/220.46  |- mesh__historyNote mesh__D018878 96   
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D018878 1997
% 220.24/220.46  |- skos__prefLabel mesh__D018878 Limb Bud
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D018878 1999
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D018878 2002
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D018878 1996
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D018878 2004
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D018878 1998
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D018878 2001
% 220.24/220.46  |- skos__hiddenLabel mesh__D018878 Bud, Limb
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D018878 2006
% 220.24/220.46  |- skos__hiddenLabel mesh__D018878 Limb Buds
% 220.24/220.46  |- mesh__publicMeSHNote mesh__D018878 96   
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D018878 2003
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D018878 2000
% 220.24/220.46  |- skos__annotation mesh__D018878
% 220.24/220.46       usually NIM; no qualif when NIM; do not specify limb unless pertinent %26% then probably NIM with /embryol; specify animal %28%NIM%29%%A%  
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D018878 2005
% 220.24/220.46  |- skos__scopeNote mesh__D018878
% 220.24/220.46       A swelling on the trunk of the vertebrate embryo that becomes a limb. Limb bud cultures are used in developmental, organogenesis, morphogenesis, and cell differentiation studies. The limb bud of the chick embryo is most commonly used but mouse and rat limb buds are also used.%A%    
% 220.24/220.46  |- mesh__dateEstablished mesh__D018878 1996-01-01
% 220.24/220.46  |- rdf__type mesh__D018878sskos__Concept
% 220.24/220.46  |- skos__broader mesh__D018878smesh__D004622
% 220.24/220.46  |- skos__annotation mesh__D010895 D25-26 qualif; DF: PIT SEALANTS   
% 220.24/220.46  |- skos__broader mesh__D010895smesh__D003764
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D010895 2002
% 220.24/220.46  |- mesh__historyNote mesh__D010895
% 220.24/220.46       80%28%72%29%; was see under DENTAL MATERIALS 1975-79   
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D010895 1995
% 220.24/220.46  |- mesh__dateCreated mesh__D010895 1999-01-01
% 220.24/220.46  |- mesh__dateRevised mesh__D010895 1994-04-11
% 220.24/220.46  |- skos__altLabel mesh__D010895 Sealants, Dental
% 220.24/220.46  |- skos__hiddenLabel mesh__D010895 Tooth Sealants
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D010895 2006
% 220.24/220.46  |- mesh__publicMeSHNote mesh__D010895
% 220.24/220.46       80; was see under DENTAL MATERIALS 1975-79   
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D010895 1999
% 220.24/220.46  |- skos__altLabel mesh__D010895 Dental Sealants
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D010895 2004
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D010895 1997
% 220.24/220.46  |- mesh__dateEstablished mesh__D010895 1980-01-01
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D010895 2005
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D010895 1998
% 220.24/220.46  |- skos__hiddenLabel mesh__D010895 Fissure Sealants, Pit
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D010895 2003
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D010895 2001
% 220.24/220.46  |- mesh__recordOriginator mesh__D010895 NLM
% 220.24/220.46  |- mesh__recordAuthorizer mesh__D010895 PLS
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D010895 1996
% 220.24/220.46  |- skos__hiddenLabel mesh__D010895 Sealants, Pit Fissure
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D010895 2000
% 220.24/220.46  |- skos__altLabel mesh__D010895 Pit Fissure Sealants
% 220.24/220.46  |- skos__hiddenLabel mesh__D010895 Sealants, Fissure
% 220.24/220.46  |- rdf__type mesh__D010895sskos__Concept
% 220.24/220.46  |- skos__prefLabel mesh__D010895 Pit and Fissure Sealants
% 220.24/220.46  |- skos__historyNote mesh__D010895 Dental Materials %28%1966-1971%29%
% 220.24/220.46  |- skos__scopeNote mesh__D010895
% 220.24/220.46       Agents used to occlude dental enamel pits and fissures in the prevention of dental caries.%A%    
% 220.24/220.46  |- mesh__recordMaintainer mesh__D010895 PXP
% 220.24/220.46  |- mesh__dateEstablished mesh__D051703 2006-01-01
% 220.24/220.46  |- mesh__recordMaintainer mesh__D051703 DRC
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D051703 2006
% 220.24/220.46  |- mesh__recordOriginator mesh__D051703 DRC
% 220.24/220.46  |- skos__prefLabel mesh__D051703 Sp Transcription Factors
% 220.24/220.46  |- skos__hiddenLabel mesh__D051703 Transcription Factors, Sp
% 220.24/220.46  |- mesh__publicMeSHNote mesh__D051703 2006   
% 220.24/220.46  |- mesh__recordAuthorizer mesh__D051703 sjn
% 220.24/220.46  |- skos__broader mesh__D051703smesh__D051741
% 220.24/220.46  |- mesh__dateCreated mesh__D051703 2005-06-30
% 220.24/220.46  |- skos__altLabel mesh__D051703
% 220.24/220.46       Sephacryl Phosphocellulose Transcription Factors
% 220.24/220.46  |- rdf__type mesh__D051703sskos__Concept
% 220.24/220.46  |- mesh__historyNote mesh__D051703 2006   
% 220.24/220.46  |- skos__altLabel mesh__D051703 Specificity Protein Transcription Factors
% 220.24/220.46  |- skos__scopeNote mesh__D051703
% 220.24/220.46       A family of DNA-binding proteins that contain three ZINC FINGERS at their carboxy termini. They are transcription factors that have specificity for GC boxes.%A%    
% 220.24/220.46  |- mesh__dateRevised mesh__D010097 2000-06-22
% 220.24/220.46  |- skos__altLabel mesh__D010097 Oxiclozanidum
% 220.24/220.46  |- mesh__recordMaintainer mesh__D010097 CCR
% 220.24/220.46  |- mesh__dateCreated mesh__D010097 1974-11-19
% 220.24/220.46  |- mesh__recordAuthorizer mesh__D010097 sjn
% 220.24/220.46  |- skos__prefLabel mesh__D010097 Oxyclozanide
% 220.24/220.46  |- rdf__type mesh__D010097sskos__Concept
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D010097 2001
% 220.24/220.46  |- mesh__historyNote mesh__D010097
% 220.24/220.46       91%28%75%29%; was see under SALICYLAMIDES 1975-90   
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D010097 2003
% 220.24/220.46  |- mesh__dateEstablished mesh__D010097 1991-01-01
% 220.24/220.46  |- mesh__recordOriginator mesh__D010097 NLM
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D010097 2005
% 220.24/220.46  |- skos__scopeNote mesh__D010097
% 220.24/220.46       Anthelmintic used in grazing animals for fasciola and cestode infestations.%A%    
% 220.24/220.46  |- skos__broader mesh__D010097smesh__D012458
% 220.24/220.46  |- mesh__publicMeSHNote mesh__D010097
% 220.24/220.46       91; was see under SALICYLAMIDES 1975-90   
% 220.24/220.46  |- skos__historyNote mesh__D010097 Chlorobenzenes %28%1974%29%
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D010097 2004
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D010097 2002
% 220.24/220.46  |- mesh__activeMeSHYear mesh__D010097 2006
% 220.33/220.46  |- skos__historyNote mesh__D010097 Salicylamides %28%1971-1974%29%
% 220.33/220.47  |- mesh__dateCreated mesh__D004858 1974-12-12
% 220.33/220.47  |- skos__annotation mesh__D004858
% 220.33/220.47       infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29%; DF: EHV 3%A%  
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D004858 2003
% 220.33/220.47  |- skos__hiddenLabel mesh__D004858 ECE Viruses
% 220.33/220.47  |- mesh__recordAuthorizer mesh__D004858 sjn
% 220.33/220.47  |- skos__prefLabel mesh__D004858 Herpesvirus 3, Equid
% 220.33/220.47  |- skos__altLabel mesh__D004858 ECE Virus
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D004858 2004
% 220.33/220.47  |- skos__altLabel mesh__D004858 Equine Herpesvirus 3
% 220.33/220.47  |- skos__altLabel mesh__D004858 Coital Exanthema Virus, Equine
% 220.33/220.47  |- mesh__recordMaintainer mesh__D004858 ags
% 220.33/220.47  |- skos__hiddenLabel mesh__D004858 Herpesvirus 3, Equine
% 220.33/220.47  |- skos__broader mesh__D004858smesh__D018140
% 220.33/220.47  |- mesh__historyNote mesh__D004858
% 220.33/220.47       94; was EQUINE COITAL EXANTHEMA VIRUS 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%%A%  
% 220.33/220.47  |- mesh__onlineNote mesh__D004858
% 220.33/220.47       use HERPESVIRUS 3, EQUID to search EQUINE COITAL EXANTHEMA VIRUS 1975-93%A%  
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D004858 2005
% 220.33/220.47  |- skos__altLabel mesh__D004858 EHV-3
% 220.33/220.47  |- mesh__dateRevised mesh__D004858 2001-07-25
% 220.33/220.47  |- skos__scopeNote mesh__D004858
% 220.33/220.47       A species of VARICELLOVIRUS causing coital exanthema in horses.%A%    
% 220.33/220.47  |- mesh__publicMeSHNote mesh__D004858
% 220.33/220.47       94; was EQUINE COITAL EXANTHEMA VIRUS 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%%A%  
% 220.33/220.47  |- mesh__recordOriginator mesh__D004858 NLM
% 220.33/220.47  |- mesh__dateEstablished mesh__D004858 1991-01-01
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D004858 2006
% 220.33/220.47  |- rdf__type mesh__D004858sskos__Concept
% 220.33/220.47  |- skos__altLabel mesh__D004858 Equine coital exanthema virus
% 220.33/220.47  |- skos__altLabel mesh__D004858 Equid herpesvirus 3
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D004858 2002
% 220.33/220.47  |- skos__altLabel mesh__D004858 Herpesvirus 3 %28%alpha%29%, Equine
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D015580 2003
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D015580 1997
% 220.33/220.47  |- skos__altLabel mesh__D015580 Surgery, Mohs
% 220.33/220.47  |- skos__altLabel mesh__D015580 Mohs Micrographic Surgery
% 220.33/220.47  |- skos__prefLabel mesh__D015580 Mohs Surgery
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D015580 1998
% 220.33/220.47  |- skos__hiddenLabel mesh__D015580 Surgery, Moh%27%s
% 220.33/220.47  |- skos__altLabel mesh__D015580 Surgery, Mohs Micrographic
% 220.33/220.47  |- skos__historyNote mesh__D015580 Microsurgery %28%1975-1990%29%
% 220.33/220.47  |- skos__hiddenLabel mesh__D015580 Mohs%27% Micrographic Surgery
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D015580 1993
% 220.33/220.47  |- skos__altLabel mesh__D015580 Micrographic Surgery, Moh%27%s
% 220.33/220.47  |- skos__hiddenLabel mesh__D015580 Surgery, Mohs%27% Micrographic
% 220.33/220.47  |- skos__scopeNote mesh__D015580
% 220.33/220.47       A surgical technique used primarily in the treatment of skin neoplasms, especially basal cell or squamous cell carcinoma of the skin. This procedure is a microscopically controlled excision of cutaneous tumors either after fixation in vivo or after freezing the tissue. Serial examinations of fresh tissue specimens are most frequently done.%A%    
% 220.33/220.47  |- skos__altLabel mesh__D015580 Micrographic Surgery, Mohs%27%
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D015580 2004
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D015580 1994
% 220.33/220.47  |- skos__hiddenLabel mesh__D015580 Mohs%27% Surgery
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D015580 2005
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D015580 1999
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D015580 2000
% 220.33/220.47  |- skos__hiddenLabel mesh__D015580 Moh Micrographic Surgery
% 220.33/220.47  |- skos__hiddenLabel mesh__D015580 Surgery, Moh
% 220.33/220.47  |- mesh__historyNote mesh__D015580 91   
% 220.33/220.47  |- skos__altLabel mesh__D015580 Moh%27%s Surgery
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D015580 1995
% 220.33/220.47  |- skos__historyNote mesh__D015580 Skin Neoplasms/surgery %28%1975-1990%29%
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D015580 2006
% 220.33/220.47  |- skos__altLabel mesh__D015580 Micrographic Surgery, Mohs
% 220.33/220.47  |- skos__altLabel mesh__D015580 Moh%27%s Micrographic Surgery
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D015580 2001
% 220.33/220.47  |- skos__hiddenLabel mesh__D015580 Surgery, Moh Micrographic
% 220.33/220.47  |- skos__altLabel mesh__D015580 Surgery, Moh%27%s Micrographic
% 220.33/220.47  |- skos__altLabel mesh__D015580 Surgery, Mohs%27%
% 220.33/220.47  |- mesh__publicMeSHNote mesh__D015580 91   
% 220.33/220.47  |- skos__broader mesh__D015580smesh__D008866
% 220.33/220.47  |- rdf__type mesh__D015580sskos__Concept
% 220.33/220.47  |- skos__hiddenLabel mesh__D015580 Micrographic Surgery, Moh
% 220.33/220.47  |- mesh__dateCreated mesh__D015580 1990-05-07
% 220.33/220.47  |- skos__hiddenLabel mesh__D015580 Moh Surgery
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D015580 1996
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D015580 1991
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D015580 2002
% 220.33/220.47  |- skos__annotation mesh__D015580
% 220.33/220.47       note spelling: no apostrophe; named for Dr. F.E. Mohs   
% 220.33/220.47  |- mesh__dateEstablished mesh__D015580 1991-01-01
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D015580 1992
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D009543 2005
% 220.33/220.47  |- mesh__dateCreated mesh__D009543 1974-11-11
% 220.33/220.47  |- skos__historyNote mesh__D009543 Dicarboxylic Acids %28%1972-1974%29%
% 220.33/220.47  |- mesh__recordMaintainer mesh__D009543 ssb
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D009543 2004
% 220.33/220.47  |- mesh__dateEstablished mesh__D009543 1984-01-01
% 220.33/220.47  |- skos__altLabel mesh__D009543 Cordipine
% 220.33/220.47  |- mesh__publicMeSHNote mesh__D009543
% 220.33/220.47       84; was see under PYRIDINES 1975-83   
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D009543 2003
% 220.33/220.47  |- mesh__recordOriginator mesh__D009543 NLM
% 220.33/220.47  |- skos__scopeNote mesh__D009543
% 220.33/220.47       A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.%A%    
% 220.33/220.47  |- skos__historyNote mesh__D009543 Nitrobenzenes %28%1972-1974%29%
% 220.33/220.47  |- rdf__type mesh__D009543sskos__Concept
% 220.33/220.47  |- mesh__recordAuthorizer mesh__D009543 sjn
% 220.33/220.47  |- mesh__historyNote mesh__D009543
% 220.33/220.47       84%28%75%29%; was see under PYRIDINES 1975-83   
% 220.33/220.47  |- skos__altLabel mesh__D009543 Korinfar
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D009543 2002
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D009543 2006
% 220.33/220.47  |- skos__prefLabel mesh__D009543 Nifedipine
% 220.33/220.47  |- skos__historyNote mesh__D009543 Pyridines %28%1972-1974%29%
% 220.33/220.47  |- skos__hiddenLabel mesh__D009543 Monohydrochloride, Nifedipine
% 220.33/220.47  |- mesh__dateRevised mesh__D009543 2001-07-25
% 220.33/220.47  |- skos__broader mesh__D009543smesh__D004095
% 220.33/220.47  |- rdf__type mesh__D001560sskos__Concept
% 220.33/220.47  |- skos__altLabel mesh__D001560 Biphenyldiamines
% 220.33/220.47  |- mesh__dateCreated mesh__D001560 1999-01-01
% 220.33/220.47  |- skos__related mesh__D001560smesh__D002273
% 220.33/220.47  |- mesh__dateEstablished mesh__D001560 1977-01-01
% 220.33/220.47  |- skos__altLabel mesh__D001560 Bianilines
% 220.33/220.47  |- skos__broader mesh__D001560smesh__D001713
% 220.33/220.47  |- mesh__historyNote mesh__D001560
% 220.33/220.47       77; was BENZIDINE see under AMINOBIPHENYL COMPOUNDS 1975-76, was BENZIDINE see under BIPHENYL COMPOUNDS 1966-74%A%  
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D001560 2002
% 220.33/220.47  |- skos__prefLabel mesh__D001560 Benzidines
% 220.33/220.47  |- skos__scopeNote mesh__D001560
% 220.33/220.47       Very toxic industrial chemicals. They are absorbed through the skin, causing lethal blood, bladder, liver, and kidney damage and are potent, broad-spectrum carcinogens in most species.%A%    
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D001560 2004
% 220.33/220.47  |- mesh__onlineNote mesh__D001560
% 220.33/220.47       use BENZIDINES to search BENZIDINE 1975-77; use BIPHENYL COMPOUNDS 1966-74%A%  
% 220.33/220.47  |- mesh__recordOriginator mesh__D001560 NLM
% 220.33/220.47  |- mesh__dateRevised mesh__D001560 2000-06-22
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D001560 2003
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D001560 2001
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D001560 2006
% 220.33/220.47  |- mesh__publicMeSHNote mesh__D001560
% 220.33/220.47       77; was BENZIDINE see under AMINOBIPHENYL COMPOUNDS 1975-76, was BENZIDINE see under BIPHENYL COMPOUNDS 1966-74; 3,3%27%-DIAMINOBENZIDINE %26% DIANISIDINE were see under AMINOBIPHENYL COMPOUNDS 1975-76%A%  
% 220.33/220.47  |- mesh__recordAuthorizer mesh__D001560 sjn
% 220.33/220.47  |- mesh__recordMaintainer mesh__D001560 CCR
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D001560 2005
% 220.33/220.47  |- mesh__dateRevised mesh__D014488 1997-06-20
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D014488 1999
% 220.33/220.47  |- skos__broader mesh__D014488smesh__D014492
% 220.33/220.47  |- rdf__type mesh__D014488sskos__Concept
% 220.33/220.47  |- skos__annotation mesh__D014488
% 220.33/220.47       add UNITED STATES %28%NIM%29%; research support by this agency is checked as NIH/PHS SUP; DF: HRSA      CATALOG: use NAF entry%A%  
% 220.33/220.47  |- mesh__recordAuthorizer mesh__D014488 SJN
% 220.33/220.47  |- skos__prefLabel mesh__D014488
% 220.33/220.47       United States Health Resources and Services Administration
% 220.33/220.47  |- mesh__dateEstablished mesh__D014488 1980-01-01
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D014488 1998
% 220.33/220.47  |- skos__altLabel mesh__D014488
% 220.33/220.47       Health Resources and Services Administration %28%U.S.%29%
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D014488 2004
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D014488 2002
% 220.33/220.47  |- skos__altLabel mesh__D014488
% 220.33/220.47       United States Health Resources Administration
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D014488 2006
% 220.33/220.47  |- mesh__recordOriginator mesh__D014488 EC
% 220.33/220.47  |- mesh__dateCreated mesh__D014488 1978-05-10
% 220.33/220.47  |- skos__altLabel mesh__D014488
% 220.33/220.47       Health Resources Administration %28%U.S.%29%
% 220.33/220.47  |- skos__scopeNote mesh__D014488
% 220.33/220.47       A component of the PUBLIC HEALTH SERVICE that provides leadership related to the delivery of health services and the requirements for and distribution of health resources, including manpower training.%A%    
% 220.33/220.47  |- mesh__historyNote mesh__D014488
% 220.33/220.47       84; was UNITED STATES HEALTH RESOURCES ADMINISTRATION 1980-83; was see under UNITED STATES PUBLIC HEALTH SERVICE 1979%A%  
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D014488 2003
% 220.33/220.47  |- skos__altLabel mesh__D014488
% 220.33/220.47       Health Resources and Services Administration
% 220.33/220.47  |- mesh__onlineNote mesh__D014488
% 220.33/220.47       use UNITED STATES HEALTH RESOURCES AND SERVICES ADMINISTRATION to search UNITED STATES HEALTH RESOURCES ADMINISTRATION 1979-83%A%  
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D014488 2001
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D014488 2005
% 220.33/220.47  |- mesh__publicMeSHNote mesh__D014488
% 220.33/220.47       84; was UNITED STATES HEALTH RESOURCES ADMINISTRATION 1980-83; was see under UNITED STATES PUBLIC HEALTH SERVICE 1979%A%  
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D014488 2000
% 220.33/220.47  |- mesh__recordMaintainer mesh__D014488 PXP
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D000468 1998
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D000468 2000
% 220.33/220.47  |- skos__scopeNote mesh__D000468
% 220.33/220.47       Usually a hydroxide of lithium, sodium, potassium, rubidium or cesium, but also the carbonates of these metals, ammonia, and the amines. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D000468 2003
% 220.33/220.47  |- mesh__recordAuthorizer mesh__D000468 PLS
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D000468 1997
% 220.33/220.47  |- rdf__type mesh__D000468sskos__Concept
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D000468 1996
% 220.33/220.47  |- skos__prefLabel mesh__D000468 Alkalies
% 220.33/220.47  |- skos__altLabel mesh__D000468 Alkali
% 220.33/220.47  |- skos__annotation mesh__D000468
% 220.33/220.47       singular form is %22%alkali%22%; /adv eff: consider also MILK-ALKALI SYNDROME see HYPERCALCEMIA%A%  
% 220.33/220.47  |- skos__related mesh__D000468smesh__D006934
% 220.33/220.47  |- skos__altLabel mesh__D000468 Alkalis
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D000468 2006
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D000468 2002
% 220.33/220.47  |- mesh__dateCreated mesh__D000468 1999-01-01
% 220.33/220.47  |- mesh__recordOriginator mesh__D000468 NLM
% 220.33/220.47  |- mesh__dateRevised mesh__D000468 1993-06-04
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D000468 1995
% 220.33/220.47  |- mesh__recordMaintainer mesh__D000468 TPW
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D000468 2005
% 220.33/220.47  |- skos__broader mesh__D000468smesh__D007287
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D000468 1999
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D000468 2001
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D000468 1994
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D000468 2004
% 220.33/220.47  |- mesh__dateRevised mesh__D011190 2003-07-09
% 220.33/220.47  |- mesh__recordMaintainer mesh__D011190 ssb
% 220.33/220.47  |- skos__broader mesh__D011190smesh__D017680
% 220.33/220.47  |- rdf__type mesh__D011190sskos__Concept
% 220.33/220.47  |- mesh__publicMeSHNote mesh__D011190 91; was see under CYANIDES 1979-90   
% 220.33/220.47  |- skos__scopeNote mesh__D011190
% 220.33/220.47       A highly poisonous compound that is an inhibitor of many metabolic processes, but has been shown to be an especially potent inhibitor of heme enzymes and hemeproteins. It is used in many industrial processes.%A%    
% 220.33/220.47  |- mesh__dateCreated mesh__D011190 1978-03-13
% 220.33/220.47  |- mesh__historyNote mesh__D011190
% 220.33/220.47       91%28%79%29%; was see under CYANIDES 1979-90   
% 220.33/220.47  |- skos__hiddenLabel mesh__D011190 Cyanide, Potassium
% 220.33/220.47  |- skos__broader mesh__D011190smesh__D003486
% 220.33/220.47  |- skos__historyNote mesh__D011190 Potassium %28%1966-1978%29%
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D011190 2005
% 220.33/220.47  |- skos__prefLabel mesh__D011190 Potassium Cyanide
% 220.33/220.47  |- mesh__recordAuthorizer mesh__D011190 sjn
% 220.33/220.47  |- mesh__recordOriginator mesh__D011190 RLS
% 220.33/220.47  |- mesh__dateEstablished mesh__D011190 1991-01-01
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D011190 2006
% 220.33/220.47  |- skos__historyNote mesh__D011190 Cyanides %28%1966-1978%29%
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D011190 2004
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D005951 2004
% 220.33/220.47  |- skos__hiddenLabel mesh__D005951 Glucose Tolerance, Oral
% 220.33/220.47  |- mesh__recordOriginator mesh__D005951 NLM
% 220.33/220.47  |- skos__prefLabel mesh__D005951 Glucose Tolerance Test
% 220.33/220.47  |- skos__annotation mesh__D005951 NIM   
% 220.33/220.47  |- mesh__recordMaintainer mesh__D005951 lkt
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D005951 2006
% 220.33/220.47  |- skos__hiddenLabel mesh__D005951 Glucose Tolerance Tests
% 220.33/220.47  |- skos__scopeNote mesh__D005951
% 220.33/220.47       A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake %28%75 or 100 g%29% or intravenous infusion %28%0.5 g/kg%29%.%A%    
% 220.33/220.47  |- skos__altLabel mesh__D005951 OGTT
% 220.33/220.47  |- skos__broader mesh__D005951smesh__D003940
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D005951 2005
% 220.33/220.47  |- mesh__dateRevised mesh__D005951 2003-07-09
% 220.33/220.47  |- rdf__type mesh__D005951sskos__Concept
% 220.33/220.47  |- skos__broader mesh__D005951smesh__D001774
% 220.33/220.47  |- mesh__recordAuthorizer mesh__D005951 sjn
% 220.33/220.47  |- skos__altLabel mesh__D005951 Intravenous Glucose Tolerance
% 220.33/220.47  |- mesh__dateCreated mesh__D005951 1999-01-01
% 220.33/220.47  |- skos__altLabel mesh__D005951 Oral Glucose Tolerance
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D005153 2006
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D005153 2002
% 220.33/220.47  |- skos__annotation mesh__D005153
% 220.33/220.47       usually of soft part of face; not for facial bone neopl %28% = FACIAL BONES %28%IM%29% + SKULL NEOPLASMS %28%IM%29% %29%; HEAD AND NECK NEOPLASMS is also available; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with site %28%NIM%29% as merely locational + histol type of neopl %28%IM%29%%A%  
% 220.33/220.47  |- skos__hiddenLabel mesh__D005153 Neoplasm, Facial
% 220.33/220.47  |- mesh__recordMaintainer mesh__D005153 KEV
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D005153 2005
% 220.33/220.47  |- mesh__dateRevised mesh__D005153 1995-06-08
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D005153 1999
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D005153 2001
% 220.33/220.47  |- mesh__recordOriginator mesh__D005153 NLM
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D005153 2004
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D005153 2000
% 220.33/220.47  |- mesh__dateCreated mesh__D005153 1999-01-01
% 220.33/220.47  |- skos__prefLabel mesh__D005153 Facial Neoplasms
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D005153 1998
% 220.33/220.47  |- mesh__recordAuthorizer mesh__D005153 PLS
% 220.33/220.47  |- skos__hiddenLabel mesh__D005153 Facial Neoplasm
% 220.33/220.47  |- rdf__type mesh__D005153sskos__Concept
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D005153 2003
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D005153 1997
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D005153 1996
% 220.33/220.47  |- skos__broader mesh__D005153smesh__D006258
% 220.33/220.47  |- skos__hiddenLabel mesh__D005153 Neoplasms, Facial
% 220.33/220.47  |- rdf__type mesh__D018879sskos__Concept
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Complices, Premature Ventricular
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D018879 2003
% 220.33/220.47  |- skos__prefLabel mesh__D018879 Ventricular Premature Complexes
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Beats, Ventricular Ectopic
% 220.33/220.47  |- skos__annotation mesh__D018879 a type of arrhythmia   
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Ventricular Extrasystole
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Complices, Ventricular Premature
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Extrasystoles, Ventricular
% 220.33/220.47  |- skos__altLabel mesh__D018879 Ventricular Premature Complex
% 220.33/220.47  |- mesh__publicMeSHNote mesh__D018879 96   
% 220.33/220.47  |- mesh__recordAuthorizer mesh__D018879 sjn
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Beat, Premature Ventricular
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Ventricular Ectopic Beat
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D018879 2004
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Ventricular Beat, Premature
% 220.33/220.47  |- skos__altLabel mesh__D018879 Ventricular Ectopic Beats
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Beat, Ventricular Ectopic
% 220.33/220.47  |- skos__historyNote mesh__D018879
% 220.33/220.47       Cardiac Complexes, Premature %28%1966-1995%29%
% 220.33/220.47  |- skos__scopeNote mesh__D018879
% 220.33/220.47       Premature contractions of the ventricle, the most common of all arrhythmias. In the absence of heart disease, they are not of great clinical significance, but in patients with coronary disease, they represent a constant danger of ventricular tachycardia or fibrillation and sudden death. The longer-term prognosis for asymptomatic, healthy subjects with frequent and complex ectopy is similar to that for the healthy United States population. %28%From Sokolow, et al., Clinical Cardiology, 5th ed, p491%29%%A%    
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Premature Ventricular Complices
% 220.33/220.47  |- mesh__recordOriginator mesh__D018879 TGC
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Ventricular Complex, Premature
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Complex, Premature Ventricular
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Complexes, Ventricular Premature
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D018879 2000
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Ventricular Premature Complices
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Premature Complices, Ventricular
% 220.33/220.47  |- skos__altLabel mesh__D018879 Premature Ventricular Complex
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Contraction, Premature Ventricular
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Ventricular Beats, Premature
% 220.33/220.47  |- skos__broader mesh__D018879smesh__D005117
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Ventricular Extrasystoles
% 220.33/220.47  |- mesh__dateRevised mesh__D018879 1999-11-03
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Ectopic Beats, Ventricular
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Ectopic Beat, Ventricular
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Premature Ventricular Beat
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Contractions, Premature Ventricular
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Premature Ventricular Contraction
% 220.33/220.47  |- mesh__dateCreated mesh__D018879 1995-06-09
% 220.33/220.47  |- mesh__recordMaintainer mesh__D018879 MCC
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Premature Complexes, Ventricular
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D018879 2001
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Ventricular Contraction, Premature
% 220.33/220.47  |- skos__altLabel mesh__D018879 Extrasystole, Ventricular
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Premature Complex, Ventricular
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D018879 2005
% 220.33/220.47  |- skos__altLabel mesh__D018879 Complex, Ventricular Premature
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Ventricular Complices, Premature
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Ventricular Contractions, Premature
% 220.33/220.47  |- skos__hiddenLabel mesh__D018879 Beats, Premature Ventricular
% 220.33/220.47  |- mesh__historyNote mesh__D018879 96   
% 220.33/220.47  |- skos__altLabel mesh__D018879 Premature Ventricular Beats
% 220.33/220.47  |- skos__altLabel mesh__D018879 Premature Ventricular Contractions
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D018879 2002
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D018879 2006
% 220.33/220.47  |- mesh__dateEstablished mesh__D018879 1996-01-01
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D010896 2004
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D010896 1997
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D010896 2005
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D010896 2000
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D010896 1998
% 220.33/220.47  |- mesh__dateRevised mesh__D010896 1995-06-08
% 220.33/220.47  |- mesh__recordMaintainer mesh__D010896 TGC
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D010896 2003
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D010896 1996
% 220.33/220.47  |- skos__scopeNote mesh__D010896
% 220.33/220.47       An island in Polynesia, in the south Pacific Ocean. It was discovered in 1767 by Philip Carteret, uninhabited until 1790 when settled by mutineers from the English ship, Bounty. The settlement was discovered in 1808; the population was removed temporarily to Tahiti in 1831 and to Norfolk Island %28%between New Caledonia and New Zealand%29% in 1856. Some later returned to Pitcairn and their descendents constitute the present population of this British colony. The island is named for the midshipman who first sighted it from the ship. %28%From Webster%27%s New Geographical Dictionary, 1988, p958 %26% Room, Brewer%27%s Dictionary of Names, 1992, p422%29%%A%    
% 220.33/220.47  |- mesh__dateCreated mesh__D010896 1974-11-11
% 220.33/220.47  |- rdf__type mesh__D010896sskos__Concept
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D010896 2002
% 220.33/220.47  |- skos__broader mesh__D010896smesh__D011114
% 220.33/220.47  |- mesh__dateEstablished mesh__D010896 1975-01-01
% 220.33/220.47  |- skos__annotation mesh__D010896
% 220.33/220.47       an island in Polynesia, settled by the mutineers from the Bounty%A%  
% 220.33/220.47  |- skos__prefLabel mesh__D010896 Pitcairn Island
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D010896 2006
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D010896 2001
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D010896 1999
% 220.33/220.47  |- mesh__recordOriginator mesh__D010896 NLM
% 220.33/220.47  |- mesh__historyNote mesh__D010896 75   
% 220.33/220.47  |- mesh__recordAuthorizer mesh__D010896 PLS
% 220.33/220.47  |- skos__broader mesh__D051704smesh__D051703
% 220.33/220.47  |- mesh__recordOriginator mesh__D051704 DRC
% 220.33/220.47  |- skos__altLabel mesh__D051704 Transcription Factor Sp2
% 220.33/220.47  |- mesh__historyNote mesh__D051704 2006%28%1992%29%   
% 220.33/220.47  |- mesh__dateEstablished mesh__D051704 2006-01-01
% 220.33/220.47  |- mesh__recordMaintainer mesh__D051704 DRC
% 220.33/220.47  |- skos__hiddenLabel mesh__D051704 Transcription Factor, Sp2
% 220.33/220.47  |- skos__scopeNote mesh__D051704
% 220.33/220.47       A ubiquitously expressed Sp transcription factor that binds to the consensus DNA sequence GGGCGGGAC.%A%    
% 220.33/220.47  |- rdf__type mesh__D051704sskos__Concept
% 220.33/220.47  |- mesh__publicMeSHNote mesh__D051704
% 220.33/220.47       2006; SP2 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1992-2005%A%  
% 220.33/220.47  |- mesh__recordAuthorizer mesh__D051704 sjn
% 220.33/220.47  |- skos__altLabel mesh__D051704 Specificity Protein 2 Transcription Factor
% 220.33/220.47  |- skos__prefLabel mesh__D051704 Sp2 Transcription Factor
% 220.33/220.47  |- mesh__dateCreated mesh__D051704 2005-06-30
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D051704 2006
% 220.33/220.47  |- skos__altLabel mesh__D010098 Oxycodeinon
% 220.33/220.47  |- mesh__publicMeSHNote mesh__D010098 91; was see under CODEINE 1976-90   
% 220.33/220.47  |- mesh__recordMaintainer mesh__D010098 ags
% 220.33/220.47  |- rdf__type mesh__D010098sskos__Concept
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D010098 2006A
% 220.33/220.47  |- mesh__recordOriginator mesh__D010098 SH
% 220.33/220.47  |- skos__historyNote mesh__D010098 Morphinans %28%1969-1975%29%
% 220.33/220.47  |- mesh__dateEstablished mesh__D010098 1991-01-01
% 220.33/220.47  |- mesh__historyNote mesh__D010098
% 220.33/220.47       91%28%76%29%; was see under CODEINE 1976-90   
% 220.33/220.47  |- skos__annotation mesh__D010098
% 220.33/220.47       do not confuse OXYCODONE x refs with HYDROCODONE x refs   
% 220.33/220.47  |- mesh__dateCreated mesh__D010098 1975-07-25
% 220.33/220.47  |- skos__prefLabel mesh__D010098 Oxycodone
% 220.33/220.47  |- skos__scopeNote mesh__D010098
% 220.33/220.47       Semisynthetic derivative of CODEINE that acts as a narcotic analgesic more potent and addicting than codeine.%A%    
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D010098 2005
% 220.33/220.47  |- skos__historyNote mesh__D010098 Ethers, Cyclic %28%1974-1975%29%
% 220.33/220.47  |- skos__altLabel mesh__D010098 Dihydrohydroxycodeinone
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D010098 2004
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D010098 2006
% 220.33/220.47  |- mesh__recordAuthorizer mesh__D010098 ags
% 220.33/220.47  |- mesh__dateRevised mesh__D010098 2005-07-18
% 220.33/220.47  |- skos__broader mesh__D010098smesh__D003061
% 220.33/220.47  |- mesh__recordMaintainer mesh__D004859 ags
% 220.33/220.47  |- skos__hiddenLabel mesh__D004859 Anemia, Equine Infectious
% 220.33/220.47  |- rdf__type mesh__D004859sskos__Concept
% 220.33/220.47  |- skos__hiddenLabel mesh__D004859 Fever, Swamp
% 220.33/220.47  |- skos__annotation mesh__D004859
% 220.33/220.47       caused by a lentivirus; don%27%t forget also HORSES %28%NIM%29% %26% check tag ANIMALS; DGF: note short X ref%A%  
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D004859 2005
% 220.33/220.47  |- mesh__recordOriginator mesh__D004859 NLM
% 220.33/220.47  |- skos__broader mesh__D004859smesh__D012897
% 220.33/220.47  |- skos__prefLabel mesh__D004859 Equine Infectious Anemia
% 220.33/220.47  |- skos__broader mesh__D004859smesh__D006734
% 220.33/220.47  |- skos__historyNote mesh__D004859 Virus Diseases %28%1966-1969%29%
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D004859 2004
% 220.33/220.47  |- mesh__publicMeSHNote mesh__D004859 70   
% 220.33/220.47  |- skos__hiddenLabel mesh__D004859 Swamp Fevers
% 220.33/220.47  |- mesh__dateRevised mesh__D004859 2003-07-30
% 220.33/220.47  |- mesh__dateEstablished mesh__D004859 1970-01-01
% 220.33/220.47  |- skos__broader mesh__D004859smesh__D016180
% 220.33/220.47  |- skos__hiddenLabel mesh__D004859 Anemias, Equine Infectious
% 220.33/220.47  |- mesh__recordAuthorizer mesh__D004859 sjn
% 220.33/220.47  |- skos__hiddenLabel mesh__D004859 Infectious Anemia, Equine
% 220.33/220.47  |- mesh__historyNote mesh__D004859 70   
% 220.33/220.47  |- skos__hiddenLabel mesh__D004859 Equine Infectious Anemias
% 220.33/220.47  |- skos__hiddenLabel mesh__D004859 Infectious Anemias, Equine
% 220.33/220.47  |- skos__historyNote mesh__D004859 Horse Diseases %28%1966-1969%29%
% 220.33/220.47  |- skos__scopeNote mesh__D004859
% 220.33/220.47       Viral disease of horses caused by the equine infectious anemia virus %28%EIAV; INFECTIOUS ANEMIA VIRUS, EQUINE%29%. It is characterized by intermittent fever, weakness, and anemia. Chronic infection consists of acute episodes with remissions.%A%    
% 220.33/220.47  |- skos__hiddenLabel mesh__D004859 Fevers, Swamp
% 220.33/220.47  |- skos__altLabel mesh__D004859 Swamp Fever
% 220.33/220.47  |- mesh__dateCreated mesh__D004859 1999-01-01
% 220.33/220.47  |- mesh__activeMeSHYear mesh__D004859 2006
% 220.33/220.47  |- skos__prefLabel mesh__D009544 Niflumic Acid
% 220.33/220.47  |- skos__altLabel mesh__D009544 UPSA Brand 2 of Niflumic Acid
% 220.33/220.48  |- skos__altLabel mesh__D009544 UPSA Brand 1 of Niflumic Acid
% 220.33/220.48  |- skos__altLabel mesh__D009544 Upsamedica Brand of Niflumic Acid
% 220.33/220.48  |- rdf__type mesh__D009544sskos__Concept
% 220.33/220.48  |- skos__historyNote mesh__D009544 Nicotinic Acids %28%1968-1974%29%
% 220.33/220.48  |- skos__scopeNote mesh__D009544
% 220.33/220.48       An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.%A%    
% 220.33/220.48  |- mesh__dateCreated mesh__D009544 1974-11-19
% 220.33/220.48  |- skos__hiddenLabel mesh__D009544 Acid, Niflumic
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D009544 2006
% 220.33/220.48  |- mesh__recordMaintainer mesh__D009544 CCR
% 220.33/220.48  |- mesh__publicMeSHNote mesh__D009544
% 220.33/220.48       91; was see under NICOTINIC ACIDS 1975-90   
% 220.33/220.48  |- mesh__recordOriginator mesh__D009544 NLM
% 220.33/220.48  |- skos__broader mesh__D009544smesh__D009539
% 220.33/220.48  |- mesh__dateRevised mesh__D009544 2004-07-07
% 220.33/220.48  |- skos__historyNote mesh__D009544 Aniline Compounds %28%1972-1974%29%
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D009544 2005
% 220.33/220.48  |- mesh__recordAuthorizer mesh__D009544 sjn
% 220.33/220.48  |- skos__altLabel mesh__D009544 UPSA Conseil Brand of Niflumic Acid
% 220.33/220.48  |- mesh__dateEstablished mesh__D009544 1991-01-01
% 220.33/220.48  |- mesh__historyNote mesh__D009544
% 220.33/220.48       91%28%75%29%; was see under NICOTINIC ACIDS 1975-90   
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D001561 1994
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D001561 2004
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D001561 2001
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D001561 2003
% 220.33/220.48  |- mesh__recordAuthorizer mesh__D001561 PLS
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D001561 2000
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D001561 2006
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D001561 1997
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D001561 2005
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D001561 1993
% 220.33/220.48  |- skos__broader mesh__D001561smesh__D004158
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D001561 1996
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D001561 2002
% 220.33/220.48  |- rdf__type mesh__D001561sskos__Concept
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D001561 1999
% 220.33/220.48  |- mesh__dateCreated mesh__D001561 1999-01-01
% 220.33/220.48  |- mesh__dateRevised mesh__D001561 1992-05-08
% 220.33/220.48  |- skos__prefLabel mesh__D001561 Benzilates
% 220.33/220.48  |- mesh__recordMaintainer mesh__D001561 TGC
% 220.33/220.48  |- mesh__recordOriginator mesh__D001561 NLM
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D001561 1995
% 220.33/220.48  |- skos__broader mesh__D001561smesh__D006880
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D001561 1998
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D014489 1999
% 220.33/220.48  |- mesh__dateRevised mesh__D014489 1997-06-20
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D014489 2001
% 220.33/220.48  |- skos__altLabel mesh__D014489
% 220.33/220.48       Occupational Safety and Health Administration %28%U.S.%29%
% 220.33/220.48  |- rdf__type mesh__D014489sskos__Concept
% 220.33/220.48  |- mesh__recordAuthorizer mesh__D014489 SJN
% 220.33/220.48  |- skos__altLabel mesh__D014489
% 220.33/220.48       Occupational Safety, Health Administration, United States
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D014489 2003
% 220.33/220.48  |- skos__altLabel mesh__D014489
% 220.33/220.48       Occupational Safety and Health Administration
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D014489 2005
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D014489 2004
% 220.33/220.48  |- skos__annotation mesh__D014489
% 220.33/220.48       add UNITED STATES %28%NIM%29%; research support by this agency is checked as OTHER US GOVT SUP; DF: OSHA      CATALOG: use NAF entry%A%  
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D014489 2002
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D014489 2006
% 220.33/220.48  |- mesh__recordOriginator mesh__D014489 EC
% 220.33/220.48  |- mesh__dateCreated mesh__D014489 1981-02-26
% 220.33/220.48  |- mesh__historyNote mesh__D014489 82   
% 220.33/220.48  |- skos__prefLabel mesh__D014489
% 220.33/220.48       United States Occupational Safety and Health Administration
% 220.33/220.48  |- skos__altLabel mesh__D014489
% 220.33/220.48       United States Occupational Safety, Health Administration
% 220.33/220.48  |- mesh__publicMeSHNote mesh__D014489 82   
% 220.33/220.48  |- skos__historyNote mesh__D014489 Government Agencies %28%1968-1981%29%
% 220.33/220.48  |- skos__broader mesh__D014489smesh__D006077
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D014489 1998
% 220.33/220.48  |- skos__scopeNote mesh__D014489
% 220.33/220.48       An office in the Department of Labor responsible for developing and establishing occupational safety and health standards.%A%    
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D014489 2000
% 220.33/220.48  |- mesh__dateEstablished mesh__D014489 1982-01-01
% 220.33/220.48  |- mesh__recordMaintainer mesh__D014489 PXP
% 220.33/220.48  |- skos__hiddenLabel mesh__D019174 Signal Transductions, Light
% 220.33/220.48  |- skos__hiddenLabel mesh__D019174 Light Signal Transductions
% 220.33/220.48  |- skos__altLabel mesh__D019174 Light Signal Transduction
% 220.33/220.48  |- mesh__recordAuthorizer mesh__D019174 sjn
% 220.33/220.48  |- mesh__dateEstablished mesh__D019174 1997-01-01
% 220.33/220.48  |- skos__altLabel mesh__D019174 Visual Transduction
% 220.33/220.48  |- skos__broader mesh__D019174smesh__D015398
% 220.33/220.48  |- skos__hiddenLabel mesh__D019174 Phototransductions
% 220.33/220.48  |- skos__annotation mesh__D019174
% 220.33/220.48       %22%transducing of light energy to afferent nerve impulses%22%   
% 220.33/220.48  |- skos__prefLabel mesh__D019174 Phototransduction
% 220.33/220.48  |- mesh__recordMaintainer mesh__D019174 nns
% 220.33/220.48  |- skos__historyNote mesh__D019174
% 220.33/220.48       Photoreceptors/physiology %28%1966-1996%29%
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D019174 2005
% 220.33/220.48  |- skos__hiddenLabel mesh__D019174 Visual Transductions
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D019174 2004
% 220.33/220.48  |- skos__historyNote mesh__D019174 Signal Transduction %28%1989-1996%29%
% 220.33/220.48  |- mesh__historyNote mesh__D019174 97   
% 220.33/220.48  |- mesh__publicMeSHNote mesh__D019174 97   
% 220.33/220.48  |- skos__related mesh__D019174smesh__D020419
% 220.33/220.48  |- mesh__activeMeSHYear mesh__D019174 2006
% 220.34/220.48  |- skos__scopeNote mesh__D019174
% 220.34/220.48       The transducing of light energy to afferent nerve impulses, such as takes place in the retinal rods and cones. After light photons are absorbed by the photopigments, the signal is transmitted to the outer segment membrane by the cyclic GMP second messenger system, where it closes the sodium channels. This channel gating ultimately generates an action potential in the inner retina.%A%    
% 220.34/220.48  |- mesh__recordOriginator mesh__D019174 AGS
% 220.34/220.48  |- rdf__type mesh__D019174sskos__Concept
% 220.34/220.48  |- skos__altLabel mesh__D019174 Signal Transduction, Light
% 220.34/220.48  |- mesh__dateRevised mesh__D019174 2003-07-09
% 220.34/220.48  |- mesh__dateCreated mesh__D019174 1996-06-10
% 220.34/220.48  |- skos__broader mesh__D019174smesh__D043723
% 220.34/220.48  |- skos__related mesh__D019174smesh__D010786
% 220.34/220.48  |- mesh__recordOriginator mesh__D000469 NLM
% 220.34/220.48  |- skos__annotation mesh__D000469 /defic: consider also HYPOPHOSPHATASIA   
% 220.34/220.48  |- mesh__recordAuthorizer mesh__D000469 sjn
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D000469 2006
% 220.34/220.48  |- mesh__dateCreated mesh__D000469 1999-01-01
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D000469 2005
% 220.34/220.48  |- skos__broader mesh__D000469smesh__D010744
% 220.34/220.48  |- mesh__publicMeSHNote mesh__D000469
% 220.34/220.48       /blood was BLOOD ALKALINE PHOSPHATASE 1963-67   
% 220.34/220.48  |- mesh__dateRevised mesh__D000469 2003-07-09
% 220.34/220.48  |- skos__scopeNote mesh__D000469
% 220.34/220.48       An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.%A%    
% 220.34/220.48  |- mesh__onlineNote mesh__D000469
% 220.34/220.48       use ALKALINE PHOSPHATASE to search BLOOD ALKALINE PHOSPHATASE 1966-67%A%  
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D000469 2004
% 220.34/220.48  |- skos__prefLabel mesh__D000469 Alkaline Phosphatase
% 220.34/220.48  |- rdf__type mesh__D000469sskos__Concept
% 220.34/220.48  |- skos__related mesh__D000469smesh__D007014
% 220.34/220.48  |- mesh__historyNote mesh__D000469
% 220.34/220.48       /blood was BLOOD ALKALINE PHOSPHATASE 1963-67   
% 220.34/220.48  |- mesh__recordMaintainer mesh__D000469 ssb
% 220.34/220.48  |- mesh__recordAuthorizer mesh__D011191 sjn
% 220.34/220.48  |- rdf__type mesh__D011191sskos__Concept
% 220.34/220.48  |- skos__prefLabel mesh__D011191 Potassium Deficiency
% 220.34/220.48  |- skos__hiddenLabel mesh__D011191 Deficiencies, Potassium
% 220.34/220.48  |- mesh__recordMaintainer mesh__D011191 lkt
% 220.34/220.48  |- skos__related mesh__D011191smesh__D007008
% 220.34/220.48  |- mesh__dateCreated mesh__D011191 1999-01-01
% 220.34/220.48  |- mesh__recordOriginator mesh__D011191 NLM
% 220.34/220.48  |- skos__broader mesh__D011191smesh__D003677
% 220.34/220.48  |- skos__hiddenLabel mesh__D011191 Potassium Deficiencies
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D011191 2005
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D011191 2006
% 220.34/220.48  |- skos__scopeNote mesh__D011191
% 220.34/220.48       A condition due to decreased dietary intake of potassium, as in starvation or failure to administer in intravenous solutions, or to gastrointestinal loss in diarrhea, chronic laxative abuse, vomiting, gastric suction, or bowel diversion. Severe potassium deficiency may produce muscular weakness and lead to paralysis and respiratory failure. Muscular malfunction may result in hypoventilation, paralytic ileus, hypotension, muscle twitches, tetany, and rhabomyolysis. Nephropathy from potassium deficit impairs the concentrating mechanism, producing polyuria and decreased maximal urinary concentrating ability with secondary polydipsia. %28%Merck Manual, 16th ed%29%%A%    
% 220.34/220.48  |- skos__hiddenLabel mesh__D011191 Deficiency, Potassium
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D011191 2004
% 220.34/220.48  |- skos__annotation mesh__D011191 DF: POTASSIUM DEFIC   
% 220.34/220.48  |- mesh__dateRevised mesh__D011191 2003-07-09
% 220.34/220.48  |- mesh__recordAuthorizer mesh__D005952 sjn
% 220.34/220.48  |- skos__altLabel mesh__D005952 Glucose-6-Phosphate Phosphohydrolase
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D005952 2006
% 220.34/220.48  |- mesh__recordMaintainer mesh__D005952 ssb
% 220.34/220.48  |- skos__broader mesh__D005952smesh__D010744
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D005952 2005
% 220.34/220.48  |- mesh__recordOriginator mesh__D005952 NLM
% 220.34/220.48  |- mesh__dateRevised mesh__D005952 2003-07-09
% 220.34/220.48  |- skos__scopeNote mesh__D005952
% 220.34/220.48       An enzyme that catalyzes the conversion of D-glucose 6-phosphate and water to D-glucose and orthophosphate. EC 3.1.3.9.%A%    
% 220.34/220.48  |- mesh__onlineNote mesh__D005952
% 220.34/220.48       use GLUCOSE-6-PHOSPHATASE to search GLUCOSEPHOSPHATASE 1966-93%A%  
% 220.34/220.48  |- skos__hiddenLabel mesh__D005952 Glucose 6 Phosphatase
% 220.34/220.48  |- mesh__publicMeSHNote mesh__D005952
% 220.34/220.48       94; was GLUCOSEPHOSPHATASE 1965-93; was GLUCOSE PHOSPHATASES 1964%A%  
% 220.34/220.48  |- rdf__type mesh__D005952sskos__Concept
% 220.34/220.48  |- mesh__historyNote mesh__D005952
% 220.34/220.48       94; was GLUCOSEPHOSPHATASE 1965-93; was GLUCOSE PHOSPHATASES 1964%A%  
% 220.34/220.48  |- mesh__dateCreated mesh__D005952 1999-01-01
% 220.34/220.48  |- skos__altLabel mesh__D005952 Glucose 6-Phosphatase
% 220.34/220.48  |- mesh__dateEstablished mesh__D005952 1965-01-01
% 220.34/220.48  |- skos__prefLabel mesh__D005952 Glucose-6-Phosphatase
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D005952 2004
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D005154 2005
% 220.34/220.48  |- skos__scopeNote mesh__D005154
% 220.34/220.48       The 7th cranial nerve. The facial nerve has two parts, the larger motor root which may be called the facial nerve proper, and the smaller intermediate or sensory root. Together they provide efferent innervation to the muscles of facial expression and to the lacrimal and salivary glands, and convey afferent information for taste from the anterior two-thirds of the tongue and for touch from the external ear.%A%    
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D005154 2004
% 220.34/220.48  |- mesh__dateRevised mesh__D005154 1999-11-03
% 220.34/220.48  |- mesh__dateCreated mesh__D005154 1999-01-01
% 220.34/220.48  |- mesh__recordAuthorizer mesh__D005154 sjn
% 220.34/220.48  |- skos__hiddenLabel mesh__D005154 VIIs, Cranial Nerve
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D005154 2002
% 220.34/220.48  |- skos__prefLabel mesh__D005154 Facial Nerve
% 220.34/220.48  |- rdf__type mesh__D005154sskos__Concept
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D005154 2003
% 220.34/220.48  |- skos__hiddenLabel mesh__D005154 Cranial Nerve VIIs
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D005154 2001
% 220.34/220.48  |- mesh__recordOriginator mesh__D005154 NLM
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D005154 2000
% 220.34/220.48  |- skos__broader mesh__D005154smesh__D003391
% 220.34/220.48  |- skos__hiddenLabel mesh__D005154 Nerve, Facial
% 220.34/220.48  |- skos__altLabel mesh__D005154 Seventh Cranial Nerve
% 220.34/220.48  |- skos__hiddenLabel mesh__D005154 VII, Cranial Nerve
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D005154 2006
% 220.34/220.48  |- skos__hiddenLabel mesh__D005154 Nerve VIIs, Cranial
% 220.34/220.48  |- skos__annotation mesh__D005154
% 220.34/220.48       7th cranial nerve; neopl: coord FACIAL NERVE DISEASES %28%IM%29% + CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 220.34/220.48  |- skos__hiddenLabel mesh__D005154 Cranial Nerve, Seventh
% 220.34/220.48  |- skos__altLabel mesh__D005154 Cranial Nerve VII
% 220.34/220.48  |- skos__hiddenLabel mesh__D005154 Nerve VII, Cranial
% 220.34/220.48  |- skos__hiddenLabel mesh__D005154 Nerve, Seventh Cranial
% 220.34/220.48  |- mesh__recordMaintainer mesh__D005154 KEV
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D010897 1996
% 220.34/220.48  |- mesh__recordMaintainer mesh__D010897 TAP
% 220.34/220.48  |- skos__hiddenLabel mesh__D010897 Pitch Discriminations
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D010897 2001
% 220.34/220.48  |- mesh__recordOriginator mesh__D010897 NLM
% 220.34/220.48  |- skos__annotation mesh__D010897 do not confuse with PITCH PERCEPTION   
% 220.34/220.48  |- mesh__recordAuthorizer mesh__D010897 PLS
% 220.34/220.48  |- rdf__type mesh__D010897sskos__Concept
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D010897 2000
% 220.34/220.48  |- skos__hiddenLabel mesh__D010897 Discriminations, Pitch
% 220.34/220.48  |- skos__hiddenLabel mesh__D010897 Discrimination, Pitch
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D010897 1995
% 220.34/220.48  |- mesh__dateCreated mesh__D010897 1999-01-01
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D010897 1993
% 220.34/220.48  |- skos__broader mesh__D010897smesh__D010898
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D010897 2006
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D010897 2002
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D010897 1999
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D010897 1994
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D010897 2004
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D010897 1997
% 220.34/220.48  |- skos__prefLabel mesh__D010897 Pitch Discrimination
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D010897 2005
% 220.34/220.48  |- mesh__dateRevised mesh__D010897 1992-05-18
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D010897 1998
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D010897 2003
% 220.34/220.48  |- skos__scopeNote mesh__D010897 The ability to differentiate tones.     
% 220.34/220.48  |- skos__broader mesh__D010099smesh__D011412
% 220.34/220.48  |- skos__broader mesh__D010099smesh__D010665
% 220.34/220.48  |- skos__scopeNote mesh__D010099
% 220.34/220.48       A drug used in the treatment of angina pectoris, heart failure, conduction defects, and myocardial infarction. It is a partial agonist at beta adrenergic receptors and acts as a coronary vasodilator and cardiotonic agent.%A%    
% 220.34/220.48  |- mesh__dateEstablished mesh__D010099 1991-01-01
% 220.34/220.48  |- mesh__dateRevised mesh__D010099 2005-06-30
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D010099 2006
% 220.34/220.48  |- skos__prefLabel mesh__D010099 Oxyfedrine
% 220.34/220.48  |- mesh__recordOriginator mesh__D010099 NLM
% 220.34/220.48  |- skos__altLabel mesh__D010099 Oxifedrine
% 220.34/220.48  |- mesh__publicMeSHNote mesh__D010099
% 220.34/220.48       91; was see under PROPIOPHENONES 1975-90   
% 220.34/220.48  |- mesh__historyNote mesh__D010099
% 220.34/220.48       91%28%75%29%; was see under PROPIOPHENONES 1975-90   
% 220.34/220.48  |- skos__historyNote mesh__D010099 Propiophenones %28%1971-1974%29%
% 220.34/220.48  |- skos__broader mesh__D010099smesh__D010627
% 220.34/220.48  |- mesh__recordMaintainer mesh__D010099 ssb
% 220.34/220.48  |- mesh__dateCreated mesh__D010099 1974-11-19
% 220.34/220.48  |- skos__broader mesh__D010099smesh__D011427
% 220.34/220.48  |- skos__altLabel mesh__D010099 Oxiphedrin
% 220.34/220.48  |- rdf__type mesh__D010099sskos__Concept
% 220.34/220.48  |- skos__altLabel mesh__D010099 Oxyphedrin
% 220.34/220.48  |- mesh__recordAuthorizer mesh__D010099 sjn
% 220.34/220.48  |- skos__historyNote mesh__D010099 Propanolamines %28%1974%29%
% 220.34/220.48  |- skos__prefLabel mesh__D051705 Sp3 Transcription Factor
% 220.34/220.48  |- skos__broader mesh__D051705smesh__D051703
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D051705 2006
% 220.34/220.48  |- mesh__dateCreated mesh__D051705 2005-06-30
% 220.34/220.48  |- skos__altLabel mesh__D051705 Specificity Protein 3 Transcription Factor
% 220.34/220.48  |- mesh__recordOriginator mesh__D051705 DRC
% 220.34/220.48  |- skos__altLabel mesh__D051705 Transcription Factor Sp3
% 220.34/220.48  |- mesh__recordMaintainer mesh__D051705 DRC
% 220.34/220.48  |- mesh__publicMeSHNote mesh__D051705
% 220.34/220.48       2006; SP3 TRANSCRIPTION FACTOR  was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1992-2005%A%  
% 220.34/220.48  |- skos__scopeNote mesh__D051705
% 220.34/220.48       A specificity protein transcription factor that regulates expression of a variety of genes including VASCULAR ENDOTHELIAL GROWTH FACTOR and CYCLIN-DEPENDENT KINASE INHIBITOR P27.%A%    
% 220.34/220.48  |- rdf__type mesh__D051705sskos__Concept
% 220.34/220.48  |- mesh__dateEstablished mesh__D051705 2006-01-01
% 220.34/220.48  |- mesh__historyNote mesh__D051705 2006%28%1992%29%   
% 220.34/220.48  |- mesh__recordAuthorizer mesh__D051705 sjn
% 220.34/220.48  |- rdf__type mesh__D009545sskos__Concept
% 220.34/220.48  |- skos__altLabel mesh__D009545 Taurus Brand of Nifuratel
% 220.34/220.48  |- skos__hiddenLabel mesh__D009545 Nifuratel Taurus Brand
% 220.34/220.48  |- skos__altLabel mesh__D009545 Metilmercadon
% 220.34/220.48  |- mesh__recordAuthorizer mesh__D009545 sjn
% 220.34/220.48  |- skos__altLabel mesh__D009545 Methylmercadone
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D009545 2006
% 220.34/220.48  |- skos__broader mesh__D009545smesh__D023303
% 220.34/220.48  |- mesh__dateCreated mesh__D009545 1975-07-25
% 220.34/220.48  |- skos__broader mesh__D009545smesh__D009581
% 220.34/220.48  |- skos__historyNote mesh__D009545 Sulfides %28%1972-1975%29%
% 220.34/220.48  |- skos__altLabel mesh__D009545 Thiodinon
% 220.34/220.48  |- mesh__historyNote mesh__D009545
% 220.34/220.48       91%28%76%29%; was see under NITROFURANS 1976-90   
% 220.34/220.48  |- mesh__dateRevised mesh__D009545 2005-06-30
% 220.34/220.48  |- skos__hiddenLabel mesh__D009545 Nifuratel Italmex Brand
% 220.34/220.48  |- mesh__publicMeSHNote mesh__D009545
% 220.34/220.48       91; was see under NITROFURANS 1976-90   
% 220.34/220.48  |- skos__historyNote mesh__D009545 Nitrofurans %28%1968-1975%29%
% 220.34/220.48  |- mesh__dateEstablished mesh__D009545 1991-01-01
% 220.34/220.48  |- mesh__recordOriginator mesh__D009545 SH
% 220.34/220.48  |- skos__scopeNote mesh__D009545
% 220.34/220.48       Local antiprotozoal and antifungal agent that may also be given orally.%A%    
% 220.34/220.48  |- skos__prefLabel mesh__D009545 Nifuratel
% 220.34/220.48  |- mesh__recordMaintainer mesh__D009545 ssb
% 220.34/220.48  |- skos__historyNote mesh__D009545 Oxazoles %28%1968-1975%29%
% 220.34/220.48  |- skos__altLabel mesh__D009545 Italmex Brand of Nifuratel
% 220.34/220.48  |- mesh__recordOriginator mesh__D001562 NLM
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D001562 2006
% 220.34/220.48  |- skos__scopeNote mesh__D001562
% 220.34/220.48       Compounds with a BENZENE fused to IMIDAZOLES.     
% 220.34/220.48  |- mesh__dateRevised mesh__D001562 2004-07-07
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D001562 2005
% 220.34/220.48  |- mesh__recordAuthorizer mesh__D001562 sjn
% 220.34/220.48  |- skos__related mesh__D001562smesh__D007093
% 220.34/220.48  |- mesh__dateCreated mesh__D001562 1999-01-01
% 220.34/220.48  |- rdf__type mesh__D001562sskos__Concept
% 220.34/220.48  |- skos__prefLabel mesh__D001562 Benzimidazoles
% 220.34/220.48  |- mesh__recordMaintainer mesh__D001562 ssb
% 220.34/220.48  |- skos__broader mesh__D001562smesh__D006574
% 220.34/220.48  |- mesh__historyNote mesh__D019973 98   
% 220.34/220.48  |- mesh__dateRevised mesh__D019973 1999-11-03
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D019973 2000
% 220.34/220.48  |- mesh__dateCreated mesh__D019973 1997-06-20
% 220.34/220.48  |- mesh__recordOriginator mesh__D019973 JLS
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D019973 2006
% 220.34/220.48  |- skos__broader mesh__D019973smesh__D019966
% 220.34/220.48  |- mesh__recordAuthorizer mesh__D019973 sjn
% 220.34/220.48  |- mesh__recordMaintainer mesh__D019973 adp
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D019973 2005
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D019973 2004
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D019973 2002
% 220.34/220.48  |- skos__hiddenLabel mesh__D019973 Alcohol-Related Disorder
% 220.34/220.48  |- skos__hiddenLabel mesh__D019973 Alcohol Related Disorders
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D019973 2003
% 220.34/220.48  |- skos__prefLabel mesh__D019973 Alcohol-Related Disorders
% 220.34/220.48  |- rdf__type mesh__D019973sskos__Concept
% 220.34/220.48  |- skos__scopeNote mesh__D019973
% 220.34/220.48       Disorders related to or resulting from abuse or mis-use of alcohol.%A%    
% 220.34/220.48  |- mesh__publicMeSHNote mesh__D019973 98   
% 220.34/220.48  |- skos__related mesh__D019973smesh__D011604
% 220.34/220.48  |- skos__hiddenLabel mesh__D019973 Disorder, Alcohol-Related
% 220.34/220.48  |- skos__hiddenLabel mesh__D019973 Disorders, Alcohol-Related
% 220.34/220.48  |- mesh__dateEstablished mesh__D019973 1998-01-01
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D019973 2001
% 220.34/220.48  |- mesh__dateEstablished mesh__D011990 1987-01-01
% 220.34/220.48  |- mesh__recordMaintainer mesh__D011990 KEV
% 220.34/220.48  |- skos__hiddenLabel mesh__D011990 Receptor, Transferrin
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D011990 2006
% 220.34/220.48  |- skos__broader mesh__D011990smesh__D033863
% 220.34/220.48  |- mesh__dateRevised mesh__D011990 2002-07-03
% 220.34/220.48  |- mesh__historyNote mesh__D011990 87   
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D011990 2003
% 220.34/220.48  |- skos__historyNote mesh__D011990
% 220.34/220.48       Receptors, Endogenous Substances %28%1973-1986%29%
% 220.34/220.48  |- mesh__recordOriginator mesh__D011990 SH
% 220.34/220.48  |- skos__altLabel mesh__D011990 Transferrin Receptors
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D011990 2004
% 220.34/220.48  |- mesh__publicMeSHNote mesh__D011990 87   
% 220.34/220.48  |- mesh__recordAuthorizer mesh__D011990 sjn
% 220.34/220.48  |- skos__scopeNote mesh__D011990
% 220.34/220.48       Membrane glycoproteins found in high concentrations on iron-utilizing cells. They specifically bind iron-bearing transferrin, are endocytosed with its ligand and then returned to the cell surface where transferrin without its iron is released.%A%    
% 220.34/220.48  |- skos__broader mesh__D011990smesh__D011956
% 220.34/220.48  |- skos__historyNote mesh__D011990 Transferrin %28%1966-1986%29%
% 220.34/220.48  |- skos__altLabel mesh__D011990 Transferrin Receptor
% 220.34/220.48  |- mesh__dateCreated mesh__D011990 1986-03-31
% 220.34/220.48  |- rdf__type mesh__D011990sskos__Concept
% 220.34/220.48  |- skos__annotation mesh__D011990 DF: RECEPT TRANSFERRIN   
% 220.34/220.48  |- skos__prefLabel mesh__D011990 Receptors, Transferrin
% 220.34/220.48  |- skos__related mesh__D011990smesh__D002352
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D011990 2005
% 220.34/220.48  |- mesh__dateCreated mesh__D019175 1996-06-10
% 220.34/220.48  |- skos__related mesh__D019175smesh__D044127
% 220.34/220.48  |- skos__broader mesh__D019175smesh__D008745
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D019175 2005
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D019175 2004
% 220.34/220.48  |- skos__prefLabel mesh__D019175 DNA Methylation
% 220.34/220.48  |- skos__historyNote mesh__D019175 DNA %28%1966-1996%29%
% 220.34/220.48  |- skos__hiddenLabel mesh__D019175 Methylation, DNA
% 220.34/220.48  |- mesh__recordAuthorizer mesh__D019175 sjn
% 220.34/220.48  |- mesh__historyNote mesh__D019175 97   
% 220.34/220.48  |- mesh__dateEstablished mesh__D019175 1997-01-01
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D019175 2006
% 220.34/220.48  |- skos__broader mesh__D019175smesh__D039361
% 220.34/220.48  |- rdf__type mesh__D019175sskos__Concept
% 220.34/220.48  |- mesh__dateRevised mesh__D019175 2003-07-09
% 220.34/220.48  |- mesh__recordMaintainer mesh__D019175 nns
% 220.34/220.48  |- skos__hiddenLabel mesh__D019175 DNA Methylations
% 220.34/220.48  |- skos__related mesh__D019175smesh__D020868
% 220.34/220.48  |- skos__historyNote mesh__D019175 Methylation %28%1966-1996%29%
% 220.34/220.48  |- skos__scopeNote mesh__D019175
% 220.34/220.48       Addition of methyl groups to DNA.  DNA methyltransferases %28%DNA methylases%29% perform this reaction using S-ADENOSYLMETHIONINE as the methyl group donor.%A%    
% 220.34/220.48  |- mesh__publicMeSHNote mesh__D019175 97   
% 220.34/220.48  |- skos__hiddenLabel mesh__D019175 Methylations, DNA
% 220.34/220.48  |- mesh__recordOriginator mesh__D019175 AGS
% 220.34/220.48  |- skos__altLabel mesh__D011192 K2Cr2O7
% 220.34/220.48  |- skos__altLabel mesh__D011192 Potassium Bichromate
% 220.34/220.48  |- mesh__publicMeSHNote mesh__D011192
% 220.34/220.48       91; was see under CHROMATES 1975-90   
% 220.34/220.48  |- mesh__dateCreated mesh__D011192 1974-11-19
% 220.34/220.48  |- mesh__recordAuthorizer mesh__D011192 NLM
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D011192 2006
% 220.34/220.48  |- skos__hiddenLabel mesh__D011192 Dichromate, Potassium
% 220.34/220.48  |- mesh__dateRevised mesh__D011192 2005-07-06
% 220.34/220.48  |- skos__broader mesh__D011192smesh__D002840
% 220.34/220.48  |- skos__hiddenLabel mesh__D011192 Bichromate, Potassium
% 220.34/220.48  |- mesh__dateEstablished mesh__D011192 1991-01-01
% 220.34/220.48  |- mesh__recordMaintainer mesh__D011192 NLM
% 220.34/220.48  |- skos__prefLabel mesh__D011192 Potassium Dichromate
% 220.34/220.48  |- skos__historyNote mesh__D011192 Chromates %28%1969-1974%29%
% 220.34/220.48  |- skos__annotation mesh__D011192
% 220.34/220.48       an astringent, caustic, antiseptic %26% dye   
% 220.34/220.48  |- skos__broader mesh__D011192smesh__D017680
% 220.34/220.48  |- rdf__type mesh__D011192sskos__Concept
% 220.34/220.48  |- skos__scopeNote mesh__D011192
% 220.34/220.48       Chromic acid %28%H2Cr2O7%29%, dipotassium salt. A compound having bright orange-red crystals and used in dyeing, staining, tanning leather, as bleach, oxidizer, depolarizer for dry cells, etc. Medically it has been used externally as an astringent, antiseptic, and caustic. When taken internally, it is a corrosive poison.%A%    
% 220.34/220.48  |- mesh__recordOriginator mesh__D011192 NLM
% 220.34/220.48  |- mesh__historyNote mesh__D011192
% 220.34/220.48       91%28%75%29%; was see under CHROMATES 1975-90   
% 220.34/220.48  |- skos__altLabel mesh__D005953 Von Gierke Disease
% 220.34/220.48  |- skos__altLabel mesh__D005953 Gierke%27%s Disease
% 220.34/220.48  |- mesh__historyNote mesh__D005953
% 220.34/220.48       89; was GLUCOSEPHOSPHATASE DEFICIENCY 1964-88 %28%Prov 1964%29%; VON GIERKE%27%S DISEASE was see GLYCOGENOSIS 1963-64%A%  
% 220.34/220.48  |- skos__hiddenLabel mesh__D005953 Disease, Von Gierke%27%s
% 220.34/220.48  |- rdf__type mesh__D005953sskos__Concept
% 220.34/220.48  |- skos__hiddenLabel mesh__D005953 Gierkes Disease
% 220.34/220.48  |- mesh__activeMeSHYear mesh__D005953 2004
% 220.34/220.49  |- mesh__recordOriginator mesh__D005953 NLM
% 220.34/220.49  |- mesh__dateCreated mesh__D005953 1999-01-01
% 220.34/220.49  |- skos__prefLabel mesh__D005953 Glycogen Storage Disease Type I
% 220.34/220.49  |- mesh__recordMaintainer mesh__D005953 nns
% 220.34/220.49  |- skos__annotation mesh__D005953
% 220.34/220.49       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 220.34/220.49  |- mesh__publicMeSHNote mesh__D005953
% 220.34/220.49       89; was GLUCOSEPHOSPHATASE DEFICIENCY 1964-88 %28%Prov 1964%29%; VON GIERKE%27%S DISEASE was see GLYCOGENOSIS 1963-64%A%  
% 220.34/220.49  |- skos__hiddenLabel mesh__D005953 Glucose 6 Phosphatase Deficiency
% 220.34/220.49  |- skos__hiddenLabel mesh__D005953 Disease, Gierke
% 220.34/220.49  |- mesh__onlineNote mesh__D005953
% 220.34/220.49       use GLYCOGEN STORAGE DISEASE TYPE I to search GLUCOSEPHOSPHATASE DEFICIENCY 1966-88%A%  
% 220.34/220.49  |- skos__hiddenLabel mesh__D005953 Glucosephosphatase Deficiencies
% 220.34/220.49  |- skos__hiddenLabel mesh__D005953 Disease, Gierke%27%s
% 220.34/220.49  |- skos__hiddenLabel mesh__D005953 Deficiencies, Glucose-6-Phosphatase
% 220.34/220.49  |- skos__altLabel mesh__D005953 Glycogenosis 1
% 220.34/220.49  |- skos__altLabel mesh__D005953 Hepatorenal Glycogen Storage Disease
% 220.34/220.49  |- skos__altLabel mesh__D005953 Glucose-6-Phosphatase Deficiency
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D005953 2005
% 220.34/220.49  |- skos__scopeNote mesh__D005953
% 220.34/220.49       An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.%A%    
% 220.34/220.49  |- skos__hiddenLabel mesh__D005953 Deficiency, Glucose-6-Phosphatase
% 220.34/220.49  |- skos__altLabel mesh__D005953 Glucosephosphatase Deficiency
% 220.34/220.49  |- skos__hiddenLabel mesh__D005953 Von Gierkes Disease
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D005953 2006
% 220.34/220.49  |- skos__hiddenLabel mesh__D005953 Disease, Von Gierke
% 220.34/220.49  |- skos__broader mesh__D005953smesh__D006008
% 220.34/220.49  |- skos__hiddenLabel mesh__D005953 Glucose-6-Phosphatase Deficiencies
% 220.34/220.49  |- skos__altLabel mesh__D005953 Deficiency, Glucosephosphatase
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D005953 2002
% 220.34/220.49  |- skos__hiddenLabel mesh__D005953 Deficiencies, Glucosephosphatase
% 220.34/220.49  |- mesh__dateRevised mesh__D005953 2001-07-25
% 220.34/220.49  |- mesh__dateEstablished mesh__D005953 1965-01-01
% 220.34/220.49  |- skos__altLabel mesh__D005953 Gierke Disease
% 220.34/220.49  |- skos__altLabel mesh__D005953 Von Gierke%27%s Disease
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D005953 2003
% 220.34/220.49  |- mesh__recordAuthorizer mesh__D005953 sjn
% 220.34/220.49  |- skos__altLabel mesh__D005155 Cranial Nerve VII Diseases
% 220.34/220.49  |- skos__broader mesh__D005155smesh__D003389
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D005155 2005
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Disorders, Facial Nerve
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Neuropathy, Facial
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Diseases, Facial Nerve
% 220.34/220.49  |- skos__historyNote mesh__D005155
% 220.34/220.49       Peripheral Nerve Diseases %28%1966-1980%29%
% 220.34/220.49  |- skos__altLabel mesh__D005155 Cranial Nerve VII Disorders
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Familial Facial Neuropathies
% 220.34/220.49  |- mesh__dateCreated mesh__D005155 1980-04-04
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Facial Myokymias
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Myokymia, Facial
% 220.34/220.49  |- skos__altLabel mesh__D005155 Motor Disorders, Facial Nerve
% 220.34/220.49  |- mesh__historyNote mesh__D005155 81   
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Facial Nerve Disease
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Geniculate Ganglionitides
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Ganglionitides, Geniculate
% 220.34/220.49  |- skos__altLabel mesh__D005155 Sensory Disorders, Facial Nerve
% 220.34/220.49  |- mesh__dateEstablished mesh__D005155 1981-01-01
% 220.34/220.49  |- mesh__recordMaintainer mesh__D005155 nns
% 220.34/220.49  |- skos__altLabel mesh__D005155 Facial Nerve Disorders
% 220.34/220.49  |- skos__prefLabel mesh__D005155 Facial Nerve Diseases
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D005155 2004
% 220.34/220.49  |- rdf__type mesh__D005155sskos__Concept
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Facial Neuritides
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Ganglionitis, Geniculate
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Neuropathies, Facial
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Neuritides, Facial
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Myokymias, Facial
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Facial Neuropathies, Acquired
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D005155 2003
% 220.34/220.49  |- mesh__publicMeSHNote mesh__D005155 81   
% 220.34/220.49  |- mesh__dateRevised mesh__D005155 2001-07-25
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Neuropathy, Familial Facial
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Facial Neuropathy, Familial
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D005155 2002
% 220.34/220.49  |- skos__scopeNote mesh__D005155
% 220.34/220.49       Diseases of the facial nerve or nuclei. Pontine disorders may affect the facial nuclei or nerve fascicle. The nerve may be involved intracranially, along its course through the petrous portion of the temporal bone, or along its extracranial course. Clinical manifestations include facial muscle weakness, loss of taste from the anterior tongue, hyperacusis, and decreased lacrimation.%A%    
% 220.34/220.49  |- skos__historyNote mesh__D005155 Facial Nerve %28%1966-1980%29%
% 220.34/220.49  |- mesh__recordAuthorizer mesh__D005155 sjn
% 220.34/220.49  |- skos__altLabel mesh__D005155 Seventh Cranial Nerve Diseases
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Disease, Facial Nerve
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Disorder, Facial Nerve
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Facial Neuropathies
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Facial Nerve Disorder
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Facial Neuropathy, Acquired
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D005155 2006
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Facial Neuropathies, Familial
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Acquired Facial Neuropathies
% 220.34/220.49  |- mesh__recordOriginator mesh__D005155 RC
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Neuropathies, Familial Facial
% 220.34/220.49  |- skos__hiddenLabel mesh__D005155 Neuritis, Facial
% 220.34/220.49  |- skos__altLabel mesh__D005155 Facial Neuropathy
% 220.34/220.49  |- skos__annotation mesh__D010898
% 220.34/220.49       do not confuse with PITCH DISCRIMINATION   
% 220.34/220.49  |- mesh__recordAuthorizer mesh__D010898 PLS
% 220.34/220.49  |- rdf__type mesh__D010898sskos__Concept
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D010898 2000
% 220.34/220.49  |- mesh__dateCreated mesh__D010898 1978-12-14
% 220.34/220.49  |- mesh__recordOriginator mesh__D010898 RC
% 220.34/220.49  |- skos__historyNote mesh__D010898 Auditory Perception %28%1967-1979%29%
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D010898 1994
% 220.34/220.49  |- mesh__publicMeSHNote mesh__D010898 80   
% 220.34/220.49  |- skos__historyNote mesh__D010898 Pitch Discrimination %28%1966-1979%29%
% 220.34/220.49  |- mesh__recordMaintainer mesh__D010898 TAP
% 220.34/220.49  |- skos__hiddenLabel mesh__D010898 Perceptions, Pitch
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D010898 2005
% 220.34/220.49  |- mesh__dateRevised mesh__D010898 1992-05-18
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D010898 1998
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D010898 2001
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D010898 1995
% 220.34/220.49  |- skos__prefLabel mesh__D010898 Pitch Perception
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D010898 2003
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D010898 1993
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D010898 1996
% 220.34/220.49  |- skos__hiddenLabel mesh__D010898 Perception, Pitch
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D010898 2006
% 220.34/220.49  |- mesh__historyNote mesh__D010898 80   
% 220.34/220.49  |- skos__historyNote mesh__D010898 Perception %28%1966%29%
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D010898 1999
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D010898 2002
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D010898 2004
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D010898 1997
% 220.34/220.49  |- mesh__dateEstablished mesh__D010898 1980-01-01
% 220.34/220.49  |- skos__broader mesh__D010898smesh__D001307
% 220.34/220.49  |- skos__scopeNote mesh__D010898
% 220.34/220.49       A dimension of auditory sensation varying with cycles per second of the sound stimulus.%A%    
% 220.34/220.49  |- skos__hiddenLabel mesh__D010898 Pitch Perceptions
% 220.34/220.49  |- mesh__publicMeSHNote mesh__D051706
% 220.34/220.49       2006; SP4 TRANSCRIPTION FACTOR was indexed under TRANSCRIPTION FACTORS 1996-2005%A%  
% 220.34/220.49  |- mesh__dateEstablished mesh__D051706 2006-01-01
% 220.34/220.49  |- mesh__recordAuthorizer mesh__D051706 sjn
% 220.34/220.49  |- mesh__recordOriginator mesh__D051706 DRC
% 220.34/220.49  |- mesh__dateCreated mesh__D051706 2005-06-30
% 220.34/220.49  |- skos__altLabel mesh__D051706 Transcription Factor Sp4
% 220.34/220.49  |- rdf__type mesh__D051706sskos__Concept
% 220.34/220.49  |- skos__scopeNote mesh__D051706
% 220.34/220.49       A specificity protein transcription factor that is expressed primarily in the CENTRAL NERVOUS SYSTEM.%A%    
% 220.34/220.49  |- mesh__recordMaintainer mesh__D051706 DRC
% 220.34/220.49  |- skos__broader mesh__D051706smesh__D051703
% 220.34/220.49  |- mesh__historyNote mesh__D051706 2006%28%1996%29%   
% 220.34/220.49  |- skos__altLabel mesh__D051706 Specificity Protein 4 Transcription Factor
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D051706 2006
% 220.34/220.49  |- skos__prefLabel mesh__D051706 Sp4 Transcription Factor
% 220.34/220.49  |- mesh__historyNote mesh__D019974 98   
% 220.34/220.49  |- mesh__dateEstablished mesh__D019974 1998-01-01
% 220.34/220.49  |- skos__historyNote mesh__D019974 Pan troglodytes %28%1972-1997%29%
% 220.34/220.49  |- mesh__publicMeSHNote mesh__D019974 98   
% 220.34/220.49  |- mesh__dateCreated mesh__D019974 1997-06-20
% 220.34/220.49  |- skos__annotation mesh__D019974
% 220.34/220.49       diseases: coordinate IM with APE DISEASES %28%IM%29% + specific disease /vet %28%IM%29%%A%  
% 220.34/220.49  |- mesh__recordMaintainer mesh__D019974 ags
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D019974 2006
% 220.34/220.49  |- skos__altLabel mesh__D019974 Chimpanzee, Pygmy
% 220.34/220.49  |- skos__altLabel mesh__D019974 Pygmy Chimpanzee
% 220.34/220.49  |- skos__prefLabel mesh__D019974 Pan paniscus
% 220.34/220.49  |- skos__hiddenLabel mesh__D019974 paniscus, Pan
% 220.34/220.49  |- skos__altLabel mesh__D019974 Bonobo
% 220.34/220.49  |- rdf__type mesh__D019974sskos__Concept
% 220.34/220.49  |- skos__hiddenLabel mesh__D019974 Bonobos
% 220.34/220.49  |- skos__broader mesh__D019974smesh__D015186
% 220.34/220.49  |- mesh__recordAuthorizer mesh__D019974 sjn
% 220.34/220.49  |- skos__historyNote mesh__D019974 Pongidae %28%1966-1971%29%
% 220.34/220.49  |- skos__hiddenLabel mesh__D019974 Pygmy Chimpanzees
% 220.34/220.49  |- mesh__recordOriginator mesh__D019974 AGS
% 220.34/220.49  |- skos__scopeNote mesh__D019974
% 220.34/220.49       The pygmy chimpanzee, a species of the genus Pan, family HOMINIDAE. Its common name is Bonobo, which was once considered a separate genus by some; others considered it a subspecies of PAN TROGLODYTES. Its range is confined to the forests of the central Zaire basin. Despite its name, it is often of equal size to P. troglodytes.%A%    
% 220.34/220.49  |- skos__hiddenLabel mesh__D019974 Chimpanzees, Pygmy
% 220.34/220.49  |- mesh__dateRevised mesh__D019974 2005-06-30
% 220.34/220.49  |- mesh__dateEstablished mesh__D011991 1979-01-01
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D011991 1997
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D011991 2003
% 220.34/220.49  |- skos__annotation mesh__D011991
% 220.34/220.49       receptor on or within the cell binding the virus; do not confuse X ref PHAGE RECEPTORS with PHAGE ATTACHMENT SITES see ATTACHMENT SITES %28%MICROBIOLOGY%29%; DF: RECEPT VIRUS%A%  
% 220.34/220.49  |- skos__scopeNote mesh__D011991
% 220.34/220.49       Specific molecular components of the cell capable of recognizing and interacting with a virus, and which, after binding it, are capable of generating some signal that initiates the chain of events leading to the biological response.%A%    
% 220.34/220.49  |- skos__altLabel mesh__D011991 Receptors, Phage
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D011991 2000
% 220.34/220.49  |- mesh__recordOriginator mesh__D011991 VDK
% 220.34/220.49  |- mesh__historyNote mesh__D011991 79   
% 220.34/220.49  |- mesh__dateCreated mesh__D011991 1978-05-19
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D011991 2004
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D011991 2001
% 220.34/220.49  |- mesh__recordAuthorizer mesh__D011991 PLS
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D011991 1998
% 220.34/220.49  |- rdf__type mesh__D011991sskos__Concept
% 220.34/220.49  |- mesh__dateRevised mesh__D011991 1995-06-08
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D011991 1999
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D011991 2005
% 220.34/220.49  |- skos__broader mesh__D011991smesh__D011956
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D011991 2002
% 220.34/220.49  |- mesh__recordMaintainer mesh__D011991 KEV
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D011991 2006
% 220.34/220.49  |- mesh__publicMeSHNote mesh__D011991 79   
% 220.34/220.49  |- skos__historyNote mesh__D011991 Binding Sites %28%1968-1978%29%
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D011991 1996
% 220.34/220.49  |- skos__altLabel mesh__D011991 Virus Receptors
% 220.34/220.49  |- skos__prefLabel mesh__D011991 Receptors, Virus
% 220.34/220.49  |- mesh__historyNote mesh__D019176 97   
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D019176 2006
% 220.34/220.49  |- skos__broader mesh__D019176smesh__D010942
% 220.34/220.49  |- rdf__type mesh__D019176sskos__Concept
% 220.34/220.49  |- skos__prefLabel mesh__D019176 Potyviridae
% 220.34/220.49  |- skos__annotation mesh__D019176
% 220.34/220.49       a family of plant viruses; coord IM with specific plant /virol %28%IM or NIM%29%%A%  
% 220.34/220.49  |- skos__scopeNote mesh__D019176
% 220.34/220.49       A family of RNA plant viruses with flexuous, filamentous particles and consisting of three genera: POTYVIRUS, Rymovirus, and Bymovirus. A fourth genus, Ipomovirus, is possible. All members of the family form cytoplasmic cylindrical inclusion bodies during infection.%A%    
% 220.34/220.49  |- mesh__publicMeSHNote mesh__D019176 97   
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D019176 2002
% 220.34/220.49  |- mesh__dateCreated mesh__D019176 1996-06-10
% 220.34/220.49  |- skos__broader mesh__D019176smesh__D012328
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D019176 1997
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D019176 1998
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D019176 2000
% 220.34/220.49  |- mesh__dateEstablished mesh__D019176 1997-01-01
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D019176 2003
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D019176 1999
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D019176 2001
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D019176 2004
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D019176 2005
% 220.34/220.49  |- skos__altLabel mesh__D011193 Rovi Brand of Potassium Iodide
% 220.34/220.49  |- skos__hiddenLabel mesh__D011193 Iodide, Potassium
% 220.34/220.49  |- skos__altLabel mesh__D011193 Merck Brand of Potassium Iodide
% 220.34/220.49  |- skos__altLabel mesh__D011193 W%C3%%B6%rwag Brand of Potassium Iodide
% 220.34/220.49  |- mesh__recordOriginator mesh__D011193 NLM
% 220.34/220.49  |- skos__broader mesh__D011193smesh__D007454
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D011193 2006
% 220.34/220.49  |- skos__scopeNote mesh__D011193
% 220.34/220.49       An inorganic compound that is used as a source of iodine in thyrotoxic crisis and in the preparation of thyrotoxic patients for thyroidectomy. %28%From Dorland, 27th ed%29%%A%    
% 220.34/220.49  |- skos__hiddenLabel mesh__D011193 Jodid ratiopharm
% 220.34/220.49  |- skos__altLabel mesh__D011193 ratiopharm Brand of Potassium Iodide
% 220.34/220.49  |- skos__altLabel mesh__D011193 Upsher-Smith Brand of Potassium Iodide
% 220.34/220.49  |- skos__altLabel mesh__D011193 Fleming Brand of Potassium Iodide
% 220.34/220.49  |- skos__prefLabel mesh__D011193 Potassium Iodide
% 220.34/220.49  |- skos__altLabel mesh__D011193 Antistrumin
% 220.34/220.49  |- skos__hiddenLabel mesh__D011193 Thyro Block
% 220.34/220.49  |- skos__altLabel mesh__D011193 Wallace Brand of Potassium Iodide
% 220.34/220.49  |- rdf__type mesh__D011193sskos__Concept
% 220.34/220.49  |- mesh__dateRevised mesh__D011193 2005-06-30
% 220.34/220.49  |- mesh__historyNote mesh__D011193 65   
% 220.34/220.49  |- skos__altLabel mesh__D011193 Philopharm Brand of Potassium Iodide
% 220.34/220.49  |- mesh__publicMeSHNote mesh__D011193 65   
% 220.34/220.49  |- skos__altLabel mesh__D011193 Merck dura Brand of Potassium Iodide
% 220.34/220.49  |- skos__altLabel mesh__D011193 Thyroprotect
% 220.34/220.49  |- mesh__recordAuthorizer mesh__D011193 sjn
% 220.34/220.49  |- skos__hiddenLabel mesh__D011193 Mono Jod
% 220.34/220.49  |- mesh__dateEstablished mesh__D011193 1965-01-01
% 220.34/220.49  |- skos__altLabel mesh__D011193 betapharm Brand of Potassium Iodide
% 220.34/220.49  |- skos__annotation mesh__D011193
% 220.34/220.49       useful source of iodine in thyrotoxic crisis   
% 220.34/220.49  |- skos__altLabel mesh__D011193 Verla Brand of Potassium Iodide
% 220.34/220.49  |- skos__broader mesh__D011193smesh__D017680
% 220.34/220.49  |- mesh__recordMaintainer mesh__D011193 lkw
% 220.34/220.49  |- mesh__dateCreated mesh__D011193 1999-01-01
% 220.34/220.49  |- skos__altLabel mesh__D011193 Henning Berlin Brand of Potassium Iodide
% 220.34/220.49  |- skos__altLabel mesh__D011193 Hexal Brand of Potassium Iodide
% 220.34/220.49  |- skos__altLabel mesh__D011193 Anbex Brand of Potassium Iodide
% 220.34/220.49  |- rdf__type mesh__D005954sskos__Concept
% 220.34/220.49  |- skos__hiddenLabel mesh__D005954 Dehydrogenase, Glucose-6-Phosphate
% 220.34/220.49  |- mesh__dateCreated mesh__D005954 1999-01-01
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D005954 2004
% 220.34/220.49  |- skos__prefLabel mesh__D005954 Glucosephosphate Dehydrogenase
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D005954 2006
% 220.34/220.49  |- skos__broader mesh__D005954smesh__D002237
% 220.34/220.49  |- skos__altLabel mesh__D005954 Glucose-6-Phosphate Dehydrogenase
% 220.34/220.49  |- mesh__recordAuthorizer mesh__D005954 sjn
% 220.34/220.49  |- skos__hiddenLabel mesh__D005954 Glucose 6 Phosphate Dehydrogenase
% 220.34/220.49  |- skos__annotation mesh__D005954 DF: GPD   
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D005954 2005
% 220.34/220.49  |- mesh__recordMaintainer mesh__D005954 ssb
% 220.34/220.49  |- mesh__dateRevised mesh__D005954 2003-07-09
% 220.34/220.49  |- skos__hiddenLabel mesh__D005954 Dehydrogenase, Glucosephosphate
% 220.34/220.49  |- mesh__recordOriginator mesh__D005954 NLM
% 220.34/220.49  |- skos__hiddenLabel mesh__D005156 Neuralgias, Sphenopalatine
% 220.34/220.49  |- skos__hiddenLabel mesh__D005156 Syndromes, Craniofacial Pain
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D005156 2005
% 220.34/220.49  |- skos__hiddenLabel mesh__D005156 Syndrome, Craniofacial Pain
% 220.34/220.49  |- skos__altLabel mesh__D005156 Facial Pain Syndromes
% 220.34/220.49  |- skos__hiddenLabel mesh__D005156 Craniofacial Pain Syndrome
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D005156 2001
% 220.34/220.49  |- skos__hiddenLabel mesh__D005156 Pain Syndromes, Facial
% 220.34/220.49  |- skos__hiddenLabel mesh__D005156 Myofacial Pain Syndrome
% 220.34/220.49  |- skos__hiddenLabel mesh__D005156 Pain Syndrome, Craniofacial
% 220.34/220.49  |- mesh__recordMaintainer mesh__D005156 KEV
% 220.34/220.49  |- skos__scopeNote mesh__D005156
% 220.34/220.49       Neuralgic syndromes and other conditions which feature chronic or recurrent FACIAL PAIN as the primary manifestation of disease. Disorders of the trigeminal and facial nerves are frequently associated with these conditions.%A%    
% 220.34/220.49  |- skos__hiddenLabel mesh__D005156 Syndromes, Myofacial Pain
% 220.34/220.49  |- skos__prefLabel mesh__D005156 Facial Neuralgia
% 220.34/220.49  |- skos__hiddenLabel mesh__D005156 Pain Syndrome, Facial
% 220.34/220.49  |- skos__hiddenLabel mesh__D005156 Pain Syndromes, Myofacial
% 220.34/220.49  |- skos__hiddenLabel mesh__D005156 Syndrome, Facial Pain
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D005156 2000
% 220.34/220.49  |- skos__related mesh__D005156smesh__D005157
% 220.34/220.49  |- skos__hiddenLabel mesh__D005156 Facial Neuralgias
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D005156 2004
% 220.34/220.49  |- rdf__type mesh__D005156sskos__Concept
% 220.34/220.49  |- skos__broader mesh__D005156smesh__D009059
% 220.34/220.49  |- skos__altLabel mesh__D005156 Craniofacial Pain Syndromes
% 220.34/220.49  |- skos__hiddenLabel mesh__D005156 Sphenopalatine Neuralgias
% 220.34/220.49  |- skos__hiddenLabel mesh__D005156 Neuralgias, Facial
% 220.34/220.49  |- skos__hiddenLabel mesh__D005156 Syndromes, Facial Pain
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D005156 2003
% 220.34/220.49  |- skos__hiddenLabel mesh__D005156 Neuralgia, Sphenopalatine
% 220.34/220.49  |- skos__hiddenLabel mesh__D005156 Pain Syndromes, Craniofacial
% 220.34/220.49  |- mesh__recordOriginator mesh__D005156 NLM
% 220.34/220.49  |- mesh__dateCreated mesh__D005156 1999-01-01
% 220.34/220.49  |- skos__hiddenLabel mesh__D005156 Pain Syndrome, Myofacial
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D005156 2002
% 220.34/220.49  |- mesh__recordAuthorizer mesh__D005156 sjn
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D005156 2006
% 220.34/220.49  |- skos__hiddenLabel mesh__D005156 Facial Pain Syndrome
% 220.34/220.49  |- mesh__dateRevised mesh__D005156 1999-11-03
% 220.34/220.49  |- skos__hiddenLabel mesh__D005156 Syndrome, Myofacial Pain
% 220.34/220.49  |- skos__broader mesh__D005156smesh__D005155
% 220.34/220.49  |- skos__hiddenLabel mesh__D005156 Neuralgia, Facial
% 220.34/220.49  |- skos__broader mesh__D005156smesh__D003389
% 220.34/220.49  |- mesh__recordAuthorizer mesh__D010899 sjn
% 220.34/220.49  |- skos__broader mesh__D010899smesh__D010900
% 220.34/220.49  |- skos__scopeNote mesh__D010899
% 220.34/220.49       The sudden loss of blood supply to the PITUITARY GLAND, leading to tissue NECROSIS and loss of function %28%PANHYPOPITUITARISM%29%. The most common cause is hemorrhage or INFARCTION of a PITUITARY ADENOMA. It can also result from acute hemorrhage into SELLA TURCICA due to HEAD TRAUMA; INTRACRANIAL HYPERTENSION; or other acute effects of central nervous system hemorrhage. Clinical signs include severe HEADACHE; HYPOTENSION; bilateral visual disturbances; UNCONSCIOUSNESS; and COMA.%A%    
% 220.34/220.49  |- mesh__recordOriginator mesh__D010899 VDK
% 220.34/220.49  |- skos__historyNote mesh__D010899 Pituitary Diseases %28%1966-1986%29%
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D010899 2006
% 220.34/220.49  |- mesh__dateRevised mesh__D010899 2005-06-30
% 220.34/220.49  |- mesh__dateCreated mesh__D010899 1986-04-18
% 220.34/220.49  |- mesh__recordMaintainer mesh__D010899 lkt
% 220.34/220.49  |- skos__broader mesh__D010899smesh__D020300
% 220.34/220.49  |- skos__altLabel mesh__D010899 Apoplexy, Pituitary
% 220.34/220.49  |- skos__prefLabel mesh__D010899 Pituitary Apoplexy
% 220.34/220.49  |- mesh__historyNote mesh__D010899 1987   
% 220.34/220.49  |- mesh__publicMeSHNote mesh__D010899 1987   
% 220.34/220.49  |- mesh__dateEstablished mesh__D010899 1987-01-01
% 220.34/220.49  |- skos__historyNote mesh__D010899 Pituitary Neoplasms %28%1966-1986%29%
% 220.34/220.49  |- rdf__type mesh__D010899sskos__Concept
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D009547 2006
% 220.34/220.49  |- skos__historyNote mesh__D009547 Thiazines %28%1973-1974%29%
% 220.34/220.49  |- mesh__recordMaintainer mesh__D009547 ssb
% 220.34/220.49  |- skos__historyNote mesh__D009547 Cyclic S-Oxides %28%1973-1974%29%
% 220.34/220.49  |- mesh__dateCreated mesh__D009547 1974-11-19
% 220.34/220.49  |- skos__broader mesh__D009547smesh__D009581
% 220.34/220.49  |- mesh__dateRevised mesh__D009547 2005-06-30
% 220.34/220.49  |- mesh__historyNote mesh__D009547
% 220.34/220.49       91%28%75%29%; was see under NITROFURANS 1975-90   
% 220.34/220.49  |- skos__prefLabel mesh__D009547 Nifurtimox
% 220.34/220.49  |- skos__hiddenLabel mesh__D009547 2502, Bayer
% 220.34/220.49  |- skos__scopeNote mesh__D009547
% 220.34/220.49       Possibly effective against parasites. Synonyms: Lampit; Bayer 2502.%A%    
% 220.34/220.49  |- skos__historyNote mesh__D009547 Nitrofurans %28%1971-1974%29%
% 220.34/220.49  |- mesh__recordOriginator mesh__D009547 NLM
% 220.34/220.49  |- mesh__publicMeSHNote mesh__D009547
% 220.34/220.49       91; was see under NITROFURANS 1975-90   
% 220.34/220.49  |- rdf__type mesh__D009547sskos__Concept
% 220.34/220.49  |- mesh__recordAuthorizer mesh__D009547 sjn
% 220.34/220.49  |- skos__broader mesh__D009547smesh__D013843
% 220.34/220.49  |- mesh__dateEstablished mesh__D009547 1991-01-01
% 220.34/220.49  |- skos__scopeNote mesh__D001564
% 220.34/220.49       A potent mutagen and carcinogen. It is a public health concern because of its possible effects on industrial workers, as an environmental pollutant, an as a component of tobacco smoke.%A%    
% 220.34/220.49  |- skos__annotation mesh__D001564
% 220.34/220.49       a mutagen %26% carcinogen; D25-26 qualif   
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D001564 2002
% 220.34/220.49  |- mesh__dateCreated mesh__D001564 1984-04-11
% 220.34/220.49  |- mesh__dateEstablished mesh__D001564 1985-01-01
% 220.34/220.49  |- skos__broader mesh__D001564smesh__D001580
% 220.34/220.49  |- skos__altLabel mesh__D001564 3,4-Benzopyrene
% 220.34/220.49  |- skos__hiddenLabel mesh__D001564 3,4 Benzpyrene
% 220.34/220.49  |- skos__hiddenLabel mesh__D001564 3,4 Benzopyrene
% 220.34/220.49  |- rdf__type mesh__D001564sskos__Concept
% 220.34/220.49  |- mesh__recordMaintainer mesh__D001564 adp
% 220.34/220.49  |- mesh__recordOriginator mesh__D001564 RLS
% 220.34/220.49  |- skos__related mesh__D001564smesh__D018383
% 220.34/220.49  |- skos__historyNote mesh__D001564 Benzopyrenes %28%1966-1984%29%
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D001564 2003
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D001564 2004
% 220.34/220.49  |- skos__prefLabel mesh__D001564 Benzo%28%a%29%pyrene
% 220.34/220.49  |- mesh__dateRevised mesh__D001564 1999-11-03
% 220.34/220.49  |- mesh__historyNote mesh__D001564 85   
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D001564 2000
% 220.34/220.49  |- skos__altLabel mesh__D001564 3,4-Benzpyrene
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D001564 2005
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D001564 2001
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D001564 2006
% 220.34/220.49  |- mesh__publicMeSHNote mesh__D001564 85   
% 220.34/220.49  |- mesh__recordAuthorizer mesh__D001564 sjn
% 220.34/220.49  |- skos__hiddenLabel mesh__D028701 Right, Patient%27%s
% 220.34/220.49  |- skos__related mesh__D028701smesh__D026688
% 220.34/220.49  |- skos__altLabel mesh__D028701 Patient%27%s Rights
% 220.34/220.49  |- skos__hiddenLabel mesh__D028701 Rights, Patient%27%s
% 220.34/220.49  |- mesh__publicMeSHNote mesh__D028701
% 220.34/220.49       2002; for PATIENT ADVOCACY 1978-2001; for RIGHT TO TREATMENT see PATIENT ADVOCACY 1978-2001%A%  
% 220.34/220.49  |- skos__hiddenLabel mesh__D028701 Right, Patient
% 220.34/220.49  |- skos__hiddenLabel mesh__D028701 Rights, Patients%27%
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D028701 2004
% 220.34/220.49  |- skos__hiddenLabel mesh__D028701 Patient Right
% 220.34/220.49  |- skos__scopeNote mesh__D028701
% 220.34/220.49       Fundamental claims of patients, as expressed in statutes, declarations, or generally accepted moral principles. %28%Bioethics Thesaurus%29% The term is used for discussions of patient rights as a group of many rights, as in a hospital%27%s posting of a list of patient rights.%A%    
% 220.34/220.49  |- mesh__dateEstablished mesh__D028701 2002-01-01
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D028701 2006
% 220.34/220.49  |- mesh__historyNote mesh__D028701
% 220.34/220.49       2002; use PATIENT ADVOCACY 1978-2001; for RIGHT TO TREATMENT use PATIENT ADVOCACY 1978-2001%A%  
% 220.34/220.49  |- mesh__dateRevised mesh__D028701 2003-07-09
% 220.34/220.49  |- skos__related mesh__D028701smesh__D010344
% 220.34/220.49  |- skos__broader mesh__D028701smesh__D006806
% 220.34/220.49  |- skos__hiddenLabel mesh__D028701 Treatment, Right to
% 220.34/220.49  |- mesh__dateCreated mesh__D028701 2001-07-25
% 220.34/220.49  |- skos__hiddenLabel mesh__D028701 Right, Patients%27%
% 220.34/220.49  |- skos__hiddenLabel mesh__D028701 Patients%27% Right
% 220.34/220.49  |- skos__historyNote mesh__D028701 Patient Advocacy %28%1974-2001%29%
% 220.34/220.49  |- skos__hiddenLabel mesh__D028701 Treatments, Right to
% 220.34/220.49  |- skos__hiddenLabel mesh__D028701 Patient%27%s Right
% 220.34/220.49  |- mesh__activeMeSHYear mesh__D028701 2005
% 220.34/220.49  |- rdf__type mesh__D028701sskos__Concept
% 220.34/220.49  |- skos__hiddenLabel mesh__D028701 Right to Treatments
% 220.34/220.49  |- skos__prefLabel mesh__D028701 Patient Rights
% 220.34/220.49  |- skos__annotation mesh__D028701 GEN or unspecified; prefer specifics   
% 220.34/220.49  |- mesh__recordMaintainer mesh__D028701 tjk
% 220.34/220.49  |- mesh__recordAuthorizer mesh__D028701 sjn
% 220.34/220.49  |- skos__hiddenLabel mesh__D028701 Patients Rights
% 220.34/220.49  |- skos__hiddenLabel mesh__D028701 Rights, Patient
% 220.34/220.49  |- mesh__recordOriginator mesh__D028701 jrf
% 220.34/220.49  |- skos__altLabel mesh__D028701 Patients%27% Rights
% 220.34/220.50  |- mesh__historyNote mesh__D011992 95; was RECEPTOSOMES 1983-94   
% 220.34/220.50  |- skos__annotation mesh__D011992
% 220.34/220.50       cytoplasmic vesicles; A 11 qualif except /cytol; /genet permitted%A%  
% 220.34/220.50  |- rdf__type mesh__D011992sskos__Concept
% 220.34/220.50  |- mesh__recordAuthorizer mesh__D011992 sjn
% 220.34/220.50  |- skos__altLabel mesh__D011992 Receptosomes
% 220.34/220.50  |- mesh__dateRevised mesh__D011992 2003-07-09
% 220.34/220.50  |- mesh__recordMaintainer mesh__D011992 nns
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D011992 2005
% 220.34/220.50  |- mesh__onlineNote mesh__D011992
% 220.34/220.50       use ENDOSOMES to search RECEPTOSOMES 1983-94   
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D011992 2006
% 220.34/220.50  |- mesh__publicMeSHNote mesh__D011992 95; was RECEPTOSOMES 1983-94   
% 220.34/220.50  |- skos__prefLabel mesh__D011992 Endosomes
% 220.34/220.50  |- skos__hiddenLabel mesh__D011992 Endosome
% 220.34/220.50  |- mesh__dateCreated mesh__D011992 1982-04-19
% 220.34/220.50  |- mesh__dateEstablished mesh__D011992 1983-01-01
% 220.34/220.50  |- skos__scopeNote mesh__D011992
% 220.34/220.50       Cytoplasmic vesicles formed when COATED VESICLES shed their CLATHRIN coat. Endosomes internalize macromolecules bound by receptors on the cell surface.%A%    
% 220.34/220.50  |- skos__related mesh__D011992smesh__D004705
% 220.34/220.50  |- skos__hiddenLabel mesh__D011992 Receptosome
% 220.34/220.50  |- mesh__recordOriginator mesh__D011992 AEP
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D011992 2004
% 220.34/220.50  |- skos__broader mesh__D011992smesh__D022162
% 220.34/220.50  |- skos__historyNote mesh__D011992 Endocytosis %28%1973-1982%29%
% 220.34/220.50  |- mesh__recordAuthorizer mesh__D019177 sjn
% 220.34/220.50  |- mesh__recordMaintainer mesh__D019177 ags
% 220.34/220.50  |- skos__broader mesh__D019177smesh__D010942
% 220.34/220.50  |- mesh__dateRevised mesh__D019177 2001-07-25
% 220.34/220.50  |- mesh__publicMeSHNote mesh__D019177 97   
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D019177 2002
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D019177 2003
% 220.34/220.50  |- mesh__dateCreated mesh__D019177 1996-06-10
% 220.34/220.50  |- mesh__recordOriginator mesh__D019177 AGS
% 220.34/220.50  |- skos__scopeNote mesh__D019177
% 220.34/220.50       A family of RNA plant viruses with a wide host range in crops and horticultural species. All viruses are readily transmitted by mechanical means and some by insects and pollen. The genera include: ALFAMOVIRUS; BROMOVIRUS; CUCUMOVIRUS; ILARVIRUS; and OLEAVIRUS.%A%    
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D019177 2004
% 220.34/220.50  |- skos__broader mesh__D019177smesh__D012328
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D019177 2005
% 220.34/220.50  |- skos__prefLabel mesh__D019177 Bromoviridae
% 220.34/220.50  |- skos__annotation mesh__D019177 coord IM with specific plant /virol   
% 220.34/220.50  |- mesh__historyNote mesh__D019177 97   
% 220.34/220.50  |- mesh__dateEstablished mesh__D019177 1997-01-01
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D019177 2006
% 220.34/220.50  |- rdf__type mesh__D019177sskos__Concept
% 220.34/220.50  |- mesh__recordAuthorizer mesh__D011194 sjn
% 220.34/220.50  |- skos__prefLabel mesh__D011194 Potassium Isotopes
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D011194 2004
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D011194 2006
% 220.34/220.50  |- skos__broader mesh__D011194smesh__D007554
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D011194 2003
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D011194 2005
% 220.34/220.50  |- mesh__recordOriginator mesh__D011194 NLM
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D011194 2002
% 220.34/220.50  |- mesh__recordMaintainer mesh__D011194 nns
% 220.34/220.50  |- mesh__dateCreated mesh__D011194 1999-01-01
% 220.34/220.50  |- mesh__dateRevised mesh__D011194 2000-06-22
% 220.34/220.50  |- rdf__type mesh__D011194sskos__Concept
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D011194 2001
% 220.34/220.50  |- skos__hiddenLabel mesh__D011194 Isotopes, Potassium
% 220.34/220.50  |- skos__annotation mesh__D011194 K-41; NIM   
% 220.34/220.50  |- skos__scopeNote mesh__D011194
% 220.34/220.50       Stable potassium atoms that have the same atomic number as the element potassium, but differ in atomic weight. K-41 is a stable potassium isotope.%A%    
% 220.34/220.50  |- skos__hiddenLabel mesh__D005955
% 220.34/220.50       Deficiencies, Glucosephosphate Dehydrogenase
% 220.34/220.50  |- mesh__dateCreated mesh__D005955 1999-01-01
% 220.34/220.50  |- mesh__dateEstablished mesh__D005955 1964-01-01
% 220.34/220.50  |- mesh__publicMeSHNote mesh__D005955 64   
% 220.34/220.50  |- skos__scopeNote mesh__D005955
% 220.34/220.50       A disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of enzyme activity in erythrocytes, leading to hemolytic anemia.%A%    
% 220.34/220.50  |- skos__altLabel mesh__D005955 GPD Deficiency
% 220.34/220.50  |- skos__altLabel mesh__D005955 Deficiency, Glucosephosphate Dehydrogenase
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D005955 2002
% 220.34/220.50  |- mesh__recordMaintainer mesh__D005955 nns
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D005955 2004
% 220.34/220.50  |- skos__prefLabel mesh__D005955 Glucosephosphate Dehydrogenase Deficiency
% 220.34/220.50  |- skos__altLabel mesh__D005955 Glucosephosphate Dehydrogenase Deficiencies
% 220.34/220.50  |- mesh__dateRevised mesh__D005955 2001-07-25
% 220.34/220.50  |- skos__altLabel mesh__D005955 Deficiency, GPD
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D005955 2003
% 220.34/220.50  |- skos__hiddenLabel mesh__D005955
% 220.34/220.50       Dehydrogenase Deficiencies, Glucosephosphate
% 220.34/220.50  |- mesh__recordAuthorizer mesh__D005955 sjn
% 220.34/220.50  |- skos__hiddenLabel mesh__D005955 Deficiencies, GPD
% 220.34/220.50  |- skos__hiddenLabel mesh__D005955 GPD Deficiencies
% 220.34/220.50  |- skos__hiddenLabel mesh__D005955
% 220.34/220.50       Dehydrogenase Deficiency, Glucosephosphate
% 220.34/220.50  |- skos__annotation mesh__D005955
% 220.34/220.50       a congen hemolytic anemia; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: GPD DEFIC%A%  
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D005955 2006
% 220.34/220.50  |- mesh__recordOriginator mesh__D005955 NLM
% 220.34/220.50  |- skos__broader mesh__D005955smesh__D000745
% 220.34/220.50  |- skos__broader mesh__D005955smesh__D008661
% 220.34/220.50  |- rdf__type mesh__D005955sskos__Concept
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D005955 2005
% 220.34/220.50  |- mesh__historyNote mesh__D005955 64   
% 220.34/220.50  |- mesh__recordOriginator mesh__D052002 DRC
% 220.34/220.50  |- skos__altLabel mesh__D052002 NF-kappaB 50-kDa
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D052002 2006A
% 220.34/220.50  |- mesh__historyNote mesh__D052002 2006%28%1992%29%   
% 220.34/220.50  |- skos__scopeNote mesh__D052002
% 220.34/220.50       A component of NF-kappa B transcription factor. It is proteolytically processed from NF-kappa B p105 precursor protein and is capable of forming dimeric complexes with itself or with TRANSCRIPTION FACTOR RELA. It regulates expression of GENES involved in immune and inflammatory responses.%A%    
% 220.34/220.50  |- mesh__dateEstablished mesh__D052002 2006-01-01
% 220.34/220.50  |- mesh__dateCreated mesh__D052002 2005-06-30
% 220.34/220.50  |- skos__hiddenLabel mesh__D052002 NF kappa B p105 Precursor Protein
% 220.34/220.50  |- skos__hiddenLabel mesh__D052002 NF kappa B p50
% 220.34/220.50  |- skos__prefLabel mesh__D052002 NF-kappa B p50 Subunit
% 220.34/220.50  |- skos__hiddenLabel mesh__D052002 p50, NF-kappa B
% 220.34/220.50  |- skos__altLabel mesh__D052002 NFKB1 Transcription Factor
% 220.34/220.50  |- skos__hiddenLabel mesh__D052002 NF kappa B p50 Subunit
% 220.34/220.50  |- mesh__recordAuthorizer mesh__D052002 ags
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D052002 2006
% 220.34/220.50  |- skos__broader mesh__D052002smesh__D016328
% 220.34/220.50  |- skos__altLabel mesh__D052002 NF-kappa B p50
% 220.34/220.50  |- mesh__publicMeSHNote mesh__D052002
% 220.34/220.50       2006; NF-KAPPA B P50 SUBUNIT was indexed under NF-KAPPA B %26% PROTEIN PRECURSORS 1992-2005%A%  
% 220.34/220.50  |- skos__hiddenLabel mesh__D052002 Transcription Factor, NFKB1
% 220.34/220.50  |- rdf__type mesh__D052002sskos__Concept
% 220.34/220.50  |- skos__hiddenLabel mesh__D052002 NF kappaB 50 kDa
% 220.34/220.50  |- mesh__recordMaintainer mesh__D052002 ags
% 220.34/220.50  |- mesh__dateRevised mesh__D052002 2005-07-19
% 220.34/220.50  |- skos__historyNote mesh__D005157
% 220.34/220.50       Temporomandibular Joint Syndrome %28%1973-1985%29%
% 220.34/220.50  |- skos__hiddenLabel mesh__D005157 Pain, Neuralgic Facial
% 220.34/220.50  |- skos__altLabel mesh__D005157 Face Pain
% 220.34/220.50  |- mesh__dateRevised mesh__D005157 1999-12-03
% 220.34/220.50  |- skos__historyNote mesh__D005157 Facial Neuralgia %28%1966-1985%29%
% 220.34/220.50  |- skos__hiddenLabel mesh__D005157 Pain, Referred Facial
% 220.34/220.50  |- skos__hiddenLabel mesh__D005157 Facial Pain, Referred
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D005157 2006
% 220.34/220.50  |- skos__hiddenLabel mesh__D005157 Pain, Myofacial
% 220.34/220.50  |- skos__prefLabel mesh__D005157 Facial Pain
% 220.34/220.50  |- skos__hiddenLabel mesh__D005157 Pain, Orofacial
% 220.34/220.50  |- mesh__recordOriginator mesh__D005157 RC
% 220.34/220.50  |- skos__historyNote mesh__D005157 Trigeminal Neuralgia %28%1966-1985%29%
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D005157 2000
% 220.34/220.50  |- mesh__publicMeSHNote mesh__D005157 1986   
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D005157 2003
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D005157 2001
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D005157 2000A
% 220.34/220.50  |- mesh__historyNote mesh__D005157 1986   
% 220.34/220.50  |- skos__hiddenLabel mesh__D005157 Pain, Craniofacial
% 220.34/220.50  |- mesh__dateCreated mesh__D005157 1985-05-07
% 220.34/220.50  |- mesh__recordAuthorizer mesh__D005157 ags
% 220.34/220.50  |- skos__scopeNote mesh__D005157
% 220.34/220.50       Pain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES.%A%    
% 220.34/220.50  |- skos__hiddenLabel mesh__D005157 Facial Pain, Neuralgic
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D005157 2004
% 220.34/220.50  |- mesh__dateEstablished mesh__D005157 1986-01-01
% 220.34/220.50  |- skos__related mesh__D005157smesh__D005156
% 220.34/220.50  |- skos__related mesh__D005157smesh__D013706
% 220.34/220.50  |- skos__altLabel mesh__D005157 Pain, Facial
% 220.34/220.50  |- skos__historyNote mesh__D005157 Face %28%1966-1985%29%
% 220.34/220.50  |- skos__broader mesh__D005157smesh__D010146
% 220.34/220.50  |- rdf__type mesh__D005157sskos__Concept
% 220.34/220.50  |- skos__related mesh__D005157smesh__D014277
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D005157 2002
% 220.34/220.50  |- mesh__recordMaintainer mesh__D005157 ags
% 220.34/220.50  |- skos__hiddenLabel mesh__D005157 Pain, Face
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D005157 2005
% 220.34/220.50  |- skos__historyNote mesh__D005157 Pain %28%1966-1985%29%
% 220.34/220.50  |- mesh__dateRevised mesh__D009548 1995-02-21
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D009548 2003
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D009548 2000
% 220.34/220.50  |- mesh__recordAuthorizer mesh__D009548 PLS
% 220.34/220.50  |- skos__broader mesh__D009548smesh__D000354
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D009548 2004
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D009548 2001
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D009548 1998
% 220.34/220.50  |- mesh__dateCreated mesh__D009548 1999-01-01
% 220.34/220.50  |- skos__scopeNote mesh__D009548
% 220.34/220.50       A republic in western Africa, north of NIGERIA and west of CHAD. Its capital is Niamey. It was first explored by the Europeans in the late 18th century. It became part of the French sphere of influence in the latter part of the 19th century and was formally constituted as part of French West Africa in 1904. Nigeria gained independence in 1960. The country took its name from the river Niger flowing through it. The river%27%s name came from the Tuareg egereou n-igereouen, river of rivers, the second part of the name giving the modern European form Niger. %28%From Webster%27%s New Geographical Dictionary, 1988, p847 %26% Room, Brewer%27%s Dictionary of Names, 1992, p379%29%%A%    
% 220.34/220.50  |- rdf__type mesh__D009548sskos__Concept
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D009548 1999
% 220.34/220.50  |- skos__annotation mesh__D009548
% 220.34/220.50       a republic in western Africa; do not confuse with NIGERIA, another western Africa republic to its south%A%  
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D009548 2005
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D009548 2002
% 220.34/220.50  |- skos__prefLabel mesh__D009548 Niger
% 220.34/220.50  |- mesh__recordMaintainer mesh__D009548 TGC
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D009548 2006
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D009548 1996
% 220.34/220.50  |- mesh__recordOriginator mesh__D009548 NLM
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D009548 1997
% 220.34/220.50  |- mesh__recordOriginator mesh__D001565 NLM
% 220.34/220.50  |- skos__related mesh__D001565smesh__D002599
% 220.34/220.50  |- skos__hiddenLabel mesh__D001565 Benzoate, Potassium
% 220.34/220.50  |- skos__scopeNote mesh__D001565
% 220.34/220.50       Salts and esters of BENZOIC ACID that possess antibacterial and antifungal properties. They are used as preservatives in pharmaceuticals, cosmetics, and foods.%A%    
% 220.34/220.50  |- mesh__dateRevised mesh__D001565 2004-07-07
% 220.34/220.50  |- mesh__recordAuthorizer mesh__D001565 sjn
% 220.34/220.50  |- mesh__recordMaintainer mesh__D001565 ssb
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D001565 2005
% 220.34/220.50  |- mesh__dateCreated mesh__D001565 1999-01-01
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D001565 2006
% 220.34/220.50  |- skos__prefLabel mesh__D001565 Benzoates
% 220.34/220.50  |- skos__broader mesh__D001565smesh__D019817
% 220.34/220.50  |- mesh__publicMeSHNote mesh__D001565
% 220.34/220.50       99; BENZOATE %26% POTASSIUM BENZOATE were indexed under BENZOATES 1980-98;%A%  
% 220.34/220.50  |- mesh__historyNote mesh__D001565
% 220.34/220.50       99; for BENZOATE %26% POTASSIUM BENZOATE use BENZOIC ACID %28%NM%29% 1980-98%A%  
% 220.34/220.50  |- rdf__type mesh__D001565sskos__Concept
% 220.34/220.50  |- skos__broader mesh__D008511Q000331smesh__D008511
% 220.34/220.50  |- mesh__preferredCombination mesh__D008511Q000331smesh__D007883
% 220.34/220.50  |- rdf__type mesh__D008511Q000331smesh__CompoundConcept
% 220.34/220.50  |- skos__broader mesh__D014925Q000627smesh__D014925
% 220.34/220.50  |- mesh__preferredCombination mesh__D014925Q000627smesh__D027641
% 220.34/220.50  |- rdf__type mesh__D014925Q000627smesh__CompoundConcept
% 220.34/220.50  |- rdf__type mesh__D006250sskos__Concept
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D006250 2004
% 220.34/220.50  |- skos__altLabel mesh__D006250 Neutral Amino Acid Transport Defect
% 220.34/220.50  |- mesh__recordAuthorizer mesh__D006250 sjn
% 220.34/220.50  |- skos__broader mesh__D006250smesh__D020739
% 220.34/220.50  |- skos__scopeNote mesh__D006250
% 220.34/220.50       A disorder of amino acid transport characterized by the childhood %28%or rarely adult%29% onset of photosensitive dermatitis and intermittent neurologic symptoms. Ataxia, personality changes, migraine headaches, and photophobia may occur periodically. The disorder results from impaired sodium-dependent transport of neutral amino acids across the brush border membrane of the small intestine and renal tubular epithelium. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp59-60%29%%A%    
% 220.34/220.50  |- mesh__dateCreated mesh__D006250 1999-01-01
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D006250 2005
% 220.34/220.50  |- skos__broader mesh__D006250smesh__D020157
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D006250 2002
% 220.34/220.50  |- mesh__dateEstablished mesh__D006250 1965-01-01
% 220.34/220.50  |- skos__altLabel mesh__D006250 Transport Disorder, Neutral Amino Acids
% 220.34/220.50  |- skos__altLabel mesh__D006250 Neutral Amino Acid Transport Disorder
% 220.34/220.50  |- mesh__recordOriginator mesh__D006250 NLM
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D006250 2006
% 220.34/220.50  |- skos__prefLabel mesh__D006250 Hartnup Disease
% 220.34/220.50  |- skos__broader mesh__D006250smesh__D000608
% 220.34/220.50  |- mesh__dateRevised mesh__D006250 2001-07-25
% 220.34/220.50  |- mesh__historyNote mesh__D006250 1965   
% 220.34/220.50  |- skos__altLabel mesh__D006250 Transport Disorder, Neutral Amino Acid
% 220.34/220.50  |- mesh__publicMeSHNote mesh__D006250 1965   
% 220.34/220.50  |- mesh__recordMaintainer mesh__D006250 nns
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D006250 2003
% 220.34/220.50  |- skos__altLabel mesh__D006250 Amino Acid Transport Disorder, Neutral
% 220.34/220.50  |- rdf__type mesh__D019976sskos__Concept
% 220.34/220.50  |- skos__hiddenLabel mesh__D019976 Human Clonings
% 220.34/220.50  |- skos__hiddenLabel mesh__D019976 Clonings, Human
% 220.34/220.50  |- skos__altLabel mesh__D019976 Cloning, Embryo
% 220.34/220.50  |- skos__related mesh__D019976smesh__D003001
% 220.34/220.50  |- skos__annotation mesh__D019976
% 220.34/220.50        check tags  HUMANS or ANIMALS; differentiate from CLONING, MOLECULAR and CLONE CELLS; DF: CLONING%A%  
% 220.34/220.50  |- skos__hiddenLabel mesh__D019976 Organism Cloning
% 220.34/220.50  |- mesh__dateRevised mesh__D019976 2004-07-13
% 220.34/220.50  |- skos__broader mesh__D019976smesh__D005821
% 220.34/220.50  |- skos__historyNote mesh__D019976
% 220.34/220.50       Cell Nucleus/transplantation %28%1994-1997%29%
% 220.34/220.50  |- skos__altLabel mesh__D019976 Cloning, Human
% 220.34/220.50  |- mesh__recordAuthorizer mesh__D019976 sjn
% 220.34/220.50  |- skos__scopeNote mesh__D019976
% 220.34/220.50       The formation of one or more genetically identical organisms derived by vegetative reproduction from a single cell. The source nuclear material can be embryo-derived, fetus-derived, or taken from an adult somatic cell.%A%    
% 220.34/220.50  |- skos__hiddenLabel mesh__D019976 Embryo Clonings
% 220.34/220.50  |- mesh__historyNote mesh__D019976 98   
% 220.34/220.50  |- skos__hiddenLabel mesh__D019976 Organism Clonings
% 220.34/220.50  |- mesh__recordOriginator mesh__D019976 AGS
% 220.34/220.50  |- mesh__recordMaintainer mesh__D019976 sjn
% 220.34/220.50  |- skos__hiddenLabel mesh__D019976 Clonings, Embryo
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D019976 2005
% 220.34/220.50  |- mesh__dateEstablished mesh__D019976 1998-01-01
% 220.34/220.50  |- skos__historyNote mesh__D019976 Genetic Engineering %28%1993-1997%29%
% 220.34/220.50  |- skos__historyNote mesh__D019976
% 220.34/220.50       Reproduction Techniques %28%1994-1997%29%
% 220.34/220.50  |- skos__hiddenLabel mesh__D019976 Clonings, Organism
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D019976 2006
% 220.34/220.50  |- mesh__dateCreated mesh__D019976 1997-06-20
% 220.34/220.50  |- mesh__publicMeSHNote mesh__D019976 98   
% 220.34/220.50  |- skos__prefLabel mesh__D019976 Cloning, Organism
% 220.34/220.50  |- skos__broader mesh__D019976smesh__D012099
% 220.34/220.50  |- skos__related mesh__D019976smesh__D012100
% 220.34/220.50  |- skos__related mesh__D011993smesh__D000922
% 220.34/220.50  |- skos__altLabel mesh__D011993 Recombinant Chimeric Proteins
% 220.34/220.50  |- mesh__dateEstablished mesh__D011993 1990-01-01
% 220.34/220.50  |- mesh__publicMeSHNote mesh__D011993
% 220.34/220.50       1990%28%1987%29%; see RECOMBINANT PROTEINS 1987-1989; for CHIMERIC PROTEINS, RECOMBINANT see CHIMERIC PROTEINS 1993-2005%A%  
% 220.34/220.50  |- mesh__recordOriginator mesh__D011993 RLS
% 220.34/220.50  |- mesh__recordAuthorizer mesh__D011993 ags
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D011993 2006A
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D011993 2006
% 220.34/220.50  |- skos__broader mesh__D011993smesh__D011994
% 220.34/220.50  |- skos__hiddenLabel mesh__D011993 Proteins, Recombinant Fusion
% 220.34/220.50  |- mesh__dateRevised mesh__D011993 2005-07-19
% 220.34/220.50  |- skos__annotation mesh__D011993
% 220.34/220.50       do not confuse with MEMBRANE FUSION PROTEINS; VIRAL FUSION PROTEINS; MUTANT CHIMERIC PROTEINS; or ONCOGENE PROTEINS, FUSION%A%  
% 220.34/220.50  |- skos__altLabel mesh__D011993 Fusion Proteins, Recombinant
% 220.34/220.50  |- mesh__historyNote mesh__D011993 1990%28%1987%29%   
% 220.34/220.50  |- mesh__dateCreated mesh__D011993 1986-06-16
% 220.34/220.50  |- skos__prefLabel mesh__D011993 Recombinant Fusion Proteins
% 220.34/220.50  |- skos__scopeNote mesh__D011993
% 220.34/220.50       Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes.%A%    
% 220.34/220.50  |- skos__hiddenLabel mesh__D011993 Proteins, Recombinant Chimeric
% 220.34/220.50  |- rdf__type mesh__D011993sskos__Concept
% 220.34/220.50  |- mesh__recordMaintainer mesh__D011993 ags
% 220.34/220.50  |- skos__scopeNote mesh__D019178
% 220.34/220.50       A genus of the family BROMOVIRIDAE with a wide host range. Transmission is by aphids and the type species is ALFALFA MOSAIC VIRUS.%A%    
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D019178 1998
% 220.34/220.50  |- mesh__historyNote mesh__D019178 97   
% 220.34/220.50  |- skos__hiddenLabel mesh__D019178 Alfamoviruses
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D019178 2006
% 220.34/220.50  |- rdf__type mesh__D019178sskos__Concept
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D019178 2002
% 220.34/220.50  |- mesh__dateCreated mesh__D019178 1996-06-10
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D019178 2005
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D019178 1997
% 220.34/220.50  |- skos__prefLabel mesh__D019178 Alfamovirus
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D019178 2004
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D019178 2001
% 220.34/220.50  |- mesh__dateEstablished mesh__D019178 1997-01-01
% 220.34/220.50  |- skos__broader mesh__D019178smesh__D009029
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D019178 1999
% 220.34/220.50  |- skos__broader mesh__D019178smesh__D019177
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D019178 2000
% 220.34/220.50  |- mesh__publicMeSHNote mesh__D019178 97   
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D019178 2003
% 220.34/220.50  |- skos__annotation mesh__D019178
% 220.34/220.50       a genus of mosaic viruses; from ALFAlfa MOsaic virus; coord IM with specific plant /virol %28%IM or NIM%29%%A%  
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D011195 2004
% 220.34/220.50  |- mesh__dateRevised mesh__D011195 2001-07-25
% 220.34/220.50  |- skos__historyNote mesh__D011195 Magnesium %28%1972-1975%29%
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D011195 2006
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D011195 2003
% 220.34/220.50  |- skos__hiddenLabel mesh__D011195 Magnesium Asparaginate, Potassium
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D011195 2005
% 220.34/220.50  |- mesh__recordAuthorizer mesh__D011195 sjn
% 220.34/220.50  |- mesh__historyNote mesh__D011195
% 220.34/220.50       91%28%77%29%; was see under ASPARTIC ACID 1977-90   
% 220.34/220.50  |- skos__scopeNote mesh__D011195
% 220.34/220.50       An intra-extracellular electrolyte exchange agent with a variety of effects.%A%    
% 220.34/220.50  |- skos__hiddenLabel mesh__D011195 Asparaginate, Potassium Magnesium
% 220.34/220.50  |- skos__prefLabel mesh__D011195 Potassium Magnesium Aspartate
% 220.34/220.50  |- skos__related mesh__D011195smesh__D004573
% 220.34/220.50  |- skos__broader mesh__D011195smesh__D001224
% 220.34/220.50  |- skos__hiddenLabel mesh__D011195 Magnesium Aspartate, Potassium
% 220.34/220.50  |- mesh__publicMeSHNote mesh__D011195
% 220.34/220.50       91; was see under ASPARTIC ACID 1977-90   
% 220.34/220.50  |- mesh__dateEstablished mesh__D011195 1991-01-01
% 220.34/220.50  |- rdf__type mesh__D011195sskos__Concept
% 220.34/220.50  |- skos__hiddenLabel mesh__D011195 Aspartate, Potassium Magnesium
% 220.34/220.50  |- skos__altLabel mesh__D011195 K-Mg Aspartate
% 220.34/220.50  |- skos__historyNote mesh__D011195 Asparagine %28%1972-1973%29%
% 220.34/220.50  |- skos__hiddenLabel mesh__D011195 Aspartate, K-Mg
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D011195 2002
% 220.34/220.50  |- skos__historyNote mesh__D011195 Aspartic Acid %28%1974-1976%29%
% 220.34/220.50  |- mesh__dateCreated mesh__D011195 1976-04-13
% 220.34/220.50  |- mesh__recordOriginator mesh__D011195 RLS
% 220.34/220.50  |- mesh__recordMaintainer mesh__D011195 nns
% 220.34/220.50  |- skos__historyNote mesh__D011195 Potassium %28%1972-1975%29%
% 220.34/220.50  |- skos__altLabel mesh__D005956 Phosphoglucose Isomerase
% 220.34/220.50  |- skos__hiddenLabel mesh__D005956 Isomerase, Glucose-6-Phosphate
% 220.34/220.50  |- skos__hiddenLabel mesh__D005956 Isomerase, Phosphohexose
% 220.34/220.50  |- mesh__publicMeSHNote mesh__D005956
% 220.34/220.50       98%28%65%29%; see GLUCOSEPHOSPHATE ISOMERASE 1965-97   
% 220.34/220.50  |- mesh__historyNote mesh__D005956 98%28%65%29%   
% 220.34/220.50  |- mesh__recordOriginator mesh__D005956 NLM
% 220.34/220.50  |- skos__altLabel mesh__D005956 Isomerase, Glucose 6 Phosphate
% 220.34/220.50  |- skos__scopeNote mesh__D005956
% 220.34/220.50       An enzyme that catalyzes the reversible interconversion of glucose 6-phosphate and fructose 6-phosphate, and is a part of the glycolytic and gluconeogenic pathways. Deficiency of the enzyme, an autosomal recessive trait, results in liver glycogenesis and hemolytic anemia. EC 5.3.1.9.%A%    
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D005956 2004
% 220.34/220.50  |- skos__hiddenLabel mesh__D005956 Glucose 6 Phosphate Isomerase
% 220.34/220.50  |- skos__hiddenLabel mesh__D005956 Isomerase, Glucosephosphate
% 220.34/220.50  |- skos__altLabel mesh__D005956 Phosphohexose Isomerase
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D005956 2005
% 220.34/220.50  |- mesh__dateEstablished mesh__D005956 1965-01-01
% 220.34/220.50  |- skos__prefLabel mesh__D005956 Glucose-6-Phosphate Isomerase
% 220.34/220.50  |- skos__altLabel mesh__D005956 Glucosephosphate Isomerase
% 220.34/220.50  |- mesh__dateCreated mesh__D005956 1999-01-01
% 220.34/220.50  |- skos__hiddenLabel mesh__D005956 Isomerase, Phosphoglucose
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D005956 2006
% 220.34/220.50  |- mesh__recordMaintainer mesh__D005956 ssb
% 220.34/220.50  |- rdf__type mesh__D005956sskos__Concept
% 220.34/220.50  |- mesh__recordAuthorizer mesh__D005956 sjn
% 220.34/220.50  |- mesh__dateRevised mesh__D005956 2003-07-09
% 220.34/220.50  |- skos__broader mesh__D005956smesh__D019747
% 220.34/220.50  |- skos__broader mesh__D052003smesh__D016328
% 220.34/220.50  |- skos__prefLabel mesh__D052003 NF-kappa B p52 Subunit
% 220.34/220.50  |- skos__altLabel mesh__D052003 NF-kappaB p52
% 220.34/220.50  |- mesh__recordAuthorizer mesh__D052003 sjn
% 220.34/220.50  |- mesh__dateCreated mesh__D052003 2005-06-30
% 220.34/220.50  |- mesh__dateEstablished mesh__D052003 2006-01-01
% 220.34/220.50  |- skos__hiddenLabel mesh__D052003 NF kappa B p52 Subunit
% 220.34/220.50  |- mesh__publicMeSHNote mesh__D052003
% 220.34/220.50       2006; NF-KAPPAB P52 SUBUNIT was indexed under NF-KAPPA B 1994-2005, %26% under TRANSCRIPTION FACTORS 1993%A%  
% 220.34/220.50  |- skos__hiddenLabel mesh__D052003 p52, NK-kappa B
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D052003 2006
% 220.34/220.50  |- skos__hiddenLabel mesh__D052003 NK kappa B p52
% 220.34/220.50  |- skos__hiddenLabel mesh__D052003 NF kappaB2
% 220.34/220.50  |- skos__hiddenLabel mesh__D052003 NF kappaB p52 Subunit
% 220.34/220.50  |- mesh__historyNote mesh__D052003 2006%28%1993%29%   
% 220.34/220.50  |- skos__scopeNote mesh__D052003
% 220.34/220.50       A component of NF-kappa B transcription factor. It is proteolytically processed from NF-kappa B p100 precursor protein and is important for maturation of B-LYMPHOCYTES and adaptive HUMORAL IMMUNITY.%A%    
% 220.34/220.50  |- skos__hiddenLabel mesh__D052003 NF kappaB2 p100
% 220.34/220.50  |- rdf__type mesh__D052003sskos__Concept
% 220.34/220.50  |- skos__hiddenLabel mesh__D052003 p100, NF-kappaB2
% 220.34/220.50  |- mesh__recordMaintainer mesh__D052003 DRC
% 220.34/220.50  |- skos__hiddenLabel mesh__D052003 H2TF1, Transcription Factor
% 220.34/220.50  |- skos__altLabel mesh__D052003 NFKB2 Transcription Factor
% 220.34/220.50  |- mesh__recordOriginator mesh__D052003 DRC
% 220.34/220.50  |- skos__hiddenLabel mesh__D052003 NF kappaB p52
% 220.34/220.50  |- skos__altLabel mesh__D052003 Transcription Factor H2TF1
% 220.34/220.50  |- skos__hiddenLabel mesh__D052003 Transcription Factor, NFKB2
% 220.34/220.50  |- skos__altLabel mesh__D052003 NK-kappa B p52
% 220.34/220.50  |- skos__altLabel mesh__D052003 NF-kappaB2
% 220.34/220.50  |- skos__hiddenLabel mesh__D052003 NF kappa B p100 Precursor Protein
% 220.34/220.50  |- skos__altLabel mesh__D052003 NF-kappaB p52 Subunit
% 220.34/220.50  |- skos__altLabel mesh__D052003 NF-kappaB2 p100
% 220.34/220.50  |- skos__hiddenLabel mesh__D005158 Palsy, Facial
% 220.34/220.50  |- skos__altLabel mesh__D005158 Upper Motor Neuron Facial Palsy
% 220.34/220.50  |- skos__hiddenLabel mesh__D005158 Facial Paralyses, Central
% 220.34/220.50  |- skos__related mesh__D005158smesh__D020331
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D005158 2001
% 220.34/220.50  |- skos__hiddenLabel mesh__D005158 Paralyses, Facial
% 220.34/220.50  |- skos__altLabel mesh__D005158 Facial Paralysis, Peripheral
% 220.34/220.50  |- skos__hiddenLabel mesh__D005158 Paralyses, Hemifacial
% 220.34/220.50  |- skos__hiddenLabel mesh__D005158 Facial Paralyses, Peripheral
% 220.34/220.50  |- skos__hiddenLabel mesh__D005158 Paralyses, Central Facial
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D005158 2005
% 220.34/220.50  |- skos__hiddenLabel mesh__D005158 Palsies, Facial
% 220.34/220.50  |- skos__hiddenLabel mesh__D005158 Paralysis, Peripheral Facial
% 220.34/220.50  |- skos__scopeNote mesh__D005158
% 220.34/220.50       Severe or complete loss of facial muscle motor function. This condition may result from central or peripheral lesions. Damage to CNS motor pathways from the cerebral cortex to the facial nuclei in the pons leads to facial weakness that generally spares the forehead muscles. FACIAL NERVE DISEASES generally results in generalized hemifacial weakness. NEUROMUSCULAR JUNCTION DISEASES and MUSCULAR DISEASES may also cause facial paralysis or paresis.%A%    
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D005158 2000
% 220.34/220.50  |- skos__related mesh__D005158smesh__D016697
% 220.34/220.50  |- mesh__recordMaintainer mesh__D005158 KEV
% 220.34/220.50  |- skos__hiddenLabel mesh__D005158 Paralysis, Central Facial
% 220.34/220.50  |- skos__hiddenLabel mesh__D005158 Peripheral Facial Paralysis
% 220.34/220.50  |- mesh__dateRevised mesh__D005158 1999-11-05
% 220.34/220.50  |- skos__altLabel mesh__D005158 Facial Palsy
% 220.34/220.50  |- skos__hiddenLabel mesh__D005158 Paralysis, Facial
% 220.34/220.50  |- rdf__type mesh__D005158sskos__Concept
% 220.34/220.50  |- mesh__activeMeSHYear mesh__D005158 2004
% 220.34/220.50  |- skos__broader mesh__D005158smesh__D009059
% 220.34/220.50  |- mesh__recordOriginator mesh__D005158 NLM
% 220.34/220.50  |- skos__hiddenLabel mesh__D005158 Pareses, Facial
% 220.34/220.50  |- skos__prefLabel mesh__D005158 Facial Paralysis
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D005158 2002
% 220.34/220.51  |- mesh__recordAuthorizer mesh__D005158 sjn
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D005158 2003
% 220.34/220.51  |- skos__altLabel mesh__D005158 Facial Paralysis, Central
% 220.34/220.51  |- skos__broader mesh__D005158smesh__D010243
% 220.34/220.51  |- skos__hiddenLabel mesh__D005158 Paresis, Facial
% 220.34/220.51  |- skos__altLabel mesh__D005158 Lower Motor Neuron Facial Palsy
% 220.34/220.51  |- mesh__dateCreated mesh__D005158 1999-01-01
% 220.34/220.51  |- skos__hiddenLabel mesh__D005158 Facial Palsies
% 220.34/220.51  |- skos__hiddenLabel mesh__D005158 Central Facial Paralyses
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D005158 2006
% 220.34/220.51  |- skos__hiddenLabel mesh__D005158 Paralysis, Hemifacial
% 220.34/220.51  |- skos__hiddenLabel mesh__D005158 Central Facial Paralysis
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D009549 1998
% 220.34/220.51  |- mesh__dateCreated mesh__D009549 1999-01-01
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D009549 2002
% 220.34/220.51  |- rdf__type mesh__D009549sskos__Concept
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D009549 1999
% 220.34/220.51  |- skos__annotation mesh__D009549
% 220.34/220.51       a republic in western Africa; do not confuse with NIGER, another western Africa republic to its north; Biafra goes here%A%  
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D009549 2005
% 220.34/220.51  |- mesh__recordOriginator mesh__D009549 NLM
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D009549 2006
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D009549 1996
% 220.34/220.51  |- skos__prefLabel mesh__D009549 Nigeria
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D009549 2000
% 220.34/220.51  |- mesh__recordAuthorizer mesh__D009549 PLS
% 220.34/220.51  |- mesh__recordMaintainer mesh__D009549 TGC
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D009549 1997
% 220.34/220.51  |- mesh__dateRevised mesh__D009549 1995-02-21
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D009549 2003
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D009549 2001
% 220.34/220.51  |- skos__scopeNote mesh__D009549
% 220.34/220.51       A republic in western Africa, south of NIGER between BENIN and CAMEROON. Its capital is Lagos. From the time it was visited in the 18th and 19th centuries by many European explorers, figuring in its administrative history were Great Britain, the native king, Sierra Leone, and the Gold Coast colony. Nigeria gained independence in 1960, becoming a republic in 1961. Nigeria derives its name from the Niger River which flows through it. %28%From Webster%27%s New Geographical Dictionary, 1988, p848 %26% Room, Brewer%27%s Dictionary of Names, 1992, p379%29%%A%    
% 220.34/220.51  |- skos__broader mesh__D009549smesh__D000354
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D009549 2004
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D001566 2003
% 220.34/220.51  |- mesh__recordMaintainer mesh__D001566 CCR
% 220.34/220.51  |- skos__hiddenLabel mesh__D001566 Formate, Benzocaine
% 220.34/220.51  |- mesh__recordAuthorizer mesh__D001566 sjn
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D001566 2001
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D001566 2004
% 220.34/220.51  |- mesh__dateRevised mesh__D001566 2000-06-21
% 220.34/220.51  |- skos__scopeNote mesh__D001566
% 220.34/220.51       A surface anesthetic that acts by preventing transmission of impulses along nerve fibers and at nerve endings.%A%    
% 220.34/220.51  |- skos__hiddenLabel mesh__D001566 4 Aminobenzoic Acid Ethyl Ester
% 220.34/220.51  |- skos__altLabel mesh__D001566 Anesthesin
% 220.34/220.51  |- mesh__dateCreated mesh__D001566 1999-01-01
% 220.34/220.51  |- mesh__historyNote mesh__D001566 65; was ETHYL AMINOBENZOATE 1963-64   
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D001566 2002
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D001566 2005
% 220.34/220.51  |- skos__prefLabel mesh__D001566 Benzocaine
% 220.34/220.51  |- skos__hiddenLabel mesh__D001566 Hydrobromide, Benzocaine
% 220.34/220.51  |- skos__hiddenLabel mesh__D001566 Hydrochloride, Benzocaine
% 220.34/220.51  |- skos__hiddenLabel mesh__D001566 Methanesulfonate, Benzocaine
% 220.34/220.51  |- skos__hiddenLabel mesh__D001566 Acetate, Benzocaine
% 220.34/220.51  |- skos__altLabel mesh__D001566 Bensokain
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D001566 2006
% 220.34/220.51  |- rdf__type mesh__D001566sskos__Concept
% 220.34/220.51  |- skos__altLabel mesh__D001566 4-Aminobenzoic Acid Ethyl Ester
% 220.34/220.51  |- mesh__publicMeSHNote mesh__D001566
% 220.34/220.51       65; was ETHYL AMINOBENZOATE 1963-64   
% 220.34/220.51  |- skos__altLabel mesh__D001566 Ethyl Aminobenzoate
% 220.34/220.51  |- mesh__recordOriginator mesh__D001566 NLM
% 220.34/220.51  |- skos__broader mesh__D001566smesh__D010129
% 220.34/220.51  |- mesh__dateEstablished mesh__D001566 1965-01-01
% 220.34/220.51  |- rdf__type mesh__D020720sskos__Concept
% 220.34/220.51  |- mesh__publicMeSHNote mesh__D020720
% 220.34/220.51       2005; see MYASTHENIA GRAVIS, EXPERIMENTAL AUTOIMMUNE 2000-2004%A%  
% 220.34/220.51  |- skos__historyNote mesh__D020720 Autoimmune Diseases %28%1969-1999%29%
% 220.34/220.51  |- skos__prefLabel mesh__D020720
% 220.34/220.51       Myasthenia Gravis, Autoimmune, Experimental
% 220.34/220.51  |- skos__broader mesh__D020720smesh__D009157
% 220.34/220.51  |- skos__hiddenLabel mesh__D020720 Myasthenias, Experimental
% 220.34/220.51  |- skos__altLabel mesh__D020720 Myasthenia Gravis, Autoimmune Experimental
% 220.34/220.51  |- mesh__dateCreated mesh__D020720 1999-11-05
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D020720 2006
% 220.34/220.51  |- skos__hiddenLabel mesh__D020720 Myasthenia Gravis, Experimental
% 220.34/220.51  |- skos__altLabel mesh__D020720 Myasthenia Gravis, Experimental Autoimmune
% 220.34/220.51  |- skos__hiddenLabel mesh__D020720 Experimental Myasthenias
% 220.34/220.51  |- mesh__historyNote mesh__D020720 2005 %28%2000%29%   
% 220.34/220.51  |- mesh__recordMaintainer mesh__D020720 sjn
% 220.34/220.51  |- skos__historyNote mesh__D020720 Myasthenia Gravis %28%1968-1999%29%
% 220.34/220.51  |- skos__hiddenLabel mesh__D020720 Myasthenia, Experimental
% 220.34/220.51  |- skos__broader mesh__D020720smesh__D020721
% 220.34/220.51  |- mesh__recordAuthorizer mesh__D020720 sjn
% 220.34/220.51  |- mesh__dateEstablished mesh__D020720 2000-01-01
% 220.34/220.51  |- skos__altLabel mesh__D020720 Experimental Myasthenia Gravis
% 220.34/220.51  |- skos__altLabel mesh__D020720 Autoimmune Experimental Myasthenia Gravis
% 220.34/220.51  |- mesh__recordOriginator mesh__D020720 KEV
% 220.34/220.51  |- skos__altLabel mesh__D020720
% 220.34/220.51       Passive Transfer Experimental Autoimmune Myasthenia Gravis
% 220.34/220.51  |- skos__scopeNote mesh__D020720
% 220.34/220.51       Any autoimmune animal disease model used in the study of MYASTHENIA GRAVIS. Injection with purified neuromuscular junction acetylcholine receptor %28%AChR%29% %28%see RECEPTORS, CHOLINERGIC%29% components results in a myasthenic syndrome that has acute and chronic phases. The motor endplate pathology, loss of acetylcholine receptors, presence of circulating anti-AChR antibodies, and electrophysiologic changes make this condition virtually identical to human myasthenia gravis. Passive transfer of AChR antibodies or lymphocytes from afflicted animals to normals induces passive transfer experimental autoimmune myasthenia gravis. %28%From Joynt, Clinical Neurology, 1997, Ch 54, p3%29%%A%    
% 220.34/220.51  |- skos__altLabel mesh__D020720 Experimental Myasthenia
% 220.34/220.51  |- mesh__dateRevised mesh__D020720 2004-07-13
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D020720 2005
% 220.34/220.51  |- skos__annotation mesh__D006251
% 220.34/220.51       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% + SARCOMA, EXPERIMENTAL %28%IM%29%%A%  
% 220.34/220.51  |- mesh__dateCreated mesh__D006251 1983-03-11
% 220.34/220.51  |- mesh__recordMaintainer mesh__D006251 ags
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D006251 2005
% 220.34/220.51  |- skos__hiddenLabel mesh__D006251 Sarcoma Virus, Harvey
% 220.34/220.51  |- mesh__dateRevised mesh__D006251 2002-07-03
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D006251 2006
% 220.34/220.51  |- mesh__recordAuthorizer mesh__D006251 sjn
% 220.34/220.51  |- skos__historyNote mesh__D006251 Mouse Sarcoma Viruses %28%1980-1983%29%
% 220.34/220.51  |- skos__altLabel mesh__D006251 Harvey Sarcoma Virus
% 220.34/220.51  |- skos__scopeNote mesh__D006251
% 220.34/220.51       A replication-defective mouse sarcoma virus %28%SARCOMA VIRUSES, MURINE%29% first described by J.J. Harvey in 1964.%A%    
% 220.34/220.51  |- mesh__historyNote mesh__D006251 2002 %28%1984%29%   
% 220.34/220.51  |- mesh__recordOriginator mesh__D006251 RC
% 220.34/220.51  |- mesh__dateEstablished mesh__D006251 1991-01-01
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D006251 2003
% 220.34/220.51  |- skos__broader mesh__D006251smesh__D009053
% 220.34/220.51  |- skos__historyNote mesh__D006251 Mouse Tumor Viruses %28%1966-1979%29%
% 220.34/220.51  |- rdf__type mesh__D006251sskos__Concept
% 220.34/220.51  |- mesh__publicMeSHNote mesh__D006251
% 220.34/220.51       2002; see HARVEY SARCOMA VIRUS 1991-2001, see MOUSE SARCOMA VIRUSES 1984-1990%A%  
% 220.34/220.51  |- skos__prefLabel mesh__D006251 Harvey murine sarcoma virus
% 220.34/220.51  |- skos__hiddenLabel mesh__D006251 Virus, Harvey Sarcoma
% 220.34/220.51  |- mesh__activeMeSHYear mesh__D006251 2004
% 220.34/220.51  |- mesh__recordOriginator mesh__D047668 nns
% 220.34/220.51  |- mesh__publicMeSHNote mesh__D047668 2005   
% 220.34/220.51  |- mesh__dateCreated mesh__D047668 2004-07-07
% 220.37/220.51  |- skos__hiddenLabel mesh__D047668 Protein Sequences, Intervening
% 220.37/220.51  |- skos__hiddenLabel mesh__D047668 Intein
% 220.37/220.51  |- skos__historyNote mesh__D047668 Protein Splicing %28%1997-2004%29%
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D047668 2005
% 220.37/220.51  |- skos__hiddenLabel mesh__D047668 Intervening Protein Sequences
% 220.37/220.51  |- skos__scopeNote mesh__D047668
% 220.37/220.51       The internal fragments of precursor proteins %28%INternal proTEINS%29% that are autocatalytically removed by PROTEIN SPLICING. The flanking fragments %28%EXTEINS%29% are ligated forming mature proteins. The nucleic acid sequences coding for inteins are considered to be MOBILE GENETIC ELEMENTS. Inteins are composed of self-splicing domains and an endonuclease domain which plays a role in the spread of the intein%27%s genomic sequence. Mini-inteins are composed of the self-splicing domains only.%A%    
% 220.37/220.51  |- mesh__historyNote mesh__D047668 2005   
% 220.37/220.51  |- skos__related mesh__D047668smesh__D047669
% 220.37/220.51  |- skos__hiddenLabel mesh__D047668 Sequences, Intervening Protein
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D047668 2006
% 220.37/220.51  |- skos__prefLabel mesh__D047668 Inteins
% 220.37/220.51  |- mesh__dateEstablished mesh__D047668 2005-01-01
% 220.37/220.51  |- rdf__type mesh__D047668sskos__Concept
% 220.37/220.51  |- mesh__recordAuthorizer mesh__D047668 sjn
% 220.37/220.51  |- skos__altLabel mesh__D047668 Intervening Protein Sequence
% 220.37/220.51  |- skos__altLabel mesh__D047668 Introns, Protein
% 220.37/220.51  |- skos__hiddenLabel mesh__D047668 Sequence, Intervening Protein
% 220.37/220.51  |- mesh__recordMaintainer mesh__D047668 nns
% 220.37/220.51  |- skos__related mesh__D047668smesh__D011498
% 220.37/220.51  |- skos__hiddenLabel mesh__D047668 Protein Sequence, Intervening
% 220.37/220.51  |- skos__altLabel mesh__D047668 Protein Introns
% 220.37/220.51  |- skos__broader mesh__D047668smesh__D000595
% 220.37/220.51  |- skos__related mesh__D047668smesh__D019154
% 220.37/220.51  |- skos__hiddenLabel mesh__D047668 Protein Intron
% 220.37/220.51  |- skos__hiddenLabel mesh__D047668 Intron, Protein
% 220.37/220.51  |- skos__altLabel mesh__D011994 DNA Recombinant Proteins
% 220.37/220.51  |- mesh__recordAuthorizer mesh__D011994 sjn
% 220.37/220.51  |- skos__hiddenLabel mesh__D011994 DNA Proteins, Recombinant
% 220.37/220.51  |- skos__scopeNote mesh__D011994
% 220.37/220.51       Proteins prepared by recombinant DNA technology.     
% 220.37/220.51  |- mesh__dateEstablished mesh__D011994 1986-01-01
% 220.37/220.51  |- mesh__historyNote mesh__D011994 86   
% 220.37/220.51  |- mesh__recordOriginator mesh__D011994 RLS
% 220.37/220.51  |- skos__broader mesh__D011994smesh__D011506
% 220.37/220.51  |- skos__altLabel mesh__D011994 Biosynthetic Proteins
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D011994 2006
% 220.37/220.51  |- mesh__recordMaintainer mesh__D011994 SYSTEM
% 220.37/220.51  |- mesh__publicMeSHNote mesh__D011994 86   
% 220.37/220.51  |- skos__prefLabel mesh__D011994 Recombinant Proteins
% 220.37/220.51  |- mesh__dateCreated mesh__D011994 1985-03-08
% 220.37/220.51  |- skos__historyNote mesh__D011994
% 220.37/220.51       Proteins or specific protein %28%1966-1985%29%
% 220.37/220.51  |- mesh__dateRevised mesh__D011994 2005-06-30
% 220.37/220.51  |- skos__annotation mesh__D011994
% 220.37/220.51       %22%proteins prepared by recombinant DNA technology%22%; IM; GEN only; prefer specifics; for synthesis of these proteins, coord IM with /biosyn + specific protein /biosyn %28%IM%29%%A%  
% 220.37/220.51  |- rdf__type mesh__D011994sskos__Concept
% 220.37/220.51  |- skos__altLabel mesh__D011994 Proteins, Biosynthetic
% 220.37/220.51  |- skos__hiddenLabel mesh__D011994 Recombinant Proteins, DNA
% 220.37/220.51  |- skos__hiddenLabel mesh__D011994 Proteins, Recombinant
% 220.37/220.51  |- skos__historyNote mesh__D011994 DNA, Recombinant %28%1977-1985%29%
% 220.37/220.51  |- skos__hiddenLabel mesh__D011994 Proteins, DNA Recombinant
% 220.37/220.51  |- skos__hiddenLabel mesh__D011994 Recombinant DNA Proteins
% 220.37/220.51  |- skos__broader mesh__D019179smesh__D019177
% 220.37/220.51  |- mesh__publicMeSHNote mesh__D019179 97   
% 220.37/220.51  |- mesh__recordMaintainer mesh__D019179 ags
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D019179 2005
% 220.37/220.51  |- skos__hiddenLabel mesh__D019179 Ilarviruses
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D019179 2002
% 220.37/220.51  |- mesh__dateCreated mesh__D019179 1996-06-10
% 220.37/220.51  |- skos__scopeNote mesh__D019179
% 220.37/220.51       A genus of the family BROMOVIRIDAE which infects mainly woody plants. Species are divided into ten subgroups. Tobacco streak virus is the type species.%A%    
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D019179 2004
% 220.37/220.51  |- mesh__recordOriginator mesh__D019179 AGS
% 220.37/220.51  |- mesh__dateRevised mesh__D019179 2001-07-25
% 220.37/220.51  |- mesh__recordAuthorizer mesh__D019179 sjn
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D019179 2003
% 220.37/220.51  |- mesh__historyNote mesh__D019179 97   
% 220.37/220.51  |- skos__annotation mesh__D019179
% 220.37/220.51       coord IM with specific plant /virol or tree /virol   
% 220.37/220.51  |- mesh__dateEstablished mesh__D019179 1997-01-01
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D019179 2006
% 220.37/220.51  |- skos__prefLabel mesh__D019179 Ilarvirus
% 220.37/220.51  |- rdf__type mesh__D019179sskos__Concept
% 220.37/220.51  |- skos__hiddenLabel mesh__D019179 Tobacco streak viruses
% 220.37/220.51  |- skos__scopeNote mesh__D011196
% 220.37/220.51       Permanganic acid %28%HMnO4%29%, potassium salt. A highly oxidative, water-soluble compound with purple crystals, and a sweet taste. %28%From McGraw-Hill Dictionary of Scientific and Technical Information, 4th ed%29%%A%    
% 220.37/220.51  |- mesh__recordOriginator mesh__D011196 NLM
% 220.37/220.51  |- mesh__recordAuthorizer mesh__D011196 PLS
% 220.37/220.51  |- mesh__dateCreated mesh__D011196 1999-01-01
% 220.37/220.51  |- skos__broader mesh__D011196smesh__D017680
% 220.37/220.51  |- rdf__type mesh__D011196sskos__Concept
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D011196 2002
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D011196 2001
% 220.37/220.51  |- skos__hiddenLabel mesh__D011196 Permanganate, Potassium
% 220.37/220.51  |- mesh__recordMaintainer mesh__D011196 TPW
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D011196 1997
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D011196 1999
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D011196 2004
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D011196 1996
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D011196 2000
% 220.37/220.51  |- mesh__dateRevised mesh__D011196 1993-06-02
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D011196 2006
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D011196 1995
% 220.37/220.51  |- skos__prefLabel mesh__D011196 Potassium Permanganate
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D011196 1998
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D011196 2003
% 220.37/220.51  |- skos__broader mesh__D011196smesh__D017895
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D011196 2005
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D011196 1994
% 220.37/220.51  |- mesh__dateCreated mesh__D005957 1974-11-19
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D005957 2004
% 220.37/220.51  |- mesh__recordAuthorizer mesh__D005957 sjn
% 220.37/220.51  |- skos__altLabel mesh__D005957 Glucosephosphate Uridylyltransferase
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D005957 2005
% 220.37/220.51  |- mesh__recordOriginator mesh__D005957 NLM
% 220.37/220.51  |- skos__historyNote mesh__D005957 Glucosephosphates %28%1972-1974%29%
% 220.37/220.51  |- skos__prefLabel mesh__D005957
% 220.37/220.51       UTP-Glucose-1-Phosphate Uridylyltransferase
% 220.37/220.51  |- skos__altLabel mesh__D005957 UDPG Pyrophosphorylase
% 220.37/220.51  |- skos__broader mesh__D005957smesh__D009713
% 220.37/220.51  |- skos__hiddenLabel mesh__D005957 Pyrophosphorylase, UDP Glucose
% 220.37/220.51  |- mesh__historyNote mesh__D005957 98%28%75%29%   
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D005957 2006
% 220.37/220.51  |- skos__historyNote mesh__D005957
% 220.37/220.51       Nucleotidyltransferases %28%1972-1974%29%
% 220.37/220.51  |- skos__hiddenLabel mesh__D005957 Uridylyltransferase, Glucosephosphate
% 220.37/220.51  |- mesh__dateEstablished mesh__D005957 1991-01-01
% 220.37/220.51  |- rdf__type mesh__D005957sskos__Concept
% 220.37/220.51  |- mesh__publicMeSHNote mesh__D005957
% 220.37/220.51       98; see GLUCOSEPHOSPHATE URIDYLYLTRANSFERASE 1991-97; see NUCLEOTIDYLTRANSFERASES 1975-90%A%  
% 220.37/220.51  |- mesh__dateRevised mesh__D005957 2003-07-09
% 220.37/220.51  |- skos__hiddenLabel mesh__D005957 Pyrophosphorylase, UDPG
% 220.37/220.51  |- skos__hiddenLabel mesh__D005957
% 220.37/220.51       UTP Glucose 1 Phosphate Uridylyltransferase
% 220.37/220.51  |- skos__historyNote mesh__D005957
% 220.37/220.51       Uridine Diphosphate Sugars %28%1973-1974%29%
% 220.37/220.51  |- skos__altLabel mesh__D005957 UDP Glucose Pyrophosphorylase
% 220.37/220.51  |- skos__hiddenLabel mesh__D005957
% 220.37/220.51       Uridylyltransferase, UTP-Glucose-1-Phosphate
% 220.37/220.51  |- mesh__recordMaintainer mesh__D005957 ssb
% 220.37/220.51  |- skos__scopeNote mesh__D005957
% 220.37/220.51       An enzyme that catalyzes the formation of UDPglucose from UTP plus glucose 1-phosphate. EC 2.7.7.9.%A%    
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D052004 2006
% 220.37/220.51  |- skos__altLabel mesh__D052004 BMP Receptor
% 220.37/220.51  |- skos__prefLabel mesh__D052004 Bone Morphogenetic Protein Receptors
% 220.37/220.51  |- skos__altLabel mesh__D052004 BMP Receptors
% 220.37/220.51  |- rdf__type mesh__D052004sskos__Concept
% 220.37/220.51  |- mesh__historyNote mesh__D052004 2006%28%1994%29%   
% 220.37/220.51  |- skos__broader mesh__D052004smesh__D017346
% 220.37/220.51  |- mesh__recordOriginator mesh__D052004 DRC
% 220.37/220.51  |- mesh__publicMeSHNote mesh__D052004
% 220.37/220.51       2006; BONE MORPHOGENETIC PROTEIN RECEPTORS was indexed under RECEPTORS, GROWTH FACTOR 2004-2005, %26% under RECEPTORS, CELL SURFACE 1994-2003%A%  
% 220.37/220.51  |- skos__hiddenLabel mesh__D052004 Receptors, BMP
% 220.37/220.51  |- skos__scopeNote mesh__D052004
% 220.37/220.51       A family of CELL SURFACE RECEPTORS that bind BONE MORPHOGENETIC PROTEINS. They are PROTEIN-SERINE-THREONINE KINASES that mediate SIGNAL TRANSDUCTION PATHWAYS through SMAD PROTEINS.%A%    
% 220.37/220.51  |- mesh__dateEstablished mesh__D052004 2006-01-01
% 220.37/220.51  |- mesh__recordAuthorizer mesh__D052004 sjn
% 220.37/220.51  |- skos__altLabel mesh__D052004 Receptor, BMP
% 220.37/220.51  |- mesh__dateCreated mesh__D052004 2005-06-30
% 220.37/220.51  |- skos__broader mesh__D052004smesh__D017978
% 220.37/220.51  |- mesh__recordMaintainer mesh__D052004 DRC
% 220.37/220.51  |- mesh__dateRevised mesh__D005159 1997-06-26
% 220.37/220.51  |- mesh__recordMaintainer mesh__D005159 TGC
% 220.37/220.51  |- mesh__recordOriginator mesh__D005159 NLM
% 220.37/220.51  |- skos__altLabel mesh__D005159
% 220.37/220.51       Healthcare Facilities, Manpower, and Services
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D005159 2006
% 220.37/220.51  |- skos__annotation mesh__D005159
% 220.37/220.51       not used for indexing      CATALOG: do not use   
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D005159 2001
% 220.37/220.51  |- mesh__historyNote mesh__D005159 98; use explode   
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D005159 2004
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D005159 2005
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D005159 1999
% 220.37/220.51  |- mesh__dateCreated mesh__D005159 1999-01-01
% 220.37/220.51  |- mesh__dateEstablished mesh__D005159 1998-01-01
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D005159 2000
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D005159 2003
% 220.37/220.51  |- skos__scopeNote mesh__D005159
% 220.37/220.51       The services provided in the delivery of health care, associated facilities in health care, and attendant manpower required or available.%A%    
% 220.37/220.51  |- mesh__publicMeSHNote mesh__D005159 98   
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D005159 1998
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D005159 2002
% 220.37/220.51  |- mesh__recordAuthorizer mesh__D005159 SJN
% 220.37/220.51  |- rdf__type mesh__D005159sskos__Concept
% 220.37/220.51  |- skos__prefLabel mesh__D005159
% 220.37/220.51       Health Care Facilities, Manpower, and Services
% 220.37/220.51  |- mesh__runningHead mesh__D005159
% 220.37/220.51       N2 - HEALTH CARE FACILITIES, MANPOWER, AND SERVICES   
% 220.37/220.51  |- skos__related mesh__D034741smesh__D035683
% 220.37/220.51  |- skos__related mesh__D034741smesh__D034622
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D034741 2006A
% 220.37/220.51  |- skos__hiddenLabel mesh__D034741 Interfering RNA, Small
% 220.37/220.51  |- mesh__historyNote mesh__D034741
% 220.37/220.51       2003; use RNA, SMALL INTERFERING %28%NM%29% 2001-2002   
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D034741 2003
% 220.37/220.51  |- rdf__type mesh__D034741sskos__Concept
% 220.37/220.51  |- skos__altLabel mesh__D034741 Small Interfering RNA
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D034741 2004
% 220.37/220.51  |- skos__broader mesh__D034741smesh__D016372
% 220.37/220.51  |- skos__related mesh__D034741smesh__D034743
% 220.37/220.51  |- mesh__recordOriginator mesh__D034741 nns
% 220.37/220.51  |- mesh__recordMaintainer mesh__D034741 ags
% 220.37/220.51  |- mesh__dateCreated mesh__D034741 2002-07-03
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D034741 2005
% 220.37/220.51  |- skos__altLabel mesh__D034741 siRNA
% 220.37/220.51  |- mesh__recordAuthorizer mesh__D034741 ags
% 220.37/220.51  |- skos__prefLabel mesh__D034741 RNA, Small Interfering
% 220.37/220.51  |- skos__scopeNote mesh__D034741
% 220.37/220.51       Small ANTISENSE RNAs %28%20 -25 nucleotides%29% that are generated from specific dsRNAs %28%RNA, DOUBLE-STRANDED%29% which trigger targeted mRNA %28%RNA, MESSENGER%29% degradation %28%RNA INTERFERENCE%29%. They serve as guides for the cleavage of homologous mRNA in the RNA-INDUCED SILENCING COMPLEX. The same ribonuclease, Dicer, that is required for processing of the dsRNAs to siRNA is also involved in processing MICRORNAS %28%miRNAs%29% from their precursor RNAs.%A%    
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D034741 2006
% 220.37/220.51  |- mesh__dateEstablished mesh__D034741 2003-01-01
% 220.37/220.51  |- skos__annotation mesh__D034741
% 220.37/220.51       Do not confuse with defective interfering RNA %28%diRNA%29%, a viral RNA of DEFECTIVE VIRUSES.%A%  
% 220.37/220.51  |- mesh__dateRevised mesh__D034741 2005-07-28
% 220.37/220.51  |- skos__broader mesh__D034741smesh__D022661
% 220.37/220.51  |- mesh__publicMeSHNote mesh__D034741
% 220.37/220.51       2003; RNA, SMALL INTERFERING was indexed under RNA, UNTRANSLATED 2001-2002%A%  
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D001567 2004
% 220.37/220.51  |- mesh__recordAuthorizer mesh__D001567 PLS
% 220.37/220.51  |- mesh__recordOriginator mesh__D001567 NLM
% 220.37/220.51  |- mesh__dateCreated mesh__D001567 1999-01-01
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D001567 2000
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D001567 1997
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D001567 2005
% 220.37/220.51  |- mesh__publicMeSHNote mesh__D001567 68   
% 220.37/220.51  |- skos__prefLabel mesh__D001567 Benzocycloheptenes
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D001567 2001
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D001567 1998
% 220.37/220.51  |- mesh__dateRevised mesh__D001567 1992-05-08
% 220.37/220.51  |- mesh__historyNote mesh__D001567 68   
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D001567 2006
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D001567 1993
% 220.37/220.51  |- rdf__type mesh__D001567sskos__Concept
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D001567 2002
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D001567 1999
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D001567 1994
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D001567 2003
% 220.37/220.51  |- skos__broader mesh__D001567smesh__D011084
% 220.37/220.51  |- mesh__dateEstablished mesh__D001567 1968-01-01
% 220.37/220.51  |- mesh__recordMaintainer mesh__D001567 PLS
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D001567 1995
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D001567 1996
% 220.37/220.51  |- skos__annotation mesh__D020721
% 220.37/220.51       coordinate with specific autoimmune disease but note specifics indented here%A%  
% 220.37/220.51  |- skos__altLabel mesh__D020721 Autoimmune Disease Models, Nervous System
% 220.37/220.51  |- skos__altLabel mesh__D020721 Nervous System Autoimmune Disease Models
% 220.37/220.51  |- mesh__dateRevised mesh__D020721 2004-07-13
% 220.37/220.51  |- skos__altLabel mesh__D020721 Myositis, Experimental Autoimmune
% 220.37/220.51  |- skos__hiddenLabel mesh__D020721 Experimental Myositis, Autoimmune
% 220.37/220.51  |- skos__hiddenLabel mesh__D020721 Autoimmune Experimental Myositis
% 220.37/220.51  |- skos__prefLabel mesh__D020721
% 220.37/220.51       Nervous System Autoimmune Disease, Experimental
% 220.37/220.51  |- skos__altLabel mesh__D020721 Experimental Autoimmune Myositis
% 220.37/220.51  |- mesh__dateEstablished mesh__D020721 2000-01-01
% 220.37/220.51  |- mesh__dateCreated mesh__D020721 1999-11-05
% 220.37/220.51  |- skos__broader mesh__D020721smesh__D020274
% 220.37/220.51  |- skos__broader mesh__D020721smesh__D004195
% 220.37/220.51  |- skos__scopeNote mesh__D020721
% 220.37/220.51       Experimental animal models for human AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM. They include GUILLAIN-BARRE SYNDROME %28%see NEURITIS, AUTOIMMUNE, EXPERIMENTAL%29%; MYASTHENIA GRAVIS %28%see MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL%29%; and MULTIPLE SCLEROSIS %28%see ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL%29%.%A%    
% 220.37/220.51  |- mesh__publicMeSHNote mesh__D020721
% 220.37/220.51       2005; see DISEASE MODELS, AUTOIMMUNE, NERVOUS SYSTEM 2000-2004%A%  
% 220.37/220.51  |- skos__historyNote mesh__D020721 Disease Models, Animal %28%1967-1999%29%
% 220.37/220.51  |- mesh__historyNote mesh__D020721 2005 %28%2000%29%   
% 220.37/220.51  |- mesh__recordMaintainer mesh__D020721 sjn
% 220.37/220.51  |- skos__altLabel mesh__D020721 Disease Models, Autoimmune, Nervous System
% 220.37/220.51  |- skos__altLabel mesh__D020721 Myositis, Autoimmune Experimental
% 220.37/220.51  |- mesh__recordAuthorizer mesh__D020721 sjn
% 220.37/220.51  |- rdf__type mesh__D020721sskos__Concept
% 220.37/220.51  |- skos__historyNote mesh__D020721 Autoimmune Diseases %28%1973-1999%29%
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D020721 2005
% 220.37/220.51  |- mesh__recordOriginator mesh__D020721 KEV
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D020721 2006
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D006252 1995
% 220.37/220.51  |- skos__scopeNote mesh__D006252
% 220.37/220.51       An enduring attitude or sentiment toward persons or objects manifested by anger, aversion and desire for the misfortune of others.%A%    
% 220.37/220.51  |- skos__broader mesh__D006252smesh__D004644
% 220.37/220.51  |- mesh__dateRevised mesh__D006252 1989-04-28
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D006252 1990
% 220.37/220.51  |- skos__prefLabel mesh__D006252 Hate
% 220.37/220.51  |- rdf__type mesh__D006252sskos__Concept
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D006252 2003
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D006252 1994
% 220.37/220.51  |- mesh__recordOriginator mesh__D006252 NLM
% 220.37/220.51  |- mesh__recordAuthorizer mesh__D006252 PLS
% 220.37/220.51  |- skos__hiddenLabel mesh__D006252 Hates
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D006252 1993
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D006252 1999
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D006252 2002
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D006252 1992
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D006252 1998
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D006252 2006
% 220.37/220.51  |- skos__annotation mesh__D006252 no qualif   
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D006252 1997
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D006252 2001
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D006252 2000
% 220.37/220.51  |- mesh__activeMeSHYear mesh__D006252 2005
% 220.37/220.51  |- mesh__recordMaintainer mesh__D006252 TGC
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D006252 1991
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D006252 1996
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D006252 2004
% 220.37/220.52  |- mesh__dateCreated mesh__D006252 1999-01-01
% 220.37/220.52  |- skos__prefLabel mesh__D047669 Exteins
% 220.37/220.52  |- mesh__historyNote mesh__D047669 2005   
% 220.37/220.52  |- mesh__publicMeSHNote mesh__D047669 2005   
% 220.37/220.52  |- mesh__recordOriginator mesh__D047669 nns
% 220.37/220.52  |- mesh__recordMaintainer mesh__D047669 nns
% 220.37/220.52  |- skos__scopeNote mesh__D047669
% 220.37/220.52       The %28%EXternal proTEIN%29% sequences flanking INTEINS, which are internal fragments of precursor proteins removed by PROTEIN SPLICING.  Concomitantly, as the inteins are excised, the exteins are ligated to form mature proteins.%A%    
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D047669 2006
% 220.37/220.52  |- mesh__dateEstablished mesh__D047669 2005-01-01
% 220.37/220.52  |- rdf__type mesh__D047669sskos__Concept
% 220.37/220.52  |- skos__broader mesh__D047669smesh__D000595
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D047669 2005
% 220.37/220.52  |- skos__related mesh__D047669smesh__D019154
% 220.37/220.52  |- mesh__recordAuthorizer mesh__D047669 sjn
% 220.37/220.52  |- mesh__dateCreated mesh__D047669 2004-07-07
% 220.37/220.52  |- skos__hiddenLabel mesh__D047669 Extein
% 220.37/220.52  |- skos__related mesh__D047669smesh__D047668
% 220.37/220.52  |- skos__hiddenLabel mesh__D011995 Genetic Recombinations
% 220.37/220.52  |- mesh__dateRevised mesh__D011995 2005-07-12
% 220.37/220.52  |- skos__related mesh__D011995smesh__D016865
% 220.37/220.52  |- mesh__recordMaintainer mesh__D011995 ags
% 220.37/220.52  |- skos__altLabel mesh__D011995 Genetic Recombination
% 220.37/220.52  |- skos__broader mesh__D011995smesh__D039361
% 220.37/220.52  |- skos__hiddenLabel mesh__D011995 Recombinations, Genetic
% 220.37/220.52  |- mesh__publicMeSHNote mesh__D011995 68   
% 220.37/220.52  |- mesh__dateEstablished mesh__D011995 1968-01-01
% 220.37/220.52  |- skos__hiddenLabel mesh__D011995 Recombinations
% 220.37/220.52  |- mesh__historyNote mesh__D011995 68   
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011995 2006A
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011995 2006
% 220.37/220.52  |- skos__historyNote mesh__D011995 Genetics %28%1966-1967%29%
% 220.37/220.52  |- mesh__recordOriginator mesh__D011995 NLM
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011995 2004
% 220.37/220.52  |- mesh__recordAuthorizer mesh__D011995 ags
% 220.37/220.52  |- skos__altLabel mesh__D011995 Recombination
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011995 2005
% 220.37/220.52  |- skos__prefLabel mesh__D011995 Recombination, Genetic
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011995 2003
% 220.37/220.52  |- mesh__dateCreated mesh__D011995 1999-01-01
% 220.37/220.52  |- rdf__type mesh__D011995sskos__Concept
% 220.37/220.52  |- skos__scopeNote mesh__D011995
% 220.37/220.52       Production of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses.%A%    
% 220.37/220.52  |- skos__prefLabel mesh__D011197 Potassium Radioisotopes
% 220.37/220.52  |- mesh__historyNote mesh__D011197 75   
% 220.37/220.52  |- skos__broader mesh__D011197smesh__D011868
% 220.37/220.52  |- skos__annotation mesh__D011197
% 220.37/220.52       K-37,38,40,42-45; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 220.37/220.52  |- mesh__recordMaintainer mesh__D011197 TPW
% 220.37/220.52  |- mesh__recordOriginator mesh__D011197 NLM
% 220.37/220.52  |- mesh__recordAuthorizer mesh__D011197 PLS
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011197 1997
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011197 1999
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011197 2004
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011197 2002
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011197 1996
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011197 2006
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011197 1995
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011197 1998
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011197 2003
% 220.37/220.52  |- skos__broader mesh__D011197smesh__D011194
% 220.37/220.52  |- skos__scopeNote mesh__D011197
% 220.37/220.52       Unstable isotopes of potassium that decay or disintegrate emitting radiation. K atoms with atomic weights 37, 38, 40, and 42-45 are radioactive potassium isotopes.%A%    
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011197 2001
% 220.37/220.52  |- skos__historyNote mesh__D011197 Radioisotopes %28%1966-1974%29%
% 220.37/220.52  |- skos__historyNote mesh__D011197 Potassium Isotopes %28%1966-1974%29%
% 220.37/220.52  |- mesh__onlineNote mesh__D011197 search POTASSIUM ISOTOPES 1966-74   
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011197 2005
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011197 1994
% 220.37/220.52  |- mesh__dateCreated mesh__D011197 1974-11-11
% 220.37/220.52  |- mesh__publicMeSHNote mesh__D011197 75   
% 220.37/220.52  |- mesh__dateEstablished mesh__D011197 1975-09-01
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011197 2000
% 220.37/220.52  |- skos__hiddenLabel mesh__D011197 Radioisotopes, Potassium
% 220.37/220.52  |- rdf__type mesh__D011197sskos__Concept
% 220.37/220.52  |- mesh__dateRevised mesh__D011197 1993-06-04
% 220.37/220.52  |- mesh__dateCreated mesh__D005958 1999-01-01
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D005958 2006
% 220.37/220.52  |- skos__prefLabel mesh__D005958 Glucosephosphates
% 220.37/220.52  |- rdf__type mesh__D005958sskos__Concept
% 220.37/220.52  |- mesh__recordMaintainer mesh__D005958 ssb
% 220.37/220.52  |- skos__broader mesh__D005958smesh__D006600
% 220.37/220.52  |- mesh__recordAuthorizer mesh__D005958 sjn
% 220.37/220.52  |- skos__historyNote mesh__D005958 Hexosephosphates %28%1966-1971%29%
% 220.37/220.52  |- mesh__dateRevised mesh__D005958 2004-07-07
% 220.37/220.52  |- skos__historyNote mesh__D005958 Glucose %28%1966-1970%29%
% 220.37/220.52  |- mesh__dateEstablished mesh__D005958 1973-01-01
% 220.37/220.52  |- mesh__publicMeSHNote mesh__D005958 73   
% 220.37/220.52  |- mesh__recordOriginator mesh__D005958 NLM
% 220.37/220.52  |- mesh__historyNote mesh__D005958 73%28%71%29%   
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D005958 2005
% 220.37/220.52  |- mesh__historyNote mesh__D016680 92   
% 220.37/220.52  |- skos__broader mesh__D016680smesh__D016678
% 220.37/220.52  |- skos__historyNote mesh__D016680 DNA, Bacterial %28%1966-1991%29%
% 220.37/220.52  |- mesh__dateEstablished mesh__D016680 1992-01-01
% 220.37/220.52  |- skos__annotation mesh__D016680
% 220.37/220.52       coordinate IM with specific bacterium /genet %28%IM%29%; DF: GENOME BACT%A%  
% 220.37/220.52  |- skos__altLabel mesh__D016680 Bacterial Genome
% 220.37/220.52  |- mesh__dateCreated mesh__D016680 1991-02-11
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D016680 2006
% 220.37/220.52  |- mesh__publicMeSHNote mesh__D016680 92   
% 220.37/220.52  |- mesh__recordMaintainer mesh__D016680 nns
% 220.37/220.52  |- mesh__dateRevised mesh__D016680 2005-06-30
% 220.37/220.52  |- skos__related mesh__D016680smesh__D005798
% 220.37/220.52  |- mesh__recordAuthorizer mesh__D016680 sjn
% 220.37/220.52  |- skos__scopeNote mesh__D016680
% 220.37/220.52       The genetic complement of a BACTERIA as represented in its DNA.%A%    
% 220.37/220.52  |- skos__prefLabel mesh__D016680 Genome, Bacterial
% 220.37/220.52  |- skos__altLabel mesh__D016680 Bacterial Genomes
% 220.37/220.52  |- rdf__type mesh__D016680sskos__Concept
% 220.37/220.52  |- mesh__recordOriginator mesh__D016680 PXP
% 220.37/220.52  |- skos__historyNote mesh__D016680 Base Sequence %28%1971-1991%29%
% 220.37/220.52  |- skos__altLabel mesh__D016680 Genomes, Bacterial
% 220.37/220.52  |- skos__altLabel mesh__D052005 Type I Bone Morphogenetic Protein Receptors
% 220.37/220.52  |- rdf__type mesh__D052005sskos__Concept
% 220.37/220.52  |- skos__altLabel mesh__D052005 Serine-Threonine Protein Kinase Receptor R6
% 220.37/220.52  |- skos__scopeNote mesh__D052005
% 220.37/220.52       A subtype of bone morphogenetic protein receptors with high affinity for BONE MORPHOGENETIC PROTEINS. They can interact with and undergo PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II. They signal primarily through RECEPTOR-REGULATED SMAD PROTEINS.%A%    
% 220.37/220.52  |- mesh__recordOriginator mesh__D052005 DRC
% 220.37/220.52  |- skos__altLabel mesh__D052005 BMPR-IB Receptor
% 220.37/220.52  |- mesh__dateRevised mesh__D052005 2005-08-03
% 220.37/220.52  |- skos__broader mesh__D052005smesh__D052004
% 220.37/220.52  |- skos__hiddenLabel mesh__D052005 BMPR I Receptors
% 220.37/220.52  |- skos__hiddenLabel mesh__D052005 BMPR IA Receptor
% 220.37/220.52  |- skos__altLabel mesh__D052005 BMPR-IA Receptor
% 220.37/220.52  |- skos__altLabel mesh__D052005 BMP Type I Receptor
% 220.37/220.52  |- mesh__recordMaintainer mesh__D052005 ags
% 220.37/220.52  |- skos__hiddenLabel mesh__D052005 Activin Receptor Like Kinase 6
% 220.37/220.52  |- mesh__historyNote mesh__D052005 2006%28%1994%29%   
% 220.37/220.52  |- skos__altLabel mesh__D052005 BMP Type IB Receptor
% 220.37/220.52  |- skos__hiddenLabel mesh__D052005 Activin Receptor Like Kinase 3
% 220.37/220.52  |- skos__altLabel mesh__D052005 Activin Receptor-Like Kinase 3
% 220.37/220.52  |- mesh__publicMeSHNote mesh__D052005
% 220.37/220.52       2006; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I was indexed under PROTEIN-SERINE-THREONINE KINASES %26% RECEPTORS, GROWTH FACTOR 1994-2005%A%  
% 220.37/220.52  |- skos__altLabel mesh__D052005 BMP Type IA Receptor
% 220.37/220.52  |- skos__hiddenLabel mesh__D052005
% 220.37/220.52       Serine Threonine Protein Kinase Receptor R6
% 220.37/220.52  |- skos__prefLabel mesh__D052005
% 220.37/220.52       Bone Morphogenetic Protein Receptors, Type I
% 220.37/220.52  |- mesh__dateEstablished mesh__D052005 2006-01-01
% 220.37/220.52  |- skos__altLabel mesh__D052005 Activin Receptor-Like Kinase 6
% 220.37/220.52  |- skos__altLabel mesh__D052005 Type IA Bone Morphogenetic Protein Receptor
% 220.37/220.52  |- skos__altLabel mesh__D052005 BMPR-I Receptors
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D052005 2006A
% 220.37/220.52  |- mesh__recordAuthorizer mesh__D052005 ags
% 220.37/220.52  |- skos__altLabel mesh__D052005 Bone Morphogenetic Protein Receptor Type I
% 220.37/220.52  |- skos__altLabel mesh__D052005 Type IB Bone Morphogenetic Protein Receptor
% 220.37/220.52  |- skos__hiddenLabel mesh__D052005 BMPR IB Receptor
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D052005 2006
% 220.37/220.52  |- mesh__dateCreated mesh__D052005 2005-06-30
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D002660 1991
% 220.37/220.52  |- skos__prefLabel mesh__D002660 Child Guidance
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D002660 2000
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D002660 2003
% 220.37/220.52  |- mesh__dateRevised mesh__D002660 1989-04-28
% 220.37/220.52  |- skos__hiddenLabel mesh__D002660 Guidance, Child
% 220.37/220.52  |- skos__annotation mesh__D002660
% 220.37/220.52       SPEC; SPEC qualif; check also tag CHILD or specific   
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D002660 2006
% 220.37/220.52  |- skos__hiddenLabel mesh__D002660 Child Guidances
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D002660 2002
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D002660 1997
% 220.37/220.52  |- mesh__recordMaintainer mesh__D002660 TGC
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D002660 1990
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D002660 2005
% 220.37/220.52  |- skos__hiddenLabel mesh__D002660 Guidances, Child
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D002660 1996
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D002660 1993
% 220.37/220.52  |- mesh__dateCreated mesh__D002660 1999-01-01
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D002660 1999
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D002660 1992
% 220.37/220.52  |- skos__broader mesh__D002660smesh__D008605
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D002660 2001
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D002660 1995
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D002660 1998
% 220.37/220.52  |- skos__scopeNote mesh__D002660
% 220.37/220.52       The psychiatric, sociological and psychological study and treatment of the developing child with emphasis on preventive or prophylactic measures focused on the familial, educational and socio-environmental milieu of the child.%A%    
% 220.37/220.52  |- skos__broader mesh__D002660smesh__D011588
% 220.37/220.52  |- mesh__recordOriginator mesh__D002660 NLM
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D002660 2004
% 220.37/220.52  |- rdf__type mesh__D002660sskos__Concept
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D002660 1994
% 220.37/220.52  |- mesh__recordAuthorizer mesh__D002660 PLS
% 220.37/220.52  |- skos__broader mesh__D004912Q000002smesh__D004912
% 220.37/220.52  |- mesh__preferredCombination mesh__D004912Q000002smesh__D004913
% 220.37/220.52  |- rdf__type mesh__D004912Q000002smesh__CompoundConcept
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Intraobserver Variations
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Variabilities, Inter-Observer
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D015588 1999
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Inter-Observer Variabilities
% 220.37/220.52  |- skos__altLabel mesh__D015588 Intra-Observer Variation
% 220.37/220.52  |- skos__annotation mesh__D015588
% 220.37/220.52       IM GEN only; coord NIM with disease /epidemiol %28%IM%29% or specific non-disease term /statist %28%IM%29%; no qualif; specify geog if pertinent%A%  
% 220.37/220.52  |- skos__altLabel mesh__D015588 Observer Bias
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Variabilities, Intraobserver
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Inter-Observer Variations
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Variabilities, Intra-Observer
% 220.37/220.52  |- skos__altLabel mesh__D015588 Inter-Observer Variation
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D015588 2004
% 220.37/220.52  |- rdf__type mesh__D015588sskos__Concept
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Intra-Observer Variations
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Variations, Intra-Observer
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Intra-Observer Variabilities
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Variations, Interobserver
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Variations, Inter-Observer
% 220.37/220.52  |- mesh__historyNote mesh__D015588 90   
% 220.37/220.52  |- mesh__recordMaintainer mesh__D015588 PXP
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Intra Observer Variation
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D015588 2000
% 220.37/220.52  |- skos__altLabel mesh__D015588 Intra-Observer Variability
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Variations, Intraobserver
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Variability, Interobserver
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Variation, Interobserver
% 220.37/220.52  |- mesh__dateCreated mesh__D015588 1989-05-25
% 220.37/220.52  |- skos__altLabel mesh__D015588 Inter-Observer Variability
% 220.37/220.52  |- mesh__recordOriginator mesh__D015588 EGC
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Variabilities, Interobserver
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Variability, Inter-Observer
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Variation, Intraobserver
% 220.37/220.52  |- mesh__publicMeSHNote mesh__D015588 90   
% 220.37/220.52  |- skos__broader mesh__D015588smesh__D003951
% 220.37/220.52  |- skos__altLabel mesh__D015588 Interobserver Variability
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Observer Variations
% 220.37/220.52  |- skos__altLabel mesh__D015588 Bias, Observer
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D015588 2001
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Intra Observer Variability
% 220.37/220.52  |- skos__scopeNote mesh__D015588
% 220.37/220.52       The failure by the observer to measure or identify a phenomenon accurately, which results in an error. Sources for this may be due to the observer%27%s missing an abnormality, or to faulty technique resulting in incorrect test measurement, or to misinterpretation of the data. Two varieties are inter-observer variation %28%the amount observers vary from one another when reporting on the same material%29% and intra-observer variation %28%the amount one observer varies between observations when reporting more than once on the same material%29%.%A%    
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Variability, Intraobserver
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Variation, Observer
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Inter Observer Variation
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D015588 2005
% 220.37/220.52  |- mesh__dateRevised mesh__D015588 1997-06-20
% 220.37/220.52  |- skos__broader mesh__D015588smesh__D019300
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Intraobserver Variabilities
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Variation, Inter-Observer
% 220.37/220.52  |- skos__prefLabel mesh__D015588 Observer Variation
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D015588 2002
% 220.37/220.52  |- skos__broader mesh__D015588smesh__D015981
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D015588 1998
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Inter Observer Variability
% 220.37/220.52  |- mesh__dateEstablished mesh__D015588 1990-01-01
% 220.37/220.52  |- skos__altLabel mesh__D015588 Intraobserver Variability
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D015588 2006
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Interobserver Variabilities
% 220.37/220.52  |- skos__broader mesh__D015588smesh__D015982
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Variations, Observer
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D015588 2003
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Interobserver Variations
% 220.37/220.52  |- mesh__recordAuthorizer mesh__D015588 SJN
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Variation, Intra-Observer
% 220.37/220.52  |- skos__hiddenLabel mesh__D015588 Variability, Intra-Observer
% 220.37/220.52  |- skos__hiddenLabel mesh__D034742 E-Mails
% 220.37/220.52  |- skos__hiddenLabel mesh__D034742 Mail, Electronic
% 220.37/220.52  |- skos__hiddenLabel mesh__D034742 Emails
% 220.37/220.52  |- mesh__dateEstablished mesh__D034742 2003-01-01
% 220.37/220.52  |- skos__broader mesh__D034742smesh__D015709
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D034742 2006
% 220.37/220.52  |- rdf__type mesh__D034742sskos__Concept
% 220.37/220.52  |- skos__altLabel mesh__D034742 Email
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D034742 2003
% 220.37/220.52  |- mesh__historyNote mesh__D034742
% 220.37/220.52       2003; use COMPUTER COMMUNICATION NETWORKS 1996-2002; use OFFICE AUTOMATION 1987-1995%A%  
% 220.37/220.52  |- skos__hiddenLabel mesh__D034742 E Mail
% 220.37/220.52  |- skos__broader mesh__D034742smesh__D013685
% 220.37/220.52  |- skos__prefLabel mesh__D034742 Electronic Mail
% 220.37/220.52  |- skos__scopeNote mesh__D034742
% 220.37/220.52       Messages between computer users via COMPUTER COMMUNICATION NETWORKS.  This feature duplicates most of the features of paper mail, such as forwarding, multiple copies, and attachments of images and other file types, but with a speed advantage. The term also refers to an individual message sent in this way.%A%    
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D034742 2004
% 220.37/220.52  |- mesh__dateCreated mesh__D034742 2002-07-03
% 220.37/220.52  |- skos__altLabel mesh__D034742 E-Mail
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D034742 2005
% 220.37/220.52  |- mesh__publicMeSHNote mesh__D034742
% 220.37/220.52       2003; see COMPUTER COMMUNICATION NETWORKS 1996-2002; see OFFICE AUTOMATION 1987-1995%A%  
% 220.37/220.52  |- skos__historyNote mesh__D034742
% 220.37/220.52       Computer Communication Networks %28%1995-2002%29%
% 220.37/220.52  |- mesh__recordMaintainer mesh__D012290 ssb
% 220.37/220.52  |- mesh__dateRevised mesh__D012290 2005-06-30
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D012290 2006
% 220.37/220.52  |- mesh__dateCreated mesh__D012290 1976-05-25
% 220.37/220.52  |- skos__prefLabel mesh__D012290 Rickettsial Vaccines
% 220.37/220.52  |- mesh__recordAuthorizer mesh__D012290 sjn
% 220.37/220.52  |- skos__hiddenLabel mesh__D012290 Vaccines, Rickettsial
% 220.37/220.52  |- rdf__type mesh__D012290sskos__Concept
% 220.37/220.52  |- mesh__dateEstablished mesh__D012290 1991-01-01
% 220.37/220.52  |- mesh__publicMeSHNote mesh__D012290 91; was see under VACCINES 1973-90   
% 220.37/220.52  |- mesh__recordOriginator mesh__D012290 FPG
% 220.37/220.52  |- skos__scopeNote mesh__D012290
% 220.37/220.52       Vaccines for the prevention of diseases caused by various species of Rickettsia.%A%    
% 220.37/220.52  |- skos__broader mesh__D012290smesh__D001428
% 220.37/220.52  |- skos__annotation mesh__D012290
% 220.37/220.52       coord IM with specific Rickettsia /immunol %28%IM%29%   
% 220.37/220.52  |- mesh__historyNote mesh__D012290
% 220.37/220.52       91%28%73%29%; was see under VACCINES 1973-90   
% 220.37/220.52  |- skos__prefLabel mesh__D020722 Glucuronic Acids
% 220.37/220.52  |- mesh__dateCreated mesh__D020722 1999-11-03
% 220.37/220.52  |- skos__broader mesh__D020722smesh__D014574
% 220.37/220.52  |- mesh__recordAuthorizer mesh__D020722 sjn
% 220.37/220.52  |- mesh__dateEstablished mesh__D020722 2000-01-01
% 220.37/220.52  |- mesh__historyNote mesh__D020722
% 220.37/220.52       2000; use GLUCURONIC ACID %28%NM%29% 1981-1999   
% 220.37/220.52  |- rdf__type mesh__D020722sskos__Concept
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D020722 2005
% 220.37/220.52  |- mesh__publicMeSHNote mesh__D020722
% 220.37/220.52       2000; GLUCURONIC ACID was indexed under GLUCURONATES 1981-1999%A%  
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D020722 2006
% 220.37/220.52  |- skos__hiddenLabel mesh__D020722 Acids, Glucuronic
% 220.37/220.52  |- skos__annotation mesh__D020722 GLUCURONIC ACID is available   
% 220.37/220.52  |- mesh__recordOriginator mesh__D020722 adp
% 220.37/220.52  |- mesh__dateRevised mesh__D020722 2004-07-07
% 220.37/220.52  |- skos__scopeNote mesh__D020722
% 220.37/220.52       Derivatives of uronic acid that are distributed widely throughout the plant and animal kingdoms.%A%    
% 220.37/220.52  |- mesh__recordMaintainer mesh__D020722 ssb
% 220.37/220.52  |- mesh__historyNote mesh__D006253 73%28%64%29%   
% 220.37/220.52  |- skos__hiddenLabel mesh__D006253 Osteons
% 220.37/220.52  |- skos__prefLabel mesh__D006253 Haversian System
% 220.37/220.52  |- mesh__recordAuthorizer mesh__D006253 sjn
% 220.37/220.52  |- skos__altLabel mesh__D006253 Osteon
% 220.37/220.52  |- mesh__dateEstablished mesh__D006253 1973-01-01
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D006253 2006
% 220.37/220.52  |- mesh__recordOriginator mesh__D006253 NLM
% 220.37/220.52  |- skos__hiddenLabel mesh__D006253 Canals, Haversian
% 220.37/220.52  |- skos__broader mesh__D006253smesh__D001842
% 220.37/220.52  |- skos__altLabel mesh__D006253 Haversian Canals
% 220.37/220.52  |- mesh__recordMaintainer mesh__D006253 ags
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D006253 2005
% 220.37/220.52  |- skos__hiddenLabel mesh__D006253 Canal, Nutrient
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D006253 2002
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D006253 2004
% 220.37/220.52  |- skos__hiddenLabel mesh__D006253 System, Haversian
% 220.37/220.52  |- mesh__dateRevised mesh__D006253 2001-07-25
% 220.37/220.52  |- mesh__dateCreated mesh__D006253 1999-01-01
% 220.37/220.52  |- skos__hiddenLabel mesh__D006253 Nutrient Canal
% 220.37/220.52  |- skos__hiddenLabel mesh__D006253 Canals, Nutrient
% 220.37/220.52  |- rdf__type mesh__D006253sskos__Concept
% 220.37/220.52  |- mesh__publicMeSHNote mesh__D006253 73   
% 220.37/220.52  |- skos__scopeNote mesh__D006253
% 220.37/220.52       A circular structural unit of bone tissue. It consists of a central hole, the Haversian canal through which blood vessels run, surrounded by concentric rings, called lamellae.%A%    
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D006253 2003
% 220.37/220.52  |- skos__hiddenLabel mesh__D011996 Systems, Personal Identification
% 220.37/220.52  |- mesh__publicMeSHNote mesh__D011996 68   
% 220.37/220.52  |- skos__hiddenLabel mesh__D011996 Document, Travel
% 220.37/220.52  |- skos__annotation mesh__D011996
% 220.37/220.52       GEN or unspecified; prefer specifics; vet records go here %28%IM%29% + VETERINARY MEDICINE %28%IM%29%; case reports as a form of writing probably goes under MEDICAL RECORDS or specific records term %28%IM%29%; FORMS AND RECORDS CONTROL is also available%A%  
% 220.37/220.52  |- mesh__dateEstablished mesh__D011996 1968-01-01
% 220.37/220.52  |- skos__hiddenLabel mesh__D011996 System, Personal Identification
% 220.37/220.52  |- skos__historyNote mesh__D011996 Dental Records %28%1967%29%
% 220.37/220.52  |- skos__scopeNote mesh__D011996
% 220.37/220.52       The commitment in writing, as authentic evidence, of something having legal importance. The concept includes certificates of birth, death, etc., as well as hospital, medical, and other institutional records.%A%    
% 220.37/220.52  |- skos__hiddenLabel mesh__D011996 Identification System, Personal
% 220.37/220.52  |- skos__hiddenLabel mesh__D011996 Travel Document
% 220.37/220.52  |- skos__prefLabel mesh__D011996 Records
% 220.37/220.52  |- skos__broader mesh__D011996smesh__D003625
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011996 2006
% 220.37/220.52  |- skos__broader mesh__D011996smesh__D009934
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011996 2004
% 220.37/220.52  |- mesh__recordMaintainer mesh__D011996 tjk
% 220.37/220.52  |- skos__historyNote mesh__D011996 Medical Records %28%1966-1967%29%
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011996 2005
% 220.37/220.52  |- skos__hiddenLabel mesh__D011996 Identification Systems, Personal
% 220.37/220.52  |- skos__hiddenLabel mesh__D011996 Documents, Travel
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011996 2003
% 220.37/220.52  |- rdf__type mesh__D011996sskos__Concept
% 220.37/220.52  |- mesh__dateCreated mesh__D011996 1999-01-01
% 220.37/220.52  |- mesh__recordAuthorizer mesh__D011996 sjn
% 220.37/220.52  |- skos__hiddenLabel mesh__D011996 Personal Identification System
% 220.37/220.52  |- skos__historyNote mesh__D011996 Nursing Records %28%1967%29%
% 220.37/220.52  |- mesh__historyNote mesh__D011996 68   
% 220.37/220.52  |- mesh__dateRevised mesh__D011996 2002-07-03
% 220.37/220.52  |- mesh__recordOriginator mesh__D011996 NLM
% 220.37/220.52  |- skos__historyNote mesh__D011198 Plants, Edible %28%1966-1985%29%
% 220.37/220.52  |- skos__scopeNote mesh__D011198
% 220.37/220.52       A plant species of the genus SOLANUM, family SOLANACEAE. The starchy roots are used as food. SOLANINE is found in green parts.%A%    
% 220.37/220.52  |- mesh__dateRevised mesh__D011198 2005-08-01
% 220.37/220.52  |- skos__prefLabel mesh__D011198 Solanum tuberosum
% 220.37/220.52  |- skos__broader mesh__D011198smesh__D014675
% 220.37/220.52  |- mesh__publicMeSHNote mesh__D011198 2006; see POTATOES 1986-2005   
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011198 2006
% 220.37/220.52  |- mesh__dateEstablished mesh__D011198 1986-01-01
% 220.37/220.52  |- skos__broader mesh__D011198smesh__D032322
% 220.37/220.52  |- mesh__historyNote mesh__D011198 2006%28%1986%29%   
% 220.37/220.52  |- skos__historyNote mesh__D011198 Plants %28%1966-1985%29%
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D011198 2006A
% 220.37/220.52  |- mesh__recordMaintainer mesh__D011198 ags
% 220.37/220.52  |- skos__annotation mesh__D011198
% 220.37/220.52       Solanum tuberosum only: does not include sweet potatoes %28% = SWEET POTATO see IPOMOEA BATATAS%29%; coordinate with specific PLANT COMPONENTS term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.37/220.52  |- mesh__recordOriginator mesh__D011198 SH
% 220.37/220.52  |- mesh__dateCreated mesh__D011198 1985-05-03
% 220.37/220.52  |- skos__altLabel mesh__D011198 Potato
% 220.37/220.52  |- skos__historyNote mesh__D011198 Vegetables %28%1966-1985%29%
% 220.37/220.52  |- rdf__type mesh__D011198sskos__Concept
% 220.37/220.52  |- mesh__recordAuthorizer mesh__D011198 ags
% 220.37/220.52  |- mesh__recordOriginator mesh__D005959 NLM
% 220.37/220.52  |- rdf__type mesh__D005959sskos__Concept
% 220.37/220.52  |- skos__broader mesh__D005959smesh__D006026
% 220.37/220.52  |- mesh__dateRevised mesh__D005959 2003-07-09
% 220.37/220.52  |- skos__prefLabel mesh__D005959 Glucosidases
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D005959 2004
% 220.37/220.52  |- mesh__recordMaintainer mesh__D005959 ssb
% 220.37/220.52  |- mesh__publicMeSHNote mesh__D005959 75; was GLUCOSIDASE 1963-74   
% 220.37/220.52  |- mesh__recordAuthorizer mesh__D005959 sjn
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D005959 2005
% 220.37/220.52  |- skos__scopeNote mesh__D005959
% 220.37/220.52       Enzymes that hydrolyze O-glucosyl-compounds. %28%Enzyme Nomenclature, 1992%29% EC 3.2.1.-.%A%    
% 220.37/220.52  |- mesh__onlineNote mesh__D005959
% 220.37/220.52       use GLUCOSIDASES to search GLUCOSIDASE 1966-74   
% 220.37/220.52  |- mesh__historyNote mesh__D005959 75; was GLUCOSIDASE 1963-74   
% 220.37/220.52  |- mesh__dateCreated mesh__D005959 1999-01-01
% 220.37/220.52  |- skos__altLabel mesh__D005959 Glucosidase
% 220.37/220.52  |- mesh__activeMeSHYear mesh__D005959 2006
% 220.37/220.52  |- skos__scopeNote mesh__D016681
% 220.37/220.52       The complete gene complement contained in a set of chromosomes in a fungus.%A%    
% 220.37/220.52  |- mesh__recordAuthorizer mesh__D016681 sjn
% 220.37/220.52  |- skos__historyNote mesh__D016681 Base Sequence %28%1971-1991%29%
% 220.37/220.52  |- skos__prefLabel mesh__D016681 Genome, Fungal
% 220.37/220.52  |- mesh__dateEstablished mesh__D016681 1992-01-01
% 220.37/220.52  |- skos__related mesh__D016681smesh__D005800
% 220.37/220.52  |- rdf__type mesh__D016681sskos__Concept
% 220.37/220.52  |- skos__altLabel mesh__D016681 Fungal Genome
% 220.37/220.52  |- skos__broader mesh__D016681smesh__D016678
% 220.37/220.52  |- mesh__recordOriginator mesh__D016681 PXP
% 220.37/220.53  |- skos__historyNote mesh__D016681 Genes, Fungal %28%1984-1991%29%
% 220.37/220.53  |- skos__hiddenLabel mesh__D016681 Fungal Genomes
% 220.37/220.53  |- mesh__historyNote mesh__D016681 92   
% 220.37/220.53  |- skos__historyNote mesh__D016681 DNA, Fungal %28%1980-1991%29%
% 220.37/220.53  |- mesh__dateCreated mesh__D016681 1991-02-11
% 220.37/220.53  |- mesh__recordMaintainer mesh__D016681 nns
% 220.37/220.53  |- skos__hiddenLabel mesh__D016681 Genomes, Fungal
% 220.37/220.53  |- skos__annotation mesh__D016681
% 220.37/220.53       coordinate IM with specific fungus /genet %28%IM%29%   
% 220.37/220.53  |- mesh__publicMeSHNote mesh__D016681 92   
% 220.37/220.53  |- mesh__dateRevised mesh__D016681 2005-06-30
% 220.37/220.53  |- mesh__activeMeSHYear mesh__D016681 2006
% 220.37/220.53  |- mesh__historyNote mesh__D052006 2006%28%1995%29%   
% 220.37/220.53  |- skos__altLabel mesh__D052006 Bone Morphogenetic Protein Receptor Type II
% 220.37/220.53  |- mesh__recordOriginator mesh__D052006 DRC
% 220.37/220.53  |- skos__altLabel mesh__D052006 BMPR-II Receptor
% 220.37/220.53  |- mesh__activeMeSHYear mesh__D052006 2006
% 220.37/220.53  |- mesh__recordAuthorizer mesh__D052006 sjn
% 220.37/220.53  |- skos__altLabel mesh__D052006 BMP Type II Receptor
% 220.37/220.53  |- skos__scopeNote mesh__D052006
% 220.37/220.53       A subtype of bone morphogenetic protein receptors with low affinity for BONE MORPHOGENETIC PROTEINS. They are constitutively active PROTEIN-SERINE-THREONINE KINASES that can interact with and phosphorylate TYPE I BONE MORPHOGENETIC PROTEIN RECEPTORS.%A%    
% 220.37/220.53  |- skos__altLabel mesh__D052006 BMP Type II Receptors
% 220.37/220.53  |- mesh__dateEstablished mesh__D052006 2006-01-01
% 220.37/220.53  |- rdf__type mesh__D052006sskos__Concept
% 220.37/220.53  |- skos__broader mesh__D052006smesh__D052004
% 220.37/220.53  |- mesh__recordMaintainer mesh__D052006 DRC
% 220.37/220.53  |- skos__altLabel mesh__D052006 BMPR2 Receptor
% 220.37/220.53  |- mesh__publicMeSHNote mesh__D052006
% 220.37/220.53       2006; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II was indexed under PROTEIN-SERINE-THREONINE KINASES 1995-2005%A%  
% 220.37/220.53  |- skos__hiddenLabel mesh__D052006 Receptor, BMPR-II
% 220.37/220.53  |- skos__prefLabel mesh__D052006
% 220.37/220.53       Bone Morphogenetic Protein Receptors, Type II
% 220.37/220.53  |- skos__hiddenLabel mesh__D052006 Receptor, BMPR2
% 220.37/220.53  |- skos__hiddenLabel mesh__D052006 BMPR II Receptor
% 220.37/220.53  |- skos__altLabel mesh__D052006 Receptor, Type II BMP
% 220.37/220.53  |- mesh__dateCreated mesh__D052006 2005-06-30
% 220.37/220.53  |- skos__altLabel mesh__D052006 Bone Morphogenetic Protein Receptor II
% 220.37/220.53  |- skos__hiddenLabel mesh__D002661 Clinics, Child Guidance
% 220.37/220.53  |- mesh__activeMeSHYear mesh__D002661 2006
% 220.37/220.53  |- mesh__recordOriginator mesh__D002661 NLM
% 220.37/220.53  |- skos__prefLabel mesh__D002661 Child Guidance Clinics
% 220.37/220.53  |- mesh__activeMeSHYear mesh__D002661 2005
% 220.37/220.53  |- mesh__onlineNote mesh__D002661
% 220.37/220.53       search COMMUNITY MENTAL HEALTH SERVICES 1967-74   
% 220.37/220.53  |- mesh__dateEstablished mesh__D002661 1991-01-01
% 220.37/220.53  |- mesh__recordMaintainer mesh__D002661 kle
% 220.37/220.53  |- mesh__activeMeSHYear mesh__D002661 2000
% 220.37/220.53  |- mesh__historyNote mesh__D002661
% 220.37/220.53       91%28%75%29%; was see under COMMUNITY MENTAL HEALTH CENTERS 1979-90; was see under COMMUNITY MENTAL HEALTH SERVICES 1967-78%A%  
% 220.37/220.53  |- mesh__publicMeSHNote mesh__D002661
% 220.37/220.53       91; was see under COMMUNITY MENTAL HEALTH CENTERS 1979-90; was see under COMMUNITY MENTAL HEALTH SERVICES 1967-78%A%  
% 220.37/220.53  |- skos__hiddenLabel mesh__D002661 Child Guidance Clinic
% 220.38/220.53  |- mesh__dateCreated mesh__D002661 1999-01-01
% 220.38/220.53  |- skos__scopeNote mesh__D002661
% 220.38/220.53       Facilities which administer the delivery of mental health counseling services to children.%A%    
% 220.38/220.53  |- skos__annotation mesh__D002661 check also tag CHILD or specific   
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D002661 2002
% 220.38/220.53  |- skos__hiddenLabel mesh__D002661 Guidance Clinics, Child
% 220.38/220.53  |- skos__broader mesh__D002661smesh__D003155
% 220.38/220.53  |- rdf__type mesh__D002661sskos__Concept
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D002661 2004
% 220.38/220.53  |- skos__hiddenLabel mesh__D002661 Clinic, Child Guidance
% 220.38/220.53  |- skos__hiddenLabel mesh__D002661 Guidance Clinic, Child
% 220.38/220.53  |- mesh__dateRevised mesh__D002661 1999-11-03
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D002661 2003
% 220.38/220.53  |- mesh__recordAuthorizer mesh__D002661 sjn
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D002661 2001
% 220.38/220.53  |- mesh__dateEstablished mesh__D034743 2003-01-01
% 220.38/220.53  |- mesh__dateRevised mesh__D034743 2005-06-30
% 220.38/220.53  |- skos__hiddenLabel mesh__D034743 Nuclease, RISC Multicomponent
% 220.38/220.53  |- mesh__dateCreated mesh__D034743 2002-07-03
% 220.38/220.53  |- mesh__publicMeSHNote mesh__D034743
% 220.38/220.53       2003; RNA-INDUCED SILENCING COMPLEX was indexed under RIBONUCLEOPROTEINS 2001-2002%A%  
% 220.38/220.53  |- skos__hiddenLabel mesh__D034743 Silencing Complex, RNA-Induced
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D034743 2006
% 220.38/220.53  |- rdf__type mesh__D034743sskos__Concept
% 220.38/220.53  |- skos__broader mesh__D034743smesh__D012261
% 220.38/220.53  |- skos__hiddenLabel mesh__D034743 Multicomponent Nuclease, RISC
% 220.38/220.53  |- skos__related mesh__D034743smesh__D034622
% 220.38/220.53  |- skos__hiddenLabel mesh__D034743 RNA Induced Silencing Complex
% 220.38/220.53  |- mesh__recordMaintainer mesh__D034743 SYSTEM
% 220.38/220.53  |- skos__altLabel mesh__D034743 RISC Multicomponent Nuclease
% 220.38/220.53  |- skos__prefLabel mesh__D034743 RNA-Induced Silencing Complex
% 220.38/220.53  |- skos__related mesh__D034743smesh__D034741
% 220.38/220.53  |- skos__hiddenLabel mesh__D034743 Complex, RNA-Induced Silencing
% 220.38/220.53  |- skos__scopeNote mesh__D034743
% 220.38/220.53       A multicomponent, ribonucleoprotein complex that cleaves specific mRNAs %28%RNA, MESSENGER%29% which are targeted for degradation by homologous dsRNAs %28%RNA, DOUBLE-STRANDED%29% during the process of RNA INTERFERENCE. It includes siRNA %28%RNA, SMALL INTERFERING%29% that is generated from the specific dsRNA.%A%    
% 220.38/220.53  |- skos__historyNote mesh__D034743 Endoribonucleases %28%2001-2002%29%
% 220.38/220.53  |- skos__broader mesh__D034743smesh__D004722
% 220.38/220.53  |- mesh__historyNote mesh__D034743
% 220.38/220.53       2003; use RNA-INDUCED SILENCING COMPLEX %28%NM%29% 2001-2002   
% 220.38/220.53  |- mesh__recordOriginator mesh__D034743 nns
% 220.38/220.53  |- mesh__recordAuthorizer mesh__D034743 sjn
% 220.38/220.53  |- mesh__recordAuthorizer mesh__D001569 sjn
% 220.38/220.53  |- skos__broader mesh__D001569smesh__D001552
% 220.38/220.53  |- skos__related mesh__D001569smesh__D014151
% 220.38/220.53  |- skos__prefLabel mesh__D001569 Benzodiazepines
% 220.38/220.53  |- skos__annotation mesh__D001569 do not confuse with BENZODIAZEPINONES   
% 220.38/220.53  |- mesh__historyNote mesh__D001569 75   
% 220.38/220.53  |- skos__related mesh__D001569smesh__D011963
% 220.38/220.53  |- mesh__dateRevised mesh__D001569 2004-07-07
% 220.38/220.53  |- mesh__dateCreated mesh__D001569 1974-11-11
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D001569 2006
% 220.38/220.53  |- rdf__type mesh__D001569sskos__Concept
% 220.38/220.53  |- mesh__publicMeSHNote mesh__D001569 75   
% 220.38/220.53  |- mesh__recordMaintainer mesh__D001569 ssb
% 220.38/220.53  |- skos__altLabel mesh__D001569 Benzodiazepine Compounds
% 220.38/220.53  |- mesh__recordOriginator mesh__D001569 NLM
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D001569 2005
% 220.38/220.53  |- skos__historyNote mesh__D001569 Benzazepines %28%1968-1974%29%
% 220.38/220.53  |- mesh__dateEstablished mesh__D001569 1975-09-01
% 220.38/220.53  |- skos__scopeNote mesh__D001569
% 220.38/220.53       A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring. Permitted is any degree of hydrogenation, any substituents and any H-isomer.%A%    
% 220.38/220.53  |- mesh__recordOriginator mesh__D020723 adp
% 220.38/220.53  |- mesh__historyNote mesh__D020723
% 220.38/220.53       2000; use GLUCURONIC ACID %28%NM%29% 1981-1999   
% 220.38/220.53  |- mesh__recordMaintainer mesh__D020723 ssb
% 220.38/220.53  |- rdf__type mesh__D020723sskos__Concept
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D020723 2005
% 220.38/220.53  |- mesh__dateCreated mesh__D020723 1999-11-03
% 220.38/220.53  |- mesh__publicMeSHNote mesh__D020723
% 220.38/220.53       2000; GLUCURONIC ACID was indexed under GLUCURONATES 1981-1999%A%  
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D020723 2006
% 220.38/220.53  |- mesh__recordAuthorizer mesh__D020723 sjn
% 220.38/220.53  |- skos__historyNote mesh__D020723 Glucuronates %28%1981-1999%29%
% 220.38/220.53  |- skos__annotation mesh__D020723 GLUCURONIC ACIDS is available   
% 220.38/220.53  |- mesh__dateRevised mesh__D020723 2004-07-07
% 220.38/220.53  |- skos__prefLabel mesh__D020723 Glucuronic Acid
% 220.38/220.53  |- skos__scopeNote mesh__D020723
% 220.38/220.53       Derivatives of uronic acid found throughout the plant and animal kingdoms. They detoxify drugs and toxins by conjugating with them to form GLUCURONIDES in the liver which are more water-soluble metabolites that can be easily eliminated from the body.%A%    
% 220.38/220.53  |- skos__broader mesh__D020723smesh__D020722
% 220.38/220.53  |- mesh__dateEstablished mesh__D020723 2000-01-01
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D006254 2006
% 220.38/220.53  |- mesh__recordMaintainer mesh__D006254 mdb
% 220.38/220.53  |- skos__scopeNote mesh__D006254
% 220.38/220.53       A group of islands in Polynesia, in the north central Pacific Ocean, comprising eight major and 114 minor islands, largely volcanic and coral. Its capital is Honolulu. It was first reached by Polynesians about 500 A.D. It was discovered and named the Sandwich Islands in 1778 by Captain Cook. The islands were united under the rule of King Kamehameha 1795-1819 and requested annexation to the United States in 1893 when a provisional government was set up. Hawaii was established as a territory in 1900 and admitted as a state in 1959. The name is from the Polynesian Owhyhii, place of the gods, with reference to the two volcanoes Mauna Kea and Mauna Loa, regarded as the abode of the gods. %28%From Webster%27%s New Geographical Dictionary, 1988, p493 %26% Room, Brewer%27%s Dictionary of Names, 1992, p2330%29%%A%    
% 220.38/220.53  |- skos__altLabel mesh__D006254 Midway Islands
% 220.38/220.53  |- skos__broader mesh__D006254smesh__D019601
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D006254 2005
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D006254 2004
% 220.38/220.53  |- mesh__dateRevised mesh__D006254 2003-07-09
% 220.38/220.53  |- skos__annotation mesh__D006254
% 220.38/220.53       an island group in Polynesia; Hawaii is also the name of the largest island in the group%A%  
% 220.38/220.53  |- skos__prefLabel mesh__D006254 Hawaii
% 220.38/220.53  |- mesh__dateCreated mesh__D006254 1999-01-01
% 220.38/220.53  |- mesh__recordAuthorizer mesh__D006254 sjn
% 220.38/220.53  |- rdf__type mesh__D006254sskos__Concept
% 220.38/220.53  |- mesh__recordOriginator mesh__D006254 NLM
% 220.38/220.53  |- skos__broader mesh__D006254smesh__D011114
% 220.38/220.53  |- mesh__dateEstablished mesh__D011997 1979-01-01
% 220.38/220.53  |- skos__historyNote mesh__D011997 Intensive Care Units %28%1966-1974%29%
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011997 2006
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011997 2001
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011997 2004
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011997 2005
% 220.38/220.53  |- skos__altLabel mesh__D011997 Hospital Recovery Rooms
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011997 2000
% 220.38/220.53  |- mesh__recordOriginator mesh__D011997 NLM
% 220.38/220.53  |- skos__altLabel mesh__D011997 Rooms, Hospital Recovery
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011997 2003
% 220.38/220.53  |- mesh__dateCreated mesh__D011997 1999-01-01
% 220.38/220.53  |- rdf__type mesh__D011997sskos__Concept
% 220.38/220.53  |- skos__altLabel mesh__D011997 Rooms, Recovery
% 220.38/220.53  |- skos__altLabel mesh__D011997 Room, Recovery
% 220.38/220.53  |- skos__prefLabel mesh__D011997 Recovery Room
% 220.38/220.53  |- mesh__recordAuthorizer mesh__D011997 PLS
% 220.38/220.53  |- mesh__publicMeSHNote mesh__D011997
% 220.38/220.53       79; was see under INTENSIVE CARE UNITS 1966-78   
% 220.38/220.53  |- skos__broader mesh__D011997smesh__D007362
% 220.38/220.53  |- mesh__recordMaintainer mesh__D011997 KEV
% 220.38/220.53  |- mesh__historyNote mesh__D011997
% 220.38/220.53       79%28%75%29%; was see under INTENSIVE CARE UNITS 1966-78   
% 220.38/220.53  |- skos__altLabel mesh__D011997 Room, Hospital Recovery
% 220.38/220.53  |- skos__scopeNote mesh__D011997
% 220.38/220.53       Hospital unit providing continuous monitoring of the patient following anesthesia.%A%    
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011997 1999
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011997 2002
% 220.38/220.53  |- skos__altLabel mesh__D011997 Hospital Recovery Room
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011997 1997
% 220.38/220.53  |- skos__altLabel mesh__D011997 Recovery Rooms, Hospital
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011997 1998
% 220.38/220.53  |- skos__altLabel mesh__D011997 Recovery Rooms
% 220.38/220.53  |- skos__altLabel mesh__D011997 Recovery Room, Hospital
% 220.38/220.53  |- mesh__dateRevised mesh__D011997 1996-06-10
% 220.38/220.53  |- mesh__onlineNote mesh__D011997 search INTENSIVE CARE UNITS 1966-74   
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011199 2003
% 220.38/220.53  |- mesh__publicMeSHNote mesh__D011199 67   
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011199 2005
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011199 2004
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011199 2006
% 220.38/220.53  |- mesh__dateCreated mesh__D011199 1999-01-01
% 220.38/220.53  |- mesh__recordAuthorizer mesh__D011199 sjn
% 220.38/220.53  |- skos__scopeNote mesh__D011199
% 220.38/220.53       Solution titration in which the end point is read from the electrode-potential variations with the concentrations of potential determining ions. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 220.38/220.53  |- rdf__type mesh__D011199sskos__Concept
% 220.38/220.53  |- mesh__recordMaintainer mesh__D011199 lkt
% 220.38/220.53  |- mesh__dateEstablished mesh__D011199 1967-01-01
% 220.38/220.53  |- skos__annotation mesh__D011199 a type of titrimetry; NIM   
% 220.38/220.53  |- skos__broader mesh__D011199smesh__D017186
% 220.38/220.53  |- mesh__dateRevised mesh__D011199 2002-07-03
% 220.38/220.53  |- skos__broader mesh__D011199smesh__D004563
% 220.38/220.53  |- mesh__historyNote mesh__D011199 67%28%64%29%   
% 220.38/220.53  |- mesh__recordOriginator mesh__D011199 NLM
% 220.38/220.53  |- skos__prefLabel mesh__D011199 Potentiometry
% 220.38/220.53  |- mesh__dateCreated mesh__D016682 1991-07-12
% 220.38/220.53  |- skos__altLabel mesh__D016682 Coagulation Inhibitor, Lupus
% 220.38/220.53  |- skos__altLabel mesh__D016682 Lupus Anticoagulant
% 220.38/220.53  |- rdf__type mesh__D016682sskos__Concept
% 220.38/220.53  |- skos__altLabel mesh__D016682 Inhibitor, Lupus Coagulation
% 220.38/220.53  |- mesh__onlineNote mesh__D016682
% 220.38/220.53       use LUPUS COAGULATION INHIBITOR %28%NM%29% to search LUPUS COAGULATION INHIBITOR 1980-91%A%  
% 220.38/220.53  |- mesh__recordMaintainer mesh__D016682 ags
% 220.38/220.53  |- skos__prefLabel mesh__D016682 Lupus Coagulation Inhibitor
% 220.38/220.53  |- mesh__historyNote mesh__D016682
% 220.38/220.53       92; was LUPUS COAGULATION INHIBITOR %28%NM%29% 1978-91   
% 220.38/220.53  |- skos__broader mesh__D016682smesh__D019774
% 220.38/220.53  |- skos__related mesh__D016682smesh__D016736
% 220.38/220.53  |- mesh__dateEstablished mesh__D016682 1992-01-01
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D016682 2006A
% 220.38/220.53  |- skos__scopeNote mesh__D016682
% 220.38/220.53       An antiphospholipid antibody found in association with systemic lupus erythematosus %28%LUPUS ERYTHEMATOSUS, SYSTEMIC;%29%, ANTIPHOSPHOLIPID SYNDROME; and in a variety of other diseases as well as in healthy individuals. In vitro, the antibody interferes with the conversion of prothrombin to thrombin and prolongs the partial thromboplastin time. In vivo, it exerts a procoagulant effect resulting in thrombosis mainly in the larger veins and arteries. It further causes obstetrical complications, including fetal death and spontaneous abortion, as well as a variety of hematologic and neurologic complications.%A%    
% 220.38/220.53  |- mesh__publicMeSHNote mesh__D016682
% 220.38/220.53       92; LUPUS COAGULATION INHIBITOR was indexed under BLOOD COAGULATION FACTORS/immunology 1986-91 %26% BLOOD COAGULATION FACTORS/antagonists %26% inhibitors 1978-88%A%  
% 220.38/220.53  |- skos__historyNote mesh__D016682 Autoantibodies %28%1966-1991%29%
% 220.38/220.53  |- skos__altLabel mesh__D016682 Anticoagulant, Lupus
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D016682 2006
% 220.38/220.53  |- mesh__recordOriginator mesh__D016682 RLS
% 220.38/220.53  |- skos__historyNote mesh__D016682
% 220.38/220.53       Blood Coagulation Factors %28%1966-1991%29%
% 220.38/220.53  |- mesh__recordAuthorizer mesh__D016682 ags
% 220.38/220.53  |- skos__annotation mesh__D016682 DF: LUPUS COAG INHIB   
% 220.38/220.53  |- skos__broader mesh__D016682smesh__D017152
% 220.38/220.53  |- mesh__dateRevised mesh__D016682 2005-07-19
% 220.38/220.53  |- mesh__dateEstablished mesh__D002662 1968-01-01
% 220.38/220.53  |- skos__hiddenLabel mesh__D002662 Infant Health Service
% 220.38/220.53  |- skos__historyNote mesh__D002662 Child Care %28%1966-1967%29%
% 220.38/220.53  |- skos__altLabel mesh__D002662 Child Services, Health
% 220.38/220.53  |- skos__broader mesh__D002662smesh__D003153
% 220.38/220.53  |- skos__scopeNote mesh__D002662
% 220.38/220.53       Organized services to provide health care for children.%A%    
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D002662 2006
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D002662 2002
% 220.38/220.53  |- skos__hiddenLabel mesh__D002662 Infant Service, Health
% 220.38/220.53  |- skos__hiddenLabel mesh__D002662 Child Health Service
% 220.38/220.53  |- skos__hiddenLabel mesh__D002662 Health Infant Service
% 220.38/220.53  |- skos__altLabel mesh__D002662 Services, Infant Health
% 220.38/220.53  |- skos__hiddenLabel mesh__D002662 Health Service, Infant
% 220.38/220.53  |- skos__hiddenLabel mesh__D002662 Health Child Service
% 220.38/220.53  |- mesh__recordAuthorizer mesh__D002662 sjn
% 220.38/220.53  |- mesh__publicMeSHNote mesh__D002662
% 220.38/220.53       68; WELL CHILD CONFERENCE was see under CHILD HEALTH SERVICES 1968-78, was see CHILD HEALTH SERVICES 1979-92%A%  
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D002662 2003
% 220.38/220.53  |- mesh__recordOriginator mesh__D002662 NLM
% 220.38/220.53  |- mesh__dateCreated mesh__D002662 1999-01-01
% 220.38/220.53  |- rdf__type mesh__D002662sskos__Concept
% 220.38/220.53  |- mesh__recordMaintainer mesh__D002662 kle
% 220.38/220.53  |- skos__prefLabel mesh__D002662 Child Health Services
% 220.38/220.53  |- skos__hiddenLabel mesh__D002662 Health Service, Child
% 220.38/220.53  |- skos__annotation mesh__D002662
% 220.38/220.53       check also tag CHILD or specific; DF: CHILD HEALTH SERV   
% 220.38/220.53  |- mesh__historyNote mesh__D002662
% 220.38/220.53       68; INFANT HEALTH SERVICES was see under CHILD HEALTH SERVICES 1968-78; WELL CHILD CONFERENCE was see under CHILD HEALTH SERVICES 1968-78, was see CHILD HEALTH SERVICES 1979-92%A%  
% 220.38/220.53  |- skos__historyNote mesh__D002662 Child Welfare %28%1966-1967%29%
% 220.38/220.53  |- skos__altLabel mesh__D002662 Services, Child Health
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D002662 2004
% 220.38/220.53  |- skos__hiddenLabel mesh__D002662 Services, Health Infant
% 220.38/220.53  |- skos__hiddenLabel mesh__D002662 Services, Health Child
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D002662 2000
% 220.38/220.53  |- skos__hiddenLabel mesh__D002662 Service, Child Health
% 220.38/220.53  |- skos__hiddenLabel mesh__D002662 Service, Infant Health
% 220.38/220.53  |- mesh__dateRevised mesh__D002662 1999-11-03
% 220.38/220.53  |- mesh__onlineNote mesh__D002662
% 220.38/220.53       use CHILD HEALTH SERVICES to search INFANT HEALTH SERVICES 1968-78 %26% WELL CHILD CONFERENCE 1968-92%A%  
% 220.38/220.53  |- skos__hiddenLabel mesh__D002662 Service, Health Infant
% 220.38/220.53  |- skos__altLabel mesh__D002662 Infant Health Services
% 220.38/220.53  |- skos__hiddenLabel mesh__D002662 Service, Health Child
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D002662 2001
% 220.38/220.53  |- skos__hiddenLabel mesh__D002662 Health Child Services
% 220.38/220.53  |- skos__hiddenLabel mesh__D002662 Health Infant Services
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D002662 2005
% 220.38/220.53  |- skos__altLabel mesh__D002662 Infant Services, Health
% 220.38/220.53  |- skos__hiddenLabel mesh__D002662 Child Service, Health
% 220.38/220.53  |- skos__altLabel mesh__D002662 Health Services, Child
% 220.38/220.53  |- skos__prefLabel mesh__D029001 Medicine, Herbal
% 220.38/220.53  |- mesh__recordAuthorizer mesh__D029001 sjn
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D029001 2004
% 220.38/220.53  |- skos__broader mesh__D029001smesh__D008511
% 220.38/220.53  |- mesh__recordMaintainer mesh__D029001 ssb
% 220.38/220.53  |- mesh__dateEstablished mesh__D029001 2002-01-01
% 220.38/220.53  |- mesh__publicMeSHNote mesh__D029001 2002   
% 220.38/220.53  |- skos__altLabel mesh__D029001 Herbal Medicine
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D029001 2003
% 220.38/220.53  |- skos__scopeNote mesh__D029001
% 220.38/220.53       The study of medicines derived from botanical sources.     
% 220.38/220.53  |- mesh__historyNote mesh__D029001 2002   
% 220.38/220.53  |- mesh__recordOriginator mesh__D029001 ssb
% 220.38/220.53  |- skos__broader mesh__D029001smesh__D010600
% 220.38/220.53  |- skos__annotation mesh__D029001
% 220.38/220.53       SPEC only; do not confuse with PHYTOTHERAPY   
% 220.38/220.53  |- mesh__dateRevised mesh__D029001 2002-07-03
% 220.38/220.53  |- skos__related mesh__D029001smesh__D008517
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D029001 2006
% 220.38/220.53  |- skos__related mesh__D029001smesh__D010946
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D029001 2005
% 220.38/220.53  |- mesh__dateCreated mesh__D029001 2001-07-25
% 220.38/220.53  |- rdf__type mesh__D029001sskos__Concept
% 220.38/220.53  |- skos__historyNote mesh__D029001 Phytotherapy %28%1989-2001%29%
% 220.38/220.53  |- mesh__recordOriginator mesh__D020724 adp
% 220.38/220.53  |- mesh__dateRevised mesh__D020724 2004-07-07
% 220.38/220.53  |- mesh__recordMaintainer mesh__D020724 jmp
% 220.38/220.53  |- skos__broader mesh__D020724smesh__D008420
% 220.38/220.53  |- skos__broader mesh__D020724smesh__D011108
% 220.38/220.53  |- mesh__dateEstablished mesh__D020724 2000-01-01
% 220.38/220.53  |- mesh__publicMeSHNote mesh__D020724
% 220.38/220.53       2000; for ELASTOMERS see RUBBER 1981-1999   
% 220.38/220.53  |- mesh__historyNote mesh__D020724
% 220.38/220.53       2000; for ELASTOMERS use RUBBER 1981-1999   
% 220.38/220.53  |- skos__related mesh__D020724smesh__D004548
% 220.38/220.53  |- rdf__type mesh__D020724sskos__Concept
% 220.38/220.53  |- skos__hiddenLabel mesh__D020724 Elastomer
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D020724 2006
% 220.38/220.53  |- skos__scopeNote mesh__D020724
% 220.38/220.53       A generic term for all substances having the properties of natural, reclaimed, vulcanized, or synthetic rubber, in that they stretch under tension, have a high tensile strength, retract rapidly, and recover their original dimensions fully.%A%    
% 220.38/220.53  |- mesh__recordAuthorizer mesh__D020724 sjn
% 220.38/220.53  |- skos__prefLabel mesh__D020724 Elastomers
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D020724 2005
% 220.38/220.53  |- mesh__dateCreated mesh__D020724 1999-11-03
% 220.38/220.53  |- skos__annotation mesh__D020724 SILICONE ELASTOMERS is available   
% 220.38/220.53  |- skos__altLabel mesh__D006255 Seasonal Allergic Rhinitis
% 220.38/220.53  |- mesh__recordOriginator mesh__D006255 NLM
% 220.38/220.53  |- skos__hiddenLabel mesh__D006255 Allergies, Pollen
% 220.38/220.53  |- mesh__recordMaintainer mesh__D006255 ags
% 220.38/220.53  |- skos__hiddenLabel mesh__D006255 Pollinoses
% 220.38/220.53  |- skos__hiddenLabel mesh__D006255 Allergy, Pollen
% 220.38/220.53  |- skos__broader mesh__D006255smesh__D012220
% 220.38/220.53  |- skos__hiddenLabel mesh__D006255 Seasonal Allergic Rhinitides
% 220.38/220.53  |- mesh__dateCreated mesh__D006255 1999-01-01
% 220.38/220.53  |- rdf__type mesh__D006255sskos__Concept
% 220.38/220.53  |- skos__hiddenLabel mesh__D006255 Pollen Allergies
% 220.38/220.53  |- skos__scopeNote mesh__D006255
% 220.38/220.53       Allergic rhinitis that occurs at the same time every year. It is characterized by acute CONJUNCTIVITIS with lacrimation and ITCHING, and regarded as an allergic condition triggered by specific ALLERGENS.%A%    
% 220.38/220.53  |- skos__altLabel mesh__D006255 Pollinosis
% 220.38/220.53  |- skos__altLabel mesh__D006255 Hayfever
% 220.38/220.53  |- skos__altLabel mesh__D006255 Pollen Allergy
% 220.38/220.53  |- skos__prefLabel mesh__D006255 Rhinitis, Allergic, Seasonal
% 220.38/220.53  |- skos__hiddenLabel mesh__D006255 Rhinitides, Seasonal Allergic
% 220.38/220.53  |- mesh__historyNote mesh__D006255 2006 %28%1963%29%   
% 220.38/220.53  |- skos__hiddenLabel mesh__D006255 Rhinitis, Seasonal Allergic
% 220.38/220.53  |- mesh__dateRevised mesh__D006255 2005-06-30
% 220.38/220.53  |- skos__broader mesh__D006255smesh__D012130
% 220.38/220.53  |- skos__hiddenLabel mesh__D006255 Fever, Hay
% 220.38/220.53  |- mesh__recordAuthorizer mesh__D006255 sjn
% 220.38/220.53  |- skos__altLabel mesh__D006255 Hay Fever
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D006255 2006
% 220.38/220.53  |- skos__hiddenLabel mesh__D006255 Allergic Rhinitis, Seasonal
% 220.38/220.53  |- skos__annotation mesh__D006255
% 220.38/220.53       do not confuse with RHINITIS, ALLERGIC, NONSEASONAL   
% 220.38/220.53  |- mesh__publicMeSHNote mesh__D006255 2006; see HAY FEVER 1963-2005   
% 220.38/220.53  |- skos__hiddenLabel mesh__D006255 Allergic Rhinitides, Seasonal
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011998 2005
% 220.38/220.53  |- mesh__dateCreated mesh__D011998 1999-01-01
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011998 2003
% 220.38/220.53  |- rdf__type mesh__D011998sskos__Concept
% 220.38/220.53  |- skos__hiddenLabel mesh__D011998 Recreations
% 220.38/220.53  |- skos__prefLabel mesh__D011998 Recreation
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011998 1995
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011998 2001
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011998 1993
% 220.38/220.53  |- skos__broader mesh__D011998smesh__D007899
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011998 1999
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011998 2000
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011998 1994
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011998 1997
% 220.38/220.53  |- mesh__recordOriginator mesh__D011998 NLM
% 220.38/220.53  |- skos__annotation mesh__D011998 /econ /physiol /psychol permitted   
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011998 1998
% 220.38/220.53  |- mesh__recordMaintainer mesh__D011998 TGC
% 220.38/220.53  |- mesh__recordAuthorizer mesh__D011998 PLS
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011998 1996
% 220.38/220.53  |- mesh__dateRevised mesh__D011998 1992-05-18
% 220.38/220.53  |- skos__scopeNote mesh__D011998 Activity engaged in for pleasure.     
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011998 2006
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011998 2002
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D011998 2004
% 220.38/220.53  |- mesh__recordMaintainer mesh__D016683 nns
% 220.38/220.53  |- skos__broader mesh__D016683smesh__D011187
% 220.38/220.53  |- skos__historyNote mesh__D016683 Supination %28%1988-1991%29%
% 220.38/220.53  |- mesh__onlineNote mesh__D016683
% 220.38/220.53       use SUPINATION to search SUPINE POSITION 1988-91   
% 220.38/220.53  |- skos__hiddenLabel mesh__D016683 Position, Dorsal
% 220.38/220.53  |- rdf__type mesh__D016683sskos__Concept
% 220.38/220.53  |- mesh__dateRevised mesh__D016683 2003-07-09
% 220.38/220.53  |- skos__prefLabel mesh__D016683 Supine Position
% 220.38/220.53  |- skos__scopeNote mesh__D016683
% 220.38/220.53       The posture of an individual lying face up.     
% 220.38/220.53  |- skos__hiddenLabel mesh__D016683 Supine Positions
% 220.38/220.53  |- skos__hiddenLabel mesh__D016683 Positions, Dorsal
% 220.38/220.53  |- skos__hiddenLabel mesh__D016683 Position, Supine
% 220.38/220.53  |- mesh__historyNote mesh__D016683 92; was see SUPINATION 1988-91   
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D016683 2005
% 220.38/220.53  |- skos__hiddenLabel mesh__D016683 Dorsal Positions
% 220.38/220.53  |- skos__annotation mesh__D016683
% 220.38/220.53       almost never IM; do not confuse with SUPINATION, a movement of the foot or forearm%A%  
% 220.38/220.53  |- mesh__dateEstablished mesh__D016683 1992-01-01
% 220.38/220.53  |- mesh__dateCreated mesh__D016683 1991-01-25
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D016683 2006
% 220.38/220.53  |- mesh__recordAuthorizer mesh__D016683 sjn
% 220.38/220.53  |- skos__historyNote mesh__D016683 Posture %28%1966-1991%29%
% 220.38/220.53  |- mesh__publicMeSHNote mesh__D016683 92; was see SUPINATION 1988-91   
% 220.38/220.53  |- skos__hiddenLabel mesh__D016683 Positions, Supine
% 220.38/220.53  |- skos__altLabel mesh__D016683 Dorsal Position
% 220.38/220.53  |- mesh__recordOriginator mesh__D016683 PXP
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D016683 2004
% 220.38/220.53  |- mesh__onlineNote mesh__D002663 search LANGUAGE DEVELOPMENT 1968-74   
% 220.38/220.53  |- mesh__dateRevised mesh__D002663 2003-07-09
% 220.38/220.53  |- mesh__activeMeSHYear mesh__D002663 2004
% 220.38/220.53  |- skos__hiddenLabel mesh__D002663 Languages, Child
% 220.38/220.53  |- rdf__type mesh__D002663sskos__Concept
% 220.38/220.53  |- mesh__publicMeSHNote mesh__D002663
% 220.38/220.53       91; was see under LANGUAGE DEVELOPMENT 1975-90   
% 220.38/220.53  |- skos__broader mesh__D002663smesh__D007804
% 220.38/220.53  |- mesh__recordMaintainer mesh__D002663 lkt
% 220.38/220.54  |- skos__hiddenLabel mesh__D002663 Language, Child
% 220.38/220.54  |- skos__scopeNote mesh__D002663
% 220.38/220.54       The language and sounds expressed by a child at a particular maturational stage in development.%A%    
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002663 2006
% 220.38/220.54  |- mesh__recordAuthorizer mesh__D002663 sjn
% 220.38/220.54  |- skos__prefLabel mesh__D002663 Child Language
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002663 2005
% 220.38/220.54  |- mesh__recordOriginator mesh__D002663 NLM
% 220.38/220.54  |- mesh__dateEstablished mesh__D002663 1991-01-01
% 220.38/220.54  |- mesh__dateCreated mesh__D002663 1999-01-01
% 220.38/220.54  |- mesh__historyNote mesh__D002663
% 220.38/220.54       91%28%75%29%; was see under LANGUAGE DEVELOPMENT 1975-90   
% 220.38/220.54  |- skos__annotation mesh__D002663
% 220.38/220.54       no qualif; check also tag CHILD or specific   
% 220.38/220.54  |- skos__hiddenLabel mesh__D002663 Child Languages
% 220.38/220.54  |- skos__scopeNote mesh__D029800
% 220.38/220.54       A plant species of the family VACCINIUM.     
% 220.38/220.54  |- skos__broader mesh__D029800smesh__D029796
% 220.38/220.54  |- mesh__historyNote mesh__D029800 2002   
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D029800 2006
% 220.38/220.54  |- skos__altLabel mesh__D029800 Whortleberry
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D029800 2002
% 220.38/220.54  |- rdf__type mesh__D029800sskos__Concept
% 220.38/220.54  |- mesh__dateCreated mesh__D029800 2001-07-25
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D029800 2005
% 220.38/220.54  |- skos__annotation mesh__D029800
% 220.38/220.54       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.38/220.54  |- mesh__publicMeSHNote mesh__D029800 2002   
% 220.38/220.54  |- mesh__dateEstablished mesh__D029800 2002-01-01
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D029800 2004
% 220.38/220.54  |- skos__prefLabel mesh__D029800 Vaccinium myrtillus
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D029800 2003
% 220.38/220.54  |- skos__hiddenLabel mesh__D029002 Lodge, Sweat
% 220.38/220.54  |- skos__prefLabel mesh__D029002 Steam Bath
% 220.38/220.54  |- mesh__recordMaintainer mesh__D029002 lkt
% 220.38/220.54  |- mesh__recordOriginator mesh__D029002 ssb
% 220.38/220.54  |- skos__altLabel mesh__D029002 Sauna
% 220.38/220.54  |- skos__hiddenLabel mesh__D029002 Bath, Finnish
% 220.38/220.54  |- mesh__dateRevised mesh__D029002 2005-06-30
% 220.38/220.54  |- skos__hiddenLabel mesh__D029002 Finnish Bath
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D029002 2006
% 220.38/220.54  |- mesh__dateCreated mesh__D029002 2001-07-25
% 220.38/220.54  |- skos__altLabel mesh__D029002 Finnish Sauna
% 220.38/220.54  |- mesh__recordAuthorizer mesh__D029002 sjn
% 220.38/220.54  |- skos__scopeNote mesh__D029002
% 220.38/220.54       Therapy of sitting in a hot steamy room followed by a cool bath or shower.%A%    
% 220.38/220.54  |- rdf__type mesh__D029002sskos__Concept
% 220.38/220.54  |- skos__historyNote mesh__D029002 Baths, Finnish %28%1963-2001%29%
% 220.38/220.54  |- mesh__publicMeSHNote mesh__D029002
% 220.38/220.54       2002; use Baths, Finnish %28%1963-2001%29%   
% 220.38/220.54  |- skos__hiddenLabel mesh__D029002 Bath, Steam
% 220.38/220.54  |- mesh__historyNote mesh__D029002
% 220.38/220.54       2002; see Baths, Finnish %28%1963-2001%29%   
% 220.38/220.54  |- skos__broader mesh__D029002smesh__D001452
% 220.38/220.54  |- skos__broader mesh__D029002smesh__D006979
% 220.38/220.54  |- mesh__dateEstablished mesh__D029002 2002-01-01
% 220.38/220.54  |- mesh__publicMeSHNote mesh__D012293 73   
% 220.38/220.54  |- mesh__recordOriginator mesh__D012293 NLM
% 220.38/220.54  |- mesh__historyNote mesh__D012293 73   
% 220.38/220.54  |- skos__altLabel mesh__D012293 Benemycin
% 220.38/220.54  |- skos__broader mesh__D012293smesh__D012294
% 220.38/220.54  |- skos__scopeNote mesh__D012293
% 220.38/220.54       A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. %28%From Gilman et al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 9th ed, p1160%29%%A%    
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D012293 2005
% 220.38/220.54  |- skos__prefLabel mesh__D012293 Rifampin
% 220.38/220.54  |- mesh__recordAuthorizer mesh__D012293 sjn
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D012293 2006
% 220.38/220.54  |- skos__altLabel mesh__D012293 Rifampicin
% 220.38/220.54  |- skos__historyNote mesh__D012293 Rifamycins %28%1966-1972%29%
% 220.38/220.54  |- mesh__recordMaintainer mesh__D012293 ssb
% 220.38/220.54  |- mesh__dateCreated mesh__D012293 1999-01-01
% 220.38/220.54  |- rdf__type mesh__D012293sskos__Concept
% 220.38/220.54  |- mesh__dateEstablished mesh__D012293 1973-01-01
% 220.38/220.54  |- mesh__dateRevised mesh__D012293 2004-07-07
% 220.38/220.54  |- skos__altLabel mesh__D020725 ral A GTP-Binding Protein
% 220.38/220.54  |- mesh__recordAuthorizer mesh__D020725 sjn
% 220.38/220.54  |- skos__hiddenLabel mesh__D020725 ral A GTP Binding Protein
% 220.38/220.54  |- mesh__historyNote mesh__D020725
% 220.38/220.54       2000; use RAL GTP-BINDING PROTEINS %28%NM%29% 1993-1999; for RAL A PROTEIN use RAL GTP-BINDING PROTEINS %28%NM%29% 1993-1999%A%  
% 220.38/220.54  |- skos__prefLabel mesh__D020725 ral GTP-Binding Proteins
% 220.38/220.54  |- skos__annotation mesh__D020725 DF: RAL PROTEIN   
% 220.38/220.54  |- skos__historyNote mesh__D020725 G-Proteins %28%1994-1999%29%
% 220.38/220.54  |- rdf__type mesh__D020725sskos__Concept
% 220.38/220.54  |- skos__hiddenLabel mesh__D020725 ral GTP Binding Proteins
% 220.38/220.54  |- mesh__recordOriginator mesh__D020725 jmp
% 220.38/220.54  |- skos__altLabel mesh__D020725 ral GTP-Binding Protein
% 220.38/220.54  |- mesh__dateRevised mesh__D020725 2005-06-30
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D020725 2006
% 220.38/220.54  |- mesh__publicMeSHNote mesh__D020725
% 220.38/220.54       2000; RAL PROTEIN %26% RAL A PROTEIN were indexed under G-PROTEINS 1993-1999%A%  
% 220.38/220.54  |- skos__hiddenLabel mesh__D020725 ral GTP Binding Protein
% 220.38/220.54  |- skos__scopeNote mesh__D020725
% 220.38/220.54       A family of ubiquitously expressed MONOMERIC GTP-BINDING PROTEINS that are involved in intracellular signal transduction. This enzyme was formerly listed as EC 3.6.1.47.%A%    
% 220.38/220.54  |- mesh__dateCreated mesh__D020725 1999-11-05
% 220.38/220.54  |- skos__altLabel mesh__D020725 ral Protein
% 220.38/220.54  |- skos__hiddenLabel mesh__D020725 GTP-Binding Proteins, ral
% 220.38/220.54  |- mesh__recordMaintainer mesh__D020725 jmp
% 220.38/220.54  |- skos__hiddenLabel mesh__D020725 GTP-Binding Protein, ral
% 220.38/220.54  |- mesh__dateEstablished mesh__D020725 2000-01-01
% 220.38/220.54  |- skos__broader mesh__D020725smesh__D020559
% 220.38/220.54  |- skos__prefLabel mesh__D006256 Hazardous Waste
% 220.38/220.54  |- mesh__dateRevised mesh__D006256 2005-06-30
% 220.38/220.54  |- skos__hiddenLabel mesh__D006256 Waste Site, Hazardous
% 220.38/220.54  |- skos__hiddenLabel mesh__D006256 Hazardous Waste Site
% 220.38/220.54  |- mesh__recordAuthorizer mesh__D006256 sjn
% 220.38/220.54  |- skos__hiddenLabel mesh__D006256 Sites, Hazardous Waste
% 220.38/220.54  |- skos__annotation mesh__D006256
% 220.38/220.54       note category: do not confuse with HAZARDOUS SUBSTANCES   
% 220.38/220.54  |- mesh__dateCreated mesh__D006256 1987-05-04
% 220.38/220.54  |- skos__broader mesh__D006256smesh__D014866
% 220.38/220.54  |- skos__hiddenLabel mesh__D006256 Waste Sites, Hazardous
% 220.38/220.54  |- mesh__publicMeSHNote mesh__D006256 88   
% 220.38/220.54  |- mesh__historyNote mesh__D006256 88   
% 220.38/220.54  |- skos__hiddenLabel mesh__D006256 Hazardous Wastes
% 220.38/220.54  |- rdf__type mesh__D006256sskos__Concept
% 220.38/220.54  |- skos__hiddenLabel mesh__D006256 Wastes, Hazardous
% 220.38/220.54  |- skos__historyNote mesh__D006256 Industrial Waste %28%1966-1987%29%
% 220.38/220.54  |- skos__historyNote mesh__D006256 Refuse Disposal %28%1966-1987%29%
% 220.38/220.54  |- mesh__recordMaintainer mesh__D006256 ssb
% 220.38/220.54  |- mesh__dateEstablished mesh__D006256 1988-01-01
% 220.38/220.54  |- skos__hiddenLabel mesh__D006256 Site, Hazardous Waste
% 220.38/220.54  |- skos__historyNote mesh__D006256
% 220.38/220.54       Environmental Pollutants %28%1975-1987%29%
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D006256 2006
% 220.38/220.54  |- skos__hiddenLabel mesh__D006256 Waste, Hazardous
% 220.38/220.54  |- skos__scopeNote mesh__D006256
% 220.38/220.54       Waste products which, upon release into the atmosphere, water or soil, cause health risks to humans or animals through skin contact, inhalation or ingestion. Hazardous waste sites which contain hazardous waste substances go here.%A%    
% 220.38/220.54  |- skos__historyNote mesh__D006256 Waste Products %28%1976-1987%29%
% 220.38/220.54  |- skos__historyNote mesh__D006256
% 220.38/220.54       Environmental Pollution %28%1971-1987%29%
% 220.38/220.54  |- mesh__recordOriginator mesh__D006256 RLS
% 220.38/220.54  |- mesh__publicMeSHNote mesh__D011999
% 220.38/220.54       91; was see under NEURAL CONDUCTION 1977-90; was see under NEURAL TRANSMISSION 1975-76%A%  
% 220.38/220.54  |- rdf__type mesh__D011999sskos__Concept
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D011999 1998
% 220.38/220.54  |- skos__historyNote mesh__D011999 Neural Transmission %28%1968-1971%29%
% 220.38/220.54  |- skos__prefLabel mesh__D011999 Recruitment %28%Neurology%29%
% 220.38/220.54  |- mesh__dateEstablished mesh__D011999 1991-01-01
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D011999 1999
% 220.38/220.54  |- mesh__recordMaintainer mesh__D011999 TGC
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D011999 2000
% 220.38/220.54  |- mesh__dateRevised mesh__D011999 1996-06-10
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D011999 1997
% 220.38/220.54  |- mesh__historyNote mesh__D011999
% 220.38/220.54       91%28%72%29%; was see under NEURAL CONDUCTION 1977-90; was see under NEURAL TRANSMISSION 1975-76%A%  
% 220.38/220.54  |- skos__hiddenLabel mesh__D011999 Recruitments %28%Neurology%29%
% 220.38/220.54  |- skos__annotation mesh__D011999 DF: RECRUITMENT NEUROL   
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D011999 2005
% 220.38/220.54  |- skos__scopeNote mesh__D011999
% 220.38/220.54       The gradual increase to a maximum in a reflex when a stimulus of unaltered intensity is prolonged. %28%Dorland, 28th ed%29%%A%    
% 220.38/220.54  |- mesh__recordAuthorizer mesh__D011999 PLS
% 220.38/220.54  |- skos__broader mesh__D011999smesh__D009431
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D011999 2001
% 220.38/220.54  |- mesh__dateCreated mesh__D011999 1999-01-01
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D011999 2003
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D011999 2006
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D011999 2002
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D011999 2004
% 220.38/220.54  |- mesh__recordOriginator mesh__D011999 NLM
% 220.38/220.54  |- rdf__type mesh__D016684sskos__Concept
% 220.38/220.54  |- skos__historyNote mesh__D016684 Pronation %28%1988-1991%29%
% 220.38/220.54  |- mesh__publicMeSHNote mesh__D016684 92; was see PRONATION 1988-91   
% 220.38/220.54  |- mesh__dateRevised mesh__D016684 2003-07-09
% 220.38/220.54  |- skos__historyNote mesh__D016684 Posture %28%1966-1991%29%
% 220.38/220.54  |- skos__annotation mesh__D016684
% 220.38/220.54       almost never IM; do not confuse with PRONATION, a movement of the foot or forearm%A%  
% 220.38/220.54  |- mesh__historyNote mesh__D016684 92; was see PRONATION 1988-91   
% 220.38/220.54  |- mesh__recordMaintainer mesh__D016684 nns
% 220.38/220.54  |- skos__prefLabel mesh__D016684 Prone Position
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D016684 2005
% 220.38/220.54  |- skos__scopeNote mesh__D016684
% 220.38/220.54       The posture of an individual lying face down.     
% 220.38/220.54  |- mesh__onlineNote mesh__D016684
% 220.38/220.54       use PRONATION to search PRONE POSITION 1988-91   
% 220.38/220.54  |- mesh__dateCreated mesh__D016684 1991-01-25
% 220.38/220.54  |- skos__hiddenLabel mesh__D016684 Positions, Prone
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D016684 2006
% 220.38/220.54  |- skos__hiddenLabel mesh__D016684 Prone Positions
% 220.38/220.54  |- skos__hiddenLabel mesh__D016684 Position, Prone
% 220.38/220.54  |- mesh__recordOriginator mesh__D016684 PXP
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D016684 2004
% 220.38/220.54  |- mesh__dateEstablished mesh__D016684 1992-01-01
% 220.38/220.54  |- skos__broader mesh__D016684smesh__D011187
% 220.38/220.54  |- mesh__recordAuthorizer mesh__D016684 sjn
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002664 2001
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002664 1995
% 220.38/220.54  |- mesh__historyNote mesh__D002664 67   
% 220.38/220.54  |- skos__related mesh__D002664smesh__D007227
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002664 2004
% 220.38/220.54  |- rdf__type mesh__D002664sskos__Concept
% 220.38/220.54  |- mesh__recordOriginator mesh__D002664 NLM
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002664 2002
% 220.38/220.54  |- mesh__publicMeSHNote mesh__D002664 67   
% 220.38/220.54  |- mesh__dateEstablished mesh__D002664 1967-01-01
% 220.38/220.54  |- skos__scopeNote mesh__D002664
% 220.38/220.54       Nutrition of children aged 2-12 years.     
% 220.38/220.54  |- skos__historyNote mesh__D002664 Nutrition %28%1966%29%
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002664 2005
% 220.38/220.54  |- mesh__dateRevised mesh__D002664 1992-05-13
% 220.38/220.54  |- skos__hiddenLabel mesh__D002664 Nutrition, Child
% 220.38/220.54  |- skos__hiddenLabel mesh__D002664 Child Nutritions
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002664 1996
% 220.38/220.54  |- skos__prefLabel mesh__D002664 Child Nutrition
% 220.38/220.54  |- skos__broader mesh__D002664smesh__D009747
% 220.38/220.54  |- mesh__dateCreated mesh__D002664 1999-01-01
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002664 2006
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002664 1997
% 220.38/220.54  |- mesh__recordMaintainer mesh__D002664 TGC
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002664 1998
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002664 1993
% 220.38/220.54  |- mesh__recordAuthorizer mesh__D002664 PLS
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002664 2000
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002664 1994
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002664 1999
% 220.38/220.54  |- skos__annotation mesh__D002664
% 220.38/220.54       ages 2-12; check also tag CHILD or specific   
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002664 2003
% 220.38/220.54  |- skos__related mesh__D002664smesh__D017195
% 220.38/220.54  |- skos__hiddenLabel mesh__D002664 Nutritions, Child
% 220.38/220.54  |- rdf__type mesh__D029801sskos__Concept
% 220.38/220.54  |- skos__prefLabel mesh__D029801 Vaccinium vitis-idaea
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D029801 2005
% 220.38/220.54  |- skos__annotation mesh__D029801
% 220.38/220.54       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.38/220.54  |- mesh__historyNote mesh__D029801 2002   
% 220.38/220.54  |- mesh__publicMeSHNote mesh__D029801 2002   
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D029801 2002
% 220.38/220.54  |- mesh__dateEstablished mesh__D029801 2002-01-01
% 220.38/220.54  |- mesh__dateCreated mesh__D029801 2001-07-25
% 220.38/220.54  |- skos__scopeNote mesh__D029801
% 220.38/220.54       A plant species of the genus VACCINIUM.     
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D029801 2004
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D029801 2003
% 220.38/220.54  |- skos__broader mesh__D029801smesh__D029796
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D029801 2006
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D012294 2005
% 220.38/220.54  |- mesh__dateEstablished mesh__D012294 1973-01-01
% 220.38/220.54  |- skos__broader mesh__D012294smesh__D006576
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D012294 2006
% 220.38/220.54  |- skos__altLabel mesh__D012294 Rifomycins
% 220.38/220.54  |- mesh__recordOriginator mesh__D012294 NLM
% 220.38/220.54  |- mesh__historyNote mesh__D012294 73; was RIFOMYCIN 1963-72   
% 220.38/220.54  |- skos__prefLabel mesh__D012294 Rifamycins
% 220.38/220.54  |- mesh__publicMeSHNote mesh__D012294 73; was RIFOMYCIN 1963-72   
% 220.38/220.54  |- mesh__dateCreated mesh__D012294 1999-01-01
% 220.38/220.54  |- mesh__recordAuthorizer mesh__D012294 sjn
% 220.38/220.54  |- rdf__type mesh__D012294sskos__Concept
% 220.38/220.54  |- skos__broader mesh__D012294smesh__D047029
% 220.38/220.54  |- skos__scopeNote mesh__D012294
% 220.38/220.54       A group of ANTI-BACTERIAL AGENTS characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known ANTI-BACTERIAL AGENTS. They have been isolated from fermentation broths of Streptomyces mediterranei.%A%    
% 220.38/220.54  |- mesh__dateRevised mesh__D012294 2004-07-07
% 220.38/220.54  |- mesh__onlineNote mesh__D012294
% 220.38/220.54       use RIFAMYCINS to search RIFOMYCIN 1966-72   
% 220.38/220.54  |- mesh__recordMaintainer mesh__D012294 ssb
% 220.38/220.54  |- mesh__recordAuthorizer mesh__D020726 ags
% 220.38/220.54  |- skos__prefLabel mesh__D020726 ral Guanine Nucleotide Exchange Factor
% 220.38/220.54  |- mesh__dateRevised mesh__D020726 2005-07-28
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D020726 2005
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D020726 2006A
% 220.38/220.54  |- skos__altLabel mesh__D020726 ralGDS
% 220.38/220.54  |- mesh__publicMeSHNote mesh__D020726
% 220.38/220.54       2000; RAL-GUANINE NUCLEOTIDE EXCHANGE FACTOR was indexed under G-PROTEINS 1997-1999%A%  
% 220.38/220.54  |- skos__altLabel mesh__D020726 ral-GDS
% 220.38/220.54  |- skos__altLabel mesh__D020726 ral GDP Dissociation Stimulator
% 220.38/220.54  |- mesh__dateEstablished mesh__D020726 2000-01-01
% 220.38/220.54  |- mesh__recordOriginator mesh__D020726 jmp
% 220.38/220.54  |- mesh__historyNote mesh__D020726
% 220.38/220.54       2000; for RAL-GUANINE NUCLEOTIDE EXCHANGE FACTOR use RAL-GUANINE NUCLEOTIDE EXCHANGE FACTOR 1997-1999%A%  
% 220.38/220.54  |- skos__historyNote mesh__D020726 G-Proteins %28%1997-1999%29%
% 220.38/220.54  |- skos__scopeNote mesh__D020726
% 220.38/220.54       A guanine nucleotide exchange factor that stimulates the dissociation of GDP from RAL GTP-BINDING PROTEINS. It also has GDP exchange activity towards other MONOMERIC GTP-BINDING PROTEINS.%A%    
% 220.38/220.54  |- mesh__recordMaintainer mesh__D020726 ags
% 220.38/220.54  |- rdf__type mesh__D020726sskos__Concept
% 220.38/220.54  |- skos__broader mesh__D020726smesh__D020662
% 220.38/220.54  |- mesh__dateCreated mesh__D020726 1999-11-05
% 220.38/220.54  |- skos__hiddenLabel mesh__D020726 ral GDS
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D020726 2006
% 220.38/220.54  |- skos__related mesh__D006257smesh__D012886
% 220.38/220.54  |- mesh__dateRevised mesh__D006257 2004-07-07
% 220.38/220.54  |- skos__hiddenLabel mesh__D006257 Heads
% 220.38/220.54  |- rdf__type mesh__D006257sskos__Concept
% 220.38/220.54  |- skos__annotation mesh__D006257
% 220.38/220.54       usually NIM as site; soft parts = FACE, bony parts = SKULL;  /anat: consider also CEPHALOMETRY; /inj = CRANIOCEREBRAL TRAUMA but consider also SKULL %26% FACIAL BONES %26% specifics under each with /inj; HEAD-DOWN TILT is available for physiological aspects of this position%A%  
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D006257 2005
% 220.38/220.54  |- mesh__recordAuthorizer mesh__D006257 sjn
% 220.38/220.54  |- skos__prefLabel mesh__D006257 Head
% 220.38/220.54  |- skos__related mesh__D006257smesh__D005147
% 220.38/220.54  |- skos__broader mesh__D006257smesh__D001829
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D006257 2006
% 220.38/220.54  |- mesh__recordOriginator mesh__D006257 NLM
% 220.38/220.54  |- mesh__dateCreated mesh__D006257 1999-01-01
% 220.38/220.54  |- mesh__recordMaintainer mesh__D006257 nns
% 220.38/220.54  |- mesh__historyNote mesh__D016685
% 220.38/220.54       2000%28%1992%29%; for MITOMYCIN use MITOMYCIN %28%NM%29% 1981-1991   
% 220.38/220.54  |- mesh__recordMaintainer mesh__D016685 ssb
% 220.38/220.54  |- mesh__dateRevised mesh__D016685 2004-07-07
% 220.38/220.54  |- mesh__dateEstablished mesh__D016685 1992-01-01
% 220.38/220.54  |- mesh__dateCreated mesh__D016685 1991-01-25
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D016685 2006
% 220.38/220.54  |- skos__prefLabel mesh__D016685 Mitomycin
% 220.38/220.54  |- skos__altLabel mesh__D016685 Mitomycin C
% 220.38/220.54  |- skos__altLabel mesh__D016685 Mitomycin-C
% 220.38/220.54  |- mesh__recordAuthorizer mesh__D016685 sjn
% 220.38/220.54  |- skos__annotation mesh__D016685 MITOMYCINS is also available   
% 220.38/220.54  |- skos__hiddenLabel mesh__D016685 NSC 26980
% 220.38/220.54  |- skos__scopeNote mesh__D016685
% 220.38/220.54       An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.%A%    
% 220.38/220.54  |- mesh__publicMeSHNote mesh__D016685
% 220.38/220.54       2000%28%1992%29%; see MITOMYCIN C 1992-1999; MITOMYCIN C was indexed  under MITOMYCINS 1981-1990%A%  
% 220.38/220.54  |- skos__hiddenLabel mesh__D016685 MitocinC
% 220.38/220.54  |- rdf__type mesh__D016685sskos__Concept
% 220.38/220.54  |- mesh__recordOriginator mesh__D016685 RLS
% 220.38/220.54  |- skos__historyNote mesh__D016685 Mitomycins %28%1966-1991%29%
% 220.38/220.54  |- skos__hiddenLabel mesh__D016685 NSC26980
% 220.38/220.54  |- skos__hiddenLabel mesh__D016685 Mitocin C
% 220.38/220.54  |- skos__broader mesh__D016685smesh__D008937
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D016685 2005
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002665 2000
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002665 2005
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002665 2001
% 220.38/220.54  |- mesh__dateCreated mesh__D002665 1999-01-01
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002665 2006
% 220.38/220.54  |- mesh__dateRevised mesh__D002665 1997-06-20
% 220.38/220.54  |- skos__prefLabel mesh__D002665 Child Psychiatry
% 220.38/220.54  |- mesh__recordOriginator mesh__D002665 NLM
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002665 2002
% 220.38/220.54  |- skos__scopeNote mesh__D002665
% 220.38/220.54       The medical science that deals with the origin, diagnosis, prevention, and treatment of mental disorders in children.%A%    
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002665 1998
% 220.38/220.54  |- skos__annotation mesh__D002665
% 220.38/220.54       SPEC: SPEC qualif; not for mental disord in children %28% = MENTAL DISORDERS %28%IM%29% + CHILD or other child check tag %28%NIM%29% %29%: Manual 27.9%A%  
% 220.38/220.54  |- mesh__recordMaintainer mesh__D002665 PXP
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002665 1999
% 220.38/220.54  |- skos__hiddenLabel mesh__D002665 Psychiatry, Child
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002665 2003
% 220.38/220.54  |- mesh__recordAuthorizer mesh__D002665 SJN
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D002665 2004
% 220.38/220.54  |- rdf__type mesh__D002665sskos__Concept
% 220.38/220.54  |- skos__broader mesh__D002665smesh__D011570
% 220.38/220.54  |- mesh__dateCreated mesh__D035041 2002-07-02
% 220.38/220.54  |- mesh__dateEstablished mesh__D035041 2003-01-01
% 220.38/220.54  |- rdf__type mesh__D035041sskos__Concept
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D035041 2005
% 220.38/220.54  |- skos__hiddenLabel mesh__D035041 Testing, Anonymous
% 220.38/220.54  |- mesh__publicMeSHNote mesh__D035041 2003   
% 220.38/220.54  |- skos__prefLabel mesh__D035041 Anonymous Testing
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D035041 2003
% 220.38/220.54  |- skos__related mesh__D035041smesh__D003219
% 220.38/220.54  |- mesh__historyNote mesh__D035041 2003   
% 220.38/220.54  |- skos__scopeNote mesh__D035041
% 220.38/220.54       Testing in which the source of the specimen or the person being tested is not individually identified.%A%    
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D035041 2006
% 220.38/220.54  |- skos__broader mesh__D035041smesh__D008403
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D035041 2004
% 220.38/220.54  |- mesh__dateRevised mesh__D029802 2005-07-22
% 220.38/220.54  |- mesh__recordOriginator mesh__D029802 ssb
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D029802 2004
% 220.38/220.54  |- mesh__dateEstablished mesh__D029802 2002-01-01
% 220.38/220.54  |- mesh__recordAuthorizer mesh__D029802 ags
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D029802 2003
% 220.38/220.54  |- mesh__recordMaintainer mesh__D029802 ags
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D029802 2006
% 220.38/220.54  |- skos__broader mesh__D029802smesh__D019665
% 220.38/220.54  |- rdf__type mesh__D029802sskos__Concept
% 220.38/220.54  |- mesh__historyNote mesh__D029802 2002   
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D029802 2005
% 220.38/220.54  |- mesh__dateCreated mesh__D029802 2001-07-25
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D029802 2006A
% 220.38/220.54  |- skos__annotation mesh__D029802
% 220.38/220.54       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.38/220.54  |- skos__prefLabel mesh__D029802 Croton
% 220.38/220.54  |- mesh__publicMeSHNote mesh__D029802 2002   
% 220.38/220.54  |- skos__scopeNote mesh__D029802
% 220.38/220.54       A plant genus of the family EUPHORBIACEAE. The common name of dragon%27%s blood is also used for DRACAENA and Daemonorops %28%ARECACEAE%29%. Croton tiglium is the source of CROTON OIL.%A%    
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D007350 2002
% 220.38/220.54  |- mesh__publicMeSHNote mesh__D007350
% 220.38/220.54       GROUP HOSPITALIZATION was heading 1991, was see under INSURANCE, HOSPITALIZATION 1975-90%A%  
% 220.38/220.54  |- mesh__recordAuthorizer mesh__D007350 sjn
% 220.38/220.54  |- mesh__historyNote mesh__D007350
% 220.38/220.54       GROUP HOSPITALIZATION was heading 1975-91 %28%see under INSURANCE, HOSPITALIZATION 1975-90%29%%A%  
% 220.38/220.54  |- rdf__type mesh__D007350sskos__Concept
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D007350 2003
% 220.38/220.54  |- mesh__onlineNote mesh__D007350
% 220.38/220.54       use INSURANCE, HOSPITALIZATION to search GROUP HOSPITALIZATION 1975-91%A%  
% 220.38/220.54  |- skos__hiddenLabel mesh__D007350 Hospitalization, Group
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D007350 2004
% 220.38/220.54  |- mesh__dateRevised mesh__D007350 1999-11-03
% 220.38/220.54  |- skos__altLabel mesh__D007350 Hospitalization Insurance
% 220.38/220.54  |- mesh__dateCreated mesh__D007350 1999-01-01
% 220.38/220.54  |- skos__annotation mesh__D007350 specify geog if possible   
% 220.38/220.54  |- skos__prefLabel mesh__D007350 Insurance, Hospitalization
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D007350 2000
% 220.38/220.54  |- mesh__recordMaintainer mesh__D007350 kle
% 220.38/220.54  |- mesh__recordOriginator mesh__D007350 NLM
% 220.38/220.54  |- skos__scopeNote mesh__D007350
% 220.38/220.54       Health insurance providing benefits to cover or partly cover hospital expenses.%A%    
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D007350 2005
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D007350 2001
% 220.38/220.54  |- skos__broader mesh__D007350smesh__D007348
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D007350 2006
% 220.38/220.54  |- mesh__dateRevised mesh__D012295 2004-07-07
% 220.38/220.54  |- skos__broader mesh__D012295smesh__D006482
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D012295 2006
% 220.38/220.54  |- skos__hiddenLabel mesh__D012295 Fever, Rift Valley
% 220.38/220.54  |- mesh__recordMaintainer mesh__D012295 lkt
% 220.38/220.54  |- skos__broader mesh__D012295smesh__D002044
% 220.38/220.54  |- mesh__dateCreated mesh__D012295 1999-01-01
% 220.38/220.54  |- skos__broader mesh__D012295smesh__D006524
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D012295 2005
% 220.38/220.54  |- skos__broader mesh__D012295smesh__D001102
% 220.38/220.54  |- rdf__type mesh__D012295sskos__Concept
% 220.38/220.54  |- mesh__recordOriginator mesh__D012295 NLM
% 220.38/220.54  |- skos__scopeNote mesh__D012295
% 220.38/220.54       An acute infection caused by the RIFT VALLEY FEVER VIRUS, an RNA arthropod-borne virus, affecting domestic animals and humans. In animals, symptoms include HEPATITIS; abortion %28%ABORTION, VETERINARY%29%; and DEATH. In humans, symptoms range from those of a flu-like disease to hemorrhagic fever, ENCEPHALITIS, or BLINDNESS.%A%    
% 220.38/220.54  |- skos__prefLabel mesh__D012295 Rift Valley Fever
% 220.38/220.54  |- mesh__recordAuthorizer mesh__D012295 sjn
% 220.38/220.54  |- skos__hiddenLabel mesh__D020727 ADP Ribosylation Factors
% 220.38/220.54  |- mesh__historyNote mesh__D020727
% 220.38/220.54       2000; use ADP-RIBOSYLATION FACTORS %28%NM%29% 1984-1999   
% 220.38/220.54  |- mesh__publicMeSHNote mesh__D020727
% 220.38/220.54       2000; ARF PROTEIN COFACTOR %28%now ADP-RIBOSYLATION FACTORS%29% was indexed under G-PROTEINS 1984-1999%A%  
% 220.38/220.54  |- mesh__recordMaintainer mesh__D020727 jmp
% 220.38/220.54  |- skos__prefLabel mesh__D020727 ADP-Ribosylation Factors
% 220.38/220.54  |- mesh__dateCreated mesh__D020727 1999-11-03
% 220.38/220.54  |- skos__broader mesh__D020727smesh__D020559
% 220.38/220.54  |- mesh__dateEstablished mesh__D020727 2000-01-01
% 220.38/220.54  |- mesh__recordAuthorizer mesh__D020727 sjn
% 220.38/220.54  |- rdf__type mesh__D020727sskos__Concept
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D020727 2006
% 220.38/220.54  |- skos__historyNote mesh__D020727 G-Proteins %28%1985-1999%29%
% 220.38/220.54  |- skos__altLabel mesh__D020727 ADP-Ribosylation Factor
% 220.38/220.54  |- skos__hiddenLabel mesh__D020727 ADP Ribosylation Factor
% 220.38/220.54  |- mesh__recordOriginator mesh__D020727 jmp
% 220.38/220.54  |- skos__altLabel mesh__D020727 ARF Protein Cofactor
% 220.38/220.54  |- skos__scopeNote mesh__D020727
% 220.38/220.54       MONOMERIC GTP-BINDING PROTEINS that were initially recognized as allosteric activators of the MONO%28%ADP-RIBOSE%29% TRANSFERASE of the CHOLERA TOXIN catalytic subunit. They are involved in vesicle trafficking and activation of PHOSPHOLIPASE D. This enzyme was formerly listed as EC 3.6.1.47%A%    
% 220.38/220.54  |- mesh__dateRevised mesh__D020727 2005-06-30
% 220.38/220.54  |- mesh__publicMeSHNote mesh__D006258
% 220.38/220.54       76; NECK NEOPLASMS was heading 1963-75   
% 220.38/220.54  |- mesh__recordMaintainer mesh__D006258 nns
% 220.38/220.54  |- skos__broader mesh__D006258smesh__D009371
% 220.38/220.54  |- mesh__onlineNote mesh__D006258
% 220.38/220.54       use HEAD AND NECK NEOPLASMS to search NECK NEOPLASMS 1966-75%A%  
% 220.38/220.54  |- skos__hiddenLabel mesh__D006258 Neoplasms, UADT
% 220.38/220.54  |- skos__altLabel mesh__D006258 Head Cancer
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D006258 2006
% 220.38/220.54  |- skos__altLabel mesh__D006258 Neoplasms, Upper Aerodigestive Tract
% 220.38/220.54  |- skos__altLabel mesh__D006258 Head and Neck Cancer
% 220.38/220.54  |- mesh__activeMeSHYear mesh__D006258 2003
% 220.38/220.54  |- mesh__historyNote mesh__D006258
% 220.38/220.54       76; NECK NEOPLASMS was heading 1963-75   
% 220.38/220.54  |- mesh__dateEstablished mesh__D006258 1976-01-01
% 220.38/220.55  |- skos__prefLabel mesh__D006258 Head and Neck Neoplasms
% 220.38/220.55  |- skos__hiddenLabel mesh__D006258 UADT Neoplasm
% 220.38/220.55  |- skos__altLabel mesh__D006258 UADT Neoplasms
% 220.38/220.55  |- skos__hiddenLabel mesh__D006258 Neoplasm, UADT
% 220.38/220.55  |- skos__altLabel mesh__D006258 Cancer of the Neck
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D006258 2004
% 220.38/220.55  |- skos__scopeNote mesh__D006258
% 220.38/220.55       Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. %28%from Holland et al., Cancer Medicine, 4th ed, p1651%29%%A%    
% 220.38/220.55  |- skos__altLabel mesh__D006258 Neoplasms, Neck
% 220.38/220.55  |- skos__altLabel mesh__D006258 Head, Neck Neoplasms
% 220.38/220.55  |- mesh__recordAuthorizer mesh__D006258 sjn
% 220.38/220.55  |- skos__altLabel mesh__D006258 Cancer of the Head and Neck
% 220.38/220.55  |- rdf__type mesh__D006258sskos__Concept
% 220.38/220.55  |- skos__altLabel mesh__D006258 Neoplasms, Head and Neck
% 220.38/220.55  |- skos__annotation mesh__D006258
% 220.38/220.55       soft tissue neopls only; GEN: prefer FACIAL NEOPLASMS, %26% other specific organ/neopl terms pertinent to the soft tissues of the head %26% neck; coord IM with histol type of neopl if possible; DF: HEAD NEOPLASMS or HEAD NEOPL%A%  
% 220.38/220.55  |- skos__altLabel mesh__D006258 Cancer of the Head
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D006258 2002
% 220.38/220.55  |- mesh__dateRevised mesh__D006258 2001-07-25
% 220.38/220.55  |- mesh__recordOriginator mesh__D006258 SMH
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D006258 2005
% 220.38/220.55  |- mesh__dateCreated mesh__D006258 1975-07-25
% 220.38/220.55  |- skos__altLabel mesh__D006258 Neoplasms, Head
% 220.38/220.55  |- skos__altLabel mesh__D006258 Neck Cancer
% 220.38/220.55  |- skos__broader mesh__D017895Q000633smesh__D017895
% 220.38/220.55  |- mesh__preferredCombination mesh__D017895Q000633smesh__D020149
% 220.38/220.55  |- rdf__type mesh__D017895Q000633smesh__CompoundConcept
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D016686 2004
% 220.38/220.55  |- mesh__recordMaintainer mesh__D016686 ssb
% 220.38/220.55  |- mesh__publicMeSHNote mesh__D016686
% 220.38/220.55       92; MONOCROTALINE was indexed under PYRROLIZIDINE ALKALOIDS 1973-91%A%  
% 220.38/220.55  |- mesh__dateEstablished mesh__D016686 1992-01-01
% 220.38/220.55  |- skos__broader mesh__D016686smesh__D011763
% 220.38/220.55  |- mesh__historyNote mesh__D016686
% 220.38/220.55       92; was MONOCROTALINE %28%NM%29% 1973-91   
% 220.38/220.55  |- rdf__type mesh__D016686sskos__Concept
% 220.38/220.55  |- skos__scopeNote mesh__D016686
% 220.38/220.55       A pyrrolizidine alkaloid and a toxic plant constituent that poisons livestock and humans through the ingestion of contaminated grains and other foods. The alkaloid causes pulmonary artery hypertension, right ventricular hypertrophy, and pathological changes in the pulmonary vasculature. Significant attenuation of the cardiopulmonary changes are noted after oral magnesium treatment.%A%    
% 220.38/220.55  |- skos__prefLabel mesh__D016686 Monocrotaline
% 220.38/220.55  |- mesh__dateRevised mesh__D016686 2003-07-09
% 220.38/220.55  |- mesh__onlineNote mesh__D016686
% 220.38/220.55       use MONOCROTALINE %28%NM%29% to search MONOCROTALINE 1980-91   
% 220.38/220.55  |- mesh__recordAuthorizer mesh__D016686 sjn
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D016686 2005
% 220.38/220.55  |- skos__historyNote mesh__D016686
% 220.38/220.55       Pyrrolizidine Alkaloids %28%1971-1973%29%
% 220.38/220.55  |- mesh__dateCreated mesh__D016686 1991-01-25
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D016686 2006
% 220.38/220.55  |- mesh__recordOriginator mesh__D016686 RLS
% 220.38/220.55  |- skos__altLabel mesh__D002666 Psychology, Pediatric
% 220.38/220.55  |- mesh__dateRevised mesh__D002666 1991-06-26
% 220.38/220.55  |- mesh__dateCreated mesh__D002666 1999-01-01
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D002666 2001
% 220.38/220.55  |- mesh__recordOriginator mesh__D002666 NLM
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D002666 2005
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D002666 1997
% 220.38/220.55  |- skos__annotation mesh__D002666
% 220.38/220.55       SPEC but also the way a normal child thinks %26% acts; GEN only: consider also /psychol with specific child terms %28%e.g., CHILD, ABANDONED /psychol, ONLY CHILD /psychol%29%; SPEC qualif; Manual 27.11, 27.12, 34.12; check also tag CHILD or specific; DF: CHILD PSYCHOL%A%  
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D002666 2002
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D002666 1992
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D002666 2006
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D002666 1998
% 220.38/220.55  |- mesh__recordMaintainer mesh__D002666 TGC
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D002666 1993
% 220.38/220.55  |- skos__altLabel mesh__D002666 Infant Psychology
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D002666 1999
% 220.38/220.55  |- skos__prefLabel mesh__D002666 Child Psychology
% 220.38/220.55  |- skos__related mesh__D002666smesh__D002657
% 220.38/220.55  |- skos__scopeNote mesh__D002666
% 220.38/220.55       The study of normal and abnormal behavior of children.     
% 220.38/220.55  |- skos__altLabel mesh__D002666 Psychology, Child
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D002666 2003
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D002666 1994
% 220.38/220.55  |- rdf__type mesh__D002666sskos__Concept
% 220.38/220.55  |- mesh__recordAuthorizer mesh__D002666 PLS
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D002666 2000
% 220.38/220.55  |- skos__broader mesh__D002666smesh__D011584
% 220.38/220.55  |- skos__altLabel mesh__D002666 Pediatric Psychology
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D002666 2004
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D002666 1995
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D002666 1996
% 220.38/220.55  |- skos__prefLabel mesh__D029803 Phyllanthus
% 220.38/220.55  |- mesh__publicMeSHNote mesh__D029803 2002   
% 220.38/220.55  |- mesh__dateEstablished mesh__D029803 2002-01-01
% 220.38/220.55  |- skos__annotation mesh__D029803
% 220.38/220.55       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D029803 2004
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D029803 2003
% 220.38/220.55  |- skos__broader mesh__D029803smesh__D019665
% 220.38/220.55  |- rdf__type mesh__D029803sskos__Concept
% 220.38/220.55  |- mesh__dateRevised mesh__D029803 2002-07-02
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D029803 2006
% 220.38/220.55  |- skos__scopeNote mesh__D029803
% 220.38/220.55       A plant genus of the family EUPHORBIACEAE.  Bahupatra %28%MEDICINE, AYURVEDIC%29% is prepared from this.%A%    
% 220.38/220.55  |- mesh__historyNote mesh__D029803 2002   
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D029803 2005
% 220.38/220.55  |- mesh__dateCreated mesh__D029803 2001-07-25
% 220.38/220.55  |- mesh__recordMaintainer mesh__D007351 kle
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D007351 2004
% 220.38/220.55  |- mesh__dateCreated mesh__D007351 1999-01-01
% 220.38/220.55  |- mesh__recordOriginator mesh__D007351 NLM
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D007351 2001
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D007351 2005
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D007351 2002
% 220.38/220.55  |- skos__annotation mesh__D007351 specify geog if possible   
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D007351 2006
% 220.38/220.55  |- mesh__recordAuthorizer mesh__D007351 sjn
% 220.38/220.55  |- skos__hiddenLabel mesh__D007351 Insurance, No-Fault
% 220.38/220.55  |- skos__broader mesh__D007351smesh__D007341
% 220.38/220.55  |- mesh__dateRevised mesh__D007351 1999-11-03
% 220.38/220.55  |- rdf__type mesh__D007351sskos__Concept
% 220.38/220.55  |- skos__hiddenLabel mesh__D007351 No Fault Insurance
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D007351 2003
% 220.38/220.55  |- skos__hiddenLabel mesh__D007351 Liability Insurance
% 220.38/220.55  |- skos__scopeNote mesh__D007351
% 220.38/220.55       Insurance against loss resulting from liability for injury or damage to the persons or property of others.%A%    
% 220.38/220.55  |- skos__prefLabel mesh__D007351 Insurance, Liability
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D007351 2000
% 220.38/220.55  |- mesh__historyNote mesh__D048768 2005%28%1997%29%   
% 220.38/220.55  |- skos__altLabel mesh__D048768 MEKK4 Protein Kinase
% 220.38/220.55  |- mesh__dateCreated mesh__D048768 2004-07-07
% 220.38/220.55  |- mesh__recordMaintainer mesh__D048768 jmp
% 220.38/220.55  |- mesh__dateEstablished mesh__D048768 2005-01-01
% 220.38/220.55  |- skos__altLabel mesh__D048768 MAPKKK4 Protein
% 220.38/220.55  |- mesh__recordAuthorizer mesh__D048768 sjn
% 220.38/220.55  |- skos__hiddenLabel mesh__D048768
% 220.38/220.55       Mitogen Activated Protein Kinase Kinase Kinase 4
% 220.38/220.55  |- skos__altLabel mesh__D048768
% 220.38/220.55       Mitogen-Activated Protein Kinase Kinase Kinase 4
% 220.38/220.55  |- mesh__recordOriginator mesh__D048768 jmp
% 220.38/220.55  |- skos__hiddenLabel mesh__D048768 Kinase, MEKK4 Protein
% 220.38/220.55  |- skos__broader mesh__D048768smesh__D020930
% 220.38/220.55  |- skos__historyNote mesh__D048768
% 220.38/220.55       Protein-Serine-Threonine Kinases %28%1997-1999%29%
% 220.38/220.55  |- skos__historyNote mesh__D048768 Protein Kinases %28%1997-1999%29%
% 220.38/220.55  |- skos__altLabel mesh__D048768 MAP3K4 Protein Kinase
% 220.38/220.55  |- skos__prefLabel mesh__D048768 MAP Kinase Kinase Kinase 4
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D048768 2005
% 220.38/220.55  |- skos__altLabel mesh__D048768 MEK Kinase 4
% 220.38/220.55  |- rdf__type mesh__D048768sskos__Concept
% 220.38/220.55  |- mesh__publicMeSHNote mesh__D048768
% 220.38/220.55       2005; MAP KINASE KINASE KINASE 4 was indexed under MAP KINASE KINASE KINASES 2000-2004, %26% under PROTEIN-SERINE-THREONINE KINASES %26% PROTEIN KINASES 1997-1999%A%  
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D048768 2006
% 220.38/220.55  |- skos__hiddenLabel mesh__D048768 Protein Kinase, MAP3K4
% 220.38/220.55  |- skos__altLabel mesh__D048768 MEKK4 Protein
% 220.38/220.55  |- skos__historyNote mesh__D048768
% 220.38/220.55       MAP Kinase Kinase Kinases %28%2000-2004%29%
% 220.38/220.55  |- skos__scopeNote mesh__D048768
% 220.38/220.55       A 180-kDa MAP kinase kinase kinase with specificity for MAP KINASE KINASE 4 and MAP KINASE KINASE 6.%A%    
% 220.38/220.55  |- skos__annotation mesh__D045470
% 220.38/220.55       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D045470 2004
% 220.38/220.55  |- skos__broader mesh__D045470smesh__D019666
% 220.38/220.55  |- mesh__historyNote mesh__D045470 2004   
% 220.38/220.55  |- skos__scopeNote mesh__D045470
% 220.38/220.55       A plant genus of the family RUBIACEAE. The root is a source of red dyes %28%madder color and 1,2,4-trihydroxy-9,10-anthracenedione%29% and ANTHRAQUINONES.%A%    
% 220.38/220.55  |- mesh__dateCreated mesh__D045470 2003-07-09
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D045470 2006
% 220.38/220.55  |- mesh__publicMeSHNote mesh__D045470 2004   
% 220.38/220.55  |- rdf__type mesh__D045470sskos__Concept
% 220.38/220.55  |- skos__prefLabel mesh__D045470 Rubia
% 220.38/220.55  |- mesh__dateEstablished mesh__D045470 2004-01-01
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D045470 2005
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D012296 2002
% 220.38/220.55  |- mesh__dateRevised mesh__D012296 2001-07-25
% 220.38/220.55  |- skos__scopeNote mesh__D012296
% 220.38/220.55       A mosquito-borne species of the PHLEBOVIRUS genus found in eastern, central, and southern Africa, producing massive hepatitis, abortion, and death in sheep, goats, cattle, and other animals. It also has caused disease in humans.%A%    
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D012296 2004
% 220.38/220.55  |- mesh__recordAuthorizer mesh__D012296 sjn
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D012296 2006
% 220.38/220.55  |- mesh__recordMaintainer mesh__D012296 ags
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D012296 2003
% 220.38/220.55  |- mesh__publicMeSHNote mesh__D012296
% 220.38/220.55       91; was see under BUNYAVIRIDAE 1981-90; was see under ARBOVIRUSES 1975-80; was see under ARBOVIRUS 1965-74; was see under ARBORVIRUSES 1963-64%A%  
% 220.38/220.55  |- mesh__dateCreated mesh__D012296 1999-01-01
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D012296 2005
% 220.38/220.55  |- skos__annotation mesh__D012296 infection = RIFT VALLEY FEVER   
% 220.38/220.55  |- rdf__type mesh__D012296sskos__Concept
% 220.38/220.55  |- mesh__onlineNote mesh__D012296
% 220.38/220.55       use ARBOVIRUSES to search RIFT VALLEY FEVER VIRUS 1966-74%A%  
% 220.38/220.55  |- skos__prefLabel mesh__D012296 Rift Valley fever virus
% 220.38/220.55  |- skos__broader mesh__D012296smesh__D016856
% 220.38/220.55  |- mesh__historyNote mesh__D012296
% 220.38/220.55       91%28%75%29%; was see under BUNYAVIRIDAE 1981-90; was see under ARBOVIRUSES 1975-80; was see under ARBOVIRUS 1965-74; was see under ARBORVIRUSES 1963-64%A%  
% 220.38/220.55  |- mesh__dateEstablished mesh__D012296 1991-01-01
% 220.38/220.55  |- mesh__recordOriginator mesh__D012296 NLM
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728 Prostate Resections, Transurethral
% 220.38/220.55  |- mesh__recordMaintainer mesh__D020728 ags
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728 Thermotherapy, Transurethral Microwave
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728 Prostate Transurethral Electroresection
% 220.38/220.55  |- skos__altLabel mesh__D020728 TUVP
% 220.38/220.55  |- skos__altLabel mesh__D020728 TURP
% 220.38/220.55  |- rdf__type mesh__D020728sskos__Concept
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728 Thermotherapies, Transurethral
% 220.38/220.55  |- skos__altLabel mesh__D020728
% 220.38/220.55       Transurethral Radiofrequency Thermal Ablation
% 220.38/220.55  |- mesh__dateEstablished mesh__D020728 2000-01-01
% 220.38/220.55  |- skos__altLabel mesh__D020728 Transurethral Vaporesection of Prostate
% 220.38/220.55  |- mesh__publicMeSHNote mesh__D020728
% 220.38/220.55       2000; see PROSTATECTOMY 1999; for PROSTATECTOMY, TRANSURETHRAL see PROSTATECTOMY 1992-1999%A%  
% 220.38/220.55  |- mesh__recordOriginator mesh__D020728 ndw
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728
% 220.38/220.55       Prostate Transurethral Electrovaporization
% 220.38/220.55  |- mesh__dateRevised mesh__D020728 2002-07-03
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728 Resections, Transurethral Prostate
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D020728 2006
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728 Prostate Resection, Transurethral
% 220.38/220.55  |- skos__altLabel mesh__D020728 VLAP
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728 TURPs
% 220.38/220.55  |- skos__altLabel mesh__D020728 Prostatectomy, Transurethral
% 220.38/220.55  |- mesh__historyNote mesh__D020728
% 220.38/220.55       2000; use PROSTATECTOMY 1999; for PROSTATECTOMY, TRANSURETHRAL use PROSTATECTOMY 1992-1999%A%  
% 220.38/220.55  |- skos__prefLabel mesh__D020728 Transurethral Resection of Prostate
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728 Prostatectomies, Transurethral
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728 Prostate Transurethral Vaporesection
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728 Transurethral Prostate Resections
% 220.38/220.55  |- mesh__dateCreated mesh__D020728 1999-11-03
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728 Microwave Thermotherapy, Transurethral
% 220.38/220.55  |- skos__altLabel mesh__D020728 Transurethral Electroresection of Prostate
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728 Prostate Transurethral Resection
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D020728 2005
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728
% 220.38/220.55       Prostate Transurethral Electrovaporizations
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728 Resection, Transurethral Prostate
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728 Transurethral Thermotherapies
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728 Prostate Transurethral Vaporesections
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728 Transurethral Prostatectomy
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D020728 2004
% 220.38/220.55  |- mesh__recordAuthorizer mesh__D020728 sjn
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728 Prostate Transurethral Resections
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728
% 220.38/220.55       Transurethral Ultrasound Guided Laser Induced Prostatectomy
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728 Thermotherapy, Transurethral
% 220.38/220.55  |- skos__altLabel mesh__D020728 Transurethral Prostate Resection
% 220.38/220.55  |- skos__altLabel mesh__D020728 Transurethral Thermotherapy
% 220.38/220.55  |- skos__historyNote mesh__D020728 Prostatectomy %28%1966-1999%29%
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728 Prostate Transurethral Electroresections
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D020728 2003
% 220.38/220.55  |- skos__scopeNote mesh__D020728
% 220.38/220.55       Removal of all or part of the PROSTATE, often using a cystoscope and/or resectoscope passed through the URETHRA.%A%    
% 220.38/220.55  |- skos__broader mesh__D020728smesh__D011468
% 220.38/220.55  |- skos__hiddenLabel mesh__D020728 Transurethral Prostatectomies
% 220.38/220.55  |- skos__scopeNote mesh__D031450
% 220.38/220.55       A plant genus of the family LOGANIACEAE %28%classified by some botanists as Gelsemiaceae%29%. The sometimes used common name of trumpet flower is also used for DATURA.%A%    
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D031450 2006
% 220.38/220.55  |- mesh__dateEstablished mesh__D031450 2003-01-01
% 220.38/220.55  |- mesh__dateCreated mesh__D031450 2002-07-03
% 220.38/220.55  |- mesh__historyNote mesh__D031450 2003   
% 220.38/220.55  |- skos__altLabel mesh__D031450 Woodbine
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D031450 2003
% 220.38/220.55  |- skos__altLabel mesh__D031450 Jessamine, Yellow
% 220.38/220.55  |- mesh__publicMeSHNote mesh__D031450 2003   
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D031450 2004
% 220.38/220.55  |- skos__broader mesh__D031450smesh__D029541
% 220.38/220.55  |- rdf__type mesh__D031450sskos__Concept
% 220.38/220.55  |- skos__altLabel mesh__D031450 Hu-man-teng
% 220.38/220.55  |- skos__prefLabel mesh__D031450 Gelsemium
% 220.38/220.55  |- skos__annotation mesh__D031450
% 220.38/220.55       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D031450 2005
% 220.38/220.55  |- skos__altLabel mesh__D031450 Yellow-Jessamine
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Skull Injuries, Crushing
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Head Injuries, Superficial
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Temporal Region Traumas
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Occipital Region Traumas
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Minor Head Injuries
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Region Trauma, Parietal
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Injuries, Minor Head
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Trauma, Occipital Region
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Injuries, Open Head
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Traumas, Frontal Region
% 220.38/220.55  |- skos__altLabel mesh__D006259 Injuries, Head
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Region Traumas, Frontal
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Parietal Region Traumas
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Region Traumas, Occipital
% 220.38/220.55  |- skos__annotation mesh__D006259
% 220.38/220.55       general or unspecified; do not consider a substitute for /inj with various bones or other portions of the head; do not confuse with BRAIN INJURIES; DF: HEAD INJ%A%  
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Region Trauma, Occipital
% 220.38/220.55  |- skos__altLabel mesh__D006259 Head Injuries
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D006259 2004
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Region Traumas, Parietal
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Injury, Multiple Head
% 220.38/220.55  |- mesh__dateRevised mesh__D006259 1999-11-08
% 220.38/220.55  |- skos__broader mesh__D006259smesh__D014947
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Head Injuries, Minor
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Frontal Region Traumas
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Skull Injury, Crushing
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Trauma, Forehead
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Injury, Open Head
% 220.38/220.55  |- skos__altLabel mesh__D006259 Forehead Trauma
% 220.38/220.55  |- mesh__recordOriginator mesh__D006259 NLM
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Traumas, Temporal Region
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Region Trauma, Frontal
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Traumas, Occipital
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D006259 2002
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Injury, Craniocerebral
% 220.38/220.55  |- skos__prefLabel mesh__D006259 Craniocerebral Trauma
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Trauma, Temporal Region
% 220.38/220.55  |- mesh__publicMeSHNote mesh__D006259
% 220.38/220.55       2000; see HEAD INJURIES 1966-1999; for CRANIOCEREBRAL INJURIES see BRAIN INJURIES 1998-1999%A%  
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D006259 2003
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Head Traumas
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Injuries, Multiple Head
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Trauma, Craniocerebral
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Multiple Head Injury
% 220.38/220.55  |- skos__altLabel mesh__D006259 Superficial Head Injury
% 220.38/220.55  |- mesh__recordMaintainer mesh__D006259 adp
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Head Injury, Multiple
% 220.38/220.55  |- rdf__type mesh__D006259sskos__Concept
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Traumas, Parietal Region
% 220.38/220.55  |- skos__altLabel mesh__D006259 Craniocerebral Injuries
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Superficial Head Injuries
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Injuries, Superficial Head
% 220.38/220.55  |- skos__scopeNote mesh__D006259
% 220.38/220.55       Traumatic injuries involving the cranium and intracranial structures %28%i.e., BRAIN; CRANIAL NERVES; MENINGES; and other structures%29%. Injuries may be classified by whether or not the skull is penetrated %28%i.e., penetrating vs. nonpenetrating%29% or whether there is an associated hemorrhage.%A%    
% 220.38/220.55  |- skos__altLabel mesh__D006259 Open Head Injury
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Trauma, Frontal Region
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D006259 2006
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Traumas, Occipital Region
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Occipital Traumas
% 220.38/220.55  |- mesh__dateCreated mesh__D006259 1999-01-01
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Craniocerebral Traumas
% 220.38/220.55  |- skos__altLabel mesh__D006259 Occipital Trauma
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Traumas, Craniocerebral
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Head Injury
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Forehead Traumas
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Crushing Skull Injuries
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D006259 2001
% 220.38/220.55  |- mesh__recordAuthorizer mesh__D006259 sjn
% 220.38/220.55  |- skos__altLabel mesh__D006259 Head Trauma
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Open Head Injuries
% 220.38/220.55  |- skos__altLabel mesh__D006259 Trauma, Head
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D006259 2005
% 220.38/220.55  |- skos__related mesh__D006259smesh__D020221
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Craniocerebral Injury
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Injury, Superficial Head
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Injury, Minor Head
% 220.38/220.55  |- skos__altLabel mesh__D006259 Injuries, Craniocerebral
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Traumas, Head
% 220.38/220.55  |- skos__broader mesh__D006259smesh__D020196
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Head Injuries, Open
% 220.38/220.55  |- skos__altLabel mesh__D006259 Multiple Head Injuries
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Trauma, Parietal Region
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D006259 2000
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Minor Head Injury
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Traumas, Forehead
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Trauma, Occipital
% 220.38/220.55  |- mesh__historyNote mesh__D006259 2000%28%1966%29%   
% 220.38/220.55  |- skos__hiddenLabel mesh__D006259 Injury, Head
% 220.38/220.55  |- skos__broader mesh__D016687smesh__D011091
% 220.38/220.55  |- mesh__recordMaintainer mesh__D016687 jmp
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D016687 2006
% 220.38/220.55  |- mesh__dateRevised mesh__D016687 2004-07-07
% 220.38/220.55  |- mesh__dateEstablished mesh__D016687 1992-01-01
% 220.38/220.55  |- mesh__recordOriginator mesh__D016687 RLS
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D016687 2005
% 220.38/220.55  |- skos__historyNote mesh__D016687 Polyesters %28%1977-1991%29%
% 220.38/220.55  |- mesh__historyNote mesh__D016687
% 220.38/220.55       92; was POLYDIOXANONE %28%NM%29% 1979-91   
% 220.38/220.55  |- mesh__onlineNote mesh__D016687
% 220.38/220.55       use POLYDIOXANONE %28%NM%29% to search POLYDIOXANONE 1981-91   
% 220.38/220.55  |- skos__historyNote mesh__D016687 Sutures %28%1966-1991%29%
% 220.38/220.55  |- skos__broader mesh__D016687smesh__D001672
% 220.38/220.55  |- skos__prefLabel mesh__D016687 Polydioxanone
% 220.38/220.55  |- mesh__publicMeSHNote mesh__D016687
% 220.38/220.55       92; POLYDIOXANONE was indexed under POLYESTERS 1979-91   
% 220.38/220.55  |- rdf__type mesh__D016687sskos__Concept
% 220.38/220.55  |- skos__scopeNote mesh__D016687
% 220.38/220.55       An absorbable suture material used also as ligating clips, as pins for internal fixation of broken bones, and as ligament reinforcement for surgically managed ligament injuries. Its promising characteristics are elasticity, complete biodegradability, and lack of side effects such as infections.%A%    
% 220.38/220.55  |- mesh__dateCreated mesh__D016687 1991-01-25
% 220.38/220.55  |- mesh__recordAuthorizer mesh__D016687 sjn
% 220.38/220.55  |- skos__annotation mesh__D016687 D25-26 qualif   
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D035841 2006
% 220.38/220.55  |- skos__hiddenLabel mesh__D035841 Research, Behavioral
% 220.38/220.55  |- mesh__dateRevised mesh__D035841 2003-07-09
% 220.38/220.55  |- skos__scopeNote mesh__D035841
% 220.38/220.55       Research that involves the application of the behavioral and social sciences to the study of the actions or reactions of persons or animals in response to external or internal stimuli. %28%from American Heritage Dictionary, 4th ed%29%%A%    
% 220.38/220.55  |- mesh__historyNote mesh__D035841 2003   
% 220.38/220.55  |- mesh__recordAuthorizer mesh__D035841 sjn
% 220.38/220.55  |- mesh__dateEstablished mesh__D035841 2003-01-01
% 220.38/220.55  |- skos__annotation mesh__D035841
% 220.38/220.55       behavioral research as a field or the progress or status of behavioral research; do not add routinely for specific studies in behavior: Manual 29.16%A%  
% 220.38/220.55  |- skos__prefLabel mesh__D035841 Behavioral Research
% 220.38/220.55  |- mesh__publicMeSHNote mesh__D035841 2003   
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D035841 2004
% 220.38/220.55  |- mesh__recordMaintainer mesh__D035841 jls
% 220.38/220.55  |- mesh__dateCreated mesh__D035841 2002-07-02
% 220.38/220.55  |- skos__historyNote mesh__D035841 Research %28%1968-2002%29%
% 220.38/220.55  |- skos__broader mesh__D035841smesh__D012106
% 220.38/220.55  |- rdf__type mesh__D035841sskos__Concept
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D035841 2005
% 220.38/220.55  |- skos__broader mesh__D035841smesh__D001525
% 220.38/220.55  |- mesh__recordOriginator mesh__D035841 jrf
% 220.38/220.55  |- mesh__historyNote mesh__D002667
% 220.38/220.55       84%28%75%29%; was see under CHILD BEHAVIOR DISORDERS 1968-83   
% 220.38/220.55  |- skos__hiddenLabel mesh__D002667 Reactive Disorder, Child
% 220.38/220.55  |- skos__annotation mesh__D002667
% 220.38/220.55       child reaction to separation from parents: index under ANXIETY, SEPARATION; check also tag CHILD or specific%A%  
% 220.38/220.55  |- mesh__recordMaintainer mesh__D002667 JLS
% 220.38/220.55  |- skos__broader mesh__D002667smesh__D001526
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D002667 2003
% 220.38/220.55  |- mesh__recordAuthorizer mesh__D002667 sjn
% 220.38/220.55  |- skos__scopeNote mesh__D002667
% 220.38/220.55       Reactions to an event or set of events which are considered to be of pathological degree, that have not developed into a neurosis, psychosis, or personality disorder with fixed patterns.%A%    
% 220.38/220.55  |- rdf__type mesh__D002667sskos__Concept
% 220.38/220.55  |- mesh__publicMeSHNote mesh__D002667
% 220.38/220.55       84; was see under CHILD BEHAVIOR DISORDERS 1968-83   
% 220.38/220.55  |- mesh__dateRevised mesh__D002667 2002-07-03
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D002667 2004
% 220.38/220.55  |- mesh__recordOriginator mesh__D002667 NLM
% 220.38/220.55  |- skos__prefLabel mesh__D002667 Child Reactive Disorders
% 220.38/220.55  |- mesh__onlineNote mesh__D002667
% 220.38/220.55       search CHILD BEHAVIOR DISORDERS 1968-74   
% 220.38/220.55  |- mesh__dateCreated mesh__D002667 1999-01-01
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D002667 2005
% 220.38/220.55  |- mesh__dateEstablished mesh__D002667 1984-01-01
% 220.38/220.55  |- skos__hiddenLabel mesh__D002667 Child Reactive Disorder
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D002667 2006
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D021821 2006
% 220.38/220.55  |- skos__hiddenLabel mesh__D021821 Emerging Communicable Disease
% 220.38/220.55  |- skos__hiddenLabel mesh__D021821 Diseases, Emerging Communicable
% 220.38/220.55  |- skos__hiddenLabel mesh__D021821 Disease, Emerging Communicable
% 220.38/220.55  |- skos__hiddenLabel mesh__D021821 Disease, Emerging Infectious
% 220.38/220.55  |- skos__hiddenLabel mesh__D021821 Emerging Infectious Diseases
% 220.38/220.55  |- skos__hiddenLabel mesh__D021821 Diseases, Emerging Infectious
% 220.38/220.55  |- skos__scopeNote mesh__D021821
% 220.38/220.55       Reporting of new and reemerging infectious diseases and studies that seek to improve the understanding of factors involved in disease emergence, prevention, and elimination.%A%    
% 220.38/220.55  |- skos__hiddenLabel mesh__D021821 Infectious Disease, Emerging
% 220.38/220.55  |- mesh__publicMeSHNote mesh__D021821 2001   
% 220.38/220.55  |- skos__hiddenLabel mesh__D021821 Communicable Disease, Emerging
% 220.38/220.55  |- skos__prefLabel mesh__D021821 Communicable Diseases, Emerging
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D021821 2001
% 220.38/220.55  |- skos__altLabel mesh__D021821 Infectious Diseases, Emerging
% 220.38/220.55  |- mesh__dateCreated mesh__D021821 2000-06-22
% 220.38/220.55  |- skos__broader mesh__D021821smesh__D003141
% 220.38/220.55  |- skos__historyNote mesh__D021821 Communicable Diseases %28%1966-2000%29%
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D021821 2003
% 220.38/220.55  |- rdf__type mesh__D021821sskos__Concept
% 220.38/220.55  |- skos__hiddenLabel mesh__D021821 Emerging Infectious Disease
% 220.38/220.55  |- skos__hiddenLabel mesh__D021821 Emerging Communicable Diseases
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D021821 2002
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D021821 2005
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D021821 2004
% 220.38/220.55  |- mesh__historyNote mesh__D021821 2001   
% 220.38/220.55  |- mesh__dateEstablished mesh__D021821 2001-01-01
% 220.38/220.55  |- skos__hiddenLabel mesh__D007352 Insurances, Life
% 220.38/220.55  |- mesh__activeMeSHYear mesh__D007352 2005
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D007352 2000
% 220.38/220.56  |- skos__scopeNote mesh__D007352
% 220.38/220.56       Insurance providing for payment of a stipulated sum to a designated beneficiary upon death of the insured.%A%    
% 220.38/220.56  |- mesh__recordMaintainer mesh__D007352 kle
% 220.38/220.56  |- skos__annotation mesh__D007352 specify geog if possible   
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D007352 2006
% 220.38/220.56  |- skos__prefLabel mesh__D007352 Insurance, Life
% 220.38/220.56  |- mesh__recordOriginator mesh__D007352 NLM
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D007352 2001
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D007352 2002
% 220.38/220.56  |- rdf__type mesh__D007352sskos__Concept
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D007352 2003
% 220.38/220.56  |- mesh__recordAuthorizer mesh__D007352 sjn
% 220.38/220.56  |- skos__hiddenLabel mesh__D007352 Life Insurances
% 220.38/220.56  |- skos__altLabel mesh__D007352 Life Insurance
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D007352 2004
% 220.38/220.56  |- mesh__dateCreated mesh__D007352 1999-01-01
% 220.38/220.56  |- skos__broader mesh__D007352smesh__D007341
% 220.38/220.56  |- mesh__dateRevised mesh__D007352 1999-11-03
% 220.38/220.56  |- mesh__dateCreated mesh__D045471 2003-07-09
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D045471 2006
% 220.38/220.56  |- mesh__publicMeSHNote mesh__D045471 2004   
% 220.38/220.56  |- rdf__type mesh__D045471sskos__Concept
% 220.38/220.56  |- mesh__historyNote mesh__D045471 2004   
% 220.38/220.56  |- skos__annotation mesh__D045471
% 220.38/220.56       X ref CRATEVA MARMELOS: CRATEVA see CAPPARACEAE is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.38/220.56  |- skos__broader mesh__D045471smesh__D027821
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D045471 2005
% 220.38/220.56  |- skos__scopeNote mesh__D045471 A plant genus of the family RUTACEAE.     
% 220.38/220.56  |- mesh__dateEstablished mesh__D045471 2004-01-01
% 220.38/220.56  |- skos__altLabel mesh__D045471 Crateva marmelos
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D045471 2004
% 220.38/220.56  |- skos__prefLabel mesh__D045471 Aegle
% 220.38/220.56  |- mesh__dateEstablished mesh__D031451 2003-01-01
% 220.38/220.56  |- skos__broader mesh__D031451smesh__D029541
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D031451 2006
% 220.38/220.56  |- skos__prefLabel mesh__D031451 Strychnos
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D031451 2004
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D031451 2005
% 220.38/220.56  |- mesh__dateCreated mesh__D031451 2002-07-03
% 220.38/220.56  |- mesh__historyNote mesh__D031451 2003   
% 220.38/220.56  |- mesh__publicMeSHNote mesh__D031451 2003   
% 220.38/220.56  |- skos__annotation mesh__D031451
% 220.38/220.56       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D031451 2003
% 220.38/220.56  |- rdf__type mesh__D031451sskos__Concept
% 220.38/220.56  |- skos__scopeNote mesh__D031451
% 220.38/220.56       A plant genus of the family LOGANIACEAE %28%classified by some botanists as Strychnaceae%29%.%A%    
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D012297 2005
% 220.38/220.56  |- mesh__dateEstablished mesh__D012297 1987-01-01
% 220.38/220.56  |- skos__hiddenLabel mesh__D012297 Dignity, Death with
% 220.38/220.56  |- skos__related mesh__D012297smesh__D017236
% 220.38/220.56  |- skos__related mesh__D012297smesh__D005065
% 220.38/220.56  |- rdf__type mesh__D012297sskos__Concept
% 220.38/220.56  |- mesh__dateCreated mesh__D012297 1986-05-30
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D012297 2003A
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D012297 2002
% 220.38/220.56  |- skos__broader mesh__D012297smesh__D028701
% 220.38/220.56  |- mesh__recordMaintainer mesh__D012297 jls
% 220.38/220.56  |- skos__prefLabel mesh__D012297 Right to Die
% 220.38/220.56  |- skos__historyNote mesh__D012297 Euthanasia, Passive %28%1978-1986%29%
% 220.38/220.56  |- skos__annotation mesh__D012297
% 220.38/220.56       differentiate from ALLOWING TO DIE see EUTHANASIA, PASSIVE%A%  
% 220.38/220.56  |- skos__scopeNote mesh__D012297
% 220.38/220.56       The right of the patient or the patient%27%s representative to make decisions with regard to the patient%27%s dying.%A%    
% 220.38/220.56  |- mesh__recordOriginator mesh__D012297 EC
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D012297 2004
% 220.38/220.56  |- skos__historyNote mesh__D012297 Patient Advocacy %28%1976-1986%29%
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D012297 2006
% 220.38/220.56  |- mesh__recordAuthorizer mesh__D012297 jls
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D012297 2003
% 220.38/220.56  |- mesh__dateRevised mesh__D012297 2002-10-31
% 220.38/220.56  |- mesh__publicMeSHNote mesh__D012297 87   
% 220.38/220.56  |- mesh__historyNote mesh__D012297 87   
% 220.38/220.56  |- skos__annotation mesh__D020729 DF: P120 GAP   
% 220.38/220.56  |- skos__hiddenLabel mesh__D020729 GAP, p120
% 220.38/220.56  |- skos__hiddenLabel mesh__D020729 p125 GAP Protein
% 220.38/220.56  |- skos__hiddenLabel mesh__D020729 p120 GAP Protein
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D020729 2006A
% 220.38/220.56  |- mesh__recordAuthorizer mesh__D020729 ags
% 220.38/220.56  |- skos__broader mesh__D020729smesh__D020703
% 220.38/220.56  |- skos__hiddenLabel mesh__D020729 GAP, p100
% 220.38/220.56  |- skos__historyNote mesh__D020729 Proteins %28%1989-1999%29%
% 220.38/220.56  |- skos__prefLabel mesh__D020729 p120 GTPase Activating Protein
% 220.38/220.56  |- mesh__dateRevised mesh__D020729 2005-07-28
% 220.38/220.56  |- mesh__publicMeSHNote mesh__D020729
% 220.38/220.56       2000; P120-GAP PROTEIN was indexed under PROTEINS 1994-1999; P100-GAP PROTEIN was indexed under PROTEINS 1995-1999; P120RASGAP %26% P125 GAP were indexed under PROTEINS 1996-1999%A%  
% 220.38/220.56  |- mesh__recordMaintainer mesh__D020729 ags
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D020729 2005
% 220.38/220.56  |- skos__altLabel mesh__D020729 p120-GAP Protein
% 220.38/220.56  |- skos__altLabel mesh__D020729 p125-GAP Protein
% 220.38/220.56  |- skos__altLabel mesh__D020729 p100 GAP
% 220.38/220.56  |- rdf__type mesh__D020729sskos__Concept
% 220.38/220.56  |- mesh__activeMeSHYear mesh__D020729 2006
% 220.38/220.56  |- mesh__recordOriginator mesh__D020729 jmp
% 220.38/220.56  |- skos__scopeNote mesh__D020729
% 220.38/220.56       A 120-kDa RAS GTPase-activating protein that binds to tyrosine phosphoproteins through its SH2 domains. The 100-kDa RNA-splicing variant %28%p100 GAP protein%29% is expressed in placenta.%A%    
% 220.38/220.59  |- skos__altLabel mesh__D020729 p125 GAP
% 220.38/220.59  |- mesh__dateEstablished mesh__D020729 2000-01-01
% 220.38/220.59  |- skos__altLabel mesh__D020729 p120rasGAP
% 220.38/220.59  |- skos__hiddenLabel mesh__D020729 GAP, p125
% 220.38/220.59  |- skos__hiddenLabel mesh__D020729 p100 GAP Protein
% 220.38/220.59  |- mesh__historyNote mesh__D020729
% 220.38/220.59       2000; for P120-GAP PROTEIN use GTPASE ACTIVATING PROTEINS %28%NM%29% 1994-1999; for P100-GAP PROTEIN use GTPASE ACTIVATING PROTEINS %28%NM%29% 1995-1999; for P120RASGAP %26% P125 GAP use GTPASE ACTIVATING PROTEINS %28%NM%29% 1996-1999%A%  
% 220.38/220.59  |- skos__altLabel mesh__D020729 p120 GAP
% 220.38/220.59  |- mesh__dateCreated mesh__D020729 1999-11-05
% 220.38/220.59  |- skos__prefLabel mesh__D017780 Malaria Vaccines
% 220.38/220.59  |- mesh__recordAuthorizer mesh__D017780 sjn
% 220.38/220.59  |- skos__hiddenLabel mesh__D017780 Vaccines, Malarial
% 220.38/220.59  |- skos__annotation mesh__D017780
% 220.38/220.59       coord IM with specific Plasmodium /immunol %28%IM%29%   
% 220.38/220.59  |- mesh__publicMeSHNote mesh__D017780 94   
% 220.38/220.59  |- mesh__historyNote mesh__D017780 94   
% 220.38/220.59  |- skos__historyNote mesh__D017780 Vaccines %28%1972-1993%29%
% 220.38/220.59  |- skos__scopeNote mesh__D017780
% 220.38/220.59       Vaccines made from antigens arising from any of the four strains of Plasmodium which cause malaria in humans, or from P. berghei which causes malaria in rodents.%A%    
% 220.38/220.59  |- skos__altLabel mesh__D017780 Malarial Vaccines
% 220.38/220.59  |- skos__hiddenLabel mesh__D017780 Vaccines, Malaria
% 220.38/220.59  |- mesh__dateRevised mesh__D017780 2005-06-30
% 220.38/220.59  |- skos__broader mesh__D017780smesh__D016052
% 220.38/220.59  |- skos__historyNote mesh__D017780 Protozoan Vaccines %28%1991-1993%29%
% 220.38/220.59  |- mesh__dateCreated mesh__D017780 1992-12-28
% 220.38/220.59  |- mesh__recordOriginator mesh__D017780 AGS
% 220.38/220.59  |- skos__historyNote mesh__D017780 Malaria %28%1972-1993%29%
% 220.38/220.59  |- mesh__dateEstablished mesh__D017780 1994-01-01
% 220.38/220.59  |- rdf__type mesh__D017780sskos__Concept
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D017780 2006
% 220.38/220.59  |- mesh__recordMaintainer mesh__D017780 ssb
% 220.38/220.59  |- skos__broader mesh__D012867Q000637smesh__D012867
% 220.38/220.59  |- mesh__preferredCombination mesh__D012867Q000637smesh__D016038
% 220.38/220.59  |- rdf__type mesh__D012867Q000637smesh__CompoundConcept
% 220.38/220.59  |- mesh__recordAuthorizer mesh__D003760 sjn
% 220.38/220.59  |- mesh__historyNote mesh__D003760 65   
% 220.38/220.59  |- skos__related mesh__D003760smesh__D012826
% 220.38/220.59  |- mesh__publicMeSHNote mesh__D003760 65   
% 220.38/220.59  |- skos__altLabel mesh__D003760 Material, Dental Impression
% 220.38/220.59  |- mesh__dateRevised mesh__D003760 2000-06-22
% 220.38/220.59  |- skos__annotation mesh__D003760
% 220.38/220.59       IM; coord with specific material if pertinent %28%IM%29%; DF: DENT IMPRESSION MATERIALS%A%  
% 220.38/220.59  |- skos__altLabel mesh__D003760 Impression Materials, Dental
% 220.38/220.59  |- skos__scopeNote mesh__D003760
% 220.38/220.59       Substances used to create an impression, or negative reproduction, of the teeth and dental arches. These materials include dental plasters and cements, metallic oxide pastes, silicone base materials, or elastomeric materials.%A%    
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D003760 2002
% 220.38/220.59  |- mesh__recordMaintainer mesh__D003760 adp
% 220.38/220.59  |- mesh__recordOriginator mesh__D003760 NLM
% 220.38/220.59  |- skos__prefLabel mesh__D003760 Dental Impression Materials
% 220.38/220.59  |- rdf__type mesh__D003760sskos__Concept
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D003760 2003
% 220.38/220.59  |- mesh__dateEstablished mesh__D003760 1965-01-01
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D003760 2005
% 220.38/220.59  |- skos__altLabel mesh__D003760 Impression Material, Dental
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D003760 2004
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D003760 2006
% 220.38/220.59  |- mesh__dateCreated mesh__D003760 1999-01-01
% 220.38/220.59  |- skos__altLabel mesh__D003760 Dental Impression Material
% 220.38/220.59  |- skos__broader mesh__D003760smesh__D003764
% 220.38/220.59  |- skos__altLabel mesh__D003760 Materials, Dental Impression
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D003760 2001
% 220.38/220.59  |- skos__broader mesh__D019856Q000031smesh__D019856
% 220.38/220.59  |- mesh__preferredCombination mesh__D019856Q000031smesh__D004983
% 220.38/220.59  |- rdf__type mesh__D019856Q000031smesh__CompoundConcept
% 220.38/220.59  |- mesh__recordMaintainer mesh__D016688 ags
% 220.38/220.59  |- skos__altLabel mesh__D016688 Mice, NOD
% 220.38/220.59  |- skos__hiddenLabel mesh__D016688 NOD Mouse
% 220.38/220.59  |- mesh__recordAuthorizer mesh__D016688 sjn
% 220.38/220.59  |- skos__hiddenLabel mesh__D016688 NOD Mouse, Inbred
% 220.38/220.59  |- skos__hiddenLabel mesh__D016688 NOD Mice, Inbred
% 220.38/220.59  |- skos__prefLabel mesh__D016688 Mice, Inbred NOD
% 220.38/220.59  |- skos__altLabel mesh__D016688 Non-Obese Diabetic Mice
% 220.38/220.59  |- skos__altLabel mesh__D016688 Nonobese Diabetic Mice
% 220.38/220.59  |- mesh__recordOriginator mesh__D016688 PXP
% 220.38/220.59  |- mesh__publicMeSHNote mesh__D016688 92   
% 220.38/220.59  |- skos__hiddenLabel mesh__D016688 Mice, Nonobese Diabetic
% 220.38/220.59  |- skos__altLabel mesh__D016688 Mouse, Inbred NOD
% 220.38/220.59  |- skos__altLabel mesh__D016688 Non-Obese Diabetic Mouse
% 220.38/220.59  |- skos__hiddenLabel mesh__D016688 Non Obese Diabetic Mouse
% 220.38/220.59  |- mesh__dateEstablished mesh__D016688 1992-01-01
% 220.38/220.59  |- rdf__type mesh__D016688sskos__Concept
% 220.38/220.59  |- mesh__dateCreated mesh__D016688 1991-01-25
% 220.38/220.59  |- skos__hiddenLabel mesh__D016688 Inbred NOD Mouse
% 220.38/220.59  |- skos__hiddenLabel mesh__D016688 Mice, Non-Obese Diabetic
% 220.38/220.59  |- mesh__historyNote mesh__D016688 92   
% 220.38/220.59  |- skos__altLabel mesh__D016688 Mouse, NOD
% 220.38/220.59  |- skos__hiddenLabel mesh__D016688 Mouse, Non-Obese Diabetic
% 220.38/220.59  |- skos__hiddenLabel mesh__D016688 Diabetic Mouse, Nonobese
% 220.38/220.59  |- skos__scopeNote mesh__D016688
% 220.38/220.59       A strain of non-obese diabetic mice developed in Japan that has been widely studied as a model for T-cell-dependent autoimmune insulin-dependent diabetes mellitus in which insulitis is a major histopathologic feature, and in which genetic susceptibility is strongly MHC-linked.%A%    
% 220.38/220.59  |- skos__historyNote mesh__D016688 Mice %28%1980-1991%29%
% 220.38/220.59  |- skos__annotation mesh__D016688
% 220.38/220.59       a model for DIABETES MELLITUS, INSULIN-DEPENDENT, the most likely type of exper diabetes mellitus, not DIABETES MELLITUS, EXPERIMENTAL %28%see MeSH definition%29%; NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check MICE%A%  
% 220.38/220.59  |- skos__hiddenLabel mesh__D016688 Inbred NOD Mice
% 220.38/220.59  |- skos__hiddenLabel mesh__D016688 Non Obese Diabetic Mice
% 220.38/220.59  |- skos__altLabel mesh__D016688 Nonobese Diabetic Mouse
% 220.38/220.59  |- skos__historyNote mesh__D016688
% 220.38/220.59       Diabetes Mellitus, Experimental %28%1980-1991%29%
% 220.38/220.59  |- skos__broader mesh__D016688smesh__D008815
% 220.38/220.59  |- skos__hiddenLabel mesh__D016688 NOD Mice
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D016688 2006
% 220.38/220.59  |- skos__hiddenLabel mesh__D016688 Diabetic Mouse, Non-Obese
% 220.38/220.59  |- skos__hiddenLabel mesh__D016688 Mouse, Nonobese Diabetic
% 220.38/220.59  |- skos__hiddenLabel mesh__D016688 Diabetic Mice, Non-Obese
% 220.38/220.59  |- mesh__dateRevised mesh__D016688 2005-06-30
% 220.38/220.59  |- skos__hiddenLabel mesh__D016688 Diabetic Mice, Nonobese
% 220.38/220.59  |- mesh__publicMeSHNote mesh__D041081 2003   
% 220.38/220.59  |- skos__annotation mesh__D041081
% 220.38/220.59       infection: coord IM with EHRLICHIOSIS %28%IM%29%   
% 220.38/220.59  |- skos__broader mesh__D041081smesh__D000709
% 220.38/220.59  |- mesh__dateEstablished mesh__D041081 2003-01-01
% 220.38/220.59  |- mesh__recordOriginator mesh__D041081 ags
% 220.38/220.59  |- mesh__recordAuthorizer mesh__D041081 sjn
% 220.38/220.59  |- skos__altLabel mesh__D041081 Ehrlichia equi
% 220.38/220.59  |- mesh__historyNote mesh__D041081 2003   
% 220.38/220.59  |- mesh__dateCreated mesh__D041081 2002-07-02
% 220.38/220.59  |- mesh__dateRevised mesh__D041081 2005-06-30
% 220.38/220.59  |- skos__altLabel mesh__D041081 HGE Agent
% 220.38/220.59  |- skos__altLabel mesh__D041081 Cytoecetes phagocytophila
% 220.38/220.59  |- skos__prefLabel mesh__D041081 Anaplasma phagocytophilum
% 220.38/220.59  |- rdf__type mesh__D041081sskos__Concept
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D041081 2006
% 220.38/220.59  |- mesh__recordMaintainer mesh__D041081 SYSTEM
% 220.38/220.59  |- skos__scopeNote mesh__D041081
% 220.38/220.59       A species of gram-negative bacteria in the genus ANAPLASMA, family ANAPLASMATACEAE, formerly called Ehrlichia phagocytophila or Ehrlichia equi. This organism is tick-borne %28%IXODES%29% and causes disease in horses and sheep. In humans, it causes human granulocytic EHRLICHIOSIS.%A%    
% 220.38/220.59  |- skos__altLabel mesh__D041081 Ehrlichia phagocytophila
% 220.38/220.59  |- skos__historyNote mesh__D041081 Ehrlichia %28%1975-2002%29%
% 220.38/220.59  |- skos__broader mesh__D035842smesh__D009272
% 220.38/220.59  |- skos__annotation mesh__D035842
% 220.38/220.59       use when the ethical, legal, psychological, or social implications of the subjects%27% status are discussed%A%  
% 220.38/220.59  |- skos__hiddenLabel mesh__D035842 Subjects, Research
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D035842 2006
% 220.38/220.59  |- skos__related mesh__D035842smesh__D006805
% 220.38/220.59  |- skos__hiddenLabel mesh__D035842 Research Subject
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D035842 2003
% 220.38/220.59  |- skos__historyNote mesh__D035842 Human Experimentation %28%1975-2002%29%
% 220.38/220.59  |- mesh__historyNote mesh__D035842 2003   
% 220.38/220.59  |- mesh__dateEstablished mesh__D035842 2003-01-01
% 220.38/220.59  |- mesh__dateCreated mesh__D035842 2002-07-03
% 220.38/220.59  |- skos__prefLabel mesh__D035842 Research Subjects
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D035842 2004
% 220.38/220.59  |- mesh__publicMeSHNote mesh__D035842 2003   
% 220.38/220.59  |- rdf__type mesh__D035842sskos__Concept
% 220.38/220.59  |- skos__scopeNote mesh__D035842
% 220.38/220.59       Persons who are enrolled in research studies or who are otherwise the subjects of research.%A%    
% 220.38/220.59  |- skos__hiddenLabel mesh__D035842 Subject, Research
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D035842 2005
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D002668 1993
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D002668 1999
% 220.38/220.59  |- skos__scopeNote mesh__D002668
% 220.38/220.59       The training or bringing-up of children by parents or parent-substitutes. It is used also for child rearing practices in different societies, at different economic levels, in different ethnic groups, etc. It differs from PARENTING in that in child rearing the emphasis is on the act of training or bringing up the child and the interaction between the parent and child, while parenting emphasizes the responsibility and qualities of exemplary behavior of the parent.%A%    
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D002668 2003
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D002668 1994
% 220.38/220.59  |- rdf__type mesh__D002668sskos__Concept
% 220.38/220.59  |- skos__hiddenLabel mesh__D002668 Rearing, Child
% 220.38/220.59  |- mesh__historyNote mesh__D002668 68%28%64%29%   
% 220.38/220.59  |- mesh__dateEstablished mesh__D002668 1968-01-01
% 220.38/220.59  |- skos__hiddenLabel mesh__D002668 Rearings, Child
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D002668 2004
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D002668 1995
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D002668 1996
% 220.38/220.59  |- mesh__recordAuthorizer mesh__D002668 PLS
% 220.38/220.59  |- mesh__dateCreated mesh__D002668 1999-01-01
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D002668 2000
% 220.38/220.59  |- mesh__recordMaintainer mesh__D002668 TAP
% 220.38/220.59  |- skos__broader mesh__D002668smesh__D001520
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D002668 2005
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D002668 1997
% 220.38/220.59  |- mesh__publicMeSHNote mesh__D002668 68   
% 220.38/220.59  |- skos__hiddenLabel mesh__D002668 Child Rearings
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D002668 2001
% 220.38/220.59  |- skos__annotation mesh__D002668
% 220.38/220.59       check also tag CHILD or specific; differentiate from PARENTING which emphasizes the role %26% responsibility of the parent while CHILD REARING emphasizes the upbringing: read MeSH definitions but if in doubt use term of author%A%  
% 220.38/220.59  |- mesh__recordOriginator mesh__D002668 NLM
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D002668 2006
% 220.38/220.59  |- skos__prefLabel mesh__D002668 Child Rearing
% 220.38/220.59  |- mesh__activeMeSHYear mesh__D002668 1998
% 220.38/220.59  |- mesh__dateRevised mesh__D002668 1992-05-07
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D002668 2002
% 220.38/220.60  |- skos__related mesh__D002668smesh__D016487
% 220.38/220.60  |- skos__broader mesh__D013390smesh__D013386
% 220.38/220.60  |- rdf__type mesh__D013390sskos__Concept
% 220.38/220.60  |- skos__scopeNote mesh__D013390
% 220.38/220.60       A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for.%A%    
% 220.38/220.60  |- skos__altLabel mesh__D013390 Succinylcholine Chloride
% 220.38/220.60  |- skos__altLabel mesh__D013390 Listenon
% 220.38/220.60  |- skos__hiddenLabel mesh__D013390 Dichloride, Succinylcholine
% 220.38/220.60  |- skos__hiddenLabel mesh__D013390 Diperchlorate, Succinylcholine
% 220.38/220.60  |- mesh__dateRevised mesh__D013390 2005-06-30
% 220.38/220.60  |- skos__altLabel mesh__D013390 Succinyldicholine
% 220.38/220.60  |- skos__hiddenLabel mesh__D013390 Succinylcholine Dichloride, Di H2O
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D013390 2006
% 220.38/220.60  |- mesh__recordOriginator mesh__D013390 NLM
% 220.38/220.60  |- mesh__dateCreated mesh__D013390 1999-01-01
% 220.38/220.60  |- skos__hiddenLabel mesh__D013390 Bromide, Suxamethonium
% 220.38/220.60  |- skos__hiddenLabel mesh__D013390 Dibromide, Succinylcholine
% 220.38/220.60  |- skos__broader mesh__D013390smesh__D002794
% 220.38/220.60  |- skos__hiddenLabel mesh__D013390 Diiodide, Succinylcholine
% 220.38/220.60  |- mesh__recordAuthorizer mesh__D013390 sjn
% 220.38/220.60  |- skos__altLabel mesh__D013390 Suxamethonium
% 220.38/220.60  |- mesh__recordMaintainer mesh__D013390 ssb
% 220.38/220.60  |- skos__prefLabel mesh__D013390 Succinylcholine
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D007353 2003
% 220.38/220.60  |- skos__prefLabel mesh__D007353 Insurance, Long-Term Care
% 220.38/220.60  |- mesh__recordMaintainer mesh__D007353 kle
% 220.38/220.60  |- mesh__recordAuthorizer mesh__D007353 sjn
% 220.38/220.60  |- mesh__dateEstablished mesh__D007353 1987-01-01
% 220.38/220.60  |- mesh__onlineNote mesh__D007353
% 220.38/220.60       use INSURANCE, LONG-TERM CARE to search INSURANCE, LONG TERM CARE 1987-91%A%  
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D007353 2002
% 220.38/220.60  |- skos__broader mesh__D007353smesh__D007348
% 220.38/220.60  |- mesh__dateCreated mesh__D007353 1986-05-30
% 220.38/220.60  |- mesh__dateRevised mesh__D007353 1999-11-03
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D007353 2006
% 220.38/220.60  |- skos__altLabel mesh__D007353 Long-Term Care Insurance
% 220.38/220.60  |- mesh__historyNote mesh__D007353
% 220.38/220.60       92; was INSURANCE, LONG TERM CARE 1987-91   
% 220.38/220.60  |- skos__hiddenLabel mesh__D007353 Insurance, Long Term Care
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D007353 2001
% 220.38/220.60  |- skos__annotation mesh__D007353 specify geog if possible   
% 220.38/220.60  |- mesh__publicMeSHNote mesh__D007353
% 220.38/220.60       92; was INSURANCE, LONG TERM CARE 1987-91   
% 220.38/220.60  |- skos__historyNote mesh__D007353 Insurance, Health %28%1966-1986%29%
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D007353 2000
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D007353 2005
% 220.38/220.60  |- skos__historyNote mesh__D007353 Long-Term Care %28%1968-1986%29%
% 220.38/220.60  |- rdf__type mesh__D007353sskos__Concept
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D007353 2004
% 220.38/220.60  |- mesh__recordOriginator mesh__D007353 EC
% 220.38/220.60  |- skos__hiddenLabel mesh__D007353 Long Term Care Insurance
% 220.38/220.60  |- skos__scopeNote mesh__D007353
% 220.38/220.60       Health insurance to provide full or partial coverage for long-term home care services or for long-term nursing care provided in a residential facility such as a nursing home.%A%    
% 220.38/220.60  |- mesh__dateEstablished mesh__D045472 2004-01-01
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D045472 2005
% 220.38/220.60  |- skos__prefLabel mesh__D045472 Hemodynamic Phenomena
% 220.38/220.60  |- skos__hiddenLabel mesh__D045472 Phenomenon, Hemodynamic
% 220.38/220.60  |- skos__broader mesh__D045472smesh__D045124
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D045472 2004
% 220.38/220.60  |- skos__annotation mesh__D045472
% 220.38/220.60       not used for indexing or cataloging; use specific indentations; for hemodynamics in general, use HEMODYNAMIC PROCESSES%A%  
% 220.38/220.60  |- skos__altLabel mesh__D045472 Hemodynamic Phenomenon
% 220.38/220.60  |- mesh__dateCreated mesh__D045472 2003-07-09
% 220.38/220.60  |- mesh__historyNote mesh__D045472 2004   
% 220.38/220.60  |- skos__hiddenLabel mesh__D045472 Phenomena, Hemodynamic
% 220.38/220.60  |- skos__historyNote mesh__D045472 Hemodynamic Processes %28%1976-2003%29%
% 220.38/220.60  |- skos__scopeNote mesh__D045472
% 220.38/220.60       Observable or measurable characteristics of the BLOOD CIRCULATION.%A%    
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D045472 2006
% 220.38/220.60  |- mesh__publicMeSHNote mesh__D045472 2004   
% 220.38/220.60  |- rdf__type mesh__D045472sskos__Concept
% 220.38/220.60  |- skos__scopeNote mesh__D012298
% 220.38/220.60       Muscular rigidity which develops in the cadaver usually from 4 to 10 hours after death and lasts 3 or 4 days.%A%    
% 220.38/220.60  |- mesh__onlineNote mesh__D012298 search DEATH 1966-69   
% 220.38/220.60  |- mesh__publicMeSHNote mesh__D012298 70; was see under DEATH 1963-69   
% 220.38/220.60  |- skos__hiddenLabel mesh__D012298 Mortis, Rigor
% 220.38/220.60  |- mesh__dateRevised mesh__D012298 2002-07-03
% 220.38/220.60  |- skos__prefLabel mesh__D012298 Rigor Mortis
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D012298 2004
% 220.38/220.60  |- skos__broader mesh__D012298smesh__D011180
% 220.38/220.60  |- mesh__recordOriginator mesh__D012298 NLM
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D012298 2006
% 220.38/220.60  |- skos__historyNote mesh__D012298 Death %28%1966-1969%29%
% 220.38/220.60  |- mesh__recordMaintainer mesh__D012298 mdb
% 220.38/220.60  |- mesh__recordAuthorizer mesh__D012298 sjn
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D012298 2003
% 220.38/220.60  |- mesh__dateCreated mesh__D012298 1999-01-01
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D012298 2005
% 220.38/220.60  |- rdf__type mesh__D012298sskos__Concept
% 220.38/220.60  |- mesh__dateEstablished mesh__D012298 1970-01-01
% 220.38/220.60  |- mesh__historyNote mesh__D012298 70; was see under DEATH 1963-69   
% 220.38/220.60  |- skos__altLabel mesh__D017781 Immediate-Early Genes
% 220.38/220.60  |- skos__prefLabel mesh__D017781 Genes, Immediate-Early
% 220.38/220.60  |- mesh__historyNote mesh__D017781 94   
% 220.38/220.60  |- skos__hiddenLabel mesh__D017781 Genes, Immediate Early
% 220.38/220.60  |- skos__hiddenLabel mesh__D017781 Gene, Immediate-Early
% 220.38/220.60  |- skos__scopeNote mesh__D017781
% 220.38/220.60       Genes that show rapid and transient expression in the absence of de novo protein synthesis. The term was originally used exclusively for viral genes where immediate-early referred to transcription immediately following virus integration into the host cell. It is also used to describe cellular genes which are expressed immediately after resting cells are stimulated by extracellular signals such as growth factors and neurotransmitters.%A%    
% 220.38/220.60  |- skos__hiddenLabel mesh__D017781 Immediate-Early Gene
% 220.38/220.60  |- skos__related mesh__D017781smesh__D017874
% 220.38/220.60  |- mesh__recordAuthorizer mesh__D017781 sjn
% 220.38/220.60  |- mesh__dateCreated mesh__D017781 1992-12-28
% 220.38/220.60  |- skos__historyNote mesh__D017781 specific genes %28%1972-1993%29%
% 220.38/220.60  |- mesh__publicMeSHNote mesh__D017781 94   
% 220.38/220.60  |- rdf__type mesh__D017781sskos__Concept
% 220.38/220.60  |- mesh__recordMaintainer mesh__D017781 nns
% 220.38/220.60  |- skos__broader mesh__D017781smesh__D005814
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D017781 2006
% 220.38/220.60  |- skos__hiddenLabel mesh__D017781 Immediate Early Genes
% 220.38/220.60  |- mesh__dateRevised mesh__D017781 2005-06-30
% 220.38/220.60  |- mesh__recordOriginator mesh__D017781 AGS
% 220.38/220.60  |- skos__broader mesh__D017781smesh__D005796
% 220.38/220.60  |- mesh__dateEstablished mesh__D017781 1994-01-01
% 220.38/220.60  |- skos__annotation mesh__D017781
% 220.38/220.60       genes showing rapid %26% transient expression in absence of protein synthesis: read MeSH definition for history of %22%immediate-early%22%%A%  
% 220.38/220.60  |- skos__historyNote mesh__D017781 Genes, Viral %28%1980-1993%29%
% 220.38/220.60  |- mesh__recordMaintainer mesh__D003761 kle
% 220.38/220.60  |- skos__scopeNote mesh__D003761
% 220.38/220.60       Procedure of producing an imprint or negative likeness of the teeth and/or edentulous areas. Impressions are made in plastic material which becomes hardened or set while in contact with the tissue. They are later filled with plaster of Paris or artificial stone to produce a facsimile of the oral structures present. Impressions may be made of a full complement of teeth, of areas where some teeth have been removed, or in a mouth from which all teeth have been extracted. %28%Illustrated Dictionary of Dentistry, 1982%29%%A%    
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D003761 2006
% 220.38/220.60  |- skos__prefLabel mesh__D003761 Dental Impression Technique
% 220.38/220.60  |- skos__altLabel mesh__D003761 Impression Techniques, Dental
% 220.38/220.60  |- skos__annotation mesh__D003761 DF: DENT IMPRESSION TECHNIQUE   
% 220.38/220.60  |- mesh__dateEstablished mesh__D003761 1965-01-01
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D003761 2002
% 220.38/220.60  |- skos__altLabel mesh__D003761 Impression Technique, Dental
% 220.38/220.60  |- mesh__dateCreated mesh__D003761 1999-01-01
% 220.38/220.60  |- mesh__onlineNote mesh__D003761
% 220.38/220.60       use DENTAL IMPRESSION TECHNIQUE to search DENTAL IMPRESSION TECHNIC 1966-90%A%  
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D003761 2005
% 220.38/220.60  |- skos__altLabel mesh__D003761 Impression Technic, Dental
% 220.38/220.60  |- skos__altLabel mesh__D003761 Technics, Dental Impression
% 220.38/220.60  |- mesh__dateRevised mesh__D003761 1999-11-03
% 220.38/220.60  |- mesh__recordAuthorizer mesh__D003761 sjn
% 220.38/220.60  |- skos__broader mesh__D003761smesh__D013674
% 220.38/220.60  |- mesh__publicMeSHNote mesh__D003761
% 220.38/220.60       91; was DENTAL IMPRESSION TECHNIC 1965-90   
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D003761 2001
% 220.38/220.60  |- skos__altLabel mesh__D003761 Dental Impression Techniques
% 220.38/220.60  |- skos__altLabel mesh__D003761 Dental Impression Technic
% 220.38/220.60  |- skos__altLabel mesh__D003761 Techniques, Dental Impression
% 220.38/220.60  |- rdf__type mesh__D003761sskos__Concept
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D003761 2004
% 220.38/220.60  |- mesh__historyNote mesh__D003761
% 220.38/220.60       91; was DENTAL IMPRESSION TECHNIC 1965-90   
% 220.38/220.60  |- skos__altLabel mesh__D003761 Technic, Dental Impression
% 220.38/220.60  |- skos__altLabel mesh__D003761 Impression Technics, Dental
% 220.38/220.60  |- mesh__recordOriginator mesh__D003761 NLM
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D003761 2000
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D003761 2003
% 220.38/220.60  |- skos__altLabel mesh__D003761 Technique, Dental Impression
% 220.38/220.60  |- skos__altLabel mesh__D003761 Dental Impression Technics
% 220.38/220.60  |- mesh__recordOriginator mesh__D016689 PXP
% 220.38/220.60  |- rdf__type mesh__D016689sskos__Concept
% 220.38/220.60  |- mesh__dateCreated mesh__D016689 1991-05-02
% 220.38/220.60  |- skos__broader mesh__D016689smesh__D014345
% 220.38/220.60  |- mesh__historyNote mesh__D016689 92   
% 220.38/220.60  |- skos__annotation mesh__D016689
% 220.38/220.60       causes nagana in African cattle %26% other animals: see note at TRYPANOSOMIASIS, AFRICAN; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 220.38/220.60  |- mesh__dateRevised mesh__D016689 2003-07-09
% 220.38/220.60  |- skos__historyNote mesh__D016689 Trypanosoma %28%1966-1991%29%
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D016689 2004
% 220.38/220.60  |- mesh__recordAuthorizer mesh__D016689 sjn
% 220.38/220.60  |- skos__scopeNote mesh__D016689
% 220.38/220.60       An active blood parasite that is present in practically all domestic animals in Africa, the West Indies, and parts of Central and South America. In Africa, the insect vector is the tsetse fly. In other countries, infection is by mechanical means indicating that the parasites have been introduced to these countries and have been able to maintain themselves in spite of the lack of a suitable intermediate host. It is a cause of nagana, the severity of which depends on the species affected.%A%    
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D016689 2006
% 220.38/220.60  |- mesh__dateEstablished mesh__D016689 1992-01-01
% 220.38/220.60  |- mesh__publicMeSHNote mesh__D016689 92   
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D016689 2005
% 220.38/220.60  |- mesh__recordMaintainer mesh__D016689 ags
% 220.38/220.60  |- skos__prefLabel mesh__D016689 Trypanosoma vivax
% 220.38/220.60  |- skos__historyNote mesh__D035843 Research %28%1965-2002%29%
% 220.38/220.60  |- mesh__recordOriginator mesh__D035843 jrf
% 220.38/220.60  |- skos__altLabel mesh__D035843 Research, Clinical
% 220.38/220.60  |- skos__prefLabel mesh__D035843 Biomedical Research
% 220.38/220.60  |- mesh__publicMeSHNote mesh__D035843 2003   
% 220.38/220.60  |- mesh__recordAuthorizer mesh__D035843 sjn
% 220.38/220.60  |- skos__altLabel mesh__D035843 Research, Biomedical
% 220.38/220.60  |- rdf__type mesh__D035843sskos__Concept
% 220.38/220.60  |- mesh__historyNote mesh__D035843 2003   
% 220.38/220.60  |- mesh__recordMaintainer mesh__D035843 sjn
% 220.38/220.60  |- mesh__dateEstablished mesh__D035843 2003-01-01
% 220.38/220.60  |- skos__altLabel mesh__D035843 Research, Medical
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D035843 2005
% 220.38/220.60  |- skos__annotation mesh__D035843
% 220.38/220.60       biomedical research as a field or the progress or status of biomedical research; do not add routinely for specific studies in biomedicine; do not coord with MEDICINE: Manual 29.16; for Clinical Research, CLINICAL TRIALS %28%see note there%29% and HUMAN EXPERIMENTATION are also available%A%  
% 220.38/220.60  |- mesh__dateCreated mesh__D035843 2002-07-02
% 220.38/220.60  |- skos__broader mesh__D035843smesh__D012106
% 220.38/220.60  |- mesh__dateRevised mesh__D035843 2004-07-13
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D035843 2006
% 220.38/220.60  |- skos__scopeNote mesh__D035843
% 220.38/220.60       Research that involves the application of the natural sciences, especially biology and physiology, to medicine. %28%from American Heritage Dictionary, 4th ed%29%%A%    
% 220.38/220.60  |- skos__broader mesh__D002669smesh__D012946
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D002669 2006
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D002669 2000
% 220.38/220.60  |- skos__prefLabel mesh__D002669 Child Welfare
% 220.38/220.60  |- mesh__recordOriginator mesh__D002669 NLM
% 220.38/220.60  |- mesh__dateRevised mesh__D002669 1999-11-03
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D002669 2005
% 220.38/220.60  |- skos__annotation mesh__D002669 check also tag CHILD or specific   
% 220.38/220.60  |- mesh__dateCreated mesh__D002669 1999-01-01
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D002669 2004
% 220.38/220.60  |- rdf__type mesh__D002669sskos__Concept
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D002669 2003
% 220.38/220.60  |- skos__scopeNote mesh__D002669
% 220.38/220.60       Organized efforts by communities or organizations to improve the health and well-being of the child.%A%    
% 220.38/220.60  |- skos__related mesh__D002669smesh__D005581
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D002669 2002
% 220.38/220.60  |- skos__hiddenLabel mesh__D002669 Welfare, Child
% 220.38/220.60  |- mesh__recordMaintainer mesh__D002669 kle
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D002669 2001
% 220.38/220.60  |- skos__hiddenLabel mesh__D002669 Health, Child
% 220.38/220.60  |- mesh__recordAuthorizer mesh__D002669 sjn
% 220.38/220.60  |- mesh__historyNote mesh__D013391 68%28%65%29%   
% 220.38/220.60  |- mesh__dateEstablished mesh__D013391 1968-01-01
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D013391 2006
% 220.38/220.60  |- skos__scopeNote mesh__D013391
% 220.38/220.60       Any suction exerted by the mouth; response of the mammalian infant to draw milk from the breast. Includes sucking on inanimate objects. Not to be used for thumb sucking, which is indexed under fingersucking.%A%    
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D013391 2004
% 220.38/220.60  |- mesh__dateCreated mesh__D013391 1999-01-01
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D013391 2005
% 220.38/220.60  |- skos__hiddenLabel mesh__D013391 Sucking Behaviors
% 220.38/220.60  |- skos__broader mesh__D013391smesh__D001519
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D013391 2003
% 220.38/220.60  |- mesh__recordMaintainer mesh__D013391 TAP
% 220.38/220.60  |- skos__hiddenLabel mesh__D013391 Behaviors, Sucking
% 220.38/220.60  |- mesh__recordOriginator mesh__D013391 NLM
% 220.38/220.60  |- skos__hiddenLabel mesh__D013391 Behavior, Sucking
% 220.38/220.60  |- skos__prefLabel mesh__D013391 Sucking Behavior
% 220.38/220.60  |- mesh__dateRevised mesh__D013391 2002-07-02
% 220.38/220.60  |- rdf__type mesh__D013391sskos__Concept
% 220.38/220.60  |- mesh__recordAuthorizer mesh__D013391 sjn
% 220.38/220.60  |- skos__annotation mesh__D013391 human %26% animal   
% 220.38/220.60  |- mesh__publicMeSHNote mesh__D013391 68   
% 220.38/220.60  |- skos__hiddenLabel mesh__D007354 Comprehensive Health Insurances
% 220.38/220.60  |- skos__hiddenLabel mesh__D007354 Insurance, Catastrophic Health
% 220.38/220.60  |- skos__hiddenLabel mesh__D007354 Catastrophic Health Insurances
% 220.38/220.60  |- skos__annotation mesh__D007354
% 220.38/220.60       specify geog if possible; DF: INSURANCE MAJOR MED   
% 220.38/220.60  |- mesh__historyNote mesh__D007354 68   
% 220.38/220.60  |- mesh__publicMeSHNote mesh__D007354 68   
% 220.38/220.60  |- skos__hiddenLabel mesh__D007354 Insurances, Comprehensive Health
% 220.38/220.60  |- skos__broader mesh__D007354smesh__D007348
% 220.38/220.60  |- mesh__recordMaintainer mesh__D007354 kle
% 220.38/220.60  |- mesh__recordAuthorizer mesh__D007354 sjn
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D007354 2006
% 220.38/220.60  |- skos__hiddenLabel mesh__D007354 Insurance, Comprehensive Health
% 220.38/220.60  |- skos__hiddenLabel mesh__D007354 Health Insurances, Catastrophic
% 220.38/220.60  |- skos__hiddenLabel mesh__D007354 Health Insurance, Comprehensive
% 220.38/220.60  |- skos__altLabel mesh__D007354 Catastrophic Health Insurance
% 220.38/220.60  |- skos__prefLabel mesh__D007354 Insurance, Major Medical
% 220.38/220.60  |- mesh__dateCreated mesh__D007354 1999-01-01
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D007354 2005
% 220.38/220.60  |- skos__scopeNote mesh__D007354
% 220.38/220.60       Insurance providing a broad range of medical services and supplies, when prescribed by a physician, whether or not the patient is hospitalized. It frequently is an extension of a basic policy and benefits will not begin until the basic policy is exhausted.%A%    
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D007354 2002
% 220.38/220.60  |- skos__historyNote mesh__D007354 Insurance, Health %28%1966-1967%29%
% 220.38/220.60  |- skos__related mesh__D007354smesh__D002388
% 220.38/220.60  |- skos__hiddenLabel mesh__D007354 Insurances, Catastrophic Health
% 220.38/220.60  |- rdf__type mesh__D007354sskos__Concept
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D007354 2004
% 220.38/220.60  |- mesh__dateRevised mesh__D007354 1999-11-03
% 220.38/220.60  |- skos__altLabel mesh__D007354 Medical Insurance, Major
% 220.38/220.60  |- mesh__dateEstablished mesh__D007354 1968-01-01
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D007354 2001
% 220.38/220.60  |- skos__altLabel mesh__D007354 Major Medical Insurance
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D007354 2003
% 220.38/220.60  |- mesh__recordOriginator mesh__D007354 NLM
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D007354 2000
% 220.38/220.60  |- skos__hiddenLabel mesh__D007354 Health Insurances, Comprehensive
% 220.38/220.60  |- skos__hiddenLabel mesh__D007354 Health Insurance, Catastrophic
% 220.38/220.60  |- skos__annotation mesh__D045473
% 220.38/220.60       infection = SEVERE ACUTE RESPIRATORY SYNDROME; do not confuse SARS with SAR used for STRUCTURE ACTIVITY RELATIONSHIP, or with Scaffold Attachment Regions see MATRIX ATTACHMENT REGIONS.%A%  
% 220.38/220.60  |- skos__altLabel mesh__D045473 Severe Acute Respiratory Syndrome Virus
% 220.38/220.60  |- mesh__recordAuthorizer mesh__D045473 sjn
% 220.38/220.60  |- skos__altLabel mesh__D045473 SARS-Related Coronavirus
% 220.38/220.60  |- skos__broader mesh__D045473smesh__D017934
% 220.38/220.60  |- skos__altLabel mesh__D045473 SARS-CoV
% 220.38/220.60  |- mesh__dateEstablished mesh__D045473 2003-04-17
% 220.38/220.60  |- skos__altLabel mesh__D045473 SARS-Associated Coronavirus
% 220.38/220.60  |- mesh__recordOriginator mesh__D045473 ags
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D045473 2004
% 220.38/220.60  |- mesh__dateRevised mesh__D045473 2003-07-09
% 220.38/220.60  |- skos__hiddenLabel mesh__D045473 Coronavirus, SARS-Associated
% 220.38/220.60  |- mesh__publicMeSHNote mesh__D045473 2003   
% 220.38/220.60  |- skos__hiddenLabel mesh__D045473 SARS-Associated Coronavirus, Urbani
% 220.38/220.60  |- mesh__recordMaintainer mesh__D045473 ags
% 220.38/220.60  |- skos__prefLabel mesh__D045473 SARS Virus
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D045473 2006
% 220.38/220.60  |- skos__hiddenLabel mesh__D045473 SARS Related Coronavirus
% 220.38/220.60  |- skos__hiddenLabel mesh__D045473 Coronavirus, SARS
% 220.38/220.60  |- skos__scopeNote mesh__D045473
% 220.38/220.60       A species of CORONAVIRUS causing atypical respiratory disease %28%SEVERE ACUTE RESPIRATORY SYNDROME%29% in humans. The organism is believed to have first emerged in Guangdong Province, China, in 2002.%A%    
% 220.38/220.60  |- rdf__type mesh__D045473sskos__Concept
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D045473 2005
% 220.38/220.60  |- skos__hiddenLabel mesh__D045473 SARS Associated Coronavirus
% 220.38/220.60  |- skos__hiddenLabel mesh__D045473 Urbani SARS Associated Coronavirus
% 220.38/220.60  |- skos__altLabel mesh__D045473 Urbani SARS-Associated Coronavirus
% 220.38/220.60  |- skos__hiddenLabel mesh__D045473 Coronavirus, Urbani SARS-Associated
% 220.38/220.60  |- skos__hiddenLabel mesh__D045473 Coronavirus, SARS-Related
% 220.38/220.60  |- skos__altLabel mesh__D045473 SARS Coronavirus
% 220.38/220.60  |- mesh__dateCreated mesh__D045473 2003-04-17
% 220.38/220.60  |- mesh__historyNote mesh__D045473 2003   
% 220.38/220.60  |- skos__altLabel mesh__D012299 Forest Brand of Rimantadine Hydrochloride
% 220.38/220.60  |- skos__broader mesh__D012299smesh__D000218
% 220.38/220.60  |- skos__prefLabel mesh__D012299 Rimantadine
% 220.38/220.60  |- mesh__publicMeSHNote mesh__D012299
% 220.38/220.60       91; was see under ADAMANTANE 1980-90   
% 220.38/220.60  |- mesh__recordAuthorizer mesh__D012299 sjn
% 220.38/220.60  |- skos__scopeNote mesh__D012299
% 220.38/220.60       An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.%A%    
% 220.38/220.60  |- mesh__recordMaintainer mesh__D012299 CCR
% 220.38/220.60  |- mesh__historyNote mesh__D012299
% 220.38/220.60       91%28%80%29%; was see under ADAMANTANE 1980-90   
% 220.38/220.60  |- skos__altLabel mesh__D012299 Riamantadine
% 220.38/220.60  |- skos__altLabel mesh__D012299 Remantadine
% 220.38/220.60  |- skos__hiddenLabel mesh__D012299 Hydrochloride, Rimantadine
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D012299 2006
% 220.38/220.60  |- mesh__dateEstablished mesh__D012299 1991-01-01
% 220.38/220.60  |- skos__altLabel mesh__D012299 Roche Brand of Rimantadine Hydrochloride
% 220.38/220.60  |- mesh__recordOriginator mesh__D012299 SH
% 220.38/220.60  |- mesh__dateRevised mesh__D012299 2005-06-30
% 220.38/220.60  |- skos__historyNote mesh__D012299
% 220.38/220.60       Adamantane/analogs %26% derivatives %28%1975-1979%29%
% 220.38/220.60  |- mesh__dateCreated mesh__D012299 1979-03-02
% 220.38/220.60  |- skos__historyNote mesh__D012299 Bridged Compounds %28%1966-1975%29%
% 220.38/220.60  |- skos__historyNote mesh__D012299 Ethylamines %28%1966-1975%29%
% 220.38/220.60  |- rdf__type mesh__D012299sskos__Concept
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D003762 2000
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D003762 2005
% 220.38/220.60  |- mesh__recordOriginator mesh__D003762 NLM
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D003762 1997
% 220.38/220.60  |- skos__scopeNote mesh__D003762
% 220.38/220.60       Hand-held tools or implements especially used by dental professionals for the performance of clinical tasks.%A%    
% 220.38/220.60  |- mesh__historyNote mesh__D003762 65   
% 220.38/220.60  |- mesh__recordAuthorizer mesh__D003762 PLS
% 220.38/220.60  |- skos__prefLabel mesh__D003762 Dental Instruments
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D003762 2002
% 220.38/220.60  |- mesh__dateEstablished mesh__D003762 1965-01-01
% 220.38/220.60  |- mesh__publicMeSHNote mesh__D003762 65   
% 220.38/220.60  |- skos__hiddenLabel mesh__D003762 Dental Instrument
% 220.38/220.60  |- skos__hiddenLabel mesh__D003762 Instruments, Dental
% 220.38/220.60  |- rdf__type mesh__D003762sskos__Concept
% 220.38/220.60  |- skos__altLabel mesh__D003762 Instrument, Dental
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D003762 2004
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D003762 1999
% 220.38/220.60  |- mesh__dateRevised mesh__D003762 1996-06-10
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D003762 2003
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D003762 1998
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D003762 2001
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D003762 2006
% 220.38/220.60  |- mesh__recordMaintainer mesh__D003762 JLS
% 220.38/220.60  |- skos__annotation mesh__D003762
% 220.38/220.60       differentiate from DENTAL EQUIPMENT on the basis of size %28%instrum are entirely holdable in the hand%29%; reamers %26% broaches: index under ROOT CANAL PREPARATION /instrum; DF: DENT INSTRUM%A%  
% 220.38/220.60  |- skos__broader mesh__D003762smesh__D003748
% 220.38/220.60  |- mesh__dateCreated mesh__D003762 1999-01-01
% 220.38/220.60  |- skos__scopeNote mesh__D041881
% 220.38/220.60       Acute inflammation of the GALLBLADDER wall. It is characterized by the presence of ABDOMINAL PAIN; FEVER; and LEUKOCYTOSIS. Gallstone obstruction of the CYSTIC DUCT is present in approximately 90%25% of the cases.%A%    
% 220.38/220.60  |- mesh__publicMeSHNote mesh__D041881 2004   
% 220.38/220.60  |- mesh__historyNote mesh__D041881 2004   
% 220.38/220.60  |- mesh__recordMaintainer mesh__D041881 lkt
% 220.38/220.60  |- skos__altLabel mesh__D041881 Acute Cholecystitis
% 220.38/220.60  |- skos__prefLabel mesh__D041881 Cholecystitis, Acute
% 220.38/220.60  |- skos__historyNote mesh__D041881 Cholecystitis %28%1964-2003%29%
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D041881 2004
% 220.38/220.60  |- mesh__dateEstablished mesh__D041881 2004-01-01
% 220.38/220.60  |- rdf__type mesh__D041881sskos__Concept
% 220.38/220.60  |- mesh__dateCreated mesh__D041881 2003-07-09
% 220.38/220.60  |- mesh__recordAuthorizer mesh__D041881 sjn
% 220.38/220.60  |- skos__broader mesh__D041881smesh__D002764
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D041881 2006
% 220.38/220.60  |- mesh__recordOriginator mesh__D041881 lkt
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D041881 2005
% 220.38/220.60  |- skos__hiddenLabel mesh__D035844 Investigator Subject Relationship
% 220.38/220.60  |- mesh__recordOriginator mesh__D035844 jrf
% 220.38/220.60  |- skos__prefLabel mesh__D035844 Researcher-Subject Relations
% 220.38/220.60  |- mesh__dateCreated mesh__D035844 2002-07-03
% 220.38/220.60  |- skos__broader mesh__D035844smesh__D011369
% 220.38/220.60  |- skos__hiddenLabel mesh__D035844 Researcher Subject Relations
% 220.38/220.60  |- skos__hiddenLabel mesh__D035844 Relationship, Investigator-Subject
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D035844 2006
% 220.38/220.60  |- skos__altLabel mesh__D035844 Investigator-Subject Relationship
% 220.38/220.60  |- skos__hiddenLabel mesh__D035844 Relations, Researcher-Subject
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D035844 2004
% 220.38/220.60  |- skos__hiddenLabel mesh__D035844 Investigator-Subject Relationships
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D035844 2005
% 220.38/220.60  |- skos__hiddenLabel mesh__D035844 Investigator Subject Relations
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D035844 2003
% 220.38/220.60  |- mesh__dateRevised mesh__D035844 2002-10-31
% 220.38/220.60  |- mesh__publicMeSHNote mesh__D035844 2003   
% 220.38/220.60  |- skos__altLabel mesh__D035844 Researcher Subject Relationship
% 220.38/220.60  |- skos__altLabel mesh__D035844 Investigator-Subject Relations
% 220.38/220.60  |- mesh__dateEstablished mesh__D035844 2003-01-01
% 220.38/220.60  |- skos__hiddenLabel mesh__D035844 Relation, Investigator-Subject
% 220.38/220.60  |- skos__hiddenLabel mesh__D035844 Investigator-Subject Relation
% 220.38/220.60  |- rdf__type mesh__D035844sskos__Concept
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D035844 2003A
% 220.38/220.60  |- mesh__recordMaintainer mesh__D035844 jls
% 220.38/220.60  |- skos__hiddenLabel mesh__D035844 Researcher Subject Relationships
% 220.38/220.60  |- skos__hiddenLabel mesh__D035844 Relationships, Investigator-Subject
% 220.38/220.60  |- skos__hiddenLabel mesh__D035844 Relations, Investigator-Subject
% 220.38/220.60  |- mesh__recordAuthorizer mesh__D035844 jls
% 220.38/220.60  |- skos__scopeNote mesh__D035844
% 220.38/220.60       Interaction between research personnel and research subjects.%A%    
% 220.38/220.60  |- mesh__historyNote mesh__D035844 2003   
% 220.38/220.60  |- skos__broader mesh__D013392smesh__D009942
% 220.38/220.60  |- mesh__recordMaintainer mesh__D013392 ssb
% 220.38/220.60  |- mesh__historyNote mesh__D013392 87   
% 220.38/220.60  |- mesh__recordOriginator mesh__D013392 RLS
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D013392 2006
% 220.38/220.60  |- skos__broader mesh__D013392smesh__D013865
% 220.38/220.60  |- mesh__dateCreated mesh__D013392 1986-04-09
% 220.38/220.60  |- mesh__recordAuthorizer mesh__D013392 sjn
% 220.38/220.60  |- skos__prefLabel mesh__D013392 Sucralfate
% 220.38/220.60  |- skos__historyNote mesh__D013392 Aluminum %28%1966-1986%29%
% 220.38/220.60  |- mesh__publicMeSHNote mesh__D013392 87   
% 220.38/220.60  |- skos__historyNote mesh__D013392
% 220.38/220.60       Sucrose/analogs %26% derivatives %28%1977-1981%29%
% 220.38/220.60  |- mesh__dateEstablished mesh__D013392 1987-01-01
% 220.38/220.60  |- skos__altLabel mesh__D013392 Aluminum Sucrose Sulfate
% 220.38/220.60  |- skos__altLabel mesh__D013392 Basic Aluminum Sucrose Sulfate
% 220.38/220.60  |- skos__scopeNote mesh__D013392
% 220.38/220.60       A basic aluminum complex of sulfated sucrose.     
% 220.38/220.60  |- mesh__dateRevised mesh__D013392 2005-06-30
% 220.38/220.60  |- rdf__type mesh__D013392sskos__Concept
% 220.38/220.60  |- skos__broader mesh__D013392smesh__D013395
% 220.38/220.60  |- skos__hiddenLabel mesh__D013392 Sulfate, Aluminum Sucrose
% 220.38/220.60  |- mesh__dateCreated mesh__D007355 1983-06-06
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D007355 2005
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D007355 2001
% 220.38/220.60  |- skos__hiddenLabel mesh__D007355 Nursing Services Insurances
% 220.38/220.60  |- skos__hiddenLabel mesh__D007355 Services Insurance, Nursing
% 220.38/220.60  |- mesh__recordOriginator mesh__D007355 EC
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D007355 2004
% 220.38/220.60  |- rdf__type mesh__D007355sskos__Concept
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D007355 2000
% 220.38/220.60  |- skos__scopeNote mesh__D007355
% 220.38/220.60       Insurance providing benefits for the costs of care provided by nurses, especially nurse practitioners and nurse clinicians.%A%    
% 220.38/220.60  |- mesh__activeMeSHYear mesh__D007355 2003
% 220.38/220.60  |- skos__hiddenLabel mesh__D007355 Insurances, Nursing Services
% 220.38/220.61  |- skos__prefLabel mesh__D007355 Insurance, Nursing Services
% 220.38/220.61  |- mesh__dateEstablished mesh__D007355 1991-01-01
% 220.38/220.61  |- skos__hiddenLabel mesh__D007355 Services Insurances, Nursing
% 220.38/220.61  |- mesh__recordMaintainer mesh__D007355 kle
% 220.38/220.61  |- mesh__historyNote mesh__D007355
% 220.38/220.61       91%28%84%29%; was see under INSURANCE, HEALTH 1984-90   
% 220.38/220.61  |- skos__annotation mesh__D007355
% 220.38/220.61       specify geog if possible; DF: INSURANCE NURS SERV   
% 220.38/220.61  |- mesh__recordAuthorizer mesh__D007355 sjn
% 220.38/220.61  |- skos__altLabel mesh__D007355 Nursing Services Insurance
% 220.38/220.61  |- mesh__dateRevised mesh__D007355 1999-11-03
% 220.38/220.61  |- skos__broader mesh__D007355smesh__D007348
% 220.38/220.61  |- mesh__publicMeSHNote mesh__D007355
% 220.38/220.61       91; was see under INSURANCE, HEALTH 1984-90   
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D007355 2006
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D007355 2002
% 220.38/220.61  |- mesh__publicMeSHNote mesh__D017783 94   
% 220.38/220.61  |- skos__altLabel mesh__D017783 Superior Cervical Ganglia
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D017783 1996
% 220.38/220.61  |- mesh__dateRevised mesh__D017783 1994-04-11
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D017783 2005
% 220.38/220.61  |- skos__scopeNote mesh__D017783
% 220.38/220.61       The largest and uppermost of the paravertebral sympathetic ganglia.%A%    
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D017783 2004
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D017783 2002
% 220.38/220.61  |- skos__hiddenLabel mesh__D017783 Cervical Ganglia, Superior
% 220.38/220.61  |- mesh__dateEstablished mesh__D017783 1994-01-01
% 220.38/220.61  |- mesh__dateCreated mesh__D017783 1993-06-21
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D017783 2003
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D017783 1995
% 220.38/220.61  |- skos__hiddenLabel mesh__D017783 Ganglia, Superior Cervical
% 220.38/220.61  |- skos__hiddenLabel mesh__D017783 Cervical Ganglion, Superior
% 220.38/220.61  |- mesh__historyNote mesh__D017783 94   
% 220.38/220.61  |- skos__historyNote mesh__D017783 Ganglia, Autonomic %28%1966-1979%29%
% 220.38/220.61  |- mesh__recordMaintainer mesh__D017783 TGC
% 220.38/220.61  |- mesh__recordAuthorizer mesh__D017783 PLS
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D017783 2001
% 220.38/220.61  |- skos__broader mesh__D017783smesh__D005728
% 220.38/220.61  |- skos__annotation mesh__D017783 the largest sympath ganglion   
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D017783 1999
% 220.38/220.61  |- mesh__recordOriginator mesh__D017783 RAZ
% 220.38/220.61  |- skos__historyNote mesh__D017783 Ganglia, Sympathetic %28%1980-1993%29%
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D017783 2000
% 220.38/220.61  |- skos__prefLabel mesh__D017783 Superior Cervical Ganglion
% 220.38/220.61  |- skos__hiddenLabel mesh__D017783 Ganglion, Superior Cervical
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D017783 1998
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D017783 1997
% 220.38/220.61  |- rdf__type mesh__D017783sskos__Concept
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D017783 2006
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003763 1996
% 220.38/220.61  |- rdf__type mesh__D003763sskos__Concept
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003763 2004
% 220.38/220.61  |- skos__historyNote mesh__D003763 Composite Resins %28%1972-1983%29%
% 220.38/220.61  |- skos__historyNote mesh__D003763 Bonding, Dental %28%1971-1983%29%
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003763 1999
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003763 2001
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003763 1992
% 220.38/220.61  |- mesh__historyNote mesh__D003763 84   
% 220.38/220.61  |- mesh__dateRevised mesh__D003763 1990-05-29
% 220.38/220.61  |- mesh__dateCreated mesh__D003763 1983-03-11
% 220.38/220.61  |- skos__scopeNote mesh__D003763
% 220.38/220.61       The seepage of fluids, debris, and micro-organisms between the walls of a prepared dental cavity and the restoration.%A%    
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003763 1995
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003763 2003
% 220.38/220.61  |- skos__historyNote mesh__D003763
% 220.38/220.61       Dental Restoration, Permanent %28%1966-1983%29%
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003763 1998
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003763 2000
% 220.38/220.61  |- mesh__publicMeSHNote mesh__D003763 84   
% 220.38/220.61  |- mesh__dateEstablished mesh__D003763 1984-01-01
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003763 2006
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003763 1994
% 220.38/220.61  |- skos__annotation mesh__D003763
% 220.38/220.61       seepage of fluids, debris %26% micro-organisms into dental cavity restorations; DF: DENT LEAKAGE%A%  
% 220.38/220.61  |- mesh__recordMaintainer mesh__D003763 TAP
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003763 1991
% 220.38/220.61  |- skos__altLabel mesh__D003763 Leakage, Dental
% 220.38/220.61  |- skos__altLabel mesh__D003763 Dental Leakages
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003763 2005
% 220.38/220.61  |- mesh__recordAuthorizer mesh__D003763 PLS
% 220.38/220.61  |- skos__altLabel mesh__D003763 Leakages, Dental
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003763 2002
% 220.38/220.61  |- skos__prefLabel mesh__D003763 Dental Leakage
% 220.38/220.61  |- mesh__recordOriginator mesh__D003763 RC
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003763 1997
% 220.38/220.61  |- skos__broader mesh__D003763smesh__D014076
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003763 1993
% 220.38/220.61  |- skos__broader mesh__D041882smesh__D041881
% 220.38/220.61  |- skos__scopeNote mesh__D041882
% 220.38/220.61       A variant of acute cholecystitis with inflammation of the GALLBLADDER that is characterized by the pockets of gas in the gallbladder wall. It is due to secondary infection caused by gas-forming organisms, and has a high risk of perforation.%A%    
% 220.38/220.61  |- mesh__historyNote mesh__D041882 2004   
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D041882 2004
% 220.38/220.61  |- rdf__type mesh__D041882sskos__Concept
% 220.38/220.61  |- mesh__dateCreated mesh__D041882 2003-07-09
% 220.38/220.61  |- skos__historyNote mesh__D041882 Cholecystitis %28%1965-2003%29%
% 220.38/220.61  |- skos__altLabel mesh__D041882 Cholecystitis, Emphysematous
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D041882 2006
% 220.38/220.61  |- skos__prefLabel mesh__D041882 Emphysematous Cholecystitis
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D041882 2005
% 220.38/220.61  |- mesh__dateEstablished mesh__D041882 2004-01-01
% 220.38/220.61  |- mesh__publicMeSHNote mesh__D041882 2004   
% 220.38/220.61  |- skos__historyNote mesh__D035845 Research %28%1985-2002%29%
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D035845 2006
% 220.38/220.61  |- mesh__recordMaintainer mesh__D035845 jls
% 220.38/220.61  |- skos__hiddenLabel mesh__D035845 Creations, Research Embryo
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D035845 2004
% 220.38/220.61  |- mesh__recordAuthorizer mesh__D035845 jls
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D035845 2005
% 220.38/220.61  |- mesh__historyNote mesh__D035845 2003   
% 220.38/220.61  |- skos__scopeNote mesh__D035845
% 220.38/220.61       The creation of embryos specifically for research purposes.%A%    
% 220.38/220.61  |- skos__hiddenLabel mesh__D035845 Research Embryo Creations
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D035845 2003
% 220.38/220.61  |- mesh__dateCreated mesh__D035845 2002-07-03
% 220.38/220.61  |- skos__hiddenLabel mesh__D035845 Embryo Creations, Research
% 220.38/220.61  |- mesh__publicMeSHNote mesh__D035845 2003   
% 220.38/220.61  |- skos__altLabel mesh__D035845 Embryo Creation, Research
% 220.38/220.61  |- skos__historyNote mesh__D035845 Embryo %28%1985-2002%29%
% 220.38/220.61  |- rdf__type mesh__D035845sskos__Concept
% 220.38/220.61  |- skos__hiddenLabel mesh__D035845 Creation, Research Embryo
% 220.38/220.61  |- mesh__dateRevised mesh__D035845 2002-10-31
% 220.38/220.61  |- skos__broader mesh__D035845smesh__D033041
% 220.38/220.61  |- skos__prefLabel mesh__D035845 Research Embryo Creation
% 220.38/220.61  |- mesh__dateEstablished mesh__D035845 2003-01-01
% 220.38/220.61  |- skos__annotation mesh__D035845 mammalian only   
% 220.38/220.61  |- mesh__recordOriginator mesh__D035845 hjn
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D035845 2003A
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D013393 2006
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D013393 2004
% 220.38/220.61  |- mesh__recordOriginator mesh__D013393 NLM
% 220.38/220.61  |- skos__broader mesh__D013393smesh__D004186
% 220.38/220.61  |- skos__hiddenLabel mesh__D013393 alpha-D-Glucohydrolase, Sucrose
% 220.38/220.61  |- mesh__recordMaintainer mesh__D013393 ssb
% 220.38/220.61  |- skos__hiddenLabel mesh__D013393 Sucrose alpha D Glucohydrolase
% 220.38/220.61  |- mesh__publicMeSHNote mesh__D013393 72   
% 220.38/220.61  |- mesh__dateEstablished mesh__D013393 1972-01-01
% 220.38/220.61  |- mesh__recordAuthorizer mesh__D013393 sjn
% 220.38/220.61  |- mesh__dateRevised mesh__D013393 2003-07-09
% 220.38/220.61  |- rdf__type mesh__D013393sskos__Concept
% 220.38/220.61  |- skos__prefLabel mesh__D013393 Sucrase
% 220.38/220.61  |- mesh__dateCreated mesh__D013393 1999-01-01
% 220.38/220.61  |- skos__annotation mesh__D013393
% 220.38/220.61       do not confuse with SUCROSE; /defic: consider also SUCROSE /metab %28%IM%29% + CARBOHYDRATE METABOLISM, INBORN ERRORS %28%IM%29%%A%  
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D013393 2005
% 220.38/220.61  |- mesh__historyNote mesh__D013393 72%28%63%29%   
% 220.38/220.61  |- skos__altLabel mesh__D013393 Sucrose alpha-D-Glucohydrolase
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D007356 2004
% 220.38/220.61  |- rdf__type mesh__D007356sskos__Concept
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D007356 2002
% 220.38/220.61  |- mesh__dateEstablished mesh__D007356 1968-01-01
% 220.38/220.61  |- skos__altLabel mesh__D007356 Insurance, Pharmaceutic Services
% 220.38/220.61  |- skos__hiddenLabel mesh__D007356 Plans, Drug Benefit
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D007356 2003
% 220.38/220.61  |- skos__historyNote mesh__D007356 Prescriptions %28%1966-1967%29%
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D007356 2001
% 220.38/220.61  |- skos__scopeNote mesh__D007356
% 220.38/220.61       Insurance providing for payment of services rendered by the pharmacist. Services include the preparation and distribution of medical products.%A%    
% 220.38/220.61  |- skos__hiddenLabel mesh__D007356 Plan, Drug Benefit
% 220.38/220.61  |- skos__altLabel mesh__D007356 Pharmacy Services Insurance
% 220.38/220.61  |- skos__prefLabel mesh__D007356 Insurance, Pharmaceutical Services
% 220.38/220.61  |- skos__annotation mesh__D007356
% 220.38/220.61       specify geog if possible; DF: INSURANCE PHARM SERV   
% 220.38/220.61  |- skos__altLabel mesh__D007356 Insurance, Pharmacy Services
% 220.38/220.61  |- mesh__recordOriginator mesh__D007356 NLM
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D007356 2000
% 220.38/220.61  |- skos__broader mesh__D007356smesh__D007348
% 220.38/220.61  |- mesh__publicMeSHNote mesh__D007356 68   
% 220.38/220.61  |- skos__hiddenLabel mesh__D007356 Insurance, Drug
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D007356 2006
% 220.38/220.61  |- skos__altLabel mesh__D007356 Pharmaceutical Services Insurance
% 220.38/220.61  |- mesh__historyNote mesh__D007356 68   
% 220.38/220.61  |- skos__hiddenLabel mesh__D007356 Drug Benefit Plan
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D007356 2005
% 220.38/220.61  |- mesh__recordMaintainer mesh__D007356 kle
% 220.38/220.61  |- skos__historyNote mesh__D007356 Pharmacy %28%1966-1967%29%
% 220.38/220.61  |- skos__hiddenLabel mesh__D007356 Insurance, Prescription
% 220.38/220.61  |- skos__altLabel mesh__D007356 Pharmaceutic Services Insurance
% 220.38/220.61  |- mesh__recordAuthorizer mesh__D007356 sjn
% 220.38/220.61  |- mesh__dateCreated mesh__D007356 1999-01-01
% 220.38/220.61  |- mesh__dateRevised mesh__D007356 1999-11-03
% 220.38/220.61  |- mesh__recordOriginator mesh__D017784 JLS
% 220.38/220.61  |- skos__hiddenLabel mesh__D017784 Milk Bank
% 220.38/220.61  |- skos__broader mesh__D017784smesh__D018070
% 220.38/220.61  |- mesh__dateRevised mesh__D017784 2004-07-13
% 220.38/220.61  |- skos__prefLabel mesh__D017784 Milk Banks
% 220.38/220.61  |- mesh__recordAuthorizer mesh__D017784 sjn
% 220.38/220.61  |- mesh__publicMeSHNote mesh__D017784 94   
% 220.38/220.61  |- mesh__historyNote mesh__D017784 94   
% 220.38/220.61  |- mesh__dateEstablished mesh__D017784 1994-01-01
% 220.38/220.61  |- skos__scopeNote mesh__D017784
% 220.38/220.61       Centers for acquiring, storing, and distributing human milk.%A%    
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D017784 2005
% 220.38/220.61  |- skos__hiddenLabel mesh__D017784 Banks, Milk
% 220.38/220.61  |- mesh__dateCreated mesh__D017784 1993-06-04
% 220.38/220.61  |- rdf__type mesh__D017784sskos__Concept
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D017784 2006
% 220.38/220.61  |- mesh__recordMaintainer mesh__D017784 sjn
% 220.38/220.61  |- mesh__recordMaintainer mesh__D003764 ADP
% 220.38/220.61  |- skos__altLabel mesh__D003764 Dental Material
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003764 2003
% 220.38/220.61  |- mesh__dateRevised mesh__D003764 1998-06-10
% 220.38/220.61  |- skos__altLabel mesh__D003764 Materials, Dental
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003764 2006
% 220.38/220.61  |- skos__prefLabel mesh__D003764 Dental Materials
% 220.38/220.61  |- mesh__dateCreated mesh__D003764 1999-01-01
% 220.38/220.61  |- mesh__recordAuthorizer mesh__D003764 SJN
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003764 2001
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003764 2005
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003764 2000
% 220.38/220.61  |- mesh__recordOriginator mesh__D003764 NLM
% 220.38/220.61  |- skos__annotation mesh__D003764 D25-26 qualif; DF: DENT MATERIALS   
% 220.38/220.61  |- skos__related mesh__D003764smesh__D007284
% 220.38/220.61  |- skos__broader mesh__D003764smesh__D001697
% 220.38/220.61  |- rdf__type mesh__D003764sskos__Concept
% 220.38/220.61  |- skos__related mesh__D003764smesh__D001840
% 220.38/220.61  |- skos__scopeNote mesh__D003764
% 220.38/220.61       Materials used in the production of dental bases, restorations, impressions, prostheses, etc.%A%    
% 220.38/220.61  |- skos__altLabel mesh__D003764 Material, Dental
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003764 2004
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003764 2002
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003764 1999
% 220.38/220.61  |- mesh__publicMeSHNote mesh__D041883
% 220.38/220.61       2004; see GREEN SULFUR BACTERIA 1997-2003   
% 220.38/220.61  |- skos__broader mesh__D041883smesh__D016965
% 220.38/220.61  |- skos__historyNote mesh__D041883 Chlorobi %28%1996-2003%29%
% 220.38/220.61  |- mesh__historyNote mesh__D041883 2004; use CHLOROBI 1997-2003   
% 220.38/220.61  |- skos__broader mesh__D041883smesh__D019414
% 220.38/220.61  |- mesh__recordAuthorizer mesh__D041883 sjn
% 220.38/220.61  |- mesh__dateEstablished mesh__D041883 2004-01-01
% 220.38/220.61  |- rdf__type mesh__D041883sskos__Concept
% 220.38/220.61  |- mesh__dateCreated mesh__D041883 2003-07-09
% 220.38/220.61  |- skos__historyNote mesh__D041883 Bacteria %28%1964-2003%29%
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D041883 2006
% 220.38/220.61  |- skos__prefLabel mesh__D041883 Chlorobium
% 220.38/220.61  |- mesh__dateRevised mesh__D041883 2005-06-30
% 220.38/220.61  |- skos__scopeNote mesh__D041883
% 220.38/220.61       A genus of phototrophic, obligately anaerobic bacteria in the family Chlorobiaceae. They are found in hydrogen sulfide-containing mud and water environments.%A%    
% 220.38/220.61  |- mesh__recordMaintainer mesh__D041883 SYSTEM
% 220.38/220.61  |- mesh__recordOriginator mesh__D041883 ags
% 220.38/220.61  |- mesh__dateCreated mesh__D049068 2004-07-07
% 220.38/220.61  |- skos__prefLabel mesh__D049068 Plagiocephaly, Nonsynostotic
% 220.38/220.61  |- skos__altLabel mesh__D049068 Nonsynostotic Plagiocephaly
% 220.38/220.61  |- skos__broader mesh__D049068smesh__D019465
% 220.38/220.61  |- mesh__recordMaintainer mesh__D049068 ags
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D049068 2006
% 220.38/220.61  |- rdf__type mesh__D049068sskos__Concept
% 220.38/220.61  |- mesh__recordAuthorizer mesh__D049068 sjn
% 220.38/220.61  |- mesh__dateEstablished mesh__D049068 2005-01-01
% 220.38/220.61  |- mesh__publicMeSHNote mesh__D049068 2005   
% 220.38/220.61  |- mesh__historyNote mesh__D049068 2005   
% 220.38/220.61  |- mesh__dateRevised mesh__D049068 2005-06-30
% 220.38/220.61  |- skos__scopeNote mesh__D049068
% 220.38/220.61       A deformity of the SKULL that is not due to bone fusion %28%SYNOSTOSIS%29%, such as CRANIOSYNOSTOSES, and is characterized by an asymmetric skull and face. It is observed with increased frequencies in INFANTS after the adoption of supine sleeping recommendations to prevent SUDDEN INFANT DEATH SYNDROME.%A%    
% 220.38/220.61  |- mesh__recordOriginator mesh__D049068 lkt
% 220.38/220.61  |- mesh__dateEstablished mesh__D035846 2003-01-01
% 220.38/220.61  |- mesh__dateRevised mesh__D035846 2002-10-31
% 220.38/220.61  |- rdf__type mesh__D035846sskos__Concept
% 220.38/220.61  |- skos__related mesh__D035846smesh__D016495
% 220.38/220.61  |- skos__related mesh__D035846smesh__D005554
% 220.38/220.61  |- mesh__recordMaintainer mesh__D035846 jls
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D035846 2003A
% 220.38/220.61  |- skos__scopeNote mesh__D035846
% 220.38/220.61       Organized efforts to insure obedience to the laws of a community.%A%    
% 220.38/220.61  |- skos__hiddenLabel mesh__D035846 Enforcement, Law
% 220.38/220.61  |- mesh__recordOriginator mesh__D035846 jrf
% 220.38/220.61  |- mesh__recordAuthorizer mesh__D035846 jls
% 220.38/220.61  |- skos__historyNote mesh__D035846 Social Control, Formal %28%1971-2002%29%
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D035846 2006
% 220.38/220.61  |- mesh__historyNote mesh__D035846 2003   
% 220.38/220.61  |- skos__broader mesh__D035846smesh__D012926
% 220.38/220.61  |- mesh__dateCreated mesh__D035846 2002-07-03
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D035846 2004
% 220.38/220.61  |- skos__prefLabel mesh__D035846 Law Enforcement
% 220.38/220.61  |- skos__annotation mesh__D035846 specify geog   
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D035846 2005
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D035846 2003
% 220.38/220.61  |- skos__related mesh__D035846smesh__D003416
% 220.38/220.61  |- mesh__publicMeSHNote mesh__D035846 2003   
% 220.38/220.61  |- mesh__dateEstablished mesh__D013394 1991-01-01
% 220.38/220.61  |- mesh__publicMeSHNote mesh__D013394
% 220.38/220.61       91; was see under MULTIENZYME COMPLEXES 1978-90   
% 220.38/220.61  |- skos__historyNote mesh__D013394 Glycoside Hydrolases %28%1966-1977%29%
% 220.38/220.61  |- skos__hiddenLabel mesh__D013394 Complex, Sucrase-Isomaltase
% 220.38/220.61  |- skos__altLabel mesh__D013394 Sucrase Isomaltase Complex
% 220.38/220.61  |- skos__hiddenLabel mesh__D013394 Complex, Sucrase Isomaltase
% 220.38/220.61  |- skos__scopeNote mesh__D013394
% 220.38/220.61       An enzyme complex found in the brush border membranes of the small intestine. It is believed to be an enzyme complex with different catalytic sites. Its absence is manifested by an inherited disease called sucrase-isomaltase deficiency.%A%    
% 220.38/220.61  |- skos__broader mesh__D013394smesh__D013393
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D013394 2005
% 220.38/220.61  |- rdf__type mesh__D013394sskos__Concept
% 220.38/220.61  |- skos__historyNote mesh__D013394 Sucrase %28%1972-1977%29%
% 220.38/220.61  |- skos__annotation mesh__D013394
% 220.38/220.61       /defic: consider also SUCROSE /metab %28%IM%29% + CARBOHYDRATE METABOLISM, INBORN ERRORS %28%IM%29%%A%  
% 220.38/220.61  |- mesh__recordOriginator mesh__D013394 RLS
% 220.38/220.61  |- skos__broader mesh__D013394smesh__D009834
% 220.38/220.61  |- mesh__dateCreated mesh__D013394 1977-04-15
% 220.38/220.61  |- mesh__dateRevised mesh__D013394 2004-07-07
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D013394 2006
% 220.38/220.61  |- skos__historyNote mesh__D013394 Multienzyme Complexes %28%1973-1977%29%
% 220.38/220.61  |- mesh__historyNote mesh__D013394
% 220.38/220.61       91%28%78%29%; was see under MULTIENZYME COMPLEXES 1978-90   
% 220.38/220.61  |- skos__prefLabel mesh__D013394 Sucrase-Isomaltase Complex
% 220.38/220.61  |- mesh__recordMaintainer mesh__D013394 jmp
% 220.38/220.61  |- skos__broader mesh__D013394smesh__D009097
% 220.38/220.61  |- skos__hiddenLabel mesh__D013394 Isomaltase Complex, Sucrase
% 220.38/220.61  |- mesh__recordAuthorizer mesh__D013394 sjn
% 220.38/220.61  |- skos__hiddenLabel mesh__D007357 Physician Service, Insurance
% 220.38/220.61  |- skos__hiddenLabel mesh__D007357 Service, Insurance Physician
% 220.38/220.61  |- skos__annotation mesh__D007357
% 220.38/220.61       specify geog if possible; DF: INSURANCE PHYSICIAN SERV   
% 220.38/220.61  |- rdf__type mesh__D007357sskos__Concept
% 220.38/220.61  |- skos__hiddenLabel mesh__D007357 Insurance Physician Services
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D007357 2004
% 220.38/220.61  |- skos__hiddenLabel mesh__D007357 Services, Insurance Physician
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D007357 2002
% 220.38/220.61  |- skos__broader mesh__D007357smesh__D007348
% 220.38/220.61  |- mesh__historyNote mesh__D007357 68   
% 220.38/220.61  |- mesh__recordMaintainer mesh__D007357 kle
% 220.38/220.61  |- mesh__recordAuthorizer mesh__D007357 sjn
% 220.38/220.61  |- skos__hiddenLabel mesh__D007357 Insurance Physician Service
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D007357 2005
% 220.38/220.61  |- skos__hiddenLabel mesh__D007357 Insurances, Physician Services
% 220.38/220.61  |- skos__altLabel mesh__D007357 Physician Services, Insurance
% 220.38/220.61  |- mesh__dateRevised mesh__D007357 1999-11-03
% 220.38/220.61  |- mesh__dateCreated mesh__D007357 1999-01-01
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D007357 2000
% 220.38/220.61  |- mesh__publicMeSHNote mesh__D007357 68   
% 220.38/220.61  |- skos__scopeNote mesh__D007357
% 220.38/220.61       Insurance providing benefits for the costs of care by a physician which can be comprehensive or limited to surgical expenses or for care provided only in the hospital. It is frequently called %22%regular medical expense%22% or %22%surgical expense%22%.%A%    
% 220.38/220.61  |- skos__hiddenLabel mesh__D007357 Services Insurances, Physician
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D007357 2006
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D007357 2001
% 220.38/220.61  |- mesh__dateEstablished mesh__D007357 1968-01-01
% 220.38/220.61  |- skos__prefLabel mesh__D007357 Insurance, Physician Services
% 220.38/220.61  |- skos__hiddenLabel mesh__D007357 Physician Services Insurance
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D007357 2003
% 220.38/220.61  |- mesh__recordOriginator mesh__D007357 NLM
% 220.38/220.61  |- skos__historyNote mesh__D007357 Insurance, Health %28%1966-1967%29%
% 220.38/220.61  |- skos__hiddenLabel mesh__D007357 Physician Services Insurances
% 220.38/220.61  |- skos__altLabel mesh__D007357 Services Insurance, Physician
% 220.38/220.61  |- skos__prefLabel mesh__D017785 Photons
% 220.38/220.61  |- mesh__dateCreated mesh__D017785 1993-06-04
% 220.38/220.61  |- skos__broader mesh__D017785smesh__D008027
% 220.38/220.61  |- mesh__historyNote mesh__D017785 94; was see RADIATION 1985-1993   
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D017785 2005
% 220.38/220.61  |- mesh__recordAuthorizer mesh__D017785 sjn
% 220.38/220.61  |- skos__scopeNote mesh__D017785
% 220.38/220.61       Discrete concentrations of energy, apparently massless elementary particles, that move at the speed of light. They are the unit or quantum of electromagnetic radiation. Photons are emitted when electrons move from one energy state to another. %28%From Hawley%27%s Condensed Chemical Dictionary, 11th ed%29%%A%    
% 220.38/220.61  |- mesh__dateEstablished mesh__D017785 1994-01-01
% 220.38/220.61  |- rdf__type mesh__D017785sskos__Concept
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D017785 2006
% 220.38/220.61  |- skos__broader mesh__D017785smesh__D004601
% 220.38/220.61  |- mesh__recordOriginator mesh__D017785 JLS
% 220.38/220.61  |- mesh__publicMeSHNote mesh__D017785 94; was see RADIATION 1985-1993   
% 220.38/220.61  |- skos__annotation mesh__D017785 elementary particles; IM   
% 220.38/220.61  |- mesh__dateRevised mesh__D017785 2004-07-07
% 220.38/220.61  |- mesh__onlineNote mesh__D017785
% 220.38/220.61       use RADIATION to search PHOTONS 1985-93   
% 220.38/220.61  |- mesh__recordMaintainer mesh__D017785 ssb
% 220.38/220.61  |- skos__hiddenLabel mesh__D050610
% 220.38/220.61       Type II Sodium Phosphate Cotransporter Proteins
% 220.38/220.61  |- skos__altLabel mesh__D050610
% 220.38/220.61       Type II Na-Dependent Phosphate Cotransporter
% 220.38/220.61  |- mesh__dateCreated mesh__D050610 2005-06-30
% 220.38/220.61  |- skos__altLabel mesh__D050610 Type II Sodium-Phosphate Symporter Proteins
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D050610 2006
% 220.38/220.61  |- mesh__recordMaintainer mesh__D050610 ags
% 220.38/220.61  |- rdf__type mesh__D050610sskos__Concept
% 220.38/220.61  |- skos__hiddenLabel mesh__D050610
% 220.38/220.61       Sodium Phosphate Cotransporter Proteins, Type II
% 220.38/220.61  |- skos__hiddenLabel mesh__D050610
% 220.38/220.61       Type II Sodium Phosphate Symporter Proteins
% 220.38/220.61  |- mesh__dateRevised mesh__D050610 2005-07-25
% 220.38/220.61  |- skos__scopeNote mesh__D050610
% 220.38/220.61       A family of sodium-phosphate cotransporter proteins with eight transmembrane domains. They are present primarily in the KIDNEY and SMALL INTESTINE and are responsible for renal and small intestinal epithelial transport of phosphate.%A%    
% 220.38/220.61  |- mesh__publicMeSHNote mesh__D050610
% 220.38/220.61       2006; TYPE II NA-PI COTRANSPORTER PROTEIN was indexed under SYMPORTERS 2002-2005, %26% under CARRIER PROTEINS 1987-2001%A%  
% 220.38/220.61  |- mesh__recordOriginator mesh__D050610 DRC
% 220.38/220.61  |- skos__hiddenLabel mesh__D050610
% 220.38/220.61       Type II Na Dependent Phosphate Cotransporter
% 220.38/220.61  |- mesh__dateEstablished mesh__D050610 2006-01-01
% 220.38/220.61  |- skos__broader mesh__D050610smesh__D050608
% 220.38/220.61  |- skos__altLabel mesh__D050610
% 220.38/220.61       Type II Sodium-Phosphate Cotransporter Proteins
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D050610 2006A
% 220.38/220.61  |- mesh__historyNote mesh__D050610 2006%28%1987%29%   
% 220.38/220.61  |- skos__prefLabel mesh__D050610
% 220.38/220.61       Sodium-Phosphate Cotransporter Proteins, Type II
% 220.38/220.61  |- mesh__recordAuthorizer mesh__D050610 ags
% 220.38/220.61  |- mesh__recordOriginator mesh__D003765 NLM
% 220.38/220.61  |- mesh__activeMeSHYear mesh__D003765 2005
% 220.48/220.61  |- mesh__activeMeSHYear mesh__D003765 1995
% 220.48/220.61  |- mesh__recordMaintainer mesh__D003765 TAP
% 220.48/220.61  |- mesh__activeMeSHYear mesh__D003765 2006
% 220.48/220.61  |- skos__altLabel mesh__D003765 Models, Dental
% 220.48/220.61  |- skos__altLabel mesh__D003765 Model, Dental
% 220.48/220.61  |- mesh__historyNote mesh__D003765 65   
% 220.48/220.61  |- skos__broader mesh__D003765smesh__D003813
% 220.48/220.61  |- mesh__dateEstablished mesh__D003765 1965-01-01
% 220.48/220.61  |- mesh__activeMeSHYear mesh__D003765 1996
% 220.48/220.61  |- mesh__dateRevised mesh__D003765 1992-05-14
% 220.48/220.61  |- mesh__activeMeSHYear mesh__D003765 1997
% 220.48/220.61  |- mesh__activeMeSHYear mesh__D003765 2000
% 220.48/220.61  |- mesh__activeMeSHYear mesh__D003765 2003
% 220.48/220.61  |- mesh__activeMeSHYear mesh__D003765 1993
% 220.48/220.61  |- mesh__activeMeSHYear mesh__D003765 1998
% 220.48/220.61  |- mesh__activeMeSHYear mesh__D003765 2001
% 220.48/220.61  |- skos__prefLabel mesh__D003765 Dental Models
% 220.48/220.61  |- rdf__type mesh__D003765sskos__Concept
% 220.48/220.61  |- skos__altLabel mesh__D003765 Dental Model
% 220.48/220.61  |- mesh__activeMeSHYear mesh__D003765 2004
% 220.48/220.61  |- mesh__recordAuthorizer mesh__D003765 PLS
% 220.48/220.61  |- mesh__activeMeSHYear mesh__D003765 1994
% 220.48/220.61  |- mesh__activeMeSHYear mesh__D003765 2002
% 220.48/220.61  |- mesh__activeMeSHYear mesh__D003765 1999
% 220.48/220.61  |- mesh__publicMeSHNote mesh__D003765 65   
% 220.48/220.61  |- skos__annotation mesh__D003765 DF: DENT MODELS   
% 220.48/220.61  |- mesh__dateCreated mesh__D003765 1999-01-01
% 220.48/220.61  |- skos__altLabel mesh__D036141 Receptor Tyrosine Kinase Cek11
% 220.48/220.61  |- mesh__recordOriginator mesh__D036141 jmp
% 220.48/220.61  |- mesh__recordAuthorizer mesh__D036141 sjn
% 220.48/220.61  |- skos__altLabel mesh__D036141 Cek11 Kinase
% 220.48/220.61  |- skos__altLabel mesh__D036141 EphA7 Protein
% 220.48/220.61  |- mesh__dateEstablished mesh__D036141 2003-01-01
% 220.48/220.61  |- mesh__activeMeSHYear mesh__D036141 2006
% 220.48/220.61  |- skos__altLabel mesh__D036141 EphA7 Receptor
% 220.48/220.61  |- mesh__historyNote mesh__D036141
% 220.48/220.61       2003; use RECEPTOR, EPHA7 %28%NM%29% 1997-2002   
% 220.48/220.61  |- mesh__dateRevised mesh__D036141 2005-06-30
% 220.48/220.61  |- skos__broader mesh__D036141smesh__D036081
% 220.48/220.61  |- skos__scopeNote mesh__D036141
% 220.48/220.61       An eph family receptor found widely expressed in embryo tissues, including the NERVOUS SYSTEM. In the BRAIN high levels of EphA7 expression occurs in the anterior tectum, medulla, RHOMBENCEPHALON, and SUBCOMMISSURAL ORGAN. Several isoforms of the protein occur due to multiple alternative spicing of the EphA7 mRNA.%A%    
% 220.48/220.61  |- mesh__publicMeSHNote mesh__D036141
% 220.48/220.61       2003; RECEPTOR TYROSINE KINASE CEK11 %26% EPHA7 PROTEIN %28%now RECEPTOR, EPHA7%29% were indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1997-2002, MDK1 %28%RTK%29% %26% MDK1 GENE PRODUCT were indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1997-2002%A%  
% 220.48/220.61  |- rdf__type mesh__D036141sskos__Concept
% 220.48/220.61  |- mesh__recordMaintainer mesh__D036141 jmp
% 220.48/220.61  |- mesh__dateCreated mesh__D036141 2002-07-03
% 220.48/220.61  |- skos__prefLabel mesh__D036141 Receptor, EphA7
% 220.48/220.61  |- skos__historyNote mesh__D036141
% 220.48/220.61       Receptor Protein-Tyrosine Kinases %28%1997-2002%29%
% 220.48/220.62  |- skos__scopeNote mesh__D008450
% 220.48/220.62       Measurement of rate of airflow over the middle half of a FORCED VITAL CAPACITY determination %28%from the 25 percent level to the 75 percent level%29%. Common abbreviations are MMFR and FEF 25%25%-75%25%.%A%    
% 220.48/220.62  |- skos__hiddenLabel mesh__D008450 25-75 Percents, FEF
% 220.48/220.62  |- skos__hiddenLabel mesh__D008450 Percent, FEF 25-75
% 220.48/220.62  |- skos__altLabel mesh__D008450 Flow Rate, Maximal Midexpiratory
% 220.48/220.62  |- skos__hiddenLabel mesh__D008450 25-75 Percent, FEF
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D008450 2005
% 220.48/220.62  |- skos__altLabel mesh__D008450 Forced Expiratory Flow 025-075 Percent
% 220.48/220.62  |- skos__annotation mesh__D008450
% 220.48/220.62       usually NIM; do not confuse with MAXIMAL EXPIRATORY FLOW RATE; %28%MEFR%29%; DF: MMFR%A%  
% 220.48/220.62  |- mesh__dateRevised mesh__D008450 2003-07-09
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D008450 2006
% 220.48/220.62  |- skos__hiddenLabel mesh__D008450 Percents, FEF 25-75
% 220.48/220.62  |- mesh__publicMeSHNote mesh__D008450
% 220.48/220.62       91; was see under FORCED EXPIRATORY FLOW RATES 1975-90   
% 220.48/220.62  |- mesh__recordAuthorizer mesh__D008450 sjn
% 220.48/220.62  |- skos__hiddenLabel mesh__D008450 FEF 25-75 Percents
% 220.48/220.62  |- skos__broader mesh__D008450smesh__D005540
% 220.48/220.62  |- mesh__historyNote mesh__D008450
% 220.48/220.62       91%28%75%29%; was see under FORCED EXPIRATORY FLOW RATES 1975-90%A%  
% 220.48/220.62  |- mesh__recordMaintainer mesh__D008450 nns
% 220.48/220.62  |- skos__hiddenLabel mesh__D008450 Forced Expiratory Flow 025 075 Percent
% 220.48/220.62  |- rdf__type mesh__D008450sskos__Concept
% 220.48/220.62  |- mesh__dateEstablished mesh__D008450 1991-01-01
% 220.48/220.62  |- mesh__dateCreated mesh__D008450 1974-12-12
% 220.48/220.62  |- skos__altLabel mesh__D008450 FEF 25-75 Percent
% 220.48/220.62  |- mesh__recordOriginator mesh__D008450 NLM
% 220.48/220.62  |- skos__hiddenLabel mesh__D008450 FEF 25 75 Percent
% 220.48/220.62  |- skos__prefLabel mesh__D008450 Maximal Midexpiratory Flow Rate
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D008450 2004
% 220.48/220.62  |- skos__altLabel mesh__D008450 MMFR
% 220.48/220.62  |- mesh__publicMeSHNote mesh__D022121
% 220.48/220.62       2001; see CHOLERA VACCINE 1965-2000   
% 220.48/220.62  |- mesh__recordAuthorizer mesh__D022121 sjn
% 220.48/220.62  |- skos__scopeNote mesh__D022121
% 220.48/220.62       Vaccines or candidate vaccines used to prevent infection with VIBRIO CHOLERAE. The original cholera vaccine consisted of killed bacteria, but other kinds of vaccines now exist.%A%    
% 220.48/220.62  |- rdf__type mesh__D022121sskos__Concept
% 220.48/220.62  |- mesh__dateCreated mesh__D022121 2000-06-22
% 220.48/220.62  |- mesh__dateEstablished mesh__D022121 2001-01-01
% 220.48/220.62  |- mesh__recordMaintainer mesh__D022121 ssb
% 220.48/220.62  |- mesh__recordOriginator mesh__D022121 ags
% 220.48/220.62  |- mesh__dateRevised mesh__D022121 2005-06-30
% 220.48/220.62  |- skos__hiddenLabel mesh__D022121 Vaccines, Cholera
% 220.48/220.62  |- skos__prefLabel mesh__D022121 Cholera Vaccines
% 220.48/220.62  |- mesh__historyNote mesh__D022121 2001   
% 220.48/220.62  |- skos__broader mesh__D022121smesh__D001428
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D022121 2006
% 220.48/220.62  |- skos__altLabel mesh__D049069 Endoprotease, ATP-Dependent
% 220.48/220.62  |- skos__altLabel mesh__D049069
% 220.48/220.62       Adenosine Triphosphate-Dependent Proteolytic System
% 220.48/220.62  |- skos__hiddenLabel mesh__D049069 ATP Dependent Endoprotease
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D049069 2005
% 220.48/220.62  |- mesh__historyNote mesh__D049069 2005%28%1981%29%   
% 220.48/220.62  |- skos__altLabel mesh__D049069 ATP-Requiring Protease
% 220.48/220.62  |- skos__hiddenLabel mesh__D049069 Protease, ATP-Requiring
% 220.48/220.62  |- mesh__publicMeSHNote mesh__D049069
% 220.48/220.62       2005; ATP-DEPENDENT PROTEASE was indexed under SERINE ENDOPEPTIDASES and HEAT-SHOCK PROTEINS 1989-2004 %26% under PEPTIDE PEPTIDOHYDROLASES 1981-1988%A%  
% 220.48/220.62  |- skos__hiddenLabel mesh__D049069 ATP Dependent Protease
% 220.48/220.62  |- mesh__recordOriginator mesh__D049069 jmp
% 220.48/220.62  |- skos__scopeNote mesh__D049069
% 220.48/220.62       Proteases that contain proteolytic core domains and ATPase-containing regulatory domains. They are usually comprised of large multi-subunit assemblies. The domains can occur within a single peptide chain or on distinct subunits.%A%    
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D049069 2006
% 220.48/220.62  |- rdf__type mesh__D049069sskos__Concept
% 220.48/220.62  |- skos__altLabel mesh__D049069 ATP-Dependent Protease
% 220.48/220.62  |- skos__historyNote mesh__D049069 Serine Endopeptidases %28%1989-2004%29%
% 220.48/220.62  |- mesh__recordMaintainer mesh__D049069 jmp
% 220.48/220.62  |- skos__historyNote mesh__D049069 Heat-Shock Proteins %28%1989-2004%29%
% 220.48/220.62  |- skos__hiddenLabel mesh__D049069 Endoprotease, ATP Dependent
% 220.48/220.62  |- skos__hiddenLabel mesh__D049069
% 220.48/220.62       Adenosine Triphosphate Dependent Proteolytic System
% 220.48/220.62  |- skos__hiddenLabel mesh__D049069 ATP Dependent Proteases
% 220.48/220.62  |- skos__broader mesh__D049069smesh__D010447
% 220.48/220.62  |- skos__hiddenLabel mesh__D049069 ATP Requiring Protease
% 220.48/220.62  |- mesh__dateCreated mesh__D049069 2004-07-07
% 220.48/220.62  |- skos__historyNote mesh__D049069
% 220.48/220.62       Peptide Peptidohydrolases %28%1981-1988%29%
% 220.48/220.62  |- skos__prefLabel mesh__D049069 ATP-Dependent Proteases
% 220.48/220.62  |- mesh__recordAuthorizer mesh__D049069 sjn
% 220.48/220.62  |- mesh__dateEstablished mesh__D049069 2005-01-01
% 220.48/220.62  |- skos__scopeNote mesh__D013395
% 220.48/220.62       A nonreducing disaccharide composed of GLUCOSE and FRUCTOSE linked via their anomeric carbons. It is obtained commercially from SUGARCANE, sugar beet %28%BETA VULGARIS%29%, and other plants and used extensively as a food and a sweetener.%A%    
% 220.48/220.62  |- skos__prefLabel mesh__D013395 Sucrose
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D013395 2005
% 220.48/220.62  |- mesh__recordAuthorizer mesh__D013395 sjn
% 220.48/220.62  |- rdf__type mesh__D013395sskos__Concept
% 220.48/220.62  |- mesh__dateCreated mesh__D013395 1999-01-01
% 220.48/220.62  |- skos__altLabel mesh__D013395 Saccharose
% 220.48/220.62  |- mesh__dateRevised mesh__D013395 2004-07-07
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D013395 2006
% 220.48/220.62  |- mesh__recordOriginator mesh__D013395 NLM
% 220.48/220.62  |- skos__broader mesh__D013395smesh__D004187
% 220.48/220.62  |- skos__annotation mesh__D013395
% 220.48/220.62       do not confuse with SUCRASE; table sugar is DIETARY SUCROSE; sucrose density gradient is CENTRIFUGATION, DENSITY GRADIENT %26% ignore sucrose%A%  
% 220.48/220.62  |- mesh__recordMaintainer mesh__D013395 ssb
% 220.48/220.62  |- mesh__recordOriginator mesh__D007358 NLM
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D007358 2005
% 220.48/220.62  |- skos__annotation mesh__D007358 specify geog if possible   
% 220.48/220.62  |- skos__scopeNote mesh__D007358
% 220.48/220.62       Insurance providing benefits to cover part or all of the psychiatric care.%A%    
% 220.48/220.62  |- skos__prefLabel mesh__D007358 Insurance, Psychiatric
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D007358 2002
% 220.48/220.62  |- mesh__dateCreated mesh__D007358 1999-01-01
% 220.48/220.62  |- mesh__historyNote mesh__D007358 68   
% 220.48/220.62  |- mesh__publicMeSHNote mesh__D007358 68   
% 220.48/220.62  |- skos__hiddenLabel mesh__D007358 Insurances, Psychiatric
% 220.48/220.62  |- mesh__recordMaintainer mesh__D007358 kle
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D007358 2006
% 220.48/220.62  |- mesh__recordAuthorizer mesh__D007358 sjn
% 220.48/220.62  |- mesh__dateEstablished mesh__D007358 1968-01-01
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D007358 2003
% 220.48/220.62  |- skos__historyNote mesh__D007358 Insurance, Health %28%1966-1967%29%
% 220.48/220.62  |- mesh__dateRevised mesh__D007358 1999-11-03
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D007358 2000
% 220.48/220.62  |- skos__hiddenLabel mesh__D007358 Psychiatric Insurances
% 220.48/220.62  |- rdf__type mesh__D007358sskos__Concept
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D007358 2004
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D007358 2001
% 220.48/220.62  |- skos__hiddenLabel mesh__D007358 Psychiatric Insurance
% 220.48/220.62  |- skos__broader mesh__D007358smesh__D007348
% 220.48/220.62  |- mesh__dateRevised mesh__D018080 2003-07-09
% 220.48/220.62  |- skos__hiddenLabel mesh__D018080 GABA B Receptors
% 220.48/220.62  |- rdf__type mesh__D018080sskos__Concept
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D018080 2004
% 220.48/220.62  |- skos__broader mesh__D018080smesh__D043562
% 220.48/220.62  |- skos__broader mesh__D018080smesh__D018079
% 220.48/220.62  |- mesh__recordMaintainer mesh__D018080 jmp
% 220.48/220.62  |- skos__hiddenLabel mesh__D018080 Receptor, Baclofen
% 220.48/220.62  |- mesh__recordOriginator mesh__D018080 RAZ
% 220.48/220.62  |- skos__altLabel mesh__D018080 Receptors, Baclofen
% 220.48/220.62  |- skos__altLabel mesh__D018080 Baclofen Receptors
% 220.48/220.62  |- mesh__onlineNote mesh__D018080
% 220.48/220.62       use RECEPTORS, GABA-B %28%NM%29% to search BACLOFEN RECEPTORS 1985-93%A%  
% 220.48/220.62  |- skos__hiddenLabel mesh__D018080 GABA B Receptor
% 220.48/220.62  |- mesh__dateEstablished mesh__D018080 1994-01-01
% 220.48/220.62  |- skos__prefLabel mesh__D018080 Receptors, GABA-B
% 220.48/220.62  |- skos__altLabel mesh__D018080 Baclofen Receptor
% 220.48/220.62  |- skos__historyNote mesh__D018080
% 220.48/220.62       Receptors, Cell Surface %28%1981-1984%29%
% 220.48/220.62  |- skos__hiddenLabel mesh__D018080 Receptors, GABA B
% 220.48/220.62  |- skos__annotation mesh__D018080 DF: RECEPT GABA B   
% 220.48/220.62  |- mesh__historyNote mesh__D018080
% 220.48/220.62       94; BACLOFEN RECEPTORS was BACLOFEN RECEPTOR %28%NM%29% 1985-93%A%  
% 220.48/220.62  |- skos__altLabel mesh__D018080 GABA-B Receptor
% 220.48/220.62  |- skos__scopeNote mesh__D018080
% 220.48/220.62       Cell surface proteins which bind GAMMA-AMINOBUTYRIC ACID and influence cells via interactions with G-proteins. GABA-B receptors are pharmacologically characterized by their insensitivity to the blocker bicuculline and sensitivity to the agonist L-baclofen. They are found both presynaptically and postsynaptically, and act variously by inhibition of adenylate cyclase, activation of phospholipase A2, activation of potassium channels, and inactivation of voltage-activated calcium channels.%A%    
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D018080 2005
% 220.48/220.62  |- skos__historyNote mesh__D018080 Receptors, GABA-A %28%1985-1993%29%
% 220.48/220.62  |- skos__altLabel mesh__D018080 GABA-B Receptors
% 220.48/220.62  |- skos__historyNote mesh__D018080 GABA %28%1980-1993%29%
% 220.48/220.62  |- skos__hiddenLabel mesh__D018080 Receptor, GABA-B
% 220.48/220.62  |- mesh__publicMeSHNote mesh__D018080
% 220.48/220.62       94; BACLOFEN RECEPTOR was indexed under RECEPTORS, GABA-BENZODIAZEPINE 1985-93%A%  
% 220.48/220.62  |- mesh__dateCreated mesh__D018080 1993-06-21
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D018080 2006
% 220.48/220.62  |- mesh__recordAuthorizer mesh__D018080 sjn
% 220.48/220.62  |- mesh__recordMaintainer mesh__D004060 exl
% 220.48/220.62  |- skos__historyNote mesh__D004060 Pregnadienediols %28%1974-1979%29%
% 220.48/220.62  |- mesh__dateRevised mesh__D004060 2005-06-30
% 220.48/220.62  |- skos__broader mesh__D004060smesh__D005448
% 220.48/220.62  |- skos__prefLabel mesh__D004060 Diflucortolone
% 220.48/220.62  |- skos__hiddenLabel mesh__D004060 Ro 107614
% 220.48/220.62  |- skos__historyNote mesh__D004060
% 220.48/220.62       Glucocorticoids, Topical %28%1973-1979%29%
% 220.48/220.62  |- skos__historyNote mesh__D004060 Pregnadienes %28%1973%29%
% 220.48/220.62  |- mesh__dateEstablished mesh__D004060 1991-01-01
% 220.48/220.62  |- rdf__type mesh__D004060sskos__Concept
% 220.48/220.62  |- skos__hiddenLabel mesh__D004060 Ro 10 7614
% 220.48/220.62  |- skos__scopeNote mesh__D004060
% 220.48/220.62       A topical glucocorticoid used in various DERMATOSES. It is absorbed through the skin, bound to plasma albumin, and may cause adrenal suppression. It is also administered as the valerate.%A%    
% 220.48/220.62  |- mesh__publicMeSHNote mesh__D004060
% 220.48/220.62       91; was see under FLUOCORTOLONE 1980-90   
% 220.48/220.62  |- skos__historyNote mesh__D004060 Glucocorticoids %28%1967%29%
% 220.48/220.62  |- mesh__recordAuthorizer mesh__D004060 sjn
% 220.48/220.62  |- mesh__dateCreated mesh__D004060 1979-05-30
% 220.48/220.62  |- skos__historyNote mesh__D004060
% 220.48/220.62       Fluocortolone/analogs %26% derivatives %28%1975-1979%29%
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D004060 2006
% 220.48/220.62  |- mesh__historyNote mesh__D004060
% 220.48/220.62       91%28%80%29%; was see under FLUOCORTOLONE 1980-90   
% 220.48/220.62  |- skos__historyNote mesh__D004060 Pregnanes %28%1968-1972%29%
% 220.48/220.62  |- mesh__recordOriginator mesh__D004060 SH
% 220.48/220.62  |- mesh__dateEstablished mesh__D050611 2006-01-01
% 220.48/220.62  |- skos__altLabel mesh__D050611 NPT1 Protein
% 220.48/220.62  |- skos__hiddenLabel mesh__D050611 Ram 1 Receptor
% 220.48/220.62  |- mesh__recordOriginator mesh__D050611 DRC
% 220.48/220.62  |- skos__altLabel mesh__D050611 Amphoteric Virus Receptor GLVR-2
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D050611 2006C
% 220.48/220.62  |- mesh__historyNote mesh__D050611 2006%28%1987%29%   
% 220.48/220.62  |- skos__altLabel mesh__D050611 Amphotropic Murine Leukemia Virus Receptor
% 220.48/220.62  |- skos__hiddenLabel mesh__D050611 Sodium-Phosphate Cotransporter, Pit2
% 220.48/220.62  |- rdf__type mesh__D050611sskos__Concept
% 220.48/220.62  |- skos__altLabel mesh__D050611 Pit1 Sodium-Phosphate Cotransporter
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D050611 2006
% 220.48/220.62  |- skos__altLabel mesh__D050611
% 220.48/220.62       Type III Sodium-Phosphate Cotransporter Proteins
% 220.48/220.62  |- skos__hiddenLabel mesh__D050611 Transporter Proteins, GLVR1
% 220.48/220.62  |- mesh__dateCreated mesh__D050611 2005-06-30
% 220.48/220.62  |- skos__hiddenLabel mesh__D050611 Amphoteric Virus Receptor GLVR 2
% 220.48/220.62  |- skos__altLabel mesh__D050611 Amphotropic MuLV Receptor
% 220.48/220.62  |- skos__scopeNote mesh__D050611
% 220.48/220.62       A family of highly conserved and widely expressed sodium-phosphate cotransporter proteins. They are electrogenic sodium-dependent transporters of phosphate that were originally identified as retroviral receptors in HUMANS and have been described in yeast and many other organisms.%A%    
% 220.48/220.62  |- skos__altLabel mesh__D050611
% 220.48/220.62       Type III Na-Dependent Phosphate Cotransporter
% 220.48/220.62  |- skos__hiddenLabel mesh__D050611
% 220.48/220.62       Sodium Phosphate Cotransporter Proteins, Type III
% 220.48/220.62  |- skos__hiddenLabel mesh__D050611 Sodium-Phosphate Cotransporter, Pit1
% 220.48/220.62  |- skos__altLabel mesh__D050611 Pit2 Sodium-Phosphate Cotransporter
% 220.48/220.62  |- skos__hiddenLabel mesh__D050611
% 220.48/220.62       Type III Na Dependent Phosphate Cotransporter
% 220.48/220.62  |- skos__hiddenLabel mesh__D050611 Pit2 Sodium Phosphate Cotransporter
% 220.48/220.62  |- skos__altLabel mesh__D050611
% 220.48/220.62       Solute Carrier Family 20 %28%Phosphate Transporter%29%, Member 1
% 220.48/220.62  |- skos__broader mesh__D050611smesh__D050608
% 220.48/220.62  |- skos__hiddenLabel mesh__D050611 Cotransporter, Pit2 Sodium-Phosphate
% 220.48/220.62  |- mesh__publicMeSHNote mesh__D050611
% 220.48/220.62       2006; TYPE III NA-DEPENDENT PHOSPHATE COTRANSPORTER; PIT1 SODIUM-DEPENDENT PHOSPHATE SYMPORTER; NPT1 PROTEIN; AMPHOTERIC VIRUS RECEPTOR GLVR-2; AMPHOTROPIC MULV RECEPTOR; AMPHOTROPIC MURINE LEUKEMIA VIRUS RECEPTOR; GLVR-2 RECEPTOR; %26% RAM-1 RECEPTOR were indexed under SYMPORTERS 2001-2005 %26% under CARRIER PROTEINS 1987-2001%A%  
% 220.48/220.62  |- skos__prefLabel mesh__D050611
% 220.48/220.62       Sodium-Phosphate Cotransporter Proteins, Type III
% 220.48/220.62  |- skos__hiddenLabel mesh__D050611 Cotransporter, Pit1 Sodium-Phosphate
% 220.48/220.62  |- skos__historyNote mesh__D050611 Symporters %28%1987-2005%29%
% 220.48/220.62  |- skos__altLabel mesh__D050611
% 220.48/220.62       Type III Sodium-Phosphate Symporter Proteins
% 220.48/220.62  |- mesh__dateRevised mesh__D050611 2005-08-03
% 220.48/220.62  |- skos__hiddenLabel mesh__D050611 Receptor, Ram-1
% 220.48/220.62  |- skos__altLabel mesh__D050611 SLC20A1 Transporter
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D050611 2006A
% 220.48/220.62  |- skos__hiddenLabel mesh__D050611
% 220.48/220.62       Pit2 Sodium Dependent Phosphate Symporter
% 220.48/220.62  |- skos__altLabel mesh__D050611 GLVR1 Transporter Proteins
% 220.48/220.62  |- skos__altLabel mesh__D050611
% 220.48/220.62       Solute Carrier Family 20 %28%Phosphate Transporter%29%, Member 2
% 220.48/220.62  |- skos__hiddenLabel mesh__D050611
% 220.48/220.62       Pit1 Sodium Dependent Phosphate Symporter
% 220.48/220.62  |- mesh__recordAuthorizer mesh__D050611 ags
% 220.48/220.62  |- skos__altLabel mesh__D050611 GLVR-2 Receptor
% 220.48/220.62  |- skos__hiddenLabel mesh__D050611
% 220.48/220.62       Type III Sodium Phosphate Symporter Proteins
% 220.48/220.62  |- mesh__recordMaintainer mesh__D050611 ags
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D050611 2006B
% 220.48/220.62  |- skos__hiddenLabel mesh__D050611 MuLV Receptor, Amphotropic
% 220.48/220.62  |- skos__hiddenLabel mesh__D050611 Pit1 Sodium Phosphate Cotransporter
% 220.48/220.62  |- skos__hiddenLabel mesh__D050611 GLVR 2 Receptor
% 220.48/220.62  |- skos__hiddenLabel mesh__D050611
% 220.48/220.62       Type III Sodium Phosphate Cotransporter Proteins
% 220.48/220.62  |- skos__altLabel mesh__D050611 Ram-1 Receptor
% 220.48/220.62  |- skos__hiddenLabel mesh__D003766 Planes, Occlusal
% 220.48/220.62  |- skos__hiddenLabel mesh__D003766 Guidance, Canine
% 220.48/220.62  |- mesh__historyNote mesh__D003766 65   
% 220.48/220.62  |- skos__related mesh__D003766smesh__D007574
% 220.48/220.62  |- skos__annotation mesh__D003766
% 220.48/220.62       no qualif; MALOCCLUSION %26% its specifics are also available; DF: DENT OCCLUSION%A%  
% 220.48/220.62  |- skos__broader mesh__D003766smesh__D003813
% 220.48/220.62  |- mesh__dateEstablished mesh__D003766 1965-01-01
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D003766 2005
% 220.48/220.62  |- mesh__recordAuthorizer mesh__D003766 SJN
% 220.48/220.62  |- mesh__dateRevised mesh__D003766 1997-06-20
% 220.48/220.62  |- skos__broader mesh__D003766smesh__D009063
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D003766 2006
% 220.48/220.62  |- skos__hiddenLabel mesh__D003766 Guidance, Occlusal
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D003766 2000
% 220.48/220.62  |- skos__hiddenLabel mesh__D003766 Occlusal Planes
% 220.48/220.62  |- skos__related mesh__D003766smesh__D008310
% 220.48/220.62  |- skos__hiddenLabel mesh__D003766 Plane, Occlusal
% 220.48/220.62  |- skos__hiddenLabel mesh__D003766 Dental Occlusions
% 220.48/220.62  |- skos__prefLabel mesh__D003766 Dental Occlusion
% 220.48/220.62  |- skos__altLabel mesh__D003766 Occlusion, Dental
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D003766 1998
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D003766 2001
% 220.48/220.62  |- skos__scopeNote mesh__D003766
% 220.48/220.62       The relationship of all the components of the masticatory system in normal function. It has special reference to the position and contact of the maxillary and mandibular teeth for the highest efficiency during the excursive movements of the jaw that are essential for mastication. %28%From Jablonski, Dictionary of Dentistry, 1992, p556, p472%29%%A%    
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D003766 2003
% 220.48/220.62  |- rdf__type mesh__D003766sskos__Concept
% 220.48/220.62  |- mesh__publicMeSHNote mesh__D003766 65   
% 220.48/220.62  |- skos__hiddenLabel mesh__D003766 Occlusal Guidances
% 220.48/220.62  |- skos__hiddenLabel mesh__D003766 Occlusions, Dental
% 220.48/220.62  |- mesh__dateCreated mesh__D003766 1999-01-01
% 220.48/220.62  |- mesh__recordOriginator mesh__D003766 NLM
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D003766 1999
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D003766 2002
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D003766 2004
% 220.48/220.62  |- mesh__recordMaintainer mesh__D003766 TGC
% 220.48/220.62  |- skos__altLabel mesh__D036142 Peppermint
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D036142 2004
% 220.48/220.62  |- mesh__dateCreated mesh__D036142 2002-07-03
% 220.48/220.62  |- skos__historyNote mesh__D036142 Plant Extracts %28%1973-2002%29%
% 220.48/220.62  |- skos__broader mesh__D036142smesh__D027541
% 220.48/220.62  |- rdf__type mesh__D036142sskos__Concept
% 220.48/220.62  |- mesh__dateEstablished mesh__D036142 2003-01-01
% 220.48/220.62  |- skos__annotation mesh__D036142
% 220.48/220.62       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D036142 2005
% 220.48/220.62  |- mesh__historyNote mesh__D036142
% 220.48/220.62       2003; for PEPPERMINT use MENTHA PIPERITA %28%NM%29% 1973-2002   
% 220.48/220.62  |- skos__prefLabel mesh__D036142 Mentha piperita
% 220.48/220.62  |- skos__scopeNote mesh__D036142
% 220.48/220.62       A plant genus of the family LAMIACEAE that is the source of peppermint oil.%A%    
% 220.48/220.62  |- mesh__publicMeSHNote mesh__D036142
% 220.48/220.62       2003; PEPPERMINT was indexed under PLANT EXTRACTS 1973-2002%A%  
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D036142 2003
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D036142 2006
% 220.48/220.62  |- skos__hiddenLabel mesh__D008451 Capacity, Maximal Breathing
% 220.48/220.62  |- skos__hiddenLabel mesh__D008451 Maximal Breathing Capacities
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D008451 2006
% 220.48/220.62  |- skos__altLabel mesh__D008451 Maximal Breathing Capacity
% 220.48/220.62  |- mesh__dateRevised mesh__D008451 2003-07-09
% 220.48/220.62  |- skos__broader mesh__D008451smesh__D012123
% 220.48/220.62  |- skos__scopeNote mesh__D008451
% 220.48/220.62       Measure of the maximum amount of air that can be breathed in and blown out over a sustained interval such as 15 or 20 seconds. Common abbreviations are MVV and MBC.%A%    
% 220.48/220.62  |- skos__hiddenLabel mesh__D008451 Voluntary Ventilations, Maximal
% 220.48/220.62  |- skos__hiddenLabel mesh__D008451 Breathing Capacity, Maximal
% 220.48/220.62  |- mesh__dateEstablished mesh__D008451 1991-01-01
% 220.48/220.62  |- mesh__historyNote mesh__D008451
% 220.48/220.62       91%28%75%29%; was see under RESPIRATORY AIRFLOW 1975-90   
% 220.48/220.62  |- rdf__type mesh__D008451sskos__Concept
% 220.48/220.62  |- mesh__dateCreated mesh__D008451 1974-12-12
% 220.48/220.62  |- skos__hiddenLabel mesh__D008451 Voluntary Ventilation, Maximal
% 220.48/220.62  |- skos__hiddenLabel mesh__D008451 Ventilation, Maximal Voluntary
% 220.48/220.62  |- skos__hiddenLabel mesh__D008451 Breathing Capacities, Maximal
% 220.48/220.62  |- mesh__recordAuthorizer mesh__D008451 sjn
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D008451 2004
% 220.48/220.62  |- skos__hiddenLabel mesh__D008451 Ventilations, Maximal Voluntary
% 220.48/220.62  |- skos__hiddenLabel mesh__D008451 Capacities, Maximal Breathing
% 220.48/220.62  |- mesh__recordMaintainer mesh__D008451 nns
% 220.48/220.62  |- skos__prefLabel mesh__D008451 Maximal Voluntary Ventilation
% 220.48/220.62  |- skos__altLabel mesh__D008451 MVV %28%Ventilation%29%
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D008451 2005
% 220.48/220.62  |- mesh__recordOriginator mesh__D008451 NLM
% 220.48/220.62  |- mesh__publicMeSHNote mesh__D008451
% 220.48/220.62       91; was see under RESPIRATORY AIRFLOW 1975-90   
% 220.48/220.62  |- skos__annotation mesh__D008451 NIM; DF: MVV   
% 220.48/220.62  |- skos__hiddenLabel mesh__D008451 Maximal Voluntary Ventilations
% 220.48/220.62  |- rdf__type mesh__D022122sskos__Concept
% 220.48/220.62  |- skos__broader mesh__D022122smesh__D001428
% 220.48/220.62  |- mesh__dateEstablished mesh__D022122 2001-01-01
% 220.48/220.62  |- mesh__publicMeSHNote mesh__D022122 2001   
% 220.48/220.62  |- mesh__recordAuthorizer mesh__D022122 sjn
% 220.48/220.62  |- mesh__dateCreated mesh__D022122 2000-06-21
% 220.48/220.62  |- skos__prefLabel mesh__D022122 Anthrax Vaccines
% 220.48/220.62  |- skos__scopeNote mesh__D022122
% 220.48/220.62       Vaccines or candidate vaccines used to prevent ANTHRAX.%A%    
% 220.48/220.62  |- mesh__historyNote mesh__D022122 2001   
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D022122 2006
% 220.48/220.62  |- mesh__recordMaintainer mesh__D022122 ssb
% 220.48/220.62  |- mesh__recordOriginator mesh__D022122 ags
% 220.48/220.62  |- mesh__dateRevised mesh__D022122 2005-06-30
% 220.48/220.62  |- skos__altLabel mesh__D022122 Vaccines, Anthrax
% 220.48/220.62  |- skos__hiddenLabel mesh__D013396 Mechanical Aspirations
% 220.48/220.62  |- skos__hiddenLabel mesh__D013396 Suction Drainages
% 220.48/220.62  |- skos__hiddenLabel mesh__D013396 Suction Drainage
% 220.48/220.62  |- skos__hiddenLabel mesh__D013396 Mechanical Aspiration
% 220.48/220.62  |- skos__annotation mesh__D013396
% 220.48/220.62       NIM; note X ref DRAINAGE, SUCTION: differentiate from DRAINAGE; do not use /util except by MeSH definition; SUCTION LIPECTOMY see LIPECTOMY is available%A%  
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D013396 2001
% 220.48/220.62  |- mesh__recordOriginator mesh__D013396 VDK
% 220.48/220.62  |- skos__hiddenLabel mesh__D013396 Aspirations, Mechanical
% 220.48/220.62  |- skos__altLabel mesh__D013396 Drainage, Suction
% 220.48/220.62  |- skos__prefLabel mesh__D013396 Suction
% 220.48/220.62  |- mesh__publicMeSHNote mesh__D013396 77   
% 220.48/220.62  |- skos__hiddenLabel mesh__D013396 Suctions
% 220.48/220.62  |- mesh__dateRevised mesh__D013396 2005-07-13
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D013396 2000
% 220.48/220.62  |- rdf__type mesh__D013396sskos__Concept
% 220.48/220.62  |- skos__hiddenLabel mesh__D013396 Drainages, Suction
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D013396 2004
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D013396 2006A
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D013396 2006
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D013396 1999
% 220.48/220.62  |- mesh__dateCreated mesh__D013396 1976-05-19
% 220.48/220.62  |- mesh__dateEstablished mesh__D013396 1977-01-01
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D013396 2003
% 220.48/220.62  |- skos__scopeNote mesh__D013396
% 220.48/220.62       The removal of secretions, gas or fluid from hollow or tubular organs or cavities by means of a tube and a device that acts on negative pressure.%A%    
% 220.48/220.62  |- skos__altLabel mesh__D013396 Aspiration, Mechanical
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D013396 2005
% 220.48/220.62  |- mesh__recordMaintainer mesh__D013396 ags
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D013396 1998
% 220.48/220.62  |- mesh__recordAuthorizer mesh__D013396 ags
% 220.48/220.62  |- skos__broader mesh__D013396smesh__D004322
% 220.48/220.62  |- mesh__historyNote mesh__D013396 77   
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D013396 2002
% 220.48/220.62  |- skos__broader mesh__D002056Q000139smesh__D002056
% 220.48/220.62  |- mesh__preferredCombination mesh__D002056Q000139smesh__D002057
% 220.48/220.62  |- rdf__type mesh__D002056Q000139smesh__CompoundConcept
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D007359 2006
% 220.48/220.62  |- skos__hiddenLabel mesh__D007359 Insurances, Surgical
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D007359 2000
% 220.48/220.62  |- skos__hiddenLabel mesh__D007359 Surgical Insurances
% 220.48/220.62  |- skos__prefLabel mesh__D007359 Insurance, Surgical
% 220.48/220.62  |- skos__annotation mesh__D007359
% 220.48/220.62       specify geog if possible; DF: INSURANCE SURG   
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D007359 2003
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D007359 2001
% 220.48/220.62  |- mesh__dateEstablished mesh__D007359 1991-01-01
% 220.48/220.62  |- mesh__historyNote mesh__D007359
% 220.48/220.62       91%28%75%29%; was see under INSURANCE, HEALTH 1975-90   
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D007359 2004
% 220.48/220.62  |- mesh__publicMeSHNote mesh__D007359
% 220.48/220.62       91; was see under INSURANCE, HEALTH 1975-90   
% 220.48/220.62  |- rdf__type mesh__D007359sskos__Concept
% 220.48/220.62  |- mesh__recordOriginator mesh__D007359 NLM
% 220.48/220.62  |- skos__altLabel mesh__D007359 Surgical Insurance
% 220.48/220.62  |- skos__broader mesh__D007359smesh__D007348
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D007359 2002
% 220.48/220.62  |- skos__scopeNote mesh__D007359
% 220.48/220.62       A specific type of health insurance which provides surgeons%27% fees for specified amounts according to the type of surgery listed in the policy.%A%    
% 220.48/220.62  |- mesh__recordMaintainer mesh__D007359 kle
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D007359 2005
% 220.48/220.62  |- mesh__recordAuthorizer mesh__D007359 sjn
% 220.48/220.62  |- mesh__onlineNote mesh__D007359 search INSURANCE, HEALTH 1966-74   
% 220.48/220.62  |- mesh__dateCreated mesh__D007359 1999-01-01
% 220.48/220.62  |- mesh__dateRevised mesh__D007359 1999-11-03
% 220.48/220.62  |- skos__altLabel mesh__D004061 Merck Brand of Diflunisal
% 220.48/220.62  |- mesh__recordAuthorizer mesh__D004061 sjn
% 220.48/220.62  |- skos__broader mesh__D004061smesh__D012461
% 220.48/220.62  |- skos__scopeNote mesh__D004061
% 220.48/220.62       A salicylate derivative and anti-inflammatory analgesic with actions and side effects similar to those of ASPIRIN.%A%    
% 220.48/220.62  |- skos__historyNote mesh__D004061 Salicylic Acids %28%1966-1979%29%
% 220.48/220.62  |- rdf__type mesh__D004061sskos__Concept
% 220.48/220.62  |- mesh__historyNote mesh__D004061
% 220.48/220.62       90%28%80%29%; was see under SALICYLIC ACIDS 1980-89   
% 220.48/220.62  |- mesh__dateRevised mesh__D004061 2005-06-30
% 220.48/220.62  |- skos__hiddenLabel mesh__D004061 Diflunisal Novopharm Brand
% 220.48/220.62  |- skos__altLabel mesh__D004061 Merck Sharp %26% Dohme Brand of Diflunisal
% 220.48/220.62  |- mesh__dateCreated mesh__D004061 1979-05-30
% 220.48/220.62  |- skos__altLabel mesh__D004061 Nu-Pharm Brand of Diflunisal
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D004061 2006
% 220.48/220.62  |- skos__hiddenLabel mesh__D004061 MK647
% 220.48/220.62  |- skos__altLabel mesh__D004061 Cahill May Roberts Brand of Diflunisal
% 220.48/220.62  |- mesh__recordOriginator mesh__D004061 SH
% 220.48/220.62  |- mesh__dateEstablished mesh__D004061 1990-01-01
% 220.48/220.62  |- skos__altLabel mesh__D004061 Novopharm Brand of Diflunisal
% 220.48/220.62  |- skos__altLabel mesh__D004061 Dolobis
% 220.48/220.62  |- skos__altLabel mesh__D004061 Apotex Brand of Diflunisal
% 220.48/220.62  |- skos__hiddenLabel mesh__D004061 Nu Pharm Brand of Diflunisal
% 220.48/220.62  |- mesh__recordMaintainer mesh__D004061 exl
% 220.48/220.62  |- skos__altLabel mesh__D004061 Frosst SA Brand of Diflunisal
% 220.48/220.62  |- mesh__publicMeSHNote mesh__D004061
% 220.48/220.62       90; was see under SALICYLIC ACIDS 1980-89   
% 220.48/220.62  |- skos__altLabel mesh__D004061 Dolocid
% 220.48/220.62  |- skos__prefLabel mesh__D004061 Diflunisal
% 220.48/220.62  |- skos__hiddenLabel mesh__D004061 MK 647
% 220.48/220.62  |- mesh__activeMeSHYear mesh__D050612 2006
% 220.48/220.62  |- skos__prefLabel mesh__D050612 Fatty Acid Transport Proteins
% 220.48/220.62  |- skos__altLabel mesh__D050612 Fatty Acid-Transport Protein
% 220.48/220.62  |- rdf__type mesh__D050612sskos__Concept
% 220.48/220.62  |- skos__historyNote mesh__D050612 Membrane Proteins %28%1997-2004%29%
% 220.48/220.62  |- skos__hiddenLabel mesh__D050612 Fatty Acid Transport Protein
% 220.48/220.63  |- skos__scopeNote mesh__D050612
% 220.48/220.63       A broad category of membrane transport proteins that specifically transport FREE FATTY ACIDS across cellular membranes. They play an important role in LIPID METABOLISM in CELLS that utilize free fatty acids as an energy source.%A%    
% 220.48/220.63  |- mesh__recordOriginator mesh__D050612 jmp
% 220.48/220.63  |- skos__broader mesh__D050612smesh__D026901
% 220.48/220.63  |- mesh__recordAuthorizer mesh__D050612 sjn
% 220.48/220.63  |- skos__historyNote mesh__D050612 Membrane Transport Proteins %28%2005%29%
% 220.48/220.63  |- skos__historyNote mesh__D050612 Carrier Proteins %28%1997-2004%29%
% 220.48/220.63  |- mesh__dateEstablished mesh__D050612 2006-01-01
% 220.48/220.63  |- mesh__recordMaintainer mesh__D050612 jmp
% 220.48/220.63  |- mesh__publicMeSHNote mesh__D050612
% 220.48/220.63       2006; FATTY ACID TRANSPORT PROTEINS was indexed under MEMBRANE TRANSPORT PROTEINS 2005, MEMBRANE PROTEINS %26% CARRIER PROTEINS 1997-2004%A%  
% 220.48/220.63  |- mesh__dateCreated mesh__D050612 2005-06-30
% 220.48/220.63  |- mesh__historyNote mesh__D050612 2006%28%1997%29%   
% 220.48/220.63  |- rdf__type mesh__D036941sskos__Concept
% 220.48/220.63  |- mesh__dateEstablished mesh__D036941 2003-01-01
% 220.48/220.63  |- mesh__historyNote mesh__D036941 2003   
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D036941 2005
% 220.48/220.63  |- skos__prefLabel mesh__D036941 Peperomia
% 220.48/220.63  |- skos__broader mesh__D036941smesh__D026321
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D036941 2006
% 220.48/220.63  |- skos__scopeNote mesh__D036941
% 220.48/220.63       A plant genus of the family PIPERACEAE. Members contain prenylated quinones.%A%    
% 220.48/220.63  |- skos__annotation mesh__D036941
% 220.48/220.63       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D036941 2003
% 220.48/220.63  |- mesh__publicMeSHNote mesh__D036941 2003   
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D036941 2004
% 220.48/220.63  |- mesh__dateCreated mesh__D036941 2002-07-03
% 220.48/220.63  |- mesh__recordOriginator mesh__D003767 NLM
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003767 2002
% 220.48/220.63  |- skos__hiddenLabel mesh__D003767 Dental Occlusions, Balanced
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003767 2006
% 220.48/220.63  |- skos__annotation mesh__D003767 DF: DENT OCCLUSION BALANCED   
% 220.48/220.63  |- skos__hiddenLabel mesh__D003767 Occlusions, Balanced Dental
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003767 1997
% 220.48/220.63  |- skos__altLabel mesh__D003767 Occlusion, Balanced Dental
% 220.48/220.63  |- mesh__dateEstablished mesh__D003767 1965-01-01
% 220.48/220.63  |- skos__related mesh__D003767smesh__D019558
% 220.48/220.63  |- skos__hiddenLabel mesh__D003767 Balanced Dental Occlusions
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003767 1998
% 220.48/220.63  |- skos__broader mesh__D003767smesh__D003766
% 220.48/220.63  |- rdf__type mesh__D003767sskos__Concept
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003767 2003
% 220.48/220.63  |- skos__scopeNote mesh__D003767
% 220.48/220.63       Dental occlusion in which the occlusal contact of the teeth on the working side of the jaw is accompanied by the harmonious contact of the teeth on the opposite %28%balancing%29% side. %28%From Jablonski, Dictionary of Dentistry, 1992, p556%29%%A%    
% 220.48/220.63  |- skos__prefLabel mesh__D003767 Dental Occlusion, Balanced
% 220.48/220.63  |- mesh__dateRevised mesh__D003767 1996-06-13
% 220.48/220.63  |- mesh__dateCreated mesh__D003767 1999-01-01
% 220.48/220.63  |- skos__altLabel mesh__D003767 Balanced Dental Occlusion
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003767 2000
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003767 1999
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003767 2004
% 220.48/220.63  |- mesh__recordMaintainer mesh__D003767 JLS
% 220.48/220.63  |- mesh__historyNote mesh__D003767 65   
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003767 2001
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003767 2005
% 220.48/220.63  |- mesh__recordAuthorizer mesh__D003767 PLS
% 220.48/220.63  |- mesh__publicMeSHNote mesh__D003767 65   
% 220.48/220.63  |- skos__broader mesh__D036143smesh__D036081
% 220.48/220.63  |- mesh__dateRevised mesh__D036143 2005-06-30
% 220.48/220.63  |- skos__altLabel mesh__D036143 EphA8 Receptor
% 220.48/220.63  |- rdf__type mesh__D036143sskos__Concept
% 220.48/220.63  |- skos__prefLabel mesh__D036143 Receptor, EphA8
% 220.48/220.63  |- mesh__recordMaintainer mesh__D036143 jmp
% 220.48/220.63  |- skos__hiddenLabel mesh__D036143 ELK Related Kinase
% 220.48/220.63  |- mesh__dateCreated mesh__D036143 2002-07-03
% 220.48/220.63  |- skos__altLabel mesh__D036143 eph- and elk-Related Kinase
% 220.48/220.63  |- skos__altLabel mesh__D036143 ELK-Related Kinase
% 220.48/220.63  |- mesh__recordOriginator mesh__D036143 jmp
% 220.48/220.63  |- skos__altLabel mesh__D036143 EphA8 Protein
% 220.48/220.63  |- skos__hiddenLabel mesh__D036143 eph  and elk Related Kinase
% 220.48/220.63  |- mesh__dateEstablished mesh__D036143 2003-01-01
% 220.48/220.63  |- skos__scopeNote mesh__D036143
% 220.48/220.63       An eph family receptor found exclusively in BRAIN. EphA8 receptors may play a role in the axonal guidance of a subset of tectal commissural NEURONS.%A%    
% 220.48/220.63  |- mesh__historyNote mesh__D036143
% 220.48/220.63       2003; use RECEPTOR, EPHA8  %28%NM%29% 1991-2002   
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D036143 2006
% 220.48/220.63  |- mesh__publicMeSHNote mesh__D036143
% 220.48/220.63       2003; EEK PROTEIN %28%now RECEPTOR, EPHA8 %29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1991-2002; EPHA8 PROTEIN %28%now RECEPTOR, EPHA8%29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 2002-2002%A%  
% 220.48/220.63  |- mesh__recordAuthorizer mesh__D036143 sjn
% 220.48/220.63  |- skos__hiddenLabel mesh__D036143 Kinase, ELK-Related
% 220.48/220.63  |- mesh__dateRevised mesh__D022921 2005-06-30
% 220.48/220.63  |- skos__altLabel mesh__D022921 Book Reviews %28%PT%29%
% 220.48/220.63  |- mesh__dateCreated mesh__D022921 2000-03-31
% 220.48/220.63  |- rdf__type mesh__D022921sskos__Concept
% 220.48/220.63  |- skos__prefLabel mesh__D022921 Book Reviews %5B%Publication Type%5D%
% 220.48/220.63  |- skos__scopeNote mesh__D022921
% 220.48/220.63       Works consisting of critical analyses of books or other monographic works.%A%    
% 220.48/220.63  |- mesh__recordOriginator mesh__D022921 jls
% 220.48/220.63  |- skos__broader mesh__D022921smesh__D052180
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D022921 2006
% 220.48/220.63  |- mesh__recordMaintainer mesh__D022921 jls
% 220.48/220.63  |- mesh__dateEstablished mesh__D022921 2000-03-31
% 220.48/220.63  |- skos__annotation mesh__D022921 used by collaborating partners only   
% 220.48/220.63  |- mesh__recordAuthorizer mesh__D022921 sjn
% 220.48/220.63  |- mesh__historyNote mesh__D022921 2000   
% 220.48/220.63  |- skos__hiddenLabel mesh__D008452 Concentrations, Maximum Allowable
% 220.48/220.63  |- mesh__publicMeSHNote mesh__D008452
% 220.48/220.63       1991; see MAXIMUM PERMISSIBLE EXPOSURE LEVEL 1991-1999, see ENVIRONMENTAL EXPOSURE 1975-1990; for MAXIMUM ALLOWABLE CONCENTRATION see MAXIMUM PERMISSIBLE EXPOSURE LEVEL 1976-1999%A%  
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D008452 2003
% 220.48/220.63  |- skos__historyNote mesh__D008452
% 220.48/220.63       appropriate environment heading %28%1966-1968%29%
% 220.48/220.63  |- skos__hiddenLabel mesh__D008452 Allowable Concentration, Maximum
% 220.48/220.63  |- mesh__dateEstablished mesh__D008452 1991-01-01
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D008452 2000
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D008452 2000A
% 220.48/220.63  |- mesh__dateRevised mesh__D008452 1999-12-16
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D008452 2004
% 220.48/220.63  |- skos__prefLabel mesh__D008452 Maximum Allowable Concentration
% 220.48/220.63  |- skos__historyNote mesh__D008452 Environmental Health %28%1966-1968%29%
% 220.48/220.63  |- mesh__recordOriginator mesh__D008452 NLM
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D008452 2000B
% 220.48/220.63  |- skos__altLabel mesh__D008452 MPEL
% 220.48/220.63  |- skos__hiddenLabel mesh__D008452 Allowable Concentrations, Maximum
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D008452 2001
% 220.48/220.63  |- skos__annotation mesh__D008452
% 220.48/220.63       NIM; no qualif; coord NIM with specific drug or substance %28%IM without qualif%29%; DF: MPEL%A%  
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D008452 2005
% 220.48/220.63  |- skos__altLabel mesh__D008452 Maximum Permissible Exposure Concentration
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D008452 2002
% 220.48/220.63  |- skos__scopeNote mesh__D008452
% 220.48/220.63       The maximum exposure to a biologically active physical or chemical agent that is allowed during an 8-hour period %28%a workday%29% in a population of workers, or during a 24-hour period in the general population, which does not appear to cause appreciable harm, whether immediate or delayed for any period, in the target population. %28%From Lewis Dictionary of Toxicology, 1st ed%29%%A%    
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D008452 2006
% 220.48/220.63  |- mesh__historyNote mesh__D008452 2000%28%1991%29%   
% 220.48/220.63  |- skos__historyNote mesh__D008452 specific agent %28%1966-1968%29%
% 220.48/220.63  |- skos__altLabel mesh__D008452 Maximum Permissible Exposure Level
% 220.48/220.63  |- mesh__dateCreated mesh__D008452 1999-01-01
% 220.48/220.63  |- skos__hiddenLabel mesh__D008452 MPELs
% 220.48/220.63  |- skos__broader mesh__D008452smesh__D016273
% 220.48/220.63  |- skos__broader mesh__D008452smesh__D004781
% 220.48/220.63  |- skos__hiddenLabel mesh__D008452 Maximum Allowable Concentrations
% 220.48/220.63  |- rdf__type mesh__D008452sskos__Concept
% 220.48/220.63  |- skos__hiddenLabel mesh__D008452 Concentration, Maximum Allowable
% 220.48/220.63  |- mesh__recordMaintainer mesh__D008452 ags
% 220.48/220.63  |- mesh__recordAuthorizer mesh__D008452 sjn
% 220.48/220.63  |- mesh__dateCreated mesh__D022123 2000-06-22
% 220.48/220.63  |- mesh__dateEstablished mesh__D022123 2001-01-01
% 220.48/220.63  |- skos__scopeNote mesh__D022123
% 220.48/220.63       Vaccines or candidate vaccines used to prevent LYME DISEASE.%A%    
% 220.48/220.63  |- mesh__recordMaintainer mesh__D022123 ssb
% 220.48/220.63  |- mesh__recordOriginator mesh__D022123 ags
% 220.48/220.63  |- skos__historyNote mesh__D022123 Bacterial Vaccines %28%1992-2000%29%
% 220.48/220.63  |- mesh__dateRevised mesh__D022123 2005-06-30
% 220.48/220.63  |- mesh__historyNote mesh__D022123 2001   
% 220.48/220.63  |- skos__altLabel mesh__D022123 Vaccines, Lyme Disease
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D022123 2006
% 220.48/220.63  |- skos__broader mesh__D022123smesh__D001428
% 220.48/220.63  |- rdf__type mesh__D022123sskos__Concept
% 220.48/220.63  |- mesh__publicMeSHNote mesh__D022123 2001   
% 220.48/220.63  |- mesh__recordAuthorizer mesh__D022123 sjn
% 220.48/220.63  |- skos__prefLabel mesh__D022123 Lyme Disease Vaccines
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D013397 2002
% 220.48/220.63  |- mesh__recordAuthorizer mesh__D013397 PLS
% 220.48/220.63  |- rdf__type mesh__D013397sskos__Concept
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D013397 1997
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D013397 2004
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D013397 2001
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D013397 1999
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D013397 2006
% 220.48/220.63  |- skos__scopeNote mesh__D013397
% 220.48/220.63       A republic in eastern Africa, south of EGYPT and west of ETHIOPIA. Its capital is Khartoum. It was under Egypt 1820-82, then jointly administered by Egypt and Great Britain after 1899 as the Anglo-Egyptian Sudan. It gained independence in 1956. The name is of Arabic origin, balad as-sudan: bal %28%land%29% + al %28%as%29% %28%the%29% + sudan %28%black%29%, the land of the blacks, the name given originally by Arabian travelers. %28%From Webster%27%s New Geographical Dictionary, 1988, p1161 %26% Room, Brewer%27%s Dictionary of Names, 1992, p524%29%%A%    
% 220.48/220.63  |- mesh__recordOriginator mesh__D013397 NLM
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D013397 1996
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D013397 2003
% 220.48/220.63  |- mesh__dateRevised mesh__D013397 1995-02-21
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D013397 1998
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D013397 2005
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D013397 2000
% 220.48/220.63  |- skos__annotation mesh__D013397
% 220.48/220.63       a republic in eastern Africa, formerly the Anglo-Egyptian Sudan%A%  
% 220.48/220.63  |- mesh__dateCreated mesh__D013397 1999-01-01
% 220.48/220.63  |- skos__prefLabel mesh__D013397 Sudan
% 220.48/220.63  |- mesh__recordMaintainer mesh__D013397 TGC
% 220.48/220.63  |- skos__broader mesh__D013397smesh__D000351
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Ectopic Beats, Atrial
% 220.48/220.63  |- mesh__dateEstablished mesh__D018880 1996-01-01
% 220.48/220.63  |- skos__altLabel mesh__D018880 Premature Atrial Beats
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Premature Complexes, Atrial
% 220.48/220.63  |- skos__scopeNote mesh__D018880
% 220.48/220.63       Premature contractions of the heart arising from an ectopic atrial focus. With ventricular premature complexes, they represent one of the most common causes of irregular pulse. They are more apt to occur if there is atrial or conduction system disease such as left atrial enlargement in mitral stenosis. In community prospective studies, atrial premature complexes are not related to sudden death, as are ventricular premature beats in coronary disease. %28%From Stedman, 25th ed; Braunwald, Heart Disease, 4th ed, p679; Sokolow, et al., Clinical Cardiology, 5th ed, p472%29%%A%    
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Contractions, Premature Atrial
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D018880 2004
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Extrasystoles, Atrial
% 220.48/220.63  |- skos__annotation mesh__D018880 a type of arrhythmia   
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Supraventricular Beats, Premature
% 220.48/220.63  |- mesh__recordAuthorizer mesh__D018880 sjn
% 220.48/220.63  |- skos__altLabel mesh__D018880 Extrasystole, Atrial
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Beats, Premature Atrial
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Atrial Beat, Premature
% 220.48/220.63  |- skos__altLabel mesh__D018880 Premature Atrial Contractions
% 220.48/220.63  |- skos__prefLabel mesh__D018880 Atrial Premature Complexes
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Supraventricular Beat, Premature
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Complices, Atrial Premature
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D018880 2002
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D018880 2003
% 220.48/220.63  |- mesh__recordOriginator mesh__D018880 TGC
% 220.48/220.63  |- skos__altLabel mesh__D018880 Premature Atrial Complex
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Complexes, Atrial Premature
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Atrial Premature Complices
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Premature Atrial Contraction
% 220.48/220.63  |- mesh__historyNote mesh__D018880 96   
% 220.48/220.63  |- mesh__dateCreated mesh__D018880 1995-06-08
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Atrial Beats, Premature
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Complex, Premature Atrial
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Atrial Extrasystoles
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Contraction, Premature Atrial
% 220.48/220.63  |- skos__broader mesh__D018880smesh__D005117
% 220.48/220.63  |- skos__historyNote mesh__D018880
% 220.48/220.63       Cardiac Complexes, Premature %28%1967-1995%29%
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Atrial Complices, Premature
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Atrial Contractions, Premature
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Premature Atrial Complices
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D018880 2006
% 220.48/220.63  |- skos__altLabel mesh__D018880 Atrial Ectopic Beats
% 220.48/220.63  |- rdf__type mesh__D018880sskos__Concept
% 220.48/220.63  |- skos__altLabel mesh__D018880 Premature Supraventricular Beats
% 220.48/220.63  |- mesh__dateRevised mesh__D018880 1999-11-03
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Beat, Premature Atrial
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Premature Atrial Beat
% 220.48/220.63  |- skos__altLabel mesh__D018880 Complex, Atrial Premature
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Atrial Contraction, Premature
% 220.48/220.63  |- mesh__recordMaintainer mesh__D018880 MCC
% 220.48/220.63  |- skos__altLabel mesh__D018880 Atrial Premature Complex
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Beats, Premature Supraventricular
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Premature Complices, Atrial
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D018880 2001
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Beats, Atrial Ectopic
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D018880 2005
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Beat, Premature Supraventricular
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Complices, Premature Atrial
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Ectopic Beat, Atrial
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Atrial Extrasystole
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Beat, Atrial Ectopic
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D018880 2000
% 220.48/220.63  |- mesh__publicMeSHNote mesh__D018880 96   
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Atrial Ectopic Beat
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Atrial Complex, Premature
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Premature Supraventricular Beat
% 220.48/220.63  |- skos__hiddenLabel mesh__D018880 Premature Complex, Atrial
% 220.48/220.63  |- skos__hiddenLabel mesh__D018082 Kringle
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D018082 2005
% 220.48/220.63  |- skos__hiddenLabel mesh__D018082 Domain, Kringle
% 220.48/220.63  |- mesh__recordMaintainer mesh__D018082 nns
% 220.48/220.63  |- skos__hiddenLabel mesh__D018082 Kringle Domain
% 220.48/220.63  |- mesh__dateEstablished mesh__D018082 1994-01-01
% 220.48/220.63  |- mesh__recordOriginator mesh__D018082 PXP
% 220.48/220.63  |- mesh__recordAuthorizer mesh__D018082 sjn
% 220.48/220.63  |- mesh__onlineNote mesh__D018082
% 220.48/220.63       use PEPTIDE FRAGMENTS %28%NM%29% to search KRINGLES 1980-93   
% 220.48/220.63  |- mesh__dateCreated mesh__D018082 1993-06-03
% 220.48/220.63  |- mesh__publicMeSHNote mesh__D018082
% 220.48/220.63       94; KRINGLES was indexed under PEPTIDE FRAGMENTS 1980-93   
% 220.48/220.63  |- mesh__dateRevised mesh__D018082 2004-07-07
% 220.48/220.63  |- skos__prefLabel mesh__D018082 Kringles
% 220.48/220.63  |- skos__historyNote mesh__D018082 Amino Acid Sequence %28%1981-1993%29%
% 220.48/220.63  |- skos__scopeNote mesh__D018082
% 220.48/220.63       Triple-looped protein domains linked by disulfide bonds. These common structural domains, so-named for their resemblance to Danish pastries known as kringlers, play a role in binding membranes, proteins, and phospholipids as well as in regulating proteolysis. Kringles are also present in coagulation-related and fibrinolytic proteins and other plasma proteinases.%A%    
% 220.48/220.63  |- skos__historyNote mesh__D018082 Peptide Fragments %28%1980-1993%29%
% 220.48/220.63  |- mesh__historyNote mesh__D018082 94; was KRINGLES %28%NM%29% 1980-93   
% 220.48/220.63  |- skos__hiddenLabel mesh__D018082 Domains, Kringle
% 220.48/220.63  |- skos__altLabel mesh__D018082 Kringle Domains
% 220.48/220.63  |- skos__broader mesh__D018082smesh__D017434
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D018082 2006
% 220.48/220.63  |- rdf__type mesh__D018082sskos__Concept
% 220.48/220.63  |- skos__hiddenLabel mesh__D004860 Swamp Fever Viruses
% 220.48/220.63  |- skos__altLabel mesh__D004860 Swamp Fever Virus
% 220.48/220.63  |- mesh__dateRevised mesh__D004860 2001-07-25
% 220.48/220.63  |- rdf__type mesh__D004860sskos__Concept
% 220.48/220.63  |- mesh__historyNote mesh__D004860
% 220.48/220.63       94; was EQUINE INFECTIOUS ANEMIA VIRUS 1963-93   
% 220.48/220.63  |- skos__prefLabel mesh__D004860 Infectious Anemia Virus, Equine
% 220.48/220.63  |- mesh__recordAuthorizer mesh__D004860 sjn
% 220.48/220.63  |- mesh__onlineNote mesh__D004860
% 220.48/220.63       use INFECTIOUS ANEMIA VIRUS, EQUINE to search EQUINE INFECTIOUS ANEMIA VIRUS 1966-93%A%  
% 220.48/220.63  |- skos__altLabel mesh__D004860 EIAV
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D004860 2003
% 220.48/220.63  |- skos__scopeNote mesh__D004860
% 220.48/220.63       A species of LENTIVIRUS, subgenus equine lentiviruses %28%LENTIVIRUSES, EQUINE%29%, causing acute and chronic infection in horses. It is transmitted mechanically by biting flies, mosquitoes, and midges, and iatrogenically through unsterilized equipment. Chronic infection often consists of acute episodes with remissions.%A%    
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D004860 2005
% 220.48/220.63  |- mesh__recordMaintainer mesh__D004860 ags
% 220.48/220.63  |- skos__annotation mesh__D004860
% 220.48/220.63       infection = EQUINE INFECTIOUS ANEMIA; DF: note short X ref%A%  
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D004860 2004
% 220.48/220.63  |- mesh__dateCreated mesh__D004860 1999-01-01
% 220.48/220.63  |- skos__altLabel mesh__D004860 Equine infectious anemia virus
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D004860 2006
% 220.48/220.63  |- skos__broader mesh__D004860smesh__D017961
% 220.48/220.63  |- mesh__publicMeSHNote mesh__D004860
% 220.48/220.63       94; was EQUINE INFECTIOUS ANEMIA VIRUS 1963-93   
% 220.48/220.63  |- mesh__recordOriginator mesh__D004860 NLM
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D004860 2002
% 220.48/220.63  |- skos__altLabel mesh__D004062 Chromosome 22q11.2 Deletion Syndrome
% 220.48/220.63  |- skos__historyNote mesh__D004062 Parathyroid Glands %28%1966-1976%29%
% 220.48/220.63  |- mesh__historyNote mesh__D004062
% 220.48/220.63       91%28%77%29%; was see under IMMUNOLOGIC DEFICIENCY SYNDROMES 1977-90%A%  
% 220.48/220.63  |- mesh__recordMaintainer mesh__D004062 lkt
% 220.48/220.63  |- skos__broader mesh__D004062smesh__D000013
% 220.48/220.63  |- mesh__recordOriginator mesh__D004062 MM
% 220.48/220.63  |- mesh__recordAuthorizer mesh__D004062 sjn
% 220.48/220.63  |- skos__altLabel mesh__D004062 Velo-Cardio-Facial Syndrome
% 220.48/220.63  |- skos__altLabel mesh__D004062 Hypoplasia of Thymus and Parathyroids
% 220.48/220.63  |- skos__hiddenLabel mesh__D004062 Velo Cardio Facial Syndrome
% 220.48/220.63  |- skos__broader mesh__D004062smesh__D007153
% 220.48/220.63  |- skos__prefLabel mesh__D004062 DiGeorge Syndrome
% 220.48/220.63  |- rdf__type mesh__D004062sskos__Concept
% 220.48/220.63  |- skos__scopeNote mesh__D004062
% 220.48/220.63       Congenital syndrome characterized by a spectrum of malformations including the absence of the THYMUS and PARATHYROID GLANDS resulting in T-cell immunodeficiency and HYPOCALCEMIA. Other features include defects in the outflow tract of the HEART and craniofacial anomalies %28%velocardiofacial syndrome%29%. Most cases result from a deletion of chromosome 21q11.2 or mutation in the TBX1 gene.%A%    
% 220.48/220.63  |- skos__hiddenLabel mesh__D004062 Syndrome, Velo-Cardio-Facial
% 220.48/220.63  |- mesh__dateCreated mesh__D004062 1976-04-16
% 220.48/220.63  |- mesh__dateEstablished mesh__D004062 1991-01-01
% 220.48/220.63  |- mesh__publicMeSHNote mesh__D004062
% 220.48/220.63       91; was see under IMMUNOLOGIC DEFICIENCY SYNDROMES 1977-90%A%  
% 220.48/220.63  |- skos__historyNote mesh__D004062 Thymus Gland %28%1966-1976%29%
% 220.48/220.63  |- mesh__dateRevised mesh__D004062 2005-06-30
% 220.48/220.63  |- skos__hiddenLabel mesh__D004062 Syndrome, DiGeorge
% 220.48/220.63  |- skos__broader mesh__D004062smesh__D007011
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D004062 2006
% 220.48/220.63  |- skos__hiddenLabel mesh__D004062 Syndrome, Velocardiofacial
% 220.48/220.63  |- skos__historyNote mesh__D017788 Plant Viruses %28%1976-1993%29%
% 220.48/220.63  |- mesh__publicMeSHNote mesh__D017788 94   
% 220.48/220.63  |- skos__broader mesh__D017788smesh__D012328
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D017788 2004
% 220.48/220.63  |- skos__hiddenLabel mesh__D017788 Carlaviruses
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D017788 2006
% 220.48/220.63  |- rdf__type mesh__D017788sskos__Concept
% 220.48/220.63  |- mesh__dateRevised mesh__D017788 2001-07-25
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D017788 2003
% 220.48/220.63  |- mesh__recordAuthorizer mesh__D017788 sjn
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D017788 2005
% 220.48/220.63  |- mesh__dateCreated mesh__D017788 1993-06-04
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D017788 2002
% 220.48/220.63  |- skos__broader mesh__D017788smesh__D010942
% 220.48/220.63  |- skos__annotation mesh__D017788 coord IM with specific plant /virol   
% 220.48/220.63  |- mesh__dateEstablished mesh__D017788 1994-01-01
% 220.48/220.63  |- mesh__recordMaintainer mesh__D017788 ags
% 220.48/220.63  |- skos__scopeNote mesh__D017788
% 220.48/220.63       A genus of RNA plant viruses, with unassigned family, containing slightly flexuous filaments, often transmitted by aphids in a non-persistent manner. Carnation latent virus is the type species.%A%    
% 220.48/220.63  |- mesh__recordOriginator mesh__D017788 AGS
% 220.48/220.63  |- skos__prefLabel mesh__D017788 Carlavirus
% 220.48/220.63  |- mesh__historyNote mesh__D017788 94   
% 220.48/220.63  |- skos__broader mesh__D042181smesh__D020579
% 220.48/220.63  |- mesh__publicMeSHNote mesh__D042181 2004   
% 220.48/220.63  |- mesh__recordOriginator mesh__D042181 ags
% 220.48/220.63  |- mesh__recordAuthorizer mesh__D042181 sjn
% 220.48/220.63  |- mesh__dateRevised mesh__D042181 2005-06-30
% 220.48/220.63  |- mesh__dateEstablished mesh__D042181 2004-01-01
% 220.48/220.63  |- mesh__historyNote mesh__D042181 2004   
% 220.48/220.63  |- skos__scopeNote mesh__D042181
% 220.48/220.63       A species of gram-negative, aerobic bacteria that is a fast-growing and soybean-nodulating innoculant.%A%    
% 220.48/220.63  |- mesh__dateCreated mesh__D042181 2003-07-09
% 220.48/220.63  |- skos__historyNote mesh__D042181 Sinorhizobium %28%1999-2003%29%
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D042181 2006
% 220.48/220.63  |- skos__prefLabel mesh__D042181 Sinorhizobium fredii
% 220.48/220.63  |- mesh__recordMaintainer mesh__D042181 SYSTEM
% 220.48/220.63  |- rdf__type mesh__D042181sskos__Concept
% 220.48/220.63  |- skos__altLabel mesh__D050613 NPTIIa Transporter Proteins
% 220.48/220.63  |- skos__hiddenLabel mesh__D050613
% 220.48/220.63       Sodium Phosphate Cotransporter Proteins, Type IIa
% 220.48/220.63  |- skos__prefLabel mesh__D050613
% 220.48/220.63       Sodium-Phosphate Cotransporter Proteins, Type IIa
% 220.48/220.63  |- skos__scopeNote mesh__D050613
% 220.48/220.63       An electrogenic sodium-dependent phosphate transporter. It is present primarily in BRUSH BORDER membranes of PROXIMAL RENAL TUBULES.%A%    
% 220.48/220.63  |- skos__hiddenLabel mesh__D050613
% 220.48/220.63       Type IIa Sodium Phosphate Symporter Proteins
% 220.48/220.63  |- skos__broader mesh__D050613smesh__D050610
% 220.48/220.63  |- mesh__recordAuthorizer mesh__D050613 sjn
% 220.48/220.63  |- skos__hiddenLabel mesh__D050613
% 220.48/220.63       Type IIa Sodium Phosphate Cotransporter Proteins
% 220.48/220.63  |- mesh__dateEstablished mesh__D050613 2006-01-01
% 220.48/220.63  |- mesh__recordOriginator mesh__D050613 DRC
% 220.48/220.63  |- skos__hiddenLabel mesh__D050613 Transporter Proteins, NPTIIa
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D050613 2006
% 220.48/220.63  |- mesh__recordMaintainer mesh__D050613 DRC
% 220.48/220.63  |- skos__altLabel mesh__D050613
% 220.48/220.63       Type IIa Sodium-Phosphate Cotransporter Proteins
% 220.48/220.63  |- mesh__dateCreated mesh__D050613 2005-06-30
% 220.48/220.63  |- skos__altLabel mesh__D050613
% 220.48/220.63       Type IIa Sodium-Phosphate Symporter Proteins
% 220.48/220.63  |- mesh__historyNote mesh__D050613 2006%28%2004%29%   
% 220.48/220.63  |- mesh__publicMeSHNote mesh__D050613
% 220.48/220.63       2006; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIa was indexed under SYMPORTERS 2004-2005%A%  
% 220.48/220.63  |- rdf__type mesh__D050613sskos__Concept
% 220.48/220.63  |- mesh__dateRevised mesh__D003768 1992-05-14
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003768 2000
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003768 1998
% 220.48/220.63  |- rdf__type mesh__D003768sskos__Concept
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003768 2003
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003768 1993
% 220.48/220.63  |- skos__annotation mesh__D003768 DF: DENT OCCLUSION CENTRIC   
% 220.48/220.63  |- mesh__dateCreated mesh__D003768 1999-01-01
% 220.48/220.63  |- skos__altLabel mesh__D003768 Centric Dental Occlusion
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003768 2001
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003768 1999
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003768 2004
% 220.48/220.63  |- mesh__publicMeSHNote mesh__D003768 65   
% 220.48/220.63  |- mesh__recordAuthorizer mesh__D003768 PLS
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003768 1994
% 220.48/220.63  |- mesh__recordOriginator mesh__D003768 NLM
% 220.48/220.63  |- mesh__historyNote mesh__D003768 65   
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003768 2002
% 220.48/220.63  |- mesh__dateEstablished mesh__D003768 1965-01-01
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003768 2005
% 220.48/220.63  |- mesh__recordMaintainer mesh__D003768 TAP
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003768 1995
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003768 1996
% 220.48/220.63  |- skos__prefLabel mesh__D003768 Dental Occlusion, Centric
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003768 2006
% 220.48/220.63  |- skos__altLabel mesh__D003768 Occlusion, Centric Dental
% 220.48/220.63  |- skos__broader mesh__D003768smesh__D003766
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D003768 1997
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D014490 2002
% 220.48/220.63  |- skos__broader mesh__D014490smesh__D006077
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D014490 2004
% 220.48/220.63  |- mesh__historyNote mesh__D014490 68   
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D014490 2005
% 220.48/220.63  |- mesh__dateRevised mesh__D014490 1997-06-20
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D014490 2003
% 220.48/220.63  |- skos__historyNote mesh__D014490 Government %28%1966-1967%29%
% 220.48/220.63  |- skos__altLabel mesh__D014490 Office of Economic Opportunity
% 220.48/220.63  |- mesh__recordAuthorizer mesh__D014490 SJN
% 220.48/220.63  |- mesh__recordOriginator mesh__D014490 NLM
% 220.48/220.63  |- mesh__dateCreated mesh__D014490 1999-01-01
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D014490 2001
% 220.48/220.63  |- skos__annotation mesh__D014490
% 220.48/220.63       add UNITED STATES %28%NIM%29%; research support by this agency is checked as OTHER US GOVT SUP; DF: OEO      CATALOG: use NAF entry%A%  
% 220.48/220.63  |- rdf__type mesh__D014490sskos__Concept
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D014490 1999
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D014490 2000
% 220.48/220.63  |- mesh__publicMeSHNote mesh__D014490 68   
% 220.48/220.63  |- mesh__dateEstablished mesh__D014490 1968-01-01
% 220.48/220.63  |- skos__altLabel mesh__D014490 Office of Economic Opportunity %28%U.S.%29%
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D014490 1998
% 220.48/220.63  |- mesh__recordMaintainer mesh__D014490 PXP
% 220.48/220.63  |- skos__prefLabel mesh__D014490
% 220.48/220.63       United States Office of Economic Opportunity
% 220.48/220.63  |- skos__scopeNote mesh__D014490
% 220.48/220.63       A division of the Executive Branch of the United States government concerned with overall planning, promoting, and administering programs relative to the provision of opportunities for economic advancement.%A%    
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D014490 2006
% 220.48/220.63  |- rdf__type mesh__D022922sskos__Concept
% 220.48/220.63  |- mesh__recordAuthorizer mesh__D022922 sjn
% 220.48/220.63  |- mesh__dateEstablished mesh__D022922 2000-03-31
% 220.48/220.63  |- skos__broader mesh__D022922smesh__D052180
% 220.48/220.63  |- mesh__activeMeSHYear mesh__D022922 2006
% 220.48/220.63  |- skos__altLabel mesh__D022922 Fiction %5B%Publication Type%5D%
% 220.48/220.63  |- mesh__dateRevised mesh__D022922 2005-06-30
% 220.48/220.64  |- mesh__historyNote mesh__D022922 2000   
% 220.48/220.64  |- mesh__dateCreated mesh__D022922 2000-03-31
% 220.48/220.64  |- skos__prefLabel mesh__D022922 Fictional Works %5B%Publication Type%5D%
% 220.48/220.64  |- skos__scopeNote mesh__D022922
% 220.48/220.64       Works consisting of creative writing, not presented as factual.%A%    
% 220.48/220.64  |- skos__altLabel mesh__D022922 Fiction %28%PT%29%
% 220.48/220.64  |- mesh__recordMaintainer mesh__D022922 jls
% 220.48/220.64  |- mesh__recordOriginator mesh__D022922 jls
% 220.48/220.64  |- skos__altLabel mesh__D022922 Fictional Works %28%PT%29%
% 220.48/220.64  |- mesh__historyNote mesh__D008453
% 220.48/220.64       91%28%77%29%; was see under OXAZINES 1977-90   
% 220.48/220.64  |- skos__altLabel mesh__D008453 Maitansine
% 220.48/220.64  |- mesh__publicMeSHNote mesh__D008453 91; was see under OXAZINES 1977-90   
% 220.48/220.64  |- mesh__recordAuthorizer mesh__D008453 sjn
% 220.48/220.64  |- skos__prefLabel mesh__D008453 Maytansine
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D008453 2005
% 220.48/220.64  |- skos__broader mesh__D008453smesh__D018942
% 220.48/220.64  |- skos__historyNote mesh__D008453 Morpholines %28%1966-1975%29%
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D008453 2006
% 220.48/220.64  |- mesh__recordOriginator mesh__D008453 SH
% 220.48/220.64  |- mesh__dateCreated mesh__D008453 1976-05-03
% 220.48/220.64  |- mesh__recordMaintainer mesh__D008453 ssb
% 220.48/220.64  |- skos__broader mesh__D008453smesh__D047029
% 220.48/220.64  |- skos__scopeNote mesh__D008453
% 220.48/220.64       An ansa macrolide isolated from the East African shrubs Maytenus serrata and M. buchananii. It has antineoplastic activity, probably due to its inhibition of DNA synthesis.%A%    
% 220.48/220.64  |- mesh__dateRevised mesh__D008453 2004-07-07
% 220.48/220.64  |- rdf__type mesh__D008453sskos__Concept
% 220.48/220.64  |- skos__annotation mesh__D008453 /biosyn permitted if by plant   
% 220.48/220.64  |- mesh__dateEstablished mesh__D008453 1991-01-01
% 220.48/220.64  |- skos__historyNote mesh__D008453 Oxazines %28%1976%29%
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D000470 1999
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D000470 2001
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D000470 1998
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D000470 2004
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D000470 2000
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D000470 2003
% 220.48/220.64  |- skos__broader mesh__D000470smesh__D006571
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D000470 2006
% 220.48/220.64  |- skos__scopeNote mesh__D000470
% 220.48/220.64       Organic nitrogenous bases. Many alkaloids of medical importance occur in the animal and vegetable kingdoms, and some have been synthesized. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 220.48/220.64  |- skos__prefLabel mesh__D000470 Alkaloids
% 220.48/220.64  |- rdf__type mesh__D000470sskos__Concept
% 220.48/220.64  |- mesh__dateRevised mesh__D000470 1995-03-16
% 220.48/220.64  |- mesh__dateCreated mesh__D000470 1999-01-01
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D000470 2002
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D000470 2005
% 220.48/220.64  |- mesh__recordOriginator mesh__D000470 NLM
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D000470 1997
% 220.48/220.64  |- mesh__recordMaintainer mesh__D000470 PLS
% 220.48/220.64  |- skos__annotation mesh__D000470
% 220.48/220.64       GEN or unspecified; prefer specific groups or specific alkaloid; alkaloids from specific plants go here %28%IM%29% + name of plant or PLANTS, MEDICINAL, etc.%A%  
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D000470 1996
% 220.48/220.64  |- mesh__recordAuthorizer mesh__D000470 PLS
% 220.48/220.64  |- skos__historyNote mesh__D022124 Ammonia %28%1966-2000%29%
% 220.48/220.64  |- mesh__historyNote mesh__D022124 2001   
% 220.48/220.64  |- skos__scopeNote mesh__D022124
% 220.48/220.64       Metabolic disorder characterized by elevated level of ammonia in blood.%A%    
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D022124 2006
% 220.48/220.64  |- skos__broader mesh__D022124smesh__D008659
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D022124 2001
% 220.48/220.64  |- rdf__type mesh__D022124sskos__Concept
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D022124 2002
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D022124 2003
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D022124 2004
% 220.48/220.64  |- mesh__dateEstablished mesh__D022124 2001-01-01
% 220.48/220.64  |- mesh__dateCreated mesh__D022124 2000-06-22
% 220.48/220.64  |- mesh__publicMeSHNote mesh__D022124 2001   
% 220.48/220.64  |- skos__hiddenLabel mesh__D022124 Hyperammonemias
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D022124 2005
% 220.48/220.64  |- skos__prefLabel mesh__D022124 Hyperammonemia
% 220.48/220.64  |- skos__scopeNote mesh__D013398
% 220.48/220.64       The abrupt and unexplained death of an apparently healthy infant under one year of age, remaining unexplained after a thorough case investigation, including performance of a complete autopsy, examination of the death scene, and review of the clinical history. %28%Pediatr Pathol 1991 Sep-Oct;11%28%5%29%:677-84%29%%A%    
% 220.48/220.64  |- skos__hiddenLabel mesh__D013398 Infant Death, Sudden
% 220.48/220.64  |- skos__hiddenLabel mesh__D013398 Death, Sudden Infant
% 220.48/220.64  |- mesh__recordAuthorizer mesh__D013398 sjn
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D013398 2003
% 220.48/220.64  |- skos__altLabel mesh__D013398 Crib Death
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D013398 2005
% 220.48/220.64  |- mesh__publicMeSHNote mesh__D013398
% 220.48/220.64       75; SID was see SUDDEN INFANT DEATH 1993   
% 220.48/220.64  |- mesh__recordMaintainer mesh__D013398 KEV
% 220.48/220.64  |- skos__hiddenLabel mesh__D013398 Cot Deaths
% 220.48/220.64  |- mesh__dateCreated mesh__D013398 1974-11-11
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D013398 2002
% 220.48/220.64  |- skos__historyNote mesh__D013398 Death, Sudden %28%1966-1974%29%
% 220.48/220.64  |- skos__hiddenLabel mesh__D013398 Death, Cot
% 220.48/220.64  |- mesh__dateRevised mesh__D013398 1999-11-08
% 220.48/220.64  |- mesh__historyNote mesh__D013398
% 220.48/220.64       75; SID was see SUDDEN INFANT DEATH 1993   
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D013398 2001
% 220.48/220.64  |- skos__altLabel mesh__D013398 Cot Death
% 220.48/220.64  |- rdf__type mesh__D013398sskos__Concept
% 220.48/220.64  |- skos__broader mesh__D013398smesh__D003645
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D013398 2004
% 220.48/220.64  |- mesh__dateEstablished mesh__D013398 1975-09-01
% 220.48/220.64  |- mesh__onlineNote mesh__D013398
% 220.48/220.64       use SUDDEN INFANT DEATH to search SID 1993   
% 220.48/220.64  |- mesh__recordOriginator mesh__D013398 NLM
% 220.48/220.64  |- skos__prefLabel mesh__D013398 Sudden Infant Death
% 220.48/220.64  |- skos__altLabel mesh__D013398 Sudden Infant Death Syndrome
% 220.48/220.64  |- skos__altLabel mesh__D013398 SIDS
% 220.48/220.64  |- skos__hiddenLabel mesh__D013398 Death, Crib
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D013398 2000
% 220.48/220.64  |- skos__altLabel mesh__D013398 SID
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D013398 2006
% 220.48/220.64  |- skos__prefLabel mesh__D018881 Suburban Health
% 220.48/220.64  |- mesh__publicMeSHNote mesh__D018881 96   
% 220.48/220.64  |- skos__hiddenLabel mesh__D018881 Health, Suburban
% 220.48/220.64  |- mesh__recordAuthorizer mesh__D018881 sjn
% 220.48/220.64  |- mesh__historyNote mesh__D018881 96   
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D018881 2002
% 220.48/220.64  |- skos__historyNote mesh__D018881 Suburban Population %28%1980-1995%29%
% 220.48/220.64  |- mesh__dateEstablished mesh__D018881 1996-01-01
% 220.48/220.64  |- mesh__dateCreated mesh__D018881 1995-05-26
% 220.48/220.64  |- skos__annotation mesh__D018881 specify geog   
% 220.48/220.64  |- mesh__dateRevised mesh__D018881 1999-11-03
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D018881 2006
% 220.48/220.64  |- skos__historyNote mesh__D018881 Urban Health %28%1971-1979%29%
% 220.48/220.64  |- skos__broader mesh__D018881smesh__D006262
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D018881 2004
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D018881 2001
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D018881 2000
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D018881 2005
% 220.48/220.64  |- rdf__type mesh__D018881sskos__Concept
% 220.48/220.64  |- skos__scopeNote mesh__D018881
% 220.48/220.64       The status of health in suburban populations.     
% 220.48/220.64  |- mesh__recordOriginator mesh__D018881 TGC
% 220.48/220.64  |- mesh__recordMaintainer mesh__D018881 kle
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D018881 2003
% 220.48/220.64  |- skos__prefLabel mesh__D018083 Border disease virus
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D018083 2002
% 220.48/220.64  |- skos__annotation mesh__D018083 infection = BORDER DISEASE   
% 220.48/220.64  |- mesh__dateCreated mesh__D018083 1993-06-04
% 220.48/220.64  |- skos__scopeNote mesh__D018083
% 220.48/220.64       A species of PESTIVIRUS causing a congenital sheep disease characterized by an abnormally hairy birth-coat, tremors, and poor growth.%A%    
% 220.48/220.64  |- mesh__publicMeSHNote mesh__D018083 94   
% 220.48/220.64  |- skos__historyNote mesh__D018083 RNA Viruses %28%1976-1979%29%
% 220.48/220.64  |- skos__historyNote mesh__D018083 Pestivirus %28%1982-1993%29%
% 220.48/220.64  |- mesh__recordOriginator mesh__D018083 AGS
% 220.48/220.64  |- mesh__recordMaintainer mesh__D018083 ags
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D018083 2004
% 220.48/220.64  |- mesh__historyNote mesh__D018083 94   
% 220.48/220.64  |- mesh__dateEstablished mesh__D018083 1994-01-01
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D018083 2003
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D018083 2006
% 220.48/220.64  |- rdf__type mesh__D018083sskos__Concept
% 220.48/220.64  |- skos__historyNote mesh__D018083 Togaviridae %28%1980-1990%29%
% 220.48/220.64  |- skos__broader mesh__D018083smesh__D010576
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D018083 2005
% 220.48/220.64  |- mesh__dateRevised mesh__D018083 2001-07-25
% 220.48/220.64  |- mesh__recordAuthorizer mesh__D018083 sjn
% 220.48/220.64  |- mesh__recordOriginator mesh__D004861 NLM
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D004861 2002
% 220.48/220.64  |- mesh__publicMeSHNote mesh__D004861
% 220.48/220.64       94; was EQUINE RHINOPNEUMONITIS VIRUS 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%%A%  
% 220.48/220.64  |- skos__annotation mesh__D004861
% 220.48/220.64       infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29%   
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D004861 2003
% 220.48/220.64  |- skos__prefLabel mesh__D004861 Herpesvirus 1, Equid
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D004861 2005
% 220.48/220.64  |- skos__altLabel mesh__D004861 Equine abortion Virus
% 220.48/220.64  |- mesh__recordMaintainer mesh__D004861 ags
% 220.48/220.64  |- mesh__dateRevised mesh__D004861 2001-07-25
% 220.48/220.64  |- mesh__onlineNote mesh__D004861
% 220.48/220.64       use HERPESVIRUS 1, EQUID to search EQUINE RHINOPNEUMONITIS VIRUS 1975-93%A%  
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D004861 2004
% 220.48/220.64  |- skos__scopeNote mesh__D004861
% 220.48/220.64       A species of VARICELLOVIRUS causing abortion and respiratory disease in horses.%A%    
% 220.48/220.64  |- mesh__historyNote mesh__D004861
% 220.48/220.64       94; was EQUINE RHINOPNEUMONITIS VIRUS 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%%A%  
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D004861 2006
% 220.48/220.64  |- mesh__recordAuthorizer mesh__D004861 sjn
% 220.48/220.64  |- skos__broader mesh__D004861smesh__D018140
% 220.48/220.64  |- skos__altLabel mesh__D004861 Herpesvirus 1 %28%alpha%29%, Equine
% 220.48/220.64  |- skos__altLabel mesh__D004861 EHV-1
% 220.48/220.64  |- skos__altLabel mesh__D004861 Equid herpesvirus 1
% 220.48/220.64  |- mesh__dateEstablished mesh__D004861 1991-01-01
% 220.48/220.64  |- skos__hiddenLabel mesh__D004861 Equine abortion Viruses
% 220.48/220.64  |- skos__hiddenLabel mesh__D004861 Herpesvirus 1, Equine
% 220.48/220.64  |- skos__altLabel mesh__D004861 Equine Herpesvirus 1
% 220.48/220.64  |- rdf__type mesh__D004861sskos__Concept
% 220.48/220.64  |- mesh__dateCreated mesh__D004861 1974-12-12
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D004063 2004
% 220.48/220.64  |- mesh__recordMaintainer mesh__D004063 adp
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D004063 2001
% 220.48/220.64  |- mesh__recordOriginator mesh__D004063 NLM
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D004063 2003
% 220.48/220.64  |- skos__prefLabel mesh__D004063 Digestion
% 220.48/220.64  |- rdf__type mesh__D004063sskos__Concept
% 220.48/220.64  |- mesh__dateCreated mesh__D004063 1999-01-01
% 220.48/220.64  |- mesh__recordAuthorizer mesh__D004063 sjn
% 220.48/220.64  |- mesh__dateRevised mesh__D004063 2000-06-22
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D004063 2006
% 220.48/220.64  |- skos__scopeNote mesh__D004063
% 220.48/220.64       The process of breakdown of food for metabolism and use by the body.%A%    
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D004063 2005
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D004063 2002
% 220.48/220.64  |- skos__broader mesh__D004063smesh__D004068
% 220.48/220.64  |- mesh__dateEstablished mesh__D017789 1994-01-01
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D017789 2004
% 220.48/220.64  |- skos__altLabel mesh__D017789 Granuloma Pyogenicum
% 220.48/220.64  |- skos__annotation mesh__D017789
% 220.48/220.64       non-neoplastic; coord IM with organ/dis %28%IM%29%; do not confuse X ref HEMANGIOMA, LOBULAR CAPILLARY with neopl HEMANGIOMA, CAPILLARY%A%  
% 220.48/220.64  |- skos__hiddenLabel mesh__D017789 Capillary Hemangioma, Lobular
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D017789 2001
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D017789 2006
% 220.48/220.64  |- rdf__type mesh__D017789sskos__Concept
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D017789 2003
% 220.48/220.64  |- mesh__publicMeSHNote mesh__D017789 94   
% 220.48/220.64  |- skos__historyNote mesh__D017789 Hemangioma %28%1969-1993%29%
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D017789 2000
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D017789 2005
% 220.48/220.64  |- skos__hiddenLabel mesh__D017789 Pyogenic Granuloma
% 220.48/220.64  |- skos__scopeNote mesh__D017789
% 220.48/220.64       A disorder of the skin, the oral mucosa, and the gingiva, that usually presents as a solitary polypoid capillary hemangioma often resulting from trauma.  It is manifested as an inflammatory response with similar characteristics to those of a granuloma.%A%    
% 220.48/220.64  |- mesh__dateRevised mesh__D017789 1999-11-03
% 220.48/220.64  |- skos__historyNote mesh__D017789 Granuloma %28%1967-1993%29%
% 220.48/220.64  |- skos__broader mesh__D017789smesh__D006099
% 220.48/220.64  |- skos__altLabel mesh__D017789 Granuloma Telangiecticum
% 220.48/220.64  |- skos__hiddenLabel mesh__D017789 Angiogranulomas
% 220.48/220.64  |- skos__altLabel mesh__D017789 Hemangioma, Lobular Capillary
% 220.48/220.64  |- mesh__recordAuthorizer mesh__D017789 sjn
% 220.48/220.64  |- mesh__dateCreated mesh__D017789 1993-06-03
% 220.48/220.64  |- mesh__historyNote mesh__D017789 94   
% 220.48/220.64  |- mesh__recordMaintainer mesh__D017789 KEV
% 220.48/220.64  |- skos__prefLabel mesh__D017789 Granuloma, Pyogenic
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D017789 2002
% 220.48/220.64  |- mesh__recordOriginator mesh__D017789 TGC
% 220.48/220.64  |- skos__hiddenLabel mesh__D017789 Lobular Capillary Hemangioma
% 220.48/220.64  |- mesh__recordMaintainer mesh__D042182 ags
% 220.48/220.64  |- skos__prefLabel mesh__D042182 Rhodospirillum centenum
% 220.48/220.64  |- mesh__recordOriginator mesh__D042182 ags
% 220.48/220.64  |- mesh__dateCreated mesh__D042182 2003-07-09
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D042182 2006
% 220.48/220.64  |- mesh__recordAuthorizer mesh__D042182 sjn
% 220.48/220.64  |- skos__broader mesh__D042182smesh__D012246
% 220.48/220.64  |- mesh__dateRevised mesh__D042182 2005-06-30
% 220.48/220.64  |- mesh__dateEstablished mesh__D042182 2004-01-01
% 220.48/220.64  |- mesh__historyNote mesh__D042182 2004   
% 220.48/220.64  |- rdf__type mesh__D042182sskos__Concept
% 220.48/220.64  |- skos__scopeNote mesh__D042182
% 220.48/220.64       A thermotolerant, cyst-forming, anoxygenic photosynthetic species, in the genus RHODOSPIRILLUM.%A%    
% 220.48/220.64  |- mesh__publicMeSHNote mesh__D042182 2004   
% 220.48/220.64  |- skos__historyNote mesh__D042182 Rhodospirillum %28%1989-2003%29%
% 220.48/220.64  |- mesh__recordMaintainer mesh__D050614 DRC
% 220.48/220.64  |- mesh__recordAuthorizer mesh__D050614 sjn
% 220.48/220.64  |- skos__hiddenLabel mesh__D050614 Transporter Proteins, NPTIIb
% 220.48/220.64  |- skos__prefLabel mesh__D050614
% 220.48/220.64       Sodium-Phosphate Cotransporter Proteins, Type IIb
% 220.48/220.64  |- mesh__dateCreated mesh__D050614 2005-06-30
% 220.48/220.64  |- skos__altLabel mesh__D050614
% 220.48/220.64       Type IIb Sodium-Phosphate Symporter Proteins
% 220.48/220.64  |- skos__altLabel mesh__D050614
% 220.48/220.64       Type IIb Sodium-Phosphate Cotransporter Proteins
% 220.48/220.64  |- mesh__recordOriginator mesh__D050614 DRC
% 220.48/220.64  |- mesh__historyNote mesh__D050614 2006%28%2004%29%   
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D050614 2006
% 220.48/220.64  |- skos__hiddenLabel mesh__D050614
% 220.48/220.64       Type IIb Sodium Phosphate Symporter Proteins
% 220.48/220.64  |- mesh__publicMeSHNote mesh__D050614
% 220.48/220.64       2006; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIb was indexed under SYMPORTERS 2004-2005%A%  
% 220.48/220.64  |- rdf__type mesh__D050614sskos__Concept
% 220.48/220.64  |- skos__hiddenLabel mesh__D050614
% 220.48/220.64       Sodium Phosphate Cotransporter Proteins, Type IIb
% 220.48/220.64  |- skos__hiddenLabel mesh__D050614
% 220.48/220.64       Type IIb Sodium Phosphate Cotransporter Proteins
% 220.48/220.64  |- skos__scopeNote mesh__D050614
% 220.48/220.64       A sodium-dependent phosphate transporter present primarily at apical sites of EPITHELIAL CELLS in the SMALL INTESTINE.%A%    
% 220.48/220.64  |- skos__altLabel mesh__D050614 NPTIIb Transporter Proteins
% 220.48/220.64  |- mesh__dateEstablished mesh__D050614 2006-01-01
% 220.48/220.64  |- skos__broader mesh__D050614smesh__D050610
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D003769 1993
% 220.48/220.64  |- mesh__dateCreated mesh__D003769 1999-01-01
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D003769 1999
% 220.48/220.64  |- skos__altLabel mesh__D003769 Occlusion, Dental, Traumatic
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D003769 2004
% 220.48/220.64  |- skos__altLabel mesh__D003769 Traumatic Dental Occlusion
% 220.48/220.64  |- mesh__dateRevised mesh__D003769 1990-05-29
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D003769 1994
% 220.48/220.64  |- skos__broader mesh__D003769smesh__D008310
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D003769 2000
% 220.48/220.64  |- mesh__historyNote mesh__D003769 65   
% 220.48/220.64  |- skos__hiddenLabel mesh__D003769 Traumatic Dental Occlusions
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D003769 2005
% 220.48/220.64  |- skos__prefLabel mesh__D003769 Dental Occlusion, Traumatic
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D003769 1995
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D003769 1996
% 220.48/220.64  |- skos__altLabel mesh__D003769 Occlusion, Traumatic Dental
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D003769 2001
% 220.48/220.64  |- skos__hiddenLabel mesh__D003769 Dental Occlusions, Traumatic
% 220.48/220.64  |- mesh__publicMeSHNote mesh__D003769 65   
% 220.48/220.64  |- mesh__recordAuthorizer mesh__D003769 PLS
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D003769 1991
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D003769 2006
% 220.48/220.64  |- mesh__recordOriginator mesh__D003769 NLM
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D003769 1997
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D003769 2002
% 220.48/220.64  |- mesh__dateEstablished mesh__D003769 1965-01-01
% 220.48/220.64  |- skos__scopeNote mesh__D003769
% 220.48/220.64       An occlusion resulting in overstrain and injury to teeth, periodontal tissue, or other oral structures.%A%    
% 220.48/220.64  |- skos__annotation mesh__D003769
% 220.48/220.64       an occlusion injuring the teeth or other oral structures; DF: DENT OCCLUSION TRAUMATIC%A%  
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D003769 1992
% 220.48/220.64  |- skos__hiddenLabel mesh__D003769 Occlusions, Traumatic Dental
% 220.48/220.64  |- mesh__recordMaintainer mesh__D003769 TAP
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D003769 1998
% 220.48/220.64  |- rdf__type mesh__D003769sskos__Concept
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D003769 2003
% 220.48/220.64  |- skos__historyNote mesh__D014491
% 220.48/220.64       Technology Assessment, Biomedical %28%1980-1987%29%
% 220.48/220.64  |- skos__prefLabel mesh__D014491
% 220.48/220.64       United States Office of Technology Assessment
% 220.48/220.64  |- mesh__historyNote mesh__D014491 88   
% 220.48/220.64  |- rdf__type mesh__D014491sskos__Concept
% 220.48/220.64  |- skos__altLabel mesh__D014491
% 220.48/220.64       United States Congress Office of Technology Assessment
% 220.48/220.64  |- mesh__dateEstablished mesh__D014491 1988-01-01
% 220.48/220.64  |- mesh__dateCreated mesh__D014491 1987-05-04
% 220.48/220.64  |- mesh__publicMeSHNote mesh__D014491 88   
% 220.48/220.64  |- skos__broader mesh__D014491smesh__D006077
% 220.48/220.64  |- skos__annotation mesh__D014491
% 220.48/220.64       add UNITED STATES %28%NIM%29%; research support by this agency is checked as OTHER US GOVT SUP; DF: OTA      CATALOG: use NAF entry%A%  
% 220.48/220.64  |- mesh__dateRevised mesh__D014491 2001-07-25
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D014491 2002
% 220.48/220.64  |- skos__altLabel mesh__D014491
% 220.48/220.64       Office of Technology Assessment %28%U.S.%29%
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D014491 2006
% 220.48/220.64  |- mesh__recordMaintainer mesh__D014491 jls
% 220.48/220.64  |- mesh__recordAuthorizer mesh__D014491 sjn
% 220.48/220.64  |- skos__historyNote mesh__D014491 Government Agencies %28%1968-1987%29%
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D014491 2004
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D014491 2005
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D014491 2003
% 220.48/220.64  |- skos__scopeNote mesh__D014491
% 220.48/220.64       An office established to help Congress participate and plan for the consequences of uses of technology. It provided information on both the beneficial and adverse effects of technological applications. The Office of Technology Assessment closed on September 29, 1995.%A%    
% 220.48/220.64  |- mesh__recordOriginator mesh__D014491 EC
% 220.48/220.64  |- mesh__historyNote mesh__D036145
% 220.48/220.64       2003; for GINSENOSIDES use GINSENOSIDES %28%NM%29% 1977-2002   
% 220.48/220.64  |- skos__broader mesh__D036145smesh__D012503
% 220.48/220.64  |- skos__prefLabel mesh__D036145 Ginsenosides
% 220.48/220.64  |- rdf__type mesh__D036145sskos__Concept
% 220.48/220.64  |- mesh__dateRevised mesh__D036145 2004-07-07
% 220.48/220.64  |- mesh__dateEstablished mesh__D036145 2003-01-01
% 220.48/220.64  |- mesh__recordAuthorizer mesh__D036145 sjn
% 220.48/220.64  |- mesh__recordMaintainer mesh__D036145 ssb
% 220.48/220.64  |- skos__scopeNote mesh__D036145
% 220.48/220.64       Dammarane type triterpene saponins based mainly on the aglycones, protopanaxadiol and protopanaxatriol.%A%    
% 220.48/220.64  |- skos__broader mesh__D036145smesh__D014315
% 220.48/220.64  |- mesh__dateCreated mesh__D036145 2002-07-03
% 220.48/220.64  |- skos__altLabel mesh__D036145 Sanchinosides
% 220.48/220.64  |- mesh__recordOriginator mesh__D036145 ssb
% 220.48/220.64  |- mesh__publicMeSHNote mesh__D036145
% 220.48/220.64       2003; GINSENOSIDES was indexed under SAPONINS 1977-2002   
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D036145 2006
% 220.48/220.64  |- skos__altLabel mesh__D036145 Panaxosides
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D036145 2005
% 220.48/220.64  |- mesh__recordMaintainer mesh__D022923 jls
% 220.48/220.64  |- mesh__dateEstablished mesh__D022923 2000-03-31
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D022923 2006
% 220.48/220.64  |- skos__scopeNote mesh__D022923
% 220.48/220.64       Books intended for use in the study of specific subjects, containing systematic presentation of the principles and essential knowledge of the subjects.%A%    
% 220.48/220.64  |- mesh__historyNote mesh__D022923 2000   
% 220.48/220.64  |- mesh__recordAuthorizer mesh__D022923 sjn
% 220.48/220.64  |- mesh__recordOriginator mesh__D022923 jls
% 220.48/220.64  |- mesh__dateRevised mesh__D022923 2005-06-30
% 220.48/220.64  |- mesh__dateCreated mesh__D022923 2000-03-31
% 220.48/220.64  |- skos__altLabel mesh__D022923 Textbooks %28%PT%29%
% 220.48/220.64  |- skos__prefLabel mesh__D022923 Textbooks %5B%Publication Type%5D%
% 220.48/220.64  |- rdf__type mesh__D022923sskos__Concept
% 220.48/220.64  |- skos__annotation mesh__D022923
% 220.48/220.64       used by collaborating partners only; CATALOG: do not use   
% 220.48/220.64  |- skos__broader mesh__D022923smesh__D016467
% 220.48/220.64  |- skos__hiddenLabel mesh__D008454 AN448
% 220.48/220.64  |- skos__broader mesh__D008454smesh__D007211
% 220.48/220.64  |- skos__altLabel mesh__D008454 Mazindole
% 220.48/220.64  |- mesh__dateRevised mesh__D008454 2005-06-30
% 220.48/220.64  |- skos__hiddenLabel mesh__D008454 Mazindol Medix Brand
% 220.48/220.64  |- skos__hiddenLabel mesh__D008454 Mazindol Searle Brand
% 220.48/220.64  |- skos__scopeNote mesh__D008454
% 220.48/220.64       Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.%A%    
% 220.48/220.64  |- mesh__dateEstablished mesh__D008454 1991-01-01
% 220.48/220.64  |- skos__hiddenLabel mesh__D008454 Mazindol Wyeth Brand
% 220.48/220.64  |- skos__altLabel mesh__D008454 Teronak
% 220.48/220.64  |- mesh__recordAuthorizer mesh__D008454 sjn
% 220.48/220.64  |- skos__altLabel mesh__D008454 Sanjorex
% 220.48/220.64  |- skos__historyNote mesh__D008454 Indoles %28%1972-1974%29%
% 220.48/220.64  |- skos__prefLabel mesh__D008454 Mazindol
% 220.48/220.64  |- skos__altLabel mesh__D008454 Medix Brand of Mazindol
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D008454 2006
% 220.48/220.64  |- mesh__recordMaintainer mesh__D008454 CCR
% 220.48/220.64  |- mesh__dateCreated mesh__D008454 1974-11-11
% 220.48/220.64  |- mesh__publicMeSHNote mesh__D008454 91; was see under INDOLES 1975-90   
% 220.48/220.64  |- skos__altLabel mesh__D008454 Wyeth Brand of Mazindol
% 220.48/220.64  |- mesh__historyNote mesh__D008454
% 220.48/220.64       91%28%75%29%; was see under INDOLES 1975-90   
% 220.48/220.64  |- skos__altLabel mesh__D008454 Searle Brand of Mazindol
% 220.48/220.64  |- skos__historyNote mesh__D008454 Imidazoles %28%1972-1974%29%
% 220.48/220.64  |- mesh__recordOriginator mesh__D008454 NLM
% 220.48/220.64  |- skos__altLabel mesh__D008454 Novartis Brand of Mazindol
% 220.48/220.64  |- skos__hiddenLabel mesh__D008454 Mazindol Novartis Brand
% 220.48/220.64  |- rdf__type mesh__D008454sskos__Concept
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D000471 2004
% 220.48/220.64  |- mesh__recordAuthorizer mesh__D000471 sjn
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D000471 2003
% 220.48/220.64  |- mesh__dateRevised mesh__D000471 1999-11-03
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D000471 2001
% 220.48/220.64  |- skos__broader mesh__D000471smesh__D000137
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D000471 2006
% 220.48/220.64  |- rdf__type mesh__D000471sskos__Concept
% 220.48/220.64  |- mesh__dateCreated mesh__D000471 1999-01-01
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D000471 2005
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D000471 2000
% 220.48/220.64  |- skos__scopeNote mesh__D000471
% 220.48/220.64       A pathological condition that removes acid or adds base to the body fluids.%A%    
% 220.48/220.64  |- skos__hiddenLabel mesh__D000471 Alkaloses
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D000471 2002
% 220.48/220.64  |- mesh__recordMaintainer mesh__D000471 KEV
% 220.48/220.64  |- mesh__recordOriginator mesh__D000471 NLM
% 220.48/220.64  |- skos__prefLabel mesh__D000471 Alkalosis
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D022125 2005
% 220.48/220.64  |- skos__historyNote mesh__D022125 Wounds and Injuries %28%1966-2000%29%
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D022125 2001
% 220.48/220.64  |- skos__scopeNote mesh__D022125 Torn, ragged, mangled wounds.     
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D022125 2006
% 220.48/220.64  |- rdf__type mesh__D022125sskos__Concept
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D022125 2002
% 220.48/220.64  |- skos__prefLabel mesh__D022125 Lacerations
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D022125 2003
% 220.48/220.64  |- skos__broader mesh__D022125smesh__D014947
% 220.48/220.64  |- skos__hiddenLabel mesh__D022125 Laceration
% 220.48/220.64  |- mesh__dateEstablished mesh__D022125 2001-01-01
% 220.48/220.64  |- mesh__publicMeSHNote mesh__D022125 2001   
% 220.48/220.64  |- mesh__dateCreated mesh__D022125 2000-06-22
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D022125 2004
% 220.48/220.64  |- mesh__historyNote mesh__D022125 2001   
% 220.48/220.64  |- skos__hiddenLabel mesh__D018882 Heat Stresses
% 220.48/220.64  |- mesh__dateCreated mesh__D018882 1994-12-27
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D018882 1997
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D018882 2006
% 220.48/220.64  |- rdf__type mesh__D018882sskos__Concept
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D018882 1998
% 220.48/220.64  |- skos__hiddenLabel mesh__D018882 Cramps, Heat
% 220.48/220.64  |- skos__hiddenLabel mesh__D018882 Stress Syndrome, Heat
% 220.48/220.64  |- mesh__activeMeSHYear mesh__D018882 2000
% 220.48/220.64  |- skos__hiddenLabel mesh__D018882 Stress Disorder, Heat
% 220.48/220.64  |- skos__hiddenLabel mesh__D018882 Heat Stress Disorder
% 220.48/220.64  |- skos__hiddenLabel mesh__D018882 Cramp, Heat
% 220.48/220.64  |- skos__hiddenLabel mesh__D018882 Stresses, Heat
% 220.48/220.64  |- skos__broader mesh__D018882smesh__D014947
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018882 1999
% 220.48/220.65  |- skos__scopeNote mesh__D018882
% 220.48/220.65       A group of conditions due to overexposure to or overexertion in excess environmental temperature. It includes heat cramps, which are non-emergent and treated by salt replacement; HEAT EXHAUSTION, which is more serious, treated with fluid and salt replacement; and HEAT STROKE, a condition most commonly affecting extremes of age, especially the elderly, accompanied by convulsions, delusions, or coma and treated with cooling the body and replacement of fluids and salts. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 220.48/220.65  |- skos__hiddenLabel mesh__D018882 Syndromes, Heat Stress
% 220.48/220.65  |- mesh__dateEstablished mesh__D018882 1996-01-01
% 220.48/220.65  |- skos__hiddenLabel mesh__D018882 Stress, Heat
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018882 2001
% 220.48/220.65  |- skos__historyNote mesh__D018882 Stress %28%1966-1995%29%
% 220.48/220.65  |- skos__annotation mesh__D018882
% 220.48/220.65       GEN or unspecified; prefer specifics; DF: HEAT STRESS DIS%A%  
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018882 2003
% 220.48/220.65  |- skos__altLabel mesh__D018882 Stress Disorders, Heat
% 220.48/220.65  |- skos__hiddenLabel mesh__D018882 Stress Syndromes, Heat
% 220.48/220.65  |- skos__historyNote mesh__D018882 Heat %28%1966-1995%29%
% 220.48/220.65  |- skos__altLabel mesh__D018882 Heat Stress Syndromes
% 220.48/220.65  |- skos__prefLabel mesh__D018882 Heat Stress Disorders
% 220.48/220.65  |- mesh__publicMeSHNote mesh__D018882 96   
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018882 2002
% 220.48/220.65  |- skos__altLabel mesh__D018882 Heat Stress
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018882 2004
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018882 1996
% 220.48/220.65  |- skos__hiddenLabel mesh__D018882 Disorders, Heat Stress
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018882 2005
% 220.48/220.65  |- skos__hiddenLabel mesh__D018882 Syndrome, Heat Stress
% 220.48/220.65  |- skos__hiddenLabel mesh__D018882 Heat Stress Syndrome
% 220.48/220.65  |- skos__hiddenLabel mesh__D018882 Disorder, Heat Stress
% 220.48/220.65  |- mesh__historyNote mesh__D018882 96   
% 220.48/220.65  |- skos__hiddenLabel mesh__D018882 Heat Cramp
% 220.48/220.65  |- skos__hiddenLabel mesh__D018084 Interventional Ultrasound
% 220.48/220.65  |- skos__altLabel mesh__D018084 Ultrasound, Interventional
% 220.48/220.65  |- skos__altLabel mesh__D018084 Intravascular Ultrasonography
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018084 2004
% 220.48/220.65  |- skos__historyNote mesh__D018084 Ultrasonography %28%1985-1993%29%
% 220.48/220.65  |- mesh__dateCreated mesh__D018084 1993-06-03
% 220.48/220.65  |- mesh__recordMaintainer mesh__D018084 PXP
% 220.48/220.65  |- mesh__historyNote mesh__D018084 94   
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018084 2002
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018084 2003
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018084 2006
% 220.48/220.65  |- skos__scopeNote mesh__D018084
% 220.48/220.65       Ultrasonography using invasive or surgical procedures. Its widest application is intravascular ultrasound imaging but it is useful also in urology and intra-abdominal conditions.%A%    
% 220.48/220.65  |- mesh__dateRevised mesh__D018084 1997-06-20
% 220.48/220.65  |- skos__prefLabel mesh__D018084 Ultrasonography, Interventional
% 220.48/220.65  |- mesh__publicMeSHNote mesh__D018084 94   
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018084 2001
% 220.48/220.65  |- skos__annotation mesh__D018084
% 220.48/220.65       do not use /util except by MeSH definition; DF: ULTRASONOGR INTERVENTIONAL%A%  
% 220.48/220.65  |- rdf__type mesh__D018084sskos__Concept
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018084 2005
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018084 2000
% 220.48/220.65  |- mesh__dateEstablished mesh__D018084 1994-01-01
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018084 1999
% 220.48/220.65  |- skos__broader mesh__D018084smesh__D014463
% 220.48/220.65  |- skos__altLabel mesh__D018084 Interventional Ultrasonography
% 220.48/220.65  |- mesh__recordAuthorizer mesh__D018084 SJN
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018084 1998
% 220.48/220.65  |- mesh__recordOriginator mesh__D018084 TGC
% 220.48/220.65  |- mesh__dateRevised mesh__D004064 2004-07-07
% 220.48/220.65  |- mesh__historyNote mesh__D004064 1972   
% 220.48/220.65  |- mesh__publicMeSHNote mesh__D004064
% 220.48/220.65       1972; see GASTROINTESTINAL SYSTEM 1963-1971   
% 220.48/220.65  |- mesh__dateCreated mesh__D004064 1999-01-01
% 220.48/220.65  |- mesh__dateEstablished mesh__D004064 1972-01-01
% 220.48/220.65  |- mesh__runningHead mesh__D004064 A3 - ANATOMY-DIGESTIVE SYSTEM   
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D004064 2006
% 220.48/220.65  |- skos__altLabel mesh__D004064 Ailmentary System
% 220.48/220.65  |- skos__prefLabel mesh__D004064 Digestive System
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D004064 2005
% 220.48/220.65  |- skos__historyNote mesh__D004064
% 220.48/220.65       Gastrointestinal System %28%1966-1971%29%
% 220.48/220.65  |- mesh__recordOriginator mesh__D004064 NLM
% 220.48/220.65  |- mesh__recordMaintainer mesh__D004064 lkt
% 220.48/220.65  |- skos__altLabel mesh__D004064 Alimentary System
% 220.48/220.65  |- skos__annotation mesh__D004064
% 220.48/220.65       GEN: prefer specifics; /abnorm = DIGESTIVE SYSTEM ABNORMALITIES but consider also specific part of digest syst with /abnorm or specific abnorm%A%  
% 220.48/220.65  |- skos__scopeNote mesh__D004064
% 220.48/220.65       A group of organs stretching from the MOUTH to the ANUS, serving to breakdown foods, assimilate nutrients, and eliminate waste. In humans, the digestive system includes the GASTROINTESTINAL TRACT and the accessory glands %28%LIVER; BILIARY TRACT; PANCREAS%29%.%A%    
% 220.48/220.65  |- rdf__type mesh__D004064sskos__Concept
% 220.48/220.65  |- mesh__recordAuthorizer mesh__D004064 sjn
% 220.48/220.65  |- mesh__publicMeSHNote mesh__D050615
% 220.48/220.65       2006; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIc was indexed under SYMPORTERS 2004-2005%A%  
% 220.48/220.65  |- mesh__recordOriginator mesh__D050615 DRC
% 220.48/220.65  |- mesh__dateEstablished mesh__D050615 2006-01-01
% 220.48/220.65  |- skos__broader mesh__D050615smesh__D050610
% 220.48/220.65  |- mesh__recordMaintainer mesh__D050615 DRC
% 220.48/220.65  |- mesh__recordAuthorizer mesh__D050615 sjn
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D050615 2006
% 220.48/220.65  |- skos__hiddenLabel mesh__D050615
% 220.48/220.65       Sodium Phosphate Cotransporter Proteins, Type IIc
% 220.48/220.65  |- rdf__type mesh__D050615sskos__Concept
% 220.48/220.65  |- skos__scopeNote mesh__D050615
% 220.48/220.65       A non-electrogenic sodium-dependent phosphate transporter. It is found primarily in apical membranes of PROXIMAL RENAL TUBULES.%A%    
% 220.48/220.65  |- skos__hiddenLabel mesh__D050615
% 220.48/220.65       Type IIc Sodium Phosphate Symporter Proteins
% 220.48/220.65  |- mesh__dateCreated mesh__D050615 2005-06-30
% 220.48/220.65  |- skos__altLabel mesh__D050615
% 220.48/220.65       Type IIc Sodium-Phosphate Symporter Proteins
% 220.48/220.65  |- skos__altLabel mesh__D050615
% 220.48/220.65       Type IIc Sodium-Phosphate Cotransporter Proteins
% 220.48/220.65  |- skos__hiddenLabel mesh__D050615
% 220.48/220.65       Sodium Phosphate Symporter Proteins, Type IIc
% 220.48/220.65  |- skos__hiddenLabel mesh__D050615
% 220.48/220.65       Type IIc Sodium Phosphate Cotransporter Proteins
% 220.48/220.65  |- mesh__historyNote mesh__D050615 2006%28%2004%29%   
% 220.48/220.65  |- skos__hiddenLabel mesh__D050615 Transporter Proteins, NPTIIc
% 220.48/220.65  |- skos__prefLabel mesh__D050615
% 220.48/220.65       Sodium-Phosphate Cotransporter Proteins, Type IIc
% 220.48/220.65  |- skos__altLabel mesh__D050615
% 220.48/220.65       Sodium-Phosphate Symporter Proteins, Type IIc
% 220.48/220.65  |- skos__altLabel mesh__D050615 NPTIIc Transporter Proteins
% 220.48/220.65  |- mesh__recordOriginator mesh__D014492 NLM
% 220.48/220.65  |- skos__altLabel mesh__D014492 Public Health Service
% 220.48/220.65  |- skos__prefLabel mesh__D014492 United States Public Health Service
% 220.48/220.65  |- mesh__dateRevised mesh__D014492 2004-07-13
% 220.48/220.65  |- skos__altLabel mesh__D014492 Public Health Service %28%U.S.%29%
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D014492 2006
% 220.48/220.65  |- mesh__recordMaintainer mesh__D014492 sjn
% 220.48/220.65  |- skos__broader mesh__D014492smesh__D014483
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D014492 2005
% 220.48/220.65  |- mesh__publicMeSHNote mesh__D014492 66   
% 220.48/220.65  |- mesh__dateEstablished mesh__D014492 1966-01-01
% 220.48/220.65  |- mesh__historyNote mesh__D014492 66   
% 220.48/220.65  |- skos__scopeNote mesh__D014492
% 220.48/220.65       A constituent organization of the DEPARTMENT OF HEALTH AND HUMAN SERVICES concerned with protecting and improving the health of the nation.%A%    
% 220.48/220.65  |- skos__altLabel mesh__D014492 USPHS
% 220.48/220.65  |- mesh__recordAuthorizer mesh__D014492 sjn
% 220.48/220.65  |- mesh__dateCreated mesh__D014492 1999-01-01
% 220.48/220.65  |- rdf__type mesh__D014492sskos__Concept
% 220.48/220.65  |- skos__annotation mesh__D014492
% 220.48/220.65       add UNITED STATES %28%NIM%29%; research support by this agency is checked as NIH/PHS SUP; DF:PHS      CATALOG: use NAF entry%A%  
% 220.48/220.65  |- skos__hiddenLabel mesh__D008455 McN A343
% 220.48/220.65  |- skos__hiddenLabel mesh__D008455 A 343, McNeil
% 220.48/220.65  |- mesh__recordOriginator mesh__D008455 NLM
% 220.48/220.65  |- mesh__dateCreated mesh__D008455 1974-11-19
% 220.48/220.65  |- skos__broader mesh__D008455smesh__D000480
% 220.48/220.65  |- mesh__dateEstablished mesh__D008455 1991-01-01
% 220.48/220.65  |- skos__historyNote mesh__D008455 Ammonium Compounds %28%1968-1974%29%
% 220.48/220.65  |- skos__hiddenLabel mesh__D008455 McN A 343
% 220.48/220.65  |- skos__broader mesh__D008455smesh__D000644
% 220.48/220.65  |- skos__altLabel mesh__D008455 McN A-343
% 220.48/220.65  |- mesh__dateRevised mesh__D008455 2005-06-30
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D008455 2006
% 220.48/220.65  |- skos__altLabel mesh__D008455 McNeil A 343
% 220.48/220.65  |- skos__hiddenLabel mesh__D008455 343, McNeil A
% 220.48/220.65  |- mesh__historyNote mesh__D008455 2005%28%1975%29%   
% 220.48/220.65  |- skos__prefLabel mesh__D008455
% 220.48/220.65       %28%4-%28%m-Chlorophenylcarbamoyloxy%29%-2-butynyl%29%trimethylammonium Chloride
% 220.48/220.65  |- mesh__publicMeSHNote mesh__D008455
% 220.48/220.65       2005; see McN-A-343 1991-2004; see AMMONIUM COMPOUNDS 1975-1990%A%  
% 220.48/220.65  |- skos__scopeNote mesh__D008455
% 220.48/220.65       A drug that selectively activates certain subclasses of muscarinic receptors and also activates postganglionic nicotinic receptors. It is commonly used experimentally to distinguish muscarinic receptor subtypes.%A%    
% 220.48/220.65  |- skos__annotation mesh__D008455
% 220.48/220.65       McN stands for McNeil %28%a pharmaceut co%29%   
% 220.48/220.65  |- skos__broader mesh__D008455smesh__D050338
% 220.48/220.65  |- skos__altLabel mesh__D008455 McN-A343
% 220.48/220.65  |- mesh__recordMaintainer mesh__D008455 ssb
% 220.48/220.65  |- mesh__recordAuthorizer mesh__D008455 sjn
% 220.48/220.65  |- rdf__type mesh__D008455sskos__Concept
% 220.48/220.65  |- skos__historyNote mesh__D008455 Carbamates %28%1968-1974%29%
% 220.48/220.65  |- skos__hiddenLabel mesh__D008455 McNA343
% 220.48/220.65  |- skos__historyNote mesh__D008455 Alkynes %28%1972-1974%29%
% 220.48/220.65  |- mesh__dateCreated mesh__D000472 1999-01-01
% 220.48/220.65  |- skos__broader mesh__D000472smesh__D000471
% 220.48/220.65  |- mesh__historyNote mesh__D000472 74%28%71%29%   
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D000472 2005
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D000472 2002
% 220.48/220.65  |- mesh__recordAuthorizer mesh__D000472 SJN
% 220.48/220.65  |- skos__scopeNote mesh__D000472
% 220.48/220.65       A state due to excess loss of carbon dioxide from the body. %28%Dorland, 27th ed%29%%A%    
% 220.48/220.65  |- mesh__recordOriginator mesh__D000472 NLM
% 220.48/220.65  |- skos__annotation mesh__D000472 excess loss of CO2 from body   
% 220.48/220.65  |- skos__historyNote mesh__D000472 Alkalosis %28%1966-1970%29%
% 220.48/220.65  |- mesh__dateRevised mesh__D000472 1998-06-10
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D000472 1999
% 220.48/220.65  |- skos__hiddenLabel mesh__D000472 Respiratory Alkaloses
% 220.48/220.65  |- skos__historyNote mesh__D000472 Hyperventilation %28%1966-1970%29%
% 220.48/220.65  |- skos__prefLabel mesh__D000472 Alkalosis, Respiratory
% 220.48/220.65  |- skos__hiddenLabel mesh__D000472 Alkaloses, Respiratory
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D000472 2004
% 220.48/220.65  |- skos__broader mesh__D000472smesh__D006985
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D000472 2001
% 220.48/220.65  |- mesh__publicMeSHNote mesh__D000472 74   
% 220.48/220.65  |- skos__altLabel mesh__D000472 Respiratory Alkalosis
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D000472 2003
% 220.48/220.65  |- mesh__recordMaintainer mesh__D000472 SJN
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D000472 2000
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D000472 2006
% 220.48/220.65  |- rdf__type mesh__D000472sskos__Concept
% 220.48/220.65  |- mesh__dateEstablished mesh__D000472 1974-01-01
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D022126 2003
% 220.48/220.65  |- skos__hiddenLabel mesh__D022126 Information, Access to
% 220.48/220.65  |- skos__broader mesh__D022126smesh__D018907
% 220.48/220.65  |- skos__hiddenLabel mesh__D022126 FOIA Request
% 220.48/220.65  |- skos__prefLabel mesh__D022126 Access to Information
% 220.48/220.65  |- mesh__dateEstablished mesh__D022126 2002-01-01
% 220.48/220.65  |- mesh__dateRevised mesh__D022126 2002-10-31
% 220.48/220.65  |- mesh__recordOriginator mesh__D022126 jls
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D022126 2002
% 220.48/220.65  |- skos__hiddenLabel mesh__D022126 Requests, FOIA
% 220.48/220.65  |- skos__hiddenLabel mesh__D022126 Request, FOIA
% 220.48/220.65  |- skos__altLabel mesh__D022126 FOIA Requests
% 220.48/220.65  |- mesh__dateCreated mesh__D022126 2001-07-27
% 220.48/220.65  |- rdf__type mesh__D022126sskos__Concept
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D022126 2006
% 220.48/220.65  |- mesh__recordAuthorizer mesh__D022126 jls
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D022126 2003B
% 220.48/220.65  |- skos__scopeNote mesh__D022126
% 220.48/220.65       Individual%27%s rights to obtain and use information collected or generated by others.%A%    
% 220.48/220.65  |- mesh__recordMaintainer mesh__D022126 jls
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D022126 2005
% 220.48/220.65  |- mesh__historyNote mesh__D022126 2001   
% 220.48/220.65  |- mesh__publicMeSHNote mesh__D022126 2001   
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D022126 2003A
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D022126 2004
% 220.48/220.65  |- skos__hiddenLabel mesh__D018883 Heatstrokes
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018883 2006
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018883 1996
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018883 2005
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018883 2004
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018883 2001
% 220.48/220.65  |- mesh__dateCreated mesh__D018883 1994-12-27
% 220.48/220.65  |- skos__annotation mesh__D018883
% 220.48/220.65       a heat stress disorder where body temp is dangerously high: differentiate from HEAT EXHAUSTION where body temp is subnormal; SUNSTROKE is also available%A%  
% 220.48/220.65  |- skos__hiddenLabel mesh__D018883 Strokes, Heat
% 220.48/220.65  |- skos__historyNote mesh__D018883 Heat Exhaustion %28%1966-1995%29%
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018883 2003
% 220.48/220.65  |- rdf__type mesh__D018883sskos__Concept
% 220.48/220.65  |- skos__altLabel mesh__D018883 Heatstroke
% 220.48/220.65  |- skos__scopeNote mesh__D018883
% 220.48/220.65       Overexposure to heat or overexertion most common in old age or infancy but especially in the elderly, accompanied by convulsions, delusions, or coma. It is treated by cooling the body and replacing fluids and salts. %28%From Segen, Dictionary of Modern Medicine, 1992, p282%29%%A%    
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018883 2000
% 220.48/220.65  |- mesh__publicMeSHNote mesh__D018883 96   
% 220.48/220.65  |- mesh__historyNote mesh__D018883 96   
% 220.48/220.65  |- mesh__dateEstablished mesh__D018883 1996-01-01
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018883 1999
% 220.48/220.65  |- skos__prefLabel mesh__D018883 Heat Stroke
% 220.48/220.65  |- skos__hiddenLabel mesh__D018883 Stroke, Heat
% 220.48/220.65  |- skos__broader mesh__D018883smesh__D018882
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018883 2002
% 220.48/220.65  |- skos__hiddenLabel mesh__D018883 Heat Strokes
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018883 1998
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018883 1997
% 220.48/220.65  |- skos__broader mesh__D018085smesh__D040481
% 220.48/220.65  |- mesh__recordMaintainer mesh__D018085 nns
% 220.48/220.65  |- skos__historyNote mesh__D018085 Base Sequence %28%1984-1993%29%
% 220.48/220.65  |- mesh__historyNote mesh__D018085 94   
% 220.48/220.65  |- skos__prefLabel mesh__D018085 Regulon
% 220.48/220.65  |- mesh__dateRevised mesh__D018085 2005-06-30
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D018085 2006
% 220.48/220.65  |- skos__annotation mesh__D018085
% 220.48/220.65       in bacteria, coord IM with specific bacterium /genet %28%IM%29%%A%  
% 220.48/220.65  |- rdf__type mesh__D018085sskos__Concept
% 220.48/220.65  |- skos__hiddenLabel mesh__D018085 Regulons
% 220.48/220.65  |- mesh__recordOriginator mesh__D018085 PXP
% 220.48/220.65  |- mesh__dateCreated mesh__D018085 1993-06-03
% 220.48/220.65  |- mesh__recordAuthorizer mesh__D018085 sjn
% 220.48/220.65  |- skos__scopeNote mesh__D018085
% 220.48/220.65       In eukaryotes, a genetic unit consisting of a noncontiguous group of genes under the control of a single regulator gene. In bacteria, regulons are global regulatory systems involved in the interplay of pleiotropic regulatory domains and consist of several OPERONS.%A%    
% 220.48/220.65  |- mesh__dateEstablished mesh__D018085 1994-01-01
% 220.48/220.65  |- mesh__publicMeSHNote mesh__D018085 94   
% 220.48/220.65  |- skos__historyNote mesh__D018085 Genes, Regulator %28%1969-1993%29%
% 220.48/220.65  |- mesh__recordAuthorizer mesh__D004863 sjn
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D004863 2004
% 220.48/220.65  |- mesh__dateRevised mesh__D004863 2002-07-03
% 220.48/220.65  |- mesh__recordMaintainer mesh__D004863 ags
% 220.48/220.65  |- skos__hiddenLabel mesh__D004863 Deformity, Equinus
% 220.48/220.65  |- mesh__publicMeSHNote mesh__D004863 88   
% 220.48/220.65  |- skos__hiddenLabel mesh__D004863 Equinus Deformities
% 220.48/220.65  |- mesh__recordOriginator mesh__D004863 EC
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D004863 2003
% 220.48/220.65  |- skos__hiddenLabel mesh__D004863 Contracture, Equinus
% 220.48/220.65  |- skos__scopeNote mesh__D004863 Plantar declination of the foot.     
% 220.48/220.65  |- mesh__dateCreated mesh__D004863 1987-04-02
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D004863 2006
% 220.48/220.65  |- skos__altLabel mesh__D004863 Equinus Contracture
% 220.48/220.65  |- mesh__dateEstablished mesh__D004863 1988-01-01
% 220.48/220.65  |- skos__hiddenLabel mesh__D004863 Deformities, Equinus
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D004863 2005
% 220.48/220.65  |- skos__annotation mesh__D004863
% 220.48/220.65       do not confuse with EQUINOVARUS see CLUBFOOT   
% 220.48/220.65  |- skos__altLabel mesh__D004863 Talipes Equinus
% 220.48/220.65  |- mesh__historyNote mesh__D004863 88   
% 220.48/220.65  |- skos__broader mesh__D004863smesh__D005531
% 220.48/220.65  |- rdf__type mesh__D004863sskos__Concept
% 220.48/220.65  |- skos__hiddenLabel mesh__D004863 Equinus Contractures
% 220.48/220.65  |- skos__hiddenLabel mesh__D004863 Contractures, Equinus
% 220.48/220.65  |- skos__prefLabel mesh__D004863 Equinus Deformity
% 220.48/220.65  |- mesh__dateEstablished mesh__D004065 1998-01-01
% 220.48/220.65  |- mesh__dateRevised mesh__D004065 2003-07-09
% 220.48/220.65  |- skos__broader mesh__D004065smesh__D004066
% 220.48/220.65  |- skos__scopeNote mesh__D004065
% 220.48/220.65       Congenital structural abnormalities of the DIGESTIVE SYSTEM.%A%    
% 220.48/220.65  |- mesh__publicMeSHNote mesh__D004065 98   
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D004065 2006
% 220.48/220.65  |- skos__altLabel mesh__D004065 Abnormalities, Digestive System
% 220.48/220.65  |- mesh__recordAuthorizer mesh__D004065 sjn
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D004065 2005
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D004065 2004
% 220.48/220.65  |- skos__broader mesh__D004065smesh__D000013
% 220.48/220.65  |- skos__hiddenLabel mesh__D004065 Abnormality, Digestive System
% 220.48/220.65  |- skos__hiddenLabel mesh__D004065 Digestive System Abnormality
% 220.48/220.65  |- rdf__type mesh__D004065sskos__Concept
% 220.48/220.65  |- skos__prefLabel mesh__D004065 Digestive System Abnormalities
% 220.48/220.65  |- mesh__recordOriginator mesh__D004065 NLM
% 220.48/220.65  |- mesh__recordMaintainer mesh__D004065 lkt
% 220.48/220.65  |- mesh__historyNote mesh__D004065 98; use explode 1971-97   
% 220.48/220.65  |- mesh__dateCreated mesh__D004065 1999-01-01
% 220.48/220.65  |- skos__annotation mesh__D004065
% 220.48/220.65       GEN or unspecified; prefer specifics or specific organ /abnorm; DF: DIGESTIVE SYSTEM ABNORM%A%  
% 220.48/220.65  |- skos__historyNote mesh__D004065
% 220.48/220.65       Digestive System/abnormalities %28%1968-1997%29%
% 220.48/220.65  |- skos__altLabel mesh__D050616 Balaenoptera brydei
% 220.48/220.65  |- skos__historyNote mesh__D050616 Whales %28%1975-2005%29%
% 220.48/220.65  |- skos__hiddenLabel mesh__D050616 Sei Whales
% 220.48/220.65  |- skos__prefLabel mesh__D050616 Balaenoptera
% 220.48/220.65  |- skos__hiddenLabel mesh__D050616 Bryde Whale
% 220.48/220.65  |- skos__broader mesh__D050616smesh__D014907
% 220.48/220.65  |- mesh__recordMaintainer mesh__D050616 ags
% 220.48/220.65  |- mesh__publicMeSHNote mesh__D050616
% 220.48/220.65       2006; see WHALES 1998-2005; for Blue Whale, Bryde%27%s Whale, and Sei Whale see WHALES 1998-2005%A%  
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D050616 2006
% 220.48/220.65  |- skos__hiddenLabel mesh__D050616 Brydes Whale
% 220.48/220.65  |- rdf__type mesh__D050616sskos__Concept
% 220.48/220.65  |- mesh__recordAuthorizer mesh__D050616 sjn
% 220.48/220.65  |- mesh__dateEstablished mesh__D050616 2006-01-01
% 220.48/220.65  |- mesh__historyNote mesh__D050616
% 220.48/220.65       2006; use WHALES 1998-2005; for Blue Whale, Bryde%27%s Whale, and Sei Whale use WHALES 1998-2005%A%  
% 220.48/220.65  |- skos__scopeNote mesh__D050616
% 220.48/220.65       A genus of WHALES in the family Balaenopteridae, consisting of five species: Blue Whale, Bryde%27%s Whale, FIN WHALE, Sei Whale, and MINKE WHALE. They are distinguished by a relatively slender body, a compressed tail stock, and a pointed snout.%A%    
% 220.48/220.65  |- mesh__dateCreated mesh__D050616 2005-06-30
% 220.48/220.65  |- skos__hiddenLabel mesh__D050616 Blue Whales
% 220.48/220.65  |- mesh__recordOriginator mesh__D050616 ags
% 220.48/220.65  |- skos__altLabel mesh__D050616 Balaenoptera borealis
% 220.48/220.65  |- skos__historyNote mesh__D050616 Cetacea %28%1965-1990%29%
% 220.48/220.65  |- skos__altLabel mesh__D050616 Balaenoptera musculus
% 220.48/220.65  |- mesh__recordMaintainer mesh__D014493 JLS
% 220.48/220.65  |- skos__scopeNote mesh__D014493
% 220.48/220.65       A division of the Executive Branch of the United States government concerned with overall planning, promoting, and administering programs pertaining to veterans. The Department of Veterans Affairs %28%VA%29% was established March 15, 1989 as a Cabinet-level position.%A%    
% 220.48/220.65  |- skos__altLabel mesh__D014493 Veterans Administration %28%U.S.%29%
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D014493 2000
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D014493 2005
% 220.48/220.65  |- skos__annotation mesh__D014493
% 220.48/220.65       add UNITED STATES %28%NIM%29%; research support by this agency is checked as OTHER US GOVT SUP: DF: VA      CATALOG: use NAF entry%A%  
% 220.48/220.65  |- skos__altLabel mesh__D014493 United States Veterans Administration
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D014493 2003
% 220.48/220.65  |- skos__altLabel mesh__D014493 United States Veterans%27% Administration
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D014493 2006
% 220.48/220.65  |- mesh__recordOriginator mesh__D014493 NLM
% 220.48/220.65  |- mesh__onlineNote mesh__D014493
% 220.48/220.65       use UNITED STATES DEPARTMENT OF VETERANS AFFAIRS to search UNITED STATES VETERANS ADMINISTRATION 1966-90%A%  
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D014493 2004
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D014493 2001
% 220.48/220.65  |- mesh__dateCreated mesh__D014493 1999-01-01
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D014493 2002
% 220.48/220.65  |- skos__broader mesh__D014493smesh__D006077
% 220.48/220.65  |- mesh__publicMeSHNote mesh__D014493
% 220.48/220.65       91; was UNITED STATES VETERANS ADMINISTRATION 1966-90   
% 220.48/220.65  |- skos__prefLabel mesh__D014493
% 220.48/220.65       United States Department of Veterans Affairs
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D014493 1998
% 220.48/220.65  |- skos__altLabel mesh__D014493 Veterans Administration
% 220.48/220.65  |- mesh__dateRevised mesh__D014493 1997-06-20
% 220.48/220.65  |- mesh__dateEstablished mesh__D014493 1966-01-01
% 220.48/220.65  |- mesh__historyNote mesh__D014493
% 220.48/220.65       91; was UNITED STATES VETERANS ADMINISTRATION 1966-90   
% 220.48/220.65  |- rdf__type mesh__D014493sskos__Concept
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D014493 1999
% 220.48/220.65  |- skos__altLabel mesh__D014493 Veterans Affairs %28%U.S.%29%
% 220.48/220.65  |- mesh__recordAuthorizer mesh__D014493 SJN
% 220.48/220.65  |- skos__broader mesh__D014688Q000037smesh__D014688
% 220.48/220.65  |- mesh__preferredCombination mesh__D014688Q000037smesh__D000997
% 220.48/220.65  |- rdf__type mesh__D014688Q000037smesh__CompoundConcept
% 220.48/220.65  |- skos__historyNote mesh__D008456 Glycolates %28%1969-1974%29%
% 220.48/220.65  |- mesh__dateEstablished mesh__D008456 1991-01-01
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D008456 2006
% 220.48/220.65  |- skos__hiddenLabel mesh__D008456 2 Methyl 4 chlorophenoxyacetic Acid
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D008456 2002
% 220.48/220.65  |- mesh__recordMaintainer mesh__D008456 jmp
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D008456 2005
% 220.48/220.65  |- mesh__recordAuthorizer mesh__D008456 sjn
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D008456 2001
% 220.48/220.65  |- mesh__dateCreated mesh__D008456 1974-11-19
% 220.48/220.65  |- skos__prefLabel mesh__D008456 2-Methyl-4-chlorophenoxyacetic Acid
% 220.48/220.65  |- skos__altLabel mesh__D008456 MCPA
% 220.48/220.65  |- skos__scopeNote mesh__D008456
% 220.48/220.65       A powerful herbicide used as a selective weed killer.     
% 220.48/220.65  |- rdf__type mesh__D008456sskos__Concept
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D008456 2004
% 220.48/220.65  |- mesh__recordOriginator mesh__D008456 NLM
% 220.48/220.65  |- mesh__dateRevised mesh__D008456 2000-06-21
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D008456 2003
% 220.48/220.65  |- mesh__historyNote mesh__D008456 2001%28%1975%29%   
% 220.48/220.65  |- skos__historyNote mesh__D008456 Toluene %28%1974%29%
% 220.48/220.65  |- mesh__publicMeSHNote mesh__D008456
% 220.48/220.65       2001; see MCPA 1991-2000 %26% GLYCOLATES 1975-90   
% 220.48/220.65  |- skos__broader mesh__D008456smesh__D006016
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D000473 2000
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D000473 1996
% 220.48/220.65  |- mesh__publicMeSHNote mesh__D000473 66   
% 220.48/220.65  |- mesh__dateEstablished mesh__D000473 1966-01-01
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D000473 1999
% 220.48/220.65  |- skos__prefLabel mesh__D000473 Alkanes
% 220.48/220.65  |- skos__annotation mesh__D000473 cycloalkanes = CYCLOPARAFFINS   
% 220.48/220.65  |- mesh__recordMaintainer mesh__D000473 TGC
% 220.48/220.65  |- skos__broader mesh__D000473smesh__D006839
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D000473 2004
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D000473 2002
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D000473 1998
% 220.48/220.65  |- mesh__recordOriginator mesh__D000473 NLM
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D000473 2003
% 220.48/220.65  |- skos__scopeNote mesh__D000473
% 220.48/220.65       The generic name for the group of aliphatic hydrocarbons Cn-H2n+2. They are denoted by the suffix -ane. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D000473 2006
% 220.48/220.65  |- mesh__recordAuthorizer mesh__D000473 PLS
% 220.48/220.65  |- rdf__type mesh__D000473sskos__Concept
% 220.48/220.65  |- mesh__dateRevised mesh__D000473 1995-03-16
% 220.48/220.65  |- mesh__dateCreated mesh__D000473 1999-01-01
% 220.48/220.65  |- mesh__historyNote mesh__D000473 66   
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D000473 2001
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D000473 1997
% 220.48/220.65  |- mesh__activeMeSHYear mesh__D000473 2005
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D018884 2005
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D018884 2004
% 220.48/220.66  |- skos__altLabel mesh__D018884 Black-legged Tick
% 220.48/220.66  |- mesh__recordAuthorizer mesh__D018884 sjn
% 220.48/220.66  |- skos__scopeNote mesh__D018884
% 220.48/220.66       The largest genus of TICKS in the family IXODIDAE, containing over 200 species. Many infest humans and other mammals and several are vectors of diseases such as LYME DISEASE, tick-borne encephalitis %28%ENCEPHALITIS, TICK-BORNE%29%, and KYASANUR FOREST DISEASE.%A%    
% 220.48/220.66  |- skos__historyNote mesh__D018884 Ticks %28%1966-1995%29%
% 220.48/220.66  |- mesh__recordOriginator mesh__D018884 PXP
% 220.48/220.66  |- rdf__type mesh__D018884sskos__Concept
% 220.48/220.66  |- skos__altLabel mesh__D018884 Castor Bean Tick
% 220.48/220.66  |- skos__annotation mesh__D018884
% 220.48/220.66       infestation: coord IM with TICK INFESTATIONS %28%IM%29%   
% 220.48/220.66  |- mesh__dateCreated mesh__D018884 1995-05-24
% 220.48/220.66  |- mesh__historyNote mesh__D018884 96   
% 220.48/220.66  |- skos__broader mesh__D018884smesh__D026863
% 220.48/220.66  |- mesh__dateRevised mesh__D018884 2003-07-09
% 220.48/220.66  |- skos__prefLabel mesh__D018884 Ixodes
% 220.48/220.66  |- mesh__publicMeSHNote mesh__D018884 96   
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D018884 2006
% 220.48/220.66  |- mesh__dateEstablished mesh__D018884 1996-01-01
% 220.48/220.66  |- skos__altLabel mesh__D018884 Deer Tick
% 220.48/220.66  |- mesh__recordMaintainer mesh__D018884 ags
% 220.48/220.66  |- mesh__dateEstablished mesh__D018086 1994-01-01
% 220.48/220.66  |- skos__historyNote mesh__D018086
% 220.48/220.66       Glutamate Dehydrogenase %28%1982-1993%29%
% 220.48/220.66  |- mesh__onlineNote mesh__D018086
% 220.48/220.66       use GLUTAMATE DEHYDROGENASE %28%NADP+%29% %28%NM%29% to search GLUTAMATE DEHYDROGENASE %28%NADP+%29% 1982-93%A%  
% 220.48/220.66  |- mesh__recordMaintainer mesh__D018086 jmp
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D018086 2006
% 220.48/220.66  |- skos__altLabel mesh__D018086 NADPH-Dependent Glutamate Dehydrogenase
% 220.48/220.66  |- rdf__type mesh__D018086sskos__Concept
% 220.48/220.66  |- skos__hiddenLabel mesh__D018086 Dehydrogenase, NADP-Dependent Glutamate
% 220.48/220.66  |- skos__broader mesh__D018086smesh__D000594
% 220.48/220.66  |- skos__altLabel mesh__D018086 NADP-Dependent Glutamate Dehydrogenase
% 220.48/220.66  |- skos__scopeNote mesh__D018086
% 220.48/220.66       An enzyme that catalyzes the conversion of L-glutamate, H2O, and NADP+ to 2-oxoglutarate, NH3, and NADPH. %28%From Enzyme Nomenclature, 1992%29% EC 1.4.1.4.%A%    
% 220.48/220.66  |- skos__hiddenLabel mesh__D018086 Glutamate Dehydrogenase, NADP-Dependent
% 220.48/220.66  |- skos__hiddenLabel mesh__D018086 NADP+ Dependent Glutamate Dehydrogenase
% 220.48/220.66  |- mesh__historyNote mesh__D018086
% 220.48/220.66       94; was GLUTAMATE DEHYDROGENASE %28%NADP+%29% %28%NM%29% 1982-93   
% 220.48/220.66  |- mesh__publicMeSHNote mesh__D018086
% 220.48/220.66       94; GLUTAMATE DEHYDROGENASE %28%NADP+%29% was indexed under GLUTAMATE DEHYDROGENASE 1982-93%A%  
% 220.48/220.66  |- mesh__dateRevised mesh__D018086 2005-06-30
% 220.48/220.66  |- skos__hiddenLabel mesh__D018086 Glutamate Dehydrogenase, NADP+-Dependent
% 220.48/220.66  |- mesh__recordOriginator mesh__D018086 TPW
% 220.48/220.66  |- skos__prefLabel mesh__D018086 Glutamate Dehydrogenase %28%NADP+%29%
% 220.48/220.66  |- mesh__dateCreated mesh__D018086 1993-06-04
% 220.48/220.66  |- skos__hiddenLabel mesh__D018086 Dehydrogenase, NADPH-Dependent Glutamate
% 220.48/220.66  |- skos__hiddenLabel mesh__D018086 NADP Specific Glutamate Dehydrogenase
% 220.48/220.66  |- mesh__recordAuthorizer mesh__D018086 sjn
% 220.48/220.66  |- skos__hiddenLabel mesh__D018086 NADP Dependent Glutamate Dehydrogenase
% 220.48/220.66  |- skos__hiddenLabel mesh__D018086 Dehydrogenase, NADP+-Dependent Glutamate
% 220.48/220.66  |- skos__hiddenLabel mesh__D018086 Dehydrogenase, NADP-Specific Glutamate
% 220.48/220.66  |- skos__altLabel mesh__D018086 NADP+-Dependent Glutamate Dehydrogenase
% 220.48/220.66  |- skos__hiddenLabel mesh__D018086 Glutamate Dehydrogenase, NADPH-Dependent
% 220.48/220.66  |- skos__altLabel mesh__D018086 NADP-Specific Glutamate Dehydrogenase
% 220.48/220.66  |- skos__hiddenLabel mesh__D018086 NADPH Dependent Glutamate Dehydrogenase
% 220.48/220.66  |- skos__hiddenLabel mesh__D018086 Glutamate Dehydrogenase, NADP-Specific
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004864 2000
% 220.48/220.66  |- mesh__recordAuthorizer mesh__D004864 SJN
% 220.48/220.66  |- mesh__onlineNote mesh__D004864
% 220.48/220.66       pre-explosion = EQUIPMENT A%23%D SUPPLIES %28%PX%29%   
% 220.48/220.66  |- mesh__recordOriginator mesh__D004864 NLM
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004864 2006
% 220.48/220.66  |- skos__prefLabel mesh__D004864 Equipment and Supplies
% 220.48/220.66  |- mesh__dateCreated mesh__D004864 1999-01-01
% 220.48/220.66  |- skos__hiddenLabel mesh__D004864 Device
% 220.48/220.66  |- skos__altLabel mesh__D004864 Medical Device
% 220.48/220.66  |- skos__related mesh__D004864smesh__D002379
% 220.48/220.66  |- mesh__dateRevised mesh__D004864 1997-06-20
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004864 2005
% 220.48/220.66  |- skos__scopeNote mesh__D004864
% 220.48/220.66       Expendable and nonexpendable equipment, supplies, apparatus, and instruments that are used in diagnostic, surgical, therapeutic, scientific, and experimental procedures.%A%    
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004864 2002
% 220.48/220.66  |- skos__altLabel mesh__D004864 Apparatus and Instruments
% 220.48/220.66  |- skos__hiddenLabel mesh__D004864 Inventory
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004864 1999
% 220.48/220.66  |- skos__hiddenLabel mesh__D004864 Supplies and Equipment
% 220.48/220.66  |- rdf__type mesh__D004864sskos__Concept
% 220.48/220.66  |- skos__annotation mesh__D004864
% 220.48/220.66       GEN only: prefer /instrum: Manual 19.7+, 19.8.40; when GEN %26% IM,  Manual 26.24+; DF: EQUIPMENT%A%  
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004864 1998
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004864 2004
% 220.48/220.66  |- mesh__runningHead mesh__D004864 E7 - EQUIPMENT AND SUPPLIES   
% 220.48/220.66  |- skos__altLabel mesh__D004864 Devices, Medical
% 220.48/220.66  |- skos__hiddenLabel mesh__D004864 Instruments and Apparatus
% 220.48/220.66  |- skos__altLabel mesh__D004864 Device, Medical
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004864 2001
% 220.48/220.66  |- mesh__recordMaintainer mesh__D004864 PXP
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004864 2003
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004066 2006
% 220.48/220.66  |- skos__prefLabel mesh__D004066 Digestive System Diseases
% 220.48/220.66  |- skos__hiddenLabel mesh__D004066 Digestive System Disease
% 220.48/220.66  |- mesh__historyNote mesh__D004066 80; was NON MESH before 1980   
% 220.48/220.66  |- skos__hiddenLabel mesh__D004066 Disease, Digestive System
% 220.48/220.66  |- mesh__recordOriginator mesh__D004066 NLM
% 220.48/220.66  |- skos__scopeNote mesh__D004066
% 220.48/220.66       Diseases in any part of the GASTROINTESTINAL TRACT or the accessory organs %28%LIVER; BILIARY TRACT; PANCREAS%29%.%A%    
% 220.48/220.66  |- mesh__runningHead mesh__D004066 C6 - DISEASES-DIGESTIVE   
% 220.48/220.66  |- mesh__publicMeSHNote mesh__D004066 80   
% 220.48/220.66  |- mesh__recordMaintainer mesh__D004066 lkt
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004066 2004
% 220.48/220.66  |- skos__historyNote mesh__D004066
% 220.48/220.66       Gastrointestinal Diseases %28%1966-1979%29%
% 220.48/220.66  |- skos__hiddenLabel mesh__D004066 Diseases, Digestive System
% 220.48/220.66  |- mesh__dateEstablished mesh__D004066 1980-01-01
% 220.48/220.66  |- mesh__dateCreated mesh__D004066 1999-01-01
% 220.48/220.66  |- mesh__recordAuthorizer mesh__D004066 sjn
% 220.48/220.66  |- skos__hiddenLabel mesh__D004066 System Disease, Digestive
% 220.48/220.66  |- rdf__type mesh__D004066sskos__Concept
% 220.48/220.66  |- skos__annotation mesh__D004066
% 220.48/220.66       GEN or unspecified; refers to all organs of digestive tract: do not confuse with GASTROINTESTINAL DISEASES %28%diseases of the GASTROINTESTINAL TRACT%29%; /diag: consider also DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM%A%  
% 220.48/220.66  |- mesh__onlineNote mesh__D004066
% 220.48/220.66       pre-explosion = DIGESTIVE SYSTEM DISEASES %28%PX%29%   
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004066 2005
% 220.48/220.66  |- skos__hiddenLabel mesh__D004066 System Diseases, Digestive
% 220.48/220.66  |- mesh__dateRevised mesh__D004066 2003-07-09
% 220.48/220.66  |- mesh__dateCreated mesh__D050617 2005-06-30
% 220.48/220.66  |- mesh__publicMeSHNote mesh__D050617 2006; see WHALES 1998-2005   
% 220.48/220.66  |- mesh__recordOriginator mesh__D050617 ags
% 220.48/220.66  |- skos__scopeNote mesh__D050617
% 220.48/220.66       The species Balaenoptera physalus, in the family Balaenopteridae, characterized by a large, strongly curved, dorsal fin. It is the second largest of the WHALES, highly migratory, but rarely seen near the shore.%A%    
% 220.48/220.66  |- skos__altLabel mesh__D050617 Finback Whale
% 220.48/220.66  |- mesh__recordMaintainer mesh__D050617 ags
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D050617 2006
% 220.48/220.66  |- skos__altLabel mesh__D050617 Balaenoptera physalus
% 220.48/220.66  |- skos__historyNote mesh__D050617 Whales %28%1975-2005%29%
% 220.48/220.66  |- skos__hiddenLabel mesh__D050617 Finback Whales
% 220.48/220.66  |- rdf__type mesh__D050617sskos__Concept
% 220.48/220.66  |- skos__hiddenLabel mesh__D050617 Whales, Finback
% 220.48/220.66  |- skos__hiddenLabel mesh__D050617 Whale, Finback
% 220.48/220.66  |- skos__broader mesh__D050617smesh__D050616
% 220.48/220.66  |- skos__hiddenLabel mesh__D050617 Fin Whales
% 220.48/220.66  |- mesh__recordAuthorizer mesh__D050617 sjn
% 220.48/220.66  |- mesh__dateEstablished mesh__D050617 2006-01-01
% 220.48/220.66  |- skos__historyNote mesh__D050617 Cetacea %28%1965-1974%29%
% 220.48/220.66  |- mesh__historyNote mesh__D050617 2006; use WHALES 1998-2005   
% 220.48/220.66  |- skos__prefLabel mesh__D050617 Fin Whale
% 220.48/220.66  |- mesh__dateEstablished mesh__D014494 1991-01-01
% 220.48/220.66  |- skos__altLabel mesh__D014494 2,3-Dimercaptopropane 1-Sodium Sulfonate
% 220.48/220.66  |- skos__altLabel mesh__D014494 Sodium 2,3-Dithiopropanesulfate
% 220.48/220.66  |- mesh__dateRevised mesh__D014494 2005-06-30
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D014494 2006
% 220.48/220.66  |- skos__hiddenLabel mesh__D014494 2,3 Dimercaptopropanesulfonic Acid
% 220.48/220.66  |- mesh__recordOriginator mesh__D014494 SH
% 220.48/220.66  |- mesh__publicMeSHNote mesh__D014494
% 220.48/220.66       91; was see under DIMERCAPROL 1976-90   
% 220.48/220.66  |- skos__altLabel mesh__D014494 Sodium 2,3-Dimercaptopropane Sulfonate
% 220.48/220.66  |- skos__altLabel mesh__D014494 2,3-Dimercaptopropane-1-sulfonate Sodium
% 220.48/220.66  |- skos__altLabel mesh__D014494 2,3-Dimercapto-1-propanesulfonic Acid
% 220.48/220.66  |- mesh__dateCreated mesh__D014494 1975-07-25
% 220.48/220.66  |- skos__annotation mesh__D014494 D25-26 qualif   
% 220.48/220.66  |- skos__altLabel mesh__D014494 DMPS-Heyl
% 220.48/220.66  |- skos__prefLabel mesh__D014494 Unithiol
% 220.48/220.66  |- mesh__historyNote mesh__D014494
% 220.48/220.66       91%28%76%29%; was see under DIMERCAPROL 1976-90   
% 220.48/220.66  |- mesh__recordAuthorizer mesh__D014494 sjn
% 220.48/220.66  |- skos__historyNote mesh__D014494 Sulfhydryl Compounds %28%1974-1975%29%
% 220.48/220.66  |- skos__historyNote mesh__D014494 Alkyl Sulfonates %28%1974-1975%29%
% 220.48/220.66  |- skos__altLabel mesh__D014494 2,3-Dimercaptopropanesulfonic Acid
% 220.48/220.66  |- skos__altLabel mesh__D014494 Unitiol
% 220.48/220.66  |- skos__scopeNote mesh__D014494
% 220.48/220.66       A chelating agent used as an antidote to heavy metal poisoning.%A%    
% 220.48/220.66  |- skos__altLabel mesh__D014494 Heyl Brand of Unithiol
% 220.48/220.66  |- mesh__recordMaintainer mesh__D014494 CCR
% 220.48/220.66  |- skos__hiddenLabel mesh__D014494 2,3-Dimercaptopropane Sulfonate, Sodium
% 220.48/220.66  |- skos__hiddenLabel mesh__D014494 2,3-Dithiopropanesulfate, Sodium
% 220.48/220.66  |- skos__altLabel mesh__D014494 biosyn Brand of Unithiol
% 220.48/220.66  |- rdf__type mesh__D014494sskos__Concept
% 220.48/220.66  |- skos__hiddenLabel mesh__D014494 2,3 Dimercaptopropane 1 sulfonate Sodium
% 220.48/220.66  |- skos__hiddenLabel mesh__D014494 2,3 Dimercapto 1 propanesulfonic Acid
% 220.48/220.66  |- skos__hiddenLabel mesh__D014494 DMPS Heyl
% 220.48/220.66  |- skos__hiddenLabel mesh__D014494
% 220.48/220.66       1-Sodium Sulfonate, 2,3-Dimercaptopropane
% 220.48/220.66  |- skos__altLabel mesh__D014494 DMPS
% 220.48/220.66  |- skos__hiddenLabel mesh__D014494 2,3 Dimercaptopropane 1 Sodium Sulfonate
% 220.48/220.66  |- skos__broader mesh__D014494smesh__D004112
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D008457 2005
% 220.48/220.66  |- skos__annotation mesh__D008457
% 220.48/220.66       caused by a morbillivirus; do not confuse X ref RUBEOLA with RUBELLA %28%German measles%29%; French for measles = rougeole %28%not rub%C3%%A9%ole which = RUBELLA%29%, Ital for measles = rosolia %28%not rubeola which = RUBELLA%29%; Span for measles = sarampi %28%not rubeola which = RUBELLA%29%%A%  
% 220.48/220.66  |- rdf__type mesh__D008457sskos__Concept
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D008457 2004
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D008457 2002
% 220.48/220.66  |- skos__scopeNote mesh__D008457
% 220.48/220.66       A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the reticuloendothelial system. %28%From Dorland, 27th ed%29%%A%    
% 220.48/220.66  |- skos__prefLabel mesh__D008457 Measles
% 220.48/220.66  |- mesh__recordAuthorizer mesh__D008457 sjn
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D008457 2003
% 220.48/220.66  |- mesh__recordMaintainer mesh__D008457 jls
% 220.48/220.66  |- mesh__dateCreated mesh__D008457 1999-01-01
% 220.48/220.66  |- mesh__recordOriginator mesh__D008457 NLM
% 220.48/220.66  |- skos__broader mesh__D008457smesh__D018185
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D008457 2006
% 220.48/220.66  |- skos__altLabel mesh__D008457 Rubeola
% 220.48/220.66  |- mesh__dateRevised mesh__D008457 2001-08-13
% 220.48/220.66  |- mesh__recordAuthorizer mesh__D000474 sjn
% 220.48/220.66  |- skos__broader mesh__D000474smesh__D000592
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D000474 2003
% 220.48/220.66  |- mesh__dateRevised mesh__D000474 2001-07-25
% 220.48/220.66  |- mesh__recordMaintainer mesh__D000474 nns
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D000474 2004
% 220.48/220.66  |- mesh__dateCreated mesh__D000474 1999-01-01
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D000474 2002
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D000474 2005
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D000474 2006
% 220.48/220.66  |- skos__scopeNote mesh__D000474
% 220.48/220.66       An inborn error of amino acid metabolism resulting from a defect in the enzyme homogentisate 1,2-dioxygenase and causing an accumulation of homogentisic acid in the urine. The condition is characterized by ochronosis in various tissues and arthritis.%A%    
% 220.48/220.66  |- rdf__type mesh__D000474sskos__Concept
% 220.48/220.66  |- skos__prefLabel mesh__D000474 Alkaptonuria
% 220.48/220.66  |- skos__annotation mesh__D000474
% 220.48/220.66       an inborn error of amino acid metab; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 220.48/220.66  |- mesh__recordOriginator mesh__D000474 NLM
% 220.48/220.66  |- mesh__dateRevised mesh__D018087 2003-07-09
% 220.48/220.66  |- mesh__recordAuthorizer mesh__D018087 sjn
% 220.48/220.66  |- mesh__recordOriginator mesh__D018087 PXP
% 220.48/220.66  |- mesh__dateCreated mesh__D018087 1993-06-03
% 220.48/220.66  |- skos__historyNote mesh__D018087 Base Sequence %28%1987-1993%29%
% 220.48/220.66  |- skos__historyNote mesh__D018087 Chloroplasts %28%1966-1993%29%
% 220.48/220.66  |- skos__hiddenLabel mesh__D018087 Plastid
% 220.48/220.66  |- mesh__dateEstablished mesh__D018087 1994-01-01
% 220.48/220.66  |- mesh__publicMeSHNote mesh__D018087 94   
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D018087 2004
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D018087 2005
% 220.48/220.66  |- mesh__recordMaintainer mesh__D018087 nns
% 220.48/220.66  |- mesh__historyNote mesh__D018087 94   
% 220.48/220.66  |- skos__scopeNote mesh__D018087
% 220.48/220.66       Self-replicating cytoplasmic organelles of plant and algal cells that contain pigments and may synthesize and accumulate various substances. Plastids are used in phylogenetic studies.%A%    
% 220.48/220.66  |- skos__hiddenLabel mesh__D018087 Chromoplast
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D018087 2006
% 220.48/220.66  |- skos__prefLabel mesh__D018087 Plastids
% 220.48/220.66  |- rdf__type mesh__D018087sskos__Concept
% 220.48/220.66  |- skos__broader mesh__D018087smesh__D015388
% 220.48/220.66  |- skos__annotation mesh__D018087
% 220.48/220.66       organelles in plants or algae; A 11 qualif except /cytol; /genet permitted; coord IM with PLANTS; ALGAE; or specific plant or alga usually NIM%A%  
% 220.48/220.66  |- mesh__recordMaintainer mesh__D004865 KEV
% 220.48/220.66  |- skos__hiddenLabel mesh__D004865 Hospital Supply
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004865 2001
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004865 2005
% 220.48/220.66  |- skos__broader mesh__D004865smesh__D004864
% 220.48/220.66  |- skos__scopeNote mesh__D004865
% 220.48/220.66       Any materials used in providing care specifically in the hospital.%A%    
% 220.48/220.66  |- skos__altLabel mesh__D004865 Supplies, Hospital
% 220.48/220.66  |- skos__altLabel mesh__D004865 Equipment, Hospital
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004865 2000
% 220.48/220.66  |- mesh__publicMeSHNote mesh__D004865
% 220.48/220.66       78; was HOSPITAL EQUIPMENT AND SUPPLIES 1963-77   
% 220.48/220.66  |- mesh__recordAuthorizer mesh__D004865 PLS
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004865 1999
% 220.48/220.66  |- mesh__recordOriginator mesh__D004865 NLM
% 220.48/220.66  |- skos__prefLabel mesh__D004865 Equipment and Supplies, Hospital
% 220.48/220.66  |- rdf__type mesh__D004865sskos__Concept
% 220.48/220.66  |- mesh__dateRevised mesh__D004865 1996-06-10
% 220.48/220.66  |- mesh__onlineNote mesh__D004865
% 220.48/220.66       use EQUIPMENT AND SUPPLIES, HOSPITAL to search HOSPITAL EQUIPMENT AND SUPPLIES 1966-77%A%  
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004865 1998
% 220.48/220.66  |- skos__annotation mesh__D004865
% 220.48/220.66       covers wide range from furnaces to surgical dressings; DF: EQUIPMENT HOSP%A%  
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004865 2004
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004865 2002
% 220.48/220.66  |- skos__altLabel mesh__D004865 Hospital Equipment and Supplies
% 220.48/220.66  |- skos__altLabel mesh__D004865 Supply, Hospital
% 220.48/220.66  |- mesh__historyNote mesh__D004865
% 220.48/220.66       78; was HOSPITAL EQUIPMENT AND SUPPLIES 1963-77   
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004865 2003
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004865 2006
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004865 1997
% 220.48/220.66  |- mesh__dateCreated mesh__D004865 1999-01-01
% 220.48/220.66  |- mesh__recordAuthorizer mesh__D037241 sjn
% 220.48/220.66  |- mesh__recordOriginator mesh__D037241 jmp
% 220.48/220.66  |- skos__broader mesh__D037241smesh__D037102
% 220.48/220.66  |- skos__hiddenLabel mesh__D037241 Mannose Specific Lectin
% 220.48/220.66  |- mesh__dateRevised mesh__D037241 2005-06-30
% 220.48/220.66  |- mesh__dateEstablished mesh__D037241 2003-01-01
% 220.48/220.66  |- skos__altLabel mesh__D037241 Mannose-Specific Lectin
% 220.48/220.66  |- mesh__dateCreated mesh__D037241 2002-07-03
% 220.48/220.66  |- skos__scopeNote mesh__D037241
% 220.48/220.66       A subclass of lectins that are specific for CARBOHYDRATES that contain MANNOSE.%A%    
% 220.48/220.66  |- skos__prefLabel mesh__D037241 Mannose-Binding Lectins
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D037241 2006
% 220.48/220.66  |- skos__hiddenLabel mesh__D037241 Mannose Binding Lectins
% 220.48/220.66  |- skos__hiddenLabel mesh__D037241 Lectin, Mannose-Specific
% 220.48/220.66  |- mesh__historyNote mesh__D037241
% 220.48/220.66       2003; use MANNOSE-BINDING LECTINS %28%NM%29% 1989-2002   
% 220.48/220.66  |- skos__annotation mesh__D037241
% 220.48/220.66       MANNOSE-BINDING LECTIN is also available   
% 220.48/220.66  |- skos__hiddenLabel mesh__D037241 Lectins, Mannose-Binding
% 220.48/220.66  |- rdf__type mesh__D037241sskos__Concept
% 220.48/220.66  |- mesh__publicMeSHNote mesh__D037241
% 220.48/220.66       2003; MANNOSE-SPECIFIC LECTIN %28%now MANNOSE-BINDING LECTINS%29% was indexed under LECTINS 1989-2002%A%  
% 220.48/220.66  |- mesh__recordMaintainer mesh__D037241 SYSTEM
% 220.48/220.66  |- skos__historyNote mesh__D037241 Lectins %28%1989-2002%29%
% 220.48/220.66  |- skos__historyNote mesh__D037241 Carrier Proteins %28%1983-2002%29%
% 220.48/220.66  |- skos__hiddenLabel mesh__D004067 Neoplasm, Digestive System
% 220.48/220.66  |- skos__altLabel mesh__D004067 Neoplasms, Digestive System
% 220.48/220.66  |- skos__hiddenLabel mesh__D004067 Cancer, Digestive System
% 220.48/220.66  |- skos__hiddenLabel mesh__D004067 Digestive System Neoplasm
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004067 2004
% 220.48/220.66  |- mesh__historyNote mesh__D004067 80; was NON MESH before 1980   
% 220.48/220.66  |- skos__hiddenLabel mesh__D004067 Digestive System Cancers
% 220.48/220.66  |- skos__hiddenLabel mesh__D004067 Cancers, Digestive System
% 220.48/220.66  |- mesh__recordOriginator mesh__D004067 NLM
% 220.48/220.66  |- mesh__dateEstablished mesh__D004067 1980-01-01
% 220.48/220.66  |- mesh__dateCreated mesh__D004067 1999-01-01
% 220.48/220.66  |- skos__scopeNote mesh__D004067
% 220.48/220.66       Tumors or cancer of the DIGESTIVE SYSTEM.     
% 220.48/220.66  |- rdf__type mesh__D004067sskos__Concept
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004067 2005
% 220.48/220.66  |- mesh__publicMeSHNote mesh__D004067 80   
% 220.48/220.66  |- mesh__recordMaintainer mesh__D004067 lkt
% 220.48/220.66  |- skos__altLabel mesh__D004067 Cancer of the Digestive System
% 220.48/220.66  |- skos__historyNote mesh__D004067
% 220.48/220.66       Gastrointestinal Neoplasms %28%1966-1979%29%
% 220.48/220.66  |- mesh__dateRevised mesh__D004067 2003-07-09
% 220.48/220.66  |- skos__broader mesh__D004067smesh__D009371
% 220.48/220.66  |- skos__broader mesh__D004067smesh__D004066
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D004067 2006
% 220.48/220.66  |- mesh__recordAuthorizer mesh__D004067 sjn
% 220.48/220.66  |- skos__annotation mesh__D004067
% 220.48/220.66       GEN or unspecified; refers to all organs and accessory organs %28%biliary, liver, %26% pancreas%29% of the DIGESTIVE TRACT: do not confuse with GASTROINTESTINAL NEOPLASMS %28%eosphagus, stomach %26% intestines only%29%; coord IM with histol type of neopl %28%IM%29%%A%  
% 220.48/220.66  |- skos__altLabel mesh__D004067 Digestive System Cancer
% 220.48/220.66  |- skos__prefLabel mesh__D004067 Digestive System Neoplasms
% 220.48/220.66  |- mesh__publicMeSHNote mesh__D009550
% 220.48/220.66       91; was see under ANTIBIOTICS 1975-90   
% 220.48/220.66  |- mesh__recordOriginator mesh__D009550 NLM
% 220.48/220.66  |- skos__prefLabel mesh__D009550 Nigericin
% 220.48/220.66  |- skos__historyNote mesh__D009550 Antibiotics %28%1969-1974%29%
% 220.48/220.66  |- mesh__recordAuthorizer mesh__D009550 sjn
% 220.48/220.66  |- mesh__dateEstablished mesh__D009550 1991-01-01
% 220.48/220.66  |- mesh__historyNote mesh__D009550
% 220.48/220.66       91%28%75%29%; was see under ANTIBIOTICS 1975-90   
% 220.48/220.66  |- rdf__type mesh__D009550sskos__Concept
% 220.48/220.66  |- mesh__dateCreated mesh__D009550 1974-11-19
% 220.48/220.66  |- skos__scopeNote mesh__D009550
% 220.48/220.66       A polyether antibiotic which affects ion transport and ATPase activity in mitochondria. It is produced by Streptomyces hygroscopicus. %28%From Merck Index, 11th ed%29%%A%    
% 220.48/220.66  |- skos__historyNote mesh__D009550 Carboxylic Acids %28%1973-1974%29%
% 220.48/220.66  |- mesh__recordMaintainer mesh__D009550 ssb
% 220.48/220.66  |- skos__broader mesh__D009550smesh__D011714
% 220.48/220.66  |- mesh__dateRevised mesh__D009550 2005-06-30
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D009550 2006
% 220.48/220.66  |- skos__broader mesh__D009550smesh__D005663
% 220.48/220.66  |- skos__hiddenLabel mesh__D050618 Dehydrogenase, Glycol Aldehyde
% 220.48/220.66  |- mesh__dateEstablished mesh__D050618 2006-01-01
% 220.48/220.66  |- skos__hiddenLabel mesh__D050618 Aldehyde Dehydrogenase, Glycol
% 220.48/220.66  |- mesh__recordAuthorizer mesh__D050618 sjn
% 220.48/220.66  |- mesh__historyNote mesh__D050618 2006%28%1978%29%   
% 220.48/220.66  |- skos__prefLabel mesh__D050618 Glycolaldehyde Dehydrogenase
% 220.48/220.66  |- mesh__publicMeSHNote mesh__D050618
% 220.48/220.66       2006; GLYCOLALDEHYDE DEHYDROGENASE was indexd under ALDEHYDE OXIDREDUCTASES 1978-2005%A%  
% 220.48/220.66  |- skos__broader mesh__D050618smesh__D000445
% 220.48/220.66  |- skos__scopeNote mesh__D050618
% 220.48/220.66       An enzyme that catalyzes the oxidation of GLYCOLALDEHYDE to GLYCOLATE, using NAD and NADP as COENZYMES.%A%    
% 220.48/220.66  |- skos__historyNote mesh__D050618
% 220.48/220.66       Aldehyde Oxidoreductases %28%1978-2005%29%
% 220.48/220.66  |- mesh__dateCreated mesh__D050618 2005-06-30
% 220.48/220.66  |- mesh__recordMaintainer mesh__D050618 AKE
% 220.48/220.66  |- mesh__recordOriginator mesh__D050618 AKE
% 220.48/220.66  |- skos__hiddenLabel mesh__D050618 Dehydrogenase, Glycolaldehyde
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D050618 2006
% 220.48/220.66  |- skos__altLabel mesh__D050618 Glycol Aldehyde Dehydrogenase
% 220.48/220.66  |- rdf__type mesh__D050618sskos__Concept
% 220.48/220.66  |- mesh__recordOriginator mesh__D014495 NLM
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D014495 2002
% 220.48/220.66  |- skos__prefLabel mesh__D014495 Universities
% 220.48/220.66  |- mesh__dateRevised mesh__D014495 1999-11-03
% 220.48/220.66  |- rdf__type mesh__D014495sskos__Concept
% 220.48/220.66  |- skos__annotation mesh__D014495
% 220.48/220.66       IM; Manual 30.8, 36.18; specify locale if pertinent; colleges as educ institutions go here: do not confuse with bodies such as %22%College of Physicians%22% which are indexed under SOCIETIES, MEDICAL;  Uniformed Services University of the Health Sciences %28%USUHS%29%, under US Dept of Defense, goes under SCHOOLS, MEDICAL + UNITED STATES; DF: UNIV%A%  
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D014495 2005
% 220.48/220.66  |- skos__broader mesh__D014495smesh__D012574
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D014495 2003
% 220.48/220.66  |- mesh__recordMaintainer mesh__D014495 kle
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D014495 2006
% 220.48/220.66  |- skos__hiddenLabel mesh__D014495 University
% 220.48/220.66  |- skos__scopeNote mesh__D014495
% 220.48/220.66       Educational institutions providing facilities for teaching and research and authorized to grant academic degrees.%A%    
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D014495 2000
% 220.48/220.66  |- mesh__recordAuthorizer mesh__D014495 sjn
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D014495 2004
% 220.48/220.66  |- mesh__dateCreated mesh__D014495 1999-01-01
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D014495 2001
% 220.48/220.66  |- mesh__recordOriginator mesh__D008458 NLM
% 220.48/220.66  |- mesh__historyNote mesh__D008458 64   
% 220.48/220.66  |- skos__prefLabel mesh__D008458 Measles Vaccine
% 220.48/220.66  |- rdf__type mesh__D008458sskos__Concept
% 220.48/220.66  |- skos__broader mesh__D008458smesh__D014765
% 220.48/220.66  |- mesh__dateCreated mesh__D008458 1999-01-01
% 220.48/220.66  |- mesh__dateEstablished mesh__D008458 1964-01-01
% 220.48/220.66  |- mesh__publicMeSHNote mesh__D008458 64   
% 220.48/220.66  |- mesh__dateRevised mesh__D008458 2005-06-30
% 220.48/220.66  |- mesh__recordMaintainer mesh__D008458 ssb
% 220.48/220.66  |- skos__hiddenLabel mesh__D008458 Vaccine, Measles
% 220.48/220.66  |- mesh__recordAuthorizer mesh__D008458 sjn
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D008458 2006
% 220.48/220.66  |- skos__scopeNote mesh__D008458
% 220.48/220.66       A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. %28%From Dorland, 28th ed%29%%A%    
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D000475 2003
% 220.48/220.66  |- mesh__recordOriginator mesh__D000475 NLM
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D000475 2004
% 220.48/220.66  |- mesh__dateCreated mesh__D000475 1999-01-01
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D000475 2000
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D000475 2005
% 220.48/220.66  |- skos__scopeNote mesh__D000475
% 220.48/220.66       Unsaturated hydrocarbons of the type Cn-H2n, indicated by the suffix -ene. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed, p408%29%%A%    
% 220.48/220.66  |- mesh__historyNote mesh__D000475 66   
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D000475 2001
% 220.48/220.66  |- mesh__dateRevised mesh__D000475 1997-06-20
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D000475 2006
% 220.48/220.66  |- rdf__type mesh__D000475sskos__Concept
% 220.48/220.66  |- mesh__dateEstablished mesh__D000475 1966-01-01
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D000475 2002
% 220.48/220.66  |- mesh__recordAuthorizer mesh__D000475 SJN
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D000475 1998
% 220.48/220.66  |- skos__prefLabel mesh__D000475 Alkenes
% 220.48/220.66  |- mesh__publicMeSHNote mesh__D000475 66   
% 220.48/220.66  |- mesh__recordMaintainer mesh__D000475 TGC
% 220.48/220.66  |- skos__broader mesh__D000475smesh__D006839
% 220.48/220.66  |- skos__altLabel mesh__D000475 Olefins
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D000475 1999
% 220.48/220.66  |- mesh__recordMaintainer mesh__D019180 mdb
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D019180 2006
% 220.48/220.66  |- skos__broader mesh__D019180smesh__D010942
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D019180 2003
% 220.48/220.66  |- mesh__dateCreated mesh__D019180 1996-06-10
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D019180 2004
% 220.48/220.66  |- mesh__activeMeSHYear mesh__D019180 2002
% 220.48/220.66  |- mesh__publicMeSHNote mesh__D019180 97   
% 220.48/220.66  |- skos__scopeNote mesh__D019180
% 220.48/220.66       A family of non-enveloped RNA plant viruses, transmitted by biological vectors and experimentally by mechanical inoculation. There are three genera: COMOVIRUS; FABAVIRUS; and NEPOVIRUS.%A%    
% 220.48/220.66  |- mesh__recordOriginator mesh__D019180 AGS
% 220.48/220.67  |- mesh__historyNote mesh__D019180 97   
% 220.48/220.67  |- mesh__dateEstablished mesh__D019180 1997-01-01
% 220.48/220.67  |- skos__broader mesh__D019180smesh__D012328
% 220.48/220.67  |- mesh__dateRevised mesh__D019180 2001-07-25
% 220.48/220.67  |- skos__prefLabel mesh__D019180 Comoviridae
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D019180 2005
% 220.48/220.67  |- mesh__recordAuthorizer mesh__D019180 sjn
% 220.48/220.67  |- rdf__type mesh__D019180sskos__Concept
% 220.48/220.67  |- skos__annotation mesh__D019180 a family of plant viruses   
% 220.48/220.67  |- skos__broader mesh__D015222Q000037smesh__D015222
% 220.48/220.67  |- mesh__preferredCombination mesh__D015222Q000037smesh__D026941
% 220.48/220.67  |- rdf__type mesh__D015222Q000037smesh__CompoundConcept
% 220.48/220.67  |- skos__scopeNote mesh__D005160
% 220.48/220.67       Architecture, exterior and interior design, and construction of facilities other than hospitals, e.g., dental schools, medical schools, ambulatory care clinics, and specified units of health care facilities. The concept also includes architecture, design, and construction of specialized contained, controlled, or closed research environments including those of space labs and stations.%A%    
% 220.48/220.67  |- rdf__type mesh__D005160sskos__Concept
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D005160 2004
% 220.48/220.67  |- mesh__dateRevised mesh__D005160 1999-11-03
% 220.48/220.67  |- skos__hiddenLabel mesh__D005160 Facility Constructions
% 220.48/220.67  |- mesh__historyNote mesh__D005160 73%28%67%29%   
% 220.48/220.67  |- skos__annotation mesh__D005160
% 220.48/220.67       facilities other than hosp; HOSPITAL DESIGN AND CONSTRUCTION is available; DF: FACILITY DESIGN%A%  
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D005160 2000
% 220.48/220.67  |- skos__hiddenLabel mesh__D005160 Design, Facility
% 220.48/220.67  |- mesh__recordOriginator mesh__D005160 NLM
% 220.48/220.67  |- skos__broader mesh__D005160smesh__D001108
% 220.48/220.67  |- mesh__dateCreated mesh__D005160 1999-01-01
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D005160 2005
% 220.48/220.67  |- skos__hiddenLabel mesh__D005160 Facility Designs
% 220.48/220.67  |- skos__hiddenLabel mesh__D005160 Designs, Facility
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D005160 2001
% 220.48/220.67  |- mesh__dateEstablished mesh__D005160 1973-01-01
% 220.48/220.67  |- skos__hiddenLabel mesh__D005160 Construction, Facility
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D005160 2006
% 220.48/220.67  |- skos__historyNote mesh__D005160 Architecture %28%1966%29%
% 220.48/220.67  |- skos__prefLabel mesh__D005160 Facility Design and Construction
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D005160 2002
% 220.48/220.67  |- mesh__recordMaintainer mesh__D005160 kle
% 220.48/220.67  |- mesh__publicMeSHNote mesh__D005160 73   
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D005160 2003
% 220.48/220.67  |- skos__related mesh__D005160smesh__D002028
% 220.48/220.67  |- mesh__recordAuthorizer mesh__D005160 sjn
% 220.48/220.67  |- skos__hiddenLabel mesh__D005160 Constructions, Facility
% 220.48/220.67  |- skos__broader mesh__D005160smesh__D006268
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018886 2001
% 220.48/220.67  |- skos__historyNote mesh__D018886 Aphasia %28%1966-1995%29%
% 220.48/220.67  |- skos__hiddenLabel mesh__D018886 Conduction Aphasias
% 220.48/220.67  |- mesh__recordMaintainer mesh__D018886 KEV
% 220.48/220.67  |- mesh__publicMeSHNote mesh__D018886 1996   
% 220.48/220.67  |- skos__prefLabel mesh__D018886 Aphasia, Conduction
% 220.48/220.67  |- skos__altLabel mesh__D018886 Aphasia, Associative
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018886 2002
% 220.48/220.67  |- mesh__dateEstablished mesh__D018886 1996-01-01
% 220.48/220.67  |- skos__hiddenLabel mesh__D018886 Aphasias, Associative
% 220.48/220.67  |- skos__historyNote mesh__D018886 Aphasia, Wernicke %28%1980-1995%29%
% 220.48/220.67  |- skos__broader mesh__D018886smesh__D001037
% 220.48/220.67  |- skos__hiddenLabel mesh__D018886 Associative Dysphasias
% 220.48/220.67  |- skos__hiddenLabel mesh__D018886 Conduction Dysphasia
% 220.48/220.67  |- mesh__recordOriginator mesh__D018886 TGC
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018886 2005
% 220.48/220.67  |- mesh__historyNote mesh__D018886 1996   
% 220.48/220.67  |- skos__altLabel mesh__D018886 Dysphasia, Conduction
% 220.48/220.67  |- skos__scopeNote mesh__D018886
% 220.48/220.67       A type of fluent aphasia characterized by an impaired ability to repeat one and two word phrases, despite retained comprehension. This condition is associated with dominant hemisphere lesions involving the arcuate fasciculus %28%a white matter projection between Broca%27%s and Wernicke%27%s areas%29% and adjacent structures. Like patients with Wernicke aphasia %28%APHASIA, WERNICKE%29%, patients with conduction aphasia are fluent but commit paraphasic errors during attempts at written and oral forms of communication. %28%From Adams et al., Principles of Neurology, 6th ed, p482; Brain %26% Bannister, Clinical Neurology, 7th ed, p142; Kandel et al., Principles of Neural Science, 3d ed, p848%29%%A%    
% 220.48/220.67  |- skos__hiddenLabel mesh__D018886 Conduction Dysphasias
% 220.48/220.67  |- skos__altLabel mesh__D018886 Associative Dysphasia
% 220.48/220.67  |- mesh__dateCreated mesh__D018886 1994-12-27
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018886 2003
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018886 2006
% 220.48/220.67  |- skos__hiddenLabel mesh__D018886 Conduction Aphasia
% 220.48/220.67  |- skos__hiddenLabel mesh__D018886 Dysphasias, Associative
% 220.48/220.67  |- mesh__recordAuthorizer mesh__D018886 sjn
% 220.48/220.67  |- skos__altLabel mesh__D018886 Dysphasia, Associative
% 220.48/220.67  |- skos__hiddenLabel mesh__D018886 Dysphasias, Conduction
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018886 2004
% 220.48/220.67  |- skos__hiddenLabel mesh__D018886 Associative Aphasias
% 220.48/220.67  |- skos__altLabel mesh__D018886 Associative Aphasia
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018886 2000
% 220.48/220.67  |- mesh__dateRevised mesh__D018886 1999-11-03
% 220.48/220.67  |- rdf__type mesh__D018886sskos__Concept
% 220.48/220.67  |- skos__hiddenLabel mesh__D018886 Aphasias, Conduction
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018088 2002
% 220.48/220.67  |- skos__hiddenLabel mesh__D018088 Drug-Resistant Tuberculosis
% 220.48/220.67  |- skos__historyNote mesh__D018088
% 220.48/220.67       Tuberculosis, Pulmonary %28%1990-1993%29%
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018088 2003
% 220.48/220.67  |- skos__hiddenLabel mesh__D018088 Multidrug-Resistant Tuberculosis
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018088 2004
% 220.48/220.67  |- skos__historyNote mesh__D018088
% 220.48/220.67       Drug Resistance, Microbial %28%1990-1993%29%
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018088 2005
% 220.48/220.67  |- mesh__dateCreated mesh__D018088 1993-06-03
% 220.48/220.67  |- skos__altLabel mesh__D018088 Tuberculosis, Multi-Drug Resistant
% 220.48/220.67  |- mesh__historyNote mesh__D018088 94   
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018088 2000
% 220.48/220.67  |- skos__annotation mesh__D018088
% 220.48/220.67       IM; coord with specific type of tuberc %28%IM%29% + specific antituberc agents %28%IM or NIM%29%%A%  
% 220.48/220.67  |- mesh__dateEstablished mesh__D018088 1994-01-01
% 220.48/220.67  |- skos__hiddenLabel mesh__D018088 Tuberculosis, Multidrug Resistant
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018088 2006
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018088 1996
% 220.48/220.67  |- skos__hiddenLabel mesh__D018088 Tuberculosis, Multi Drug Resistant
% 220.48/220.67  |- skos__scopeNote mesh__D018088
% 220.48/220.67       Tuberculosis resistant to chemotherapy with two or more antitubercular agents. The problem of resistance is particularly troublesome in tuberculosis as an opportunistic disease in HIV infection.%A%    
% 220.48/220.67  |- skos__prefLabel mesh__D018088 Tuberculosis, Multidrug-Resistant
% 220.48/220.67  |- rdf__type mesh__D018088sskos__Concept
% 220.48/220.67  |- skos__historyNote mesh__D018088 Tuberculosis %28%1990-1993%29%
% 220.48/220.67  |- skos__hiddenLabel mesh__D018088 MDR Tuberculosis
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018088 2001
% 220.48/220.67  |- mesh__publicMeSHNote mesh__D018088 94   
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018088 1997
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018088 1998
% 220.48/220.67  |- skos__hiddenLabel mesh__D018088 Multi-Drug Resistant Tuberculosis
% 220.48/220.67  |- skos__altLabel mesh__D018088 Tuberculosis, MDR
% 220.48/220.67  |- skos__hiddenLabel mesh__D018088 Tuberculosis, Drug Resistant
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018088 1994
% 220.48/220.67  |- skos__broader mesh__D018088smesh__D014376
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018088 1999
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018088 1995
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004866 2006
% 220.48/220.67  |- skos__hiddenLabel mesh__D004866 Contaminations, Equipment
% 220.48/220.67  |- rdf__type mesh__D004866sskos__Concept
% 220.48/220.67  |- skos__related mesh__D004866smesh__D050456
% 220.48/220.67  |- skos__prefLabel mesh__D004866 Equipment Contamination
% 220.48/220.67  |- mesh__dateCreated mesh__D004866 1984-04-06
% 220.48/220.67  |- skos__hiddenLabel mesh__D004866 Contamination, Equipment
% 220.48/220.67  |- mesh__dateEstablished mesh__D004866 1985-01-01
% 220.48/220.67  |- mesh__historyNote mesh__D004866 85   
% 220.48/220.67  |- mesh__recordAuthorizer mesh__D004866 sjn
% 220.48/220.67  |- mesh__publicMeSHNote mesh__D004866 85   
% 220.48/220.67  |- skos__scopeNote mesh__D004866
% 220.48/220.67       The presence of an infectious agent on instruments, prostheses, or other inanimate articles.%A%    
% 220.48/220.67  |- skos__hiddenLabel mesh__D004866 Equipment Contaminations
% 220.48/220.67  |- mesh__recordOriginator mesh__D004866 EC
% 220.48/220.67  |- mesh__dateRevised mesh__D004866 2005-06-30
% 220.48/220.67  |- mesh__recordMaintainer mesh__D004866 ags
% 220.48/220.67  |- skos__broader mesh__D004866smesh__D011634
% 220.48/220.67  |- skos__altLabel mesh__D004068 Physiology, Digestive
% 220.48/220.67  |- mesh__dateCreated mesh__D004068 1999-01-01
% 220.48/220.67  |- mesh__publicMeSHNote mesh__D004068 98   
% 220.48/220.67  |- mesh__dateRevised mesh__D004068 1998-06-10
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004068 2002
% 220.48/220.67  |- rdf__type mesh__D004068sskos__Concept
% 220.48/220.67  |- skos__annotation mesh__D004068
% 220.48/220.67       GEN or unspecified; prefer specifics; DF: DIGESTIVE PHYSIOL%A%  
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004068 2005
% 220.48/220.67  |- mesh__recordAuthorizer mesh__D004068 SJN
% 220.48/220.67  |- mesh__historyNote mesh__D004068 98; use explode 1970-97   
% 220.48/220.67  |- skos__historyNote mesh__D004068
% 220.48/220.67       Digestive System/physiology %28%1970-1997%29%
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004068 2006
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004068 2000
% 220.48/220.67  |- mesh__recordMaintainer mesh__D004068 NNS
% 220.48/220.67  |- skos__broader mesh__D004068smesh__D004069
% 220.48/220.67  |- mesh__dateEstablished mesh__D004068 1998-01-01
% 220.48/220.67  |- skos__hiddenLabel mesh__D004068 Digestive Physiologies
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004068 2003
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004068 2001
% 220.48/220.67  |- skos__prefLabel mesh__D004068 Digestive Physiology
% 220.48/220.67  |- mesh__recordOriginator mesh__D004068 NLM
% 220.48/220.67  |- skos__scopeNote mesh__D004068
% 220.48/220.67       Functions and activities of the digestive system as a whole or of any of its parts.%A%    
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004068 1999
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004068 2004
% 220.48/220.67  |- skos__hiddenLabel mesh__D004068 Physiologies, Digestive
% 220.48/220.67  |- mesh__dateEstablished mesh__D009551 1968-01-01
% 220.48/220.67  |- skos__scopeNote mesh__D009551 Institutional night care of patients.     
% 220.48/220.67  |- mesh__dateCreated mesh__D009551 1999-01-01
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D009551 2003
% 220.48/220.67  |- mesh__publicMeSHNote mesh__D009551 68   
% 220.48/220.67  |- skos__prefLabel mesh__D009551 Night Care
% 220.48/220.67  |- mesh__historyNote mesh__D009551 68   
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D009551 2004
% 220.48/220.67  |- mesh__recordMaintainer mesh__D009551 lkt
% 220.48/220.67  |- mesh__dateRevised mesh__D009551 2002-07-03
% 220.48/220.67  |- skos__hiddenLabel mesh__D009551 Care, Night
% 220.48/220.67  |- rdf__type mesh__D009551sskos__Concept
% 220.48/220.67  |- skos__broader mesh__D009551smesh__D005791
% 220.48/220.67  |- skos__related mesh__D009551smesh__D039602
% 220.48/220.67  |- skos__hiddenLabel mesh__D009551 Cares, Night
% 220.48/220.67  |- mesh__recordOriginator mesh__D009551 NLM
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D009551 2005
% 220.48/220.67  |- mesh__recordAuthorizer mesh__D009551 sjn
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D009551 2006
% 220.48/220.67  |- skos__annotation mesh__D009551 institutional care only   
% 220.48/220.67  |- skos__hiddenLabel mesh__D009551 Night Cares
% 220.48/220.67  |- skos__hiddenLabel mesh__D014496 Cysts, Umbilical
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D014496 2000
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D014496 1996
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D014496 1999
% 220.48/220.67  |- mesh__recordMaintainer mesh__D014496 TGC
% 220.48/220.67  |- rdf__type mesh__D014496sskos__Concept
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D014496 2001
% 220.48/220.67  |- skos__annotation mesh__D014496
% 220.48/220.67       non-neoplastic; /blood supply /chem /secret /ultrastruct permitted; do not confuse with patent urachus %28%index under URACHUS /abnorm%29%%A%  
% 220.48/220.67  |- mesh__recordOriginator mesh__D014496 NLM
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D014496 1997
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D014496 2005
% 220.48/220.67  |- mesh__historyNote mesh__D014496 81; was UMBILICAL CYST 1963-80   
% 220.48/220.67  |- skos__hiddenLabel mesh__D014496 Cysts, Urachal
% 220.48/220.67  |- skos__scopeNote mesh__D014496
% 220.48/220.67       Cyst occurring in a persistent portion of the urachus, presenting as an extraperitoneal mass in the umbilical region. It is characterized by abdominal pain, and fever if infected. It may rupture, leading to peritonitis, or it may drain through the umbilicus.%A%    
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D014496 2002
% 220.48/220.67  |- mesh__dateRevised mesh__D014496 1993-06-03
% 220.48/220.67  |- skos__hiddenLabel mesh__D014496 Urachal Cysts
% 220.48/220.67  |- skos__hiddenLabel mesh__D014496 Umbilical Cysts
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D014496 2003
% 220.48/220.67  |- mesh__recordAuthorizer mesh__D014496 PLS
% 220.48/220.67  |- mesh__publicMeSHNote mesh__D014496 81; was UMBILICAL CYST 1963-80   
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D014496 1994
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D014496 2006
% 220.48/220.67  |- skos__prefLabel mesh__D014496 Urachal Cyst
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D014496 2004
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D014496 1995
% 220.48/220.67  |- mesh__dateCreated mesh__D014496 1999-01-01
% 220.48/220.67  |- mesh__onlineNote mesh__D014496
% 220.48/220.67       use URACHAL CYST to search UMBILICAL CYST 1966-80   
% 220.48/220.67  |- skos__broader mesh__D014496smesh__D003560
% 220.48/220.67  |- skos__hiddenLabel mesh__D014496 Cyst, Umbilical
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D014496 1998
% 220.48/220.67  |- skos__hiddenLabel mesh__D014496 Cyst, Urachal
% 220.48/220.67  |- mesh__recordAuthorizer mesh__D008459 sjn
% 220.48/220.67  |- rdf__type mesh__D008459sskos__Concept
% 220.48/220.67  |- mesh__dateCreated mesh__D008459 1999-01-01
% 220.48/220.67  |- mesh__recordOriginator mesh__D008459 NLM
% 220.48/220.67  |- skos__scopeNote mesh__D008459
% 220.48/220.67       The type species of MORBILLIVIRUS and the cause of the highly infectious human disease MEASLES, which affects mostly children.%A%    
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D008459 2005
% 220.48/220.67  |- mesh__dateRevised mesh__D008459 2004-07-13
% 220.48/220.67  |- mesh__recordMaintainer mesh__D008459 sjn
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D008459 2006
% 220.48/220.67  |- skos__annotation mesh__D008459
% 220.48/220.67       %22%morbilli virus%22% sometimes refers to the MEASLES VIRUS %26% sometimes to the genus Morbillivirus: check text; infection = MEASLES%A%  
% 220.48/220.67  |- skos__broader mesh__D008459smesh__D018103
% 220.48/220.67  |- skos__prefLabel mesh__D008459 Measles virus
% 220.48/220.67  |- skos__related mesh__D008459smesh__D013344
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D000476 2002
% 220.48/220.67  |- skos__prefLabel mesh__D000476 Alkanesulfonates
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D000476 2006
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D000476 1996
% 220.48/220.67  |- mesh__dateEstablished mesh__D000476 1973-01-01
% 220.48/220.67  |- rdf__type mesh__D000476sskos__Concept
% 220.48/220.67  |- mesh__onlineNote mesh__D000476
% 220.48/220.67       use ALKANESULFONATES to search ALKYL SULFONATES 1973-93   
% 220.48/220.67  |- mesh__historyNote mesh__D000476 94; was ALKYL SULFONATES 1973-93   
% 220.48/220.67  |- mesh__dateRevised mesh__D000476 1993-06-04
% 220.48/220.67  |- skos__historyNote mesh__D000476 Alkylating Agents %28%1966-1972%29%
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D000476 1997
% 220.48/220.67  |- mesh__recordAuthorizer mesh__D000476 PLS
% 220.48/220.67  |- mesh__recordMaintainer mesh__D000476 TPW
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D000476 1998
% 220.48/220.67  |- mesh__recordOriginator mesh__D000476 NLM
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D000476 1994
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D000476 1999
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D000476 2003
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D000476 2000
% 220.48/220.67  |- skos__scopeNote mesh__D000476
% 220.48/220.67       Organic esters or salts of sulfonic acid derivatives containing an aliphatic hydrocarbon radical.%A%    
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D000476 1995
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D000476 2004
% 220.48/220.67  |- skos__broader mesh__D000476smesh__D017738
% 220.48/220.67  |- mesh__dateCreated mesh__D000476 1999-01-01
% 220.48/220.67  |- skos__altLabel mesh__D000476 Alkyl Sulfonates
% 220.48/220.67  |- mesh__publicMeSHNote mesh__D000476 94; was ALKYL SULFONATES 1973-93   
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D000476 2001
% 220.48/220.67  |- skos__hiddenLabel mesh__D000476 Sulfonates, Alkyl
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D000476 2005
% 220.48/220.67  |- skos__historyNote mesh__D000476 Sulfonic Acids %28%1966-1972%29%
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D019181 2004
% 220.48/220.67  |- skos__scopeNote mesh__D019181
% 220.48/220.67       A genus of the family COMOVIRIDAE with a wide host range among dicotyledons and some monocotyledons. They are transmitted nonpersistently by aphids. The type species is broad bean wilt virus 1.%A%    
% 220.48/220.67  |- skos__broader mesh__D019181smesh__D019180
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D019181 1998
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D019181 2000
% 220.48/220.67  |- mesh__historyNote mesh__D019181 97   
% 220.48/220.67  |- skos__prefLabel mesh__D019181 Fabavirus
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D019181 1999
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D019181 2001
% 220.48/220.67  |- mesh__dateCreated mesh__D019181 1996-06-10
% 220.48/220.67  |- skos__hiddenLabel mesh__D019181 Fabaviruses
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D019181 2002
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D019181 1997
% 220.48/220.67  |- mesh__publicMeSHNote mesh__D019181 97   
% 220.48/220.67  |- mesh__dateEstablished mesh__D019181 1997-01-01
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D019181 2005
% 220.48/220.67  |- rdf__type mesh__D019181sskos__Concept
% 220.48/220.67  |- skos__annotation mesh__D019181
% 220.48/220.67       a genus of plant viruses; from FABA %28%Latin for bean%29% virus; coord IM with specific plant /virol %28%IM or NIM%29%%A%  
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D019181 2006
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D019181 2003
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D005161 2002
% 220.48/220.67  |- skos__broader mesh__D005161smesh__D012926
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D005161 2006
% 220.48/220.67  |- skos__hiddenLabel mesh__D005161 Control, Facility
% 220.48/220.67  |- mesh__publicMeSHNote mesh__D005161 78   
% 220.48/220.67  |- mesh__recordMaintainer mesh__D005161 kle
% 220.48/220.67  |- skos__annotation mesh__D005161
% 220.48/220.67       coord IM with facility %28%IM%29%; DF: FACILITY REG   
% 220.48/220.67  |- mesh__recordAuthorizer mesh__D005161 sjn
% 220.48/220.67  |- skos__hiddenLabel mesh__D005161 Controls, Facility
% 220.48/220.67  |- skos__hiddenLabel mesh__D005161 Regulations, Facility
% 220.48/220.67  |- skos__prefLabel mesh__D005161 Facility Regulation and Control
% 220.48/220.67  |- mesh__historyNote mesh__D005161 78   
% 220.48/220.67  |- skos__altLabel mesh__D005161 Facility Regulation
% 220.48/220.67  |- mesh__recordOriginator mesh__D005161 EC
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D005161 2003
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D005161 2000
% 220.48/220.67  |- mesh__dateEstablished mesh__D005161 1978-01-01
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D005161 2004
% 220.48/220.67  |- rdf__type mesh__D005161sskos__Concept
% 220.48/220.67  |- mesh__dateRevised mesh__D005161 1999-11-05
% 220.48/220.67  |- skos__hiddenLabel mesh__D005161 Facility Controls
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D005161 2001
% 220.48/220.67  |- skos__hiddenLabel mesh__D005161 Facility Regulations
% 220.48/220.67  |- skos__broader mesh__D005161smesh__D011785
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D005161 2005
% 220.48/220.67  |- skos__scopeNote mesh__D005161
% 220.48/220.67       Formal voluntary or governmental procedures and standards required of hospitals and health or other facilities to improve operating efficiency, and for the protection of the consumer.%A%    
% 220.48/220.67  |- mesh__dateCreated mesh__D005161 1977-05-05
% 220.48/220.67  |- skos__hiddenLabel mesh__D018887 Acquired Epileptic Aphasia
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018887 2005
% 220.48/220.67  |- mesh__recordAuthorizer mesh__D018887 sjn
% 220.48/220.67  |- skos__scopeNote mesh__D018887
% 220.48/220.67       A syndrome characterized by the onset of isolated language dysfunction in otherwise normal children %28%age of onset 4-7 years%29% and epileptiform discharges on ELECTROENCEPHALOGRAPHY. Seizures, including atypical absence %28%EPILEPSY, ABSENCE%29%, complex partial %28%EPILEPSY, COMPLEX PARTIAL%29%, and other types may occur. The electroencephalographic abnormalities and seizures tend to resolve by puberty. The language disorder may also resolve although some individuals are left with severe language dysfunction, including APHASIA and auditory AGNOSIA. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp749-50; J Child Neurol 1997 Nov;12%28%8%29%:489-495%29%%A%    
% 220.48/220.67  |- skos__hiddenLabel mesh__D018887 Landau Kleffner Syndrome
% 220.48/220.67  |- mesh__dateCreated mesh__D018887 1994-12-27
% 220.48/220.67  |- skos__altLabel mesh__D018887
% 220.48/220.67       Acquired Childhoood Aphasia with Convulsive Disorder
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018887 2006
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018887 2003
% 220.48/220.67  |- mesh__recordMaintainer mesh__D018887 ags
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018887 2004
% 220.48/220.67  |- skos__hiddenLabel mesh__D018887 Aphasias, Acquired Epileptic
% 220.48/220.67  |- mesh__dateRevised mesh__D018887 2001-07-25
% 220.48/220.67  |- skos__related mesh__D018887smesh__D001037
% 220.48/220.67  |- mesh__dateEstablished mesh__D018887 1996-01-01
% 220.48/220.67  |- skos__hiddenLabel mesh__D018887 Epileptic Aphasias, Acquired
% 220.48/220.67  |- skos__historyNote mesh__D018887 Epilepsy %28%1982-1995%29%
% 220.48/220.67  |- rdf__type mesh__D018887sskos__Concept
% 220.48/220.67  |- skos__hiddenLabel mesh__D018887 Epileptic Aphasia, Acquired
% 220.48/220.67  |- skos__broader mesh__D018887smesh__D004827
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018887 2002
% 220.48/220.67  |- skos__altLabel mesh__D018887 Aphasia, Acquired Epileptic
% 220.48/220.67  |- skos__altLabel mesh__D018887 Aphasia, Epileptic, Acquired
% 220.48/220.67  |- skos__altLabel mesh__D018887
% 220.48/220.67       Landau-Kleffner Acquired Epileptiform Aphasia
% 220.48/220.67  |- skos__hiddenLabel mesh__D018887 Acquired Epileptic Aphasias
% 220.48/220.67  |- skos__prefLabel mesh__D018887 Landau-Kleffner Syndrome
% 220.48/220.67  |- mesh__recordOriginator mesh__D018887 TGC
% 220.48/220.67  |- skos__historyNote mesh__D018887 Aphasia %28%1982-1995%29%
% 220.48/220.67  |- skos__hiddenLabel mesh__D018887
% 220.48/220.67       Landau Kleffner Acquired Epileptiform Aphasia
% 220.48/220.67  |- mesh__historyNote mesh__D018887 1996   
% 220.48/220.67  |- mesh__publicMeSHNote mesh__D018887 1996   
% 220.48/220.67  |- skos__hiddenLabel mesh__D018887 Syndrome, Landau-Kleffner
% 220.48/220.67  |- skos__related mesh__D018089smesh__D016693
% 220.48/220.67  |- mesh__publicMeSHNote mesh__D018089 94   
% 220.48/220.67  |- mesh__recordMaintainer mesh__D018089 ssb
% 220.48/220.67  |- mesh__recordOriginator mesh__D018089 AGS
% 220.48/220.67  |- skos__broader mesh__D018089smesh__D000941
% 220.48/220.67  |- mesh__dateRevised mesh__D018089 2005-06-30
% 220.48/220.67  |- mesh__dateCreated mesh__D018089 1993-07-01
% 220.48/220.67  |- skos__scopeNote mesh__D018089
% 220.48/220.67       Microbial antigens that have in common an extremely potent activating effect on T-cells that bear a specific variable region. Superantigens cross-link the variable region with class II MHC proteins regardless of the peptide binding in the T-cell receptor%27%s pocket. The result is a transient expansion and subsequent death and anergy of the T-cells with the appropriate variable regions.%A%    
% 220.48/220.67  |- mesh__historyNote mesh__D018089 94   
% 220.48/220.67  |- skos__related mesh__D018089smesh__D017209
% 220.48/220.67  |- skos__prefLabel mesh__D018089 Superantigens
% 220.48/220.67  |- mesh__dateEstablished mesh__D018089 1994-01-01
% 220.48/220.67  |- skos__annotation mesh__D018089
% 220.48/220.67       microbial antigens; coord IM with specific microbe /immunol %28%IM%29%%A%  
% 220.48/220.67  |- mesh__recordAuthorizer mesh__D018089 sjn
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D018089 2006
% 220.48/220.67  |- skos__related mesh__D018089smesh__D017635
% 220.48/220.67  |- rdf__type mesh__D018089sskos__Concept
% 220.48/220.67  |- skos__historyNote mesh__D018089 specific antigens %28%1989-1993%29%
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004867 1998
% 220.48/220.67  |- skos__hiddenLabel mesh__D004867 Designs, Device
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004867 2006
% 220.48/220.67  |- skos__related mesh__D004867smesh__D011474
% 220.48/220.67  |- skos__hiddenLabel mesh__D004867 Equipment Designs
% 220.48/220.67  |- mesh__recordAuthorizer mesh__D004867 PLS
% 220.48/220.67  |- mesh__recordOriginator mesh__D004867 SMH
% 220.48/220.67  |- mesh__dateEstablished mesh__D004867 1982-01-01
% 220.48/220.67  |- skos__altLabel mesh__D004867 Device Design, Medical
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004867 2000
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004867 1993
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004867 1999
% 220.48/220.67  |- mesh__dateCreated mesh__D004867 1981-05-15
% 220.48/220.67  |- mesh__recordMaintainer mesh__D004867 TAP
% 220.48/220.67  |- rdf__type mesh__D004867sskos__Concept
% 220.48/220.67  |- mesh__historyNote mesh__D004867 82   
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004867 1994
% 220.48/220.67  |- mesh__dateRevised mesh__D004867 1992-05-15
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004867 2001
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004867 2003
% 220.48/220.67  |- skos__hiddenLabel mesh__D004867 Designs, Equipment
% 220.48/220.67  |- skos__related mesh__D004867smesh__D003779
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004867 1995
% 220.48/220.67  |- mesh__publicMeSHNote mesh__D004867 82   
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004867 1996
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004867 2002
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004867 2004
% 220.48/220.67  |- skos__altLabel mesh__D004867 Device Designs, Medical
% 220.48/220.67  |- skos__altLabel mesh__D004867 Designs, Medical Device
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004867 1997
% 220.48/220.67  |- skos__altLabel mesh__D004867 Design, Medical Device
% 220.48/220.67  |- skos__hiddenLabel mesh__D004867 Design, Device
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004867 2005
% 220.48/220.67  |- skos__prefLabel mesh__D004867 Equipment Design
% 220.48/220.67  |- skos__altLabel mesh__D004867 Medical Device Designs
% 220.48/220.67  |- skos__broader mesh__D004867smesh__D008919
% 220.48/220.67  |- skos__hiddenLabel mesh__D004867 Device Designs
% 220.48/220.67  |- skos__altLabel mesh__D004867 Design, Equipment
% 220.48/220.67  |- skos__annotation mesh__D004867
% 220.48/220.67       NIM; coord with specific equip %28%IM%29% or specific techn /instrum %28%IM%29%%A%  
% 220.48/220.67  |- mesh__recordOriginator mesh__D004069 NLM
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004069 2005
% 220.48/220.67  |- mesh__runningHead mesh__D004069
% 220.48/220.67       G10 - PHYSIOLOGY-DIGESTIVE, ORAL, AND SKIN   
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004069 2006
% 220.48/220.67  |- mesh__publicMeSHNote mesh__D004069 98   
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004069 2002
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004069 1998
% 220.48/220.67  |- mesh__activeMeSHYear mesh__D004069 2003
% 220.48/220.68  |- mesh__dateRevised mesh__D004069 1997-06-27
% 220.48/220.68  |- mesh__recordAuthorizer mesh__D004069 SJN
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D004069 1999
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D004069 2004
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D004069 2000
% 220.48/220.68  |- mesh__historyNote mesh__D004069 98; use explode   
% 220.48/220.68  |- mesh__recordMaintainer mesh__D004069 TGC
% 220.48/220.68  |- mesh__dateCreated mesh__D004069 1999-01-01
% 220.48/220.68  |- mesh__dateEstablished mesh__D004069 1998-01-01
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D004069 2001
% 220.48/220.68  |- skos__annotation mesh__D004069
% 220.48/220.68       not used for indexing      CATALOG: do not use   
% 220.48/220.68  |- rdf__type mesh__D004069sskos__Concept
% 220.48/220.68  |- skos__prefLabel mesh__D004069 Digestive, Oral, and Skin Physiology
% 220.48/220.68  |- skos__altLabel mesh__D009552 Nicethamide
% 220.48/220.68  |- mesh__recordAuthorizer mesh__D009552 sjn
% 220.48/220.68  |- mesh__recordMaintainer mesh__D009552 TWD
% 220.48/220.68  |- skos__altLabel mesh__D009552 Nizethamid
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D009552 2003
% 220.48/220.68  |- skos__broader mesh__D009552smesh__D009536
% 220.48/220.68  |- skos__hiddenLabel mesh__D009552 Diethylamide, Nicotinic
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D009552 2004
% 220.48/220.68  |- rdf__type mesh__D009552sskos__Concept
% 220.48/220.68  |- mesh__dateRevised mesh__D009552 2000-06-22
% 220.48/220.68  |- skos__altLabel mesh__D009552 Diethylnicotinamid
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D009552 2005
% 220.48/220.68  |- skos__altLabel mesh__D009552 Corethamid
% 220.48/220.68  |- skos__altLabel mesh__D009552 Nicotinic Diethylamide
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D009552 2001
% 220.48/220.68  |- skos__prefLabel mesh__D009552 Nikethamide
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D009552 2006
% 220.48/220.68  |- skos__scopeNote mesh__D009552
% 220.48/220.68       A CENTRAL NERVOUS SYSTEM STIMULANT.  It was formerly used in the treatment of barbiturate overdose but is now considered to be of no value for such purposes and may be dangerous. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1229%29%%A%    
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D009552 2002
% 220.48/220.68  |- mesh__recordOriginator mesh__D009552 NLM
% 220.48/220.68  |- mesh__dateCreated mesh__D009552 1999-01-01
% 220.48/220.68  |- skos__annotation mesh__D014497
% 220.48/220.68       a fetal canal connecting the bladder with the allantois; patent urachus: index under URACHUS /abnorm: do not confuse with URACHAL CYST%A%  
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D014497 2002
% 220.48/220.68  |- skos__scopeNote mesh__D014497
% 220.48/220.68       The urinary canal of the fetus; postnatally it is usually a fibrous cord but occasionally persists as a vesicoumbilical fistula.%A%    
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D014497 2001
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D014497 1997
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D014497 1999
% 220.48/220.68  |- rdf__type mesh__D014497sskos__Concept
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D014497 1996
% 220.48/220.68  |- mesh__recordOriginator mesh__D014497 NLM
% 220.48/220.68  |- mesh__recordAuthorizer mesh__D014497 PLS
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D014497 1995
% 220.48/220.68  |- mesh__dateRevised mesh__D014497 1993-06-03
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D014497 2000
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D014497 1998
% 220.48/220.68  |- mesh__dateCreated mesh__D014497 1999-01-01
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D014497 2004
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D014497 1994
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D014497 2006
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D014497 2003
% 220.48/220.68  |- mesh__recordMaintainer mesh__D014497 TGC
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D014497 2005
% 220.48/220.68  |- skos__broader mesh__D014497smesh__D004622
% 220.48/220.68  |- skos__prefLabel mesh__D014497 Urachus
% 220.48/220.68  |- skos__altLabel mesh__D019980 Clavulanate Potentiated Amoxycillin
% 220.48/220.68  |- skos__altLabel mesh__D019980 Amoxicillin-Clavulanic Acid
% 220.48/220.68  |- skos__hiddenLabel mesh__D019980 Amoxycillin Clavulanic Acid
% 220.48/220.68  |- mesh__recordMaintainer mesh__D019980 ssb
% 220.48/220.68  |- mesh__recordAuthorizer mesh__D019980 sjn
% 220.48/220.68  |- skos__hiddenLabel mesh__D019980 Amoxicillin Clavulanic Acid
% 220.48/220.68  |- mesh__recordOriginator mesh__D019980 ADP
% 220.48/220.68  |- skos__altLabel mesh__D019980 Co-amoxiclav
% 220.48/220.68  |- skos__broader mesh__D019980smesh__D000658
% 220.48/220.68  |- skos__altLabel mesh__D019980 Amox-clav
% 220.48/220.68  |- skos__hiddenLabel mesh__D019980 Amoxycillin, Clavulanate Potentiated
% 220.48/220.68  |- skos__prefLabel mesh__D019980
% 220.48/220.68       Amoxicillin-Potassium Clavulanate Combination
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D019980 2006
% 220.48/220.68  |- rdf__type mesh__D019980sskos__Concept
% 220.48/220.68  |- skos__hiddenLabel mesh__D019980 Amoxi Clavulanate
% 220.48/220.68  |- skos__hiddenLabel mesh__D019980 Amox clav
% 220.48/220.68  |- skos__broader mesh__D019980smesh__D019818
% 220.48/220.68  |- mesh__historyNote mesh__D019980
% 220.48/220.68       98; use AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION %28%NM%29% 1981-97%A%  
% 220.48/220.68  |- mesh__dateCreated mesh__D019980 1997-06-20
% 220.48/220.68  |- skos__scopeNote mesh__D019980
% 220.48/220.68       A fixed-ratio combination of amoxicillin trihydrate %28%see AMOXICILLIN%29%, an aminopenicillin, and potassium clavulanate %28%see CLAVULANIC ACID%29%, a beta-lactamase inhibitor, used to treat a broad-spectrum of bacterial infections, especially resistant strains.%A%    
% 220.48/220.68  |- mesh__dateEstablished mesh__D019980 1998-01-01
% 220.48/220.68  |- skos__hiddenLabel mesh__D019980
% 220.48/220.68       Combination, Potassium Clavulanate-Amoxicillin
% 220.48/220.68  |- skos__altLabel mesh__D019980 Amoxycillin-Clavulanic Acid
% 220.48/220.68  |- skos__hiddenLabel mesh__D019980 BRL25000
% 220.48/220.68  |- skos__historyNote mesh__D019980 Amoxicillin %28%1981-1997%29%
% 220.48/220.68  |- skos__hiddenLabel mesh__D019980 Potentiated Amoxycillin, Clavulanate
% 220.48/220.68  |- skos__altLabel mesh__D019980
% 220.48/220.68       Potassium Clavulanate-Amoxicillin Combination
% 220.48/220.68  |- mesh__publicMeSHNote mesh__D019980
% 220.48/220.68       98; BRL 25000 %28%now AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION%29% was indexed under ANTIBIOTICS, COMBINED 1989-97 AMOXICILLIN %26% CLAVULANIC ACIDS 1981-97, DRUG COMBINATIONS 1981-88, %26% LACTAMS 1981-82%A%  
% 220.48/220.68  |- skos__hiddenLabel mesh__D019980 BRL 25000
% 220.48/220.68  |- skos__altLabel mesh__D019980 Coamoxiclav
% 220.48/220.68  |- skos__hiddenLabel mesh__D019980 Co amoxiclav
% 220.48/220.68  |- skos__historyNote mesh__D019980 Drug Combinations %28%1981-1988%29%
% 220.48/220.68  |- skos__hiddenLabel mesh__D019980
% 220.48/220.68       Potassium Clavulanate Amoxicillin Combination
% 220.48/220.68  |- skos__historyNote mesh__D019980 Antibiotics, Combined %28%1989-1997%29%
% 220.48/220.68  |- skos__hiddenLabel mesh__D019980
% 220.48/220.68       Clavulanate-Amoxicillin Combination, Potassium
% 220.48/220.68  |- skos__altLabel mesh__D019980 Amoxi-Clavulanate
% 220.48/220.68  |- skos__hiddenLabel mesh__D019980
% 220.48/220.68       Amoxicillin Potassium Clavulanate Combination
% 220.48/220.68  |- mesh__dateRevised mesh__D019980 2005-06-30
% 220.48/220.68  |- skos__historyNote mesh__D019980 Lactams %28%1981-1982%29%
% 220.48/220.68  |- skos__historyNote mesh__D019980 Clavulanic Acids %28%1981-1997%29%
% 220.48/220.68  |- rdf__type mesh__D000477sskos__Concept
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D000477 2005
% 220.48/220.68  |- mesh__historyNote mesh__D000477 66%28%64%29%   
% 220.48/220.68  |- skos__altLabel mesh__D000477 Alkylators
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D000477 2006
% 220.48/220.68  |- mesh__recordOriginator mesh__D000477 NLM
% 220.48/220.68  |- skos__prefLabel mesh__D000477 Alkylating Agents
% 220.48/220.68  |- mesh__dateRevised mesh__D000477 2003-07-09
% 220.48/220.68  |- mesh__recordAuthorizer mesh__D000477 sjn
% 220.48/220.68  |- mesh__recordMaintainer mesh__D000477 ssb
% 220.48/220.68  |- mesh__dateEstablished mesh__D000477 1966-01-01
% 220.48/220.68  |- mesh__publicMeSHNote mesh__D000477 66   
% 220.48/220.68  |- mesh__dateCreated mesh__D000477 1999-01-01
% 220.48/220.68  |- skos__broader mesh__D000477smesh__D009676
% 220.48/220.68  |- skos__broader mesh__D000477smesh__D045504
% 220.48/220.68  |- skos__hiddenLabel mesh__D000477 Agents, Alkylating
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D000477 2004
% 220.48/220.68  |- skos__scopeNote mesh__D000477
% 220.48/220.68       Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases.%A%    
% 220.48/220.68  |- skos__broader mesh__D005960smesh__D006027
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D005960 2005
% 220.48/220.68  |- skos__annotation mesh__D005960 do not confuse with GLYCOSIDES   
% 220.48/220.68  |- skos__prefLabel mesh__D005960 Glucosides
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D005960 2006
% 220.48/220.68  |- mesh__onlineNote mesh__D005960 search GLYCOSIDES 1966-74   
% 220.48/220.68  |- mesh__dateRevised mesh__D005960 2004-07-07
% 220.48/220.68  |- mesh__recordAuthorizer mesh__D005960 sjn
% 220.48/220.68  |- mesh__dateEstablished mesh__D005960 1991-01-01
% 220.48/220.68  |- rdf__type mesh__D005960sskos__Concept
% 220.48/220.68  |- mesh__dateCreated mesh__D005960 1999-01-01
% 220.48/220.68  |- mesh__publicMeSHNote mesh__D005960
% 220.48/220.68       91; was see under GLYCOSIDES 1975-90   
% 220.48/220.68  |- mesh__recordOriginator mesh__D005960 NLM
% 220.48/220.68  |- mesh__recordMaintainer mesh__D005960 ssb
% 220.48/220.68  |- mesh__historyNote mesh__D005960
% 220.48/220.68       91%28%75%29%; was see under GLYCOSIDES 1975-90   
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D005162 2001
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D005162 1999
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D005162 2002
% 220.48/220.68  |- mesh__historyNote mesh__D005162 81   
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D005162 2003
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D005162 2004
% 220.48/220.68  |- rdf__type mesh__D005162sskos__Concept
% 220.48/220.68  |- skos__annotation mesh__D005162
% 220.48/220.68       differentiate from SOMATOFORM DISORDERS: factitious are phys or psychol sympt under voluntary control, somatoform are phys sympt linked to psychol factors but not under voluntary control%A%  
% 220.48/220.68  |- mesh__dateCreated mesh__D005162 1980-05-21
% 220.48/220.68  |- mesh__recordOriginator mesh__D005162 EC
% 220.48/220.68  |- skos__prefLabel mesh__D005162 Factitious Disorders
% 220.48/220.68  |- mesh__recordAuthorizer mesh__D005162 SJN
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D005162 2005
% 220.48/220.68  |- mesh__publicMeSHNote mesh__D005162 81   
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D005162 2000
% 220.48/220.68  |- mesh__dateRevised mesh__D005162 1997-06-20
% 220.48/220.68  |- skos__hiddenLabel mesh__D005162 Syndrome, Ganser
% 220.48/220.68  |- skos__scopeNote mesh__D005162
% 220.48/220.68       Disorders characterized by physical or psychological symptoms that are not real, genuine, or natural.%A%    
% 220.48/220.68  |- mesh__dateEstablished mesh__D005162 1981-01-01
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D005162 2006
% 220.48/220.68  |- skos__broader mesh__D005162smesh__D001523
% 220.48/220.68  |- mesh__recordMaintainer mesh__D005162 JLS
% 220.48/220.68  |- skos__hiddenLabel mesh__D005162 Disorders, Factitious
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D005162 1998
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D018888 2006
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D018888 2003
% 220.48/220.68  |- skos__historyNote mesh__D018888 Aphasia %28%1982-1995%29%
% 220.48/220.68  |- mesh__historyNote mesh__D018888 1996   
% 220.48/220.68  |- skos__hiddenLabel mesh__D018888 Syndrome, Mesulam%27%s
% 220.48/220.68  |- skos__hiddenLabel mesh__D018888 Aphasias, Progressive Nonfluent
% 220.48/220.68  |- skos__hiddenLabel mesh__D018888 Nonfluent Aphasias, Progressive
% 220.48/220.68  |- skos__hiddenLabel mesh__D018888 Aphasias, Primary Progressive
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D018888 2004
% 220.48/220.68  |- skos__hiddenLabel mesh__D018888 Progressive Aphasia, Primary
% 220.48/220.68  |- skos__altLabel mesh__D018888 Mesulam Syndrome
% 220.48/220.68  |- mesh__recordAuthorizer mesh__D018888 sjn
% 220.48/220.68  |- skos__broader mesh__D018888smesh__D003704
% 220.48/220.68  |- rdf__type mesh__D018888sskos__Concept
% 220.48/220.68  |- mesh__dateRevised mesh__D018888 1999-11-03
% 220.48/220.68  |- skos__annotation mesh__D018888
% 220.48/220.68       a clin entity: do not confuse with descriptions of the progression of aphasia in case reports%A%  
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D018888 2000
% 220.48/220.68  |- skos__scopeNote mesh__D018888
% 220.48/220.68       A progressive form of dementia characterized by the global loss of language abilities and initial preservation of other cognitive functions. Fluent and nonfluent subtypes have been described. Eventually a pattern of global cognitive dysfunction, similar to ALZHEIMER DISEASE, emerges. Pathologically, there are no Alzheimer or PICK DISEASE like changes, however, spongiform changes of cortical layers II and III are present in the TEMPORAL LOBE and FRONTAL LOBE. %28%From Brain 1998 Jan;121%28%Pt 1%29%:115-26%29%%A%    
% 220.48/220.68  |- skos__hiddenLabel mesh__D018888 Primary Progressive Aphasias
% 220.48/220.68  |- skos__hiddenLabel mesh__D018888 Primary Progressive Aphasia
% 220.48/220.68  |- mesh__recordMaintainer mesh__D018888 KEV
% 220.48/220.68  |- skos__hiddenLabel mesh__D018888 Progressive Aphasias, Primary
% 220.48/220.68  |- mesh__publicMeSHNote mesh__D018888 1996   
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D018888 2001
% 220.48/220.68  |- mesh__dateEstablished mesh__D018888 1996-01-01
% 220.48/220.68  |- skos__prefLabel mesh__D018888 Aphasia, Primary Progressive
% 220.48/220.68  |- skos__broader mesh__D018888smesh__D001037
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D018888 2005
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D018888 2002
% 220.48/220.68  |- skos__hiddenLabel mesh__D018888 Aphasia, Progressive Nonfluent
% 220.48/220.68  |- skos__hiddenLabel mesh__D018888 Progressive Nonfluent Aphasias
% 220.48/220.68  |- skos__altLabel mesh__D018888 Mesulam%27%s Syndrome
% 220.48/220.68  |- mesh__dateCreated mesh__D018888 1994-12-27
% 220.48/220.68  |- skos__hiddenLabel mesh__D018888 Syndrome, Mesulam
% 220.48/220.68  |- skos__hiddenLabel mesh__D018888 Nonfluent Aphasia, Progressive
% 220.48/220.68  |- mesh__recordOriginator mesh__D018888 TGC
% 220.48/220.68  |- skos__hiddenLabel mesh__D004868 Misuses, Equipment
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D004868 1999
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D004868 1994
% 220.48/220.68  |- rdf__type mesh__D004868sskos__Concept
% 220.48/220.68  |- mesh__historyNote mesh__D004868 82   
% 220.48/220.68  |- skos__hiddenLabel mesh__D004868 Device Failures
% 220.48/220.68  |- skos__altLabel mesh__D004868 Failure, Medical Device
% 220.48/220.68  |- mesh__dateCreated mesh__D004868 1981-05-15
% 220.48/220.68  |- skos__broader mesh__D004868smesh__D008919
% 220.48/220.68  |- skos__hiddenLabel mesh__D004868 Equipment Malfunction
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D004868 2001
% 220.48/220.68  |- skos__prefLabel mesh__D004868 Equipment Failure
% 220.48/220.68  |- skos__scopeNote mesh__D004868
% 220.48/220.68       Failure of equipment to perform up to standards. The failure may be due to defects or improper use.%A%    
% 220.48/220.68  |- skos__hiddenLabel mesh__D004868 Equipment Defect
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D004868 2006
% 220.48/220.68  |- skos__hiddenLabel mesh__D004868 Equipment Defects
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D004868 1998
% 220.48/220.68  |- skos__hiddenLabel mesh__D004868 Alarm Systems, Equipment
% 220.48/220.68  |- skos__altLabel mesh__D004868 Failure, Equipment
% 220.48/220.68  |- skos__hiddenLabel mesh__D004868 Failure, Device
% 220.48/220.68  |- skos__altLabel mesh__D004868 Device Failures, Medical
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D004868 2000
% 220.48/220.68  |- mesh__publicMeSHNote mesh__D004868 82   
% 220.48/220.68  |- skos__hiddenLabel mesh__D004868 Equipment Malfunctions
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D004868 2005
% 220.48/220.68  |- skos__hiddenLabel mesh__D004868 Failures, Device
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D004868 1997
% 220.48/220.68  |- skos__altLabel mesh__D004868 Failures, Medical Device
% 220.48/220.68  |- skos__hiddenLabel mesh__D004868 Malfunctions, Equipment
% 220.48/220.68  |- skos__hiddenLabel mesh__D004868 Equipment Failures
% 220.48/220.68  |- skos__hiddenLabel mesh__D004868 Equipment Misuse
% 220.48/220.68  |- skos__hiddenLabel mesh__D004868 Defect, Equipment
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D004868 2004
% 220.48/220.68  |- mesh__dateRevised mesh__D004868 1992-05-15
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D004868 1996
% 220.48/220.68  |- mesh__recordOriginator mesh__D004868 SMH
% 220.48/220.68  |- skos__annotation mesh__D004868
% 220.48/220.68       NIM; coord with specific equip %28%IM%29% or specific techn /instrum %28%IM%29%%A%  
% 220.48/220.68  |- skos__hiddenLabel mesh__D004868 Systems, Equipment Alarm
% 220.48/220.68  |- mesh__recordMaintainer mesh__D004868 TAP
% 220.48/220.68  |- skos__hiddenLabel mesh__D004868 Equipment Alarm System
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D004868 2003
% 220.48/220.68  |- mesh__recordAuthorizer mesh__D004868 PLS
% 220.48/220.68  |- skos__hiddenLabel mesh__D004868 Equipment Misuses
% 220.48/220.68  |- skos__altLabel mesh__D004868 Malfunction, Equipment
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D004868 1995
% 220.48/220.68  |- skos__altLabel mesh__D004868 Device Failure, Medical
% 220.48/220.68  |- skos__hiddenLabel mesh__D004868 Failures, Equipment
% 220.48/220.68  |- mesh__dateEstablished mesh__D004868 1982-01-01
% 220.48/220.68  |- skos__hiddenLabel mesh__D004868 Alarm System, Equipment
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D004868 2002
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D004868 1993
% 220.48/220.68  |- skos__hiddenLabel mesh__D004868 System, Equipment Alarm
% 220.48/220.68  |- skos__altLabel mesh__D015590 Ocular Fluorophotometry
% 220.48/220.68  |- skos__broader mesh__D015590smesh__D003941
% 220.48/220.68  |- skos__hiddenLabel mesh__D015590 Fluorophotometry, Vitreous
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D015590 2006
% 220.48/220.68  |- mesh__dateRevised mesh__D015590 2004-07-07
% 220.48/220.68  |- skos__annotation mesh__D015590
% 220.48/220.68       NIM; note X refs %26% read MeSH definition: restrict to ophthalmology%A%  
% 220.48/220.68  |- skos__historyNote mesh__D015590 Photometry %28%1966-1989%29%
% 220.48/220.68  |- skos__broader mesh__D015590smesh__D005470
% 220.48/220.68  |- mesh__dateEstablished mesh__D015590 1990-01-01
% 220.48/220.68  |- mesh__recordOriginator mesh__D015590 AGS
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D015590 2005
% 220.48/220.68  |- mesh__dateCreated mesh__D015590 1989-04-07
% 220.48/220.68  |- skos__historyNote mesh__D015590 Fluorometry %28%1966-1989%29%
% 220.48/220.68  |- mesh__publicMeSHNote mesh__D015590 90   
% 220.48/220.68  |- mesh__recordMaintainer mesh__D015590 ssb
% 220.48/220.68  |- mesh__historyNote mesh__D015590 90   
% 220.48/220.68  |- rdf__type mesh__D015590sskos__Concept
% 220.48/220.68  |- skos__scopeNote mesh__D015590
% 220.48/220.68       Measurement of light given off by fluorescein in order to assess the integrity of various ocular barriers. The method is used to investigate the blood-aqueous barrier, blood-retinal barrier, aqueous flow measurements, corneal endothelial permeability, and tear flow dynamics.%A%    
% 220.48/220.68  |- skos__prefLabel mesh__D015590 Fluorophotometry
% 220.48/220.68  |- mesh__recordAuthorizer mesh__D015590 sjn
% 220.48/220.68  |- skos__hiddenLabel mesh__D015590 Fluorophotometry, Ocular
% 220.48/220.68  |- skos__altLabel mesh__D015590 Vitreous Fluorophotometry
% 220.48/220.68  |- rdf__type mesh__D009553sskos__Concept
% 220.48/220.68  |- skos__broader mesh__D009553smesh__D009539
% 220.48/220.68  |- skos__altLabel mesh__D009553 Esteve Brand of Nimodipine
% 220.48/220.68  |- skos__altLabel mesh__D009553 Cantabria Brand of Nimodipine
% 220.48/220.68  |- mesh__recordOriginator mesh__D009553 RLS
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D009553 2005
% 220.48/220.68  |- skos__hiddenLabel mesh__D009553 NimodipinISIS
% 220.48/220.68  |- skos__altLabel mesh__D009553 Vita Brand of Nimodipine
% 220.48/220.68  |- skos__altLabel mesh__D009553 Elan Brand of Nimodipine
% 220.48/220.68  |- mesh__dateRevised mesh__D009553 2004-07-07
% 220.48/220.68  |- skos__altLabel mesh__D009553 Almirall Brand of Nimodipine
% 220.48/220.68  |- skos__altLabel mesh__D009553 Alpharma Brand of Nimodipine
% 220.48/220.68  |- skos__altLabel mesh__D009553 Bayer Brand of Nimodipine
% 220.48/220.68  |- mesh__dateCreated mesh__D009553 1986-06-03
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D009553 2006
% 220.48/220.68  |- mesh__publicMeSHNote mesh__D009553
% 220.48/220.68       87; NIMODIPINE was indexed under NICOTINIC ACIDS 1981-86   
% 220.48/220.68  |- skos__broader mesh__D009553smesh__D004095
% 220.48/220.68  |- skos__historyNote mesh__D009553 Nicotinic Acids %28%1966-1986%29%
% 220.48/220.68  |- mesh__recordAuthorizer mesh__D009553 sjn
% 220.48/220.68  |- mesh__historyNote mesh__D009553 87; use NIMODIPINE %28%NM%29% 1981-86   
% 220.48/220.68  |- skos__scopeNote mesh__D009553
% 220.48/220.68       A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.%A%    
% 220.48/220.68  |- skos__hiddenLabel mesh__D009553 Nimodipin ISIS
% 220.48/220.68  |- skos__altLabel mesh__D009553 Hexal Brand of Nimodipine
% 220.48/220.68  |- skos__altLabel mesh__D009553 Andromaco Brand of Nimodipine
% 220.48/220.68  |- skos__prefLabel mesh__D009553 Nimodipine
% 220.48/220.68  |- mesh__dateEstablished mesh__D009553 1987-01-01
% 220.48/220.68  |- mesh__recordMaintainer mesh__D009553 lkw
% 220.48/220.68  |- skos__altLabel mesh__D009553 Bayvit Brand of Nimodipine
% 220.48/220.68  |- mesh__historyNote mesh__D001570 74   
% 220.48/220.68  |- mesh__recordAuthorizer mesh__D001570 PLS
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D001570 2004
% 220.48/220.68  |- skos__prefLabel mesh__D001570 Benzodiazepinones
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D001570 2006
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D001570 2000
% 220.48/220.68  |- mesh__dateRevised mesh__D001570 1992-05-08
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D001570 1996
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D001570 2001
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D001570 1998
% 220.48/220.68  |- mesh__recordMaintainer mesh__D001570 TAP
% 220.48/220.68  |- mesh__recordOriginator mesh__D001570 NLM
% 220.48/220.68  |- mesh__dateCreated mesh__D001570 1999-01-01
% 220.48/220.68  |- skos__broader mesh__D001570smesh__D001569
% 220.48/220.68  |- skos__annotation mesh__D001570 do not confuse with BENZODIAZEPINES   
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D001570 1997
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D001570 1994
% 220.48/220.68  |- mesh__dateEstablished mesh__D001570 1974-01-01
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D001570 1999
% 220.48/220.68  |- rdf__type mesh__D001570sskos__Concept
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D001570 1993
% 220.48/220.68  |- mesh__publicMeSHNote mesh__D001570 74   
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D001570 1995
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D001570 2002
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D001570 2003
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D001570 2005
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D014498 1989
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D014498 1991
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D014498 1997
% 220.48/220.68  |- mesh__recordMaintainer mesh__D014498 PLS
% 220.48/220.68  |- skos__prefLabel mesh__D014498 Uracil
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D014498 1999
% 220.48/220.68  |- rdf__type mesh__D014498sskos__Concept
% 220.48/220.68  |- mesh__activeMeSHYear mesh__D014498 1993
% 220.54/220.68  |- skos__broader mesh__D014498smesh__D011744
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D014498 2002
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D014498 1990
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D014498 1996
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D014498 1995
% 220.54/220.68  |- mesh__dateCreated mesh__D014498 1999-01-01
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D014498 1998
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D014498 1992
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D014498 2004
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D014498 2001
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D014498 1994
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D014498 2006
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D014498 2003
% 220.54/220.68  |- mesh__recordAuthorizer mesh__D014498 PLS
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D014498 2000
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D014498 2005
% 220.54/220.68  |- skos__annotation mesh__D014498
% 220.54/220.68       /biosyn /physiol permitted; uracil deoxyriboside, uracil deoxyribonucleoside = DEOXYURIDINE; uracil riboside, uracil ribonucleoside = URIDINE%A%  
% 220.54/220.68  |- mesh__recordOriginator mesh__D014498 NLM
% 220.54/220.68  |- mesh__dateRevised mesh__D014498 1989-10-31
% 220.54/220.68  |- skos__hiddenLabel mesh__D019981 Markets, Healthcare
% 220.54/220.68  |- skos__hiddenLabel mesh__D019981 Market, Health Care
% 220.54/220.68  |- skos__altLabel mesh__D019981 Healthcare Market
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D019981 2002
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D019981 2003
% 220.54/220.68  |- mesh__recordAuthorizer mesh__D019981 SJN
% 220.54/220.68  |- skos__hiddenLabel mesh__D019981 Market, Healthcare
% 220.54/220.68  |- mesh__dateRevised mesh__D019981 1998-06-10
% 220.54/220.68  |- skos__hiddenLabel mesh__D019981 Sector, Healthcare
% 220.54/220.68  |- skos__related mesh__D019981smesh__D006301
% 220.54/220.68  |- skos__altLabel mesh__D019981 Healthcare Sector
% 220.54/220.68  |- skos__hiddenLabel mesh__D019981 Industries, Healthcare
% 220.54/220.68  |- skos__hiddenLabel mesh__D019981 Markets, Health Care
% 220.54/220.68  |- skos__hiddenLabel mesh__D019981 Sector, Health Care
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D019981 2006
% 220.54/220.68  |- rdf__type mesh__D019981sskos__Concept
% 220.54/220.68  |- skos__broader mesh__D019981smesh__D007221
% 220.54/220.68  |- skos__hiddenLabel mesh__D019981 Sectors, Health Care
% 220.54/220.68  |- skos__hiddenLabel mesh__D019981 Industry, Health Care
% 220.54/220.68  |- skos__hiddenLabel mesh__D019981 Healthcare Sectors
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D019981 2001
% 220.54/220.68  |- mesh__publicMeSHNote mesh__D019981 98   
% 220.54/220.68  |- skos__hiddenLabel mesh__D019981 Industries, Health Care
% 220.54/220.68  |- mesh__recordOriginator mesh__D019981 JLS
% 220.54/220.68  |- mesh__dateCreated mesh__D019981 1997-06-20
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D019981 2005
% 220.54/220.68  |- skos__hiddenLabel mesh__D019981 Healthcare Markets
% 220.54/220.68  |- skos__hiddenLabel mesh__D019981 Health Care Industries
% 220.54/220.68  |- skos__scopeNote mesh__D019981
% 220.54/220.68       Economic sector concerned with the provision, distribution, and consumption of health care services and related products.%A%    
% 220.54/220.68  |- mesh__dateEstablished mesh__D019981 1998-01-01
% 220.54/220.68  |- skos__broader mesh__D019981smesh__D004467
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D019981 2000
% 220.54/220.68  |- skos__hiddenLabel mesh__D019981 Health Care Sectors
% 220.54/220.68  |- skos__altLabel mesh__D019981 Health Care Industry
% 220.54/220.68  |- skos__altLabel mesh__D019981 Industry, Healthcare
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D019981 1999
% 220.54/220.68  |- skos__hiddenLabel mesh__D019981 Health Care Markets
% 220.54/220.68  |- skos__hiddenLabel mesh__D019981 Healthcare Industries
% 220.54/220.68  |- mesh__historyNote mesh__D019981 98   
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D019981 2004
% 220.54/220.68  |- mesh__recordMaintainer mesh__D019981 NNS
% 220.54/220.68  |- skos__hiddenLabel mesh__D019981 Sectors, Healthcare
% 220.54/220.68  |- skos__prefLabel mesh__D019981 Health Care Sector
% 220.54/220.68  |- skos__related mesh__D019981smesh__D008389
% 220.54/220.68  |- skos__prefLabel mesh__D000478 Alkylation
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D000478 2006
% 220.54/220.68  |- skos__broader mesh__D000478smesh__D008660
% 220.54/220.68  |- mesh__historyNote mesh__D000478 66   
% 220.54/220.68  |- mesh__activeMeSHYear mesh__D000478 2002
% 220.54/220.68  |- mesh__dateRevised mesh__D000478 2000-06-21
% 220.54/220.68  |- skos__annotation mesh__D000478
% 220.54/220.68       almost never IM; enzymatic alkylation: coord NIM with TRANSFERASES %28%IM%29% + substrate %28%NIM%29%; METHYLATION %26% METHYLTRANSFERASES are also available%A%  
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D000478 2003
% 220.54/220.69  |- skos__scopeNote mesh__D000478
% 220.54/220.69       The covalent bonding of an alkyl group to an organic compound. It can occur by a simple addition reaction or by substitution of another functional group.%A%    
% 220.54/220.69  |- mesh__publicMeSHNote mesh__D000478 66   
% 220.54/220.69  |- mesh__dateCreated mesh__D000478 1999-01-01
% 220.54/220.69  |- mesh__recordOriginator mesh__D000478 NLM
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D000478 2004
% 220.54/220.69  |- mesh__recordMaintainer mesh__D000478 adp
% 220.54/220.69  |- mesh__recordAuthorizer mesh__D000478 sjn
% 220.54/220.69  |- skos__broader mesh__D000478smesh__D002625
% 220.54/220.69  |- skos__hiddenLabel mesh__D000478 Alkylations
% 220.54/220.69  |- rdf__type mesh__D000478sskos__Concept
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D000478 2005
% 220.54/220.69  |- mesh__dateEstablished mesh__D000478 1966-01-01
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D000478 2001
% 220.54/220.69  |- skos__hiddenLabel mesh__D019183 Panicoviruses
% 220.54/220.69  |- skos__hiddenLabel mesh__D019183 Necroviruses
% 220.54/220.69  |- skos__hiddenLabel mesh__D019183 Machlomoviruses
% 220.54/220.69  |- mesh__publicMeSHNote mesh__D019183 97   
% 220.54/220.69  |- mesh__dateCreated mesh__D019183 1996-06-10
% 220.54/220.69  |- skos__annotation mesh__D019183 coord IM with specific plant /virol   
% 220.54/220.69  |- mesh__dateRevised mesh__D019183 2001-07-25
% 220.54/220.69  |- skos__broader mesh__D019183smesh__D010942
% 220.54/220.69  |- skos__hiddenLabel mesh__D019183 Dianthoviruses
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D019183 2002
% 220.54/220.69  |- skos__hiddenLabel mesh__D019183 Aureusviruses
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D019183 2004
% 220.54/220.69  |- mesh__recordOriginator mesh__D019183 AGS
% 220.54/220.69  |- skos__scopeNote mesh__D019183
% 220.54/220.69       A family of RNA plant viruses infecting dicotyledons. Transmission is mainly by mechanical inoculation and through propagative plant material. All species elicit formation of multivesicular inclusion bodies. There are at least eight genera: Aureusvirus, Avenavirus, CARMOVIRUS, Dianthovirus, Machlomovirus, Necrovirus, Panicovirus, and TOMBUSVIRUS.%A%    
% 220.54/220.69  |- mesh__recordAuthorizer mesh__D019183 sjn
% 220.54/220.69  |- skos__prefLabel mesh__D019183 Tombusviridae
% 220.54/220.69  |- mesh__historyNote mesh__D019183 97   
% 220.54/220.69  |- skos__hiddenLabel mesh__D019183 Avenaviruses
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D019183 2003
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D019183 2006
% 220.54/220.69  |- mesh__dateEstablished mesh__D019183 1997-01-01
% 220.54/220.69  |- skos__broader mesh__D019183smesh__D012328
% 220.54/220.69  |- rdf__type mesh__D019183sskos__Concept
% 220.54/220.69  |- mesh__recordMaintainer mesh__D019183 ags
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D019183 2005
% 220.54/220.69  |- mesh__recordOriginator mesh__D005961 RLS
% 220.54/220.69  |- mesh__dateCreated mesh__D005961 1978-05-18
% 220.54/220.69  |- rdf__type mesh__D005961sskos__Concept
% 220.54/220.69  |- skos__scopeNote mesh__D005961
% 220.54/220.69       Substituted thioglucosides. They are found in rapeseed %28%Brassica campestris%29% products and related cruciferae. They are metabolized to a variety of toxic products which are most likely the cause of hepatocytic necrosis in animals and humans.%A%    
% 220.54/220.69  |- skos__prefLabel mesh__D005961 Glucosinolates
% 220.54/220.69  |- mesh__dateEstablished mesh__D005961 1991-01-01
% 220.54/220.69  |- mesh__publicMeSHNote mesh__D005961
% 220.54/220.69       91; was see under THIOGLYCOSIDES 1979-90   
% 220.54/220.69  |- mesh__recordMaintainer mesh__D005961 ssb
% 220.54/220.69  |- mesh__dateRevised mesh__D005961 2005-06-30
% 220.54/220.69  |- skos__historyNote mesh__D005961 Thioglycosides %28%1974%29%
% 220.54/220.69  |- mesh__historyNote mesh__D005961
% 220.54/220.69       91%28%79%29%; was see under THIOGLYCOSIDES 1979-90   
% 220.54/220.69  |- skos__historyNote mesh__D005961 Thioglucosides %28%1975-1978%29%
% 220.54/220.69  |- mesh__recordAuthorizer mesh__D005961 sjn
% 220.54/220.69  |- skos__historyNote mesh__D005961 Glycosides %28%1966-1973%29%
% 220.54/220.69  |- skos__broader mesh__D005961smesh__D013863
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D005961 2006
% 220.54/220.69  |- skos__hiddenLabel mesh__D005163 Factor Analyses
% 220.54/220.69  |- skos__hiddenLabel mesh__D005163 Analyses, Statistical Factor
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D005163 2006
% 220.54/220.69  |- skos__prefLabel mesh__D005163 Factor Analysis, Statistical
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D005163 2001
% 220.54/220.69  |- skos__altLabel mesh__D005163 Statistical Factor Analysis
% 220.54/220.69  |- mesh__recordMaintainer mesh__D005163 TGC
% 220.54/220.69  |- mesh__recordOriginator mesh__D005163 NLM
% 220.54/220.69  |- skos__hiddenLabel mesh__D005163 Analyses, Factor
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D005163 2000
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D005163 2005
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D005163 1999
% 220.54/220.69  |- mesh__dateRevised mesh__D005163 1994-04-11
% 220.54/220.69  |- mesh__recordAuthorizer mesh__D005163 PLS
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D005163 2004
% 220.54/220.69  |- skos__hiddenLabel mesh__D005163 Statistical Factor Analyses
% 220.54/220.69  |- mesh__dateCreated mesh__D005163 1999-01-01
% 220.54/220.69  |- skos__scopeNote mesh__D005163
% 220.54/220.69       A set of statistical methods for analyzing the correlations among several variables in order to estimate the number of fundamental dimensions that underlie the observed data and to describe and measure those dimensions. It is used frequently in the development of scoring systems for rating scales and questionnaires.%A%    
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D005163 1998
% 220.54/220.69  |- skos__annotation mesh__D005163
% 220.54/220.69       a specific statist technique: not a synonym for %22%analysis of various factors...%22%; IM GEN only; coord NIM with specific disease or other concept %28%IM%29%; no qualif%A%  
% 220.54/220.69  |- skos__broader mesh__D005163smesh__D013223
% 220.54/220.69  |- skos__altLabel mesh__D005163 Factor Analysis
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D005163 2003
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D005163 1997
% 220.54/220.69  |- rdf__type mesh__D005163sskos__Concept
% 220.54/220.69  |- skos__hiddenLabel mesh__D005163 Factor Analyses, Statistical
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D005163 1996
% 220.54/220.69  |- skos__altLabel mesh__D005163 Analysis, Statistical Factor
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D005163 2002
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D005163 1995
% 220.54/220.69  |- skos__historyNote mesh__D018889 Bone Lengthening %28%1981-1995%29%
% 220.54/220.69  |- skos__hiddenLabel mesh__D018889 Technique, Ilizarov
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D018889 2000
% 220.54/220.69  |- skos__related mesh__D018889smesh__D019857
% 220.54/220.69  |- mesh__recordOriginator mesh__D018889 TGC
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D018889 2004
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D018889 1998
% 220.54/220.69  |- mesh__dateEstablished mesh__D018889 1996-01-01
% 220.54/220.69  |- skos__hiddenLabel mesh__D018889 Technic, Ilizarov
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D018889 2006
% 220.54/220.69  |- skos__broader mesh__D018889smesh__D005592
% 220.54/220.69  |- skos__altLabel mesh__D018889 Ilizarov Technic
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D018889 2003
% 220.54/220.69  |- mesh__recordAuthorizer mesh__D018889 SJN
% 220.54/220.69  |- skos__historyNote mesh__D018889
% 220.54/220.69       Orthopedic Fixation Devices %28%1971-1995%29%
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D018889 2005
% 220.54/220.69  |- skos__broader mesh__D018889smesh__D001852
% 220.54/220.69  |- skos__historyNote mesh__D018889 External Fixators %28%1990-1995%29%
% 220.54/220.69  |- skos__hiddenLabel mesh__D018889 Method, Ilizarov
% 220.54/220.69  |- skos__prefLabel mesh__D018889 Ilizarov Technique
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D018889 2002
% 220.54/220.69  |- rdf__type mesh__D018889sskos__Concept
% 220.54/220.69  |- mesh__dateCreated mesh__D018889 1995-06-08
% 220.54/220.69  |- skos__annotation mesh__D018889
% 220.54/220.69       bone fixation method using an external fixator; do not use /util except by MeSH definition%A%  
% 220.54/220.69  |- mesh__dateRevised mesh__D018889 1997-06-25
% 220.54/220.69  |- skos__scopeNote mesh__D018889
% 220.54/220.69       A bone fixation technique using an external fixator %28%FIXATORS, EXTERNAL%29% for lengthening limbs, correcting pseudarthroses and other deformities, and assisting the healing of otherwise hopeless traumatic or pathological fractures and infections, such as chronic osteomyelitis. The method was devised by the Russian orthopedic surgeon Gavriil Abramovich Ilizarov %28%1921-1992%29%. %28%From Bull Hosp Jt Dis 1992 Summer;52%28%1%29%:1%29%%A%    
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D018889 2001
% 220.54/220.69  |- mesh__recordMaintainer mesh__D018889 PXP
% 220.54/220.69  |- mesh__publicMeSHNote mesh__D018889 96   
% 220.54/220.69  |- mesh__historyNote mesh__D018889 96   
% 220.54/220.69  |- skos__altLabel mesh__D018889 Ilizarov Method
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D018889 1999
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D004869 2004
% 220.54/220.69  |- skos__hiddenLabel mesh__D004869 Equipment Hazard
% 220.54/220.69  |- skos__altLabel mesh__D004869 Device Safety, Medical
% 220.54/220.69  |- mesh__publicMeSHNote mesh__D004869 82   
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D004869 2002
% 220.54/220.69  |- skos__scopeNote mesh__D004869
% 220.54/220.69       Freedom of equipment from actual or potential hazards.     
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D004869 1997
% 220.54/220.69  |- skos__altLabel mesh__D004869 Safety, Equipment
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D004869 2005
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D004869 1998
% 220.54/220.69  |- skos__altLabel mesh__D004869 Safety, Medical Device
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D004869 2006
% 220.54/220.69  |- skos__hiddenLabel mesh__D004869 Safety, Device
% 220.54/220.69  |- mesh__dateEstablished mesh__D004869 1982-01-01
% 220.54/220.69  |- skos__broader mesh__D004869smesh__D008919
% 220.54/220.69  |- skos__annotation mesh__D004869
% 220.54/220.69       NIM; coord with specific equip %28%IM%29% or specific techn /instrum %28%IM%29%%A%  
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D004869 1993
% 220.54/220.69  |- rdf__type mesh__D004869sskos__Concept
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D004869 1999
% 220.54/220.69  |- skos__hiddenLabel mesh__D004869 Equipment Hazards
% 220.54/220.69  |- mesh__recordOriginator mesh__D004869 SMH
% 220.54/220.69  |- mesh__historyNote mesh__D004869 82   
% 220.54/220.69  |- mesh__recordAuthorizer mesh__D004869 PLS
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D004869 2000
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D004869 1994
% 220.54/220.69  |- skos__hiddenLabel mesh__D004869 Hazard, Equipment
% 220.54/220.69  |- mesh__recordMaintainer mesh__D004869 TAP
% 220.54/220.69  |- mesh__dateCreated mesh__D004869 1981-05-15
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D004869 2003
% 220.54/220.69  |- skos__prefLabel mesh__D004869 Equipment Safety
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D004869 2001
% 220.54/220.69  |- mesh__dateRevised mesh__D004869 1992-05-15
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D004869 1995
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D004869 1996
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D015591 2004
% 220.54/220.69  |- skos__prefLabel mesh__D015591 Microspectrophotometry
% 220.54/220.69  |- mesh__dateEstablished mesh__D015591 1990-01-01
% 220.54/220.69  |- skos__broader mesh__D015591smesh__D013053
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D015591 2005
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D015591 2003
% 220.54/220.69  |- mesh__publicMeSHNote mesh__D015591 90   
% 220.54/220.69  |- skos__scopeNote mesh__D015591
% 220.54/220.69       Analytical technique for studying substances present at enzyme concentrations in single cells, in situ, by measuring light absorption. Light from a tungsten strip lamp or xenon arc dispersed by a grating monochromator illuminates the optical system of a microscope. The absorbance of light is measured %28%in nanometers%29% by comparing the difference between the image of the sample and a reference image.%A%    
% 220.54/220.69  |- rdf__type mesh__D015591sskos__Concept
% 220.54/220.69  |- skos__annotation mesh__D015591 a type of spectrum anal; NIM   
% 220.54/220.69  |- skos__hiddenLabel mesh__D015591 Microspectrophotometries
% 220.54/220.69  |- mesh__dateRevised mesh__D015591 2002-07-03
% 220.54/220.69  |- mesh__recordOriginator mesh__D015591 AGS
% 220.54/220.69  |- skos__historyNote mesh__D015591 Spectrophotometry %28%1966-1989%29%
% 220.54/220.69  |- mesh__recordMaintainer mesh__D015591 lkt
% 220.54/220.69  |- mesh__dateCreated mesh__D015591 1989-04-07
% 220.54/220.69  |- mesh__historyNote mesh__D015591 90   
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D015591 2006
% 220.54/220.69  |- mesh__recordAuthorizer mesh__D015591 sjn
% 220.54/220.69  |- mesh__dateRevised mesh__D009554 2005-06-30
% 220.54/220.69  |- mesh__recordMaintainer mesh__D009554 lkw
% 220.54/220.69  |- skos__broader mesh__D009554smesh__D009593
% 220.54/220.69  |- mesh__historyNote mesh__D009554
% 220.54/220.69       91%28%75%29%; was see under NITROIMIDAZOLES 1975-90   
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D009554 2006
% 220.54/220.69  |- mesh__dateEstablished mesh__D009554 1991-01-01
% 220.54/220.69  |- skos__altLabel mesh__D009554 Pharmacia Brand of Nimorazole
% 220.54/220.69  |- skos__historyNote mesh__D009554 Morpholines %28%1971-1974%29%
% 220.54/220.69  |- skos__scopeNote mesh__D009554
% 220.54/220.69       An antitrichomonal agent which is effective either topically or orally and whose urinary metabolites are also trichomonicidal.%A%    
% 220.54/220.69  |- mesh__dateCreated mesh__D009554 1974-11-19
% 220.54/220.69  |- mesh__recordOriginator mesh__D009554 NLM
% 220.54/220.69  |- mesh__recordAuthorizer mesh__D009554 sjn
% 220.54/220.69  |- skos__hiddenLabel mesh__D009554 K 1900
% 220.54/220.69  |- skos__hiddenLabel mesh__D009554 K1900
% 220.54/220.69  |- rdf__type mesh__D009554sskos__Concept
% 220.54/220.69  |- skos__historyNote mesh__D009554 Nitroimidazoles %28%1974%29%
% 220.54/220.69  |- skos__altLabel mesh__D009554 Nitrimidazine
% 220.54/220.69  |- mesh__publicMeSHNote mesh__D009554
% 220.54/220.69       91; was see under NITROIMIDAZOLES 1975-90   
% 220.54/220.69  |- skos__prefLabel mesh__D009554 Nimorazole
% 220.54/220.69  |- skos__historyNote mesh__D001571 Flavones %28%1966-1978%29%
% 220.54/220.69  |- mesh__recordAuthorizer mesh__D001571 sjn
% 220.54/220.69  |- skos__annotation mesh__D001571 enzyme inhib   
% 220.54/220.69  |- mesh__dateCreated mesh__D001571 1977-12-09
% 220.54/220.69  |- mesh__dateEstablished mesh__D001571 1991-01-01
% 220.54/220.69  |- skos__scopeNote mesh__D001571
% 220.54/220.69       Organic compounds containing a benzene ring attached to a flavone group. Some of these are potent arylhydrocarbon hydroxylase inhibitors. They may also inhibit the binding of nucleic acids to benzopyrenes and related compounds. The designation includes all isomers; the 7,8-isomer is most frequently encountered.%A%    
% 220.54/220.69  |- mesh__dateRevised mesh__D001571 2005-06-30
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D001571 2006
% 220.54/220.69  |- mesh__recordOriginator mesh__D001571 RLS
% 220.54/220.69  |- mesh__historyNote mesh__D001571
% 220.54/220.69       91%28%79%29%; was see under FLAVONES 1979-90   
% 220.54/220.69  |- mesh__recordMaintainer mesh__D001571 ssb
% 220.54/220.69  |- skos__prefLabel mesh__D001571 Benzoflavones
% 220.54/220.69  |- mesh__publicMeSHNote mesh__D001571 91; was see under FLAVONES 1979-90   
% 220.54/220.69  |- rdf__type mesh__D001571sskos__Concept
% 220.54/220.69  |- skos__broader mesh__D001571smesh__D005419
% 220.54/220.69  |- mesh__recordAuthorizer mesh__D014499 sjn
% 220.54/220.69  |- skos__altLabel mesh__D014499 Uramustine
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D014499 2004
% 220.54/220.69  |- skos__broader mesh__D014499smesh__D009588
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D014499 2006
% 220.54/220.69  |- mesh__recordOriginator mesh__D014499 NLM
% 220.54/220.69  |- mesh__historyNote mesh__D014499 66%28%63%29%   
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D014499 2003
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D014499 2005
% 220.54/220.69  |- mesh__dateEstablished mesh__D014499 1966-01-01
% 220.54/220.69  |- skos__altLabel mesh__D014499
% 220.54/220.69       5-%28%Bis%28%2-chloroethyl%29%amino%29%-2,4-%28%1H,3H%29%pyrimidinedione
% 220.54/220.69  |- skos__scopeNote mesh__D014499
% 220.54/220.69       Nitrogen mustard derivative of URACIL. It is a alkylating antineoplastic agent that is used in lymphatic malignancies, and causes mainly gastrointestinal and bone marrow damage.%A%    
% 220.54/220.69  |- mesh__dateRevised mesh__D014499 2000-06-22
% 220.54/220.69  |- mesh__recordMaintainer mesh__D014499 CCR
% 220.54/220.69  |- skos__broader mesh__D014499smesh__D014498
% 220.54/220.69  |- skos__hiddenLabel mesh__D014499 Mustard, Uracil
% 220.54/220.69  |- skos__prefLabel mesh__D014499 Uracil Mustard
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D014499 2002
% 220.54/220.69  |- rdf__type mesh__D014499sskos__Concept
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D014499 2001
% 220.54/220.69  |- mesh__publicMeSHNote mesh__D014499 66   
% 220.54/220.69  |- mesh__dateCreated mesh__D014499 1999-01-01
% 220.54/220.69  |- skos__hiddenLabel mesh__D019982 Studies, Management Case
% 220.54/220.69  |- skos__hiddenLabel mesh__D019982 Case Studies, Management
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D019982 2002
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D019982 1999
% 220.54/220.69  |- mesh__historyNote mesh__D019982 98   
% 220.54/220.69  |- skos__broader mesh__D019982smesh__D006302
% 220.54/220.69  |- mesh__publicMeSHNote mesh__D019982 98   
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D019982 1998
% 220.54/220.69  |- skos__broader mesh__D019982smesh__D017531
% 220.54/220.69  |- skos__prefLabel mesh__D019982 Organizational Case Studies
% 220.54/220.69  |- skos__scopeNote mesh__D019982
% 220.54/220.69       Descriptions and evaluations of specific health care organizations.%A%    
% 220.54/220.69  |- skos__hiddenLabel mesh__D019982 Studies, Organizational Case
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D019982 2006
% 220.54/220.69  |- skos__altLabel mesh__D019982 Case Studies, Organizational
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D019982 2004
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D019982 2001
% 220.54/220.69  |- mesh__dateEstablished mesh__D019982 1998-01-01
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D019982 2000
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D019982 2005
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D019982 2003
% 220.54/220.69  |- skos__annotation mesh__D019982 excludes clinical studies   
% 220.54/220.69  |- mesh__dateCreated mesh__D019982 1997-06-20
% 220.54/220.69  |- rdf__type mesh__D019982sskos__Concept
% 220.54/220.69  |- rdf__type mesh__D000479sskos__Concept
% 220.54/220.69  |- skos__altLabel mesh__D000479 Alkyl Mercury Compounds
% 220.54/220.69  |- skos__historyNote mesh__D000479 Mercury %28%1966-1976%29%
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D000479 1996
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D000479 2001
% 220.54/220.69  |- skos__hiddenLabel mesh__D000479 Compounds, Alkylmercury
% 220.54/220.69  |- mesh__recordMaintainer mesh__D000479 JRT
% 220.54/220.69  |- skos__altLabel mesh__D000479 Alkylmercurials
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D000479 2006
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D000479 2000
% 220.54/220.69  |- skos__scopeNote mesh__D000479
% 220.54/220.69       Organic mercury compounds in which the mercury is attached to an alkyl group.%A%    
% 220.54/220.69  |- mesh__recordAuthorizer mesh__D000479 PLS
% 220.54/220.69  |- skos__hiddenLabel mesh__D000479 Mercury Compounds, Alkyl
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D000479 2005
% 220.54/220.69  |- mesh__dateCreated mesh__D000479 1976-04-16
% 220.54/220.69  |- skos__broader mesh__D000479smesh__D009941
% 220.54/220.69  |- mesh__onlineNote mesh__D000479
% 220.54/220.69       use ALKYLMERCURY COMPOUNDS to search ALKYL MERCURY COMPOUNDS 1977-79%A%  
% 220.54/220.69  |- skos__historyNote mesh__D000479
% 220.54/220.69       Organometallic Compounds %28%1968-1976%29%
% 220.54/220.69  |- skos__annotation mesh__D000479 DF: ALKYLMERCURY CPDS   
% 220.54/220.69  |- mesh__dateRevised mesh__D000479 1995-06-08
% 220.54/220.69  |- skos__hiddenLabel mesh__D000479 Compounds, Alkyl Mercury
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D000479 1999
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D000479 2004
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D000479 1998
% 220.54/220.69  |- mesh__dateEstablished mesh__D000479 1977-01-01
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D000479 2003
% 220.54/220.69  |- skos__prefLabel mesh__D000479 Alkylmercury Compounds
% 220.54/220.69  |- mesh__historyNote mesh__D000479
% 220.54/220.69       80; was ALKYL MERCURY COMPOUNDS 1977-79   
% 220.54/220.69  |- mesh__publicMeSHNote mesh__D000479
% 220.54/220.69       80; was ALKYL MERCURY COMPOUNDS 1977-79   
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D000479 1997
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D000479 2002
% 220.54/220.69  |- mesh__recordOriginator mesh__D000479 RLS
% 220.54/220.69  |- mesh__dateRevised mesh__D019184 2001-08-07
% 220.54/220.69  |- mesh__dateEstablished mesh__D019184 1997-01-01
% 220.54/220.69  |- mesh__recordOriginator mesh__D019184 AGS
% 220.54/220.69  |- mesh__recordAuthorizer mesh__D019184 sjn
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D019184 2004
% 220.54/220.69  |- skos__hiddenLabel mesh__D019184 Carmoviruses
% 220.54/220.69  |- mesh__historyNote mesh__D019184 97   
% 220.54/220.69  |- skos__prefLabel mesh__D019184 Carmovirus
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D019184 2003
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D019184 2006
% 220.54/220.69  |- skos__hiddenLabel mesh__D019184 Carnation mottle viruses
% 220.54/220.69  |- mesh__recordMaintainer mesh__D019184 sjn
% 220.54/220.69  |- rdf__type mesh__D019184sskos__Concept
% 220.54/220.69  |- mesh__publicMeSHNote mesh__D019184 97   
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D019184 2005
% 220.54/220.69  |- skos__broader mesh__D019184smesh__D019183
% 220.54/220.69  |- mesh__dateCreated mesh__D019184 1996-06-10
% 220.54/220.69  |- skos__scopeNote mesh__D019184
% 220.54/220.69       A genus in the family TOMBUSVIRIDAE mostly found in temperate regions. Some species infecting legumes %28%FABACEAE%29% are reported from tropical areas. Most viruses are soil-borne, but some are transmitted by the fungus Olpidium radicale and others by beetles. Carnation mottle virus is the type species.%A%    
% 220.54/220.69  |- skos__annotation mesh__D019184 coord IM with specific plant /virol   
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D019184 2002
% 220.54/220.69  |- skos__hiddenLabel mesh__D005962 Acid beta Glucosidase
% 220.54/220.69  |- skos__historyNote mesh__D005962 Glucose %28%1970-1974%29%
% 220.54/220.69  |- skos__hiddenLabel mesh__D005962 Glucosylceramide beta Glucosidase
% 220.54/220.69  |- mesh__dateRevised mesh__D005962 2003-07-09
% 220.54/220.69  |- skos__hiddenLabel mesh__D005962 Hydrolase, Glucosylsphingosine Glucosyl
% 220.54/220.69  |- skos__altLabel mesh__D005962 Glucosyl Ceramidase
% 220.54/220.69  |- mesh__dateCreated mesh__D005962 1974-11-19
% 220.54/220.69  |- skos__hiddenLabel mesh__D005962 beta Glucocerebrosidase
% 220.54/220.69  |- mesh__recordOriginator mesh__D005962 NLM
% 220.54/220.69  |- skos__prefLabel mesh__D005962 Glucosylceramidase
% 220.54/220.69  |- skos__hiddenLabel mesh__D005962 Ceramidase, Glucosyl
% 220.54/220.69  |- mesh__historyNote mesh__D005962
% 220.54/220.69       91%28%75%29%; was see under GLUCOSIDASES 1975-90   
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D005962 2005
% 220.54/220.69  |- skos__broader mesh__D005962smesh__D010694
% 220.54/220.69  |- mesh__recordMaintainer mesh__D005962 ssb
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D005962 2004
% 220.54/220.69  |- skos__altLabel mesh__D005962 Glucocerebroside beta-Glucosidase
% 220.54/220.69  |- skos__altLabel mesh__D005962 Acid beta-Glucosidase
% 220.54/220.69  |- skos__historyNote mesh__D005962 Cerebrosides %28%1970-1974%29%
% 220.54/220.69  |- skos__hiddenLabel mesh__D005962 beta-Glucosidase, Glucosylceramide
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D005962 2006
% 220.54/220.69  |- skos__altLabel mesh__D005962 beta-Glucocerebrosidase
% 220.54/220.69  |- skos__hiddenLabel mesh__D005962 beta-Glucosidase, Glucocerebroside
% 220.54/220.69  |- skos__hiddenLabel mesh__D005962 beta-Glucosidase, Acid
% 220.54/220.69  |- skos__altLabel mesh__D005962 Glucosylceramide beta-Glucosidase
% 220.54/220.69  |- skos__hiddenLabel mesh__D005962 Glucosyl Hydrolase, Glucosylsphingosine
% 220.54/220.69  |- skos__historyNote mesh__D005962 Glycoside Hydrolases %28%1970-1974%29%
% 220.54/220.69  |- skos__hiddenLabel mesh__D005962 Glucocerebroside beta Glucosidase
% 220.54/220.69  |- skos__altLabel mesh__D005962 Glucosylsphingosine Glucosyl Hydrolase
% 220.54/220.69  |- mesh__publicMeSHNote mesh__D005962
% 220.54/220.69       91; was see under GLUCOSIDASES 1975-90   
% 220.54/220.69  |- skos__annotation mesh__D005962 /defic: consider also GAUCHER DISEASE   
% 220.54/220.69  |- skos__related mesh__D005962smesh__D005776
% 220.54/220.69  |- skos__scopeNote mesh__D005962
% 220.54/220.69       A glycosidase that hydrolyzes a glucosylceramide to yield free ceramide plus glucose. Deficiency of this enzyme leads to abnormally high concentrations of glucosylceramide in the brain in GAUCHER DISEASE. EC 3.2.1.45.%A%    
% 220.54/220.69  |- rdf__type mesh__D005962sskos__Concept
% 220.54/220.69  |- mesh__recordAuthorizer mesh__D005962 sjn
% 220.54/220.69  |- skos__altLabel mesh__D005962 Glucocerebrosidase
% 220.54/220.69  |- mesh__dateEstablished mesh__D005962 1991-01-01
% 220.54/220.69  |- skos__related mesh__D005164smesh__D003029
% 220.54/220.69  |- skos__altLabel mesh__D005164 Christmas Factor
% 220.54/220.69  |- skos__altLabel mesh__D005164 Blood Coagulation Factor IX
% 220.54/220.69  |- skos__hiddenLabel mesh__D005164 IX, Coagulation Factor
% 220.54/220.69  |- skos__scopeNote mesh__D005164
% 220.54/220.69       Storage-stable blood coagulation factor acting in the intrinsic pathway. Its activated form, IXa, forms a complex with factor VIII and calcium on platelet factor 3 to activate factor X to Xa. Deficiency of factor IX results in HEMOPHILIA B %28%Christmas Disease%29%.%A%    
% 220.54/220.69  |- mesh__recordAuthorizer mesh__D005164 sjn
% 220.54/220.69  |- skos__altLabel mesh__D005164 Coagulation Factor IX
% 220.54/220.69  |- mesh__recordMaintainer mesh__D005164 ssb
% 220.54/220.69  |- skos__prefLabel mesh__D005164 Factor IX
% 220.54/220.69  |- skos__altLabel mesh__D005164 Factor IX Fraction
% 220.54/220.69  |- skos__altLabel mesh__D005164 Factor IX Complex
% 220.54/220.69  |- mesh__dateCreated mesh__D005164 1999-01-01
% 220.54/220.69  |- skos__hiddenLabel mesh__D005164 Complex, Factor IX
% 220.54/220.69  |- skos__altLabel mesh__D005164 Autoprothrombin II
% 220.54/220.69  |- skos__hiddenLabel mesh__D005164 IX Fraction, Factor
% 220.54/220.69  |- mesh__recordOriginator mesh__D005164 NLM
% 220.54/220.69  |- rdf__type mesh__D005164sskos__Concept
% 220.54/220.69  |- skos__hiddenLabel mesh__D005164 IX Complex, Factor
% 220.54/220.69  |- skos__altLabel mesh__D005164 PTC
% 220.54/220.69  |- mesh__dateRevised mesh__D005164 2005-06-30
% 220.54/220.69  |- skos__hiddenLabel mesh__D005164 Fraction, Factor IX
% 220.54/220.69  |- skos__broader mesh__D005164smesh__D001779
% 220.54/220.69  |- skos__altLabel mesh__D005164 Plasma Thromboplastin Component
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D005164 2006
% 220.54/220.69  |- skos__hiddenLabel mesh__D005164 Factor IX, Coagulation
% 220.54/220.69  |- skos__hiddenLabel mesh__D043283 Fragile Site, Chromosome
% 220.54/220.69  |- mesh__recordMaintainer mesh__D043283 nns
% 220.54/220.69  |- mesh__recordAuthorizer mesh__D043283 sjn
% 220.54/220.69  |- skos__scopeNote mesh__D043283
% 220.54/220.69       Specific loci that show up during KARYOTYPING as a gap %28%an uncondensed stretch in closer views%29% on a CHROMATID arm after culturing cells under specific conditions. These sites are associated with an increase in CHROMOSOME FRAGILITY. They are classified as common or rare, and by the specific culture conditions under which they develop. Fragile site loci are named by the letters %22%FRA%22% followed by a designation for the specific chromosome, and a letter which refers to which  fragile site of that chromosome %28%e.g. FRAXA refers to fragile site A on the X chromosome. It is a rare, folic acid-sensitive fragile site associated with FRAGILE X SYNDROME.%29%%A%    
% 220.54/220.69  |- skos__hiddenLabel mesh__D043283 Sites, Chromosome Fragile
% 220.54/220.69  |- skos__related mesh__D043283smesh__D042622
% 220.54/220.69  |- skos__hiddenLabel mesh__D043283 Chromosome Fragile Site
% 220.54/220.69  |- skos__historyNote mesh__D043283 Chromosome Fragility %28%1982-2003%29%
% 220.54/220.69  |- mesh__activeMeSHYear mesh__D043283 2006
% 220.54/220.69  |- mesh__dateCreated mesh__D043283 2003-07-09
% 220.54/220.69  |- mesh__dateRevised mesh__D043283 2005-06-30
% 220.54/220.69  |- skos__hiddenLabel mesh__D043283 Site, Chromosome Fragile
% 220.54/220.69  |- skos__altLabel mesh__D043283 Fragile Sites, Chromosome
% 220.54/220.69  |- mesh__recordOriginator mesh__D043283 nns
% 220.54/220.69  |- skos__related mesh__D043283smesh__D002873
% 220.54/220.69  |- mesh__dateEstablished mesh__D043283 2004-01-01
% 220.54/220.69  |- mesh__publicMeSHNote mesh__D043283
% 220.54/220.69       2004; see CHROMOSOME FRAGILITY 1982-2003   
% 220.54/220.69  |- rdf__type mesh__D043283sskos__Concept
% 220.54/220.69  |- mesh__historyNote mesh__D043283
% 220.54/220.69       2004; use CHROMOSOME FRAGILITY 1982-2003   
% 220.54/220.69  |- skos__related mesh__D043283smesh__D005600
% 220.54/220.69  |- skos__prefLabel mesh__D043283 Chromosome Fragile Sites
% 220.54/220.69  |- skos__broader mesh__D043283smesh__D043243
% 220.54/220.69  |- rdf__type mesh__D015592sskos__Concept
% 220.54/220.69  |- mesh__publicMeSHNote mesh__D015592 90   
% 220.54/220.69  |- skos__historyNote mesh__D015592 Radioimmunoassay %28%1966-1989%29%
% 220.54/220.70  |- mesh__dateRevised mesh__D015592 2001-07-25
% 220.54/220.70  |- skos__broader mesh__D015592smesh__D011863
% 220.54/220.70  |- skos__hiddenLabel mesh__D015592 Immunoradiometric Assays
% 220.54/220.70  |- skos__annotation mesh__D015592
% 220.54/220.70       NIM; do not confuse with RADIOIMMUNOASSAY; DF: IRMA   
% 220.54/220.70  |- skos__scopeNote mesh__D015592
% 220.54/220.70       Form of radioimmunoassay in which excess specific labeled antibody is added directly to the test antigen being measured.%A%    
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015592 2002
% 220.54/220.70  |- mesh__recordAuthorizer mesh__D015592 sjn
% 220.54/220.70  |- mesh__recordMaintainer mesh__D015592 nns
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015592 2006
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015592 2004
% 220.54/220.70  |- skos__hiddenLabel mesh__D015592 Assays, Immunoradiometric
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015592 2005
% 220.54/220.70  |- mesh__dateCreated mesh__D015592 1989-04-07
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015592 2003
% 220.54/220.70  |- skos__prefLabel mesh__D015592 Immunoradiometric Assay
% 220.54/220.70  |- skos__hiddenLabel mesh__D015592 Assay, Immunoradiometric
% 220.54/220.70  |- mesh__dateEstablished mesh__D015592 1990-01-01
% 220.54/220.70  |- mesh__recordOriginator mesh__D015592 AGS
% 220.54/220.70  |- skos__historyNote mesh__D015592 Immunoassay %28%1966-1989%29%
% 220.54/220.70  |- mesh__historyNote mesh__D015592 90   
% 220.54/220.70  |- skos__hiddenLabel mesh__D009555 Monohydrate, Indantrione
% 220.54/220.70  |- rdf__type mesh__D009555sskos__Concept
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D009555 1999
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D009555 2002
% 220.54/220.70  |- mesh__dateCreated mesh__D009555 1999-01-01
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D009555 2006
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D009555 1998
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D009555 2001
% 220.54/220.70  |- mesh__historyNote mesh__D009555
% 220.54/220.70       91%28%75%29%; was see under INDENES 1975-90; was see under INDICATORS AND REAGENTS 1963-74%A%  
% 220.54/220.70  |- skos__broader mesh__D009555smesh__D007189
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D009555 2005
% 220.54/220.70  |- skos__prefLabel mesh__D009555 Ninhydrin
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D009555 1997
% 220.54/220.70  |- skos__annotation mesh__D009555 a reagent; D25-26 qualif   
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D009555 2000
% 220.54/220.70  |- mesh__recordAuthorizer mesh__D009555 PLS
% 220.54/220.70  |- mesh__recordMaintainer mesh__D009555 JRT
% 220.54/220.70  |- mesh__onlineNote mesh__D009555 search INDICATORS AND REAGENTS 1966-74   
% 220.54/220.70  |- skos__scopeNote mesh__D009555
% 220.54/220.70       2,2-Dihydroxy-1H-indene-1,3-%28%2H%29%-dione. Reagent toxic to skin and mucus membranes. It is used in chemical assay for peptide bonds, i.e., protein determinations and has radiosensitizing properties.%A%    
% 220.54/220.70  |- mesh__dateEstablished mesh__D009555 1991-01-01
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D009555 2004
% 220.54/220.70  |- mesh__dateRevised mesh__D009555 1995-06-08
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D009555 1996
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D009555 2003
% 220.54/220.70  |- mesh__publicMeSHNote mesh__D009555
% 220.54/220.70       91; was see under INDENES 1975-90; was see under INDICATORS AND REAGENTS 1963-74%A%  
% 220.54/220.70  |- mesh__recordOriginator mesh__D009555 NLM
% 220.54/220.70  |- skos__altLabel mesh__D009555 Indantrione Monohydrate
% 220.54/220.70  |- skos__broader mesh__D001572smesh__D006574
% 220.54/220.70  |- skos__prefLabel mesh__D001572 Benzofurans
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D001572 2003
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D001572 2001
% 220.54/220.70  |- mesh__historyNote mesh__D001572 66   
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D001572 2006
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D001572 1997
% 220.54/220.70  |- mesh__recordAuthorizer mesh__D001572 PLS
% 220.54/220.70  |- skos__altLabel mesh__D001572 Coumarones
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D001572 2005
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D001572 2000
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D001572 1996
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D001572 1993
% 220.54/220.70  |- mesh__dateCreated mesh__D001572 1999-01-01
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D001572 1999
% 220.54/220.70  |- mesh__dateEstablished mesh__D001572 1966-01-01
% 220.54/220.70  |- rdf__type mesh__D001572sskos__Concept
% 220.54/220.70  |- mesh__dateRevised mesh__D001572 1992-05-08
% 220.54/220.70  |- mesh__publicMeSHNote mesh__D001572 66   
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D001572 1995
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D001572 2002
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D001572 1998
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D001572 1994
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D001572 2004
% 220.54/220.70  |- mesh__recordMaintainer mesh__D001572 TAP
% 220.54/220.70  |- mesh__recordOriginator mesh__D001572 NLM
% 220.54/220.70  |- skos__hiddenLabel mesh__D019983 Compliance, Policy
% 220.54/220.70  |- mesh__historyNote mesh__D019983 98   
% 220.54/220.70  |- mesh__dateCreated mesh__D019983 1997-06-20
% 220.54/220.70  |- skos__prefLabel mesh__D019983 Guideline Adherence
% 220.54/220.70  |- skos__broader mesh__D019983smesh__D017531
% 220.54/220.70  |- skos__hiddenLabel mesh__D019983 Adherence, Guideline
% 220.54/220.70  |- mesh__recordAuthorizer mesh__D019983 sjn
% 220.54/220.70  |- skos__annotation mesh__D019983
% 220.54/220.70       by organization, health facility or facility personnel; coord with GUIDELINES or PRACTICE GUIDELINES if pertinent; for patient adherence to guidelines of care use PATIENT COMPLIANCE%A%  
% 220.54/220.70  |- mesh__recordOriginator mesh__D019983 JLS
% 220.54/220.70  |- skos__related mesh__D019983smesh__D024362
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D019983 2006
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D019983 2002
% 220.54/220.70  |- skos__hiddenLabel mesh__D019983 Compliance, Protocol
% 220.54/220.70  |- skos__hiddenLabel mesh__D019983 Adherence, Institutional
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D019983 2005
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D019983 2004
% 220.54/220.70  |- mesh__publicMeSHNote mesh__D019983 98   
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D019983 2003
% 220.54/220.70  |- skos__scopeNote mesh__D019983
% 220.54/220.70       Conformity in fulfilling or following official, recognized, or institutional requirements, guidelines, recommendations, protocols, pathways, or other standards.%A%    
% 220.54/220.70  |- mesh__recordMaintainer mesh__D019983 tjk
% 220.54/220.70  |- skos__broader mesh__D019983smesh__D011787
% 220.54/220.70  |- rdf__type mesh__D019983sskos__Concept
% 220.54/220.70  |- mesh__dateRevised mesh__D019983 2001-07-25
% 220.54/220.70  |- mesh__dateEstablished mesh__D019983 1998-01-01
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D019185 2004
% 220.54/220.70  |- mesh__historyNote mesh__D019185 97   
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D019185 2006
% 220.54/220.70  |- mesh__recordOriginator mesh__D019185 AGS
% 220.54/220.70  |- mesh__dateCreated mesh__D019185 1996-02-12
% 220.54/220.70  |- mesh__dateEstablished mesh__D019185 1997-01-01
% 220.54/220.70  |- rdf__type mesh__D019185sskos__Concept
% 220.54/220.70  |- mesh__dateRevised mesh__D019185 2003-07-09
% 220.54/220.70  |- mesh__recordAuthorizer mesh__D019185 sjn
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D019185 2005
% 220.54/220.70  |- mesh__recordMaintainer mesh__D019185 ags
% 220.54/220.70  |- skos__annotation mesh__D019185 a genus of newts   
% 220.54/220.70  |- skos__prefLabel mesh__D019185 Notophthalmus
% 220.54/220.70  |- mesh__publicMeSHNote mesh__D019185 97   
% 220.54/220.70  |- skos__broader mesh__D019185smesh__D012455
% 220.54/220.70  |- skos__scopeNote mesh__D019185
% 220.54/220.70       A genus of newts of the Salamandridae family found in North America in areas east of the 100th meridian. A common species is NOTOPHTHALMUS VIRIDESCENS.%A%    
% 220.54/220.70  |- mesh__dateRevised mesh__D005963 2004-07-07
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D005963 2005
% 220.54/220.70  |- skos__broader mesh__D005963smesh__D002554
% 220.54/220.70  |- rdf__type mesh__D005963sskos__Concept
% 220.54/220.70  |- skos__scopeNote mesh__D005963
% 220.54/220.70       Cerebrosides which contain as their polar head group a glucose moiety bound in glycosidic linkage to the hydroxyl group of ceramides. Their accumulation in tissue, due to a defect in beta-glucosidase, is the cause of Gaucher%27%s disease.%A%    
% 220.54/220.70  |- mesh__publicMeSHNote mesh__D005963
% 220.54/220.70       91; was see under CEREBROSIDES 1979-90   
% 220.54/220.70  |- skos__prefLabel mesh__D005963 Glucosylceramides
% 220.54/220.70  |- mesh__recordAuthorizer mesh__D005963 sjn
% 220.54/220.70  |- mesh__dateEstablished mesh__D005963 1991-01-01
% 220.54/220.70  |- skos__historyNote mesh__D005963 Ceramides %28%1972-1978%29%
% 220.54/220.70  |- mesh__recordMaintainer mesh__D005963 ssb
% 220.54/220.70  |- skos__historyNote mesh__D005963 Cerebrosides %28%1966-1978%29%
% 220.54/220.70  |- mesh__dateCreated mesh__D005963 1978-05-16
% 220.54/220.70  |- skos__altLabel mesh__D005963 Glucocerebrosides
% 220.54/220.70  |- mesh__historyNote mesh__D005963
% 220.54/220.70       91%28%79%29%; was see under CEREBROSIDES 1979-90   
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D005963 2006
% 220.54/220.70  |- skos__hiddenLabel mesh__D005963 Ceramides, Glucosyl
% 220.54/220.70  |- skos__altLabel mesh__D005963 Glucosyl Ceramides
% 220.54/220.70  |- mesh__recordOriginator mesh__D005963 SMH
% 220.54/220.70  |- skos__historyNote mesh__D005963 Glycosphingolipids %28%1975-1978%29%
% 220.54/220.70  |- rdf__type mesh__D005165sskos__Concept
% 220.54/220.70  |- skos__altLabel mesh__D005165 Coagulation Factor V
% 220.54/220.70  |- skos__hiddenLabel mesh__D005165 Factor V, Coagulation
% 220.54/220.70  |- mesh__dateRevised mesh__D005165 2005-06-30
% 220.54/220.70  |- skos__altLabel mesh__D005165 Factor Pi
% 220.54/220.70  |- skos__broader mesh__D005165smesh__D001779
% 220.54/220.70  |- skos__altLabel mesh__D005165 Blood Coagulation Factor V
% 220.54/220.70  |- skos__related mesh__D005165smesh__D003029
% 220.54/220.70  |- skos__annotation mesh__D005165 a blood coag factor   
% 220.54/220.70  |- mesh__recordAuthorizer mesh__D005165 sjn
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D005165 2006
% 220.54/220.70  |- mesh__recordMaintainer mesh__D005165 ssb
% 220.54/220.70  |- skos__hiddenLabel mesh__D005165 V, Coagulation Factor
% 220.54/220.70  |- skos__altLabel mesh__D005165 Proaccelerin
% 220.54/220.70  |- mesh__recordOriginator mesh__D005165 NLM
% 220.54/220.70  |- mesh__dateCreated mesh__D005165 1999-01-01
% 220.54/220.70  |- skos__scopeNote mesh__D005165
% 220.54/220.70       Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor V accomplishes this by forming a complex with factor Xa, phospholipid, and calcium %28%prothrombinase complex%29%. Deficiency of factor V leads to Owren%27%s disease.%A%    
% 220.54/220.70  |- skos__prefLabel mesh__D005165 Factor V
% 220.54/220.70  |- skos__altLabel mesh__D005165 AC Globulin
% 220.54/220.70  |- skos__scopeNote mesh__D051716
% 220.54/220.70       A single-stranded DNA-binding protein that is found in EUKARYOTIC CELLS. It is required for DNA REPLICATION; DNA REPAIR; and GENETIC RECOMBINATION.%A%    
% 220.54/220.70  |- mesh__dateEstablished mesh__D051716 2006-01-01
% 220.54/220.70  |- mesh__recordMaintainer mesh__D051716 DRC
% 220.54/220.70  |- skos__prefLabel mesh__D051716 Replication Factor A
% 220.54/220.70  |- skos__altLabel mesh__D051716
% 220.54/220.70       Replication Factor A Single-Stranded DNA-Binding Protein
% 220.54/220.70  |- skos__hiddenLabel mesh__D051716 Single Strand Binding Protein RP A
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D051716 2006
% 220.54/220.70  |- skos__broader mesh__D051716smesh__D004268
% 220.54/220.70  |- skos__altLabel mesh__D051716 Single-Strand Binding Protein RP-A
% 220.54/220.70  |- skos__altLabel mesh__D051716 Replication Protein A
% 220.54/220.70  |- skos__altLabel mesh__D051716 DNA Replication Factor A
% 220.54/220.70  |- rdf__type mesh__D051716sskos__Concept
% 220.54/220.70  |- mesh__recordOriginator mesh__D051716 DRC
% 220.54/220.70  |- mesh__historyNote mesh__D051716 2006%28%1990%29%   
% 220.54/220.70  |- mesh__recordAuthorizer mesh__D051716 sjn
% 220.54/220.70  |- skos__hiddenLabel mesh__D051716
% 220.54/220.70       Replication Factor A Single Stranded DNA Binding Protein
% 220.54/220.70  |- mesh__publicMeSHNote mesh__D051716
% 220.54/220.70       2006; REPLICATION FACTOR A was indexed under DNA-BINDING PROTEINS 1990-2005%A%  
% 220.54/220.70  |- mesh__dateCreated mesh__D051716 2005-06-30
% 220.54/220.70  |- skos__broader mesh__D014551Q000502smesh__D014551
% 220.54/220.70  |- mesh__preferredCombination mesh__D014551Q000502smesh__D014553
% 220.54/220.70  |- rdf__type mesh__D014551Q000502smesh__CompoundConcept
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015593 1997
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015593 2001
% 220.54/220.70  |- skos__historyNote mesh__D015593
% 220.54/220.70       Pigment Epithelium of Eye %28%1966-1989%29%
% 220.54/220.70  |- mesh__dateRevised mesh__D015593 1993-06-02
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015593 1998
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015593 2000
% 220.54/220.70  |- mesh__historyNote mesh__D015593 90   
% 220.54/220.70  |- skos__scopeNote mesh__D015593
% 220.54/220.70       Colloid or hyaline bodies lying beneath the retinal pigment epithelium. They may occur either secondary to changes in the choroid that affect the pigment epithelium or as an autosomal dominant disorder of the retinal pigment epithelium.%A%    
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015593 1996
% 220.54/220.70  |- skos__prefLabel mesh__D015593 Retinal Drusen
% 220.54/220.70  |- mesh__recordAuthorizer mesh__D015593 PLS
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015593 2006
% 220.54/220.70  |- skos__annotation mesh__D015593
% 220.54/220.70       colloid or hyalin bodies under retinal pigment; do not confuse with OPTIC DISK DRUSEN, hyalin bodies in optic nerve%A%  
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015593 2004
% 220.54/220.70  |- skos__broader mesh__D015593smesh__D012162
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015593 2005
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015593 2002
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015593 1995
% 220.54/220.70  |- mesh__recordOriginator mesh__D015593 EGC
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015593 2003
% 220.54/220.70  |- skos__altLabel mesh__D015593 Drusen, Retinal
% 220.54/220.70  |- skos__historyNote mesh__D015593 Macular Degeneration %28%1975-1989%29%
% 220.54/220.70  |- mesh__dateEstablished mesh__D015593 1990-01-01
% 220.54/220.70  |- mesh__recordMaintainer mesh__D015593 TGC
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015593 1994
% 220.54/220.70  |- rdf__type mesh__D015593sskos__Concept
% 220.54/220.70  |- skos__historyNote mesh__D015593 Hyalin Substance %28%1966-1989%29%
% 220.54/220.70  |- mesh__publicMeSHNote mesh__D015593 90   
% 220.54/220.70  |- mesh__dateCreated mesh__D015593 1989-05-25
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015593 1999
% 220.54/220.70  |- skos__broader mesh__D009556smesh__D028561
% 220.54/220.70  |- mesh__dateCreated mesh__D009556 1999-01-01
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D009556 2006
% 220.54/220.70  |- mesh__recordOriginator mesh__D009556 NLM
% 220.54/220.70  |- mesh__recordAuthorizer mesh__D009556 sjn
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D009556 2005
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D009556 2002
% 220.54/220.70  |- mesh__dateRevised mesh__D009556 2001-07-25
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D009556 2004
% 220.54/220.70  |- skos__annotation mesh__D009556
% 220.54/220.70       Nb-93; synonym: Columbium %28%Cb%29%; Nb-88-92, 94-101 = NIOBIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 220.54/220.70  |- skos__scopeNote mesh__D009556
% 220.54/220.70       Niobium. A metal element atomic number 41, atomic weight 92.906, symbol Nb. %28%From Dorland, 28th ed%29%%A%    
% 220.54/220.70  |- skos__prefLabel mesh__D009556 Niobium
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D009556 2003
% 220.54/220.70  |- skos__broader mesh__D009556smesh__D019216
% 220.54/220.70  |- rdf__type mesh__D009556sskos__Concept
% 220.54/220.70  |- mesh__recordMaintainer mesh__D009556 jmp
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D001573 2005
% 220.54/220.70  |- mesh__recordMaintainer mesh__D001573 ssb
% 220.54/220.70  |- mesh__dateCreated mesh__D001573 1999-01-01
% 220.54/220.70  |- rdf__type mesh__D001573sskos__Concept
% 220.54/220.70  |- skos__altLabel mesh__D001573 2-hydroxy-1,2-diphenylethanone
% 220.54/220.70  |- mesh__dateRevised mesh__D001573 2002-07-02
% 220.54/220.70  |- skos__scopeNote mesh__D001573
% 220.54/220.70       A white crystalline compound prepared by condensation of benzaldehyde in potassium cyanide and used in organic syntheses. This should not be confused with benzoin gum from%A%    
% 220.54/220.70  |- mesh__recordOriginator mesh__D001573 NLM
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D001573 2004
% 220.54/220.70  |- skos__prefLabel mesh__D001573 Benzoin
% 220.54/220.70  |- mesh__recordAuthorizer mesh__D001573 sjn
% 220.54/220.70  |- skos__annotation mesh__D001573
% 220.54/220.70       D25-26 qualif; benzoin gum %28%NM%29% is also available   
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D001573 2003
% 220.54/220.70  |- skos__hiddenLabel mesh__D001573 2 hydroxy 1,2 diphenylethanone
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D001573 2006
% 220.54/220.70  |- skos__broader mesh__D001573smesh__D000098
% 220.54/220.70  |- skos__broader mesh__D002120Q000037smesh__D002120
% 220.54/220.70  |- mesh__preferredCombination mesh__D002120Q000037smesh__D002121
% 220.54/220.70  |- rdf__type mesh__D002120Q000037smesh__CompoundConcept
% 220.54/220.70  |- mesh__publicMeSHNote mesh__D019984 98   
% 220.54/220.70  |- skos__broader mesh__D019984smesh__D011787
% 220.54/220.70  |- skos__hiddenLabel mesh__D019984 Healthcare Quality Indicators
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D019984 2005
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D019984 2004
% 220.54/220.70  |- mesh__dateEstablished mesh__D019984 1998-01-01
% 220.54/220.70  |- skos__hiddenLabel mesh__D019984 Healthcare Quality Indicator
% 220.54/220.70  |- mesh__recordMaintainer mesh__D019984 JLS
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D019984 2001
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D019984 2003
% 220.54/220.70  |- mesh__recordAuthorizer mesh__D019984 SJN
% 220.54/220.70  |- skos__hiddenLabel mesh__D019984 Indicators, Healthcare Quality
% 220.54/220.70  |- rdf__type mesh__D019984sskos__Concept
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D019984 2000
% 220.54/220.70  |- skos__hiddenLabel mesh__D019984 Indicators, Quality
% 220.54/220.70  |- mesh__dateCreated mesh__D019984 1997-06-20
% 220.54/220.70  |- skos__hiddenLabel mesh__D019984 Quality Indicator
% 220.54/220.70  |- skos__hiddenLabel mesh__D019984 Indicator, Healthcare Quality
% 220.54/220.70  |- skos__hiddenLabel mesh__D019984 Indicator, Quality
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D019984 1999
% 220.54/220.70  |- skos__scopeNote mesh__D019984
% 220.54/220.70       Norms, criteria, standards, and other direct qualitative and quantitative measures used in determining the quality of health care.%A%    
% 220.54/220.70  |- mesh__historyNote mesh__D019984 98   
% 220.54/220.70  |- skos__prefLabel mesh__D019984 Quality Indicators, Health Care
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D019984 2002
% 220.54/220.70  |- mesh__recordOriginator mesh__D019984 JLS
% 220.54/220.70  |- mesh__dateRevised mesh__D019984 1998-06-11
% 220.54/220.70  |- skos__hiddenLabel mesh__D019984 Quality Indicator, Healthcare
% 220.54/220.70  |- skos__altLabel mesh__D019984 Quality Indicators, Healthcare
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D019984 2006
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D019186 2005
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D019186 2004
% 220.54/220.70  |- mesh__dateRevised mesh__D019186 2002-07-02
% 220.54/220.70  |- skos__prefLabel mesh__D019186 Mandibular Advancement
% 220.54/220.70  |- mesh__historyNote mesh__D019186 97   
% 220.54/220.70  |- mesh__publicMeSHNote mesh__D019186 97   
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D019186 2006
% 220.54/220.70  |- mesh__recordOriginator mesh__D019186 TGC
% 220.54/220.70  |- rdf__type mesh__D019186sskos__Concept
% 220.54/220.70  |- mesh__dateCreated mesh__D019186 1996-06-10
% 220.54/220.70  |- skos__broader mesh__D019186smesh__D019647
% 220.54/220.70  |- skos__historyNote mesh__D019186 Mandible/surgery %28%1973-1996%29%
% 220.54/220.70  |- skos__hiddenLabel mesh__D019186 Advancement, Mandibular
% 220.54/220.70  |- mesh__recordAuthorizer mesh__D019186 sjn
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D019186 2003
% 220.54/220.70  |- mesh__dateEstablished mesh__D019186 1997-01-01
% 220.54/220.70  |- mesh__recordMaintainer mesh__D019186 ssb
% 220.54/220.70  |- skos__broader mesh__D019186smesh__D009970
% 220.54/220.70  |- skos__scopeNote mesh__D019186
% 220.54/220.70       Moving a retruded mandible forward to a normal position. It is commonly performed for malocclusion and retrognathia. %28%From Jablonski%27%s Dictionary of Dentistry, 1992%29%%A%    
% 220.54/220.70  |- mesh__dateRevised mesh__D005964 2003-07-09
% 220.54/220.70  |- mesh__dateCreated mesh__D005964 1999-01-01
% 220.54/220.70  |- skos__prefLabel mesh__D005964 Glucosyltransferases
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D005964 2004
% 220.54/220.70  |- mesh__recordAuthorizer mesh__D005964 sjn
% 220.54/220.70  |- skos__broader mesh__D005964smesh__D006602
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D005964 2006
% 220.54/220.70  |- mesh__recordMaintainer mesh__D005964 ssb
% 220.54/220.70  |- skos__scopeNote mesh__D005964
% 220.54/220.70       Enzymes that catalyze the transfer of glucose from a nucleoside diphosphate glucose to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-.%A%    
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D005964 2005
% 220.54/220.70  |- rdf__type mesh__D005964sskos__Concept
% 220.54/220.70  |- mesh__recordOriginator mesh__D005964 NLM
% 220.54/220.70  |- skos__hiddenLabel mesh__D005166 Diseases, Owren%27%s
% 220.54/220.70  |- skos__hiddenLabel mesh__D005166 Owrens Disease
% 220.54/220.70  |- mesh__recordOriginator mesh__D005166 NLM
% 220.54/220.70  |- mesh__dateRevised mesh__D005166 2001-07-25
% 220.54/220.70  |- skos__hiddenLabel mesh__D005166 Diseases, Owren
% 220.54/220.70  |- skos__broader mesh__D005166smesh__D020147
% 220.54/220.70  |- skos__hiddenLabel mesh__D005166 Owren Diseases
% 220.54/220.70  |- skos__broader mesh__D005166smesh__D006474
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D005166 2006
% 220.54/220.70  |- mesh__historyNote mesh__D005166
% 220.54/220.70       73%28%64%29%; was see under HYPOPROTHROMBINEMIAS 1963-72   
% 220.54/220.70  |- skos__altLabel mesh__D005166 Owren%27%s Disease
% 220.54/220.70  |- skos__altLabel mesh__D005166 Owren Disease
% 220.54/220.70  |- skos__scopeNote mesh__D005166
% 220.54/220.70       A deficiency of blood coagulation factor V %28%known as proaccelerin or accelerator globulin or labile factor%29% leading to a rare hemorrhagic tendency known as Owren%27%s disease or parahemophilia. It varies greatly in severity. Factor V deficiency is an autosomal recessive trait. %28%Dorland, 27th ed%29%%A%    
% 220.54/220.70  |- skos__hiddenLabel mesh__D005166 Disease, Owren%27%s
% 220.54/220.70  |- mesh__publicMeSHNote mesh__D005166
% 220.54/220.70       73; was see under HYPOPROTHROMBINEMIAS 1963-72   
% 220.54/220.70  |- skos__hiddenLabel mesh__D005166 Disease, Owren
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D005166 2005
% 220.54/220.70  |- skos__altLabel mesh__D005166 Deficiency, Factor V
% 220.54/220.70  |- skos__broader mesh__D005166smesh__D025861
% 220.54/220.70  |- skos__altLabel mesh__D005166 Parahemophilia
% 220.54/220.70  |- skos__annotation mesh__D005166
% 220.54/220.70       a blood coag disord; DF: FACTOR V DEFIC   
% 220.54/220.70  |- skos__hiddenLabel mesh__D005166 Deficiencies, Factor V
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D005166 2004
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D005166 2002
% 220.54/220.70  |- mesh__dateCreated mesh__D005166 1999-01-01
% 220.54/220.70  |- skos__prefLabel mesh__D005166 Factor V Deficiency
% 220.54/220.70  |- mesh__recordAuthorizer mesh__D005166 sjn
% 220.54/220.70  |- skos__hiddenLabel mesh__D005166 Owren%27%s Diseases
% 220.54/220.70  |- mesh__recordMaintainer mesh__D005166 nns
% 220.54/220.70  |- mesh__dateEstablished mesh__D005166 1973-01-01
% 220.54/220.70  |- skos__hiddenLabel mesh__D005166 Factor V Deficiencies
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D005166 2003
% 220.54/220.70  |- skos__hiddenLabel mesh__D005166 Parahemophilias
% 220.54/220.70  |- mesh__onlineNote mesh__D005166
% 220.54/220.70       use HYPOPROTHROMBINEMIAS to search FACTOR V DEFICIENCY 1966-72%A%  
% 220.54/220.70  |- rdf__type mesh__D005166sskos__Concept
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D010300 2002
% 220.54/220.70  |- mesh__publicMeSHNote mesh__D010300
% 220.54/220.70       1979; see PARKINSONISM 1967-1978, see PARALYSIS AGITANS 1963-1966%A%  
% 220.54/220.70  |- skos__scopeNote mesh__D010300
% 220.54/220.70       A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion %28%i.e. a tendency to fall backwards%29%, rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition %28%LEWY BODY DISEASE, DIFFUSE%29% characterized by dementia in combination with varying degrees of parkinsonism. %28%Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75%29%%A%    
% 220.54/220.70  |- mesh__dateEstablished mesh__D010300 1967-01-01
% 220.54/220.70  |- skos__altLabel mesh__D010300 Parkinson%27%s Disease, Idiopathic
% 220.54/220.70  |- skos__altLabel mesh__D010300 Paralysis Agitans
% 220.54/220.70  |- mesh__recordOriginator mesh__D010300 NLM
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D010300 2006
% 220.54/220.70  |- skos__related mesh__D010300smesh__D016631
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D010300 2003
% 220.54/220.70  |- skos__annotation mesh__D010300
% 220.54/220.70       drug ther: consider also ANTIPARKINSON AGENTS; /chem ind = PARKINSON DISEASE, SECONDARY/chem ind%A%  
% 220.54/220.70  |- skos__altLabel mesh__D010300 Parkinson%27%s Disease, Lewy Body
% 220.54/220.70  |- rdf__type mesh__D010300sskos__Concept
% 220.54/220.70  |- mesh__recordAuthorizer mesh__D010300 sjn
% 220.54/220.70  |- skos__altLabel mesh__D010300 Lewy Body Parkinson Disease
% 220.54/220.70  |- skos__altLabel mesh__D010300 Idiopathic Parkinson Disease
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D010300 2004
% 220.54/220.70  |- mesh__historyNote mesh__D010300 1979%28%1963%29%   
% 220.54/220.70  |- skos__broader mesh__D010300smesh__D019636
% 220.54/220.70  |- skos__altLabel mesh__D010300 Primary Parkinsonism
% 220.54/220.70  |- skos__altLabel mesh__D010300 Idiopathic Parkinson%27%s Disease
% 220.54/220.70  |- mesh__recordMaintainer mesh__D010300 sjn
% 220.54/220.70  |- skos__hiddenLabel mesh__D010300 Parkinsonism, Primary
% 220.54/220.70  |- skos__prefLabel mesh__D010300 Parkinson Disease
% 220.54/220.70  |- skos__broader mesh__D010300smesh__D020734
% 220.54/220.70  |- skos__altLabel mesh__D010300 Lewy Body Parkinson%27%s Disease
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D010300 2003A
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D010300 2005
% 220.54/220.70  |- skos__altLabel mesh__D010300 Parkinson%27%s Disease
% 220.54/220.70  |- skos__altLabel mesh__D010300 Parkinson Disease, Idiopathic
% 220.54/220.70  |- mesh__dateRevised mesh__D010300 2002-09-24
% 220.54/220.70  |- mesh__dateCreated mesh__D010300 1999-01-01
% 220.54/220.70  |- skos__broader mesh__D009729Q000266smesh__D009729
% 220.54/220.70  |- mesh__preferredCombination mesh__D009729Q000266smesh__D006676
% 220.54/220.70  |- rdf__type mesh__D009729Q000266smesh__CompoundConcept
% 220.54/220.70  |- skos__prefLabel mesh__D051717 Fushi Tarazu Transcription Factors
% 220.54/220.70  |- mesh__dateCreated mesh__D051717 2005-06-30
% 220.54/220.70  |- mesh__recordMaintainer mesh__D051717 DRC
% 220.54/220.70  |- mesh__historyNote mesh__D051717 2006%28%2005%29%   
% 220.54/220.70  |- mesh__publicMeSHNote mesh__D051717
% 220.54/220.70       2006; FUSHI TARAZU TRANSCRIPTION FACTORS was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 2005%A%  
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D051717 2006
% 220.54/220.70  |- skos__broader mesh__D051717smesh__D014157
% 220.54/220.70  |- mesh__dateEstablished mesh__D051717 2006-01-01
% 220.54/220.70  |- rdf__type mesh__D051717sskos__Concept
% 220.54/220.70  |- mesh__recordOriginator mesh__D051717 DRC
% 220.54/220.70  |- skos__scopeNote mesh__D051717
% 220.54/220.70       Fushi tarazu transcription factors were originally identified in DROSOPHILA. They are found throughout ARTHROPODS and play important roles in segmentation and CENTRAL NERVOUS SYSTEM development.%A%    
% 220.54/220.70  |- skos__broader mesh__D051717smesh__D018398
% 220.54/220.70  |- skos__altLabel mesh__D051717 Fushi Tarazu Protein
% 220.54/220.70  |- mesh__recordAuthorizer mesh__D051717 sjn
% 220.54/220.70  |- skos__altLabel mesh__D051717 Segmentation Protein Fushi Tarazu
% 220.54/220.70  |- mesh__recordAuthorizer mesh__D015594 sjn
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015594 2005
% 220.54/220.70  |- skos__scopeNote mesh__D015594
% 220.54/220.70       Optic disk bodies composed primarily of acid mucopolysaccharides that may produce pseudopapilledema %28%elevation of the optic disk without associated INTRACRANIAL HYPERTENSION%29% and visual field deficits. Drusen may also occur in the retina %28%see RETINAL DRUSEN%29%. %28%Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p355%29%%A%    
% 220.54/220.70  |- mesh__dateCreated mesh__D015594 1989-05-26
% 220.54/220.70  |- skos__historyNote mesh__D015594 Optic Nerve %28%1968-1985%29%
% 220.54/220.70  |- skos__hiddenLabel mesh__D015594 Optic Disk Drusens
% 220.54/220.70  |- skos__altLabel mesh__D015594 Optic Disc Drusen
% 220.54/220.70  |- skos__annotation mesh__D015594 do not confuse with RETINAL DRUSEN   
% 220.54/220.70  |- skos__historyNote mesh__D015594 Optic Nerve Diseases %28%1975-1989%29%
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015594 2003
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015594 2006
% 220.54/220.70  |- skos__hiddenLabel mesh__D015594 Optic Disc Drusens
% 220.54/220.70  |- skos__altLabel mesh__D015594 Drusen, Optic Disk
% 220.54/220.70  |- mesh__recordMaintainer mesh__D015594 mdb
% 220.54/220.70  |- mesh__dateRevised mesh__D015594 2002-07-03
% 220.54/220.70  |- mesh__activeMeSHYear mesh__D015594 2004
% 220.54/220.70  |- mesh__dateEstablished mesh__D015594 1991-01-01
% 220.54/220.70  |- skos__historyNote mesh__D015594 Optic Disk %28%1975-1989%29%
% 220.54/220.70  |- skos__altLabel mesh__D015594 Drusen, Optic Nerve
% 220.54/220.70  |- skos__altLabel mesh__D015594 Drusen, Optic Disc
% 220.54/220.70  |- skos__hiddenLabel mesh__D015594 Optic Nerve Drusen
% 220.54/220.71  |- skos__broader mesh__D015594smesh__D009901
% 220.54/220.71  |- skos__prefLabel mesh__D015594 Optic Disk Drusen
% 220.54/220.71  |- mesh__publicMeSHNote mesh__D015594
% 220.54/220.71       91; was see under OPTIC NERVE DISEASES 1990   
% 220.54/220.71  |- mesh__historyNote mesh__D015594
% 220.54/220.71       91%28%90%29%; was see under OPTIC NERVE DISEASES 1990   
% 220.54/220.71  |- rdf__type mesh__D015594sskos__Concept
% 220.54/220.71  |- mesh__recordOriginator mesh__D015594 EGC
% 220.54/220.71  |- skos__broader mesh__D017673Q000737smesh__D017673
% 220.54/220.71  |- mesh__preferredCombination mesh__D017673Q000737smesh__D012965Q000737
% 220.54/220.71  |- rdf__type mesh__D017673Q000737smesh__CompoundConcept
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D009557 1997
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D009557 2004
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D009557 1996
% 220.54/220.71  |- skos__broader mesh__D009557smesh__D000147
% 220.54/220.71  |- mesh__recordMaintainer mesh__D009557 TAP
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D009557 2000
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D009557 1995
% 220.54/220.71  |- mesh__recordAuthorizer mesh__D009557 PLS
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D009557 2003
% 220.54/220.71  |- mesh__historyNote mesh__D009557 68   
% 220.54/220.71  |- mesh__dateEstablished mesh__D009557 1968-01-01
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D009557 1994
% 220.54/220.71  |- rdf__type mesh__D009557sskos__Concept
% 220.54/220.71  |- mesh__recordOriginator mesh__D009557 NLM
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D009557 1999
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D009557 1993
% 220.54/220.71  |- skos__prefLabel mesh__D009557 Nipecotic Acids
% 220.54/220.71  |- mesh__dateRevised mesh__D009557 1992-05-19
% 220.54/220.71  |- mesh__dateCreated mesh__D009557 1999-01-01
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D009557 2006
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D009557 1998
% 220.54/220.71  |- skos__broader mesh__D009557smesh__D010880
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D009557 2002
% 220.54/220.71  |- mesh__publicMeSHNote mesh__D009557 68   
% 220.54/220.71  |- skos__hiddenLabel mesh__D009557 Acids, Nipecotic
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D009557 2005
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D009557 2001
% 220.54/220.71  |- rdf__type mesh__D001574sskos__Concept
% 220.54/220.71  |- mesh__dateCreated mesh__D001574 1975-07-23
% 220.54/220.71  |- mesh__dateRevised mesh__D001574 2005-06-30
% 220.54/220.71  |- mesh__recordMaintainer mesh__D001574 ssb
% 220.54/220.71  |- skos__historyNote mesh__D001574 Thiadiazoles %28%1972-1975%29%
% 220.54/220.71  |- skos__scopeNote mesh__D001574
% 220.54/220.71       Selective renal carbonic anhydrase inhibitor. It may also be of use in certain cases of respiratory failure.%A%    
% 220.54/220.71  |- skos__hiddenLabel mesh__D001574 CL11366
% 220.54/220.71  |- skos__prefLabel mesh__D001574 Benzolamide
% 220.54/220.71  |- mesh__historyNote mesh__D001574
% 220.54/220.71       91%28%76%29%; was see under THIADIAZOLES 1976-90   
% 220.54/220.71  |- mesh__dateEstablished mesh__D001574 1991-01-01
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D001574 2006
% 220.54/220.71  |- mesh__recordOriginator mesh__D001574 SH
% 220.54/220.71  |- mesh__publicMeSHNote mesh__D001574
% 220.54/220.71       91; was see under THIADIAZOLES 1976-90   
% 220.54/220.71  |- skos__broader mesh__D001574smesh__D013449
% 220.54/220.71  |- mesh__recordAuthorizer mesh__D001574 sjn
% 220.54/220.71  |- skos__broader mesh__D001574smesh__D013830
% 220.54/220.71  |- skos__hiddenLabel mesh__D001574 CL 11366
% 220.54/220.71  |- skos__historyNote mesh__D001574 Sulfonamides %28%1970-1975%29%
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019985 2002
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019985 2003
% 220.54/220.71  |- skos__altLabel mesh__D019985 Benchmarking, Healthcare
% 220.54/220.71  |- rdf__type mesh__D019985sskos__Concept
% 220.54/220.71  |- mesh__publicMeSHNote mesh__D019985 98   
% 220.54/220.71  |- skos__hiddenLabel mesh__D019985 Health Care Benchmarking
% 220.54/220.71  |- mesh__dateEstablished mesh__D019985 1998-01-01
% 220.54/220.71  |- skos__altLabel mesh__D019985 Best Practice Analysis
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019985 2001
% 220.54/220.71  |- skos__hiddenLabel mesh__D019985 Analysis, Best Practice
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019985 1999
% 220.54/220.71  |- mesh__historyNote mesh__D019985 98   
% 220.54/220.71  |- skos__prefLabel mesh__D019985 Benchmarking
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019985 1998
% 220.54/220.71  |- skos__hiddenLabel mesh__D019985 Healthcare Benchmarking
% 220.54/220.71  |- skos__broader mesh__D019985smesh__D008330
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019985 2000
% 220.54/220.71  |- skos__broader mesh__D019985smesh__D011785
% 220.54/220.71  |- mesh__dateCreated mesh__D019985 1997-06-20
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019985 2006
% 220.54/220.71  |- skos__broader mesh__D019985smesh__D015397
% 220.54/220.71  |- skos__scopeNote mesh__D019985
% 220.54/220.71       Method of measuring performance against established standards of best practice.%A%    
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019985 2005
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019985 2004
% 220.54/220.71  |- mesh__dateEstablished mesh__D019187 1997-01-01
% 220.54/220.71  |- rdf__type mesh__D019187sskos__Concept
% 220.54/220.71  |- skos__historyNote mesh__D019187 Cadmium %28%1966-1996%29%
% 220.54/220.71  |- mesh__publicMeSHNote mesh__D019187 97   
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019187 2002
% 220.54/220.71  |- skos__broader mesh__D019187smesh__D007287
% 220.54/220.71  |- skos__prefLabel mesh__D019187 Cadmium Compounds
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019187 1997
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019187 1998
% 220.54/220.71  |- mesh__dateCreated mesh__D019187 1996-06-10
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019187 2003
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019187 1999
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019187 2000
% 220.54/220.71  |- skos__hiddenLabel mesh__D019187 Compounds, Cadmium
% 220.54/220.71  |- skos__annotation mesh__D019187
% 220.54/220.71       inorganic; GEN or unspecified; prefer specifics; DF: CADMIUM CPDS%A%  
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019187 2004
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019187 2005
% 220.54/220.71  |- skos__scopeNote mesh__D019187
% 220.54/220.71       Inorganic compounds that contain cadmium as an integral part of the molecule.%A%    
% 220.54/220.71  |- mesh__historyNote mesh__D019187 97   
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019187 2001
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019187 2006
% 220.54/220.71  |- skos__broader mesh__D005965smesh__D020723
% 220.54/220.71  |- mesh__recordMaintainer mesh__D005965 ssb
% 220.54/220.71  |- skos__altLabel mesh__D005965 Glucosiduronates
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D005965 2006
% 220.54/220.71  |- mesh__recordOriginator mesh__D005965 NLM
% 220.54/220.71  |- mesh__dateRevised mesh__D005965 2004-07-07
% 220.54/220.71  |- skos__annotation mesh__D005965 do not confuse with GLUCONATES   
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D005965 2005
% 220.54/220.71  |- skos__scopeNote mesh__D005965 Salts and esters of GLUCURONIC ACID.     
% 220.54/220.71  |- rdf__type mesh__D005965sskos__Concept
% 220.54/220.71  |- mesh__dateCreated mesh__D005965 1999-01-01
% 220.54/220.71  |- skos__prefLabel mesh__D005965 Glucuronates
% 220.54/220.71  |- mesh__recordAuthorizer mesh__D005965 sjn
% 220.54/220.71  |- skos__broader mesh__D038341smesh__D017346
% 220.54/220.71  |- skos__historyNote mesh__D038341
% 220.54/220.71       Ca%28%2+%29%-Calmodulin Dependent Protein Kinase %28%1973-2002%29%
% 220.54/220.71  |- rdf__type mesh__D038341sskos__Concept
% 220.54/220.71  |- mesh__publicMeSHNote mesh__D038341
% 220.54/220.71       2003; see CA%28%2+%29%-CALMODULIN-DEPENDENT PROTEIN KINASE 1994-2002%A%  
% 220.54/220.71  |- skos__hiddenLabel mesh__D038341 Kinase, Glycogen Synthase
% 220.54/220.71  |- mesh__dateRevised mesh__D038341 2004-07-07
% 220.54/220.71  |- skos__hiddenLabel mesh__D038341 Synthase Kinase, Glycogen
% 220.54/220.71  |- skos__broader mesh__D038341smesh__D047908
% 220.54/220.71  |- skos__hiddenLabel mesh__D038341 Kinases, Glycogen Synthase
% 220.54/220.71  |- mesh__recordOriginator mesh__D038341 jmp
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D038341 2006
% 220.54/220.71  |- skos__prefLabel mesh__D038341 Glycogen Synthase Kinases
% 220.54/220.71  |- mesh__recordAuthorizer mesh__D038341 sjn
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D038341 2005
% 220.54/220.71  |- mesh__recordMaintainer mesh__D038341 jmp
% 220.54/220.71  |- mesh__historyNote mesh__D038341
% 220.54/220.71       2003; use CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1994-2002%A%  
% 220.54/220.71  |- mesh__dateEstablished mesh__D038341 2003-01-01
% 220.54/220.71  |- skos__scopeNote mesh__D038341
% 220.54/220.71       A class of protein-serine-threonine kinases that was originally found as one of the three types of kinases that phosphorylate GLYCOGEN SYNTHASE. Glycogen synthase kinases along with CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASES and CYCLIC AMP-DEPENDENT PROTEIN KINASES regulate glycogen synthase activity.%A%    
% 220.54/220.71  |- skos__altLabel mesh__D038341 Glycogen Synthase Kinase
% 220.54/220.71  |- mesh__dateCreated mesh__D038341 2002-07-03
% 220.54/220.71  |- skos__hiddenLabel mesh__D005167 Factor, Stable
% 220.54/220.71  |- skos__hiddenLabel mesh__D005167 Factor VII, Coagulation
% 220.54/220.71  |- skos__scopeNote mesh__D005167
% 220.54/220.71       Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor VIIa in the extrinsic pathway of blood coagulation. The activated form then catalyzes the activation of factor X to factor Xa.%A%    
% 220.54/220.71  |- skos__related mesh__D005167smesh__D003029
% 220.54/220.71  |- skos__altLabel mesh__D005167 Proconvertin
% 220.54/220.71  |- skos__altLabel mesh__D005167 Coagulation Factor VII
% 220.54/220.71  |- mesh__recordAuthorizer mesh__D005167 sjn
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D005167 2006
% 220.54/220.71  |- skos__annotation mesh__D005167 a blood coag factor   
% 220.54/220.71  |- mesh__dateCreated mesh__D005167 1999-01-01
% 220.54/220.71  |- skos__broader mesh__D005167smesh__D001779
% 220.54/220.71  |- mesh__recordOriginator mesh__D005167 NLM
% 220.54/220.71  |- skos__altLabel mesh__D005167 Stable Factor
% 220.54/220.71  |- skos__prefLabel mesh__D005167 Factor VII
% 220.54/220.71  |- skos__hiddenLabel mesh__D005167 VII, Coagulation Factor
% 220.54/220.71  |- mesh__dateRevised mesh__D005167 2005-06-30
% 220.54/220.71  |- mesh__recordMaintainer mesh__D005167 ssb
% 220.54/220.71  |- skos__altLabel mesh__D005167 Blood Coagulation Factor VII
% 220.54/220.71  |- rdf__type mesh__D005167sskos__Concept
% 220.54/220.71  |- mesh__publicMeSHNote mesh__D024321
% 220.54/220.71       2002; for ZETA-CAROTENE see CAROTENE 1988-2001   
% 220.54/220.71  |- mesh__historyNote mesh__D024321
% 220.54/220.71       2002; for ZETA-CAROTENE use CAROTENOIDS 1988-2001   
% 220.54/220.71  |- skos__prefLabel mesh__D024321 zeta Carotene
% 220.54/220.71  |- skos__historyNote mesh__D024321 Carotenoids %28%1986-2001%29%
% 220.54/220.71  |- skos__broader mesh__D024321smesh__D002338
% 220.54/220.71  |- rdf__type mesh__D024321sskos__Concept
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D024321 2006
% 220.54/220.71  |- mesh__recordMaintainer mesh__D024321 ssb
% 220.54/220.71  |- mesh__dateEstablished mesh__D024321 2002-01-01
% 220.54/220.71  |- skos__altLabel mesh__D024321 zeta-Carotene
% 220.54/220.71  |- mesh__dateCreated mesh__D024321 2001-07-25
% 220.54/220.71  |- skos__hiddenLabel mesh__D024321 Carotene, zeta
% 220.54/220.71  |- mesh__dateRevised mesh__D024321 2005-06-30
% 220.54/220.71  |- mesh__recordAuthorizer mesh__D024321 sjn
% 220.54/220.71  |- skos__scopeNote mesh__D024321
% 220.54/220.71       A carotenoid produced in most carotenogenic organisms. It is one of several sequentially synthesized molecules that are precursors to BETA CAROTENE.%A%    
% 220.54/220.71  |- mesh__recordOriginator mesh__D024321 jmp
% 220.54/220.71  |- skos__hiddenLabel mesh__D010301 Postencephalitis Parkinsonian Syndrome
% 220.54/220.71  |- skos__altLabel mesh__D010301 Von Economo Encephalitis Type Parkinsonism
% 220.54/220.71  |- skos__hiddenLabel mesh__D010301
% 220.54/220.71       Postencephalitic Economo Type Parkinsonism
% 220.54/220.71  |- mesh__publicMeSHNote mesh__D010301
% 220.54/220.71       1979; see PARKINSONISM, POSTENCEPHALITIC 1967-1978   
% 220.54/220.71  |- mesh__recordMaintainer mesh__D010301 ags
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D010301 2003
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D010301 2002
% 220.54/220.71  |- skos__altLabel mesh__D010301 Postencephalitic Economo-Type Parkinsonism
% 220.54/220.71  |- skos__altLabel mesh__D010301 Parkinson Disease, Post-Encephalitic
% 220.54/220.71  |- mesh__dateCreated mesh__D010301 1999-01-01
% 220.54/220.71  |- skos__prefLabel mesh__D010301 Parkinson Disease, Postencephalitic
% 220.54/220.71  |- skos__altLabel mesh__D010301 Encephalitis Lethargica Type Parkinsonism
% 220.54/220.71  |- skos__altLabel mesh__D010301 Viral Meningoencephalitic Parkinsonism
% 220.54/220.71  |- skos__scopeNote mesh__D010301
% 220.54/220.71       Parkinsonism following encephalitis, historically seen as a sequella of encephalitis lethargica %28%Von Economo Encephalitis%29%. The early age of onset, the rapid progression of symptoms followed by stabilization, and the presence of a variety of other neurological disorders %28%e.g., sociopathic behavior; TICS; MUSCLE SPASMS; oculogyric crises; hyperphagia; and bizarre movements%29% distinguish this condition from primary PARKINSON DISEASE. Pathologic features include neuronal loss and gliosis concentrated in the MESENCEPHALON; SUBTHALAMUS; and HYPOTHALAMUS. %28%From Adams et al., Principles of Neurology, 6th ed, p754%29%%A%    
% 220.54/220.71  |- skos__hiddenLabel mesh__D010301 Post Encephalitic Parkinson Disease
% 220.54/220.71  |- mesh__recordAuthorizer mesh__D010301 ags
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D010301 2004
% 220.54/220.71  |- skos__altLabel mesh__D010301 Post-Encephalitic Parkinson Disease
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D010301 2005
% 220.54/220.71  |- mesh__historyNote mesh__D010301 1979%28%1967%29%   
% 220.54/220.71  |- skos__altLabel mesh__D010301 Postencephalitic Parkinsonism
% 220.54/220.71  |- skos__hiddenLabel mesh__D010301 Parkinsonisms, Viral Meningoencephalitic
% 220.54/220.71  |- skos__hiddenLabel mesh__D010301 Parkinson Disease, Post Encephalitic
% 220.54/220.71  |- mesh__dateEstablished mesh__D010301 1967-01-01
% 220.54/220.71  |- skos__altLabel mesh__D010301 Postencephalitic Parkinson Disease
% 220.54/220.71  |- skos__broader mesh__D010301smesh__D010302
% 220.54/220.71  |- skos__altLabel mesh__D010301 Parkinsonism, Postencephalitic
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D010301 2000
% 220.54/220.71  |- mesh__dateRevised mesh__D010301 2005-08-02
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D010301 2006
% 220.54/220.71  |- mesh__recordOriginator mesh__D010301 NLM
% 220.54/220.71  |- skos__hiddenLabel mesh__D010301 Meningoencephalitic Parkinsonism, Viral
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D010301 2006A
% 220.54/220.71  |- skos__historyNote mesh__D010301 Parkinson Disease %28%1966%29%
% 220.54/220.71  |- skos__hiddenLabel mesh__D010301
% 220.54/220.71       Parkinsonism, Postencephalitic Economo-Type
% 220.54/220.71  |- skos__hiddenLabel mesh__D010301
% 220.54/220.71       Economo-Type Parkinsonism, Postencephalitic
% 220.54/220.71  |- skos__altLabel mesh__D010301 Parkinsonian Syndrome, Postencephalitis
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D010301 2001
% 220.54/220.71  |- rdf__type mesh__D010301sskos__Concept
% 220.54/220.71  |- skos__annotation mesh__D010301 DF: PARKINSON DIS POSTENCEPH   
% 220.54/220.71  |- mesh__historyNote mesh__D051718 2006%28%1994%29%   
% 220.54/220.71  |- skos__prefLabel mesh__D051718 MutS Homolog 2 Protein
% 220.54/220.71  |- skos__broader mesh__D051718smesh__D004268
% 220.54/220.71  |- skos__broader mesh__D051718smesh__D011518
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D051718 2006A
% 220.54/220.71  |- mesh__dateCreated mesh__D051718 2005-06-30
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D051718 2006
% 220.54/220.71  |- mesh__recordAuthorizer mesh__D051718 ags
% 220.54/220.71  |- rdf__type mesh__D051718sskos__Concept
% 220.54/220.71  |- mesh__recordOriginator mesh__D051718 DRC
% 220.54/220.71  |- mesh__publicMeSHNote mesh__D051718
% 220.54/220.71       2006; MUTS HOMOLOG 2 PROTEIN was indexed under DNA-BINDING PROTEINS %26% PROTO-ONCOGENE PROTEINS 1994-2005%A%  
% 220.54/220.71  |- mesh__dateEstablished mesh__D051718 2006-01-01
% 220.54/220.71  |- skos__scopeNote mesh__D051718
% 220.54/220.71       MutS homolog 2 protein is found throughout eukaryotes and is a homolog of the MUTS DNA MISMATCH-BINDING PROTEIN. It plays an essential role in meiotic RECOMBINATION and DNA REPAIR of mismatched NUCLEOTIDES.%A%    
% 220.54/220.71  |- mesh__dateRevised mesh__D051718 2005-07-13
% 220.54/220.71  |- skos__broader mesh__D051718smesh__D000251
% 220.54/220.71  |- mesh__recordMaintainer mesh__D051718 ags
% 220.54/220.71  |- skos__broader mesh__D051718smesh__D045643
% 220.54/220.71  |- mesh__dateRevised mesh__D015595 1997-06-20
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D015595 2003
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D015595 2006
% 220.54/220.71  |- mesh__recordAuthorizer mesh__D015595 SJN
% 220.54/220.71  |- skos__broader mesh__D015595smesh__D012879
% 220.54/220.71  |- skos__historyNote mesh__D015595 Aging %28%1966-1989%29%
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D015595 2004
% 220.54/220.71  |- mesh__dateEstablished mesh__D015595 1990-01-01
% 220.54/220.71  |- skos__hiddenLabel mesh__D015595 Wrinkling, Skin
% 220.54/220.71  |- skos__hiddenLabel mesh__D015595 Aging, Skin
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D015595 2000
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D015595 1998
% 220.54/220.71  |- mesh__publicMeSHNote mesh__D015595 90   
% 220.54/220.71  |- skos__historyNote mesh__D015595 Skin %28%1966-1989%29%
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D015595 2001
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D015595 1999
% 220.54/220.71  |- rdf__type mesh__D015595sskos__Concept
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D015595 2002
% 220.54/220.71  |- mesh__recordOriginator mesh__D015595 EGC
% 220.54/220.71  |- skos__historyNote mesh__D015595 Sunlight %28%1966-1989%29%
% 220.54/220.71  |- skos__hiddenLabel mesh__D015595 Skin Wrinklings
% 220.54/220.71  |- skos__altLabel mesh__D015595 Solar Aging of Skin
% 220.54/220.71  |- skos__prefLabel mesh__D015595 Skin Aging
% 220.54/220.71  |- mesh__recordMaintainer mesh__D015595 TPW
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D015595 2005
% 220.54/220.71  |- skos__scopeNote mesh__D015595
% 220.54/220.71       The process of aging due to changes in the structure and elasticity of the skin over time. It may be a part of physiological aging or it may be due to the effects of ultraviolet radiation, usually through exposure to sunlight.%A%    
% 220.54/220.71  |- mesh__dateCreated mesh__D015595 1989-05-26
% 220.54/220.71  |- mesh__historyNote mesh__D015595 90   
% 220.54/220.71  |- skos__altLabel mesh__D015595 Photoaging of Skin
% 220.54/220.71  |- mesh__dateEstablished mesh__D009558 1991-01-01
% 220.54/220.71  |- skos__prefLabel mesh__D009558 Nipples
% 220.54/220.71  |- mesh__recordMaintainer mesh__D009558 lkt
% 220.54/220.71  |- rdf__type mesh__D009558sskos__Concept
% 220.54/220.71  |- mesh__dateRevised mesh__D009558 2003-07-09
% 220.54/220.71  |- skos__scopeNote mesh__D009558
% 220.54/220.71       The conic organs which usually give outlet to milk from the mammary glands.%A%    
% 220.54/220.71  |- mesh__publicMeSHNote mesh__D009558 91; was see under BREAST 1975-90   
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D009558 2006
% 220.54/220.71  |- skos__annotation mesh__D009558
% 220.54/220.71       human %26% animal, male %26% female; for cow use UDDER; teat use UDDER; diseases: coord IM with BREAST DISEASES %28%NIM%29%%A%  
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D009558 2005
% 220.54/220.71  |- mesh__recordOriginator mesh__D009558 NLM
% 220.54/220.71  |- mesh__dateCreated mesh__D009558 1974-11-11
% 220.54/220.71  |- skos__broader mesh__D009558smesh__D001940
% 220.54/220.71  |- skos__hiddenLabel mesh__D009558 Nipple
% 220.54/220.71  |- mesh__historyNote mesh__D009558
% 220.54/220.71       91%28%75%29%; was see under BREAST 1975-90   
% 220.54/220.71  |- mesh__recordAuthorizer mesh__D009558 sjn
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D009558 2004
% 220.54/220.71  |- mesh__dateEstablished mesh__D001575 1991-01-01
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D001575 1995
% 220.54/220.71  |- skos__annotation mesh__D001575 analgesics   
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D001575 2003
% 220.54/220.71  |- mesh__onlineNote mesh__D001575
% 220.54/220.71       use BENZOMORPHANS to search BENZOMORPHAN 1975-84; use MORPHINANS 1973-74 %26% BRIDGED COMPOUNDS 1966-72%A%  
% 220.54/220.71  |- skos__prefLabel mesh__D001575 Benzomorphans
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D001575 2001
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D001575 2004
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D001575 2002
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D001575 2005
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D001575 1996
% 220.54/220.71  |- mesh__publicMeSHNote mesh__D001575
% 220.54/220.71       91; was see under MORPHINANS 1985-90; was BENZOMORPHAN see under MORPHINANS 1973-84 %26% see under BRIDGED COMPOUNDS 1966-72%A%  
% 220.54/220.71  |- mesh__dateCreated mesh__D001575 1999-01-01
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D001575 2006
% 220.54/220.71  |- mesh__dateRevised mesh__D001575 1992-05-08
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D001575 1997
% 220.54/220.71  |- skos__broader mesh__D001575smesh__D009019
% 220.54/220.71  |- skos__scopeNote mesh__D001575
% 220.54/220.71       Morphine derivatives of the methanobenzazocine family that act as potent analgesics.%A%    
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D001575 1998
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D001575 1993
% 220.54/220.71  |- mesh__historyNote mesh__D001575
% 220.54/220.71       91%28%85%29%; was see under MORPHINANS 1985-90; was BENZOMORPHAN see under MORPHINANS 1973-84 %26% see under BRIDGED COMPOUNDS 1966-72%A%  
% 220.54/220.71  |- mesh__recordAuthorizer mesh__D001575 PLS
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D001575 1994
% 220.54/220.71  |- mesh__recordMaintainer mesh__D001575 TAP
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D001575 1999
% 220.54/220.71  |- rdf__type mesh__D001575sskos__Concept
% 220.54/220.71  |- mesh__recordOriginator mesh__D001575 NLM
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D001575 2000
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D006260 2003
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D006260 2001
% 220.54/220.71  |- rdf__type mesh__D006260sskos__Concept
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D006260 2004
% 220.54/220.71  |- skos__hiddenLabel mesh__D006260 Helmet
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D006260 1998
% 220.54/220.71  |- mesh__publicMeSHNote mesh__D006260 91; see PROTECTIVE DEVICES 1975-90   
% 220.54/220.71  |- skos__hiddenLabel mesh__D006260 Protective Devices, Head
% 220.54/220.71  |- skos__broader mesh__D006260smesh__D011482
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D006260 2002
% 220.54/220.71  |- mesh__recordOriginator mesh__D006260 NLM
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D006260 2005
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D006260 1999
% 220.54/220.71  |- skos__prefLabel mesh__D006260 Head Protective Devices
% 220.54/220.71  |- skos__scopeNote mesh__D006260
% 220.54/220.71       Personal devices for protection of heads from impact, penetration from falling and flying objects, and from limited electric shock and burn.%A%    
% 220.54/220.71  |- skos__hiddenLabel mesh__D006260 Devices, Head Protective
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D006260 2006
% 220.54/220.71  |- skos__hiddenLabel mesh__D006260 Device, Head Protective
% 220.54/220.71  |- mesh__historyNote mesh__D006260 91%28%75%29%   
% 220.54/220.71  |- mesh__recordMaintainer mesh__D006260 PXP
% 220.54/220.71  |- mesh__dateEstablished mesh__D006260 1991-01-01
% 220.54/220.71  |- mesh__dateCreated mesh__D006260 1974-12-12
% 220.54/220.71  |- mesh__recordAuthorizer mesh__D006260 SJN
% 220.54/220.71  |- mesh__dateRevised mesh__D006260 1997-06-20
% 220.54/220.71  |- skos__hiddenLabel mesh__D006260 Protective Device, Head
% 220.54/220.71  |- skos__hiddenLabel mesh__D006260 Head Protective Device
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D006260 2000
% 220.54/220.71  |- mesh__dateRevised mesh__D019986 1998-06-10
% 220.54/220.71  |- skos__scopeNote mesh__D019986
% 220.54/220.71       Persons with any degree of loss of hearing that has an impact on their activities of daily living or that requires special assistance or intervention.%A%    
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019986 2002
% 220.54/220.71  |- skos__prefLabel mesh__D019986 Hearing Impaired Persons
% 220.54/220.71  |- skos__broader mesh__D019986smesh__D006233
% 220.54/220.71  |- skos__hiddenLabel mesh__D019986 Hearing Impaired Person
% 220.54/220.71  |- rdf__type mesh__D019986sskos__Concept
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019986 1999
% 220.54/220.71  |- mesh__recordMaintainer mesh__D019986 NNS
% 220.54/220.71  |- mesh__historyNote mesh__D019986 98   
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019986 2005
% 220.54/220.71  |- mesh__dateEstablished mesh__D019986 1998-01-01
% 220.54/220.71  |- mesh__recordAuthorizer mesh__D019986 SJN
% 220.54/220.71  |- mesh__recordOriginator mesh__D019986 JLS
% 220.54/220.71  |- mesh__publicMeSHNote mesh__D019986 98   
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019986 2000
% 220.54/220.71  |- skos__hiddenLabel mesh__D019986 Persons, Hearing Impaired
% 220.54/220.71  |- skos__hiddenLabel mesh__D019986 Person, Hearing Impaired
% 220.54/220.71  |- mesh__dateCreated mesh__D019986 1997-06-20
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019986 2003
% 220.54/220.71  |- skos__altLabel mesh__D019986 Deaf
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019986 2006
% 220.54/220.71  |- skos__altLabel mesh__D019986 Hard of Hearing Persons
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019986 2001
% 220.54/220.71  |- skos__altLabel mesh__D019986 Persons With Hearing Impairments
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019986 2004
% 220.54/220.71  |- skos__related mesh__D019986smesh__D003638
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019188 2005A
% 220.54/220.71  |- skos__scopeNote mesh__D019188
% 220.54/220.71       Solutions used to store organs and minimize tissue damage, particularly while awaiting implantation.%A%    
% 220.54/220.71  |- skos__hiddenLabel mesh__D019188 Solutions, Tissue Preservation
% 220.54/220.71  |- mesh__dateRevised mesh__D019188 2004-07-29
% 220.54/220.71  |- mesh__dateEstablished mesh__D019188 1997-01-01
% 220.54/220.71  |- skos__related mesh__D019188smesh__D003451
% 220.54/220.71  |- skos__historyNote mesh__D019188 Tissue Preservation %28%1969-1974%29%
% 220.54/220.71  |- mesh__recordOriginator mesh__D019188 TPW
% 220.54/220.71  |- skos__annotation mesh__D019188
% 220.54/220.71       coord with specific chem components of solution %28%IM%29% + specific organ or tissue %28%IM with no qualif%29%%A%  
% 220.54/220.71  |- skos__hiddenLabel mesh__D019188 Preservation Solutions, Tissue
% 220.54/220.71  |- mesh__recordMaintainer mesh__D019188 jls
% 220.54/220.71  |- skos__altLabel mesh__D019188 Solutions, Organ Preservation
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019188 2004
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019188 2005
% 220.54/220.71  |- skos__broader mesh__D019188smesh__D012996
% 220.54/220.71  |- skos__historyNote mesh__D019188 Organ Preservation %28%1975-1996%29%
% 220.54/220.71  |- mesh__historyNote mesh__D019188 97   
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D019188 2006
% 220.54/220.71  |- rdf__type mesh__D019188sskos__Concept
% 220.54/220.71  |- mesh__publicMeSHNote mesh__D019188 97   
% 220.54/220.71  |- skos__hiddenLabel mesh__D019188 Preservation Solutions, Organ
% 220.54/220.71  |- mesh__recordAuthorizer mesh__D019188 jls
% 220.54/220.71  |- skos__historyNote mesh__D019188 Solutions %28%1969-1996%29%
% 220.54/220.71  |- skos__altLabel mesh__D019188 Tissue Preservation Solutions
% 220.54/220.71  |- mesh__dateCreated mesh__D019188 1996-06-10
% 220.54/220.71  |- skos__prefLabel mesh__D019188 Organ Preservation Solutions
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D005966 2004
% 220.54/220.71  |- skos__hiddenLabel mesh__D005966 beta Glucuronidase
% 220.54/220.71  |- skos__altLabel mesh__D005966 beta-Glucuronidase
% 220.54/220.71  |- mesh__recordOriginator mesh__D005966 NLM
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D005966 2006
% 220.54/220.71  |- rdf__type mesh__D005966sskos__Concept
% 220.54/220.71  |- skos__hiddenLabel mesh__D005966 Exo beta D Glucuronidase
% 220.54/220.71  |- skos__prefLabel mesh__D005966 Glucuronidase
% 220.54/220.71  |- mesh__dateCreated mesh__D005966 1999-01-01
% 220.54/220.71  |- skos__hiddenLabel mesh__D005966 Endo beta D Glucuronidase
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D005966 2005
% 220.54/220.71  |- skos__altLabel mesh__D005966 Endo-beta-D-Glucuronidase
% 220.54/220.71  |- mesh__dateRevised mesh__D005966 2003-07-09
% 220.54/220.71  |- mesh__recordAuthorizer mesh__D005966 sjn
% 220.54/220.71  |- skos__broader mesh__D005966smesh__D006026
% 220.54/220.71  |- mesh__recordMaintainer mesh__D005966 ssb
% 220.54/220.71  |- mesh__onlineNote mesh__D005168
% 220.54/220.71       use FACTOR VII DEFICIENCY to search HYPOPROCONVERTINEMIA 1966-84%A%  
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D005168 2006
% 220.54/220.71  |- skos__scopeNote mesh__D005168
% 220.54/220.71       An autosomal recessive characteristic or a coagulation disorder acquired in association with VITAMIN K DEFICIENCY. FACTOR VII is a Vitamin K dependent glycoprotein essential to the extrinsic pathway of coagulation.%A%    
% 220.54/220.71  |- mesh__dateCreated mesh__D005168 1999-01-01
% 220.54/220.71  |- mesh__recordMaintainer mesh__D005168 nns
% 220.54/220.71  |- skos__hiddenLabel mesh__D005168 Factor VII Deficiencies
% 220.54/220.71  |- mesh__activeMeSHYear mesh__D005168 2003
% 220.54/220.71  |- skos__broader mesh__D005168smesh__D020147
% 220.54/220.71  |- skos__altLabel mesh__D005168 Deficiency, Factor VII
% 220.54/220.71  |- mesh__dateRevised mesh__D005168 2001-07-25
% 220.54/220.71  |- mesh__recordAuthorizer mesh__D005168 sjn
% 220.54/220.72  |- mesh__publicMeSHNote mesh__D005168
% 220.54/220.72       85; was HYPOPROCONVERTINEMIA 1963-84   
% 220.54/220.72  |- skos__hiddenLabel mesh__D005168 Hypoproconvertinemias
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D005168 2004
% 220.54/220.72  |- skos__annotation mesh__D005168 DF: FACTOR VII DEFIC   
% 220.54/220.72  |- mesh__historyNote mesh__D005168 85; was HYPOPROCONVERTINEMIA 1963-84   
% 220.54/220.72  |- skos__altLabel mesh__D005168 Hypoproconvertinemia
% 220.54/220.72  |- mesh__recordOriginator mesh__D005168 NLM
% 220.54/220.72  |- rdf__type mesh__D005168sskos__Concept
% 220.54/220.72  |- skos__hiddenLabel mesh__D005168 Deficiencies, Factor VII
% 220.54/220.72  |- skos__prefLabel mesh__D005168 Factor VII Deficiency
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D005168 2005
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D005168 2002
% 220.54/220.72  |- skos__broader mesh__D005168smesh__D025861
% 220.54/220.72  |- skos__broader mesh__D005168smesh__D006474
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D024322 2002
% 220.54/220.72  |- mesh__dateCreated mesh__D024322 2001-07-25
% 220.54/220.72  |- skos__hiddenLabel mesh__D024322 Aromatic Amino Acid
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D024322 2003
% 220.54/220.72  |- skos__altLabel mesh__D024322 Aromatic Amino Acids
% 220.54/220.72  |- rdf__type mesh__D024322sskos__Concept
% 220.54/220.72  |- skos__scopeNote mesh__D024322
% 220.54/220.72       Amino acids containing an aromatic side chain.     
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D024322 2006
% 220.54/220.72  |- mesh__historyNote mesh__D024322 2002   
% 220.54/220.72  |- skos__broader mesh__D024322smesh__D000598
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D024322 2005
% 220.54/220.72  |- mesh__dateEstablished mesh__D024322 2002-01-01
% 220.54/220.72  |- skos__prefLabel mesh__D024322 Amino Acids, Aromatic
% 220.54/220.72  |- skos__historyNote mesh__D024322 Amino Acids %28%1965-2001%29%
% 220.54/220.72  |- mesh__publicMeSHNote mesh__D024322 2002   
% 220.54/220.72  |- skos__altLabel mesh__D024322 Amino Acid, Aromatic
% 220.54/220.72  |- skos__historyNote mesh__D024322 specific amino acid %28%1965-2001%29%
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D024322 2004
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D010302 2002
% 220.54/220.72  |- mesh__publicMeSHNote mesh__D010302
% 220.54/220.72       2000; see PARKINSON DISEASE, SYMPTOMATIC 1979-1999, see PARKINSONISM, SYMPTOMATIC 1973-1978%A%  
% 220.54/220.72  |- skos__scopeNote mesh__D010302
% 220.54/220.72       Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. %28%From Joynt, Clinical Neurology, 1998, Ch38, pp39-42%29%%A%    
% 220.54/220.72  |- skos__hiddenLabel mesh__D010302 Symptomatic Parkinsonism
% 220.54/220.72  |- skos__prefLabel mesh__D010302 Parkinson Disease, Secondary
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D010302 2000A
% 220.54/220.72  |- skos__altLabel mesh__D010302 Parkinsonism, Secondary
% 220.54/220.72  |- mesh__dateEstablished mesh__D010302 1973-01-01
% 220.54/220.72  |- mesh__dateCreated mesh__D010302 1999-01-01
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D010302 2006
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D010302 2004
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D010302 2005
% 220.54/220.72  |- mesh__recordAuthorizer mesh__D010302 ags
% 220.54/220.72  |- skos__hiddenLabel mesh__D010302 Parkinsonism, Atherosclerotic
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D010302 2001
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D010302 2003
% 220.54/220.72  |- rdf__type mesh__D010302sskos__Concept
% 220.54/220.72  |- mesh__recordMaintainer mesh__D010302 ags
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D010302 2000
% 220.54/220.72  |- mesh__dateRevised mesh__D010302 2000-01-03
% 220.54/220.72  |- skos__altLabel mesh__D010302 Parkinson Disease, Symptomatic
% 220.54/220.72  |- skos__broader mesh__D010302smesh__D020734
% 220.54/220.72  |- mesh__recordOriginator mesh__D010302 NLM
% 220.54/220.72  |- skos__historyNote mesh__D010302 Parkinson Disease %28%1966-1972%29%
% 220.54/220.72  |- skos__annotation mesh__D010302
% 220.54/220.72       /chem ind permitted: coord IM with drug /adv eff-pois-tox %28%IM%29%; coord IM with other cause %28%IM%29%%A%  
% 220.54/220.72  |- mesh__historyNote mesh__D010302 2000%28%1973%29%   
% 220.54/220.72  |- skos__altLabel mesh__D010302 Secondary Vascular Parkinson Disease
% 220.54/220.72  |- skos__altLabel mesh__D010302 Secondary Parkinsonism
% 220.54/220.72  |- skos__hiddenLabel mesh__D010302 Secondary Parkinson Disease
% 220.54/220.72  |- skos__altLabel mesh__D010302 Symptomatic Parkinson Disease
% 220.54/220.72  |- skos__altLabel mesh__D010302 Parkinsonism, Symptomatic
% 220.54/220.72  |- rdf__type mesh__D051719sskos__Concept
% 220.54/220.72  |- mesh__dateEstablished mesh__D051719 2006-01-01
% 220.54/220.72  |- mesh__recordOriginator mesh__D051719 DRC
% 220.54/220.72  |- skos__altLabel mesh__D051719 DNA Mismatch Repair Protein MutS
% 220.54/220.72  |- skos__broader mesh__D051719smesh__D045643
% 220.54/220.72  |- mesh__historyNote mesh__D051719 2006%28%1991%29%   
% 220.54/220.72  |- skos__hiddenLabel mesh__D051719 MutS DNA Mismatch Binding Protein
% 220.54/220.72  |- skos__broader mesh__D051719smesh__D000251
% 220.54/220.72  |- skos__broader mesh__D051719smesh__D001426
% 220.54/220.72  |- skos__prefLabel mesh__D051719 MutS DNA Mismatch-Binding Protein
% 220.54/220.72  |- mesh__recordAuthorizer mesh__D051719 sjn
% 220.54/220.72  |- skos__scopeNote mesh__D051719
% 220.54/220.72       A methyl-directed mismatch DNA REPAIR protein that has weak ATPASE activity. MutS was originally described in ESCHERICHIA COLI.%A%    
% 220.54/220.72  |- mesh__recordMaintainer mesh__D051719 DRC
% 220.54/220.72  |- mesh__dateCreated mesh__D051719 2005-06-30
% 220.54/220.72  |- skos__broader mesh__D051719smesh__D004268
% 220.54/220.72  |- mesh__publicMeSHNote mesh__D051719
% 220.54/220.72       2006; MUTS DNA MISMATCH-BINDING PROTEIN was indexed under ADENOSINETRIPHOSPHATASE %26% DNA-BINDING PROTEINS 1991-2005, %26% under BACTERIAL PROTEINS 2005, %26% under ESCHERIA COLI PROTEINS 2002-2004%A%  
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D051719 2006
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D015596 1998
% 220.54/220.72  |- mesh__dateEstablished mesh__D015596 1990-01-01
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D015596 2002
% 220.54/220.72  |- mesh__historyNote mesh__D015596 90   
% 220.54/220.72  |- skos__hiddenLabel mesh__D015596
% 220.54/220.72       Indices, Prognostic Nutritional %28%PNI%29%
% 220.54/220.72  |- rdf__type mesh__D015596sskos__Concept
% 220.54/220.72  |- skos__scopeNote mesh__D015596
% 220.54/220.72       Evaluation and measurement of nutritional variables in order to assess the level of nutrition or the nutritional status of the individual. Nutrition surveys may be used in making the assessment.%A%    
% 220.54/220.72  |- skos__hiddenLabel mesh__D015596 Nutrition Assessments
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D015596 1996
% 220.54/220.72  |- mesh__publicMeSHNote mesh__D015596 90   
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D015596 1999
% 220.54/220.72  |- skos__altLabel mesh__D015596 Assessment, Nutrition
% 220.54/220.72  |- mesh__recordMaintainer mesh__D015596 PLS
% 220.54/220.72  |- mesh__dateCreated mesh__D015596 1989-07-06
% 220.54/220.72  |- skos__historyNote mesh__D015596 Nutritional Status %28%1987-1989%29%
% 220.54/220.72  |- skos__hiddenLabel mesh__D015596
% 220.54/220.72       Prognostic Nutritional Indices %28%PNI%29%
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D015596 1997
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D015596 2005
% 220.54/220.72  |- skos__hiddenLabel mesh__D015596
% 220.54/220.72       Nutritional Index, Prognostic %28%PNI%29%
% 220.54/220.72  |- mesh__dateRevised mesh__D015596 1994-02-08
% 220.54/220.72  |- mesh__recordOriginator mesh__D015596 EGC
% 220.54/220.72  |- skos__hiddenLabel mesh__D015596 Assessments, Nutrition
% 220.54/220.72  |- skos__historyNote mesh__D015596 Nutrition Surveys %28%1966-1989%29%
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D015596 2003
% 220.54/220.72  |- skos__hiddenLabel mesh__D015596
% 220.54/220.72       Index, Prognostic Nutritional %28%PNI%29%
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D015596 2006
% 220.54/220.72  |- skos__prefLabel mesh__D015596 Nutrition Assessment
% 220.54/220.72  |- skos__hiddenLabel mesh__D015596
% 220.54/220.72       Nutritional Indices, Prognostic %28%PNI%29%
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D015596 2000
% 220.54/220.72  |- skos__broader mesh__D015596smesh__D003625
% 220.54/220.72  |- skos__historyNote mesh__D015596 Nutrition Disorders %28%1966-1989%29%
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D015596 2004
% 220.54/220.72  |- skos__annotation mesh__D015596
% 220.54/220.72       no qualif; do not confuse with NUTRITION SURVEYS: survey refers to a population in a given geog area, assessment refers to an individual; DF: NUTRITION ASSESS%A%  
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D015596 2001
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D015596 1995
% 220.54/220.72  |- mesh__recordAuthorizer mesh__D015596 PLS
% 220.54/220.72  |- mesh__publicMeSHNote mesh__D009559
% 220.54/220.72       79; was see under HOOKWORMS 1975-78   
% 220.54/220.72  |- skos__broader mesh__D009559smesh__D006369
% 220.54/220.72  |- mesh__recordOriginator mesh__D009559 NLM
% 220.54/220.72  |- skos__historyNote mesh__D009559 Ancylostomatoidea %28%1966-1974%29%
% 220.54/220.72  |- mesh__recordAuthorizer mesh__D009559 sjn
% 220.54/220.72  |- rdf__type mesh__D009559sskos__Concept
% 220.54/220.72  |- skos__scopeNote mesh__D009559
% 220.54/220.72       A genus of intestinal nematode parasites belonging to the superfamily HELIGMOSOMATOIDEA, which commonly occurs in rats but has been experimentally transmitted to other rodents and rabbits. Infection is usually through the skin.%A%    
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D009559 2005
% 220.54/220.72  |- mesh__dateRevised mesh__D009559 2003-07-09
% 220.54/220.72  |- skos__annotation mesh__D009559
% 220.54/220.72       a genus of nematodes; infection: coord IM with STRONGYLIDA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D009559 2006
% 220.54/220.72  |- mesh__recordMaintainer mesh__D009559 ags
% 220.54/220.72  |- mesh__historyNote mesh__D009559
% 220.54/220.72       79%28%75%29%; was see under HOOKWORMS 1975-78   
% 220.54/220.72  |- mesh__dateCreated mesh__D009559 1974-12-12
% 220.54/220.72  |- mesh__dateEstablished mesh__D009559 1979-01-01
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D009559 2004
% 220.54/220.72  |- skos__prefLabel mesh__D009559 Nippostrongylus
% 220.54/220.72  |- mesh__historyNote mesh__D001576
% 220.54/220.72       91%28%75%29%; was see under ANILINE COMPOUNDS 1975-90; PYOCTANIUM AUREUM was see BENZOPHENONEIDUM 1975-95%A%  
% 220.54/220.72  |- mesh__dateRevised mesh__D001576 2005-07-06
% 220.54/220.72  |- skos__historyNote mesh__D001576 Aniline Compounds %28%1969-1974%29%
% 220.54/220.72  |- mesh__recordOriginator mesh__D001576 NLM
% 220.54/220.72  |- skos__hiddenLabel mesh__D001576 O, Auramine
% 220.54/220.72  |- skos__annotation mesh__D001576 D25-26 qualif   
% 220.54/220.72  |- mesh__recordMaintainer mesh__D001576 NLM
% 220.54/220.72  |- mesh__publicMeSHNote mesh__D001576
% 220.54/220.72       91; was see under ANILINE COMPOUNDS 1975-90; PYOCTANIUM AUREUM was see BENZOPHENONEIUM 1975-95%A%  
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D001576 2006
% 220.54/220.72  |- skos__altLabel mesh__D001576 Auramine
% 220.54/220.72  |- skos__historyNote mesh__D001576 Imines %28%1972-1974%29%
% 220.54/220.72  |- mesh__dateCreated mesh__D001576 1974-11-19
% 220.54/220.72  |- skos__broader mesh__D001576smesh__D000814
% 220.54/220.72  |- skos__prefLabel mesh__D001576 Benzophenoneidum
% 220.54/220.72  |- skos__scopeNote mesh__D001576
% 220.54/220.72       An aniline dye used as a disinfectant and an antiseptic agent. It is weakly fluorescing and binds specifically to certain proteins.%A%    
% 220.54/220.72  |- rdf__type mesh__D001576sskos__Concept
% 220.54/220.72  |- mesh__dateEstablished mesh__D001576 1991-01-01
% 220.54/220.72  |- mesh__recordAuthorizer mesh__D001576 NLM
% 220.54/220.72  |- skos__historyNote mesh__D001576 Dimethylamines %28%1974%29%
% 220.54/220.72  |- skos__altLabel mesh__D020730 Inhibitors, Guanine Nucleotide Dissociation
% 220.54/220.72  |- skos__broader mesh__D020730smesh__D020555
% 220.54/220.72  |- mesh__historyNote mesh__D020730 2000   
% 220.54/220.72  |- skos__hiddenLabel mesh__D020730 Dissociation Inhibitors, GDP
% 220.54/220.72  |- skos__altLabel mesh__D020730 GDIs
% 220.54/220.72  |- mesh__dateCreated mesh__D020730 1999-11-03
% 220.54/220.72  |- skos__hiddenLabel mesh__D020730 Inhibitors, GDP Dissociation
% 220.54/220.72  |- mesh__publicMeSHNote mesh__D020730 2000   
% 220.54/220.72  |- mesh__recordAuthorizer mesh__D020730 sjn
% 220.54/220.72  |- rdf__type mesh__D020730sskos__Concept
% 220.54/220.72  |- mesh__recordMaintainer mesh__D020730 SYSTEM
% 220.54/220.72  |- skos__scopeNote mesh__D020730
% 220.54/220.72       Protein factors that inhibit the dissociation of GDP from GTP-BINDING PROTEINS.%A%    
% 220.54/220.72  |- mesh__dateEstablished mesh__D020730 2000-01-01
% 220.54/220.72  |- mesh__recordOriginator mesh__D020730 jmp
% 220.54/220.72  |- mesh__dateRevised mesh__D020730 2005-06-30
% 220.54/220.72  |- skos__historyNote mesh__D020730 G-Proteins %28%1992-1999%29%
% 220.54/220.72  |- skos__altLabel mesh__D020730 GDI Proteins
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D020730 2006
% 220.54/220.72  |- skos__prefLabel mesh__D020730 Guanine Nucleotide Dissociation Inhibitors
% 220.54/220.72  |- skos__altLabel mesh__D020730 GDP Dissociation Inhibitors
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Orthostatic Headaches
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Headache, Bilateral
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Periorbital Headaches
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Headache, Orthostatic
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Headaches, Unilateral
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Headaches, Generalized
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Headache, Throbbing
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Retro Ocular Headache
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Cephalodynias
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Headache, Vertex
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Sharp Headaches
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Headache, Ocular
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Headaches, Orthostatic
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Headaches, Sharp
% 220.54/220.72  |- rdf__type mesh__D006261sskos__Concept
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Vertex Headaches
% 220.54/220.72  |- mesh__publicMeSHNote mesh__D006261
% 220.54/220.72       2006 %28%1963%29%; for HEMICRANIA see MIGRAINE 1963-2005   
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Headaches, Bilateral
% 220.54/220.72  |- skos__altLabel mesh__D006261 Hemicrania
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Cephalalgias
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Generalized Headaches
% 220.54/220.72  |- skos__altLabel mesh__D006261 Cranial Pain
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Retro-Ocular Headaches
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Head Pains
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Headache, Sharp
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Headaches, Retro-Ocular
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Ocular Headaches
% 220.54/220.72  |- mesh__dateRevised mesh__D006261 2005-06-30
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Headaches
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Cranial Pains
% 220.54/220.72  |- skos__altLabel mesh__D006261 Cephalalgia
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Throbbing Headaches
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Headache, Unilateral
% 220.54/220.72  |- skos__annotation mesh__D006261
% 220.54/220.72       HEADACHE DISORDERS and specifics are also available but do not diagnose: use word of text%A%  
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Headaches, Periorbital
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Pain, Cranial
% 220.54/220.72  |- skos__altLabel mesh__D006261 Cephalgia
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Bilateral Headaches
% 220.54/220.72  |- skos__broader mesh__D006261smesh__D010146
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Headaches, Ocular
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Pain, Head
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D006261 2006
% 220.54/220.72  |- skos__altLabel mesh__D006261 Head Pain
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Headaches, Vertex
% 220.54/220.72  |- mesh__recordOriginator mesh__D006261 NLM
% 220.54/220.72  |- skos__related mesh__D006261smesh__D020773
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Unilateral Headaches
% 220.54/220.72  |- skos__scopeNote mesh__D006261
% 220.54/220.72       The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.%A%    
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Pains, Cranial
% 220.54/220.72  |- skos__prefLabel mesh__D006261 Headache
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Pains, Head
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Headaches, Throbbing
% 220.54/220.72  |- skos__altLabel mesh__D006261 Cephalodynia
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Headache, Generalized
% 220.54/220.72  |- mesh__dateCreated mesh__D006261 1999-01-01
% 220.54/220.72  |- mesh__recordMaintainer mesh__D006261 lkt
% 220.54/220.72  |- mesh__historyNote mesh__D006261
% 220.54/220.72       2006 %28%1963%29%; for HEMICRANIA use MIGRAINE 1963-2005   
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Cephalgias
% 220.54/220.72  |- mesh__recordAuthorizer mesh__D006261 sjn
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Headache, Retro-Ocular
% 220.54/220.72  |- skos__hiddenLabel mesh__D006261 Headache, Periorbital
% 220.54/220.72  |- rdf__type mesh__D019987sskos__Concept
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D019987 1998
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D019987 2001
% 220.54/220.72  |- skos__altLabel mesh__D019987 Blind
% 220.54/220.72  |- skos__related mesh__D019987smesh__D001766
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D019987 2002
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D019987 1999
% 220.54/220.72  |- skos__hiddenLabel mesh__D019987 Visually Impaired Person
% 220.54/220.72  |- skos__hiddenLabel mesh__D019987 Impaired Persons, Visually
% 220.54/220.72  |- mesh__historyNote mesh__D019987 98   
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D019987 2005
% 220.54/220.72  |- skos__hiddenLabel mesh__D019987 Impaired Person, Visually
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D019987 2006
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D019987 2003
% 220.54/220.72  |- skos__hiddenLabel mesh__D019987 Persons, Visually Impaired
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D019987 2004
% 220.54/220.72  |- skos__prefLabel mesh__D019987 Visually Impaired Persons
% 220.54/220.72  |- skos__scopeNote mesh__D019987
% 220.54/220.72       Persons with loss of vision such that there is an impact on activities of daily living.%A%    
% 220.54/220.72  |- mesh__dateEstablished mesh__D019987 1998-01-01
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D019987 2000
% 220.54/220.72  |- skos__hiddenLabel mesh__D019987 Blinds
% 220.54/220.72  |- mesh__dateCreated mesh__D019987 1997-06-20
% 220.54/220.72  |- mesh__publicMeSHNote mesh__D019987 98   
% 220.54/220.72  |- skos__broader mesh__D019987smesh__D006233
% 220.54/220.72  |- mesh__dateCreated mesh__D019189 1996-02-12
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D019189 2003
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D019189 1999
% 220.54/220.72  |- skos__hiddenLabel mesh__D019189 Iron Metabolism Disorder
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D019189 2004
% 220.54/220.72  |- skos__annotation mesh__D019189
% 220.54/220.72       GEN or unspecified; prefer specifics; DF: IRON METAB DIS   
% 220.54/220.72  |- skos__hiddenLabel mesh__D019189 Disorder, Iron Metabolism
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D019189 2005
% 220.54/220.72  |- skos__hiddenLabel mesh__D019189 Disorders, Iron Metabolism
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D019189 2000
% 220.54/220.72  |- skos__prefLabel mesh__D019189 Iron Metabolism Disorders
% 220.54/220.72  |- mesh__historyNote mesh__D019189 97   
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D019189 2006
% 220.54/220.72  |- mesh__dateEstablished mesh__D019189 1997-01-01
% 220.54/220.72  |- skos__hiddenLabel mesh__D019189 Metabolism Disorder, Iron
% 220.54/220.72  |- rdf__type mesh__D019189sskos__Concept
% 220.54/220.72  |- skos__historyNote mesh__D019189 Iron/metabolism %28%1966-1996%29%
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D019189 2001
% 220.54/220.72  |- skos__broader mesh__D019189smesh__D008659
% 220.54/220.72  |- skos__hiddenLabel mesh__D019189 Metabolism Disorders, Iron
% 220.54/220.72  |- skos__scopeNote mesh__D019189
% 220.54/220.72       Disorders in the processing of iron in the body: its absorption, transport, storage, and utilization. %28%From Mosby%27%s Medical, Nursing, %26% Allied Health Dictionary, 4th ed%29%%A%    
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D019189 1997
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D019189 1998
% 220.54/220.72  |- mesh__publicMeSHNote mesh__D019189 97   
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D019189 2002
% 220.54/220.72  |- skos__historyNote mesh__D005967 Proteins %28%1966-1976%29%
% 220.54/220.72  |- mesh__recordAuthorizer mesh__D005967 sjn
% 220.54/220.72  |- skos__altLabel mesh__D005967 Drosophila Glue Proteins
% 220.54/220.72  |- skos__scopeNote mesh__D005967
% 220.54/220.72       Glycosylated proteins which are part of the salivary glue that Drosophila larvae secrete as a means of fixing themselves to an external substrate for the duration of the pre-pupal and pupal period. The proteins which consist of at least eight polypeptides that are expressed during the third larval instar.%A%    
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D005967 2006
% 220.54/220.72  |- rdf__type mesh__D005967sskos__Concept
% 220.54/220.72  |- skos__prefLabel mesh__D005967 Glue Proteins, Drosophila
% 220.54/220.72  |- skos__hiddenLabel mesh__D005967 Drosophila Glue Protein
% 220.54/220.72  |- mesh__recordMaintainer mesh__D005967 SYSTEM
% 220.54/220.72  |- skos__hiddenLabel mesh__D005967 Protein, Drosophila Glue
% 220.54/220.72  |- skos__broader mesh__D005967smesh__D029721
% 220.54/220.72  |- mesh__historyNote mesh__D005967
% 220.54/220.72       91%28%88%29%; was see under SALIVARY PROTEINS 1988-90   
% 220.54/220.72  |- skos__historyNote mesh__D005967 Salivary Proteins %28%1977-1987%29%
% 220.54/220.72  |- mesh__dateCreated mesh__D005967 1987-05-05
% 220.54/220.72  |- mesh__dateEstablished mesh__D005967 1991-01-01
% 220.54/220.72  |- mesh__publicMeSHNote mesh__D005967
% 220.54/220.72       91; was see under SALIVARY PROTEINS 1988-90   
% 220.54/220.72  |- mesh__dateRevised mesh__D005967 2005-06-30
% 220.54/220.72  |- skos__broader mesh__D005967smesh__D012471
% 220.54/220.72  |- skos__hiddenLabel mesh__D005967 Proteins, Drosophila Glue
% 220.54/220.72  |- mesh__recordOriginator mesh__D005967 RLS
% 220.54/220.72  |- skos__annotation mesh__D005967 DF: DME GLUE PROTEINS   
% 220.54/220.72  |- skos__broader mesh__D005169smesh__D001779
% 220.54/220.72  |- mesh__recordOriginator mesh__D005169 NLM
% 220.54/220.72  |- skos__hiddenLabel mesh__D005169 HumateP
% 220.54/220.72  |- skos__hiddenLabel mesh__D005169 Factor VIII Heavy Chain
% 220.54/220.72  |- skos__altLabel mesh__D005169 Blood Coagulation Factor VIII
% 220.54/220.72  |- skos__altLabel mesh__D005169 Hyate-C
% 220.54/220.72  |- skos__altLabel mesh__D005169 Thromboplastinogen
% 220.54/220.72  |- rdf__type mesh__D005169sskos__Concept
% 220.54/220.72  |- skos__scopeNote mesh__D005169
% 220.54/220.72       Blood-coagulation factor VIII. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin.%A%    
% 220.54/220.72  |- skos__hiddenLabel mesh__D005169 Factor VIII, Coagulation
% 220.54/220.72  |- skos__altLabel mesh__D005169 Coagulation Factor VIII
% 220.54/220.72  |- skos__hiddenLabel mesh__D005169 VIII, Coagulation Factor
% 220.54/220.72  |- skos__hiddenLabel mesh__D005169 HyateC
% 220.54/220.72  |- mesh__recordMaintainer mesh__D005169 ssb
% 220.54/220.72  |- mesh__dateRevised mesh__D005169 2005-06-30
% 220.54/220.72  |- skos__altLabel mesh__D005169 F VIII-C
% 220.54/220.72  |- skos__hiddenLabel mesh__D005169 Humate P
% 220.54/220.72  |- skos__hiddenLabel mesh__D005169 HyattC
% 220.54/220.72  |- skos__altLabel mesh__D005169 Hemofil HM
% 220.54/220.72  |- skos__altLabel mesh__D005169 Hemophil
% 220.54/220.72  |- skos__altLabel mesh__D005169 Factor VIII Clotting Antigen
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D005169 2006
% 220.54/220.72  |- skos__related mesh__D005169smesh__D003029
% 220.54/220.72  |- skos__annotation mesh__D005169 a blood coag factor   
% 220.54/220.72  |- skos__altLabel mesh__D005169 Hemofil M
% 220.54/220.72  |- mesh__recordAuthorizer mesh__D005169 sjn
% 220.54/220.72  |- mesh__dateCreated mesh__D005169 1999-01-01
% 220.54/220.72  |- skos__hiddenLabel mesh__D005169 Hyatt C
% 220.54/220.72  |- skos__hiddenLabel mesh__D005169 Hyate C
% 220.54/220.72  |- skos__hiddenLabel mesh__D005169 F VIII C
% 220.54/220.72  |- skos__prefLabel mesh__D005169 Factor VIII
% 220.54/220.72  |- skos__altLabel mesh__D005169 Antihemophilic Factor
% 220.54/220.72  |- skos__scopeNote mesh__D010303
% 220.54/220.72       An oligosaccharide antibiotic produced by various STREPTOMYCES.%A%    
% 220.54/220.72  |- rdf__type mesh__D010303sskos__Concept
% 220.54/220.72  |- mesh__recordMaintainer mesh__D010303 lkw
% 220.54/220.72  |- skos__altLabel mesh__D010303 Pfizer Brand of Paromomycin Sulfate
% 220.54/220.72  |- skos__hiddenLabel mesh__D010303
% 220.54/220.72       Paromomycin, beta D Glucopyranosyl Isomer
% 220.54/220.72  |- mesh__recordOriginator mesh__D010303 NLM
% 220.54/220.72  |- skos__altLabel mesh__D010303 Catenulin
% 220.54/220.72  |- skos__altLabel mesh__D010303 Monarch Brand of Paromomycin Sulfate
% 220.54/220.72  |- skos__altLabel mesh__D010303 Aminosidine
% 220.54/220.72  |- skos__altLabel mesh__D010303 Parke Davis Brand of Paromomycin Sulfate
% 220.54/220.72  |- skos__altLabel mesh__D010303 Paramomycin
% 220.54/220.72  |- skos__altLabel mesh__D010303 Hydroxymycin
% 220.54/220.72  |- mesh__recordAuthorizer mesh__D010303 sjn
% 220.54/220.72  |- skos__altLabel mesh__D010303 Estomycin
% 220.54/220.72  |- skos__broader mesh__D010303smesh__D009355
% 220.54/220.72  |- skos__prefLabel mesh__D010303 Paromomycin
% 220.54/220.72  |- skos__altLabel mesh__D010303 Cheminova Brand of Paromomycin Sulfate
% 220.54/220.72  |- mesh__dateCreated mesh__D010303 1999-01-01
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D010303 2006
% 220.54/220.72  |- skos__hiddenLabel mesh__D010303 beta-D-Glucopyranosyl-Isomer Paromomycin
% 220.54/220.72  |- skos__hiddenLabel mesh__D010303 Sulfate, Paromomycin
% 220.54/220.72  |- mesh__dateRevised mesh__D010303 2005-06-30
% 220.54/220.72  |- skos__hiddenLabel mesh__D010303 Phosphate, Paromomycin
% 220.54/220.72  |- skos__altLabel mesh__D010303 Neomycin E
% 220.54/220.72  |- rdf__type mesh__D015597sskos__Concept
% 220.54/220.72  |- mesh__historyNote mesh__D015597 93   
% 220.54/220.72  |- skos__broader mesh__D015597smesh__D011251
% 220.54/220.72  |- mesh__recordMaintainer mesh__D015597 lkt
% 220.54/220.72  |- skos__hiddenLabel mesh__D015597 Pregnancies, Parasitic Complications
% 220.54/220.72  |- mesh__dateRevised mesh__D015597 2005-06-30
% 220.54/220.72  |- skos__hiddenLabel mesh__D015597 Parasitic Pregnancy Complication
% 220.54/220.72  |- skos__hiddenLabel mesh__D015597 Parasitic Complications Pregnancies
% 220.54/220.72  |- skos__historyNote mesh__D015597
% 220.54/220.72       Pregnancy Complications, Infectious %28%1966-1992%29%
% 220.54/220.72  |- skos__altLabel mesh__D015597 Pregnancy, Parasitic Complications
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D015597 2006
% 220.54/220.72  |- mesh__dateCreated mesh__D015597 1992-05-22
% 220.54/220.72  |- mesh__recordOriginator mesh__D015597 PLS
% 220.54/220.72  |- skos__altLabel mesh__D015597 Parasitic Pregnancy Complications
% 220.54/220.72  |- skos__hiddenLabel mesh__D015597 Complications Pregnancy, Parasitic
% 220.54/220.72  |- skos__annotation mesh__D015597
% 220.54/220.72       coordinate IM with specific parasitic disease %28%IM%29%; check the tags FEMALE %26% PREGNANCY; Manual 18.4.7; DF: PREGN COMPL PARASITIC%A%  
% 220.54/220.72  |- skos__hiddenLabel mesh__D015597 Parasitic Complications Pregnancy
% 220.54/220.72  |- skos__altLabel mesh__D015597 Complications, Parasitic Pregnancy
% 220.54/220.72  |- skos__hiddenLabel mesh__D015597 Complication, Parasitic Pregnancy
% 220.54/220.72  |- skos__broader mesh__D015597smesh__D010272
% 220.54/220.72  |- skos__hiddenLabel mesh__D015597 Complications Pregnancies, Parasitic
% 220.54/220.72  |- mesh__recordAuthorizer mesh__D015597 sjn
% 220.54/220.72  |- skos__hiddenLabel mesh__D015597 Pregnancy Complication, Parasitic
% 220.54/220.72  |- mesh__dateEstablished mesh__D015597 1993-01-01
% 220.54/220.72  |- skos__scopeNote mesh__D015597
% 220.54/220.72       The co-occurrence of pregnancy and parasitic diseases. The parasitic infection may precede or follow FERTILIZATION.%A%    
% 220.54/220.72  |- mesh__publicMeSHNote mesh__D015597 93   
% 220.54/220.72  |- skos__prefLabel mesh__D015597 Pregnancy Complications, Parasitic
% 220.54/220.72  |- mesh__recordOriginator mesh__D001577 NLM
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D001577 2000
% 220.54/220.72  |- mesh__dateEstablished mesh__D001577 1968-01-01
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D001577 1995
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D001577 1996
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D001577 2004
% 220.54/220.72  |- skos__historyNote mesh__D001577 Ketones %28%1966-1967%29%
% 220.54/220.72  |- skos__prefLabel mesh__D001577 Benzophenones
% 220.54/220.72  |- skos__broader mesh__D001577smesh__D007659
% 220.54/220.72  |- mesh__dateCreated mesh__D001577 1999-01-01
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D001577 2001
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D001577 1997
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D001577 2005
% 220.54/220.72  |- mesh__historyNote mesh__D001577 68   
% 220.54/220.72  |- mesh__publicMeSHNote mesh__D001577 68   
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D001577 2002
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D001577 1998
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D001577 2006
% 220.54/220.72  |- mesh__dateRevised mesh__D001577 1992-05-08
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D001577 1993
% 220.54/220.72  |- rdf__type mesh__D001577sskos__Concept
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D001577 1999
% 220.54/220.72  |- mesh__activeMeSHYear mesh__D001577 1994
% 220.54/220.72  |- mesh__recordMaintainer mesh__D001577 TGC
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D001577 2003
% 220.54/220.73  |- mesh__recordAuthorizer mesh__D001577 PLS
% 220.54/220.73  |- skos__altLabel mesh__D020731 Laser Intrastromal Keratomileusis
% 220.54/220.73  |- skos__hiddenLabel mesh__D020731 Intrastromal Keratomileuses, Laser
% 220.54/220.73  |- mesh__recordAuthorizer mesh__D020731 jls
% 220.54/220.73  |- skos__altLabel mesh__D020731
% 220.54/220.73       Laser-Assisted Stromal In Situ Keratomileusis
% 220.54/220.73  |- mesh__recordMaintainer mesh__D020731 jls
% 220.54/220.73  |- skos__altLabel mesh__D020731 Laser In Situ Keratomileusis
% 220.54/220.73  |- skos__hiddenLabel mesh__D020731
% 220.54/220.73       Laser Assisted Stromal In Situ Keratomileusis
% 220.54/220.73  |- mesh__dateRevised mesh__D020731 2004-07-28
% 220.54/220.73  |- mesh__recordOriginator mesh__D020731 ndw
% 220.54/220.73  |- skos__broader mesh__D020731smesh__D013508
% 220.54/220.73  |- skos__hiddenLabel mesh__D020731 Intrastromal Keratomileusis, Laser
% 220.54/220.73  |- mesh__dateCreated mesh__D020731 1999-11-03
% 220.54/220.73  |- skos__hiddenLabel mesh__D020731 Laser Intrastromal Keratomileuses
% 220.54/220.73  |- rdf__type mesh__D020731sskos__Concept
% 220.54/220.73  |- skos__prefLabel mesh__D020731 Keratomileusis, Laser In Situ
% 220.54/220.73  |- mesh__publicMeSHNote mesh__D020731 2000   
% 220.54/220.73  |- mesh__dateEstablished mesh__D020731 2000-01-01
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D020731 2006
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D020731 2005A
% 220.54/220.73  |- skos__historyNote mesh__D020731 Cornea/surgery %28%1995-1999%29%
% 220.54/220.73  |- skos__scopeNote mesh__D020731
% 220.54/220.73       A surgical procedure to correct MYOPIA by CORNEAL STROMA subtraction. It involves the use of a microkeratome to make a lamellar dissection of the CORNEA creating a flap with intact CORNEAL EPITHELIUM. After the flap is lifted, the underlying midstroma is reshaped with an excimer laser and the flap is returned to its original position.%A%    
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D020731 2005
% 220.54/220.73  |- skos__altLabel mesh__D020731 LASIK
% 220.54/220.73  |- skos__broader mesh__D020731smesh__D048988
% 220.54/220.73  |- mesh__historyNote mesh__D020731 2000   
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D006262 2006
% 220.54/220.73  |- mesh__recordOriginator mesh__D006262 NLM
% 220.54/220.73  |- skos__prefLabel mesh__D006262 Health
% 220.54/220.73  |- skos__altLabel mesh__D006262 Normalcy
% 220.54/220.73  |- skos__hiddenLabel mesh__D006262 Normalities
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D006262 2003
% 220.54/220.73  |- mesh__recordMaintainer mesh__D006262 jls
% 220.54/220.73  |- mesh__dateRevised mesh__D006262 2002-07-03
% 220.54/220.73  |- rdf__type mesh__D006262sskos__Concept
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D006262 2004
% 220.54/220.73  |- skos__broader mesh__D006262smesh__D011154
% 220.54/220.73  |- skos__scopeNote mesh__D006262
% 220.54/220.73       The state of the organism when it functions optimally without evidence of disease.%A%    
% 220.54/220.73  |- mesh__recordAuthorizer mesh__D006262 sjn
% 220.54/220.73  |- mesh__dateCreated mesh__D006262 1999-01-01
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D006262 2005
% 220.54/220.73  |- mesh__dateEstablished mesh__D019988 1998-01-01
% 220.54/220.73  |- mesh__recordOriginator mesh__D019988 JLS
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D019988 2006
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D019988 2003
% 220.54/220.73  |- skos__altLabel mesh__D019988 Children, Disabled
% 220.54/220.73  |- mesh__dateCreated mesh__D019988 1997-06-20
% 220.54/220.73  |- mesh__publicMeSHNote mesh__D019988 98   
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D019988 2004
% 220.54/220.73  |- skos__hiddenLabel mesh__D019988 Children with Disability
% 220.54/220.73  |- mesh__recordMaintainer mesh__D019988 JLS
% 220.54/220.73  |- skos__hiddenLabel mesh__D019988 Children, Handicapped
% 220.54/220.73  |- skos__hiddenLabel mesh__D019988 Disability, Children with
% 220.54/220.73  |- skos__broader mesh__D019988smesh__D006233
% 220.54/220.73  |- skos__altLabel mesh__D019988 Handicapped Children
% 220.54/220.73  |- skos__hiddenLabel mesh__D019988 Disabled Child
% 220.54/220.73  |- rdf__type mesh__D019988sskos__Concept
% 220.54/220.73  |- skos__scopeNote mesh__D019988
% 220.54/220.73       Children with mental or physical disabilities that interfere with usual activities of daily living and that may require accommodation or intervention.%A%    
% 220.54/220.73  |- mesh__dateRevised mesh__D019988 2002-07-03
% 220.54/220.73  |- skos__annotation mesh__D019988
% 220.54/220.73       coord with type of disability if given %28%e.g. HEARING IMPAIRED PERSONS%29% + appropriate check tag%A%  
% 220.54/220.73  |- mesh__recordAuthorizer mesh__D019988 sjn
% 220.54/220.73  |- mesh__historyNote mesh__D019988 98   
% 220.54/220.73  |- skos__altLabel mesh__D019988 Child, Disabled
% 220.54/220.73  |- skos__prefLabel mesh__D019988 Disabled Children
% 220.54/220.73  |- skos__altLabel mesh__D019988 Children with Disabilities
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D019988 2005
% 220.54/220.73  |- mesh__dateCreated mesh__D005968 1974-11-19
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D005968 2005
% 220.54/220.73  |- skos__historyNote mesh__D005968 Glutamates %28%1973-1974%29%
% 220.54/220.73  |- skos__prefLabel mesh__D005968 Glutamate Decarboxylase
% 220.54/220.73  |- mesh__publicMeSHNote mesh__D005968
% 220.54/220.73       84; was see under CARBOXY-LYASES 1975-83   
% 220.54/220.73  |- mesh__recordMaintainer mesh__D005968 ssb
% 220.54/220.73  |- skos__hiddenLabel mesh__D005968 Acid Decarboxylase, Glutamic
% 220.54/220.73  |- rdf__type mesh__D005968sskos__Concept
% 220.54/220.73  |- skos__scopeNote mesh__D005968
% 220.54/220.73       A pyridoxal-phosphate protein that catalyzes the alpha-decarboxylation of L-glutamic acid to form gamma-aminobutyric acid and carbon dioxide. The enzyme is found in bacteria and in invertebrate and vertebrate nervous systems. It is the rate-limiting enzyme in determining GAMMA-AMINOBUTYRIC ACID levels in normal nervous tissues. The brain enzyme also acts on L-cysteate, L-cysteine sulfinate, and L-aspartate. EC 4.1.1.15.%A%    
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D005968 2006
% 220.54/220.73  |- mesh__dateEstablished mesh__D005968 1984-01-01
% 220.54/220.73  |- skos__broader mesh__D005968smesh__D002262
% 220.54/220.73  |- skos__altLabel mesh__D005968 Glutamate Carboxy-Lyase
% 220.54/220.73  |- skos__altLabel mesh__D005968 Glutamic Acid Decarboxylase
% 220.54/220.73  |- mesh__recordAuthorizer mesh__D005968 sjn
% 220.54/220.73  |- skos__hiddenLabel mesh__D005968 Glutamate Carboxy Lyase
% 220.54/220.73  |- skos__hiddenLabel mesh__D005968 Decarboxylase, Glutamic Acid
% 220.54/220.73  |- mesh__dateRevised mesh__D005968 2003-07-09
% 220.54/220.73  |- skos__historyNote mesh__D005968 Carboxy-Lyases %28%1973-1974%29%
% 220.54/220.73  |- mesh__historyNote mesh__D005968
% 220.54/220.73       84%28%75%29%; was see under CARBOXY-LYASES 1975-83   
% 220.54/220.73  |- mesh__recordOriginator mesh__D005968 NLM
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D005968 2004
% 220.54/220.73  |- skos__hiddenLabel mesh__D005968 Decarboxylase, Glutamate
% 220.54/220.73  |- skos__hiddenLabel mesh__D005968 Carboxy-Lyase, Glutamate
% 220.54/220.73  |- skos__prefLabel mesh__D030361 Papillomavirus Infections
% 220.54/220.73  |- skos__historyNote mesh__D030361 DNA Virus Infections %28%1992-2001%29%
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D030361 2003
% 220.54/220.73  |- mesh__dateEstablished mesh__D030361 2002-01-01
% 220.54/220.73  |- skos__broader mesh__D030361smesh__D004266
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D030361 2004
% 220.54/220.73  |- mesh__dateCreated mesh__D030361 2001-07-25
% 220.54/220.73  |- skos__historyNote mesh__D030361 Tumor Virus Infections %28%1966-1993%29%
% 220.54/220.73  |- skos__hiddenLabel mesh__D030361 Papillomavirus Infection
% 220.54/220.73  |- skos__broader mesh__D030361smesh__D014412
% 220.54/220.73  |- rdf__type mesh__D030361sskos__Concept
% 220.54/220.73  |- mesh__historyNote mesh__D030361 2002   
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D030361 2005
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D030361 2006
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D030361 2002
% 220.54/220.73  |- mesh__publicMeSHNote mesh__D030361 2002   
% 220.54/220.73  |- skos__scopeNote mesh__D030361
% 220.54/220.73       Neoplasms of the skin and mucous membranes caused by papillomaviruses. They are usually benign but some have a high risk for malignant progression.%A%    
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D002670 2003
% 220.54/220.73  |- mesh__recordMaintainer mesh__D002670 PXP
% 220.54/220.73  |- mesh__dateRevised mesh__D002670 2002-07-02
% 220.54/220.73  |- skos__hiddenLabel mesh__D002670 Adolescents, Abandoned
% 220.54/220.73  |- skos__hiddenLabel mesh__D002670 Abandoned Adolescents
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D002670 2005
% 220.54/220.73  |- skos__hiddenLabel mesh__D002670 Abandoned Child
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D002670 2004
% 220.54/220.73  |- mesh__publicMeSHNote mesh__D002670 72   
% 220.54/220.73  |- skos__altLabel mesh__D002670 Children, Abandoned
% 220.54/220.73  |- mesh__historyNote mesh__D002670 72%28%69%29%   
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D002670 2006
% 220.54/220.73  |- mesh__dateEstablished mesh__D002670 1972-01-01
% 220.54/220.73  |- skos__hiddenLabel mesh__D002670 Abandoned Adolescent
% 220.54/220.73  |- skos__scopeNote mesh__D002670
% 220.54/220.73       A child or adolescent who is deserted by parents or parent substitutes without regard for its future care.%A%    
% 220.54/220.73  |- mesh__recordOriginator mesh__D002670 NLM
% 220.54/220.73  |- skos__prefLabel mesh__D002670 Child, Abandoned
% 220.54/220.73  |- skos__broader mesh__D002670smesh__D009272
% 220.54/220.73  |- skos__historyNote mesh__D002670 Child %28%1966-1968%29%
% 220.54/220.73  |- mesh__dateCreated mesh__D002670 1999-01-01
% 220.54/220.73  |- skos__annotation mesh__D002670 check also tag CHILD or specific   
% 220.54/220.73  |- mesh__recordAuthorizer mesh__D002670 sjn
% 220.54/220.73  |- skos__hiddenLabel mesh__D002670 Abandoned Children
% 220.54/220.73  |- rdf__type mesh__D002670sskos__Concept
% 220.54/220.73  |- skos__hiddenLabel mesh__D010304 Paronychias
% 220.54/220.73  |- skos__broader mesh__D010304smesh__D009260
% 220.54/220.73  |- skos__broader mesh__D010304smesh__D012874
% 220.54/220.73  |- skos__annotation mesh__D010304
% 220.54/220.73       infect dis of skin surrounding nail; coord IM with specific infect %28%IM%29%%A%  
% 220.54/220.73  |- mesh__recordOriginator mesh__D010304 NLM
% 220.54/220.73  |- skos__scopeNote mesh__D010304
% 220.54/220.73       An inflammatory reaction involving the folds of the skin surrounding the fingernail. It is characterized by acute or chronic purulent, tender, and painful swellings of the tissues around the nail, caused by an abscess of the nail fold. The pathogenic yeast causing paronychia is most frequently Candida albicans. Saprophytic fungi may also be involved. The causative bacteria are usually Staphylococcus, Pseudomonas aeruginosa, or Streptococcus. %28%Andrews%27% Diseases of the Skin, 8th ed, p271%29%%A%    
% 220.54/220.73  |- mesh__dateCreated mesh__D010304 1999-01-01
% 220.54/220.73  |- mesh__dateRevised mesh__D010304 2001-07-25
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D010304 2006
% 220.54/220.73  |- mesh__recordAuthorizer mesh__D010304 sjn
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D010304 2002
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D010304 2004
% 220.54/220.73  |- skos__prefLabel mesh__D010304 Paronychia
% 220.54/220.73  |- mesh__recordMaintainer mesh__D010304 lkt
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D010304 2005
% 220.54/220.73  |- rdf__type mesh__D010304sskos__Concept
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D010304 2003
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D001578 2006
% 220.54/220.73  |- mesh__dateRevised mesh__D001578 2005-06-30
% 220.54/220.73  |- rdf__type mesh__D001578sskos__Concept
% 220.54/220.73  |- mesh__recordOriginator mesh__D001578 NLM
% 220.54/220.73  |- skos__broader mesh__D001578smesh__D006574
% 220.54/220.73  |- skos__broader mesh__D001578smesh__D011714
% 220.54/220.73  |- mesh__dateEstablished mesh__D001578 1966-01-01
% 220.54/220.73  |- mesh__publicMeSHNote mesh__D001578 66   
% 220.54/220.73  |- mesh__recordAuthorizer mesh__D001578 sjn
% 220.54/220.73  |- skos__prefLabel mesh__D001578 Benzopyrans
% 220.54/220.73  |- mesh__recordMaintainer mesh__D001578 ssb
% 220.54/220.73  |- skos__annotation mesh__D001578 do not confuse with BENZOPYRENES   
% 220.54/220.73  |- mesh__dateCreated mesh__D001578 1999-01-01
% 220.54/220.73  |- skos__altLabel mesh__D001578 Chromenes
% 220.54/220.73  |- mesh__historyNote mesh__D001578 66   
% 220.54/220.73  |- skos__scopeNote mesh__D001578
% 220.54/220.73       Compounds with a core of fused benzo-pyran rings.     
% 220.54/220.73  |- skos__hiddenLabel mesh__D020732 Techniques, Molecular Cytogenetic
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D020732 2003
% 220.54/220.73  |- skos__hiddenLabel mesh__D020732 Analyses, Cytogenetic
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D020732 2002
% 220.54/220.73  |- skos__hiddenLabel mesh__D020732 Technic, Molecular Cytogenetic
% 220.54/220.73  |- skos__related mesh__D020732smesh__D002874
% 220.54/220.73  |- skos__related mesh__D020732smesh__D005820
% 220.54/220.73  |- skos__broader mesh__D020732smesh__D005821
% 220.54/220.73  |- skos__hiddenLabel mesh__D020732 Technique, Molecular Cytogenetic
% 220.54/220.73  |- mesh__recordMaintainer mesh__D020732 nns
% 220.54/220.73  |- skos__altLabel mesh__D020732 Molecular Cytogenetic Techniques
% 220.54/220.73  |- skos__altLabel mesh__D020732 Cytogenetic Technics
% 220.54/220.73  |- mesh__publicMeSHNote mesh__D020732 2000   
% 220.54/220.73  |- skos__hiddenLabel mesh__D020732 Cytogenetic Technique
% 220.54/220.73  |- skos__altLabel mesh__D020732 Cytogenetic Techniques
% 220.54/220.73  |- skos__hiddenLabel mesh__D020732 Cytogenetic Technics, Molecular
% 220.54/220.73  |- skos__hiddenLabel mesh__D020732 Analysis, Cytogenetic
% 220.54/220.73  |- skos__hiddenLabel mesh__D020732 Molecular Cytogenetic Technic
% 220.54/220.73  |- skos__hiddenLabel mesh__D020732 Molecular Cytogenetic Technique
% 220.54/220.73  |- skos__hiddenLabel mesh__D020732 Cytogenetic Technique, Molecular
% 220.54/220.73  |- skos__broader mesh__D020732smesh__D003584
% 220.54/220.73  |- skos__prefLabel mesh__D020732 Cytogenetic Analysis
% 220.54/220.73  |- skos__hiddenLabel mesh__D020732 Techniques, Cytogenetic
% 220.54/220.73  |- skos__hiddenLabel mesh__D020732 Cytogenetic Analyses
% 220.54/220.73  |- mesh__dateEstablished mesh__D020732 2000-01-01
% 220.54/220.73  |- skos__related mesh__D020732smesh__D002869
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D020732 2006
% 220.54/220.73  |- mesh__historyNote mesh__D020732 2000   
% 220.54/220.73  |- skos__historyNote mesh__D020732 Genetic Techniques %28%1967-1999%29%
% 220.54/220.73  |- skos__altLabel mesh__D020732 Molecular Cytogenetic Technics
% 220.54/220.73  |- skos__hiddenLabel mesh__D020732 Technic, Cytogenetic
% 220.54/220.73  |- skos__hiddenLabel mesh__D020732 Cytogenetic Techniques, Molecular
% 220.54/220.73  |- skos__hiddenLabel mesh__D020732 Cytogenetic Technic
% 220.54/220.73  |- mesh__dateRevised mesh__D020732 2001-07-25
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D020732 2005
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D020732 2004
% 220.54/220.73  |- mesh__recordAuthorizer mesh__D020732 sjn
% 220.54/220.73  |- skos__hiddenLabel mesh__D020732 Technics, Cytogenetic
% 220.54/220.73  |- skos__hiddenLabel mesh__D020732 Technics, Molecular Cytogenetic
% 220.54/220.73  |- skos__hiddenLabel mesh__D020732 Cytogenetic Technic, Molecular
% 220.54/220.73  |- mesh__dateCreated mesh__D020732 1999-11-03
% 220.54/220.73  |- skos__related mesh__D020732smesh__D025202
% 220.54/220.73  |- skos__scopeNote mesh__D020732
% 220.54/220.73       Examination of chromosomes to diagnose, classify, screen for, or manage genetic diseases and abnormalities. Following preparation of the sample, KARYOTYPING is performed and/or the specific chromosomes are analyzed.%A%    
% 220.54/220.73  |- skos__hiddenLabel mesh__D020732 Technique, Cytogenetic
% 220.54/220.73  |- skos__historyNote mesh__D020732 Cytological Techniques %28%1971-1999%29%
% 220.54/220.73  |- mesh__recordOriginator mesh__D020732 ags
% 220.54/220.73  |- skos__related mesh__D020732smesh__D003582
% 220.54/220.73  |- rdf__type mesh__D020732sskos__Concept
% 220.54/220.73  |- skos__altLabel mesh__D019989 Mentally Disabled
% 220.54/220.73  |- mesh__recordAuthorizer mesh__D019989 sjn
% 220.54/220.73  |- skos__prefLabel mesh__D019989 Mentally Disabled Persons
% 220.54/220.73  |- mesh__recordMaintainer mesh__D019989 sjn
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D019989 2004
% 220.54/220.73  |- mesh__dateEstablished mesh__D019989 1998-01-01
% 220.54/220.73  |- skos__related mesh__D019989smesh__D008607
% 220.54/220.73  |- skos__hiddenLabel mesh__D019989 Disabled, Mentally
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D019989 2003A
% 220.54/220.73  |- skos__broader mesh__D019989smesh__D006233
% 220.54/220.73  |- skos__hiddenLabel mesh__D019989 Persons, Mentally Disabled
% 220.54/220.73  |- rdf__type mesh__D019989sskos__Concept
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D019989 2000
% 220.54/220.73  |- skos__scopeNote mesh__D019989
% 220.54/220.73       Persons diagnosed as having significantly lower than average intelligence and considerable problems in adapting to everyday life or lacking independence in regard to activities of daily living.%A%    
% 220.54/220.73  |- mesh__dateCreated mesh__D019989 1997-06-20
% 220.54/220.73  |- mesh__publicMeSHNote mesh__D019989 98   
% 220.54/220.73  |- skos__hiddenLabel mesh__D019989 Mentally Disabled Person
% 220.54/220.73  |- skos__hiddenLabel mesh__D019989 Person, Mentally Disabled
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D019989 1999
% 220.54/220.73  |- skos__altLabel mesh__D019989 Mentally Handicapped
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D019989 2001
% 220.54/220.73  |- mesh__historyNote mesh__D019989 98   
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D019989 2005
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D019989 2002
% 220.54/220.73  |- skos__altLabel mesh__D019989 Mentally Retarded
% 220.54/220.73  |- mesh__dateRevised mesh__D019989 2002-09-24
% 220.54/220.73  |- mesh__recordOriginator mesh__D019989 JLS
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D019989 2006
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D019989 2003
% 220.54/220.73  |- skos__hiddenLabel mesh__D044382 Population, Indigenous
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D044382 2005
% 220.54/220.73  |- rdf__type mesh__D044382sskos__Concept
% 220.54/220.73  |- skos__hiddenLabel mesh__D044382 Group, Population
% 220.54/220.73  |- skos__broader mesh__D044382smesh__D003710
% 220.54/220.73  |- skos__scopeNote mesh__D044382
% 220.54/220.73       Individuals classified according to their sex, racial origin, religion, common place of living, financial or social status, or some other cultural or behavioral attribute. %28%UMLS, 2003%29%%A%    
% 220.54/220.73  |- skos__annotation mesh__D044382 GEN or unspecified; prefer specifics   
% 220.54/220.73  |- skos__prefLabel mesh__D044382 Population Groups
% 220.54/220.73  |- mesh__dateCreated mesh__D044382 2003-07-14
% 220.54/220.73  |- skos__broader mesh__D044382smesh__D009272
% 220.54/220.73  |- mesh__historyNote mesh__D044382 2004   
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D044382 2004
% 220.54/220.73  |- skos__altLabel mesh__D044382 Indigenous Population
% 220.54/220.73  |- mesh__recordMaintainer mesh__D044382 jls
% 220.54/220.73  |- mesh__publicMeSHNote mesh__D044382 2004   
% 220.54/220.73  |- mesh__recordAuthorizer mesh__D044382 sjn
% 220.54/220.73  |- skos__hiddenLabel mesh__D044382 Populations, Indigenous
% 220.54/220.73  |- skos__hiddenLabel mesh__D044382 Indigenous Populations
% 220.54/220.73  |- skos__hiddenLabel mesh__D044382 Native Born
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D044382 2006
% 220.54/220.73  |- mesh__recordOriginator mesh__D044382 jls
% 220.54/220.73  |- skos__altLabel mesh__D044382 Native-Born
% 220.54/220.73  |- skos__hiddenLabel mesh__D044382 Population Group
% 220.54/220.73  |- mesh__dateEstablished mesh__D044382 2004-01-01
% 220.54/220.73  |- skos__hiddenLabel mesh__D044382 Groups, Population
% 220.54/220.73  |- skos__scopeNote mesh__D005969
% 220.54/220.73       An enzyme that catalyzes the conversion of L-glutamate and water to 2-oxoglutarate and NH3 in the presence of NAD+. %28%From Enzyme Nomenclature, 1992%29% EC 1.4.1.2.%A%    
% 220.54/220.73  |- rdf__type mesh__D005969sskos__Concept
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D005969 2006
% 220.54/220.73  |- mesh__historyNote mesh__D005969 65   
% 220.54/220.73  |- skos__prefLabel mesh__D005969 Glutamate Dehydrogenase
% 220.54/220.73  |- mesh__dateRevised mesh__D005969 2005-06-30
% 220.54/220.73  |- mesh__dateEstablished mesh__D005969 1965-01-01
% 220.54/220.73  |- mesh__recordAuthorizer mesh__D005969 sjn
% 220.54/220.73  |- mesh__dateCreated mesh__D005969 1999-01-01
% 220.54/220.73  |- skos__hiddenLabel mesh__D005969 Dehydrogenase, Glutamate
% 220.54/220.73  |- mesh__publicMeSHNote mesh__D005969 65   
% 220.54/220.73  |- mesh__recordMaintainer mesh__D005969 jmp
% 220.54/220.73  |- skos__broader mesh__D005969smesh__D000594
% 220.54/220.73  |- mesh__recordOriginator mesh__D005969 NLM
% 220.54/220.73  |- mesh__historyNote mesh__D052016 2006   
% 220.54/220.73  |- skos__historyNote mesh__D052016 Stomatitis %28%1979-2005%29%
% 220.54/220.73  |- mesh__dateEstablished mesh__D052016 2006-01-01
% 220.54/220.73  |- skos__scopeNote mesh__D052016
% 220.54/220.73       An INFLAMMATION of the MUCOSA with burning or tingling sensation. It is characterized by atrophy of the squamous EPITHELIUM, vascular damage, inflammatory infiltration, and ulceration. It usually occurs at the mucous lining of the MOUTH, the GASTROINTESTINAL TRACT or the airway due to chemical irritations, CHEMOTHERAPY, or radiation therapy %28%RADIOTHERAPY%29%.%A%    
% 220.54/220.73  |- mesh__recordAuthorizer mesh__D052016 sjn
% 220.54/220.73  |- mesh__dateCreated mesh__D052016 2005-06-30
% 220.54/220.73  |- skos__prefLabel mesh__D052016 Mucositis
% 220.54/220.73  |- mesh__recordMaintainer mesh__D052016 lkt
% 220.54/220.73  |- skos__historyNote mesh__D052016 Mucous Membrane %28%1967-2005%29%
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D052016 2006
% 220.54/220.73  |- mesh__recordOriginator mesh__D052016 lkt
% 220.54/220.73  |- skos__broader mesh__D052016smesh__D009059
% 220.54/220.73  |- skos__broader mesh__D052016smesh__D005759
% 220.54/220.73  |- rdf__type mesh__D052016sskos__Concept
% 220.54/220.73  |- mesh__publicMeSHNote mesh__D052016 2006   
% 220.54/220.73  |- skos__hiddenLabel mesh__D052016 Mucositides
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D002671 2004
% 220.54/220.73  |- mesh__dateRevised mesh__D002671 2005-07-19
% 220.54/220.73  |- skos__altLabel mesh__D002671 Children, Exceptional
% 220.54/220.73  |- mesh__publicMeSHNote mesh__D002671
% 220.54/220.73       75; was see under CHILD, GIFTED %26% MENTAL RETARDATION 1969-74; was see under MENTAL RETARDATION %28%but EXCEPTIONAL CHILD was see under CHILD, GIFTED%29% 1968; was see under MENTAL RETARDATION 1967; was see under MENTAL DEFICIENCY 1966%A%  
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D002671 2006
% 220.54/220.73  |- skos__altLabel mesh__D002671 Exceptional Child
% 220.54/220.73  |- skos__related mesh__D002671smesh__D018479
% 220.54/220.73  |- mesh__recordMaintainer mesh__D002671 ags
% 220.54/220.73  |- skos__related mesh__D002671smesh__D008282
% 220.54/220.73  |- skos__prefLabel mesh__D002671 Child, Exceptional
% 220.54/220.73  |- mesh__dateCreated mesh__D002671 1999-01-01
% 220.54/220.73  |- skos__annotation mesh__D002671
% 220.54/220.73       consider also CHILD, GIFTED %26% MENTALLY DISABLED PERSONS; check also tag CHILD or specific%A%  
% 220.54/220.73  |- mesh__onlineNote mesh__D002671
% 220.54/220.73       search CHILD, GIFTED %26% MENTAL RETARDATION 1968-74 %26% MENTAL RETARDATION 1966-67%A%  
% 220.54/220.73  |- mesh__dateEstablished mesh__D002671 1975-01-01
% 220.54/220.73  |- rdf__type mesh__D002671sskos__Concept
% 220.54/220.73  |- mesh__recordOriginator mesh__D002671 NLM
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D002671 2006A
% 220.54/220.73  |- mesh__recordAuthorizer mesh__D002671 ags
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D002671 2003
% 220.54/220.73  |- skos__hiddenLabel mesh__D002671 Exceptional Children
% 220.54/220.73  |- skos__broader mesh__D002671smesh__D011588
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D002671 2005
% 220.54/220.73  |- mesh__historyNote mesh__D002671
% 220.54/220.73       75; was see under CHILD, GIFTED %26% MENTAL RETARDATION 1969-74; was see under MENTAL RETARDATION %28%but EXCEPTIONAL CHILD was see under CHILD, GIFTED%29% 1968; was see under MENTAL RETARDATION 1967; was see under MENTAL DEFICIENCY 1966%A%  
% 220.54/220.73  |- skos__broader mesh__D002671smesh__D009272
% 220.54/220.73  |- skos__scopeNote mesh__D002671
% 220.54/220.73       A child whose needs, abilities, or other characteristics vary so much from the average in mental, physical, or social areas that a greater than usual level of services is needed to facilitate the child%27%s maximum potential development.%A%    
% 220.54/220.73  |- skos__broader mesh__D019266Q000737smesh__D019266
% 220.54/220.73  |- mesh__preferredCombination mesh__D019266Q000737smesh__D007501Q000737
% 220.54/220.73  |- rdf__type mesh__D019266Q000737smesh__CompoundConcept
% 220.54/220.73  |- skos__broader mesh__D007422Q000557smesh__D007422
% 220.54/220.73  |- mesh__preferredCombination mesh__D007422Q000557smesh__D007413Q000557
% 220.54/220.73  |- rdf__type mesh__D007422Q000557smesh__CompoundConcept
% 220.54/220.73  |- mesh__recordOriginator mesh__D010305 SMH
% 220.54/220.73  |- skos__historyNote mesh__D010305
% 220.54/220.73       Salivary Gland Diseases %28%1966-1979%29%
% 220.54/220.73  |- mesh__publicMeSHNote mesh__D010305 80   
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D010305 2000
% 220.54/220.73  |- mesh__dateCreated mesh__D010305 1979-04-27
% 220.54/220.73  |- skos__hiddenLabel mesh__D010305 Disease, Parotid
% 220.54/220.73  |- skos__prefLabel mesh__D010305 Parotid Diseases
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D010305 2005
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D010305 1994
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D010305 2001
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D010305 2003
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D010305 1992
% 220.54/220.73  |- mesh__dateEstablished mesh__D010305 1980-01-01
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D010305 2006
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D010305 2004
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D010305 1998
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D010305 1995
% 220.54/220.73  |- mesh__recordMaintainer mesh__D010305 PLS
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D010305 1991
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D010305 2002
% 220.54/220.73  |- skos__annotation mesh__D010305 inflamm dis = PAROTITIS   
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D010305 1993
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D010305 1996
% 220.54/220.73  |- skos__hiddenLabel mesh__D010305 Diseases, Parotid
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D010305 1999
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D010305 1997
% 220.54/220.73  |- mesh__recordAuthorizer mesh__D010305 NLM
% 220.54/220.73  |- rdf__type mesh__D010305sskos__Concept
% 220.54/220.73  |- skos__broader mesh__D010305smesh__D012466
% 220.54/220.73  |- skos__hiddenLabel mesh__D010305 Parotid Disease
% 220.54/220.73  |- mesh__dateRevised mesh__D010305 1990-05-29
% 220.54/220.73  |- mesh__historyNote mesh__D010305 80   
% 220.54/220.73  |- skos__historyNote mesh__D010305 Parotid Gland %28%1966-1979%29%
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D015599 1999
% 220.54/220.73  |- skos__prefLabel mesh__D015599 Trauma Severity Indices
% 220.54/220.73  |- rdf__type mesh__D015599sskos__Concept
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D015599 1993
% 220.54/220.73  |- mesh__publicMeSHNote mesh__D015599 90   
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D015599 1996
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D015599 1995
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D015599 2002
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D015599 1998
% 220.54/220.73  |- mesh__recordAuthorizer mesh__D015599 PLS
% 220.54/220.73  |- skos__hiddenLabel mesh__D015599 Indexes, Trauma Severity
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D015599 2004
% 220.54/220.73  |- mesh__historyNote mesh__D015599 90   
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D015599 1994
% 220.54/220.73  |- mesh__dateCreated mesh__D015599 1989-05-25
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D015599 2001
% 220.54/220.73  |- skos__hiddenLabel mesh__D015599 Index, Trauma Severity
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D015599 2006
% 220.54/220.73  |- skos__broader mesh__D015599smesh__D008919
% 220.54/220.73  |- mesh__recordMaintainer mesh__D015599 PLS
% 220.54/220.73  |- skos__altLabel mesh__D015599 Trauma Severity Index
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D015599 2003
% 220.54/220.73  |- skos__altLabel mesh__D015599 Trauma Severity Indexes
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D015599 2000
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D015599 2005
% 220.54/220.73  |- skos__broader mesh__D015599smesh__D008499
% 220.54/220.73  |- skos__annotation mesh__D015599
% 220.54/220.73       no qualif; do not confuse with TRIAGE, emerg selection of patients by priority of need; SEVERITY OF ILLNESS INDEX is also available%A%  
% 220.54/220.73  |- mesh__dateEstablished mesh__D015599 1990-01-01
% 220.54/220.73  |- skos__hiddenLabel mesh__D015599 Severity Index, Trauma
% 220.54/220.73  |- skos__hiddenLabel mesh__D015599 Severity Indices, Trauma
% 220.54/220.73  |- mesh__recordOriginator mesh__D015599 EGC
% 220.54/220.73  |- skos__hiddenLabel mesh__D015599 Indices, Trauma Severity
% 220.54/220.73  |- skos__scopeNote mesh__D015599
% 220.54/220.73       Systems for assessing, classifying, and coding injuries. These systems are used in medical records, surveillance systems, and state and national registries to aid in the collection and reporting of trauma.%A%    
% 220.54/220.73  |- mesh__dateRevised mesh__D015599 1992-05-22
% 220.54/220.73  |- skos__historyNote mesh__D015599
% 220.54/220.73       Wounds and Injuries/classification %28%1966-1989%29%
% 220.54/220.73  |- mesh__activeMeSHYear mesh__D015599 1997
% 220.54/220.73  |- skos__hiddenLabel mesh__D015599 Severity Indexes, Trauma
% 220.54/220.73  |- skos__prefLabel mesh__D001579 Benzopyrene Hydroxylase
% 220.54/220.73  |- rdf__type mesh__D001579sskos__Concept
% 220.54/220.73  |- mesh__dateCreated mesh__D001579 1974-11-11
% 220.54/220.73  |- skos__scopeNote mesh__D001579
% 220.54/220.73       A drug-metabolizing, cytochrome P-448 %28%P-450%29% enzyme which catalyzes the hydroxylation of benzopyrene to 3-hydroxybenzopyrene in the presence of reduced flavoprotein and molecular oxygen. Also acts on certain anthracene derivatives. An aspect of EC 1.14.14.1.%A%    
% 220.54/220.73  |- mesh__dateEstablished mesh__D001579 1991-01-01
% 220.54/220.73  |- mesh__publicMeSHNote mesh__D001579
% 220.54/220.73       91; was see under ARYL HYDROCARBON HYDROXYLASES 1977-90; was see under HYDROXYLASES 1975-76%A%  
% 220.54/220.73  |- skos__historyNote mesh__D001579 Hydroxylases %28%1968-1974%29%
% 220.54/220.73  |- skos__historyNote mesh__D001579 Benzopyrenes %28%1968-1974%29%
% 220.54/220.73  |- skos__altLabel mesh__D001579 Benzo%28%a%29%pyrene Monooxygenase
% 220.54/220.73  |- skos__altLabel mesh__D001579 Benzopyrene-3-Monooxygenase
% 220.54/220.74  |- skos__altLabel mesh__D001579 Benzo%28%a%29%pyrene Hydroxylase
% 220.54/220.74  |- skos__annotation mesh__D001579 a cytochrome   
% 220.54/220.74  |- mesh__historyNote mesh__D001579
% 220.54/220.74       91%28%75%29%; was see under ARYL HYDROCARBON HYDROXYLASES 1977-90; was see under HYDROXYLASES 1975-76%A%  
% 220.54/220.74  |- mesh__recordOriginator mesh__D001579 NLM
% 220.54/220.74  |- skos__hiddenLabel mesh__D001579 Benzopyrene 3 Monooxygenase
% 220.54/220.74  |- mesh__dateRevised mesh__D001579 2004-07-07
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D001579 2005
% 220.54/220.74  |- skos__broader mesh__D001579smesh__D001189
% 220.54/220.74  |- skos__hiddenLabel mesh__D001579 Hydroxylase, Benzopyrene
% 220.54/220.74  |- mesh__recordAuthorizer mesh__D001579 sjn
% 220.54/220.74  |- mesh__recordMaintainer mesh__D001579 ssb
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D001579 2006
% 220.54/220.74  |- skos__broader mesh__D001921Q000637smesh__D001921
% 220.54/220.74  |- mesh__preferredCombination mesh__D001921Q000637smesh__D016380
% 220.54/220.74  |- rdf__type mesh__D001921Q000637smesh__CompoundConcept
% 220.54/220.74  |- mesh__recordMaintainer mesh__D020733 nns
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D020733 2003
% 220.54/220.74  |- mesh__publicMeSHNote mesh__D020733
% 220.54/220.74       2000; SMALL CYTOPLASMIC RNA was indexed under RNA %28%NM%29% 1984-1999; for 7S RNA see RNA, SMALL NUCLEAR 1993-1999%A%  
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D020733 2001
% 220.54/220.74  |- skos__scopeNote mesh__D020733
% 220.54/220.74       Small RNAs found in the cytoplasm usually complexed with proteins in scRNPs %28%RIBONUCLEOPROTEINS, SMALL CYTOPLASMIC%29%.%A%    
% 220.54/220.74  |- mesh__recordAuthorizer mesh__D020733 sjn
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D020733 2004
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D020733 2005
% 220.54/220.74  |- mesh__dateCreated mesh__D020733 1999-11-03
% 220.54/220.74  |- rdf__type mesh__D020733sskos__Concept
% 220.54/220.74  |- mesh__historyNote mesh__D020733
% 220.54/220.74       2000; for SMALL CYTOPLASMIC RNA use RNA, SMALL CYTOPLASMIC %28%NM%29% 1984-1999; for 7S RNA use RNA, SMALL NUCLEAR 1993-1999%A%  
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D020733 2006
% 220.54/220.74  |- skos__historyNote mesh__D020733 Cytoplasm %28%1980-1999%29%
% 220.54/220.74  |- skos__historyNote mesh__D020733 RNA or specifics %28%1980-1999%29%
% 220.54/220.74  |- mesh__recordOriginator mesh__D020733 nns
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D020733 2002
% 220.54/220.74  |- skos__prefLabel mesh__D020733 RNA, Small Cytoplasmic
% 220.54/220.74  |- skos__altLabel mesh__D020733 scRNA
% 220.54/220.74  |- mesh__dateEstablished mesh__D020733 2000-01-01
% 220.54/220.74  |- skos__broader mesh__D020733smesh__D022661
% 220.54/220.74  |- skos__altLabel mesh__D020733 Small Cytoplasmic RNA
% 220.54/220.74  |- mesh__dateRevised mesh__D020733 2000-06-22
% 220.54/220.74  |- mesh__publicMeSHNote mesh__D006264
% 220.54/220.74       91; was see under INSURANCE, HEALTH 1975-90   
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D006264 2006
% 220.54/220.74  |- mesh__historyNote mesh__D006264
% 220.54/220.74       91%28%75%29%; was see under INSURANCE, HEALTH 1975-90   
% 220.54/220.74  |- skos__broader mesh__D006264smesh__D012456
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D006264 2001
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D006264 2000
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D006264 2005
% 220.54/220.74  |- skos__scopeNote mesh__D006264
% 220.54/220.74       Health insurance plans for employees, and generally including their dependents, usually on a cost-sharing basis with the employer paying a percentage of the premium.%A%    
% 220.54/220.74  |- skos__prefLabel mesh__D006264 Health Benefit Plans, Employee
% 220.54/220.74  |- mesh__recordAuthorizer mesh__D006264 sjn
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D006264 2004
% 220.54/220.74  |- mesh__onlineNote mesh__D006264 search INSURANCE, HEALTH 1968-74   
% 220.54/220.74  |- mesh__dateCreated mesh__D006264 1999-01-01
% 220.54/220.74  |- mesh__dateEstablished mesh__D006264 1991-01-01
% 220.54/220.74  |- rdf__type mesh__D006264sskos__Concept
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D006264 2003
% 220.54/220.74  |- mesh__recordOriginator mesh__D006264 NLM
% 220.54/220.74  |- skos__broader mesh__D006264smesh__D007348
% 220.54/220.74  |- skos__annotation mesh__D006264 specify geog if possible   
% 220.54/220.74  |- mesh__dateRevised mesh__D006264 1999-11-03
% 220.54/220.74  |- skos__altLabel mesh__D006264 Employee Health Benefit Plans
% 220.54/220.74  |- mesh__recordMaintainer mesh__D006264 kle
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D006264 2002
% 220.54/220.74  |- skos__prefLabel mesh__D044383 African Continental Ancestry Group
% 220.54/220.74  |- skos__annotation mesh__D044383 specify geog if pertinent   
% 220.54/220.74  |- skos__hiddenLabel mesh__D044383 Race, Negroid
% 220.54/220.74  |- skos__altLabel mesh__D044383 Negro
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D044383 2004
% 220.54/220.74  |- mesh__recordAuthorizer mesh__D044383 sjn
% 220.54/220.74  |- skos__broader mesh__D044383smesh__D044469
% 220.54/220.74  |- mesh__dateEstablished mesh__D044383 2004-01-01
% 220.54/220.74  |- mesh__publicMeSHNote mesh__D044383 2004   
% 220.54/220.74  |- skos__hiddenLabel mesh__D044383 Races, Negroid
% 220.54/220.74  |- mesh__recordOriginator mesh__D044383 jls
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D044383 2006
% 220.54/220.74  |- skos__altLabel mesh__D044383 Negroes
% 220.54/220.74  |- rdf__type mesh__D044383sskos__Concept
% 220.54/220.74  |- skos__scopeNote mesh__D044383
% 220.54/220.74       Individuals whose ancestral origins are in the continent of Africa.%A%    
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D044383 2005
% 220.54/220.74  |- skos__hiddenLabel mesh__D044383 Negroid Races
% 220.54/220.74  |- mesh__dateCreated mesh__D044383 2003-07-14
% 220.54/220.74  |- mesh__recordMaintainer mesh__D044383 jls
% 220.54/220.74  |- mesh__historyNote mesh__D044383 2004   
% 220.54/220.74  |- skos__related mesh__D016692smesh__D019675
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D016692 2006
% 220.54/220.74  |- skos__hiddenLabel mesh__D016692 delta-Chain, T-Cell Receptors
% 220.54/220.74  |- skos__altLabel mesh__D016692 TcR gamma-delta
% 220.54/220.74  |- skos__prefLabel mesh__D016692 Receptors, Antigen, T-Cell, gamma-delta
% 220.54/220.74  |- skos__hiddenLabel mesh__D016692 gamma-Chain, T-Cell Receptors
% 220.54/220.74  |- skos__hiddenLabel mesh__D016692 gamma-Chain, T-Cell Receptor
% 220.54/220.74  |- skos__hiddenLabel mesh__D016692 gamma-delta T-Cell Receptor
% 220.54/220.74  |- skos__scopeNote mesh__D016692
% 220.54/220.74       T-cell receptors composed of CD3-associated gamma and delta polypeptide chains and expressed primarily in CD4-/CD8- T-cells. The receptors appear to be preferentially located in epithelial sites and probably play a role in the recognition of bacterial antigens. The T-cell receptor gamma/delta chains are separate and not related to the gamma and delta chains which are subunits of CD3 %28%see ANTIGENS, CD3%29%.%A%    
% 220.54/220.74  |- skos__hiddenLabel mesh__D016692 T Cell Receptors delta Chain
% 220.54/220.74  |- skos__annotation mesh__D016692
% 220.54/220.74       do not confuse with CD3 gamma %26% delta chains %28%index under ANTIGENS, CD3%29%; DF: TCR G D%A%  
% 220.54/220.74  |- skos__altLabel mesh__D016692 T-Cell Receptors gamma-Chain
% 220.54/220.74  |- skos__altLabel mesh__D016692 Receptors, Antigen, T Cell, gamma delta
% 220.54/220.74  |- mesh__onlineNote mesh__D016692
% 220.54/220.74       use RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA %28%NM%29% to search T-CELL RECEPTORS DELTA CHAIN %28%NM%29% 1988-91 %26% T-CELL RECEPTORS GAMMA CHAIN 1986-91%A%  
% 220.54/220.74  |- skos__hiddenLabel mesh__D016692 delta-Chain, T-Cell Receptor
% 220.54/220.74  |- rdf__type mesh__D016692sskos__Concept
% 220.54/220.74  |- mesh__dateCreated mesh__D016692 1991-08-13
% 220.54/220.74  |- skos__hiddenLabel mesh__D016692 T Cell Receptor delta Chain
% 220.54/220.74  |- skos__altLabel mesh__D016692 Antigen Receptors, T-Cell, gamma-delta
% 220.54/220.74  |- skos__hiddenLabel mesh__D016692 gamma-delta T-Cell Receptors
% 220.54/220.74  |- skos__altLabel mesh__D016692 T Cell Receptors, gamma delta
% 220.54/220.74  |- mesh__historyNote mesh__D016692
% 220.54/220.74       92; T-CELL RECEPTORS DELTA CHAIN was ANTIGEN T CELL RECEPTOR, DELTA CHAIN %28%NM%29% 1988-91; T-CELL RECEPTORS GAMMA CHAIN was ANTIGEN T CELL RECEPTOR, GAMMA CHAIN %28%NM%29% 1986-91%A%  
% 220.54/220.74  |- skos__hiddenLabel mesh__D016692 T Cell Receptors gamma Chain
% 220.54/220.74  |- skos__historyNote mesh__D016692
% 220.54/220.74       Receptors, Antigen, T-Cell %28%1986-1991%29%
% 220.54/220.74  |- skos__hiddenLabel mesh__D016692 gamma-delta, TcR
% 220.54/220.74  |- skos__related mesh__D016692smesh__D015334
% 220.54/220.74  |- skos__broader mesh__D016692smesh__D011948
% 220.54/220.74  |- mesh__recordAuthorizer mesh__D016692 sjn
% 220.54/220.74  |- mesh__recordOriginator mesh__D016692 AGS
% 220.54/220.74  |- skos__hiddenLabel mesh__D016692 TcR gamma delta
% 220.54/220.74  |- skos__altLabel mesh__D016692 T-Cell Receptors, gamma-delta
% 220.54/220.74  |- mesh__dateRevised mesh__D016692 2003-07-09
% 220.54/220.74  |- skos__hiddenLabel mesh__D016692 T Cell Receptor gamma Chain
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D016692 2004
% 220.54/220.74  |- skos__altLabel mesh__D016692 T-Cell Receptor, gamma-delta
% 220.54/220.74  |- skos__related mesh__D016692smesh__D019676
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D016692 2005
% 220.54/220.74  |- skos__altLabel mesh__D016692 T-Cell Receptor gamma-Chain
% 220.54/220.74  |- mesh__dateEstablished mesh__D016692 1992-01-01
% 220.54/220.74  |- skos__related mesh__D016692smesh__D016694
% 220.54/220.74  |- mesh__publicMeSHNote mesh__D016692
% 220.54/220.74       92; T-CELL RECEPTORS DELTA CHAIN was indexed under RECEPTORS, ANTIGEN, T-CELL 1988-91; T-CELL RECEPTORS GAMMA CHAIN was indexed under RECEPTORS, ANTIGEN, T-CELL 1987-91 %26% under PEPTIDE FRAGMENTS 1986-87%A%  
% 220.54/220.74  |- mesh__recordMaintainer mesh__D016692 jmp
% 220.54/220.74  |- skos__altLabel mesh__D016692 T-Cell Receptor delta-Chain
% 220.54/220.74  |- skos__altLabel mesh__D016692 Antigen T Cell Receptor, delta Chain
% 220.54/220.74  |- skos__hiddenLabel mesh__D016692 T Cell Receptor, gamma delta
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D002672 2004
% 220.54/220.74  |- skos__scopeNote mesh__D002672
% 220.54/220.74       A child or adolescent who, when compared to others of the same age or experience, exhibits capability of high performance in intellectual, creative, or artistic areas, possesses an unusual capacity for leadership or excels in specific academic fields. %28%From PL 100-297, Sec. 4103, Definitions%29%%A%    
% 220.54/220.74  |- skos__hiddenLabel mesh__D002672 Gifted Adolescent
% 220.54/220.74  |- skos__altLabel mesh__D002672 Children, Gifted
% 220.54/220.74  |- mesh__historyNote mesh__D002672 66   
% 220.54/220.74  |- mesh__recordOriginator mesh__D002672 NLM
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D002672 2003
% 220.54/220.74  |- mesh__dateEstablished mesh__D002672 1966-01-01
% 220.54/220.74  |- mesh__dateRevised mesh__D002672 2002-07-02
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D002672 2006
% 220.54/220.74  |- skos__annotation mesh__D002672 check also tag CHILD or specific   
% 220.54/220.74  |- mesh__recordMaintainer mesh__D002672 jls
% 220.54/220.74  |- mesh__recordAuthorizer mesh__D002672 sjn
% 220.54/220.74  |- skos__hiddenLabel mesh__D002672 Gifted Children
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D002672 2005
% 220.54/220.74  |- mesh__publicMeSHNote mesh__D002672 66   
% 220.54/220.74  |- skos__hiddenLabel mesh__D002672 Adolescents, Gifted
% 220.54/220.74  |- skos__broader mesh__D002672smesh__D002671
% 220.54/220.74  |- skos__prefLabel mesh__D002672 Child, Gifted
% 220.54/220.74  |- skos__hiddenLabel mesh__D002672 Gifted Adolescents
% 220.54/220.74  |- rdf__type mesh__D002672sskos__Concept
% 220.54/220.74  |- skos__altLabel mesh__D002672 Gifted Child
% 220.54/220.74  |- mesh__dateCreated mesh__D002672 1999-01-01
% 220.54/220.74  |- skos__hiddenLabel mesh__D010306 Glands, Parotid
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D010306 2005
% 220.54/220.74  |- mesh__recordAuthorizer mesh__D010306 sjn
% 220.54/220.74  |- skos__hiddenLabel mesh__D010306 Parotid Glands
% 220.54/220.74  |- skos__scopeNote mesh__D010306
% 220.54/220.74       The largest of the three pairs of SALIVARY GLANDS. They lie on the sides of the FACE immediately below and in front of the EAR.%A%    
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D010306 2006
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D010306 2004
% 220.54/220.74  |- mesh__recordMaintainer mesh__D010306 lkt
% 220.54/220.74  |- rdf__type mesh__D010306sskos__Concept
% 220.54/220.74  |- skos__broader mesh__D010306smesh__D012469
% 220.54/220.74  |- skos__prefLabel mesh__D010306 Parotid Gland
% 220.54/220.74  |- skos__hiddenLabel mesh__D010306 Gland, Parotid
% 220.54/220.74  |- mesh__recordOriginator mesh__D010306 NLM
% 220.54/220.74  |- mesh__dateCreated mesh__D010306 1999-01-01
% 220.54/220.74  |- skos__annotation mesh__D010306 inflammation = PAROTITIS   
% 220.54/220.74  |- mesh__dateRevised mesh__D010306 2003-07-09
% 220.54/220.74  |- skos__hiddenLabel mesh__D020734
% 220.54/220.74       Chromosome 6 Linked Autosomal Recessive Parkinsonism
% 220.54/220.74  |- mesh__dateCreated mesh__D020734 1999-11-08
% 220.54/220.74  |- skos__altLabel mesh__D020734
% 220.54/220.74       Parkinson Disease, Juvenile, Autosomal Dominant
% 220.54/220.74  |- skos__broader mesh__D020734smesh__D009069
% 220.54/220.74  |- skos__hiddenLabel mesh__D020734 Parkinsonism, MPTP-Induced Experimental
% 220.54/220.74  |- skos__broader mesh__D020734smesh__D001480
% 220.54/220.74  |- skos__hiddenLabel mesh__D020734 Juvenile Parkinsonisms
% 220.54/220.74  |- rdf__type mesh__D020734sskos__Concept
% 220.54/220.74  |- skos__altLabel mesh__D020734
% 220.54/220.74       Familial Parkinson Disease, Autosomal Recessive
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D020734 2003
% 220.54/220.74  |- skos__hiddenLabel mesh__D020734 Parkinsonism, Familial Juvenile
% 220.54/220.74  |- skos__altLabel mesh__D020734
% 220.54/220.74       Juvenile Parkinson Disease, Autosomal Dominant
% 220.54/220.74  |- skos__altLabel mesh__D020734 Juvenile Parkinsonism, Autosomal Recessive
% 220.54/220.74  |- mesh__publicMeSHNote mesh__D020734
% 220.54/220.74       2000; for PARKINSONISM see PARKINSON DISEASE 1978-1999; for PARKINSONIAN SYNDROME see PARKINSON DISEASE, SECONDARY 1974-1999: for RAMSAY HUNT PARALYSIS SYNDROME see PARKINSON DISEASE 1992-1999%A%  
% 220.54/220.74  |- skos__prefLabel mesh__D020734 Parkinsonian Disorders
% 220.54/220.74  |- skos__related mesh__D020734smesh__D020955
% 220.54/220.74  |- skos__hiddenLabel mesh__D020734 Juvenile Parkinsonism
% 220.54/220.74  |- skos__hiddenLabel mesh__D020734 Experimental Parkinsonisms
% 220.54/220.74  |- skos__altLabel mesh__D020734 Experimental Parkinson Disease
% 220.54/220.74  |- skos__altLabel mesh__D020734
% 220.54/220.74       Juvenile Parkinson Disease, Autosomal Recessive
% 220.54/220.74  |- mesh__recordOriginator mesh__D020734 KEV
% 220.54/220.74  |- skos__hiddenLabel mesh__D020734 Diseases, Experimental Parkinson
% 220.54/220.74  |- skos__altLabel mesh__D020734
% 220.54/220.74       Chromosome 6-Linked Autosomal Recessive Parkinsonism
% 220.54/220.74  |- skos__altLabel mesh__D020734 MPTP-Induced Experimental Parkinsonism
% 220.54/220.74  |- skos__hiddenLabel mesh__D020734 Parkinsonisms, Juvenile
% 220.54/220.74  |- skos__hiddenLabel mesh__D020734 Parkinsonisms, Experimental
% 220.54/220.74  |- mesh__historyNote mesh__D020734
% 220.54/220.74       2000; for PARKINSONISM use PARKINSON DISEASE 1978-1999; for PARKINSONIAN SYNDROME use PARKINSON DISEASE, SECONDARY 1974-1999; for RAMSAY HUNT PARALYSIS SYNDROME use PARKINSON DISEASE 1992-1999%A%  
% 220.54/220.74  |- skos__scopeNote mesh__D020734
% 220.54/220.74       A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism %28%see PARKINSON DISEASE%29%, secondary parkinsonism %28%see PARKINSON DISEASE, SECONDARY%29% and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.%A%    
% 220.54/220.74  |- skos__altLabel mesh__D020734 Experimental Parkinsonism
% 220.54/220.74  |- skos__altLabel mesh__D020734
% 220.54/220.74       Parkinson Disease, Familial, Autosomal Recessive
% 220.54/220.74  |- mesh__recordMaintainer mesh__D020734 lkt
% 220.54/220.74  |- skos__altLabel mesh__D020734 Parkinsonism, Juvenile, Autosomal Recessive
% 220.54/220.74  |- skos__altLabel mesh__D020734 Parkinson Disease, Experimental
% 220.54/220.74  |- mesh__dateEstablished mesh__D020734 2000-01-01
% 220.54/220.74  |- skos__hiddenLabel mesh__D020734 Experimental Parkinsonism, MPTP Induced
% 220.54/220.74  |- skos__altLabel mesh__D020734 Parkinsonism, Juvenile, Autosomal Dominant
% 220.54/220.74  |- skos__altLabel mesh__D020734 Parkinsonian Syndromes
% 220.54/220.74  |- skos__hiddenLabel mesh__D020734 Dominant Parkinsonism, Autosomal
% 220.54/220.74  |- skos__altLabel mesh__D020734 Experimental Parkinsonism, MPTP-Induced
% 220.54/220.74  |- skos__hiddenLabel mesh__D020734 Parkinson Diseases, Experimental
% 220.54/220.74  |- skos__historyNote mesh__D020734 Parkinson Disease %28%1966-1999%29%
% 220.54/220.74  |- skos__hiddenLabel mesh__D020734 Juvenile Parkinsonism, Familial
% 220.54/220.74  |- skos__hiddenLabel mesh__D020734 Experimental Parkinson Diseases
% 220.54/220.74  |- mesh__dateRevised mesh__D020734 2001-07-25
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D020734 2006
% 220.54/220.74  |- skos__hiddenLabel mesh__D020734 Recessive Parkinsonism, Autosomal
% 220.54/220.74  |- mesh__recordAuthorizer mesh__D020734 sjn
% 220.54/220.74  |- skos__altLabel mesh__D020734 Autosomal Dominant Juvenile Parkinsonism
% 220.54/220.74  |- skos__altLabel mesh__D020734 Parkinson Disease, Juvenile
% 220.54/220.74  |- skos__altLabel mesh__D020734 Parkinsonian Diseases
% 220.54/220.74  |- skos__altLabel mesh__D020734
% 220.54/220.74       Parkinson Disease, Autosomal Dominant. Juvenile
% 220.54/220.74  |- skos__hiddenLabel mesh__D020734 MPTP Induced Experimental Parkinsonism
% 220.54/220.74  |- skos__altLabel mesh__D020734 Juvenile Parkinson Disease
% 220.54/220.74  |- skos__altLabel mesh__D020734 Juvenile Parkinsonism, Autosomal Dominant
% 220.54/220.74  |- skos__annotation mesh__D020734
% 220.54/220.74       Gen: prefer specifics; do not confuse X ref RAMSAY HUNT PARALYSIS SYNDROME with RAMSAY HUNT AURICULAR SYNDROME see HERPES ZOSTER OTICUS or RAMSAY HUNT CEREBELLAR SYNDROME see MYOCLONIC CEREBELLAR DYSSYNERGIA%A%  
% 220.54/220.74  |- skos__hiddenLabel mesh__D020734 Parkinsonism, Autosomal Dominant
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D020734 2005
% 220.54/220.74  |- skos__altLabel mesh__D020734 Parkinsonian Syndrome
% 220.54/220.74  |- skos__altLabel mesh__D020734 Autosomal Recesssive Juvenile Parkinsonism
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D020734 2004
% 220.54/220.74  |- skos__hiddenLabel mesh__D020734 Parkinsonism, Autosomal Recessive
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D020734 2002
% 220.54/220.74  |- skos__altLabel mesh__D020734 Parkinsonism
% 220.54/220.74  |- mesh__dateRevised mesh__D006265 1999-11-03
% 220.54/220.74  |- skos__hiddenLabel mesh__D006265 Coalitions, Health Care
% 220.54/220.74  |- skos__hiddenLabel mesh__D006265 Healthcare Coalition
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D006265 2005
% 220.54/220.74  |- mesh__historyNote mesh__D006265
% 220.54/220.74       91%28%86%29%; was see under HEALTH PLANNING ORGANIZATIONS 1986-90; was see HEALTH PLANNING ORGANIZATIONS 1984-85%A%  
% 220.54/220.74  |- mesh__recordMaintainer mesh__D006265 kle
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D006265 2002
% 220.54/220.74  |- mesh__recordOriginator mesh__D006265 EC
% 220.54/220.74  |- skos__hiddenLabel mesh__D006265 Coalition, Healthcare
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D006265 2004
% 220.54/220.74  |- skos__altLabel mesh__D006265 Healthcare Coalitions
% 220.54/220.74  |- skos__hiddenLabel mesh__D006265 Coalition, Health Care
% 220.54/220.74  |- skos__hiddenLabel mesh__D006265 Coalitions, Healthcare
% 220.54/220.74  |- skos__hiddenLabel mesh__D006265 Coalitions, Business %28%Healthcare%29%
% 220.54/220.74  |- skos__hiddenLabel mesh__D006265 Business Coalition %28%Health Care%29%
% 220.54/220.74  |- skos__hiddenLabel mesh__D006265 Health Care Coalition
% 220.54/220.74  |- rdf__type mesh__D006265sskos__Concept
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D006265 2001
% 220.54/220.74  |- mesh__onlineNote mesh__D006265
% 220.54/220.74       search HEALTH PLANNING ORGANIZATIONS 1984-85   
% 220.54/220.74  |- mesh__publicMeSHNote mesh__D006265
% 220.54/220.74       91; was see under HEALTH PLANNING ORGANIZATIONS 1986-90; was see HEALTH PLANNING ORGANIZATIONS 1984-85%A%  
% 220.54/220.74  |- mesh__dateEstablished mesh__D006265 1991-01-01
% 220.54/220.74  |- skos__hiddenLabel mesh__D006265 Coalition, Business %28%Health Care%29%
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D006265 2003
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D006265 2000
% 220.54/220.74  |- mesh__recordAuthorizer mesh__D006265 sjn
% 220.54/220.74  |- skos__hiddenLabel mesh__D006265 Coalition, Business %28%Healthcare%29%
% 220.54/220.74  |- skos__broader mesh__D006265smesh__D006288
% 220.54/220.74  |- skos__altLabel mesh__D006265 Business Coalitions %28%Healthcare%29%
% 220.54/220.74  |- mesh__dateCreated mesh__D006265 1985-05-23
% 220.54/220.74  |- skos__historyNote mesh__D006265
% 220.54/220.74       Health Planning Organizations %28%1980-1985%29%
% 220.54/220.74  |- skos__scopeNote mesh__D006265
% 220.54/220.74       Voluntary groups of people representing diverse interests in the community such as hospitals, businesses, physicians, and insurers, with the principal objective to improve health care cost effectiveness.%A%    
% 220.54/220.74  |- skos__hiddenLabel mesh__D006265 Business Coalition %28%Healthcare%29%
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D006265 2006
% 220.54/220.74  |- skos__hiddenLabel mesh__D006265 Coalitions, Business %28%Health Care%29%
% 220.54/220.74  |- skos__prefLabel mesh__D006265 Health Care Coalitions
% 220.54/220.74  |- mesh__historyNote mesh__D044384 2004   
% 220.54/220.74  |- mesh__publicMeSHNote mesh__D044384 2004   
% 220.54/220.74  |- skos__broader mesh__D044384smesh__D012099
% 220.54/220.74  |- skos__scopeNote mesh__D044384
% 220.54/220.74       Predicting the time of OVULATION can be achieved by measuring the preovulatory elevation of ESTRADIOL; LUTEINIZING HORMONE or other hormones in BLOOD or URINE. Accuracy of ovulation prediction depends on the completeness of the hormone profiles, and the ability to determine the preovulatory LH peak.%A%    
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D044384 2006
% 220.54/220.74  |- mesh__dateEstablished mesh__D044384 2004-01-01
% 220.54/220.74  |- rdf__type mesh__D044384sskos__Concept
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D044384 2005
% 220.54/220.74  |- skos__broader mesh__D044384smesh__D010050
% 220.54/220.74  |- mesh__dateCreated mesh__D044384 2003-07-09
% 220.54/220.74  |- skos__altLabel mesh__D044384 Predicting Ovulation
% 220.54/220.74  |- skos__related mesh__D044384smesh__D010061
% 220.54/220.74  |- skos__historyNote mesh__D044384 Ovulation Detection %28%1976-2003%29%
% 220.54/220.74  |- skos__hiddenLabel mesh__D044384 Prediction, Ovulation
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D044384 2004
% 220.54/220.74  |- skos__prefLabel mesh__D044384 Ovulation Prediction
% 220.54/220.74  |- mesh__publicMeSHNote mesh__D016693
% 220.54/220.74       92; T-CELL RECEPTORS ALPHA-CHAIN %26% T-CELL RECEPTORS BETA-CHAIN were indexed under RECEPTORS, ANTIGEN, T-CELL 1986-91%A%  
% 220.54/220.74  |- skos__altLabel mesh__D016693 TcR alpha-beta
% 220.54/220.74  |- mesh__historyNote mesh__D016693
% 220.54/220.74       92; T-CELL RECEPTORS ALPHA-CHAIN was ANTIGEN T CELL RECEPTOR, ALPHA CHAIN %28%NM%29% 1986-91; T-CELL RECEPTORS BETA-CHAIN was ANTIGEN T CELL RECEPTOR, BETA CHAIN %28%NM%29% 1986-91%A%  
% 220.54/220.74  |- skos__altLabel mesh__D016693 T Cell Receptors, alpha beta
% 220.54/220.74  |- skos__related mesh__D016693smesh__D015333
% 220.54/220.74  |- skos__hiddenLabel mesh__D016693 beta-Chain, T-Cell Receptor
% 220.54/220.74  |- skos__altLabel mesh__D016693 T-Cell Receptors beta-Chain
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D016693 2006
% 220.54/220.74  |- mesh__dateCreated mesh__D016693 1991-08-13
% 220.54/220.74  |- skos__hiddenLabel mesh__D016693 T Cell Receptors beta Chain
% 220.54/220.74  |- skos__related mesh__D016693smesh__D019674
% 220.54/220.74  |- skos__hiddenLabel mesh__D016693 alpha-Chain, T-Cell Receptors
% 220.54/220.74  |- skos__altLabel mesh__D016693 T-Cell Receptor alpha-Chain
% 220.54/220.74  |- skos__hiddenLabel mesh__D016693 alpha-Chain, T-Cell Receptor
% 220.54/220.74  |- skos__related mesh__D016693smesh__D015332
% 220.54/220.74  |- skos__hiddenLabel mesh__D016693 T Cell Receptors alpha Chain
% 220.54/220.74  |- skos__altLabel mesh__D016693 Receptors, Antigen, T Cell, alpha beta
% 220.54/220.74  |- skos__altLabel mesh__D016693 T-Cell Receptor beta-Chain
% 220.54/220.74  |- skos__related mesh__D016693smesh__D019673
% 220.54/220.74  |- mesh__onlineNote mesh__D016693
% 220.54/220.74       use RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA %28%NM%29% to search T-CELL RECEPTORS ALPHA-CHAIN %28%NM%29% 1986-91 %26% T-CELL RECEPTORS BETA-CHAIN %28%NM%29% 1986-91%A%  
% 220.54/220.74  |- mesh__recordAuthorizer mesh__D016693 sjn
% 220.54/220.74  |- mesh__recordOriginator mesh__D016693 AGS
% 220.54/220.74  |- rdf__type mesh__D016693sskos__Concept
% 220.54/220.74  |- skos__hiddenLabel mesh__D016693 beta-Chain, T-Cell Receptors
% 220.54/220.74  |- skos__prefLabel mesh__D016693 Receptors, Antigen, T-Cell, alpha-beta
% 220.54/220.74  |- skos__hiddenLabel mesh__D016693 alpha-beta T-Cell Receptor
% 220.54/220.74  |- skos__broader mesh__D016693smesh__D011948
% 220.54/220.74  |- skos__historyNote mesh__D016693
% 220.54/220.74       Receptors, Antigen, T-Cell %28%1980-1991%29%
% 220.54/220.74  |- skos__annotation mesh__D016693 DF: TCR AB   
% 220.54/220.74  |- skos__altLabel mesh__D016693 T-Cell Receptors, alpha-beta
% 220.54/220.74  |- skos__hiddenLabel mesh__D016693 T Cell Receptor, alpha beta
% 220.54/220.74  |- skos__hiddenLabel mesh__D016693 T Cell Receptor alpha Chain
% 220.54/220.74  |- skos__scopeNote mesh__D016693
% 220.54/220.74       T-cell receptors composed of CD3-associated alpha and beta polypeptide chains and expressed primarily in CD4+ or CD8+ T-cells. Unlike immunoglobulins, the alpha-beta T-cell receptors recognize antigens only when presented in association with major histocompatibility %28%MHC%29% molecules.%A%    
% 220.54/220.74  |- skos__altLabel mesh__D016693 T-Cell Receptor, alpha-beta
% 220.54/220.74  |- skos__altLabel mesh__D016693 Antigen Receptors, T-Cell, alpha-beta
% 220.54/220.74  |- mesh__dateRevised mesh__D016693 2003-07-09
% 220.54/220.74  |- skos__hiddenLabel mesh__D016693 alpha-beta, TcR
% 220.54/220.74  |- skos__hiddenLabel mesh__D016693 alpha-beta T-Cell Receptors
% 220.54/220.74  |- mesh__recordMaintainer mesh__D016693 jmp
% 220.54/220.74  |- skos__hiddenLabel mesh__D016693 TcR alpha beta
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D016693 2004
% 220.54/220.74  |- mesh__dateEstablished mesh__D016693 1992-01-01
% 220.54/220.74  |- skos__hiddenLabel mesh__D016693 T Cell Receptor beta Chain
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D016693 2005
% 220.54/220.74  |- skos__altLabel mesh__D016693 Antigen T Cell Receptor, alpha Chain
% 220.54/220.74  |- skos__broader mesh__D052018smesh__D001068
% 220.54/220.74  |- skos__hiddenLabel mesh__D052018 Disorder, Binge-Eating
% 220.54/220.74  |- skos__altLabel mesh__D052018 Binge-Eating Disorder
% 220.54/220.74  |- mesh__recordOriginator mesh__D052018 lkt
% 220.54/220.74  |- mesh__recordMaintainer mesh__D052018 lkt
% 220.54/220.74  |- skos__hiddenLabel mesh__D052018 Disorders, Binge-Eating
% 220.54/220.74  |- skos__hiddenLabel mesh__D052018 Binge Eating Disorder
% 220.54/220.74  |- mesh__publicMeSHNote mesh__D052018
% 220.54/220.74       2006; see BULIMIA 1987-2005, use HYPERPHAGIA 1981-1986   
% 220.54/220.74  |- skos__annotation mesh__D052018 BULIMIA is also available   
% 220.54/220.74  |- mesh__dateCreated mesh__D052018 2005-06-30
% 220.54/220.74  |- skos__hiddenLabel mesh__D052018 Nervosa, Bulimia
% 220.54/220.74  |- skos__historyNote mesh__D052018 Hyperphagia %28%1981-1986%29%
% 220.54/220.74  |- skos__scopeNote mesh__D052018
% 220.54/220.74       An eating disorder that is characterized by a cycle of binge eating %28%BULIMIA or bingeing%29% followed by inappropriate acts %28%purging%29% to avert weight gain. Purging methods often include self-induced VOMITING, use of LAXATIVES or DIURETICS, excessive exercise, and FASTING.%A%    
% 220.54/220.74  |- skos__historyNote mesh__D052018 Bulimia %28%1986-2005%29%
% 220.54/220.74  |- mesh__historyNote mesh__D052018
% 220.54/220.74       2006; use BULIMIA 1987-2005, use HYPERPHAGIA 1981-1986   
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D052018 2006
% 220.54/220.74  |- mesh__recordAuthorizer mesh__D052018 sjn
% 220.54/220.74  |- skos__hiddenLabel mesh__D052018 Binge-Eating Disorders
% 220.54/220.74  |- skos__prefLabel mesh__D052018 Bulimia Nervosa
% 220.54/220.74  |- mesh__dateEstablished mesh__D052018 2006-01-01
% 220.54/220.74  |- skos__related mesh__D052018smesh__D002032
% 220.54/220.74  |- rdf__type mesh__D052018sskos__Concept
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D002673 2003
% 220.54/220.74  |- mesh__dateEstablished mesh__D002673 1967-01-01
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D002673 2006
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D002673 2005
% 220.54/220.74  |- mesh__recordOriginator mesh__D002673 NLM
% 220.54/220.74  |- mesh__recordMaintainer mesh__D002673 PXP
% 220.54/220.74  |- skos__prefLabel mesh__D002673 Child, Hospitalized
% 220.54/220.74  |- skos__annotation mesh__D002673
% 220.54/220.74       not for dis in child in hosp for diag or ther: use only for hospitalized child as a psychol, sociol or social entity; check also tag CHILD or specific%A%  
% 220.54/220.74  |- skos__hiddenLabel mesh__D002673 Hospitalized Children
% 220.54/220.74  |- mesh__publicMeSHNote mesh__D002673 67   
% 220.54/220.74  |- skos__broader mesh__D002673smesh__D010361
% 220.54/220.74  |- mesh__recordAuthorizer mesh__D002673 sjn
% 220.54/220.74  |- mesh__dateRevised mesh__D002673 2002-07-03
% 220.54/220.74  |- rdf__type mesh__D002673sskos__Concept
% 220.54/220.74  |- mesh__dateCreated mesh__D002673 1999-01-01
% 220.54/220.74  |- mesh__historyNote mesh__D002673 67%28%65%29%   
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D002673 2004
% 220.54/220.74  |- skos__altLabel mesh__D002673 Hospitalized Child
% 220.54/220.74  |- skos__scopeNote mesh__D002673
% 220.54/220.74       Child hospitalized for short term care.     
% 220.54/220.74  |- skos__altLabel mesh__D002673 Children, Hospitalized
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D010307 2001
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D010307 2004
% 220.54/220.74  |- skos__altLabel mesh__D010307 Parotid Cancer
% 220.54/220.74  |- skos__hiddenLabel mesh__D010307 Parotid Neoplasm
% 220.54/220.74  |- skos__scopeNote mesh__D010307
% 220.54/220.74       Tumors or cancer of the PAROTID GLAND.     
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D010307 2002
% 220.54/220.74  |- rdf__type mesh__D010307sskos__Concept
% 220.54/220.74  |- skos__annotation mesh__D010307
% 220.54/220.74       coord IM with histol type of neopl %28%IM%29%   
% 220.54/220.74  |- mesh__dateRevised mesh__D010307 1999-11-08
% 220.54/220.74  |- mesh__recordOriginator mesh__D010307 NLM
% 220.54/220.74  |- skos__broader mesh__D010307smesh__D012468
% 220.54/220.74  |- skos__broader mesh__D010307smesh__D010305
% 220.54/220.74  |- mesh__recordMaintainer mesh__D010307 adp
% 220.54/220.74  |- mesh__dateCreated mesh__D010307 1999-01-01
% 220.54/220.74  |- mesh__recordAuthorizer mesh__D010307 sjn
% 220.54/220.74  |- skos__hiddenLabel mesh__D010307 Cancer, Parotid
% 220.54/220.74  |- skos__altLabel mesh__D010307 Neoplasms, Parotid
% 220.54/220.74  |- skos__hiddenLabel mesh__D010307 Cancers, Parotid
% 220.54/220.74  |- skos__prefLabel mesh__D010307 Parotid Neoplasms
% 220.54/220.74  |- skos__altLabel mesh__D010307 Cancer of the Parotid
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D010307 2000
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D010307 2005
% 220.54/220.74  |- skos__hiddenLabel mesh__D010307 Neoplasm, Parotid
% 220.54/220.74  |- skos__hiddenLabel mesh__D010307 Parotid Cancers
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D010307 2003
% 220.54/220.74  |- mesh__activeMeSHYear mesh__D010307 2006
% 220.54/220.74  |- skos__scopeNote mesh__D020735
% 220.54/220.74       A 145-kDa guanine nucleotide exchange factor that is specific for rap1 and ras GTP-BINDING PROTEINS. It associates with SH3 domains of the crk family of signaling proteins.%A%    
% 220.54/220.74  |- skos__altLabel mesh__D020735 Guanine Nucleotide Exchange Factor C3G
% 220.54/220.74  |- mesh__dateRevised mesh__D020735 2004-07-07
% 220.54/220.74  |- mesh__historyNote mesh__D020735
% 220.54/220.74       2000; use GUANINE NUCLEOTIDE EXCHANGE FACTORS %28%NM%29% 1997-1999%A%  
% 220.54/220.74  |- mesh__recordOriginator mesh__D020735 jmp
% 220.54/220.74  |- skos__hiddenLabel mesh__D020735 GRF 2
% 220.54/220.74  |- skos__altLabel mesh__D020735 GRF2 Protein, Mammalian
% 220.54/220.74  |- skos__altLabel mesh__D020735 C3G Protein
% 220.54/220.74  |- skos__prefLabel mesh__D020735 Guanine Nucleotide-Releasing Factor 2
% 220.54/220.74  |- skos__altLabel mesh__D020735 GRF-2
% 220.54/220.74  |- mesh__dateEstablished mesh__D020735 2000-01-01
% 220.54/220.74  |- mesh__recordMaintainer mesh__D020735 jmp
% 220.54/220.74  |- mesh__publicMeSHNote mesh__D020735
% 220.54/220.74       2000; GRF2 PROTEIN, MAMMALIAN was indexed under PROTEINS 1995-1999; C3G PROTEIN was indexed under PROTEINS 1997-1999%A%  
% 220.54/220.75  |- skos__historyNote mesh__D020735 Proteins %28%1997-1999%29%
% 220.54/220.75  |- mesh__dateCreated mesh__D020735 1999-11-03
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D020735 2005
% 220.54/220.75  |- rdf__type mesh__D020735sskos__Concept
% 220.54/220.75  |- skos__broader mesh__D020735smesh__D020662
% 220.54/220.75  |- skos__altLabel mesh__D020735 GRF2
% 220.54/220.75  |- mesh__recordAuthorizer mesh__D020735 sjn
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D020735 2006
% 220.54/220.75  |- skos__altLabel mesh__D020735 GRF2 Protein
% 220.54/220.75  |- skos__altLabel mesh__D020735 RAP1GRF1
% 220.54/220.75  |- mesh__recordAuthorizer mesh__D006266 sjn
% 220.54/220.75  |- skos__broader mesh__D006266smesh__D011634
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006266 2003
% 220.54/220.75  |- skos__broader mesh__D006266smesh__D004505
% 220.54/220.75  |- skos__scopeNote mesh__D006266
% 220.54/220.75       Education that increases the awareness and favorably influences the attitudes and knowledge relating to the improvement of health on a personal or community basis.%A%    
% 220.54/220.75  |- rdf__type mesh__D006266sskos__Concept
% 220.54/220.75  |- skos__prefLabel mesh__D006266 Health Education
% 220.54/220.75  |- mesh__dateRevised mesh__D006266 1999-11-03
% 220.54/220.75  |- skos__related mesh__D006266smesh__D006293
% 220.54/220.75  |- skos__annotation mesh__D006266
% 220.54/220.75       educ of general public or individuals; educ of patients in %26% outside hosp = PATIENT EDUCATION%A%  
% 220.54/220.75  |- skos__altLabel mesh__D006266 Education, Community Health
% 220.54/220.75  |- mesh__recordOriginator mesh__D006266 NLM
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006266 2006
% 220.54/220.75  |- mesh__recordMaintainer mesh__D006266 kle
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006266 2002
% 220.54/220.75  |- skos__broader mesh__D006266smesh__D011314
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006266 2005
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006266 2001
% 220.54/220.75  |- skos__altLabel mesh__D006266 Education, Health
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006266 2004
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006266 2000
% 220.54/220.75  |- mesh__dateCreated mesh__D006266 1999-01-01
% 220.54/220.75  |- skos__altLabel mesh__D006266 Health Education, Community
% 220.54/220.75  |- skos__scopeNote mesh__D044385
% 220.54/220.75       The GTPase-containing subunits of heterotrimeric GTP-binding proteins. When dissociated from the heterotrimeric complex these subunits interact with a variety of second messenger systems. Hydrolysis of GTP by the inherent GTPase activity of the subunit causes it to revert to its inactive %28%heterotrimeric%29% form. The GTP-Binding protein alpha subunits are grouped into families according to the type of action they have on second messenger systems.%A%    
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D044385 2005
% 220.54/220.75  |- mesh__recordOriginator mesh__D044385 jmp
% 220.54/220.75  |- skos__hiddenLabel mesh__D044385 G Protein alpha Subunit
% 220.54/220.75  |- skos__prefLabel mesh__D044385 GTP-Binding Protein alpha Subunits
% 220.54/220.75  |- skos__altLabel mesh__D044385 G-Protein alpha Subunit
% 220.54/220.75  |- mesh__publicMeSHNote mesh__D044385
% 220.54/220.75       2004; see HETEROTRIMERIC GTP-BINDING PROTEINS 2001-2003   
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D044385 2006
% 220.54/220.75  |- mesh__dateRevised mesh__D044385 2004-07-07
% 220.54/220.75  |- rdf__type mesh__D044385sskos__Concept
% 220.54/220.75  |- skos__historyNote mesh__D044385
% 220.54/220.75       Heterotrimeric GTP-Binding Proteins %28%2000-2003%29%
% 220.54/220.75  |- skos__hiddenLabel mesh__D044385 GTP Binding Protein alpha Subunits
% 220.54/220.75  |- mesh__dateCreated mesh__D044385 2003-07-09
% 220.54/220.75  |- mesh__recordAuthorizer mesh__D044385 sjn
% 220.54/220.75  |- skos__altLabel mesh__D044385 GTP-Binding Protein alpha Subunit
% 220.54/220.75  |- skos__broader mesh__D044385smesh__D020962
% 220.54/220.75  |- mesh__recordMaintainer mesh__D044385 jmp
% 220.54/220.75  |- mesh__historyNote mesh__D044385
% 220.54/220.75       2004; use HETEROTRIMERIC GTP-BINDING PROTEINS 2001-2003   
% 220.54/220.75  |- skos__hiddenLabel mesh__D044385 GTP Binding Protein alpha Subunit
% 220.54/220.75  |- mesh__dateEstablished mesh__D044385 2004-01-01
% 220.54/220.75  |- skos__hiddenLabel mesh__D044385 alpha Subunit, G-Protein
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D011400 2005
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D011400 2006
% 220.54/220.75  |- mesh__recordOriginator mesh__D011400 NLM
% 220.54/220.75  |- skos__altLabel mesh__D011400 Prometryn
% 220.54/220.75  |- skos__hiddenLabel mesh__D011400 50, Gesaguard
% 220.54/220.75  |- mesh__dateEstablished mesh__D011400 1991-01-01
% 220.54/220.75  |- rdf__type mesh__D011400sskos__Concept
% 220.54/220.75  |- skos__prefLabel mesh__D011400 Prometryne
% 220.54/220.75  |- mesh__recordMaintainer mesh__D011400 ssb
% 220.54/220.75  |- skos__historyNote mesh__D011400 Triazines %28%1966-1971%29%
% 220.54/220.75  |- skos__scopeNote mesh__D011400
% 220.54/220.75       A triazine used as a selective pre- and post-emergence herbicide. %28%From Merck Index, 11th ed%29%%A%    
% 220.54/220.75  |- mesh__historyNote mesh__D011400
% 220.54/220.75       91%28%72%29%; was see under HERBICIDES, TRIAZINE 1972-90   
% 220.54/220.75  |- mesh__dateCreated mesh__D011400 1999-01-01
% 220.54/220.75  |- skos__historyNote mesh__D011400 Herbicides %28%1966-1971%29%
% 220.54/220.75  |- skos__broader mesh__D011400smesh__D014227
% 220.54/220.75  |- mesh__publicMeSHNote mesh__D011400
% 220.54/220.75       91; was see under HERBICIDES, TRIAZINE 1972-90   
% 220.54/220.75  |- mesh__dateRevised mesh__D011400 2004-07-07
% 220.54/220.75  |- mesh__recordAuthorizer mesh__D011400 sjn
% 220.54/220.75  |- skos__hiddenLabel mesh__D016694 T Cell delta Chain Gene Rearrangement
% 220.54/220.75  |- skos__historyNote mesh__D016694
% 220.54/220.75       Receptors, Antigen, T-Cell/genetics %28%1987-1988%29%
% 220.54/220.75  |- mesh__dateRevised mesh__D016694 2002-07-03
% 220.54/220.75  |- skos__altLabel mesh__D016694 T Cell delta-Chain Gene Rearrangement
% 220.54/220.75  |- mesh__recordMaintainer mesh__D016694 TPW
% 220.54/220.75  |- skos__prefLabel mesh__D016694
% 220.54/220.75       Gene Rearrangement, delta-Chain T-Cell Antigen Receptor
% 220.54/220.75  |- skos__hiddenLabel mesh__D016694
% 220.54/220.75       Gene Rearrangement, delta Chain T Cell Antigen Receptor
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D016694 2006
% 220.54/220.75  |- skos__altLabel mesh__D016694
% 220.54/220.75       Gene Rearrangement, delta-Chain T Cell Antigen Receptor
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D016694 2005
% 220.54/220.75  |- skos__historyNote mesh__D016694
% 220.54/220.75       Gene Rearrangement, T-Lymphocyte %28%1989-1991%29%
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D016694 2004
% 220.54/220.75  |- skos__annotation mesh__D016694 DF: GENE REARR DELTA CHAIN   
% 220.54/220.75  |- mesh__publicMeSHNote mesh__D016694 92   
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D016694 2003
% 220.54/220.75  |- mesh__dateCreated mesh__D016694 1991-01-25
% 220.54/220.75  |- skos__scopeNote mesh__D016694
% 220.54/220.75       Ordered rearrangement of T-cell variable gene regions coding for the delta-chain of antigen receptors.%A%    
% 220.54/220.75  |- skos__altLabel mesh__D016694
% 220.54/220.75       T-Cell Antigen Receptor delta-Chain Gene Rearrangement
% 220.54/220.75  |- skos__hiddenLabel mesh__D016694
% 220.54/220.75       T Lymphocyte Antigen Receptor delta Chain Gene Rearrangement
% 220.54/220.75  |- skos__broader mesh__D016694smesh__D015329
% 220.54/220.75  |- skos__altLabel mesh__D016694
% 220.54/220.75       T-Lymphocyte Antigen Receptor delta-Chain Gene Rearrangement
% 220.54/220.75  |- skos__altLabel mesh__D016694 T Lymphocyte delta-Chain Gene Rearrangement
% 220.54/220.75  |- rdf__type mesh__D016694sskos__Concept
% 220.54/220.75  |- mesh__recordOriginator mesh__D016694 AGS
% 220.54/220.75  |- mesh__recordAuthorizer mesh__D016694 sjn
% 220.54/220.75  |- skos__hiddenLabel mesh__D016694
% 220.54/220.75       T Lymphocyte delta Chain Gene Rearrangement
% 220.54/220.75  |- mesh__historyNote mesh__D016694 92   
% 220.54/220.75  |- mesh__dateEstablished mesh__D016694 1992-01-01
% 220.54/220.75  |- skos__hiddenLabel mesh__D016694
% 220.54/220.75       T Cell Antigen Receptor delta Chain Gene Rearrangement
% 220.54/220.75  |- rdf__type mesh__D049070sskos__Concept
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D049070 2006
% 220.54/220.75  |- mesh__recordMaintainer mesh__D049070 jmp
% 220.54/220.75  |- mesh__dateEstablished mesh__D049070 2005-01-01
% 220.54/220.75  |- mesh__recordAuthorizer mesh__D049070 sjn
% 220.54/220.75  |- mesh__recordOriginator mesh__D049070 jmp
% 220.54/220.75  |- skos__broader mesh__D049070smesh__D049069
% 220.54/220.75  |- skos__historyNote mesh__D049070 Serine Endopeptidases %28%1989-2004%29%
% 220.54/220.75  |- skos__scopeNote mesh__D049070
% 220.54/220.75       A prokaryotic ATP-dependent protease that plays a role in the degradation of many abnormal proteins. It is a tetramer of 87-kDa subunits, each of which contains a proteolytic site and a ATP-binding site.%A%    
% 220.54/220.75  |- mesh__dateCreated mesh__D049070 2004-07-07
% 220.54/220.75  |- skos__prefLabel mesh__D049070 Protease La
% 220.54/220.75  |- skos__altLabel mesh__D049070 Lon Protease
% 220.54/220.75  |- skos__historyNote mesh__D049070
% 220.54/220.75       Peptide Peptidohydrolases %28%1981-1988%29%
% 220.54/220.75  |- mesh__historyNote mesh__D049070 2005%28%1981%29%   
% 220.54/220.75  |- skos__altLabel mesh__D049070 Endopeptidase La
% 220.54/220.75  |- skos__historyNote mesh__D049070 Heat-Shock Proteins %28%1989-2004%29%
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D049070 2005
% 220.54/220.75  |- mesh__publicMeSHNote mesh__D049070
% 220.54/220.75       2005; PROTEASE LA was indexed under SERINE ENDOPEPTIDASES and HEAT-SHOCK PROTEINS 1989-2004 %26% under PEPTIDE PEPTIDOHYDROLASES 1981-1988%A%  
% 220.54/220.75  |- skos__broader mesh__D049070smesh__D012697
% 220.54/220.75  |- mesh__recordAuthorizer mesh__D002674 sjn
% 220.54/220.75  |- mesh__dateRevised mesh__D002674 2002-07-03
% 220.54/220.75  |- mesh__historyNote mesh__D002674 67%28%65%29%   
% 220.54/220.75  |- mesh__publicMeSHNote mesh__D002674 67   
% 220.54/220.75  |- skos__hiddenLabel mesh__D002674 Institutionalized Children
% 220.54/220.75  |- skos__broader mesh__D002674smesh__D010361
% 220.54/220.75  |- skos__prefLabel mesh__D002674 Child, Institutionalized
% 220.54/220.75  |- rdf__type mesh__D002674sskos__Concept
% 220.54/220.75  |- mesh__dateCreated mesh__D002674 1999-01-01
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D002674 2004
% 220.54/220.75  |- skos__altLabel mesh__D002674 Children, Institutionalized
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D002674 2003
% 220.54/220.75  |- mesh__dateEstablished mesh__D002674 1967-01-01
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D002674 2006
% 220.54/220.75  |- mesh__recordOriginator mesh__D002674 NLM
% 220.54/220.75  |- mesh__recordMaintainer mesh__D002674 jls
% 220.54/220.75  |- skos__altLabel mesh__D002674 Institutionalized Child
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D002674 2005
% 220.54/220.75  |- skos__scopeNote mesh__D002674
% 220.54/220.75       A child who is receiving long-term in-patient services or who resides in an institutional setting.%A%    
% 220.54/220.75  |- skos__annotation mesh__D002674 check also tag CHILD or specific   
% 220.54/220.75  |- skos__broader mesh__D050718Q000172smesh__D050718
% 220.54/220.75  |- mesh__preferredCombination mesh__D050718Q000172smesh__D000799
% 220.54/220.75  |- rdf__type mesh__D050718Q000172smesh__CompoundConcept
% 220.54/220.75  |- rdf__type mesh__D020736sskos__Concept
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D020736 2006
% 220.54/220.75  |- skos__altLabel mesh__D020736 Small Cytoplasmic Ribonucleoproteins
% 220.54/220.75  |- mesh__historyNote mesh__D020736 2000   
% 220.54/220.75  |- mesh__dateCreated mesh__D020736 1999-11-03
% 220.54/220.75  |- mesh__recordAuthorizer mesh__D020736 sjn
% 220.54/220.75  |- mesh__recordOriginator mesh__D020736 nns
% 220.54/220.75  |- mesh__publicMeSHNote mesh__D020736 2000   
% 220.54/220.75  |- mesh__dateEstablished mesh__D020736 2000-01-01
% 220.54/220.75  |- skos__broader mesh__D020736smesh__D012261
% 220.54/220.75  |- mesh__dateRevised mesh__D020736 2005-06-30
% 220.54/220.75  |- skos__scopeNote mesh__D020736
% 220.54/220.75       Complexes of scRNA %28%RNA, SMALL CYTOPLASMIC%29% and protein found in the cytoplasm. An example is SIGNAL RECOGNITION PARTICLE.%A%    
% 220.54/220.75  |- mesh__recordMaintainer mesh__D020736 SYSTEM
% 220.54/220.75  |- skos__altLabel mesh__D020736 scRNP
% 220.54/220.75  |- skos__prefLabel mesh__D020736 Ribonucleoproteins, Small Cytoplasmic
% 220.54/220.75  |- skos__historyNote mesh__D020736 Ribonucleoproteins %28%1982-1999%29%
% 220.54/220.75  |- skos__hiddenLabel mesh__D039441 Integrin, alpha4
% 220.54/220.75  |- skos__altLabel mesh__D039441 Antigens, CD49d
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D039441 2006
% 220.54/220.75  |- skos__prefLabel mesh__D039441 Integrin alpha4
% 220.54/220.75  |- mesh__dateEstablished mesh__D039441 2003-01-01
% 220.54/220.75  |- skos__altLabel mesh__D039441 alpha4 Integrin
% 220.54/220.75  |- mesh__dateCreated mesh__D039441 2002-07-03
% 220.54/220.75  |- mesh__publicMeSHNote mesh__D039441
% 220.54/220.75       2003; ALPHA4 INTEGRIN %28%now INTEGRIN ALPHA4%29% was indexed under ANTIGENS, CD 1994-2002%A%  
% 220.54/220.75  |- mesh__recordOriginator mesh__D039441 MDJ
% 220.54/220.75  |- skos__scopeNote mesh__D039441
% 220.54/220.75       An integrin alpha subunit that is unique in that it does not contain an I domain, and its proteolytic cleavage site is near the middle of the extracellular portion of the polypeptide rather than close to the membrane as in other integrin alpha subunits.%A%    
% 220.54/220.75  |- skos__broader mesh__D039441smesh__D015703
% 220.54/220.75  |- rdf__type mesh__D039441sskos__Concept
% 220.54/220.75  |- skos__broader mesh__D039441smesh__D039001
% 220.54/220.75  |- skos__altLabel mesh__D039441 CD49d Antigen
% 220.54/220.75  |- skos__hiddenLabel mesh__D039441 Antigen, CD49d
% 220.54/220.75  |- mesh__recordMaintainer mesh__D039441 ssb
% 220.54/220.75  |- mesh__recordAuthorizer mesh__D039441 sjn
% 220.54/220.75  |- mesh__dateRevised mesh__D039441 2005-06-30
% 220.54/220.75  |- skos__historyNote mesh__D039441 Antigens, CD %28%1994-2002%29%
% 220.54/220.75  |- skos__altLabel mesh__D039441 CD49d Antigens
% 220.54/220.75  |- mesh__historyNote mesh__D039441
% 220.54/220.75       2003; use INTEGRIN ALPHA4 %28%NM%29% 1994-2002   
% 220.54/220.75  |- mesh__publicMeSHNote mesh__D006267 65   
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006267 2000
% 220.54/220.75  |- mesh__recordAuthorizer mesh__D006267 sjn
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006267 2006
% 220.54/220.75  |- skos__scopeNote mesh__D006267
% 220.54/220.75       Education which increases the awareness and favorably influences the attitudes and knowledge relating to the improvement of dental health on a personal or community basis.%A%    
% 220.54/220.75  |- mesh__dateRevised mesh__D006267 1999-11-03
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006267 2005
% 220.54/220.75  |- mesh__recordOriginator mesh__D006267 NLM
% 220.54/220.75  |- skos__broader mesh__D006267smesh__D011636
% 220.54/220.75  |- skos__altLabel mesh__D006267 Education, Dental Health
% 220.54/220.75  |- skos__annotation mesh__D006267 DF: HEALTH EDUC DENT   
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006267 2004
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006267 2002
% 220.54/220.75  |- mesh__recordMaintainer mesh__D006267 kle
% 220.54/220.75  |- mesh__dateCreated mesh__D006267 1999-01-01
% 220.54/220.75  |- skos__altLabel mesh__D006267 Dental Health Education
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006267 2003
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006267 2001
% 220.54/220.75  |- skos__prefLabel mesh__D006267 Health Education, Dental
% 220.54/220.75  |- skos__broader mesh__D006267smesh__D006266
% 220.54/220.75  |- rdf__type mesh__D006267sskos__Concept
% 220.54/220.75  |- mesh__dateEstablished mesh__D006267 1965-01-01
% 220.54/220.75  |- mesh__historyNote mesh__D006267 65   
% 220.54/220.75  |- skos__broader mesh__D005744Q000032smesh__D005744
% 220.54/220.75  |- mesh__preferredCombination mesh__D005744Q000032smesh__D005745
% 220.54/220.75  |- rdf__type mesh__D005744Q000032smesh__CompoundConcept
% 220.54/220.75  |- skos__related mesh__D011401smesh__D017930
% 220.54/220.75  |- skos__altLabel mesh__D011401 Promoter Regions
% 220.54/220.75  |- skos__broader mesh__D011401smesh__D012045
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Promotor Region
% 220.54/220.75  |- mesh__onlineNote mesh__D011401
% 220.54/220.75       use OPERON to search PROMOTER %28%GENETICS%29% 1980-84   
% 220.54/220.75  |- skos__altLabel mesh__D011401 Promotor Regions
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D011401 2006
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Pseudopromoters %28%Genetics%29%
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Regions, Promoter
% 220.54/220.75  |- skos__historyNote mesh__D011401 Operon %28%1969-1985%29%
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Region, Promoter %28%Genetics%29%
% 220.54/220.75  |- skos__broader mesh__D011401smesh__D050436
% 220.54/220.75  |- skos__altLabel mesh__D011401 Promoter
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Promotors
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 rRNA Promoters
% 220.54/220.75  |- mesh__publicMeSHNote mesh__D011401
% 220.54/220.75       85; for rRNA PROMOTER see rRNA OPERON 1990-98; for PROMOTER %28%GENETICS%29% see OPERON 1980-84%A%  
% 220.54/220.75  |- mesh__historyNote mesh__D011401
% 220.54/220.75       85; for rRNA PROMOTER use rRNA OPERON 1990-98; for PROMOTER %28%GENETICS%29% use OPERON 1980-84%A%  
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Promotor Region %28%Genetics%29%
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Promoter Region %28%Genetics%29%
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Promotors %28%Genetics%29%
% 220.54/220.75  |- mesh__recordMaintainer mesh__D011401 nns
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Promoters
% 220.54/220.75  |- skos__historyNote mesh__D011401
% 220.54/220.75       Gene Expression Regulation %28%1981-1984%29%
% 220.54/220.75  |- rdf__type mesh__D011401sskos__Concept
% 220.54/220.75  |- skos__prefLabel mesh__D011401 Promoter Regions %28%Genetics%29%
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Promoter, rRNA
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Middle Promoter
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Early Promoter
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Promoters, rRNA
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Promoter Region
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Region, Promoter
% 220.54/220.75  |- skos__historyNote mesh__D011401 Genes %28%1966-1967%29%
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Regions, Promotor
% 220.54/220.75  |- skos__historyNote mesh__D011401 Genes, Regulator %28%1968-1984%29%
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Late Promoter
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Promoters, Middle
% 220.54/220.75  |- skos__altLabel mesh__D011401 Promotor
% 220.54/220.75  |- mesh__dateEstablished mesh__D011401 1985-01-01
% 220.54/220.75  |- mesh__recordOriginator mesh__D011401 AEP
% 220.54/220.75  |- skos__historyNote mesh__D011401 Transcription, Genetic %28%1973-1984%29%
% 220.54/220.75  |- skos__scopeNote mesh__D011401
% 220.54/220.75       DNA sequences which are recognized %28%directly or indirectly%29% and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes.%A%    
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Promoters, Late
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Promoter, Late
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Region, Promotor
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Promoter, Early
% 220.54/220.75  |- mesh__recordAuthorizer mesh__D011401 sjn
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Promoter, Middle
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Region, Promotor %28%Genetics%29%
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Regions, Promotor %28%Genetics%29%
% 220.54/220.75  |- skos__altLabel mesh__D011401 Promotor Regions %28%Genetics%29%
% 220.54/220.75  |- mesh__dateRevised mesh__D011401 2005-06-30
% 220.54/220.75  |- skos__altLabel mesh__D011401 Pseudopromoter
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Regions, Promoter %28%Genetics%29%
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Promoters, Early
% 220.54/220.75  |- mesh__dateCreated mesh__D011401 1984-04-17
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Pseudopromoters
% 220.54/220.75  |- skos__hiddenLabel mesh__D011401 Promoters %28%Genetics%29%
% 220.54/220.75  |- skos__annotation mesh__D011401 DF: PROMOTER REGIONS   
% 220.54/220.75  |- skos__altLabel mesh__D011401 Promotor %28%Genetics%29%
% 220.54/220.75  |- skos__broader mesh__D016695smesh__D014166
% 220.54/220.75  |- skos__historyNote mesh__D016695 Transferases %28%1966-1991%29%
% 220.54/220.75  |- mesh__dateEstablished mesh__D016695 1992-01-01
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D016695 2006
% 220.54/220.75  |- mesh__recordAuthorizer mesh__D016695 sjn
% 220.54/220.75  |- skos__hiddenLabel mesh__D016695 Transferases, Glycoside
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D016695 2004
% 220.54/220.75  |- skos__prefLabel mesh__D016695 Glycosyltransferases
% 220.54/220.75  |- skos__altLabel mesh__D016695 Glycoside Transferases
% 220.54/220.75  |- mesh__dateCreated mesh__D016695 1991-02-11
% 220.54/220.75  |- mesh__dateRevised mesh__D016695 2003-07-09
% 220.54/220.75  |- rdf__type mesh__D016695sskos__Concept
% 220.54/220.75  |- skos__scopeNote mesh__D016695
% 220.54/220.75       Enzymes that catalyze the transfer of glycosyl groups to an acceptor. Most often another carbohydrate molecule acts as an acceptor, but inorganic phosphate can also act as an acceptor, such as in the case of PHOSPHORYLASES. Some of the enzymes in this group also catalyze hydrolysis, which can be regarded as transfer of a glycosyl group from the donor to water. Subclasses include the HEXOSYLTRANSFERASES; PENTOSYLTRANSFERASES; SIALYLTRANSFERASES; and those transferring other glycosyl groups. EC 2.4.%A%    
% 220.54/220.75  |- mesh__publicMeSHNote mesh__D016695 92   
% 220.54/220.75  |- mesh__historyNote mesh__D016695 92   
% 220.54/220.75  |- mesh__recordOriginator mesh__D016695 RLS
% 220.54/220.75  |- mesh__recordMaintainer mesh__D016695 ssb
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D016695 2005
% 220.54/220.75  |- skos__altLabel mesh__D049071 Protease Ti
% 220.54/220.75  |- skos__broader mesh__D049071smesh__D049069
% 220.54/220.75  |- mesh__dateCreated mesh__D049071 2004-07-07
% 220.54/220.75  |- mesh__publicMeSHNote mesh__D049071
% 220.54/220.75       2005; ATP-DEPENDENT ENDOPROTEASE TI %28%now ENDOPEPTIDASE CLP%29% was indexed under SERINE ENDOPEPTIDASES %26% ADENOSINETRIPHOSPHATASE 1988-2004%A%  
% 220.54/220.75  |- skos__altLabel mesh__D049071 Ti Protease
% 220.54/220.75  |- mesh__dateEstablished mesh__D049071 2005-01-01
% 220.54/220.75  |- mesh__recordAuthorizer mesh__D049071 sjn
% 220.54/220.75  |- skos__historyNote mesh__D049071 Serine Endopeptidases %28%1988-2004%29%
% 220.54/220.75  |- mesh__recordOriginator mesh__D049071 jmp
% 220.54/220.75  |- skos__hiddenLabel mesh__D049071 Endoprotease Ti, ATP-Dependent
% 220.54/220.75  |- skos__historyNote mesh__D049071
% 220.54/220.75       Adenosinetriphosphatase %28%1988-2004%29%
% 220.54/220.75  |- skos__hiddenLabel mesh__D049071 ATP Dependent Endoprotease Ti
% 220.54/220.75  |- skos__prefLabel mesh__D049071 Endopeptidase Clp
% 220.54/220.75  |- skos__scopeNote mesh__D049071
% 220.54/220.75       An ATP-dependent protease found in prokaryotes, CHLOROPLASTS, and MITOCHONDRIA. It is a soluble multisubunit complex that plays a role in the degradation of many abnormal proteins.%A%    
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D049071 2005
% 220.54/220.75  |- skos__altLabel mesh__D049071 ATP-Dependent Endoprotease Ti
% 220.54/220.75  |- mesh__historyNote mesh__D049071 2005%28%1988%29%   
% 220.54/220.75  |- skos__broader mesh__D049071smesh__D012697
% 220.54/220.75  |- rdf__type mesh__D049071sskos__Concept
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D049071 2006
% 220.54/220.75  |- mesh__recordMaintainer mesh__D049071 jmp
% 220.54/220.75  |- skos__altLabel mesh__D049071 Clp Protease
% 220.54/220.75  |- rdf__type mesh__D002675sskos__Concept
% 220.54/220.75  |- mesh__dateCreated mesh__D002675 1999-01-01
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D002675 2004
% 220.54/220.75  |- mesh__recordAuthorizer mesh__D002675 sjn
% 220.54/220.75  |- skos__altLabel mesh__D002675 Children, Preschool
% 220.54/220.75  |- mesh__dateRevised mesh__D002675 2002-07-03
% 220.54/220.75  |- skos__hiddenLabel mesh__D002675 Preschool Child
% 220.54/220.75  |- skos__prefLabel mesh__D002675 Child, Preschool
% 220.54/220.75  |- skos__annotation mesh__D002675
% 220.54/220.75       age 2-5 yr; IM only as psychol %26% sociol or social entity: Manual 18.5.11, 34.9.3; NIM as check tag: Manual 18.5+; no qualif for IM but psychol of the preschool child = CHILD PSYCHOLOGY %28%IM%29% %26% check the tag CHILD, PRESCHOOL%A%  
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D002675 2003
% 220.54/220.75  |- skos__hiddenLabel mesh__D002675 Preschool Children
% 220.54/220.75  |- skos__broader mesh__D002675smesh__D002648
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D002675 2006
% 220.54/220.75  |- mesh__publicMeSHNote mesh__D002675 66   
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D002675 2005
% 220.54/220.75  |- mesh__dateEstablished mesh__D002675 1966-01-01
% 220.54/220.75  |- mesh__historyNote mesh__D002675 66   
% 220.54/220.75  |- mesh__recordOriginator mesh__D002675 NLM
% 220.54/220.75  |- skos__scopeNote mesh__D002675 A child between the ages of 2 and 5.     
% 220.54/220.75  |- mesh__recordMaintainer mesh__D002675 PXP
% 220.54/220.75  |- skos__scopeNote mesh__D010309 INFLAMMATION of the PAROTID GLAND.     
% 220.54/220.75  |- skos__hiddenLabel mesh__D010309 Parotiditides
% 220.54/220.75  |- skos__hiddenLabel mesh__D010309 Parotitides
% 220.54/220.75  |- skos__annotation mesh__D010309
% 220.54/220.75       in translations use %22%parotitis%22%, not %22%parotiditis%22% despite form of vernacular%A%  
% 220.54/220.75  |- mesh__recordAuthorizer mesh__D010309 sjn
% 220.54/220.75  |- mesh__dateCreated mesh__D010309 1999-01-01
% 220.54/220.75  |- skos__altLabel mesh__D010309 Parotiditis
% 220.54/220.75  |- rdf__type mesh__D010309sskos__Concept
% 220.54/220.75  |- mesh__recordMaintainer mesh__D010309 lkt
% 220.54/220.75  |- skos__prefLabel mesh__D010309 Parotitis
% 220.54/220.75  |- mesh__dateRevised mesh__D010309 2005-06-30
% 220.54/220.75  |- skos__broader mesh__D010309smesh__D012793
% 220.54/220.75  |- skos__broader mesh__D010309smesh__D010305
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D010309 2006
% 220.54/220.75  |- mesh__recordOriginator mesh__D010309 NLM
% 220.54/220.75  |- mesh__recordAuthorizer mesh__D007360 sjn
% 220.54/220.75  |- mesh__dateRevised mesh__D007360 2005-06-30
% 220.54/220.75  |- skos__annotation mesh__D007360 /genet permitted   
% 220.54/220.75  |- mesh__dateCreated mesh__D007360 1999-01-01
% 220.54/220.75  |- mesh__recordOriginator mesh__D007360 NLM
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D007360 2006
% 220.54/220.75  |- skos__scopeNote mesh__D007360
% 220.54/220.75       The ability to learn and to deal with new situations and to deal effectively with tasks involving abstractions.%A%    
% 220.54/220.75  |- skos__broader mesh__D007360smesh__D010551
% 220.54/220.75  |- skos__prefLabel mesh__D007360 Intelligence
% 220.54/220.75  |- rdf__type mesh__D007360sskos__Concept
% 220.54/220.75  |- mesh__recordMaintainer mesh__D007360 jls
% 220.54/220.75  |- mesh__onlineNote mesh__D006268
% 220.54/220.75       pre-explosion = HEALTH FACILITIES %28%PX%29%   
% 220.54/220.75  |- mesh__recordAuthorizer mesh__D006268 ags
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006268 2005
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006268 2000A
% 220.54/220.75  |- skos__historyNote mesh__D006268 specific facility %28%1966-1967%29%
% 220.54/220.75  |- skos__hiddenLabel mesh__D006268 Facility, Health
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006268 2000
% 220.54/220.75  |- skos__scopeNote mesh__D006268
% 220.54/220.75       Institutions which provide medical or health-related services.%A%    
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006268 2006
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006268 2001
% 220.54/220.75  |- mesh__historyNote mesh__D006268 1968   
% 220.54/220.75  |- skos__hiddenLabel mesh__D006268 Health Facility
% 220.54/220.75  |- mesh__dateCreated mesh__D006268 1999-01-01
% 220.54/220.75  |- mesh__dateRevised mesh__D006268 1999-12-16
% 220.54/220.75  |- mesh__recordMaintainer mesh__D006268 ags
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006268 2003
% 220.54/220.75  |- mesh__dateEstablished mesh__D006268 1968-01-01
% 220.54/220.75  |- skos__annotation mesh__D006268 IM   
% 220.54/220.75  |- skos__hiddenLabel mesh__D006268 Facilities, Health
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006268 2004
% 220.54/220.75  |- skos__broader mesh__D006268smesh__D005159
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D006268 2002
% 220.54/220.75  |- skos__prefLabel mesh__D006268 Health Facilities
% 220.54/220.75  |- mesh__recordOriginator mesh__D006268 NLM
% 220.54/220.75  |- rdf__type mesh__D006268sskos__Concept
% 220.54/220.75  |- mesh__publicMeSHNote mesh__D006268 1968   
% 220.54/220.75  |- skos__hiddenLabel mesh__D044387 GTP Binding Protein beta Subunits
% 220.54/220.75  |- skos__altLabel mesh__D044387 G-Protein beta Subunit
% 220.54/220.75  |- skos__scopeNote mesh__D044387
% 220.54/220.75       Heterotrimeric GTP-binding protein subunits that tightly associate with GTP-BINDING PROTEIN GAMMA SUBUNITS. A dimer of beta and gamma subunits is formed when the GTP-BINDING PROTEIN ALPHA SUBUNIT dissociates from the GTP-binding protein heterotrimeric complex. The beta-gamma dimer can play an important role in signal transduction by interacting with a variety of second messengers.%A%    
% 220.54/220.75  |- mesh__historyNote mesh__D044387
% 220.54/220.75       2004; use HETEROTRIMERIC GTP-BINDING PROTEINS 2001-2003   
% 220.54/220.75  |- skos__hiddenLabel mesh__D044387 G Protein beta Subunit
% 220.54/220.75  |- mesh__recordAuthorizer mesh__D044387 sjn
% 220.54/220.75  |- skos__broader mesh__D044387smesh__D020962
% 220.54/220.75  |- mesh__dateEstablished mesh__D044387 2004-01-01
% 220.54/220.75  |- skos__prefLabel mesh__D044387 GTP-Binding Protein beta Subunits
% 220.54/220.75  |- skos__hiddenLabel mesh__D044387 beta Subunit, G-Protein
% 220.54/220.75  |- mesh__activeMeSHYear mesh__D044387 2006
% 220.54/220.75  |- mesh__recordOriginator mesh__D044387 jmp
% 220.54/220.75  |- skos__hiddenLabel mesh__D044387 Subunit, G-Protein beta
% 220.54/220.75  |- mesh__recordMaintainer mesh__D044387 SYSTEM
% 220.54/220.75  |- skos__altLabel mesh__D044387 GTP-Binding Protein beta Subunit
% 220.54/220.75  |- mesh__dateRevised mesh__D044387 2005-06-30
% 220.54/220.75  |- mesh__publicMeSHNote mesh__D044387
% 220.54/220.75       2004; see HETEROTRIMERIC GTP-BINDING PROTEINS 2001-2003   
% 220.54/220.75  |- rdf__type mesh__D044387sskos__Concept
% 220.54/220.75  |- skos__historyNote mesh__D044387
% 220.54/220.75       Heterotrimeric GTP-Binding Proteins %28%2000-2003%29%
% 220.54/220.75  |- skos__hiddenLabel mesh__D044387 GTP Binding Protein beta Subunit
% 220.54/220.75  |- mesh__dateCreated mesh__D044387 2003-07-09
% 220.54/220.75  |- mesh__dateRevised mesh__D011402 2003-07-09
% 220.54/220.75  |- skos__historyNote mesh__D011402 Peptide Hydrolases %28%1966-1970%29%
% 220.54/220.75  |- skos__scopeNote mesh__D011402
% 220.54/220.75       A proteolytic enzyme obtained from Streptomyces griseus.%A%    
% 220.54/220.75  |- mesh__historyNote mesh__D011402 73%28%71%29%   
% 220.54/220.75  |- skos__hiddenLabel mesh__D011402 P, Pronase
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D011402 2006
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D011402 2004
% 220.54/220.76  |- skos__altLabel mesh__D011402 Protease XIV
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D011402 2005
% 220.54/220.76  |- mesh__dateEstablished mesh__D011402 1973-01-01
% 220.54/220.76  |- rdf__type mesh__D011402sskos__Concept
% 220.54/220.76  |- mesh__publicMeSHNote mesh__D011402 73   
% 220.54/220.76  |- mesh__recordAuthorizer mesh__D011402 sjn
% 220.54/220.76  |- skos__hiddenLabel mesh__D011402 XIV, Protease
% 220.54/220.76  |- skos__hiddenLabel mesh__D011402 E, Pronase
% 220.54/220.76  |- mesh__recordMaintainer mesh__D011402 jmp
% 220.54/220.76  |- mesh__recordOriginator mesh__D011402 NLM
% 220.54/220.76  |- mesh__dateCreated mesh__D011402 1999-01-01
% 220.54/220.76  |- skos__prefLabel mesh__D011402 Pronase
% 220.54/220.76  |- skos__broader mesh__D011402smesh__D012697
% 220.54/220.76  |- skos__broader mesh__D011402smesh__D008666
% 220.54/220.76  |- mesh__dateEstablished mesh__D049870 2006-01-01
% 220.54/220.76  |- mesh__recordOriginator mesh__D049870 ags
% 220.54/220.76  |- skos__prefLabel mesh__D049870 Hermissenda
% 220.54/220.76  |- mesh__historyNote mesh__D049870 2006   
% 220.54/220.76  |- mesh__recordAuthorizer mesh__D049870 sjn
% 220.54/220.76  |- skos__scopeNote mesh__D049870
% 220.54/220.76       A genus of marine sea slugs in the family Glaucidae, superorder GASTROPODA, found on the Pacific coast of North America. They are used in behavioral and neurological laboratory studies.%A%    
% 220.54/220.76  |- mesh__publicMeSHNote mesh__D049870 2006   
% 220.54/220.76  |- mesh__recordMaintainer mesh__D049870 ags
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D049870 2006
% 220.54/220.76  |- skos__historyNote mesh__D049870 Mollusca %28%1967-2005%29%
% 220.54/220.76  |- skos__broader mesh__D049870smesh__D049851
% 220.54/220.76  |- mesh__dateCreated mesh__D049870 2005-06-30
% 220.54/220.76  |- rdf__type mesh__D049870sskos__Concept
% 220.54/220.76  |- skos__hiddenLabel mesh__D002676 Births, Unwanted
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002676 2003
% 220.54/220.76  |- skos__hiddenLabel mesh__D002676 Unwanted Birth
% 220.54/220.76  |- rdf__type mesh__D002676sskos__Concept
% 220.54/220.76  |- mesh__dateRevised mesh__D002676 2002-07-02
% 220.54/220.76  |- skos__hiddenLabel mesh__D002676 Children, Unwanted
% 220.54/220.76  |- skos__hiddenLabel mesh__D002676 Birth, Unwanted
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002676 2004
% 220.54/220.76  |- skos__scopeNote mesh__D002676
% 220.54/220.76       The child who is not wanted by one or both parents.     
% 220.54/220.76  |- mesh__publicMeSHNote mesh__D002676 78   
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002676 2005
% 220.54/220.76  |- mesh__dateEstablished mesh__D002676 1978-01-01
% 220.54/220.76  |- mesh__recordMaintainer mesh__D002676 TPW
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002676 2006
% 220.54/220.76  |- skos__annotation mesh__D002676 check also tag CHILD or specific   
% 220.54/220.76  |- mesh__recordAuthorizer mesh__D002676 sjn
% 220.54/220.76  |- skos__altLabel mesh__D002676 Unwanted Children
% 220.54/220.76  |- skos__historyNote mesh__D002676 Parent-Child Relations %28%1966-1977%29%
% 220.54/220.76  |- skos__broader mesh__D002676smesh__D009272
% 220.54/220.76  |- mesh__recordOriginator mesh__D002676 EC
% 220.54/220.76  |- mesh__dateCreated mesh__D002676 1977-04-22
% 220.54/220.76  |- skos__prefLabel mesh__D002676 Child, Unwanted
% 220.54/220.76  |- mesh__historyNote mesh__D002676 78   
% 220.54/220.76  |- skos__hiddenLabel mesh__D002676 Unwanted Child
% 220.54/220.76  |- skos__historyNote mesh__D002676 Pregnancy, Unwanted %28%1973-1977%29%
% 220.54/220.76  |- skos__hiddenLabel mesh__D007361 Mental Test
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007361 1996
% 220.54/220.76  |- mesh__recordAuthorizer mesh__D007361 PLS
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007361 2001
% 220.54/220.76  |- skos__hiddenLabel mesh__D007361 Test, Mental
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007361 2004
% 220.54/220.76  |- mesh__dateCreated mesh__D007361 1999-01-01
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007361 1997
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007361 2002
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007361 2005
% 220.54/220.76  |- skos__hiddenLabel mesh__D007361 Tests, Mental
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007361 1993
% 220.54/220.76  |- mesh__dateRevised mesh__D007361 1992-05-14
% 220.54/220.76  |- skos__scopeNote mesh__D007361
% 220.54/220.76       Standardized tests that measure the present general ability or aptitude for intellectual performance.%A%    
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007361 1998
% 220.54/220.76  |- skos__hiddenLabel mesh__D007361 Intelligence Test
% 220.54/220.76  |- skos__hiddenLabel mesh__D007361 Test, Intelligence
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007361 2006
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007361 1994
% 220.54/220.76  |- skos__hiddenLabel mesh__D007361 Tests, Intelligence
% 220.54/220.76  |- mesh__recordMaintainer mesh__D007361 TAP
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007361 1999
% 220.54/220.76  |- skos__broader mesh__D007361smesh__D001077
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007361 1995
% 220.54/220.76  |- skos__prefLabel mesh__D007361 Intelligence Tests
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007361 2000
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007361 2003
% 220.54/220.76  |- rdf__type mesh__D007361sskos__Concept
% 220.54/220.76  |- mesh__recordOriginator mesh__D007361 NLM
% 220.54/220.76  |- mesh__dateRevised mesh__D020738 2004-07-07
% 220.54/220.76  |- skos__scopeNote mesh__D020738
% 220.54/220.76       A 16-kDa peptide hormone secreted from white adipocytes and implicated in the regulation of food intake and energy balance. Leptin provides the key afferent signal from fat cells in the feedback system that controls body fat stores.%A%    
% 220.54/220.76  |- skos__altLabel mesh__D020738 Obese Gene Product
% 220.54/220.76  |- skos__hiddenLabel mesh__D020738 Product, Ob Gene
% 220.54/220.76  |- mesh__recordMaintainer mesh__D020738 jmp
% 220.54/220.76  |- mesh__recordOriginator mesh__D020738 ags
% 220.54/220.76  |- skos__hiddenLabel mesh__D020738 Protein, Ob
% 220.54/220.76  |- mesh__historyNote mesh__D020738 2000; use LEPTIN %28%NM%29% 1995-1999   
% 220.54/220.76  |- mesh__dateEstablished mesh__D020738 2000-01-01
% 220.54/220.76  |- skos__altLabel mesh__D020738 Obese Protein
% 220.54/220.76  |- rdf__type mesh__D020738sskos__Concept
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D020738 2006
% 220.54/220.76  |- skos__prefLabel mesh__D020738 Leptin
% 220.54/220.76  |- skos__hiddenLabel mesh__D020738 Gene Product, Obese
% 220.54/220.76  |- skos__altLabel mesh__D020738 Ob Protein
% 220.54/220.76  |- mesh__publicMeSHNote mesh__D020738
% 220.54/220.76       2000; OB PROTEIN %28%now LEPTIN%29% was indexed under PROTEINS 1995-1999%A%  
% 220.54/220.76  |- skos__altLabel mesh__D020738 Ob Gene Product
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D020738 2005
% 220.54/220.76  |- mesh__dateCreated mesh__D020738 1999-11-03
% 220.54/220.76  |- skos__historyNote mesh__D020738 Proteins %28%1995-1999%29%
% 220.54/220.76  |- skos__hiddenLabel mesh__D020738 Product, Obese Gene
% 220.54/220.76  |- mesh__recordAuthorizer mesh__D020738 sjn
% 220.54/220.76  |- skos__hiddenLabel mesh__D020738 Gene Product, Ob
% 220.54/220.76  |- skos__broader mesh__D020738smesh__D036361
% 220.54/220.76  |- skos__hiddenLabel mesh__D020738 Protein, Obese
% 220.54/220.76  |- skos__hiddenLabel mesh__D006269 Facility, Proprietary Health
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D006269 2006
% 220.54/220.76  |- skos__broader mesh__D006269smesh__D006268
% 220.54/220.76  |- mesh__dateRevised mesh__D006269 1999-11-03
% 220.54/220.76  |- skos__hiddenLabel mesh__D006269 Facilities, Proprietary Health
% 220.54/220.76  |- skos__hiddenLabel mesh__D006269 Privately Sponsored Program
% 220.54/220.76  |- skos__hiddenLabel mesh__D006269 Program, Privately Sponsored
% 220.54/220.76  |- skos__hiddenLabel mesh__D006269 Health Facility, Proprietary
% 220.54/220.76  |- skos__prefLabel mesh__D006269 Health Facilities, Proprietary
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D006269 2003
% 220.54/220.76  |- mesh__recordMaintainer mesh__D006269 kle
% 220.54/220.76  |- mesh__dateEstablished mesh__D006269 1991-01-01
% 220.54/220.76  |- skos__altLabel mesh__D006269 Proprietary Health Facilities
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D006269 2000
% 220.54/220.76  |- mesh__historyNote mesh__D006269
% 220.54/220.76       91%28%Aug 77%29%; was see under HEALTH FACILITIES 1977-90   
% 220.54/220.76  |- skos__hiddenLabel mesh__D006269 Programs, Privately Sponsored
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D006269 2004
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D006269 2001
% 220.54/220.76  |- skos__scopeNote mesh__D006269
% 220.54/220.76       Health care institutions operated by private groups or corporations for a profit.%A%    
% 220.54/220.76  |- skos__hiddenLabel mesh__D006269 Proprietary Health Facility
% 220.54/220.76  |- rdf__type mesh__D006269sskos__Concept
% 220.54/220.76  |- skos__annotation mesh__D006269
% 220.54/220.76       %22%operated by private groups or corporations for a profit%22%%A%  
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D006269 2005
% 220.54/220.76  |- mesh__recordAuthorizer mesh__D006269 sjn
% 220.54/220.76  |- mesh__dateCreated mesh__D006269 1977-05-05
% 220.54/220.76  |- mesh__publicMeSHNote mesh__D006269
% 220.54/220.76       91; was see under HEALTH FACILITIES Aug 1977-90   
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D006269 2002
% 220.54/220.76  |- mesh__recordOriginator mesh__D006269 EC
% 220.54/220.76  |- skos__historyNote mesh__D044388
% 220.54/220.76       Heterotrimeric GTP-Binding Proteins %28%2000-2003%29%
% 220.54/220.76  |- skos__prefLabel mesh__D044388 GTP-Binding Protein gamma Subunits
% 220.54/220.76  |- skos__hiddenLabel mesh__D044388 Subunit, G-Protein gamma
% 220.54/220.76  |- skos__hiddenLabel mesh__D044388 G Protein gamma Subunit
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D044388 2006
% 220.54/220.76  |- mesh__historyNote mesh__D044388
% 220.54/220.76       2004; use HETEROTRIMERIC GTP-BINDING PROTEINS 2001-2003   
% 220.54/220.76  |- skos__hiddenLabel mesh__D044388 GTP Binding Protein gamma Subunits
% 220.54/220.76  |- mesh__recordMaintainer mesh__D044388 SYSTEM
% 220.54/220.76  |- mesh__recordAuthorizer mesh__D044388 sjn
% 220.54/220.76  |- skos__broader mesh__D044388smesh__D020962
% 220.54/220.76  |- mesh__dateEstablished mesh__D044388 2004-01-01
% 220.54/220.76  |- skos__altLabel mesh__D044388 G-Protein gamma Subunit
% 220.54/220.76  |- rdf__type mesh__D044388sskos__Concept
% 220.54/220.76  |- mesh__dateCreated mesh__D044388 2003-07-09
% 220.54/220.76  |- skos__hiddenLabel mesh__D044388 GTP Binding Protein gamma Subunit
% 220.54/220.76  |- mesh__recordOriginator mesh__D044388 jmp
% 220.54/220.76  |- skos__hiddenLabel mesh__D044388 gamma Subunit, G-Protein
% 220.54/220.76  |- skos__scopeNote mesh__D044388
% 220.54/220.76       Heterotrimeric GTP-binding protein subunits that tightly associate with GTP-BINDING PROTEIN BETA SUBUNITS. A dimer of beta and gamma subunits is formed when the GTP-BINDING PROTEIN ALPHA SUBUNIT dissociates from the GTP-binding protein heterotrimeric complex. The beta-gamma dimer can play an important role in signal transduction by interacting with a variety of second messengers.%A%    
% 220.54/220.76  |- skos__altLabel mesh__D044388 GTP-Binding Protein gamma Subunit
% 220.54/220.76  |- mesh__dateRevised mesh__D044388 2005-06-30
% 220.54/220.76  |- mesh__publicMeSHNote mesh__D044388
% 220.54/220.76       2004; see HETEROTRIMERIC GTP-BINDING PROTEINS 2001-2003   
% 220.54/220.76  |- skos__historyNote mesh__D011403 Movement %28%1966-1987%29%
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D011403 2006
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D011403 2004
% 220.54/220.76  |- mesh__historyNote mesh__D011403 88   
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D011403 2005
% 220.54/220.76  |- skos__historyNote mesh__D011403 Posture %28%1966-1987%29%
% 220.54/220.76  |- rdf__type mesh__D011403sskos__Concept
% 220.54/220.76  |- skos__scopeNote mesh__D011403
% 220.54/220.76       Applies to movements of the forearm in turning the palm backward or downward or when applied to the foot, a combination of eversion and abduction movements in the tarsal and metatarsal joints, %28%turning the foot up and in toward the midline of the body%29%.%A%    
% 220.54/220.76  |- mesh__recordOriginator mesh__D011403 EC
% 220.54/220.76  |- skos__annotation mesh__D011403
% 220.54/220.76       refers to foot or forearm; do not confuse with PRONE POSITION%A%  
% 220.54/220.76  |- mesh__recordMaintainer mesh__D011403 nns
% 220.54/220.76  |- mesh__dateCreated mesh__D011403 1987-04-02
% 220.54/220.76  |- skos__hiddenLabel mesh__D011403 Pronations
% 220.54/220.76  |- mesh__recordAuthorizer mesh__D011403 sjn
% 220.54/220.76  |- mesh__dateRevised mesh__D011403 2003-07-09
% 220.54/220.76  |- mesh__publicMeSHNote mesh__D011403 88   
% 220.54/220.76  |- skos__broader mesh__D011403smesh__D009068
% 220.54/220.76  |- skos__prefLabel mesh__D011403 Pronation
% 220.54/220.76  |- mesh__dateEstablished mesh__D011403 1988-01-01
% 220.54/220.76  |- mesh__publicMeSHNote mesh__D049871 2006   
% 220.54/220.76  |- mesh__dateEstablished mesh__D049871 2006-01-01
% 220.54/220.76  |- mesh__recordOriginator mesh__D049871 ags
% 220.54/220.76  |- mesh__recordMaintainer mesh__D049871 ags
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D049871 2006
% 220.54/220.76  |- skos__scopeNote mesh__D049871
% 220.54/220.76       A genus of large marine sea slugs in the family Tritoniidae found in the northern Pacific Ocean. They are used in neurological research.%A%    
% 220.54/220.76  |- mesh__historyNote mesh__D049871 2006   
% 220.54/220.76  |- skos__prefLabel mesh__D049871 Tritonia Sea Slug
% 220.54/220.76  |- mesh__recordAuthorizer mesh__D049871 sjn
% 220.54/220.76  |- skos__broader mesh__D049871smesh__D049851
% 220.54/220.76  |- rdf__type mesh__D049871sskos__Concept
% 220.54/220.76  |- skos__historyNote mesh__D049871 Mollusca %28%1965-2005%29%
% 220.54/220.76  |- mesh__dateCreated mesh__D049871 2005-06-30
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D016697 2006A
% 220.54/220.76  |- skos__related mesh__D016697smesh__D005158
% 220.54/220.76  |- skos__prefLabel mesh__D016697 Herpes Zoster Oticus
% 220.54/220.76  |- skos__broader mesh__D016697smesh__D004427
% 220.54/220.76  |- rdf__type mesh__D016697sskos__Concept
% 220.54/220.76  |- mesh__dateCreated mesh__D016697 1991-07-03
% 220.54/220.76  |- skos__hiddenLabel mesh__D016697 Geniculate Neuralgia
% 220.54/220.76  |- mesh__historyNote mesh__D016697 92   
% 220.54/220.76  |- skos__hiddenLabel mesh__D016697 Geniculate Ganglionitides, Herpetic
% 220.54/220.76  |- skos__altLabel mesh__D016697 Ramsay Hunt Auricular Syndrome
% 220.54/220.76  |- skos__altLabel mesh__D016697 Herpes Zoster Auricularis
% 220.54/220.76  |- mesh__recordMaintainer mesh__D016697 ags
% 220.54/220.76  |- skos__altLabel mesh__D016697 Geniculate Herpes Zoster
% 220.54/220.76  |- mesh__recordAuthorizer mesh__D016697 ags
% 220.54/220.76  |- mesh__recordOriginator mesh__D016697 TGC
% 220.54/220.76  |- skos__historyNote mesh__D016697 Herpes Zoster %28%1966-1991%29%
% 220.54/220.76  |- mesh__publicMeSHNote mesh__D016697 92   
% 220.54/220.76  |- skos__broader mesh__D016697smesh__D006562
% 220.54/220.76  |- skos__hiddenLabel mesh__D016697 Herpetic Geniculate Ganglionitides
% 220.54/220.76  |- skos__hiddenLabel mesh__D016697 Geniculate Neuralgias
% 220.54/220.76  |- mesh__dateRevised mesh__D016697 2005-07-20
% 220.54/220.76  |- skos__altLabel mesh__D016697 Herpetic Geniculate Ganglionitis
% 220.54/220.76  |- skos__altLabel mesh__D016697 Auricular Syndrome of Ramsay Hunt
% 220.54/220.76  |- mesh__dateEstablished mesh__D016697 1992-01-01
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D016697 2006
% 220.54/220.76  |- skos__hiddenLabel mesh__D016697 Herpes Zoster, Geniculate
% 220.54/220.76  |- skos__scopeNote mesh__D016697
% 220.54/220.76       A syndrome characterized by facial palsy in association with a herpetic eruption of the external auditory meatus. This may occasionally be associated with tinnitus, vertigo, deafness, severe otalgia, and inflammation of the pinna. The condition is caused by reactivation of a latent HERPESVIRUS 3, HUMAN infection which causes inflammation of the facial and vestibular nerves, and may occasionally involve additional cranial nerves. %28%From Adams et al., Principles of Neurology, 6th ed, p757%29%%A%    
% 220.54/220.76  |- skos__altLabel mesh__D016697 Herpes Zoster Cephalicus
% 220.54/220.76  |- skos__hiddenLabel mesh__D016697 Neuralgias, Geniculate
% 220.54/220.76  |- skos__altLabel mesh__D016697 Neuralgia, Geniculate
% 220.54/220.76  |- skos__hiddenLabel mesh__D016697 Geniculate Ganglionitis, Herpetic
% 220.54/220.76  |- skos__historyNote mesh__D016697 Facial Paralysis %28%1966-1991%29%
% 220.54/220.76  |- skos__broader mesh__D016697smesh__D005155
% 220.54/220.76  |- skos__annotation mesh__D016697
% 220.54/220.76       do not confuse X ref RAMSAY HUNT AURICULAR SYNDROME with RAMSAY HUNT PARALYSIS SYNDROME see PARKINSONIAN DISORDERS or RAMSAY HUNT CEREBELLAR SYNDROME see MYOCLONIC CEREBELLAR DYSSYNERGIA%A%  
% 220.54/220.76  |- skos__hiddenLabel mesh__D016697 Ganglionitis, Herpetic Geniculate
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002677 2001
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002677 2003
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002677 1997
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002677 1990
% 220.54/220.76  |- mesh__recordOriginator mesh__D002677 NLM
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002677 1992
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002677 2002
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002677 2004
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002677 1998
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002677 1991
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002677 1993
% 220.54/220.76  |- mesh__dateRevised mesh__D002677 1991-11-04
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002677 2005
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002677 1999
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002677 1994
% 220.54/220.76  |- mesh__dateCreated mesh__D002677 1999-01-01
% 220.54/220.76  |- skos__prefLabel mesh__D002677 Chile
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002677 2006
% 220.54/220.76  |- mesh__recordMaintainer mesh__D002677 PLS
% 220.54/220.76  |- skos__broader mesh__D002677smesh__D013020
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002677 1989
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002677 2000
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002677 1995
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D002677 1996
% 220.54/220.76  |- mesh__recordAuthorizer mesh__D002677 PLS
% 220.54/220.76  |- rdf__type mesh__D002677sskos__Concept
% 220.54/220.76  |- mesh__historyNote mesh__D007362 66%28%63%29%   
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007362 1997
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007362 2000
% 220.54/220.76  |- skos__hiddenLabel mesh__D007362 Care Units, Intensive
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007362 2005
% 220.54/220.76  |- mesh__recordOriginator mesh__D007362 NLM
% 220.54/220.76  |- mesh__recordAuthorizer mesh__D007362 PLS
% 220.54/220.76  |- mesh__recordMaintainer mesh__D007362 KEV
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007362 1998
% 220.54/220.76  |- mesh__publicMeSHNote mesh__D007362 66   
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007362 2001
% 220.54/220.76  |- skos__scopeNote mesh__D007362
% 220.54/220.76       Hospital units providing continuous surveillance and care to acutely ill patients.%A%    
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007362 2006
% 220.54/220.76  |- mesh__dateEstablished mesh__D007362 1966-01-01
% 220.54/220.76  |- skos__broader mesh__D007362smesh__D006757
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007362 1999
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007362 2002
% 220.54/220.76  |- skos__hiddenLabel mesh__D007362 Unit, Intensive Care
% 220.54/220.76  |- skos__hiddenLabel mesh__D007362 Care Unit, Intensive
% 220.54/220.76  |- rdf__type mesh__D007362sskos__Concept
% 220.54/220.76  |- skos__hiddenLabel mesh__D007362 Intensive Care Unit
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007362 2003
% 220.54/220.76  |- mesh__dateRevised mesh__D007362 1995-05-23
% 220.54/220.76  |- skos__hiddenLabel mesh__D007362 Units, Intensive Care
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007362 1996
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D007362 2004
% 220.54/220.76  |- skos__prefLabel mesh__D007362 Intensive Care Units
% 220.54/220.76  |- mesh__dateCreated mesh__D007362 1999-01-01
% 220.54/220.76  |- mesh__historyNote mesh__D020739 2000   
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D020739 2005
% 220.54/220.76  |- skos__historyNote mesh__D020739
% 220.54/220.76       Metabolic Diseases/genetics %28%1968-1999%29%
% 220.54/220.76  |- skos__prefLabel mesh__D020739 Brain Diseases, Metabolic, Inborn
% 220.54/220.76  |- skos__altLabel mesh__D020739 Inborn Errors of Metabolism, Brain
% 220.54/220.76  |- skos__altLabel mesh__D020739 Metabolic Diseases, Inborn, Brain
% 220.54/220.76  |- skos__altLabel mesh__D020739 Inborn Metabolic Disorders, Brain
% 220.54/220.76  |- mesh__dateRevised mesh__D020739 2003-07-25
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D020739 2006
% 220.54/220.76  |- skos__altLabel mesh__D020739 Metabolic Brain Syndrome, Inborn
% 220.54/220.76  |- skos__altLabel mesh__D020739
% 220.54/220.76       Central Nervous System Inborn Metabolic Disorders
% 220.54/220.76  |- skos__altLabel mesh__D020739 Metabolic Brain Diseases, Familial
% 220.54/220.76  |- skos__altLabel mesh__D020739 Inherited Metabolic Brain Diseases
% 220.54/220.76  |- skos__historyNote mesh__D020739 Brain/metabolism %28%1968-1999%29%
% 220.54/220.76  |- skos__altLabel mesh__D020739 Inborn Metabolic Brain Diseases
% 220.54/220.76  |- skos__altLabel mesh__D020739 Brain Diseases, Metabolic, Familial
% 220.54/220.76  |- skos__altLabel mesh__D020739 Brain Syndrome, Metabolic, Inborn
% 220.54/220.76  |- skos__altLabel mesh__D020739 Inborn Metabolic Brain Disorders
% 220.54/220.76  |- skos__annotation mesh__D020739
% 220.54/220.76       GEN: prefer specifics; DF: BRAIN DIS METAB INBORN   
% 220.54/220.76  |- skos__related mesh__D020739smesh__D008607
% 220.54/220.76  |- skos__altLabel mesh__D020739 Metabolic Disorders, Familial, Brain
% 220.54/220.76  |- mesh__publicMeSHNote mesh__D020739 2000   
% 220.54/220.76  |- skos__altLabel mesh__D020739 Metabolic Disorders, CNS, Inborn
% 220.54/220.76  |- skos__historyNote mesh__D020739 Hereditary Diseases %28%1968-1999%29%
% 220.54/220.76  |- skos__historyNote mesh__D020739
% 220.54/220.76       Metabolism, Inborn Errors %28%1972-1999%29%
% 220.54/220.76  |- skos__altLabel mesh__D020739
% 220.54/220.76       Metabolic Diseases, Inborn, Central Nervous System
% 220.54/220.76  |- mesh__recordAuthorizer mesh__D020739 sjn
% 220.54/220.76  |- skos__altLabel mesh__D020739 CNS Metabolic Disorders, Inborn
% 220.54/220.76  |- skos__altLabel mesh__D020739 Metabolic Brain Diseases, Inborn
% 220.54/220.76  |- mesh__recordMaintainer mesh__D020739 sjn
% 220.54/220.76  |- rdf__type mesh__D020739sskos__Concept
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D020739 2004
% 220.54/220.76  |- skos__altLabel mesh__D020739 Metabolic Brain Diseases, Inherited
% 220.54/220.76  |- skos__broader mesh__D020739smesh__D008661
% 220.54/220.76  |- mesh__dateEstablished mesh__D020739 2000-01-01
% 220.54/220.76  |- skos__altLabel mesh__D020739 Inherited Metabolic Disorders, Brain
% 220.54/220.76  |- skos__scopeNote mesh__D020739
% 220.54/220.76       Errors of brain metabolism resulting from inborn, primarily enzymatic, deficiency states. The majority of these conditions are familial, however spontaneous mutation may also occur. Deficient enzyme activity may cause brain dysfunction by leading to the accumulation of substrate, reduced product formation, or by causing metabolism to occur through alternate pathways.%A%    
% 220.54/220.76  |- skos__broader mesh__D020739smesh__D001928
% 220.54/220.76  |- mesh__dateCreated mesh__D020739 1999-11-03
% 220.54/220.76  |- skos__altLabel mesh__D020739 Encephalopathies, Metabolic, Inborn
% 220.54/220.76  |- skos__altLabel mesh__D020739 Familial Metabolic Disorders, Brain
% 220.54/220.76  |- skos__altLabel mesh__D020739 Familial Metabolic Brain Diseases
% 220.54/220.76  |- skos__altLabel mesh__D020739 Metabolic Disorders, Brain, Inherited
% 220.54/220.76  |- mesh__recordOriginator mesh__D020739 KEV
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D017790 2005
% 220.54/220.76  |- skos__historyNote mesh__D017790 Plant Viruses %28%1979-1993%29%
% 220.54/220.76  |- mesh__recordOriginator mesh__D017790 AGS
% 220.54/220.76  |- rdf__type mesh__D017790sskos__Concept
% 220.54/220.76  |- skos__prefLabel mesh__D017790 Closterovirus
% 220.54/220.76  |- skos__scopeNote mesh__D017790
% 220.54/220.76       A genus of plant viruses in the family CLOSTEROVIRIDAE containing highly flexuous filaments. Some members are important pathogens of crop plants. Natural vectors include APHIDS, whiteflies, and mealybugs. The type species is Beet yellows virus.%A%    
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D017790 2006
% 220.54/220.76  |- mesh__dateCreated mesh__D017790 1993-06-04
% 220.54/220.76  |- skos__broader mesh__D017790smesh__D029381
% 220.54/220.76  |- mesh__recordMaintainer mesh__D017790 ags
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D017790 2003
% 220.54/220.76  |- mesh__historyNote mesh__D017790 1994   
% 220.54/220.76  |- mesh__publicMeSHNote mesh__D017790 1994   
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D017790 2004
% 220.54/220.76  |- mesh__dateRevised mesh__D017790 2001-07-25
% 220.54/220.76  |- mesh__dateEstablished mesh__D017790 1994-01-01
% 220.54/220.76  |- skos__annotation mesh__D017790 coord IM with specific plant /virol   
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D017790 2002
% 220.54/220.76  |- mesh__recordAuthorizer mesh__D017790 sjn
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D031461 2003
% 220.54/220.76  |- mesh__historyNote mesh__D031461
% 220.54/220.76       2003; for NUX-VOMICA use STRYCHNINE 1979-2001, use NUX VOMICA 1963-1978%A%  
% 220.54/220.76  |- mesh__publicMeSHNote mesh__D031461
% 220.54/220.76       2003; for NUX-VOMICA see STRYCHNINE 1979-2001, see NUX VOMICA 1963-1978%A%  
% 220.54/220.76  |- mesh__recordOriginator mesh__D031461 ssb
% 220.54/220.76  |- skos__hiddenLabel mesh__D031461 Vomica, Nux
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D031461 2004
% 220.54/220.76  |- skos__altLabel mesh__D031461 Strychninetree
% 220.54/220.76  |- skos__altLabel mesh__D031461 Nux Vomica
% 220.54/220.76  |- rdf__type mesh__D031461sskos__Concept
% 220.54/220.76  |- skos__annotation mesh__D031461
% 220.54/220.76       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.54/220.76  |- mesh__recordMaintainer mesh__D031461 ssb
% 220.54/220.76  |- mesh__dateEstablished mesh__D031461 2003-01-01
% 220.54/220.76  |- mesh__dateCreated mesh__D031461 2002-07-03
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D031461 2005
% 220.54/220.76  |- skos__scopeNote mesh__D031461
% 220.54/220.76       A plant genus of the genus STRYCHNOS, family LOGANIACEAE that is the source of STRYCHNINE.%A%    
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D031461 2006
% 220.54/220.76  |- skos__prefLabel mesh__D031461 Strychnos nux-vomica
% 220.54/220.76  |- mesh__recordAuthorizer mesh__D031461 sjn
% 220.54/220.76  |- skos__broader mesh__D031461smesh__D031451
% 220.54/220.76  |- mesh__dateEstablished mesh__D003770 1972-01-01
% 220.54/220.76  |- skos__scopeNote mesh__D003770
% 220.54/220.76       The room or rooms in which the dentist and dental staff provide care. Offices include all rooms in the dentist%27%s office suite.%A%    
% 220.54/220.76  |- skos__altLabel mesh__D003770 Office, Dental
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D003770 2002
% 220.54/220.76  |- skos__altLabel mesh__D003770 Dental Office
% 220.54/220.76  |- skos__prefLabel mesh__D003770 Dental Offices
% 220.54/220.76  |- mesh__recordOriginator mesh__D003770 NLM
% 220.54/220.76  |- mesh__onlineNote mesh__D003770
% 220.54/220.76       use DENTAL OFFICES to search DENTAL OFFICE 1970-71 %28%as Prov%29%%A%  
% 220.54/220.76  |- skos__annotation mesh__D003770 DF: DENT OFFICES   
% 220.54/220.76  |- mesh__historyNote mesh__D003770
% 220.54/220.76       72; was DENTAL OFFICE 1970-71 %28%Prov%29%   
% 220.54/220.76  |- skos__historyNote mesh__D003770 Health Facilities %28%1968-1969%29%
% 220.54/220.76  |- mesh__publicMeSHNote mesh__D003770 72   
% 220.54/220.76  |- mesh__recordMaintainer mesh__D003770 jls
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D003770 2003
% 220.54/220.76  |- rdf__type mesh__D003770sskos__Concept
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D003770 2005
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D003770 2000
% 220.54/220.76  |- skos__broader mesh__D003770smesh__D003749
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D003770 2004
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D003770 2001
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D003770 2006
% 220.54/220.76  |- mesh__dateCreated mesh__D003770 1999-01-01
% 220.54/220.76  |- mesh__dateRevised mesh__D003770 1999-11-03
% 220.54/220.76  |- mesh__recordAuthorizer mesh__D003770 sjn
% 220.54/220.76  |- skos__altLabel mesh__D003770 Offices, Dental
% 220.54/220.76  |- skos__scopeNote mesh__D049872
% 220.54/220.76       A class in the phylum MOLLUSCA comprised of mussels; clams; OYSTERS; COCKLES; and SCALLOPS. They are characterized by a bilaterally symmetrical hinged shell and a muscular foot used for burrowing and anchoring.%A%    
% 220.54/220.76  |- skos__historyNote mesh__D049872 Mollusca %28%1968-2005%29%
% 220.54/220.76  |- mesh__recordMaintainer mesh__D049872 ags
% 220.54/220.76  |- rdf__type mesh__D049872sskos__Concept
% 220.54/220.76  |- mesh__recordAuthorizer mesh__D049872 ags
% 220.54/220.76  |- mesh__dateCreated mesh__D049872 2005-06-30
% 220.54/220.76  |- skos__altLabel mesh__D049872 Bivalves
% 220.54/220.76  |- mesh__dateEstablished mesh__D049872 2006-01-01
% 220.54/220.76  |- skos__broader mesh__D049872smesh__D008974
% 220.54/220.76  |- skos__annotation mesh__D049872
% 220.54/220.76       as animal %26% food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH %28%IM%29%%A%  
% 220.54/220.76  |- mesh__recordOriginator mesh__D049872 ags
% 220.54/220.76  |- mesh__publicMeSHNote mesh__D049872
% 220.54/220.76       2006; for MUSSELS see MUSSELS 1972-2005; for CLAMS see CLAMS 1972-2005%A%  
% 220.54/220.76  |- mesh__historyNote mesh__D049872 2006   
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D049872 2006A
% 220.54/220.76  |- mesh__activeMeSHYear mesh__D049872 2006
% 220.54/220.76  |- mesh__dateRevised mesh__D049872 2005-07-14
% 220.54/220.76  |- skos__prefLabel mesh__D049872 Bivalvia
% 220.54/220.77  |- skos__altLabel mesh__D016698 99mTc-Pyrophosphate
% 220.54/220.77  |- skos__hiddenLabel mesh__D016698 99mTc Pyrophosphate
% 220.54/220.77  |- skos__broader mesh__D016698smesh__D017556
% 220.54/220.77  |- mesh__recordMaintainer mesh__D016698 WXM
% 220.54/220.77  |- skos__altLabel mesh__D016698 Diphosphoric Acid, Technetium Salt
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D016698 2005
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D016698 2002
% 220.54/220.77  |- mesh__onlineNote mesh__D016698
% 220.54/220.77       use TECHNETIUM TC 99M PYROPHOSPHATE %28%NM%29% to search TECHNETIUM TC 99M PYROPHOSPHATE 1978-91%A%  
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D016698 2006
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D016698 2003
% 220.54/220.77  |- mesh__dateCreated mesh__D016698 1991-02-11
% 220.54/220.77  |- skos__broader mesh__D016698smesh__D011756
% 220.54/220.77  |- mesh__recordOriginator mesh__D016698 RLS
% 220.54/220.77  |- skos__prefLabel mesh__D016698 Technetium Tc 99m Pyrophosphate
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D016698 2004
% 220.54/220.77  |- skos__hiddenLabel mesh__D016698 Tc 99m Pyrophosphate
% 220.54/220.77  |- skos__scopeNote mesh__D016698
% 220.54/220.77       A radionuclide imaging agent used primarily in scintigraphy or tomography of the heart to evaluate the extent of the necrotic myocardial process. It has also been used in noninvasive tests for the distribution of organ involvement in different types of amyloidosis and for the evaluation of muscle necrosis in the extremities.%A%    
% 220.54/220.77  |- skos__historyNote mesh__D016698 Technetium %28%1966-1991%29%
% 220.54/220.77  |- skos__historyNote mesh__D016698 Pyrophosphates %28%1966-1991%29%
% 220.54/220.77  |- skos__hiddenLabel mesh__D016698 Tc PYP
% 220.54/220.77  |- skos__altLabel mesh__D016698 Tc 99m-Pyrophosphate
% 220.54/220.77  |- mesh__dateEstablished mesh__D016698 1992-01-01
% 220.54/220.77  |- mesh__publicMeSHNote mesh__D016698
% 220.54/220.77       92; TECHNETIUM TC 99M PYROPHOSPHATE was indexed under TECHNETIUM 1978-91%A%  
% 220.54/220.77  |- skos__altLabel mesh__D016698 Tc-PYP
% 220.54/220.77  |- skos__annotation mesh__D016698
% 220.54/220.77       as label, use /diag use; DF: TC PYRO or TC PYP   
% 220.54/220.77  |- mesh__dateRevised mesh__D016698 2001-07-25
% 220.54/220.77  |- mesh__historyNote mesh__D016698
% 220.54/220.77       92; was TECHNETIUM TC 99M PYROPHOSPHATE %28%NM%29% 1978-91   
% 220.54/220.77  |- rdf__type mesh__D016698sskos__Concept
% 220.54/220.77  |- mesh__recordAuthorizer mesh__D016698 sjn
% 220.54/220.77  |- skos__historyNote mesh__D002678 Genetics %28%1966%29%
% 220.54/220.77  |- skos__hiddenLabel mesh__D002678 Chimeras
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D002678 2004
% 220.54/220.77  |- mesh__publicMeSHNote mesh__D002678
% 220.54/220.77       78; was see under MOSAICISM 1967-77   
% 220.54/220.77  |- skos__historyNote mesh__D002678 Mosaicism %28%1966-1977%29%
% 220.54/220.77  |- skos__prefLabel mesh__D002678 Chimera
% 220.54/220.77  |- skos__related mesh__D002678smesh__D009030
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D002678 2005
% 220.54/220.77  |- mesh__dateEstablished mesh__D002678 1978-01-01
% 220.54/220.77  |- mesh__dateRevised mesh__D002678 2003-07-09
% 220.54/220.77  |- mesh__recordOriginator mesh__D002678 NLM
% 220.54/220.77  |- mesh__dateCreated mesh__D002678 1999-01-01
% 220.54/220.77  |- mesh__recordMaintainer mesh__D002678 ags
% 220.54/220.77  |- skos__broader mesh__D002678smesh__D010944
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D002678 2006
% 220.54/220.77  |- skos__hiddenLabel mesh__D002678 Hybrid
% 220.54/220.77  |- mesh__recordAuthorizer mesh__D002678 sjn
% 220.54/220.77  |- mesh__onlineNote mesh__D002678 search MOSAICISM 1967-74   
% 220.54/220.77  |- rdf__type mesh__D002678sskos__Concept
% 220.54/220.77  |- skos__related mesh__D002678smesh__D005611
% 220.54/220.77  |- skos__broader mesh__D002678smesh__D000828
% 220.54/220.77  |- skos__scopeNote mesh__D002678
% 220.54/220.77       An individual that contains cell populations derived from different zygotes.%A%    
% 220.54/220.77  |- mesh__historyNote mesh__D002678
% 220.54/220.77       78%28%75%29%; was see under MOSAICISM 1967-77   
% 220.54/220.77  |- mesh__recordMaintainer mesh__D007363 sjn
% 220.54/220.77  |- skos__altLabel mesh__D007363 Newborn Intensive Care Units
% 220.54/220.77  |- rdf__type mesh__D007363sskos__Concept
% 220.54/220.77  |- skos__annotation mesh__D007363
% 220.54/220.77        check also tags  HUMANS %26% INFANT, NEWBORN; DF: ICU NEONATAL%A%  
% 220.54/220.77  |- skos__scopeNote mesh__D007363
% 220.54/220.77       Hospital units providing continuing surveillance and care to acutely ill newborn infants.%A%    
% 220.54/220.77  |- mesh__dateEstablished mesh__D007363 1982-01-01
% 220.54/220.77  |- skos__altLabel mesh__D007363 Neonatal Intensive Care Units
% 220.54/220.77  |- skos__historyNote mesh__D007363 Infant, Newborn %28%1966-1981%29%
% 220.54/220.77  |- mesh__publicMeSHNote mesh__D007363 82   
% 220.54/220.77  |- skos__broader mesh__D007363smesh__D015278
% 220.54/220.77  |- skos__prefLabel mesh__D007363 Intensive Care Units, Neonatal
% 220.54/220.77  |- mesh__dateRevised mesh__D007363 2004-07-13
% 220.54/220.77  |- mesh__recordOriginator mesh__D007363 EC
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D007363 2005
% 220.54/220.77  |- skos__historyNote mesh__D007363 Intensive Care Units %28%1966-1981%29%
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D007363 2006
% 220.54/220.77  |- mesh__recordAuthorizer mesh__D007363 sjn
% 220.54/220.77  |- mesh__historyNote mesh__D007363 82   
% 220.54/220.77  |- mesh__dateCreated mesh__D007363 1981-02-26
% 220.54/220.77  |- mesh__publicMeSHNote mesh__D045482 2004   
% 220.54/220.77  |- skos__hiddenLabel mesh__D045482 Hot Spring
% 220.54/220.77  |- skos__broader mesh__D045482smesh__D014867
% 220.54/220.77  |- rdf__type mesh__D045482sskos__Concept
% 220.54/220.77  |- mesh__dateEstablished mesh__D045482 2004-01-01
% 220.54/220.77  |- skos__hiddenLabel mesh__D045482 Springs, Geothermal
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D045482 2005
% 220.54/220.77  |- skos__hiddenLabel mesh__D045482 Spring, Warm
% 220.54/220.77  |- skos__hiddenLabel mesh__D045482 Geothermal Spring
% 220.54/220.77  |- skos__prefLabel mesh__D045482 Hot Springs
% 220.54/220.77  |- skos__hiddenLabel mesh__D045482 Spring, Geothermal
% 220.54/220.77  |- skos__scopeNote mesh__D045482
% 220.54/220.77       Habitat of hot water naturally heated by underlying geologic processes. Surface hot springs have been used for BALNEOLOGY.%A%    
% 220.54/220.77  |- skos__hiddenLabel mesh__D045482 Springs, Hot
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D045482 2004
% 220.54/220.77  |- mesh__historyNote mesh__D045482 2004   
% 220.54/220.77  |- skos__hiddenLabel mesh__D045482 Warm Spring
% 220.54/220.77  |- skos__hiddenLabel mesh__D045482 Springs, Warm
% 220.54/220.77  |- skos__hiddenLabel mesh__D045482 Spring, Hot
% 220.54/220.77  |- mesh__dateCreated mesh__D045482 2003-07-09
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D045482 2006
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D017791 2006
% 220.54/220.77  |- skos__historyNote mesh__D017791 Plant Viruses %28%1985-1993%29%
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D017791 2002
% 220.54/220.77  |- skos__annotation mesh__D017791 coord IM with specific plant /virol   
% 220.54/220.77  |- skos__prefLabel mesh__D017791 Geminiviridae
% 220.54/220.77  |- skos__hiddenLabel mesh__D017791 Curtoviruses
% 220.54/220.77  |- mesh__recordMaintainer mesh__D017791 ags
% 220.54/220.77  |- mesh__recordAuthorizer mesh__D017791 sjn
% 220.54/220.77  |- skos__hiddenLabel mesh__D017791 Mastreviruses
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D017791 2003
% 220.54/220.77  |- mesh__recordOriginator mesh__D017791 AGS
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D017791 2004
% 220.54/220.77  |- skos__hiddenLabel mesh__D017791 Begomoviruses
% 220.54/220.77  |- mesh__publicMeSHNote mesh__D017791 1997; see GEMINIVIRUS 1994-96   
% 220.54/220.77  |- mesh__dateCreated mesh__D017791 1993-06-04
% 220.54/220.77  |- mesh__historyNote mesh__D017791 1997%28%1994%29%   
% 220.54/220.77  |- skos__broader mesh__D017791smesh__D010942
% 220.54/220.77  |- mesh__dateRevised mesh__D017791 2001-07-25
% 220.54/220.77  |- skos__broader mesh__D017791smesh__D004267
% 220.54/220.77  |- skos__altLabel mesh__D017791 Geminivirus
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D017791 2005
% 220.54/220.77  |- skos__scopeNote mesh__D017791
% 220.54/220.77       A family of plant viruses where the virions possess an unusual morphology consisting of a pair of isometric particles. Transmission occurs via leafhoppers or whitefly. Some viruses cause economically important diseases in cultivated plants. There are three genera: Mastrevirus, Curtovirus, and Begomovirus.%A%    
% 220.54/220.77  |- skos__hiddenLabel mesh__D017791 Geminiviruses
% 220.54/220.77  |- mesh__dateEstablished mesh__D017791 1994-01-01
% 220.54/220.77  |- rdf__type mesh__D017791sskos__Concept
% 220.54/220.77  |- skos__altLabel mesh__D003771 Dental Papillae
% 220.54/220.77  |- skos__prefLabel mesh__D003771 Dental Papilla
% 220.54/220.77  |- rdf__type mesh__D003771sskos__Concept
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D003771 2005
% 220.54/220.77  |- mesh__recordAuthorizer mesh__D003771 sjn
% 220.54/220.77  |- mesh__historyNote mesh__D003771
% 220.54/220.77       91%28%75%29%; was see under TOOTH GERM 1975-90   
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D003771 2004
% 220.54/220.77  |- skos__annotation mesh__D003771
% 220.54/220.77       gives rise to dentin %26% pulp; do not confuse with interdental papilla %28%index under GINGIVA%29%; DF: DENT PAPILLA%A%  
% 220.54/220.77  |- mesh__recordMaintainer mesh__D003771 lkt
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D003771 2006
% 220.54/220.77  |- mesh__dateCreated mesh__D003771 1999-01-01
% 220.54/220.77  |- skos__altLabel mesh__D003771 Papillae, Dental
% 220.54/220.77  |- mesh__recordOriginator mesh__D003771 NLM
% 220.54/220.77  |- mesh__onlineNote mesh__D003771 search TOOTH GERM 1966-74   
% 220.54/220.77  |- skos__scopeNote mesh__D003771
% 220.54/220.77       Mesodermal tissue enclosed in the invaginated portion of the epithelial enamel organ and giving rise to the dentin and pulp.%A%    
% 220.54/220.77  |- mesh__dateRevised mesh__D003771 2003-07-09
% 220.54/220.77  |- skos__altLabel mesh__D003771 Papilla, Dental
% 220.54/220.77  |- skos__broader mesh__D003771smesh__D014083
% 220.54/220.77  |- mesh__publicMeSHNote mesh__D003771
% 220.54/220.77       91; was see under TOOTH GERM 1975-90   
% 220.54/220.77  |- mesh__dateEstablished mesh__D003771 1991-01-01
% 220.54/220.77  |- skos__altLabel mesh__D011405 Arythmol
% 220.54/220.77  |- skos__altLabel mesh__D011405 Knoll Brand of Propafenone Hydrochloride
% 220.54/220.77  |- skos__altLabel mesh__D011405 Norfenon
% 220.54/220.77  |- skos__broader mesh__D011405smesh__D011427
% 220.54/220.77  |- skos__scopeNote mesh__D011405
% 220.54/220.77       An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity. The drug is generally well tolerated.%A%    
% 220.54/220.77  |- skos__altLabel mesh__D011405 Apotex Brand of Propafenone Hydrochloride
% 220.54/220.77  |- skos__altLabel mesh__D011405 Alpharma Brand of Propafenone Hydrochloride
% 220.54/220.77  |- mesh__historyNote mesh__D011405 87   
% 220.54/220.77  |- mesh__recordAuthorizer mesh__D011405 sjn
% 220.54/220.77  |- skos__altLabel mesh__D011405 Rytmonorm
% 220.54/220.77  |- skos__altLabel mesh__D011405 Kendrick Brand of Propafenone Hydrochloride
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D011405 2006
% 220.54/220.77  |- skos__altLabel mesh__D011405 Q-Pharm Brand of Propafenone Hydrochloride
% 220.54/220.77  |- mesh__dateEstablished mesh__D011405 1987-01-01
% 220.54/220.77  |- skos__altLabel mesh__D011405 Hexal Brand of Propafenone
% 220.54/220.77  |- skos__altLabel mesh__D011405 Abbott Brand of Propafenone Hydrochloride
% 220.54/220.77  |- skos__hiddenLabel mesh__D011405 Hydrochloride, Propafenone
% 220.54/220.77  |- rdf__type mesh__D011405sskos__Concept
% 220.54/220.77  |- skos__hiddenLabel mesh__D011405 SA 79
% 220.54/220.77  |- skos__hiddenLabel mesh__D011405 SA79
% 220.54/220.77  |- skos__altLabel mesh__D011405 Propafenon Minden
% 220.54/220.77  |- skos__altLabel mesh__D011405 Juta Brand of Propafenone Hydrochloride
% 220.54/220.77  |- skos__altLabel mesh__D011405 Aliud Brand of Propafenone Hydrochloride
% 220.54/220.77  |- skos__altLabel mesh__D011405
% 220.54/220.77       Azupharma Brand of Propafenone Hydrochloride
% 220.54/220.77  |- skos__altLabel mesh__D011405
% 220.54/220.77       Merck dura Brand of Propafenone Hydrochloride
% 220.54/220.77  |- mesh__publicMeSHNote mesh__D011405 87   
% 220.54/220.77  |- mesh__dateRevised mesh__D011405 2005-06-30
% 220.54/220.77  |- mesh__recordOriginator mesh__D011405 RLS
% 220.54/220.77  |- skos__altLabel mesh__D011405 TAD Brand of Propafenone Hydrochloride
% 220.54/220.77  |- skos__altLabel mesh__D011405 Pintoform
% 220.54/220.77  |- skos__prefLabel mesh__D011405 Propafenone
% 220.54/220.77  |- skos__historyNote mesh__D011405 Propiophenones %28%1966-1986%29%
% 220.54/220.77  |- mesh__dateCreated mesh__D011405 1986-04-09
% 220.54/220.77  |- mesh__recordMaintainer mesh__D011405 lkw
% 220.54/220.77  |- skos__prefLabel mesh__D049873 Cardiidae
% 220.54/220.77  |- skos__altLabel mesh__D049873 Cockles
% 220.54/220.77  |- mesh__dateCreated mesh__D049873 2005-06-30
% 220.54/220.77  |- mesh__publicMeSHNote mesh__D049873 2006   
% 220.54/220.77  |- skos__broader mesh__D049873smesh__D049872
% 220.54/220.77  |- mesh__dateEstablished mesh__D049873 2006-01-01
% 220.54/220.77  |- skos__scopeNote mesh__D049873
% 220.54/220.77       A family of bivalve MOLLUSKS with heart-shaped shells, commonly known as cockles. Unlike most BIVALVES, cockles are hermaphroditic.%A%    
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D049873 2006
% 220.54/220.77  |- mesh__recordOriginator mesh__D049873 ags
% 220.54/220.77  |- mesh__recordMaintainer mesh__D049873 ags
% 220.54/220.77  |- rdf__type mesh__D049873sskos__Concept
% 220.54/220.77  |- mesh__historyNote mesh__D049873 2006   
% 220.54/220.77  |- mesh__recordAuthorizer mesh__D049873 sjn
% 220.54/220.77  |- mesh__dateCreated mesh__D016699 1991-01-25
% 220.54/220.77  |- mesh__dateEstablished mesh__D016699 1992-01-01
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D016699 2006
% 220.54/220.77  |- mesh__historyNote mesh__D016699
% 220.54/220.77       92; TARSIIDAE %26% TARSIUS were see PROSIMII 1981-91   
% 220.54/220.77  |- mesh__recordAuthorizer mesh__D016699 sjn
% 220.54/220.77  |- skos__broader mesh__D016699smesh__D051099
% 220.54/220.77  |- skos__annotation mesh__D016699
% 220.54/220.77       diseases: coordinate IM with PRIMATE DISEASES %28%IM%29%   
% 220.54/220.77  |- mesh__onlineNote mesh__D016699
% 220.54/220.77       use PROSIMII to search TARSIIDAE %26% TARSIUS 1981-91   
% 220.54/220.77  |- rdf__type mesh__D016699sskos__Concept
% 220.54/220.77  |- skos__altLabel mesh__D016699 Tarsiers
% 220.54/220.77  |- mesh__publicMeSHNote mesh__D016699
% 220.54/220.77       92; TARSIIDAE %26% TARSIUS were see PROSIMII 1981-91   
% 220.54/220.77  |- mesh__dateRevised mesh__D016699 2005-06-30
% 220.54/220.77  |- skos__prefLabel mesh__D016699 Tarsiidae
% 220.54/220.77  |- skos__hiddenLabel mesh__D016699 Tarsier
% 220.54/220.77  |- mesh__recordMaintainer mesh__D016699 ags
% 220.54/220.77  |- skos__scopeNote mesh__D016699
% 220.54/220.77       The single family of PRIMATES in the infraorder TARSII, suborder HAPLORHINI. It is comprised of one genus, Tarsius, that inhabits southern Sumatra, Borneo, Sulawesi, and the Philippines.%A%    
% 220.54/220.77  |- mesh__recordOriginator mesh__D016699 MXR
% 220.54/220.77  |- mesh__dateCreated mesh__D002679 1999-01-01
% 220.54/220.77  |- skos__altLabel mesh__D002679 Chimpanzee troglodytes
% 220.54/220.77  |- mesh__recordAuthorizer mesh__D002679 sjn
% 220.54/220.77  |- mesh__dateRevised mesh__D002679 2005-06-30
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D002679 2006
% 220.54/220.77  |- skos__hiddenLabel mesh__D002679 troglodytes, Pan
% 220.54/220.77  |- skos__hiddenLabel mesh__D002679 troglodytes, Chimpanzee
% 220.54/220.77  |- mesh__recordMaintainer mesh__D002679 ags
% 220.54/220.77  |- skos__hiddenLabel mesh__D002679 Chimpanzee troglodyte
% 220.54/220.77  |- skos__hiddenLabel mesh__D002679 troglodyte, Pan
% 220.54/220.77  |- rdf__type mesh__D002679sskos__Concept
% 220.54/220.77  |- skos__hiddenLabel mesh__D002679 troglodyte, Chimpanzee
% 220.54/220.77  |- skos__hiddenLabel mesh__D002679 Pan troglodyte
% 220.54/220.77  |- skos__scopeNote mesh__D002679
% 220.54/220.77       The common chimpanzee, a species of the genus Pan, family HOMINIDAE. It lives in Africa, primarily in the tropical rainforests. There are a number of recognized subspecies.%A%    
% 220.54/220.77  |- skos__broader mesh__D002679smesh__D015186
% 220.54/220.77  |- mesh__historyNote mesh__D002679 1998 %28%1972%29%   
% 220.54/220.77  |- mesh__recordOriginator mesh__D002679 NLM
% 220.54/220.77  |- skos__annotation mesh__D002679
% 220.54/220.77       diseases: coordinate IM with APE DISEASES %28%IM%29% + specific disease/vet %28%IM%29%%A%  
% 220.54/220.77  |- skos__hiddenLabel mesh__D002679 Chimpanzees
% 220.54/220.77  |- skos__prefLabel mesh__D002679 Pan troglodytes
% 220.54/220.77  |- mesh__dateEstablished mesh__D002679 1972-01-01
% 220.54/220.77  |- mesh__publicMeSHNote mesh__D002679
% 220.54/220.77       1998; see CHIMPANZEE TROGLODYTES 1981-1997 %26% CHIMPANZEES 1972-1980%A%  
% 220.54/220.77  |- skos__historyNote mesh__D002679 Pongidae %28%1966-1971%29%
% 220.54/220.77  |- skos__altLabel mesh__D002679 Chimpanzee
% 220.54/220.77  |- skos__historyNote mesh__D007364
% 220.54/220.77       Nucleic Acid Conformation %28%1972-1979%29%
% 220.54/220.77  |- rdf__type mesh__D007364sskos__Concept
% 220.54/220.77  |- mesh__dateCreated mesh__D007364 1979-05-01
% 220.54/220.77  |- skos__prefLabel mesh__D007364 Intercalating Agents
% 220.54/220.77  |- mesh__recordAuthorizer mesh__D007364 sjn
% 220.54/220.77  |- skos__hiddenLabel mesh__D007364 Compounds, Intercalative
% 220.54/220.77  |- skos__historyNote mesh__D007364 DNA %28%1966-1979%29%
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D007364 2004
% 220.54/220.77  |- mesh__recordOriginator mesh__D007364 SH
% 220.54/220.77  |- mesh__dateEstablished mesh__D007364 1980-01-01
% 220.54/220.77  |- mesh__publicMeSHNote mesh__D007364 80   
% 220.54/220.77  |- skos__broader mesh__D007364smesh__D007202
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D007364 2005
% 220.54/220.77  |- skos__annotation mesh__D007364
% 220.54/220.77       agents %22%capable of inserting themselves ... between the successive bases in DNA%22%; used in DNA studies; D25-26 qualif%A%  
% 220.54/220.77  |- mesh__dateRevised mesh__D007364 2003-07-09
% 220.54/220.77  |- skos__altLabel mesh__D007364 Intercalators
% 220.54/220.77  |- mesh__historyNote mesh__D007364 80   
% 220.54/220.77  |- skos__scopeNote mesh__D007364
% 220.54/220.77       Agents that are capable of inserting themselves between the successive bases in DNA, thus kinking, uncoiling or otherwise deforming it and therefore preventing its proper functioning. They are used in the study of DNA.%A%    
% 220.54/220.77  |- skos__hiddenLabel mesh__D007364 Ligands, Intercalating
% 220.54/220.77  |- skos__altLabel mesh__D007364 Intercalative Compounds
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D007364 2006
% 220.54/220.77  |- mesh__recordMaintainer mesh__D007364 ssb
% 220.54/220.77  |- skos__hiddenLabel mesh__D007364 Agents, Intercalating
% 220.54/220.77  |- skos__historyNote mesh__D007364 specific DNA %28%1966-1979%29%
% 220.54/220.77  |- skos__altLabel mesh__D007364 Intercalating Ligands
% 220.54/220.77  |- skos__broader mesh__D045483smesh__D005618
% 220.54/220.77  |- skos__prefLabel mesh__D045483 Rivers
% 220.54/220.77  |- mesh__dateEstablished mesh__D045483 2004-01-01
% 220.54/220.77  |- skos__hiddenLabel mesh__D045483 Stream
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D045483 2004
% 220.54/220.77  |- mesh__dateCreated mesh__D045483 2003-07-09
% 220.54/220.77  |- skos__hiddenLabel mesh__D045483 River
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D045483 2006
% 220.54/220.77  |- mesh__publicMeSHNote mesh__D045483 2004   
% 220.54/220.77  |- mesh__historyNote mesh__D045483 2004   
% 220.54/220.77  |- rdf__type mesh__D045483sskos__Concept
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D045483 2005
% 220.54/220.77  |- skos__scopeNote mesh__D045483
% 220.54/220.77       Large natural streams of FRESH WATER formed by converging tributaries and which empty into a body of water %28%lake or ocean%29%.%A%    
% 220.54/220.77  |- skos__prefLabel mesh__D017792 Surgical Stapling
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D017792 1999
% 220.54/220.77  |- skos__hiddenLabel mesh__D017792 Staplings, Surgical
% 220.54/220.77  |- mesh__dateEstablished mesh__D017792 1994-01-01
% 220.54/220.77  |- rdf__type mesh__D017792sskos__Concept
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D017792 1997
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D017792 2006
% 220.54/220.77  |- skos__annotation mesh__D017792
% 220.54/220.77       /instrum: consider also SURGICAL STAPLERS; coord IM with staple material %28%IM or NIM%29% if pertinent; do not use /util except by MeSH definition; DF: SURG STAPLING%A%  
% 220.54/220.77  |- skos__scopeNote mesh__D017792
% 220.54/220.77       A technique of closing incisions and wounds, or of joining and connecting tissues, in which staples are used as sutures.%A%    
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D017792 1998
% 220.54/220.77  |- skos__altLabel mesh__D017792 Stapling, Surgical
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D017792 2004
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D017792 2001
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D017792 1996
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D017792 2005
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D017792 2000
% 220.54/220.77  |- mesh__dateCreated mesh__D017792 1993-06-04
% 220.54/220.77  |- skos__historyNote mesh__D017792 Surgical Staplers %28%1966-1993%29%
% 220.54/220.77  |- skos__broader mesh__D017792smesh__D013536
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D017792 2003
% 220.54/220.77  |- mesh__publicMeSHNote mesh__D017792 94   
% 220.54/220.77  |- skos__hiddenLabel mesh__D017792 Surgical Staplings
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D017792 1995
% 220.54/220.77  |- mesh__historyNote mesh__D017792 94   
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D017792 2002
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D017792 1994
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D003772 2003
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D003772 1999
% 220.54/220.77  |- mesh__dateEstablished mesh__D003772 1970-01-01
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D003772 2005
% 220.54/220.77  |- mesh__recordAuthorizer mesh__D003772 SJN
% 220.54/220.77  |- mesh__dateRevised mesh__D003772 1997-06-20
% 220.54/220.77  |- skos__altLabel mesh__D003772 Pegs, Dental
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D003772 2004
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D003772 2006
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D003772 2000
% 220.54/220.77  |- mesh__recordMaintainer mesh__D003772 TGC
% 220.54/220.77  |- mesh__dateCreated mesh__D003772 1999-01-01
% 220.54/220.77  |- skos__historyNote mesh__D003772
% 220.54/220.77       Dental Cavity Preparation %28%1966-1969%29%
% 220.54/220.77  |- mesh__publicMeSHNote mesh__D003772 70   
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D003772 2001
% 220.54/220.77  |- skos__altLabel mesh__D003772 Dental Pin
% 220.54/220.77  |- skos__scopeNote mesh__D003772
% 220.54/220.77       Small cylindrical pieces of metal used to enhance retention.%A%    
% 220.54/220.77  |- skos__altLabel mesh__D003772 Peg, Dental
% 220.54/220.77  |- skos__prefLabel mesh__D003772 Dental Pins
% 220.54/220.77  |- skos__altLabel mesh__D003772 Pin, Dental
% 220.54/220.77  |- skos__annotation mesh__D003772 DF: DENT PINS   
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D003772 1998
% 220.54/220.77  |- mesh__historyNote mesh__D003772 70   
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D003772 2002
% 220.54/220.77  |- skos__broader mesh__D003772smesh__D003813
% 220.54/220.77  |- skos__historyNote mesh__D003772 Inlays %28%1966-1969%29%
% 220.54/220.77  |- skos__altLabel mesh__D003772 Pins, Dental
% 220.54/220.77  |- mesh__recordOriginator mesh__D003772 NLM
% 220.54/220.77  |- skos__altLabel mesh__D003772 Dental Peg
% 220.54/220.77  |- rdf__type mesh__D003772sskos__Concept
% 220.54/220.77  |- skos__altLabel mesh__D003772 Dental Pegs
% 220.54/220.77  |- skos__prefLabel mesh__D011406 Propaganda
% 220.54/220.77  |- mesh__recordOriginator mesh__D011406 NLM
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D011406 2005
% 220.54/220.77  |- mesh__dateRevised mesh__D011406 2004-07-30
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D011406 2003
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D011406 2005A
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D011406 2006
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D011406 2004
% 220.54/220.77  |- skos__scopeNote mesh__D011406
% 220.54/220.77       The deliberate attempt to influence attitudes and beliefs for furthering one%27%s cause or damaging an opponent%27%s cause.%A%    
% 220.54/220.77  |- rdf__type mesh__D011406sskos__Concept
% 220.54/220.77  |- mesh__dateCreated mesh__D011406 1999-01-01
% 220.54/220.77  |- mesh__recordAuthorizer mesh__D011406 jls
% 220.54/220.77  |- mesh__recordMaintainer mesh__D011406 jls
% 220.54/220.77  |- skos__broader mesh__D011406smesh__D003142
% 220.54/220.77  |- skos__annotation mesh__D011406 no qualif   
% 220.54/220.77  |- rdf__type mesh__D049874sskos__Concept
% 220.54/220.77  |- mesh__dateEstablished mesh__D049874 2006-01-01
% 220.54/220.77  |- skos__scopeNote mesh__D049874
% 220.54/220.77       A genus of freshwater clams, in the family Corbiculidae, class BIVALVIA. It originated in Asia but was introduced in  North America and is now found throughout the United States.%A%    
% 220.54/220.77  |- mesh__recordOriginator mesh__D049874 ags
% 220.54/220.77  |- mesh__historyNote mesh__D049874 2006   
% 220.54/220.77  |- mesh__recordAuthorizer mesh__D049874 sjn
% 220.54/220.77  |- skos__prefLabel mesh__D049874 Corbicula
% 220.54/220.77  |- skos__historyNote mesh__D049874 Mollusca %28%1966-2005%29%
% 220.54/220.77  |- mesh__publicMeSHNote mesh__D049874 2006   
% 220.54/220.77  |- skos__broader mesh__D049874smesh__D049872
% 220.54/220.77  |- mesh__dateCreated mesh__D049874 2005-06-30
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D049874 2006
% 220.54/220.77  |- mesh__recordMaintainer mesh__D049874 ags
% 220.54/220.77  |- skos__hiddenLabel mesh__D007365 Junction, Intercellular
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D007365 2001
% 220.54/220.77  |- skos__hiddenLabel mesh__D007365 Junctions, Intercellular
% 220.54/220.77  |- skos__broader mesh__D007365smesh__D021961
% 220.54/220.77  |- mesh__dateCreated mesh__D007365 1999-01-01
% 220.54/220.77  |- mesh__recordOriginator mesh__D007365 NLM
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D007365 2005
% 220.54/220.77  |- skos__hiddenLabel mesh__D007365 Junctions, Cell
% 220.54/220.77  |- skos__hiddenLabel mesh__D007365 Cell Junction
% 220.54/220.77  |- skos__prefLabel mesh__D007365 Intercellular Junctions
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D007365 2004
% 220.54/220.77  |- mesh__recordMaintainer mesh__D007365 AGS
% 220.54/220.77  |- rdf__type mesh__D007365sskos__Concept
% 220.54/220.77  |- mesh__dateRevised mesh__D007365 2000-06-22
% 220.54/220.77  |- mesh__activeMeSHYear mesh__D007365 2003
% 220.54/220.77  |- mesh__recordAuthorizer mesh__D007365 sjn
% 220.54/220.77  |- mesh__historyNote mesh__D007365 72%28%70%29%   
% 220.54/220.77  |- mesh__dateEstablished mesh__D007365 1972-01-01
% 220.54/220.77  |- skos__hiddenLabel mesh__D007365 Intercellular Junction
% 220.54/220.77  |- mesh__publicMeSHNote mesh__D007365 72   
% 220.54/220.77  |- skos__altLabel mesh__D007365 Cell Junctions
% 220.54/220.78  |- skos__annotation mesh__D007365
% 220.54/220.78       A 11 qualif except /cytol /transpl; /genet permitted   
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D007365 2002
% 220.54/220.78  |- skos__hiddenLabel mesh__D007365 Junction, Cell
% 220.54/220.78  |- skos__scopeNote mesh__D007365
% 220.54/220.78       Direct contact of a cell with a neighboring cell. Most such junctions are too small to be resolved by light microscopy, but they can be visualized by conventional or freeze-fracture electron microscopy, both of which show that the interacting CELL MEMBRANE and often the underlying CYTOPLASM and the intervening EXTRACELLULAR SPACE are highly specialized in these regions. %28%From Alberts et al., Molecular Biology of the Cell, 2d ed, p792%29%%A%    
% 220.54/220.78  |- skos__historyNote mesh__D007365 Cell Membrane %28%1966-1969%29%
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D007365 2006
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D017793 2006
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D017793 2002
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D017793 2004
% 220.54/220.78  |- skos__historyNote mesh__D017793 Plant Viruses %28%1986-1993%29%
% 220.54/220.78  |- skos__broader mesh__D017793smesh__D012328
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D017793 2005
% 220.54/220.78  |- mesh__recordOriginator mesh__D017793 AGS
% 220.54/220.78  |- skos__annotation mesh__D017793
% 220.54/220.78       coord IM with specific plant /virol %28%IM or NIM%29%   
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D017793 2003
% 220.54/220.78  |- mesh__dateEstablished mesh__D017793 1994-01-01
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D017793 2001
% 220.54/220.78  |- mesh__historyNote mesh__D017793 94   
% 220.54/220.78  |- skos__hiddenLabel mesh__D017793 Luteoviruses
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D017793 2000
% 220.54/220.78  |- mesh__dateRevised mesh__D017793 1999-11-03
% 220.54/220.78  |- mesh__dateCreated mesh__D017793 1993-06-04
% 220.54/220.78  |- skos__altLabel mesh__D017793 Barley Yellow Dwarf Viruses
% 220.54/220.78  |- mesh__recordAuthorizer mesh__D017793 sjn
% 220.54/220.78  |- skos__broader mesh__D017793smesh__D010942
% 220.54/220.78  |- mesh__publicMeSHNote mesh__D017793 94   
% 220.54/220.78  |- skos__scopeNote mesh__D017793
% 220.54/220.78       A genus of plant viruses that infects both monocotyledonous and dicotyledonous plants. Its organisms are persistently transmitted by aphids, and weeds may provide reservoirs of infection.%A%    
% 220.54/220.78  |- skos__prefLabel mesh__D017793 Luteovirus
% 220.54/220.78  |- rdf__type mesh__D017793sskos__Concept
% 220.54/220.78  |- mesh__recordMaintainer mesh__D017793 ags
% 220.54/220.78  |- skos__hiddenLabel mesh__D053118 H1N1 Viruses
% 220.54/220.78  |- mesh__historyNote mesh__D053118 2006   
% 220.54/220.78  |- mesh__recordMaintainer mesh__D053118 ags
% 220.54/220.78  |- mesh__publicMeSHNote mesh__D053118 2006   
% 220.54/220.78  |- mesh__dateEstablished mesh__D053118 2005-11-10
% 220.54/220.78  |- mesh__recordAuthorizer mesh__D053118 ags
% 220.54/220.78  |- skos__annotation mesh__D053118
% 220.54/220.78       infection: coordinate IM with INFLUENZA, HUMAN %28%IM%29% in humans, or INFLUENZA IN BIRDS %28%IM%29% in birds, or ORTHOMYXOVIRIDAE INFECTIONS %28%IM%29% in other animals%A%  
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D053118 2006A
% 220.54/220.78  |- mesh__recordOriginator mesh__D053118 ags
% 220.54/220.78  |- skos__scopeNote mesh__D053118
% 220.54/220.78       A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 1 and neuraminidase 1. The H1N1 subtype was responsible for the Spanish flu pandemic of 1918 and for swine flu.%A%    
% 220.54/220.78  |- skos__historyNote mesh__D053118 Influenza A Virus %28%1978-2005%29%
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D053118 2006
% 220.54/220.78  |- rdf__type mesh__D053118sskos__Concept
% 220.54/220.78  |- skos__hiddenLabel mesh__D053118 Virus, H1N1
% 220.54/220.78  |- skos__broader mesh__D053118smesh__D009980
% 220.54/220.78  |- mesh__dateRevised mesh__D053118 2005-11-10
% 220.54/220.78  |- skos__prefLabel mesh__D053118 Influenza A Virus, H1N1 Subtype
% 220.54/220.78  |- skos__altLabel mesh__D053118 H1N1 Virus
% 220.54/220.78  |- skos__hiddenLabel mesh__D053118 Viruses, H1N1
% 220.54/220.78  |- mesh__dateCreated mesh__D053118 2005-11-10
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003773 2001
% 220.54/220.78  |- mesh__recordMaintainer mesh__D003773 KEV
% 220.54/220.78  |- skos__annotation mesh__D003773
% 220.54/220.78       note categories; from Cat A /chem /ultrastruct permitted; DF: DENT PLAQUE%A%  
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003773 2004
% 220.54/220.78  |- skos__broader mesh__D003773smesh__D003741
% 220.54/220.78  |- mesh__historyNote mesh__D003773
% 220.54/220.78       65%28%64%29%; was in Cat C only 1964-74   
% 220.54/220.78  |- rdf__type mesh__D003773sskos__Concept
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003773 2000
% 220.54/220.78  |- skos__altLabel mesh__D003773 Plaque, Dental
% 220.54/220.78  |- skos__prefLabel mesh__D003773 Dental Plaque
% 220.54/220.78  |- mesh__recordOriginator mesh__D003773 NLM
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003773 2003
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003773 2006
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003773 2002
% 220.54/220.78  |- mesh__dateEstablished mesh__D003773 1965-01-01
% 220.54/220.78  |- mesh__publicMeSHNote mesh__D003773 65   
% 220.54/220.78  |- mesh__dateCreated mesh__D003773 1999-01-01
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003773 2005
% 220.54/220.78  |- mesh__recordAuthorizer mesh__D003773 sjn
% 220.54/220.78  |- mesh__dateRevised mesh__D003773 1999-11-03
% 220.54/220.78  |- skos__scopeNote mesh__D003773
% 220.54/220.78       A film that attaches to teeth, often causing DENTAL CARIES and GINGIVITIS. It is composed of MUCINS, secreted from salivary glands, and microorganisms.%A%    
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D011407 2005
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D011407 2003
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D011407 2006
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D011407 2000
% 220.54/220.78  |- mesh__recordAuthorizer mesh__D011407 PLS
% 220.54/220.78  |- mesh__recordOriginator mesh__D011407 NLM
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D011407 2004
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D011407 1994
% 220.54/220.78  |- skos__prefLabel mesh__D011407 Propane
% 220.54/220.78  |- rdf__type mesh__D011407sskos__Concept
% 220.54/220.78  |- mesh__dateCreated mesh__D011407 1999-01-01
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D011407 2001
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D011407 1998
% 220.54/220.78  |- skos__historyNote mesh__D011407 Alkanes %28%1966-1972%29%
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D011407 1995
% 220.54/220.78  |- mesh__dateRevised mesh__D011407 1992-05-20
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D011407 1996
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D011407 1993
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D011407 2002
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D011407 1999
% 220.54/220.78  |- mesh__recordMaintainer mesh__D011407 TAP
% 220.54/220.78  |- skos__broader mesh__D011407smesh__D000473
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D011407 1997
% 220.54/220.78  |- mesh__dateEstablished mesh__D011407 1973-01-01
% 220.54/220.78  |- mesh__publicMeSHNote mesh__D011407 73   
% 220.54/220.78  |- mesh__historyNote mesh__D011407 73   
% 220.54/220.78  |- mesh__dateCreated mesh__D049875 2005-06-30
% 220.54/220.78  |- mesh__dateEstablished mesh__D049875 2006-01-01
% 220.54/220.78  |- skos__altLabel mesh__D049875 Dreissena polymorpha
% 220.54/220.78  |- mesh__recordOriginator mesh__D049875 ags
% 220.54/220.78  |- mesh__publicMeSHNote mesh__D049875 2006   
% 220.54/220.78  |- mesh__historyNote mesh__D049875 2006   
% 220.54/220.78  |- skos__prefLabel mesh__D049875 Dreissena
% 220.54/220.78  |- mesh__recordAuthorizer mesh__D049875 sjn
% 220.54/220.78  |- skos__broader mesh__D049875smesh__D049872
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D049875 2006
% 220.54/220.78  |- skos__historyNote mesh__D049875 Mollusca %28%1966-2005%29%
% 220.54/220.78  |- mesh__recordMaintainer mesh__D049875 ags
% 220.54/220.78  |- skos__altLabel mesh__D049875 Zebra Mussels
% 220.54/220.78  |- rdf__type mesh__D049875sskos__Concept
% 220.54/220.78  |- skos__scopeNote mesh__D049875
% 220.54/220.78       A genus of mussels in the family Dreissenidae, class BIVALVIA. They are found in both fresh and brackish water and are not native to North America.  Accidentally introduced into the Great Lakes in 1986, they now proliferate widely throughout the United States.%A%    
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D007366 2002
% 220.54/220.78  |- mesh__dateCreated mesh__D007366 1999-01-01
% 220.54/220.78  |- mesh__dateRevised mesh__D007366 2001-07-25
% 220.54/220.78  |- skos__broader mesh__D007366smesh__D012132
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D007366 2004
% 220.54/220.78  |- skos__annotation mesh__D007366
% 220.54/220.78       /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 220.54/220.78  |- rdf__type mesh__D007366sskos__Concept
% 220.54/220.78  |- skos__hiddenLabel mesh__D007366 Muscle, Intercostal
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D007366 2003
% 220.54/220.78  |- mesh__recordMaintainer mesh__D007366 nns
% 220.54/220.78  |- mesh__recordOriginator mesh__D007366 NLM
% 220.54/220.78  |- skos__scopeNote mesh__D007366
% 220.54/220.78       Respiratory muscles that arise from the lower border of one rib and insert into the upper border of the adjoining rib, and contract during inspiration or respiration. %28%From Stedman, 25th ed%29%%A%    
% 220.54/220.78  |- skos__hiddenLabel mesh__D007366 Muscles, Intercostal
% 220.54/220.78  |- skos__prefLabel mesh__D007366 Intercostal Muscles
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D007366 2006
% 220.54/220.78  |- skos__hiddenLabel mesh__D007366 Intercostal Muscle
% 220.54/220.78  |- mesh__recordAuthorizer mesh__D007366 sjn
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D007366 2005
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D012500 2005A
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D012500 2002
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D012500 2005
% 220.54/220.78  |- mesh__recordMaintainer mesh__D012500 jls
% 220.54/220.78  |- skos__scopeNote mesh__D012500
% 220.54/220.78       Anthelmintic isolated from the dried unexpanded flower heads of Artemisia maritima and other species of Artemisia found principally in Russian and Chinese Turkestan and the Southern Ural region. %28%From Merck, 11th ed.%29%%A%    
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D012500 2006
% 220.54/220.78  |- rdf__type mesh__D012500sskos__Concept
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D012500 2003
% 220.54/220.78  |- mesh__recordOriginator mesh__D012500 NLM
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D012500 2001
% 220.54/220.78  |- mesh__dateCreated mesh__D012500 1999-01-01
% 220.54/220.78  |- mesh__dateRevised mesh__D012500 2004-08-02
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D012500 2004
% 220.54/220.78  |- mesh__recordAuthorizer mesh__D012500 jls
% 220.54/220.78  |- skos__broader mesh__D012500smesh__D012717
% 220.54/220.78  |- skos__prefLabel mesh__D012500 Santonin
% 220.54/220.78  |- skos__annotation mesh__D017794 coord IM with specific plant /virol   
% 220.54/220.78  |- mesh__dateCreated mesh__D017794 1993-06-04
% 220.54/220.78  |- skos__hiddenLabel mesh__D017794 mosaic virus, Alfalfa
% 220.54/220.78  |- mesh__historyNote mesh__D017794 94   
% 220.54/220.78  |- mesh__recordAuthorizer mesh__D017794 sjn
% 220.54/220.78  |- mesh__publicMeSHNote mesh__D017794 94   
% 220.54/220.78  |- mesh__dateRevised mesh__D017794 2001-07-25
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D017794 2002
% 220.54/220.78  |- skos__historyNote mesh__D017794 Mosaic Viruses %28%1973-1993%29%
% 220.54/220.78  |- mesh__dateEstablished mesh__D017794 1994-01-01
% 220.54/220.78  |- skos__broader mesh__D017794smesh__D019178
% 220.54/220.78  |- mesh__recordOriginator mesh__D017794 AGS
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D017794 2006
% 220.54/220.78  |- rdf__type mesh__D017794sskos__Concept
% 220.54/220.78  |- skos__hiddenLabel mesh__D017794 Alfalfa mosaic viruses
% 220.54/220.78  |- skos__historyNote mesh__D017794 Plant Viruses %28%1966-1993%29%
% 220.54/220.78  |- skos__prefLabel mesh__D017794 Alfalfa mosaic virus
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D017794 2005
% 220.54/220.78  |- mesh__recordMaintainer mesh__D017794 ags
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D017794 2004
% 220.54/220.78  |- skos__scopeNote mesh__D017794
% 220.54/220.78       The type species of the genus ALFAMOVIRUS that is non-persistently transmitted by aphids.%A%    
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D017794 2003
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003774 1999
% 220.54/220.78  |- mesh__dateRevised mesh__D003774 1992-05-14
% 220.54/220.78  |- skos__altLabel mesh__D003774 Indices, Dental Plaque
% 220.54/220.78  |- mesh__recordMaintainer mesh__D003774 PLS
% 220.54/220.78  |- skos__altLabel mesh__D003774 Dental Plaque Indexes
% 220.54/220.78  |- skos__altLabel mesh__D003774 Dental Plaque Indices
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003774 1995
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003774 2003
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003774 1998
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003774 2001
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003774 2006
% 220.54/220.78  |- skos__altLabel mesh__D003774 Indexes, Dental Plaque
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003774 1994
% 220.54/220.78  |- skos__historyNote mesh__D003774 Dental Plaque %28%1966-1982%29%
% 220.54/220.78  |- skos__annotation mesh__D003774 no qualif; DF: DENT PLAQUE INDEX   
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003774 2000
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003774 2005
% 220.54/220.78  |- skos__historyNote mesh__D003774 Periodontal Index %28%1966-1982%29%
% 220.54/220.78  |- skos__altLabel mesh__D003774 Index, Dental Plaque
% 220.54/220.78  |- mesh__publicMeSHNote mesh__D003774
% 220.54/220.78       91; was see under DENTAL HEALTH SURVEYS 1983-90   
% 220.54/220.78  |- mesh__historyNote mesh__D003774
% 220.54/220.78       91%28%83%29%; was see under DENTAL HEALTH SURVEYS 1983-90   
% 220.54/220.78  |- skos__scopeNote mesh__D003774
% 220.54/220.78       An index which scores the degree of dental plaque accumulation.%A%    
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003774 1997
% 220.54/220.78  |- mesh__recordOriginator mesh__D003774 RC
% 220.54/220.78  |- mesh__recordAuthorizer mesh__D003774 PLS
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003774 2002
% 220.54/220.78  |- skos__prefLabel mesh__D003774 Dental Plaque Index
% 220.54/220.78  |- mesh__dateCreated mesh__D003774 1982-04-22
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003774 1993
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003774 1996
% 220.54/220.78  |- mesh__dateEstablished mesh__D003774 1991-01-01
% 220.54/220.78  |- skos__broader mesh__D003774smesh__D003753
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003774 2004
% 220.54/220.78  |- rdf__type mesh__D003774sskos__Concept
% 220.54/220.78  |- skos__hiddenLabel mesh__D011408 Dehydratase, Propanediol
% 220.54/220.78  |- mesh__dateEstablished mesh__D011408 1991-01-01
% 220.54/220.78  |- skos__hiddenLabel mesh__D011408 Dehydratase, Diol
% 220.54/220.78  |- rdf__type mesh__D011408sskos__Concept
% 220.54/220.78  |- skos__altLabel mesh__D011408 Diol Dehydrase
% 220.54/220.78  |- mesh__recordMaintainer mesh__D011408 ssb
% 220.54/220.78  |- mesh__dateCreated mesh__D011408 1974-11-19
% 220.54/220.78  |- mesh__recordAuthorizer mesh__D011408 sjn
% 220.54/220.78  |- skos__prefLabel mesh__D011408 Propanediol Dehydratase
% 220.54/220.78  |- skos__historyNote mesh__D011408 Propanediols %28%1972-1974%29%
% 220.54/220.78  |- mesh__dateRevised mesh__D011408 2003-07-09
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D011408 2005
% 220.54/220.78  |- skos__hiddenLabel mesh__D011408 Dehydrase, Diol
% 220.54/220.78  |- mesh__recordOriginator mesh__D011408 NLM
% 220.54/220.78  |- mesh__publicMeSHNote mesh__D011408
% 220.54/220.78       91; was see under HYDRO-LYASES 1975-90   
% 220.54/220.78  |- skos__scopeNote mesh__D011408
% 220.54/220.78       An enzyme that catalyzes the dehydration of 1,2-propanediol to propionaldehyde. EC 4.2.1.28.%A%    
% 220.54/220.78  |- skos__historyNote mesh__D011408 Hydro-Lyases %28%1972-1974%29%
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D011408 2006
% 220.54/220.78  |- skos__broader mesh__D011408smesh__D006836
% 220.54/220.78  |- mesh__historyNote mesh__D011408
% 220.54/220.78       91%28%75%29%; was see under HYDRO-LYASES 1975-90   
% 220.54/220.78  |- skos__altLabel mesh__D011408 Diol Dehydratase
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D011408 2004
% 220.54/220.78  |- mesh__recordAuthorizer mesh__D049876 ags
% 220.54/220.78  |- mesh__publicMeSHNote mesh__D049876 2006   
% 220.54/220.78  |- skos__altLabel mesh__D049876 Unionids
% 220.54/220.78  |- mesh__dateRevised mesh__D049876 2005-07-14
% 220.54/220.78  |- skos__historyNote mesh__D049876 Mollusca %28%1971-2005%29%
% 220.54/220.78  |- skos__broader mesh__D049876smesh__D049872
% 220.54/220.78  |- skos__scopeNote mesh__D049876
% 220.54/220.78       A family of freshwater mussels in the class BIVALVIA. They differ from ZEBRA MUSSELS in that they are larger and posses a larval stage called glochidia, which requires attachment to the GILLS or fins of particular species of FISHES.%A%    
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D049876 2006A
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D049876 2006
% 220.54/220.78  |- skos__prefLabel mesh__D049876 Unionidae
% 220.54/220.78  |- mesh__dateCreated mesh__D049876 2005-06-30
% 220.54/220.78  |- mesh__recordMaintainer mesh__D049876 ags
% 220.54/220.78  |- rdf__type mesh__D049876sskos__Concept
% 220.54/220.78  |- mesh__dateEstablished mesh__D049876 2006-01-01
% 220.54/220.78  |- skos__altLabel mesh__D049876 Mussels, Native
% 220.54/220.78  |- skos__annotation mesh__D049876
% 220.54/220.78       as animal %26% food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH %28%IM%29%%A%  
% 220.54/220.78  |- mesh__recordOriginator mesh__D049876 ags
% 220.54/220.78  |- mesh__historyNote mesh__D049876 2006   
% 220.54/220.78  |- skos__hiddenLabel mesh__D007367 Nerve, Intercostal
% 220.54/220.78  |- mesh__dateEstablished mesh__D007367 1991-01-01
% 220.54/220.78  |- mesh__recordMaintainer mesh__D007367 kle
% 220.54/220.78  |- mesh__onlineNote mesh__D007367 search THORACIC NERVES 1966-74   
% 220.54/220.78  |- skos__prefLabel mesh__D007367 Intercostal Nerves
% 220.54/220.78  |- mesh__recordAuthorizer mesh__D007367 sjn
% 220.54/220.78  |- skos__annotation mesh__D007367
% 220.54/220.78       dis: coord IM with PERIPHERAL NERVOUS SYSTEM DISEASES %28%IM%29%; neopl: coord IM with PERIPHERAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D007367 2006
% 220.54/220.78  |- skos__hiddenLabel mesh__D007367 Nerves, Intercostal
% 220.54/220.78  |- skos__hiddenLabel mesh__D007367 Intercostal Nerve
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D007367 2002
% 220.54/220.78  |- skos__scopeNote mesh__D007367
% 220.54/220.78       The ventral rami of the thoracic nerves from segments T1 through T11. The intercostal nerves supply motor and sensory innervation to the thorax and abdomen. The skin and muscles supplied by a given pair are called, respectively, a dermatome and a myotome.%A%    
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D007367 2005
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D007367 2001
% 220.54/220.78  |- mesh__dateCreated mesh__D007367 1999-01-01
% 220.54/220.78  |- skos__broader mesh__D007367smesh__D013900
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D007367 2004
% 220.54/220.78  |- rdf__type mesh__D007367sskos__Concept
% 220.54/220.78  |- mesh__recordOriginator mesh__D007367 NLM
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D007367 2000
% 220.54/220.78  |- mesh__dateRevised mesh__D007367 1999-11-08
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D007367 2003
% 220.54/220.78  |- mesh__historyNote mesh__D007367
% 220.54/220.78       91%28%75%29%; was see under THORACIC NERVES 1975-90   
% 220.54/220.78  |- mesh__publicMeSHNote mesh__D007367
% 220.54/220.78       91; was see under THORACIC NERVES 1975-90   
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D012501 2006
% 220.54/220.78  |- skos__hiddenLabel mesh__D012501 Vein, Saphenous
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D012501 2001
% 220.54/220.78  |- rdf__type mesh__D012501sskos__Concept
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D012501 1999
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D012501 2003
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D012501 1996
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D012501 1993
% 220.54/220.78  |- mesh__dateCreated mesh__D012501 1999-01-01
% 220.54/220.78  |- mesh__dateRevised mesh__D012501 1992-05-18
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D012501 2004
% 220.54/220.78  |- skos__scopeNote mesh__D012501
% 220.54/220.78       The vein which drains the foot and leg.     
% 220.54/220.78  |- skos__hiddenLabel mesh__D012501 Veins, Saphenous
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D012501 1997
% 220.54/220.78  |- skos__prefLabel mesh__D012501 Saphenous Vein
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D012501 2002
% 220.54/220.78  |- mesh__recordAuthorizer mesh__D012501 PLS
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D012501 1994
% 220.54/220.78  |- skos__hiddenLabel mesh__D012501 Saphenous Veins
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D012501 2005
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D012501 2000
% 220.54/220.78  |- mesh__recordMaintainer mesh__D012501 TAP
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D012501 1998
% 220.54/220.78  |- skos__broader mesh__D012501smesh__D014680
% 220.54/220.78  |- mesh__recordOriginator mesh__D012501 NLM
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D012501 1995
% 220.54/220.78  |- skos__annotation mesh__D017795 coord IM with specific plant /virol   
% 220.54/220.78  |- skos__prefLabel mesh__D017795 Bromovirus
% 220.54/220.78  |- skos__scopeNote mesh__D017795
% 220.54/220.78       A genus of tripartite plant viruses in the family BROMOVIRIDAE. Transmission is by beetles. Brome mosaic virus is the type species.%A%    
% 220.54/220.78  |- skos__hiddenLabel mesh__D017795 mosaic virus, Brome
% 220.54/220.78  |- mesh__dateCreated mesh__D017795 1993-06-04
% 220.54/220.78  |- skos__historyNote mesh__D017795 Mosaic Viruses %28%1973-1993%29%
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D017795 2006
% 220.54/220.78  |- mesh__recordAuthorizer mesh__D017795 sjn
% 220.54/220.78  |- rdf__type mesh__D017795sskos__Concept
% 220.54/220.78  |- skos__historyNote mesh__D017795 Plant Viruses %28%1966-1993%29%
% 220.54/220.78  |- mesh__dateRevised mesh__D017795 2001-07-25
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D017795 2005
% 220.54/220.78  |- mesh__recordMaintainer mesh__D017795 ags
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D017795 2004
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D017795 2002
% 220.54/220.78  |- mesh__historyNote mesh__D017795
% 220.54/220.78       94; BROME MOSAIC VIRUSES was see BROMOVIRUS 1994-96   
% 220.54/220.78  |- skos__broader mesh__D017795smesh__D009029
% 220.54/220.78  |- skos__hiddenLabel mesh__D017795 Brome mosaic viruses
% 220.54/220.78  |- skos__broader mesh__D017795smesh__D019177
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D017795 2003
% 220.54/220.78  |- mesh__dateEstablished mesh__D017795 1994-01-01
% 220.54/220.78  |- mesh__recordOriginator mesh__D017795 AGS
% 220.54/220.78  |- mesh__onlineNote mesh__D017795
% 220.54/220.78       use BROMOVIRUS to search BROME MOSAIC VIRUSES 1994-96   
% 220.54/220.78  |- mesh__publicMeSHNote mesh__D017795
% 220.54/220.78       94; BROME MOSAIC VIRUSES was see BROMOVIRUS 1994-96   
% 220.54/220.78  |- mesh__recordMaintainer mesh__D003775 TAP
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003775 2005
% 220.54/220.78  |- mesh__recordAuthorizer mesh__D003775 PLS
% 220.54/220.78  |- skos__broader mesh__D003775smesh__D003813
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003775 2002
% 220.54/220.78  |- skos__altLabel mesh__D003775 Polishing, Dental
% 220.54/220.78  |- mesh__recordOriginator mesh__D003775 RC
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003775 1997
% 220.54/220.78  |- skos__altLabel mesh__D003775 Dental Finishing
% 220.54/220.78  |- skos__historyNote mesh__D003775 Surface Properties %28%1968-1983%29%
% 220.54/220.78  |- mesh__dateRevised mesh__D003775 1992-05-14
% 220.54/220.78  |- mesh__activeMeSHYear mesh__D003775 1993
% 220.64/220.78  |- skos__prefLabel mesh__D003775 Dental Polishing
% 220.64/220.78  |- skos__scopeNote mesh__D003775
% 220.64/220.78       Creation of a smooth and glossy surface finish on a denture or amalgam.%A%    
% 220.64/220.78  |- skos__annotation mesh__D003775
% 220.64/220.78       restrict to polishing of dentures, amalgams %26% resins; tooth polishing: index under DENTAL PROPHYLAXIS or DENTAL SCALING or TOOTHBRUSHING; DF: DENT POLISHING%A%  
% 220.64/220.78  |- mesh__activeMeSHYear mesh__D003775 1996
% 220.64/220.78  |- mesh__activeMeSHYear mesh__D003775 2004
% 220.64/220.78  |- rdf__type mesh__D003775sskos__Concept
% 220.64/220.78  |- mesh__activeMeSHYear mesh__D003775 1999
% 220.64/220.78  |- mesh__dateCreated mesh__D003775 1983-04-21
% 220.64/220.78  |- mesh__activeMeSHYear mesh__D003775 2001
% 220.64/220.78  |- mesh__historyNote mesh__D003775 84   
% 220.64/220.78  |- skos__altLabel mesh__D003775 Burnishing, Dental
% 220.64/220.78  |- mesh__activeMeSHYear mesh__D003775 1995
% 220.64/220.78  |- mesh__activeMeSHYear mesh__D003775 2003
% 220.64/220.78  |- skos__historyNote mesh__D003775
% 220.64/220.78       Dental Restoration, Permanent %28%1966-1983%29%
% 220.64/220.78  |- mesh__activeMeSHYear mesh__D003775 1998
% 220.64/220.78  |- mesh__activeMeSHYear mesh__D003775 2000
% 220.64/220.78  |- mesh__dateEstablished mesh__D003775 1984-01-01
% 220.64/220.78  |- mesh__activeMeSHYear mesh__D003775 2006
% 220.64/220.78  |- mesh__publicMeSHNote mesh__D003775 84   
% 220.64/220.78  |- mesh__activeMeSHYear mesh__D003775 1994
% 220.64/220.78  |- mesh__activeMeSHYear mesh__D011409 2001
% 220.64/220.78  |- skos__hiddenLabel mesh__D011409 Glycols, Propylene
% 220.64/220.78  |- mesh__activeMeSHYear mesh__D011409 1999
% 220.64/220.78  |- mesh__publicMeSHNote mesh__D011409 98; see PROPANEDIOLS 1963-97   
% 220.64/220.78  |- skos__broader mesh__D011409smesh__D006018
% 220.64/220.78  |- mesh__recordMaintainer mesh__D011409 ADP
% 220.64/220.78  |- mesh__activeMeSHYear mesh__D011409 2002
% 220.64/220.78  |- mesh__activeMeSHYear mesh__D011409 2005
% 220.64/220.78  |- mesh__dateRevised mesh__D011409 1997-06-20
% 220.64/220.78  |- mesh__recordAuthorizer mesh__D011409 SJN
% 220.64/220.78  |- skos__annotation mesh__D011409 PROPYLENE GLYCOL is also available   
% 220.64/220.78  |- mesh__activeMeSHYear mesh__D011409 2003
% 220.64/220.78  |- skos__altLabel mesh__D011409 Propanediols
% 220.64/220.78  |- mesh__activeMeSHYear mesh__D011409 2006
% 220.64/220.78  |- skos__prefLabel mesh__D011409 Propylene Glycols
% 220.64/220.78  |- skos__scopeNote mesh__D011409
% 220.64/220.78       Derivatives of propylene glycol %28%1,2-propanediol%29%. They are used as humectants and solvents in pharmaceutical preparations.%A%    
% 220.64/220.78  |- mesh__activeMeSHYear mesh__D011409 2004
% 220.64/220.78  |- mesh__activeMeSHYear mesh__D011409 1998
% 220.64/220.78  |- mesh__activeMeSHYear mesh__D011409 2000
% 220.64/220.78  |- mesh__recordOriginator mesh__D011409 NLM
% 220.64/220.78  |- mesh__dateCreated mesh__D011409 1999-01-01
% 220.64/220.78  |- mesh__historyNote mesh__D011409 98%28%63%29%   
% 220.64/220.78  |- rdf__type mesh__D011409sskos__Concept
% 220.64/220.78  |- skos__broader mesh__D008460smesh__D005502
% 220.64/220.78  |- skos__scopeNote mesh__D008460
% 220.64/220.78       The edible portions of any animal used for food including domestic mammals %28%the major ones being cattle, swine, and sheep%29% along with poultry, fish, shellfish, and game.%A%    
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D008460 2005
% 220.64/220.79  |- rdf__type mesh__D008460sskos__Concept
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D008460 2002
% 220.64/220.79  |- mesh__dateCreated mesh__D008460 1999-01-01
% 220.64/220.79  |- mesh__recordAuthorizer mesh__D008460 sjn
% 220.64/220.79  |- mesh__dateRevised mesh__D008460 2001-07-25
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D008460 2004
% 220.64/220.79  |- skos__prefLabel mesh__D008460 Meat
% 220.64/220.79  |- mesh__recordMaintainer mesh__D008460 mdb
% 220.64/220.79  |- mesh__recordOriginator mesh__D008460 NLM
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D008460 2003
% 220.64/220.79  |- skos__annotation mesh__D008460
% 220.64/220.79       IM; coord with animal source of meat %28%NIM%29%, as beef = MEAT %28%IM%29% + CATTLE %28%NIM%29%, pork = MEAT %28%IM%29% + SWINE %28%NIM%29%: Manual 31.7; canned meat = MEAT %28%IM%29% + source %28%NIM%29% + FOOD PRESERVATION %28%IM%29%; note MEAT PRODUCTS; FISH PRODUCTS %26% POULTRY PRODUCTS are available: see notes there%A%  
% 220.64/220.79  |- skos__hiddenLabel mesh__D008460 Meats
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D008460 2006
% 220.64/220.79  |- mesh__recordOriginator mesh__D049877 ags
% 220.64/220.79  |- skos__historyNote mesh__D049877 Mollusca %28%1965-2005%29%
% 220.64/220.79  |- mesh__historyNote mesh__D049877 2006   
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D049877 2006
% 220.64/220.79  |- mesh__recordAuthorizer mesh__D049877 sjn
% 220.64/220.79  |- skos__broader mesh__D049877smesh__D049876
% 220.64/220.79  |- mesh__recordMaintainer mesh__D049877 ags
% 220.64/220.79  |- rdf__type mesh__D049877sskos__Concept
% 220.64/220.79  |- skos__scopeNote mesh__D049877
% 220.64/220.79       A genus of thin-shelled freshwater mussels in the family UNIONIDAE, class BIVALVIA.%A%    
% 220.64/220.79  |- skos__prefLabel mesh__D049877 Anodonta
% 220.64/220.79  |- mesh__dateCreated mesh__D049877 2005-06-30
% 220.64/220.79  |- mesh__dateEstablished mesh__D049877 2006-01-01
% 220.64/220.79  |- mesh__publicMeSHNote mesh__D049877 2006   
% 220.64/220.79  |- skos__historyNote mesh__D049877 Bivalvia %28%1970-2005%29%
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D007368 2000
% 220.64/220.79  |- mesh__recordOriginator mesh__D007368 SMH
% 220.64/220.79  |- skos__scopeNote mesh__D007368
% 220.64/220.79       Measurement of distances or movements by means of the phenomena caused by the interference of two rays of light %28%optical interferometry%29% or of sound %28%acoustic interferometry%29%.%A%    
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D007368 1994
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D007368 2006
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D007368 1999
% 220.64/220.79  |- skos__annotation mesh__D007368
% 220.64/220.79       NIM; coord with LIGHT %28%NIM%29% or SOUND %28%NIM%29% if specified   
% 220.64/220.79  |- skos__historyNote mesh__D007368 Lasers %28%1966-1976%29%
% 220.64/220.79  |- skos__historyNote mesh__D007368 Optics %28%1966-1976%29%
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D007368 2005
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D007368 1993
% 220.64/220.79  |- mesh__publicMeSHNote mesh__D007368 77   
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D007368 1998
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D007368 2004
% 220.64/220.79  |- rdf__type mesh__D007368sskos__Concept
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D007368 2002
% 220.64/220.79  |- mesh__recordMaintainer mesh__D007368 TAP
% 220.64/220.79  |- mesh__dateRevised mesh__D007368 1992-05-14
% 220.64/220.79  |- skos__hiddenLabel mesh__D007368 Interferometries
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D007368 1997
% 220.64/220.79  |- mesh__recordAuthorizer mesh__D007368 PLS
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D007368 2003
% 220.64/220.79  |- skos__broader mesh__D007368smesh__D008919
% 220.64/220.79  |- mesh__dateCreated mesh__D007368 1976-04-13
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D007368 2001
% 220.64/220.79  |- mesh__dateEstablished mesh__D007368 1977-01-01
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D007368 1996
% 220.64/220.79  |- skos__prefLabel mesh__D007368 Interferometry
% 220.64/220.79  |- mesh__historyNote mesh__D007368 77   
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D007368 1995
% 220.64/220.79  |- skos__annotation mesh__D004070
% 220.64/220.79       the plant, not the drug which is probably DIGITALIS GLYCOSIDES; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.64/220.79  |- mesh__recordAuthorizer mesh__D004070 ags
% 220.64/220.79  |- skos__altLabel mesh__D004070 Foxglove
% 220.64/220.79  |- skos__broader mesh__D004070smesh__D028083
% 220.64/220.79  |- mesh__dateRevised mesh__D004070 2005-07-29
% 220.64/220.79  |- mesh__dateCreated mesh__D004070 1999-01-01
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D004070 2003
% 220.64/220.79  |- mesh__recordOriginator mesh__D004070 NLM
% 220.64/220.79  |- skos__prefLabel mesh__D004070 Digitalis
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D004070 2004
% 220.64/220.79  |- rdf__type mesh__D004070sskos__Concept
% 220.64/220.79  |- skos__scopeNote mesh__D004070
% 220.64/220.79       A genus of toxic herbaceous Eurasian plants of the SCROPHULARIACEAE which yield cardiotonic DIGITALIS GLYCOSIDES. The most useful species are Digitalis lanata and D. purpurea.%A%    
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D004070 2005
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D004070 2006A
% 220.64/220.79  |- mesh__recordMaintainer mesh__D004070 ags
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D004070 2006
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D012502 2000
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D012502 1996
% 220.64/220.79  |- mesh__recordMaintainer mesh__D012502 TAP
% 220.64/220.79  |- mesh__dateCreated mesh__D012502 1977-12-16
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D012502 1993
% 220.64/220.79  |- skos__broader mesh__D012502smesh__D013150
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D012502 2004
% 220.64/220.79  |- skos__prefLabel mesh__D012502 Sapogenins
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D012502 2001
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D012502 1997
% 220.64/220.79  |- mesh__recordOriginator mesh__D012502 RLS
% 220.64/220.79  |- mesh__dateRevised mesh__D012502 1992-05-20
% 220.64/220.79  |- mesh__historyNote mesh__D012502 79   
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D012502 1994
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D012502 2005
% 220.64/220.79  |- mesh__dateEstablished mesh__D012502 1979-01-01
% 220.64/220.79  |- skos__historyNote mesh__D012502 Triterpenes %28%1974-1978%29%
% 220.64/220.79  |- skos__historyNote mesh__D012502 Terpenes %28%1966-1973%29%
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D012502 2002
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D012502 1998
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D012502 1995
% 220.64/220.79  |- skos__broader mesh__D012502smesh__D014315
% 220.64/220.79  |- skos__historyNote mesh__D012502 Spirostans %28%1968-1978%29%
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D012502 2006
% 220.64/220.79  |- mesh__recordAuthorizer mesh__D012502 PLS
% 220.64/220.79  |- rdf__type mesh__D012502sskos__Concept
% 220.64/220.79  |- skos__scopeNote mesh__D012502
% 220.64/220.79       The aglucon moiety of a saponin molecule. It may be triterpenoid or steroid, usually spirostan, in nature.%A%    
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D012502 1999
% 220.64/220.79  |- mesh__publicMeSHNote mesh__D012502
% 220.64/220.79       79; OLEANOLIC ACID was see under TRITERPENES 1975-78   
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D012502 2003
% 220.64/220.79  |- mesh__historyNote mesh__D017796 94   
% 220.64/220.79  |- skos__historyNote mesh__D017796 Mosaic Viruses %28%1973-1993%29%
% 220.64/220.79  |- skos__prefLabel mesh__D017796 Caulimovirus
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D017796 2005
% 220.64/220.79  |- skos__broader mesh__D017796smesh__D004267
% 220.64/220.79  |- skos__broader mesh__D017796smesh__D009029
% 220.64/220.79  |- mesh__dateCreated mesh__D017796 1993-06-04
% 220.64/220.79  |- mesh__recordMaintainer mesh__D017796 ags
% 220.64/220.79  |- skos__hiddenLabel mesh__D017796 Caulimoviruses
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D017796 2003
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D017796 2006
% 220.64/220.79  |- rdf__type mesh__D017796sskos__Concept
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D017796 2004
% 220.64/220.79  |- mesh__dateRevised mesh__D017796 2002-07-03
% 220.64/220.79  |- skos__historyNote mesh__D017796 Plant Viruses %28%1969-1993%29%
% 220.64/220.79  |- mesh__recordOriginator mesh__D017796 AGS
% 220.64/220.79  |- mesh__recordAuthorizer mesh__D017796 sjn
% 220.64/220.79  |- skos__annotation mesh__D017796
% 220.64/220.79       coord IM with specific plant /virol %28%IM or NIM%29%   
% 220.64/220.79  |- mesh__publicMeSHNote mesh__D017796 94   
% 220.64/220.79  |- skos__scopeNote mesh__D017796
% 220.64/220.79       A genus of PLANT VIRUSES, in the family Caulimoviridae, that are transmitted by APHIDS in a semipersistent manner. Aphid-borne transmission of some caulimoviruses requires certain virus-coded proteins termed transmission factors.%A%    
% 220.64/220.79  |- mesh__dateEstablished mesh__D017796 1994-01-01
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D003776 2000
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D003776 1997
% 220.64/220.79  |- skos__broader mesh__D003776smesh__D003764
% 220.64/220.79  |- mesh__historyNote mesh__D003776 65   
% 220.64/220.79  |- mesh__recordOriginator mesh__D003776 NLM
% 220.64/220.79  |- skos__annotation mesh__D003776 D25-26 qualif; DF: DENT PORCELAIN   
% 220.64/220.79  |- mesh__dateEstablished mesh__D003776 1965-01-01
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D003776 1996
% 220.64/220.79  |- skos__broader mesh__D003776smesh__D002516
% 220.64/220.79  |- mesh__recordAuthorizer mesh__D003776 PLS
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D003776 2004
% 220.64/220.79  |- rdf__type mesh__D003776sskos__Concept
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D003776 2002
% 220.64/220.79  |- mesh__publicMeSHNote mesh__D003776 65   
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D003776 1999
% 220.64/220.79  |- mesh__recordMaintainer mesh__D003776 TGC
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D003776 2003
% 220.64/220.79  |- skos__altLabel mesh__D003776 Porcelain
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D003776 1998
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D003776 2006
% 220.64/220.79  |- skos__prefLabel mesh__D003776 Dental Porcelain
% 220.64/220.79  |- mesh__dateRevised mesh__D003776 1995-03-16
% 220.64/220.79  |- mesh__dateCreated mesh__D003776 1999-01-01
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D003776 2001
% 220.64/220.79  |- skos__altLabel mesh__D003776 Porcelain, Dental
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D003776 2005
% 220.64/220.79  |- skos__scopeNote mesh__D003776
% 220.64/220.79       A type of porcelain used in dental restorations, either jacket crowns or inlays, artificial teeth, or metal-ceramic crowns. It is essentially a mixture of particles of feldspar and quartz, the feldspar melting first and providing a glass matrix for the quartz. Dental porcelain is produced by mixing ceramic powder %28%a mixture of quartz, kaolin, pigments, opacifiers, a suitable flux, and other substances%29% with distilled water. %28%From Jablonski%27%s Dictionary of Dentistry, 1992%29%%A%    
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D008461 2000
% 220.64/220.79  |- skos__hiddenLabel mesh__D008461 Product, Meat
% 220.64/220.79  |- mesh__recordMaintainer mesh__D008461 JLS
% 220.64/220.79  |- skos__prefLabel mesh__D008461 Meat Products
% 220.64/220.79  |- mesh__recordOriginator mesh__D008461 VDK
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D008461 2004
% 220.64/220.79  |- skos__hiddenLabel mesh__D008461 Products, Meat
% 220.64/220.79  |- mesh__dateEstablished mesh__D008461 1991-01-01
% 220.64/220.79  |- mesh__historyNote mesh__D008461
% 220.64/220.79       91%28%78%29%; was see under MEAT 1978-90   
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D008461 2002
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D008461 2003
% 220.64/220.79  |- skos__annotation mesh__D008461
% 220.64/220.79       %22%derived by a process of manufacture from any portion of carcasses of any animal%22% %28%e.g., sausage, scrapple%29% but for canned meat see note on MEAT; coord IM with animal source %28%NIM%29%%A%  
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D008461 1999
% 220.64/220.79  |- skos__hiddenLabel mesh__D008461 Meat Product
% 220.64/220.79  |- mesh__recordAuthorizer mesh__D008461 SJN
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D008461 1998
% 220.64/220.79  |- mesh__publicMeSHNote mesh__D008461 91; was see under MEAT 1978-90   
% 220.64/220.79  |- skos__broader mesh__D008461smesh__D008460
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D008461 2006
% 220.64/220.79  |- mesh__dateCreated mesh__D008461 1977-04-27
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D008461 2001
% 220.64/220.79  |- mesh__dateRevised mesh__D008461 1997-06-20
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D008461 2005
% 220.64/220.79  |- skos__scopeNote mesh__D008461
% 220.64/220.79       Articles of food which are derived by a process of manufacture from any portion of carcasses of any animal used for food %28%e.g., head cheese, sausage, scrapple%29%.%A%    
% 220.64/220.79  |- rdf__type mesh__D008461sskos__Concept
% 220.64/220.79  |- skos__broader mesh__D000005Q000293smesh__D000005
% 220.64/220.79  |- mesh__preferredCombination mesh__D000005Q000293smesh__D000007
% 220.64/220.79  |- rdf__type mesh__D000005Q000293smesh__CompoundConcept
% 220.64/220.79  |- mesh__recordAuthorizer mesh__D049878 sjn
% 220.64/220.79  |- skos__historyNote mesh__D049878 Bivalvia %28%1978-2005%29%
% 220.64/220.79  |- rdf__type mesh__D049878sskos__Concept
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D049878 2006
% 220.64/220.79  |- mesh__recordMaintainer mesh__D049878 ags
% 220.64/220.79  |- skos__scopeNote mesh__D049878
% 220.64/220.79       A genus of marine mussels in the family MYTILIDAE, class BIVALVIA. The species MYTILUS EDULIS is the highly edible common mussel.%A%    
% 220.64/220.79  |- skos__prefLabel mesh__D049878 Mytilus
% 220.64/220.79  |- mesh__publicMeSHNote mesh__D049878 2006; see MUSSELS 1979-2005   
% 220.64/220.79  |- skos__broader mesh__D049878smesh__D049879
% 220.64/220.79  |- mesh__historyNote mesh__D049878 2006; use BIVALVIA 1979-2005   
% 220.64/220.79  |- mesh__dateCreated mesh__D049878 2005-06-30
% 220.64/220.79  |- mesh__dateEstablished mesh__D049878 2006-01-01
% 220.64/220.79  |- skos__historyNote mesh__D049878 Mollusca %28%1966-2005%29%
% 220.64/220.79  |- mesh__recordOriginator mesh__D049878 ags
% 220.64/220.79  |- skos__historyNote mesh__D007369
% 220.64/220.79       Interferons/biosynthesis %28%1966-1972%29%
% 220.64/220.79  |- mesh__dateCreated mesh__D007369 1999-01-01
% 220.64/220.79  |- skos__hiddenLabel mesh__D007369 Inducers, Interferon
% 220.64/220.79  |- mesh__dateRevised mesh__D007369 2005-06-30
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D007369 2006
% 220.64/220.79  |- skos__broader mesh__D007369smesh__D015545
% 220.64/220.79  |- skos__related mesh__D007369smesh__D000998
% 220.64/220.79  |- mesh__recordOriginator mesh__D007369 NLM
% 220.64/220.79  |- skos__scopeNote mesh__D007369
% 220.64/220.79       Agents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers Poly A-U and Poly I-C. Viruses, bacteria, and protozoa have been also known to induce interferons.%A%    
% 220.64/220.79  |- skos__prefLabel mesh__D007369 Interferon Inducers
% 220.64/220.79  |- skos__related mesh__D007369smesh__D000970
% 220.64/220.79  |- rdf__type mesh__D007369sskos__Concept
% 220.64/220.79  |- mesh__recordMaintainer mesh__D007369 ssb
% 220.64/220.79  |- mesh__dateEstablished mesh__D007369 1973-01-01
% 220.64/220.79  |- mesh__recordAuthorizer mesh__D007369 sjn
% 220.64/220.79  |- mesh__historyNote mesh__D007369 73   
% 220.64/220.79  |- skos__annotation mesh__D007369 DF: INTERFERON IND   
% 220.64/220.79  |- mesh__publicMeSHNote mesh__D007369 73   
% 220.64/220.79  |- skos__altLabel mesh__D018091 AMPA Receptor
% 220.64/220.79  |- mesh__recordAuthorizer mesh__D018091 PLS
% 220.64/220.79  |- mesh__onlineNote mesh__D018091
% 220.64/220.79       use RECEPTORS, AMPA %28%NM%29% to search AMPA RECEPTOR 1981-93   
% 220.64/220.79  |- mesh__dateCreated mesh__D018091 1993-06-21
% 220.64/220.79  |- mesh__recordOriginator mesh__D018091 RAZ
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D018091 2005
% 220.64/220.79  |- mesh__historyNote mesh__D018091
% 220.64/220.79       94; was AMPA RECEPTOR %28%NM%29% 1981-93   
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D018091 2000
% 220.64/220.79  |- rdf__type mesh__D018091sskos__Concept
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D018091 1998
% 220.64/220.79  |- skos__prefLabel mesh__D018091 Receptors, AMPA
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D018091 2006
% 220.64/220.79  |- mesh__publicMeSHNote mesh__D018091
% 220.64/220.79       94; AMPA RECEPTOR was indexed under RECEPTORS, GLUTAMATE 1993, RECEPTORS, SYNAPTIC 1990-92, %26% RECEPTORS, DRUG 1981-89%A%  
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D018091 2003
% 220.64/220.79  |- skos__altLabel mesh__D018091 Quisqualate Receptors
% 220.64/220.79  |- skos__historyNote mesh__D018091 Receptors, Drug %28%1981-1989%29%
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D018091 2001
% 220.64/220.79  |- skos__historyNote mesh__D018091
% 220.64/220.79       Receptors, Neurotransmitter %28%1990-1992%29%
% 220.64/220.79  |- skos__historyNote mesh__D018091 Receptors, Glutamate %28%1993%29%
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D018091 1999
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D018091 1996
% 220.64/220.79  |- mesh__dateEstablished mesh__D018091 1994-01-01
% 220.64/220.79  |- mesh__dateRevised mesh__D018091 1995-06-08
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D018091 2004
% 220.64/220.79  |- skos__altLabel mesh__D018091 AMPA Receptors
% 220.64/220.79  |- mesh__recordMaintainer mesh__D018091 KEV
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D018091 2002
% 220.64/220.79  |- skos__broader mesh__D018091smesh__D017470
% 220.64/220.79  |- skos__hiddenLabel mesh__D018091 Receptors, Quisqualate
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D018091 1997
% 220.64/220.79  |- skos__annotation mesh__D018091 DF: RECEPT AMPA   
% 220.64/220.79  |- skos__hiddenLabel mesh__D018091 Receptor, AMPA
% 220.64/220.79  |- skos__scopeNote mesh__D018091
% 220.64/220.79       Cell surface proteins that bind glutamate and directly gate ion channels in cell membranes. AMPA receptors were originally discriminated from other glutamate receptors by their affinity for the agonist AMPA %28%alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid%29%. They are probably the most common mediators of fast excitatory synaptic transmission in the central nervous system. Several subtypes have been cloned, and for some types the traditional distinction from kainate receptors may not apply.%A%    
% 220.64/220.79  |- skos__hiddenLabel mesh__D018091 Receptor, Quisqualate
% 220.64/220.79  |- mesh__dateCreated mesh__D004071 1999-01-01
% 220.64/220.79  |- skos__broader mesh__D004071smesh__D002301
% 220.64/220.79  |- skos__hiddenLabel mesh__D004071 Glycosides, Digitalis
% 220.64/220.79  |- skos__scopeNote mesh__D004071
% 220.64/220.79       Glycosides from plants of the genus DIGITALIS. Some of these are useful as cardiotonic and anti-arrhythmia agents. Included also are semi-synthetic derivatives of the naturally occurring glycosides. The term has sometimes been used more broadly to include all CARDIAC GLYCOSIDES, but here is restricted to those related to Digitalis.%A%    
% 220.64/220.79  |- rdf__type mesh__D004071sskos__Concept
% 220.64/220.79  |- mesh__dateRevised mesh__D004071 2004-07-07
% 220.64/220.79  |- mesh__recordOriginator mesh__D004071 NLM
% 220.64/220.79  |- mesh__recordMaintainer mesh__D004071 ssb
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D004071 2005
% 220.64/220.79  |- skos__prefLabel mesh__D004071 Digitalis Glycosides
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D004071 2006
% 220.64/220.79  |- mesh__recordAuthorizer mesh__D004071 sjn
% 220.64/220.79  |- skos__annotation mesh__D004071
% 220.64/220.79       cardiotonics; the pharmacological principle in the plant Digitalis%A%  
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D012503 2006
% 220.64/220.79  |- skos__scopeNote mesh__D012503
% 220.64/220.79       Sapogenin glycosides. A type of glycoside widely distributed in plants. Each consists of a sapogenin as the aglycon moiety, and a sugar. The sapogenin may be a steroid or a triterpene and the sugar may be glucose, galactose, a pentose, or a methylpentose. Sapogenins are poisonous towards the lower forms of life and are powerful hemolytics when injected into the blood stream able to dissolve red blood cells at even extreme dilutions.%A%    
% 220.64/220.79  |- rdf__type mesh__D012503sskos__Concept
% 220.64/220.79  |- mesh__recordMaintainer mesh__D012503 ssb
% 220.64/220.79  |- skos__annotation mesh__D012503 glycosides found in plants   
% 220.64/220.79  |- skos__broader mesh__D012503smesh__D006027
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D012503 2005
% 220.64/220.79  |- mesh__dateCreated mesh__D012503 1999-01-01
% 220.64/220.79  |- mesh__recordAuthorizer mesh__D012503 sjn
% 220.64/220.79  |- mesh__recordOriginator mesh__D012503 NLM
% 220.64/220.79  |- mesh__dateRevised mesh__D012503 2004-07-07
% 220.64/220.79  |- skos__prefLabel mesh__D012503 Saponins
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D017797 2005
% 220.64/220.79  |- skos__altLabel mesh__D017797 Coloring, Dental Prosthesis
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D017797 1999
% 220.64/220.79  |- mesh__dateRevised mesh__D017797 1997-06-20
% 220.64/220.79  |- mesh__publicMeSHNote mesh__D017797 94   
% 220.64/220.79  |- skos__annotation mesh__D017797
% 220.64/220.79       coord IM with specific prosthesis %28%IM%29% or DENTAL PROSTHESIS DESIGN %28%IM%29%%A%  
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D017797 2003
% 220.64/220.79  |- mesh__dateEstablished mesh__D017797 1994-01-01
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D017797 2006
% 220.64/220.79  |- rdf__type mesh__D017797sskos__Concept
% 220.64/220.79  |- mesh__recordOriginator mesh__D017797 JLS
% 220.64/220.79  |- skos__broader mesh__D017797smesh__D011474
% 220.64/220.79  |- skos__altLabel mesh__D017797 Prosthesis Coloring, Dental
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D017797 2004
% 220.64/220.79  |- mesh__recordMaintainer mesh__D017797 PXP
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D017797 2000
% 220.64/220.79  |- skos__hiddenLabel mesh__D017797 Coloring, Prosthesis
% 220.64/220.79  |- mesh__dateCreated mesh__D017797 1993-06-04
% 220.64/220.79  |- mesh__recordAuthorizer mesh__D017797 SJN
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D017797 2001
% 220.64/220.79  |- mesh__historyNote mesh__D017797 94   
% 220.64/220.79  |- skos__historyNote mesh__D017797 specific prosthesis %28%1966-1993%29%
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D017797 1998
% 220.64/220.79  |- skos__historyNote mesh__D017797 Color %28%1966-1993%29%
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D017797 2002
% 220.64/220.79  |- skos__scopeNote mesh__D017797
% 220.64/220.79       Coloring, shading, or tinting of prosthetic components, devices, and materials.%A%    
% 220.64/220.79  |- skos__prefLabel mesh__D017797 Prosthesis Coloring
% 220.64/220.79  |- skos__altLabel mesh__D003777 Prophylaxis, Dental
% 220.64/220.79  |- mesh__dateEstablished mesh__D003777 1965-01-01
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D003777 2005
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D003777 1996
% 220.64/220.79  |- mesh__recordMaintainer mesh__D003777 TAP
% 220.64/220.79  |- mesh__publicMeSHNote mesh__D003777 65   
% 220.64/220.79  |- mesh__recordAuthorizer mesh__D003777 PLS
% 220.64/220.79  |- rdf__type mesh__D003777sskos__Concept
% 220.64/220.79  |- mesh__activeMeSHYear mesh__D003777 1993
% 220.65/220.83  |- skos__scopeNote mesh__D003777
% 220.65/220.83       Treatment for the prevention of periodontal diseases or other dental diseases by the cleaning of the teeth in the dental office using the procedures of DENTAL SCALING and DENTAL POLISHING. The treatment may include plaque detection, removal of supra- and subgingival plaque and calculus, application of caries-preventing agents, checking of restorations and prostheses and correcting overhanging margins and proximal contours of restorations, and checking for signs of food impaction.%A%    
% 220.65/220.83  |- skos__prefLabel mesh__D003777 Dental Prophylaxis
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D003777 2002
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D003777 1999
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D003777 2004
% 220.65/220.83  |- mesh__dateRevised mesh__D003777 1992-05-14
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D003777 1998
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D003777 2003
% 220.65/220.83  |- skos__broader mesh__D003777smesh__D011313
% 220.65/220.83  |- mesh__dateCreated mesh__D003777 1999-01-01
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D003777 1995
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D003777 2001
% 220.65/220.83  |- skos__broader mesh__D003777smesh__D010517
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D003777 2006
% 220.65/220.83  |- skos__annotation mesh__D003777
% 220.65/220.83       removal of calculus %26% stains by dentist or hygienist: prev of calculus %26% stains by patient = DENTAL HYGIENE see ORAL HYGIENE or TOOTHBRUSHING or DENTAL DEVICES, HOME CARE; DF: DENT PROPHYLAXIS%A%  
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D003777 1994
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D003777 2000
% 220.65/220.83  |- mesh__historyNote mesh__D003777 65   
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D003777 1997
% 220.65/220.83  |- mesh__recordOriginator mesh__D003777 NLM
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D008462 2000
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D008462 2003
% 220.65/220.83  |- skos__hiddenLabel mesh__D008462 Industry, Meat Packing
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D008462 2004
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D008462 2001
% 220.65/220.83  |- mesh__recordOriginator mesh__D008462 NLM
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D008462 1998
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D008462 2002
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D008462 1999
% 220.65/220.83  |- skos__altLabel mesh__D008462 Industry, Meat-Packing
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D008462 2005
% 220.65/220.83  |- mesh__recordAuthorizer mesh__D008462 SJN
% 220.65/220.83  |- mesh__dateCreated mesh__D008462 1999-01-01
% 220.65/220.83  |- skos__hiddenLabel mesh__D008462 Industries, Meat-Packing
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D008462 2006
% 220.65/220.83  |- skos__hiddenLabel mesh__D008462 Meat Packing Industry
% 220.65/220.83  |- skos__prefLabel mesh__D008462 Meat-Packing Industry
% 220.65/220.83  |- mesh__recordMaintainer mesh__D008462 JLS
% 220.65/220.83  |- skos__annotation mesh__D008462
% 220.65/220.83       SPEC: SPEC qualif; DF: MEAT PACKING INDUST   
% 220.65/220.83  |- mesh__dateRevised mesh__D008462 1997-06-20
% 220.65/220.83  |- rdf__type mesh__D008462sskos__Concept
% 220.65/220.83  |- skos__scopeNote mesh__D008462
% 220.65/220.83       The aggregate enterprise of technically producing packaged meat.%A%    
% 220.65/220.83  |- skos__broader mesh__D008462smesh__D005511
% 220.65/220.83  |- skos__hiddenLabel mesh__D008462 Meat-Packing Industries
% 220.65/220.83  |- mesh__recordMaintainer mesh__D049879 ags
% 220.65/220.83  |- rdf__type mesh__D049879sskos__Concept
% 220.65/220.83  |- mesh__dateCreated mesh__D049879 2005-06-30
% 220.65/220.83  |- skos__prefLabel mesh__D049879 Mytilidae
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D049879 2006
% 220.65/220.83  |- skos__scopeNote mesh__D049879
% 220.65/220.83       A family of marine MUSSELS in the class BIVALVIA.     
% 220.65/220.83  |- mesh__recordOriginator mesh__D049879 ags
% 220.65/220.83  |- mesh__recordAuthorizer mesh__D049879 sjn
% 220.65/220.83  |- mesh__historyNote mesh__D049879 2006   
% 220.65/220.83  |- mesh__dateEstablished mesh__D049879 2006-01-01
% 220.65/220.83  |- skos__historyNote mesh__D049879 Bivalvia %28%1973-2005%29%
% 220.65/220.83  |- mesh__publicMeSHNote mesh__D049879 2006   
% 220.65/220.83  |- skos__broader mesh__D049879smesh__D049872
% 220.65/220.83  |- skos__related mesh__D018890smesh__D016588
% 220.65/220.83  |- mesh__historyNote mesh__D018890 96   
% 220.65/220.83  |- skos__annotation mesh__D018890
% 220.65/220.83       IM general or unspecified only; prefer specific chemotherapeutic agent /ther use + disease /prev; DF: CHEMOPREV%A%  
% 220.65/220.83  |- skos__prefLabel mesh__D018890 Chemoprevention
% 220.65/220.83  |- mesh__dateEstablished mesh__D018890 1996-01-01
% 220.65/220.83  |- mesh__recordOriginator mesh__D018890 AGS
% 220.65/220.83  |- skos__historyNote mesh__D018890
% 220.65/220.83       specific disease/prevention %26% control %28%1966-1995%29%
% 220.65/220.83  |- mesh__activeMeSHYear mesh__D018890 2006
% 220.65/220.83  |- mesh__publicMeSHNote mesh__D018890 96   
% 220.65/220.83  |- mesh__dateCreated mesh__D018890 1994-12-27
% 220.65/220.83  |- mesh__recordMaintainer mesh__D018890 lkt
% 220.65/220.83  |- skos__altLabel mesh__D018890 Chemoprophylaxis
% 220.65/220.83  |- skos__scopeNote mesh__D018890
% 220.65/220.83       The use of chemical compounds to prevent the development of a specific disease.%A%    
% 220.65/220.83  |- mesh__recordAuthorizer mesh__D018890 sjn
% 220.65/220.83  |- rdf__type mesh__D018890sskos__Concept
% 220.65/220.83  |- mesh__dateRevised mesh__D018890 2005-06-30
% 220.65/220.83  |- skos__broader mesh__D018890smesh__D004358
% 220.68/220.83  |- skos__hiddenLabel mesh__D032561 Fiber, Cotton
% 220.68/220.83  |- skos__prefLabel mesh__D032561 Cotton Fiber
% 220.68/220.83  |- skos__broader mesh__D032561smesh__D013784
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D032561 2003
% 220.68/220.83  |- skos__related mesh__D032561smesh__D003368
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D032561 2004
% 220.68/220.83  |- skos__annotation mesh__D032561
% 220.68/220.83       lung dis from cotton dust = BYSSINOSIS; COTTON PLANT see GOSSYPIUM is also available%A%  
% 220.68/220.83  |- rdf__type mesh__D032561sskos__Concept
% 220.68/220.83  |- skos__hiddenLabel mesh__D032561 Cotton Fibers
% 220.68/220.83  |- mesh__historyNote mesh__D032561 2003   
% 220.68/220.83  |- skos__historyNote mesh__D032561 Gossypium %28%1963-2002%29%
% 220.68/220.83  |- mesh__dateCreated mesh__D032561 2002-07-03
% 220.68/220.83  |- skos__scopeNote mesh__D032561
% 220.68/220.83       A TEXTILE fiber obtained from the pappus %28%outside the SEEDS%29% of cotton plant %28%GOSSYPIUM%29%. Inhalation of cotton fiber dust over a prolonged period can result in BYSSINOSIS.%A%    
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D032561 2005
% 220.68/220.83  |- skos__hiddenLabel mesh__D032561 Fibers, Cotton
% 220.68/220.83  |- mesh__dateEstablished mesh__D032561 2003-01-01
% 220.68/220.83  |- mesh__publicMeSHNote mesh__D032561 2003   
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D032561 2006
% 220.68/220.83  |- skos__hiddenLabel mesh__D018092 Receptor, Kainate
% 220.68/220.83  |- mesh__publicMeSHNote mesh__D018092
% 220.68/220.83       94; KAINIC ACID RECEPTOR was indexed under RECEPTORS, GLUTAMATE 1993, RECEPTORS, SYNAPTIC 1985-92, %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1981-84%A%  
% 220.68/220.83  |- skos__historyNote mesh__D018092
% 220.68/220.83       Receptors, Cell Surface %28%1981-1984%29%
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D018092 2002
% 220.68/220.83  |- skos__broader mesh__D018092smesh__D017470
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D018092 2005
% 220.68/220.83  |- mesh__recordAuthorizer mesh__D018092 PLS
% 220.68/220.83  |- rdf__type mesh__D018092sskos__Concept
% 220.68/220.83  |- skos__hiddenLabel mesh__D018092 Receptor, Kainic Acid
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D018092 1998
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D018092 2006
% 220.68/220.83  |- skos__annotation mesh__D018092 DF: RECEPT KAINIC ACID   
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D018092 2003
% 220.68/220.83  |- skos__altLabel mesh__D018092 Kainate Receptor
% 220.68/220.83  |- mesh__dateCreated mesh__D018092 1993-06-21
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D018092 2004
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D018092 1999
% 220.68/220.83  |- mesh__dateRevised mesh__D018092 1995-06-08
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D018092 1996
% 220.68/220.83  |- mesh__recordMaintainer mesh__D018092 KEV
% 220.68/220.83  |- mesh__recordOriginator mesh__D018092 RAZ
% 220.68/220.83  |- skos__scopeNote mesh__D018092
% 220.68/220.83       Cell surface proteins that bind glutamate and directly gate ion channels. Kainic acid receptors were originally discriminated from other glutamate receptors by their affinity for the agonist kainic acid. Activation of kainic acid receptors is generally excitatory to cells. Subtypes have been cloned, and for some the traditional distinction from AMPA receptors may not apply.%A%    
% 220.68/220.83  |- skos__altLabel mesh__D018092 Kainate Receptors
% 220.68/220.83  |- mesh__onlineNote mesh__D018092
% 220.68/220.83       use RECEPTORS, KAINIC ACID %28%NM%29% to search KAINIC ACID RECEPTOR 1981-93%A%  
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D018092 2000
% 220.68/220.83  |- mesh__historyNote mesh__D018092
% 220.68/220.83       94; was KAINIC ACID RECEPTOR %28%NM%29% 1981-93   
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D018092 1997
% 220.68/220.83  |- skos__altLabel mesh__D018092 Kainic Acid Receptor
% 220.68/220.83  |- skos__altLabel mesh__D018092 Receptors, Kainate
% 220.68/220.83  |- skos__prefLabel mesh__D018092 Receptors, Kainic Acid
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D018092 2001
% 220.68/220.83  |- skos__historyNote mesh__D018092
% 220.68/220.83       Receptors, Neurotransmitter %28%1985-1992%29%
% 220.68/220.83  |- skos__historyNote mesh__D018092 Receptors, Glutamate %28%1993%29%
% 220.68/220.83  |- skos__altLabel mesh__D018092 Kainic Acid Receptors
% 220.68/220.83  |- mesh__dateEstablished mesh__D018092 1994-01-01
% 220.68/220.83  |- mesh__publicMeSHNote mesh__D004870
% 220.68/220.83       91; was see under HYDROPHID VENOMS 1978-90; was see under SNAKE VENOMS 1975-77%A%  
% 220.68/220.83  |- mesh__recordAuthorizer mesh__D004870 sjn
% 220.68/220.83  |- skos__scopeNote mesh__D004870
% 220.68/220.83       Toxins isolated from the venom of Laticauda semifasciata, a sea snake %28%Hydrophid%29%; immunogenic, basic polypeptides of 62 amino acids, folded by four disulfide bonds, block neuromuscular end-plates irreversibly, thus causing paralysis and severe muscle damage; they are similar to Elapid neurotoxins.%A%    
% 220.68/220.83  |- skos__broader mesh__D004870smesh__D006870
% 220.68/220.83  |- skos__annotation mesh__D004870
% 220.68/220.83       toxins from venom of a sea snake; /antag permitted but consider also ANTIVENINS%A%  
% 220.68/220.83  |- mesh__dateRevised mesh__D004870 2005-06-30
% 220.68/220.83  |- rdf__type mesh__D004870sskos__Concept
% 220.68/220.83  |- mesh__historyNote mesh__D004870
% 220.68/220.83       91%28%73%29%; was see under HYDROPHID VENOMS 1978-90; was see under SNAKE VENOMS 1975-77%A%  
% 220.68/220.83  |- mesh__dateCreated mesh__D004870 1999-01-01
% 220.68/220.83  |- mesh__recordOriginator mesh__D004870 NLM
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D004870 2006
% 220.68/220.83  |- mesh__dateEstablished mesh__D004870 1991-01-01
% 220.68/220.83  |- mesh__recordMaintainer mesh__D004870 ssb
% 220.68/220.83  |- skos__prefLabel mesh__D004870 Erabutoxins
% 220.68/220.83  |- rdf__type mesh__D004072sskos__Concept
% 220.68/220.83  |- skos__historyNote mesh__D004072 Digitalis Glycosides %28%1966-1972%29%
% 220.68/220.83  |- mesh__dateRevised mesh__D004072 2004-07-07
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D004072 2005
% 220.68/220.83  |- skos__historyNote mesh__D004072
% 220.68/220.83       Indicators and Reagents %28%1966-1972%29%
% 220.68/220.83  |- mesh__publicMeSHNote mesh__D004072
% 220.68/220.83       79; was see under DIGITALIS GLYCOSIDES 1975-78   
% 220.68/220.83  |- skos__altLabel mesh__D004072 Digitin
% 220.68/220.83  |- mesh__recordAuthorizer mesh__D004072 sjn
% 220.68/220.83  |- skos__scopeNote mesh__D004072
% 220.68/220.83       A glycoside obtained from Digitalis purpurea; the aglycone is digitogenin which is bound to five sugars. Digitonin solubilizes lipids, especially in membranes and is used as a tool in cellular biochemistry, and reagent for precipitating cholesterol. It has no cardiac effects.%A%    
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D004072 2006
% 220.68/220.83  |- mesh__historyNote mesh__D004072
% 220.68/220.83       79%28%73%29%; was see under DIGITALIS GLYCOSIDES 1975-78   
% 220.68/220.83  |- mesh__dateCreated mesh__D004072 1999-01-01
% 220.68/220.83  |- skos__broader mesh__D004072smesh__D004071
% 220.68/220.83  |- mesh__recordOriginator mesh__D004072 NLM
% 220.68/220.83  |- mesh__recordMaintainer mesh__D004072 ssb
% 220.68/220.83  |- skos__prefLabel mesh__D004072 Digitonin
% 220.68/220.83  |- mesh__dateEstablished mesh__D004072 1979-01-01
% 220.68/220.83  |- skos__prefLabel mesh__D012504 Saralasin
% 220.68/220.83  |- skos__historyNote mesh__D012504 Sarcosine %28%1974%29%
% 220.68/220.83  |- skos__hiddenLabel mesh__D012504 Angiotensin II, 1-Sar-8-Ala
% 220.68/220.83  |- skos__altLabel mesh__D012504 angiotensin II, Sar%28%1%29%-Ala%28%8%29%-
% 220.68/220.83  |- skos__altLabel mesh__D012504 %28%Sar1,Val5,Ala8%29%Angiotensin II
% 220.68/220.83  |- skos__hiddenLabel mesh__D012504 Angiotensin II, 1-Sarcosine-8-Alanine
% 220.68/220.83  |- skos__hiddenLabel mesh__D012504 Acetate, Hydrated Saralasin
% 220.68/220.83  |- skos__altLabel mesh__D012504
% 220.68/220.83       angiotensin II, sarcosyl%28%1%29%-alanine%28%8%29%-
% 220.68/220.83  |- skos__altLabel mesh__D012504 Sar-Arg-Val-Tyr-Val-His-Pro-Ala
% 220.68/220.83  |- skos__altLabel mesh__D012504 1-Sarcosine-8-Alanine Angiotensin II
% 220.68/220.83  |- mesh__dateCreated mesh__D012504 1974-11-19
% 220.68/220.83  |- skos__historyNote mesh__D012504 Angiotensin II %28%1974%29%
% 220.68/220.83  |- mesh__recordMaintainer mesh__D012504 ssb
% 220.68/220.83  |- skos__hiddenLabel mesh__D012504 Hydrated Saralasin Acetate
% 220.68/220.83  |- skos__broader mesh__D012504smesh__D000804
% 220.68/220.83  |- skos__hiddenLabel mesh__D012504 Anhydrous Saralasin Acetate
% 220.68/220.83  |- mesh__dateEstablished mesh__D012504 1984-01-01
% 220.68/220.83  |- mesh__publicMeSHNote mesh__D012504
% 220.68/220.83       1984; see ANGIOTENSIN II 1978-83; 1-SARCOSINE-8-ALANINE ANGIOTENSIN II was indexed under ANGIOTENSIN II 1975-77%A%  
% 220.68/220.83  |- skos__altLabel mesh__D012504 %28%Sar%28%1%29%,Ala%28%8%29%%29%ANGII
% 220.68/220.83  |- mesh__dateRevised mesh__D012504 2005-06-30
% 220.68/220.83  |- mesh__historyNote mesh__D012504 1984%28%1978%29%   
% 220.68/220.83  |- skos__scopeNote mesh__D012504
% 220.68/220.83       An octapeptide analog of angiotensin II %28%bovine%29% with amino acids 1 and 8 replaced with sarcosine and alanine, respectively. It is a highly specific competitive inhibitor of angiotensin II.%A%    
% 220.68/220.83  |- skos__altLabel mesh__D012504 1-Sar-8-Ala-angiotensin II
% 220.68/220.83  |- mesh__recordAuthorizer mesh__D012504 sjn
% 220.68/220.83  |- skos__hiddenLabel mesh__D012504 1 Sarcosine 8 Alanine Angiotensin II
% 220.68/220.83  |- skos__hiddenLabel mesh__D012504 Sar Arg Val Tyr Val His Pro Ala
% 220.68/220.83  |- skos__hiddenLabel mesh__D012504 1 Sar 8 Ala Angiotensin II
% 220.68/220.83  |- skos__altLabel mesh__D012504 Saralasin Acetate, Hydrated
% 220.68/220.83  |- mesh__recordOriginator mesh__D012504 NLM
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D012504 2006
% 220.68/220.83  |- skos__altLabel mesh__D012504 1-Sar-8-Ala Angiotensin II
% 220.68/220.83  |- rdf__type mesh__D012504sskos__Concept
% 220.68/220.83  |- skos__historyNote mesh__D012504 Alanine %28%1974%29%
% 220.68/220.83  |- mesh__recordMaintainer mesh__D017798 ags
% 220.68/220.83  |- mesh__publicMeSHNote mesh__D017798
% 220.68/220.83       94; COWPEA MOSAIC VIRUSES was see COMOVIRUS 1994-96   
% 220.68/220.83  |- mesh__dateRevised mesh__D017798 2001-07-25
% 220.68/220.83  |- skos__annotation mesh__D017798 coord IM with specific plant /virol   
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D017798 2002
% 220.68/220.83  |- mesh__historyNote mesh__D017798
% 220.68/220.83       94; COWPEA MOSAIC VIRUSES was see COMOVIRUS 1994-96   
% 220.68/220.83  |- mesh__onlineNote mesh__D017798
% 220.68/220.83       use COMOVIRUS to search COWPEA MOSAIC VIRUSES 1994-96   
% 220.68/220.83  |- skos__hiddenLabel mesh__D017798 Mosaic Virus, Cowpea
% 220.68/220.83  |- mesh__recordAuthorizer mesh__D017798 sjn
% 220.68/220.83  |- mesh__dateEstablished mesh__D017798 1994-01-01
% 220.68/220.83  |- mesh__recordOriginator mesh__D017798 AGS
% 220.68/220.83  |- skos__historyNote mesh__D017798 Plant Viruses %28%1966-1993%29%
% 220.68/220.83  |- skos__scopeNote mesh__D017798
% 220.68/220.83       A genus of plant viruses of the family COMOVIRIDAE in which the bipartite genome is encapsidated in separate icosahedral particles. Mosaic and mottle symptoms are characteristic, and transmission is exclusively by leaf-feeding beetles. Cowpea mosaic virus is the type species.%A%    
% 220.68/220.83  |- skos__prefLabel mesh__D017798 Comovirus
% 220.68/220.83  |- skos__hiddenLabel mesh__D017798 Mosaic Viruses, Cowpea
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D017798 2005
% 220.68/220.83  |- skos__broader mesh__D017798smesh__D009029
% 220.68/220.83  |- skos__historyNote mesh__D017798 Mosaic Viruses %28%1973-1993%29%
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D017798 2006
% 220.68/220.83  |- rdf__type mesh__D017798sskos__Concept
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D017798 2003
% 220.68/220.83  |- skos__hiddenLabel mesh__D017798 Cowpea Mosaic Viruses
% 220.68/220.83  |- skos__broader mesh__D017798smesh__D019180
% 220.68/220.83  |- mesh__dateCreated mesh__D017798 1993-06-04
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D017798 2004
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D003778 2003
% 220.68/220.83  |- rdf__type mesh__D003778sskos__Concept
% 220.68/220.83  |- skos__annotation mesh__D003778
% 220.68/220.83       GEN or unspecified; prefer specifics; labeling for ownership or identification = DENTURE IDENTIFICATION MARKING%A%  
% 220.68/220.83  |- mesh__dateCreated mesh__D003778 1999-01-01
% 220.68/220.83  |- mesh__recordOriginator mesh__D003778 NLM
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D003778 2002
% 220.68/220.83  |- skos__broader mesh__D003778smesh__D017266
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D003778 2004
% 220.68/220.83  |- skos__prefLabel mesh__D003778 Dentures
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D003778 2005
% 220.68/220.83  |- mesh__publicMeSHNote mesh__D003778
% 220.68/220.83       91; was DENTAL PROSTHESIS 1963-90; DENTURES was see DENTAL PROSTHESIS 1984-90%A%  
% 220.68/220.83  |- skos__scopeNote mesh__D003778
% 220.68/220.83       An appliance used as an artificial or prosthetic replacement for missing teeth and adjacent tissues. It does not include CROWNS; DENTAL ABUTMENTS; nor TOOTH, ARTIFICIAL.%A%    
% 220.68/220.83  |- mesh__historyNote mesh__D003778
% 220.68/220.83       91; was DENTAL PROSTHESIS 1963-90; DENTURES was see DENTAL PROSTHESIS 1984-90%A%  
% 220.68/220.83  |- mesh__dateRevised mesh__D003778 2001-07-25
% 220.68/220.83  |- skos__hiddenLabel mesh__D003778 Denture
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D003778 2006
% 220.68/220.83  |- mesh__recordMaintainer mesh__D003778 mdb
% 220.68/220.83  |- mesh__recordAuthorizer mesh__D003778 sjn
% 220.68/220.83  |- mesh__recordMaintainer mesh__D008463 CCR
% 220.68/220.83  |- skos__hiddenLabel mesh__D008463 Anti Worm
% 220.68/220.83  |- skos__altLabel mesh__D008463 SSL Brand of Mebendazole
% 220.68/220.83  |- mesh__recordAuthorizer mesh__D008463 sjn
% 220.68/220.83  |- skos__historyNote mesh__D008463 Benzoates %28%1971-1974%29%
% 220.68/220.83  |- skos__altLabel mesh__D008463 Diba Brand of Mebendazole
% 220.68/220.83  |- mesh__publicMeSHNote mesh__D008463
% 220.68/220.83       86; was see under BENZIMIDAZOLES 1975-85   
% 220.68/220.83  |- skos__altLabel mesh__D008463 Tedec Meiji Brand of Mebendazole
% 220.68/220.83  |- skos__altLabel mesh__D008463 Pfizer Brand of Mebendazole
% 220.68/220.83  |- skos__altLabel mesh__D008463 Degort%27%s Brand of Mebendazole
% 220.68/220.83  |- mesh__historyNote mesh__D008463
% 220.68/220.83       86%28%75%29%; was see under BENZIMIDAZOLES 1975-85   
% 220.68/220.83  |- skos__scopeNote mesh__D008463
% 220.68/220.83       A nematocide in humans and animals. It acts by interfering with the carbohydrate metabolism and associated energy production of the parasite.%A%    
% 220.68/220.83  |- skos__altLabel mesh__D008463 Taxandria Brand of Mebendazole
% 220.68/220.83  |- skos__altLabel mesh__D008463 Janssen Brand of Mebendazole
% 220.68/220.83  |- skos__altLabel mesh__D008463 Esteve Brand of Mebendazole
% 220.68/220.83  |- skos__altLabel mesh__D008463 Leidapharm Brand of Mebendazole
% 220.68/220.83  |- skos__altLabel mesh__D008463 Elfar Brand of Mebendazole
% 220.68/220.83  |- mesh__recordOriginator mesh__D008463 NLM
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D008463 2006
% 220.68/220.83  |- skos__altLabel mesh__D008463 Norgine Brand of Mebendazole
% 220.68/220.83  |- skos__altLabel mesh__D008463 Healthypharm Brand of Mebendazole
% 220.68/220.83  |- skos__altLabel mesh__D008463 Boots Brand of Mebendazole
% 220.68/220.83  |- skos__altLabel mesh__D008463 Abello Farmacia Brand of Mebendazole
% 220.68/220.83  |- mesh__dateEstablished mesh__D008463 1986-01-01
% 220.68/220.83  |- skos__altLabel mesh__D008463 Ardeypharm Brand of Mebendazole
% 220.68/220.83  |- skos__historyNote mesh__D008463 Carbamates %28%1971-1974%29%
% 220.68/220.83  |- mesh__dateCreated mesh__D008463 1974-11-11
% 220.68/220.83  |- skos__altLabel mesh__D008463 Streger Brand of Mebendazole
% 220.68/220.83  |- rdf__type mesh__D008463sskos__Concept
% 220.68/220.83  |- skos__broader mesh__D008463smesh__D002219
% 220.68/220.83  |- skos__historyNote mesh__D008463 Benzimidazoles %28%1971-1974%29%
% 220.68/220.83  |- mesh__dateRevised mesh__D008463 2005-06-30
% 220.68/220.83  |- skos__broader mesh__D008463smesh__D001562
% 220.68/220.83  |- skos__prefLabel mesh__D008463 Mebendazole
% 220.68/220.83  |- skos__prefLabel mesh__D000480 Alkynes
% 220.68/220.83  |- rdf__type mesh__D000480sskos__Concept
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D000480 2002
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D000480 1996
% 220.68/220.83  |- mesh__recordAuthorizer mesh__D000480 PLS
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D000480 1998
% 220.68/220.83  |- mesh__dateRevised mesh__D000480 1995-03-16
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D000480 1997
% 220.68/220.83  |- mesh__publicMeSHNote mesh__D000480 66   
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D000480 1999
% 220.68/220.83  |- skos__broader mesh__D000480smesh__D006839
% 220.68/220.83  |- skos__scopeNote mesh__D000480
% 220.68/220.83       Acyclic hydrocarbons with one triple bond of the general formula Cn-H2n-2. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D000480 2000
% 220.68/220.83  |- mesh__recordOriginator mesh__D000480 NLM
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D000480 2003
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D000480 2001
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D000480 2005
% 220.68/220.83  |- mesh__recordMaintainer mesh__D000480 TGC
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D000480 2004
% 220.68/220.83  |- mesh__dateCreated mesh__D000480 1999-01-01
% 220.68/220.83  |- mesh__dateEstablished mesh__D000480 1966-01-01
% 220.68/220.83  |- mesh__historyNote mesh__D000480 66   
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D000480 2006
% 220.68/220.83  |- skos__broader mesh__D003546Q000037smesh__D003546
% 220.68/220.83  |- mesh__preferredCombination mesh__D003546Q000037smesh__D015853
% 220.68/220.83  |- rdf__type mesh__D003546Q000037smesh__CompoundConcept
% 220.68/220.83  |- skos__hiddenLabel mesh__D018891 Dentata, Fascia
% 220.68/220.83  |- mesh__historyNote mesh__D018891 1996   
% 220.68/220.83  |- skos__hiddenLabel mesh__D018891 Fascia, Dentate
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D018891 2006
% 220.68/220.83  |- mesh__recordAuthorizer mesh__D018891 sjn
% 220.68/220.83  |- mesh__recordMaintainer mesh__D018891 ags
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D018891 2003
% 220.68/220.83  |- skos__historyNote mesh__D018891 Hippocampus %28%1966-1995%29%
% 220.68/220.83  |- mesh__dateRevised mesh__D018891 2000-06-22
% 220.68/220.83  |- skos__altLabel mesh__D018891 Dentate Fascia
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D018891 2001
% 220.68/220.83  |- rdf__type mesh__D018891sskos__Concept
% 220.68/220.83  |- skos__prefLabel mesh__D018891 Dentate Gyrus
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D018891 2004
% 220.68/220.83  |- mesh__dateCreated mesh__D018891 1995-02-17
% 220.68/220.83  |- skos__broader mesh__D018891smesh__D006624
% 220.68/220.83  |- skos__scopeNote mesh__D018891
% 220.68/220.83       Gray matter situated above the gyrus hippocampi. It is composed of three layers. The molecular layer is continuous with the HIPPOCAMPUS in the hippocampal fissure. The granular layer consists of closely arranged spherical or oval neurons, called granule cells, whose AXONS pass through the polymorphic layer ending on the DENDRITES of pyramidal cells in the hippocampus.%A%    
% 220.68/220.83  |- mesh__dateEstablished mesh__D018891 1996-01-01
% 220.68/220.83  |- skos__hiddenLabel mesh__D018891 Gyrus, Dentate
% 220.68/220.83  |- skos__altLabel mesh__D018891 Fascia Dentata
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D018891 2002
% 220.68/220.83  |- mesh__publicMeSHNote mesh__D018891 1996   
% 220.68/220.83  |- mesh__recordOriginator mesh__D018891 AGS
% 220.68/220.83  |- skos__altLabel mesh__D018891 Gyrus Dentatus
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D018891 2005
% 220.68/220.83  |- mesh__dateCreated mesh__D018093 1993-06-04
% 220.68/220.83  |- mesh__dateRevised mesh__D018093 2003-07-09
% 220.68/220.83  |- skos__historyNote mesh__D018093 Gelatin %28%1973-1981%29%
% 220.68/220.83  |- mesh__publicMeSHNote mesh__D018093
% 220.68/220.83       94; GELATINASE was indexed under PEPTIDE PEPTIDOHYDROLASES 1993, PEPSIN A 1975-92, GELATIN 1973-81 %26% PEPTIDE HYDROLASES 1973-74%A%  
% 220.68/220.83  |- skos__annotation mesh__D018093
% 220.68/220.83       GELATINASE A and GELATINASE B are available   
% 220.68/220.83  |- skos__historyNote mesh__D018093 Peptide Hydrolases %28%1973-1974%29%
% 220.68/220.83  |- skos__scopeNote mesh__D018093
% 220.68/220.83       A class of enzymes that catalyzes the degradation of gelatin by acting on the peptide bonds. EC 3.4.24.-.%A%    
% 220.68/220.83  |- skos__broader mesh__D018093smesh__D008666
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D018093 2004
% 220.68/220.83  |- skos__prefLabel mesh__D018093 Gelatinases
% 220.68/220.83  |- skos__altLabel mesh__D018093 Gelatinase
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D018093 2006
% 220.68/220.83  |- skos__historyNote mesh__D018093 Pepsin A %28%1975-1992%29%
% 220.68/220.83  |- rdf__type mesh__D018093sskos__Concept
% 220.68/220.83  |- mesh__historyNote mesh__D018093 94; was GELATINASE %28%NM%29% 1973-93   
% 220.68/220.83  |- skos__historyNote mesh__D018093 Peptide Peptidohydrolases %28%1993%29%
% 220.68/220.83  |- mesh__dateEstablished mesh__D018093 1994-01-01
% 220.68/220.83  |- mesh__recordAuthorizer mesh__D018093 sjn
% 220.68/220.83  |- mesh__recordOriginator mesh__D018093 TPW
% 220.68/220.83  |- mesh__recordMaintainer mesh__D018093 jmp
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D018093 2005
% 220.68/220.83  |- mesh__onlineNote mesh__D018093
% 220.68/220.83       use GELATINASES %28%NM%29% to search GELATINASE 1973-93   
% 220.68/220.83  |- mesh__recordMaintainer mesh__D004871 jmp
% 220.68/220.83  |- rdf__type mesh__D004871sskos__Concept
% 220.68/220.83  |- skos__broader mesh__D004871smesh__D028581
% 220.68/220.83  |- mesh__dateRevised mesh__D004871 2001-07-25
% 220.68/220.83  |- skos__annotation mesh__D004871
% 220.68/220.83       a rare earth metal; Er-166; Er-162, 164, 167, 168, 170 = ERBIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Er-158-161, 163, 165, 169, 171, 172 = ERBIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D004871 2003
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D004871 2005
% 220.68/220.83  |- mesh__recordAuthorizer mesh__D004871 sjn
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D004871 2004
% 220.68/220.83  |- mesh__dateCreated mesh__D004871 1999-01-01
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D004871 2006
% 220.68/220.83  |- mesh__recordOriginator mesh__D004871 NLM
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D004871 2002
% 220.68/220.83  |- skos__scopeNote mesh__D004871
% 220.68/220.83       Erbium. An element of the rare earth family of metals. It has the atomic symbol Er, atomic number 68, and atomic weight 167.26.%A%    
% 220.68/220.83  |- skos__prefLabel mesh__D004871 Erbium
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D004073 2000
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D004073 1997
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D004073 2006
% 220.68/220.83  |- mesh__recordOriginator mesh__D004073 NLM
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D004073 1993
% 220.68/220.83  |- mesh__dateEstablished mesh__D004073 1977-01-01
% 220.68/220.83  |- mesh__publicMeSHNote mesh__D004073
% 220.68/220.83       77; was see under CARDANOLIDES 1968-76   
% 220.68/220.83  |- mesh__onlineNote mesh__D004073 search CARDANOLIDES 1968-74   
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D004073 2001
% 220.68/220.83  |- mesh__historyNote mesh__D004073
% 220.68/220.83       77%28%75%29%; was see under CARDANOLIDES 1968-76   
% 220.68/220.83  |- skos__prefLabel mesh__D004073 Digitoxigenin
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D004073 1998
% 220.68/220.83  |- skos__broader mesh__D004073smesh__D004074
% 220.68/220.83  |- mesh__dateCreated mesh__D004073 1999-01-01
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D004073 2002
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D004073 1994
% 220.68/220.83  |- mesh__dateRevised mesh__D004073 1992-05-13
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D004073 1999
% 220.68/220.83  |- mesh__activeMeSHYear mesh__D004073 2003
% 220.68/220.83  |- skos__annotation mesh__D004073
% 220.68/220.83       a Digitalis glycoside; do not confuse with DIGOXIGENIN   
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D004073 1995
% 220.68/220.84  |- mesh__recordAuthorizer mesh__D004073 PLS
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D004073 2004
% 220.68/220.84  |- skos__historyNote mesh__D004073 Cardanolides %28%1968-1974%29%
% 220.68/220.84  |- rdf__type mesh__D004073sskos__Concept
% 220.68/220.84  |- skos__scopeNote mesh__D004073
% 220.68/220.84       3 beta,14-Dihydroxy-5 beta-card-20%28%22%29%enolide. A cardenolide which is the aglycon of digitoxin. Synonyms: Cerberigenin; Echujetin; Evonogenin; Thevetigenin.%A%    
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D004073 1996
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D004073 2005
% 220.68/220.84  |- mesh__recordMaintainer mesh__D004073 TGC
% 220.68/220.84  |- skos__annotation mesh__D012505 in air, water, soil, mud   
% 220.68/220.84  |- mesh__recordAuthorizer mesh__D012505 sjn
% 220.68/220.84  |- mesh__recordOriginator mesh__D012505 NLM
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D012505 2006
% 220.68/220.84  |- mesh__recordMaintainer mesh__D012505 SYSTEM
% 220.68/220.84  |- rdf__type mesh__D012505sskos__Concept
% 220.68/220.84  |- skos__broader mesh__D012505smesh__D006095
% 220.68/220.84  |- skos__prefLabel mesh__D012505 Sarcina
% 220.68/220.84  |- mesh__dateCreated mesh__D012505 1999-01-01
% 220.68/220.84  |- skos__scopeNote mesh__D012505
% 220.68/220.84       A genus of gram-positive, anaerobic bacteria whose organisms divide in three perpendicular planes and occur in packets of eight or more cells. It has been isolated from soil, grains, and clinical specimens.%A%    
% 220.68/220.84  |- mesh__dateRevised mesh__D012505 2005-06-30
% 220.68/220.84  |- mesh__dateCreated mesh__D017799 1993-06-04
% 220.68/220.84  |- mesh__onlineNote mesh__D017799
% 220.68/220.84       use CUCUMOVIRUS to search CUCUMBER MOSAIC VIRUSES 1994-96%A%  
% 220.68/220.84  |- skos__hiddenLabel mesh__D017799 Cucumoviruses
% 220.68/220.84  |- skos__scopeNote mesh__D017799
% 220.68/220.84       A genus of plant viruses of the family BROMOVIRIDAE, which infect cucurbits and solanaceous plants. Transmission occurs via aphids in a non-persistent manner, and also via seeds. The type species Cucumber mosaic virus, a CUCUMOVIRUS, should not be confused with Cucumber green mottle mosaic virus, a TOBAMOVIRUS.%A%    
% 220.68/220.84  |- skos__historyNote mesh__D017799 Plant Viruses %28%1966-1993%29%
% 220.68/220.84  |- skos__hiddenLabel mesh__D017799 Cucumber mosaic viruses
% 220.68/220.84  |- mesh__dateRevised mesh__D017799 2001-07-25
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D017799 2005
% 220.68/220.84  |- skos__annotation mesh__D017799 coord IM with specific plant /virol   
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D017799 2002
% 220.68/220.84  |- skos__broader mesh__D017799smesh__D009029
% 220.68/220.84  |- skos__historyNote mesh__D017799 Mosaic Viruses %28%1973-1993%29%
% 220.68/220.84  |- skos__broader mesh__D017799smesh__D019177
% 220.68/220.84  |- rdf__type mesh__D017799sskos__Concept
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D017799 2006
% 220.68/220.84  |- mesh__historyNote mesh__D017799
% 220.68/220.84       94; CUCUMBER MOSAIC VIRUSES was see CUCUMOVIRUS 1994-96   
% 220.68/220.84  |- skos__prefLabel mesh__D017799 Cucumovirus
% 220.68/220.84  |- mesh__recordAuthorizer mesh__D017799 sjn
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D017799 2003
% 220.68/220.84  |- mesh__dateEstablished mesh__D017799 1994-01-01
% 220.68/220.84  |- skos__hiddenLabel mesh__D017799 mosaic virus, Cucumber
% 220.68/220.84  |- mesh__recordOriginator mesh__D017799 AGS
% 220.68/220.84  |- mesh__publicMeSHNote mesh__D017799
% 220.68/220.84       94; CUCUMBER MOSAIC VIRUSES was see CUCUMOVIRUS 1994-96   
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D017799 2004
% 220.68/220.84  |- mesh__recordMaintainer mesh__D017799 ags
% 220.68/220.84  |- skos__hiddenLabel mesh__D003779 Denture Designs
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D003779 2003
% 220.68/220.84  |- rdf__type mesh__D003779sskos__Concept
% 220.68/220.84  |- skos__historyNote mesh__D003779
% 220.68/220.84       Cleft Palate Prosthesis %28%1966-1969%29%
% 220.68/220.84  |- mesh__dateCreated mesh__D003779 1999-01-01
% 220.68/220.84  |- skos__annotation mesh__D003779
% 220.68/220.84       coord IM with specific denture %28%IM or NIM%29%   
% 220.68/220.84  |- mesh__recordAuthorizer mesh__D003779 sjn
% 220.68/220.84  |- skos__hiddenLabel mesh__D003779 Design, Denture
% 220.68/220.84  |- mesh__dateRevised mesh__D003779 2002-07-18
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D003779 2004
% 220.68/220.84  |- skos__historyNote mesh__D003779 Dental Prosthesis %28%1966-1969%29%
% 220.68/220.84  |- mesh__historyNote mesh__D003779
% 220.68/220.84       91; was DENTAL PROSTHESIS DESIGN 1970-90   
% 220.68/220.84  |- mesh__dateEstablished mesh__D003779 1970-01-01
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D003779 2005
% 220.68/220.84  |- skos__prefLabel mesh__D003779 Denture Design
% 220.68/220.84  |- mesh__publicMeSHNote mesh__D003779
% 220.68/220.84       91; was DENTAL PROSTHESIS DESIGN 1970-90   
% 220.68/220.84  |- mesh__recordOriginator mesh__D003779 NLM
% 220.68/220.84  |- skos__hiddenLabel mesh__D003779 Designs, Denture
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D003779 2006
% 220.68/220.84  |- skos__broader mesh__D003779smesh__D013674
% 220.68/220.84  |- mesh__recordMaintainer mesh__D003779 sjn
% 220.68/220.84  |- skos__historyNote mesh__D003779 Mandibular Prosthesis %28%1967-1969%29%
% 220.68/220.84  |- skos__scopeNote mesh__D003779
% 220.68/220.84       The plan, delineation, and location of actual structural elements of dentures. The design can relate to retainers, stress-breakers, occlusal rests, flanges, framework, lingual or palatal bars, reciprocal arms, etc.%A%    
% 220.68/220.84  |- skos__broader mesh__D003779smesh__D003778
% 220.68/220.84  |- mesh__dateCreated mesh__D008464 1999-01-01
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D008464 2006
% 220.68/220.84  |- mesh__dateRevised mesh__D008464 2003-07-09
% 220.68/220.84  |- rdf__type mesh__D008464sskos__Concept
% 220.68/220.84  |- mesh__recordAuthorizer mesh__D008464 sjn
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D008464 2004
% 220.68/220.84  |- mesh__recordMaintainer mesh__D008464 ssb
% 220.68/220.84  |- skos__scopeNote mesh__D008464
% 220.68/220.84       A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.%A%    
% 220.68/220.84  |- mesh__recordOriginator mesh__D008464 NLM
% 220.68/220.84  |- skos__broader mesh__D008464smesh__D009636
% 220.68/220.84  |- skos__prefLabel mesh__D008464 Mecamylamine
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D008464 2005
% 220.68/220.84  |- skos__hiddenLabel mesh__D000481 Allantoin Sween Brand
% 220.68/220.84  |- skos__hiddenLabel mesh__D000481 HerpecinL
% 220.68/220.84  |- skos__prefLabel mesh__D000481 Allantoin
% 220.68/220.84  |- skos__hiddenLabel mesh__D000481 Herpecin L
% 220.68/220.84  |- skos__hiddenLabel mesh__D000481 Allantoin Campbell Brand
% 220.68/220.84  |- mesh__historyNote mesh__D000481 72%28%64%29%   
% 220.68/220.84  |- mesh__dateEstablished mesh__D000481 1972-01-01
% 220.68/220.84  |- skos__altLabel mesh__D000481 Sween Brand of Allantoin
% 220.68/220.84  |- mesh__publicMeSHNote mesh__D000481 72   
% 220.68/220.84  |- mesh__dateRevised mesh__D000481 2005-06-30
% 220.68/220.84  |- skos__altLabel mesh__D000481 Campbell Brand of Allantoin
% 220.68/220.84  |- skos__altLabel mesh__D000481 Reed %26% Carnrick Brand of Allantoin
% 220.68/220.84  |- mesh__dateCreated mesh__D000481 1999-01-01
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D000481 2006
% 220.68/220.84  |- mesh__recordOriginator mesh__D000481 NLM
% 220.68/220.84  |- rdf__type mesh__D000481sskos__Concept
% 220.68/220.84  |- mesh__recordMaintainer mesh__D000481 ssb
% 220.68/220.84  |- skos__broader mesh__D000481smesh__D006827
% 220.68/220.84  |- skos__annotation mesh__D000481 /biosyn /defic /physiol permitted   
% 220.68/220.84  |- mesh__recordAuthorizer mesh__D000481 sjn
% 220.68/220.84  |- mesh__dateCreated mesh__D018892 1994-12-27
% 220.68/220.84  |- mesh__recordOriginator mesh__D018892 AGS
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018892 2003
% 220.68/220.84  |- skos__hiddenLabel mesh__D018892 gradient, pH
% 220.68/220.84  |- skos__related mesh__D018892smesh__D017494
% 220.68/220.84  |- mesh__publicMeSHNote mesh__D018892 96   
% 220.68/220.84  |- mesh__dateRevised mesh__D018892 2002-07-03
% 220.68/220.84  |- rdf__type mesh__D018892sskos__Concept
% 220.68/220.84  |- skos__altLabel mesh__D018892 deltapH
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018892 2004
% 220.68/220.84  |- skos__altLabel mesh__D018892 pH gradient
% 220.68/220.84  |- mesh__recordAuthorizer mesh__D018892 sjn
% 220.68/220.84  |- skos__broader mesh__D018892smesh__D004734
% 220.68/220.84  |- mesh__historyNote mesh__D018892 96   
% 220.68/220.84  |- skos__prefLabel mesh__D018892 Proton-Motive Force
% 220.68/220.84  |- skos__broader mesh__D018892smesh__D002627
% 220.68/220.84  |- skos__hiddenLabel mesh__D018892 Proton Motive Force
% 220.68/220.84  |- skos__hiddenLabel mesh__D018892 pH, delta
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018892 2005
% 220.68/220.84  |- skos__hiddenLabel mesh__D018892 Chemiosmotic Mechanism
% 220.68/220.84  |- skos__hiddenLabel mesh__D018892 Proton-Motive Forces
% 220.68/220.84  |- mesh__dateEstablished mesh__D018892 1996-01-01
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018892 2006
% 220.68/220.84  |- skos__related mesh__D018892smesh__D006863
% 220.68/220.84  |- skos__scopeNote mesh__D018892
% 220.68/220.84       Energy that is generated by the transfer of protons or electrons across an energy-transducing membrane and that can be used for chemical, osmotic, or mechanical work. Proton-motive force can be generated by a variety of phenomena including the operation of an electron transport chain, illumination of a PURPLE MEMBRANE, and the hydrolysis of ATP by a proton ATPase. %28%From Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed, p171%29%%A%    
% 220.68/220.84  |- mesh__recordMaintainer mesh__D018892 ags
% 220.68/220.84  |- skos__hiddenLabel mesh__D018094 Receptor, Metabotropic Glutamate
% 220.68/220.84  |- mesh__recordAuthorizer mesh__D018094 sjn
% 220.68/220.84  |- skos__annotation mesh__D018094
% 220.68/220.84       metabotropic refers to action via the second messenger system; DF: RECEPT METAB GLUTAMATE%A%  
% 220.68/220.84  |- skos__altLabel mesh__D018094 Glutamate Receptors, Metabotropic
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018094 2004
% 220.68/220.84  |- mesh__historyNote mesh__D018094 94   
% 220.68/220.84  |- mesh__publicMeSHNote mesh__D018094 94   
% 220.68/220.84  |- mesh__recordOriginator mesh__D018094 RAZ
% 220.68/220.84  |- skos__prefLabel mesh__D018094 Receptors, Metabotropic Glutamate
% 220.68/220.84  |- skos__broader mesh__D018094smesh__D043562
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018094 2006
% 220.68/220.84  |- mesh__dateCreated mesh__D018094 1993-06-21
% 220.68/220.84  |- mesh__recordMaintainer mesh__D018094 jmp
% 220.68/220.84  |- skos__scopeNote mesh__D018094
% 220.68/220.84       Cell surface proteins that bind glutamate and act through G-proteins to influence second messenger systems. Several types of metabotropic glutamate receptors have been cloned. They differ in pharmacology, distribution, and mechanisms of action.%A%    
% 220.68/220.84  |- skos__historyNote mesh__D018094
% 220.68/220.84       Receptors, Neurotransmitter %28%1988-1992%29%
% 220.68/220.84  |- skos__altLabel mesh__D018094 Metabotropic Glutamate Receptor
% 220.68/220.84  |- skos__altLabel mesh__D018094 Metabotropic Glutamate Receptors
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018094 2005
% 220.68/220.84  |- rdf__type mesh__D018094sskos__Concept
% 220.68/220.84  |- skos__historyNote mesh__D018094 Receptors, Glutamate %28%1993%29%
% 220.68/220.84  |- mesh__dateEstablished mesh__D018094 1994-01-01
% 220.68/220.84  |- mesh__dateRevised mesh__D018094 2003-07-09
% 220.68/220.84  |- skos__broader mesh__D018094smesh__D017470
% 220.68/220.84  |- skos__hiddenLabel mesh__D018094 Glutamate Receptor, Metabotropic
% 220.68/220.84  |- skos__altLabel mesh__D018094 Receptors, Glutamate, Metabotropic
% 220.68/220.84  |- skos__hiddenLabel mesh__D004872 D2, Vitamin
% 220.68/220.84  |- skos__altLabel mesh__D004872 Ergocalciferol
% 220.68/220.84  |- mesh__dateCreated mesh__D004872 1999-01-01
% 220.68/220.84  |- skos__broader mesh__D004872smesh__D013261
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D004872 2006
% 220.68/220.84  |- mesh__dateEstablished mesh__D004872 1967-01-01
% 220.68/220.84  |- mesh__recordOriginator mesh__D004872 NLM
% 220.68/220.84  |- mesh__publicMeSHNote mesh__D004872
% 220.68/220.84       90; was ERGOCALCIFEROL 1967-89; was VITAMIN D 2 1963-66   
% 220.68/220.84  |- skos__annotation mesh__D004872
% 220.68/220.84       deficiency: coordinate ERGOCALCIFEROLS /defic %28%IM%29% with VITAMIN D DEFICIENCY %28%IM%29%%A%  
% 220.68/220.84  |- skos__altLabel mesh__D004872 Vitamin D2
% 220.68/220.84  |- skos__prefLabel mesh__D004872 Ergocalciferols
% 220.68/220.84  |- skos__broader mesh__D004872smesh__D014807
% 220.68/220.84  |- mesh__recordMaintainer mesh__D004872 ssb
% 220.68/220.84  |- rdf__type mesh__D004872sskos__Concept
% 220.68/220.84  |- skos__scopeNote mesh__D004872
% 220.68/220.84       Derivatives of ERGOSTEROL formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. They differ from CHOLECALCIFEROL in having a double bond between C22 and C23 and a methyl group at C24.%A%    
% 220.68/220.84  |- skos__altLabel mesh__D004872 Calciferols
% 220.68/220.84  |- skos__hiddenLabel mesh__D004872 D 2, Vitamin
% 220.68/220.84  |- skos__broader mesh__D004872smesh__D002782
% 220.68/220.84  |- mesh__recordAuthorizer mesh__D004872 sjn
% 220.68/220.84  |- mesh__dateRevised mesh__D004872 2005-06-30
% 220.68/220.84  |- mesh__historyNote mesh__D004872
% 220.68/220.84       90; was ERGOCALCIFEROL 1967-89; was VITAMIN D 2 1963-66   
% 220.68/220.84  |- mesh__onlineNote mesh__D004872
% 220.68/220.84       use ERGOCALCIFEROLS to search ERGOCALCIFEROL 1967-89; VITAMIN D 2 1966%A%  
% 220.68/220.84  |- rdf__type mesh__D004074sskos__Concept
% 220.68/220.84  |- skos__altLabel mesh__D004074 Chauvin Brand of Digitoxin
% 220.68/220.84  |- skos__altLabel mesh__D004074 corax Brand of Digitoxin
% 220.68/220.84  |- skos__altLabel mesh__D004074 Ysatfabrik Brand of Digitoxin
% 220.68/220.84  |- mesh__dateRevised mesh__D004074 2005-06-30
% 220.68/220.84  |- mesh__dateCreated mesh__D004074 1999-01-01
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D004074 2006
% 220.68/220.84  |- skos__altLabel mesh__D004074 Hormosan Brand of Digitoxin
% 220.68/220.84  |- mesh__recordOriginator mesh__D004074 NLM
% 220.68/220.84  |- mesh__recordMaintainer mesh__D004074 exl
% 220.68/220.84  |- skos__altLabel mesh__D004074 Merck Brand of Digitoxin
% 220.68/220.84  |- skos__prefLabel mesh__D004074 Digitoxin
% 220.68/220.84  |- skos__annotation mesh__D004074
% 220.68/220.84       a Digitalis glycoside; do not confuse with DIGOXIN   
% 220.68/220.84  |- skos__altLabel mesh__D004074 Proctor %26% Gamble Brand of Digitoxin
% 220.68/220.84  |- skos__altLabel mesh__D004074 Medice Brand of Digitoxin
% 220.68/220.84  |- skos__broader mesh__D004074smesh__D004071
% 220.68/220.84  |- skos__broader mesh__D004074smesh__D002298
% 220.68/220.84  |- mesh__recordAuthorizer mesh__D004074 sjn
% 220.68/220.84  |- skos__scopeNote mesh__D004074
% 220.68/220.84       A cardiac glycoside sometimes used in place of DIGOXIN. It has a longer half-life than digoxin; toxic effects, which are similar to those of digoxin, are longer lasting. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p665%29%%A%    
% 220.68/220.84  |- skos__altLabel mesh__D004074 Philopharm Brand of Digitoxin
% 220.68/220.84  |- skos__altLabel mesh__D004074 AWD.pharma Brand of Digitoxin
% 220.68/220.84  |- mesh__recordMaintainer mesh__D012506 ags
% 220.68/220.84  |- mesh__dateRevised mesh__D012506 2003-07-09
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D012506 2006
% 220.68/220.84  |- mesh__recordAuthorizer mesh__D012506 sjn
% 220.68/220.84  |- rdf__type mesh__D012506sskos__Concept
% 220.68/220.84  |- skos__scopeNote mesh__D012506
% 220.68/220.84       A subphylum of protozoa characterized by the ability to alter their body shape. Its organisms acquire food by pseudopodia of various types, or by locomotive protoplasmic flow without the production of discrete pseudopodia. Flagella, when present, are usually restricted to developmental or other temporary stages.%A%    
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D012506 2004
% 220.68/220.84  |- mesh__recordOriginator mesh__D012506 NLM
% 220.68/220.84  |- skos__prefLabel mesh__D012506 Sarcodina
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D012506 2005
% 220.68/220.84  |- mesh__dateCreated mesh__D012506 1999-01-01
% 220.68/220.84  |- skos__broader mesh__D012506smesh__D016820
% 220.68/220.84  |- skos__annotation mesh__D012506 a subphylum of protozoa   
% 220.68/220.84  |- mesh__onlineNote mesh__D008465
% 220.68/220.84       use MECHANORECEPTORS to search NEUROTENDINOUS SPINDLES 1975-96 %26% GOLGI TENDON ORGANS 1994-96; use RECEPTORS, NEURAL to search NEUROTENDINOUS SPINDLES 1972-74, use NERVE ENDINGS 1966-71; use THERMORECEPTORS to search KRAUSE%27%S END BULBS %26% RUFFINI%27%S CORPUSCLES 1975-93; use RECEPTORS, SENSORY 1972-74 %26% NERVE ENDINGS 1966-71%A%  
% 220.68/220.84  |- skos__related mesh__D008465smesh__D040542
% 220.68/220.84  |- rdf__type mesh__D008465sskos__Concept
% 220.68/220.84  |- skos__hiddenLabel mesh__D008465 Corpuscles, Ruffini%27%s
% 220.68/220.84  |- skos__hiddenLabel mesh__D008465 Spindle, Neurotendinous
% 220.68/220.84  |- skos__scopeNote mesh__D008465
% 220.68/220.84       Cells specialized to transduce mechanical stimuli and relay that information centrally in the nervous system. Mechanoreceptors include HAIR CELLS, which mediate hearing and balance, and the various somatosensory receptors, often with non-neural accessory structures.%A%    
% 220.68/220.84  |- skos__hiddenLabel mesh__D008465 Neurotendinous Spindle
% 220.68/220.84  |- mesh__recordOriginator mesh__D008465 NLM
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D008465 2004
% 220.68/220.84  |- skos__altLabel mesh__D008465 Receptors, Stretch
% 220.68/220.84  |- skos__hiddenLabel mesh__D008465 Spindles, Neurotendinous
% 220.68/220.84  |- skos__hiddenLabel mesh__D008465 Organs, Golgi Tendon
% 220.68/220.84  |- skos__hiddenLabel mesh__D008465 Receptor, Stretch
% 220.68/220.84  |- skos__hiddenLabel mesh__D008465 End Bulbs, Krause%27%s
% 220.68/220.84  |- skos__hiddenLabel mesh__D008465 Ruffini Corpuscles
% 220.68/220.84  |- mesh__publicMeSHNote mesh__D008465
% 220.68/220.84       71; NEUROTENDINOUS SPINDLES was heading 1975-96 %28%see under MECHANORECEPTORS 1977-90, see under RECEPTORS, NEURAL 1975-76%29%, was see under RECEPTORS, NEURAL 1972-74, was see under NERVE ENDINGS 1963-71; GOLGI TENDON ORGANS was see NEUROTENDINOUS SPINDLES 1994-96; KRAUSE%27%S END BULBS %26% RUFFINI%27%S CORPUSCLES were see THERMORECEPTORS 1979-93; were see under THERMORECEPTORS 1975-78; were see under RECEPTORS, NEURAL 1972-74; were see under NERVE ENDINGS 1963-71%A%  
% 220.68/220.84  |- skos__hiddenLabel mesh__D008465 Ruffinis Corpuscles
% 220.68/220.84  |- mesh__dateEstablished mesh__D008465 1971-01-01
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D008465 2003
% 220.68/220.84  |- skos__hiddenLabel mesh__D008465 Meissners Corpuscle
% 220.68/220.84  |- mesh__dateRevised mesh__D008465 2002-07-02
% 220.68/220.84  |- skos__hiddenLabel mesh__D008465 Bulbs, Krause%27%s End
% 220.68/220.84  |- skos__hiddenLabel mesh__D008465 Stretch Receptor
% 220.68/220.84  |- skos__hiddenLabel mesh__D008465 Krauses End Bulbs
% 220.68/220.84  |- skos__historyNote mesh__D008465 Nerve Endings %28%1966-1970%29%
% 220.68/220.84  |- skos__hiddenLabel mesh__D008465 Krause End Bulbs
% 220.68/220.84  |- skos__related mesh__D008465smesh__D011434
% 220.68/220.84  |- skos__broader mesh__D008465smesh__D011984
% 220.68/220.84  |- skos__hiddenLabel mesh__D008465 Meissner Corpuscle
% 220.68/220.84  |- skos__hiddenLabel mesh__D008465 Mechanoreceptor
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D008465 2006
% 220.68/220.84  |- skos__hiddenLabel mesh__D008465 Corpuscle, Meissner%27%s
% 220.68/220.84  |- skos__historyNote mesh__D008465 Receptors, Sensory %28%1966-1970%29%
% 220.68/220.84  |- skos__annotation mesh__D008465 DF: MECHANORECEPT   
% 220.68/220.84  |- mesh__historyNote mesh__D008465
% 220.68/220.84       71; NEUROTENDINOUS SPINDLES was heading 1975-96 %28%see under MECHANORECEPTORS 1977-90, see under RECEPTORS, NEURAL 1975-76%29%, was see under RECEPTORS, NEURAL 1972-74, was see under NERVE ENDINGS 1963-71; GOLGI TENDON ORGANS was see NEUROTENDINOUS SPINDLES 1994-96; KRAUSE%27%S END BULBS %26% RUFFINI%27%S CORPUSCLES were see THERMORECEPTORS 1979-93; were see under THERMORECEPTORS 1975-78; were see under RECEPTORS, NEURAL 1972-74; were see under NERVE ENDINGS 1963-71%A%  
% 220.68/220.84  |- mesh__recordMaintainer mesh__D008465 ags
% 220.68/220.84  |- mesh__dateCreated mesh__D008465 1999-01-01
% 220.68/220.84  |- skos__altLabel mesh__D008465 Golgi Tendon Organs
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D008465 2005
% 220.68/220.84  |- mesh__recordAuthorizer mesh__D008465 sjn
% 220.68/220.84  |- skos__prefLabel mesh__D008465 Mechanoreceptors
% 220.68/220.84  |- skos__hiddenLabel mesh__D008465 Tendon Organs, Golgi
% 220.68/220.84  |- mesh__dateRevised mesh__D000482 2005-06-30
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D000482 2006
% 220.68/220.84  |- rdf__type mesh__D000482sskos__Concept
% 220.68/220.84  |- mesh__dateCreated mesh__D000482 1999-01-01
% 220.68/220.84  |- skos__broader mesh__D000482smesh__D005321
% 220.68/220.84  |- skos__scopeNote mesh__D000482
% 220.68/220.84       An extra-embryonic membranous sac derived from the YOLK SAC of REPTILES; BIRDS; and MAMMALS. It lies between two other extra-embryonic membranes, the AMNION and the CHORION. The allantois serves to store urinary wastes and mediate exchange of gas and nutrients for the developing EMBRYO.%A%    
% 220.68/220.84  |- mesh__onlineNote mesh__D000482 search FETAL MEMBRANES 1966-74   
% 220.68/220.84  |- mesh__recordOriginator mesh__D000482 NLM
% 220.68/220.84  |- mesh__recordAuthorizer mesh__D000482 sjn
% 220.68/220.84  |- mesh__recordMaintainer mesh__D000482 lkt
% 220.68/220.84  |- skos__hiddenLabel mesh__D000482 Membrane, Allantoic
% 220.68/220.84  |- mesh__publicMeSHNote mesh__D000482
% 220.68/220.84       91; was see under FETAL MEMBRANES 1975-90   
% 220.68/220.84  |- skos__prefLabel mesh__D000482 Allantois
% 220.68/220.84  |- skos__altLabel mesh__D000482 Allantoic Membrane
% 220.68/220.84  |- mesh__historyNote mesh__D000482
% 220.68/220.84       91%28%75%29%; was see under FETAL MEMBRANES 1975-90   
% 220.68/220.84  |- skos__related mesh__D000482smesh__D049033
% 220.68/220.84  |- mesh__dateEstablished mesh__D000482 1991-01-01
% 220.68/220.84  |- skos__broader mesh__D009206Q000528smesh__D009206
% 220.68/220.84  |- mesh__preferredCombination mesh__D009206Q000528smesh__D006321Q000528
% 220.68/220.84  |- rdf__type mesh__D009206Q000528smesh__CompoundConcept
% 220.68/220.84  |- skos__hiddenLabel mesh__D018893 Lavages, Bronchopulmonary
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018893 1998
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018893 2006
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018893 1996
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018893 2004
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018893 2001
% 220.68/220.84  |- skos__hiddenLabel mesh__D018893 Lavage, Bronchoalveolar
% 220.68/220.84  |- skos__hiddenLabel mesh__D018893 Lavage, Bronchial
% 220.68/220.84  |- skos__hiddenLabel mesh__D018893 Bronchioalveolar Lavages
% 220.68/220.84  |- skos__hiddenLabel mesh__D018893 Bronchopulmonary Lavages
% 220.68/220.84  |- skos__altLabel mesh__D018893 Lung Lavage
% 220.68/220.84  |- skos__altLabel mesh__D018893 Bronchioalveolar Lavage
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018893 2005
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018893 2000
% 220.68/220.84  |- mesh__dateCreated mesh__D018893 1994-12-27
% 220.68/220.84  |- skos__hiddenLabel mesh__D018893 Lavages, Bronchioalveolar
% 220.68/220.84  |- skos__broader mesh__D018893smesh__D007507
% 220.68/220.84  |- skos__hiddenLabel mesh__D018893 Lavages, Bronchial
% 220.68/220.84  |- skos__hiddenLabel mesh__D018893 Bronchoalveolar Lavages
% 220.68/220.84  |- rdf__type mesh__D018893sskos__Concept
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018893 2003
% 220.68/220.84  |- skos__hiddenLabel mesh__D018893 Lavages, Lung
% 220.68/220.84  |- skos__hiddenLabel mesh__D018893 Lavage, Lung
% 220.68/220.84  |- skos__hiddenLabel mesh__D018893 Lavage, Bronchioalveolar
% 220.68/220.84  |- mesh__publicMeSHNote mesh__D018893 96   
% 220.68/220.84  |- skos__hiddenLabel mesh__D018893 Lavages, Bronchoalveolar
% 220.68/220.84  |- skos__altLabel mesh__D018893 Bronchopulmonary Lavage
% 220.68/220.84  |- skos__annotation mesh__D018893
% 220.68/220.84       an irrigation technique: do not confuse with BRONCHOALVEOLAR LAVAGE FLUID, the washings obtained by lavage; DF: note short X ref%A%  
% 220.68/220.84  |- skos__hiddenLabel mesh__D018893 Lung Lavages
% 220.68/220.84  |- skos__historyNote mesh__D018893 Irrigation %28%1977-1995%29%
% 220.68/220.84  |- skos__scopeNote mesh__D018893
% 220.68/220.84       Washing out of the lungs with saline or mucolytic agents for diagnostic or therapeutic purposes. It is very useful in the diagnosis of diffuse pulmonary infiltrates in immunosuppressed patients.%A%    
% 220.68/220.84  |- skos__prefLabel mesh__D018893 Bronchoalveolar Lavage
% 220.68/220.84  |- skos__hiddenLabel mesh__D018893 Bronchial Lavages
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018893 2002
% 220.68/220.84  |- mesh__historyNote mesh__D018893 96   
% 220.68/220.84  |- mesh__dateEstablished mesh__D018893 1996-01-01
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018893 1999
% 220.68/220.84  |- skos__altLabel mesh__D018893 Lavage, Bronchopulmonary
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018893 1997
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018095 2006
% 220.68/220.84  |- skos__hiddenLabel mesh__D018095 Mutation, Germ Line
% 220.68/220.84  |- skos__hiddenLabel mesh__D018095 Mutation, Germline
% 220.68/220.84  |- skos__scopeNote mesh__D018095
% 220.68/220.84       Any detectable and heritable alteration in the lineage of germ cells. Mutations in these cells %28%i.e., %22%generative%22% cells ancestral to the gametes%29% are transmitted to progeny while those in somatic cells are not.%A%    
% 220.68/220.84  |- skos__altLabel mesh__D018095 Mutation, Germ-Line
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018095 2005
% 220.68/220.84  |- rdf__type mesh__D018095sskos__Concept
% 220.68/220.84  |- skos__broader mesh__D018095smesh__D009154
% 220.68/220.84  |- skos__hiddenLabel mesh__D018095 Germ Line Mutation
% 220.68/220.84  |- mesh__dateCreated mesh__D018095 1993-06-03
% 220.68/220.84  |- skos__hiddenLabel mesh__D018095 Germline Mutations
% 220.68/220.84  |- skos__prefLabel mesh__D018095 Germ-Line Mutation
% 220.68/220.84  |- skos__historyNote mesh__D018095 Mutation %28%1980-1993%29%
% 220.68/220.84  |- mesh__publicMeSHNote mesh__D018095 94   
% 220.68/220.84  |- skos__hiddenLabel mesh__D018095 Germ-Line Mutations
% 220.68/220.84  |- skos__altLabel mesh__D018095 Germline Mutation
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018095 2004
% 220.68/220.84  |- mesh__historyNote mesh__D018095 94   
% 220.68/220.84  |- skos__hiddenLabel mesh__D018095 Mutations, Germline
% 220.68/220.84  |- mesh__dateRevised mesh__D018095 2002-07-03
% 220.68/220.84  |- mesh__dateEstablished mesh__D018095 1994-01-01
% 220.68/220.84  |- skos__hiddenLabel mesh__D018095 Mutations, Germ-Line
% 220.68/220.84  |- skos__annotation mesh__D018095
% 220.68/220.84       germ-line refers to germ cells %28%ovum or spermatozoon%29%, not micro-organisms%A%  
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D018095 2003
% 220.68/220.84  |- mesh__historyNote mesh__D004873 69   
% 220.68/220.84  |- skos__historyNote mesh__D004873
% 220.68/220.84       Lysergic Acid Diethylamide %28%1966-1968%29%
% 220.68/220.84  |- skos__historyNote mesh__D004873 Ergot Alkaloids %28%1966-1968%29%
% 220.68/220.84  |- skos__broader mesh__D004873smesh__D006576
% 220.68/220.84  |- skos__prefLabel mesh__D004873 Ergolines
% 220.68/220.84  |- skos__historyNote mesh__D004873 Methysergide %28%1966-1968%29%
% 220.68/220.84  |- skos__scopeNote mesh__D004873
% 220.68/220.84       A series of structurally-related alkaloids that contain the ergoline backbone structure.%A%    
% 220.68/220.84  |- mesh__dateEstablished mesh__D004873 1969-01-01
% 220.68/220.84  |- skos__broader mesh__D004873smesh__D004876
% 220.68/220.84  |- rdf__type mesh__D004873sskos__Concept
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D004873 2002
% 220.68/220.84  |- mesh__recordOriginator mesh__D004873 NLM
% 220.68/220.84  |- skos__historyNote mesh__D004873 Ergotamine %28%1966-1968%29%
% 220.68/220.84  |- mesh__recordMaintainer mesh__D004873 jmp
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D004873 2003
% 220.68/220.84  |- mesh__publicMeSHNote mesh__D004873 69   
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D004873 2005
% 220.68/220.84  |- mesh__dateRevised mesh__D004873 2001-07-25
% 220.68/220.84  |- skos__historyNote mesh__D004873 Ergonovine %28%1966-1968%29%
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D004873 2004
% 220.68/220.84  |- mesh__dateCreated mesh__D004873 1999-01-01
% 220.68/220.84  |- skos__historyNote mesh__D004873 Methylergonovine %28%1966-1968%29%
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D004873 2006
% 220.68/220.84  |- mesh__recordAuthorizer mesh__D004873 sjn
% 220.68/220.84  |- mesh__dateCreated mesh__D004075 1999-01-01
% 220.68/220.84  |- mesh__recordAuthorizer mesh__D004075 sjn
% 220.68/220.84  |- mesh__dateRevised mesh__D004075 2003-07-09
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D004075 2006
% 220.68/220.84  |- skos__prefLabel mesh__D004075 Diglycerides
% 220.68/220.84  |- mesh__recordMaintainer mesh__D004075 ssb
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D004075 2005
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D004075 2004
% 220.68/220.84  |- skos__altLabel mesh__D004075 Diacylglycerols
% 220.68/220.84  |- mesh__onlineNote mesh__D004075 search GLYCERIDES 1968-74   
% 220.68/220.84  |- mesh__recordOriginator mesh__D004075 NLM
% 220.68/220.84  |- mesh__historyNote mesh__D004075
% 220.68/220.84       91%28%75%29%; was see under GLYCERIDES 1975-90   
% 220.68/220.84  |- skos__broader mesh__D004075smesh__D005989
% 220.68/220.84  |- rdf__type mesh__D004075sskos__Concept
% 220.68/220.84  |- mesh__dateEstablished mesh__D004075 1991-01-01
% 220.68/220.84  |- mesh__publicMeSHNote mesh__D004075
% 220.68/220.84       91; was see under GLYCERIDES 1975-90   
% 220.68/220.84  |- skos__hiddenLabel mesh__D012507 Sarcoid, Boeck%27%s
% 220.68/220.84  |- mesh__onlineNote mesh__D012507
% 220.68/220.84       use SARCOIDOSIS  to search PSEUDOTUBERCULOSIS 1966-92   
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D012507 2005
% 220.68/220.84  |- skos__prefLabel mesh__D012507 Sarcoidosis
% 220.68/220.84  |- skos__hiddenLabel mesh__D012507 Disease, Schaumann
% 220.68/220.84  |- skos__hiddenLabel mesh__D012507 Schaumanns Disease
% 220.68/220.84  |- mesh__activeMeSHYear mesh__D012507 2006
% 220.68/220.84  |- mesh__dateCreated mesh__D012507 1999-01-01
% 220.68/220.84  |- mesh__recordMaintainer mesh__D012507 sjn
% 220.68/220.84  |- rdf__type mesh__D012507sskos__Concept
% 220.68/220.84  |- skos__hiddenLabel mesh__D012507 Disease, Schaumann%27%s
% 220.68/220.84  |- skos__hiddenLabel mesh__D012507 Boeck Sarcoid
% 220.68/220.84  |- skos__altLabel mesh__D012507 Schaumann Disease
% 220.68/220.84  |- skos__hiddenLabel mesh__D012507 Besnier Boeck Disease
% 220.68/220.84  |- mesh__dateRevised mesh__D012507 2004-07-13
% 220.68/220.84  |- skos__broader mesh__D012507smesh__D008232
% 220.68/220.84  |- skos__hiddenLabel mesh__D012507 Disease, Besnier-Boeck
% 220.68/220.84  |- skos__altLabel mesh__D012507 Boeck%27%s Sarcoid
% 220.68/220.84  |- mesh__recordAuthorizer mesh__D012507 sjn
% 220.68/220.84  |- mesh__historyNote mesh__D012507
% 220.68/220.84       PSEUDOTUBERCULOSIS was see SARCOIDOSIS 1963-92   
% 220.68/220.84  |- skos__altLabel mesh__D012507 Schaumann%27%s Disease
% 220.68/220.84  |- mesh__publicMeSHNote mesh__D012507
% 220.68/220.84       PSEUDOTUBERCULOSIS was see SARCOIDOSIS 1963-92   
% 220.68/220.84  |- skos__annotation mesh__D012507
% 220.68/220.84        coord IM with organ/dis precoord %28%IM%29%; sarcoidosis of heart: coord IM with  CARDIOMYOPATHIES %28%IM%29%, not HEART DISEASES%A%  
% 220.68/220.84  |- skos__hiddenLabel mesh__D012507 Sarcoidoses
% 220.68/220.84  |- mesh__recordOriginator mesh__D012507 NLM
% 220.68/220.85  |- skos__related mesh__D012507smesh__D007731
% 220.68/220.85  |- skos__scopeNote mesh__D012507
% 220.68/220.85       An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.%A%    
% 220.68/220.85  |- skos__hiddenLabel mesh__D012507 Boecks Sarcoid
% 220.68/220.85  |- skos__altLabel mesh__D012507 Besnier-Boeck Disease
% 220.68/220.85  |- skos__altLabel mesh__D008466 Chlorethazine
% 220.68/220.85  |- skos__altLabel mesh__D008466 Bis%28%2-chloroethyl%29%methylamine
% 220.68/220.85  |- skos__altLabel mesh__D008466 Chlormethine
% 220.68/220.85  |- skos__altLabel mesh__D008466 Nitrogen Mustard N-Oxide
% 220.68/220.85  |- skos__hiddenLabel mesh__D008466 Mechlorethamine N Oxide
% 220.68/220.85  |- mesh__dateRevised mesh__D008466 2005-06-30
% 220.68/220.85  |- skos__hiddenLabel mesh__D008466 Hydrochloride N-Oxide, Mechlorethamine
% 220.68/220.85  |- mesh__publicMeSHNote mesh__D008466
% 220.68/220.85       MECHLORETHAMINE OXIDE was heading 1963-79; NITROGEN MUSTARD N-OXIDE was indexed under NITROGEN MUSTARD COMPOUNDS 1984-91%A%  
% 220.68/220.85  |- mesh__recordMaintainer mesh__D008466 lkw
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D008466 2006
% 220.68/220.85  |- skos__hiddenLabel mesh__D008466 NLost
% 220.68/220.85  |- skos__altLabel mesh__D008466
% 220.68/220.85       Merck Frosst Brand of Mechlorethamine Hydrochloride
% 220.68/220.85  |- skos__prefLabel mesh__D008466 Mechlorethamine
% 220.68/220.85  |- skos__altLabel mesh__D008466 Nitrogen Mustard
% 220.68/220.85  |- skos__hiddenLabel mesh__D008466 NSC 762
% 220.68/220.85  |- skos__hiddenLabel mesh__D008466 NSC10107
% 220.68/220.85  |- skos__hiddenLabel mesh__D008466 Nitrogen Mustard N Oxide
% 220.68/220.85  |- skos__hiddenLabel mesh__D008466 NSC 10107
% 220.68/220.85  |- mesh__onlineNote mesh__D008466
% 220.68/220.85       use MECHLORETHAMINE to search MECHLORETHAMINE OXIDE 1966-79; use MECHLORETHAMINE %28%NM%29% to search NITROGEN MUSTARD N-OXIDE %28%NM%29% 1984-91%A%  
% 220.68/220.85  |- skos__hiddenLabel mesh__D008466 N Lost
% 220.68/220.85  |- skos__altLabel mesh__D008466
% 220.68/220.85       Merck Brand of Mechlorethamine Hydrochloride
% 220.68/220.85  |- skos__hiddenLabel mesh__D008466 Mechlorethamine Hydrochloride N Oxide
% 220.68/220.85  |- skos__hiddenLabel mesh__D008466 NSC762
% 220.68/220.85  |- skos__hiddenLabel mesh__D008466 N-Oxide, Mechlorethamine
% 220.68/220.85  |- skos__scopeNote mesh__D008466
% 220.68/220.85       A vesicant and necrotizing irritant destructive to mucous membranes. It was formerly used as a war gas. The hydrochloride is used as an antineoplastic in Hodgkin%27%s disease and lymphomas. It causes severe gastrointestinal and bone marrow damage.%A%    
% 220.68/220.85  |- skos__altLabel mesh__D008466 Methylchlorethamine
% 220.68/220.85  |- skos__hiddenLabel mesh__D008466 Oxide, Mechlorethamine
% 220.68/220.85  |- skos__altLabel mesh__D008466 Mustine
% 220.68/220.85  |- rdf__type mesh__D008466sskos__Concept
% 220.68/220.85  |- skos__hiddenLabel mesh__D008466 N-Oxide, Nitrogen Mustard
% 220.68/220.85  |- skos__altLabel mesh__D008466 HN2
% 220.68/220.85  |- skos__altLabel mesh__D008466
% 220.68/220.85       Genopharm Brand of Mechlorethamine Hydrochloride
% 220.68/220.85  |- skos__hiddenLabel mesh__D008466 N-Oxide, Mechlorethamine Hydrochloride
% 220.68/220.85  |- mesh__recordAuthorizer mesh__D008466 sjn
% 220.68/220.85  |- skos__broader mesh__D008466smesh__D009588
% 220.68/220.85  |- skos__hiddenLabel mesh__D008466 HN 2
% 220.68/220.85  |- mesh__dateCreated mesh__D008466 1999-01-01
% 220.68/220.85  |- mesh__historyNote mesh__D008466
% 220.68/220.85       MECHLORETHAMINE OXIDE was heading 1963-79; NITROGEN MUSTARD N-OXIDE was NITROGEN MUSTARD N-OXIDE %28%NM%29% 1984-91%A%  
% 220.68/220.85  |- skos__altLabel mesh__D008466 HN-2
% 220.68/220.85  |- skos__hiddenLabel mesh__D008466 Hydrochloride, Mechlorethamine
% 220.68/220.85  |- mesh__recordOriginator mesh__D008466 NLM
% 220.68/220.85  |- mesh__recordMaintainer mesh__D000483 nns
% 220.68/220.85  |- mesh__dateRevised mesh__D000483 2005-06-30
% 220.68/220.85  |- skos__broader mesh__D000483smesh__D005796
% 220.68/220.85  |- skos__prefLabel mesh__D000483 Alleles
% 220.68/220.85  |- mesh__dateEstablished mesh__D000483 1968-01-01
% 220.68/220.85  |- skos__historyNote mesh__D000483 Genes %28%1966-1967%29%
% 220.68/220.85  |- mesh__recordOriginator mesh__D000483 NLM
% 220.68/220.85  |- skos__hiddenLabel mesh__D000483 Allele
% 220.68/220.85  |- mesh__recordAuthorizer mesh__D000483 sjn
% 220.68/220.85  |- skos__altLabel mesh__D000483 Allelomorphs
% 220.68/220.85  |- mesh__publicMeSHNote mesh__D000483 68   
% 220.68/220.85  |- skos__hiddenLabel mesh__D000483 Allelomorph
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D000483 2006
% 220.68/220.85  |- mesh__historyNote mesh__D000483 68   
% 220.68/220.85  |- rdf__type mesh__D000483sskos__Concept
% 220.68/220.85  |- mesh__dateCreated mesh__D000483 1999-01-01
% 220.68/220.85  |- skos__scopeNote mesh__D000483
% 220.68/220.85       Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product.%A%    
% 220.68/220.85  |- skos__broader mesh__D042262Q000295smesh__D042262
% 220.68/220.85  |- mesh__preferredCombination mesh__D042262Q000295smesh__D042261
% 220.68/220.85  |- rdf__type mesh__D042262Q000295smesh__CompoundConcept
% 220.68/220.85  |- mesh__recordAuthorizer mesh__D018894 sjn
% 220.68/220.85  |- mesh__dateCreated mesh__D018894 1995-06-08
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D018894 2005
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D018894 2004
% 220.68/220.85  |- skos__altLabel mesh__D018894 Inhibitors, Reverse Transcriptase
% 220.68/220.85  |- skos__prefLabel mesh__D018894 Reverse Transcriptase Inhibitors
% 220.68/220.85  |- mesh__recordOriginator mesh__D018894 JRT
% 220.68/220.85  |- skos__historyNote mesh__D018894
% 220.68/220.85       RNA-Directed DNA Polymerase/antagonists %26% inhibitors %28%1972-1995%29%
% 220.68/220.85  |- rdf__type mesh__D018894sskos__Concept
% 220.68/220.85  |- skos__scopeNote mesh__D018894
% 220.68/220.85       Inhibitors of reverse transcriptase %28%RNA-DIRECTED DNA POLYMERASE%29%, an enzyme that synthesizes DNA on an RNA template.%A%    
% 220.68/220.85  |- skos__broader mesh__D018894smesh__D044966
% 220.68/220.85  |- mesh__historyNote mesh__D018894 96   
% 220.68/220.85  |- mesh__dateRevised mesh__D018894 2003-07-09
% 220.68/220.85  |- mesh__publicMeSHNote mesh__D018894 96   
% 220.68/220.85  |- mesh__recordMaintainer mesh__D018894 ssb
% 220.68/220.85  |- skos__annotation mesh__D018894 DF: REVERSE TRANSCRIPTASE INHIB   
% 220.68/220.85  |- skos__broader mesh__D018894smesh__D019384
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D018894 2006
% 220.68/220.85  |- mesh__dateEstablished mesh__D018894 1996-01-01
% 220.68/220.85  |- skos__prefLabel mesh__D018096 Mononegavirales
% 220.68/220.85  |- mesh__dateEstablished mesh__D018096 1994-01-01
% 220.68/220.85  |- skos__annotation mesh__D018096 infection = MONONEGAVIRALES INFECTIONS   
% 220.68/220.85  |- skos__scopeNote mesh__D018096
% 220.68/220.85       An order comprising four families of eukaryotic viruses possessing linear, non-segmented, negative-strand RNA genomes. The families are BORNAVIRIDAE; FILOVIRIDAE; PARAMYXOVIRIDAE; and RHABDOVIRIDAE.%A%    
% 220.68/220.85  |- skos__broader mesh__D018096smesh__D012328
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D018096 2004
% 220.68/220.85  |- mesh__recordMaintainer mesh__D018096 ags
% 220.68/220.85  |- mesh__dateRevised mesh__D018096 2001-07-25
% 220.68/220.85  |- mesh__recordAuthorizer mesh__D018096 sjn
% 220.68/220.85  |- mesh__historyNote mesh__D018096 94   
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D018096 2002
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D018096 2003
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D018096 2006
% 220.68/220.85  |- mesh__dateCreated mesh__D018096 1993-06-04
% 220.68/220.85  |- mesh__publicMeSHNote mesh__D018096 94   
% 220.68/220.85  |- rdf__type mesh__D018096sskos__Concept
% 220.68/220.85  |- mesh__recordOriginator mesh__D018096 AGS
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D018096 2005
% 220.68/220.85  |- skos__prefLabel mesh__D004874 Ergonovine
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D004874 2006
% 220.68/220.85  |- mesh__dateCreated mesh__D004874 1999-01-01
% 220.68/220.85  |- skos__altLabel mesh__D004874 Ergobasin
% 220.68/220.85  |- mesh__recordAuthorizer mesh__D004874 sjn
% 220.68/220.85  |- skos__altLabel mesh__D004874 Ergometrine
% 220.68/220.85  |- mesh__dateRevised mesh__D004874 2005-06-30
% 220.68/220.85  |- mesh__dateEstablished mesh__D004874 1965-01-01
% 220.68/220.85  |- skos__broader mesh__D004874smesh__D004873
% 220.68/220.85  |- skos__altLabel mesh__D004874 Ergometrin
% 220.68/220.85  |- skos__altLabel mesh__D004874 Bedford Brand of Ergonovine Maleate
% 220.68/220.85  |- mesh__publicMeSHNote mesh__D004874
% 220.68/220.85       1965; see ERGOLINES 1969-1974; ERGONIVINE MALEATE was indexed under ERGONOVINE 1979-2001%A%  
% 220.68/220.85  |- mesh__historyNote mesh__D004874
% 220.68/220.85       1965; for ERGONOVINE MALEATE use ERGONOVINE %28%NM%29% 1979-2001%A%  
% 220.68/220.85  |- rdf__type mesh__D004874sskos__Concept
% 220.68/220.85  |- skos__scopeNote mesh__D004874
% 220.68/220.85       An ergot alkaloid %28%ERGOT ALKALOIDS%29% with uterine and vascular smooth muscle contractile properties.%A%    
% 220.68/220.85  |- skos__altLabel mesh__D004874 Ergometrine Maleate
% 220.68/220.85  |- mesh__recordMaintainer mesh__D004874 exl
% 220.68/220.85  |- mesh__recordOriginator mesh__D004874 NLM
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D004076 2005
% 220.68/220.85  |- skos__historyNote mesh__D004076 Cardanolides %28%1968-1974%29%
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D004076 1994
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D004076 2001
% 220.68/220.85  |- skos__historyNote mesh__D004076 Digoxin/AA %28%1975-1976%29%
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D004076 2004
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D004076 1993
% 220.68/220.85  |- skos__prefLabel mesh__D004076 Digoxigenin
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D004076 1999
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D004076 2000
% 220.68/220.85  |- mesh__publicMeSHNote mesh__D004076 91; was see under DIGOXIN 1977-90   
% 220.68/220.85  |- mesh__recordAuthorizer mesh__D004076 PLS
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D004076 2003
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D004076 1998
% 220.68/220.85  |- mesh__recordMaintainer mesh__D004076 TGC
% 220.68/220.85  |- rdf__type mesh__D004076sskos__Concept
% 220.68/220.85  |- mesh__dateCreated mesh__D004076 1976-04-16
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D004076 1997
% 220.68/220.85  |- skos__annotation mesh__D004076
% 220.68/220.85       a Digitalis glycoside; do not confuse with DIGITOXIGENIN;  /biosyn permitted if by plant%A%  
% 220.68/220.85  |- skos__scopeNote mesh__D004076
% 220.68/220.85       3 beta,12 beta,14-Trihydroxy-5 beta-card-20%28%22%29%-enolide. A cardenolide which is the aglycon of digoxin. Can be obtained by hydrolysis of digoxin or from Digitalis orientalis L. and Digitalis lanata Ehrh.%A%    
% 220.68/220.85  |- skos__broader mesh__D004076smesh__D004077
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D004076 1996
% 220.68/220.85  |- mesh__dateEstablished mesh__D004076 1991-01-01
% 220.68/220.85  |- skos__altLabel mesh__D004076 Lanadigenin
% 220.68/220.85  |- mesh__historyNote mesh__D004076
% 220.68/220.85       91%28%77%29%; was see under DIGOXIN 1977-90   
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D004076 2006
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D004076 1995
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D004076 2002
% 220.68/220.85  |- mesh__dateRevised mesh__D004076 1992-05-13
% 220.68/220.85  |- mesh__recordOriginator mesh__D004076 RLS
% 220.68/220.85  |- skos__historyNote mesh__D012508 Cell Membrane %28%1966%29%
% 220.68/220.85  |- mesh__recordOriginator mesh__D012508 NLM
% 220.68/220.85  |- mesh__dateCreated mesh__D012508 1999-01-01
% 220.68/220.85  |- rdf__type mesh__D012508sskos__Concept
% 220.68/220.85  |- skos__historyNote mesh__D012508 Muscles %28%1966%29%
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D012508 2004
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D012508 2001
% 220.68/220.85  |- mesh__dateRevised mesh__D012508 2000-06-22
% 220.68/220.85  |- skos__hiddenLabel mesh__D012508 Sarcolemmas
% 220.68/220.85  |- mesh__dateEstablished mesh__D012508 1972-01-01
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D012508 2002
% 220.68/220.85  |- skos__broader mesh__D012508smesh__D002462
% 220.68/220.85  |- skos__prefLabel mesh__D012508 Sarcolemma
% 220.68/220.85  |- mesh__recordMaintainer mesh__D012508 TGC
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D012508 2005
% 220.68/220.85  |- skos__scopeNote mesh__D012508
% 220.68/220.85       The excitable plasma membrane of a muscle cell. %28%Glick, Glossary of Biochemistry and Molecular Biology, 1990%29%%A%    
% 220.68/220.85  |- mesh__publicMeSHNote mesh__D012508 72   
% 220.68/220.85  |- skos__annotation mesh__D012508
% 220.68/220.85       A 11 qualif except /cytol; /genet permitted   
% 220.68/220.85  |- mesh__historyNote mesh__D012508 72%28%67%29%   
% 220.68/220.85  |- mesh__recordAuthorizer mesh__D012508 sjn
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D012508 2003
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D012508 2006
% 220.68/220.85  |- skos__broader mesh__D009985Q000295smesh__D009985
% 220.68/220.85  |- mesh__preferredCombination mesh__D009985Q000295smesh__D009983
% 220.68/220.85  |- rdf__type mesh__D009985Q000295smesh__CompoundConcept
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D008467 2005
% 220.68/220.85  |- mesh__recordMaintainer mesh__D008467 lkt
% 220.68/220.85  |- skos__related mesh__D008467smesh__D014816
% 220.68/220.85  |- mesh__publicMeSHNote mesh__D008467
% 220.68/220.85       2004; see MECKEL%27%S DIVERTICULUM 1966-2003   
% 220.68/220.85  |- skos__scopeNote mesh__D008467
% 220.68/220.85       A congenital abnormality characterized by the outpouching or sac formation in the ILEUM. It is a remnant of the embryonic YOLK SAC in which the VITELLINE DUCT failed to close.%A%    
% 220.68/220.85  |- skos__broader mesh__D008467smesh__D004240
% 220.68/220.85  |- mesh__dateRevised mesh__D008467 2003-07-09
% 220.68/220.85  |- rdf__type mesh__D008467sskos__Concept
% 220.68/220.85  |- mesh__recordAuthorizer mesh__D008467 sjn
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D008467 2004
% 220.68/220.85  |- skos__annotation mesh__D008467
% 220.68/220.85       Meckel%27%s diverticulitis: coord IM with DIVERTICULITIS %28%IM%29%%A%  
% 220.68/220.85  |- skos__altLabel mesh__D008467 Meckel%27%s Diverticulum
% 220.68/220.85  |- mesh__dateCreated mesh__D008467 1999-01-01
% 220.68/220.85  |- skos__broader mesh__D008467smesh__D007082
% 220.68/220.85  |- skos__broader mesh__D008467smesh__D004065
% 220.68/220.85  |- skos__prefLabel mesh__D008467 Meckel Diverticulum
% 220.68/220.85  |- mesh__recordOriginator mesh__D008467 NLM
% 220.68/220.85  |- skos__altLabel mesh__D008467 Diverticulum, Meckel
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D008467 2006
% 220.68/220.85  |- mesh__historyNote mesh__D008467 2004 %28%1966%29%   
% 220.68/220.85  |- skos__broader mesh__D027621smesh__D019684
% 220.68/220.85  |- skos__altLabel mesh__D027621 Homeria
% 220.68/220.85  |- mesh__dateEstablished mesh__D027621 2002-01-01
% 220.68/220.85  |- mesh__recordOriginator mesh__D027621 ssb
% 220.68/220.85  |- mesh__recordMaintainer mesh__D027621 ssb
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D027621 2003
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D027621 2005
% 220.68/220.85  |- mesh__dateCreated mesh__D027621 2001-07-25
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D027621 2004
% 220.68/220.85  |- skos__prefLabel mesh__D027621 Iridaceae
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D027621 2006
% 220.68/220.85  |- mesh__publicMeSHNote mesh__D027621 2002   
% 220.68/220.85  |- mesh__recordAuthorizer mesh__D027621 sjn
% 220.68/220.85  |- mesh__dateRevised mesh__D027621 2002-07-03
% 220.68/220.85  |- skos__annotation mesh__D027621
% 220.68/220.85       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.68/220.85  |- rdf__type mesh__D027621sskos__Concept
% 220.68/220.85  |- mesh__historyNote mesh__D027621 2002   
% 220.68/220.85  |- skos__scopeNote mesh__D027621
% 220.68/220.85       A monocot plant family of the Liliopsida class.  It is classified by some in the Liliales order and some in the Asparagales order.%A%    
% 220.68/220.85  |- skos__broader mesh__D006761Q000191smesh__D006761
% 220.68/220.85  |- mesh__preferredCombination mesh__D006761Q000191smesh__D004469
% 220.68/220.85  |- rdf__type mesh__D006761Q000191smesh__CompoundConcept
% 220.68/220.85  |- skos__broader mesh__D006282Q000364smesh__D006282
% 220.68/220.85  |- mesh__preferredCombination mesh__D006282Q000364smesh__D006280
% 220.68/220.85  |- rdf__type mesh__D006282Q000364smesh__CompoundConcept
% 220.68/220.85  |- skos__annotation mesh__D013601
% 220.68/220.85       general; prefer specifics; subpopulations: coordinate T-LYMPHOCYTE SUBSETS %28%IM%29% with specific T-LYMPHOCYTE %28%IM%29%%A%  
% 220.68/220.85  |- skos__altLabel mesh__D013601 T-Cells
% 220.68/220.85  |- skos__broader mesh__D013601smesh__D008214
% 220.68/220.85  |- skos__related mesh__D013601smesh__D008211
% 220.68/220.85  |- skos__hiddenLabel mesh__D013601 Lymphocytes, Thymus-Dependent
% 220.68/220.85  |- mesh__dateEstablished mesh__D013601 1973-01-01
% 220.68/220.85  |- mesh__recordMaintainer mesh__D013601 ags
% 220.68/220.85  |- mesh__historyNote mesh__D013601 1990 %28%1973%29%   
% 220.68/220.85  |- skos__hiddenLabel mesh__D013601 Thymus Dependent Lymphocytes
% 220.68/220.85  |- skos__scopeNote mesh__D013601
% 220.68/220.85       Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic %28%T-LYMPHOCYTES, CYTOTOXIC%29% and helper T-lymphocytes %28%T-LYMPHOCYTES, HELPER-INDUCER%29%. They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.%A%    
% 220.68/220.85  |- skos__prefLabel mesh__D013601 T-Lymphocytes
% 220.68/220.85  |- mesh__dateRevised mesh__D013601 2005-06-30
% 220.68/220.85  |- mesh__recordOriginator mesh__D013601 NLM
% 220.68/220.85  |- skos__hiddenLabel mesh__D013601 T Lymphocytes
% 220.68/220.85  |- skos__altLabel mesh__D013601 Thymus-Dependent Lymphocytes
% 220.68/220.85  |- skos__hiddenLabel mesh__D013601 T-Cell
% 220.68/220.85  |- skos__hiddenLabel mesh__D013601 T-Lymphocyte
% 220.68/220.85  |- mesh__recordAuthorizer mesh__D013601 sjn
% 220.68/220.85  |- skos__related mesh__D013601smesh__D007111
% 220.68/220.85  |- skos__hiddenLabel mesh__D013601 Thymus-Dependent Lymphocyte
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D013601 2006
% 220.68/220.85  |- rdf__type mesh__D013601sskos__Concept
% 220.68/220.85  |- skos__related mesh__D013601smesh__D016516
% 220.68/220.85  |- skos__hiddenLabel mesh__D013601 Lymphocyte, Thymus-Dependent
% 220.68/220.85  |- mesh__publicMeSHNote mesh__D013601 1990; see T LYMPHOCYTES 1973-1989   
% 220.68/220.85  |- skos__hiddenLabel mesh__D013601 T Cells
% 220.68/220.85  |- skos__historyNote mesh__D013601 Lymphocytes %28%1966-1972%29%
% 220.68/220.85  |- mesh__dateCreated mesh__D013601 1999-01-01
% 220.68/220.85  |- skos__scopeNote mesh__D018895
% 220.68/220.85       A variety of simple di- %28%DINUCLEOTIDE REPEATS%29%, tri- %28%TRINUCLEOTIDE REPEATS%29%, tetra-, and pentanucleotide tandem repeats %28%usually less than 100 bases long%29%. They are dispersed in the euchromatic arms of most chromosomes.%A%    
% 220.68/220.85  |- mesh__publicMeSHNote mesh__D018895 96   
% 220.68/220.85  |- skos__hiddenLabel mesh__D018895 Tetranucleotide Repeat
% 220.68/220.85  |- skos__hiddenLabel mesh__D018895 Repeat, Tetranucleotide
% 220.68/220.85  |- skos__hiddenLabel mesh__D018895 Markers, Microsatellite
% 220.68/220.85  |- mesh__historyNote mesh__D018895 96   
% 220.68/220.85  |- mesh__dateEstablished mesh__D018895 1996-01-01
% 220.68/220.85  |- skos__historyNote mesh__D018895 DNA, Satellite %28%1989-1995%29%
% 220.68/220.85  |- skos__hiddenLabel mesh__D018895 Repeat, Microsatellite
% 220.68/220.85  |- skos__hiddenLabel mesh__D018895 Repeats, Microsatellite
% 220.68/220.85  |- skos__hiddenLabel mesh__D018895 Pentanucleotide Repeat
% 220.68/220.85  |- skos__hiddenLabel mesh__D018895 Marker, Microsatellite
% 220.68/220.85  |- mesh__recordOriginator mesh__D018895 AGS
% 220.68/220.85  |- skos__hiddenLabel mesh__D018895 Repeats, Pentanucleotide
% 220.68/220.85  |- skos__hiddenLabel mesh__D018895 Repeat, Pentanucleotide
% 220.68/220.85  |- mesh__recordAuthorizer mesh__D018895 sjn
% 220.68/220.85  |- skos__altLabel mesh__D018895 Microsatellites
% 220.68/220.85  |- skos__prefLabel mesh__D018895 Microsatellite Repeats
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D018895 2006
% 220.68/220.85  |- skos__broader mesh__D018895smesh__D020080
% 220.68/220.85  |- skos__hiddenLabel mesh__D018895 Repeats, Tetranucleotide
% 220.68/220.85  |- mesh__dateRevised mesh__D018895 2005-06-30
% 220.68/220.85  |- skos__altLabel mesh__D018895 Microsatellite Markers
% 220.68/220.85  |- mesh__dateCreated mesh__D018895 1994-12-27
% 220.68/220.85  |- skos__historyNote mesh__D018895
% 220.68/220.85       Repetitive Sequences, Nucleic Acid %28%1991-1995%29%
% 220.68/220.85  |- skos__hiddenLabel mesh__D018895 Microsatellite Repeat
% 220.68/220.85  |- skos__hiddenLabel mesh__D018895 Microsatellite
% 220.68/220.85  |- mesh__recordMaintainer mesh__D018895 nns
% 220.68/220.85  |- skos__hiddenLabel mesh__D018895 Microsatellite Marker
% 220.68/220.85  |- rdf__type mesh__D018895sskos__Concept
% 220.68/220.85  |- mesh__historyNote mesh__D051720 2006%28%1988%29%   
% 220.68/220.85  |- mesh__dateEstablished mesh__D051720 2006-01-01
% 220.68/220.85  |- mesh__recordOriginator mesh__D051720 DRC
% 220.68/220.85  |- skos__scopeNote mesh__D051720
% 220.68/220.85       Ubiquitously expressed basic HELIX-LOOP-HELIX MOTIF transcription factors. They bind CANNTG sequences in the PROMOTERS of a variety of GENES involved in carbohydrate and lipid metabolism.%A%    
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D051720 2006A
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D051720 2006
% 220.68/220.85  |- rdf__type mesh__D051720sskos__Concept
% 220.68/220.85  |- mesh__dateRevised mesh__D051720 2005-07-11
% 220.68/220.85  |- skos__prefLabel mesh__D051720 Upstream Stimulatory Factors
% 220.68/220.85  |- mesh__recordAuthorizer mesh__D051720 ags
% 220.68/220.85  |- skos__broader mesh__D051720smesh__D051792
% 220.68/220.85  |- mesh__dateCreated mesh__D051720 2005-06-30
% 220.68/220.85  |- mesh__recordMaintainer mesh__D051720 ags
% 220.68/220.85  |- skos__hiddenLabel mesh__D051720 USF, Helix-Loop-Helix Activator
% 220.68/220.85  |- skos__hiddenLabel mesh__D051720 Helix Loop Helix Activator USF
% 220.68/220.85  |- skos__altLabel mesh__D051720 USF Transcription Factors
% 220.68/220.85  |- skos__altLabel mesh__D051720 Helix-Loop-Helix Activator USF
% 220.68/220.85  |- mesh__publicMeSHNote mesh__D051720
% 220.68/220.85       2006; UPSTREAM STIMULATORY FACTORS  was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1988-2005%A%  
% 220.68/220.85  |- skos__broader mesh__D025203Q000172smesh__D025203
% 220.68/220.85  |- mesh__preferredCombination mesh__D025203Q000172smesh__D006014
% 220.68/220.85  |- rdf__type mesh__D025203Q000172smesh__CompoundConcept
% 220.68/220.85  |- skos__prefLabel mesh__D004875 Ergosterol
% 220.68/220.85  |- mesh__dateCreated mesh__D004875 1999-01-01
% 220.68/220.85  |- mesh__recordOriginator mesh__D004875 NLM
% 220.68/220.85  |- mesh__onlineNote mesh__D004875
% 220.68/220.85       search VITAMIN D 1967-71 %26% ERGOCALCIFEROL 1966   
% 220.68/220.85  |- mesh__dateEstablished mesh__D004875 1974-01-01
% 220.68/220.85  |- skos__scopeNote mesh__D004875
% 220.68/220.85       A steroid of interest both because its biosynthesis in FUNGI is a target of ANTIFUNGAL AGENTS, notably AZOLES, and because when it is present in SKIN of animals, ULTRAVIOLET RAYS break a bond to result in ERGOCALCIFEROL.%A%    
% 220.68/220.85  |- skos__broader mesh__D004875smesh__D010840
% 220.68/220.85  |- mesh__publicMeSHNote mesh__D004875
% 220.68/220.85       74; was see under VITAMIN D 1967-73, was see under VITAMIN D 2 1963-66%A%  
% 220.68/220.85  |- rdf__type mesh__D004875sskos__Concept
% 220.68/220.85  |- mesh__recordAuthorizer mesh__D004875 sjn
% 220.68/220.85  |- skos__historyNote mesh__D004875 Ergocalciferol %28%1966%29%
% 220.68/220.85  |- mesh__dateRevised mesh__D004875 2005-06-30
% 220.68/220.85  |- skos__historyNote mesh__D004875 Vitamin D %28%1967-1971%29%
% 220.68/220.85  |- skos__broader mesh__D004875smesh__D002782
% 220.68/220.85  |- mesh__historyNote mesh__D004875
% 220.68/220.85       74%28%72%29%; was see under VITAMIN D 1967-73, was see under VITAMIN D 2 1963-66%A%  
% 220.68/220.85  |- skos__altLabel mesh__D004875 Provitamin D 2
% 220.68/220.85  |- mesh__recordMaintainer mesh__D004875 ssb
% 220.68/220.85  |- skos__hiddenLabel mesh__D004875 Pro Vitamin D2
% 220.68/220.85  |- skos__altLabel mesh__D004875 Pro-Vitamin D2
% 220.68/220.85  |- skos__hiddenLabel mesh__D004875 D2, Pro-Vitamin
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D004875 2006
% 220.68/220.85  |- skos__altLabel mesh__D004077 Proctor %26% Gamble Brand of Digoxin
% 220.68/220.85  |- skos__annotation mesh__D004077 do not confuse with DIGITOXIN   
% 220.68/220.85  |- skos__broader mesh__D004077smesh__D002298
% 220.68/220.85  |- skos__hiddenLabel mesh__D004077 Nativelle, Digoxine
% 220.68/220.85  |- mesh__dateRevised mesh__D004077 2005-06-30
% 220.68/220.85  |- skos__altLabel mesh__D004077 Bertek Brand of Digoxin
% 220.68/220.85  |- skos__altLabel mesh__D004077 Lanoxin-PG
% 220.68/220.85  |- rdf__type mesh__D004077sskos__Concept
% 220.68/220.85  |- skos__altLabel mesh__D004077 Virco Brand of Digoxin
% 220.68/220.85  |- mesh__recordOriginator mesh__D004077 NLM
% 220.68/220.85  |- skos__prefLabel mesh__D004077 Digoxin
% 220.68/220.85  |- skos__hiddenLabel mesh__D004077 Nativelle, Hemigoxine
% 220.68/220.85  |- skos__altLabel mesh__D004077 GlaxoSmithKline Brand 2 of Digoxin
% 220.68/220.85  |- skos__broader mesh__D004077smesh__D004071
% 220.68/220.85  |- mesh__dateCreated mesh__D004077 1999-01-01
% 220.68/220.85  |- skos__altLabel mesh__D004077 AWD.pharma Brand of Digoxin
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D004077 2006
% 220.68/220.85  |- skos__altLabel mesh__D004077 UDL Brand of Digoxin
% 220.68/220.85  |- skos__altLabel mesh__D004077 Teofarma Brand of Digoxin
% 220.68/220.85  |- skos__scopeNote mesh__D004077
% 220.68/220.85       A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p666%29%%A%    
% 220.68/220.85  |- skos__altLabel mesh__D004077 Roche Brand of Digoxin
% 220.68/220.85  |- skos__hiddenLabel mesh__D004077 Boehringer, Digoxina
% 220.68/220.85  |- skos__altLabel mesh__D004077 Glaxo Wellcome Brand of Digoxin
% 220.68/220.85  |- mesh__recordAuthorizer mesh__D004077 sjn
% 220.68/220.85  |- skos__altLabel mesh__D004077 Lilly Brand of Digoxin
% 220.68/220.85  |- mesh__recordMaintainer mesh__D004077 exl
% 220.68/220.85  |- skos__altLabel mesh__D004077 R.A.N. Brand of Digoxin
% 220.68/220.85  |- skos__altLabel mesh__D004077 Novartis Brand of Digoxin
% 220.68/220.85  |- skos__altLabel mesh__D004077 Kern Brand of Digoxin
% 220.68/220.85  |- skos__altLabel mesh__D004077 Hemigoxine Nativelle
% 220.68/220.85  |- skos__altLabel mesh__D004077 Lenoxin
% 220.68/220.85  |- skos__altLabel mesh__D004077 GlaxoSmithKline Brand 1 of Digoxin
% 220.68/220.85  |- skos__hiddenLabel mesh__D004077 Lanoxin PG
% 220.68/220.85  |- skos__hiddenLabel mesh__D012509 Sarcomas, Spindle Cell
% 220.68/220.85  |- skos__scopeNote mesh__D012509
% 220.68/220.85       A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.%A%    
% 220.68/220.85  |- skos__hiddenLabel mesh__D012509 Epithelioid Sarcomas
% 220.68/220.85  |- skos__hiddenLabel mesh__D012509 Sarcomas
% 220.68/220.85  |- mesh__dateRevised mesh__D012509 1996-06-10
% 220.68/220.85  |- mesh__recordAuthorizer mesh__D012509 PLS
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D012509 2005
% 220.68/220.85  |- skos__hiddenLabel mesh__D012509 Sarcomas, Epithelioid
% 220.68/220.85  |- mesh__recordOriginator mesh__D012509 NLM
% 220.68/220.85  |- skos__annotation mesh__D012509
% 220.68/220.85       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; SARCOMA, EXPERIMENTAL is also available%A%  
% 220.68/220.85  |- mesh__recordMaintainer mesh__D012509 TGC
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D012509 1998
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D012509 2000
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D012509 2003
% 220.68/220.85  |- skos__broader mesh__D012509smesh__D018204
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D012509 2006
% 220.68/220.85  |- skos__hiddenLabel mesh__D012509 Spindle Cell Sarcoma
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D012509 2001
% 220.68/220.85  |- skos__hiddenLabel mesh__D012509 Soft Tissue Sarcoma
% 220.68/220.85  |- skos__hiddenLabel mesh__D012509 Sarcomas, Soft Tissue
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D012509 1999
% 220.68/220.85  |- mesh__dateCreated mesh__D012509 1999-01-01
% 220.68/220.85  |- rdf__type mesh__D012509sskos__Concept
% 220.68/220.85  |- skos__hiddenLabel mesh__D012509 Epithelioid Sarcoma
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D012509 2004
% 220.68/220.85  |- skos__hiddenLabel mesh__D012509 Spindle Cell Sarcomas
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D012509 2002
% 220.68/220.85  |- skos__prefLabel mesh__D012509 Sarcoma
% 220.68/220.85  |- skos__altLabel mesh__D012509 Sarcoma, Soft Tissue
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D012509 1997
% 220.68/220.85  |- skos__related mesh__D012509smesh__D001358
% 220.68/220.85  |- skos__hiddenLabel mesh__D012509 Soft Tissue Sarcomas
% 220.68/220.85  |- mesh__publicMeSHNote mesh__D009560 73   
% 220.68/220.85  |- skos__prefLabel mesh__D009560 Niridazole
% 220.68/220.85  |- mesh__activeMeSHYear mesh__D009560 2006
% 220.68/220.85  |- mesh__dateEstablished mesh__D009560 1973-01-01
% 220.68/220.85  |- skos__historyNote mesh__D009560 Anthelmintics %28%1966-1971%29%
% 220.68/220.85  |- mesh__historyNote mesh__D009560 73%28%72%29%   
% 220.68/220.85  |- mesh__recordOriginator mesh__D009560 NLM
% 220.68/220.85  |- skos__broader mesh__D009560smesh__D013844
% 220.68/220.85  |- skos__altLabel mesh__D009560 Ambilhar
% 220.68/220.85  |- skos__broader mesh__D009560smesh__D007093
% 220.68/220.85  |- mesh__recordAuthorizer mesh__D009560 sjn
% 220.68/220.85  |- skos__hiddenLabel mesh__D009560 32.644 BA, CIBA
% 220.68/220.85  |- skos__hiddenLabel mesh__D009560 BA, CIBA 32.644
% 220.68/220.85  |- skos__scopeNote mesh__D009560
% 220.68/220.85       An antischistosomal agent that has become obsolete.     
% 220.68/220.85  |- skos__historyNote mesh__D009560 Amebicides %28%1966-1971%29%
% 220.68/220.86  |- mesh__dateCreated mesh__D009560 1999-01-01
% 220.68/220.86  |- skos__historyNote mesh__D009560 Thiazoles %28%1966-1971%29%
% 220.68/220.86  |- mesh__recordMaintainer mesh__D009560 ssb
% 220.68/220.86  |- rdf__type mesh__D009560sskos__Concept
% 220.68/220.86  |- mesh__dateRevised mesh__D009560 2005-06-30
% 220.68/220.86  |- skos__historyNote mesh__D009560 Imidazoles %28%1966-1971%29%
% 220.68/220.86  |- skos__altLabel mesh__D008468
% 220.68/220.86       Pfizer Consumer Healthcare Brand of Meclizine Dihydrochloride
% 220.68/220.86  |- skos__altLabel mesh__D008468 Parachloramine
% 220.68/220.86  |- mesh__recordOriginator mesh__D008468 NLM
% 220.68/220.86  |- mesh__dateCreated mesh__D008468 1999-01-01
% 220.68/220.86  |- skos__broader mesh__D008468smesh__D001559
% 220.68/220.86  |- skos__altLabel mesh__D008468 Pfizer Brand 2 of Meclizine Dihydrochloride
% 220.68/220.86  |- skos__hiddenLabel mesh__D008468 Dihydrochloride, Meclizine
% 220.68/220.86  |- skos__scopeNote mesh__D008468
% 220.68/220.86       A histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness.%A%    
% 220.68/220.86  |- skos__hiddenLabel mesh__D008468 Hydrochloride, Meclizine
% 220.68/220.86  |- skos__prefLabel mesh__D008468 Meclizine
% 220.68/220.86  |- skos__hiddenLabel mesh__D008468 RuVertM
% 220.68/220.86  |- skos__hiddenLabel mesh__D008468 DVert
% 220.68/220.86  |- mesh__dateRevised mesh__D008468 2005-06-30
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D008468 2006
% 220.68/220.86  |- skos__broader mesh__D008468smesh__D010879
% 220.68/220.86  |- skos__altLabel mesh__D008468 Vedim Brand of Meclizine Dihydrochloride
% 220.68/220.86  |- skos__hiddenLabel mesh__D008468 Ru Vert M
% 220.68/220.86  |- skos__hiddenLabel mesh__D008468 Monohydrochloride, Meclizine
% 220.68/220.86  |- mesh__recordAuthorizer mesh__D008468 sjn
% 220.68/220.86  |- skos__hiddenLabel mesh__D008468 D Vert
% 220.68/220.86  |- rdf__type mesh__D008468sskos__Concept
% 220.68/220.86  |- skos__altLabel mesh__D008468 Pfizer Brand 1 of Meclizine Dihydrochloride
% 220.68/220.86  |- skos__altLabel mesh__D008468 Meclozine
% 220.68/220.86  |- mesh__recordMaintainer mesh__D008468 CCR
% 220.68/220.86  |- skos__altLabel mesh__D008468 Roberts Brand of Meclizine Dihydrochloride
% 220.68/220.86  |- skos__altLabel mesh__D008468 Torrens Brand of Meclizine Dihydrochloride
% 220.68/220.86  |- skos__related mesh__D000485smesh__D001733
% 220.68/220.86  |- mesh__recordOriginator mesh__D000485 NLM
% 220.68/220.86  |- mesh__recordAuthorizer mesh__D000485 sjn
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D000485 2006
% 220.68/220.86  |- rdf__type mesh__D000485sskos__Concept
% 220.68/220.86  |- mesh__dateCreated mesh__D000485 1999-01-01
% 220.68/220.86  |- skos__related mesh__D000485smesh__D005658
% 220.68/220.86  |- skos__prefLabel mesh__D000485 Allergens
% 220.68/220.86  |- skos__broader mesh__D000485smesh__D000941
% 220.68/220.86  |- mesh__historyNote mesh__D000485 65   
% 220.68/220.86  |- mesh__recordMaintainer mesh__D000485 ssb
% 220.68/220.86  |- mesh__dateEstablished mesh__D000485 1965-01-01
% 220.68/220.86  |- skos__related mesh__D000485smesh__D004391
% 220.68/220.86  |- mesh__dateRevised mesh__D000485 2005-06-30
% 220.68/220.86  |- skos__scopeNote mesh__D000485
% 220.68/220.86       Antigen-type substances that produce immediate hypersensitivity %28%HYPERSENSITIVITY, IMMEDIATE%29%.%A%    
% 220.68/220.86  |- skos__annotation mesh__D000485
% 220.68/220.86       coord IM with specific allergen %28%IM%29%, e.g., pollen as an allergen = ALLERGENS + POLLEN%A%  
% 220.68/220.86  |- skos__related mesh__D000485smesh__D005241
% 220.68/220.86  |- mesh__publicMeSHNote mesh__D000485 65   
% 220.68/220.86  |- mesh__onlineNote mesh__D019190
% 220.68/220.86       use HEMOSIDEROSIS to search IRON OVERLOAD 1996   
% 220.68/220.86  |- skos__scopeNote mesh__D019190
% 220.68/220.86       An excessive accumulation of iron in the body due to a greater than normal absorption of iron from the gastrointestinal tract or from parenteral injection. This may arise from idiopathic hemochromatosis, excessive iron intake, chronic alcoholism, certain types of refractory anemia, or transfusional hemosiderosis. %28%From Churchill%27%s Illustrated Medical Dictionary, 1989%29%%A%    
% 220.68/220.86  |- skos__broader mesh__D019190smesh__D019189
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D019190 2006
% 220.68/220.86  |- rdf__type mesh__D019190sskos__Concept
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D019190 2003
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D019190 2002
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D019190 2004
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D019190 1998
% 220.68/220.86  |- mesh__dateEstablished mesh__D019190 1997-01-01
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D019190 1999
% 220.68/220.86  |- skos__historyNote mesh__D019190 Hemosiderosis %28%1996%29%
% 220.68/220.86  |- skos__annotation mesh__D019190 disord of iron metab   
% 220.68/220.86  |- skos__prefLabel mesh__D019190 Iron Overload
% 220.68/220.86  |- mesh__historyNote mesh__D019190 97; was see HEMOSIDEROSIS 1996   
% 220.68/220.86  |- mesh__publicMeSHNote mesh__D019190 97; was see HEMOSIDEROSIS 1996   
% 220.68/220.86  |- skos__historyNote mesh__D019190 Iron/metabolism %28%1966-1995%29%
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D019190 1997
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D019190 2000
% 220.68/220.86  |- mesh__dateCreated mesh__D019190 1996-02-12
% 220.68/220.86  |- skos__hiddenLabel mesh__D019190 Overload, Iron
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D019190 2005
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D019190 2001
% 220.68/220.86  |- mesh__publicMeSHNote mesh__D027622
% 220.68/220.86       2002; for SAFFRON see Liliaceae 1998-2001   
% 220.68/220.86  |- rdf__type mesh__D027622sskos__Concept
% 220.68/220.86  |- skos__historyNote mesh__D027622 Plants %28%1969-2001%29%
% 220.68/220.86  |- skos__altLabel mesh__D027622 Saffron
% 220.68/220.86  |- skos__annotation mesh__D027622
% 220.68/220.86       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.68/220.86  |- skos__broader mesh__D027622smesh__D027621
% 220.68/220.86  |- skos__scopeNote mesh__D027622
% 220.68/220.86       A plant genus, in the IRIDACEAE family, known as a source of Saffron.%A%    
% 220.68/220.86  |- skos__prefLabel mesh__D027622 Crocus
% 220.68/220.86  |- mesh__dateCreated mesh__D027622 2001-07-25
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D027622 2004
% 220.68/220.86  |- skos__historyNote mesh__D027622 Liliaceae %28%1996-2001%29%
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D027622 2003
% 220.68/220.86  |- mesh__historyNote mesh__D027622
% 220.68/220.86       2002; for SAFFRON use Liliaceae 1998-2001   
% 220.68/220.86  |- mesh__dateEstablished mesh__D027622 2002-01-01
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D027622 2006
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D027622 2002
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D027622 2005
% 220.68/220.86  |- skos__altLabel mesh__D027622 Saffron Crocus
% 220.68/220.86  |- mesh__recordAuthorizer mesh__D005170 sjn
% 220.68/220.86  |- mesh__dateRevised mesh__D005170 2005-06-30
% 220.68/220.86  |- skos__altLabel mesh__D005170 Blood Coagulation Factor X
% 220.68/220.86  |- mesh__dateCreated mesh__D005170 1999-01-01
% 220.68/220.86  |- skos__scopeNote mesh__D005170
% 220.68/220.86       Storage-stable glycoprotein blood coagulation factor that can be activated to factor Xa by both the intrinsic and extrinsic pathways. A deficiency of factor X, sometimes called Stuart-Prower factor deficiency, may lead to a systemic coagulation disorder.%A%    
% 220.68/220.86  |- rdf__type mesh__D005170sskos__Concept
% 220.68/220.86  |- skos__altLabel mesh__D005170 Autoprothrombin III
% 220.68/220.86  |- skos__altLabel mesh__D005170 Coagulation Factor X
% 220.68/220.86  |- skos__prefLabel mesh__D005170 Factor X
% 220.68/220.86  |- skos__related mesh__D005170smesh__D003029
% 220.68/220.86  |- skos__altLabel mesh__D005170 Stuart Factor
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D005170 2006
% 220.68/220.86  |- skos__altLabel mesh__D005170 Stuart Prower Factor
% 220.68/220.86  |- skos__altLabel mesh__D005170 Stuart-Prower Factor
% 220.68/220.86  |- mesh__recordOriginator mesh__D005170 NLM
% 220.68/220.86  |- skos__hiddenLabel mesh__D005170 Factor X, Coagulation
% 220.68/220.86  |- skos__hiddenLabel mesh__D005170 X, Coagulation Factor
% 220.68/220.86  |- skos__annotation mesh__D005170 a blood coag factor   
% 220.68/220.86  |- mesh__recordMaintainer mesh__D005170 ssb
% 220.68/220.86  |- skos__broader mesh__D005170smesh__D001779
% 220.68/220.86  |- skos__hiddenLabel mesh__D013602 T Lymphocytes, Cytotoxic
% 220.68/220.86  |- skos__historyNote mesh__D013602
% 220.68/220.86       Cytotoxicity, Immunologic %28%1978-1982%29%
% 220.68/220.86  |- skos__hiddenLabel mesh__D013602 Lympholytic Cells, Cell-Mediated
% 220.68/220.86  |- skos__hiddenLabel mesh__D013602 Cell-Mediated Lympholytic Cell
% 220.68/220.86  |- skos__hiddenLabel mesh__D013602 Cells, TC2
% 220.68/220.86  |- skos__hiddenLabel mesh__D013602 Cytotoxic T-Lymphocyte
% 220.68/220.86  |- skos__hiddenLabel mesh__D013602 Cell, TC2
% 220.68/220.86  |- skos__annotation mesh__D013602
% 220.68/220.86       subpopulations: coord IM with T-LYMPHOCYTE SUBSETS %28%IM%29%   
% 220.68/220.86  |- mesh__recordAuthorizer mesh__D013602 sjn
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D013602 2005
% 220.68/220.86  |- mesh__historyNote mesh__D013602
% 220.68/220.86       90; was T LYMPHOCYTES, CYTOTOXIC 1983-89   
% 220.68/220.86  |- skos__hiddenLabel mesh__D013602 Cell Mediated Lympholytic Cells
% 220.68/220.86  |- skos__hiddenLabel mesh__D013602 Cells, TC1
% 220.68/220.86  |- mesh__recordMaintainer mesh__D013602 jmp
% 220.68/220.86  |- skos__historyNote mesh__D013602 T Lymphocytes %28%1973-1982%29%
% 220.68/220.86  |- skos__hiddenLabel mesh__D013602 Lympholytic Cell, Cell-Mediated
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D013602 2006
% 220.68/220.86  |- rdf__type mesh__D013602sskos__Concept
% 220.68/220.86  |- skos__hiddenLabel mesh__D013602 T-Lymphocyte, Cytotoxic
% 220.68/220.86  |- skos__hiddenLabel mesh__D013602 Cell, TC1
% 220.68/220.86  |- mesh__onlineNote mesh__D013602
% 220.68/220.86       use T-LYMPHOCYTES, CYTOTOXIC to search T LYMPHOCYTES, CYTOTOXIC 1983-89%A%  
% 220.68/220.86  |- skos__broader mesh__D013602smesh__D018414
% 220.68/220.86  |- skos__scopeNote mesh__D013602
% 220.68/220.86       Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures %28%MLC%29%, in vivo during a graft-versus-host %28%GVH%29% reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis %28%CML%29%. These CD8-positive cells are distinct from natural killer cells %28%KILLER CELLS, NATURAL%29% and from KILLER CELLS mediating antibody-dependent cell cytotoxicity. There are two effector phenotypes: TC1 and TC2.%A%    
% 220.68/220.86  |- skos__hiddenLabel mesh__D013602 TC2 Cell
% 220.68/220.86  |- mesh__dateEstablished mesh__D013602 1983-01-01
% 220.68/220.86  |- mesh__dateRevised mesh__D013602 2003-07-09
% 220.68/220.86  |- skos__hiddenLabel mesh__D013602 Cell, Cell-Mediated Lympholytic
% 220.68/220.86  |- skos__hiddenLabel mesh__D013602 TC1 Cell
% 220.68/220.86  |- skos__prefLabel mesh__D013602 T-Lymphocytes, Cytotoxic
% 220.68/220.86  |- skos__altLabel mesh__D013602 Cell-Mediated Lympholytic Cells
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D013602 2004
% 220.68/220.86  |- mesh__publicMeSHNote mesh__D013602
% 220.68/220.86       90; was T LYMPHOCYTES, CYTOTOXIC 1983-89   
% 220.68/220.86  |- mesh__recordOriginator mesh__D013602 SAG
% 220.68/220.86  |- skos__hiddenLabel mesh__D013602 Cells, Cell-Mediated Lympholytic
% 220.68/220.86  |- skos__altLabel mesh__D013602 Cytotoxic T-Lymphocytes
% 220.68/220.86  |- skos__hiddenLabel mesh__D013602 Cytotoxic T Lymphocytes
% 220.68/220.86  |- mesh__dateCreated mesh__D013602 1982-04-29
% 220.68/220.86  |- mesh__recordAuthorizer mesh__D051721 sjn
% 220.68/220.86  |- mesh__publicMeSHNote mesh__D051721
% 220.68/220.86       2006; RAD52 PROTEIN was indexed under DNA-BINDING PROTEINS 1993-2005, %26% under FUNGAL PROTEINS 1993-1998%A%  
% 220.68/220.86  |- mesh__recordMaintainer mesh__D051721 DRC
% 220.68/220.86  |- skos__prefLabel mesh__D051721 Rad52 DNA Repair and Recombination Protein
% 220.68/220.86  |- skos__altLabel mesh__D051721 Rad52 Protein
% 220.68/220.86  |- mesh__dateCreated mesh__D051721 2005-06-30
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D051721 2006
% 220.68/220.86  |- skos__broader mesh__D051721smesh__D004268
% 220.68/220.86  |- rdf__type mesh__D051721sskos__Concept
% 220.68/220.86  |- skos__scopeNote mesh__D051721
% 220.68/220.86       A DNA-binding protein that mediates DNA REPAIR of double strand break, and GENETIC RECOMBINATION.%A%    
% 220.68/220.86  |- skos__altLabel mesh__D051721 DNA Repair And Recombination Protein RAD52
% 220.68/220.86  |- mesh__dateEstablished mesh__D051721 2006-01-01
% 220.68/220.86  |- mesh__historyNote mesh__D051721 2006%28%1993%29%   
% 220.68/220.86  |- mesh__recordOriginator mesh__D051721 DRC
% 220.68/220.86  |- mesh__dateCreated mesh__D018098 1993-06-04
% 220.68/220.86  |- mesh__recordAuthorizer mesh__D018098 sjn
% 220.68/220.86  |- mesh__recordOriginator mesh__D018098 AGS
% 220.68/220.86  |- skos__scopeNote mesh__D018098
% 220.68/220.86       A subfamily of PARAMYXOVIRIDAE. Genera include RUBULAVIRUS; RESPIROVIRUS; MORBILLIVIRUS; HENIPAVIRUS; and AVULAVIRUS.%A%    
% 220.68/220.86  |- mesh__recordMaintainer mesh__D018098 ags
% 220.68/220.86  |- skos__annotation mesh__D018098
% 220.68/220.86       infection: coord IM with PARAMYXOVIRIDAE INFECTIONS %28%IM%29%   
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D018098 2004
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D018098 2005
% 220.68/220.86  |- skos__broader mesh__D018098smesh__D010252
% 220.68/220.86  |- mesh__historyNote mesh__D018098 94   
% 220.68/220.86  |- mesh__publicMeSHNote mesh__D018098 94   
% 220.68/220.86  |- mesh__dateEstablished mesh__D018098 1994-01-01
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D018098 2006
% 220.68/220.86  |- skos__prefLabel mesh__D018098 Paramyxovirinae
% 220.68/220.86  |- rdf__type mesh__D018098sskos__Concept
% 220.68/220.86  |- mesh__dateRevised mesh__D018098 2003-07-09
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D004876 2006A
% 220.68/220.86  |- mesh__recordAuthorizer mesh__D004876 ags
% 220.68/220.86  |- rdf__type mesh__D004876sskos__Concept
% 220.68/220.86  |- skos__hiddenLabel mesh__D004876 Alkaloids, Clavine
% 220.68/220.86  |- mesh__dateRevised mesh__D004876 2005-07-13
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D004876 2004
% 220.68/220.86  |- skos__altLabel mesh__D004876 Clavine Alkaloids
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D004876 2003
% 220.68/220.86  |- mesh__recordMaintainer mesh__D004876 ags
% 220.68/220.86  |- mesh__recordOriginator mesh__D004876 NLM
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D004876 2006
% 220.68/220.86  |- mesh__dateCreated mesh__D004876 1999-01-01
% 220.68/220.86  |- skos__hiddenLabel mesh__D004876 Alkaloids, Ergot
% 220.68/220.86  |- skos__prefLabel mesh__D004876 Ergot Alkaloids
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D004876 2005
% 220.68/220.86  |- skos__scopeNote mesh__D004876
% 220.68/220.86       Alkaloids originally isolated from the ergot fungus Claviceps purpurea %28%Hypocreaceae%29%. They include compounds that are structurally related to ergoline %28%ERGOLINES%29% and ergotamine %28%ERGOTAMINES%29%. Many of the ergot alkaloids act as alpha-adrenergic antagonists.%A%    
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D004876 2002
% 220.68/220.86  |- skos__broader mesh__D004876smesh__D000470
% 220.68/220.86  |- mesh__dateEstablished mesh__D004078 1991-01-01
% 220.68/220.86  |- mesh__recordAuthorizer mesh__D004078 sjn
% 220.68/220.86  |- skos__historyNote mesh__D004078 Hydrazines %28%1968-1975%29%
% 220.68/220.86  |- rdf__type mesh__D004078sskos__Concept
% 220.68/220.86  |- skos__hiddenLabel mesh__D004078 Sulfate, Dihydralazine
% 220.68/220.86  |- mesh__dateRevised mesh__D004078 2005-06-30
% 220.68/220.86  |- skos__broader mesh__D004078smesh__D006830
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D004078 2006
% 220.68/220.86  |- skos__altLabel mesh__D004078 Dihydrazinophthalazin
% 220.68/220.86  |- skos__annotation mesh__D004078 an antihypertensive   
% 220.68/220.86  |- mesh__recordOriginator mesh__D004078 SH
% 220.68/220.86  |- skos__historyNote mesh__D004078 Pyridazines %28%1968-1975%29%
% 220.68/220.86  |- skos__altLabel mesh__D004078
% 220.68/220.86       Altana Pharma Oranienburg Brand of Dihydralazine Sulfate
% 220.68/220.86  |- skos__altLabel mesh__D004078 Dihydrallazine
% 220.68/220.86  |- skos__prefLabel mesh__D004078 Dihydralazine
% 220.68/220.86  |- mesh__recordMaintainer mesh__D004078 exl
% 220.68/220.86  |- skos__scopeNote mesh__D004078
% 220.68/220.86       1,4-Dihydrazinophthalazine. An antihypertensive agent with actions and uses similar to those of HYDRALAZINE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p354%29%%A%    
% 220.68/220.86  |- mesh__historyNote mesh__D004078
% 220.68/220.86       91%28%76%29%; was see under HYDRALAZINE 1976-90   
% 220.68/220.86  |- skos__historyNote mesh__D004078 Heterocyclic Compounds %28%1968-1974%29%
% 220.68/220.86  |- mesh__dateCreated mesh__D004078 1975-07-18
% 220.68/220.86  |- mesh__publicMeSHNote mesh__D004078
% 220.68/220.86       91; was see under HYDRALAZINE 1976-90   
% 220.68/220.86  |- skos__historyNote mesh__D009561 Antibiotics %28%1966-1972%29%
% 220.68/220.86  |- skos__broader mesh__D009561smesh__D010456
% 220.68/220.86  |- mesh__recordMaintainer mesh__D009561 ssb
% 220.68/220.86  |- skos__scopeNote mesh__D009561
% 220.68/220.86       A 34-amino acid polypeptide antibiotic produced by Streptococcus lactis. It has been used as a food preservative in canned fruits and vegetables, and cheese.%A%    
% 220.68/220.86  |- mesh__dateRevised mesh__D009561 2005-06-30
% 220.68/220.86  |- mesh__dateEstablished mesh__D009561 1973-01-01
% 220.68/220.86  |- mesh__dateCreated mesh__D009561 1999-01-01
% 220.68/220.86  |- rdf__type mesh__D009561sskos__Concept
% 220.68/220.86  |- mesh__publicMeSHNote mesh__D009561 73   
% 220.68/220.86  |- mesh__recordOriginator mesh__D009561 NLM
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D009561 2006
% 220.68/220.86  |- mesh__recordAuthorizer mesh__D009561 sjn
% 220.68/220.86  |- skos__broader mesh__D009561smesh__D001430
% 220.68/220.86  |- mesh__historyNote mesh__D009561 73   
% 220.68/220.86  |- skos__prefLabel mesh__D009561 Nisin
% 220.68/220.86  |- mesh__dateEstablished mesh__D008469 1991-01-01
% 220.68/220.86  |- mesh__dateCreated mesh__D008469 1974-11-11
% 220.68/220.86  |- skos__altLabel mesh__D008469 Meclofenamate Sodium
% 220.68/220.86  |- mesh__recordMaintainer mesh__D008469 CCR
% 220.68/220.86  |- skos__prefLabel mesh__D008469 Meclofenamic Acid
% 220.68/220.86  |- skos__hiddenLabel mesh__D008469 Sodium, Meclofenamate
% 220.68/220.86  |- skos__hiddenLabel mesh__D008469 Meclofenamate, Sodium
% 220.68/220.86  |- mesh__recordOriginator mesh__D008469 NLM
% 220.68/220.86  |- skos__scopeNote mesh__D008469
% 220.68/220.86       A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.%A%    
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D008469 2006
% 220.68/220.86  |- skos__broader mesh__D008469smesh__D000879
% 220.68/220.86  |- skos__historyNote mesh__D008469 Anthranilic Acids %28%1969-1974%29%
% 220.68/220.86  |- skos__hiddenLabel mesh__D008469 Acid, Meclofenamic
% 220.68/220.86  |- skos__altLabel mesh__D008469 Parke Davis Brand of Sodium Meclofenamate
% 220.68/220.86  |- mesh__publicMeSHNote mesh__D008469
% 220.68/220.86       91; was see under ANTHRANILIC ACIDS 1975-90   
% 220.68/220.86  |- rdf__type mesh__D008469sskos__Concept
% 220.68/220.86  |- mesh__dateRevised mesh__D008469 2005-06-30
% 220.68/220.86  |- mesh__historyNote mesh__D008469
% 220.68/220.86       91%28%75%29%; was see under ANTHRANILIC ACIDS 1975-90   
% 220.68/220.86  |- skos__historyNote mesh__D008469 Toluene %28%1972-1974%29%
% 220.68/220.86  |- mesh__recordAuthorizer mesh__D008469 sjn
% 220.68/220.86  |- mesh__publicMeSHNote mesh__D000486
% 220.68/220.86       80; IMMUNOLOGY was heading 1963-79; RADIATION IMMUNOLOGY was heading 1964-66%A%  
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D000486 2005
% 220.68/220.86  |- skos__scopeNote mesh__D000486
% 220.68/220.86       A medical specialty concerned with the hypersensitivity of the individual to foreign substances and protection from the resultant infection or disorder.%A%    
% 220.68/220.86  |- skos__broader mesh__D000486smesh__D013040
% 220.68/220.86  |- skos__altLabel mesh__D000486 Immunology, Allergy
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D000486 2006
% 220.68/220.86  |- rdf__type mesh__D000486sskos__Concept
% 220.68/220.86  |- mesh__recordAuthorizer mesh__D000486 PLS
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D000486 1997
% 220.68/220.86  |- mesh__onlineNote mesh__D000486
% 220.68/220.86       use ALLERGY AND IMMUNOLOGY to search IMMUNOLOGY 1966-79; search RADIATION IMMUNOLOGY under RADIATION EFFECTS 1966%A%  
% 220.68/220.86  |- mesh__recordOriginator mesh__D000486 NLM
% 220.68/220.86  |- skos__annotation mesh__D000486
% 220.68/220.86       SPEC: SPEC qualif; do not confuse with ALLERGY see HYPERSENSITIVITY %28%Cat C%29%; consider also /immunol: Manual 19.7+, 19.8.37; immunohematology is indexed under BLOOD GROUPS; immunologic processes = IMMUNITY or specific; DF: ALLERGY IMMUNOL%A%  
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D000486 1998
% 220.68/220.86  |- mesh__historyNote mesh__D000486
% 220.68/220.86       80; IMMUNOLOGY was heading 1963-79; RADIATION IMMUNOLOGY was heading 1964-66%A%  
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D000486 2000
% 220.68/220.86  |- mesh__recordMaintainer mesh__D000486 TGC
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D000486 1999
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D000486 2003
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D000486 2001
% 220.68/220.86  |- mesh__dateRevised mesh__D000486 1996-06-10
% 220.68/220.86  |- skos__prefLabel mesh__D000486 Allergy and Immunology
% 220.68/220.86  |- skos__altLabel mesh__D000486 Immunology and Allergy
% 220.68/220.86  |- skos__altLabel mesh__D000486 Allergy, Immunology
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D000486 2004
% 220.68/220.86  |- skos__hiddenLabel mesh__D000486 Allergies %28%Specialty%29%
% 220.68/220.86  |- mesh__dateCreated mesh__D000486 1999-01-01
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D000486 2002
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D019191 2000
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D019191 2004
% 220.68/220.86  |- skos__broader mesh__D019191smesh__D010942
% 220.68/220.86  |- skos__scopeNote mesh__D019191
% 220.68/220.86       A family of monopartite RNA plant viruses resembling picornaviruses and containing two genera: SEQUIVIRUS and WAIKAVIRUS. Transmission is by aphids or leafhoppers and requires a helper protein.%A%    
% 220.68/220.86  |- skos__prefLabel mesh__D019191 Sequiviridae
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D019191 2001
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D019191 1998
% 220.68/220.86  |- mesh__dateCreated mesh__D019191 1996-06-10
% 220.68/220.86  |- mesh__historyNote mesh__D019191 97   
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D019191 2002
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D019191 1999
% 220.68/220.86  |- mesh__publicMeSHNote mesh__D019191 97   
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D019191 1997
% 220.68/220.86  |- skos__broader mesh__D019191smesh__D012328
% 220.68/220.86  |- skos__annotation mesh__D019191 a family of plant viruses   
% 220.68/220.86  |- mesh__dateEstablished mesh__D019191 1997-01-01
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D019191 2005
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D019191 2006
% 220.68/220.86  |- rdf__type mesh__D019191sskos__Concept
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D019191 2003
% 220.68/220.86  |- skos__broader mesh__D027623smesh__D027881
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D027623 2002
% 220.68/220.86  |- skos__scopeNote mesh__D027623
% 220.68/220.86       A genus %28%and common name%29% in the AGAVACEAE family.  It is known for SAPONINS in the root that are used in SOAPS.%A%    
% 220.68/220.86  |- skos__historyNote mesh__D027623 Liliaceae %28%1998-2001%29%
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D027623 2004
% 220.68/220.86  |- skos__annotation mesh__D027623
% 220.68/220.86       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D027623 2003
% 220.68/220.86  |- mesh__dateEstablished mesh__D027623 2002-01-01
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D027623 2006
% 220.68/220.86  |- mesh__dateCreated mesh__D027623 2001-07-25
% 220.68/220.86  |- mesh__publicMeSHNote mesh__D027623 2002; see Liliaceae 1998-2001   
% 220.68/220.86  |- skos__prefLabel mesh__D027623 Yucca
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D027623 2005
% 220.68/220.86  |- rdf__type mesh__D027623sskos__Concept
% 220.68/220.86  |- skos__historyNote mesh__D027623 Plants %28%1965-2001%29%
% 220.68/220.86  |- mesh__historyNote mesh__D027623 2002; use Liliaceae 1998-2001   
% 220.68/220.86  |- mesh__publicMeSHNote mesh__D005171
% 220.68/220.86       91; was see under HYPOPROTHROMBINEMIAS 1975-90   
% 220.68/220.86  |- skos__altLabel mesh__D005171 Stuart-Prower Factor Deficiency
% 220.68/220.86  |- skos__altLabel mesh__D005171 Stuart-Prower Deficiency
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D005171 2003
% 220.68/220.86  |- skos__hiddenLabel mesh__D005171 Factor X Deficiencies
% 220.68/220.86  |- skos__prefLabel mesh__D005171 Factor X Deficiency
% 220.68/220.86  |- mesh__recordOriginator mesh__D005171 NLM
% 220.68/220.86  |- rdf__type mesh__D005171sskos__Concept
% 220.68/220.86  |- skos__broader mesh__D005171smesh__D020147
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D005171 2004
% 220.68/220.86  |- mesh__recordAuthorizer mesh__D005171 sjn
% 220.68/220.86  |- mesh__onlineNote mesh__D005171 search HYPOPROTHROMBINEMIAS 1966-74   
% 220.68/220.86  |- mesh__dateRevised mesh__D005171 2001-07-25
% 220.68/220.86  |- skos__scopeNote mesh__D005171
% 220.68/220.86       Blood coagulation disorder usually inherited as an autosomal recessive trait, though it can be acquired. It is characterized by defective activity in both the intrinsic and extrinsic pathways, impaired thromboplastin time, and impaired prothrombin consumption.%A%    
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D005171 2002
% 220.68/220.86  |- skos__altLabel mesh__D005171 Deficiency, Stuart-Prower
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D005171 2005
% 220.68/220.86  |- skos__hiddenLabel mesh__D005171 Stuart Prower Factor Deficiency
% 220.68/220.86  |- skos__hiddenLabel mesh__D005171 Deficiency, Stuart Prower
% 220.68/220.86  |- mesh__historyNote mesh__D005171
% 220.68/220.86       91%28%75%29%; was see under HYPOPROTHROMBINEMIAS 1975-90   
% 220.68/220.86  |- mesh__dateEstablished mesh__D005171 1991-01-01
% 220.68/220.86  |- skos__altLabel mesh__D005171 Deficiency, Stuart-Prower Factor
% 220.68/220.86  |- skos__annotation mesh__D005171
% 220.68/220.86       a blood coag disord; DF: FACTOR X DEFIC   
% 220.68/220.86  |- skos__hiddenLabel mesh__D005171 Deficiency, Stuart Prower Factor
% 220.68/220.86  |- mesh__recordMaintainer mesh__D005171 nns
% 220.68/220.86  |- skos__broader mesh__D005171smesh__D025861
% 220.68/220.86  |- skos__broader mesh__D005171smesh__D006474
% 220.68/220.86  |- skos__altLabel mesh__D005171 Deficiency, Factor X
% 220.68/220.86  |- skos__hiddenLabel mesh__D005171 Deficiencies, Factor X
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D005171 2006
% 220.68/220.86  |- mesh__dateCreated mesh__D005171 1999-01-01
% 220.68/220.86  |- skos__hiddenLabel mesh__D005171 Stuart Prower Deficiency
% 220.68/220.86  |- skos__scopeNote mesh__D046588
% 220.68/220.86       A kingdom of hyperthermophilic ARCHAEA found in diverse environments.%A%    
% 220.68/220.86  |- mesh__recordAuthorizer mesh__D046588 sjn
% 220.68/220.86  |- rdf__type mesh__D046588sskos__Concept
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D046588 2006
% 220.68/220.86  |- skos__historyNote mesh__D046588 Archaea %28%2002-2004%29%
% 220.68/220.86  |- mesh__publicMeSHNote mesh__D046588 2005   
% 220.68/220.86  |- skos__broader mesh__D046588smesh__D001105
% 220.68/220.86  |- mesh__recordOriginator mesh__D046588 ags
% 220.68/220.86  |- skos__prefLabel mesh__D046588 Nanoarchaeota
% 220.68/220.86  |- mesh__recordMaintainer mesh__D046588 ags
% 220.68/220.86  |- mesh__dateEstablished mesh__D046588 2005-01-01
% 220.68/220.86  |- mesh__dateRevised mesh__D046588 2005-06-30
% 220.68/220.86  |- mesh__historyNote mesh__D046588 2005   
% 220.68/220.86  |- mesh__dateCreated mesh__D046588 2004-07-07
% 220.68/220.86  |- skos__broader mesh__D051722smesh__D006023
% 220.68/220.86  |- skos__scopeNote mesh__D051722
% 220.68/220.86       A family of membrane-anchored glycoproteins that contain a disintegrin and metalloprotease domain. They are responsible for the proteolytic cleavage of many transmembrane proteins and the release of their extracellular domain.%A%    
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D051722 2006A
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D051722 2006
% 220.68/220.86  |- rdf__type mesh__D051722sskos__Concept
% 220.68/220.86  |- mesh__recordAuthorizer mesh__D051722 ags
% 220.68/220.86  |- skos__altLabel mesh__D051722 A Disintegrin and Metalloprotease Proteins
% 220.68/220.86  |- skos__altLabel mesh__D051722
% 220.68/220.86       ADAM %28%A Disintegrin and Metalloprotease%29% Proteins
% 220.68/220.86  |- skos__broader mesh__D051722smesh__D008666
% 220.68/220.86  |- mesh__dateCreated mesh__D051722 2005-06-30
% 220.68/220.86  |- mesh__publicMeSHNote mesh__D051722 2006   
% 220.68/220.86  |- skos__prefLabel mesh__D051722 ADAM Proteins
% 220.68/220.86  |- mesh__dateRevised mesh__D051722 2005-07-13
% 220.68/220.86  |- mesh__historyNote mesh__D051722 2006   
% 220.68/220.86  |- mesh__recordMaintainer mesh__D051722 ags
% 220.68/220.86  |- mesh__recordOriginator mesh__D051722 DRC
% 220.68/220.86  |- mesh__dateEstablished mesh__D051722 2006-01-01
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D018099 2005
% 220.68/220.86  |- skos__broader mesh__D018099smesh__D010252
% 220.68/220.86  |- skos__scopeNote mesh__D018099
% 220.68/220.86       A subfamily of PARAMYXOVIRIDAE containing two genera: PNEUMOVIRUS; and METAPNEUMOVIRUS.%A%    
% 220.68/220.86  |- mesh__recordMaintainer mesh__D018099 ags
% 220.68/220.86  |- mesh__historyNote mesh__D018099 94   
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D018099 2006
% 220.68/220.86  |- mesh__dateRevised mesh__D018099 2001-07-25
% 220.68/220.86  |- mesh__activeMeSHYear mesh__D018099 2002
% 220.68/220.86  |- rdf__type mesh__D018099sskos__Concept
% 220.68/220.86  |- mesh__dateCreated mesh__D018099 1993-06-04
% 220.68/220.86  |- skos__annotation mesh__D018099
% 220.68/220.86       infecton: coord IM with PARAMYXOVIRIDAE INFECTIONS %28%IM%29%   
% 220.68/220.86  |- mesh__recordAuthorizer mesh__D018099 sjn
% 220.68/220.86  |- mesh__recordOriginator mesh__D018099 AGS
% 220.68/220.87  |- mesh__dateEstablished mesh__D018099 1994-01-01
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D018099 2003
% 220.68/220.87  |- mesh__publicMeSHNote mesh__D018099 94   
% 220.68/220.87  |- skos__prefLabel mesh__D018099 Pneumovirinae
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D018099 2004
% 220.68/220.87  |- skos__altLabel mesh__D004877 Co-Dergocrine Mesylate
% 220.68/220.87  |- mesh__recordAuthorizer mesh__D004877 ags
% 220.68/220.87  |- mesh__dateRevised mesh__D004877 2005-07-13
% 220.68/220.87  |- skos__hiddenLabel mesh__D004877 Co Dergine Mesylate
% 220.68/220.87  |- skos__hiddenLabel mesh__D004877 Co Dergocrine Mesilate
% 220.68/220.87  |- mesh__historyNote mesh__D004877
% 220.68/220.87       92; was ERGOT ALKALOIDS, HYDROGENATED 1963-91; ERGOLOID MESYLATE was see DIHYDROERGOTOXINE 1984-91; HYDERGINE was see DIHYDROERGOTOXINE 1977-91, see under ERGOT ALKALOIDS, HYDROGENATED 1963-76%A%  
% 220.68/220.87  |- skos__altLabel mesh__D004877 Redergine
% 220.68/220.87  |- skos__altLabel mesh__D004877 Ergoloid Mesylate
% 220.68/220.87  |- skos__altLabel mesh__D004877 Dihydroergotoxine Monomethanesulfonate
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D004877 2004
% 220.68/220.87  |- mesh__recordOriginator mesh__D004877 NLM
% 220.68/220.87  |- skos__scopeNote mesh__D004877
% 220.68/220.87       A mixture of the mesylates %28%methane sulfonates%29% of DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and the alpha- and beta-isomers of DIHYDROERGOCRYPTINE. The substance produces a generalized peripheral vasodilation and a fall in arterial pressure and has been used to treat symptoms of mild to moderate impairment of mental function in the elderly.%A%    
% 220.68/220.87  |- skos__altLabel mesh__D004877 Co-Dergocrine Mesilate
% 220.68/220.87  |- skos__altLabel mesh__D004877 Ergotoxin, Dihydro-, Monomethasulfonate
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D004877 2003
% 220.68/220.87  |- mesh__dateCreated mesh__D004877 1999-01-01
% 220.68/220.87  |- mesh__onlineNote mesh__D004877
% 220.68/220.87       use ERGOLOID MESYLATES to search ERGOT ALKALOIDS, HYDROGENATED 1966-91; use DIHYDROERGOTOXINE to search ERGOLOID MESYLATE 1984-91; use DIHYDROERGOTOXINE to search HYDERGINE 1977-91, use ERGOLOID MESYLATES 1966-76%A%  
% 220.68/220.87  |- mesh__recordMaintainer mesh__D004877 ags
% 220.68/220.87  |- skos__broader mesh__D004877smesh__D004088
% 220.68/220.87  |- mesh__publicMeSHNote mesh__D004877
% 220.68/220.87       92; was ERGOT ALKALOIDS, HYDROGENATED 1963-91; ERGOLOID MESYLATE was see DIHYDROERGOTOXINE 1984-91; HYDERGINE was see DIHYDROERGOTOXINE 1977-91, see under ERGOT ALKALOIDS, HYDROGENATED 1963-76%A%  
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D004877 2006
% 220.68/220.87  |- skos__hiddenLabel mesh__D004877 Monomethanesulfonate, Dihydroergotoxine
% 220.68/220.87  |- skos__altLabel mesh__D004877 Co-Dergine Mesylate
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D004877 2002
% 220.68/220.87  |- skos__hiddenLabel mesh__D004877 Methanesulfonate, Dihydroergotoxine
% 220.68/220.87  |- skos__prefLabel mesh__D004877 Ergoloid Mesylates
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D004877 2006A
% 220.68/220.87  |- skos__altLabel mesh__D004877 Dihydroergotoxine Methanesulfonate
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D004877 2005
% 220.68/220.87  |- skos__hiddenLabel mesh__D004877 Co Dergocrine Mesylate
% 220.68/220.87  |- rdf__type mesh__D004877sskos__Concept
% 220.68/220.87  |- skos__altLabel mesh__D004877 Dihydroergotoxine Mesylate
% 220.68/220.87  |- mesh__publicMeSHNote mesh__D004079
% 220.68/220.87       91; was see under ALKALOIDS 1975-90   
% 220.68/220.87  |- rdf__type mesh__D004079sskos__Concept
% 220.68/220.87  |- skos__historyNote mesh__D004079 Indoles %28%1969-1974%29%
% 220.68/220.87  |- skos__prefLabel mesh__D004079 Dihydro-beta-Erythroidine
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D004079 2005
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D004079 2002
% 220.68/220.87  |- skos__historyNote mesh__D004079 Alkaloids %28%1969-1974%29%
% 220.68/220.87  |- skos__hiddenLabel mesh__D004079 beta Erythroidine, Dihydro
% 220.68/220.87  |- mesh__historyNote mesh__D004079
% 220.68/220.87       91%28%75%29%; was see under ALKALOIDS 1975-90   
% 220.68/220.87  |- skos__hiddenLabel mesh__D004079 Erythroidine, Dihydro beta
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D004079 2006
% 220.68/220.87  |- skos__altLabel mesh__D004079 Dihydro beta Erythroidine
% 220.68/220.87  |- mesh__recordAuthorizer mesh__D004079 sjn
% 220.68/220.87  |- skos__scopeNote mesh__D004079
% 220.68/220.87       Dihydro analog of beta-erythroidine, which is isolated from the seeds and other plant parts of Erythrina sp. Leguminosae. It is an alkaloid with curarimimetic properties.%A%    
% 220.68/220.87  |- mesh__dateCreated mesh__D004079 1974-11-19
% 220.68/220.87  |- mesh__recordMaintainer mesh__D004079 TWD
% 220.68/220.87  |- skos__broader mesh__D004079smesh__D000470
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D004079 2003
% 220.68/220.87  |- mesh__recordOriginator mesh__D004079 PLS
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D004079 2004
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D004079 2001
% 220.68/220.87  |- mesh__dateEstablished mesh__D004079 1991-01-01
% 220.68/220.87  |- mesh__dateRevised mesh__D004079 2000-06-22
% 220.68/220.87  |- skos__broader mesh__D004079smesh__D006576
% 220.68/220.87  |- mesh__dateRevised mesh__D009562 2003-07-09
% 220.68/220.87  |- mesh__dateCreated mesh__D009562 1999-01-01
% 220.68/220.87  |- mesh__recordMaintainer mesh__D009562 nns
% 220.68/220.87  |- rdf__type mesh__D009562sskos__Concept
% 220.68/220.87  |- skos__hiddenLabel mesh__D009562 Granules, Nissl
% 220.68/220.87  |- mesh__historyNote mesh__D009562
% 220.68/220.87       65%28%64%29%; CHROMATIN, NERVE was see NISSL BODIES 1973-94   
% 220.68/220.87  |- skos__broader mesh__D009562smesh__D018870
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D009562 2006
% 220.68/220.87  |- mesh__publicMeSHNote mesh__D009562
% 220.68/220.87       65; CHROMATIN, NERVE was see NISSL BODIES 1973-94   
% 220.68/220.87  |- skos__broader mesh__D009562smesh__D003594
% 220.68/220.87  |- mesh__dateEstablished mesh__D009562 1965-01-01
% 220.68/220.87  |- skos__broader mesh__D009562smesh__D009474
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D009562 2005
% 220.68/220.87  |- mesh__onlineNote mesh__D009562
% 220.68/220.87       use NISSL BODIES to search CHROMATIN, NERVE 1973-94   
% 220.68/220.87  |- skos__hiddenLabel mesh__D009562 Bodies, Nissl
% 220.68/220.87  |- skos__scopeNote mesh__D009562
% 220.68/220.87       Subcellular structures found in nerve cell bodies and DENDRITES. They consist of granular endoplasmic reticulum %28%ENDOPLASMIC RETICULUM, ROUGH%29% and RIBOSOMES.%A%    
% 220.68/220.87  |- skos__prefLabel mesh__D009562 Nissl Bodies
% 220.68/220.87  |- skos__hiddenLabel mesh__D009562 Granule, Nissl
% 220.68/220.87  |- skos__hiddenLabel mesh__D009562 Nissl Granule
% 220.68/220.87  |- mesh__recordOriginator mesh__D009562 NLM
% 220.68/220.87  |- skos__altLabel mesh__D009562 Nissl Granules
% 220.68/220.87  |- mesh__recordAuthorizer mesh__D009562 sjn
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D009562 2004
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D019990 1999
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D019990 2002
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D019990 2000
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D019990 2005
% 220.68/220.87  |- mesh__dateCreated mesh__D019990 1997-06-20
% 220.68/220.87  |- mesh__publicMeSHNote mesh__D019990 98   
% 220.68/220.87  |- mesh__recordAuthorizer mesh__D019990 SJN
% 220.68/220.87  |- mesh__historyNote mesh__D019990 98   
% 220.68/220.87  |- skos__hiddenLabel mesh__D019990 Care, Perioperative
% 220.68/220.87  |- mesh__recordMaintainer mesh__D019990 NNS
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D019990 2006
% 220.68/220.87  |- mesh__dateEstablished mesh__D019990 1998-01-01
% 220.68/220.87  |- skos__broader mesh__D019990smesh__D005791
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D019990 2001
% 220.68/220.87  |- mesh__recordOriginator mesh__D019990 JLS
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D019990 2003
% 220.68/220.87  |- skos__annotation mesh__D019990
% 220.68/220.87       do not confuse with PEROPERATIVE CARE see INTRAOPERATIVE CARE%A%  
% 220.68/220.87  |- skos__scopeNote mesh__D019990
% 220.68/220.87       Interventions to provide care prior to, during, and immediately after surgery.%A%    
% 220.68/220.87  |- skos__prefLabel mesh__D019990 Perioperative Care
% 220.68/220.87  |- rdf__type mesh__D019990sskos__Concept
% 220.68/220.87  |- mesh__dateRevised mesh__D019990 1998-06-10
% 220.68/220.87  |- skos__broader mesh__D019990smesh__D013514
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D019990 2004
% 220.68/220.87  |- mesh__recordOriginator mesh__D033661 ags
% 220.68/220.87  |- mesh__dateCreated mesh__D033661 2002-07-03
% 220.68/220.87  |- mesh__dateEstablished mesh__D033661 2003-01-01
% 220.68/220.87  |- mesh__recordAuthorizer mesh__D033661 sjn
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D033661 2006
% 220.68/220.87  |- skos__broader mesh__D033661smesh__D033761
% 220.68/220.87  |- mesh__historyNote mesh__D033661 2003   
% 220.68/220.87  |- skos__prefLabel mesh__D033661 Oocysts
% 220.68/220.87  |- mesh__dateRevised mesh__D033661 2005-06-30
% 220.68/220.87  |- skos__scopeNote mesh__D033661
% 220.68/220.87       Encapsulated zygotes of sporozoan protozoa. Further development in an oocyst produces small individual infective organisms called SPOROZOITES. Then, depending on the genus, the entire oocyst is called a sporocyst or the oocyst contains multiple sporocysts encapsulating the sporozoites.%A%    
% 220.68/220.87  |- rdf__type mesh__D033661sskos__Concept
% 220.68/220.87  |- mesh__recordMaintainer mesh__D033661 SYSTEM
% 220.68/220.87  |- mesh__publicMeSHNote mesh__D033661 2003   
% 220.68/220.87  |- mesh__publicMeSHNote mesh__D000487 74   
% 220.68/220.87  |- rdf__type mesh__D000487sskos__Concept
% 220.68/220.87  |- mesh__dateEstablished mesh__D000487 1974-01-01
% 220.68/220.87  |- skos__altLabel mesh__D000487 Allethrins
% 220.68/220.87  |- skos__scopeNote mesh__D000487
% 220.68/220.87       Synthetic analogs of the naturally occurring insecticides cinerin, jasmolin, and pyrethrin. %28%From Merck Index, 11th ed%29%%A%    
% 220.68/220.87  |- skos__broader mesh__D000487smesh__D011722
% 220.68/220.87  |- mesh__dateRevised mesh__D000487 2004-07-19
% 220.68/220.87  |- mesh__recordOriginator mesh__D000487 NLM
% 220.68/220.87  |- mesh__recordMaintainer mesh__D000487 jls
% 220.68/220.87  |- skos__historyNote mesh__D000487 Pyrethrum %28%1966-1971%29%
% 220.68/220.87  |- mesh__recordAuthorizer mesh__D000487 sjn
% 220.68/220.87  |- mesh__dateCreated mesh__D000487 1999-01-01
% 220.68/220.87  |- skos__prefLabel mesh__D000487 Allethrin
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D000487 2005
% 220.68/220.87  |- skos__historyNote mesh__D000487 Cycloparaffins %28%1966-1971%29%
% 220.68/220.87  |- mesh__historyNote mesh__D000487 74%28%72%29%   
% 220.68/220.87  |- skos__annotation mesh__D000487 TN 111 for eff on insects   
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D000487 2006
% 220.68/220.87  |- skos__broader mesh__D019192smesh__D019191
% 220.68/220.87  |- mesh__dateRevised mesh__D019192 2001-07-25
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D019192 2005
% 220.68/220.87  |- mesh__recordAuthorizer mesh__D019192 sjn
% 220.68/220.87  |- rdf__type mesh__D019192sskos__Concept
% 220.68/220.87  |- mesh__recordMaintainer mesh__D019192 ags
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D019192 2006
% 220.68/220.87  |- skos__prefLabel mesh__D019192 Sequivirus
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D019192 2003
% 220.68/220.87  |- skos__annotation mesh__D019192
% 220.68/220.87       coord IM with specific plant /virol %28%IM or NIM%29%   
% 220.68/220.87  |- skos__scopeNote mesh__D019192
% 220.68/220.87       A genus of plant viruses in the family SEQUIVIRIDAE. Transmission is by APHIDS but depends on the presence of a helper protein encoded by the Anthriscus yellow virus, a WAIKAVIRUS. The type species is Parsnip yellow fleck virus %28%parsnip serotype%29%.%A%    
% 220.68/220.87  |- mesh__dateCreated mesh__D019192 1996-06-10
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D019192 2004
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D019192 2002
% 220.68/220.87  |- mesh__publicMeSHNote mesh__D019192 97   
% 220.68/220.87  |- mesh__recordOriginator mesh__D019192 AGS
% 220.68/220.87  |- mesh__historyNote mesh__D019192 97   
% 220.68/220.87  |- mesh__dateEstablished mesh__D019192 1997-01-01
% 220.68/220.87  |- mesh__recordMaintainer mesh__D005970 jmp
% 220.68/220.87  |- skos__altLabel mesh__D005970 Ketoglutarate Glutamine Amidotransferase
% 220.68/220.87  |- skos__broader mesh__D005970smesh__D000594
% 220.68/220.87  |- skos__hiddenLabel mesh__D005970
% 220.68/220.87       Amidotransferase, Ketoglutarate Glutamine
% 220.68/220.87  |- mesh__recordAuthorizer mesh__D005970 sjn
% 220.68/220.87  |- skos__hiddenLabel mesh__D005970
% 220.68/220.87       Ketoglutarate Amidotransferase, Glutamine
% 220.68/220.87  |- skos__hiddenLabel mesh__D005970
% 220.68/220.87       Glutamine Amidotransferase, Ketoglutarate
% 220.68/220.87  |- rdf__type mesh__D005970sskos__Concept
% 220.68/220.87  |- skos__historyNote mesh__D005970 Ketoglutaric Acid %28%1972-1974%29%
% 220.68/220.87  |- skos__hiddenLabel mesh__D005970
% 220.68/220.87       Amidotransferase, Glutamine Ketoglutarate
% 220.68/220.87  |- skos__scopeNote mesh__D005970
% 220.68/220.87       An enzyme that catalyzes the formation of 2 molecules of glutamate from glutamine plus alpha-ketoglutarate in the presence of NADPH. EC 1.4.1.13.%A%    
% 220.68/220.87  |- skos__prefLabel mesh__D005970 Glutamate Synthase
% 220.68/220.87  |- mesh__historyNote mesh__D005970
% 220.68/220.87       91%28%75%29%; was see under AMINOTRANSFERASES 1975-90   
% 220.68/220.87  |- skos__altLabel mesh__D005970 Glutamine Ketoglutarate Amidotransferase
% 220.68/220.87  |- skos__historyNote mesh__D005970 NADP %28%1974%29%
% 220.68/220.87  |- mesh__dateEstablished mesh__D005970 1991-01-01
% 220.68/220.87  |- mesh__recordOriginator mesh__D005970 NLM
% 220.68/220.87  |- skos__historyNote mesh__D005970 Aminotransferases %28%1972-1974%29%
% 220.68/220.87  |- skos__broader mesh__D005970smesh__D000637
% 220.68/220.87  |- skos__historyNote mesh__D005970 Glutamine %28%1972-1974%29%
% 220.68/220.87  |- mesh__dateRevised mesh__D005970 2005-06-30
% 220.68/220.87  |- skos__hiddenLabel mesh__D005970 Synthase, Glutamate
% 220.68/220.87  |- mesh__publicMeSHNote mesh__D005970
% 220.68/220.87       91; was see under AMINOTRANSFERASES 1975-90   
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D005970 2006
% 220.68/220.87  |- mesh__dateCreated mesh__D005970 1974-11-19
% 220.68/220.87  |- skos__prefLabel mesh__D005172 Factor XI
% 220.68/220.87  |- rdf__type mesh__D005172sskos__Concept
% 220.68/220.87  |- skos__altLabel mesh__D005172 Coagulation Factor XI
% 220.68/220.87  |- mesh__historyNote mesh__D005172 68%28%64%29%   
% 220.68/220.87  |- skos__hiddenLabel mesh__D005172 XI, Coagulation Factor
% 220.68/220.87  |- mesh__recordMaintainer mesh__D005172 ssb
% 220.68/220.87  |- skos__broader mesh__D005172smesh__D001779
% 220.68/220.87  |- skos__related mesh__D005172smesh__D003029
% 220.68/220.87  |- skos__hiddenLabel mesh__D005172 Factor XI, Coagulation
% 220.68/220.87  |- skos__scopeNote mesh__D005172
% 220.68/220.87       Stable blood coagulation factor involved in the intrinsic pathway. The activated form XIa activates factor IX to IXa. Deficiency of factor XI is often called hemophilia C.%A%    
% 220.68/220.87  |- mesh__recordOriginator mesh__D005172 NLM
% 220.68/220.87  |- mesh__publicMeSHNote mesh__D005172 68   
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D005172 2006
% 220.68/220.87  |- mesh__dateCreated mesh__D005172 1999-01-01
% 220.68/220.87  |- skos__altLabel mesh__D005172 Blood Coagulation Factor XI
% 220.68/220.87  |- mesh__recordAuthorizer mesh__D005172 sjn
% 220.68/220.87  |- skos__hiddenLabel mesh__D005172 Thromboplastin Antecedent, Plasma
% 220.68/220.87  |- mesh__dateRevised mesh__D005172 2005-06-30
% 220.68/220.87  |- mesh__dateEstablished mesh__D005172 1968-01-01
% 220.68/220.87  |- skos__annotation mesh__D005172 a blood coag factor   
% 220.68/220.87  |- skos__hiddenLabel mesh__D005172 Antecedent, Plasma Thromboplastin
% 220.68/220.87  |- skos__altLabel mesh__D005172 Plasma Thromboplastin Antecedent
% 220.68/220.87  |- skos__broader mesh__D046589smesh__D015140
% 220.68/220.87  |- skos__prefLabel mesh__D046589 CADASIL
% 220.68/220.87  |- mesh__dateCreated mesh__D046589 2004-07-07
% 220.68/220.87  |- skos__broader mesh__D046589smesh__D030342
% 220.68/220.87  |- mesh__recordMaintainer mesh__D046589 nns
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D046589 2006
% 220.68/220.87  |- skos__historyNote mesh__D046589
% 220.68/220.87       Dementia, Multi-Infarct %28%1994-2004%29%
% 220.68/220.87  |- mesh__recordOriginator mesh__D046589 ags
% 220.68/220.87  |- skos__historyNote mesh__D046589
% 220.68/220.87       Cerebrovascular Disorders %28%1994-2004%29%
% 220.68/220.87  |- skos__scopeNote mesh__D046589
% 220.68/220.87       A familial, cerebral arteriopathy mapped to chromosome 19q12, and characterized by the presence of granular deposits in small CEREBRAL ARTERIES producing ischemic STROKE; PSEUDOBULBAR PALSY; and multiple subcortical infarcts %28%CEREBRAL INFARCTION%29%. CADASIL is an acronym for Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. CADASIL differs from BINSWANGER DISEASE by the presence of MIGRAINE WITH AURA and usually by the lack of history of arterial HYPERTENSION. %28%From Bradley et al, Neurology in Clinical Practice, 2000, p1146%29%%A%    
% 220.68/220.87  |- mesh__publicMeSHNote mesh__D046589
% 220.68/220.87       2005; see DEMENTIA, MULTI-INFARCT 2000-2004   
% 220.68/220.87  |- skos__broader mesh__D046589smesh__D002539
% 220.68/220.87  |- mesh__dateEstablished mesh__D046589 2005-01-01
% 220.68/220.87  |- mesh__recordAuthorizer mesh__D046589 sjn
% 220.68/220.87  |- mesh__dateRevised mesh__D046589 2005-06-30
% 220.68/220.87  |- mesh__historyNote mesh__D046589
% 220.68/220.87       2005; use DEMENTIA, MULTI-INFARCT 2000-2004   
% 220.68/220.87  |- rdf__type mesh__D046589sskos__Concept
% 220.68/220.87  |- skos__broader mesh__D013604smesh__D003090
% 220.68/220.87  |- skos__annotation mesh__D013604
% 220.68/220.87       coliphages; GEN or unspecified; prefer specifics; do not confuse with T VIRUS see RETICULOENDOTHELIOSIS VIRUS%A%  
% 220.68/220.87  |- mesh__dateEstablished mesh__D013604 1980-01-01
% 220.68/220.87  |- skos__altLabel mesh__D013604 Phages T
% 220.68/220.87  |- skos__historyNote mesh__D013604 Coliphages %28%1966-1979%29%
% 220.68/220.87  |- skos__altLabel mesh__D013604 Bacteriophages T
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D013604 2006
% 220.68/220.87  |- rdf__type mesh__D013604sskos__Concept
% 220.68/220.87  |- skos__hiddenLabel mesh__D013604 T Phages
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D013604 2004
% 220.68/220.87  |- mesh__recordMaintainer mesh__D013604 sjn
% 220.68/220.87  |- skos__prefLabel mesh__D013604 T-Phages
% 220.68/220.87  |- skos__altLabel mesh__D013604 Coliphages T
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D013604 2005
% 220.68/220.87  |- mesh__dateRevised mesh__D013604 2001-08-03
% 220.68/220.87  |- mesh__dateCreated mesh__D013604 1979-04-16
% 220.68/220.87  |- skos__hiddenLabel mesh__D013604 T-Phage
% 220.68/220.87  |- mesh__publicMeSHNote mesh__D013604 80   
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D013604 2003
% 220.68/220.87  |- mesh__recordAuthorizer mesh__D013604 sjn
% 220.68/220.87  |- mesh__historyNote mesh__D013604 80   
% 220.68/220.87  |- skos__scopeNote mesh__D013604
% 220.68/220.87       A series of 7 virulent phages which infect E. coli. The T-even phages T2, T4; %28%BACTERIOPHAGE T4%29%, and T6, and the phage T5 are called %22%autonomously virulent%22% because they cause cessation of all bacterial metabolism on infection. Phages T1, T3; %28%BACTERIOPHAGE T3%29%, and T7; %28%BACTERIOPHAGE T7%29% are called %22%dependent virulent%22% because they depend on continued bacterial metabolism during the lytic cycle. The T-even phages contain 5-hydroxymethylcytosine in place of ordinary cytosine in their DNA.%A%    
% 220.68/220.87  |- mesh__recordOriginator mesh__D013604 AEP
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D013604 2002
% 220.68/220.87  |- mesh__recordAuthorizer mesh__D004878 sjn
% 220.68/220.87  |- mesh__historyNote mesh__D004878
% 220.68/220.87       ERGOTAMINE TARTRATE was ERGOTAMINE TARTRATE %28%NM%29% 1975-91   
% 220.68/220.87  |- skos__altLabel mesh__D004878 Krewel Brand of Ergotamine Tartrate
% 220.68/220.87  |- skos__altLabel mesh__D004878 Lotus Brand of Ergotamine Tartrate
% 220.68/220.87  |- skos__broader mesh__D004878smesh__D004879
% 220.68/220.87  |- skos__altLabel mesh__D004878
% 220.68/220.87       Sanofi Winthrop Brand of Ergotamine Tartrate
% 220.68/220.87  |- skos__hiddenLabel mesh__D004878 sanol, ergo
% 220.68/220.87  |- mesh__dateCreated mesh__D004878 1999-01-01
% 220.68/220.87  |- mesh__publicMeSHNote mesh__D004878
% 220.68/220.87       ERGOTAMINE TARTRATE was indexed under ERGOTAMINE DERIVATIVES 1977-91 %26% under ERGOTAMINE 1975-76%A%  
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D004878 2006
% 220.68/220.87  |- mesh__recordOriginator mesh__D004878 NLM
% 220.68/220.87  |- skos__hiddenLabel mesh__D004878 ErgoKranit
% 220.68/220.87  |- skos__altLabel mesh__D004878 Ergostat
% 220.68/220.87  |- mesh__onlineNote mesh__D004878
% 220.68/220.87       use ERGOTAMINE %28%NM%29% to search ERGOTAMINE TARTRATE %28%NM%29% 1980-91%A%  
% 220.68/220.87  |- skos__hiddenLabel mesh__D004878 Ergo Kranit
% 220.68/220.87  |- rdf__type mesh__D004878sskos__Concept
% 220.68/220.87  |- mesh__recordMaintainer mesh__D004878 sjn
% 220.68/220.87  |- skos__prefLabel mesh__D004878 Ergotamine
% 220.68/220.87  |- skos__hiddenLabel mesh__D004878 Tartrate, Ergotamine
% 220.68/220.87  |- skos__hiddenLabel mesh__D004878 Mono, Ergodryl
% 220.68/220.87  |- mesh__dateRevised mesh__D004878 2005-07-01
% 220.68/220.87  |- skos__scopeNote mesh__D004878
% 220.68/220.87       A vasoconstrictor found in ergot of Central Europe. It is an alpha-1 selective adrenergic agonist and is commonly used in the treatment of MIGRAINE DISORDERS.%A%    
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D001580 2005
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D001580 2000
% 220.68/220.87  |- skos__broader mesh__D001580smesh__D011721
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D001580 2004
% 220.68/220.87  |- mesh__recordMaintainer mesh__D001580 JRT
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D001580 2001
% 220.68/220.87  |- mesh__recordOriginator mesh__D001580 NLM
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D001580 2006
% 220.68/220.87  |- skos__annotation mesh__D001580 do not confuse with BENZOPYRANS   
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D001580 1996
% 220.68/220.87  |- mesh__dateCreated mesh__D001580 1999-01-01
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D001580 1998
% 220.68/220.87  |- mesh__dateRevised mesh__D001580 1995-06-08
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D001580 1997
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D001580 2002
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D001580 1999
% 220.68/220.87  |- rdf__type mesh__D001580sskos__Concept
% 220.68/220.87  |- skos__prefLabel mesh__D001580 Benzopyrenes
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D001580 2003
% 220.68/220.87  |- mesh__recordAuthorizer mesh__D001580 PLS
% 220.68/220.87  |- skos__scopeNote mesh__D001580
% 220.68/220.87       A class of chemicals that contain an anthracene ring with a naphthalene ring attached to it.%A%    
% 220.68/220.87  |- skos__annotation mesh__D019991
% 220.68/220.87       publication type only; for databases as a subject index under DATABASES or DATABASES, BIBLIOGRAPHIC or DATABASES, FACTUAL%A%  
% 220.68/220.87  |- skos__altLabel mesh__D019991 Data Base %28%PT%29%
% 220.68/220.87  |- skos__broader mesh__D019991smesh__D052180
% 220.68/220.87  |- skos__altLabel mesh__D019991 Database
% 220.68/220.87  |- skos__altLabel mesh__D019991 Data Base
% 220.68/220.87  |- skos__altLabel mesh__D019991 Database %28%PT%29%
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D019991 2006
% 220.68/220.87  |- mesh__recordAuthorizer mesh__D019991 sjn
% 220.68/220.87  |- mesh__recordOriginator mesh__D019991 JLS
% 220.68/220.87  |- mesh__recordMaintainer mesh__D019991 jls
% 220.68/220.87  |- skos__scopeNote mesh__D019991
% 220.68/220.87       Work consisting of a structured file of information or a set of logically related data stored and retrieved using computer-based means.%A%    
% 220.68/220.87  |- mesh__dateCreated mesh__D019991 1997-07-15
% 220.68/220.87  |- rdf__type mesh__D019991sskos__Concept
% 220.68/220.87  |- skos__prefLabel mesh__D019991 Database %5B%Publication Type%5D%
% 220.68/220.87  |- mesh__historyNote mesh__D019991 1998   
% 220.68/220.87  |- mesh__dateRevised mesh__D019991 2005-06-30
% 220.68/220.87  |- mesh__dateEstablished mesh__D019991 1998-01-01
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D000488 1997
% 220.68/220.87  |- skos__hiddenLabel mesh__D000488 Paramedic
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D000488 2002
% 220.68/220.87  |- skos__hiddenLabel mesh__D000488 Specialists, Population Program
% 220.68/220.87  |- skos__hiddenLabel mesh__D000488 Specialist, Population Program
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D000488 2006
% 220.68/220.87  |- skos__hiddenLabel mesh__D000488 Health Personnel, Allied
% 220.68/220.87  |- skos__hiddenLabel mesh__D000488 Personnel, Paramedical
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D000488 1998
% 220.68/220.87  |- mesh__historyNote mesh__D000488 71   
% 220.68/220.87  |- skos__prefLabel mesh__D000488 Allied Health Personnel
% 220.68/220.87  |- mesh__recordAuthorizer mesh__D000488 PLS
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D000488 1993
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D000488 1999
% 220.68/220.87  |- mesh__recordOriginator mesh__D000488 NLM
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D000488 2003
% 220.68/220.87  |- skos__hiddenLabel mesh__D000488 Program Specialists, Population
% 220.68/220.87  |- skos__hiddenLabel mesh__D000488 Personnel, Allied Health
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D000488 1994
% 220.68/220.87  |- mesh__dateCreated mesh__D000488 1999-01-01
% 220.68/220.87  |- skos__altLabel mesh__D000488 Paramedical Personnel
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D000488 2000
% 220.68/220.87  |- skos__historyNote mesh__D000488 Health Manpower %28%1968-1970%29%
% 220.68/220.87  |- skos__broader mesh__D000488smesh__D006282
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D000488 2004
% 220.68/220.87  |- mesh__recordMaintainer mesh__D000488 PLS
% 220.68/220.87  |- skos__historyNote mesh__D000488 Health Occupations %28%1966-1970%29%
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D000488 1995
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D000488 1996
% 220.68/220.87  |- mesh__publicMeSHNote mesh__D000488 71   
% 220.68/220.87  |- skos__hiddenLabel mesh__D000488 Program Specialist, Population
% 220.68/220.87  |- mesh__dateEstablished mesh__D000488 1971-01-01
% 220.68/220.87  |- skos__hiddenLabel mesh__D000488 Population Program Specialist
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D000488 2001
% 220.68/220.87  |- rdf__type mesh__D000488sskos__Concept
% 220.68/220.87  |- skos__scopeNote mesh__D000488
% 220.68/220.87       Health care workers specially trained and licensed to assist and support the work of health professionals. Often used synonymously with paramedical personnel, the term generally refers to all health care workers who perform tasks which must otherwise be performed by a physician or other health professional.%A%    
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D000488 2005
% 220.68/220.87  |- mesh__dateRevised mesh__D000488 1994-10-19
% 220.68/220.87  |- mesh__publicMeSHNote mesh__D019193 97   
% 220.68/220.87  |- mesh__recordOriginator mesh__D019193 AGS
% 220.68/220.87  |- skos__scopeNote mesh__D019193
% 220.68/220.87       A genus of plant viruses in the family SEQUIVIRIDAE. Transmission is by leafhoppers or APHIDS and depends on a self-encoded helper protein. The type species is Rice tungro spherical virus.%A%    
% 220.68/220.87  |- mesh__dateEstablished mesh__D019193 1997-01-01
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D019193 2005
% 220.68/220.87  |- rdf__type mesh__D019193sskos__Concept
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D019193 2006
% 220.68/220.87  |- mesh__recordMaintainer mesh__D019193 ags
% 220.68/220.87  |- mesh__dateRevised mesh__D019193 2001-07-25
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D019193 2003
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D019193 2004
% 220.68/220.87  |- mesh__recordAuthorizer mesh__D019193 sjn
% 220.68/220.87  |- mesh__historyNote mesh__D019193 97   
% 220.68/220.87  |- skos__prefLabel mesh__D019193 Waikavirus
% 220.68/220.87  |- skos__annotation mesh__D019193
% 220.68/220.87       coord IM with specific plant %28%often RICE%29% /virol   
% 220.68/220.87  |- skos__broader mesh__D019193smesh__D019191
% 220.68/220.87  |- mesh__dateCreated mesh__D019193 1996-06-10
% 220.68/220.87  |- skos__hiddenLabel mesh__D019193 Waikaviruses
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D019193 2002
% 220.68/220.87  |- mesh__historyNote mesh__D005971
% 220.68/220.87       POTASSIUM GLUTAMATE was SY to GLUTAMIC ACID %28%NM%29% 1983-94; ALUMINUM L-GLUTAMATE was SY to GLUTAMIC ACID %28%NM%29% 1994%A%  
% 220.68/220.87  |- mesh__recordOriginator mesh__D005971 NLM
% 220.68/220.87  |- mesh__recordMaintainer mesh__D005971 nns
% 220.68/220.87  |- skos__related mesh__D005971smesh__D018690
% 220.68/220.87  |- skos__scopeNote mesh__D005971 Salts and esters of glutamic acid.     
% 220.68/220.87  |- skos__annotation mesh__D005971
% 220.68/220.87       %22%salts %26% esters of glutamic acid%22%, an amino acid; /agon = EXCITATORY AMINO ACID AGONISTS%A%  
% 220.68/220.87  |- mesh__dateCreated mesh__D005971 1999-01-01
% 220.68/220.87  |- skos__broader mesh__D005971smesh__D018698
% 220.68/220.87  |- skos__hiddenLabel mesh__D005971 Glutamate, Potassium
% 220.68/220.87  |- rdf__type mesh__D005971sskos__Concept
% 220.68/220.87  |- skos__related mesh__D005971smesh__D017470
% 220.68/220.87  |- skos__hiddenLabel mesh__D005971 Aluminum L Glutamate
% 220.68/220.87  |- mesh__onlineNote mesh__D005971
% 220.68/220.87       use GLUTAMIC ACID %28%NM%29% to search POTASSIUM GLUTAMATE 1983-94 %26% ALUMINUM L-GLUTAMATE 1994%A%  
% 220.68/220.87  |- mesh__publicMeSHNote mesh__D005971
% 220.68/220.87       POTASSIUM GLUTAMATE was indexed under GLUTAMATES 1983-94; ALUMINUM L-GLUTAMATE was indexed under GLUTAMATES 1994%A%  
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D005971 2003
% 220.68/220.87  |- skos__hiddenLabel mesh__D005971 Acids, Glutaminic
% 220.68/220.87  |- mesh__recordAuthorizer mesh__D005971 sjn
% 220.68/220.87  |- skos__related mesh__D005971smesh__D011099
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D005971 2005
% 220.68/220.87  |- skos__prefLabel mesh__D005971 Glutamates
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D005971 2004
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D005971 2002
% 220.68/220.87  |- mesh__dateRevised mesh__D005971 2001-07-25
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D005971 2006
% 220.68/220.87  |- skos__hiddenLabel mesh__D005971 L-Glutamate, Aluminum
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D005173 2002
% 220.68/220.87  |- mesh__dateRevised mesh__D005173 2001-07-25
% 220.68/220.87  |- skos__prefLabel mesh__D005173 Factor XI Deficiency
% 220.68/220.87  |- skos__altLabel mesh__D005173 Deficiency, PTA
% 220.68/220.87  |- skos__broader mesh__D005173smesh__D025861
% 220.68/220.87  |- skos__scopeNote mesh__D005173
% 220.68/220.87       A deficiency of blood coagulation factor XI %28%known as plasma thromboplastin antecedent or PTA or antihemophilic factor C%29% resulting in a systemic blood-clotting defect called hemophilia C or Rosenthal%27%s syndrome, that may resemble classical hemophilia. %28%Dorland, 27th ed%29%%A%    
% 220.68/220.87  |- mesh__recordMaintainer mesh__D005173 nns
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D005173 2006
% 220.68/220.87  |- mesh__dateCreated mesh__D005173 1999-01-01
% 220.68/220.87  |- skos__broader mesh__D005173smesh__D006474
% 220.68/220.87  |- skos__altLabel mesh__D005173 Hemophilia C
% 220.68/220.87  |- mesh__publicMeSHNote mesh__D005173 73   
% 220.68/220.87  |- skos__hiddenLabel mesh__D005173 Syndrome, Rosenthal%27%s
% 220.68/220.87  |- skos__hiddenLabel mesh__D005173 Deficiencies, PTA
% 220.68/220.87  |- skos__hiddenLabel mesh__D005173 Factor XI Deficiencies
% 220.68/220.87  |- skos__altLabel mesh__D005173 PTA Deficiency
% 220.68/220.87  |- mesh__activeMeSHYear mesh__D005173 2003
% 220.68/220.87  |- skos__hiddenLabel mesh__D005173 Syndrome, Rosenthal
% 220.68/220.88  |- skos__altLabel mesh__D005173 Rosenthal%27%s Syndrome
% 220.68/220.88  |- rdf__type mesh__D005173sskos__Concept
% 220.68/220.88  |- skos__hiddenLabel mesh__D005173 Rosenthal Syndromes
% 220.68/220.88  |- mesh__dateEstablished mesh__D005173 1973-01-01
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D005173 2004
% 220.68/220.88  |- skos__hiddenLabel mesh__D005173 Rosenthal%27%s Syndromes
% 220.68/220.88  |- skos__broader mesh__D005173smesh__D020147
% 220.68/220.88  |- skos__hiddenLabel mesh__D005173 PTA Deficiencies
% 220.68/220.88  |- skos__altLabel mesh__D005173 Deficiency, Factor XI
% 220.68/220.88  |- mesh__recordOriginator mesh__D005173 NLM
% 220.68/220.88  |- mesh__historyNote mesh__D005173 73%28%66%29%   
% 220.68/220.88  |- skos__annotation mesh__D005173
% 220.68/220.88       a blood coag disord; DF: FACTOR XI DEFIC   
% 220.68/220.88  |- skos__altLabel mesh__D005173 Rosenthal Syndrome
% 220.68/220.88  |- skos__hiddenLabel mesh__D005173 Rosenthals Syndrome
% 220.68/220.88  |- skos__hiddenLabel mesh__D005173 Deficiencies, Factor XI
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D005173 2005
% 220.68/220.88  |- mesh__recordAuthorizer mesh__D005173 sjn
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D013605 2006
% 220.68/220.88  |- rdf__type mesh__D013605sskos__Concept
% 220.68/220.88  |- mesh__dateCreated mesh__D013605 1976-04-16
% 220.68/220.88  |- skos__historyNote mesh__D013605 Ethers %28%1975%29%
% 220.68/220.88  |- mesh__recordMaintainer mesh__D013605 ssb
% 220.68/220.88  |- skos__altLabel mesh__D013605 Fusaritoxin
% 220.68/220.88  |- skos__hiddenLabel mesh__D013605 Toxin, T2
% 220.68/220.88  |- mesh__historyNote mesh__D013605
% 220.68/220.88       91%28%77%29%; was see under SESQUITERPENES 1977-90   
% 220.68/220.88  |- skos__historyNote mesh__D013605 Trichothecenes %28%1975-1976%29%
% 220.68/220.88  |- mesh__dateRevised mesh__D013605 2005-06-30
% 220.68/220.88  |- skos__historyNote mesh__D013605 Sesquiterpenes %28%1974%29%
% 220.68/220.88  |- skos__scopeNote mesh__D013605
% 220.68/220.88       A potent mycotoxin produced in feedstuffs by several species of the genus FUSARIUM. It elicits a severe inflammatory reaction in animals and has teratogenic effects.%A%    
% 220.68/220.88  |- skos__hiddenLabel mesh__D013605 Toxin, T-2
% 220.68/220.88  |- skos__altLabel mesh__D013605 Fusariotoxin
% 220.68/220.88  |- skos__prefLabel mesh__D013605 T-2 Toxin
% 220.68/220.88  |- mesh__publicMeSHNote mesh__D013605
% 220.68/220.88       91; was see under SESQUITERPENES 1977-90   
% 220.68/220.88  |- skos__broader mesh__D013605smesh__D014255
% 220.68/220.88  |- skos__altLabel mesh__D013605 T2 Toxin
% 220.68/220.88  |- mesh__recordOriginator mesh__D013605 RLS
% 220.68/220.88  |- mesh__dateEstablished mesh__D013605 1991-01-01
% 220.68/220.88  |- mesh__recordAuthorizer mesh__D013605 sjn
% 220.68/220.88  |- skos__hiddenLabel mesh__D013605 T 2 Toxin
% 220.68/220.88  |- mesh__dateEstablished mesh__D018899 1996-01-01
% 220.68/220.88  |- skos__scopeNote mesh__D018899
% 220.68/220.88       Areas of increased density of the dinucleotide sequence cytosine--phosphate diester--guanine. They form stretches of DNA several hundred to several thousand base pairs long. In humans there are about 45,000 CpG islands, mostly found at the 5%27% ends of genes. They are unmethylated except for those on the inactive X chromosome and some associated with imprinted genes.%A%    
% 220.68/220.88  |- rdf__type mesh__D018899sskos__Concept
% 220.68/220.88  |- skos__hiddenLabel mesh__D018899 Clusters, CpG
% 220.68/220.88  |- skos__hiddenLabel mesh__D018899 CpG Cluster
% 220.68/220.88  |- skos__historyNote mesh__D018899
% 220.68/220.88       Dinucleoside Phosphates %28%1989-1995%29%
% 220.68/220.88  |- skos__prefLabel mesh__D018899 CpG Islands
% 220.68/220.88  |- mesh__recordOriginator mesh__D018899 AGS
% 220.68/220.88  |- skos__hiddenLabel mesh__D018899 Islands, CpG-Rich
% 220.68/220.88  |- skos__hiddenLabel mesh__D018899 Island, CpG-Rich
% 220.68/220.88  |- skos__historyNote mesh__D018899 Base Sequence %28%1989-1995%29%
% 220.68/220.88  |- mesh__publicMeSHNote mesh__D018899 96   
% 220.68/220.88  |- mesh__historyNote mesh__D018899 96   
% 220.68/220.88  |- skos__broader mesh__D018899smesh__D020862
% 220.68/220.88  |- skos__broader mesh__D018899smesh__D040481
% 220.68/220.88  |- mesh__recordAuthorizer mesh__D018899 sjn
% 220.68/220.88  |- skos__hiddenLabel mesh__D018899 CpG Rich Islands
% 220.68/220.88  |- skos__hiddenLabel mesh__D018899 Island, CpG
% 220.68/220.88  |- mesh__dateCreated mesh__D018899 1994-12-27
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D018899 2006
% 220.68/220.88  |- mesh__recordMaintainer mesh__D018899 nns
% 220.68/220.88  |- mesh__dateRevised mesh__D018899 2005-06-30
% 220.68/220.88  |- skos__hiddenLabel mesh__D018899 CpG Island
% 220.68/220.88  |- skos__hiddenLabel mesh__D018899 CpG-Rich Island
% 220.68/220.88  |- skos__hiddenLabel mesh__D018899 Islands, CpG
% 220.68/220.88  |- skos__hiddenLabel mesh__D018899 Cluster, CpG
% 220.68/220.88  |- skos__altLabel mesh__D018899 CpG-Rich Islands
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D004879 2002
% 220.68/220.88  |- mesh__publicMeSHNote mesh__D004879
% 220.68/220.88       2001; see ERGOTAMINE DERIVATIVES 1978-2001, see ERGOTAMINE 1975-1977, see ERGOLINES 1969-1974%A%  
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D004879 2004
% 220.68/220.88  |- skos__broader mesh__D004879smesh__D006576
% 220.68/220.88  |- mesh__dateEstablished mesh__D004879 1978-01-01
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D004879 2005
% 220.68/220.88  |- skos__prefLabel mesh__D004879 Ergotamines
% 220.68/220.88  |- mesh__recordAuthorizer mesh__D004879 sjn
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D004879 2006
% 220.68/220.88  |- mesh__historyNote mesh__D004879 2001%28%1969%29%   
% 220.68/220.88  |- skos__historyNote mesh__D004879 Ergotamine %28%1966-1974%29%
% 220.68/220.88  |- skos__historyNote mesh__D004879 Ergolines %28%1969-1974%29%
% 220.68/220.88  |- rdf__type mesh__D004879sskos__Concept
% 220.68/220.88  |- mesh__dateRevised mesh__D004879 2001-07-25
% 220.68/220.88  |- skos__scopeNote mesh__D004879
% 220.68/220.88       A series of structurally-related alkaloids containing the ergotaman backbone structure.%A%    
% 220.68/220.88  |- mesh__recordMaintainer mesh__D004879 jmp
% 220.68/220.88  |- skos__broader mesh__D004879smesh__D004876
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D004879 2003
% 220.68/220.88  |- mesh__dateCreated mesh__D004879 1999-01-01
% 220.68/220.88  |- mesh__recordOriginator mesh__D004879 NLM
% 220.68/220.88  |- skos__historyNote mesh__D009564 Acridines %28%1971-1974%29%
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D009564 2005
% 220.68/220.88  |- mesh__dateEstablished mesh__D009564 1991-01-01
% 220.68/220.88  |- skos__prefLabel mesh__D009564 Nitracrine
% 220.68/220.88  |- mesh__historyNote mesh__D009564
% 220.68/220.88       91%28%85%29%; was see under AMINOACRIDINES 1985-90; was C 283 see under AMINOACRIDINES 1981-84; was C 283 see under ACRIDINES 1975-80%A%  
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D009564 2006
% 220.68/220.88  |- skos__broader mesh__D009564smesh__D000609
% 220.68/220.88  |- skos__historyNote mesh__D009564 Nitro Compounds %28%1972-1974%29%
% 220.68/220.88  |- skos__scopeNote mesh__D009564
% 220.68/220.88       Acridine antineoplastic agent used in mammary and ovarian tumors. It inhibits RNA synthesis.%A%    
% 220.68/220.88  |- skos__historyNote mesh__D009564 Dimethylamines %28%1973-1974%29%
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D009564 2002
% 220.68/220.88  |- mesh__recordOriginator mesh__D009564 NLM
% 220.68/220.88  |- mesh__recordAuthorizer mesh__D009564 sjn
% 220.68/220.88  |- mesh__recordMaintainer mesh__D009564 ssb
% 220.68/220.88  |- mesh__dateCreated mesh__D009564 1974-11-19
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D009564 2003
% 220.68/220.88  |- mesh__onlineNote mesh__D009564 use NITRACRINE to search C 283 1975-84   
% 220.68/220.88  |- mesh__dateRevised mesh__D009564 2001-07-25
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D009564 2004
% 220.68/220.88  |- skos__hiddenLabel mesh__D009564 C283
% 220.68/220.88  |- mesh__publicMeSHNote mesh__D009564
% 220.68/220.88       91; was see under AMINOACRIDINES 1985-90; was C 283 see under AMINOACRIDINES 1981-84; was C 283 see under ACRIDINES 1975-80%A%  
% 220.68/220.88  |- skos__hiddenLabel mesh__D009564 C 283
% 220.68/220.88  |- rdf__type mesh__D009564sskos__Concept
% 220.68/220.88  |- mesh__dateCreated mesh__D001581 1999-01-01
% 220.68/220.88  |- skos__prefLabel mesh__D001581 Benzothiadiazines
% 220.68/220.88  |- skos__broader mesh__D001581smesh__D006574
% 220.68/220.88  |- skos__broader mesh__D001581smesh__D013449
% 220.68/220.88  |- rdf__type mesh__D001581sskos__Concept
% 220.68/220.88  |- mesh__dateRevised mesh__D001581 2005-06-30
% 220.68/220.88  |- mesh__recordOriginator mesh__D001581 NLM
% 220.68/220.88  |- mesh__recordMaintainer mesh__D001581 ssb
% 220.68/220.88  |- skos__broader mesh__D001581smesh__D049971
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D001581 2006
% 220.68/220.88  |- mesh__recordAuthorizer mesh__D001581 sjn
% 220.68/220.88  |- skos__scopeNote mesh__D001581
% 220.68/220.88       Heterocyclic compounds of a ring with SULFUR and two NITROGEN atoms fused to a BENZENE ring. Members inhibit SODIUM-POTASSIUM-CHLORIDE SYMPORTERS and are used as DIURETICS.%A%    
% 220.68/220.88  |- skos__altLabel mesh__D019992 Data Bases
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019992 2006
% 220.68/220.88  |- skos__scopeNote mesh__D019992
% 220.68/220.88       Organized collections of computer records, standardized in format and content, that are stored in any of a variety of computer-readable modes. They are the basic sets of data from which computer-readable files are created. %28%from ALA Glossary of Library and Information Science, 1983%29%%A%    
% 220.68/220.88  |- mesh__dateEstablished mesh__D019992 1998-01-01
% 220.68/220.88  |- mesh__dateCreated mesh__D019992 1997-06-26
% 220.68/220.88  |- mesh__recordOriginator mesh__D019992 JLS
% 220.68/220.88  |- mesh__publicMeSHNote mesh__D019992
% 220.68/220.88       1998; DATABASES was see INFORMATION SYSTEMS 1994-1996; for DATABANKS see DATABASES, FACTUAL 1991-2001; DATA BANKS was see INFORMATION SYSTEMS 1982-90%A%  
% 220.68/220.88  |- rdf__type mesh__D019992sskos__Concept
% 220.68/220.88  |- mesh__dateRevised mesh__D019992 2004-07-07
% 220.68/220.88  |- skos__hiddenLabel mesh__D019992 Data Bank
% 220.68/220.88  |- skos__altLabel mesh__D019992 Databanks
% 220.68/220.88  |- skos__prefLabel mesh__D019992 Databases
% 220.68/220.88  |- skos__broader mesh__D019992smesh__D016247
% 220.68/220.88  |- mesh__recordMaintainer mesh__D019992 jls
% 220.68/220.88  |- mesh__historyNote mesh__D019992
% 220.68/220.88       1998; DATABASES was see INFORMATION SYSTEMS 1994-1996; for DATABANKS use DATABASES, FACTUAL 1991-2001; DATA BANKS was see INFORMATION SYSTEMS 1982-90%A%  
% 220.68/220.88  |- mesh__recordAuthorizer mesh__D019992 sjn
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019992 2005
% 220.68/220.88  |- skos__altLabel mesh__D019992 Data Banks
% 220.68/220.88  |- skos__historyNote mesh__D019992 Information Systems %28%1966-1997%29%
% 220.68/220.88  |- skos__broader mesh__D019992smesh__D007256
% 220.68/220.88  |- skos__hiddenLabel mesh__D019992 Databank
% 220.68/220.88  |- skos__annotation mesh__D000489 IM; qualif permitted; DF: ALLIGATORS   
% 220.68/220.88  |- skos__prefLabel mesh__D000489 Alligators and Crocodiles
% 220.68/220.88  |- skos__broader mesh__D000489smesh__D012104
% 220.68/220.88  |- mesh__dateEstablished mesh__D000489 1991-01-01
% 220.68/220.88  |- skos__hiddenLabel mesh__D000489 Cayman
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D000489 2004
% 220.68/220.88  |- skos__hiddenLabel mesh__D000489 Alligator
% 220.68/220.88  |- mesh__publicMeSHNote mesh__D000489 91; was see under REPTILES 1975-90   
% 220.68/220.88  |- rdf__type mesh__D000489sskos__Concept
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D000489 2005
% 220.68/220.88  |- skos__hiddenLabel mesh__D000489 Crocodile
% 220.68/220.88  |- mesh__historyNote mesh__D000489
% 220.68/220.88       91%28%75%29%; was see under REPTILES 1975-90   
% 220.68/220.88  |- skos__hiddenLabel mesh__D000489 Crocodiles and Alligators
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D000489 2006
% 220.68/220.88  |- mesh__recordOriginator mesh__D000489 NLM
% 220.68/220.88  |- skos__altLabel mesh__D000489 Caymans
% 220.68/220.88  |- mesh__dateRevised mesh__D000489 2003-07-09
% 220.68/220.88  |- skos__hiddenLabel mesh__D000489 Caiman
% 220.68/220.88  |- skos__scopeNote mesh__D000489
% 220.68/220.88       Large, long-tailed reptiles, including caimans, of the order Loricata.%A%    
% 220.68/220.88  |- mesh__dateCreated mesh__D000489 1974-12-12
% 220.68/220.88  |- mesh__recordAuthorizer mesh__D000489 sjn
% 220.68/220.88  |- mesh__recordMaintainer mesh__D000489 ags
% 220.68/220.88  |- skos__hiddenLabel mesh__D019194 Preconditioning, Ischemic
% 220.68/220.88  |- mesh__historyNote mesh__D019194 97   
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019194 2003
% 220.68/220.88  |- mesh__dateCreated mesh__D019194 1996-02-12
% 220.68/220.88  |- rdf__type mesh__D019194sskos__Concept
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019194 2006
% 220.68/220.88  |- skos__hiddenLabel mesh__D019194 Ischemic Preconditionings
% 220.68/220.88  |- skos__hiddenLabel mesh__D019194 Preconditionings, Ischemic
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019194 2005
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019194 1997
% 220.68/220.88  |- skos__prefLabel mesh__D019194 Ischemic Preconditioning
% 220.68/220.88  |- skos__scopeNote mesh__D019194
% 220.68/220.88       A technique in which tissue is rendered resistant to the deleterious effects of prolonged ischemia and reperfusion by prior exposure to brief, repeated periods of vascular occlusion. %28%Am J Physiol 1995 May;268%28%5 Pt 2%29%:H2063-7, Abstract%29%%A%    
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019194 2002
% 220.68/220.88  |- skos__annotation mesh__D019194
% 220.68/220.88       IM; coord with tissue /blood supply %28%IM%29%; ISCHEMIC PRECONDITIONING, MYOCARDIAL is also available%A%  
% 220.68/220.88  |- skos__broader mesh__D019194smesh__D008919
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019194 1999
% 220.68/220.88  |- mesh__dateEstablished mesh__D019194 1997-01-01
% 220.68/220.88  |- mesh__publicMeSHNote mesh__D019194 97   
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019194 2001
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019194 1998
% 220.68/220.88  |- skos__broader mesh__D019194smesh__D013812
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019194 2000
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019194 2004
% 220.68/220.88  |- skos__broader mesh__D005972smesh__D000581
% 220.68/220.88  |- mesh__dateCreated mesh__D005972 1999-01-01
% 220.68/220.88  |- rdf__type mesh__D005972sskos__Concept
% 220.68/220.88  |- mesh__dateRevised mesh__D005972 2003-07-09
% 220.68/220.88  |- mesh__recordOriginator mesh__D005972 NLM
% 220.68/220.88  |- mesh__recordMaintainer mesh__D005972 ssb
% 220.68/220.88  |- skos__hiddenLabel mesh__D005972 Glutaminase, Phosphate-Activated
% 220.68/220.88  |- skos__prefLabel mesh__D005972 Glutaminase
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D005972 2005
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D005972 2004
% 220.68/220.88  |- skos__hiddenLabel mesh__D005972 Phosphate Activated Glutaminase
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D005972 2006
% 220.68/220.88  |- mesh__recordAuthorizer mesh__D005972 sjn
% 220.68/220.88  |- mesh__recordOriginator mesh__D005174 NLM
% 220.68/220.88  |- skos__altLabel mesh__D005174 Coagulation Factor XII
% 220.68/220.88  |- skos__annotation mesh__D005174 a blood coag factor   
% 220.68/220.88  |- mesh__publicMeSHNote mesh__D005174 66   
% 220.68/220.88  |- mesh__recordAuthorizer mesh__D005174 sjn
% 220.68/220.88  |- mesh__dateRevised mesh__D005174 2005-06-30
% 220.68/220.88  |- mesh__historyNote mesh__D005174 66%28%64%29%   
% 220.68/220.88  |- skos__scopeNote mesh__D005174
% 220.68/220.88       Stable blood coagulation factor activated by contact with the subendothelial surface of an injured vessel. Along with prekallikrein, it serves as the contact factor that initiates the intrinsic pathway of blood coagulation. Kallikrein activates factor XII to XIIa. Deficiency of factor XII, also called the Hageman trait, leads to increased incidence of thromboembolic disease.%A%    
% 220.68/220.88  |- skos__hiddenLabel mesh__D005174 Factor XII, Coagulation
% 220.68/220.88  |- rdf__type mesh__D005174sskos__Concept
% 220.68/220.88  |- skos__hiddenLabel mesh__D005174 XII, Coagulation Factor
% 220.68/220.88  |- mesh__recordMaintainer mesh__D005174 ssb
% 220.68/220.88  |- skos__broader mesh__D005174smesh__D001779
% 220.68/220.88  |- skos__related mesh__D005174smesh__D003029
% 220.68/220.88  |- skos__altLabel mesh__D005174 Hageman Factor
% 220.68/220.88  |- skos__prefLabel mesh__D005174 Factor XII
% 220.68/220.88  |- skos__hiddenLabel mesh__D005174 Coagulation FactorXI, Blood
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D005174 2006
% 220.68/220.88  |- mesh__dateCreated mesh__D005174 1999-01-01
% 220.68/220.88  |- skos__altLabel mesh__D005174 Blood Coagulation FactorXI
% 220.68/220.88  |- skos__hiddenLabel mesh__D005174 FactorXI, Blood Coagulation
% 220.68/220.88  |- mesh__dateEstablished mesh__D005174 1966-01-01
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D013606 2000
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D013606 2005
% 220.68/220.88  |- skos__hiddenLabel mesh__D013606 Ataxia, Locomotor
% 220.68/220.88  |- skos__altLabel mesh__D013606 Syphilis, Spinal Cord
% 220.68/220.88  |- mesh__recordOriginator mesh__D013606 NLM
% 220.68/220.88  |- skos__altLabel mesh__D013606 Spinal Cord Syphilis
% 220.68/220.88  |- mesh__dateCreated mesh__D013606 1999-01-01
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D013606 2003
% 220.68/220.88  |- mesh__recordAuthorizer mesh__D013606 ags
% 220.68/220.88  |- skos__altLabel mesh__D013606 Myelosyphilis
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D013606 2002
% 220.68/220.88  |- skos__hiddenLabel mesh__D013606 Spinalis, Tabes
% 220.68/220.88  |- skos__hiddenLabel mesh__D013606 Meningomyelitides, Syphilitic
% 220.68/220.88  |- skos__hiddenLabel mesh__D013606 Syphilis, Spinal Meningovascular
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D013606 2006A
% 220.68/220.88  |- mesh__recordMaintainer mesh__D013606 ags
% 220.68/220.88  |- skos__hiddenLabel mesh__D013606 Meningomyelitis, Syphilitic
% 220.68/220.88  |- mesh__dateRevised mesh__D013606 2005-08-03
% 220.68/220.88  |- skos__scopeNote mesh__D013606
% 220.68/220.88       Parenchymatous NEUROSYPHILIS marked by slowly progressive degeneration of the posterior columns, posterior roots, and ganglia of the spinal cord. The condition tends to present 15 to 20 years after the initial infection and is characterized by lightening-like pains in the lower extremities, URINARY INCONTINENCE; ATAXIA; severely impaired position and vibratory sense, abnormal gait %28%see GAIT DISORDERS, NEUROLOGIC%29%, OPTIC ATROPHY; Argyll-Robertson pupils, hypotonia, hyperreflexia, and trophic joint degeneration %28%Charcot%27%s Joint; see ARTHROPATHY, NEUROGENIC%29%. %28%From Adams et al., Principles of Neurology, 6th ed, p726%29%%A%    
% 220.68/220.88  |- skos__hiddenLabel mesh__D013606 Ataxias, Locomotor
% 220.68/220.88  |- skos__altLabel mesh__D013606 Tabetic Neurosyphilis
% 220.68/220.88  |- skos__hiddenLabel mesh__D013606 Syphilitic Meningomyelitides
% 220.68/220.88  |- skos__altLabel mesh__D013606 Syphilitic Meningomyelitis
% 220.68/220.88  |- skos__hiddenLabel mesh__D013606 Meningovascular Syphilis, Spinal
% 220.68/220.88  |- skos__broader mesh__D013606smesh__D009494
% 220.68/220.88  |- skos__hiddenLabel mesh__D013606 Locomotor Ataxias
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D013606 2006
% 220.68/220.88  |- rdf__type mesh__D013606sskos__Concept
% 220.68/220.88  |- skos__broader mesh__D013606smesh__D013118
% 220.68/220.88  |- skos__hiddenLabel mesh__D013606 Neurosyphilis, Tabetic
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D013606 2001
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D013606 2004
% 220.68/220.88  |- skos__prefLabel mesh__D013606 Tabes Dorsalis
% 220.68/220.88  |- skos__altLabel mesh__D013606 Tabes Spinalis
% 220.68/220.88  |- mesh__dateCreated mesh__D009565 1999-01-01
% 220.68/220.88  |- skos__historyNote mesh__D009565 Oxidoreductases %28%1966-1972%29%
% 220.68/220.88  |- skos__prefLabel mesh__D009565 Nitrate Reductases
% 220.68/220.88  |- skos__broader mesh__D009565smesh__D009601
% 220.68/220.88  |- mesh__recordMaintainer mesh__D009565 AKE
% 220.68/220.88  |- mesh__dateRevised mesh__D009565 2005-06-30
% 220.68/220.88  |- mesh__dateEstablished mesh__D009565 1974-01-01
% 220.68/220.88  |- skos__scopeNote mesh__D009565
% 220.68/220.88       Oxidoreductases that are specific for the reduction of NITRATES.%A%    
% 220.68/220.88  |- rdf__type mesh__D009565sskos__Concept
% 220.68/220.88  |- mesh__historyNote mesh__D009565 74%28%73%29%   
% 220.68/220.88  |- skos__annotation mesh__D009565
% 220.68/220.88       general; prefer specifics; do not confuse with NITRITE REDUCTASES%A%  
% 220.68/220.88  |- skos__hiddenLabel mesh__D009565 Reductases, Nitrate
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D009565 2006
% 220.68/220.88  |- mesh__recordOriginator mesh__D009565 NLM
% 220.68/220.88  |- mesh__recordAuthorizer mesh__D009565 sjn
% 220.68/220.88  |- mesh__publicMeSHNote mesh__D009565 74   
% 220.68/220.88  |- skos__broader mesh__D001582smesh__D006574
% 220.68/220.88  |- mesh__historyNote mesh__D001582 68   
% 220.68/220.88  |- rdf__type mesh__D001582sskos__Concept
% 220.68/220.88  |- mesh__dateEstablished mesh__D001582 1968-01-01
% 220.68/220.88  |- mesh__recordAuthorizer mesh__D001582 sjn
% 220.68/220.88  |- mesh__dateRevised mesh__D001582 2005-06-30
% 220.68/220.88  |- mesh__publicMeSHNote mesh__D001582 68   
% 220.68/220.88  |- skos__prefLabel mesh__D001582 Benzothiepins
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D001582 2006
% 220.68/220.88  |- mesh__recordOriginator mesh__D001582 NLM
% 220.68/220.88  |- skos__broader mesh__D001582smesh__D013457
% 220.68/220.88  |- mesh__dateCreated mesh__D001582 1999-01-01
% 220.68/220.88  |- mesh__recordMaintainer mesh__D001582 ssb
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019195 2005
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019195 1997
% 220.68/220.88  |- skos__prefLabel mesh__D019195 Badnavirus
% 220.68/220.88  |- skos__broader mesh__D019195smesh__D010942
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019195 1999
% 220.68/220.88  |- mesh__dateCreated mesh__D019195 1996-06-10
% 220.68/220.88  |- skos__annotation mesh__D019195
% 220.68/220.88       a genus of plant viruses; from BAcilliform DNA virus; coord IM with specific plant /virol %28%IM or NIM%29%%A%  
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019195 1998
% 220.68/220.88  |- skos__scopeNote mesh__D019195
% 220.68/220.88       A genus of DNA plant viruses with bacilliform morphology. Transmission in clonally-propagated plants is by vegetative propagation of infected plant materials. Transmission in nature is by mealybugs, seeds, pollen, and leafhoppers %28%rice tungro bacilliform%29%. The type species is Commelina yellow mottle virus.%A%    
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019195 2002
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019195 2004
% 220.68/220.88  |- mesh__dateEstablished mesh__D019195 1997-01-01
% 220.68/220.88  |- mesh__publicMeSHNote mesh__D019195 97   
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019195 2001
% 220.68/220.88  |- skos__hiddenLabel mesh__D019195 Badnaviruses
% 220.68/220.88  |- skos__broader mesh__D019195smesh__D004267
% 220.68/220.88  |- mesh__historyNote mesh__D019195 97   
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019195 2003
% 220.68/220.88  |- rdf__type mesh__D019195sskos__Concept
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019195 2006
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D019195 2000
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D005973 2003
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D005973 2005
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D005973 2004
% 220.68/220.88  |- mesh__recordAuthorizer mesh__D005973 sjn
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D005973 2006
% 220.68/220.88  |- skos__hiddenLabel mesh__D005973 L Glutamine
% 220.68/220.88  |- skos__prefLabel mesh__D005973 Glutamine
% 220.68/220.88  |- skos__scopeNote mesh__D005973
% 220.68/220.88       A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from GLUTAMIC ACID and AMMONIA. It is the principal carrier of NITROGEN in the body and is an important energy source for many cells.%A%    
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D005973 2002
% 220.68/220.88  |- skos__hiddenLabel mesh__D005973 D Glutamine
% 220.68/220.88  |- mesh__dateRevised mesh__D005973 2001-07-25
% 220.68/220.88  |- skos__broader mesh__D005973smesh__D021542
% 220.68/220.88  |- mesh__recordMaintainer mesh__D005973 nns
% 220.68/220.88  |- mesh__dateCreated mesh__D005973 1999-01-01
% 220.68/220.88  |- rdf__type mesh__D005973sskos__Concept
% 220.68/220.88  |- skos__broader mesh__D005973smesh__D024361
% 220.68/220.88  |- mesh__recordOriginator mesh__D005973 NLM
% 220.68/220.88  |- skos__altLabel mesh__D005973 L-Glutamine
% 220.68/220.88  |- skos__annotation mesh__D005973 /biosyn /physiol permitted   
% 220.68/220.88  |- skos__broader mesh__D005973smesh__D000599
% 220.68/220.88  |- skos__hiddenLabel mesh__D005175 Trait, Hageman
% 220.68/220.88  |- mesh__recordMaintainer mesh__D005175 nns
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D005175 2002
% 220.68/220.88  |- mesh__publicMeSHNote mesh__D005175 78   
% 220.68/220.88  |- skos__hiddenLabel mesh__D005175 Deficiencies, Factor XII
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D005175 2006
% 220.68/220.88  |- mesh__recordOriginator mesh__D005175 VDK
% 220.68/220.88  |- skos__broader mesh__D005175smesh__D025861
% 220.68/220.88  |- skos__altLabel mesh__D005175 Hageman Trait
% 220.68/220.88  |- skos__annotation mesh__D005175
% 220.68/220.88       a blood coag disord; DF: FACTOR XII DEFIC   
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D005175 2005
% 220.68/220.88  |- mesh__dateEstablished mesh__D005175 1978-01-01
% 220.68/220.88  |- skos__prefLabel mesh__D005175 Factor XII Deficiency
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D005175 2004
% 220.68/220.88  |- skos__scopeNote mesh__D005175
% 220.68/220.88       An absence or reduced level of blood coagulation factor XII. It normally occurs in the absence of patient or family history of hemorrhagic disorders and is marked by prolonged clotting time.%A%    
% 220.68/220.88  |- mesh__recordAuthorizer mesh__D005175 sjn
% 220.68/220.88  |- mesh__dateCreated mesh__D005175 1977-04-27
% 220.68/220.88  |- rdf__type mesh__D005175sskos__Concept
% 220.68/220.88  |- skos__historyNote mesh__D005175 Factor XII %28%1966-1977%29%
% 220.68/220.88  |- skos__hiddenLabel mesh__D005175 Factor XII Deficiencies
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D005175 2003
% 220.68/220.88  |- skos__historyNote mesh__D005175
% 220.68/220.88       Blood Coagulation Disorders %28%1966-1977%29%
% 220.68/220.88  |- skos__broader mesh__D005175smesh__D020147
% 220.68/220.88  |- mesh__dateRevised mesh__D005175 2001-07-25
% 220.68/220.88  |- skos__altLabel mesh__D005175 Deficiency, Factor XII
% 220.68/220.88  |- skos__broader mesh__D005175smesh__D006474
% 220.68/220.88  |- mesh__historyNote mesh__D005175 78   
% 220.68/220.88  |- skos__broader mesh__D013607smesh__D004304
% 220.68/220.88  |- skos__prefLabel mesh__D013607 Tablets
% 220.68/220.88  |- skos__scopeNote mesh__D013607
% 220.68/220.88       Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. %28%Dorland, 28th ed%29%%A%    
% 220.68/220.88  |- mesh__recordOriginator mesh__D013607 NLM
% 220.68/220.88  |- mesh__recordAuthorizer mesh__D013607 sjn
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D013607 2006
% 220.68/220.88  |- rdf__type mesh__D013607sskos__Concept
% 220.68/220.88  |- mesh__dateRevised mesh__D013607 2003-07-09
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D013607 2004
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D013607 2005
% 220.68/220.88  |- skos__annotation mesh__D013607
% 220.68/220.88       IM for general only, qualif permitted; NIM %28%no qualif%29% when drug in tablet form is IM %28%with qualif%29%; /adv eff permitted but be careful: it may be the adv eff of the drug in the tablet, not the %22%tablet%22%%A%  
% 220.68/220.88  |- mesh__recordMaintainer mesh__D013607 ssb
% 220.68/220.88  |- mesh__dateCreated mesh__D013607 1999-01-01
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D009566 2003
% 220.68/220.88  |- mesh__recordOriginator mesh__D009566 NLM
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D009566 1997
% 220.68/220.88  |- mesh__dateRevised mesh__D009566 1993-06-04
% 220.68/220.88  |- mesh__recordAuthorizer mesh__D009566 PLS
% 220.68/220.88  |- skos__broader mesh__D009566smesh__D000838
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D009566 1998
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D009566 2004
% 220.68/220.88  |- skos__scopeNote mesh__D009566
% 220.68/220.88       Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.%A%    
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D009566 1994
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D009566 2005
% 220.68/220.88  |- rdf__type mesh__D009566sskos__Concept
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D009566 1999
% 220.68/220.88  |- skos__broader mesh__D009566smesh__D017942
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D009566 2006
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D009566 1995
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D009566 2000
% 220.68/220.88  |- skos__annotation mesh__D009566
% 220.68/220.88       /physiol permitted for micro-organisms only   
% 220.68/220.88  |- skos__broader mesh__D009566smesh__D009930
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D009566 2001
% 220.68/220.88  |- skos__prefLabel mesh__D009566 Nitrates
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D009566 1996
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D009566 2002
% 220.68/220.88  |- mesh__recordMaintainer mesh__D009566 TPW
% 220.68/220.88  |- mesh__dateCreated mesh__D009566 1999-01-01
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D001583 1997
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D001583 2002
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D001583 2005
% 220.68/220.88  |- skos__annotation mesh__D001583
% 220.68/220.88       includes benzoxazolines, benzoxazolidines   
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D001583 1993
% 220.68/220.88  |- mesh__activeMeSHYear mesh__D001583 1996
% 220.68/220.88  |- mesh__recordOriginator mesh__D001583 NLM
% 220.68/220.88  |- mesh__recordMaintainer mesh__D001583 TAP
% 220.68/220.89  |- mesh__dateCreated mesh__D001583 1999-01-01
% 220.68/220.89  |- mesh__dateRevised mesh__D001583 1992-05-08
% 220.68/220.89  |- rdf__type mesh__D001583sskos__Concept
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001583 1999
% 220.68/220.89  |- mesh__publicMeSHNote mesh__D001583 66   
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001583 2001
% 220.68/220.89  |- mesh__historyNote mesh__D001583 66   
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001583 1995
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001583 1998
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001583 2004
% 220.68/220.89  |- mesh__recordAuthorizer mesh__D001583 PLS
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001583 1994
% 220.68/220.89  |- skos__broader mesh__D001583smesh__D006574
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001583 2000
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001583 2003
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001583 2006
% 220.68/220.89  |- mesh__dateEstablished mesh__D001583 1966-01-01
% 220.68/220.89  |- skos__prefLabel mesh__D001583 Benzoxazoles
% 220.68/220.89  |- skos__prefLabel mesh__D014700 Verapamil
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D014700 2005
% 220.68/220.89  |- skos__altLabel mesh__D014700 Isoptine
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D014700 2002
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D014700 2004
% 220.68/220.89  |- skos__altLabel mesh__D014700 Isoptin
% 220.68/220.89  |- mesh__publicMeSHNote mesh__D014700 84; was IPROVERATRIL 1972-83   
% 220.68/220.89  |- rdf__type mesh__D014700sskos__Concept
% 220.68/220.89  |- mesh__recordAuthorizer mesh__D014700 sjn
% 220.68/220.89  |- mesh__recordMaintainer mesh__D014700 ssb
% 220.68/220.89  |- mesh__dateCreated mesh__D014700 1999-01-01
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D014700 2003
% 220.68/220.89  |- mesh__historyNote mesh__D014700
% 220.68/220.89       84; was IPROVERATRIL 1964-83 %28%Prov 1964-71%29%   
% 220.68/220.89  |- skos__broader mesh__D014700smesh__D010627
% 220.68/220.89  |- skos__altLabel mesh__D014700 Iproveratril
% 220.68/220.89  |- mesh__onlineNote mesh__D014700
% 220.68/220.89       use VERAPAMIL to search IPROVERATRIL 1966-83 %28%as Prov 1966-71%29%%A%  
% 220.68/220.89  |- skos__scopeNote mesh__D014700
% 220.68/220.89       A calcium channel blocker that is a class IV anti-arrhythmia agent.%A%    
% 220.68/220.89  |- mesh__recordOriginator mesh__D014700 NLM
% 220.68/220.89  |- mesh__dateRevised mesh__D014700 2001-07-25
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D014700 2006
% 220.68/220.89  |- mesh__dateEstablished mesh__D014700 1972-01-01
% 220.68/220.89  |- mesh__dateRevised mesh__D019196 2001-07-25
% 220.68/220.89  |- mesh__recordMaintainer mesh__D019196 mdb
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D019196 2002
% 220.68/220.89  |- mesh__publicMeSHNote mesh__D019196 97   
% 220.68/220.89  |- skos__prefLabel mesh__D019196 Totiviridae
% 220.68/220.89  |- skos__annotation mesh__D019196
% 220.68/220.89       a family of RNA viruses infecting fungi %26% protozoa; coord IM with specific fungus /virol %28%IM or NIM%29% or specific protozoon /virol %28%IM or NIM%29%%A%  
% 220.68/220.89  |- skos__scopeNote mesh__D019196
% 220.68/220.89       A family of RNA viruses that infect fungi and protozoa. There are three genera: TOTIVIRUS; GIARDIAVIRUS; and LEISHMANIAVIRUS.%A%    
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D019196 2004
% 220.68/220.89  |- mesh__historyNote mesh__D019196 97   
% 220.68/220.89  |- rdf__type mesh__D019196sskos__Concept
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D019196 2003
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D019196 2006
% 220.68/220.89  |- mesh__recordAuthorizer mesh__D019196 sjn
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D019196 2005
% 220.68/220.89  |- skos__broader mesh__D019196smesh__D012328
% 220.68/220.89  |- mesh__dateCreated mesh__D019196 1996-06-10
% 220.68/220.89  |- mesh__recordOriginator mesh__D019196 AGS
% 220.68/220.89  |- mesh__dateEstablished mesh__D019196 1997-01-01
% 220.68/220.89  |- skos__altLabel mesh__D005974 Glutamine Synthetase
% 220.68/220.89  |- mesh__recordMaintainer mesh__D005974 ssb
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D005974 2004
% 220.68/220.89  |- mesh__onlineNote mesh__D005974
% 220.68/220.89       use GLUTAMATE-AMMONIA LIGASE to search GLUTAMINE SYNTHETASE 1972-94%A%  
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D005974 2006
% 220.68/220.89  |- mesh__dateEstablished mesh__D005974 1972-01-01
% 220.68/220.89  |- skos__altLabel mesh__D005974 Glutamate Ammonia Ligase %28%ADP%29%
% 220.68/220.89  |- skos__hiddenLabel mesh__D005974 Synthetase, Glutamine
% 220.68/220.89  |- mesh__dateCreated mesh__D005974 1999-01-01
% 220.68/220.89  |- skos__scopeNote mesh__D005974
% 220.68/220.89       An enzyme that catalyzes the conversion of ATP, L-glutamate, and NH3 to ADP, orthophosphate, and L-glutamine. It also acts more slowly on 4-methylene-L-glutamate. %28%From Enzyme Nomenclature, 1992%29% EC 6.3.1.2.%A%    
% 220.68/220.89  |- mesh__recordAuthorizer mesh__D005974 sjn
% 220.68/220.89  |- rdf__type mesh__D005974sskos__Concept
% 220.68/220.89  |- skos__hiddenLabel mesh__D005974 Ligase, Glutamate-Ammonia
% 220.68/220.89  |- skos__hiddenLabel mesh__D005974 Glutamate Ammonia Ligase
% 220.68/220.89  |- mesh__publicMeSHNote mesh__D005974
% 220.68/220.89       95; was GLUTAMINE SYNTHETASE 1972-94   
% 220.68/220.89  |- skos__prefLabel mesh__D005974 Glutamate-Ammonia Ligase
% 220.68/220.89  |- skos__broader mesh__D005974smesh__D019732
% 220.68/220.89  |- mesh__dateRevised mesh__D005974 2003-07-09
% 220.68/220.89  |- mesh__recordOriginator mesh__D005974 NLM
% 220.68/220.89  |- skos__historyNote mesh__D005974 Ligases %28%1966-1971%29%
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D005974 2005
% 220.68/220.89  |- mesh__historyNote mesh__D005974 95; was GLUTAMINE SYNTHETASE 1972-94   
% 220.68/220.89  |- mesh__historyNote mesh__D005176
% 220.68/220.89       1970%28%1964%29%; for FACTOR XIII TRANSAMIDASE see TRANSGLUTAMINASES %28%1990-2001%29%%A%  
% 220.68/220.89  |- skos__annotation mesh__D005176 activated form use FACTOR XIIIA   
% 220.68/220.89  |- mesh__publicMeSHNote mesh__D005176
% 220.68/220.89       1970; for FACTOR XIII TRANSAMIDASE use PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE %28%1990-2001%29%%A%  
% 220.68/220.89  |- skos__altLabel mesh__D005176 Fibrin Stabilizing Factor
% 220.68/220.89  |- skos__hiddenLabel mesh__D005176 Transamidase, Factor XIII
% 220.68/220.89  |- skos__altLabel mesh__D005176 Laki-Lorand Factor
% 220.68/220.89  |- skos__hiddenLabel mesh__D005176 Stabilizing Factor, Fibrin
% 220.68/220.89  |- skos__altLabel mesh__D005176 Coagulation Factor XIII
% 220.68/220.89  |- skos__hiddenLabel mesh__D005176 Factor XIII, Coagulation
% 220.68/220.89  |- rdf__type mesh__D005176sskos__Concept
% 220.68/220.89  |- skos__hiddenLabel mesh__D005176 Factor XIII A Chain
% 220.68/220.89  |- skos__altLabel mesh__D005176 Fibrinase
% 220.68/220.89  |- skos__scopeNote mesh__D005176
% 220.68/220.89       A fibrin-stabilizing plasma enzyme %28%TRANSGLUTAMINASES%29% that is activated by THROMBIN and CALCIUM to form FACTOR XIIIA.  It is important for stabilizing the formation of the fibrin polymer %28%clot%29% which culminates the coagulation cascade.%A%    
% 220.68/220.89  |- skos__hiddenLabel mesh__D005176 XIII, Coagulation Factor
% 220.68/220.89  |- skos__altLabel mesh__D005176 Laki Lorand Factor
% 220.68/220.89  |- skos__prefLabel mesh__D005176 Factor XIII
% 220.68/220.89  |- mesh__dateCreated mesh__D005176 1999-01-01
% 220.68/220.89  |- mesh__recordOriginator mesh__D005176 NLM
% 220.68/220.89  |- skos__related mesh__D005176smesh__D003029
% 220.68/220.89  |- mesh__dateEstablished mesh__D005176 1970-01-01
% 220.68/220.89  |- skos__altLabel mesh__D005176 Factor XIII Transamidase
% 220.68/220.89  |- skos__broader mesh__D005176smesh__D001779
% 220.68/220.89  |- mesh__recordAuthorizer mesh__D005176 sjn
% 220.68/220.89  |- mesh__dateRevised mesh__D005176 2005-06-30
% 220.68/220.89  |- skos__altLabel mesh__D005176 Blood Coagulation Factor XIII
% 220.68/220.89  |- mesh__recordMaintainer mesh__D005176 ssb
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D005176 2006
% 220.68/220.89  |- mesh__recordMaintainer mesh__D013608 ssb
% 220.68/220.89  |- skos__annotation mesh__D013608
% 220.68/220.89       IM for general only, qualif permitted; NIM %28%no qualif%29% when drug in tablet form is IM %28%with qualif%29%; /adv eff permitted but be careful: it may be the adv eff of the drug in the tablet, not the %22%tablet%22%%A%  
% 220.68/220.89  |- skos__broader mesh__D013608smesh__D013607
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D013608 2005
% 220.68/220.89  |- skos__hiddenLabel mesh__D013608 Tablets, Enteric Coated
% 220.68/220.89  |- skos__scopeNote mesh__D013608
% 220.68/220.89       Tablets coated with material that delays release of the medication until after they leave the stomach. %28%Dorland, 28th ed%29%%A%    
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D013608 2006
% 220.68/220.89  |- mesh__dateRevised mesh__D013608 2003-07-09
% 220.68/220.89  |- mesh__dateCreated mesh__D013608 1999-01-01
% 220.68/220.89  |- skos__broader mesh__D013608smesh__D003692
% 220.68/220.89  |- mesh__recordOriginator mesh__D013608 NLM
% 220.68/220.89  |- rdf__type mesh__D013608sskos__Concept
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D013608 2004
% 220.68/220.89  |- skos__prefLabel mesh__D013608 Tablets, Enteric-Coated
% 220.68/220.89  |- skos__hiddenLabel mesh__D013608 Enteric-Coated Tablets
% 220.68/220.89  |- mesh__recordAuthorizer mesh__D013608 sjn
% 220.68/220.89  |- skos__hiddenLabel mesh__D010310 Morgagni Hydatid Cysts
% 220.68/220.89  |- skos__broader mesh__D010310smesh__D003560
% 220.68/220.89  |- mesh__dateRevised mesh__D010310 2005-06-30
% 220.68/220.89  |- rdf__type mesh__D010310sskos__Concept
% 220.68/220.89  |- skos__scopeNote mesh__D010310
% 220.68/220.89       A cyst %28%CYSTS%29% near the OVARY, derived from anomalies of the FALLOPIAN TUBES or the BROAD LIGAMENT. The paramesonephric type consists of ciliated cells similar to the oviduct epithelium. The mesonephric type consisted of an epithelium with minimally surface structures. They can be found on the thin oviduct %28%paratubal cysts%29% or near its fimbriated end %28%hydatid of Morgagni%29%.%A%    
% 220.68/220.89  |- skos__hiddenLabel mesh__D010310 Cyst, Paratubal
% 220.68/220.89  |- skos__hiddenLabel mesh__D010310 Parovarian Cysts
% 220.68/220.89  |- skos__hiddenLabel mesh__D010310 Morgagni Hydatid
% 220.68/220.89  |- skos__hiddenLabel mesh__D010310 Morgagni Hydatids
% 220.68/220.89  |- mesh__recordOriginator mesh__D010310 NLM
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D010310 2006
% 220.68/220.89  |- mesh__recordMaintainer mesh__D010310 lkt
% 220.68/220.89  |- skos__hiddenLabel mesh__D010310 Cysts, Parovarian
% 220.68/220.89  |- skos__hiddenLabel mesh__D010310 Paratubal Cysts
% 220.68/220.89  |- mesh__dateCreated mesh__D010310 1999-01-01
% 220.68/220.89  |- skos__hiddenLabel mesh__D010310 Morgagni Hydatid Cyst
% 220.68/220.89  |- mesh__recordAuthorizer mesh__D010310 sjn
% 220.68/220.89  |- skos__hiddenLabel mesh__D010310 Cyst, Parovarian
% 220.68/220.89  |- skos__annotation mesh__D010310 non-neoplastic   
% 220.68/220.89  |- skos__prefLabel mesh__D010310 Parovarian Cyst
% 220.68/220.89  |- skos__hiddenLabel mesh__D010310 Cysts, Paratubal
% 220.68/220.89  |- skos__altLabel mesh__D010310 Hydatid Cyst of Morgagni
% 220.68/220.89  |- mesh__dateRevised mesh__D009567 2005-06-30
% 220.68/220.89  |- skos__altLabel mesh__D009567 Wernigerode Brand of Nitrazepam
% 220.68/220.89  |- skos__altLabel mesh__D009567 Rhoxalpharma Brand of Nitrazepam
% 220.68/220.89  |- skos__altLabel mesh__D009567 United Drug Brand of Nitrazepam
% 220.68/220.89  |- mesh__dateEstablished mesh__D009567 1974-01-01
% 220.68/220.89  |- skos__altLabel mesh__D009567 Dermatech Brand of Nitrazepam
% 220.68/220.89  |- skos__broader mesh__D009567smesh__D001570
% 220.68/220.89  |- skos__altLabel mesh__D009567 Aliud Brand of Nitrazepam
% 220.68/220.89  |- mesh__recordOriginator mesh__D009567 NLM
% 220.68/220.89  |- skos__historyNote mesh__D009567
% 220.68/220.89       Hypnotics and Sedatives %28%1966-1971%29%
% 220.68/220.89  |- skos__altLabel mesh__D009567 Taurus Brand of Nitrazepam
% 220.68/220.89  |- skos__altLabel mesh__D009567 CSP Brand of Nitrazepam
% 220.68/220.89  |- skos__historyNote mesh__D009567 Tranquilizing Agents %28%1966-1971%29%
% 220.68/220.89  |- mesh__recordAuthorizer mesh__D009567 sjn
% 220.68/220.89  |- skos__prefLabel mesh__D009567 Nitrazepam
% 220.68/220.89  |- skos__altLabel mesh__D009567 ICN Brand of Nitrazepam
% 220.68/220.89  |- rdf__type mesh__D009567sskos__Concept
% 220.68/220.89  |- skos__scopeNote mesh__D009567
% 220.68/220.89       A benzodiazepine derivative used as an anticonvulsant and hypnotic.%A%    
% 220.68/220.89  |- skos__altLabel mesh__D009567 ct-Arzneimittel Brand of Nitrazepam
% 220.68/220.89  |- mesh__publicMeSHNote mesh__D009567 74   
% 220.68/220.89  |- skos__historyNote mesh__D009567 Benzazepines %28%1968-1971%29%
% 220.68/220.89  |- skos__altLabel mesh__D009567 neuraxpharm Brand of Nitrazepam
% 220.68/220.89  |- skos__altLabel mesh__D009567 Scheurich Brand of Nitrazepam
% 220.68/220.89  |- skos__altLabel mesh__D009567 Norgine Brand of Nitrazepam
% 220.68/220.89  |- mesh__recordMaintainer mesh__D009567 lkw
% 220.68/220.89  |- skos__altLabel mesh__D009567 Alphapharma Brand of Nitrazepam
% 220.68/220.89  |- mesh__dateCreated mesh__D009567 1999-01-01
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D009567 2006
% 220.68/220.89  |- skos__altLabel mesh__D009567 Nitrazadon
% 220.68/220.89  |- skos__altLabel mesh__D009567 Protea Brand of Nitrazepam
% 220.68/220.89  |- skos__altLabel mesh__D009567 Alpharma Brand of Nitrazepam
% 220.68/220.89  |- skos__altLabel mesh__D009567 Desitin Brand of Nitrazepam
% 220.68/220.89  |- skos__altLabel mesh__D009567 Alter Brand of Nitrazepam
% 220.68/220.89  |- mesh__historyNote mesh__D009567 74%28%72%29%   
% 220.68/220.89  |- skos__altLabel mesh__D009567 DDSA Brand of Nitrazepam
% 220.68/220.89  |- skos__altLabel mesh__D009567 Pfleger Brand of Nitrazepam
% 220.68/220.89  |- skos__altLabel mesh__D009567 Nitrodiazepam
% 220.68/220.89  |- skos__altLabel mesh__D009567 Allphar Brand of Nitrazepam
% 220.68/220.89  |- mesh__dateCreated mesh__D001584 1999-01-01
% 220.68/220.89  |- mesh__dateRevised mesh__D001584 1992-05-08
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001584 1999
% 220.68/220.89  |- rdf__type mesh__D001584sskos__Concept
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001584 2002
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001584 1995
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001584 1998
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001584 2004
% 220.68/220.89  |- mesh__recordOriginator mesh__D001584 NLM
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001584 1994
% 220.68/220.89  |- skos__broader mesh__D001584smesh__D006574
% 220.68/220.89  |- mesh__recordMaintainer mesh__D001584 TAP
% 220.68/220.89  |- mesh__dateEstablished mesh__D001584 1968-01-01
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001584 2003
% 220.68/220.89  |- mesh__publicMeSHNote mesh__D001584 68   
% 220.68/220.89  |- mesh__historyNote mesh__D001584 68   
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001584 2001
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001584 2006
% 220.68/220.89  |- mesh__recordAuthorizer mesh__D001584 PLS
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001584 1997
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001584 2000
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001584 2005
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001584 1993
% 220.68/220.89  |- skos__prefLabel mesh__D001584 Benzoxepins
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D001584 1996
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D014701 2003
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D014701 2002
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D014701 2004
% 220.68/220.89  |- mesh__recordOriginator mesh__D014701 NLM
% 220.68/220.89  |- mesh__historyNote mesh__D014701
% 220.68/220.89       91%28%75%29%; was see under VERATRINE 1975-90   
% 220.68/220.89  |- skos__broader mesh__D014701smesh__D014702
% 220.68/220.89  |- rdf__type mesh__D014701sskos__Concept
% 220.68/220.89  |- mesh__dateCreated mesh__D014701 1974-11-19
% 220.68/220.89  |- skos__prefLabel mesh__D014701 Veratridine
% 220.68/220.89  |- skos__scopeNote mesh__D014701
% 220.68/220.89       One of the components in the veratrine mixture of alkaloids. Found in the seed of Schoenocaulon officinale and in rhizome of Veratrum album L., Liliaceae.%A%    
% 220.68/220.89  |- mesh__publicMeSHNote mesh__D014701
% 220.68/220.89       91; was see under VERATRINE 1975-90   
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D014701 2005
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D014701 2001
% 220.68/220.89  |- mesh__recordAuthorizer mesh__D014701 sjn
% 220.68/220.89  |- mesh__dateEstablished mesh__D014701 1991-01-01
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D014701 2006
% 220.68/220.89  |- mesh__dateRevised mesh__D014701 2000-06-22
% 220.68/220.89  |- skos__historyNote mesh__D014701 Veratrine %28%1973-1974%29%
% 220.68/220.89  |- mesh__recordMaintainer mesh__D014701 TWD
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D019995 2005
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D019995 2004
% 220.68/220.89  |- mesh__recordMaintainer mesh__D019995 ssb
% 220.68/220.89  |- skos__scopeNote mesh__D019995
% 220.68/220.89       Chemicals necessary to perform experimental and/or investigative procedures and for the preparation of drugs and other chemicals.%A%    
% 220.68/220.89  |- mesh__dateRevised mesh__D019995 2003-07-09
% 220.68/220.89  |- rdf__type mesh__D019995sskos__Concept
% 220.68/220.89  |- mesh__dateCreated mesh__D019995 1997-06-20
% 220.68/220.89  |- skos__prefLabel mesh__D019995 Laboratory Chemicals
% 220.68/220.89  |- mesh__recordOriginator mesh__D019995 ADP
% 220.68/220.89  |- mesh__recordAuthorizer mesh__D019995 sjn
% 220.68/220.89  |- mesh__dateEstablished mesh__D019995 1998-01-01
% 220.68/220.89  |- skos__annotation mesh__D019995
% 220.68/220.89       GEN OR unspecified; prefer specifics; DF: LABORATORY CHEM%A%  
% 220.68/220.89  |- skos__broader mesh__D019995smesh__D020313
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D019995 2006
% 220.68/220.89  |- mesh__historyNote mesh__D019995 98   
% 220.68/220.89  |- mesh__publicMeSHNote mesh__D019995 98   
% 220.68/220.89  |- skos__altLabel mesh__D019995 Chemicals, Laboratory
% 220.68/220.89  |- skos__scopeNote mesh__D019197
% 220.68/220.89       A genus of RNA fungi viruses in the family TOTIVIRIDAE. Some of the viruses contain additional satellite RNA or defective RNA. Transmission occurs during cell division, sporogenesis and cell fusion. The type species is Saccharomyces cerevisiae virus L-A.%A%    
% 220.68/220.89  |- mesh__recordOriginator mesh__D019197 AGS
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D019197 2004
% 220.68/220.89  |- mesh__dateEstablished mesh__D019197 1997-01-01
% 220.68/220.89  |- mesh__dateRevised mesh__D019197 1997-06-20
% 220.68/220.89  |- skos__broader mesh__D019197smesh__D019196
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D019197 2002
% 220.68/220.89  |- mesh__historyNote mesh__D019197 97   
% 220.68/220.89  |- rdf__type mesh__D019197sskos__Concept
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D019197 2003
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D019197 2006
% 220.68/220.89  |- mesh__recordAuthorizer mesh__D019197 SJN
% 220.68/220.89  |- mesh__publicMeSHNote mesh__D019197 97   
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D019197 2001
% 220.68/220.89  |- mesh__recordMaintainer mesh__D019197 AGS
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D019197 2005
% 220.68/220.89  |- skos__annotation mesh__D019197
% 220.68/220.89       a genus of the family Totiviridae infecting fungi; coord IM with specific fungus /virol %28%IM or NIM%29%%A%  
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D019197 2000
% 220.68/220.89  |- skos__prefLabel mesh__D019197 Totivirus
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D019197 1999
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D019197 1998
% 220.68/220.89  |- mesh__dateCreated mesh__D019197 1996-06-10
% 220.68/220.89  |- skos__altLabel mesh__D005975 Glu-tRNA Ligase
% 220.68/220.89  |- mesh__recordMaintainer mesh__D005975 ssb
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D005975 2004
% 220.68/220.89  |- skos__historyNote mesh__D005975 Glutamates %28%1972-1974%29%
% 220.68/220.89  |- skos__hiddenLabel mesh__D005975 Glutamyl tRNA Synthetase
% 220.68/220.89  |- skos__hiddenLabel mesh__D005975 Glu tRNA Ligase
% 220.68/220.89  |- skos__scopeNote mesh__D005975
% 220.68/220.89       An enzyme that activates glutamic acid with its specific transfer RNA. EC 6.1.1.17.%A%    
% 220.68/220.89  |- skos__prefLabel mesh__D005975 Glutamate-tRNA Ligase
% 220.68/220.89  |- mesh__recordOriginator mesh__D005975 NLM
% 220.68/220.89  |- skos__hiddenLabel mesh__D005975 Glutamate tRNA Ligase
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D005975 2006
% 220.68/220.89  |- mesh__publicMeSHNote mesh__D005975
% 220.68/220.89       98; see GLUTAMYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A%  
% 220.68/220.89  |- skos__historyNote mesh__D005975
% 220.68/220.89       Amino Acyl T RNA Synthetases %28%1972-1974%29%
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D005975 2005
% 220.68/220.89  |- skos__broader mesh__D005975smesh__D000604
% 220.68/220.89  |- skos__hiddenLabel mesh__D005975 Synthetase, Glutamyl-tRNA
% 220.68/220.89  |- rdf__type mesh__D005975sskos__Concept
% 220.68/220.89  |- mesh__dateRevised mesh__D005975 2003-07-09
% 220.68/220.89  |- skos__altLabel mesh__D005975 Glutamyl-tRNA Synthetase
% 220.68/220.89  |- skos__altLabel mesh__D005975 Glutamyl T RNA Synthetase
% 220.68/220.89  |- mesh__dateCreated mesh__D005975 1974-11-19
% 220.68/220.89  |- mesh__historyNote mesh__D005975 98%28%75%29%   
% 220.68/220.89  |- mesh__recordAuthorizer mesh__D005975 sjn
% 220.68/220.89  |- skos__hiddenLabel mesh__D005975 Ligase, Glutamate-tRNA
% 220.68/220.89  |- skos__hiddenLabel mesh__D005975 Ligase, Glu-tRNA
% 220.68/220.89  |- mesh__dateEstablished mesh__D005975 1991-01-01
% 220.68/220.89  |- skos__prefLabel mesh__D005177 Factor XIII Deficiency
% 220.68/220.89  |- mesh__recordOriginator mesh__D005177 NLM
% 220.68/220.89  |- rdf__type mesh__D005177sskos__Concept
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D005177 2003
% 220.68/220.89  |- mesh__publicMeSHNote mesh__D005177 73   
% 220.68/220.89  |- skos__annotation mesh__D005177 DF: FACTOR XIII DEFIC   
% 220.68/220.89  |- skos__scopeNote mesh__D005177
% 220.68/220.89       A deficiency of blood coagulation FACTOR XIII or fibrin stabilizing factor %28%FSF%29% that prevents blood clot formation and results in a clinical hemorrhagic diathesis.%A%    
% 220.68/220.89  |- mesh__recordAuthorizer mesh__D005177 sjn
% 220.68/220.89  |- mesh__dateCreated mesh__D005177 1999-01-01
% 220.68/220.89  |- mesh__dateRevised mesh__D005177 2001-07-25
% 220.68/220.89  |- mesh__recordMaintainer mesh__D005177 nns
% 220.68/220.89  |- skos__broader mesh__D005177smesh__D006474
% 220.68/220.89  |- skos__hiddenLabel mesh__D005177 Deficiencies, Factor XIII
% 220.68/220.89  |- skos__broader mesh__D005177smesh__D020147
% 220.68/220.89  |- skos__historyNote mesh__D005177 Hemorrhagic Diathesis %28%1966-1972%29%
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D005177 2006
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D005177 2002
% 220.68/220.89  |- skos__hiddenLabel mesh__D005177 Factor XIII Deficiencies
% 220.68/220.89  |- skos__broader mesh__D005177smesh__D025861
% 220.68/220.89  |- skos__altLabel mesh__D005177 Deficiency, Factor XIII
% 220.68/220.89  |- mesh__historyNote mesh__D005177 73   
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D005177 2005
% 220.68/220.89  |- mesh__dateEstablished mesh__D005177 1973-01-01
% 220.68/220.89  |- skos__related mesh__D005177smesh__D026122
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D005177 2004
% 220.68/220.89  |- skos__prefLabel mesh__D013609 Taboo
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D013609 2005
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D013609 1998
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D013609 2003
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D013609 2006
% 220.68/220.89  |- mesh__dateCreated mesh__D013609 1999-01-01
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D013609 1999
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D013609 2000
% 220.68/220.89  |- mesh__recordMaintainer mesh__D013609 JLS
% 220.68/220.89  |- rdf__type mesh__D013609sskos__Concept
% 220.68/220.89  |- skos__hiddenLabel mesh__D013609 Taboos
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D013609 2004
% 220.68/220.89  |- skos__broader mesh__D013609smesh__D003469
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D013609 2001
% 220.68/220.89  |- mesh__recordAuthorizer mesh__D013609 SJN
% 220.68/220.89  |- mesh__dateRevised mesh__D013609 1997-06-20
% 220.68/220.89  |- skos__scopeNote mesh__D013609
% 220.68/220.89       Any negative tradition or behavior that is generally regarded as harmful to social welfare and forbidden within a cultural or social group.%A%    
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D013609 2002
% 220.68/220.89  |- mesh__recordOriginator mesh__D013609 NLM
% 220.68/220.89  |- mesh__historyNote mesh__D010311 1991%28%1975%29%   
% 220.68/220.89  |- mesh__dateRevised mesh__D010311 2005-07-19
% 220.68/220.89  |- rdf__type mesh__D010311sskos__Concept
% 220.68/220.89  |- skos__broader mesh__D010311smesh__D011563
% 220.68/220.89  |- skos__altLabel mesh__D010311 Psittacidae
% 220.68/220.89  |- mesh__recordMaintainer mesh__D010311 ags
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D010311 2006A
% 220.68/220.89  |- mesh__recordOriginator mesh__D010311 NLM
% 220.68/220.89  |- skos__hiddenLabel mesh__D010311 Parrot
% 220.68/220.89  |- skos__scopeNote mesh__D010311
% 220.68/220.89       BIRDS of the large family Psittacidae, widely distributed in tropical regions and having a distinctive stout, curved hooked bill. The family includes LOVEBIRDS; AMAZON PARROTS; conures; PARAKEETS; and many other kinds of parrots.%A%    
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D010311 2005
% 220.68/220.89  |- mesh__dateCreated mesh__D010311 1999-01-01
% 220.68/220.89  |- mesh__recordAuthorizer mesh__D010311 ags
% 220.68/220.89  |- mesh__publicMeSHNote mesh__D010311 1991; see PSITTACINES 1975-1990   
% 220.68/220.89  |- mesh__dateEstablished mesh__D010311 1991-01-01
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D010311 2006
% 220.68/220.89  |- skos__prefLabel mesh__D010311 Parrots
% 220.68/220.89  |- mesh__publicMeSHNote mesh__D009568 87   
% 220.68/220.89  |- skos__altLabel mesh__D009568 AbZ Brand of Nitrendipine
% 220.68/220.89  |- skos__altLabel mesh__D009568 Heumann Brand of Nitrendipine
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Nitrendipine acis Brand
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Heumann, Nitrendipin
% 220.68/220.89  |- skos__altLabel mesh__D009568 KSK Pharma Brand of Nitrendipine
% 220.68/220.89  |- skos__altLabel mesh__D009568 Schwarz Brand of Nitrendipine
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 ct, nitrendipin von
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Nitrendipine TAD Brand
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Nitrendipine Elan Brand
% 220.68/220.89  |- skos__altLabel mesh__D009568 BC Brand of Nitrendipine
% 220.68/220.89  |- skos__altLabel mesh__D009568 Elfar Brand of Nitrendipine
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Nitrendipine ct-Arzneimittel Brand
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Nitrendipine Lindopharm Brand
% 220.68/220.89  |- skos__altLabel mesh__D009568 Docpharm Brand of Nitrendipine
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Nitrendipine Q-Pharm Brand
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 KSK, Nitrend
% 220.68/220.89  |- mesh__activeMeSHYear mesh__D009568 2006
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Nitrendipine Jenapharm Brand
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Stada, Nitrendipin
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Nitrendipine Dexcel Brand
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Nitrendipine Basics Brand
% 220.68/220.89  |- mesh__dateEstablished mesh__D009568 1987-01-01
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 nitrendipin corax
% 220.68/220.89  |- skos__altLabel mesh__D009568 Bayvit Brand of Nitrendipine
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Nitrendipine Elfar Brand
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Nitrendipine Alpharma Brand
% 220.68/220.89  |- skos__historyNote mesh__D009568
% 220.68/220.89       Nifedipine/analogs %26% derivatives %28%1982-1986%29%
% 220.68/220.89  |- skos__altLabel mesh__D009568 Alpharma Brand of Nitrendipine
% 220.68/220.89  |- skos__altLabel mesh__D009568 Biomed Brand of Nitrendipine
% 220.68/220.89  |- mesh__recordAuthorizer mesh__D009568 sjn
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Nitrendipine Aliud Brand
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Lich, Nitren
% 220.68/220.89  |- mesh__recordOriginator mesh__D009568 RLS
% 220.68/220.89  |- skos__altLabel mesh__D009568 Bayer Brand of Nitrendipine
% 220.68/220.89  |- skos__altLabel mesh__D009568 TAD Brand of Nitrendipine
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Apogepha, Nitrendipin
% 220.68/220.89  |- skos__altLabel mesh__D009568 ratiopharm Brand of Nitrendipine
% 220.68/220.89  |- mesh__dateRevised mesh__D009568 2004-07-07
% 220.68/220.89  |- skos__altLabel mesh__D009568 Niprina
% 220.68/220.89  |- rdf__type mesh__D009568sskos__Concept
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 von ct, nitrendipin
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Nitrendipine Schwarz Brand
% 220.68/220.89  |- mesh__dateCreated mesh__D009568 1986-06-03
% 220.68/220.89  |- skos__altLabel mesh__D009568 Prevision y Salud Brand of Nitrendipine
% 220.68/220.89  |- skos__altLabel mesh__D009568 Bayotensin
% 220.68/220.89  |- skos__altLabel mesh__D009568 W%C3%%B6%rwag Brand of Nitrendipine
% 220.68/220.89  |- skos__altLabel mesh__D009568 Azupharma Brand of Nitrendipine
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Nitrendipine corax Brand
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Nitrendipin ratiopharm
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Ratiopharm, Nitrendipino
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Nitrendipine betapharm Brand
% 220.68/220.89  |- skos__hiddenLabel mesh__D009568 Bayvit, Nitrendipino
% 220.68/220.89  |- skos__altLabel mesh__D009568 Jenapharm Brand of Nitrendipine
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 1A Pharma, Nitren
% 220.68/220.90  |- skos__altLabel mesh__D009568 Apogepha Brand of Nitrendipine
% 220.68/220.90  |- skos__broader mesh__D009568smesh__D004095
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Nitrendipine Biomed Brand
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Nitrendipine Seid Brand
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 AbZ, Nitre
% 220.68/220.90  |- skos__altLabel mesh__D009568 acis Brand of Nitrendipine
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Nitrendipine Heumann Brand
% 220.68/220.90  |- mesh__historyNote mesh__D009568 87   
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Nitrendipine ratiopharm Brand
% 220.68/220.90  |- skos__historyNote mesh__D009568 Pyridines %28%1966-1981%29%
% 220.68/220.90  |- skos__altLabel mesh__D009568 Hexal Brand of Nitrendipine
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Nitrendipine BC Brand
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Nitrendipine Stadapharm Brand
% 220.68/220.90  |- skos__altLabel mesh__D009568 Basics Brand of Nitrendipine
% 220.68/220.90  |- skos__altLabel mesh__D009568 Nitrendipin-ratiopharm
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Biochemie, Nitrendi
% 220.68/220.90  |- skos__altLabel mesh__D009568 Seid Brand of Nitrendipine
% 220.68/220.90  |- skos__altLabel mesh__D009568 corax Brand of Nitrendipine
% 220.68/220.90  |- skos__altLabel mesh__D009568 Elan Brand of Nitrendipine
% 220.68/220.90  |- skos__altLabel mesh__D009568 Aliud Brand of Nitrendipine
% 220.68/220.90  |- skos__altLabel mesh__D009568 Lindopharm Brand of Nitrendipine
% 220.68/220.90  |- skos__altLabel mesh__D009568 Q-Pharm Brand of Nitrendipine
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Nitrendipine Juta Brand
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Nitrendipine Apogepha Brand
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Nitrendipine W%C3%%B6%rwag Brand
% 220.68/220.90  |- skos__altLabel mesh__D009568 Merck dura Brand of Nitrendipine
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 acis, Nitren
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Nitre Puren
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Jenapharm, Nitrendipin
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Nitrendipine Bayvit Brand
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Nitrendipinratiopharm
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 beta, Nitrendipin
% 220.68/220.90  |- mesh__recordMaintainer mesh__D009568 lkw
% 220.68/220.90  |- skos__altLabel mesh__D009568 Juta Brand of Nitrendipine
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Nitrendipine Almirall Brand
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Atid, Nitrendipin
% 220.68/220.90  |- skos__altLabel mesh__D009568 betapharm Brand of Nitrendipine
% 220.68/220.90  |- skos__altLabel mesh__D009568 1A Brand of Nitrendipine
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Nitrendipine Azupharma Brand
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 NitrePuren
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Nitrendipine Hexal Brand
% 220.68/220.90  |- skos__altLabel mesh__D009568 Dexcel Brand of Nitrendipine
% 220.68/220.90  |- skos__altLabel mesh__D009568 Stadapharm Brand of Nitrendipine
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Basics, Nitrendipin
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 ct Arzneimittel Brand of Nitrendipine
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Nitrendipine Bayer Brand
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Pharma, Nitren 1A
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 nitrendipincorax
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D009568 2005
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Lindo, Nitrendipin
% 220.68/220.90  |- skos__prefLabel mesh__D009568 Nitrendipine
% 220.68/220.90  |- skos__altLabel mesh__D009568 ct-Arzneimittel Brand of Nitrendipine
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 AL, Nitrendipin
% 220.68/220.90  |- skos__scopeNote mesh__D009568
% 220.68/220.90       A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.%A%    
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Nitrendipine Docpharm Brand
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Nitrendipine 1A Brand
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Nitrendipine AbZ Brand
% 220.68/220.90  |- skos__hiddenLabel mesh__D009568 Nitrendipine Lichtenstein Brand
% 220.68/220.90  |- skos__altLabel mesh__D009568 Lichtenstein Brand of Nitrendipine
% 220.68/220.90  |- skos__altLabel mesh__D009568 Almirall Brand of Nitrendipine
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D001585 2001
% 220.68/220.90  |- mesh__recordAuthorizer mesh__D001585 sjn
% 220.68/220.90  |- skos__altLabel mesh__D001585 Dibenzoyl Peroxide
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D001585 2003
% 220.68/220.90  |- skos__hiddenLabel mesh__D001585 Peroxide, Dibenzoyl
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D001585 2000
% 220.68/220.90  |- skos__altLabel mesh__D001585 Diphenylglyoxal Superoxide
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D001585 2006
% 220.68/220.90  |- mesh__dateEstablished mesh__D001585 1991-01-01
% 220.68/220.90  |- mesh__recordMaintainer mesh__D001585 adp
% 220.68/220.90  |- skos__hiddenLabel mesh__D001585 Superoxide, Benzoyl
% 220.68/220.90  |- mesh__publicMeSHNote mesh__D001585
% 220.68/220.90       91; was see under PEROXIDES 1976-90   
% 220.68/220.90  |- mesh__recordOriginator mesh__D001585 RLS
% 220.68/220.90  |- skos__hiddenLabel mesh__D001585 Peroxide, Benzoyl
% 220.68/220.90  |- skos__broader mesh__D001585smesh__D020185
% 220.68/220.90  |- mesh__historyNote mesh__D001585
% 220.68/220.90       91%28%76%29%; was see under PEROXIDES 1976-90   
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D001585 2005
% 220.68/220.90  |- skos__altLabel mesh__D001585 Benzoyl Superoxide
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D001585 2002
% 220.68/220.90  |- mesh__dateRevised mesh__D001585 1999-11-03
% 220.68/220.90  |- skos__historyNote mesh__D001585 Benzoates %28%1972-1975%29%
% 220.68/220.90  |- skos__historyNote mesh__D001585 Peroxides %28%1972-1975%29%
% 220.68/220.90  |- rdf__type mesh__D001585sskos__Concept
% 220.68/220.90  |- skos__prefLabel mesh__D001585 Benzoyl Peroxide
% 220.68/220.90  |- skos__scopeNote mesh__D001585
% 220.68/220.90       A peroxide derivative that has been used topically for burns and as a dermatologic agent in the treatment of acne and poison ivy. It is used also as a bleach in the food industry.%A%    
% 220.68/220.90  |- skos__hiddenLabel mesh__D001585 Superoxide, Diphenylglyoxal
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D001585 2004
% 220.68/220.90  |- mesh__dateCreated mesh__D001585 1975-07-21
% 220.68/220.90  |- mesh__publicMeSHNote mesh__D028722 2002; see SOCIAL VALUES 1987-2001   
% 220.68/220.90  |- skos__prefLabel mesh__D028722 Virtues
% 220.68/220.90  |- rdf__type mesh__D028722sskos__Concept
% 220.68/220.90  |- skos__related mesh__D028722smesh__D012945
% 220.68/220.90  |- skos__broader mesh__D028722smesh__D009014
% 220.68/220.90  |- mesh__dateRevised mesh__D028722 2003-07-09
% 220.68/220.90  |- mesh__dateEstablished mesh__D028722 2002-01-01
% 220.68/220.90  |- skos__scopeNote mesh__D028722
% 220.68/220.90       Character traits that are considered to be morally praiseworthy. %28%Bioethics Thesaurus%29%%A%    
% 220.68/220.90  |- skos__historyNote mesh__D028722 Social Values %28%1976-2001%29%
% 220.68/220.90  |- skos__annotation mesh__D028722
% 220.68/220.90       for %22%virtue theory,%22% coordinate with ETHICAL THEORY   
% 220.68/220.90  |- mesh__historyNote mesh__D028722 2002; use SOCIAL VALUES 1987-2001   
% 220.68/220.90  |- mesh__recordOriginator mesh__D028722 jrf
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D028722 2005
% 220.68/220.90  |- skos__hiddenLabel mesh__D028722 Virtue
% 220.68/220.90  |- mesh__recordMaintainer mesh__D028722 lkt
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D028722 2004
% 220.68/220.90  |- mesh__recordAuthorizer mesh__D028722 sjn
% 220.68/220.90  |- mesh__dateCreated mesh__D028722 2001-07-25
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D028722 2006
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006270 2001
% 220.68/220.90  |- mesh__recordOriginator mesh__D006270 EC
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006270 2003
% 220.68/220.90  |- skos__hiddenLabel mesh__D006270 Facility Administrator, Health
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006270 1999
% 220.68/220.90  |- mesh__recordAuthorizer mesh__D006270 PLS
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006270 2000
% 220.68/220.90  |- mesh__historyNote mesh__D006270 78   
% 220.68/220.90  |- mesh__publicMeSHNote mesh__D006270 78   
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006270 1995
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006270 1998
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006270 2006
% 220.68/220.90  |- skos__scopeNote mesh__D006270
% 220.68/220.90       Managerial personnel responsible for implementing policy and directing the activities of health care facilities such as nursing homes.%A%    
% 220.68/220.90  |- mesh__recordMaintainer mesh__D006270 TAP
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006270 1994
% 220.68/220.90  |- mesh__dateCreated mesh__D006270 1977-05-05
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006270 2005
% 220.68/220.90  |- skos__prefLabel mesh__D006270 Health Facility Administrators
% 220.68/220.90  |- skos__hiddenLabel mesh__D006270 Health Facility Administrator
% 220.68/220.90  |- skos__hiddenLabel mesh__D006270 Administrators, Health Facility
% 220.68/220.90  |- mesh__dateEstablished mesh__D006270 1978-01-01
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006270 2002
% 220.68/220.90  |- mesh__dateRevised mesh__D006270 1992-05-15
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006270 1997
% 220.68/220.90  |- skos__hiddenLabel mesh__D006270 Administrator, Health Facility
% 220.68/220.90  |- skos__hiddenLabel mesh__D006270 Facility Administrators, Health
% 220.68/220.90  |- skos__broader mesh__D006270smesh__D006282
% 220.68/220.90  |- skos__broader mesh__D006270smesh__D000288
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006270 2004
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006270 1996
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006270 1993
% 220.68/220.90  |- rdf__type mesh__D006270sskos__Concept
% 220.68/220.90  |- skos__broader mesh__D014702smesh__D002595
% 220.68/220.90  |- mesh__publicMeSHNote mesh__D014702 73   
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D014702 2004
% 220.68/220.90  |- mesh__recordMaintainer mesh__D014702 TWD
% 220.68/220.90  |- rdf__type mesh__D014702sskos__Concept
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D014702 2002
% 220.68/220.90  |- mesh__historyNote mesh__D014702 73%28%63%29%   
% 220.68/220.90  |- mesh__recordOriginator mesh__D014702 NLM
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D014702 2005
% 220.68/220.90  |- mesh__dateEstablished mesh__D014702 1973-01-01
% 220.68/220.90  |- mesh__dateRevised mesh__D014702 2000-06-22
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D014702 2006
% 220.68/220.90  |- skos__annotation mesh__D014702 do not confuse with VERATRIDINE   
% 220.68/220.90  |- skos__prefLabel mesh__D014702 Veratrine
% 220.68/220.90  |- mesh__dateCreated mesh__D014702 1999-01-01
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D014702 2003
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D014702 2001
% 220.68/220.90  |- mesh__recordAuthorizer mesh__D014702 sjn
% 220.68/220.90  |- skos__historyNote mesh__D019198 Giardia lamblia %28%1991-1996%29%
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D019198 2005
% 220.68/220.90  |- mesh__recordOriginator mesh__D019198 AGS
% 220.68/220.90  |- skos__scopeNote mesh__D019198
% 220.68/220.90       A genus of RNA protozoan viruses of the family TOTIVIRIDAE. It infects many isolates of the flagellated protozoan human parasite G. lamblia, but does not seem to be associated with the virulence of the parasite. The type species is Giardia lamblia virus.%A%    
% 220.68/220.90  |- mesh__recordAuthorizer mesh__D019198 sjn
% 220.68/220.90  |- mesh__historyNote mesh__D019198 97   
% 220.68/220.90  |- skos__prefLabel mesh__D019198 Giardiavirus
% 220.68/220.90  |- skos__annotation mesh__D019198
% 220.68/220.90       a genus of the family Totiviridae; infects the protozoan Giardia lamblia; coord IM with GIARDIA LAMBLIA /virol %28%IM%29%%A%  
% 220.68/220.90  |- rdf__type mesh__D019198sskos__Concept
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D019198 2006
% 220.68/220.90  |- mesh__dateCreated mesh__D019198 1996-06-10
% 220.68/220.90  |- mesh__dateRevised mesh__D019198 2004-07-13
% 220.68/220.90  |- skos__historyNote mesh__D019198 RNA Viruses %28%1991-1996%29%
% 220.68/220.90  |- mesh__dateEstablished mesh__D019198 1997-01-01
% 220.68/220.90  |- mesh__publicMeSHNote mesh__D019198 97   
% 220.68/220.90  |- skos__broader mesh__D019198smesh__D019196
% 220.68/220.90  |- skos__hiddenLabel mesh__D019198 Giardiaviruses
% 220.68/220.90  |- mesh__recordMaintainer mesh__D019198 sjn
% 220.68/220.90  |- skos__altLabel mesh__D005976 Cahill May Roberts Brand of Glutaral
% 220.68/220.90  |- skos__altLabel mesh__D005976 Dermatech Brand of Glutaral
% 220.68/220.90  |- mesh__recordAuthorizer mesh__D005976 sjn
% 220.68/220.90  |- mesh__publicMeSHNote mesh__D005976
% 220.68/220.90       92; was GLUTARALDEHYDE 1973-91 %28%see under ALDEHYDES 1973-90%29%%A%  
% 220.68/220.90  |- skos__altLabel mesh__D005976 Glutardialdehyde
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D005976 2006
% 220.68/220.90  |- mesh__historyNote mesh__D005976
% 220.68/220.90       92; was GLUTARALDEHYDE 1973-91 %28%see under ALDEHYDES 1973-90%29%%A%  
% 220.68/220.90  |- mesh__recordMaintainer mesh__D005976 CCR
% 220.68/220.90  |- skos__altLabel mesh__D005976 Dermal Brand of Glutaral
% 220.68/220.90  |- rdf__type mesh__D005976sskos__Concept
% 220.68/220.90  |- mesh__recordOriginator mesh__D005976 NLM
% 220.68/220.90  |- skos__broader mesh__D005976smesh__D000447
% 220.68/220.90  |- mesh__dateCreated mesh__D005976 1999-01-01
% 220.68/220.90  |- skos__prefLabel mesh__D005976 Glutaral
% 220.68/220.90  |- mesh__dateRevised mesh__D005976 2005-06-30
% 220.68/220.90  |- skos__altLabel mesh__D005976 Johnson %26% Johnson Brand of Glutaral
% 220.68/220.90  |- skos__altLabel mesh__D005976 Bioglan Brand of Glutaral
% 220.68/220.90  |- mesh__dateEstablished mesh__D005976 1991-01-01
% 220.68/220.90  |- skos__altLabel mesh__D005976 Bode Brand of Glutaral
% 220.68/220.90  |- mesh__onlineNote mesh__D005976
% 220.68/220.90       use GLUTARAL to search GLUTARALDEHYDE 1973-91   
% 220.68/220.90  |- skos__altLabel mesh__D005976 Ecolab Brand of Glutaral
% 220.68/220.90  |- skos__scopeNote mesh__D005976
% 220.68/220.90       One of the protein CROSS-LINKING REAGENTS that is used as a disinfectant for sterilization of heat-sensitive equipment and as a laboratory reagent, especially as a fixative.%A%    
% 220.68/220.90  |- skos__altLabel mesh__D005976 Glutaraldehyde
% 220.68/220.90  |- mesh__recordMaintainer mesh__D005178 jls
% 220.68/220.90  |- skos__hiddenLabel mesh__D005178 Teacher, School
% 220.68/220.90  |- mesh__historyNote mesh__D005178
% 220.68/220.90       68; FACULTY, PHARMACY was heading 1968-85   
% 220.68/220.90  |- mesh__dateCreated mesh__D005178 1999-01-01
% 220.68/220.90  |- skos__historyNote mesh__D005178 Teaching %28%1966-1967%29%
% 220.68/220.90  |- mesh__dateRevised mesh__D005178 2001-08-13
% 220.68/220.90  |- skos__hiddenLabel mesh__D005178 Faculties
% 220.68/220.90  |- mesh__recordOriginator mesh__D005178 NLM
% 220.68/220.90  |- mesh__onlineNote mesh__D005178
% 220.68/220.90       use FACULTY to search FACULTY, PHARMACY 1968-85   
% 220.68/220.90  |- skos__broader mesh__D005178smesh__D009274
% 220.68/220.90  |- skos__hiddenLabel mesh__D005178 Teachers, School
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D005178 2006
% 220.68/220.90  |- skos__scopeNote mesh__D005178
% 220.68/220.90       The teaching staff and members of the administrative staff having academic rank in an educational institution.%A%    
% 220.68/220.90  |- skos__broader mesh__D005178smesh__D004493
% 220.68/220.90  |- mesh__recordAuthorizer mesh__D005178 sjn
% 220.68/220.90  |- skos__annotation mesh__D005178
% 220.68/220.90       not for Facult%C3%%A9% de M%C3%%A9%decine nor Facultad de Medicina %28% = SCHOOLS, MEDICAL%29%; do not confuse FACULTY with TEACHING: FACULTY suggests differentiation from student or administrator, teaching suggests the imparting of knowledge %28%Manual 30.10%29%; Manual 30.9, 34.14%A%  
% 220.68/220.90  |- skos__prefLabel mesh__D005178 Faculty
% 220.68/220.90  |- skos__altLabel mesh__D005178 Faculties, Pharmacy
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D005178 2005
% 220.68/220.90  |- mesh__publicMeSHNote mesh__D005178
% 220.68/220.90       68; FACULTY, PHARMACY was heading 1968-85   
% 220.68/220.90  |- skos__hiddenLabel mesh__D005178 Pharmacy Faculties
% 220.68/220.90  |- skos__altLabel mesh__D005178 Pharmacy Faculty
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D005178 2004
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D005178 2002
% 220.68/220.90  |- mesh__dateEstablished mesh__D005178 1968-01-01
% 220.68/220.90  |- skos__hiddenLabel mesh__D005178 School Teacher
% 220.68/220.90  |- rdf__type mesh__D005178sskos__Concept
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D005178 2003
% 220.68/220.90  |- skos__broader mesh__D010312smesh__D012100
% 220.68/220.90  |- skos__hiddenLabel mesh__D010312 Parthenogeneses
% 220.68/220.90  |- skos__scopeNote mesh__D010312
% 220.68/220.90       A unisexual reproduction without the fusion of a male and a female gamete %28%FERTILIZATION%29%. In parthenogenesis, an individual is formed from an unfertilized OVUM that did not complete MEIOSIS. Parthenogenesis occurs in nature and can be artificially induced.%A%    
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D010312 2005
% 220.68/220.90  |- mesh__dateCreated mesh__D010312 1999-01-01
% 220.68/220.90  |- mesh__dateRevised mesh__D010312 2004-07-07
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D010312 2006
% 220.68/220.90  |- skos__prefLabel mesh__D010312 Parthenogenesis
% 220.68/220.90  |- mesh__recordOriginator mesh__D010312 NLM
% 220.68/220.90  |- mesh__recordAuthorizer mesh__D010312 sjn
% 220.68/220.90  |- mesh__recordMaintainer mesh__D010312 lkt
% 220.68/220.90  |- rdf__type mesh__D010312sskos__Concept
% 220.68/220.90  |- skos__altLabel mesh__D009569 Nitrogen Monoxide
% 220.68/220.90  |- rdf__type mesh__D009569sskos__Concept
% 220.68/220.90  |- mesh__recordOriginator mesh__D009569 NLM
% 220.68/220.90  |- skos__broader mesh__D009569smesh__D009589
% 220.68/220.90  |- skos__related mesh__D009569smesh__D045462
% 220.68/220.90  |- skos__hiddenLabel mesh__D009569 Vasodilator, Endogenous Nitrate
% 220.68/220.90  |- skos__hiddenLabel mesh__D009569 Nitric Oxide, Endothelium Derived
% 220.68/220.90  |- skos__hiddenLabel mesh__D009569 Endothelium-Derived Nitric Oxide
% 220.68/220.90  |- mesh__recordAuthorizer mesh__D009569 sjn
% 220.68/220.90  |- mesh__dateEstablished mesh__D009569 1965-01-01
% 220.68/220.90  |- skos__hiddenLabel mesh__D009569 Nitrate Vasodilator, Endogenous
% 220.68/220.90  |- mesh__dateCreated mesh__D009569 1999-01-01
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D009569 2006
% 220.68/220.90  |- skos__hiddenLabel mesh__D009569 Protoxide, Nitrogen
% 220.68/220.90  |- skos__hiddenLabel mesh__D009569 Monoxide, Nitrogen
% 220.68/220.90  |- skos__altLabel mesh__D009569 Mononitrogen Monoxide
% 220.68/220.90  |- skos__altLabel mesh__D009569 Endogenous Nitrate Vasodilator
% 220.68/220.90  |- skos__altLabel mesh__D009569 Nitrogen Protoxide
% 220.68/220.90  |- mesh__publicMeSHNote mesh__D009569 1965   
% 220.68/220.90  |- mesh__dateRevised mesh__D009569 2005-06-30
% 220.68/220.90  |- skos__broader mesh__D009569smesh__D005609
% 220.68/220.90  |- skos__scopeNote mesh__D009569
% 220.68/220.90       A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of  the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP.%A%    
% 220.68/220.90  |- skos__hiddenLabel mesh__D009569 Oxide, Nitric
% 220.68/220.90  |- mesh__recordMaintainer mesh__D009569 ssb
% 220.68/220.90  |- skos__altLabel mesh__D009569 Nitric Oxide, Endothelium-Derived
% 220.68/220.90  |- skos__related mesh__D009569smesh__D020030
% 220.68/220.90  |- mesh__historyNote mesh__D009569 1965   
% 220.68/220.90  |- skos__hiddenLabel mesh__D009569 Monoxide, Mononitrogen
% 220.68/220.90  |- skos__broader mesh__D009569smesh__D026361
% 220.68/220.90  |- skos__prefLabel mesh__D009569 Nitric Oxide
% 220.68/220.90  |- mesh__recordOriginator mesh__D001586 NLM
% 220.68/220.90  |- skos__broader mesh__D001586smesh__D001120
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D001586 2006
% 220.68/220.90  |- skos__hiddenLabel mesh__D001586 N Benzoylarginyl 4 nitroanilide
% 220.68/220.90  |- skos__hiddenLabel mesh__D001586 N Benzoylarginine 4 nitroanilide
% 220.68/220.90  |- mesh__dateEstablished mesh__D001586 1991-01-01
% 220.68/220.90  |- skos__altLabel mesh__D001586 N-Benzoylarginine-4-nitroanilide
% 220.68/220.90  |- skos__annotation mesh__D001586 DF: BAPA   
% 220.68/220.90  |- mesh__onlineNote mesh__D001586
% 220.68/220.90       use BENZOYLARGININE NITROANILIDE %28%NM%29% to search N-BENZOYLARGINYL-4-NITROANILIDE 1988-93%A%  
% 220.68/220.90  |- skos__historyNote mesh__D001586 Anilides %28%1971-1974%29%
% 220.68/220.90  |- skos__hiddenLabel mesh__D001586
% 220.68/220.90       Monohydrochloride, Benzoylarginine Nitroanilide
% 220.68/220.90  |- skos__historyNote mesh__D001586 Benzamides %28%1974%29%
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D001586 2005
% 220.68/220.90  |- mesh__recordAuthorizer mesh__D001586 sjn
% 220.68/220.90  |- mesh__recordMaintainer mesh__D001586 nns
% 220.68/220.90  |- skos__hiddenLabel mesh__D001586 Nitroanilide, Benzoylarginine
% 220.68/220.90  |- skos__scopeNote mesh__D001586
% 220.68/220.90       A chromogenic substrate that permits direct measurement of peptide hydrolase activity, e.g., papain and trypsin, by colorimetry. The substrate liberates p-nitroaniline as a chromogenic product.%A%    
% 220.68/220.90  |- mesh__dateRevised mesh__D001586 2001-07-25
% 220.68/220.90  |- skos__historyNote mesh__D001586 Nitro Compounds %28%1971-1974%29%
% 220.68/220.90  |- rdf__type mesh__D001586sskos__Concept
% 220.68/220.90  |- skos__altLabel mesh__D001586 N-Benzoylarginyl-4-nitroanilide
% 220.68/220.90  |- skos__altLabel mesh__D001586 BAPNA
% 220.68/220.90  |- mesh__historyNote mesh__D001586
% 220.68/220.90       91%28%75%29%; was see under ARGININE 1975-90; N-BENZOYLARGINYL-4-NITROANILIDE was %28%NM%29% 1988-93%A%  
% 220.68/220.90  |- mesh__dateCreated mesh__D001586 1974-11-19
% 220.68/220.90  |- skos__broader mesh__D001586smesh__D000813
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D001586 2004
% 220.68/220.90  |- mesh__publicMeSHNote mesh__D001586
% 220.68/220.90       91; was see under ARGININE 1975-90; N-BENZOYLARGINYL-4-NITROANILIDE was indexed under BENZOYLARGININE NITROANILIDE 1993 %26% ARGININE/*analogs %26% derivatives 1988-92%A%  
% 220.68/220.90  |- skos__hiddenLabel mesh__D001586
% 220.68/220.90       N alpha Benzoyl DL arginine 4 nitroanilide
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D001586 2002
% 220.68/220.90  |- skos__prefLabel mesh__D001586 Benzoylarginine Nitroanilide
% 220.68/220.90  |- skos__historyNote mesh__D001586 Arginine %28%1971-1974%29%
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D001586 2003
% 220.68/220.90  |- skos__prefLabel mesh__D028723 Personhood
% 220.68/220.90  |- skos__annotation mesh__D028723 do not confuse with INDIVIDUALITY   
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D028723 2006
% 220.68/220.90  |- skos__related mesh__D028723smesh__D033421
% 220.68/220.90  |- mesh__recordAuthorizer mesh__D028723 sjn
% 220.68/220.90  |- rdf__type mesh__D028723sskos__Concept
% 220.68/220.90  |- skos__scopeNote mesh__D028723
% 220.68/220.90       The state or condition of being a human individual accorded moral and/or legal rights. Criteria to be used to determine this status are subject to debate, and range from the requirement of simply being a human organism to such requirements as that the individual be self-aware and capable of rational thought and moral agency.%A%    
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D028723 2005
% 220.68/220.90  |- mesh__recordMaintainer mesh__D028723 sjn
% 220.68/220.90  |- mesh__recordOriginator mesh__D028723 jrf
% 220.68/220.90  |- skos__historyNote mesh__D028723 Individuality %28%1974-2001%29%
% 220.68/220.90  |- mesh__dateEstablished mesh__D028723 2002-01-01
% 220.68/220.90  |- skos__broader mesh__D028723smesh__D004989
% 220.68/220.90  |- skos__related mesh__D028723smesh__D040821
% 220.68/220.90  |- mesh__dateRevised mesh__D028723 2004-07-13
% 220.68/220.90  |- mesh__publicMeSHNote mesh__D028723 2002; see INDIVIDUALITY 1995-2001   
% 220.68/220.90  |- mesh__dateCreated mesh__D028723 2001-07-25
% 220.68/220.90  |- mesh__historyNote mesh__D028723 2002; use INDIVIDUALITY 1995-2001   
% 220.68/220.90  |- skos__historyNote mesh__D020740 Nerve Tissue Proteins %28%1991-1999%29%
% 220.68/220.90  |- mesh__historyNote mesh__D020740 2000   
% 220.68/220.90  |- skos__hiddenLabel mesh__D020740 Proteins, Chimaerin
% 220.68/220.90  |- mesh__publicMeSHNote mesh__D020740 2000   
% 220.68/220.90  |- skos__altLabel mesh__D020740 Chimaerin Proteins
% 220.68/220.90  |- mesh__recordAuthorizer mesh__D020740 sjn
% 220.68/220.90  |- mesh__dateCreated mesh__D020740 1999-11-03
% 220.68/220.90  |- skos__scopeNote mesh__D020740
% 220.68/220.90       A family of GTPASE-ACTIVATING PROTEINS that are specific for RAC GTP-BINDING PROTEINS.%A%    
% 220.68/220.90  |- skos__prefLabel mesh__D020740 Chimerin Proteins
% 220.68/220.90  |- skos__historyNote mesh__D020740 Proteins %28%1996-1999%29%
% 220.68/220.90  |- mesh__recordMaintainer mesh__D020740 SYSTEM
% 220.68/220.90  |- skos__broader mesh__D020740smesh__D009419
% 220.68/220.90  |- skos__broader mesh__D020740smesh__D020690
% 220.68/220.90  |- mesh__dateEstablished mesh__D020740 2000-01-01
% 220.68/220.90  |- mesh__recordOriginator mesh__D020740 jmp
% 220.68/220.90  |- mesh__dateRevised mesh__D020740 2005-06-30
% 220.68/220.90  |- rdf__type mesh__D020740sskos__Concept
% 220.68/220.90  |- skos__historyNote mesh__D020740 Neoplasm Proteins %28%1996-1999%29%
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D020740 2006
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006271 1999
% 220.68/220.90  |- skos__altLabel mesh__D006271 Hospital Closures
% 220.68/220.90  |- skos__historyNote mesh__D006271
% 220.68/220.90       Hospital Administration %28%1966-Jul 1977%29%
% 220.68/220.90  |- mesh__dateCreated mesh__D006271 1977-05-11
% 220.68/220.90  |- skos__altLabel mesh__D006271 Closures, Health Facility
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006271 1998
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006271 2006
% 220.68/220.90  |- skos__altLabel mesh__D006271 Closure, Health Facility
% 220.68/220.90  |- skos__altLabel mesh__D006271 Closures, Hospital
% 220.68/220.90  |- skos__scopeNote mesh__D006271
% 220.68/220.90       The closing of any health facility, e.g., health centers, residential facilities, and hospitals.%A%    
% 220.68/220.90  |- mesh__recordOriginator mesh__D006271 EC
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006271 2001
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006271 2005
% 220.68/220.90  |- mesh__publicMeSHNote mesh__D006271
% 220.68/220.90       91; was see under HEALTH FACILITIES 1983-90; was HOSPITAL CLOSURE see under HOSPITAL ADMINISTRATION Aug 1977-82%A%  
% 220.68/220.90  |- skos__altLabel mesh__D006271 Health Facility Closures
% 220.68/220.90  |- mesh__recordAuthorizer mesh__D006271 SJN
% 220.68/220.90  |- mesh__dateRevised mesh__D006271 1997-06-20
% 220.68/220.90  |- skos__broader mesh__D006271smesh__D006268
% 220.68/220.90  |- skos__altLabel mesh__D006271 Hospital Closure
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006271 2000
% 220.68/220.90  |- skos__altLabel mesh__D006271 Facility Closure, Health
% 220.68/220.90  |- mesh__recordMaintainer mesh__D006271 TPW
% 220.68/220.90  |- mesh__historyNote mesh__D006271
% 220.68/220.90       91%28%83%29%; was see under HEALTH FACILITIES 1983-90; was HOSPITAL CLOSURE see under HOSPITAL ADMINISTRATION Aug 1977-82%A%  
% 220.68/220.90  |- skos__prefLabel mesh__D006271 Health Facility Closure
% 220.68/220.90  |- skos__broader mesh__D006271smesh__D006297
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006271 2004
% 220.68/220.90  |- rdf__type mesh__D006271sskos__Concept
% 220.68/220.90  |- skos__altLabel mesh__D006271 Facility Closures, Health
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006271 2002
% 220.68/220.90  |- mesh__dateEstablished mesh__D006271 1991-01-01
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D006271 2003
% 220.68/220.90  |- mesh__onlineNote mesh__D006271
% 220.68/220.90       use HEALTH FACILITY CLOSURE to search HOSPITAL CLOSURE Aug 1977-82%A%  
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D047688 2006
% 220.68/220.90  |- skos__altLabel mesh__D047688 Breast Cysts
% 220.68/220.90  |- skos__broader mesh__D047688smesh__D001941
% 220.68/220.90  |- mesh__historyNote mesh__D047688
% 220.68/220.90       2005; use FIBROCYSTIC BREAST DISEASE 1993-2004   
% 220.68/220.90  |- skos__historyNote mesh__D047688 Cysts %28%1967-1979%29%
% 220.68/220.90  |- mesh__recordOriginator mesh__D047688 lkt
% 220.68/220.90  |- skos__scopeNote mesh__D047688
% 220.68/220.90       A fluid-filled closed cavity or sac that is lined by an EPITHELIUM and found in the BREAST. It may appear as a single large cyst in one breast, multifocal, or bilateral in FIBROCYSTIC BREAST DISEASE.%A%    
% 220.68/220.90  |- skos__prefLabel mesh__D047688 Breast Cyst
% 220.68/220.90  |- skos__annotation mesh__D047688
% 220.68/220.90       FIBROCYSTIC BREAST DISEASE is also available   
% 220.68/220.90  |- rdf__type mesh__D047688sskos__Concept
% 220.68/220.90  |- mesh__recordMaintainer mesh__D047688 lkt
% 220.68/220.90  |- skos__hiddenLabel mesh__D047688 Cysts, Breast
% 220.68/220.90  |- mesh__dateCreated mesh__D047688 2004-07-07
% 220.68/220.90  |- mesh__recordAuthorizer mesh__D047688 sjn
% 220.68/220.90  |- mesh__dateEstablished mesh__D047688 2005-01-01
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D047688 2005
% 220.68/220.90  |- skos__broader mesh__D047688smesh__D003560
% 220.68/220.90  |- skos__historyNote mesh__D047688
% 220.68/220.90       Fibrocystic Disease of Breast %28%1980-2004%29%
% 220.68/220.90  |- mesh__publicMeSHNote mesh__D047688
% 220.68/220.90       2005; see FIBROCYSTIC DISEASE OF BREAST 1993-2004   
% 220.68/220.90  |- skos__hiddenLabel mesh__D047688 Cyst, Breast
% 220.68/220.90  |- skos__historyNote mesh__D047688 Breast Diseases %28%1967-1979%29%
% 220.68/220.90  |- skos__related mesh__D047688smesh__D005348
% 220.68/220.90  |- mesh__historyNote mesh__D014703
% 220.68/220.90       91%28%86%29%63; was see under PLANTS, TOXIC 1986-90; was heading 1963-85; was in Cat B %26% D 1963-77%A%  
% 220.68/220.90  |- skos__annotation mesh__D014703
% 220.68/220.90       plant only; VERATRUM ALKALOIDS is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D014703 2005
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D014703 2006
% 220.68/220.90  |- skos__altLabel mesh__D014703 Hellebore, White
% 220.68/220.90  |- mesh__recordAuthorizer mesh__D014703 sjn
% 220.68/220.90  |- mesh__dateCreated mesh__D014703 1999-01-01
% 220.68/220.90  |- mesh__activeMeSHYear mesh__D014703 2003
% 220.68/220.90  |- mesh__dateEstablished mesh__D014703 1991-01-01
% 220.68/220.90  |- skos__broader mesh__D014703smesh__D019668
% 220.68/220.90  |- skos__prefLabel mesh__D014703 Veratrum
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D014703 2004
% 220.68/220.91  |- mesh__dateRevised mesh__D014703 2002-07-03
% 220.68/220.91  |- rdf__type mesh__D014703sskos__Concept
% 220.68/220.91  |- mesh__publicMeSHNote mesh__D014703
% 220.68/220.91       91,63-85; was see under PLANTS, TOXIC 1986-90; was heading 1963-85; was in Cat B %26% D 1963-77%A%  
% 220.68/220.91  |- skos__altLabel mesh__D014703 Hellebore, Black
% 220.68/220.91  |- skos__altLabel mesh__D014703 Hellebore, False
% 220.68/220.91  |- mesh__recordOriginator mesh__D014703 NLM
% 220.68/220.91  |- mesh__recordMaintainer mesh__D014703 ssb
% 220.68/220.91  |- skos__scopeNote mesh__D014703
% 220.68/220.91       A plant genus of the family LILIACEAE with roots that contain VERATRUM ALKALOIDS used as emetics, parasiticides, antihypertensives. It is the main ingredient of Boicil.%A%    
% 220.68/220.91  |- mesh__historyNote mesh__D019199 97   
% 220.68/220.91  |- skos__broader mesh__D019199smesh__D019196
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D019199 2001
% 220.68/220.91  |- rdf__type mesh__D019199sskos__Concept
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D019199 2006
% 220.68/220.91  |- skos__annotation mesh__D019199
% 220.68/220.91       a genus of the family Totiviridae; infects the protozoan Leishmania; coord IM with specific Leishmania /virol %28%IM%29%%A%  
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D019199 1997
% 220.68/220.91  |- skos__hiddenLabel mesh__D019199 Leishmaniaviruses
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D019199 1998
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D019199 2002
% 220.68/220.91  |- skos__scopeNote mesh__D019199
% 220.68/220.91       A genus of RNA protozoan viruses of the family TOTIVIRIDAE. Several different strains of Leishmania are infected by a variety of viral species. The type species is Leishmania RNA virus 1-1.%A%    
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D019199 1999
% 220.68/220.91  |- mesh__dateCreated mesh__D019199 1996-06-10
% 220.68/220.91  |- skos__prefLabel mesh__D019199 Leishmaniavirus
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D019199 2003
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D019199 2000
% 220.68/220.91  |- skos__historyNote mesh__D019199 RNA Viruses %28%1988-1996%29%
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D019199 2005
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D019199 2004
% 220.68/220.91  |- mesh__publicMeSHNote mesh__D019199 97   
% 220.68/220.91  |- mesh__dateEstablished mesh__D019199 1997-01-01
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005977 2001
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005977 2003
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005977 1993
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005977 1999
% 220.68/220.91  |- mesh__dateRevised mesh__D005977 1992-05-19
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005977 2000
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005977 1998
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005977 2006
% 220.68/220.91  |- mesh__recordOriginator mesh__D005977 NLM
% 220.68/220.91  |- rdf__type mesh__D005977sskos__Concept
% 220.68/220.91  |- mesh__dateCreated mesh__D005977 1999-01-01
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005977 1995
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005977 2005
% 220.68/220.91  |- skos__prefLabel mesh__D005977 Glutarates
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005977 1994
% 220.68/220.91  |- mesh__recordMaintainer mesh__D005977 TGC
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005977 2002
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005977 1997
% 220.68/220.91  |- skos__broader mesh__D005977smesh__D003998
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005977 1996
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005977 2004
% 220.68/220.91  |- mesh__recordAuthorizer mesh__D005977 PLS
% 220.68/220.91  |- mesh__dateRevised mesh__D005179 1996-06-10
% 220.68/220.91  |- mesh__publicMeSHNote mesh__D005179 66   
% 220.68/220.91  |- skos__altLabel mesh__D005179 Dental Faculty
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005179 2005
% 220.68/220.91  |- mesh__recordMaintainer mesh__D005179 TAP
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005179 1999
% 220.68/220.91  |- skos__altLabel mesh__D005179 Dental Faculties
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005179 2000
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005179 2006
% 220.68/220.91  |- mesh__dateEstablished mesh__D005179 1966-01-01
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005179 2001
% 220.68/220.91  |- mesh__historyNote mesh__D005179 66   
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005179 2003
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005179 1997
% 220.68/220.91  |- skos__scopeNote mesh__D005179
% 220.68/220.91       The teaching staff and members of the administrative staff having academic rank in a dental school.%A%    
% 220.68/220.91  |- mesh__recordAuthorizer mesh__D005179 PLS
% 220.68/220.91  |- skos__prefLabel mesh__D005179 Faculty, Dental
% 220.68/220.91  |- skos__altLabel mesh__D005179 Faculties, Dental
% 220.68/220.91  |- mesh__recordOriginator mesh__D005179 NLM
% 220.68/220.91  |- skos__annotation mesh__D005179 Manual 30.9; DF: FACULTY DENT   
% 220.68/220.91  |- mesh__dateCreated mesh__D005179 1999-01-01
% 220.68/220.91  |- skos__broader mesh__D005179smesh__D006282
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005179 2004
% 220.68/220.91  |- skos__broader mesh__D005179smesh__D005178
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005179 2002
% 220.68/220.91  |- rdf__type mesh__D005179sskos__Concept
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005179 1998
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D010313 1999
% 220.68/220.91  |- mesh__recordOriginator mesh__D010313 NLM
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D010313 1994
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D010313 2003
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D010313 1997
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D010313 1992
% 220.68/220.91  |- rdf__type mesh__D010313sskos__Concept
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D010313 1998
% 220.68/220.91  |- skos__prefLabel mesh__D010313 Partial Pressure
% 220.68/220.91  |- skos__hiddenLabel mesh__D010313 Pressures, Partial
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D010313 1996
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D010313 2002
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D010313 1991
% 220.68/220.91  |- skos__hiddenLabel mesh__D010313 Pressure, Partial
% 220.68/220.91  |- mesh__recordAuthorizer mesh__D010313 PLS
% 220.68/220.91  |- skos__broader mesh__D010313smesh__D011312
% 220.68/220.91  |- skos__annotation mesh__D010313 NIM; no qualif   
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D010313 2001
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D010313 1990
% 220.68/220.91  |- skos__hiddenLabel mesh__D010313 Partial Pressures
% 220.68/220.91  |- mesh__publicMeSHNote mesh__D010313 68   
% 220.68/220.91  |- mesh__historyNote mesh__D010313 68%28%64%29%   
% 220.68/220.91  |- mesh__dateEstablished mesh__D010313 1968-01-01
% 220.68/220.91  |- mesh__dateCreated mesh__D010313 1999-01-01
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D010313 2006
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D010313 2000
% 220.68/220.91  |- mesh__recordMaintainer mesh__D010313 TGC
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D010313 1995
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D010313 2004
% 220.68/220.91  |- mesh__dateRevised mesh__D010313 1989-06-14
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D010313 1993
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D010313 2005
% 220.68/220.91  |- rdf__type mesh__D034761sskos__Concept
% 220.68/220.91  |- skos__altLabel mesh__D034761 Heterogeneous-Nuclear Ribonucleoprotein M
% 220.68/220.91  |- mesh__dateEstablished mesh__D034761 2003-01-01
% 220.68/220.91  |- mesh__recordMaintainer mesh__D034761 SYSTEM
% 220.68/220.91  |- skos__altLabel mesh__D034761 hnRNP M
% 220.68/220.91  |- skos__hiddenLabel mesh__D034761
% 220.68/220.91       Heterogeneous Nuclear Ribonucleoprotein M
% 220.68/220.91  |- skos__historyNote mesh__D034761 Nucleoproteins %28%2000-2002%29%
% 220.68/220.91  |- mesh__historyNote mesh__D034761
% 220.68/220.91       2003; for HNRNP M use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 2000-2002%A%  
% 220.68/220.91  |- mesh__dateCreated mesh__D034761 2002-07-03
% 220.68/220.91  |- mesh__dateRevised mesh__D034761 2005-06-30
% 220.68/220.91  |- mesh__recordOriginator mesh__D034761 jmp
% 220.68/220.91  |- mesh__recordAuthorizer mesh__D034761 sjn
% 220.68/220.91  |- skos__prefLabel mesh__D034761
% 220.68/220.91       Heterogeneous-Nuclear Ribonucleoprotein Group M
% 220.68/220.91  |- mesh__publicMeSHNote mesh__D034761
% 220.68/220.91       2003; HNRNP M was indexed under NUCLEOPROTEINS 2000-2002   
% 220.68/220.91  |- skos__broader mesh__D034761smesh__D034441
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D034761 2006
% 220.68/220.91  |- skos__hiddenLabel mesh__D034761
% 220.68/220.91       Ribonucleoprotein M, Heterogeneous-Nuclear
% 220.68/220.91  |- skos__hiddenLabel mesh__D034761
% 220.68/220.91       Heterogeneous Nuclear Ribonucleoprotein Group M
% 220.68/220.91  |- skos__annotation mesh__D034761 see SCR for specific hnRNP entries   
% 220.68/220.91  |- skos__scopeNote mesh__D034761
% 220.68/220.91       A group of closely-related 72-74-kDa heterogeneous-nuclear ribonucleoproteins that are involved in RNA SPLICING events.%A%    
% 220.68/220.91  |- mesh__dateCreated mesh__D001587 1975-07-23
% 220.68/220.91  |- skos__broader mesh__D001587smesh__D000577
% 220.68/220.91  |- skos__scopeNote mesh__D001587
% 220.68/220.91       An enzyme substrate which permits the measurement of peptide hydrolase activity, e.g. trypsin and thrombin. The enzymes liberate 2-naphthylamine, which is measured by colorimetric procedures.%A%    
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D001587 2006
% 220.68/220.91  |- skos__prefLabel mesh__D001587 Benzoylarginine-2-Naphthylamide
% 220.68/220.91  |- skos__hiddenLabel mesh__D001587 beta-Naphthylamide, Benzoylarginine
% 220.68/220.91  |- mesh__historyNote mesh__D001587
% 220.68/220.91       91%28%77%29%; was see under ARGININE 1977-90; was BENZOYLARGININE BETA NAPHTHYLAMIDE see under ARGININE 1976%A%  
% 220.68/220.91  |- mesh__recordOriginator mesh__D001587 RLS
% 220.68/220.91  |- mesh__onlineNote mesh__D001587
% 220.68/220.91       use BENZOYLARGININE-2-NAPHTHYLAMIDE to search BENZOYLARGININE BETA NAPHTHYLAMIDE 1976%A%  
% 220.68/220.91  |- skos__annotation mesh__D001587 DF: BANA   
% 220.68/220.91  |- mesh__publicMeSHNote mesh__D001587
% 220.68/220.91       91; was see under ARGININE 1977-90; was BENZOYLARGININE BETA NAPHTHYLAMIDE see under ARGININE 1976%A%  
% 220.68/220.91  |- skos__historyNote mesh__D001587 Benzamides %28%1974-1975%29%
% 220.68/220.91  |- mesh__dateRevised mesh__D001587 2001-07-25
% 220.68/220.91  |- rdf__type mesh__D001587sskos__Concept
% 220.68/220.91  |- mesh__recordMaintainer mesh__D001587 nns
% 220.68/220.91  |- mesh__dateEstablished mesh__D001587 1991-01-01
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D001587 2003
% 220.68/220.91  |- skos__broader mesh__D001587smesh__D001120
% 220.68/220.91  |- skos__hiddenLabel mesh__D001587 Benzoylarginine beta Naphthylamide
% 220.68/220.91  |- mesh__recordAuthorizer mesh__D001587 sjn
% 220.68/220.91  |- skos__historyNote mesh__D001587 Naphthalenes %28%1973-1975%29%
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D001587 2004
% 220.68/220.91  |- skos__hiddenLabel mesh__D001587 Naphthylamide, Benzoylarginine 2
% 220.68/220.91  |- skos__historyNote mesh__D001587
% 220.68/220.91       Arginine %28%1973-1974%29% /analogs %26% derivatives %28%1975%29%
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D001587 2002
% 220.68/220.91  |- skos__altLabel mesh__D001587 Benzoylarginine beta-Naphthylamide
% 220.68/220.91  |- skos__hiddenLabel mesh__D001587 2 Naphthylamide, Benzoylarginine
% 220.68/220.91  |- skos__altLabel mesh__D001587 Benzoylarginine 2 Naphthylamide
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D001587 2005
% 220.68/220.91  |- skos__hiddenLabel mesh__D020741 GTP-Binding Protein, rho
% 220.68/220.91  |- skos__altLabel mesh__D020741 rho GTP-Binding Protein
% 220.68/220.91  |- mesh__recordMaintainer mesh__D020741 jmp
% 220.68/220.91  |- skos__prefLabel mesh__D020741 rho GTP-Binding Proteins
% 220.68/220.91  |- skos__scopeNote mesh__D020741
% 220.68/220.91       A large family of MONOMERIC GTP-BINDING PROTEINS that are involved in regulation of actin organization, gene expression and cell cycle progression. This enzyme was formerly listed as EC 3.6.1.47.%A%    
% 220.68/220.91  |- skos__hiddenLabel mesh__D020741 rho GTP Binding Protein
% 220.68/220.91  |- skos__altLabel mesh__D020741 rho GTPases
% 220.68/220.91  |- skos__hiddenLabel mesh__D020741 rho GTP Binding Proteins
% 220.68/220.91  |- skos__historyNote mesh__D020741 G-Proteins %28%1993-1999%29%
% 220.68/220.91  |- skos__hiddenLabel mesh__D020741 rho Small GTP Binding Proteins
% 220.68/220.91  |- skos__hiddenLabel mesh__D020741 GTP-Binding Proteins, rho
% 220.68/220.91  |- skos__hiddenLabel mesh__D020741 P21, rho Protein
% 220.68/220.91  |- skos__hiddenLabel mesh__D020741 G-Proteins, rho
% 220.68/220.91  |- skos__broader mesh__D020741smesh__D020559
% 220.68/220.91  |- mesh__dateEstablished mesh__D020741 2000-01-01
% 220.68/220.91  |- mesh__recordAuthorizer mesh__D020741 sjn
% 220.68/220.91  |- skos__hiddenLabel mesh__D020741 GTPases, rho
% 220.68/220.91  |- mesh__dateCreated mesh__D020741 1999-11-03
% 220.68/220.91  |- rdf__type mesh__D020741sskos__Concept
% 220.68/220.91  |- skos__altLabel mesh__D020741 rho Protein P21
% 220.68/220.91  |- skos__hiddenLabel mesh__D020741 rho G Proteins
% 220.68/220.91  |- skos__altLabel mesh__D020741 rho G-Proteins
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D020741 2006
% 220.68/220.91  |- mesh__publicMeSHNote mesh__D020741
% 220.68/220.91       2000; P21 %28%RHO%29%PROTEIN %28%now RHO GTP-BINDING PROTEINS%29% was indexed under PROTEINS 1992-1999%A%  
% 220.68/220.91  |- skos__altLabel mesh__D020741 P21 %28%rho%29%Protein
% 220.68/220.91  |- mesh__historyNote mesh__D020741
% 220.68/220.91       2000; use RHO GTP-BINDING PROTEINS %28%NM%29% 1992-1999   
% 220.68/220.91  |- skos__altLabel mesh__D020741 rho Small GTP-Binding Proteins
% 220.68/220.91  |- mesh__recordOriginator mesh__D020741 jmp
% 220.68/220.91  |- mesh__dateRevised mesh__D020741 2005-06-30
% 220.68/220.91  |- skos__prefLabel mesh__D006272 Health Facility Environment
% 220.68/220.91  |- skos__hiddenLabel mesh__D006272 Environments, Health Facility
% 220.68/220.91  |- skos__hiddenLabel mesh__D006272 Health Facility Environments
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D006272 2006
% 220.68/220.91  |- mesh__dateEstablished mesh__D006272 1991-01-01
% 220.68/220.91  |- skos__scopeNote mesh__D006272
% 220.68/220.91       Physical surroundings or conditions of a hospital or other health facility and influence of these factors on patients and staff.%A%    
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D006272 1996
% 220.68/220.91  |- skos__broader mesh__D006272smesh__D006268
% 220.68/220.91  |- mesh__recordAuthorizer mesh__D006272 PLS
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D006272 2000
% 220.68/220.91  |- mesh__recordOriginator mesh__D006272 EC
% 220.68/220.91  |- mesh__historyNote mesh__D006272
% 220.68/220.91       91%28%80%29%; was see under HEALTH FACILITIES 1980-90   
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D006272 2003
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D006272 1997
% 220.68/220.91  |- skos__hiddenLabel mesh__D006272 Facility Environment, Health
% 220.68/220.91  |- mesh__dateCreated mesh__D006272 1979-05-29
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D006272 2001
% 220.68/220.91  |- skos__annotation mesh__D006272 DF: HEALTH FACILITY ENVIR   
% 220.68/220.91  |- skos__altLabel mesh__D006272 Environment, Health Facility
% 220.68/220.91  |- mesh__dateRevised mesh__D006272 1995-05-19
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D006272 2004
% 220.68/220.91  |- rdf__type mesh__D006272sskos__Concept
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D006272 1998
% 220.68/220.91  |- mesh__recordMaintainer mesh__D006272 KEV
% 220.68/220.91  |- skos__broader mesh__D006272smesh__D006297
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D006272 2002
% 220.68/220.91  |- mesh__publicMeSHNote mesh__D006272
% 220.68/220.91       91; was see under HEALTH FACILITIES 1980-90   
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D006272 2005
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D006272 1999
% 220.68/220.91  |- skos__annotation mesh__D014704 antihypertensives   
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D014704 2006
% 220.68/220.91  |- mesh__recordMaintainer mesh__D014704 PXP
% 220.68/220.91  |- mesh__historyNote mesh__D014704 75   
% 220.68/220.91  |- mesh__recordOriginator mesh__D014704 NLM
% 220.68/220.91  |- mesh__dateCreated mesh__D014704 1999-01-01
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D014704 2003
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D014704 2000
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D014704 2004
% 220.68/220.91  |- skos__historyNote mesh__D014704 Veratrum %28%1966-1974%29%
% 220.68/220.91  |- rdf__type mesh__D014704sskos__Concept
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D014704 2001
% 220.68/220.91  |- mesh__publicMeSHNote mesh__D014704
% 220.68/220.91       75; PROTOVERATRINE A was see under CEVANES 1975-79; PROTOVERATRINE A DERIVATIVES was see under CEVANES 1969-77; PROTOVERATRINE was see under VERATRUM 1963-68; CRYPTENAMINE %28%now see PROTOVERATRINES%29% was see under VERATRUM ALKALOIDS 1975-79, was see under VERATRUM 1963-74%A%  
% 220.68/220.91  |- skos__prefLabel mesh__D014704 Veratrum Alkaloids
% 220.68/220.91  |- mesh__recordAuthorizer mesh__D014704 SJN
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D014704 1998
% 220.68/220.91  |- mesh__dateRevised mesh__D014704 1997-06-20
% 220.68/220.91  |- skos__scopeNote mesh__D014704
% 220.68/220.91       Alkaloids with powerful hypotensive effects isolated from American or European Hellebore %28%Veratrum viride Ait. Liliaceae and Veratrum album L. Liliaceae%29%. They increase cholinergic and decrease adrenergic tone with appropriate side effects and at higher doses depress respiration and produce cardiac arrhythmias; only the ester alkaloids have been used as hypotensive agents in specific instances. They have been generally replaced by drugs with fewer adverse effects.%A%    
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D014704 1999
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D014704 2005
% 220.68/220.91  |- mesh__dateEstablished mesh__D014704 1975-01-01
% 220.68/220.91  |- skos__hiddenLabel mesh__D014704 Alkaloids, Veratrum
% 220.68/220.91  |- skos__broader mesh__D014704smesh__D000470
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D014704 2002
% 220.68/220.91  |- skos__broader mesh__D019998smesh__D007535
% 220.68/220.91  |- mesh__publicMeSHNote mesh__D019998
% 220.68/220.91       98; see RACEMASES 1991-97, see EPIMERASES 1991-97, see ISOMERASES 1975-90%A%  
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D019998 2005
% 220.68/220.91  |- mesh__dateCreated mesh__D019998 1997-06-20
% 220.68/220.91  |- skos__prefLabel mesh__D019998 Racemases and Epimerases
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D019998 2006
% 220.68/220.91  |- skos__altLabel mesh__D019998 Epimerases and Racemases
% 220.68/220.91  |- mesh__dateEstablished mesh__D019998 1998-01-01
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D019998 2004
% 220.68/220.91  |- mesh__onlineNote mesh__D019998 search ISOMERASES 1966-74   
% 220.68/220.91  |- rdf__type mesh__D019998sskos__Concept
% 220.68/220.91  |- mesh__dateRevised mesh__D019998 2003-07-09
% 220.68/220.91  |- skos__scopeNote mesh__D019998
% 220.68/220.91       Enzymes that catalyze inversion of the configuration around an asymmetric carbon in a substrate having one %28%racemase%29% or more %28%epimerase%29% center%28%s%29% of asymmetry. %28%Dorland, 28th ed%29% EC 5.1.%A%    
% 220.68/220.91  |- mesh__historyNote mesh__D019998 98%28%75%29%   
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005978 2002
% 220.68/220.91  |- mesh__dateCreated mesh__D005978 1999-01-01
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005978 2005
% 220.68/220.91  |- skos__prefLabel mesh__D005978 Glutathione
% 220.68/220.91  |- skos__hiddenLabel mesh__D005978 gamma L Glutamyl L Cysteinylglycine
% 220.68/220.91  |- mesh__recordAuthorizer mesh__D005978 sjn
% 220.68/220.91  |- skos__broader mesh__D005978smesh__D009842
% 220.68/220.91  |- skos__altLabel mesh__D005978 gamma-L-Glu-L-Cys-Gly
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005978 2004
% 220.68/220.91  |- mesh__dateRevised mesh__D005978 2001-07-25
% 220.68/220.91  |- mesh__recordMaintainer mesh__D005978 ssb
% 220.68/220.91  |- skos__scopeNote mesh__D005978
% 220.68/220.91       A tripeptide with many roles in cells.  It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides.%A%    
% 220.68/220.91  |- skos__altLabel mesh__D005978 gamma-L-Glutamyl-L-Cysteinylglycine
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005978 2003
% 220.68/220.91  |- mesh__recordOriginator mesh__D005978 NLM
% 220.68/220.91  |- skos__hiddenLabel mesh__D005978 gamma L Glu L Cys Gly
% 220.68/220.91  |- skos__hiddenLabel mesh__D005978 Glutathione, Reduced
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D005978 2006
% 220.68/220.91  |- rdf__type mesh__D005978sskos__Concept
% 220.68/220.91  |- rdf__type mesh__D002680sskos__Concept
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D002680 2003
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D002680 1996
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D002680 2005
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D002680 1998
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D002680 1992
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D002680 2004
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D002680 1997
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D002680 1994
% 220.68/220.91  |- mesh__dateRevised mesh__D002680 1991-05-30
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D002680 2002
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D002680 2006
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D002680 1999
% 220.68/220.91  |- skos__annotation mesh__D002680
% 220.68/220.91       bone or site; usually NIM as site: submental %28%beneath the chin%29% refers to skin, fat %26% other tissue below the chin as in %22%submental lipectomy for double chin%22%; /growth: consider also MAXILLOFACIAL DEVELOPMENT%A%  
% 220.68/220.91  |- skos__scopeNote mesh__D002680
% 220.68/220.91       The anatomical frontal portion of the mandible, also known as the mentum, that contains the line of fusion of the two separate halves of the mandible %28%symphysis menti%29%. This line of fusion divides inferiorly to enclose a triangular area called the mental protuberance. On each side, inferior to the second premolar tooth, is the mental foramen for the passage of blood vessels and a nerve.%A%    
% 220.68/220.91  |- mesh__recordOriginator mesh__D002680 NLM
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D002680 1993
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D002680 1995
% 220.68/220.91  |- skos__broader mesh__D002680smesh__D005145
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D002680 2000
% 220.68/220.91  |- skos__prefLabel mesh__D002680 Chin
% 220.68/220.91  |- mesh__dateCreated mesh__D002680 1999-01-01
% 220.68/220.91  |- mesh__recordMaintainer mesh__D002680 MXR
% 220.68/220.91  |- skos__broader mesh__D002680smesh__D008334
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D002680 2001
% 220.68/220.91  |- skos__altLabel mesh__D002680 Mentum
% 220.68/220.91  |- mesh__recordAuthorizer mesh__D002680 PLS
% 220.68/220.91  |- skos__altLabel mesh__D010314 Thromboplastin Time, Partial
% 220.68/220.91  |- mesh__recordMaintainer mesh__D010314 nns
% 220.68/220.91  |- skos__scopeNote mesh__D010314
% 220.68/220.91       The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute %28%e.g., crude cephalins, soybean phosphatides%29%. It is a test of the intrinsic pathway %28%factors VIII, IX, XI, and XII%29% and the common pathway %28%fibrinogen, prothrombin, factors V and X%29% of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy.%A%    
% 220.68/220.91  |- skos__hiddenLabel mesh__D010314 Kaolin Cephalin Coagulation Time
% 220.68/220.91  |- skos__prefLabel mesh__D010314 Partial Thromboplastin Time
% 220.68/220.91  |- skos__altLabel mesh__D010314 Coagulation Time, Cephalin-Kaolin
% 220.68/220.91  |- skos__hiddenLabel mesh__D010314 Cephalin Kaolin Coagulation Time
% 220.68/220.91  |- skos__annotation mesh__D010314 usually NIM; DF: PTT   
% 220.68/220.91  |- mesh__dateRevised mesh__D010314 2003-07-09
% 220.68/220.91  |- skos__broader mesh__D010314smesh__D001780
% 220.68/220.91  |- skos__historyNote mesh__D010314 Thromboplastin %28%1966-1979%29%
% 220.68/220.91  |- mesh__historyNote mesh__D010314
% 220.68/220.91       91%28%80%29%; was see under BLOOD COAGULATION TESTS 1980-90   
% 220.68/220.91  |- mesh__recordAuthorizer mesh__D010314 sjn
% 220.68/220.91  |- skos__hiddenLabel mesh__D010314 Coagulation Time, Kaolin-Cephalin
% 220.68/220.91  |- skos__broader mesh__D010314smesh__D045122
% 220.68/220.91  |- mesh__recordOriginator mesh__D010314 SMH
% 220.68/220.91  |- mesh__publicMeSHNote mesh__D010314
% 220.68/220.91       91; was see under BLOOD COAGULATION TESTS 1980-90   
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D010314 2006
% 220.68/220.91  |- skos__altLabel mesh__D010314 Activated Partial Thromboplastin Time
% 220.68/220.91  |- mesh__dateCreated mesh__D010314 1979-03-07
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D010314 2004
% 220.68/220.91  |- mesh__dateEstablished mesh__D010314 1991-01-01
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D010314 2005
% 220.68/220.91  |- skos__historyNote mesh__D010314
% 220.68/220.91       Blood Coagulation Tests %28%1966-1979%29%
% 220.68/220.91  |- skos__altLabel mesh__D010314 Cephalin-Kaolin Coagulation Time
% 220.68/220.91  |- skos__hiddenLabel mesh__D010314 Coagulation Time, Cephalin Kaolin
% 220.68/220.91  |- rdf__type mesh__D010314sskos__Concept
% 220.68/220.91  |- skos__related mesh__D010314smesh__D001777
% 220.68/220.91  |- rdf__type mesh__D034762sskos__Concept
% 220.68/220.91  |- skos__scopeNote mesh__D034762
% 220.68/220.91       A plant genus of the family AMARANTHACEAE. Young leaves are used as vegetables in Asia. Members contain betacyanins, celogentins, betaxanthin, and celosian.%A%    
% 220.68/220.91  |- skos__altLabel mesh__D034762 Cockscomb, Common
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D034762 2004
% 220.68/220.91  |- skos__annotation mesh__D034762
% 220.68/220.91       X ref COCKSCOMB, COMMON: COCKSCOMB, GREEN see SEDUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.68/220.91  |- mesh__dateEstablished mesh__D034762 2003-01-01
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D034762 2005
% 220.68/220.91  |- mesh__historyNote mesh__D034762 2003   
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D034762 2006
% 220.68/220.91  |- skos__broader mesh__D034762smesh__D027703
% 220.68/220.91  |- mesh__dateCreated mesh__D034762 2002-07-03
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D034762 2003
% 220.68/220.91  |- skos__prefLabel mesh__D034762 Celosia
% 220.68/220.91  |- mesh__publicMeSHNote mesh__D034762 2003   
% 220.68/220.91  |- skos__broader mesh__D001588smesh__D002794
% 220.68/220.91  |- mesh__dateRevised mesh__D001588 2005-06-30
% 220.68/220.91  |- skos__historyNote mesh__D001588 Benzoates %28%1972-1975%29%
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D001588 2006
% 220.68/220.91  |- mesh__publicMeSHNote mesh__D001588 91; was see under CHOLINE 1976-90   
% 220.68/220.91  |- mesh__recordOriginator mesh__D001588 RLS
% 220.68/220.91  |- rdf__type mesh__D001588sskos__Concept
% 220.68/220.91  |- mesh__dateEstablished mesh__D001588 1991-01-01
% 220.68/220.91  |- skos__broader mesh__D001588smesh__D020185
% 220.68/220.91  |- skos__historyNote mesh__D001588
% 220.68/220.91       Choline %28%1968-1974%29% /AA %28%1975%29%
% 220.68/220.91  |- mesh__dateCreated mesh__D001588 1975-07-21
% 220.68/220.91  |- mesh__recordAuthorizer mesh__D001588 sjn
% 220.68/220.91  |- mesh__recordMaintainer mesh__D001588 ssb
% 220.68/220.91  |- mesh__historyNote mesh__D001588
% 220.68/220.91       91%28%76%29%; was see under CHOLINE 1976-90   
% 220.68/220.91  |- skos__prefLabel mesh__D001588 Benzoylcholine
% 220.68/220.91  |- skos__scopeNote mesh__D001588 The benzoic acid ester of choline.     
% 220.68/220.91  |- rdf__type mesh__D028725sskos__Concept
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D028725 2006
% 220.68/220.91  |- mesh__dateCreated mesh__D028725 2001-07-25
% 220.68/220.91  |- skos__broader mesh__D028725smesh__D012067
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D028725 2005
% 220.68/220.91  |- mesh__publicMeSHNote mesh__D028725 2002; see RELIGION 1978-2001   
% 220.68/220.91  |- mesh__dateEstablished mesh__D028725 2002-01-01
% 220.68/220.91  |- skos__prefLabel mesh__D028725 Theology
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D028725 2002
% 220.68/220.91  |- skos__scopeNote mesh__D028725
% 220.68/220.91       The study of religion and religious belief, or a particular system or school of religious beliefs and teachings %28%from online Cambridge Dictionary of American English, 2000 and WordNet: An Electronic Lexical Database, 1997%29%%A%    
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D028725 2004
% 220.68/220.91  |- skos__historyNote mesh__D028725 Religion %28%1974-2001%29%
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D028725 2003
% 220.68/220.91  |- mesh__historyNote mesh__D028725 2002; use RELIGION 1978-2001   
% 220.68/220.91  |- skos__hiddenLabel mesh__D020742 rhoA GTP Binding Protein
% 220.68/220.91  |- mesh__publicMeSHNote mesh__D020742
% 220.68/220.91       2000; RHOA P21 PROTEIN %28%now RHOA GTP-BINDING PROTEIN%29% was indexed under G-PROTEINS %28%1991-1999%29%%A%  
% 220.68/220.91  |- skos__scopeNote mesh__D020742
% 220.68/220.91       A RHO GTP-BINDING PROTEIN involved in regulating signal transduction pathways that control assembly of focal adhesions and actin stress fibers. This enzyme was formerly listed as EC 3.6.1.47.%A%    
% 220.68/220.91  |- skos__altLabel mesh__D020742 rho12 Protein
% 220.68/220.91  |- skos__prefLabel mesh__D020742 rhoA GTP-Binding Protein
% 220.68/220.91  |- rdf__type mesh__D020742sskos__Concept
% 220.68/220.91  |- skos__altLabel mesh__D020742 rhoA Protein
% 220.68/220.91  |- mesh__recordOriginator mesh__D020742 jmp
% 220.68/220.91  |- mesh__dateEstablished mesh__D020742 2000-01-01
% 220.68/220.91  |- mesh__dateRevised mesh__D020742 2005-06-30
% 220.68/220.91  |- mesh__activeMeSHYear mesh__D020742 2006
% 220.68/220.91  |- skos__hiddenLabel mesh__D020742 GTP-Binding Protein, rho12
% 220.68/220.91  |- skos__hiddenLabel mesh__D020742 ARHA GTP Binding Protein
% 220.68/220.91  |- skos__hiddenLabel mesh__D020742 GTP-Binding Protein, rhoA
% 220.68/220.91  |- skos__altLabel mesh__D020742 ARHA GTP-Binding Protein
% 220.68/220.91  |- skos__annotation mesh__D020742 DF: RHOA PROTEIN   
% 220.68/220.91  |- skos__altLabel mesh__D020742 rho12 GTP-Binding Protein
% 220.68/220.91  |- skos__altLabel mesh__D020742 rhoA P21 Protein
% 220.68/220.91  |- mesh__dateCreated mesh__D020742 1999-11-03
% 220.68/220.91  |- skos__broader mesh__D020742smesh__D020741
% 220.68/220.91  |- skos__hiddenLabel mesh__D020742 GTP-Binding Protein, ARHA
% 220.68/220.91  |- mesh__historyNote mesh__D020742
% 220.68/220.91       2000; use RHOA GTP-BINDING PROTEIN %28%NM%29% 1991-1999   
% 220.68/220.91  |- mesh__recordMaintainer mesh__D020742 jmp
% 220.68/220.91  |- skos__altLabel mesh__D020742 V14rhoA
% 220.68/220.91  |- mesh__recordAuthorizer mesh__D020742 sjn
% 220.68/220.91  |- skos__hiddenLabel mesh__D020742 rho12 GTP Binding Protein
% 220.68/220.91  |- skos__historyNote mesh__D020742 G-Proteins %28%1991-1999%29%
% 220.68/220.91  |- skos__hiddenLabel mesh__D006273 Acquisitions, Health Facility
% 220.68/220.92  |- mesh__historyNote mesh__D006273
% 220.68/220.92       91%28%Aug 77%29%; was see under HEALTH FACILITIES 1977-90   
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006273 2002
% 220.68/220.92  |- mesh__dateEstablished mesh__D006273 1991-01-01
% 220.68/220.92  |- skos__hiddenLabel mesh__D006273 Health Facility Mergers
% 220.68/220.92  |- skos__hiddenLabel mesh__D006273 Facility Acquisition, Health
% 220.68/220.92  |- mesh__dateRevised mesh__D006273 1992-05-15
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006273 1996
% 220.68/220.92  |- skos__broader mesh__D006273smesh__D006268
% 220.68/220.92  |- skos__hiddenLabel mesh__D006273 Merger, Hospital
% 220.68/220.92  |- mesh__publicMeSHNote mesh__D006273
% 220.68/220.92       91; was see under HEALTH FACILITIES Aug 1977-90   
% 220.68/220.92  |- skos__prefLabel mesh__D006273 Health Facility Merger
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006273 1997
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006273 2003
% 220.68/220.92  |- skos__hiddenLabel mesh__D006273 Facility Acquisitions, Health
% 220.68/220.92  |- skos__hiddenLabel mesh__D006273 Mergers, Health Facility
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006273 2004
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006273 1993
% 220.68/220.92  |- mesh__recordMaintainer mesh__D006273 TGC
% 220.68/220.92  |- rdf__type mesh__D006273sskos__Concept
% 220.68/220.92  |- skos__altLabel mesh__D006273 Acquisition, Health Facility
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006273 1998
% 220.68/220.92  |- mesh__recordAuthorizer mesh__D006273 PLS
% 220.68/220.92  |- skos__altLabel mesh__D006273 Merger, Health Facility
% 220.68/220.92  |- skos__scopeNote mesh__D006273
% 220.68/220.92       The combining of administrative and organizational resources of two or more health care facilities.%A%    
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006273 2000
% 220.68/220.92  |- skos__hiddenLabel mesh__D006273 Health Facility Acquisitions
% 220.68/220.92  |- mesh__recordOriginator mesh__D006273 EC
% 220.68/220.92  |- mesh__dateCreated mesh__D006273 1977-05-05
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006273 1994
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006273 1999
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006273 2005
% 220.68/220.92  |- skos__hiddenLabel mesh__D006273 Facility Mergers, Health
% 220.68/220.92  |- skos__hiddenLabel mesh__D006273 Facility Merger, Health
% 220.68/220.92  |- skos__hiddenLabel mesh__D006273 Mergers, Hospital
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006273 1995
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006273 2001
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006273 2006
% 220.68/220.92  |- skos__hiddenLabel mesh__D006273 Hospital Mergers
% 220.68/220.92  |- mesh__dateEstablished mesh__D014705 1966-01-01
% 220.68/220.92  |- mesh__historyNote mesh__D014705 66%28%64%29%   
% 220.68/220.92  |- mesh__publicMeSHNote mesh__D014705 66   
% 220.68/220.92  |- mesh__dateRevised mesh__D014705 2002-07-02
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D014705 2006
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D014705 2004
% 220.68/220.92  |- skos__broader mesh__D014705smesh__D003142
% 220.68/220.92  |- skos__scopeNote mesh__D014705
% 220.68/220.92       Includes both producing and responding to words, either written or spoken.%A%    
% 220.68/220.92  |- skos__prefLabel mesh__D014705 Verbal Behavior
% 220.68/220.92  |- mesh__recordOriginator mesh__D014705 NLM
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D014705 2005
% 220.68/220.92  |- mesh__dateCreated mesh__D014705 1999-01-01
% 220.68/220.92  |- skos__hiddenLabel mesh__D014705 Behaviors, Verbal
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D014705 2003
% 220.68/220.92  |- skos__hiddenLabel mesh__D014705 Behavior, Verbal
% 220.68/220.92  |- rdf__type mesh__D014705sskos__Concept
% 220.68/220.92  |- skos__related mesh__D014705smesh__D007806
% 220.68/220.92  |- skos__hiddenLabel mesh__D014705 Verbal Behaviors
% 220.68/220.92  |- mesh__recordAuthorizer mesh__D014705 sjn
% 220.68/220.92  |- mesh__recordMaintainer mesh__D014705 TAP
% 220.68/220.92  |- skos__related mesh__D014705smesh__D013064
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D019999 2006
% 220.68/220.92  |- mesh__historyNote mesh__D019999 98   
% 220.68/220.92  |- mesh__publicMeSHNote mesh__D019999 98   
% 220.68/220.92  |- skos__broader mesh__D019999smesh__D012996
% 220.68/220.92  |- skos__annotation mesh__D019999
% 220.68/220.92       IM for general only; NIM when drug in solution is IM; DF: PHARM SOL%A%  
% 220.68/220.92  |- mesh__dateCreated mesh__D019999 1997-06-20
% 220.68/220.92  |- mesh__dateRevised mesh__D019999 2005-06-30
% 220.68/220.92  |- rdf__type mesh__D019999sskos__Concept
% 220.68/220.92  |- skos__hiddenLabel mesh__D019999 Solutions, Pharmaceutic
% 220.68/220.92  |- skos__historyNote mesh__D019999 Solutions %28%1970-1997%29%
% 220.68/220.92  |- skos__scopeNote mesh__D019999
% 220.68/220.92       Homogeneous liquid preparations that contain one or more chemical substances dissolved, i.e., molecularly dispersed, in a suitable solvent or mixture of mutually miscible solvents. For reasons of their ingredients, method of preparation, or use, they do not fall into another group of products.%A%    
% 220.68/220.92  |- skos__prefLabel mesh__D019999 Pharmaceutical Solutions
% 220.68/220.92  |- mesh__dateEstablished mesh__D019999 1998-01-01
% 220.68/220.92  |- skos__broader mesh__D019999smesh__D004304
% 220.68/220.92  |- skos__altLabel mesh__D019999 Pharmaceutic Solutions
% 220.68/220.92  |- mesh__recordMaintainer mesh__D019999 DRC
% 220.68/220.92  |- mesh__recordOriginator mesh__D019999 ADP
% 220.68/220.92  |- mesh__recordAuthorizer mesh__D019999 sjn
% 220.68/220.92  |- skos__altLabel mesh__D019999 Solutions, Pharmaceutical
% 220.68/220.92  |- skos__related mesh__D019999smesh__D012996
% 220.68/220.92  |- skos__broader mesh__D005979smesh__D010544
% 220.68/220.92  |- mesh__dateRevised mesh__D005979 2003-07-09
% 220.68/220.92  |- skos__hiddenLabel mesh__D005979 Lipoperoxidase, Glutathione
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D005979 2004
% 220.68/220.92  |- skos__historyNote mesh__D005979 Peroxidases %28%1968-1974%29%
% 220.68/220.92  |- mesh__dateCreated mesh__D005979 1974-11-19
% 220.68/220.92  |- skos__hiddenLabel mesh__D005979 Peroxidase, Glutathione
% 220.68/220.92  |- skos__prefLabel mesh__D005979 Glutathione Peroxidase
% 220.68/220.92  |- skos__scopeNote mesh__D005979
% 220.68/220.92       An enzyme catalyzing the oxidation of 2 moles of glutathione in the presence of hydrogen peroxide to yield oxidized glutathione and water. EC 1.11.1.9.%A%    
% 220.68/220.92  |- mesh__recordAuthorizer mesh__D005979 sjn
% 220.68/220.92  |- mesh__publicMeSHNote mesh__D005979
% 220.68/220.92       84; was see under PEROXIDASES 1975-83   
% 220.68/220.92  |- mesh__dateEstablished mesh__D005979 1984-01-01
% 220.68/220.92  |- skos__hiddenLabel mesh__D005979 Peroxidase, Selenoglutathione
% 220.68/220.92  |- skos__historyNote mesh__D005979 Glutathione %28%1968-1974%29%
% 220.68/220.92  |- mesh__historyNote mesh__D005979
% 220.68/220.92       84%28%75%29%; was see under PEROXIDASES 1975-83   
% 220.68/220.92  |- mesh__recordMaintainer mesh__D005979 ssb
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D005979 2006
% 220.68/220.92  |- rdf__type mesh__D005979sskos__Concept
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D005979 2005
% 220.68/220.92  |- mesh__recordOriginator mesh__D005979 NLM
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D002681 2006
% 220.68/220.92  |- mesh__recordMaintainer mesh__D002681 jls
% 220.68/220.92  |- skos__annotation mesh__D002681
% 220.68/220.92       mainland China: do not confuse with TAIWAN, the Republic of China; in translations use spelling: People%27%s Republic of China, not Peoples%27% nor Peoples%A%  
% 220.68/220.92  |- skos__altLabel mesh__D002681 Mainland China
% 220.68/220.92  |- skos__broader mesh__D002681smesh__D005202
% 220.68/220.92  |- skos__scopeNote mesh__D002681
% 220.68/220.92       A republic in east and central Asia, known also as the People%27%s Republic of China. It is an ancient country, with a civilization existing as early as 3000 B.C. Until 1912 it was known as the Chinese Empire. It was one of the four Great Powers in World War II. By 1950 the Communist regime had gained control. China became a member of the United Nations in 1971. The name may be derived from the qin or Ts%27%in dynasty %28%221-206 B.C.%29% or the Sanskrit name cina or the central province of Shaanxi or Shensi %28%its capital is Shian%29%. %28%From Webster%27%s New Geographical Dictionary, 1988, p257 %26% Room, Brewer%27%s Dictionary of Names, 1992, p111%29%%A%    
% 220.68/220.92  |- mesh__dateRevised mesh__D002681 2004-07-19
% 220.68/220.92  |- skos__prefLabel mesh__D002681 China
% 220.68/220.92  |- mesh__recordOriginator mesh__D002681 NLM
% 220.68/220.92  |- mesh__dateCreated mesh__D002681 1999-01-01
% 220.68/220.92  |- rdf__type mesh__D002681sskos__Concept
% 220.68/220.92  |- mesh__recordAuthorizer mesh__D002681 sjn
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D002681 2005
% 220.68/220.92  |- skos__historyNote mesh__D010315 Neutrons %28%1966-1977%29%
% 220.68/220.92  |- skos__hiddenLabel mesh__D010315 Accelerator, Particle
% 220.68/220.92  |- skos__hiddenLabel mesh__D010315 Accelerator, Linear
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010315 2006
% 220.68/220.92  |- mesh__recordOriginator mesh__D010315 VDK
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010315 1995
% 220.68/220.92  |- skos__hiddenLabel mesh__D010315 Linear Accelerator
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010315 2001
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010315 2004
% 220.68/220.92  |- skos__prefLabel mesh__D010315 Particle Accelerators
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010315 1993
% 220.68/220.92  |- skos__broader mesh__D010315smesh__D009686
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010315 1999
% 220.68/220.92  |- skos__annotation mesh__D010315
% 220.68/220.92       CYCLOTRONS %26% SYNCHROTRONS are also available   
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010315 2000
% 220.68/220.92  |- skos__historyNote mesh__D010315 Nuclear Medicine %28%1967-1977%29%
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010315 2005
% 220.68/220.92  |- skos__hiddenLabel mesh__D010315 Accelerators, Particle
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010315 1994
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010315 1997
% 220.68/220.92  |- mesh__publicMeSHNote mesh__D010315 78   
% 220.68/220.92  |- skos__historyNote mesh__D010315 Fast Neutrons %28%1971-1977%29%
% 220.68/220.92  |- mesh__dateCreated mesh__D010315 1977-04-27
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010315 2003
% 220.68/220.92  |- rdf__type mesh__D010315sskos__Concept
% 220.68/220.92  |- mesh__dateRevised mesh__D010315 1992-05-15
% 220.68/220.92  |- skos__hiddenLabel mesh__D010315 Particle Accelerator
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010315 1998
% 220.68/220.92  |- mesh__recordMaintainer mesh__D010315 PXP
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010315 1996
% 220.68/220.92  |- skos__hiddenLabel mesh__D010315 Accelerators, Linear
% 220.68/220.92  |- mesh__dateEstablished mesh__D010315 1978-01-01
% 220.68/220.92  |- skos__hiddenLabel mesh__D010315 Betatron
% 220.68/220.92  |- skos__related mesh__D010315smesh__D016634
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010315 2002
% 220.68/220.92  |- mesh__historyNote mesh__D010315 78   
% 220.68/220.92  |- skos__scopeNote mesh__D010315
% 220.68/220.92       Devices which accelerate electrically charged atomic or subatomic particles, such as electrons, protons or ions, to high velocities so they have high kinetic energy.%A%    
% 220.68/220.92  |- mesh__recordAuthorizer mesh__D010315 PLS
% 220.68/220.92  |- mesh__recordAuthorizer mesh__D015000 sjn
% 220.68/220.92  |- mesh__publicMeSHNote mesh__D015000 87   
% 220.68/220.92  |- skos__scopeNote mesh__D015000
% 220.68/220.92       An involuntary deep INHALATION with the MOUTH open, often accompanied by the act of stretching.%A%    
% 220.68/220.92  |- mesh__recordMaintainer mesh__D015000 nns
% 220.68/220.92  |- mesh__dateRevised mesh__D015000 2003-07-09
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D015000 2006
% 220.68/220.92  |- skos__prefLabel mesh__D015000 Yawning
% 220.68/220.92  |- mesh__recordOriginator mesh__D015000 VDK
% 220.68/220.92  |- mesh__dateEstablished mesh__D015000 1987-01-01
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D015000 2005
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D015000 2004
% 220.68/220.92  |- mesh__historyNote mesh__D015000 87   
% 220.68/220.92  |- skos__hiddenLabel mesh__D015000 Yawnings
% 220.68/220.92  |- skos__broader mesh__D015000smesh__D044703
% 220.68/220.92  |- rdf__type mesh__D015000sskos__Concept
% 220.68/220.92  |- mesh__dateCreated mesh__D015000 1986-04-18
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D001589 2006
% 220.68/220.92  |- mesh__publicMeSHNote mesh__D001589
% 220.68/220.92       91; was see under PHENETHYLAMINES 1966-90   
% 220.68/220.92  |- rdf__type mesh__D001589sskos__Concept
% 220.68/220.92  |- mesh__dateEstablished mesh__D001589 1991-01-01
% 220.68/220.92  |- skos__scopeNote mesh__D001589
% 220.68/220.92       A sympathomimetic agent with properties similar to DEXTROAMPHETAMINE. It is used in the treatment of obesity. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1222%29%%A%    
% 220.68/220.92  |- skos__altLabel mesh__D001589
% 220.68/220.92       Pharmacia Brand of Benzfetamine Hydrochloride
% 220.68/220.92  |- mesh__recordOriginator mesh__D001589 NLM
% 220.68/220.92  |- skos__broader mesh__D001589smesh__D008694
% 220.68/220.92  |- skos__prefLabel mesh__D001589 Benzphetamine
% 220.68/220.92  |- mesh__dateCreated mesh__D001589 1999-01-01
% 220.68/220.92  |- mesh__dateRevised mesh__D001589 2004-07-07
% 220.68/220.92  |- mesh__recordAuthorizer mesh__D001589 sjn
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D001589 2005
% 220.68/220.92  |- mesh__historyNote mesh__D001589
% 220.68/220.92       91%28%66%29%; was see under PHENETHYLAMINES 1966-90   
% 220.68/220.92  |- skos__altLabel mesh__D001589 Benzfetamine
% 220.68/220.92  |- mesh__recordMaintainer mesh__D001589 mdb
% 220.68/220.92  |- skos__hiddenLabel mesh__D020743 arh6 GTP Binding Protein
% 220.68/220.92  |- mesh__dateCreated mesh__D020743 1999-11-03
% 220.68/220.92  |- skos__broader mesh__D020743smesh__D020741
% 220.68/220.92  |- rdf__type mesh__D020743sskos__Concept
% 220.68/220.92  |- skos__altLabel mesh__D020743 arh6 Protein
% 220.68/220.92  |- skos__hiddenLabel mesh__D020743 rhoB GTP Binding Protein
% 220.68/220.92  |- skos__altLabel mesh__D020743 arh6 GTP-Binding Protein
% 220.68/220.92  |- mesh__dateEstablished mesh__D020743 2000-01-01
% 220.68/220.92  |- mesh__recordAuthorizer mesh__D020743 sjn
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D020743 2006
% 220.68/220.92  |- skos__altLabel mesh__D020743 rhoB p20 Protein
% 220.68/220.92  |- skos__annotation mesh__D020743 DF: RHOB PROTEIN   
% 220.68/220.92  |- skos__altLabel mesh__D020743 ARHB Protein
% 220.68/220.92  |- skos__prefLabel mesh__D020743 rhoB GTP-Binding Protein
% 220.68/220.92  |- skos__hiddenLabel mesh__D020743 ARHB GTP Binding Protein
% 220.68/220.92  |- skos__altLabel mesh__D020743 ARHB GTP-Binding Protein
% 220.68/220.92  |- mesh__dateRevised mesh__D020743 2005-06-30
% 220.68/220.92  |- skos__hiddenLabel mesh__D020743 GTP-Binding Protein, rhoB
% 220.68/220.92  |- mesh__recordOriginator mesh__D020743 jmp
% 220.68/220.92  |- skos__historyNote mesh__D020743 G-Proteins %28%1989-1999%29%
% 220.68/220.92  |- mesh__publicMeSHNote mesh__D020743
% 220.68/220.92       2000; RHOB P20 PROTEIN %28%now RHOB GTP-BINDING PROTEIN%29% was indexed under G-PROTEINS 1988-1999%A%  
% 220.68/220.92  |- skos__hiddenLabel mesh__D020743 GTP-Binding Protein, ARHB
% 220.68/220.92  |- skos__altLabel mesh__D020743 rhoB Protein
% 220.68/220.92  |- mesh__recordMaintainer mesh__D020743 jmp
% 220.68/220.92  |- skos__scopeNote mesh__D020743
% 220.68/220.92       A GTP-BINDING PROTEIN involved in regulating a signal transduction pathway that controls assembly of focal adhesions and actin stress fibers. This enzyme was formerly listed as EC 3.6.1.47.%A%    
% 220.68/220.92  |- skos__hiddenLabel mesh__D020743 p20 Protein, rhoB
% 220.68/220.92  |- skos__hiddenLabel mesh__D020743 GTP-Binding Protein, arh6
% 220.68/220.92  |- mesh__historyNote mesh__D020743
% 220.68/220.92       2000; use RHOB GTP-BINDING PROTEIN %28%NM%29% 1988-1999   
% 220.68/220.92  |- mesh__recordMaintainer mesh__D006274 TPW
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006274 2000
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006274 2004
% 220.68/220.92  |- rdf__type mesh__D006274sskos__Concept
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006274 1998
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006274 2001
% 220.68/220.92  |- mesh__dateCreated mesh__D006274 1977-05-05
% 220.68/220.92  |- skos__altLabel mesh__D006274 Moving, Health Facility
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006274 1999
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006274 2005
% 220.68/220.92  |- mesh__historyNote mesh__D006274
% 220.68/220.92       91%28%Aug 77%29%; was see under HEALTH FACILITIES 1977-90   
% 220.68/220.92  |- mesh__publicMeSHNote mesh__D006274
% 220.68/220.92       91; was see under HEALTH FACILITIES Aug 1977-90   
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006274 2002
% 220.68/220.92  |- skos__prefLabel mesh__D006274 Health Facility Moving
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006274 2006
% 220.68/220.92  |- skos__scopeNote mesh__D006274
% 220.68/220.92       The relocation of health care institutions or units thereof. The concept includes equipment relocation.%A%    
% 220.68/220.92  |- skos__hiddenLabel mesh__D006274 Facility Moving, Health
% 220.68/220.92  |- skos__altLabel mesh__D006274 Hospital Moving
% 220.68/220.92  |- skos__broader mesh__D006274smesh__D006268
% 220.68/220.92  |- mesh__dateEstablished mesh__D006274 1991-01-01
% 220.68/220.92  |- mesh__recordOriginator mesh__D006274 EC
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006274 2003
% 220.68/220.92  |- mesh__recordAuthorizer mesh__D006274 SJN
% 220.68/220.92  |- mesh__dateRevised mesh__D006274 1997-06-20
% 220.68/220.92  |- skos__related mesh__D014706smesh__D007806
% 220.68/220.92  |- mesh__dateRevised mesh__D014706 1992-05-18
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D014706 2006
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D014706 1998
% 220.68/220.92  |- mesh__recordMaintainer mesh__D014706 TAP
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D014706 1996
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D014706 2004
% 220.68/220.92  |- skos__hiddenLabel mesh__D014706 Learnings, Verbal
% 220.68/220.92  |- skos__prefLabel mesh__D014706 Verbal Learning
% 220.68/220.92  |- skos__hiddenLabel mesh__D014706 Verbal Learnings
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D014706 2005
% 220.68/220.92  |- mesh__dateCreated mesh__D014706 1999-01-01
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D014706 2001
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D014706 2003
% 220.68/220.92  |- rdf__type mesh__D014706sskos__Concept
% 220.68/220.92  |- mesh__recordAuthorizer mesh__D014706 PLS
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D014706 2000
% 220.68/220.92  |- skos__broader mesh__D014706smesh__D007858
% 220.68/220.92  |- mesh__recordOriginator mesh__D014706 NLM
% 220.68/220.92  |- skos__scopeNote mesh__D014706
% 220.68/220.92       Learning to respond verbally to a verbal stimulus cue.     
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D014706 1995
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D014706 1993
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D014706 1999
% 220.68/220.92  |- skos__hiddenLabel mesh__D014706 Learning, Verbal
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D014706 2002
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D014706 1994
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D014706 1997
% 220.68/220.92  |- mesh__historyNote mesh__D002682 82; was CHINCHILLAS 1968-81   
% 220.68/220.92  |- mesh__recordOriginator mesh__D002682 NLM
% 220.68/220.92  |- mesh__recordMaintainer mesh__D002682 ags
% 220.68/220.92  |- mesh__dateEstablished mesh__D002682 1968-01-01
% 220.68/220.92  |- skos__scopeNote mesh__D002682
% 220.68/220.92       A genus of the family Chinchillidae which consists of three species: C. brevicaudata, C. lanigera, and C. villidera. They are used extensively in biomedical research.%A%    
% 220.68/220.92  |- skos__prefLabel mesh__D002682 Chinchilla
% 220.68/220.92  |- mesh__dateCreated mesh__D002682 1999-01-01
% 220.68/220.92  |- skos__broader mesh__D002682smesh__D012377
% 220.68/220.92  |- mesh__recordAuthorizer mesh__D002682 sjn
% 220.68/220.92  |- mesh__dateRevised mesh__D002682 2004-07-07
% 220.68/220.92  |- skos__historyNote mesh__D002682 Rodentia %28%1966-1967%29%
% 220.68/220.92  |- rdf__type mesh__D002682sskos__Concept
% 220.68/220.92  |- mesh__onlineNote mesh__D002682
% 220.68/220.92       use CHINCHILLA to search CHINCHILLAS 1968-81   
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D002682 2005
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D002682 2006
% 220.68/220.92  |- mesh__publicMeSHNote mesh__D002682 82; was CHINCHILLAS 1968-81   
% 220.68/220.92  |- skos__hiddenLabel mesh__D002682 Chinchillas
% 220.68/220.92  |- skos__prefLabel mesh__D010316 Particle Size
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010316 2006
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010316 2002
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010316 1995
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010316 1991
% 220.68/220.92  |- skos__annotation mesh__D010316 NIM; no qualif   
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010316 2004
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010316 1993
% 220.68/220.92  |- mesh__recordAuthorizer mesh__D010316 PLS
% 220.68/220.92  |- mesh__publicMeSHNote mesh__D010316 73   
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010316 1999
% 220.68/220.92  |- skos__hiddenLabel mesh__D010316 Sizes, Particle
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010316 2005
% 220.68/220.92  |- mesh__recordMaintainer mesh__D010316 TGC
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010316 1994
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010316 1997
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010316 2003
% 220.68/220.92  |- rdf__type mesh__D010316sskos__Concept
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010316 1992
% 220.68/220.92  |- mesh__dateRevised mesh__D010316 1989-05-15
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010316 1998
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010316 1996
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010316 2001
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010316 1990
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D010316 2000
% 220.68/220.92  |- mesh__historyNote mesh__D010316 73   
% 220.68/220.92  |- skos__hiddenLabel mesh__D010316 Size, Particle
% 220.68/220.92  |- skos__hiddenLabel mesh__D010316 Particle Sizes
% 220.68/220.92  |- mesh__recordOriginator mesh__D010316 NLM
% 220.68/220.92  |- skos__broader mesh__D010316smesh__D002627
% 220.68/220.92  |- mesh__dateEstablished mesh__D010316 1973-01-01
% 220.68/220.92  |- mesh__dateCreated mesh__D010316 1999-01-01
% 220.68/220.92  |- skos__broader mesh__D029021smesh__D000820
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D029021 2005
% 220.68/220.92  |- mesh__dateCreated mesh__D029021 2001-07-25
% 220.68/220.92  |- skos__scopeNote mesh__D029021
% 220.68/220.92       A highly fatal contagious disease of goats and sheep caused by PESTE-DES-PETITS-RUMINANTS VIRUS. The disease may be acute or subacute and is characterized by stomatitis, conjunctivitis, diarrhea, and pneumonia.%A%    
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D029021 2006
% 220.68/220.92  |- mesh__recordOriginator mesh__D029021 ags
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D029021 2002
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D029021 2002A
% 220.68/220.92  |- mesh__dateRevised mesh__D029021 2001-12-06
% 220.68/220.92  |- skos__historyNote mesh__D029021 Rinderpest %28%1971-2001%29%
% 220.68/220.92  |- skos__altLabel mesh__D029021 Pseudorinderpest
% 220.68/220.92  |- mesh__historyNote mesh__D029021 2002; use RINDERPEST 1998-2001   
% 220.68/220.92  |- rdf__type mesh__D029021sskos__Concept
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D029021 2003
% 220.68/220.92  |- mesh__publicMeSHNote mesh__D029021 2002; see RINDERPEST 1998-2001   
% 220.68/220.92  |- skos__hiddenLabel mesh__D029021 Peste des Petits Ruminants
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D029021 2004
% 220.68/220.92  |- skos__prefLabel mesh__D029021 Peste-des-Petits-Ruminants
% 220.68/220.92  |- mesh__recordAuthorizer mesh__D029021 sjn
% 220.68/220.92  |- mesh__recordMaintainer mesh__D029021 sjn
% 220.68/220.92  |- mesh__dateEstablished mesh__D029021 2002-01-01
% 220.68/220.92  |- skos__broader mesh__D029021smesh__D018185
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D015001 1997
% 220.68/220.92  |- skos__annotation mesh__D015001
% 220.68/220.92       caused by Treponema pallidum subsp. pertenue   
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D015001 2005
% 220.68/220.92  |- skos__prefLabel mesh__D015001 Yaws
% 220.68/220.92  |- skos__broader mesh__D015001smesh__D017192
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D015001 2000
% 220.68/220.92  |- mesh__recordOriginator mesh__D015001 NLM
% 220.68/220.92  |- skos__scopeNote mesh__D015001
% 220.68/220.92       A systemic non-venereal infection of the tropics caused by Treponema pallidum subspecies pertenue.%A%    
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D015001 2003
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D015001 2006
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D015001 2001
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D015001 1995
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D015001 2004
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D015001 1998
% 220.68/220.92  |- skos__hiddenLabel mesh__D015001 Frambesias
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D015001 2002
% 220.68/220.92  |- mesh__recordMaintainer mesh__D015001 PXP
% 220.68/220.92  |- skos__broader mesh__D015001smesh__D014211
% 220.68/220.92  |- rdf__type mesh__D015001sskos__Concept
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D015001 1999
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D015001 1996
% 220.68/220.92  |- mesh__recordAuthorizer mesh__D015001 PLS
% 220.68/220.92  |- mesh__dateRevised mesh__D015001 1994-02-08
% 220.68/220.92  |- skos__altLabel mesh__D015001 Frambesia
% 220.68/220.92  |- mesh__dateCreated mesh__D015001 1999-01-01
% 220.68/220.92  |- mesh__publicMeSHNote mesh__D020744
% 220.68/220.92       2000; RAC PROTEINS was indexed under G-Proteins 1991-1999 %26% Proteins 1989-1990; RAC G PROTEIN was indexed under GTP PHOSPHOHYDROLASE 1998-1999%A%  
% 220.68/220.92  |- rdf__type mesh__D020744sskos__Concept
% 220.68/220.92  |- skos__broader mesh__D020744smesh__D020741
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D020744 2006
% 220.68/220.92  |- skos__scopeNote mesh__D020744
% 220.68/220.92       A sub-family of RHO GTP-BINDING PROTEINS that is involved in regulating the organization of cytoskeletal filaments. This enzyme was formerly listed as EC 3.6.1.47.%A%    
% 220.68/220.92  |- mesh__historyNote mesh__D020744
% 220.68/220.92       2000; for RAC PROTEINS use RAC GTP-BINDING PROTEINS %28%NM%29% 1989-1999; for RAC G PROTEIN use RAC GTP-BINDING PROTEINS %28%NM%29% 1998-1999%A%  
% 220.68/220.92  |- skos__altLabel mesh__D020744 rac G Protein
% 220.68/220.92  |- skos__hiddenLabel mesh__D020744 rac GTP Binding Proteins
% 220.68/220.92  |- mesh__recordAuthorizer mesh__D020744 sjn
% 220.68/220.92  |- mesh__dateEstablished mesh__D020744 2000-01-01
% 220.68/220.92  |- skos__hiddenLabel mesh__D020744 G Protein, rac
% 220.68/220.92  |- mesh__recordMaintainer mesh__D020744 jmp
% 220.68/220.92  |- skos__historyNote mesh__D020744 G-Proteins %28%1991-1999%29%
% 220.68/220.92  |- mesh__dateCreated mesh__D020744 1999-11-03
% 220.68/220.92  |- skos__prefLabel mesh__D020744 rac GTP-Binding Proteins
% 220.68/220.92  |- skos__historyNote mesh__D020744 Proteins %28%1989-1999%29%
% 220.68/220.92  |- skos__hiddenLabel mesh__D020744 GTP-Binding Proteins, rac
% 220.68/220.92  |- mesh__dateRevised mesh__D020744 2005-06-30
% 220.68/220.92  |- mesh__recordOriginator mesh__D020744 jmp
% 220.68/220.92  |- skos__altLabel mesh__D020744 rac Proteins
% 220.68/220.92  |- skos__hiddenLabel mesh__D006275 Conversions, Health Facility
% 220.68/220.92  |- skos__hiddenLabel mesh__D006275 Plannings, Health Facility
% 220.68/220.92  |- skos__scopeNote mesh__D006275
% 220.68/220.92       Areawide planning for health care institutions on the basis of projected consumer need.%A%    
% 220.68/220.92  |- mesh__dateCreated mesh__D006275 1999-01-01
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006275 2005
% 220.68/220.92  |- skos__hiddenLabel mesh__D006275 Facility Conversions, Health
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006275 2000
% 220.68/220.92  |- skos__historyNote mesh__D006275
% 220.68/220.92       Hospital Design and Construction %28%1966-1967%29%
% 220.68/220.92  |- skos__hiddenLabel mesh__D006275 Health Facility Conversions
% 220.68/220.92  |- mesh__historyNote mesh__D006275 68   
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006275 2006
% 220.68/220.92  |- mesh__publicMeSHNote mesh__D006275 68   
% 220.68/220.92  |- skos__altLabel mesh__D006275 Planning, Health Facility
% 220.68/220.92  |- skos__hiddenLabel mesh__D006275 Facility Conversion, Health
% 220.68/220.92  |- mesh__recordAuthorizer mesh__D006275 sjn
% 220.68/220.92  |- skos__related mesh__D006275smesh__D005160
% 220.68/220.92  |- mesh__activeMeSHYear mesh__D006275 2001
% 220.68/220.92  |- skos__hiddenLabel mesh__D006275 Facility Planning, Health
% 220.68/220.92  |- mesh__recordMaintainer mesh__D006275 kle
% 220.68/220.93  |- skos__annotation mesh__D006275
% 220.68/220.93       differentiate from FACILITY DESIGN AND CONSTRUCTION   
% 220.68/220.93  |- mesh__dateEstablished mesh__D006275 1968-01-01
% 220.68/220.93  |- skos__prefLabel mesh__D006275 Health Facility Planning
% 220.68/220.93  |- skos__broader mesh__D006275smesh__D012040
% 220.68/220.93  |- skos__hiddenLabel mesh__D006275 Facility Plannings, Health
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D006275 2002
% 220.68/220.93  |- skos__hiddenLabel mesh__D006275 Health Facility Plannings
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D006275 2003
% 220.68/220.93  |- mesh__dateRevised mesh__D006275 1999-11-03
% 220.68/220.93  |- mesh__recordOriginator mesh__D006275 NLM
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D006275 2004
% 220.68/220.93  |- rdf__type mesh__D006275sskos__Concept
% 220.68/220.93  |- skos__hiddenLabel mesh__D006275 Conversion, Health Facility
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D014707 2003
% 220.68/220.93  |- mesh__recordOriginator mesh__D014707 NLM
% 220.68/220.93  |- rdf__type mesh__D014707sskos__Concept
% 220.68/220.93  |- mesh__recordAuthorizer mesh__D014707 SJN
% 220.68/220.93  |- mesh__dateRevised mesh__D014707 1997-06-20
% 220.68/220.93  |- skos__prefLabel mesh__D014707 Vermont
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D014707 2002
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D014707 1999
% 220.68/220.93  |- skos__broader mesh__D014707smesh__D009511
% 220.68/220.93  |- mesh__recordMaintainer mesh__D014707 PXP
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D014707 1998
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D014707 2006
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D014707 2001
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D014707 2004
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D014707 2000
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D014707 2005
% 220.68/220.93  |- mesh__dateCreated mesh__D014707 1999-01-01
% 220.68/220.93  |- mesh__recordOriginator mesh__D002683 SMH
% 220.68/220.93  |- mesh__historyNote mesh__D002683 91%28%81%29%   
% 220.68/220.93  |- skos__scopeNote mesh__D002683
% 220.68/220.93       A family of nonbiting midges, in the order DIPTERA. Salivary glands of the genus Chironomus are used in studies of cellular genetics and biochemistry.%A%    
% 220.68/220.93  |- rdf__type mesh__D002683sskos__Concept
% 220.68/220.93  |- skos__altLabel mesh__D002683 Midges, Nonbiting
% 220.68/220.93  |- mesh__publicMeSHNote mesh__D002683 91; see DIPTERA 1981-90   
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D002683 2005
% 220.68/220.93  |- skos__prefLabel mesh__D002683 Chironomidae
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D002683 2004
% 220.68/220.93  |- mesh__recordAuthorizer mesh__D002683 sjn
% 220.68/220.93  |- mesh__dateCreated mesh__D002683 1980-05-19
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D002683 2006
% 220.68/220.93  |- skos__broader mesh__D002683smesh__D004175
% 220.68/220.93  |- mesh__dateRevised mesh__D002683 2003-07-09
% 220.68/220.93  |- skos__historyNote mesh__D002683 Diptera %28%1975-1980%29%
% 220.68/220.93  |- mesh__dateEstablished mesh__D002683 1991-01-01
% 220.68/220.93  |- mesh__recordMaintainer mesh__D002683 ags
% 220.68/220.93  |- skos__annotation mesh__D002683
% 220.68/220.93       do not use /drug eff for insecticides: TN 111; gall midges: index under DIPTERA%A%  
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D010317 2006
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D010317 1998
% 220.68/220.93  |- mesh__recordMaintainer mesh__D010317 TGC
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D010317 1995
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D010317 2002
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D010317 2004
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D010317 1996
% 220.68/220.93  |- mesh__recordAuthorizer mesh__D010317 PLS
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D010317 1999
% 220.68/220.93  |- mesh__recordOriginator mesh__D010317 NLM
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D010317 1997
% 220.68/220.93  |- rdf__type mesh__D010317sskos__Concept
% 220.68/220.93  |- skos__scopeNote mesh__D010317
% 220.68/220.93       A voluntary contract between two or more doctors who may or may not share responsibility for the care of patients, with proportional sharing of profits and losses.%A%    
% 220.68/220.93  |- skos__broader mesh__D010317smesh__D011364
% 220.68/220.93  |- mesh__historyNote mesh__D010317 68   
% 220.68/220.93  |- skos__hiddenLabel mesh__D010317 Practice, Partnership
% 220.68/220.93  |- skos__hiddenLabel mesh__D010317 Practices, Partnership
% 220.68/220.93  |- skos__historyNote mesh__D010317 Group Practice %28%1966-1967%29%
% 220.68/220.93  |- mesh__dateCreated mesh__D010317 1999-01-01
% 220.68/220.93  |- mesh__dateEstablished mesh__D010317 1968-01-01
% 220.68/220.93  |- mesh__activeMeSHYear mesh__D010317 2000
% 220.68/220.93  |- mesh__dateRevised mesh__D010317 1994-05-05
% 220.78/220.93  |- skos__hiddenLabel mesh__D010317 Partnership Practices
% 220.78/220.93  |- skos__prefLabel mesh__D010317 Partnership Practice
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D010317 2005
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D010317 2001
% 220.78/220.93  |- skos__historyNote mesh__D010317 Group Practice, Dental %28%1967%29%
% 220.78/220.93  |- mesh__publicMeSHNote mesh__D010317 68   
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D010317 2003
% 220.78/220.93  |- skos__annotation mesh__D010317
% 220.78/220.93       coord IM with med or other specialty %28%IM%29%; do not confuse with GROUP PRACTICE but do not interpret: use word of text%A%  
% 220.78/220.93  |- skos__prefLabel mesh__D029022 Acoraceae
% 220.78/220.93  |- rdf__type mesh__D029022sskos__Concept
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D029022 2003
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D029022 2004
% 220.78/220.93  |- mesh__dateCreated mesh__D029022 2001-07-25
% 220.78/220.93  |- skos__scopeNote mesh__D029022
% 220.78/220.93       A plant family of the order Arales, subclass Arecidae, class Liliopsida %28%monocot%29%.%A%    
% 220.78/220.93  |- mesh__historyNote mesh__D029022 2002   
% 220.78/220.93  |- skos__annotation mesh__D029022
% 220.78/220.93       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.78/220.93  |- mesh__dateEstablished mesh__D029022 2002-01-01
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D029022 2005
% 220.78/220.93  |- skos__broader mesh__D029022smesh__D019684
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D029022 2002
% 220.78/220.93  |- mesh__publicMeSHNote mesh__D029022 2002   
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D029022 2006
% 220.78/220.93  |- mesh__historyNote mesh__D015800 90   
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D015800 2006
% 220.78/220.93  |- skos__hiddenLabel mesh__D015800 Proteins, Protozoan
% 220.78/220.93  |- mesh__recordMaintainer mesh__D015800 SYSTEM
% 220.78/220.93  |- mesh__dateCreated mesh__D015800 1989-05-26
% 220.78/220.93  |- mesh__publicMeSHNote mesh__D015800 90   
% 220.78/220.93  |- skos__prefLabel mesh__D015800 Protozoan Proteins
% 220.78/220.93  |- mesh__recordOriginator mesh__D015800 RLS
% 220.78/220.93  |- rdf__type mesh__D015800sskos__Concept
% 220.78/220.93  |- skos__broader mesh__D015800smesh__D011506
% 220.78/220.93  |- skos__annotation mesh__D015800
% 220.78/220.93       /drug eff /ultrastruct permitted; /physiol permitted for function within the protozoon; coord IM with specific protein %28%IM%29% + specific protozoon %28%IM%29%%A%  
% 220.78/220.93  |- mesh__dateRevised mesh__D015800 2005-06-30
% 220.78/220.93  |- skos__scopeNote mesh__D015800
% 220.78/220.93       Proteins found in any species of protozoan.     
% 220.78/220.93  |- mesh__dateEstablished mesh__D015800 1990-01-01
% 220.78/220.93  |- mesh__recordAuthorizer mesh__D015800 sjn
% 220.78/220.93  |- skos__historyNote mesh__D015800 Proteins %28%1966-1989%29%
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D015002 2005
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D015002 2003
% 220.78/220.93  |- skos__hiddenLabel mesh__D015002 Nutritional Yeast
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D015002 2006
% 220.78/220.93  |- skos__hiddenLabel mesh__D015002 Dried Yeast
% 220.78/220.93  |- mesh__dateRevised mesh__D015002 2002-07-03
% 220.78/220.93  |- skos__scopeNote mesh__D015002
% 220.78/220.93       The dry cells of any suitable strain of SACCHAROMYCES CEREVISIAE or CANDIDA. It can be obtained as a by-product from the brewing of beer or by growing on media not suitable for beer production. Dried yeast serves as a source of protein and VITAMIN B COMPLEX.%A%    
% 220.78/220.93  |- mesh__recordMaintainer mesh__D015002 TPW
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D015002 2004
% 220.78/220.93  |- skos__prefLabel mesh__D015002 Yeast, Dried
% 220.78/220.93  |- mesh__recordOriginator mesh__D015002 NLM
% 220.78/220.93  |- rdf__type mesh__D015002sskos__Concept
% 220.78/220.93  |- mesh__recordAuthorizer mesh__D015002 sjn
% 220.78/220.93  |- skos__altLabel mesh__D015002 Yeast, Nutritional
% 220.78/220.93  |- skos__broader mesh__D015002smesh__D019587
% 220.78/220.93  |- mesh__dateCreated mesh__D015002 1999-01-01
% 220.78/220.93  |- skos__annotation mesh__D015002
% 220.78/220.93       when brewer%27%s or baker%27%s yeast is given as therapy, index here; when the yeast is the source of matter in enzyme or other metab studies, index as SACCHAROMYCES CEREVISIAE%A%  
% 220.78/220.93  |- skos__hiddenLabel mesh__D020745 Archaeal Genome
% 220.78/220.93  |- mesh__recordOriginator mesh__D020745 nns
% 220.78/220.93  |- skos__annotation mesh__D020745
% 220.78/220.93       coordinate IM with specific archaeon/genet%28%IM%29%   
% 220.78/220.93  |- mesh__dateRevised mesh__D020745 2005-06-30
% 220.78/220.93  |- mesh__publicMeSHNote mesh__D020745 2000   
% 220.78/220.93  |- mesh__dateEstablished mesh__D020745 2000-01-01
% 220.78/220.93  |- skos__hiddenLabel mesh__D020745 Archaeal Genomes
% 220.78/220.93  |- mesh__recordMaintainer mesh__D020745 nns
% 220.78/220.93  |- skos__hiddenLabel mesh__D020745 Genomes, Archaeal
% 220.78/220.93  |- skos__historyNote mesh__D020745 Genome, Bacterial %28%1994-1999%29%
% 220.78/220.93  |- skos__scopeNote mesh__D020745
% 220.78/220.93       The genetic complement of an archaeal organism %28%ARCHAEA%29% as represented in its DNA.%A%    
% 220.78/220.93  |- skos__broader mesh__D020745smesh__D016678
% 220.78/220.93  |- mesh__recordAuthorizer mesh__D020745 sjn
% 220.78/220.93  |- mesh__historyNote mesh__D020745 2000   
% 220.78/220.93  |- skos__related mesh__D020745smesh__D019766
% 220.78/220.93  |- mesh__dateCreated mesh__D020745 1999-11-03
% 220.78/220.93  |- rdf__type mesh__D020745sskos__Concept
% 220.78/220.93  |- skos__prefLabel mesh__D020745 Genome, Archaeal
% 220.78/220.93  |- skos__historyNote mesh__D020745 Archaea/genetics %28%1993-1999%29%
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D020745 2006
% 220.78/220.93  |- mesh__dateCreated mesh__D053121 2005-11-10
% 220.78/220.93  |- mesh__publicMeSHNote mesh__D053121 2006   
% 220.78/220.93  |- mesh__dateEstablished mesh__D053121 2005-11-10
% 220.78/220.93  |- skos__annotation mesh__D053121
% 220.78/220.93       infection: coordinate IM with INFLUENZA, HUMAN %28%IM%29% in humans, or INFLUENZA IN BIRDS %28%IM%29% in birds, or ORTHOMYXOVIRIDAE INFECTIONS %28%IM%29% in other animals%A%  
% 220.78/220.93  |- mesh__historyNote mesh__D053121 2006   
% 220.78/220.93  |- mesh__recordAuthorizer mesh__D053121 ags
% 220.78/220.93  |- skos__altLabel mesh__D053121 H2N2 Virus
% 220.78/220.93  |- skos__historyNote mesh__D053121 Influenza A Virus %28%1975-2005%29%
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D053121 2006
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D053121 2006A
% 220.78/220.93  |- skos__scopeNote mesh__D053121
% 220.78/220.93       A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 2 and neuraminidase 2. The H2N2 subtype was responsible for the Asian flu pandemic of 1957.%A%    
% 220.78/220.93  |- skos__hiddenLabel mesh__D053121 Virus, H2N2
% 220.78/220.93  |- mesh__recordOriginator mesh__D053121 ags
% 220.78/220.93  |- rdf__type mesh__D053121sskos__Concept
% 220.78/220.93  |- skos__broader mesh__D053121smesh__D009980
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D053121 2006B
% 220.78/220.93  |- mesh__recordMaintainer mesh__D053121 ags
% 220.78/220.93  |- skos__hiddenLabel mesh__D053121 Viruses, H2N2
% 220.78/220.93  |- skos__hiddenLabel mesh__D053121 H2N2 Viruses
% 220.78/220.93  |- skos__prefLabel mesh__D053121 Influenza A Virus, H2N2 Subtype
% 220.78/220.93  |- mesh__dateRevised mesh__D053121 2005-11-10
% 220.78/220.93  |- skos__hiddenLabel mesh__D006276 Sizes, Health Facility
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D006276 1995
% 220.78/220.93  |- skos__annotation mesh__D006276 note X ref   
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D006276 2003
% 220.78/220.93  |- mesh__publicMeSHNote mesh__D006276 68   
% 220.78/220.93  |- rdf__type mesh__D006276sskos__Concept
% 220.78/220.93  |- mesh__recordOriginator mesh__D006276 NLM
% 220.78/220.93  |- mesh__recordAuthorizer mesh__D006276 PLS
% 220.78/220.93  |- mesh__dateEstablished mesh__D006276 1968-01-01
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D006276 1994
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D006276 1999
% 220.78/220.93  |- skos__hiddenLabel mesh__D006276 Facility Size, Health
% 220.78/220.93  |- skos__broader mesh__D006276smesh__D006297
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D006276 2002
% 220.78/220.93  |- skos__hiddenLabel mesh__D006276 Facility Sizes, Health
% 220.78/220.93  |- skos__broader mesh__D006276smesh__D006268
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D006276 2006
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D006276 1998
% 220.78/220.93  |- skos__hiddenLabel mesh__D006276 Size, Hospital
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D006276 2001
% 220.78/220.93  |- skos__scopeNote mesh__D006276
% 220.78/220.93       The physical space or dimensions of a facility. Size may be indicated by bed capacity.%A%    
% 220.78/220.93  |- skos__prefLabel mesh__D006276 Health Facility Size
% 220.78/220.93  |- mesh__historyNote mesh__D006276 68   
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D006276 1997
% 220.78/220.93  |- skos__hiddenLabel mesh__D006276 Size, Health Facility
% 220.78/220.93  |- skos__hiddenLabel mesh__D006276 Health Facility Sizes
% 220.78/220.93  |- skos__hiddenLabel mesh__D006276 Sizes, Hospital
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D006276 2000
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D006276 2005
% 220.78/220.93  |- skos__hiddenLabel mesh__D006276 Hospital Sizes
% 220.78/220.93  |- mesh__dateRevised mesh__D006276 1993-06-04
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D006276 2004
% 220.78/220.93  |- skos__historyNote mesh__D006276 Hospitals %28%1966-1967%29%
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D006276 1996
% 220.78/220.93  |- mesh__recordMaintainer mesh__D006276 JLS
% 220.78/220.93  |- mesh__dateCreated mesh__D006276 1999-01-01
% 220.78/220.93  |- rdf__type mesh__D014708sskos__Concept
% 220.78/220.93  |- skos__prefLabel mesh__D014708 Vernix Caseosa
% 220.78/220.93  |- skos__broader mesh__D014708smesh__D012634
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D014708 2000
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D014708 1999
% 220.78/220.93  |- skos__scopeNote mesh__D014708
% 220.78/220.93       An unctuous substance composed of sebum and desquamated epithelial cells, which covers the skin of the fetus.%A%    
% 220.78/220.93  |- mesh__recordOriginator mesh__D014708 NLM
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D014708 1998
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D014708 2006
% 220.78/220.93  |- mesh__recordAuthorizer mesh__D014708 SJN
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D014708 2002
% 220.78/220.93  |- mesh__dateRevised mesh__D014708 1997-06-20
% 220.78/220.93  |- skos__broader mesh__D014708smesh__D005333
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D014708 2005
% 220.78/220.93  |- skos__hiddenLabel mesh__D014708 Caseosa, Vernix
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D014708 2004
% 220.78/220.93  |- skos__hiddenLabel mesh__D014708 Caseosas, Vernix
% 220.78/220.93  |- skos__hiddenLabel mesh__D014708 Vernix Caseosas
% 220.78/220.93  |- mesh__dateCreated mesh__D014708 1999-01-01
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D014708 2003
% 220.78/220.93  |- mesh__recordMaintainer mesh__D014708 PXP
% 220.78/220.93  |- skos__annotation mesh__D014708 check the tag INFANT, NEWBORN   
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D014708 2001
% 220.78/220.93  |- mesh__publicMeSHNote mesh__D011410 70   
% 220.78/220.93  |- mesh__recordOriginator mesh__D011410 NLM
% 220.78/220.93  |- mesh__recordAuthorizer mesh__D011410 sjn
% 220.78/220.93  |- skos__altLabel mesh__D011410 Cryopharma Brand of Propanidid
% 220.78/220.93  |- skos__prefLabel mesh__D011410 Propanidid
% 220.78/220.93  |- mesh__historyNote mesh__D011410 70   
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D011410 2006
% 220.78/220.93  |- mesh__dateCreated mesh__D011410 1999-01-01
% 220.78/220.93  |- mesh__recordMaintainer mesh__D011410 lkw
% 220.78/220.93  |- skos__scopeNote mesh__D011410
% 220.78/220.93       An intravenous anesthetic that has been used for rapid induction of anesthesia and for maintenance of anesthesia of short duration. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p918%29%%A%    
% 220.78/220.93  |- skos__broader mesh__D011410smesh__D010648
% 220.78/220.93  |- skos__historyNote mesh__D011410 Anesthetics %28%1966-1969%29%
% 220.78/220.93  |- mesh__dateEstablished mesh__D011410 1970-01-01
% 220.78/220.93  |- rdf__type mesh__D011410sskos__Concept
% 220.78/220.93  |- mesh__dateRevised mesh__D011410 2005-06-30
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D002684 2005
% 220.78/220.93  |- skos__related mesh__D002684smesh__D008349
% 220.78/220.93  |- mesh__recordMaintainer mesh__D002684 ssb
% 220.78/220.93  |- skos__related mesh__D002684smesh__D026882
% 220.78/220.93  |- mesh__dateCreated mesh__D002684 1999-01-01
% 220.78/220.93  |- rdf__type mesh__D002684sskos__Concept
% 220.78/220.93  |- skos__scopeNote mesh__D002684
% 220.78/220.93       An occupational discipline founded by D.D. Palmer in the 1890%27%s based on the relationship of the spine to health and disease.  The spine is analyzed by X-rays and palpation, and vertebrae are adjusted manually to relieve pressures on the spinal cord.  OSTEOPATHIC MEDICINE was originally similar but has become more like FAMILY PRACTICE.%A%    
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D002684 2004
% 220.78/220.93  |- mesh__recordOriginator mesh__D002684 NLM
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D002684 2003
% 220.78/220.93  |- skos__prefLabel mesh__D002684 Chiropractic
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D002684 2006
% 220.78/220.93  |- mesh__dateRevised mesh__D002684 2001-07-25
% 220.78/220.93  |- skos__broader mesh__D002684smesh__D006281
% 220.78/220.93  |- mesh__recordAuthorizer mesh__D002684 sjn
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D002684 2002
% 220.78/220.93  |- skos__annotation mesh__D002684
% 220.78/220.93       SPEC only; do not confuse with MANIPULATION, CHIROPRACTIC%A%  
% 220.78/220.93  |- mesh__historyNote mesh__D029821 2002   
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D029821 2003
% 220.78/220.93  |- skos__broader mesh__D029821smesh__D004770
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D029821 2005
% 220.78/220.93  |- skos__prefLabel mesh__D029821 Enterovirus A, Human
% 220.78/220.93  |- skos__scopeNote mesh__D029821
% 220.78/220.93       A species of ENTEROVIRUS infecting humans and containing 10 serotypes, mostly coxsackieviruses.%A%    
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D029821 2004
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D029821 2006
% 220.78/220.93  |- mesh__dateCreated mesh__D029821 2001-07-25
% 220.78/220.93  |- rdf__type mesh__D029821sskos__Concept
% 220.78/220.93  |- mesh__dateEstablished mesh__D029821 2002-01-01
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D029821 2002
% 220.78/220.93  |- mesh__publicMeSHNote mesh__D029821 2002   
% 220.78/220.93  |- skos__altLabel mesh__D029821 Human enterovirus A
% 220.78/220.93  |- skos__annotation mesh__D029821
% 220.78/220.93       infection: coord IM with ENTEROVIRUS INFECTIONS %28%IM%29%   
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D010318 1997
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D010318 2001
% 220.78/220.93  |- mesh__historyNote mesh__D010318
% 220.78/220.93       91%28%72%29%; was see under PARTNERSHIP PRACTICE 1972-90   
% 220.78/220.93  |- rdf__type mesh__D010318sskos__Concept
% 220.78/220.93  |- skos__historyNote mesh__D010318 specific dentistry specialty
% 220.78/220.93  |- skos__altLabel mesh__D010318 Dental Partnership Practices
% 220.78/220.93  |- skos__historyNote mesh__D010318 Partnership Practice %28%1968-1971%29%
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D010318 2002
% 220.78/220.93  |- skos__historyNote mesh__D010318 Dentistry %28%1966-1971%29%
% 220.78/220.93  |- mesh__recordAuthorizer mesh__D010318 PLS
% 220.78/220.93  |- skos__altLabel mesh__D010318 Dental Partnership Practice
% 220.78/220.93  |- mesh__dateCreated mesh__D010318 1999-01-01
% 220.78/220.93  |- skos__altLabel mesh__D010318 Dental Associateship Practices
% 220.78/220.93  |- mesh__recordOriginator mesh__D010318 NLM
% 220.78/220.93  |- skos__broader mesh__D010318smesh__D010317
% 220.78/220.93  |- skos__annotation mesh__D010318
% 220.78/220.93       coord IM with specific dent specialty %28%IM%29%; do not confuse with GROUP PRACTICE, DENTAL but do not interpret: use word of text; DF: PARTNERSHIP PRACTICE DENT%A%  
% 220.78/220.93  |- skos__altLabel mesh__D010318 Practice, Dental Associateship
% 220.78/220.93  |- mesh__dateRevised mesh__D010318 1994-05-05
% 220.78/220.93  |- mesh__dateEstablished mesh__D010318 1991-01-01
% 220.78/220.93  |- skos__altLabel mesh__D010318 Practices, Dental Partnership
% 220.78/220.93  |- skos__scopeNote mesh__D010318
% 220.78/220.93       A voluntary contract between two or more dentists who may or may not share responsibility for the care of patients, with proportional sharing of profits and losses.%A%    
% 220.78/220.93  |- skos__altLabel mesh__D010318 Associateship Practices, Dental
% 220.78/220.93  |- skos__altLabel mesh__D010318 Practices, Dental Associateship
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D010318 2005
% 220.78/220.93  |- skos__prefLabel mesh__D010318 Partnership Practice, Dental
% 220.78/220.93  |- skos__altLabel mesh__D010318 Partnership Practices, Dental
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D010318 2003
% 220.78/220.93  |- skos__altLabel mesh__D010318 Practice, Dental Partnership
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D010318 2006
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D010318 2000
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D010318 1998
% 220.78/220.93  |- mesh__recordMaintainer mesh__D010318 TGC
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D010318 1995
% 220.78/220.93  |- skos__altLabel mesh__D010318 Dental Associateship Practice
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D010318 2004
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D010318 1996
% 220.78/220.93  |- mesh__publicMeSHNote mesh__D010318
% 220.78/220.93       91; was see under PARTNERSHIP PRACTICE 1972-90   
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D010318 1999
% 220.78/220.93  |- skos__scopeNote mesh__D029023
% 220.78/220.93       A plant genus of the family ACORACEAE, order Arales, subclass Arecidae most notable for Acorus calamus L. root which contains asarone and has been used in traditional medicine.%A%    
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D029023 2003
% 220.78/220.93  |- skos__prefLabel mesh__D029023 Acorus
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D029023 2004
% 220.78/220.93  |- skos__altLabel mesh__D029023 Sedge, Sweet
% 220.78/220.93  |- skos__historyNote mesh__D029023 Plants, Medicinal %28%1966-2001%29%
% 220.78/220.93  |- skos__annotation mesh__D029023
% 220.78/220.93       do not confuse with the Calamus genus = ARECACEAE; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.78/220.93  |- mesh__dateEstablished mesh__D029023 2002-01-01
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D029023 2005
% 220.78/220.93  |- mesh__publicMeSHNote mesh__D029023 2002   
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D029023 2006
% 220.78/220.93  |- mesh__dateCreated mesh__D029023 2001-07-25
% 220.78/220.93  |- mesh__historyNote mesh__D029023 2002   
% 220.78/220.93  |- skos__broader mesh__D029023smesh__D029022
% 220.78/220.93  |- rdf__type mesh__D029023sskos__Concept
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D029023 2002
% 220.78/220.93  |- mesh__publicMeSHNote mesh__D015801 90   
% 220.78/220.93  |- mesh__recordAuthorizer mesh__D015801 sjn
% 220.78/220.93  |- skos__historyNote mesh__D015801 Proteins %28%1966-1989%29%
% 220.78/220.93  |- rdf__type mesh__D015801sskos__Concept
% 220.78/220.93  |- mesh__historyNote mesh__D015801 90   
% 220.78/220.93  |- skos__scopeNote mesh__D015801
% 220.78/220.93       Proteins found in any species of helminth.     
% 220.78/220.93  |- skos__prefLabel mesh__D015801 Helminth Proteins
% 220.78/220.93  |- skos__hiddenLabel mesh__D015801 Proteins, Helminth
% 220.78/220.93  |- mesh__recordOriginator mesh__D015801 RLS
% 220.78/220.93  |- mesh__dateCreated mesh__D015801 1989-09-06
% 220.78/220.93  |- skos__historyNote mesh__D015801 specific helminth %28%1966-1989%29%
% 220.78/220.93  |- mesh__dateEstablished mesh__D015801 1990-01-01
% 220.78/220.93  |- skos__annotation mesh__D015801
% 220.78/220.93       /drug eff /ultrastruct permitted; /physiol permitted for function within the helminth; coord IM with specific protein %28%IM%29% + specific helminth %28%IM%29%%A%  
% 220.78/220.93  |- skos__broader mesh__D015801smesh__D011506
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D015801 2006
% 220.78/220.93  |- mesh__recordMaintainer mesh__D015801 SYSTEM
% 220.78/220.93  |- mesh__dateRevised mesh__D015801 2005-06-30
% 220.78/220.93  |- mesh__recordAuthorizer mesh__D015003 sjn
% 220.78/220.93  |- rdf__type mesh__D015003sskos__Concept
% 220.78/220.93  |- skos__related mesh__D015003smesh__D005656
% 220.78/220.93  |- mesh__dateCreated mesh__D015003 1999-01-01
% 220.78/220.93  |- skos__prefLabel mesh__D015003 Yeasts
% 220.78/220.93  |- mesh__recordMaintainer mesh__D015003 SYSTEM
% 220.78/220.93  |- mesh__dateRevised mesh__D015003 2005-06-30
% 220.78/220.93  |- skos__annotation mesh__D015003
% 220.78/220.93       not for %22%yeast%22% %28% = YEAST, DRIED; see note there%29%; most %22%yeast infections%22% = CANDIDIASIS or specific but if general or unspecified yeast infect, index under MYCOSES%A%  
% 220.78/220.93  |- skos__scopeNote mesh__D015003
% 220.78/220.93       A general term for single-celled rounded fungi that reproduce by budding. Brewers%27% and bakers%27% yeasts are SACCHAROMYCES CEREVISIAE; therapeutic dried yeast is YEAST, DRIED.%A%    
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D015003 2006
% 220.78/220.93  |- skos__broader mesh__D015003smesh__D005658
% 220.78/220.93  |- mesh__recordOriginator mesh__D015003 NLM
% 220.78/220.93  |- skos__hiddenLabel mesh__D020746 Calcium Channels, L Type
% 220.78/220.93  |- skos__altLabel mesh__D020746 L-Type Voltage-Dependent Calcium Channels
% 220.78/220.93  |- skos__hiddenLabel mesh__D020746 Calcium Channels, Long-Lasting
% 220.78/220.93  |- mesh__recordMaintainer mesh__D020746 SYSTEM
% 220.78/220.93  |- skos__altLabel mesh__D020746 L-Type Calcium Channel
% 220.78/220.93  |- skos__altLabel mesh__D020746 L-Type Calcium Channels
% 220.78/220.93  |- skos__altLabel mesh__D020746 Long-Lasting Calcium Channels
% 220.78/220.93  |- mesh__recordAuthorizer mesh__D020746 sjn
% 220.78/220.93  |- mesh__dateEstablished mesh__D020746 2000-01-01
% 220.78/220.93  |- skos__hiddenLabel mesh__D020746 L Type Calcium Channels
% 220.78/220.93  |- skos__hiddenLabel mesh__D020746 Calcium Channel, L-Type
% 220.78/220.93  |- mesh__historyNote mesh__D020746
% 220.78/220.93       2000; use L-TYPE CALCIUM CHANNELS %28%NM%29% 1993-1999   
% 220.78/220.93  |- skos__hiddenLabel mesh__D020746 L Type VDCC alpha 2 Subunit
% 220.78/220.93  |- skos__altLabel mesh__D020746 Dihydropyridine Receptors
% 220.78/220.93  |- mesh__publicMeSHNote mesh__D020746
% 220.78/220.93       2000; DIHYDROPYRIDINE RECEPTOR %28%now L-TYPE CALCIUM CHANNELS%29% was indexed under CALCIUM CHANNELS %26% MUSCLE PROTEINS 1993-1999%A%  
% 220.78/220.93  |- rdf__type mesh__D020746sskos__Concept
% 220.78/220.93  |- skos__annotation mesh__D020746 DF: VDCC L   
% 220.78/220.93  |- skos__hiddenLabel mesh__D020746 VDCC, L-Type
% 220.78/220.93  |- mesh__activeMeSHYear mesh__D020746 2006
% 220.78/220.93  |- mesh__dateRevised mesh__D020746 2005-06-30
% 220.78/220.93  |- skos__hiddenLabel mesh__D020746
% 220.78/220.93       L Type Voltage Dependent Calcium Channels
% 220.78/220.93  |- skos__hiddenLabel mesh__D020746 Long Lasting Calcium Channels
% 220.78/220.93  |- skos__altLabel mesh__D020746 L-Type VDCC
% 220.78/220.93  |- skos__hiddenLabel mesh__D020746 L Type VDCC beta Subunit
% 220.78/220.94  |- skos__hiddenLabel mesh__D020746 L Type VDCC alpha 1 Subunit
% 220.78/220.94  |- skos__hiddenLabel mesh__D020746 L Type Calcium Channel
% 220.78/220.94  |- skos__hiddenLabel mesh__D020746 L Type VDCC
% 220.78/220.94  |- skos__broader mesh__D020746smesh__D015220
% 220.78/220.94  |- skos__historyNote mesh__D020746 Calcium Channels %28%1993-1999%29%
% 220.78/220.94  |- skos__hiddenLabel mesh__D020746 Receptor, Dihydropyridine
% 220.78/220.94  |- mesh__dateCreated mesh__D020746 1999-11-04
% 220.78/220.94  |- skos__altLabel mesh__D020746 L-Type VDCC alpha-1 Subunit
% 220.78/220.94  |- mesh__recordOriginator mesh__D020746 adp
% 220.78/220.94  |- skos__prefLabel mesh__D020746 Calcium Channels, L-Type
% 220.78/220.94  |- skos__hiddenLabel mesh__D020746 L Type VDCC delta Subunit
% 220.78/220.94  |- skos__altLabel mesh__D020746 Dihydropyridine Receptor
% 220.78/220.94  |- skos__historyNote mesh__D020746 Muscle Proteins %28%1993-1999%29%
% 220.78/220.94  |- skos__hiddenLabel mesh__D020746 L Type VDCC gamma Subunit
% 220.78/220.94  |- skos__scopeNote mesh__D020746
% 220.78/220.94       Long-lasting voltage-gated CALCIUM CHANNELS found in both excitable and nonexcitable tissue. They are responsible for normal myocardial and vascular smooth muscle contractility. Five subunits %28%alpha-1, alpha-2, beta, gamma, and delta%29% make up the L-type channel. The alpha-1 subunit is the binding site for calcium-based antagonists. Dihydropyridine-based calcium antagonists are used as markers for these binding sites.%A%    
% 220.78/220.94  |- mesh__recordOriginator mesh__D053122 ags
% 220.78/220.94  |- mesh__dateEstablished mesh__D053122 2005-11-10
% 220.78/220.94  |- skos__historyNote mesh__D053122 Influenza A Virus %28%1975-2005%29%
% 220.78/220.94  |- skos__hiddenLabel mesh__D053122 H3N2 Viruses
% 220.78/220.94  |- skos__hiddenLabel mesh__D053122 Viruses, H3N2
% 220.78/220.94  |- mesh__publicMeSHNote mesh__D053122 2006   
% 220.78/220.94  |- skos__hiddenLabel mesh__D053122 Virus, H3N2
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D053122 2006
% 220.78/220.94  |- mesh__historyNote mesh__D053122 2006   
% 220.78/220.94  |- skos__broader mesh__D053122smesh__D009980
% 220.78/220.94  |- skos__scopeNote mesh__D053122
% 220.78/220.94       A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 3 and neuraminidase 2. The H3N2 subtype was responsible for the Hong Kong flu pandemic of 1968.%A%    
% 220.78/220.94  |- mesh__recordAuthorizer mesh__D053122 ags
% 220.78/220.94  |- rdf__type mesh__D053122sskos__Concept
% 220.78/220.94  |- skos__annotation mesh__D053122
% 220.78/220.94       infection: coordinate IM with INFLUENZA, HUMAN %28%IM%29% in humans, or INFLUENZA IN BIRDS %28%IM%29% in birds, or ORTHOMYXOVIRIDAE INFECTIONS %28%IM%29% in other animals%A%  
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D053122 2006A
% 220.78/220.94  |- mesh__recordMaintainer mesh__D053122 ags
% 220.78/220.94  |- skos__altLabel mesh__D053122 H3N2 Virus
% 220.78/220.94  |- skos__prefLabel mesh__D053122 Influenza A Virus, H3N2 Subtype
% 220.78/220.94  |- mesh__dateRevised mesh__D053122 2005-11-10
% 220.78/220.94  |- mesh__dateCreated mesh__D053122 2005-11-10
% 220.78/220.94  |- skos__broader mesh__D006277smesh__D006266
% 220.78/220.94  |- rdf__type mesh__D006277sskos__Concept
% 220.78/220.94  |- mesh__dateCreated mesh__D006277 1982-04-28
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D006277 2000
% 220.78/220.94  |- skos__scopeNote mesh__D006277
% 220.78/220.94       Community health education events focused on prevention of disease and promotion of health through audiovisual exhibits.%A%    
% 220.78/220.94  |- skos__historyNote mesh__D006277 Health Education %28%1966-1982%29%
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D006277 1999
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D006277 1993
% 220.78/220.94  |- skos__hiddenLabel mesh__D006277 Fair, Health
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D006277 1998
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D006277 2006
% 220.78/220.94  |- mesh__publicMeSHNote mesh__D006277
% 220.78/220.94       91; was see under HEALTH EDUCATION 1983-90   
% 220.78/220.94  |- mesh__recordAuthorizer mesh__D006277 PLS
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D006277 2005
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D006277 1997
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D006277 2002
% 220.78/220.94  |- mesh__recordMaintainer mesh__D006277 TGC
% 220.78/220.94  |- mesh__recordOriginator mesh__D006277 EC
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D006277 1996
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D006277 2004
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D006277 2001
% 220.78/220.94  |- skos__hiddenLabel mesh__D006277 Fairs, Health
% 220.78/220.94  |- skos__hiddenLabel mesh__D006277 Health Fair
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D006277 1995
% 220.78/220.94  |- mesh__historyNote mesh__D006277
% 220.78/220.94       91%28%83%29%; was see under HEALTH EDUCATION 1983-90   
% 220.78/220.94  |- mesh__dateRevised mesh__D006277 1992-05-15
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D006277 2003
% 220.78/220.94  |- skos__historyNote mesh__D006277 Exhibits %28%1966-1982%29%
% 220.78/220.94  |- mesh__dateEstablished mesh__D006277 1991-01-01
% 220.78/220.94  |- skos__prefLabel mesh__D006277 Health Fairs
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D006277 1994
% 220.78/220.94  |- rdf__type mesh__D014709sskos__Concept
% 220.78/220.94  |- skos__historyNote mesh__D014709 Cell Line %28%1969-1986%29%
% 220.78/220.94  |- skos__broader mesh__D014709smesh__D004847
% 220.78/220.94  |- skos__broader mesh__D014709smesh__D002460
% 220.78/220.94  |- skos__hiddenLabel mesh__D014709 Cell, Vero
% 220.78/220.94  |- skos__historyNote mesh__D014709 Cercopithecus aethiops %28%1981-1986%29%
% 220.78/220.94  |- mesh__recordMaintainer mesh__D014709 sjn
% 220.78/220.94  |- skos__hiddenLabel mesh__D014709 Cells, Vero
% 220.78/220.94  |- mesh__recordAuthorizer mesh__D014709 sjn
% 220.78/220.94  |- skos__hiddenLabel mesh__D014709 Vero Cell
% 220.78/220.94  |- mesh__historyNote mesh__D014709 87   
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D014709 2005
% 220.78/220.94  |- skos__related mesh__D014709smesh__D019556
% 220.78/220.94  |- skos__annotation mesh__D014709
% 220.78/220.94       almost always NIM with no subheadings; check ANIMALS %26% add CERCOPITHECUS AETHIOPS %28%NIM%29%; do not routinely add KIDNEY%A%  
% 220.78/220.94  |- mesh__dateEstablished mesh__D014709 1987-01-01
% 220.78/220.94  |- skos__historyNote mesh__D014709 Cercopithecus %28%1975-1980%29%
% 220.78/220.94  |- skos__scopeNote mesh__D014709
% 220.78/220.94       A CELL LINE derived from the kidney of the African green %28%vervet%29% monkey, %28%CERCOPITHECUS AETHIOPS%29% used primarily in virus replication studies and plaque assays.%A%    
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D014709 2006
% 220.78/220.94  |- skos__historyNote mesh__D014709 Kidney %28%1966-1986%29%
% 220.78/220.94  |- mesh__publicMeSHNote mesh__D014709 87   
% 220.78/220.94  |- skos__prefLabel mesh__D014709 Vero Cells
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D014709 2004
% 220.78/220.94  |- mesh__dateRevised mesh__D014709 2003-07-30
% 220.78/220.94  |- mesh__recordOriginator mesh__D014709 SCD
% 220.78/220.94  |- mesh__dateCreated mesh__D014709 1986-06-18
% 220.78/220.94  |- mesh__historyNote mesh__D011411
% 220.78/220.94       91%28%72%29%; was see under ANILIDES 1972-90   
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D011411 2004
% 220.78/220.94  |- mesh__recordAuthorizer mesh__D011411 sjn
% 220.78/220.94  |- mesh__dateRevised mesh__D011411 2000-06-22
% 220.78/220.94  |- skos__altLabel mesh__D011411 Propanide
% 220.78/220.94  |- mesh__publicMeSHNote mesh__D011411 91; was see under ANILIDES 1972-90   
% 220.78/220.94  |- skos__hiddenLabel mesh__D011411 36, Propagrin
% 220.78/220.94  |- skos__scopeNote mesh__D011411
% 220.78/220.94       A chlorinated anilide that is used as an herbicide.     
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D011411 2002
% 220.78/220.94  |- mesh__dateCreated mesh__D011411 1999-01-01
% 220.78/220.94  |- skos__broader mesh__D011411smesh__D000813
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D011411 2005
% 220.78/220.94  |- skos__prefLabel mesh__D011411 Propanil
% 220.78/220.94  |- skos__historyNote mesh__D011411 Anilides %28%1966-1971%29%
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D011411 2006
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D011411 2003
% 220.78/220.94  |- mesh__recordMaintainer mesh__D011411 CCR
% 220.78/220.94  |- rdf__type mesh__D011411sskos__Concept
% 220.78/220.94  |- mesh__dateEstablished mesh__D011411 1991-01-01
% 220.78/220.94  |- mesh__recordOriginator mesh__D011411 NLM
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D011411 2001
% 220.78/220.94  |- skos__historyNote mesh__D011411 Herbicides %28%1966-1971%29%
% 220.78/220.94  |- skos__prefLabel mesh__D002685 Chiroptera
% 220.78/220.94  |- mesh__recordAuthorizer mesh__D002685 sjn
% 220.78/220.94  |- skos__altLabel mesh__D002685 Bats
% 220.78/220.94  |- skos__altLabel mesh__D002685 Flying Foxes
% 220.78/220.94  |- mesh__dateCreated mesh__D002685 1999-01-01
% 220.78/220.94  |- rdf__type mesh__D002685sskos__Concept
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D002685 2004
% 220.78/220.94  |- skos__hiddenLabel mesh__D002685 Foxes, Flying
% 220.78/220.94  |- mesh__dateRevised mesh__D002685 2003-07-09
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D002685 2006
% 220.78/220.94  |- mesh__recordMaintainer mesh__D002685 ags
% 220.78/220.94  |- skos__scopeNote mesh__D002685
% 220.78/220.94       Order of mammals whose members are adapted for flight. It includes bats, flying foxes, and fruit bats.%A%    
% 220.78/220.94  |- skos__broader mesh__D002685smesh__D008322
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D002685 2005
% 220.78/220.94  |- mesh__recordOriginator mesh__D002685 NLM
% 220.78/220.94  |- skos__scopeNote mesh__D035061
% 220.78/220.94       Groups that serve as a standard for comparison in experimental studies. They are similar in relevant characteristics to the experimental group but do not receive the experimental intervention.%A%    
% 220.78/220.94  |- skos__broader mesh__D035061smesh__D015340
% 220.78/220.94  |- skos__related mesh__D035061smesh__D018849
% 220.78/220.94  |- mesh__dateEstablished mesh__D035061 2003-01-01
% 220.78/220.94  |- skos__hiddenLabel mesh__D035061 Control Group
% 220.78/220.94  |- skos__annotation mesh__D035061
% 220.78/220.94       do not use routinely for the presence of control groups in a study design; reserve for discussions about control groups.%A%  
% 220.78/220.94  |- mesh__dateCreated mesh__D035061 2002-07-03
% 220.78/220.94  |- mesh__historyNote mesh__D035061 2003   
% 220.78/220.94  |- skos__hiddenLabel mesh__D035061 Groups, Control
% 220.78/220.94  |- skos__hiddenLabel mesh__D035061 Group, Control
% 220.78/220.94  |- mesh__publicMeSHNote mesh__D035061 2003   
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D035061 2006
% 220.78/220.94  |- skos__prefLabel mesh__D035061 Control Groups
% 220.78/220.94  |- skos__historyNote mesh__D035061 Research Design %28%1973-2002%29%
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D035061 2004
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D035061 2005
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D035061 2003
% 220.78/220.94  |- skos__broader mesh__D035061smesh__D012107
% 220.78/220.94  |- rdf__type mesh__D035061sskos__Concept
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D029822 2006
% 220.78/220.94  |- mesh__recordMaintainer mesh__D029822 ags
% 220.78/220.94  |- skos__prefLabel mesh__D029822 Enterovirus B, Human
% 220.78/220.94  |- skos__annotation mesh__D029822
% 220.78/220.94       infection: coordinate IM with ENTEROVIRUS INFECTIONS %28%IM%29%; for entry terms, infection may be a specific indented under ENTEROVIRUS INFECTIONS, check text%A%  
% 220.78/220.94  |- skos__altLabel mesh__D029822 Coxsackie A9 Virus
% 220.78/220.94  |- skos__altLabel mesh__D029822 Human enterovirus B
% 220.78/220.94  |- skos__altLabel mesh__D029822 Coxsackievirus A9, Human
% 220.78/220.94  |- mesh__historyNote mesh__D029822
% 220.78/220.94       2002; for COXSACKIE A9 VIRUS see ENTEROVIRUSES 1979-2001   
% 220.78/220.94  |- rdf__type mesh__D029822sskos__Concept
% 220.78/220.94  |- skos__hiddenLabel mesh__D029822 Pleurodynia Viruses
% 220.78/220.94  |- skos__altLabel mesh__D029822 Coxsackie B Viruses
% 220.78/220.94  |- mesh__dateRevised mesh__D029822 2005-07-27
% 220.78/220.94  |- skos__hiddenLabel mesh__D029822 Virus, Bornholm Disease
% 220.78/220.94  |- skos__hiddenLabel mesh__D029822 Echo Virus
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D029822 2006A
% 220.78/220.94  |- mesh__recordAuthorizer mesh__D029822 ags
% 220.78/220.94  |- mesh__dateEstablished mesh__D029822 2002-01-01
% 220.78/220.94  |- skos__scopeNote mesh__D029822
% 220.78/220.94       A species of ENTEROVIRUS infecting humans and containing 36 serotypes. It is comprised of all the echoviruses and a few coxsackieviruses, including all of those previously named coxsackievirus B.%A%    
% 220.78/220.94  |- skos__hiddenLabel mesh__D029822 Echovirus
% 220.78/220.94  |- skos__hiddenLabel mesh__D029822 Disease Virus, Bornholm
% 220.78/220.94  |- skos__altLabel mesh__D029822 Echo Viruses
% 220.78/220.94  |- skos__altLabel mesh__D029822 Pleurodynia Virus
% 220.78/220.94  |- skos__broader mesh__D029822smesh__D004770
% 220.78/220.94  |- mesh__recordOriginator mesh__D029822 ags
% 220.78/220.94  |- mesh__publicMeSHNote mesh__D029822
% 220.78/220.94       2002; for COXSACKIEVIRUSES B see COXSACKIEVIRUSES B 1994-2001, see COXSACKIE B VIRUSES 1979-1993; for PLEURODYNIA VIRUS see COXSACKIE VIRUSES 1963-1978; for ECHOVIRUSES see ECHOVIRUSES 1966-2001; for COXSACKIE A9 VIRUS see COXSACKIEVIRUSES A 1979-2001%A%  
% 220.78/220.94  |- mesh__dateCreated mesh__D029822 2001-07-25
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D029024 2005
% 220.78/220.94  |- mesh__recordAuthorizer mesh__D029024 ags
% 220.78/220.94  |- skos__hiddenLabel mesh__D029024 Marburg-like Virus
% 220.78/220.94  |- rdf__type mesh__D029024sskos__Concept
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D029024 2004
% 220.78/220.94  |- mesh__recordOriginator mesh__D029024 ags
% 220.78/220.94  |- mesh__dateEstablished mesh__D029024 2002-01-01
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D029024 2006A
% 220.78/220.94  |- mesh__dateRevised mesh__D029024 2005-07-14
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D029024 2003
% 220.78/220.94  |- mesh__historyNote mesh__D029024
% 220.78/220.94       2002; for MARBURG VIRUS use MARBURG-LIKE VIRUSES 1991-2001, use RHABDOVIRIDAE 1981-1990, use RHABDOVIRUSES 1978-1980, see RNA VIRUSES 1975-1977%A%  
% 220.78/220.94  |- mesh__publicMeSHNote mesh__D029024
% 220.78/220.94       2002; for MARBURG VIRUS see MARBURG VIRUS 1991-2001, see RHABDOVIRIDAE 1981-1990, see RHABDOVIRUSES 1978-1980, see RNA VIRUSES 1975-1977%A%  
% 220.78/220.94  |- skos__broader mesh__D029024smesh__D016563
% 220.78/220.94  |- skos__annotation mesh__D029024 infection = MARBURG VIRUS DISEASE   
% 220.78/220.94  |- skos__scopeNote mesh__D029024
% 220.78/220.94       A genus in the family FILOVIRIDAE consisting of one species %28%Marburg virus%29% with several strains. The genus shows no antigenic cross-reactivity with EBOLA-LIKE VIRUSES.%A%    
% 220.78/220.94  |- skos__hiddenLabel mesh__D029024 Marburg like Viruses
% 220.78/220.94  |- mesh__dateCreated mesh__D029024 2001-07-25
% 220.78/220.94  |- skos__prefLabel mesh__D029024 Marburg-like Viruses
% 220.78/220.94  |- skos__hiddenLabel mesh__D029024 Frankfurt Marburg Syndrome Virus
% 220.78/220.94  |- skos__altLabel mesh__D029024 Frankfurt-Marburg Syndrome Virus
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D029024 2002
% 220.78/220.94  |- mesh__recordMaintainer mesh__D029024 ags
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D029024 2006
% 220.78/220.94  |- skos__altLabel mesh__D010319 Milk Fever, Animal
% 220.78/220.94  |- skos__broader mesh__D010319smesh__D000820
% 220.78/220.94  |- mesh__recordMaintainer mesh__D010319 ags
% 220.78/220.94  |- mesh__recordAuthorizer mesh__D010319 sjn
% 220.78/220.94  |- mesh__publicMeSHNote mesh__D010319 75   
% 220.78/220.94  |- skos__hiddenLabel mesh__D010319 Pareses, Parturient
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D010319 2005
% 220.78/220.94  |- skos__annotation mesh__D010319
% 220.78/220.94       animal only, exper or vet; in cows %26% ewes: check tags ANIMALS + FEMALE + PREGNANCY %26% don%27%t forget CATTLE DISEASES %28%IM%29% + CATTLE %28%NIM%29% or SHEEP DISEASES %28%IM%29% + SHEEP %28%NIM%29%%A%  
% 220.78/220.94  |- mesh__dateRevised mesh__D010319 2003-07-30
% 220.78/220.94  |- mesh__dateEstablished mesh__D010319 1975-09-01
% 220.78/220.94  |- skos__hiddenLabel mesh__D010319 Fever, Animal Milk
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D010319 2006
% 220.78/220.94  |- skos__prefLabel mesh__D010319 Parturient Paresis
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D010319 2004
% 220.78/220.94  |- skos__scopeNote mesh__D010319
% 220.78/220.94       A disease of pregnant and lactating cows and ewes leading to generalized paresis and death. The disease, which is characterized by hypocalcemia, occurs at or shortly after parturition in cows and within weeks before or after parturition in ewes.%A%    
% 220.78/220.94  |- skos__historyNote mesh__D010319
% 220.78/220.94       Hypocalcemia/veterinary %28%1966-1974%29%
% 220.78/220.94  |- mesh__dateCreated mesh__D010319 1974-11-11
% 220.78/220.94  |- skos__hiddenLabel mesh__D010319 Paresis, Parturient
% 220.78/220.94  |- rdf__type mesh__D010319sskos__Concept
% 220.78/220.94  |- mesh__recordOriginator mesh__D010319 NLM
% 220.78/220.94  |- skos__hiddenLabel mesh__D010319 Parturient Pareses
% 220.78/220.94  |- mesh__historyNote mesh__D010319 75   
% 220.78/220.94  |- skos__hiddenLabel mesh__D010319 Animal Milk Fever
% 220.78/220.94  |- rdf__type mesh__D007370sskos__Concept
% 220.78/220.94  |- skos__historyNote mesh__D007370 Interferons %28%1966-1982%29%
% 220.78/220.94  |- skos__broader mesh__D007370smesh__D007372
% 220.78/220.94  |- mesh__dateRevised mesh__D007370 2005-06-30
% 220.78/220.94  |- skos__altLabel mesh__D007370 Interferons Type I
% 220.78/220.94  |- mesh__historyNote mesh__D007370 83   
% 220.78/220.94  |- skos__scopeNote mesh__D007370
% 220.78/220.94       Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons %28%INTERFERON-ALPHA and INTERFERON-BETA%29%.%A%    
% 220.78/220.94  |- skos__prefLabel mesh__D007370 Interferon Type I
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D007370 2006
% 220.78/220.94  |- skos__hiddenLabel mesh__D007370 Interferons, Type I
% 220.78/220.94  |- mesh__recordOriginator mesh__D007370 RLS
% 220.78/220.94  |- mesh__publicMeSHNote mesh__D007370 83   
% 220.78/220.94  |- skos__altLabel mesh__D007370 Type I Interferons
% 220.78/220.94  |- skos__altLabel mesh__D007370 Type I Interferon
% 220.78/220.94  |- mesh__recordMaintainer mesh__D007370 ssb
% 220.78/220.94  |- skos__hiddenLabel mesh__D007370 Interferon, Type I
% 220.78/220.94  |- mesh__dateEstablished mesh__D007370 1983-01-01
% 220.78/220.94  |- mesh__recordAuthorizer mesh__D007370 sjn
% 220.78/220.94  |- mesh__dateCreated mesh__D007370 1982-05-19
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D021041 2004
% 220.78/220.94  |- mesh__historyNote mesh__D021041 2001%28%1995%29%   
% 220.78/220.94  |- mesh__dateEstablished mesh__D021041 2001-01-01
% 220.78/220.94  |- skos__annotation mesh__D021041 DF: PLACENTAL CIRC   
% 220.78/220.94  |- skos__prefLabel mesh__D021041 Placental Circulation
% 220.78/220.94  |- skos__hiddenLabel mesh__D021041 Fetal Placental Circulation
% 220.78/220.94  |- skos__altLabel mesh__D021041 Circulation, Placental
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D021041 2006
% 220.78/220.94  |- skos__broader mesh__D021041smesh__D001775
% 220.78/220.94  |- skos__historyNote mesh__D021041
% 220.78/220.94       Maternal-Fetal Exchange %28%1968-1994%29%
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D021041 2005
% 220.78/220.94  |- skos__hiddenLabel mesh__D021041 Circulations, Fetoplacental
% 220.78/220.94  |- skos__hiddenLabel mesh__D021041 Circulation, Fetal-Placental
% 220.78/220.94  |- mesh__publicMeSHNote mesh__D021041
% 220.78/220.94       2001; for UTEROPLACENTAL CIRCULATION see UTEROPLACENTAL CIRCULATION 1995-2000%A%  
% 220.78/220.94  |- skos__altLabel mesh__D021041 Fetal-Placental Circulation
% 220.78/220.94  |- mesh__dateCreated mesh__D021041 2000-06-22
% 220.78/220.94  |- skos__hiddenLabel mesh__D021041 Fetoplacental Circulations
% 220.78/220.94  |- rdf__type mesh__D021041sskos__Concept
% 220.78/220.94  |- skos__historyNote mesh__D021041 Placenta/blood supply %28%1966-2000%29%
% 220.78/220.94  |- mesh__dateRevised mesh__D021041 2003-07-09
% 220.78/220.94  |- skos__altLabel mesh__D021041 Circulation, Uteroplacental
% 220.78/220.94  |- skos__hiddenLabel mesh__D021041 Fetal-Placental Circulations
% 220.78/220.94  |- skos__hiddenLabel mesh__D021041 Circulations, Fetal-Placental
% 220.78/220.94  |- skos__altLabel mesh__D021041 Circulation, Fetoplacental
% 220.78/220.94  |- skos__scopeNote mesh__D021041
% 220.78/220.94       The circulation of BLOOD, of both the mother and the FETUS, through the PLACENTA.%A%    
% 220.78/220.94  |- rdf__type mesh__D015802sskos__Concept
% 220.78/220.94  |- mesh__dateRevised mesh__D015802 2005-06-30
% 220.78/220.94  |- mesh__dateEstablished mesh__D015802 1990-01-01
% 220.78/220.94  |- mesh__recordAuthorizer mesh__D015802 sjn
% 220.78/220.94  |- skos__altLabel mesh__D015802 HLA-DR2
% 220.78/220.94  |- skos__historyNote mesh__D015802
% 220.78/220.94       Histocompatibility Antigens Class II %28%1980-1986%29%
% 220.78/220.94  |- skos__historyNote mesh__D015802 HLA-DR Antigens %28%1986-1989%29%
% 220.78/220.94  |- skos__hiddenLabel mesh__D015802 Antigen, HLA-DR2
% 220.78/220.94  |- mesh__recordOriginator mesh__D015802 AGS
% 220.78/220.94  |- skos__historyNote mesh__D015802 HLA Antigens %28%1980-1986%29%
% 220.78/220.94  |- mesh__dateCreated mesh__D015802 1989-05-15
% 220.78/220.94  |- mesh__recordMaintainer mesh__D015802 ssb
% 220.78/220.94  |- skos__prefLabel mesh__D015802 HLA-DR2 Antigen
% 220.78/220.94  |- mesh__publicMeSHNote mesh__D015802 90   
% 220.78/220.94  |- skos__annotation mesh__D015802
% 220.78/220.94       assoc with Goodpasture syndrome, multiple sclerosis %26% narcolepsy; DF: HLA DR2%A%  
% 220.78/220.94  |- mesh__historyNote mesh__D015802 90   
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D015802 2006
% 220.78/220.94  |- skos__hiddenLabel mesh__D015802 HLA DR2 Antigen
% 220.78/220.94  |- skos__scopeNote mesh__D015802
% 220.78/220.94       Human immune-response, D-related antigen encoded by the D locus on chromosome 6 and found on lymphoid cells. It is in linkage disequilibrium with HLA-A3 and HLA-B7 and is strongly associated with Goodpasture syndrome, multiple sclerosis, and narcolepsy.%A%    
% 220.78/220.94  |- skos__broader mesh__D015802smesh__D006684
% 220.78/220.94  |- mesh__recordMaintainer mesh__D015004 PLS
% 220.78/220.94  |- skos__broader mesh__D015004smesh__D018177
% 220.78/220.94  |- rdf__type mesh__D015004sskos__Concept
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D015004 1999
% 220.78/220.94  |- mesh__dateCreated mesh__D015004 1999-01-01
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D015004 1996
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D015004 2000
% 220.78/220.94  |- skos__prefLabel mesh__D015004 Yellow Fever
% 220.78/220.94  |- mesh__recordOriginator mesh__D015004 NLM
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D015004 1997
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D015004 2001
% 220.78/220.94  |- skos__hiddenLabel mesh__D015004 Fevers, Yellow
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D015004 2005
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D015004 2002
% 220.78/220.94  |- skos__annotation mesh__D015004 caused by a flavivirus   
% 220.78/220.94  |- skos__broader mesh__D015004smesh__D001102
% 220.78/220.94  |- skos__scopeNote mesh__D015004
% 220.78/220.94       An acute infectious disease primarily of the tropics, caused by a virus and transmitted to man by mosquitoes of the genera Aedes and Haemagogus.%A%    
% 220.78/220.94  |- mesh__recordAuthorizer mesh__D015004 PLS
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D015004 2006
% 220.78/220.94  |- skos__hiddenLabel mesh__D015004 Fever, Yellow
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D015004 2003
% 220.78/220.94  |- skos__hiddenLabel mesh__D015004 Yellow Fevers
% 220.78/220.94  |- mesh__dateRevised mesh__D015004 1995-05-25
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D015004 2004
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D015004 1998
% 220.78/220.94  |- skos__hiddenLabel mesh__D020747 T Type VDCC
% 220.78/220.94  |- skos__hiddenLabel mesh__D020747 T Type Calcium Channel
% 220.78/220.94  |- skos__hiddenLabel mesh__D020747 Calcium Channel, T-Type
% 220.78/220.94  |- mesh__dateCreated mesh__D020747 1999-11-08
% 220.78/220.94  |- skos__scopeNote mesh__D020747
% 220.78/220.94       A heterogenous group of transient or low voltage activated type CALCIUM CHANNELS. They are found in cardiac myocyte membranes, the sinoatrial node, Purkinje cells of the heart and the central nervous system.%A%    
% 220.78/220.94  |- skos__hiddenLabel mesh__D020747 Calcium Channels, Transient-Type
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D020747 2006
% 220.78/220.94  |- rdf__type mesh__D020747sskos__Concept
% 220.78/220.94  |- skos__hiddenLabel mesh__D020747 Transient Type Calcium Channels
% 220.78/220.94  |- skos__altLabel mesh__D020747 T-Type Voltage-Dependent Calcium Channels
% 220.78/220.94  |- mesh__recordAuthorizer mesh__D020747 sjn
% 220.78/220.94  |- skos__hiddenLabel mesh__D020747 Channel, T-Type Calcium
% 220.78/220.94  |- skos__hiddenLabel mesh__D020747 T Type Calcium Channels
% 220.78/220.94  |- skos__altLabel mesh__D020747 Transient-Type Calcium Channels
% 220.78/220.94  |- skos__hiddenLabel mesh__D020747 Calcium Channels, T Type
% 220.78/220.94  |- skos__broader mesh__D020747smesh__D015220
% 220.78/220.94  |- skos__hiddenLabel mesh__D020747 Channels, T-Type Calcium
% 220.78/220.94  |- skos__altLabel mesh__D020747 Calcium Channel %28%T-Type%29%
% 220.78/220.94  |- mesh__publicMeSHNote mesh__D020747
% 220.78/220.94       2000; CALCIUM CHANNEL %28%T-TYPE%29% was indexed under CALCIUM CHANNELS 1999%A%  
% 220.78/220.94  |- skos__altLabel mesh__D020747 T-Type VDCC
% 220.78/220.94  |- skos__altLabel mesh__D020747 T-Type Calcium Channel
% 220.78/220.94  |- skos__altLabel mesh__D020747 T-Type Calcium Channels
% 220.78/220.94  |- mesh__historyNote mesh__D020747
% 220.78/220.94       2000; use CALCIUM CHANNELS, T-TYPE %28%NM%29% 1999   
% 220.78/220.94  |- mesh__dateRevised mesh__D020747 2005-06-30
% 220.78/220.94  |- mesh__recordMaintainer mesh__D020747 SYSTEM
% 220.78/220.94  |- skos__prefLabel mesh__D020747 Calcium Channels, T-Type
% 220.78/220.94  |- skos__hiddenLabel mesh__D020747 Channels, Transient-Type Calcium
% 220.78/220.94  |- mesh__dateEstablished mesh__D020747 2000-01-01
% 220.78/220.94  |- skos__historyNote mesh__D020747 Calcium Channels %28%1989-1999%29%
% 220.78/220.94  |- skos__hiddenLabel mesh__D020747 VDCC, T-Type
% 220.78/220.94  |- mesh__recordOriginator mesh__D020747 adp
% 220.78/220.94  |- skos__hiddenLabel mesh__D020747
% 220.78/220.94       T Type Voltage Dependent Calcium Channels
% 220.78/220.94  |- skos__annotation mesh__D053123
% 220.78/220.94       infection: coordinate IM with INFLUENZA, HUMAN %28%IM%29% in humans, or INFLUENZA IN BIRDS %28%IM%29% in birds, or ORTHOMYXOVIRIDAE INFECTIONS %28%IM%29% in other animals%A%  
% 220.78/220.94  |- skos__altLabel mesh__D053123 H3N8 Virus
% 220.78/220.94  |- mesh__dateCreated mesh__D053123 2005-11-10
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D053123 2006C
% 220.78/220.94  |- mesh__dateRevised mesh__D053123 2005-11-14
% 220.78/220.94  |- mesh__dateEstablished mesh__D053123 2005-11-10
% 220.78/220.94  |- skos__historyNote mesh__D053123 Influenza A Virus %28%1983-2005%29%
% 220.78/220.94  |- skos__hiddenLabel mesh__D053123 Viruses, H3N8
% 220.78/220.94  |- skos__altLabel mesh__D053123 Equine Influenza Virus
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D053123 2006B
% 220.78/220.94  |- mesh__publicMeSHNote mesh__D053123
% 220.78/220.94       2006; for INFLUENZA VIRUS, EQUINE see INFLUENZA A VIRUS 1980-2005, see INFECTIOUS ARTERITIS VIRUS OF HORSES 1975-1979%A%  
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D053123 2006D
% 220.78/220.94  |- skos__prefLabel mesh__D053123 Influenza A Virus, H3N8 Subtype
% 220.78/220.94  |- skos__scopeNote mesh__D053123
% 220.78/220.94       A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 3 and neuraminidase 8. The H3N8 subtype has frequently been found in horses.%A%    
% 220.78/220.94  |- skos__hiddenLabel mesh__D053123 H3N8 Viruses
% 220.78/220.94  |- skos__hiddenLabel mesh__D053123 Virus, H3N8
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D053123 2006
% 220.78/220.94  |- mesh__recordAuthorizer mesh__D053123 ags
% 220.78/220.94  |- mesh__historyNote mesh__D053123
% 220.78/220.94       2006; for INFLUENZA VIRUS, EQUINE use INFLUENZA A VIRUS 1980-2005, use INFECTIOUS ARTERITIS VIRUS OF HORSES 1975-1979%A%  
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D053123 2006A
% 220.78/220.94  |- rdf__type mesh__D053123sskos__Concept
% 220.78/220.94  |- skos__broader mesh__D053123smesh__D009980
% 220.78/220.94  |- mesh__recordOriginator mesh__D053123 ags
% 220.78/220.94  |- mesh__recordMaintainer mesh__D053123 ags
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D006278 2002
% 220.78/220.94  |- skos__altLabel mesh__D006278
% 220.78/220.94       Health Insurance for Aged and Disabled, Title 18
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D006278 2005
% 220.78/220.94  |- mesh__dateEstablished mesh__D006278 1967-01-01
% 220.78/220.94  |- mesh__publicMeSHNote mesh__D006278
% 220.78/220.94       91; was HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1979-90, was HEALTH INSURANCE FOR AGED, TITLE 18 1966-78 %28%PROV 1966%29%; MEDICARE was see HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1979-90, %26% HEALTH INSURANCE FOR AGED, TITLE 18 1975-78%A%  
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D006278 2001
% 220.78/220.94  |- skos__scopeNote mesh__D006278
% 220.78/220.94       Federal program, created by Public Law 89-97, Title XVIII-Health Insurance for the Aged, a 1965 amendment to the Social Security Act, that provides health insurance benefits to persons over the age of 65 and others eligible for Social Security benefits. It consists of two separate but coordinated programs: hospital insurance %28%MEDICARE PART A%29% and supplementary medical insurance %28%MEDICARE PART B%29%. %28%Hospital Administration Terminology, AHA, 2d ed and A Discursive Dictionary of Health Care, US House of Representatives, 1976%29%%A%    
% 220.78/220.94  |- skos__broader mesh__D006278smesh__D008483
% 220.78/220.94  |- skos__annotation mesh__D006278
% 220.78/220.94       U.S. only: for Canada %26% Australia index under NATIONAL HEALTH PROGRAMS + country; specify geog; Public Law 89-97%A%  
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D006278 2004
% 220.78/220.94  |- skos__altLabel mesh__D006278 Health Insurance for Aged, Title 18
% 220.78/220.94  |- mesh__onlineNote mesh__D006278
% 220.78/220.94       use MEDICARE to search HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1979-90; HEALTH INSURANCE FOR AGED, TITLE l8 1966-78 %28%as Prov 1966%29%%A%  
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D006278 2000
% 220.78/220.94  |- mesh__dateCreated mesh__D006278 1999-01-01
% 220.78/220.94  |- mesh__recordAuthorizer mesh__D006278 sjn
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D006278 2003
% 220.78/220.94  |- mesh__historyNote mesh__D006278
% 220.78/220.94       91; was HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1979-90, was HEALTH INSURANCE FOR AGED, TITLE 18 1966-78 %28%PROV 1966%29%; MEDICARE was see HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1979-90, %26% HEALTH INSURANCE FOR AGED, TITLE 18 1975-78 1966-78 %28%Prov 1966%29%%A%  
% 220.78/220.94  |- skos__broader mesh__D006278smesh__D007348
% 220.78/220.94  |- rdf__type mesh__D006278sskos__Concept
% 220.78/220.94  |- skos__related mesh__D006278smesh__D017054
% 220.78/220.94  |- mesh__dateRevised mesh__D006278 1999-11-03
% 220.78/220.94  |- skos__altLabel mesh__D006278
% 220.78/220.94       Health Insurance for Aged, Disabled, Title 18
% 220.78/220.94  |- mesh__recordOriginator mesh__D006278 NLM
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D006278 2006
% 220.78/220.94  |- skos__prefLabel mesh__D006278 Medicare
% 220.78/220.94  |- mesh__recordMaintainer mesh__D006278 kle
% 220.78/220.94  |- mesh__dateCreated mesh__D011412 1999-01-01
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D011412 2005
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D011412 2000
% 220.78/220.94  |- mesh__historyNote mesh__D011412 74   
% 220.78/220.94  |- mesh__recordAuthorizer mesh__D011412 SJN
% 220.78/220.94  |- mesh__recordOriginator mesh__D011412 NLM
% 220.78/220.94  |- mesh__activeMeSHYear mesh__D011412 2006
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D011412 2001
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D011412 1998
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D011412 2003
% 220.78/220.95  |- mesh__dateRevised mesh__D011412 1997-06-20
% 220.78/220.95  |- skos__altLabel mesh__D011412 Aminopropanols
% 220.78/220.95  |- skos__broader mesh__D011412smesh__D000605
% 220.78/220.95  |- skos__prefLabel mesh__D011412 Propanolamines
% 220.78/220.95  |- rdf__type mesh__D011412sskos__Concept
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D011412 1999
% 220.78/220.95  |- mesh__dateEstablished mesh__D011412 1974-01-01
% 220.78/220.95  |- skos__scopeNote mesh__D011412
% 220.78/220.95       AMINO ALCOHOLS containing the propanolamine %28%NH2CH2CHOHCH2%29% group and its derivatives.%A%    
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D011412 2004
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D011412 2002
% 220.78/220.95  |- mesh__publicMeSHNote mesh__D011412 74   
% 220.78/220.95  |- mesh__recordMaintainer mesh__D011412 ADP
% 220.78/220.95  |- skos__broader mesh__D011412smesh__D020005
% 220.78/220.95  |- mesh__recordOriginator mesh__D049880 ags
% 220.78/220.95  |- mesh__publicMeSHNote mesh__D049880 2006   
% 220.78/220.95  |- mesh__historyNote mesh__D049880 2006   
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D049880 2006
% 220.78/220.95  |- skos__historyNote mesh__D049880 Mollusca %28%1964-2005%29%
% 220.78/220.95  |- skos__altLabel mesh__D049880 Mussels, Blue
% 220.78/220.95  |- skos__prefLabel mesh__D049880 Mytilus edulis
% 220.78/220.95  |- skos__altLabel mesh__D049880 Mussel, Common
% 220.78/220.95  |- mesh__recordMaintainer mesh__D049880 ags
% 220.78/220.95  |- rdf__type mesh__D049880sskos__Concept
% 220.78/220.95  |- skos__scopeNote mesh__D049880
% 220.78/220.95       A species of mussel in the genus MYTILUS, family MYTILIDAE, class BIVALVIA, known as the common mussel. It has a bluish-black shell and is highly edible.%A%    
% 220.78/220.95  |- skos__altLabel mesh__D049880 Mussels, Common
% 220.78/220.95  |- mesh__dateCreated mesh__D049880 2005-06-30
% 220.78/220.95  |- mesh__dateEstablished mesh__D049880 2006-01-01
% 220.78/220.95  |- skos__altLabel mesh__D049880 Mussel, Blue
% 220.78/220.95  |- skos__annotation mesh__D049880
% 220.78/220.95       as animal %26% food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH %28%IM%29%%A%  
% 220.78/220.95  |- skos__broader mesh__D049880smesh__D049878
% 220.78/220.95  |- skos__historyNote mesh__D049880 Bivalvia %28%1970-2005%29%
% 220.78/220.95  |- mesh__recordAuthorizer mesh__D049880 sjn
% 220.78/220.95  |- mesh__historyNote mesh__D002686 72%28%67%29%   
% 220.78/220.95  |- mesh__publicMeSHNote mesh__D002686 72   
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D002686 2006
% 220.78/220.95  |- mesh__recordOriginator mesh__D002686 NLM
% 220.78/220.95  |- skos__historyNote mesh__D002686 Polysaccharides %28%1966%29%
% 220.78/220.95  |- skos__prefLabel mesh__D002686 Chitin
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D002686 2005
% 220.78/220.95  |- mesh__recordAuthorizer mesh__D002686 sjn
% 220.78/220.95  |- mesh__dateEstablished mesh__D002686 1972-01-01
% 220.78/220.95  |- mesh__recordMaintainer mesh__D002686 jmp
% 220.78/220.95  |- skos__broader mesh__D002686smesh__D001704
% 220.78/220.95  |- skos__scopeNote mesh__D002686
% 220.78/220.95       A linear polysaccharide of beta-1-%3E%4 linked units of ACETYLGLUCOSAMINE. It is the second most abundant biopolymer on earth, found especially in INSECTS and FUNGI. When deacetylated it is called CHITOSAN.%A%    
% 220.78/220.95  |- rdf__type mesh__D002686sskos__Concept
% 220.78/220.95  |- mesh__dateCreated mesh__D002686 1999-01-01
% 220.78/220.95  |- skos__broader mesh__D002686smesh__D011134
% 220.78/220.95  |- mesh__dateRevised mesh__D002686 2004-07-07
% 220.78/220.95  |- skos__hiddenLabel mesh__D007371 Interferon, Type II
% 220.78/220.95  |- mesh__dateEstablished mesh__D007371 1983-01-01
% 220.78/220.95  |- mesh__recordMaintainer mesh__D007371 ssb
% 220.78/220.95  |- mesh__publicMeSHNote mesh__D007371
% 220.78/220.95       83; INTERFERON-GAMMA was INTERFERON, GAMMA 1983-90   
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D007371 2006
% 220.78/220.95  |- mesh__recordAuthorizer mesh__D007371 sjn
% 220.78/220.95  |- skos__altLabel mesh__D007371 Interferon, gamma
% 220.78/220.95  |- skos__historyNote mesh__D007371 Interferons %28%1966-1982%29%
% 220.78/220.95  |- skos__broader mesh__D007371smesh__D007372
% 220.78/220.95  |- skos__altLabel mesh__D007371 Type II Interferon
% 220.78/220.95  |- skos__broader mesh__D007371smesh__D016215
% 220.78/220.95  |- mesh__historyNote mesh__D007371
% 220.78/220.95       83; INTERFERON-GAMMA was INTERFERON, GAMMA 1983-90   
% 220.78/220.95  |- mesh__dateCreated mesh__D007371 1982-05-19
% 220.78/220.95  |- skos__altLabel mesh__D007371 Interferon, Immune
% 220.78/220.95  |- skos__prefLabel mesh__D007371 Interferon Type II
% 220.78/220.95  |- skos__scopeNote mesh__D007371
% 220.78/220.95       The major interferon produced by mitogenically or antigenically stimulated lymphocytes. It is structurally different from type I interferon %28%INTERFERON TYPE I%29% and its major activity is immunoregulation. It has been implicated in the expression of class II histocompatibility antigens in cells that do not normally produce them, leading to autoimmune disease.%A%    
% 220.78/220.95  |- mesh__dateRevised mesh__D007371 2005-06-30
% 220.78/220.95  |- rdf__type mesh__D007371sskos__Concept
% 220.78/220.95  |- skos__broader mesh__D007371smesh__D008222
% 220.78/220.95  |- skos__altLabel mesh__D007371 gamma-Interferon
% 220.78/220.95  |- skos__hiddenLabel mesh__D007371 gamma Interferon
% 220.78/220.95  |- skos__hiddenLabel mesh__D007371 Interferon gamma
% 220.78/220.95  |- mesh__recordOriginator mesh__D007371 RLS
% 220.78/220.95  |- skos__hiddenLabel mesh__D007371 Immune Interferon
% 220.78/220.95  |- skos__altLabel mesh__D007371 Interferon-gamma
% 220.78/220.95  |- mesh__recordOriginator mesh__D048788 nns
% 220.78/220.95  |- skos__broader mesh__D048788smesh__D010829
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D048788 2006
% 220.78/220.95  |- mesh__historyNote mesh__D048788 2005   
% 220.78/220.95  |- skos__scopeNote mesh__D048788
% 220.78/220.95       The series of changes to the shape, size, components, and functions of an individual organism that occur over time as the organism progresses from its initial form to full size and maturity.%A%    
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D048788 2005
% 220.78/220.95  |- mesh__dateEstablished mesh__D048788 2005-01-01
% 220.78/220.95  |- mesh__dateRevised mesh__D048788 2004-08-06
% 220.78/220.95  |- rdf__type mesh__D048788sskos__Concept
% 220.78/220.95  |- skos__prefLabel mesh__D048788 Growth and Development
% 220.78/220.95  |- mesh__recordAuthorizer mesh__D048788 jls
% 220.78/220.95  |- skos__annotation mesh__D048788
% 220.78/220.95       general only; prefer specifics or /growth with specific organism, organ or tissue%A%  
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D048788 2005A
% 220.78/220.95  |- skos__hiddenLabel mesh__D048788 Development and Growth
% 220.78/220.95  |- mesh__publicMeSHNote mesh__D048788 2005   
% 220.78/220.95  |- skos__related mesh__D048788smesh__D015509
% 220.78/220.95  |- skos__related mesh__D048788smesh__D018507
% 220.78/220.95  |- mesh__recordMaintainer mesh__D048788 jls
% 220.78/220.95  |- mesh__dateCreated mesh__D048788 2004-07-07
% 220.78/220.95  |- rdf__type mesh__D015803sskos__Concept
% 220.78/220.95  |- mesh__historyNote mesh__D015803 90   
% 220.78/220.95  |- mesh__dateEstablished mesh__D015803 1990-01-01
% 220.78/220.95  |- skos__hiddenLabel mesh__D015803 Antigen, HLA-DR3
% 220.78/220.95  |- mesh__dateCreated mesh__D015803 1989-05-15
% 220.78/220.95  |- skos__hiddenLabel mesh__D015803 HLA DR3 Antigen
% 220.78/220.95  |- skos__prefLabel mesh__D015803 HLA-DR3 Antigen
% 220.78/220.95  |- mesh__dateRevised mesh__D015803 2005-06-30
% 220.78/220.95  |- mesh__publicMeSHNote mesh__D015803 90   
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D015803 2006
% 220.78/220.95  |- mesh__recordAuthorizer mesh__D015803 sjn
% 220.78/220.95  |- skos__broader mesh__D015803smesh__D006684
% 220.78/220.95  |- skos__historyNote mesh__D015803 HLA-DR Antigens %28%1986-1989%29%
% 220.78/220.95  |- skos__historyNote mesh__D015803
% 220.78/220.95       Histocompatibility Antigens Class II %28%1980-1986%29%
% 220.78/220.95  |- mesh__recordOriginator mesh__D015803 AGS
% 220.78/220.95  |- skos__historyNote mesh__D015803 HLA Antigens %28%1980-1986%29%
% 220.78/220.95  |- mesh__recordMaintainer mesh__D015803 ssb
% 220.78/220.95  |- skos__scopeNote mesh__D015803
% 220.78/220.95       Human immune-response, D-related antigen encoded by the D locus on chromosome 6 and found on lymphoid cells. It is in linkage disequilibrium with HLA-A1 and HLA-B8. The HLA-DR3 antigen is strongly associated with celiac disease, Grave%27%s disease, dermatitis herpetiformis, early-age onset myasthenia gravis, systemic lupus erythematosus, juvenile diabetes, and opportunistic infections in AIDS.%A%    
% 220.78/220.95  |- skos__altLabel mesh__D015803 HLA-DR3
% 220.78/220.95  |- skos__annotation mesh__D015803
% 220.78/220.95       read MeSH definition for assoc dis; DF: HLA DR3   
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D015005 2003
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D015005 2005
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D015005 2002
% 220.78/220.95  |- rdf__type mesh__D015005sskos__Concept
% 220.78/220.95  |- mesh__dateRevised mesh__D015005 2001-07-25
% 220.78/220.95  |- skos__prefLabel mesh__D015005 Yellow fever virus
% 220.78/220.95  |- skos__scopeNote mesh__D015005
% 220.78/220.95       The type species of the FLAVIVIRUS genus. Principal vector transmission to humans is by AEDES spp. mosquitoes.%A%    
% 220.78/220.95  |- mesh__recordAuthorizer mesh__D015005 sjn
% 220.78/220.95  |- skos__annotation mesh__D015005 infection = YELLOW FEVER   
% 220.78/220.95  |- mesh__recordOriginator mesh__D015005 NLM
% 220.78/220.95  |- mesh__recordMaintainer mesh__D015005 ags
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D015005 2004
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D015005 2006
% 220.78/220.95  |- skos__broader mesh__D015005smesh__D005416
% 220.78/220.95  |- mesh__dateCreated mesh__D015005 1999-01-01
% 220.78/220.95  |- skos__hiddenLabel mesh__D020748 Ro 405967
% 220.78/220.95  |- mesh__dateEstablished mesh__D020748 2000-01-01
% 220.78/220.95  |- mesh__historyNote mesh__D020748 2000; use MIBEFRADIL 1989-1999   
% 220.78/220.95  |- mesh__dateRevised mesh__D020748 2005-06-30
% 220.78/220.95  |- skos__hiddenLabel mesh__D020748 Ro 40 5967
% 220.78/220.95  |- skos__prefLabel mesh__D020748 Mibefradil
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D020748 2006
% 220.78/220.95  |- rdf__type mesh__D020748sskos__Concept
% 220.78/220.95  |- skos__historyNote mesh__D020748 Benzimidazoles %28%1989-1999%29%
% 220.78/220.95  |- skos__altLabel mesh__D020748 Roche Brand of Mibefradil Dihydrochloride
% 220.78/220.95  |- mesh__publicMeSHNote mesh__D020748
% 220.78/220.95       2000; MIBEFRADIL was indexed under BENZIMIDAZOLES %26% TETRAHYDRONAPHTHALENS 1989-1999%A%  
% 220.78/220.95  |- skos__historyNote mesh__D020748 Tetrahydronaphthalenes %28%1989-1999%29%
% 220.78/220.95  |- skos__scopeNote mesh__D020748
% 220.78/220.95       A benzimidazoyl-substituted tetraline that selectively binds and inhibits CALCIUM CHANNELS, T-TYPE.%A%    
% 220.78/220.95  |- mesh__recordAuthorizer mesh__D020748 sjn
% 220.78/220.95  |- skos__broader mesh__D020748smesh__D001562
% 220.78/220.95  |- mesh__dateCreated mesh__D020748 1999-11-03
% 220.78/220.95  |- mesh__recordMaintainer mesh__D020748 CCR
% 220.78/220.95  |- skos__broader mesh__D020748smesh__D013764
% 220.78/220.95  |- mesh__recordOriginator mesh__D020748 adp
% 220.78/220.95  |- mesh__publicMeSHNote mesh__D053124 2006   
% 220.78/220.95  |- skos__hiddenLabel mesh__D053124 Viruses, H5N1
% 220.78/220.95  |- skos__broader mesh__D053124smesh__D009980
% 220.78/220.95  |- mesh__recordOriginator mesh__D053124 ags
% 220.78/220.95  |- skos__annotation mesh__D053124
% 220.78/220.95       infection: coordinate IM with INFLUENZA, HUMAN %28%IM%29% in humans, or INFLUENZA IN BIRDS %28%IM%29% in birds, or ORTHOMYXOVIRIDAE INFECTIONS %28%IM%29% in other animals%A%  
% 220.78/220.95  |- skos__prefLabel mesh__D053124 Influenza A Virus, H5N1 Subtype
% 220.78/220.95  |- mesh__dateEstablished mesh__D053124 2005-11-10
% 220.78/220.95  |- skos__altLabel mesh__D053124 H5N1 Virus
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D053124 2006
% 220.78/220.95  |- skos__historyNote mesh__D053124 Influenza A Virus %28%1988-2005%29%
% 220.78/220.95  |- mesh__recordAuthorizer mesh__D053124 ags
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D053124 2006B
% 220.78/220.95  |- rdf__type mesh__D053124sskos__Concept
% 220.78/220.95  |- mesh__historyNote mesh__D053124 2006   
% 220.78/220.95  |- mesh__recordMaintainer mesh__D053124 ags
% 220.78/220.95  |- skos__scopeNote mesh__D053124
% 220.78/220.95       A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 5 and neuraminidase 1. The H5N1 subtype, frequently referred to as the bird flu virus, is endemic in wild birds and very contagious among both domestic %28%POULTRY%29% and wild birds. It does not usually infect humans, but some cases have been reported.%A%    
% 220.78/220.95  |- skos__hiddenLabel mesh__D053124 H5N1 Viruses
% 220.78/220.95  |- mesh__dateCreated mesh__D053124 2005-11-10
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D053124 2006A
% 220.78/220.95  |- mesh__dateRevised mesh__D053124 2005-11-14
% 220.78/220.95  |- skos__hiddenLabel mesh__D053124 Virus, H5N1
% 220.78/220.95  |- mesh__recordOriginator mesh__D006279 NLM
% 220.78/220.95  |- skos__broader mesh__D006279smesh__D006123
% 220.78/220.95  |- skos__altLabel mesh__D006279 Prepaid Group Health Organizations
% 220.78/220.95  |- skos__broader mesh__D006279smesh__D017061
% 220.78/220.95  |- mesh__historyNote mesh__D006279 74%28%71%29%   
% 220.78/220.95  |- skos__altLabel mesh__D006279 HMO
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D006279 2004
% 220.78/220.95  |- skos__hiddenLabel mesh__D006279 Organization, Health Maintenance
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D006279 2002
% 220.78/220.95  |- mesh__dateCreated mesh__D006279 1999-01-01
% 220.78/220.95  |- skos__historyNote mesh__D006279 Group Practice %28%1966-1970%29%
% 220.78/220.95  |- mesh__publicMeSHNote mesh__D006279 74   
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D006279 2003
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D006279 2001
% 220.78/220.95  |- mesh__dateRevised mesh__D006279 1999-11-08
% 220.78/220.95  |- rdf__type mesh__D006279sskos__Concept
% 220.78/220.95  |- skos__altLabel mesh__D006279 Group Health Organizations, Prepaid
% 220.78/220.95  |- skos__prefLabel mesh__D006279 Health Maintenance Organizations
% 220.78/220.95  |- skos__scopeNote mesh__D006279
% 220.78/220.95       Organized systems for providing comprehensive prepaid health care that have five basic attributes: %28%1%29% provide care in a defined geographic area; %28%2%29% provide or ensure delivery of an agreed-upon set of basic and supplemental health maintenance and treatment services; %28%3%29% provide care to a voluntarily enrolled group of persons; %28%4%29% require their enrollees to use the services of designated providers; and %28%5%29% receive reimbursement through a predetermined, fixed, periodic prepayment made by the enrollee without regard to the degree of services provided. %28%From Facts on File Dictionary of Health Care Management, 1988%29%%A%    
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D006279 2000
% 220.78/220.95  |- skos__altLabel mesh__D006279 Organizations, Health Maintenance
% 220.78/220.95  |- skos__altLabel mesh__D006279 Health Maintenance Organization
% 220.78/220.95  |- skos__annotation mesh__D006279 DF: note short X ref   
% 220.78/220.95  |- mesh__recordAuthorizer mesh__D006279 sjn
% 220.78/220.95  |- mesh__dateEstablished mesh__D006279 1974-01-01
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D006279 2006
% 220.78/220.95  |- skos__broader mesh__D006279smesh__D008329
% 220.78/220.95  |- mesh__recordMaintainer mesh__D006279 adp
% 220.78/220.95  |- skos__historyNote mesh__D006279 Insurance, Health %28%1966-1970%29%
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D006279 2005
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D011413 2006
% 220.78/220.95  |- skos__broader mesh__D011413smesh__D000644
% 220.78/220.95  |- rdf__type mesh__D011413sskos__Concept
% 220.78/220.95  |- skos__hiddenLabel mesh__D011413 Pro Banthine
% 220.78/220.95  |- mesh__publicMeSHNote mesh__D011413
% 220.78/220.95       81; was see under METHANTHELINE 1963-67; PROPANTHELINE BROMIDE was heading 1972-80%A%  
% 220.78/220.95  |- mesh__recordOriginator mesh__D011413 NLM
% 220.78/220.95  |- skos__altLabel mesh__D011413 Pro-Banthine
% 220.78/220.95  |- mesh__historyNote mesh__D011413
% 220.78/220.95       81; was see under METHANTHELINE 1963-67; PROPANTHELINE BROMIDE was heading 1964-80 %28%Prov 1964-71%29%%A%  
% 220.78/220.95  |- skos__hiddenLabel mesh__D011413 Bromide, Propantheline
% 220.78/220.95  |- mesh__recordAuthorizer mesh__D011413 sjn
% 220.78/220.95  |- skos__prefLabel mesh__D011413 Propantheline
% 220.78/220.95  |- mesh__dateRevised mesh__D011413 2005-06-30
% 220.78/220.95  |- mesh__onlineNote mesh__D011413
% 220.78/220.95       use PROPANTHELINE %26% METHANTHELINE to search PROPANTHELINE 1966-67; use PROPANTHELINE to search PROPANTHELINE BROMIDE 1966-80 %28%as Prov 1966-71%29%%A%  
% 220.78/220.95  |- mesh__dateEstablished mesh__D011413 1972-01-01
% 220.78/220.95  |- mesh__recordMaintainer mesh__D011413 ssb
% 220.78/220.95  |- mesh__dateCreated mesh__D011413 1999-01-01
% 220.78/220.95  |- skos__broader mesh__D011413smesh__D014966
% 220.78/220.95  |- skos__scopeNote mesh__D011413
% 220.78/220.95       A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking.%A%    
% 220.78/220.95  |- skos__broader mesh__D049881smesh__D049876
% 220.78/220.95  |- mesh__recordOriginator mesh__D049881 ags
% 220.78/220.95  |- mesh__recordMaintainer mesh__D049881 ags
% 220.78/220.95  |- skos__prefLabel mesh__D049881 Unio
% 220.78/220.95  |- rdf__type mesh__D049881sskos__Concept
% 220.78/220.95  |- skos__historyNote mesh__D049881 Mollusca %28%1966-2005%29%
% 220.78/220.95  |- mesh__historyNote mesh__D049881 2006   
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D049881 2006A
% 220.78/220.95  |- skos__scopeNote mesh__D049881
% 220.78/220.95       A genus of freshwater mussels in the family UNIONIDAE, class BIVALVIA.%A%    
% 220.78/220.95  |- mesh__dateRevised mesh__D049881 2005-08-03
% 220.78/220.95  |- mesh__recordAuthorizer mesh__D049881 ags
% 220.78/220.95  |- skos__historyNote mesh__D049881 Bivalvia %28%1973-2005%29%
% 220.78/220.95  |- mesh__dateCreated mesh__D049881 2005-06-30
% 220.78/220.95  |- mesh__publicMeSHNote mesh__D049881 2006   
% 220.78/220.95  |- mesh__dateEstablished mesh__D049881 2006-01-01
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D049881 2006
% 220.78/220.95  |- skos__hiddenLabel mesh__D002687
% 220.78/220.95       Acetylglucosaminyltransferase, Chitin-UDP
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D002687 2006
% 220.78/220.95  |- skos__broader mesh__D002687smesh__D005964
% 220.78/220.95  |- mesh__recordMaintainer mesh__D002687 ssb
% 220.78/220.95  |- mesh__historyNote mesh__D002687
% 220.78/220.95       91%28%75%29%; was see under GLUCOSYLTRANSFERASES 1979-90; was see under HEXOSYLTRANSFERASES 1975-78%A%  
% 220.78/220.95  |- skos__prefLabel mesh__D002687 Chitin Synthase
% 220.78/220.95  |- skos__historyNote mesh__D002687 Uridine Diphosphate Sugars %28%1974%29%
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D002687 2005
% 220.78/220.95  |- mesh__recordOriginator mesh__D002687 NLM
% 220.78/220.95  |- skos__historyNote mesh__D002687 Hexosyltransferases %28%1974%29%
% 220.78/220.95  |- mesh__dateEstablished mesh__D002687 1991-01-01
% 220.78/220.95  |- mesh__publicMeSHNote mesh__D002687
% 220.78/220.95       91; was see under GLUCOSYLTRANSFERASES 1979-90; was see under HEXOSYLTRANSFERASES 1975-78%A%  
% 220.78/220.95  |- mesh__dateCreated mesh__D002687 1974-11-19
% 220.78/220.95  |- rdf__type mesh__D002687sskos__Concept
% 220.78/220.95  |- skos__scopeNote mesh__D002687
% 220.78/220.95       An enzyme that converts UDP glucosamine into chitin and UDP. EC 2.4.1.16.%A%    
% 220.78/220.95  |- skos__altLabel mesh__D002687 trans-N-Acetylglucosaminosylase
% 220.78/220.95  |- skos__hiddenLabel mesh__D002687 trans N Acetylglucosaminosylase
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D002687 2004
% 220.78/220.95  |- mesh__recordAuthorizer mesh__D002687 sjn
% 220.78/220.95  |- skos__historyNote mesh__D002687 Chitin %28%1974%29%
% 220.78/220.95  |- skos__altLabel mesh__D002687 Chitin-UDP Acetylglucosaminyltransferase
% 220.78/220.95  |- skos__hiddenLabel mesh__D002687 Chitin UDP Acetylglucosaminyltransferase
% 220.78/220.95  |- mesh__dateRevised mesh__D002687 2003-07-09
% 220.78/220.95  |- skos__historyNote mesh__D002687 Glucosamine %28%1974%29%
% 220.78/220.95  |- skos__hiddenLabel mesh__D021841 Sex, Safe
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D021841 2005
% 220.78/220.95  |- mesh__historyNote mesh__D021841 2001   
% 220.78/220.95  |- skos__related mesh__D021841smesh__D012736
% 220.78/220.95  |- skos__broader mesh__D021841smesh__D012725
% 220.78/220.95  |- skos__altLabel mesh__D021841 Protected Sex
% 220.78/220.95  |- mesh__dateCreated mesh__D021841 2000-06-27
% 220.78/220.95  |- mesh__recordOriginator mesh__D021841 jls
% 220.78/220.95  |- skos__hiddenLabel mesh__D021841 Sex, Protected
% 220.78/220.95  |- skos__historyNote mesh__D021841 Sex Behavior %28%1966-2000%29%
% 220.78/220.95  |- mesh__recordAuthorizer mesh__D021841 sjn
% 220.78/220.95  |- mesh__publicMeSHNote mesh__D021841 2001   
% 220.78/220.95  |- skos__altLabel mesh__D021841 Responsible Sex
% 220.78/220.95  |- rdf__type mesh__D021841sskos__Concept
% 220.78/220.95  |- skos__hiddenLabel mesh__D021841 Sex, Responsible
% 220.78/220.95  |- mesh__dateEstablished mesh__D021841 2001-01-01
% 220.78/220.95  |- mesh__dateRevised mesh__D021841 2004-07-07
% 220.78/220.95  |- mesh__recordMaintainer mesh__D021841 lkt
% 220.78/220.95  |- skos__prefLabel mesh__D021841 Safe Sex
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D021841 2006
% 220.78/220.95  |- skos__scopeNote mesh__D021841
% 220.78/220.95       Sexual behavior that prevents or reduces the spread of SEXUALLY TRANSMITTED DISEASES or PREGNANCY.%A%    
% 220.78/220.95  |- mesh__recordAuthorizer mesh__D007372 ags
% 220.78/220.95  |- mesh__dateCreated mesh__D007372 1999-01-01
% 220.78/220.95  |- mesh__recordOriginator mesh__D007372 NLM
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D007372 2006
% 220.78/220.95  |- mesh__publicMeSHNote mesh__D007372 83; was INTERFERON 1963-82   
% 220.78/220.95  |- mesh__historyNote mesh__D007372 83; was INTERFERON 1963-82   
% 220.78/220.95  |- skos__annotation mesh__D007372
% 220.78/220.95       %22%stimulators%22% or %22%inducers%22% = INTERFERON INDUCERS   
% 220.78/220.95  |- mesh__recordMaintainer mesh__D007372 ags
% 220.78/220.95  |- skos__prefLabel mesh__D007372 Interferons
% 220.78/220.95  |- mesh__onlineNote mesh__D007372
% 220.78/220.95       use INTERFERONS to search INTERFERON 1966-82   
% 220.78/220.95  |- skos__related mesh__D007372smesh__D017471
% 220.78/220.95  |- skos__scopeNote mesh__D007372
% 220.78/220.95       Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions.%A%    
% 220.78/220.95  |- rdf__type mesh__D007372sskos__Concept
% 220.78/220.95  |- skos__broader mesh__D007372smesh__D016207
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D007372 2006A
% 220.78/220.95  |- mesh__dateRevised mesh__D007372 2005-08-03
% 220.78/220.95  |- skos__altLabel mesh__D007372 Interferon
% 220.78/220.95  |- skos__broader mesh__D007372smesh__D036341
% 220.78/220.95  |- mesh__dateCreated mesh__D048789 2004-07-07
% 220.78/220.95  |- mesh__recordAuthorizer mesh__D048789 sjn
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D048789 2006
% 220.78/220.95  |- rdf__type mesh__D048789sskos__Concept
% 220.78/220.95  |- skos__altLabel mesh__D048789 Phyto-Estrogen
% 220.78/220.95  |- mesh__recordMaintainer mesh__D048789 ssb
% 220.78/220.95  |- mesh__recordOriginator mesh__D048789 ssb
% 220.78/220.95  |- mesh__dateEstablished mesh__D048789 2005-01-01
% 220.78/220.95  |- skos__scopeNote mesh__D048789
% 220.78/220.95       PLANT EXTRACTS and compounds, primarily ISOFLAVONES, that mimic or modulate endogenous estrogens, usually by binding to ESTROGEN RECEPTORS.%A%    
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D048789 2005
% 220.78/220.95  |- skos__broader mesh__D048789smesh__D004968
% 220.78/220.95  |- mesh__publicMeSHNote mesh__D048789
% 220.78/220.95       2005; PHYTOESTROGENS was indexed under ISOFLAVONES 2004 and ESTROGENS, NON-STEROIDAL 1978-2003%A%  
% 220.78/220.95  |- skos__historyNote mesh__D048789 Isoflavones %28%2004%29%
% 220.78/220.95  |- mesh__historyNote mesh__D048789 2005%28%1978%29%   
% 220.78/220.95  |- skos__historyNote mesh__D048789
% 220.78/220.95       Estrogens, Non-Steroidal %28%1978-2003%29%
% 220.78/220.95  |- skos__hiddenLabel mesh__D048789 Phyto Estrogen
% 220.78/220.95  |- skos__prefLabel mesh__D048789 Phytoestrogens
% 220.78/220.95  |- skos__altLabel mesh__D048789 Phytoestrogen
% 220.78/220.95  |- mesh__dateCreated mesh__D015804 1989-05-15
% 220.78/220.95  |- mesh__recordAuthorizer mesh__D015804 sjn
% 220.78/220.95  |- mesh__dateEstablished mesh__D015804 1990-01-01
% 220.78/220.95  |- mesh__recordOriginator mesh__D015804 AGS
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D015804 2006
% 220.78/220.95  |- mesh__recordMaintainer mesh__D015804 ssb
% 220.78/220.95  |- mesh__historyNote mesh__D015804 90   
% 220.78/220.95  |- skos__historyNote mesh__D015804 HLA Antigens %28%1981-1986%29%
% 220.78/220.95  |- skos__altLabel mesh__D015804 HLA-DR4
% 220.78/220.95  |- skos__broader mesh__D015804smesh__D006684
% 220.78/220.95  |- skos__scopeNote mesh__D015804
% 220.78/220.95       Human immune-response, D-related antigen encoded by the D locus on chromosome 6 and found on lymphoid cells. It is strongly associated with rheumatoid arthritis and juvenile diabetes.%A%    
% 220.78/220.95  |- skos__hiddenLabel mesh__D015804 HLA DR4 Antigen
% 220.78/220.95  |- skos__prefLabel mesh__D015804 HLA-DR4 Antigen
% 220.78/220.95  |- mesh__publicMeSHNote mesh__D015804 90   
% 220.78/220.95  |- skos__historyNote mesh__D015804
% 220.78/220.95       Histocompatibility Antigens Class II %28%1981-1986%29%
% 220.78/220.95  |- skos__hiddenLabel mesh__D015804 Antigen, HLA-DR4
% 220.78/220.95  |- rdf__type mesh__D015804sskos__Concept
% 220.78/220.95  |- skos__annotation mesh__D015804
% 220.78/220.95       assoc with rheumatoid arthritis %26% insulin-depend diabetes mellitus; DF: HLA DR4%A%  
% 220.78/220.95  |- mesh__dateRevised mesh__D015804 2005-06-30
% 220.78/220.95  |- skos__historyNote mesh__D015804 HLA-DR Antigens %28%1986-1989%29%
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D015006 1997
% 220.78/220.95  |- mesh__recordMaintainer mesh__D015006 TGC
% 220.78/220.95  |- rdf__type mesh__D015006sskos__Concept
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D015006 1999
% 220.78/220.95  |- skos__prefLabel mesh__D015006 Yemen
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D015006 1996
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D015006 1995
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D015006 1998
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D015006 2002
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D015006 1994
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D015006 2004
% 220.78/220.95  |- skos__broader mesh__D015006smesh__D008877
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D015006 2001
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D015006 2006
% 220.78/220.95  |- mesh__dateCreated mesh__D015006 1999-01-01
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D015006 2003
% 220.78/220.95  |- mesh__recordOriginator mesh__D015006 NLM
% 220.78/220.95  |- skos__altLabel mesh__D015006 Democratic Yemen
% 220.78/220.95  |- mesh__recordAuthorizer mesh__D015006 PLS
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D015006 2000
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D015006 2005
% 220.78/220.95  |- mesh__dateRevised mesh__D015006 1993-06-03
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D053125 2006
% 220.78/220.95  |- mesh__historyNote mesh__D053125 2006   
% 220.78/220.95  |- mesh__recordAuthorizer mesh__D053125 ags
% 220.78/220.95  |- rdf__type mesh__D053125sskos__Concept
% 220.78/220.95  |- skos__broader mesh__D053125smesh__D009980
% 220.78/220.95  |- skos__hiddenLabel mesh__D053125 H5N2 Viruses
% 220.78/220.95  |- skos__prefLabel mesh__D053125 Influenza A Virus, H5N2 Subtype
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D053125 2006A
% 220.78/220.95  |- skos__annotation mesh__D053125
% 220.78/220.95       infection: coordinate IM with INFLUENZA, HUMAN %28%IM%29% in humans, or INFLUENZA IN BIRDS %28%IM%29% in birds, or ORTHOMYXOVIRIDAE INFECTIONS %28%IM%29% in other animals%A%  
% 220.78/220.95  |- mesh__dateRevised mesh__D053125 2005-11-10
% 220.78/220.95  |- mesh__recordOriginator mesh__D053125 ags
% 220.78/220.95  |- mesh__recordMaintainer mesh__D053125 ags
% 220.78/220.95  |- mesh__dateCreated mesh__D053125 2005-11-10
% 220.78/220.95  |- skos__hiddenLabel mesh__D053125 Virus, H5N2
% 220.78/220.95  |- mesh__dateEstablished mesh__D053125 2005-11-10
% 220.78/220.95  |- skos__scopeNote mesh__D053125
% 220.78/220.95       A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 5 and neuraminidase 2. The H5N2 subtype has been found to be highly pathogenic in chickens.%A%    
% 220.78/220.95  |- mesh__publicMeSHNote mesh__D053125 2006   
% 220.78/220.95  |- skos__historyNote mesh__D053125 Influenza A Virus %28%1984-2005%29%
% 220.78/220.95  |- skos__altLabel mesh__D053125 H5N2 Virus
% 220.78/220.95  |- skos__hiddenLabel mesh__D053125 Viruses, H5N2
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D053125 2006B
% 220.78/220.95  |- mesh__dateCreated mesh__D003780 1999-01-01
% 220.78/220.95  |- mesh__recordMaintainer mesh__D003780 lkt
% 220.78/220.95  |- skos__hiddenLabel mesh__D003780 Repair, Denture
% 220.78/220.95  |- rdf__type mesh__D003780sskos__Concept
% 220.78/220.95  |- mesh__recordOriginator mesh__D003780 NLM
% 220.78/220.95  |- mesh__dateRevised mesh__D003780 2001-07-25
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D003780 2004
% 220.78/220.95  |- skos__broader mesh__D003780smesh__D003778
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D003780 2002
% 220.78/220.95  |- skos__annotation mesh__D003780
% 220.78/220.95       coord IM with specific denture %28%IM or NIM%29%   
% 220.78/220.95  |- skos__scopeNote mesh__D003780
% 220.78/220.95       The process of reuniting or replacing broken or worn parts of a denture.%A%    
% 220.78/220.95  |- skos__hiddenLabel mesh__D003780 Repairs, Denture
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D003780 2006
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D003780 2003
% 220.78/220.95  |- mesh__publicMeSHNote mesh__D003780
% 220.78/220.95       91; was DENTAL PROSTHESIS REPAIR 1974-90   
% 220.78/220.95  |- mesh__activeMeSHYear mesh__D003780 2005
% 220.78/220.95  |- skos__prefLabel mesh__D003780 Denture Repair
% 220.78/220.95  |- mesh__recordAuthorizer mesh__D003780 sjn
% 220.78/220.95  |- skos__historyNote mesh__D003780 Dental Prosthesis %28%1966-1971%29%
% 220.78/220.95  |- mesh__historyNote mesh__D003780
% 220.78/220.95       91; was DENTAL PROSTHESIS REPAIR 1972-90 %28%Prov 1972-73%29%   
% 220.78/220.96  |- skos__hiddenLabel mesh__D003780 Denture Repairs
% 220.78/220.96  |- mesh__dateEstablished mesh__D003780 1974-01-01
% 220.78/220.96  |- skos__broader mesh__D003780smesh__D013674
% 220.78/220.96  |- mesh__dateRevised mesh__D011414 2005-06-30
% 220.78/220.96  |- mesh__recordAuthorizer mesh__D011414 sjn
% 220.78/220.96  |- skos__broader mesh__D011414smesh__D003165
% 220.78/220.96  |- mesh__dateCreated mesh__D011414 1999-01-01
% 220.78/220.96  |- skos__altLabel mesh__D011414 Complement Factor P
% 220.78/220.96  |- skos__hiddenLabel mesh__D011414 Factor P, Complement
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D011414 2006
% 220.78/220.96  |- skos__prefLabel mesh__D011414 Properdin
% 220.78/220.96  |- rdf__type mesh__D011414sskos__Concept
% 220.78/220.96  |- skos__broader mesh__D011414smesh__D007162
% 220.78/220.96  |- skos__broader mesh__D011414smesh__D001609
% 220.78/220.96  |- skos__scopeNote mesh__D011414
% 220.78/220.96       A 53-kDa protein that is a positive regulator of the alternate pathway of complement activation %28%COMPLEMENT ACTIVATION PATHWAY, ALTERNATIVE%29%. It stabilizes the ALTERNATIVE PATHWAY C3 CONVERTASE %28%C3bBb%29% and protects it from rapid inactivation, thus facilitating the cascade of COMPLEMENT ACTIVATION and the formation of MEMBRANE ATTACK COMPLEX. Individuals with mutation in the PFC gene exhibit properdin deficiency and have a high susceptibility to infections.%A%    
% 220.78/220.96  |- mesh__recordOriginator mesh__D011414 NLM
% 220.78/220.96  |- mesh__recordMaintainer mesh__D011414 lkt
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D035862 2004
% 220.78/220.96  |- mesh__recordMaintainer mesh__D035862 tjk
% 220.78/220.96  |- skos__broader mesh__D035862smesh__D009272
% 220.78/220.96  |- skos__hiddenLabel mesh__D035862 Populations, Vulnerable
% 220.78/220.96  |- mesh__publicMeSHNote mesh__D035862 2003   
% 220.78/220.96  |- skos__hiddenLabel mesh__D035862 Population, Vulnerable
% 220.78/220.96  |- mesh__historyNote mesh__D035862 2003   
% 220.78/220.96  |- skos__hiddenLabel mesh__D035862 Vulnerable Population
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D035862 2003
% 220.78/220.96  |- mesh__recordAuthorizer mesh__D035862 sjn
% 220.78/220.96  |- rdf__type mesh__D035862sskos__Concept
% 220.78/220.96  |- mesh__dateCreated mesh__D035862 2002-07-03
% 220.78/220.96  |- skos__prefLabel mesh__D035862 Vulnerable Populations
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D035862 2006
% 220.78/220.96  |- skos__scopeNote mesh__D035862
% 220.78/220.96       Groups of persons whose range of options is severely limited, who are frequently subjected to COERCION in their DECISION MAKING, or who may be compromised in their ability to give INFORMED CONSENT.%A%    
% 220.78/220.96  |- mesh__dateEstablished mesh__D035862 2003-01-01
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D035862 2005
% 220.78/220.96  |- mesh__recordOriginator mesh__D035862 hjn
% 220.78/220.96  |- skos__annotation mesh__D035862 HUMAN only   
% 220.78/220.96  |- mesh__dateRevised mesh__D002688 2003-07-09
% 220.78/220.96  |- skos__prefLabel mesh__D002688 Chitinase
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D002688 2006
% 220.78/220.96  |- mesh__recordOriginator mesh__D002688 NLM
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D002688 2005
% 220.78/220.96  |- mesh__dateCreated mesh__D002688 1999-01-01
% 220.78/220.96  |- rdf__type mesh__D002688sskos__Concept
% 220.78/220.96  |- skos__broader mesh__D002688smesh__D006026
% 220.78/220.96  |- mesh__recordAuthorizer mesh__D002688 sjn
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D002688 2004
% 220.78/220.96  |- mesh__recordMaintainer mesh__D002688 ssb
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007373 2006
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007373 1998
% 220.78/220.96  |- mesh__recordAuthorizer mesh__D007373 SJN
% 220.78/220.96  |- mesh__recordMaintainer mesh__D007373 JLS
% 220.78/220.96  |- mesh__dateCreated mesh__D007373 1979-06-01
% 220.78/220.96  |- skos__hiddenLabel mesh__D007373 Interinstitutional Relation
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007373 1999
% 220.78/220.96  |- skos__scopeNote mesh__D007373
% 220.78/220.96       The interactions between representatives of institutions, agencies, or organizations.%A%    
% 220.78/220.96  |- mesh__publicMeSHNote mesh__D007373 80   
% 220.78/220.96  |- skos__hiddenLabel mesh__D007373 Relations, Interagency
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007373 2000
% 220.78/220.96  |- mesh__dateRevised mesh__D007373 1997-06-20
% 220.78/220.96  |- rdf__type mesh__D007373sskos__Concept
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007373 2003
% 220.78/220.96  |- skos__hiddenLabel mesh__D007373 Relation, Interinstitutional
% 220.78/220.96  |- skos__hiddenLabel mesh__D007373 Relations, Interinstitutional
% 220.78/220.96  |- skos__prefLabel mesh__D007373 Interinstitutional Relations
% 220.78/220.96  |- skos__broader mesh__D007373smesh__D011641
% 220.78/220.96  |- skos__annotation mesh__D007373
% 220.78/220.96       no qualif; coord IM with specific institution, agency or organization %28%IM%29%; DF: INTERINSTITUTIONAL RELAT%A%  
% 220.78/220.96  |- skos__hiddenLabel mesh__D007373 Interagency Relation
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007373 2004
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007373 2001
% 220.78/220.96  |- mesh__dateEstablished mesh__D007373 1980-01-01
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007373 2002
% 220.78/220.96  |- mesh__recordOriginator mesh__D007373 EC
% 220.78/220.96  |- skos__hiddenLabel mesh__D007373 Relation, Interagency
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007373 2005
% 220.78/220.96  |- mesh__historyNote mesh__D007373 80   
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D015805 2006
% 220.78/220.96  |- skos__hiddenLabel mesh__D015805 HLA DR5 Antigen
% 220.78/220.96  |- mesh__dateRevised mesh__D015805 2005-06-30
% 220.78/220.96  |- skos__broader mesh__D015805smesh__D006684
% 220.78/220.96  |- skos__historyNote mesh__D015805 HLA-DR Antigens %28%1986-1989%29%
% 220.78/220.96  |- skos__historyNote mesh__D015805
% 220.78/220.96       Histocompatibility Antigens Class II %28%1980-1986%29%
% 220.78/220.96  |- mesh__publicMeSHNote mesh__D015805 90   
% 220.78/220.96  |- skos__hiddenLabel mesh__D015805 Antigen, HLA-DR5
% 220.78/220.96  |- mesh__recordAuthorizer mesh__D015805 sjn
% 220.78/220.96  |- skos__altLabel mesh__D015805 HLA-DR5
% 220.78/220.96  |- skos__prefLabel mesh__D015805 HLA-DR5 Antigen
% 220.78/220.96  |- skos__historyNote mesh__D015805 HLA Antigens %28%1983-1986%29%
% 220.78/220.96  |- mesh__recordOriginator mesh__D015805 AGS
% 220.78/220.96  |- rdf__type mesh__D015805sskos__Concept
% 220.78/220.96  |- skos__scopeNote mesh__D015805
% 220.78/220.96       Human immune-response, D-related antigen encoded by the D-locus on chromosome 6 and found on lymphoid cells. It is associated with Kaposi sarcoma in AIDS and juvenile rheumatoid arthritis.%A%    
% 220.78/220.96  |- mesh__recordMaintainer mesh__D015805 ssb
% 220.78/220.96  |- mesh__historyNote mesh__D015805 90   
% 220.78/220.96  |- skos__annotation mesh__D015805
% 220.78/220.96       assoc with Kaposi sarcoma in AIDS %26% juvenile rheumatoid arthritis; DF: HLA DR5%A%  
% 220.78/220.96  |- mesh__dateCreated mesh__D015805 1989-05-15
% 220.78/220.96  |- mesh__dateEstablished mesh__D015805 1990-01-01
% 220.78/220.96  |- mesh__onlineNote mesh__D015007 search PASTEURELLA 1972-74   
% 220.78/220.96  |- skos__broader mesh__D015007smesh__D004755
% 220.78/220.96  |- mesh__recordAuthorizer mesh__D015007 sjn
% 220.78/220.96  |- mesh__recordOriginator mesh__D015007 NLM
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D015007 2006
% 220.78/220.96  |- skos__scopeNote mesh__D015007
% 220.78/220.96       A genus of gram-negative, facultatively anaerobic rod- to coccobacillus-shaped bacteria that occurs in a broad spectrum of habitats.%A%    
% 220.78/220.96  |- mesh__dateCreated mesh__D015007 1999-01-01
% 220.78/220.96  |- skos__prefLabel mesh__D015007 Yersinia
% 220.78/220.96  |- mesh__publicMeSHNote mesh__D015007
% 220.78/220.96       75; was see under PASTEURELLA 1972-74   
% 220.78/220.96  |- skos__annotation mesh__D015007
% 220.78/220.96       infect = YERSINIA INFECTIONS but YERSINIA PESTIS infect = PLAGUE%A%  
% 220.78/220.96  |- rdf__type mesh__D015007sskos__Concept
% 220.78/220.96  |- mesh__historyNote mesh__D015007 75; was see under PASTEURELLA 1972-74   
% 220.78/220.96  |- mesh__dateRevised mesh__D015007 2005-06-30
% 220.78/220.96  |- mesh__dateEstablished mesh__D015007 1975-01-01
% 220.78/220.96  |- mesh__recordMaintainer mesh__D015007 SYSTEM
% 220.78/220.96  |- skos__hiddenLabel mesh__D053126 Virus, H7N7
% 220.78/220.96  |- skos__historyNote mesh__D053126 Influenza A Virus %28%1982-2005%29%
% 220.78/220.96  |- skos__scopeNote mesh__D053126
% 220.78/220.96       A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 7 and neuraminidase 7. The H7N7 subtype produced an epidemic in 2003 which was highly pathogenic among domestic birds %28%POULTRY%29%. Some infections in humans were reported.%A%    
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D053126 2006B
% 220.78/220.96  |- skos__hiddenLabel mesh__D053126 H7N7 Viruses
% 220.78/220.96  |- mesh__historyNote mesh__D053126 2006   
% 220.78/220.96  |- mesh__recordMaintainer mesh__D053126 ags
% 220.78/220.96  |- mesh__dateCreated mesh__D053126 2005-11-10
% 220.78/220.96  |- mesh__dateRevised mesh__D053126 2005-11-14
% 220.78/220.96  |- mesh__publicMeSHNote mesh__D053126 2006   
% 220.78/220.96  |- skos__broader mesh__D053126smesh__D009980
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D053126 2006A
% 220.78/220.96  |- skos__annotation mesh__D053126
% 220.78/220.96       infection: coordinate IM with INFLUENZA, HUMAN %28%IM%29% in humans, or INFLUENZA IN BIRDS %28%IM%29% in birds, or ORTHOMYXOVIRIDAE INFECTIONS %28%IM%29% in other animals%A%  
% 220.78/220.96  |- mesh__recordOriginator mesh__D053126 ags
% 220.78/220.96  |- mesh__dateEstablished mesh__D053126 2005-11-10
% 220.78/220.96  |- skos__prefLabel mesh__D053126 Influenza A Virus, H7N7 Subtype
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D053126 2006
% 220.78/220.96  |- mesh__recordAuthorizer mesh__D053126 ags
% 220.78/220.96  |- skos__altLabel mesh__D053126 H7N7 Virus
% 220.78/220.96  |- rdf__type mesh__D053126sskos__Concept
% 220.78/220.96  |- skos__hiddenLabel mesh__D053126 Viruses, H7N7
% 220.78/220.96  |- mesh__dateEstablished mesh__D003781 1965-01-01
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D003781 1996
% 220.78/220.96  |- mesh__recordMaintainer mesh__D003781 PXP
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D003781 2001
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D003781 1998
% 220.78/220.96  |- rdf__type mesh__D003781sskos__Concept
% 220.78/220.96  |- skos__prefLabel mesh__D003781 Denture Retention
% 220.78/220.96  |- skos__scopeNote mesh__D003781
% 220.78/220.96       The retention of a denture in place by design, device, or adhesion.%A%    
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D003781 2003
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D003781 1997
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D003781 1994
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D003781 2005
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D003781 1999
% 220.78/220.96  |- mesh__onlineNote mesh__D003781
% 220.78/220.96       use DENTURE RETENTION to search DENTURE STABILITY 1966-77%A%  
% 220.78/220.96  |- mesh__recordAuthorizer mesh__D003781 PLS
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D003781 1993
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D003781 2004
% 220.78/220.96  |- mesh__historyNote mesh__D003781
% 220.78/220.96       91; was DENTAL PROSTHESIS RETENTION 1985-90, was DENTURE RETENTION 1965-84; DENTURE RETENTION was see DENTAL PROSTHESIS RETENTION 1985-90; DENTURE STABILITY was heading 1965-77%A%  
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D003781 1995
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D003781 2002
% 220.78/220.96  |- skos__annotation mesh__D003781
% 220.78/220.96       coord IM with specific denture %28%IM or NIM%29%; for denture fixative %26% adhesives, coord IM with ADHESIVES %28%IM%29%%A%  
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D003781 2006
% 220.78/220.96  |- mesh__publicMeSHNote mesh__D003781
% 220.78/220.96       91; was DENTAL PROSTHESIS RETENTION 1985-90, was DENTURE RETENTION 1965-84; DENTURE RETENTION was see DENTAL PROSTHESIS RETENTION 1985-90; DENTURE STABILITY was heading 1965-77%A%  
% 220.78/220.96  |- mesh__dateCreated mesh__D003781 1999-01-01
% 220.78/220.96  |- mesh__recordOriginator mesh__D003781 NLM
% 220.78/220.96  |- mesh__dateRevised mesh__D003781 1992-05-11
% 220.78/220.96  |- skos__hiddenLabel mesh__D003781 Stability, Denture
% 220.78/220.96  |- skos__broader mesh__D003781smesh__D003778
% 220.78/220.96  |- skos__hiddenLabel mesh__D003781 Retention, Denture
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D003781 2000
% 220.78/220.96  |- skos__hiddenLabel mesh__D011415 Proactivator, C3
% 220.78/220.96  |- skos__hiddenLabel mesh__D011415 Proactivator, Complement 3
% 220.78/220.96  |- skos__altLabel mesh__D011415 C3 Proactivator
% 220.78/220.96  |- mesh__dateRevised mesh__D011415 2005-06-30
% 220.78/220.96  |- mesh__historyNote mesh__D011415 99%28%78%29%   
% 220.78/220.96  |- skos__hiddenLabel mesh__D011415 Factor Bb, Complement
% 220.78/220.96  |- skos__hiddenLabel mesh__D011415 Protein B, Complement
% 220.78/220.96  |- rdf__type mesh__D011415sskos__Concept
% 220.78/220.96  |- skos__scopeNote mesh__D011415
% 220.78/220.96       A glycine-rich, heat-labile serum glycoprotein that contains a component of the ALTERNATIVE COMPLEMENT C3 CONVERTASE %28%C3bBb%29%. Bb, a serine protease, is generated when factor B is cleaved by COMPLEMENT FACTOR D into Ba and Bb.%A%    
% 220.78/220.96  |- mesh__recordMaintainer mesh__D011415 lkt
% 220.78/220.96  |- mesh__dateCreated mesh__D011415 1977-04-15
% 220.78/220.96  |- skos__hiddenLabel mesh__D011415 Factor Ba, Properdin
% 220.78/220.96  |- skos__prefLabel mesh__D011415 Complement Factor B
% 220.78/220.96  |- mesh__recordAuthorizer mesh__D011415 sjn
% 220.78/220.96  |- skos__altLabel mesh__D011415 Complement Protein B
% 220.78/220.96  |- skos__historyNote mesh__D011415 Glycoproteins %28%1966-1977%29%
% 220.78/220.96  |- skos__hiddenLabel mesh__D011415 Factor Bf, Properdin
% 220.78/220.96  |- skos__hiddenLabel mesh__D011415 Bb, Complement Factor
% 220.78/220.96  |- skos__broader mesh__D011415smesh__D003165
% 220.78/220.96  |- skos__altLabel mesh__D011415 Properdin Factor Ba
% 220.78/220.96  |- skos__historyNote mesh__D011415 Complement 3 %28%1975-1977%29%
% 220.78/220.96  |- skos__altLabel mesh__D011415 Properdin Factor B
% 220.78/220.96  |- skos__altLabel mesh__D011415 Complement Factor B, Alternative Pathway
% 220.78/220.96  |- skos__altLabel mesh__D011415 C3PA
% 220.78/220.96  |- skos__altLabel mesh__D011415 Complement 3 Proactivator
% 220.78/220.96  |- skos__altLabel mesh__D011415 Bb Fragment of Factor B
% 220.78/220.96  |- mesh__dateEstablished mesh__D011415 1991-01-01
% 220.78/220.96  |- skos__hiddenLabel mesh__D011415 Complement Factor B Derived Fragment Bb
% 220.78/220.96  |- skos__altLabel mesh__D011415 Properdin Factor Bb
% 220.78/220.96  |- skos__altLabel mesh__D011415 Complement Protein Factor B
% 220.78/220.96  |- skos__hiddenLabel mesh__D011415 Factor Ba, Complement
% 220.78/220.96  |- mesh__recordOriginator mesh__D011415 RLS
% 220.78/220.96  |- skos__altLabel mesh__D011415 Complement Factor B Fragment, Bb
% 220.78/220.96  |- skos__hiddenLabel mesh__D011415 Factor B, Complement
% 220.78/220.96  |- mesh__publicMeSHNote mesh__D011415
% 220.78/220.96       99; see PROPERDIN FACTOR B 1991-98, see ENZYME PRECURSORS 1978-90; for COMPLEMENT FACTOR B see PROPERDIN FACTOR B 1988-98%A%  
% 220.78/220.96  |- skos__hiddenLabel mesh__D011415 Factor Bb, Properdin
% 220.78/220.96  |- skos__broader mesh__D011415smesh__D004792
% 220.78/220.96  |- skos__hiddenLabel mesh__D011415 Factor B, Properdin
% 220.78/220.96  |- skos__altLabel mesh__D011415 Factor B
% 220.78/220.96  |- skos__altLabel mesh__D011415 Complement Factor B-Derived Fragment Bb
% 220.78/220.96  |- skos__historyNote mesh__D011415 Enzyme Precursors %28%1966-1977%29%
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D011415 2006
% 220.78/220.96  |- skos__broader mesh__D011415smesh__D012697
% 220.78/220.96  |- rdf__type mesh__D049883sskos__Concept
% 220.78/220.96  |- skos__scopeNote mesh__D049883
% 220.78/220.96       A genus of freshwater mussel in the family MYTILIDAE, class BIVALVIA. It is found in tropical and warm temperate coastal waters. Most species have green in their shells.%A%    
% 220.78/220.96  |- skos__broader mesh__D049883smesh__D049879
% 220.78/220.96  |- mesh__dateCreated mesh__D049883 2005-06-30
% 220.78/220.96  |- skos__prefLabel mesh__D049883 Perna
% 220.78/220.96  |- mesh__publicMeSHNote mesh__D049883 2006   
% 220.78/220.96  |- skos__historyNote mesh__D049883 Bivalvia %28%1979-2005%29%
% 220.78/220.96  |- mesh__recordOriginator mesh__D049883 ags
% 220.78/220.96  |- mesh__dateEstablished mesh__D049883 2006-01-01
% 220.78/220.96  |- mesh__recordMaintainer mesh__D049883 ags
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D049883 2006
% 220.78/220.96  |- mesh__recordAuthorizer mesh__D049883 sjn
% 220.78/220.96  |- mesh__historyNote mesh__D049883 2006   
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D035863 2004
% 220.78/220.96  |- mesh__publicMeSHNote mesh__D035863 2003   
% 220.78/220.96  |- rdf__type mesh__D035863sskos__Concept
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D035863 2005
% 220.78/220.96  |- skos__broader mesh__D035863smesh__D010553
% 220.78/220.96  |- skos__historyNote mesh__D035863 Morals %28%1969-2002%29%
% 220.78/220.96  |- mesh__historyNote mesh__D035863 2003   
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D035863 2006
% 220.78/220.96  |- skos__broader mesh__D035863smesh__D009014
% 220.78/220.96  |- skos__hiddenLabel mesh__D035863 Development, Moral
% 220.78/220.96  |- mesh__dateCreated mesh__D035863 2002-07-03
% 220.78/220.96  |- mesh__dateEstablished mesh__D035863 2003-01-01
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D035863 2003
% 220.78/220.96  |- skos__prefLabel mesh__D035863 Moral Development
% 220.78/220.96  |- skos__scopeNote mesh__D035863
% 220.78/220.96       The process by which individuals internalize standards of right and wrong conduct.%A%    
% 220.78/220.96  |- mesh__dateRevised mesh__D002689 2005-06-30
% 220.78/220.96  |- mesh__dateCreated mesh__D002689 1999-01-01
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D002689 2006
% 220.78/220.96  |- skos__prefLabel mesh__D002689 Chlamydia
% 220.78/220.96  |- skos__annotation mesh__D002689
% 220.78/220.96       GEN or unspecified; prefer specific species; infection = CHLAMYDIA INFECTIONS%A%  
% 220.78/220.96  |- skos__broader mesh__D002689smesh__D002693
% 220.78/220.96  |- rdf__type mesh__D002689sskos__Concept
% 220.78/220.96  |- mesh__recordMaintainer mesh__D002689 SYSTEM
% 220.78/220.96  |- mesh__recordOriginator mesh__D002689 NLM
% 220.78/220.96  |- mesh__recordAuthorizer mesh__D002689 sjn
% 220.78/220.96  |- skos__scopeNote mesh__D002689
% 220.78/220.96       A genus of the family CHLAMYDIACEAE whose species cause a variety of diseases in vertebrates including humans, mice, and swine. Chlamydia species are gram-negative and produce glycogen. The type species is CHLAMYDIA TRACHOMATIS.%A%    
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007374 1994
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007374 1999
% 220.78/220.96  |- skos__hiddenLabel mesh__D007374 Interior Designs
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007374 1995
% 220.78/220.96  |- mesh__publicMeSHNote mesh__D007374
% 220.78/220.96       91; was see under FACILITY DESIGN AND CONSTRUCTION Aug 1977-90%A%  
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007374 2003
% 220.78/220.96  |- mesh__dateRevised mesh__D007374 1993-06-02
% 220.78/220.96  |- rdf__type mesh__D007374sskos__Concept
% 220.78/220.96  |- skos__hiddenLabel mesh__D007374 Interior Furnishing
% 220.78/220.96  |- skos__scopeNote mesh__D007374
% 220.78/220.96       The planning of the furnishings and decorations of an architectural interior.%A%    
% 220.78/220.96  |- skos__hiddenLabel mesh__D007374 Design, Interior
% 220.78/220.96  |- mesh__recordMaintainer mesh__D007374 TGC
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007374 2004
% 220.78/220.96  |- skos__broader mesh__D007374smesh__D005160
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007374 1996
% 220.78/220.96  |- mesh__historyNote mesh__D007374
% 220.78/220.96       91%28%Aug 77%29%; was see under FACILITY DESIGN AND CONSTRUCTION 1977-90%A%  
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007374 2000
% 220.78/220.96  |- skos__hiddenLabel mesh__D007374 Designs, Interior
% 220.78/220.96  |- skos__hiddenLabel mesh__D007374 Furnishing, Interior
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007374 1997
% 220.78/220.96  |- mesh__dateCreated mesh__D007374 1977-05-11
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007374 2005
% 220.78/220.96  |- skos__prefLabel mesh__D007374 Interior Design and Furnishings
% 220.78/220.96  |- mesh__recordAuthorizer mesh__D007374 PLS
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007374 2001
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007374 2006
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007374 1998
% 220.78/220.96  |- mesh__dateEstablished mesh__D007374 1991-01-01
% 220.78/220.96  |- skos__annotation mesh__D007374
% 220.78/220.96       for houses, commerc estab, hosp, institutions, etc.; DF: INTERIOR DESIGN%A%  
% 220.78/220.96  |- skos__hiddenLabel mesh__D007374 Furnishings, Interior
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D007374 2002
% 220.78/220.96  |- mesh__recordOriginator mesh__D007374 EC
% 220.78/220.96  |- mesh__publicMeSHNote mesh__D015806 90   
% 220.78/220.96  |- skos__scopeNote mesh__D015806
% 220.78/220.96       A species of motile, free-living, gram-negative bacteria that occur in the soil. They are aerobic or microaerophilic and are sometimes capable of nitrogen fixation.%A%    
% 220.78/220.96  |- mesh__recordMaintainer mesh__D015806 ags
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D015806 2006
% 220.78/220.96  |- mesh__historyNote mesh__D015806 90   
% 220.78/220.96  |- skos__broader mesh__D015806smesh__D016949
% 220.78/220.96  |- mesh__dateCreated mesh__D015806 1989-05-15
% 220.78/220.96  |- skos__historyNote mesh__D015806 Spirillum %28%1978-1989%29%
% 220.78/220.96  |- mesh__dateRevised mesh__D015806 2005-06-30
% 220.78/220.96  |- rdf__type mesh__D015806sskos__Concept
% 220.78/220.96  |- mesh__recordAuthorizer mesh__D015806 sjn
% 220.78/220.96  |- mesh__recordOriginator mesh__D015806 PXP
% 220.78/220.96  |- skos__prefLabel mesh__D015806 Azospirillum brasilense
% 220.78/220.96  |- mesh__dateEstablished mesh__D015806 1990-01-01
% 220.78/220.96  |- mesh__recordMaintainer mesh__D015008 SYSTEM
% 220.78/220.96  |- mesh__recordAuthorizer mesh__D015008 sjn
% 220.78/220.96  |- skos__broader mesh__D015008smesh__D015007
% 220.78/220.96  |- mesh__recordOriginator mesh__D015008 RC
% 220.78/220.96  |- skos__annotation mesh__D015008
% 220.78/220.96       infection: coord IM with YERSINIA INFECTIONS %28%IM%29%   
% 220.78/220.96  |- mesh__historyNote mesh__D015008 83   
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D015008 2006
% 220.78/220.96  |- skos__historyNote mesh__D015008 Yersinia %28%1975-1982%29%
% 220.78/220.96  |- mesh__publicMeSHNote mesh__D015008 83   
% 220.78/220.96  |- rdf__type mesh__D015008sskos__Concept
% 220.78/220.96  |- skos__historyNote mesh__D015008 Pasteurella %28%1972-1974%29%
% 220.78/220.96  |- mesh__dateEstablished mesh__D015008 1983-01-01
% 220.78/220.96  |- skos__prefLabel mesh__D015008 Yersinia enterocolitica
% 220.78/220.96  |- mesh__dateRevised mesh__D015008 2005-06-30
% 220.78/220.96  |- mesh__dateCreated mesh__D015008 1982-04-28
% 220.78/220.96  |- skos__scopeNote mesh__D015008
% 220.78/220.96       A species of the genus YERSINIA, isolated from both man and animal. It is a frequent cause of bacterial gastroenteritis in children.%A%    
% 220.78/220.96  |- skos__prefLabel mesh__D053127 Influenza A Virus, H9N2 Subtype
% 220.78/220.96  |- mesh__recordOriginator mesh__D053127 ags
% 220.78/220.96  |- skos__hiddenLabel mesh__D053127 H9N2 Viruses
% 220.78/220.96  |- mesh__recordMaintainer mesh__D053127 ags
% 220.78/220.96  |- mesh__dateRevised mesh__D053127 2005-11-10
% 220.78/220.96  |- skos__annotation mesh__D053127
% 220.78/220.96       infection: coordinate IM with INFLUENZA, HUMAN %28%IM%29% in humans, or INFLUENZA IN BIRDS %28%IM%29% in birds, or ORTHOMYXOVIRIDAE INFECTIONS %28%IM%29% in other animals%A%  
% 220.78/220.96  |- mesh__dateCreated mesh__D053127 2005-11-10
% 220.78/220.96  |- mesh__publicMeSHNote mesh__D053127 2006   
% 220.78/220.96  |- skos__historyNote mesh__D053127 Influenza A Virus %28%1999-2005%29%
% 220.78/220.96  |- mesh__recordAuthorizer mesh__D053127 ags
% 220.78/220.96  |- skos__broader mesh__D053127smesh__D009980
% 220.78/220.96  |- mesh__historyNote mesh__D053127 2006   
% 220.78/220.96  |- skos__hiddenLabel mesh__D053127 Virus, H9N2
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D053127 2006
% 220.78/220.96  |- skos__hiddenLabel mesh__D053127 Viruses, H9N2
% 220.78/220.96  |- skos__scopeNote mesh__D053127
% 220.78/220.96       A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 9 and neuraminidase 2. The H9N2 subtype usually infects domestic birds %28%POULTRY%29% but there have been some human infections reported.%A%    
% 220.78/220.96  |- rdf__type mesh__D053127sskos__Concept
% 220.78/220.96  |- skos__altLabel mesh__D053127 H9N2 Virus
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D053127 2006A
% 220.78/220.96  |- mesh__dateEstablished mesh__D053127 2005-11-10
% 220.78/220.96  |- skos__annotation mesh__D003782
% 220.78/220.96       /surg = PULPECTOMY or PULPOTOMY; inflammation = PULPITIS; DF: DENT PULP%A%  
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D003782 2005
% 220.78/220.96  |- skos__related mesh__D003782smesh__D011670
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D003782 2004
% 220.78/220.96  |- skos__related mesh__D003782smesh__D011672
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D003782 2006
% 220.78/220.96  |- mesh__recordAuthorizer mesh__D003782 sjn
% 220.78/220.96  |- skos__broader mesh__D003782smesh__D019589
% 220.78/220.96  |- mesh__dateCreated mesh__D003782 1999-01-01
% 220.78/220.96  |- skos__altLabel mesh__D003782 Pulps, Dental
% 220.78/220.96  |- skos__prefLabel mesh__D003782 Dental Pulp
% 220.78/220.96  |- skos__altLabel mesh__D003782 Dental Pulps
% 220.78/220.96  |- skos__scopeNote mesh__D003782
% 220.78/220.96       A richly vascularized and innervated connective tissue of mesodermal origin, contained in the central cavity of a tooth and delimited by the dentin, and having formative, nutritive, sensory, and protective functions. %28%Jablonski, Dictionary of Dentistry, 1992%29%%A%    
% 220.78/220.96  |- mesh__dateRevised mesh__D003782 2003-07-09
% 220.78/220.96  |- skos__altLabel mesh__D003782 Pulp, Dental
% 220.78/220.96  |- mesh__recordMaintainer mesh__D003782 lkt
% 220.78/220.96  |- mesh__recordOriginator mesh__D003782 NLM
% 220.78/220.96  |- rdf__type mesh__D003782sskos__Concept
% 220.78/220.96  |- skos__hiddenLabel mesh__D011416 Convertase, Proactivator
% 220.78/220.96  |- mesh__publicMeSHNote mesh__D011416
% 220.78/220.96       1999; see PROPERDIN FACTOR D 1991-1998, see COMPLEMENT ACTIVATING ENZYMES 1978-1990; ADIPSIN was indexed under SERINE ENDOPEPTIDASES 1987-2005%A%  
% 220.78/220.96  |- skos__historyNote mesh__D011416 Properdin %28%1966-1977%29%
% 220.78/220.96  |- skos__scopeNote mesh__D011416
% 220.78/220.96       A serum protein which is important in the ALTERNATIVE COMPLEMENT ACTIVATION PATHWAY. This enzyme cleaves the COMPLEMENT C3B-bound COMPLEMENT FACTOR B to form C3bBb which is ALTERNATIVE PATHWAY C3 CONVERTASE.%A%    
% 220.78/220.96  |- skos__altLabel mesh__D011416 Properdin Factor D
% 220.78/220.96  |- skos__historyNote mesh__D011416 Enzyme Precursors %28%1966-1977%29%
% 220.78/220.96  |- skos__hiddenLabel mesh__D011416 Factor D, Complement
% 220.78/220.96  |- mesh__recordOriginator mesh__D011416 RLS
% 220.78/220.96  |- skos__hiddenLabel mesh__D011416 Activator, C3 Convertase
% 220.78/220.96  |- mesh__dateCreated mesh__D011416 1977-05-20
% 220.78/220.96  |- skos__hiddenLabel mesh__D011416 Protein D, Complement
% 220.78/220.96  |- skos__altLabel mesh__D011416 Proactivator Convertase
% 220.78/220.96  |- mesh__recordMaintainer mesh__D011416 lkt
% 220.78/220.96  |- skos__hiddenLabel mesh__D011416 Convertase, C3 Proactivator
% 220.78/220.96  |- skos__historyNote mesh__D011416 Serum Globulins %28%1970-1977%29%
% 220.78/220.96  |- mesh__dateEstablished mesh__D011416 1991-01-01
% 220.78/220.96  |- skos__altLabel mesh__D011416 D Component of Complement
% 220.78/220.96  |- skos__broader mesh__D011416smesh__D012697
% 220.78/220.96  |- mesh__historyNote mesh__D011416 1999 %28%1978%29%   
% 220.78/220.96  |- mesh__recordAuthorizer mesh__D011416 sjn
% 220.78/220.96  |- mesh__dateRevised mesh__D011416 2005-06-30
% 220.78/220.96  |- skos__broader mesh__D011416smesh__D003166
% 220.78/220.96  |- skos__hiddenLabel mesh__D011416 Convertase, C3PA
% 220.78/220.96  |- skos__hiddenLabel mesh__D011416 Convertase Activator, C3
% 220.78/220.96  |- mesh__activeMeSHYear mesh__D011416 2006
% 220.78/220.96  |- skos__altLabel mesh__D011416 28 kDa Protein, Adipocyte
% 220.78/220.96  |- skos__hiddenLabel mesh__D011416 Complement D Component
% 220.78/220.96  |- skos__altLabel mesh__D011416 Complement Protein D
% 220.78/220.96  |- skos__altLabel mesh__D011416 C3 Convertase Activator
% 220.78/220.96  |- skos__altLabel mesh__D011416 GBGase
% 220.78/220.96  |- skos__altLabel mesh__D011416 Adipsin
% 220.78/220.96  |- skos__hiddenLabel mesh__D011416 Factor D, Properdin
% 220.78/220.96  |- rdf__type mesh__D011416sskos__Concept
% 220.78/220.96  |- skos__altLabel mesh__D011416 C3 Proactivator Convertase
% 220.78/220.96  |- skos__altLabel mesh__D011416 C3PAse
% 220.78/220.96  |- skos__altLabel mesh__D011416 C3PA Convertase
% 220.78/220.96  |- skos__annotation mesh__D011416 see SCR for organism-specific terms   
% 220.78/220.96  |- skos__prefLabel mesh__D011416 Complement Factor D
% 220.78/220.96  |- skos__altLabel mesh__D011416 Factor D
% 220.78/220.96  |- skos__broader mesh__D009206Q000530smesh__D009206
% 220.78/220.96  |- mesh__preferredCombination mesh__D009206Q000530smesh__D006321Q000530
% 220.78/220.96  |- rdf__type mesh__D009206Q000530smesh__CompoundConcept
% 220.78/220.96  |- skos__altLabel mesh__D007375 Interleukin I
% 220.78/220.96  |- skos__hiddenLabel mesh__D007375 Interleukin 1
% 220.78/220.96  |- skos__altLabel mesh__D007375 IL-1 alpha
% 220.78/220.96  |- skos__hiddenLabel mesh__D007375 Interleukin 1alpha
% 220.78/220.96  |- skos__broader mesh__D007375smesh__D015846
% 220.78/220.96  |- skos__altLabel mesh__D007375 Interleukin-1 alpha
% 220.78/220.96  |- mesh__historyNote mesh__D007375 90; was INTERLEUKIN 1 1983-89   
% 220.78/220.96  |- rdf__type mesh__D007375sskos__Concept
% 220.78/220.96  |- mesh__recordMaintainer mesh__D007375 ssb
% 220.78/220.96  |- skos__altLabel mesh__D007375 IL-1
% 220.78/220.97  |- skos__prefLabel mesh__D007375 Interleukin-1
% 220.78/220.97  |- skos__historyNote mesh__D007375 Lymphocytes %28%1966-1971%29%
% 220.78/220.97  |- skos__altLabel mesh__D007375 IL-1 beta
% 220.78/220.97  |- skos__hiddenLabel mesh__D007375
% 220.78/220.97       Epidermal Cell Derived Thymocyte Activating Factor
% 220.78/220.97  |- skos__altLabel mesh__D007375 Lymphocyte-Activating Factor
% 220.78/220.97  |- skos__historyNote mesh__D007375 Lymphokines %28%1974-1982%29%
% 220.78/220.97  |- skos__related mesh__D007375smesh__D017472
% 220.78/220.97  |- mesh__publicMeSHNote mesh__D007375 90; was INTERLEUKIN 1 1983-89   
% 220.78/220.97  |- skos__hiddenLabel mesh__D007375 Interleukin 1beta
% 220.78/220.97  |- skos__historyNote mesh__D007375 Toxins %28%1966-1973%29%
% 220.78/220.97  |- mesh__dateEstablished mesh__D007375 1983-01-01
% 220.78/220.97  |- skos__altLabel mesh__D007375 Macrophage Cell Factor
% 220.78/220.97  |- skos__altLabel mesh__D007375 T Helper Factor
% 220.78/220.97  |- skos__altLabel mesh__D007375 IL1
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D007375 2006
% 220.78/220.97  |- skos__related mesh__D007375smesh__D020170
% 220.78/220.97  |- skos__hiddenLabel mesh__D007375 CG Antigen Specific Helper Factor
% 220.78/220.97  |- mesh__onlineNote mesh__D007375
% 220.78/220.97       use INTERLEUKIN-1 to search INTERLEUKIN 1 1983-89   
% 220.78/220.97  |- mesh__recordOriginator mesh__D007375 SAG
% 220.78/220.97  |- skos__altLabel mesh__D007375 Lymphocyte-Stimulating Hormone
% 220.78/220.97  |- mesh__dateCreated mesh__D007375 1982-04-29
% 220.78/220.97  |- mesh__recordAuthorizer mesh__D007375 sjn
% 220.78/220.97  |- skos__historyNote mesh__D007375 Macrophages %28%1966-1982%29%
% 220.78/220.97  |- mesh__dateRevised mesh__D007375 2005-06-30
% 220.78/220.97  |- skos__hiddenLabel mesh__D007375 Lymphocyte Stimulating Hormone
% 220.78/220.97  |- skos__hiddenLabel mesh__D007375 Interleukin 1 alpha
% 220.78/220.97  |- skos__hiddenLabel mesh__D007375 Lymphocyte Activating Factor
% 220.78/220.97  |- skos__annotation mesh__D007375 DF: IL 1 or IL1   
% 220.78/220.97  |- skos__scopeNote mesh__D007375
% 220.78/220.97       A soluble factor produced by monocytes, macrophages, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. IL-1 consists of two distinct forms, IL-1 alpha and IL-1 beta which perform the same functions but are distinct proteins. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. The factor is distinct from INTERLEUKIN-2.%A%    
% 220.78/220.97  |- skos__hiddenLabel mesh__D007375 Hormone, Lymphocyte-Stimulating
% 220.78/220.97  |- skos__broader mesh__D007375smesh__D007378
% 220.78/220.97  |- skos__altLabel mesh__D007375 Interleukin-1 beta
% 220.78/220.97  |- skos__hiddenLabel mesh__D007375 Interleukin 1 beta
% 220.78/220.97  |- skos__historyNote mesh__D007375
% 220.78/220.97       Lymphocyte Transformation %28%1972-1982%29%
% 220.78/220.97  |- mesh__recordOriginator mesh__D015807 EGC
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D015807 2006
% 220.78/220.97  |- skos__altLabel mesh__D015807 Injuries, Penetrating Eye
% 220.78/220.97  |- skos__prefLabel mesh__D015807 Eye Injuries, Penetrating
% 220.78/220.97  |- skos__broader mesh__D015807smesh__D014950
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D015807 2004
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D015807 2005
% 220.78/220.97  |- skos__broader mesh__D015807smesh__D005131
% 220.78/220.97  |- skos__hiddenLabel mesh__D015807 Penetrating Eye Injury
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D015807 2001
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D015807 2003
% 220.78/220.97  |- rdf__type mesh__D015807sskos__Concept
% 220.78/220.97  |- skos__altLabel mesh__D015807 Penetrating Eye Injuries
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D015807 2000
% 220.78/220.97  |- skos__hiddenLabel mesh__D015807 Eye Injury, Penetrating
% 220.78/220.97  |- skos__historyNote mesh__D015807 Wounds, Penetrating %28%1974-1989%29%
% 220.78/220.97  |- mesh__historyNote mesh__D015807 90   
% 220.78/220.97  |- mesh__recordMaintainer mesh__D015807 PXP
% 220.78/220.97  |- mesh__dateRevised mesh__D015807 1999-11-03
% 220.78/220.97  |- skos__hiddenLabel mesh__D015807 Injury, Penetrating Eye
% 220.78/220.97  |- mesh__dateEstablished mesh__D015807 1990-01-01
% 220.78/220.97  |- skos__scopeNote mesh__D015807
% 220.78/220.97       Deeply perforating or puncturing type intraocular injuries.%A%    
% 220.78/220.97  |- mesh__publicMeSHNote mesh__D015807 90   
% 220.78/220.97  |- mesh__recordAuthorizer mesh__D015807 sjn
% 220.78/220.97  |- skos__historyNote mesh__D015807 Eye Injuries %28%1966-1989%29%
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D015807 2002
% 220.78/220.97  |- mesh__dateCreated mesh__D015807 1989-05-25
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D015009 2002
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D015009 2004
% 220.78/220.97  |- skos__annotation mesh__D015009
% 220.78/220.97       gram-neg bact infect; Yersinia pestis infect = PLAGUE; Yersinia pseudotuberculosis infect = YERSINIA PSEUDOTUBERCULOSIS INFECTIONS%A%  
% 220.78/220.97  |- skos__hiddenLabel mesh__D015009 Yersinia Infection
% 220.78/220.97  |- mesh__recordOriginator mesh__D015009 FPG
% 220.78/220.97  |- mesh__dateRevised mesh__D015009 1997-06-20
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D015009 2001
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D015009 2006
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D015009 2003
% 220.78/220.97  |- skos__altLabel mesh__D015009 Infections, Yersinia
% 220.78/220.97  |- skos__prefLabel mesh__D015009 Yersinia Infections
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D015009 2000
% 220.78/220.97  |- rdf__type mesh__D015009sskos__Concept
% 220.78/220.97  |- skos__related mesh__D015009smesh__D016918
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D015009 2005
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D015009 1999
% 220.78/220.97  |- mesh__historyNote mesh__D015009 77   
% 220.78/220.97  |- mesh__dateCreated mesh__D015009 1976-04-16
% 220.78/220.97  |- skos__historyNote mesh__D015009 Pasteurella Infections %28%1966-1976%29%
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D015009 1998
% 220.78/220.97  |- mesh__dateEstablished mesh__D015009 1977-01-01
% 220.78/220.97  |- skos__broader mesh__D015009smesh__D004756
% 220.78/220.97  |- skos__hiddenLabel mesh__D015009 Infection, Yersinia
% 220.78/220.97  |- mesh__recordAuthorizer mesh__D015009 SJN
% 220.78/220.97  |- skos__scopeNote mesh__D015009
% 220.78/220.97       Infections with bacteria of the genus YERSINIA.     
% 220.78/220.97  |- mesh__recordMaintainer mesh__D015009 TGC
% 220.78/220.97  |- mesh__publicMeSHNote mesh__D015009 77   
% 220.78/220.97  |- skos__hiddenLabel mesh__D016900 Protein, Heavy Neurofilament
% 220.78/220.97  |- skos__hiddenLabel mesh__D016900 Proteins, Neurofilament
% 220.78/220.97  |- skos__broader mesh__D016900smesh__D009419
% 220.78/220.97  |- skos__broader mesh__D016900smesh__D007381
% 220.78/220.97  |- skos__scopeNote mesh__D016900
% 220.78/220.97       Type III intermediate filament proteins that assemble into neurofilaments, the major cytoskeletal element in nerve axons and dendrites. They consist of three distinct polypeptides, the neurofilament triplet. Types I, II, and IV intermediate filament proteins form other cytoskeletal elements such as keratins and lamins. It appears that the metabolism of neurofilaments is disturbed in Alzheimer%27%s disease, as indicated by the presence of neurofilament epitopes in the neurofibrillary tangles, as well as by the severe reduction of the expression of the gene for the light neurofilament subunit of the neurofilament triplet in brains of Alzheimer%27%s patients. %28%Can J Neurol Sci 1990 Aug;17%28%3%29%:302%29%%A%    
% 220.78/220.97  |- skos__hiddenLabel mesh__D016900 Triplet Proteins, Neurofilament
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D016900 2006
% 220.78/220.97  |- mesh__publicMeSHNote mesh__D016900
% 220.78/220.97       92; NEUROFILAMENT PROTEINS was indexed under INTERMEDIATE FILAMENT PROTEINS 1982-91 %26% NERVE TISSUE PROTEINS 1977-82%A%  
% 220.78/220.97  |- skos__hiddenLabel mesh__D016900 Proteins, Neurofilament Triplet
% 220.78/220.97  |- skos__prefLabel mesh__D016900 Neurofilament Proteins
% 220.78/220.97  |- rdf__type mesh__D016900sskos__Concept
% 220.78/220.97  |- mesh__historyNote mesh__D016900
% 220.78/220.97       92; was NEUROFILAMENT PROTEINS %28%NM%29% 1977-91   
% 220.78/220.97  |- mesh__recordAuthorizer mesh__D016900 sjn
% 220.78/220.97  |- mesh__dateRevised mesh__D016900 2005-06-30
% 220.78/220.97  |- mesh__dateCreated mesh__D016900 1991-05-30
% 220.78/220.97  |- skos__historyNote mesh__D016900
% 220.78/220.97       Intermediate Filament Proteins %28%1982-1991%29%
% 220.78/220.97  |- skos__historyNote mesh__D016900 Nerve Tissue Proteins %28%1970-1982%29%
% 220.78/220.97  |- mesh__recordMaintainer mesh__D016900 SYSTEM
% 220.78/220.97  |- mesh__onlineNote mesh__D016900
% 220.78/220.97       use NEUROFILAMENT PROTEINS %28%NM%29% to search NEUROFILAMENT PROTEINS 1977-91%A%  
% 220.78/220.97  |- skos__annotation mesh__D016900 /biosyn /physiol permitted   
% 220.78/220.97  |- mesh__dateEstablished mesh__D016900 1992-01-01
% 220.78/220.97  |- skos__hiddenLabel mesh__D016900 Neurofilament Protein, Heavy
% 220.78/220.97  |- mesh__recordOriginator mesh__D016900 MXR
% 220.78/220.97  |- skos__broader mesh__D009206Q000531smesh__D009206
% 220.78/220.97  |- mesh__preferredCombination mesh__D009206Q000531smesh__D006321Q000531
% 220.78/220.97  |- rdf__type mesh__D009206Q000531smesh__CompoundConcept
% 220.78/220.97  |- mesh__dateRevised mesh__D007376 2005-06-30
% 220.78/220.97  |- skos__broader mesh__D007376smesh__D008222
% 220.78/220.97  |- mesh__historyNote mesh__D007376
% 220.78/220.97       90; was INTERLEUKIN 2 1987-89; was MITOGENIC FACTORS, LYMPHOCYTE 1983-86; was MITOGENIC FACTOR see under LYMPHOKINES 1978-82%A%  
% 220.78/220.97  |- skos__hiddenLabel mesh__D007376 Ro236019
% 220.78/220.97  |- skos__hiddenLabel mesh__D007376 Ro 23 6019
% 220.78/220.97  |- skos__altLabel mesh__D007376 Interleukin II
% 220.78/220.97  |- skos__altLabel mesh__D007376 Co-Stimulator
% 220.78/220.97  |- skos__hiddenLabel mesh__D007376 Co Stimulator
% 220.78/220.97  |- skos__historyNote mesh__D007376 Mitogens %28%1973-1977%29%
% 220.78/220.97  |- skos__altLabel mesh__D007376 IL-2
% 220.78/220.97  |- skos__broader mesh__D007376smesh__D007378
% 220.78/220.97  |- skos__altLabel mesh__D007376 Lymphocyte Mitogenic Factor
% 220.78/220.97  |- mesh__recordMaintainer mesh__D007376 ssb
% 220.78/220.97  |- skos__altLabel mesh__D007376 IL2
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D007376 2006
% 220.78/220.97  |- skos__annotation mesh__D007376 DF: IL 2 or IL2   
% 220.78/220.97  |- skos__hiddenLabel mesh__D007376 Mitogenic Factor, Lymphocyte
% 220.78/220.97  |- skos__altLabel mesh__D007376 Costimulator
% 220.78/220.97  |- skos__altLabel mesh__D007376 T-Cell Stimulating Factor
% 220.78/220.97  |- skos__hiddenLabel mesh__D007376 T Cell Stimulating Factor
% 220.78/220.97  |- skos__related mesh__D007376smesh__D015375
% 220.78/220.97  |- skos__altLabel mesh__D007376 Thymocyte Stimulating Factor
% 220.78/220.97  |- mesh__publicMeSHNote mesh__D007376
% 220.78/220.97       90; was INTERLEUKIN 2 1987-89; was MITOGENIC FACTORS, LYMPHOCYTE 1983-86; was MITOGENIC FACTOR see under LYMPHOKINES 1978-82%A%  
% 220.78/220.97  |- mesh__dateEstablished mesh__D007376 1983-01-01
% 220.78/220.97  |- skos__hiddenLabel mesh__D007376 Ro 236019
% 220.78/220.97  |- skos__hiddenLabel mesh__D007376 Interleukin 2
% 220.78/220.97  |- skos__altLabel mesh__D007376 Interleukine 2
% 220.78/220.97  |- rdf__type mesh__D007376sskos__Concept
% 220.78/220.97  |- skos__altLabel mesh__D007376 T-Cell Growth Factor
% 220.78/220.97  |- mesh__recordAuthorizer mesh__D007376 sjn
% 220.78/220.97  |- skos__scopeNote mesh__D007376
% 220.78/220.97       A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes.%A%    
% 220.78/220.97  |- mesh__dateCreated mesh__D007376 1977-03-01
% 220.78/220.97  |- skos__hiddenLabel mesh__D007376 T Cell Growth Factor
% 220.78/220.97  |- skos__altLabel mesh__D007376 TCGF
% 220.78/220.97  |- skos__altLabel mesh__D007376 Ro-236019
% 220.78/220.97  |- mesh__onlineNote mesh__D007376
% 220.78/220.97       use INTERLEUKIN-2 to search INTERLEUKIN 2 1987-89, MITOGENIC FACTORS, LYMPHOCYTE 1983-86 %26% MITOGENIC FACTOR 1978-82%A%  
% 220.78/220.97  |- skos__prefLabel mesh__D007376 Interleukin-2
% 220.78/220.97  |- mesh__recordOriginator mesh__D007376 SH
% 220.78/220.97  |- skos__prefLabel mesh__D015808 HLA-DR6 Antigen
% 220.78/220.97  |- skos__historyNote mesh__D015808 HLA Antigens %28%1978-1986%29%
% 220.78/220.97  |- mesh__recordMaintainer mesh__D015808 ssb
% 220.78/220.97  |- rdf__type mesh__D015808sskos__Concept
% 220.78/220.97  |- skos__annotation mesh__D015808 read MeSH definition; DF: HLA DR6   
% 220.78/220.97  |- mesh__dateRevised mesh__D015808 2005-06-30
% 220.78/220.97  |- mesh__recordAuthorizer mesh__D015808 sjn
% 220.78/220.97  |- skos__altLabel mesh__D015808 HLA-DR6
% 220.78/220.97  |- skos__hiddenLabel mesh__D015808 Antigen, HLA-DR6
% 220.78/220.97  |- mesh__dateEstablished mesh__D015808 1990-01-01
% 220.78/220.97  |- skos__broader mesh__D015808smesh__D006684
% 220.78/220.97  |- skos__historyNote mesh__D015808 HLA-DR Antigens %28%1986-1989%29%
% 220.78/220.97  |- mesh__publicMeSHNote mesh__D015808 90   
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D015808 2006
% 220.78/220.97  |- skos__scopeNote mesh__D015808
% 220.78/220.97       Human immune-response, D-related antigen encoded by the D locus on chromosome 6 and found on lymphoid cells.%A%    
% 220.78/220.97  |- mesh__recordOriginator mesh__D015808 AGS
% 220.78/220.97  |- mesh__historyNote mesh__D015808 90   
% 220.78/220.97  |- skos__hiddenLabel mesh__D015808 HLA DR6 Antigen
% 220.78/220.97  |- skos__altLabel mesh__D015808 HLA-DRw6
% 220.78/220.97  |- skos__historyNote mesh__D015808
% 220.78/220.97       Histocompatibility Antigens Class II %28%1981-1986%29%
% 220.78/220.97  |- mesh__dateCreated mesh__D015808 1989-05-15
% 220.78/220.97  |- rdf__type mesh__D040201sskos__Concept
% 220.78/220.97  |- skos__historyNote mesh__D040201 Integrins %28%1992-1995%29%
% 220.78/220.97  |- skos__altLabel mesh__D040201 GPalpha IIb
% 220.78/220.97  |- skos__altLabel mesh__D040201 Integrin alpha IIb
% 220.78/220.97  |- skos__altLabel mesh__D040201 CD41 Antigen
% 220.78/220.97  |- mesh__recordMaintainer mesh__D040201 ssb
% 220.78/220.97  |- mesh__recordOriginator mesh__D040201 MDJ
% 220.78/220.97  |- skos__historyNote mesh__D040201
% 220.78/220.97       Platelet Membrane Glycoproteins %28%1987-2002%29%
% 220.78/220.97  |- skos__altLabel mesh__D040201 GP IIb
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D040201 2006
% 220.78/220.97  |- skos__altLabel mesh__D040201 Plasma Membrane Glycoprotein IIb
% 220.78/220.97  |- skos__altLabel mesh__D040201 Membrane Glycoprotein IIb
% 220.78/220.97  |- skos__altLabel mesh__D040201 CD41 Antigens
% 220.78/220.97  |- mesh__recordAuthorizer mesh__D040201 sjn
% 220.78/220.97  |- mesh__historyNote mesh__D040201
% 220.78/220.97       2003; use PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX 1996-2002%A%  
% 220.78/220.97  |- skos__historyNote mesh__D040201
% 220.78/220.97       Platelet Glycoprotein GPIIb-IIIa Complex %28%1996-2002%29%
% 220.78/220.97  |- skos__hiddenLabel mesh__D040201 Antigen, HUPL-ml Surface
% 220.78/220.97  |- skos__altLabel mesh__D040201 HUPL-ml Surface Antigen
% 220.78/220.97  |- skos__altLabel mesh__D040201 CD41 Cell Surface Antigen
% 220.78/220.97  |- skos__hiddenLabel mesh__D040201 alphaIIb, Integrin
% 220.78/220.97  |- skos__altLabel mesh__D040201 Antigens, CD41
% 220.78/220.97  |- skos__related mesh__D040201smesh__D019039
% 220.78/220.97  |- skos__hiddenLabel mesh__D040201 Glycoprotein IIb, Membrane
% 220.78/220.97  |- skos__broader mesh__D040201smesh__D015703
% 220.78/220.97  |- skos__hiddenLabel mesh__D040201 Surface Antigen, HUPL-ml
% 220.78/220.97  |- skos__hiddenLabel mesh__D040201 HUPL ml Surface Antigen
% 220.78/220.97  |- skos__altLabel mesh__D040201 Integrin alphaIIb
% 220.78/220.97  |- mesh__publicMeSHNote mesh__D040201
% 220.78/220.97       2003; see PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX 1996-2002%A%  
% 220.78/220.97  |- mesh__dateRevised mesh__D040201 2005-06-30
% 220.78/220.97  |- mesh__dateCreated mesh__D040201 2002-07-02
% 220.78/220.97  |- mesh__dateEstablished mesh__D040201 2003-01-01
% 220.78/220.97  |- skos__hiddenLabel mesh__D040201 Antigen, CD41
% 220.78/220.97  |- skos__broader mesh__D040201smesh__D039001
% 220.78/220.97  |- skos__prefLabel mesh__D040201 Platelet Membrane Glycoprotein IIb
% 220.78/220.97  |- skos__scopeNote mesh__D040201
% 220.78/220.97       Platelet membrane glycoprotein IIb is an integrin alpha subunit that heterodimerizes with INTEGRIN BETA3 to form PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX. It is synthesized as a single polypeptide chain which is then postranslationally cleaved and processed into two disulfide-linked subunits of approximately 18 and 110 kDa in size.%A%    
% 220.78/220.97  |- mesh__onlineNote mesh__D012510
% 220.78/220.97       use SARCOMA 180 to search SARCOMA 180, CROCKER 1966-82   
% 220.78/220.97  |- mesh__recordOriginator mesh__D012510 NLM
% 220.78/220.97  |- skos__prefLabel mesh__D012510 Sarcoma 180
% 220.78/220.97  |- mesh__publicMeSHNote mesh__D012510
% 220.78/220.97       83; was SARCOMA 180, CROCKER 1963-82   
% 220.78/220.97  |- rdf__type mesh__D012510sskos__Concept
% 220.78/220.97  |- skos__hiddenLabel mesh__D012510 Crocker Sarcoma 180
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D012510 2004
% 220.78/220.97  |- skos__altLabel mesh__D012510 Sarcoma 180, Crocker
% 220.78/220.97  |- mesh__dateRevised mesh__D012510 2003-07-30
% 220.78/220.97  |- mesh__dateCreated mesh__D012510 1999-01-01
% 220.78/220.97  |- mesh__historyNote mesh__D012510 83; was SARCOMA 180, CROCKER 1963-82   
% 220.78/220.97  |- skos__annotation mesh__D012510
% 220.78/220.97       exper neopl; /blood supply /chem /second /secret /ultrastruct permitted; don%27%t forget check tag ANIMALS%A%  
% 220.78/220.97  |- mesh__recordMaintainer mesh__D012510 ags
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D012510 2005
% 220.78/220.97  |- mesh__recordAuthorizer mesh__D012510 sjn
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D012510 2006
% 220.78/220.97  |- skos__broader mesh__D012510smesh__D012513
% 220.78/220.97  |- skos__broader mesh__D011941Q000819smesh__D011941
% 220.78/220.97  |- mesh__preferredCombination mesh__D011941Q000819smesh__D000322
% 220.78/220.97  |- rdf__type mesh__D011941Q000819smesh__CompoundConcept
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D003784 1996
% 220.78/220.97  |- skos__prefLabel mesh__D003784 Dental Pulp Calcification
% 220.78/220.97  |- skos__broader mesh__D003784smesh__D003788
% 220.78/220.97  |- mesh__historyNote mesh__D003784 65   
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D003784 2001
% 220.78/220.97  |- mesh__recordOriginator mesh__D003784 NLM
% 220.78/220.97  |- skos__altLabel mesh__D003784 Denticles
% 220.78/220.97  |- mesh__dateEstablished mesh__D003784 1965-01-01
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D003784 2006
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D003784 2000
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D003784 1995
% 220.78/220.97  |- skos__altLabel mesh__D003784 Dental Pulp Stones
% 220.78/220.97  |- skos__annotation mesh__D003784
% 220.78/220.97       note category; DF: DENT PULP CALCIFICATION   
% 220.78/220.97  |- skos__hiddenLabel mesh__D003784 Pulp Calcifications, Dental
% 220.78/220.97  |- skos__altLabel mesh__D003784 Pulp Stones, Dental
% 220.78/220.97  |- mesh__dateCreated mesh__D003784 1999-01-01
% 220.78/220.97  |- skos__hiddenLabel mesh__D003784 Calcifications, Dental Pulp
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D003784 2005
% 220.78/220.97  |- skos__altLabel mesh__D003784 Denticle
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D003784 1999
% 220.78/220.97  |- mesh__recordAuthorizer mesh__D003784 PLS
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D003784 2004
% 220.78/220.97  |- rdf__type mesh__D003784sskos__Concept
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D003784 1994
% 220.78/220.97  |- mesh__dateRevised mesh__D003784 1990-05-29
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D003784 1993
% 220.78/220.97  |- skos__altLabel mesh__D003784 Stone, Dental Pulp
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D003784 2002
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D003784 1998
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D003784 2003
% 220.78/220.97  |- skos__altLabel mesh__D003784 Stones, Dental Pulp
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D003784 1991
% 220.78/220.97  |- skos__hiddenLabel mesh__D003784 Dental Pulp Calcifications
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D003784 1997
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D003784 1992
% 220.78/220.97  |- mesh__recordMaintainer mesh__D003784 TAP
% 220.78/220.97  |- mesh__publicMeSHNote mesh__D003784 65   
% 220.78/220.97  |- skos__altLabel mesh__D003784 Pulp Stone, Dental
% 220.78/220.97  |- skos__altLabel mesh__D003784 Calcification, Dental Pulp
% 220.78/220.97  |- skos__altLabel mesh__D003784 Pulp Calcification, Dental
% 220.78/220.97  |- skos__annotation mesh__D011418
% 220.78/220.97       coordinate with specific cell /cytol; permitted with microorganisms%A%  
% 220.78/220.97  |- mesh__recordAuthorizer mesh__D011418 sjn
% 220.78/220.97  |- mesh__dateRevised mesh__D011418 2005-06-30
% 220.78/220.97  |- mesh__dateCreated mesh__D011418 1977-05-10
% 220.78/220.97  |- skos__prefLabel mesh__D011418 Prophase
% 220.78/220.97  |- skos__historyNote mesh__D011418 Cell Division %28%1966-1977%29%
% 220.78/220.97  |- skos__hiddenLabel mesh__D011418 Prophases
% 220.78/220.97  |- skos__historyNote mesh__D011418 Mitosis %28%1968-1977%29%
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D011418 2006
% 220.78/220.97  |- skos__historyNote mesh__D011418 Meiosis %28%1968-1977%29%
% 220.78/220.97  |- rdf__type mesh__D011418sskos__Concept
% 220.78/220.97  |- mesh__dateEstablished mesh__D011418 1981-01-01
% 220.78/220.97  |- skos__broader mesh__D011418smesh__D048750
% 220.78/220.97  |- mesh__historyNote mesh__D011418
% 220.78/220.97       81%28%78%29%; was see under CELL CYCLE 1978-80   
% 220.78/220.97  |- mesh__recordOriginator mesh__D011418 AEP
% 220.78/220.97  |- skos__scopeNote mesh__D011418
% 220.78/220.97       The first phase of cell nucleus division, in which the CHROMOSOMES become visible, the CELL NUCLEUS starts to lose its identity, the MITOTIC SPINDLE APPARATUS appears, and the CENTRIOLES migrate toward opposite poles.%A%    
% 220.78/220.97  |- skos__broader mesh__D011418smesh__D008938
% 220.78/220.97  |- mesh__recordMaintainer mesh__D011418 nns
% 220.78/220.97  |- mesh__publicMeSHNote mesh__D011418
% 220.78/220.97       81; was see under CELL CYCLE 1978-80   
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D016901 2001
% 220.78/220.97  |- skos__hiddenLabel mesh__D016901 Relation, Intergenerational
% 220.78/220.97  |- skos__hiddenLabel mesh__D016901 Gaps, Generation
% 220.78/220.97  |- mesh__dateEstablished mesh__D016901 1992-01-01
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D016901 2005
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D016901 2000
% 220.78/220.97  |- rdf__type mesh__D016901sskos__Concept
% 220.78/220.97  |- mesh__recordMaintainer mesh__D016901 TGC
% 220.78/220.97  |- skos__broader mesh__D016901smesh__D005195
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D016901 2004
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D016901 1999
% 220.78/220.97  |- mesh__recordAuthorizer mesh__D016901 SJN
% 220.78/220.97  |- skos__hiddenLabel mesh__D016901 Generation Gaps
% 220.78/220.97  |- mesh__publicMeSHNote mesh__D016901 92   
% 220.78/220.97  |- skos__prefLabel mesh__D016901 Intergenerational Relations
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D016901 2003
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D016901 1998
% 220.78/220.97  |- mesh__historyNote mesh__D016901 92   
% 220.78/220.97  |- mesh__dateCreated mesh__D016901 1991-05-30
% 220.78/220.97  |- skos__broader mesh__D016901smesh__D007398
% 220.78/220.97  |- skos__altLabel mesh__D016901 Relations, Intergenerational
% 220.78/220.97  |- skos__hiddenLabel mesh__D016901 Intergenerational Relation
% 220.78/220.97  |- skos__hiddenLabel mesh__D016901 Gap, Generation
% 220.78/220.97  |- skos__annotation mesh__D016901
% 220.78/220.97       interactions between persons of different generations; not restricted to family; DF: INTERGENERAT RELAT%A%  
% 220.78/220.97  |- mesh__recordOriginator mesh__D016901 MXR
% 220.78/220.97  |- skos__scopeNote mesh__D016901
% 220.78/220.97       The interactions between individuals of different generations. These interactions include communication, caring, accountability, loyalty, and even conflict between related or non-related individuals.%A%    
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D016901 2002
% 220.78/220.97  |- mesh__dateRevised mesh__D016901 1997-06-20
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D016901 2006
% 220.78/220.97  |- skos__scopeNote mesh__D049088
% 220.78/220.97       Discipline or activities related to WEIGHT REDUCTION in patients with OBESITY. Treatment methods include DIET; EXERCISE; BEHAVIOR MODIFICATION; medications; and bariatric surgeries.%A%    
% 220.78/220.97  |- skos__prefLabel mesh__D049088 Bariatrics
% 220.78/220.97  |- rdf__type mesh__D049088sskos__Concept
% 220.78/220.97  |- mesh__dateCreated mesh__D049088 2004-07-07
% 220.78/220.97  |- mesh__recordMaintainer mesh__D049088 lkt
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D049088 2006
% 220.78/220.97  |- mesh__recordAuthorizer mesh__D049088 sjn
% 220.78/220.97  |- mesh__publicMeSHNote mesh__D049088 2005   
% 220.78/220.97  |- skos__historyNote mesh__D049088 Obesity %28%1974-2004%29%
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D049088 2005
% 220.78/220.97  |- mesh__historyNote mesh__D049088 2005   
% 220.78/220.97  |- mesh__recordOriginator mesh__D049088 lkt
% 220.78/220.97  |- skos__broader mesh__D049088smesh__D008511
% 220.78/220.97  |- mesh__dateEstablished mesh__D049088 2005-01-01
% 220.78/220.97  |- mesh__historyNote mesh__D016103 91   
% 220.78/220.97  |- skos__broader mesh__D016103smesh__D013124
% 220.78/220.97  |- mesh__dateEstablished mesh__D016103 1991-01-01
% 220.78/220.97  |- mesh__publicMeSHNote mesh__D016103 91   
% 220.78/220.97  |- mesh__recordAuthorizer mesh__D016103 sjn
% 220.78/220.97  |- skos__scopeNote mesh__D016103 Broken bones in the vertebral column.     
% 220.78/220.97  |- skos__annotation mesh__D016103
% 220.78/220.97       coord IM with specific vertebrae /inj %28%IM%29%   
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D016103 2006
% 220.78/220.97  |- skos__prefLabel mesh__D016103 Spinal Fractures
% 220.78/220.97  |- mesh__recordOriginator mesh__D016103 AGS
% 220.78/220.97  |- skos__hiddenLabel mesh__D016103 Fractures, Spinal
% 220.78/220.97  |- skos__historyNote mesh__D016103 Fractures %28%1966-1990%29%
% 220.78/220.97  |- mesh__recordMaintainer mesh__D016103 ssb
% 220.78/220.97  |- skos__hiddenLabel mesh__D016103 Fracture, Spinal
% 220.78/220.97  |- rdf__type mesh__D016103sskos__Concept
% 220.78/220.97  |- mesh__dateCreated mesh__D016103 1990-03-23
% 220.78/220.97  |- mesh__dateRevised mesh__D016103 2005-06-30
% 220.78/220.97  |- skos__hiddenLabel mesh__D016103 Spinal Fracture
% 220.78/220.97  |- skos__historyNote mesh__D016103 Spinal Injuries %28%1966-1990%29%
% 220.78/220.97  |- skos__broader mesh__D016103smesh__D050723
% 220.78/220.97  |- skos__hiddenLabel mesh__D007377 Burst Promoting Factor, Erythrocyte
% 220.78/220.97  |- mesh__activeMeSHYear mesh__D007377 2006
% 220.78/220.97  |- skos__altLabel mesh__D007377 P-CSF
% 220.78/220.97  |- skos__historyNote mesh__D007377 Glycoproteins %28%1976-1978%29%
% 220.78/220.97  |- skos__altLabel mesh__D007377 IL 3
% 220.78/220.97  |- mesh__dateEstablished mesh__D007377 1987-01-01
% 220.78/220.97  |- skos__altLabel mesh__D007377 Colony-Stimulating Factor 2 Alpha
% 220.78/220.97  |- mesh__dateCreated mesh__D007377 1986-04-08
% 220.78/220.97  |- mesh__historyNote mesh__D007377
% 220.78/220.97       90; was INTERLEUKIN 3 1987-89; GROWTH FACTOR, MAST-CELL was see INTERLEUKIN-3 1987-94%A%  
% 220.78/220.97  |- skos__related mesh__D007377smesh__D016185
% 220.78/220.97  |- skos__altLabel mesh__D007377 Colony-Stimulating Factor, Mast-Cell
% 220.78/220.97  |- skos__altLabel mesh__D007377 Erythrocyte Burst-Promoting Factor
% 220.78/220.97  |- skos__historyNote mesh__D007377 Lymphokines %28%1974-1986%29%
% 220.78/220.97  |- skos__altLabel mesh__D007377 Burst-Promoting Factor, Erythrocyte
% 220.78/220.97  |- skos__hiddenLabel mesh__D007377 P Cell Stimulating Factor
% 220.78/220.97  |- skos__hiddenLabel mesh__D007377 Colony Stimulating Factor, Mast Cell
% 220.78/220.97  |- skos__altLabel mesh__D007377 IL3
% 220.78/220.97  |- skos__annotation mesh__D007377 DF: IL 3 or IL3   
% 220.78/220.97  |- mesh__publicMeSHNote mesh__D007377
% 220.78/220.97       90; was INTERLEUKIN 3 1987-89; GROWTH FACTOR, MAST-CELL was see INTERLEUKIN-3 1987-94%A%  
% 220.78/220.97  |- skos__hiddenLabel mesh__D007377
% 220.78/220.97       Colony Stimulating Factor, Multipotential
% 220.78/220.97  |- mesh__recordMaintainer mesh__D007377 ssb
% 220.78/220.97  |- skos__altLabel mesh__D007377 IL-3
% 220.78/220.97  |- skos__hiddenLabel mesh__D007377 Multipotential Colony Stimulating Factor
% 220.78/220.97  |- mesh__recordOriginator mesh__D007377 SH
% 220.78/220.97  |- mesh__recordAuthorizer mesh__D007377 sjn
% 220.78/220.97  |- skos__altLabel mesh__D007377 Multipotential Colony-Stimulating Factor
% 220.78/220.97  |- skos__altLabel mesh__D007377 Mast-Cell Colony-Stimulating Factor
% 220.78/220.97  |- skos__altLabel mesh__D007377 Colony-Stimulating Factor, Multipotential
% 220.78/220.97  |- skos__altLabel mesh__D007377 Eosinophil-Mast Cell Growth-Factor
% 220.78/220.97  |- skos__hiddenLabel mesh__D007377 Eosinophil Mast Cell Growth Factor
% 220.78/220.97  |- mesh__dateRevised mesh__D007377 2005-06-30
% 220.78/220.97  |- rdf__type mesh__D007377sskos__Concept
% 220.78/220.97  |- skos__hiddenLabel mesh__D007377 Erythrocyte Burst Promoting Factor
% 220.78/220.97  |- mesh__onlineNote mesh__D007377
% 220.78/220.97       use INTERLEUKIN-3 to search GROWTH FACTOR, MAST-CELL 1987-94 %26% INTERLEUKIN 3 1987-89%A%  
% 220.78/220.97  |- skos__prefLabel mesh__D007377 Interleukin-3
% 220.78/220.97  |- skos__broader mesh__D007377smesh__D007378
% 220.78/220.97  |- skos__broader mesh__D007377smesh__D003115
% 220.78/220.97  |- skos__historyNote mesh__D007377
% 220.78/220.97       Colony-Stimulating Factor %28%1979-1986%29%
% 220.78/220.97  |- skos__scopeNote mesh__D007377
% 220.78/220.97       A multilineage cell growth factor secreted by lymphocytes, epithelial cells, and astrocytes which stimulates clonal proliferation and differentiation of various types of blood and tissue cells. Also called multi-CSF, it is considered one of the hematopoietic colony stimulating factors.%A%    
% 220.78/220.97  |- skos__hiddenLabel mesh__D007377 Interleukin 3
% 220.78/220.97  |- skos__altLabel mesh__D007377 P-Cell Stimulating Factor
% 220.78/220.97  |- skos__historyNote mesh__D015809
% 220.78/220.97       Histocompatibility Antigens Class II %28%1981-1986%29%
% 220.78/220.97  |- skos__annotation mesh__D015809
% 220.78/220.97       assoc with celiac dis %26% psoriasis; DF: HLA DR7   
% 220.78/220.97  |- skos__hiddenLabel mesh__D015809 Antigen, HLA-DR7
% 220.78/220.97  |- skos__altLabel mesh__D015809 HLA-DR7
% 220.78/220.97  |- skos__broader mesh__D015809smesh__D006684
% 220.78/220.97  |- mesh__dateEstablished mesh__D015809 1990-01-01
% 220.78/220.97  |- mesh__recordMaintainer mesh__D015809 ssb
% 220.78/220.97  |- skos__historyNote mesh__D015809 HLA Antigens %28%1981-1986%29%
% 220.78/220.97  |- mesh__dateRevised mesh__D015809 2005-06-30
% 220.78/220.97  |- mesh__publicMeSHNote mesh__D015809 90   
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D015809 2006
% 220.78/220.98  |- mesh__recordAuthorizer mesh__D015809 sjn
% 220.78/220.98  |- skos__prefLabel mesh__D015809 HLA-DR7 Antigen
% 220.78/220.98  |- mesh__dateCreated mesh__D015809 1989-05-15
% 220.78/220.98  |- skos__historyNote mesh__D015809 HLA-DR Antigens %28%1986-1989%29%
% 220.78/220.98  |- skos__scopeNote mesh__D015809
% 220.78/220.98       Human immune-response, D-related antigen encoded by the D locus on chromosome 6 and found on lymphoid cells. It is strongly associated with celiac disease and psoriasis vulgaris.%A%    
% 220.78/220.98  |- mesh__recordOriginator mesh__D015809 AGS
% 220.78/220.98  |- rdf__type mesh__D015809sskos__Concept
% 220.78/220.98  |- skos__hiddenLabel mesh__D015809 HLA DR7 Antigen
% 220.78/220.98  |- mesh__historyNote mesh__D015809 90   
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D012511 2006
% 220.78/220.98  |- mesh__dateEstablished mesh__D012511 1991-01-01
% 220.78/220.98  |- rdf__type mesh__D012511sskos__Concept
% 220.78/220.98  |- mesh__dateRevised mesh__D012511 2003-07-30
% 220.78/220.98  |- skos__prefLabel mesh__D012511 Sarcoma 37
% 220.78/220.98  |- mesh__dateCreated mesh__D012511 1999-01-01
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D012511 2004
% 220.78/220.98  |- mesh__historyNote mesh__D012511
% 220.78/220.98       91%28%84%29%63; was see under SARCOMA, EXPERIMENTAL 1984-90; was heading 1963-83%A%  
% 220.78/220.98  |- mesh__recordMaintainer mesh__D012511 ags
% 220.78/220.98  |- skos__annotation mesh__D012511
% 220.78/220.98       exper neopl; /blood supply /chem /second /secret /ultrastruct permitted; don%27%t forget check tag ANIMALS%A%  
% 220.78/220.98  |- mesh__recordAuthorizer mesh__D012511 sjn
% 220.78/220.98  |- skos__broader mesh__D012511smesh__D012513
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D012511 2005
% 220.78/220.98  |- mesh__recordOriginator mesh__D012511 NLM
% 220.78/220.98  |- mesh__publicMeSHNote mesh__D012511
% 220.78/220.98       91,63-83; was see under SARCOMA, EXPERIMENTAL 1984-90; was heading 1963-83%A%  
% 220.78/220.98  |- skos__related mesh__D003785smesh__D002126
% 220.78/220.98  |- skos__altLabel mesh__D003785 Capping, Dental Pulp
% 220.78/220.98  |- skos__altLabel mesh__D003785 Capping, Pulp
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D003785 2002
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D003785 1994
% 220.78/220.98  |- skos__hiddenLabel mesh__D003785 Dental Pulp Cappings
% 220.78/220.98  |- skos__hiddenLabel mesh__D003785 Pulp Cappings, Dental
% 220.78/220.98  |- mesh__publicMeSHNote mesh__D003785 65   
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D003785 2005
% 220.78/220.98  |- mesh__recordAuthorizer mesh__D003785 PLS
% 220.78/220.98  |- mesh__dateEstablished mesh__D003785 1965-01-01
% 220.78/220.98  |- mesh__dateCreated mesh__D003785 1999-01-01
% 220.78/220.98  |- mesh__historyNote mesh__D003785 65   
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D003785 1997
% 220.78/220.98  |- mesh__dateRevised mesh__D003785 1993-06-04
% 220.78/220.98  |- skos__annotation mesh__D003785 DF: DENT PULP CAPPING   
% 220.78/220.98  |- skos__altLabel mesh__D003785 Pulp Capping
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D003785 2001
% 220.78/220.98  |- rdf__type mesh__D003785sskos__Concept
% 220.78/220.98  |- mesh__recordMaintainer mesh__D003785 AGS
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D003785 2004
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D003785 1996
% 220.78/220.98  |- skos__hiddenLabel mesh__D003785 Cappings, Pulp
% 220.78/220.98  |- skos__scopeNote mesh__D003785
% 220.78/220.98       Application of a protective agent to an exposed pulp %28%direct capping%29% or the remaining thin layer of dentin over a nearly exposed pulp %28%indirect capping%29% in order to allow the pulp to recover and maintain its normal vitality and function.%A%    
% 220.78/220.98  |- skos__altLabel mesh__D003785 Pulp Capping, Dental
% 220.78/220.98  |- skos__hiddenLabel mesh__D003785 Cappings, Dental Pulp
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D003785 2000
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D003785 1999
% 220.78/220.98  |- skos__hiddenLabel mesh__D003785 Pulp Cappings
% 220.78/220.98  |- skos__broader mesh__D003785smesh__D004708
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D003785 2003
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D003785 1995
% 220.78/220.98  |- skos__prefLabel mesh__D003785 Dental Pulp Capping
% 220.78/220.98  |- mesh__recordOriginator mesh__D003785 NLM
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D003785 2006
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D003785 1998
% 220.78/220.98  |- skos__hiddenLabel mesh__D011419 Diiodide, Propidium
% 220.78/220.98  |- skos__broader mesh__D011419smesh__D010617
% 220.78/220.98  |- skos__scopeNote mesh__D011419
% 220.78/220.98       Quaternary ammonium analog of ethidium; an intercalating dye with a specific affinity to certain forms of DNA and, used as diiodide, to separate them in density gradients; also forms fluorescent complexes with cholinesterase which it inhibits.%A%    
% 220.78/220.98  |- mesh__recordAuthorizer mesh__D011419 NLM
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D011419 2006
% 220.78/220.98  |- skos__historyNote mesh__D011419 Ethidium %28%1974-1978%29%
% 220.78/220.98  |- skos__hiddenLabel mesh__D011419 Iodide, Propidium
% 220.78/220.98  |- mesh__dateRevised mesh__D011419 2005-07-06
% 220.78/220.98  |- skos__prefLabel mesh__D011419 Propidium
% 220.78/220.98  |- skos__altLabel mesh__D011419 Propidium Diiodide
% 220.78/220.98  |- rdf__type mesh__D011419sskos__Concept
% 220.78/220.98  |- mesh__dateEstablished mesh__D011419 1991-01-01
% 220.78/220.98  |- mesh__dateCreated mesh__D011419 1978-02-08
% 220.78/220.98  |- mesh__publicMeSHNote mesh__D011419
% 220.78/220.98       91; was see under PHENANTHRIDINES 1979-90   
% 220.78/220.98  |- mesh__recordMaintainer mesh__D011419 NLM
% 220.78/220.98  |- mesh__recordOriginator mesh__D011419 SH
% 220.78/220.98  |- skos__annotation mesh__D011419 D25-26 qualif   
% 220.78/220.98  |- mesh__historyNote mesh__D011419
% 220.78/220.98       91%28%79%29%; was see under PHENANTHRIDINES 1979-90   
% 220.78/220.98  |- skos__historyNote mesh__D011419 Phenanthridines %28%1969-1978%29%
% 220.78/220.98  |- mesh__dateRevised mesh__D008470 2005-06-30
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D008470 2006
% 220.78/220.98  |- mesh__recordAuthorizer mesh__D008470 sjn
% 220.78/220.98  |- skos__prefLabel mesh__D008470 Meconium
% 220.78/220.98  |- skos__scopeNote mesh__D008470
% 220.78/220.98       The thick green-to-black mucilaginous material found in the intestines of a full-term fetus. It consists of secretions of the INTESTINAL GLANDS; BILE PIGMENTS; FATTY ACIDS; AMNIOTIC FLUID; and intrauterine debris. It constitutes the first stools passed by a newborn.%A%    
% 220.78/220.98  |- skos__broader mesh__D008470smesh__D005243
% 220.78/220.98  |- rdf__type mesh__D008470sskos__Concept
% 220.78/220.98  |- mesh__dateCreated mesh__D008470 1999-01-01
% 220.78/220.98  |- mesh__recordOriginator mesh__D008470 NLM
% 220.78/220.98  |- skos__annotation mesh__D008470 check the tag INFANT, NEWBORN   
% 220.78/220.98  |- skos__hiddenLabel mesh__D008470 Meconiums
% 220.78/220.98  |- mesh__recordMaintainer mesh__D008470 lkt
% 220.78/220.98  |- skos__broader mesh__D008470smesh__D005333
% 220.78/220.98  |- skos__hiddenLabel mesh__D022141 sheep retroviruses, Jaagsiekte
% 220.78/220.98  |- skos__scopeNote mesh__D022141
% 220.78/220.98       A BETARETROVIRUS that causes pulmonary adenomatosis in sheep %28%PULMONARY ADENOMATOSIS, OVINE%29%.%A%    
% 220.78/220.98  |- skos__hiddenLabel mesh__D022141 Jaagsiekte Retroviruses
% 220.78/220.98  |- skos__historyNote mesh__D022141 Retroviruses, Type D %28%1989-2000%29%
% 220.78/220.98  |- skos__annotation mesh__D022141
% 220.78/220.98       infection = PULMONARY ADENOMATOSIS, OVINE   
% 220.78/220.98  |- skos__hiddenLabel mesh__D022141 Jaagsiekte sheep retroviruses
% 220.78/220.98  |- mesh__dateEstablished mesh__D022141 2001-01-01
% 220.78/220.98  |- skos__prefLabel mesh__D022141 Ovine pulmonary adenocarcinoma virus
% 220.78/220.98  |- mesh__recordOriginator mesh__D022141 ags
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D022141 2004
% 220.78/220.98  |- mesh__recordMaintainer mesh__D022141 ags
% 220.78/220.98  |- skos__altLabel mesh__D022141 Jaagsiekte sheep retrovirus
% 220.78/220.98  |- mesh__historyNote mesh__D022141 2002 %28%2001%29%   
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D022141 2003
% 220.78/220.98  |- mesh__dateRevised mesh__D022141 2001-07-25
% 220.78/220.98  |- skos__broader mesh__D022141smesh__D030121
% 220.78/220.98  |- skos__hiddenLabel mesh__D022141 sheep retrovirus, Jaagsiekte
% 220.78/220.98  |- mesh__publicMeSHNote mesh__D022141
% 220.78/220.98       2002; see JAAGSIEKTE SHEEP RETROVIRUS 2001   
% 220.78/220.98  |- skos__historyNote mesh__D022141 Retroviridae %28%1983-2000%29%
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D022141 2006
% 220.78/220.98  |- mesh__dateCreated mesh__D022141 2000-06-28
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D022141 2002
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D022141 2005
% 220.78/220.98  |- rdf__type mesh__D022141sskos__Concept
% 220.78/220.98  |- skos__altLabel mesh__D022141 Jaagsiekte Retrovirus
% 220.78/220.98  |- skos__altLabel mesh__D022141 JSRV
% 220.78/220.98  |- mesh__recordAuthorizer mesh__D022141 sjn
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016902 2002
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016902 2004
% 220.78/220.98  |- skos__historyNote mesh__D016902 Air Pollution %28%1968-1991%29%
% 220.78/220.98  |- skos__related mesh__D016902smesh__D014028
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016902 2001
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016902 2003
% 220.78/220.98  |- mesh__recordAuthorizer mesh__D016902 sjn
% 220.78/220.98  |- mesh__dateEstablished mesh__D016902 1992-01-01
% 220.78/220.98  |- mesh__historyNote mesh__D016902 92   
% 220.78/220.98  |- mesh__dateCreated mesh__D016902 1991-05-30
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016902 2000
% 220.78/220.98  |- skos__hiddenLabel mesh__D016902 Pollution, Indoor Air
% 220.78/220.98  |- mesh__recordMaintainer mesh__D016902 kle
% 220.78/220.98  |- skos__annotation mesh__D016902
% 220.78/220.98       IM; specify environ if pertinent %28%IM%29%   
% 220.78/220.98  |- mesh__recordOriginator mesh__D016902 MXR
% 220.78/220.98  |- skos__scopeNote mesh__D016902 The contamination of indoor air.     
% 220.78/220.98  |- mesh__publicMeSHNote mesh__D016902 92   
% 220.78/220.98  |- skos__altLabel mesh__D016902 Indoor Air Pollution
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016902 2006
% 220.78/220.98  |- mesh__dateRevised mesh__D016902 1999-11-03
% 220.78/220.98  |- skos__related mesh__D016902smesh__D018876
% 220.78/220.98  |- skos__altLabel mesh__D016902 Indoor Air Quality
% 220.78/220.98  |- skos__broader mesh__D016902smesh__D000397
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016902 2005
% 220.78/220.98  |- skos__prefLabel mesh__D016902 Air Pollution, Indoor
% 220.78/220.98  |- rdf__type mesh__D016902sskos__Concept
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016104 2006
% 220.78/220.98  |- mesh__recordOriginator mesh__D016104 AGS
% 220.78/220.98  |- mesh__dateCreated mesh__D016104 1990-06-06
% 220.78/220.98  |- mesh__dateRevised mesh__D016104 2005-06-30
% 220.78/220.98  |- skos__broader mesh__D016104smesh__D011248
% 220.78/220.98  |- rdf__type mesh__D016104sskos__Concept
% 220.78/220.98  |- mesh__recordMaintainer mesh__D016104 lkt
% 220.78/220.98  |- skos__scopeNote mesh__D016104
% 220.78/220.98       A condition of abnormally low AMNIOTIC FLUID volume. Principal causes include malformations of fetal URINARY TRACT; FETAL GROWTH RETARDATION; GESTATIONAL HYPERTENSION; nicotine poisoning; and PROLONGED PREGNANCY.%A%    
% 220.78/220.98  |- mesh__publicMeSHNote mesh__D016104 91   
% 220.78/220.98  |- mesh__recordAuthorizer mesh__D016104 sjn
% 220.78/220.98  |- skos__historyNote mesh__D016104 Polyhydramnios %28%1966-1990%29%
% 220.78/220.98  |- mesh__historyNote mesh__D016104 91   
% 220.78/220.98  |- skos__prefLabel mesh__D016104 Oligohydramnios
% 220.78/220.98  |- mesh__dateEstablished mesh__D016104 1991-01-01
% 220.78/220.98  |- mesh__dateCreated mesh__D007378 1987-05-09
% 220.78/220.98  |- skos__annotation mesh__D007378 GEN or unspecified; prefer specifics   
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D007378 2006
% 220.78/220.98  |- skos__scopeNote mesh__D007378
% 220.78/220.98       Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli.%A%    
% 220.78/220.98  |- mesh__recordOriginator mesh__D007378 SCD
% 220.78/220.98  |- skos__altLabel mesh__D007378 Interleukin
% 220.78/220.98  |- mesh__recordAuthorizer mesh__D007378 sjn
% 220.78/220.98  |- mesh__historyNote mesh__D007378
% 220.78/220.98       1988; for MITOGENIC FACTORS, LYMPHOCYTE use INTERLEUKIN-2 1983-2001,  LYMPHOKINES 1978-1982%A%  
% 220.78/220.98  |- mesh__recordMaintainer mesh__D007378 ssb
% 220.78/220.98  |- mesh__dateRevised mesh__D007378 2005-06-30
% 220.78/220.98  |- mesh__publicMeSHNote mesh__D007378
% 220.78/220.98       1988; for MITOGENIC FACTORS, LYMPHOCYTE see INTERLEUKIN-2 1990-2001, INTERLEUKIN 2 1987-1989, LYMPHOKINES 1978-1982%A%  
% 220.78/220.98  |- mesh__dateEstablished mesh__D007378 1988-01-01
% 220.78/220.98  |- rdf__type mesh__D007378sskos__Concept
% 220.78/220.98  |- skos__prefLabel mesh__D007378 Interleukins
% 220.78/220.98  |- skos__broader mesh__D007378smesh__D006133
% 220.78/220.98  |- mesh__historyNote mesh__D004080
% 220.78/220.98       95; was DIHYDRO-OROTASE 1977-94 %28%see under AMIDOHYDROLASES 1977-90%29%%A%  
% 220.78/220.98  |- skos__altLabel mesh__D004080 Carbamoylaspartic Dehydrase
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D004080 2004
% 220.78/220.98  |- skos__hiddenLabel mesh__D004080 Amidohydrolase, Dihydro-Orotate
% 220.78/220.98  |- mesh__recordOriginator mesh__D004080 RLS
% 220.78/220.98  |- rdf__type mesh__D004080sskos__Concept
% 220.78/220.98  |- mesh__dateRevised mesh__D004080 2003-07-09
% 220.78/220.98  |- mesh__publicMeSHNote mesh__D004080
% 220.78/220.98       95; was DIHYDRO-OROTASE 1977-94 %28%see under AMIDOHYDROLASES 1977-90%29%%A%  
% 220.78/220.98  |- skos__hiddenLabel mesh__D004080 Dihydro Orotate Amidohydrolase
% 220.78/220.98  |- skos__prefLabel mesh__D004080 Dihydroorotase
% 220.78/220.98  |- skos__altLabel mesh__D004080 Dihydro-Orotase
% 220.78/220.98  |- skos__historyNote mesh__D004080 Orotic Acid %28%1966-1976%29%
% 220.78/220.98  |- mesh__recordAuthorizer mesh__D004080 sjn
% 220.78/220.98  |- mesh__recordMaintainer mesh__D004080 ssb
% 220.78/220.98  |- skos__altLabel mesh__D004080 Dihydro-Orotate Amidohydrolase
% 220.78/220.98  |- mesh__onlineNote mesh__D004080
% 220.78/220.98       use DIHYDROOROTASE to search DIHYDRO-OROTASE 1977-94   
% 220.78/220.98  |- mesh__dateCreated mesh__D004080 1976-04-27
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D004080 2006
% 220.78/220.98  |- skos__scopeNote mesh__D004080
% 220.78/220.98       An enzyme that, in the course of pyrimidine biosynthesis, catalyzes ring closure by removal of water from N-carbamoylaspartate to yield dihydro-orotic acid. EC 3.5.2.3.%A%    
% 220.78/220.98  |- mesh__dateEstablished mesh__D004080 1991-01-01
% 220.78/220.98  |- skos__hiddenLabel mesh__D004080 Dehydrase, Carbamoylaspartic
% 220.78/220.98  |- skos__broader mesh__D004080smesh__D000581
% 220.78/220.98  |- skos__hiddenLabel mesh__D004080 Dihydro Orotase
% 220.78/220.98  |- skos__historyNote mesh__D004080 Amidohydrolases %28%1966-1976%29%
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D004080 2005
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D012512 2003
% 220.78/220.98  |- rdf__type mesh__D012512sskos__Concept
% 220.78/220.98  |- skos__annotation mesh__D012512
% 220.78/220.98       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS %28%IM%29% or specific bone/neopl term %28%IM%29% or specific bone %28%IM%29% + BONE NEOPLASMS %28%IM%29%%A%  
% 220.78/220.98  |- mesh__recordOriginator mesh__D012512 NLM
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D012512 2001
% 220.78/220.98  |- mesh__dateCreated mesh__D012512 1999-01-01
% 220.78/220.98  |- skos__hiddenLabel mesh__D012512 Ewing%27%s Sarcoma
% 220.78/220.98  |- skos__prefLabel mesh__D012512 Sarcoma, Ewing%27%s
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D012512 2004
% 220.78/220.98  |- skos__broader mesh__D012512smesh__D012516
% 220.78/220.98  |- skos__scopeNote mesh__D012512
% 220.78/220.98       A malignant tumor of the bone which always arises in the medullary tissue, occurring more often in cylindrical bones. There are conspicuous foci of necrosis in association with irregular masses of small, regular, rounded or ovoid cells with very scanty cytoplasm. The tumor occurs usually before the age of 20, about twice as frequently in males as in females. %28%From Dorland, 27th ed; Stedman, 25th ed%29%%A%    
% 220.78/220.98  |- mesh__dateRevised mesh__D012512 1999-11-08
% 220.78/220.98  |- skos__hiddenLabel mesh__D012512 Sarcoma, Ewings
% 220.78/220.98  |- skos__hiddenLabel mesh__D012512 Ewing Tumor
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D012512 2002
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D012512 2005
% 220.78/220.98  |- skos__hiddenLabel mesh__D012512 Tumor, Ewing%27%s
% 220.78/220.98  |- skos__hiddenLabel mesh__D012512 Ewings Tumor
% 220.78/220.98  |- mesh__recordMaintainer mesh__D012512 KEV
% 220.78/220.98  |- skos__altLabel mesh__D012512 Ewing%27%s Tumor
% 220.78/220.98  |- skos__hiddenLabel mesh__D012512 Sarcoma, Ewing
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D012512 2006
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D012512 2000
% 220.78/220.98  |- skos__related mesh__D012512smesh__D018241
% 220.78/220.98  |- mesh__recordAuthorizer mesh__D012512 sjn
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D003786 2005
% 220.78/220.98  |- mesh__dateRevised mesh__D003786 2003-07-09
% 220.78/220.98  |- mesh__dateCreated mesh__D003786 1999-01-01
% 220.78/220.98  |- mesh__recordMaintainer mesh__D003786 lkt
% 220.78/220.98  |- skos__prefLabel mesh__D003786 Dental Pulp Cavity
% 220.78/220.98  |- skos__hiddenLabel mesh__D003786 Chamber, Pulp
% 220.78/220.98  |- mesh__recordOriginator mesh__D003786 NLM
% 220.78/220.98  |- mesh__historyNote mesh__D003786 65   
% 220.78/220.98  |- skos__hiddenLabel mesh__D003786 Canals, Root
% 220.78/220.98  |- skos__broader mesh__D003786smesh__D019589
% 220.78/220.98  |- skos__altLabel mesh__D003786 Dental Pulp Cavities
% 220.78/220.98  |- skos__hiddenLabel mesh__D003786 Canal, Root
% 220.78/220.98  |- rdf__type mesh__D003786sskos__Concept
% 220.78/220.98  |- mesh__publicMeSHNote mesh__D003786 65   
% 220.78/220.98  |- skos__altLabel mesh__D003786 Root Canal
% 220.78/220.98  |- skos__hiddenLabel mesh__D003786 Canals, Pulp
% 220.78/220.98  |- mesh__dateEstablished mesh__D003786 1965-01-01
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D003786 2004
% 220.78/220.98  |- skos__altLabel mesh__D003786 Pulp Cavities, Dental
% 220.78/220.98  |- skos__altLabel mesh__D003786 Cavities, Dental Pulp
% 220.78/220.98  |- skos__scopeNote mesh__D003786
% 220.78/220.98       The space in a tooth bounded by the dentin and containing the dental pulp. The portion of the cavity within the crown of the tooth is the pulp chamber; the portion within the root is the pulp canal or root canal.%A%    
% 220.78/220.98  |- skos__annotation mesh__D003786
% 220.78/220.98       note category %26% X refs; DF: DENT PULP CAVITY   
% 220.78/220.98  |- mesh__recordAuthorizer mesh__D003786 sjn
% 220.78/220.98  |- skos__hiddenLabel mesh__D003786 Pulp Canals
% 220.78/220.98  |- skos__altLabel mesh__D003786 Pulp Cavity, Dental
% 220.78/220.98  |- skos__altLabel mesh__D003786 Cavity, Dental Pulp
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D003786 2006
% 220.78/220.98  |- skos__hiddenLabel mesh__D003786 Root Canals
% 220.78/220.98  |- skos__hiddenLabel mesh__D003786 Canal, Pulp
% 220.78/220.98  |- skos__hiddenLabel mesh__D003786 Chambers, Pulp
% 220.78/220.98  |- skos__hiddenLabel mesh__D003786 Pulp Chambers
% 220.78/220.98  |- mesh__dateCreated mesh__D008471 1987-03-25
% 220.78/220.98  |- rdf__type mesh__D008471sskos__Concept
% 220.78/220.98  |- skos__prefLabel mesh__D008471 Meconium Aspiration Syndrome
% 220.78/220.98  |- skos__hiddenLabel mesh__D008471 Syndrome, Meconium Aspiration
% 220.78/220.98  |- mesh__recordMaintainer mesh__D008471 lkt
% 220.78/220.98  |- mesh__dateEstablished mesh__D008471 1988-01-01
% 220.78/220.98  |- skos__altLabel mesh__D008471 Meconium Aspiration
% 220.78/220.98  |- mesh__dateRevised mesh__D008471 2005-06-30
% 220.78/220.98  |- skos__historyNote mesh__D008471
% 220.78/220.98       Infant, Newborn, Diseases %28%1971-1983%29%
% 220.78/220.98  |- skos__historyNote mesh__D008471 Meconium %28%1966-1987%29%
% 220.78/220.98  |- mesh__publicMeSHNote mesh__D008471
% 220.78/220.98       2006; see MECONIUM ASPIRATION 1988-2005   
% 220.78/220.98  |- mesh__recordAuthorizer mesh__D008471 sjn
% 220.78/220.98  |- skos__historyNote mesh__D008471 Pneumonia, Aspiration %28%1966-1987%29%
% 220.78/220.98  |- skos__broader mesh__D008471smesh__D007232
% 220.78/220.98  |- skos__historyNote mesh__D008471 Aspiration %28%1975-1987%29%
% 220.78/220.98  |- skos__altLabel mesh__D008471 Aspiration, Meconium
% 220.78/220.98  |- mesh__recordOriginator mesh__D008471 SCD
% 220.78/220.98  |- skos__broader mesh__D008471smesh__D008171
% 220.78/220.98  |- skos__scopeNote mesh__D008471
% 220.78/220.98       A condition caused by inhalation of MECONIUM into the LUNG of FETUS or NEWBORN, usually due to vigorous respiratory movements during difficult PARTURITION or respiratory system abnormalities. Meconium aspirate may block small airways leading to difficulties in PULMONARY GAS EXCHANGE and ASPIRATION PNEUMONIA.%A%    
% 220.78/220.98  |- skos__broader mesh__D008471smesh__D005315
% 220.78/220.98  |- mesh__historyNote mesh__D008471 2006 %28%1988%29%   
% 220.78/220.98  |- skos__hiddenLabel mesh__D008471 Aspiration Syndrome, Meconium
% 220.78/220.98  |- skos__historyNote mesh__D008471
% 220.78/220.98       Respiratory Distress Syndrome %28%1971-1987%29%
% 220.78/220.98  |- skos__broader mesh__D008471smesh__D012120
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D008471 2006
% 220.78/220.98  |- skos__historyNote mesh__D008471 Asphyxia Neonatorum %28%1977-1987%29%
% 220.78/220.98  |- skos__hiddenLabel mesh__D022142 Vacuoles, Condensing
% 220.78/220.98  |- skos__hiddenLabel mesh__D022142 Vacuole, Condensing
% 220.78/220.98  |- mesh__dateEstablished mesh__D022142 2001-01-01
% 220.78/220.98  |- skos__hiddenLabel mesh__D022142 Core Vesicles, Dense
% 220.78/220.98  |- skos__hiddenLabel mesh__D022142 Granule, Secretory
% 220.78/220.98  |- skos__hiddenLabel mesh__D022142 Secretory Vesicle
% 220.78/220.98  |- skos__broader mesh__D022142smesh__D022161
% 220.78/220.98  |- mesh__recordOriginator mesh__D022142 nns
% 220.78/220.98  |- mesh__publicMeSHNote mesh__D022142
% 220.78/220.98       2001; see CYTOPLASMIC GRANULES 1980-2000   
% 220.78/220.98  |- mesh__recordAuthorizer mesh__D022142 sjn
% 220.78/220.98  |- skos__hiddenLabel mesh__D022142 Vesicle, Dense Core
% 220.78/220.98  |- skos__hiddenLabel mesh__D022142 Vesicles, Secretory
% 220.78/220.98  |- skos__hiddenLabel mesh__D022142 Dense Core Vesicle
% 220.78/220.98  |- skos__altLabel mesh__D022142 Secretory Granules
% 220.78/220.98  |- skos__annotation mesh__D022142
% 220.78/220.98       for zymogen granules coord with ENZYME PRECURSORS + specific enzyme%A%  
% 220.78/220.98  |- skos__hiddenLabel mesh__D022142 Condensing Vacuole
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D022142 2006
% 220.78/220.98  |- mesh__dateRevised mesh__D022142 2004-07-07
% 220.78/220.98  |- skos__prefLabel mesh__D022142 Secretory Vesicles
% 220.78/220.98  |- skos__hiddenLabel mesh__D022142 Vesicles, Dense Core
% 220.78/220.98  |- skos__hiddenLabel mesh__D022142 Secretory Granule
% 220.78/220.98  |- skos__hiddenLabel mesh__D022142 Vesicle, Secretory
% 220.78/220.98  |- skos__hiddenLabel mesh__D022142 Granules, Secretory
% 220.78/220.98  |- mesh__historyNote mesh__D022142
% 220.78/220.98       2001; use CYTOPLASMIC GRANULES 1980-2000   
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D022142 2005
% 220.78/220.98  |- mesh__dateCreated mesh__D022142 2000-06-22
% 220.78/220.98  |- rdf__type mesh__D022142sskos__Concept
% 220.78/220.98  |- mesh__recordMaintainer mesh__D022142 nns
% 220.78/220.98  |- skos__historyNote mesh__D022142 Cytoplasmic Granules %28%1976-2000%29%
% 220.78/220.98  |- skos__scopeNote mesh__D022142
% 220.78/220.98       Vesicles derived from the GOLGI APPARATUS containing material to be released at the cell surface.%A%    
% 220.78/220.98  |- mesh__publicMeSHNote mesh__D016903 92   
% 220.78/220.98  |- mesh__recordMaintainer mesh__D016903 PXP
% 220.78/220.98  |- skos__related mesh__D016903smesh__D016907
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016903 2002
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016903 2004
% 220.78/220.98  |- mesh__dateRevised mesh__D016903 1997-06-20
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016903 1999
% 220.78/220.98  |- skos__broader mesh__D016903smesh__D008991
% 220.78/220.98  |- mesh__recordOriginator mesh__D016903 MXR
% 220.78/220.98  |- mesh__historyNote mesh__D016903 92   
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016903 2000
% 220.78/220.98  |- skos__scopeNote mesh__D016903
% 220.78/220.98       The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically.%A%    
% 220.78/220.98  |- mesh__dateEstablished mesh__D016903 1992-01-01
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016903 2005
% 220.78/220.98  |- skos__prefLabel mesh__D016903 Drug Monitoring
% 220.78/220.98  |- mesh__recordAuthorizer mesh__D016903 SJN
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016903 2001
% 220.78/220.98  |- skos__altLabel mesh__D016903 Monitoring, Drug
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016903 2006
% 220.78/220.98  |- mesh__dateCreated mesh__D016903 1991-05-30
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016903 2003
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016903 1998
% 220.78/220.98  |- rdf__type mesh__D016903sskos__Concept
% 220.78/220.98  |- skos__annotation mesh__D016903 in diag or ther   
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016105 2004
% 220.78/220.98  |- skos__prefLabel mesh__D016105 Parathyroidectomy
% 220.78/220.98  |- rdf__type mesh__D016105sskos__Concept
% 220.78/220.98  |- mesh__recordOriginator mesh__D016105 AGS
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016105 2000
% 220.78/220.98  |- mesh__historyNote mesh__D016105 91   
% 220.78/220.98  |- mesh__dateRevised mesh__D016105 1997-06-20
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016105 2001
% 220.78/220.98  |- skos__scopeNote mesh__D016105
% 220.78/220.98       Excision of one or both of the parathyroid glands.     
% 220.78/220.98  |- skos__broader mesh__D016105smesh__D013507
% 220.78/220.98  |- skos__annotation mesh__D016105
% 220.78/220.98       do not use /util except by MeSH definition   
% 220.78/220.98  |- mesh__recordMaintainer mesh__D016105 PXP
% 220.78/220.98  |- mesh__dateEstablished mesh__D016105 1991-01-01
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016105 2005
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016105 2002
% 220.78/220.98  |- mesh__publicMeSHNote mesh__D016105 91   
% 220.78/220.98  |- mesh__recordAuthorizer mesh__D016105 SJN
% 220.78/220.98  |- mesh__dateCreated mesh__D016105 1990-02-12
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016105 1998
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016105 2006
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016105 2003
% 220.78/220.98  |- skos__hiddenLabel mesh__D016105 Parathyroidectomies
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D016105 1999
% 220.78/220.98  |- skos__historyNote mesh__D016105
% 220.78/220.98       Parathyroid Glands/surgery %28%1966-1990%29%
% 220.78/220.98  |- rdf__type mesh__D046590sskos__Concept
% 220.78/220.98  |- skos__hiddenLabel mesh__D046590 Spectroscopy, Electron Energy Loss
% 220.78/220.98  |- skos__hiddenLabel mesh__D046590 Electron Energy Loss Spectroscopy
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D046590 2006
% 220.78/220.98  |- mesh__dateEstablished mesh__D046590 2005-01-01
% 220.78/220.98  |- mesh__historyNote mesh__D046590 2005   
% 220.78/220.98  |- mesh__publicMeSHNote mesh__D046590 2005   
% 220.78/220.98  |- skos__prefLabel mesh__D046590 Spectroscopy, Electron Energy-Loss
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D046590 2005
% 220.78/220.98  |- mesh__recordAuthorizer mesh__D046590 sjn
% 220.78/220.98  |- skos__broader mesh__D046590smesh__D013057
% 220.78/220.98  |- mesh__recordOriginator mesh__D046590 nns
% 220.78/220.98  |- skos__scopeNote mesh__D046590
% 220.78/220.98       A technique for analysis of the chemical composition of molecules. A substance is bombarded with monochromatic ELECTRONS. Some of the electrons passing through the specimen will lose energy when they ionize inner shell electrons of the atoms in the specimen. The energy loss is element dependent. Analysis of the energy loss spectrum reveals the elemental composition of a specimen. ENERGY-FILTERED TRANSMISSION ELECTRON MICROSCOPY is a type of electron energy loss spectroscopy carried out in electron microscopes specially outfitted to analyze the spectrum of electron energy loss.%A%    
% 220.78/220.98  |- mesh__dateCreated mesh__D046590 2004-07-07
% 220.78/220.98  |- skos__hiddenLabel mesh__D046590 Energy-Loss Spectroscopy, Electron
% 220.78/220.98  |- mesh__recordMaintainer mesh__D046590 nns
% 220.78/220.98  |- skos__altLabel mesh__D046590 Electron Energy-Loss Spectroscopy
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D007379 2005
% 220.78/220.98  |- mesh__recordAuthorizer mesh__D007379 PLS
% 220.78/220.98  |- skos__hiddenLabel mesh__D007379 Loan, Interlibrary
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D007379 1999
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D007379 2001
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D007379 1993
% 220.78/220.98  |- mesh__dateCreated mesh__D007379 1999-01-01
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D007379 1998
% 220.78/220.98  |- mesh__recordOriginator mesh__D007379 NLM
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D007379 2004
% 220.78/220.98  |- skos__hiddenLabel mesh__D007379 Interlibrary Loan
% 220.78/220.98  |- skos__prefLabel mesh__D007379 Interlibrary Loans
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D007379 2000
% 220.78/220.98  |- rdf__type mesh__D007379sskos__Concept
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D007379 2003
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D007379 1997
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D007379 1996
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D007379 1995
% 220.78/220.98  |- skos__hiddenLabel mesh__D007379 Loans, Interlibrary
% 220.78/220.98  |- skos__broader mesh__D007379smesh__D007999
% 220.78/220.98  |- mesh__activeMeSHYear mesh__D007379 2006
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D007379 1994
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D007379 2002
% 220.78/220.99  |- mesh__dateRevised mesh__D007379 1992-05-14
% 220.78/220.99  |- mesh__recordMaintainer mesh__D007379 TAP
% 220.78/220.99  |- skos__historyNote mesh__D004081 Oxidoreductases %28%1966-1976%29%
% 220.78/220.99  |- skos__hiddenLabel mesh__D004081 Oxidase, Dihydro-Orotate
% 220.78/220.99  |- rdf__type mesh__D004081sskos__Concept
% 220.78/220.99  |- mesh__dateRevised mesh__D004081 2005-06-30
% 220.78/220.99  |- mesh__recordMaintainer mesh__D004081 jmp
% 220.78/220.99  |- skos__historyNote mesh__D004081 Orotic Acid %28%1966-1976%29%
% 220.78/220.99  |- mesh__dateCreated mesh__D004081 1976-04-27
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D004081 2006
% 220.78/220.99  |- skos__prefLabel mesh__D004081 Dihydroorotate Oxidase
% 220.78/220.99  |- mesh__dateEstablished mesh__D004081 1991-01-01
% 220.78/220.99  |- mesh__recordOriginator mesh__D004081 RLS
% 220.78/220.99  |- mesh__onlineNote mesh__D004081
% 220.78/220.99       use DIHYDROOROTATE OXIDASE to search DIHYDRO-OROTATE OXIDASE, DIHYDRO-OROTATE DEHYDROGENASE %26% OROTATE REDUCTASE 1977-93%A%  
% 220.78/220.99  |- mesh__historyNote mesh__D004081
% 220.78/220.99       94; was DIHYDRO-OROTATE OXIDASE 1977-93 %28%see under OXIDOREDUCTASES 1977-90%29%; DIHYDRO-OROTATE DEHYDROGENASE %26% OROTATE REDUCTASE were see DIHYDRO-OROTATE OXIDASE 1977-93%A%  
% 220.78/220.99  |- skos__hiddenLabel mesh__D004081 Oxidase, Dihydroorotate
% 220.78/220.99  |- mesh__publicMeSHNote mesh__D004081
% 220.78/220.99       94; was DIHYDRO-OROTATE OXIDASE 1977-93 %28%see under OXIDOREDUCTASES 1977-90%29%; DIHYDRO-OROTATE DEHYDROGENASE %26% OROTATE REDUCTASE were see DIHYDRO-OROTATE OXIDASE 1977-93%A%  
% 220.78/220.99  |- skos__hiddenLabel mesh__D004081 Dihydro Orotate Oxidase
% 220.78/220.99  |- skos__scopeNote mesh__D004081
% 220.78/220.99       An enzyme that in the course of pyrimidine biosynthesis, catalyzes the oxidation of dihydro-orotic acid to orotic acid utilizing oxygen as the electron acceptor. This enzyme is a flavoprotein which contains both FLAVIN-ADENINE DINUCLEOTIDE and FLAVIN MONONUCLEOTIDE as well as iron-sulfur centers. EC 1.3.3.1.%A%    
% 220.78/220.99  |- mesh__recordAuthorizer mesh__D004081 sjn
% 220.78/220.99  |- skos__broader mesh__D004081smesh__D044925
% 220.78/220.99  |- skos__altLabel mesh__D004081 Dihydro-Orotate Oxidase
% 220.78/220.99  |- mesh__onlineNote mesh__D012513
% 220.78/220.99       use SARCOMA, EXPERIMENTAL to search SARCOMA, JENSEN 1966-81%A%  
% 220.78/220.99  |- skos__broader mesh__D012513smesh__D012509
% 220.78/220.99  |- skos__annotation mesh__D012513
% 220.78/220.99       coordinate IM with pre-coordinated organ/neoplasm term %28%IM or NIM%29%; DF: SARCOMA EXPER%A%  
% 220.78/220.99  |- mesh__dateRevised mesh__D012513 2004-07-13
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D012513 2005
% 220.78/220.99  |- mesh__recordAuthorizer mesh__D012513 sjn
% 220.78/220.99  |- skos__prefLabel mesh__D012513 Sarcoma, Experimental
% 220.78/220.99  |- skos__hiddenLabel mesh__D012513 Jensen Sarcoma
% 220.78/220.99  |- mesh__recordOriginator mesh__D012513 NLM
% 220.78/220.99  |- skos__hiddenLabel mesh__D012513 Tumor, EHS
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D012513 2006
% 220.78/220.99  |- skos__altLabel mesh__D012513 Experimental Sarcoma
% 220.78/220.99  |- skos__altLabel mesh__D012513 EHS Tumor
% 220.78/220.99  |- mesh__publicMeSHNote mesh__D012513
% 220.78/220.99       SARCOMA, JENSEN was heading 1963-81   
% 220.78/220.99  |- skos__hiddenLabel mesh__D012513 Engelbreth-Holm-Swarm Sarcoma
% 220.78/220.99  |- rdf__type mesh__D012513sskos__Concept
% 220.78/220.99  |- mesh__historyNote mesh__D012513 SARCOMA, JENSEN was heading 1963-81   
% 220.78/220.99  |- skos__hiddenLabel mesh__D012513 Sarcoma, Engelbreth Holm Swarm
% 220.78/220.99  |- mesh__recordMaintainer mesh__D012513 sjn
% 220.78/220.99  |- skos__broader mesh__D012513smesh__D009374
% 220.78/220.99  |- mesh__dateCreated mesh__D012513 1999-01-01
% 220.78/220.99  |- skos__altLabel mesh__D012513 Sarcomas, Experimental
% 220.78/220.99  |- skos__scopeNote mesh__D012513
% 220.78/220.99       Experimentally induced neoplasms of CONNECTIVE TISSUE in animals to provide a model for studying human SARCOMA.%A%    
% 220.78/220.99  |- skos__altLabel mesh__D012513 Experimental Sarcomas
% 220.78/220.99  |- mesh__dateRevised mesh__D036961 2005-06-30
% 220.78/220.99  |- mesh__publicMeSHNote mesh__D036961 2003   
% 220.78/220.99  |- skos__scopeNote mesh__D036961
% 220.78/220.99       Proteins that bind to the MATRIX ATTACHMENT REGIONS of DNA.%A%    
% 220.78/220.99  |- rdf__type mesh__D036961sskos__Concept
% 220.78/220.99  |- mesh__dateEstablished mesh__D036961 2003-01-01
% 220.78/220.99  |- skos__broader mesh__D036961smesh__D004268
% 220.78/220.99  |- mesh__historyNote mesh__D036961 2003   
% 220.78/220.99  |- mesh__dateCreated mesh__D036961 2002-07-03
% 220.78/220.99  |- mesh__recordMaintainer mesh__D036961 SYSTEM
% 220.78/220.99  |- skos__prefLabel mesh__D036961 Matrix Attachment Region Binding Proteins
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D036961 2006
% 220.78/220.99  |- mesh__recordOriginator mesh__D036961 jmp
% 220.78/220.99  |- mesh__recordAuthorizer mesh__D036961 sjn
% 220.78/220.99  |- skos__altLabel mesh__D036961 MAR Binding Proteins
% 220.78/220.99  |- skos__scopeNote mesh__D003787
% 220.78/220.99       The destruction of the vitality of the pulp of the tooth. %28%From Jablonski, Dictionary of Dentistry, 1992, p243%29%%A%    
% 220.78/220.99  |- skos__annotation mesh__D003787
% 220.78/220.99       a root canal proced: do not confuse with TOOTH, DEVITALIZED see TOOTH, NONVITAL; DF: DENT PULP DEVITALIZATION%A%  
% 220.78/220.99  |- skos__altLabel mesh__D003787 Pulp Devitalization, Dental
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D003787 2004
% 220.78/220.99  |- mesh__recordMaintainer mesh__D003787 TGC
% 220.78/220.99  |- mesh__historyNote mesh__D003787
% 220.78/220.99       70; DENTAL PULP MUMMIFICATION was heading 1965-69   
% 220.78/220.99  |- mesh__dateRevised mesh__D003787 1996-06-10
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D003787 2001
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D003787 1999
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D003787 2003
% 220.78/220.99  |- mesh__dateEstablished mesh__D003787 1970-01-01
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D003787 2000
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D003787 2006
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D003787 1998
% 220.78/220.99  |- skos__altLabel mesh__D003787 Devitalization, Dental Pulp
% 220.78/220.99  |- mesh__recordOriginator mesh__D003787 NLM
% 220.78/220.99  |- mesh__publicMeSHNote mesh__D003787
% 220.78/220.99       70; DENTAL PULP MUMMIFICATION was heading 1965-69   
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D003787 2005
% 220.78/220.99  |- skos__historyNote mesh__D003787 Dental Pulp %28%1966-1969%29%
% 220.78/220.99  |- mesh__dateCreated mesh__D003787 1999-01-01
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D003787 2002
% 220.78/220.99  |- skos__prefLabel mesh__D003787 Dental Pulp Devitalization
% 220.78/220.99  |- mesh__recordAuthorizer mesh__D003787 PLS
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D003787 1997
% 220.78/220.99  |- skos__broader mesh__D003787smesh__D012390
% 220.78/220.99  |- mesh__onlineNote mesh__D003787
% 220.78/220.99       search DENTAL PULP MUMMIFICATION under DENTAL PULP 1966-69%A%  
% 220.78/220.99  |- rdf__type mesh__D003787sskos__Concept
% 220.78/220.99  |- mesh__dateCreated mesh__D008472 1974-11-14
% 220.78/220.99  |- skos__altLabel mesh__D008472 Medazepam Monohydrochloride
% 220.78/220.99  |- skos__altLabel mesh__D008472 AWD.pharma Brand of Medazepam
% 220.78/220.99  |- mesh__dateEstablished mesh__D008472 1991-01-01
% 220.78/220.99  |- skos__historyNote mesh__D008472 Benzazepines %28%1970-1974%29%
% 220.78/220.99  |- skos__hiddenLabel mesh__D008472 Ro 5 4556
% 220.78/220.99  |- mesh__recordOriginator mesh__D008472 NLM
% 220.78/220.99  |- skos__scopeNote mesh__D008472
% 220.78/220.99       A benzodiazepine derivative used in the treatment of anxiety. It has sedative, muscle relaxant, and anticonvulsant properties. One of its metabolites is DIAZEPAM and one of its excretion products is OXAZEPAM.%A%    
% 220.78/220.99  |- skos__altLabel mesh__D008472 Rudotel
% 220.78/220.99  |- skos__altLabel mesh__D008472 Roche Brand of Medazepam
% 220.78/220.99  |- skos__altLabel mesh__D008472
% 220.78/220.99       Altana Pharma Oranienburg Brand of Mebendazole
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D008472 2006
% 220.78/220.99  |- skos__broader mesh__D008472smesh__D001569
% 220.78/220.99  |- skos__prefLabel mesh__D008472 Medazepam
% 220.78/220.99  |- mesh__historyNote mesh__D008472
% 220.78/220.99       91%28%75%29%; was see under BENZODIAZEPINE TRANQUILIZERS 1975-90%A%  
% 220.78/220.99  |- mesh__recordMaintainer mesh__D008472 CCR
% 220.78/220.99  |- skos__hiddenLabel mesh__D008472 Monohydrochloride, Medazepam
% 220.78/220.99  |- mesh__dateRevised mesh__D008472 2005-06-30
% 220.78/220.99  |- rdf__type mesh__D008472sskos__Concept
% 220.78/220.99  |- mesh__publicMeSHNote mesh__D008472
% 220.78/220.99       91; was see under BENZODIAZEPINE TRANQUILIZERS 1975-90   
% 220.78/220.99  |- skos__hiddenLabel mesh__D008472 Hydrochloride, Medazepam
% 220.78/220.99  |- mesh__recordAuthorizer mesh__D008472 sjn
% 220.78/220.99  |- skos__hiddenLabel mesh__D008472 Ro 54556
% 220.78/220.99  |- skos__hiddenLabel mesh__D022143 Nursing, Family-Centered
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D022143 2006
% 220.78/220.99  |- skos__hiddenLabel mesh__D022143 Family Centered Nursing
% 220.78/220.99  |- skos__altLabel mesh__D022143 Family-Centered Nursing
% 220.78/220.99  |- skos__hiddenLabel mesh__D022143 Nursing, Family
% 220.78/220.99  |- skos__hiddenLabel mesh__D022143 Family Nursings
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D022143 2005
% 220.78/220.99  |- rdf__type mesh__D022143sskos__Concept
% 220.78/220.99  |- skos__hiddenLabel mesh__D022143 Nursings, Family
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D022143 2002
% 220.78/220.99  |- mesh__dateCreated mesh__D022143 2000-06-22
% 220.78/220.99  |- skos__hiddenLabel mesh__D022143 Family-Centered Nursings
% 220.78/220.99  |- skos__prefLabel mesh__D022143 Family Nursing
% 220.78/220.99  |- mesh__historyNote mesh__D022143 2001   
% 220.78/220.99  |- skos__broader mesh__D022143smesh__D013041
% 220.78/220.99  |- mesh__publicMeSHNote mesh__D022143 2001   
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D022143 2004
% 220.78/220.99  |- skos__historyNote mesh__D022143 Family Health %28%1991-2000%29%
% 220.78/220.99  |- skos__historyNote mesh__D022143 Nursing Care %28%1991-2000%29%
% 220.78/220.99  |- mesh__dateEstablished mesh__D022143 2001-01-01
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D022143 2001
% 220.78/220.99  |- skos__hiddenLabel mesh__D022143 Nursings, Family-Centered
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D022143 2003
% 220.78/220.99  |- skos__scopeNote mesh__D022143
% 220.78/220.99       The provision of care involving the nursing process, to families and family members in health and illness situations. From Lippincott Manual of Nursing Practice. 6th ed.%A%    
% 220.78/220.99  |- skos__broader mesh__D016106smesh__D010403
% 220.78/220.99  |- skos__scopeNote mesh__D016106
% 220.78/220.99       Non-susceptibility of a microbe to the action of METHICILLIN, a semi-synthetic penicillin derivative.%A%    
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016106 2006
% 220.78/220.99  |- mesh__recordOriginator mesh__D016106 AGS
% 220.78/220.99  |- mesh__historyNote mesh__D016106 91   
% 220.78/220.99  |- mesh__recordAuthorizer mesh__D016106 sjn
% 220.78/220.99  |- mesh__publicMeSHNote mesh__D016106 91   
% 220.78/220.99  |- mesh__dateEstablished mesh__D016106 1991-01-01
% 220.78/220.99  |- mesh__recordMaintainer mesh__D016106 ssb
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016106 2005
% 220.78/220.99  |- skos__historyNote mesh__D016106 Methicillin %28%1966-1990%29%
% 220.78/220.99  |- mesh__dateCreated mesh__D016106 1990-02-12
% 220.78/220.99  |- rdf__type mesh__D016106sskos__Concept
% 220.78/220.99  |- skos__historyNote mesh__D016106
% 220.78/220.99       Drug Resistance, Microbial %28%1986-1990%29%
% 220.78/220.99  |- skos__hiddenLabel mesh__D016106 Resistance, Methicillin
% 220.78/220.99  |- mesh__dateRevised mesh__D016106 2003-07-09
% 220.78/220.99  |- skos__prefLabel mesh__D016106 Methicillin Resistance
% 220.78/220.99  |- skos__historyNote mesh__D016106 Penicillin Resistance %28%1966-1990%29%
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016106 2004
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D004880 2002
% 220.78/220.99  |- rdf__type mesh__D004880sskos__Concept
% 220.78/220.99  |- mesh__dateRevised mesh__D004880 2004-07-27
% 220.78/220.99  |- skos__broader mesh__D004880smesh__D006639
% 220.78/220.99  |- skos__altLabel mesh__D004880 2-Thiol-L-histidine-betaine
% 220.78/220.99  |- skos__broader mesh__D004880smesh__D013438
% 220.78/220.99  |- mesh__recordAuthorizer mesh__D004880 jls
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D004880 2004
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D004880 2006
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D004880 2003
% 220.78/220.99  |- skos__prefLabel mesh__D004880 Ergothioneine
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D004880 2005
% 220.78/220.99  |- mesh__recordOriginator mesh__D004880 NLM
% 220.78/220.99  |- mesh__dateCreated mesh__D004880 1999-01-01
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D004880 2005A
% 220.78/220.99  |- mesh__recordMaintainer mesh__D004880 jls
% 220.78/220.99  |- skos__hiddenLabel mesh__D004880 2 Thiol L histidine betaine
% 220.78/220.99  |- skos__scopeNote mesh__D004880
% 220.78/220.99       A naturally occurring metabolite of HISTIDINE that has antioxidant properties.%A%    
% 220.78/220.99  |- skos__altLabel mesh__D004880 Thioneine
% 220.78/220.99  |- skos__broader mesh__D004082smesh__D000526
% 220.78/220.99  |- rdf__type mesh__D004082sskos__Concept
% 220.78/220.99  |- mesh__historyNote mesh__D004082
% 220.78/220.99       91%28%80%29%; was see under ALPRENOLOL 1980-90   
% 220.78/220.99  |- mesh__recordAuthorizer mesh__D004082 sjn
% 220.78/220.99  |- skos__scopeNote mesh__D004082
% 220.78/220.99       Hydrogenated alprenolol derivative where the extra hydrogens are often tritiated. This radiolabeled form of ALPRENOLOL, a beta-adrenergic blocker, is used to label the beta-adrenergic receptor for isolation and study.%A%    
% 220.78/220.99  |- mesh__publicMeSHNote mesh__D004082
% 220.78/220.99       91; was see under ALPRENOLOL 1980-90   
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D004082 2006
% 220.78/220.99  |- mesh__dateCreated mesh__D004082 1979-05-30
% 220.78/220.99  |- skos__altLabel mesh__D004082
% 220.78/220.99       1-%28%%28%Methylethyl%29%amino%29%-3-%28%2-propylphenoxy%29%-2-propanol
% 220.78/220.99  |- skos__historyNote mesh__D004082
% 220.78/220.99       Alprenolol %28%1972-1974%29% /analogs %26% derivatives %28%1975-1979%29%
% 220.78/220.99  |- mesh__dateRevised mesh__D004082 2005-06-30
% 220.78/220.99  |- mesh__recordOriginator mesh__D004082 SH
% 220.78/220.99  |- skos__prefLabel mesh__D004082 Dihydroalprenolol
% 220.78/220.99  |- mesh__recordMaintainer mesh__D004082 ssb
% 220.78/220.99  |- skos__historyNote mesh__D004082 Sympatholytics %28%1966-1971%29%
% 220.78/220.99  |- mesh__dateEstablished mesh__D004082 1991-01-01
% 220.78/220.99  |- skos__altLabel mesh__D012514 Kaposi Sarcoma
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D012514 2005
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D012514 2002
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D012514 1998
% 220.78/220.99  |- skos__broader mesh__D012514smesh__D006566
% 220.78/220.99  |- skos__hiddenLabel mesh__D012514 Kaposis Sarcoma
% 220.78/220.99  |- skos__scopeNote mesh__D012514
% 220.78/220.99       A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi%27%s sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04%25% of kidney transplant patients. There is also a high incidence in AIDS patients. %28%From Dorland, 27th ed %26% Holland et al., Cancer Medicine, 3d ed, pp2105-7%29% HHV-8 is the suspected cause.%A%    
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D012514 2006
% 220.78/220.99  |- mesh__recordAuthorizer mesh__D012514 SJN
% 220.78/220.99  |- rdf__type mesh__D012514sskos__Concept
% 220.78/220.99  |- skos__annotation mesh__D012514
% 220.78/220.99       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D012514 1999
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D012514 2003
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D012514 2000
% 220.78/220.99  |- mesh__dateCreated mesh__D012514 1999-01-01
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D012514 2004
% 220.78/220.99  |- mesh__publicMeSHNote mesh__D012514
% 220.78/220.99       98; was SARCOMA, KAPOSI%27%S 1963-97; KAPOSI SARCOMA was KAPOSI%27%S SARCOMA 1963-97%A%  
% 220.78/220.99  |- skos__prefLabel mesh__D012514 Sarcoma, Kaposi
% 220.78/220.99  |- mesh__recordOriginator mesh__D012514 NLM
% 220.78/220.99  |- skos__broader mesh__D012514smesh__D009383
% 220.78/220.99  |- mesh__dateRevised mesh__D012514 1997-06-20
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D012514 2001
% 220.78/220.99  |- skos__hiddenLabel mesh__D012514 Sarcoma, Kaposi%27%s
% 220.78/220.99  |- mesh__recordMaintainer mesh__D012514 AGS
% 220.78/220.99  |- skos__altLabel mesh__D012514 Kaposi%27%s Sarcoma
% 220.78/220.99  |- mesh__historyNote mesh__D012514
% 220.78/220.99       98; was SARCOMA, KAPOSI%27%S 1963-97; KAPOSI SARCOMA was KAPOSI%27%S SARCOMA 1963-97%A%  
% 220.78/220.99  |- skos__broader mesh__D012514smesh__D012509
% 220.78/220.99  |- skos__broader mesh__D003788smesh__D014076
% 220.78/220.99  |- skos__altLabel mesh__D003788 Disease, Dental Pulp
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D003788 2004
% 220.78/220.99  |- mesh__recordMaintainer mesh__D003788 ssb
% 220.78/220.99  |- skos__altLabel mesh__D003788 Pulp Diseases, Dental
% 220.78/220.99  |- skos__annotation mesh__D003788
% 220.78/220.99       inflamm dis = PULPITIS; DF: DENT PULP DIS   
% 220.78/220.99  |- mesh__recordOriginator mesh__D003788 NLM
% 220.78/220.99  |- mesh__dateEstablished mesh__D003788 1965-01-01
% 220.78/220.99  |- skos__altLabel mesh__D003788 Diseases, Dental Pulp
% 220.78/220.99  |- skos__altLabel mesh__D003788 Dental Pulp Disease
% 220.78/220.99  |- mesh__dateCreated mesh__D003788 1999-01-01
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D003788 2006
% 220.78/220.99  |- mesh__publicMeSHNote mesh__D003788 65   
% 220.78/220.99  |- mesh__historyNote mesh__D003788 65   
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D003788 2005
% 220.78/220.99  |- mesh__dateRevised mesh__D003788 2003-07-09
% 220.78/220.99  |- skos__related mesh__D003788smesh__D010483
% 220.78/220.99  |- skos__prefLabel mesh__D003788 Dental Pulp Diseases
% 220.78/220.99  |- rdf__type mesh__D003788sskos__Concept
% 220.78/220.99  |- mesh__recordAuthorizer mesh__D003788 sjn
% 220.78/220.99  |- skos__altLabel mesh__D003788 Pulp Disease, Dental
% 220.78/220.99  |- skos__scopeNote mesh__D003788
% 220.78/220.99       Endodontic diseases of the DENTAL PULP inside the tooth, which is distinguished from PERIAPICAL DISEASES of the tissue surrounding the root.%A%    
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D008473 2006
% 220.78/220.99  |- mesh__recordAuthorizer mesh__D008473 ags
% 220.78/220.99  |- skos__annotation mesh__D008473
% 220.78/220.99       diseases: coordinate IM with BRAIN DISEASES %28%IM%29%   
% 220.78/220.99  |- mesh__historyNote mesh__D008473
% 220.78/220.99       83%28%75%29%; was see under HYPOTHALAMO-HYPOPHYSEAL SYSTEM 1974-82%A%  
% 220.78/220.99  |- mesh__recordOriginator mesh__D008473 NLM
% 220.78/220.99  |- rdf__type mesh__D008473sskos__Concept
% 220.78/220.99  |- skos__scopeNote mesh__D008473
% 220.78/220.99       Raised area at the infundibular region of the HYPOTHALAMUS at the floor of the BRAIN, ventral to the THIRD VENTRICLE and adjacent to the ARCUATE NUCLEUS. It contains the terminals of hypothalamic neurons and the capillary network of hypophyseal portal system, thus serving as a neuroendocrine link between the brain and the PITUITARY GLAND.%A%    
% 220.78/220.99  |- skos__prefLabel mesh__D008473 Median Eminence
% 220.78/220.99  |- mesh__dateRevised mesh__D008473 2005-07-27
% 220.78/220.99  |- mesh__dateCreated mesh__D008473 1999-01-01
% 220.78/220.99  |- skos__broader mesh__D008473smesh__D007030
% 220.78/220.99  |- mesh__dateEstablished mesh__D008473 1983-01-01
% 220.78/220.99  |- mesh__recordMaintainer mesh__D008473 ags
% 220.78/220.99  |- mesh__publicMeSHNote mesh__D008473
% 220.78/220.99       83; was see under HYPOTHALAMO-HYPOPHYSEAL SYSTEM 1974-82   
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D008473 2006A
% 220.78/220.99  |- skos__hiddenLabel mesh__D008473 Eminence, Median
% 220.78/220.99  |- skos__broader mesh__D000490smesh__D019668
% 220.78/220.99  |- mesh__dateCreated mesh__D000490 1985-05-03
% 220.78/220.99  |- skos__historyNote mesh__D000490 Garlic %28%1966-1985%29%
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D000490 2006
% 220.78/220.99  |- skos__historyNote mesh__D000490 Plants %28%1966-1985%29%
% 220.78/220.99  |- skos__historyNote mesh__D000490 Vegetables %28%1966-1985%29%
% 220.78/220.99  |- mesh__historyNote mesh__D000490 86   
% 220.78/220.99  |- mesh__recordMaintainer mesh__D000490 ssb
% 220.78/220.99  |- mesh__dateEstablished mesh__D000490 1986-01-01
% 220.78/220.99  |- mesh__publicMeSHNote mesh__D000490 86   
% 220.78/220.99  |- mesh__recordAuthorizer mesh__D000490 sjn
% 220.78/220.99  |- skos__broader mesh__D000490smesh__D014675
% 220.78/220.99  |- skos__prefLabel mesh__D000490 Allium
% 220.78/220.99  |- skos__scopeNote mesh__D000490
% 220.78/220.99       A genus of the plant family Liliaceae %28%sometimes classified as Alliaceae%29% in the order Liliales.  Many produce pungent, often bacteriostatic and physiologically active compounds and are used as food, condiment, and medicament, the latter in traditional medicine.%A%    
% 220.78/220.99  |- mesh__recordOriginator mesh__D000490 SH
% 220.78/220.99  |- mesh__dateRevised mesh__D000490 2004-07-07
% 220.78/220.99  |- skos__annotation mesh__D000490
% 220.78/220.99       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.78/220.99  |- rdf__type mesh__D000490sskos__Concept
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D000490 2005
% 220.78/220.99  |- skos__altLabel mesh__D016905 Bacterial Infections, Gram-Negative
% 220.78/220.99  |- skos__annotation mesh__D016905
% 220.78/220.99       GEN: avoid; prefer specifics; DF: GRAM NEG BACT INFECT   
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016905 2006
% 220.78/220.99  |- skos__prefLabel mesh__D016905 Gram-Negative Bacterial Infections
% 220.78/220.99  |- skos__hiddenLabel mesh__D016905 Gram-Negative Bacterial Infection
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016905 1994
% 220.78/220.99  |- skos__altLabel mesh__D016905 Infections, Gram-Negative Bacterial
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016905 2001
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016905 2003
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016905 1998
% 220.78/220.99  |- mesh__dateCreated mesh__D016905 1991-05-30
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016905 1995
% 220.78/220.99  |- rdf__type mesh__D016905sskos__Concept
% 220.78/220.99  |- skos__historyNote mesh__D016905 Gram-Negative Bacteria %28%1984-1991%29%
% 220.78/220.99  |- skos__hiddenLabel mesh__D016905 Gram Negative Bacterial Infections
% 220.78/220.99  |- skos__hiddenLabel mesh__D016905 Bacterial Infections, Gram Negative
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016905 2004
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016905 1992
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016905 1999
% 220.78/220.99  |- skos__hiddenLabel mesh__D016905 Infections, Gram Negative Bacterial
% 220.78/220.99  |- skos__scopeNote mesh__D016905
% 220.78/220.99       Infections caused by bacteria that show up as pink %28%negative%29% when treated by the gram-staining method.%A%    
% 220.78/220.99  |- skos__historyNote mesh__D016905
% 220.78/220.99       specific bacterial infection %28%1966-1971%29%
% 220.78/220.99  |- skos__historyNote mesh__D016905 specific bacteria %28%1972-1983%29%
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016905 2002
% 220.78/220.99  |- mesh__publicMeSHNote mesh__D016905 92   
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016905 1993
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016905 1996
% 220.78/220.99  |- skos__hiddenLabel mesh__D016905 Bacterial Infection, Gram-Negative
% 220.78/220.99  |- mesh__historyNote mesh__D016905 92   
% 220.78/220.99  |- skos__hiddenLabel mesh__D016905 Infection, Gram-Negative Bacterial
% 220.78/220.99  |- skos__broader mesh__D016905smesh__D001424
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016905 1997
% 220.78/220.99  |- mesh__dateEstablished mesh__D016905 1992-01-01
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016905 2000
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016905 2005
% 220.78/220.99  |- skos__historyNote mesh__D016905 Bacterial Infections %28%1972-1991%29%
% 220.78/220.99  |- skos__altLabel mesh__D016107 Epidermolysis Bullosa, Acquired
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016107 2005
% 220.78/220.99  |- skos__broader mesh__D016107smesh__D004820
% 220.78/220.99  |- rdf__type mesh__D016107sskos__Concept
% 220.78/220.99  |- mesh__recordOriginator mesh__D016107 AGS
% 220.78/220.99  |- mesh__recordAuthorizer mesh__D016107 sjn
% 220.78/220.99  |- mesh__publicMeSHNote mesh__D016107 91   
% 220.78/220.99  |- mesh__dateRevised mesh__D016107 2001-08-07
% 220.78/220.99  |- skos__historyNote mesh__D016107 Epidermolysis Bullosa %28%1966-1990%29%
% 220.78/220.99  |- skos__hiddenLabel mesh__D016107 Acquired Epidermolysis Bullosa
% 220.78/220.99  |- skos__scopeNote mesh__D016107
% 220.78/220.99       Form of epidermolysis bullosa characterized by trauma-induced, subepidermal blistering with no family history of the disease. Direct immunofluorescence shows IMMUNOGLOBULIN G deposited at the dermo-epidermal junction.%A%    
% 220.78/220.99  |- mesh__dateCreated mesh__D016107 1990-02-12
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016107 2002
% 220.78/220.99  |- skos__annotation mesh__D016107 note that this is acquired   
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016107 2004
% 220.78/220.99  |- skos__prefLabel mesh__D016107 Epidermolysis Bullosa Acquisita
% 220.78/220.99  |- mesh__historyNote mesh__D016107 91   
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016107 2006
% 220.78/220.99  |- mesh__recordMaintainer mesh__D016107 sjn
% 220.78/220.99  |- mesh__dateEstablished mesh__D016107 1991-01-01
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D016107 2003
% 220.78/220.99  |- skos__broader mesh__D004881smesh__D015651
% 220.78/220.99  |- skos__prefLabel mesh__D004881 Ergotism
% 220.78/220.99  |- skos__annotation mesh__D004881
% 220.78/220.99       pois from eating ergot-tainted grain or ergot admin as ther agent%A%  
% 220.78/220.99  |- skos__altLabel mesh__D004881 Poisoning, Ergot
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D004881 2004
% 220.78/220.99  |- mesh__recordMaintainer mesh__D004881 ags
% 220.78/220.99  |- skos__altLabel mesh__D004881 St. Anthonys Fire
% 220.78/220.99  |- mesh__recordAuthorizer mesh__D004881 sjn
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D004881 2006
% 220.78/220.99  |- skos__hiddenLabel mesh__D004881 Fire, St. Anthonys
% 220.78/220.99  |- skos__scopeNote mesh__D004881
% 220.78/220.99       Poisoning caused by ingesting ergotized grain or by the misdirected or excessive use of ergot as a medicine.%A%    
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D004881 2003
% 220.78/220.99  |- mesh__dateRevised mesh__D004881 2002-07-03
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D004881 2005
% 220.78/220.99  |- skos__hiddenLabel mesh__D004881 Ergotisms
% 220.78/220.99  |- skos__broader mesh__D004881smesh__D010939
% 220.78/220.99  |- skos__hiddenLabel mesh__D004881 St. Anthony Fire
% 220.78/220.99  |- mesh__dateCreated mesh__D004881 1999-01-01
% 220.78/220.99  |- skos__hiddenLabel mesh__D004881 Ergot Poisonings
% 220.78/220.99  |- skos__hiddenLabel mesh__D004881 Saint Anthony Fire
% 220.78/220.99  |- skos__altLabel mesh__D004881 Saint Anthonys Fire
% 220.78/220.99  |- skos__altLabel mesh__D004881 Saint Anthony%27%s Fire
% 220.78/220.99  |- skos__hiddenLabel mesh__D004881 Poisonings, Ergot
% 220.78/220.99  |- skos__altLabel mesh__D004881 St. Anthony%27%s Fire
% 220.78/220.99  |- rdf__type mesh__D004881sskos__Concept
% 220.78/220.99  |- skos__broader mesh__D004881smesh__D011041
% 220.78/220.99  |- mesh__recordOriginator mesh__D004881 NLM
% 220.78/220.99  |- skos__altLabel mesh__D004881 Ergot Poisoning
% 220.78/220.99  |- skos__altLabel mesh__D004083 Cholestan-3-ol
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D004083 2005
% 220.78/220.99  |- skos__broader mesh__D004083smesh__D002784
% 220.78/220.99  |- skos__altLabel mesh__D004083 beta-Cholestanol
% 220.78/220.99  |- mesh__recordMaintainer mesh__D004083 sjn
% 220.78/220.99  |- skos__hiddenLabel mesh__D004083 Cholestan 3 ol
% 220.78/220.99  |- mesh__dateRevised mesh__D004083 2004-07-13
% 220.78/220.99  |- skos__broader mesh__D004083smesh__D002777
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D004083 2006
% 220.78/220.99  |- mesh__recordAuthorizer mesh__D004083 sjn
% 220.78/220.99  |- skos__altLabel mesh__D004083 5 beta-Cholestan-3 alpha-ol
% 220.78/220.99  |- mesh__dateCreated mesh__D004083 1999-01-01
% 220.78/220.99  |- skos__altLabel mesh__D004083 Dihydrocholesterol
% 220.78/220.99  |- skos__scopeNote mesh__D004083
% 220.78/220.99       A cholesterol derivative found in human feces, gallstones, eggs, and other biological matter.%A%    
% 220.78/220.99  |- skos__hiddenLabel mesh__D004083 5 alpha Cholestan 3 beta ol
% 220.78/220.99  |- skos__hiddenLabel mesh__D004083 5 alpha Cholestan 3 alpha ol
% 220.78/220.99  |- skos__altLabel mesh__D004083 Coprostanol
% 220.78/220.99  |- skos__altLabel mesh__D004083 5 alpha-Cholestan-3 beta-ol
% 220.78/220.99  |- mesh__publicMeSHNote mesh__D004083
% 220.78/220.99       91; was DIHYDROCHOLESTEROL see under CHOLESTEROL/analogs %26% derivatives 1975-90, see under CHOLESTEROL 1973-74, see under CHOLESTANES 1969-72%A%  
% 220.78/220.99  |- skos__hiddenLabel mesh__D004083 5 beta Cholestan 3 beta ol
% 220.78/220.99  |- skos__hiddenLabel mesh__D004083 beta-ol, 5 beta-Cholestan-3
% 220.78/220.99  |- mesh__dateEstablished mesh__D004083 1991-01-01
% 220.78/220.99  |- skos__prefLabel mesh__D004083 Cholestanol
% 220.78/220.99  |- skos__hiddenLabel mesh__D004083 beta Cholestanol
% 220.78/220.99  |- skos__annotation mesh__D004083
% 220.78/220.99       do not confuse with CHOLESTANOLS; do not confuse x-ref DIHYDROCHOLESTEROL with DEHYDROCHOLESTEROLS%A%  
% 220.78/220.99  |- rdf__type mesh__D004083sskos__Concept
% 220.78/220.99  |- mesh__onlineNote mesh__D004083
% 220.78/220.99       use CHOLESTANOL to search DIHYDROCHOLESTEROL 1975-90; use CHOLESTEROL 1973-74; use CHOLESTANES 1969-72; use STEROLS 1966-68 %28%as prov%29%%A%  
% 220.78/220.99  |- mesh__historyNote mesh__D004083
% 220.78/220.99       91%28%64%29%; was DIHYDROCHOLESTEROL see under CHOLESTEROL/analogs %26% derivatives 1975-90, see under CHOLESTEROL 1973-74, see under CHOLESTANES 1969-72, %26% see under STEROLS 1964-68 %28%Prov%29%%A%  
% 220.78/220.99  |- skos__hiddenLabel mesh__D004083 beta-Cholestan-3 beta-ol, 5
% 220.78/220.99  |- mesh__recordOriginator mesh__D004083 NLM
% 220.78/220.99  |- skos__hiddenLabel mesh__D012515 Mast Cell Sarcoma
% 220.78/220.99  |- mesh__recordMaintainer mesh__D012515 lkt
% 220.78/220.99  |- mesh__recordOriginator mesh__D012515 NLM
% 220.78/220.99  |- mesh__historyNote mesh__D012515 92; was SARCOMA, MAST CELL 1968-91   
% 220.78/220.99  |- skos__historyNote mesh__D012515 Mast Cells %28%1966-1967%29%
% 220.78/220.99  |- skos__broader mesh__D012515smesh__D008415
% 220.78/220.99  |- skos__hiddenLabel mesh__D012515 Mastocytomas, Malignant
% 220.78/220.99  |- skos__hiddenLabel mesh__D012515 Sarcoma, Mast Cell
% 220.78/220.99  |- skos__prefLabel mesh__D012515 Mast-Cell Sarcoma
% 220.78/220.99  |- mesh__activeMeSHYear mesh__D012515 2006
% 220.78/220.99  |- skos__hiddenLabel mesh__D012515 Malignant Mastocytoma
% 220.78/220.99  |- mesh__publicMeSHNote mesh__D012515 92; was SARCOMA, MAST CELL 1968-91   
% 220.78/221.00  |- mesh__activeMeSHYear mesh__D012515 2004
% 220.78/221.00  |- rdf__type mesh__D012515sskos__Concept
% 220.78/221.00  |- skos__hiddenLabel mesh__D012515 Malignant Mastocytomas
% 220.78/221.00  |- skos__hiddenLabel mesh__D012515 Sarcomas, Mast-Cell
% 220.78/221.00  |- mesh__activeMeSHYear mesh__D012515 2005
% 220.78/221.00  |- mesh__dateRevised mesh__D012515 2002-07-03
% 220.78/221.00  |- skos__historyNote mesh__D012515 Sarcoma %28%1966-1967%29%
% 220.78/221.00  |- skos__scopeNote mesh__D012515
% 220.78/221.00       A unifocal malignant tumor that consists of atypical pathological MAST CELLS without systemic involvement. It causes local destructive growth in organs other than in skin or bone marrow.%A%    
% 220.78/221.00  |- skos__broader mesh__D012515smesh__D012158
% 220.78/221.00  |- skos__altLabel mesh__D012515 Sarcoma, Mast-Cell
% 220.78/221.00  |- mesh__activeMeSHYear mesh__D012515 2003
% 220.78/221.00  |- skos__altLabel mesh__D012515 Mastocytoma, Malignant
% 220.78/221.00  |- mesh__dateCreated mesh__D012515 1999-01-01
% 220.78/221.00  |- skos__hiddenLabel mesh__D012515 Mast-Cell Sarcomas
% 220.78/221.00  |- mesh__dateEstablished mesh__D012515 1968-01-01
% 220.78/221.00  |- mesh__recordAuthorizer mesh__D012515 sjn
% 220.86/221.00  |- mesh__onlineNote mesh__D012515
% 220.86/221.00       use SARCOMA, MAST-CELL to search SARCOMA, MAST CELL 1968-91%A%  
% 220.86/221.00  |- mesh__recordMaintainer mesh__D003789 TGC
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D003789 2003
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D003789 1998
% 220.86/221.00  |- mesh__dateRevised mesh__D003789 1993-05-27
% 220.86/221.00  |- skos__scopeNote mesh__D003789
% 220.86/221.00       The result of pathological changes in the hard tissue of a tooth caused by carious lesions, mechanical factors, or trauma, which render the pulp susceptible to bacterial invasion from the external environment.%A%    
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D003789 2001
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D003789 1995
% 220.86/221.00  |- mesh__dateCreated mesh__D003789 1999-01-01
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D003789 2006
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D003789 2000
% 220.86/221.00  |- mesh__historyNote mesh__D003789 65   
% 220.86/221.00  |- skos__altLabel mesh__D003789 Exposure, Dental Pulp
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D003789 1994
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D003789 2005
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D003789 1997
% 220.86/221.00  |- skos__annotation mesh__D003789
% 220.86/221.00       note category: exposure from caries, trauma, etc; DF: DENT PULP EXPOSURE%A%  
% 220.86/221.00  |- mesh__recordOriginator mesh__D003789 NLM
% 220.86/221.00  |- skos__altLabel mesh__D003789 Pulp Exposure, Dental
% 220.86/221.00  |- rdf__type mesh__D003789sskos__Concept
% 220.86/221.00  |- mesh__dateEstablished mesh__D003789 1965-01-01
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D003789 1996
% 220.86/221.00  |- skos__broader mesh__D003789smesh__D003788
% 220.86/221.00  |- mesh__publicMeSHNote mesh__D003789 65   
% 220.86/221.00  |- skos__prefLabel mesh__D003789 Dental Pulp Exposure
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D003789 2002
% 220.86/221.00  |- mesh__recordAuthorizer mesh__D003789 PLS
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D003789 2004
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D003789 1999
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D008474 2002
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D008474 1993
% 220.86/221.00  |- skos__historyNote mesh__D008474 Neural Pathways %28%1974-1976%29%
% 220.86/221.00  |- skos__hiddenLabel mesh__D008474 Forebrain Bundle, Median
% 220.86/221.00  |- mesh__recordAuthorizer mesh__D008474 PLS
% 220.86/221.00  |- skos__hiddenLabel mesh__D008474 Bundle, Median Forebrain
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D008474 1999
% 220.86/221.00  |- skos__hiddenLabel mesh__D008474 Forebrain Bundles, Median
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D008474 1994
% 220.86/221.00  |- mesh__recordOriginator mesh__D008474 MM
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D008474 2001
% 220.86/221.00  |- skos__broader mesh__D008474smesh__D009434
% 220.86/221.00  |- skos__hiddenLabel mesh__D008474 Bundles, Medial Forebrain
% 220.86/221.00  |- skos__hiddenLabel mesh__D008474 Medial Forebrain Bundles
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D008474 2006
% 220.86/221.00  |- skos__scopeNote mesh__D008474
% 220.86/221.00       A complex group of fibers arising from the basal olfactory regions, the periamygdaloid region, and the septal nuclei, and passing to the lateral hypothalamus. Some fibers continue into the tegmentum.%A%    
% 220.86/221.00  |- rdf__type mesh__D008474sskos__Concept
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D008474 1998
% 220.86/221.00  |- skos__hiddenLabel mesh__D008474 Median Forebrain Bundles
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D008474 2000
% 220.86/221.00  |- skos__historyNote mesh__D008474 Limbic System %28%1966-1976%29%
% 220.86/221.00  |- mesh__recordMaintainer mesh__D008474 TAP
% 220.86/221.00  |- skos__altLabel mesh__D008474 Median Forebrain Bundle
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D008474 2005
% 220.86/221.00  |- mesh__dateCreated mesh__D008474 1976-05-19
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D008474 1997
% 220.86/221.00  |- mesh__historyNote mesh__D008474
% 220.86/221.00       90%28%75%29%; was MEDIAN FOREBRAIN BUNDLE see under NEURAL PATHWAYS 1975-89%A%  
% 220.86/221.00  |- skos__prefLabel mesh__D008474 Medial Forebrain Bundle
% 220.86/221.00  |- skos__hiddenLabel mesh__D008474 Bundle, Medial Forebrain
% 220.86/221.00  |- skos__hiddenLabel mesh__D008474 Forebrain Bundle, Medial
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D008474 2004
% 220.86/221.00  |- skos__hiddenLabel mesh__D008474 Forebrain Bundles, Medial
% 220.86/221.00  |- mesh__dateEstablished mesh__D008474 1990-01-01
% 220.86/221.00  |- mesh__dateRevised mesh__D008474 1992-05-14
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D008474 1996
% 220.86/221.00  |- mesh__onlineNote mesh__D008474
% 220.86/221.00       use MEDIAL FOREBRAIN BUNDLE to search MEDIAN FOREBRAIN BUNDLE 1975-89%A%  
% 220.86/221.00  |- skos__historyNote mesh__D008474 Hypothalamus %28%1966-1976%29%
% 220.86/221.00  |- skos__hiddenLabel mesh__D008474 Bundles, Median Forebrain
% 220.86/221.00  |- mesh__publicMeSHNote mesh__D008474
% 220.86/221.00       90; was MEDIAN FOREBRAIN BUNDLE see under NEURAL PATHWAYS 1975-89%A%  
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D008474 2003
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D008474 1995
% 220.86/221.00  |- mesh__dateCreated mesh__D016906 1991-07-12
% 220.86/221.00  |- skos__altLabel mesh__D016906 P40 T-Cell Growth Factor
% 220.86/221.00  |- skos__annotation mesh__D016906 DF: IL 9 or IL9   
% 220.86/221.00  |- rdf__type mesh__D016906sskos__Concept
% 220.86/221.00  |- mesh__historyNote mesh__D016906
% 220.86/221.00       92; was INTERLEUKIN 9 %28%NM%29% 1989-91   
% 220.86/221.00  |- mesh__dateEstablished mesh__D016906 1992-01-01
% 220.86/221.00  |- skos__historyNote mesh__D016906 Growth Substances %28%1989-1990%29%
% 220.86/221.00  |- mesh__publicMeSHNote mesh__D016906
% 220.86/221.00       92; INTERLEUKIN 9 %28%NM%29% was indexed under INTERLEUKINS 1990-91 %26% under GROWTH SUBSTANCES 1989-90%A%  
% 220.86/221.00  |- mesh__recordOriginator mesh__D016906 AGS
% 220.86/221.00  |- skos__hiddenLabel mesh__D016906 Interleukin 9
% 220.86/221.00  |- skos__altLabel mesh__D016906 IL9
% 220.86/221.00  |- skos__hiddenLabel mesh__D016906 T Cell Growth Factor P40
% 220.86/221.00  |- skos__altLabel mesh__D016906 T-Cell Growth Factor P40
% 220.86/221.00  |- mesh__recordAuthorizer mesh__D016906 sjn
% 220.86/221.00  |- mesh__dateRevised mesh__D016906 2005-06-30
% 220.86/221.00  |- skos__historyNote mesh__D016906 Interleukins %28%1990-1991%29%
% 220.86/221.00  |- skos__prefLabel mesh__D016906 Interleukin-9
% 220.86/221.00  |- skos__scopeNote mesh__D016906
% 220.86/221.00       Factor that is thought to be a regulator of hematopoiesis. It has been shown to enhance the growth of human mast cells and megakaryoblastic leukemic cells as well as murine helper t-cell clones. IL-9 is a glycoprotein with a molecular weight of 32-39 that is derived from T-cells, and maps to human chromosome 5.%A%    
% 220.86/221.00  |- skos__altLabel mesh__D016906 IL-9
% 220.86/221.00  |- skos__broader mesh__D016906smesh__D007378
% 220.86/221.00  |- mesh__onlineNote mesh__D016906
% 220.86/221.00       use INTERLEUKIN-9 %28%NM%29% to search INTERLEUKIN-9 1989-91   
% 220.86/221.00  |- mesh__recordMaintainer mesh__D016906 ssb
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016906 2006
% 220.86/221.00  |- skos__hiddenLabel mesh__D016906 P40 T Cell Growth Factor
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016108 2003
% 220.86/221.00  |- mesh__historyNote mesh__D016108 91   
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016108 2006
% 220.86/221.00  |- skos__altLabel mesh__D016108
% 220.86/221.00       Epidermolysis Bullosa Dystrophica, Recessive
% 220.86/221.00  |- mesh__recordMaintainer mesh__D016108 nns
% 220.86/221.00  |- rdf__type mesh__D016108sskos__Concept
% 220.86/221.00  |- mesh__recordAuthorizer mesh__D016108 sjn
% 220.86/221.00  |- mesh__recordOriginator mesh__D016108 AGS
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016108 2005
% 220.86/221.00  |- skos__broader mesh__D016108smesh__D004820
% 220.86/221.00  |- mesh__dateRevised mesh__D016108 2001-07-25
% 220.86/221.00  |- skos__hiddenLabel mesh__D016108 Dystrophic Epidermolysis Bullosa
% 220.86/221.00  |- skos__scopeNote mesh__D016108
% 220.86/221.00       Form of epidermolysis bullosa characterized by atrophy of blistered areas, severe scarring, and nail changes. It is most often present at birth or in early infancy and occurs in both autosomal dominant and recessive forms.%A%    
% 220.86/221.00  |- skos__prefLabel mesh__D016108 Epidermolysis Bullosa Dystrophica
% 220.86/221.00  |- skos__altLabel mesh__D016108 Epidermolysis Bullosa Dystrophica, Dominant
% 220.86/221.00  |- mesh__publicMeSHNote mesh__D016108 91   
% 220.86/221.00  |- skos__hiddenLabel mesh__D016108 Cockayne Touraine Disease
% 220.86/221.00  |- skos__historyNote mesh__D016108 Epidermolysis Bullosa %28%1966-1990%29%
% 220.86/221.00  |- mesh__dateCreated mesh__D016108 1990-02-12
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016108 2002
% 220.86/221.00  |- skos__annotation mesh__D016108
% 220.86/221.00       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 220.86/221.00  |- skos__hiddenLabel mesh__D016108 Hallopeau Siemens Disease
% 220.86/221.00  |- mesh__dateEstablished mesh__D016108 1991-01-01
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016108 2004
% 220.86/221.00  |- skos__altLabel mesh__D016108 Epidermolysis Bullosa, Dystrophic
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D004882 2005
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D004882 2004
% 220.86/221.00  |- mesh__dateCreated mesh__D004882 1999-01-01
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D004882 2002
% 220.86/221.00  |- mesh__recordMaintainer mesh__D004882 TGC
% 220.86/221.00  |- mesh__dateRevised mesh__D004882 1996-06-10
% 220.86/221.00  |- mesh__recordOriginator mesh__D004882 NLM
% 220.86/221.00  |- skos__broader mesh__D004882smesh__D003146
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D004882 2006
% 220.86/221.00  |- skos__annotation mesh__D004882 only /hist /legis /psychol   
% 220.86/221.00  |- skos__prefLabel mesh__D004882 Erotica
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D004882 1998
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D004882 1997
% 220.86/221.00  |- mesh__recordAuthorizer mesh__D004882 PLS
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D004882 2000
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D004882 1999
% 220.86/221.00  |- skos__scopeNote mesh__D004882
% 220.86/221.00       Literary or artistic items having an erotic theme. It refers especially to books treating sexual love in a sensuous or voluptuous manner. %28%Webster, 3d ed%29%%A%    
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D004882 2001
% 220.86/221.00  |- rdf__type mesh__D004882sskos__Concept
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D004882 2003
% 220.86/221.00  |- skos__annotation mesh__D012516
% 220.86/221.00       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS %28%IM%29% or specific precoord bone/neopl term %28%IM%29% or specific bone %28%IM%29% + BONE NEOPLASMS %28%IM%29%%A%  
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D012516 2002
% 220.86/221.00  |- mesh__publicMeSHNote mesh__D012516
% 220.86/221.00       89; was SARCOMA, OSTEOGENIC 1963-88   
% 220.86/221.00  |- mesh__historyNote mesh__D012516 89; was SARCOMA, OSTEOGENIC 1963-88   
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D012516 2006
% 220.86/221.00  |- skos__broader mesh__D012516smesh__D018213
% 220.86/221.00  |- mesh__recordOriginator mesh__D012516 NLM
% 220.86/221.00  |- mesh__dateRevised mesh__D012516 1995-06-08
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D012516 2004
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D012516 1999
% 220.86/221.00  |- rdf__type mesh__D012516sskos__Concept
% 220.86/221.00  |- skos__hiddenLabel mesh__D012516 Osteogenic Sarcomas
% 220.86/221.00  |- skos__scopeNote mesh__D012516
% 220.86/221.00       A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. %28%From Stedman, 25th ed%29%%A%    
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D012516 1997
% 220.86/221.00  |- mesh__recordAuthorizer mesh__D012516 PLS
% 220.86/221.00  |- mesh__onlineNote mesh__D012516
% 220.86/221.00       use OSTEOSARCOMA to search SARCOMA, OSTEOGENIC 1966-88   
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D012516 2005
% 220.86/221.00  |- skos__hiddenLabel mesh__D012516 Osteogenic Sarcoma
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D012516 2001
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D012516 2003
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D012516 1998
% 220.86/221.00  |- skos__altLabel mesh__D012516 Sarcoma, Osteogenic
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D012516 2000
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D012516 1996
% 220.86/221.00  |- mesh__dateCreated mesh__D012516 1999-01-01
% 220.86/221.00  |- skos__prefLabel mesh__D012516 Osteosarcoma
% 220.86/221.00  |- skos__hiddenLabel mesh__D012516 Sarcomas, Osteogenic
% 220.86/221.00  |- skos__broader mesh__D012516smesh__D012509
% 220.86/221.00  |- skos__hiddenLabel mesh__D012516 Osteosarcomas
% 220.86/221.00  |- mesh__recordMaintainer mesh__D012516 KEV
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D017201 2002
% 220.86/221.00  |- skos__scopeNote mesh__D017201
% 220.86/221.00       The expelling of virus particles from the body. Important routes include the respiratory tract, genital tract, and intestinal tract. Virus shedding is an important means of vertical transmission %28%DISEASE TRANSMISSION, VERTICAL%29%.%A%    
% 220.86/221.00  |- skos__hiddenLabel mesh__D017201 Shedding, Viral
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D017201 1999
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D017201 2006
% 220.86/221.00  |- mesh__dateRevised mesh__D017201 1994-02-08
% 220.86/221.00  |- skos__broader mesh__D017201smesh__D018406
% 220.86/221.00  |- skos__hiddenLabel mesh__D017201 Viral Sheddings
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D017201 1998
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D017201 2005
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D017201 1997
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D017201 2004
% 220.86/221.00  |- mesh__dateEstablished mesh__D017201 1993-01-01
% 220.86/221.00  |- skos__hiddenLabel mesh__D017201 Virus Sheddings
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D017201 2001
% 220.86/221.00  |- rdf__type mesh__D017201sskos__Concept
% 220.86/221.00  |- mesh__recordMaintainer mesh__D017201 PXP
% 220.86/221.00  |- skos__hiddenLabel mesh__D017201 Sheddings, Virus
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D017201 1996
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D017201 2003
% 220.86/221.00  |- mesh__recordAuthorizer mesh__D017201 PLS
% 220.86/221.00  |- mesh__publicMeSHNote mesh__D017201 93   
% 220.86/221.00  |- skos__annotation mesh__D017201
% 220.86/221.00       expelling of virus particles from the body   
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D017201 2000
% 220.86/221.00  |- skos__prefLabel mesh__D017201 Virus Shedding
% 220.86/221.00  |- mesh__dateCreated mesh__D017201 1992-05-22
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D017201 1995
% 220.86/221.00  |- mesh__recordOriginator mesh__D017201 AGS
% 220.86/221.00  |- mesh__historyNote mesh__D017201 93   
% 220.86/221.00  |- skos__hiddenLabel mesh__D017201 Sheddings, Viral
% 220.86/221.00  |- skos__altLabel mesh__D017201 Viral Shedding
% 220.86/221.00  |- skos__hiddenLabel mesh__D017201 Shedding, Virus
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D008475 2006
% 220.86/221.00  |- mesh__recordOriginator mesh__D008475 NLM
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D008475 2002
% 220.86/221.00  |- rdf__type mesh__D008475sskos__Concept
% 220.86/221.00  |- skos__annotation mesh__D008475
% 220.86/221.00       dis = MEDIAN NEUROPATHY %28%IM%29%; neopl = MEDIAN NEUROPATHY %28%IM%29% + PERIPHERAL NERVOUS SYSTEM NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 220.86/221.00  |- mesh__recordMaintainer mesh__D008475 ags
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D008475 2003
% 220.86/221.00  |- skos__hiddenLabel mesh__D008475 Nerves, Median
% 220.86/221.00  |- skos__prefLabel mesh__D008475 Median Nerve
% 220.86/221.00  |- mesh__recordAuthorizer mesh__D008475 sjn
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D008475 2004
% 220.86/221.00  |- skos__hiddenLabel mesh__D008475 Median Nerves
% 220.86/221.00  |- skos__related mesh__D008475smesh__D002349
% 220.86/221.00  |- skos__scopeNote mesh__D008475
% 220.86/221.00       A major nerve of the upper extremity. In humans, the fibers of the median nerve originate in the lower cervical and upper thoracic spinal cord %28%usually C6 to T1%29%, travel via the brachial plexus, and supply sensory and motor innervation to parts of the forearm and hand.%A%    
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D008475 2000
% 220.86/221.00  |- skos__hiddenLabel mesh__D008475 Nerve, Median
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D008475 2005
% 220.86/221.00  |- mesh__dateRevised mesh__D008475 1999-11-03
% 220.86/221.00  |- mesh__dateCreated mesh__D008475 1999-01-01
% 220.86/221.00  |- skos__broader mesh__D008475smesh__D001917
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D008475 2001
% 220.86/221.00  |- mesh__dateCreated mesh__D000492 1974-11-19
% 220.86/221.00  |- mesh__publicMeSHNote mesh__D000492
% 220.86/221.00       91; was see under AMIDOHYDROLASES 1975-90   
% 220.86/221.00  |- skos__historyNote mesh__D000492 Urea %28%1974%29%
% 220.86/221.00  |- mesh__recordMaintainer mesh__D000492 ssb
% 220.86/221.00  |- mesh__historyNote mesh__D000492
% 220.86/221.00       91%28%75%29%; was see under AMIDOHYDROLASES 1975-90   
% 220.86/221.00  |- mesh__recordOriginator mesh__D000492 NLM
% 220.86/221.00  |- mesh__recordAuthorizer mesh__D000492 sjn
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D000492 2005
% 220.86/221.00  |- mesh__dateEstablished mesh__D000492 1991-01-01
% 220.86/221.00  |- skos__hiddenLabel mesh__D000492 Hydrolase, Allophanate
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D000492 2004
% 220.86/221.00  |- rdf__type mesh__D000492sskos__Concept
% 220.86/221.00  |- skos__historyNote mesh__D000492 Amidohydrolases %28%1974%29%
% 220.86/221.00  |- skos__historyNote mesh__D000492 Carboxylic Acids %28%1974%29%
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D000492 2006
% 220.86/221.00  |- skos__broader mesh__D000492smesh__D000581
% 220.86/221.00  |- skos__prefLabel mesh__D000492 Allophanate Hydrolase
% 220.86/221.00  |- mesh__dateRevised mesh__D000492 2003-07-09
% 220.86/221.00  |- skos__scopeNote mesh__D000492
% 220.86/221.00       An enzyme that catalyzes the hydrolysis of allophanic acid to two molecules of ammonia plus two molecules of %22%active carbon dioxide%22%. EC 3.5.1.54.%A%    
% 220.86/221.00  |- skos__scopeNote mesh__D016907
% 220.86/221.00       Systems developed for collecting reports from government agencies, manufacturers, hospitals, physicians, and other sources on adverse drug reactions.%A%    
% 220.86/221.00  |- skos__broader mesh__D016907smesh__D011358
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016907 2001
% 220.86/221.00  |- skos__altLabel mesh__D016907 Drug Reaction Reporting Systems, Adverse
% 220.86/221.00  |- mesh__dateEstablished mesh__D016907 1992-01-01
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016907 2006
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016907 2000
% 220.86/221.00  |- skos__prefLabel mesh__D016907 Adverse Drug Reaction Reporting Systems
% 220.86/221.00  |- skos__annotation mesh__D016907 DF: ADR REPORT SYSTEMS   
% 220.86/221.00  |- mesh__publicMeSHNote mesh__D016907 92   
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016907 2004
% 220.86/221.00  |- skos__historyNote mesh__D016907
% 220.86/221.00       specific drug/adverse effects %28%1966-1991%29%
% 220.86/221.00  |- skos__broader mesh__D016907smesh__D004346
% 220.86/221.00  |- rdf__type mesh__D016907sskos__Concept
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016907 2005
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016907 1995
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016907 1993
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016907 2003
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016907 1999
% 220.86/221.00  |- mesh__dateCreated mesh__D016907 1991-05-30
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016907 2002
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016907 1994
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016907 1997
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016907 1992
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016907 1998
% 220.86/221.00  |- mesh__historyNote mesh__D016907 92   
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016907 1996
% 220.86/221.00  |- skos__historyNote mesh__D016907
% 220.86/221.00       Drug Therapy/adverse effects %28%1966-1991%29%
% 220.86/221.00  |- skos__scopeNote mesh__D016109
% 220.86/221.00       Form of epidermolysis bullosa having onset at birth or during the neonatal period and transmitted through autosomal recessive inheritance. It is characterized by generalized blister formation, extensive denudation, and separation and cleavage of the basal cell plasma membranes from the basement membrane.%A%    
% 220.86/221.00  |- mesh__historyNote mesh__D016109
% 220.86/221.00       91; HERLITZ DISEASE was HERLITZ%27%S DISEASE 1991-92   
% 220.86/221.00  |- mesh__recordMaintainer mesh__D016109 jmp
% 220.86/221.00  |- skos__altLabel mesh__D016109 Herlitz Disease
% 220.86/221.00  |- skos__annotation mesh__D016109
% 220.86/221.00       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016109 2004
% 220.86/221.00  |- mesh__recordAuthorizer mesh__D016109 sjn
% 220.86/221.00  |- mesh__recordOriginator mesh__D016109 AGS
% 220.86/221.00  |- mesh__publicMeSHNote mesh__D016109
% 220.86/221.00       91; HERLITZ DISEASE was HERLITZ%27%S DISEASE 1991-92   
% 220.86/221.00  |- skos__altLabel mesh__D016109 Herlitz%27%s Disease
% 220.86/221.00  |- mesh__dateEstablished mesh__D016109 1991-01-01
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016109 2003
% 220.86/221.00  |- mesh__dateRevised mesh__D016109 2001-07-25
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016109 2006
% 220.86/221.00  |- skos__altLabel mesh__D016109 Junctional Epidermolysis Bullosa
% 220.86/221.00  |- skos__altLabel mesh__D016109 Lethal Junctional Epidermolysis Bullosa
% 220.86/221.00  |- skos__prefLabel mesh__D016109 Epidermolysis Bullosa, Junctional
% 220.86/221.00  |- rdf__type mesh__D016109sskos__Concept
% 220.86/221.00  |- mesh__onlineNote mesh__D016109
% 220.86/221.00       use EPIDERMOLYSIS BULLOSA, JUNCTIONAL to search HERLITZ%27%S DISEASE 1991-92%A%  
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016109 2005
% 220.86/221.00  |- skos__broader mesh__D016109smesh__D004820
% 220.86/221.00  |- skos__historyNote mesh__D016109 Epidermolysis Bullosa %28%1966-1990%29%
% 220.86/221.00  |- mesh__dateCreated mesh__D016109 1990-02-12
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D016109 2002
% 220.86/221.00  |- skos__hiddenLabel mesh__D004883 Acids, Docosenoic
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D004883 2006
% 220.86/221.00  |- skos__altLabel mesh__D004883 Docosenoic Acids
% 220.86/221.00  |- mesh__dateCreated mesh__D004883 1974-11-27
% 220.86/221.00  |- mesh__dateEstablished mesh__D004883 1991-01-01
% 220.86/221.00  |- skos__hiddenLabel mesh__D004883 Acids, Brassidic
% 220.86/221.00  |- skos__hiddenLabel mesh__D004883 Acids, Erucic
% 220.86/221.00  |- mesh__publicMeSHNote mesh__D004883
% 220.86/221.00       91; was see under FATTY ACIDS, MONOUNSATURATED 1988-90; was see under FATTY ACIDS, UNSATURATED 1975-87%A%  
% 220.86/221.00  |- mesh__historyNote mesh__D004883
% 220.86/221.00       91%28%75%29%; was see under FATTY ACIDS, MONOUNSATURATED 1988-90; was see under FATTY ACIDS, UNSATURATED 1975-87%A%  
% 220.86/221.00  |- mesh__dateRevised mesh__D004883 2003-07-09
% 220.86/221.00  |- mesh__recordOriginator mesh__D004883 NLM
% 220.86/221.00  |- rdf__type mesh__D004883sskos__Concept
% 220.86/221.00  |- skos__historyNote mesh__D004883
% 220.86/221.00       Fatty Acids, Unsaturated %28%1973-1974%29%
% 220.86/221.00  |- mesh__recordMaintainer mesh__D004883 ssb
% 220.86/221.00  |- skos__broader mesh__D004883smesh__D005229
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D004883 2005
% 220.86/221.00  |- mesh__recordAuthorizer mesh__D004883 sjn
% 220.86/221.00  |- skos__prefLabel mesh__D004883 Erucic Acids
% 220.86/221.00  |- skos__scopeNote mesh__D004883
% 220.86/221.00       cis-13-Docosenoic Acids. 22-Carbon monounsaturated, monocarboxylic acids.%A%    
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D004883 2004
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D012517 2004
% 220.86/221.00  |- rdf__type mesh__D012517sskos__Concept
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D012517 2005
% 220.86/221.00  |- skos__altLabel mesh__D012517 Reticulum Cell-Like Sarcoma, Yoshida
% 220.86/221.00  |- skos__annotation mesh__D012517
% 220.86/221.00       exper neopl; /blood supply /chem /second /secret /ultrastruct permitted; don%27%t forget check tag ANIMALS%A%  
% 220.86/221.00  |- mesh__dateCreated mesh__D012517 1999-01-01
% 220.86/221.00  |- skos__prefLabel mesh__D012517 Sarcoma, Yoshida
% 220.86/221.00  |- mesh__dateRevised mesh__D012517 2003-07-30
% 220.86/221.00  |- mesh__recordAuthorizer mesh__D012517 sjn
% 220.86/221.00  |- mesh__recordOriginator mesh__D012517 NLM
% 220.86/221.00  |- mesh__recordMaintainer mesh__D012517 ags
% 220.86/221.00  |- skos__hiddenLabel mesh__D012517 Reticulum Cell Like Sarcoma, Yoshida
% 220.86/221.00  |- skos__broader mesh__D012517smesh__D012513
% 220.86/221.00  |- skos__hiddenLabel mesh__D012517 Yoshida Sarcoma
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D012517 2006
% 220.86/221.00  |- skos__broader mesh__D017202smesh__D006331
% 220.86/221.00  |- skos__altLabel mesh__D017202 Ischemia, Myocardial
% 220.86/221.00  |- skos__hiddenLabel mesh__D017202 Disease, Ischemic Heart
% 220.86/221.00  |- skos__hiddenLabel mesh__D017202 Ischemias, Myocardial
% 220.86/221.00  |- skos__related mesh__D017202smesh__D009203
% 220.86/221.00  |- skos__hiddenLabel mesh__D017202 Heart Diseases, Ischemic
% 220.86/221.00  |- mesh__dateEstablished mesh__D017202 1993-01-01
% 220.86/221.00  |- skos__hiddenLabel mesh__D017202 Myocardial Ischemias
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D017202 2002
% 220.86/221.00  |- mesh__dateRevised mesh__D017202 1996-06-10
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D017202 2003
% 220.86/221.00  |- skos__annotation mesh__D017202
% 220.86/221.00       = defic of myocard blood supply; may lead to MYOCARDIAL INFARCTION%A%  
% 220.86/221.00  |- skos__scopeNote mesh__D017202
% 220.86/221.00       A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries %28%CORONARY ARTERIOSCLEROSIS%29%, to obstruction by a thrombus %28%CORONARY THROMBOSIS%29%, or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle %28%MYOCARDIAL INFARCTION%29%.%A%    
% 220.86/221.00  |- mesh__recordAuthorizer mesh__D017202 PLS
% 220.86/221.00  |- mesh__dateCreated mesh__D017202 1992-05-22
% 220.86/221.00  |- skos__hiddenLabel mesh__D017202 Diseases, Ischemic Heart
% 220.86/221.00  |- mesh__recordOriginator mesh__D017202 TGC
% 220.86/221.00  |- mesh__onlineNote mesh__D017202
% 220.86/221.00       use CORONARY DISEASE to search HEART DISEASE, ISCHEMIC %26% ISCHEMIC HEART DISEASE 1969-92%A%  
% 220.86/221.00  |- skos__broader mesh__D017202smesh__D007511
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D017202 2004
% 220.86/221.00  |- skos__altLabel mesh__D017202 Ischemic Heart Disease
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D017202 2005
% 220.86/221.00  |- skos__historyNote mesh__D017202 Coronary Disease %28%1966-1992%29%
% 220.86/221.00  |- mesh__publicMeSHNote mesh__D017202
% 220.86/221.00       93; HEART DISEASE, ISCHEMIC %26% ISCHEMIC HEART DISEASE were see CORONARY DISEASE 1969-92%A%  
% 220.86/221.00  |- mesh__historyNote mesh__D017202
% 220.86/221.00       93; HEART DISEASE, ISCHEMIC %26% ISCHEMIC HEART DISEASE were see CORONARY DISEASE 1969-92%A%  
% 220.86/221.00  |- skos__altLabel mesh__D017202 Heart Disease, Ischemic
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D017202 1997
% 220.86/221.00  |- skos__related mesh__D017202smesh__D017682
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D017202 1998
% 220.86/221.00  |- skos__related mesh__D017202smesh__D019157
% 220.86/221.00  |- mesh__activeMeSHYear mesh__D017202 2000
% 220.86/221.00  |- skos__related mesh__D017202smesh__D009204
% 220.86/221.01  |- skos__hiddenLabel mesh__D017202 Ischemic Heart Diseases
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D017202 2006
% 220.86/221.01  |- skos__related mesh__D017202smesh__D015425
% 220.86/221.01  |- rdf__type mesh__D017202sskos__Concept
% 220.86/221.01  |- mesh__recordMaintainer mesh__D017202 TGC
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D017202 1999
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D017202 2001
% 220.86/221.01  |- skos__prefLabel mesh__D017202 Myocardial Ischemia
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D050636 2006
% 220.86/221.01  |- skos__historyNote mesh__D050636 Cetacea %28%1977-1989%29%
% 220.86/221.01  |- rdf__type mesh__D050636sskos__Concept
% 220.86/221.01  |- skos__altLabel mesh__D050636 Balaenoptera acutorostrata bonaerensis
% 220.86/221.01  |- skos__scopeNote mesh__D050636
% 220.86/221.01       The species Balaenoptera acutorostrata, in the family Balaenopteridae. It is the smallest of the WHALES in the family and though mainly oceanic, is often found in coastal waters including bays and estuaries.%A%    
% 220.86/221.01  |- mesh__recordAuthorizer mesh__D050636 sjn
% 220.86/221.01  |- mesh__dateEstablished mesh__D050636 2006-01-01
% 220.86/221.01  |- mesh__historyNote mesh__D050636 2006; use WHALES 1998-2005   
% 220.86/221.01  |- skos__historyNote mesh__D050636 Whales %28%1975-2005%29%
% 220.86/221.01  |- skos__broader mesh__D050636smesh__D050616
% 220.86/221.01  |- skos__prefLabel mesh__D050636 Minke Whale
% 220.86/221.01  |- skos__hiddenLabel mesh__D050636 Minke Whales
% 220.86/221.01  |- mesh__recordOriginator mesh__D050636 ags
% 220.86/221.01  |- mesh__publicMeSHNote mesh__D050636 2006; see WHALES 1998-2005   
% 220.86/221.01  |- mesh__dateCreated mesh__D050636 2005-06-30
% 220.86/221.01  |- skos__altLabel mesh__D050636 Balaenoptera acutorostrata
% 220.86/221.01  |- mesh__recordMaintainer mesh__D050636 ags
% 220.86/221.01  |- skos__hiddenLabel mesh__D008476 Cysts, Mediastinal
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D008476 2003
% 220.86/221.01  |- skos__broader mesh__D008476smesh__D003560
% 220.86/221.01  |- skos__prefLabel mesh__D008476 Mediastinal Cyst
% 220.86/221.01  |- mesh__recordMaintainer mesh__D008476 KEV
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D008476 2000
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D008476 2004
% 220.86/221.01  |- skos__hiddenLabel mesh__D008476 Thymic Cysts
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D008476 2001
% 220.86/221.01  |- mesh__recordOriginator mesh__D008476 NLM
% 220.86/221.01  |- skos__broader mesh__D008476smesh__D008477
% 220.86/221.01  |- skos__hiddenLabel mesh__D008476 Cysts, Thymic
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D008476 2005
% 220.86/221.01  |- skos__hiddenLabel mesh__D008476 Cyst, Mediastinal
% 220.86/221.01  |- skos__hiddenLabel mesh__D008476 Cyst, Pericardial
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D008476 2002
% 220.86/221.01  |- skos__annotation mesh__D008476
% 220.86/221.01       non-neoplastic; simple mediastinal cysts commonly adjacent to pericardium; note X refs: do not coord pericardial, thoracic, thymic or tracheal cysts with respective organs or organ/dis precoord: index only under MEDIASTINAL CYST%A%  
% 220.86/221.01  |- mesh__dateCreated mesh__D008476 1999-01-01
% 220.86/221.01  |- skos__hiddenLabel mesh__D008476 Cysts, Thoracic
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D008476 2006
% 220.86/221.01  |- skos__scopeNote mesh__D008476
% 220.86/221.01       Cysts of one of the parts of the mediastinum: the superior part, containing the trachea, esophagus, thoracic duct and thymus organs; the inferior middle part, containing the pericardium; the inferior anterior part containing some lymph nodes; and the inferior posterior part, containing the thoracic duct and esophagus.%A%    
% 220.86/221.01  |- skos__hiddenLabel mesh__D008476 Tracheal Cysts
% 220.86/221.01  |- skos__hiddenLabel mesh__D008476 Cyst, Tracheal
% 220.86/221.01  |- skos__hiddenLabel mesh__D008476 Cysts, Tracheal
% 220.86/221.01  |- mesh__dateRevised mesh__D008476 1999-11-08
% 220.86/221.01  |- skos__hiddenLabel mesh__D008476 Pericardial Cysts
% 220.86/221.01  |- skos__hiddenLabel mesh__D008476 Cyst, Thymic
% 220.86/221.01  |- rdf__type mesh__D008476sskos__Concept
% 220.86/221.01  |- skos__hiddenLabel mesh__D008476 Thoracic Cysts
% 220.86/221.01  |- skos__hiddenLabel mesh__D008476 Cyst, Thoracic
% 220.86/221.01  |- skos__hiddenLabel mesh__D008476 Mediastinal Cysts
% 220.86/221.01  |- mesh__recordAuthorizer mesh__D008476 sjn
% 220.86/221.01  |- skos__hiddenLabel mesh__D008476 Cysts, Pericardial
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Azupharma Brand
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Quimica, Pan
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Merckle Brand
% 220.86/221.01  |- skos__altLabel mesh__D000493 Hennig Brand of Allopurinol
% 220.86/221.01  |- skos__altLabel mesh__D000493 Wellcome Brand of Allopurinol
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol TAD Brand
% 220.86/221.01  |- mesh__recordAuthorizer mesh__D000493 sjn
% 220.86/221.01  |- skos__altLabel mesh__D000493 Douglas Brand of Allopurinol
% 220.86/221.01  |- skos__altLabel mesh__D000493 Merz Brand of Allopurinol
% 220.86/221.01  |- skos__altLabel mesh__D000493 R.A.N. Brand of Allopurinol
% 220.86/221.01  |- skos__altLabel mesh__D000493 Allohexan
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Pharmafarm Brand
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Hennig Brand
% 220.86/221.01  |- skos__altLabel mesh__D000493 Pharmafarm Brand of Allopurinol
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Rima Brand
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Bicther Brand
% 220.86/221.01  |- skos__altLabel mesh__D000493 TAD Brand of Allopurinol
% 220.86/221.01  |- mesh__publicMeSHNote mesh__D000493 68   
% 220.86/221.01  |- skos__altLabel mesh__D000493 Merckle Brand of Allopurinol
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493
% 220.86/221.01       Rh%C3%%B4%ne Poulenc Rorer Brand of Allopurinol
% 220.86/221.01  |- rdf__type mesh__D000493sskos__Concept
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D000493 2005
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol ICN Brand
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Merz Brand
% 220.86/221.01  |- skos__altLabel mesh__D000493 Horner Brand of Allopurinol
% 220.86/221.01  |- mesh__dateRevised mesh__D000493 2004-07-07
% 220.86/221.01  |- skos__altLabel mesh__D000493
% 220.86/221.01       Rh%C3%%B4%ne-Poulenc Rorer Brand of Allopurinol
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Jenapharm Brand
% 220.86/221.01  |- skos__altLabel mesh__D000493 Pan Quimica
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Novopharm Brand
% 220.86/221.01  |- skos__altLabel mesh__D000493 BASF Brand of Allopurinol
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Wellcome Brand
% 220.86/221.01  |- skos__altLabel mesh__D000493 ICN Brand of Allopurinol
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Nicholas Brand
% 220.86/221.01  |- skos__altLabel mesh__D000493 Multipharma Brand of Allopurinol
% 220.86/221.01  |- skos__altLabel mesh__D000493 Hexal Brand of Allopurinol
% 220.86/221.01  |- skos__scopeNote mesh__D000493
% 220.86/221.01       A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms.%A%    
% 220.86/221.01  |- skos__altLabel mesh__D000493 APS Brand of Allopurinol
% 220.86/221.01  |- skos__altLabel mesh__D000493 Jenapharm Brand of Allopurinol
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Multipharma Brand
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Hexal Brand
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol R.A.N. Brand
% 220.86/221.01  |- skos__historyNote mesh__D000493 Enzymes %28%1966%29%
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Amrad Brand
% 220.86/221.01  |- skos__altLabel mesh__D000493 Bicther Brand of Allopurinol
% 220.86/221.01  |- skos__altLabel mesh__D000493 Protea Brand of Allopurinol
% 220.86/221.01  |- mesh__dateCreated mesh__D000493 1999-01-01
% 220.86/221.01  |- skos__altLabel mesh__D000493 Rosen Brand of Allopurinol
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Ashbourne Brand
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Clonmel Brand
% 220.86/221.01  |- skos__altLabel mesh__D000493 Glaxo Wellcome Brand of Allopurinol
% 220.86/221.01  |- skos__altLabel mesh__D000493 Clonmel Brand of Allopurinol
% 220.86/221.01  |- skos__altLabel mesh__D000493 Roche Brand of Allopurinol
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Boots Brand
% 220.86/221.01  |- skos__altLabel mesh__D000493 Fawns %26% McAllan Brand of Allopurinol
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol BASF Brand
% 220.86/221.01  |- skos__altLabel mesh__D000493 Reig Jofre Brand of Allopurinol
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Protea Brand
% 220.86/221.01  |- skos__altLabel mesh__D000493 Novopharm Brand of Allopurinol
% 220.86/221.01  |- skos__altLabel mesh__D000493 Ashbourne Brand of Allopurinol
% 220.86/221.01  |- skos__altLabel mesh__D000493 Dorsch Brand of Allopurinol
% 220.86/221.01  |- skos__altLabel mesh__D000493 gepepharm Brand of Allopurinol
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Roche Brand
% 220.86/221.01  |- skos__altLabel mesh__D000493 Pinewood Brand of Allopurinol
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Pinewood Brand
% 220.86/221.01  |- skos__altLabel mesh__D000493 Boots Brand of Allopurinol
% 220.86/221.01  |- skos__altLabel mesh__D000493 Amrad Brand of Allopurinol
% 220.86/221.01  |- mesh__historyNote mesh__D000493 68%28%67%29%   
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Rosen Brand
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Douglas Brand
% 220.86/221.01  |- skos__altLabel mesh__D000493 Nicholas Brand of Allopurinol
% 220.86/221.01  |- skos__altLabel mesh__D000493 Alphapharm Brand of Allopurinol
% 220.86/221.01  |- skos__altLabel mesh__D000493 Byk Gulden Brand of Allopurinol
% 220.86/221.01  |- mesh__recordMaintainer mesh__D000493 mdb
% 220.86/221.01  |- skos__broader mesh__D000493smesh__D011687
% 220.86/221.01  |- skos__altLabel mesh__D000493 Rima Brand of Allopurinol
% 220.86/221.01  |- mesh__recordOriginator mesh__D000493 NLM
% 220.86/221.01  |- mesh__dateEstablished mesh__D000493 1968-01-01
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol gepepharm Brand
% 220.86/221.01  |- skos__prefLabel mesh__D000493 Allopurinol
% 220.86/221.01  |- skos__altLabel mesh__D000493 Zyloric
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Horner Brand
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol APS Brand
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Alphapharm Brand
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Dorsch Brand
% 220.86/221.01  |- skos__historyNote mesh__D000493 Xanthine Oxidase %28%1966%29%
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Rougier Brand
% 220.86/221.01  |- skos__altLabel mesh__D000493 Azupharma Brand of Allopurinol
% 220.86/221.01  |- skos__altLabel mesh__D000493 Rougier Brand of Allopurinol
% 220.86/221.01  |- skos__altLabel mesh__D000493 Henning Berlin Brand of Allopurinol
% 220.86/221.01  |- skos__altLabel mesh__D000493 Thiemann Brand of Allopurinol
% 220.86/221.01  |- skos__altLabel mesh__D000493 Suspendol
% 220.86/221.01  |- skos__altLabel mesh__D000493 Boehringer Mannheim Brand of Allopurinol
% 220.86/221.01  |- skos__hiddenLabel mesh__D000493 Allopurinol Thiemann Brand
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D000493 2006
% 220.86/221.01  |- skos__hiddenLabel mesh__D016908 Gram-Positive Bacterial Infection
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016908 2005
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016908 2004
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016908 1995
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016908 2001
% 220.86/221.01  |- mesh__dateEstablished mesh__D016908 1992-01-01
% 220.86/221.01  |- rdf__type mesh__D016908sskos__Concept
% 220.86/221.01  |- skos__historyNote mesh__D016908 Gram-Positive Bacteria %28%1984-1991%29%
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016908 2003
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016908 1999
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016908 1993
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016908 1994
% 220.86/221.01  |- skos__historyNote mesh__D016908 specific bacteria %28%1972-1983%29%
% 220.86/221.01  |- skos__hiddenLabel mesh__D016908 Bacterial Infection, Gram-Positive
% 220.86/221.01  |- mesh__publicMeSHNote mesh__D016908 92   
% 220.86/221.01  |- skos__hiddenLabel mesh__D016908 Infection, Gram-Positive Bacterial
% 220.86/221.01  |- skos__hiddenLabel mesh__D016908 Gram Positive Bacterial Infections
% 220.86/221.01  |- skos__altLabel mesh__D016908 Infections, Gram-Positive Bacterial
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016908 2000
% 220.86/221.01  |- mesh__dateCreated mesh__D016908 1991-05-30
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016908 1998
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016908 1997
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016908 1992
% 220.86/221.01  |- skos__prefLabel mesh__D016908 Gram-Positive Bacterial Infections
% 220.86/221.01  |- mesh__historyNote mesh__D016908 92   
% 220.86/221.01  |- skos__historyNote mesh__D016908 Bacterial Infections %28%1972-1991%29%
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016908 1996
% 220.86/221.01  |- skos__hiddenLabel mesh__D016908 Infections, Gram Positive Bacterial
% 220.86/221.01  |- skos__hiddenLabel mesh__D016908 Bacterial Infections, Gram Positive
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016908 2002
% 220.86/221.01  |- skos__altLabel mesh__D016908 Bacterial Infections, Gram-Positive
% 220.86/221.01  |- skos__broader mesh__D016908smesh__D001424
% 220.86/221.01  |- skos__annotation mesh__D016908
% 220.86/221.01       GEN: avoid; prefer specifics, DF: GRAM POS BACT INFECT   
% 220.86/221.01  |- skos__scopeNote mesh__D016908
% 220.86/221.01       Infections caused by bacteria that retain the crystal violet stain %28%positive%29% when treated by the gram-staining method.%A%    
% 220.86/221.01  |- skos__historyNote mesh__D016908
% 220.86/221.01       specific bacterial infection %28%1966-1971%29%
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016908 2006
% 220.86/221.01  |- skos__broader mesh__D041301smesh__D007921
% 220.86/221.01  |- skos__annotation mesh__D041301
% 220.86/221.01       do not confuse with the seroGROUP autumnalis, sometimes termed Leptospira autumnalis %28%index LEPTOSPIRA INTERROGANS%29%; infection: coord IM with probably LEPTOSPIROSIS %28%IM%29%%A%  
% 220.86/221.01  |- mesh__dateEstablished mesh__D041301 2003-01-01
% 220.86/221.01  |- mesh__publicMeSHNote mesh__D041301 2003   
% 220.86/221.01  |- skos__historyNote mesh__D041301 Leptospira interrogans %28%1966-2002%29%
% 220.86/221.01  |- mesh__recordAuthorizer mesh__D041301 sjn
% 220.86/221.01  |- rdf__type mesh__D041301sskos__Concept
% 220.86/221.01  |- mesh__recordOriginator mesh__D041301 ags
% 220.86/221.01  |- mesh__dateRevised mesh__D041301 2005-06-30
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D041301 2006
% 220.86/221.01  |- mesh__recordMaintainer mesh__D041301 SYSTEM
% 220.86/221.01  |- skos__scopeNote mesh__D041301
% 220.86/221.01       A serovar of the bacterial species LEPTOSPIRA INTERROGANS, whose primary host is the MOUSE.%A%    
% 220.86/221.01  |- mesh__dateCreated mesh__D041301 2002-07-03
% 220.86/221.01  |- skos__prefLabel mesh__D041301 Leptospira interrogans serovar autumnalis
% 220.86/221.01  |- mesh__historyNote mesh__D041301 2003   
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D013610 2001
% 220.86/221.01  |- skos__annotation mesh__D013610
% 220.86/221.01       GEN or unspecified: prefer specific types; exercise tachycardia = HEART RATE %28%IM%29% + EXERTION %28%NIM%29%%A%  
% 220.86/221.01  |- mesh__dateCreated mesh__D013610 1999-01-01
% 220.86/221.01  |- skos__hiddenLabel mesh__D013610 Tachycardias
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D013610 2000
% 220.86/221.01  |- mesh__dateRevised mesh__D013610 1999-11-08
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D013610 2006
% 220.86/221.01  |- mesh__recordMaintainer mesh__D013610 KEV
% 220.86/221.01  |- mesh__recordOriginator mesh__D013610 NLM
% 220.86/221.01  |- skos__hiddenLabel mesh__D013610 Tachyarrhythmias
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D013610 2005
% 220.86/221.01  |- skos__prefLabel mesh__D013610 Tachycardia
% 220.86/221.01  |- rdf__type mesh__D013610sskos__Concept
% 220.86/221.01  |- skos__broader mesh__D013610smesh__D001145
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D013610 2004
% 220.86/221.01  |- mesh__recordAuthorizer mesh__D013610 sjn
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D013610 2002
% 220.86/221.01  |- skos__scopeNote mesh__D013610
% 220.86/221.01       Excessive rapidity in the action of the heart, usually with a heart rate above 100 beats per minute.%A%    
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D013610 2003
% 220.86/221.01  |- skos__hiddenLabel mesh__D004884 Eructations
% 220.86/221.01  |- mesh__dateRevised mesh__D004884 1999-11-24
% 220.86/221.01  |- rdf__type mesh__D004884sskos__Concept
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D004884 2000
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D004884 2003
% 220.86/221.01  |- skos__altLabel mesh__D004884 Belching
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D004884 2001
% 220.86/221.01  |- skos__broader mesh__D004884smesh__D012817
% 220.86/221.01  |- skos__prefLabel mesh__D004884 Eructation
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D004884 2005
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D004884 2004
% 220.86/221.01  |- mesh__dateCreated mesh__D004884 1999-01-01
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D004884 2000A
% 220.86/221.01  |- mesh__recordMaintainer mesh__D004884 ags
% 220.86/221.01  |- skos__hiddenLabel mesh__D004884 Belchings
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D004884 2006
% 220.86/221.01  |- mesh__recordAuthorizer mesh__D004884 ags
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D004884 2002
% 220.86/221.01  |- mesh__recordOriginator mesh__D004884 NLM
% 220.86/221.01  |- skos__scopeNote mesh__D004884
% 220.86/221.01       The ejection of gas or air through the mouth from the stomach.%A%    
% 220.86/221.01  |- skos__broader mesh__D012518smesh__D009210
% 220.86/221.01  |- skos__annotation mesh__D012518
% 220.86/221.01       A 11 qualif except /cytol; /genet permitted   
% 220.86/221.01  |- skos__prefLabel mesh__D012518 Sarcomeres
% 220.86/221.01  |- skos__historyNote mesh__D012518 Muscle Contraction %28%1966-1983%29%
% 220.86/221.01  |- skos__scopeNote mesh__D012518
% 220.86/221.01       The repeating contractile units of the myofibril, delimited by Z bands along its length.%A%    
% 220.86/221.01  |- mesh__dateEstablished mesh__D012518 1991-01-01
% 220.86/221.01  |- skos__historyNote mesh__D012518 Muscles %28%1966-1983%29%
% 220.86/221.01  |- mesh__recordMaintainer mesh__D012518 ags
% 220.86/221.01  |- mesh__dateCreated mesh__D012518 1983-06-15
% 220.86/221.01  |- mesh__historyNote mesh__D012518
% 220.86/221.01       91%28%84%29%; was see under MYOFIBRILS 1984-90   
% 220.86/221.01  |- mesh__publicMeSHNote mesh__D012518
% 220.86/221.01       91; was see under MYOFIBRILS 1984-90   
% 220.86/221.01  |- mesh__dateRevised mesh__D012518 2005-06-30
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D012518 2006
% 220.86/221.01  |- mesh__recordOriginator mesh__D012518 RC
% 220.86/221.01  |- mesh__recordAuthorizer mesh__D012518 sjn
% 220.86/221.01  |- rdf__type mesh__D012518sskos__Concept
% 220.86/221.01  |- skos__broader mesh__D012518smesh__D015388
% 220.86/221.01  |- skos__historyNote mesh__D012518 Myofibrils %28%1966-1983%29%
% 220.86/221.01  |- skos__hiddenLabel mesh__D012518 Sarcomere
% 220.86/221.01  |- skos__altLabel mesh__D017203 Interview
% 220.86/221.01  |- mesh__dateEstablished mesh__D017203 1996-01-01
% 220.86/221.01  |- mesh__dateCreated mesh__D017203 1995-06-23
% 220.86/221.01  |- skos__prefLabel mesh__D017203 Interview %5B%Publication Type%5D%
% 220.86/221.01  |- mesh__recordAuthorizer mesh__D017203 sjn
% 220.86/221.01  |- rdf__type mesh__D017203sskos__Concept
% 220.86/221.01  |- mesh__recordMaintainer mesh__D017203 jls
% 220.86/221.01  |- skos__altLabel mesh__D017203 Interview %28%PT%29%
% 220.86/221.01  |- skos__broader mesh__D017203smesh__D019215
% 220.86/221.01  |- mesh__recordOriginator mesh__D017203 TGC
% 220.86/221.01  |- mesh__dateRevised mesh__D017203 2005-06-30
% 220.86/221.01  |- mesh__historyNote mesh__D017203 1993   
% 220.86/221.01  |- skos__annotation mesh__D017203
% 220.86/221.01       publication type only; interviews as a subject are indexed under the main heading INTERVIEWS%A%  
% 220.86/221.01  |- skos__scopeNote mesh__D017203
% 220.86/221.01       Work consisting of a conversation with an individual regarding his or her background and other personal and professional details, opinions on specific subjects posed by the interviewer, etc.%A%    
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D017203 2006
% 220.86/221.01  |- rdf__type mesh__D050637sskos__Concept
% 220.86/221.01  |- skos__broader mesh__D050637smesh__D017448
% 220.86/221.01  |- skos__hiddenLabel mesh__D050637 D3 Receptor, Dopamine
% 220.86/221.01  |- skos__annotation mesh__D050637 see SCR for organism-specific terms   
% 220.86/221.01  |- mesh__historyNote mesh__D050637 2006%28%1987%29%   
% 220.86/221.01  |- skos__prefLabel mesh__D050637 Receptors, Dopamine D3
% 220.86/221.01  |- skos__altLabel mesh__D050637 Dopamine D3 Receptor
% 220.86/221.01  |- skos__altLabel mesh__D050637 Dopamine D3 Receptors
% 220.86/221.01  |- mesh__publicMeSHNote mesh__D050637
% 220.86/221.01       2006; RECEPTORS, DOPAMINE D3 was indexed under RECEPTORS, DOPAMINE D2 1997-2005, %26% under RECEPTORS, DOPAMINE 1987-1996%A%  
% 220.86/221.01  |- mesh__recordAuthorizer mesh__D050637 sjn
% 220.86/221.01  |- mesh__dateEstablished mesh__D050637 2006-01-01
% 220.86/221.01  |- skos__historyNote mesh__D050637 Receptors, Dopamine D2 %28%1987-2005%29%
% 220.86/221.01  |- skos__hiddenLabel mesh__D050637 Dopamine-D3 Receptor
% 220.86/221.01  |- mesh__recordOriginator mesh__D050637 DRC
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D050637 2006
% 220.86/221.01  |- skos__altLabel mesh__D050637 Receptor, Dopamine-D3
% 220.86/221.01  |- mesh__recordMaintainer mesh__D050637 DRC
% 220.86/221.01  |- mesh__dateCreated mesh__D050637 2005-06-30
% 220.86/221.01  |- skos__hiddenLabel mesh__D050637 D3 Receptors, Dopamine
% 220.86/221.01  |- skos__scopeNote mesh__D050637
% 220.86/221.01       A subtype of dopamine D2 receptors that are highly expressed in the LIMBIC SYSTEM of the brain.%A%    
% 220.86/221.01  |- skos__hiddenLabel mesh__D050637 Receptor, Dopamine D3
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D008477 2004
% 220.86/221.01  |- skos__annotation mesh__D008477 inflamm dis = MEDIASTINITIS   
% 220.86/221.01  |- mesh__publicMeSHNote mesh__D008477 66   
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D008477 2005
% 220.86/221.01  |- mesh__dateRevised mesh__D008477 1999-11-03
% 220.86/221.01  |- mesh__historyNote mesh__D008477 66   
% 220.86/221.01  |- mesh__recordAuthorizer mesh__D008477 sjn
% 220.86/221.01  |- skos__hiddenLabel mesh__D008477 Mediastinal Disease
% 220.86/221.01  |- skos__prefLabel mesh__D008477 Mediastinal Diseases
% 220.86/221.01  |- skos__scopeNote mesh__D008477
% 220.86/221.01       Disorders of the mediastinum, general or unspecified.     
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D008477 2006
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D008477 2000
% 220.86/221.01  |- mesh__dateCreated mesh__D008477 1999-01-01
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D008477 2001
% 220.86/221.01  |- skos__hiddenLabel mesh__D008477 Diseases, Mediastinal
% 220.86/221.01  |- mesh__dateEstablished mesh__D008477 1966-01-01
% 220.86/221.01  |- mesh__recordOriginator mesh__D008477 NLM
% 220.86/221.01  |- skos__broader mesh__D008477smesh__D013896
% 220.86/221.01  |- skos__hiddenLabel mesh__D008477 Disease, Mediastinal
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D008477 2002
% 220.86/221.01  |- rdf__type mesh__D008477sskos__Concept
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D008477 2003
% 220.86/221.01  |- mesh__recordMaintainer mesh__D008477 KEV
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D000494 2001
% 220.86/221.01  |- skos__annotation mesh__D000494 almost never IM; DF: ALLOSTERIC REG   
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D000494 1999
% 220.86/221.01  |- mesh__recordAuthorizer mesh__D000494 PLS
% 220.86/221.01  |- mesh__publicMeSHNote mesh__D000494
% 220.86/221.01       78; was see under BIOCHEMISTRY 1975-77   
% 220.86/221.01  |- skos__hiddenLabel mesh__D000494 Regulations, Allosteric
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D000494 2004
% 220.86/221.01  |- skos__historyNote mesh__D000494 Binding Sites %28%1968-1970%29%
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D000494 1995
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D000494 1998
% 220.86/221.01  |- skos__historyNote mesh__D000494 Chemistry %28%1966-1970%29%
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D000494 2000
% 220.86/221.01  |- skos__prefLabel mesh__D000494 Allosteric Regulation
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D000494 2003
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D000494 1994
% 220.86/221.01  |- rdf__type mesh__D000494sskos__Concept
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D000494 2006
% 220.86/221.01  |- skos__historyNote mesh__D000494 Kinetics %28%1966-1970%29%
% 220.86/221.01  |- skos__broader mesh__D000494smesh__D001669
% 220.86/221.01  |- mesh__dateRevised mesh__D000494 1992-03-25
% 220.86/221.01  |- skos__historyNote mesh__D000494 Enzyme Induction %28%1966-1970%29%
% 220.86/221.01  |- skos__historyNote mesh__D000494 Enzyme Activation %28%1969-1970%29%
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D000494 2002
% 220.86/221.01  |- mesh__recordMaintainer mesh__D000494 TAP
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D000494 2005
% 220.86/221.01  |- mesh__dateEstablished mesh__D000494 1978-01-01
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D000494 1997
% 220.86/221.01  |- mesh__dateCreated mesh__D000494 1999-01-01
% 220.86/221.01  |- skos__hiddenLabel mesh__D000494 Allosteric Regulations
% 220.86/221.01  |- mesh__recordOriginator mesh__D000494 NLM
% 220.86/221.01  |- mesh__historyNote mesh__D000494
% 220.86/221.01       78%28%71%29%; was see under BIOCHEMISTRY 1975-77   
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D000494 1993
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D000494 1996
% 220.86/221.01  |- skos__altLabel mesh__D000494 Regulation, Allosteric
% 220.86/221.01  |- mesh__dateCreated mesh__D016909 1991-05-30
% 220.86/221.01  |- skos__hiddenLabel mesh__D016909 Tibial Arteries, Posterior
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016909 1996
% 220.86/221.01  |- skos__hiddenLabel mesh__D016909 Artery, Posterior Tibial
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016909 2001
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016909 2006
% 220.86/221.01  |- mesh__historyNote mesh__D016909 92   
% 220.86/221.01  |- skos__hiddenLabel mesh__D016909 Tibial Artery, Posterior
% 220.86/221.01  |- skos__historyNote mesh__D016909 Leg/blood supply %28%1977-1991%29%
% 220.86/221.01  |- skos__hiddenLabel mesh__D016909 Tibial Artery
% 220.86/221.01  |- skos__hiddenLabel mesh__D016909 Artery, Anterior Tibial
% 220.86/221.01  |- skos__hiddenLabel mesh__D016909 Tibial Artery, Anterior
% 220.86/221.01  |- skos__prefLabel mesh__D016909 Tibial Arteries
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016909 1997
% 220.86/221.01  |- skos__hiddenLabel mesh__D016909 Anterior Tibial Arteries
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016909 1998
% 220.86/221.01  |- mesh__recordAuthorizer mesh__D016909 PLS
% 220.86/221.01  |- skos__hiddenLabel mesh__D016909 Tibial Arteries, Anterior
% 220.86/221.01  |- skos__historyNote mesh__D016909 Tibia %28%1972-1991%29%
% 220.86/221.01  |- skos__hiddenLabel mesh__D016909 Arteries, Anterior Tibial
% 220.86/221.01  |- skos__hiddenLabel mesh__D016909 Posterior Tibial Arteries
% 220.86/221.01  |- skos__hiddenLabel mesh__D016909 Arteries, Posterior Tibial
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016909 2002
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016909 1994
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016909 1999
% 220.86/221.01  |- skos__broader mesh__D016909smesh__D001158
% 220.86/221.01  |- mesh__dateEstablished mesh__D016909 1992-01-01
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016909 2003
% 220.86/221.01  |- skos__hiddenLabel mesh__D016909 Arteries, Tibial
% 220.86/221.01  |- mesh__recordMaintainer mesh__D016909 TAP
% 220.86/221.01  |- skos__hiddenLabel mesh__D016909 Artery, Tibial
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016909 1995
% 220.86/221.01  |- rdf__type mesh__D016909sskos__Concept
% 220.86/221.01  |- mesh__publicMeSHNote mesh__D016909 92   
% 220.86/221.01  |- mesh__recordOriginator mesh__D016909 MXR
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016909 1993
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016909 2004
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016909 2005
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D016909 2000
% 220.86/221.01  |- mesh__dateRevised mesh__D016909 1992-05-18
% 220.86/221.01  |- skos__scopeNote mesh__D016909
% 220.86/221.01       The anterior and posterior arteries created at the bifurcation of the popliteal artery. The anterior tibial artery begins at the lower border of the popliteus muscle and lies along the tibia at the distal part of the leg to surface superficially anterior to the ankle joint. Its branches are distributed throughout the leg, ankle, and foot. The posterior tibial artery begins at the lower border of the popliteus muscle, lies behind the tibia in the lower part of its course, and is found situated between the medial malleolus and the medial process of the calcaneal tuberosity. Its branches are distributed throughout the leg and foot.%A%    
% 220.86/221.01  |- skos__historyNote mesh__D016909 Popliteal Artery %28%1966-1991%29%
% 220.86/221.01  |- skos__annotation mesh__D013611 a supraventric tachycardia; DF: AVNRT   
% 220.86/221.01  |- mesh__recordMaintainer mesh__D013611 TGC
% 220.86/221.01  |- mesh__activeMeSHYear mesh__D013611 2000
% 220.86/221.01  |- skos__prefLabel mesh__D013611
% 220.86/221.01       Tachycardia, Atrioventricular Nodal Reentry
% 220.86/221.01  |- mesh__recordOriginator mesh__D013611 VDK
% 220.86/221.01  |- mesh__dateCreated mesh__D013611 1986-06-23
% 220.86/221.02  |- mesh__historyNote mesh__D013611
% 220.86/221.02       91%28%87%29%; was see under TACHYCARDIA, SUPRAVENTRICULAR 1987-90%A%  
% 220.86/221.02  |- skos__scopeNote mesh__D013611
% 220.86/221.02       A tachycardia characterized by rates between 150 and 250 beats per minute and a QRS complex of supraventricular origin.%A%    
% 220.86/221.02  |- mesh__publicMeSHNote mesh__D013611
% 220.86/221.02       91; was see under TACHYCARDIA, SUPRAVENTRICULAR 1987-90   
% 220.86/221.02  |- skos__altLabel mesh__D013611 Atrioventricular Nodal Reentry Tachycardia
% 220.86/221.02  |- mesh__dateEstablished mesh__D013611 1991-01-01
% 220.86/221.02  |- skos__altLabel mesh__D013611 Tachycardia, AV Nodal Reentrant
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D013611 2006
% 220.86/221.02  |- skos__historyNote mesh__D013611
% 220.86/221.02       Heart Conduction System %28%1966-1974%29%
% 220.86/221.02  |- rdf__type mesh__D013611sskos__Concept
% 220.86/221.02  |- skos__historyNote mesh__D013611 Tachycardia %28%1966-1986%29%
% 220.86/221.02  |- mesh__recordAuthorizer mesh__D013611 sjn
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D013611 2005
% 220.86/221.02  |- skos__historyNote mesh__D013611
% 220.86/221.02       Tachycardia, Paroxysmal %28%1966-1986%29%
% 220.86/221.02  |- skos__broader mesh__D013611smesh__D013617
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D013611 2002
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D013611 2004
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D013611 2001
% 220.86/221.02  |- mesh__dateRevised mesh__D013611 1999-11-03
% 220.86/221.02  |- skos__historyNote mesh__D013611 Atrioventricular Node %28%1975-1986%29%
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D013611 2003
% 220.86/221.02  |- mesh__recordOriginator mesh__D004885 NLM
% 220.86/221.02  |- skos__prefLabel mesh__D004885 Erwinia
% 220.86/221.02  |- mesh__dateCreated mesh__D004885 1999-01-01
% 220.86/221.02  |- mesh__recordAuthorizer mesh__D004885 sjn
% 220.86/221.02  |- skos__scopeNote mesh__D004885
% 220.86/221.02       A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms are associated with plants as pathogens, saprophytes, or as constituents of the epiphytic flora.%A%    
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D004885 2006
% 220.86/221.02  |- mesh__recordMaintainer mesh__D004885 SYSTEM
% 220.86/221.02  |- mesh__dateRevised mesh__D004885 2005-06-30
% 220.86/221.02  |- skos__broader mesh__D004885smesh__D004755
% 220.86/221.02  |- skos__annotation mesh__D004885
% 220.86/221.02       in plants; rarely infects humans but if so, coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 220.86/221.02  |- rdf__type mesh__D004885sskos__Concept
% 220.86/221.02  |- skos__altLabel mesh__D004087
% 220.86/221.02       Farmasan Brand of Dihydroergotamine Mesylate
% 220.86/221.02  |- skos__hiddenLabel mesh__D004087
% 220.86/221.02       ct Arzneimittel Brand of Dihydroergotamine Mesylate
% 220.86/221.02  |- skos__hiddenLabel mesh__D004087 DHE45
% 220.86/221.02  |- mesh__onlineNote mesh__D004087 search ERGOTAMINE 1966-74   
% 220.86/221.02  |- skos__broader mesh__D004087smesh__D004879
% 220.86/221.02  |- skos__altLabel mesh__D004087
% 220.86/221.02       Fujisawa Brand of Dihydroergotamine Mesylate
% 220.86/221.02  |- skos__scopeNote mesh__D004087
% 220.86/221.02       A 9,10alpha-dihydro derivative of ERGOTAMINE. It is used as a vasoconstrictor, specifically for the therapy of MIGRAINE DISORDERS.%A%    
% 220.86/221.02  |- mesh__dateEstablished mesh__D004087 1978-01-01
% 220.86/221.02  |- skos__altLabel mesh__D004087 Xcel Brand 2 of Dihydroergotamine Mesylate
% 220.86/221.02  |- mesh__recordOriginator mesh__D004087 NLM
% 220.86/221.02  |- skos__hiddenLabel mesh__D004087
% 220.86/221.02       Q Pharm Brand of Dihydroergotamine Mesylate
% 220.86/221.02  |- skos__altLabel mesh__D004087
% 220.86/221.02       Pharmafrid Brand of Dihydroergotamine Mesylate
% 220.86/221.02  |- skos__altLabel mesh__D004087 D.H.E. 45
% 220.86/221.02  |- mesh__recordAuthorizer mesh__D004087 sjn
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D004087 2006
% 220.86/221.02  |- skos__hiddenLabel mesh__D004087 Mesylate, Dihydroergotamine
% 220.86/221.02  |- skos__altLabel mesh__D004087
% 220.86/221.02       Wernigeroide Brand of Dihydroergotamine Mesylate
% 220.86/221.02  |- skos__altLabel mesh__D004087 Sanol Brand of Dihydroergotamine Mesylate
% 220.86/221.02  |- skos__altLabel mesh__D004087 IPRAD Brand of Dihydroergotamine Mesylate
% 220.86/221.02  |- skos__altLabel mesh__D004087
% 220.86/221.02       ct-Arzneimittel Brand of Dihydroergotamine Mesylate
% 220.86/221.02  |- skos__hiddenLabel mesh__D004087 D Tamin retard L.U.T.
% 220.86/221.02  |- skos__altLabel mesh__D004087 Xcel Brand 1 of Dihydroergotamine Mesylate
% 220.86/221.02  |- skos__hiddenLabel mesh__D004087 DHE ratiopharm
% 220.86/221.02  |- skos__altLabel mesh__D004087 Shire Brand of Dihydroergotamine Mesylate
% 220.86/221.02  |- skos__altLabel mesh__D004087
% 220.86/221.02       Hormosan Brand of Dihydroergotamine Mesylate
% 220.86/221.02  |- skos__historyNote mesh__D004087 Ergotamine %28%1966-1974%29%
% 220.86/221.02  |- skos__altLabel mesh__D004087 Dihydroergotamine-Sandoz
% 220.86/221.02  |- skos__altLabel mesh__D004087
% 220.86/221.02       Pierre Fabre Brand of Dihydroergotamine Mesylate
% 220.86/221.02  |- mesh__dateCreated mesh__D004087 1999-01-01
% 220.86/221.02  |- skos__altLabel mesh__D004087
% 220.86/221.02       Novartis Brand of Dihydroergotamine Mesylate
% 220.86/221.02  |- skos__altLabel mesh__D004087 Q-Pharm Brand of Dihydroergotamine Mesylate
% 220.86/221.02  |- skos__altLabel mesh__D004087 Anto Brand of Dihydroergotamine Mesylate
% 220.86/221.02  |- mesh__dateRevised mesh__D004087 2005-07-01
% 220.86/221.02  |- skos__altLabel mesh__D004087
% 220.86/221.02       ratiopharm Brand of Dihydroergotamine Mesylate
% 220.86/221.02  |- skos__prefLabel mesh__D004087 Dihydroergotamine
% 220.86/221.02  |- skos__altLabel mesh__D004087 Agit
% 220.86/221.02  |- rdf__type mesh__D004087sskos__Concept
% 220.86/221.02  |- skos__altLabel mesh__D004087 Desitin Brand of Dihydroergotamine Mesylate
% 220.86/221.02  |- skos__hiddenLabel mesh__D004087 DHE Puren
% 220.86/221.02  |- mesh__recordMaintainer mesh__D004087 sjn
% 220.86/221.02  |- skos__hiddenLabel mesh__D004087 Dihydroergotamine Sandoz
% 220.86/221.02  |- mesh__historyNote mesh__D004087
% 220.86/221.02       78%28%75%29%; was see under ERGOTAMINE 1963-77   
% 220.86/221.02  |- skos__altLabel mesh__D004087 Verla Brand of Dihydroergotamine Mesylate
% 220.86/221.02  |- skos__altLabel mesh__D004087
% 220.86/221.02       Alpharma Brand of Dihydroergotamine Mesylate
% 220.86/221.02  |- mesh__publicMeSHNote mesh__D004087
% 220.86/221.02       78; was see under ERGOTAMINE 1963-77   
% 220.86/221.02  |- skos__altLabel mesh__D004087 Schwarz Brand of Dihydroergotamine Mesylate
% 220.86/221.02  |- skos__altLabel mesh__D004087 Aliud Brand of Dihydroergotamine Mesylate
% 220.86/221.02  |- skos__hiddenLabel mesh__D004087 DHE 45
% 220.86/221.02  |- skos__hiddenLabel mesh__D004087 Methanesulfonate, Dihydroergotamine
% 220.86/221.02  |- skos__altLabel mesh__D004087 Dihydroergotamine Methanesulfonate
% 220.86/221.02  |- skos__altLabel mesh__D004087 Dihydergot
% 220.86/221.02  |- mesh__publicMeSHNote mesh__D012519 72   
% 220.86/221.02  |- mesh__recordAuthorizer mesh__D012519 sjn
% 220.86/221.02  |- skos__prefLabel mesh__D012519 Sarcoplasmic Reticulum
% 220.86/221.02  |- mesh__recordOriginator mesh__D012519 NLM
% 220.86/221.02  |- skos__hiddenLabel mesh__D012519 Reticulums, Sarcoplasmic
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D012519 2005
% 220.86/221.02  |- skos__broader mesh__D012519smesh__D018871
% 220.86/221.02  |- mesh__dateEstablished mesh__D012519 1972-01-01
% 220.86/221.02  |- skos__annotation mesh__D012519
% 220.86/221.02       A 11 qualif except /cytol; /genet permitted   
% 220.86/221.02  |- mesh__dateRevised mesh__D012519 2003-07-09
% 220.86/221.02  |- skos__hiddenLabel mesh__D012519 Reticulum, Sarcoplasmic
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D012519 2006
% 220.86/221.02  |- mesh__dateCreated mesh__D012519 1999-01-01
% 220.86/221.02  |- skos__broader mesh__D012519smesh__D018482
% 220.86/221.02  |- skos__hiddenLabel mesh__D012519 Sarcoplasmic Reticulums
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D012519 2004
% 220.86/221.02  |- skos__historyNote mesh__D012519 Endoplasmic Reticulum %28%1966-1971%29%
% 220.86/221.02  |- rdf__type mesh__D012519sskos__Concept
% 220.86/221.02  |- mesh__recordMaintainer mesh__D012519 nns
% 220.86/221.02  |- skos__scopeNote mesh__D012519
% 220.86/221.02       A network of tubules and sacs in the cytoplasm of skeletal muscles that assist with muscle contraction and relaxation by releasing and storing calcium ions.%A%    
% 220.86/221.02  |- mesh__historyNote mesh__D012519 72   
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D009570 1996
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D009570 2002
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D009570 2003
% 220.86/221.02  |- mesh__recordAuthorizer mesh__D009570 PLS
% 220.86/221.02  |- rdf__type mesh__D009570sskos__Concept
% 220.86/221.02  |- skos__scopeNote mesh__D009570
% 220.86/221.02       Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE.%A%    
% 220.86/221.02  |- mesh__dateCreated mesh__D009570 1999-01-01
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D009570 1998
% 220.86/221.02  |- skos__related mesh__D009570smesh__D003486
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D009570 1997
% 220.86/221.02  |- mesh__recordOriginator mesh__D009570 NLM
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D009570 2005
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D009570 2004
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D009570 1994
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D009570 2000
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D009570 1999
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D009570 2006
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D009570 1995
% 220.86/221.02  |- skos__broader mesh__D009570smesh__D009930
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D009570 2001
% 220.86/221.02  |- mesh__historyNote mesh__D009570 68; was see under CYANIDES 1963-67   
% 220.86/221.02  |- skos__historyNote mesh__D009570 Cyanides %28%1966-1967%29%
% 220.86/221.02  |- skos__annotation mesh__D009570
% 220.86/221.02       organic cpds having -CN radical: differentiate from CYANIDES which are inorganic with -CN%A%  
% 220.86/221.02  |- mesh__publicMeSHNote mesh__D009570 68; was see under CYANIDES 1963-67   
% 220.86/221.02  |- mesh__dateEstablished mesh__D009570 1968-01-01
% 220.86/221.02  |- mesh__onlineNote mesh__D009570
% 220.86/221.02       use CYANIDES to search NITRILES 1966-67   
% 220.86/221.02  |- mesh__recordMaintainer mesh__D009570 TPW
% 220.86/221.02  |- mesh__dateRevised mesh__D009570 1993-06-04
% 220.86/221.02  |- skos__prefLabel mesh__D009570 Nitriles
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D023241 2003
% 220.86/221.02  |- skos__broader mesh__D023241smesh__D004359
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D023241 2005
% 220.86/221.02  |- mesh__historyNote mesh__D023241 2001   
% 220.86/221.02  |- mesh__dateRevised mesh__D023241 2002-07-02
% 220.86/221.02  |- mesh__publicMeSHNote mesh__D023241 2001   
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D023241 2004
% 220.86/221.02  |- skos__altLabel mesh__D023241 HAART
% 220.86/221.02  |- mesh__recordOriginator mesh__D023241 ags
% 220.86/221.02  |- mesh__recordAuthorizer mesh__D023241 sjn
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D023241 2006
% 220.86/221.02  |- skos__scopeNote mesh__D023241
% 220.86/221.02       Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor.%A%    
% 220.86/221.02  |- skos__historyNote mesh__D023241
% 220.86/221.02       Anti-HIV Agents/therapeutic use %28%1997-2000%29%
% 220.86/221.02  |- rdf__type mesh__D023241sskos__Concept
% 220.86/221.02  |- skos__altLabel mesh__D023241 Highly Active Antiretroviral Therapy
% 220.86/221.02  |- skos__prefLabel mesh__D023241 Antiretroviral Therapy, Highly Active
% 220.86/221.02  |- mesh__recordMaintainer mesh__D023241 mdb
% 220.86/221.02  |- skos__related mesh__D023241smesh__D019380
% 220.86/221.02  |- mesh__dateEstablished mesh__D023241 2001-01-01
% 220.86/221.02  |- skos__annotation mesh__D023241
% 220.86/221.02       IM when general; NIM when with specific drugs   
% 220.86/221.02  |- skos__historyNote mesh__D023241
% 220.86/221.02       Drug Therapy, Combination %28%1997-2000%29%
% 220.86/221.02  |- mesh__dateCreated mesh__D023241 2000-06-21
% 220.86/221.02  |- skos__historyNote mesh__D017204 Movement Disorders %28%1967-1992%29%
% 220.86/221.02  |- mesh__dateRevised mesh__D017204 2001-07-25
% 220.86/221.02  |- skos__hiddenLabel mesh__D017204 Syndrome, Angelman
% 220.86/221.02  |- rdf__type mesh__D017204sskos__Concept
% 220.86/221.02  |- skos__hiddenLabel mesh__D017204 Children, Puppet
% 220.86/221.02  |- mesh__dateCreated mesh__D017204 1992-05-07
% 220.86/221.02  |- skos__broader mesh__D017204smesh__D000015
% 220.86/221.02  |- skos__historyNote mesh__D017204 Ataxia %28%1972-1992%29%
% 220.86/221.02  |- mesh__publicMeSHNote mesh__D017204 93   
% 220.86/221.02  |- mesh__dateEstablished mesh__D017204 1993-01-01
% 220.86/221.02  |- skos__historyNote mesh__D017204 Mental Disorders %28%1967-1992%29%
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D017204 2002
% 220.86/221.02  |- mesh__recordAuthorizer mesh__D017204 sjn
% 220.86/221.02  |- mesh__historyNote mesh__D017204 93   
% 220.86/221.02  |- skos__prefLabel mesh__D017204 Angelman Syndrome
% 220.86/221.02  |- skos__scopeNote mesh__D017204
% 220.86/221.02       A syndrome characterized by multiple abnormalities, MENTAL RETARDATION, and movement disorders. Present usually are skull and other abnormalities, frequent infantile spasms %28%SPASMS, INFANTILE%29%; easily provoked and prolonged paroxysms of laughter %28%hence %22%happy%22%%29%; jerky puppetlike movements %28%hence %22%puppet%22%%29%; continuous tongue protrusion; motor retardation; ATAXIA; MUSCLE HYPOTONIA; and a peculiar facies. It is associated with maternal deletions of chromosome 15q11-13 and other genetic abnormalities. %28%From Am J Med Genet 1998 Dec 4;80%28%4%29%:385-90; Hum Mol Genet 1999 Jan;8%28%1%29%:129-35%29%%A%    
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D017204 2005
% 220.86/221.02  |- mesh__recordMaintainer mesh__D017204 nns
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D017204 2006
% 220.86/221.02  |- skos__altLabel mesh__D017204 Puppet Children
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D017204 2003
% 220.86/221.02  |- skos__broader mesh__D017204smesh__D009069
% 220.86/221.02  |- skos__altLabel mesh__D017204 Happy Puppet Syndrome
% 220.86/221.02  |- mesh__recordOriginator mesh__D017204 TGC
% 220.86/221.02  |- skos__hiddenLabel mesh__D017204 Syndrome, Happy Puppet
% 220.86/221.02  |- skos__related mesh__D017204smesh__D008607
% 220.86/221.02  |- skos__broader mesh__D017204smesh__D025063
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D017204 2004
% 220.86/221.02  |- skos__altLabel mesh__D050638 Dopamine D4 Receptor
% 220.86/221.02  |- skos__altLabel mesh__D050638 Receptor, Dopamine D4
% 220.86/221.02  |- mesh__recordMaintainer mesh__D050638 DRC
% 220.86/221.02  |- skos__altLabel mesh__D050638 Dopamine D4 Receptors
% 220.86/221.02  |- skos__hiddenLabel mesh__D050638 D4 Receptors, Dopamine
% 220.86/221.02  |- mesh__publicMeSHNote mesh__D050638
% 220.86/221.02       2006; RECEPTORS, DOPAMINE D4 was indexed under RECEPTORS, DOPAMINE D2 2005, %26% under RECEPTORS, DOPAMINE 1991-2004%A%  
% 220.86/221.02  |- mesh__dateCreated mesh__D050638 2005-06-30
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D050638 2006
% 220.86/221.02  |- mesh__recordOriginator mesh__D050638 DRC
% 220.86/221.02  |- skos__scopeNote mesh__D050638
% 220.86/221.02       A subtype of dopamine D2 receptors that has high affinity for the antipsychotic CLOZAPINE.%A%    
% 220.86/221.02  |- skos__hiddenLabel mesh__D050638 D4 Receptor, Dopamine
% 220.86/221.02  |- skos__annotation mesh__D050638 see SCR for organism-specific terms   
% 220.86/221.02  |- skos__prefLabel mesh__D050638 Receptors, Dopamine D4
% 220.86/221.02  |- rdf__type mesh__D050638sskos__Concept
% 220.86/221.02  |- skos__broader mesh__D050638smesh__D017448
% 220.86/221.02  |- skos__historyNote mesh__D050638 Receptors, Dopamine D2 %28%1991-2005%29%
% 220.86/221.02  |- mesh__dateEstablished mesh__D050638 2006-01-01
% 220.86/221.02  |- mesh__recordAuthorizer mesh__D050638 sjn
% 220.86/221.02  |- mesh__historyNote mesh__D050638 2006%28%1991%29%   
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D008478 2004
% 220.86/221.02  |- mesh__recordOriginator mesh__D008478 NLM
% 220.86/221.02  |- skos__hiddenLabel mesh__D008478 Mediastinal Emphysemas
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D008478 2003
% 220.86/221.02  |- skos__altLabel mesh__D008478 Emphysema, Mediastinal
% 220.86/221.02  |- mesh__dateCreated mesh__D008478 1999-01-01
% 220.86/221.02  |- skos__hiddenLabel mesh__D008478 Emphysemas, Mediastinal
% 220.86/221.02  |- skos__broader mesh__D008478smesh__D008477
% 220.86/221.02  |- mesh__recordMaintainer mesh__D008478 KEV
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D008478 2002
% 220.86/221.02  |- skos__altLabel mesh__D008478 Pneumomediastinum
% 220.86/221.02  |- skos__prefLabel mesh__D008478 Mediastinal Emphysema
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D008478 2006
% 220.86/221.02  |- mesh__recordAuthorizer mesh__D008478 sjn
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D008478 2001
% 220.86/221.02  |- skos__scopeNote mesh__D008478
% 220.86/221.02       Presence of air in the mediastinal tissues due to leakage of air from the tracheobronchial tree, usually as a result of trauma.%A%    
% 220.86/221.02  |- mesh__dateRevised mesh__D008478 1999-11-03
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D008478 2005
% 220.86/221.02  |- skos__annotation mesh__D008478
% 220.86/221.02       do not confuse with radiogr pneumomediastinum %28% = PNEUMOMEDIASTINUM, DIAGNOSTIC%29%%A%  
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D008478 2000
% 220.86/221.02  |- skos__broader mesh__D008478smesh__D004646
% 220.86/221.02  |- rdf__type mesh__D008478sskos__Concept
% 220.86/221.02  |- skos__scopeNote mesh__D000495
% 220.86/221.02       A site on an enzyme which upon binding of a modulator, causes the protein to undergo a conformational change that may alter the catalytic or binding properties of the enzyme.%A%    
% 220.86/221.02  |- mesh__recordOriginator mesh__D000495 NLM
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D000495 2003
% 220.86/221.02  |- rdf__type mesh__D000495sskos__Concept
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D000495 2001
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D000495 2006
% 220.86/221.02  |- mesh__dateEstablished mesh__D000495 1991-01-01
% 220.86/221.02  |- mesh__recordMaintainer mesh__D000495 adp
% 220.86/221.02  |- mesh__onlineNote mesh__D000495 search BINDING SITES 1968-74   
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D000495 2005
% 220.86/221.02  |- skos__hiddenLabel mesh__D000495 Sites, Allosteric
% 220.86/221.02  |- mesh__dateCreated mesh__D000495 1999-01-01
% 220.86/221.02  |- skos__prefLabel mesh__D000495 Allosteric Site
% 220.86/221.02  |- skos__broader mesh__D000495smesh__D001665
% 220.86/221.02  |- skos__hiddenLabel mesh__D000495 Site, Allosteric
% 220.86/221.02  |- mesh__dateRevised mesh__D000495 2000-06-21
% 220.86/221.02  |- mesh__publicMeSHNote mesh__D000495
% 220.86/221.02       91; was see under BINDING SITES 1975-90   
% 220.86/221.02  |- skos__hiddenLabel mesh__D000495 Allosteric Sites
% 220.86/221.02  |- mesh__historyNote mesh__D000495
% 220.86/221.02       91%28%75%29%; was see under BINDING SITES 1975-90   
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D000495 2002
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D000495 2004
% 220.86/221.02  |- mesh__recordAuthorizer mesh__D000495 sjn
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D005180 2005
% 220.86/221.02  |- mesh__publicMeSHNote mesh__D005180 66   
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D005180 1997
% 220.86/221.02  |- mesh__dateCreated mesh__D005180 1999-01-01
% 220.86/221.02  |- mesh__dateEstablished mesh__D005180 1966-01-01
% 220.86/221.02  |- mesh__dateRevised mesh__D005180 1996-06-10
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D005180 2002
% 220.86/221.02  |- rdf__type mesh__D005180sskos__Concept
% 220.86/221.02  |- skos__altLabel mesh__D005180 Medical Faculties
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D005180 2004
% 220.86/221.02  |- skos__annotation mesh__D005180
% 220.86/221.02       Manual 30.9; see also note under FACULTY; DF: FACULTY MED%A%  
% 220.86/221.02  |- skos__altLabel mesh__D005180 Faculties, Medical
% 220.86/221.02  |- skos__broader mesh__D005180smesh__D006282
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D005180 2003
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D005180 1999
% 220.86/221.02  |- mesh__historyNote mesh__D005180 66   
% 220.86/221.02  |- skos__broader mesh__D005180smesh__D005178
% 220.86/221.02  |- mesh__recordOriginator mesh__D005180 NLM
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D005180 2001
% 220.86/221.02  |- mesh__recordAuthorizer mesh__D005180 PLS
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D005180 1998
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D005180 2006
% 220.86/221.02  |- skos__scopeNote mesh__D005180
% 220.86/221.02       The teaching staff and members of the administrative staff having academic rank in a medical school.%A%    
% 220.86/221.02  |- skos__altLabel mesh__D005180 Medical Faculty
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D005180 2000
% 220.86/221.02  |- mesh__recordMaintainer mesh__D005180 TGC
% 220.86/221.02  |- skos__prefLabel mesh__D005180 Faculty, Medical
% 220.86/221.02  |- skos__hiddenLabel mesh__D013612 Atrial Tachycardia, Ectopic
% 220.86/221.02  |- mesh__recordAuthorizer mesh__D013612 sjn
% 220.86/221.02  |- mesh__historyNote mesh__D013612
% 220.86/221.02       91%28%87%29%; was see under TACHYCARDIA, SUPRAVENTRICULAR 1987-90%A%  
% 220.86/221.02  |- skos__hiddenLabel mesh__D013612 Tachycardia, Atrial Ectopic
% 220.86/221.02  |- skos__hiddenLabel mesh__D013612 Atrial Tachycardias, Ectopic
% 220.86/221.02  |- skos__hiddenLabel mesh__D013612 Ectopic Tachycardias, Atrial
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D013612 2000
% 220.86/221.02  |- skos__hiddenLabel mesh__D013612 Ectopic Atrial Tachycardias
% 220.86/221.02  |- skos__hiddenLabel mesh__D013612 Atrial Ectopic Tachycardias
% 220.86/221.02  |- skos__scopeNote mesh__D013612
% 220.86/221.02       A tachycardia originating in the atrial myocardium and characterized by rates between 135 and 175 beats per minute.%A%    
% 220.86/221.02  |- skos__hiddenLabel mesh__D013612 Tachycardias, Ectopic Atrial
% 220.86/221.02  |- mesh__dateCreated mesh__D013612 1986-06-23
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D013612 2005
% 220.86/221.02  |- skos__altLabel mesh__D013612 Atrial Ectopic Tachycardia
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D013612 2001
% 220.86/221.02  |- skos__annotation mesh__D013612 a supraventric tachycardia   
% 220.86/221.02  |- skos__hiddenLabel mesh__D013612 Tachycardias, Atrial Ectopic
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D013612 2006
% 220.86/221.02  |- mesh__dateRevised mesh__D013612 1999-11-03
% 220.86/221.02  |- skos__prefLabel mesh__D013612 Tachycardia, Ectopic Atrial
% 220.86/221.02  |- rdf__type mesh__D013612sskos__Concept
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D013612 2003
% 220.86/221.02  |- skos__altLabel mesh__D013612 Ectopic Atrial Tachycardia
% 220.86/221.02  |- skos__historyNote mesh__D013612 Tachycardia %28%1966-1986%29%
% 220.86/221.02  |- skos__hiddenLabel mesh__D013612 Ectopic Tachycardia, Atrial
% 220.86/221.02  |- mesh__recordOriginator mesh__D013612 VDK
% 220.86/221.02  |- skos__broader mesh__D013612smesh__D013617
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D013612 2002
% 220.86/221.02  |- mesh__publicMeSHNote mesh__D013612
% 220.86/221.02       91; was see under TACHYCARDIA, SUPRAVENTRICULAR 1987-90   
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D013612 2004
% 220.86/221.02  |- mesh__recordMaintainer mesh__D013612 TGC
% 220.86/221.02  |- mesh__dateEstablished mesh__D013612 1991-01-01
% 220.86/221.02  |- skos__historyNote mesh__D013612 Heart Atrium %28%1966-1986%29%
% 220.86/221.02  |- skos__broader mesh__D004886smesh__D017192
% 220.86/221.02  |- skos__broader mesh__D004886smesh__D013290
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D004886 1999
% 220.86/221.02  |- rdf__type mesh__D004886sskos__Concept
% 220.86/221.02  |- mesh__dateRevised mesh__D004886 1994-02-08
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D004886 2001
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D004886 1995
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D004886 1998
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D004886 2004
% 220.86/221.02  |- mesh__recordMaintainer mesh__D004886 PXP
% 220.86/221.02  |- mesh__recordAuthorizer mesh__D004886 PLS
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D004886 2000
% 220.86/221.02  |- mesh__recordOriginator mesh__D004886 NLM
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D004886 2003
% 220.86/221.02  |- skos__scopeNote mesh__D004886
% 220.86/221.02       An acute infection of the skin caused by species of STREPTOCOCCUS. This disease most frequently affects infants, young children, and the elderly. Characteristics include pink-to-red lesions that spread rapidly and are warm to the touch. The commonest site of involvement is the face.%A%    
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D004886 2006
% 220.86/221.02  |- mesh__dateCreated mesh__D004886 1999-01-01
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D004886 2002
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D004886 1997
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D004886 2005
% 220.86/221.02  |- skos__prefLabel mesh__D004886 Erysipelas
% 220.86/221.02  |- skos__annotation mesh__D004886
% 220.86/221.02       Strep skin dis; do not confuse with ERYSIPELOID, caused by Erysipelothrix; do not confuse with SWINE ERYSIPELAS, also an Erysipelothrix infection%A%  
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D004886 1996
% 220.86/221.02  |- rdf__type mesh__D004088sskos__Concept
% 220.86/221.02  |- mesh__historyNote mesh__D004088
% 220.86/221.02       1977%28%1975%29%; for ERGOT ALKALOIDS, HYDROGENATED use ERGOLOID MESYLATES 1992-2001%A%  
% 220.86/221.02  |- mesh__dateEstablished mesh__D004088 1977-01-01
% 220.86/221.02  |- mesh__publicMeSHNote mesh__D004088
% 220.86/221.02       1977; see ERGOT ALKALOIDS HYDROGENATED 1975-1976; for ERGOT ALKALOIDS, HYDROGENATED see ERGOLOID MESYLATES 1992-2001%A%  
% 220.86/221.02  |- mesh__recordAuthorizer mesh__D004088 ags
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D004088 2006
% 220.86/221.02  |- skos__altLabel mesh__D004088 Dihydroergotoxin
% 220.86/221.02  |- skos__related mesh__D004088smesh__D025441
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D004088 2006A
% 220.86/221.02  |- mesh__dateRevised mesh__D004088 2005-07-13
% 220.86/221.02  |- mesh__dateCreated mesh__D004088 1974-11-27
% 220.86/221.02  |- skos__historyNote mesh__D004088 Ergot Mesylates %28%1973-1974%29%
% 220.86/221.02  |- skos__related mesh__D004088smesh__D025442
% 220.86/221.02  |- mesh__recordOriginator mesh__D004088 NLM
% 220.86/221.02  |- skos__scopeNote mesh__D004088
% 220.86/221.02       A mixture of three different hydrogenated derivatives of ERGOTAMINE: DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and DIHYDROERGOCRYPTINE. Dihydroergotoxine has been proposed to be a neuroprotective agent and a nootropic agent. The mechanism of its therapeutic actions is not clear, but it can act as an alpha-adrenergic antagonist and a dopamine agonist. The methanesulfonate salts of this mixture of alkaloids are called ERGOLOID MESYLATES.%A%    
% 220.86/221.02  |- skos__altLabel mesh__D004088 Co-Dergocrine
% 220.86/221.02  |- skos__related mesh__D004088smesh__D025443
% 220.86/221.02  |- skos__broader mesh__D004088smesh__D004879
% 220.86/221.02  |- skos__hiddenLabel mesh__D004088 Hydrogenated Ergot Alkaloids
% 220.86/221.02  |- skos__hiddenLabel mesh__D004088 Alkaloids, Hydrogenated Ergot
% 220.86/221.02  |- mesh__recordMaintainer mesh__D004088 ags
% 220.86/221.02  |- skos__prefLabel mesh__D004088 Dihydroergotoxine
% 220.86/221.02  |- mesh__historyNote mesh__D009571
% 220.86/221.02       91%28%73%29%; was see under ACETIC ACIDS 1973-90   
% 220.86/221.02  |- skos__hiddenLabel mesh__D009571 Acid, Nitrilotriacetic
% 220.86/221.02  |- mesh__dateRevised mesh__D009571 1998-06-10
% 220.86/221.02  |- mesh__dateEstablished mesh__D009571 1991-01-01
% 220.86/221.02  |- skos__broader mesh__D009571smesh__D000088
% 220.86/221.02  |- skos__hiddenLabel mesh__D009571 Nitrilotriacetate, Aluminum
% 220.86/221.02  |- skos__scopeNote mesh__D009571
% 220.86/221.02       A derivative of acetic acid, N%28%CH2COOH%29%3. It is a complexing %28%sequestering%29% agent that forms stable complexes with Zn2+. %28%From Miall%27%s Dictionary of Chemistry, 5th ed.%29%%A%    
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D009571 2001
% 220.86/221.02  |- mesh__recordAuthorizer mesh__D009571 SJN
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D009571 2004
% 220.86/221.02  |- rdf__type mesh__D009571sskos__Concept
% 220.86/221.02  |- mesh__publicMeSHNote mesh__D009571
% 220.86/221.02       91; was see under ACETIC ACIDS 1973-90   
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D009571 2000
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D009571 2003
% 220.86/221.02  |- mesh__dateCreated mesh__D009571 1999-01-01
% 220.86/221.02  |- skos__hiddenLabel mesh__D009571 Nitrilotriacetate, Trisodium
% 220.86/221.02  |- mesh__recordMaintainer mesh__D009571 ADP
% 220.86/221.02  |- mesh__recordOriginator mesh__D009571 NLM
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D009571 1999
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D009571 2006
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D009571 2002
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D009571 2005
% 220.86/221.02  |- skos__hiddenLabel mesh__D009571 Nitrilotriacetate, Dysprosium
% 220.86/221.02  |- skos__prefLabel mesh__D009571 Nitrilotriacetic Acid
% 220.86/221.02  |- skos__altLabel mesh__D017205 Infections, Spirurida
% 220.86/221.02  |- mesh__historyNote mesh__D017205 93; HABRONEMIASIS was heading 1968-92   
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D017205 2005
% 220.86/221.02  |- mesh__recordOriginator mesh__D017205 PXP
% 220.86/221.02  |- skos__prefLabel mesh__D017205 Spirurida Infections
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D017205 2006
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D017205 2003
% 220.86/221.02  |- skos__hiddenLabel mesh__D017205 Spirurida Infection
% 220.86/221.02  |- mesh__dateRevised mesh__D017205 2001-07-25
% 220.86/221.02  |- skos__hiddenLabel mesh__D017205 Habronemiases
% 220.86/221.02  |- skos__broader mesh__D017205smesh__D017190
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D017205 2004
% 220.86/221.02  |- mesh__dateEstablished mesh__D017205 1993-01-01
% 220.86/221.02  |- mesh__onlineNote mesh__D017205
% 220.86/221.02       use SPIRURIDA INFECTIONS to search HABRONEMIASIS 1968-92   
% 220.86/221.02  |- rdf__type mesh__D017205sskos__Concept
% 220.86/221.02  |- mesh__activeMeSHYear mesh__D017205 2002
% 220.86/221.03  |- skos__scopeNote mesh__D017205
% 220.86/221.03       Infections with nematodes of the order SPIRURIDA.     
% 220.86/221.03  |- mesh__recordAuthorizer mesh__D017205 sjn
% 220.86/221.03  |- mesh__recordMaintainer mesh__D017205 ags
% 220.86/221.03  |- mesh__dateCreated mesh__D017205 1992-05-22
% 220.86/221.03  |- skos__hiddenLabel mesh__D017205 Infection, Spirurida
% 220.86/221.03  |- mesh__publicMeSHNote mesh__D017205
% 220.86/221.03       93; HABRONEMIASIS was heading 1968-92   
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D008479 2003
% 220.86/221.03  |- skos__hiddenLabel mesh__D008479 Cancers, Mediastinum
% 220.86/221.03  |- skos__scopeNote mesh__D008479 Tumors or cancer of the MEDIASTINUM.     
% 220.86/221.03  |- mesh__dateCreated mesh__D008479 1999-01-01
% 220.86/221.03  |- skos__broader mesh__D008479smesh__D008477
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D008479 2000
% 220.86/221.03  |- mesh__recordMaintainer mesh__D008479 KEV
% 220.86/221.03  |- skos__hiddenLabel mesh__D008479 Mediastinal Cancers
% 220.86/221.03  |- skos__hiddenLabel mesh__D008479 Cancers, Mediastinal
% 220.86/221.03  |- skos__hiddenLabel mesh__D008479 Mediastinum Neoplasm
% 220.86/221.03  |- mesh__recordOriginator mesh__D008479 NLM
% 220.86/221.03  |- skos__altLabel mesh__D008479 Cancer of the Mediastinum
% 220.86/221.03  |- skos__hiddenLabel mesh__D008479 Cancer, Mediastinal
% 220.86/221.03  |- skos__altLabel mesh__D008479 Mediastinum Cancer
% 220.86/221.03  |- skos__hiddenLabel mesh__D008479 Mediastinum Cancers
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D008479 2006
% 220.86/221.03  |- skos__prefLabel mesh__D008479 Mediastinal Neoplasms
% 220.86/221.03  |- skos__hiddenLabel mesh__D008479 Neoplasm, Mediastinal
% 220.86/221.03  |- mesh__dateRevised mesh__D008479 1999-11-08
% 220.86/221.03  |- skos__altLabel mesh__D008479 Mediastinum Neoplasms
% 220.86/221.03  |- skos__annotation mesh__D008479
% 220.86/221.03       coord IM with histol type of neopl %28%IM%29%   
% 220.86/221.03  |- skos__altLabel mesh__D008479 Mediastinal Cancer
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D008479 2005
% 220.86/221.03  |- skos__hiddenLabel mesh__D008479 Neoplasms, Mediastinum
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D008479 2002
% 220.86/221.03  |- rdf__type mesh__D008479sskos__Concept
% 220.86/221.03  |- skos__broader mesh__D008479smesh__D013899
% 220.86/221.03  |- skos__hiddenLabel mesh__D008479 Cancer, Mediastinum
% 220.86/221.03  |- skos__hiddenLabel mesh__D008479 Neoplasm, Mediastinum
% 220.86/221.03  |- mesh__recordAuthorizer mesh__D008479 sjn
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D008479 2004
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D008479 2001
% 220.86/221.03  |- skos__hiddenLabel mesh__D008479 Mediastinal Neoplasm
% 220.86/221.03  |- skos__altLabel mesh__D008479 Neoplasms, Mediastinal
% 220.86/221.03  |- skos__prefLabel mesh__D000496 Alloxan
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D000496 2005
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D000496 1997
% 220.86/221.03  |- mesh__dateRevised mesh__D000496 1992-05-07
% 220.86/221.03  |- mesh__dateCreated mesh__D000496 1999-01-01
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D000496 2002
% 220.86/221.03  |- mesh__recordMaintainer mesh__D000496 TAP
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D000496 1993
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D000496 1996
% 220.86/221.03  |- mesh__recordOriginator mesh__D000496 NLM
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D000496 1999
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D000496 2004
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D000496 1995
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D000496 2001
% 220.86/221.03  |- mesh__recordAuthorizer mesh__D000496 PLS
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D000496 1998
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D000496 2003
% 220.86/221.03  |- skos__broader mesh__D000496smesh__D011744
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D000496 1994
% 220.86/221.03  |- rdf__type mesh__D000496sskos__Concept
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D000496 2000
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D000496 2006
% 220.86/221.03  |- skos__annotation mesh__D000496
% 220.86/221.03       ALLOXAN DIABETES indexed as DIABETES MELLITUS, EXPERIMENTAL %28%IM%29% + ALLOXAN %28%NIM%29% only if chem is particularly discussed%A%  
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D005181 2004
% 220.86/221.03  |- skos__annotation mesh__D005181 Manual 30.9; DF: FACULTY NURS   
% 220.86/221.03  |- mesh__historyNote mesh__D005181 66   
% 220.86/221.03  |- skos__altLabel mesh__D005181 Faculties, Nursing
% 220.86/221.03  |- skos__scopeNote mesh__D005181
% 220.86/221.03       The teaching staff and members of the administrative staff having academic rank in a nursing school.%A%    
% 220.86/221.03  |- mesh__recordOriginator mesh__D005181 NLM
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D005181 2001
% 220.86/221.03  |- mesh__recordAuthorizer mesh__D005181 PLS
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D005181 2003
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D005181 1999
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D005181 2000
% 220.86/221.03  |- skos__broader mesh__D005181smesh__D005178
% 220.86/221.03  |- skos__altLabel mesh__D005181 Nursing Faculties
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D005181 1998
% 220.86/221.03  |- skos__altLabel mesh__D005181 Nursing Faculty
% 220.86/221.03  |- skos__prefLabel mesh__D005181 Faculty, Nursing
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D005181 2006
% 220.86/221.03  |- mesh__dateEstablished mesh__D005181 1966-01-01
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D005181 2005
% 220.86/221.03  |- mesh__publicMeSHNote mesh__D005181 66   
% 220.86/221.03  |- mesh__recordMaintainer mesh__D005181 TAP
% 220.86/221.03  |- mesh__dateRevised mesh__D005181 1996-06-10
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D005181 2002
% 220.86/221.03  |- skos__broader mesh__D005181smesh__D006282
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D005181 1997
% 220.86/221.03  |- mesh__dateCreated mesh__D005181 1999-01-01
% 220.86/221.03  |- rdf__type mesh__D005181sskos__Concept
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D013613 2002
% 220.86/221.03  |- skos__hiddenLabel mesh__D013613 Ectopic Tachycardia, Junctional
% 220.86/221.03  |- mesh__publicMeSHNote mesh__D013613
% 220.86/221.03       91; was see under TACHYCARDIA, SUPRAVENTRICULAR 1987-90   
% 220.86/221.03  |- mesh__dateCreated mesh__D013613 1986-06-23
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D013613 2005
% 220.86/221.03  |- skos__hiddenLabel mesh__D013613 Junctional Tachycardias, Ectopic
% 220.86/221.03  |- skos__annotation mesh__D013613 a supraventric tachycardia   
% 220.86/221.03  |- mesh__recordAuthorizer mesh__D013613 sjn
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D013613 2006
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D013613 2000
% 220.86/221.03  |- rdf__type mesh__D013613sskos__Concept
% 220.86/221.03  |- skos__hiddenLabel mesh__D013613 Ectopic Tachycardias, Junctional
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D013613 2003
% 220.86/221.03  |- skos__hiddenLabel mesh__D013613 Tachycardias, Ectopic Junctional
% 220.86/221.03  |- skos__altLabel mesh__D013613 Junctional Ectopic Tachycardia
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D013613 2001
% 220.86/221.03  |- mesh__recordMaintainer mesh__D013613 TGC
% 220.86/221.03  |- mesh__activeMeSHYear mesh__D013613 2004
% 220.86/221.03  |- mesh__dateEstablished mesh__D013613 1991-01-01
% 220.86/221.03  |- skos__hiddenLabel mesh__D013613 Tachycardia, Junctional Ectopic
% 220.86/221.03  |- mesh__dateRevised mesh__D013613 1999-11-03
% 220.86/221.03  |- skos__prefLabel mesh__D013613 Tachycardia, Ectopic Junctional
% 220.86/221.03  |- skos__historyNote mesh__D013613 Atrioventricular Node %28%1975-1986%29%
% 220.86/221.03  |- skos__hiddenLabel mesh__D013613 Junctional Tachycardia, Ectopic
% 220.86/221.06  |- skos__hiddenLabel mesh__D013613 Tachycardias, Junctional Ectopic
% 220.86/221.06  |- skos__scopeNote mesh__D013613
% 220.86/221.06       A tachycardia arising in the conduction tissues surrounding the atrioventricular node. It usually occurs during myocardial infarction, after heart surgery, or in digitalis intoxication. The rate may range from 140 to 250 beats per minute.%A%    
% 220.86/221.06  |- mesh__historyNote mesh__D013613
% 220.86/221.06       91%28%87%29%; was see under TACHYCARDIA, SUPRAVENTRICULAR 1987-90%A%  
% 220.86/221.06  |- skos__hiddenLabel mesh__D013613 Ectopic Junctional Tachycardias
% 220.86/221.06  |- skos__historyNote mesh__D013613 Tachycardia %28%1966-1986%29%
% 220.86/221.06  |- mesh__recordOriginator mesh__D013613 VDK
% 220.86/221.06  |- skos__broader mesh__D013613smesh__D013617
% 220.86/221.06  |- skos__historyNote mesh__D013613
% 220.86/221.06       Heart Conduction System %28%1966-1986%29%
% 220.86/221.06  |- skos__hiddenLabel mesh__D013613 Junctional Ectopic Tachycardias
% 220.86/221.06  |- skos__altLabel mesh__D013613 Ectopic Junctional Tachycardia
% 220.86/221.06  |- rdf__type mesh__D004887sskos__Concept
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D004887 1995
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D004887 1998
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D004887 2004
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D004887 1994
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D004887 2003
% 220.86/221.06  |- skos__hiddenLabel mesh__D004887 Erysipeloids
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D004887 2001
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D004887 2006
% 220.86/221.06  |- skos__prefLabel mesh__D004887 Erysipeloid
% 220.86/221.06  |- mesh__dateCreated mesh__D004887 1999-01-01
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D004887 1997
% 220.86/221.06  |- mesh__recordMaintainer mesh__D004887 PXP
% 220.86/221.06  |- mesh__recordAuthorizer mesh__D004887 PLS
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D004887 2000
% 220.86/221.06  |- mesh__recordOriginator mesh__D004887 NLM
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D004887 2005
% 220.86/221.06  |- skos__broader mesh__D004887smesh__D004889
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D004887 1993
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D004887 1996
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D004887 1999
% 220.86/221.06  |- skos__scopeNote mesh__D004887
% 220.86/221.06       An infection caused by Erysipelothrix rhusiopathiae that is almost wholly restricted to persons who in their occupation handle infected fish, shellfish, poultry, or meat. Three forms of this condition exist: a mild localized form manifested by local swelling and redness of the skin; a diffuse form that might present with fever; and a rare systemic form associated with endocarditis.%A%    
% 220.86/221.06  |- skos__annotation mesh__D004887
% 220.86/221.06       caused by the bacterium Erysipelothrix; do not confuse with ERYSIPELAS, caused by a Streptococcus%A%  
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D004887 1992
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D004887 2002
% 220.86/221.06  |- mesh__dateRevised mesh__D004887 1991-06-12
% 220.86/221.06  |- skos__hiddenLabel mesh__D037263 Carbohydrate-Binding Protein, Liver
% 220.86/221.06  |- skos__historyNote mesh__D037263
% 220.86/221.06       Receptors, Cell Surface %28%1980-2002%29%
% 220.86/221.06  |- skos__hiddenLabel mesh__D037263 Asialoglycoprotein Receptor, Hepatic
% 220.86/221.06  |- skos__hiddenLabel mesh__D037263 Receptors, Asialoglycoprotein
% 220.86/221.06  |- skos__altLabel mesh__D037263 Asialoorosomucoid-Binding Protein
% 220.86/221.06  |- skos__altLabel mesh__D037263 Asialoglycoprotein Receptors
% 220.86/221.06  |- skos__broader mesh__D037263smesh__D037181
% 220.86/221.06  |- skos__altLabel mesh__D037263 Liver Carbohydrate-Binding Protein
% 220.86/221.06  |- skos__broader mesh__D037263smesh__D011956
% 220.86/221.06  |- skos__scopeNote mesh__D037263
% 220.86/221.06       A C-type lectin that is a cell surface receptor for ASIALOGLYCOPROTEINS. It is found primarily in the LIVER where it mediates the endocytosis of serum glycoproteins.%A%    
% 220.86/221.06  |- skos__related mesh__D037263smesh__D001212
% 220.86/221.06  |- mesh__recordAuthorizer mesh__D037263 sjn
% 220.86/221.06  |- mesh__historyNote mesh__D037263
% 220.86/221.06       2003; use ASIALOGLYCOPROTEIN RECEPTOR %28%NM%29% 1980-2002   
% 220.86/221.06  |- mesh__recordOriginator mesh__D037263 jmp
% 220.86/221.06  |- skos__altLabel mesh__D037263 Asialoorosomucoid Receptor
% 220.86/221.06  |- skos__altLabel mesh__D037263 Hepatic Lectin
% 220.86/221.06  |- mesh__dateCreated mesh__D037263 2002-07-02
% 220.86/221.06  |- mesh__recordMaintainer mesh__D037263 SYSTEM
% 220.86/221.06  |- skos__hiddenLabel mesh__D037263 Lectin, Hepatic
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D037263 2006
% 220.86/221.06  |- skos__hiddenLabel mesh__D037263 Receptor, Hepatic Asialoglycoprotein
% 220.86/221.06  |- mesh__dateRevised mesh__D037263 2005-06-30
% 220.86/221.06  |- skos__altLabel mesh__D037263 ASGP-R
% 220.86/221.06  |- mesh__publicMeSHNote mesh__D037263
% 220.86/221.06       2003; ASIALOGLYCOPROTEIN RECEPTOR was indexed under RECEPTORS, CELL SURFACE 1980-2002%A%  
% 220.86/221.06  |- skos__prefLabel mesh__D037263 Asialoglycoprotein Receptor
% 220.86/221.06  |- skos__altLabel mesh__D037263 Receptor, Asialoglycoprotein
% 220.86/221.06  |- rdf__type mesh__D037263sskos__Concept
% 220.86/221.06  |- skos__hiddenLabel mesh__D037263 Liver Carbohydrate Binding Protein
% 220.86/221.06  |- skos__altLabel mesh__D037263 Asialoorosomucoid Receptors
% 220.86/221.06  |- skos__altLabel mesh__D037263 Receptor, Asialoorosomucoid
% 220.86/221.06  |- skos__hiddenLabel mesh__D037263 Receptors, Asialoorosomucoid
% 220.86/221.06  |- skos__hiddenLabel mesh__D037263 Asialoorosomucoid Binding Protein
% 220.86/221.06  |- mesh__dateEstablished mesh__D037263 2003-01-01
% 220.86/221.06  |- mesh__recordMaintainer mesh__D009572 AKE
% 220.86/221.06  |- rdf__type mesh__D009572sskos__Concept
% 220.86/221.06  |- mesh__dateRevised mesh__D009572 2005-06-30
% 220.86/221.06  |- skos__scopeNote mesh__D009572
% 220.86/221.06       A group of enzymes that oxidize diverse nitrogenous substances to yield nitrite. %28%Enzyme Nomenclature, 1992%29% EC 1.%A%    
% 220.86/221.06  |- skos__historyNote mesh__D009572 Oxidoreductases %28%1966-1972%29%
% 220.86/221.06  |- skos__altLabel mesh__D009572 Nitrite Reductase
% 220.86/221.06  |- skos__annotation mesh__D009572 do not confuse with NITRATE REDUCTASES   
% 220.86/221.06  |- mesh__dateCreated mesh__D009572 1999-01-01
% 220.86/221.06  |- skos__broader mesh__D009572smesh__D009601
% 220.86/221.06  |- skos__hiddenLabel mesh__D009572 Reductases, Nitrite
% 220.86/221.06  |- skos__prefLabel mesh__D009572 Nitrite Reductases
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D009572 2006
% 220.86/221.06  |- mesh__historyNote mesh__D009572
% 220.86/221.06       91%28%75%29%; was see under NADH, NADPH OXIDOREDUCTASES 1975-90; was NITRITE REDUCTASE 1973-74 %28%Prov%29%%A%  
% 220.86/221.06  |- skos__hiddenLabel mesh__D009572 Reductase, Nitrite
% 220.86/221.06  |- mesh__publicMeSHNote mesh__D009572
% 220.86/221.06       91; was see under NADH, NADPH OXIDOREDUCTASES 1975-90; was NITRITE REDUCTASE 1973-74 %28%Prov%29%%A%  
% 220.86/221.06  |- mesh__onlineNote mesh__D009572
% 220.86/221.06       use NITRITE REDUCTASES to search NITRITE REDUCTASE 1973-74 %28%as Prov%29%%A%  
% 220.86/221.06  |- mesh__recordOriginator mesh__D009572 NLM
% 220.86/221.06  |- mesh__recordAuthorizer mesh__D009572 sjn
% 220.86/221.06  |- mesh__dateEstablished mesh__D009572 1991-01-01
% 220.86/221.06  |- skos__scopeNote mesh__D017206
% 220.86/221.06       Infections with nematodes of the order STRONGYLIDA.     
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D017206 2002
% 220.86/221.06  |- mesh__recordMaintainer mesh__D017206 TGC
% 220.86/221.06  |- skos__hiddenLabel mesh__D017206 Syngamiases
% 220.86/221.06  |- mesh__onlineNote mesh__D017206
% 220.86/221.06       use STRONGYLIDA INFECTIONS to search STEPHANURUS DENTATUS INFECTION 1975-92, SYNGAMIASIS 1968-92 %26% SYNGAMOSIS 1967%A%  
% 220.86/221.06  |- mesh__dateCreated mesh__D017206 1992-05-22
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D017206 1999
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D017206 2006
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D017206 1996
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D017206 2003
% 220.86/221.06  |- mesh__dateRevised mesh__D017206 1993-06-03
% 220.86/221.06  |- skos__altLabel mesh__D017206 Infections, Stephanurus dentatus
% 220.86/221.06  |- skos__broader mesh__D017206smesh__D017190
% 220.86/221.06  |- mesh__publicMeSHNote mesh__D017206
% 220.86/221.06       93; STEPHANURUS DENTATUS INFECTION was heading 1975-92 %28%see under NEMATODE INFECTIONS 1975-90%29%; SYNGAMIASIS was heading 1968-92, was SYNGAMOSIS 1967%A%  
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D017206 1997
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D017206 2004
% 220.86/221.06  |- skos__hiddenLabel mesh__D017206 Infection, Stephanurus dentatus
% 220.86/221.06  |- skos__altLabel mesh__D017206 Infections, Strongylida
% 220.86/221.06  |- skos__prefLabel mesh__D017206 Strongylida Infections
% 220.86/221.06  |- skos__hiddenLabel mesh__D017206 Infection, Strongylida
% 220.86/221.06  |- rdf__type mesh__D017206sskos__Concept
% 220.86/221.06  |- skos__hiddenLabel mesh__D017206 dentatus Infection, Stephanurus
% 220.86/221.06  |- mesh__recordAuthorizer mesh__D017206 PLS
% 220.86/221.06  |- mesh__historyNote mesh__D017206
% 220.86/221.06       93; STEPHANURUS DENTATUS INFECTION was heading 1975-92 %28%see under NEMATODE INFECTIONS 1975-90%29%; SYNGAMIASIS was heading 1968-92, was SYNGAMOSIS 1967%A%  
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D017206 1994
% 220.86/221.06  |- skos__hiddenLabel mesh__D017206 Strongylida Infection
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D017206 2000
% 220.86/221.06  |- skos__hiddenLabel mesh__D017206 dentatus Infections, Stephanurus
% 220.86/221.06  |- mesh__dateEstablished mesh__D017206 1993-01-01
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D017206 1995
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D017206 2001
% 220.86/221.06  |- skos__annotation mesh__D017206 nematode infect   
% 220.86/221.06  |- skos__hiddenLabel mesh__D017206 Stephanurus dentatus Infection
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D017206 2005
% 220.86/221.06  |- mesh__recordOriginator mesh__D017206 PXP
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D017206 1998
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D000497 2000
% 220.86/221.06  |- mesh__historyNote mesh__D000497 65   
% 220.86/221.06  |- mesh__recordMaintainer mesh__D000497 TPW
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D000497 1996
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D000497 1999
% 220.86/221.06  |- mesh__dateEstablished mesh__D000497 1965-01-01
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D000497 2004
% 220.86/221.06  |- skos__broader mesh__D000497smesh__D008670
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D000497 2002
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D000497 1995
% 220.86/221.06  |- skos__prefLabel mesh__D000497 Alloys
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D000497 1998
% 220.86/221.06  |- mesh__publicMeSHNote mesh__D000497 65   
% 220.86/221.06  |- skos__broader mesh__D000497smesh__D001697
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D000497 2003
% 220.86/221.06  |- mesh__dateRevised mesh__D000497 1993-06-04
% 220.86/221.06  |- rdf__type mesh__D000497sskos__Concept
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D000497 1994
% 220.86/221.06  |- mesh__recordOriginator mesh__D000497 NLM
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D000497 2006
% 220.86/221.06  |- skos__annotation mesh__D000497 D25-26 qualif   
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D000497 2001
% 220.86/221.06  |- mesh__recordAuthorizer mesh__D000497 PLS
% 220.86/221.06  |- skos__scopeNote mesh__D000497
% 220.86/221.06       A mixture of metallic elements or compounds with other metallic or metalloid elements in varying proportions.%A%    
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D000497 2005
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D000497 1997
% 220.86/221.06  |- mesh__dateCreated mesh__D000497 1999-01-01
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D005980 2006
% 220.86/221.06  |- skos__prefLabel mesh__D005980 Glutathione Reductase
% 220.86/221.06  |- mesh__recordAuthorizer mesh__D005980 sjn
% 220.86/221.06  |- mesh__historyNote mesh__D005980 65   
% 220.86/221.06  |- skos__hiddenLabel mesh__D005980 Reductase, Glutathione
% 220.86/221.06  |- skos__broader mesh__D005980smesh__D050862
% 220.86/221.06  |- rdf__type mesh__D005980sskos__Concept
% 220.86/221.06  |- mesh__recordOriginator mesh__D005980 NLM
% 220.86/221.06  |- skos__altLabel mesh__D005980 Glutathione-Disulfide Reductase
% 220.86/221.06  |- mesh__publicMeSHNote mesh__D005980 65   
% 220.86/221.06  |- skos__scopeNote mesh__D005980
% 220.86/221.06       Catalyzes the oxidation of GLUTATHIONE to GLUTATHIONE DISULFIDE in the presence of NADP+. Deficiency in the enzyme is associated with HEMOLYTIC ANEMIA. Formerly listed as EC 1.6.4.2.%A%    
% 220.86/221.06  |- mesh__recordMaintainer mesh__D005980 AKE
% 220.86/221.06  |- mesh__dateCreated mesh__D005980 1999-01-01
% 220.86/221.06  |- mesh__dateRevised mesh__D005980 2005-06-30
% 220.86/221.06  |- skos__hiddenLabel mesh__D005980 Reductase, Glutathione-Disulfide
% 220.86/221.06  |- mesh__dateEstablished mesh__D005980 1965-01-01
% 220.86/221.06  |- skos__broader mesh__D005182smesh__D012256
% 220.86/221.06  |- mesh__publicMeSHNote mesh__D005182
% 220.86/221.06       2002; see FAD 1963-2001; for FLAVIN-ADENINE DINUCLEOTIDE see FAD 1963-2001%A%  
% 220.86/221.06  |- skos__prefLabel mesh__D005182 Flavin-Adenine Dinucleotide
% 220.86/221.06  |- skos__hiddenLabel mesh__D005182 Flavin Adenine Dinucleotide
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D005182 2006
% 220.86/221.06  |- mesh__recordOriginator mesh__D005182 NLM
% 220.86/221.06  |- mesh__historyNote mesh__D005182 2002%28%1963%29%   
% 220.86/221.06  |- skos__hiddenLabel mesh__D005182 Dinucleotide, Flavin-Adenine
% 220.86/221.06  |- mesh__recordMaintainer mesh__D005182 ssb
% 220.86/221.06  |- skos__scopeNote mesh__D005182
% 220.86/221.06       A condensation product of riboflavin and adenosine diphosphate. The coenzyme of various aerobic dehydrogenases, e.g., D-amino acid oxidase and L-amino acid oxidase. %28%Lehninger, Principles of Biochemistry, 1982, p972%29%%A%    
% 220.86/221.06  |- skos__altLabel mesh__D005182 FAD
% 220.86/221.06  |- mesh__recordAuthorizer mesh__D005182 sjn
% 220.86/221.06  |- mesh__dateRevised mesh__D005182 2005-06-30
% 220.86/221.06  |- skos__broader mesh__D005182smesh__D000227
% 220.86/221.06  |- mesh__dateCreated mesh__D005182 1999-01-01
% 220.86/221.06  |- rdf__type mesh__D005182sskos__Concept
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D013614 2003
% 220.86/221.06  |- mesh__dateCreated mesh__D013614 1999-01-01
% 220.86/221.06  |- skos__hiddenLabel mesh__D013614 Reciprocal Tachycardias, Paroxysmal
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D013614 2004
% 220.86/221.06  |- skos__annotation mesh__D013614
% 220.86/221.06       tachycardia of sudden onset %26% cessation   
% 220.86/221.06  |- mesh__recordOriginator mesh__D013614 NLM
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D013614 2002
% 220.86/221.06  |- skos__prefLabel mesh__D013614 Tachycardia, Paroxysmal
% 220.86/221.06  |- skos__hiddenLabel mesh__D013614 Reciprocal Tachycardias
% 220.86/221.06  |- skos__hiddenLabel mesh__D013614 Tachycardias, Paroxysmal Reciprocal
% 220.86/221.06  |- skos__hiddenLabel mesh__D013614 Tachycardia, Paroxysmal Reciprocal
% 220.86/221.06  |- skos__hiddenLabel mesh__D013614 Reciprocal Tachycardia
% 220.86/221.06  |- mesh__recordAuthorizer mesh__D013614 sjn
% 220.86/221.06  |- skos__hiddenLabel mesh__D013614 Paroxysmal Tachycardias
% 220.86/221.06  |- skos__hiddenLabel mesh__D013614 Paroxysmal Tachycardia
% 220.86/221.06  |- skos__hiddenLabel mesh__D013614 Paroxysmal Reciprocal Tachycardias
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D013614 2005
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D013614 2000
% 220.86/221.06  |- mesh__recordMaintainer mesh__D013614 JLS
% 220.86/221.06  |- skos__broader mesh__D013614smesh__D013610
% 220.86/221.06  |- skos__hiddenLabel mesh__D013614 Tachycardias, Reciprocal
% 220.86/221.06  |- skos__scopeNote mesh__D013614
% 220.86/221.06       Condition marked by attacks of rapid action of the heart having sudden onset and cessation.%A%    
% 220.86/221.06  |- skos__hiddenLabel mesh__D013614 Reciprocal Tachycardia, Paroxysmal
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D013614 2006
% 220.86/221.06  |- mesh__dateRevised mesh__D013614 1999-11-03
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D013614 2001
% 220.86/221.06  |- rdf__type mesh__D013614sskos__Concept
% 220.86/221.06  |- skos__hiddenLabel mesh__D013614 Tachycardias, Paroxysmal
% 220.86/221.06  |- skos__scopeNote mesh__D004888
% 220.86/221.06       A genus of gram-positive, facultatively anaerobic, rod-shaped bacteria that has a tendency to form long filaments. Its organisms are widely distributed in nature and are found in MAMMALS; BIRDS; and FISHES.%A%    
% 220.86/221.06  |- skos__broader mesh__D004888smesh__D016989
% 220.86/221.06  |- skos__broader mesh__D004888smesh__D008973
% 220.86/221.06  |- mesh__recordMaintainer mesh__D004888 ags
% 220.86/221.06  |- skos__prefLabel mesh__D004888 Erysipelothrix
% 220.86/221.06  |- mesh__dateCreated mesh__D004888 1999-01-01
% 220.86/221.06  |- mesh__dateRevised mesh__D004888 2005-07-14
% 220.86/221.06  |- mesh__recordOriginator mesh__D004888 NLM
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D004888 2006
% 220.86/221.06  |- skos__annotation mesh__D004888 infection = ERYSIPELOTHRIX INFECTIONS   
% 220.86/221.06  |- rdf__type mesh__D004888sskos__Concept
% 220.86/221.06  |- mesh__recordAuthorizer mesh__D004888 ags
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D004888 2006A
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D009573 1999
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D009573 2006
% 220.86/221.06  |- skos__broader mesh__D009573smesh__D000838
% 220.86/221.06  |- mesh__activeMeSHYear mesh__D009573 1995
% 220.92/221.06  |- mesh__activeMeSHYear mesh__D009573 1998
% 220.92/221.06  |- mesh__recordOriginator mesh__D009573 NLM
% 220.92/221.06  |- mesh__activeMeSHYear mesh__D009573 2005
% 220.92/221.06  |- skos__broader mesh__D009573smesh__D009608
% 220.92/221.06  |- mesh__dateRevised mesh__D009573 1993-06-18
% 220.92/221.06  |- mesh__activeMeSHYear mesh__D009573 1994
% 220.92/221.06  |- mesh__activeMeSHYear mesh__D009573 2002
% 220.92/221.06  |- mesh__activeMeSHYear mesh__D009573 1997
% 220.92/221.06  |- skos__broader mesh__D009573smesh__D009930
% 220.92/221.06  |- mesh__recordMaintainer mesh__D009573 TPW
% 220.92/221.06  |- mesh__activeMeSHYear mesh__D009573 2004
% 220.92/221.06  |- mesh__recordAuthorizer mesh__D009573 PLS
% 220.92/221.06  |- skos__scopeNote mesh__D009573
% 220.92/221.06       Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 %28%where M=metal%29% are all insoluble, except the alkali nitrites. The organic nitrites may be isomeric, but not identical with the corresponding nitro compounds. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 220.92/221.07  |- rdf__type mesh__D009573sskos__Concept
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D009573 1996
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D009573 2001
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D009573 2003
% 220.92/221.07  |- mesh__dateCreated mesh__D009573 1999-01-01
% 220.92/221.07  |- skos__prefLabel mesh__D009573 Nitrites
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D009573 2000
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D001590 2006
% 220.92/221.07  |- mesh__recordOriginator mesh__D001590 NLM
% 220.92/221.07  |- skos__hiddenLabel mesh__D001590 PMS Benztropine
% 220.92/221.07  |- skos__hiddenLabel mesh__D001590 N Methylbenztropine
% 220.92/221.07  |- skos__hiddenLabel mesh__D001590
% 220.92/221.07       Hydrobromide Benzatropine Methanesulfonate
% 220.92/221.07  |- mesh__recordAuthorizer mesh__D001590 sjn
% 220.92/221.07  |- rdf__type mesh__D001590sskos__Concept
% 220.92/221.07  |- skos__hiddenLabel mesh__D001590 Methanesulfonate, Benzatropine
% 220.92/221.07  |- mesh__publicMeSHNote mesh__D001590
% 220.92/221.07       1991; see TROPANES 1972-1990; BENZATROPINE METHANESULFONATE was indexed under BENZOTROPINE 1977-2005%A%  
% 220.92/221.07  |- skos__altLabel mesh__D001590 ICN Brand of Benzatropine Mesilate
% 220.92/221.07  |- mesh__dateCreated mesh__D001590 1999-01-01
% 220.92/221.07  |- skos__altLabel mesh__D001590
% 220.92/221.07       Pharmascience Brand of Benzatropine Mesilate
% 220.92/221.07  |- skos__hiddenLabel mesh__D001590 Apo Benztropine
% 220.92/221.07  |- mesh__recordMaintainer mesh__D001590 ssb
% 220.92/221.07  |- skos__historyNote mesh__D001590 Tropanes %28%1972-1990%29%
% 220.92/221.07  |- skos__altLabel mesh__D001590 Astra Brand of Benzatropine Mesilate
% 220.92/221.07  |- skos__hiddenLabel mesh__D001590 Mesylate, Benztropine
% 220.92/221.07  |- skos__scopeNote mesh__D001590
% 220.92/221.07       A centrally active muscarinic antagonist that has been used in the symptomatic treatment of PARKINSON DISEASE. Benztropine also inhibits the uptake of dopamine.%A%    
% 220.92/221.07  |- skos__altLabel mesh__D001590 Benzatropine
% 220.92/221.07  |- skos__hiddenLabel mesh__D001590
% 220.92/221.07       Methanesulfonate, Hydrobromide Benzatropine
% 220.92/221.07  |- mesh__dateRevised mesh__D001590 2005-06-30
% 220.92/221.07  |- skos__altLabel mesh__D001590 Benztropine Mesylate
% 220.92/221.07  |- mesh__historyNote mesh__D001590
% 220.92/221.07       1991%28%1972%29%; use TROPANES 1972-1990   
% 220.92/221.07  |- skos__altLabel mesh__D001590 Apotex Brand of Benzatropine Mesilate
% 220.92/221.07  |- skos__prefLabel mesh__D001590 Benztropine
% 220.92/221.07  |- skos__hiddenLabel mesh__D001590 ApoBenztropine
% 220.92/221.07  |- skos__altLabel mesh__D001590 Benzatropine Mesylate
% 220.92/221.07  |- skos__broader mesh__D001590smesh__D014326
% 220.92/221.07  |- skos__hiddenLabel mesh__D001590 PMSBenztropine
% 220.92/221.07  |- mesh__dateEstablished mesh__D001590 1991-01-01
% 220.92/221.07  |- skos__hiddenLabel mesh__D001590 Mesylate, Benzatropine
% 220.92/221.07  |- mesh__publicMeSHNote mesh__D017207
% 220.92/221.07       93; was see RATS, INBRED STRAINS 1982-92   
% 220.92/221.07  |- mesh__dateEstablished mesh__D017207 1993-01-01
% 220.92/221.07  |- mesh__recordMaintainer mesh__D017207 ags
% 220.92/221.07  |- mesh__recordOriginator mesh__D017207 MXR
% 220.92/221.07  |- skos__historyNote mesh__D017207 Rats %28%1966-1982%29%
% 220.92/221.07  |- skos__scopeNote mesh__D017207
% 220.92/221.07       A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.%A%    
% 220.92/221.07  |- mesh__recordAuthorizer mesh__D017207 sjn
% 220.92/221.07  |- skos__hiddenLabel mesh__D017207 Sprague-Dawley Rats
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D017207 2006
% 220.92/221.07  |- mesh__historyNote mesh__D017207
% 220.92/221.07       93; was see RATS, INBRED STRAINS 1982-92   
% 220.92/221.07  |- skos__annotation mesh__D017207
% 220.92/221.07       usually NIM: no qualif; when IM, qualif permitted; do not forget also to check tag RATS%A%  
% 220.92/221.07  |- skos__historyNote mesh__D017207 Rats, Inbred Strains %28%1982-1992%29%
% 220.92/221.07  |- skos__hiddenLabel mesh__D017207 Sprague Dawley Rats
% 220.92/221.07  |- skos__prefLabel mesh__D017207 Rats, Sprague-Dawley
% 220.92/221.07  |- skos__broader mesh__D017207smesh__D051381
% 220.92/221.07  |- skos__hiddenLabel mesh__D017207 Holtzman Rats
% 220.92/221.07  |- mesh__dateCreated mesh__D017207 1992-05-22
% 220.92/221.07  |- rdf__type mesh__D017207sskos__Concept
% 220.92/221.07  |- mesh__dateRevised mesh__D017207 2005-06-30
% 220.92/221.07  |- mesh__onlineNote mesh__D017207
% 220.92/221.07       use RATS, INBRED STRAINS to search RATS, SPRAGUE-DAWLEY 1982-92%A%  
% 220.92/221.07  |- skos__altLabel mesh__D017207 Rats, Sprague Dawley
% 220.92/221.07  |- mesh__recordOriginator mesh__D000498 NLM
% 220.92/221.07  |- mesh__recordMaintainer mesh__D000498 TGC
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D000498 1993
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D000498 2000
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D000498 1998
% 220.92/221.07  |- skos__annotation mesh__D000498 DF: ALLYL CPDS   
% 220.92/221.07  |- skos__prefLabel mesh__D000498 Allyl Compounds
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D000498 2003
% 220.92/221.07  |- mesh__historyNote mesh__D000498 73%28%71%29%   
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D000498 1994
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D000498 2001
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D000498 1999
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D000498 2004
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D000498 1995
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D000498 2002
% 220.92/221.07  |- skos__historyNote mesh__D000498 Alkenes %28%1966-1970%29%
% 220.92/221.07  |- skos__broader mesh__D000498smesh__D000475
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D000498 2005
% 220.92/221.07  |- mesh__dateCreated mesh__D000498 1999-01-01
% 220.92/221.07  |- mesh__dateEstablished mesh__D000498 1973-01-01
% 220.92/221.07  |- rdf__type mesh__D000498sskos__Concept
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D000498 2006
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D000498 1996
% 220.92/221.07  |- mesh__publicMeSHNote mesh__D000498 73   
% 220.92/221.07  |- mesh__recordAuthorizer mesh__D000498 PLS
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D000498 1997
% 220.92/221.07  |- mesh__dateRevised mesh__D000498 1992-05-07
% 220.92/221.07  |- skos__hiddenLabel mesh__D000498 Compounds, Allyl
% 220.92/221.07  |- rdf__type mesh__D005981sskos__Concept
% 220.92/221.07  |- skos__prefLabel mesh__D005981 Glutathione Synthase
% 220.92/221.07  |- skos__broader mesh__D005981smesh__D010453
% 220.92/221.07  |- mesh__dateRevised mesh__D005981 2003-07-09
% 220.92/221.07  |- skos__historyNote mesh__D005981 Glutathione %28%1973-1976%29%
% 220.92/221.07  |- mesh__publicMeSHNote mesh__D005981
% 220.92/221.07       98; see GLUTATHIONE SYNTHETASE 1991-97; see PEPTIDE SYNTHETASES 1977-90%A%  
% 220.92/221.07  |- skos__hiddenLabel mesh__D005981 Synthetase, Glutathione
% 220.92/221.07  |- mesh__dateEstablished mesh__D005981 1991-01-01
% 220.92/221.07  |- mesh__recordMaintainer mesh__D005981 ssb
% 220.92/221.07  |- skos__historyNote mesh__D005981 Peptide Synthetases %28%1973-1976%29%
% 220.92/221.07  |- skos__hiddenLabel mesh__D005981 Synthase, Glutathione
% 220.92/221.07  |- mesh__recordAuthorizer mesh__D005981 sjn
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D005981 2004
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D005981 2006
% 220.92/221.07  |- mesh__dateCreated mesh__D005981 1976-05-19
% 220.92/221.07  |- skos__altLabel mesh__D005981 Glutathione Synthetase
% 220.92/221.07  |- mesh__historyNote mesh__D005981 98%28%77%29%   
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D005981 2005
% 220.92/221.07  |- skos__scopeNote mesh__D005981
% 220.92/221.07       One of the enzymes active in the gamma-glutamyl cycle. It catalyzes the synthesis of glutathione from gamma-glutamylcysteine and glycine in the presence of ATP with the formation of ADP and orthophosphate. EC 6.3.2.3.%A%    
% 220.92/221.07  |- mesh__recordOriginator mesh__D005981 RLS
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D005183 2005
% 220.92/221.07  |- skos__scopeNote mesh__D005183
% 220.92/221.07       A condition in which an infant or child%27%s weight gain and growth are far below usual levels for age.%A%    
% 220.92/221.07  |- mesh__recordOriginator mesh__D005183 VDK
% 220.92/221.07  |- skos__broader mesh__D005183smesh__D006130
% 220.92/221.07  |- mesh__dateEstablished mesh__D005183 1984-01-01
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D005183 2006
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D005183 2000
% 220.92/221.07  |- skos__hiddenLabel mesh__D005183 Thrive, Failure to
% 220.92/221.07  |- mesh__publicMeSHNote mesh__D005183 84   
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D005183 2003
% 220.92/221.07  |- skos__prefLabel mesh__D005183 Failure to Thrive
% 220.92/221.07  |- rdf__type mesh__D005183sskos__Concept
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D005183 2001
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D005183 2004
% 220.92/221.07  |- skos__historyNote mesh__D005183 Growth Disorders %28%1969-1983%29%
% 220.92/221.07  |- mesh__historyNote mesh__D005183 84   
% 220.92/221.07  |- mesh__recordAuthorizer mesh__D005183 sjn
% 220.92/221.07  |- mesh__dateRevised mesh__D005183 1999-11-08
% 220.92/221.07  |- mesh__dateCreated mesh__D005183 1983-02-24
% 220.92/221.07  |- mesh__recordMaintainer mesh__D005183 KEV
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D005183 2002
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D013615 2004
% 220.92/221.07  |- skos__scopeNote mesh__D013615
% 220.92/221.07       A tachycardia arising from the sinus node region and characterized by rates between 115 and 140 beats per minute. It is paroxysmal rather than constant.%A%    
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D013615 2001
% 220.92/221.07  |- mesh__dateRevised mesh__D013615 1999-11-03
% 220.92/221.07  |- mesh__recordMaintainer mesh__D013615 TGC
% 220.92/221.07  |- skos__altLabel mesh__D013615 Tachycardia, SA Nodal Reentrant
% 220.92/221.07  |- mesh__dateEstablished mesh__D013615 1991-01-01
% 220.92/221.07  |- skos__historyNote mesh__D013615 Sinoatrial Node %28%1978-1986%29%
% 220.92/221.07  |- mesh__recordOriginator mesh__D013615 VDK
% 220.92/221.07  |- skos__historyNote mesh__D013615 Tachycardia %28%1966-1986%29%
% 220.92/221.07  |- mesh__dateCreated mesh__D013615 1986-06-23
% 220.92/221.07  |- mesh__historyNote mesh__D013615
% 220.92/221.07       91%28%87%29%; was see under TACHYCARDIA, SUPRAVENTRICULAR 1987-90%A%  
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D013615 2005
% 220.92/221.07  |- skos__broader mesh__D013615smesh__D013617
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D013615 2002
% 220.92/221.07  |- mesh__publicMeSHNote mesh__D013615
% 220.92/221.07       91; was see under TACHYCARDIA, SUPRAVENTRICULAR 1987-90   
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D013615 2006
% 220.92/221.07  |- skos__annotation mesh__D013615 a supraventric tachycardia   
% 220.92/221.07  |- rdf__type mesh__D013615sskos__Concept
% 220.92/221.07  |- mesh__recordAuthorizer mesh__D013615 sjn
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D013615 2003
% 220.92/221.07  |- skos__altLabel mesh__D013615 Sinoatrial Nodal Reentry Tachycardia
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D013615 2000
% 220.92/221.07  |- skos__prefLabel mesh__D013615 Tachycardia, Sinoatrial Nodal Reentry
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D018300 1997
% 220.92/221.07  |- mesh__recordAuthorizer mesh__D018300 PLS
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D018300 2005
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D018300 2004
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D018300 1996
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D018300 2000
% 220.92/221.07  |- rdf__type mesh__D018300sskos__Concept
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D018300 2003
% 220.92/221.07  |- mesh__recordMaintainer mesh__D018300 KEV
% 220.92/221.07  |- skos__scopeNote mesh__D018300
% 220.92/221.07       A small, often impalpable benign papilloma arising in a lactiferous duct and frequently causing bleeding from the nipple. %28%Stedman, 25th ed%29%%A%    
% 220.92/221.07  |- mesh__dateEstablished mesh__D018300 1994-01-01
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D018300 2002
% 220.92/221.07  |- skos__historyNote mesh__D018300 Papilloma %28%1966-1993%29%
% 220.92/221.07  |- mesh__dateRevised mesh__D018300 1995-06-08
% 220.92/221.07  |- mesh__recordOriginator mesh__D018300 PLS
% 220.92/221.07  |- skos__broader mesh__D018300smesh__D018299
% 220.92/221.07  |- skos__annotation mesh__D018300
% 220.92/221.07       intraductal refers to mammary ducts only; /blood supply /chem /secret /ultrastruct permitted; coord IM with BREAST NEOPLASMS %28%IM%29%%A%  
% 220.92/221.07  |- skos__hiddenLabel mesh__D018300 Intraductal Papilloma
% 220.92/221.07  |- mesh__dateCreated mesh__D018300 1993-06-28
% 220.92/221.07  |- skos__hiddenLabel mesh__D018300 Papillomas, Intraductal
% 220.92/221.07  |- skos__hiddenLabel mesh__D018300 Intraductal Papillomas
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D018300 1999
% 220.92/221.07  |- mesh__historyNote mesh__D018300 94   
% 220.92/221.07  |- skos__prefLabel mesh__D018300 Papilloma, Intraductal
% 220.92/221.07  |- skos__historyNote mesh__D018300 Breast Neoplasms %28%1966-1993%29%
% 220.92/221.07  |- mesh__publicMeSHNote mesh__D018300 94   
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D018300 2006
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D018300 1998
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D018300 2001
% 220.92/221.07  |- skos__prefLabel mesh__D004889 Erysipelothrix Infections
% 220.92/221.07  |- skos__hiddenLabel mesh__D004889 Erysipelothrix Infection
% 220.92/221.07  |- skos__historyNote mesh__D004889 Erysipeloid %28%1966-1967%29%
% 220.92/221.07  |- mesh__recordMaintainer mesh__D004889 ags
% 220.92/221.07  |- skos__broader mesh__D004889smesh__D016908
% 220.92/221.07  |- skos__broader mesh__D004889smesh__D000820
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D004889 2006
% 220.92/221.07  |- skos__altLabel mesh__D004889 Infections, Erysipelothrix
% 220.92/221.07  |- mesh__recordAuthorizer mesh__D004889 sjn
% 220.92/221.07  |- mesh__dateRevised mesh__D004889 2003-07-30
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D004889 2005
% 220.92/221.07  |- mesh__historyNote mesh__D004889 68   
% 220.92/221.07  |- skos__hiddenLabel mesh__D004889 Infection, Erysipelothrix
% 220.92/221.07  |- rdf__type mesh__D004889sskos__Concept
% 220.92/221.07  |- mesh__publicMeSHNote mesh__D004889 68   
% 220.92/221.07  |- skos__annotation mesh__D004889
% 220.92/221.07       gram-pos bact infect; usually animal; check tag ANIMALS   
% 220.92/221.07  |- mesh__dateEstablished mesh__D004889 1968-01-01
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D004889 2004
% 220.92/221.07  |- mesh__recordOriginator mesh__D004889 NLM
% 220.92/221.07  |- skos__scopeNote mesh__D004889
% 220.92/221.07       Infections with bacteria of the genus ERYSIPELOTHRIX.     
% 220.92/221.07  |- mesh__dateCreated mesh__D004889 1999-01-01
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D009574 1998
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D009574 2001
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D009574 2005
% 220.92/221.07  |- skos__hiddenLabel mesh__D009574 Compounds, Nitro
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D009574 2000
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D009574 1994
% 220.92/221.07  |- mesh__recordMaintainer mesh__D009574 TAP
% 220.92/221.07  |- mesh__dateEstablished mesh__D009574 1974-01-01
% 220.92/221.07  |- mesh__dateRevised mesh__D009574 1992-05-19
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D009574 1997
% 220.92/221.07  |- mesh__publicMeSHNote mesh__D009574 74   
% 220.92/221.07  |- skos__broader mesh__D009574smesh__D009930
% 220.92/221.07  |- mesh__recordOriginator mesh__D009574 NLM
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D009574 2004
% 220.92/221.07  |- rdf__type mesh__D009574sskos__Concept
% 220.92/221.07  |- mesh__historyNote mesh__D009574 74%28%71%29%   
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D009574 1993
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D009574 2002
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D009574 1996
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D009574 2003
% 220.92/221.07  |- mesh__dateCreated mesh__D009574 1999-01-01
% 220.92/221.07  |- skos__historyNote mesh__D009574
% 220.92/221.07       specific compound containing nitro group %28%1971-1974%29%
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D009574 1999
% 220.92/221.07  |- skos__prefLabel mesh__D009574 Nitro Compounds
% 220.92/221.07  |- mesh__recordAuthorizer mesh__D009574 PLS
% 220.92/221.07  |- skos__annotation mesh__D009574 DF: NITRO CPDS   
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D009574 2006
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D009574 1995
% 220.92/221.07  |- skos__altLabel mesh__D001591 Innotech Brand of Benzydamine Hydrochloride
% 220.92/221.07  |- skos__hiddenLabel mesh__D001591 Hydrochloride, Benzydamine
% 220.92/221.07  |- skos__hiddenLabel mesh__D001591 Novo Benzydamine
% 220.92/221.07  |- skos__altLabel mesh__D001591
% 220.92/221.07       Novopharm Brand of Benzydamine Hydrochloride
% 220.92/221.07  |- skos__altLabel mesh__D001591 Eipico Brand of Benzydamine Hydrochloride
% 220.92/221.07  |- skos__scopeNote mesh__D001591
% 220.92/221.07       A benzyl-indazole having analgesic, antipyretic, and anti-inflammatory effects. It is used to reduce post-surgical and post-traumatic pain and edema and to promote healing. It is also used topically in treatment of RHEUMATIC DISEASES and INFLAMMATION of the mouth and throat.%A%    
% 220.92/221.07  |- skos__altLabel mesh__D001591
% 220.92/221.07       Ratiopharm Brand of Benzydamine Hydrochloride
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D001591 2006A
% 220.92/221.07  |- mesh__dateCreated mesh__D001591 1974-11-19
% 220.92/221.07  |- skos__altLabel mesh__D001591 Benzidamine
% 220.92/221.07  |- skos__historyNote mesh__D001591 Pyrazoles %28%1968-1973%29%
% 220.92/221.07  |- skos__altLabel mesh__D001591 Rosalgin
% 220.92/221.07  |- skos__altLabel mesh__D001591 Tantum
% 220.92/221.07  |- skos__altLabel mesh__D001591 Benzydamine Monohydrochloride
% 220.92/221.07  |- skos__altLabel mesh__D001591
% 220.92/221.07       Farma Lepori Brand of Benzydamine Hydrochloride
% 220.92/221.07  |- skos__altLabel mesh__D001591
% 220.92/221.07       Pharmascience Brand of Benzydamine Hydrochloride
% 220.92/221.07  |- mesh__recordAuthorizer mesh__D001591 jls
% 220.92/221.07  |- skos__altLabel mesh__D001591 CSC Brand of Benzydamine Hydrochloride
% 220.92/221.07  |- skos__historyNote mesh__D001591 Benzyl Compounds %28%1971-1974%29%
% 220.92/221.07  |- skos__altLabel mesh__D001591 Benzindamine
% 220.92/221.07  |- mesh__dateRevised mesh__D001591 2005-07-30
% 220.92/221.07  |- skos__prefLabel mesh__D001591 Benzydamine
% 220.92/221.07  |- skos__altLabel mesh__D001591 Tantum Topico
% 220.92/221.07  |- mesh__recordOriginator mesh__D001591 NLM
% 220.92/221.07  |- skos__hiddenLabel mesh__D001591 ratio Benzydamine
% 220.92/221.07  |- skos__hiddenLabel mesh__D001591 PMS Benzydamine
% 220.92/221.07  |- skos__altLabel mesh__D001591
% 220.92/221.07       Grossmann Brand of Benzydamine Hydrochloride
% 220.92/221.07  |- skos__broader mesh__D001591smesh__D007191
% 220.92/221.07  |- skos__altLabel mesh__D001591 Promeco Brand of Benzydamine Hydrochloride
% 220.92/221.07  |- skos__hiddenLabel mesh__D001591 Sun Benz
% 220.92/221.07  |- skos__historyNote mesh__D001591 Dimethylamines %28%1973-1974%29%
% 220.92/221.07  |- mesh__historyNote mesh__D001591
% 220.92/221.07       91%28%75%29%; was see under PYRAZOLES 1975-90   
% 220.92/221.07  |- mesh__publicMeSHNote mesh__D001591
% 220.92/221.07       91; was see under PYRAZOLES 1975-90   
% 220.92/221.07  |- skos__altLabel mesh__D001591 3M Brand of Benzydamine Hydrochloride
% 220.92/221.07  |- skos__historyNote mesh__D001591 Indazoles %28%1973-1974%29%
% 220.92/221.07  |- skos__altLabel mesh__D001591 Sun Brand of Benzydamine Hydrochloride
% 220.92/221.07  |- skos__altLabel mesh__D001591
% 220.92/221.07       United Drug Brand of Benzydamine Hydrochloride
% 220.92/221.07  |- mesh__dateEstablished mesh__D001591 1991-01-01
% 220.92/221.07  |- skos__hiddenLabel mesh__D001591 Monohydrochloride, Benzydamine
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D001591 2006B
% 220.92/221.07  |- mesh__recordMaintainer mesh__D001591 jls
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D001591 2006
% 220.92/221.07  |- skos__altLabel mesh__D001591 Chefaro Brand of Benzydamine Hydrochloride
% 220.92/221.07  |- rdf__type mesh__D001591sskos__Concept
% 220.92/221.07  |- mesh__publicMeSHNote mesh__D017208
% 220.92/221.07       93; was see RATS, INBRED STRAINS 1982-92   
% 220.92/221.07  |- mesh__recordOriginator mesh__D017208 MXR
% 220.92/221.07  |- skos__scopeNote mesh__D017208
% 220.92/221.07       A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain.%A%    
% 220.92/221.07  |- skos__historyNote mesh__D017208 Rats %28%1966-1980%29%
% 220.92/221.07  |- mesh__recordMaintainer mesh__D017208 ags
% 220.92/221.07  |- mesh__recordAuthorizer mesh__D017208 sjn
% 220.92/221.07  |- mesh__dateEstablished mesh__D017208 1993-01-01
% 220.92/221.07  |- mesh__historyNote mesh__D017208
% 220.92/221.07       93; was see RATS, INBRED STRAINS 1982-92   
% 220.92/221.07  |- skos__historyNote mesh__D017208 Rats, Inbred Strains %28%1980-1992%29%
% 220.92/221.07  |- mesh__onlineNote mesh__D017208
% 220.92/221.07       use RATS, INBRED STRAINS to search RATS, WISTAR 1982-92   
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D017208 2006
% 220.92/221.07  |- skos__annotation mesh__D017208
% 220.92/221.07       usually NIM: no qualif; when IM, qualif permitted; do not forget also to check tag RATS%A%  
% 220.92/221.07  |- rdf__type mesh__D017208sskos__Concept
% 220.92/221.07  |- skos__prefLabel mesh__D017208 Rats, Wistar
% 220.92/221.07  |- mesh__dateCreated mesh__D017208 1992-05-22
% 220.92/221.07  |- skos__hiddenLabel mesh__D017208 Wistar Rats
% 220.92/221.07  |- mesh__dateRevised mesh__D017208 2005-06-30
% 220.92/221.07  |- skos__broader mesh__D017208smesh__D051381
% 220.92/221.07  |- mesh__publicMeSHNote mesh__D000499 91; was see under AMINES 1976-90   
% 220.92/221.07  |- skos__historyNote mesh__D000499 Allyl Compounds %28%1974-1975%29%
% 220.92/221.07  |- mesh__recordMaintainer mesh__D000499 CCR
% 220.92/221.07  |- skos__altLabel mesh__D000499 3-Aminopropylene
% 220.92/221.07  |- skos__hiddenLabel mesh__D000499 3 Aminopropylene
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D000499 2001
% 220.92/221.07  |- mesh__dateEstablished mesh__D000499 1991-01-01
% 220.92/221.07  |- skos__broader mesh__D000499smesh__D000498
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D000499 2003
% 220.92/221.07  |- skos__scopeNote mesh__D000499
% 220.92/221.07       Possesses an unusual and selective cytotoxicity for vascular smooth muscle cells in dogs and rats. Useful for experiments dealing with arterial injury, myocardial fibrosis or cardiac decompensation.%A%    
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D000499 2002
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D000499 2004
% 220.92/221.07  |- mesh__dateCreated mesh__D000499 1975-07-23
% 220.92/221.07  |- rdf__type mesh__D000499sskos__Concept
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D000499 2005
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D000499 2006
% 220.92/221.07  |- mesh__recordAuthorizer mesh__D000499 sjn
% 220.92/221.07  |- skos__broader mesh__D000499smesh__D000588
% 220.92/221.07  |- skos__prefLabel mesh__D000499 Allylamine
% 220.92/221.07  |- mesh__historyNote mesh__D000499
% 220.92/221.07       91%28%76%29%; was see under AMINES 1976-90   
% 220.92/221.07  |- mesh__recordOriginator mesh__D000499 RLS
% 220.92/221.07  |- mesh__dateRevised mesh__D000499 2000-06-21
% 220.92/221.07  |- skos__historyNote mesh__D000499 Amines %28%1974-1975%29%
% 220.92/221.07  |- skos__altLabel mesh__D005982 Ligandins
% 220.92/221.07  |- skos__altLabel mesh__D005982 Glutathione S-Aryltransferase
% 220.92/221.07  |- mesh__dateRevised mesh__D005982 2005-06-30
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 Glutathione S Epoxidetransferase
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 S-Transferase, Glutathione
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 Protein, Heme Transfer
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 Glutathione S Transferase 3
% 220.92/221.07  |- skos__historyNote mesh__D005982 Glutathione %28%1970-1976%29%
% 220.92/221.07  |- skos__altLabel mesh__D005982 Glutathione S-Alkyltransferase
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 S-Transferase 3, Glutathione
% 220.92/221.07  |- mesh__dateCreated mesh__D005982 1976-04-19
% 220.92/221.07  |- skos__prefLabel mesh__D005982 Glutathione Transferase
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 S-Transferase A, Glutathione
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 Transfer Protein, Heme
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 Glutathione S Alkyltransferase
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 Glutathione S Aryltransferase
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D005982 2006
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 Glutathione Lyase, S-Hydroxyalkyl
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 S-Epoxidetransferase, Glutathione
% 220.92/221.07  |- skos__altLabel mesh__D005982 Glutathione Organic Nitrate Ester Reductase
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 Transferase, Glutathione
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 S-Alkyltransferase, Glutathione
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 Glutathione S Transferase
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 Glutathione S Transferase C
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 S-Aryltransferase, Glutathione
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 P, Glutathione S-Transferase
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 Transferase mu, Glutathione
% 220.92/221.07  |- mesh__recordAuthorizer mesh__D005982 sjn
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 S-Transferase C, Glutathione
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 S-Transferase B, Glutathione
% 220.92/221.07  |- skos__altLabel mesh__D005982 Glutathione S-Transferase
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 Glutathione S Transferase III
% 220.92/221.07  |- skos__scopeNote mesh__D005982
% 220.92/221.07       A transferase that catalyzes the addition of aliphatic, aromatic, or heterocyclic FREE RADICALS as well as EPOXIDES and arene oxides to GLUTATHIONE. Addition takes place at the SULFUR. It also catalyzes the reduction of polyol nitrate by glutathione to polyol and nitrite.%A%    
% 220.92/221.07  |- mesh__publicMeSHNote mesh__D005982
% 220.92/221.07       1977; see CARRIER PROTEINS %26% TRANSFERASES 1975-1976   
% 220.92/221.07  |- skos__altLabel mesh__D005982 Glutathione Transferases
% 220.92/221.07  |- skos__broader mesh__D005982smesh__D019883
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 Glutathione S Transferase P
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 Glutathione S Transferase B
% 220.92/221.07  |- mesh__historyNote mesh__D005982
% 220.92/221.07       1977; use CARRIER PROTEINS %26% TRANSFERASES 1975-1976   
% 220.92/221.07  |- mesh__recordMaintainer mesh__D005982 jmp
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 S Hydroxyalkyl Glutathione Lyase
% 220.92/221.07  |- mesh__dateEstablished mesh__D005982 1977-01-01
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 Transferase E, Glutathione
% 220.92/221.07  |- skos__historyNote mesh__D005982 Transferases %28%1970-1976%29%
% 220.92/221.07  |- skos__altLabel mesh__D005982 Ligandin
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 Transferases, Glutathione
% 220.92/221.07  |- skos__altLabel mesh__D005982 Glutathione S-Transferase III
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 Lyase, S-Hydroxyalkyl Glutathione
% 220.92/221.07  |- skos__altLabel mesh__D005982 Glutathione S-Epoxidetransferase
% 220.92/221.07  |- skos__altLabel mesh__D005982 Heme Transfer Protein
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 S-Transferase P, Glutathione
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 Glutathione S Transferase A
% 220.92/221.07  |- skos__altLabel mesh__D005982 S-Hydroxyalkyl Glutathione Lyase
% 220.92/221.07  |- mesh__recordOriginator mesh__D005982 RLS
% 220.92/221.07  |- rdf__type mesh__D005982sskos__Concept
% 220.92/221.07  |- skos__hiddenLabel mesh__D005982 S-Transferase III, Glutathione
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D005184 2006
% 220.92/221.07  |- skos__hiddenLabel mesh__D005184 Tubal Obstructions
% 220.92/221.07  |- mesh__activeMeSHYear mesh__D005184 2006A
% 220.92/221.07  |- skos__prefLabel mesh__D005184 Fallopian Tube Diseases
% 220.92/221.07  |- mesh__recordAuthorizer mesh__D005184 ags
% 220.92/221.07  |- skos__historyNote mesh__D005184 Fallopian Tubes %28%1966-1979%29%
% 220.92/221.08  |- skos__annotation mesh__D005184 inflamm dis = SALPINGITIS   
% 220.92/221.08  |- mesh__recordOriginator mesh__D005184 SMH
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D005184 2003
% 220.92/221.08  |- mesh__publicMeSHNote mesh__D005184 80   
% 220.92/221.08  |- mesh__dateRevised mesh__D005184 2005-07-13
% 220.92/221.08  |- skos__broader mesh__D005184smesh__D000291
% 220.92/221.08  |- rdf__type mesh__D005184sskos__Concept
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D005184 2004
% 220.92/221.08  |- mesh__recordMaintainer mesh__D005184 ags
% 220.92/221.08  |- skos__hiddenLabel mesh__D005184 Obstructions, Tubal
% 220.92/221.08  |- skos__hiddenLabel mesh__D005184 Fallopian Tube Disease
% 220.92/221.08  |- skos__hiddenLabel mesh__D005184 Disease, Fallopian Tube
% 220.92/221.08  |- mesh__dateCreated mesh__D005184 1979-05-30
% 220.92/221.08  |- skos__hiddenLabel mesh__D005184 Obstruction, Tubal
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D005184 2005
% 220.92/221.08  |- mesh__dateEstablished mesh__D005184 1980-01-01
% 220.92/221.08  |- skos__scopeNote mesh__D005184
% 220.92/221.08       Diseases involving the FALLOPIAN TUBES including neoplasms %28%FALLOPIAN TUBE NEOPLASMS%29%; SALPINGITIS; tubo-ovarian abscess; and blockage.%A%    
% 220.92/221.08  |- mesh__historyNote mesh__D005184 80   
% 220.92/221.08  |- skos__historyNote mesh__D005184 Adnexal Diseases %28%1966-1979%29%
% 220.92/221.08  |- skos__hiddenLabel mesh__D005184 Diseases, Fallopian Tube
% 220.92/221.08  |- mesh__recordMaintainer mesh__D013616 TGC
% 220.92/221.08  |- skos__prefLabel mesh__D013616 Tachycardia, Sinus
% 220.92/221.08  |- skos__hiddenLabel mesh__D013616 Tachycardias, Sinus
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013616 2005
% 220.92/221.08  |- mesh__recordOriginator mesh__D013616 VDK
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013616 2003
% 220.92/221.08  |- mesh__recordAuthorizer mesh__D013616 sjn
% 220.92/221.08  |- skos__scopeNote mesh__D013616
% 220.92/221.08       A simple tachycardia with origin in the sinus node with gradual onset and termination.%A%    
% 220.92/221.08  |- mesh__publicMeSHNote mesh__D013616
% 220.92/221.08       91; was see under TACHYCARDIA, SUPRAVENTRICULAR 1987-90   
% 220.92/221.08  |- skos__broader mesh__D013616smesh__D013617
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013616 2002
% 220.92/221.08  |- skos__historyNote mesh__D013616 Sinoatrial Node %28%1978-1986%29%
% 220.92/221.08  |- skos__historyNote mesh__D013616 Tachycardia %28%1966-1986%29%
% 220.92/221.08  |- skos__hiddenLabel mesh__D013616 Sinus Tachycardias
% 220.92/221.08  |- mesh__historyNote mesh__D013616
% 220.92/221.08       91%28%87%29%; was see under TACHYCARDIA, SUPRAVENTRICULAR 1987-90%A%  
% 220.92/221.08  |- skos__altLabel mesh__D013616 Sinus Tachycardia
% 220.92/221.08  |- mesh__dateEstablished mesh__D013616 1991-01-01
% 220.92/221.08  |- mesh__dateCreated mesh__D013616 1986-06-23
% 220.92/221.08  |- mesh__dateRevised mesh__D013616 1999-11-03
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013616 2001
% 220.92/221.08  |- skos__annotation mesh__D013616
% 220.92/221.08       sinus refers to sinus node; a supraventric tachycardia   
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013616 2006
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013616 2000
% 220.92/221.08  |- rdf__type mesh__D013616sskos__Concept
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013616 2004
% 220.92/221.08  |- skos__hiddenLabel mesh__D018301 Neoplasm, Mesothelial
% 220.92/221.08  |- rdf__type mesh__D018301sskos__Concept
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D018301 2003
% 220.92/221.08  |- mesh__publicMeSHNote mesh__D018301 94   
% 220.92/221.08  |- mesh__recordMaintainer mesh__D018301 KEV
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D018301 2001
% 220.92/221.08  |- mesh__recordAuthorizer mesh__D018301 PLS
% 220.92/221.08  |- skos__annotation mesh__D018301
% 220.92/221.08       neoplasms composed of mesothelium, NOT neoplasms located in the mesothelium: TN 135; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; restricted use: Manual 24.2.2.5; DF: NEOPL MESOTHELIAL%A%  
% 220.92/221.08  |- skos__prefLabel mesh__D018301 Neoplasms, Mesothelial
% 220.92/221.08  |- skos__altLabel mesh__D018301 Mesothelial Neoplasms
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D018301 2000
% 220.92/221.08  |- mesh__dateRevised mesh__D018301 1995-06-08
% 220.92/221.08  |- mesh__recordOriginator mesh__D018301 PLS
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D018301 1999
% 220.92/221.08  |- mesh__dateEstablished mesh__D018301 1994-01-01
% 220.92/221.08  |- mesh__historyNote mesh__D018301 94   
% 220.92/221.08  |- skos__broader mesh__D018301smesh__D009375
% 220.92/221.08  |- skos__hiddenLabel mesh__D018301 Mesothelial Neoplasm
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D018301 2006
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D018301 1998
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D018301 2002
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D018301 1997
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D018301 2005
% 220.92/221.08  |- mesh__dateCreated mesh__D018301 1993-06-25
% 220.92/221.08  |- skos__scopeNote mesh__D018301
% 220.92/221.08       Neoplasms composed of tissue of the mesothelium, the layer of flat cells, derived from the mesoderm, which lines the body cavity of the embryo. In the adult it forms the simple squamous epithelium which covers all true serous membranes %28%peritoneum, pericardium, pleura%29%. The concept does not refer to neoplasms located in these organs. %28%From Dorland, 27th ed%29%%A%    
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D018301 2004
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D018301 1996
% 220.92/221.08  |- skos__hiddenLabel mesh__D009575 O Demethylase, Nitroanisole
% 220.92/221.08  |- skos__historyNote mesh__D009575 Anisoles %28%1974%29%
% 220.92/221.08  |- skos__prefLabel mesh__D009575 Nitroanisole O-Demethylase
% 220.92/221.08  |- skos__historyNote mesh__D009575 Nitro Compounds %28%1974%29%
% 220.92/221.08  |- skos__hiddenLabel mesh__D009575 O-Demethylase, Nitroanisole
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D009575 2004
% 220.92/221.08  |- rdf__type mesh__D009575sskos__Concept
% 220.92/221.08  |- skos__scopeNote mesh__D009575
% 220.92/221.08       Oxidative enzyme which transforms p-nitroanisole into p-nitrophenol.%A%    
% 220.92/221.08  |- mesh__historyNote mesh__D009575
% 220.92/221.08       91%28%75%29%; was see under OXIDOREDUCTASES 1975-90   
% 220.92/221.08  |- mesh__dateRevised mesh__D009575 2003-07-09
% 220.92/221.08  |- skos__historyNote mesh__D009575 Oxidoreductases %28%1974%29%
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D009575 2005
% 220.92/221.08  |- mesh__publicMeSHNote mesh__D009575
% 220.92/221.08       91; was see under OXIDOREDUCTASES 1975-90   
% 220.92/221.08  |- mesh__recordMaintainer mesh__D009575 ssb
% 220.92/221.08  |- mesh__recordAuthorizer mesh__D009575 sjn
% 220.92/221.08  |- mesh__recordOriginator mesh__D009575 NLM
% 220.92/221.08  |- skos__altLabel mesh__D009575 Nitroanisole O Demethylase
% 220.92/221.08  |- skos__broader mesh__D009575smesh__D010090
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D009575 2006
% 220.92/221.08  |- mesh__dateEstablished mesh__D009575 1991-01-01
% 220.92/221.08  |- mesh__dateCreated mesh__D009575 1974-11-19
% 220.92/221.08  |- skos__hiddenLabel mesh__D009575 Demethylase, Nitroanisole O
% 220.92/221.08  |- skos__broader mesh__D001592smesh__D001593
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001592 2002
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001592 1999
% 220.92/221.08  |- rdf__type mesh__D001592sskos__Concept
% 220.92/221.08  |- mesh__dateEstablished mesh__D001592 1991-01-01
% 220.92/221.08  |- mesh__dateCreated mesh__D001592 1974-11-19
% 220.92/221.08  |- skos__historyNote mesh__D001592 Alcohols %28%1972-1974%29%
% 220.92/221.08  |- skos__prefLabel mesh__D001592 Benzyl Alcohols
% 220.92/221.08  |- skos__broader mesh__D001592smesh__D000438
% 220.92/221.08  |- mesh__publicMeSHNote mesh__D001592
% 220.92/221.08       91; was see under BENZYL COMPOUNDS 1975-90   
% 220.92/221.08  |- skos__altLabel mesh__D001592 Phenylmethanols
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001592 2003
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001592 2005
% 220.92/221.08  |- mesh__historyNote mesh__D001592
% 220.92/221.08       91%28%75%29%; was see under BENZYL COMPOUNDS 1975-90   
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001592 2000
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001592 2004
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001592 2001
% 220.92/221.08  |- skos__hiddenLabel mesh__D001592 Alcohols, Benzyl
% 220.92/221.08  |- skos__annotation mesh__D001592 BENZYL ALCOHOL also available   
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001592 2006
% 220.92/221.08  |- mesh__recordAuthorizer mesh__D001592 SJN
% 220.92/221.08  |- mesh__recordOriginator mesh__D001592 NLM
% 220.92/221.08  |- mesh__recordMaintainer mesh__D001592 ADP
% 220.92/221.08  |- skos__scopeNote mesh__D001592
% 220.92/221.08       Alcohols derived from the aryl radical %28%C6H5CH2-%29% and defined by C6H5CHOH. The concept includes derivatives with any substituents on the benzene ring.%A%    
% 220.92/221.08  |- skos__altLabel mesh__D001592 Phenylcarbinols
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001592 1998
% 220.92/221.08  |- skos__historyNote mesh__D001592 Benzyl Compounds %28%1972-1974%29%
% 220.92/221.08  |- mesh__dateRevised mesh__D001592 1997-06-20
% 220.92/221.08  |- skos__related mesh__D017209smesh__D020287
% 220.92/221.08  |- mesh__dateRevised mesh__D017209 2005-06-30
% 220.92/221.08  |- skos__prefLabel mesh__D017209 Apoptosis
% 220.92/221.08  |- skos__altLabel mesh__D017209 Programmed Cell Death, Type I
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D017209 2006
% 220.92/221.08  |- skos__related mesh__D017209smesh__D009336
% 220.92/221.08  |- mesh__historyNote mesh__D017209 93   
% 220.92/221.08  |- mesh__recordAuthorizer mesh__D017209 sjn
% 220.92/221.08  |- mesh__dateEstablished mesh__D017209 1993-01-01
% 220.92/221.08  |- rdf__type mesh__D017209sskos__Concept
% 220.92/221.08  |- skos__related mesh__D017209smesh__D041722
% 220.92/221.08  |- mesh__publicMeSHNote mesh__D017209 93   
% 220.92/221.08  |- skos__related mesh__D017209smesh__D029563
% 220.92/221.08  |- skos__annotation mesh__D017209
% 220.92/221.08       do not confuse with NECROSIS, pathological cell death; unspecified probably goes here; PROGRAMMED CELL DEATH, TYPE II see AUTOPHAGY is also available%A%  
% 220.92/221.08  |- skos__historyNote mesh__D017209 Cell Survival %28%1972-1992%29%
% 220.92/221.08  |- mesh__dateCreated mesh__D017209 1992-05-07
% 220.92/221.08  |- mesh__recordOriginator mesh__D017209 MXR
% 220.92/221.08  |- skos__scopeNote mesh__D017209
% 220.92/221.08       One of the mechanisms by which CELL DEATH occurs %28%compare with NECROSIS and AUTOPHAGOCYTOSIS%29%. Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; %28%DNA FRAGMENTATION%29%; at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.%A%    
% 220.92/221.08  |- skos__related mesh__D017209smesh__D020170
% 220.92/221.08  |- mesh__recordMaintainer mesh__D017209 ssb
% 220.92/221.08  |- skos__broader mesh__D017209smesh__D016923
% 220.92/221.08  |- skos__annotation mesh__D005983 a plant protein   
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D005983 2003
% 220.92/221.08  |- mesh__recordAuthorizer mesh__D005983 sjn
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D005983 2005
% 220.92/221.08  |- skos__altLabel mesh__D005983 Glutelin
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D005983 2004
% 220.92/221.08  |- mesh__recordMaintainer mesh__D005983 jmp
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D005983 2002
% 220.92/221.08  |- mesh__dateRevised mesh__D005983 2001-07-25
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D005983 2006
% 220.92/221.08  |- mesh__recordOriginator mesh__D005983 NLM
% 220.92/221.08  |- skos__altLabel mesh__D005983 Glutens
% 220.92/221.08  |- skos__prefLabel mesh__D005983 Gluten
% 220.92/221.08  |- mesh__dateCreated mesh__D005983 1999-01-01
% 220.92/221.08  |- rdf__type mesh__D005983sskos__Concept
% 220.92/221.08  |- skos__scopeNote mesh__D005983
% 220.92/221.08       A protein substance of wheat which is intermixed with the starchy endosperm of the grain. It causes the carbon dioxide produced during dough fermentation to be retained by the dough in a manner which provides the porous and spongy structure of bread. %28%From Merck Index, 11th ed%29%%A%    
% 220.92/221.08  |- skos__broader mesh__D005983smesh__D010940
% 220.92/221.08  |- skos__annotation mesh__D005185
% 220.92/221.08       coordinate IM with histologic type of neoplasm %28%IM%29%   
% 220.92/221.08  |- skos__hiddenLabel mesh__D005185 Fallopian Tube Cancers
% 220.92/221.08  |- rdf__type mesh__D005185sskos__Concept
% 220.92/221.08  |- skos__hiddenLabel mesh__D005185 Neoplasms, Fallopian Tube
% 220.92/221.08  |- mesh__recordAuthorizer mesh__D005185 jls
% 220.92/221.08  |- skos__prefLabel mesh__D005185 Fallopian Tube Neoplasms
% 220.92/221.08  |- mesh__recordOriginator mesh__D005185 NLM
% 220.92/221.08  |- skos__scopeNote mesh__D005185
% 220.92/221.08       Benign or malignant neoplasms of the FALLOPIAN TUBES. They are uncommon. If they develop, they may be located in the wall or within the lumen as a growth attached to the wall by a stalk.%A%    
% 220.92/221.08  |- skos__broader mesh__D005185smesh__D005833
% 220.92/221.08  |- skos__hiddenLabel mesh__D005185 Neoplasm, Fallopian Tube
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D005185 2006A
% 220.92/221.08  |- skos__hiddenLabel mesh__D005185 Fallopian Tube Neoplasm
% 220.92/221.08  |- skos__hiddenLabel mesh__D005185 Cancers, Fallopian Tube
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D005185 2006
% 220.92/221.08  |- mesh__dateCreated mesh__D005185 1999-01-01
% 220.92/221.08  |- skos__altLabel mesh__D005185 Cancer of the Fallopian Tube
% 220.92/221.08  |- skos__broader mesh__D005185smesh__D005184
% 220.92/221.08  |- skos__hiddenLabel mesh__D005185 Cancer, Fallopian Tube
% 220.92/221.08  |- mesh__recordMaintainer mesh__D005185 jls
% 220.92/221.08  |- mesh__dateRevised mesh__D005185 2005-07-30
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013617 2001
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013617 2003
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013617 2000
% 220.92/221.08  |- skos__hiddenLabel mesh__D013617 Supraventricular Tachycardia
% 220.92/221.08  |- mesh__recordOriginator mesh__D013617 VDK
% 220.92/221.08  |- mesh__recordAuthorizer mesh__D013617 sjn
% 220.92/221.08  |- skos__annotation mesh__D013617
% 220.92/221.08       GEN: prefer specific types of supraventric tachycardia; originates above the bundle of His: do not confuse with TACHYCARDIA, VENTRICULAR which originates below the bundle of His%A%  
% 220.92/221.08  |- skos__prefLabel mesh__D013617 Tachycardia, Supraventricular
% 220.92/221.08  |- mesh__dateCreated mesh__D013617 1986-06-23
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013617 2002
% 220.92/221.08  |- mesh__historyNote mesh__D013617 87   
% 220.92/221.08  |- skos__historyNote mesh__D013617 Tachycardia %28%1966-1986%29%
% 220.92/221.08  |- skos__historyNote mesh__D013617
% 220.92/221.08       Tachycardia, Paroxysmal %28%1966-1986%29%
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013617 2006
% 220.92/221.08  |- rdf__type mesh__D013617sskos__Concept
% 220.92/221.08  |- skos__scopeNote mesh__D013617
% 220.92/221.08       A generic expression for any tachycardia that originates above the BUNDLE OF HIS.%A%    
% 220.92/221.08  |- mesh__recordMaintainer mesh__D013617 TGC
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013617 2004
% 220.92/221.08  |- skos__hiddenLabel mesh__D013617 Supraventricular Tachycardias
% 220.92/221.08  |- skos__hiddenLabel mesh__D013617 Tachycardias, Supraventricular
% 220.92/221.08  |- mesh__dateEstablished mesh__D013617 1987-01-01
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013617 2005
% 220.92/221.08  |- mesh__dateRevised mesh__D013617 1999-11-03
% 220.92/221.08  |- skos__broader mesh__D013617smesh__D013610
% 220.92/221.08  |- mesh__publicMeSHNote mesh__D013617 87   
% 220.92/221.08  |- skos__hiddenLabel mesh__D018302 Neuroepithelial Neoplasm
% 220.92/221.08  |- skos__hiddenLabel mesh__D018302 Tumors, Neuroepithelial
% 220.92/221.08  |- skos__hiddenLabel mesh__D018302 Spongioblastomas, Polar
% 220.92/221.08  |- skos__altLabel mesh__D018302 Neuroepithelial Tumors
% 220.92/221.08  |- mesh__recordOriginator mesh__D018302 PLS
% 220.92/221.08  |- skos__prefLabel mesh__D018302 Neoplasms, Neuroepithelial
% 220.92/221.08  |- skos__scopeNote mesh__D018302
% 220.92/221.08       Neoplasms composed of neuroepithelial cells, which have the capacity to differentiate into NEURONS, oligodendrocytes, and ASTROCYTES. The majority of craniospinal tumors are of neuroepithelial origin. %28%From Dev Biol 1998 Aug 1;200%28%1%29%:1-5%29%%A%    
% 220.92/221.08  |- mesh__recordAuthorizer mesh__D018302 sjn
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D018302 2002
% 220.92/221.08  |- mesh__historyNote mesh__D018302 94   
% 220.92/221.08  |- skos__hiddenLabel mesh__D018302 Polar Spongioblastomas
% 220.92/221.08  |- mesh__dateCreated mesh__D018302 1993-06-25
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D018302 2006
% 220.92/221.08  |- skos__hiddenLabel mesh__D018302 Neuroepithelial Tumor
% 220.92/221.08  |- skos__hiddenLabel mesh__D018302 Ependymoastrocytomas
% 220.92/221.08  |- mesh__publicMeSHNote mesh__D018302 94   
% 220.92/221.08  |- skos__hiddenLabel mesh__D018302 Tumor, Neuroepithelial
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D018302 2005
% 220.92/221.08  |- mesh__dateRevised mesh__D018302 1999-11-03
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D018302 2004
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D018302 2001
% 220.92/221.08  |- skos__altLabel mesh__D018302 Neuroepithelial Neoplasms
% 220.92/221.08  |- skos__annotation mesh__D018302
% 220.92/221.08       neoplasms composed of neural epithelium, NOT neoplasms located in the neural epithelium or neuroepithelium; coord IM with precoord organ/neopl term %28%IM%29%; restricted use: Manual 24.2.2.5; DF: NEOPL NEUROEPITHELIAL%A%  
% 220.92/221.08  |- skos__broader mesh__D018302smesh__D017599
% 220.92/221.08  |- rdf__type mesh__D018302sskos__Concept
% 220.92/221.08  |- mesh__recordMaintainer mesh__D018302 KEV
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D018302 2003
% 220.92/221.08  |- mesh__dateEstablished mesh__D018302 1994-01-01
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D018302 2000
% 220.92/221.08  |- skos__hiddenLabel mesh__D018302 Neoplasm, Neuroepithelial
% 220.92/221.08  |- skos__hiddenLabel mesh__D018302 Astroblastomas
% 220.92/221.08  |- skos__broader mesh__D018302smesh__D009375
% 220.92/221.08  |- skos__hiddenLabel mesh__D018302 Polar Spongioblastoma
% 220.92/221.08  |- mesh__historyNote mesh__D051736 2006%28%1991%29%   
% 220.92/221.08  |- skos__altLabel mesh__D051736 Mdm-2 Protein
% 220.92/221.08  |- skos__broader mesh__D051736smesh__D044767
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D051736 2006
% 220.92/221.08  |- skos__broader mesh__D051736smesh__D011518
% 220.92/221.08  |- skos__hiddenLabel mesh__D051736 c mdm2 Proto Oncogene Protein
% 220.92/221.08  |- skos__altLabel mesh__D051736 c-mdm2 Proto-Oncogene Protein
% 220.92/221.08  |- skos__hiddenLabel mesh__D051736 Proto-Oncogene Protein, c-mdm2
% 220.92/221.08  |- rdf__type mesh__D051736sskos__Concept
% 220.92/221.08  |- mesh__recordMaintainer mesh__D051736 DRC
% 220.92/221.08  |- skos__prefLabel mesh__D051736 Proto-Oncogene Proteins c-mdm2
% 220.92/221.08  |- skos__altLabel mesh__D051736 Murine Double Minute 2 Protein
% 220.92/221.08  |- skos__hiddenLabel mesh__D051736 Mdm 2 Protein
% 220.92/221.08  |- mesh__recordAuthorizer mesh__D051736 sjn
% 220.92/221.08  |- skos__hiddenLabel mesh__D051736 c-mdm2, Proto-Oncogene Proteins
% 220.92/221.08  |- skos__altLabel mesh__D051736 MDMX Protein
% 220.92/221.08  |- skos__altLabel mesh__D051736 Mdm2 Protein
% 220.92/221.08  |- skos__broader mesh__D051736smesh__D009687
% 220.92/221.08  |- mesh__dateCreated mesh__D051736 2005-06-30
% 220.92/221.08  |- mesh__recordOriginator mesh__D051736 DRC
% 220.92/221.08  |- mesh__publicMeSHNote mesh__D051736
% 220.92/221.08       2006; PROTO-ONCOGENE PROTEINS C-MDM2 was indexed under PROTO-ONCOGENE PROTEINS 2005, %26% under NUCLEAR PROTEINS 1991-2005, %26% under NEOPLASM PROTEINS 1991-2004%A%  
% 220.92/221.08  |- skos__hiddenLabel mesh__D051736 Proto Oncogene Proteins c mdm2
% 220.92/221.08  |- mesh__dateEstablished mesh__D051736 2006-01-01
% 220.92/221.08  |- skos__altLabel mesh__D051736 Double Minute 2 Protein
% 220.92/221.08  |- skos__scopeNote mesh__D051736
% 220.92/221.08       An E3 UBIQUITIN LIGASE that interacts with and inhibits TUMOR SUPPRESSOR PROTEIN P53. Its ability to ubiquitinate p53 is regulated by TUMOR SUPPRESSOR PROTEIN P14ARF.%A%    
% 220.92/221.08  |- mesh__recordOriginator mesh__D009576 NLM
% 220.92/221.08  |- mesh__dateCreated mesh__D009576 1999-01-01
% 220.92/221.08  |- skos__broader mesh__D009576smesh__D041841
% 220.92/221.08  |- skos__prefLabel mesh__D009576 Nitrobacter
% 220.92/221.08  |- rdf__type mesh__D009576sskos__Concept
% 220.92/221.08  |- mesh__dateRevised mesh__D009576 2005-06-30
% 220.92/221.08  |- mesh__recordMaintainer mesh__D009576 SYSTEM
% 220.92/221.08  |- skos__scopeNote mesh__D009576
% 220.92/221.08       A genus of gram-negative, rod-shaped bacteria that oxidizes nitrites to nitrates. Its organisms occur in aerobic environments where organic matter is being mineralized, including soil, fresh water, and sea water.%A%    
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D009576 2006
% 220.92/221.08  |- mesh__recordAuthorizer mesh__D009576 sjn
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001593 2003
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001593 2001
% 220.92/221.08  |- skos__annotation mesh__D001593
% 220.92/221.08       do not confuse with benzil; DF: BENZYL CPDS   
% 220.92/221.08  |- mesh__recordOriginator mesh__D001593 NLM
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001593 2005
% 220.92/221.08  |- mesh__recordMaintainer mesh__D001593 TGC
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001593 2004
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001593 2006
% 220.92/221.08  |- mesh__dateRevised mesh__D001593 1992-05-08
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001593 1996
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001593 2002
% 220.92/221.08  |- mesh__dateCreated mesh__D001593 1999-01-01
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001593 1998
% 220.92/221.08  |- mesh__historyNote mesh__D001593 72%28%71%29%   
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001593 1997
% 220.92/221.08  |- mesh__dateEstablished mesh__D001593 1972-01-01
% 220.92/221.08  |- skos__prefLabel mesh__D001593 Benzyl Compounds
% 220.92/221.08  |- mesh__publicMeSHNote mesh__D001593 72   
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001593 1994
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001593 1999
% 220.92/221.08  |- rdf__type mesh__D001593sskos__Concept
% 220.92/221.08  |- mesh__recordAuthorizer mesh__D001593 PLS
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001593 1993
% 220.92/221.08  |- skos__broader mesh__D001593smesh__D001555
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001593 1995
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D001593 2000
% 220.92/221.08  |- skos__hiddenLabel mesh__D001593 Compounds, Benzyl
% 220.92/221.08  |- skos__historyNote mesh__D001593 Benzene Derivatives %28%1968-1970%29%
% 220.92/221.08  |- mesh__publicMeSHNote mesh__D042401 2004   
% 220.92/221.08  |- skos__broader mesh__D042401smesh__D020562
% 220.92/221.08  |- skos__prefLabel mesh__D042401 Alcaligenaceae
% 220.92/221.08  |- mesh__historyNote mesh__D042401 2004   
% 220.92/221.08  |- mesh__recordAuthorizer mesh__D042401 sjn
% 220.92/221.08  |- mesh__recordOriginator mesh__D042401 ags
% 220.92/221.08  |- mesh__dateRevised mesh__D042401 2005-06-30
% 220.92/221.08  |- skos__scopeNote mesh__D042401
% 220.92/221.08       A family of gram-negative, aerobic, non-spore forming rods or cocci. Well known genera include ACHROMOBACTER; ALCALIGENES; and BORDETELLA.%A%    
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D042401 2006
% 220.92/221.08  |- rdf__type mesh__D042401sskos__Concept
% 220.92/221.08  |- mesh__dateCreated mesh__D042401 2003-07-09
% 220.92/221.08  |- mesh__recordMaintainer mesh__D042401 SYSTEM
% 220.92/221.08  |- skos__broader mesh__D042401smesh__D016946
% 220.92/221.08  |- mesh__dateEstablished mesh__D042401 2004-01-01
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D014710 2003
% 220.92/221.08  |- skos__hiddenLabel mesh__D014710 Fetal Versions
% 220.92/221.08  |- rdf__type mesh__D014710sskos__Concept
% 220.92/221.08  |- skos__hiddenLabel mesh__D014710 Cephalic Version, External
% 220.92/221.08  |- mesh__dateCreated mesh__D014710 1999-01-01
% 220.92/221.08  |- mesh__dateEstablished mesh__D014710 1991-01-01
% 220.92/221.08  |- skos__prefLabel mesh__D014710 Version, Fetal
% 220.92/221.08  |- skos__hiddenLabel mesh__D014710 Versions, External Cephalic
% 220.92/221.08  |- mesh__recordOriginator mesh__D014710 NLM
% 220.92/221.08  |- skos__hiddenLabel mesh__D014710 External Cephalic Versions
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D014710 2006
% 220.92/221.08  |- mesh__publicMeSHNote mesh__D014710
% 220.92/221.08       91; was see under DELIVERY 1981-90; was VERSION see under DELIVERY 1963-80%A%  
% 220.92/221.08  |- skos__hiddenLabel mesh__D014710 Cephalic Versions, External
% 220.92/221.08  |- mesh__recordMaintainer mesh__D014710 ags
% 220.92/221.08  |- skos__altLabel mesh__D014710 External Cephalic Version
% 220.92/221.08  |- skos__hiddenLabel mesh__D014710 Versions, Fetal
% 220.92/221.08  |- skos__broader mesh__D014710smesh__D036861
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D014710 2005
% 220.92/221.08  |- skos__scopeNote mesh__D014710
% 220.92/221.08       The artificial alteration of the fetal position to facilitate birth.%A%    
% 220.92/221.08  |- skos__altLabel mesh__D014710 Fetal Version
% 220.92/221.08  |- mesh__recordAuthorizer mesh__D014710 sjn
% 220.92/221.08  |- mesh__onlineNote mesh__D014710
% 220.92/221.08       to search VERSION use VERSION, FETAL 1975-80 %26% DELIVERY 1966-74%A%  
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D014710 2004
% 220.92/221.08  |- mesh__dateRevised mesh__D014710 2002-07-03
% 220.92/221.08  |- mesh__historyNote mesh__D014710
% 220.92/221.08       91%28%81%29%; was see under DELIVERY 1981-90; was VERSION see under DELIVERY 1963-80%A%  
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D005984 2005
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D005984 2004
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D005984 2006
% 220.92/221.08  |- mesh__recordAuthorizer mesh__D005984 sjn
% 220.92/221.08  |- mesh__dateCreated mesh__D005984 1999-01-01
% 220.92/221.08  |- rdf__type mesh__D005984sskos__Concept
% 220.92/221.08  |- skos__scopeNote mesh__D005984
% 220.92/221.08       A hypnotic and sedative. Its use has been largely superseded by other drugs.%A%    
% 220.92/221.08  |- mesh__recordOriginator mesh__D005984 NLM
% 220.92/221.08  |- skos__broader mesh__D005984smesh__D010881
% 220.92/221.08  |- mesh__dateRevised mesh__D005984 2003-07-09
% 220.92/221.08  |- mesh__recordMaintainer mesh__D005984 ssb
% 220.92/221.08  |- skos__prefLabel mesh__D005984 Glutethimide
% 220.92/221.08  |- mesh__dateEstablished mesh__D005186 1975-09-01
% 220.92/221.08  |- mesh__dateCreated mesh__D005186 1974-11-19
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D005186 2005
% 220.92/221.08  |- skos__scopeNote mesh__D005186
% 220.92/221.08       Methods for assessing the patency of the fallopian tubes.%A%    
% 220.92/221.08  |- skos__altLabel mesh__D005186 Patency Tests, Fallopian Tube
% 220.92/221.08  |- skos__historyNote mesh__D005186 Infertility, Female/DI %28%1966-1974%29%
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D005186 2006
% 220.92/221.08  |- skos__historyNote mesh__D005186 Hysterosalpingography %28%1966-1974%29%
% 220.92/221.08  |- skos__historyNote mesh__D005186 Fallopian Tubes %28%1966-1974%29%
% 220.92/221.08  |- skos__prefLabel mesh__D005186 Fallopian Tube Patency Tests
% 220.92/221.08  |- skos__broader mesh__D005186smesh__D003944
% 220.92/221.08  |- mesh__recordOriginator mesh__D005186 NLM
% 220.92/221.08  |- mesh__recordAuthorizer mesh__D005186 sjn
% 220.92/221.08  |- skos__annotation mesh__D005186 NIM   
% 220.92/221.08  |- mesh__recordMaintainer mesh__D005186 lkt
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D005186 2002
% 220.92/221.08  |- mesh__dateRevised mesh__D005186 2001-07-25
% 220.92/221.08  |- mesh__publicMeSHNote mesh__D005186 75   
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D005186 2003
% 220.92/221.08  |- rdf__type mesh__D005186sskos__Concept
% 220.92/221.08  |- mesh__historyNote mesh__D005186 75   
% 220.92/221.08  |- skos__broader mesh__D005186smesh__D012099
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D005186 2004
% 220.92/221.08  |- mesh__publicMeSHNote mesh__D013618 66   
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013618 2001A
% 220.92/221.08  |- mesh__dateEstablished mesh__D013618 1966-01-01
% 220.92/221.08  |- skos__annotation mesh__D013618
% 220.92/221.08       %22%rapidly decreasing response to a drug or physiol active agent after admin of a few doses%22%%A%  
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013618 2006
% 220.92/221.08  |- skos__scopeNote mesh__D013618
% 220.92/221.08       Rapidly decreasing response to a drug or physiologically active agent after administration of a few doses. In immunology, it is the rapid immunization against the effect of toxic doses of an extract or serum by previous injection of small doses. %28%Dorland, 28th ed%29%%A%    
% 220.92/221.08  |- rdf__type mesh__D013618sskos__Concept
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013618 2001
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013618 2004
% 220.92/221.08  |- skos__broader mesh__D013618smesh__D007108
% 220.92/221.08  |- mesh__dateRevised mesh__D013618 2001-05-17
% 220.92/221.08  |- mesh__recordMaintainer mesh__D013618 sjn
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013618 2005
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013618 2000
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013618 1999
% 220.92/221.08  |- mesh__recordOriginator mesh__D013618 NLM
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013618 2003
% 220.92/221.08  |- mesh__dateCreated mesh__D013618 1999-01-01
% 220.92/221.08  |- mesh__activeMeSHYear mesh__D013618 1997
% 220.92/221.08  |- mesh__historyNote mesh__D013618 66%28%63%29%   
% 220.92/221.09  |- skos__prefLabel mesh__D013618 Tachyphylaxis
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D013618 1998
% 220.92/221.09  |- mesh__recordAuthorizer mesh__D013618 sjn
% 220.92/221.09  |- skos__broader mesh__D013618smesh__D004361
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D013618 2002
% 220.92/221.09  |- skos__prefLabel mesh__D010320 Parvalbumins
% 220.92/221.09  |- mesh__dateRevised mesh__D010320 2005-06-30
% 220.92/221.09  |- skos__historyNote mesh__D010320 Muscle Proteins %28%1973-1976%29%
% 220.92/221.09  |- mesh__recordMaintainer mesh__D010320 SYSTEM
% 220.92/221.09  |- skos__broader mesh__D010320smesh__D000418
% 220.92/221.09  |- skos__annotation mesh__D010320
% 220.92/221.09       muscle proteins; /biosyn /physiol permitted   
% 220.92/221.09  |- rdf__type mesh__D010320sskos__Concept
% 220.92/221.09  |- skos__scopeNote mesh__D010320
% 220.92/221.09       Low molecular weight, calcium binding muscle proteins. Their physiological function is possibly related to the contractile process.%A%    
% 220.92/221.09  |- skos__hiddenLabel mesh__D010320 B, Parvalbumin
% 220.92/221.09  |- skos__broader mesh__D010320smesh__D009124
% 220.92/221.09  |- mesh__recordOriginator mesh__D010320 RLS
% 220.92/221.09  |- mesh__publicMeSHNote mesh__D010320
% 220.92/221.09       91; was see under MUSCLE PROTEINS 1977-90   
% 220.92/221.09  |- mesh__recordAuthorizer mesh__D010320 sjn
% 220.92/221.09  |- mesh__historyNote mesh__D010320
% 220.92/221.09       91%28%77%29%; was see under MUSCLE PROTEINS 1977-90   
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D010320 2006
% 220.92/221.09  |- mesh__dateCreated mesh__D010320 1976-04-13
% 220.92/221.09  |- mesh__dateEstablished mesh__D010320 1991-01-01
% 220.92/221.09  |- mesh__historyNote mesh__D018303 94   
% 220.92/221.09  |- mesh__recordMaintainer mesh__D018303 jls
% 220.92/221.09  |- mesh__dateEstablished mesh__D018303 1994-01-01
% 220.92/221.09  |- skos__hiddenLabel mesh__D018303 Intracranial Ganglioglioma
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D018303 2000
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D018303 2006
% 220.92/221.09  |- skos__hiddenLabel mesh__D018303 Malignant Ganglioglioma
% 220.92/221.09  |- skos__hiddenLabel mesh__D018303 Gangliogliomas, Intracranial
% 220.92/221.09  |- skos__hiddenLabel mesh__D018303 Gangliogliomas
% 220.92/221.09  |- mesh__dateRevised mesh__D018303 1999-11-08
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D018303 2005
% 220.92/221.09  |- mesh__recordAuthorizer mesh__D018303 sjn
% 220.92/221.09  |- skos__hiddenLabel mesh__D018303 Benign Ganglioglioma
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D018303 2004
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D018303 2002
% 220.92/221.09  |- skos__hiddenLabel mesh__D018303 Gangliogliomas, Malignant
% 220.92/221.09  |- rdf__type mesh__D018303sskos__Concept
% 220.92/221.09  |- skos__historyNote mesh__D018303 Neuroblastoma %28%1966-1993%29%
% 220.92/221.09  |- skos__scopeNote mesh__D018303
% 220.92/221.09       Rare indolent tumors comprised of neoplastic glial and neuronal cells which occur primarily in children and young adults. Benign lesions tend to be associated with long survival unless the tumor degenerates into a histologically malignant form. They tend to occur in the optic nerve and white matter of the brain and spinal cord.%A%    
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D018303 2003
% 220.92/221.09  |- mesh__dateCreated mesh__D018303 1993-06-25
% 220.92/221.09  |- mesh__publicMeSHNote mesh__D018303 94   
% 220.92/221.09  |- skos__broader mesh__D018303smesh__D005910
% 220.92/221.09  |- skos__hiddenLabel mesh__D018303 Benign Gangliogliomas
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D018303 2001
% 220.92/221.09  |- skos__hiddenLabel mesh__D018303 Intracranial Gangliogliomas
% 220.92/221.09  |- mesh__recordOriginator mesh__D018303 PLS
% 220.92/221.09  |- skos__hiddenLabel mesh__D018303 Malignant Gangliogliomas
% 220.92/221.09  |- skos__annotation mesh__D018303
% 220.92/221.09       coord IM with probably BRAIN NEOPLASMS %28%IM%29% + site %28%IM%29%   
% 220.92/221.09  |- skos__prefLabel mesh__D018303 Ganglioglioma
% 220.92/221.09  |- skos__hiddenLabel mesh__D018303 Gangliogliomas, Benign
% 220.92/221.09  |- mesh__recordAuthorizer mesh__D001594 PLS
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D001594 2004
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D001594 2006
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D001594 2000
% 220.92/221.09  |- mesh__dateRevised mesh__D001594 1992-05-08
% 220.92/221.09  |- skos__hiddenLabel mesh__D001594 Viologen, Benzyl
% 220.92/221.09  |- mesh__historyNote mesh__D001594
% 220.92/221.09       91%28%75%29%; was see under PYRIDINIUM COMPOUNDS 1975-90   
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D001594 2001
% 220.92/221.09  |- skos__annotation mesh__D001594 an indicator   
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D001594 1996
% 220.92/221.09  |- skos__prefLabel mesh__D001594 Benzyl Viologen
% 220.92/221.09  |- mesh__recordOriginator mesh__D001594 NLM
% 220.92/221.09  |- mesh__recordMaintainer mesh__D001594 TAP
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D001594 1998
% 220.92/221.09  |- skos__historyNote mesh__D001594 Benzyl Compounds %28%1972-1974%29%
% 220.92/221.09  |- mesh__publicMeSHNote mesh__D001594
% 220.92/221.09       91; was see under PYRIDINIUM COMPOUNDS 1975-90   
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D001594 1997
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D001594 1994
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D001594 1999
% 220.92/221.09  |- skos__broader mesh__D001594smesh__D014755
% 220.92/221.09  |- rdf__type mesh__D001594sskos__Concept
% 220.92/221.09  |- mesh__dateCreated mesh__D001594 1974-11-19
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D001594 1993
% 220.92/221.09  |- skos__historyNote mesh__D001594 Pyridinium Compounds %28%1970-1974%29%
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D001594 2002
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D001594 1995
% 220.92/221.09  |- mesh__dateEstablished mesh__D001594 1991-01-01
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D001594 2003
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D001594 2005
% 220.92/221.09  |- skos__scopeNote mesh__D001594
% 220.92/221.09       1,1%27%-Bis%28%phenylmethyl%29%4,4%27%-bipyridinium dichloride. Oxidation-reduction indicator.%A%    
% 220.92/221.09  |- skos__historyNote mesh__D042402 Alcaligenes %28%1965-2003%29%
% 220.92/221.09  |- skos__prefLabel mesh__D042402 Achromobacter
% 220.92/221.09  |- mesh__historyNote mesh__D042402
% 220.92/221.09       2004, 1963-1975; use ALCALIGENES 1976-2003   
% 220.92/221.09  |- mesh__publicMeSHNote mesh__D042402
% 220.92/221.09       2004; see ALCALIGENES 1976-2003, see ACROMOBACTER 1963-1975%A%  
% 220.92/221.09  |- skos__annotation mesh__D042402
% 220.92/221.09       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 220.92/221.09  |- mesh__recordAuthorizer mesh__D042402 sjn
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D042402 2006
% 220.92/221.09  |- mesh__recordOriginator mesh__D042402 ags
% 220.92/221.09  |- rdf__type mesh__D042402sskos__Concept
% 220.92/221.09  |- mesh__dateCreated mesh__D042402 2003-07-09
% 220.92/221.09  |- mesh__recordMaintainer mesh__D042402 SYSTEM
% 220.92/221.09  |- mesh__dateRevised mesh__D042402 2005-06-30
% 220.92/221.09  |- skos__broader mesh__D042402smesh__D042401
% 220.92/221.09  |- skos__scopeNote mesh__D042402
% 220.92/221.09       A genus of gram-negative, strictly aerobic, non-spore forming rods. Soil and water are regarded as the natural habitat. They are sometimes isolated from a hospital environment and humans.%A%    
% 220.92/221.09  |- mesh__dateEstablished mesh__D042402 2004-01-01
% 220.92/221.09  |- skos__broader mesh__D014711smesh__D001158
% 220.92/221.09  |- rdf__type mesh__D014711sskos__Concept
% 220.92/221.09  |- mesh__dateCreated mesh__D014711 1999-01-01
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014711 2003
% 220.92/221.09  |- skos__hiddenLabel mesh__D014711 Arteries, Vertebral
% 220.92/221.09  |- mesh__recordOriginator mesh__D014711 NLM
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014711 1995
% 220.92/221.09  |- skos__prefLabel mesh__D014711 Vertebral Artery
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014711 1999
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014711 1994
% 220.92/221.09  |- skos__hiddenLabel mesh__D014711 Artery, Vertebral
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014711 2002
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014711 1998
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014711 1993
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014711 2006
% 220.92/221.09  |- skos__scopeNote mesh__D014711
% 220.92/221.09       The first branch of the subclavian artery with distribution to muscles of the neck, vertebrae, spinal cord, cerebellum and interior of the cerebrum.%A%    
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014711 2001
% 220.92/221.09  |- mesh__recordMaintainer mesh__D014711 TAP
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014711 1997
% 220.92/221.09  |- mesh__dateRevised mesh__D014711 1992-05-18
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014711 2005
% 220.92/221.09  |- mesh__recordAuthorizer mesh__D014711 PLS
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014711 2000
% 220.92/221.09  |- skos__hiddenLabel mesh__D014711 Vertebral Arteries
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014711 1996
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014711 2004
% 220.92/221.09  |- mesh__dateCreated mesh__D005985 1999-01-01
% 220.92/221.09  |- mesh__recordOriginator mesh__D005985 NLM
% 220.92/221.09  |- rdf__type mesh__D005985sskos__Concept
% 220.92/221.09  |- skos__broader mesh__D005985smesh__D000447
% 220.92/221.09  |- mesh__recordMaintainer mesh__D005985 ssb
% 220.92/221.09  |- skos__prefLabel mesh__D005985 Glyceraldehyde
% 220.92/221.09  |- skos__broader mesh__D005985smesh__D014306
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D005985 2005
% 220.92/221.09  |- mesh__recordAuthorizer mesh__D005985 sjn
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D005985 2006
% 220.92/221.09  |- mesh__dateRevised mesh__D005985 2004-07-07
% 220.92/221.09  |- skos__altLabel mesh__D038361 Frameless Stereotaxy
% 220.92/221.09  |- mesh__dateEstablished mesh__D038361 2003-01-01
% 220.92/221.09  |- skos__broader mesh__D038361smesh__D007090
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D038361 2003
% 220.92/221.09  |- skos__scopeNote mesh__D038361
% 220.92/221.09       Intraoperative computer-assisted 3D navigation and guidance system generally used in neurosurgery for tracking surgical tools and localize them with respect to the patient%27%s 3D anatomy. The pre-operative diagnostic scan is used as a reference and is transferred onto the operative field during surgery.%A%    
% 220.92/221.09  |- skos__historyNote mesh__D038361 Stereotaxic Techniques %28%1995-2002%29%
% 220.92/221.09  |- mesh__historyNote mesh__D038361 2003   
% 220.92/221.09  |- skos__historyNote mesh__D038361 Neurosurgery %28%1995-2002%29%
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D038361 2004
% 220.92/221.09  |- skos__hiddenLabel mesh__D038361 Stereotaxy, Frameless
% 220.92/221.09  |- mesh__publicMeSHNote mesh__D038361 2003   
% 220.92/221.09  |- rdf__type mesh__D038361sskos__Concept
% 220.92/221.09  |- skos__related mesh__D038361smesh__D025321
% 220.92/221.09  |- mesh__dateCreated mesh__D038361 2002-07-03
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D038361 2005
% 220.92/221.09  |- skos__broader mesh__D038361smesh__D013238
% 220.92/221.09  |- skos__prefLabel mesh__D038361 Neuronavigation
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D038361 2006
% 220.92/221.09  |- mesh__recordAuthorizer mesh__D005187 sjn
% 220.92/221.09  |- rdf__type mesh__D005187sskos__Concept
% 220.92/221.09  |- skos__related mesh__D005187smesh__D013246
% 220.92/221.09  |- skos__related mesh__D005187smesh__D012489
% 220.92/221.09  |- skos__hiddenLabel mesh__D005187 Oviduct, Mammalian
% 220.92/221.09  |- mesh__dateRevised mesh__D005187 2005-06-30
% 220.92/221.09  |- skos__altLabel mesh__D005187 Fallopian Tube
% 220.92/221.09  |- skos__altLabel mesh__D005187 Salpinges
% 220.92/221.09  |- mesh__dateCreated mesh__D005187 1999-01-01
% 220.92/221.09  |- mesh__recordMaintainer mesh__D005187 lkt
% 220.92/221.09  |- skos__hiddenLabel mesh__D005187 Tubes, Fallopian
% 220.92/221.09  |- skos__related mesh__D005187smesh__D007047
% 220.92/221.09  |- skos__prefLabel mesh__D005187 Fallopian Tubes
% 220.92/221.09  |- skos__annotation mesh__D005187
% 220.92/221.09       mammalian only; non-mammalian use OVIDUCTS; inflammation = SALPINGITIS; tubal sterilization = STERILIZATION, TUBAL; %22%fallopian%22% is not capitalized in titles or translations%A%  
% 220.92/221.09  |- skos__hiddenLabel mesh__D005187 Mammalian Oviducts
% 220.92/221.09  |- skos__broader mesh__D005187smesh__D000290
% 220.92/221.09  |- skos__hiddenLabel mesh__D005187 Tube, Fallopian
% 220.92/221.09  |- skos__scopeNote mesh__D005187
% 220.92/221.09       A pair of highly specialized muscular canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM collection, and the site for the final maturation of gametes and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three histologic layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells.%A%    
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D005187 2006
% 220.92/221.09  |- skos__broader mesh__D005187smesh__D010057
% 220.92/221.09  |- skos__hiddenLabel mesh__D005187 Tube, Uterine
% 220.92/221.09  |- skos__hiddenLabel mesh__D005187 Mammalian Oviduct
% 220.92/221.09  |- skos__altLabel mesh__D005187 Salpinx
% 220.92/221.09  |- skos__altLabel mesh__D005187 Oviducts, Mammalian
% 220.92/221.09  |- skos__hiddenLabel mesh__D005187 Tubes, Uterine
% 220.92/221.09  |- skos__altLabel mesh__D005187 Uterine Tubes
% 220.92/221.09  |- mesh__recordOriginator mesh__D005187 NLM
% 220.92/221.09  |- skos__related mesh__D005187smesh__D010057
% 220.92/221.09  |- skos__hiddenLabel mesh__D005187 Uterine Tube
% 220.92/221.09  |- skos__scopeNote mesh__D013619
% 220.92/221.09       A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer%27%s disease and other central nervous system disorders.%A%    
% 220.92/221.09  |- mesh__dateCreated mesh__D013619 1974-11-19
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D013619 2006
% 220.92/221.09  |- mesh__recordAuthorizer mesh__D013619 sjn
% 220.92/221.09  |- mesh__dateEstablished mesh__D013619 1991-01-01
% 220.92/221.09  |- mesh__historyNote mesh__D013619
% 220.92/221.09       91%28%75%29%; was see under AMINOACRIDINES 1984-90; was see under ACRIDINES 1975-83%A%  
% 220.92/221.09  |- rdf__type mesh__D013619sskos__Concept
% 220.92/221.09  |- skos__altLabel mesh__D013619 9-Amino-1,2,3,4-Tetrahydroacridine
% 220.92/221.09  |- skos__altLabel mesh__D013619 1,2,3,4-Tetrahydro-9-acridinamine
% 220.92/221.09  |- skos__broader mesh__D013619smesh__D000609
% 220.92/221.09  |- mesh__publicMeSHNote mesh__D013619
% 220.92/221.09       91; was see under AMINOACRIDINES 1984-90; was see under ACRIDINES 1975-83%A%  
% 220.92/221.09  |- skos__altLabel mesh__D013619 OTL Pharm Brand of Tacrine Hydrochloride
% 220.92/221.09  |- mesh__recordOriginator mesh__D013619 NLM
% 220.92/221.09  |- skos__historyNote mesh__D013619 Amines %28%1972-1974%29%
% 220.92/221.09  |- skos__historyNote mesh__D013619 Acridines %28%1969-1974%29%
% 220.92/221.09  |- skos__altLabel mesh__D013619 Horizon Brand of Tacrine Hydrochloride
% 220.92/221.09  |- mesh__dateRevised mesh__D013619 2005-06-30
% 220.92/221.09  |- skos__altLabel mesh__D013619 Woods Brand of Tacrine Hydrochloride
% 220.92/221.09  |- skos__prefLabel mesh__D013619 Tacrine
% 220.92/221.09  |- mesh__recordMaintainer mesh__D013619 CCR
% 220.92/221.09  |- skos__altLabel mesh__D013619 Parke Davis Brand of Tacrine Hydrochloride
% 220.92/221.09  |- skos__altLabel mesh__D013619 1,2,3,4-Tetrahydroaminoacridine
% 220.92/221.09  |- skos__altLabel mesh__D013619 Tetrahydroaminoacridine
% 220.92/221.09  |- mesh__historyNote mesh__D024341 2002   
% 220.92/221.09  |- mesh__dateEstablished mesh__D024341 2002-01-01
% 220.92/221.09  |- skos__historyNote mesh__D024341 Lutein %28%1965-2001%29%
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D024341 2006
% 220.92/221.09  |- rdf__type mesh__D024341sskos__Concept
% 220.92/221.09  |- skos__hiddenLabel mesh__D024341 Carotenoids, Xanthophyll
% 220.92/221.09  |- skos__scopeNote mesh__D024341
% 220.92/221.09       Oxygenated forms of carotenoids. They are usually derived from alpha and beta carotene.%A%    
% 220.92/221.09  |- skos__broader mesh__D024341smesh__D002338
% 220.92/221.09  |- mesh__publicMeSHNote mesh__D024341 2002   
% 220.92/221.09  |- skos__prefLabel mesh__D024341 Xanthophylls
% 220.92/221.09  |- mesh__recordOriginator mesh__D024341 jmp
% 220.92/221.09  |- skos__altLabel mesh__D024341 Xanthophyll Carotenoids
% 220.92/221.09  |- mesh__recordAuthorizer mesh__D024341 sjn
% 220.92/221.09  |- mesh__dateRevised mesh__D024341 2005-06-30
% 220.92/221.09  |- mesh__recordMaintainer mesh__D024341 ssb
% 220.92/221.09  |- mesh__dateCreated mesh__D024341 2001-07-25
% 220.92/221.09  |- mesh__recordMaintainer mesh__D010321 ags
% 220.92/221.09  |- skos__prefLabel mesh__D010321 Parvoviridae
% 220.92/221.09  |- rdf__type mesh__D010321sskos__Concept
% 220.92/221.09  |- mesh__onlineNote mesh__D010321
% 220.92/221.09       use PARVOVIRIDAE to search PARVOVIRUSES 1974-80   
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D010321 2005
% 220.92/221.09  |- mesh__dateEstablished mesh__D010321 1974-01-01
% 220.92/221.09  |- skos__annotation mesh__D010321 infection = PARVOVIRIDAE INFECTIONS   
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D010321 2006
% 220.92/221.09  |- mesh__dateRevised mesh__D010321 2004-07-07
% 220.92/221.09  |- skos__scopeNote mesh__D010321
% 220.92/221.09       A family of very small DNA viruses containing a single molecule of single-stranded DNA and consisting of two subfamilies: PARVOVIRINAE and DENSOVIRINAE. They infect both vertebrates and invertebrates.%A%    
% 220.92/221.09  |- mesh__recordOriginator mesh__D010321 NLM
% 220.92/221.09  |- mesh__dateCreated mesh__D010321 1999-01-01
% 220.92/221.09  |- skos__broader mesh__D010321smesh__D004267
% 220.92/221.09  |- mesh__historyNote mesh__D010321 81; was PARVOVIRUSES 1974-80   
% 220.92/221.09  |- mesh__recordAuthorizer mesh__D010321 sjn
% 220.92/221.09  |- skos__altLabel mesh__D010321 Picodnaviruses
% 220.92/221.09  |- mesh__publicMeSHNote mesh__D010321 81; was PARVOVIRUSES 1974-80   
% 220.92/221.09  |- skos__altLabel mesh__D018304 Neuroblastoma, Olfactory
% 220.92/221.09  |- skos__broader mesh__D018304smesh__D009447
% 220.92/221.09  |- skos__hiddenLabel mesh__D018304 Esthesioneuroblastomas
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D018304 2006
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D018304 2003
% 220.92/221.09  |- skos__hiddenLabel mesh__D018304 Olfactory Neuroblastomas
% 220.92/221.09  |- skos__hiddenLabel mesh__D018304
% 220.92/221.09       Paranasal Sinus Nasal Cavity Esthesioneuroblastoma
% 220.92/221.09  |- mesh__dateEstablished mesh__D018304 1994-01-01
% 220.92/221.09  |- skos__hiddenLabel mesh__D018304 Esthesioneuroblastomas, Olfactory
% 220.92/221.09  |- skos__broader mesh__D018304smesh__D020431
% 220.92/221.09  |- skos__scopeNote mesh__D018304
% 220.92/221.09       A malignant olfactory neuroblastoma arising from the olfactory epithelium of the superior nasal cavity and cribriform plate. It is uncommon %28%3%25% of nasal tumors%29% and rarely is associated with the production of excess hormones %28%e.g., SIADH, Cushing Syndrome%29%. It has a high propensity for multiple local recurrences and bony metastases. %28%From Holland et al., Cancer Medicine, 3rd ed, p1245; J Laryngol Otol 1998 Jul;112%28%7%29%:628-33%29%%A%    
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D018304 2004
% 220.92/221.09  |- skos__historyNote mesh__D018304 Neuroepithelioma %28%1966-1993%29%
% 220.92/221.09  |- skos__altLabel mesh__D018304 Esthesioneuroblastoma
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D018304 2002
% 220.92/221.09  |- skos__hiddenLabel mesh__D018304 Neuroblastomas, Olfactory
% 220.92/221.09  |- mesh__publicMeSHNote mesh__D018304
% 220.92/221.09       2000; see ESTHESIONEUROBLASTOMA 1994-1999   
% 220.92/221.09  |- skos__hiddenLabel mesh__D018304
% 220.92/221.09       Esthesioneuroblastoma, Paranasal Sinus Nasal Cavity
% 220.92/221.09  |- rdf__type mesh__D018304sskos__Concept
% 220.92/221.09  |- mesh__dateRevised mesh__D018304 2001-07-25
% 220.92/221.09  |- mesh__recordMaintainer mesh__D018304 ags
% 220.92/221.09  |- skos__hiddenLabel mesh__D018304 Olfactory Esthesioneuroblastoma
% 220.92/221.09  |- skos__altLabel mesh__D018304 Aesthesioneuroblastoma
% 220.92/221.09  |- mesh__recordAuthorizer mesh__D018304 sjn
% 220.92/221.09  |- skos__annotation mesh__D018304
% 220.92/221.09       coord IM with NASAL CAVITY %28%IM%29% + NOSE NEOPLASMS %28%IM%29%   
% 220.92/221.09  |- skos__hiddenLabel mesh__D018304 Aesthesioneuroblastomas
% 220.92/221.09  |- skos__prefLabel mesh__D018304 Esthesioneuroblastoma, Olfactory
% 220.92/221.09  |- skos__hiddenLabel mesh__D018304 Olfactory Esthesioneuroblastomas
% 220.92/221.09  |- skos__altLabel mesh__D018304
% 220.92/221.09       Paranasal Sinus-Nasal Cavity Esthesioneuroblastoma
% 220.92/221.09  |- skos__altLabel mesh__D018304
% 220.92/221.09       Esthesioneuroblastoma, Paranasal Sinus-Nasal Cavity
% 220.92/221.09  |- mesh__historyNote mesh__D018304 2000%28%1994%29%   
% 220.92/221.09  |- mesh__recordOriginator mesh__D018304 PLS
% 220.92/221.09  |- mesh__dateCreated mesh__D018304 1993-06-25
% 220.92/221.09  |- skos__altLabel mesh__D018304 Olfactory Neuroblastoma
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D018304 2005
% 220.92/221.09  |- rdf__type mesh__D051738sskos__Concept
% 220.92/221.09  |- mesh__recordOriginator mesh__D051738 DRC
% 220.92/221.09  |- skos__prefLabel mesh__D051738 Origin Recognition Complex
% 220.92/221.09  |- mesh__dateCreated mesh__D051738 2005-06-30
% 220.92/221.09  |- mesh__publicMeSHNote mesh__D051738
% 220.92/221.09       2006; ORIGIN RECOGNTION COMPLEX was indexed under DNA-BINDING PROTEINS 1997-2005, %26% under REPRESSOR PROTEINS 1993-1996, %26% under FUNGAL PROTEINS 1993-1995%A%  
% 220.92/221.09  |- skos__altLabel mesh__D051738 ORC2 Protein
% 220.92/221.09  |- skos__altLabel mesh__D051738 ORC4 Protein
% 220.92/221.09  |- skos__scopeNote mesh__D051738
% 220.92/221.09       The origin recognition complex is a multi-subunit DNA-binding protein that initiates DNA REPLICATION in eukaryotes.%A%    
% 220.92/221.09  |- mesh__dateEstablished mesh__D051738 2006-01-01
% 220.92/221.09  |- mesh__historyNote mesh__D051738 2006%28%1993%29%   
% 220.92/221.09  |- skos__altLabel mesh__D051738 ORC1 Protein
% 220.92/221.09  |- mesh__recordMaintainer mesh__D051738 DRC
% 220.92/221.09  |- skos__altLabel mesh__D051738 ORC5 Protein
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D051738 2006
% 220.92/221.09  |- skos__broader mesh__D051738smesh__D004268
% 220.92/221.09  |- mesh__recordAuthorizer mesh__D051738 sjn
% 220.92/221.09  |- skos__altLabel mesh__D051738 ORC3 Protein
% 220.92/221.09  |- skos__altLabel mesh__D051738 ORC6 Protein
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D009578 2006
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D009578 2000
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D009578 1995
% 220.92/221.09  |- skos__broader mesh__D009578smesh__D009574
% 220.92/221.09  |- skos__prefLabel mesh__D009578 Nitrobenzenes
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D009578 2001
% 220.92/221.09  |- skos__broader mesh__D009578smesh__D001555
% 220.92/221.09  |- mesh__recordMaintainer mesh__D009578 TAP
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D009578 2002
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D009578 1996
% 220.92/221.09  |- mesh__dateRevised mesh__D009578 1992-05-19
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D009578 2003
% 220.92/221.09  |- mesh__dateCreated mesh__D009578 1999-01-01
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D009578 1997
% 220.92/221.09  |- mesh__recordOriginator mesh__D009578 NLM
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D009578 2004
% 220.92/221.09  |- mesh__recordAuthorizer mesh__D009578 PLS
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D009578 1998
% 220.92/221.09  |- rdf__type mesh__D009578sskos__Concept
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D009578 1993
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D009578 2005
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D009578 1994
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D009578 1999
% 220.92/221.09  |- skos__historyNote mesh__D001595 Benzyl Compounds %28%1973-1974%29%
% 220.92/221.09  |- skos__hiddenLabel mesh__D001595 Clorgyline Resistant Amine Oxidase
% 220.92/221.09  |- skos__hiddenLabel mesh__D001595 Oxidase, Benzylamine
% 220.92/221.09  |- mesh__dateEstablished mesh__D001595 1991-01-01
% 220.92/221.09  |- skos__broader mesh__D001595smesh__D008995
% 220.92/221.09  |- skos__hiddenLabel mesh__D001595 Oxidase, Clorgyline-Resistant Amine
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D001595 2006
% 220.92/221.09  |- mesh__historyNote mesh__D001595
% 220.92/221.09       91%28%75%29%; was see under MONOAMINE OXIDASE 1975-90   
% 220.92/221.09  |- mesh__dateRevised mesh__D001595 2005-06-30
% 220.92/221.09  |- skos__prefLabel mesh__D001595 Benzylamine Oxidase
% 220.92/221.09  |- mesh__publicMeSHNote mesh__D001595
% 220.92/221.09       91; was see under MONOAMINE OXIDASE 1975-90   
% 220.92/221.09  |- mesh__dateCreated mesh__D001595 1974-11-19
% 220.92/221.09  |- skos__historyNote mesh__D001595 Monoamine Oxidase %28%1973-1974%29%
% 220.92/221.09  |- mesh__recordOriginator mesh__D001595 NLM
% 220.92/221.09  |- mesh__recordMaintainer mesh__D001595 jmp
% 220.92/221.09  |- rdf__type mesh__D001595sskos__Concept
% 220.92/221.09  |- skos__hiddenLabel mesh__D001595 Amine Oxidase, Clorgyline-Resistant
% 220.92/221.09  |- skos__scopeNote mesh__D001595
% 220.92/221.09       An aspect of monoamine oxidase, EC 1.4.3.4. Catalyzes the oxidation of benzylamine to form benzaldehyde, ammonia and hydrogen peroxide.%A%    
% 220.92/221.09  |- mesh__recordAuthorizer mesh__D001595 sjn
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D006280 2004
% 220.92/221.09  |- skos__altLabel mesh__D006280 Manpower, Health
% 220.92/221.09  |- skos__broader mesh__D006280smesh__D006295
% 220.92/221.09  |- skos__altLabel mesh__D006280 Health Occupations Manpower
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D006280 2000
% 220.92/221.09  |- skos__annotation mesh__D006280
% 220.92/221.09       = availability of HEALTH PERSONNEL: do not confuse with the HEALTH PERSONNEL themselves, the persons in the field of health care %26% delivery; GEN only: prefer /manpower with specific headings; when GEN %26% IM, /educ = HEALTH OCCUPATIONS /educ or HEALTH PERSONNEL /educ; DF: HEALTH MAN%A%  
% 220.92/221.09  |- mesh__recordMaintainer mesh__D006280 kle
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D006280 2003
% 220.92/221.09  |- mesh__dateEstablished mesh__D006280 1968-01-01
% 220.92/221.09  |- skos__prefLabel mesh__D006280 Health Manpower
% 220.92/221.09  |- mesh__dateRevised mesh__D006280 1999-11-03
% 220.92/221.09  |- mesh__recordOriginator mesh__D006280 NLM
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D006280 2006
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D006280 2002
% 220.92/221.09  |- skos__altLabel mesh__D006280 Manpower, Health Occupations
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D006280 2005
% 220.92/221.09  |- mesh__publicMeSHNote mesh__D006280 68   
% 220.92/221.09  |- skos__broader mesh__D006280smesh__D005159
% 220.92/221.09  |- skos__hiddenLabel mesh__D006280 Manpower Need
% 220.92/221.09  |- skos__historyNote mesh__D006280 Health Occupations %28%1966-1967%29%
% 220.92/221.09  |- skos__scopeNote mesh__D006280
% 220.92/221.09       The availability of HEALTH PERSONNEL. It includes the demand and recruitment of both professional and allied health personnel, their present and future supply and distribution, and their assignment and utilization.%A%    
% 220.92/221.09  |- skos__hiddenLabel mesh__D006280 Human Resource
% 220.92/221.09  |- mesh__historyNote mesh__D006280 68   
% 220.92/221.09  |- mesh__dateCreated mesh__D006280 1999-01-01
% 220.92/221.09  |- skos__hiddenLabel mesh__D006280 Resource, Human
% 220.92/221.09  |- skos__hiddenLabel mesh__D006280 Resources, Human
% 220.92/221.09  |- rdf__type mesh__D006280sskos__Concept
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D006280 2001
% 220.92/221.09  |- mesh__recordAuthorizer mesh__D006280 sjn
% 220.92/221.09  |- skos__scopeNote mesh__D014712
% 220.92/221.09       Viruses infecting man and other vertebrates.     
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014712 1999
% 220.92/221.09  |- skos__prefLabel mesh__D014712 Vertebrate Viruses
% 220.92/221.09  |- skos__historyNote mesh__D014712 Viruses %28%1966-1997%29%
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014712 1998
% 220.92/221.09  |- mesh__recordAuthorizer mesh__D014712 SJN
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014712 2006
% 220.92/221.09  |- mesh__recordOriginator mesh__D014712 NLM
% 220.92/221.09  |- mesh__publicMeSHNote mesh__D014712
% 220.92/221.09       98, 66-91; see ANIMAL VIRUSES 1963-65   
% 220.92/221.09  |- mesh__dateRevised mesh__D014712 1997-06-26
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014712 2005
% 220.92/221.09  |- skos__hiddenLabel mesh__D014712 Vertebrate Virus
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014712 2002
% 220.92/221.09  |- skos__broader mesh__D014712smesh__D014780
% 220.92/221.09  |- mesh__historyNote mesh__D014712
% 220.92/221.09       98, 66-91; use ANIMAL VIRUSES 1963-65; use pre-explosion   
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014712 2004
% 220.92/221.09  |- mesh__recordMaintainer mesh__D014712 TGC
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014712 2001
% 220.92/221.09  |- mesh__dateEstablished mesh__D014712 1966-01-01
% 220.92/221.09  |- skos__annotation mesh__D014712 not used for indexing   
% 220.92/221.09  |- rdf__type mesh__D014712sskos__Concept
% 220.92/221.09  |- mesh__dateCreated mesh__D014712 1999-01-01
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014712 2003
% 220.92/221.09  |- skos__hiddenLabel mesh__D014712 Virus, Vertebrate
% 220.92/221.09  |- skos__hiddenLabel mesh__D014712 Viruses, Vertebrate
% 220.92/221.09  |- mesh__onlineNote mesh__D014712
% 220.92/221.09       pre-explosion = VERTEBRATE VIRUSES %28%PX%29%   
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D014712 2000
% 220.92/221.09  |- skos__historyNote mesh__D005986
% 220.92/221.09       Glyceraldehyde %28%1966-1974%29% /AA %28%1975-1979%29%
% 220.92/221.09  |- mesh__dateCreated mesh__D005986 1979-02-21
% 220.92/221.09  |- mesh__dateEstablished mesh__D005986 1991-01-01
% 220.92/221.09  |- skos__broader mesh__D005986smesh__D005985
% 220.92/221.09  |- skos__annotation mesh__D005986 /physiol permitted   
% 220.92/221.09  |- mesh__recordOriginator mesh__D005986 RLS
% 220.92/221.09  |- skos__hiddenLabel mesh__D005986 Glyceraldehyde 3 Phosphate
% 220.92/221.09  |- mesh__activeMeSHYear mesh__D005986 2005
% 220.92/221.10  |- mesh__recordMaintainer mesh__D005986 ssb
% 220.92/221.10  |- skos__hiddenLabel mesh__D005986 3 Phosphoglyceraldehyde
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D005986 2006
% 220.92/221.10  |- skos__prefLabel mesh__D005986 Glyceraldehyde 3-Phosphate
% 220.92/221.10  |- skos__altLabel mesh__D005986 3-Phosphoglyceraldehyde
% 220.92/221.10  |- mesh__dateRevised mesh__D005986 2004-07-07
% 220.92/221.10  |- skos__scopeNote mesh__D005986
% 220.92/221.10       An aldotriose which is an important intermediate in glycolysis and in tryptophan biosynthesis.%A%    
% 220.92/221.10  |- mesh__historyNote mesh__D005986
% 220.92/221.10       91%28%80%29%; was see under GLYCERALDEHYDE 1980-90   
% 220.92/221.10  |- mesh__recordAuthorizer mesh__D005986 sjn
% 220.92/221.10  |- mesh__publicMeSHNote mesh__D005986
% 220.92/221.10       91; was see under GLYCERALDEHYDE 1980-90   
% 220.92/221.10  |- rdf__type mesh__D005986sskos__Concept
% 220.92/221.10  |- mesh__dateEstablished mesh__D038362 2003-01-01
% 220.92/221.10  |- mesh__historyNote mesh__D038362
% 220.92/221.10       2003; use GLYCOGEN SYNTHASE KINASE 3 %28%NM%29% 1995-2002   
% 220.92/221.10  |- mesh__dateCreated mesh__D038362 2002-07-03
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D038362 2006
% 220.92/221.10  |- mesh__publicMeSHNote mesh__D038362
% 220.92/221.10       2003; GLYCOGEN SYNTEHASE KINASE 3 was indexed under CA%28%2+%29%-CALMODULIN PROTEIN KINASE 1995-2002%A%  
% 220.92/221.10  |- skos__historyNote mesh__D038362
% 220.92/221.10       Ca%28%2+%29%-Calmodulin Dependent Protein Kinase %28%1995-2002%29%
% 220.92/221.10  |- mesh__recordMaintainer mesh__D038362 jmp
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D038362 2005
% 220.92/221.10  |- skos__prefLabel mesh__D038362 Glycogen Synthase Kinase 3
% 220.92/221.10  |- mesh__recordOriginator mesh__D038362 jmp
% 220.92/221.10  |- skos__broader mesh__D038362smesh__D038341
% 220.92/221.10  |- mesh__recordAuthorizer mesh__D038362 sjn
% 220.92/221.10  |- skos__altLabel mesh__D038362 gsk-3 Gene Product
% 220.92/221.10  |- skos__scopeNote mesh__D038362
% 220.92/221.10       A glycogen synthase kinase that was originally described as a key enzyme involved in glycogen metabolism. It regulates a diverse array of functions such as CELL DIVISION, microtubule function and APOPTOSIS.%A%    
% 220.92/221.10  |- skos__broader mesh__D038362smesh__D038461
% 220.92/221.10  |- skos__altLabel mesh__D038362 GSK-3
% 220.92/221.10  |- rdf__type mesh__D038362sskos__Concept
% 220.92/221.10  |- mesh__dateRevised mesh__D038362 2004-07-07
% 220.92/221.10  |- mesh__recordMaintainer mesh__D005188 PXP
% 220.92/221.10  |- rdf__type mesh__D005188sskos__Concept
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D005188 2000
% 220.92/221.10  |- skos__scopeNote mesh__D005188
% 220.92/221.10       Negative test results in subjects who possess the attribute for which the test is conducted. The labeling of diseased persons as healthy when screening in the detection of disease. %28%Last, A Dictionary of Epidemiology, 2d ed%29%%A%    
% 220.92/221.10  |- mesh__dateCreated mesh__D005188 1999-01-01
% 220.92/221.10  |- skos__hiddenLabel mesh__D005188 Reaction, False Negative
% 220.92/221.10  |- mesh__recordOriginator mesh__D005188 NLM
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D005188 1999
% 220.92/221.10  |- mesh__publicMeSHNote mesh__D005188 73   
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D005188 1998
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D005188 2006
% 220.92/221.10  |- skos__annotation mesh__D005188 NIM; no qualif   
% 220.92/221.10  |- mesh__dateRevised mesh__D005188 1997-06-20
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D005188 2005
% 220.92/221.10  |- skos__broader mesh__D005188smesh__D003951
% 220.92/221.10  |- skos__hiddenLabel mesh__D005188 Reactions, False Negative
% 220.92/221.10  |- skos__historyNote mesh__D005188 Diagnosis %28%1966-1969%29%
% 220.92/221.10  |- skos__prefLabel mesh__D005188 False Negative Reactions
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D005188 2002
% 220.92/221.10  |- mesh__historyNote mesh__D005188 73%28%70%29%   
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D005188 2004
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D005188 2001
% 220.92/221.10  |- skos__hiddenLabel mesh__D005188 False Negative Reaction
% 220.92/221.10  |- mesh__recordAuthorizer mesh__D005188 SJN
% 220.92/221.10  |- mesh__dateEstablished mesh__D005188 1973-01-01
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D005188 2003
% 220.92/221.10  |- skos__historyNote mesh__D024342 Amino Acids %28%1968-2001%29%
% 220.92/221.10  |- mesh__dateCreated mesh__D024342 2001-07-25
% 220.92/221.10  |- mesh__historyNote mesh__D024342 2002   
% 220.92/221.10  |- mesh__publicMeSHNote mesh__D024342 2002   
% 220.92/221.10  |- skos__prefLabel mesh__D024342 Amino Acids, Acidic
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D024342 2002
% 220.92/221.10  |- skos__altLabel mesh__D024342 Amino Acid, Acidic
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D024342 2003
% 220.92/221.10  |- skos__broader mesh__D024342smesh__D000596
% 220.92/221.10  |- skos__altLabel mesh__D024342 Acidic Amino Acids
% 220.92/221.10  |- skos__historyNote mesh__D024342 specific amino acids %28%1970-2001%29%
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D024342 2005
% 220.92/221.10  |- skos__scopeNote mesh__D024342
% 220.92/221.10       Amino acids with side chains that are negatively charged at physiological pH.%A%    
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D024342 2004
% 220.92/221.10  |- mesh__dateEstablished mesh__D024342 2002-01-01
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D024342 2006
% 220.92/221.10  |- rdf__type mesh__D024342sskos__Concept
% 220.92/221.10  |- skos__hiddenLabel mesh__D024342 Acidic Amino Acid
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010322 2004
% 220.92/221.10  |- skos__historyNote mesh__D010322 Parvoviridae %28%1981-1983%29%
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010322 1996
% 220.92/221.10  |- rdf__type mesh__D010322sskos__Concept
% 220.92/221.10  |- skos__hiddenLabel mesh__D010322 Parvovirus Infection
% 220.92/221.10  |- mesh__recordAuthorizer mesh__D010322 PLS
% 220.92/221.10  |- mesh__onlineNote mesh__D010322
% 220.92/221.10       use PARVOVIRIDAE INFECTIONS to search PARVOVIRUS INFECTIONS 1984-93%A%  
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010322 1997
% 220.92/221.10  |- mesh__recordOriginator mesh__D010322 RC
% 220.92/221.10  |- mesh__recordMaintainer mesh__D010322 AGS
% 220.92/221.10  |- skos__hiddenLabel mesh__D010322 Infection, Parvoviridae
% 220.92/221.10  |- mesh__dateRevised mesh__D010322 1993-06-04
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010322 2002
% 220.92/221.10  |- skos__altLabel mesh__D010322 Infections, Parvoviridae
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010322 2005
% 220.92/221.10  |- skos__altLabel mesh__D010322 Parvovirus Infections
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010322 1994
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010322 2006
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010322 2000
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010322 1998
% 220.92/221.10  |- mesh__dateCreated mesh__D010322 1983-06-15
% 220.92/221.10  |- mesh__dateEstablished mesh__D010322 1984-01-01
% 220.92/221.10  |- skos__historyNote mesh__D010322 Virus Diseases %28%1966-1983%29%
% 220.92/221.10  |- skos__broader mesh__D010322smesh__D004266
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010322 1995
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010322 2003
% 220.92/221.10  |- mesh__historyNote mesh__D010322 94; was PARVOVIRUS INFECTIONS 1984-93   
% 220.92/221.10  |- skos__prefLabel mesh__D010322 Parvoviridae Infections
% 220.92/221.10  |- skos__hiddenLabel mesh__D010322 Parvoviridae Infection
% 220.92/221.10  |- skos__hiddenLabel mesh__D010322 Infection, Parvovirus
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010322 2001
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010322 1999
% 220.92/221.10  |- mesh__publicMeSHNote mesh__D010322
% 220.92/221.10       94; was PARVOVIRUS INFECTIONS 1984-93   
% 220.92/221.10  |- skos__historyNote mesh__D010322 Dog Diseases %28%1966-1983%29%
% 220.92/221.10  |- skos__scopeNote mesh__D010322
% 220.92/221.10       Virus infections caused by the PARVOVIRIDAE.     
% 220.92/221.10  |- skos__annotation mesh__D010322 GEN or unspecified; prefer specifics   
% 220.92/221.10  |- skos__prefLabel mesh__D018305 Ganglioneuroblastoma
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D018305 2004
% 220.92/221.10  |- mesh__dateCreated mesh__D018305 1993-06-25
% 220.92/221.10  |- skos__hiddenLabel mesh__D018305 Ganglioneuroblastomas
% 220.92/221.10  |- skos__annotation mesh__D018305
% 220.92/221.10       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D018305 2000
% 220.92/221.10  |- rdf__type mesh__D018305sskos__Concept
% 220.92/221.10  |- skos__historyNote mesh__D018305 Neuroblastoma %28%1966-1993%29%
% 220.92/221.10  |- skos__scopeNote mesh__D018305
% 220.92/221.10       A moderately malignant neoplasm composed of primitive neuroectodermal cells dispersed in myxomatous or fibrous stroma intermixed with mature ganglion cells. It may undergo transformation into a neuroblastoma. It arises from the sympathetic trunk or less frequently from the adrenal medulla, cerebral cortex, and other locations. Cervical ganglioneuroblastomas may be associated with HORNER SYNDROME and the tumor may occasionally secrete vasoactive intestinal peptide, resulting in chronic diarrhea.%A%    
% 220.92/221.10  |- mesh__publicMeSHNote mesh__D018305 94   
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D018305 2001
% 220.92/221.10  |- skos__historyNote mesh__D018305 Ganglioneuroma %28%1966-1993%29%
% 220.92/221.10  |- mesh__dateEstablished mesh__D018305 1994-01-01
% 220.92/221.10  |- mesh__recordMaintainer mesh__D018305 jls
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D018305 2002
% 220.92/221.10  |- mesh__dateRevised mesh__D018305 1999-11-08
% 220.92/221.10  |- mesh__recordOriginator mesh__D018305 PLS
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D018305 2005
% 220.92/221.10  |- skos__broader mesh__D018305smesh__D009447
% 220.92/221.10  |- mesh__historyNote mesh__D018305 94   
% 220.92/221.10  |- mesh__recordAuthorizer mesh__D018305 sjn
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D018305 2006
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D018305 2003
% 220.92/221.10  |- skos__scopeNote mesh__D051739
% 220.92/221.10       A basic helix-loop-helix leucine zipper transcription factor that regulates the CELL DIFFERENTIATION and development of a variety of cell types including MELANOCYTES; OSTEOCLASTS; and RETINAL PIGMENT EPITHELIUM. Mutations in MITF protein have been associated with OSTEOPETROSIS and WAARDENBURG%27%S SYNDROME.%A%    
% 220.92/221.10  |- mesh__historyNote mesh__D051739 2006%28%1993%29%   
% 220.92/221.10  |- mesh__recordAuthorizer mesh__D051739 ags
% 220.92/221.10  |- skos__altLabel mesh__D051739 MITF Transcription Factor
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D051739 2006A
% 220.92/221.10  |- mesh__publicMeSHNote mesh__D051739
% 220.92/221.10       2006; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1993-2005%A%  
% 220.92/221.10  |- skos__altLabel mesh__D051739 Transcription Factor Microphthalmia
% 220.92/221.10  |- mesh__recordMaintainer mesh__D051739 ags
% 220.92/221.10  |- skos__hiddenLabel mesh__D051739
% 220.92/221.10       Microphthalmia Associated Transcription Factor
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D051739 2006
% 220.92/221.10  |- skos__altLabel mesh__D051739 MITF Protein
% 220.92/221.10  |- mesh__dateRevised mesh__D051739 2005-07-13
% 220.92/221.10  |- mesh__dateCreated mesh__D051739 2005-06-30
% 220.92/221.10  |- skos__broader mesh__D051739smesh__D051778
% 220.92/221.10  |- rdf__type mesh__D051739sskos__Concept
% 220.92/221.10  |- skos__prefLabel mesh__D051739
% 220.92/221.10       Microphthalmia-Associated Transcription Factor
% 220.92/221.10  |- mesh__recordOriginator mesh__D051739 DRC
% 220.92/221.10  |- skos__hiddenLabel mesh__D051739 Microphthalmia, Transcription Factor
% 220.92/221.10  |- mesh__dateEstablished mesh__D051739 2006-01-01
% 220.92/221.10  |- skos__hiddenLabel mesh__D051739
% 220.92/221.10       Transcription Factor, Microphthalmia-Associated
% 220.92/221.10  |- skos__prefLabel mesh__D048790 Renilla
% 220.92/221.10  |- skos__altLabel mesh__D048790 Sea Pansy
% 220.92/221.10  |- mesh__publicMeSHNote mesh__D048790 2005   
% 220.92/221.10  |- skos__broader mesh__D048790smesh__D037421
% 220.92/221.10  |- skos__historyNote mesh__D048790 Cnidaria %28%1965-2002%29%
% 220.92/221.10  |- mesh__recordAuthorizer mesh__D048790 ags
% 220.92/221.10  |- skos__scopeNote mesh__D048790
% 220.92/221.10       A genus of bioluminescent marine invertebrates in the family Renillidae, order Pennatulacea, class ANTHOZOA. It contains Renilla LUCIFERASE which oxidizes coelenterazine resulting in LUMINESCENCE.%A%    
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D048790 2006
% 220.92/221.10  |- mesh__dateCreated mesh__D048790 2004-07-07
% 220.92/221.10  |- mesh__recordMaintainer mesh__D048790 ags
% 220.92/221.10  |- mesh__dateRevised mesh__D048790 2005-07-28
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D048790 2006A
% 220.92/221.10  |- skos__historyNote mesh__D048790 Anthozoa %28%2002-2004%29%
% 220.92/221.10  |- mesh__historyNote mesh__D048790 2005   
% 220.92/221.10  |- mesh__recordOriginator mesh__D048790 ags
% 220.92/221.10  |- mesh__dateEstablished mesh__D048790 2005-01-01
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D048790 2005
% 220.92/221.10  |- rdf__type mesh__D048790sskos__Concept
% 220.92/221.10  |- rdf__type mesh__D009579sskos__Concept
% 220.92/221.10  |- skos__broader mesh__D009579smesh__D001565
% 220.92/221.10  |- mesh__recordOriginator mesh__D009579 NLM
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D009579 2002
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D009579 1999
% 220.92/221.10  |- skos__historyNote mesh__D009579 Benzoates %28%1968-1974%29%
% 220.92/221.10  |- mesh__historyNote mesh__D009579 75   
% 220.92/221.10  |- mesh__recordMaintainer mesh__D009579 ADP
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D009579 2006
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D009579 2001
% 220.92/221.10  |- skos__prefLabel mesh__D009579 Nitrobenzoates
% 220.92/221.10  |- mesh__dateEstablished mesh__D009579 1975-09-01
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D009579 2005
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D009579 2000
% 220.92/221.10  |- mesh__dateCreated mesh__D009579 1974-11-11
% 220.92/221.10  |- mesh__publicMeSHNote mesh__D009579 75   
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D009579 2004
% 220.92/221.10  |- skos__scopeNote mesh__D009579
% 220.92/221.10       Benzoic acid or benzoic acid esters substituted with one or more nitro groups.%A%    
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D009579 2003
% 220.92/221.10  |- mesh__dateRevised mesh__D009579 1998-06-10
% 220.92/221.10  |- mesh__recordAuthorizer mesh__D009579 SJN
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D001596 2003
% 220.92/221.10  |- mesh__dateEstablished mesh__D001596 1987-01-01
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D001596 2001
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D001596 2006
% 220.92/221.10  |- mesh__recordAuthorizer mesh__D001596 PLS
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D001596 1997
% 220.92/221.10  |- skos__historyNote mesh__D001596 Amines %28%1969-1975%29%
% 220.92/221.10  |- mesh__historyNote mesh__D001596
% 220.92/221.10       87%28%76%29%; was see under AMINES 1976-86   
% 220.92/221.10  |- skos__historyNote mesh__D001596 Benzyl Compounds %28%1974-1975%29%
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D001596 2000
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D001596 2005
% 220.92/221.10  |- skos__broader mesh__D001596smesh__D001593
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D001596 1993
% 220.92/221.10  |- skos__scopeNote mesh__D001596
% 220.92/221.10       Toluenes in which one hydrogen of the methyl group is substituted by an amino group. Permitted are any substituents on the benzene ring or the amino group.%A%    
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D001596 1996
% 220.92/221.10  |- mesh__dateCreated mesh__D001596 1975-07-23
% 220.92/221.10  |- mesh__recordMaintainer mesh__D001596 TGC
% 220.92/221.10  |- mesh__dateRevised mesh__D001596 1992-05-08
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D001596 1999
% 220.92/221.10  |- rdf__type mesh__D001596sskos__Concept
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D001596 2002
% 220.92/221.10  |- skos__prefLabel mesh__D001596 Benzylamines
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D001596 1995
% 220.92/221.10  |- mesh__recordOriginator mesh__D001596 RLS
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D001596 1998
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D001596 2004
% 220.92/221.10  |- skos__hiddenLabel mesh__D001596 alpha Aminotoluene
% 220.92/221.10  |- mesh__publicMeSHNote mesh__D001596 87; was see under AMINES 1976-86   
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D001596 1994
% 220.92/221.10  |- skos__broader mesh__D001596smesh__D000588
% 220.92/221.10  |- skos__broader mesh__D007998Q000193smesh__D007998
% 220.92/221.10  |- rdf__type mesh__D007998Q000193smesh__CompoundConcept
% 220.92/221.10  |- mesh__dateEstablished mesh__D006281 1968-01-01
% 220.92/221.10  |- skos__hiddenLabel mesh__D006281 Health Occupation
% 220.92/221.10  |- skos__scopeNote mesh__D006281
% 220.92/221.10       Professions or other business activities directed to the cure and prevention of disease. For occupations of medical personnel who are not physicians but who are working in the fields of medical technology, physical therapy, etc., ALLIED HEALTH OCCUPATIONS is available.%A%    
% 220.92/221.10  |- skos__hiddenLabel mesh__D006281 Occupation, Health
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D006281 2001
% 220.92/221.10  |- mesh__recordAuthorizer mesh__D006281 sjn
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D006281 2006
% 220.92/221.10  |- mesh__runningHead mesh__D006281 G2 - HEALTH OCCUPATIONS   
% 220.92/221.10  |- skos__hiddenLabel mesh__D006281 Professions, Health
% 220.92/221.10  |- mesh__onlineNote mesh__D006281
% 220.92/221.10       use HEALTH OCCUPATIONS to search HEALTH PROFESSIONS 1966-67%A%  
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D006281 2000
% 220.92/221.10  |- mesh__publicMeSHNote mesh__D006281 68; was HEALTH PROFESSIONS 1963-67   
% 220.92/221.10  |- mesh__recordMaintainer mesh__D006281 kle
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D006281 2005
% 220.92/221.10  |- skos__hiddenLabel mesh__D006281 Profession, Health
% 220.92/221.10  |- mesh__dateCreated mesh__D006281 1999-01-01
% 220.92/221.10  |- mesh__dateRevised mesh__D006281 1999-11-03
% 220.92/221.10  |- skos__hiddenLabel mesh__D006281 Occupations, Health
% 220.92/221.10  |- mesh__recordOriginator mesh__D006281 NLM
% 220.92/221.10  |- skos__prefLabel mesh__D006281 Health Occupations
% 220.92/221.10  |- rdf__type mesh__D006281sskos__Concept
% 220.92/221.10  |- skos__altLabel mesh__D006281 Health Professions
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D006281 2002
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D006281 2004
% 220.92/221.10  |- mesh__historyNote mesh__D006281 68; was HEALTH PROFESSIONS 1963-67   
% 220.92/221.10  |- skos__hiddenLabel mesh__D006281 Health Profession
% 220.92/221.10  |- skos__annotation mesh__D006281
% 220.92/221.10       the occup themselves: do not confuse with OCCUPATIONAL HEALTH %28%see note there%29%; SPEC: SPEC qualif; ALLIED HEALTH OCCUPATIONS is also available; for health aides try HEALTH MANPOWER or ALLIED HEALTH PERSONNEL or PHYSICIAN ASSISTANTS; DF: HEALTH OCCUP%A%  
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D006281 2003
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D014713 2000
% 220.92/221.10  |- mesh__recordAuthorizer mesh__D014713 PLS
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D014713 1995
% 220.92/221.10  |- mesh__dateRevised mesh__D014713 1993-06-03
% 220.92/221.10  |- mesh__dateEstablished mesh__D014713 1966-01-01
% 220.92/221.10  |- mesh__historyNote mesh__D014713
% 220.92/221.10       92; was VERTEBRATE VIRUSES, UNCLASSIFIED 1966-91   
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D014713 1999
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D014713 2005
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D014713 2001
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D014713 1996
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D014713 2006
% 220.92/221.10  |- mesh__publicMeSHNote mesh__D014713
% 220.92/221.10       92; was VERTEBRATE VIRUSES, UNCLASSIFIED 1966-91   
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D014713 1997
% 220.92/221.10  |- mesh__dateCreated mesh__D014713 1999-01-01
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D014713 2003
% 220.92/221.10  |- skos__annotation mesh__D014713
% 220.92/221.10       viruses of as yet unclassified taxonomy: author will state %22%unclassified%22%: do not confuse with viruses %22%unnamed%22% or unspecified by the author %28% = probably VIRUSES%29%; GEN: avoid; infections by unclassified viruses: coord IM with VIRUS DISEASES %28%IM%29%%A%  
% 220.92/221.10  |- skos__prefLabel mesh__D014713 Viruses, Unclassified
% 220.92/221.10  |- mesh__recordMaintainer mesh__D014713 TGC
% 220.92/221.10  |- skos__broader mesh__D014713smesh__D014780
% 220.92/221.10  |- skos__scopeNote mesh__D014713
% 220.92/221.10       Viruses whose taxonomic relationships have not been established.%A%    
% 220.92/221.10  |- mesh__onlineNote mesh__D014713
% 220.92/221.10       use VIRUSES, UNCLASSIFIED to search VERTEBRATE VIRUSES, UNCLASSIFIED 1966-91%A%  
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D014713 2002
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D014713 2004
% 220.92/221.10  |- mesh__recordOriginator mesh__D014713 NLM
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D014713 1994
% 220.92/221.10  |- rdf__type mesh__D014713sskos__Concept
% 220.92/221.10  |- skos__hiddenLabel mesh__D014713 Unclassified Virus
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D014713 1998
% 220.92/221.10  |- skos__hiddenLabel mesh__D014713 Unclassified Viruses
% 220.92/221.10  |- skos__hiddenLabel mesh__D005987 Dehydrogenase, Triosephosphate
% 220.92/221.10  |- skos__altLabel mesh__D005987 Phosphoglyceraldehyde Dehydrogenase
% 220.92/221.10  |- skos__broader mesh__D005987smesh__D000445
% 220.92/221.10  |- mesh__dateEstablished mesh__D005987 1965-01-01
% 220.92/221.10  |- rdf__type mesh__D005987sskos__Concept
% 220.92/221.10  |- skos__hiddenLabel mesh__D005987 Dehydrogenase, Phosphoglyceraldehyde
% 220.92/221.10  |- mesh__dateCreated mesh__D005987 1999-01-01
% 220.92/221.10  |- skos__scopeNote mesh__D005987
% 220.92/221.10       Enzymes that catalyze the dehydrogenation of GLYCERALDEHYDE 3-PHOSPHATE. Several types of glyceraldehyde-3-phosphate-dehydrogenase exist including phosphorylating and non-phosphorylating varieties and ones that transfer hydrogen to NADP and ones that transfer hydrogen to NAD.%A%    
% 220.92/221.10  |- skos__hiddenLabel mesh__D005987 Dehydrogenase, Glyceraldehydephosphate
% 220.92/221.10  |- mesh__recordAuthorizer mesh__D005987 sjn
% 220.92/221.10  |- skos__altLabel mesh__D005987 Glyceraldehydephosphate Dehydrogenase
% 220.92/221.10  |- skos__altLabel mesh__D005987 GAPD
% 220.92/221.10  |- skos__annotation mesh__D005987 GEN; note specifics   
% 220.92/221.10  |- skos__hiddenLabel mesh__D005987
% 220.92/221.10       Dehydrogenases, Glyceraldehyde-3-Phosphate
% 220.92/221.10  |- mesh__publicMeSHNote mesh__D005987
% 220.92/221.10       1999; see GLYCERALDEHYDEPHOSPHATE DEHYDROGENASE 1965-1998%A%  
% 220.92/221.10  |- skos__altLabel mesh__D005987 Triosephosphate Dehydrogenase
% 220.92/221.10  |- mesh__historyNote mesh__D005987 1999%28%1965%29%   
% 220.92/221.10  |- mesh__recordOriginator mesh__D005987 NLM
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D005987 2006
% 220.92/221.10  |- mesh__recordMaintainer mesh__D005987 jmp
% 220.92/221.10  |- skos__prefLabel mesh__D005987 Glyceraldehyde-3-Phosphate Dehydrogenases
% 220.92/221.10  |- mesh__dateRevised mesh__D005987 2005-06-30
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D005189 2006
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D005189 2002
% 220.92/221.10  |- skos__historyNote mesh__D005189
% 220.92/221.10       specific disease/diagnosis %28%1966-1967%29%
% 220.92/221.10  |- skos__prefLabel mesh__D005189 False Positive Reactions
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D005189 2005
% 220.92/221.10  |- skos__hiddenLabel mesh__D005189 Reaction, False Positive
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D005189 2001
% 220.92/221.10  |- skos__broader mesh__D005189smesh__D003951
% 220.92/221.10  |- skos__historyNote mesh__D005189 specific test %28%1966-1967%29%
% 220.92/221.10  |- skos__hiddenLabel mesh__D005189 False Positive Reaction
% 220.92/221.10  |- mesh__recordAuthorizer mesh__D005189 SJN
% 220.92/221.10  |- mesh__dateEstablished mesh__D005189 1970-01-01
% 220.92/221.10  |- mesh__recordMaintainer mesh__D005189 PXP
% 220.92/221.10  |- mesh__publicMeSHNote mesh__D005189 70   
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D005189 2004
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D005189 2000
% 220.92/221.10  |- mesh__recordOriginator mesh__D005189 NLM
% 220.92/221.10  |- mesh__historyNote mesh__D005189 70%28%68%29%   
% 220.92/221.10  |- skos__hiddenLabel mesh__D005189 Positive Reactions, False
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D005189 2003
% 220.92/221.10  |- rdf__type mesh__D005189sskos__Concept
% 220.92/221.10  |- skos__annotation mesh__D005189 NIM; no qualif   
% 220.92/221.10  |- mesh__dateCreated mesh__D005189 1999-01-01
% 220.92/221.10  |- skos__hiddenLabel mesh__D005189 Reactions, False Positive
% 220.92/221.10  |- skos__hiddenLabel mesh__D005189 Positive Reaction, False
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D005189 1999
% 220.92/221.10  |- mesh__dateRevised mesh__D005189 1997-06-20
% 220.92/221.10  |- skos__scopeNote mesh__D005189
% 220.92/221.10       Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. %28%Last, A Dictionary of Epidemiology, 2d ed%29%%A%    
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D005189 1998
% 220.92/221.10  |- skos__altLabel mesh__D024343 Nonocclusion
% 220.92/221.10  |- skos__altLabel mesh__D024343 Apertognathia
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D024343 2006
% 220.92/221.10  |- rdf__type mesh__D024343sskos__Concept
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D024343 2002
% 220.92/221.10  |- mesh__dateCreated mesh__D024343 2001-07-25
% 220.92/221.10  |- mesh__dateEstablished mesh__D024343 2002-01-01
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D024343 2005
% 220.92/221.10  |- skos__altLabel mesh__D024343 Openbite
% 220.92/221.10  |- skos__prefLabel mesh__D024343 Open Bite
% 220.92/221.10  |- mesh__publicMeSHNote mesh__D024343 2002   
% 220.92/221.10  |- mesh__historyNote mesh__D024343 2002   
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D024343 2004
% 220.92/221.10  |- skos__hiddenLabel mesh__D024343 Bite, Open
% 220.92/221.10  |- skos__broader mesh__D024343smesh__D008310
% 220.92/221.10  |- skos__historyNote mesh__D024343 Malocclusion %28%1965-2001%29%
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D024343 2003
% 220.92/221.10  |- skos__scopeNote mesh__D024343
% 220.92/221.10       A condition in which certain opposing teeth fail to establish occlusal contact when the jaws are closed.%A%    
% 220.92/221.10  |- skos__scopeNote mesh__D010323
% 220.92/221.10       An evanescent cutaneous reaction occurring when antibody is injected into a local area on the skin and antigen is subsequently injected intravenously along with a dye. The dye makes the rapidly occurring capillary dilatation and increased vascular permeability readily visible by leakage into the reaction site. PCA is a sensitive reaction for detecting very small quantities of antibodies and is also a method for studying the mechanisms of immediate hypersensitivity.%A%    
% 220.92/221.10  |- skos__altLabel mesh__D010323 Anaphylaxis, Passive Cutaneous
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010323 2005
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010323 2000
% 220.92/221.10  |- mesh__dateCreated mesh__D010323 1999-01-01
% 220.92/221.10  |- mesh__historyNote mesh__D010323 67%28%65%29%   
% 220.92/221.10  |- skos__broader mesh__D010323smesh__D000937
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010323 2006
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010323 2001
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010323 1998
% 220.92/221.10  |- mesh__dateEstablished mesh__D010323 1967-01-01
% 220.92/221.10  |- skos__altLabel mesh__D010323 PCA
% 220.92/221.10  |- mesh__recordMaintainer mesh__D010323 PXP
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010323 2003
% 220.92/221.10  |- skos__hiddenLabel mesh__D010323 Cutaneous Anaphylaxis, Passive
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010323 1999
% 220.92/221.10  |- mesh__dateRevised mesh__D010323 1997-06-20
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010323 2004
% 220.92/221.10  |- skos__broader mesh__D010323smesh__D012882
% 220.92/221.10  |- rdf__type mesh__D010323sskos__Concept
% 220.92/221.10  |- mesh__publicMeSHNote mesh__D010323 67   
% 220.92/221.10  |- mesh__recordAuthorizer mesh__D010323 SJN
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D010323 2002
% 220.92/221.10  |- mesh__recordOriginator mesh__D010323 NLM
% 220.92/221.10  |- skos__prefLabel mesh__D010323 Passive Cutaneous Anaphylaxis
% 220.92/221.10  |- skos__hiddenLabel mesh__D018306 Central Neurocytoma
% 220.92/221.10  |- skos__prefLabel mesh__D018306 Neurocytoma
% 220.92/221.10  |- skos__scopeNote mesh__D018306
% 220.92/221.10       A benign brain tumor composed of neural elements which most often arise from the SEPTUM PELLUCIDUM and the walls of the lateral ventricles. Immunohistochemistry and electron microscopy evaluations may reveal expression of neuron specific enolase and synaptophysin and cells containing microtubuli, neurosecretory granules, and presynaptic vesicles. %28%From Acta Med Port 1994 Feb;7%28%2%29%:113-9%29%%A%    
% 220.92/221.10  |- skos__hiddenLabel mesh__D018306 Central Neurocytomas
% 220.92/221.10  |- skos__broader mesh__D018306smesh__D001932
% 220.92/221.10  |- mesh__recordAuthorizer mesh__D018306 sjn
% 220.92/221.10  |- mesh__recordOriginator mesh__D018306 PLS
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D018306 2005
% 220.92/221.10  |- skos__hiddenLabel mesh__D018306 Neurocytomas
% 220.92/221.10  |- mesh__dateRevised mesh__D018306 2000-06-22
% 220.92/221.10  |- mesh__historyNote mesh__D018306 94   
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D018306 2006
% 220.92/221.10  |- mesh__dateCreated mesh__D018306 1993-06-25
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D018306 2003
% 220.92/221.10  |- skos__annotation mesh__D018306
% 220.92/221.10       coord IM with specific precoord  brain/neopl term %28%IM%29%   
% 220.92/221.10  |- skos__broader mesh__D018306smesh__D018302
% 220.92/221.10  |- mesh__dateEstablished mesh__D018306 1994-01-01
% 220.92/221.10  |- mesh__recordMaintainer mesh__D018306 jmp
% 220.92/221.10  |- mesh__publicMeSHNote mesh__D018306 94   
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D018306 2004
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D018306 2001
% 220.92/221.10  |- skos__historyNote mesh__D018306 Neuroblastoma %28%1973-1993%29%
% 220.92/221.10  |- rdf__type mesh__D018306sskos__Concept
% 220.92/221.10  |- skos__hiddenLabel mesh__D018306 Neurocytomas, Central
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D018306 2002
% 220.92/221.10  |- mesh__dateCreated mesh__D001597 1974-11-19
% 220.92/221.10  |- mesh__activeMeSHYear mesh__D001597 1993
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D001597 2002
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D001597 1996
% 220.92/221.11  |- mesh__dateRevised mesh__D001597 1992-05-08
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D001597 1999
% 220.92/221.11  |- skos__prefLabel mesh__D001597 Benzylidene Compounds
% 220.92/221.11  |- rdf__type mesh__D001597sskos__Concept
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D001597 1995
% 220.92/221.11  |- mesh__recordOriginator mesh__D001597 NLM
% 220.92/221.11  |- skos__scopeNote mesh__D001597
% 220.92/221.11       Compounds containing the PhCH= radical.     
% 220.92/221.11  |- mesh__recordMaintainer mesh__D001597 TAP
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D001597 1998
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D001597 2004
% 220.92/221.11  |- mesh__publicMeSHNote mesh__D001597 75   
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D001597 2001
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D001597 1994
% 220.92/221.11  |- mesh__recordAuthorizer mesh__D001597 PLS
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D001597 2003
% 220.92/221.11  |- skos__historyNote mesh__D001597 Benzene Derivatives %28%1968-1974%29%
% 220.92/221.11  |- skos__broader mesh__D001597smesh__D001555
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D001597 2000
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D001597 2006
% 220.92/221.11  |- skos__annotation mesh__D001597 = benzals; DF: BENZYLIDENE CPDS   
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D001597 1997
% 220.92/221.11  |- skos__hiddenLabel mesh__D001597 Compounds, Benzylidene
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D001597 2005
% 220.92/221.11  |- mesh__dateEstablished mesh__D001597 1975-09-01
% 220.92/221.11  |- mesh__historyNote mesh__D001597 75   
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D020751 2005
% 220.92/221.11  |- mesh__dateEstablished mesh__D020751 2000-01-01
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D020751 2003
% 220.92/221.11  |- rdf__type mesh__D020751sskos__Concept
% 220.92/221.11  |- skos__broader mesh__D020751smesh__D019973
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D020751 2006
% 220.92/221.11  |- mesh__publicMeSHNote mesh__D020751 2000   
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D020751 2004
% 220.92/221.11  |- mesh__historyNote mesh__D020751 2000   
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D020751 2000
% 220.92/221.11  |- skos__scopeNote mesh__D020751
% 220.92/221.11       Disorders stemming from the misuse and abuse of alcohol.%A%    
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D020751 2001
% 220.92/221.11  |- skos__hiddenLabel mesh__D020751 Alcohol-Induced Disorder
% 220.92/221.11  |- mesh__dateCreated mesh__D020751 1999-11-03
% 220.92/221.11  |- skos__prefLabel mesh__D020751 Alcohol-Induced Disorders
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D020751 2002
% 220.92/221.11  |- skos__hiddenLabel mesh__D020751 Alcohol Induced Disorders
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D006282 2005
% 220.92/221.11  |- skos__hiddenLabel mesh__D006282 Personnel, Health
% 220.92/221.11  |- skos__broader mesh__D006282smesh__D005159
% 220.92/221.11  |- skos__annotation mesh__D006282
% 220.92/221.11       persons working in the field of health: do not confuse with HEALTH MANPOWER, the availability of HEALTH PERSONNEL%A%  
% 220.92/221.11  |- mesh__historyNote mesh__D006282
% 220.92/221.11       92; was NON MESH 1966-91; was see HEALTH MANPOWER 1989-91%A%  
% 220.92/221.11  |- skos__hiddenLabel mesh__D006282 Provider, Health Care
% 220.92/221.11  |- skos__historyNote mesh__D006282 Health Manpower %28%1966-1991%29%
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D006282 2002
% 220.92/221.11  |- mesh__dateCreated mesh__D006282 1999-01-01
% 220.92/221.11  |- skos__hiddenLabel mesh__D006282 Workers, Field
% 220.92/221.11  |- skos__hiddenLabel mesh__D006282 Fieldworker
% 220.92/221.11  |- rdf__type mesh__D006282sskos__Concept
% 220.92/221.11  |- skos__hiddenLabel mesh__D006282 Provider, Healthcare
% 220.92/221.11  |- skos__altLabel mesh__D006282 Health Care Providers
% 220.92/221.11  |- skos__scopeNote mesh__D006282
% 220.92/221.11       Men and women working in the provision of health services, whether as individual practitioners or employees of health institutions and programs, whether or not professionally trained, and whether or not subject to public regulation. %28%From A Discursive Dictionary of Health Care, 1976%29%%A%    
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D006282 2004
% 220.92/221.11  |- skos__hiddenLabel mesh__D006282 Providers, Health Care
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D006282 2001
% 220.92/221.11  |- mesh__recordAuthorizer mesh__D006282 sjn
% 220.92/221.11  |- skos__hiddenLabel mesh__D006282 Field Worker
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D006282 2003
% 220.92/221.11  |- skos__broader mesh__D006282smesh__D009274
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D006282 2000
% 220.92/221.11  |- mesh__publicMeSHNote mesh__D006282
% 220.92/221.11       92; was see HEALTH MANPOWER 1989-91   
% 220.92/221.11  |- mesh__onlineNote mesh__D006282
% 220.92/221.11       pre-explosion = HEALTH PERSONNEL %28%PX%29%   
% 220.92/221.11  |- mesh__recordMaintainer mesh__D006282 kle
% 220.92/221.11  |- skos__hiddenLabel mesh__D006282 Providers, Healthcare
% 220.92/221.11  |- mesh__dateEstablished mesh__D006282 1992-01-01
% 220.92/221.11  |- mesh__dateRevised mesh__D006282 1999-11-03
% 220.92/221.11  |- skos__hiddenLabel mesh__D006282 Healthcare Provider
% 220.92/221.11  |- skos__altLabel mesh__D006282 Field Workers
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D006282 2006
% 220.92/221.11  |- skos__hiddenLabel mesh__D006282 Health Care Provider
% 220.92/221.11  |- skos__altLabel mesh__D006282 Healthcare Providers
% 220.92/221.11  |- skos__prefLabel mesh__D006282 Health Personnel
% 220.92/221.11  |- skos__hiddenLabel mesh__D006282 Worker, Field
% 220.92/221.11  |- mesh__recordOriginator mesh__D006282 NLM
% 220.92/221.11  |- mesh__recordOriginator mesh__D014714 NLM
% 220.92/221.11  |- skos__prefLabel mesh__D014714 Vertebrates
% 220.92/221.11  |- skos__scopeNote mesh__D014714
% 220.92/221.11       Animals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising mammals, birds, reptiles, amphibians, and fishes.%A%    
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D014714 2006A
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D014714 2006
% 220.92/221.11  |- mesh__dateCreated mesh__D014714 1999-01-01
% 220.92/221.11  |- skos__broader mesh__D014714smesh__D043344
% 220.92/221.11  |- mesh__dateRevised mesh__D014714 2005-08-15
% 220.92/221.11  |- mesh__recordAuthorizer mesh__D014714 sjn
% 220.92/221.11  |- mesh__recordMaintainer mesh__D014714 sjn
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D014714 2004
% 220.92/221.11  |- rdf__type mesh__D014714sskos__Concept
% 220.92/221.11  |- skos__hiddenLabel mesh__D014714 Vertebrate
% 220.92/221.11  |- mesh__onlineNote mesh__D014714 pre-explosion = VERTEBRATES %28%PX%29%   
% 220.92/221.11  |- skos__annotation mesh__D014714
% 220.92/221.11       avoid: too general; prefer specific classes, orders, families %26% genera; IM; qualif permitted%A%  
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D014714 2005
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D005988 2006
% 220.92/221.11  |- rdf__type mesh__D005988sskos__Concept
% 220.92/221.11  |- mesh__dateCreated mesh__D005988 1999-01-01
% 220.92/221.11  |- mesh__dateRevised mesh__D005988 2004-07-07
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D005988 2005
% 220.92/221.11  |- mesh__recordAuthorizer mesh__D005988 sjn
% 220.92/221.11  |- mesh__dateEstablished mesh__D005988 1968-01-01
% 220.92/221.11  |- mesh__publicMeSHNote mesh__D005988 68   
% 220.92/221.11  |- mesh__recordMaintainer mesh__D005988 ssb
% 220.92/221.11  |- skos__broader mesh__D005988smesh__D013400
% 220.92/221.11  |- skos__prefLabel mesh__D005988 Glyceric Acids
% 220.92/221.11  |- mesh__recordOriginator mesh__D005988 NLM
% 220.92/221.11  |- mesh__historyNote mesh__D005988 68   
% 220.92/221.11  |- skos__hiddenLabel mesh__D005988 Acids, Glyceric
% 220.92/221.11  |- skos__historyNote mesh__D030381 RNA Viruses %28%1996-2001%29%
% 220.92/221.11  |- mesh__dateEstablished mesh__D030381 2002-01-01
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D030381 2006
% 220.92/221.11  |- mesh__dateCreated mesh__D030381 2001-07-25
% 220.92/221.11  |- skos__prefLabel mesh__D030381 Nodaviridae
% 220.92/221.11  |- mesh__historyNote mesh__D030381 2002   
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D030381 2005
% 220.92/221.11  |- skos__scopeNote mesh__D030381
% 220.92/221.11       A family of RNA viruses infecting insects and fish. There are two genera: Alphanodavirus and Betanodavirus.%A%    
% 220.92/221.11  |- mesh__publicMeSHNote mesh__D030381 2002   
% 220.92/221.11  |- skos__broader mesh__D030381smesh__D007304
% 220.92/221.11  |- skos__annotation mesh__D030381
% 220.92/221.11       infection: coord IM with RNA VIRUS INFECTIONS %28%IM%29% + FISH DISEASES %28%IM%29% %28%see note there%29%; in insects: coord IM with specific insect /virol%A%  
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D030381 2004
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D030381 2002
% 220.92/221.11  |- skos__broader mesh__D030381smesh__D012328
% 220.92/221.11  |- skos__historyNote mesh__D030381 Insect Viruses %28%1985-2001%29%
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D030381 2003
% 220.92/221.11  |- rdf__type mesh__D030381sskos__Concept
% 220.92/221.11  |- mesh__onlineNote mesh__D002690
% 220.92/221.11       use CHLAMYDIA INFECTIONS to search MIYAGAWANELLA INFECTIONS 1967-91%A%  
% 220.92/221.11  |- skos__prefLabel mesh__D002690 Chlamydia Infections
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D002690 2006
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D002690 2003
% 220.92/221.11  |- mesh__dateEstablished mesh__D002690 1967-01-01
% 220.92/221.11  |- skos__hiddenLabel mesh__D002690 Chlamydia Infection
% 220.92/221.11  |- mesh__historyNote mesh__D002690
% 220.92/221.11       67; MIYAGAWANELLA INFECTIONS was see CHLAMYDIA INFECTIONS 1977-91; was heading 1967-76%A%  
% 220.92/221.11  |- skos__historyNote mesh__D002690 Trachoma %28%1966%29%
% 220.92/221.11  |- mesh__recordOriginator mesh__D002690 NLM
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D002690 2005
% 220.92/221.11  |- mesh__recordMaintainer mesh__D002690 ags
% 220.92/221.11  |- skos__broader mesh__D002690smesh__D002694
% 220.92/221.11  |- mesh__publicMeSHNote mesh__D002690
% 220.92/221.11       67; MIYAGAWANELLA INFECTIONS was see CHLAMYDIA INFECTIONS 1977-91; was heading 1967-76%A%  
% 220.92/221.11  |- skos__scopeNote mesh__D002690
% 220.92/221.11       Infections with bacteria of the genus CHLAMYDIA.     
% 220.92/221.11  |- mesh__dateRevised mesh__D002690 2000-06-23
% 220.92/221.11  |- mesh__recordAuthorizer mesh__D002690 sjn
% 220.92/221.11  |- skos__historyNote mesh__D002690 Conjunctivitis %28%1966%29%
% 220.92/221.11  |- rdf__type mesh__D002690sskos__Concept
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D002690 2002
% 220.92/221.11  |- skos__annotation mesh__D002690
% 220.92/221.11       infect by genus Chlamydia: do not confuse with CHLAMYDIACEAE INFECTIONS %28%family%29%; Chlamydophila psittaci infect = ORNITHOSIS; Chlamydia trachomatis infect: see note under CHLAMYDIA TRACHOMATIS; DF: CHLAMYDIA INFECT%A%  
% 220.92/221.11  |- skos__altLabel mesh__D002690 Infections, Chlamydia
% 220.92/221.11  |- mesh__dateCreated mesh__D002690 1999-01-01
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D002690 2001
% 220.92/221.11  |- skos__broader mesh__D002690smesh__D015231
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D002690 2004
% 220.92/221.11  |- skos__hiddenLabel mesh__D002690 Infection, Chlamydia
% 220.92/221.11  |- rdf__type mesh__D010324sskos__Concept
% 220.92/221.11  |- skos__altLabel mesh__D010324 Passive-Aggressive Personality
% 220.92/221.11  |- skos__hiddenLabel mesh__D010324 Personality Disorder, Negativistic
% 220.92/221.11  |- skos__broader mesh__D010324smesh__D010554
% 220.92/221.11  |- skos__hiddenLabel mesh__D010324 Passive Aggressive Personality Disorder
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D010324 2004
% 220.92/221.11  |- mesh__recordAuthorizer mesh__D010324 SJN
% 220.92/221.11  |- skos__hiddenLabel mesh__D010324 Disorders, Negativistic Personality
% 220.92/221.11  |- skos__hiddenLabel mesh__D010324 Disorder, Negativistic Personality
% 220.92/221.11  |- skos__hiddenLabel mesh__D010324 Personality, Passive-Aggressive
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D010324 2002
% 220.92/221.11  |- mesh__recordOriginator mesh__D010324 NLM
% 220.92/221.11  |- mesh__publicMeSHNote mesh__D010324
% 220.92/221.11       91; was see under PERSONALITY DISORDERS 1981-90; was PASSIVE-AGGRESSIVE PERSONALITY see under PERSONALITY DISORDERS 1968-80%A%  
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D010324 2003
% 220.92/221.11  |- mesh__dateCreated mesh__D010324 1999-01-01
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D010324 2006
% 220.92/221.11  |- skos__altLabel mesh__D010324 Personality Disorders, Passive Aggressive
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D010324 2001
% 220.92/221.11  |- mesh__historyNote mesh__D010324
% 220.92/221.11       91%28%81%29%; was see under PERSONALITY DISORDERS 1981-90; was PASSIVE-AGGRESSIVE PERSONALITY see under PERSONALITY DISORDERS 1968-80%A%  
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D010324 1999
% 220.92/221.11  |- skos__hiddenLabel mesh__D010324 Passive-Aggressive Personalities
% 220.92/221.11  |- skos__hiddenLabel mesh__D010324 Personality Disorders, Negativistic
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D010324 2005
% 220.92/221.11  |- mesh__dateEstablished mesh__D010324 1991-01-01
% 220.92/221.11  |- skos__hiddenLabel mesh__D010324 Negativistic Personality Disorders
% 220.92/221.11  |- skos__prefLabel mesh__D010324 Passive-Aggressive Personality Disorder
% 220.92/221.11  |- skos__hiddenLabel mesh__D010324 Personality Disorder, Passive Aggressive
% 220.92/221.11  |- skos__hiddenLabel mesh__D010324 Disorder, Passive-Aggressive Personality
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D010324 2000
% 220.92/221.11  |- skos__altLabel mesh__D010324 Personality Disorder, Passive-Aggressive
% 220.92/221.11  |- skos__altLabel mesh__D010324 Passive Aggressive Personality Disorders
% 220.92/221.11  |- mesh__dateRevised mesh__D010324 1997-06-20
% 220.92/221.11  |- skos__scopeNote mesh__D010324
% 220.92/221.11       A personality disorder characterized by an indirect resistance to demands for adequate social and occupational performance; anger and opposition to authority and the expectations of others that is expressed covertly by obstructionism, procrastination, stubbornness, dawdling, forgetfulness, and intentional inefficiency. %28%Dorland, 27th ed%29%%A%    
% 220.92/221.11  |- skos__hiddenLabel mesh__D010324 Passive Aggressive Personality
% 220.92/221.11  |- skos__hiddenLabel mesh__D010324 Passive-Aggressive Personality Disorders
% 220.92/221.11  |- skos__altLabel mesh__D010324 Negativistic Personality Disorder
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D010324 1998
% 220.92/221.11  |- mesh__onlineNote mesh__D010324
% 220.92/221.11       use PASSIVE-AGGRESSIVE PERSONALITY DISORDER to search PASSIVE-AGGRESSIVE PERSONALITY 1975-80; use PERSONALITY DISORDERS 1968-74%A%  
% 220.92/221.11  |- skos__hiddenLabel mesh__D010324
% 220.92/221.11       Disorders, Passive-Aggressive Personality
% 220.92/221.11  |- skos__hiddenLabel mesh__D010324
% 220.92/221.11       Personality Disorders, Passive-Aggressive
% 220.92/221.11  |- mesh__recordMaintainer mesh__D010324 JLS
% 220.92/221.11  |- skos__hiddenLabel mesh__D010324 Personalities, Passive-Aggressive
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D018307 2001
% 220.92/221.11  |- mesh__recordMaintainer mesh__D018307 nns
% 220.92/221.11  |- skos__hiddenLabel mesh__D018307 Cell Neoplasms, Squamous
% 220.92/221.11  |- mesh__recordOriginator mesh__D018307 PLS
% 220.92/221.11  |- skos__hiddenLabel mesh__D018307 Cancers, Squamous Cell
% 220.92/221.11  |- skos__annotation mesh__D018307
% 220.92/221.11       coord IM with precoord organ/neopl term %28%IM%29%; DF: NEOPL SQUAMOUS CELL%A%  
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D018307 2005
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D018307 2002
% 220.92/221.11  |- skos__hiddenLabel mesh__D018307 Squamous Cell Neoplasm
% 220.92/221.11  |- mesh__historyNote mesh__D018307 94   
% 220.92/221.11  |- skos__hiddenLabel mesh__D018307 Cell Cancers, Squamous
% 220.92/221.11  |- skos__broader mesh__D018307smesh__D009375
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D018307 2006
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D018307 2003
% 220.92/221.11  |- skos__hiddenLabel mesh__D018307 Neoplasm, Squamous Cell
% 220.92/221.11  |- skos__historyNote mesh__D018307
% 220.92/221.11       Carcinoma, Squamous Cell %28%1973-1993%29%
% 220.92/221.11  |- skos__scopeNote mesh__D018307
% 220.92/221.11       Neoplasms composed of squamous cells of the epithelium. The concept does not refer to neoplasms located in tissue composed of squamous elements.%A%    
% 220.92/221.11  |- skos__prefLabel mesh__D018307 Neoplasms, Squamous Cell
% 220.92/221.11  |- skos__altLabel mesh__D018307 Squamous Cell Neoplasms
% 220.92/221.11  |- mesh__recordAuthorizer mesh__D018307 sjn
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D018307 2004
% 220.92/221.11  |- skos__hiddenLabel mesh__D018307 Cell Cancer, Squamous
% 220.92/221.11  |- skos__hiddenLabel mesh__D018307 Squamous Cell Cancers
% 220.92/221.11  |- rdf__type mesh__D018307sskos__Concept
% 220.92/221.11  |- skos__hiddenLabel mesh__D018307 Cell Neoplasm, Squamous
% 220.92/221.11  |- mesh__dateCreated mesh__D018307 1993-06-25
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D018307 2000
% 220.92/221.11  |- mesh__dateEstablished mesh__D018307 1994-01-01
% 220.92/221.11  |- skos__hiddenLabel mesh__D018307 Cancer, Squamous Cell
% 220.92/221.11  |- mesh__publicMeSHNote mesh__D018307 94   
% 220.92/221.11  |- mesh__dateRevised mesh__D018307 1999-11-03
% 220.92/221.11  |- rdf__type mesh__D001598sskos__Concept
% 220.92/221.11  |- mesh__recordMaintainer mesh__D001598 ssb
% 220.92/221.11  |- mesh__dateRevised mesh__D001598 2005-06-30
% 220.92/221.11  |- skos__altLabel mesh__D001598 Bephenium Derivatives
% 220.92/221.11  |- skos__broader mesh__D001598smesh__D050339
% 220.92/221.11  |- mesh__recordOriginator mesh__D001598 NLM
% 220.92/221.11  |- skos__hiddenLabel mesh__D001598 Compounds, Bephenium
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D001598 2006
% 220.92/221.11  |- skos__scopeNote mesh__D001598
% 220.92/221.11       Analogs or derivatives of bephenium %28%N,N-dimethyl-N-%28%2-phenoxyethyl%29%benzenemethanaminium%29%.%A%    
% 220.92/221.11  |- skos__broader mesh__D001598smesh__D000644
% 220.92/221.11  |- skos__prefLabel mesh__D001598 Bephenium Compounds
% 220.92/221.11  |- mesh__recordAuthorizer mesh__D001598 sjn
% 220.92/221.11  |- mesh__dateCreated mesh__D001598 1999-01-01
% 220.92/221.11  |- skos__hiddenLabel mesh__D001598 Derivatives, Bephenium
% 220.92/221.11  |- skos__annotation mesh__D001598 DF: BEPHENIUM CPDS   
% 220.92/221.11  |- skos__broader mesh__D008511Q000364smesh__D008511
% 220.92/221.11  |- mesh__preferredCombination mesh__D008511Q000364smesh__D006280
% 220.92/221.11  |- rdf__type mesh__D008511Q000364smesh__CompoundConcept
% 220.92/221.11  |- skos__hiddenLabel mesh__D020752 Neuroectodermal Dysplasia Syndrome
% 220.92/221.11  |- skos__historyNote mesh__D020752
% 220.92/221.11       Abnormalities, Multiple %28%1966-1999%29%
% 220.92/221.11  |- skos__annotation mesh__D020752
% 220.92/221.11       for neurocutaneous melanosis, coord with MELANOSIS   
% 220.92/221.11  |- skos__broader mesh__D020752smesh__D009422
% 220.92/221.11  |- mesh__dateCreated mesh__D020752 1999-11-04
% 220.92/221.11  |- rdf__type mesh__D020752sskos__Concept
% 220.92/221.11  |- skos__hiddenLabel mesh__D020752 Neurocutaneous Syndrome
% 220.92/221.11  |- skos__altLabel mesh__D020752 Phacomatoses
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D020752 2004
% 220.92/221.11  |- skos__altLabel mesh__D020752 Phacomatosis
% 220.92/221.11  |- skos__hiddenLabel mesh__D020752 Syndrome, Neuroectodermal Dysplasia
% 220.92/221.11  |- mesh__dateEstablished mesh__D020752 2000-01-01
% 220.92/221.11  |- skos__hiddenLabel mesh__D020752 Syndrome, Neurocutaneous
% 220.92/221.11  |- skos__broader mesh__D020752smesh__D004476
% 220.92/221.11  |- skos__altLabel mesh__D020752 Phakomatoses
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D020752 2003
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D020752 2006
% 220.92/221.11  |- skos__hiddenLabel mesh__D020752 Neurocutaneous Disorder
% 220.92/221.11  |- skos__scopeNote mesh__D020752
% 220.92/221.11       A group of disorders characterized by ectodermal-based malformations and neoplastic growths in the skin, nervous system, and other organs.%A%    
% 220.92/221.11  |- skos__altLabel mesh__D020752 Phakomatosis
% 220.92/221.11  |- skos__altLabel mesh__D020752 Neuroectodermal Dysplasia Syndromes
% 220.92/221.11  |- mesh__historyNote mesh__D020752 2000   
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D020752 2002
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D020752 2005
% 220.92/221.11  |- mesh__dateRevised mesh__D020752 2001-07-25
% 220.92/221.11  |- skos__prefLabel mesh__D020752 Neurocutaneous Syndromes
% 220.92/221.11  |- skos__hiddenLabel mesh__D020752 Syndromes, Neuroectodermal Dysplasia
% 220.92/221.11  |- mesh__recordAuthorizer mesh__D020752 sjn
% 220.92/221.11  |- skos__altLabel mesh__D020752 Neurocutaneous Disorders
% 220.92/221.11  |- skos__hiddenLabel mesh__D020752 Syndromes, Neurocutaneous
% 220.92/221.11  |- mesh__recordOriginator mesh__D020752 KEV
% 220.92/221.11  |- mesh__publicMeSHNote mesh__D020752 2000   
% 220.92/221.11  |- mesh__recordMaintainer mesh__D020752 nns
% 220.92/221.11  |- skos__historyNote mesh__D020752
% 220.92/221.11       Nervous System Diseases %28%1967-1999%29%
% 220.92/221.11  |- skos__historyNote mesh__D020752 Skin Diseases %28%1967-1999%29%
% 220.92/221.11  |- mesh__recordAuthorizer mesh__D006283 PLS
% 220.92/221.11  |- rdf__type mesh__D006283sskos__Concept
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D006283 1997
% 220.92/221.11  |- mesh__recordOriginator mesh__D006283 NLM
% 220.92/221.11  |- skos__related mesh__D006283smesh__D011835
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D006283 2004
% 220.92/221.11  |- skos__altLabel mesh__D006283 Physics, Radiologic
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D006283 1996
% 220.92/221.11  |- skos__hiddenLabel mesh__D006283 Physics, Health
% 220.92/221.11  |- skos__related mesh__D006283smesh__D011874
% 220.92/221.11  |- skos__prefLabel mesh__D006283 Health Physics
% 220.92/221.11  |- mesh__recordMaintainer mesh__D006283 TGC
% 220.92/221.11  |- skos__broader mesh__D006283smesh__D010825
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D006283 2002
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D006283 2003
% 220.92/221.11  |- skos__historyNote mesh__D006283 Radiation Protection %28%1966%29%
% 220.92/221.11  |- mesh__dateRevised mesh__D006283 1995-02-23
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D006283 1999
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D006283 2006
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D006283 1998
% 220.92/221.11  |- skos__broader mesh__D006283smesh__D004782
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D006283 2001
% 220.92/221.11  |- mesh__publicMeSHNote mesh__D006283 73   
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D006283 2005
% 220.92/221.11  |- skos__annotation mesh__D006283
% 220.92/221.11       SPEC: SPEC qualif; physics or phys principles in the field of med = specific med term %28%IM%29% + PHYSICS %28%NIM%29% or specific phys principle %28%IM%29%, as %22%The physics of brachytherapy%22% = BRACHYTHERAPY %28%IM%29% + PHYSICS %28%NIM%29%%A%  
% 220.92/221.11  |- skos__related mesh__D006283smesh__D011834
% 220.92/221.11  |- skos__altLabel mesh__D006283 Radiologic Physics
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D006283 2000
% 220.92/221.11  |- mesh__historyNote mesh__D006283 73%28%67%29%   
% 220.92/221.11  |- mesh__dateEstablished mesh__D006283 1973-01-01
% 220.92/221.11  |- skos__scopeNote mesh__D006283
% 220.92/221.11       The science concerned with problems of radiation protection relevant to reducing or preventing radiation exposure, and the effects of ionizing radiation on humans and their environment.%A%    
% 220.92/221.11  |- mesh__dateCreated mesh__D006283 1999-01-01
% 220.92/221.11  |- skos__altLabel mesh__D014715 Vertebral Artery Ischemia
% 220.92/221.11  |- skos__historyNote mesh__D014715 Vertebral Artery %28%1966-1979%29%
% 220.92/221.11  |- skos__altLabel mesh__D014715 Basilar Insufficiency
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Artery Ischemia, Vertebral
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Artery Ischemias, Vertebral
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Ischemia, Vertebrobasilar
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Artery Insufficiencies, Vertebral
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Insufficiency, Vertebro-Basilar
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Vertebro Basilar Ischemia
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Dolichoectasia, Vertebrobasilar
% 220.92/221.11  |- mesh__publicMeSHNote mesh__D014715 1980   
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Artery Insufficiency, Basilar
% 220.92/221.11  |- mesh__recordOriginator mesh__D014715 VDK
% 220.92/221.11  |- skos__altLabel mesh__D014715 Vertebrobasilar Ischemia
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Artery Insufficiencies, Basilar
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Insufficiencies, Vertebral Artery
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Artery Stenosis, Vertebral
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Insufficiencies, Vertebro-Basilar
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D014715 2003
% 220.92/221.11  |- rdf__type mesh__D014715sskos__Concept
% 220.92/221.11  |- skos__altLabel mesh__D014715 Vertebro-Basilar Insufficiency
% 220.92/221.11  |- skos__prefLabel mesh__D014715 Vertebrobasilar Insufficiency
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Insufficiencies, Basilar
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Artery Ischemias, Basilar
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Vertebro-Basilar Insufficiencies
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Dolichoectasias, Vertebrobasilar
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Vertebral Artery Ischemias
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Stenosis, Vertebral Artery
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Ischemia, Vertebro-Basilar
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Artery Ischemia, Basilar
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Vertebrobasilar Insufficiencies
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Stenoses, Vertebral Artery
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Ischemias, Vertebral Artery
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Insufficiency, Vertebral Artery
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Insufficiency, Vertebrobasilar
% 220.92/221.11  |- mesh__dateRevised mesh__D014715 2000-06-21
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D014715 2001
% 220.92/221.11  |- skos__altLabel mesh__D014715 Basilar Artery Ischemia
% 220.92/221.11  |- mesh__historyNote mesh__D014715 1980   
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D014715 2006
% 220.92/221.11  |- skos__altLabel mesh__D014715 Vertebro-Basilar Ischemia
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Basilar Insufficiencies
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Ischemias, Vertebrobasilar
% 220.92/221.11  |- skos__historyNote mesh__D014715 Basilar Artery %28%1966-1979%29%
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Vertebral Artery Stenoses
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Artery Stenoses, Vertebral
% 220.92/221.11  |- mesh__recordMaintainer mesh__D014715 ags
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Insufficiency, Basilar
% 220.92/221.11  |- skos__annotation mesh__D014715
% 220.92/221.11       BRACHIAL-BASILAR INSUFFICIENCY SYNDROME see SUBCLAVIAN STEAL SYNDROME is available%A%  
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Vertebral Artery Insufficiencies
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D014715 2005
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Ischemia, Basilar Artery
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Vertebro-Basilar Ischemias
% 220.92/221.11  |- mesh__dateEstablished mesh__D014715 1980-01-01
% 220.92/221.11  |- mesh__dateCreated mesh__D014715 1979-04-25
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Ischemias, Basilar Artery
% 220.92/221.11  |- skos__broader mesh__D014715smesh__D002545
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Insufficiencies, Basilar Artery
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Artery Insufficiency, Vertebral
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Stenoses, Basilar Artery
% 220.92/221.11  |- skos__historyNote mesh__D014715
% 220.92/221.11       Cerebrovascular Disorders %28%1966-1979%29%
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Insufficiency, Basilar Artery
% 220.92/221.11  |- mesh__recordAuthorizer mesh__D014715 sjn
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Artery Stenosis, Basilar
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Artery Stenoses, Basilar
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Insufficiencies, Vertebrobasilar
% 220.92/221.11  |- skos__broader mesh__D014715smesh__D002561
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Basilar Artery Ischemias
% 220.92/221.11  |- skos__scopeNote mesh__D014715
% 220.92/221.11       Localized or diffuse reduction in blood flow through the vertebrobasilar arterial system, which supplies the BRAIN STEM; CEREBELLUM; OCCIPITAL LOBE; medial TEMPORAL LOBE; and THALAMUS. Characteristic clinical features include SYNCOPE; lightheadedness; visual disturbances; and VERTIGO. BRAIN STEM INFARCTIONS or other BRAIN INFARCTION may be associated.%A%    
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Stenosis, Basilar Artery
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Ischemia, Vertebral Artery
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Vertebrobasilar Dolichoectasias
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Basilar Artery Stenoses
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Basilar Artery Insufficiencies
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Vertebro Basilar Insufficiency
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Ischemias, Vertebro-Basilar
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D014715 2004
% 220.92/221.11  |- skos__hiddenLabel mesh__D014715 Vertebrobasilar Ischemias
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D014715 2002
% 220.92/221.11  |- skos__altLabel mesh__D019400 Satellite Tobacco Mosaic Virus
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D019400 2004
% 220.92/221.11  |- mesh__historyNote mesh__D019400 2002 %28%1997%29%   
% 220.92/221.11  |- skos__scopeNote mesh__D019400
% 220.92/221.11       A spherical RNA satellite virus which requires an obligatory helper TOBACCO MOSAIC VIRUS for replication.%A%    
% 220.92/221.11  |- skos__altLabel mesh__D019400 Tobacco Mosaic Virus Satellite
% 220.92/221.11  |- mesh__recordAuthorizer mesh__D019400 sjn
% 220.92/221.11  |- skos__prefLabel mesh__D019400 Tobacco mosaic satellite virus
% 220.92/221.11  |- skos__broader mesh__D019400smesh__D012526
% 220.92/221.11  |- mesh__activeMeSHYear mesh__D019400 2005
% 220.92/221.11  |- mesh__dateRevised mesh__D019400 2001-07-25
% 220.92/221.12  |- mesh__recordMaintainer mesh__D019400 ags
% 220.92/221.12  |- mesh__dateEstablished mesh__D019400 1997-01-01
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D019400 2006
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D019400 2002
% 220.92/221.12  |- rdf__type mesh__D019400sskos__Concept
% 220.92/221.12  |- mesh__recordOriginator mesh__D019400 AGS
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D019400 2003
% 220.92/221.12  |- mesh__dateCreated mesh__D019400 1996-06-10
% 220.92/221.12  |- skos__historyNote mesh__D019400 Satellite Viruses %28%1989-1996%29%
% 220.92/221.12  |- mesh__publicMeSHNote mesh__D019400
% 220.92/221.12       2002; see TOBACCO MOSAIC VIRUS SATELLITE 1997-2001   
% 220.92/221.12  |- skos__altLabel mesh__D005989 Acylglycerols
% 220.92/221.12  |- mesh__dateRevised mesh__D005989 2005-06-30
% 220.92/221.12  |- skos__scopeNote mesh__D005989 GLYCEROL esterified with FATTY ACIDS.     
% 220.92/221.12  |- mesh__recordAuthorizer mesh__D005989 sjn
% 220.92/221.12  |- skos__prefLabel mesh__D005989 Glycerides
% 220.92/221.12  |- skos__broader mesh__D005989smesh__D008055
% 220.92/221.12  |- mesh__recordMaintainer mesh__D005989 ssb
% 220.92/221.12  |- mesh__recordOriginator mesh__D005989 NLM
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D005989 2006
% 220.92/221.12  |- rdf__type mesh__D005989sskos__Concept
% 220.92/221.12  |- mesh__dateCreated mesh__D005989 1999-01-01
% 220.92/221.12  |- skos__scopeNote mesh__D002691
% 220.92/221.12       A genus of CHLAMYDOPHILA infecting primarily birds. It contains eight known serovars, some of which infect more than one type of host, including humans.%A%    
% 220.92/221.12  |- mesh__dateEstablished mesh__D002691 1976-01-01
% 220.92/221.12  |- mesh__recordMaintainer mesh__D002691 sjn
% 220.92/221.12  |- skos__prefLabel mesh__D002691 Chlamydophila psittaci
% 220.92/221.12  |- skos__annotation mesh__D002691 infection = PSITTACOSIS   
% 220.92/221.12  |- mesh__dateCreated mesh__D002691 1975-07-25
% 220.92/221.12  |- mesh__publicMeSHNote mesh__D002691
% 220.92/221.12       2001;  see CHLAMYDIA PSITTACI 1976-2000, see MIYAGAWANELLA 1963-75%A%  
% 220.92/221.12  |- skos__broader mesh__D002691smesh__D023501
% 220.92/221.12  |- rdf__type mesh__D002691sskos__Concept
% 220.92/221.12  |- skos__historyNote mesh__D002691 Chlamydia %28%1966-1974%29%
% 220.92/221.12  |- mesh__dateRevised mesh__D002691 2005-07-01
% 220.92/221.12  |- mesh__historyNote mesh__D002691 2001%28%1963%29%   
% 220.92/221.12  |- mesh__recordAuthorizer mesh__D002691 sjn
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D002691 2006
% 220.92/221.12  |- skos__altLabel mesh__D002691 Chlamydia psittaci
% 220.92/221.12  |- mesh__recordOriginator mesh__D002691 JW
% 220.92/221.12  |- mesh__recordMaintainer mesh__D010325 SYSTEM
% 220.92/221.12  |- skos__annotation mesh__D010325
% 220.92/221.12       infection = PASTEURELLA INFECTIONS or its specifics   
% 220.92/221.12  |- mesh__dateCreated mesh__D010325 1999-01-01
% 220.92/221.12  |- skos__broader mesh__D010325smesh__D015661
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D010325 2006
% 220.92/221.12  |- skos__scopeNote mesh__D010325
% 220.92/221.12       The oldest recognized genus of the family PASTEURELLACEAE. It consists of several species. Its organisms occur most frequently as coccobacillus or rod-shaped and are gram-negative, nonmotile, facultative anaerobes. Species of this genus are found in both animals and humans.%A%    
% 220.92/221.12  |- mesh__dateRevised mesh__D010325 2005-06-30
% 220.92/221.12  |- mesh__recordOriginator mesh__D010325 NLM
% 220.92/221.12  |- skos__prefLabel mesh__D010325 Pasteurella
% 220.92/221.12  |- rdf__type mesh__D010325sskos__Concept
% 220.92/221.12  |- mesh__recordAuthorizer mesh__D010325 sjn
% 220.92/221.12  |- skos__hiddenLabel mesh__D018308 Inverted Papilloma
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D018308 1996
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D018308 2002
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D018308 1999
% 220.92/221.12  |- skos__historyNote mesh__D018308 Papilloma %28%1966-1993%29%
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D018308 1997
% 220.92/221.12  |- mesh__historyNote mesh__D018308 94   
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D018308 2005
% 220.92/221.12  |- skos__scopeNote mesh__D018308
% 220.92/221.12       A mucosal tumor of the urinary bladder or nasal cavity in which proliferating epithelium is invaginated beneath the surface and is more smoothly rounded than in other papillomas. %28%Stedman, 25th ed%29%%A%    
% 220.92/221.12  |- skos__broader mesh__D018308smesh__D010212
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D018308 2003
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D018308 2006
% 220.92/221.12  |- rdf__type mesh__D018308sskos__Concept
% 220.92/221.12  |- skos__annotation mesh__D018308
% 220.92/221.12       /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 220.92/221.12  |- mesh__dateCreated mesh__D018308 1993-06-25
% 220.92/221.12  |- mesh__recordAuthorizer mesh__D018308 PLS
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D018308 2004
% 220.92/221.12  |- skos__hiddenLabel mesh__D018308 Papillomas, Inverted
% 220.92/221.12  |- mesh__recordMaintainer mesh__D018308 KEV
% 220.92/221.12  |- skos__prefLabel mesh__D018308 Papilloma, Inverted
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D018308 2000
% 220.92/221.12  |- skos__hiddenLabel mesh__D018308 Inverted Papillomas
% 220.92/221.12  |- mesh__dateEstablished mesh__D018308 1994-01-01
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D018308 2001
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D018308 1998
% 220.92/221.12  |- mesh__publicMeSHNote mesh__D018308 94   
% 220.92/221.12  |- mesh__dateRevised mesh__D018308 1995-06-08
% 220.92/221.12  |- mesh__recordOriginator mesh__D018308 PLS
% 220.92/221.12  |- mesh__historyNote mesh__D015010 76; was PASTEURELLA PESTIS 1963-75   
% 220.92/221.12  |- skos__broader mesh__D015010smesh__D015007
% 220.92/221.12  |- skos__annotation mesh__D015010 infection = PLAGUE   
% 220.92/221.12  |- skos__scopeNote mesh__D015010
% 220.92/221.12       The etiologic agent of PLAGUE in man, rats, ground squirrels, and other rodents.%A%    
% 220.92/221.12  |- mesh__dateEstablished mesh__D015010 1976-01-01
% 220.92/221.12  |- mesh__dateRevised mesh__D015010 2005-06-30
% 220.92/221.12  |- mesh__recordMaintainer mesh__D015010 SYSTEM
% 220.92/221.12  |- mesh__recordOriginator mesh__D015010 JW
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D015010 2006
% 220.92/221.12  |- mesh__publicMeSHNote mesh__D015010 76; was PASTEURELLA PESTIS 1963-75   
% 220.92/221.12  |- mesh__dateCreated mesh__D015010 1975-07-23
% 220.92/221.12  |- mesh__onlineNote mesh__D015010
% 220.92/221.12       use YERSINIA PESTIS to search PASTEURELLA PESTIS 1966-75   
% 220.92/221.12  |- skos__prefLabel mesh__D015010 Yersinia pestis
% 220.92/221.12  |- mesh__recordAuthorizer mesh__D015010 sjn
% 220.92/221.12  |- rdf__type mesh__D015010sskos__Concept
% 220.92/221.12  |- skos__altLabel mesh__D015010 Pasteurella pestis
% 220.92/221.12  |- skos__scopeNote mesh__D001599
% 220.92/221.12       An alkaloid from Hydrastis canadensis L., Berberidaceae. It is also found in many other plants. It is relatively toxic parenterally, but has been used orally for various parasitic and fungal infections and as antidiarrheal.%A%    
% 220.92/221.12  |- skos__historyNote mesh__D001599 Dioxoles %28%1972-1974%29%
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D001599 2002
% 220.92/221.12  |- mesh__recordMaintainer mesh__D001599 jmp
% 220.92/221.12  |- skos__altLabel mesh__D001599 Umbellatine
% 220.92/221.12  |- mesh__recordOriginator mesh__D001599 RLS
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D001599 2004
% 220.92/221.12  |- skos__broader mesh__D001599smesh__D001600
% 220.92/221.12  |- mesh__dateRevised mesh__D001599 2000-06-21
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D001599 2003
% 220.92/221.12  |- mesh__dateEstablished mesh__D001599 1991-01-01
% 220.92/221.12  |- mesh__dateCreated mesh__D001599 1975-07-25
% 220.92/221.12  |- skos__historyNote mesh__D001599 Berbines %28%1972-1975%29%
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D001599 2001
% 220.92/221.12  |- mesh__recordAuthorizer mesh__D001599 sjn
% 220.92/221.12  |- mesh__publicMeSHNote mesh__D001599 91; was see under BERBINES 1976-90   
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D001599 2006
% 220.92/221.12  |- skos__prefLabel mesh__D001599 Berberine
% 220.92/221.12  |- mesh__historyNote mesh__D001599
% 220.92/221.12       91%28%76%29%; was see under BERBINES 1976-90   
% 220.92/221.12  |- skos__historyNote mesh__D001599 Dioxolanes %28%1975%29%
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D001599 2005
% 220.92/221.12  |- rdf__type mesh__D001599sskos__Concept
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D006284 2003
% 220.92/221.12  |- mesh__recordOriginator mesh__D006284 EC
% 220.92/221.12  |- skos__hiddenLabel mesh__D006284 Plan Implementation, Health
% 220.92/221.12  |- rdf__type mesh__D006284sskos__Concept
% 220.92/221.12  |- mesh__recordAuthorizer mesh__D006284 sjn
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D006284 2004
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D006284 2001
% 220.92/221.12  |- skos__hiddenLabel mesh__D006284 Implementations, Health Plan
% 220.92/221.12  |- skos__historyNote mesh__D006284 Health Planning %28%1968-1979%29%
% 220.92/221.12  |- skos__hiddenLabel mesh__D006284 Health Plan Implementations
% 220.92/221.12  |- mesh__recordMaintainer mesh__D006284 kle
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D006284 2002
% 220.92/221.12  |- skos__broader mesh__D006284smesh__D006285
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D006284 2005
% 220.92/221.12  |- skos__prefLabel mesh__D006284 Health Plan Implementation
% 220.92/221.12  |- skos__hiddenLabel mesh__D006284 Plan Implementations, Health
% 220.92/221.12  |- mesh__dateCreated mesh__D006284 1979-06-01
% 220.92/221.12  |- mesh__dateRevised mesh__D006284 1999-11-03
% 220.92/221.12  |- skos__hiddenLabel mesh__D006284 Implementation, Health Plan
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D006284 2006
% 220.92/221.12  |- skos__scopeNote mesh__D006284
% 220.92/221.12       Those actions designed to carry out recommendations pertaining to health plans or programs.%A%    
% 220.92/221.12  |- mesh__publicMeSHNote mesh__D006284
% 220.92/221.12       91; was see under HEALTH PLANNING 1980-90   
% 220.92/221.12  |- mesh__historyNote mesh__D006284
% 220.92/221.12       91%28%80%29%; was see under HEALTH PLANNING 1980-90   
% 220.92/221.12  |- mesh__dateEstablished mesh__D006284 1991-01-01
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D006284 2000
% 220.92/221.12  |- skos__annotation mesh__D006284 specify geog   
% 220.92/221.12  |- rdf__type mesh__D014716sskos__Concept
% 220.92/221.12  |- skos__hiddenLabel mesh__D014716 Dimension, Vertical
% 220.92/221.12  |- skos__hiddenLabel mesh__D014716 Occlusion Vertical Dimension
% 220.92/221.12  |- skos__hiddenLabel mesh__D014716 Dimensions, Rest Vertical
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D014716 2001
% 220.92/221.12  |- skos__hiddenLabel mesh__D014716 Vertical Dimensions, Rest
% 220.92/221.12  |- skos__hiddenLabel mesh__D014716 Dimension, Rest Vertical
% 220.92/221.12  |- skos__broader mesh__D014716smesh__D003768
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D014716 1998
% 220.92/221.12  |- skos__prefLabel mesh__D014716 Vertical Dimension
% 220.92/221.12  |- skos__scopeNote mesh__D014716
% 220.92/221.12       The length of the face determined by the distance of separation of jaws. Occlusal vertical dimension %28%OVD or VDO%29% or contact vertical dimension is the lower face height with the teeth in centric occlusion. Rest vertical dimension %28%VDR%29% is the lower face height measured from a chin point to a point just below the nose, with the mandible in rest position. %28%From Jablonski, Dictionary of Dentistry, 1992, p250%29%%A%    
% 220.92/221.12  |- skos__annotation mesh__D014716
% 220.92/221.12       length of face in relation to separation of jaws; no qualif%A%  
% 220.92/221.12  |- mesh__historyNote mesh__D014716 66   
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D014716 1999
% 220.92/221.12  |- mesh__publicMeSHNote mesh__D014716 66   
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D014716 2005
% 220.92/221.12  |- skos__hiddenLabel mesh__D014716 Vertical Dimension, Rest
% 220.92/221.12  |- skos__hiddenLabel mesh__D014716 Rest Position, Mandibular
% 220.92/221.12  |- skos__hiddenLabel mesh__D014716 Dimensions, Vertical
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D014716 2002
% 220.92/221.12  |- skos__hiddenLabel mesh__D014716 Position, Mandibular Rest
% 220.92/221.12  |- mesh__dateRevised mesh__D014716 1996-06-10
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D014716 2006
% 220.92/221.12  |- mesh__dateEstablished mesh__D014716 1966-01-01
% 220.92/221.12  |- skos__hiddenLabel mesh__D014716 Mandibular Rest Positions
% 220.92/221.12  |- mesh__recordOriginator mesh__D014716 NLM
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D014716 1997
% 220.92/221.12  |- mesh__dateCreated mesh__D014716 1999-01-01
% 220.92/221.12  |- skos__hiddenLabel mesh__D014716 Vertical Dimensions
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D014716 2003
% 220.92/221.12  |- skos__hiddenLabel mesh__D014716 Positions, Mandibular Rest
% 220.92/221.12  |- mesh__recordAuthorizer mesh__D014716 PLS
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D014716 2000
% 220.92/221.12  |- skos__hiddenLabel mesh__D014716 Rest Positions, Mandibular
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D014716 2004
% 220.92/221.12  |- skos__hiddenLabel mesh__D014716 Rest Vertical Dimensions
% 220.92/221.12  |- mesh__recordMaintainer mesh__D014716 TGC
% 220.92/221.12  |- skos__hiddenLabel mesh__D014716 Occlusion Vertical Dimensions
% 220.92/221.12  |- mesh__historyNote mesh__D019401 97   
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D019401 2005
% 220.92/221.12  |- rdf__type mesh__D019401sskos__Concept
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D019401 2004
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D019401 1999
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D019401 2000
% 220.92/221.12  |- mesh__publicMeSHNote mesh__D019401 97   
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D019401 2003
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D019401 1998
% 220.92/221.12  |- skos__historyNote mesh__D019401 RNA, Viral %28%1983-1996%29%
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D019401 1997
% 220.92/221.12  |- skos__prefLabel mesh__D019401 Cucumber Mosaic Virus Satellite
% 220.92/221.12  |- mesh__dateEstablished mesh__D019401 1997-01-01
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D019401 2002
% 220.92/221.12  |- mesh__dateCreated mesh__D019401 1996-06-10
% 220.92/221.12  |- skos__broader mesh__D019401smesh__D019244
% 220.92/221.12  |- skos__altLabel mesh__D019401 Cucumber Mosaic Virus Satellite RNA
% 220.92/221.12  |- skos__scopeNote mesh__D019401
% 220.92/221.12       A satellite RNA %28%not a satellite virus%29% which has several types. Different cucumoviruses can act as helper viruses for different types.%A%    
% 220.92/221.12  |- skos__annotation mesh__D019401 satellite RNA, not a satellite virus   
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D019401 2006
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D019401 2001
% 220.92/221.12  |- mesh__recordMaintainer mesh__D002692 ags
% 220.92/221.12  |- mesh__onlineNote mesh__D002692
% 220.92/221.12       use CHLAMYDIA TRACHOMATIS to search TRACHOMA VIRUS 1976-91; use CHLAMYDIA 1966-74%A%  
% 220.92/221.12  |- skos__broader mesh__D002692smesh__D002689
% 220.92/221.12  |- skos__annotation mesh__D002692
% 220.92/221.12       infection: coord IM with CHLAMYDIA INFECTIONS %28%IM%29% or index TRACHOMA; LYMPHOGRANULOMA VENEREUM; or CONJUNCTIVITIS, INCLUSION if specified in text%A%  
% 220.92/221.12  |- mesh__dateEstablished mesh__D002692 1976-01-01
% 220.92/221.12  |- mesh__recordOriginator mesh__D002692 JW
% 220.92/221.12  |- skos__historyNote mesh__D002692 Chlamydia %28%1966-1975%29%
% 220.92/221.12  |- mesh__publicMeSHNote mesh__D002692
% 220.92/221.12       76; TRACHOMA VIRUS was see CHLAMYDIA TRACHOMATIS 1976-91, was see CHLAMYDIA 1963-74%A%  
% 220.92/221.12  |- mesh__dateRevised mesh__D002692 2005-08-02
% 220.92/221.12  |- skos__prefLabel mesh__D002692 Chlamydia trachomatis
% 220.92/221.12  |- rdf__type mesh__D002692sskos__Concept
% 220.92/221.12  |- mesh__recordAuthorizer mesh__D002692 ags
% 220.92/221.12  |- skos__scopeNote mesh__D002692
% 220.92/221.12       Type species of CHLAMYDIA causing a variety of ocular and urogenital diseases.%A%    
% 220.92/221.12  |- mesh__historyNote mesh__D002692
% 220.92/221.12       76; TRACHOMA VIRUS was see CHLAMYDIA TRACHOMATIS 1976-91, was see CHLAMYDIA 1963-74%A%  
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D002692 2006
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D002692 2006A
% 220.92/221.12  |- mesh__dateCreated mesh__D002692 1975-07-25
% 220.92/221.12  |- mesh__recordAuthorizer mesh__D010326 PLS
% 220.92/221.12  |- mesh__dateCreated mesh__D010326 1999-01-01
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D010326 2006
% 220.92/221.12  |- mesh__publicMeSHNote mesh__D010326 64   
% 220.92/221.12  |- mesh__historyNote mesh__D010326 64   
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D010326 2004
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D010326 1995
% 220.92/221.12  |- mesh__dateRevised mesh__D010326 1993-06-02
% 220.92/221.12  |- skos__scopeNote mesh__D010326
% 220.92/221.12       Infections with bacteria of the genus PASTEURELLA.     
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D010326 2005
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D010326 1999
% 220.92/221.12  |- skos__hiddenLabel mesh__D010326 Pasteurella Infection
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D010326 2001
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D010326 2003
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D010326 1994
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D010326 1997
% 220.92/221.12  |- mesh__recordMaintainer mesh__D010326 TAP
% 220.92/221.12  |- skos__hiddenLabel mesh__D010326 Infection, Pasteurella
% 220.92/221.12  |- rdf__type mesh__D010326sskos__Concept
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D010326 2000
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D010326 1998
% 220.92/221.12  |- skos__broader mesh__D010326smesh__D016871
% 220.92/221.12  |- skos__hiddenLabel mesh__D010326 Pasteurelloses
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D010326 1996
% 220.92/221.12  |- skos__prefLabel mesh__D010326 Pasteurella Infections
% 220.92/221.12  |- skos__altLabel mesh__D010326 Pasteurellosis
% 220.92/221.12  |- mesh__dateEstablished mesh__D010326 1964-01-01
% 220.92/221.12  |- mesh__recordOriginator mesh__D010326 NLM
% 220.92/221.12  |- skos__annotation mesh__D010326
% 220.92/221.12       gram-neg bact infect; GEN; prefer specifics   
% 220.92/221.12  |- skos__altLabel mesh__D010326 Infections, Pasteurella
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D010326 2002
% 220.92/221.12  |- skos__annotation mesh__D018309
% 220.92/221.12       neoplasms composed of gonadal tissue, not neoplasms located in the ovaries or testes: Manual 24.2.2.5; coordinate IM with pre-coordinated organ/neoplasm term %28%IM%29%; DF: NEOPL GONADAL TISSUE%A%  
% 220.92/221.12  |- mesh__dateCreated mesh__D018309 1993-06-25
% 220.92/221.12  |- mesh__dateRevised mesh__D018309 2004-07-07
% 220.92/221.12  |- skos__scopeNote mesh__D018309
% 220.92/221.12       Neoplasms composed of tissues of the OVARY or the TESTIS, not neoplasms located in the ovaries or testes. Gonadal tissues include GERM CELLS, cells from the sex cord, and gonadal stromal cells.%A%    
% 220.92/221.12  |- mesh__recordOriginator mesh__D018309 PLS
% 220.92/221.12  |- mesh__publicMeSHNote mesh__D018309
% 220.92/221.12       94; GYNANDROBLASTOMA was heading 1963-96   
% 220.92/221.12  |- mesh__historyNote mesh__D018309
% 220.92/221.12       94; GYNANDROBLASTOMA was heading 1963-96   
% 220.92/221.12  |- mesh__dateEstablished mesh__D018309 1994-01-01
% 220.92/221.12  |- rdf__type mesh__D018309sskos__Concept
% 220.92/221.12  |- skos__hiddenLabel mesh__D018309 Tissue Neoplasms, Gonadal
% 220.92/221.12  |- skos__hiddenLabel mesh__D018309 Gonadal Tissue Neoplasm
% 220.92/221.12  |- mesh__recordAuthorizer mesh__D018309 sjn
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D018309 2006
% 220.92/221.12  |- skos__hiddenLabel mesh__D018309 Tissue Neoplasm, Gonadal
% 220.92/221.12  |- skos__broader mesh__D018309smesh__D009370
% 220.92/221.12  |- skos__hiddenLabel mesh__D018309 Neoplasm, Gonadal Tissue
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D018309 2005
% 220.92/221.12  |- mesh__recordMaintainer mesh__D018309 lkt
% 220.92/221.12  |- skos__prefLabel mesh__D018309 Neoplasms, Gonadal Tissue
% 220.92/221.12  |- skos__altLabel mesh__D018309 Gonadal Tissue Neoplasms
% 220.92/221.12  |- skos__broader mesh__D049992Q000037smesh__D049992
% 220.92/221.12  |- mesh__preferredCombination mesh__D049992Q000037smesh__D049993
% 220.92/221.12  |- rdf__type mesh__D049992Q000037smesh__CompoundConcept
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D015011 2006
% 220.92/221.12  |- skos__scopeNote mesh__D015011
% 220.92/221.12       A human and animal pathogen causing mesenteric lymphadenitis, diarrhea, and bacteremia.%A%    
% 220.92/221.12  |- mesh__recordMaintainer mesh__D015011 SYSTEM
% 220.92/221.12  |- mesh__recordAuthorizer mesh__D015011 sjn
% 220.92/221.12  |- mesh__publicMeSHNote mesh__D015011 87   
% 220.92/221.12  |- mesh__recordOriginator mesh__D015011 RC
% 220.92/221.12  |- mesh__historyNote mesh__D015011 87   
% 220.92/221.12  |- skos__prefLabel mesh__D015011 Yersinia pseudotuberculosis
% 220.92/221.12  |- rdf__type mesh__D015011sskos__Concept
% 220.92/221.12  |- mesh__dateCreated mesh__D015011 1986-06-18
% 220.92/221.12  |- skos__annotation mesh__D015011
% 220.92/221.12       note category; infect = YERSINIA PSEUDOTUBERCULOSIS INFECTIONS%A%  
% 220.92/221.12  |- skos__historyNote mesh__D015011 Yersinia %28%1975-1986%29%
% 220.92/221.12  |- mesh__dateEstablished mesh__D015011 1987-01-01
% 220.92/221.12  |- skos__broader mesh__D015011smesh__D015007
% 220.92/221.12  |- mesh__dateRevised mesh__D015011 2005-06-30
% 220.92/221.12  |- skos__hiddenLabel mesh__D020754 Spinocerebellar Ataxia 4
% 220.92/221.12  |- skos__prefLabel mesh__D020754 Spinocerebellar Ataxias
% 220.92/221.12  |- skos__altLabel mesh__D020754 Spinocerebellar Ataxia-7
% 220.92/221.12  |- skos__hiddenLabel mesh__D020754 Spinocerebellar Ataxia
% 220.92/221.12  |- skos__hiddenLabel mesh__D020754 Spinocerebellar Ataxia 5
% 220.92/221.12  |- skos__hiddenLabel mesh__D020754
% 220.92/221.12       Spinocerebellar Ataxia, Dominantly-Inherited
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D020754 2006
% 220.92/221.12  |- mesh__dateEstablished mesh__D020754 2000-01-01
% 220.92/221.12  |- skos__hiddenLabel mesh__D020754
% 220.92/221.12       Ataxia, Dominantly-Inherited Spinocerebellar
% 220.92/221.12  |- skos__altLabel mesh__D020754 Spinocerebellar Ataxia-4
% 220.92/221.12  |- skos__altLabel mesh__D020754 Type 1 Spinocerebellar Ataxia
% 220.92/221.12  |- skos__altLabel mesh__D020754 Spinocerebellar Ataxia-1
% 220.92/221.12  |- mesh__recordAuthorizer mesh__D020754 sjn
% 220.92/221.12  |- skos__hiddenLabel mesh__D020754 Atrophies, Spinocerebellar
% 220.92/221.12  |- rdf__type mesh__D020754sskos__Concept
% 220.92/221.12  |- skos__hiddenLabel mesh__D020754
% 220.92/221.12       Ataxias, Dominantly-Inherited Spinocerebellar
% 220.92/221.12  |- skos__hiddenLabel mesh__D020754
% 220.92/221.12       Dominantly Inherited Spinocerebellar Ataxias
% 220.92/221.12  |- skos__historyNote mesh__D020754
% 220.92/221.12       Spinocerebellar Degenerations %28%1987-1999%29%
% 220.92/221.12  |- skos__hiddenLabel mesh__D020754
% 220.92/221.12       Dominantly-Inherited Spinocerebellar Ataxia
% 220.92/221.12  |- skos__historyNote mesh__D020754 Ataxia/genetics %28%1965-1999%29%
% 220.92/221.12  |- skos__hiddenLabel mesh__D020754 Spinocerebellar Ataxia 2
% 220.92/221.12  |- skos__altLabel mesh__D020754 Type 5 Spinocerebellar Ataxia
% 220.92/221.12  |- skos__altLabel mesh__D020754 Spinocerebellar Ataxia-5
% 220.92/221.12  |- skos__altLabel mesh__D020754
% 220.92/221.12       Dominantly-Inherited Spinocerebellar Ataxias
% 220.92/221.12  |- mesh__recordOriginator mesh__D020754 KEV
% 220.92/221.12  |- skos__hiddenLabel mesh__D020754 Spinocerebellar Atrophy
% 220.92/221.12  |- skos__hiddenLabel mesh__D020754 Ataxias, Spinocerebellar
% 220.92/221.12  |- skos__hiddenLabel mesh__D020754
% 220.92/221.12       Spinocerebellar Ataxias, Dominantly Inherited
% 220.92/221.12  |- skos__hiddenLabel mesh__D020754 Atrophy, Spinocerebellar
% 220.92/221.12  |- mesh__recordMaintainer mesh__D020754 nns
% 220.92/221.12  |- skos__historyNote mesh__D020754 Spinal Cord Diseases %28%1966-1999%29%
% 220.92/221.12  |- skos__broader mesh__D020754smesh__D002524
% 220.92/221.12  |- skos__hiddenLabel mesh__D020754 Spinocerebellar Ataxia 1
% 220.92/221.12  |- skos__altLabel mesh__D020754 Type 6 Spinocerebellar Ataxia
% 220.92/221.12  |- skos__historyNote mesh__D020754 Cerebellar Diseases %28%1966-1999%29%
% 220.92/221.12  |- skos__altLabel mesh__D020754 Spinocerebellar Ataxia-2
% 220.92/221.12  |- skos__altLabel mesh__D020754 Spinocerebellar Atrophies
% 220.92/221.12  |- skos__hiddenLabel mesh__D020754 Spinocerebellar Ataxia 7
% 220.92/221.12  |- skos__altLabel mesh__D020754 Type 4 Spinocerebellar Ataxia
% 220.92/221.12  |- mesh__historyNote mesh__D020754
% 220.92/221.12       2000; use SPINOCEREBELLAR DEGENERATION 1987-1999   
% 220.92/221.12  |- skos__altLabel mesh__D020754 Type 2 Spinocerebellar Ataxia
% 220.92/221.12  |- skos__broader mesh__D020754smesh__D013132
% 220.92/221.12  |- mesh__dateCreated mesh__D020754 1999-11-08
% 220.92/221.12  |- mesh__dateRevised mesh__D020754 2005-06-30
% 220.92/221.12  |- skos__altLabel mesh__D020754 Spinocerebellar Ataxia-6
% 220.92/221.12  |- skos__annotation mesh__D020754
% 220.92/221.12       SPINOCEREBELLAR ATAXIA TYPE 3 see MACHADO-JOSEPH DISEASE is  available%A%  
% 220.92/221.12  |- mesh__publicMeSHNote mesh__D020754
% 220.92/221.12       2000; see SPINOCEREBELLAR DEGENERATION 1987-1999   
% 220.92/221.12  |- skos__hiddenLabel mesh__D020754 Spinocerebellar Ataxia 6
% 220.92/221.12  |- skos__hiddenLabel mesh__D020754 Ataxia, Spinocerebellar
% 220.92/221.12  |- skos__altLabel mesh__D020754 Type 7 Spinocerebellar Ataxia
% 220.92/221.12  |- skos__scopeNote mesh__D020754
% 220.92/221.12       A group of dominantly inherited, predominately late-onset, cerebellar ataxias which have been divided into multiple subtypes based on clinical features and genetic mapping. Progressive ataxia is a central feature of these conditions, and in certain subtypes POLYNEUROPATHY; DYSARTHRIA; visual loss; and other disorders may develop. %28%From Joynt, Clinical Neurology, 1997, Ch65, pp 12-17; J Neuropathol Exp Neurol 1998 Jun;57%28%6%29%:531-43%29%%A%    
% 220.92/221.12  |- skos__altLabel mesh__D020754
% 220.92/221.12       Spinocerebellar Ataxias, Dominantly-Inherited
% 220.92/221.12  |- mesh__historyNote mesh__D006285
% 220.92/221.12       79; was HEALTH AND WELFARE PLANNING 1968-78; NATIONAL HEALTH PLANNING AND RESOURCES DEVELOPMENT ACT OF 1974 was heading 1982-95; HEALTH PLANNING AND RESOURCES DEVELOPMENT AMENDMENTS OF 1979, PL96-79; HEALTH PLANNING ACT 93-641; PUBLIC LAW 93-641; %26% PL93-641 were see NATIONAL HEALTH PLANNING AND RESOURCES DEVELOPMENT ACT OF 1974 1982-95%A%  
% 220.92/221.12  |- skos__hiddenLabel mesh__D006285 Public Law 93 641
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D006285 2005
% 220.92/221.12  |- mesh__onlineNote mesh__D006285
% 220.92/221.12       use HEALTH PLANNING to search HEALTH AND WELFARE PLANNING 1968-78%A%  
% 220.92/221.12  |- mesh__dateCreated mesh__D006285 1999-01-01
% 220.92/221.12  |- mesh__recordMaintainer mesh__D006285 lkt
% 220.92/221.12  |- mesh__recordAuthorizer mesh__D006285 sjn
% 220.92/221.12  |- skos__annotation mesh__D006285
% 220.92/221.12       specify geog %26% add UNITED STATES %28%NIM%29% for X ref STATE HEALTH PLANNING, UNITED STATES%A%  
% 220.92/221.12  |- skos__historyNote mesh__D006285 Social Medicine %28%1966-1967%29%
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D006285 2006
% 220.92/221.12  |- skos__broader mesh__D006285smesh__D004472
% 220.92/221.12  |- skos__altLabel mesh__D006285 Public Law 93-641
% 220.92/221.12  |- skos__scopeNote mesh__D006285
% 220.92/221.12       Planning for needed health and/or welfare services and facilities.%A%    
% 220.92/221.12  |- skos__altLabel mesh__D006285 Health and Welfare Planning
% 220.92/221.12  |- mesh__dateRevised mesh__D006285 2003-07-09
% 220.92/221.12  |- skos__prefLabel mesh__D006285 Health Planning
% 220.92/221.12  |- skos__historyNote mesh__D006285 Social Welfare %28%1966-1967%29%
% 220.92/221.12  |- skos__hiddenLabel mesh__D006285 Planning, Health
% 220.92/221.12  |- mesh__dateEstablished mesh__D006285 1968-01-01
% 220.92/221.12  |- mesh__recordOriginator mesh__D006285 NLM
% 220.92/221.12  |- rdf__type mesh__D006285sskos__Concept
% 220.92/221.12  |- mesh__publicMeSHNote mesh__D006285
% 220.92/221.12       79; was HEALTH AND WELFARE PLANNING 1968-78; NATIONAL HEALTH PLANNING AND RESOURCES DEVELOPMENT ACT OF 1974 was heading 1982-95; HEALTH PLANNING AND RESOURCES DEVELOPMENT AMENDMENTS OF 1979, PL96-79; HEALTH PLANNING ACT 93-641; PUBLIC LAW 93-641; %26% PL93-641 were see NATIONAL HEALTH PLANNING AND RESOURCES DEVELOPMENT ACT OF 1974 1982-95%A%  
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D006285 2004
% 220.92/221.12  |- skos__altLabel mesh__D014717 Spinning Sensation
% 220.92/221.12  |- mesh__dateRevised mesh__D014717 2005-07-01
% 220.92/221.12  |- mesh__recordOriginator mesh__D014717 NLM
% 220.92/221.12  |- skos__hiddenLabel mesh__D014717 Brainstem Vertigo
% 220.92/221.12  |- mesh__dateCreated mesh__D014717 1999-01-01
% 220.92/221.12  |- skos__hiddenLabel mesh__D014717 Constant Vertigo
% 220.92/221.12  |- skos__hiddenLabel mesh__D014717 Central Origin Vertigo
% 220.92/221.12  |- skos__related mesh__D014717smesh__D004244
% 220.92/221.12  |- skos__broader mesh__D014717smesh__D009461
% 220.92/221.12  |- skos__annotation mesh__D014717
% 220.92/221.12       differentiate from DIZZINESS, %22%sensation of unsteadiness or lightheadedness%22%, but use word of text%A%  
% 220.92/221.12  |- rdf__type mesh__D014717sskos__Concept
% 220.92/221.12  |- skos__hiddenLabel mesh__D014717 Sensation, Spinning
% 220.92/221.12  |- skos__altLabel mesh__D014717 Vertigo, Central Nervous System Origin
% 220.92/221.12  |- skos__hiddenLabel mesh__D014717 Peripheral Vertigo
% 220.92/221.12  |- skos__hiddenLabel mesh__D014717 Vertigo, Positional
% 220.92/221.12  |- mesh__recordAuthorizer mesh__D014717 sjn
% 220.92/221.12  |- skos__scopeNote mesh__D014717
% 220.92/221.12       An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear %28%EAR, INNER%29%; VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. %28%From Adams et al., Principles of Neurology, 6th ed, pp300-1%29%%A%    
% 220.92/221.12  |- skos__hiddenLabel mesh__D014717 Brain Stem Vertigo
% 220.92/221.12  |- skos__prefLabel mesh__D014717 Vertigo
% 220.92/221.12  |- skos__hiddenLabel mesh__D014717 Intermittant Vertigo
% 220.92/221.12  |- mesh__activeMeSHYear mesh__D014717 2006
% 220.92/221.12  |- skos__hiddenLabel mesh__D014717 Vertigos, Brainstem
% 220.92/221.12  |- skos__altLabel mesh__D014717 Vertigo, Subjective
% 220.92/221.12  |- skos__altLabel mesh__D014717 Vertigo, Brainstem
% 220.92/221.12  |- skos__hiddenLabel mesh__D014717 Sensations, Spinning
% 220.92/221.12  |- mesh__recordMaintainer mesh__D014717 sjn
% 220.92/221.12  |- skos__hiddenLabel mesh__D014717 Spinning Sensations
% 220.92/221.12  |- skos__broader mesh__D014717smesh__D015837
% 220.92/221.12  |- skos__hiddenLabel mesh__D014717 Brainstem Vertigos
% 220.92/221.12  |- skos__altLabel mesh__D014717 Vertigo, Central Origin
% 220.92/221.12  |- skos__hiddenLabel mesh__D014717 Subjective Vertigo
% 220.92/221.12  |- skos__hiddenLabel mesh__D014717 Paroxysmal Vertigo
% 220.92/221.12  |- skos__hiddenLabel mesh__D014717 Essential Vertigo
% 220.92/221.12  |- mesh__dateRevised mesh__D019402 2005-06-30
% 220.92/221.12  |- skos__scopeNote mesh__D019402
% 220.92/221.12       Heparin-binding proteins that exhibit a number of inflammatory and immunoregulatory activities. Originally identified as secretory products of macrophages, these chemokines are produced by a variety of cell types including neutrophils, fibroblasts, and epithelial cells. They likely play a significant role in respiratory tract defenses.%A%    
% 220.92/221.12  |- mesh__recordMaintainer mesh__D019402 ssb
% 220.92/221.13  |- skos__broader mesh__D019402smesh__D018925
% 220.92/221.13  |- mesh__publicMeSHNote mesh__D019402 97   
% 220.92/221.13  |- skos__annotation mesh__D019402
% 220.92/221.13       heparin-binding proteins; DF: MACROPHAGE INFLAMM PROTEINS%A%  
% 220.92/221.13  |- skos__prefLabel mesh__D019402 Macrophage Inflammatory Proteins
% 220.92/221.13  |- mesh__dateEstablished mesh__D019402 1997-01-01
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D019402 2006
% 220.92/221.13  |- mesh__dateCreated mesh__D019402 1996-06-10
% 220.92/221.13  |- mesh__recordOriginator mesh__D019402 AGS
% 220.92/221.13  |- skos__hiddenLabel mesh__D019402 Inflammatory Proteins, Macrophage
% 220.92/221.13  |- mesh__historyNote mesh__D019402 97   
% 220.92/221.13  |- rdf__type mesh__D019402sskos__Concept
% 220.92/221.13  |- mesh__recordAuthorizer mesh__D019402 sjn
% 220.92/221.13  |- mesh__recordOriginator mesh__D002693 NLM
% 220.92/221.13  |- mesh__dateCreated mesh__D002693 1999-01-01
% 220.92/221.13  |- mesh__recordMaintainer mesh__D002693 SYSTEM
% 220.92/221.13  |- mesh__onlineNote mesh__D002693
% 220.92/221.13       use CHLAMYDIACEAE to search BASOPHILIC VIRUSES 1975-91   
% 220.92/221.13  |- skos__scopeNote mesh__D002693
% 220.92/221.13       A family of gram-negative, coccoid microorganisms, in the order CHLAMYDIALES, pathogenic for vertebrates. Genera include CHLAMYDIA and CHLAMYDOPHILA.%A%    
% 220.92/221.13  |- mesh__dateRevised mesh__D002693 2005-06-30
% 220.92/221.13  |- rdf__type mesh__D002693sskos__Concept
% 220.92/221.13  |- mesh__recordAuthorizer mesh__D002693 sjn
% 220.92/221.13  |- mesh__dateEstablished mesh__D002693 1976-01-01
% 220.92/221.13  |- mesh__publicMeSHNote mesh__D002693
% 220.92/221.13       76; was see under RICKETTSIA 1975; BASOPHILIC VIRUSES was see CHLAMYDIACEAE 1975-91%A%  
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D002693 2006
% 220.92/221.13  |- skos__broader mesh__D002693smesh__D002695
% 220.92/221.13  |- skos__prefLabel mesh__D002693 Chlamydiaceae
% 220.92/221.13  |- skos__annotation mesh__D002693 infection = CHLAMYDIACEAE INFECTIONS   
% 220.92/221.13  |- mesh__historyNote mesh__D002693
% 220.92/221.13       76%28%64%29%; was see under RICKETTSIA 1975; BASOPHILIC VIRUSES was see CHLAMYDIACEAE 1975-91%A%  
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010327 2003
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010327 1994
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010327 1997
% 220.92/221.13  |- rdf__type mesh__D010327sskos__Concept
% 220.92/221.13  |- mesh__recordOriginator mesh__D010327 NLM
% 220.92/221.13  |- mesh__publicMeSHNote mesh__D010327
% 220.92/221.13       79; was PSYCHOLOGY, PASTORAL 1963-78   
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010327 1998
% 220.92/221.13  |- skos__hiddenLabel mesh__D010327 Care, Pastoral
% 220.92/221.13  |- skos__broader mesh__D010327smesh__D012069
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010327 1996
% 220.92/221.13  |- skos__prefLabel mesh__D010327 Pastoral Care
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010327 2002
% 220.92/221.13  |- skos__annotation mesh__D010327 SPEC: SPEC qualif   
% 220.92/221.13  |- mesh__recordAuthorizer mesh__D010327 PLS
% 220.92/221.13  |- mesh__dateRevised mesh__D010327 1993-06-04
% 220.92/221.13  |- mesh__onlineNote mesh__D010327
% 220.92/221.13       use PASTORAL CARE to search PSYCHOLOGY, PASTORAL 1966-78   
% 220.92/221.13  |- mesh__historyNote mesh__D010327 79; was PSYCHOLOGY, PASTORAL 1963-78   
% 220.92/221.13  |- mesh__dateCreated mesh__D010327 1999-01-01
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010327 2006
% 220.92/221.13  |- skos__altLabel mesh__D010327 Psychology, Pastoral
% 220.92/221.13  |- skos__broader mesh__D010327smesh__D003376
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010327 2001
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010327 2004
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010327 1995
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010327 2000
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010327 2005
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010327 1999
% 220.92/221.13  |- mesh__recordMaintainer mesh__D010327 JLS
% 220.92/221.13  |- skos__scopeNote mesh__D010327
% 220.92/221.13       Counseling or comfort given by ministers, priests, rabbis, etc., to those in need of help with emotional problems or stressful situations.%A%    
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015810 2005
% 220.92/221.13  |- mesh__publicMeSHNote mesh__D015810 90   
% 220.92/221.13  |- mesh__recordAuthorizer mesh__D015810 sjn
% 220.92/221.13  |- mesh__dateCreated mesh__D015810 1989-05-15
% 220.92/221.13  |- skos__hiddenLabel mesh__D015810 Linkage Disequilibriums
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015810 2004
% 220.92/221.13  |- rdf__type mesh__D015810sskos__Concept
% 220.92/221.13  |- skos__broader mesh__D015810smesh__D008040
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015810 2003
% 220.92/221.13  |- mesh__dateRevised mesh__D015810 2002-07-03
% 220.92/221.13  |- skos__historyNote mesh__D015810 Linkage %28%1966-1989%29%
% 220.92/221.13  |- skos__hiddenLabel mesh__D015810 Disequilibrium, Linkage
% 220.92/221.13  |- mesh__recordOriginator mesh__D015810 AGS
% 220.92/221.13  |- mesh__dateEstablished mesh__D015810 1990-01-01
% 220.92/221.13  |- mesh__historyNote mesh__D015810 90   
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015810 2006
% 220.92/221.13  |- mesh__recordMaintainer mesh__D015810 TGC
% 220.92/221.13  |- skos__scopeNote mesh__D015810
% 220.92/221.13       Nonrandom association of linked genes. This is the tendency of the alleles of two separate but already linked loci to be found together more frequently than would be expected by chance alone.%A%    
% 220.92/221.13  |- skos__hiddenLabel mesh__D015810 Disequilibriums, Linkage
% 220.92/221.13  |- skos__prefLabel mesh__D015810 Linkage Disequilibrium
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015012 1995
% 220.92/221.13  |- mesh__historyNote mesh__D015012
% 220.92/221.13       91%28%87%29%; was see under YERSINIA INFECTIONS 1987-90; was PSEUDOTUBERCULOSIS, YERSINIA 1977-86; was PSEUDOTUBERCULOSIS, PASTEURELLA see under PASTEURELLA INFECTIONS 1964-76, was see under PASTEURELLA 1963; PSEUDOTUBERCULOSIS INFECTIONS, YERSINIA was see YERSINIA PSEUDOTUBERCULOSIS INFECTIONS 1987-93%A%  
% 220.92/221.13  |- mesh__dateRevised mesh__D015012 1993-06-04
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015012 2005
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015012 2004
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015012 2002
% 220.92/221.13  |- mesh__recordMaintainer mesh__D015012 TPW
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015012 1994
% 220.92/221.13  |- skos__historyNote mesh__D015012 Pasteurella Infections %28%1966-1974%29%
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015012 2003
% 220.92/221.13  |- mesh__recordAuthorizer mesh__D015012 PLS
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015012 1999
% 220.92/221.13  |- rdf__type mesh__D015012sskos__Concept
% 220.92/221.13  |- skos__hiddenLabel mesh__D015012 Pasteurella Pseudotuberculosis
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015012 1998
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015012 1997
% 220.92/221.13  |- mesh__recordOriginator mesh__D015012 FPG
% 220.92/221.13  |- skos__altLabel mesh__D015012 Pseudotuberculosis, Pasteurella
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015012 2001
% 220.92/221.13  |- mesh__dateCreated mesh__D015012 1976-04-19
% 220.92/221.13  |- skos__hiddenLabel mesh__D015012 Pseudotuberculoses, Pasteurella
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015012 1996
% 220.92/221.13  |- skos__broader mesh__D015012smesh__D015009
% 220.92/221.13  |- skos__hiddenLabel mesh__D015012 Pasteurella Pseudotuberculoses
% 220.92/221.13  |- skos__altLabel mesh__D015012 Infections, Yersinia pseudotuberculosis
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015012 2000
% 220.92/221.13  |- mesh__dateEstablished mesh__D015012 1991-01-01
% 220.92/221.13  |- skos__scopeNote mesh__D015012
% 220.92/221.13       Infections with bacteria of the species YERSINIA PSEUDOTUBERCULOSIS.%A%    
% 220.92/221.13  |- mesh__publicMeSHNote mesh__D015012
% 220.92/221.13       91; was see under YERSINIA INFECTIONS 1987-90; was PSEUDOTUBERCULOSIS, YERSINIA 1977-86; was PSEUDOTUBERCULOSIS, PASTEURELLA see under PASTEURELLA INFECTIONS 1964-76, was see under PASTEURELLA 1963; TUBERCULOSIS INFECTIONS, YERSINIA was see YERSINIA PSEUDOTUBERCULOSIS INFECTIONS 1987-93%A%  
% 220.92/221.13  |- skos__prefLabel mesh__D015012 Yersinia pseudotuberculosis Infections
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015012 2006
% 220.92/221.13  |- mesh__onlineNote mesh__D015012
% 220.92/221.13       use YERSINIA PSEUDOTUBERCPLOSIS INFECTIONS to search PSEUDOTUBERCULOSIS, YERSINIA 1977-86 %26% PSEUDOTUBERCULOSIS INFECTIONS, YERSINIA 1987-93; use YERSINIA PSEUDOTUBERCULOSIS INFECTIONS to search PSEUDOTUBERCULOSIS, PASTEURELLA 1975-76, use PASTEURELLA INFECTIONS 1966-74%A%  
% 220.92/221.13  |- skos__broader mesh__D005680Q000819smesh__D005680
% 220.92/221.13  |- mesh__preferredCombination mesh__D005680Q000819smesh__D018755
% 220.92/221.13  |- rdf__type mesh__D005680Q000819smesh__CompoundConcept
% 220.92/221.13  |- mesh__recordOriginator mesh__D020755 jmp
% 220.92/221.13  |- mesh__publicMeSHNote mesh__D020755
% 220.92/221.13       2000; COPI PROTEIN %28%now COAT PROTEIN PROTEIN COMPLEX I%29% was indexed under MEMBRANE PROTEINS 1994-1999%A%  
% 220.92/221.13  |- mesh__historyNote mesh__D020755
% 220.92/221.13       2000; use COATOMER PROTEIN %28%NM%29% 1994-1999   
% 220.92/221.13  |- skos__altLabel mesh__D020755 COPI Protein
% 220.92/221.13  |- skos__altLabel mesh__D020755 COPI
% 220.92/221.13  |- rdf__type mesh__D020755sskos__Concept
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D020755 2004
% 220.92/221.13  |- skos__scopeNote mesh__D020755
% 220.92/221.13       A protein complex comprised of COATOMER PROTEIN and ADP RIBOSYLATION FACTOR 1. It is involved in transport of vesicles between the ENDOPLASMIC RETICULUM and the GOLGI APPARATUS.%A%    
% 220.92/221.13  |- skos__annotation mesh__D020755
% 220.92/221.13       for alpha, beta, delta, and epsilon-COP see COATOMER PROTEIN%A%  
% 220.92/221.13  |- mesh__recordAuthorizer mesh__D020755 sjn
% 220.92/221.13  |- mesh__dateCreated mesh__D020755 1999-11-03
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D020755 2006
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D020755 2003
% 220.92/221.13  |- mesh__dateEstablished mesh__D020755 2000-01-01
% 220.92/221.13  |- mesh__recordMaintainer mesh__D020755 sjn
% 220.92/221.13  |- mesh__dateRevised mesh__D020755 2002-07-03
% 220.92/221.13  |- skos__historyNote mesh__D020755 Membrane Proteins %28%1995-1999%29%
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D020755 2005
% 220.92/221.13  |- skos__prefLabel mesh__D020755 Coat Protein Complex I
% 220.92/221.13  |- skos__altLabel mesh__D020755 COP-I
% 220.92/221.13  |- skos__broader mesh__D020755smesh__D033921
% 220.92/221.13  |- skos__altLabel mesh__D020755 COP-1
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D006286 2006
% 220.92/221.13  |- mesh__publicMeSHNote mesh__D006286
% 220.92/221.13       91; was see under HEALTH PLANNING ORGANIZATIONS 1980-90   
% 220.92/221.13  |- skos__hiddenLabel mesh__D006286 Planning Councils, Health
% 220.92/221.13  |- skos__prefLabel mesh__D006286 Health Planning Councils
% 220.92/221.13  |- skos__annotation mesh__D006286 Public Law 93-641; specify geog   
% 220.92/221.13  |- skos__hiddenLabel mesh__D006286 Councils, Health Planning
% 220.92/221.13  |- mesh__historyNote mesh__D006286
% 220.92/221.13       91%28%80%29%; was see under HEALTH PLANNING ORGANIZATIONS 1980-90%A%  
% 220.92/221.13  |- skos__hiddenLabel mesh__D006286 Council, Health Planning
% 220.92/221.13  |- skos__hiddenLabel mesh__D006286 Planning Council, Health
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D006286 2003
% 220.92/221.13  |- mesh__dateEstablished mesh__D006286 1991-01-01
% 220.92/221.13  |- mesh__recordOriginator mesh__D006286 EC
% 220.92/221.13  |- rdf__type mesh__D006286sskos__Concept
% 220.92/221.13  |- skos__scopeNote mesh__D006286
% 220.92/221.13       Organized groups serving in advisory capacities related to health planning activities.%A%    
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D006286 2000
% 220.92/221.13  |- skos__hiddenLabel mesh__D006286 Health Planning Council
% 220.92/221.13  |- skos__broader mesh__D006286smesh__D006288
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D006286 2004
% 220.92/221.13  |- skos__historyNote mesh__D006286 Health Planning %28%1968-1979%29%
% 220.92/221.13  |- mesh__recordAuthorizer mesh__D006286 sjn
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D006286 2001
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D006286 2005
% 220.92/221.13  |- mesh__recordMaintainer mesh__D006286 kle
% 220.92/221.13  |- mesh__dateCreated mesh__D006286 1979-06-01
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D006286 2002
% 220.92/221.13  |- mesh__dateRevised mesh__D006286 1999-11-03
% 220.92/221.13  |- mesh__recordAuthorizer mesh__D014718 PLS
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D014718 2000
% 220.92/221.13  |- rdf__type mesh__D014718sskos__Concept
% 220.92/221.13  |- skos__altLabel mesh__D014718 Vesicoureteral Reflux
% 220.92/221.13  |- skos__hiddenLabel mesh__D014718 Vesico Ureteral Reflux
% 220.92/221.13  |- skos__broader mesh__D014718smesh__D001745
% 220.92/221.13  |- skos__scopeNote mesh__D014718
% 220.92/221.13       The passage of urine from the bladder back into a ureter. %28%Dorland, 27th ed%29%%A%    
% 220.92/221.13  |- mesh__recordOriginator mesh__D014718 NLM
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D014718 1995
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D014718 1999
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D014718 2002
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D014718 1997
% 220.92/221.13  |- mesh__recordMaintainer mesh__D014718 TGC
% 220.92/221.13  |- mesh__dateRevised mesh__D014718 1994-05-24
% 220.92/221.13  |- skos__hiddenLabel mesh__D014718 Reflux, Vesico-Ureteral
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D014718 1998
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D014718 2006
% 220.92/221.13  |- skos__prefLabel mesh__D014718 Vesico-Ureteral Reflux
% 220.92/221.13  |- skos__annotation mesh__D014718
% 220.92/221.13       reflux of urine from bladder back into a ureter   
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D014718 1996
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D014718 2004
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D014718 2005
% 220.92/221.13  |- mesh__dateCreated mesh__D014718 1999-01-01
% 220.92/221.13  |- skos__hiddenLabel mesh__D014718 Reflux, Vesicoureteral
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D014718 2001
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D014718 2003
% 220.92/221.13  |- mesh__recordAuthorizer mesh__D011420 sjn
% 220.92/221.13  |- mesh__dateCreated mesh__D011420 1974-11-19
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D011420 2006
% 220.92/221.13  |- mesh__dateEstablished mesh__D011420 1991-01-01
% 220.92/221.13  |- skos__altLabel mesh__D011420 beta-Propiolactone
% 220.92/221.13  |- mesh__dateRevised mesh__D011420 2000-06-22
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D011420 2005
% 220.92/221.13  |- mesh__historyNote mesh__D011420
% 220.92/221.13       91%28%75%29%; was see under LACTONES 1975-90   
% 220.92/221.13  |- mesh__publicMeSHNote mesh__D011420 91; was see under LACTONES 1975-90   
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D011420 2004
% 220.92/221.13  |- mesh__recordMaintainer mesh__D011420 CCR
% 220.92/221.13  |- rdf__type mesh__D011420sskos__Concept
% 220.92/221.13  |- skos__scopeNote mesh__D011420
% 220.92/221.13       Disinfectant used in vapor form to sterilize vaccines, grafts, etc. The vapor is very irritating and the liquid form is carcinogenic.%A%    
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D011420 2002
% 220.92/221.13  |- skos__broader mesh__D011420smesh__D007783
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D011420 2003
% 220.92/221.13  |- skos__prefLabel mesh__D011420 Propiolactone
% 220.92/221.13  |- skos__hiddenLabel mesh__D011420 beta Propiolactone
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D011420 2001
% 220.92/221.13  |- skos__historyNote mesh__D011420 Propionates %28%1972-1974%29%
% 220.92/221.13  |- skos__historyNote mesh__D011420 Lactones %28%1969-1974%29%
% 220.92/221.13  |- mesh__recordOriginator mesh__D011420 NLM
% 220.92/221.13  |- skos__altLabel mesh__D011420 Propanolide
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D002694 2001
% 220.92/221.13  |- mesh__recordMaintainer mesh__D002694 PXP
% 220.92/221.13  |- mesh__dateRevised mesh__D002694 1997-06-20
% 220.92/221.13  |- skos__historyNote mesh__D002694 Chlamydia Infections %28%1967-1976%29%
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D002694 2005
% 220.92/221.13  |- skos__hiddenLabel mesh__D002694 Infections, Chlamydiaceae
% 220.92/221.13  |- mesh__recordAuthorizer mesh__D002694 SJN
% 220.92/221.13  |- skos__broader mesh__D002694smesh__D016905
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D002694 1998
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D002694 2004
% 220.92/221.13  |- skos__annotation mesh__D002694 rickettsial infect   
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D002694 2006
% 220.92/221.13  |- skos__historyNote mesh__D002694 Rickettsial Infections %28%1966-1976%29%
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D002694 1999
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D002694 2002
% 220.92/221.13  |- mesh__recordOriginator mesh__D002694 FPG
% 220.92/221.13  |- skos__scopeNote mesh__D002694
% 220.92/221.13       Infections with bacteria of the family CHLAMYDIACEAE.     
% 220.92/221.13  |- skos__hiddenLabel mesh__D002694 Infection, Chlamydiaceae
% 220.92/221.13  |- mesh__publicMeSHNote mesh__D002694 77   
% 220.92/221.13  |- mesh__dateCreated mesh__D002694 1976-04-27
% 220.92/221.13  |- mesh__historyNote mesh__D002694 77   
% 220.92/221.13  |- skos__prefLabel mesh__D002694 Chlamydiaceae Infections
% 220.92/221.13  |- skos__hiddenLabel mesh__D002694 Chlamydiaceae Infection
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D002694 2000
% 220.92/221.13  |- mesh__dateEstablished mesh__D002694 1977-01-01
% 220.92/221.13  |- rdf__type mesh__D002694sskos__Concept
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D002694 2003
% 220.92/221.13  |- skos__broader mesh__D010328smesh__D012882
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010328 2000
% 220.92/221.13  |- mesh__publicMeSHNote mesh__D010328
% 220.92/221.13       91; was see under SKIN TESTS 1975-90   
% 220.92/221.13  |- mesh__recordOriginator mesh__D010328 NLM
% 220.92/221.13  |- mesh__onlineNote mesh__D010328 search SKIN TESTS 1966-74   
% 220.92/221.13  |- mesh__recordMaintainer mesh__D010328 PXP
% 220.92/221.13  |- skos__hiddenLabel mesh__D010328 Patch Test
% 220.92/221.13  |- skos__annotation mesh__D010328 a type of skin test   
% 220.92/221.13  |- skos__scopeNote mesh__D010328
% 220.92/221.13       Skin tests in which the sensitizer is applied to a patch of cotton cloth or gauze held in place for approximately 48-72 hours. It is used for the elicitation of a contact hypersensitivity reaction.%A%    
% 220.92/221.13  |- mesh__dateCreated mesh__D010328 1999-01-01
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010328 2006
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010328 2002
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010328 2004
% 220.92/221.13  |- mesh__dateRevised mesh__D010328 1997-06-20
% 220.92/221.13  |- mesh__historyNote mesh__D010328
% 220.92/221.13       91%28%75%29%; was see under SKIN TESTS 1975-90   
% 220.92/221.13  |- mesh__recordAuthorizer mesh__D010328 SJN
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010328 2005
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010328 1999
% 220.92/221.13  |- skos__prefLabel mesh__D010328 Patch Tests
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010328 2003
% 220.92/221.13  |- rdf__type mesh__D010328sskos__Concept
% 220.92/221.13  |- mesh__dateEstablished mesh__D010328 1991-01-01
% 220.92/221.13  |- skos__hiddenLabel mesh__D010328 Tests, Patch
% 220.92/221.13  |- skos__hiddenLabel mesh__D010328 Test, Patch
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010328 1998
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D010328 2001
% 220.92/221.13  |- skos__scopeNote mesh__D015811
% 220.92/221.13       Tumors of the iris characterized by increased pigmentation of melanocytes. Iris nevi are composed of proliferated melanocytes and are associated with neurofibromatosis and malignant melanoma of the choroid and ciliary body. Malignant melanoma of the iris often originates from preexisting nevi.%A%    
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015811 2002
% 220.92/221.13  |- mesh__dateCreated mesh__D015811 1989-05-25
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015811 2005
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015811 2001
% 220.92/221.13  |- mesh__recordOriginator mesh__D015811 EGC
% 220.92/221.13  |- rdf__type mesh__D015811sskos__Concept
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015811 2004
% 220.92/221.13  |- skos__broader mesh__D015811smesh__D014604
% 220.92/221.13  |- skos__broader mesh__D015811smesh__D007499
% 220.92/221.13  |- skos__hiddenLabel mesh__D015811 Iris Neoplasm
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015811 2003
% 220.92/221.13  |- mesh__dateEstablished mesh__D015811 1990-01-01
% 220.92/221.13  |- skos__altLabel mesh__D015811 Neoplasms, Iris
% 220.92/221.13  |- skos__historyNote mesh__D015811 Iris %28%1968-1989%29%
% 220.92/221.13  |- mesh__historyNote mesh__D015811 90   
% 220.92/221.13  |- skos__hiddenLabel mesh__D015811 Neoplasm, Iris
% 220.92/221.13  |- mesh__dateRevised mesh__D015811 2000-06-22
% 220.92/221.13  |- skos__annotation mesh__D015811
% 220.92/221.13       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%  
% 220.92/221.13  |- skos__prefLabel mesh__D015811 Iris Neoplasms
% 220.92/221.13  |- mesh__publicMeSHNote mesh__D015811 90   
% 220.92/221.13  |- skos__historyNote mesh__D015811 Eye Neoplasms %28%1968-1989%29%
% 220.92/221.13  |- skos__historyNote mesh__D015811 Melanoma %28%1968-1989%29%
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015811 2006
% 220.92/221.13  |- mesh__recordAuthorizer mesh__D015811 sjn
% 220.92/221.13  |- mesh__recordMaintainer mesh__D015811 KEV
% 220.92/221.13  |- skos__prefLabel mesh__D015013 Yoga
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015013 2004
% 220.92/221.13  |- skos__annotation mesh__D015013 IM; specify geog if pertinent   
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015013 2002
% 220.92/221.13  |- skos__broader mesh__D015013smesh__D026443
% 220.92/221.13  |- rdf__type mesh__D015013sskos__Concept
% 220.92/221.13  |- skos__scopeNote mesh__D015013
% 220.92/221.13       A major orthodox system of Hindu philosophy based on Sankhya %28%metaphysical dualism%29% but differing from it in being theistic and characterized by the teaching of raja-yoga as a practical method of liberating the self. It includes a system of exercises for attaining bodily or mental control and well-being with liberation of the self and union with the universal spirit. %28%From Webster, 3d ed%29%%A%    
% 220.92/221.13  |- mesh__dateCreated mesh__D015013 1999-01-01
% 220.92/221.13  |- mesh__recordMaintainer mesh__D015013 ssb
% 220.92/221.13  |- mesh__dateRevised mesh__D015013 2001-07-25
% 220.92/221.13  |- skos__broader mesh__D015013smesh__D026241
% 220.92/221.13  |- skos__broader mesh__D015013smesh__D026441
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015013 2005
% 220.92/221.13  |- skos__broader mesh__D015013smesh__D012072
% 220.92/221.13  |- mesh__recordOriginator mesh__D015013 NLM
% 220.92/221.13  |- mesh__recordAuthorizer mesh__D015013 sjn
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015013 2003
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D015013 2006
% 220.92/221.13  |- mesh__recordAuthorizer mesh__D020756 sjn
% 220.92/221.13  |- skos__hiddenLabel mesh__D020756 HEP COP
% 220.92/221.13  |- skos__altLabel mesh__D020756 beta-COP
% 220.92/221.13  |- skos__altLabel mesh__D020756 delta-COP
% 220.92/221.13  |- skos__hiddenLabel mesh__D020756 beta COP
% 220.92/221.13  |- mesh__dateEstablished mesh__D020756 2000-01-01
% 220.92/221.13  |- mesh__recordMaintainer mesh__D020756 jmp
% 220.92/221.13  |- mesh__publicMeSHNote mesh__D020756
% 220.92/221.13       2000; COATOMER PROTEIN %26% COATOMER SUBUNIT EPSILON-COP were indexed under MEMBRANE PROTEINS 1994-1999; RET1 PROTEIN %26% ZETA-COP were indexed under MEMBRANE PROTEINS 1995-1999; DELTA-COP PROTEIN %26% HEP-COP PROTEIN were indexed under MEMBRANE PROTEINS 1996-1999; BETA-COP was indexed under MEMBRANE PROTEINS 1991-1999; ARCN1 PROTEIN was indexed under PROTEINS 1995-1999; P102 PROTEIN %28%GOLGI%29% was indexed under MEMBRANE PROTEINS 1993-1999;%A%  
% 220.92/221.13  |- mesh__dateCreated mesh__D020756 1999-11-03
% 220.92/221.13  |- skos__altLabel mesh__D020756 epsilon-COP
% 220.92/221.13  |- skos__historyNote mesh__D020756 Membrane Proteins %28%1995-1999%29%
% 220.92/221.13  |- rdf__type mesh__D020756sskos__Concept
% 220.92/221.13  |- skos__hiddenLabel mesh__D020756 Protein, ARCN1
% 220.92/221.13  |- skos__altLabel mesh__D020756 delta-COP Protein
% 220.92/221.13  |- skos__hiddenLabel mesh__D020756 zeta COP
% 220.92/221.13  |- mesh__recordOriginator mesh__D020756 jmp
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D020756 2005
% 220.92/221.13  |- skos__broader mesh__D020756smesh__D020755
% 220.92/221.13  |- skos__altLabel mesh__D020756 HEP-COP
% 220.92/221.13  |- skos__altLabel mesh__D020756 ARCN1 Protein
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D020756 2006
% 220.92/221.13  |- skos__altLabel mesh__D020756 alpha-COP
% 220.92/221.13  |- skos__hiddenLabel mesh__D020756 Coatomer Subunit epsilon COP
% 220.92/221.13  |- skos__altLabel mesh__D020756 Ret1 Protein
% 220.92/221.13  |- skos__altLabel mesh__D020756 Coatomer Subunit epsilon-COP
% 220.92/221.13  |- skos__altLabel mesh__D020756 Archain
% 220.92/221.13  |- mesh__dateRevised mesh__D020756 2004-07-07
% 220.92/221.13  |- skos__scopeNote mesh__D020756
% 220.92/221.13       A 700-kDa cytosolic protein complex consisting of seven equimolar subunits %28%alpha, beta, beta%27%, gamma, delta, epsilon and zeta%29%. COATOMER PROTEIN and ADP-RIBOSYLATION FACTOR 1 are principle components of COAT PROTEIN COMPLEX I and are involved in vesicle transport between the ENDOPLASMIC RETICULUM and the GOLGI APPARATUS.%A%    
% 220.92/221.13  |- skos__hiddenLabel mesh__D020756 epsilon-COP, Coatomer Subunit
% 220.92/221.13  |- skos__prefLabel mesh__D020756 Coatomer Protein
% 220.92/221.13  |- skos__altLabel mesh__D020756 zeta-COP
% 220.92/221.13  |- mesh__historyNote mesh__D020756
% 220.92/221.13       2000; for COATOMER PROTEIN %26% COATOMER SUBUNIT EPSILON-COP use COATOMER PROTEIN %28%NM%29% 1994-1999; for ACRN1 PROTEIN, %26% RET1 PROTEIN use COATOMER PROTEIN %28%NM%29% 1995-1999; for BETA-COP use COATOMER PROTEIN %28%NM%29% 1991-1999; for P102 PROTEIN %28%GOLGI%29% use COATOMER PROTEIN %28%NM%29% 1993-1999; for ZETA-COP use RHOB GTP-BINDING PROTEIN %28%NM%29% 1995-1999%A%  
% 220.92/221.13  |- skos__scopeNote mesh__D006287
% 220.92/221.13       Recommendations for directing health planning functions and policies. These may be mandated by PL93-641 and issued by the Department of Health and Human Services for use by state and local planning agencies.%A%    
% 220.92/221.13  |- skos__broader mesh__D006287smesh__D006285
% 220.92/221.13  |- skos__prefLabel mesh__D006287 Health Planning Guidelines
% 220.92/221.13  |- skos__annotation mesh__D006287 no qualif   
% 220.92/221.13  |- mesh__dateEstablished mesh__D006287 1991-01-01
% 220.92/221.13  |- rdf__type mesh__D006287sskos__Concept
% 220.92/221.13  |- mesh__historyNote mesh__D006287
% 220.92/221.13       91%28%80%29%; was see under HEALTH PLANNING 1980-90   
% 220.92/221.13  |- skos__hiddenLabel mesh__D006287 Planning Guideline, Health
% 220.92/221.13  |- skos__altLabel mesh__D006287 Guidelines for Health Planning
% 220.92/221.13  |- mesh__publicMeSHNote mesh__D006287
% 220.92/221.13       91; was see under HEALTH PLANNING 1980-90   
% 220.92/221.13  |- skos__hiddenLabel mesh__D006287 Health Planning Guideline
% 220.92/221.13  |- skos__hiddenLabel mesh__D006287 Planning Guidelines, Health
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D006287 2005
% 220.92/221.13  |- mesh__recordOriginator mesh__D006287 EC
% 220.92/221.13  |- mesh__dateCreated mesh__D006287 1979-06-01
% 220.92/221.13  |- skos__hiddenLabel mesh__D006287 Recommendation
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D006287 2006
% 220.92/221.13  |- skos__hiddenLabel mesh__D006287 Guideline, Health Planning
% 220.92/221.13  |- skos__hiddenLabel mesh__D006287 Guidelines, Health Planning
% 220.92/221.13  |- mesh__dateRevised mesh__D006287 2004-07-13
% 220.92/221.13  |- skos__historyNote mesh__D006287 Health Planning %28%1968-1979%29%
% 220.92/221.13  |- mesh__recordAuthorizer mesh__D006287 sjn
% 220.92/221.13  |- mesh__recordMaintainer mesh__D006287 sjn
% 220.92/221.13  |- mesh__recordAuthorizer mesh__D014719 sjn
% 220.92/221.13  |- skos__annotation mesh__D014719 fistula policy: Manual 23.19+   
% 220.92/221.13  |- skos__hiddenLabel mesh__D014719 Fistula, Vesicovaginal
% 220.92/221.13  |- skos__hiddenLabel mesh__D014719 Vesicovaginal Fistulas
% 220.92/221.13  |- skos__prefLabel mesh__D014719 Vesicovaginal Fistula
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D014719 2006
% 220.92/221.13  |- skos__scopeNote mesh__D014719
% 220.92/221.13       An abnormal anatomical passage between the BLADDER and the VAGINA.%A%    
% 220.92/221.13  |- skos__hiddenLabel mesh__D014719 Fistulas, Vesicovaginal
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D014719 2005
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D014719 2004
% 220.92/221.13  |- mesh__recordMaintainer mesh__D014719 lkt
% 220.92/221.13  |- mesh__dateCreated mesh__D014719 1999-01-01
% 220.92/221.13  |- mesh__dateRevised mesh__D014719 2003-07-09
% 220.92/221.13  |- mesh__recordOriginator mesh__D014719 NLM
% 220.92/221.13  |- rdf__type mesh__D014719sskos__Concept
% 220.92/221.13  |- skos__broader mesh__D014719smesh__D001747
% 220.92/221.13  |- skos__broader mesh__D014719smesh__D014624
% 220.92/221.13  |- mesh__recordOriginator mesh__D025441 jmp
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D025441 2005
% 220.92/221.13  |- mesh__recordAuthorizer mesh__D025441 sjn
% 220.92/221.13  |- mesh__historyNote mesh__D025441
% 220.92/221.13       2002, 1977-1991; use DIHYDROERGOTOXINE 1992-2001; for DIHYDROERGOCORNINE MESYLATE use ERGOLOID MESYLATES 1991-2001%A%  
% 220.92/221.13  |- skos__related mesh__D025441smesh__D004088
% 220.92/221.13  |- skos__hiddenLabel mesh__D025441 Monomesylate, Dihydroergocornine
% 220.92/221.13  |- mesh__dateCreated mesh__D025441 2001-07-25
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D025441 2004
% 220.92/221.13  |- skos__prefLabel mesh__D025441 Dihydroergocornine
% 220.92/221.13  |- rdf__type mesh__D025441sskos__Concept
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D025441 2006
% 220.92/221.13  |- mesh__dateEstablished mesh__D025441 2002-01-01
% 220.92/221.13  |- skos__scopeNote mesh__D025441
% 220.92/221.13       A 9,10alpha-dihydro derivative of ERGOTAMINE that contains isopropyl sidechains at the 2%27% and 5%27% positions of the molecule.%A%    
% 220.92/221.13  |- mesh__recordMaintainer mesh__D025441 jmp
% 220.92/221.13  |- skos__altLabel mesh__D025441 Ergocornine, 9,10-dihydro-
% 220.92/221.13  |- mesh__publicMeSHNote mesh__D025441
% 220.92/221.13       2002; see DIHYDROERGOTOXINE 1992-2001; for DIHYDROERGOCORNINE MESYLATE see ERGOLOID MESYLATES 1991-2001%A%  
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D025441 2002
% 220.92/221.13  |- skos__broader mesh__D025441smesh__D004879
% 220.92/221.13  |- skos__historyNote mesh__D025441 Dihydroergotoxine %28%1991-2001%29%
% 220.92/221.13  |- mesh__activeMeSHYear mesh__D025441 2003
% 220.92/221.13  |- skos__hiddenLabel mesh__D025441 Mesylate, Dihydroergocornine
% 220.92/221.13  |- skos__altLabel mesh__D019404 IL-14
% 220.92/221.13  |- mesh__dateEstablished mesh__D019404 1997-01-01
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D019404 2006
% 220.92/221.14  |- skos__scopeNote mesh__D019404
% 220.92/221.14       Cytokine that induces B-cell proliferation, inhibits immunoglobulin secretion, and selectively expands certain B-cell subpopulations.%A%    
% 220.92/221.14  |- skos__altLabel mesh__D019404 IL14
% 220.92/221.14  |- rdf__type mesh__D019404sskos__Concept
% 220.92/221.14  |- mesh__dateCreated mesh__D019404 1996-06-10
% 220.92/221.14  |- skos__broader mesh__D019404smesh__D007378
% 220.92/221.14  |- skos__hiddenLabel mesh__D019404
% 220.92/221.14       B Cell Growth Factor, High Molecular Weight
% 220.92/221.14  |- skos__annotation mesh__D019404 DF:IL 14 or IL14   
% 220.92/221.14  |- skos__historyNote mesh__D019404 Interleukins %28%1995-1996%29%
% 220.92/221.14  |- mesh__recordOriginator mesh__D019404 AGS
% 220.92/221.14  |- mesh__onlineNote mesh__D019404
% 220.92/221.14       use INTERLEUKIN-14 %28%NM%29% to search INTERLEUKIN-14 1995-96   
% 220.92/221.14  |- skos__altLabel mesh__D019404 HMW-BCGF
% 220.92/221.14  |- skos__altLabel mesh__D019404 B-Cell Growth Factor, High Molecular Weight
% 220.92/221.14  |- mesh__recordAuthorizer mesh__D019404 sjn
% 220.92/221.14  |- skos__altLabel mesh__D019404 High Molecular Weight-B-Cell Growth Factor
% 220.92/221.14  |- mesh__dateRevised mesh__D019404 2005-06-30
% 220.92/221.14  |- skos__prefLabel mesh__D019404 Interleukin-14
% 220.92/221.14  |- skos__hiddenLabel mesh__D019404 Interleukin 14
% 220.92/221.14  |- skos__hiddenLabel mesh__D019404
% 220.92/221.14       High Molecular Weight B Cell Growth Factor
% 220.92/221.14  |- mesh__recordMaintainer mesh__D019404 ssb
% 220.92/221.14  |- mesh__historyNote mesh__D019404
% 220.92/221.14       97; was INTERLEUKIN-14 %28%NM%29% 1995-96   
% 220.92/221.14  |- mesh__publicMeSHNote mesh__D019404
% 220.92/221.14       97; INTERLEUKIN-14 was indexed under INTERLEUKINS 1995-96%A%  
% 220.92/221.14  |- mesh__historyNote mesh__D002695 1976   
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D002695 2006
% 220.92/221.14  |- mesh__dateCreated mesh__D002695 1975-07-25
% 220.92/221.14  |- mesh__recordOriginator mesh__D002695 JW
% 220.92/221.14  |- mesh__publicMeSHNote mesh__D002695 1976   
% 220.92/221.14  |- skos__prefLabel mesh__D002695 Chlamydiales
% 220.92/221.14  |- skos__historyNote mesh__D002695 Micotatobiotes %28%1975%29%
% 220.92/221.14  |- skos__altLabel mesh__D002695 Microorganism Z
% 220.92/221.14  |- rdf__type mesh__D002695sskos__Concept
% 220.92/221.14  |- mesh__recordMaintainer mesh__D002695 SYSTEM
% 220.92/221.14  |- mesh__dateRevised mesh__D002695 2005-06-30
% 220.92/221.14  |- skos__scopeNote mesh__D002695
% 220.92/221.14       An order of obligately intracellular bacteria that have the chlamydia-like developmental cycle of replication. This is a two-stage cycle that includes a metabolically inactive infectious form, and a vegetative form that replicates by binary fission. Members of Chlamydiales are disseminated by aerosol or by contact. There are at least four recognized families: CHLAMYDIACEAE, Parachlamydiaceae, Simkaniaceae, and Waddliaceae.%A%    
% 220.92/221.14  |- skos__broader mesh__D002695smesh__D006090
% 220.92/221.14  |- mesh__recordAuthorizer mesh__D002695 sjn
% 220.92/221.14  |- mesh__dateEstablished mesh__D002695 1976-01-01
% 220.92/221.14  |- skos__historyNote mesh__D002695 Bacteria %28%1966-1974%29%
% 220.92/221.14  |- skos__prefLabel mesh__D007380 Intermediate Care Facilities
% 220.92/221.14  |- mesh__dateCreated mesh__D007380 1978-05-08
% 220.92/221.14  |- mesh__recordMaintainer mesh__D007380 TGC
% 220.92/221.14  |- skos__historyNote mesh__D007380 Nursing Homes %28%1966-1978%29%
% 220.92/221.14  |- skos__hiddenLabel mesh__D007380 Facility, Intermediate Care
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D007380 1998
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D007380 2006
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D007380 1997
% 220.92/221.14  |- mesh__historyNote mesh__D007380
% 220.92/221.14       91%28%79%29%; was see under NURSING HOMES 1979-90   
% 220.92/221.14  |- mesh__recordAuthorizer mesh__D007380 PLS
% 220.92/221.14  |- skos__hiddenLabel mesh__D007380 Intermediate Care Facility
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D007380 2001
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D007380 1994
% 220.92/221.14  |- skos__hiddenLabel mesh__D007380 Facilities, Intermediate Care
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D007380 1993
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D007380 1999
% 220.92/221.14  |- skos__broader mesh__D007380smesh__D009735
% 220.92/221.14  |- mesh__dateEstablished mesh__D007380 1991-01-01
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D007380 1995
% 220.92/221.14  |- skos__scopeNote mesh__D007380
% 220.92/221.14       Institutions which provide health-related care and services to individuals who do not require the degree of care which hospitals or skilled nursing facilities provide, but because of their physical or mental condition require care and services above the level of room and board.%A%    
% 220.92/221.14  |- mesh__recordOriginator mesh__D007380 EC
% 220.92/221.14  |- rdf__type mesh__D007380sskos__Concept
% 220.92/221.14  |- mesh__dateRevised mesh__D007380 1992-05-14
% 220.92/221.14  |- skos__hiddenLabel mesh__D007380 Care Facilities, Intermediate
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D007380 2002
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D007380 2003
% 220.92/221.14  |- mesh__publicMeSHNote mesh__D007380
% 220.92/221.14       91; was see under NURSING HOMES 1979-90   
% 220.92/221.14  |- skos__annotation mesh__D007380
% 220.92/221.14       intermediate = not requiring degree of care provided by hosp or skilled nurs facility%A%  
% 220.92/221.14  |- skos__hiddenLabel mesh__D007380 Care Facility, Intermediate
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D007380 2005
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D007380 1996
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D007380 2004
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D007380 2000
% 220.92/221.14  |- mesh__dateCreated mesh__D010329 1999-01-01
% 220.92/221.14  |- skos__broader mesh__D010329smesh__D007867
% 220.92/221.14  |- skos__hiddenLabel mesh__D010329 Patellas
% 220.92/221.14  |- skos__annotation mesh__D010329
% 220.92/221.14       /inj permitted: do not convert to KNEE INJURIES   
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D010329 2006
% 220.92/221.14  |- mesh__dateRevised mesh__D010329 2005-06-30
% 220.92/221.14  |- mesh__recordOriginator mesh__D010329 NLM
% 220.92/221.14  |- skos__scopeNote mesh__D010329
% 220.92/221.14       The flat, triangular bone situated at the anterior part of the KNEE.%A%    
% 220.92/221.14  |- skos__prefLabel mesh__D010329 Patella
% 220.92/221.14  |- rdf__type mesh__D010329sskos__Concept
% 220.92/221.14  |- mesh__recordAuthorizer mesh__D010329 sjn
% 220.92/221.14  |- mesh__recordMaintainer mesh__D010329 ags
% 220.92/221.14  |- skos__hiddenLabel mesh__D015812 Uncompensative Glaucoma
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015812 1993
% 220.92/221.14  |- skos__hiddenLabel mesh__D015812 Angle-Closure Glaucomas
% 220.92/221.14  |- skos__hiddenLabel mesh__D015812 Glaucomas, Angle Closure
% 220.92/221.14  |- skos__hiddenLabel mesh__D015812 Angle Closure Glaucoma
% 220.92/221.14  |- skos__altLabel mesh__D015812 Glaucoma, Angle Closure
% 220.92/221.14  |- skos__hiddenLabel mesh__D015812 Uncompensated Glaucomas
% 220.92/221.14  |- skos__hiddenLabel mesh__D015812 Closed-Angle Glaucoma
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015812 1995
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015812 2000
% 220.92/221.14  |- skos__hiddenLabel mesh__D015812 Angle Closure Glaucomas
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015812 2005
% 220.92/221.14  |- skos__hiddenLabel mesh__D015812 Glaucomas, Uncompensated
% 220.92/221.14  |- skos__hiddenLabel mesh__D015812 Glaucoma, Narrow Angle
% 220.92/221.14  |- skos__hiddenLabel mesh__D015812 Closed-Angle Glaucomas
% 220.92/221.14  |- skos__altLabel mesh__D015812 Glaucoma, Narrow-Angle
% 220.92/221.14  |- skos__broader mesh__D015812smesh__D005901
% 220.92/221.14  |- mesh__dateRevised mesh__D015812 1990-05-29
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015812 1996
% 220.92/221.14  |- mesh__dateCreated mesh__D015812 1989-05-25
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015812 2001
% 220.92/221.14  |- mesh__publicMeSHNote mesh__D015812 90   
% 220.92/221.14  |- skos__scopeNote mesh__D015812
% 220.92/221.14       A form of glaucoma in which the intraocular pressure increases because the angle of the anterior chamber is blocked and the aqueous humor cannot drain from the anterior chamber.%A%    
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015812 2006
% 220.92/221.14  |- skos__historyNote mesh__D015812 Glaucoma %28%1966-1989%29%
% 220.92/221.14  |- skos__altLabel mesh__D015812 Glaucoma, Closed-Angle
% 220.92/221.14  |- skos__hiddenLabel mesh__D015812 Glaucomas, Angle-Closure
% 220.92/221.14  |- skos__prefLabel mesh__D015812 Glaucoma, Angle-Closure
% 220.92/221.14  |- skos__hiddenLabel mesh__D015812 Narrow-Angle Glaucomas
% 220.92/221.14  |- skos__hiddenLabel mesh__D015812 Glaucoma, Closed Angle
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015812 1997
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015812 2002
% 220.92/221.14  |- rdf__type mesh__D015812sskos__Concept
% 220.92/221.14  |- skos__hiddenLabel mesh__D015812 Narrow-Angle Glaucoma
% 220.92/221.14  |- skos__hiddenLabel mesh__D015812 Glaucomas, Uncompensative
% 220.92/221.14  |- skos__hiddenLabel mesh__D015812 Glaucomas, Narrow-Angle
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015812 1991
% 220.92/221.14  |- mesh__historyNote mesh__D015812 90   
% 220.92/221.14  |- skos__hiddenLabel mesh__D015812 Glaucomas, Closed-Angle
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015812 1998
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015812 2003
% 220.92/221.14  |- skos__hiddenLabel mesh__D015812 Uncompensated Glaucoma
% 220.92/221.14  |- mesh__dateEstablished mesh__D015812 1990-01-01
% 220.92/221.14  |- mesh__recordOriginator mesh__D015812 EGC
% 220.92/221.14  |- skos__altLabel mesh__D015812 Glaucoma, Uncompensative
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015812 1992
% 220.92/221.14  |- skos__annotation mesh__D015812
% 220.92/221.14       do not confuse with GLAUCOMA, OPEN-ANGLE: note X ref   
% 220.92/221.14  |- mesh__recordAuthorizer mesh__D015812 NLM
% 220.92/221.14  |- skos__hiddenLabel mesh__D015812 Angle-Closure Glaucoma
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015812 1994
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015812 1999
% 220.92/221.14  |- skos__hiddenLabel mesh__D015812 Uncompensative Glaucomas
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015812 2004
% 220.92/221.14  |- mesh__recordMaintainer mesh__D015812 PLS
% 220.92/221.14  |- skos__altLabel mesh__D015812 Glaucoma, Uncompensated
% 220.92/221.14  |- mesh__dateCreated mesh__D015014 1977-03-01
% 220.92/221.14  |- skos__altLabel mesh__D015014 Yoghurt
% 220.92/221.14  |- mesh__dateEstablished mesh__D015014 1991-01-01
% 220.92/221.14  |- mesh__historyNote mesh__D015014
% 220.92/221.14       91%28%78%29%; was see under DAIRY PRODUCTS 1978-90   
% 220.92/221.14  |- mesh__recordAuthorizer mesh__D015014 sjn
% 220.92/221.14  |- rdf__type mesh__D015014sskos__Concept
% 220.92/221.14  |- skos__prefLabel mesh__D015014 Yogurt
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015014 2005
% 220.92/221.14  |- mesh__dateRevised mesh__D015014 2003-07-09
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015014 2006
% 220.92/221.14  |- mesh__recordOriginator mesh__D015014 VDK
% 220.92/221.14  |- mesh__recordMaintainer mesh__D015014 ssb
% 220.92/221.14  |- skos__broader mesh__D015014smesh__D043302
% 220.92/221.14  |- skos__historyNote mesh__D015014 Dairy Products %28%1966-1977%29%
% 220.92/221.14  |- skos__scopeNote mesh__D015014
% 220.92/221.14       A slightly acid milk food produced by fermentation due to the combined action of Lactobacillus acidophilus and Streptococcus thermophilus.%A%    
% 220.92/221.14  |- mesh__publicMeSHNote mesh__D015014
% 220.92/221.14       91; was see under DAIRY PRODUCTS 1978-90   
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015014 2004
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D020757 2003
% 220.92/221.14  |- rdf__type mesh__D020757sskos__Concept
% 220.92/221.14  |- mesh__historyNote mesh__D020757 2000   
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D020757 2001
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D020757 2004
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D020757 2005
% 220.92/221.14  |- mesh__dateCreated mesh__D020757 1999-11-03
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D020757 2006
% 220.92/221.14  |- skos__hiddenLabel mesh__D020757 Blindness, Transient Monocular
% 220.92/221.14  |- skos__hiddenLabel mesh__D020757 Transient Monocular Blindness
% 220.92/221.14  |- skos__historyNote mesh__D020757 Vision Disorders %28%1967-1999%29%
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D020757 2002
% 220.92/221.14  |- skos__broader mesh__D020757smesh__D001766
% 220.92/221.14  |- skos__altLabel mesh__D020757 Monocular Blindness, Transient
% 220.92/221.14  |- skos__altLabel mesh__D020757 Blindness, Monocular, Transient
% 220.92/221.14  |- skos__scopeNote mesh__D020757
% 220.92/221.14       Transient complete or partial monocular blindness due to retinal ischemia. This may be caused by EMBOLI from the CAROTID ARTERY %28%usually in association with CAROTID STENOSIS%29% and other locations that enter the central RETINAL ARTERY. %28%From Adams et al., Principles of Neurology, 6th ed, p245%29%%A%    
% 220.92/221.14  |- skos__historyNote mesh__D020757 Blindness %28%1966-1999%29%
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D020757 2000
% 220.92/221.14  |- mesh__publicMeSHNote mesh__D020757 2000   
% 220.92/221.14  |- mesh__dateEstablished mesh__D020757 2000-01-01
% 220.92/221.14  |- skos__historyNote mesh__D020757
% 220.92/221.14       Carotid Artery Diseases %28%1966-1999%29%
% 220.92/221.14  |- skos__prefLabel mesh__D020757 Amaurosis Fugax
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D006288 2006
% 220.92/221.14  |- mesh__publicMeSHNote mesh__D006288 80   
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D006288 2001
% 220.92/221.14  |- mesh__dateEstablished mesh__D006288 1980-01-01
% 220.92/221.14  |- mesh__recordOriginator mesh__D006288 EC
% 220.92/221.14  |- skos__hiddenLabel mesh__D006288 Planning Organization, Health
% 220.92/221.14  |- mesh__historyNote mesh__D006288 80   
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D006288 2005
% 220.92/221.14  |- skos__annotation mesh__D006288 specify geog   
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D006288 2000
% 220.92/221.14  |- mesh__recordAuthorizer mesh__D006288 sjn
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D006288 2004
% 220.92/221.14  |- skos__hiddenLabel mesh__D006288 Health Planning Organization
% 220.92/221.14  |- skos__hiddenLabel mesh__D006288 Organization, Health Planning
% 220.92/221.14  |- rdf__type mesh__D006288sskos__Concept
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D006288 2003
% 220.92/221.14  |- mesh__dateRevised mesh__D006288 1999-11-03
% 220.92/221.14  |- skos__scopeNote mesh__D006288
% 220.92/221.14       Organizations involved in all aspects of health planning activities.%A%    
% 220.92/221.14  |- mesh__dateCreated mesh__D006288 1979-05-31
% 220.92/221.14  |- skos__altLabel mesh__D006288 Planning Organizations, Health
% 220.92/221.14  |- skos__altLabel mesh__D006288 Centers for Health Planning
% 220.92/221.14  |- skos__altLabel mesh__D006288 Organizations, Health Planning
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D006288 2002
% 220.92/221.14  |- skos__prefLabel mesh__D006288 Health Planning Organizations
% 220.92/221.14  |- mesh__recordMaintainer mesh__D006288 kle
% 220.92/221.14  |- skos__broader mesh__D006288smesh__D009938
% 220.92/221.14  |- skos__broader mesh__D025442smesh__D004879
% 220.92/221.14  |- skos__altLabel mesh__D025442
% 220.92/221.14       Davur Brand of Dihydroergocristine Monomesylate
% 220.92/221.14  |- mesh__dateEstablished mesh__D025442 2002-01-01
% 220.92/221.14  |- mesh__dateRevised mesh__D025442 2005-06-30
% 220.92/221.14  |- mesh__recordMaintainer mesh__D025442 exl
% 220.92/221.14  |- skos__historyNote mesh__D025442 Dihydroergotoxine %28%1975-2001%29%
% 220.92/221.14  |- skos__prefLabel mesh__D025442 Dihydroergocristine
% 220.92/221.14  |- mesh__recordOriginator mesh__D025442 jmp
% 220.92/221.14  |- skos__altLabel mesh__D025442 Dihydroergocristine Mesylate
% 220.92/221.14  |- mesh__recordAuthorizer mesh__D025442 sjn
% 220.92/221.14  |- mesh__historyNote mesh__D025442
% 220.92/221.14       2002, 1975-1991; use DIHYDROERGOTOXINE 1992-2001, for DIHYDROERGOCRISTINE MESYLATE use ERGOLOID MESYLATES 1977-2001%A%  
% 220.92/221.14  |- mesh__dateCreated mesh__D025442 2001-07-25
% 220.92/221.14  |- skos__altLabel mesh__D025442
% 220.92/221.14       Desitin Brand of Dihydroergocristine Monomesylate
% 220.92/221.14  |- skos__related mesh__D025442smesh__D004088
% 220.92/221.14  |- mesh__publicMeSHNote mesh__D025442
% 220.92/221.14       2002;  see DIHYDROERGOTOXINE 1975-2001, for DIHYDROERGOCRISTINE MESYLATE see ERGOLOID MESYLATES 1991-2001%A%  
% 220.92/221.14  |- skos__altLabel mesh__D025442
% 220.92/221.14       Yamanouchi Brand of Dihydroergocristine Monomesylate
% 220.92/221.14  |- skos__historyNote mesh__D025442 Ergoloid Mesylates %28%1973-1974%29%
% 220.92/221.14  |- skos__scopeNote mesh__D025442
% 220.92/221.14       A 9,10alpha-dihydro derivative of ERGOTAMINE that contains an isopropyl sidechain at the 2%27% position of the molecule.%A%    
% 220.92/221.14  |- rdf__type mesh__D025442sskos__Concept
% 220.92/221.14  |- skos__hiddenLabel mesh__D025442 Mesylate, Dihydroergocristine
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D025442 2006
% 220.92/221.14  |- skos__hiddenLabel mesh__D025442 Monomesylate, Dihydroergocristine
% 220.92/221.14  |- skos__hiddenLabel mesh__D019405 Cytochrome P 450c11AS
% 220.92/221.14  |- skos__historyNote mesh__D019405 Desoxycorticosterone %28%1979-1982%29%
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D019405 2006
% 220.92/221.14  |- skos__altLabel mesh__D019405 Cytochrome P450 11B2
% 220.92/221.14  |- skos__prefLabel mesh__D019405 Aldosterone Synthase
% 220.92/221.14  |- skos__altLabel mesh__D019405 Aldosterone Synthase Cytochrome P-450
% 220.92/221.14  |- skos__scopeNote mesh__D019405
% 220.92/221.14       A mitochondrial cytochrome P450 enzyme that catalyzes the 18-hydroxylation of steroids in the presence of molecular oxygen and NADPH-specific flavoprotein. This enzyme, encoded by CYP11B2 gene, is important in the conversion of CORTICOSTERONE to 18-hydroxycorticosterone and the subsequent conversion to ALDOSTERONE.%A%    
% 220.92/221.14  |- skos__historyNote mesh__D019405 Steroid Hydroxylases %28%1979-1993%29%
% 220.92/221.14  |- rdf__type mesh__D019405sskos__Concept
% 220.92/221.14  |- skos__altLabel mesh__D019405 Steroid 18-Hydroxylase
% 220.92/221.14  |- skos__altLabel mesh__D019405 P450c11AS
% 220.92/221.14  |- skos__historyNote mesh__D019405
% 220.92/221.14       Steroid 11 beta-Monooxygenase %28%1994-1996%29%
% 220.92/221.14  |- skos__altLabel mesh__D019405 Cytochrome P450Aldo
% 220.92/221.14  |- skos__altLabel mesh__D019405 Aldosynthase
% 220.92/221.14  |- mesh__publicMeSHNote mesh__D019405
% 220.92/221.14       2003; see CYTOCHROME P-450 CYP11B2 1977-2002; for STEROID 18-HYDROXYLASE see CYTOCHROME P-450 1984-1996, see STEROID 11-HYDROXYLASE 1994-1996, see STEROID HYDROXYLASES 1979-1993, %26% see DESOXYCORTICOSTERONE 1979-1982%A%  
% 220.92/221.14  |- skos__altLabel mesh__D019405 Cyctochrome P-450 c11AS
% 220.92/221.14  |- mesh__dateCreated mesh__D019405 1996-06-24
% 220.92/221.14  |- skos__hiddenLabel mesh__D019405 Cytochrome P 450 CYP11B2
% 220.92/221.14  |- mesh__recordOriginator mesh__D019405 ADP
% 220.92/221.14  |- mesh__dateEstablished mesh__D019405 1997-01-01
% 220.92/221.14  |- skos__historyNote mesh__D019405 Cytochrome P-450 %28%1984-1996%29%
% 220.92/221.14  |- skos__altLabel mesh__D019405 Cytochrome P-450 CYP11B2
% 220.92/221.14  |- skos__hiddenLabel mesh__D019405 Steroid 18 Hydroxylase
% 220.92/221.14  |- skos__altLabel mesh__D019405 Cytochrome P-450c11AS
% 220.92/221.14  |- mesh__dateRevised mesh__D019405 2004-07-07
% 220.92/221.14  |- skos__altLabel mesh__D019405 CYP11B2
% 220.92/221.14  |- skos__altLabel mesh__D019405 CYP 11B2
% 220.92/221.14  |- mesh__historyNote mesh__D019405 2003 %28%1979%29%   
% 220.92/221.14  |- mesh__recordMaintainer mesh__D019405 ssb
% 220.92/221.14  |- skos__broader mesh__D019405smesh__D013250
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D019405 2005
% 220.92/221.14  |- mesh__recordAuthorizer mesh__D019405 sjn
% 220.92/221.14  |- skos__annotation mesh__D019405
% 220.92/221.14       do not confuse with other cytochrome P-450 CYP%27%s   
% 220.92/221.14  |- mesh__dateCreated mesh__D011422 1999-01-01
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D011422 2005
% 220.92/221.14  |- mesh__recordOriginator mesh__D011422 NLM
% 220.92/221.14  |- skos__prefLabel mesh__D011422 Propionates
% 220.92/221.14  |- mesh__recordAuthorizer mesh__D011422 sjn
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D011422 2006
% 220.92/221.14  |- mesh__recordMaintainer mesh__D011422 ssb
% 220.92/221.14  |- rdf__type mesh__D011422sskos__Concept
% 220.92/221.14  |- skos__broader mesh__D011422smesh__D000144
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D011422 2004
% 220.92/221.14  |- skos__broader mesh__D011422smesh__D005232
% 220.92/221.14  |- mesh__dateRevised mesh__D011422 2003-07-09
% 220.92/221.14  |- skos__historyNote mesh__D049890 Mollusca %28%1967-1970%29%
% 220.92/221.14  |- skos__prefLabel mesh__D049890 Spisula
% 220.92/221.14  |- mesh__publicMeSHNote mesh__D049890 2006   
% 220.92/221.14  |- skos__broader mesh__D049890smesh__D049872
% 220.92/221.14  |- mesh__recordMaintainer mesh__D049890 ags
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D049890 2006
% 220.92/221.14  |- rdf__type mesh__D049890sskos__Concept
% 220.92/221.14  |- mesh__dateCreated mesh__D049890 2005-06-30
% 220.92/221.14  |- skos__historyNote mesh__D049890 Bivalvia %28%1971-2005%29%
% 220.92/221.14  |- mesh__dateEstablished mesh__D049890 2006-01-01
% 220.92/221.14  |- mesh__recordAuthorizer mesh__D049890 sjn
% 220.92/221.14  |- skos__scopeNote mesh__D049890
% 220.92/221.14       A genus of surf clams in the family Mactridae, class BIVALVIA. They are often used in EMBRYOLOGY research.%A%    
% 220.92/221.14  |- mesh__historyNote mesh__D049890 2006   
% 220.92/221.14  |- skos__annotation mesh__D049890
% 220.92/221.14       as animal %26% food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH %28%IM%29%%A%  
% 220.92/221.14  |- mesh__recordOriginator mesh__D049890 ags
% 220.92/221.14  |- mesh__recordOriginator mesh__D002696 NLM
% 220.92/221.14  |- mesh__dateRevised mesh__D002696 2003-07-09
% 220.92/221.14  |- skos__broader mesh__D002696smesh__D016823
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D002696 2006
% 220.92/221.14  |- mesh__recordAuthorizer mesh__D002696 sjn
% 220.92/221.14  |- skos__annotation mesh__D002696
% 220.92/221.14       %22%considered both a protozoon %26% an alga%22% %28%green%29%; in freshwater %26% damp soil%A%  
% 220.92/221.14  |- mesh__recordMaintainer mesh__D002696 ags
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D002696 2005
% 220.92/221.14  |- skos__broader mesh__D002696smesh__D000460
% 220.92/221.14  |- skos__prefLabel mesh__D002696 Chlamydomonas
% 220.92/221.14  |- mesh__publicMeSHNote mesh__D002696 74   
% 220.92/221.14  |- skos__historyNote mesh__D002696 Algae, Green %28%1970-1971%29%
% 220.92/221.14  |- skos__scopeNote mesh__D002696
% 220.92/221.14       A genus of organisms considered both a protozoon %28%Dorland, 27th ed%29% and an alga %28%Bold %26% Wynne, Introduction to the Algae, 2d ed, p84%29%. It consists of solitary biflagellated organisms common in fresh water and damp soil.%A%    
% 220.92/221.14  |- mesh__dateCreated mesh__D002696 1999-01-01
% 220.92/221.14  |- rdf__type mesh__D002696sskos__Concept
% 220.92/221.14  |- mesh__dateEstablished mesh__D002696 1974-01-01
% 220.92/221.14  |- mesh__historyNote mesh__D002696 74%28%72%29%   
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D002696 2004
% 220.92/221.14  |- mesh__recordOriginator mesh__D007381 RLS
% 220.92/221.14  |- skos__hiddenLabel mesh__D007381 Filament Proteins, Intermediate
% 220.92/221.14  |- mesh__publicMeSHNote mesh__D007381 83   
% 220.92/221.14  |- skos__annotation mesh__D007381 /biosyn /drug eff /physiol permitted   
% 220.92/221.14  |- skos__scopeNote mesh__D007381
% 220.92/221.14       Filaments 7-11 nm in diameter found in the cytoplasm of all cells. Many specific proteins belong to this group, e.g., desmin, vimentin, prekeratin, decamin, skeletin, neurofilin, neurofilament protein, and glial fibrillary acid protein.%A%    
% 220.92/221.14  |- mesh__recordAuthorizer mesh__D007381 sjn
% 220.92/221.14  |- mesh__dateEstablished mesh__D007381 1983-01-01
% 220.92/221.14  |- skos__hiddenLabel mesh__D007381 Proteins, Intermediate Filament
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D007381 2006
% 220.92/221.14  |- skos__broader mesh__D007381smesh__D001704
% 220.92/221.14  |- skos__historyNote mesh__D007381 Muscle Proteins %28%1966-1982%29%
% 220.92/221.14  |- skos__altLabel mesh__D007381 Fibroblast Intermediate Filament Proteins
% 220.92/221.14  |- skos__prefLabel mesh__D007381 Intermediate Filament Proteins
% 220.92/221.14  |- mesh__recordMaintainer mesh__D007381 SYSTEM
% 220.92/221.14  |- skos__historyNote mesh__D007381 Proteins %28%1966-1982%29%
% 220.92/221.14  |- mesh__dateRevised mesh__D007381 2005-06-30
% 220.92/221.14  |- mesh__dateCreated mesh__D007381 1982-05-11
% 220.92/221.14  |- skos__broader mesh__D007381smesh__D003598
% 220.92/221.14  |- rdf__type mesh__D007381sskos__Concept
% 220.92/221.14  |- skos__historyNote mesh__D007381 Nerve Tissue Proteins %28%1966-1982%29%
% 220.92/221.14  |- skos__historyNote mesh__D007381 Peptides %28%1966-1982%29%
% 220.92/221.14  |- mesh__historyNote mesh__D007381 83   
% 220.92/221.14  |- mesh__recordAuthorizer mesh__D015813 sjn
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Testings, Drug Abuse
% 220.92/221.14  |- skos__related mesh__D015813smesh__D017248
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Detections, Drug Abuse
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015813 2005
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Illicit Drug Detections
% 220.92/221.14  |- skos__annotation mesh__D015813
% 220.92/221.14       coord IM with precoord substance abuse term %28%IM%29% or substance abused %28%IM%29%%A%  
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Testings, Substance Abuse
% 220.92/221.14  |- mesh__dateRevised mesh__D015813 2000-06-22
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Drug Testing, Illicit
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Substance Abuse Testings
% 220.92/221.14  |- mesh__recordMaintainer mesh__D015813 jmp
% 220.92/221.14  |- skos__altLabel mesh__D015813 Drug Abuse Testing
% 220.92/221.14  |- skos__historyNote mesh__D015813 Street Drugs %28%1977-1989%29%
% 220.92/221.14  |- mesh__publicMeSHNote mesh__D015813 90   
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015813 2006
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Detection, Illicit Drug
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Screenings, Drug Abuse
% 220.92/221.14  |- mesh__recordOriginator mesh__D015813 AGS
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Detection, Drug Abuse
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015813 2001
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Testing, Substance Abuse
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Detection, Substance Abuse
% 220.92/221.14  |- skos__historyNote mesh__D015813 Mass Screening %28%1986-1989%29%
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Drug Testings, Illicit
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Testing, Drug Abuse
% 220.92/221.14  |- rdf__type mesh__D015813sskos__Concept
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Detections, Substance Abuse
% 220.92/221.14  |- skos__broader mesh__D015813smesh__D008403
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Testing, Street Drug
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Detections, Illicit Drug
% 220.92/221.14  |- skos__broader mesh__D015813smesh__D008919
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Detection, Street Drug
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015813 2002
% 220.92/221.14  |- skos__altLabel mesh__D015813 Substance Abuse Testing
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Testings, Street Drug
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015813 2003
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Street Drug Detections
% 220.92/221.14  |- mesh__dateEstablished mesh__D015813 1990-01-01
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Testing, Illicit Drug
% 220.92/221.14  |- mesh__historyNote mesh__D015813 90   
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Drug Abuse Testings
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Screening, Drug Abuse
% 220.92/221.14  |- mesh__dateCreated mesh__D015813 1989-05-16
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Testings, Illicit Drug
% 220.92/221.14  |- skos__scopeNote mesh__D015813
% 220.92/221.14       Detection of drugs that have been abused, overused, or misused, including legal and illegal drugs. Urine screening is the usual method of detection.%A%    
% 220.92/221.14  |- skos__altLabel mesh__D015813 Drug Abuse Screening
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Detections, Street Drug
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Illicit Drug Testings
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Drug Abuse Screenings
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Street Drug Testings
% 220.92/221.14  |- skos__historyNote mesh__D015813 Substance Abuse %28%1968-1989%29%
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D015813 2004
% 220.92/221.14  |- skos__prefLabel mesh__D015813 Substance Abuse Detection
% 220.92/221.14  |- skos__altLabel mesh__D015813 Drug Abuse Detection
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Substance Abuse Detections
% 220.92/221.14  |- skos__hiddenLabel mesh__D015813 Drug Abuse Detections
% 220.92/221.14  |- skos__hiddenLabel mesh__D020758 Hematomyelias
% 220.92/221.14  |- skos__prefLabel mesh__D020758 Spinal Cord Vascular Diseases
% 220.92/221.14  |- skos__historyNote mesh__D020758 Spinal Cord %28%1965-1999%29%
% 220.92/221.14  |- skos__altLabel mesh__D020758 Vascular Diseases, Spinal Cord
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D020758 2000
% 220.92/221.14  |- mesh__publicMeSHNote mesh__D020758 2000   
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D020758 2001
% 220.92/221.14  |- mesh__dateCreated mesh__D020758 1999-11-03
% 220.92/221.14  |- skos__historyNote mesh__D020758 Vascular Diseases %28%1965-1999%29%
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D020758 2003
% 220.92/221.14  |- mesh__dateEstablished mesh__D020758 2000-01-01
% 220.92/221.14  |- skos__scopeNote mesh__D020758
% 220.92/221.14       Hypoxic-ischemic and hemorrhagic disorders of the spinal cord. ARTERIOSCLEROSIS, emboli, and vascular malformations are potential causes of these conditions.%A%    
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D020758 2005
% 220.92/221.14  |- skos__broader mesh__D020758smesh__D013118
% 220.92/221.14  |- mesh__historyNote mesh__D020758 2000   
% 220.92/221.14  |- skos__broader mesh__D020758smesh__D014652
% 220.92/221.14  |- rdf__type mesh__D020758sskos__Concept
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D020758 2004
% 220.92/221.14  |- mesh__activeMeSHYear mesh__D020758 2002
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D020758 2006
% 220.92/221.15  |- skos__scopeNote mesh__D006289
% 220.92/221.15       Financial resources provided for activities related to health planning and development.%A%    
% 220.92/221.15  |- skos__hiddenLabel mesh__D006289 Health Planning Subsidies
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D006289 2002
% 220.92/221.15  |- skos__hiddenLabel mesh__D006289 Support, Health Planning
% 220.92/221.15  |- skos__historyNote mesh__D006289 Financing, Government %28%1968-1979%29%
% 220.92/221.15  |- mesh__recordMaintainer mesh__D006289 kle
% 220.92/221.15  |- skos__hiddenLabel mesh__D006289 Planning Supports, Health
% 220.92/221.15  |- skos__hiddenLabel mesh__D006289 Health Planning Supports
% 220.92/221.15  |- mesh__publicMeSHNote mesh__D006289 80   
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D006289 2004
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D006289 2001
% 220.92/221.15  |- mesh__recordOriginator mesh__D006289 EC
% 220.92/221.15  |- skos__broader mesh__D006289smesh__D005378
% 220.92/221.15  |- skos__hiddenLabel mesh__D006289 Supports, Health Planning
% 220.92/221.15  |- rdf__type mesh__D006289sskos__Concept
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D006289 2003
% 220.92/221.15  |- skos__annotation mesh__D006289 IM   
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D006289 2000
% 220.92/221.15  |- skos__hiddenLabel mesh__D006289 Planning Support, Health
% 220.92/221.15  |- mesh__recordAuthorizer mesh__D006289 sjn
% 220.92/221.15  |- skos__prefLabel mesh__D006289 Health Planning Support
% 220.92/221.15  |- skos__hiddenLabel mesh__D006289 Subsidy, Health Planning
% 220.92/221.15  |- skos__hiddenLabel mesh__D006289 Health Planning Subsidy
% 220.92/221.15  |- mesh__dateCreated mesh__D006289 1979-06-01
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D006289 2006
% 220.92/221.15  |- skos__hiddenLabel mesh__D006289 Planning Subsidies, Health
% 220.92/221.15  |- mesh__dateEstablished mesh__D006289 1980-01-01
% 220.92/221.15  |- skos__historyNote mesh__D006289 Health Planning %28%1968-1979%29%
% 220.92/221.15  |- mesh__dateRevised mesh__D006289 1999-11-03
% 220.92/221.15  |- mesh__historyNote mesh__D006289 80   
% 220.92/221.15  |- skos__hiddenLabel mesh__D006289 Planning Subsidy, Health
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D006289 2005
% 220.92/221.15  |- skos__hiddenLabel mesh__D025443 Monomesylate, Dihydroergocryptine
% 220.92/221.15  |- skos__altLabel mesh__D025443
% 220.92/221.15       Hormosan Brand of Dihydroergocryptine Monomesylate
% 220.92/221.15  |- mesh__recordMaintainer mesh__D025443 exl
% 220.92/221.15  |- skos__altLabel mesh__D025443 Dihydroergokryptine Monomesylate
% 220.92/221.15  |- skos__prefLabel mesh__D025443 Dihydroergocryptine
% 220.92/221.15  |- skos__hiddenLabel mesh__D025443 Monomesylate, Dihydroergokryptine
% 220.92/221.15  |- skos__broader mesh__D025443smesh__D004879
% 220.92/221.15  |- skos__historyNote mesh__D025443 Dihydroergotoxine %28%1991-2001%29%
% 220.92/221.15  |- skos__altLabel mesh__D025443
% 220.92/221.15       Desitin Brand of Dihydroergocryptine Monomesylate
% 220.92/221.15  |- mesh__dateRevised mesh__D025443 2005-06-30
% 220.92/221.15  |- skos__hiddenLabel mesh__D025443 Mesylate, Dihydroergokryptine
% 220.92/221.15  |- skos__related mesh__D025443smesh__D004088
% 220.92/221.15  |- rdf__type mesh__D025443sskos__Concept
% 220.92/221.15  |- skos__scopeNote mesh__D025443
% 220.92/221.15       A 9,10alpha-dihydro derivative of ERGOTAMINE that contains an isopropyl sidechain at the 2%27% position and an alpha-isobutyl sidechain at 5%27%alpha position of the molecule.%A%    
% 220.92/221.15  |- skos__altLabel mesh__D025443 Dihydroergokryptine Mesylate
% 220.92/221.15  |- skos__hiddenLabel mesh__D025443 Mesylate, Dihydroergocryptine
% 220.92/221.15  |- mesh__recordAuthorizer mesh__D025443 sjn
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D025443 2006
% 220.92/221.15  |- mesh__recordOriginator mesh__D025443 jmp
% 220.92/221.15  |- skos__altLabel mesh__D025443
% 220.92/221.15       Taurus Brand of Dihydroergocryptine Monomesylate
% 220.92/221.15  |- mesh__dateCreated mesh__D025443 2001-07-25
% 220.92/221.15  |- mesh__publicMeSHNote mesh__D025443
% 220.92/221.15       2002; see DIHYDROERGOTOXINE 1991-2001; for DIHYDROERGOCRYPTINE MESYLATE see ERGOLOID MESYLATES 1991-2001%A%  
% 220.92/221.15  |- mesh__historyNote mesh__D025443
% 220.92/221.15       2002, 1971-1991; use DIHYDROERGOTOXINE 1992-2001; for DIHYDROERGOCRYPTINE MESYLATE use ERGOLOID MESYLATES 1991-2001%A%  
% 220.92/221.15  |- mesh__dateEstablished mesh__D025443 2002-01-01
% 220.92/221.15  |- skos__broader mesh__D019925Q000031smesh__D019925
% 220.92/221.15  |- mesh__preferredCombination mesh__D019925Q000031smesh__D016213
% 220.92/221.15  |- rdf__type mesh__D019925Q000031smesh__CompoundConcept
% 220.92/221.15  |- skos__annotation mesh__D011423
% 220.92/221.15       in dairy products or intestinal tracts of animals   
% 220.92/221.15  |- skos__broader mesh__D011423smesh__D016988
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D011423 2006
% 220.92/221.15  |- skos__prefLabel mesh__D011423 Propionibacteriaceae
% 220.92/221.15  |- rdf__type mesh__D011423sskos__Concept
% 220.92/221.15  |- mesh__recordOriginator mesh__D011423 NLM
% 220.92/221.15  |- mesh__publicMeSHNote mesh__D011423 75   
% 220.92/221.15  |- mesh__recordAuthorizer mesh__D011423 sjn
% 220.92/221.15  |- mesh__dateRevised mesh__D011423 2005-06-30
% 220.92/221.15  |- skos__scopeNote mesh__D011423
% 220.92/221.15       A family of gram-positive bacteria found in dairy products or in the intestinal tracts of animals.%A%    
% 220.92/221.15  |- mesh__historyNote mesh__D011423 75   
% 220.92/221.15  |- skos__historyNote mesh__D011423 Bacteria %28%1966-1974%29%
% 220.92/221.15  |- skos__broader mesh__D011423smesh__D000192
% 220.92/221.15  |- mesh__dateEstablished mesh__D011423 1975-01-01
% 220.92/221.15  |- mesh__dateCreated mesh__D011423 1999-01-01
% 220.92/221.15  |- mesh__recordMaintainer mesh__D011423 SYSTEM
% 220.92/221.15  |- mesh__recordAuthorizer mesh__D049891 sjn
% 220.92/221.15  |- mesh__recordMaintainer mesh__D049891 ags
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D049891 2006
% 220.92/221.15  |- skos__annotation mesh__D049891
% 220.92/221.15       as animal %26% food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH %28%IM%29%%A%  
% 220.92/221.15  |- mesh__historyNote mesh__D049891 2006   
% 220.92/221.15  |- skos__altLabel mesh__D049891 Quahogs
% 220.92/221.15  |- mesh__recordOriginator mesh__D049891 ags
% 220.92/221.15  |- skos__prefLabel mesh__D049891 Mercenaria
% 220.92/221.15  |- rdf__type mesh__D049891sskos__Concept
% 220.92/221.15  |- skos__scopeNote mesh__D049891
% 220.92/221.15       A genus of hard-shelled clams in the family Veneridae, class BIVALVIA, commonly called quahogs. They are found just below the surface in the subtidal or lower intertidal coastal waters.%A%    
% 220.92/221.15  |- mesh__dateCreated mesh__D049891 2005-06-30
% 220.92/221.15  |- skos__historyNote mesh__D049891 Mollusca %28%1965-1970%29%
% 220.92/221.15  |- skos__historyNote mesh__D049891 Bivalvia %28%1971-2005%29%
% 220.92/221.15  |- mesh__dateEstablished mesh__D049891 2006-01-01
% 220.92/221.15  |- mesh__publicMeSHNote mesh__D049891 2006   
% 220.92/221.15  |- skos__broader mesh__D049891smesh__D049872
% 220.92/221.15  |- skos__broader mesh__D002697smesh__D005026
% 220.92/221.15  |- mesh__dateRevised mesh__D002697 2003-07-09
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D002697 2006
% 220.92/221.15  |- skos__scopeNote mesh__D002697
% 220.92/221.15       A hypnotic and sedative used in the treatment of insomnia. The safety margin is too narrow for chloral hydrate to be used as a general anesthetic in humans, but it is commonly used for that purpose in animal experiments. It is no longer considered useful as an anti-anxiety medication.%A%    
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D002697 2005
% 220.92/221.15  |- mesh__recordOriginator mesh__D002697 NLM
% 220.92/221.15  |- mesh__recordAuthorizer mesh__D002697 sjn
% 220.92/221.15  |- skos__prefLabel mesh__D002697 Chloral Hydrate
% 220.92/221.15  |- mesh__dateCreated mesh__D002697 1999-01-01
% 220.92/221.15  |- rdf__type mesh__D002697sskos__Concept
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D002697 2004
% 220.92/221.15  |- skos__hiddenLabel mesh__D002697 Hydrate, Chloral
% 220.92/221.15  |- mesh__recordMaintainer mesh__D002697 ssb
% 220.92/221.15  |- mesh__dateRevised mesh__D007382 2003-07-09
% 220.92/221.15  |- mesh__recordOriginator mesh__D007382 AEP
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D007382 2006
% 220.92/221.15  |- mesh__historyNote mesh__D007382
% 220.92/221.15       91%28%86%29%; was see under CYTOSKELETON 1986-90; was see CYTOPLASMIC FILAMENTS 1980-85%A%  
% 220.92/221.15  |- skos__annotation mesh__D007382
% 220.92/221.15       A 11 qualif except /cytol; /genet permitted   
% 220.92/221.15  |- skos__hiddenLabel mesh__D007382 Filaments, Intermediate
% 220.92/221.15  |- skos__hiddenLabel mesh__D007382 Tonofilament
% 220.92/221.15  |- mesh__recordMaintainer mesh__D007382 nns
% 220.92/221.15  |- skos__hiddenLabel mesh__D007382 Filament, Intermediate
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D007382 2005
% 220.92/221.15  |- mesh__recordAuthorizer mesh__D007382 sjn
% 220.92/221.15  |- skos__historyNote mesh__D007382 Cytoskeleton %28%1977-1985%29%
% 220.92/221.15  |- mesh__dateCreated mesh__D007382 1985-02-25
% 220.92/221.15  |- rdf__type mesh__D007382sskos__Concept
% 220.92/221.15  |- skos__scopeNote mesh__D007382
% 220.92/221.15       Cytoplasmic filaments intermediate in diameter %28%about 10 nanometers%29% between the microfilaments and the microtubules. They may be composed of any of a number of different proteins and form a ring around the cell nucleus.%A%    
% 220.92/221.15  |- mesh__dateEstablished mesh__D007382 1991-01-01
% 220.92/221.15  |- mesh__onlineNote mesh__D007382 search CYTOSKELETON 1980-85   
% 220.92/221.15  |- skos__prefLabel mesh__D007382 Intermediate Filaments
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D007382 2004
% 220.92/221.15  |- skos__hiddenLabel mesh__D007382 Intermediate Filament
% 220.92/221.15  |- skos__broader mesh__D007382smesh__D003599
% 220.92/221.15  |- skos__historyNote mesh__D007382 Cytoplasm %28%1975-1976%29%
% 220.92/221.15  |- mesh__publicMeSHNote mesh__D007382
% 220.92/221.15       91; was see under CYTOSKELETON 1986-90; was see CYTOPLASMIC FILAMENTS 1980-85%A%  
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D015814 1998
% 220.92/221.15  |- mesh__dateCreated mesh__D015814 1989-05-25
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D015814 2005
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D015814 1995
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D015814 2001
% 220.92/221.15  |- skos__historyNote mesh__D015814 Intraocular Pressure %28%1966-1989%29%
% 220.92/221.15  |- mesh__recordOriginator mesh__D015814 EGC
% 220.92/221.15  |- mesh__publicMeSHNote mesh__D015814 90   
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D015814 1999
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D015814 2006
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D015814 1996
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D015814 2003
% 220.92/221.15  |- mesh__historyNote mesh__D015814 90   
% 220.92/221.15  |- mesh__recordAuthorizer mesh__D015814 PLS
% 220.92/221.15  |- skos__broader mesh__D015814smesh__D005128
% 220.92/221.15  |- rdf__type mesh__D015814sskos__Concept
% 220.92/221.15  |- skos__hiddenLabel mesh__D015814 Hypotension, Ocular
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D015814 1997
% 220.92/221.15  |- mesh__dateRevised mesh__D015814 1993-08-09
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D015814 2002
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D015814 2004
% 220.92/221.15  |- mesh__dateEstablished mesh__D015814 1990-01-01
% 220.92/221.15  |- skos__scopeNote mesh__D015814
% 220.92/221.15       Abnormally low intraocular pressure often related to chronic inflammation %28%uveitis%29%.%A%    
% 220.92/221.15  |- skos__annotation mesh__D015814
% 220.92/221.15       %22%abnormally low intraocular pressure%22%: do not confuse with OCULAR HYPERTENSION%A%  
% 220.92/221.15  |- skos__altLabel mesh__D015814 Ocular Hypotony
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D015814 1994
% 220.92/221.15  |- skos__hiddenLabel mesh__D015814 Hypotony, Ocular
% 220.92/221.15  |- mesh__recordMaintainer mesh__D015814 PLS
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D015814 2000
% 220.92/221.15  |- skos__prefLabel mesh__D015814 Ocular Hypotension
% 220.92/221.15  |- skos__scopeNote mesh__D015016
% 220.92/221.15       A plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of impotence. It is also alleged to be an aphrodisiac.%A%    
% 220.92/221.15  |- skos__hiddenLabel mesh__D015016 Tartrate, Corynanthine
% 220.92/221.15  |- skos__altLabel mesh__D015016 Palisades Brand of Yohimbine Hydrochloride
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D015016 2006
% 220.92/221.15  |- skos__altLabel mesh__D015016 Kramer Brand of Yohimbine Hydrochloride
% 220.92/221.15  |- skos__altLabel mesh__D015016 Glenwood Brand of Yohimbine Hydrochloride
% 220.92/221.15  |- skos__altLabel mesh__D015016 Solvay Brand of Yohimbine Hydrochloride
% 220.92/221.15  |- mesh__dateRevised mesh__D015016 2005-06-30
% 220.92/221.15  |- skos__altLabel mesh__D015016 Star Brand of Yohimbine Hydrochloride
% 220.92/221.15  |- skos__altLabel mesh__D015016 Aventis Brand of Yohimbine Hydrochloride
% 220.92/221.15  |- skos__altLabel mesh__D015016
% 220.92/221.15       StegroPharm Brand of Yohimbine Hydrochloride
% 220.92/221.15  |- rdf__type mesh__D015016sskos__Concept
% 220.92/221.15  |- mesh__dateCreated mesh__D015016 1999-01-01
% 220.92/221.15  |- mesh__publicMeSHNote mesh__D015016
% 220.92/221.15       CORYNANTHIDINE, RAUWOLSCINE %26% YOHIMBINE DERIVATIVES were see under YOHIMBINE 1975-77, were see under YOHIMBANS 1969-74%A%  
% 220.92/221.15  |- mesh__recordAuthorizer mesh__D015016 sjn
% 220.92/221.15  |- mesh__recordOriginator mesh__D015016 NLM
% 220.92/221.15  |- mesh__historyNote mesh__D015016
% 220.92/221.15       YOHIMBINE DERIVATIVES was see under YOHIMBINE 1975-77, was see under YOHIMBANS 1969-74%A%  
% 220.92/221.15  |- mesh__onlineNote mesh__D015016
% 220.92/221.15       use YOHIMBINE /analogs %26% derivatives to search YOHIMBINE DERIVATIVES, CORYNANTHINE, %26% RAUWOLSCINE 1975-77; use YOHIMBANS 1969-74%A%  
% 220.92/221.15  |- skos__hiddenLabel mesh__D015016 Hydrochloride, Yohimbine
% 220.92/221.15  |- skos__broader mesh__D015016smesh__D046948
% 220.92/221.15  |- mesh__recordMaintainer mesh__D015016 lkw
% 220.92/221.15  |- skos__prefLabel mesh__D015016 Yohimbine
% 220.92/221.15  |- skos__historyNote mesh__D020759 Thrombosis/etiology %28%1968-1999%29%
% 220.92/221.15  |- skos__historyNote mesh__D020759
% 220.92/221.15       Spinal Cord/blood supply %28%1968-1999%29%
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D020759 2002
% 220.92/221.15  |- skos__historyNote mesh__D020759 Spinal Cord Diseases %28%1966-1999%29%
% 220.92/221.15  |- skos__broader mesh__D020759smesh__D020758
% 220.92/221.15  |- skos__prefLabel mesh__D020759 Anterior Spinal Artery Syndrome
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D020759 2003
% 220.92/221.15  |- mesh__dateEstablished mesh__D020759 2000-01-01
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D020759 2005
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D020759 2000
% 220.92/221.15  |- mesh__publicMeSHNote mesh__D020759 2000   
% 220.92/221.15  |- skos__altLabel mesh__D020759 Syndrome, Anterior Spinal Artery
% 220.92/221.15  |- skos__scopeNote mesh__D020759
% 220.92/221.15       Ischemia or infarction of the spinal cord in the distribution of the anterior spinal artery, which supplies the ventral two-thirds of the spinal cord. This condition is usually associated with ATHEROSCLEROSIS of the aorta and may result from dissection of an AORTIC ANEURYSM or rarely dissection of the anterior spinal artery. Clinical features include weakness and loss of pain and temperature sensation below the level of injury, with relative sparing of position and vibratory sensation. %28%From Adams et al., Principles of Neurology, 6th ed, pp1249-50%29%%A%    
% 220.92/221.15  |- mesh__historyNote mesh__D020759 2000   
% 220.92/221.15  |- rdf__type mesh__D020759sskos__Concept
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D020759 2001
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D020759 2004
% 220.92/221.15  |- skos__altLabel mesh__D020759 Dissection, Anterior Spinal Artery
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D020759 2006
% 220.92/221.15  |- mesh__dateCreated mesh__D020759 1999-11-03
% 220.92/221.15  |- skos__broader mesh__D020759smesh__D020760
% 220.92/221.15  |- skos__broader mesh__D003790smesh__D003788
% 220.92/221.15  |- skos__prefLabel mesh__D003790 Dental Pulp Necrosis
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D003790 2006
% 220.92/221.15  |- skos__altLabel mesh__D003790 Pulp Autolysis, Dental
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D003790 2001
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D003790 2003
% 220.92/221.15  |- skos__hiddenLabel mesh__D003790 Dental Pulp Autolyses
% 220.92/221.15  |- skos__hiddenLabel mesh__D003790 Pulp Gangrenes
% 220.92/221.15  |- skos__altLabel mesh__D003790 Pulp Necrosis, Dental
% 220.92/221.15  |- mesh__publicMeSHNote mesh__D003790
% 220.92/221.15       97; was DENTAL PULP GANGRENE 1965-96; DENTAL PULP AUTOLYSIS was heading 1965-96%A%  
% 220.92/221.15  |- skos__altLabel mesh__D003790 Pulp Gangrene, Dental
% 220.92/221.15  |- skos__hiddenLabel mesh__D003790 Pulp Necroses, Dental
% 220.92/221.15  |- skos__altLabel mesh__D003790 Necroses, Pulp
% 220.92/221.15  |- mesh__recordMaintainer mesh__D003790 adp
% 220.92/221.15  |- skos__altLabel mesh__D003790 Necrosis, Dental Pulp
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D003790 2002
% 220.92/221.15  |- skos__altLabel mesh__D003790 Pulp Gangrene
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D003790 2004
% 220.92/221.15  |- mesh__historyNote mesh__D003790
% 220.92/221.15       97; was DENTAL PULP GANGRENE 1965-96; DENTAL PULP AUTOLYSIS was heading 1965-96%A%  
% 220.92/221.15  |- skos__altLabel mesh__D003790 Autolysis, Dental Pulp
% 220.92/221.15  |- skos__hiddenLabel mesh__D003790 Dental Pulp Necroses
% 220.92/221.15  |- skos__scopeNote mesh__D003790
% 220.92/221.15       Death of pulp tissue. When the necrosis is due to ischemia with superimposed bacterial infection, it is referred to as pulp gangrene.%A%    
% 220.92/221.15  |- skos__altLabel mesh__D003790 Dental Pulp Gangrene
% 220.92/221.15  |- skos__hiddenLabel mesh__D003790 Gangrenes, Pulp
% 220.92/221.15  |- skos__altLabel mesh__D003790 Pulp Necroses
% 220.92/221.15  |- skos__broader mesh__D003790smesh__D009336
% 220.92/221.15  |- mesh__dateRevised mesh__D003790 1999-11-08
% 220.92/221.15  |- skos__hiddenLabel mesh__D003790 Gangrene, Pulp
% 220.92/221.15  |- skos__hiddenLabel mesh__D003790 Necrosis, Pulp
% 220.92/221.15  |- skos__hiddenLabel mesh__D003790 Autolyses, Dental Pulp
% 220.92/221.15  |- mesh__dateCreated mesh__D003790 1999-01-01
% 220.92/221.15  |- mesh__recordOriginator mesh__D003790 NLM
% 220.92/221.15  |- skos__hiddenLabel mesh__D003790 Necroses, Dental Pulp
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D003790 2000
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D003790 2005
% 220.92/221.15  |- skos__hiddenLabel mesh__D003790 Pulp Autolyses, Dental
% 220.92/221.15  |- mesh__dateEstablished mesh__D003790 1965-01-01
% 220.92/221.15  |- mesh__recordAuthorizer mesh__D003790 sjn
% 220.92/221.15  |- skos__altLabel mesh__D003790 Pulp Necrosis
% 220.92/221.15  |- rdf__type mesh__D003790sskos__Concept
% 220.92/221.15  |- mesh__recordOriginator mesh__D019407 AGS
% 220.92/221.15  |- skos__hiddenLabel mesh__D019407 BB10010
% 220.92/221.15  |- mesh__dateEstablished mesh__D019407 1997-01-01
% 220.92/221.15  |- skos__historyNote mesh__D019407 Cytokines %28%1991-1996%29%
% 220.92/221.15  |- skos__altLabel mesh__D019407 Stem Cell Inhibitor
% 220.92/221.15  |- skos__altLabel mesh__D019407 MIP-1
% 220.92/221.15  |- mesh__historyNote mesh__D019407
% 220.92/221.15       97; was MACROPHAGE INFLAMMATORY PROTEIN 1 %28%NM%29% 1990-96   
% 220.92/221.15  |- skos__hiddenLabel mesh__D019407 Inhibitor, Stem Cell
% 220.92/221.15  |- skos__hiddenLabel mesh__D019407 MIP 1beta
% 220.92/221.15  |- skos__altLabel mesh__D019407 MIP 1
% 220.92/221.15  |- skos__annotation mesh__D019407 DF: note short X ref   
% 220.92/221.15  |- skos__hiddenLabel mesh__D019407 Macrophage Inflammatory Protein 1
% 220.92/221.15  |- mesh__dateCreated mesh__D019407 1996-06-10
% 220.92/221.15  |- mesh__recordMaintainer mesh__D019407 ssb
% 220.92/221.15  |- skos__historyNote mesh__D019407 Monokines %28%1991-1996%29%
% 220.92/221.15  |- skos__scopeNote mesh__D019407
% 220.92/221.15       A chemokine that is chemotactic for neutrophils and monocytes, stimulates macrophages, and may play a role in regulating hematopoiesis. Its two variants, MIP-1alpha and MIP-1beta, are 60%25% homologous to each other.%A%    
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D019407 2006
% 220.92/221.15  |- mesh__recordAuthorizer mesh__D019407 sjn
% 220.92/221.15  |- skos__altLabel mesh__D019407 LD78
% 220.92/221.15  |- mesh__dateRevised mesh__D019407 2005-06-30
% 220.92/221.15  |- skos__broader mesh__D019407smesh__D019402
% 220.92/221.15  |- rdf__type mesh__D019407sskos__Concept
% 220.92/221.15  |- skos__hiddenLabel mesh__D019407 Cell Inhibitor, Stem
% 220.92/221.15  |- skos__altLabel mesh__D019407 Act2
% 220.92/221.15  |- mesh__onlineNote mesh__D019407
% 220.92/221.15       use MACROPHAGE INFLAMMATORY PROTEIN-1 %28%NM%29% to search MACROPHAGE INFLAMMATORY PROTEIN 1 1990-96%A%  
% 220.92/221.15  |- mesh__publicMeSHNote mesh__D019407
% 220.92/221.15       97; MACROPHAGE INFLAMMATORY PROTEIN 1 was indexed under MONOKINES %26% CYTOKINES 1991-96 and PROTEINS 1990%A%  
% 220.92/221.15  |- skos__prefLabel mesh__D019407 Macrophage Inflammatory Protein-1
% 220.92/221.15  |- skos__hiddenLabel mesh__D019407 BB 10010
% 220.92/221.15  |- skos__hiddenLabel mesh__D019407 MIP 1alpha
% 220.92/221.15  |- skos__historyNote mesh__D019407 Proteins %28%1990%29%
% 220.92/221.15  |- skos__altLabel mesh__D019407 Act-2
% 220.92/221.15  |- skos__broader mesh__D011424smesh__D011423
% 220.92/221.15  |- skos__annotation mesh__D011424
% 220.92/221.15       do not confuse with PROPIONIGENIUM; DF: PROPIONIBACT   
% 220.92/221.15  |- skos__prefLabel mesh__D011424 Propionibacterium
% 220.92/221.15  |- mesh__dateCreated mesh__D011424 1999-01-01
% 220.92/221.15  |- mesh__recordMaintainer mesh__D011424 SYSTEM
% 220.92/221.15  |- skos__scopeNote mesh__D011424
% 220.92/221.15       A genus of gram-positive, rod-shaped bacteria whose cells occur singly, in pairs or short chains, in V or Y configurations, or in clumps resembling letters of the Chinese alphabet. Its organisms are found in cheese and dairy products as well as on human skin and can occasionally cause soft tissue infections.%A%    
% 220.92/221.15  |- mesh__recordOriginator mesh__D011424 NLM
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D011424 2006
% 220.92/221.15  |- mesh__recordAuthorizer mesh__D011424 sjn
% 220.92/221.15  |- mesh__dateRevised mesh__D011424 2005-06-30
% 220.92/221.15  |- rdf__type mesh__D011424sskos__Concept
% 220.92/221.15  |- skos__altLabel mesh__D049892 Clam, Softshell
% 220.92/221.15  |- mesh__dateCreated mesh__D049892 2005-06-30
% 220.92/221.15  |- mesh__dateEstablished mesh__D049892 2006-01-01
% 220.92/221.15  |- skos__historyNote mesh__D049892 Bivalvia %28%1971-2005%29%
% 220.92/221.15  |- skos__annotation mesh__D049892
% 220.92/221.15       as animal %26% food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH %28%IM%29%%A%  
% 220.92/221.15  |- skos__scopeNote mesh__D049892
% 220.92/221.15       A genus of soft-shell clams in the family Myidae, class BIVALVIA.%A%    
% 220.92/221.15  |- mesh__historyNote mesh__D049892 2006   
% 220.92/221.15  |- mesh__recordOriginator mesh__D049892 ags
% 220.92/221.15  |- mesh__recordAuthorizer mesh__D049892 sjn
% 220.92/221.15  |- mesh__publicMeSHNote mesh__D049892 2006   
% 220.92/221.15  |- skos__broader mesh__D049892smesh__D049872
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D049892 2006
% 220.92/221.15  |- skos__altLabel mesh__D049892 Mya arenaria
% 220.92/221.15  |- skos__historyNote mesh__D049892 Mollusca %28%1965-1999%29%
% 220.92/221.15  |- mesh__recordMaintainer mesh__D049892 ags
% 220.92/221.15  |- skos__prefLabel mesh__D049892 Mya
% 220.92/221.15  |- rdf__type mesh__D049892sskos__Concept
% 220.92/221.15  |- skos__broader mesh__D003304Q000172smesh__D003304
% 220.92/221.15  |- mesh__preferredCombination mesh__D003304Q000172smesh__D017094
% 220.92/221.15  |- rdf__type mesh__D003304Q000172smesh__CompoundConcept
% 220.92/221.15  |- skos__hiddenLabel mesh__D002698 beta Chloralose
% 220.92/221.15  |- skos__altLabel mesh__D002698 Anhydroglucochloral
% 220.92/221.15  |- skos__altLabel mesh__D002698 Glucochloralose
% 220.92/221.15  |- mesh__dateCreated mesh__D002698 1999-01-01
% 220.92/221.15  |- rdf__type mesh__D002698sskos__Concept
% 220.92/221.15  |- mesh__recordMaintainer mesh__D002698 ssb
% 220.92/221.15  |- skos__scopeNote mesh__D002698
% 220.92/221.15       A derivative of CHLORAL HYDRATE that was used as a sedative but has been replaced by safer and more effective drugs. Its most common use is as a general anesthetic in animal experiments.%A%    
% 220.92/221.15  |- mesh__dateRevised mesh__D002698 2004-07-07
% 220.92/221.15  |- skos__hiddenLabel mesh__D002698 alpha Chloralose
% 220.92/221.15  |- skos__altLabel mesh__D002698 alpha-Chloralose
% 220.92/221.15  |- skos__broader mesh__D002698smesh__D005960
% 220.92/221.15  |- mesh__recordOriginator mesh__D002698 NLM
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D002698 2006
% 220.92/221.15  |- skos__altLabel mesh__D002698 Glucochloral
% 220.92/221.15  |- skos__prefLabel mesh__D002698 Chloralose
% 220.92/221.15  |- skos__broader mesh__D002698smesh__D002697
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D002698 2005
% 220.92/221.15  |- mesh__recordAuthorizer mesh__D002698 sjn
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D007383 2002
% 220.92/221.15  |- skos__hiddenLabel mesh__D007383 Intermittent Claudications
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D007383 1995
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D007383 1998
% 220.92/221.15  |- mesh__recordMaintainer mesh__D007383 TAP
% 220.92/221.15  |- rdf__type mesh__D007383sskos__Concept
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D007383 1994
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D007383 2004
% 220.92/221.15  |- mesh__dateRevised mesh__D007383 1993-06-02
% 220.92/221.15  |- mesh__recordOriginator mesh__D007383 NLM
% 220.92/221.15  |- skos__hiddenLabel mesh__D007383 Claudication, Intermittent
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D007383 2001
% 220.92/221.15  |- skos__prefLabel mesh__D007383 Intermittent Claudication
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D007383 2003
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D007383 1997
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D007383 2000
% 220.92/221.15  |- skos__scopeNote mesh__D007383
% 220.92/221.15       A symptom complex characterized by leg pain and weakness brought on by walking, with the disappearance of the symptoms following a brief rest.%A%    
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D007383 1996
% 220.92/221.15  |- mesh__dateCreated mesh__D007383 1999-01-01
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D007383 2006
% 220.92/221.15  |- mesh__recordAuthorizer mesh__D007383 PLS
% 220.92/221.15  |- skos__hiddenLabel mesh__D007383 Claudications, Intermittent
% 220.92/221.15  |- skos__broader mesh__D007383smesh__D001161
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D007383 2005
% 220.92/221.15  |- skos__annotation mesh__D007383
% 220.92/221.15       intermittent leg pain caused by walking   
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D007383 1999
% 220.92/221.15  |- mesh__publicMeSHNote mesh__D015815 90   
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D015815 2006
% 220.92/221.15  |- mesh__recordAuthorizer mesh__D015815 sjn
% 220.92/221.15  |- mesh__dateCreated mesh__D015815 1989-05-26
% 220.92/221.15  |- skos__hiddenLabel mesh__D015815 Molecules, Cell Adhesion
% 220.92/221.15  |- mesh__recordMaintainer mesh__D015815 ssb
% 220.92/221.15  |- skos__historyNote mesh__D015815 Antigens, Surface %28%1979-1989%29%
% 220.92/221.15  |- rdf__type mesh__D015815sskos__Concept
% 220.92/221.15  |- skos__prefLabel mesh__D015815 Cell Adhesion Molecules
% 220.92/221.15  |- skos__broader mesh__D015815smesh__D000954
% 220.92/221.15  |- skos__historyNote mesh__D015815 Membrane Glycoproteins %28%1988-1989%29%
% 220.92/221.15  |- skos__historyNote mesh__D015815 Glycoproteins %28%1966-1987%29%
% 220.92/221.15  |- skos__hiddenLabel mesh__D015815 Adhesion Molecules, Cell
% 220.92/221.15  |- skos__annotation mesh__D015815
% 220.92/221.15       GEN or unspecified; prefer specifics; DF: I CAMS   
% 220.92/221.15  |- skos__related mesh__D015815smesh__D016023
% 220.92/221.15  |- skos__altLabel mesh__D015815 Saccharide Mediated Cell Adhesion Molecules
% 220.92/221.15  |- mesh__dateEstablished mesh__D015815 1990-01-01
% 220.92/221.15  |- skos__hiddenLabel mesh__D015815 Molecules, Leukocyte Adhesion
% 220.92/221.15  |- mesh__historyNote mesh__D015815 90   
% 220.92/221.15  |- skos__hiddenLabel mesh__D015815 Molecules, Intercellular Adhesion
% 220.92/221.15  |- mesh__recordOriginator mesh__D015815 RLS
% 220.92/221.15  |- skos__broader mesh__D015815smesh__D008562
% 220.92/221.15  |- skos__hiddenLabel mesh__D015815 Adhesion Molecules, Intercellular
% 220.92/221.15  |- skos__scopeNote mesh__D015815
% 220.92/221.15       Surface ligands, usually glycoproteins, that mediate cell-to-cell adhesion. Their functions include the assembly and interconnection of various vertebrate systems, as well as maintenance of tissue integration, wound healing, morphogenic movements, cellular migrations, and metastasis.%A%    
% 220.92/221.15  |- mesh__dateRevised mesh__D015815 2005-06-30
% 220.92/221.15  |- skos__hiddenLabel mesh__D015815 Adhesion Molecules, Leukocyte
% 220.92/221.15  |- skos__altLabel mesh__D015017 Vitelline Sac of Embryo
% 220.92/221.15  |- mesh__recordAuthorizer mesh__D015017 sjn
% 220.92/221.15  |- skos__broader mesh__D015017smesh__D005321
% 220.92/221.15  |- skos__historyNote mesh__D015017 Vitelline Membrane %28%1966-1974%29%
% 220.92/221.15  |- skos__hiddenLabel mesh__D015017 Sacs, Yolk
% 220.92/221.15  |- mesh__recordOriginator mesh__D015017 AEP
% 220.92/221.15  |- skos__hiddenLabel mesh__D015017 Embryo Vitelline Sacs
% 220.92/221.15  |- skos__hiddenLabel mesh__D015017 Sac, Yolk
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D015017 2006
% 220.92/221.15  |- mesh__publicMeSHNote mesh__D015017
% 220.92/221.15       78; was see VITELLINE MEMBRANE 1973-77   
% 220.92/221.15  |- skos__prefLabel mesh__D015017 Yolk Sac
% 220.92/221.15  |- skos__historyNote mesh__D015017 Chick Embryo %28%1966-1972%29%
% 220.92/221.15  |- mesh__recordMaintainer mesh__D015017 lkt
% 220.92/221.15  |- mesh__dateRevised mesh__D015017 2005-06-30
% 220.92/221.15  |- mesh__onlineNote mesh__D015017 search VITELLINE MEMBRANE 1973-77   
% 220.92/221.15  |- mesh__historyNote mesh__D015017
% 220.92/221.15       78; was see VITELLINE MEMBRANE 1973-77   
% 220.92/221.15  |- skos__hiddenLabel mesh__D015017 Embryo Vitelline Sac
% 220.92/221.15  |- rdf__type mesh__D015017sskos__Concept
% 220.92/221.15  |- skos__historyNote mesh__D015017 Fetal Membranes %28%1966-1972%29%
% 220.92/221.15  |- skos__hiddenLabel mesh__D015017 Yolk Sacs
% 220.92/221.15  |- mesh__dateCreated mesh__D015017 1977-05-13
% 220.92/221.15  |- mesh__dateEstablished mesh__D015017 1978-01-01
% 220.92/221.15  |- skos__broader mesh__D015017smesh__D004625
% 220.92/221.15  |- skos__scopeNote mesh__D015017
% 220.92/221.15       The first of four extra-embryonic membranes to form during EMBRYOGENESIS. In REPTILES and BIRDS, it arises from endoderm and mesoderm to incorporate the EGG YOLK into the DIGESTIVE TRACT for nourishing the EMBRYO. In placental MAMMALS, its nutritional function is vestigial; however, it is the source of INTESTINAL MUCOSA; BLOOD CELLS; and GERM CELLS. It is sometimes called the vitelline sac, which should not be confused with the VITELLINE MEMBRANE of the egg.%A%    
% 220.92/221.15  |- mesh__activeMeSHYear mesh__D031482 2003
% 220.92/221.15  |- skos__annotation mesh__D031482
% 220.92/221.15       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.92/221.15  |- rdf__type mesh__D031482sskos__Concept
% 220.92/221.16  |- skos__scopeNote mesh__D031482
% 220.92/221.16       A plant genus of the family BALANOPHORACEAE. Members contain stigmastanes and ursanes %28%TRITERPENES%29% and lignan glucopyranosides %28%LIGNANS%29%.%A%    
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D031482 2006
% 220.92/221.16  |- mesh__dateCreated mesh__D031482 2002-07-03
% 220.92/221.16  |- skos__prefLabel mesh__D031482 Cynomorium
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D031482 2005
% 220.92/221.16  |- mesh__historyNote mesh__D031482 2003   
% 220.92/221.16  |- mesh__publicMeSHNote mesh__D031482 2003   
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D031482 2004
% 220.92/221.16  |- skos__broader mesh__D031482smesh__D031111
% 220.92/221.16  |- mesh__dateEstablished mesh__D031482 2003-01-01
% 220.92/221.16  |- skos__altLabel mesh__D003791 Pulp Tests, Dental
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003791 1999
% 220.92/221.16  |- skos__altLabel mesh__D003791 Pulp Test, Dental
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003791 1996
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003791 1993
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003791 2004
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003791 1995
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003791 1998
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003791 2000
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003791 2006
% 220.92/221.16  |- skos__altLabel mesh__D003791 Dental Pulp Tests
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003791 2003
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003791 1994
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003791 2005
% 220.92/221.16  |- skos__altLabel mesh__D003791 Tests, Dental Pulp
% 220.92/221.16  |- mesh__publicMeSHNote mesh__D003791 65   
% 220.92/221.16  |- mesh__recordAuthorizer mesh__D003791 PLS
% 220.92/221.16  |- mesh__recordOriginator mesh__D003791 NLM
% 220.92/221.16  |- mesh__recordMaintainer mesh__D003791 TAP
% 220.92/221.16  |- mesh__dateRevised mesh__D003791 1992-05-14
% 220.92/221.16  |- skos__altLabel mesh__D003791 Test, Dental Pulp
% 220.92/221.16  |- mesh__dateCreated mesh__D003791 1999-01-01
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003791 2002
% 220.92/221.16  |- skos__broader mesh__D003791smesh__D003945
% 220.92/221.16  |- mesh__historyNote mesh__D003791 65   
% 220.92/221.16  |- rdf__type mesh__D003791sskos__Concept
% 220.92/221.16  |- skos__prefLabel mesh__D003791 Dental Pulp Test
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003791 2001
% 220.92/221.16  |- skos__annotation mesh__D003791 DF: DENT PULP TEST   
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003791 1997
% 220.92/221.16  |- skos__hiddenLabel mesh__D019408
% 220.92/221.16       Platelet Endothelial Cell Adhesion Molecule 1
% 220.92/221.16  |- skos__prefLabel mesh__D019408 Antigens, CD31
% 220.92/221.16  |- mesh__recordMaintainer mesh__D019408 ssb
% 220.92/221.16  |- skos__historyNote mesh__D019408
% 220.92/221.16       Cell Adhesion Molecules %28%1995-1996%29%
% 220.92/221.16  |- skos__altLabel mesh__D019408 CD31 Antigen
% 220.92/221.16  |- mesh__dateCreated mesh__D019408 1996-06-10
% 220.92/221.16  |- mesh__recordAuthorizer mesh__D019408 sjn
% 220.92/221.16  |- skos__altLabel mesh__D019408 CD31 Antigens
% 220.92/221.16  |- skos__broader mesh__D019408smesh__D015815
% 220.92/221.16  |- mesh__historyNote mesh__D019408
% 220.92/221.16       97; was CD31 ANTIGEN %28%NM%29% 1990-96   
% 220.92/221.16  |- skos__broader mesh__D019408smesh__D015703
% 220.92/221.16  |- rdf__type mesh__D019408sskos__Concept
% 220.92/221.16  |- skos__scopeNote mesh__D019408
% 220.92/221.16       Cell adhesion molecules present on virtually all monocytes, platelets, and granulocytes. CD31 is highly expressed on endothelial cells and concentrated at the junctions between them.%A%    
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D019408 2006
% 220.92/221.16  |- skos__altLabel mesh__D019408
% 220.92/221.16       Platelet Endothelial Cell Adhesion Molecule-1
% 220.92/221.16  |- mesh__dateRevised mesh__D019408 2005-06-30
% 220.92/221.16  |- skos__altLabel mesh__D019408 PECAM-1
% 220.92/221.16  |- skos__broader mesh__D019408smesh__D015214
% 220.92/221.16  |- skos__hiddenLabel mesh__D019408 Antigen, CD31
% 220.92/221.16  |- mesh__onlineNote mesh__D019408
% 220.92/221.16       use ANTIGENS, CD31 %28%NM%29% to search CD31 ANTIGEN 1990-96   
% 220.92/221.16  |- skos__historyNote mesh__D019408 Membrane Glycoproteins %28%1990-1994%29%
% 220.92/221.16  |- skos__historyNote mesh__D019408
% 220.92/221.16       Antigens, Differentiation, Myelomonocytic %28%1990-1996%29%
% 220.92/221.16  |- mesh__recordOriginator mesh__D019408 AGS
% 220.92/221.16  |- mesh__publicMeSHNote mesh__D019408
% 220.92/221.16       97; CD31 ANTIGEN was indexed under CELL ADHESION MOLECULES 1995-96, ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1990-96, %26% MEMBRANE GLYCOPROTEINS 1990-94%A%  
% 220.92/221.16  |- mesh__dateEstablished mesh__D019408 1997-01-01
% 220.92/221.16  |- skos__prefLabel mesh__D011425 Propionibacterium acnes
% 220.92/221.16  |- mesh__publicMeSHNote mesh__D011425
% 220.92/221.16       76; CORYNEBACTERIUM ACNES %26% CORYNEBACTERIUM PARVUM were see under CORYNEBACTERIUM 1975%A%  
% 220.92/221.16  |- mesh__dateCreated mesh__D011425 1975-07-21
% 220.92/221.16  |- mesh__recordAuthorizer mesh__D011425 sjn
% 220.92/221.16  |- skos__scopeNote mesh__D011425
% 220.92/221.16       A bacteria isolated from normal skin, intestinal contents, wounds, blood, pus, and soft tissue abscesses. It is a common contaminant of clinical specimens, presumably from the skin of patients or attendants.%A%    
% 220.92/221.16  |- skos__annotation mesh__D011425
% 220.92/221.16       infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS %28%IM%29%; DF: PROPIONIBACT ACNES%A%  
% 220.92/221.16  |- mesh__dateRevised mesh__D011425 2005-06-30
% 220.92/221.16  |- mesh__historyNote mesh__D011425
% 220.92/221.16       76; CORYNEBACTERIUM ACNES %26% CORYNEBACTERIUM PARVUM were see under CORYNEBACTERIUM 1972-75 %28%Provs 1972-74%29%%A%  
% 220.92/221.16  |- skos__historyNote mesh__D011425 Corynebacterium %28%1966-1974%29%
% 220.92/221.16  |- mesh__recordMaintainer mesh__D011425 SYSTEM
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D011425 2006
% 220.92/221.16  |- skos__altLabel mesh__D011425 Corynebacterium parvum
% 220.92/221.16  |- mesh__dateEstablished mesh__D011425 1976-01-01
% 220.92/221.16  |- mesh__recordOriginator mesh__D011425 JW
% 220.92/221.16  |- mesh__onlineNote mesh__D011425
% 220.92/221.16       use PROPIONIBACTERIUM ACNES to search CORYNEBACTERIUM ACNES %26% CORYNEBACTERIUM PARVUM 1975; use CORYNEBACTERIUM 1972-74%A%  
% 220.92/221.16  |- rdf__type mesh__D011425sskos__Concept
% 220.92/221.16  |- skos__broader mesh__D011425smesh__D011424
% 220.92/221.16  |- skos__altLabel mesh__D011425 Corynebacterium acnes
% 220.92/221.16  |- skos__prefLabel mesh__D049893 Arcidae
% 220.92/221.16  |- skos__altLabel mesh__D049893 Ark Shells
% 220.92/221.16  |- mesh__dateCreated mesh__D049893 2005-06-30
% 220.92/221.16  |- mesh__publicMeSHNote mesh__D049893 2006   
% 220.92/221.16  |- skos__historyNote mesh__D049893 Mollusca %28%1984-2005%29%
% 220.92/221.16  |- mesh__dateEstablished mesh__D049893 2006-01-01
% 220.92/221.16  |- skos__broader mesh__D049893smesh__D049872
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D049893 2006
% 220.92/221.16  |- mesh__recordOriginator mesh__D049893 ags
% 220.92/221.16  |- mesh__historyNote mesh__D049893 2006   
% 220.92/221.16  |- mesh__recordMaintainer mesh__D049893 ags
% 220.92/221.16  |- mesh__recordAuthorizer mesh__D049893 sjn
% 220.92/221.16  |- rdf__type mesh__D049893sskos__Concept
% 220.92/221.16  |- skos__scopeNote mesh__D049893
% 220.92/221.16       A family of ark shell mollusks, in the class BIVALVIA. They have soft bodies with platelike GILLS enclosed within two shells hinged together.%A%    
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D016110 2004
% 220.92/221.16  |- mesh__recordAuthorizer mesh__D016110 sjn
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D016110 2005
% 220.92/221.16  |- mesh__recordOriginator mesh__D016110 AGS
% 220.92/221.16  |- rdf__type mesh__D016110sskos__Concept
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D016110 2003
% 220.92/221.16  |- mesh__publicMeSHNote mesh__D016110 91   
% 220.92/221.16  |- mesh__dateCreated mesh__D016110 1990-02-12
% 220.92/221.16  |- skos__altLabel mesh__D016110 Epidermolysis Bullosa Simplex, Generalized
% 220.92/221.16  |- mesh__dateRevised mesh__D016110 2001-07-25
% 220.92/221.16  |- skos__scopeNote mesh__D016110
% 220.92/221.16       Form of epidermolysis bullosa characterized by autosomal dominant inheritance and by serous bullae that heal without scarring.%A%    
% 220.92/221.16  |- mesh__recordMaintainer mesh__D016110 nns
% 220.92/221.16  |- mesh__historyNote mesh__D016110 91   
% 220.92/221.16  |- skos__hiddenLabel mesh__D016110 Weber Cockayne Syndrome
% 220.92/221.16  |- skos__prefLabel mesh__D016110 Epidermolysis Bullosa Simplex
% 220.92/221.16  |- skos__altLabel mesh__D016110
% 220.92/221.16       Epidermolysis Bullosa Herpetiformis Dowling Meara
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D016110 2002
% 220.92/221.16  |- skos__historyNote mesh__D016110 Epidermolysis Bullosa %28%1966-1990%29%
% 220.92/221.16  |- skos__altLabel mesh__D016110 Epidermolysis Bullosa Simplex, Localized
% 220.92/221.16  |- skos__broader mesh__D016110smesh__D004820
% 220.92/221.16  |- skos__annotation mesh__D016110
% 220.92/221.16       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 220.92/221.16  |- mesh__dateEstablished mesh__D016110 1991-01-01
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D016110 2006
% 220.92/221.16  |- skos__broader mesh__D002699smesh__D009588
% 220.92/221.16  |- skos__altLabel mesh__D002699 Chlorbutin
% 220.92/221.16  |- skos__altLabel mesh__D002699
% 220.92/221.16       N,N-Di-%28%2-chloroethyl%29%-p-aminophenylbutyric Acid
% 220.92/221.16  |- mesh__dateCreated mesh__D002699 1999-01-01
% 220.92/221.16  |- rdf__type mesh__D002699sskos__Concept
% 220.92/221.16  |- skos__prefLabel mesh__D002699 Chlorambucil
% 220.92/221.16  |- skos__altLabel mesh__D002699 Wellcome Brand of Chlorambucil
% 220.92/221.16  |- skos__altLabel mesh__D002699 GlaxoSmithKline Brand of Chlorambucil
% 220.92/221.16  |- mesh__recordOriginator mesh__D002699 NLM
% 220.92/221.16  |- skos__hiddenLabel mesh__D002699 CB1348
% 220.92/221.16  |- skos__hiddenLabel mesh__D002699 NSC 3088
% 220.92/221.16  |- skos__hiddenLabel mesh__D002699 NSC3088
% 220.92/221.16  |- mesh__recordMaintainer mesh__D002699 lkw
% 220.92/221.16  |- skos__altLabel mesh__D002699 Glaxo Wellcome Brand of Chlorambucil
% 220.92/221.16  |- skos__scopeNote mesh__D002699
% 220.92/221.16       A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin%27%s disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%. %28%Merck Index, 11th ed%29%%A%    
% 220.92/221.16  |- skos__hiddenLabel mesh__D002699 CB 1348
% 220.92/221.16  |- mesh__recordAuthorizer mesh__D002699 sjn
% 220.92/221.16  |- skos__altLabel mesh__D002699
% 220.92/221.16       4-%28%Bis%28%2-chloroethyl%29%amino%29%benzenebutanoic Acid
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D002699 2006
% 220.92/221.16  |- skos__altLabel mesh__D002699 Chloraminophene
% 220.92/221.16  |- mesh__dateRevised mesh__D002699 2005-06-30
% 220.92/221.16  |- skos__altLabel mesh__D007384 Inspiratory Positive-Pressure Breathing
% 220.92/221.16  |- skos__hiddenLabel mesh__D007384 Intermittent Positive Pressure Breathing
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D007384 2004
% 220.92/221.16  |- mesh__dateEstablished mesh__D007384 1991-01-01
% 220.92/221.16  |- mesh__recordMaintainer mesh__D007384 TGC
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D007384 2002
% 220.92/221.16  |- skos__broader mesh__D007384smesh__D011175
% 220.92/221.16  |- mesh__historyNote mesh__D007384
% 220.92/221.16       91%28%79%29%; was INTERMITTENT POSITIVE PRESSURE BREATHING see under POSITIVE PRESSURE RESPIRATION 1979-90; was INTERMITTENT POSITIVE PRESSURE BREATHING %28%IPPB%29% see under POSITIVE PRESSURE RESPIRATION 1969-78%A%  
% 220.92/221.16  |- skos__altLabel mesh__D007384
% 220.92/221.16       Intermittent Positive Pressure Breathing %28%IPPB%29%
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D007384 2003
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D007384 1997
% 220.92/221.16  |- mesh__dateRevised mesh__D007384 1996-06-10
% 220.92/221.16  |- skos__hiddenLabel mesh__D007384
% 220.92/221.16       Breathing, Intermittent Positive-Pressure
% 220.92/221.16  |- skos__scopeNote mesh__D007384
% 220.92/221.16       Application of positive pressure to the inspiratory phase of spontaneous respiration.%A%    
% 220.92/221.16  |- mesh__dateCreated mesh__D007384 1999-01-01
% 220.92/221.16  |- skos__hiddenLabel mesh__D007384
% 220.92/221.16       Positive-Pressure Breathing, Intermittent
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D007384 2006
% 220.92/221.16  |- skos__hiddenLabel mesh__D007384 Breathing, Inspiratory Positive-Pressure
% 220.92/221.16  |- mesh__recordOriginator mesh__D007384 NLM
% 220.92/221.16  |- skos__hiddenLabel mesh__D007384 Positive-Pressure Breathing, Inspiratory
% 220.92/221.16  |- mesh__publicMeSHNote mesh__D007384
% 220.92/221.16       91; was INTERMITTENT POSITIVE PRESSURE BREATHING see under POSITIVE PRESSURE RESPIRATION 1979-90; was INTERMITTENT POSITIVE PRESSURE BREATHING %28%IPPB%29% see under POSITIVE PRESSURE RESPIRATION 1969-78%A%  
% 220.92/221.16  |- skos__annotation mesh__D007384
% 220.92/221.16       do not use /util except by MeSH definition; do not confuse with INTERMITTENT POSITIVE-PRESSURE VENTILATION: IPPB is spontaneous, IPPV is on a ventilator; DF: note short X ref%A%  
% 220.92/221.16  |- skos__altLabel mesh__D007384 IPPB
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D007384 2001
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D007384 1999
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D007384 2005
% 220.92/221.16  |- mesh__onlineNote mesh__D007384
% 220.92/221.16       use INTERMITTENT POSITIVE-PRESSURE BREATHING to search INTERMITTENT POSITIVE PRESSURE BREATHING 1979-90 %26% INTERMITTENT POSITIVE PRESSURE BREATHING %28%IPPB%29% 1975-78; use POSITIVE PRESSURE RESPIRATION 1969-74%A%  
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D007384 2000
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D007384 1998
% 220.92/221.16  |- rdf__type mesh__D007384sskos__Concept
% 220.92/221.16  |- skos__hiddenLabel mesh__D007384 Inspiratory Positive Pressure Breathing
% 220.92/221.16  |- skos__prefLabel mesh__D007384 Intermittent Positive-Pressure Breathing
% 220.92/221.16  |- mesh__recordAuthorizer mesh__D007384 PLS
% 220.92/221.16  |- rdf__type mesh__D015816sskos__Concept
% 220.92/221.16  |- skos__annotation mesh__D015816
% 220.92/221.16       do not confuse with CELL ADHESION MOLECULES, NEURON-GLIA; do not confuse X ref NEURONAL CELL ADHESION MOLECULES with NCAM for X ref NEURAL CELL ADHESION MOLECULE%A%  
% 220.92/221.16  |- skos__broader mesh__D015816smesh__D015815
% 220.92/221.16  |- skos__historyNote mesh__D015816 Antigens, Surface %28%1979-1989%29%
% 220.92/221.16  |- skos__hiddenLabel mesh__D015816 Molecules, Axon-Associated Adhesion
% 220.92/221.16  |- skos__prefLabel mesh__D015816 Cell Adhesion Molecules, Neuronal
% 220.92/221.16  |- skos__altLabel mesh__D015816 Neuronal Cell Adhesion Molecules
% 220.92/221.16  |- mesh__dateRevised mesh__D015816 2005-06-30
% 220.92/221.16  |- skos__hiddenLabel mesh__D015816 Adhesion Molecules, Axon-Associated
% 220.92/221.16  |- mesh__dateEstablished mesh__D015816 1990-01-01
% 220.92/221.16  |- mesh__recordAuthorizer mesh__D015816 sjn
% 220.92/221.16  |- skos__hiddenLabel mesh__D015816 Axon Associated Adhesion Molecules
% 220.92/221.16  |- skos__historyNote mesh__D015816 Membrane Glycoproteins %28%1988-1989%29%
% 220.92/221.16  |- mesh__recordMaintainer mesh__D015816 ssb
% 220.92/221.16  |- skos__scopeNote mesh__D015816
% 220.92/221.16       Surface ligands that mediate cell-to-cell adhesion and function in the assembly and interconnection of the vertebrate nervous system. These molecules promote cell adhesion via a homophilic mechanism. These are not to be confused with NEURAL CELL ADHESION MOLECULES, now known to be expressed in a variety of tissues and cell types in addition to nervous tissue.%A%    
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D015816 2006
% 220.92/221.16  |- mesh__dateCreated mesh__D015816 1989-05-26
% 220.92/221.16  |- mesh__publicMeSHNote mesh__D015816 90   
% 220.92/221.16  |- mesh__historyNote mesh__D015816 90   
% 220.92/221.16  |- skos__historyNote mesh__D015816 Glycoproteins %28%1966-1987%29%
% 220.92/221.16  |- mesh__recordOriginator mesh__D015816 RLS
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D015018 2004
% 220.92/221.16  |- mesh__dateRevised mesh__D015018 2001-07-25
% 220.92/221.16  |- skos__prefLabel mesh__D015018 Ytterbium
% 220.92/221.16  |- mesh__recordMaintainer mesh__D015018 jmp
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D015018 2006
% 220.92/221.16  |- mesh__recordAuthorizer mesh__D015018 sjn
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D015018 2003
% 220.92/221.16  |- skos__annotation mesh__D015018
% 220.92/221.16       a rare earth metal; Yb-174; Yb-168, 170-173, 176 = YTTERBIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Yb-164-167, 169, 175, 177 = YTTERBIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 220.92/221.16  |- mesh__dateCreated mesh__D015018 1999-01-01
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D015018 2005
% 220.92/221.16  |- mesh__recordOriginator mesh__D015018 NLM
% 220.92/221.16  |- rdf__type mesh__D015018sskos__Concept
% 220.92/221.16  |- skos__broader mesh__D015018smesh__D028581
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D015018 2002
% 220.92/221.16  |- skos__scopeNote mesh__D015018
% 220.92/221.16       Ytterbium. An element of the rare earth family of metals. It has the atomic symbol Yb, atomic number 70, and atomic weight 173. Ytterbium has been used in lasers and as a portable x-ray source.%A%    
% 220.92/221.16  |- mesh__historyNote mesh__D031483 2003   
% 220.92/221.16  |- skos__prefLabel mesh__D031483 Capparaceae
% 220.92/221.16  |- rdf__type mesh__D031483sskos__Concept
% 220.92/221.16  |- mesh__dateEstablished mesh__D031483 2003-01-01
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D031483 2005
% 220.92/221.16  |- mesh__recordAuthorizer mesh__D031483 sjn
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D031483 2006
% 220.92/221.16  |- skos__annotation mesh__D031483
% 220.92/221.16       X ref CRATEVA: Crateva marmelos see AEGLE MARMELOS is also available; prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 220.92/221.16  |- mesh__recordOriginator mesh__D031483 ssb
% 220.92/221.16  |- mesh__publicMeSHNote mesh__D031483 2003   
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D031483 2004
% 220.92/221.16  |- mesh__recordMaintainer mesh__D031483 ssb
% 220.92/221.16  |- skos__scopeNote mesh__D031483
% 220.92/221.16       A plant family of the order Capparales, subclass Dilleniidae, class Magnoliopsida that are mostly herbs and shrubs growing in warm arid regions. Several produce GLUCOSINOLATES.%A%    
% 220.92/221.16  |- mesh__dateCreated mesh__D031483 2002-07-03
% 220.92/221.16  |- skos__broader mesh__D031483smesh__D019684
% 220.92/221.16  |- mesh__dateRevised mesh__D031483 2003-07-09
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003792 1995
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003792 2002
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003792 1998
% 220.92/221.16  |- skos__historyNote mesh__D003792 Medical Records %28%1966%29%
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003792 2006
% 220.92/221.16  |- skos__broader mesh__D003792smesh__D011996
% 220.92/221.16  |- skos__scopeNote mesh__D003792
% 220.92/221.16       Data collected during dental examination for the purpose of study, diagnosis, or treatment planning.%A%    
% 220.92/221.16  |- skos__altLabel mesh__D003792 Records, Dental
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003792 2003
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003792 1994
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003792 2001
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003792 2005
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003792 2000
% 220.92/221.16  |- skos__prefLabel mesh__D003792 Dental Records
% 220.92/221.16  |- mesh__publicMeSHNote mesh__D003792 67   
% 220.92/221.16  |- mesh__historyNote mesh__D003792 67   
% 220.92/221.16  |- mesh__dateCreated mesh__D003792 1999-01-01
% 220.92/221.16  |- skos__altLabel mesh__D003792 Dental Record
% 220.92/221.16  |- mesh__dateEstablished mesh__D003792 1967-01-01
% 220.92/221.16  |- skos__altLabel mesh__D003792 Record, Dental
% 220.92/221.16  |- rdf__type mesh__D003792sskos__Concept
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003792 1997
% 220.92/221.16  |- skos__annotation mesh__D003792 DF: DENT RECORDS   
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003792 1999
% 220.92/221.16  |- mesh__recordOriginator mesh__D003792 NLM
% 220.92/221.16  |- mesh__recordAuthorizer mesh__D003792 PLS
% 220.92/221.16  |- mesh__recordMaintainer mesh__D003792 PLS
% 220.92/221.16  |- mesh__dateRevised mesh__D003792 1992-05-14
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003792 1996
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003792 1993
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D003792 2004
% 220.92/221.16  |- skos__prefLabel mesh__D019409 Interleukin-15
% 220.92/221.16  |- skos__altLabel mesh__D019409 IL-15
% 220.92/221.16  |- mesh__onlineNote mesh__D019409
% 220.92/221.16       use INTERLEUKIN-15 %28%NM%29% to search INTERLEUKIN 15 1994-96   
% 220.92/221.16  |- skos__broader mesh__D019409smesh__D007378
% 220.92/221.16  |- mesh__recordOriginator mesh__D019409 AGS
% 220.92/221.16  |- skos__scopeNote mesh__D019409
% 220.92/221.16       Cytokine that stimulates the proliferation of T-lymphocytes and shares biological activities with IL-2. IL-15 also can induce B-lymphocyte proliferation and differentiation.%A%    
% 220.92/221.16  |- mesh__dateEstablished mesh__D019409 1997-01-01
% 220.92/221.16  |- skos__historyNote mesh__D019409 Interleukins %28%1994-1996%29%
% 220.92/221.16  |- rdf__type mesh__D019409sskos__Concept
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D019409 2006
% 220.92/221.16  |- mesh__recordMaintainer mesh__D019409 ssb
% 220.92/221.16  |- mesh__dateCreated mesh__D019409 1996-06-10
% 220.92/221.16  |- mesh__recordAuthorizer mesh__D019409 sjn
% 220.92/221.16  |- skos__altLabel mesh__D019409 Interleukin 15
% 220.92/221.16  |- mesh__historyNote mesh__D019409
% 220.92/221.16       97; was INTERLEUKIN 15 %28%NM%29% 1994-96   
% 220.92/221.16  |- skos__annotation mesh__D019409 DF: IL 15 or IL15   
% 220.92/221.16  |- mesh__publicMeSHNote mesh__D019409
% 220.92/221.16       97; INTERLEUKIN 15 was indexed under INTERLEUKINS 1994-96%A%  
% 220.92/221.16  |- mesh__dateRevised mesh__D019409 2005-06-30
% 220.92/221.16  |- skos__altLabel mesh__D019409 IL15
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D011426 2005
% 220.92/221.16  |- mesh__dateRevised mesh__D011426 2003-07-09
% 220.92/221.16  |- skos__historyNote mesh__D011426 Propionates %28%1966-1974%29%
% 220.92/221.16  |- mesh__recordMaintainer mesh__D011426 ssb
% 220.92/221.16  |- mesh__dateEstablished mesh__D011426 1991-01-01
% 220.92/221.16  |- skos__scopeNote mesh__D011426
% 220.92/221.16       3-carbon saturated monocarboxylic acids.     
% 220.92/221.16  |- mesh__recordOriginator mesh__D011426 NLM
% 220.92/221.16  |- mesh__historyNote mesh__D011426
% 220.92/221.16       91%28%75%29%; was see under PROPIONATES 1975-90   
% 220.92/221.16  |- mesh__recordAuthorizer mesh__D011426 sjn
% 220.92/221.16  |- mesh__dateCreated mesh__D011426 1974-11-11
% 220.92/221.16  |- skos__annotation mesh__D011426
% 220.92/221.16       propionic acidemia: index PROPIONIC ACIDS /blood %28%IM%29% + AMINO ACID METABOLISM, INBORN ERRORS %28%IM%29%%A%  
% 220.92/221.16  |- mesh__publicMeSHNote mesh__D011426
% 220.92/221.16       91; was see under PROPIONATES 1975-90   
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D011426 2006
% 220.92/221.16  |- skos__prefLabel mesh__D011426 Propionic Acids
% 220.92/221.16  |- skos__broader mesh__D011426smesh__D011422
% 220.92/221.16  |- skos__hiddenLabel mesh__D011426 Acids, Propionic
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D011426 2004
% 220.92/221.16  |- rdf__type mesh__D011426sskos__Concept
% 220.92/221.16  |- mesh__dateEstablished mesh__D049894 2006-01-01
% 220.92/221.16  |- mesh__recordOriginator mesh__D049894 ags
% 220.92/221.16  |- mesh__historyNote mesh__D049894 2006   
% 220.92/221.16  |- mesh__recordAuthorizer mesh__D049894 sjn
% 220.92/221.16  |- mesh__publicMeSHNote mesh__D049894 2006   
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D049894 2006
% 220.92/221.16  |- mesh__recordMaintainer mesh__D049894 ags
% 220.92/221.16  |- skos__scopeNote mesh__D049894
% 220.92/221.16       A genus of mollusks in the family ARCIDAE, class BIVALVIA. It is used in the study of HEMOGLOBINS.%A%    
% 220.92/221.16  |- skos__prefLabel mesh__D049894 Scapharca
% 220.92/221.16  |- mesh__dateCreated mesh__D049894 2005-06-30
% 220.92/221.16  |- rdf__type mesh__D049894sskos__Concept
% 220.92/221.16  |- skos__broader mesh__D049894smesh__D049893
% 220.92/221.16  |- skos__historyNote mesh__D049894 Mollusca %28%1981-2005%29%
% 220.92/221.16  |- mesh__dateCreated mesh__D016111 1990-06-06
% 220.92/221.16  |- skos__broader mesh__D016111smesh__D007057
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D016111 2003
% 220.92/221.16  |- skos__scopeNote mesh__D016111
% 220.92/221.16       Rare syndrome of autosomal recessive inheritance characterized by ichthyosis, mental retardation, and spastic pyramidal symptoms. It is associated with a defect in fatty alcohol metabolism.%A%    
% 220.92/221.16  |- rdf__type mesh__D016111sskos__Concept
% 220.92/221.16  |- mesh__onlineNote mesh__D016111 search ICHTHYOSIS 1984-90   
% 220.92/221.16  |- skos__hiddenLabel mesh__D016111 Sjogren Larsson Syndrome
% 220.92/221.16  |- skos__annotation mesh__D016111
% 220.92/221.16       a type of ichthyosis: do not confuse with SJOGREN%27%S SYNDROME; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; in titles %26% translations use diacrit: Sj%C3%%B6%gren-Larsson%A%  
% 220.92/221.16  |- mesh__historyNote mesh__D016111 91; was see ICHTHYOSIS 1984-90   
% 220.92/221.16  |- mesh__recordOriginator mesh__D016111 AGS
% 220.92/221.16  |- skos__broader mesh__D016111smesh__D012873
% 220.92/221.16  |- skos__prefLabel mesh__D016111 Sjogren-Larsson Syndrome
% 220.92/221.16  |- mesh__recordAuthorizer mesh__D016111 sjn
% 220.92/221.16  |- mesh__recordMaintainer mesh__D016111 nns
% 220.92/221.16  |- skos__broader mesh__D016111smesh__D008064
% 220.92/221.16  |- mesh__publicMeSHNote mesh__D016111 91; was see ICHTHYOSIS 1984-90   
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D016111 2006
% 220.92/221.16  |- skos__historyNote mesh__D016111 Ichthyosis %28%1966-1990%29%
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D016111 2002
% 220.92/221.16  |- mesh__dateEstablished mesh__D016111 1991-01-01
% 220.92/221.16  |- mesh__dateRevised mesh__D016111 2001-08-13
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D016111 2005
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D016111 2004
% 220.92/221.16  |- mesh__recordAuthorizer mesh__D007385 PLS
% 220.92/221.16  |- mesh__recordMaintainer mesh__D007385 TGC
% 220.92/221.16  |- skos__annotation mesh__D007385
% 220.92/221.16       do not use /util except by MeSH definition; do not confuse with INTERMITTENT POSITIVE-PRESSURE BREATHING: IPPV is on a ventilator, IPPB is spontaneous; DF: note short X ref%A%  
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D007385 2004
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D007385 2001
% 220.92/221.16  |- mesh__dateCreated mesh__D007385 1978-03-13
% 220.92/221.16  |- mesh__recordOriginator mesh__D007385 SMH
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D007385 2002
% 220.92/221.16  |- skos__hiddenLabel mesh__D007385
% 220.92/221.16       Intermittent Positive Pressure Ventilation
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D007385 1997
% 220.92/221.16  |- skos__prefLabel mesh__D007385 Intermittent Positive-Pressure Ventilation
% 220.92/221.16  |- skos__altLabel mesh__D007385 Ventilation, Intermittent Positive-Pressure
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D007385 2005
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D007385 2006
% 220.92/221.16  |- skos__hiddenLabel mesh__D007385
% 220.92/221.16       Positive-Pressure Ventilation, Intermittent
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D007385 1998
% 220.92/221.16  |- mesh__publicMeSHNote mesh__D007385
% 220.92/221.16       91; was INTERMITTENT POSITIVE PRESSURE VENTILATION see under POSITIVE PRESSURE RESPIRATION 1979-90%A%  
% 220.92/221.16  |- mesh__dateEstablished mesh__D007385 1991-01-01
% 220.92/221.16  |- skos__historyNote mesh__D007385
% 220.92/221.16       Intermittent Positive Pressure Breathing %28%1975-1978%29%
% 220.92/221.16  |- skos__altLabel mesh__D007385 IPPV
% 220.92/221.16  |- mesh__dateRevised mesh__D007385 1996-06-10
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D007385 1999
% 220.92/221.16  |- skos__historyNote mesh__D007385
% 220.92/221.16       Positive Pressure Respiration %28%1966-1978%29%
% 220.92/221.16  |- skos__hiddenLabel mesh__D007385
% 220.92/221.16       Positive-Pressure Ventilation, Inspiratory
% 220.92/221.16  |- mesh__onlineNote mesh__D007385
% 220.92/221.16       use INTERMITTENT POSITIVE-PRESSURE VENTILATION to search INTERMITTENT POSITIVE PRESSURE VENTILATION 1979-90%A%  
% 220.92/221.16  |- skos__scopeNote mesh__D007385
% 220.92/221.16       Application of positive pressure to the inspiratory phase when the patient has an artificial airway in place and is connected to a ventilator.%A%    
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D007385 2000
% 220.92/221.16  |- skos__broader mesh__D007385smesh__D011175
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D007385 2003
% 220.92/221.16  |- skos__hiddenLabel mesh__D007385
% 220.92/221.16       Ventilation, Intermittent Positive Pressure
% 220.92/221.16  |- mesh__historyNote mesh__D007385
% 220.92/221.16       91%28%79%29%; was INTERMITTENT POSITIVE PRESSURE VENTILATION see under POSITIVE PRESSURE RESPIRATION 1979-90%A%  
% 220.92/221.16  |- skos__altLabel mesh__D007385 Inspiratory Positive-Pressure Ventilation
% 220.92/221.16  |- skos__hiddenLabel mesh__D007385
% 220.92/221.16       Ventilation, Inspiratory Positive-Pressure
% 220.92/221.16  |- rdf__type mesh__D007385sskos__Concept
% 220.92/221.16  |- skos__hiddenLabel mesh__D007385
% 220.92/221.16       Inspiratory Positive Pressure Ventilation
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D015817 2001
% 220.92/221.16  |- skos__broader mesh__D015817smesh__D007239
% 220.92/221.16  |- skos__hiddenLabel mesh__D015817 Infection, Eye
% 220.92/221.16  |- mesh__historyNote mesh__D015817 90   
% 220.92/221.16  |- skos__hiddenLabel mesh__D015817 Eye Infection
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D015817 1994
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D015817 1991
% 220.92/221.16  |- mesh__dateEstablished mesh__D015817 1990-01-01
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D015817 1998
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D015817 1995
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D015817 2005
% 220.92/221.16  |- skos__hiddenLabel mesh__D015817 Infections, Ocular
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D015817 2002
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D015817 1992
% 220.92/221.16  |- skos__annotation mesh__D015817
% 220.92/221.16       coord IM with specific infect dis %28%IM%29%; DF: EYE INFECT   
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D015817 1999
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D015817 2006
% 220.92/221.16  |- skos__hiddenLabel mesh__D015817 Infection, Ocular
% 220.92/221.16  |- skos__historyNote mesh__D015817 Eye Diseases %28%1966-1989%29%
% 220.92/221.16  |- skos__scopeNote mesh__D015817
% 220.92/221.16       Infection, moderate to severe, caused by bacteria, fungi, or viruses, which occurs either on the external surface of the eye or intraocularly with probable inflammation, visual impairment, or blindness.%A%    
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D015817 1993
% 220.92/221.16  |- skos__prefLabel mesh__D015817 Eye Infections
% 220.92/221.16  |- mesh__dateCreated mesh__D015817 1989-05-26
% 220.92/221.16  |- mesh__activeMeSHYear mesh__D015817 1996
% 220.92/221.16  |- mesh__publicMeSHNote mesh__D015817 90   
% 221.02/221.16  |- skos__hiddenLabel mesh__D015817 Infections, Eye
% 221.02/221.16  |- mesh__activeMeSHYear mesh__D015817 2003
% 221.02/221.16  |- mesh__activeMeSHYear mesh__D015817 2000
% 221.02/221.16  |- skos__broader mesh__D015817smesh__D005128
% 221.02/221.16  |- mesh__activeMeSHYear mesh__D015817 1990
% 221.02/221.16  |- rdf__type mesh__D015817sskos__Concept
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D015817 1997
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D015817 2004
% 221.02/221.17  |- skos__hiddenLabel mesh__D015817 Ocular Infection
% 221.02/221.17  |- skos__altLabel mesh__D015817 Ocular Infections
% 221.02/221.17  |- skos__annotation mesh__D015019 a rare earth metal; Y-89   
% 221.02/221.17  |- mesh__recordAuthorizer mesh__D015019 sjn
% 221.02/221.17  |- skos__related mesh__D015019smesh__D015021
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D015019 2004
% 221.02/221.17  |- mesh__recordMaintainer mesh__D015019 jmp
% 221.02/221.17  |- mesh__dateRevised mesh__D015019 2001-07-25
% 221.02/221.17  |- mesh__dateCreated mesh__D015019 1999-01-01
% 221.02/221.17  |- mesh__recordOriginator mesh__D015019 NLM
% 221.02/221.17  |- skos__prefLabel mesh__D015019 Yttrium
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D015019 2003
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D015019 2006
% 221.02/221.17  |- rdf__type mesh__D015019sskos__Concept
% 221.02/221.17  |- skos__related mesh__D015019smesh__D015020
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D015019 2005
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D015019 2002
% 221.02/221.17  |- skos__scopeNote mesh__D015019
% 221.02/221.17       An element of the rare earth family of metals. It has the atomic symbol Y, atomic number 39, and atomic weight 88.91. In conjunction with other rare earths, yttrium is used as a phosphor in television receivers and is a component of the yttrium-aluminum garnet %28%YAG%29% lasers.%A%    
% 221.02/221.17  |- skos__broader mesh__D015019smesh__D028561
% 221.02/221.17  |- skos__broader mesh__D015019smesh__D008674
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D031484 2005
% 221.02/221.17  |- mesh__dateCreated mesh__D031484 2002-07-03
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D031484 2006
% 221.02/221.17  |- mesh__historyNote mesh__D031484 2003   
% 221.02/221.17  |- mesh__dateEstablished mesh__D031484 2003-01-01
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D031484 2003
% 221.02/221.17  |- skos__altLabel mesh__D031484 Caper
% 221.02/221.17  |- skos__broader mesh__D031484smesh__D031483
% 221.02/221.17  |- mesh__publicMeSHNote mesh__D031484 2003   
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D031484 2004
% 221.02/221.17  |- skos__prefLabel mesh__D031484 Capparis
% 221.02/221.17  |- skos__annotation mesh__D031484
% 221.02/221.17       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.02/221.17  |- rdf__type mesh__D031484sskos__Concept
% 221.02/221.17  |- skos__scopeNote mesh__D031484
% 221.02/221.17       A plant genus of the family CAPPARACEAE that contains mabinlin, a sweet protein.%A%    
% 221.02/221.17  |- mesh__dateCreated mesh__D003793 1999-01-01
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D003793 2000
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D003793 2005
% 221.02/221.17  |- skos__altLabel mesh__D003793 Permanent Dental Filling
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D003793 1999
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D003793 2004
% 221.02/221.17  |- skos__altLabel mesh__D003793 Permanent Fillings, Dental
% 221.02/221.17  |- skos__altLabel mesh__D003793 Permanent Filling, Dental
% 221.02/221.17  |- skos__altLabel mesh__D003793 Restorations, Permanent Dental
% 221.02/221.17  |- skos__altLabel mesh__D003793 Restoration, Permanent Dental
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D003793 1998
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D003793 2003
% 221.02/221.17  |- skos__altLabel mesh__D003793 Filling, Permanent Dental
% 221.02/221.17  |- skos__altLabel mesh__D003793 Permanent Dental Restorations
% 221.02/221.17  |- skos__annotation mesh__D003793
% 221.02/221.17       dent restoration unspecified probably goes here; DF: DENT RESTORATION PERMANENT%A%  
% 221.02/221.17  |- skos__altLabel mesh__D003793 Dental Fillings, Permanent
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D003793 2002
% 221.02/221.17  |- mesh__recordOriginator mesh__D003793 NLM
% 221.02/221.17  |- skos__altLabel mesh__D003793 Dental Restorations, Permanent
% 221.02/221.17  |- skos__altLabel mesh__D003793 Permanent Dental Restoration
% 221.02/221.17  |- mesh__publicMeSHNote mesh__D003793 65   
% 221.02/221.17  |- skos__altLabel mesh__D003793 Fillings, Dental Permanent
% 221.02/221.17  |- skos__altLabel mesh__D003793 Permanent Dental Fillings
% 221.02/221.17  |- skos__broader mesh__D003793smesh__D003814
% 221.02/221.17  |- mesh__historyNote mesh__D003793 65   
% 221.02/221.17  |- skos__related mesh__D003793smesh__D003764
% 221.02/221.17  |- skos__altLabel mesh__D003793 Fillings, Permanent Dental
% 221.02/221.17  |- mesh__dateEstablished mesh__D003793 1965-01-01
% 221.02/221.17  |- mesh__dateRevised mesh__D003793 1997-06-20
% 221.02/221.17  |- skos__broader mesh__D003793smesh__D017266
% 221.02/221.17  |- skos__altLabel mesh__D003793 Filling, Dental Permanent
% 221.02/221.17  |- skos__scopeNote mesh__D003793
% 221.02/221.17       A restoration designed to remain in service for not less than 20 to 30 years, usually made of gold casting, cohesive gold, or amalgam. %28%Jablonski, Dictionary of Dentistry, 1992%29%%A%    
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D003793 2001
% 221.02/221.17  |- skos__related mesh__D003793smesh__D000180
% 221.02/221.17  |- rdf__type mesh__D003793sskos__Concept
% 221.02/221.17  |- mesh__recordAuthorizer mesh__D003793 SJN
% 221.02/221.17  |- mesh__recordMaintainer mesh__D003793 PXP
% 221.02/221.17  |- skos__prefLabel mesh__D003793 Dental Restoration, Permanent
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D003793 2006
% 221.02/221.17  |- skos__altLabel mesh__D003793 Dental Filling, Permanent
% 221.02/221.17  |- skos__altLabel mesh__D003793 Dental Permanent Filling
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D011427 2000
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D011427 1998
% 221.02/221.17  |- mesh__dateRevised mesh__D011427 1992-05-20
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D011427 1996
% 221.02/221.17  |- skos__broader mesh__D011427smesh__D007659
% 221.02/221.17  |- skos__prefLabel mesh__D011427 Propiophenones
% 221.02/221.17  |- mesh__recordAuthorizer mesh__D011427 PLS
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D011427 2002
% 221.02/221.17  |- mesh__dateCreated mesh__D011427 1999-01-01
% 221.02/221.17  |- mesh__recordMaintainer mesh__D011427 TAP
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D011427 2006
% 221.02/221.17  |- mesh__recordOriginator mesh__D011427 NLM
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D011427 2004
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D011427 1995
% 221.02/221.17  |- rdf__type mesh__D011427sskos__Concept
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D011427 1993
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D011427 2005
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D011427 1999
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D011427 2001
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D011427 2003
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D011427 1994
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D011427 1997
% 221.02/221.17  |- mesh__publicMeSHNote mesh__D049895 2006   
% 221.02/221.17  |- skos__annotation mesh__D049895
% 221.02/221.17       as animal %26% food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH %28%IM%29%; index oysters unspecified at OYSTERS see OSTREIDAE%A%  
% 221.02/221.17  |- mesh__dateEstablished mesh__D049895 2006-01-01
% 221.02/221.17  |- skos__altLabel mesh__D049895 Oysters, True
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D049895 2006
% 221.02/221.17  |- mesh__recordOriginator mesh__D049895 ags
% 221.02/221.17  |- mesh__recordMaintainer mesh__D049895 ags
% 221.02/221.17  |- mesh__historyNote mesh__D049895 2006   
% 221.02/221.17  |- skos__broader mesh__D049895smesh__D010125
% 221.02/221.17  |- mesh__recordAuthorizer mesh__D049895 sjn
% 221.02/221.17  |- skos__historyNote mesh__D049895 Oysters %28%1972-2005%29%
% 221.02/221.17  |- skos__prefLabel mesh__D049895 Ostrea
% 221.02/221.17  |- rdf__type mesh__D049895sskos__Concept
% 221.02/221.17  |- skos__altLabel mesh__D049895 Oyster, True
% 221.02/221.17  |- skos__scopeNote mesh__D049895
% 221.02/221.17       A genus of oysters in the family OSTREIDAE, which includes the edible true oyster, Ostrea edulis.%A%    
% 221.02/221.17  |- mesh__dateCreated mesh__D049895 2005-06-30
% 221.02/221.17  |- skos__scopeNote mesh__D016910
% 221.02/221.17       Small metal or ceramic attachments used to fasten an arch wire. These attachments are soldered or welded to an orthodontic band or cemented directly onto the teeth. Bowles brackets, edgewise brackets, multiphase brackets, ribbon arch brackets, twin-wire brackets, and universal brackets are all types of orthodontic brackets.%A%    
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016910 2005
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016910 1996
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016910 1995
% 221.02/221.17  |- mesh__dateEstablished mesh__D016910 1992-01-01
% 221.02/221.17  |- skos__historyNote mesh__D016910 Orthodontic Appliances %28%1967-1991%29%
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016910 2000
% 221.02/221.17  |- skos__hiddenLabel mesh__D016910 Bracket, Orthodontic
% 221.02/221.17  |- skos__hiddenLabel mesh__D016910 Brackets, Orthodontic
% 221.02/221.17  |- mesh__publicMeSHNote mesh__D016910 92   
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016910 2004
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016910 1994
% 221.02/221.17  |- skos__prefLabel mesh__D016910 Orthodontic Brackets
% 221.02/221.17  |- mesh__recordMaintainer mesh__D016910 TAP
% 221.02/221.17  |- rdf__type mesh__D016910sskos__Concept
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016910 1999
% 221.02/221.17  |- skos__hiddenLabel mesh__D016910 Orthodontic Bracket
% 221.02/221.17  |- skos__broader mesh__D016910smesh__D009967
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016910 2003
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016910 1993
% 221.02/221.17  |- mesh__historyNote mesh__D016910 92   
% 221.02/221.17  |- mesh__dateCreated mesh__D016910 1991-05-30
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016910 1998
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016910 2002
% 221.02/221.17  |- mesh__dateRevised mesh__D016910 1992-05-15
% 221.02/221.17  |- mesh__recordOriginator mesh__D016910 MXR
% 221.02/221.17  |- mesh__recordAuthorizer mesh__D016910 PLS
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016910 1997
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016910 2006
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016910 2001
% 221.02/221.17  |- skos__broader mesh__D016112smesh__D012873
% 221.02/221.17  |- skos__scopeNote mesh__D016112
% 221.02/221.17       Most common form of ICHTHYOSIS characterized by prominent scaling especially on the exterior surfaces of the extremities. It is inherited as an autosomal dominant trait.%A%    
% 221.02/221.17  |- skos__historyNote mesh__D016112 Ichthyosis %28%1966-1990%29%
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016112 2002
% 221.02/221.17  |- skos__altLabel mesh__D016112 Ichthyosis Vulgaris, Dominant
% 221.02/221.17  |- skos__broader mesh__D016112smesh__D007057
% 221.02/221.17  |- skos__annotation mesh__D016112
% 221.02/221.17       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016112 2006
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016112 2005
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016112 2004
% 221.02/221.17  |- skos__prefLabel mesh__D016112 Ichthyosis Vulgaris
% 221.02/221.17  |- mesh__dateEstablished mesh__D016112 1991-01-01
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016112 2003
% 221.02/221.17  |- mesh__recordMaintainer mesh__D016112 nns
% 221.02/221.17  |- rdf__type mesh__D016112sskos__Concept
% 221.02/221.17  |- mesh__recordOriginator mesh__D016112 AGS
% 221.02/221.17  |- mesh__recordAuthorizer mesh__D016112 sjn
% 221.02/221.17  |- mesh__historyNote mesh__D016112 91   
% 221.02/221.17  |- mesh__dateRevised mesh__D016112 2001-07-25
% 221.02/221.17  |- mesh__publicMeSHNote mesh__D016112 91   
% 221.02/221.17  |- mesh__dateCreated mesh__D016112 1990-02-12
% 221.02/221.17  |- skos__hiddenLabel mesh__D016112 Dominant Ichthyosis Vulgaris
% 221.02/221.17  |- skos__hiddenLabel mesh__D015818 Infection, Bacterial Ocular
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D015818 1998
% 221.02/221.17  |- mesh__recordAuthorizer mesh__D015818 PLS
% 221.02/221.17  |- mesh__publicMeSHNote mesh__D015818 90   
% 221.02/221.17  |- skos__hiddenLabel mesh__D015818 Ocular Infection, Bacterial
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D015818 2003
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D015818 1994
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D015818 1999
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D015818 2002
% 221.02/221.17  |- mesh__dateCreated mesh__D015818 1989-09-06
% 221.02/221.17  |- mesh__dateEstablished mesh__D015818 1990-01-01
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D015818 2004
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D015818 1995
% 221.02/221.17  |- mesh__dateRevised mesh__D015818 1993-05-27
% 221.02/221.17  |- skos__annotation mesh__D015818
% 221.02/221.17       coord IM with specific bact dis %28%IM%29%; DF: EYE INFECT BACT%A%  
% 221.02/221.17  |- mesh__recordOriginator mesh__D015818 EGC
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D015818 2005
% 221.02/221.17  |- skos__hiddenLabel mesh__D015818 Bacterial Ocular Infection
% 221.02/221.17  |- skos__broader mesh__D015818smesh__D015817
% 221.02/221.17  |- skos__prefLabel mesh__D015818 Eye Infections, Bacterial
% 221.02/221.17  |- skos__altLabel mesh__D015818 Bacterial Eye Infections
% 221.02/221.17  |- skos__broader mesh__D015818smesh__D001424
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D015818 2000
% 221.02/221.17  |- skos__scopeNote mesh__D015818
% 221.02/221.17       Infections in the inner or external eye caused by microorganisms belonging to several families of bacteria. Some of the more common genera found are Haemophilus, Neisseria, Staphylococcus, Streptococcus, and Chlamydia.%A%    
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D015818 2006
% 221.02/221.17  |- skos__altLabel mesh__D015818 Bacterial Ocular Infections
% 221.02/221.17  |- skos__historyNote mesh__D015818
% 221.02/221.17       specific bacterial infection %28%1966-1989%29%
% 221.02/221.17  |- skos__hiddenLabel mesh__D015818 Eye Infection, Bacterial
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D015818 1996
% 221.02/221.17  |- skos__historyNote mesh__D015818 Eye Diseases %28%1966-1989%29%
% 221.02/221.17  |- skos__hiddenLabel mesh__D015818 Bacterial Eye Infection
% 221.02/221.17  |- rdf__type mesh__D015818sskos__Concept
% 221.02/221.17  |- skos__altLabel mesh__D015818 Ocular Infections, Bacterial
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D015818 2001
% 221.02/221.17  |- skos__altLabel mesh__D015818 Infections, Bacterial Eye
% 221.02/221.17  |- skos__hiddenLabel mesh__D015818 Infection, Bacterial Eye
% 221.02/221.17  |- skos__altLabel mesh__D015818 Infections, Bacterial Ocular
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D015818 1997
% 221.02/221.17  |- mesh__recordMaintainer mesh__D015818 TGC
% 221.02/221.17  |- mesh__historyNote mesh__D015818 90   
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D012520 2004
% 221.02/221.17  |- mesh__recordOriginator mesh__D012520 NLM
% 221.02/221.17  |- skos__prefLabel mesh__D012520 Sarcoptes scabiei
% 221.02/221.17  |- mesh__recordMaintainer mesh__D012520 ags
% 221.02/221.17  |- skos__annotation mesh__D012520 infestation = SCABIES   
% 221.02/221.17  |- skos__scopeNote mesh__D012520
% 221.02/221.17       A species of mite that causes SCABIES in humans and sarcoptic mange in other animals. Specific variants of S. scabiei exist for humans and animals, but many have the ability to cross species and cause disease.%A%    
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D012520 2006
% 221.02/221.17  |- mesh__dateCreated mesh__D012520 1999-01-01
% 221.02/221.17  |- mesh__recordAuthorizer mesh__D012520 sjn
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D012520 2005
% 221.02/221.17  |- skos__broader mesh__D012520smesh__D040021
% 221.02/221.17  |- rdf__type mesh__D012520sskos__Concept
% 221.02/221.17  |- mesh__dateRevised mesh__D012520 2003-07-09
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D031485 2003
% 221.02/221.17  |- skos__broader mesh__D031485smesh__D031483
% 221.02/221.17  |- mesh__publicMeSHNote mesh__D031485 2003   
% 221.02/221.17  |- skos__scopeNote mesh__D031485
% 221.02/221.17       A plant genus of the family CAPPARACEAE that contains cleogynol and 15alpha-acetoxycleomblynol %28%dammaranes%29% and 1-epibrachyacarpone %28%a triterpene%29%, and ISOTHIOCYANATES.%A%    
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D031485 2004
% 221.02/221.17  |- skos__prefLabel mesh__D031485 Cleome
% 221.02/221.17  |- skos__annotation mesh__D031485
% 221.02/221.17       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.02/221.17  |- rdf__type mesh__D031485sskos__Concept
% 221.02/221.17  |- mesh__dateCreated mesh__D031485 2002-07-03
% 221.02/221.17  |- mesh__dateEstablished mesh__D031485 2003-01-01
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D031485 2005
% 221.02/221.17  |- mesh__historyNote mesh__D031485 2003   
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D031485 2006
% 221.02/221.17  |- skos__broader mesh__D003794smesh__D003814
% 221.02/221.17  |- mesh__dateCreated mesh__D003794 1999-01-01
% 221.02/221.17  |- mesh__publicMeSHNote mesh__D003794 65   
% 221.02/221.17  |- skos__hiddenLabel mesh__D003794 Temporary Dental Prostheses
% 221.02/221.17  |- mesh__historyNote mesh__D003794 65   
% 221.02/221.17  |- skos__altLabel mesh__D003794 Temporary Dental Fillings
% 221.02/221.17  |- skos__related mesh__D003794smesh__D003764
% 221.02/221.17  |- skos__hiddenLabel mesh__D003794 Temporary Dental Prosthesis
% 221.02/221.17  |- skos__related mesh__D003794smesh__D000180
% 221.02/221.17  |- skos__hiddenLabel mesh__D003794 Dental Prostheses, Temporary
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D003794 2002
% 221.02/221.17  |- skos__altLabel mesh__D003794 Restorations, Temporary Dental
% 221.02/221.17  |- skos__hiddenLabel mesh__D003794 Prosthesis, Temporary Dental
% 221.02/221.17  |- mesh__recordOriginator mesh__D003794 NLM
% 221.02/221.17  |- rdf__type mesh__D003794sskos__Concept
% 221.02/221.17  |- skos__annotation mesh__D003794
% 221.02/221.17       dent restoration unspecified probably goes under DENTAL RESTORATION, PERMANENT; DF: DENT RESTORATION TEMPORARY%A%  
% 221.02/221.17  |- mesh__recordMaintainer mesh__D003794 jls
% 221.02/221.17  |- skos__altLabel mesh__D003794 Temporary Dental Restorations
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D003794 2003
% 221.02/221.17  |- skos__broader mesh__D003794smesh__D017266
% 221.02/221.17  |- skos__scopeNote mesh__D003794
% 221.02/221.17       A prosthesis or restoration placed for a limited period, from several days to several months, which is designed to seal the tooth and maintain its position until a permanent restoration %28%DENTAL RESTORATION, PERMANENT%29% will replace it. %28%From Jablonski, Dictionary of Dentistry, 1992%29%%A%    
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D003794 2005
% 221.02/221.17  |- skos__altLabel mesh__D003794 Dental Restorations, Temporary
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D003794 2000
% 221.02/221.17  |- mesh__dateEstablished mesh__D003794 1965-01-01
% 221.02/221.17  |- mesh__dateRevised mesh__D003794 1999-11-04
% 221.02/221.17  |- skos__altLabel mesh__D003794 Fillings, Temporary Dental
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D003794 2004
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D003794 2001
% 221.02/221.17  |- skos__altLabel mesh__D003794 Restoration, Temporary Dental
% 221.02/221.17  |- skos__altLabel mesh__D003794 Dental Filling, Temporary
% 221.02/221.17  |- skos__altLabel mesh__D003794 Temporary Dental Restoration
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D003794 2006
% 221.02/221.17  |- skos__altLabel mesh__D003794 Temporary Dental Filling
% 221.02/221.17  |- skos__prefLabel mesh__D003794 Dental Restoration, Temporary
% 221.02/221.17  |- mesh__recordAuthorizer mesh__D003794 sjn
% 221.02/221.17  |- skos__altLabel mesh__D003794 Filling, Temporary Dental
% 221.02/221.17  |- skos__historyNote mesh__D044602 Glucosidases %28%1966-2003%29%
% 221.02/221.17  |- skos__hiddenLabel mesh__D044602 beta Glucosidases
% 221.02/221.17  |- skos__hiddenLabel mesh__D044602 Systems, Cellulase Enzyme
% 221.02/221.17  |- skos__hiddenLabel mesh__D044602 Enzyme Systems, Cellulase
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D044602 2006
% 221.02/221.17  |- rdf__type mesh__D044602sskos__Concept
% 221.02/221.17  |- mesh__dateCreated mesh__D044602 2003-07-09
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D044602 2005
% 221.02/221.17  |- skos__altLabel mesh__D044602 Exocellulase
% 221.02/221.17  |- mesh__publicMeSHNote mesh__D044602
% 221.02/221.17       2004; for BETA-GLUCOSIDASES see BETA-GLUCOSIDASE 1991-2003; for LAMINARINASE use GLUCAN ENDO-1,3-BETA-GLUCOSIDASE 1974-2003; EXO-CELLULASE was indexed under CELLULASE 1991-2003; EXOCELLULASE was indexed under CELLULASE 2001-2003;  AVICELASE was indexed under CELLULASE 1996-2003; AVICELASE II was indexed under CELLULASE 1997-2003%A%  
% 221.02/221.17  |- mesh__historyNote mesh__D044602
% 221.02/221.17       2004; for BETA-GLUCOSIDASES use BETA-GLUCOSIDASE 1992-2003; for LAMINARINASE use GLUCAN ENDO-1,3-BETA-GLUCOSIDASE 1980-2003; for EXO-CELLULASE use CELLULOSE 1,4-BETA-CELLOBIOSIDASE %28%NM%29% 1991-2003; for EXOCELLULASE use CELLULOSE 1,4-BETA-CELLOBIOSIDASE %28%NM%29% 2001-2003; for AVICELASE use CELLULOSE 1,4-BETA-CELLOBIOSIDASE %28%NM%29% 1996-2003;  for AVICELASE II use CELLULOSE 1,4-BETA-CELLOBIOSIDASE %28%NM%29% 1997-2003%A%  
% 221.02/221.17  |- skos__hiddenLabel mesh__D044602 Enzyme System, Cellulase
% 221.02/221.17  |- skos__prefLabel mesh__D044602 Cellulases
% 221.02/221.17  |- skos__altLabel mesh__D044602 Cellulase Enzyme System
% 221.02/221.17  |- skos__annotation mesh__D044602 CELLULASE is also available   
% 221.02/221.17  |- skos__scopeNote mesh__D044602
% 221.02/221.17       A family of glycosidases that hydrolyse crystalline CELLULOSE into soluble sugar molecules. Within this family there are a variety of enzyme subtypes with differing substrate specificities that must work together to bring about complete cellulose hydrolysis. They are found in structures called CELLULOSOMES.%A%    
% 221.02/221.17  |- skos__altLabel mesh__D044602 Exo-cellulase
% 221.02/221.17  |- mesh__recordAuthorizer mesh__D044602 jls
% 221.02/221.17  |- skos__hiddenLabel mesh__D044602 Exo cellulase
% 221.02/221.17  |- skos__broader mesh__D044602smesh__D005959
% 221.02/221.17  |- mesh__dateEstablished mesh__D044602 2004-01-01
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D044602 2005A
% 221.02/221.17  |- skos__altLabel mesh__D044602 Endocellulase
% 221.02/221.17  |- mesh__recordMaintainer mesh__D044602 jls
% 221.02/221.17  |- mesh__dateRevised mesh__D044602 2004-07-27
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D044602 2004
% 221.02/221.17  |- mesh__recordOriginator mesh__D044602 jmp
% 221.02/221.17  |- skos__altLabel mesh__D011428 Proplast I
% 221.02/221.17  |- mesh__historyNote mesh__D011428
% 221.02/221.17       91%28%80%29%; was see under POLYTETRAFLUOROETHYLENE 1980-90   
% 221.02/221.17  |- mesh__dateRevised mesh__D011428 2004-07-07
% 221.02/221.17  |- mesh__recordAuthorizer mesh__D011428 sjn
% 221.02/221.17  |- skos__broader mesh__D011428smesh__D011138
% 221.02/221.17  |- skos__historyNote mesh__D011428 Fluorocarbon Polymers %28%1966-1972%29%
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D011428 2006
% 221.02/221.17  |- mesh__recordMaintainer mesh__D011428 jmp
% 221.02/221.17  |- rdf__type mesh__D011428sskos__Concept
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D011428 2005
% 221.02/221.17  |- skos__historyNote mesh__D011428 Carbon %28%1966-1979%29%
% 221.02/221.17  |- skos__prefLabel mesh__D011428 Proplast
% 221.02/221.17  |- skos__annotation mesh__D011428
% 221.02/221.17       a polymer used in reconstruct surg; D25-26 qualif   
% 221.02/221.17  |- skos__scopeNote mesh__D011428
% 221.02/221.17       Polymer of polytetrafluoroethylene and carbon filaments; porous biocompatible material used in orofacial and middle ear reconstruction and as coating for metal implants.%A%    
% 221.02/221.17  |- mesh__recordOriginator mesh__D011428 SH
% 221.02/221.17  |- skos__hiddenLabel mesh__D011428 I, Proplast
% 221.02/221.17  |- skos__historyNote mesh__D011428
% 221.02/221.17       Polytetrafluoroethylene %28%1973-1979%29%
% 221.02/221.17  |- mesh__dateCreated mesh__D011428 1979-05-30
% 221.02/221.17  |- mesh__dateEstablished mesh__D011428 1991-01-01
% 221.02/221.17  |- mesh__publicMeSHNote mesh__D011428
% 221.02/221.17       91; was see under POLYTETRAFLUOROETHYLENE 1980-90   
% 221.02/221.17  |- rdf__type mesh__D049896sskos__Concept
% 221.02/221.17  |- mesh__recordMaintainer mesh__D049896 ags
% 221.02/221.17  |- skos__altLabel mesh__D049896 Oysters, Eastern
% 221.02/221.17  |- mesh__dateCreated mesh__D049896 2005-06-30
% 221.02/221.17  |- mesh__dateEstablished mesh__D049896 2006-01-01
% 221.02/221.17  |- skos__annotation mesh__D049896
% 221.02/221.17       as animal %26% food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH %28%IM%29%%A%  
% 221.02/221.17  |- mesh__historyNote mesh__D049896 2006   
% 221.02/221.17  |- mesh__recordAuthorizer mesh__D049896 sjn
% 221.02/221.17  |- mesh__publicMeSHNote mesh__D049896 2006   
% 221.02/221.17  |- mesh__recordOriginator mesh__D049896 ags
% 221.02/221.17  |- skos__broader mesh__D049896smesh__D010125
% 221.02/221.17  |- skos__prefLabel mesh__D049896 Crassostrea
% 221.02/221.17  |- skos__historyNote mesh__D049896 Mollusca %28%1966-2005%29%
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D049896 2006
% 221.02/221.17  |- skos__historyNote mesh__D049896 Oysters %28%1971-2005%29%
% 221.02/221.17  |- skos__scopeNote mesh__D049896
% 221.02/221.17       A genus of oysters in the family OSTREIDAE, class BIVALVIA.%A%    
% 221.02/221.17  |- skos__altLabel mesh__D049896 Oyster, Eastern
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016911 2006
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016911 2000
% 221.02/221.17  |- skos__annotation mesh__D016911
% 221.02/221.17       a depersonalization disord; do not confuse with KURU, a neurol dis; specify ethnic group %28%IM%29% if pertinent; check tag MALE%A%  
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016911 2005
% 221.02/221.17  |- mesh__dateEstablished mesh__D016911 1992-01-01
% 221.02/221.17  |- mesh__recordAuthorizer mesh__D016911 SJN
% 221.02/221.17  |- skos__historyNote mesh__D016911
% 221.02/221.17       Depersonalization Disorder %28%1969-1991%29%
% 221.02/221.17  |- rdf__type mesh__D016911sskos__Concept
% 221.02/221.17  |- mesh__publicMeSHNote mesh__D016911 92   
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016911 2004
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016911 1999
% 221.02/221.17  |- mesh__dateCreated mesh__D016911 1991-05-30
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016911 2003
% 221.02/221.17  |- skos__scopeNote mesh__D016911
% 221.02/221.17       A culture-specific acute delusional syndrome occurring mostly in the Malay people and Southern Chinese. The syndrome is characterized by the individual%27%s sudden experience of depersonalization depicted by the belief that his penis is shrinking into his abdomen and that he will die when this occurs. Although generally classified as a culture-specific syndrome, koro may be no more than a variant of castration anxiety %28%ANXIETY, CASTRATION%29% as it has been described in non-Asian patients.%A%    
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016911 1998
% 221.02/221.17  |- skos__prefLabel mesh__D016911 Koro
% 221.02/221.17  |- skos__historyNote mesh__D016911 Anxiety, Castration %28%1976-1991%29%
% 221.02/221.17  |- mesh__recordOriginator mesh__D016911 MXR
% 221.02/221.17  |- mesh__historyNote mesh__D016911 92   
% 221.02/221.17  |- mesh__recordMaintainer mesh__D016911 JLS
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016911 2002
% 221.02/221.17  |- mesh__dateRevised mesh__D016911 1997-06-20
% 221.02/221.17  |- skos__historyNote mesh__D016911 Delusions %28%1983-1991%29%
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016911 2001
% 221.02/221.17  |- skos__broader mesh__D016911smesh__D001009
% 221.02/221.17  |- skos__altLabel mesh__D016113 Congenital Ichthyosiform Erythroderma
% 221.02/221.17  |- mesh__recordAuthorizer mesh__D016113 sjn
% 221.02/221.17  |- mesh__dateRevised mesh__D016113 2001-07-25
% 221.02/221.17  |- mesh__publicMeSHNote mesh__D016113 91   
% 221.02/221.17  |- skos__prefLabel mesh__D016113 Ichthyosiform Erythroderma, Congenital
% 221.02/221.17  |- mesh__dateCreated mesh__D016113 1990-02-12
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016113 2006
% 221.02/221.17  |- skos__annotation mesh__D016113
% 221.02/221.17       an ichthyosis rather than an erythroderma; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016113 2005
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016113 2004
% 221.02/221.17  |- skos__historyNote mesh__D016113 Ichthyosis %28%1966-1990%29%
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016113 2002
% 221.02/221.17  |- mesh__dateEstablished mesh__D016113 1991-01-01
% 221.02/221.17  |- skos__scopeNote mesh__D016113
% 221.02/221.17       Designation for several severe forms of ichthyosis, present at birth, that are characterized by hyperkeratotic scaling. Infants may be born encased in a collodion membrane which begins shedding within 24 hours. This is followed in about two weeks by persistent generalized scaling. The forms include bullous %28%HYPERKERATOSIS, EPIDERMOLYTIC%29%, non-bullous %28%ICHTHYOSIS, LAMELLAR%29%, wet type, and dry type.%A%    
% 221.02/221.17  |- skos__broader mesh__D016113smesh__D007057
% 221.02/221.17  |- skos__hiddenLabel mesh__D016113 Ichthyosiform Erythrodermas, Congenital
% 221.02/221.17  |- mesh__activeMeSHYear mesh__D016113 2003
% 221.02/221.17  |- rdf__type mesh__D016113sskos__Concept
% 221.02/221.17  |- skos__hiddenLabel mesh__D016113 Congenital Ichthyosiform Erythrodermas
% 221.02/221.18  |- mesh__historyNote mesh__D016113 91   
% 221.02/221.18  |- skos__altLabel mesh__D016113 Erythroderma, Congenital Ichthyosiform
% 221.02/221.18  |- skos__broader mesh__D016113smesh__D012873
% 221.02/221.18  |- skos__hiddenLabel mesh__D016113 Erythrodermas, Congenital Ichthyosiform
% 221.02/221.18  |- mesh__recordMaintainer mesh__D016113 nns
% 221.02/221.18  |- mesh__recordOriginator mesh__D016113 AGS
% 221.02/221.18  |- skos__altLabel mesh__D007387
% 221.02/221.18       Coronary-Internal Mammary Artery Anastomosis
% 221.02/221.18  |- mesh__dateCreated mesh__D007387 1974-12-12
% 221.02/221.18  |- skos__scopeNote mesh__D007387
% 221.02/221.18       Direct myocardial revascularization in which the internal mammary artery is anastomosed to the right coronary artery, circumflex artery, or anterior descending coronary artery. The internal mammary artery is the most frequent choice, especially for a single graft, for coronary artery bypass surgery.%A%    
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D007387 1999
% 221.02/221.18  |- mesh__publicMeSHNote mesh__D007387
% 221.02/221.18       88; was see under MYOCARDIAL REVASCULARIZATION 1975-87   
% 221.02/221.18  |- mesh__recordAuthorizer mesh__D007387 SJN
% 221.02/221.18  |- skos__prefLabel mesh__D007387
% 221.02/221.18       Internal Mammary-Coronary Artery Anastomosis
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D007387 2003
% 221.02/221.18  |- rdf__type mesh__D007387sskos__Concept
% 221.02/221.18  |- skos__altLabel mesh__D007387
% 221.02/221.18       Internal Mammary Coronary Artery Anastomosis
% 221.02/221.18  |- skos__altLabel mesh__D007387
% 221.02/221.18       Anastomosis, Internal Mammary-Coronary Artery
% 221.02/221.18  |- mesh__historyNote mesh__D007387
% 221.02/221.18       88%28%75%29%; was see under MYOCARDIAL REVASCULARIZATION 1975-87%A%  
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D007387 2000
% 221.02/221.18  |- skos__hiddenLabel mesh__D007387
% 221.02/221.18       Coronary Internal Mammary Artery Anastomosis
% 221.02/221.18  |- mesh__dateRevised mesh__D007387 1997-06-20
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D007387 2004
% 221.02/221.18  |- mesh__recordOriginator mesh__D007387 NLM
% 221.02/221.18  |- mesh__dateEstablished mesh__D007387 1988-01-01
% 221.02/221.18  |- skos__annotation mesh__D007387
% 221.02/221.18       do not use /util except by MeSH definition; DF: IMA ANASTOMOSIS%A%  
% 221.02/221.18  |- mesh__recordMaintainer mesh__D007387 PXP
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D007387 2001
% 221.02/221.18  |- skos__hiddenLabel mesh__D007387
% 221.02/221.18       Anastomosis, Internal Mammary Coronary Artery
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D007387 2005
% 221.02/221.18  |- skos__broader mesh__D007387smesh__D001026
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D007387 2002
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D007387 2006
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D007387 1998
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D015819 2000
% 221.02/221.18  |- skos__hiddenLabel mesh__D015819 Drug User, IV
% 221.02/221.18  |- mesh__dateCreated mesh__D015819 1989-06-20
% 221.02/221.18  |- mesh__dateEstablished mesh__D015819 1990-01-01
% 221.02/221.18  |- mesh__historyNote mesh__D015819 90   
% 221.02/221.18  |- skos__altLabel mesh__D015819 Drug Abuse, Intravenous
% 221.02/221.18  |- mesh__publicMeSHNote mesh__D015819 90   
% 221.02/221.18  |- skos__related mesh__D015819smesh__D016485
% 221.02/221.18  |- skos__related mesh__D015819smesh__D018671
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D015819 2002
% 221.02/221.18  |- mesh__recordMaintainer mesh__D015819 adp
% 221.02/221.18  |- mesh__recordAuthorizer mesh__D015819 sjn
% 221.02/221.18  |- skos__historyNote mesh__D015819
% 221.02/221.18       Injections, Intravenous %28%1966-1989%29%
% 221.02/221.18  |- skos__scopeNote mesh__D015819
% 221.02/221.18       Abuse, overuse, or misuse of a substance by its injection into a vein.%A%    
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D015819 2006
% 221.02/221.18  |- skos__hiddenLabel mesh__D015819 User, IV Drug
% 221.02/221.18  |- skos__hiddenLabel mesh__D015819 Parenteral Drug Abuse
% 221.02/221.18  |- skos__broader mesh__D015819smesh__D019966
% 221.02/221.18  |- skos__historyNote mesh__D015819 Substance Abuse %28%1966-1989%29%
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D015819 2005
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D015819 2004
% 221.02/221.18  |- skos__prefLabel mesh__D015819 Substance Abuse, Intravenous
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D015819 2001
% 221.02/221.18  |- skos__hiddenLabel mesh__D015819 Intravenous Substance Abuse
% 221.02/221.18  |- skos__hiddenLabel mesh__D015819 Users, IV Drug
% 221.02/221.18  |- skos__hiddenLabel mesh__D015819 IV Drug User
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D015819 2003
% 221.02/221.18  |- mesh__recordOriginator mesh__D015819 AGS
% 221.02/221.18  |- rdf__type mesh__D015819sskos__Concept
% 221.02/221.18  |- mesh__dateRevised mesh__D015819 1999-11-03
% 221.02/221.18  |- skos__annotation mesh__D015819
% 221.02/221.18       IM + specific drug or substance IM %28%without qualif%29%; for %22%abuse, overuse or misuse%22%; DF: IVDA%A%  
% 221.02/221.18  |- skos__hiddenLabel mesh__D015819 Drug Users, IV
% 221.02/221.18  |- skos__hiddenLabel mesh__D026541 Heymanns Antigen
% 221.02/221.18  |- skos__broader mesh__D026541smesh__D001324
% 221.02/221.18  |- skos__related mesh__D026541smesh__D005921
% 221.02/221.18  |- skos__hiddenLabel mesh__D026541 Heyman Nephritis Antigen
% 221.02/221.18  |- skos__altLabel mesh__D026541 Heymann%27%s Antigen
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D026541 2006
% 221.02/221.18  |- skos__altLabel mesh__D026541 Nephritis Antigen, Heyman
% 221.02/221.18  |- mesh__publicMeSHNote mesh__D026541
% 221.02/221.18       2002; NEPHRITIS ANTIGEN, HEYMAN now HEYMANN NEPHRITIS ANTIGENIC COMPLEX was indexed under MEMBRANE GLYCOPROTEINS 1989-2001 %26% under ANTIGENS, SURFACE 1986-1988%A%  
% 221.02/221.18  |- skos__historyNote mesh__D026541 Membrane Glycoproteins %28%1989-2001%29%
% 221.02/221.18  |- skos__annotation mesh__D026541
% 221.02/221.18       HEYMANN NEPHRITIS ANTIGEN GP330 see LDL-RECEPTOR RELATED PROTEIN 2 is also available%A%  
% 221.02/221.18  |- skos__hiddenLabel mesh__D026541
% 221.02/221.18       Receptor Associated Protein, Heymann Nephritis
% 221.02/221.18  |- rdf__type mesh__D026541sskos__Concept
% 221.02/221.18  |- skos__prefLabel mesh__D026541 Heymann Nephritis Antigenic Complex
% 221.02/221.18  |- mesh__dateRevised mesh__D026541 2005-06-30
% 221.02/221.18  |- skos__hiddenLabel mesh__D026541 Heymann Antigen
% 221.02/221.18  |- mesh__recordMaintainer mesh__D026541 ssb
% 221.02/221.18  |- mesh__recordOriginator mesh__D026541 jmp
% 221.02/221.18  |- mesh__dateCreated mesh__D026541 2001-07-25
% 221.02/221.18  |- skos__historyNote mesh__D026541 Antigens, Surface %28%1986-1988%29%
% 221.02/221.18  |- mesh__recordAuthorizer mesh__D026541 sjn
% 221.02/221.18  |- skos__scopeNote mesh__D026541
% 221.02/221.18       A complex of antigenic proteins obtained from the brush border of kidney tubules. It contains two principal components LDL-RECEPTOR RELATED PROTEIN 2 and LDL-RECEPTOR RELATED PROTEIN-ASSOCIATED PROTEIN. The name of this complex is derived from researcher, Dr. Walter Heymann, who developed an experimental model of membranous glomerulonephritis %28%GLOMERULONEPHRITIS%29% by injecting this antigenic complex into rats to induce an autoimmune response.%A%    
% 221.02/221.18  |- skos__altLabel mesh__D026541
% 221.02/221.18       Receptor-Associated Protein, Heymann Nephritis
% 221.02/221.18  |- mesh__dateEstablished mesh__D026541 2002-01-01
% 221.02/221.18  |- skos__altLabel mesh__D026541 Nephritogenic Antigen
% 221.02/221.18  |- mesh__historyNote mesh__D026541
% 221.02/221.18       2002; use HEYMANN NEPHRITIS ANTIGENIC COMPLEX %28%NM%29% 1983-2001%A%  
% 221.02/221.18  |- mesh__recordAuthorizer mesh__D012521 sjn
% 221.02/221.18  |- skos__hiddenLabel mesh__D012521 Sarcosinate, Sodium
% 221.02/221.18  |- mesh__recordOriginator mesh__D012521 NLM
% 221.02/221.18  |- skos__hiddenLabel mesh__D012521 Sarcosylate, Magnesium
% 221.02/221.18  |- mesh__recordMaintainer mesh__D012521 jmp
% 221.02/221.18  |- skos__prefLabel mesh__D012521 Sarcosine
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D012521 2006
% 221.02/221.18  |- mesh__dateCreated mesh__D012521 1999-01-01
% 221.02/221.18  |- skos__broader mesh__D012521smesh__D034442
% 221.02/221.18  |- mesh__historyNote mesh__D012521
% 221.02/221.18       68; was see under GLYCINE 1963-67; METHYLGLYCINE was heading 1963-95 %28%see under GLYCINE 1963-67%29%%A%  
% 221.02/221.18  |- skos__hiddenLabel mesh__D012521 N Methylglycine
% 221.02/221.18  |- mesh__dateRevised mesh__D012521 2005-06-30
% 221.02/221.18  |- rdf__type mesh__D012521sskos__Concept
% 221.02/221.18  |- skos__scopeNote mesh__D012521
% 221.02/221.18       An amino acid intermediate in the metabolism of choline.%A%    
% 221.02/221.18  |- mesh__onlineNote mesh__D012521 search GLYCINE 1966-67   
% 221.02/221.18  |- mesh__publicMeSHNote mesh__D012521
% 221.02/221.18       68; was see under GLYCINE 1963-67; METHYLGLYCINE was heading 1963-95 %28%see under GLYCINE 1963-67%29%%A%  
% 221.02/221.18  |- skos__altLabel mesh__D012521 N-Methylglycine
% 221.02/221.18  |- skos__historyNote mesh__D012521 Glycine %28%1966-1967%29%
% 221.02/221.18  |- mesh__dateEstablished mesh__D012521 1968-01-01
% 221.02/221.18  |- skos__altLabel mesh__D012521 Methylglycine
% 221.02/221.18  |- skos__hiddenLabel mesh__D050640 Humpback Whales
% 221.02/221.18  |- mesh__dateEstablished mesh__D050640 2006-01-01
% 221.02/221.18  |- skos__scopeNote mesh__D050640
% 221.02/221.18       The species Megaptera novaeangliae, in the family Balaenopteridae, characterized by its huge flippers and the arching of their back when diving. They are also known for their breaching and singing.%A%    
% 221.02/221.18  |- skos__hiddenLabel mesh__D050640 Whales, Humpback
% 221.02/221.18  |- mesh__dateCreated mesh__D050640 2005-06-30
% 221.02/221.18  |- mesh__recordMaintainer mesh__D050640 ags
% 221.02/221.18  |- rdf__type mesh__D050640sskos__Concept
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D050640 2006
% 221.02/221.18  |- mesh__publicMeSHNote mesh__D050640 2006; see WHALES 1998-2005   
% 221.02/221.18  |- mesh__recordAuthorizer mesh__D050640 sjn
% 221.02/221.18  |- mesh__recordOriginator mesh__D050640 ags
% 221.02/221.18  |- skos__broader mesh__D050640smesh__D014907
% 221.02/221.18  |- skos__prefLabel mesh__D050640 Humpback Whale
% 221.02/221.18  |- skos__historyNote mesh__D050640 Whales %28%1978-2005%29%
% 221.02/221.18  |- mesh__historyNote mesh__D050640 2006; use WHALES 1998-2005   
% 221.02/221.18  |- skos__altLabel mesh__D050640 Megaptera novaeangliae
% 221.02/221.18  |- skos__hiddenLabel mesh__D050640 Whale, Humpback
% 221.02/221.18  |- rdf__type mesh__D003795sskos__Concept
% 221.02/221.18  |- skos__altLabel mesh__D003795 Dental Follicle
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D003795 2005
% 221.02/221.18  |- mesh__recordAuthorizer mesh__D003795 sjn
% 221.02/221.18  |- skos__altLabel mesh__D003795 Dental Follicles
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D003795 2004
% 221.02/221.18  |- skos__prefLabel mesh__D003795 Dental Sac
% 221.02/221.18  |- mesh__historyNote mesh__D003795
% 221.02/221.18       91%28%75%29%; was see under TOOTH GERM 1975-90   
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D003795 2006
% 221.02/221.18  |- skos__scopeNote mesh__D003795
% 221.02/221.18       Dense fibrous layer formed from mesodermal tissue that surrounds the epithelial enamel organ. The cells eventually migrate to the external surface of the newly formed root dentin and give rise to the cementoblasts that deposit cementum on the developing root, fibroblasts of the developing periodontal ligament, and osteoblasts of the developing alveolar bone.%A%    
% 221.02/221.18  |- mesh__dateCreated mesh__D003795 1999-01-01
% 221.02/221.18  |- mesh__recordMaintainer mesh__D003795 lkt
% 221.02/221.18  |- skos__altLabel mesh__D003795 Follicles, Dental
% 221.02/221.18  |- mesh__onlineNote mesh__D003795 search TOOTH GERM 1966-74   
% 221.02/221.18  |- mesh__publicMeSHNote mesh__D003795
% 221.02/221.18       91; was see under TOOTH GERM 1975-90   
% 221.02/221.18  |- skos__broader mesh__D003795smesh__D014083
% 221.02/221.18  |- skos__altLabel mesh__D003795 Sacs, Dental
% 221.02/221.18  |- mesh__recordOriginator mesh__D003795 NLM
% 221.02/221.18  |- skos__altLabel mesh__D003795 Sac, Dental
% 221.02/221.18  |- mesh__dateRevised mesh__D003795 2003-07-09
% 221.02/221.18  |- skos__altLabel mesh__D003795 Dental Sacs
% 221.02/221.18  |- mesh__dateEstablished mesh__D003795 1991-01-01
% 221.02/221.18  |- skos__altLabel mesh__D003795 Follicle, Dental
% 221.02/221.18  |- mesh__dateEstablished mesh__D044603 2004-01-01
% 221.02/221.18  |- mesh__historyNote mesh__D044603 2004   
% 221.02/221.18  |- skos__prefLabel mesh__D044603 Cellulosomes
% 221.02/221.18  |- skos__scopeNote mesh__D044603
% 221.02/221.18       Extracellular structures found in a variety of microorganisms. They contain CELLULASES and play an important role in the digestion of CELLULOSE.%A%    
% 221.02/221.18  |- mesh__publicMeSHNote mesh__D044603 2004   
% 221.02/221.18  |- skos__hiddenLabel mesh__D044603 Cellulosome
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D044603 2004
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D044603 2006
% 221.02/221.18  |- rdf__type mesh__D044603sskos__Concept
% 221.02/221.18  |- skos__broader mesh__D044603smesh__D022081
% 221.02/221.18  |- mesh__dateCreated mesh__D044603 2003-07-09
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D044603 2005
% 221.02/221.18  |- mesh__recordAuthorizer mesh__D008480 sjn
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D008480 2003
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D008480 2001
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D008480 2005
% 221.02/221.18  |- skos__scopeNote mesh__D008480
% 221.02/221.18       Inflammation of the mediastinum, the area between the pleural sacs.%A%    
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D008480 2004
% 221.02/221.18  |- mesh__recordMaintainer mesh__D008480 KEV
% 221.02/221.18  |- skos__altLabel mesh__D008480 Mediastinum Inflammation
% 221.02/221.18  |- skos__broader mesh__D008480smesh__D008477
% 221.02/221.18  |- skos__hiddenLabel mesh__D008480 Inflammations, Mediastinum
% 221.02/221.18  |- skos__hiddenLabel mesh__D008480 Mediastinitides
% 221.02/221.18  |- mesh__recordOriginator mesh__D008480 NLM
% 221.02/221.18  |- skos__hiddenLabel mesh__D008480 Inflammation, Mediastinum
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D008480 2006
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D008480 2002
% 221.02/221.18  |- mesh__dateCreated mesh__D008480 1999-01-01
% 221.02/221.18  |- skos__hiddenLabel mesh__D008480 Mediastinum Inflammations
% 221.02/221.18  |- rdf__type mesh__D008480sskos__Concept
% 221.02/221.18  |- skos__prefLabel mesh__D008480 Mediastinitis
% 221.02/221.18  |- mesh__dateRevised mesh__D008480 1999-11-04
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D008480 2000
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D011429 2006
% 221.02/221.18  |- mesh__recordMaintainer mesh__D011429 ssb
% 221.02/221.18  |- skos__hiddenLabel mesh__D011429 Glue, Bee
% 221.02/221.18  |- rdf__type mesh__D011429sskos__Concept
% 221.02/221.18  |- skos__altLabel mesh__D011429 Bee Glue
% 221.02/221.18  |- skos__hiddenLabel mesh__D011429 Bread, Bee
% 221.02/221.18  |- mesh__recordAuthorizer mesh__D011429 sjn
% 221.02/221.18  |- mesh__dateRevised mesh__D011429 2005-06-30
% 221.02/221.18  |- skos__altLabel mesh__D011429 Bee Bread
% 221.02/221.18  |- mesh__publicMeSHNote mesh__D011429 91; was see under RESINS 1979-90   
% 221.02/221.18  |- mesh__recordOriginator mesh__D011429 SH
% 221.02/221.18  |- mesh__historyNote mesh__D011429
% 221.02/221.18       91%28%79%29%; was see under RESINS 1979-90   
% 221.02/221.18  |- skos__broader mesh__D011429smesh__D012116
% 221.02/221.18  |- skos__historyNote mesh__D011429 Bees %28%1966-1978%29%
% 221.02/221.18  |- mesh__dateEstablished mesh__D011429 1991-01-01
% 221.02/221.18  |- skos__prefLabel mesh__D011429 Propolis
% 221.02/221.18  |- skos__scopeNote mesh__D011429
% 221.02/221.18       A resinous substance obtained from beehives that is used traditionally as an antimicrobial.  It is a heterogeneous mixture of many substances.%A%    
% 221.02/221.18  |- skos__historyNote mesh__D011429 Resins %28%1966-1978%29%
% 221.02/221.18  |- mesh__dateCreated mesh__D011429 1977-12-09
% 221.02/221.18  |- mesh__dateCreated mesh__D049897 2005-06-30
% 221.02/221.18  |- mesh__publicMeSHNote mesh__D049897 2006   
% 221.02/221.18  |- skos__prefLabel mesh__D049897 Pectinidae
% 221.02/221.18  |- mesh__dateEstablished mesh__D049897 2006-01-01
% 221.02/221.18  |- skos__broader mesh__D049897smesh__D049872
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D049897 2006
% 221.02/221.18  |- skos__scopeNote mesh__D049897
% 221.02/221.18       A large family of mollusks in the class BIVALVIA, known commonly as scallops. They possess flat, almost circular shells and are found in all seas from shallow water to great depths.%A%    
% 221.02/221.18  |- skos__annotation mesh__D049897
% 221.02/221.18       as animal %26% food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH %28%IM%29%%A%  
% 221.02/221.18  |- mesh__historyNote mesh__D049897 2006   
% 221.02/221.18  |- mesh__recordAuthorizer mesh__D049897 sjn
% 221.02/221.18  |- mesh__recordOriginator mesh__D049897 ags
% 221.02/221.18  |- mesh__recordMaintainer mesh__D049897 ags
% 221.02/221.18  |- rdf__type mesh__D049897sskos__Concept
% 221.02/221.18  |- skos__historyNote mesh__D049897 Mollusca %28%1966-2005%29%
% 221.02/221.18  |- skos__altLabel mesh__D049897 Scallops
% 221.02/221.18  |- skos__altLabel mesh__D016912 Schering Brand 1 of Levonorgestrel
% 221.02/221.18  |- skos__altLabel mesh__D016912 Alcala Brand of Levonorgestrel
% 221.02/221.18  |- skos__altLabel mesh__D016912 Schering Brand 3 of Levonorgestrel
% 221.02/221.18  |- skos__altLabel mesh__D016912 Microval
% 221.02/221.18  |- skos__hiddenLabel mesh__D016912 D Norgestrel
% 221.02/221.18  |- mesh__publicMeSHNote mesh__D016912
% 221.02/221.18       1992; LEVONORGESTREL was indexed under NORGESTREL 1980-1991; for D-NORGESTREL use NORGESTREL 1978-2001%A%  
% 221.02/221.18  |- skos__altLabel mesh__D016912 HRA Brand 1 of Levonorgestrel
% 221.02/221.18  |- skos__altLabel mesh__D016912 Wyeth Brand of Levonorgestrel
% 221.02/221.18  |- skos__hiddenLabel mesh__D016912 Norplant2
% 221.02/221.18  |- skos__altLabel mesh__D016912 Women%27%s Capital Brand of Levonorgestrel
% 221.02/221.18  |- mesh__historyNote mesh__D016912
% 221.02/221.18       1992; use LEVONORGESTREL %28%NM%29% 1980-1991; for D-NORGESTREL use NORGESTREL 1978-2001%A%  
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D016912 2006
% 221.02/221.18  |- mesh__dateCreated mesh__D016912 1991-05-30
% 221.02/221.18  |- mesh__recordMaintainer mesh__D016912 CCR
% 221.02/221.18  |- mesh__dateEstablished mesh__D016912 1992-01-01
% 221.02/221.18  |- skos__altLabel mesh__D016912 Hexal Brand of Levonorgestrel
% 221.02/221.18  |- mesh__recordAuthorizer mesh__D016912 sjn
% 221.02/221.18  |- skos__altLabel mesh__D016912 Schering Brand 2 of Levonorgestrel
% 221.02/221.18  |- rdf__type mesh__D016912sskos__Concept
% 221.02/221.18  |- skos__prefLabel mesh__D016912 Levonorgestrel
% 221.02/221.18  |- skos__altLabel mesh__D016912 Aventis Pharma Brand of Levonorgestrel
% 221.02/221.18  |- skos__altLabel mesh__D016912 D-Norgestrel
% 221.02/221.18  |- mesh__recordOriginator mesh__D016912 PLS
% 221.02/221.18  |- skos__hiddenLabel mesh__D016912 Levonorgestrel Wyeth Brand
% 221.02/221.18  |- skos__hiddenLabel mesh__D016912 Levonorgestrel Hexal Brand
% 221.02/221.18  |- mesh__dateRevised mesh__D016912 2004-07-07
% 221.02/221.18  |- skos__hiddenLabel mesh__D016912 Levonorgestrel Berlex Brand
% 221.02/221.18  |- skos__altLabel mesh__D016912 HRA Brand 2 of Levonorgestrel
% 221.02/221.18  |- skos__altLabel mesh__D016912 Berlex Brand of Levonorgestrel
% 221.02/221.18  |- skos__broader mesh__D016912smesh__D009644
% 221.02/221.18  |- skos__hiddenLabel mesh__D016912 Levonorgestrel Alcala Brand
% 221.02/221.18  |- skos__hiddenLabel mesh__D016912 Norplant 2
% 221.02/221.18  |- skos__altLabel mesh__D016912 l-Norgestrel
% 221.02/221.18  |- skos__altLabel mesh__D016912 Paladin Brand of Levonorgestrel
% 221.02/221.18  |- skos__historyNote mesh__D016912 Norgestrel %28%1980-1991%29%
% 221.02/221.18  |- skos__altLabel mesh__D016912 Norplant-2
% 221.02/221.18  |- skos__hiddenLabel mesh__D016912 Levonorgestrel Paladin Brand
% 221.02/221.18  |- skos__hiddenLabel mesh__D016912 l Norgestrel
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D016912 2005
% 221.02/221.18  |- skos__scopeNote mesh__D016912
% 221.02/221.18       A synthetic progestational hormone with actions similar to those of PROGESTERONE and about twice as potent as its racemic or %28%+-%29%-isomer %28%NORGESTREL%29%. It is used for contraception, control of menstrual disorders, and treatment of endometriosis.%A%    
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D016114 2006
% 221.02/221.18  |- skos__hiddenLabel mesh__D016114 Ichthyoses, X-Linked
% 221.02/221.18  |- skos__hiddenLabel mesh__D016114 X-Linked Ichthyosis
% 221.02/221.18  |- skos__prefLabel mesh__D016114 Ichthyosis, X-Linked
% 221.02/221.18  |- skos__related mesh__D016114smesh__D043266
% 221.02/221.18  |- skos__broader mesh__D016114smesh__D043202
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D016114 2004
% 221.02/221.18  |- skos__scopeNote mesh__D016114
% 221.02/221.18       Chronic form of ichthyosis that is inherited as a sex-linked recessive trait carried on the X-chromosome and transmitted to the male offspring. It is characterized by severe scaling, especially on the extremities, and is associated with steroid sulfatase deficiency.%A%    
% 221.02/221.18  |- skos__hiddenLabel mesh__D016114 Sex-Linked Ichthyosis
% 221.02/221.18  |- mesh__recordAuthorizer mesh__D016114 sjn
% 221.02/221.18  |- skos__hiddenLabel mesh__D016114 Ichthyosis, X Linked
% 221.02/221.18  |- mesh__dateRevised mesh__D016114 2003-07-09
% 221.02/221.18  |- mesh__publicMeSHNote mesh__D016114 91   
% 221.02/221.18  |- mesh__dateCreated mesh__D016114 1990-02-12
% 221.02/221.18  |- rdf__type mesh__D016114sskos__Concept
% 221.02/221.18  |- skos__hiddenLabel mesh__D016114 X-Linked Ichthyoses
% 221.02/221.18  |- skos__hiddenLabel mesh__D016114 Ichthyoses, Sex-Linked
% 221.02/221.18  |- mesh__recordMaintainer mesh__D016114 jmp
% 221.02/221.18  |- mesh__historyNote mesh__D016114 91   
% 221.02/221.18  |- skos__broader mesh__D016114smesh__D007057
% 221.02/221.18  |- skos__broader mesh__D016114smesh__D040181
% 221.02/221.18  |- skos__historyNote mesh__D016114 Ichthyosis %28%1966-1990%29%
% 221.02/221.18  |- skos__broader mesh__D016114smesh__D012873
% 221.02/221.18  |- skos__hiddenLabel mesh__D016114 Ichthyosis, Sex Linked
% 221.02/221.18  |- mesh__dateEstablished mesh__D016114 1991-01-01
% 221.02/221.18  |- skos__annotation mesh__D016114
% 221.02/221.18       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D016114 2005
% 221.02/221.18  |- skos__hiddenLabel mesh__D016114 Sex-Linked Ichthyoses
% 221.02/221.18  |- skos__altLabel mesh__D016114 Ichthyosis, Sex-Linked
% 221.02/221.18  |- mesh__recordOriginator mesh__D016114 AGS
% 221.02/221.18  |- skos__broader mesh__D007388smesh__D013040
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D007388 2002
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D007388 1995
% 221.02/221.18  |- skos__scopeNote mesh__D007388
% 221.02/221.18       A medical specialty concerned with the diagnosis and treatment of diseases of the internal organ systems of adults.%A%    
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D007388 2003
% 221.02/221.18  |- rdf__type mesh__D007388sskos__Concept
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D007388 2004
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D007388 1996
% 221.02/221.18  |- mesh__dateCreated mesh__D007388 1999-01-01
% 221.02/221.18  |- mesh__recordMaintainer mesh__D007388 TGC
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D007388 2005
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D007388 1997
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D007388 2006
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D007388 1998
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D007388 2000
% 221.02/221.18  |- mesh__dateRevised mesh__D007388 1994-06-30
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D007388 2001
% 221.02/221.18  |- mesh__recordOriginator mesh__D007388 NLM
% 221.02/221.18  |- skos__annotation mesh__D007388
% 221.02/221.18       SPEC: SPEC qualif; when permitted for %22%internal diseases%22%: Manual 28.10; DF: INTERNAL MED%A%  
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D007388 1999
% 221.02/221.18  |- mesh__recordAuthorizer mesh__D007388 PLS
% 221.02/221.18  |- skos__altLabel mesh__D007388 Medicine, Internal
% 221.02/221.18  |- skos__prefLabel mesh__D007388 Internal Medicine
% 221.02/221.18  |- skos__scopeNote mesh__D004090
% 221.02/221.18       A semisynthetic analgesic used in the study of narcotic receptors. It has abuse potential.%A%    
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D004090 2001
% 221.02/221.18  |- skos__prefLabel mesh__D004090 Dihydromorphine
% 221.02/221.18  |- mesh__dateCreated mesh__D004090 1977-12-09
% 221.02/221.18  |- skos__broader mesh__D004090smesh__D009022
% 221.02/221.18  |- mesh__publicMeSHNote mesh__D004090
% 221.02/221.18       91; was see under MORPHINE DERIVATIVES 1979-90   
% 221.02/221.18  |- rdf__type mesh__D004090sskos__Concept
% 221.02/221.18  |- mesh__recordAuthorizer mesh__D004090 sjn
% 221.02/221.18  |- skos__altLabel mesh__D004090 Paramorfan
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D004090 2004
% 221.02/221.18  |- skos__historyNote mesh__D004090 Morphine Derivatives %28%1969-1978%29%
% 221.02/221.18  |- mesh__dateEstablished mesh__D004090 1991-01-01
% 221.02/221.18  |- skos__historyNote mesh__D004090 Morphine %28%1966-1968%29%
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D004090 2003
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D004090 2002
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D004090 2006
% 221.02/221.18  |- mesh__recordOriginator mesh__D004090 SH
% 221.02/221.18  |- mesh__historyNote mesh__D004090
% 221.02/221.18       91%28%79%29%; was see under MORPHINE DERIVATIVES 1979-90   
% 221.02/221.18  |- mesh__dateRevised mesh__D004090 2000-06-22
% 221.02/221.18  |- skos__annotation mesh__D004090
% 221.02/221.18       do not confuse with DIHYDROMORPHINONE see HYDROMORPHONE, also a narcotic analgesic%A%  
% 221.02/221.18  |- mesh__recordMaintainer mesh__D004090 TWD
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D004090 2005
% 221.02/221.18  |- mesh__recordOriginator mesh__D012522 NLM
% 221.02/221.18  |- skos__altLabel mesh__D012522 Sarcosporidia
% 221.02/221.18  |- skos__scopeNote mesh__D012522
% 221.02/221.18       A genus of protozoa found in reptiles, birds, and mammals, including humans. This heteroxenous parasite produces muscle cysts in intermediate hosts such as domestic herbivores %28%cattle, sheep, pigs%29% and rodents. Final hosts are predators such as dogs, cats, and man.%A%    
% 221.02/221.18  |- skos__annotation mesh__D012522
% 221.02/221.18       infection = SARCOCYSTOSIS; /drug eff: consider also COCCIDIOSTATS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 221.02/221.18  |- mesh__recordMaintainer mesh__D012522 ags
% 221.02/221.18  |- mesh__publicMeSHNote mesh__D012522
% 221.02/221.18       92; was SARCOSPORIDIA 1963-91; SARCOCYSTIS was see SARCOSPORIDIA 1979-91, was see under SARCOSPORIDIA 1963-78%A%  
% 221.02/221.18  |- mesh__dateCreated mesh__D012522 1999-01-01
% 221.02/221.18  |- skos__prefLabel mesh__D012522 Sarcocystis
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D012522 2006
% 221.02/221.18  |- rdf__type mesh__D012522sskos__Concept
% 221.02/221.18  |- skos__broader mesh__D012522smesh__D021745
% 221.02/221.18  |- mesh__onlineNote mesh__D012522
% 221.02/221.18       use SARCOCYSTIS to search SARCOSPORIDIA 1966-91   
% 221.02/221.18  |- mesh__historyNote mesh__D012522
% 221.02/221.18       92; was SARCOSPORIDIA 1963-91; SARCOCYSTIS was see SARCOSPORIDIA 1979-91, was see under SARCOSPORIDIA 1963-78%A%  
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D012522 2005
% 221.02/221.18  |- mesh__dateRevised mesh__D012522 2003-07-09
% 221.02/221.18  |- mesh__recordAuthorizer mesh__D012522 sjn
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D012522 2004
% 221.02/221.18  |- skos__scopeNote mesh__D050641
% 221.02/221.18       A subtype of dopamine D1 receptors that has higher affinity for DOPAMINE and differentially couples to GTP-BINDING PROTEINS.%A%    
% 221.02/221.18  |- mesh__recordMaintainer mesh__D050641 DRC
% 221.02/221.18  |- skos__altLabel mesh__D050641 Dopamine D5 Receptors
% 221.02/221.18  |- skos__altLabel mesh__D050641 Dopamine D1B Receptor
% 221.02/221.18  |- skos__hiddenLabel mesh__D050641 D1B Receptor, Dopamine
% 221.02/221.18  |- skos__broader mesh__D050641smesh__D017447
% 221.02/221.18  |- mesh__dateEstablished mesh__D050641 2006-01-01
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D050641 2006
% 221.02/221.18  |- rdf__type mesh__D050641sskos__Concept
% 221.02/221.18  |- skos__prefLabel mesh__D050641 Receptors, Dopamine D5
% 221.02/221.18  |- skos__altLabel mesh__D050641 Dopamine D5 Receptor
% 221.02/221.18  |- skos__hiddenLabel mesh__D050641 Receptor, Dopamine D1B
% 221.02/221.18  |- mesh__historyNote mesh__D050641 2006%28%1991%29%   
% 221.02/221.18  |- skos__annotation mesh__D050641 see SCR for organism-specific terms   
% 221.02/221.18  |- mesh__dateCreated mesh__D050641 2005-06-30
% 221.02/221.18  |- mesh__recordOriginator mesh__D050641 DRC
% 221.02/221.18  |- skos__hiddenLabel mesh__D050641 D5 Receptors, Dopamine
% 221.02/221.18  |- mesh__recordAuthorizer mesh__D050641 sjn
% 221.02/221.18  |- skos__hiddenLabel mesh__D050641 Receptor, Dopamine D5
% 221.02/221.18  |- mesh__publicMeSHNote mesh__D050641
% 221.02/221.18       2006; RECEPTORS, DOPAMINE D5 was indexed under RECEPTORS DOPAMINE 1997-2005, %26% under RECEPTORS, DOPAMINE 1991-1996%A%  
% 221.02/221.18  |- skos__hiddenLabel mesh__D050641 D5 Receptor, Dopamine
% 221.02/221.18  |- skos__historyNote mesh__D050641 Receptors, Dopamine D1 %28%1991-2005%29%
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D003796 1999
% 221.02/221.18  |- skos__hiddenLabel mesh__D003796 Dental Services, Hospital
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D003796 2005
% 221.02/221.18  |- mesh__recordOriginator mesh__D003796 NLM
% 221.02/221.18  |- skos__broader mesh__D003796smesh__D003752
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D003796 2004
% 221.02/221.18  |- mesh__recordMaintainer mesh__D003796 KEV
% 221.02/221.18  |- mesh__publicMeSHNote mesh__D003796
% 221.02/221.18       78; was HOSPITAL DENTAL SERVICE 1963-77   
% 221.02/221.18  |- skos__hiddenLabel mesh__D003796 Hospital Dental Services
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D003796 2006
% 221.02/221.18  |- skos__annotation mesh__D003796 DF: DENT SERV HOSP   
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D003796 2000
% 221.02/221.18  |- skos__prefLabel mesh__D003796 Dental Service, Hospital
% 221.02/221.18  |- mesh__dateCreated mesh__D003796 1999-01-01
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D003796 2001
% 221.02/221.18  |- mesh__dateRevised mesh__D003796 1995-05-22
% 221.02/221.18  |- skos__scopeNote mesh__D003796
% 221.02/221.18       Hospital department providing dental care.     
% 221.02/221.18  |- skos__altLabel mesh__D003796 Hospital Dental Service
% 221.02/221.18  |- mesh__recordAuthorizer mesh__D003796 PLS
% 221.02/221.18  |- skos__hiddenLabel mesh__D003796 Services, Hospital Dental
% 221.02/221.18  |- skos__broader mesh__D003796smesh__D006748
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D003796 1996
% 221.02/221.18  |- mesh__onlineNote mesh__D003796
% 221.02/221.18       use DENTAL SERVICE, HOSPITAL to search HOSPITAL DENTAL SERVICE 1966-77%A%  
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D003796 2002
% 221.02/221.18  |- skos__altLabel mesh__D003796 Service, Hospital Dental
% 221.02/221.18  |- mesh__historyNote mesh__D003796
% 221.02/221.18       78; was HOSPITAL DENTAL SERVICE 1963-77   
% 221.02/221.18  |- rdf__type mesh__D003796sskos__Concept
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D003796 1998
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D003796 1997
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D003796 2003
% 221.02/221.18  |- mesh__activeMeSHYear mesh__D008481 2005
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D008481 2004
% 221.02/221.19  |- skos__prefLabel mesh__D008481 Mediastinoscopy
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D008481 2000
% 221.02/221.19  |- mesh__publicMeSHNote mesh__D008481 74   
% 221.02/221.19  |- mesh__recordMaintainer mesh__D008481 nns
% 221.02/221.19  |- mesh__recordAuthorizer mesh__D008481 sjn
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D008481 2006
% 221.02/221.19  |- mesh__dateRevised mesh__D008481 1999-11-03
% 221.02/221.19  |- skos__hiddenLabel mesh__D008481 Procedure, Mediastinoscopic Surgical
% 221.02/221.19  |- mesh__historyNote mesh__D008481 74   
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D008481 2001
% 221.02/221.19  |- skos__altLabel mesh__D008481 Surgery, Mediastinoscopic
% 221.02/221.19  |- mesh__dateCreated mesh__D008481 1999-01-01
% 221.02/221.19  |- skos__hiddenLabel mesh__D008481 Mediastinoscopic Surgeries
% 221.02/221.19  |- skos__hiddenLabel mesh__D008481 Surgeries, Mediastinoscopic
% 221.02/221.19  |- skos__altLabel mesh__D008481 Surgical Procedures, Mediastinoscopic
% 221.02/221.19  |- rdf__type mesh__D008481sskos__Concept
% 221.02/221.19  |- skos__hiddenLabel mesh__D008481 Surgical Procedure, Mediastinoscopic
% 221.02/221.19  |- skos__scopeNote mesh__D008481
% 221.02/221.19       Endoscopic examination, therapy or surgery of the anterior superior mediastinum of the thorax.%A%    
% 221.02/221.19  |- mesh__recordOriginator mesh__D008481 NLM
% 221.02/221.19  |- skos__hiddenLabel mesh__D008481 Procedures, Mediastinoscopic Surgical
% 221.02/221.19  |- skos__altLabel mesh__D008481 Mediastinoscopic Surgery
% 221.02/221.19  |- mesh__dateEstablished mesh__D008481 1974-01-01
% 221.02/221.19  |- skos__hiddenLabel mesh__D008481 Mediastinoscopic Surgical Procedure
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D008481 2002
% 221.02/221.19  |- skos__broader mesh__D008481smesh__D004724
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D008481 2003
% 221.02/221.19  |- skos__broader mesh__D008481smesh__D019616
% 221.02/221.19  |- skos__hiddenLabel mesh__D008481 Mediastinoscopies
% 221.02/221.19  |- mesh__historyNote mesh__D016913 92   
% 221.02/221.19  |- skos__broader mesh__D016913smesh__D001803
% 221.02/221.19  |- skos__hiddenLabel mesh__D016913 Transfusions, Blood Component
% 221.02/221.19  |- skos__annotation mesh__D016913
% 221.02/221.19       GEN or unspecified; prefer specifics; for transfusion back to donor, coord IM with BLOOD TRANSFUSION, AUTOLOGOUS %28%NIM%29%; do not confuse with BLOOD COMPONENT REMOVAL %26% its specifics where component is removed but remainder goes back to donor; read MeSH definitions; do not use /util except by MeSH definition%A%  
% 221.02/221.19  |- skos__hiddenLabel mesh__D016913 Component Transfusion, Blood
% 221.02/221.19  |- skos__hiddenLabel mesh__D016913 Component Transfusions, Blood
% 221.02/221.19  |- skos__prefLabel mesh__D016913 Blood Component Transfusion
% 221.02/221.19  |- mesh__recordOriginator mesh__D016913 MXR
% 221.02/221.19  |- skos__hiddenLabel mesh__D016913 Transfusion, Blood Component
% 221.02/221.19  |- skos__scopeNote mesh__D016913
% 221.02/221.19       The transfer of blood components such as erythrocytes, leukocytes, platelets, and plasma from a donor to a recipient or back to the donor. This process differs from the procedures undertaken in PLASMAPHERESIS and types of CYTAPHERESIS; %28%PLATELETPHERESIS and LEUKAPHERESIS%29% where, following the removal of plasma or the specific cell components, the remainder is transfused back to the donor.%A%    
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D016913 2002
% 221.02/221.19  |- mesh__dateCreated mesh__D016913 1991-06-20
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D016913 2006
% 221.02/221.19  |- skos__hiddenLabel mesh__D016913 Blood Component Transfusions
% 221.02/221.19  |- mesh__recordAuthorizer mesh__D016913 sjn
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D016913 2005
% 221.02/221.19  |- mesh__dateEstablished mesh__D016913 1992-01-01
% 221.02/221.19  |- skos__historyNote mesh__D016913 Blood Transfusion %28%1974-1991%29%
% 221.02/221.19  |- rdf__type mesh__D016913sskos__Concept
% 221.02/221.19  |- mesh__recordMaintainer mesh__D016913 mdb
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D016913 2004
% 221.02/221.19  |- mesh__dateRevised mesh__D016913 2001-07-25
% 221.02/221.19  |- mesh__publicMeSHNote mesh__D016913 92   
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D016913 2003
% 221.02/221.19  |- skos__scopeNote mesh__D016115
% 221.02/221.19       Heterogeneous group of autosomal recessive disorders comprising at least four recognized types, all having in common varying degrees of hypopigmentation of the skin, hair, and eyes. The two most common are the tyrosinase-positive and tyrosinase-negative types.%A%    
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D016115 2004
% 221.02/221.19  |- mesh__recordOriginator mesh__D016115 AGS
% 221.02/221.19  |- skos__hiddenLabel mesh__D016115 Albinism, Tyrosinase Negative
% 221.02/221.19  |- rdf__type mesh__D016115sskos__Concept
% 221.02/221.19  |- mesh__dateRevised mesh__D016115 2001-07-25
% 221.02/221.19  |- mesh__recordMaintainer mesh__D016115 nns
% 221.02/221.19  |- mesh__historyNote mesh__D016115 91   
% 221.02/221.19  |- skos__broader mesh__D016115smesh__D000417
% 221.02/221.19  |- skos__hiddenLabel mesh__D016115 Tyrosinase-Positive Albinism
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D016115 2002
% 221.02/221.19  |- mesh__recordAuthorizer mesh__D016115 sjn
% 221.02/221.19  |- mesh__dateEstablished mesh__D016115 1991-01-01
% 221.02/221.19  |- mesh__dateCreated mesh__D016115 1990-02-12
% 221.02/221.19  |- mesh__publicMeSHNote mesh__D016115 91   
% 221.02/221.19  |- skos__historyNote mesh__D016115 Albinism %28%1966-1990%29%
% 221.02/221.19  |- skos__hiddenLabel mesh__D016115 Albinism, Tyrosinase Positive
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D016115 2005
% 221.02/221.19  |- skos__hiddenLabel mesh__D016115 Oculocutaneous Albinism
% 221.02/221.19  |- skos__hiddenLabel mesh__D016115 Yellow-Mutant Albinism
% 221.02/221.19  |- skos__prefLabel mesh__D016115 Albinism, Oculocutaneous
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D016115 2006
% 221.02/221.19  |- skos__hiddenLabel mesh__D016115 Tyrosinase-Negative Albinism
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D016115 2003
% 221.02/221.19  |- skos__hiddenLabel mesh__D016115 Albinism, Yellow Mutant
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D007389 2005
% 221.02/221.19  |- skos__historyNote mesh__D007389 Perception %28%1966-1971%29%
% 221.02/221.19  |- skos__historyNote mesh__D007389 Self Concept %28%1969-1971%29%
% 221.02/221.19  |- mesh__recordOriginator mesh__D007389 NLM
% 221.02/221.19  |- mesh__dateCreated mesh__D007389 1999-01-01
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D007389 2000
% 221.02/221.19  |- skos__hiddenLabel mesh__D007389 Control, Internal-External
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D007389 2004
% 221.02/221.19  |- skos__hiddenLabel mesh__D007389 Internal External Control
% 221.02/221.19  |- rdf__type mesh__D007389sskos__Concept
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D007389 2003
% 221.02/221.19  |- skos__historyNote mesh__D007389
% 221.02/221.19       Social Control, Informal %28%1968-1971%29%
% 221.02/221.19  |- mesh__recordMaintainer mesh__D007389 jls
% 221.02/221.19  |- mesh__recordAuthorizer mesh__D007389 sjn
% 221.02/221.19  |- skos__hiddenLabel mesh__D007389 Internal-External Controls
% 221.02/221.19  |- skos__prefLabel mesh__D007389 Internal-External Control
% 221.02/221.19  |- mesh__dateEstablished mesh__D007389 1972-01-01
% 221.02/221.19  |- skos__broader mesh__D007389smesh__D011593
% 221.02/221.19  |- skos__hiddenLabel mesh__D007389 Controls, Internal-External
% 221.02/221.19  |- mesh__publicMeSHNote mesh__D007389 72   
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D007389 2002
% 221.02/221.19  |- skos__scopeNote mesh__D007389
% 221.02/221.19       Personality construct referring to an individual%27%s perception of the locus of events as determined internally by his or her own behavior versus fate, luck, or external forces. %28%ERIC Thesaurus, 1996%29%.%A%    
% 221.02/221.19  |- skos__annotation mesh__D007389 no qualif   
% 221.02/221.19  |- mesh__dateRevised mesh__D007389 1999-11-03
% 221.02/221.19  |- skos__hiddenLabel mesh__D007389 Control Locus
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D007389 2006
% 221.02/221.19  |- mesh__historyNote mesh__D007389 72   
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D007389 2001
% 221.02/221.19  |- skos__prefLabel mesh__D004091 Hydromorphone
% 221.02/221.19  |- mesh__dateRevised mesh__D004091 2005-06-30
% 221.02/221.19  |- mesh__dateCreated mesh__D004091 1999-01-01
% 221.02/221.19  |- mesh__publicMeSHNote mesh__D004091
% 221.02/221.19       96; was DIHYDROMORPHINONE 1963-95; DIHYDROMORPHINONE DERIVATIVES was see under DIHYDROMORPHINONE 1975-77, was see under MORPHINANS 1969-74%A%  
% 221.02/221.19  |- rdf__type mesh__D004091sskos__Concept
% 221.02/221.19  |- mesh__recordOriginator mesh__D004091 NLM
% 221.02/221.19  |- mesh__onlineNote mesh__D004091
% 221.02/221.19       use HYDROMORPHONE/analogs %26% derivatives to search DIHYDROMORPHINONE DERIVATIVES 1975-77; use MORPHINANS 1969-74%A%  
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D004091 2006
% 221.02/221.19  |- skos__broader mesh__D004091smesh__D009022
% 221.02/221.19  |- skos__annotation mesh__D004091
% 221.02/221.19       do not confuse with entry term DIHYDROMORPHINONE with DIHYDROMORPHINE%A%  
% 221.02/221.19  |- mesh__recordAuthorizer mesh__D004091 sjn
% 221.02/221.19  |- skos__altLabel mesh__D004091 Hydromorphon
% 221.02/221.19  |- mesh__recordMaintainer mesh__D004091 ssb
% 221.02/221.19  |- mesh__historyNote mesh__D004091
% 221.02/221.19       96; was DIHYDROMORPHINONE 1963-95; DIHYDROMORPHINONE DERIVATIVES was see under DIHYDROMORPHINONE 1975-77, was see under MORPHINANS 1969-74%A%  
% 221.02/221.19  |- skos__altLabel mesh__D004091 Dihydromorphinone
% 221.02/221.19  |- skos__scopeNote mesh__D004091
% 221.02/221.19       An opioid analgesic made from MORPHINE and used mainly as an analgesic. It has a shorter duration of action than morphine.%A%    
% 221.02/221.19  |- skos__annotation mesh__D012523
% 221.02/221.19       /drug ther: consider also COCCIDIOSTATS   
% 221.02/221.19  |- mesh__dateRevised mesh__D012523 2000-06-22
% 221.02/221.19  |- mesh__recordAuthorizer mesh__D012523 sjn
% 221.02/221.19  |- skos__altLabel mesh__D012523 Sarcosporidiosis
% 221.02/221.19  |- skos__hiddenLabel mesh__D012523 Sarcosporidioses
% 221.02/221.19  |- skos__prefLabel mesh__D012523 Sarcocystosis
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D012523 2005
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D012523 2001
% 221.02/221.19  |- mesh__recordMaintainer mesh__D012523 TGC
% 221.02/221.19  |- mesh__recordOriginator mesh__D012523 NLM
% 221.02/221.19  |- skos__scopeNote mesh__D012523
% 221.02/221.19       Infection of the striated muscle of mammals by parasites of the genus SARCOCYSTIS. Disease symptoms such as vomiting, diarrhea, muscle weakness, and paralysis are produced by sarcocystin, a toxin produced by the organism.%A%    
% 221.02/221.19  |- rdf__type mesh__D012523sskos__Concept
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D012523 2006
% 221.02/221.19  |- mesh__historyNote mesh__D012523 1992 %28%1963%29%   
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D012523 2003
% 221.02/221.19  |- skos__broader mesh__D012523smesh__D003048
% 221.02/221.19  |- mesh__publicMeSHNote mesh__D012523
% 221.02/221.19       1992; see SARCOSPORIDIOSIS 1963-1991   
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D012523 2002
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D012523 2004
% 221.02/221.19  |- skos__hiddenLabel mesh__D012523 Sarcocystoses
% 221.02/221.19  |- mesh__dateCreated mesh__D012523 1999-01-01
% 221.02/221.19  |- skos__altLabel mesh__D050642 Balaena mysticetus
% 221.02/221.19  |- mesh__recordMaintainer mesh__D050642 ags
% 221.02/221.19  |- mesh__recordAuthorizer mesh__D050642 sjn
% 221.02/221.19  |- mesh__recordOriginator mesh__D050642 ags
% 221.02/221.19  |- mesh__historyNote mesh__D050642 2006; use WHALES 1998-2005   
% 221.02/221.19  |- skos__broader mesh__D050642smesh__D014907
% 221.02/221.19  |- skos__altLabel mesh__D050642 Greenland, Right Whale
% 221.02/221.19  |- skos__prefLabel mesh__D050642 Bowhead Whale
% 221.02/221.19  |- skos__hiddenLabel mesh__D050642 Greenland Right Whales
% 221.02/221.19  |- skos__hiddenLabel mesh__D050642 Greenland Right Whale
% 221.02/221.19  |- mesh__dateEstablished mesh__D050642 2006-01-01
% 221.02/221.19  |- skos__hiddenLabel mesh__D050642 Right Whale Greenland
% 221.02/221.19  |- skos__scopeNote mesh__D050642
% 221.02/221.19       The species Balaena mysticetus, in the family Balaenidae, found in the colder waters of the Northern Hemisphere. The common name is derived from the extreme arching of the lower jaw.%A%    
% 221.02/221.19  |- skos__altLabel mesh__D050642 Right Whale, Greenland
% 221.02/221.19  |- skos__hiddenLabel mesh__D050642 Bowhead Whales
% 221.02/221.19  |- skos__hiddenLabel mesh__D050642 Whales, Greenland Right
% 221.02/221.19  |- mesh__dateCreated mesh__D050642 2005-06-30
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D050642 2006
% 221.02/221.19  |- rdf__type mesh__D050642sskos__Concept
% 221.02/221.19  |- skos__hiddenLabel mesh__D050642 Right Whales, Greenland
% 221.02/221.19  |- mesh__publicMeSHNote mesh__D050642 2006; see WHALES 1998-2005   
% 221.02/221.19  |- skos__historyNote mesh__D050642 Whales %28%1982-2005%29%
% 221.02/221.19  |- skos__scopeNote mesh__D003797
% 221.02/221.19       Personnel who provide dental service to patients in an organized facility, institution or agency.%A%    
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003797 2001
% 221.02/221.19  |- rdf__type mesh__D003797sskos__Concept
% 221.02/221.19  |- skos__altLabel mesh__D003797 Staff, Dental
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003797 1993
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003797 2004
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003797 1996
% 221.02/221.19  |- skos__annotation mesh__D003797 DF: DENT STAFF   
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003797 2000
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003797 1999
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003797 2003
% 221.02/221.19  |- mesh__publicMeSHNote mesh__D003797 73   
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003797 1995
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003797 2006
% 221.02/221.19  |- mesh__recordOriginator mesh__D003797 NLM
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003797 1998
% 221.02/221.19  |- mesh__recordMaintainer mesh__D003797 TAP
% 221.02/221.19  |- skos__altLabel mesh__D003797 Dental Staffs
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003797 2002
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003797 1994
% 221.02/221.19  |- skos__altLabel mesh__D003797 Staffs, Dental
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003797 2005
% 221.02/221.19  |- skos__prefLabel mesh__D003797 Dental Staff
% 221.02/221.19  |- mesh__recordAuthorizer mesh__D003797 PLS
% 221.02/221.19  |- mesh__dateCreated mesh__D003797 1999-01-01
% 221.02/221.19  |- mesh__dateEstablished mesh__D003797 1973-01-01
% 221.02/221.19  |- mesh__dateRevised mesh__D003797 1992-05-14
% 221.02/221.19  |- skos__broader mesh__D003797smesh__D006282
% 221.02/221.19  |- mesh__historyNote mesh__D003797 73   
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003797 1997
% 221.02/221.19  |- skos__prefLabel mesh__D008482 Mediastinum
% 221.02/221.19  |- skos__related mesh__D008482smesh__D008481
% 221.02/221.19  |- mesh__recordOriginator mesh__D008482 NLM
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D008482 2004
% 221.02/221.19  |- skos__annotation mesh__D008482
% 221.02/221.19       radiogr is probably PNEUMOMEDIASTINUM, DIAGNOSTIC; inflammation = MEDIASTINITIS%A%  
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D008482 2003
% 221.02/221.19  |- skos__related mesh__D008482smesh__D011012
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D008482 2006
% 221.02/221.19  |- mesh__recordAuthorizer mesh__D008482 sjn
% 221.02/221.19  |- mesh__recordMaintainer mesh__D008482 TAP
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D008482 2005
% 221.02/221.19  |- rdf__type mesh__D008482sskos__Concept
% 221.02/221.19  |- skos__broader mesh__D008482smesh__D035423
% 221.02/221.19  |- mesh__dateCreated mesh__D008482 1999-01-01
% 221.02/221.19  |- mesh__dateRevised mesh__D008482 2002-07-03
% 221.02/221.19  |- mesh__publicMeSHNote mesh__D016914
% 221.02/221.19       94; was RIBONUCLEASE H 1992-93; ENDORIBONUCLEASE H was indexed under ENDORIBONUCLEASES 1983-91 and under ENDONUCLEASES %26% RIBONUCLEASES 1973-82%A%  
% 221.02/221.19  |- mesh__dateRevised mesh__D016914 2003-07-09
% 221.02/221.19  |- skos__scopeNote mesh__D016914
% 221.02/221.19       A ribonuclease that specifically cleaves the RNA moiety of RNA:DNA hybrids. It has been isolated from a wide variety of prokaryotic and eukaryotic organisms %28%particularly calf thymus%29% as well as retroviruses. EC 3.1.26.4.%A%    
% 221.02/221.19  |- skos__prefLabel mesh__D016914 Ribonuclease H, Calf Thymus
% 221.02/221.19  |- mesh__onlineNote mesh__D016914
% 221.02/221.19       use RIBONUCLEASE H, CALF THYMUS to search RIBONUCLEASE H 1992-93; use RIBONUCLEASE H, CALF THYMUS %28%NM%29% to search ENDORIBONUCLEASE H 1979-91%A%  
% 221.02/221.19  |- skos__altLabel mesh__D016914 Endoribonuclease H
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D016914 2006
% 221.02/221.19  |- skos__altLabel mesh__D016914 Endoribonuclease H %28%Calf Thymus%29%
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D016914 2005
% 221.02/221.19  |- skos__annotation mesh__D016914
% 221.02/221.19       despite name, ribonuclease H from other sources goes here; DF: note short X ref%A%  
% 221.02/221.19  |- rdf__type mesh__D016914sskos__Concept
% 221.02/221.19  |- skos__altLabel mesh__D016914 Ribonuclease H
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D016914 2004
% 221.02/221.19  |- skos__historyNote mesh__D016914 Endoribonucleases %28%1983-1991%29%
% 221.02/221.19  |- skos__historyNote mesh__D016914 Endonucleases %28%1973-1982%29%
% 221.02/221.19  |- mesh__recordMaintainer mesh__D016914 ssb
% 221.02/221.19  |- mesh__dateCreated mesh__D016914 1991-07-12
% 221.02/221.19  |- skos__altLabel mesh__D016914 Calf Thymus Ribonuclease H
% 221.02/221.19  |- mesh__recordAuthorizer mesh__D016914 sjn
% 221.02/221.19  |- skos__broader mesh__D016914smesh__D004722
% 221.02/221.19  |- mesh__historyNote mesh__D016914
% 221.02/221.19       94; was RIBONUCLEASE H 1992-93; was ENDORIBONUCLEASE H %28%NM%29% 1973-91%A%  
% 221.02/221.19  |- mesh__dateEstablished mesh__D016914 1992-01-01
% 221.02/221.19  |- skos__altLabel mesh__D016914 RNase H
% 221.02/221.19  |- mesh__recordOriginator mesh__D016914 AGS
% 221.02/221.19  |- skos__historyNote mesh__D016914 Ribonucleases %28%1973-1982%29%
% 221.02/221.19  |- skos__altLabel mesh__D016914 RNAase H
% 221.02/221.19  |- mesh__historyNote mesh__D016116 91   
% 221.02/221.19  |- mesh__publicMeSHNote mesh__D016116 91   
% 221.02/221.19  |- skos__historyNote mesh__D016116 Pigmentation Disorders %28%1966-1990%29%
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D016116 2005
% 221.02/221.19  |- mesh__dateEstablished mesh__D016116 1991-01-01
% 221.02/221.19  |- skos__scopeNote mesh__D016116
% 221.02/221.19       Autosomal dominant, congenital disorder characterized by localized hypomelanosis of the skin and hair. The most familiar feature is a white forelock presenting in 80 to 90 percent of the patients. The underlying defect is possibly related to the differentiation and migration of melanoblasts, as well as to defective development of the neural crest %28%neurocristopathy%29%. Piebaldism may be closely related to Waardenburg%27%s syndrome.%A%    
% 221.02/221.19  |- skos__hiddenLabel mesh__D016116 Partial Albinism
% 221.02/221.19  |- skos__prefLabel mesh__D016116 Piebaldism
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D016116 2006
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D016116 2003
% 221.02/221.19  |- mesh__recordMaintainer mesh__D016116 nns
% 221.02/221.19  |- skos__altLabel mesh__D016116 Albinism, Cutaneous
% 221.02/221.19  |- mesh__recordOriginator mesh__D016116 AGS
% 221.02/221.19  |- skos__annotation mesh__D016116
% 221.02/221.19       hypopigmentation of skin %26% hair; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 221.02/221.19  |- mesh__dateCreated mesh__D016116 1990-06-06
% 221.02/221.19  |- skos__historyNote mesh__D016116 Albinism %28%1966-1971%29%
% 221.02/221.19  |- mesh__dateRevised mesh__D016116 2001-07-25
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D016116 2004
% 221.02/221.19  |- skos__related mesh__D016116smesh__D014849
% 221.02/221.19  |- skos__altLabel mesh__D016116 Albinism, Partial
% 221.02/221.19  |- skos__broader mesh__D016116smesh__D000417
% 221.02/221.19  |- skos__hiddenLabel mesh__D016116 Cutaneous Albinism
% 221.02/221.19  |- rdf__type mesh__D016116sskos__Concept
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D016116 2002
% 221.02/221.19  |- mesh__recordAuthorizer mesh__D016116 sjn
% 221.02/221.19  |- skos__historyNote mesh__D032581 BCG Vaccine %28%1966-2002%29%
% 221.02/221.19  |- rdf__type mesh__D032581sskos__Concept
% 221.02/221.19  |- mesh__dateCreated mesh__D032581 2002-07-03
% 221.02/221.19  |- skos__scopeNote mesh__D032581
% 221.02/221.19       Vaccines or candidate vaccines used to prevent or treat TUBERCULOSIS.%A%    
% 221.02/221.19  |- mesh__historyNote mesh__D032581
% 221.02/221.19       2003, 1965-1978; use BCG VACCINE 1965-2002   
% 221.02/221.19  |- skos__hiddenLabel mesh__D032581 Vaccines, Tuberculosis
% 221.02/221.19  |- mesh__recordOriginator mesh__D032581 ags
% 221.02/221.19  |- mesh__dateRevised mesh__D032581 2005-06-30
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D032581 2006
% 221.02/221.19  |- skos__broader mesh__D032581smesh__D001428
% 221.02/221.19  |- mesh__recordAuthorizer mesh__D032581 sjn
% 221.02/221.19  |- mesh__recordMaintainer mesh__D032581 ssb
% 221.02/221.19  |- mesh__publicMeSHNote mesh__D032581
% 221.02/221.19       2003, 1965-1978; see BCG VACCINE 1965-2002   
% 221.02/221.19  |- skos__prefLabel mesh__D032581 Tuberculosis Vaccines
% 221.02/221.19  |- mesh__dateEstablished mesh__D032581 2003-01-01
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D004890 1998
% 221.02/221.19  |- mesh__recordAuthorizer mesh__D004890 PLS
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D004890 2001
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D004890 2000
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D004890 2004
% 221.02/221.19  |- mesh__recordMaintainer mesh__D004890 TGC
% 221.02/221.19  |- skos__prefLabel mesh__D004890 Erythema
% 221.02/221.19  |- mesh__dateRevised mesh__D004890 1996-06-10
% 221.02/221.19  |- skos__hiddenLabel mesh__D004890 Erythemas
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D004890 2006
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D004890 2003
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D004890 1997
% 221.02/221.19  |- mesh__recordOriginator mesh__D004890 NLM
% 221.02/221.19  |- mesh__dateCreated mesh__D004890 1999-01-01
% 221.02/221.19  |- skos__broader mesh__D004890smesh__D012871
% 221.02/221.19  |- skos__annotation mesh__D004890
% 221.02/221.19       GEN or unspecified; prefer specifics; redness of the skin from various causes: do not confuse with ERYTHRODERMA see DERMATITIS, EXFOLIATIVE %26% do not make diagnoses: use the word of the text; prickly heat: index under MILIARIA%A%  
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D004890 2005
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D004890 1999
% 221.02/221.19  |- skos__scopeNote mesh__D004890
% 221.02/221.19       Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of causes.%A%    
% 221.02/221.19  |- rdf__type mesh__D004890sskos__Concept
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D004890 2002
% 221.02/221.19  |- skos__altLabel mesh__D004092 Dihydroprogesterone
% 221.02/221.19  |- mesh__recordAuthorizer mesh__D004092 sjn
% 221.02/221.19  |- mesh__publicMeSHNote mesh__D004092
% 221.02/221.19       2004; see DIHYDROPROGESTERONE 1991-2003, see PROGESTERONE 1975-1990%A%  
% 221.02/221.19  |- skos__hiddenLabel mesh__D004092 20 alpha Dihydroprogesterone
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D004092 2006
% 221.02/221.19  |- mesh__dateEstablished mesh__D004092 1991-01-01
% 221.02/221.19  |- skos__altLabel mesh__D004092 20 alpha-Hydroxyprogesterone
% 221.02/221.19  |- skos__historyNote mesh__D004092 Progesterone %28%1974%29%
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D004092 2005
% 221.02/221.19  |- mesh__historyNote mesh__D004092 2004 %28%1975%29%   
% 221.02/221.19  |- skos__altLabel mesh__D004092 Pregn-4-en-3-one, 20-alpha-hydroxy-
% 221.02/221.19  |- skos__hiddenLabel mesh__D004092 20 alpha Hydroxy 4 Pregnen 3 One
% 221.02/221.19  |- skos__hiddenLabel mesh__D004092 20 alpha Hydroxyprogesterone
% 221.02/221.19  |- skos__hiddenLabel mesh__D004092 20-alpha-hydroxy- Pregn-4-en-3-one
% 221.02/221.19  |- skos__altLabel mesh__D004092 20 alpha-Dihydroprogesterone
% 221.02/221.19  |- skos__scopeNote mesh__D004092
% 221.02/221.19       A biologically active 20-alpha-reduced metabolite of PROGESTERONE. It is converted from progesterone to 20-alpha-hydroxypregn-4-en-3-one by the 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE in the CORPUS LUTEUM and the PLACENTA.%A%    
% 221.02/221.19  |- skos__hiddenLabel mesh__D004092 Pregn 4 en 3 one, 20 alpha hydroxy 
% 221.02/221.19  |- skos__prefLabel mesh__D004092 20-alpha-Dihydroprogesterone
% 221.02/221.19  |- skos__hiddenLabel mesh__D004092 20alpha Hydroxypregn 4 Ene 3 One
% 221.02/221.19  |- mesh__dateCreated mesh__D004092 1974-11-11
% 221.02/221.19  |- mesh__recordMaintainer mesh__D004092 lkt
% 221.02/221.19  |- mesh__recordOriginator mesh__D004092 NLM
% 221.02/221.19  |- skos__altLabel mesh__D004092 20 alpha-Hydroxy-4-Pregnen-3-One
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D004092 2004
% 221.02/221.19  |- skos__altLabel mesh__D004092 20-alpha-Hydroxyprogesterone
% 221.02/221.19  |- mesh__dateRevised mesh__D004092 2003-07-09
% 221.02/221.19  |- rdf__type mesh__D004092sskos__Concept
% 221.02/221.19  |- skos__altLabel mesh__D004092 20alpha-Hydroxypregn-4-Ene-3-One
% 221.02/221.19  |- skos__broader mesh__D004092smesh__D011374
% 221.02/221.19  |- skos__scopeNote mesh__D012524
% 221.02/221.19       An organophosphorus ester compound that produces potent and irreversible inhibition of cholinesterase. It is toxic to the nervous system and is a chemical warfare agent.%A%    
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D012524 2002
% 221.02/221.19  |- skos__historyNote mesh__D012524
% 221.02/221.19       Cholinesterase Inhibitors %28%1966-1971%29%
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D012524 2005
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D012524 2005A
% 221.02/221.19  |- mesh__recordMaintainer mesh__D012524 jls
% 221.02/221.19  |- skos__hiddenLabel mesh__D012524 Phosphonofluoridate, o-Isopropylmethyl
% 221.02/221.19  |- rdf__type mesh__D012524sskos__Concept
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D012524 2006
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D012524 2000
% 221.02/221.19  |- skos__broader mesh__D012524smesh__D009943
% 221.02/221.19  |- mesh__dateEstablished mesh__D012524 1991-01-01
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D012524 2003
% 221.02/221.19  |- skos__hiddenLabel mesh__D012524
% 221.02/221.19       ortho Isopropylmethyl Phosphonofluoridate
% 221.02/221.19  |- skos__hiddenLabel mesh__D012524 o Isopropylmethyl Phosphonofluoridate
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D012524 1999
% 221.02/221.19  |- skos__historyNote mesh__D012524 Organophosphorus Compounds %28%1971%29%
% 221.02/221.19  |- mesh__dateRevised mesh__D012524 2004-08-02
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D012524 2001
% 221.02/221.19  |- mesh__recordOriginator mesh__D012524 NLM
% 221.02/221.19  |- mesh__recordAuthorizer mesh__D012524 jls
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D012524 2004
% 221.02/221.19  |- skos__hiddenLabel mesh__D012524
% 221.02/221.19       Phosphonofluoridate, ortho-Isopropylmethyl
% 221.02/221.19  |- skos__altLabel mesh__D012524 ortho-Isopropylmethyl Phosphonofluoridate
% 221.02/221.19  |- mesh__dateCreated mesh__D012524 1999-01-01
% 221.02/221.19  |- skos__altLabel mesh__D012524 o-Isopropylmethyl Phosphonofluoridate
% 221.02/221.19  |- mesh__publicMeSHNote mesh__D012524
% 221.02/221.19       91; was see under ORGANOPHOSPHORUS COMPOUNDS 1972-90   
% 221.02/221.19  |- mesh__historyNote mesh__D012524
% 221.02/221.19       91%28%72%29%; was see under ORGANOPHOSPHORUS COMPOUNDS 1972-90   
% 221.02/221.19  |- skos__prefLabel mesh__D012524 Sarin
% 221.02/221.19  |- skos__hiddenLabel mesh__D050643 Beluga Whales
% 221.02/221.19  |- mesh__dateCreated mesh__D050643 2005-06-30
% 221.02/221.19  |- mesh__publicMeSHNote mesh__D050643 2006; see WHALES 1998-2005   
% 221.02/221.19  |- skos__broader mesh__D050643smesh__D014907
% 221.02/221.19  |- skos__prefLabel mesh__D050643 Beluga Whale
% 221.02/221.19  |- skos__hiddenLabel mesh__D050643 Whales, White
% 221.02/221.19  |- mesh__recordAuthorizer mesh__D050643 sjn
% 221.02/221.19  |- skos__hiddenLabel mesh__D050643 Whale, White
% 221.02/221.19  |- mesh__recordOriginator mesh__D050643 ags
% 221.02/221.19  |- skos__historyNote mesh__D050643 Whales %28%1976-2005%29%
% 221.02/221.19  |- mesh__historyNote mesh__D050643 2006; use WHALES 1998-2005   
% 221.02/221.19  |- skos__hiddenLabel mesh__D050643 White Whales
% 221.02/221.19  |- skos__historyNote mesh__D050643 Cetacea %28%1969-1989%29%
% 221.02/221.19  |- rdf__type mesh__D050643sskos__Concept
% 221.02/221.19  |- mesh__dateEstablished mesh__D050643 2006-01-01
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D050643 2006
% 221.02/221.19  |- skos__altLabel mesh__D050643 White Whale
% 221.02/221.19  |- skos__scopeNote mesh__D050643
% 221.02/221.19       The species Delphinapterus leucas, in the family Monodontidae, found primarily in the Arctic Ocean and adjoining seas. They are small WHALES lacking a dorsal fin.%A%    
% 221.02/221.19  |- mesh__recordMaintainer mesh__D050643 ags
% 221.02/221.19  |- skos__altLabel mesh__D050643 Delphinapterus leucas
% 221.02/221.19  |- skos__broader mesh__D043209Q000172smesh__D043209
% 221.02/221.19  |- mesh__preferredCombination mesh__D043209Q000172smesh__D043204
% 221.02/221.19  |- rdf__type mesh__D043209Q000172smesh__CompoundConcept
% 221.02/221.19  |- skos__scopeNote mesh__D003798
% 221.02/221.19       Dental personnel practicing in hospitals.     
% 221.02/221.19  |- mesh__publicMeSHNote mesh__D003798
% 221.02/221.19       78; was HOSPITAL DENTAL STAFF 1971-77   
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003798 1999
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003798 2003
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003798 1995
% 221.02/221.19  |- skos__altLabel mesh__D003798 Hospital Dental Staffs
% 221.02/221.19  |- mesh__historyNote mesh__D003798 78; was HOSPITAL DENTAL STAFF 1971-77   
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003798 2001
% 221.02/221.19  |- skos__altLabel mesh__D003798 Hospital Dental Staff
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003798 2006
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003798 1998
% 221.02/221.19  |- skos__broader mesh__D003798smesh__D003797
% 221.02/221.19  |- skos__altLabel mesh__D003798 Staff, Hospital Dental
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003798 1994
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003798 2000
% 221.02/221.19  |- skos__prefLabel mesh__D003798 Dental Staff, Hospital
% 221.02/221.19  |- skos__annotation mesh__D003798 DF: DENT STAFF HOSP   
% 221.02/221.19  |- mesh__activeMeSHYear mesh__D003798 2005
% 221.02/221.19  |- skos__altLabel mesh__D003798 Dental Staffs, Hospital
% 221.02/221.19  |- mesh__dateCreated mesh__D003798 1999-01-01
% 221.02/221.19  |- skos__altLabel mesh__D003798 Staffs, Hospital Dental
% 221.02/221.20  |- mesh__recordOriginator mesh__D003798 NLM
% 221.02/221.20  |- mesh__dateEstablished mesh__D003798 1974-01-01
% 221.02/221.20  |- mesh__recordMaintainer mesh__D003798 TAP
% 221.02/221.20  |- mesh__activeMeSHYear mesh__D003798 1997
% 221.02/221.20  |- mesh__activeMeSHYear mesh__D003798 2002
% 221.02/221.20  |- mesh__onlineNote mesh__D003798
% 221.02/221.20       use DENTAL STAFF, HOSPITAL to search HOSPITAL DENTAL STAFF 1971-77%A%  
% 221.02/221.20  |- rdf__type mesh__D003798sskos__Concept
% 221.02/221.20  |- mesh__recordAuthorizer mesh__D003798 PLS
% 221.02/221.20  |- mesh__activeMeSHYear mesh__D003798 1993
% 221.02/221.20  |- skos__broader mesh__D003798smesh__D010564
% 221.02/221.20  |- mesh__activeMeSHYear mesh__D003798 2004
% 221.02/221.20  |- mesh__activeMeSHYear mesh__D003798 1996
% 221.02/221.20  |- mesh__dateRevised mesh__D003798 1992-05-14
% 221.02/221.20  |- mesh__activeMeSHYear mesh__D008483 2003
% 221.02/221.20  |- mesh__dateRevised mesh__D008483 1999-11-03
% 221.02/221.20  |- skos__historyNote mesh__D008483 Social Welfare %28%1966-1967%29%
% 221.02/221.20  |- mesh__historyNote mesh__D008483 68   
% 221.02/221.20  |- skos__prefLabel mesh__D008483 Medical Assistance
% 221.02/221.20  |- mesh__recordOriginator mesh__D008483 NLM
% 221.02/221.20  |- mesh__activeMeSHYear mesh__D008483 2001
% 221.02/221.20  |- skos__altLabel mesh__D008483 Assistance, Medical
% 221.02/221.20  |- mesh__activeMeSHYear mesh__D008483 2006
% 221.02/221.20  |- skos__broader mesh__D008483smesh__D011632
% 221.02/221.20  |- mesh__activeMeSHYear mesh__D008483 2000
% 221.02/221.20  |- skos__historyNote mesh__D008483 Public Health %28%1966-1967%29%
% 221.02/221.20  |- mesh__activeMeSHYear mesh__D008483 2005
% 221.02/221.20  |- mesh__recordMaintainer mesh__D008483 kle
% 221.02/221.20  |- mesh__publicMeSHNote mesh__D008483 68   
% 221.02/221.20  |- mesh__dateEstablished mesh__D008483 1968-01-01
% 221.02/221.20  |- rdf__type mesh__D008483sskos__Concept
% 221.02/221.20  |- mesh__dateCreated mesh__D008483 1999-01-01
% 221.06/221.20  |- skos__scopeNote mesh__D008483
% 221.06/221.20       Financing of medical care provided to public assistance recipients.%A%    
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D008483 2002
% 221.06/221.20  |- mesh__recordAuthorizer mesh__D008483 sjn
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D008483 2004
% 221.06/221.20  |- skos__annotation mesh__D008483 specify geog; DF: MED ASSISTANCE   
% 221.06/221.20  |- mesh__dateEstablished mesh__D016915 1992-01-01
% 221.06/221.20  |- skos__prefLabel mesh__D016915 AIDS Vaccines
% 221.06/221.20  |- mesh__recordAuthorizer mesh__D016915 sjn
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016915 2006
% 221.06/221.20  |- mesh__dateCreated mesh__D016915 1991-05-30
% 221.06/221.20  |- mesh__dateRevised mesh__D016915 2005-06-30
% 221.06/221.20  |- skos__broader mesh__D016915smesh__D014765
% 221.06/221.20  |- rdf__type mesh__D016915sskos__Concept
% 221.06/221.20  |- mesh__publicMeSHNote mesh__D016915 92   
% 221.06/221.20  |- mesh__recordMaintainer mesh__D016915 ssb
% 221.06/221.20  |- skos__historyNote mesh__D016915 Viral Vaccines %28%1987-1991%29%
% 221.06/221.20  |- mesh__historyNote mesh__D016915 92   
% 221.06/221.20  |- skos__scopeNote mesh__D016915
% 221.06/221.20       Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent or treat AIDS. Some vaccines containing antigens are recombinantly produced.%A%    
% 221.06/221.20  |- mesh__recordOriginator mesh__D016915 AGS
% 221.06/221.20  |- skos__broader mesh__D016117smesh__D000417
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016117 2005
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016117 2002
% 221.06/221.20  |- mesh__recordAuthorizer mesh__D016117 sjn
% 221.06/221.20  |- mesh__dateEstablished mesh__D016117 1991-01-01
% 221.06/221.20  |- skos__historyNote mesh__D016117 Albinism %28%1966-1990%29%
% 221.06/221.20  |- mesh__publicMeSHNote mesh__D016117 91   
% 221.06/221.20  |- mesh__dateCreated mesh__D016117 1990-02-12
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016117 2006
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016117 2003
% 221.06/221.20  |- skos__prefLabel mesh__D016117 Albinism, Ocular
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016117 2004
% 221.06/221.20  |- skos__hiddenLabel mesh__D016117 Ocular Albinism
% 221.06/221.20  |- rdf__type mesh__D016117sskos__Concept
% 221.06/221.20  |- mesh__recordMaintainer mesh__D016117 nns
% 221.06/221.20  |- mesh__recordOriginator mesh__D016117 AGS
% 221.06/221.20  |- skos__scopeNote mesh__D016117
% 221.06/221.20       Albinism affecting the eye in which pigment of the hair and skin is normal or only slightly diluted. The classic type is X-linked %28%Nettleship-Falls%29%, but an autosomal recessive form also exists. Ocular abnormalities may include reduced pigmentation of the iris, nystagmus, photophobia, strabismus, and decreased visual acuity.%A%    
% 221.06/221.20  |- mesh__historyNote mesh__D016117 91   
% 221.06/221.20  |- skos__annotation mesh__D016117
% 221.06/221.20       hypopigmentation of eye; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 221.06/221.20  |- mesh__dateRevised mesh__D016117 2001-07-25
% 221.06/221.20  |- skos__altLabel mesh__D004891 Tuberculosis Cutis Indurativa
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D004891 2002
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D004891 2004
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D004891 2001
% 221.06/221.20  |- skos__altLabel mesh__D004891 Bazin Disease
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D004891 2006
% 221.06/221.20  |- mesh__recordAuthorizer mesh__D004891 PLS
% 221.06/221.20  |- skos__broader mesh__D004891smesh__D015434
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D004891 2003
% 221.06/221.20  |- mesh__recordMaintainer mesh__D004891 PXP
% 221.06/221.20  |- mesh__historyNote mesh__D004891
% 221.06/221.20       91%28%75%29%; was see under TUBERCULOSIS, CUTANEOUS 1975-90   
% 221.06/221.20  |- skos__scopeNote mesh__D004891
% 221.06/221.20       A type of panniculitis characterized histologically by the presence of granulomas, vasculitis, and necrosis. It is traditionally considered to be the tuberculous counterpart of nodular vasculitis, but is now known to occur without tuberculous precedent. It is seen most commonly in adolescent and menopausal women, is initiated or exacerbated by cold weather, and typically presents as one or more recurrent erythrocyanotic nodules or plaques on the calves. The nodules may progress to form indurations, ulcerations, and scars.%A%    
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D004891 1997
% 221.06/221.20  |- mesh__dateRevised mesh__D004891 1994-02-08
% 221.06/221.20  |- mesh__dateCreated mesh__D004891 1999-01-01
% 221.06/221.20  |- skos__altLabel mesh__D004891 Bazin%27%s Disease
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D004891 2005
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D004891 2000
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D004891 1999
% 221.06/221.20  |- mesh__onlineNote mesh__D004891 search TUBERCULOSIS, CUTANEOUS 1966-74   
% 221.06/221.20  |- skos__hiddenLabel mesh__D004891 Disease, Bazin%27%s
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D004891 1996
% 221.06/221.20  |- mesh__dateEstablished mesh__D004891 1991-01-01
% 221.06/221.20  |- skos__annotation mesh__D004891 a form of cutaneous tuberc   
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D004891 1995
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D004891 1998
% 221.06/221.20  |- skos__broader mesh__D004891smesh__D014382
% 221.06/221.20  |- rdf__type mesh__D004891sskos__Concept
% 221.06/221.20  |- skos__prefLabel mesh__D004891 Erythema Induratum
% 221.06/221.20  |- mesh__publicMeSHNote mesh__D004891
% 221.06/221.20       91; was see under TUBERCULOSIS, CUTANEOUS 1975-90   
% 221.06/221.20  |- mesh__recordOriginator mesh__D004891 NLM
% 221.06/221.20  |- skos__hiddenLabel mesh__D004891 Disease, Bazin
% 221.06/221.20  |- skos__broader mesh__D004891smesh__D004890
% 221.06/221.20  |- skos__hiddenLabel mesh__D004891 Bazins Disease
% 221.06/221.20  |- mesh__recordMaintainer mesh__D004093 AKE
% 221.06/221.20  |- mesh__recordAuthorizer mesh__D004093 sjn
% 221.06/221.20  |- skos__prefLabel mesh__D004093 Dihydropteridine Reductase
% 221.06/221.20  |- mesh__publicMeSHNote mesh__D004093
% 221.06/221.20       91; was see under NADH, NADPH OXIDOREDUCTASES 1975-90   
% 221.06/221.20  |- skos__altLabel mesh__D004093 6,7-Dihydropteridine Reductase
% 221.06/221.20  |- skos__broader mesh__D004093smesh__D000587
% 221.06/221.20  |- skos__broader mesh__D004093smesh__D010089
% 221.06/221.20  |- skos__scopeNote mesh__D004093
% 221.06/221.20       An enzyme that catalyzes the reduction of 6,7-dihydropteridine to 5,6,7,8-tetrahydropteridine in the presence of NADP+. Defects in the enzyme are a cause of PHENYLKETONURIA II. Formerly listed as EC 1.6.99.7.%A%    
% 221.06/221.20  |- skos__hiddenLabel mesh__D004093 Reductase, Dihydropteridine
% 221.06/221.20  |- rdf__type mesh__D004093sskos__Concept
% 221.06/221.20  |- mesh__historyNote mesh__D004093
% 221.06/221.20       91%28%75%29%; was see under NADH, NADPH OXIDOREDUCTASES 1975-90%A%  
% 221.06/221.20  |- mesh__dateRevised mesh__D004093 2005-06-30
% 221.06/221.20  |- skos__hiddenLabel mesh__D004093 Reductase, 6,7-Dihydropteridine
% 221.06/221.20  |- mesh__dateCreated mesh__D004093 1974-11-27
% 221.06/221.20  |- skos__hiddenLabel mesh__D004093 6,7 Dihydropteridine Reductase
% 221.06/221.20  |- skos__historyNote mesh__D004093
% 221.06/221.20       NADH, NADPH Oxidoreductases %28%1973-1974%29%
% 221.06/221.20  |- mesh__recordOriginator mesh__D004093 NLM
% 221.06/221.20  |- skos__historyNote mesh__D004093 Pteridines %28%1973-1974%29%
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D004093 2006
% 221.06/221.20  |- mesh__dateEstablished mesh__D004093 1991-01-01
% 221.06/221.20  |- mesh__recordMaintainer mesh__D012525 TGC
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D012525 2001
% 221.06/221.20  |- skos__broader mesh__D012525smesh__D002170
% 221.06/221.20  |- mesh__recordOriginator mesh__D012525 NLM
% 221.06/221.20  |- skos__prefLabel mesh__D012525 Saskatchewan
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D012525 2003
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D012525 1999
% 221.06/221.20  |- mesh__dateRevised mesh__D012525 1995-02-21
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D012525 1996
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D012525 2004
% 221.06/221.20  |- mesh__dateCreated mesh__D012525 1999-01-01
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D012525 2002
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D012525 1997
% 221.06/221.20  |- skos__scopeNote mesh__D012525
% 221.06/221.20       A province of Canada, lying between the provinces of Alberta and Manitoba. Its capital is Regina. It is entirely a plains region with prairie in the south and wooded country with many lakes and swamps in the north. The name was taken from the Saskatchewan River from the Cree name Kisiskatchewani Sipi, meaning rapid-flowing river. %28%From Webster%27%s New Geographical Dictionary, 1988, p1083 %26% Room, Brewer%27%s Dictionary of Names, 1992, p486%29%%A%    
% 221.06/221.20  |- mesh__recordAuthorizer mesh__D012525 PLS
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D012525 2005
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D012525 2000
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D012525 1998
% 221.06/221.20  |- rdf__type mesh__D012525sskos__Concept
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D012525 2006
% 221.06/221.20  |- mesh__publicMeSHNote mesh__D017210 93   
% 221.06/221.20  |- skos__altLabel mesh__D017210 Mozambique Tilapia
% 221.06/221.20  |- mesh__recordAuthorizer mesh__D017210 sjn
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D017210 2006
% 221.06/221.20  |- skos__scopeNote mesh__D017210
% 221.06/221.20       A freshwater fish used as an experimental organism and for food. This genus of the family Cichlidae %28%CICHLIDS%29% inhabits Central and South America %28%one species extends north into Texas%29%, West Indies, Africa, Madagascar, Syria, and coastal India.%A%    
% 221.06/221.20  |- skos__hiddenLabel mesh__D017210 Tilapias, Mozambique
% 221.06/221.20  |- skos__broader mesh__D017210smesh__D023681
% 221.06/221.20  |- skos__hiddenLabel mesh__D017210 Tilapia, Mozambique
% 221.06/221.20  |- skos__prefLabel mesh__D017210 Tilapia
% 221.06/221.20  |- skos__altLabel mesh__D017210 Oreochromis mossambicus
% 221.06/221.20  |- mesh__dateRevised mesh__D017210 2003-07-09
% 221.06/221.20  |- skos__historyNote mesh__D017210 Fishes %28%1966-1992%29%
% 221.06/221.20  |- rdf__type mesh__D017210sskos__Concept
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D017210 2004
% 221.06/221.20  |- mesh__recordMaintainer mesh__D017210 ags
% 221.06/221.20  |- mesh__recordOriginator mesh__D017210 MXR
% 221.06/221.20  |- skos__annotation mesh__D017210
% 221.06/221.20       TILAPIA NILOTICA and NILE TILAPIA see CICHLIDS are also available%A%  
% 221.06/221.20  |- mesh__historyNote mesh__D017210 93   
% 221.06/221.20  |- mesh__dateEstablished mesh__D017210 1993-01-01
% 221.06/221.20  |- skos__hiddenLabel mesh__D017210 Mozambique Tilapias
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D017210 2005
% 221.06/221.20  |- mesh__dateCreated mesh__D017210 1992-05-22
% 221.06/221.20  |- mesh__recordMaintainer mesh__D050644 AKE
% 221.06/221.20  |- mesh__publicMeSHNote mesh__D050644
% 221.06/221.20       2006; SUCCINATE-SEMIALDEHYDE DEHYDROGENASE was indexed under ALDEHYDE OXIDOREDUCTASES 1977-2005%A%  
% 221.06/221.20  |- skos__hiddenLabel mesh__D050644 Dehydrogenase, Succinate-Semialdehyde
% 221.06/221.20  |- mesh__dateEstablished mesh__D050644 2006-01-01
% 221.06/221.20  |- skos__altLabel mesh__D050644 Succinate Semialdehyde Dehydrogenase
% 221.06/221.20  |- skos__altLabel mesh__D050644
% 221.06/221.20       NAD%28%+%29%-Dependent Succinic Semialdehyde Dehydrogenase
% 221.06/221.20  |- mesh__recordOriginator mesh__D050644 AKE
% 221.06/221.20  |- skos__scopeNote mesh__D050644
% 221.06/221.20       An enzyme that plays a role in the GLUTAMATE and butanoate metabolism pathways by catalyzing the oxidation of succinate semialdehyde to SUCCINATE using NAD+ as a coenzyme. Deficiency of this enzyme, causes 4-hydroxybutyricaciduria, a rare inborn error in the metabolism of the neurotransmitter 4-aminobutyric acid %28%GABA%29%.%A%    
% 221.06/221.20  |- mesh__historyNote mesh__D050644
% 221.06/221.20       2006%28%1980%29%; use ALDEHYDE OXIDREDUCTASES 1977-1979   
% 221.06/221.20  |- skos__hiddenLabel mesh__D050644 Semialdehyde Dehydrogenase, Succinate
% 221.06/221.20  |- skos__prefLabel mesh__D050644 Succinate-Semialdehyde Dehydrogenase
% 221.06/221.20  |- skos__hiddenLabel mesh__D050644 Semialdehyde Dehydrogenase, Succinic
% 221.06/221.20  |- skos__hiddenLabel mesh__D050644 Dehydrogenase, Succinic Semialdehyde
% 221.06/221.20  |- mesh__recordAuthorizer mesh__D050644 sjn
% 221.06/221.20  |- skos__hiddenLabel mesh__D050644 Dehydrogenase, Succinate Semialdehyde
% 221.06/221.20  |- skos__altLabel mesh__D050644 Succinic Semialdehyde Dehydrogenase
% 221.06/221.20  |- rdf__type mesh__D050644sskos__Concept
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D050644 2006
% 221.06/221.20  |- mesh__dateCreated mesh__D050644 2005-06-30
% 221.06/221.20  |- skos__broader mesh__D050644smesh__D000445
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D003799 2004
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D003799 1999
% 221.06/221.20  |- skos__altLabel mesh__D003799 Analyses, Dental Stress
% 221.06/221.20  |- mesh__dateRevised mesh__D003799 1996-06-10
% 221.06/221.20  |- skos__prefLabel mesh__D003799 Dental Stress Analysis
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D003799 2001
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D003799 2003
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D003799 1998
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D003799 2000
% 221.06/221.20  |- mesh__dateCreated mesh__D003799 1999-01-01
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D003799 2006
% 221.06/221.20  |- skos__annotation mesh__D003799
% 221.06/221.20       coord IM or NIM with specific dent feature %28%IM%29%; COMPRESSIVE STRENGTH %26% TENSILE STRENGTH are available for these aspects of characterization; DF: DENT STRESS ANAL%A%  
% 221.06/221.20  |- mesh__recordOriginator mesh__D003799 NLM
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D003799 2005
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D003799 1997
% 221.06/221.20  |- skos__broader mesh__D003799smesh__D003813
% 221.06/221.20  |- skos__altLabel mesh__D003799 Stress Analyses, Dental
% 221.06/221.20  |- skos__altLabel mesh__D003799 Stress Analysis, Dental
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D003799 2002
% 221.06/221.20  |- mesh__recordAuthorizer mesh__D003799 PLS
% 221.06/221.20  |- rdf__type mesh__D003799sskos__Concept
% 221.06/221.20  |- mesh__dateEstablished mesh__D003799 1972-01-01
% 221.06/221.20  |- skos__altLabel mesh__D003799 Analysis, Dental Stress
% 221.06/221.20  |- skos__hiddenLabel mesh__D003799 Dental Stress Analyses
% 221.06/221.20  |- mesh__historyNote mesh__D003799 72%28%68%29%   
% 221.06/221.20  |- skos__scopeNote mesh__D003799
% 221.06/221.20       The description and measurement of the various factors that produce physical stress upon dental restorations, prostheses, or appliances, materials associated with them, or the natural oral structures.%A%    
% 221.06/221.20  |- mesh__recordMaintainer mesh__D003799 TGC
% 221.06/221.20  |- skos__historyNote mesh__D003799 Dental Occlusion %28%1966-1969%29%
% 221.06/221.20  |- mesh__publicMeSHNote mesh__D003799 72   
% 221.06/221.20  |- skos__broader mesh__D008484smesh__D008483
% 221.06/221.20  |- mesh__publicMeSHNote mesh__D008484
% 221.06/221.20       91; was MEDICAL ASSISTANCE, TITLE 19 1971-90; MEDICAID was see MEDICAL ASSISTANCE, TITLE 19 1975-90, was see under MEDICAL ASSISTANCE 1969-70; DENTAL MEDICAID PROGRAM was see under MEDICAL ASSISTANCE, TITLE 19 1979-85, was DENTICAID see under MEDICAL ASSISTANCE, TITLE 19 1974-78, was DENTICAID see under MEDICAL ASSISTANCE 1969-73%A%  
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D008484 2005
% 221.06/221.20  |- mesh__onlineNote mesh__D008484
% 221.06/221.20       use MEDICAID to search MEDICAL ASSISTANCE, TITLE 19 1971-90; use MEDICAL ASSISTANCE to search DENTAL MEDICAID PROGRAM 1969-73%A%  
% 221.06/221.20  |- rdf__type mesh__D008484sskos__Concept
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D008484 2002
% 221.06/221.20  |- skos__prefLabel mesh__D008484 Medicaid
% 221.06/221.20  |- mesh__dateCreated mesh__D008484 1999-01-01
% 221.06/221.20  |- mesh__recordAuthorizer mesh__D008484 sjn
% 221.06/221.20  |- mesh__dateRevised mesh__D008484 1999-11-03
% 221.06/221.20  |- skos__altLabel mesh__D008484 Medicaid Program, Dental
% 221.06/221.20  |- skos__altLabel mesh__D008484 Dental Medicaid Programs
% 221.06/221.20  |- skos__annotation mesh__D008484 specify geog; Public Law 89-97   
% 221.06/221.20  |- mesh__historyNote mesh__D008484
% 221.06/221.20       91; was MEDICAL ASSISTANCE, TITLE 19 1971-90; MEDICAID was see MEDICAL ASSISTANCE, TITLE 19 1975-90, was see under MEDICAL ASSISTANCE 1969-70; DENTAL MEDICAID PROGRAM was see under MEDICAL ASSISTANCE, TITLE 19 1979-85, was DENTICAID see under MEDICAL ASSISTANCE, TITLE 19 1974-78, was DENTICAID see under MEDICAL ASSISTANCE 1969-73%A%  
% 221.06/221.20  |- skos__hiddenLabel mesh__D008484 Program, Dental Medicaid
% 221.06/221.20  |- skos__hiddenLabel mesh__D008484 Programs, Dental Medicaid
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D008484 2004
% 221.06/221.20  |- mesh__dateEstablished mesh__D008484 1971-01-01
% 221.06/221.20  |- skos__altLabel mesh__D008484 Medicaid Programs, Dental
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D008484 2001
% 221.06/221.20  |- mesh__recordOriginator mesh__D008484 NLM
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D008484 2003
% 221.06/221.20  |- skos__scopeNote mesh__D008484
% 221.06/221.20       Federal program, created by Public Law 89-97, Title XIX, a 1965 amendment to the Social Security Act, administered by the states, that provides health care benefits to indigent and medically indigent persons.%A%    
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D008484 2000
% 221.06/221.20  |- skos__historyNote mesh__D008484 Medical Assistance %28%1968-1970%29%
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D008484 2006
% 221.06/221.20  |- mesh__recordMaintainer mesh__D008484 kle
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016916 2006
% 221.06/221.20  |- skos__hiddenLabel mesh__D016916 Joint Deformity, Acquired
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016916 2000
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016916 1994
% 221.06/221.20  |- skos__annotation mesh__D016916
% 221.06/221.20       coord IM with specific joint %28%IM%29%; HAND DEFORMITIES, ACQUIRED %26% FOOT DEFORMITIES, ACQUIRED are also available%A%  
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016916 2003
% 221.06/221.20  |- skos__broader mesh__D016916smesh__D007592
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016916 1998
% 221.06/221.20  |- skos__hiddenLabel mesh__D016916 Acquired Joint Deformities
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016916 1995
% 221.06/221.20  |- mesh__dateRevised mesh__D016916 1992-05-20
% 221.06/221.20  |- mesh__dateEstablished mesh__D016916 1992-01-01
% 221.06/221.20  |- rdf__type mesh__D016916sskos__Concept
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016916 2001
% 221.06/221.20  |- mesh__recordOriginator mesh__D016916 TGC
% 221.06/221.20  |- skos__scopeNote mesh__D016916
% 221.06/221.20       Deformities acquired after birth as the result of injury or disease. The joint deformity is often associated with rheumatoid arthritis and leprosy.%A%    
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016916 2004
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016916 1999
% 221.06/221.20  |- mesh__dateCreated mesh__D016916 1991-06-27
% 221.06/221.20  |- mesh__recordMaintainer mesh__D016916 PLS
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016916 1996
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016916 1993
% 221.06/221.20  |- skos__hiddenLabel mesh__D016916 Deformities, Acquired Joint
% 221.06/221.20  |- skos__hiddenLabel mesh__D016916 Deformity, Acquired Joint
% 221.06/221.20  |- skos__hiddenLabel mesh__D016916 Acquired Joint Deformity
% 221.06/221.20  |- mesh__historyNote mesh__D016916 92   
% 221.06/221.20  |- mesh__recordAuthorizer mesh__D016916 PLS
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016916 1997
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016916 2002
% 221.06/221.20  |- mesh__publicMeSHNote mesh__D016916 92   
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016916 2005
% 221.06/221.20  |- skos__prefLabel mesh__D016916 Joint Deformities, Acquired
% 221.06/221.20  |- skos__historyNote mesh__D016118 Ligaments, Articular %28%1966-1990%29%
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016118 2001
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016118 1994
% 221.06/221.20  |- skos__annotation mesh__D016118 a ligament of the knee   
% 221.06/221.20  |- skos__related mesh__D016118smesh__D017888
% 221.06/221.20  |- skos__hiddenLabel mesh__D016118 Cruciate Ligaments, Anterior
% 221.06/221.20  |- skos__scopeNote mesh__D016118
% 221.06/221.20       A strong ligament of the knee that originates from the posteromedial portion of the lateral condyle of the femur, passes anteriorly and inferiorly between the condyles, and attaches to the depression in front of the intercondylar eminence of the tibia.%A%    
% 221.06/221.20  |- skos__hiddenLabel mesh__D016118 Ligament, Anterior Cruciate
% 221.06/221.20  |- skos__altLabel mesh__D016118 Cruciate Ligament, Anterior
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016118 2000
% 221.06/221.20  |- mesh__recordOriginator mesh__D016118 PXP
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016118 2004
% 221.06/221.20  |- mesh__dateRevised mesh__D016118 1993-02-16
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016118 2006
% 221.06/221.20  |- mesh__historyNote mesh__D016118 91   
% 221.06/221.20  |- mesh__recordAuthorizer mesh__D016118 PLS
% 221.06/221.20  |- mesh__recordMaintainer mesh__D016118 TGC
% 221.06/221.20  |- skos__hiddenLabel mesh__D016118 Ligaments, Anterior Cruciate
% 221.06/221.20  |- mesh__publicMeSHNote mesh__D016118 91   
% 221.06/221.20  |- mesh__dateEstablished mesh__D016118 1991-01-01
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016118 1997
% 221.06/221.20  |- skos__prefLabel mesh__D016118 Anterior Cruciate Ligament
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016118 2003
% 221.06/221.20  |- skos__hiddenLabel mesh__D016118 Anterior Cruciate Ligaments
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016118 1999
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016118 2005
% 221.06/221.20  |- skos__historyNote mesh__D016118 Knee Joint %28%1966-1990%29%
% 221.06/221.20  |- skos__broader mesh__D016118smesh__D008023
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016118 1996
% 221.06/221.20  |- mesh__dateCreated mesh__D016118 1990-02-12
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016118 1995
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016118 2002
% 221.06/221.20  |- rdf__type mesh__D016118sskos__Concept
% 221.06/221.20  |- skos__related mesh__D016118smesh__D016119
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D016118 1998
% 221.06/221.20  |- skos__broader mesh__D001151Q000506smesh__D001151
% 221.06/221.20  |- mesh__preferredCombination mesh__D001151Q000506smesh__D020261
% 221.06/221.20  |- rdf__type mesh__D001151Q000506smesh__CompoundConcept
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D004892 2003
% 221.06/221.20  |- skos__related mesh__D004892smesh__D013262
% 221.06/221.20  |- mesh__dateCreated mesh__D004892 1999-01-01
% 221.06/221.20  |- skos__broader mesh__D004892smesh__D004890
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D004892 2005
% 221.06/221.20  |- skos__related mesh__D004892smesh__D012058
% 221.06/221.20  |- mesh__recordMaintainer mesh__D004892 NLM
% 221.06/221.20  |- mesh__recordOriginator mesh__D004892 NLM
% 221.06/221.20  |- skos__broader mesh__D004892smesh__D012872
% 221.06/221.20  |- rdf__type mesh__D004892sskos__Concept
% 221.06/221.20  |- skos__scopeNote mesh__D004892
% 221.06/221.20       A skin and mucous membrane disease characterized by an eruption of macules, papules, nodules, vesicles, and/or bullae with characteristic %22%bull%27%s-eye%22% lesions usually occurring on the dorsal aspect of the hands and forearms.%A%    
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D004892 2002
% 221.06/221.20  |- skos__prefLabel mesh__D004892 Erythema Multiforme
% 221.06/221.20  |- mesh__recordAuthorizer mesh__D004892 NLM
% 221.06/221.20  |- mesh__dateRevised mesh__D004892 2001-08-14
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D004892 2004
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D004892 2006
% 221.06/221.20  |- mesh__historyNote mesh__D004094
% 221.06/221.20       91%28%75%29%; was see under TRANSFERASES 1975-90   
% 221.06/221.20  |- skos__altLabel mesh__D004094 Dihydropteroate Synthetase
% 221.06/221.20  |- skos__historyNote mesh__D004094 Aminobenzoic Acids %28%1969-1974%29%
% 221.06/221.20  |- mesh__publicMeSHNote mesh__D004094
% 221.06/221.20       91; was see under TRANSFERASES 1975-90   
% 221.06/221.20  |- mesh__recordOriginator mesh__D004094 NLM
% 221.06/221.20  |- mesh__recordMaintainer mesh__D004094 ssb
% 221.06/221.20  |- skos__scopeNote mesh__D004094
% 221.06/221.20       An enzyme that catalyzes the formation of dihydropteroate from p-aminobenzoic acid and dihydropteridine-hydroxymethyl-pyrophosphate. EC 2.5.1.15.%A%    
% 221.06/221.20  |- mesh__dateEstablished mesh__D004094 1991-01-01
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D004094 2004
% 221.06/221.20  |- skos__hiddenLabel mesh__D004094 Pyrophosphorylase, Dihydropteroate
% 221.06/221.20  |- skos__hiddenLabel mesh__D004094 Synthetase, Dihydropteroate
% 221.06/221.20  |- rdf__type mesh__D004094sskos__Concept
% 221.06/221.20  |- mesh__dateRevised mesh__D004094 2003-07-09
% 221.06/221.20  |- mesh__recordAuthorizer mesh__D004094 sjn
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D004094 2005
% 221.06/221.20  |- skos__historyNote mesh__D004094 Pteridines %28%1969-1974%29%
% 221.06/221.20  |- skos__hiddenLabel mesh__D004094 Synthase, Dihydropteroate
% 221.06/221.20  |- skos__altLabel mesh__D004094 Dihydropteroate Pyrophosphorylase
% 221.06/221.20  |- skos__historyNote mesh__D004094 Ligases %28%1969-1974%29%
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D004094 2006
% 221.06/221.20  |- skos__broader mesh__D004094smesh__D019883
% 221.06/221.20  |- skos__prefLabel mesh__D004094 Dihydropteroate Synthase
% 221.06/221.20  |- mesh__dateCreated mesh__D004094 1974-11-27
% 221.06/221.20  |- mesh__recordAuthorizer mesh__D012526 sjn
% 221.06/221.20  |- skos__scopeNote mesh__D012526
% 221.06/221.20       Defective viruses which can multiply only by association with a helper virus which complements the defective gene. Satellite viruses may be associated with certain plant viruses, animal viruses, or bacteriophages. They differ from satellite RNA; %28%RNA, SATELLITE%29% in that satellite viruses encode their own coat protein.%A%    
% 221.06/221.20  |- skos__altLabel mesh__D012526 Associated Virus
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D012526 2004
% 221.06/221.20  |- mesh__historyNote mesh__D012526
% 221.06/221.20       79%28%75%29%; was see under ASSOCIATED VIRUSES 1975-78, was SATELLITE VIRUS see under ASSOCIATED VIRUS 1974; ASSOCIATED VIRUSES was heading 1975-78, was ASSOCIATED VIRUS 1967-74 %28%Prov 1967-72%29%%A%  
% 221.06/221.20  |- skos__related mesh__D012526smesh__D019244
% 221.06/221.20  |- mesh__dateCreated mesh__D012526 1999-01-01
% 221.06/221.20  |- skos__hiddenLabel mesh__D012526 Virus, Satellite
% 221.06/221.20  |- skos__hiddenLabel mesh__D012526 Viruses, Satellite
% 221.06/221.20  |- mesh__recordOriginator mesh__D012526 NLM
% 221.06/221.20  |- skos__historyNote mesh__D012526 Defective Viruses %28%1967-1974%29%
% 221.06/221.20  |- skos__related mesh__D012526smesh__D006378
% 221.06/221.20  |- mesh__dateEstablished mesh__D012526 1979-01-01
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D012526 2005
% 221.06/221.20  |- skos__hiddenLabel mesh__D012526 Satellite Virus
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D012526 2002
% 221.06/221.20  |- skos__altLabel mesh__D012526 Viruses, Associated
% 221.06/221.20  |- skos__historyNote mesh__D012526 Viruses %28%1966%29%
% 221.06/221.20  |- mesh__onlineNote mesh__D012526
% 221.06/221.20       use SATELLITE VIRUSES to search ASSOCIATED VIRUSES 1975-78 %26% ASSOCIATED VIRUS 1967-74 %28%as Prov 1967-72%29%%A%  
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D012526 2006
% 221.06/221.20  |- mesh__recordMaintainer mesh__D012526 mdb
% 221.06/221.20  |- rdf__type mesh__D012526sskos__Concept
% 221.06/221.20  |- skos__prefLabel mesh__D012526 Satellite Viruses
% 221.06/221.20  |- skos__annotation mesh__D012526
% 221.06/221.20       defective viruses able to multiply only with a helper virus; coord IM with specific virus %28%IM%29%%A%  
% 221.06/221.20  |- mesh__publicMeSHNote mesh__D012526
% 221.06/221.20       79; was see under ASSOCIATED VIRUSES 1975-78, was SATELLITE VIRUS see under ASSOCIATED VIRUS 1974; ASSOCIATED VIRUSES was heading 1975-78, was ASSOCIATED VIRUS 1973-74%A%  
% 221.06/221.20  |- mesh__dateRevised mesh__D012526 2001-07-25
% 221.06/221.20  |- mesh__activeMeSHYear mesh__D012526 2003
% 221.06/221.20  |- skos__broader mesh__D012526smesh__D003673
% 221.06/221.20  |- skos__altLabel mesh__D012526 Virus, Associated
% 221.06/221.21  |- skos__altLabel mesh__D012526 Associated Viruses
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D017211 1999
% 221.06/221.21  |- mesh__recordAuthorizer mesh__D017211 SJN
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D017211 2006
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D017211 2001
% 221.06/221.21  |- skos__broader mesh__D017211smesh__D016896
% 221.06/221.21  |- skos__scopeNote mesh__D017211
% 221.06/221.21       A measure of the quality of health care by assessment of unsuccessful results of management and procedures used in combating disease, in individual cases or series.%A%    
% 221.06/221.21  |- mesh__recordMaintainer mesh__D017211 JLS
% 221.06/221.21  |- skos__annotation mesh__D017211
% 221.06/221.21       IM: GEN only; coord NIM with dis /ther %28%IM%29%, as %22%analysis of treatment failure in AIDS%22% or with specific ther or intervention %28%IM%29%%A%  
% 221.06/221.21  |- skos__hiddenLabel mesh__D017211 Failures, Treatment
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D017211 2005
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D017211 2004
% 221.06/221.21  |- mesh__publicMeSHNote mesh__D017211 93   
% 221.06/221.21  |- mesh__dateEstablished mesh__D017211 1993-01-01
% 221.06/221.21  |- skos__hiddenLabel mesh__D017211 Treatment Failures
% 221.06/221.21  |- mesh__recordOriginator mesh__D017211 MXR
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D017211 2000
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D017211 2003
% 221.06/221.21  |- mesh__dateCreated mesh__D017211 1992-05-22
% 221.06/221.21  |- skos__prefLabel mesh__D017211 Treatment Failure
% 221.06/221.21  |- rdf__type mesh__D017211sskos__Concept
% 221.06/221.21  |- skos__hiddenLabel mesh__D017211 Failure, Treatment
% 221.06/221.21  |- mesh__dateRevised mesh__D017211 1998-06-11
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D017211 2002
% 221.06/221.21  |- mesh__historyNote mesh__D017211 93   
% 221.06/221.21  |- skos__hiddenLabel mesh__D050645 2 Oxoisovalerate Dehydrogenase
% 221.06/221.21  |- mesh__recordAuthorizer mesh__D050645 sjn
% 221.06/221.21  |- mesh__dateCreated mesh__D050645 2005-06-30
% 221.06/221.21  |- skos__hiddenLabel mesh__D050645 Dehydrogenase, 2-Oxoisovalerate
% 221.06/221.21  |- skos__prefLabel mesh__D050645
% 221.06/221.21       2-Oxoisovalerate Dehydrogenase %28%Acylating%29%
% 221.06/221.21  |- skos__altLabel mesh__D050645 2-Oxoisovalerate Dehydrogenase
% 221.06/221.21  |- skos__broader mesh__D050645smesh__D007658
% 221.06/221.21  |- skos__hiddenLabel mesh__D050645 Dehydrogenase, alpha-Ketoisovalerate
% 221.06/221.21  |- mesh__publicMeSHNote mesh__D050645
% 221.06/221.21       2006; 2-OXOISOVALERATE DEHYDROGENASE %28%ACYLATING%29% was indexed under KETONE OXIDOREDUCTASES 1983-2005, under AMINO ACIDS, BRANCHED-CHAIN 1979-1982, under KETO ACIDS 1973-1982, %26% VALERATES 1973-1979%A%  
% 221.06/221.21  |- mesh__dateEstablished mesh__D050645 2006-01-01
% 221.06/221.21  |- mesh__historyNote mesh__D050645
% 221.06/221.21       2006%28%1980%29%; use AMINO ACIDS, BRANCHED-CHAIN 1979, %26% KETO ACIDS %26% VALERATES 1973-1979%A%  
% 221.06/221.21  |- mesh__recordOriginator mesh__D050645 AKE
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D050645 2006
% 221.06/221.21  |- skos__hiddenLabel mesh__D050645 alpha Ketoisovalerate Dehydrogenase
% 221.06/221.21  |- mesh__recordMaintainer mesh__D050645 AKE
% 221.06/221.21  |- rdf__type mesh__D050645sskos__Concept
% 221.06/221.21  |- skos__scopeNote mesh__D050645
% 221.06/221.21       An NAD+ dependent enzyme that catalyzes the oxidation 3-methyl-2-oxobutanoate to 2-methylpropanoyl-CoA. It plays a role in the degradation of VALINE; LEUCINE; and ISOLEUCINE.%A%    
% 221.06/221.21  |- skos__altLabel mesh__D050645 alpha-Ketoisovalerate Dehydrogenase
% 221.06/221.21  |- mesh__dateCreated mesh__D008485 1999-01-01
% 221.06/221.21  |- mesh__recordMaintainer mesh__D008485 TGC
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008485 1997
% 221.06/221.21  |- skos__broader mesh__D008485smesh__D011785
% 221.06/221.21  |- skos__altLabel mesh__D008485 Audits, Medical
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008485 2004
% 221.06/221.21  |- skos__historyNote mesh__D008485
% 221.06/221.21       Hospital Administration %28%1966-1967%29%
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008485 1996
% 221.06/221.21  |- skos__scopeNote mesh__D008485
% 221.06/221.21       A detailed review and evaluation of selected clinical records by qualified professional personnel for evaluating quality of medical care.%A%    
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008485 2002
% 221.06/221.21  |- skos__prefLabel mesh__D008485 Medical Audit
% 221.06/221.21  |- skos__altLabel mesh__D008485 Audit, Medical
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008485 2003
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008485 1999
% 221.06/221.21  |- skos__broader mesh__D008485smesh__D011787
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008485 1995
% 221.06/221.21  |- mesh__dateRevised mesh__D008485 1994-05-05
% 221.06/221.21  |- mesh__historyNote mesh__D008485 68   
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008485 2006
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008485 1998
% 221.06/221.21  |- skos__altLabel mesh__D008485 Medical Audits
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008485 2005
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008485 2001
% 221.06/221.21  |- mesh__recordOriginator mesh__D008485 NLM
% 221.06/221.21  |- mesh__dateEstablished mesh__D008485 1968-01-01
% 221.06/221.21  |- mesh__publicMeSHNote mesh__D008485 68   
% 221.06/221.21  |- skos__annotation mesh__D008485 DF: MED AUDIT   
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008485 2000
% 221.06/221.21  |- mesh__recordAuthorizer mesh__D008485 PLS
% 221.06/221.21  |- rdf__type mesh__D008485sskos__Concept
% 221.06/221.21  |- skos__hiddenLabel mesh__D016917 Angiomatoses, Bacillary
% 221.06/221.21  |- skos__broader mesh__D016917smesh__D001474
% 221.06/221.21  |- skos__scopeNote mesh__D016917
% 221.06/221.21       An infectious bacterial disease characterized by cutaneous vascular lesions. It is caused by BARTONELLA HENSELAE and is seen in AIDS patients and other immunocompromised hosts.%A%    
% 221.06/221.21  |- skos__prefLabel mesh__D016917 Angiomatosis, Bacillary
% 221.06/221.21  |- skos__hiddenLabel mesh__D016917 Bacillary Angiomatoses
% 221.06/221.21  |- skos__hiddenLabel mesh__D016917 Epithelioid Angiomatosis, Bacillary
% 221.06/221.21  |- mesh__publicMeSHNote mesh__D016917 92   
% 221.06/221.21  |- mesh__historyNote mesh__D016917 92   
% 221.06/221.21  |- mesh__recordMaintainer mesh__D016917 ags
% 221.06/221.21  |- skos__altLabel mesh__D016917 Angiomatosis, Epithelioid
% 221.06/221.21  |- mesh__recordOriginator mesh__D016917 PXP
% 221.06/221.21  |- skos__annotation mesh__D016917
% 221.06/221.21       gram-neg bact infect caused by Bartonella henselae; seen in AIDS %26% other immunocompromised states%A%  
% 221.06/221.21  |- skos__hiddenLabel mesh__D016917 Angiomatoses, Epithelioid
% 221.06/221.21  |- skos__historyNote mesh__D016917 Angiomatosis %28%1989-1991%29%
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D016917 2005
% 221.06/221.21  |- mesh__dateRevised mesh__D016917 2003-07-09
% 221.06/221.21  |- mesh__dateEstablished mesh__D016917 1992-01-01
% 221.06/221.21  |- skos__broader mesh__D016917smesh__D017192
% 221.06/221.21  |- skos__broader mesh__D016917smesh__D017445
% 221.06/221.21  |- skos__hiddenLabel mesh__D016917 Bacillary Epithelioid Angiomatosis
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D016917 2006
% 221.06/221.21  |- skos__hiddenLabel mesh__D016917 Bacillary Angiomatosis
% 221.06/221.21  |- skos__hiddenLabel mesh__D016917 Bacillary Epithelioid Angiomatoses
% 221.06/221.21  |- mesh__recordAuthorizer mesh__D016917 sjn
% 221.06/221.21  |- skos__hiddenLabel mesh__D016917 Epithelioid Angiomatosis
% 221.06/221.21  |- mesh__dateCreated mesh__D016917 1991-05-30
% 221.06/221.21  |- skos__broader mesh__D016917smesh__D000798
% 221.06/221.21  |- rdf__type mesh__D016917sskos__Concept
% 221.06/221.21  |- skos__hiddenLabel mesh__D016917 Epithelioid Angiomatoses, Bacillary
% 221.06/221.21  |- skos__hiddenLabel mesh__D016917 Angiomatoses, Bacillary Epithelioid
% 221.06/221.21  |- skos__altLabel mesh__D016917 Angiomatosis, Bacillary Epithelioid
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D016917 2004
% 221.06/221.21  |- skos__hiddenLabel mesh__D016917 Epithelioid Angiomatoses
% 221.06/221.21  |- skos__altLabel mesh__D016119 Cruciate Ligament, Posterior
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D016119 2001
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D016119 1995
% 221.06/221.21  |- skos__hiddenLabel mesh__D016119 Posterior Cruciate Ligaments
% 221.06/221.21  |- skos__related mesh__D016119smesh__D017888
% 221.06/221.21  |- skos__historyNote mesh__D016119 Knee Joint %28%1973-1990%29%
% 221.06/221.21  |- skos__historyNote mesh__D016119 Ligaments, Articular %28%1973-1990%29%
% 221.06/221.21  |- skos__hiddenLabel mesh__D016119 Cruciate Ligaments, Posterior
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D016119 2000
% 221.06/221.21  |- skos__hiddenLabel mesh__D016119 Ligament, Posterior Cruciate
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D016119 1994
% 221.06/221.21  |- skos__scopeNote mesh__D016119
% 221.06/221.21       A strong ligament of the knee that originates from the anterolateral surface of the medial condyle of the femur, passes posteriorly and inferiorly between the condyles, and attaches to the posterior intercondylar area of the tibia.%A%    
% 221.06/221.21  |- skos__annotation mesh__D016119 a ligament of the knee   
% 221.06/221.21  |- skos__hiddenLabel mesh__D016119 Ligaments, Posterior Cruciate
% 221.06/221.21  |- mesh__dateRevised mesh__D016119 1993-02-16
% 221.06/221.21  |- mesh__recordOriginator mesh__D016119 PXP
% 221.06/221.21  |- mesh__recordAuthorizer mesh__D016119 PLS
% 221.06/221.21  |- mesh__dateEstablished mesh__D016119 1991-01-01
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D016119 2004
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D016119 1997
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D016119 2003
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D016119 1996
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D016119 2006
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D016119 1999
% 221.06/221.21  |- mesh__historyNote mesh__D016119 91   
% 221.06/221.21  |- skos__related mesh__D016119smesh__D016118
% 221.06/221.21  |- mesh__recordMaintainer mesh__D016119 TGC
% 221.06/221.21  |- skos__prefLabel mesh__D016119 Posterior Cruciate Ligament
% 221.06/221.21  |- mesh__publicMeSHNote mesh__D016119 91   
% 221.06/221.21  |- rdf__type mesh__D016119sskos__Concept
% 221.06/221.21  |- mesh__dateCreated mesh__D016119 1990-02-12
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D016119 2005
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D016119 2002
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D016119 1998
% 221.06/221.21  |- skos__broader mesh__D016119smesh__D008023
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004893 1996
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004893 1995
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004893 2000
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004893 1998
% 221.06/221.21  |- rdf__type mesh__D004893sskos__Concept
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004893 1994
% 221.06/221.21  |- skos__broader mesh__D004893smesh__D004890
% 221.06/221.21  |- mesh__dateRevised mesh__D004893 1993-06-02
% 221.06/221.21  |- skos__scopeNote mesh__D004893
% 221.06/221.21       An erythematous eruption commonly associated with drug reactions or infection and characterized by inflammatory nodules that are usually tender, multiple, and bilateral. These nodules are located predominantly on the shins with less common occurrence on the thighs and forearms. They undergo characteristic color changes ending in temporary bruise-like areas. This condition usually subsides in 3-6 weeks without scarring or atrophy.%A%    
% 221.06/221.21  |- mesh__recordOriginator mesh__D004893 NLM
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004893 2004
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004893 2002
% 221.06/221.21  |- skos__broader mesh__D004893smesh__D003875
% 221.06/221.21  |- skos__annotation mesh__D004893
% 221.06/221.21       a drug eruption with inflamm nodules; erythema nodosum leprosum %28%ENL%29% = ERYTHEMA NODOSUM %28%IM%29% + LEPROSY, LEPROMATOUS %28%IM%29%%A%  
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004893 2006
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004893 2003
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004893 2001
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004893 1997
% 221.06/221.21  |- mesh__dateCreated mesh__D004893 1999-01-01
% 221.06/221.21  |- skos__prefLabel mesh__D004893 Erythema Nodosum
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004893 2005
% 221.06/221.21  |- mesh__recordAuthorizer mesh__D004893 PLS
% 221.06/221.21  |- mesh__recordMaintainer mesh__D004893 PLS
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004893 1999
% 221.06/221.21  |- skos__historyNote mesh__D004095 Pyridines %28%1966-1987%29%
% 221.06/221.21  |- mesh__recordAuthorizer mesh__D004095 PLS
% 221.06/221.21  |- mesh__historyNote mesh__D004095 88   
% 221.06/221.21  |- mesh__dateCreated mesh__D004095 1987-03-31
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004095 2003
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004095 1994
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004095 1999
% 221.06/221.21  |- skos__prefLabel mesh__D004095 Dihydropyridines
% 221.06/221.21  |- skos__broader mesh__D004095smesh__D011725
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004095 2004
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004095 1995
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004095 2000
% 221.06/221.21  |- rdf__type mesh__D004095sskos__Concept
% 221.06/221.21  |- skos__historyNote mesh__D004095
% 221.06/221.21       Nifedipine/analogs %26% derivatives %28%1975-1987%29%
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004095 2005
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004095 1996
% 221.06/221.21  |- skos__scopeNote mesh__D004095
% 221.06/221.21       Pyridine moieties which are partially saturated by the addition of two hydrogen atoms in any position.%A%    
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004095 2001
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004095 2006
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004095 1997
% 221.06/221.21  |- mesh__dateEstablished mesh__D004095 1988-01-01
% 221.06/221.21  |- mesh__publicMeSHNote mesh__D004095 88   
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004095 2002
% 221.06/221.21  |- mesh__recordOriginator mesh__D004095 RLS
% 221.06/221.21  |- mesh__dateRevised mesh__D004095 1992-05-13
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004095 1993
% 221.06/221.21  |- mesh__recordMaintainer mesh__D004095 TAP
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004095 1998
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D012527 1995
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D012527 2004
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D012527 1993
% 221.06/221.21  |- mesh__publicMeSHNote mesh__D012527 73   
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D012527 1999
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D012527 2005
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D012527 1994
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D012527 1997
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D012527 2003
% 221.06/221.21  |- skos__prefLabel mesh__D012527 Satiation
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D012527 1998
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D012527 2002
% 221.06/221.21  |- mesh__dateRevised mesh__D012527 1992-05-18
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D012527 1996
% 221.06/221.21  |- mesh__dateCreated mesh__D012527 1999-01-01
% 221.06/221.21  |- mesh__recordMaintainer mesh__D012527 TAP
% 221.06/221.21  |- skos__annotation mesh__D012527 human %26% animal   
% 221.06/221.21  |- mesh__dateEstablished mesh__D012527 1973-01-01
% 221.06/221.21  |- mesh__recordOriginator mesh__D012527 NLM
% 221.06/221.21  |- skos__scopeNote mesh__D012527
% 221.06/221.21       Full gratification of a need or desire followed by a state of relative insensitivity to that particular need or desire.%A%    
% 221.06/221.21  |- skos__broader mesh__D012527smesh__D011603
% 221.06/221.21  |- skos__hiddenLabel mesh__D012527 Satiations
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D012527 2001
% 221.06/221.21  |- mesh__recordAuthorizer mesh__D012527 PLS
% 221.06/221.21  |- rdf__type mesh__D012527sskos__Concept
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D012527 2006
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D012527 2000
% 221.06/221.21  |- mesh__historyNote mesh__D012527 73   
% 221.06/221.21  |- skos__altLabel mesh__D050646
% 221.06/221.21       Methylmalonic-Semialdehyde Dehydrogenase %28%Acylating%29%
% 221.06/221.21  |- skos__prefLabel mesh__D050646
% 221.06/221.21       Methylmalonate-Semialdehyde Dehydrogenase %28%Acylating%29%
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D050646 2006
% 221.06/221.21  |- skos__scopeNote mesh__D050646
% 221.06/221.21       An enzyme that plays a role in the VALINE; LEUCINE; and ISOLEUCINE catabolic pathways by catalyzing the oxidation of 2-methyl-3-oxopropanate to propanoyl-CoA using NAD+ as a coenzyme. Methylmalonate semialdehyde dehydrogenase deficiency is characterized by elevated BETA-ALANINE and 3-HYDROXYPROPIONIC ACID.%A%    
% 221.06/221.21  |- mesh__recordMaintainer mesh__D050646 AKE
% 221.06/221.21  |- rdf__type mesh__D050646sskos__Concept
% 221.06/221.21  |- mesh__recordAuthorizer mesh__D050646 sjn
% 221.06/221.21  |- skos__broader mesh__D050646smesh__D000445
% 221.06/221.21  |- skos__altLabel mesh__D050646 MMSDH
% 221.06/221.21  |- mesh__dateCreated mesh__D050646 2005-06-30
% 221.06/221.21  |- mesh__historyNote mesh__D050646 2006%28%1987%29%   
% 221.06/221.21  |- mesh__publicMeSHNote mesh__D050646
% 221.06/221.21       2006; METHYLMALONATE-SEMIALDEHYDE DEHYDROGENASE %28%ACYLATING%29% was indexed under ALDEHYDE OXIDOREDUCTASES 1987-2005%A%  
% 221.06/221.21  |- mesh__dateEstablished mesh__D050646 2006-01-01
% 221.06/221.21  |- skos__altLabel mesh__D050646 MMSA Dehydrogenase
% 221.06/221.21  |- skos__hiddenLabel mesh__D050646 Dehydrogenase, MMSA
% 221.06/221.21  |- mesh__recordOriginator mesh__D050646 AKE
% 221.06/221.21  |- mesh__recordAuthorizer mesh__D008486 PLS
% 221.06/221.21  |- skos__broader mesh__D008486smesh__D006282
% 221.06/221.21  |- skos__hiddenLabel mesh__D008486 Physician Executive
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008486 2003
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008486 1997
% 221.06/221.21  |- skos__scopeNote mesh__D008486
% 221.06/221.21       Physicians who serve in a medical and administrative capacity as head of an organized medical staff and who also may serve as liaison for the medical staff with the administration and governing board.%A%    
% 221.06/221.21  |- skos__altLabel mesh__D008486 Directors, Medical
% 221.06/221.21  |- mesh__dateCreated mesh__D008486 1977-05-11
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008486 2004
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008486 2001
% 221.06/221.21  |- skos__hiddenLabel mesh__D008486 Executives, Physician
% 221.06/221.21  |- mesh__recordOriginator mesh__D008486 EC
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008486 1998
% 221.06/221.21  |- skos__hiddenLabel mesh__D008486 Executive, Physician
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008486 2002
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008486 2005
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008486 1999
% 221.06/221.21  |- mesh__dateRevised mesh__D008486 1996-06-13
% 221.06/221.21  |- mesh__dateEstablished mesh__D008486 1978-01-01
% 221.06/221.21  |- mesh__publicMeSHNote mesh__D008486 97; was MEDICAL DIRECTORS 1978-96   
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008486 2006
% 221.06/221.21  |- mesh__recordMaintainer mesh__D008486 TGC
% 221.06/221.21  |- skos__broader mesh__D008486smesh__D000288
% 221.06/221.21  |- skos__altLabel mesh__D008486 Medical Directors
% 221.06/221.21  |- mesh__historyNote mesh__D008486 97; was MEDICAL DIRECTORS 1978-96   
% 221.06/221.21  |- skos__altLabel mesh__D008486 Director, Medical
% 221.06/221.21  |- skos__altLabel mesh__D008486 Medical Director
% 221.06/221.21  |- skos__prefLabel mesh__D008486 Physician Executives
% 221.06/221.21  |- rdf__type mesh__D008486sskos__Concept
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D008486 2000
% 221.06/221.21  |- skos__annotation mesh__D008486
% 221.06/221.21       note X ref MEDICAL DIRECTORS; DF: MED DIRECTORS   
% 221.06/221.21  |- skos__broader mesh__D016918smesh__D001170
% 221.06/221.21  |- skos__altLabel mesh__D016918 Post-Infectious Arthritis
% 221.06/221.21  |- skos__scopeNote mesh__D016918
% 221.06/221.21       An abacterial form of arthritis developing after infection at a site distant from the affected joint or joints. The causative bacteria cannot be cultured from synovial specimens but bacterial antigens have been demonstrated in cells from the synovial fluid and membrane. It often follows Yersinia infection.%A%    
% 221.06/221.21  |- skos__hiddenLabel mesh__D016918 Reactive Arthritis
% 221.06/221.21  |- mesh__historyNote mesh__D016918 92   
% 221.06/221.21  |- mesh__dateCreated mesh__D016918 1991-06-24
% 221.06/221.21  |- mesh__recordMaintainer mesh__D016918 ags
% 221.06/221.21  |- skos__hiddenLabel mesh__D016918 Post Infectious Arthritis
% 221.06/221.21  |- skos__hiddenLabel mesh__D016918 Arthritides, Reactive
% 221.06/221.21  |- skos__hiddenLabel mesh__D016918 Arthritides, Postinfectious
% 221.06/221.21  |- skos__prefLabel mesh__D016918 Arthritis, Reactive
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D016918 2005
% 221.06/221.21  |- skos__hiddenLabel mesh__D016918 Arthritis, Post Infectious
% 221.06/221.21  |- skos__historyNote mesh__D016918 Arthritis, Infectious %28%1966-1991%29%
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D016918 2002
% 221.06/221.21  |- mesh__publicMeSHNote mesh__D016918 92   
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D016918 2006
% 221.06/221.21  |- skos__hiddenLabel mesh__D016918 Arthritides, Post-Infectious
% 221.06/221.21  |- skos__hiddenLabel mesh__D016918 Postinfectious Arthritides
% 221.06/221.21  |- skos__hiddenLabel mesh__D016918 Post-Infectious Arthritides
% 221.06/221.21  |- skos__related mesh__D016918smesh__D012058
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D016918 2003
% 221.06/221.21  |- skos__altLabel mesh__D016918 Arthritis, Post-Infectious
% 221.06/221.21  |- rdf__type mesh__D016918sskos__Concept
% 221.06/221.21  |- mesh__dateEstablished mesh__D016918 1992-01-01
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D016918 2004
% 221.06/221.21  |- skos__altLabel mesh__D016918 Arthritis, Postinfectious
% 221.06/221.21  |- skos__broader mesh__D016918smesh__D025242
% 221.06/221.21  |- skos__annotation mesh__D016918
% 221.06/221.21       coord IM with specific infect or organism/infect precoord %28%IM%29%%A%  
% 221.06/221.21  |- mesh__dateRevised mesh__D016918 2001-07-25
% 221.06/221.21  |- mesh__recordOriginator mesh__D016918 TGC
% 221.06/221.21  |- skos__altLabel mesh__D016918 Postinfectious Arthritis
% 221.06/221.21  |- mesh__recordAuthorizer mesh__D016918 sjn
% 221.06/221.21  |- skos__hiddenLabel mesh__D016918 Reactive Arthritides
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D013620 1998
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D013620 2003
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D013620 2000
% 221.06/221.21  |- mesh__recordAuthorizer mesh__D013620 PLS
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D013620 1997
% 221.06/221.21  |- mesh__dateCreated mesh__D013620 1999-01-01
% 221.06/221.21  |- mesh__onlineNote mesh__D013620
% 221.06/221.21       use TAJIKISTAN to search TADZHIK S.S.R. 1982-92 %26% TADZHIKISTAN 1966-81%A%  
% 221.06/221.21  |- mesh__recordMaintainer mesh__D013620 PLS
% 221.06/221.21  |- mesh__dateRevised mesh__D013620 1994-03-17
% 221.06/221.21  |- skos__altLabel mesh__D013620 Tadzhik SSR
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D013620 2006
% 221.06/221.21  |- mesh__recordOriginator mesh__D013620 NLM
% 221.06/221.21  |- mesh__historyNote mesh__D013620
% 221.06/221.21       93; was TADZHIK S.S.R. 1982-92; was TADZHIKISTAN 1963-81   
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D013620 1996
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D013620 1995
% 221.06/221.21  |- skos__prefLabel mesh__D013620 Tajikistan
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D013620 2005
% 221.06/221.21  |- skos__altLabel mesh__D013620 Tadzhikistan
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D013620 2002
% 221.06/221.21  |- skos__broader mesh__D013620smesh__D017517
% 221.06/221.21  |- skos__annotation mesh__D013620 use this spelling in translations   
% 221.06/221.21  |- skos__broader mesh__D013620smesh__D014586
% 221.06/221.21  |- rdf__type mesh__D013620sskos__Concept
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D013620 1999
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D013620 2004
% 221.06/221.21  |- skos__altLabel mesh__D013620 Tadjikistan
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D013620 2001
% 221.06/221.21  |- skos__broader mesh__D013620smesh__D001209
% 221.06/221.21  |- skos__altLabel mesh__D013620 Tadzhik S.S.R.
% 221.06/221.21  |- mesh__recordMaintainer mesh__D004894 PXP
% 221.06/221.21  |- skos__scopeNote mesh__D004894
% 221.06/221.21       A chronic bacterial infection of major folds of the skin, caused by Corynebacterium minutissimum.%A%    
% 221.06/221.21  |- skos__annotation mesh__D004894
% 221.06/221.21       bact skin dis caused by Corynebacterium minutissimum   
% 221.06/221.21  |- mesh__historyNote mesh__D004894
% 221.06/221.21       91%28%75%29%; was see under CORYNEBACTERIUM INFECTIONS 1977-90; was see under NOCARDIA INFECTIONS 1963-76%A%  
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004894 1995
% 221.06/221.21  |- mesh__dateRevised mesh__D004894 1994-02-08
% 221.06/221.21  |- mesh__onlineNote mesh__D004894 search NOCARDIA INFECTIONS 1966-74   
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004894 2000
% 221.06/221.21  |- rdf__type mesh__D004894sskos__Concept
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004894 2001
% 221.06/221.21  |- skos__broader mesh__D004894smesh__D017192
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004894 2003
% 221.06/221.21  |- skos__prefLabel mesh__D004894 Erythrasma
% 221.06/221.21  |- mesh__dateCreated mesh__D004894 1999-01-01
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004894 2005
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004894 2004
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004894 1996
% 221.06/221.21  |- mesh__publicMeSHNote mesh__D004894
% 221.06/221.21       91; was see under CORYNEBACTERIUM INFECTIONS 1977-90; was see under NOCARDIA INFECTIONS 1963-76%A%  
% 221.06/221.21  |- mesh__dateEstablished mesh__D004894 1991-01-01
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004894 2002
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004894 2006
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004894 1998
% 221.06/221.21  |- mesh__recordOriginator mesh__D004894 NLM
% 221.06/221.21  |- skos__broader mesh__D004894smesh__D003354
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004894 1997
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004894 1999
% 221.06/221.21  |- mesh__recordAuthorizer mesh__D004894 PLS
% 221.06/221.21  |- skos__broader mesh__D004096smesh__D013307
% 221.06/221.21  |- rdf__type mesh__D004096sskos__Concept
% 221.06/221.21  |- skos__prefLabel mesh__D004096 Dihydrostreptomycin Sulfate
% 221.06/221.21  |- mesh__recordAuthorizer mesh__D004096 sjn
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D004096 2006
% 221.06/221.21  |- mesh__publicMeSHNote mesh__D004096
% 221.06/221.21       96; was DIHYDROSTREPTOMYCIN 1963-95   
% 221.06/221.21  |- mesh__dateCreated mesh__D004096 1999-01-01
% 221.06/221.21  |- mesh__recordMaintainer mesh__D004096 exl
% 221.06/221.21  |- mesh__dateRevised mesh__D004096 2005-06-30
% 221.06/221.21  |- skos__hiddenLabel mesh__D004096 Sulfate, Dihydrostreptomycin
% 221.06/221.21  |- skos__altLabel mesh__D004096
% 221.06/221.21       Instituto Farmacologica Brand of Dihydrostreptomycin Sulfate
% 221.06/221.21  |- mesh__recordOriginator mesh__D004096 NLM
% 221.06/221.21  |- skos__scopeNote mesh__D004096
% 221.06/221.21       A semi-synthetic aminoglycoside antibiotic that is used in the treatment of TUBERCULOSIS.%A%    
% 221.06/221.21  |- mesh__historyNote mesh__D004096 96; was DIHYDROSTREPTOMYCIN 1963-95   
% 221.06/221.21  |- skos__altLabel mesh__D045702 Endoprotease PC6
% 221.06/221.21  |- skos__hiddenLabel mesh__D045702 Preprotein Convertase, PC5B
% 221.06/221.21  |- skos__altLabel mesh__D045702 PC5 Proprotein Convertase
% 221.06/221.21  |- rdf__type mesh__D045702sskos__Concept
% 221.06/221.21  |- mesh__publicMeSHNote mesh__D045702
% 221.06/221.21       2004; PC5 PROPROTEIN CONVERTASE %28%now PREPROTEIN CONVERTASE 5%29% was indexed under SERINE ENDOPEPTIDASES 1993-1997 %26% SUBTILISINS 1998-2003%A%  
% 221.06/221.21  |- skos__hiddenLabel mesh__D045702 Convertase, PC5 Proprotein
% 221.06/221.21  |- skos__prefLabel mesh__D045702 Proprotein Convertase 5
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D045702 2005
% 221.06/221.21  |- skos__hiddenLabel mesh__D045702 Convertase, PC6A Proprotein
% 221.06/221.21  |- skos__hiddenLabel mesh__D045702 Prohormone Convertase PC 6
% 221.06/221.21  |- skos__altLabel mesh__D045702 SPC6
% 221.06/221.21  |- mesh__dateEstablished mesh__D045702 2004-01-01
% 221.06/221.21  |- skos__hiddenLabel mesh__D045702 Endoprotease, PC6
% 221.06/221.21  |- skos__historyNote mesh__D045702 Serine Endopeptidases %28%1993-2003%29%
% 221.06/221.21  |- skos__hiddenLabel mesh__D045702 5, Proprotein Convertase
% 221.06/221.21  |- skos__altLabel mesh__D045702 PC5 Protein
% 221.06/221.21  |- mesh__recordOriginator mesh__D045702 jmp
% 221.06/221.21  |- mesh__recordMaintainer mesh__D045702 jmp
% 221.06/221.21  |- skos__broader mesh__D045702smesh__D012697
% 221.06/221.21  |- skos__hiddenLabel mesh__D045702 Convertase-6, Prohormone
% 221.06/221.21  |- skos__hiddenLabel mesh__D045702 Proprotein Convertase, PC6A
% 221.06/221.21  |- mesh__activeMeSHYear mesh__D045702 2006
% 221.06/221.21  |- skos__broader mesh__D045702smesh__D043484
% 221.06/221.21  |- skos__hiddenLabel mesh__D045702 Convertase 5, Proprotein
% 221.06/221.21  |- skos__altLabel mesh__D045702 PC6 Endoprotease
% 221.06/221.21  |- skos__altLabel mesh__D045702 PC6 Protein
% 221.06/221.21  |- skos__hiddenLabel mesh__D045702 Convertase, PC5B Preprotein
% 221.06/221.21  |- skos__hiddenLabel mesh__D045702 Proprotein Convertase, PC5
% 221.06/221.22  |- skos__hiddenLabel mesh__D045702 Convertase, PC5A Proprotein
% 221.06/221.22  |- skos__hiddenLabel mesh__D045702 Proprotein Convertase, PC5A
% 221.06/221.22  |- skos__hiddenLabel mesh__D045702 Convertase PC5, Prohormone
% 221.06/221.22  |- skos__hiddenLabel mesh__D045702 Convertase, PC5 Prohormone
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D045702 2004
% 221.06/221.22  |- skos__altLabel mesh__D045702 Prohormone Convertase, PC5
% 221.06/221.22  |- skos__altLabel mesh__D045702 Prohormone Convertase-6
% 221.06/221.22  |- mesh__recordAuthorizer mesh__D045702 sjn
% 221.06/221.22  |- skos__altLabel mesh__D045702 Prohormone Convertase PC-6
% 221.06/221.22  |- skos__hiddenLabel mesh__D045702 PC5 Prohormone Convertase
% 221.06/221.22  |- mesh__historyNote mesh__D045702
% 221.06/221.22       2004; use PREPROTEIN CONVERTASE 5 %28%NM%29% 1993-2003; for PC6 ENDOPROTEASE use PREPROTEIN CONVERTASE 5 %28%NM%29% 1993-2003%A%  
% 221.06/221.22  |- skos__hiddenLabel mesh__D045702 Prohormone Convertase 6
% 221.06/221.22  |- skos__scopeNote mesh__D045702
% 221.06/221.22       A serine endopeptidase found primarily in the EXTRACELLULAR MATRIX. It has specificity for cleavage of a variety of substrates including PRORENIN, pro-membrane type-1 matrix metalloproteinase, and NEURAL CELL ADHESION MOLECULE L1.%A%    
% 221.06/221.22  |- skos__hiddenLabel mesh__D045702 Convertase PC-6, Prohormone
% 221.06/221.22  |- skos__altLabel mesh__D045702 Prohormone Convertase PC5
% 221.06/221.22  |- mesh__dateCreated mesh__D045702 2003-07-09
% 221.06/221.22  |- skos__historyNote mesh__D045702 Subtilisins %28%1998-2003%29%
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012528 2005
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012528 1994
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012528 1997
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012528 2001
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012528 2003
% 221.06/221.22  |- mesh__recordAuthorizer mesh__D012528 PLS
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012528 1998
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012528 2000
% 221.06/221.22  |- skos__hiddenLabel mesh__D012528 Satiety Responses
% 221.06/221.22  |- mesh__dateRevised mesh__D012528 1992-05-18
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012528 1996
% 221.06/221.22  |- mesh__dateEstablished mesh__D012528 1991-01-01
% 221.06/221.22  |- skos__hiddenLabel mesh__D012528 Responses, Satiety
% 221.06/221.22  |- mesh__dateCreated mesh__D012528 1999-01-01
% 221.06/221.22  |- skos__broader mesh__D012528smesh__D012527
% 221.06/221.22  |- skos__annotation mesh__D012528 human %26% animal   
% 221.06/221.22  |- skos__scopeNote mesh__D012528
% 221.06/221.22       Behavioral response associated with the achieving of gratification.%A%    
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012528 2002
% 221.06/221.22  |- mesh__publicMeSHNote mesh__D012528
% 221.06/221.22       91; was see under SATIATION 1975-90   
% 221.06/221.22  |- mesh__historyNote mesh__D012528
% 221.06/221.22       91%28%75%29%; was see under SATIATION 1975-90   
% 221.06/221.22  |- mesh__recordMaintainer mesh__D012528 TAP
% 221.06/221.22  |- rdf__type mesh__D012528sskos__Concept
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012528 2006
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012528 1995
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012528 2004
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012528 1993
% 221.06/221.22  |- skos__prefLabel mesh__D012528 Satiety Response
% 221.06/221.22  |- mesh__recordOriginator mesh__D012528 NLM
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012528 1999
% 221.06/221.22  |- mesh__onlineNote mesh__D012528 search SATIATION 1973-74   
% 221.06/221.22  |- skos__hiddenLabel mesh__D012528 Response, Satiety
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D017213 2003
% 221.06/221.22  |- mesh__recordAuthorizer mesh__D017213 PLS
% 221.06/221.22  |- mesh__publicMeSHNote mesh__D017213 93   
% 221.06/221.22  |- rdf__type mesh__D017213sskos__Concept
% 221.06/221.22  |- skos__altLabel mesh__D017213 Cervical Caries
% 221.06/221.22  |- skos__annotation mesh__D017213
% 221.06/221.22       caries of root, cementum or cervical portion of tooth   
% 221.06/221.22  |- mesh__recordOriginator mesh__D017213 MXR
% 221.06/221.22  |- skos__hiddenLabel mesh__D017213 Cary, Cervical
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D017213 2000
% 221.06/221.22  |- mesh__dateRevised mesh__D017213 1996-06-10
% 221.06/221.22  |- skos__broader mesh__D017213smesh__D003731
% 221.06/221.22  |- mesh__dateCreated mesh__D017213 1992-05-22
% 221.06/221.22  |- skos__altLabel mesh__D017213 Caries, Root
% 221.06/221.22  |- mesh__historyNote mesh__D017213 93   
% 221.06/221.22  |- skos__scopeNote mesh__D017213
% 221.06/221.22       Dental caries involving the tooth root, cementum, or cervical area of the tooth.%A%    
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D017213 2002
% 221.06/221.22  |- mesh__recordMaintainer mesh__D017213 TGC
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D017213 1999
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D017213 2006
% 221.06/221.22  |- skos__historyNote mesh__D017213 Dental Caries %28%1966-1992%29%
% 221.06/221.22  |- skos__hiddenLabel mesh__D017213 Cervical Cary
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D017213 1998
% 221.06/221.22  |- skos__prefLabel mesh__D017213 Root Caries
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D017213 2005
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D017213 1997
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D017213 2004
% 221.06/221.22  |- mesh__dateEstablished mesh__D017213 1993-01-01
% 221.06/221.22  |- skos__historyNote mesh__D017213 Tooth Root %28%1966-1992%29%
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D017213 2001
% 221.06/221.22  |- skos__hiddenLabel mesh__D050647 2 Aminoadipate Reductase
% 221.06/221.22  |- mesh__recordOriginator mesh__D050647 AKE
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D050647 2006
% 221.06/221.22  |- skos__hiddenLabel mesh__D050647 Reductase, alpha-Aminoadipate
% 221.06/221.22  |- mesh__recordMaintainer mesh__D050647 AKE
% 221.06/221.22  |- rdf__type mesh__D050647sskos__Concept
% 221.06/221.22  |- skos__hiddenLabel mesh__D050647 Aminoadipate Semialdehyde Dehydrogenase
% 221.06/221.22  |- skos__hiddenLabel mesh__D050647
% 221.06/221.22       Dehydrogenase, L-Aminoadipate Semialdehyde
% 221.06/221.22  |- skos__altLabel mesh__D050647 alpha-Aminoadipate Reductase System
% 221.06/221.22  |- skos__hiddenLabel mesh__D050647 Dehydrogenase, Aminoadipate-Semialdehyde
% 221.06/221.22  |- skos__altLabel mesh__D050647 Aminoadipate-Semialdehyde Dehydrogenase
% 221.06/221.22  |- skos__altLabel mesh__D050647 alpha-Aminoadipate Reductase
% 221.06/221.22  |- skos__hiddenLabel mesh__D050647 alpha Aminoadipate Reductase System
% 221.06/221.22  |- skos__hiddenLabel mesh__D050647
% 221.06/221.22       L Aminoadipate Semialdehyde Dehydrogenase
% 221.06/221.22  |- skos__hiddenLabel mesh__D050647 alpha Aminoadipate Reductase
% 221.06/221.22  |- skos__hiddenLabel mesh__D050647
% 221.06/221.22       Dehydrogenase, L-Aminoadipate-Semialdehyde
% 221.06/221.22  |- skos__altLabel mesh__D050647 2-Aminoadipate Reductase
% 221.06/221.22  |- mesh__historyNote mesh__D050647 2006%28%1985%29%   
% 221.06/221.22  |- mesh__publicMeSHNote mesh__D050647
% 221.06/221.22       2006; L-AMINOADIPATE-SEMIALDEHYDE DEHYDROGENASE was indexed under ALDEHYDE OXIDOREDUCTASE 1985-2005%A%  
% 221.06/221.22  |- skos__scopeNote mesh__D050647
% 221.06/221.22       An enzyme that catalyzes the oxidation of  L-2-aminoadipate 6-semialdehyde to L-2-aminoadipate %28%alpha-aminoadipic acid%29%. It is involved in the biosynthetic pathway of LYSINE.%A%    
% 221.06/221.22  |- skos__broader mesh__D050647smesh__D000445
% 221.06/221.22  |- mesh__recordAuthorizer mesh__D050647 sjn
% 221.06/221.22  |- skos__hiddenLabel mesh__D050647 Reductase, 2-Aminoadipate
% 221.06/221.22  |- mesh__dateCreated mesh__D050647 2005-06-30
% 221.06/221.22  |- skos__prefLabel mesh__D050647 L-Aminoadipate-Semialdehyde Dehydrogenase
% 221.06/221.22  |- skos__altLabel mesh__D050647 L-Aminoadipate Semialdehyde Dehydrogenase
% 221.06/221.22  |- mesh__dateEstablished mesh__D050647 2006-01-01
% 221.06/221.22  |- skos__annotation mesh__D008487 DF: MED HIST TAKING   
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D008487 2004
% 221.06/221.22  |- skos__prefLabel mesh__D008487 Medical History Taking
% 221.06/221.22  |- skos__altLabel mesh__D008487 History Taking, Medical
% 221.06/221.22  |- skos__broader mesh__D008487smesh__D019937
% 221.06/221.22  |- mesh__dateRevised mesh__D008487 1997-06-20
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D008487 1998
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D008487 2000
% 221.06/221.22  |- mesh__historyNote mesh__D008487 70%28%67%29%   
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D008487 2005
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D008487 1999
% 221.06/221.22  |- mesh__recordOriginator mesh__D008487 NLM
% 221.06/221.22  |- mesh__dateCreated mesh__D008487 1999-01-01
% 221.06/221.22  |- mesh__recordMaintainer mesh__D008487 PXP
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D008487 2001
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D008487 2006
% 221.06/221.22  |- mesh__dateEstablished mesh__D008487 1970-01-01
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D008487 2002
% 221.06/221.22  |- mesh__publicMeSHNote mesh__D008487 70   
% 221.06/221.22  |- rdf__type mesh__D008487sskos__Concept
% 221.06/221.22  |- mesh__recordAuthorizer mesh__D008487 SJN
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D008487 2003
% 221.06/221.22  |- skos__related mesh__D008487smesh__D003625
% 221.06/221.22  |- skos__historyNote mesh__D008487 Diagnosis %28%1966%29%
% 221.06/221.22  |- skos__hiddenLabel mesh__D016919 Cryptococcal Meningitides
% 221.06/221.22  |- skos__broader mesh__D016919smesh__D003453
% 221.06/221.22  |- skos__hiddenLabel mesh__D016919 Cerebral Cryptococcoses, Granulomous
% 221.06/221.22  |- mesh__publicMeSHNote mesh__D016919 1992   
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D016919 2002
% 221.06/221.22  |- mesh__dateCreated mesh__D016919 1991-05-30
% 221.06/221.22  |- skos__related mesh__D016919smesh__D003389
% 221.06/221.22  |- mesh__recordMaintainer mesh__D016919 ags
% 221.06/221.22  |- skos__hiddenLabel mesh__D016919 Torulomas
% 221.06/221.22  |- skos__hiddenLabel mesh__D016919 Cerebral Cryptococcosis, Granulomous
% 221.06/221.22  |- skos__prefLabel mesh__D016919 Meningitis, Cryptococcal
% 221.06/221.22  |- mesh__recordOriginator mesh__D016919 PXP
% 221.06/221.22  |- skos__scopeNote mesh__D016919
% 221.06/221.22       Meningeal inflammation produced by CRYPTOCOCCUS NEOFORMANS, an encapsulated yeast that tends to infect individuals with ACQUIRED IMMUNODEFICIENCY SYNDROME and other immunocompromised states. The organism enters the body through the respiratory tract, but symptomatic infections are usually limited to the lungs and nervous system. The organism may also produce parenchymal brain lesions %28%torulomas%29%. Clinically, the course is subacute and may feature HEADACHE; NAUSEA; PHOTOPHOBIA; focal neurologic deficits; SEIZURES; cranial neuropathies; and HYDROCEPHALUS. %28%From Adams et al., Principles of Neurology, 6th ed, pp721-2%29%%A%    
% 221.06/221.22  |- skos__hiddenLabel mesh__D016919 Meningitides, Cryptococcal
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D016919 2001
% 221.06/221.22  |- mesh__historyNote mesh__D016919 1992   
% 221.06/221.22  |- skos__hiddenLabel mesh__D016919 Cryptococcosis, Cerebral
% 221.06/221.22  |- skos__historyNote mesh__D016919 Meningitis %28%1967-1991%29%
% 221.06/221.22  |- skos__hiddenLabel mesh__D016919 Granulomous Cerebral Cryptococcoses
% 221.06/221.22  |- mesh__dateEstablished mesh__D016919 1992-01-01
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D016919 2000B
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D016919 2006
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D016919 2000A
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D016919 2000
% 221.06/221.22  |- skos__historyNote mesh__D016919 Cryptococcosis %28%1967-1991%29%
% 221.06/221.22  |- skos__hiddenLabel mesh__D016919 Cryptococcoses, Cerebral
% 221.06/221.22  |- skos__altLabel mesh__D016919 Cryptococcal Meningitis
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D016919 2005
% 221.06/221.22  |- skos__hiddenLabel mesh__D016919 Cryptococcosis, Granulomous Cerebral
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D016919 2004
% 221.06/221.22  |- mesh__dateRevised mesh__D016919 1999-12-09
% 221.06/221.22  |- skos__altLabel mesh__D016919 Toruloma
% 221.06/221.22  |- skos__broader mesh__D016919smesh__D016921
% 221.06/221.22  |- skos__hiddenLabel mesh__D016919 Cryptococcoses, Granulomous Cerebral
% 221.06/221.22  |- skos__hiddenLabel mesh__D016919 Cerebral Cryptococcoses
% 221.06/221.22  |- mesh__recordAuthorizer mesh__D016919 ags
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D016919 2003
% 221.06/221.22  |- rdf__type mesh__D016919sskos__Concept
% 221.06/221.22  |- skos__related mesh__D027641smesh__D014925
% 221.06/221.22  |- skos__broader mesh__D027641smesh__D026441
% 221.06/221.22  |- skos__related mesh__D027641smesh__D007845
% 221.06/221.22  |- skos__historyNote mesh__D027641 Laughter %28%1965-2001%29%
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D027641 2004
% 221.06/221.22  |- skos__scopeNote mesh__D027641
% 221.06/221.22       Therapeutic use of humor and laughter to improve emotional well being in order to facilitate improvement in health.%A%    
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D027641 2002
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D027641 2006
% 221.06/221.22  |- mesh__publicMeSHNote mesh__D027641 2002   
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D027641 2003
% 221.06/221.22  |- skos__hiddenLabel mesh__D027641 Therapy, Laughter
% 221.06/221.22  |- skos__prefLabel mesh__D027641 Laughter Therapy
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D027641 2005
% 221.06/221.22  |- mesh__dateEstablished mesh__D027641 2002-01-01
% 221.06/221.22  |- mesh__dateCreated mesh__D027641 2001-07-25
% 221.06/221.22  |- rdf__type mesh__D027641sskos__Concept
% 221.06/221.22  |- mesh__historyNote mesh__D027641 2002   
% 221.06/221.22  |- skos__historyNote mesh__D027641 Wit and Humor %28%1963-2001%29%
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D013621 2006
% 221.06/221.22  |- mesh__recordAuthorizer mesh__D013621 sjn
% 221.06/221.22  |- skos__annotation mesh__D013621
% 221.06/221.22       a tapeworm: do not confuse with TINEA %28%ringworm, a disease%29%; do not confuse with TAENIA COLI see COLON; do not confuse X ref TAENIARHYNCHUS with Taeniorhyncus, a mosquito; infection = TAENIASIS; Taenia echinococcus = Echinococcus granulosus, its infection = ECHINOCOCCOSIS; larval form of TAENIA SAGINATA = Cysticercus bovis, its infection = CYSTICERCOSIS; larval form of TAENIA SOLIUM = CYSTICERCUS; its infection = CYSTICERCOSIS or NEUROCYSTICERCOSIS; coord with specific precoord helminth term %28%ANTIGENS, HELMINTH, etc%29% if pertinent%A%  
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D013621 2005
% 221.06/221.22  |- skos__scopeNote mesh__D013621 A genus of large tapeworms.     
% 221.06/221.22  |- mesh__dateRevised mesh__D013621 2003-07-09
% 221.06/221.22  |- rdf__type mesh__D013621sskos__Concept
% 221.06/221.22  |- mesh__historyNote mesh__D013621
% 221.06/221.22       TAENIARHYNCHUS was see under TAENIA 1966-78   
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D013621 2004
% 221.06/221.22  |- mesh__onlineNote mesh__D013621
% 221.06/221.22       use TAENIA to search TAENIARHYNCHUS 1966-78   
% 221.06/221.22  |- skos__altLabel mesh__D013621 Taeniarhynchus
% 221.06/221.22  |- skos__prefLabel mesh__D013621 Taenia
% 221.06/221.22  |- skos__related mesh__D013621smesh__D003551
% 221.06/221.22  |- mesh__publicMeSHNote mesh__D013621
% 221.06/221.22       TAENIARHYNCHUS was see under TAENIA 1966-78   
% 221.06/221.22  |- skos__related mesh__D013621smesh__D020019
% 221.06/221.22  |- skos__broader mesh__D013621smesh__D002589
% 221.06/221.22  |- mesh__recordOriginator mesh__D013621 NLM
% 221.06/221.22  |- mesh__dateCreated mesh__D013621 1999-01-01
% 221.06/221.22  |- mesh__recordMaintainer mesh__D013621 ags
% 221.06/221.22  |- skos__broader mesh__D011042Q000037smesh__D011042
% 221.06/221.22  |- mesh__preferredCombination mesh__D011042Q000037smesh__D000931
% 221.06/221.22  |- rdf__type mesh__D011042Q000037smesh__CompoundConcept
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D051740 2006
% 221.06/221.22  |- mesh__recordMaintainer mesh__D051740 DRC
% 221.06/221.22  |- skos__broader mesh__D051740smesh__D051741
% 221.06/221.22  |- rdf__type mesh__D051740sskos__Concept
% 221.06/221.22  |- mesh__dateCreated mesh__D051740 2005-06-30
% 221.06/221.22  |- skos__altLabel mesh__D051740 Ikaros Protein
% 221.06/221.22  |- mesh__recordOriginator mesh__D051740 DRC
% 221.06/221.22  |- skos__hiddenLabel mesh__D051740 Transcription Factor, Ikaros
% 221.06/221.22  |- mesh__recordAuthorizer mesh__D051740 sjn
% 221.06/221.22  |- mesh__publicMeSHNote mesh__D051740
% 221.06/221.22       2006; IKAROS TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1992-2005%A%  
% 221.06/221.22  |- mesh__historyNote mesh__D051740 2006%28%1992%29%   
% 221.06/221.22  |- skos__prefLabel mesh__D051740 Ikaros Transcription Factor
% 221.06/221.22  |- mesh__dateEstablished mesh__D051740 2006-01-01
% 221.06/221.22  |- skos__scopeNote mesh__D051740
% 221.06/221.22       A transcription factor that plays a role as a key regulator of HEMATOPOIESIS. Aberrant Ikaros expression has been associated with LYMPHOBLASTIC LEUKEMIAS.%A%    
% 221.06/221.22  |- mesh__recordOriginator mesh__D004895 NLM
% 221.06/221.22  |- mesh__publicMeSHNote mesh__D004895
% 221.06/221.22       91; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85%A%  
% 221.06/221.22  |- mesh__recordMaintainer mesh__D004895 ssb
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D004895 2003
% 221.06/221.22  |- mesh__dateCreated mesh__D004895 1999-01-01
% 221.06/221.22  |- mesh__recordAuthorizer mesh__D004895 sjn
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D004895 2005
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D004895 2004
% 221.06/221.22  |- mesh__dateEstablished mesh__D004895 1991-01-01
% 221.06/221.22  |- mesh__dateRevised mesh__D004895 2001-07-25
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D004895 2006
% 221.06/221.22  |- skos__broader mesh__D004895smesh__D007887
% 221.06/221.22  |- skos__annotation mesh__D004895
% 221.06/221.22       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.06/221.22  |- skos__prefLabel mesh__D004895 Erythrina
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D004895 2002
% 221.06/221.22  |- skos__scopeNote mesh__D004895
% 221.06/221.22       A genus of leguminous shrubs or trees, mainly tropical, yielding certain alkaloids, lectins, and other useful compounds.%A%    
% 221.06/221.22  |- mesh__historyNote mesh__D004895
% 221.06/221.22       91%28%86%29%63; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85%A%  
% 221.06/221.22  |- rdf__type mesh__D004895sskos__Concept
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D045703 2005
% 221.06/221.22  |- mesh__historyNote mesh__D045703 2004; use EXCIPIENTS 1983-2003   
% 221.06/221.22  |- skos__scopeNote mesh__D045703
% 221.06/221.22       SURFACE-ACTIVE AGENTS that induce a dispersion of undissolved material throughout a liquid.%A%    
% 221.06/221.22  |- skos__prefLabel mesh__D045703 Emulsifying Agents
% 221.06/221.22  |- mesh__publicMeSHNote mesh__D045703 2004; see EXCIPIENTS 1983-2003   
% 221.06/221.22  |- skos__altLabel mesh__D045703 Emulsifyers
% 221.06/221.22  |- skos__historyNote mesh__D045703 Excipients %28%1984-2003%29%
% 221.06/221.22  |- skos__broader mesh__D045703smesh__D013501
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D045703 2004
% 221.06/221.22  |- rdf__type mesh__D045703sskos__Concept
% 221.06/221.22  |- skos__hiddenLabel mesh__D045703 Agents, Emulsifying
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D045703 2006
% 221.06/221.22  |- mesh__dateCreated mesh__D045703 2003-07-09
% 221.06/221.22  |- mesh__dateEstablished mesh__D045703 2004-01-01
% 221.06/221.22  |- skos__scopeNote mesh__D004097
% 221.06/221.22       A VITAMIN D that can be regarded as a reduction product of vitamin D2.%A%    
% 221.06/221.22  |- skos__altLabel mesh__D004097 Dihydrotachysterin
% 221.06/221.22  |- mesh__recordOriginator mesh__D004097 NLM
% 221.06/221.22  |- mesh__recordMaintainer mesh__D004097 ssb
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D004097 2006
% 221.06/221.22  |- skos__hiddenLabel mesh__D004097 AT10
% 221.06/221.22  |- mesh__dateCreated mesh__D004097 1999-01-01
% 221.06/221.22  |- skos__broader mesh__D004097smesh__D002782
% 221.06/221.22  |- mesh__recordAuthorizer mesh__D004097 sjn
% 221.06/221.22  |- skos__prefLabel mesh__D004097 Dihydrotachysterol
% 221.06/221.22  |- skos__broader mesh__D004097smesh__D004872
% 221.06/221.22  |- skos__broader mesh__D004097smesh__D013261
% 221.06/221.22  |- rdf__type mesh__D004097sskos__Concept
% 221.06/221.22  |- skos__altLabel mesh__D004097 AT-10
% 221.06/221.22  |- mesh__dateRevised mesh__D004097 2005-06-30
% 221.06/221.22  |- skos__altLabel mesh__D004097 Tachystin
% 221.06/221.22  |- mesh__historyNote mesh__D009580
% 221.06/221.22       91%28%75%29%; was see under TETRAZOLIUM SALTS 1975-90   
% 221.06/221.22  |- skos__hiddenLabel mesh__D009580 Blue, Nitrotetrazolium
% 221.06/221.22  |- mesh__recordAuthorizer mesh__D009580 sjn
% 221.06/221.22  |- mesh__publicMeSHNote mesh__D009580
% 221.06/221.22       91; was see under TETRAZOLIUM SALTS 1975-90   
% 221.06/221.22  |- skos__annotation mesh__D009580 D25-26 qualif; DF: NITRO BT   
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D009580 2003
% 221.06/221.22  |- mesh__recordOriginator mesh__D009580 NLM
% 221.06/221.22  |- skos__hiddenLabel mesh__D009580 Tetrazolium, Nitroblue
% 221.06/221.22  |- mesh__recordMaintainer mesh__D009580 TWD
% 221.06/221.22  |- rdf__type mesh__D009580sskos__Concept
% 221.06/221.22  |- skos__broader mesh__D009580smesh__D013778
% 221.06/221.22  |- skos__altLabel mesh__D009580 Nitrotetrazolium Blue
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D009580 2005
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D009580 2004
% 221.06/221.22  |- skos__prefLabel mesh__D009580 Nitroblue Tetrazolium
% 221.06/221.22  |- skos__historyNote mesh__D009580 Nitro Compounds %28%1973-1974%29%
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D009580 2001
% 221.06/221.22  |- mesh__dateCreated mesh__D009580 1974-11-11
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D009580 2006
% 221.06/221.22  |- mesh__dateEstablished mesh__D009580 1991-01-01
% 221.06/221.22  |- skos__hiddenLabel mesh__D009580 Nitroblue, Tetrazolium
% 221.06/221.22  |- skos__scopeNote mesh__D009580
% 221.06/221.22       Colorless to yellow dye that is reducible to blue or black formazan crystals by certain cells; formerly used to distinguish between nonbacterial and bacterial diseases, the latter causing neutrophils to reduce the dye; used to confirm diagnosis of chronic granulomatous disease.%A%    
% 221.06/221.22  |- mesh__dateRevised mesh__D009580 2000-06-22
% 221.06/221.22  |- skos__historyNote mesh__D009580 Tetrazolium Salts %28%1972-1974%29%
% 221.06/221.22  |- skos__altLabel mesh__D009580 Nitro-BT
% 221.06/221.22  |- skos__altLabel mesh__D009580 Tetrazolium Nitroblue
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D009580 2002
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012529 2002
% 221.06/221.22  |- mesh__recordMaintainer mesh__D012529 KEV
% 221.06/221.22  |- mesh__dateCreated mesh__D012529 1974-11-11
% 221.06/221.22  |- mesh__recordOriginator mesh__D012529 NLM
% 221.06/221.22  |- rdf__type mesh__D012529sskos__Concept
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012529 2006
% 221.06/221.22  |- skos__broader mesh__D012529smesh__D008877
% 221.06/221.22  |- mesh__dateEstablished mesh__D012529 1975-01-01
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012529 2001
% 221.06/221.22  |- mesh__historyNote mesh__D012529 75   
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012529 2004
% 221.06/221.22  |- mesh__dateRevised mesh__D012529 1995-05-23
% 221.06/221.22  |- mesh__recordAuthorizer mesh__D012529 PLS
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012529 1999
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012529 2000
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012529 2005
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012529 1997
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012529 2003
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012529 1998
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D012529 1996
% 221.06/221.22  |- skos__prefLabel mesh__D012529 Saudi Arabia
% 221.06/221.22  |- skos__scopeNote mesh__D017214
% 221.06/221.22       A type of oropharyngeal airway that provides an alternative to endotracheal intubation and standard mask anesthesia in certain patients. It is introduced into the hypopharynx to form a seal around the larynx thus permitting spontaneous or positive pressure ventilation without penetration of the larynx or esophagus. It is used in place of a facemask in routine anesthesia. The advantages over standard mask anesthesia are better airway control, minimal anesthetic gas leakage, a secure airway during patient transport to the recovery area, and minimal postoperative problems.%A%    
% 221.06/221.22  |- skos__annotation mesh__D017214
% 221.06/221.22       %22%an alternative to endotracheal intubation%22%   
% 221.06/221.22  |- mesh__dateCreated mesh__D017214 1992-05-20
% 221.06/221.22  |- mesh__recordAuthorizer mesh__D017214 SJN
% 221.06/221.22  |- mesh__dateEstablished mesh__D017214 1993-01-01
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D017214 2001
% 221.06/221.22  |- mesh__historyNote mesh__D017214 93   
% 221.06/221.22  |- mesh__recordMaintainer mesh__D017214 PXP
% 221.06/221.22  |- mesh__publicMeSHNote mesh__D017214 93   
% 221.06/221.22  |- skos__historyNote mesh__D017214
% 221.06/221.22       Intubation, Intratracheal %28%1985-1992%29%
% 221.06/221.22  |- skos__hiddenLabel mesh__D017214 Masks, Laryngeal
% 221.06/221.22  |- skos__broader mesh__D017214smesh__D008397
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D017214 2000
% 221.06/221.22  |- skos__hiddenLabel mesh__D017214 Mask, Laryngeal
% 221.06/221.22  |- skos__historyNote mesh__D017214 Masks %28%1989-1992%29%
% 221.06/221.22  |- skos__hiddenLabel mesh__D017214 Laryngeal Mask
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D017214 1999
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D017214 2006
% 221.06/221.22  |- skos__altLabel mesh__D017214 Laryngeal Mask Airway
% 221.06/221.22  |- skos__historyNote mesh__D017214 Intubation %28%1985-1992%29%
% 221.06/221.22  |- skos__broader mesh__D017214smesh__D007442
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D017214 1998
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D017214 2005
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D017214 2004
% 221.06/221.22  |- mesh__dateRevised mesh__D017214 1997-06-20
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D017214 2002
% 221.06/221.22  |- skos__hiddenLabel mesh__D017214 Laryngeal Mask Airways
% 221.06/221.22  |- skos__prefLabel mesh__D017214 Laryngeal Masks
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D017214 2003
% 221.06/221.22  |- rdf__type mesh__D017214sskos__Concept
% 221.06/221.22  |- mesh__recordOriginator mesh__D017214 MXR
% 221.06/221.22  |- skos__hiddenLabel mesh__D017214 Airways, Laryngeal Mask
% 221.06/221.22  |- skos__hiddenLabel mesh__D017214 Airway, Laryngeal Mask
% 221.06/221.22  |- skos__hiddenLabel mesh__D050648
% 221.06/221.22       6-Semialdehyde Dehydrogenase, 2-Aminomuconic
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D050648 2006
% 221.06/221.22  |- mesh__recordAuthorizer mesh__D050648 sjn
% 221.06/221.22  |- skos__broader mesh__D050648smesh__D000445
% 221.06/221.22  |- mesh__dateCreated mesh__D050648 2005-06-30
% 221.06/221.22  |- skos__altLabel mesh__D050648 2-Aminomuconic 6-Semialdehyde Dehydrogenase
% 221.06/221.22  |- mesh__recordMaintainer mesh__D050648 AKE
% 221.06/221.22  |- rdf__type mesh__D050648sskos__Concept
% 221.06/221.22  |- mesh__publicMeSHNote mesh__D050648
% 221.06/221.22       2006; AMINOMUCONATE-SEMIALDEHYDE DEHYDROGENASE was indexed under ALDEHUDE OXIDREDUCTASES 1998-2005%A%  
% 221.06/221.22  |- skos__hiddenLabel mesh__D050648 Dehydrogenase, 2-AMS
% 221.06/221.22  |- skos__hiddenLabel mesh__D050648
% 221.06/221.22       Dehydrogenase, Aminomuconate-Semialdehyde
% 221.06/221.22  |- mesh__historyNote mesh__D050648 2006%28%1998%29%   
% 221.06/221.22  |- skos__hiddenLabel mesh__D050648 2 AMS Dehydrogenase
% 221.06/221.22  |- skos__scopeNote mesh__D050648
% 221.06/221.22       An NAD+ dependent enzyme that catalyzes the oxidation of 2-aminomuconate 6-semialdehyde to 2-aminomuconate.%A%    
% 221.06/221.22  |- skos__hiddenLabel mesh__D050648
% 221.06/221.22       2 Aminomuconic 6 Semialdehyde Dehydrogenase
% 221.06/221.22  |- mesh__dateEstablished mesh__D050648 2006-01-01
% 221.06/221.22  |- skos__hiddenLabel mesh__D050648
% 221.06/221.22       Dehydrogenase, 2-Aminomuconic 6-Semialdehyde
% 221.06/221.22  |- skos__historyNote mesh__D050648
% 221.06/221.22       Aldehyde Oxidoreductases %28%1998-2005%29%
% 221.06/221.22  |- mesh__recordOriginator mesh__D050648 AKE
% 221.06/221.22  |- skos__altLabel mesh__D050648 2-AMS Dehydrogenase
% 221.06/221.22  |- skos__prefLabel mesh__D050648 Aminomuconate-Semialdehyde Dehydrogenase
% 221.06/221.22  |- skos__hiddenLabel mesh__D050648 Aminomuconate Semialdehyde Dehydrogenase
% 221.06/221.22  |- skos__scopeNote mesh__D008488
% 221.06/221.22       The field which deals with illustrative clarification of biomedical concepts, as in the use of diagrams and drawings. The illustration may be produced by hand, photography, computer, or other electronic or mechanical methods.%A%    
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D008488 2006
% 221.06/221.22  |- mesh__dateCreated mesh__D008488 1999-01-01
% 221.06/221.22  |- skos__broader mesh__D008488smesh__D001154
% 221.06/221.22  |- skos__altLabel mesh__D008488 Illustration, Medical
% 221.06/221.22  |- rdf__type mesh__D008488sskos__Concept
% 221.06/221.22  |- skos__annotation mesh__D008488
% 221.06/221.22       MODELS, ANATOMIC is also available; anatomical atlases go here %28%IM%29% + ANATOMY, ARTISTIC %28%IM%29% if general; if specific coord IM with specific subject illustrated %28%IM%29% + illus medium %28%IM or NIM%29%; DF: MED ILLUSTRATION%A%  
% 221.06/221.22  |- mesh__recordAuthorizer mesh__D008488 sjn
% 221.06/221.22  |- skos__broader mesh__D008488smesh__D001296
% 221.06/221.22  |- skos__broader mesh__D008488smesh__D006281
% 221.06/221.22  |- mesh__dateRevised mesh__D008488 2004-07-07
% 221.06/221.22  |- mesh__recordMaintainer mesh__D008488 ags
% 221.06/221.22  |- skos__hiddenLabel mesh__D008488 Illustrations, Medical
% 221.06/221.22  |- skos__hiddenLabel mesh__D008488 Medical Illustrations
% 221.06/221.22  |- skos__prefLabel mesh__D008488 Medical Illustration
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D008488 2005
% 221.06/221.22  |- mesh__recordOriginator mesh__D008488 NLM
% 221.06/221.22  |- skos__scopeNote mesh__D005190
% 221.06/221.22       A social group consisting of parents or parent substitutes and children.%A%    
% 221.06/221.22  |- skos__hiddenLabel mesh__D005190 Research, Family
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D005190 2003
% 221.06/221.22  |- mesh__dateRevised mesh__D005190 2002-07-03
% 221.06/221.22  |- skos__hiddenLabel mesh__D005190 Networks, Kinship
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D005190 2005
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D005190 2004
% 221.06/221.22  |- skos__prefLabel mesh__D005190 Family
% 221.06/221.22  |- mesh__activeMeSHYear mesh__D005190 2006
% 221.06/221.22  |- skos__hiddenLabel mesh__D005190 Reconstituted Families
% 221.06/221.22  |- skos__hiddenLabel mesh__D005190 Family, Extended
% 221.06/221.22  |- skos__annotation mesh__D005190
% 221.06/221.22       X ref FAMILY LIFE CYCLES refers to stages through which the family evolves %28%e.g., marriage, childbearing %26% death%29%: do not confuse with LIFE CHANGE EVENTS%A%  
% 221.06/221.22  |- skos__hiddenLabel mesh__D005190 Life Cycles, Family
% 221.06/221.23  |- skos__hiddenLabel mesh__D005190 Reconstituted Family
% 221.06/221.23  |- mesh__dateCreated mesh__D005190 1999-01-01
% 221.06/221.23  |- skos__broader mesh__D005190smesh__D012961
% 221.06/221.23  |- skos__hiddenLabel mesh__D005190 Families, Reconstituted
% 221.06/221.23  |- mesh__recordOriginator mesh__D005190 NLM
% 221.06/221.23  |- skos__hiddenLabel mesh__D005190 Network, Kinship
% 221.06/221.23  |- skos__hiddenLabel mesh__D005190 Family Member
% 221.06/221.23  |- skos__related mesh__D005190smesh__D003241
% 221.06/221.23  |- skos__hiddenLabel mesh__D005190 Families
% 221.06/221.23  |- skos__hiddenLabel mesh__D005190 Extended Families
% 221.06/221.23  |- skos__hiddenLabel mesh__D005190 Stepfamilies
% 221.06/221.23  |- mesh__recordAuthorizer mesh__D005190 sjn
% 221.06/221.23  |- rdf__type mesh__D005190sskos__Concept
% 221.06/221.23  |- skos__hiddenLabel mesh__D005190 Kinship Network
% 221.06/221.23  |- skos__altLabel mesh__D005190 Family Life Cycle
% 221.06/221.23  |- skos__hiddenLabel mesh__D005190 Life Cycle, Family
% 221.06/221.23  |- skos__broader mesh__D005190smesh__D011593
% 221.06/221.23  |- skos__hiddenLabel mesh__D005190 Families, Extended
% 221.06/221.23  |- mesh__recordMaintainer mesh__D005190 tjk
% 221.06/221.23  |- skos__hiddenLabel mesh__D013622 Taenia Infection
% 221.06/221.23  |- mesh__activeMeSHYear mesh__D013622 2002
% 221.06/221.23  |- mesh__activeMeSHYear mesh__D013622 2006
% 221.06/221.23  |- mesh__publicMeSHNote mesh__D013622 68   
% 221.06/221.23  |- mesh__activeMeSHYear mesh__D013622 2001
% 221.06/221.23  |- mesh__dateRevised mesh__D013622 1998-06-11
% 221.06/221.23  |- rdf__type mesh__D013622sskos__Concept
% 221.06/221.23  |- skos__scopeNote mesh__D013622
% 221.06/221.23       Infection with tapeworms of the genus Taenia.     
% 221.06/221.23  |- skos__broader mesh__D013622smesh__D002590
% 221.06/221.23  |- mesh__activeMeSHYear mesh__D013622 2005
% 221.06/221.23  |- mesh__activeMeSHYear mesh__D013622 2000
% 221.06/221.23  |- mesh__activeMeSHYear mesh__D013622 1999
% 221.06/221.23  |- skos__historyNote mesh__D013622 Cestode Infections %28%1966-1967%29%
% 221.06/221.23  |- mesh__historyNote mesh__D013622 68   
% 221.06/221.23  |- mesh__activeMeSHYear mesh__D013622 2004
% 221.06/221.23  |- skos__altLabel mesh__D013622 Infections, Taenia
% 221.06/221.23  |- skos__prefLabel mesh__D013622 Taeniasis
% 221.06/221.23  |- skos__annotation mesh__D013622
% 221.06/221.23       tapeworm infect by Taenia but infect by Taenia larva %28%cysticerci%29% = CYSTICERCOSIS or NEUROCYSTICERCOSIS %26% by Taenia echinococcus or T. granulosus = ECHINOCOCCOSIS%A%  
% 221.06/221.23  |- skos__hiddenLabel mesh__D013622 Taeniases
% 221.06/221.23  |- skos__altLabel mesh__D013622 Taenia Infections
% 221.06/221.23  |- mesh__recordOriginator mesh__D013622 NLM
% 221.06/221.23  |- mesh__activeMeSHYear mesh__D013622 2003
% 221.06/221.23  |- mesh__recordMaintainer mesh__D013622 AGS
% 221.06/221.23  |- mesh__recordAuthorizer mesh__D013622 SJN
% 221.06/221.23  |- mesh__dateCreated mesh__D013622 1999-01-01
% 221.06/221.23  |- skos__related mesh__D013622smesh__D020019
% 221.06/221.23  |- skos__related mesh__D013622smesh__D003551
% 221.06/221.23  |- skos__hiddenLabel mesh__D013622 Infection, Taenia
% 221.06/221.23  |- mesh__dateEstablished mesh__D013622 1968-01-01
% 221.06/221.23  |- skos__prefLabel mesh__D051741 Kruppel-Like Transcription Factors
% 221.06/221.23  |- rdf__type mesh__D051741sskos__Concept
% 221.06/221.23  |- skos__broader mesh__D051741smesh__D014157
% 221.06/221.23  |- skos__altLabel mesh__D051741 Kruppel-Like Factors
% 221.06/221.23  |- skos__broader mesh__D051741smesh__D004268
% 221.06/221.23  |- mesh__historyNote mesh__D051741 2006%28%1989%29%   
% 221.06/221.23  |- mesh__recordMaintainer mesh__D051741 DRC
% 221.06/221.23  |- mesh__dateEstablished mesh__D051741 2006-01-01
% 221.06/221.23  |- skos__hiddenLabel mesh__D051741 Transcription Factors, Kruppel-Like
% 221.06/221.23  |- mesh__publicMeSHNote mesh__D051741
% 221.06/221.23       2006; KRUPPEL-LIKE TRANSCRIPTION FACTORS was indexed under DNA-BINDING PROTEINS %26% REPRESSOR PROTEINS %26% TRANSCRIPTION FACTORS 1993-2005, %26% under JUVENILE HORMONES 1989-1992%A%  
% 221.06/221.23  |- mesh__dateCreated mesh__D051741 2005-06-30
% 221.06/221.23  |- skos__hiddenLabel mesh__D051741 Kruppel Like Transcription Factors
% 221.09/221.23  |- mesh__recordAuthorizer mesh__D051741 sjn
% 221.09/221.23  |- skos__hiddenLabel mesh__D051741 Kruppel Like Factors
% 221.09/221.23  |- skos__scopeNote mesh__D051741
% 221.09/221.23       A family of zinc finger transcription factors that share homology with Kruppel protein, Drosophila. They contain a highly conserved seven amino acid spacer sequence in between their ZINC FINGER MOTIFS.%A%    
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D051741 2006
% 221.09/221.23  |- mesh__recordOriginator mesh__D051741 DRC
% 221.09/221.23  |- mesh__publicMeSHNote mesh__D004896 73   
% 221.09/221.23  |- mesh__dateEstablished mesh__D004896 1973-01-01
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D004896 2006
% 221.09/221.23  |- skos__broader mesh__D004896smesh__D013402
% 221.09/221.23  |- skos__prefLabel mesh__D004896 Erythritol
% 221.09/221.23  |- skos__scopeNote mesh__D004896
% 221.09/221.23       A four-carbon sugar that is found in algae, fungi, and lichens. It is twice as sweet as sucrose and can be used as a coronary vasodilator.%A%    
% 221.09/221.23  |- mesh__recordOriginator mesh__D004896 NLM
% 221.09/221.23  |- mesh__recordMaintainer mesh__D004896 ssb
% 221.09/221.23  |- rdf__type mesh__D004896sskos__Concept
% 221.09/221.23  |- mesh__recordAuthorizer mesh__D004896 sjn
% 221.09/221.23  |- mesh__dateRevised mesh__D004896 2004-07-07
% 221.09/221.23  |- mesh__historyNote mesh__D004896 73%28%65%29%   
% 221.09/221.23  |- mesh__dateCreated mesh__D004896 1999-01-01
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D004896 2005
% 221.09/221.23  |- rdf__type mesh__D004098sskos__Concept
% 221.09/221.23  |- skos__historyNote mesh__D004098 Acetone %28%1969-1974%29%
% 221.09/221.23  |- mesh__dateEstablished mesh__D004098 1991-01-01
% 221.09/221.23  |- mesh__dateRevised mesh__D004098 2005-06-30
% 221.09/221.23  |- skos__altLabel mesh__D004098 Summers Brand of Dihydroxyacetone
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D004098 2006
% 221.09/221.23  |- skos__hiddenLabel mesh__D004098 1,3 Dihydroxy 2 Propanone
% 221.09/221.23  |- skos__historyNote mesh__D004098 Trioses %28%1969-1974%29%
% 221.09/221.23  |- mesh__recordOriginator mesh__D004098 NLM
% 221.09/221.23  |- mesh__dateCreated mesh__D004098 1974-11-19
% 221.09/221.23  |- mesh__historyNote mesh__D004098
% 221.09/221.23       91%28%75%29%; was see under TRIOSES 1975-90   
% 221.09/221.23  |- skos__prefLabel mesh__D004098 Dihydroxyacetone
% 221.09/221.23  |- mesh__recordMaintainer mesh__D004098 exl
% 221.09/221.23  |- skos__altLabel mesh__D004098 ICN Brand of Dihydroxyacetone
% 221.09/221.23  |- mesh__recordAuthorizer mesh__D004098 sjn
% 221.09/221.23  |- skos__broader mesh__D004098smesh__D014306
% 221.09/221.23  |- skos__broader mesh__D004098smesh__D007661
% 221.09/221.23  |- skos__scopeNote mesh__D004098
% 221.09/221.23       A ketotriose compound. Its addition to blood preservation solutions results in better maintenance of 2,3-diphosphoglycerate levels during storage. It is readily phosphorylated to dihydroxyacetone phosphate by triokinase in erythrocytes. In combination with naphthoquinones it acts as a sunscreening agent.%A%    
% 221.09/221.23  |- mesh__publicMeSHNote mesh__D004098 91; was see under TRIOSES 1975-90   
% 221.09/221.23  |- skos__altLabel mesh__D004098 1,3-Dihydroxy-2-Propanone
% 221.09/221.23  |- skos__broader mesh__D045704smesh__D009174
% 221.09/221.23  |- mesh__dateEstablished mesh__D045704 2004-01-01
% 221.09/221.23  |- skos__historyNote mesh__D045704 Mycoplasma %28%1981-2003%29%
% 221.09/221.23  |- rdf__type mesh__D045704sskos__Concept
% 221.09/221.23  |- mesh__publicMeSHNote mesh__D045704 2004   
% 221.09/221.23  |- skos__prefLabel mesh__D045704 Mycoplasma genitalium
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D045704 2006
% 221.09/221.23  |- mesh__dateCreated mesh__D045704 2003-07-09
% 221.09/221.23  |- mesh__recordAuthorizer mesh__D045704 sjn
% 221.09/221.23  |- mesh__recordOriginator mesh__D045704 ags
% 221.09/221.23  |- mesh__dateRevised mesh__D045704 2005-06-30
% 221.09/221.23  |- skos__scopeNote mesh__D045704
% 221.09/221.23       A species of gram-negative bacteria originally isolated from urethral specimens of patients with non-gonoccocal URETHRITIS. In primates it exists in parasitic association with ciliated EPITHELIAL CELLS in the genital and respiratory tracts.%A%    
% 221.09/221.23  |- mesh__historyNote mesh__D045704 2004   
% 221.09/221.23  |- skos__annotation mesh__D045704
% 221.09/221.23       infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29%   
% 221.09/221.23  |- mesh__recordMaintainer mesh__D045704 SYSTEM
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D009581 1999
% 221.09/221.23  |- mesh__dateRevised mesh__D009581 1995-06-08
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D009581 2006
% 221.09/221.23  |- mesh__recordMaintainer mesh__D009581 JRT
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D009581 2002
% 221.09/221.23  |- mesh__recordAuthorizer mesh__D009581 PLS
% 221.09/221.23  |- skos__prefLabel mesh__D009581 Nitrofurans
% 221.09/221.23  |- mesh__recordOriginator mesh__D009581 NLM
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D009581 2000
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D009581 1996
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D009581 2003
% 221.09/221.23  |- skos__broader mesh__D009581smesh__D009574
% 221.09/221.23  |- skos__broader mesh__D009581smesh__D005663
% 221.09/221.23  |- mesh__dateCreated mesh__D009581 1999-01-01
% 221.09/221.23  |- rdf__type mesh__D009581sskos__Concept
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D009581 2001
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D009581 1998
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D009581 1997
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D009581 2005
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D009581 2004
% 221.09/221.23  |- skos__annotation mesh__D009581 urinary anti-infectives   
% 221.09/221.23  |- mesh__recordMaintainer mesh__D017215 AGS
% 221.09/221.23  |- skos__altLabel mesh__D017215 Telecommunications, Satellite
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D017215 1995
% 221.09/221.23  |- skos__hiddenLabel mesh__D017215 Satellite Telecommunications
% 221.09/221.23  |- mesh__publicMeSHNote mesh__D017215
% 221.09/221.23       93; was see TELECOMMUNICATIONS 1985-92   
% 221.09/221.23  |- skos__hiddenLabel mesh__D017215 Telecommunication, Satellite
% 221.09/221.23  |- skos__hiddenLabel mesh__D017215 Satellite Telecommunication
% 221.09/221.23  |- mesh__recordAuthorizer mesh__D017215 PLS
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D017215 1998
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D017215 2005
% 221.09/221.23  |- skos__hiddenLabel mesh__D017215 Communications, Satellite
% 221.09/221.23  |- mesh__recordOriginator mesh__D017215 JLS
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D017215 2000
% 221.09/221.23  |- skos__prefLabel mesh__D017215 Satellite Communications
% 221.09/221.23  |- skos__historyNote mesh__D017215 Telecommunications %28%1976-1992%29%
% 221.09/221.23  |- skos__altLabel mesh__D017215 Communication, Satellite
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D017215 1999
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D017215 2006
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D017215 1996
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D017215 2003
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D017215 2001
% 221.09/221.23  |- skos__scopeNote mesh__D017215
% 221.09/221.23       Communications using an active or passive satellite to extend the range of radio, television, or other electronic transmission by returning signals to earth from an orbiting satellite.%A%    
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D017215 1997
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D017215 2004
% 221.09/221.23  |- mesh__dateEstablished mesh__D017215 1993-01-01
% 221.09/221.23  |- mesh__historyNote mesh__D017215
% 221.09/221.23       93; was see TELECOMMUNICATIONS 1985-92   
% 221.09/221.23  |- skos__hiddenLabel mesh__D017215 Satellite Communication
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D017215 2002
% 221.09/221.23  |- mesh__dateRevised mesh__D017215 1993-06-04
% 221.09/221.23  |- mesh__onlineNote mesh__D017215
% 221.09/221.23       use TELECOMMUNICATIONS to search SATELLITE COMMUNICATIONS 1985-92%A%  
% 221.09/221.23  |- mesh__dateCreated mesh__D017215 1992-05-22
% 221.09/221.23  |- rdf__type mesh__D017215sskos__Concept
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D017215 1994
% 221.09/221.23  |- skos__historyNote mesh__D017215 Communication %28%1972-1975%29%
% 221.09/221.23  |- skos__broader mesh__D017215smesh__D013685
% 221.09/221.23  |- mesh__onlineNote mesh__D008489
% 221.09/221.23       use MEDICAL INDIGENCY to search INDIGENT CARE 1966-67   
% 221.09/221.23  |- mesh__recordOriginator mesh__D008489 NLM
% 221.09/221.23  |- skos__hiddenLabel mesh__D008489 Medical Indigencies
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D008489 2002
% 221.09/221.23  |- rdf__type mesh__D008489sskos__Concept
% 221.09/221.23  |- mesh__publicMeSHNote mesh__D008489 68; was INDIGENT CARE 1963-67   
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D008489 2003
% 221.09/221.23  |- skos__broader mesh__D008489smesh__D012959
% 221.09/221.23  |- skos__scopeNote mesh__D008489
% 221.09/221.23       The condition in which individuals are financially unable to access adequate medical care without depriving themselves and their dependents of food, clothing, shelter, and other essentials of living.%A%    
% 221.09/221.23  |- skos__prefLabel mesh__D008489 Medical Indigency
% 221.09/221.23  |- skos__related mesh__D008489smesh__D017057
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D008489 2004
% 221.09/221.23  |- skos__annotation mesh__D008489 DF: MED INDIGENCY   
% 221.09/221.23  |- mesh__recordMaintainer mesh__D008489 jls
% 221.09/221.23  |- mesh__dateRevised mesh__D008489 1999-11-03
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D008489 2005
% 221.09/221.23  |- mesh__recordAuthorizer mesh__D008489 sjn
% 221.09/221.23  |- mesh__dateEstablished mesh__D008489 1968-01-01
% 221.09/221.23  |- skos__related mesh__D008489smesh__D017664
% 221.09/221.23  |- skos__broader mesh__D008489smesh__D004467
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D008489 2006
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D008489 2000
% 221.09/221.23  |- skos__hiddenLabel mesh__D008489 Indigencies, Medical
% 221.09/221.23  |- mesh__dateCreated mesh__D008489 1999-01-01
% 221.09/221.23  |- skos__altLabel mesh__D008489 Indigency, Medical
% 221.09/221.23  |- mesh__historyNote mesh__D008489 68; was INDIGENT CARE 1963-67   
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D008489 2001
% 221.09/221.23  |- mesh__dateEstablished mesh__D005191 1968-01-01
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Completed Family Sizes
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Family Sizes, Desired
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Life Surveys, Family
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Family Demographies
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Demography, Family
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Life Survey, Family
% 221.09/221.23  |- mesh__recordMaintainer mesh__D005191 jls
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Average Family Size
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Ideal Family Sizes
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D005191 2003
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Average Family Sizes
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Surveys, Family Life
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D005191 2002
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Desired Family Sizes
% 221.09/221.23  |- mesh__recordOriginator mesh__D005191 NLM
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Household Head
% 221.09/221.23  |- skos__broader mesh__D005191smesh__D005190
% 221.09/221.23  |- mesh__recordAuthorizer mesh__D005191 sjn
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Family Sizes, Ideal
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Family Sizes, Expected
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 One Person Household
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Household and Family
% 221.09/221.23  |- mesh__dateCreated mesh__D005191 1999-01-01
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D005191 2004
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Ideal Family Size
% 221.09/221.23  |- skos__prefLabel mesh__D005191 Family Characteristics
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Expected Family Size
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Household
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Family Sizes, Average
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Completed Family Size
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Patriarchies
% 221.09/221.23  |- rdf__type mesh__D005191sskos__Concept
% 221.09/221.23  |- skos__historyNote mesh__D005191 Family %28%1966-1967%29%
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Matriarchies
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Demographies, Family
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Family Sizes, Completed
% 221.09/221.23  |- skos__broader mesh__D005191smesh__D012959
% 221.09/221.23  |- mesh__historyNote mesh__D005191 68   
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D005191 2000
% 221.09/221.23  |- mesh__dateRevised mesh__D005191 1999-11-09
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D005191 2005
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Expected Family Sizes
% 221.09/221.23  |- mesh__publicMeSHNote mesh__D005191 68   
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Desired Family Size
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Family Life Survey
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Household Heads
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Family Sizes
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Survey, Family Life
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Households, One-Person
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Household, One-Person
% 221.09/221.23  |- skos__scopeNote mesh__D005191 Size and composition of the family.     
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Characteristics, Family
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D005191 2001
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Family Characteristic
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 One-Person Households
% 221.09/221.23  |- skos__hiddenLabel mesh__D005191 Characteristic, Family
% 221.09/221.23  |- skos__broader mesh__D005191smesh__D003710
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D005191 2006
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D013623 1995
% 221.09/221.23  |- skos__annotation mesh__D013623
% 221.09/221.23       avoid such combinations as TAIL /metab or TAIL /chem, etc. where tail is merely test tissue%A%  
% 221.09/221.23  |- rdf__type mesh__D013623sskos__Concept
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D013623 2005
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D013623 1999
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D013623 1994
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D013623 2002
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D013623 2004
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D013623 1998
% 221.09/221.23  |- skos__hiddenLabel mesh__D013623 Tails
% 221.09/221.23  |- mesh__dateRevised mesh__D013623 1991-06-28
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D013623 1993
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D013623 2001
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D013623 2003
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D013623 1997
% 221.09/221.23  |- mesh__recordMaintainer mesh__D013623 TGC
% 221.09/221.23  |- mesh__dateCreated mesh__D013623 1999-01-01
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D013623 1992
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D013623 2000
% 221.09/221.23  |- skos__historyNote mesh__D013623 specific animal %28%1966-1967%29%
% 221.09/221.23  |- mesh__recordAuthorizer mesh__D013623 PLS
% 221.09/221.23  |- mesh__historyNote mesh__D013623 68   
% 221.09/221.23  |- mesh__dateEstablished mesh__D013623 1968-01-01
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D013623 1996
% 221.09/221.23  |- skos__prefLabel mesh__D013623 Tail
% 221.09/221.23  |- mesh__recordOriginator mesh__D013623 NLM
% 221.09/221.23  |- skos__broader mesh__D013623smesh__D000825
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D013623 2006
% 221.09/221.23  |- mesh__publicMeSHNote mesh__D013623 68   
% 221.09/221.23  |- mesh__recordAuthorizer mesh__D051742 sjn
% 221.09/221.23  |- skos__altLabel mesh__D051742 C-EBP Homologous Protein
% 221.09/221.23  |- skos__hiddenLabel mesh__D051742 C EBP Homologous Protein
% 221.09/221.23  |- skos__hiddenLabel mesh__D051742 CHOP, Transcription Factor
% 221.09/221.23  |- skos__altLabel mesh__D051742
% 221.09/221.23       Growth Arrest And DNA Damage-Inducible Protein 153
% 221.09/221.23  |- skos__hiddenLabel mesh__D051742 Homologous Protein, C-EBP
% 221.09/221.23  |- skos__hiddenLabel mesh__D051742
% 221.09/221.23       Growth Arrest And DNA Damage Inducible Protein 153
% 221.09/221.23  |- skos__altLabel mesh__D051742 DDIT3 Protein
% 221.09/221.23  |- skos__prefLabel mesh__D051742 Transcription Factor CHOP
% 221.09/221.23  |- skos__broader mesh__D051742smesh__D022762
% 221.09/221.23  |- skos__hiddenLabel mesh__D051742
% 221.09/221.23       DNA Damage Inducible Transcript 3 Protein
% 221.09/221.23  |- mesh__recordMaintainer mesh__D051742 DRC
% 221.09/221.23  |- mesh__dateEstablished mesh__D051742 2006-01-01
% 221.09/221.23  |- mesh__publicMeSHNote mesh__D051742
% 221.09/221.23       2006; TRANSCRIPTION FACTOR CHOP was indexed under TRANSCRIPTION FACTORS 1995-2005, under CCAAT-ENHANCER BINDING PROTEINS 2001-2005, under DNA-BINDING PROTEINS 1993-2000, %26% under PROTEINS 1992-1994%A%  
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D051742 2006
% 221.09/221.23  |- mesh__recordOriginator mesh__D051742 DRC
% 221.09/221.23  |- mesh__historyNote mesh__D051742 2006%28%1992%29%   
% 221.09/221.23  |- mesh__dateCreated mesh__D051742 2005-06-30
% 221.09/221.23  |- skos__scopeNote mesh__D051742
% 221.09/221.23       A CCAAT-enhancer binding protein that is induced by DNA DAMAGE and growth arrest. It serves as a dominant negative inhibitor of other CCAAT-enhancer binding proteins.%A%    
% 221.09/221.23  |- rdf__type mesh__D051742sskos__Concept
% 221.09/221.23  |- skos__altLabel mesh__D051742 GADD153 Protein
% 221.09/221.23  |- skos__altLabel mesh__D051742 DNA Damage-Inducible Transcript 3 Protein
% 221.09/221.23  |- rdf__type mesh__D004897sskos__Concept
% 221.09/221.23  |- skos__scopeNote mesh__D004897
% 221.09/221.23       A vasodilator with general properties similar to NITROGLYCERIN. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1020%29%%A%    
% 221.09/221.23  |- mesh__dateRevised mesh__D004897 2004-07-07
% 221.09/221.23  |- skos__prefLabel mesh__D004897 Erythrityl Tetranitrate
% 221.09/221.23  |- mesh__recordOriginator mesh__D004897 NLM
% 221.09/221.23  |- mesh__recordMaintainer mesh__D004897 ssb
% 221.09/221.23  |- mesh__dateCreated mesh__D004897 1999-01-01
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D004897 2005
% 221.09/221.23  |- skos__broader mesh__D004897smesh__D009566
% 221.09/221.23  |- skos__hiddenLabel mesh__D004897 Tetranitrate, Erythrityl
% 221.09/221.23  |- skos__broader mesh__D004897smesh__D004896
% 221.09/221.23  |- mesh__recordAuthorizer mesh__D004897 sjn
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D004897 2006
% 221.09/221.23  |- mesh__dateEstablished mesh__D004099 1991-01-01
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D004099 2006
% 221.09/221.23  |- mesh__recordAuthorizer mesh__D004099 sjn
% 221.09/221.23  |- mesh__dateRevised mesh__D004099 2004-07-07
% 221.09/221.23  |- skos__broader mesh__D004099smesh__D013403
% 221.09/221.23  |- skos__historyNote mesh__D004099 Acetone %28%1972-1974%29%
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D004099 2005
% 221.09/221.23  |- skos__prefLabel mesh__D004099 Dihydroxyacetone Phosphate
% 221.09/221.23  |- skos__altLabel mesh__D004099 Dihydroxyacetone 3-Phosphate
% 221.09/221.23  |- mesh__historyNote mesh__D004099
% 221.09/221.23       91%28%75%29%; was see under TRIOSES 1975-90   
% 221.09/221.23  |- skos__historyNote mesh__D004099 Trioses %28%1972-1974%29%
% 221.09/221.23  |- mesh__recordMaintainer mesh__D004099 ssb
% 221.09/221.23  |- skos__annotation mesh__D004099 /biosyn /physiol permitted   
% 221.09/221.23  |- skos__scopeNote mesh__D004099
% 221.09/221.23       An important intermediate in lipid biosynthesis and in glycolysis.%A%    
% 221.09/221.23  |- mesh__dateCreated mesh__D004099 1974-11-19
% 221.09/221.23  |- skos__hiddenLabel mesh__D004099 Phosphate, Dihydroxyacetone
% 221.09/221.23  |- skos__hiddenLabel mesh__D004099 Dihydroxyacetone 3 Phosphate
% 221.09/221.23  |- mesh__recordOriginator mesh__D004099 NLM
% 221.09/221.23  |- mesh__publicMeSHNote mesh__D004099 91; was see under TRIOSES 1975-90   
% 221.09/221.23  |- skos__hiddenLabel mesh__D004099 3-Phosphate, Dihydroxyacetone
% 221.09/221.23  |- skos__historyNote mesh__D004099
% 221.09/221.23       Organophosphorus Compounds %28%1973-1974%29%
% 221.09/221.23  |- rdf__type mesh__D004099sskos__Concept
% 221.09/221.23  |- mesh__historyNote mesh__D045705 2004   
% 221.09/221.23  |- rdf__type mesh__D045705sskos__Concept
% 221.09/221.23  |- skos__annotation mesh__D045705
% 221.09/221.23       infection = PNEUMONIA OF SWINE, MYCOPLASMAL; do not confuse with PNEUMONIA, MYCOPLASMA%A%  
% 221.09/221.23  |- mesh__publicMeSHNote mesh__D045705 2004   
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D045705 2006
% 221.09/221.23  |- mesh__dateCreated mesh__D045705 2003-07-09
% 221.09/221.23  |- skos__broader mesh__D045705smesh__D009174
% 221.09/221.23  |- skos__scopeNote mesh__D045705
% 221.09/221.23       A species of gram-negative bacteria that causes MYCOPLASMA PNEUMONIA OF SWINE. The organism damages the CILIA in the airways of the pig, and thus compromises one of the most effective mechanical barriers against invading pathogens. The resulting weakening of the IMMUNE SYSTEM can encourage secondary infections, leading to porcine respiratory disease complex.%A%    
% 221.09/221.23  |- mesh__dateEstablished mesh__D045705 2004-01-01
% 221.09/221.23  |- mesh__recordMaintainer mesh__D045705 SYSTEM
% 221.09/221.23  |- mesh__recordAuthorizer mesh__D045705 sjn
% 221.09/221.23  |- mesh__recordOriginator mesh__D045705 ags
% 221.09/221.23  |- mesh__dateRevised mesh__D045705 2005-06-30
% 221.09/221.23  |- skos__prefLabel mesh__D045705 Mycoplasma hyopneumoniae
% 221.09/221.23  |- skos__historyNote mesh__D045705 Mycoplasma %28%1968-2003%29%
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D009582 2001
% 221.09/221.23  |- skos__broader mesh__D009582smesh__D009581
% 221.09/221.23  |- skos__hiddenLabel mesh__D009582 Sodium Salt, Nitrofurantoin
% 221.09/221.23  |- mesh__dateRevised mesh__D009582 2000-06-22
% 221.09/221.23  |- skos__scopeNote mesh__D009582
% 221.09/221.23       A urinary anti-infective agent effective against most gram-positive and gram-negative organisms. Although sulfonamides and antibiotics are usually the agents of choice for urinary tract infections, nitrofurantoin is widely used for prophylaxis and long-term suppression.%A%    
% 221.09/221.23  |- skos__hiddenLabel mesh__D009582 Monohydrate Nitrofurantoin
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D009582 2002
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D009582 2003
% 221.09/221.23  |- skos__prefLabel mesh__D009582 Nitrofurantoin
% 221.09/221.23  |- rdf__type mesh__D009582sskos__Concept
% 221.09/221.23  |- mesh__dateCreated mesh__D009582 1999-01-01
% 221.09/221.23  |- mesh__recordAuthorizer mesh__D009582 sjn
% 221.09/221.23  |- mesh__recordOriginator mesh__D009582 NLM
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D009582 2005
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D009582 2004
% 221.09/221.23  |- mesh__recordMaintainer mesh__D009582 CCR
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D009582 2006
% 221.09/221.23  |- mesh__dateCreated mesh__D017216 1992-05-22
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D017216 1998
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D017216 2005
% 221.09/221.23  |- skos__related mesh__D017216smesh__D013686
% 221.09/221.23  |- mesh__recordOriginator mesh__D017216 JLS
% 221.09/221.23  |- skos__broader mesh__D017216smesh__D003695
% 221.09/221.23  |- skos__annotation mesh__D017216
% 221.09/221.23       %22%deliv of health serv via remote telecommun%22%; note specifics; DF: TELEMED%A%  
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D017216 1999
% 221.09/221.23  |- mesh__activeMeSHYear mesh__D017216 2006
% 221.09/221.24  |- mesh__recordAuthorizer mesh__D017216 SJN
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D017216 2003
% 221.09/221.24  |- skos__broader mesh__D017216smesh__D008511
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D017216 2004
% 221.09/221.24  |- skos__prefLabel mesh__D017216 Telemedicine
% 221.09/221.24  |- skos__scopeNote mesh__D017216
% 221.09/221.24       Delivery of health services via remote telecommunications. This includes interactive consultative and diagnostic services.%A%    
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D017216 2000
% 221.09/221.24  |- skos__historyNote mesh__D017216 Telecommunications %28%1976-1992%29%
% 221.09/221.24  |- mesh__recordMaintainer mesh__D017216 TPW
% 221.09/221.24  |- rdf__type mesh__D017216sskos__Concept
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D017216 2001
% 221.09/221.24  |- skos__broader mesh__D017216smesh__D013685
% 221.09/221.24  |- mesh__publicMeSHNote mesh__D017216 93   
% 221.09/221.24  |- mesh__dateEstablished mesh__D017216 1993-01-01
% 221.09/221.24  |- mesh__dateRevised mesh__D017216 1997-06-20
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D017216 2002
% 221.09/221.24  |- mesh__historyNote mesh__D017216 93   
% 221.09/221.24  |- mesh__recordAuthorizer mesh__D033681 sjn
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D033681 2006
% 221.09/221.24  |- mesh__recordMaintainer mesh__D033681 SYSTEM
% 221.09/221.24  |- skos__broader mesh__D033681smesh__D026901
% 221.09/221.24  |- skos__broader mesh__D033681smesh__D024101
% 221.09/221.24  |- mesh__recordOriginator mesh__D033681 jmp
% 221.09/221.24  |- mesh__historyNote mesh__D033681 2003   
% 221.09/221.24  |- mesh__dateRevised mesh__D033681 2005-06-30
% 221.09/221.24  |- rdf__type mesh__D033681sskos__Concept
% 221.09/221.24  |- mesh__dateEstablished mesh__D033681 2003-01-01
% 221.09/221.24  |- skos__altLabel mesh__D033681 Membrane Transport Proteins, Mitochondrial
% 221.09/221.24  |- skos__prefLabel mesh__D033681 Mitochondrial Membrane Transport Proteins
% 221.09/221.24  |- mesh__publicMeSHNote mesh__D033681 2003   
% 221.09/221.24  |- mesh__dateCreated mesh__D033681 2002-07-03
% 221.09/221.24  |- skos__scopeNote mesh__D033681
% 221.09/221.24       Proteins involved in the transport of specific substances across the membranes of the MITOCHONDRIA.%A%    
% 221.09/221.24  |- mesh__recordAuthorizer mesh__D005990 sjn
% 221.09/221.24  |- mesh__historyNote mesh__D005990 98   
% 221.09/221.24  |- mesh__publicMeSHNote mesh__D005990
% 221.09/221.24       98; see GLYCERIN 1963-97; for GLYCEROL see GLYCERIN 1976-97%A%  
% 221.09/221.24  |- skos__prefLabel mesh__D005990 Glycerol
% 221.09/221.24  |- skos__broader mesh__D005990smesh__D013402
% 221.09/221.24  |- mesh__recordMaintainer mesh__D005990 ssb
% 221.09/221.24  |- skos__altLabel mesh__D005990 Glycerine
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D005990 2005
% 221.09/221.24  |- skos__scopeNote mesh__D005990
% 221.09/221.24       A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism. It is used as a solvent, emollient, pharmaceutical agent, and sweetening agent.%A%    
% 221.09/221.24  |- mesh__recordOriginator mesh__D005990 NLM
% 221.09/221.24  |- mesh__dateCreated mesh__D005990 1999-01-01
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D005990 2006
% 221.09/221.24  |- skos__altLabel mesh__D005990 Glycerin
% 221.09/221.24  |- rdf__type mesh__D005990sskos__Concept
% 221.09/221.24  |- mesh__dateRevised mesh__D005990 2004-07-07
% 221.09/221.24  |- skos__altLabel mesh__D005990 1,2,3-Trihydroxypropane
% 221.09/221.24  |- mesh__historyNote mesh__D005192
% 221.09/221.24       91%28%79%29%; was see under FAMILY 1979-90   
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D005192 2003
% 221.09/221.24  |- skos__annotation mesh__D005192
% 221.09/221.24       health status of family as a unit %26% impact on individual  members; /ethnol permitted%A%  
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D005192 1999
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D005192 2001
% 221.09/221.24  |- skos__hiddenLabel mesh__D005192 Health, Family
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D005192 2006
% 221.09/221.24  |- skos__historyNote mesh__D005192 Health %28%1966-1978%29%
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D005192 1998
% 221.09/221.24  |- mesh__dateRevised mesh__D005192 1997-06-20
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D005192 2000
% 221.09/221.24  |- skos__scopeNote mesh__D005192
% 221.09/221.24       The health status of the family as a unit including the impact of the health of one member of the family on the family as a unit and on individual family members; also, the impact of family organization or disorganization on the health status of its members.%A%    
% 221.09/221.24  |- skos__prefLabel mesh__D005192 Family Health
% 221.09/221.24  |- mesh__recordMaintainer mesh__D005192 PXP
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D005192 2005
% 221.09/221.24  |- mesh__dateCreated mesh__D005192 1978-05-08
% 221.09/221.24  |- mesh__dateEstablished mesh__D005192 1991-01-01
% 221.09/221.24  |- mesh__publicMeSHNote mesh__D005192 91; was see under FAMILY 1979-90   
% 221.09/221.24  |- skos__broader mesh__D005192smesh__D006262
% 221.09/221.24  |- mesh__recordAuthorizer mesh__D005192 SJN
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D005192 2002
% 221.09/221.24  |- skos__historyNote mesh__D005192 Family %28%1966-1978%29%
% 221.09/221.24  |- rdf__type mesh__D005192sskos__Concept
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D005192 2004
% 221.09/221.24  |- mesh__recordOriginator mesh__D005192 EC
% 221.09/221.24  |- mesh__recordAuthorizer mesh__D013624 ags
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013624 1995
% 221.09/221.24  |- rdf__type mesh__D013624sskos__Concept
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013624 2003
% 221.09/221.24  |- skos__prefLabel mesh__D013624 Taiwan
% 221.09/221.24  |- mesh__dateCreated mesh__D013624 1999-01-01
% 221.09/221.24  |- skos__altLabel mesh__D013624 Republic of China
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013624 1992
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013624 1999
% 221.09/221.24  |- mesh__recordOriginator mesh__D013624 NLM
% 221.09/221.24  |- skos__broader mesh__D013624smesh__D005202
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013624 2002
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013624 2004
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013624 1996
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013624 1993
% 221.09/221.24  |- skos__altLabel mesh__D013624 Formosa
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013624 1997
% 221.09/221.24  |- mesh__recordMaintainer mesh__D013624 ags
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013624 2000A
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013624 2000
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013624 2005
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013624 2001
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013624 1994
% 221.09/221.24  |- mesh__dateRevised mesh__D013624 1999-12-01
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013624 2006
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013624 1998
% 221.09/221.24  |- skos__hiddenLabel mesh__D051743 IL 6beta NF
% 221.09/221.24  |- skos__altLabel mesh__D051743 Nuclear Factor Interleukin 6beta
% 221.09/221.24  |- skos__altLabel mesh__D051743 Interleukin-6beta Nuclear Factor
% 221.09/221.24  |- skos__hiddenLabel mesh__D051743 CCAAT Enhancer Binding Protein delta
% 221.09/221.24  |- mesh__dateCreated mesh__D051743 2005-06-30
% 221.09/221.24  |- skos__hiddenLabel mesh__D051743 Interleukin 6beta Nuclear Factor
% 221.09/221.24  |- mesh__recordOriginator mesh__D051743 DRC
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D051743 2006
% 221.09/221.24  |- mesh__recordAuthorizer mesh__D051743 sjn
% 221.09/221.24  |- mesh__historyNote mesh__D051743 2006%28%1991%29%   
% 221.09/221.24  |- rdf__type mesh__D051743sskos__Concept
% 221.09/221.24  |- mesh__publicMeSHNote mesh__D051743
% 221.09/221.24       2006; CCAAT-ENHANCER-BINDING PROTEIN-DELTA was indexed under TRANSCRIPTION FACTORS 1991-2005, under CCAAT-ENHANCER-BINDING PROTEINS 2001-2005, under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS 1991-2000%A%  
% 221.09/221.24  |- skos__hiddenLabel mesh__D051743 C EBP delta Protein
% 221.09/221.24  |- skos__altLabel mesh__D051743 C-EBP delta Protein
% 221.09/221.24  |- skos__prefLabel mesh__D051743 CCAAT-Enhancer-Binding Protein-delta
% 221.09/221.24  |- skos__altLabel mesh__D051743 IL-6beta-NF
% 221.09/221.24  |- mesh__recordMaintainer mesh__D051743 DRC
% 221.09/221.24  |- mesh__dateEstablished mesh__D051743 2006-01-01
% 221.09/221.24  |- skos__scopeNote mesh__D051743
% 221.09/221.24       A member of the C-EBP protein family of transcription factors. It plays a key role in G0 PHASE mammary EPITHELIAL CELL growth arrest, and it is involved in transcriptional regulation of INTERLEUKIN 1; INTERLEUKIN 6; and TUMOR NECROSIS FACTOR-ALPHA.%A%    
% 221.09/221.24  |- skos__broader mesh__D051743smesh__D022762
% 221.09/221.24  |- mesh__historyNote mesh__D004898
% 221.09/221.24       91%28%75%29%; was see under AVIAN LEUKOSIS VIRUSES 1975-90; was see under AVIAN LEUKOSIS VIRUS 1963-74%A%  
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D004898 2003
% 221.09/221.24  |- mesh__dateCreated mesh__D004898 1999-01-01
% 221.09/221.24  |- mesh__recordOriginator mesh__D004898 NLM
% 221.09/221.24  |- mesh__recordMaintainer mesh__D004898 ags
% 221.09/221.24  |- mesh__dateRevised mesh__D004898 2001-07-25
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D004898 2006
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D004898 2002
% 221.09/221.24  |- mesh__recordAuthorizer mesh__D004898 sjn
% 221.09/221.24  |- mesh__onlineNote mesh__D004898
% 221.09/221.24       use AVIAN LEUKOSIS VIRUSES to search ERYTHROBLASTOSIS VIRUS, AVIAN 1966-74%A%  
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D004898 2005
% 221.09/221.24  |- skos__altLabel mesh__D004898 Avian Erythroblastosis Virus
% 221.09/221.24  |- skos__prefLabel mesh__D004898 Erythroblastosis Virus, Avian
% 221.09/221.24  |- mesh__publicMeSHNote mesh__D004898
% 221.09/221.24       91; was see under AVIAN LEUKOSIS VIRUSES 1975-90; was see under AVIAN LEUKOSIS VIRUS 1963-74%A%  
% 221.09/221.24  |- mesh__dateEstablished mesh__D004898 1991-01-01
% 221.09/221.24  |- skos__broader mesh__D004898smesh__D001355
% 221.09/221.24  |- skos__hiddenLabel mesh__D004898 Viruses, Avian Erythroblastosis
% 221.09/221.24  |- skos__hiddenLabel mesh__D004898 Erythroblastosis Viruses, Avian
% 221.09/221.24  |- skos__hiddenLabel mesh__D004898 Avian Erythroblastosis Viruses
% 221.09/221.24  |- rdf__type mesh__D004898sskos__Concept
% 221.09/221.24  |- skos__scopeNote mesh__D004898
% 221.09/221.24       A species of ALPHARETROVIRUS causing progressive anemia and weakness in domestic and wild fowl.%A%    
% 221.09/221.24  |- skos__hiddenLabel mesh__D004898 Virus, Avian Erythroblastosis
% 221.09/221.24  |- skos__annotation mesh__D004898
% 221.09/221.24       infection: coord IM with AVIAN LEUKOSIS %28%IM%29%   
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D004898 2004
% 221.09/221.24  |- skos__altLabel mesh__D045706 PC2 Protein
% 221.09/221.24  |- skos__altLabel mesh__D045706 Prohormone Convertase, PC2
% 221.09/221.24  |- skos__altLabel mesh__D045706 Prohormone Convertase 2
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D045706 2004
% 221.09/221.24  |- rdf__type mesh__D045706sskos__Concept
% 221.09/221.24  |- skos__altLabel mesh__D045706 PC2 Prohormone Convertase
% 221.09/221.24  |- skos__altLabel mesh__D045706 PC2 Endoprotease
% 221.09/221.24  |- mesh__recordAuthorizer mesh__D045706 sjn
% 221.09/221.24  |- skos__altLabel mesh__D045706 Endopeptidase PC2
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D045706 2006
% 221.09/221.24  |- mesh__historyNote mesh__D045706
% 221.09/221.24       2004; use PROPROTEIN CONVERTASE 2 %28%NM%29% 1991-2003   
% 221.09/221.24  |- mesh__dateCreated mesh__D045706 2003-07-09
% 221.09/221.24  |- skos__hiddenLabel mesh__D045706 Convertase, PC2 Prohormone
% 221.09/221.24  |- skos__historyNote mesh__D045706 Subtilisins %28%1991-2003%29%
% 221.09/221.24  |- skos__hiddenLabel mesh__D045706 Endoprotease, PC2
% 221.09/221.24  |- skos__altLabel mesh__D045706 Proinsulin Convertase 2
% 221.09/221.24  |- skos__altLabel mesh__D045706 Prohormone Convertase PC2
% 221.09/221.24  |- mesh__publicMeSHNote mesh__D045706
% 221.09/221.24       2004; PC2 PROTEIN %28%now PROPROTEIN CONVERTASE 2%29% was indexed under SUBTILISINS 1991-2003%A%  
% 221.09/221.24  |- skos__hiddenLabel mesh__D045706 Convertase 2, Proinsulin
% 221.09/221.24  |- skos__altLabel mesh__D045706 Neuroendocrine Convertase PC2
% 221.09/221.24  |- skos__broader mesh__D045706smesh__D043484
% 221.09/221.24  |- skos__prefLabel mesh__D045706 Proprotein Convertase 2
% 221.09/221.24  |- skos__scopeNote mesh__D045706
% 221.09/221.24       A serine endopeptidase that has specificity for cleavage at ARGININE. It cleaves a variety of prohormones including PRO-OPIOMELANOCORTIN, proluteinizing-hormone-releasing hormone, proenkephalins, prodynorphin, and PROINSULIN.%A%    
% 221.09/221.24  |- skos__broader mesh__D045706smesh__D012697
% 221.09/221.24  |- skos__hiddenLabel mesh__D045706 Convertase 2, Prohormone
% 221.09/221.24  |- mesh__recordMaintainer mesh__D045706 jmp
% 221.09/221.24  |- mesh__dateEstablished mesh__D045706 2004-01-01
% 221.09/221.24  |- skos__hiddenLabel mesh__D045706 PC2, Endopeptidase
% 221.09/221.24  |- skos__hiddenLabel mesh__D045706 Convertase PC2, Neuroendocrine
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D045706 2005
% 221.09/221.24  |- mesh__recordOriginator mesh__D045706 jmp
% 221.09/221.24  |- skos__hiddenLabel mesh__D045706 Convertase PC2, Prohormone
% 221.09/221.24  |- mesh__dateCreated mesh__D009583 1999-01-01
% 221.09/221.24  |- mesh__recordAuthorizer mesh__D009583 sjn
% 221.09/221.24  |- mesh__recordOriginator mesh__D009583 NLM
% 221.09/221.24  |- skos__prefLabel mesh__D009583 Nitrofurazone
% 221.09/221.24  |- skos__altLabel mesh__D009583 Furacillin
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D009583 2006
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D009583 2002
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D009583 2005
% 221.09/221.24  |- skos__scopeNote mesh__D009583
% 221.09/221.24       A topical anti-infective agent effective against gram-negative and gram-positive bacteria. It is used for superficial wounds, burns, ulcers, and skin infections. Nitrofurazone has also been administered orally in the treatment of trypanosomiasis.%A%    
% 221.09/221.24  |- mesh__dateRevised mesh__D009583 2000-06-22
% 221.09/221.24  |- mesh__recordMaintainer mesh__D009583 CCR
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D009583 2001
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D009583 2004
% 221.09/221.24  |- rdf__type mesh__D009583sskos__Concept
% 221.09/221.24  |- skos__altLabel mesh__D009583 Nitrofural
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D009583 2003
% 221.09/221.24  |- skos__broader mesh__D009583smesh__D009581
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D017217 1997
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D017217 2004
% 221.09/221.24  |- mesh__dateEstablished mesh__D017217 1993-01-01
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D017217 2001
% 221.09/221.24  |- skos__hiddenLabel mesh__D017217 Patch, Epidural Blood
% 221.09/221.24  |- skos__hiddenLabel mesh__D017217 Blood Patchs, Epidural
% 221.09/221.24  |- mesh__publicMeSHNote mesh__D017217 93   
% 221.09/221.24  |- rdf__type mesh__D017217sskos__Concept
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D017217 2002
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D017217 1994
% 221.09/221.24  |- skos__broader mesh__D017217smesh__D001691
% 221.09/221.24  |- mesh__dateCreated mesh__D017217 1992-05-07
% 221.09/221.24  |- skos__prefLabel mesh__D017217 Blood Patch, Epidural
% 221.09/221.24  |- skos__altLabel mesh__D017217 Epidural Blood Patch
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D017217 1995
% 221.09/221.24  |- mesh__historyNote mesh__D017217 93   
% 221.09/221.24  |- skos__hiddenLabel mesh__D017217 Patchs, Epidural Blood
% 221.09/221.24  |- skos__broader mesh__D017217smesh__D007268
% 221.09/221.24  |- skos__historyNote mesh__D017217 Blood %28%1974-1992%29%
% 221.09/221.24  |- skos__hiddenLabel mesh__D017217 Epidural Blood Patchs
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D017217 2005
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D017217 1998
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D017217 1993
% 221.09/221.24  |- skos__scopeNote mesh__D017217
% 221.09/221.24       The injection of autologous blood into the epidural space either as a prophylactic treatment immediately following an epidural puncture or for treatment of headache as a result of an epidural puncture.%A%    
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D017217 1999
% 221.09/221.24  |- skos__annotation mesh__D017217 IM; for repair of epidural puncture   
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D017217 2006
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D017217 1996
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D017217 2003
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D017217 2000
% 221.09/221.24  |- skos__historyNote mesh__D017217 Injections, Epidural %28%1989-1992%29%
% 221.09/221.24  |- skos__broader mesh__D005991smesh__D017853
% 221.09/221.24  |- rdf__type mesh__D005991sskos__Concept
% 221.09/221.24  |- mesh__historyNote mesh__D005991
% 221.09/221.24       91%28%75%29%; was see under PHOSPHOTRANSFERASES, ATP 1975-90   
% 221.09/221.24  |- mesh__publicMeSHNote mesh__D005991
% 221.09/221.24       91; was see under PHOSPHOTRANSFERASES, ATP 1975-90   
% 221.09/221.24  |- skos__historyNote mesh__D005991 Phosphotransferases %28%1973-1974%29%
% 221.09/221.24  |- mesh__dateRevised mesh__D005991 2003-07-09
% 221.09/221.24  |- mesh__dateEstablished mesh__D005991 1991-01-01
% 221.09/221.24  |- mesh__recordMaintainer mesh__D005991 ssb
% 221.09/221.24  |- mesh__dateCreated mesh__D005991 1974-11-19
% 221.09/221.24  |- mesh__recordAuthorizer mesh__D005991 sjn
% 221.09/221.24  |- skos__historyNote mesh__D005991 Glycerin %28%1973-1974%29%
% 221.09/221.24  |- skos__hiddenLabel mesh__D005991 Kinase, Glycerol
% 221.09/221.24  |- skos__altLabel mesh__D005991 Glycerokinase
% 221.09/221.24  |- skos__prefLabel mesh__D005991 Glycerol Kinase
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D005991 2004
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D005991 2006
% 221.09/221.24  |- skos__historyNote mesh__D005991 Phosphotransferases, ATP %28%1974%29%
% 221.09/221.24  |- skos__scopeNote mesh__D005991
% 221.09/221.24       An enzyme that catalyzes the formation of glycerol 3-phosphate from ATP and glycerol. Dihydroxyacetone and L-glyceraldehyde can also act as acceptors; UTP and, in the case of the yeast enzyme, ITP and GTP can act as donors. It provides a way for glycerol derived from fats or glycerides to enter the glycolytic pathway. EC 2.7.1.30.%A%    
% 221.09/221.24  |- mesh__recordOriginator mesh__D005991 NLM
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D005991 2005
% 221.09/221.24  |- skos__hiddenLabel mesh__D005193 Planning Service, Family
% 221.09/221.24  |- mesh__publicMeSHNote mesh__D005193
% 221.09/221.24       2004; see FAMILY PLANNING 1968-2003; for FAMILY PLANNING PROGRAMS see HEALTH PLANNING 1980-2003%A%  
% 221.09/221.24  |- mesh__dateRevised mesh__D005193 2003-07-09
% 221.09/221.24  |- skos__hiddenLabel mesh__D005193 Family Planning Service
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D005193 2005
% 221.09/221.24  |- mesh__historyNote mesh__D005193
% 221.09/221.24       2004 %28%1968%29%;  for FAMILY PLANNING PROGRAMS use HEALTH PLANNING 1980-2003%A%  
% 221.09/221.24  |- skos__hiddenLabel mesh__D005193 Service, Family Planning
% 221.09/221.24  |- mesh__dateCreated mesh__D005193 1999-01-01
% 221.09/221.24  |- skos__broader mesh__D005193smesh__D034121
% 221.09/221.24  |- skos__altLabel mesh__D005193 Planned Pregnancy
% 221.09/221.24  |- mesh__dateEstablished mesh__D005193 1968-01-01
% 221.09/221.24  |- rdf__type mesh__D005193sskos__Concept
% 221.09/221.24  |- skos__broader mesh__D005193smesh__D003153
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D005193 2004
% 221.09/221.24  |- skos__hiddenLabel mesh__D005193 Services, Family Planning
% 221.09/221.24  |- mesh__recordOriginator mesh__D005193 NLM
% 221.09/221.24  |- skos__hiddenLabel mesh__D005193 Programs, Family Planning
% 221.09/221.24  |- skos__hiddenLabel mesh__D005193 Program, Family Planning
% 221.09/221.24  |- skos__altLabel mesh__D005193 Family Planning
% 221.09/221.24  |- skos__annotation mesh__D005193
% 221.09/221.24       /legis: consider also FAMILY PLANNING POLICY   
% 221.09/221.24  |- skos__hiddenLabel mesh__D005193 Planning Services, Family
% 221.09/221.24  |- skos__hiddenLabel mesh__D005193 Pregnancies, Planned
% 221.09/221.24  |- skos__hiddenLabel mesh__D005193 Planned Pregnancies
% 221.09/221.24  |- skos__prefLabel mesh__D005193 Family Planning Services
% 221.09/221.24  |- mesh__recordMaintainer mesh__D005193 lkt
% 221.09/221.24  |- mesh__recordAuthorizer mesh__D005193 sjn
% 221.09/221.24  |- skos__scopeNote mesh__D005193
% 221.09/221.24       Health care programs or services designed to assist individuals in the planning of family size. Various methods of CONTRACEPTION can be used to control the number and timing of childbirths.%A%    
% 221.09/221.24  |- skos__hiddenLabel mesh__D005193 Family Planning Program
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D005193 2006
% 221.09/221.24  |- skos__related mesh__D005193smesh__D003267
% 221.09/221.24  |- skos__altLabel mesh__D013625 Takayasu Syndrome
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013625 2001
% 221.09/221.24  |- skos__prefLabel mesh__D013625 Takayasu%27%s Arteritis
% 221.09/221.24  |- skos__hiddenLabel mesh__D013625 Takayasu Arteritis
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013625 2004
% 221.09/221.24  |- mesh__dateEstablished mesh__D013625 1991-01-01
% 221.09/221.24  |- skos__hiddenLabel mesh__D013625 Takayasus Arteritis
% 221.09/221.24  |- mesh__dateRevised mesh__D013625 1999-11-03
% 221.09/221.24  |- mesh__onlineNote mesh__D013625
% 221.09/221.24       use TAKAYASU%27%S ARTERITIS to search PULSELESS DISEASE 1993-94 %26% TAKAYASU SYNDROME 1975-92; search AORTIC ARCH SYNDROMES 1966-74%A%  
% 221.09/221.24  |- mesh__recordMaintainer mesh__D013625 ags
% 221.09/221.24  |- skos__scopeNote mesh__D013625
% 221.09/221.24       A thrombo-obliterative process of the great vessels stemming from the aortic arch, occurring generally in young women. Radial and carotid pulses are typically obliterated. Skin changes are due to the disturbed circulation. There may be loss of hair and atrophy of the skin and its appendages with underlying muscle atrophy. %28%Andrews%27% Diseases of the Skin, 8th ed%29%%A%    
% 221.09/221.24  |- mesh__recordOriginator mesh__D013625 NLM
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013625 2002
% 221.09/221.24  |- skos__hiddenLabel mesh__D013625 Arteritis, Takayasus
% 221.09/221.24  |- skos__annotation mesh__D013625 an aortic arch syndrome   
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013625 2005
% 221.09/221.24  |- skos__broader mesh__D013625smesh__D017445
% 221.09/221.24  |- skos__broader mesh__D013625smesh__D001015
% 221.09/221.24  |- mesh__recordAuthorizer mesh__D013625 sjn
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013625 2006
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013625 2000
% 221.09/221.24  |- skos__altLabel mesh__D013625 Pulseless Disease
% 221.09/221.24  |- rdf__type mesh__D013625sskos__Concept
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D013625 2003
% 221.09/221.24  |- skos__broader mesh__D013625smesh__D001167
% 221.09/221.24  |- mesh__publicMeSHNote mesh__D013625
% 221.09/221.24       95; was PULSELESS DISEASE 1993-94, was TAKAYASU SYNDROME 1963-92 %28%see under AORTIC ARCH SYNDROMES 1965-90, see under AORTIC DISEASES 1963-64%29%; TAKAYASU ARTERITIS was see PULSELESS DISEASE 1993-94, was see TAKAYASU SYNDROME 1987-92; PULSELESS DISEASE was see AORTIC ARCH SYNDROMES 1965-92, was see under AORTIC DISEASES 1963-64%A%  
% 221.09/221.24  |- skos__altLabel mesh__D013625 Arteritis, Takayasu%27%s
% 221.09/221.24  |- mesh__dateCreated mesh__D013625 1999-01-01
% 221.09/221.24  |- skos__hiddenLabel mesh__D013625 Arteritis, Takayasu
% 221.09/221.24  |- mesh__historyNote mesh__D013625
% 221.09/221.24       95; was PULSELESS DISEASE 1993-94; was TAKAYASU SYNDROME 1963-92 %28%see under AORTIC ARCH SYNDROMES 1965-90, see under AORTIC DISEASES 1963-64%29%; TAKAYASU ARTERITIS was see PULSELESS DISEASE 1993-94, was see TAKAYASU SYNDROME 1987-92; PULSELESS DISEASE was see AORTIC ARCH SYNDROMES 1965-92, was see under AORTIC DISEASES 1963-64%A%  
% 221.09/221.24  |- skos__broader mesh__D051744smesh__D011493
% 221.09/221.24  |- mesh__dateEstablished mesh__D051744 2006-01-01
% 221.09/221.24  |- mesh__recordOriginator mesh__D051744 AKE
% 221.09/221.24  |- mesh__historyNote mesh__D051744 2006%28%1994%29%   
% 221.09/221.24  |- mesh__publicMeSHNote mesh__D051744
% 221.09/221.24       2006; PROTEIN KINASE C EPSILON was indexed under PROTEIN KINASE C 1994-2005%A%  
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D051744 2006A
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D051744 2006
% 221.09/221.24  |- skos__altLabel mesh__D051744 PKC-epsilon Serine Threonine Kinase
% 221.09/221.24  |- rdf__type mesh__D051744sskos__Concept
% 221.09/221.24  |- skos__scopeNote mesh__D051744
% 221.09/221.24       A protein kinase C subtype that was originally characterized as a CALCIUM-independent, serine-threonine kinase that is activated by PHORBOL ESTERS and DIACYLGLYCEROLS. It is targeted to specific cellular compartments in response to extracellular signals that activate G-PROTEIN-COUPLED RECEPTORS; TYROSINE KINASE RECEPTORS; and intracellular protein tyrosine kinase.%A%    
% 221.09/221.24  |- skos__prefLabel mesh__D051744 Protein Kinase C-epsilon
% 221.09/221.24  |- mesh__recordAuthorizer mesh__D051744 ags
% 221.09/221.24  |- mesh__dateRevised mesh__D051744 2005-07-27
% 221.09/221.24  |- skos__altLabel mesh__D051744 Protein Kinase C epsilon
% 221.09/221.24  |- mesh__recordMaintainer mesh__D051744 ags
% 221.09/221.24  |- mesh__dateCreated mesh__D051744 2005-06-30
% 221.09/221.24  |- skos__hiddenLabel mesh__D051744 Kinase C-epsilon, Protein
% 221.09/221.24  |- skos__hiddenLabel mesh__D051744 PKC epsilon Serine Threonine Kinase
% 221.09/221.24  |- skos__altLabel mesh__D051744 PKC epsilon
% 221.09/221.24  |- mesh__dateRevised mesh__D018310 2005-06-30
% 221.09/221.24  |- skos__prefLabel mesh__D018310 Sertoli-Leydig Cell Tumor
% 221.09/221.24  |- skos__historyNote mesh__D018310 Leydig Cell Tumor %28%1968-1993%29%
% 221.09/221.24  |- skos__broader mesh__D018310smesh__D013736
% 221.09/221.24  |- skos__historyNote mesh__D018310 Sertoli Cell Tumor %28%1968-1993%29%
% 221.09/221.24  |- mesh__recordMaintainer mesh__D018310 lkt
% 221.09/221.24  |- mesh__recordOriginator mesh__D018310 PLS
% 221.09/221.24  |- skos__altLabel mesh__D018310 Androblastoma
% 221.09/221.24  |- skos__hiddenLabel mesh__D018310 Tumor, Sertoli-Leydig Cell
% 221.09/221.24  |- mesh__recordAuthorizer mesh__D018310 sjn
% 221.09/221.24  |- skos__altLabel mesh__D018310 Arrhenoblastoma
% 221.09/221.24  |- skos__historyNote mesh__D018310 Ovarian Neoplasms %28%1968-1993%29%
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D018310 2006
% 221.09/221.24  |- mesh__dateEstablished mesh__D018310 1994-01-01
% 221.09/221.24  |- skos__scopeNote mesh__D018310
% 221.09/221.24       A sex cord-gonadal stromal tumor consists of LEYDIG CELLS; SERTOLI CELLS; and FIBROBLASTS in varying proportions and degree of differentiation. Most such tumors produce ANDROGENS in the Leydig cells, formerly known as androblastoma or arrhenoblastoma. Androblastomas occur in the TESTIS or the OVARY causing precocious masculinization in the males, and defeminization, or virilization %28%VIRILISM%29% in the females. In some cases, the Sertoli cells produce ESTROGENS.%A%    
% 221.09/221.24  |- rdf__type mesh__D018310sskos__Concept
% 221.09/221.24  |- skos__hiddenLabel mesh__D018310 Arrhenoblastomas
% 221.09/221.24  |- skos__broader mesh__D018310smesh__D018312
% 221.09/221.24  |- skos__hiddenLabel mesh__D018310 Androblastomas
% 221.09/221.24  |- skos__hiddenLabel mesh__D018310 Sertoli Leydig Cell Tumor
% 221.09/221.24  |- mesh__dateCreated mesh__D018310 1993-06-25
% 221.09/221.24  |- skos__annotation mesh__D018310
% 221.09/221.24       coord IM with OVARIAN NEOPLASMS or TESTICULAR NEOPLASMS   
% 221.09/221.24  |- mesh__historyNote mesh__D018310
% 221.09/221.24       1994; for ARRHENOBLASTOMA use ARRHENOBLASTOMA 1966-1994, use ANDROBLASTOMA 1994-2004; for ANDROBLASTOMA use ANDROBLASTOMA 1994-2004%A%  
% 221.09/221.24  |- mesh__publicMeSHNote mesh__D018310
% 221.09/221.24       1994; for ARRHENOBLASTOMA see ARRHENOBLASTOMA 1966-1994, see ANDROBLASTOMA 1994-2004; for ANDROBLASTOMA see ANDROBLASTOMA 1994-2004%A%  
% 221.09/221.24  |- skos__broader mesh__D018310smesh__D010051
% 221.09/221.24  |- mesh__recordMaintainer mesh__D004899 lkt
% 221.09/221.24  |- skos__broader mesh__D004899smesh__D001787
% 221.09/221.24  |- skos__hiddenLabel mesh__D004899 Fetalis, Erythroblastosis
% 221.09/221.24  |- mesh__recordAuthorizer mesh__D004899 sjn
% 221.09/221.24  |- skos__hiddenLabel mesh__D004899 Newborn Hemolytic Disease
% 221.09/221.24  |- skos__prefLabel mesh__D004899 Erythroblastosis, Fetal
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D004899 2006
% 221.09/221.24  |- skos__hiddenLabel mesh__D004899 Erythroblastosis Fetali
% 221.09/221.24  |- skos__broader mesh__D004899smesh__D007232
% 221.09/221.24  |- rdf__type mesh__D004899sskos__Concept
% 221.09/221.24  |- skos__hiddenLabel mesh__D004899 Fetal Erythroblastoses
% 221.09/221.24  |- skos__scopeNote mesh__D004899
% 221.09/221.24       A condition characterized by the abnormal presence of ERYTHROBLASTS in the circulation of the FETUS or NEWBORNS. It is a disorder due to BLOOD GROUP INCOMPATIBILITY, such as the maternal alloimmunization by fetal antigen RH FACTORS leading to HEMOLYSIS of ERYTHROCYTES, hemolytic anemia %28%ANEMIA, HEMOLYTIC%29%, general edema %28%HYDROPS FETALIS%29%, and SEVERE JAUNDICE IN NEWBORN.%A%    
% 221.09/221.24  |- skos__altLabel mesh__D004899 Erythroblastosis Fetalis
% 221.09/221.24  |- mesh__dateRevised mesh__D004899 2005-06-30
% 221.09/221.24  |- skos__broader mesh__D004899smesh__D005315
% 221.09/221.24  |- skos__hiddenLabel mesh__D004899 Fetali, Erythroblastosis
% 221.09/221.24  |- skos__hiddenLabel mesh__D004899 Erythroblastoses, Fetal
% 221.09/221.24  |- skos__related mesh__D004899smesh__D007567
% 221.09/221.24  |- skos__annotation mesh__D004899
% 221.09/221.24       erythroblastosis, non-fetal may be ERYTHREMIC MYELOSIS but be careful; do not confuse with HEMORRHAGIC DISEASE OF NEWBORN%A%  
% 221.09/221.24  |- skos__hiddenLabel mesh__D004899 Fetal Erythroblastosis
% 221.09/221.24  |- skos__altLabel mesh__D004899 Hemolytic Disease of Newborn
% 221.09/221.24  |- skos__hiddenLabel mesh__D004899 Newborn Hemolytic Diseases
% 221.09/221.24  |- mesh__recordOriginator mesh__D004899 NLM
% 221.09/221.24  |- mesh__dateCreated mesh__D004899 1999-01-01
% 221.09/221.24  |- skos__broader mesh__D014551Q000530smesh__D014551
% 221.09/221.24  |- mesh__preferredCombination mesh__D014551Q000530smesh__D014567
% 221.09/221.24  |- rdf__type mesh__D014551Q000530smesh__CompoundConcept
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D009584 2000
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D009584 1998
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D009584 2005
% 221.09/221.24  |- skos__related mesh__D009584smesh__D009587
% 221.09/221.24  |- mesh__recordOriginator mesh__D009584 NLM
% 221.09/221.24  |- mesh__dateRevised mesh__D009584 1997-06-20
% 221.09/221.24  |- skos__annotation mesh__D009584 N-14; /physiol permitted   
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D009584 2002
% 221.09/221.24  |- skos__related mesh__D009584smesh__D009590
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D009584 2004
% 221.09/221.24  |- rdf__type mesh__D009584sskos__Concept
% 221.09/221.24  |- skos__prefLabel mesh__D009584 Nitrogen
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D009584 2003
% 221.09/221.24  |- mesh__dateCreated mesh__D009584 1999-01-01
% 221.09/221.24  |- skos__scopeNote mesh__D009584
% 221.09/221.24       An element with the atomic symbol N, atomic number 7, and atomic weight 14. Nitrogen exists as a diatomic gas and makes up about 78%25% of the earth%27%s atmosphere by volume. It is a constituent of proteins and nucleic acids and found in all living cells.%A%    
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D009584 1999
% 221.09/221.24  |- mesh__recordMaintainer mesh__D009584 ADP
% 221.09/221.24  |- mesh__recordAuthorizer mesh__D009584 SJN
% 221.09/221.24  |- mesh__activeMeSHYear mesh__D009584 2001
% 221.09/221.24  |- skos__broader mesh__D009584smesh__D004602
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D009584 2006
% 221.09/221.25  |- skos__broader mesh__D009584smesh__D005740
% 221.09/221.25  |- rdf__type mesh__D017218sskos__Concept
% 221.09/221.25  |- skos__scopeNote mesh__D017218
% 221.09/221.25       The collecting of fetal blood samples via ultrasound-guided needle aspiration of the blood in the umbilical vein.%A%    
% 221.09/221.25  |- mesh__recordOriginator mesh__D017218 MXR
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D017218 2000
% 221.09/221.25  |- mesh__dateCreated mesh__D017218 1992-05-07
% 221.09/221.25  |- mesh__dateEstablished mesh__D017218 1993-01-01
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D017218 2001
% 221.09/221.25  |- mesh__historyNote mesh__D017218 93   
% 221.09/221.25  |- skos__hiddenLabel mesh__D017218 Cordocenteses
% 221.09/221.25  |- mesh__publicMeSHNote mesh__D017218 93   
% 221.09/221.25  |- skos__historyNote mesh__D017218
% 221.09/221.25       Blood Specimen Collection %28%1987-1992%29%
% 221.09/221.25  |- mesh__dateRevised mesh__D017218 1997-06-20
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D017218 1998
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D017218 2005
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D017218 2002
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D017218 1999
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D017218 2006
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D017218 2003
% 221.09/221.25  |- skos__annotation mesh__D017218
% 221.09/221.25       collection of fetal blood samples from umbilical vein   
% 221.09/221.25  |- skos__prefLabel mesh__D017218 Cordocentesis
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D017218 2004
% 221.09/221.25  |- mesh__recordAuthorizer mesh__D017218 SJN
% 221.09/221.25  |- skos__broader mesh__D017218smesh__D001800
% 221.09/221.25  |- mesh__recordMaintainer mesh__D017218 PXP
% 221.09/221.25  |- skos__hiddenLabel mesh__D005992 Acyltransferase, Glycerophosphate
% 221.09/221.25  |- skos__scopeNote mesh__D005992
% 221.09/221.25       An enzyme that transfers acyl groups from acyl-CoA to glycerol-3-phosphate to form monoglyceride phosphates. It acts only with CoA derivatives of fatty acids of chain length above C-10. Also forms diglyceride phosphates. EC 2.3.1.15.%A%    
% 221.09/221.25  |- mesh__recordOriginator mesh__D005992 NLM
% 221.09/221.25  |- mesh__dateEstablished mesh__D005992 1991-01-01
% 221.09/221.25  |- mesh__publicMeSHNote mesh__D005992
% 221.09/221.25       98; see GLYCEROLPHOSPHATE ACYLTRANSFERASE 1991-97; see ACYLTRANSFERASES 1975-90%A%  
% 221.09/221.25  |- skos__hiddenLabel mesh__D005992 Acyltransferase, Glycerolphosphate
% 221.09/221.25  |- skos__hiddenLabel mesh__D005992
% 221.09/221.25       Stearyl CoA Glycerophosphate Transstearylase
% 221.09/221.25  |- skos__hiddenLabel mesh__D005992
% 221.09/221.25       Sn-Glycerol-3-Phosphate-O-Acyltransferase, Acyl-CoA
% 221.09/221.25  |- mesh__dateRevised mesh__D005992 2005-06-30
% 221.09/221.25  |- skos__hiddenLabel mesh__D005992
% 221.09/221.25       Glycerophosphate Transstearylase, Stearyl-CoA
% 221.09/221.25  |- skos__historyNote mesh__D005992 Coenzyme A %28%1972-1974%29%
% 221.09/221.25  |- skos__hiddenLabel mesh__D005992 Glycerol 3 Phosphate O Acyltransferase
% 221.09/221.25  |- mesh__historyNote mesh__D005992 98%28%75%29%   
% 221.09/221.25  |- skos__historyNote mesh__D005992 Acyltransferases %28%1972-1974%29%
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005992 2006
% 221.09/221.25  |- skos__hiddenLabel mesh__D005992
% 221.09/221.25       Acyl CoA Sn Glycerol 3 Phosphate O Acyltransferase
% 221.09/221.25  |- mesh__recordMaintainer mesh__D005992 ags
% 221.09/221.25  |- skos__hiddenLabel mesh__D005992
% 221.09/221.25       Transstearylase, Stearyl-CoA Glycerophosphate
% 221.09/221.25  |- skos__altLabel mesh__D005992 Glycerolphosphate Acyltransferase
% 221.09/221.25  |- skos__altLabel mesh__D005992
% 221.09/221.25       Acyl-CoA Sn-Glycerol-3-Phosphate-O-Acyltransferase
% 221.09/221.25  |- mesh__dateCreated mesh__D005992 1974-11-19
% 221.09/221.25  |- mesh__recordAuthorizer mesh__D005992 sjn
% 221.09/221.25  |- skos__prefLabel mesh__D005992 Glycerol-3-Phosphate O-Acyltransferase
% 221.09/221.25  |- skos__broader mesh__D005992smesh__D000217
% 221.09/221.25  |- skos__historyNote mesh__D005992 Glycerophosphates %28%1972-1974%29%
% 221.09/221.25  |- skos__hiddenLabel mesh__D005992 O-Acyltransferase, Glycerol-3-Phosphate
% 221.09/221.25  |- rdf__type mesh__D005992sskos__Concept
% 221.09/221.25  |- skos__altLabel mesh__D005992
% 221.09/221.25       Stearyl-CoA Glycerophosphate Transstearylase
% 221.09/221.25  |- skos__altLabel mesh__D005992 Glycerophosphate Acyltransferase
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005194 2000
% 221.09/221.25  |- skos__scopeNote mesh__D005194
% 221.09/221.25       A medical specialty concerned with the provision of continuing, comprehensive primary health care for the entire family.%A%    
% 221.09/221.25  |- mesh__dateCreated mesh__D005194 1999-01-01
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005194 1997
% 221.09/221.25  |- mesh__onlineNote mesh__D005194
% 221.09/221.25       use FAMILY PRACTICE to search GENERAL PRACTICE 1966-77   
% 221.09/221.25  |- rdf__type mesh__D005194sskos__Concept
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005194 2004
% 221.09/221.25  |- skos__hiddenLabel mesh__D005194 Practices, General
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005194 1996
% 221.09/221.25  |- skos__hiddenLabel mesh__D005194 Family Practices
% 221.09/221.25  |- skos__broader mesh__D005194smesh__D013040
% 221.09/221.25  |- mesh__recordMaintainer mesh__D005194 TAP
% 221.09/221.25  |- skos__hiddenLabel mesh__D005194 General Practices
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005194 2002
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005194 2003
% 221.09/221.25  |- mesh__historyNote mesh__D005194
% 221.09/221.25       78; was see under GENERAL PRACTICE 1975-77, was see GENERAL PRACTICE 1969-74; GENERAL PRACTICE was heading 1963-77%A%  
% 221.09/221.25  |- skos__prefLabel mesh__D005194 Family Practice
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005194 1999
% 221.09/221.25  |- skos__hiddenLabel mesh__D005194 Practice, General
% 221.09/221.25  |- mesh__dateRevised mesh__D005194 1995-05-18
% 221.09/221.25  |- mesh__publicMeSHNote mesh__D005194
% 221.09/221.25       78; was indexed under GENERAL PRACTICE 1969-77; GENERAL PRACTICE was heading 1963-77%A%  
% 221.09/221.25  |- skos__related mesh__D005194smesh__D010821
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005194 2006
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005194 1998
% 221.09/221.25  |- mesh__recordOriginator mesh__D005194 NLM
% 221.09/221.25  |- skos__hiddenLabel mesh__D005194 Practices, Family
% 221.09/221.25  |- skos__related mesh__D005194smesh__D003191
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005194 2001
% 221.09/221.25  |- mesh__recordAuthorizer mesh__D005194 PLS
% 221.09/221.25  |- skos__hiddenLabel mesh__D005194 Practice, Family
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005194 2005
% 221.09/221.25  |- skos__annotation mesh__D005194
% 221.09/221.25       SPEC: SPEC qualif; articles with titles reading, e.g., %22%cortisone in general practice%22% are indexed under FAMILY PRACTICE as NIM if indexed there at all: use circumspectly%A%  
% 221.09/221.25  |- mesh__dateEstablished mesh__D005194 1978-01-01
% 221.09/221.25  |- mesh__recordAuthorizer mesh__D013626 sjn
% 221.09/221.25  |- mesh__publicMeSHNote mesh__D013626
% 221.09/221.25       91; was see under AMPICILLIN 1978-90   
% 221.09/221.25  |- skos__altLabel mesh__D013626 Phthalidyl Ampicillin
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D013626 2005
% 221.09/221.25  |- mesh__historyNote mesh__D013626
% 221.09/221.25       91%28%78%29%; was see under AMPICILLIN 1978-90   
% 221.09/221.25  |- mesh__dateRevised mesh__D013626 2004-07-07
% 221.09/221.25  |- skos__historyNote mesh__D013626 Ampicillin %28%1966-1977%29%
% 221.09/221.25  |- mesh__dateCreated mesh__D013626 1977-03-01
% 221.09/221.25  |- skos__scopeNote mesh__D013626
% 221.09/221.25       An ester of AMPICILLIN which is readily hydrolysed on absorption to release ampicillin. It is well absorbed from the gastrointestinal tract resulting in a greater bioavailability of ampicillin than can be achieved with equivalent doses of ampicillin.%A%    
% 221.09/221.25  |- skos__prefLabel mesh__D013626 Talampicillin
% 221.09/221.25  |- skos__hiddenLabel mesh__D013626 Hydrochloride, Talampicillin
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D013626 2006
% 221.09/221.25  |- rdf__type mesh__D013626sskos__Concept
% 221.09/221.25  |- skos__historyNote mesh__D013626 Benzofurans %28%1966-1976%29%
% 221.09/221.25  |- skos__hiddenLabel mesh__D013626 BRL 8988
% 221.09/221.25  |- skos__broader mesh__D013626smesh__D000667
% 221.09/221.25  |- mesh__recordOriginator mesh__D013626 SH
% 221.09/221.25  |- mesh__recordMaintainer mesh__D013626 ssb
% 221.09/221.25  |- skos__hiddenLabel mesh__D013626 BRL8988
% 221.09/221.25  |- skos__hiddenLabel mesh__D013626 Ampicillin, Phthalidyl
% 221.09/221.25  |- mesh__dateEstablished mesh__D013626 1991-01-01
% 221.09/221.25  |- skos__hiddenLabel mesh__D018311 Pregnancy Luteomas
% 221.09/221.25  |- mesh__recordOriginator mesh__D018311 PLS
% 221.09/221.25  |- skos__prefLabel mesh__D018311 Luteoma
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D018311 2006
% 221.09/221.25  |- mesh__dateRevised mesh__D018311 2005-06-30
% 221.09/221.25  |- skos__scopeNote mesh__D018311
% 221.09/221.25       An ovarian neoplasm composed of LUTEAL CELLS derived from luteinized GRANULOSA CELLS and THECA CELLS. Luteomas respond to GONADOTROPINS, and vary in their hormone production %28%PROGESTERONE; ESTROGENS; or ANDROGENS%29%. During PREGNANCY, a transient type of luteoma may develop due to an exaggerated LUTEINIZATION of the OVARY.%A%    
% 221.09/221.25  |- skos__historyNote mesh__D018311 Ovarian Neoplasms %28%1967-1993%29%
% 221.09/221.25  |- skos__broader mesh__D018311smesh__D018312
% 221.09/221.25  |- skos__hiddenLabel mesh__D018311 Luteomas
% 221.09/221.25  |- mesh__recordMaintainer mesh__D018311 lkt
% 221.09/221.25  |- skos__altLabel mesh__D018311 Gestational Luteoma
% 221.09/221.25  |- skos__annotation mesh__D018311
% 221.09/221.25       coord IM with OVARIAN NEOPLASMS %28%IM%29%   
% 221.09/221.25  |- rdf__type mesh__D018311sskos__Concept
% 221.09/221.25  |- mesh__historyNote mesh__D018311
% 221.09/221.25       1994; use THECOMA 1981-93; for LUTEINOMA use THECOMA 1981-1993%A%  
% 221.09/221.25  |- skos__hiddenLabel mesh__D018311 Luteoma, Pregnancy
% 221.09/221.25  |- skos__hiddenLabel mesh__D018311 Gestational Luteomas
% 221.09/221.25  |- mesh__publicMeSHNote mesh__D018311
% 221.09/221.25       1994; see THECA CELL TUMOR 1981-93; for LUTEINOMA see THECA CELL TUMOR 1981-1993%A%  
% 221.09/221.25  |- skos__hiddenLabel mesh__D018311 Luteoma, Gestational
% 221.09/221.25  |- mesh__recordAuthorizer mesh__D018311 sjn
% 221.09/221.25  |- skos__broader mesh__D018311smesh__D010051
% 221.09/221.25  |- mesh__dateEstablished mesh__D018311 1994-01-01
% 221.09/221.25  |- skos__historyNote mesh__D018311 Thecoma %28%1966-1993%29%
% 221.09/221.25  |- skos__altLabel mesh__D018311 Luteinoma
% 221.09/221.25  |- skos__hiddenLabel mesh__D018311 Luteomas, Gestational
% 221.09/221.25  |- skos__hiddenLabel mesh__D018311 Luteomas, Pregnancy
% 221.09/221.25  |- skos__altLabel mesh__D018311 Luteoma of Pregnancy
% 221.09/221.25  |- mesh__dateCreated mesh__D018311 1993-06-25
% 221.09/221.25  |- mesh__recordMaintainer mesh__D051745 ags
% 221.09/221.25  |- skos__hiddenLabel mesh__D051745 Kinase C-delta, Protein
% 221.09/221.25  |- skos__hiddenLabel mesh__D051745 Protein Kinase C delta
% 221.09/221.25  |- mesh__recordOriginator mesh__D051745 AKE
% 221.09/221.25  |- skos__scopeNote mesh__D051745
% 221.09/221.25       A ubiquitously expressed protein kinase that is involved in a variety of cellular SIGNAL PATHWAYS. Its activity is regulated by a variety of signaling protein tyrosine kinase.%A%    
% 221.09/221.25  |- mesh__dateCreated mesh__D051745 2005-06-30
% 221.09/221.25  |- skos__prefLabel mesh__D051745 Protein Kinase C-delta
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D051745 2006
% 221.09/221.25  |- mesh__dateRevised mesh__D051745 2005-07-29
% 221.09/221.25  |- mesh__recordAuthorizer mesh__D051745 ags
% 221.09/221.25  |- mesh__publicMeSHNote mesh__D051745
% 221.09/221.25       2006; PROTEIN KINASE C-DELTA was indexed under PROTEIN KINASE C 2004-2006, %26% under ISOENZYMES 1993-2003%A%  
% 221.09/221.25  |- skos__altLabel mesh__D051745 PKC-delta Serine-Threonine Kinase
% 221.09/221.25  |- rdf__type mesh__D051745sskos__Concept
% 221.09/221.25  |- skos__broader mesh__D051745smesh__D011493
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D051745 2006B
% 221.09/221.25  |- mesh__dateEstablished mesh__D051745 2006-01-01
% 221.09/221.25  |- mesh__historyNote mesh__D051745 2006%28%1993%29%   
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D051745 2006A
% 221.09/221.25  |- skos__hiddenLabel mesh__D051745 PKC delta Serine Threonine Kinase
% 221.09/221.25  |- skos__hiddenLabel mesh__D051745 Serine-Threonine Kinase, PKC-delta
% 221.09/221.25  |- skos__hiddenLabel mesh__D009585 Dioxide, Nitrogen
% 221.09/221.25  |- mesh__dateRevised mesh__D009585 1999-11-03
% 221.09/221.25  |- skos__broader mesh__D009585smesh__D009589
% 221.09/221.25  |- mesh__publicMeSHNote mesh__D009585 65   
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D009585 2004
% 221.09/221.25  |- rdf__type mesh__D009585sskos__Concept
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D009585 2001
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D009585 2003
% 221.09/221.25  |- mesh__dateCreated mesh__D009585 1999-01-01
% 221.09/221.25  |- mesh__dateEstablished mesh__D009585 1965-01-01
% 221.09/221.25  |- skos__altLabel mesh__D009585 Nitrogen Peroxide
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D009585 2000
% 221.09/221.25  |- mesh__recordMaintainer mesh__D009585 adp
% 221.09/221.25  |- skos__prefLabel mesh__D009585 Nitrogen Dioxide
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D009585 2006
% 221.09/221.25  |- mesh__recordAuthorizer mesh__D009585 sjn
% 221.09/221.25  |- skos__annotation mesh__D009585 a highly poisonous gas   
% 221.09/221.25  |- mesh__recordOriginator mesh__D009585 NLM
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D009585 2005
% 221.09/221.25  |- skos__scopeNote mesh__D009585
% 221.09/221.25       Nitrogen oxide %28%NO2%29%. A highly poisonous gas. Exposure produces inflammation of lungs that may only cause slight pain or pass unnoticed, but resulting edema several days later may cause death. %28%From Merck, 11th ed%29% It is a major atmospheric pollutant that is able to absorb UV light that does not reach the earth%27%s surface.%A%    
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D009585 2002
% 221.09/221.25  |- mesh__historyNote mesh__D009585 65%28%63%29%   
% 221.09/221.25  |- skos__hiddenLabel mesh__D009585 Peroxide, Nitrogen
% 221.09/221.25  |- skos__hiddenLabel mesh__D017219 Outlet Obstruction, Gastric
% 221.09/221.25  |- mesh__recordAuthorizer mesh__D017219 sjn
% 221.09/221.25  |- mesh__dateCreated mesh__D017219 1992-05-20
% 221.09/221.25  |- mesh__historyNote mesh__D017219 93   
% 221.09/221.25  |- skos__hiddenLabel mesh__D017219 Outlet Obstructions, Gastric
% 221.09/221.25  |- mesh__dateEstablished mesh__D017219 1993-01-01
% 221.09/221.25  |- mesh__publicMeSHNote mesh__D017219 93   
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D017219 2005
% 221.09/221.25  |- skos__hiddenLabel mesh__D017219 Obstruction, Gastric Outlet
% 221.09/221.25  |- mesh__recordMaintainer mesh__D017219 lkt
% 221.09/221.25  |- skos__historyNote mesh__D017219 Stomach Diseases %28%1978-1992%29%
% 221.09/221.25  |- skos__prefLabel mesh__D017219 Gastric Outlet Obstruction
% 221.09/221.25  |- skos__historyNote mesh__D017219 Pyloric Stenosis %28%1967-1992%29%
% 221.09/221.25  |- skos__hiddenLabel mesh__D017219 Obstructions, Gastric Outlet
% 221.09/221.25  |- mesh__dateRevised mesh__D017219 2004-07-07
% 221.09/221.25  |- skos__scopeNote mesh__D017219
% 221.09/221.25       The hindering of output from the STOMACH into the SMALL INTESTINE. This obstruction may be of mechanical or functional origin such as EDEMA from PEPTIC ULCER; NEOPLASMS; FOREIGN BODIES; or AGING.%A%    
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D017219 2006
% 221.09/221.25  |- skos__hiddenLabel mesh__D017219 Gastric Outlet Obstructions
% 221.09/221.25  |- skos__annotation mesh__D017219
% 221.09/221.25       coord IM with cause of obstruct %28%IM%29%   
% 221.09/221.25  |- skos__broader mesh__D017219smesh__D013272
% 221.09/221.25  |- rdf__type mesh__D017219sskos__Concept
% 221.09/221.25  |- mesh__recordOriginator mesh__D017219 MXR
% 221.09/221.25  |- mesh__recordAuthorizer mesh__D005993 sjn
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005993 2004
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005993 2006
% 221.09/221.25  |- skos__hiddenLabel mesh__D005993 Dehydrogenase, Alpha-Glycerophosphate
% 221.09/221.25  |- skos__broader mesh__D005993smesh__D013401
% 221.09/221.25  |- mesh__historyNote mesh__D005993 65   
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005993 2005
% 221.09/221.25  |- skos__hiddenLabel mesh__D005993 Alpha Glycerophosphate Dehydrogenase
% 221.09/221.25  |- mesh__recordOriginator mesh__D005993 NLM
% 221.09/221.25  |- mesh__publicMeSHNote mesh__D005993 65   
% 221.09/221.25  |- rdf__type mesh__D005993sskos__Concept
% 221.09/221.25  |- skos__altLabel mesh__D005993 Alpha-Glycerophosphate Dehydrogenase
% 221.09/221.25  |- skos__altLabel mesh__D005993 Glycerophosphate Dehydrogenase
% 221.09/221.25  |- skos__hiddenLabel mesh__D005993 Oxidase, Glycerophosphate
% 221.09/221.25  |- skos__prefLabel mesh__D005993 Glycerolphosphate Dehydrogenase
% 221.09/221.25  |- mesh__dateEstablished mesh__D005993 1965-01-01
% 221.09/221.25  |- skos__hiddenLabel mesh__D005993 Dehydrogenase, Glycerophosphate
% 221.09/221.25  |- mesh__dateRevised mesh__D005993 2003-07-09
% 221.09/221.25  |- skos__hiddenLabel mesh__D005993 Dehydrogenase, Glycerol-3-Phosphate
% 221.09/221.25  |- mesh__dateCreated mesh__D005993 1999-01-01
% 221.09/221.25  |- skos__hiddenLabel mesh__D005993 Glycerol 3 Phosphate Dehydrogenase
% 221.09/221.25  |- skos__altLabel mesh__D005993 Glycerophosphate Oxidase
% 221.09/221.25  |- skos__altLabel mesh__D005993 Glycerol-3-Phosphate Dehydrogenase
% 221.09/221.25  |- skos__hiddenLabel mesh__D005993 Dehydrogenase, Glycerolphosphate
% 221.09/221.25  |- mesh__recordMaintainer mesh__D005993 ssb
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005195 2003
% 221.09/221.25  |- skos__hiddenLabel mesh__D005195 Relations, Family
% 221.09/221.25  |- mesh__recordMaintainer mesh__D005195 hjn
% 221.09/221.25  |- rdf__type mesh__D005195sskos__Concept
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005195 2004
% 221.09/221.25  |- skos__altLabel mesh__D005195 Family Relationships
% 221.09/221.25  |- skos__historyNote mesh__D005195 Family %28%1966-1997%29%
% 221.09/221.25  |- mesh__recordAuthorizer mesh__D005195 sjn
% 221.09/221.25  |- mesh__historyNote mesh__D005195
% 221.09/221.25       98; use explode 1978-97; for FAMILY RELATIONSHIP use FAMILY 1978-97%A%  
% 221.09/221.25  |- skos__prefLabel mesh__D005195 Family Relations
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005195 2005
% 221.09/221.25  |- mesh__recordOriginator mesh__D005195 EC
% 221.09/221.25  |- skos__annotation mesh__D005195
% 221.09/221.25       GEN or unspecified; prefer specifics; DF: FAMILY RELAT   
% 221.09/221.25  |- mesh__dateEstablished mesh__D005195 1998-01-01
% 221.09/221.25  |- mesh__dateRevised mesh__D005195 2002-07-03
% 221.09/221.25  |- skos__scopeNote mesh__D005195
% 221.09/221.25       Behavioral, psychological, and social relations among various members of the nuclear family and the extended family.%A%    
% 221.09/221.25  |- mesh__publicMeSHNote mesh__D005195
% 221.09/221.25       98; for FAMILY RELATIONSHIP see FAMILY 1978-97   
% 221.09/221.25  |- mesh__dateCreated mesh__D005195 1977-05-05
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005195 2006
% 221.09/221.25  |- skos__altLabel mesh__D005195 Family Relationship
% 221.09/221.25  |- skos__hiddenLabel mesh__D005195 Family Relation
% 221.09/221.25  |- skos__broader mesh__D005195smesh__D005190
% 221.09/221.25  |- skos__hiddenLabel mesh__D005195 Relation, Family
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D013627 2002
% 221.09/221.25  |- mesh__recordOriginator mesh__D013627 NLM
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D013627 2006
% 221.09/221.25  |- mesh__recordMaintainer mesh__D013627 jmp
% 221.09/221.25  |- rdf__type mesh__D013627sskos__Concept
% 221.09/221.25  |- mesh__recordAuthorizer mesh__D013627 sjn
% 221.09/221.25  |- mesh__dateCreated mesh__D013627 1999-01-01
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D013627 2003
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D013627 2000
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D013627 2004
% 221.09/221.25  |- skos__broader mesh__D013627smesh__D017633
% 221.09/221.25  |- skos__prefLabel mesh__D013627 Talc
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D013627 2001
% 221.09/221.25  |- mesh__dateRevised mesh__D013627 1999-11-03
% 221.09/221.25  |- skos__annotation mesh__D013627
% 221.09/221.25       a magnesium silicate; talc granuloma = TALC /adv eff + GRANULOMA, FOREIGN-BODY /etiol %28%not /chem ind%29%%A%  
% 221.09/221.25  |- skos__scopeNote mesh__D013627
% 221.09/221.25       Finely powdered native hydrous magnesium silicate. It is used as a dusting powder, either alone or with starch or boric acid, for medicinal and toilet preparations. It is also an excipient and filler for pills, tablets, and for dusting tablet molds. %28%From Merck Index, 11th ed%29%%A%    
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D013627 2005
% 221.09/221.25  |- skos__hiddenLabel mesh__D018312 Tumors, Sex Cord-Stromal
% 221.09/221.25  |- mesh__recordAuthorizer mesh__D018312 sjn
% 221.09/221.25  |- mesh__recordMaintainer mesh__D018312 lkt
% 221.09/221.25  |- mesh__recordOriginator mesh__D018312 PLS
% 221.09/221.25  |- skos__prefLabel mesh__D018312 Sex Cord-Gonadal Stromal Tumors
% 221.09/221.25  |- skos__hiddenLabel mesh__D018312 Sex Cord-Stromal Tumors
% 221.09/221.25  |- skos__historyNote mesh__D018312 Ovarian Neoplasms %28%1980-1993%29%
% 221.09/221.25  |- mesh__dateRevised mesh__D018312 2004-07-07
% 221.09/221.25  |- skos__hiddenLabel mesh__D018312 Sex Cord Stromal Tumor
% 221.09/221.25  |- mesh__publicMeSHNote mesh__D018312
% 221.09/221.25       2005; see SEX CORD-STROMAL TUMOR 1994-2004; for GYNANDROBLASTOMA see NEOPLASMS, GONADAL TISSUE 1997-2004%A%  
% 221.09/221.25  |- skos__historyNote mesh__D018312 Testicular Neoplasms %28%1981-1993%29%
% 221.09/221.25  |- mesh__dateCreated mesh__D018312 1993-06-25
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D018312 2006
% 221.09/221.25  |- skos__annotation mesh__D018312
% 221.09/221.25       coordinate IM with TESTICULAR NEOPLASMS %28%IM%29% in male or OVARIAN NEOPLASMS %28%IM%29% if in female%A%  
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D018312 2005
% 221.09/221.25  |- rdf__type mesh__D018312sskos__Concept
% 221.09/221.25  |- skos__scopeNote mesh__D018312
% 221.09/221.25       Neoplasms derived from the primitive sex cord or gonadal stromal cells of the embryonic GONADS. They are classified by their presumed histogenesis and differentiation. From the sex cord, there are SERTOLI CELL TUMOR and GRANULOSA CELL TUMOR; from the gonadal stroma, LEYDIG CELL TUMOR and THECOMA. These tumors may be identified in either the OVARY or the TESTIS.%A%    
% 221.09/221.25  |- skos__hiddenLabel mesh__D018312 Gynandroblastomas
% 221.09/221.25  |- mesh__historyNote mesh__D018312
% 221.09/221.25       2005 %28%1994%29%; for GYNANDROBLASTOMA use NEOPLASMS, GONADAL TISSUE 1997-2004%A%  
% 221.09/221.25  |- skos__hiddenLabel mesh__D018312 Tumor, Sex Cord-Stromal
% 221.09/221.25  |- skos__altLabel mesh__D018312 Sex Cord-Stromal Tumor
% 221.09/221.25  |- mesh__dateEstablished mesh__D018312 1994-01-01
% 221.09/221.25  |- skos__broader mesh__D018312smesh__D018309
% 221.09/221.25  |- skos__hiddenLabel mesh__D051746 Tyrosine Kinase, Syk-Related
% 221.09/221.25  |- skos__hiddenLabel mesh__D051746 Protein, ZAP-70
% 221.09/221.25  |- skos__altLabel mesh__D051746 70 kDa Zeta-Associated Protein
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D051746 2006
% 221.09/221.25  |- skos__hiddenLabel mesh__D051746 Kinase, ZAP-70
% 221.09/221.25  |- skos__hiddenLabel mesh__D051746 ZAP 70 Protein
% 221.09/221.25  |- skos__altLabel mesh__D051746 Syk-Related Tyrosine Kinase
% 221.09/221.25  |- mesh__recordAuthorizer mesh__D051746 sjn
% 221.09/221.25  |- skos__hiddenLabel mesh__D051746 Protein-Tyrosine Kinase, ZAP-70
% 221.09/221.25  |- skos__broader mesh__D051746smesh__D011505
% 221.09/221.25  |- mesh__publicMeSHNote mesh__D051746
% 221.09/221.25       2006; ZAP-70 KINASE was indexed under PROTEIN-TYROSINE KINASE 1992-2005%A%  
% 221.09/221.25  |- mesh__recordOriginator mesh__D051746 AKE
% 221.09/221.25  |- mesh__historyNote mesh__D051746 2006%28%1992%29%   
% 221.09/221.25  |- rdf__type mesh__D051746sskos__Concept
% 221.09/221.25  |- skos__altLabel mesh__D051746 ZAP-70 Protein
% 221.09/221.25  |- mesh__dateCreated mesh__D051746 2005-06-30
% 221.09/221.25  |- skos__prefLabel mesh__D051746 ZAP-70 Protein-Tyrosine Kinase
% 221.09/221.25  |- skos__hiddenLabel mesh__D051746 Syk Related Tyrosine Kinase
% 221.09/221.25  |- skos__hiddenLabel mesh__D051746 70 kDa Zeta Associated Protein
% 221.09/221.25  |- skos__hiddenLabel mesh__D051746 ZAP 70 Protein Tyrosine Kinase
% 221.09/221.25  |- skos__altLabel mesh__D051746 ZAP-70 Kinase
% 221.09/221.25  |- mesh__recordMaintainer mesh__D051746 AKE
% 221.09/221.25  |- skos__hiddenLabel mesh__D051746 ZAP 70 Kinase
% 221.09/221.25  |- skos__scopeNote mesh__D051746
% 221.09/221.25       A protein tyrosine kinase that is required for T-CELL development and T-CELL ANTIGEN RECEPTOR function.%A%    
% 221.09/221.25  |- mesh__dateEstablished mesh__D051746 2006-01-01
% 221.09/221.25  |- rdf__type mesh__D009586sskos__Concept
% 221.09/221.25  |- mesh__recordMaintainer mesh__D009586 nns
% 221.09/221.25  |- skos__broader mesh__D009586smesh__D001669
% 221.09/221.25  |- mesh__dateCreated mesh__D009586 1999-01-01
% 221.09/221.25  |- skos__hiddenLabel mesh__D009586 Fixations, Nitrogen
% 221.09/221.25  |- mesh__dateRevised mesh__D009586 2005-06-30
% 221.09/221.25  |- skos__scopeNote mesh__D009586
% 221.09/221.25       The process in certain BACTERIA; FUNGI; and BLUE-GREEN ALGAE converting free atmospheric NITROGEN to biologically usable forms of nitrogen, such as AMMONIA; NITRATES; and amino compounds.%A%    
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D009586 2006
% 221.09/221.25  |- skos__broader mesh__D009586smesh__D008827
% 221.09/221.25  |- skos__broader mesh__D009586smesh__D018407
% 221.09/221.25  |- skos__prefLabel mesh__D009586 Nitrogen Fixation
% 221.09/221.25  |- skos__broader mesh__D009586smesh__D008660
% 221.09/221.25  |- mesh__recordAuthorizer mesh__D009586 sjn
% 221.09/221.25  |- skos__hiddenLabel mesh__D009586 Fixation, Nitrogen
% 221.09/221.25  |- skos__hiddenLabel mesh__D009586 Nitrogen Fixations
% 221.09/221.25  |- mesh__recordOriginator mesh__D009586 NLM
% 221.09/221.25  |- mesh__publicMeSHNote mesh__D014720 71   
% 221.09/221.25  |- skos__historyNote mesh__D014720
% 221.09/221.25       Virus Diseases/veterinary %28%1966-1970%29%
% 221.09/221.25  |- skos__annotation mesh__D014720
% 221.09/221.25       caused by a calicivirus; don%27%t forget also SWINE %28%NIM%29% %26% check tag ANIMALS%A%  
% 221.09/221.25  |- mesh__dateEstablished mesh__D014720 1971-01-01
% 221.09/221.25  |- mesh__dateRevised mesh__D014720 2003-07-30
% 221.09/221.25  |- mesh__recordOriginator mesh__D014720 NLM
% 221.09/221.25  |- rdf__type mesh__D014720sskos__Concept
% 221.09/221.25  |- mesh__dateCreated mesh__D014720 1999-01-01
% 221.09/221.25  |- skos__historyNote mesh__D014720 Swine Diseases %28%1966-1970%29%
% 221.09/221.25  |- mesh__recordMaintainer mesh__D014720 ags
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D014720 2006
% 221.09/221.25  |- mesh__historyNote mesh__D014720 71   
% 221.09/221.25  |- skos__scopeNote mesh__D014720
% 221.09/221.25       A calicivirus infection of swine characterized by hydropic degeneration of the oral and cutaneous epithelia.%A%    
% 221.09/221.25  |- skos__hiddenLabel mesh__D014720 Swine Vesicular Exanthemas
% 221.09/221.25  |- skos__broader mesh__D014720smesh__D017250
% 221.09/221.25  |- mesh__recordAuthorizer mesh__D014720 sjn
% 221.09/221.25  |- skos__hiddenLabel mesh__D014720 Swine Vesicular Exanthema
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D014720 2005
% 221.09/221.25  |- skos__broader mesh__D014720smesh__D013553
% 221.09/221.25  |- skos__prefLabel mesh__D014720 Vesicular Exanthema of Swine
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D014720 2004
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D000700 2006
% 221.09/221.25  |- mesh__recordMaintainer mesh__D000700 ssb
% 221.09/221.25  |- skos__annotation mesh__D000700
% 221.09/221.25       GEN or unspecified; prefer specific groups or specific analgesics; no qualif for analgesics when used with ANALGESIA; /ther use permitted for relief of pain in dis%A%  
% 221.09/221.25  |- mesh__recordOriginator mesh__D000700 NLM
% 221.09/221.25  |- skos__broader mesh__D000700smesh__D018689
% 221.09/221.25  |- skos__hiddenLabel mesh__D000700 Agents, Analgesic
% 221.09/221.25  |- mesh__dateCreated mesh__D000700 1999-01-01
% 221.09/221.25  |- skos__prefLabel mesh__D000700 Analgesics
% 221.09/221.25  |- skos__altLabel mesh__D000700 Anodynes
% 221.09/221.25  |- skos__broader mesh__D000700smesh__D002491
% 221.09/221.25  |- mesh__onlineNote mesh__D000700
% 221.09/221.25       use ANALGESICS to search ANALGESICS AND ANTIPYRETICS 1966-77%A%  
% 221.09/221.25  |- skos__scopeNote mesh__D000700
% 221.09/221.25       Compounds capable of relieving pain without the loss of CONSCIOUSNESS or without producing ANESTHESIA.%A%    
% 221.09/221.25  |- skos__altLabel mesh__D000700 Antinociceptive Drugs
% 221.09/221.25  |- mesh__dateRevised mesh__D000700 2005-06-30
% 221.09/221.25  |- skos__altLabel mesh__D000700 Analgesic Agents
% 221.09/221.25  |- skos__altLabel mesh__D000700 Antinociceptive Agents
% 221.09/221.25  |- mesh__publicMeSHNote mesh__D000700
% 221.09/221.25       78; ANALGESICS AND ANTIPYRETICS was heading 1963-77   
% 221.09/221.25  |- skos__hiddenLabel mesh__D000700 Drugs, Analgesic
% 221.09/221.25  |- rdf__type mesh__D000700sskos__Concept
% 221.09/221.25  |- skos__hiddenLabel mesh__D000700 Drugs, Antinociceptive
% 221.09/221.25  |- skos__altLabel mesh__D000700 Analgesic Drugs
% 221.09/221.25  |- mesh__historyNote mesh__D000700
% 221.09/221.25       78; ANALGESICS AND ANTIPYRETICS was heading 1963-77   
% 221.09/221.25  |- mesh__recordAuthorizer mesh__D000700 sjn
% 221.09/221.25  |- skos__hiddenLabel mesh__D000700 Agents, Antinociceptive
% 221.09/221.25  |- skos__prefLabel mesh__D005994 Glycerophosphates
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005994 2005
% 221.09/221.25  |- skos__broader mesh__D005994smesh__D013403
% 221.09/221.25  |- mesh__recordMaintainer mesh__D005994 ssb
% 221.09/221.25  |- mesh__recordAuthorizer mesh__D005994 sjn
% 221.09/221.25  |- skos__hiddenLabel mesh__D005994 Glycerophosphate, Calcium
% 221.09/221.25  |- rdf__type mesh__D005994sskos__Concept
% 221.09/221.25  |- mesh__dateRevised mesh__D005994 2004-07-07
% 221.09/221.25  |- skos__broader mesh__D005994smesh__D010743
% 221.09/221.25  |- mesh__dateCreated mesh__D005994 1999-01-01
% 221.09/221.25  |- mesh__recordOriginator mesh__D005994 NLM
% 221.09/221.25  |- skos__scopeNote mesh__D005994
% 221.09/221.25       Any salt or ester of glycerophosphoric acid.     
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005994 2006
% 221.09/221.25  |- skos__altLabel mesh__D005994 Glycerolphosphates
% 221.09/221.25  |- rdf__type mesh__D005196sskos__Concept
% 221.09/221.25  |- mesh__recordAuthorizer mesh__D005196 PLS
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005196 2004
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005196 1998
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005196 2000
% 221.09/221.25  |- skos__prefLabel mesh__D005196 Family Therapy
% 221.09/221.25  |- skos__scopeNote mesh__D005196
% 221.09/221.25       A form of group psychotherapy. It involves treatment of more than one member of the family simultaneously in the same session.%A%    
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005196 2005
% 221.09/221.25  |- mesh__dateRevised mesh__D005196 1995-05-31
% 221.09/221.25  |- mesh__activeMeSHYear mesh__D005196 1999
% 221.09/221.25  |- mesh__publicMeSHNote mesh__D005196 68   
% 221.09/221.26  |- mesh__recordOriginator mesh__D005196 NLM
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005196 2001
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005196 2006
% 221.09/221.26  |- mesh__dateCreated mesh__D005196 1999-01-01
% 221.09/221.26  |- skos__hiddenLabel mesh__D005196 Therapies, Family
% 221.09/221.26  |- skos__altLabel mesh__D005196 Therapy, Family
% 221.09/221.26  |- skos__annotation mesh__D005196
% 221.09/221.26       a group psychother technique; DF: FAMILY THER   
% 221.09/221.26  |- mesh__dateEstablished mesh__D005196 1968-01-01
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005196 2002
% 221.09/221.26  |- mesh__historyNote mesh__D005196 68%28%65%29%   
% 221.09/221.26  |- mesh__recordMaintainer mesh__D005196 TGC
% 221.09/221.26  |- skos__hiddenLabel mesh__D005196 Family Therapies
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005196 1996
% 221.09/221.26  |- skos__broader mesh__D005196smesh__D011615
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005196 2003
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005196 1997
% 221.09/221.26  |- mesh__recordMaintainer mesh__D013628 ags
% 221.09/221.26  |- skos__hiddenLabel mesh__D013628 Astragalus Bones
% 221.09/221.26  |- skos__scopeNote mesh__D013628
% 221.09/221.26       The second largest of the TARSAL BONES. It articulates with the TIBIA and FIBULA  to form the ANKLE JOINT.%A%    
% 221.09/221.26  |- skos__hiddenLabel mesh__D013628 Bones, Astragalus
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D013628 2006
% 221.09/221.26  |- mesh__recordOriginator mesh__D013628 NLM
% 221.09/221.26  |- rdf__type mesh__D013628sskos__Concept
% 221.09/221.26  |- mesh__dateRevised mesh__D013628 2005-06-30
% 221.09/221.26  |- skos__altLabel mesh__D013628 Astragalus Bone
% 221.09/221.26  |- mesh__recordAuthorizer mesh__D013628 sjn
% 221.09/221.26  |- mesh__dateCreated mesh__D013628 1999-01-01
% 221.09/221.26  |- skos__broader mesh__D013628smesh__D013639
% 221.09/221.26  |- skos__hiddenLabel mesh__D013628 Bone, Astragalus
% 221.09/221.26  |- skos__prefLabel mesh__D013628 Talus
% 221.09/221.26  |- skos__altLabel mesh__D018313 Leishmania %28%Leishmania%29% enrietti
% 221.09/221.26  |- skos__broader mesh__D018313smesh__D007891
% 221.09/221.26  |- skos__historyNote mesh__D018313 Leishmania mexicana %28%1986-1993%29%
% 221.09/221.26  |- mesh__dateEstablished mesh__D018313 1994-01-01
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D018313 2006
% 221.09/221.26  |- skos__altLabel mesh__D018313 Leishmania enrietti
% 221.09/221.26  |- mesh__onlineNote mesh__D018313
% 221.09/221.26       use LEISHMANIA MEXICANA to search LEISHMANIA ENRIETTI 1986-93%A%  
% 221.09/221.26  |- mesh__dateCreated mesh__D018313 1993-06-03
% 221.09/221.26  |- mesh__dateRevised mesh__D018313 2003-07-09
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D018313 2005
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D018313 2004
% 221.09/221.26  |- rdf__type mesh__D018313sskos__Concept
% 221.09/221.26  |- skos__altLabel mesh__D018313 Leishmania leishmania enriettii
% 221.09/221.26  |- mesh__publicMeSHNote mesh__D018313
% 221.09/221.26       94; was LEISHMANIA ENRIETTI see LEISHMANIA MEXICANA 1986-93%A%  
% 221.09/221.26  |- skos__altLabel mesh__D018313 Leishmania leishmania enrietti
% 221.09/221.26  |- skos__altLabel mesh__D018313 Leishmania %28%Leishmania%29% enriettii
% 221.09/221.26  |- mesh__historyNote mesh__D018313
% 221.09/221.26       94; was LEISHMANIA ENRIETTI see LEISHMANIA MEXICANA 1986-93%A%  
% 221.09/221.26  |- skos__prefLabel mesh__D018313 Leishmania enriettii
% 221.09/221.26  |- skos__historyNote mesh__D018313 Leishmania %28%1978-1985%29%
% 221.09/221.26  |- skos__scopeNote mesh__D018313
% 221.09/221.26       A parasitic hemoflagellate of the subgenus Leishmania leishmania that has been found as a natural infection of the Brazilian guinea pig. Its host-tissue relationship is, in general, comparable to that of L. braziliensis.%A%    
% 221.09/221.26  |- skos__annotation mesh__D018313
% 221.09/221.26       infection: coord IM with LEISHMANIASIS %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D010330 2003
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D010330 2003A
% 221.09/221.26  |- rdf__type mesh__D010330sskos__Concept
% 221.09/221.26  |- skos__broader mesh__D010330smesh__D018973
% 221.09/221.26  |- mesh__recordMaintainer mesh__D010330 jls
% 221.09/221.26  |- skos__hiddenLabel mesh__D010330 Patent
% 221.09/221.26  |- mesh__dateRevised mesh__D010330 2002-10-31
% 221.09/221.26  |- mesh__recordOriginator mesh__D010330 NLM
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D010330 2006
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D010330 2002
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D010330 2005
% 221.09/221.26  |- skos__hiddenLabel mesh__D010330 Trademark
% 221.09/221.26  |- skos__scopeNote mesh__D010330
% 221.09/221.26       Exclusive legal rights or privileges applied to inventions, plants, etc.%A%    
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D010330 2001
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D010330 2004
% 221.09/221.26  |- skos__prefLabel mesh__D010330 Patents
% 221.09/221.26  |- mesh__recordAuthorizer mesh__D010330 jls
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D010330 2000
% 221.09/221.26  |- mesh__dateCreated mesh__D010330 1999-01-01
% 221.09/221.26  |- skos__annotation mesh__D010330 IM   
% 221.09/221.26  |- rdf__type mesh__D051747sskos__Concept
% 221.09/221.26  |- skos__hiddenLabel mesh__D051747 DNA Dependent Protein Kinase
% 221.09/221.26  |- skos__broader mesh__D051747smesh__D017346
% 221.09/221.26  |- mesh__dateEstablished mesh__D051747 2006-01-01
% 221.09/221.26  |- skos__prefLabel mesh__D051747 DNA-Activated Protein Kinase
% 221.09/221.26  |- mesh__recordMaintainer mesh__D051747 AKE
% 221.09/221.26  |- skos__scopeNote mesh__D051747
% 221.09/221.26       A serine-threonine protein kinase that, when activated by DNA, phosphorylates several DNA-binding protein substrates including the TUMOR SUPPRESSOR PROTEIN P53 and a variety of TRANSCRIPTION FACTORS.%A%    
% 221.09/221.26  |- mesh__historyNote mesh__D051747 2006%28%1993%29%   
% 221.09/221.26  |- skos__hiddenLabel mesh__D051747 DNA Activated Protein Kinase
% 221.09/221.26  |- skos__hiddenLabel mesh__D051747 Kinase, DNA-Activated Protein
% 221.09/221.26  |- skos__hiddenLabel mesh__D051747
% 221.09/221.26       DNA Dependent Protein Serine Threonine Kinase
% 221.09/221.26  |- mesh__recordOriginator mesh__D051747 AKE
% 221.09/221.26  |- mesh__publicMeSHNote mesh__D051747
% 221.09/221.26       2006; DNA-ACTIVATED PROTEIN KINASE was indexed under PROTEIN-SERINE-THREONINE KINASES %26% DNA-BINDING PROTEINS 1993-2005%A%  
% 221.09/221.26  |- mesh__recordAuthorizer mesh__D051747 sjn
% 221.09/221.26  |- skos__altLabel mesh__D051747 DNA-Dependent Protein Kinase
% 221.09/221.26  |- skos__altLabel mesh__D051747
% 221.09/221.26       DNA-Dependent Protein Serine-Threonine Kinase
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D051747 2006
% 221.09/221.26  |- skos__hiddenLabel mesh__D051747 Protein Kinase, DNA-Dependent
% 221.09/221.26  |- mesh__dateCreated mesh__D051747 2005-06-30
% 221.09/221.26  |- skos__hiddenLabel mesh__D051747 Protein Kinase, DNA-Activated
% 221.09/221.26  |- skos__hiddenLabel mesh__D051747 Kinase, DNA-Dependent Protein
% 221.09/221.26  |- rdf__type mesh__D009587sskos__Concept
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D009587 2002
% 221.09/221.26  |- skos__scopeNote mesh__D009587
% 221.09/221.26       Stable nitrogen atoms that have the same atomic number as the element nitrogen, but differ in atomic weight. N-15 is a stable nitrogen isotope.%A%    
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D009587 2005
% 221.09/221.26  |- mesh__dateRevised mesh__D009587 2000-06-22
% 221.09/221.26  |- skos__broader mesh__D009587smesh__D007554
% 221.09/221.26  |- mesh__recordAuthorizer mesh__D009587 sjn
% 221.09/221.26  |- mesh__recordMaintainer mesh__D009587 nns
% 221.09/221.26  |- mesh__recordOriginator mesh__D009587 NLM
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D009587 2006
% 221.09/221.26  |- skos__hiddenLabel mesh__D009587 Isotopes, Nitrogen
% 221.09/221.26  |- mesh__historyNote mesh__D009587 73%28%71%29%   
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D009587 2003
% 221.09/221.26  |- mesh__dateCreated mesh__D009587 1999-01-01
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D009587 2004
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D009587 2001
% 221.09/221.26  |- skos__historyNote mesh__D009587 Nitrogen %28%1966-1970%29%
% 221.09/221.26  |- mesh__dateEstablished mesh__D009587 1973-01-01
% 221.09/221.26  |- skos__prefLabel mesh__D009587 Nitrogen Isotopes
% 221.09/221.26  |- mesh__publicMeSHNote mesh__D009587 73   
% 221.09/221.26  |- skos__annotation mesh__D009587 N-15; NIM   
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D028741 2003
% 221.09/221.26  |- mesh__publicMeSHNote mesh__D028741 2002   
% 221.09/221.26  |- skos__altLabel mesh__D028741 Hospital Ethics Committees
% 221.09/221.26  |- skos__altLabel mesh__D028741 Hospital Ethics Committee
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D028741 2005
% 221.09/221.26  |- skos__altLabel mesh__D028741 Committee, Clinical Ethics
% 221.09/221.26  |- skos__altLabel mesh__D028741 Clinical Ethics Committees
% 221.09/221.26  |- skos__altLabel mesh__D028741 Ethics Committee, Hospital
% 221.09/221.26  |- rdf__type mesh__D028741sskos__Concept
% 221.09/221.26  |- skos__altLabel mesh__D028741 Committee, Hospital Ethics
% 221.09/221.26  |- skos__prefLabel mesh__D028741 Ethics Committees, Clinical
% 221.09/221.26  |- skos__altLabel mesh__D028741 Clinical Ethics Committee
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D028741 2002
% 221.09/221.26  |- skos__related mesh__D028741smesh__D026690
% 221.09/221.26  |- skos__annotation mesh__D028741
% 221.09/221.26       distinguish from ETHICS COMMITTEES, RESEARCH   
% 221.09/221.26  |- skos__altLabel mesh__D028741 Ethics Committees, Hospital
% 221.09/221.26  |- skos__broader mesh__D028741smesh__D017041
% 221.09/221.26  |- skos__altLabel mesh__D028741 Committees, Clinical Ethics
% 221.09/221.26  |- mesh__dateEstablished mesh__D028741 2002-01-01
% 221.09/221.26  |- skos__altLabel mesh__D028741 Ethics Committee, Clinical
% 221.09/221.26  |- mesh__dateCreated mesh__D028741 2001-07-25
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D028741 2004
% 221.09/221.26  |- skos__scopeNote mesh__D028741
% 221.09/221.26       Hospital or other institutional ethics committees established to consider the ethical dimensions of patient care.  Distinguish from ETHICS COMMITTEES, RESEARCH, which are established to monitor the welfare of patients or healthy volunteers participating in research studies.%A%    
% 221.09/221.26  |- skos__altLabel mesh__D028741 Committees, Hospital Ethics
% 221.09/221.26  |- skos__historyNote mesh__D028741 Ethics Committees %28%1979-2001%29%
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D028741 2006
% 221.09/221.26  |- mesh__historyNote mesh__D028741 2002   
% 221.09/221.26  |- skos__altLabel mesh__D014721 Vesicular Stomatitis Virus
% 221.09/221.26  |- skos__hiddenLabel mesh__D014721 Stomatitis Virus, Vesicular
% 221.09/221.26  |- rdf__type mesh__D014721sskos__Concept
% 221.09/221.26  |- mesh__dateCreated mesh__D014721 1999-01-01
% 221.09/221.26  |- skos__scopeNote mesh__D014721
% 221.09/221.26       The type species of VESICULOVIRUS causing a disease symptomatically similar to FOOT-AND-MOUTH DISEASE in cattle, horses, and pigs. It may be transmitted to other species including humans, where it causes influenza-like symptoms.%A%    
% 221.09/221.26  |- mesh__dateRevised mesh__D014721 2001-07-25
% 221.09/221.26  |- mesh__historyNote mesh__D014721
% 221.09/221.26       94; was VESICULAR STOMATITIS VIRUS 1963-93   
% 221.09/221.26  |- skos__hiddenLabel mesh__D014721 Vesicular stomatitis Indiana virus
% 221.09/221.26  |- mesh__recordMaintainer mesh__D014721 ags
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D014721 2006
% 221.09/221.26  |- mesh__recordOriginator mesh__D014721 NLM
% 221.09/221.26  |- skos__annotation mesh__D014721
% 221.09/221.26       infection: coord IM with RHABDOVIRIDAE INFECTIONS %28%IM%29% + probably STOMATITIS %28%IM%29% + precoord animal/dis term %28%IM%29%, using qualif /vet if pertinent; DF: note short X ref%A%  
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D014721 2005
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D014721 2002
% 221.09/221.26  |- mesh__onlineNote mesh__D014721
% 221.09/221.26       use VESICULAR STOMATITIS-INDIANA VIRUS to search VESICULAR STOMATITIS VIRUS 1966-93%A%  
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D014721 2004
% 221.09/221.26  |- skos__prefLabel mesh__D014721 Vesicular stomatitis-Indiana virus
% 221.09/221.26  |- mesh__recordAuthorizer mesh__D014721 sjn
% 221.09/221.26  |- mesh__publicMeSHNote mesh__D014721
% 221.09/221.26       94; was VESICULAR STOMATITIS VIRUS 1963-93   
% 221.09/221.26  |- skos__broader mesh__D014721smesh__D018116
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D014721 2003
% 221.09/221.26  |- skos__related mesh__D000701smesh__D009294
% 221.09/221.26  |- mesh__historyNote mesh__D000701 95; was ANALGESICS, ADDICTIVE 1975-94   
% 221.09/221.26  |- mesh__recordAuthorizer mesh__D000701 sjn
% 221.09/221.26  |- skos__prefLabel mesh__D000701 Analgesics, Opioid
% 221.09/221.26  |- mesh__dateEstablished mesh__D000701 1975-01-01
% 221.09/221.26  |- skos__hiddenLabel mesh__D000701 Addictive Analgesics
% 221.09/221.26  |- mesh__dateCreated mesh__D000701 1999-01-01
% 221.09/221.26  |- skos__altLabel mesh__D000701 Opioid Analgesics
% 221.09/221.26  |- skos__annotation mesh__D000701 GEN or unspecified; prefer specifics   
% 221.09/221.26  |- mesh__recordMaintainer mesh__D000701 ssb
% 221.09/221.26  |- mesh__onlineNote mesh__D000701
% 221.09/221.26       use ANALGESICS, OPIOID to search ANALGESICS, ADDICTIVE 1975-94%A%  
% 221.09/221.26  |- skos__historyNote mesh__D000701 Analgesics %28%1966-1974%29%
% 221.09/221.26  |- skos__altLabel mesh__D000701 Analgesics, Narcotic
% 221.09/221.26  |- mesh__publicMeSHNote mesh__D000701
% 221.09/221.26       95; was ANALGESICS, ADDICTIVE 1975-94   
% 221.09/221.26  |- mesh__recordOriginator mesh__D000701 NLM
% 221.09/221.26  |- skos__broader mesh__D000701smesh__D000700
% 221.09/221.26  |- rdf__type mesh__D000701sskos__Concept
% 221.09/221.26  |- mesh__dateRevised mesh__D000701 2005-06-30
% 221.09/221.26  |- skos__scopeNote mesh__D000701
% 221.09/221.26       Narcotic or opioid substances, synthetic or semisynthetic agents producing profound analgesia, drowsiness, and changes in mood. Mood changes may be pleasurable, therefore creating a potential for the abuse of these agents; the prototype of these is morphine to which all other analgesics are compared.%A%    
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D000701 2006
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005995 1993
% 221.09/221.26  |- mesh__recordAuthorizer mesh__D005995 PLS
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005995 1995
% 221.09/221.26  |- skos__historyNote mesh__D005995 Glycerides %28%1966-1987%29%
% 221.09/221.26  |- skos__broader mesh__D005995smesh__D004987
% 221.09/221.26  |- skos__prefLabel mesh__D005995 Glyceryl Ethers
% 221.09/221.26  |- skos__scopeNote mesh__D005995
% 221.09/221.26       Compounds in which one or more of the three hydroxyl groups of glycerol are in ethereal linkage with a saturated or unsaturated aliphatic alcohol; one or two of the hydroxyl groups of glycerol may be esterified. These compounds have been found in various animal tissue.%A%    
% 221.09/221.26  |- skos__hiddenLabel mesh__D005995 Ethers, Glycerol
% 221.09/221.26  |- mesh__recordOriginator mesh__D005995 RLS
% 221.09/221.26  |- mesh__dateCreated mesh__D005995 1987-03-23
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005995 2000
% 221.09/221.26  |- mesh__dateEstablished mesh__D005995 1988-01-01
% 221.09/221.26  |- rdf__type mesh__D005995sskos__Concept
% 221.09/221.26  |- mesh__publicMeSHNote mesh__D005995 88   
% 221.09/221.26  |- skos__hiddenLabel mesh__D005995 Glyceryl Ethers, Alkyl
% 221.09/221.26  |- skos__historyNote mesh__D005995
% 221.09/221.26       Glycerin/analogs %26% derivatives %28%1975-1987%29%
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005995 2001
% 221.09/221.26  |- mesh__recordMaintainer mesh__D005995 TGC
% 221.09/221.26  |- skos__historyNote mesh__D005995 Ethers %28%1966-1987%29%
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005995 2003
% 221.09/221.26  |- skos__hiddenLabel mesh__D005995 Ethers, Alkyl Glyceryl
% 221.09/221.26  |- skos__broader mesh__D005995smesh__D005990
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005995 1996
% 221.09/221.26  |- mesh__dateRevised mesh__D005995 1992-05-19
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005995 2005
% 221.09/221.26  |- skos__historyNote mesh__D005995 Glycerin %28%1966-1974%29%
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005995 2004
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005995 1998
% 221.09/221.26  |- skos__hiddenLabel mesh__D005995 Ethers, Glyceryl
% 221.09/221.26  |- skos__altLabel mesh__D005995 Glycerol Ethers
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005995 2002
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005995 1997
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005995 2006
% 221.09/221.26  |- mesh__historyNote mesh__D005995 88   
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005995 1994
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005995 1999
% 221.09/221.26  |- skos__broader mesh__D005197smesh__D009272
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005197 2002
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005197 2006
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005197 1995
% 221.09/221.26  |- mesh__dateCreated mesh__D005197 1999-01-01
% 221.09/221.26  |- skos__annotation mesh__D005197
% 221.09/221.26       IM; no qualif; Manual 32.16.11, 32.16.12; when not to use: 32.16.7%A%  
% 221.09/221.26  |- skos__hiddenLabel mesh__D005197 Persons, Famous
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005197 1996
% 221.09/221.26  |- mesh__recordMaintainer mesh__D005197 TGC
% 221.09/221.26  |- mesh__recordAuthorizer mesh__D005197 PLS
% 221.09/221.26  |- skos__prefLabel mesh__D005197 Famous Persons
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005197 2003
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005197 1997
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005197 2000
% 221.09/221.26  |- rdf__type mesh__D005197sskos__Concept
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005197 2004
% 221.09/221.26  |- mesh__dateRevised mesh__D005197 1994-04-11
% 221.09/221.26  |- skos__hiddenLabel mesh__D005197 Person, Famous
% 221.09/221.26  |- skos__hiddenLabel mesh__D005197 Famous Person
% 221.09/221.26  |- mesh__recordOriginator mesh__D005197 NLM
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005197 1998
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005197 2001
% 221.09/221.26  |- skos__broader mesh__D005197smesh__D001680
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005197 2005
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D005197 1999
% 221.09/221.26  |- skos__broader mesh__D001432Q000379smesh__D001432
% 221.09/221.26  |- mesh__preferredCombination mesh__D001432Q000379smesh__D001431
% 221.09/221.26  |- rdf__type mesh__D001432Q000379smesh__CompoundConcept
% 221.09/221.26  |- skos__altLabel mesh__D013629 ICI-46,474
% 221.09/221.26  |- skos__altLabel mesh__D013629 Novaldex
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D013629 2006
% 221.09/221.26  |- mesh__recordMaintainer mesh__D013629 ssb
% 221.09/221.26  |- skos__broader mesh__D013629smesh__D013267
% 221.09/221.26  |- rdf__type mesh__D013629sskos__Concept
% 221.09/221.26  |- mesh__publicMeSHNote mesh__D013629
% 221.09/221.26       78; was see under STILBENES 1975-77   
% 221.09/221.26  |- skos__historyNote mesh__D013629 Stilbenes %28%1966-1974%29%
% 221.09/221.26  |- skos__historyNote mesh__D013629 Phenyl Ethers %28%1974%29%
% 221.09/221.26  |- skos__hiddenLabel mesh__D013629 ICI46,474
% 221.09/221.26  |- skos__hiddenLabel mesh__D013629 ICI 46,474
% 221.09/221.26  |- mesh__dateCreated mesh__D013629 1974-11-11
% 221.09/221.26  |- mesh__historyNote mesh__D013629
% 221.09/221.26       78%28%75%29%; was see under STILBENES 1975-77   
% 221.09/221.26  |- skos__historyNote mesh__D013629 Dimethylamines %28%1973-1974%29%
% 221.09/221.26  |- mesh__dateEstablished mesh__D013629 1978-01-01
% 221.09/221.26  |- skos__hiddenLabel mesh__D013629 ICI 47699
% 221.09/221.26  |- skos__scopeNote mesh__D013629
% 221.09/221.26       One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS, it is agonist for bone tissue and cholesterol metabolism but antagonist in mammary and uterine tissues. Concern has been raised about increased cancer risk.%A%    
% 221.09/221.26  |- mesh__recordOriginator mesh__D013629 NLM
% 221.09/221.26  |- mesh__dateRevised mesh__D013629 2005-06-30
% 221.09/221.26  |- skos__hiddenLabel mesh__D013629 ICI47699
% 221.09/221.26  |- skos__hiddenLabel mesh__D013629 ICI46474
% 221.09/221.26  |- skos__hiddenLabel mesh__D013629 ICI 46474
% 221.09/221.26  |- mesh__recordAuthorizer mesh__D013629 sjn
% 221.09/221.26  |- skos__prefLabel mesh__D013629 Tamoxifen
% 221.09/221.26  |- skos__altLabel mesh__D018314 Leishmania donovani infantum
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D018314 2005
% 221.09/221.26  |- skos__altLabel mesh__D018314 Leishmania donovani chagasi
% 221.09/221.26  |- skos__altLabel mesh__D018314 Leishmania %28%Leishmania%29% infantum
% 221.09/221.26  |- rdf__type mesh__D018314sskos__Concept
% 221.09/221.26  |- mesh__historyNote mesh__D018314
% 221.09/221.26       94; was LEISHMANIA DONOVANI INFANTUM see LEISHMANIA DONOVANI 1992-93, was LEISHMANIA INFANTUM see LEISHMANIA DONOVANI 1986-91; LEISHMANIA DONOVANI CHAGASI was see LEISHMANIA DONOVANI 1992-93, was LEISHMANIA CHAGASI see LEISHMANIA DONOVANI 1986-91%A%  
% 221.09/221.26  |- skos__historyNote mesh__D018314 Leishmania %28%1980-1985%29%
% 221.09/221.26  |- skos__scopeNote mesh__D018314
% 221.09/221.26       A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes visceral leishmaniasis %28%LEISHMANIASIS, VISCERAL%29%. Human infections are confined almost entirely to children. This parasite is commonly seen in dogs, other Canidae, and porcupines with humans considered only an accidental host. Transmission is by Phlebotomus sandflies.%A%    
% 221.09/221.26  |- mesh__recordMaintainer mesh__D018314 sjn
% 221.09/221.26  |- skos__broader mesh__D018314smesh__D007891
% 221.09/221.26  |- skos__prefLabel mesh__D018314 Leishmania infantum
% 221.09/221.26  |- mesh__dateEstablished mesh__D018314 1994-01-01
% 221.09/221.26  |- mesh__recordOriginator mesh__D018314 PXP
% 221.09/221.26  |- skos__annotation mesh__D018314
% 221.09/221.26       infection: coord IM with LEISHMANIASIS, VISCERAL %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 221.09/221.26  |- mesh__publicMeSHNote mesh__D018314
% 221.09/221.26       94; was LEISHMANIA DONOVANI INFANTUM see LEISHMANIA DONOVANI 1992-93, was LEISHMANIA INFANTUM see LEISHMANIA DONOVANI 1986-91; LEISHMANIA DONOVANI CHAGASI was see LEISHMANIA DONOVANI 1992-93, was LEISHMANIA CHAGASI see LEISHMANIA DONOVANI 1986-91%A%  
% 221.09/221.26  |- mesh__recordAuthorizer mesh__D018314 sjn
% 221.09/221.26  |- mesh__dateCreated mesh__D018314 1993-06-03
% 221.09/221.26  |- skos__historyNote mesh__D018314 Leishmania donovani %28%1986-1993%29%
% 221.09/221.26  |- mesh__dateRevised mesh__D018314 2004-07-13
% 221.09/221.26  |- skos__altLabel mesh__D018314 Leishmania leishmania infantum
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D018314 2006
% 221.09/221.26  |- mesh__onlineNote mesh__D018314
% 221.09/221.26       use LEISHMANIA DONOVANI to search LEISHMANIA DONOVANI INFANTUM %26% LEISHMANIA DONOVANI CHAGASI 1992-93 %26% LEISHMANIA INFANTUM %26% LEISHMANIA CHAGASI 1986-91%A%  
% 221.09/221.26  |- skos__prefLabel mesh__D010331 Paternal Age
% 221.09/221.26  |- skos__hiddenLabel mesh__D010331 Paternal Ages
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D010331 2006
% 221.09/221.26  |- skos__hiddenLabel mesh__D010331 Ages, Paternal
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D010331 2005
% 221.09/221.26  |- mesh__dateEstablished mesh__D010331 1977-01-01
% 221.09/221.26  |- skos__scopeNote mesh__D010331 Age of the biological father.     
% 221.09/221.26  |- mesh__recordMaintainer mesh__D010331 lkt
% 221.09/221.26  |- skos__broader mesh__D010331smesh__D012098
% 221.09/221.26  |- mesh__publicMeSHNote mesh__D010331 77   
% 221.09/221.26  |- mesh__dateRevised mesh__D010331 2004-07-07
% 221.09/221.26  |- skos__hiddenLabel mesh__D010331 Age, Paternal
% 221.09/221.26  |- mesh__recordAuthorizer mesh__D010331 sjn
% 221.09/221.26  |- mesh__historyNote mesh__D010331 77   
% 221.09/221.26  |- mesh__recordOriginator mesh__D010331 VDK
% 221.09/221.26  |- rdf__type mesh__D010331sskos__Concept
% 221.09/221.26  |- mesh__dateCreated mesh__D010331 1976-05-19
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D009588 2001
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D009588 2006
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D009588 2002
% 221.09/221.26  |- skos__prefLabel mesh__D009588 Nitrogen Mustard Compounds
% 221.09/221.26  |- skos__broader mesh__D009588smesh__D009150
% 221.09/221.26  |- mesh__recordMaintainer mesh__D009588 adp
% 221.09/221.26  |- mesh__recordAuthorizer mesh__D009588 sjn
% 221.09/221.26  |- skos__annotation mesh__D009588
% 221.09/221.26       alkyating antineoplastics; do not confuse with NITROGEN MUSTARD, a specific chemical; DF: NITROGEN MUSTARD CPDS%A%  
% 221.09/221.26  |- mesh__recordOriginator mesh__D009588 NLM
% 221.09/221.26  |- mesh__activeMeSHYear mesh__D009588 2003
% 221.09/221.29  |- mesh__dateCreated mesh__D009588 1999-01-01
% 221.09/221.29  |- skos__scopeNote mesh__D009588
% 221.09/221.29       A group of alkylating agents derived from mustard gas, with the sulfur replaced by nitrogen. They were formerly used as toxicants and vesicants, but now function as antineoplastic agents. These compounds are also powerful mutagens, teratogens, immunosuppressants, and carcinogens.%A%    
% 221.09/221.29  |- skos__hiddenLabel mesh__D009588 Mustard Compounds, Nitrogen
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D009588 2004
% 221.09/221.29  |- rdf__type mesh__D009588sskos__Concept
% 221.09/221.29  |- skos__hiddenLabel mesh__D009588 Compounds, Nitrogen Mustard
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D009588 2005
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D009588 2000
% 221.09/221.29  |- mesh__dateRevised mesh__D009588 1999-11-03
% 221.09/221.29  |- mesh__publicMeSHNote mesh__D006290
% 221.09/221.29       91; was see under HEALTH PLANNING 1980-90   
% 221.09/221.29  |- skos__prefLabel mesh__D006290 Health Planning Technical Assistance
% 221.09/221.29  |- mesh__dateEstablished mesh__D006290 1991-01-01
% 221.09/221.29  |- mesh__dateRevised mesh__D006290 1993-09-16
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D006290 2000
% 221.09/221.29  |- rdf__type mesh__D006290sskos__Concept
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D006290 1996
% 221.09/221.29  |- mesh__historyNote mesh__D006290
% 221.09/221.29       91%28%80%29%; was see under HEALTH PLANNING 1980-90   
% 221.09/221.29  |- mesh__recordOriginator mesh__D006290 EC
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D006290 1998
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D006290 2001
% 221.09/221.29  |- skos__scopeNote mesh__D006290
% 221.09/221.29       The provision of expert assistance in developing health planning programs, plans as technical materials, etc., as requested by Health Systems Agencies or other health planning organizations.%A%    
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D006290 1997
% 221.09/221.29  |- mesh__recordAuthorizer mesh__D006290 NLM
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D006290 1999
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D006290 2003
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D006290 2005
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D006290 2004
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D006290 2002
% 221.09/221.29  |- mesh__dateCreated mesh__D006290 1979-06-01
% 221.09/221.29  |- mesh__recordMaintainer mesh__D006290 PLS
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D006290 2006
% 221.09/221.29  |- skos__altLabel mesh__D006290 Technical Assistance for Health Planning
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D006290 1995
% 221.09/221.29  |- skos__broader mesh__D006290smesh__D006285
% 221.09/221.29  |- skos__scopeNote mesh__D014722
% 221.09/221.29       A small, oval, bony chamber of the labyrinth. The vestibule contains the utricle and saccule, organs which are part of the balancing apparatus of the ear.%A%    
% 221.09/221.29  |- skos__altLabel mesh__D014722 Vestibular Apparatus
% 221.09/221.29  |- skos__annotation mesh__D014722
% 221.09/221.29       vestibule of the labyrinth; dis = VESTIBULAR DISEASES   
% 221.09/221.29  |- skos__hiddenLabel mesh__D014722 Vestibules
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D014722 1995
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D014722 1991
% 221.09/221.29  |- mesh__recordOriginator mesh__D014722 NLM
% 221.09/221.29  |- mesh__publicMeSHNote mesh__D014722
% 221.09/221.29       90; was VESTIBULAR APPARATUS 1963-89; ENDOLYMPHATIC DUCT was see under LABYRINTH 1979-89; ENDOLYMPHATIC SAC was see under LABYRINTH 1979-89%A%  
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D014722 1999
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D014722 1994
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D014722 1990
% 221.09/221.29  |- mesh__historyNote mesh__D014722
% 221.09/221.29       90; was VESTIBULAR APPARATUS 1963-89; ENDOLYMPHATIC DUCT was see under LABYRINTH 1979-89; ENDOLYMPHATIC SAC was see under LABYRINTH 1979-89%A%  
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D014722 2006
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D014722 1993
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D014722 1998
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D014722 2002
% 221.09/221.29  |- mesh__onlineNote mesh__D014722
% 221.09/221.29       use VESTIBULE to search VESTIBULAR APPARATUS 1966-89   
% 221.09/221.29  |- skos__prefLabel mesh__D014722 Vestibule
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D014722 2005
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D014722 1992
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D014722 1997
% 221.09/221.29  |- mesh__dateRevised mesh__D014722 1989-07-06
% 221.09/221.29  |- skos__hiddenLabel mesh__D014722 Apparatus, Vestibular
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D014722 2001
% 221.09/221.29  |- mesh__recordMaintainer mesh__D014722 PXP
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D014722 2004
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D014722 1996
% 221.09/221.29  |- skos__broader mesh__D014722smesh__D007758
% 221.09/221.29  |- mesh__recordAuthorizer mesh__D014722 PLS
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D014722 2000
% 221.09/221.29  |- mesh__dateCreated mesh__D014722 1999-01-01
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D014722 2003
% 221.09/221.29  |- rdf__type mesh__D014722sskos__Concept
% 221.09/221.29  |- skos__broader mesh__D025101Q000172smesh__D025101
% 221.09/221.29  |- mesh__preferredCombination mesh__D025101Q000172smesh__D026681
% 221.09/221.29  |- rdf__type mesh__D025101Q000172smesh__CompoundConcept
% 221.09/221.29  |- skos__scopeNote mesh__D005996
% 221.09/221.29       A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium.%A%    
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D005996 2002
% 221.09/221.29  |- skos__hiddenLabel mesh__D005996 Trinitrate, Glyceryl
% 221.09/221.29  |- rdf__type mesh__D005996sskos__Concept
% 221.09/221.29  |- mesh__dateRevised mesh__D005996 2001-07-25
% 221.09/221.29  |- mesh__recordOriginator mesh__D005996 NLM
% 221.09/221.29  |- skos__altLabel mesh__D005996 Glyceryl Trinitrate
% 221.09/221.29  |- mesh__recordMaintainer mesh__D005996 ssb
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D005996 2003
% 221.09/221.29  |- mesh__publicMeSHNote mesh__D005996
% 221.09/221.29       92; was GLYCERYL TRINITRATE 1963-91; NITROGLYCERIN was see GLYCERYL TRINITRATE 1963-91%A%  
% 221.09/221.29  |- skos__hiddenLabel mesh__D005996 Nitro Dur
% 221.09/221.29  |- skos__prefLabel mesh__D005996 Nitroglycerin
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D005996 2005
% 221.09/221.29  |- skos__broader mesh__D005996smesh__D009574
% 221.09/221.29  |- skos__related mesh__D005996smesh__D009574
% 221.09/221.29  |- skos__related mesh__D005996smesh__D020030
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D005996 2004
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D005996 2006
% 221.09/221.29  |- mesh__onlineNote mesh__D005996
% 221.09/221.29       use NITROGLYCERIN to search GLYCERYL TRINITRATE 1966-91   
% 221.09/221.29  |- skos__hiddenLabel mesh__D005996 NitroBid
% 221.09/221.29  |- mesh__recordAuthorizer mesh__D005996 sjn
% 221.09/221.29  |- mesh__historyNote mesh__D005996
% 221.09/221.29       92; was GLYCERYL TRINITRATE 1963-91; NITROGLYCERIN was see GLYCERYL TRINITRATE 1963-91%A%  
% 221.09/221.29  |- skos__broader mesh__D005996smesh__D005990
% 221.09/221.29  |- skos__hiddenLabel mesh__D005996 NitroDur
% 221.09/221.29  |- skos__hiddenLabel mesh__D005996 Nitro Bid
% 221.09/221.29  |- mesh__dateCreated mesh__D005996 1999-01-01
% 221.09/221.29  |- skos__broader mesh__D005198smesh__D003554
% 221.09/221.29  |- mesh__recordAuthorizer mesh__D005198 sjn
% 221.09/221.29  |- skos__annotation mesh__D005198
% 221.09/221.29       TN 79: Fanconi syndromes not in MeSH: how to index; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; do not confuse with FANCONI ANEMIA which is sometimes refered to as Fanconi syndrome%A%  
% 221.09/221.29  |- mesh__publicMeSHNote mesh__D005198
% 221.09/221.29       65; LIGNAC-FANCONI SYNDROME was LIGNAC-FANCONI DISEASE see under METABOLIC DISEASES 1963-64%A%  
% 221.09/221.29  |- skos__hiddenLabel mesh__D005198 Lignac Fanconi Syndrome
% 221.09/221.29  |- skos__prefLabel mesh__D005198 Fanconi Syndrome
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D005198 2002
% 221.09/221.29  |- mesh__dateRevised mesh__D005198 2001-07-25
% 221.09/221.29  |- mesh__recordMaintainer mesh__D005198 nns
% 221.09/221.29  |- skos__altLabel mesh__D005198 De Toni-Debre-Fanconi Syndrome
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D005198 2003
% 221.09/221.29  |- rdf__type mesh__D005198sskos__Concept
% 221.09/221.29  |- skos__altLabel mesh__D005198 Lignac-Fanconi Syndrome
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D005198 2004
% 221.09/221.29  |- skos__hiddenLabel mesh__D005198 Syndrome, Fanconi
% 221.09/221.29  |- mesh__dateEstablished mesh__D005198 1965-01-01
% 221.09/221.29  |- skos__hiddenLabel mesh__D005198 Syndrome, De Toni-Debre-Fanconi
% 221.09/221.29  |- skos__hiddenLabel mesh__D005198 Syndrome, Lignac-Fanconi
% 221.09/221.29  |- skos__broader mesh__D005198smesh__D007674
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D005198 2005
% 221.09/221.29  |- skos__scopeNote mesh__D005198
% 221.09/221.29       Constellation of clinical and laboratory manifestations produced by generalized proximal tubular insufficiency in the presence of normal, or nearly normal, glomerular filtration.%A%    
% 221.09/221.29  |- mesh__historyNote mesh__D005198
% 221.09/221.29       65; LIGNAC-FANCONI SYNDROME was LIGNAC-FANCONI DISEASE see under METABOLIC DISEASES 1963-64%A%  
% 221.09/221.29  |- skos__hiddenLabel mesh__D005198 De Toni Debre Fanconi Syndrome
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D005198 2006
% 221.09/221.29  |- mesh__dateCreated mesh__D005198 1999-01-01
% 221.09/221.29  |- mesh__recordOriginator mesh__D005198 NLM
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D018315 2003
% 221.09/221.29  |- skos__scopeNote mesh__D018315
% 221.09/221.29       Rare, slow-growing, benign intraventricular tumors, often asymptomatic and discovered incidentally. The tumors are classified histologically as ependymomas and demonstrate a proliferation of subependymal fibrillary astrocytes among the ependymal tumor cells. %28%From Clin Neurol Neurosurg 1997 Feb;99%28%1%29%:17-22%29%%A%    
% 221.09/221.29  |- mesh__recordMaintainer mesh__D018315 KEV
% 221.09/221.29  |- skos__hiddenLabel mesh__D018315 Subependymal Astrocytomas, Adult
% 221.09/221.29  |- skos__hiddenLabel mesh__D018315 Astrocytomas, Subependymal
% 221.09/221.29  |- skos__hiddenLabel mesh__D018315 Adult Subependymal Astrocytoma
% 221.09/221.29  |- mesh__publicMeSHNote mesh__D018315 94   
% 221.09/221.29  |- mesh__dateRevised mesh__D018315 1999-11-03
% 221.09/221.29  |- skos__hiddenLabel mesh__D018315 Astrocytoma, Subependymal
% 221.09/221.29  |- skos__hiddenLabel mesh__D018315 Subependymal Glioses
% 221.09/221.29  |- skos__altLabel mesh__D018315 Subependymal Glioma
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D018315 2001
% 221.09/221.29  |- mesh__recordOriginator mesh__D018315 PLS
% 221.09/221.29  |- skos__hiddenLabel mesh__D018315 Subependymal Astrocytomas
% 221.09/221.29  |- skos__hiddenLabel mesh__D018315 Adult Subependymal Astrocytomas
% 221.09/221.29  |- skos__hiddenLabel mesh__D018315 Subependymal Gliomas
% 221.09/221.29  |- skos__hiddenLabel mesh__D018315 Gliosis, Subependymal
% 221.09/221.29  |- skos__hiddenLabel mesh__D018315 Astrocytomas, Adult Subependymal
% 221.09/221.29  |- mesh__activeMeSHYear mesh__D018315 2000
% 221.09/221.30  |- skos__broader mesh__D018315smesh__D004806
% 221.09/221.30  |- skos__altLabel mesh__D018315 Subependymal Astrocytoma
% 221.09/221.30  |- skos__hiddenLabel mesh__D018315 Subependymomas
% 221.09/221.30  |- mesh__dateEstablished mesh__D018315 1994-01-01
% 221.09/221.30  |- skos__hiddenLabel mesh__D018315 Glioses, Subependymal
% 221.09/221.30  |- mesh__historyNote mesh__D018315 94   
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D018315 2006
% 221.09/221.30  |- skos__hiddenLabel mesh__D018315 Gliomas, Subependymal
% 221.09/221.30  |- skos__altLabel mesh__D018315 Subependymoma
% 221.09/221.30  |- skos__prefLabel mesh__D018315 Glioma, Subependymal
% 221.09/221.30  |- skos__hiddenLabel mesh__D018315 Astrocytoma, Adult Subependymal
% 221.09/221.30  |- skos__annotation mesh__D018315
% 221.09/221.30       coord IM with precoord brain/neopl term %28%IM%29% + site %28%IM%29%; do not confuse with ASTROCYTOMA, SUBEPENDYMAL GIANT CELL see ASTROCYTOMA%A%  
% 221.09/221.30  |- mesh__recordAuthorizer mesh__D018315 sjn
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D018315 2004
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D018315 2005
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D018315 2002
% 221.09/221.30  |- rdf__type mesh__D018315sskos__Concept
% 221.09/221.30  |- mesh__dateCreated mesh__D018315 1993-06-03
% 221.09/221.30  |- mesh__recordMaintainer mesh__D010332 JLS
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010332 2005
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010332 2000
% 221.09/221.30  |- skos__historyNote mesh__D010332 Child Psychology %28%1966-1968%29%
% 221.09/221.30  |- skos__annotation mesh__D010332 human %26% animal   
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010332 2006
% 221.09/221.30  |- skos__hiddenLabel mesh__D010332 Behavior, Paternal
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010332 2001
% 221.09/221.30  |- mesh__dateCreated mesh__D010332 1999-01-01
% 221.09/221.30  |- mesh__dateEstablished mesh__D010332 1969-01-01
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010332 2003
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010332 1998
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010332 2004
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010332 1999
% 221.09/221.30  |- mesh__dateRevised mesh__D010332 1997-06-20
% 221.09/221.30  |- skos__broader mesh__D010332smesh__D005195
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010332 2002
% 221.09/221.30  |- skos__prefLabel mesh__D010332 Paternal Behavior
% 221.09/221.30  |- mesh__recordAuthorizer mesh__D010332 SJN
% 221.09/221.30  |- mesh__publicMeSHNote mesh__D010332 69   
% 221.09/221.30  |- skos__hiddenLabel mesh__D010332 Behaviors, Paternal
% 221.09/221.30  |- rdf__type mesh__D010332sskos__Concept
% 221.09/221.30  |- skos__scopeNote mesh__D010332
% 221.09/221.30       The behavior patterns associated with or characteristic of a father.%A%    
% 221.09/221.30  |- skos__hiddenLabel mesh__D010332 Paternal Behaviors
% 221.09/221.30  |- mesh__recordOriginator mesh__D010332 NLM
% 221.09/221.30  |- mesh__historyNote mesh__D010332 69   
% 221.09/221.30  |- skos__historyNote mesh__D010332 Parent-Child Relations %28%1966-1968%29%
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D009589 2006A
% 221.09/221.30  |- skos__prefLabel mesh__D009589 Nitrogen Oxides
% 221.09/221.30  |- mesh__historyNote mesh__D009589 73%28%71%29%   
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D009589 2003
% 221.09/221.30  |- skos__broader mesh__D009589smesh__D017672
% 221.09/221.30  |- skos__broader mesh__D009589smesh__D010087
% 221.09/221.30  |- mesh__dateCreated mesh__D009589 1999-01-01
% 221.09/221.30  |- skos__historyNote mesh__D009589 Nitrogen %28%1966-1970%29%
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D009589 2000
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D009589 1997
% 221.09/221.30  |- mesh__recordMaintainer mesh__D009589 ags
% 221.09/221.30  |- mesh__dateEstablished mesh__D009589 1973-01-01
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D009589 2004
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D009589 2001
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D009589 1998
% 221.09/221.30  |- skos__broader mesh__D009589smesh__D005740
% 221.09/221.30  |- mesh__publicMeSHNote mesh__D009589 73   
% 221.09/221.30  |- rdf__type mesh__D009589sskos__Concept
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D009589 2005
% 221.09/221.30  |- skos__annotation mesh__D009589
% 221.09/221.30       GEN or unspecified; prefer specifics; NO = NITRIC OXIDE; N2O = NITROUS OXIDE; NO2 = NITROGEN DIOXIDE%A%  
% 221.09/221.30  |- mesh__dateRevised mesh__D009589 2005-07-21
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D009589 2002
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D009589 1999
% 221.09/221.30  |- skos__scopeNote mesh__D009589
% 221.09/221.30       Inorganic oxides that contain nitrogen.     
% 221.09/221.30  |- skos__historyNote mesh__D009589 Oxides %28%1966-1970%29%
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D009589 2006
% 221.09/221.30  |- skos__historyNote mesh__D009589 Peroxides %28%1966-1970%29%
% 221.09/221.30  |- skos__hiddenLabel mesh__D009589 Oxides, Nitrogen
% 221.09/221.30  |- mesh__recordAuthorizer mesh__D009589 ags
% 221.09/221.30  |- mesh__recordOriginator mesh__D009589 NLM
% 221.09/221.30  |- mesh__recordAuthorizer mesh__D028743 sjn
% 221.09/221.30  |- skos__historyNote mesh__D028743 Malpractice %28%1974-2001%29%
% 221.09/221.30  |- mesh__dateCreated mesh__D028743 2001-07-25
% 221.09/221.30  |- mesh__recordOriginator mesh__D028743 tjk
% 221.09/221.30  |- skos__broader mesh__D028743smesh__D004989
% 221.09/221.30  |- skos__related mesh__D028743smesh__D005607
% 221.09/221.30  |- skos__scopeNote mesh__D028743
% 221.09/221.30       Violation of laws, regulations, or professional standards.%A%    
% 221.09/221.30  |- skos__annotation mesh__D028743
% 221.09/221.30       coord IM with profession %28%IM%29%; SCIENTIFIC MISCONDUCT is also available%A%  
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D028743 2003
% 221.09/221.30  |- skos__related mesh__D028743smesh__D028661
% 221.09/221.30  |- skos__related mesh__D028743smesh__D008192
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D028743 2005
% 221.09/221.30  |- skos__prefLabel mesh__D028743 Professional Misconduct
% 221.09/221.30  |- mesh__recordMaintainer mesh__D028743 hjn
% 221.09/221.30  |- mesh__historyNote mesh__D028743 2002   
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D028743 2004
% 221.09/221.30  |- skos__related mesh__D028743smesh__D004995
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D028743 2006
% 221.09/221.30  |- mesh__publicMeSHNote mesh__D028743 2002   
% 221.09/221.30  |- mesh__dateRevised mesh__D028743 2002-07-03
% 221.09/221.30  |- skos__related mesh__D028743smesh__D035481
% 221.09/221.30  |- skos__related mesh__D028743smesh__D008318
% 221.09/221.30  |- skos__related mesh__D028743smesh__D016265
% 221.09/221.30  |- skos__altLabel mesh__D028743 Misconduct, Professional
% 221.09/221.30  |- mesh__dateEstablished mesh__D028743 2002-01-01
% 221.09/221.30  |- skos__broader mesh__D028743smesh__D012919
% 221.09/221.30  |- rdf__type mesh__D028743sskos__Concept
% 221.09/221.30  |- skos__historyNote mesh__D020760
% 221.09/221.30       Spinal Cord/blood supply %28%1966-1999%29%
% 221.09/221.30  |- skos__broader mesh__D020760smesh__D007511
% 221.09/221.30  |- skos__altLabel mesh__D020760 Spinal Cord Ischemia, Experimental
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D020760 2006
% 221.09/221.30  |- mesh__dateEstablished mesh__D020760 2000-01-01
% 221.09/221.30  |- skos__hiddenLabel mesh__D020760 Cord Ischemia, Spinal
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D020760 2003
% 221.09/221.30  |- skos__hiddenLabel mesh__D020760 Ischemias, Spinal Cord
% 221.09/221.30  |- rdf__type mesh__D020760sskos__Concept
% 221.09/221.30  |- skos__broader mesh__D020760smesh__D020758
% 221.09/221.30  |- skos__hiddenLabel mesh__D020760 Myelopathy, Ischemic
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D020760 2004
% 221.09/221.30  |- skos__scopeNote mesh__D020760
% 221.09/221.30       Reduced blood flow to the spinal cord which is supplied by the anterior spinal artery and the paired posterior spinal arteries. This condition may be associated with ARTERIOSCLEROSIS, trauma, emboli, diseases of the aorta, and other disorders. Prolonged ischemia may lead to INFARCTION of spinal cord tissue.%A%    
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D020760 2000
% 221.09/221.30  |- mesh__publicMeSHNote mesh__D020760 2000   
% 221.09/221.30  |- skos__prefLabel mesh__D020760 Spinal Cord Ischemia
% 221.09/221.30  |- mesh__historyNote mesh__D020760 2000   
% 221.09/221.30  |- skos__historyNote mesh__D020760 Spinal Cord Diseases %28%1966-1999%29%
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D020760 2001
% 221.09/221.30  |- skos__related mesh__D020760smesh__D020210
% 221.09/221.30  |- skos__historyNote mesh__D020760 Ischemia %28%1966-1999%29%
% 221.09/221.30  |- skos__hiddenLabel mesh__D020760 Spinal Cord Ischemias
% 221.09/221.30  |- skos__hiddenLabel mesh__D020760 Cord Ischemias, Spinal
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D020760 2002
% 221.09/221.30  |- skos__altLabel mesh__D020760 Ischemic Myelopathy
% 221.09/221.30  |- skos__hiddenLabel mesh__D020760 Ischemia, Spinal Cord
% 221.09/221.30  |- skos__hiddenLabel mesh__D020760 Ischemic Myelopathies
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D020760 2005
% 221.09/221.30  |- mesh__dateCreated mesh__D020760 1999-11-03
% 221.09/221.30  |- skos__hiddenLabel mesh__D020760 Myelopathies, Ischemic
% 221.09/221.30  |- skos__broader mesh__D006291smesh__D011640
% 221.09/221.30  |- mesh__recordAuthorizer mesh__D006291 sjn
% 221.09/221.30  |- skos__hiddenLabel mesh__D006291 Health Policy, National
% 221.09/221.30  |- skos__hiddenLabel mesh__D006291 National Health Policies
% 221.09/221.30  |- skos__hiddenLabel mesh__D006291 Policy, Health
% 221.09/221.30  |- skos__annotation mesh__D006291
% 221.09/221.30       specify state or country or other body if pertinent   
% 221.09/221.30  |- rdf__type mesh__D006291sskos__Concept
% 221.09/221.30  |- mesh__recordMaintainer mesh__D006291 kle
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D006291 2002
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D006291 2003
% 221.09/221.30  |- mesh__dateRevised mesh__D006291 1999-11-03
% 221.09/221.30  |- skos__scopeNote mesh__D006291
% 221.09/221.30       Decisions, usually developed by government policymakers, for determining present and future objectives pertaining to the health care system.%A%    
% 221.09/221.30  |- skos__hiddenLabel mesh__D006291 Policies, National Health
% 221.09/221.30  |- mesh__publicMeSHNote mesh__D006291 80   
% 221.09/221.30  |- skos__hiddenLabel mesh__D006291 Health Policies
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D006291 2005
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D006291 2004
% 221.09/221.30  |- skos__historyNote mesh__D006291
% 221.09/221.30       National Health Programs %28%1977-1979%29%
% 221.09/221.30  |- skos__prefLabel mesh__D006291 Health Policy
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D006291 2000
% 221.09/221.30  |- skos__historyNote mesh__D006291 Public Policy %28%1978-1979%29%
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D006291 2006
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D006291 2001
% 221.09/221.30  |- mesh__dateCreated mesh__D006291 1979-06-01
% 221.09/221.30  |- mesh__dateEstablished mesh__D006291 1980-01-01
% 221.09/221.30  |- mesh__recordOriginator mesh__D006291 EC
% 221.09/221.30  |- skos__hiddenLabel mesh__D006291 Health Policies, National
% 221.09/221.30  |- skos__hiddenLabel mesh__D006291 Policies, Health
% 221.09/221.30  |- mesh__historyNote mesh__D006291 80   
% 221.09/221.30  |- skos__hiddenLabel mesh__D006291 Policy, National Health
% 221.09/221.30  |- skos__historyNote mesh__D014723 Vestibular Apparatus %28%1966-1978%29%
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D014723 2006
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D014723 1993
% 221.09/221.30  |- mesh__recordOriginator mesh__D014723 RC
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D014723 1998
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D014723 2001
% 221.09/221.30  |- mesh__dateRevised mesh__D014723 1990-04-13
% 221.09/221.30  |- skos__broader mesh__D014723smesh__D014722
% 221.09/221.30  |- skos__hiddenLabel mesh__D014723 Aqueducts, Vestibular
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D014723 2005
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D014723 1997
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D014723 1992
% 221.09/221.30  |- mesh__recordAuthorizer mesh__D014723 PLS
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D014723 2000
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D014723 2004
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D014723 1996
% 221.09/221.30  |- skos__hiddenLabel mesh__D014723 Aqueduct, Vestibular
% 221.09/221.30  |- rdf__type mesh__D014723sskos__Concept
% 221.09/221.30  |- skos__hiddenLabel mesh__D014723 Vestibular Aqueducts
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D014723 2003
% 221.09/221.30  |- skos__prefLabel mesh__D014723 Vestibular Aqueduct
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D014723 1991
% 221.09/221.30  |- mesh__dateEstablished mesh__D014723 1991-01-01
% 221.09/221.30  |- mesh__publicMeSHNote mesh__D014723
% 221.09/221.30       91; was see under VESTIBULE 1990-90; was see under VESTIBULAR APPARATUS 1979-89%A%  
% 221.09/221.30  |- mesh__dateCreated mesh__D014723 1978-05-19
% 221.09/221.30  |- mesh__recordMaintainer mesh__D014723 NLM
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D014723 1995
% 221.09/221.30  |- mesh__historyNote mesh__D014723
% 221.09/221.30       91%28%79%29%; was see under VESTIBULE 1990-90; was see under VESTIBULAR APPARATUS 1979-89%A%  
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D014723 1999
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D014723 2002
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D014723 1994
% 221.09/221.30  |- skos__scopeNote mesh__D014723
% 221.09/221.30       A small bony canal linking the vestibule of the inner ear to the posterior part of the internal surface of the petrous temporal bone. It surrounds the endolymphatic duct.%A%    
% 221.09/221.30  |- mesh__recordOriginator mesh__D000703 NLM
% 221.09/221.30  |- skos__scopeNote mesh__D000703
% 221.09/221.30       The process of converting analog data such as continually measured voltage to discrete, digital form.%A%    
% 221.09/221.30  |- skos__hiddenLabel mesh__D000703 Analog-Digital Conversions
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D000703 2005
% 221.09/221.30  |- mesh__publicMeSHNote mesh__D000703 73   
% 221.09/221.30  |- skos__hiddenLabel mesh__D000703 Analogue-Digital Conversions
% 221.09/221.30  |- skos__hiddenLabel mesh__D000703 Conversion, Analogue-Digital
% 221.09/221.30  |- mesh__dateRevised mesh__D000703 2004-07-07
% 221.09/221.30  |- skos__hiddenLabel mesh__D000703 Analog Digital Conversion
% 221.09/221.30  |- skos__altLabel mesh__D000703 Analogue-Digital Conversion
% 221.09/221.30  |- skos__hiddenLabel mesh__D000703 Conversion, Analog-Digital
% 221.09/221.30  |- mesh__recordMaintainer mesh__D000703 jls
% 221.09/221.30  |- skos__broader mesh__D000703smesh__D003203
% 221.09/221.30  |- mesh__dateEstablished mesh__D000703 1973-01-01
% 221.09/221.30  |- skos__annotation mesh__D000703 no qualif   
% 221.09/221.30  |- rdf__type mesh__D000703sskos__Concept
% 221.09/221.30  |- mesh__recordAuthorizer mesh__D000703 sjn
% 221.09/221.30  |- skos__hiddenLabel mesh__D000703 Conversions, Analogue-Digital
% 221.09/221.30  |- mesh__historyNote mesh__D000703 73%28%64%29%   
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D000703 2006
% 221.09/221.30  |- mesh__dateCreated mesh__D000703 1999-01-01
% 221.09/221.30  |- skos__prefLabel mesh__D000703 Analog-Digital Conversion
% 221.09/221.30  |- skos__hiddenLabel mesh__D000703 Analogue Digital Conversion
% 221.09/221.30  |- skos__hiddenLabel mesh__D000703 Conversions, Analog-Digital
% 221.09/221.30  |- skos__broader mesh__D005997smesh__D020404
% 221.09/221.30  |- mesh__publicMeSHNote mesh__D005997 73   
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D005997 2005
% 221.09/221.30  |- skos__scopeNote mesh__D005997
% 221.09/221.30       A component of PHOSPHATIDYLCHOLINES %28%lecithins%29%, in which the two hydroxy groups of GLYCEROL are esterified with fatty acids. %28%From Stedman, 26th ed%29% It counteracts the effects of urea on enzymes and other macromolecules.%A%    
% 221.09/221.30  |- skos__altLabel mesh__D005997 L-alpha-Glycerylphosphorylcholine
% 221.09/221.30  |- mesh__recordAuthorizer mesh__D005997 sjn
% 221.09/221.30  |- mesh__dateEstablished mesh__D005997 1973-01-01
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D005997 2006
% 221.09/221.30  |- skos__prefLabel mesh__D005997 Glycerylphosphorylcholine
% 221.09/221.30  |- skos__altLabel mesh__D005997 Glycerol 3-Phosphocholine
% 221.09/221.30  |- mesh__dateRevised mesh__D005997 2004-07-07
% 221.09/221.30  |- skos__broader mesh__D005997smesh__D005994
% 221.09/221.30  |- skos__hiddenLabel mesh__D005997 Alfoscerate, Choline
% 221.09/221.30  |- skos__hiddenLabel mesh__D005997 3-Phosphocholine, Glycerol
% 221.09/221.30  |- skos__altLabel mesh__D005997 Choline Glycerophosphate
% 221.09/221.30  |- mesh__dateCreated mesh__D005997 1999-01-01
% 221.09/221.30  |- skos__altLabel mesh__D005997 Choline Alfoscerate
% 221.09/221.30  |- mesh__recordOriginator mesh__D005997 NLM
% 221.09/221.30  |- rdf__type mesh__D005997sskos__Concept
% 221.09/221.30  |- mesh__recordMaintainer mesh__D005997 ssb
% 221.09/221.30  |- skos__hiddenLabel mesh__D005997 Glycerophosphate, Choline
% 221.09/221.30  |- skos__altLabel mesh__D005997 Glycerophosphorylcholine
% 221.09/221.30  |- skos__altLabel mesh__D005997 Choline Alphoscerate
% 221.09/221.30  |- skos__hiddenLabel mesh__D005997 L alpha Glycerylphosphorylcholine
% 221.09/221.30  |- skos__hiddenLabel mesh__D005997 Alphoscerate, Choline
% 221.09/221.30  |- skos__hiddenLabel mesh__D005997 Glycerol 3 Phosphocholine
% 221.09/221.30  |- mesh__historyNote mesh__D005997 73%28%64%29%   
% 221.09/221.30  |- skos__annotation mesh__D005199
% 221.09/221.30       do not confuse with FANCONI SYNDROME, a dysfunction of proximal renal tubules%A%  
% 221.09/221.30  |- skos__scopeNote mesh__D005199
% 221.09/221.30       Congenital disorder affecting all bone marrow elements, resulting in ANEMIA; LEUKOPENIA; and THROMBOPENIA, and associated with cardiac, renal, and limb malformations as well as dermal pigmentary changes. Spontaneous CHROMOSOME BREAKAGE is a feature of this disease along with predisposition to LEUKEMIA. There are at least 7 complementation groups in Fanconi anemia: FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, and FANCL. %28%from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=227650, August 20, 2004%29%%A%    
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D005199 2006
% 221.09/221.30  |- mesh__historyNote mesh__D005199
% 221.09/221.30       2002%28%1975%29%; was see under ANEMIA, APLASTIC 1975-1990   
% 221.09/221.30  |- skos__hiddenLabel mesh__D005199 Anemias, Fanconi
% 221.09/221.30  |- skos__prefLabel mesh__D005199 Fanconi Anemia
% 221.09/221.30  |- skos__altLabel mesh__D005199 Anemia, Fanconi
% 221.09/221.30  |- skos__broader mesh__D005199smesh__D049914
% 221.09/221.30  |- mesh__recordOriginator mesh__D005199 NLM
% 221.09/221.30  |- mesh__dateEstablished mesh__D005199 1991-01-01
% 221.09/221.30  |- mesh__recordAuthorizer mesh__D005199 sjn
% 221.09/221.30  |- mesh__dateRevised mesh__D005199 2005-06-30
% 221.09/221.30  |- skos__broader mesh__D005199smesh__D029502
% 221.09/221.30  |- rdf__type mesh__D005199sskos__Concept
% 221.09/221.30  |- mesh__dateCreated mesh__D005199 1974-11-11
% 221.09/221.30  |- skos__hiddenLabel mesh__D005199 Anemia, Fanconi%27%s
% 221.09/221.30  |- mesh__publicMeSHNote mesh__D005199
% 221.09/221.30       2002; see FANCONI%27%S ANEMIA 1991-2001; was see under ANEMIA, APLASTIC 1975-1990%A%  
% 221.09/221.30  |- skos__hiddenLabel mesh__D005199 Fanconi Anemias
% 221.09/221.30  |- skos__altLabel mesh__D005199 Fanconi%27%s Anemia
% 221.09/221.30  |- mesh__recordMaintainer mesh__D005199 nns
% 221.09/221.30  |- skos__hiddenLabel mesh__D018316 Sarcomatous Gliomas
% 221.09/221.30  |- skos__prefLabel mesh__D018316 Gliosarcoma
% 221.09/221.30  |- skos__scopeNote mesh__D018316
% 221.09/221.30       Rare mixed tumors of the brain and rarely the spinal cord which contain malignant neuroectodermal %28%glial%29% and mesenchymal components, including spindle-shaped fibrosarcoma cells. These tumors are highly aggressive and present primarily in adults as rapidly expanding mass lesions. They may arise in tissue that has been previously irradiated. %28%From Br J Neurosurg 1995 Apr;9%28%2%29%:171-8%29%%A%    
% 221.09/221.30  |- skos__hiddenLabel mesh__D018316 Glioma, Sarcomatous
% 221.09/221.30  |- mesh__recordAuthorizer mesh__D018316 sjn
% 221.09/221.30  |- mesh__recordOriginator mesh__D018316 PLS
% 221.09/221.30  |- skos__altLabel mesh__D018316 Sarcomatous Glioma
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D018316 2005
% 221.09/221.30  |- skos__hiddenLabel mesh__D018316 Gliosarcomas
% 221.09/221.30  |- skos__annotation mesh__D018316
% 221.09/221.30       coord IM with precoord brain/neopl term %28%IM%29% + site %28%IM%29%   
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D018316 2000
% 221.09/221.30  |- mesh__dateCreated mesh__D018316 1993-06-25
% 221.09/221.30  |- mesh__historyNote mesh__D018316 94   
% 221.09/221.30  |- mesh__publicMeSHNote mesh__D018316 94   
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D018316 2006
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D018316 2003
% 221.09/221.30  |- skos__historyNote mesh__D018316 Glioma %28%1967-1993%29%
% 221.09/221.30  |- skos__altLabel mesh__D018316 Glioblastoma with Sarcomatous Component
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D018316 2001
% 221.09/221.30  |- mesh__recordMaintainer mesh__D018316 jls
% 221.09/221.30  |- skos__hiddenLabel mesh__D018316 Gliomas, Sarcomatous
% 221.09/221.30  |- mesh__dateEstablished mesh__D018316 1994-01-01
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D018316 2004
% 221.09/221.30  |- rdf__type mesh__D018316sskos__Concept
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D018316 2002
% 221.09/221.30  |- mesh__dateRevised mesh__D018316 1999-11-08
% 221.09/221.30  |- skos__broader mesh__D018316smesh__D005910
% 221.09/221.30  |- skos__annotation mesh__D010333 human %26% animal   
% 221.09/221.30  |- skos__hiddenLabel mesh__D010333 Deprivations, Paternal
% 221.09/221.30  |- mesh__dateRevised mesh__D010333 1992-05-15
% 221.09/221.30  |- skos__hiddenLabel mesh__D010333 Deprivation, Paternal
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010333 2005
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010333 2001
% 221.09/221.30  |- mesh__dateCreated mesh__D010333 1999-01-01
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010333 1994
% 221.09/221.30  |- skos__scopeNote mesh__D010333
% 221.09/221.30       Prolonged separation of the offspring from the father.     
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010333 2006
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010333 1998
% 221.09/221.30  |- mesh__dateEstablished mesh__D010333 1969-01-01
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010333 1995
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010333 2003
% 221.09/221.30  |- mesh__recordAuthorizer mesh__D010333 PLS
% 221.09/221.30  |- mesh__recordMaintainer mesh__D010333 TAP
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010333 1999
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010333 2002
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010333 2004
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010333 1996
% 221.09/221.30  |- rdf__type mesh__D010333sskos__Concept
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010333 1993
% 221.09/221.30  |- mesh__recordOriginator mesh__D010333 NLM
% 221.09/221.30  |- mesh__publicMeSHNote mesh__D010333 69   
% 221.09/221.30  |- skos__prefLabel mesh__D010333 Paternal Deprivation
% 221.09/221.30  |- skos__hiddenLabel mesh__D010333 Paternal Deprivations
% 221.09/221.30  |- skos__broader mesh__D010333smesh__D005195
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010333 1997
% 221.09/221.30  |- mesh__historyNote mesh__D010333 69   
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D010333 2000
% 221.09/221.30  |- skos__altLabel mesh__D034781 N-Acetylglucosamine Receptors
% 221.09/221.30  |- skos__hiddenLabel mesh__D034781 N Acetylglucosamine Receptors
% 221.09/221.30  |- skos__altLabel mesh__D034781 N-Acetylglucosamine Receptor
% 221.09/221.30  |- skos__hiddenLabel mesh__D034781 N Acetylglucosamine Specific Lectin
% 221.09/221.30  |- skos__altLabel mesh__D034781 GlcNAc Specific Lectin
% 221.09/221.30  |- mesh__publicMeSHNote mesh__D034781
% 221.09/221.30       2003; N-ACETYLGLUCOSAMIN RECEPTORS was indexed under RECEPTORS, IMMUNOLOGIC %26% RECEPTORS, THRYOID HORMONE 1988-2002%A%  
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D034781 2006
% 221.09/221.30  |- skos__historyNote mesh__D034781
% 221.09/221.30       Receptors, Thyroid Hormone %28%1988-2002%29%
% 221.09/221.30  |- skos__hiddenLabel mesh__D034781 N Acetylglucosamine Receptor
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D034781 2006A
% 221.09/221.30  |- skos__hiddenLabel mesh__D034781 Lectin, GlcNAc Specific
% 221.09/221.30  |- skos__scopeNote mesh__D034781
% 221.09/221.30       Cell surface receptors that bind to ACETYLGLUCOSAMINE.     
% 221.09/221.30  |- mesh__recordMaintainer mesh__D034781 ags
% 221.09/221.30  |- skos__historyNote mesh__D034781 Receptors, Immunologic %28%1988-2002%29%
% 221.09/221.30  |- mesh__historyNote mesh__D034781
% 221.09/221.30       2003; use RECEPTORS, N-ACETYLGLUCOSAMINE %28%NM%29% 1988-2002   
% 221.09/221.30  |- skos__altLabel mesh__D034781 Receptor, N-Acetylglucosamine
% 221.09/221.30  |- skos__altLabel mesh__D034781 N-Acetylglucosamine Specific Lectin
% 221.09/221.30  |- rdf__type mesh__D034781sskos__Concept
% 221.09/221.30  |- skos__hiddenLabel mesh__D034781 Lectin, N-Acetylglucosamine Specific
% 221.09/221.30  |- mesh__recordAuthorizer mesh__D034781 ags
% 221.09/221.30  |- skos__broader mesh__D034781smesh__D037102
% 221.09/221.30  |- skos__prefLabel mesh__D034781 Receptors, N-Acetylglucosamine
% 221.09/221.30  |- mesh__recordOriginator mesh__D034781 jmp
% 221.09/221.30  |- skos__hiddenLabel mesh__D034781 Receptors, N Acetylglucosamine
% 221.09/221.30  |- mesh__dateRevised mesh__D034781 2005-07-21
% 221.09/221.30  |- mesh__dateCreated mesh__D034781 2002-07-03
% 221.09/221.30  |- skos__broader mesh__D034781smesh__D011956
% 221.09/221.30  |- mesh__dateEstablished mesh__D034781 2003-01-01
% 221.09/221.30  |- skos__historyNote mesh__D028744
% 221.09/221.30       Professional Staff Committees %28%1981-2001%29%
% 221.09/221.30  |- mesh__recordOriginator mesh__D028744 jrf
% 221.09/221.30  |- skos__scopeNote mesh__D028744
% 221.09/221.30       Hospital or other institutional committees established to protect the welfare of research subjects.  Federal regulations %28%the %22%Common Rule%22% %28%45 CFR 46%29%%29% mandate the use of these committees to monitor federally-funded biomedical and behavioral research involving human subjects.%A%    
% 221.09/221.30  |- mesh__recordMaintainer mesh__D028744 sjn
% 221.09/221.30  |- skos__altLabel mesh__D028744 Research Ethics Committee
% 221.09/221.30  |- skos__altLabel mesh__D028744 Institutional Review Board
% 221.09/221.30  |- skos__altLabel mesh__D028744 IRB
% 221.09/221.30  |- mesh__recordAuthorizer mesh__D028744 sjn
% 221.09/221.30  |- skos__hiddenLabel mesh__D028744 Committee, Research Ethics
% 221.09/221.30  |- skos__altLabel mesh__D028744 Institutional Review Boards
% 221.09/221.30  |- mesh__dateCreated mesh__D028744 2001-07-25
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D028744 2005
% 221.09/221.30  |- skos__altLabel mesh__D028744 Review Boards, Institutional
% 221.09/221.30  |- skos__altLabel mesh__D028744 Research Ethics Committees
% 221.09/221.30  |- skos__prefLabel mesh__D028744 Ethics Committees, Research
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D028744 2006
% 221.09/221.30  |- skos__annotation mesh__D028744 coord with geographic term   
% 221.09/221.30  |- mesh__historyNote mesh__D028744
% 221.09/221.30       2002; for INSTITUTIONAL REVIEW BOARD use PROFESSIONAL STAFF COMMITTEES 1982-2001%A%  
% 221.09/221.30  |- skos__broader mesh__D028744smesh__D017041
% 221.09/221.30  |- mesh__publicMeSHNote mesh__D028744
% 221.09/221.30       2002; for INSTITUTIONAL REVIEW BOARD see PROFESSIONAL STAFF COMMITTEES 1982-2001%A%  
% 221.09/221.30  |- skos__altLabel mesh__D028744 Ethics Committee, Research
% 221.09/221.30  |- mesh__dateEstablished mesh__D028744 2002-01-01
% 221.09/221.30  |- rdf__type mesh__D028744sskos__Concept
% 221.09/221.30  |- skos__altLabel mesh__D028744 Review Board, Institutional
% 221.09/221.30  |- skos__hiddenLabel mesh__D028744 Committees, Research Ethics
% 221.09/221.30  |- skos__historyNote mesh__D028744 Ethics Committees %28%1979-2001%29%
% 221.09/221.30  |- mesh__dateRevised mesh__D028744 2004-07-13
% 221.09/221.30  |- skos__related mesh__D028744smesh__D026661
% 221.09/221.30  |- skos__altLabel mesh__D028744 IRBs
% 221.09/221.30  |- skos__altLabel mesh__D028744 Boards, Institutional Review
% 221.09/221.30  |- skos__altLabel mesh__D028744 Board, Institutional Review
% 221.09/221.30  |- rdf__type mesh__D020761sskos__Concept
% 221.09/221.30  |- mesh__dateEstablished mesh__D020761 2000-01-01
% 221.09/221.30  |- skos__hiddenLabel mesh__D020761 GTP-Binding Proteins, rab1
% 221.09/221.30  |- mesh__publicMeSHNote mesh__D020761
% 221.09/221.30       2000; RAB1A PROTEIN was indexed under G-PROTEINS 1992-1999%A%  
% 221.09/221.30  |- skos__altLabel mesh__D020761 rab1A Protein
% 221.09/221.30  |- mesh__recordOriginator mesh__D020761 jmp
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D020761 2006
% 221.09/221.30  |- skos__broader mesh__D020761smesh__D020691
% 221.09/221.30  |- mesh__dateCreated mesh__D020761 1999-11-05
% 221.09/221.30  |- mesh__recordAuthorizer mesh__D020761 sjn
% 221.09/221.30  |- skos__altLabel mesh__D020761 rab1 GTP-Binding Protein
% 221.09/221.30  |- skos__historyNote mesh__D020761 G-Proteins %28%1990-1999%29%
% 221.09/221.30  |- skos__annotation mesh__D020761 DF: RAB1 PROTEIN   
% 221.09/221.30  |- skos__hiddenLabel mesh__D020761 rab1 GTP Binding Protein
% 221.09/221.30  |- skos__scopeNote mesh__D020761
% 221.09/221.30       A genetically related subfamily of RAB GTP-BINDING PROTEINS involved in vesicle transport between the ENDOPLASMIC RETICULUM and the GOLGI APPARATUS and through early Golgi compartments. This enzyme was formerly listed as EC 3.6.1.47.%A%    
% 221.09/221.30  |- skos__altLabel mesh__D020761 rab1 Protein
% 221.09/221.30  |- mesh__dateRevised mesh__D020761 2005-06-30
% 221.09/221.30  |- skos__hiddenLabel mesh__D020761 rab1A GTP Binding Protein
% 221.09/221.30  |- mesh__recordMaintainer mesh__D020761 jmp
% 221.09/221.30  |- skos__hiddenLabel mesh__D020761 rab1 GTP Binding Proteins
% 221.09/221.30  |- skos__hiddenLabel mesh__D020761 GTP-Binding Protein, rab1
% 221.09/221.30  |- skos__prefLabel mesh__D020761 rab1 GTP-Binding Proteins
% 221.09/221.30  |- skos__hiddenLabel mesh__D020761 GTP-Binding Protein, rab1A
% 221.09/221.30  |- mesh__historyNote mesh__D020761
% 221.09/221.30       2000; for RAB1A PROTEIN use RAB1 GTP-BINDING PROTEINS %28%NM%29% 1992-1999%A%  
% 221.09/221.30  |- mesh__activeMeSHYear mesh__D006292 2002
% 221.09/221.30  |- mesh__recordAuthorizer mesh__D006292 NLM
% 221.09/221.30  |- skos__broader mesh__D006292smesh__D006285
% 221.09/221.30  |- mesh__publicMeSHNote mesh__D006292
% 221.09/221.30       91; was see under HEALTH PLANNING 1980-90   
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D006292 2005
% 221.09/221.31  |- skos__broader mesh__D006292smesh__D003695
% 221.09/221.31  |- mesh__dateCreated mesh__D006292 1979-06-01
% 221.09/221.31  |- skos__hiddenLabel mesh__D006292 Health Priority
% 221.09/221.31  |- mesh__historyNote mesh__D006292
% 221.09/221.31       91%28%80%29%; was see under HEALTH PLANNING 1980-90   
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D006292 1997
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D006292 2001
% 221.09/221.31  |- rdf__type mesh__D006292sskos__Concept
% 221.09/221.31  |- skos__scopeNote mesh__D006292
% 221.09/221.31       Preferentially rated health-related activities or functions to be used in establishing health planning goals. This may refer specifically to PL93-641.%A%    
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D006292 2004
% 221.09/221.31  |- mesh__dateEstablished mesh__D006292 1991-01-01
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D006292 1996
% 221.09/221.31  |- mesh__dateRevised mesh__D006292 1993-09-16
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D006292 2000
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D006292 2003
% 221.09/221.31  |- skos__hiddenLabel mesh__D006292 Priority, Health
% 221.09/221.31  |- mesh__recordOriginator mesh__D006292 EC
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D006292 1999
% 221.09/221.31  |- mesh__recordMaintainer mesh__D006292 PLS
% 221.09/221.31  |- skos__altLabel mesh__D006292 Priorities, Health
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D006292 2006
% 221.09/221.31  |- skos__prefLabel mesh__D006292 Health Priorities
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D006292 1995
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D006292 1998
% 221.09/221.31  |- skos__hiddenLabel mesh__D014724 Function Test, Vestibular
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D014724 2005
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D014724 2002
% 221.09/221.31  |- skos__hiddenLabel mesh__D014724 Tests, Vestibular Function
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D014724 2004
% 221.09/221.31  |- skos__hiddenLabel mesh__D014724 Vestibular Function Test
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D014724 2001
% 221.09/221.31  |- mesh__recordMaintainer mesh__D014724 PXP
% 221.09/221.31  |- rdf__type mesh__D014724sskos__Concept
% 221.09/221.31  |- skos__hiddenLabel mesh__D014724 Function Tests, Vestibular
% 221.09/221.31  |- mesh__dateCreated mesh__D014724 1999-01-01
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D014724 2003
% 221.09/221.31  |- skos__prefLabel mesh__D014724 Vestibular Function Tests
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D014724 2000
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D014724 1999
% 221.09/221.31  |- skos__broader mesh__D014724smesh__D003939
% 221.09/221.31  |- mesh__recordOriginator mesh__D014724 NLM
% 221.09/221.31  |- skos__hiddenLabel mesh__D014724 Test, Vestibular Function
% 221.09/221.31  |- mesh__recordAuthorizer mesh__D014724 SJN
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D014724 2006
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D014724 1998
% 221.09/221.31  |- mesh__dateRevised mesh__D014724 1997-06-20
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D000704 2001
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D000704 1999
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D000704 2000
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D000704 1996
% 221.09/221.31  |- mesh__recordAuthorizer mesh__D000704 PLS
% 221.09/221.31  |- rdf__type mesh__D000704sskos__Concept
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D000704 2004
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D000704 1998
% 221.09/221.31  |- skos__annotation mesh__D000704
% 221.09/221.31       IM GEN only; coord NIM with specific disease or other concept %28%IM%29%; no qualif%A%  
% 221.09/221.31  |- skos__altLabel mesh__D000704 Variance Analysis
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D000704 2006
% 221.09/221.31  |- mesh__recordOriginator mesh__D000704 NLM
% 221.09/221.31  |- mesh__dateRevised mesh__D000704 1994-04-11
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D000704 1995
% 221.09/221.31  |- mesh__dateCreated mesh__D000704 1999-01-01
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D000704 2003
% 221.09/221.31  |- skos__altLabel mesh__D000704 ANOVA
% 221.09/221.31  |- skos__scopeNote mesh__D000704
% 221.09/221.31       A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable.%A%    
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D000704 2005
% 221.09/221.31  |- mesh__publicMeSHNote mesh__D000704 74   
% 221.09/221.31  |- mesh__recordMaintainer mesh__D000704 TGC
% 221.09/221.31  |- skos__hiddenLabel mesh__D000704 Analyses, Variance
% 221.09/221.31  |- skos__historyNote mesh__D000704 Statistics %28%1966-1967%29%
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D000704 2002
% 221.09/221.31  |- mesh__historyNote mesh__D000704 74%28%68%29%   
% 221.09/221.31  |- skos__prefLabel mesh__D000704 Analysis of Variance
% 221.09/221.31  |- skos__broader mesh__D000704smesh__D013223
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D000704 1997
% 221.09/221.31  |- skos__hiddenLabel mesh__D000704 Variance Analyses
% 221.09/221.31  |- mesh__dateEstablished mesh__D000704 1974-01-01
% 221.09/221.31  |- skos__altLabel mesh__D000704 Analysis, Variance
% 221.09/221.31  |- skos__hiddenLabel mesh__D005998 Phosphate, Glycine
% 221.09/221.31  |- skos__related mesh__D005998smesh__D018009
% 221.09/221.31  |- mesh__dateRevised mesh__D005998 2005-06-30
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D005998 2006
% 221.09/221.31  |- skos__prefLabel mesh__D005998 Glycine
% 221.09/221.31  |- skos__hiddenLabel mesh__D005998 Monosodium Salt Glycine
% 221.09/221.31  |- skos__altLabel mesh__D005998 Aminoacetic Acid
% 221.09/221.31  |- mesh__dateCreated mesh__D005998 1999-01-01
% 221.09/221.31  |- mesh__recordAuthorizer mesh__D005998 sjn
% 221.09/221.31  |- rdf__type mesh__D005998sskos__Concept
% 221.09/221.31  |- skos__hiddenLabel mesh__D005998 Acid, Aminoacetic
% 221.09/221.31  |- skos__hiddenLabel mesh__D005998 Salt Glycine, Monosodium
% 221.09/221.31  |- skos__scopeNote mesh__D005998
% 221.09/221.31       A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter.%A%    
% 221.09/221.31  |- skos__hiddenLabel mesh__D005998 Calcium Salt Glycine
% 221.09/221.31  |- skos__hiddenLabel mesh__D005998 Cobalt Salt Glycine
% 221.09/221.31  |- skos__hiddenLabel mesh__D005998 Monoammonium Salt Glycine
% 221.09/221.31  |- skos__hiddenLabel mesh__D005998 Copper Salt Glycine
% 221.09/221.31  |- skos__hiddenLabel mesh__D005998 Monopotasssium Salt Glycine
% 221.09/221.31  |- mesh__recordOriginator mesh__D005998 NLM
% 221.09/221.31  |- skos__hiddenLabel mesh__D005998 Hydrochloride, Glycine
% 221.09/221.31  |- skos__broader mesh__D005998smesh__D000596
% 221.09/221.31  |- mesh__recordMaintainer mesh__D005998 ssb
% 221.09/221.31  |- skos__hiddenLabel mesh__D005998 Salt Glycine, Monoammonium
% 221.09/221.31  |- skos__hiddenLabel mesh__D046008 Bobcat
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D046008 2005
% 221.09/221.31  |- mesh__recordOriginator mesh__D046008 ags
% 221.09/221.31  |- mesh__recordMaintainer mesh__D046008 ags
% 221.09/221.31  |- skos__scopeNote mesh__D046008
% 221.09/221.31       A genus in the family FELIDAE comprising felines with long legs, ear tufts, and a short tail.%A%    
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D046008 2006
% 221.09/221.31  |- mesh__recordAuthorizer mesh__D046008 sjn
% 221.09/221.31  |- mesh__dateCreated mesh__D046008 2004-07-07
% 221.09/221.31  |- skos__broader mesh__D046008smesh__D045989
% 221.09/221.31  |- mesh__dateEstablished mesh__D046008 2005-01-01
% 221.09/221.31  |- rdf__type mesh__D046008sskos__Concept
% 221.09/221.31  |- mesh__historyNote mesh__D046008 2005; use CARNIVORA 1998-2004   
% 221.09/221.31  |- skos__historyNote mesh__D046008 Carnivora %28%1966-2004%29%
% 221.09/221.31  |- mesh__publicMeSHNote mesh__D046008 2005; see CARNIVORA 1998-2004   
% 221.09/221.31  |- skos__prefLabel mesh__D046008 Lynx
% 221.09/221.31  |- skos__scopeNote mesh__D018317
% 221.09/221.31       Neoplasms which arise from nerve sheaths formed by SCHWANN CELLS in the PERIPHERAL NERVOUS SYSTEM or by OLIGODENDROCYTES in the CENTRAL NERVOUS SYSTEM. Malignant peripheral nerve sheath tumors, NEUROFIBROMA, and NEURILEMMOMA are relatively common tumors in this category.%A%    
% 221.09/221.31  |- mesh__dateRevised mesh__D018317 2005-06-30
% 221.09/221.31  |- mesh__recordOriginator mesh__D018317 PLS
% 221.09/221.31  |- skos__altLabel mesh__D018317 Peripheral Nerve Sheath Tumors, Malignant
% 221.09/221.31  |- skos__altLabel mesh__D018317 Nerve Sheath Tumors, Peripheral
% 221.09/221.31  |- skos__altLabel mesh__D018317 Nerve Sheath Tumors
% 221.09/221.31  |- mesh__historyNote mesh__D018317 2006 %28%1994%29%   
% 221.09/221.31  |- skos__hiddenLabel mesh__D018317 Nerve Sheath Neoplasm
% 221.09/221.31  |- skos__altLabel mesh__D018317 Tumors of the Nerve Sheath
% 221.09/221.31  |- mesh__recordAuthorizer mesh__D018317 sjn
% 221.09/221.31  |- skos__altLabel mesh__D018317 Neoplasms, Nerve Sheath
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D018317 2006
% 221.09/221.31  |- mesh__recordMaintainer mesh__D018317 lkt
% 221.09/221.31  |- skos__hiddenLabel mesh__D018317 Perineuriomas
% 221.09/221.31  |- rdf__type mesh__D018317sskos__Concept
% 221.09/221.31  |- skos__hiddenLabel mesh__D018317 Neoplasm, Nerve Sheath
% 221.09/221.31  |- skos__broader mesh__D018317smesh__D010524
% 221.09/221.31  |- mesh__publicMeSHNote mesh__D018317
% 221.09/221.31       2006; see NERVE SHEATH TUMORS 1994-2005   
% 221.09/221.31  |- skos__altLabel mesh__D018317 MPNST
% 221.09/221.31  |- mesh__dateCreated mesh__D018317 1993-06-25
% 221.09/221.31  |- skos__broader mesh__D018317smesh__D009380
% 221.09/221.31  |- skos__prefLabel mesh__D018317 Nerve Sheath Neoplasms
% 221.09/221.31  |- skos__annotation mesh__D018317
% 221.09/221.31       neoplasms composed of myelin sheaths, NOT neoplasms located in myelin sheaths: coordinate IM with precoordinated organ/neoplasm term %28%IM%29%%A%  
% 221.09/221.31  |- skos__hiddenLabel mesh__D018317 MPNSTs
% 221.09/221.31  |- mesh__dateEstablished mesh__D018317 1994-01-01
% 221.09/221.31  |- mesh__dateCreated mesh__D010334 1999-01-01
% 221.09/221.31  |- skos__prefLabel mesh__D010334 Paternity
% 221.09/221.31  |- mesh__dateRevised mesh__D010334 2003-07-09
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D010334 2006
% 221.09/221.31  |- mesh__recordAuthorizer mesh__D010334 sjn
% 221.09/221.31  |- skos__scopeNote mesh__D010334
% 221.09/221.31       Establishing the father relationship of a man and a child.%A%    
% 221.09/221.31  |- mesh__recordMaintainer mesh__D010334 lkt
% 221.09/221.31  |- skos__annotation mesh__D010334 no qualif   
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D010334 2004
% 221.09/221.31  |- rdf__type mesh__D010334sskos__Concept
% 221.09/221.31  |- skos__broader mesh__D010334smesh__D005554
% 221.09/221.31  |- skos__related mesh__D010334smesh__D016172
% 221.09/221.31  |- skos__hiddenLabel mesh__D010334 Paternities
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D010334 2005
% 221.09/221.31  |- mesh__recordOriginator mesh__D010334 NLM
% 221.09/221.31  |- skos__broader mesh__D051860Q000172smesh__D051860
% 221.09/221.31  |- mesh__preferredCombination mesh__D051860Q000172smesh__D005600
% 221.09/221.31  |- rdf__type mesh__D051860Q000172smesh__CompoundConcept
% 221.09/221.31  |- skos__broader mesh__D020762smesh__D002539
% 221.09/221.31  |- skos__prefLabel mesh__D020762 Infarction, Posterior Cerebral Artery
% 221.09/221.31  |- skos__related mesh__D020762smesh__D007238
% 221.09/221.31  |- mesh__dateRevised mesh__D020762 2005-06-30
% 221.09/221.31  |- mesh__dateCreated mesh__D020762 1999-11-03
% 221.09/221.31  |- skos__annotation mesh__D020762 DF: PCA INFARCT   
% 221.09/221.31  |- skos__broader mesh__D020762smesh__D002544
% 221.09/221.31  |- mesh__recordMaintainer mesh__D020762 ssb
% 221.09/221.31  |- skos__altLabel mesh__D020762 PCA Infarction
% 221.09/221.31  |- skos__altLabel mesh__D020762 Stroke, Posterior Cerebral Artery
% 221.09/221.31  |- mesh__recordOriginator mesh__D020762 KEV
% 221.09/221.31  |- skos__altLabel mesh__D020762
% 221.09/221.31       Posterior Cerebral Artery Embolic Infarction
% 221.09/221.31  |- skos__hiddenLabel mesh__D020762 Infarction, PCA
% 221.09/221.31  |- skos__historyNote mesh__D020762
% 221.09/221.31       Cerebral Arterial Diseases %28%1966-1999%29%
% 221.09/221.31  |- skos__altLabel mesh__D020762 Posterior Cerebral Artery Stroke
% 221.09/221.31  |- skos__altLabel mesh__D020762
% 221.09/221.31       Posterior Cerebral Artery Thrombotic Infarction
% 221.09/221.31  |- rdf__type mesh__D020762sskos__Concept
% 221.09/221.31  |- mesh__publicMeSHNote mesh__D020762 2000   
% 221.09/221.31  |- skos__altLabel mesh__D020762 Posterior Cerebral Artery Infarction
% 221.09/221.31  |- mesh__recordAuthorizer mesh__D020762 sjn
% 221.09/221.31  |- mesh__dateEstablished mesh__D020762 2000-01-01
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D020762 2006
% 221.09/221.31  |- skos__scopeNote mesh__D020762
% 221.09/221.31       Formation of an area of coagulation necrosis induced by ischemia in the vascular distribution of the posterior cerebral artery. This artery supplies portions of the MESENCEPHALON %28%see also BRAIN STEM INFARCTIONS%29% and thalamus, inferomedial TEMPORAL LOBE, and medial OCCIPITAL LOBE. Clinical manifestations vary with the size and location of infarction, but include a variety of midbrain and thalamic syndromes, HEMIANOPSIA, and behavioral syndromes related to memory and processing visual information. %28%From Adams et al., Principles of Neurology, 6th ed, pp793-8%29%%A%    
% 221.09/221.31  |- mesh__historyNote mesh__D020762 2000   
% 221.09/221.31  |- skos__annotation mesh__D006293 IM   
% 221.09/221.31  |- skos__hiddenLabel mesh__D006293 Campaigns, Health
% 221.09/221.31  |- skos__hiddenLabel mesh__D006293 Promotional Item
% 221.09/221.31  |- skos__hiddenLabel mesh__D006293 Health Campaign
% 221.09/221.31  |- skos__hiddenLabel mesh__D006293 Campaign, Health
% 221.09/221.31  |- skos__hiddenLabel mesh__D006293 Wellness Program
% 221.09/221.31  |- skos__hiddenLabel mesh__D006293 Promotion, Health
% 221.09/221.31  |- rdf__type mesh__D006293sskos__Concept
% 221.09/221.31  |- skos__hiddenLabel mesh__D006293 Item, Promotional
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D006293 2004
% 221.09/221.31  |- skos__broader mesh__D006293smesh__D011314
% 221.09/221.31  |- skos__altLabel mesh__D006293 Promotion of Health
% 221.09/221.31  |- mesh__historyNote mesh__D006293 80   
% 221.09/221.31  |- mesh__publicMeSHNote mesh__D006293 80   
% 221.09/221.31  |- skos__hiddenLabel mesh__D006293 Program, Wellness
% 221.09/221.31  |- skos__hiddenLabel mesh__D006293 Items, Promotional
% 221.09/221.31  |- skos__prefLabel mesh__D006293 Health Promotion
% 221.09/221.31  |- mesh__recordAuthorizer mesh__D006293 sjn
% 221.09/221.31  |- skos__hiddenLabel mesh__D006293 Health Promotions
% 221.09/221.31  |- mesh__dateEstablished mesh__D006293 1980-01-01
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D006293 2006
% 221.09/221.31  |- skos__hiddenLabel mesh__D006293 Programs, Wellness
% 221.09/221.31  |- skos__related mesh__D006293smesh__D015438
% 221.09/221.31  |- skos__hiddenLabel mesh__D006293 Promotions, Health
% 221.09/221.31  |- mesh__recordMaintainer mesh__D006293 nns
% 221.09/221.31  |- skos__scopeNote mesh__D006293
% 221.09/221.31       Encouraging consumer behaviors most likely to optimize health potentials %28%physical and psychosocial%29% through health information, preventive programs, and access to medical care.%A%    
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D006293 2005
% 221.09/221.31  |- mesh__dateRevised mesh__D006293 2003-07-09
% 221.09/221.31  |- skos__broader mesh__D006293smesh__D005159
% 221.09/221.31  |- mesh__dateCreated mesh__D006293 1979-06-01
% 221.09/221.31  |- mesh__recordOriginator mesh__D006293 EC
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D014725 2003
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D014725 2002
% 221.09/221.31  |- skos__hiddenLabel mesh__D014725 Ganglion, Scarpa%27%s
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D014725 2004
% 221.09/221.31  |- mesh__recordOriginator mesh__D014725 NLM
% 221.09/221.31  |- skos__hiddenLabel mesh__D014725 Vestibular Nerves
% 221.09/221.31  |- mesh__onlineNote mesh__D014725
% 221.09/221.31       use VESTIBULAR NERVE to search SCARPA%27%S GANGLION 1966-78   
% 221.09/221.31  |- skos__hiddenLabel mesh__D014725 Nerve, Vestibular
% 221.09/221.31  |- rdf__type mesh__D014725sskos__Concept
% 221.09/221.31  |- skos__hiddenLabel mesh__D014725 Scarpa Ganglion
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D014725 2000
% 221.09/221.31  |- skos__broader mesh__D014725smesh__D000159
% 221.09/221.31  |- skos__annotation mesh__D014725
% 221.09/221.31       dis: coord IM with VESTIBULOCOCHLEAR NERVE DISEASES %28%IM%29%; neopl: coord IM with VESTIBULOCOCHLEAR NERVE DISEASES %28%IM%29% + CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D014725 2005
% 221.09/221.31  |- skos__scopeNote mesh__D014725
% 221.09/221.31       The vestibular part of the 8th cranial nerve %28%VESTIBULOCOCHLEAR NERVE%29%. The vestibular nerve fibers arise from neurons of Scarpa%27%s ganglion and project peripherally to vestibular hair cells and centrally to the VESTIBULAR NUCLEI of the BRAIN STEM. These fibers mediate the sense of balance and head position.%A%    
% 221.09/221.31  |- mesh__dateRevised mesh__D014725 1999-11-03
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D014725 2001
% 221.09/221.31  |- mesh__recordMaintainer mesh__D014725 ags
% 221.09/221.31  |- mesh__recordAuthorizer mesh__D014725 sjn
% 221.09/221.31  |- skos__hiddenLabel mesh__D014725 Scarpas Ganglion
% 221.09/221.31  |- skos__prefLabel mesh__D014725 Vestibular Nerve
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D014725 2006
% 221.09/221.31  |- mesh__historyNote mesh__D014725
% 221.09/221.31       SCARPA%27%S GANGLION was see under VESTIBULAR NERVE 1963-78   
% 221.09/221.31  |- skos__hiddenLabel mesh__D014725 Nerves, Vestibular
% 221.09/221.31  |- mesh__dateCreated mesh__D014725 1999-01-01
% 221.09/221.31  |- rdf__type mesh__D000705sskos__Concept
% 221.09/221.31  |- skos__scopeNote mesh__D000705
% 221.09/221.31       The phase of cell nucleus division following METAPHASE, in which the CHROMATIDS separate and migrate to opposite poles of the spindle.%A%    
% 221.09/221.31  |- skos__prefLabel mesh__D000705 Anaphase
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D000705 2006
% 221.09/221.31  |- mesh__dateCreated mesh__D000705 1977-05-10
% 221.09/221.31  |- skos__hiddenLabel mesh__D000705 Anaphases
% 221.09/221.31  |- skos__historyNote mesh__D000705 Cell Division %28%1966-1977%29%
% 221.09/221.31  |- mesh__recordAuthorizer mesh__D000705 sjn
% 221.09/221.31  |- mesh__recordMaintainer mesh__D000705 nns
% 221.09/221.31  |- skos__broader mesh__D000705smesh__D048750
% 221.09/221.31  |- skos__annotation mesh__D000705
% 221.09/221.31       coordinate with specific cell /cytol; permitted with microorganisms%A%  
% 221.09/221.31  |- mesh__recordOriginator mesh__D000705 AEP
% 221.09/221.31  |- mesh__historyNote mesh__D000705
% 221.09/221.31       81%28%78%29%; was see under CELL CYCLE 1978-80   
% 221.09/221.31  |- mesh__publicMeSHNote mesh__D000705
% 221.09/221.31       81; was see under CELL CYCLE 1978-80   
% 221.09/221.31  |- skos__historyNote mesh__D000705 Meiosis %28%1968-1977%29%
% 221.09/221.31  |- mesh__dateEstablished mesh__D000705 1981-01-01
% 221.09/221.31  |- skos__historyNote mesh__D000705 Mitosis %28%1968-1977%29%
% 221.09/221.31  |- skos__broader mesh__D000705smesh__D008938
% 221.09/221.31  |- mesh__dateRevised mesh__D000705 2005-06-30
% 221.09/221.31  |- mesh__recordAuthorizer mesh__D019410 sjn
% 221.09/221.31  |- skos__historyNote mesh__D019410 Lymphokines %28%1987-1996%29%
% 221.09/221.31  |- mesh__dateRevised mesh__D019410 2005-06-30
% 221.09/221.31  |- skos__altLabel mesh__D019410 IL16
% 221.09/221.31  |- skos__annotation mesh__D019410 DF: IL 16 or IL16   
% 221.09/221.31  |- skos__altLabel mesh__D019410 Lymphocyte Chemoattractant Factor
% 221.09/221.31  |- mesh__publicMeSHNote mesh__D019410
% 221.09/221.31       97; LYMPHOCYTE CHEMOATTRACTANT FACTOR was indexed under LYMPHOKINES 1987-96%A%  
% 221.09/221.31  |- mesh__onlineNote mesh__D019410
% 221.09/221.31       use INTERLEUKIN-16 %28%NM%29% to search LYMPHOCYTE CHEMOATTRACTANT FACTOR 1987-96%A%  
% 221.09/221.31  |- skos__hiddenLabel mesh__D019410 Chemoattractant Factor, Lymphocyte
% 221.09/221.31  |- skos__prefLabel mesh__D019410 Interleukin-16
% 221.09/221.31  |- skos__altLabel mesh__D019410 IL-16
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D019410 2006
% 221.09/221.31  |- mesh__recordOriginator mesh__D019410 AGS
% 221.09/221.31  |- mesh__dateEstablished mesh__D019410 1997-01-01
% 221.09/221.31  |- mesh__recordMaintainer mesh__D019410 ssb
% 221.09/221.31  |- mesh__historyNote mesh__D019410
% 221.09/221.31       97; was LYMPHOCYTE CHEMOATTRACTANT FACTOR %28%NM%29% 1987-96   
% 221.09/221.31  |- rdf__type mesh__D019410sskos__Concept
% 221.09/221.31  |- mesh__dateCreated mesh__D019410 1996-06-10
% 221.09/221.31  |- skos__hiddenLabel mesh__D019410 Interleukin 16
% 221.09/221.31  |- skos__altLabel mesh__D019410 LCF Factor
% 221.09/221.31  |- skos__broader mesh__D019410smesh__D007378
% 221.09/221.31  |- skos__scopeNote mesh__D019410
% 221.09/221.31       Cytokine produced by activated T-lymphocytes that stimulates the migration of CD4-positive lymphocytes and monocytes. It has been reported to suppress HIV replication.%A%    
% 221.09/221.31  |- skos__altLabel mesh__D005999 Glycochenodeoxycholate
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D005999 2005
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D005999 2004
% 221.09/221.31  |- skos__annotation mesh__D005999
% 221.09/221.31       a bile acid; /biosyn /physiol permitted   
% 221.09/221.31  |- mesh__recordOriginator mesh__D005999 SH
% 221.09/221.31  |- skos__broader mesh__D005999smesh__D006002
% 221.09/221.31  |- skos__hiddenLabel mesh__D005999 Acid, Glycochenodeoxycholic
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D005999 2006
% 221.09/221.31  |- mesh__recordAuthorizer mesh__D005999 sjn
% 221.09/221.31  |- skos__altLabel mesh__D005999 Chenodeoxycholylglycine
% 221.09/221.31  |- rdf__type mesh__D005999sskos__Concept
% 221.09/221.31  |- mesh__recordMaintainer mesh__D005999 jmp
% 221.09/221.31  |- mesh__publicMeSHNote mesh__D005999
% 221.09/221.31       91; was see under CHENODEOXYCHOLIC ACID 1978-90   
% 221.09/221.31  |- mesh__dateEstablished mesh__D005999 1991-01-01
% 221.09/221.31  |- skos__hiddenLabel mesh__D005999 Chenodeoxycholate, Glycine
% 221.09/221.31  |- mesh__historyNote mesh__D005999
% 221.09/221.31       91%28%78%29%; was see under CHENODEOXYCHOLIC ACID 1978-90   
% 221.09/221.31  |- skos__prefLabel mesh__D005999 Glycochenodeoxycholic Acid
% 221.09/221.31  |- skos__broader mesh__D005999smesh__D002635
% 221.09/221.31  |- skos__historyNote mesh__D005999 Glycine %28%1966-1972%29%
% 221.09/221.31  |- mesh__dateCreated mesh__D005999 1977-03-01
% 221.09/221.31  |- mesh__dateRevised mesh__D005999 2003-07-09
% 221.09/221.31  |- skos__scopeNote mesh__D005999
% 221.09/221.31       A bile salt formed in the liver from chenodeoxycholate and glycine, usually as the sodium salt. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is a cholagogue and choleretic.%A%    
% 221.09/221.31  |- skos__historyNote mesh__D005999 Bile Acids and Salts %28%1966-1972%29%
% 221.09/221.31  |- skos__historyNote mesh__D005999 Chenodeoxycholic Acid %28%1973-1977%29%
% 221.09/221.31  |- skos__historyNote mesh__D005999 Glycocholic Acid %28%1973-1977%29%
% 221.09/221.31  |- mesh__publicMeSHNote mesh__D046009 2005; see CARNIVORA 1998-2004   
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D046009 2006A
% 221.09/221.31  |- skos__altLabel mesh__D046009 Panthera onca
% 221.09/221.31  |- rdf__type mesh__D046009sskos__Concept
% 221.09/221.31  |- skos__altLabel mesh__D046009 Black Panther
% 221.09/221.31  |- mesh__recordMaintainer mesh__D046009 ags
% 221.09/221.31  |- mesh__recordAuthorizer mesh__D046009 ags
% 221.09/221.31  |- mesh__historyNote mesh__D046009 2005; use CARNIVORA 1998-2004   
% 221.09/221.31  |- mesh__dateRevised mesh__D046009 2005-07-19
% 221.09/221.31  |- skos__hiddenLabel mesh__D046009 Jaguar
% 221.09/221.31  |- mesh__recordOriginator mesh__D046009 ags
% 221.09/221.31  |- mesh__dateEstablished mesh__D046009 2005-01-01
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D046009 2005
% 221.09/221.31  |- skos__scopeNote mesh__D046009
% 221.09/221.31       Genus in the family FELIDAE comprised of big felines including LIONS; TIGERS; jaguars; and the leopard.%A%    
% 221.09/221.31  |- skos__broader mesh__D046009smesh__D045989
% 221.09/221.31  |- skos__altLabel mesh__D046009 Panthera pardus
% 221.09/221.31  |- skos__historyNote mesh__D046009 Carnivora %28%1966-2004%29%
% 221.09/221.31  |- skos__hiddenLabel mesh__D046009 Panther, Black
% 221.09/221.31  |- skos__prefLabel mesh__D046009 Panthera
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D046009 2006
% 221.09/221.31  |- skos__annotation mesh__D046009
% 221.09/221.31       do not confuse X ref LEOPARD with leopards in other genera%A%  
% 221.09/221.31  |- mesh__dateCreated mesh__D046009 2004-07-07
% 221.09/221.31  |- mesh__historyNote mesh__D018318 94   
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D018318 2006
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D018318 2003
% 221.09/221.31  |- skos__scopeNote mesh__D018318
% 221.09/221.31       A type of neurofibroma manifesting as a diffuse overgrowth of subcutaneous tissue, usually involving the face, scalp, neck, and chest but occasionally occurring in the abdomen or pelvis. The tumors tend to progress, and may extend along nerve roots to eventually involve the spinal roots and spinal cord. This process is almost always a manifestation of NEUROFIBROMATOSIS 1. %28%From Adams et al., Principles of Neurology, 6th ed, p1016; J Pediatr 1997 Nov;131%28%5%29%:678-82%29%%A%    
% 221.09/221.31  |- mesh__recordMaintainer mesh__D018318 jls
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D018318 2005A
% 221.09/221.31  |- skos__hiddenLabel mesh__D018318 Plexiform Neuromas
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D018318 2000
% 221.09/221.31  |- skos__hiddenLabel mesh__D018318 Plexiform Neurofibroma
% 221.09/221.31  |- mesh__recordAuthorizer mesh__D018318 jls
% 221.09/221.31  |- mesh__dateCreated mesh__D018318 1993-06-25
% 221.09/221.31  |- mesh__dateEstablished mesh__D018318 1994-01-01
% 221.09/221.31  |- mesh__publicMeSHNote mesh__D018318 94   
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D018318 2004
% 221.09/221.31  |- skos__altLabel mesh__D018318 Tumor Royale
% 221.09/221.31  |- rdf__type mesh__D018318sskos__Concept
% 221.09/221.31  |- skos__hiddenLabel mesh__D018318 Elephantiasis Neuromatoses
% 221.09/221.31  |- skos__historyNote mesh__D018318 Neurofibromatosis 1 %28%1966-1993%29%
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D018318 2001
% 221.09/221.31  |- skos__altLabel mesh__D018318 Neuromas, Plexiform
% 221.09/221.31  |- skos__altLabel mesh__D018318 Elephantiasis Neuromatosis
% 221.09/221.31  |- skos__hiddenLabel mesh__D018318 Plexiform Neurofibromas
% 221.09/221.31  |- skos__historyNote mesh__D018318 Neurofibroma %28%1966-1993%29%
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D018318 2002
% 221.09/221.31  |- skos__altLabel mesh__D018318 Pachydermatocele
% 221.09/221.31  |- skos__hiddenLabel mesh__D018318 Neuroma, Plexiform
% 221.09/221.31  |- skos__hiddenLabel mesh__D018318 Neurofibromas, Plexiform
% 221.09/221.31  |- mesh__recordOriginator mesh__D018318 PLS
% 221.09/221.31  |- skos__hiddenLabel mesh__D018318 Plexiform Neuroma
% 221.09/221.31  |- skos__prefLabel mesh__D018318 Neurofibroma, Plexiform
% 221.09/221.31  |- skos__hiddenLabel mesh__D018318 Pachydermatoceles
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D018318 2005
% 221.09/221.31  |- skos__annotation mesh__D018318
% 221.09/221.31       coord IM with precoord organ/neopl term %28%IM%29%   
% 221.09/221.31  |- skos__broader mesh__D018318smesh__D009455
% 221.09/221.31  |- mesh__dateRevised mesh__D018318 2004-07-29
% 221.09/221.31  |- skos__broader mesh__D010335smesh__D013568
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D010335 2004
% 221.09/221.31  |- skos__altLabel mesh__D010335 Pathological Processes
% 221.09/221.31  |- rdf__type mesh__D010335sskos__Concept
% 221.09/221.31  |- mesh__publicMeSHNote mesh__D010335 98   
% 221.09/221.31  |- mesh__dateEstablished mesh__D010335 1998-01-01
% 221.09/221.31  |- skos__annotation mesh__D010335
% 221.09/221.31       not used for indexing; DF: PATHOL PROCESSES      CATALOG: do not use%A%  
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D010335 2002
% 221.09/221.31  |- mesh__recordOriginator mesh__D010335 NLM
% 221.09/221.31  |- mesh__dateRevised mesh__D010335 1999-11-03
% 221.09/221.31  |- skos__prefLabel mesh__D010335 Pathologic Processes
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D010335 2005
% 221.09/221.31  |- skos__hiddenLabel mesh__D010335 Processes, Pathological
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D010335 2000
% 221.09/221.31  |- mesh__dateCreated mesh__D010335 1999-01-01
% 221.09/221.31  |- skos__altLabel mesh__D010335 Processes, Pathologic
% 221.09/221.31  |- mesh__recordAuthorizer mesh__D010335 sjn
% 221.09/221.31  |- skos__historyNote mesh__D010335
% 221.09/221.31       specific pathologic process %28%1966-1997%29%
% 221.09/221.31  |- skos__scopeNote mesh__D010335
% 221.09/221.31       The abnormal mechanisms and forms involved in the dysfunctions of tissues and organs.%A%    
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D010335 2006
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D010335 2001
% 221.09/221.31  |- mesh__historyNote mesh__D010335 98; use explode 1971-97   
% 221.09/221.31  |- mesh__recordMaintainer mesh__D010335 KEV
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D010335 2003
% 221.09/221.31  |- skos__broader mesh__D015020smesh__D007554
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D015020 2006
% 221.09/221.31  |- mesh__dateRevised mesh__D015020 2000-06-22
% 221.09/221.31  |- skos__hiddenLabel mesh__D015020 Isotopes, Yttrium
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D015020 2002
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D015020 2003
% 221.09/221.31  |- rdf__type mesh__D015020sskos__Concept
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D015020 2004
% 221.09/221.31  |- skos__prefLabel mesh__D015020 Yttrium Isotopes
% 221.09/221.31  |- skos__scopeNote mesh__D015020
% 221.09/221.31       Stable yttrium atoms that have the same atomic number as the element yttrium, but differ in atomic weight. Y-89 is the only naturally occurring stable isotope of yttrium.%A%    
% 221.09/221.31  |- mesh__recordMaintainer mesh__D015020 nns
% 221.09/221.31  |- mesh__activeMeSHYear mesh__D015020 2001
% 221.09/221.31  |- mesh__recordAuthorizer mesh__D015020 sjn
% 221.09/221.31  |- mesh__dateCreated mesh__D015020 1999-01-01
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D015020 2005
% 221.09/221.32  |- mesh__recordOriginator mesh__D015020 NLM
% 221.09/221.32  |- skos__annotation mesh__D015020 Y-89; NIM   
% 221.09/221.32  |- mesh__dateRevised mesh__D001000 2003-07-09
% 221.09/221.32  |- rdf__type mesh__D001000sskos__Concept
% 221.09/221.32  |- mesh__recordAuthorizer mesh__D001000 sjn
% 221.09/221.32  |- skos__scopeNote mesh__D001000
% 221.09/221.32       Insects of the family Formicidae, very common and widespread, probably the most successful of all the insect groups. All ants are social insects, and most colonies contain three castes, queens, males, and workers. Their habits are often very elaborate and a great many studies have been made of ant behavior. Ants produce a number of secretions that function in offense, defense, and communication. %28%From Borror, et al., An Introduction to the Study of Insects, 4th ed, p676%29%%A%    
% 221.09/221.32  |- mesh__dateCreated mesh__D001000 1999-01-01
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D001000 2005
% 221.09/221.32  |- mesh__recordMaintainer mesh__D001000 ags
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D001000 2004
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D001000 2006
% 221.09/221.32  |- mesh__recordOriginator mesh__D001000 NLM
% 221.09/221.32  |- skos__annotation mesh__D001000
% 221.09/221.32       /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111%A%  
% 221.09/221.32  |- skos__broader mesh__D001000smesh__D006927
% 221.09/221.32  |- skos__prefLabel mesh__D001000 Ants
% 221.09/221.32  |- skos__annotation mesh__D020763
% 221.09/221.32       not to be used for indexing or cataloging   
% 221.09/221.32  |- skos__hiddenLabel mesh__D020763 Condition, Anatomical Pathological
% 221.09/221.32  |- skos__prefLabel mesh__D020763 Pathological Conditions, Anatomical
% 221.09/221.32  |- mesh__dateCreated mesh__D020763 1999-11-03
% 221.09/221.32  |- skos__hiddenLabel mesh__D020763 Pathological Condition, Anatomical
% 221.09/221.32  |- rdf__type mesh__D020763sskos__Concept
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D020763 2005
% 221.09/221.32  |- skos__hiddenLabel mesh__D020763 Anatomical Pathological Conditions
% 221.09/221.32  |- mesh__recordOriginator mesh__D020763 KEV
% 221.09/221.32  |- mesh__recordMaintainer mesh__D020763 sjn
% 221.09/221.32  |- skos__scopeNote mesh__D020763
% 221.09/221.32       An abnormal structural condition of the human body, usually macroscopic, that is common to a variety of different diseases.%A%    
% 221.09/221.32  |- skos__broader mesh__D020763smesh__D013568
% 221.09/221.32  |- mesh__dateEstablished mesh__D020763 2000-01-01
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D020763 2006
% 221.09/221.32  |- mesh__historyNote mesh__D020763 2000   
% 221.09/221.32  |- skos__hiddenLabel mesh__D020763 Conditions, Anatomical Pathological
% 221.09/221.32  |- skos__hiddenLabel mesh__D020763 Anatomical Pathological Condition
% 221.09/221.32  |- mesh__dateRevised mesh__D020763 2004-07-13
% 221.09/221.32  |- mesh__publicMeSHNote mesh__D020763 2000   
% 221.09/221.32  |- mesh__recordAuthorizer mesh__D020763 sjn
% 221.09/221.32  |- skos__hiddenLabel mesh__D006294 Resort, Health
% 221.09/221.32  |- mesh__recordAuthorizer mesh__D006294 sjn
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D006294 2001
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D006294 2003
% 221.09/221.32  |- mesh__recordMaintainer mesh__D006294 kle
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D006294 2000
% 221.09/221.32  |- mesh__dateRevised mesh__D006294 1999-11-03
% 221.09/221.32  |- skos__hiddenLabel mesh__D006294 Health Resort
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D006294 2006
% 221.09/221.32  |- skos__broader mesh__D006294smesh__D011633
% 221.09/221.32  |- mesh__recordOriginator mesh__D006294 NLM
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D006294 2005
% 221.09/221.32  |- skos__hiddenLabel mesh__D006294 Resort
% 221.09/221.32  |- skos__annotation mesh__D006294
% 221.09/221.32       sanatoria %26% sanitaria %28%often used interchangeably%29% can go here but consider also HOSPITALS, SPECIAL%A%  
% 221.09/221.32  |- mesh__dateCreated mesh__D006294 1999-01-01
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D006294 2002
% 221.09/221.32  |- skos__hiddenLabel mesh__D006294 Resorts, Health
% 221.09/221.32  |- skos__prefLabel mesh__D006294 Health Resorts
% 221.09/221.32  |- rdf__type mesh__D006294sskos__Concept
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D006294 2004
% 221.09/221.32  |- rdf__type mesh__D014726sskos__Concept
% 221.09/221.32  |- skos__broader mesh__D014726smesh__D011149
% 221.09/221.32  |- mesh__dateEstablished mesh__D014726 1967-01-01
% 221.09/221.32  |- skos__scopeNote mesh__D014726
% 221.09/221.32       The four cellular masses in the floor of the fourth ventricle giving rise to a widely dispersed special sensory system. Included is the superior, medial, inferior, and LATERAL VESTIBULAR NUCLEUS. %28%From Dorland, 27th ed%29%%A%    
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D014726 2002
% 221.09/221.32  |- mesh__recordMaintainer mesh__D014726 KEV
% 221.09/221.32  |- skos__hiddenLabel mesh__D014726 Schwalbes Nucleus
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D014726 2005
% 221.09/221.32  |- mesh__recordOriginator mesh__D014726 NLM
% 221.09/221.32  |- mesh__historyNote mesh__D014726 1967%28%1965%29%   
% 221.09/221.32  |- skos__hiddenLabel mesh__D014726 Medial Vestibular Nucleus
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D014726 2006
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D014726 2000
% 221.09/221.32  |- skos__hiddenLabel mesh__D014726 Nucleus, Schwalbe%27%s
% 221.09/221.32  |- mesh__dateCreated mesh__D014726 1999-01-01
% 221.09/221.32  |- skos__altLabel mesh__D014726 Schwalbe Nucleus
% 221.09/221.32  |- skos__prefLabel mesh__D014726 Vestibular Nuclei
% 221.09/221.32  |- skos__hiddenLabel mesh__D014726 Nucleus, Schwalbe
% 221.09/221.32  |- skos__hiddenLabel mesh__D014726 Nuclei, Vestibular
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D014726 2003
% 221.09/221.32  |- mesh__dateRevised mesh__D014726 1999-11-08
% 221.09/221.32  |- skos__altLabel mesh__D014726 Schwalbe%27%s Nucleus
% 221.09/221.32  |- mesh__publicMeSHNote mesh__D014726 1967   
% 221.09/221.32  |- mesh__recordAuthorizer mesh__D014726 sjn
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D014726 2001
% 221.09/221.32  |- skos__hiddenLabel mesh__D014726 Nucleus, Medial Vestibular
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D014726 2004
% 221.09/221.32  |- skos__historyNote mesh__D000706 Complement %28%1968-1976%29%
% 221.09/221.32  |- mesh__historyNote mesh__D000706
% 221.09/221.32       90%28%77%29%; was see under PEPTIDES 1977-89   
% 221.09/221.32  |- rdf__type mesh__D000706sskos__Concept
% 221.09/221.32  |- skos__historyNote mesh__D000706 Peptide Fragments %28%1974-1976%29%
% 221.09/221.32  |- skos__historyNote mesh__D000706 specific complement %28%1975-1976%29%
% 221.09/221.32  |- skos__historyNote mesh__D000706 Peptides %28%1966-1976%29%
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D000706 2006
% 221.09/221.32  |- mesh__recordMaintainer mesh__D000706 ssb
% 221.09/221.32  |- skos__prefLabel mesh__D000706 Anaphylatoxins
% 221.09/221.32  |- mesh__dateCreated mesh__D000706 1976-05-19
% 221.09/221.32  |- mesh__dateRevised mesh__D000706 2005-06-30
% 221.09/221.32  |- mesh__dateEstablished mesh__D000706 1990-01-01
% 221.09/221.32  |- skos__scopeNote mesh__D000706
% 221.09/221.32       Serum peptides derived from certain cleaved COMPLEMENT PROTEINS during COMPLEMENT ACTIVATION. They induce smooth MUSCLE CONTRACTION; mast cell HISTAMINE RELEASE; PLATELET AGGREGATION; and act as mediators of the local inflammatory process. The order of anaphylatoxin activity from the strongest to the weakest is C5a, C3a, C4a, and C5a des-arginine.%A%    
% 221.09/221.32  |- skos__broader mesh__D000706smesh__D003165
% 221.09/221.32  |- mesh__recordAuthorizer mesh__D000706 sjn
% 221.09/221.32  |- mesh__recordOriginator mesh__D000706 RLS
% 221.09/221.32  |- mesh__publicMeSHNote mesh__D000706 90; was see under PEPTIDES 1977-89   
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D019411 2002
% 221.09/221.32  |- skos__hiddenLabel mesh__D019411 Techniques, Clinical Laboratory
% 221.09/221.32  |- skos__hiddenLabel mesh__D019411 Laboratory Technique, Clinical
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D019411 2005
% 221.09/221.32  |- mesh__historyNote mesh__D019411 2000%28%1997%29%   
% 221.09/221.32  |- mesh__dateCreated mesh__D019411 1996-06-10
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D019411 2006
% 221.09/221.32  |- skos__scopeNote mesh__D019411
% 221.09/221.32       Techniques used to carry out clinical investigative procedures in the diagnosis and therapy of disease.%A%    
% 221.09/221.32  |- skos__related mesh__D019411smesh__D013677
% 221.09/221.32  |- mesh__publicMeSHNote mesh__D019411
% 221.09/221.32       2000; 1997-1999 was TECHNOLOGY, MEDICAL LABORATORY   
% 221.09/221.32  |- rdf__type mesh__D019411sskos__Concept
% 221.09/221.32  |- skos__related mesh__D019411smesh__D003942
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D019411 2003
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D019411 2001
% 221.09/221.32  |- skos__hiddenLabel mesh__D019411 Technique, Clinical Laboratory
% 221.09/221.32  |- skos__hiddenLabel mesh__D019411 Clinical Laboratory Technique
% 221.09/221.32  |- mesh__recordAuthorizer mesh__D019411 sjn
% 221.09/221.32  |- mesh__recordMaintainer mesh__D019411 jls
% 221.09/221.32  |- skos__broader mesh__D019411smesh__D008919
% 221.09/221.32  |- skos__prefLabel mesh__D019411 Clinical Laboratory Techniques
% 221.09/221.32  |- mesh__recordOriginator mesh__D019411 TGC
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D019411 2004
% 221.09/221.32  |- mesh__dateRevised mesh__D019411 2000-06-22
% 221.09/221.32  |- skos__altLabel mesh__D019411 Laboratory Techniques, Clinical
% 221.09/221.32  |- mesh__dateEstablished mesh__D019411 1997-01-01
% 221.09/221.32  |- skos__hiddenLabel mesh__D046808 adenoviruses, Deer
% 221.09/221.32  |- rdf__type mesh__D046808sskos__Concept
% 221.09/221.32  |- mesh__dateCreated mesh__D046808 2004-07-07
% 221.09/221.32  |- skos__hiddenLabel mesh__D046808 Deer adenoviruses
% 221.09/221.32  |- mesh__historyNote mesh__D046808 2005   
% 221.09/221.32  |- skos__hiddenLabel mesh__D046808 adenovirus, Deer
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D046808 2006
% 221.09/221.32  |- mesh__dateEstablished mesh__D046808 2005-01-01
% 221.09/221.32  |- skos__altLabel mesh__D046808 Ovine adenovirus 7
% 221.09/221.32  |- skos__scopeNote mesh__D046808
% 221.09/221.32       A genus of ADENOVIRIDAE that comprises viruses of several species of MAMMALS and BIRDS. The type species is Ovine adenovirus D.%A%    
% 221.09/221.32  |- skos__hiddenLabel mesh__D046808 adenovirus A, Duck
% 221.09/221.32  |- skos__broader mesh__D046808smesh__D000256
% 221.09/221.32  |- mesh__publicMeSHNote mesh__D046808 2005   
% 221.09/221.32  |- skos__prefLabel mesh__D046808 Atadenovirus
% 221.09/221.32  |- skos__hiddenLabel mesh__D046808 Atadenoviruses
% 221.09/221.32  |- skos__annotation mesh__D046808
% 221.09/221.32       infection: coord IM with ADENOVIRIDAE INFECTIONS %28%IM%29%   
% 221.09/221.32  |- skos__historyNote mesh__D046808 Adenoviridae %28%2002-2004%29%
% 221.09/221.32  |- mesh__recordOriginator mesh__D046808 ags
% 221.09/221.32  |- mesh__recordMaintainer mesh__D046808 ags
% 221.09/221.32  |- mesh__recordAuthorizer mesh__D046808 sjn
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D046808 2005
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D018319 2000
% 221.09/221.32  |- mesh__historyNote mesh__D018319 94   
% 221.09/221.32  |- skos__historyNote mesh__D018319 Fibrosarcoma %28%1966-1978%29%
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D018319 2003
% 221.09/221.32  |- rdf__type mesh__D018319sskos__Concept
% 221.09/221.32  |- skos__hiddenLabel mesh__D018319 Neurogenic Sarcomas
% 221.09/221.32  |- skos__hiddenLabel mesh__D018319 Sarcomas, Neurogenic
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D018319 2006
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D018319 2001
% 221.09/221.32  |- mesh__dateEstablished mesh__D018319 1994-01-01
% 221.09/221.32  |- mesh__publicMeSHNote mesh__D018319 94   
% 221.09/221.32  |- skos__scopeNote mesh__D018319
% 221.09/221.32       A malignant tumor that arises from small cutaneous nerves, is locally aggressive, and has a potential for metastasis. Characteristic histopathologic features include proliferating atypical spindle cells with slender wavy and pointed nuclei, hypocellular areas, and areas featuring organized whorls of fibroblastic proliferation. The most common primary sites are the extremities, retroperitoneum, and trunk. These tumors tend to present in childhood, often in association with NEUROFIBROMATOSIS 1. %28%From DeVita et al., Cancer: Principles %26% Practice of Oncology, 5th ed, p1662; Mayo Clin Proc 1990 Feb;65%28%2%29%:164-72%29%%A%    
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D018319 2004
% 221.09/221.32  |- mesh__dateRevised mesh__D018319 1999-11-03
% 221.09/221.32  |- skos__broader mesh__D018319smesh__D005354
% 221.09/221.32  |- skos__hiddenLabel mesh__D018319 Neurogenic Sarcoma
% 221.09/221.32  |- skos__hiddenLabel mesh__D018319 Neurofibrosarcomas
% 221.09/221.32  |- mesh__recordMaintainer mesh__D018319 KEV
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D018319 2002
% 221.09/221.32  |- skos__historyNote mesh__D018319 Neurofibroma %28%1969-1993%29%
% 221.09/221.32  |- mesh__recordOriginator mesh__D018319 PLS
% 221.09/221.32  |- skos__broader mesh__D018319smesh__D018317
% 221.09/221.32  |- mesh__recordAuthorizer mesh__D018319 sjn
% 221.09/221.32  |- skos__prefLabel mesh__D018319 Neurofibrosarcoma
% 221.09/221.32  |- skos__altLabel mesh__D018319 Sarcoma, Neurogenic
% 221.09/221.32  |- skos__annotation mesh__D018319
% 221.09/221.32       coord IM with precoord organ/neopl term %28%IM%29%   
% 221.09/221.32  |- skos__broader mesh__D018319smesh__D009455
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D018319 2005
% 221.09/221.32  |- mesh__dateCreated mesh__D018319 1993-06-25
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D010336 2001
% 221.09/221.32  |- mesh__recordMaintainer mesh__D010336 PXP
% 221.09/221.32  |- skos__hiddenLabel mesh__D010336 Pathologies
% 221.09/221.32  |- skos__broader mesh__D010336smesh__D013040
% 221.09/221.32  |- mesh__dateRevised mesh__D010336 1997-06-20
% 221.09/221.32  |- skos__prefLabel mesh__D010336 Pathology
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D010336 2005
% 221.09/221.32  |- mesh__dateCreated mesh__D010336 1999-01-01
% 221.09/221.32  |- mesh__recordAuthorizer mesh__D010336 SJN
% 221.09/221.32  |- skos__annotation mesh__D010336
% 221.09/221.32       SPEC only: SPEC qualif; prefer /pathol with organs %26% diseases: Manual 19.7+, 19.8.52; definition of /pathol applicable to PATHOLOGY: Manual 21.22+, 23.15; %22%postmortem pathol%22%: consider AUTOPSY or CADAVER or merely /pathol; DF: PATHOL%A%  
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D010336 2002
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D010336 2006
% 221.09/221.32  |- mesh__recordOriginator mesh__D010336 NLM
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D010336 1998
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D010336 2003
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D010336 2000
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D010336 1999
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D010336 2004
% 221.09/221.32  |- skos__scopeNote mesh__D010336
% 221.09/221.32       A specialty concerned with the nature and cause of disease as expressed by changes in cellular or tissue structure and function caused by the disease process.%A%    
% 221.09/221.32  |- rdf__type mesh__D010336sskos__Concept
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D029041 2006
% 221.09/221.32  |- skos__prefLabel mesh__D029041 Actinidiaceae
% 221.09/221.32  |- skos__annotation mesh__D029041
% 221.09/221.32       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.09/221.32  |- mesh__dateEstablished mesh__D029041 2002-01-01
% 221.09/221.32  |- mesh__publicMeSHNote mesh__D029041 2002   
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D029041 2005
% 221.09/221.32  |- rdf__type mesh__D029041sskos__Concept
% 221.09/221.32  |- mesh__dateCreated mesh__D029041 2001-07-25
% 221.09/221.32  |- skos__broader mesh__D029041smesh__D020448
% 221.09/221.32  |- skos__scopeNote mesh__D029041
% 221.09/221.32       A plant family of the order Theales, subclass Dilleniidae, class Magnoliopsida. It is best known for Kiwi fruit %28%ACTINIDIA%29%.%A%    
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D029041 2002
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D029041 2004
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D029041 2003
% 221.09/221.32  |- mesh__historyNote mesh__D029041 2002   
% 221.09/221.32  |- skos__historyNote mesh__D015021 Radioisotopes %28%1966-1974%29%
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D015021 1996
% 221.09/221.32  |- mesh__recordAuthorizer mesh__D015021 PLS
% 221.09/221.32  |- mesh__onlineNote mesh__D015021 search YTTRIUM ISOTOPES 1966-74   
% 221.09/221.32  |- mesh__dateEstablished mesh__D015021 1975-09-01
% 221.09/221.32  |- skos__scopeNote mesh__D015021
% 221.09/221.32       Unstable isotopes of yttrium that decay or disintegrate emitting radiation. Y atoms with atomic weights 82-88 and 90-96 are radioactive yttrium isotopes.%A%    
% 221.09/221.32  |- mesh__historyNote mesh__D015021 75   
% 221.09/221.32  |- skos__historyNote mesh__D015021 Yttrium Isotopes %28%1966-1974%29%
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D015021 2006
% 221.09/221.32  |- mesh__recordOriginator mesh__D015021 NLM
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D015021 2004
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D015021 2001
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D015021 1995
% 221.09/221.32  |- skos__hiddenLabel mesh__D015021 Radioisotopes, Yttrium
% 221.09/221.32  |- rdf__type mesh__D015021sskos__Concept
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D015021 2000
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D015021 2005
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D015021 2003
% 221.09/221.32  |- skos__broader mesh__D015021smesh__D011868
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D015021 1994
% 221.09/221.32  |- mesh__dateRevised mesh__D015021 1993-06-03
% 221.09/221.32  |- skos__prefLabel mesh__D015021 Yttrium Radioisotopes
% 221.09/221.32  |- mesh__recordMaintainer mesh__D015021 TPW
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D015021 1999
% 221.09/221.32  |- skos__broader mesh__D015021smesh__D015020
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D015021 1997
% 221.09/221.32  |- mesh__dateCreated mesh__D015021 1974-11-11
% 221.09/221.32  |- mesh__publicMeSHNote mesh__D015021 75   
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D015021 2002
% 221.09/221.32  |- skos__annotation mesh__D015021
% 221.09/221.32       Y-82-88, 90-96; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D015021 1998
% 221.09/221.32  |- skos__hiddenLabel mesh__D001001 Fire-Bellied Toad
% 221.09/221.32  |- skos__altLabel mesh__D001001 Bombina
% 221.09/221.32  |- skos__altLabel mesh__D001001 Toads and Frogs
% 221.09/221.32  |- mesh__recordOriginator mesh__D001001 EC
% 221.09/221.32  |- mesh__dateEstablished mesh__D001001 1981-01-01
% 221.09/221.32  |- skos__hiddenLabel mesh__D001001 Toads, Fire-Bellied
% 221.09/221.32  |- skos__hiddenLabel mesh__D001001 Toad, Fire Bellied
% 221.09/221.32  |- mesh__dateCreated mesh__D001001 1980-04-02
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D001001 2005
% 221.09/221.32  |- skos__hiddenLabel mesh__D001001 Fire-Bellied Toads
% 221.09/221.32  |- skos__hiddenLabel mesh__D001001 Salientias
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D001001 2004
% 221.09/221.32  |- mesh__recordAuthorizer mesh__D001001 sjn
% 221.09/221.32  |- skos__prefLabel mesh__D001001 Anura
% 221.09/221.32  |- skos__broader mesh__D001001smesh__D000663
% 221.09/221.32  |- skos__annotation mesh__D001001
% 221.09/221.32       GEN or unspecified; prefer specific available families %26% genera; frogs %26% toads; NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 221.09/221.32  |- mesh__recordMaintainer mesh__D001001 ags
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D001001 2006
% 221.09/221.32  |- mesh__onlineNote mesh__D001001
% 221.09/221.32       use ANURA to search FROGS %26% TOADS 1966-80   
% 221.09/221.32  |- skos__historyNote mesh__D001001 Amphibia %28%1966-1980%29%
% 221.09/221.32  |- skos__hiddenLabel mesh__D001001 Anuras
% 221.09/221.32  |- skos__altLabel mesh__D001001 Frogs and Toads
% 221.09/221.32  |- mesh__dateRevised mesh__D001001 2003-07-09
% 221.09/221.32  |- mesh__publicMeSHNote mesh__D001001
% 221.09/221.32       81; FROGS %26% TOADS were headings 1964-80   
% 221.09/221.32  |- rdf__type mesh__D001001sskos__Concept
% 221.09/221.32  |- skos__scopeNote mesh__D001001
% 221.09/221.32       An order of the class Amphibia, which includes several families of frogs and toads. They are characterized by well developed hind limbs adapted for jumping, fused head and trunk and webbed toes. The term %22%toad%22% is ambiguous and is properly applied only to the family Bufonidae.%A%    
% 221.09/221.32  |- mesh__historyNote mesh__D001001
% 221.09/221.32       81; FROGS %26% TOADS were headings 1964-80   
% 221.09/221.32  |- skos__scopeNote mesh__D020764
% 221.09/221.32       A member of the Rho family of MONOMERIC GTP-BINDING PROTEINS. It is associated with a diverse array of cellular functions including cytoskeletal changes, filopodia formation and transport through the GOLGI APPARATUS. This enzyme was formerly listed as EC 3.6.1.47.%A%    
% 221.09/221.32  |- skos__altLabel mesh__D020764 p21 cdc42
% 221.09/221.32  |- skos__prefLabel mesh__D020764 cdc42 GTP-Binding Protein
% 221.09/221.32  |- skos__hiddenLabel mesh__D020764 cdc42 GTP Binding Protein
% 221.09/221.32  |- mesh__historyNote mesh__D020764
% 221.09/221.32       2000; use CDC42 GTP-BINDING PROTEIN %28%NM%29% 1991-1999   
% 221.09/221.32  |- skos__broader mesh__D020764smesh__D020741
% 221.09/221.32  |- skos__hiddenLabel mesh__D020764 G25P GTP Binding Protein
% 221.09/221.32  |- skos__altLabel mesh__D020764 cdc42 Protein
% 221.09/221.32  |- mesh__dateCreated mesh__D020764 1999-11-03
% 221.09/221.32  |- skos__historyNote mesh__D020764 G-Proteins %28%1991-1999%29%
% 221.09/221.32  |- skos__hiddenLabel mesh__D020764 GTP-Binding Protein, cdc42
% 221.09/221.32  |- mesh__recordMaintainer mesh__D020764 ags
% 221.09/221.32  |- skos__altLabel mesh__D020764 G25P GTP-Binding Protein
% 221.09/221.32  |- mesh__recordOriginator mesh__D020764 jmp
% 221.09/221.32  |- rdf__type mesh__D020764sskos__Concept
% 221.09/221.32  |- skos__hiddenLabel mesh__D020764 cdc42, p21
% 221.09/221.32  |- mesh__publicMeSHNote mesh__D020764
% 221.09/221.32       2000; G25K PROTEIN %28%now CDC42 GTP-BINDING PROTEIN%29% was indexed under G-PROTEINS 1991-1999%A%  
% 221.09/221.32  |- skos__altLabel mesh__D020764 G25K Protein
% 221.09/221.32  |- mesh__dateEstablished mesh__D020764 2000-01-01
% 221.09/221.32  |- skos__annotation mesh__D020764
% 221.09/221.32       CDC42 GTP-BINDING PROTEIN, SACCHAROMYCES CEREVISIAE is also available%A%  
% 221.09/221.32  |- skos__hiddenLabel mesh__D020764
% 221.09/221.32       G25K GTP Binding Protein, Placental Isoform
% 221.09/221.32  |- skos__hiddenLabel mesh__D020764 GTP-Binding Protein, G25P
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D020764 2006A
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D020764 2006
% 221.09/221.32  |- mesh__recordAuthorizer mesh__D020764 ags
% 221.09/221.32  |- mesh__dateRevised mesh__D020764 2005-07-20
% 221.09/221.32  |- skos__hiddenLabel mesh__D006295 Health Resource
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D006295 2006
% 221.09/221.32  |- mesh__publicMeSHNote mesh__D006295 78   
% 221.09/221.32  |- mesh__recordAuthorizer mesh__D006295 sjn
% 221.09/221.32  |- skos__annotation mesh__D006295 specify geog   
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D006295 2001
% 221.09/221.32  |- skos__prefLabel mesh__D006295 Health Resources
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D006295 2005
% 221.09/221.32  |- mesh__dateEstablished mesh__D006295 1978-01-01
% 221.09/221.32  |- skos__scopeNote mesh__D006295
% 221.09/221.32       Available manpower, facilities, revenue, equipment, and supplies to produce requisite health care and services.%A%    
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D006295 2000
% 221.09/221.32  |- mesh__recordOriginator mesh__D006295 EC
% 221.09/221.32  |- skos__broader mesh__D006295smesh__D003695
% 221.09/221.32  |- mesh__recordMaintainer mesh__D006295 kle
% 221.09/221.32  |- skos__hiddenLabel mesh__D006295 Resources, Health
% 221.09/221.32  |- mesh__historyNote mesh__D006295 78   
% 221.09/221.32  |- mesh__dateRevised mesh__D006295 1999-11-03
% 221.09/221.32  |- skos__hiddenLabel mesh__D006295 Resource, Health
% 221.09/221.32  |- rdf__type mesh__D006295sskos__Concept
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D006295 2004
% 221.09/221.32  |- mesh__dateCreated mesh__D006295 1977-05-12
% 221.09/221.32  |- skos__broader mesh__D006295smesh__D006285
% 221.09/221.32  |- skos__hiddenLabel mesh__D006295 Resource
% 221.09/221.32  |- skos__related mesh__D006295smesh__D015276
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D006295 2002
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D006295 2003
% 221.09/221.32  |- skos__broader mesh__D010130Q000031smesh__D010130
% 221.09/221.32  |- mesh__preferredCombination mesh__D010130Q000031smesh__D000618
% 221.09/221.32  |- rdf__type mesh__D010130Q000031smesh__CompoundConcept
% 221.09/221.32  |- skos__hiddenLabel mesh__D014727 Vestibuloplasties
% 221.09/221.32  |- skos__broader mesh__D014727smesh__D013516
% 221.09/221.32  |- skos__scopeNote mesh__D014727
% 221.09/221.32       Those procedures designed to widen the zone of attached gingiva and deepen the vestibular depth which will facilitate the clearance of the area for natural food passage, and provide access for toothbrushing and interdental stimulation.%A%    
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D014727 2000
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D014727 2005
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D014727 1999
% 221.09/221.32  |- skos__prefLabel mesh__D014727 Vestibuloplasty
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D014727 2006
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D014727 2001
% 221.09/221.32  |- mesh__dateCreated mesh__D014727 1999-01-01
% 221.09/221.32  |- skos__annotation mesh__D014727
% 221.09/221.32       refers to the oral cavity, not to the vestib appar; do not use /util except by MeSH definition%A%  
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D014727 2003
% 221.09/221.32  |- mesh__recordAuthorizer mesh__D014727 SJN
% 221.09/221.32  |- mesh__dateRevised mesh__D014727 1997-06-20
% 221.09/221.32  |- skos__historyNote mesh__D014727 Surgery, Oral %28%1966-1967%29%
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D014727 2004
% 221.09/221.32  |- mesh__dateEstablished mesh__D014727 1972-01-01
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D014727 2002
% 221.09/221.32  |- rdf__type mesh__D014727sskos__Concept
% 221.09/221.32  |- mesh__recordOriginator mesh__D014727 NLM
% 221.09/221.32  |- mesh__publicMeSHNote mesh__D014727 72   
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D014727 1998
% 221.09/221.32  |- mesh__recordMaintainer mesh__D014727 PXP
% 221.09/221.32  |- mesh__historyNote mesh__D014727 72%28%69%29%   
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D000707 2006
% 221.09/221.32  |- mesh__recordOriginator mesh__D000707 NLM
% 221.09/221.32  |- skos__hiddenLabel mesh__D000707 Anaphylactic Shock
% 221.09/221.32  |- skos__altLabel mesh__D000707 Anaphylactic Reaction
% 221.09/221.32  |- skos__hiddenLabel mesh__D000707 Anaphylactic Reactions
% 221.09/221.32  |- skos__altLabel mesh__D000707 Shock, Anaphylactic
% 221.09/221.32  |- skos__related mesh__D000707smesh__D013189
% 221.09/221.32  |- skos__broader mesh__D000707smesh__D006969
% 221.09/221.32  |- mesh__dateRevised mesh__D000707 2005-06-30
% 221.09/221.32  |- skos__prefLabel mesh__D000707 Anaphylaxis
% 221.09/221.32  |- mesh__dateCreated mesh__D000707 1999-01-01
% 221.09/221.32  |- mesh__recordMaintainer mesh__D000707 nns
% 221.09/221.32  |- skos__scopeNote mesh__D000707
% 221.09/221.32       An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.%A%    
% 221.09/221.32  |- skos__hiddenLabel mesh__D000707 Reaction, Anaphylactic
% 221.09/221.32  |- rdf__type mesh__D000707sskos__Concept
% 221.09/221.32  |- skos__hiddenLabel mesh__D000707 Reactions, Anaphylactic
% 221.09/221.32  |- mesh__recordAuthorizer mesh__D000707 sjn
% 221.09/221.32  |- skos__altLabel mesh__D019412 Anatomy, Sectional
% 221.09/221.32  |- mesh__recordMaintainer mesh__D019412 ags
% 221.09/221.32  |- mesh__dateRevised mesh__D019412 2004-07-07
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D019412 2006
% 221.09/221.32  |- mesh__dateCreated mesh__D019412 1996-06-13
% 221.09/221.32  |- mesh__dateEstablished mesh__D019412 1997-01-01
% 221.09/221.32  |- skos__scopeNote mesh__D019412
% 221.09/221.32       Descriptive anatomy based on three-dimensional imaging %28%IMAGING, THREE-DIMENSIONAL%29% of the body, organs, and structures using a series of computer multiplane sections, displayed by transverse, coronal, and sagittal analyses. It is essential to accurate interpretation by the radiologist of such techniques as ultrasonic diagnosis, MAGNETIC RESONANCE IMAGING, and computed tomography %28%TOMOGRAPHY, X-RAY COMPUTED%29%. %28%From Lane %26% Sharfaei, Modern Sectional Anatomy, 1992, Preface%29%%A%    
% 221.09/221.32  |- skos__hiddenLabel mesh__D019412 Cross Sectional Anatomy
% 221.09/221.32  |- skos__prefLabel mesh__D019412 Anatomy, Cross-Sectional
% 221.09/221.32  |- mesh__historyNote mesh__D019412 97   
% 221.09/221.32  |- skos__related mesh__D019412smesh__D008279
% 221.09/221.32  |- mesh__publicMeSHNote mesh__D019412 97   
% 221.09/221.32  |- rdf__type mesh__D019412sskos__Concept
% 221.09/221.32  |- skos__annotation mesh__D019412
% 221.09/221.32       coordinate with organ/anat %28%IM%29%; DF: ANAT CROSS SECTION   
% 221.09/221.32  |- skos__broader mesh__D019412smesh__D000715
% 221.09/221.32  |- skos__altLabel mesh__D019412 Cross-Sectional Anatomy
% 221.09/221.32  |- skos__related mesh__D019412smesh__D014054
% 221.09/221.32  |- skos__hiddenLabel mesh__D019412 Anatomy, Cross Sectional
% 221.09/221.32  |- skos__related mesh__D019412smesh__D021621
% 221.09/221.32  |- skos__altLabel mesh__D019412 Sectional Anatomy
% 221.09/221.32  |- mesh__recordAuthorizer mesh__D019412 sjn
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D019412 2005
% 221.09/221.32  |- mesh__recordOriginator mesh__D019412 TGC
% 221.09/221.32  |- skos__related mesh__D019412smesh__D014463
% 221.09/221.32  |- skos__prefLabel mesh__D046809 Siadenovirus
% 221.09/221.32  |- skos__broader mesh__D046809smesh__D000256
% 221.09/221.32  |- mesh__publicMeSHNote mesh__D046809 2005   
% 221.09/221.32  |- mesh__recordOriginator mesh__D046809 ags
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D046809 2006A
% 221.09/221.32  |- skos__altLabel mesh__D046809 Marble spleen disease virus
% 221.09/221.32  |- mesh__dateRevised mesh__D046809 2005-07-14
% 221.09/221.32  |- skos__annotation mesh__D046809
% 221.09/221.32       infection: coord IM with ADENOVIRIDAE INFECTIONS %28%IM%29%   
% 221.09/221.32  |- mesh__dateEstablished mesh__D046809 2005-01-01
% 221.09/221.32  |- skos__hiddenLabel mesh__D046809 adenovirus, Frog
% 221.09/221.32  |- mesh__historyNote mesh__D046809 2005   
% 221.09/221.32  |- mesh__activeMeSHYear mesh__D046809 2005
% 221.09/221.32  |- skos__hiddenLabel mesh__D046809 Siadenoviruses
% 221.09/221.32  |- mesh__recordMaintainer mesh__D046809 ags
% 221.09/221.33  |- rdf__type mesh__D046809sskos__Concept
% 221.09/221.33  |- mesh__dateCreated mesh__D046809 2004-07-07
% 221.09/221.33  |- mesh__activeMeSHYear mesh__D046809 2006
% 221.09/221.33  |- skos__hiddenLabel mesh__D046809 Frog adenoviruses
% 221.09/221.33  |- skos__scopeNote mesh__D046809
% 221.09/221.33       A genus of ADENOVIRIDAE comprising species including viruses of frogs %28%FROGS AND TOADS%29% and TURKEYS. The type species is Frog adenovirus.%A%    
% 221.09/221.33  |- mesh__recordAuthorizer mesh__D046809 ags
% 221.09/221.33  |- mesh__activeMeSHYear mesh__D010337 1999
% 221.09/221.33  |- skos__hiddenLabel mesh__D010337 Hospital Pathology Departments
% 221.09/221.33  |- mesh__activeMeSHYear mesh__D010337 2003
% 221.09/221.33  |- skos__annotation mesh__D010337 DF: PATHOL DEP   
% 221.09/221.33  |- mesh__activeMeSHYear mesh__D010337 1994
% 221.09/221.33  |- mesh__activeMeSHYear mesh__D010337 1997
% 221.09/221.33  |- skos__altLabel mesh__D010337 Department, Hospital Pathology
% 221.09/221.33  |- rdf__type mesh__D010337sskos__Concept
% 221.09/221.33  |- mesh__activeMeSHYear mesh__D010337 2002
% 221.09/221.33  |- skos__scopeNote mesh__D010337
% 221.09/221.33       Hospital department which administers and provides pathology services.%A%    
% 221.09/221.33  |- mesh__activeMeSHYear mesh__D010337 1998
% 221.09/221.33  |- mesh__dateCreated mesh__D010337 1977-05-19
% 221.09/221.33  |- mesh__recordAuthorizer mesh__D010337 PLS
% 221.09/221.33  |- mesh__activeMeSHYear mesh__D010337 1996
% 221.09/221.33  |- skos__prefLabel mesh__D010337 Pathology Department, Hospital
% 221.09/221.33  |- skos__altLabel mesh__D010337 Hospital Pathology Department
% 221.09/221.33  |- mesh__recordOriginator mesh__D010337 EC
% 221.09/221.33  |- skos__altLabel mesh__D010337 Pathology Departments, Hospital
% 221.09/221.33  |- mesh__historyNote mesh__D010337
% 221.09/221.33       91%28%Aug 77%29%; was see under HOSPITAL DEPARTMENTS 1977-90   
% 221.09/221.33  |- skos__hiddenLabel mesh__D010337 Departments, Hospital Pathology
% 221.09/221.33  |- mesh__publicMeSHNote mesh__D010337
% 221.09/221.33       91; was see under HOSPITAL DEPARTMENTS Aug 1977-90   
% 221.09/221.33  |- mesh__activeMeSHYear mesh__D010337 2001
% 221.09/221.33  |- mesh__activeMeSHYear mesh__D010337 2006
% 221.09/221.33  |- mesh__activeMeSHYear mesh__D010337 2000
% 221.09/221.33  |- mesh__activeMeSHYear mesh__D010337 2004
% 221.09/221.33  |- mesh__activeMeSHYear mesh__D010337 1995
% 221.09/221.33  |- mesh__recordMaintainer mesh__D010337 PLS
% 221.09/221.33  |- mesh__dateRevised mesh__D010337 1992-05-15
% 221.09/221.33  |- mesh__dateEstablished mesh__D010337 1991-01-01
% 221.09/221.33  |- skos__broader mesh__D010337smesh__D006748
% 221.09/221.33  |- mesh__activeMeSHYear mesh__D010337 1993
% 221.09/221.33  |- mesh__activeMeSHYear mesh__D010337 2005
% 221.09/221.33  |- mesh__recordMaintainer mesh__D029042 sjn
% 221.09/221.33  |- skos__annotation mesh__D029042
% 221.09/221.33       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.09/221.33  |- skos__altLabel mesh__D029042 Kiwi Plant
% 221.09/221.33  |- mesh__activeMeSHYear mesh__D029042 2004
% 221.09/221.33  |- mesh__historyNote mesh__D029042 2002   
% 221.09/221.33  |- skos__prefLabel mesh__D029042 Actinidia
% 221.09/221.33  |- skos__broader mesh__D029042smesh__D029041
% 221.09/221.33  |- mesh__recordOriginator mesh__D029042 ssb
% 221.09/221.33  |- skos__scopeNote mesh__D029042
% 221.09/221.33       A plant species of the family ACTINIDIACEAE, order Theales.%A%    
% 221.09/221.33  |- mesh__activeMeSHYear mesh__D029042 2006
% 221.09/221.33  |- mesh__publicMeSHNote mesh__D029042 2002   
% 221.09/221.33  |- mesh__dateCreated mesh__D029042 2001-07-25
% 221.09/221.33  |- mesh__activeMeSHYear mesh__D029042 2005
% 221.09/221.33  |- rdf__type mesh__D029042sskos__Concept
% 221.18/221.33  |- mesh__dateEstablished mesh__D029042 2002-01-01
% 221.18/221.33  |- mesh__dateRevised mesh__D029042 2003-07-25
% 221.18/221.33  |- mesh__recordAuthorizer mesh__D029042 sjn
% 221.18/221.33  |- mesh__recordAuthorizer mesh__D015820 sjn
% 221.18/221.33  |- skos__hiddenLabel mesh__D015820 P Cadherin
% 221.18/221.33  |- skos__hiddenLabel mesh__D015820 P Cadherins
% 221.18/221.33  |- skos__hiddenLabel mesh__D015820 N Cadherins
% 221.18/221.33  |- skos__hiddenLabel mesh__D015820 E Cadherin
% 221.18/221.33  |- mesh__dateCreated mesh__D015820 1989-05-25
% 221.18/221.33  |- skos__altLabel mesh__D015820 N-Cadherin
% 221.18/221.33  |- skos__hiddenLabel mesh__D015820 ARC 1
% 221.18/221.33  |- skos__altLabel mesh__D015820 Liver Cell Adhesion Molecule
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D015820 2006
% 221.18/221.33  |- skos__scopeNote mesh__D015820
% 221.18/221.33       A group of functionally related glycoproteins responsible for the calcium-dependent cell-to-cell adhesion mechanism. They are divided into subclasses E-, P-, and N-cadherins, which are distinct in immunological specificity and tissue distribution. They promote cell adhesion via a homophilic mechanism. These compounds play a role in the construction of tissues and of the whole animal body.%A%    
% 221.18/221.33  |- skos__altLabel mesh__D015820 Liver Cell Adhesion Molecules
% 221.18/221.33  |- mesh__dateEstablished mesh__D015820 1990-01-01
% 221.18/221.33  |- skos__altLabel mesh__D015820 E-Cadherin
% 221.18/221.33  |- skos__broader mesh__D015820smesh__D015815
% 221.18/221.33  |- skos__hiddenLabel mesh__D015820 N Cadherin
% 221.18/221.33  |- mesh__recordOriginator mesh__D015820 RLS
% 221.18/221.33  |- skos__historyNote mesh__D015820 Antigens, Surface %28%1979-1989%29%
% 221.18/221.33  |- mesh__publicMeSHNote mesh__D015820
% 221.18/221.33       90; N CADHERIN was indexed under CADHERINS 1994-95; LIVER CELL ADHESION MOLECULES was see CELL ADHESION MOLECULES 1990-95%A%  
% 221.18/221.33  |- skos__historyNote mesh__D015820 Glycoproteins %28%1966-1987%29%
% 221.18/221.33  |- mesh__dateRevised mesh__D015820 2005-06-30
% 221.18/221.33  |- skos__hiddenLabel mesh__D015820 E Cadherins
% 221.18/221.33  |- skos__prefLabel mesh__D015820 Cadherins
% 221.18/221.33  |- mesh__onlineNote mesh__D015820
% 221.18/221.33       use CADHERINS %28%NM%29% to search N CADHERIN 1994-95; use CELL ADHESION MOLECULES to search LIVER CELL ADHESION MOLECULES 1990-95%A%  
% 221.18/221.33  |- skos__historyNote mesh__D015820 Membrane Glycoproteins %28%1988-1989%29%
% 221.18/221.33  |- skos__historyNote mesh__D015820
% 221.18/221.33       Calcium-Binding Proteins %28%1980-1989%29%
% 221.18/221.33  |- rdf__type mesh__D015820sskos__Concept
% 221.18/221.33  |- skos__altLabel mesh__D015820 P-Cadherin
% 221.18/221.33  |- mesh__recordMaintainer mesh__D015820 ssb
% 221.18/221.33  |- skos__annotation mesh__D015820
% 221.18/221.33       glycoproteins in calcium-dependent cell-to-cell adhesion, the action being the source of the name: Calcium-dependent ADHesion; /drug eff /ultrastruct permitted%A%  
% 221.18/221.33  |- mesh__historyNote mesh__D015820
% 221.18/221.33       90; N CADHERIN was NM 1994-95; LIVER CELL ADHESION MOLECULES was see CELL ADHESION MOLECULES 1990-95%A%  
% 221.18/221.33  |- mesh__dateCreated mesh__D015022 1999-01-01
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D015022 2006
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D015022 2002
% 221.18/221.33  |- mesh__dateRevised mesh__D015022 2005-07-19
% 221.18/221.33  |- skos__annotation mesh__D015022
% 221.18/221.33       see tree for YUGOSLAVIA as an Eastern European nation %26% indentions as a historical entity%A%  
% 221.18/221.33  |- mesh__recordMaintainer mesh__D015022 ags
% 221.18/221.33  |- skos__broader mesh__D015022smesh__D005061
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D015022 2005
% 221.18/221.33  |- mesh__recordAuthorizer mesh__D015022 ags
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D015022 2004
% 221.18/221.33  |- rdf__type mesh__D015022sskos__Concept
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D015022 2006A
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D015022 2003
% 221.18/221.33  |- skos__broader mesh__D015022smesh__D017516
% 221.18/221.33  |- mesh__recordOriginator mesh__D015022 NLM
% 221.18/221.33  |- skos__scopeNote mesh__D015022
% 221.18/221.33       Created as the Kingdom of Serbs, Croats, and Slovenes in 1918. Yugoslavia became the official name in 1929. BOSNIA-HERZEGOVINA; CROATIA; and SLOVENIA formed independent countries and split from Yugoslavia 7 April 1992. Macedonia, one of the Yugoslav republics, became an independent country 8 February 1994 as The Former Yugoslav Republic of Macedonia %28%MACEDONIA %28%REPUBLIC%29%;%29%.%A%    
% 221.18/221.33  |- skos__prefLabel mesh__D015022 Yugoslavia
% 221.18/221.33  |- skos__hiddenLabel mesh__D001800 Blood Specimen Collections
% 221.18/221.33  |- mesh__dateRevised mesh__D001800 1997-06-20
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D001800 2002
% 221.18/221.33  |- mesh__recordOriginator mesh__D001800 NLM
% 221.18/221.33  |- rdf__type mesh__D001800sskos__Concept
% 221.18/221.33  |- mesh__recordAuthorizer mesh__D001800 SJN
% 221.18/221.33  |- skos__hiddenLabel mesh__D001800 Specimen Collections, Blood
% 221.18/221.33  |- skos__broader mesh__D001800smesh__D011677
% 221.18/221.33  |- skos__prefLabel mesh__D001800 Blood Specimen Collection
% 221.18/221.33  |- skos__hiddenLabel mesh__D001800 Specimen Collection, Blood
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D001800 2005
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D001800 2003
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D001800 2006
% 221.18/221.33  |- skos__annotation mesh__D001800 includes %22%handling%22%   
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D001800 2000
% 221.18/221.33  |- mesh__dateCreated mesh__D001800 1999-01-01
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D001800 2004
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D001800 1998
% 221.18/221.33  |- skos__scopeNote mesh__D001800
% 221.18/221.33       The taking of a blood sample to determine its character as a whole, to identify levels of its component cells, chemicals, gases, or other constituents, to perform pathological examination, etc.%A%    
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D001800 2001
% 221.18/221.33  |- mesh__recordMaintainer mesh__D001800 PXP
% 221.18/221.33  |- skos__hiddenLabel mesh__D001800 Collection, Blood Specimen
% 221.18/221.33  |- skos__hiddenLabel mesh__D001800 Collections, Blood Specimen
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D001800 1999
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D001002 2005
% 221.18/221.33  |- skos__broader mesh__D001002smesh__D009846
% 221.18/221.33  |- rdf__type mesh__D001002sskos__Concept
% 221.18/221.33  |- skos__annotation mesh__D001002
% 221.18/221.33       do not confuse with OLIGURIA, diminished amount   
% 221.18/221.33  |- skos__hiddenLabel mesh__D001002 Anurias
% 221.18/221.33  |- mesh__dateRevised mesh__D001002 1999-11-03
% 221.18/221.33  |- skos__scopeNote mesh__D001002 Inability to form or excrete urine.     
% 221.18/221.33  |- mesh__recordMaintainer mesh__D001002 KEV
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D001002 2001
% 221.18/221.33  |- skos__prefLabel mesh__D001002 Anuria
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D001002 2004
% 221.18/221.33  |- skos__broader mesh__D001002smesh__D007674
% 221.18/221.33  |- mesh__recordOriginator mesh__D001002 NLM
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D001002 2000
% 221.18/221.33  |- skos__broader mesh__D001002smesh__D020924
% 221.18/221.33  |- mesh__dateCreated mesh__D001002 1999-01-01
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D001002 2003
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D001002 2006
% 221.18/221.33  |- mesh__recordAuthorizer mesh__D001002 sjn
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D001002 2002
% 221.18/221.33  |- skos__altLabel mesh__D020765 Arterial Brain Diseases
% 221.18/221.33  |- skos__hiddenLabel mesh__D020765 Intracranial Arterial Disease
% 221.18/221.33  |- mesh__dateCreated mesh__D020765 1999-11-08
% 221.18/221.33  |- skos__historyNote mesh__D020765
% 221.18/221.33       Cerebral Arterial Diseases/classification %28%1967-1999%29%
% 221.18/221.33  |- skos__scopeNote mesh__D020765
% 221.18/221.33       Conditions which affect the arteries of the brain, meninges, and intracranial portions of the cranial nerves. Relatively common disease processes in this category include: ATHEROSCLEROSIS; emboli; thrombosis %28%INTRACRANIAL EMBOLISM AND THROMBOSIS%29%; VASCULITIS, CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR TRAUMA; vasospasm %28%VASOSPASM, INTRACRANIAL%29%; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; and infections.%A%    
% 221.18/221.33  |- skos__hiddenLabel mesh__D020765 Brain Disorder, Arterial
% 221.18/221.33  |- skos__prefLabel mesh__D020765 Intracranial Arterial Diseases
% 221.18/221.33  |- skos__historyNote mesh__D020765
% 221.18/221.33       Cerebrovascular Disorders/complications %28%1965-1999%29%
% 221.18/221.33  |- skos__hiddenLabel mesh__D020765 Brain Arterial Disease
% 221.18/221.33  |- skos__hiddenLabel mesh__D020765 Arterial Disorder, Intracranial
% 221.18/221.33  |- skos__hiddenLabel mesh__D020765 Arterial Disease, Intracranial
% 221.18/221.33  |- skos__hiddenLabel mesh__D020765 Arterial Disease, Brain
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D020765 2002
% 221.18/221.33  |- skos__hiddenLabel mesh__D020765 Arterial Brain Disorder
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D020765 2001
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D020765 2004
% 221.18/221.33  |- rdf__type mesh__D020765sskos__Concept
% 221.18/221.33  |- skos__altLabel mesh__D020765 Intracranial Arterial Disorders
% 221.18/221.33  |- skos__hiddenLabel mesh__D020765 Brain Arterial Diseases
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D020765 2000
% 221.18/221.33  |- mesh__publicMeSHNote mesh__D020765 2000   
% 221.18/221.33  |- mesh__dateEstablished mesh__D020765 2000-01-01
% 221.18/221.33  |- skos__broader mesh__D020765smesh__D002561
% 221.18/221.33  |- skos__altLabel mesh__D020765 Arterial Diseases, Intracranial
% 221.18/221.33  |- skos__hiddenLabel mesh__D020765 Arterial Disorders, Intracranial
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D020765 2006
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D020765 2003
% 221.18/221.33  |- skos__hiddenLabel mesh__D020765 Arterial Brain Disease
% 221.18/221.33  |- mesh__historyNote mesh__D020765 2000   
% 221.18/221.33  |- skos__hiddenLabel mesh__D020765 Intracranial Arterial Disorder
% 221.18/221.33  |- skos__altLabel mesh__D020765 Brain Disorders, Arterial
% 221.18/221.33  |- skos__hiddenLabel mesh__D020765 Arterial Brain Disorders
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D020765 2005
% 221.18/221.33  |- skos__altLabel mesh__D020765 Arterial Diseases, Brain
% 221.18/221.33  |- mesh__dateCreated mesh__D006296 1999-01-01
% 221.18/221.33  |- mesh__publicMeSHNote mesh__D006296 74   
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D006296 2006
% 221.18/221.33  |- mesh__dateRevised mesh__D006296 1999-11-03
% 221.18/221.33  |- mesh__onlineNote mesh__D006296
% 221.18/221.33       pre-explosion = HEALTH SERVICES %28%PX%29%   
% 221.18/221.33  |- mesh__recordOriginator mesh__D006296 NLM
% 221.18/221.33  |- skos__broader mesh__D006296smesh__D005159
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D006296 2000
% 221.18/221.33  |- skos__altLabel mesh__D006296 Services, Health
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D006296 2003
% 221.18/221.33  |- skos__annotation mesh__D006296
% 221.18/221.33       IM GEN or unspecified; prefer specifics; DF: HEALTH SERV   
% 221.18/221.33  |- skos__hiddenLabel mesh__D006296 Service, Health
% 221.18/221.33  |- mesh__recordAuthorizer mesh__D006296 sjn
% 221.18/221.33  |- rdf__type mesh__D006296sskos__Concept
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D006296 2004
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D006296 2001
% 221.18/221.33  |- skos__scopeNote mesh__D006296
% 221.18/221.33       Services for the diagnosis and treatment of disease and the maintenance of health.%A%    
% 221.18/221.33  |- mesh__recordMaintainer mesh__D006296 kle
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D006296 2002
% 221.18/221.33  |- mesh__dateEstablished mesh__D006296 1974-01-01
% 221.18/221.33  |- skos__hiddenLabel mesh__D006296 Health Service
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D006296 2005
% 221.18/221.33  |- skos__prefLabel mesh__D006296 Health Services
% 221.18/221.33  |- mesh__historyNote mesh__D006296 74   
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D014728 2006
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D014728 1996
% 221.18/221.33  |- skos__prefLabel mesh__D014728 Veterans
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D014728 1993
% 221.18/221.33  |- mesh__recordOriginator mesh__D014728 NLM
% 221.18/221.33  |- mesh__historyNote mesh__D014728 81; was VETERANS AFFAIRS 1963-80   
% 221.18/221.33  |- mesh__dateCreated mesh__D014728 1999-01-01
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D014728 2003
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D014728 1997
% 221.18/221.33  |- mesh__recordAuthorizer mesh__D014728 PLS
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D014728 2000
% 221.18/221.33  |- mesh__publicMeSHNote mesh__D014728 81; was VETERANS AFFAIRS 1963-80   
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D014728 2004
% 221.18/221.33  |- rdf__type mesh__D014728sskos__Concept
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D014728 2001
% 221.18/221.33  |- mesh__recordMaintainer mesh__D014728 TAP
% 221.18/221.33  |- skos__broader mesh__D014728smesh__D009272
% 221.18/221.33  |- mesh__onlineNote mesh__D014728
% 221.18/221.33       use VETERANS to search VETERANS AFFAIRS 1966-80   
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D014728 1994
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D014728 1998
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D014728 1995
% 221.18/221.33  |- skos__hiddenLabel mesh__D014728 Veteran
% 221.18/221.33  |- mesh__dateRevised mesh__D014728 1992-05-18
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D014728 2005
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D014728 1999
% 221.18/221.33  |- skos__scopeNote mesh__D014728 Former members of the armed services.     
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D014728 2002
% 221.18/221.33  |- mesh__recordAuthorizer mesh__D000708 sjn
% 221.18/221.33  |- skos__prefLabel mesh__D000708 Anaplasia
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D000708 2005
% 221.18/221.33  |- skos__annotation mesh__D000708
% 221.18/221.33       IM GEN only; coord NIM with organ /pathol %28%IM%29%; note CARCINOMA, ANAPLASTIC see CARCINOMA: do not coord with ANAPLASIA unless anaplasia is particularly discussed%A%  
% 221.18/221.33  |- mesh__recordOriginator mesh__D000708 VDK
% 221.18/221.33  |- rdf__type mesh__D000708sskos__Concept
% 221.18/221.33  |- mesh__publicMeSHNote mesh__D000708 77   
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D000708 2004
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D000708 2006
% 221.18/221.33  |- mesh__dateCreated mesh__D000708 1976-05-19
% 221.18/221.33  |- mesh__dateRevised mesh__D000708 2003-07-09
% 221.18/221.33  |- mesh__historyNote mesh__D000708 77   
% 221.18/221.33  |- mesh__dateEstablished mesh__D000708 1977-01-01
% 221.18/221.33  |- mesh__recordMaintainer mesh__D000708 lkt
% 221.18/221.33  |- skos__hiddenLabel mesh__D000708 Anaplasias
% 221.18/221.33  |- skos__broader mesh__D000708smesh__D009385
% 221.18/221.33  |- skos__scopeNote mesh__D000708
% 221.18/221.33       Loss of structural differentiation and useful function of neoplastic cells.%A%    
% 221.18/221.33  |- mesh__dateCreated mesh__D019413 1996-06-10
% 221.18/221.33  |- skos__altLabel mesh__D019413 Life-Breath %28%Philosophy%29%
% 221.18/221.33  |- skos__hiddenLabel mesh__D019413 Energy, Vital %28%Philosophy%29%
% 221.18/221.33  |- mesh__recordAuthorizer mesh__D019413 sjn
% 221.18/221.33  |- mesh__publicMeSHNote mesh__D019413 2002; see CH%27%I 1997-2002   
% 221.18/221.33  |- mesh__dateRevised mesh__D019413 2002-07-03
% 221.18/221.33  |- skos__related mesh__D019413smesh__D016709
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D019413 2006
% 221.18/221.33  |- skos__broader mesh__D019413smesh__D008516
% 221.18/221.33  |- skos__hiddenLabel mesh__D019413 Energies, Vital %28%Philosophy%29%
% 221.18/221.33  |- skos__annotation mesh__D019413 Qi defic goes here   
% 221.18/221.33  |- skos__related mesh__D019413smesh__D016710
% 221.18/221.33  |- mesh__recordMaintainer mesh__D019413 ssb
% 221.18/221.33  |- rdf__type mesh__D019413sskos__Concept
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D019413 2005
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D019413 2004
% 221.18/221.33  |- mesh__historyNote mesh__D019413 2002%28%1997%29%   
% 221.18/221.33  |- mesh__recordOriginator mesh__D019413 TGC
% 221.18/221.33  |- skos__related mesh__D019413smesh__D016711
% 221.18/221.33  |- skos__scopeNote mesh__D019413
% 221.18/221.33       The vital life force in the body, supposedly able to be regulated by acupuncture. It corresponds roughly to the Greek pneuma, the Latin spiritus, and the ancient Indian prana. The concept of life-breath or vital energy was formulated as an indication of the awareness of man, originally directed externally toward nature or society but later turned inward to the self or life within. %28%From Comparison between Concepts of Life-Breath in East and West, 15th International Symposium on the Comparative History of Medicine - East and West, August 26-September 3, 1990, Shizuoka, Japan, pp. ix-x%29%%A%    
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D019413 2003
% 221.18/221.33  |- skos__prefLabel mesh__D019413 Qi
% 221.18/221.33  |- skos__broader mesh__D019413smesh__D010684
% 221.18/221.33  |- skos__altLabel mesh__D019413 Ch%27%i
% 221.18/221.33  |- skos__hiddenLabel mesh__D019413 Life Breath %28%Philosophy%29%
% 221.18/221.33  |- skos__altLabel mesh__D019413 Vital Energy %28%Philosophy%29%
% 221.18/221.33  |- mesh__dateEstablished mesh__D019413 1997-01-01
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D011430 2000
% 221.18/221.33  |- mesh__publicMeSHNote mesh__D011430 65   
% 221.18/221.33  |- skos__broader mesh__D011430smesh__D010129
% 221.18/221.33  |- skos__altLabel mesh__D011430 Propoxyprocaine
% 221.18/221.33  |- skos__scopeNote mesh__D011430
% 221.18/221.33       A local anesthetic of the ester type that has a rapid onset of action and a longer duration of action than procaine hydrochloride. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1017%29%%A%    
% 221.18/221.33  |- mesh__recordAuthorizer mesh__D011430 SJN
% 221.18/221.33  |- skos__hiddenLabel mesh__D011430 Hydrochloride, Propoxycaine
% 221.18/221.33  |- mesh__dateEstablished mesh__D011430 1965-01-01
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D011430 2006
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D011430 2005
% 221.18/221.33  |- skos__prefLabel mesh__D011430 Propoxycaine
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D011430 2002
% 221.18/221.33  |- mesh__dateCreated mesh__D011430 1999-01-01
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D011430 2004
% 221.18/221.33  |- mesh__historyNote mesh__D011430 65   
% 221.18/221.33  |- rdf__type mesh__D011430sskos__Concept
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D011430 2001
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D011430 1999
% 221.18/221.33  |- mesh__dateRevised mesh__D011430 1998-06-10
% 221.18/221.33  |- mesh__recordOriginator mesh__D011430 NLM
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D011430 2003
% 221.18/221.33  |- mesh__recordMaintainer mesh__D011430 ADP
% 221.18/221.33  |- mesh__publicMeSHNote mesh__D010338 80   
% 221.18/221.33  |- mesh__dateCreated mesh__D010338 1979-05-29
% 221.18/221.33  |- mesh__recordMaintainer mesh__D010338 JLS
% 221.18/221.33  |- skos__broader mesh__D010338smesh__D010336
% 221.18/221.33  |- skos__historyNote mesh__D010338 Pathology %28%1966-1979%29%
% 221.18/221.33  |- mesh__historyNote mesh__D010338 80   
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D010338 2002
% 221.18/221.33  |- mesh__dateRevised mesh__D010338 1998-06-10
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D010338 2006
% 221.18/221.33  |- mesh__dateEstablished mesh__D010338 1980-01-01
% 221.18/221.33  |- mesh__recordAuthorizer mesh__D010338 SJN
% 221.18/221.33  |- mesh__recordOriginator mesh__D010338 EC
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D010338 2004
% 221.18/221.33  |- skos__annotation mesh__D010338
% 221.18/221.33       SPEC only: do not use as NIM coord: use /pathol with organs %26% diseases: Manual 19.7+, 19.8.52; DF: PATHOL CLIN%A%  
% 221.18/221.33  |- skos__prefLabel mesh__D010338 Pathology, Clinical
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D010338 2005
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D010338 1999
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D010338 2001
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D010338 2003
% 221.18/221.33  |- skos__altLabel mesh__D010338 Clinical Pathology
% 221.18/221.33  |- rdf__type mesh__D010338sskos__Concept
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D010338 2000
% 221.18/221.33  |- skos__scopeNote mesh__D010338
% 221.18/221.33       A subspecialty of pathology applied to the solution of clinical problems, especially the use of laboratory methods in clinical diagnosis. %28%Dorland, 28th ed.%29%%A%    
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D029043 2002
% 221.18/221.33  |- skos__hiddenLabel mesh__D029043 Ebola-like Virus
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D029043 2003
% 221.18/221.33  |- skos__prefLabel mesh__D029043 Ebola-like Viruses
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D029043 2006
% 221.18/221.33  |- skos__altLabel mesh__D029043 Zaire Ebola virus
% 221.18/221.33  |- mesh__historyNote mesh__D029043 2002   
% 221.18/221.33  |- mesh__publicMeSHNote mesh__D029043 2002   
% 221.18/221.33  |- skos__altLabel mesh__D029043 Cote d%27%Ivoire Ebola virus
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D029043 2005
% 221.18/221.33  |- skos__broader mesh__D029043smesh__D016563
% 221.18/221.33  |- skos__altLabel mesh__D029043 Reston Ebola virus
% 221.18/221.33  |- mesh__dateEstablished mesh__D029043 2002-01-01
% 221.18/221.33  |- rdf__type mesh__D029043sskos__Concept
% 221.18/221.33  |- skos__scopeNote mesh__D029043
% 221.18/221.33       A genus in the family FILOVIRIDAE consisting of several distinct species of Ebola virus, each containing separate strains. These viruses cause outbreaks of a contagious, hemorrhagic disease %28%HEMORRHAGIC FEVER, EBOLA%29% in humans, usually with high mortality.%A%    
% 221.18/221.33  |- skos__hiddenLabel mesh__D029043 Ebola like Viruses
% 221.18/221.33  |- skos__altLabel mesh__D029043 Sudan Ebola virus
% 221.18/221.33  |- mesh__dateCreated mesh__D029043 2001-07-25
% 221.18/221.33  |- skos__annotation mesh__D029043 infection = HEMORRHAGIC FEVER, EBOLA   
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D029043 2004
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D015821 1992
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D015821 1991
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D015821 1997
% 221.18/221.33  |- skos__hiddenLabel mesh__D015821 Infections, Ocular Mycotic
% 221.18/221.33  |- skos__hiddenLabel mesh__D015821 Infections, Fungal Ocular
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D015821 2001
% 221.18/221.33  |- skos__hiddenLabel mesh__D015821 Fungal Ocular Infections
% 221.18/221.33  |- mesh__publicMeSHNote mesh__D015821 90   
% 221.18/221.33  |- skos__hiddenLabel mesh__D015821 Ocular Mycoses
% 221.18/221.33  |- mesh__dateEstablished mesh__D015821 1990-01-01
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D015821 1993
% 221.18/221.33  |- skos__hiddenLabel mesh__D015821 Ocular Infection, Fungal
% 221.18/221.33  |- mesh__historyNote mesh__D015821 90   
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D015821 2003
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D015821 1998
% 221.18/221.33  |- skos__hiddenLabel mesh__D015821 Infection, Fungal Eye
% 221.18/221.33  |- skos__hiddenLabel mesh__D015821 Ocular Mycotic Infection
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D015821 2002
% 221.18/221.33  |- skos__altLabel mesh__D015821 Fungal Eye Infections
% 221.18/221.33  |- skos__hiddenLabel mesh__D015821 Mycotic Infection, Ocular
% 221.18/221.33  |- skos__hiddenLabel mesh__D015821 Oculomycoses
% 221.18/221.33  |- skos__hiddenLabel mesh__D015821 Fungal Eye Infection
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D015821 1994
% 221.18/221.33  |- skos__altLabel mesh__D015821 Oculomycosis
% 221.18/221.33  |- skos__broader mesh__D015821smesh__D015817
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D015821 2004
% 221.18/221.33  |- skos__altLabel mesh__D015821 Mycosis, Ocular
% 221.18/221.33  |- skos__hiddenLabel mesh__D015821 Infection, Ocular Mycotic
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D015821 1999
% 221.18/221.33  |- skos__altLabel mesh__D015821 Mycotic Infections, Ocular
% 221.18/221.33  |- skos__annotation mesh__D015821
% 221.18/221.33       coord IM with specific fungal dis %28%IM%29%; DF: EYE INFECT FUNGAL%A%  
% 221.18/221.33  |- mesh__dateCreated mesh__D015821 1989-09-06
% 221.18/221.33  |- skos__prefLabel mesh__D015821 Eye Infections, Fungal
% 221.18/221.33  |- skos__hiddenLabel mesh__D015821 Ocular Mycotic Infections
% 221.18/221.33  |- skos__hiddenLabel mesh__D015821 Fungal Ocular Infection
% 221.18/221.33  |- skos__altLabel mesh__D015821 Ocular Infections, Fungal
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D015821 1995
% 221.18/221.33  |- skos__broader mesh__D015821smesh__D009181
% 221.18/221.33  |- mesh__activeMeSHYear mesh__D015821 2005
% 221.18/221.33  |- skos__hiddenLabel mesh__D015821 Infection, Fungal Ocular
% 221.18/221.33  |- skos__scopeNote mesh__D015821
% 221.18/221.33       Infection by a variety of fungi, usually through four possible mechanisms: superficial infection producing conjunctivitis, keratitis, or lacrimal obstruction; extension of infection from neighboring structures - skin, paranasal sinuses, nasopharynx; direct introduction during surgery or accidental penetrating trauma; or via the blood or lymphatic routes in patients with underlying mycoses.%A%    
% 221.18/221.33  |- skos__historyNote mesh__D015821
% 221.18/221.33       specific fungal infection %28%1966-1989%29%
% 221.18/221.33  |- rdf__type mesh__D015821sskos__Concept
% 221.18/221.33  |- skos__hiddenLabel mesh__D015821 Ocular Mycosis
% 221.18/221.33  |- skos__hiddenLabel mesh__D015821 Eye Infection, Fungal
% 221.18/221.34  |- skos__historyNote mesh__D015821 Eye Diseases %28%1966-1989%29%
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015821 2006
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015821 1990
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015821 1996
% 221.18/221.34  |- skos__hiddenLabel mesh__D015821 Infections, Fungal Eye
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015821 2000
% 221.18/221.34  |- skos__hiddenLabel mesh__D015821 Mycoses, Ocular
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015023 2003
% 221.18/221.34  |- skos__scopeNote mesh__D015023
% 221.18/221.34       A republic in central Africa, south of the CENTRAL AFRICAN REPUBLIC and north of ANGOLA and ZAMBIA. Its name changes bespeak its history: 1885-1908 Congo Free State, 1908-60 Belgian Congo, 1960-71 Democratic Republic of the Congo, 1971-97 Zaire. It changed its name back to Democratic Republic of the Congo in 1997. The name Zaire is an alternate name for the Congo River from nzai, a Kikongo dialect form of nazdi, river. %28%From Room, Brewer%27%s Dictionary of Names, 1992, p608%29%%A%    
% 221.18/221.34  |- skos__altLabel mesh__D015023 Belgian Congo
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015023 2002
% 221.18/221.34  |- mesh__historyNote mesh__D015023 98%28%74%29%   
% 221.18/221.34  |- skos__altLabel mesh__D015023 Congo %28%Kinshasa%29%
% 221.18/221.34  |- mesh__dateCreated mesh__D015023 1999-01-01
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015023 2006
% 221.18/221.34  |- skos__annotation mesh__D015023
% 221.18/221.34       formerly Zaire %28%capital at Kinshasa formerly Leopoldville%29%; do not confuse with Republic of Congo %28%capital at Brazzaville%29% %28% = CONGO%29%; for x ref ZAIRE in French titles use diacrit: Za%C3%%AF%re, in English titles spell as Zaire%A%  
% 221.18/221.34  |- skos__broader mesh__D015023smesh__D000350
% 221.18/221.34  |- mesh__recordAuthorizer mesh__D015023 sjn
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015023 2005
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015023 2004
% 221.18/221.34  |- skos__prefLabel mesh__D015023 Democratic Republic of the Congo
% 221.18/221.34  |- mesh__recordOriginator mesh__D015023 NLM
% 221.18/221.34  |- mesh__dateRevised mesh__D015023 2001-08-13
% 221.18/221.34  |- rdf__type mesh__D015023sskos__Concept
% 221.18/221.34  |- mesh__recordMaintainer mesh__D015023 jls
% 221.18/221.34  |- skos__altLabel mesh__D015023 Zaire
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D001801 2005
% 221.18/221.34  |- skos__prefLabel mesh__D001801 Blood Stains
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D001801 2006
% 221.18/221.34  |- skos__hiddenLabel mesh__D001801 Stains, Blood
% 221.18/221.34  |- mesh__dateCreated mesh__D001801 1999-01-01
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D001801 2004
% 221.18/221.34  |- skos__broader mesh__D001801smesh__D005554
% 221.18/221.34  |- skos__hiddenLabel mesh__D001801 Blood Stain
% 221.18/221.34  |- mesh__recordAuthorizer mesh__D001801 sjn
% 221.18/221.34  |- mesh__dateRevised mesh__D001801 2003-07-09
% 221.18/221.34  |- skos__annotation mesh__D001801 no qualif   
% 221.18/221.34  |- mesh__recordOriginator mesh__D001801 NLM
% 221.18/221.34  |- mesh__recordMaintainer mesh__D001801 lkt
% 221.18/221.34  |- skos__hiddenLabel mesh__D001801 Stain, Blood
% 221.18/221.34  |- rdf__type mesh__D001801sskos__Concept
% 221.18/221.34  |- skos__scopeNote mesh__D001801
% 221.18/221.34       Antigenic characteristics and DNA fingerprint patterns identified from blood stains. Their primary value is in criminal cases.%A%    
% 221.18/221.34  |- skos__prefLabel mesh__D001003 Anal Canal
% 221.18/221.34  |- mesh__recordAuthorizer mesh__D001003 sjn
% 221.18/221.34  |- mesh__dateRevised mesh__D001003 2005-06-30
% 221.18/221.34  |- skos__altLabel mesh__D001003 Anal Glands, Human
% 221.18/221.34  |- skos__hiddenLabel mesh__D001003 Human Anal Glands
% 221.18/221.34  |- skos__related mesh__D001003smesh__D011351
% 221.18/221.34  |- skos__hiddenLabel mesh__D001003 Human Anal Gland
% 221.18/221.34  |- mesh__recordMaintainer mesh__D001003 ags
% 221.18/221.34  |- mesh__dateCreated mesh__D001003 1999-01-01
% 221.18/221.34  |- skos__hiddenLabel mesh__D001003 Sphincter, Anal
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D001003 2006
% 221.18/221.34  |- skos__hiddenLabel mesh__D001003 Glands, Human Anal
% 221.18/221.34  |- skos__broader mesh__D001003smesh__D007420
% 221.18/221.34  |- mesh__recordOriginator mesh__D001003 NLM
% 221.18/221.34  |- skos__altLabel mesh__D001003 Anal Gland
% 221.18/221.34  |- skos__annotation mesh__D001003
% 221.18/221.34       inflammation = PROCTITIS; do not confuse X ref ANAL GLAND with ANAL GLAND, ANIMAL see ANAL SACS%A%  
% 221.18/221.34  |- rdf__type mesh__D001003sskos__Concept
% 221.18/221.34  |- skos__hiddenLabel mesh__D001003 Gland, Human Anal
% 221.18/221.34  |- mesh__considerAlso mesh__D001003 consider also terms at PROCT-   
% 221.18/221.34  |- skos__scopeNote mesh__D001003
% 221.18/221.34       The terminal segment of the LARGE INTESTINE, beginning from the ampulla of the RECTUM and ending at the anus.%A%    
% 221.18/221.34  |- skos__broader mesh__D020766smesh__D002542
% 221.18/221.34  |- skos__hiddenLabel mesh__D020766 Cerebral Embolus
% 221.18/221.34  |- mesh__historyNote mesh__D020766
% 221.18/221.34       2000; for CEREBRAL EMBOLISM use INTRACRANIAL EMBOLISM AND THROMBOSIS 1991-1999%A%  
% 221.18/221.34  |- skos__historyNote mesh__D020766
% 221.18/221.34       Intracranial Embolism and Thrombosis %28%1965-1999%29%
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D020766 2004
% 221.18/221.34  |- rdf__type mesh__D020766sskos__Concept
% 221.18/221.34  |- skos__altLabel mesh__D020766 Brain Emboli
% 221.18/221.34  |- skos__hiddenLabel mesh__D020766 Brain Embolus
% 221.18/221.34  |- skos__hiddenLabel mesh__D020766 Emboli, Brain
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D020766 2006
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D020766 2003
% 221.18/221.34  |- mesh__publicMeSHNote mesh__D020766
% 221.18/221.34       2000; for CEREBRAL EMBOLISM see CEREBRAL EMBOLISM AND THROMBOSIS 1991-1999%A%  
% 221.18/221.34  |- skos__hiddenLabel mesh__D020766 Embolus, Brain
% 221.18/221.34  |- mesh__dateEstablished mesh__D020766 2000-01-01
% 221.18/221.34  |- skos__prefLabel mesh__D020766 Intracranial Embolism
% 221.18/221.34  |- skos__hiddenLabel mesh__D020766 Emboli, Cerebral
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D020766 2005
% 221.18/221.34  |- skos__hiddenLabel mesh__D020766 Embolus, Cerebral
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D020766 2002
% 221.18/221.34  |- skos__hiddenLabel mesh__D020766 Embolism, Cerebral
% 221.18/221.34  |- skos__altLabel mesh__D020766 Embolism, Intracranial
% 221.18/221.34  |- skos__altLabel mesh__D020766 Cerebral Emboli
% 221.18/221.34  |- skos__altLabel mesh__D020766 Embolism, Brain
% 221.18/221.34  |- skos__scopeNote mesh__D020766
% 221.18/221.34       Migration of foreign material to the intracranial components of the nervous system via arterial pathways. Emboli most frequently are of cardiac origin and are associated with ARRHYTHMIA; mural thrombi; ENDOCARDITIS, SUBACUTE BACTERIAL; HEART VALVE DISEASES; and HEART SEPTAL DEFECTS. Noncardiac sources include lesions of the aorta, carotid arteries, vertebral arteries, and intracranial arteries. Emboli may be composed of thrombosed platelets, atherosclerotic debris, fat, air, tumor cells, or infectious materials, and may cause CEREBRAL INFARCTION. %28%From Adams et al., Principles of Neurology, 6th ed, pp824-6%29%%A%    
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D020766 2001
% 221.18/221.34  |- mesh__dateCreated mesh__D020766 1999-11-03
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D020766 2000
% 221.18/221.34  |- skos__hiddenLabel mesh__D006297 Availability, Contraceptive
% 221.18/221.34  |- skos__altLabel mesh__D006297 Availability of Health Services
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D006297 2002
% 221.18/221.34  |- skos__annotation mesh__D006297 specify geog; DF: HEALTH SERV ACCESS   
% 221.18/221.34  |- skos__prefLabel mesh__D006297 Health Services Accessibility
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D006297 2003
% 221.18/221.34  |- mesh__dateRevised mesh__D006297 1999-11-03
% 221.18/221.34  |- rdf__type mesh__D006297sskos__Concept
% 221.18/221.34  |- skos__altLabel mesh__D006297 Access to Health Care
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D006297 2004
% 221.18/221.34  |- mesh__dateCreated mesh__D006297 1977-05-12
% 221.18/221.34  |- mesh__publicMeSHNote mesh__D006297 78   
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D006297 2000
% 221.18/221.34  |- skos__hiddenLabel mesh__D006297 Locales
% 221.18/221.34  |- skos__altLabel mesh__D006297 Accessibility of Health Services
% 221.18/221.34  |- mesh__historyNote mesh__D006297 78   
% 221.18/221.34  |- skos__hiddenLabel mesh__D006297 Health Services Availability
% 221.18/221.34  |- skos__historyNote mesh__D006297
% 221.18/221.34       Delivery of Health Care %28%1971-1977%29%
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D006297 2005
% 221.18/221.34  |- mesh__dateEstablished mesh__D006297 1978-01-01
% 221.18/221.34  |- skos__hiddenLabel mesh__D006297 Distances
% 221.18/221.34  |- mesh__recordOriginator mesh__D006297 EC
% 221.18/221.34  |- skos__broader mesh__D006297smesh__D003695
% 221.18/221.34  |- mesh__recordAuthorizer mesh__D006297 sjn
% 221.18/221.34  |- skos__altLabel mesh__D006297 Accessibility, Health Services
% 221.18/221.34  |- skos__historyNote mesh__D006297 Health Services %28%1974-1977%29%
% 221.18/221.34  |- skos__scopeNote mesh__D006297
% 221.18/221.34       The degree to which individuals are inhibited or facilitated in their ability to gain entry to and to receive care and services from the health care system. Factors influencing this ability include geographic, architectural, transportational, and financial considerations, among others.%A%    
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D006297 2001
% 221.18/221.34  |- skos__hiddenLabel mesh__D006297 Accessibility, Program
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D006297 2006
% 221.18/221.34  |- mesh__recordMaintainer mesh__D006297 kle
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D014729 1995
% 221.18/221.34  |- skos__prefLabel mesh__D014729 Veterans Disability Claims
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D014729 1999
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D014729 2001
% 221.18/221.34  |- skos__annotation mesh__D014729 specify country   
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D014729 1997
% 221.18/221.34  |- mesh__recordAuthorizer mesh__D014729 NLM
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D014729 2006
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D014729 2000
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D014729 1998
% 221.18/221.34  |- skos__hiddenLabel mesh__D014729 Claims, Veterans Disability
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D014729 2004
% 221.18/221.34  |- mesh__recordMaintainer mesh__D014729 PLS
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D014729 1996
% 221.18/221.34  |- mesh__recordOriginator mesh__D014729 NLM
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D014729 2005
% 221.18/221.34  |- mesh__dateCreated mesh__D014729 1999-01-01
% 221.18/221.34  |- skos__hiddenLabel mesh__D014729 Disability Claim, Veterans
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D014729 2003
% 221.18/221.34  |- skos__hiddenLabel mesh__D014729 Claim, Veterans Disability
% 221.18/221.34  |- skos__scopeNote mesh__D014729
% 221.18/221.34       Disorders claimed as a result of military service.     
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D014729 2002
% 221.18/221.34  |- mesh__dateRevised mesh__D014729 1993-09-16
% 221.18/221.34  |- rdf__type mesh__D014729sskos__Concept
% 221.18/221.34  |- skos__hiddenLabel mesh__D014729 Veterans Disability Claim
% 221.18/221.34  |- skos__hiddenLabel mesh__D014729 Disability Claims, Veterans
% 221.18/221.34  |- skos__broader mesh__D014729smesh__D005380
% 221.18/221.34  |- mesh__dateCreated mesh__D000709 1999-01-01
% 221.18/221.34  |- mesh__dateRevised mesh__D000709 2005-06-30
% 221.18/221.34  |- skos__broader mesh__D000709smesh__D000710
% 221.18/221.34  |- rdf__type mesh__D000709sskos__Concept
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D000709 2006
% 221.18/221.34  |- mesh__recordAuthorizer mesh__D000709 sjn
% 221.18/221.34  |- skos__annotation mesh__D000709 infection = ANAPLASMOSIS   
% 221.18/221.34  |- mesh__recordMaintainer mesh__D000709 SYSTEM
% 221.18/221.34  |- skos__prefLabel mesh__D000709 Anaplasma
% 221.18/221.34  |- skos__scopeNote mesh__D000709
% 221.18/221.34       A genus of gram-negative bacteria whose organisms are obligate parasites of vertebrates. Species are transmitted by arthropod vectors with the host range limited to ruminants. Anaplasma marginale is the most pathogenic species and is the causative agent of severe bovine anaplasmosis.%A%    
% 221.18/221.34  |- mesh__recordOriginator mesh__D000709 NLM
% 221.18/221.34  |- skos__prefLabel mesh__D019414 Chlorobi
% 221.18/221.34  |- skos__historyNote mesh__D019414 Bacteria %28%1990-1996%29%
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D019414 2006
% 221.18/221.34  |- mesh__recordMaintainer mesh__D019414 SYSTEM
% 221.18/221.34  |- mesh__dateEstablished mesh__D019414 1997-01-01
% 221.18/221.34  |- mesh__historyNote mesh__D019414 97   
% 221.18/221.34  |- rdf__type mesh__D019414sskos__Concept
% 221.18/221.34  |- skos__scopeNote mesh__D019414
% 221.18/221.34       A phylum of anoxygenic, phototrophic, CHLOROBI including the family Chlorobiaceae. They occur in aquatic sediments, sulfur springs, and hot springs and utilize reduced sulfur compounds instead of oxygen.%A%    
% 221.18/221.34  |- skos__altLabel mesh__D019414 Green Sulfur Bacteria
% 221.18/221.34  |- mesh__recordAuthorizer mesh__D019414 sjn
% 221.18/221.34  |- mesh__dateRevised mesh__D019414 2005-06-30
% 221.18/221.34  |- mesh__recordOriginator mesh__D019414 JLS
% 221.18/221.34  |- skos__broader mesh__D019414smesh__D001419
% 221.18/221.34  |- skos__altLabel mesh__D019414 Bacteria, Green Sulfur
% 221.18/221.34  |- mesh__publicMeSHNote mesh__D019414 97   
% 221.18/221.34  |- mesh__dateCreated mesh__D019414 1996-06-13
% 221.18/221.34  |- skos__hiddenLabel mesh__D011431 Hydrochloride, Propoxyphene
% 221.18/221.34  |- skos__scopeNote mesh__D011431
% 221.18/221.34       A narcotic analgesic structurally related to METHADONE. Only the dextro-isomer has an analgesic effect; the levo-isomer appears to exert an antitussive effect.%A%    
% 221.18/221.34  |- mesh__recordMaintainer mesh__D011431 exl
% 221.18/221.34  |- skos__hiddenLabel mesh__D011431 D Propoxyphene
% 221.18/221.34  |- mesh__recordOriginator mesh__D011431 NLM
% 221.18/221.34  |- mesh__dateRevised mesh__D011431 2005-06-30
% 221.18/221.34  |- skos__altLabel mesh__D011431 Proxyphen
% 221.18/221.34  |- mesh__dateCreated mesh__D011431 1999-01-01
% 221.18/221.34  |- mesh__recordAuthorizer mesh__D011431 sjn
% 221.18/221.34  |- rdf__type mesh__D011431sskos__Concept
% 221.18/221.34  |- skos__altLabel mesh__D011431 Dextropropoxyphene
% 221.18/221.34  |- mesh__dateEstablished mesh__D011431 1965-01-01
% 221.18/221.34  |- mesh__publicMeSHNote mesh__D011431
% 221.18/221.34       65; DEXTRO PROPOXYPHENE was heading 1963-64   
% 221.18/221.34  |- skos__broader mesh__D011431smesh__D011422
% 221.18/221.34  |- skos__altLabel mesh__D011431 D-Propoxyphene
% 221.18/221.34  |- mesh__historyNote mesh__D011431
% 221.18/221.34       65; DEXTRO PROPOXYPHENE was heading 1963-64   
% 221.18/221.34  |- skos__prefLabel mesh__D011431 Propoxyphene
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D011431 2006
% 221.18/221.34  |- skos__hiddenLabel mesh__D035081 Policies, Editorial
% 221.18/221.34  |- mesh__publicMeSHNote mesh__D035081 2003   
% 221.18/221.34  |- skos__scopeNote mesh__D035081
% 221.18/221.34       The guidelines and policy statements set forth by the editor%28%s%29% or editorial board of a publication.%A%    
% 221.18/221.34  |- mesh__dateCreated mesh__D035081 2002-07-03
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D035081 2006
% 221.18/221.34  |- skos__prefLabel mesh__D035081 Editorial Policies
% 221.18/221.34  |- skos__historyNote mesh__D035081 Periodicals %28%1970-2002%29%
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D035081 2003
% 221.18/221.34  |- mesh__historyNote mesh__D035081 2003   
% 221.18/221.34  |- skos__hiddenLabel mesh__D035081 Editorial Policy
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D035081 2004
% 221.18/221.34  |- rdf__type mesh__D035081sskos__Concept
% 221.18/221.34  |- skos__broader mesh__D035081smesh__D011643
% 221.18/221.34  |- mesh__dateEstablished mesh__D035081 2003-01-01
% 221.18/221.34  |- skos__hiddenLabel mesh__D035081 Policy, Editorial
% 221.18/221.34  |- skos__historyNote mesh__D035081 Publishing %28%1970-2002%29%
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D035081 2005
% 221.18/221.34  |- skos__annotation mesh__D029842
% 221.18/221.34       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.18/221.34  |- skos__altLabel mesh__D029842 Mirobalanus embilica
% 221.18/221.34  |- skos__altLabel mesh__D029842 Emblica officinalis
% 221.18/221.34  |- mesh__historyNote mesh__D029842 2002   
% 221.18/221.34  |- mesh__dateCreated mesh__D029842 2001-07-25
% 221.18/221.34  |- mesh__publicMeSHNote mesh__D029842 2002   
% 221.18/221.34  |- skos__scopeNote mesh__D029842
% 221.18/221.34       A plant species of the family EUPHORBIACEAE.     
% 221.18/221.34  |- skos__broader mesh__D029842smesh__D029803
% 221.18/221.34  |- skos__altLabel mesh__D029842 Amla
% 221.18/221.34  |- mesh__dateEstablished mesh__D029842 2002-01-01
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D029842 2004
% 221.18/221.34  |- skos__prefLabel mesh__D029842 Phyllanthus emblica
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D029842 2006
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D029842 2003
% 221.18/221.34  |- rdf__type mesh__D029842sskos__Concept
% 221.18/221.34  |- mesh__dateRevised mesh__D029842 2002-07-02
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D029842 2005
% 221.18/221.34  |- mesh__dateEstablished mesh__D029044 2002-01-01
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D029044 2002
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D029044 2005
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D029044 2006
% 221.18/221.34  |- mesh__publicMeSHNote mesh__D029044 2002   
% 221.18/221.34  |- skos__annotation mesh__D029044
% 221.18/221.34       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.18/221.34  |- rdf__type mesh__D029044sskos__Concept
% 221.18/221.34  |- skos__broader mesh__D029044smesh__D027703
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D029044 2003
% 221.18/221.34  |- mesh__historyNote mesh__D029044 2002   
% 221.18/221.34  |- skos__scopeNote mesh__D029044
% 221.18/221.34       A plant genus of the family AMARANTHACEAE, order Caryophyllales, which has been used in traditional medicine %28%MEDICINE, CHINESE TRADITIONAL%29%.%A%    
% 221.18/221.34  |- skos__prefLabel mesh__D029044 Achyranthes
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D029044 2004
% 221.18/221.34  |- mesh__dateCreated mesh__D029044 2001-07-25
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D007390 2001
% 221.18/221.34  |- skos__scopeNote mesh__D007390
% 221.18/221.34       International organizations which provide health-related or other cooperative services.%A%    
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D007390 2005
% 221.18/221.34  |- mesh__dateRevised mesh__D007390 1999-11-03
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D007390 2004
% 221.18/221.34  |- skos__annotation mesh__D007390 specify geog   
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D007390 2006
% 221.18/221.34  |- skos__prefLabel mesh__D007390 International Agencies
% 221.18/221.34  |- mesh__recordOriginator mesh__D007390 NLM
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D007390 2002
% 221.18/221.34  |- rdf__type mesh__D007390sskos__Concept
% 221.18/221.34  |- skos__broader mesh__D007390smesh__D009938
% 221.18/221.34  |- skos__hiddenLabel mesh__D007390 Agency, International
% 221.18/221.34  |- mesh__recordAuthorizer mesh__D007390 sjn
% 221.18/221.34  |- skos__hiddenLabel mesh__D007390 International Agency
% 221.18/221.34  |- mesh__dateCreated mesh__D007390 1999-01-01
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D007390 2000
% 221.18/221.34  |- mesh__recordMaintainer mesh__D007390 kle
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D007390 2003
% 221.18/221.34  |- skos__hiddenLabel mesh__D007390 Agencies, International
% 221.18/221.34  |- mesh__dateEstablished mesh__D010339 1970-01-01
% 221.18/221.34  |- mesh__dateRevised mesh__D010339 1993-06-04
% 221.18/221.34  |- mesh__publicMeSHNote mesh__D010339 70   
% 221.18/221.34  |- mesh__dateCreated mesh__D010339 1999-01-01
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D010339 2006
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D010339 2001
% 221.18/221.34  |- skos__prefLabel mesh__D010339 Pathology, Oral
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D010339 2004
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D010339 1995
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D010339 2000
% 221.18/221.34  |- skos__altLabel mesh__D010339 Oral Pathology
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D010339 2005
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D010339 1999
% 221.18/221.34  |- mesh__recordMaintainer mesh__D010339 JLS
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D010339 2003
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D010339 1994
% 221.18/221.34  |- mesh__historyNote mesh__D010339 70   
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D010339 1997
% 221.18/221.34  |- rdf__type mesh__D010339sskos__Concept
% 221.18/221.34  |- mesh__recordOriginator mesh__D010339 NLM
% 221.18/221.34  |- skos__annotation mesh__D010339
% 221.18/221.34       SPEC only: SPEC qualif; not for MOUTH /pathol nor MOUTH DISEASES; DF: PATHOL ORAL%A%  
% 221.18/221.34  |- skos__scopeNote mesh__D010339
% 221.18/221.34       A dental specialty concerned with pathology of the oral cavity.%A%    
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D010339 1998
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D010339 1996
% 221.18/221.34  |- skos__historyNote mesh__D010339 Pathology %28%1966-1969%29%
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D010339 2002
% 221.18/221.34  |- skos__broader mesh__D010339smesh__D003813
% 221.18/221.34  |- mesh__recordAuthorizer mesh__D010339 PLS
% 221.18/221.34  |- skos__broader mesh__D010339smesh__D013039
% 221.18/221.34  |- skos__hiddenLabel mesh__D021061 Assisted Ventilation, Liquid
% 221.18/221.34  |- skos__hiddenLabel mesh__D021061 Ventilation, Total Liquid
% 221.18/221.34  |- mesh__historyNote mesh__D021061 2001   
% 221.18/221.34  |- mesh__dateCreated mesh__D021061 2000-06-21
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D021061 2002
% 221.18/221.34  |- skos__scopeNote mesh__D021061
% 221.18/221.34       Artificial respiration %28%RESPIRATION, ARTIFICIAL%29% using an oxygenated fluid.%A%    
% 221.18/221.34  |- skos__related mesh__D021061smesh__D012122
% 221.18/221.34  |- skos__hiddenLabel mesh__D021061 Ventilation, Partial Liquid
% 221.18/221.34  |- rdf__type mesh__D021061sskos__Concept
% 221.18/221.34  |- skos__altLabel mesh__D021061 Liquid Assisted Ventilation
% 221.18/221.34  |- skos__annotation mesh__D021061
% 221.18/221.34       /instrum: consider also VENTILATORS, MECHANICAL   
% 221.18/221.34  |- mesh__publicMeSHNote mesh__D021061 2001   
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D021061 2003
% 221.18/221.34  |- skos__broader mesh__D021061smesh__D012121
% 221.18/221.34  |- skos__hiddenLabel mesh__D021061 Liquid Ventilation, Partial
% 221.18/221.34  |- mesh__dateEstablished mesh__D021061 2001-01-01
% 221.18/221.34  |- skos__hiddenLabel mesh__D021061 Ventilation, Fluorocarbon
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D021061 2005
% 221.18/221.34  |- skos__hiddenLabel mesh__D021061 Liquid Ventilation, Total
% 221.18/221.34  |- skos__hiddenLabel mesh__D021061 Ventilation, Liquid Assisted
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D021061 2004
% 221.18/221.34  |- skos__historyNote mesh__D021061
% 221.18/221.34       Respiration, Artificial %28%1974-2000%29%
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D021061 2001
% 221.18/221.34  |- skos__hiddenLabel mesh__D021061 Ventilation, Liquid
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D021061 2006
% 221.18/221.34  |- skos__related mesh__D021061smesh__D005466
% 221.18/221.34  |- skos__prefLabel mesh__D021061 Liquid Ventilation
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015822 1992
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015822 1997
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015822 1991
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015822 2001
% 221.18/221.34  |- mesh__publicMeSHNote mesh__D015822 90   
% 221.18/221.34  |- mesh__dateEstablished mesh__D015822 1990-01-01
% 221.18/221.34  |- mesh__historyNote mesh__D015822 90   
% 221.18/221.34  |- skos__annotation mesh__D015822
% 221.18/221.34       coord IM with specific parasitic dis %28%IM%29%; DF: EYE INFECT PARASITIC%A%  
% 221.18/221.34  |- skos__broader mesh__D015822smesh__D010272
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015822 1993
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015822 1998
% 221.18/221.34  |- skos__hiddenLabel mesh__D015822 Infections, Parasitic Ocular
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015822 2003
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015822 2002
% 221.18/221.34  |- skos__scopeNote mesh__D015822
% 221.18/221.34       Mild to severe infections of the eye and its adjacent structures %28%adnexa%29% by adult or larval protozoan or metazoan parasites.%A%    
% 221.18/221.34  |- skos__hiddenLabel mesh__D015822 Eye Infection, Parasitic
% 221.18/221.34  |- skos__altLabel mesh__D015822 Ocular Infections, Parasitic
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015822 1994
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015822 1999
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015822 2004
% 221.18/221.34  |- skos__broader mesh__D015822smesh__D015817
% 221.18/221.34  |- mesh__dateCreated mesh__D015822 1989-09-06
% 221.18/221.34  |- skos__historyNote mesh__D015822
% 221.18/221.34       specific parasitic infection %28%1966-1989%29%
% 221.18/221.34  |- skos__hiddenLabel mesh__D015822 Infection, Parasitic Ocular
% 221.18/221.34  |- skos__hiddenLabel mesh__D015822 Parasitic Ocular Infection
% 221.18/221.34  |- skos__hiddenLabel mesh__D015822 Infection, Parasitic Eye
% 221.18/221.34  |- skos__hiddenLabel mesh__D015822 Parasitic Eye Infection
% 221.18/221.34  |- skos__prefLabel mesh__D015822 Eye Infections, Parasitic
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015822 1995
% 221.18/221.34  |- skos__hiddenLabel mesh__D015822 Parasitic Ocular Infections
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015822 2005
% 221.18/221.34  |- rdf__type mesh__D015822sskos__Concept
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015822 1996
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015822 1990
% 221.18/221.34  |- skos__hiddenLabel mesh__D015822 Infections, Parasitic Eye
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015822 2000
% 221.18/221.34  |- skos__hiddenLabel mesh__D015822 Ocular Infection, Parasitic
% 221.18/221.34  |- skos__altLabel mesh__D015822 Parasitic Eye Infections
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015822 2006
% 221.18/221.34  |- skos__historyNote mesh__D015822 Eye Diseases %28%1966-1989%29%
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015024 2001
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015024 1998
% 221.18/221.34  |- mesh__recordOriginator mesh__D015024 NLM
% 221.18/221.34  |- mesh__recordAuthorizer mesh__D015024 SJN
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015024 2000
% 221.18/221.34  |- skos__altLabel mesh__D015024 Northern Rhodesia
% 221.18/221.34  |- mesh__dateCreated mesh__D015024 1999-01-01
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015024 2006
% 221.18/221.34  |- skos__prefLabel mesh__D015024 Zambia
% 221.18/221.34  |- skos__annotation mesh__D015024
% 221.18/221.34       a republic in southern Africa; X ref NORTHERN RHODESIA is its former name%A%  
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015024 2005
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015024 2004
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015024 2002
% 221.18/221.34  |- mesh__dateRevised mesh__D015024 1997-06-20
% 221.18/221.34  |- rdf__type mesh__D015024sskos__Concept
% 221.18/221.34  |- skos__altLabel mesh__D015024 Rhodesia, Northern
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015024 2003
% 221.18/221.34  |- skos__broader mesh__D015024smesh__D000353
% 221.18/221.34  |- skos__scopeNote mesh__D015024
% 221.18/221.34       A republic in southern Africa, south of DEMOCRATIC REPUBLIC OF THE CONGO and TANZANIA, and north of ZIMBABWE. Its capital is Lusaka. It was formerly called Northern Rhodesia. Under the jurisdiction of the British South Africa Company 1889-1924, it became a British Protectorate in 1924, then part of the Federation of Rhodesia and Nyasaland 1953-63. It became an independent republic in 1964. The country takes its name from the Zambezi River flowing through it, the fourth longest on the continent. Za %28%river%29% also gave its name to Zaire. %28%From Webster%27%s New Geographical Dictionary, 1988, p1370 %26% Room, Brewers%27% Dictionary of Names, 1992, p608%29%%A%    
% 221.18/221.34  |- mesh__recordMaintainer mesh__D015024 AGS
% 221.18/221.34  |- mesh__activeMeSHYear mesh__D015024 1999
% 221.18/221.34  |- skos__scopeNote mesh__D001802
% 221.18/221.34       Substances that can carry oxygen to and carbon dioxide away from the tissues when introduced into the blood stream. They are used to replace hemoglobin in severe hemorrhage and also to perfuse isolated organs. The best known are perfluorocarbon emulsions and various hemoglobin solutions.%A%    
% 221.18/221.34  |- skos__historyNote mesh__D001802 Erythrocytes %28%1968-1980%29%
% 221.18/221.34  |- skos__altLabel mesh__D001802 Artificial Erythrocytes
% 221.18/221.34  |- mesh__dateCreated mesh__D001802 1980-04-02
% 221.18/221.34  |- skos__historyNote mesh__D001802 Plasma Substitutes %28%1968-1980%29%
% 221.18/221.34  |- skos__related mesh__D001802smesh__D010952
% 221.18/221.34  |- skos__altLabel mesh__D001802 Blood, Artificial
% 221.18/221.34  |- skos__hiddenLabel mesh__D001802 Hemoglobin, Artificial
% 221.18/221.34  |- skos__altLabel mesh__D001802 Erythrocyte Substitutes
% 221.18/221.34  |- mesh__dateRevised mesh__D001802 2005-06-30
% 221.18/221.34  |- mesh__onlineNote mesh__D001802 search PLASMA SUBSTITUTES 1966-80   
% 221.18/221.34  |- mesh__recordOriginator mesh__D001802 SH
% 221.18/221.34  |- skos__broader mesh__D001802smesh__D006401
% 221.18/221.34  |- mesh__historyNote mesh__D001802
% 221.18/221.34       81; was see PLASMA SUBSTITUTES 1963-80   
% 221.18/221.34  |- skos__hiddenLabel mesh__D001802 Substitutes, Erythrocyte
% 221.18/221.34  |- skos__altLabel mesh__D001802 Red Cell Substitutes
% 221.18/221.34  |- skos__hiddenLabel mesh__D001802 Substitutes, Red Cell
% 221.18/221.34  |- skos__hiddenLabel mesh__D001802 Erythrocytes, Artificial
% 221.18/221.34  |- mesh__recordAuthorizer mesh__D001802 sjn
% 221.18/221.34  |- skos__hiddenLabel mesh__D001802 Substitutes, Hemoglobin
% 221.18/221.34  |- skos__altLabel mesh__D001802 Artificial Blood
% 221.18/221.34  |- skos__annotation mesh__D001802
% 221.18/221.34       carry O2 to %26% CO2 from tissue: see MeSH definition; do not confuse with PLASMA SUBSTITUTES which replace plasma; D25-26 qualif%A%  
% 221.18/221.34  |- rdf__type mesh__D001802sskos__Concept
% 221.18/221.34  |- skos__prefLabel mesh__D001802 Blood Substitutes
% 221.18/221.34  |- skos__historyNote mesh__D001802 Hemoglobins %28%1968-1980%29%
% 221.18/221.34  |- mesh__recordMaintainer mesh__D001802 ssb
% 221.18/221.35  |- skos__hiddenLabel mesh__D001802 Substitutes, Blood
% 221.18/221.35  |- mesh__publicMeSHNote mesh__D001802
% 221.18/221.35       81; was see PLASMA SUBSTITUTES 1963-80   
% 221.18/221.35  |- skos__hiddenLabel mesh__D001802 Cell Substitutes, Red
% 221.18/221.35  |- mesh__dateEstablished mesh__D001802 1981-01-01
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001802 2006
% 221.18/221.35  |- mesh__dateCreated mesh__D001004 1999-01-01
% 221.18/221.35  |- mesh__dateEstablished mesh__D001004 1966-01-01
% 221.18/221.35  |- skos__hiddenLabel mesh__D001004 Anus Disease
% 221.18/221.35  |- mesh__recordOriginator mesh__D001004 NLM
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001004 2003
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001004 2000
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001004 2006
% 221.18/221.35  |- mesh__publicMeSHNote mesh__D001004 66   
% 221.18/221.35  |- skos__hiddenLabel mesh__D001004 Diseases, Anus
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001004 2005
% 221.18/221.35  |- rdf__type mesh__D001004sskos__Concept
% 221.18/221.35  |- skos__hiddenLabel mesh__D001004 Disease, Anus
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001004 2002
% 221.18/221.35  |- mesh__recordMaintainer mesh__D001004 TGC
% 221.18/221.35  |- skos__annotation mesh__D001004 inflamm dis = PROCTITIS   
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001004 1999
% 221.18/221.35  |- skos__broader mesh__D001004smesh__D012002
% 221.18/221.35  |- skos__prefLabel mesh__D001004 Anus Diseases
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001004 1998
% 221.18/221.35  |- mesh__dateRevised mesh__D001004 1997-06-20
% 221.18/221.35  |- mesh__historyNote mesh__D001004 66   
% 221.18/221.35  |- mesh__recordAuthorizer mesh__D001004 SJN
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001004 2004
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001004 2001
% 221.18/221.35  |- mesh__recordOriginator mesh__D020767 KEV
% 221.18/221.35  |- skos__prefLabel mesh__D020767 Intracranial Thrombosis
% 221.18/221.35  |- skos__hiddenLabel mesh__D020767 Thromboses, Intracranial
% 221.18/221.35  |- mesh__recordAuthorizer mesh__D020767 sjn
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D020767 2006
% 221.18/221.35  |- skos__altLabel mesh__D020767 Thrombosis, Intracranial
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D020767 2003
% 221.18/221.35  |- skos__hiddenLabel mesh__D020767 Thromboses, Cerebral
% 221.18/221.35  |- mesh__dateEstablished mesh__D020767 2000-01-01
% 221.18/221.35  |- skos__hiddenLabel mesh__D020767 Cerebral Thromboses
% 221.18/221.35  |- skos__scopeNote mesh__D020767
% 221.18/221.35       Formation of a clot composed of platelets and fibrin within the lumen of an intracranial artery or vein, which may result in CEREBRAL INFARCTION. Arterial thrombosis is associated with INTRACRANIAL ARTERIOSCLEROSIS, but may also result from hypercoagulability states %28%see THROMBOPHILIA%29%. Cerebral vein thrombosis is frequently complicated by INTRACRANIAL HEMORRHAGES.%A%    
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D020767 2005
% 221.18/221.35  |- skos__hiddenLabel mesh__D020767 Thromboses, Brain
% 221.18/221.35  |- mesh__publicMeSHNote mesh__D020767
% 221.18/221.35       2000; for CEREBRAL THROMBOSIS see INTRACRANIAL EMBOLISM AND THROMBOSIS 1991-1999%A%  
% 221.18/221.35  |- skos__hiddenLabel mesh__D020767 Intracranial Thromboses
% 221.18/221.35  |- skos__hiddenLabel mesh__D020767 Thrombus, Brain
% 221.18/221.35  |- skos__altLabel mesh__D020767 Thrombus, Intracranial
% 221.18/221.35  |- skos__hiddenLabel mesh__D020767 Intracranial Thrombus
% 221.18/221.35  |- mesh__historyNote mesh__D020767
% 221.18/221.35       2000; for CEREBRAL THROMBOSIS use INTRACRANIAL EMBOLISM AND THROMBOSIS 1991-1999%A%  
% 221.18/221.35  |- mesh__dateCreated mesh__D020767 1999-11-05
% 221.18/221.35  |- skos__hiddenLabel mesh__D020767 Brain Thromboses
% 221.18/221.35  |- skos__hiddenLabel mesh__D020767 Thrombosis, Cerebral
% 221.18/221.35  |- skos__broader mesh__D020767smesh__D002542
% 221.18/221.35  |- skos__altLabel mesh__D020767 Thrombosis, Brain
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D020767 2002
% 221.18/221.35  |- rdf__type mesh__D020767sskos__Concept
% 221.18/221.35  |- skos__hiddenLabel mesh__D020767 Thrombus, Cerebral
% 221.18/221.35  |- skos__historyNote mesh__D020767
% 221.18/221.35       Intracranial Embolism and Thrombosis %28%1965-1999%29%
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D020767 2004
% 221.18/221.35  |- mesh__dateRevised mesh__D020767 2001-07-25
% 221.18/221.35  |- mesh__recordMaintainer mesh__D020767 ags
% 221.18/221.35  |- rdf__type mesh__D006298sskos__Concept
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D006298 2004
% 221.18/221.35  |- mesh__dateRevised mesh__D006298 2000-06-21
% 221.18/221.35  |- mesh__recordAuthorizer mesh__D006298 sjn
% 221.18/221.35  |- skos__annotation mesh__D006298
% 221.18/221.35       GEN or unspecified; prefer specific health serv with /organ %28%for /organization %26% administration%29%; DF: HEALTH SERV ADMIN%A%  
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D006298 2001
% 221.18/221.35  |- skos__historyNote mesh__D006298
% 221.18/221.35       Public Health Administration %28%1969-1997%29%
% 221.18/221.35  |- mesh__recordMaintainer mesh__D006298 ags
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D006298 2005
% 221.18/221.35  |- mesh__publicMeSHNote mesh__D006298 1998   
% 221.18/221.35  |- mesh__dateEstablished mesh__D006298 1998-01-01
% 221.18/221.35  |- skos__prefLabel mesh__D006298 Health Services Administration
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D006298 2002
% 221.18/221.35  |- mesh__dateCreated mesh__D006298 1999-01-01
% 221.18/221.35  |- skos__altLabel mesh__D006298 Administration, Health Services
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D006298 2006
% 221.18/221.35  |- mesh__runningHead mesh__D006298
% 221.18/221.35       N4 - HEALTH CARE-HEALTH SERVICES ADMINISTRATION   
% 221.18/221.35  |- mesh__recordOriginator mesh__D006298 NLM
% 221.18/221.35  |- mesh__historyNote mesh__D006298 1998; use explode 1970-97   
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D006298 2003
% 221.18/221.35  |- skos__scopeNote mesh__D006298
% 221.18/221.35       The organization and administration of health services dedicated to the delivery of health care.%A%    
% 221.18/221.35  |- skos__broader mesh__D019415smesh__D001696
% 221.18/221.35  |- mesh__publicMeSHNote mesh__D019415 97   
% 221.18/221.35  |- skos__broader mesh__D019415smesh__D019563
% 221.18/221.35  |- skos__annotation mesh__D019415
% 221.18/221.35       a principle of mechanics; not restricted to space flight   
% 221.18/221.35  |- mesh__dateEstablished mesh__D019415 1997-01-01
% 221.18/221.35  |- skos__scopeNote mesh__D019415
% 221.18/221.35       About an axis, the product of a force and the distance of its line of action from the axis. %28%NASA Thesaurus, 1994%29%%A%    
% 221.18/221.35  |- mesh__dateCreated mesh__D019415 1996-06-20
% 221.18/221.35  |- mesh__dateRevised mesh__D019415 2003-07-09
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D019415 2006
% 221.18/221.35  |- skos__hiddenLabel mesh__D019415 Torques
% 221.18/221.35  |- mesh__historyNote mesh__D019415 97   
% 221.18/221.35  |- skos__prefLabel mesh__D019415 Torque
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D019415 2004
% 221.18/221.35  |- rdf__type mesh__D019415sskos__Concept
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D019415 2005
% 221.18/221.35  |- skos__annotation mesh__D035082
% 221.18/221.35       not restricted to the U.S.; use when legislation or regulation at the national, as opposed to the state, provincial, or local level, is under discussion; specify country%A%  
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D035082 2003
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D035082 2004
% 221.18/221.35  |- mesh__dateCreated mesh__D035082 2002-07-03
% 221.18/221.35  |- rdf__type mesh__D035082sskos__Concept
% 221.18/221.35  |- skos__broader mesh__D035082smesh__D006076
% 221.18/221.35  |- skos__scopeNote mesh__D035082
% 221.18/221.35       The level of governmental organization and function at the national or country-wide level.%A%    
% 221.18/221.35  |- mesh__historyNote mesh__D035082 2003   
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D035082 2005
% 221.18/221.35  |- skos__hiddenLabel mesh__D035082 Government, Federal
% 221.18/221.35  |- skos__altLabel mesh__D035082 National Government
% 221.18/221.35  |- mesh__dateEstablished mesh__D035082 2003-01-01
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D035082 2006
% 221.18/221.35  |- skos__prefLabel mesh__D035082 Federal Government
% 221.18/221.35  |- mesh__publicMeSHNote mesh__D035082 2003   
% 221.18/221.35  |- skos__historyNote mesh__D035082 Government %28%1966-2002%29%
% 221.18/221.35  |- skos__prefLabel mesh__D029843 Suregada
% 221.18/221.35  |- skos__altLabel mesh__D029843 Gelonium multiflora
% 221.18/221.35  |- mesh__publicMeSHNote mesh__D029843 2002   
% 221.18/221.35  |- skos__annotation mesh__D029843
% 221.18/221.35       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.18/221.35  |- mesh__historyNote mesh__D029843 2002   
% 221.18/221.35  |- mesh__dateCreated mesh__D029843 2001-07-25
% 221.18/221.35  |- mesh__dateEstablished mesh__D029843 2002-01-01
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D029843 2004
% 221.18/221.35  |- skos__scopeNote mesh__D029843
% 221.18/221.35       A plant genus of the family EUPHORBIACEAE that contains gelonin, a ribosome-inactivating protein.%A%    
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D029843 2006
% 221.18/221.35  |- mesh__recordOriginator mesh__D029843 ssb
% 221.18/221.35  |- mesh__dateRevised mesh__D029843 2002-07-03
% 221.18/221.35  |- skos__broader mesh__D029843smesh__D019665
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D029843 2003
% 221.18/221.35  |- rdf__type mesh__D029843sskos__Concept
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D029843 2005
% 221.18/221.35  |- mesh__recordAuthorizer mesh__D029843 sjn
% 221.18/221.35  |- mesh__recordMaintainer mesh__D029843 ssb
% 221.18/221.35  |- skos__hiddenLabel mesh__D007391 Cooperation, International
% 221.18/221.35  |- skos__related mesh__D007391smesh__D003226
% 221.18/221.35  |- mesh__recordAuthorizer mesh__D007391 sjn
% 221.18/221.35  |- skos__annotation mesh__D007391
% 221.18/221.35       specify geog for cooperating nations; do not index here for %22%international congresses%22%: CONGRESSES is adequate%A%  
% 221.18/221.35  |- rdf__type mesh__D007391sskos__Concept
% 221.18/221.35  |- skos__hiddenLabel mesh__D007391 Treaty
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D007391 2003
% 221.18/221.35  |- skos__scopeNote mesh__D007391
% 221.18/221.35       The interaction of persons or groups of persons representing various nations in the pursuit of a common goal or interest.%A%    
% 221.18/221.35  |- mesh__dateCreated mesh__D007391 1999-01-01
% 221.18/221.35  |- skos__prefLabel mesh__D007391 International Cooperation
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D007391 2005
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D007391 2004
% 221.18/221.35  |- skos__broader mesh__D007391smesh__D038622
% 221.18/221.35  |- mesh__recordMaintainer mesh__D007391 hjn
% 221.18/221.35  |- mesh__recordOriginator mesh__D007391 NLM
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D007391 2006
% 221.18/221.35  |- skos__hiddenLabel mesh__D007391 Aid, Foreign
% 221.18/221.35  |- mesh__dateRevised mesh__D007391 2002-07-02
% 221.18/221.35  |- mesh__historyNote mesh__D029045
% 221.18/221.35       2002; use TOXICODENDRON 1993-2001, use RHUS 1963-1992   
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D029045 2005
% 221.18/221.35  |- skos__altLabel mesh__D029045 Sumac
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D029045 2006
% 221.18/221.35  |- mesh__dateCreated mesh__D029045 2001-07-25
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D029045 2002
% 221.18/221.35  |- skos__scopeNote mesh__D029045
% 221.18/221.35       A plant genus of the family Anacardiaceae, order Sapindales, subclass Rosidae.  It is a source of gallotannin %28%TANNIC ACID%29% and of somewhat edible fruit.  Do not confuse with TOXICODENDRON which used to be part of this genus.%A%    
% 221.18/221.35  |- skos__prefLabel mesh__D029045 Rhus
% 221.18/221.35  |- rdf__type mesh__D029045sskos__Concept
% 221.18/221.35  |- skos__broader mesh__D029045smesh__D027926
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D029045 2003
% 221.18/221.35  |- skos__annotation mesh__D029045
% 221.18/221.35       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D029045 2004
% 221.18/221.35  |- mesh__publicMeSHNote mesh__D029045
% 221.18/221.35       2002; see TOXICODENDRON 1993-2001, see RHUS 1963-1992   
% 221.18/221.35  |- skos__historyNote mesh__D029045 Toxicodendron %28%1993-2001%29%
% 221.18/221.35  |- mesh__dateEstablished mesh__D029045 2002-01-01
% 221.18/221.35  |- skos__annotation mesh__D015823
% 221.18/221.35       note category: a corneal dis: do not confuse with KERATOACANTHOMA, a skin dis%A%  
% 221.18/221.35  |- mesh__dateRevised mesh__D015823 1991-05-02
% 221.18/221.35  |- skos__prefLabel mesh__D015823 Acanthamoeba Keratitis
% 221.18/221.35  |- skos__broader mesh__D015823smesh__D007634
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D015823 1995
% 221.18/221.35  |- skos__historyNote mesh__D015823 Amebiasis %28%1975-1989%29%
% 221.18/221.35  |- mesh__publicMeSHNote mesh__D015823 90   
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D015823 1999
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D015823 1994
% 221.18/221.35  |- mesh__recordAuthorizer mesh__D015823 PLS
% 221.18/221.35  |- skos__altLabel mesh__D015823 Keratitis, Acanthamoeba
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D015823 2006
% 221.18/221.35  |- skos__hiddenLabel mesh__D015823 Keratitides, Acanthamoeba
% 221.18/221.35  |- skos__scopeNote mesh__D015823
% 221.18/221.35       Infection of the cornea by an ameboid protozoan which may cause corneal ulceration leading to blindness.%A%    
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D015823 2002
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D015823 1998
% 221.18/221.35  |- skos__broader mesh__D015823smesh__D015822
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D015823 1993
% 221.18/221.35  |- mesh__dateCreated mesh__D015823 1989-05-25
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D015823 2005
% 221.18/221.35  |- skos__historyNote mesh__D015823 Keratitis %28%1975-1989%29%
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D015823 2001
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D015823 1997
% 221.18/221.35  |- mesh__recordOriginator mesh__D015823 EGC
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D015823 1992
% 221.18/221.35  |- rdf__type mesh__D015823sskos__Concept
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D015823 2004
% 221.18/221.35  |- skos__broader mesh__D015823smesh__D000562
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D015823 2000
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D015823 1996
% 221.18/221.35  |- mesh__recordMaintainer mesh__D015823 PXP
% 221.18/221.35  |- skos__hiddenLabel mesh__D015823 Acanthamoeba Keratitides
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D015823 2003
% 221.18/221.35  |- mesh__dateEstablished mesh__D015823 1990-01-01
% 221.18/221.35  |- mesh__historyNote mesh__D015823 90   
% 221.18/221.35  |- skos__annotation mesh__D015025
% 221.18/221.35       a mycotoxin %26% non-steroidal estrogen; do not confuse with zearalanone %28%index under ZEARALENONE /analogs%29%%A%  
% 221.18/221.35  |- mesh__recordMaintainer mesh__D015025 ssb
% 221.18/221.35  |- skos__altLabel mesh__D015025 F-2 Toxin
% 221.18/221.35  |- skos__altLabel mesh__D015025 F2 Toxin
% 221.18/221.35  |- skos__historyNote mesh__D015025 Resorcinols %28%1966-1974%29%
% 221.18/221.35  |- skos__prefLabel mesh__D015025 Zearalenone
% 221.18/221.35  |- mesh__historyNote mesh__D015025
% 221.18/221.35       91%28%75%29%; was see under RESORCINOLS 1975-90   
% 221.18/221.35  |- mesh__recordAuthorizer mesh__D015025 sjn
% 221.18/221.35  |- skos__hiddenLabel mesh__D015025 F 2 Toxin
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D015025 2006
% 221.18/221.35  |- mesh__recordOriginator mesh__D015025 NLM
% 221.18/221.35  |- mesh__dateCreated mesh__D015025 1974-11-11
% 221.18/221.35  |- mesh__publicMeSHNote mesh__D015025
% 221.18/221.35       91; was see under RESORCINOLS 1975-90   
% 221.18/221.35  |- skos__broader mesh__D015025smesh__D009183
% 221.18/221.35  |- skos__scopeNote mesh__D015025
% 221.18/221.35       %28%S-%28%E%29%%29%-3,4,5,6,8,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7%28%8H%29%-dione. One of a group of compounds known under the general designation of resorcylic acid lactones. Cis, trans, dextro and levo forms have been isolated from the fungus Gibberella zeae %28%formerly Fusarium graminearum%29%. They have estrogenic activity, cause toxicity in livestock as feed contaminant, and have been used as anabolic or estrogen substitutes.%A%    
% 221.18/221.35  |- rdf__type mesh__D015025sskos__Concept
% 221.18/221.35  |- skos__hiddenLabel mesh__D015025 Toxin, F2
% 221.18/221.35  |- mesh__dateEstablished mesh__D015025 1991-01-01
% 221.18/221.35  |- skos__broader mesh__D015025smesh__D007783
% 221.18/221.35  |- skos__hiddenLabel mesh__D015025 Toxin, F-2
% 221.18/221.35  |- mesh__dateRevised mesh__D015025 2005-06-30
% 221.18/221.35  |- skos__broader mesh__D015025smesh__D012118
% 221.18/221.35  |- skos__historyNote mesh__D015025 Lactones %28%1966-1974%29%
% 221.18/221.35  |- skos__hiddenLabel mesh__D001803 Transfusion, Blood
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001803 2004
% 221.18/221.35  |- mesh__recordOriginator mesh__D001803 NLM
% 221.18/221.35  |- skos__annotation mesh__D001803
% 221.18/221.35       TN 186: differentiate among various %22%transfusion%22% concepts; do not use /util except by MeSH definition; for whole blood or unspecified transfusion: note that BLOOD COMPONENT TRANSFUSION %26% BLOOD COMPONENT REMOVAL %26% its specifics are available%A%  
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001803 2006
% 221.18/221.35  |- skos__related mesh__D001803smesh__D001787
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001803 2003
% 221.18/221.35  |- skos__scopeNote mesh__D001803
% 221.18/221.35       The introduction of whole blood or blood component directly into the blood stream. %28%Dorland, 27th ed%29%%A%    
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001803 2002
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001803 2005
% 221.18/221.35  |- skos__related mesh__D001803smesh__D001788
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001803 1997
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001803 2001
% 221.18/221.35  |- mesh__recordMaintainer mesh__D001803 PLS
% 221.18/221.35  |- skos__altLabel mesh__D001803 Blood Transfusions
% 221.18/221.35  |- skos__prefLabel mesh__D001803 Blood Transfusion
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001803 1999
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001803 1996
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001803 2000
% 221.18/221.35  |- skos__hiddenLabel mesh__D001803 Transfusions, Blood
% 221.18/221.35  |- mesh__dateRevised mesh__D001803 1995-05-25
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001803 1998
% 221.18/221.35  |- mesh__dateCreated mesh__D001803 1999-01-01
% 221.18/221.35  |- rdf__type mesh__D001803sskos__Concept
% 221.18/221.35  |- skos__broader mesh__D001803smesh__D001691
% 221.18/221.35  |- mesh__recordAuthorizer mesh__D001803 PLS
% 221.18/221.35  |- skos__hiddenLabel mesh__D001005 Anus Neoplasm
% 221.18/221.35  |- skos__altLabel mesh__D001005 Neoplasms, Anal
% 221.18/221.35  |- skos__broader mesh__D001005smesh__D001004
% 221.18/221.35  |- skos__hiddenLabel mesh__D001005 Anal Cancers
% 221.18/221.35  |- skos__altLabel mesh__D001005 Neoplasms, Anus
% 221.18/221.35  |- rdf__type mesh__D001005sskos__Concept
% 221.18/221.35  |- skos__annotation mesh__D001005
% 221.18/221.35       do not confuse with ANAL GLAND NEOPLASMS %28%in animals only%29%; coord IM with histol type of neopl %28%IM%29%%A%  
% 221.18/221.35  |- skos__hiddenLabel mesh__D001005 Anus Cancers
% 221.18/221.35  |- mesh__dateRevised mesh__D001005 2005-07-01
% 221.18/221.35  |- mesh__recordAuthorizer mesh__D001005 sjn
% 221.18/221.35  |- skos__prefLabel mesh__D001005 Anus Neoplasms
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D001005 2006
% 221.18/221.35  |- skos__broader mesh__D001005smesh__D012004
% 221.18/221.35  |- skos__hiddenLabel mesh__D001005 Anal Neoplasm
% 221.18/221.35  |- skos__hiddenLabel mesh__D001005 Neoplasm, Anus
% 221.18/221.35  |- skos__hiddenLabel mesh__D001005 Anus Cancer
% 221.18/221.35  |- skos__hiddenLabel mesh__D001005 Cancer, Anal
% 221.18/221.35  |- skos__altLabel mesh__D001005 Anal Neoplasms
% 221.18/221.35  |- skos__hiddenLabel mesh__D001005 Cancers, Anal
% 221.18/221.35  |- skos__altLabel mesh__D001005 Cancer of Anus
% 221.18/221.35  |- mesh__recordMaintainer mesh__D001005 sjn
% 221.18/221.35  |- skos__hiddenLabel mesh__D001005 Neoplasm, Anal
% 221.18/221.35  |- skos__altLabel mesh__D001005 Cancer of the Anus
% 221.18/221.35  |- skos__scopeNote mesh__D001005 Tumors or cancer of the ANAL CANAL.     
% 221.18/221.35  |- mesh__dateCreated mesh__D001005 1999-01-01
% 221.18/221.35  |- mesh__recordOriginator mesh__D001005 NLM
% 221.18/221.35  |- skos__prefLabel mesh__D020768 Middle Cerebral Artery
% 221.18/221.35  |- skos__hiddenLabel mesh__D020768 Arteries, Middle Cerebral
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D020768 2006
% 221.18/221.35  |- skos__historyNote mesh__D020768 Cerebral Arteries %28%1966-1999%29%
% 221.18/221.35  |- skos__scopeNote mesh__D020768
% 221.18/221.35       The largest and most complex of the cerebral arteries. Branches of the middle cerebral artery supply the insular region, motor and premotor areas, and large regions of the association cortex.%A%    
% 221.18/221.35  |- mesh__publicMeSHNote mesh__D020768 2000   
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D020768 2000
% 221.18/221.35  |- skos__hiddenLabel mesh__D020768 Cerebral Arteries, Middle
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D020768 2001
% 221.18/221.35  |- skos__hiddenLabel mesh__D020768 Artery, Middle Cerebral
% 221.18/221.35  |- mesh__dateEstablished mesh__D020768 2000-01-01
% 221.18/221.35  |- skos__hiddenLabel mesh__D020768 Middle Cerebral Arteries
% 221.18/221.35  |- skos__broader mesh__D020768smesh__D002536
% 221.18/221.35  |- mesh__dateCreated mesh__D020768 1999-11-03
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D020768 2003
% 221.18/221.35  |- skos__altLabel mesh__D020768 Cerebral Artery, Middle
% 221.18/221.35  |- mesh__historyNote mesh__D020768 2000   
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D020768 2002
% 221.18/221.35  |- rdf__type mesh__D020768sskos__Concept
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D020768 2004
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D020768 2005
% 221.18/221.35  |- skos__hiddenLabel mesh__D006299 Geriatric Health Service
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D006299 2005
% 221.18/221.35  |- skos__historyNote mesh__D006299 Health Services %28%1974-1979%29%
% 221.18/221.35  |- skos__hiddenLabel mesh__D006299 Services, Geriatric Health
% 221.18/221.35  |- mesh__recordOriginator mesh__D006299 EC
% 221.18/221.35  |- skos__hiddenLabel mesh__D006299 Health Service, Geriatric
% 221.18/221.35  |- skos__prefLabel mesh__D006299 Health Services for the Aged
% 221.18/221.35  |- skos__scopeNote mesh__D006299
% 221.18/221.35       Services for the diagnosis and treatment of diseases in the aged and the maintenance of health in the elderly.%A%    
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D006299 2006
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D006299 2000
% 221.18/221.35  |- skos__historyNote mesh__D006299
% 221.18/221.35       specific health service %28%1966-1979%29%
% 221.18/221.35  |- skos__hiddenLabel mesh__D006299 Service, Geriatric Health
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D006299 2001
% 221.18/221.35  |- skos__altLabel mesh__D006299 Health Services for the Elderly
% 221.18/221.35  |- mesh__recordAuthorizer mesh__D006299 sjn
% 221.18/221.35  |- mesh__dateEstablished mesh__D006299 1980-01-01
% 221.18/221.35  |- mesh__historyNote mesh__D006299 80   
% 221.18/221.35  |- mesh__recordMaintainer mesh__D006299 kle
% 221.18/221.35  |- skos__altLabel mesh__D006299 Health Services, Geriatric
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D006299 2002
% 221.18/221.35  |- skos__historyNote mesh__D006299 Aged %28%1966-1979%29%
% 221.18/221.35  |- mesh__dateRevised mesh__D006299 1999-11-03
% 221.18/221.35  |- skos__broader mesh__D006299smesh__D006296
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D006299 2003
% 221.18/221.35  |- mesh__publicMeSHNote mesh__D006299 80   
% 221.18/221.35  |- skos__altLabel mesh__D006299 Geriatric Health Services
% 221.18/221.35  |- skos__annotation mesh__D006299
% 221.18/221.35       coord IM with specific serv %28%IM or NIM%29% if pertinent; check also tag AGED; DF: HEALTH SERV AGED%A%  
% 221.18/221.35  |- rdf__type mesh__D006299sskos__Concept
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D006299 2004
% 221.18/221.35  |- mesh__dateCreated mesh__D006299 1978-12-22
% 221.18/221.35  |- skos__altLabel mesh__D006299 Health Services for Aged
% 221.18/221.35  |- mesh__recordOriginator mesh__D019416 JLS
% 221.18/221.35  |- skos__scopeNote mesh__D019416
% 221.18/221.35       Voluntary or involuntary motion of head that may be relative to or independent of body; includes animals and humans.%A%    
% 221.18/221.35  |- skos__hiddenLabel mesh__D019416 Movement, Head
% 221.18/221.35  |- skos__historyNote mesh__D019416 Movement %28%1966-1996%29%
% 221.18/221.35  |- skos__hiddenLabel mesh__D019416 Movements, Head
% 221.18/221.35  |- skos__broader mesh__D019416smesh__D009068
% 221.18/221.35  |- skos__prefLabel mesh__D019416 Head Movements
% 221.18/221.35  |- mesh__dateRevised mesh__D019416 2003-07-09
% 221.18/221.35  |- skos__hiddenLabel mesh__D019416 Head Movement
% 221.18/221.35  |- mesh__publicMeSHNote mesh__D019416 97   
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D019416 2006
% 221.18/221.35  |- mesh__dateEstablished mesh__D019416 1997-01-01
% 221.18/221.35  |- mesh__recordMaintainer mesh__D019416 nns
% 221.18/221.35  |- mesh__historyNote mesh__D019416 97   
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D019416 2004
% 221.18/221.35  |- rdf__type mesh__D019416sskos__Concept
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D019416 2005
% 221.18/221.35  |- skos__annotation mesh__D019416
% 221.18/221.35       note HEAD BANGING see STEREOTYPED BEHAVIOR   
% 221.18/221.35  |- mesh__dateCreated mesh__D019416 1996-06-10
% 221.18/221.35  |- mesh__recordAuthorizer mesh__D019416 sjn
% 221.18/221.35  |- skos__scopeNote mesh__D011433
% 221.18/221.35       A widely used non-cardioselective beta-adrenergic antagonist. Propranolol is used in the treatment or prevention of many disorders including acute myocardial infarction, arrhythmias, angina pectoris, hypertension, hypertensive emergencies, hyperthyroidism, migraine, pheochromocytoma, menopause, and anxiety.%A%    
% 221.18/221.35  |- rdf__type mesh__D011433sskos__Concept
% 221.18/221.35  |- skos__broader mesh__D011433smesh__D011412
% 221.18/221.35  |- mesh__recordOriginator mesh__D011433 NLM
% 221.18/221.35  |- mesh__dateEstablished mesh__D011433 1967-01-01
% 221.18/221.35  |- skos__altLabel mesh__D011433 Anapriline
% 221.18/221.35  |- mesh__recordAuthorizer mesh__D011433 sjn
% 221.18/221.35  |- mesh__dateRevised mesh__D011433 2005-06-30
% 221.18/221.35  |- mesh__historyNote mesh__D011433 67%28%65%29%   
% 221.18/221.35  |- skos__broader mesh__D011433smesh__D050198
% 221.18/221.35  |- skos__broader mesh__D011433smesh__D009281
% 221.18/221.35  |- skos__hiddenLabel mesh__D011433 AY20694
% 221.18/221.35  |- skos__hiddenLabel mesh__D011433 AY 20694
% 221.18/221.35  |- mesh__publicMeSHNote mesh__D011433 67   
% 221.18/221.35  |- skos__altLabel mesh__D011433 Obzidan
% 221.18/221.35  |- skos__altLabel mesh__D011433 Propanolol
% 221.18/221.35  |- skos__prefLabel mesh__D011433 Propranolol
% 221.18/221.35  |- skos__hiddenLabel mesh__D011433 Hydrochloride, Propranolol
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D011433 2006
% 221.18/221.35  |- mesh__recordMaintainer mesh__D011433 ssb
% 221.18/221.35  |- mesh__dateCreated mesh__D011433 1999-01-01
% 221.18/221.35  |- skos__broader mesh__D035881smesh__D007603
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D035881 2004
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D035881 2005
% 221.18/221.35  |- mesh__historyNote mesh__D035881
% 221.18/221.35       2003; for COMPENSATION use ECONOMICS 1993-2002   
% 221.18/221.35  |- skos__hiddenLabel mesh__D035881 Redress and Compensation
% 221.18/221.35  |- rdf__type mesh__D035881sskos__Concept
% 221.18/221.35  |- skos__broader mesh__D035881smesh__D004467
% 221.18/221.35  |- skos__scopeNote mesh__D035881
% 221.18/221.35       Payment, or other means of making amends, for a wrong or injury.%A%    
% 221.18/221.35  |- mesh__dateRevised mesh__D035881 2002-10-31
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D035881 2006
% 221.18/221.35  |- mesh__dateEstablished mesh__D035881 2003-01-01
% 221.18/221.35  |- mesh__recordMaintainer mesh__D035881 jls
% 221.18/221.35  |- skos__prefLabel mesh__D035881 Compensation and Redress
% 221.18/221.35  |- mesh__dateCreated mesh__D035881 2002-07-03
% 221.18/221.35  |- skos__related mesh__D035881smesh__D014942
% 221.18/221.35  |- mesh__publicMeSHNote mesh__D035881
% 221.18/221.35       2003; for COMPENSATION see ECONOMICS 1993-2002   
% 221.18/221.35  |- mesh__recordAuthorizer mesh__D035881 jls
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D035881 2003A
% 221.18/221.35  |- mesh__recordOriginator mesh__D035881 hjn
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D035881 2003
% 221.18/221.35  |- skos__prefLabel mesh__D021861 Microsporidia, Unclassified
% 221.18/221.35  |- skos__scopeNote mesh__D021861
% 221.18/221.35       Includes newly defined organisms as well as some that will never be classified to the genus and/or species level because of loss of the specimen or other information.%A%    
% 221.18/221.35  |- mesh__historyNote mesh__D021861 2001   
% 221.18/221.35  |- skos__broader mesh__D021861smesh__D016814
% 221.18/221.35  |- rdf__type mesh__D021861sskos__Concept
% 221.18/221.35  |- mesh__dateRevised mesh__D021861 2005-10-27
% 221.18/221.35  |- mesh__recordOriginator mesh__D021861 ags
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D021861 2006A
% 221.18/221.35  |- mesh__activeMeSHYear mesh__D021861 2006
% 221.18/221.35  |- mesh__recordAuthorizer mesh__D021861 ags
% 221.18/221.35  |- mesh__recordMaintainer mesh__D021861 ags
% 221.18/221.35  |- mesh__publicMeSHNote mesh__D021861 2001   
% 221.18/221.36  |- mesh__dateEstablished mesh__D021861 2001-01-01
% 221.18/221.36  |- mesh__dateCreated mesh__D021861 2000-06-22
% 221.18/221.36  |- skos__annotation mesh__D021861
% 221.18/221.36       index here if the author uses the term microsporidium or %22%unclassifed microsporidia%22%; index MICROSPORIDIA if the author uses %22%microsporidia%22% as a general term for the phylum; infection: coordinate IM with MICROSPORIDIOSIS %28%IM%29%; coordinate with specific fungal term %28%ANTIGENS, FUNGAL, etc%29% if pertinent%A%  
% 221.18/221.36  |- mesh__dateRevised mesh__D007392 1992-05-14
% 221.18/221.36  |- skos__historyNote mesh__D007392 Societies, Nursing %28%1966-1979%29%
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D007392 2002
% 221.18/221.36  |- mesh__recordOriginator mesh__D007392 EC
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D007392 1996
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D007392 2003
% 221.18/221.36  |- mesh__dateCreated mesh__D007392 1979-04-11
% 221.18/221.36  |- skos__scopeNote mesh__D007392
% 221.18/221.36       An international professional organization composed of one association per country for the purpose of improving and developing nursing%27%s contribution to the promotion of health and care of the sick.%A%    
% 221.18/221.36  |- mesh__publicMeSHNote mesh__D007392
% 221.18/221.36       91; was see under SOCIETIES, NURSING 1980-90   
% 221.18/221.36  |- skos__prefLabel mesh__D007392 International Council of Nurses
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D007392 1998
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D007392 2005
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D007392 1997
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D007392 2004
% 221.18/221.36  |- skos__hiddenLabel mesh__D007392 Nurses International Council
% 221.18/221.36  |- skos__historyNote mesh__D007392
% 221.18/221.36       International Cooperation %28%1966-1979%29%
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D007392 2000
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D007392 1994
% 221.18/221.36  |- skos__hiddenLabel mesh__D007392 Nurses International Councils
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D007392 1993
% 221.18/221.36  |- mesh__recordAuthorizer mesh__D007392 PLS
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D007392 1999
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D007392 2006
% 221.18/221.36  |- mesh__dateEstablished mesh__D007392 1991-01-01
% 221.18/221.36  |- mesh__recordMaintainer mesh__D007392 TAP
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D007392 2001
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D007392 1995
% 221.18/221.36  |- skos__annotation mesh__D007392 IM      CATALOG: use NAF entry   
% 221.18/221.36  |- skos__broader mesh__D007392smesh__D012956
% 221.18/221.36  |- mesh__historyNote mesh__D007392
% 221.18/221.36       91%28%80%29%; was see under SOCIETIES, NURSING 1980-90   
% 221.18/221.36  |- rdf__type mesh__D007392sskos__Concept
% 221.18/221.36  |- mesh__recordOriginator mesh__D015824 PXP
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D015824 2006
% 221.18/221.36  |- skos__related mesh__D015824smesh__D011659
% 221.18/221.36  |- skos__related mesh__D015824smesh__D002199
% 221.18/221.36  |- mesh__dateRevised mesh__D015824 2003-07-09
% 221.18/221.36  |- mesh__publicMeSHNote mesh__D015824 90   
% 221.18/221.36  |- mesh__historyNote mesh__D015824 90   
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D015824 2005
% 221.18/221.36  |- skos__scopeNote mesh__D015824
% 221.18/221.36       The barrier between capillary blood and alveolar air comprising the alveolar EPITHELIUM and capillary ENDOTHELIUM with their adherent BASEMENT MEMBRANE and EPITHELIAL CELL cytoplasm. PULMONARY GAS EXCHANGE occurs across this membrane.%A%    
% 221.18/221.36  |- rdf__type mesh__D015824sskos__Concept
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D015824 2004
% 221.18/221.36  |- skos__hiddenLabel mesh__D015824 Barrier, Blood-Air
% 221.18/221.36  |- skos__broader mesh__D015824smesh__D002319
% 221.18/221.36  |- skos__hiddenLabel mesh__D015824 Barriers, Blood-Air
% 221.18/221.36  |- skos__historyNote mesh__D015824 Capillaries %28%1969-1989%29%
% 221.18/221.36  |- skos__hiddenLabel mesh__D015824 Membranes, Alveolocapillary
% 221.18/221.36  |- skos__historyNote mesh__D015824 Pulmonary Alveoli %28%1969-1989%29%
% 221.18/221.36  |- skos__hiddenLabel mesh__D015824 Air Blood Barrier
% 221.18/221.36  |- skos__prefLabel mesh__D015824 Blood-Air Barrier
% 221.18/221.36  |- mesh__recordMaintainer mesh__D015824 nns
% 221.18/221.36  |- skos__hiddenLabel mesh__D015824 Air-Blood Barriers
% 221.18/221.36  |- skos__hiddenLabel mesh__D015824 Blood Air Barrier
% 221.18/221.36  |- skos__hiddenLabel mesh__D015824 Barrier, Air-Blood
% 221.18/221.36  |- skos__hiddenLabel mesh__D015824 Blood-Air Barriers
% 221.18/221.36  |- skos__hiddenLabel mesh__D015824 Membrane, Alveolocapillary
% 221.18/221.36  |- skos__hiddenLabel mesh__D015824 Barriers, Air-Blood
% 221.18/221.36  |- mesh__dateEstablished mesh__D015824 1990-01-01
% 221.18/221.36  |- skos__hiddenLabel mesh__D015824 Alveolocapillary Membranes
% 221.18/221.36  |- mesh__recordAuthorizer mesh__D015824 sjn
% 221.18/221.36  |- mesh__dateCreated mesh__D015824 1989-09-06
% 221.18/221.36  |- skos__broader mesh__D015824smesh__D011650
% 221.18/221.36  |- skos__altLabel mesh__D015824 Alveolocapillary Membrane
% 221.18/221.36  |- skos__annotation mesh__D015824
% 221.18/221.36       coord IM with endogenous substance /metab %28%IM%29% or exogenous substance /pharmacokin %28%IM%29%%A%  
% 221.18/221.36  |- skos__altLabel mesh__D015824 Air-Blood Barrier
% 221.18/221.36  |- mesh__dateRevised mesh__D015026 2005-06-30
% 221.18/221.36  |- mesh__dateCreated mesh__D015026 1974-11-19
% 221.18/221.36  |- mesh__historyNote mesh__D015026
% 221.18/221.36       91%28%75%29%; was see under PURINES 1975-90   
% 221.18/221.36  |- skos__historyNote mesh__D015026 Amino Alcohols %28%1973-1974%29%
% 221.18/221.36  |- mesh__recordMaintainer mesh__D015026 ssb
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D015026 2006
% 221.18/221.36  |- skos__broader mesh__D015026smesh__D003583
% 221.18/221.36  |- rdf__type mesh__D015026sskos__Concept
% 221.18/221.36  |- skos__historyNote mesh__D015026 Purines %28%1973-1974%29%
% 221.18/221.36  |- mesh__recordAuthorizer mesh__D015026 sjn
% 221.18/221.36  |- mesh__dateEstablished mesh__D015026 1991-01-01
% 221.18/221.36  |- skos__prefLabel mesh__D015026 Zeatin
% 221.18/221.36  |- mesh__recordOriginator mesh__D015026 NLM
% 221.18/221.36  |- mesh__publicMeSHNote mesh__D015026 91; was see under PURINES 1975-90   
% 221.18/221.36  |- skos__scopeNote mesh__D015026
% 221.18/221.36       An aminopurine factor in plant extracts that induces cell division. %28%Grant %26% Hackh%27%s Chemical Dict, 5th ed%29%%A%    
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D001804 1994
% 221.18/221.36  |- skos__hiddenLabel mesh__D001804 Autotransfusions
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D001804 2003
% 221.18/221.36  |- skos__altLabel mesh__D001804 Blood Transfusions, Autologous
% 221.18/221.36  |- mesh__dateRevised mesh__D001804 1992-12-28
% 221.18/221.36  |- skos__altLabel mesh__D001804 Transfusion, Autologous Blood
% 221.18/221.36  |- mesh__recordAuthorizer mesh__D001804 PLS
% 221.18/221.36  |- skos__annotation mesh__D001804
% 221.18/221.36       do not use /util except by MeSH definition; DF: BLOOD TRANSFUSION AUTOL%A%  
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D001804 2005
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D001804 1997
% 221.18/221.36  |- mesh__publicMeSHNote mesh__D001804 71   
% 221.18/221.36  |- mesh__recordOriginator mesh__D001804 NLM
% 221.18/221.36  |- skos__altLabel mesh__D001804 Transfusions, Autologous Blood
% 221.18/221.36  |- skos__altLabel mesh__D001804 Autotransfusion
% 221.18/221.36  |- skos__altLabel mesh__D001804 Autologous Blood Transfusions
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D001804 1999
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D001804 1996
% 221.18/221.36  |- skos__historyNote mesh__D001804 Blood Transfusion %28%1966-1970%29%
% 221.18/221.36  |- mesh__dateEstablished mesh__D001804 1971-01-01
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D001804 2002
% 221.18/221.36  |- skos__scopeNote mesh__D001804
% 221.18/221.36       Reinfusion of blood or blood products derived from the patient%27%s own circulation. %28%Dorland, 27th ed%29%%A%    
% 221.18/221.36  |- skos__prefLabel mesh__D001804 Blood Transfusion, Autologous
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D001804 1998
% 221.18/221.36  |- mesh__dateCreated mesh__D001804 1999-01-01
% 221.18/221.36  |- rdf__type mesh__D001804sskos__Concept
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D001804 2001
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D001804 1995
% 221.18/221.36  |- mesh__recordMaintainer mesh__D001804 PLS
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D001804 2004
% 221.18/221.36  |- skos__altLabel mesh__D001804 Autologous Blood Transfusion
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D001804 2000
% 221.18/221.36  |- skos__broader mesh__D001804smesh__D001803
% 221.18/221.36  |- mesh__historyNote mesh__D001804 71   
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D001804 2006
% 221.18/221.36  |- skos__broader mesh__D020769smesh__D002536
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D020769 2002
% 221.18/221.36  |- mesh__recordOriginator mesh__D020769 ags
% 221.18/221.36  |- mesh__dateRevised mesh__D020769 2001-07-25
% 221.18/221.36  |- skos__hiddenLabel mesh__D020769 Cerebral Arteries, Posterior
% 221.18/221.36  |- skos__hiddenLabel mesh__D020769 Posterior Cerebral Arteries
% 221.18/221.36  |- mesh__dateEstablished mesh__D020769 2000-01-01
% 221.18/221.36  |- skos__hiddenLabel mesh__D020769 Arteries, Posterior Cerebral
% 221.18/221.36  |- mesh__publicMeSHNote mesh__D020769 2000   
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D020769 2003
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D020769 2005
% 221.18/221.36  |- skos__scopeNote mesh__D020769
% 221.18/221.36       Artery formed by the bifurcation of the BASILAR ARTERY. Branches of the posterior cerebral artery supply portions of the OCCIPITAL LOBE; PARIETAL LOBE; inferior temporal gyrus, brainstem, and CHOROID PLEXUS.%A%    
% 221.18/221.36  |- skos__hiddenLabel mesh__D020769 Artery, Posterior Cerebral
% 221.18/221.36  |- mesh__historyNote mesh__D020769 2000   
% 221.18/221.36  |- mesh__recordAuthorizer mesh__D020769 sjn
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D020769 2004
% 221.18/221.36  |- rdf__type mesh__D020769sskos__Concept
% 221.18/221.36  |- mesh__recordMaintainer mesh__D020769 mdb
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D020769 2006
% 221.18/221.36  |- skos__prefLabel mesh__D020769 Posterior Cerebral Artery
% 221.18/221.36  |- mesh__dateCreated mesh__D020769 1999-11-03
% 221.18/221.36  |- skos__historyNote mesh__D020769 Cerebral Arteries %28%1966-1999%29%
% 221.18/221.36  |- skos__altLabel mesh__D020769 Cerebral Artery, Posterior
% 221.18/221.36  |- skos__broader mesh__D012709Q000652smesh__D012709
% 221.18/221.36  |- mesh__preferredCombination mesh__D012709Q000652smesh__D000419
% 221.18/221.36  |- rdf__type mesh__D012709Q000652smesh__CompoundConcept
% 221.18/221.36  |- skos__hiddenLabel mesh__D001006 Imperforate Anus
% 221.18/221.36  |- mesh__dateEstablished mesh__D001006 1966-01-01
% 221.18/221.36  |- mesh__dateRevised mesh__D001006 2003-07-09
% 221.18/221.36  |- mesh__recordOriginator mesh__D001006 NLM
% 221.18/221.36  |- rdf__type mesh__D001006sskos__Concept
% 221.18/221.36  |- skos__altLabel mesh__D001006 Anal Atresia
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D001006 2006
% 221.18/221.36  |- mesh__publicMeSHNote mesh__D001006 66   
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D001006 2005
% 221.18/221.36  |- skos__altLabel mesh__D001006 Atresia, Anal
% 221.18/221.36  |- mesh__historyNote mesh__D001006 66%28%64%29%   
% 221.18/221.36  |- skos__scopeNote mesh__D001006
% 221.18/221.36       A congenital abnormality characterized by the persistence of the anal membrane, resulting in a thin membrane covering the normal ANAL CANAL. Imperforation is not always complete and is treated by surgery in infancy. This defect is often associated with NEURAL TUBE DEFECTS; MENTAL RETARDATION; and DOWN SYNDROME.%A%    
% 221.18/221.36  |- mesh__recordAuthorizer mesh__D001006 sjn
% 221.18/221.36  |- skos__broader mesh__D001006smesh__D004065
% 221.18/221.36  |- skos__prefLabel mesh__D001006 Anus, Imperforate
% 221.18/221.36  |- mesh__dateCreated mesh__D001006 1999-01-01
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D001006 2004
% 221.18/221.36  |- skos__hiddenLabel mesh__D001006 Anal Atresias
% 221.18/221.36  |- mesh__recordMaintainer mesh__D001006 lkt
% 221.18/221.36  |- skos__hiddenLabel mesh__D001006 Atresias, Anal
% 221.18/221.36  |- skos__broader mesh__D011941Q000037smesh__D011941
% 221.18/221.36  |- mesh__preferredCombination mesh__D011941Q000037smesh__D018674
% 221.18/221.36  |- rdf__type mesh__D011941Q000037smesh__CompoundConcept
% 221.18/221.36  |- skos__hiddenLabel mesh__D047108 Embryo Development, Preimplantation
% 221.18/221.36  |- mesh__recordMaintainer mesh__D047108 lkt
% 221.18/221.36  |- mesh__dateEstablished mesh__D047108 2005-01-01
% 221.18/221.36  |- skos__prefLabel mesh__D047108 Embryonic Development
% 221.18/221.36  |- skos__altLabel mesh__D047108 Embryogenesis
% 221.18/221.36  |- skos__historyNote mesh__D047108
% 221.18/221.36       Embryonic and Fetal Development %28%1973-2004%29%
% 221.18/221.36  |- skos__hiddenLabel mesh__D047108 Pre implantation Embryo Development
% 221.18/221.36  |- mesh__recordOriginator mesh__D047108 lkt
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D047108 2005
% 221.18/221.36  |- skos__hiddenLabel mesh__D047108 Embryo Development, Post-implantation
% 221.18/221.36  |- mesh__recordAuthorizer mesh__D047108 sjn
% 221.18/221.36  |- skos__hiddenLabel mesh__D047108 Embryo Development, Postnidation
% 221.18/221.36  |- skos__hiddenLabel mesh__D047108 Embryo Development, Postimplantation
% 221.18/221.36  |- skos__altLabel mesh__D047108 Embryo Development
% 221.18/221.36  |- mesh__dateCreated mesh__D047108 2004-07-07
% 221.18/221.36  |- rdf__type mesh__D047108sskos__Concept
% 221.18/221.36  |- skos__scopeNote mesh__D047108
% 221.18/221.36       Morphological and physiological development of EMBRYOS.%A%    
% 221.18/221.36  |- skos__altLabel mesh__D047108 Pre-implantation Embryo Development
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D047108 2006
% 221.18/221.36  |- skos__hiddenLabel mesh__D047108 Development, Postnidation Embryo
% 221.18/221.36  |- skos__altLabel mesh__D047108 Postnidation Embryo Development
% 221.18/221.36  |- skos__broader mesh__D047108smesh__D005314
% 221.18/221.36  |- skos__hiddenLabel mesh__D047108 Embryonic Developments
% 221.18/221.36  |- skos__hiddenLabel mesh__D047108 Embryo Development, Pre-implantation
% 221.18/221.36  |- skos__hiddenLabel mesh__D047108 Development, Embryo
% 221.18/221.36  |- skos__hiddenLabel mesh__D047108 Development, Embryonic
% 221.18/221.36  |- skos__hiddenLabel mesh__D047108 Post implantation Embryo Development
% 221.18/221.36  |- mesh__publicMeSHNote mesh__D047108
% 221.18/221.36       2005; see EMBRYONIC AND FETAL DEVELOPMENT 1985-2004; for POSTIMPLANTATION EMBRYO DEVELOPMENT see POSTIMPLANTATION PHASE 1985-2004, see POSTNIDATION PHASE 1980-1984, see PREGNANCY TRIMESTER, FIRST 1976-1979, see PREGNANCY, FIRST TRIMESTER 1975; for PREIMPLANTATION EMBRYO DEVELOPMENT see PREIMPLANTATION PHASE 1985-2004, see PRENIDATION PHASE 1980-1984, see PREGNANCY TRIMESTER, FIRST 1976-1979, see PREGNANCY, FIRST TRIMESTER 1975; for POSTNIDATION EMBRYO DEVELOPMENT, ANIMAL %26% PRENIDATION EMBRYO DEVELOPMENT, ANIMAL see PREGNANCY, ANIMAL 1975-1979%A%  
% 221.18/221.36  |- skos__altLabel mesh__D047108 Post-implantation Embryo Development
% 221.18/221.36  |- mesh__historyNote mesh__D047108
% 221.18/221.36       2005; use EMBRYONIC AND FETAL DEVELOPMENT 1985-2004; for POSTIMPLANTATION EMBRYO DEVELOPMENT %26% PREIMPLANTATION EMBRYO DEVELOPMENT use EMBRYONIC AND FETAL DEVELOPMENT 1976-2004%A%  
% 221.18/221.36  |- mesh__recordOriginator mesh__D019417 JLS
% 221.18/221.36  |- skos__altLabel mesh__D019417 Hindlimb Elevation
% 221.18/221.36  |- skos__hiddenLabel mesh__D019417 Skeletal Unloadings
% 221.18/221.36  |- mesh__dateEstablished mesh__D019417 1997-01-01
% 221.18/221.36  |- skos__hiddenLabel mesh__D019417 Suspension, Tail
% 221.18/221.36  |- skos__hiddenLabel mesh__D019417 Suspension, Hindlimb
% 221.18/221.36  |- skos__scopeNote mesh__D019417
% 221.18/221.36       Technique for limiting use, activity, or movement by immobilizing or restraining animal by suspending from hindlimbs or tails. This immobilization is used to simulate some effects of reduced gravity and study weightlessness physiology.%A%    
% 221.18/221.36  |- mesh__dateCreated mesh__D019417 1996-06-10
% 221.18/221.36  |- skos__prefLabel mesh__D019417 Hindlimb Suspension
% 221.18/221.36  |- mesh__dateRevised mesh__D019417 2004-07-07
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D019417 2005
% 221.18/221.36  |- skos__historyNote mesh__D019417 Immobilization %28%1966-1996%29%
% 221.18/221.36  |- mesh__recordAuthorizer mesh__D019417 sjn
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D019417 2006
% 221.18/221.36  |- skos__hiddenLabel mesh__D019417 Unloadings, Skeletal
% 221.18/221.36  |- skos__hiddenLabel mesh__D019417 Unloadings, Hindlimb
% 221.18/221.36  |- skos__hiddenLabel mesh__D019417 Unloading, Skeletal
% 221.18/221.36  |- mesh__historyNote mesh__D019417 97   
% 221.18/221.36  |- rdf__type mesh__D019417sskos__Concept
% 221.18/221.36  |- skos__hiddenLabel mesh__D019417 Elevation, Hindlimb
% 221.18/221.36  |- skos__altLabel mesh__D019417 Hindlimb Immobilization
% 221.18/221.36  |- skos__hiddenLabel mesh__D019417 Immobilization, Hindlimb
% 221.18/221.36  |- skos__broader mesh__D019417smesh__D018474
% 221.18/221.36  |- skos__altLabel mesh__D019417 Hindlimb Unloading
% 221.18/221.36  |- mesh__recordMaintainer mesh__D019417 nns
% 221.18/221.36  |- mesh__publicMeSHNote mesh__D019417 97   
% 221.18/221.36  |- skos__hiddenLabel mesh__D019417 Unloading, Hindlimb
% 221.18/221.36  |- skos__broader mesh__D019417smesh__D012149
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D011434 1995
% 221.18/221.36  |- mesh__publicMeSHNote mesh__D011434 73   
% 221.18/221.36  |- rdf__type mesh__D011434sskos__Concept
% 221.18/221.36  |- skos__hiddenLabel mesh__D011434 Proprioceptions
% 221.18/221.36  |- mesh__dateEstablished mesh__D011434 1973-01-01
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D011434 2002
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D011434 1999
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D011434 2004
% 221.18/221.36  |- skos__prefLabel mesh__D011434 Proprioception
% 221.18/221.36  |- mesh__historyNote mesh__D011434 73   
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D011434 1996
% 221.18/221.36  |- skos__historyNote mesh__D011434 Kinesthesis %28%1966-1972%29%
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D011434 1993
% 221.18/221.36  |- mesh__dateRevised mesh__D011434 1992-05-18
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D011434 2000
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D011434 1997
% 221.18/221.36  |- mesh__dateCreated mesh__D011434 1999-01-01
% 221.18/221.36  |- mesh__recordOriginator mesh__D011434 NLM
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D011434 2005
% 221.18/221.36  |- mesh__recordMaintainer mesh__D011434 TAP
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D011434 2001
% 221.18/221.36  |- mesh__recordAuthorizer mesh__D011434 PLS
% 221.18/221.36  |- skos__broader mesh__D011434smesh__D012677
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D011434 1994
% 221.18/221.36  |- skos__scopeNote mesh__D011434
% 221.18/221.36       The mechanism involved in the self-regulation of posture and movement through stimuli originating in the receptors imbedded in the joints, tendons, muscles, and labyrinth.%A%    
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D011434 2006
% 221.18/221.36  |- skos__historyNote mesh__D011434 Equilibrium %28%1966-1972%29%
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D011434 1998
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D011434 2003
% 221.18/221.36  |- mesh__historyNote mesh__D029845 2002   
% 221.18/221.36  |- mesh__dateRevised mesh__D029845 2005-06-30
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D029845 2006
% 221.18/221.36  |- mesh__recordAuthorizer mesh__D029845 sjn
% 221.18/221.36  |- rdf__type mesh__D029845sskos__Concept
% 221.18/221.36  |- skos__broader mesh__D029845smesh__D011506
% 221.18/221.36  |- mesh__recordMaintainer mesh__D029845 SYSTEM
% 221.18/221.36  |- mesh__dateCreated mesh__D029845 2001-07-25
% 221.18/221.36  |- mesh__dateEstablished mesh__D029845 2002-01-01
% 221.18/221.36  |- mesh__recordOriginator mesh__D029845 jmp
% 221.18/221.36  |- skos__prefLabel mesh__D029845 Amphibian Proteins
% 221.18/221.36  |- skos__scopeNote mesh__D029845
% 221.18/221.36       Proteins obtained from species in the class of AMPHIBIA.%A%    
% 221.18/221.36  |- skos__annotation mesh__D029845
% 221.18/221.36       coord IM with specific protein %28%IM%29% + specific amphibian %28%IM%29%%A%  
% 221.18/221.36  |- mesh__publicMeSHNote mesh__D029845 2002   
% 221.18/221.36  |- skos__related mesh__D029845smesh__D000663
% 221.18/221.36  |- rdf__type mesh__D021862sskos__Concept
% 221.18/221.36  |- skos__annotation mesh__D021862
% 221.18/221.36       infection: coord IM with MICROSPORIDIOSIS %28%IM%29%; coord with specific fungal terms %28%ANTIGENS, FUNGAL, etc%29% if pertinent%A%  
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D021862 2006
% 221.18/221.36  |- mesh__recordMaintainer mesh__D021862 ags
% 221.18/221.36  |- mesh__dateRevised mesh__D021862 2005-06-30
% 221.18/221.36  |- skos__scopeNote mesh__D021862
% 221.18/221.36       A genus of parasitic FUNGI in the family Enterocytozoonidae, which infects humans. Enterocytozoon bieneusi has been found in the intestines of patients with AIDS.%A%    
% 221.18/221.36  |- mesh__recordAuthorizer mesh__D021862 sjn
% 221.18/221.36  |- mesh__dateEstablished mesh__D021862 2001-01-01
% 221.18/221.36  |- skos__historyNote mesh__D021862 Microsporida %28%1992-2000%29%
% 221.18/221.36  |- mesh__dateCreated mesh__D021862 2000-06-22
% 221.18/221.36  |- mesh__recordOriginator mesh__D021862 ags
% 221.18/221.36  |- mesh__historyNote mesh__D021862 2001   
% 221.18/221.36  |- skos__broader mesh__D021862smesh__D016817
% 221.18/221.36  |- skos__prefLabel mesh__D021862 Enterocytozoon
% 221.18/221.36  |- mesh__publicMeSHNote mesh__D021862 2001   
% 221.18/221.36  |- skos__prefLabel mesh__D007393 International Educational Exchange
% 221.18/221.36  |- skos__broader mesh__D007393smesh__D004493
% 221.18/221.36  |- skos__hiddenLabel mesh__D007393 Educational Exchanges, International
% 221.18/221.36  |- rdf__type mesh__D007393sskos__Concept
% 221.18/221.36  |- skos__hiddenLabel mesh__D007393 Exchanges, International Educational
% 221.18/221.36  |- skos__scopeNote mesh__D007393
% 221.18/221.36       The exchange of students or professional personnel between countries done under the auspices of an organization for the purpose of further education.%A%    
% 221.18/221.36  |- mesh__recordMaintainer mesh__D007393 hjn
% 221.18/221.36  |- mesh__recordOriginator mesh__D007393 NLM
% 221.18/221.36  |- skos__broader mesh__D007393smesh__D007391
% 221.18/221.36  |- skos__altLabel mesh__D007393 Exchange, International Educational
% 221.18/221.36  |- skos__related mesh__D007393smesh__D005550
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D007393 2004
% 221.18/221.36  |- mesh__dateRevised mesh__D007393 2002-07-03
% 221.18/221.36  |- mesh__publicMeSHNote mesh__D007393 70   
% 221.18/221.36  |- skos__hiddenLabel mesh__D007393 International Educational Exchanges
% 221.18/221.36  |- skos__altLabel mesh__D007393 Educational Exchange, International
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D007393 2003
% 221.18/221.36  |- skos__annotation mesh__D007393 specify geog if pertinent   
% 221.18/221.36  |- mesh__dateEstablished mesh__D007393 1970-01-01
% 221.18/221.36  |- mesh__dateCreated mesh__D007393 1999-01-01
% 221.18/221.36  |- mesh__recordAuthorizer mesh__D007393 sjn
% 221.18/221.36  |- skos__historyNote mesh__D007393
% 221.18/221.36       International Cooperation %28%1966-1967%29%
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D007393 2006
% 221.18/221.36  |- mesh__historyNote mesh__D007393 70%28%68%29%   
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D007393 2005
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D015825 2005
% 221.18/221.36  |- mesh__recordAuthorizer mesh__D015825 sjn
% 221.18/221.36  |- mesh__recordMaintainer mesh__D015825 TGC
% 221.18/221.36  |- rdf__type mesh__D015825sskos__Concept
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D015825 2004
% 221.18/221.36  |- skos__hiddenLabel mesh__D015825 Chromosome, Fungal
% 221.18/221.36  |- skos__historyNote mesh__D015825 Fungi %28%1968-1985%29%
% 221.18/221.36  |- skos__historyNote mesh__D015825 Genes, Fungal %28%1984-1989%29%
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D015825 2003
% 221.18/221.36  |- skos__historyNote mesh__D015825 Chromosomes %28%1968-1989%29%
% 221.18/221.36  |- mesh__historyNote mesh__D015825 90   
% 221.18/221.36  |- skos__broader mesh__D015825smesh__D002875
% 221.18/221.36  |- skos__scopeNote mesh__D015825
% 221.18/221.36       Structures within the nucleus of fungal cells consisting of or containing DNA, which carry genetic information essential to the cell.%A%    
% 221.18/221.36  |- skos__annotation mesh__D015825
% 221.18/221.36       A 11 qualif except /cytol; /genet permitted; coord IM with specific fungus /genet %28%IM%29%%A%  
% 221.18/221.36  |- mesh__dateEstablished mesh__D015825 1990-01-01
% 221.18/221.36  |- skos__hiddenLabel mesh__D015825 Fungal Chromosome
% 221.18/221.36  |- mesh__recordOriginator mesh__D015825 PXP
% 221.18/221.36  |- skos__historyNote mesh__D015825 DNA, Fungal %28%1980-1985%29%
% 221.18/221.36  |- skos__hiddenLabel mesh__D015825 Fungal Chromosomes
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D015825 2006
% 221.18/221.36  |- mesh__dateRevised mesh__D015825 2002-07-03
% 221.18/221.36  |- skos__prefLabel mesh__D015825 Chromosomes, Fungal
% 221.18/221.36  |- mesh__publicMeSHNote mesh__D015825 90   
% 221.18/221.36  |- mesh__dateCreated mesh__D015825 1989-05-15
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D015027 2004
% 221.18/221.36  |- skos__prefLabel mesh__D015027 Zebrafish
% 221.18/221.36  |- rdf__type mesh__D015027sskos__Concept
% 221.18/221.36  |- skos__broader mesh__D015027smesh__D003530
% 221.18/221.36  |- mesh__recordMaintainer mesh__D015027 ags
% 221.18/221.36  |- skos__altLabel mesh__D015027 Zebrafishes
% 221.18/221.36  |- mesh__recordOriginator mesh__D015027 EC
% 221.18/221.36  |- skos__altLabel mesh__D015027 Brachydanio rerio
% 221.18/221.36  |- mesh__onlineNote mesh__D015027
% 221.18/221.36       use ZEBRAFISH to search BRACHYDANIO 1987-93   
% 221.18/221.36  |- mesh__dateEstablished mesh__D015027 1991-01-01
% 221.18/221.36  |- skos__scopeNote mesh__D015027
% 221.18/221.36       An exotic species of the family CYPRINIDAE, originally from Asia, that has been introduced in North America. They are used in embryological studies and to study the effects of certain chemicals on development.%A%    
% 221.18/221.36  |- mesh__publicMeSHNote mesh__D015027
% 221.18/221.36       91; was see under CYPRINIDAE 1987-90; BRACHYDANIO was see ZEBRAFISH 1987-93%A%  
% 221.18/221.36  |- mesh__dateCreated mesh__D015027 1986-04-15
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D015027 2005
% 221.18/221.36  |- mesh__historyNote mesh__D015027
% 221.18/221.36       91%28%87%29%; was see under CYPRINIDAE 1987-90; BRACHYDANIO was see ZEBRAFISH 1987-93%A%  
% 221.18/221.36  |- skos__historyNote mesh__D015027 Fishes %28%1966-1986%29%
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D015027 2006
% 221.18/221.36  |- skos__altLabel mesh__D015027 Zebra Danio
% 221.18/221.36  |- skos__related mesh__D015027smesh__D029961
% 221.18/221.36  |- mesh__dateRevised mesh__D015027 2003-07-09
% 221.18/221.36  |- skos__altLabel mesh__D015027 Zebra Fish
% 221.18/221.36  |- mesh__recordAuthorizer mesh__D015027 sjn
% 221.18/221.36  |- skos__altLabel mesh__D015027 Danio rerio
% 221.18/221.36  |- mesh__dateEstablished mesh__D001805 1968-01-01
% 221.18/221.36  |- skos__scopeNote mesh__D001805
% 221.18/221.36       In utero transfusion of BLOOD into the FETUS for the treatment of FETAL DISEASES, such as fetal erythroblastosis %28%ERYTHROBLASTOSIS, FETAL%29%.%A%    
% 221.18/221.36  |- skos__altLabel mesh__D001805 Fetal Transfusion
% 221.18/221.36  |- mesh__historyNote mesh__D001805 68%28%65%29%   
% 221.18/221.36  |- skos__hiddenLabel mesh__D001805 Transfusion, Fetal
% 221.18/221.36  |- mesh__dateCreated mesh__D001805 1999-01-01
% 221.18/221.36  |- skos__broader mesh__D001805smesh__D001803
% 221.18/221.36  |- rdf__type mesh__D001805sskos__Concept
% 221.18/221.36  |- skos__annotation mesh__D001805
% 221.18/221.36       coordinate with specific type of transfusion if pertinent%A%  
% 221.18/221.36  |- skos__hiddenLabel mesh__D001805 Transfusion, Intrauterine Blood
% 221.18/221.36  |- mesh__dateRevised mesh__D001805 2004-07-07
% 221.18/221.36  |- skos__altLabel mesh__D001805 Intrauterine Transfusion
% 221.18/221.36  |- skos__broader mesh__D001805smesh__D046128
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D001805 2006
% 221.18/221.36  |- skos__hiddenLabel mesh__D001805 Blood Transfusions, Intrauterine
% 221.18/221.36  |- mesh__recordAuthorizer mesh__D001805 sjn
% 221.18/221.36  |- skos__hiddenLabel mesh__D001805 Transfusions, Intrauterine
% 221.18/221.36  |- skos__prefLabel mesh__D001805 Blood Transfusion, Intrauterine
% 221.18/221.36  |- skos__hiddenLabel mesh__D001805 Intrauterine Blood Transfusions
% 221.18/221.36  |- mesh__recordOriginator mesh__D001805 NLM
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D001805 2005
% 221.18/221.36  |- skos__hiddenLabel mesh__D001805 Transfusions, Intrauterine Blood
% 221.18/221.36  |- skos__hiddenLabel mesh__D001805 Transfusion, Intrauterine
% 221.18/221.36  |- skos__hiddenLabel mesh__D001805 Intrauterine Transfusions
% 221.18/221.36  |- mesh__recordMaintainer mesh__D001805 lkt
% 221.18/221.36  |- skos__hiddenLabel mesh__D001805 Fetal Transfusions
% 221.18/221.36  |- skos__hiddenLabel mesh__D001805 Intrauterine Blood Transfusion
% 221.18/221.36  |- skos__hiddenLabel mesh__D001805 Transfusions, Fetal
% 221.18/221.36  |- mesh__publicMeSHNote mesh__D001805 68   
% 221.18/221.36  |- rdf__type mesh__D001007sskos__Concept
% 221.18/221.36  |- skos__hiddenLabel mesh__D001007 Anxieties
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D001007 2006
% 221.18/221.36  |- mesh__dateRevised mesh__D001007 2005-06-30
% 221.18/221.36  |- mesh__dateCreated mesh__D001007 1999-01-01
% 221.18/221.36  |- mesh__recordMaintainer mesh__D001007 ssb
% 221.18/221.36  |- skos__prefLabel mesh__D001007 Anxiety
% 221.18/221.36  |- mesh__recordOriginator mesh__D001007 NLM
% 221.18/221.36  |- skos__annotation mesh__D001007
% 221.18/221.36       human %26% animal; differentiate from ANXIETY DISORDERS, a psychiatric diagnosis%A%  
% 221.18/221.36  |- skos__scopeNote mesh__D001007
% 221.18/221.36       Feeling or emotion of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.%A%    
% 221.18/221.36  |- skos__broader mesh__D001007smesh__D004644
% 221.18/221.36  |- mesh__recordAuthorizer mesh__D001007 sjn
% 221.18/221.36  |- mesh__recordOriginator mesh__D047109 lkt
% 221.18/221.36  |- mesh__activeMeSHYear mesh__D047109 2005
% 221.18/221.36  |- skos__historyNote mesh__D047109 Fetus %28%1965-2004%29%
% 221.18/221.36  |- skos__annotation mesh__D047109 mammalian only   
% 221.18/221.36  |- mesh__dateCreated mesh__D047109 2004-07-07
% 221.18/221.36  |- skos__prefLabel mesh__D047109 Fetal Development
% 221.18/221.36  |- rdf__type mesh__D047109sskos__Concept
% 221.18/221.36  |- mesh__recordMaintainer mesh__D047109 lkt
% 221.18/221.36  |- mesh__dateEstablished mesh__D047109 2005-01-01
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D047109 2006
% 221.18/221.37  |- skos__broader mesh__D047109smesh__D005314
% 221.18/221.37  |- mesh__publicMeSHNote mesh__D047109
% 221.18/221.37       2005, 1985-2002; see EMBRYONIC AND FETAL DEVELOPMENT 2003-2004%A%  
% 221.18/221.37  |- mesh__recordAuthorizer mesh__D047109 sjn
% 221.18/221.37  |- skos__historyNote mesh__D047109
% 221.18/221.37       Embryo and Fetal Development %28%1985-2004%29%
% 221.18/221.37  |- skos__hiddenLabel mesh__D047109 Development, Fetal
% 221.18/221.37  |- mesh__historyNote mesh__D047109
% 221.18/221.37       2005, 1985-2002; use EMBRYONIC AND FETAL DEVELOPMENT 2003-2004%A%  
% 221.18/221.37  |- skos__hiddenLabel mesh__D047109 Growth, Fetal
% 221.18/221.37  |- skos__scopeNote mesh__D047109
% 221.18/221.37       Morphological and physiological development of FETUSES.%A%    
% 221.18/221.37  |- mesh__publicMeSHNote mesh__D019418 97   
% 221.18/221.37  |- skos__annotation mesh__D019418
% 221.18/221.37       in both planetary bodies %26% terrestrial biochem; DF: EVOLUTION CHEM%A%  
% 221.18/221.37  |- skos__related mesh__D019418smesh__D001678
% 221.18/221.37  |- mesh__dateCreated mesh__D019418 1996-06-13
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D019418 2005
% 221.18/221.37  |- skos__scopeNote mesh__D019418
% 221.18/221.37       Chemical and physical transformation of the biogenic elements from their nucleosynthesis in stars to their incorporation and subsequent modification in planetary bodies and terrestrial biochemistry. It includes the mechanism of incorporation of biogenic elements into complex molecules and molecular systems, leading up to the origin of life.%A%    
% 221.18/221.37  |- skos__historyNote mesh__D019418 Biogenesis %28%1993-1996%29%
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D019418 2006
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D019418 2003
% 221.18/221.37  |- mesh__dateEstablished mesh__D019418 1997-01-01
% 221.18/221.37  |- skos__altLabel mesh__D019418 Chemical Evolution
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D019418 1998
% 221.18/221.37  |- mesh__historyNote mesh__D019418 97   
% 221.18/221.37  |- rdf__type mesh__D019418sskos__Concept
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D019418 2004
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D019418 1999
% 221.18/221.37  |- skos__broader mesh__D019418smesh__D010811
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D019418 2000
% 221.18/221.37  |- skos__prefLabel mesh__D019418 Evolution, Chemical
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D019418 1997
% 221.18/221.37  |- skos__hiddenLabel mesh__D019418 Evolutions, Chemical
% 221.18/221.37  |- skos__hiddenLabel mesh__D019418 Chemical Evolutions
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D019418 2001
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D019418 2002
% 221.18/221.37  |- mesh__dateRevised mesh__D011435 1998-06-10
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D011435 2004
% 221.18/221.37  |- skos__scopeNote mesh__D011435
% 221.18/221.37       Antioxidant for foods, fats, oils, ethers, emulsions, waxes, and transformer oils.%A%    
% 221.18/221.37  |- mesh__dateCreated mesh__D011435 1974-11-19
% 221.18/221.37  |- mesh__historyNote mesh__D011435
% 221.18/221.37       91%28%75%29%; was see under GALLIC ACID 1975-90   
% 221.18/221.37  |- skos__historyNote mesh__D011435 Gallic Acid %28%1973-1974%29%
% 221.18/221.37  |- skos__broader mesh__D011435smesh__D005707
% 221.18/221.37  |- mesh__recordMaintainer mesh__D011435 ADP
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D011435 2002
% 221.18/221.37  |- skos__hiddenLabel mesh__D011435 Gallate, Propyl
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D011435 2005
% 221.18/221.37  |- skos__prefLabel mesh__D011435 Propyl Gallate
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D011435 2006
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D011435 2000
% 221.18/221.37  |- skos__historyNote mesh__D011435 Alcohol, Propyl %28%1974%29%
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D011435 2003
% 221.18/221.37  |- mesh__recordOriginator mesh__D011435 NLM
% 221.18/221.37  |- rdf__type mesh__D011435sskos__Concept
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D011435 2001
% 221.18/221.37  |- mesh__recordAuthorizer mesh__D011435 SJN
% 221.18/221.37  |- mesh__dateEstablished mesh__D011435 1991-01-01
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D011435 1999
% 221.18/221.37  |- mesh__publicMeSHNote mesh__D011435
% 221.18/221.37       91; was see under GALLIC ACID 1975-90   
% 221.18/221.37  |- mesh__dateCreated mesh__D029846 2001-07-25
% 221.18/221.37  |- rdf__type mesh__D029846sskos__Concept
% 221.18/221.37  |- skos__scopeNote mesh__D029846
% 221.18/221.37       A plant genus of the family FABACEAE. SENNA EXTRACT is obtained from members of this genus. Members contain ANTHRAQUINONES and have been an ingredient in laxatives %28%CATHARTICS%29%.  Many species of the CASSIA genus have been reclassified into this genus.  This bush should not be confused with the Cassia tree %28%CINNAMOMUM%29%.%A%    
% 221.18/221.37  |- skos__altLabel mesh__D029846 Cassia angustifolia
% 221.18/221.37  |- mesh__historyNote mesh__D029846 2002   
% 221.18/221.37  |- skos__altLabel mesh__D029846 Cassia occidentalis
% 221.18/221.37  |- mesh__recordMaintainer mesh__D029846 ssb
% 221.18/221.37  |- mesh__dateEstablished mesh__D029846 2002-01-01
% 221.18/221.37  |- mesh__recordOriginator mesh__D029846 ssb
% 221.18/221.37  |- skos__prefLabel mesh__D029846 Senna Plant
% 221.18/221.37  |- mesh__dateRevised mesh__D029846 2002-07-03
% 221.18/221.37  |- mesh__publicMeSHNote mesh__D029846 2002   
% 221.18/221.37  |- skos__broader mesh__D029846smesh__D007887
% 221.18/221.37  |- skos__annotation mesh__D029846
% 221.18/221.37       note X refs: CASSIA is also available; Cassia tree is indexed under CINNAMOMUM;  SENNA EXTRACT is also available;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D029846 2003
% 221.18/221.37  |- skos__altLabel mesh__D029846 Cassia senna
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D029846 2005
% 221.18/221.37  |- mesh__recordAuthorizer mesh__D029846 sjn
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D029846 2004
% 221.18/221.37  |- skos__altLabel mesh__D029846 Coffee Senna
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D029846 2006
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D002100 2005
% 221.18/221.37  |- mesh__dateRevised mesh__D002100 2004-07-07
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D002100 2006
% 221.18/221.37  |- skos__prefLabel mesh__D002100 Cachexia
% 221.18/221.37  |- mesh__recordAuthorizer mesh__D002100 sjn
% 221.18/221.37  |- mesh__recordOriginator mesh__D002100 NLM
% 221.18/221.37  |- skos__related mesh__D002100smesh__D019247
% 221.18/221.37  |- skos__related mesh__D002100smesh__D019282
% 221.18/221.37  |- rdf__type mesh__D002100sskos__Concept
% 221.18/221.37  |- mesh__recordMaintainer mesh__D002100 nns
% 221.18/221.37  |- mesh__dateCreated mesh__D002100 1999-01-01
% 221.18/221.37  |- skos__broader mesh__D002100smesh__D004614
% 221.18/221.37  |- skos__annotation mesh__D002100
% 221.18/221.37       WASTING SYNDROME is also available: do not make diagnosis, use words of text%A%  
% 221.18/221.37  |- skos__scopeNote mesh__D002100
% 221.18/221.37       General ill health, malnutrition, and weight loss, usually associated with chronic disease.%A%    
% 221.18/221.37  |- skos__prefLabel mesh__D021863 Vittaforma
% 221.18/221.37  |- skos__annotation mesh__D021863
% 221.18/221.37       infection: coordinate IM with MICROSPORIDIOSIS %28%IM%29%; coordinate with specific fungal terms %28%ANTIGENS, FUNGAL, etc%29% if pertinent%A%  
% 221.18/221.37  |- skos__broader mesh__D021863smesh__D016817
% 221.18/221.37  |- mesh__recordMaintainer mesh__D021863 ags
% 221.18/221.37  |- skos__scopeNote mesh__D021863
% 221.18/221.37       A genus of parasitic FUNGI in the family Nosematidae that infects humans. Vittaforma corneae has been isolated from AIDS patients.%A%    
% 221.18/221.37  |- skos__altLabel mesh__D021863 Nosema corneum
% 221.18/221.37  |- mesh__publicMeSHNote mesh__D021863 2001   
% 221.18/221.37  |- mesh__dateEstablished mesh__D021863 2001-01-01
% 221.18/221.37  |- mesh__dateCreated mesh__D021863 2000-06-22
% 221.18/221.37  |- mesh__historyNote mesh__D021863 2001   
% 221.18/221.37  |- rdf__type mesh__D021863sskos__Concept
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D021863 2006
% 221.18/221.37  |- skos__historyNote mesh__D021863 Microsporida %28%1995-2000%29%
% 221.18/221.37  |- mesh__dateRevised mesh__D021863 2005-06-30
% 221.18/221.37  |- mesh__recordAuthorizer mesh__D021863 sjn
% 221.18/221.37  |- mesh__recordOriginator mesh__D021863 ags
% 221.18/221.37  |- skos__hiddenLabel mesh__D007394 Unit, SI
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D007394 2002
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D007394 2004
% 221.18/221.37  |- skos__prefLabel mesh__D007394 International System of Units
% 221.18/221.37  |- mesh__recordOriginator mesh__D007394 VDK
% 221.18/221.37  |- skos__annotation mesh__D007394
% 221.18/221.37       in titles use diacritics: Syst%C3%%A8%me International d%27%Unites; DF: note short X ref%A%  
% 221.18/221.37  |- skos__altLabel mesh__D007394 SI Units
% 221.18/221.37  |- skos__broader mesh__D007394smesh__D014894
% 221.18/221.37  |- mesh__historyNote mesh__D007394
% 221.18/221.37       91%28%79%29%; was see under WEIGHTS AND MEASURES 1979-90   
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D007394 2003
% 221.18/221.37  |- skos__altLabel mesh__D007394 Systeme International d%27%Unites
% 221.18/221.37  |- skos__hiddenLabel mesh__D007394 Units, SI
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D007394 2006
% 221.18/221.37  |- skos__historyNote mesh__D007394 Metric System %28%1974-1978%29%
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D007394 2005
% 221.18/221.37  |- mesh__dateCreated mesh__D007394 1978-03-24
% 221.18/221.37  |- skos__scopeNote mesh__D007394
% 221.18/221.37       A system of physical units in which the fundamental quantities are length, time, mass, electric current, temperature, luminous intensity, and amount of substance, and the corresponding units are the meter, second, kilogram, ampere, kelvin, candela, and mole. The system has been given official status and recommended for universal use by the General Conference on Weights and Measures.%A%    
% 221.18/221.37  |- mesh__dateRevised mesh__D007394 2001-08-13
% 221.18/221.37  |- mesh__dateEstablished mesh__D007394 1991-01-01
% 221.18/221.37  |- mesh__recordAuthorizer mesh__D007394 sjn
% 221.18/221.37  |- skos__historyNote mesh__D007394 Weights and Measures %28%1966-1978%29%
% 221.18/221.37  |- mesh__publicMeSHNote mesh__D007394
% 221.18/221.37       91; was see under WEIGHTS AND MEASURES 1979-90   
% 221.18/221.37  |- rdf__type mesh__D007394sskos__Concept
% 221.18/221.37  |- mesh__recordMaintainer mesh__D007394 jls
% 221.18/221.37  |- skos__hiddenLabel mesh__D007394 SI Unit
% 221.18/221.37  |- skos__hiddenLabel mesh__D015826 Giedion Langer Syndrome
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015826 1997
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015826 2002
% 221.18/221.37  |- rdf__type mesh__D015826sskos__Concept
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015826 2004
% 221.18/221.37  |- skos__altLabel mesh__D015826 Acrodysplasia V
% 221.18/221.37  |- skos__prefLabel mesh__D015826 Langer-Giedion Syndrome
% 221.18/221.37  |- skos__historyNote mesh__D015826 Exostoses, Multiple %28%1972-1989%29%
% 221.18/221.37  |- skos__altLabel mesh__D015826 Giedion-Langer Syndrome
% 221.18/221.37  |- skos__broader mesh__D015826smesh__D010009
% 221.18/221.37  |- skos__hiddenLabel mesh__D015826 Syndrome, Giedion-Langer
% 221.18/221.37  |- mesh__dateEstablished mesh__D015826 1990-01-01
% 221.18/221.37  |- skos__altLabel mesh__D015826 Trichorhinophalangeal Syndrome Type II
% 221.18/221.37  |- skos__hiddenLabel mesh__D015826 Syndrome, Langer-Giedion
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015826 2000
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015826 1994
% 221.18/221.37  |- mesh__historyNote mesh__D015826
% 221.18/221.37       90; was GIEDION-LANGER SYNDROME see EXOSTOSES, MULTIPLE 1968-89%A%  
% 221.18/221.37  |- skos__annotation mesh__D015826 an osteochondrodysplasia   
% 221.18/221.37  |- mesh__recordMaintainer mesh__D015826 PLS
% 221.18/221.37  |- mesh__dateCreated mesh__D015826 1989-05-15
% 221.18/221.37  |- skos__hiddenLabel mesh__D015826 Langer Giedion Syndrome
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015826 1998
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015826 1995
% 221.18/221.37  |- mesh__dateRevised mesh__D015826 1990-02-22
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015826 2005
% 221.18/221.37  |- mesh__recordOriginator mesh__D015826 AGS
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015826 2001
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015826 1999
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015826 1992
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015826 2006
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015826 1991
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015826 1996
% 221.18/221.37  |- mesh__publicMeSHNote mesh__D015826
% 221.18/221.37       90; was GIEDION-LANGER SYNDROME see EXOSTOSES, MULTIPLE 1968-89%A%  
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015826 1993
% 221.18/221.37  |- skos__scopeNote mesh__D015826
% 221.18/221.37       Autosomal dominant disorder characterized by cone-shaped epiphyses in the hands and multiple cartilaginous exostoses. Mental retardation and abnormalities of chromosome 8 are often present. The exostoses in this syndrome appear identical to those of hereditary multiple exostoses %28%EXOSTOSES, HEREDITARY MULTIPLE%29%.%A%    
% 221.18/221.37  |- mesh__onlineNote mesh__D015826
% 221.18/221.37       use EXOSTOSES, MULTIPLE to search GIEDION-LANGER SYNDROME 1968-89%A%  
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015826 2003
% 221.18/221.37  |- mesh__recordAuthorizer mesh__D015826 PLS
% 221.18/221.37  |- skos__altLabel mesh__D015826
% 221.18/221.37       Trichorhinophalangeal Syndrome with Exostoses
% 221.18/221.37  |- skos__prefLabel mesh__D015028 Zein
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015028 1999
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015028 1996
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015028 2000
% 221.18/221.37  |- mesh__dateCreated mesh__D015028 1999-01-01
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015028 1997
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015028 2001
% 221.18/221.37  |- mesh__recordOriginator mesh__D015028 NLM
% 221.18/221.37  |- skos__annotation mesh__D015028 a plant protein   
% 221.18/221.37  |- skos__broader mesh__D015028smesh__D010940
% 221.18/221.37  |- mesh__dateRevised mesh__D015028 1995-05-22
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015028 2005
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015028 2002
% 221.18/221.37  |- mesh__recordMaintainer mesh__D015028 KEV
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015028 2006
% 221.18/221.37  |- skos__scopeNote mesh__D015028
% 221.18/221.37       A protein obtainable from corn. It has a molecular weight of about 40,000. It does not contain tryptophan or lysine. %28%Dorland, 28th ed%29%%A%    
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015028 2003
% 221.18/221.37  |- mesh__recordAuthorizer mesh__D015028 PLS
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015028 2004
% 221.18/221.37  |- rdf__type mesh__D015028sskos__Concept
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D015028 1998
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D001806 2002
% 221.18/221.37  |- mesh__dateCreated mesh__D001806 1999-01-01
% 221.18/221.37  |- rdf__type mesh__D001806sskos__Concept
% 221.18/221.37  |- skos__hiddenLabel mesh__D001806 Urea Nitrogen, Blood
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D001806 2004
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D001806 2001
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D001806 2006
% 221.18/221.37  |- skos__scopeNote mesh__D001806
% 221.18/221.37       The urea concentration of the blood stated in terms of nitrogen content. Serum %28%plasma%29% urea nitrogen is approximately 12%25% higher than blood urea nitrogen concentration because of the greater protein content of red blood cells. Increases in blood or serum urea nitrogen are referred to as azotemia and may have prerenal, renal, or postrenal causes. %28%From Saunders Dictionary %26% Encyclopedia of Laboratory Medicine and Technology, 1984%29%%A%    
% 221.18/221.37  |- skos__altLabel mesh__D001806 BUN
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D001806 2003
% 221.18/221.37  |- skos__broader mesh__D001806smesh__D007677
% 221.18/221.37  |- skos__broader mesh__D001806smesh__D001774
% 221.18/221.37  |- mesh__dateRevised mesh__D001806 1997-06-20
% 221.18/221.37  |- skos__hiddenLabel mesh__D001806 Nitrogen, Blood Urea
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D001806 2005
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D001806 2000
% 221.18/221.37  |- skos__prefLabel mesh__D001806 Blood Urea Nitrogen
% 221.18/221.37  |- mesh__dateEstablished mesh__D001806 1967-01-01
% 221.18/221.37  |- mesh__publicMeSHNote mesh__D001806 67   
% 221.18/221.37  |- skos__annotation mesh__D001806
% 221.18/221.37       note category; no qualif; often correct for foreign %22%azotemia%22%; DF: note short X ref%A%  
% 221.18/221.37  |- mesh__recordAuthorizer mesh__D001806 SJN
% 221.18/221.37  |- mesh__recordMaintainer mesh__D001806 PXP
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D001806 1999
% 221.18/221.37  |- mesh__historyNote mesh__D001806 67%28%64%29%   
% 221.18/221.37  |- mesh__recordOriginator mesh__D001806 NLM
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D001806 1998
% 221.18/221.37  |- mesh__onlineNote mesh__D001008
% 221.18/221.37       use ANXIETY DISORDERS to search NEUROSES, ANXIETY 1966-80%A%  
% 221.18/221.37  |- skos__altLabel mesh__D001008 Anxiety Neuroses
% 221.18/221.37  |- mesh__publicMeSHNote mesh__D001008 81; was NEUROSES, ANXIETY 1963-80   
% 221.18/221.37  |- mesh__historyNote mesh__D001008 81; was NEUROSES, ANXIETY 1963-80   
% 221.18/221.37  |- mesh__dateCreated mesh__D001008 1999-01-01
% 221.18/221.37  |- skos__broader mesh__D001008smesh__D001523
% 221.18/221.37  |- mesh__recordAuthorizer mesh__D001008 sjn
% 221.18/221.37  |- skos__scopeNote mesh__D001008 Persistent and disabling ANXIETY.     
% 221.18/221.37  |- skos__hiddenLabel mesh__D001008 Neurotic Anxiety State
% 221.18/221.37  |- skos__hiddenLabel mesh__D001008 States, Neurotic Anxiety
% 221.18/221.37  |- skos__hiddenLabel mesh__D001008 Disorders, Anxiety
% 221.18/221.37  |- mesh__dateRevised mesh__D001008 2005-06-30
% 221.18/221.37  |- skos__annotation mesh__D001008 differentiate from ANXIETY   
% 221.18/221.37  |- mesh__recordMaintainer mesh__D001008 ssb
% 221.18/221.37  |- skos__hiddenLabel mesh__D001008 State, Neurotic Anxiety
% 221.18/221.37  |- skos__hiddenLabel mesh__D001008 Anxiety Disorder
% 221.18/221.37  |- mesh__recordOriginator mesh__D001008 NLM
% 221.18/221.37  |- skos__hiddenLabel mesh__D001008 Neurotic Anxiety States
% 221.18/221.37  |- skos__prefLabel mesh__D001008 Anxiety Disorders
% 221.18/221.37  |- skos__hiddenLabel mesh__D001008 Disorder, Anxiety
% 221.18/221.37  |- rdf__type mesh__D001008sskos__Concept
% 221.18/221.37  |- skos__hiddenLabel mesh__D001008 Anxiety State, Neurotic
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D001008 2006
% 221.18/221.37  |- skos__broader mesh__D047908smesh__D010455
% 221.18/221.37  |- mesh__historyNote mesh__D047908 2005   
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D047908 2005
% 221.18/221.37  |- mesh__dateCreated mesh__D047908 2004-07-07
% 221.18/221.37  |- rdf__type mesh__D047908sskos__Concept
% 221.18/221.37  |- skos__hiddenLabel mesh__D047908 Signaling Proteins, Intracellular
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D047908 2006
% 221.18/221.37  |- skos__broader mesh__D047908smesh__D011506
% 221.18/221.37  |- skos__hiddenLabel mesh__D047908 Signaling Peptides, Intracellular
% 221.18/221.37  |- skos__scopeNote mesh__D047908
% 221.18/221.37       Proteins and peptides that are involved in SIGNAL TRANSDUCTION within the cell. Included here are peptides and proteins that regulate the activity of TRANSCRIPTION FACTORS and cellular processes in response to signals from CELL SURFACE RECEPTORS. Intracellular signaling peptide and proteins may be part of an enzymatic signaling cascade or act through binding to and modifying the action of other signaling factors.%A%    
% 221.18/221.37  |- skos__annotation mesh__D047908
% 221.18/221.37       don%27%t confuse with SIGNAL PEPTIDES entry term to PROTEIN SORTING SIGNALS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS is also available%A%  
% 221.18/221.37  |- skos__hiddenLabel mesh__D047908 Peptides, Intracellular Signaling
% 221.18/221.37  |- skos__prefLabel mesh__D047908
% 221.18/221.37       Intracellular Signaling Peptides and Proteins
% 221.18/221.37  |- mesh__publicMeSHNote mesh__D047908 2005   
% 221.18/221.37  |- mesh__dateEstablished mesh__D047908 2005-01-01
% 221.18/221.37  |- mesh__recordOriginator mesh__D047908 jmp
% 221.18/221.37  |- mesh__recordAuthorizer mesh__D047908 sjn
% 221.18/221.37  |- mesh__recordMaintainer mesh__D047908 jmp
% 221.18/221.37  |- skos__hiddenLabel mesh__D047908 Proteins, Intracellular Signaling
% 221.18/221.37  |- skos__scopeNote mesh__D019419
% 221.18/221.37       Creation and development of bodies within solar systems, includes study of early planetary geology.%A%    
% 221.18/221.37  |- mesh__dateCreated mesh__D019419 1996-06-13
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D019419 2005
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D019419 1998
% 221.18/221.37  |- mesh__dateEstablished mesh__D019419 1997-01-01
% 221.18/221.37  |- mesh__historyNote mesh__D019419 97   
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D019419 2003
% 221.18/221.37  |- rdf__type mesh__D019419sskos__Concept
% 221.18/221.37  |- skos__prefLabel mesh__D019419 Evolution, Planetary
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D019419 2006
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D019419 2000
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D019419 1999
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D019419 2004
% 221.18/221.37  |- skos__broader mesh__D019419smesh__D010811
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D019419 2001
% 221.18/221.37  |- mesh__recordAuthorizer mesh__D019419 SJN
% 221.18/221.37  |- skos__historyNote mesh__D019419 Planets %28%1993-1996%29%
% 221.18/221.37  |- mesh__dateRevised mesh__D019419 1997-06-20
% 221.18/221.37  |- skos__altLabel mesh__D019419 Planetary Evolution
% 221.18/221.37  |- mesh__recordMaintainer mesh__D019419 JLS
% 221.18/221.37  |- skos__annotation mesh__D019419
% 221.18/221.37       creation %26% develop of planetary bodies   
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D019419 2002
% 221.18/221.37  |- mesh__publicMeSHNote mesh__D019419 97   
% 221.18/221.37  |- mesh__recordOriginator mesh__D019419 JLS
% 221.18/221.37  |- mesh__dateRevised mesh__D011436 2004-07-07
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D011436 2005
% 221.18/221.37  |- skos__historyNote mesh__D011436 Transferases %28%1972-1974%29%
% 221.18/221.37  |- mesh__publicMeSHNote mesh__D011436
% 221.18/221.37       97; was PROPYLAMINE TRANSFERASE 1975-96 %28%see under TRANSFERASES 1975-90%29%; SPERMIDINE SYNTHASE was see PROPYLAMINE TRANSFERASE 1975-96%A%  
% 221.18/221.37  |- skos__historyNote mesh__D011436 Spermidine %28%1972-1974%29%
% 221.18/221.37  |- skos__altLabel mesh__D011436 Aminopropyltransferase
% 221.18/221.37  |- mesh__recordOriginator mesh__D011436 NLM
% 221.18/221.37  |- skos__hiddenLabel mesh__D011436 Synthase, Spermidine
% 221.18/221.37  |- skos__prefLabel mesh__D011436 Spermidine Synthase
% 221.18/221.37  |- mesh__dateCreated mesh__D011436 1974-11-19
% 221.18/221.37  |- mesh__recordMaintainer mesh__D011436 jmp
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D011436 2006
% 221.18/221.37  |- skos__altLabel mesh__D011436 Spermidine Synthetase
% 221.18/221.37  |- skos__scopeNote mesh__D011436
% 221.18/221.37       An enzyme that catalyzes the transfer of the propylamine moiety from 5%27%-deoxy-5%27%-S-%28%3-methylthiopropylamine%29%sulfonium adenosine to putrescine in the biosynthesis of spermidine. The enzyme has a molecular weight of approximately 73,000 kDa and is composed of two subunits of equal size.%A%    
% 221.18/221.37  |- mesh__recordAuthorizer mesh__D011436 sjn
% 221.18/221.37  |- skos__annotation mesh__D011436 do not confuse with SPERMINE SYNTHASE   
% 221.18/221.37  |- rdf__type mesh__D011436sskos__Concept
% 221.18/221.37  |- skos__broader mesh__D011436smesh__D019883
% 221.18/221.37  |- skos__hiddenLabel mesh__D011436 Aminopropyltransferase, Putrescine
% 221.18/221.37  |- skos__hiddenLabel mesh__D011436 Synthetase, Spermidine
% 221.18/221.37  |- skos__hiddenLabel mesh__D011436 Transferase, Propylamine
% 221.18/221.37  |- mesh__dateEstablished mesh__D011436 1991-01-01
% 221.18/221.37  |- skos__altLabel mesh__D011436 Propylamine Transferase
% 221.18/221.37  |- mesh__historyNote mesh__D011436
% 221.18/221.37       97; was PROPYLAMINE TRANSFERASE 1975-96 %28%see under TRANSFERASES 1975-90%29%; SPERMIDINE SYNTHASE was see PROPYLAMINE TRANSFERASE 1975-96%A%  
% 221.18/221.37  |- skos__altLabel mesh__D011436 Putrescine Aminopropyltransferase
% 221.18/221.37  |- skos__historyNote mesh__D011436 Propylamines %28%1972-1974%29%
% 221.18/221.37  |- mesh__dateEstablished mesh__D016121 1991-01-01
% 221.18/221.37  |- skos__hiddenLabel mesh__D016121 Veins, Innominate
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D016121 2005
% 221.18/221.37  |- mesh__historyNote mesh__D016121
% 221.18/221.37       91; INNOMINATE VEIN was heading 1963-90   
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D016121 1995
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D016121 2006
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D016121 1998
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D016121 2002
% 221.18/221.37  |- mesh__publicMeSHNote mesh__D016121
% 221.18/221.37       91; INNOMINATE VEIN was heading 1963-90   
% 221.18/221.37  |- mesh__recordOriginator mesh__D016121 PXP
% 221.18/221.37  |- mesh__recordAuthorizer mesh__D016121 PLS
% 221.18/221.37  |- skos__hiddenLabel mesh__D016121 Brachiocephalic Vein
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D016121 2003
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D016121 1993
% 221.18/221.37  |- skos__prefLabel mesh__D016121 Brachiocephalic Veins
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D016121 1999
% 221.18/221.37  |- skos__hiddenLabel mesh__D016121 Innominate Vein
% 221.18/221.37  |- skos__hiddenLabel mesh__D016121 Vein, Innominate
% 221.18/221.37  |- skos__hiddenLabel mesh__D016121 Veins, Brachiocephalic
% 221.18/221.37  |- rdf__type mesh__D016121sskos__Concept
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D016121 2004
% 221.18/221.37  |- skos__historyNote mesh__D016121 Innominate Vein %28%1966-1990%29%
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D016121 1996
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D016121 2000
% 221.18/221.37  |- skos__altLabel mesh__D016121 Innominate Veins
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D016121 1997
% 221.18/221.37  |- skos__scopeNote mesh__D016121
% 221.18/221.37       Large veins on either side of the root of the neck formed by the junction of the internal jugular and subclavian veins. They drain blood from the head, neck, and upper extremities, and unite to form the superior vena cava.%A%    
% 221.18/221.37  |- skos__broader mesh__D016121smesh__D014680
% 221.18/221.37  |- skos__hiddenLabel mesh__D016121 Vein, Brachiocephalic
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D016121 2001
% 221.18/221.37  |- mesh__dateCreated mesh__D016121 1990-06-06
% 221.18/221.37  |- mesh__recordMaintainer mesh__D016121 TAP
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D016121 1994
% 221.18/221.37  |- mesh__dateRevised mesh__D016121 1992-03-25
% 221.18/221.37  |- mesh__onlineNote mesh__D016121
% 221.18/221.37       use BRACHIOCEPHALIC VEINS to search INNOMINATE VEIN 1966-90%A%  
% 221.18/221.37  |- skos__altLabel mesh__D002101 Dimethylarsinate
% 221.18/221.37  |- mesh__historyNote mesh__D002101
% 221.18/221.37       91%28%75%29%; was see under ARSENICALS 1975-90   
% 221.18/221.37  |- mesh__dateEstablished mesh__D002101 1991-01-01
% 221.18/221.37  |- mesh__dateCreated mesh__D002101 1974-11-19
% 221.18/221.37  |- rdf__type mesh__D002101sskos__Concept
% 221.18/221.37  |- skos__broader mesh__D002101smesh__D001152
% 221.18/221.37  |- skos__hiddenLabel mesh__D002101 Acid, Dimethylarsinic
% 221.18/221.37  |- skos__historyNote mesh__D002101 Arsenicals %28%1969-1974%29%
% 221.18/221.37  |- skos__scopeNote mesh__D002101
% 221.18/221.37       An arsenical that has been used as a dermatologic agent and as an herbicide.%A%    
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D002101 2003
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D002101 2001
% 221.18/221.37  |- skos__prefLabel mesh__D002101 Cacodylic Acid
% 221.18/221.37  |- mesh__dateRevised mesh__D002101 2000-06-21
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D002101 2005
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D002101 2004
% 221.18/221.37  |- mesh__recordAuthorizer mesh__D002101 sjn
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D002101 2006
% 221.18/221.37  |- mesh__recordMaintainer mesh__D002101 CCR
% 221.18/221.37  |- skos__hiddenLabel mesh__D002101 Acid, Cacodylic
% 221.18/221.37  |- mesh__publicMeSHNote mesh__D002101
% 221.18/221.37       91; was see under ARSENICALS 1975-90   
% 221.18/221.37  |- mesh__recordOriginator mesh__D002101 NLM
% 221.18/221.37  |- skos__altLabel mesh__D002101 Dimethylarsinic Acid
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D002101 2002
% 221.18/221.37  |- mesh__recordMaintainer mesh__D021864 ags
% 221.18/221.37  |- mesh__dateRevised mesh__D021864 2005-06-30
% 221.18/221.37  |- skos__prefLabel mesh__D021864 Pleistophora
% 221.18/221.37  |- mesh__recordAuthorizer mesh__D021864 sjn
% 221.18/221.37  |- mesh__dateEstablished mesh__D021864 2001-01-01
% 221.18/221.37  |- mesh__recordOriginator mesh__D021864 ags
% 221.18/221.37  |- mesh__dateCreated mesh__D021864 2000-06-22
% 221.18/221.37  |- skos__scopeNote mesh__D021864
% 221.18/221.37       A genus of parasitic FUNGI in the family Pleistophoridae that infects humans.%A%    
% 221.18/221.37  |- skos__historyNote mesh__D021864 Protozoa %28%1968-1980%29%
% 221.18/221.37  |- mesh__historyNote mesh__D021864 2001   
% 221.18/221.37  |- rdf__type mesh__D021864sskos__Concept
% 221.18/221.37  |- mesh__publicMeSHNote mesh__D021864 2001   
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D021864 2006
% 221.18/221.37  |- skos__historyNote mesh__D021864 Apicomplexa %28%1971-1992%29%
% 221.18/221.37  |- skos__broader mesh__D021864smesh__D050175
% 221.18/221.37  |- skos__historyNote mesh__D021864 Microsporida %28%1993-2000%29%
% 221.18/221.37  |- skos__annotation mesh__D021864
% 221.18/221.37       infection: coordinate IM with MICROSPORIDIOSIS %28%IM%29%; coordinate with specific fungal terms %28%ANTIGENS, FUNGAL, etc%29% if pertinent%A%  
% 221.18/221.37  |- mesh__dateCreated mesh__D007395 1999-01-01
% 221.18/221.37  |- skos__hiddenLabel mesh__D007395 Neuron, Intercalated
% 221.18/221.37  |- skos__historyNote mesh__D007395 Neurons %28%1966-1967%29%
% 221.18/221.37  |- mesh__historyNote mesh__D007395 68   
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D007395 2000
% 221.18/221.37  |- mesh__recordAuthorizer mesh__D007395 SJN
% 221.18/221.37  |- skos__hiddenLabel mesh__D007395 Intercalated Neuron
% 221.18/221.37  |- mesh__dateRevised mesh__D007395 1997-06-20
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D007395 1999
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D007395 2006
% 221.18/221.37  |- mesh__recordMaintainer mesh__D007395 AGS
% 221.18/221.37  |- skos__hiddenLabel mesh__D007395 Interneuron
% 221.18/221.37  |- skos__hiddenLabel mesh__D007395 Neurons, Intercalated
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D007395 1998
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D007395 2005
% 221.18/221.37  |- mesh__activeMeSHYear mesh__D007395 2002
% 221.18/221.37  |- mesh__dateEstablished mesh__D007395 1968-01-01
% 221.18/221.37  |- skos__altLabel mesh__D007395 Intercalated Neurons
% 221.18/221.37  |- rdf__type mesh__D007395sskos__Concept
% 221.18/221.38  |- skos__broader mesh__D007395smesh__D009474
% 221.18/221.38  |- skos__prefLabel mesh__D007395 Interneurons
% 221.18/221.38  |- mesh__publicMeSHNote mesh__D007395 68   
% 221.18/221.38  |- skos__scopeNote mesh__D007395
% 221.18/221.38       Most generally any neurons which are not motor or sensory. Interneurons may also refer to neurons whose axons remain within a particular brain region as contrasted with projection neurons which have axons projecting to other brain regions.%A%    
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D007395 2004
% 221.18/221.38  |- skos__annotation mesh__D007395 A 11 qualif   
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D007395 2001
% 221.18/221.38  |- mesh__recordOriginator mesh__D007395 NLM
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D007395 2003
% 221.18/221.38  |- skos__historyNote mesh__D015827 Onchocerca %28%1966-1989%29%
% 221.18/221.38  |- mesh__dateEstablished mesh__D015827 1990-01-01
% 221.18/221.38  |- mesh__historyNote mesh__D015827 90   
% 221.18/221.38  |- skos__historyNote mesh__D015827 Onchocerciasis %28%1966-1989%29%
% 221.18/221.38  |- skos__scopeNote mesh__D015827
% 221.18/221.38       Filarial infection of the eyes transmitted from person to person by bites of Onchocerca volvulus-infected black flies. The microfilariae of Onchocerca are thus deposited beneath the skin. They migrate through various tissues including the eye. Those persons infected have impaired vision and up to 20%25% are blind. The incidence of eye lesions has been reported to be as high as 30%25% in Central America and parts of Africa.%A%    
% 221.18/221.38  |- mesh__dateRevised mesh__D015827 2005-06-30
% 221.18/221.38  |- mesh__recordMaintainer mesh__D015827 ags
% 221.18/221.38  |- mesh__publicMeSHNote mesh__D015827 90   
% 221.18/221.38  |- mesh__recordOriginator mesh__D015827 EGC
% 221.18/221.38  |- skos__hiddenLabel mesh__D015827 Ocular Onchocerciasis
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015827 2006
% 221.18/221.38  |- mesh__recordAuthorizer mesh__D015827 sjn
% 221.18/221.38  |- skos__broader mesh__D015827smesh__D009855
% 221.18/221.38  |- skos__hiddenLabel mesh__D015827 Ocular Onchocerciases
% 221.18/221.38  |- skos__altLabel mesh__D015827 River Blindness
% 221.18/221.38  |- skos__broader mesh__D015827smesh__D015822
% 221.18/221.38  |- mesh__dateCreated mesh__D015827 1989-05-26
% 221.18/221.38  |- skos__historyNote mesh__D015827
% 221.18/221.38       Eye Diseases or specifics %28%1966-1989%29%
% 221.18/221.38  |- skos__prefLabel mesh__D015827 Onchocerciasis, Ocular
% 221.18/221.38  |- skos__hiddenLabel mesh__D015827 Blindness, River
% 221.18/221.38  |- skos__historyNote mesh__D015827 Microfilaria %28%1967-1989%29%
% 221.18/221.38  |- rdf__type mesh__D015827sskos__Concept
% 221.18/221.38  |- skos__hiddenLabel mesh__D015827 Onchocerciases, Ocular
% 221.18/221.38  |- skos__annotation mesh__D015827 /drug ther: consider FILARICIDES   
% 221.18/221.38  |- skos__altLabel mesh__D015029 Zearanol
% 221.18/221.38  |- skos__hiddenLabel mesh__D015029 P 1496
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015029 2005
% 221.18/221.38  |- rdf__type mesh__D015029sskos__Concept
% 221.18/221.38  |- skos__historyNote mesh__D015029 Resorcinols %28%1973-1974%29%
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015029 2002
% 221.18/221.38  |- skos__broader mesh__D015029smesh__D015025
% 221.18/221.38  |- mesh__recordMaintainer mesh__D015029 CCR
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015029 2001
% 221.18/221.38  |- mesh__publicMeSHNote mesh__D015029
% 221.18/221.38       91; was see under RESORCINOLS 1975-90   
% 221.18/221.38  |- skos__altLabel mesh__D015029 P1496
% 221.18/221.38  |- mesh__recordAuthorizer mesh__D015029 sjn
% 221.18/221.38  |- mesh__dateRevised mesh__D015029 2000-06-22
% 221.18/221.38  |- mesh__dateEstablished mesh__D015029 1991-01-01
% 221.18/221.38  |- mesh__historyNote mesh__D015029
% 221.18/221.38       91%28%75%29%; was see under RESORCINOLS 1975-90   
% 221.18/221.38  |- mesh__recordOriginator mesh__D015029 NLM
% 221.18/221.38  |- skos__altLabel mesh__D015029 Zearalanol
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015029 2004
% 221.18/221.38  |- skos__historyNote mesh__D015029 Lactones %28%1973-1974%29%
% 221.18/221.38  |- skos__altLabel mesh__D015029 Xeranol
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015029 2006
% 221.18/221.38  |- skos__prefLabel mesh__D015029 Zeranol
% 221.18/221.38  |- skos__scopeNote mesh__D015029 A non-steroidal estrogen analog.     
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015029 2003
% 221.18/221.38  |- mesh__dateCreated mesh__D015029 1974-11-19
% 221.18/221.38  |- skos__hiddenLabel mesh__D001807 Prosthesis, Blood Vessel
% 221.18/221.38  |- skos__hiddenLabel mesh__D001807 Vessel Prosthesis, Blood
% 221.18/221.38  |- skos__broader mesh__D001807smesh__D019736
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D001807 2003
% 221.18/221.38  |- skos__prefLabel mesh__D001807 Blood Vessel Prosthesis
% 221.18/221.38  |- skos__hiddenLabel mesh__D001807 Vessel Prostheses, Blood
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D001807 2002
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D001807 2005
% 221.18/221.38  |- skos__hiddenLabel mesh__D001807 Prosthesis, Vascular
% 221.18/221.38  |- rdf__type mesh__D001807sskos__Concept
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D001807 2004
% 221.18/221.38  |- skos__scopeNote mesh__D001807
% 221.18/221.38       Prosthesis, constructed of either synthetic or biological material, which is used for the repair of injured or diseased blood vessels.%A%    
% 221.18/221.38  |- mesh__recordOriginator mesh__D001807 NLM
% 221.18/221.38  |- skos__hiddenLabel mesh__D001807 Prostheses, Blood Vessel
% 221.18/221.38  |- skos__hiddenLabel mesh__D001807 Vascular Prostheses
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D001807 2006
% 221.18/221.38  |- skos__hiddenLabel mesh__D001807 Blood Vessel Prostheses
% 221.18/221.38  |- skos__altLabel mesh__D001807 Vascular Prosthesis
% 221.18/221.38  |- skos__related mesh__D001807smesh__D019917
% 221.18/221.38  |- mesh__dateRevised mesh__D001807 1997-06-20
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D001807 2000
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D001807 1998
% 221.18/221.38  |- skos__hiddenLabel mesh__D001807 Prostheses, Vascular
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D001807 2001
% 221.18/221.38  |- mesh__dateCreated mesh__D001807 1999-01-01
% 221.18/221.38  |- mesh__recordAuthorizer mesh__D001807 SJN
% 221.18/221.38  |- mesh__recordMaintainer mesh__D001807 PXP
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D001807 1999
% 221.18/221.38  |- mesh__recordOriginator mesh__D001009 NLM
% 221.18/221.38  |- skos__hiddenLabel mesh__D001009 Castration Anxiety
% 221.18/221.38  |- skos__scopeNote mesh__D001009
% 221.18/221.38       Anxiety due to fantasized injuries to or loss of the genitals.%A%    
% 221.18/221.38  |- skos__broader mesh__D001009smesh__D001007
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D001009 2005
% 221.18/221.38  |- rdf__type mesh__D001009sskos__Concept
% 221.18/221.38  |- mesh__recordAuthorizer mesh__D001009 sjn
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D001009 2006
% 221.18/221.38  |- mesh__dateRevised mesh__D001009 2004-07-19
% 221.18/221.38  |- skos__hiddenLabel mesh__D001009 Complex, Castration
% 221.18/221.38  |- mesh__historyNote mesh__D001009 70%28%65%29%   
% 221.18/221.38  |- mesh__dateCreated mesh__D001009 1999-01-01
% 221.18/221.38  |- mesh__publicMeSHNote mesh__D001009 70   
% 221.18/221.38  |- skos__hiddenLabel mesh__D001009 Castration Complices
% 221.18/221.38  |- mesh__dateEstablished mesh__D001009 1970-01-01
% 221.18/221.38  |- mesh__recordMaintainer mesh__D001009 jls
% 221.18/221.38  |- skos__hiddenLabel mesh__D001009 Complices, Castration
% 221.18/221.38  |- skos__altLabel mesh__D001009 Castration Complex
% 221.18/221.38  |- skos__prefLabel mesh__D001009 Anxiety, Castration
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D011437 2006
% 221.18/221.38  |- mesh__dateRevised mesh__D011437 1992-05-20
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D011437 1994
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D011437 1998
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D011437 2003
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D011437 1995
% 221.18/221.38  |- skos__broader mesh__D011437smesh__D000588
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D011437 2000
% 221.18/221.38  |- rdf__type mesh__D011437sskos__Concept
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D011437 2004
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D011437 1999
% 221.18/221.38  |- mesh__publicMeSHNote mesh__D011437 66   
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D011437 2001
% 221.18/221.38  |- mesh__recordOriginator mesh__D011437 NLM
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D011437 1996
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D011437 1993
% 221.18/221.38  |- mesh__recordMaintainer mesh__D011437 TAP
% 221.18/221.38  |- mesh__historyNote mesh__D011437 66   
% 221.18/221.38  |- mesh__recordAuthorizer mesh__D011437 PLS
% 221.18/221.38  |- mesh__dateEstablished mesh__D011437 1966-01-01
% 221.18/221.38  |- skos__prefLabel mesh__D011437 Propylamines
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D011437 1997
% 221.18/221.38  |- mesh__dateCreated mesh__D011437 1999-01-01
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D011437 2005
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D011437 2002
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016920 2005
% 221.18/221.38  |- skos__historyNote mesh__D016920 Meningitis %28%1966-1991%29%
% 221.18/221.38  |- mesh__dateEstablished mesh__D016920 1992-01-01
% 221.18/221.38  |- skos__historyNote mesh__D016920
% 221.18/221.38       specific bacterial meningitis %28%1966-1991%29%
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016920 2002
% 221.18/221.38  |- skos__annotation mesh__D016920
% 221.18/221.38       coord IM with specific bacterial infection %28%IM%29% but note indentions here%A%  
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016920 2006
% 221.18/221.38  |- skos__historyNote mesh__D016920 specific bacterium %28%1966-1991%29%
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016920 2000A
% 221.18/221.38  |- mesh__recordMaintainer mesh__D016920 ags
% 221.18/221.38  |- skos__scopeNote mesh__D016920
% 221.18/221.38       Bacterial infections of the leptomeninges and subarachnoid space, frequently involving the cerebral cortex, cranial nerves, cerebral blood vessels, spinal cord, and nerve roots. The type of causative organism varies with age and clinical status %28%e.g., post-operative, immunodeficient, or post-traumatic states%29%. Clinical manifestations include the acute onset of fever, stiff neck, altered mentation, seizures, and focal neurologic deficits. Death may occur within 24 hours of disease onset. Pathologic features include a purulent exudate in the subarachnoid space, and diffuse inflammation of neural and vascular structures. %28%From Joynt, Clinical Neurology, 1994, Ch24, pp1-5%29%%A%    
% 221.18/221.38  |- mesh__recordAuthorizer mesh__D016920 ags
% 221.18/221.38  |- mesh__dateCreated mesh__D016920 1991-05-30
% 221.18/221.38  |- skos__prefLabel mesh__D016920 Meningitis, Bacterial
% 221.18/221.38  |- mesh__dateRevised mesh__D016920 1999-12-09
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016920 2003
% 221.18/221.38  |- skos__broader mesh__D016920smesh__D008581
% 221.18/221.38  |- mesh__recordOriginator mesh__D016920 PXP
% 221.18/221.38  |- rdf__type mesh__D016920sskos__Concept
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016920 2000
% 221.18/221.38  |- skos__altLabel mesh__D016920 Bacterial Meningitides
% 221.18/221.38  |- mesh__publicMeSHNote mesh__D016920 1992   
% 221.18/221.38  |- skos__altLabel mesh__D016920 Bacterial Meningitis
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016920 2004
% 221.18/221.38  |- mesh__historyNote mesh__D016920 1992   
% 221.18/221.38  |- skos__broader mesh__D016920smesh__D020806
% 221.18/221.38  |- skos__altLabel mesh__D016920 Meningitides, Bacterial
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016920 2001
% 221.18/221.38  |- skos__hiddenLabel mesh__D016122 Trunk, Brachiocephalic
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016122 2002
% 221.18/221.38  |- skos__hiddenLabel mesh__D016122 Innominate Arteries
% 221.18/221.38  |- skos__altLabel mesh__D016122 Innominate Artery
% 221.18/221.38  |- mesh__publicMeSHNote mesh__D016122
% 221.18/221.38       91; BRACHIOCEPHALIC TRUNK was see INNOMINATE ARTERY 1963-90%A%  
% 221.18/221.38  |- skos__broader mesh__D016122smesh__D001158
% 221.18/221.38  |- mesh__recordMaintainer mesh__D016122 TAP
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016122 1995
% 221.18/221.38  |- skos__hiddenLabel mesh__D016122 Arteries, Innominate
% 221.18/221.38  |- mesh__dateCreated mesh__D016122 1990-06-06
% 221.18/221.38  |- skos__annotation mesh__D016122 note X ref   
% 221.18/221.38  |- mesh__onlineNote mesh__D016122
% 221.18/221.38       use BRACHIOCEPHALIC TRUNK to search INNOMINATE ARTERY 1966-90%A%  
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016122 2006
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016122 1994
% 221.18/221.38  |- mesh__recordAuthorizer mesh__D016122 PLS
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016122 2001
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016122 1993
% 221.18/221.38  |- mesh__dateEstablished mesh__D016122 1991-01-01
% 221.18/221.38  |- skos__hiddenLabel mesh__D016122 Artery, Innominate
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016122 2005
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016122 2004
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016122 1999
% 221.18/221.38  |- mesh__recordOriginator mesh__D016122 PXP
% 221.18/221.38  |- skos__scopeNote mesh__D016122
% 221.18/221.38       The first and largest artery branching from the aortic arch. It distributes blood to the right side of the head and neck and to the right arm.%A%    
% 221.18/221.38  |- skos__historyNote mesh__D016122 Innominate Artery %28%1966-1990%29%
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016122 2000
% 221.18/221.38  |- mesh__historyNote mesh__D016122
% 221.18/221.38       91; BRACHIOCEPHALIC TRUNK was see INNOMINATE ARTERY 1963-90%A%  
% 221.18/221.38  |- skos__hiddenLabel mesh__D016122 Trunks, Brachiocephalic
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016122 2003
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016122 1998
% 221.18/221.38  |- skos__hiddenLabel mesh__D016122 Brachiocephalic Trunks
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016122 1997
% 221.18/221.38  |- rdf__type mesh__D016122sskos__Concept
% 221.18/221.38  |- mesh__dateRevised mesh__D016122 1992-03-25
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016122 1996
% 221.18/221.38  |- skos__prefLabel mesh__D016122 Brachiocephalic Trunk
% 221.18/221.38  |- mesh__dateRevised mesh__D002900 2004-07-13
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D002900 2005
% 221.18/221.38  |- skos__hiddenLabel mesh__D002900 Chromosomes, Group A
% 221.18/221.38  |- mesh__dateCreated mesh__D002900 1999-01-01
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D002900 2006
% 221.18/221.38  |- mesh__historyNote mesh__D002900 68   
% 221.18/221.38  |- skos__scopeNote mesh__D002900
% 221.18/221.38       The large, metacentric human chromosomes, called group A in the human chromosome classification.  This group consists of chromosome pairs 1, 2, and 3.%A%    
% 221.18/221.38  |- mesh__publicMeSHNote mesh__D002900 68   
% 221.18/221.38  |- skos__historyNote mesh__D002900 Chromosomes %28%1966-1967%29%
% 221.18/221.38  |- mesh__recordMaintainer mesh__D002900 sjn
% 221.18/221.38  |- mesh__dateEstablished mesh__D002900 1968-01-01
% 221.18/221.38  |- skos__hiddenLabel mesh__D002900 Chromosome, Group A
% 221.18/221.38  |- skos__altLabel mesh__D002900 Group A Chromosomes
% 221.18/221.38  |- mesh__recordAuthorizer mesh__D002900 sjn
% 221.18/221.38  |- skos__hiddenLabel mesh__D002900 Group A Chromosome
% 221.18/221.38  |- skos__altLabel mesh__D002900 Chromosomes A
% 221.18/221.38  |- mesh__recordOriginator mesh__D002900 NLM
% 221.18/221.38  |- rdf__type mesh__D002900sskos__Concept
% 221.18/221.38  |- skos__broader mesh__D002900smesh__D002877
% 221.18/221.38  |- skos__prefLabel mesh__D002900 Chromosomes, Human, 1-3
% 221.18/221.38  |- skos__prefLabel mesh__D002102 Cadaver
% 221.18/221.38  |- mesh__recordMaintainer mesh__D002102 sjn
% 221.18/221.38  |- rdf__type mesh__D002102sskos__Concept
% 221.18/221.38  |- mesh__recordOriginator mesh__D002102 NLM
% 221.18/221.38  |- mesh__dateCreated mesh__D002102 1999-01-01
% 221.18/221.38  |- skos__altLabel mesh__D002102 Cadavers
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D002102 2005
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D002102 2006
% 221.18/221.38  |- skos__annotation mesh__D002102
% 221.18/221.38       NIM for cadaveric organs in transpl; do not index here routinely for postmortem studies, article must be on cadavers as a corpse; AUTOPSY is available for the procedure and /pathol is available for postmortem pathol%A%  
% 221.18/221.38  |- mesh__dateRevised mesh__D002102 2004-07-13
% 221.18/221.38  |- skos__scopeNote mesh__D002102 A dead body, usually a human body.     
% 221.18/221.38  |- skos__broader mesh__D002102smesh__D003643
% 221.18/221.38  |- mesh__recordAuthorizer mesh__D002102 sjn
% 221.18/221.38  |- skos__historyNote mesh__D021865 Coccidiosis %28%1978-2000%29%
% 221.18/221.38  |- skos__broader mesh__D021865smesh__D003048
% 221.18/221.38  |- rdf__type mesh__D021865sskos__Concept
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D021865 2004
% 221.18/221.38  |- skos__scopeNote mesh__D021865
% 221.18/221.38       Infection with parasitic protozoa of the genus ISOSPORA, producing intestinal disease. It is caused by ingestion of oocysts and can produce tissue cysts.%A%    
% 221.18/221.38  |- mesh__dateCreated mesh__D021865 2000-06-22
% 221.18/221.38  |- mesh__publicMeSHNote mesh__D021865 2001   
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D021865 2006
% 221.18/221.38  |- skos__prefLabel mesh__D021865 Isosporiasis
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D021865 2003
% 221.18/221.38  |- mesh__historyNote mesh__D021865 2001   
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D021865 2002
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D021865 2005
% 221.18/221.38  |- skos__hiddenLabel mesh__D021865 Isosporiases
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D021865 2001
% 221.18/221.38  |- mesh__dateEstablished mesh__D021865 2001-01-01
% 221.18/221.38  |- skos__annotation mesh__D021865
% 221.18/221.38       /drug ther: consider also COCCIDIOSTATS   
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D007396 2006
% 221.18/221.38  |- skos__altLabel mesh__D007396 Dental Residency
% 221.18/221.38  |- skos__altLabel mesh__D007396 Residency and Internship
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D007396 2001
% 221.18/221.38  |- mesh__recordOriginator mesh__D007396 NLM
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D007396 1998
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D007396 2005
% 221.18/221.38  |- skos__altLabel mesh__D007396 Internships, Dental
% 221.18/221.38  |- skos__hiddenLabel mesh__D007396 Residencies
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D007396 2000
% 221.18/221.38  |- skos__prefLabel mesh__D007396 Internship and Residency
% 221.18/221.38  |- mesh__recordAuthorizer mesh__D007396 PLS
% 221.18/221.38  |- rdf__type mesh__D007396sskos__Concept
% 221.18/221.38  |- skos__altLabel mesh__D007396 Dental Residencies
% 221.18/221.38  |- skos__altLabel mesh__D007396 Dental Internships
% 221.18/221.38  |- skos__hiddenLabel mesh__D007396 Internships
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D007396 1997
% 221.18/221.38  |- skos__altLabel mesh__D007396 Dental Internship
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D007396 2004
% 221.18/221.38  |- skos__broader mesh__D007396smesh__D004501
% 221.18/221.38  |- skos__hiddenLabel mesh__D007396 House Staffs
% 221.18/221.38  |- skos__altLabel mesh__D007396 Medical Residency
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D007396 2002
% 221.18/221.38  |- skos__scopeNote mesh__D007396
% 221.18/221.38       Programs of training in medicine and medical specialties offered by hospitals for graduates of medicine to meet the requirements established by accrediting authorities.%A%    
% 221.18/221.38  |- mesh__dateRevised mesh__D007396 1995-05-23
% 221.18/221.38  |- mesh__recordMaintainer mesh__D007396 KEV
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D007396 1996
% 221.18/221.38  |- skos__altLabel mesh__D007396 Residencies, Dental
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D007396 2003
% 221.18/221.38  |- mesh__dateCreated mesh__D007396 1999-01-01
% 221.18/221.38  |- skos__hiddenLabel mesh__D007396 Staff, House
% 221.18/221.38  |- skos__altLabel mesh__D007396 Residency, Medical
% 221.18/221.38  |- skos__altLabel mesh__D007396 Residencies, Medical
% 221.18/221.38  |- skos__annotation mesh__D007396
% 221.18/221.38       med %26% dent only; %22%junior physicians%22% are not interns: index under MEDICAL STAFF, HOSPITAL; DF: INTERNSHIP%A%  
% 221.18/221.38  |- skos__hiddenLabel mesh__D007396 Staffs, House
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D007396 1999
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015828 2005
% 221.18/221.38  |- skos__altLabel mesh__D015828 Viral Eye Infections
% 221.18/221.38  |- skos__hiddenLabel mesh__D015828 Infection, Viral Eye
% 221.18/221.38  |- skos__hiddenLabel mesh__D015828 Ocular Infection, Viral
% 221.18/221.38  |- skos__historyNote mesh__D015828
% 221.18/221.38       specific viral infection %28%1966-1989%29%
% 221.18/221.38  |- skos__hiddenLabel mesh__D015828 Viral Ocular Infection
% 221.18/221.38  |- mesh__historyNote mesh__D015828 90   
% 221.18/221.38  |- skos__hiddenLabel mesh__D015828 Infection, Viral Ocular
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015828 1993
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015828 1996
% 221.18/221.38  |- skos__hiddenLabel mesh__D015828 Infections, Viral Ocular
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015828 1991
% 221.18/221.38  |- skos__altLabel mesh__D015828 Ocular Infections, Viral
% 221.18/221.38  |- skos__historyNote mesh__D015828 Eye Diseases %28%1966-1989%29%
% 221.18/221.38  |- skos__prefLabel mesh__D015828 Eye Infections, Viral
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015828 1992
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015828 1999
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015828 2004
% 221.18/221.38  |- mesh__recordAuthorizer mesh__D015828 PLS
% 221.18/221.38  |- mesh__recordMaintainer mesh__D015828 PLS
% 221.18/221.38  |- mesh__dateCreated mesh__D015828 1989-09-06
% 221.18/221.38  |- skos__annotation mesh__D015828
% 221.18/221.38       coord IM with specific viral dis %28%IM%29%; DF: EYE INFECT VIRAL%A%  
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015828 2002
% 221.18/221.38  |- skos__scopeNote mesh__D015828
% 221.18/221.38       Infections of the eye caused by minute intracellular agents. These infections may lead to severe inflammation in various parts of the eye - conjunctiva, iris, eyelids, etc. Several viruses have been identified as the causative agents. Among these are Herpesvirus, Adenovirus, Poxvirus, and Myxovirus.%A%    
% 221.18/221.38  |- skos__hiddenLabel mesh__D015828 Eye Infection, Viral
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015828 1990
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015828 1995
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015828 1998
% 221.18/221.38  |- skos__broader mesh__D015828smesh__D015817
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015828 2003
% 221.18/221.38  |- skos__hiddenLabel mesh__D015828 Infections, Viral Eye
% 221.18/221.38  |- skos__hiddenLabel mesh__D015828 Viral Eye Infection
% 221.18/221.38  |- mesh__recordOriginator mesh__D015828 EGC
% 221.18/221.38  |- skos__broader mesh__D015828smesh__D014777
% 221.18/221.38  |- mesh__dateRevised mesh__D015828 1994-11-21
% 221.18/221.38  |- rdf__type mesh__D015828sskos__Concept
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015828 1994
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015828 2001
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015828 2006
% 221.18/221.38  |- skos__hiddenLabel mesh__D015828 Viral Ocular Infections
% 221.18/221.38  |- mesh__publicMeSHNote mesh__D015828 90   
% 221.18/221.38  |- mesh__dateEstablished mesh__D015828 1990-01-01
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015828 1997
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D015828 2000
% 221.18/221.38  |- mesh__publicMeSHNote mesh__D001808
% 221.18/221.38       /transplantation was BLOOD VESSEL TRANSPLANTATION 1963-65%A%  
% 221.18/221.38  |- skos__prefLabel mesh__D001808 Blood Vessels
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D001808 2004
% 221.18/221.38  |- mesh__considerAlso mesh__D001808
% 221.18/221.38       consider also terms at ANGI-, VASA-, VASC-, and VASO-   
% 221.18/221.38  |- skos__hiddenLabel mesh__D001808 Vessels, Blood
% 221.18/221.38  |- skos__related mesh__D001808smesh__D014656
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D001808 2006
% 221.18/221.38  |- skos__annotation mesh__D001808
% 221.18/221.38       GEN only: prefer specifics; prefer /blood supply with Cat A terms: Manual 21.4+; permeability = CAPILLARY PERMEABILITY; consider also VASOMOTOR SYSTEM %26% all related terms; inflammation = VASCULITIS or its specifics, ARTERITIS %26% PHLEBITIS; vascular compression syndromes: index under VASCULAR DISEASES %28%IM%29% + CONSTRICTION, PATHOLOGIC %26% coord with specific blood vessel if pertinent %28%IM%29%%A%  
% 221.18/221.38  |- skos__related mesh__D001808smesh__D014666
% 221.18/221.38  |- skos__broader mesh__D001808smesh__D002319
% 221.18/221.38  |- skos__related mesh__D001808smesh__D014655
% 221.18/221.38  |- mesh__recordAuthorizer mesh__D001808 sjn
% 221.18/221.38  |- skos__hiddenLabel mesh__D001808 Vessel, Blood
% 221.18/221.38  |- mesh__recordOriginator mesh__D001808 NLM
% 221.18/221.38  |- mesh__dateCreated mesh__D001808 1999-01-01
% 221.18/221.38  |- mesh__dateRevised mesh__D001808 2003-07-09
% 221.18/221.38  |- skos__scopeNote mesh__D001808
% 221.18/221.38       Any of the tubular vessels conveying the blood %28%arteries, arterioles, capillaries, venules, and veins%29%.%A%    
% 221.18/221.38  |- mesh__recordMaintainer mesh__D001808 ssb
% 221.18/221.38  |- skos__related mesh__D001808smesh__D000792
% 221.18/221.38  |- skos__hiddenLabel mesh__D001808 Blood Vessel
% 221.18/221.38  |- mesh__historyNote mesh__D001808
% 221.18/221.38       /transplantation was BLOOD VESSEL TRANSPLANTATION 1963-65%A%  
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D001808 2005
% 221.18/221.38  |- rdf__type mesh__D001808sskos__Concept
% 221.18/221.38  |- mesh__recordOriginator mesh__D012530 NLM
% 221.18/221.38  |- rdf__type mesh__D012530sskos__Concept
% 221.18/221.38  |- skos__altLabel mesh__D012530 Saxitonin
% 221.18/221.38  |- mesh__recordMaintainer mesh__D012530 ssb
% 221.18/221.38  |- skos__altLabel mesh__D012530 Mitilotoxin
% 221.18/221.38  |- mesh__dateRevised mesh__D012530 2005-06-30
% 221.18/221.38  |- mesh__publicMeSHNote mesh__D012530 74   
% 221.18/221.38  |- skos__prefLabel mesh__D012530 Saxitoxin
% 221.18/221.38  |- mesh__dateEstablished mesh__D012530 1974-01-01
% 221.18/221.38  |- mesh__historyNote mesh__D012530 74   
% 221.18/221.38  |- mesh__recordAuthorizer mesh__D012530 sjn
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D012530 2006
% 221.18/221.38  |- skos__annotation mesh__D012530
% 221.18/221.38       /antag permitted but consider also ANTITOXINS   
% 221.18/221.38  |- skos__altLabel mesh__D012530 Gonyaulax Toxin
% 221.18/221.38  |- skos__broader mesh__D012530smesh__D011687
% 221.18/221.38  |- mesh__dateCreated mesh__D012530 1999-01-01
% 221.18/221.38  |- skos__broader mesh__D012530smesh__D008387
% 221.18/221.38  |- skos__hiddenLabel mesh__D012530 Toxin, Gonyaulax
% 221.18/221.38  |- skos__scopeNote mesh__D012530
% 221.18/221.38       A compound that contains a reduced PURINE ring system but is not biosynthetically related to the purine alkaloids. It is a poison found in certain edible mollusks at certain times; elaborated by GONYAULAX and consumed by mollusks, fishes, etc. without ill effects. It is neurotoxic and causes RESPIRATORY PARALYSIS and other effects in MAMMALS, known as paralytic SHELLFISH poisoning.%A%    
% 221.18/221.38  |- mesh__dateRevised mesh__D011438 2005-06-30
% 221.18/221.38  |- skos__historyNote mesh__D011438 Choline %28%1974-1976%29%
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D011438 2006
% 221.18/221.38  |- skos__historyNote mesh__D011438 Benzilates %28%1974-1975%29%
% 221.18/221.38  |- mesh__publicMeSHNote mesh__D011438 91; was see under CHOLINE 1977-90   
% 221.18/221.38  |- skos__prefLabel mesh__D011438 Propylbenzilylcholine Mustard
% 221.18/221.38  |- skos__hiddenLabel mesh__D011438 Mustard, Propylbenzilylcholine
% 221.18/221.38  |- skos__altLabel mesh__D011438 PRBCM
% 221.18/221.38  |- rdf__type mesh__D011438sskos__Concept
% 221.18/221.38  |- mesh__historyNote mesh__D011438
% 221.18/221.38       91%28%77%29%; was see under CHOLINE 1977-90   
% 221.18/221.38  |- skos__broader mesh__D011438smesh__D009588
% 221.18/221.38  |- skos__broader mesh__D011438smesh__D002794
% 221.18/221.38  |- mesh__dateCreated mesh__D011438 1976-04-16
% 221.18/221.38  |- mesh__recordMaintainer mesh__D011438 ssb
% 221.18/221.38  |- skos__scopeNote mesh__D011438
% 221.18/221.38       An analog of benzilylcholine mustard. It is an alkylating nitrogen mustard analog that binds specifically and irreversibly to cholinergic muscarinic receptors and is used as an affinity label to isolate and study the receptors.%A%    
% 221.18/221.38  |- skos__historyNote mesh__D011438 Mustard Compounds %28%1974-1976%29%
% 221.18/221.38  |- skos__annotation mesh__D011438 D25-26 qualif   
% 221.18/221.38  |- mesh__recordOriginator mesh__D011438 SH
% 221.18/221.38  |- mesh__dateEstablished mesh__D011438 1991-01-01
% 221.18/221.38  |- mesh__recordAuthorizer mesh__D011438 sjn
% 221.18/221.38  |- skos__hiddenLabel mesh__D016921 Pachymeningitides, Fungal
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016921 2006
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016921 2000
% 221.18/221.38  |- skos__altLabel mesh__D016921 Fungal Meningitis
% 221.18/221.38  |- skos__prefLabel mesh__D016921 Meningitis, Fungal
% 221.18/221.38  |- mesh__historyNote mesh__D016921 1992   
% 221.18/221.38  |- skos__hiddenLabel mesh__D016921 Meningitides, Fungal
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016921 2000A
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016921 2001
% 221.18/221.38  |- skos__hiddenLabel mesh__D016921 Fungal Meningitides
% 221.18/221.38  |- mesh__recordMaintainer mesh__D016921 ags
% 221.18/221.38  |- mesh__dateEstablished mesh__D016921 1992-01-01
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016921 2002
% 221.18/221.38  |- skos__historyNote mesh__D016921 specific mycosis %28%1966-1991%29%
% 221.18/221.38  |- mesh__dateCreated mesh__D016921 1991-05-30
% 221.18/221.38  |- mesh__recordAuthorizer mesh__D016921 ags
% 221.18/221.38  |- mesh__activeMeSHYear mesh__D016921 2003
% 221.18/221.38  |- mesh__recordOriginator mesh__D016921 PXP
% 221.18/221.38  |- rdf__type mesh__D016921sskos__Concept
% 221.18/221.38  |- skos__hiddenLabel mesh__D016921 Fungal Pachymeningitis
% 221.18/221.39  |- mesh__publicMeSHNote mesh__D016921 1992   
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D016921 2004
% 221.18/221.39  |- skos__scopeNote mesh__D016921
% 221.18/221.39       Meningitis caused by fungal agents which may occur as OPPORTUNISTIC INFECTIONS or arise in immunocompetent hosts.%A%    
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D016921 2005
% 221.18/221.39  |- skos__hiddenLabel mesh__D016921 Fungal Pachymeningitides
% 221.18/221.39  |- skos__historyNote mesh__D016921 Meningitis %28%1966-1991%29%
% 221.18/221.39  |- mesh__dateRevised mesh__D016921 1999-12-09
% 221.18/221.39  |- skos__broader mesh__D016921smesh__D008581
% 221.18/221.39  |- skos__annotation mesh__D016921
% 221.18/221.39       coord IM with specific fungus %28%IM%29% or specific fungal disease %28%IM%29%%A%  
% 221.18/221.39  |- skos__broader mesh__D016921smesh__D020314
% 221.18/221.39  |- skos__prefLabel mesh__D016123 Campylobacter jejuni
% 221.18/221.39  |- skos__scopeNote mesh__D016123
% 221.18/221.39       A species of bacteria that resemble small tightly coiled spirals. Its organisms are known to cause abortion in sheep and fever and enteritis in man and may be associated with enteric diseases of calves, lambs, and other animals.%A%    
% 221.18/221.39  |- skos__broader mesh__D016123smesh__D002167
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D016123 2006
% 221.18/221.39  |- mesh__dateEstablished mesh__D016123 1991-01-01
% 221.18/221.39  |- mesh__onlineNote mesh__D016123
% 221.18/221.39       use CAMPYLOBACTER FETUS to search CAMPYLOBACTER JEJUNI 1984-90%A%  
% 221.18/221.39  |- skos__historyNote mesh__D016123 Campylobacter fetus %28%1974-1990%29%
% 221.18/221.39  |- mesh__recordOriginator mesh__D016123 PXP
% 221.18/221.39  |- rdf__type mesh__D016123sskos__Concept
% 221.18/221.39  |- mesh__dateRevised mesh__D016123 2005-06-30
% 221.18/221.39  |- mesh__historyNote mesh__D016123
% 221.18/221.39       91; was see CAMPYLOBACTER FETUS 1984-90   
% 221.18/221.39  |- skos__annotation mesh__D016123
% 221.18/221.39       infection: coord IM with CAMPYLOBACTER INFECTIONS %28%IM%29%   
% 221.18/221.39  |- mesh__publicMeSHNote mesh__D016123
% 221.18/221.39       91; was see CAMPYLOBACTER FETUS 1984-90   
% 221.18/221.39  |- mesh__recordAuthorizer mesh__D016123 sjn
% 221.18/221.39  |- mesh__recordMaintainer mesh__D016123 SYSTEM
% 221.18/221.39  |- mesh__dateCreated mesh__D016123 1990-02-12
% 221.18/221.39  |- mesh__dateRevised mesh__D002901 2005-07-13
% 221.18/221.39  |- skos__broader mesh__D002901smesh__D002877
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D002901 2005
% 221.18/221.39  |- mesh__recordOriginator mesh__D002901 NLM
% 221.18/221.39  |- mesh__dateCreated mesh__D002901 1999-01-01
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D002901 2006
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D002901 2006A
% 221.18/221.39  |- mesh__publicMeSHNote mesh__D002901 68   
% 221.18/221.39  |- skos__historyNote mesh__D002901 Chromosomes %28%1966-1967%29%
% 221.18/221.39  |- skos__prefLabel mesh__D002901 Chromosomes, Human, 13-15
% 221.18/221.39  |- mesh__dateEstablished mesh__D002901 1968-01-01
% 221.18/221.39  |- skos__altLabel mesh__D002901 Chromosomes D
% 221.18/221.39  |- skos__hiddenLabel mesh__D002901 Chromosomes, Group D
% 221.18/221.39  |- skos__scopeNote mesh__D002901
% 221.18/221.39       The medium-sized, acrocentric human chromosomes, called group D in the human chromosome classification.  This group consists of chromosome pairs 13, 14, and 15.%A%    
% 221.18/221.39  |- rdf__type mesh__D002901sskos__Concept
% 221.18/221.39  |- mesh__historyNote mesh__D002901 68   
% 221.18/221.39  |- skos__altLabel mesh__D002901 Group D Chromosomes
% 221.18/221.39  |- skos__hiddenLabel mesh__D002901 Chromosome, Group D
% 221.18/221.39  |- mesh__recordMaintainer mesh__D002901 ags
% 221.18/221.39  |- mesh__recordAuthorizer mesh__D002901 ags
% 221.18/221.39  |- skos__hiddenLabel mesh__D002901 Group D Chromosome
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D002103 2005
% 221.18/221.39  |- skos__historyNote mesh__D002103 Polyamines %28%1971-1972%29%
% 221.18/221.39  |- rdf__type mesh__D002103sskos__Concept
% 221.18/221.39  |- skos__altLabel mesh__D002103 1,5-Pentanediamine
% 221.18/221.39  |- mesh__recordAuthorizer mesh__D002103 sjn
% 221.18/221.39  |- mesh__dateRevised mesh__D002103 2000-06-22
% 221.18/221.39  |- mesh__dateEstablished mesh__D002103 1991-01-01
% 221.18/221.39  |- skos__historyNote mesh__D002103 Amines %28%1966-1972%29%
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D002103 2001
% 221.18/221.39  |- mesh__historyNote mesh__D002103
% 221.18/221.39       91%28%73%29%; was see under DIAMINES 1973-90   
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D002103 2004
% 221.18/221.39  |- mesh__recordOriginator mesh__D002103 NLM
% 221.18/221.39  |- mesh__dateCreated mesh__D002103 1999-01-01
% 221.18/221.39  |- mesh__recordMaintainer mesh__D002103 CCR
% 221.18/221.39  |- mesh__publicMeSHNote mesh__D002103 91; was see under DIAMINES 1973-90   
% 221.18/221.39  |- skos__prefLabel mesh__D002103 Cadaverine
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D002103 2003
% 221.18/221.39  |- skos__broader mesh__D002103smesh__D015317
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D002103 2006
% 221.18/221.39  |- skos__broader mesh__D002103smesh__D003959
% 221.18/221.39  |- skos__altLabel mesh__D002103 Pentamethylenediamine
% 221.18/221.39  |- skos__hiddenLabel mesh__D002103 1,5 Pentanediamine
% 221.18/221.39  |- skos__scopeNote mesh__D002103
% 221.18/221.39       A foul-smelling diamine formed by bacterial decarboxylation of lysine.%A%    
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D002103 2002
% 221.18/221.39  |- skos__prefLabel mesh__D021866 Cyclosporiasis
% 221.18/221.39  |- skos__broader mesh__D021866smesh__D003048
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D021866 2001
% 221.18/221.39  |- rdf__type mesh__D021866sskos__Concept
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D021866 2004
% 221.18/221.39  |- mesh__dateCreated mesh__D021866 2000-06-22
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D021866 2006
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D021866 2003
% 221.18/221.39  |- mesh__historyNote mesh__D021866 2001   
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D021866 2005
% 221.18/221.39  |- skos__historyNote mesh__D021866 Coccidiosis %28%1993-2000%29%
% 221.18/221.39  |- mesh__publicMeSHNote mesh__D021866 2001   
% 221.18/221.39  |- skos__scopeNote mesh__D021866
% 221.18/221.39       Infection with parasitic protozoa of the genus CYCLOSPORA. It is distributed globally and causes a diarrheal illness. Transmission is waterborne.%A%    
% 221.18/221.39  |- mesh__dateEstablished mesh__D021866 2001-01-01
% 221.18/221.39  |- skos__annotation mesh__D021866
% 221.18/221.39       /drug ther: consider also COCCIDIOSTATS   
% 221.18/221.39  |- skos__hiddenLabel mesh__D021866 Cyclosporiases
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D021866 2002
% 221.18/221.39  |- rdf__type mesh__D007397sskos__Concept
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D007397 1998
% 221.18/221.39  |- skos__prefLabel mesh__D007397 Internship, Nonmedical
% 221.18/221.39  |- skos__altLabel mesh__D007397 Non-Medical Internships
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D007397 2004
% 221.18/221.39  |- skos__hiddenLabel mesh__D007397 Non-Medical Residencies
% 221.18/221.39  |- skos__hiddenLabel mesh__D007397 Internship, Non Medical
% 221.18/221.39  |- skos__altLabel mesh__D007397 Internships, Nonmedical
% 221.18/221.39  |- mesh__dateCreated mesh__D007397 1977-05-13
% 221.18/221.39  |- skos__hiddenLabel mesh__D007397 Non Medical Internship
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D007397 1997
% 221.18/221.39  |- mesh__historyNote mesh__D007397 78   
% 221.18/221.39  |- skos__scopeNote mesh__D007397
% 221.18/221.39       Advanced programs of training to meet certain professional requirements in fields other than medicine or dentistry, e.g., pharmacology, nutrition, nursing, etc.%A%    
% 221.18/221.39  |- skos__altLabel mesh__D007397 Non-Medical Internship
% 221.18/221.39  |- skos__hiddenLabel mesh__D007397 Non-Medical Residency
% 221.18/221.39  |- skos__altLabel mesh__D007397 Nonmedical Internships
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D007397 2003
% 221.18/221.39  |- skos__altLabel mesh__D007397 Internships, Non-Medical
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D007397 2002
% 221.18/221.39  |- mesh__dateEstablished mesh__D007397 1978-01-01
% 221.18/221.39  |- skos__hiddenLabel mesh__D007397 Residencies, Non Medical
% 221.18/221.39  |- skos__hiddenLabel mesh__D007397 Internships, Non Medical
% 221.18/221.39  |- skos__altLabel mesh__D007397 Residencies, Nonmedical
% 221.18/221.39  |- skos__annotation mesh__D007397 DF: INTERNSHIP NONMED   
% 221.18/221.39  |- skos__altLabel mesh__D007397 Nonmedical Residency
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D007397 2001
% 221.18/221.39  |- skos__altLabel mesh__D007397 Residency, Non-Medical
% 221.18/221.39  |- mesh__recordOriginator mesh__D007397 EC
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D007397 2006
% 221.18/221.39  |- skos__altLabel mesh__D007397 Residency, Nonmedical
% 221.18/221.39  |- skos__altLabel mesh__D007397 Internship, Non-Medical
% 221.18/221.39  |- mesh__recordAuthorizer mesh__D007397 PLS
% 221.18/221.39  |- mesh__dateRevised mesh__D007397 1996-06-10
% 221.18/221.39  |- skos__hiddenLabel mesh__D007397 Non Medical Internships
% 221.18/221.39  |- mesh__publicMeSHNote mesh__D007397 78   
% 221.18/221.39  |- mesh__recordMaintainer mesh__D007397 TGC
% 221.18/221.39  |- skos__altLabel mesh__D007397 Nonmedical Internship
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D007397 1999
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D007397 2000
% 221.18/221.39  |- skos__broader mesh__D007397smesh__D004517
% 221.18/221.39  |- skos__altLabel mesh__D007397 Residencies, Non-Medical
% 221.18/221.39  |- skos__hiddenLabel mesh__D007397 Residency, Non Medical
% 221.18/221.39  |- skos__altLabel mesh__D007397 Nonmedical Residencies
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D007397 2005
% 221.18/221.39  |- mesh__dateRevised mesh__D015829 1996-06-13
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D015829 2006
% 221.18/221.39  |- mesh__recordOriginator mesh__D015829 EGC
% 221.18/221.39  |- mesh__publicMeSHNote mesh__D015829 90   
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D015829 2003
% 221.18/221.39  |- skos__broader mesh__D015829smesh__D013492
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D015829 2000
% 221.18/221.39  |- mesh__recordMaintainer mesh__D015829 PXP
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D015829 1997
% 221.18/221.39  |- rdf__type mesh__D015829sskos__Concept
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D015829 2004
% 221.18/221.39  |- skos__hiddenLabel mesh__D015829 Suppurative Uveitis
% 221.18/221.39  |- skos__historyNote mesh__D015829 Uveitis %28%1966-1989%29%
% 221.18/221.39  |- skos__annotation mesh__D015829
% 221.18/221.39       coord IM with specific bacterial or fungal infect %28%IM%29%   
% 221.18/221.39  |- skos__scopeNote mesh__D015829
% 221.18/221.39       Intraocular infection caused mainly by pus-producing bacteria and rarely by fungi. The infection may be caused by an injury or surgical wound %28%exogenous%29% or by endogenous septic emboli in such diseases as bacterial endocarditis or meningococcemia.%A%    
% 221.18/221.39  |- skos__hiddenLabel mesh__D015829 Uveitides, Suppurative
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D015829 2001
% 221.18/221.39  |- skos__broader mesh__D015829smesh__D015821
% 221.18/221.39  |- mesh__historyNote mesh__D015829 90   
% 221.18/221.39  |- skos__broader mesh__D015829smesh__D014605
% 221.18/221.39  |- skos__broader mesh__D015829smesh__D015818
% 221.18/221.39  |- skos__hiddenLabel mesh__D015829 Suppurative Uveitides
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D015829 1998
% 221.18/221.39  |- mesh__dateEstablished mesh__D015829 1990-01-01
% 221.18/221.39  |- mesh__recordAuthorizer mesh__D015829 PLS
% 221.18/221.39  |- mesh__dateCreated mesh__D015829 1989-05-25
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D015829 2005
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D015829 2002
% 221.18/221.39  |- skos__prefLabel mesh__D015829 Uveitis, Suppurative
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D015829 1999
% 221.18/221.39  |- skos__hiddenLabel mesh__D001809 Blood Viscosities
% 221.18/221.39  |- mesh__recordMaintainer mesh__D001809 sjn
% 221.18/221.39  |- mesh__dateRevised mesh__D001809 2004-07-13
% 221.18/221.39  |- mesh__dateCreated mesh__D001809 1999-01-01
% 221.18/221.39  |- skos__broader mesh__D001809smesh__D045472
% 221.18/221.39  |- skos__related mesh__D001809smesh__D018056
% 221.18/221.39  |- rdf__type mesh__D001809sskos__Concept
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D001809 2005
% 221.18/221.39  |- skos__hiddenLabel mesh__D001809 Viscosity, Blood
% 221.18/221.39  |- skos__scopeNote mesh__D001809
% 221.18/221.39       The internal resistance of the BLOOD to shear forces. The in vitro measure of whole blood viscosity is of limited clinical utility because it bears little relationship to the actual viscosity within the circulation, but an increase in the viscosity of circulating blood can contribute to morbidity in patients suffering from disorders such as SICKLE CELL ANEMIA and POLYCYTHEMIA.%A%    
% 221.18/221.39  |- skos__prefLabel mesh__D001809 Blood Viscosity
% 221.18/221.39  |- skos__annotation mesh__D001809
% 221.18/221.39       coord IM with disease /blood %28%IM%29%, not /physiopathol   
% 221.18/221.39  |- skos__broader mesh__D001809smesh__D045122
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D001809 2006
% 221.18/221.39  |- mesh__recordAuthorizer mesh__D001809 sjn
% 221.18/221.39  |- skos__hiddenLabel mesh__D001809 Viscosities, Blood
% 221.18/221.39  |- mesh__recordOriginator mesh__D001809 NLM
% 221.18/221.39  |- skos__prefLabel mesh__D012531
% 221.18/221.39       Dibenz%28%b,f%29%%28%1,4%29%oxazepine-10%28%11H%29%-carboxylic acid, 8-chloro-, 2-acetylhydrazide
% 221.18/221.39  |- mesh__historyNote mesh__D012531 2005%28%1975%29%   
% 221.18/221.39  |- skos__broader mesh__D012531smesh__D003989
% 221.18/221.39  |- skos__historyNote mesh__D012531 Hydrazines %28%1972-1974%29%
% 221.18/221.39  |- mesh__recordOriginator mesh__D012531 NLM
% 221.18/221.39  |- mesh__dateEstablished mesh__D012531 1991-01-01
% 221.18/221.39  |- mesh__recordMaintainer mesh__D012531 jmp
% 221.18/221.39  |- skos__historyNote mesh__D012531 Dibenzoxazepines %28%1972-1974%29%
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D012531 2006
% 221.18/221.39  |- mesh__publicMeSHNote mesh__D012531
% 221.18/221.39       2005; see SC-19220 1991-2005; see DIBENZOXAZEPINES 1975-1990%A%  
% 221.18/221.39  |- mesh__dateRevised mesh__D012531 2004-07-07
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D012531 2005
% 221.18/221.39  |- mesh__dateCreated mesh__D012531 1974-11-11
% 221.18/221.39  |- skos__scopeNote mesh__D012531
% 221.18/221.39       Inhibits the activity of prostaglandins.     
% 221.18/221.39  |- rdf__type mesh__D012531sskos__Concept
% 221.18/221.39  |- mesh__recordAuthorizer mesh__D012531 sjn
% 221.18/221.39  |- skos__hiddenLabel mesh__D008490 Sciences, Medical Information
% 221.18/221.39  |- skos__hiddenLabel mesh__D008490 Sciences, Medical Computer
% 221.18/221.39  |- skos__broader mesh__D008490smesh__D048088
% 221.18/221.39  |- skos__broader mesh__D008490smesh__D007254
% 221.18/221.39  |- mesh__dateCreated mesh__D008490 1986-06-17
% 221.18/221.39  |- skos__annotation mesh__D008490 SPEC: SPEC qualif; DF: MED INFORMATICS   
% 221.18/221.39  |- mesh__recordOriginator mesh__D008490 EC
% 221.18/221.39  |- skos__historyNote mesh__D008490 Information Systems %28%1982-1986%29%
% 221.18/221.39  |- mesh__dateEstablished mesh__D008490 1987-01-01
% 221.18/221.39  |- skos__hiddenLabel mesh__D008490 Computer Sciences, Medical
% 221.18/221.39  |- skos__scopeNote mesh__D008490
% 221.18/221.39       The field of information science concerned with the analysis and dissemination of medical data through the application of computers to various aspects of health care and medicine.%A%    
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D008490 2005
% 221.18/221.39  |- mesh__dateRevised mesh__D008490 2004-07-07
% 221.18/221.39  |- skos__altLabel mesh__D008490 Computer Science, Medical
% 221.18/221.39  |- skos__hiddenLabel mesh__D008490 Science, Medical Information
% 221.18/221.39  |- skos__altLabel mesh__D008490 Informatics, Medical
% 221.18/221.39  |- mesh__historyNote mesh__D008490 87   
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D008490 2006
% 221.18/221.39  |- skos__prefLabel mesh__D008490 Medical Informatics
% 221.18/221.39  |- skos__hiddenLabel mesh__D008490 Science, Medical Computer
% 221.18/221.39  |- skos__hiddenLabel mesh__D008490 Medical Information Sciences
% 221.18/221.39  |- mesh__publicMeSHNote mesh__D008490 87   
% 221.18/221.39  |- skos__hiddenLabel mesh__D008490 Information Sciences, Medical
% 221.18/221.39  |- rdf__type mesh__D008490sskos__Concept
% 221.18/221.39  |- mesh__recordMaintainer mesh__D008490 jls
% 221.18/221.39  |- skos__altLabel mesh__D008490 Medical Information Science
% 221.18/221.39  |- skos__altLabel mesh__D008490 Informatics, Clinical
% 221.18/221.39  |- skos__hiddenLabel mesh__D008490 Medical Computer Sciences
% 221.18/221.39  |- mesh__recordAuthorizer mesh__D008490 sjn
% 221.18/221.39  |- skos__related mesh__D022161smesh__D001692
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D022161 2005
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D022161 2004
% 221.18/221.39  |- skos__historyNote mesh__D022161 Biological Transport %28%1989-2000%29%
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D022161 2006
% 221.18/221.39  |- mesh__publicMeSHNote mesh__D022161 2001   
% 221.18/221.39  |- mesh__dateCreated mesh__D022161 2000-06-22
% 221.18/221.39  |- skos__hiddenLabel mesh__D022161 Vesicle, Endocytic
% 221.18/221.39  |- skos__prefLabel mesh__D022161 Transport Vesicles
% 221.18/221.39  |- rdf__type mesh__D022161sskos__Concept
% 221.18/221.39  |- skos__hiddenLabel mesh__D022161 Vesicle, Transport
% 221.18/221.39  |- skos__hiddenLabel mesh__D022161 Vesicles, Transport
% 221.18/221.39  |- skos__hiddenLabel mesh__D022161 Transport Vesicle
% 221.18/221.39  |- mesh__historyNote mesh__D022161 2001   
% 221.18/221.39  |- skos__hiddenLabel mesh__D022161 Endocytic Vesicle
% 221.18/221.39  |- mesh__dateRevised mesh__D022161 2003-07-09
% 221.18/221.39  |- skos__scopeNote mesh__D022161
% 221.18/221.39       Vesicles that are involved in shuttling cargo from the interior of the cell to the cell surface, from the cell surface to the interior, across the cell or around the cell to various locations.%A%    
% 221.18/221.39  |- mesh__dateEstablished mesh__D022161 2001-01-01
% 221.18/221.39  |- skos__broader mesh__D022161smesh__D022162
% 221.18/221.39  |- skos__hiddenLabel mesh__D022161 Vesicles, Endocytic
% 221.18/221.39  |- skos__hiddenLabel mesh__D016922 Senescence, Cell
% 221.18/221.39  |- mesh__publicMeSHNote mesh__D016922
% 221.18/221.39       92; was see CELL SURVIVAL 1977-91; CELL SENESCENCE %26% SENESCENCE, CELLULAR were see CELL SURVIVAL 1991%A%  
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D016922 2001
% 221.18/221.39  |- mesh__onlineNote mesh__D016922
% 221.18/221.39       use CELL SURVIVAL to search CELL AGING 1977-91 and CELL SENESCENCE %26% SENESCENCE, CELLULAR 1991%A%  
% 221.18/221.39  |- skos__historyNote mesh__D016922 Cell Survival %28%1977-1991%29%
% 221.18/221.39  |- skos__historyNote mesh__D016922 Erythrocyte Aging %28%1967-1991%29%
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D016922 2006
% 221.18/221.39  |- skos__broader mesh__D016922smesh__D002468
% 221.18/221.39  |- mesh__historyNote mesh__D016922
% 221.18/221.39       92; was see CELL SURVIVAL 1977-91; CELL SENESCENCE %26% SENESCENCE, CELLULAR were see CELL SURVIVAL 1991%A%  
% 221.18/221.39  |- skos__altLabel mesh__D016922 Replicative Senescence
% 221.18/221.39  |- skos__scopeNote mesh__D016922
% 221.18/221.39       The decrease in the cell%27%s ability to proliferate with the passing of time. Each cell is programmed for a certain number of cell divisions and at the end of that time proliferation halts. The cell enters a quiescent state after which it experiences CELL DEATH via the process of APOPTOSIS.%A%    
% 221.18/221.39  |- skos__altLabel mesh__D016922 Cellular Aging
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D016922 2002
% 221.18/221.39  |- mesh__dateCreated mesh__D016922 1991-05-30
% 221.18/221.39  |- skos__altLabel mesh__D016922 Senescence, Replicative
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D016922 1999
% 221.18/221.39  |- mesh__dateEstablished mesh__D016922 1992-01-01
% 221.18/221.39  |- rdf__type mesh__D016922sskos__Concept
% 221.18/221.39  |- skos__hiddenLabel mesh__D016922 Cellular Senescence
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D016922 2003
% 221.18/221.39  |- skos__altLabel mesh__D016922 Cell Senescence
% 221.18/221.39  |- mesh__recordOriginator mesh__D016922 MXR
% 221.18/221.39  |- mesh__recordAuthorizer mesh__D016922 SJN
% 221.18/221.39  |- skos__annotation mesh__D016922 not for micro-organisms   
% 221.18/221.39  |- mesh__dateRevised mesh__D016922 1998-06-10
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D016922 2004
% 221.18/221.39  |- skos__prefLabel mesh__D016922 Cell Aging
% 221.18/221.39  |- skos__hiddenLabel mesh__D016922 Aging, Cellular
% 221.18/221.39  |- skos__altLabel mesh__D016922 Aging, Cell
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D016922 2000
% 221.18/221.39  |- mesh__recordMaintainer mesh__D016922 AGS
% 221.18/221.39  |- skos__altLabel mesh__D016922 Senescence, Cellular
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D016922 2005
% 221.18/221.39  |- skos__related mesh__D016922smesh__D016923
% 221.18/221.39  |- skos__scopeNote mesh__D016124
% 221.18/221.39       Gram-negative bacteria isolated from infections of the respiratory and intestinal tracts and from the buccal cavity, intestinal tract, and urogenital tract. They are probably part of the normal flora of man and animals.%A%    
% 221.18/221.39  |- skos__historyNote mesh__D016124 Bacteroides %28%1973-1975%29%
% 221.18/221.39  |- mesh__dateEstablished mesh__D016124 1991-01-01
% 221.18/221.39  |- skos__prefLabel mesh__D016124 Eikenella corrodens
% 221.18/221.39  |- mesh__dateRevised mesh__D016124 2005-06-30
% 221.18/221.39  |- mesh__recordOriginator mesh__D016124 PXP
% 221.18/221.39  |- mesh__publicMeSHNote mesh__D016124
% 221.18/221.39       91; BACTEROIDES CORRODENS %28%with EIKENELLA CORRODENS as see ref to it%29% was see under BACTEROIDES 1976-90%A%  
% 221.18/221.39  |- rdf__type mesh__D016124sskos__Concept
% 221.18/221.39  |- mesh__recordAuthorizer mesh__D016124 sjn
% 221.18/221.39  |- mesh__onlineNote mesh__D016124
% 221.18/221.39       use EIKENELLA CORRODENS to search BACTEROIDES CORRODENS 1976-90%A%  
% 221.18/221.39  |- mesh__dateCreated mesh__D016124 1990-02-12
% 221.18/221.39  |- mesh__recordMaintainer mesh__D016124 SYSTEM
% 221.18/221.39  |- skos__annotation mesh__D016124
% 221.18/221.39       normal bacterium in man %26% animal but if causing infect, coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D016124 2006
% 221.18/221.39  |- skos__broader mesh__D016124smesh__D016970
% 221.18/221.39  |- mesh__historyNote mesh__D016124
% 221.18/221.39       91; BACTEROIDES CORRODENS %28%with EIKENELLA CORRODENS as see ref to it%29% was see under BACTEROIDES 1976-90%A%  
% 221.18/221.39  |- skos__historyNote mesh__D016124 Bacteroides corrodens %28%1976-1990%29%
% 221.18/221.39  |- skos__altLabel mesh__D016124 Bacteroides corrodens
% 221.18/221.39  |- mesh__historyNote mesh__D002902 68   
% 221.18/221.39  |- mesh__dateEstablished mesh__D002902 1968-01-01
% 221.18/221.39  |- skos__prefLabel mesh__D002902 Chromosomes, Human, 16-18
% 221.18/221.39  |- skos__hiddenLabel mesh__D002902 E Chromosomes, Group
% 221.18/221.39  |- skos__historyNote mesh__D002902 Chromosomes %28%1966-1967%29%
% 221.18/221.39  |- rdf__type mesh__D002902sskos__Concept
% 221.18/221.39  |- mesh__recordAuthorizer mesh__D002902 sjn
% 221.18/221.39  |- skos__broader mesh__D002902smesh__D002877
% 221.18/221.39  |- mesh__recordOriginator mesh__D002902 NLM
% 221.18/221.39  |- skos__altLabel mesh__D002902 Chromosomes E
% 221.18/221.39  |- skos__hiddenLabel mesh__D002902 Chromosomes, Group E
% 221.18/221.39  |- skos__scopeNote mesh__D002902
% 221.18/221.39       The short, submetacentric human chromosomes, called group E in the human chromosome classification.  This group consists of chromosome pairs 16, 17, and 18.%A%    
% 221.18/221.39  |- skos__hiddenLabel mesh__D002902 Group E Chromosome
% 221.18/221.39  |- mesh__dateRevised mesh__D002902 2004-07-13
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D002902 2005
% 221.18/221.39  |- mesh__dateCreated mesh__D002902 1999-01-01
% 221.18/221.39  |- skos__altLabel mesh__D002902 Group E Chromosomes
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D002902 2006
% 221.18/221.39  |- mesh__publicMeSHNote mesh__D002902 68   
% 221.18/221.39  |- skos__hiddenLabel mesh__D002902 Chromosome, Group E
% 221.18/221.39  |- mesh__recordMaintainer mesh__D002902 sjn
% 221.18/221.39  |- mesh__historyNote mesh__D002104
% 221.18/221.39       /poisoning was used for indexing 1966-76   
% 221.18/221.39  |- rdf__type mesh__D002104sskos__Concept
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D002104 2002
% 221.18/221.39  |- skos__broader mesh__D002104smesh__D019216
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D002104 2004
% 221.18/221.39  |- mesh__dateCreated mesh__D002104 1999-01-01
% 221.18/221.39  |- mesh__dateRevised mesh__D002104 2001-07-25
% 221.18/221.39  |- mesh__publicMeSHNote mesh__D002104
% 221.18/221.39       /poisoning %28% = CADMIUM POISONING as of 1977%29% was used for indexing 1966-76%A%  
% 221.18/221.39  |- skos__prefLabel mesh__D002104 Cadmium
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D002104 2003
% 221.18/221.39  |- mesh__recordMaintainer mesh__D002104 jmp
% 221.18/221.39  |- mesh__recordAuthorizer mesh__D002104 sjn
% 221.18/221.39  |- skos__related mesh__D002104smesh__D002106
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D002104 2006
% 221.18/221.39  |- mesh__onlineNote mesh__D002104
% 221.18/221.39       search CADMIUM/PO under CADMIUM POISONING 1966-76   
% 221.18/221.39  |- skos__scopeNote mesh__D002104
% 221.18/221.39       An element with atomic symbol Cd, atomic number 48, and atomic weight 114. It is a metal and ingestion will lead to CADMIUM POISONING.%A%    
% 221.18/221.39  |- mesh__recordOriginator mesh__D002104 NLM
% 221.18/221.39  |- skos__broader mesh__D002104smesh__D028561
% 221.18/221.39  |- skos__annotation mesh__D002104
% 221.18/221.39       Cd-114; Cd-106, 108, 110-113, 116 = CADMIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Cd-103-105, 107, 109, 115, 117-119 = CADMIUM RADIOISOTOPES %28%IM%29%%A%  
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D002104 2005
% 221.18/221.39  |- mesh__recordAuthorizer mesh__D007398 sjn
% 221.18/221.39  |- skos__hiddenLabel mesh__D007398 Relations, Interpersonal
% 221.18/221.39  |- skos__hiddenLabel mesh__D007398 Interactions, Social
% 221.18/221.39  |- skos__hiddenLabel mesh__D007398 Issues, Gender
% 221.18/221.39  |- skos__related mesh__D007398smesh__D033062
% 221.18/221.39  |- rdf__type mesh__D007398sskos__Concept
% 221.18/221.39  |- mesh__publicMeSHNote mesh__D007398 64   
% 221.18/221.39  |- skos__hiddenLabel mesh__D007398 Relation, Interpersonal
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D007398 2003
% 221.18/221.39  |- mesh__dateCreated mesh__D007398 1999-01-01
% 221.18/221.39  |- skos__broader mesh__D007398smesh__D011593
% 221.18/221.39  |- skos__hiddenLabel mesh__D007398 Communication, Partner
% 221.18/221.39  |- skos__hiddenLabel mesh__D007398 Gender Issue
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D007398 2004
% 221.18/221.39  |- skos__hiddenLabel mesh__D007398 Communications, Partner
% 221.18/221.39  |- skos__hiddenLabel mesh__D007398 Partner Communications
% 221.18/221.39  |- skos__related mesh__D007398smesh__D017004
% 221.18/221.39  |- skos__hiddenLabel mesh__D007398 Husband-Wife Communications
% 221.18/221.39  |- skos__prefLabel mesh__D007398 Interpersonal Relations
% 221.18/221.39  |- skos__hiddenLabel mesh__D007398 Gender Relation
% 221.18/221.39  |- skos__hiddenLabel mesh__D007398 Relation, Gender
% 221.18/221.39  |- skos__annotation mesh__D007398 DF: INTERPERSONAL RELAT   
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D007398 2005
% 221.18/221.39  |- mesh__recordMaintainer mesh__D007398 tjk
% 221.18/221.39  |- mesh__historyNote mesh__D007398 64   
% 221.18/221.39  |- skos__hiddenLabel mesh__D007398 Interaction, Social
% 221.18/221.39  |- skos__hiddenLabel mesh__D007398 Husband Wife Communication
% 221.18/221.39  |- mesh__recordOriginator mesh__D007398 NLM
% 221.18/221.39  |- skos__hiddenLabel mesh__D007398 Communications, Husband-Wife
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D007398 2006
% 221.18/221.39  |- mesh__dateRevised mesh__D007398 2002-07-03
% 221.18/221.39  |- skos__scopeNote mesh__D007398
% 221.18/221.39       The reciprocal interaction of two or more persons.     
% 221.18/221.39  |- skos__altLabel mesh__D007398 Relations, Gender
% 221.18/221.39  |- mesh__dateEstablished mesh__D007398 1964-01-01
% 221.18/221.39  |- skos__hiddenLabel mesh__D007398 Interpersonal Relation
% 221.18/221.39  |- skos__hiddenLabel mesh__D007398 Issue, Gender
% 221.18/221.39  |- skos__hiddenLabel mesh__D007398 Social Interactions
% 221.18/221.39  |- skos__hiddenLabel mesh__D007398 Communication, Husband-Wife
% 221.18/221.39  |- skos__annotation mesh__D012532
% 221.18/221.39       mite infest caused by Sarcoptes scabiei   
% 221.18/221.39  |- skos__hiddenLabel mesh__D012532 Sarcoptic Mange
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D012532 2006
% 221.18/221.39  |- mesh__dateCreated mesh__D012532 1999-01-01
% 221.18/221.39  |- mesh__recordAuthorizer mesh__D012532 sjn
% 221.18/221.39  |- skos__broader mesh__D012532smesh__D008924
% 221.18/221.39  |- skos__broader mesh__D012532smesh__D012876
% 221.18/221.39  |- rdf__type mesh__D012532sskos__Concept
% 221.18/221.39  |- mesh__recordOriginator mesh__D012532 NLM
% 221.18/221.39  |- skos__scopeNote mesh__D012532
% 221.18/221.39       A contagious cutaneous inflammation caused by the bite of the mite SARCOPTES SCABIEI. It is characterized by pruritic papular eruptions and burrows and affects primarily the axillae, elbows, wrists, and genitalia, although it can spread to cover the entire body.%A%    
% 221.18/221.39  |- skos__prefLabel mesh__D012532 Scabies
% 221.18/221.39  |- mesh__historyNote mesh__D012532
% 221.18/221.39       MANGE, SARCOPTIC was see under SCABIES 1968-76   
% 221.18/221.39  |- mesh__dateRevised mesh__D012532 2005-06-30
% 221.18/221.39  |- mesh__onlineNote mesh__D012532
% 221.18/221.39       use SCABIES to search MANGE, SARCOPTIC 1968-76   
% 221.18/221.39  |- mesh__recordMaintainer mesh__D012532 ags
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D008491 1997
% 221.18/221.39  |- skos__altLabel mesh__D008491 Application, Medical Informatics
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D008491 2000
% 221.18/221.39  |- mesh__recordAuthorizer mesh__D008491 PLS
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D008491 1994
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D008491 2005
% 221.18/221.39  |- mesh__dateCreated mesh__D008491 1986-06-17
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D008491 2004
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D008491 1993
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D008491 1999
% 221.18/221.39  |- mesh__recordMaintainer mesh__D008491 TAP
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D008491 2001
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D008491 1995
% 221.18/221.39  |- mesh__activeMeSHYear mesh__D008491 2006
% 221.18/221.39  |- skos__scopeNote mesh__D008491
% 221.18/221.39       Automated systems applied to the patient care process including diagnosis, therapy, and systems of communicating medical data within the health care setting.%A%    
% 221.18/221.39  |- mesh__historyNote mesh__D008491 87   
% 221.18/221.39  |- skos__annotation mesh__D008491
% 221.18/221.39       no qualif; DF: MED INFORMATICS APPLICATIONS   
% 221.18/221.40  |- mesh__dateEstablished mesh__D008491 1987-01-01
% 221.18/221.40  |- skos__broader mesh__D008491smesh__D008490
% 221.18/221.40  |- rdf__type mesh__D008491sskos__Concept
% 221.18/221.40  |- mesh__recordOriginator mesh__D008491 EC
% 221.18/221.40  |- mesh__activeMeSHYear mesh__D008491 2002
% 221.18/221.40  |- mesh__dateRevised mesh__D008491 1990-05-17
% 221.18/221.40  |- mesh__activeMeSHYear mesh__D008491 1991
% 221.18/221.40  |- skos__prefLabel mesh__D008491 Medical Informatics Applications
% 221.18/221.40  |- skos__hiddenLabel mesh__D008491 Medical Informatics Application
% 221.18/221.40  |- mesh__activeMeSHYear mesh__D008491 1996
% 221.18/221.40  |- skos__hiddenLabel mesh__D008491 Informatics Application, Medical
% 221.18/221.40  |- skos__altLabel mesh__D008491 Applications, Medical Informatics
% 221.18/221.40  |- mesh__publicMeSHNote mesh__D008491 87   
% 221.18/221.40  |- skos__altLabel mesh__D008491 Informatics Applications, Medical
% 221.18/221.40  |- mesh__activeMeSHYear mesh__D008491 2003
% 221.18/221.40  |- mesh__activeMeSHYear mesh__D008491 1992
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D008491 1998
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D022162 2006
% 221.25/221.40  |- skos__hiddenLabel mesh__D022162 Cytoplasmic Vesicle
% 221.25/221.40  |- rdf__type mesh__D022162sskos__Concept
% 221.25/221.40  |- skos__prefLabel mesh__D022162 Cytoplasmic Vesicles
% 221.25/221.40  |- mesh__publicMeSHNote mesh__D022162 2001   
% 221.25/221.40  |- mesh__historyNote mesh__D022162 2001   
% 221.25/221.40  |- mesh__recordOriginator mesh__D022162 nns
% 221.25/221.40  |- mesh__dateRevised mesh__D022162 2003-07-09
% 221.25/221.40  |- mesh__dateEstablished mesh__D022162 2001-01-01
% 221.25/221.40  |- skos__broader mesh__D022162smesh__D015388
% 221.25/221.40  |- mesh__dateCreated mesh__D022162 2000-07-06
% 221.25/221.40  |- skos__hiddenLabel mesh__D022162 Vesicle, Cytoplasmic
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D022162 2005
% 221.25/221.40  |- skos__hiddenLabel mesh__D022162 Vesicles, Cytoplasmic
% 221.25/221.40  |- skos__scopeNote mesh__D022162
% 221.25/221.40       Membrane-limited structures derived from the plasma membrane or various intracellular membranes which function in storage, transport or metabolism.%A%    
% 221.25/221.40  |- mesh__recordAuthorizer mesh__D022162 sjn
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D022162 2004
% 221.25/221.40  |- mesh__recordMaintainer mesh__D022162 nns
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D016923 2002
% 221.25/221.40  |- skos__hiddenLabel mesh__D016923 Death, Cell
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D016923 1996
% 221.25/221.40  |- mesh__onlineNote mesh__D016923
% 221.25/221.40       use CELL SURVIVAL to search CELL DEATH 1978-91   
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D016923 2001
% 221.25/221.40  |- mesh__recordMaintainer mesh__D016923 MXR
% 221.25/221.40  |- mesh__recordOriginator mesh__D016923 MXR
% 221.25/221.40  |- mesh__dateCreated mesh__D016923 1991-05-30
% 221.25/221.40  |- mesh__recordAuthorizer mesh__D016923 PLS
% 221.25/221.40  |- skos__prefLabel mesh__D016923 Cell Death
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D016923 2006
% 221.25/221.40  |- mesh__dateEstablished mesh__D016923 1992-01-01
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D016923 2000
% 221.25/221.40  |- skos__broader mesh__D016923smesh__D002468
% 221.25/221.40  |- mesh__historyNote mesh__D016923 92; was see CELL SURVIVAL 1978-91   
% 221.25/221.40  |- mesh__publicMeSHNote mesh__D016923 92; was see CELL SURVIVAL 1978-91   
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D016923 1995
% 221.25/221.40  |- skos__annotation mesh__D016923 NIM; not for micro-organisms   
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D016923 2005
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D016923 1999
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D016923 1994
% 221.25/221.40  |- rdf__type mesh__D016923sskos__Concept
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D016923 2004
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D016923 1998
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D016923 1993
% 221.25/221.40  |- mesh__dateRevised mesh__D016923 1992-05-07
% 221.25/221.40  |- skos__related mesh__D016923smesh__D009336
% 221.25/221.40  |- skos__historyNote mesh__D016923 Cell Survival %28%1971-1991%29%
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D016923 2003
% 221.25/221.40  |- skos__scopeNote mesh__D016923
% 221.25/221.40       The termination of the cell%27%s ability to carry out vital functions such as metabolism, growth, reproduction, responsiveness, and adaptability.%A%    
% 221.25/221.40  |- skos__related mesh__D016923smesh__D017209
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D016923 1997
% 221.25/221.40  |- rdf__type mesh__D002903sskos__Concept
% 221.25/221.40  |- skos__altLabel mesh__D002903 Group F Chromosomes
% 221.25/221.40  |- mesh__recordAuthorizer mesh__D002903 ags
% 221.25/221.40  |- skos__prefLabel mesh__D002903 Chromosomes, Human, 19-20
% 221.25/221.40  |- mesh__historyNote mesh__D002903 68   
% 221.25/221.40  |- mesh__recordMaintainer mesh__D002903 ags
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002903 2005
% 221.25/221.40  |- mesh__dateCreated mesh__D002903 1999-01-01
% 221.25/221.40  |- skos__hiddenLabel mesh__D002903 Group F Chromosome
% 221.25/221.40  |- skos__hiddenLabel mesh__D002903 Chromosomes, Group F
% 221.25/221.40  |- mesh__dateRevised mesh__D002903 2005-07-13
% 221.25/221.40  |- skos__broader mesh__D002903smesh__D002877
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002903 2006
% 221.25/221.40  |- mesh__recordOriginator mesh__D002903 NLM
% 221.25/221.40  |- mesh__publicMeSHNote mesh__D002903 68   
% 221.25/221.40  |- skos__hiddenLabel mesh__D002903 Chromosome, Group F
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002903 2006A
% 221.25/221.40  |- skos__scopeNote mesh__D002903
% 221.25/221.40       The short, metacentric human chromosomes, called group F in the human chromosome classification.  This group consists of chromosome pairs 19 and 20.%A%    
% 221.25/221.40  |- mesh__dateEstablished mesh__D002903 1968-01-01
% 221.25/221.40  |- skos__altLabel mesh__D002903 Chromosomes F
% 221.25/221.40  |- skos__historyNote mesh__D002903 Chromosomes %28%1966-1967%29%
% 221.25/221.40  |- mesh__recordOriginator mesh__D002105 MM
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002105 2002
% 221.25/221.40  |- mesh__dateRevised mesh__D002105 1999-11-03
% 221.25/221.40  |- mesh__dateEstablished mesh__D002105 1977-01-01
% 221.25/221.40  |- mesh__publicMeSHNote mesh__D002105 77; was CADMIUM/poisoning 1966-76   
% 221.25/221.40  |- mesh__onlineNote mesh__D002105
% 221.25/221.40       use CADMIUM POISONING to search CADMIUM/poisoning 1966-76%A%  
% 221.25/221.40  |- skos__broader mesh__D002105smesh__D011041
% 221.25/221.40  |- skos__altLabel mesh__D002105 Itai-Itai
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002105 2004
% 221.25/221.40  |- mesh__recordAuthorizer mesh__D002105 sjn
% 221.25/221.40  |- skos__hiddenLabel mesh__D002105 Poisonings, Cadmium
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002105 2001
% 221.25/221.40  |- skos__prefLabel mesh__D002105 Cadmium Poisoning
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002105 2003
% 221.25/221.40  |- mesh__dateCreated mesh__D002105 1976-04-27
% 221.25/221.40  |- mesh__recordMaintainer mesh__D002105 ags
% 221.25/221.40  |- skos__altLabel mesh__D002105 Poisoning, Cadmium
% 221.25/221.40  |- skos__scopeNote mesh__D002105
% 221.25/221.40       Poisoning occurring after exposure to cadmium compounds or fumes. It may cause gastrointestinal syndromes, anemia, or pneumonitis.%A%    
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002105 2000
% 221.25/221.40  |- skos__hiddenLabel mesh__D002105 Itai Itai
% 221.25/221.40  |- mesh__historyNote mesh__D002105 77; was CADMIUM/poisoning 1966-76   
% 221.25/221.40  |- skos__annotation mesh__D002105
% 221.25/221.40       occup cadmium pois: coord IM with OCCUPATIONAL DISEASES %28%IM%29% but not also ENVIRONMENTAL EXPOSURE %28%see note there%29%%A%  
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002105 2006
% 221.25/221.40  |- skos__hiddenLabel mesh__D002105 Cadmium Poisonings
% 221.25/221.40  |- rdf__type mesh__D002105sskos__Concept
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002105 2005
% 221.25/221.40  |- skos__broader mesh__D007399smesh__D002453
% 221.25/221.40  |- skos__annotation mesh__D007399
% 221.25/221.40       specific phases are available; coordinate with specific cell /cytol; permitted with micro-organisms%A%  
% 221.25/221.40  |- skos__historyNote mesh__D007399 Mitosis %28%1968-1977%29%
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D007399 2005
% 221.25/221.40  |- skos__prefLabel mesh__D007399 Interphase
% 221.25/221.40  |- mesh__historyNote mesh__D007399
% 221.25/221.40       81%28%78%29%; was see under CELL CYCLE 1978-80   
% 221.25/221.40  |- mesh__recordOriginator mesh__D007399 AEP
% 221.25/221.40  |- skos__historyNote mesh__D007399 Cell Division %28%1966-1977%29%
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D007399 2006
% 221.25/221.40  |- mesh__recordMaintainer mesh__D007399 lkt
% 221.25/221.40  |- mesh__recordAuthorizer mesh__D007399 sjn
% 221.25/221.40  |- mesh__dateRevised mesh__D007399 2004-07-07
% 221.25/221.40  |- mesh__dateCreated mesh__D007399 1977-05-10
% 221.25/221.40  |- mesh__dateEstablished mesh__D007399 1981-01-01
% 221.25/221.40  |- skos__hiddenLabel mesh__D007399 Interphases
% 221.25/221.40  |- mesh__publicMeSHNote mesh__D007399
% 221.25/221.40       81; was see under CELL CYCLE 1978-80   
% 221.25/221.40  |- rdf__type mesh__D007399sskos__Concept
% 221.25/221.40  |- skos__scopeNote mesh__D007399
% 221.25/221.40       The interval between two successive CELL DIVISIONS during which the CHROMOSOMES are not individually distinguishable. It is composed of the G phases %28%G1 PHASE; G0 PHASE; AND G2 PHASE%29% and S PHASE %28%when DNA replication occurs%29%.%A%    
% 221.25/221.40  |- mesh__historyNote mesh__D012533
% 221.25/221.40       91%28%79%29%; was see under COCHLEA 1979-90   
% 221.25/221.40  |- skos__historyNote mesh__D012533 Cochlea %28%1966-1978%29%
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012533 2002
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012533 1991
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012533 2006
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012533 2001
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012533 1995
% 221.25/221.40  |- rdf__type mesh__D012533sskos__Concept
% 221.25/221.40  |- skos__scopeNote mesh__D012533
% 221.25/221.40       The lower tube of the cochlea, extending from the round window to the helicotrema and containing perilymph.%A%    
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012533 2005
% 221.25/221.40  |- mesh__recordAuthorizer mesh__D012533 PLS
% 221.25/221.40  |- mesh__recordOriginator mesh__D012533 RC
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012533 2000
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012533 1999
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012533 1994
% 221.25/221.40  |- mesh__dateCreated mesh__D012533 1978-05-19
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012533 2004
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012533 1998
% 221.25/221.40  |- mesh__publicMeSHNote mesh__D012533 91; was see under COCHLEA 1979-90   
% 221.25/221.40  |- mesh__recordMaintainer mesh__D012533 NLM
% 221.25/221.40  |- skos__prefLabel mesh__D012533 Scala Tympani
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012533 1993
% 221.25/221.40  |- skos__broader mesh__D012533smesh__D003051
% 221.25/221.40  |- mesh__dateRevised mesh__D012533 1990-04-13
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012533 2003
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012533 1997
% 221.25/221.40  |- skos__hiddenLabel mesh__D012533 Tympanus, Scala
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012533 1992
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012533 1996
% 221.25/221.40  |- mesh__dateEstablished mesh__D012533 1991-01-01
% 221.25/221.40  |- skos__hiddenLabel mesh__D012533 Scala Tympanus
% 221.25/221.40  |- skos__hiddenLabel mesh__D012533 Tympani, Scala
% 221.25/221.40  |- skos__broader mesh__D036981smesh__D005208
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D036981 2005
% 221.25/221.40  |- mesh__recordOriginator mesh__D036981 ags
% 221.25/221.40  |- skos__hiddenLabel mesh__D036981 Plantar Fasciitis, Chronic
% 221.25/221.40  |- mesh__recordMaintainer mesh__D036981 jls
% 221.25/221.40  |- skos__scopeNote mesh__D036981
% 221.25/221.40       Inflammation of the thick tissue on the bottom of the foot %28%plantar fascia%29% causing HEEL pain. The plantar fascia %28%also called plantar aponeurosis%29% are bands of fibrous tissue extending from the calcaneal tuberosity to the TOES. The etiology of plantar fasciitis remains controversial but is likely to involve a biomechanical imbalance. Though often presenting along with HEEL SPUR, they do not appear to be causally related.%A%    
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D036981 2006
% 221.25/221.40  |- skos__historyNote mesh__D036981 Fasciitis %28%1980-2002%29%
% 221.25/221.40  |- mesh__dateEstablished mesh__D036981 2003-01-01
% 221.25/221.40  |- skos__prefLabel mesh__D036981 Fasciitis, Plantar
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D036981 2005A
% 221.25/221.40  |- skos__broader mesh__D036981smesh__D005534
% 221.25/221.40  |- skos__related mesh__D036981smesh__D036982
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D036981 2003
% 221.25/221.40  |- mesh__recordAuthorizer mesh__D036981 jls
% 221.25/221.40  |- mesh__publicMeSHNote mesh__D036981 2003   
% 221.25/221.40  |- skos__hiddenLabel mesh__D036981 Fasciitis, Chronic Plantar
% 221.25/221.40  |- mesh__historyNote mesh__D036981 2003   
% 221.25/221.40  |- mesh__dateRevised mesh__D036981 2004-07-27
% 221.25/221.40  |- skos__altLabel mesh__D036981 Chronic Plantar Fasciitis
% 221.25/221.40  |- mesh__dateCreated mesh__D036981 2002-07-03
% 221.25/221.40  |- rdf__type mesh__D036981sskos__Concept
% 221.25/221.40  |- skos__historyNote mesh__D036981 Foot Diseases %28%1974-2002%29%
% 221.25/221.40  |- skos__altLabel mesh__D036981 Fasciitis, Plantar, Chronic
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D036981 2004
% 221.25/221.40  |- skos__altLabel mesh__D036981 Plantar Fasciitis
% 221.25/221.40  |- skos__altLabel mesh__D036183 EphB2 Protein
% 221.25/221.40  |- skos__hiddenLabel mesh__D036183 Receptors, EphB2
% 221.25/221.40  |- mesh__historyNote mesh__D036183
% 221.25/221.40       2003; use RECEPTOR, EPHB2 %28%NM%29% 1992-2002   
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D036183 2006
% 221.25/221.40  |- skos__historyNote mesh__D036183
% 221.25/221.40       Protein-Tyrosine Kinase %28%1992-1994%29%
% 221.25/221.40  |- skos__altLabel mesh__D036183 EphB2 Receptors
% 221.25/221.40  |- mesh__recordOriginator mesh__D036183 jmp
% 221.25/221.40  |- mesh__recordAuthorizer mesh__D036183 sjn
% 221.25/221.40  |- skos__altLabel mesh__D036183 EphB2 Receptor
% 221.25/221.40  |- skos__hiddenLabel mesh__D036183 EphB2 Tyrosine Kinase
% 221.25/221.40  |- skos__altLabel mesh__D036183 EphB2-Tyrosine Kinase
% 221.25/221.40  |- skos__altLabel mesh__D036183
% 221.25/221.40       Developmentally Regulated EPH-Related Tyrosine Kinase
% 221.25/221.40  |- skos__historyNote mesh__D036183
% 221.25/221.40       Receptor Protein-Tyrosine Kinases %28%1995-2002%29%
% 221.25/221.40  |- skos__historyNote mesh__D036183
% 221.25/221.40       Protein-Tyrosine Kinase %28%1996-2002%29%
% 221.25/221.40  |- skos__prefLabel mesh__D036183 Receptor, EphB2
% 221.25/221.40  |- rdf__type mesh__D036183sskos__Concept
% 221.25/221.40  |- skos__hiddenLabel mesh__D036183
% 221.25/221.40       Developmentally Regulated EPH Related Tyrosine Kinase
% 221.25/221.40  |- mesh__recordMaintainer mesh__D036183 jmp
% 221.25/221.40  |- mesh__dateEstablished mesh__D036183 2003-01-01
% 221.25/221.40  |- skos__broader mesh__D036183smesh__D036081
% 221.25/221.40  |- mesh__publicMeSHNote mesh__D036183
% 221.25/221.40       2003; EPHB2-TYROSINE KINASE %28%now RECEPTOR, EPHB2%29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1995-2002, PROTEIN-TYROSINE KINASE 1992-1994, DRT PROTEIN %28%now RECEPTOR, EPHB2%29% was indexed under PROTEIN-TYROSINE KINASE 1996-2002%A%  
% 221.25/221.40  |- skos__scopeNote mesh__D036183
% 221.25/221.40       An eph family receptor found widely expressed in embryonic and adult tissues. High levels of EphB2 receptor are observed in growing AXONS and NERVE FIBERS. Several isoforms of the protein exist due to multiple alternative mRNA splicing.%A%    
% 221.25/221.40  |- mesh__dateCreated mesh__D036183 2002-07-03
% 221.25/221.40  |- mesh__dateRevised mesh__D036183 2005-06-30
% 221.25/221.40  |- mesh__historyNote mesh__D008492 87   
% 221.25/221.40  |- skos__altLabel mesh__D008492 Informatics Computing, Medical
% 221.25/221.40  |- skos__annotation mesh__D008492 IM; DF: MED INFORMATICS COMPUTING   
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D008492 2002
% 221.25/221.40  |- skos__prefLabel mesh__D008492 Medical Informatics Computing
% 221.25/221.40  |- rdf__type mesh__D008492sskos__Concept
% 221.25/221.40  |- mesh__publicMeSHNote mesh__D008492 87   
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D008492 1996
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D008492 2000
% 221.25/221.40  |- mesh__recordAuthorizer mesh__D008492 PLS
% 221.25/221.40  |- skos__broader mesh__D008492smesh__D008490
% 221.25/221.40  |- mesh__dateCreated mesh__D008492 1986-06-18
% 221.25/221.40  |- skos__altLabel mesh__D008492 Computing, Medical Informatics
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D008492 2003
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D008492 1998
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D008492 1997
% 221.25/221.40  |- mesh__recordMaintainer mesh__D008492 TAP
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D008492 2001
% 221.25/221.40  |- mesh__dateRevised mesh__D008492 1992-05-14
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D008492 1994
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D008492 2005
% 221.25/221.40  |- skos__scopeNote mesh__D008492
% 221.25/221.40       Precise procedural mathematical and logical operations utilized in the study of medical information pertaining to health care.%A%    
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D008492 2004
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D008492 1993
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D008492 1999
% 221.25/221.40  |- mesh__dateEstablished mesh__D008492 1987-01-01
% 221.25/221.40  |- mesh__recordOriginator mesh__D008492 EC
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D008492 1995
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D008492 2006
% 221.25/221.40  |- skos__broader mesh__D022163smesh__D018699
% 221.25/221.40  |- mesh__historyNote mesh__D022163 2001   
% 221.25/221.40  |- mesh__dateRevised mesh__D022163 2003-07-09
% 221.25/221.40  |- skos__historyNote mesh__D022163 Coated Vesicles %28%1995-2000%29%
% 221.25/221.40  |- mesh__dateEstablished mesh__D022163 2001-01-01
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D022163 2005
% 221.25/221.40  |- skos__hiddenLabel mesh__D022163 Vesicle, Clathrin-Coated
% 221.25/221.40  |- skos__prefLabel mesh__D022163 Clathrin-Coated Vesicles
% 221.25/221.40  |- skos__hiddenLabel mesh__D022163 Vesicles, Clathrin-Coated
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D022163 2004
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D022163 2006
% 221.25/221.40  |- skos__historyNote mesh__D022163
% 221.25/221.40       Coated Pits, Cell-Membrane %28%1983-1994%29%
% 221.25/221.40  |- skos__hiddenLabel mesh__D022163 Clathrin Coated Vesicles
% 221.25/221.40  |- mesh__publicMeSHNote mesh__D022163 2001   
% 221.25/221.40  |- rdf__type mesh__D022163sskos__Concept
% 221.25/221.40  |- skos__scopeNote mesh__D022163
% 221.25/221.40       Vesicles formed when cell-membrane coated pits %28%COATED PITS, CELL-MEMBRANE%29% invaginate and pinch off. The outer surface of these vesicles is covered with a lattice-like network of the protein CLATHRIN. Shortly after formation, however, the clathrin coat is removed and the vesicles are referred to as ENDOSOMES.%A%    
% 221.25/221.40  |- mesh__dateCreated mesh__D022163 2000-06-22
% 221.25/221.40  |- skos__hiddenLabel mesh__D022163 Clathrin-Coated Vesicle
% 221.25/221.40  |- skos__scopeNote mesh__D016924
% 221.25/221.40       A species of ACTINOMYCES found in the oral cavity of man and hamsters. It has been isolated from actinomycotic lesions in swine, cats, and dogs and has been identified as a causative agent of animal diseases.%A%    
% 221.25/221.40  |- mesh__dateCreated mesh__D016924 1991-05-30
% 221.25/221.40  |- mesh__recordAuthorizer mesh__D016924 sjn
% 221.25/221.40  |- skos__prefLabel mesh__D016924 Actinomyces viscosus
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D016924 2006
% 221.25/221.40  |- skos__historyNote mesh__D016924 Actinomyces %28%1969-1991%29%
% 221.25/221.40  |- mesh__recordOriginator mesh__D016924 PXP
% 221.25/221.40  |- mesh__publicMeSHNote mesh__D016924 92   
% 221.25/221.40  |- rdf__type mesh__D016924sskos__Concept
% 221.25/221.40  |- skos__annotation mesh__D016924 infection: coord IM with ACTINOMYCOSIS   
% 221.25/221.40  |- skos__broader mesh__D016924smesh__D000190
% 221.25/221.40  |- mesh__dateEstablished mesh__D016924 1992-01-01
% 221.25/221.40  |- mesh__dateRevised mesh__D016924 2005-06-30
% 221.25/221.40  |- mesh__historyNote mesh__D016924 92   
% 221.25/221.40  |- mesh__recordMaintainer mesh__D016924 SYSTEM
% 221.25/221.40  |- mesh__recordOriginator mesh__D002904 NLM
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002904 2005
% 221.25/221.40  |- mesh__dateRevised mesh__D002904 2005-07-14
% 221.25/221.40  |- rdf__type mesh__D002904sskos__Concept
% 221.25/221.40  |- skos__hiddenLabel mesh__D002904 Chromosomes, Group G
% 221.25/221.40  |- mesh__recordAuthorizer mesh__D002904 ags
% 221.25/221.40  |- skos__broader mesh__D002904smesh__D002877
% 221.25/221.40  |- mesh__dateCreated mesh__D002904 1999-01-01
% 221.25/221.40  |- skos__hiddenLabel mesh__D002904 Chromosome, Group G
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002904 2006A
% 221.25/221.40  |- skos__historyNote mesh__D002904 Chromosomes %28%1966-1967%29%
% 221.25/221.40  |- mesh__dateEstablished mesh__D002904 1968-01-01
% 221.25/221.40  |- mesh__publicMeSHNote mesh__D002904
% 221.25/221.40       2001; see CHROMOSOMES, HUMAN, 21-22 1968-2001   
% 221.25/221.40  |- skos__hiddenLabel mesh__D002904 Group G Chromosome
% 221.25/221.40  |- skos__altLabel mesh__D002904 Group G Chromosomes
% 221.25/221.40  |- skos__altLabel mesh__D002904 Chromosomes G
% 221.25/221.40  |- skos__scopeNote mesh__D002904
% 221.25/221.40       The short, acrocentric human chromosomes, called group G in the human chromosome classification.  This group consists of chromosome pairs 21 and 22 and the Y chromosome.%A%    
% 221.25/221.40  |- skos__altLabel mesh__D002904 Chromosomes, Human, 21 22
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002904 2006
% 221.25/221.40  |- skos__prefLabel mesh__D002904 Chromosomes, Human, 21-22 and Y
% 221.25/221.40  |- mesh__historyNote mesh__D002904 2001%28%1968%29%   
% 221.25/221.40  |- mesh__recordMaintainer mesh__D002904 ags
% 221.25/221.40  |- skos__hiddenLabel mesh__D002106 Radioisotopes, Cadmium
% 221.25/221.40  |- skos__broader mesh__D002106smesh__D011868
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002106 2000
% 221.25/221.40  |- skos__historyNote mesh__D002106 Cadmium %28%1966-1987%29%
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002106 2003
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002106 1998
% 221.25/221.40  |- mesh__recordMaintainer mesh__D002106 TPW
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002106 1995
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002106 2006
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002106 1994
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002106 2002
% 221.25/221.40  |- mesh__recordOriginator mesh__D002106 RLS
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002106 1997
% 221.25/221.40  |- rdf__type mesh__D002106sskos__Concept
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002106 2005
% 221.25/221.40  |- skos__prefLabel mesh__D002106 Cadmium Radioisotopes
% 221.25/221.40  |- mesh__publicMeSHNote mesh__D002106 88   
% 221.25/221.40  |- mesh__dateEstablished mesh__D002106 1988-01-01
% 221.25/221.40  |- skos__historyNote mesh__D002106 Radioisotopes %28%1966-1987%29%
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002106 1996
% 221.25/221.40  |- mesh__historyNote mesh__D002106 88   
% 221.25/221.40  |- skos__scopeNote mesh__D002106
% 221.25/221.40       Unstable isotopes of cadmium that decay or disintegrate emitting radiation. Cd atoms with atomic weights 103-105, 107, 109, 115, and 117-119 are radioactive cadmium isotopes.%A%    
% 221.25/221.40  |- skos__annotation mesh__D002106
% 221.25/221.40       Cd-103-105, 107, 109, 115, 117-119; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 221.25/221.40  |- mesh__dateRevised mesh__D002106 1993-06-01
% 221.25/221.40  |- mesh__recordAuthorizer mesh__D002106 PLS
% 221.25/221.40  |- mesh__dateCreated mesh__D002106 1987-04-06
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002106 2001
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002106 2004
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D002106 1999
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D048208 2006
% 221.25/221.40  |- mesh__dateEstablished mesh__D048208 2005-01-01
% 221.25/221.40  |- mesh__recordMaintainer mesh__D048208 lkt
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D048208 2005
% 221.25/221.40  |- mesh__publicMeSHNote mesh__D048208 2005   
% 221.25/221.40  |- skos__hiddenLabel mesh__D048208 Nuchal Translucency Screenings
% 221.25/221.40  |- skos__historyNote mesh__D048208
% 221.25/221.40       Ultrasonography, Prenatal %28%1992-2004%29%
% 221.25/221.40  |- skos__altLabel mesh__D048208 Nuchal Translucency Screening
% 221.25/221.40  |- skos__prefLabel mesh__D048208 Nuchal Translucency Measurement
% 221.25/221.40  |- mesh__recordOriginator mesh__D048208 lkt
% 221.25/221.40  |- skos__scopeNote mesh__D048208
% 221.25/221.40       A prenatal ultrasonic measurement of the thickness or translucent area below the SKIN in the back of the fetal NECK, or nape of the neck, during the first 11-14 weeks of gestation %28%PREGNANCY TRIMESTER, FIRST%29%. Abnormal thickness or nuchal translucent measurements resulting from fluid collection, is associated with increased risks of CHROMOSOME ABNORMALITIES. %28%Nicolaides et al., 1992%29%%A%    
% 221.25/221.40  |- skos__hiddenLabel mesh__D048208 Translucency, Nuchal
% 221.25/221.40  |- skos__historyNote mesh__D048208 Neck/ultrasonography %28%1992-2004%29%
% 221.25/221.40  |- skos__hiddenLabel mesh__D048208 Nuchal Translucency Measurements
% 221.25/221.40  |- mesh__dateCreated mesh__D048208 2004-07-07
% 221.25/221.40  |- rdf__type mesh__D048208sskos__Concept
% 221.25/221.40  |- skos__hiddenLabel mesh__D048208 Measurement, Nuchal Translucency
% 221.25/221.40  |- mesh__recordAuthorizer mesh__D048208 sjn
% 221.25/221.40  |- mesh__historyNote mesh__D048208 2005   
% 221.25/221.40  |- skos__broader mesh__D048208smesh__D016216
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012534 2006
% 221.25/221.40  |- mesh__historyNote mesh__D012534
% 221.25/221.40       91%28%72%29%; was SCALING, DENTAL see under DENTAL PROPHYLAXIS 1972-90 %28%Prov 1972-74%29%%A%  
% 221.25/221.40  |- skos__hiddenLabel mesh__D012534 Root Scalings
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012534 1995
% 221.25/221.40  |- rdf__type mesh__D012534sskos__Concept
% 221.25/221.40  |- mesh__recordMaintainer mesh__D012534 MXR
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012534 2005
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012534 1999
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012534 1994
% 221.25/221.40  |- mesh__onlineNote mesh__D012534
% 221.25/221.40       use DENTAL SCALING to search SCALING, DENTAL 1972-90 %28%as Prov 1972-74%29%%A%  
% 221.25/221.40  |- skos__altLabel mesh__D012534 Root Scaling
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012534 2002
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012534 2004
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012534 1998
% 221.25/221.40  |- skos__hiddenLabel mesh__D012534 Supragingival Scaling
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012534 1993
% 221.25/221.40  |- skos__broader mesh__D012534smesh__D003777
% 221.25/221.40  |- skos__prefLabel mesh__D012534 Dental Scaling
% 221.25/221.40  |- skos__annotation mesh__D012534
% 221.25/221.40       do not use /util except by MeSH definition; do not confuse ROOT SCALING see DENTAL SCALING with ROOT PLANING; DF: DENT SCALING%A%  
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012534 2001
% 221.25/221.40  |- mesh__publicMeSHNote mesh__D012534
% 221.25/221.40       91; was SCALING, DENTAL see under DENTAL PROPHYLAXIS 1975-90%A%  
% 221.25/221.40  |- skos__altLabel mesh__D012534 Scaling, Dental
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012534 2003
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012534 1997
% 221.25/221.40  |- mesh__recordAuthorizer mesh__D012534 PLS
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012534 1992
% 221.25/221.40  |- skos__historyNote mesh__D012534 Dental Prophylaxis %28%1966-1971%29%
% 221.25/221.40  |- mesh__recordOriginator mesh__D012534 NLM
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012534 2000
% 221.25/221.40  |- mesh__activeMeSHYear mesh__D012534 1996
% 221.25/221.40  |- mesh__dateEstablished mesh__D012534 1991-01-01
% 221.25/221.40  |- skos__scopeNote mesh__D012534
% 221.25/221.40       Removal of dental plaque and dental calculus from the surface of a tooth, from the surface of a tooth apical to the gingival margin accumulated in periodontal pockets, or from the surface coronal to the gingival margin.%A%    
% 221.25/221.41  |- mesh__dateCreated mesh__D012534 1999-01-01
% 221.25/221.41  |- skos__hiddenLabel mesh__D012534 Subgingival Scaling
% 221.25/221.41  |- mesh__dateRevised mesh__D012534 1991-04-29
% 221.25/221.41  |- skos__hiddenLabel mesh__D012534 Scalings, Root
% 221.25/221.41  |- skos__hiddenLabel mesh__D036982 Heel Spurs
% 221.25/221.41  |- skos__broader mesh__D036982smesh__D005534
% 221.25/221.41  |- skos__hiddenLabel mesh__D036982 Calcaneal Spurs
% 221.25/221.41  |- skos__historyNote mesh__D036982 Exostoses %28%1970-2002%29%
% 221.25/221.41  |- mesh__dateCreated mesh__D036982 2002-07-03
% 221.25/221.41  |- mesh__historyNote mesh__D036982 2003   
% 221.25/221.41  |- skos__related mesh__D036982smesh__D036981
% 221.25/221.41  |- skos__hiddenLabel mesh__D036982 Spurs, Heel
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D036982 2003
% 221.25/221.41  |- mesh__publicMeSHNote mesh__D036982 2003   
% 221.25/221.41  |- skos__hiddenLabel mesh__D036982 Spur, Heel
% 221.25/221.41  |- rdf__type mesh__D036982sskos__Concept
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D036982 2004
% 221.25/221.41  |- mesh__dateEstablished mesh__D036982 2003-01-01
% 221.25/221.41  |- skos__prefLabel mesh__D036982 Heel Spur
% 221.25/221.41  |- skos__scopeNote mesh__D036982
% 221.25/221.41       A bony outgrowth on the lower surface of the CALCANEUS. Though often presenting along with plantar fasciitis %28%FASCIITIS, PLANTAR%29%, they are not considered causally related.%A%    
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D036982 2005
% 221.25/221.41  |- skos__annotation mesh__D036982
% 221.25/221.41       do not confuse with HEEL SPUR SYNDROME see FASCULITIS, PLANTAR%A%  
% 221.25/221.41  |- skos__altLabel mesh__D036982 Calcaneal Spur
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D036982 2006
% 221.25/221.41  |- skos__broader mesh__D036982smesh__D005096
% 221.25/221.41  |- skos__hiddenLabel mesh__D036982 Spurs, Calcaneal
% 221.25/221.41  |- skos__hiddenLabel mesh__D036982 Spur, Calcaneal
% 221.25/221.41  |- skos__broader mesh__D008493smesh__D007391
% 221.25/221.41  |- mesh__dateRevised mesh__D008493 2002-07-03
% 221.25/221.41  |- rdf__type mesh__D008493sskos__Concept
% 221.25/221.41  |- skos__hiddenLabel mesh__D008493 Official Medical Mission
% 221.25/221.41  |- mesh__recordOriginator mesh__D008493 NLM
% 221.25/221.41  |- skos__altLabel mesh__D008493 Missions, Official Medical
% 221.25/221.41  |- mesh__dateEstablished mesh__D008493 1966-01-01
% 221.25/221.41  |- mesh__recordMaintainer mesh__D008493 hjn
% 221.25/221.41  |- mesh__onlineNote mesh__D008493
% 221.25/221.41       use MEDICAL MISSIONS, OFFICIAL to search MEDICAL MISSIONS 1966-73%A%  
% 221.25/221.41  |- skos__hiddenLabel mesh__D008493 Medical Mission, Official
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008493 2003
% 221.25/221.41  |- mesh__historyNote mesh__D008493
% 221.25/221.41       74; MEDICAL MISSIONS was heading 1966-73   
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008493 2005
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008493 2004
% 221.25/221.41  |- mesh__publicMeSHNote mesh__D008493
% 221.25/221.41       74; MEDICAL MISSIONS was heading 1966-73   
% 221.25/221.41  |- skos__prefLabel mesh__D008493 Medical Missions, Official
% 221.25/221.41  |- mesh__recordAuthorizer mesh__D008493 sjn
% 221.25/221.41  |- skos__hiddenLabel mesh__D008493 Mission, Official Medical
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008493 2006
% 221.25/221.41  |- skos__annotation mesh__D008493
% 221.25/221.41       do not confuse with MISSIONS AND MISSIONARIES; DF: MED MISSIONS OFFICIAL%A%  
% 221.25/221.41  |- skos__scopeNote mesh__D008493
% 221.25/221.41       Travel by a group of physicians to a foreign country for the purpose of making a special study or of undertaking a special project of a short-term duration; not to be confused with MISSIONS AND MISSIONARIES which covers permanent medical establishments and personnel maintained by religious organizations.%A%    
% 221.25/221.41  |- skos__altLabel mesh__D008493 Official Medical Missions
% 221.25/221.41  |- mesh__dateCreated mesh__D008493 1999-01-01
% 221.25/221.41  |- mesh__dateRevised mesh__D016925 2005-06-30
% 221.25/221.41  |- rdf__type mesh__D016925sskos__Concept
% 221.25/221.41  |- mesh__recordOriginator mesh__D016925 PXP
% 221.25/221.41  |- skos__annotation mesh__D016925
% 221.25/221.41       infection: coord IM with CORYNEBACTERIUM INFECTIONS %28%IM%29%; DF: CORYNEBACT PSEUDOTUBERC%A%  
% 221.25/221.41  |- skos__prefLabel mesh__D016925 Corynebacterium pseudotuberculosis
% 221.25/221.41  |- mesh__historyNote mesh__D016925 92   
% 221.25/221.41  |- skos__historyNote mesh__D016925 Corynebacterium %28%1967-1991%29%
% 221.25/221.41  |- mesh__dateCreated mesh__D016925 1991-06-21
% 221.25/221.41  |- skos__scopeNote mesh__D016925
% 221.25/221.41       A species of gram-positive, asporogenous bacteria that was originally isolated from necrotic areas in the kidney of a sheep. It may cause ulcerative lymphangitis, abscesses, and other chronic purulent infections in sheep, horses, and other warm-blooded animals. Human disease may form from contact with infected animals.%A%    
% 221.25/221.41  |- mesh__recordAuthorizer mesh__D016925 sjn
% 221.25/221.41  |- mesh__recordMaintainer mesh__D016925 SYSTEM
% 221.25/221.41  |- mesh__publicMeSHNote mesh__D016925 92   
% 221.25/221.41  |- mesh__dateEstablished mesh__D016925 1992-01-01
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D016925 2006
% 221.25/221.41  |- skos__broader mesh__D016925smesh__D003352
% 221.25/221.41  |- skos__hiddenLabel mesh__D016127 Prolapse, Heart Valve
% 221.25/221.41  |- mesh__recordAuthorizer mesh__D016127 sjn
% 221.25/221.41  |- mesh__dateEstablished mesh__D016127 1991-01-01
% 221.25/221.41  |- mesh__publicMeSHNote mesh__D016127 91   
% 221.25/221.41  |- mesh__recordMaintainer mesh__D016127 lkt
% 221.25/221.41  |- skos__annotation mesh__D016127
% 221.25/221.41       GEN or unspecified: prefer specific valve prolapse   
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D016127 2005
% 221.25/221.41  |- mesh__recordOriginator mesh__D016127 TGC
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D016127 2006
% 221.25/221.41  |- skos__hiddenLabel mesh__D016127 Prolapses, Heart Valve
% 221.25/221.41  |- skos__prefLabel mesh__D016127 Heart Valve Prolapse
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D016127 2004
% 221.25/221.41  |- skos__historyNote mesh__D016127 Heart Valve Diseases %28%1967-1990%29%
% 221.25/221.41  |- skos__hiddenLabel mesh__D016127 Valve Prolapse, Heart
% 221.25/221.41  |- skos__hiddenLabel mesh__D016127 Heart Valve Prolapses
% 221.25/221.41  |- mesh__dateRevised mesh__D016127 2003-07-09
% 221.25/221.41  |- rdf__type mesh__D016127sskos__Concept
% 221.25/221.41  |- mesh__dateCreated mesh__D016127 1990-03-23
% 221.25/221.41  |- skos__broader mesh__D016127smesh__D006349
% 221.25/221.41  |- skos__hiddenLabel mesh__D016127 Valve Prolapses, Heart
% 221.25/221.41  |- mesh__historyNote mesh__D016127 91   
% 221.25/221.41  |- skos__scopeNote mesh__D016127
% 221.25/221.41       Displacement of the valves of the heart.     
% 221.25/221.41  |- skos__scopeNote mesh__D002905
% 221.25/221.41       The large, submetacentric human chromosomes, called group B in the human chromosome classification.  This group consists of chromosome pairs 4 and 5.%A%    
% 221.25/221.41  |- mesh__recordAuthorizer mesh__D002905 ags
% 221.25/221.41  |- rdf__type mesh__D002905sskos__Concept
% 221.25/221.41  |- skos__historyNote mesh__D002905 Chromosomes %28%1966-1967%29%
% 221.25/221.41  |- skos__altLabel mesh__D002905 Group B Chromosomes
% 221.25/221.41  |- mesh__dateCreated mesh__D002905 1999-01-01
% 221.25/221.41  |- mesh__dateEstablished mesh__D002905 1968-01-01
% 221.25/221.41  |- mesh__recordOriginator mesh__D002905 NLM
% 221.25/221.41  |- skos__prefLabel mesh__D002905 Chromosomes, Human, 4-5
% 221.25/221.41  |- mesh__publicMeSHNote mesh__D002905 68   
% 221.25/221.41  |- skos__hiddenLabel mesh__D002905 Group B Chromosome
% 221.25/221.41  |- skos__hiddenLabel mesh__D002905 Chromosome, Group B
% 221.25/221.41  |- skos__broader mesh__D002905smesh__D002877
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D002905 2006
% 221.25/221.41  |- skos__hiddenLabel mesh__D002905 Chromosomes, Group B
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D002905 2006A
% 221.25/221.41  |- mesh__recordMaintainer mesh__D002905 ags
% 221.25/221.41  |- skos__altLabel mesh__D002905 Chromosomes B
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D002905 2005
% 221.25/221.41  |- mesh__dateRevised mesh__D002905 2005-07-11
% 221.25/221.41  |- mesh__historyNote mesh__D002905 68   
% 221.25/221.41  |- mesh__dateEstablished mesh__D002107 1979-01-01
% 221.25/221.41  |- mesh__recordAuthorizer mesh__D002107 sjn
% 221.25/221.41  |- skos__prefLabel mesh__D002107 Caenorhabditis
% 221.25/221.41  |- mesh__recordMaintainer mesh__D002107 ags
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D002107 2006
% 221.25/221.41  |- rdf__type mesh__D002107sskos__Concept
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D002107 2005
% 221.25/221.41  |- skos__broader mesh__D002107smesh__D017172
% 221.25/221.41  |- mesh__dateRevised mesh__D002107 2003-07-09
% 221.25/221.41  |- mesh__recordOriginator mesh__D002107 AEP
% 221.25/221.41  |- skos__annotation mesh__D002107 a genus of nematodes used in exper   
% 221.25/221.41  |- mesh__dateCreated mesh__D002107 1978-03-02
% 221.25/221.41  |- mesh__publicMeSHNote mesh__D002107 79   
% 221.25/221.41  |- mesh__historyNote mesh__D002107 79   
% 221.25/221.41  |- skos__historyNote mesh__D002107 Nematoda %28%1966-1978%29%
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D002107 2004
% 221.25/221.41  |- skos__scopeNote mesh__D002107
% 221.25/221.41       A genus of small free-living nematodes. Two species, CAENORHABDITIS ELEGANS and C. briggsae are much used in studies of genetics, development, aging, muscle chemistry, and neuroanatomy.%A%    
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D048209 2006
% 221.25/221.41  |- mesh__recordMaintainer mesh__D048209 ags
% 221.25/221.41  |- mesh__recordOriginator mesh__D048209 ags
% 221.25/221.41  |- mesh__publicMeSHNote mesh__D048209 2005   
% 221.25/221.41  |- skos__historyNote mesh__D048209 Echinococcus %28%1965-2004%29%
% 221.25/221.41  |- mesh__dateEstablished mesh__D048209 2005-01-01
% 221.25/221.41  |- mesh__recordAuthorizer mesh__D048209 sjn
% 221.25/221.41  |- mesh__historyNote mesh__D048209 2005   
% 221.25/221.41  |- mesh__dateCreated mesh__D048209 2004-07-07
% 221.25/221.41  |- skos__broader mesh__D048209smesh__D004446
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D048209 2005
% 221.25/221.41  |- rdf__type mesh__D048209sskos__Concept
% 221.25/221.41  |- skos__annotation mesh__D048209
% 221.25/221.41       infection: coordinate %28%IM%29% with ECHINOCOCCOSIS %28%IM%29% or specifics %28%IM%29%%A%  
% 221.25/221.41  |- skos__scopeNote mesh__D048209
% 221.25/221.41       A species of hydatid tapeworm %28%class CESTODA%29% in the family Taeniidae, whose adult form infects the DIGESTIVE TRACT of DOGS, other canines, and CATS. The larval form infects SHEEP; PIGS; HORSES; and may infect humans, where it migrates to various organs and forms permanent HYDATID CYSTS.%A%    
% 221.25/221.41  |- skos__prefLabel mesh__D048209 Echinococcus granulosus
% 221.25/221.41  |- mesh__recordOriginator mesh__D012535 NLM
% 221.25/221.41  |- mesh__recordAuthorizer mesh__D012535 jls
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D012535 2006
% 221.25/221.41  |- rdf__type mesh__D012535sskos__Concept
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D012535 2003
% 221.25/221.41  |- skos__hiddenLabel mesh__D012535 Scalps
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D012535 2004
% 221.25/221.41  |- skos__annotation mesh__D012535
% 221.25/221.41       diseases of skin or hair of scalp = SCALP DERMATOSES; neopl of scalp = SKIN NEOPLASMS %28%IM%29% + SCALP %28%IM%29% + HEAD AND NECK NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 221.25/221.41  |- skos__scopeNote mesh__D012535
% 221.25/221.41       The outer covering of the calvaria. It is composed of several layers: SKIN;  subcutaneous connective tissue; the occipitofrontal muscle which includes the tendinous galea aponeurotica; loose connective tissue; and the pericranium %28%the PERIOSTEUM of the SKULL%29%.%A%    
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D012535 2005A
% 221.25/221.41  |- mesh__dateCreated mesh__D012535 1999-01-01
% 221.25/221.41  |- mesh__recordMaintainer mesh__D012535 jls
% 221.25/221.41  |- skos__broader mesh__D012535smesh__D006257
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D012535 2005
% 221.25/221.41  |- skos__prefLabel mesh__D012535 Scalp
% 221.25/221.41  |- mesh__dateRevised mesh__D012535 2004-08-02
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D017220 2002
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D017220 1998
% 221.25/221.41  |- mesh__recordAuthorizer mesh__D017220 SJN
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D017220 2006
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D017220 1999
% 221.25/221.41  |- skos__altLabel mesh__D017220 Bonding Agents, Dentin
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D017220 2003
% 221.25/221.41  |- skos__hiddenLabel mesh__D017220 Agents, Dentin Bonding
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D017220 2000
% 221.25/221.41  |- mesh__recordOriginator mesh__D017220 MXR
% 221.25/221.41  |- skos__broader mesh__D017220smesh__D003738
% 221.25/221.41  |- rdf__type mesh__D017220sskos__Concept
% 221.25/221.41  |- skos__historyNote mesh__D017220 Composite Resins %28%1983-1992%29%
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D017220 2004
% 221.25/221.41  |- skos__annotation mesh__D017220 D25-26 qualif   
% 221.25/221.41  |- mesh__recordMaintainer mesh__D017220 ADP
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D017220 2001
% 221.25/221.41  |- skos__hiddenLabel mesh__D017220 Dentin Bonding Agents
% 221.25/221.41  |- mesh__dateRevised mesh__D017220 1997-06-20
% 221.25/221.41  |- mesh__dateEstablished mesh__D017220 1993-01-01
% 221.25/221.41  |- skos__historyNote mesh__D017220 Dental Bonding %28%1976-1992%29%
% 221.25/221.41  |- mesh__dateCreated mesh__D017220 1992-05-20
% 221.25/221.41  |- skos__hiddenLabel mesh__D017220 Agents, Dentin-Bonding
% 221.25/221.41  |- mesh__historyNote mesh__D017220 93   
% 221.25/221.41  |- mesh__publicMeSHNote mesh__D017220 93   
% 221.25/221.41  |- skos__scopeNote mesh__D017220
% 221.25/221.41       Cements that act through infiltration and polymerization within the dentinal matrix and are used for dental restoration. They can be adhesive resins themselves, adhesion-promoting monomers, or polymerization initiators that act in concert with other agents to form a dentin-bonding system.%A%    
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D017220 2005
% 221.25/221.41  |- skos__prefLabel mesh__D017220 Dentin-Bonding Agents
% 221.25/221.41  |- rdf__type mesh__D003200sskos__Concept
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D003200 2000
% 221.25/221.41  |- mesh__dateEstablished mesh__D003200 1987-01-01
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D003200 1998
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D003200 2001
% 221.25/221.41  |- skos__broader mesh__D003200smesh__D013663
% 221.25/221.41  |- skos__prefLabel mesh__D003200 Computer User Training
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D003200 1999
% 221.25/221.41  |- skos__hiddenLabel mesh__D003200 Computer User Trainings
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D003200 2003
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D003200 2005
% 221.25/221.41  |- skos__hiddenLabel mesh__D003200 User Trainings, Computer
% 221.25/221.41  |- skos__hiddenLabel mesh__D003200 User Training, Computer
% 221.25/221.41  |- mesh__recordAuthorizer mesh__D003200 SJN
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D003200 2004
% 221.25/221.41  |- mesh__recordOriginator mesh__D003200 EC
% 221.25/221.41  |- skos__scopeNote mesh__D003200
% 221.25/221.41       Process of teaching a person to interact and communicate with a computer.%A%    
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D003200 2002
% 221.25/221.41  |- mesh__dateCreated mesh__D003200 1986-06-18
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D003200 2006
% 221.25/221.41  |- skos__hiddenLabel mesh__D003200 Training, Computer User
% 221.25/221.41  |- mesh__publicMeSHNote mesh__D003200 87   
% 221.25/221.41  |- skos__hiddenLabel mesh__D003200 Trainings, Computer User
% 221.25/221.41  |- mesh__recordMaintainer mesh__D003200 PXP
% 221.25/221.41  |- mesh__historyNote mesh__D003200 87   
% 221.25/221.41  |- mesh__dateRevised mesh__D003200 1997-06-20
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008494 2006
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008494 1998
% 221.25/221.41  |- skos__prefLabel mesh__D008494 Medical Office Buildings
% 221.25/221.41  |- mesh__recordOriginator mesh__D008494 EC
% 221.25/221.41  |- mesh__publicMeSHNote mesh__D008494
% 221.25/221.41       91; was see under HEALTH FACILITIES 1980-90   
% 221.25/221.41  |- skos__hiddenLabel mesh__D008494 Medical Office Building
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008494 2002
% 221.25/221.41  |- mesh__recordMaintainer mesh__D008494 TGC
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008494 1994
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008494 2005
% 221.25/221.41  |- skos__scopeNote mesh__D008494
% 221.25/221.41       Office and laboratory facilities constructed for the use of physicians and other health personnel.%A%    
% 221.25/221.41  |- mesh__historyNote mesh__D008494
% 221.25/221.41       91%28%80%29%; was see under HEALTH FACILITIES 1980-90   
% 221.25/221.41  |- skos__hiddenLabel mesh__D008494 Building, Medical Office
% 221.25/221.41  |- rdf__type mesh__D008494sskos__Concept
% 221.25/221.41  |- skos__hiddenLabel mesh__D008494 Office Building, Medical
% 221.25/221.41  |- skos__historyNote mesh__D008494 Health Facilities %28%1968-1979%29%
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008494 1997
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008494 2001
% 221.25/221.41  |- skos__annotation mesh__D008494 DF: MED OFFICE BUILDINGS   
% 221.25/221.41  |- mesh__dateEstablished mesh__D008494 1991-01-01
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008494 2004
% 221.25/221.41  |- mesh__dateRevised mesh__D008494 1992-05-14
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008494 1996
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008494 1993
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008494 2000
% 221.25/221.41  |- mesh__recordAuthorizer mesh__D008494 PLS
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008494 2003
% 221.25/221.41  |- skos__hiddenLabel mesh__D008494 Buildings, Medical Office
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008494 1999
% 221.25/221.41  |- skos__altLabel mesh__D008494 Office Buildings, Medical
% 221.25/221.41  |- skos__broader mesh__D008494smesh__D006268
% 221.25/221.41  |- mesh__dateCreated mesh__D008494 1979-04-11
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008494 1995
% 221.25/221.41  |- mesh__publicMeSHNote mesh__D016926 92   
% 221.25/221.41  |- mesh__dateEstablished mesh__D016926 1992-01-01
% 221.25/221.41  |- mesh__historyNote mesh__D016926 92   
% 221.25/221.41  |- mesh__dateRevised mesh__D016926 2005-06-30
% 221.25/221.41  |- skos__broader mesh__D016926smesh__D009170
% 221.25/221.41  |- mesh__recordMaintainer mesh__D016926 SYSTEM
% 221.25/221.41  |- skos__altLabel mesh__D016926 Mycobacterium chelonei
% 221.25/221.41  |- skos__scopeNote mesh__D016926
% 221.25/221.41       A species of gram-positive, aerobic bacteria commonly found in soil and occasionally isolated from sputum. It causes postoperative wound infections as well as gluteal abscesses.%A%    
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D016926 2006
% 221.25/221.41  |- mesh__dateCreated mesh__D016926 1991-05-30
% 221.25/221.41  |- skos__historyNote mesh__D016926
% 221.25/221.41       Mycobacterium, Atypical %28%1986-1991%29%
% 221.25/221.41  |- mesh__recordAuthorizer mesh__D016926 sjn
% 221.25/221.41  |- skos__annotation mesh__D016926
% 221.25/221.41       infection: coord IM with MYCOBACTERIUM INFECTIONS, ATYPICAL %28%IM%29%; DF: MYCOBACT CHELONAE%A%  
% 221.25/221.41  |- rdf__type mesh__D016926sskos__Concept
% 221.25/221.41  |- skos__prefLabel mesh__D016926 Mycobacterium chelonae
% 221.25/221.41  |- mesh__recordOriginator mesh__D016926 PXP
% 221.25/221.41  |- skos__broader mesh__D002906smesh__D002877
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D002906 2006A
% 221.25/221.41  |- mesh__historyNote mesh__D002906 2002%28%1968%29%   
% 221.25/221.41  |- skos__prefLabel mesh__D002906 Chromosomes, Human, 6-12 and X
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D002906 2006
% 221.25/221.41  |- mesh__dateRevised mesh__D002906 2005-07-11
% 221.25/221.41  |- skos__scopeNote mesh__D002906
% 221.25/221.41       The medium-sized, submetacentric human chromosomes, called group C in the human chromosome classification.  This group consists of chromosome pairs 6, 7, 8, 9, 10, 11, and 12 and the X chromosome.%A%    
% 221.25/221.41  |- mesh__publicMeSHNote mesh__D002906
% 221.25/221.41       2002; see CHROMOSOMES, HUMAN, 6-12 1968-2001   
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D002906 2005
% 221.25/221.41  |- mesh__recordMaintainer mesh__D002906 ags
% 221.25/221.41  |- skos__hiddenLabel mesh__D002906 Chromosome, Group C
% 221.25/221.41  |- skos__hiddenLabel mesh__D002906 Group C Chromosome
% 221.25/221.41  |- mesh__recordAuthorizer mesh__D002906 ags
% 221.25/221.41  |- mesh__recordOriginator mesh__D002906 NLM
% 221.25/221.41  |- skos__altLabel mesh__D002906 Group C Chromosomes
% 221.25/221.41  |- skos__hiddenLabel mesh__D002906 Chromosomes, Group C
% 221.25/221.41  |- rdf__type mesh__D002906sskos__Concept
% 221.25/221.41  |- mesh__dateCreated mesh__D002906 1999-01-01
% 221.25/221.41  |- mesh__dateEstablished mesh__D002906 1968-01-01
% 221.25/221.41  |- skos__altLabel mesh__D002906 Chromosomes C
% 221.25/221.41  |- skos__historyNote mesh__D002906 Chromosomes %28%1966-1967%29%
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D002108 2005
% 221.25/221.41  |- skos__scopeNote mesh__D002108
% 221.25/221.41       A specific decapeptide obtained from the skin of Hila caerulea, an Australian amphibian. Caerulein is similar in action and composition to CHOLECYSTOKININ. It stimulates gastric, biliary, and pancreatic secretion; and certain smooth muscle. It is used in paralytic ileus and as diagnostic aid in pancreatic malfunction.%A%    
% 221.25/221.41  |- mesh__dateRevised mesh__D002108 2001-07-25
% 221.25/221.41  |- skos__prefLabel mesh__D002108 Caerulein
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D002108 2006
% 221.25/221.41  |- mesh__dateCreated mesh__D002108 1999-01-01
% 221.25/221.41  |- mesh__dateEstablished mesh__D002108 1974-01-01
% 221.25/221.41  |- rdf__type mesh__D002108sskos__Concept
% 221.25/221.41  |- mesh__recordAuthorizer mesh__D002108 sjn
% 221.25/221.41  |- mesh__historyNote mesh__D002108 74%28%72%29%   
% 221.25/221.41  |- mesh__recordOriginator mesh__D002108 NLM
% 221.25/221.41  |- skos__broader mesh__D002108smesh__D009842
% 221.25/221.41  |- skos__altLabel mesh__D002108 Cerulein
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D002108 2003
% 221.25/221.41  |- skos__annotation mesh__D002108
% 221.25/221.41       /biosyn /physiol permitted; do not confuse X ref CERULEIN with CERULENIN%A%  
% 221.25/221.41  |- skos__historyNote mesh__D002108
% 221.25/221.41       Gastrointestinal Agents %28%1967-1971%29%
% 221.25/221.41  |- skos__altLabel mesh__D002108 Ceruletide
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D002108 2002
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D002108 2004
% 221.25/221.41  |- skos__altLabel mesh__D002108 Ceruletid
% 221.25/221.41  |- skos__historyNote mesh__D002108 Peptides %28%1966-1971%29%
% 221.25/221.41  |- mesh__publicMeSHNote mesh__D002108 74   
% 221.25/221.41  |- mesh__recordMaintainer mesh__D002108 jmp
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D012536 1999
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D012536 2001
% 221.25/221.41  |- skos__annotation mesh__D012536
% 221.25/221.41       consider synonym for dermatitis of scalp %26% do not add DERMATITIS unless one of the specific DERMATITIS terms in MeSH; does not include neopl of scalp: see note on SCALP%A%  
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D012536 2004
% 221.25/221.41  |- skos__altLabel mesh__D012536 Scalp Dermatosis
% 221.25/221.41  |- mesh__recordOriginator mesh__D012536 NLM
% 221.25/221.41  |- mesh__dateCreated mesh__D012536 1999-01-01
% 221.25/221.41  |- skos__prefLabel mesh__D012536 Scalp Dermatoses
% 221.25/221.41  |- skos__hiddenLabel mesh__D012536 Dermatosis, Scalp
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D012536 1997
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D012536 2002
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D012536 2005
% 221.25/221.41  |- mesh__recordMaintainer mesh__D012536 TGC
% 221.25/221.41  |- mesh__dateRevised mesh__D012536 1996-06-10
% 221.25/221.41  |- skos__broader mesh__D012536smesh__D012871
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D012536 1998
% 221.25/221.41  |- mesh__recordAuthorizer mesh__D012536 PLS
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D012536 2006
% 221.25/221.41  |- rdf__type mesh__D012536sskos__Concept
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D012536 2000
% 221.25/221.41  |- skos__hiddenLabel mesh__D012536 Dermatoses, Scalp
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D012536 2003
% 221.25/221.41  |- mesh__dateRevised mesh__D017221 2003-07-09
% 221.25/221.41  |- mesh__onlineNote mesh__D017221
% 221.25/221.41       use NECATOR to search NECATOR AMERICANUS 1979-92 %26% HOOKWORM, NEW WORLD 1979-93%A%  
% 221.25/221.41  |- skos__broader mesh__D017221smesh__D009331
% 221.25/221.41  |- rdf__type mesh__D017221sskos__Concept
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D017221 2004
% 221.25/221.41  |- skos__annotation mesh__D017221
% 221.25/221.41       a species of intestinal hookworm; coord IM with NECATORIASIS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 221.25/221.41  |- mesh__recordMaintainer mesh__D017221 ags
% 221.25/221.41  |- mesh__dateCreated mesh__D017221 1992-05-22
% 221.25/221.41  |- skos__prefLabel mesh__D017221 Necator americanus
% 221.25/221.41  |- mesh__recordAuthorizer mesh__D017221 sjn
% 221.25/221.41  |- mesh__publicMeSHNote mesh__D017221
% 221.25/221.41       93; was see NECATOR 1979-92; HOOKWORM, NEW WORLD was see NECATOR 1979-93%A%  
% 221.25/221.41  |- skos__scopeNote mesh__D017221
% 221.25/221.41       A common parasite of humans in the moist tropics and subtropics. These organisms attach to villi in the small intestine and suck blood causing diarrhea, anorexia, and anemia.%A%    
% 221.25/221.41  |- mesh__historyNote mesh__D017221
% 221.25/221.41       93; was see NECATOR 1979-92; HOOKWORM, NEW WORLD was see NECATOR 1979-93%A%  
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D017221 2005
% 221.25/221.41  |- skos__historyNote mesh__D017221 Necator %28%1966-1992%29%
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D017221 2006
% 221.25/221.41  |- mesh__recordOriginator mesh__D017221 PXP
% 221.25/221.41  |- mesh__dateEstablished mesh__D017221 1993-01-01
% 221.25/221.41  |- skos__altLabel mesh__D017221 Hookworm, New World
% 221.25/221.41  |- mesh__recordMaintainer mesh__D003201 jls
% 221.25/221.41  |- skos__prefLabel mesh__D003201 Computers
% 221.25/221.41  |- skos__hiddenLabel mesh__D003201 Calculator, Programmable
% 221.25/221.41  |- skos__hiddenLabel mesh__D003201 Programmable Calculator
% 221.25/221.41  |- skos__hiddenLabel mesh__D003201 Computer
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D003201 2005
% 221.25/221.41  |- skos__altLabel mesh__D003201 Computer Hardware
% 221.25/221.41  |- mesh__recordAuthorizer mesh__D003201 sjn
% 221.25/221.41  |- mesh__dateRevised mesh__D003201 2004-07-07
% 221.25/221.41  |- skos__broader mesh__D003201smesh__D003199
% 221.25/221.41  |- skos__related mesh__D003201smesh__D001330
% 221.25/221.41  |- skos__hiddenLabel mesh__D003201 Computer, Digital
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D003201 2006
% 221.25/221.41  |- skos__related mesh__D003201smesh__D001292
% 221.25/221.41  |- skos__hiddenLabel mesh__D003201 Digital Computer
% 221.25/221.41  |- mesh__dateCreated mesh__D003201 1999-01-01
% 221.25/221.41  |- skos__hiddenLabel mesh__D003201 Programmable Calculators
% 221.25/221.41  |- mesh__onlineNote mesh__D003201
% 221.25/221.41       use COMPUTERS to search COMPUTERS, DIGITAL 1966-77 %28%as Prov 1964-65%29%%A%  
% 221.25/221.41  |- skos__annotation mesh__D003201
% 221.25/221.41       GEN; use of computers in medicine: do not coord with MEDICINE; for processing of data by computer, COMPUTER DATA PROCESSING see AUTOMATIC DATA PROCESSING is available%A%  
% 221.25/221.41  |- mesh__dateEstablished mesh__D003201 1966-01-01
% 221.25/221.41  |- skos__hiddenLabel mesh__D003201 Digital Computers
% 221.25/221.41  |- mesh__recordOriginator mesh__D003201 NLM
% 221.25/221.41  |- rdf__type mesh__D003201sskos__Concept
% 221.25/221.41  |- mesh__publicMeSHNote mesh__D003201
% 221.25/221.41       66; COMPUTERS, DIGITAL was heading 1966-77   
% 221.25/221.41  |- mesh__historyNote mesh__D003201
% 221.25/221.41       66%28%64%29%; COMPUTERS, DIGITAL was heading 1964-77 %28%Prov 1964-65%29%%A%  
% 221.25/221.41  |- rdf__type mesh__D008495sskos__Concept
% 221.25/221.41  |- skos__annotation mesh__D008495
% 221.25/221.41       SPEC: SPEC qualif; RADIATION ONCOLOGY is also available; DF: MED ONCOL%A%  
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008495 1997
% 221.25/221.41  |- skos__altLabel mesh__D008495 Oncology, Medical
% 221.25/221.41  |- mesh__recordOriginator mesh__D008495 EC
% 221.25/221.41  |- skos__historyNote mesh__D008495 Internal Medicine %28%1966-1978%29%
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008495 2002
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008495 2004
% 221.25/221.41  |- skos__broader mesh__D008495smesh__D007388
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008495 1996
% 221.25/221.41  |- mesh__dateEstablished mesh__D008495 1979-01-01
% 221.25/221.41  |- skos__prefLabel mesh__D008495 Medical Oncology
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008495 2003
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008495 1999
% 221.25/221.41  |- mesh__dateCreated mesh__D008495 1978-05-09
% 221.25/221.41  |- skos__related mesh__D008495smesh__D009369
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008495 2001
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008495 1995
% 221.25/221.41  |- mesh__historyNote mesh__D008495 79   
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008495 2006
% 221.25/221.41  |- skos__historyNote mesh__D008495 Specialties, Medical %28%1968-1978%29%
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008495 1998
% 221.25/221.41  |- mesh__dateRevised mesh__D008495 1994-06-03
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008495 2000
% 221.25/221.41  |- mesh__recordAuthorizer mesh__D008495 PLS
% 221.25/221.41  |- skos__scopeNote mesh__D008495
% 221.25/221.41       A subspecialty of internal medicine concerned with the study of neoplasms.%A%    
% 221.25/221.41  |- mesh__recordMaintainer mesh__D008495 TGC
% 221.25/221.41  |- mesh__publicMeSHNote mesh__D008495 79   
% 221.25/221.41  |- mesh__activeMeSHYear mesh__D008495 2005
% 221.25/221.41  |- mesh__dateCreated mesh__D016927 1991-05-30
% 221.25/221.42  |- skos__annotation mesh__D016927
% 221.25/221.42       non-pathogenic for humans; infection = PARATUBERCULOSIS; DF: MYCOBACT PARATUBERC%A%  
% 221.25/221.42  |- mesh__recordAuthorizer mesh__D016927 sjn
% 221.25/221.42  |- mesh__historyNote mesh__D016927 92   
% 221.25/221.42  |- mesh__dateEstablished mesh__D016927 1992-01-01
% 221.25/221.42  |- mesh__recordOriginator mesh__D016927 PXP
% 221.25/221.42  |- mesh__publicMeSHNote mesh__D016927 92   
% 221.25/221.42  |- skos__prefLabel mesh__D016927 Mycobacterium paratuberculosis
% 221.25/221.42  |- mesh__dateRevised mesh__D016927 2005-06-30
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D016927 2006
% 221.25/221.42  |- skos__scopeNote mesh__D016927
% 221.25/221.42       A species of gram-positive, aerobic bacteria non-pathogenic for humans. It is the etiologic agent of Johne%27%s disease %28%see PARATUBERCULOSIS%29%.%A%    
% 221.25/221.42  |- skos__historyNote mesh__D016927 Mycobacterium %28%1966-1991%29%
% 221.25/221.42  |- skos__broader mesh__D016927smesh__D009161
% 221.25/221.42  |- mesh__recordMaintainer mesh__D016927 SYSTEM
% 221.25/221.42  |- rdf__type mesh__D016927sskos__Concept
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002907 2006
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002907 2003
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002907 1997
% 221.25/221.42  |- skos__hiddenLabel mesh__D002907 Chronaxies
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002907 2005
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002907 2000
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002907 1999
% 221.25/221.42  |- skos__altLabel mesh__D002907 Chronaxie
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002907 1996
% 221.25/221.42  |- mesh__dateEstablished mesh__D002907 1970-01-01
% 221.25/221.42  |- mesh__dateRevised mesh__D002907 1993-06-04
% 221.25/221.42  |- mesh__publicMeSHNote mesh__D002907 70   
% 221.25/221.42  |- skos__broader mesh__D002907smesh__D009424
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002907 1998
% 221.25/221.42  |- mesh__historyNote mesh__D002907 70%28%65%29%   
% 221.25/221.42  |- rdf__type mesh__D002907sskos__Concept
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002907 1995
% 221.25/221.42  |- mesh__dateCreated mesh__D002907 1999-01-01
% 221.25/221.42  |- skos__prefLabel mesh__D002907 Chronaxy
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002907 1994
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002907 2002
% 221.25/221.42  |- mesh__recordMaintainer mesh__D002907 AGS
% 221.25/221.42  |- mesh__recordOriginator mesh__D002907 NLM
% 221.25/221.42  |- skos__scopeNote mesh__D002907
% 221.25/221.42       The shortest duration of an effective electrical stimulus to nerve or muscle tissue, having a strength equal to twice the minimum strength required for excitation. %28%Stedman%27%s, 25th ed%29%%A%    
% 221.25/221.42  |- mesh__recordAuthorizer mesh__D002907 PLS
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002907 2004
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002907 2001
% 221.25/221.42  |- rdf__type mesh__D002109sskos__Concept
% 221.25/221.42  |- skos__hiddenLabel mesh__D002109 Acids, Caffeic
% 221.25/221.42  |- mesh__dateCreated mesh__D002109 1974-11-19
% 221.25/221.42  |- skos__historyNote mesh__D002109 Catechols %28%1972-1974%29%
% 221.25/221.42  |- skos__scopeNote mesh__D002109
% 221.25/221.42       A class of phenolic acids related to chlorogenic acid, p-coumaric acid, vanillic acid, etc., which are found in plant tissues. It is involved in plant growth regulation.%A%    
% 221.25/221.42  |- mesh__dateRevised mesh__D002109 2004-07-19
% 221.25/221.42  |- mesh__recordAuthorizer mesh__D002109 sjn
% 221.25/221.42  |- mesh__recordMaintainer mesh__D002109 jls
% 221.25/221.42  |- mesh__recordOriginator mesh__D002109 NLM
% 221.25/221.42  |- mesh__historyNote mesh__D002109
% 221.25/221.42       91%28%75%29%; was see under CINNAMATES 1975-90   
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002109 2005
% 221.25/221.42  |- mesh__dateEstablished mesh__D002109 1991-01-01
% 221.25/221.42  |- skos__broader mesh__D002109smesh__D002934
% 221.25/221.42  |- skos__historyNote mesh__D002109 Cinnamates %28%1968-1974%29%
% 221.25/221.42  |- mesh__publicMeSHNote mesh__D002109
% 221.25/221.42       91; was see under CINNAMATES 1975-90   
% 221.25/221.42  |- skos__prefLabel mesh__D002109 Caffeic Acids
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002109 2006
% 221.25/221.42  |- skos__broader mesh__D012537smesh__D005060
% 221.25/221.42  |- skos__prefLabel mesh__D012537 Scandinavia
% 221.25/221.42  |- mesh__dateRevised mesh__D012537 2001-07-25
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D012537 2005
% 221.25/221.42  |- mesh__recordAuthorizer mesh__D012537 sjn
% 221.25/221.42  |- skos__annotation mesh__D012537 includes NORWAY; SWEDEN %26% DENMARK   
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D012537 2006
% 221.25/221.42  |- mesh__recordMaintainer mesh__D012537 mdb
% 221.25/221.42  |- rdf__type mesh__D012537sskos__Concept
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D012537 2003
% 221.25/221.42  |- mesh__recordOriginator mesh__D012537 NLM
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D012537 2004
% 221.25/221.42  |- mesh__dateCreated mesh__D012537 1999-01-01
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D012537 2002
% 221.25/221.42  |- skos__hiddenLabel mesh__D017222 Laser Angioplasties, Excimer
% 221.25/221.42  |- skos__altLabel mesh__D017222 Laser-Assisted Angioplasty
% 221.25/221.42  |- skos__hiddenLabel mesh__D017222 Angioplasty, Laser-Assisted Balloon
% 221.25/221.42  |- mesh__onlineNote mesh__D017222
% 221.25/221.42       use ANGIOPLASTY, LASER to search PERCUTANEOUS TRANSLUMINAL LASER ANGIOPLASTY 1991-92%A%  
% 221.25/221.42  |- skos__hiddenLabel mesh__D017222 Laser Assisted Angioplasty
% 221.25/221.42  |- skos__historyNote mesh__D017222 Angioplasty, Laser %28%1991-1992%29%
% 221.25/221.42  |- skos__hiddenLabel mesh__D017222 Laser-Assisted Balloon Angioplasties
% 221.25/221.42  |- mesh__dateCreated mesh__D017222 1992-05-07
% 221.25/221.42  |- skos__hiddenLabel mesh__D017222 Laser-Assisted Angioplasties
% 221.25/221.42  |- mesh__dateRevised mesh__D017222 2004-07-07
% 221.25/221.42  |- skos__hiddenLabel mesh__D017222 Balloon Angioplasty, Laser
% 221.25/221.42  |- mesh__recordAuthorizer mesh__D017222 sjn
% 221.25/221.42  |- skos__scopeNote mesh__D017222
% 221.25/221.42       Techniques using laser energy in combination with a balloon catheter to perform angioplasty. These procedures can take several forms including: 1, laser fiber delivering the energy while the inflated balloon centers the fiber and occludes the blood flow; 2, balloon angioplasty immediately following laser angioplasty; or 3, laser energy transmitted through angioplasty balloons that contain an internal fiber.%A%    
% 221.25/221.42  |- mesh__publicMeSHNote mesh__D017222
% 221.25/221.42       93; PERCUTANEOUS TRANSLUMINAL LASER ANGIOPLASTY was see ANGIOPLASTY, LASER 1991-92%A%  
% 221.25/221.42  |- skos__hiddenLabel mesh__D017222 Laser Angioplasty, Excimer
% 221.25/221.42  |- skos__hiddenLabel mesh__D017222 Balloon Angioplasties, Laser-Assisted
% 221.25/221.42  |- skos__prefLabel mesh__D017222 Angioplasty, Balloon, Laser-Assisted
% 221.25/221.42  |- skos__historyNote mesh__D017222 Laser Surgery %28%1988-1992%29%
% 221.25/221.42  |- skos__hiddenLabel mesh__D017222 Angioplasty, Laser Balloon
% 221.25/221.42  |- skos__hiddenLabel mesh__D017222 Laser Balloon Angioplasties
% 221.25/221.42  |- skos__broader mesh__D017222smesh__D000800
% 221.25/221.42  |- skos__historyNote mesh__D017222 Angioplasty, Balloon %28%1985-1992%29%
% 221.25/221.42  |- skos__altLabel mesh__D017222 Angioplasty, Laser-Assisted, Balloon
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D017222 2006
% 221.25/221.42  |- skos__hiddenLabel mesh__D017222 Excimer Laser Angioplasty
% 221.25/221.42  |- skos__hiddenLabel mesh__D017222 Excimer Laser Angioplasties
% 221.25/221.42  |- skos__altLabel mesh__D017222 Laser-Assisted Balloon Angioplasty
% 221.25/221.42  |- skos__altLabel mesh__D017222 Laser Balloon Angioplasty
% 221.25/221.42  |- skos__hiddenLabel mesh__D017222 Angioplasty, Laser-Assisted
% 221.25/221.42  |- skos__broader mesh__D017222smesh__D016342
% 221.25/221.42  |- skos__hiddenLabel mesh__D017222 Angioplasties, Excimer Laser
% 221.25/221.42  |- skos__altLabel mesh__D017222 Percutaneous Transluminal Laser Angioplasty
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D017222 2005
% 221.25/221.42  |- skos__hiddenLabel mesh__D017222 Balloon Angioplasty, Laser-Assisted
% 221.25/221.42  |- skos__historyNote mesh__D017222 Lasers %28%1985-1992%29%
% 221.25/221.42  |- skos__hiddenLabel mesh__D017222 Angioplasties, Laser-Assisted Balloon
% 221.25/221.42  |- skos__hiddenLabel mesh__D017222 Balloon Angioplasties, Laser
% 221.25/221.42  |- mesh__recordOriginator mesh__D017222 AGS
% 221.25/221.42  |- rdf__type mesh__D017222sskos__Concept
% 221.25/221.42  |- skos__annotation mesh__D017222
% 221.25/221.42       coord IM with disease /surg %28%IM%29%; do not use /util except by MeSH definition; if coronary, coord IM with ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY %28%IM%29%; DF: PTLA%A%  
% 221.25/221.42  |- mesh__dateEstablished mesh__D017222 1993-01-01
% 221.25/221.42  |- skos__hiddenLabel mesh__D017222 Laser Assisted Balloon Angioplasty
% 221.25/221.42  |- mesh__recordMaintainer mesh__D017222 wdj
% 221.25/221.42  |- skos__hiddenLabel mesh__D017222 Angioplasties, Laser Balloon
% 221.25/221.42  |- skos__hiddenLabel mesh__D017222 Angioplasties, Laser-Assisted
% 221.25/221.42  |- mesh__historyNote mesh__D017222
% 221.25/221.42       93; PERCUTANEOUS TRANSLUMINAL LASER ANGIOPLASTY was see ANGIOPLASTY, LASER 1991-92%A%  
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 AP-2alpha, Transcription Factor
% 221.25/221.42  |- mesh__recordMaintainer mesh__D050656 ags
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 Ap-2delta, Transcription Factor
% 221.25/221.42  |- mesh__recordOriginator mesh__D050656 DRC
% 221.25/221.42  |- skos__altLabel mesh__D050656 Transcription Factor AP-2epsilon
% 221.25/221.42  |- skos__historyNote mesh__D050656 Transcription Factors %28%1987-2005%29%
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 AP 2 gamma Protein
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 AP-2, Activator Protein
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D050656 2006A
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 Activator Protein AP 2
% 221.25/221.42  |- skos__altLabel mesh__D050656 AP-2 Enhancer Binding Protein
% 221.25/221.42  |- mesh__dateEstablished mesh__D050656 2006-01-01
% 221.25/221.42  |- skos__broader mesh__D050656smesh__D004268
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 Transcription Factor AP 2gamma
% 221.25/221.42  |- skos__altLabel mesh__D050656 AP-2 gamma Protein
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 Transcription Factor AP 2beta
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 Transcription Factor AP 2 delta Protein
% 221.25/221.42  |- skos__altLabel mesh__D050656 AP-2delta Protein
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 Transcription Factor AP 2 alpha Protein
% 221.25/221.42  |- skos__altLabel mesh__D050656 Transcription Factor AP2
% 221.25/221.42  |- skos__altLabel mesh__D050656 TFAP2B Protein
% 221.25/221.42  |- mesh__recordAuthorizer mesh__D050656 ags
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 AP 2delta Protein
% 221.25/221.42  |- skos__altLabel mesh__D050656 AP-2 epsilon Protein
% 221.25/221.42  |- mesh__publicMeSHNote mesh__D050656
% 221.25/221.42       2006; TRANSCRIPTION FACTOR AP-2 was indexed under TRANSCRIPTION FACTORS %26% DNA-BINDING PROTEINS 1987-2005%A%  
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 Transcription Factor AP 2
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 Transcription Factor Ap 2delta
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 AP-2beta, Transcription Factor
% 221.25/221.42  |- rdf__type mesh__D050656sskos__Concept
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D050656 2006
% 221.25/221.42  |- skos__altLabel mesh__D050656 Enhancer-Binding Protein AP-2
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 AP 2 alpha Protein
% 221.25/221.42  |- skos__altLabel mesh__D050656 TFAP2alpha Protein
% 221.25/221.42  |- mesh__dateCreated mesh__D050656 2005-06-30
% 221.25/221.42  |- skos__historyNote mesh__D050656 DNA-Binding Proteins %28%1987-2005%29%
% 221.25/221.42  |- skos__scopeNote mesh__D050656
% 221.25/221.42       A family of DNA binding proteins that regulate expression of a variety of GENES during CELL DIFFERENTIATION and APOPTOSIS.  Family members contain a highly conserved carboxy-terminal basic HELIX-TURN-HELIX MOTIF involved in dimerization and sequence-specific DNA binding.%A%    
% 221.25/221.42  |- skos__altLabel mesh__D050656 AP-2 beta Protein
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 Transcription Factor AP 2 beta Protein
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 Transcription Factor AP 2epsilon
% 221.25/221.42  |- skos__altLabel mesh__D050656 AP-2 alpha Protein
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 AP-2gamma, Transcription Factor
% 221.25/221.42  |- skos__altLabel mesh__D050656 Activator Protein AP-2
% 221.25/221.42  |- skos__annotation mesh__D050656 see SCR for organism-specific terms   
% 221.25/221.42  |- skos__altLabel mesh__D050656 Transcription Factor AP-2alpha
% 221.25/221.42  |- skos__altLabel mesh__D050656 Transcription Factor AP-2gamma
% 221.25/221.42  |- skos__altLabel mesh__D050656 Transcription Factor Ap-2delta
% 221.25/221.42  |- skos__prefLabel mesh__D050656 Transcription Factor AP-2
% 221.25/221.42  |- skos__broader mesh__D050656smesh__D014157
% 221.25/221.42  |- mesh__historyNote mesh__D050656 2006%28%1987%29%   
% 221.25/221.42  |- skos__altLabel mesh__D050656 Transcription Factor AP-2beta
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 Transcription Factor AP 2 gamma Protein
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 AP-2epsilon, Transcription Factor
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 Transcription Factor AP 2alpha
% 221.25/221.42  |- mesh__dateRevised mesh__D050656 2005-07-27
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 AP 2 Enhancer Binding Protein
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 AP-2, Enhancer-Binding Protein
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 AP 2 beta Protein
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 AP-2, Transcription Factor
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656 Enhancer Binding Protein AP 2
% 221.25/221.42  |- skos__hiddenLabel mesh__D050656
% 221.25/221.42       Transcription Factor AP 2 epsilon Protein
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D003202 2006
% 221.25/221.42  |- skos__hiddenLabel mesh__D003202 Analog Computers
% 221.25/221.42  |- mesh__dateCreated mesh__D003202 1999-01-01
% 221.25/221.42  |- skos__hiddenLabel mesh__D003202 Analog Computer
% 221.25/221.42  |- mesh__recordOriginator mesh__D003202 NLM
% 221.25/221.42  |- skos__hiddenLabel mesh__D003202 Analogue Computer
% 221.25/221.42  |- mesh__recordMaintainer mesh__D003202 jls
% 221.25/221.42  |- mesh__historyNote mesh__D003202 66%28%64%29%   
% 221.25/221.42  |- skos__prefLabel mesh__D003202 Computers, Analog
% 221.25/221.42  |- rdf__type mesh__D003202sskos__Concept
% 221.25/221.42  |- skos__scopeNote mesh__D003202
% 221.25/221.42       Computers in which quantities are represented by physical variables; problem parameters are translated into equivalent mechanical or electrical circuits as an analog for the physical phenomenon being investigated. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 221.25/221.42  |- skos__hiddenLabel mesh__D003202 Computer, Analogue
% 221.25/221.42  |- skos__hiddenLabel mesh__D003202 Computer, Analog
% 221.25/221.42  |- mesh__publicMeSHNote mesh__D003202 66   
% 221.25/221.42  |- mesh__recordAuthorizer mesh__D003202 sjn
% 221.25/221.42  |- skos__annotation mesh__D003202
% 221.25/221.42       do not use /util except by MeSH definition   
% 221.25/221.42  |- skos__broader mesh__D003202smesh__D003201
% 221.25/221.42  |- skos__hiddenLabel mesh__D003202 Analogue Computers
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D003202 2005
% 221.25/221.42  |- mesh__dateEstablished mesh__D003202 1966-01-01
% 221.25/221.42  |- mesh__dateRevised mesh__D003202 2004-07-07
% 221.25/221.42  |- skos__altLabel mesh__D003202 Computers, Analogue
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008496 1996
% 221.25/221.42  |- skos__altLabel mesh__D008496 Receptionists, Medical
% 221.25/221.42  |- mesh__dateEstablished mesh__D008496 1991-01-01
% 221.25/221.42  |- mesh__onlineNote mesh__D008496 search MEDICAL SECRETARIES 1968-74   
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008496 2001
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008496 2003
% 221.25/221.42  |- mesh__dateRevised mesh__D008496 1992-05-14
% 221.25/221.42  |- mesh__recordOriginator mesh__D008496 NLM
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008496 1999
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008496 2000
% 221.25/221.42  |- skos__prefLabel mesh__D008496 Medical Receptionists
% 221.25/221.42  |- mesh__recordAuthorizer mesh__D008496 PLS
% 221.25/221.42  |- skos__altLabel mesh__D008496 Receptionist, Medical
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008496 1995
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008496 2006
% 221.25/221.42  |- skos__altLabel mesh__D008496 Medical Receptionist
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008496 1998
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008496 1994
% 221.25/221.42  |- mesh__publicMeSHNote mesh__D008496
% 221.25/221.42       91; was see under MEDICAL SECRETARIES 1975-90   
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008496 2005
% 221.25/221.42  |- skos__broader mesh__D008496smesh__D008502
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008496 2002
% 221.25/221.42  |- rdf__type mesh__D008496sskos__Concept
% 221.25/221.42  |- mesh__dateCreated mesh__D008496 1999-01-01
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008496 1997
% 221.25/221.42  |- mesh__historyNote mesh__D008496
% 221.25/221.42       91%28%75%29%; was see under MEDICAL SECRETARIES 1975-90   
% 221.25/221.42  |- mesh__recordMaintainer mesh__D008496 TAP
% 221.25/221.42  |- skos__scopeNote mesh__D008496
% 221.25/221.42       Individuals who receive patients in a medical office.     
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008496 2004
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008496 1993
% 221.25/221.42  |- mesh__recordOriginator mesh__D041321 jmp
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D041321 2006
% 221.25/221.42  |- mesh__historyNote mesh__D041321 2003   
% 221.25/221.42  |- skos__broader mesh__D041321smesh__D014960
% 221.25/221.42  |- skos__historyNote mesh__D041321 Sex Chromosomes %28%1968-1977%29%
% 221.25/221.42  |- skos__broader mesh__D041321smesh__D002906
% 221.25/221.42  |- skos__hiddenLabel mesh__D041321 Human X Chromosomes
% 221.25/221.42  |- skos__prefLabel mesh__D041321 Chromosomes, Human, X
% 221.25/221.42  |- skos__historyNote mesh__D041321 Chromosomes %28%1966-1967%29%
% 221.25/221.42  |- skos__historyNote mesh__D041321 X Chromosome %28%1978-2002%29%
% 221.25/221.42  |- mesh__publicMeSHNote mesh__D041321 2003   
% 221.25/221.42  |- skos__hiddenLabel mesh__D041321 Human X Chromosome
% 221.25/221.42  |- skos__hiddenLabel mesh__D041321 Chromosomes, Human X
% 221.25/221.42  |- skos__hiddenLabel mesh__D041321 Chromosome, Human X
% 221.25/221.42  |- skos__altLabel mesh__D041321 X Chromosome, Human
% 221.25/221.42  |- rdf__type mesh__D041321sskos__Concept
% 221.25/221.42  |- mesh__recordMaintainer mesh__D041321 sjn
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D041321 2005
% 221.25/221.42  |- mesh__dateCreated mesh__D041321 2002-07-03
% 221.25/221.42  |- skos__scopeNote mesh__D041321
% 221.25/221.42       The human female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in humans.%A%    
% 221.25/221.42  |- mesh__dateRevised mesh__D041321 2004-07-13
% 221.25/221.42  |- skos__related mesh__D041321smesh__D040181
% 221.25/221.42  |- mesh__recordAuthorizer mesh__D041321 sjn
% 221.25/221.42  |- mesh__dateEstablished mesh__D041321 2003-01-01
% 221.25/221.42  |- skos__hiddenLabel mesh__D041321 X Chromosomes, Human
% 221.25/221.42  |- skos__hiddenLabel mesh__D002908 Disease, Chronic
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002908 2006
% 221.25/221.42  |- mesh__recordAuthorizer mesh__D002908 sjn
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002908 2000
% 221.25/221.42  |- mesh__dateCreated mesh__D002908 1999-01-01
% 221.25/221.42  |- mesh__recordOriginator mesh__D002908 NLM
% 221.25/221.42  |- skos__altLabel mesh__D002908 Chronic Illness
% 221.25/221.42  |- skos__hiddenLabel mesh__D002908 Illnesses, Chronic
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002908 2001
% 221.25/221.42  |- skos__hiddenLabel mesh__D002908 Chronic Diseases
% 221.25/221.42  |- skos__broader mesh__D002908smesh__D020969
% 221.25/221.42  |- rdf__type mesh__D002908sskos__Concept
% 221.25/221.42  |- skos__scopeNote mesh__D002908
% 221.25/221.42       Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care. %28%Dictionary of Health Services Management, 2d ed%29%%A%    
% 221.25/221.42  |- skos__hiddenLabel mesh__D002908 Illness, Chronic
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002908 2003
% 221.25/221.42  |- skos__prefLabel mesh__D002908 Chronic Disease
% 221.25/221.42  |- skos__annotation mesh__D002908
% 221.25/221.42       IM GEN only; usually NIM with specific dis IM; no qualif when NIM; Manual 23.16+%A%  
% 221.25/221.42  |- mesh__recordMaintainer mesh__D002908 KEV
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002908 2002
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002908 2005
% 221.25/221.42  |- skos__hiddenLabel mesh__D002908 Chronic Illnesses
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D002908 2004
% 221.25/221.42  |- mesh__dateRevised mesh__D002908 1999-11-08
% 221.25/221.42  |- skos__hiddenLabel mesh__D002908 Diseases, Chronic
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D013630 2001
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D013630 1999
% 221.25/221.42  |- rdf__type mesh__D013630sskos__Concept
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D013630 2002
% 221.25/221.42  |- skos__hiddenLabel mesh__D013630 Tampons, Vaginal
% 221.25/221.42  |- mesh__recordAuthorizer mesh__D013630 PLS
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D013630 2003
% 221.25/221.42  |- mesh__recordOriginator mesh__D013630 NLM
% 221.25/221.42  |- mesh__recordMaintainer mesh__D013630 KEV
% 221.25/221.42  |- mesh__dateRevised mesh__D013630 1995-05-23
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D013630 2004
% 221.25/221.42  |- skos__hiddenLabel mesh__D013630 Tampon, Vaginal
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D013630 1996
% 221.25/221.42  |- skos__broader mesh__D013630smesh__D013523
% 221.25/221.42  |- skos__hiddenLabel mesh__D013630 Vaginal Tampons
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D013630 2005
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D013630 1997
% 221.25/221.42  |- skos__hiddenLabel mesh__D013630 Tampon
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D013630 2006
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D013630 2000
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D013630 1998
% 221.25/221.42  |- mesh__dateCreated mesh__D013630 1999-01-01
% 221.25/221.42  |- skos__prefLabel mesh__D013630 Tampons
% 221.25/221.42  |- skos__scopeNote mesh__D013630
% 221.25/221.42       Pads or plugs made of cotton, sponge, or other material. They are variously used in surgery to plug the nose, vagina, etc., for the control of hemorrhage or the absorption of secretions. %28%From Dorland, 28th ed%29%%A%    
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D012538 2005
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D012538 2002
% 221.25/221.42  |- mesh__recordMaintainer mesh__D012538 jmp
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D012538 2006
% 221.25/221.42  |- rdf__type mesh__D012538sskos__Concept
% 221.25/221.42  |- skos__broader mesh__D012538smesh__D028561
% 221.25/221.42  |- skos__annotation mesh__D012538
% 221.25/221.42       a rare earth metal; Sc-45; Sc-40-44, 46-50 = SCANDIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 221.25/221.42  |- mesh__dateRevised mesh__D012538 2001-07-25
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D012538 2003
% 221.25/221.42  |- mesh__recordAuthorizer mesh__D012538 sjn
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D012538 2004
% 221.25/221.42  |- skos__prefLabel mesh__D012538 Scandium
% 221.25/221.42  |- skos__scopeNote mesh__D012538
% 221.25/221.42       Scandium. An element of the rare earth family of metals. It has the atomic symbol Sc, atomic number 21, and atomic weight 45.%A%    
% 221.25/221.42  |- mesh__dateCreated mesh__D012538 1999-01-01
% 221.25/221.42  |- mesh__recordOriginator mesh__D012538 NLM
% 221.25/221.42  |- skos__broader mesh__D012538smesh__D008674
% 221.25/221.42  |- mesh__dateEstablished mesh__D050657 2006-01-01
% 221.25/221.42  |- skos__broader mesh__D050657smesh__D050660
% 221.25/221.42  |- skos__altLabel mesh__D050657 Runt Domain Factor
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D050657 2006
% 221.25/221.42  |- skos__altLabel mesh__D050657 Acute Myeloid Leukemia Proteins
% 221.25/221.42  |- mesh__recordOriginator mesh__D050657 DRC
% 221.25/221.42  |- rdf__type mesh__D050657sskos__Concept
% 221.25/221.42  |- skos__altLabel mesh__D050657 Polyomavirus Enhancer A Binding Protein 2
% 221.25/221.42  |- mesh__recordMaintainer mesh__D050657 DRC
% 221.25/221.42  |- mesh__historyNote mesh__D050657 2006%28%1987%29%   
% 221.25/221.42  |- skos__historyNote mesh__D050657 Neoplasm Proteins %28%1997-2005%29%
% 221.25/221.42  |- skos__scopeNote mesh__D050657
% 221.25/221.42       A family of transcription factors that bind to the cofactor CORE BINDING FACTOR BETA SUBUNIT to form core binding factor. Family members contain a highly conserved DNA-binding domain known as the runt domain.  They can act as both activators and repressors of expression of GENES involved in CELL DIFFERENTIATION and CELL CYCLE progression.%A%    
% 221.25/221.42  |- skos__altLabel mesh__D050657 PEBP2A Transcription Factors
% 221.25/221.42  |- skos__altLabel mesh__D050657 Runx Proteins
% 221.25/221.42  |- mesh__recordAuthorizer mesh__D050657 sjn
% 221.25/221.42  |- skos__altLabel mesh__D050657 Core Binding Factor alpha Proteins
% 221.25/221.42  |- skos__hiddenLabel mesh__D050657 Transcription Factors, PEBP2A
% 221.25/221.42  |- mesh__publicMeSHNote mesh__D050657
% 221.25/221.42       2006; POLYOMAVIRUS ENHANCER A BINDING PROTEIN 2 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1987-2005, %26% under NEOPLASM PROTEINS 1997-2005; RUNT DOMAIN FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 2000-2005, %26% under NEOPLASM PROTEINS 2000-2005%A%  
% 221.25/221.42  |- mesh__dateCreated mesh__D050657 2005-06-30
% 221.25/221.42  |- skos__altLabel mesh__D050657
% 221.25/221.42       Polyomavirus Enhancer Binding Protein 2, Alpha Subunit
% 221.25/221.42  |- skos__historyNote mesh__D050657 DNA-Binding Proteins %28%1987-2005%29%
% 221.25/221.42  |- skos__historyNote mesh__D050657 Transcription Factors %28%1987-2005%29%
% 221.25/221.42  |- skos__prefLabel mesh__D050657 Core Binding Factor alpha Subunits
% 221.25/221.42  |- mesh__publicMeSHNote mesh__D003203 73   
% 221.25/221.42  |- rdf__type mesh__D003203sskos__Concept
% 221.25/221.42  |- skos__hiddenLabel mesh__D003203 Hybrid Computers
% 221.25/221.42  |- skos__hiddenLabel mesh__D003203 Computer, Hybrid
% 221.25/221.42  |- mesh__recordOriginator mesh__D003203 NLM
% 221.25/221.42  |- mesh__recordMaintainer mesh__D003203 jls
% 221.25/221.42  |- mesh__historyNote mesh__D003203 73%28%64%29%   
% 221.25/221.42  |- skos__annotation mesh__D003203
% 221.25/221.42       do not use /util except by MeSH definition   
% 221.25/221.42  |- skos__broader mesh__D003203smesh__D003201
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D003203 2005
% 221.25/221.42  |- skos__prefLabel mesh__D003203 Computers, Hybrid
% 221.25/221.42  |- mesh__dateRevised mesh__D003203 2004-07-07
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D003203 2006
% 221.25/221.42  |- skos__scopeNote mesh__D003203
% 221.25/221.42       Computers that combine the functions of analog and digital computers. %28%Sippl, Computer Dictionary, 4th ed%29%%A%    
% 221.25/221.42  |- skos__hiddenLabel mesh__D003203 Hybrid Computer
% 221.25/221.42  |- mesh__dateCreated mesh__D003203 1999-01-01
% 221.25/221.42  |- mesh__recordAuthorizer mesh__D003203 sjn
% 221.25/221.42  |- mesh__dateEstablished mesh__D003203 1973-01-01
% 221.25/221.42  |- skos__hiddenLabel mesh__D008497 Record Librarians, Medical
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008497 1999
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008497 2002
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008497 2003
% 221.25/221.42  |- skos__altLabel mesh__D008497 Technicians, Medical Record
% 221.25/221.42  |- skos__scopeNote mesh__D008497
% 221.25/221.42       Individuals professionally qualified in the management of patients%27% records. Duties may include planning, designing, and managing systems for patient administrative and clinical data, as well as patient medical records. The concept includes medical record technicians.%A%    
% 221.25/221.42  |- skos__hiddenLabel mesh__D008497 Record Administrators, Medical
% 221.25/221.42  |- mesh__recordAuthorizer mesh__D008497 PLS
% 221.25/221.42  |- skos__hiddenLabel mesh__D008497 Medical Record Technician
% 221.25/221.42  |- mesh__dateRevised mesh__D008497 1992-05-14
% 221.25/221.42  |- rdf__type mesh__D008497sskos__Concept
% 221.25/221.42  |- skos__prefLabel mesh__D008497 Medical Record Administrators
% 221.25/221.42  |- mesh__historyNote mesh__D008497
% 221.25/221.42       77; was MEDICAL RECORDS LIBRARIANS 1963-76   
% 221.25/221.42  |- mesh__recordMaintainer mesh__D008497 TAP
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008497 1996
% 221.25/221.42  |- skos__broader mesh__D008497smesh__D000488
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008497 2004
% 221.25/221.42  |- mesh__onlineNote mesh__D008497
% 221.25/221.42       use MEDICAL RECORD ADMINISTRATORS to search MEDICAL RECORDS LIBRARIANS 1966-76%A%  
% 221.25/221.42  |- skos__hiddenLabel mesh__D008497 Medical Record Administrator
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008497 1997
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008497 2000
% 221.25/221.42  |- mesh__publicMeSHNote mesh__D008497
% 221.25/221.42       77; was MEDICAL RECORDS LIBRARIANS 1963-76   
% 221.25/221.42  |- skos__hiddenLabel mesh__D008497 Record Librarian, Medical
% 221.25/221.42  |- skos__hiddenLabel mesh__D008497 Record Administrator, Medical
% 221.25/221.42  |- skos__hiddenLabel mesh__D008497 Technician, Medical Record
% 221.25/221.42  |- skos__hiddenLabel mesh__D008497 Record Technicians, Medical
% 221.25/221.42  |- skos__hiddenLabel mesh__D008497 Record Technician, Medical
% 221.25/221.42  |- skos__hiddenLabel mesh__D008497 Medical Record Librarian
% 221.25/221.42  |- mesh__dateCreated mesh__D008497 1999-01-01
% 221.25/221.42  |- skos__hiddenLabel mesh__D008497 Librarian, Medical Record
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008497 1994
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008497 2005
% 221.25/221.42  |- skos__altLabel mesh__D008497 Librarians, Medical Record
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008497 2001
% 221.25/221.42  |- skos__hiddenLabel mesh__D008497 Administrator, Medical Record
% 221.25/221.42  |- skos__altLabel mesh__D008497 Medical Record Librarians
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008497 1998
% 221.25/221.42  |- skos__hiddenLabel mesh__D008497 Administrators, Medical Record
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008497 1995
% 221.25/221.42  |- mesh__activeMeSHYear mesh__D008497 2006
% 221.25/221.42  |- skos__annotation mesh__D008497
% 221.25/221.42       includes med rec librarians %26% med rec technicians   
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D008497 1993
% 221.25/221.43  |- mesh__recordOriginator mesh__D008497 NLM
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D016929 2006
% 221.25/221.43  |- mesh__publicMeSHNote mesh__D016929
% 221.25/221.43       92; CORYNEBACTERIUM EQUI was see RHODOCOCCUS 1987-91   
% 221.25/221.43  |- mesh__dateRevised mesh__D016929 2005-06-30
% 221.25/221.43  |- skos__annotation mesh__D016929
% 221.25/221.43       in soil, dung, cows, sheep, pigs as well as horses %28%equ-%29%; infection: coord IM with ACTINOMYCETALES INFECTIONS %28%IM%29%%A%  
% 221.25/221.43  |- rdf__type mesh__D016929sskos__Concept
% 221.25/221.43  |- skos__broader mesh__D016929smesh__D012240
% 221.25/221.43  |- mesh__recordMaintainer mesh__D016929 SYSTEM
% 221.25/221.43  |- skos__scopeNote mesh__D016929
% 221.25/221.43       A species of RHODOCOCCUS found in soil, herbivore dung, and in the intestinal tract of cows, horses, sheep, and pigs. It causes bronchopneumonia in foals and can be responsible for infection in humans compromised by immunosuppressive drug therapy, lymphoma, or AIDS.%A%    
% 221.25/221.43  |- skos__historyNote mesh__D016929 Corynebacterium %28%1966-1986%29%
% 221.25/221.43  |- skos__historyNote mesh__D016929 Rhodococcus %28%1987-1991%29%
% 221.25/221.43  |- mesh__historyNote mesh__D016929
% 221.25/221.43       92; CORYNEBACTERIUM EQUI was see RHODOCOCCUS 1987-91   
% 221.25/221.43  |- mesh__dateEstablished mesh__D016929 1992-01-01
% 221.25/221.43  |- mesh__dateCreated mesh__D016929 1991-05-30
% 221.25/221.43  |- mesh__onlineNote mesh__D016929
% 221.25/221.43       use RHODOCOCCUS to search CORYNEBACTERIUM EQUI 1987-91   
% 221.25/221.43  |- mesh__recordAuthorizer mesh__D016929 sjn
% 221.25/221.43  |- skos__altLabel mesh__D016929 Corynebacterium equi
% 221.25/221.43  |- skos__prefLabel mesh__D016929 Rhodococcus equi
% 221.25/221.43  |- mesh__recordOriginator mesh__D016929 PXP
% 221.25/221.43  |- skos__historyNote mesh__D041322 Chromosomes %28%1966-1967%29%
% 221.25/221.43  |- skos__hiddenLabel mesh__D041322 Chromosome, Human Y
% 221.25/221.43  |- rdf__type mesh__D041322sskos__Concept
% 221.25/221.43  |- skos__hiddenLabel mesh__D041322 Y Chromosomes, Human
% 221.25/221.43  |- skos__altLabel mesh__D041322 Y Chromosome, Human
% 221.25/221.43  |- mesh__historyNote mesh__D041322 2003   
% 221.25/221.43  |- skos__hiddenLabel mesh__D041322 Human Y Chromosomes
% 221.25/221.43  |- skos__hiddenLabel mesh__D041322 Chromosomes, Human Y
% 221.25/221.43  |- skos__historyNote mesh__D041322 Y Chromosome %28%1978-2002%29%
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D041322 2006
% 221.25/221.43  |- mesh__recordAuthorizer mesh__D041322 sjn
% 221.25/221.43  |- mesh__dateEstablished mesh__D041322 2003-01-01
% 221.25/221.43  |- skos__broader mesh__D041322smesh__D014998
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D041322 2005
% 221.25/221.43  |- skos__hiddenLabel mesh__D041322 Human Y Chromosome
% 221.25/221.43  |- skos__prefLabel mesh__D041322 Chromosomes, Human, Y
% 221.25/221.43  |- skos__scopeNote mesh__D041322
% 221.25/221.43       The human male sex chromosome, being the differential sex chromosome carried by half the male gametes and none of the female gametes in humans.%A%    
% 221.25/221.43  |- skos__historyNote mesh__D041322 Sex Chromosomes %28%1968-1977%29%
% 221.25/221.43  |- mesh__recordMaintainer mesh__D041322 sjn
% 221.25/221.43  |- mesh__dateRevised mesh__D041322 2004-07-13
% 221.25/221.43  |- mesh__dateCreated mesh__D041322 2002-07-03
% 221.25/221.43  |- skos__broader mesh__D041322smesh__D002904
% 221.25/221.43  |- mesh__recordOriginator mesh__D041322 jmp
% 221.25/221.43  |- mesh__publicMeSHNote mesh__D041322 2003   
% 221.25/221.43  |- skos__historyNote mesh__D002909 Periodicity %28%1966-1985%29%
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D002909 1999
% 221.25/221.43  |- skos__related mesh__D002909smesh__D019454
% 221.25/221.43  |- skos__historyNote mesh__D002909 Biological Clocks %28%1966-1985%29%
% 221.25/221.43  |- skos__broader mesh__D002909smesh__D010829
% 221.25/221.43  |- skos__scopeNote mesh__D002909
% 221.25/221.43       The study of biological systems as affected by time. Aging, biological rhythms, and cyclic phenomena are included. Statistical, computer-aided mathematical procedures are used to describe, in mathematical terminology, various biological functions over time.%A%    
% 221.25/221.43  |- mesh__recordAuthorizer mesh__D002909 SJN
% 221.25/221.43  |- mesh__historyNote mesh__D002909 86   
% 221.25/221.43  |- mesh__dateRevised mesh__D002909 1997-06-20
% 221.25/221.43  |- rdf__type mesh__D002909sskos__Concept
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D002909 2000
% 221.25/221.43  |- mesh__recordMaintainer mesh__D002909 TGC
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D002909 2003
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D002909 2001
% 221.25/221.43  |- mesh__publicMeSHNote mesh__D002909 86   
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D002909 2005
% 221.25/221.43  |- mesh__dateCreated mesh__D002909 1985-06-19
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D002909 2004
% 221.25/221.43  |- skos__annotation mesh__D002909
% 221.25/221.43       %22%biol systems as affected by time%22%; DF: CHRONOBIOL   
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D002909 2006
% 221.25/221.43  |- mesh__recordOriginator mesh__D002909 SH
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D002909 1998
% 221.25/221.43  |- skos__prefLabel mesh__D002909 Chronobiology
% 221.25/221.43  |- mesh__dateEstablished mesh__D002909 1986-01-01
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D002909 2002
% 221.25/221.43  |- skos__altLabel mesh__D013631
% 221.25/221.43       Familial High-Density Lipoprotein Deficiency Disease
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631 Neuropathies, A-alphalipoprotein
% 221.25/221.43  |- skos__historyNote mesh__D013631 Lipoproteins %28%1966-1977%29%
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631
% 221.25/221.43       Deficiency Disease, alpha High Density Lipoprotein
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631
% 221.25/221.43       Familial alpha Lipoprotein Deficiency Disease
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631
% 221.25/221.43       Familial High Density Lipoprotein Deficiency Disease
% 221.25/221.43  |- skos__historyNote mesh__D013631
% 221.25/221.43       Blood Protein Disorders %28%1966-1977%29%
% 221.25/221.43  |- skos__altLabel mesh__D013631 HDL Lipoprotein Deficiency Disease
% 221.25/221.43  |- skos__broader mesh__D013631smesh__D011115
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631 Tangier Hereditary Neuropathies
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631
% 221.25/221.43       alpha High Density Lipoprotein Deficiency Disease
% 221.25/221.43  |- rdf__type mesh__D013631sskos__Concept
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631
% 221.25/221.43       High Density Lipoprotein Deficiency Disease, Familial
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631 Hypoalphalipoproteinemias, Familial
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631 Disease, Tangier
% 221.25/221.43  |- mesh__recordAuthorizer mesh__D013631 sjn
% 221.25/221.43  |- skos__altLabel mesh__D013631 Neuropathy of Tangier Disease
% 221.25/221.43  |- mesh__publicMeSHNote mesh__D013631
% 221.25/221.43       1991; see HYPOLIPOPROTEINEMIA 1980-1990, see  HYPOLIPOPROTEINEMIAS 1978-1979%A%  
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631 A-alphalipoprotein Neuropathies
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631 Neuropathy, A-alphalipoprotein
% 221.25/221.43  |- skos__altLabel mesh__D013631 Hypoalphalipoproteinemia, Familial
% 221.25/221.43  |- skos__altLabel mesh__D013631
% 221.25/221.43       High-Density Lipoprotein Deficiency Disease, Familial
% 221.25/221.43  |- mesh__historyNote mesh__D013631 1991%28%1978%29%   
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631 Neuropathies, Tangier Hereditary
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631 Familial Hypoalphalipoproteinemias
% 221.25/221.43  |- mesh__recordOriginator mesh__D013631 VDK
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631 Hereditary Neuropathies, Tangier
% 221.25/221.43  |- mesh__dateEstablished mesh__D013631 1991-01-01
% 221.25/221.43  |- mesh__dateCreated mesh__D013631 1977-04-29
% 221.25/221.43  |- skos__altLabel mesh__D013631
% 221.25/221.43       alpha High-Density Lipoprotein Deficiency Disease
% 221.25/221.43  |- mesh__recordMaintainer mesh__D013631 lkt
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631 Familial Hypoalphalipoproteinemia
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631 Neuropathy, Tangier Hereditary
% 221.25/221.43  |- mesh__dateRevised mesh__D013631 2005-06-30
% 221.25/221.43  |- skos__altLabel mesh__D013631 Tangier Hereditary Neuropathy
% 221.25/221.43  |- skos__historyNote mesh__D013631
% 221.25/221.43       Lipid Metabolism, Inborn Errors %28%1966-1977%29%
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631
% 221.25/221.43       Deficiency Disease, Familial alpha Lipoprotein
% 221.25/221.43  |- skos__altLabel mesh__D013631
% 221.25/221.43       Familial alpha-Lipoprotein Deficiency Disease
% 221.25/221.43  |- skos__historyNote mesh__D013631 Lipoproteins, HDL %28%1972-1977%29%
% 221.25/221.43  |- skos__altLabel mesh__D013631 Deficiency Disease, HDL Lipoprotein
% 221.25/221.43  |- skos__altLabel mesh__D013631
% 221.25/221.43       Deficiency Disease, alpha High-Density Lipoprotein
% 221.25/221.43  |- skos__altLabel mesh__D013631
% 221.25/221.43       Lipoprotein Deficiency Disease, HDL, Familial
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631 Neuropathy, Tangier Disease
% 221.25/221.43  |- skos__prefLabel mesh__D013631 Tangier Disease
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631 A alphalipoprotein Neuropathy
% 221.25/221.43  |- skos__broader mesh__D013631smesh__D007009
% 221.25/221.43  |- skos__related mesh__D013631smesh__D012174
% 221.25/221.43  |- skos__altLabel mesh__D013631 A-alphalipoprotein Neuropathy
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D013631 2006
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631 Neuropathies, Tangier Disease
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631 Hereditary Neuropathy, Tangier
% 221.25/221.43  |- skos__related mesh__D013631smesh__D008075
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631 Tangier Disease Neuropathies
% 221.25/221.43  |- skos__scopeNote mesh__D013631
% 221.25/221.43       A rare autosomal recessive familial disorder of cholesterol metabolism, characterized by extremely low HDL-cholesterol, reduced total cholesterol, and increased triglyceride levels in serum. Clinical features include the onset before age 20 years of HEPATOMEGALY; SPLENOMEGALY; the deposition of cholesterol in each TONSIL %28%creating a yellow-orange appearance%29%; and RETINITIS PIGMENTOSA. A sensorimotor or distal sensory POLYNEUROPATHY occurs in approximately 50%25% of affected individuals. The condition is associated with decreased synthesis and increased catabolism of APOLIPOPROTEIN A-I and APOLIPOPROTEIN A-II, and a defect in cellular signaling and mobilization of lipids. %28%From Nat Genet 1998 Sep;20%28%1%29%:96-8; Adams et al., Principles of Neurology, 6th ed, pp1347-8; Menkes, Textbook of Child Neurology, 5th ed, p118%29%%A%    
% 221.25/221.43  |- skos__altLabel mesh__D013631
% 221.25/221.43       alpha-Lipoprotein Deficiency Disease, Familial
% 221.25/221.43  |- skos__altLabel mesh__D013631 Analphalipoproteinemia
% 221.25/221.43  |- skos__altLabel mesh__D013631
% 221.25/221.43       Deficiency Disease, Familial alpha-Lipoprotein
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631 Analphalipoproteinemias
% 221.25/221.43  |- skos__hiddenLabel mesh__D013631
% 221.25/221.43       alpha Lipoprotein Deficiency Disease, Familial
% 221.25/221.43  |- rdf__type mesh__D037281sskos__Concept
% 221.25/221.43  |- skos__hiddenLabel mesh__D037281 pp90, Phosphoprotein
% 221.25/221.43  |- skos__scopeNote mesh__D037281
% 221.25/221.43       A lectin found in ENDOPLASMIC RETICULUM membranes that binds to specific N-linked OLIGOSACCHARIDES found on newly synthesized proteins. It may play role in PROTEIN FOLDING or retention and degradation of misfolded proteins in the endoplasmic reticulum.%A%    
% 221.25/221.43  |- skos__altLabel mesh__D037281 Integral Membrane Protein IP90
% 221.25/221.43  |- skos__historyNote mesh__D037281
% 221.25/221.43       Calcium-Binding Proteins %28%1991-2002%29%
% 221.25/221.43  |- mesh__recordMaintainer mesh__D037281 jmp
% 221.25/221.43  |- skos__altLabel mesh__D037281 IP90 Protein
% 221.25/221.43  |- skos__broader mesh__D037281smesh__D052139
% 221.25/221.43  |- skos__prefLabel mesh__D037281 Calnexin
% 221.25/221.43  |- skos__broader mesh__D037281smesh__D037102
% 221.25/221.43  |- mesh__recordOriginator mesh__D037281 jmp
% 221.25/221.43  |- mesh__recordAuthorizer mesh__D037281 sjn
% 221.25/221.43  |- mesh__publicMeSHNote mesh__D037281
% 221.25/221.43       2003; CALNEXIN was indexed under CALCIUM-BINDING PROTEINS 1991-2002%A%  
% 221.25/221.43  |- skos__broader mesh__D037281smesh__D008565
% 221.25/221.43  |- mesh__dateEstablished mesh__D037281 2003-01-01
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D037281 2006
% 221.25/221.43  |- mesh__dateRevised mesh__D037281 2005-06-30
% 221.25/221.43  |- skos__altLabel mesh__D037281 Phosphoprotein pp90
% 221.25/221.43  |- mesh__dateCreated mesh__D037281 2002-07-03
% 221.25/221.43  |- mesh__historyNote mesh__D037281
% 221.25/221.43       2003; use CALNEXIN %28%NM%29% 1991-2002   
% 221.25/221.43  |- mesh__recordMaintainer mesh__D012539 ags
% 221.25/221.43  |- skos__scopeNote mesh__D012539
% 221.25/221.43       Process in which the mechanisms of projection or displacement are utilized in focusing feelings of aggression, hostility, frustration, etc., upon another individual or group; the amount of blame being unwarranted.%A%    
% 221.25/221.43  |- skos__broader mesh__D012539smesh__D011385
% 221.25/221.43  |- skos__prefLabel mesh__D012539 Scapegoating
% 221.25/221.43  |- rdf__type mesh__D012539sskos__Concept
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D012539 2006
% 221.25/221.43  |- mesh__historyNote mesh__D012539
% 221.25/221.43       91%28%76%29%; was see under DISPLACEMENT %28%PSYCHOLOGY%29% 1976-90   
% 221.25/221.43  |- mesh__dateCreated mesh__D012539 1975-07-25
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D012539 2004
% 221.25/221.43  |- skos__broader mesh__D012539smesh__D004208
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D012539 2005
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D012539 2003
% 221.25/221.43  |- mesh__publicMeSHNote mesh__D012539
% 221.25/221.43       91; was see under DISPLACEMENT %28%PSYCHOLOGY%29% 1976-90   
% 221.25/221.43  |- skos__annotation mesh__D012539 no qualif   
% 221.25/221.43  |- skos__broader mesh__D012539smesh__D012919
% 221.25/221.43  |- skos__historyNote mesh__D012539
% 221.25/221.43       Displacement %28%Psychology%29% %28%1968-1975%29%
% 221.25/221.43  |- mesh__dateRevised mesh__D012539 2002-07-03
% 221.25/221.43  |- mesh__recordOriginator mesh__D012539 EC
% 221.25/221.43  |- skos__historyNote mesh__D012539 Schizophrenia %28%1966-1975%29%
% 221.25/221.43  |- mesh__recordAuthorizer mesh__D012539 sjn
% 221.25/221.43  |- mesh__dateEstablished mesh__D012539 1991-01-01
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D009590 1997
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D009590 2002
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D009590 1999
% 221.25/221.43  |- skos__annotation mesh__D009590
% 221.25/221.43       N-12, 13, 16, 17, 18; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 221.25/221.43  |- mesh__recordAuthorizer mesh__D009590 PLS
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D009590 2004
% 221.25/221.43  |- skos__hiddenLabel mesh__D009590 Radioisotopes, Nitrogen
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D009590 1996
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D009590 2001
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D009590 2006
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D009590 1998
% 221.25/221.43  |- skos__historyNote mesh__D009590 Nitrogen Isotopes %28%1971-1974%29%
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D009590 2003
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D009590 1995
% 221.25/221.43  |- skos__historyNote mesh__D009590 Radioisotopes %28%1971-1974%29%
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D009590 2000
% 221.25/221.43  |- mesh__historyNote mesh__D009590 75   
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D009590 2005
% 221.25/221.43  |- mesh__dateCreated mesh__D009590 1974-11-11
% 221.25/221.43  |- mesh__onlineNote mesh__D009590
% 221.25/221.43       search NITROGEN ISOTOPES 1971-74 %28%as Prov 1971-72%29%   
% 221.25/221.43  |- mesh__recordMaintainer mesh__D009590 TPW
% 221.25/221.43  |- skos__broader mesh__D009590smesh__D009587
% 221.25/221.43  |- mesh__publicMeSHNote mesh__D009590 75   
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D009590 1994
% 221.25/221.43  |- skos__scopeNote mesh__D009590
% 221.25/221.43       Unstable isotopes of nitrogen that decay or disintegrate emitting radiation. N atoms with atomic weights 12, 13, 16, 17, and 18 are radioactive nitrogen isotopes.%A%    
% 221.25/221.43  |- mesh__dateEstablished mesh__D009590 1975-09-01
% 221.25/221.43  |- rdf__type mesh__D009590sskos__Concept
% 221.25/221.43  |- mesh__dateRevised mesh__D009590 1993-06-02
% 221.25/221.43  |- skos__broader mesh__D009590smesh__D011868
% 221.25/221.43  |- skos__prefLabel mesh__D009590 Nitrogen Radioisotopes
% 221.25/221.43  |- mesh__recordOriginator mesh__D009590 NLM
% 221.25/221.43  |- mesh__dateRevised mesh__D023261 2004-07-27
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D023261 2004
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D023261 2002
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D023261 2006
% 221.25/221.43  |- mesh__recordOriginator mesh__D023261 ags
% 221.25/221.43  |- skos__broader mesh__D023261smesh__D015599
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D023261 2003
% 221.25/221.43  |- rdf__type mesh__D023261sskos__Concept
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D023261 2001
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D023261 2005A
% 221.25/221.43  |- mesh__recordAuthorizer mesh__D023261 jls
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D023261 2005
% 221.25/221.43  |- mesh__publicMeSHNote mesh__D023261
% 221.25/221.43       2001; see GLASGOW COMA SCALE 1990-2000   
% 221.25/221.43  |- skos__prefLabel mesh__D023261 Glasgow Outcome Scale
% 221.25/221.43  |- skos__hiddenLabel mesh__D023261 Scale, Glasgow Outcome
% 221.25/221.43  |- skos__historyNote mesh__D023261 Glasgow Coma Scale %28%1990-2000%29%
% 221.25/221.43  |- mesh__historyNote mesh__D023261
% 221.25/221.43       2001; use GLASGOW COMA SCALE 1990-2000   
% 221.25/221.43  |- mesh__dateEstablished mesh__D023261 2001-01-01
% 221.25/221.43  |- mesh__recordMaintainer mesh__D023261 jls
% 221.25/221.43  |- mesh__dateCreated mesh__D023261 2000-06-22
% 221.25/221.43  |- skos__hiddenLabel mesh__D023261 Outcome Scale, Glasgow
% 221.25/221.43  |- skos__scopeNote mesh__D023261
% 221.25/221.43       A scale that assesses the outcome of serious craniocerebral injuries, based on the level of regained social functioning.%A%    
% 221.25/221.43  |- skos__historyNote mesh__D023261
% 221.25/221.43       Outcome and Process Assessment %28%Health Care%29% %28%1981-1989%29%
% 221.25/221.43  |- skos__altLabel mesh__D050658 Core Binding Factor beta
% 221.25/221.43  |- mesh__historyNote mesh__D050658 2006%28%1987%29%   
% 221.25/221.43  |- mesh__dateCreated mesh__D050658 2005-06-30
% 221.25/221.43  |- mesh__publicMeSHNote mesh__D050658
% 221.25/221.43       2006; CORE BINDING FACTOR BETA %26% CBFB PROTEIN were indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1987-2005%A%  
% 221.25/221.43  |- mesh__dateEstablished mesh__D050658 2006-01-01
% 221.25/221.43  |- skos__historyNote mesh__D050658 DNA-Binding Proteins %28%1987-2005%29%
% 221.25/221.43  |- skos__altLabel mesh__D050658
% 221.25/221.43       Polyomavirus Enhancer Binding Protein 2, beta Subunit
% 221.25/221.43  |- skos__broader mesh__D050658smesh__D050660
% 221.25/221.43  |- skos__altLabel mesh__D050658 Core Binding Factor beta Protein
% 221.25/221.43  |- skos__scopeNote mesh__D050658
% 221.25/221.43       A non-DNA binding transcription factor that is a subunit of core binding factor. It forms heterodimeric complexes with CORE BINDING FACTOR ALPHA SUBUNITS, and regulates GENETIC TRANSCRIPTION of a variety of GENES involved primarily in CELL DIFFERENTIATION and CELL CYCLE progression.%A%    
% 221.25/221.43  |- mesh__recordMaintainer mesh__D050658 ags
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D050658 2006A
% 221.25/221.43  |- mesh__dateRevised mesh__D050658 2005-08-03
% 221.25/221.43  |- skos__altLabel mesh__D050658 CBFB Protein
% 221.25/221.43  |- skos__prefLabel mesh__D050658 Core Binding Factor beta Subunit
% 221.25/221.43  |- skos__historyNote mesh__D050658 Transcription Factors %28%1987-2005%29%
% 221.25/221.43  |- mesh__recordOriginator mesh__D050658 DRC
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D050658 2006
% 221.25/221.43  |- mesh__recordAuthorizer mesh__D050658 ags
% 221.25/221.43  |- skos__annotation mesh__D050658 see SCR for organism-specific terms   
% 221.25/221.43  |- rdf__type mesh__D050658sskos__Concept
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D003204 2006
% 221.25/221.43  |- mesh__publicMeSHNote mesh__D003204
% 221.25/221.43       91; was see under COMPUTERS 1987-90   
% 221.25/221.43  |- mesh__dateRevised mesh__D003204 2004-07-07
% 221.25/221.43  |- mesh__recordOriginator mesh__D003204 EC
% 221.25/221.43  |- skos__hiddenLabel mesh__D003204 Mainframe Computer
% 221.25/221.43  |- mesh__dateCreated mesh__D003204 1986-06-18
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D003204 2005
% 221.25/221.43  |- mesh__recordAuthorizer mesh__D003204 sjn
% 221.25/221.43  |- skos__hiddenLabel mesh__D003204 Computer, Mainframe
% 221.25/221.43  |- skos__prefLabel mesh__D003204 Computers, Mainframe
% 221.25/221.43  |- mesh__historyNote mesh__D003204
% 221.25/221.43       91%28%87%29%; was see under COMPUTERS 1987-90   
% 221.25/221.43  |- rdf__type mesh__D003204sskos__Concept
% 221.25/221.43  |- mesh__dateEstablished mesh__D003204 1991-01-01
% 221.25/221.43  |- skos__annotation mesh__D003204
% 221.25/221.43       do not use /util except by MeSH definition   
% 221.25/221.43  |- mesh__recordMaintainer mesh__D003204 jls
% 221.25/221.43  |- skos__hiddenLabel mesh__D003204 Mainframe Computers
% 221.25/221.43  |- skos__scopeNote mesh__D003204
% 221.25/221.43       Large computers in both size and capacity.     
% 221.25/221.43  |- skos__historyNote mesh__D003204 Computers %28%1966-1986%29%
% 221.25/221.43  |- skos__broader mesh__D003204smesh__D003201
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D008498 2005
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D008498 1999
% 221.25/221.43  |- skos__prefLabel mesh__D008498 Medical Record Linkage
% 221.25/221.43  |- skos__hiddenLabel mesh__D008498 Medical Record Linkages
% 221.25/221.43  |- skos__hiddenLabel mesh__D008498 Linkages, Medical Record
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D008498 1995
% 221.25/221.43  |- skos__historyNote mesh__D008498 Medical Records %28%1966-1989%29%
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D008498 2006
% 221.25/221.43  |- skos__altLabel mesh__D008498 Record Linkage, Medical
% 221.25/221.43  |- skos__hiddenLabel mesh__D008498 Record Linkages, Medical
% 221.25/221.43  |- skos__annotation mesh__D008498
% 221.25/221.43       records in multiple institutions for combined use of a patient%27%s records; IM; DF: MED RECORD LINKAGE%A%  
% 221.25/221.43  |- skos__broader mesh__D008498smesh__D008499
% 221.25/221.43  |- mesh__dateEstablished mesh__D008498 1991-01-01
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D008498 1996
% 221.25/221.43  |- mesh__publicMeSHNote mesh__D008498
% 221.25/221.43       91; was see under MEDICAL RECORDS 1975-90   
% 221.25/221.43  |- skos__scopeNote mesh__D008498
% 221.25/221.43       The creation and maintenance of medical and vital records in multiple institutions in a manner that will facilitate the combined use of the records of identified individuals.%A%    
% 221.25/221.43  |- mesh__dateCreated mesh__D008498 1974-11-11
% 221.25/221.43  |- rdf__type mesh__D008498sskos__Concept
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D008498 2000
% 221.25/221.43  |- mesh__recordAuthorizer mesh__D008498 PLS
% 221.25/221.43  |- mesh__recordMaintainer mesh__D008498 PLS
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D008498 2003
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D008498 1997
% 221.25/221.43  |- skos__hiddenLabel mesh__D008498 Linkage, Medical Record
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D008498 2004
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D008498 2001
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D008498 1993
% 221.25/221.43  |- mesh__recordOriginator mesh__D008498 NLM
% 221.25/221.43  |- mesh__dateRevised mesh__D008498 1992-05-14
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D008498 1998
% 221.25/221.43  |- mesh__historyNote mesh__D008498
% 221.25/221.43       91%28%75%29%; was see under MEDICAL RECORDS 1975-90   
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D008498 2002
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D008498 1994
% 221.25/221.43  |- mesh__dateRevised mesh__D037282 2005-06-30
% 221.25/221.43  |- skos__hiddenLabel mesh__D037282 Calcium Binding Protein 3
% 221.25/221.43  |- mesh__dateEstablished mesh__D037282 2003-01-01
% 221.25/221.43  |- skos__altLabel mesh__D037282 CBP3 %28%Liver%29%
% 221.25/221.43  |- mesh__dateCreated mesh__D037282 2002-07-03
% 221.25/221.43  |- mesh__recordMaintainer mesh__D037282 jmp
% 221.25/221.43  |- skos__broader mesh__D037282smesh__D037102
% 221.25/221.43  |- skos__altLabel mesh__D037282 cC1qR Protein
% 221.25/221.43  |- mesh__publicMeSHNote mesh__D037282
% 221.25/221.43       2003; CALRETICULIN was indexed under CALCIUM-BINDING PROTEINS 1990-2002%A%  
% 221.25/221.43  |- skos__altLabel mesh__D037282 Calcium-Binding Protein-3
% 221.25/221.43  |- skos__prefLabel mesh__D037282 Calreticulin
% 221.25/221.43  |- skos__broader mesh__D037282smesh__D052139
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D037282 2006
% 221.25/221.43  |- skos__altLabel mesh__D037282 Calregulin
% 221.25/221.43  |- skos__altLabel mesh__D037282 CAB-63
% 221.25/221.43  |- mesh__historyNote mesh__D037282
% 221.25/221.43       2003; use CALRETICULIN %28%NM%29% 1990-2002   
% 221.25/221.43  |- skos__historyNote mesh__D037282
% 221.25/221.43       Calcium-Binding Proteins %28%1990-2002%29%
% 221.25/221.43  |- mesh__recordAuthorizer mesh__D037282 sjn
% 221.25/221.43  |- rdf__type mesh__D037282sskos__Concept
% 221.25/221.43  |- skos__hiddenLabel mesh__D037282
% 221.25/221.43       55 kDa High Affinity Calcium Binding Protein
% 221.25/221.43  |- skos__altLabel mesh__D037282 ERp60
% 221.25/221.43  |- skos__altLabel mesh__D037282 HACBP
% 221.25/221.43  |- skos__altLabel mesh__D037282
% 221.25/221.43       55-kDa High-Affinity Calcium Binding Protein
% 221.25/221.43  |- mesh__recordOriginator mesh__D037282 jmp
% 221.25/221.43  |- skos__scopeNote mesh__D037282
% 221.25/221.43       A multifunctional protein that is found primarily within membrane-bound organelles. In the ENDOPLASMIC RETICULUM it binds to specific N-linked oligosaccharides found on newly-synthesized proteins and functions as a MOLECULAR CHAPERONE that may play a role in PROTEIN FOLDING or retention and degradation of misfolded proteins. In addition calreticulin is a major storage form for CALCIUM and functions as a calcium-signaling molecule that can regulate intracellular calcium HOMEOSTASIS.%A%    
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D009591 2005
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D009591 2004
% 221.25/221.43  |- mesh__publicMeSHNote mesh__D009591 74   
% 221.25/221.43  |- mesh__recordMaintainer mesh__D009591 ssb
% 221.25/221.43  |- mesh__dateRevised mesh__D009591 2003-07-09
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D009591 2006
% 221.25/221.43  |- skos__altLabel mesh__D009591 Dinitrogenase
% 221.25/221.43  |- mesh__recordAuthorizer mesh__D009591 sjn
% 221.25/221.43  |- mesh__recordOriginator mesh__D009591 NLM
% 221.25/221.43  |- skos__scopeNote mesh__D009591
% 221.25/221.43       An enzyme system that catalyzes the fixing of nitrogen in soil bacteria and blue-green algae %28%CYANOBACTERIA%29%. EC 1.18.6.1.%A%    
% 221.25/221.43  |- skos__broader mesh__D009591smesh__D010088
% 221.25/221.43  |- mesh__historyNote mesh__D009591 74   
% 221.25/221.43  |- skos__prefLabel mesh__D009591 Nitrogenase
% 221.25/221.43  |- mesh__dateEstablished mesh__D009591 1974-01-01
% 221.25/221.43  |- mesh__dateCreated mesh__D009591 1999-01-01
% 221.25/221.43  |- skos__hiddenLabel mesh__D009591 Nitrogenase, Vanadium
% 221.25/221.43  |- rdf__type mesh__D009591sskos__Concept
% 221.25/221.43  |- skos__hiddenLabel mesh__D017225 Atherectomies, Rotational
% 221.25/221.43  |- skos__hiddenLabel mesh__D017225 Coronary Atherectomy, Directional
% 221.25/221.43  |- skos__annotation mesh__D017225
% 221.25/221.43       do not use /util except by MeSH definition   
% 221.25/221.43  |- skos__broader mesh__D017225smesh__D009204
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D017225 2006
% 221.25/221.43  |- skos__hiddenLabel mesh__D017225 Coronary Atherectomies
% 221.25/221.43  |- skos__hiddenLabel mesh__D017225 Atherectomies, Directional Coronary
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D017225 1999
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D017225 2005
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D017225 2004
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D017225 2001
% 221.25/221.43  |- mesh__dateEstablished mesh__D017225 1993-01-01
% 221.25/221.43  |- mesh__recordAuthorizer mesh__D017225 SJN
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D017225 1998
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D017225 2003
% 221.25/221.43  |- mesh__recordMaintainer mesh__D017225 PXP
% 221.25/221.43  |- mesh__publicMeSHNote mesh__D017225 93   
% 221.25/221.43  |- skos__altLabel mesh__D017225 Coronary Atherectomy
% 221.25/221.43  |- rdf__type mesh__D017225sskos__Concept
% 221.25/221.43  |- skos__hiddenLabel mesh__D017225 Rotational Atherectomies
% 221.25/221.43  |- skos__hiddenLabel mesh__D017225 Atherectomy, Directional Coronary
% 221.25/221.43  |- mesh__dateCreated mesh__D017225 1992-05-07
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D017225 2000
% 221.25/221.43  |- skos__prefLabel mesh__D017225 Atherectomy, Coronary
% 221.25/221.43  |- skos__scopeNote mesh__D017225
% 221.25/221.43       Percutaneous transluminal procedure for removing atheromatous plaque from the coronary arteries. Both directional %28%for removing focal atheromas%29% and rotational %28%for removing concentric atheromatous plaque%29% atherectomy devices have been used.%A%    
% 221.25/221.43  |- skos__hiddenLabel mesh__D017225 Directional Coronary Atherectomies
% 221.25/221.43  |- skos__broader mesh__D017225smesh__D017073
% 221.25/221.43  |- mesh__recordOriginator mesh__D017225 AGS
% 221.25/221.43  |- skos__hiddenLabel mesh__D017225 Atherectomy, Rotational
% 221.25/221.43  |- mesh__historyNote mesh__D017225 93   
% 221.25/221.43  |- skos__historyNote mesh__D017225
% 221.25/221.43       Coronary Arteriosclerosis %28%1989-1992%29%
% 221.25/221.43  |- skos__hiddenLabel mesh__D017225 Atherectomies, Coronary
% 221.25/221.43  |- skos__hiddenLabel mesh__D017225 Coronary Atherectomies, Directional
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D017225 2002
% 221.25/221.43  |- mesh__dateRevised mesh__D017225 1997-06-20
% 221.25/221.43  |- skos__altLabel mesh__D050659 AML3 Transcription Factor
% 221.25/221.43  |- skos__annotation mesh__D050659 see SCR for organism-specific terms   
% 221.25/221.43  |- skos__altLabel mesh__D050659 Osf2 Transcription Factor
% 221.25/221.43  |- skos__prefLabel mesh__D050659 Core Binding Factor Alpha 1 Subunit
% 221.25/221.43  |- skos__altLabel mesh__D050659 Runx2 Protein
% 221.25/221.43  |- mesh__historyNote mesh__D050659 2006%28%1997%29%   
% 221.25/221.43  |- mesh__recordAuthorizer mesh__D050659 sjn
% 221.25/221.43  |- skos__altLabel mesh__D050659 PEBP2alphaA Protein
% 221.25/221.43  |- skos__altLabel mesh__D050659 Acute Myeloid Leukemia 3 Protein
% 221.25/221.43  |- mesh__dateCreated mesh__D050659 2005-06-30
% 221.25/221.43  |- skos__altLabel mesh__D050659 CBFA1 Protein
% 221.25/221.43  |- skos__hiddenLabel mesh__D050659 SL3 3 Enhancer Factor 1
% 221.25/221.43  |- skos__altLabel mesh__D050659 CBFalpha Runt Domain Transcription Factor 1
% 221.25/221.43  |- mesh__dateEstablished mesh__D050659 2006-01-01
% 221.25/221.43  |- skos__scopeNote mesh__D050659
% 221.25/221.43       A transcription factor that dimerizes with CORE BINDING FACTOR BETA SUBUNIT to form core binding factor. It contains a highly conserved DNA-binding domain known as the runt domain and is involved in genetic regulation of skeletal development and CELL DIFFERENTIATION.%A%    
% 221.25/221.43  |- skos__altLabel mesh__D050659 CBFA-1 Protein
% 221.25/221.43  |- skos__altLabel mesh__D050659 SL3-3 Enhancer Factor 1
% 221.25/221.43  |- mesh__publicMeSHNote mesh__D050659
% 221.25/221.43       2006; RUNX2 PROTEIN was indexed under NEOPLASM PROTEINS %26% TRANSCRIPTION FACTORS 1997-2005%A%  
% 221.25/221.43  |- mesh__activeMeSHYear mesh__D050659 2006
% 221.25/221.43  |- mesh__recordOriginator mesh__D050659 DRC
% 221.25/221.43  |- skos__hiddenLabel mesh__D050659 CBFA 1 Protein
% 221.25/221.43  |- rdf__type mesh__D050659sskos__Concept
% 221.25/221.43  |- mesh__recordMaintainer mesh__D050659 DRC
% 221.25/221.43  |- skos__historyNote mesh__D050659 Neoplasm Proteins %28%1997-2005%29%
% 221.25/221.43  |- skos__historyNote mesh__D050659 Transcription Factors %28%1997-2005%29%
% 221.25/221.43  |- skos__broader mesh__D050659smesh__D050657
% 221.25/221.43  |- skos__altLabel mesh__D050659 SEF1 Protein
% 221.25/221.43  |- skos__altLabel mesh__D050659 CBFalpha1 Protein
% 221.25/221.43  |- skos__prefLabel mesh__D003205 Computing Methodologies
% 221.25/221.43  |- mesh__dateCreated mesh__D003205 1986-06-18
% 221.25/221.43  |- skos__hiddenLabel mesh__D003205 Performance Computing, High
% 221.25/221.43  |- mesh__recordOriginator mesh__D003205 EC
% 221.25/221.43  |- skos__annotation mesh__D003205 DF: COMPUTING METHODOL   
% 221.25/221.43  |- skos__altLabel mesh__D003205 Methodologies, Computing
% 221.25/221.44  |- mesh__dateRevised mesh__D003205 2004-07-07
% 221.25/221.44  |- mesh__recordAuthorizer mesh__D003205 sjn
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D003205 2006
% 221.25/221.44  |- skos__broader mesh__D003205smesh__D007254
% 221.25/221.44  |- rdf__type mesh__D003205sskos__Concept
% 221.25/221.44  |- mesh__historyNote mesh__D003205 97; was NON MESH 1987-96   
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D003205 2005
% 221.25/221.44  |- mesh__recordMaintainer mesh__D003205 jls
% 221.25/221.44  |- skos__scopeNote mesh__D003205
% 221.25/221.44       Computer-assisted analysis and processing of problems in a particular area.%A%    
% 221.25/221.44  |- skos__hiddenLabel mesh__D003205 Computing, High Performance
% 221.25/221.44  |- skos__hiddenLabel mesh__D003205 Methodology, Computing
% 221.25/221.44  |- mesh__publicMeSHNote mesh__D003205 97   
% 221.25/221.44  |- mesh__dateEstablished mesh__D003205 1997-01-01
% 221.25/221.44  |- skos__hiddenLabel mesh__D003205 Computing Methodology
% 221.25/221.44  |- mesh__recordOriginator mesh__D008499 NLM
% 221.25/221.44  |- skos__hiddenLabel mesh__D008499 Personal Health Record
% 221.25/221.44  |- skos__hiddenLabel mesh__D008499 Health Diary
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D008499 2002
% 221.25/221.44  |- skos__related mesh__D008499smesh__D005568
% 221.25/221.44  |- skos__hiddenLabel mesh__D008499 Personal Health Records
% 221.25/221.44  |- skos__hiddenLabel mesh__D008499 Health Record, Personal
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D008499 1996
% 221.25/221.44  |- skos__altLabel mesh__D008499 Medical Transcription
% 221.25/221.44  |- skos__hiddenLabel mesh__D008499 Medical Record
% 221.25/221.44  |- rdf__type mesh__D008499sskos__Concept
% 221.25/221.44  |- skos__hiddenLabel mesh__D008499 Medical Transcriptions
% 221.25/221.44  |- skos__hiddenLabel mesh__D008499 Records, Personal Health
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D008499 2003
% 221.25/221.44  |- skos__prefLabel mesh__D008499 Medical Records
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D008499 1997
% 221.25/221.44  |- skos__hiddenLabel mesh__D008499 Transcriptions, Medical
% 221.25/221.44  |- skos__altLabel mesh__D008499 Records, Medical
% 221.25/221.44  |- skos__hiddenLabel mesh__D008499 Record, Medical
% 221.25/221.44  |- mesh__recordMaintainer mesh__D008499 KEV
% 221.25/221.44  |- skos__related mesh__D008499smesh__D008487
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D008499 1998
% 221.25/221.44  |- mesh__dateRevised mesh__D008499 1995-05-23
% 221.25/221.44  |- skos__annotation mesh__D008499
% 221.25/221.44       vet records = RECORDS %28%IM%29% + VETERINARY MEDICINE %28%IM%29%; case reports as a form of medical presentation goes here or specific RECORDS term %28%IM%29%; FORMS AND RECORDS CONTROL, also available, is probably NIM when coord; DF: MED RECORDS%A%  
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D008499 2004
% 221.25/221.44  |- skos__scopeNote mesh__D008499
% 221.25/221.44       Recording of pertinent information concerning patient%27%s illness or illnesses.%A%    
% 221.25/221.44  |- skos__hiddenLabel mesh__D008499 Diaries, Health
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D008499 2005
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D008499 2000
% 221.25/221.44  |- mesh__recordAuthorizer mesh__D008499 PLS
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D008499 1999
% 221.25/221.44  |- skos__hiddenLabel mesh__D008499 Diary, Health
% 221.25/221.44  |- skos__broader mesh__D008499smesh__D011996
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D008499 2001
% 221.25/221.44  |- skos__hiddenLabel mesh__D008499 Record, Personal Health
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D008499 2006
% 221.25/221.44  |- mesh__dateCreated mesh__D008499 1999-01-01
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D013633 1999
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D013633 2006
% 221.25/221.44  |- rdf__type mesh__D013633sskos__Concept
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D013633 2002
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D013633 1998
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D013633 2005
% 221.25/221.44  |- mesh__recordMaintainer mesh__D013633 TPW
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D013633 2001
% 221.25/221.44  |- skos__broader mesh__D013633smesh__D007221
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D013633 2004
% 221.25/221.44  |- mesh__dateCreated mesh__D013633 1999-01-01
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D013633 2000
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D013633 2003
% 221.25/221.44  |- skos__annotation mesh__D013633
% 221.25/221.44       the leather industry, not suntanning; SPEC: SPEC qualif   
% 221.25/221.44  |- mesh__dateRevised mesh__D013633 1997-06-20
% 221.25/221.44  |- skos__scopeNote mesh__D013633
% 221.25/221.44       A process of preserving animal hides by chemical treatment %28%using vegetable tannins, metallic sulfates, and sulfurized phenol compounds, or syntans%29% to make them immune to bacterial attack, and subsequent treatments with fats and greases to make them pliable. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%    
% 221.25/221.44  |- mesh__recordOriginator mesh__D013633 NLM
% 221.25/221.44  |- skos__hiddenLabel mesh__D013633 Tannings
% 221.25/221.44  |- skos__prefLabel mesh__D013633 Tanning
% 221.25/221.44  |- mesh__recordAuthorizer mesh__D013633 SJN
% 221.25/221.44  |- mesh__dateRevised mesh__D009592 2005-06-30
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D009592 2006
% 221.25/221.44  |- skos__altLabel mesh__D009592 5-Iodo-4-hydroxy-3-nitrophenacetyl
% 221.25/221.44  |- mesh__dateEstablished mesh__D009592 1991-01-01
% 221.25/221.44  |- skos__hiddenLabel mesh__D009592 Hapten, NIP Acetyl
% 221.25/221.44  |- mesh__dateCreated mesh__D009592 1975-07-25
% 221.25/221.44  |- skos__altLabel mesh__D009592 Hydroxyiodonitrophenylacetate
% 221.25/221.44  |- mesh__recordMaintainer mesh__D009592 ssb
% 221.25/221.44  |- skos__altLabel mesh__D009592 NIP-Hapten
% 221.25/221.44  |- mesh__historyNote mesh__D009592
% 221.25/221.44       91%28%76%29%; was see under NITROPHENOLS 1976-90   
% 221.25/221.44  |- skos__broader mesh__D009592smesh__D006241
% 221.25/221.44  |- skos__hiddenLabel mesh__D009592 5 Iodo 4 hydroxy 3 nitrophenacetyl
% 221.25/221.44  |- skos__hiddenLabel mesh__D009592 Acetyl Hapten, NIP
% 221.25/221.44  |- skos__prefLabel mesh__D009592 Nitrohydroxyiodophenylacetate
% 221.25/221.44  |- mesh__recordAuthorizer mesh__D009592 sjn
% 221.25/221.44  |- skos__broader mesh__D009592smesh__D009596
% 221.25/221.44  |- rdf__type mesh__D009592sskos__Concept
% 221.25/221.44  |- skos__altLabel mesh__D009592 NIP Acetyl Hapten
% 221.25/221.44  |- skos__altLabel mesh__D009592
% 221.25/221.44       %28%4-Hydroxy-5-iodo-3-nitrophenyl%29%acetyl
% 221.25/221.44  |- skos__annotation mesh__D009592 D25-26 qualif; DF: note short X ref   
% 221.25/221.44  |- mesh__recordOriginator mesh__D009592 SH
% 221.25/221.44  |- skos__historyNote mesh__D009592 Iodine %28%1972-1975%29%
% 221.25/221.44  |- skos__altLabel mesh__D009592
% 221.25/221.44       %28%4-Hydroxy-3-iodo-5-nitrophenyl%29%acetyl
% 221.25/221.44  |- skos__historyNote mesh__D009592 Phenylacetates %28%1974-1975%29%
% 221.25/221.44  |- skos__hiddenLabel mesh__D009592 NIP Hapten
% 221.25/221.44  |- skos__scopeNote mesh__D009592
% 221.25/221.44       Also called 4-hydroxy-3-iodo-5-nitrophenylacetate. A haptenic determinant that can be radiolabeled and used as salts and derivatives for investigations of immunogenic specificity studies.%A%    
% 221.25/221.44  |- skos__historyNote mesh__D009592 Nitrophenols %28%1972-1975%29%
% 221.25/221.44  |- mesh__publicMeSHNote mesh__D009592
% 221.25/221.44       91; was see under NITROPHENOLS 1976-90   
% 221.25/221.44  |- skos__historyNote mesh__D049308 Oxygenases %28%1968-2004%29%
% 221.25/221.44  |- mesh__recordMaintainer mesh__D049308 ssb
% 221.25/221.44  |- rdf__type mesh__D049308sskos__Concept
% 221.25/221.44  |- mesh__recordAuthorizer mesh__D049308 sjn
% 221.25/221.44  |- mesh__dateEstablished mesh__D049308 2005-01-01
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D049308 2006
% 221.25/221.44  |- skos__scopeNote mesh__D049308
% 221.25/221.44       Non-heme iron-containing enzymes that incorporate two atoms of OXYGEN into the substrate. They are important in biosynthesis of FLAVONOIDS; GIBBERELLINS; and HYOSCYAMINE; and for degradation of AROMATIC HYDROCARBONS.%A%    
% 221.25/221.44  |- mesh__historyNote mesh__D049308 2005   
% 221.25/221.44  |- skos__broader mesh__D049308smesh__D010105
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D049308 2005
% 221.25/221.44  |- mesh__publicMeSHNote mesh__D049308 2005   
% 221.25/221.44  |- mesh__recordOriginator mesh__D049308 ssb
% 221.25/221.44  |- mesh__dateCreated mesh__D049308 2004-07-07
% 221.25/221.44  |- skos__prefLabel mesh__D049308 Dioxygenases
% 221.25/221.44  |- skos__hiddenLabel mesh__D013634 Acids, Tannic
% 221.25/221.44  |- skos__hiddenLabel mesh__D013634 Acid, Tannic
% 221.25/221.44  |- mesh__dateCreated mesh__D013634 1999-01-01
% 221.25/221.44  |- skos__prefLabel mesh__D013634 Tannins
% 221.25/221.44  |- skos__broader mesh__D013634smesh__D001704
% 221.25/221.44  |- mesh__recordOriginator mesh__D013634 NLM
% 221.25/221.44  |- mesh__recordAuthorizer mesh__D013634 sjn
% 221.25/221.44  |- mesh__recordMaintainer mesh__D013634 ssb
% 221.25/221.44  |- mesh__dateRevised mesh__D013634 2004-07-08
% 221.25/221.44  |- skos__altLabel mesh__D013634 Tannic Acids
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D013634 2006
% 221.25/221.44  |- rdf__type mesh__D013634sskos__Concept
% 221.25/221.44  |- skos__scopeNote mesh__D013634
% 221.25/221.44       Polyphenolic compounds with molecular weights of around 500-3000 daltons and containing enough hydroxyl groups %28%1-2 per 100 MW%29% for effective cross linking of other compounds %28%ASTRINGENTS%29%. The two main types are HYDROLYZABLE TANNINS and CONDENSED TANNINS. Historically, the term has applied to many compounds and plant extracts able to render skin COLLAGEN impervious to degradation. The word tannin derives from the Celtic word for OAK TREE which was used for leather processing.%A%    
% 221.25/221.44  |- skos__annotation mesh__D013634 HYDROLYZABLE TANNINS is also available   
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D013634 2005
% 221.25/221.44  |- skos__altLabel mesh__D013634 Tannic Acid
% 221.25/221.44  |- mesh__historyNote mesh__D046010 2005; use CARNIVORA 1998-2004   
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D046010 2005
% 221.25/221.44  |- skos__prefLabel mesh__D046010 Tigers
% 221.25/221.44  |- skos__scopeNote mesh__D046010
% 221.25/221.44       The species Panthera tigris, a large feline inhabiting Asia. Several subspecies exist including the Siberian tiger and Sumatran tiger.%A%    
% 221.25/221.44  |- mesh__dateEstablished mesh__D046010 2005-01-01
% 221.25/221.44  |- mesh__recordMaintainer mesh__D046010 ags
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D046010 2006
% 221.25/221.44  |- mesh__recordOriginator mesh__D046010 ags
% 221.25/221.44  |- mesh__publicMeSHNote mesh__D046010 2005; see CARNIVORA 1998-2004   
% 221.25/221.44  |- mesh__recordAuthorizer mesh__D046010 sjn
% 221.25/221.44  |- skos__historyNote mesh__D046010 Carnivora %28%1963-2004%29%
% 221.25/221.44  |- mesh__dateCreated mesh__D046010 2004-07-07
% 221.25/221.44  |- skos__altLabel mesh__D046010 Panthera tigris
% 221.25/221.44  |- rdf__type mesh__D046010sskos__Concept
% 221.25/221.44  |- skos__hiddenLabel mesh__D046010 Tiger
% 221.25/221.44  |- skos__broader mesh__D046010smesh__D046009
% 221.25/221.44  |- mesh__historyNote mesh__D009593 74   
% 221.25/221.44  |- skos__prefLabel mesh__D009593 Nitroimidazoles
% 221.25/221.44  |- mesh__dateEstablished mesh__D009593 1974-01-01
% 221.25/221.44  |- mesh__dateCreated mesh__D009593 1999-01-01
% 221.25/221.44  |- rdf__type mesh__D009593sskos__Concept
% 221.25/221.44  |- skos__broader mesh__D009593smesh__D009574
% 221.25/221.44  |- mesh__dateRevised mesh__D009593 2005-06-30
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D009593 2006
% 221.25/221.44  |- mesh__publicMeSHNote mesh__D009593 74   
% 221.25/221.44  |- mesh__recordMaintainer mesh__D009593 ssb
% 221.25/221.44  |- skos__broader mesh__D009593smesh__D007093
% 221.25/221.44  |- mesh__recordOriginator mesh__D009593 NLM
% 221.25/221.44  |- mesh__recordAuthorizer mesh__D009593 sjn
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D017227 1996
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D017227 2004
% 221.25/221.44  |- mesh__dateEstablished mesh__D017227 1993-01-01
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D017227 2002
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D017227 1997
% 221.25/221.44  |- mesh__dateCreated mesh__D017227 1992-05-22
% 221.25/221.44  |- skos__scopeNote mesh__D017227
% 221.25/221.44       Infections with nematodes of the genus TOXASCARIS.     
% 221.25/221.44  |- rdf__type mesh__D017227sskos__Concept
% 221.25/221.44  |- skos__prefLabel mesh__D017227 Toxascariasis
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D017227 1994
% 221.25/221.44  |- mesh__onlineNote mesh__D017227
% 221.25/221.44       use NEMATODE INFECTIONS to search TOXASCARIASIS 1968-92   
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D017227 1995
% 221.25/221.44  |- mesh__historyNote mesh__D017227
% 221.25/221.44       93; was see NEMATODE INFECTIONS 1989-92; was see under ASCARIASIS 1968-88%A%  
% 221.25/221.44  |- skos__hiddenLabel mesh__D017227 Toxascariases
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D017227 2005
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D017227 1993
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D017227 1998
% 221.25/221.44  |- skos__broader mesh__D017227smesh__D017191
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D017227 2000
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D017227 2006
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D017227 2003
% 221.25/221.44  |- skos__annotation mesh__D017227
% 221.25/221.44       an Ascaridida infect but differentiate from TOXOCARIASIS, also an Ascaridida infect%A%  
% 221.25/221.44  |- mesh__publicMeSHNote mesh__D017227
% 221.25/221.44       93; was see NEMATODE INFECTIONS 1989-92; was see under ASCARIASIS 1968-88%A%  
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D017227 1999
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D017227 2001
% 221.25/221.44  |- skos__annotation mesh__D003207 an egg protein   
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D003207 1999
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D003207 2001
% 221.25/221.44  |- skos__broader mesh__D003207smesh__D015387
% 221.25/221.44  |- mesh__recordOriginator mesh__D003207 NLM
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D003207 2004
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D003207 1998
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D003207 2000
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D003207 2003
% 221.25/221.44  |- skos__altLabel mesh__D003207 Ovotransferrin
% 221.25/221.44  |- mesh__dateRevised mesh__D003207 1995-05-19
% 221.25/221.44  |- skos__broader mesh__D003207smesh__D004527
% 221.25/221.44  |- skos__prefLabel mesh__D003207 Conalbumin
% 221.25/221.44  |- skos__broader mesh__D003207smesh__D000418
% 221.25/221.44  |- skos__historyNote mesh__D003207 Albumins %28%1969-1974%29%
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D003207 2006
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D003207 1997
% 221.25/221.44  |- mesh__recordAuthorizer mesh__D003207 PLS
% 221.25/221.44  |- rdf__type mesh__D003207sskos__Concept
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D003207 2002
% 221.25/221.44  |- skos__historyNote mesh__D003207 Egg Proteins %28%1973-1974%29%
% 221.25/221.44  |- skos__scopeNote mesh__D003207
% 221.25/221.44       A glycoprotein albumin from hen%27%s egg white with strong iron-binding affinity.%A%    
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D003207 2005
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D003207 1996
% 221.25/221.44  |- mesh__historyNote mesh__D003207
% 221.25/221.44       91%28%75%29%; was see under EGG PROTEINS 1975-90   
% 221.25/221.44  |- mesh__dateCreated mesh__D003207 1974-11-19
% 221.25/221.44  |- mesh__publicMeSHNote mesh__D003207
% 221.25/221.44       91; was see under EGG PROTEINS 1975-90   
% 221.25/221.44  |- mesh__dateEstablished mesh__D003207 1991-01-01
% 221.25/221.44  |- mesh__recordMaintainer mesh__D003207 KEV
% 221.25/221.44  |- skos__annotation mesh__D049309
% 221.25/221.44       coordinate IM with SKIN NEOPLASMS %28%IM%29%   
% 221.25/221.44  |- skos__hiddenLabel mesh__D049309 Acanthomas, Pilar Sheath
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D049309 2006
% 221.25/221.44  |- mesh__recordOriginator mesh__D049309 ags
% 221.25/221.44  |- skos__historyNote mesh__D049309 Skin Neoplasms %28%1965-2004%29%
% 221.25/221.44  |- skos__altLabel mesh__D049309 Acanthoma, Degos
% 221.25/221.44  |- skos__hiddenLabel mesh__D049309 Pilar Sheath Acanthoma
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D049309 2005
% 221.25/221.44  |- mesh__recordMaintainer mesh__D049309 ags
% 221.25/221.44  |- mesh__recordAuthorizer mesh__D049309 sjn
% 221.25/221.44  |- skos__hiddenLabel mesh__D049309 Acanthomas, Clear Cell
% 221.25/221.44  |- mesh__publicMeSHNote mesh__D049309 2005   
% 221.25/221.44  |- skos__hiddenLabel mesh__D049309 Clear Cell Acanthoma
% 221.25/221.44  |- skos__hiddenLabel mesh__D049309 Pilar Sheath Acanthomas
% 221.25/221.44  |- mesh__dateEstablished mesh__D049309 2005-01-01
% 221.25/221.44  |- skos__broader mesh__D049309smesh__D012878
% 221.25/221.44  |- skos__hiddenLabel mesh__D049309 Acanthomas
% 221.25/221.44  |- skos__scopeNote mesh__D049309
% 221.25/221.44       A neoplasm composed of squamous or epidermal cells.     
% 221.25/221.44  |- mesh__historyNote mesh__D049309 2005   
% 221.25/221.44  |- mesh__dateCreated mesh__D049309 2004-07-07
% 221.25/221.44  |- skos__prefLabel mesh__D049309 Acanthoma
% 221.25/221.44  |- skos__broader mesh__D049309smesh__D018307
% 221.25/221.44  |- skos__hiddenLabel mesh__D049309 Clear Cell Acanthomas
% 221.25/221.44  |- skos__hiddenLabel mesh__D049309 Degos Acanthoma
% 221.25/221.44  |- rdf__type mesh__D049309sskos__Concept
% 221.25/221.44  |- skos__broader mesh__D013635smesh__D028561
% 221.25/221.44  |- mesh__recordMaintainer mesh__D013635 jmp
% 221.25/221.44  |- skos__broader mesh__D013635smesh__D019216
% 221.25/221.44  |- mesh__recordOriginator mesh__D013635 NLM
% 221.25/221.44  |- rdf__type mesh__D013635sskos__Concept
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D013635 2006
% 221.25/221.44  |- mesh__dateRevised mesh__D013635 2001-07-25
% 221.25/221.44  |- mesh__recordAuthorizer mesh__D013635 sjn
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D013635 2005
% 221.25/221.44  |- skos__annotation mesh__D013635
% 221.25/221.44       Ta-181; Ta-180 = TANTALUM %28%IM%29% + ISOTOPES %28%NIM%29%; Ta-172-179, 182-186 = TANTALUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D013635 2002
% 221.25/221.44  |- skos__prefLabel mesh__D013635 Tantalum
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D013635 2004
% 221.25/221.44  |- mesh__dateCreated mesh__D013635 1999-01-01
% 221.25/221.44  |- skos__scopeNote mesh__D013635
% 221.25/221.44       Tantalum. A rare metallic element, atomic number 73, atomic weight 180.948, symbol Ta. It is a noncorrosive and malleable metal that has been used for plates or disks to replace cranial defects, for wire sutures, and for making prosthetic devices. %28%Dorland, 28th ed%29%%A%    
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D013635 2003
% 221.25/221.44  |- mesh__recordMaintainer mesh__D046011 ags
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D046011 2006
% 221.25/221.44  |- skos__altLabel mesh__D046011 Felis concolor
% 221.25/221.44  |- skos__altLabel mesh__D046011 Puma concolor coryi
% 221.25/221.44  |- skos__hiddenLabel mesh__D046011 Panther, Florida
% 221.25/221.44  |- skos__hiddenLabel mesh__D046011 Cougar
% 221.25/221.44  |- skos__prefLabel mesh__D046011 Puma
% 221.25/221.44  |- skos__hiddenLabel mesh__D046011 Lion, Mountain
% 221.25/221.44  |- skos__hiddenLabel mesh__D046011 Mountain Lions
% 221.25/221.44  |- skos__broader mesh__D046011smesh__D045989
% 221.25/221.44  |- mesh__dateCreated mesh__D046011 2004-07-07
% 221.25/221.44  |- mesh__dateEstablished mesh__D046011 2005-01-01
% 221.25/221.44  |- rdf__type mesh__D046011sskos__Concept
% 221.25/221.44  |- mesh__recordOriginator mesh__D046011 ags
% 221.25/221.44  |- skos__hiddenLabel mesh__D046011 Lions, Mountain
% 221.25/221.44  |- skos__hiddenLabel mesh__D046011 Pumas
% 221.25/221.44  |- mesh__publicMeSHNote mesh__D046011 2005; use CARNIVORA 1998-2004   
% 221.25/221.44  |- skos__altLabel mesh__D046011 Mountain Lion
% 221.25/221.44  |- mesh__recordAuthorizer mesh__D046011 sjn
% 221.25/221.44  |- skos__scopeNote mesh__D046011
% 221.25/221.44       A genus in the family FELIDAE comprising one species, Puma concolor. It is a large, long-tailed, feline of uniform color. The names puma, cougar, and mountain lion are used interchangeably for this species. There are more than 20 subspecies.%A%    
% 221.25/221.44  |- skos__altLabel mesh__D046011 Cougars
% 221.25/221.44  |- mesh__historyNote mesh__D046011 2005; use CARNIVORA 1998-2004   
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D046011 2005
% 221.25/221.44  |- skos__historyNote mesh__D046011 Carnivora %28%1969-2004%29%
% 221.25/221.44  |- skos__altLabel mesh__D018320 Leishmania %28%Leishmania%29% major
% 221.25/221.44  |- mesh__dateCreated mesh__D018320 1993-06-03
% 221.25/221.44  |- skos__altLabel mesh__D018320 Leishmania leishmania major
% 221.25/221.44  |- mesh__historyNote mesh__D018320
% 221.25/221.44       94; was LEISHMANIA TROPICA MAJOR see LEISHMANIA TROPICA 1992-93; was LEISHMANIA MAJOR see LEISHMANIA TROPICA 1986-91%A%  
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D018320 2005
% 221.25/221.44  |- mesh__publicMeSHNote mesh__D018320
% 221.25/221.44       94; was LEISHMANIA TROPICA MAJOR see LEISHMANIA TROPICA 1992-93; was LEISHMANIA MAJOR see LEISHMANIA TROPICA 1986-91%A%  
% 221.25/221.44  |- mesh__onlineNote mesh__D018320
% 221.25/221.44       use LEISHMANIA TROPICA to search LEISHMANIA TROPICA MAJOR 1992-93 %26% LEISHMANIA MAJOR 1986-91%A%  
% 221.25/221.44  |- skos__historyNote mesh__D018320 Leishmania %28%1966-1985%29%
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D018320 2006
% 221.25/221.44  |- skos__historyNote mesh__D018320 Leishmania tropica %28%1986-1993%29%
% 221.25/221.44  |- mesh__dateEstablished mesh__D018320 1994-01-01
% 221.25/221.44  |- skos__scopeNote mesh__D018320
% 221.25/221.44       A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes cutaneous leishmaniasis %28%LEISHMANIASIS, CUTANEOUS%29% of the Old World. Transmission is by Phlebotomus sandflies.%A%    
% 221.25/221.44  |- rdf__type mesh__D018320sskos__Concept
% 221.25/221.44  |- skos__prefLabel mesh__D018320 Leishmania major
% 221.25/221.44  |- skos__annotation mesh__D018320
% 221.25/221.44       infection: coord IM with LEISHMANIASIS, CUTANEOUS %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D018320 2004
% 221.25/221.44  |- skos__altLabel mesh__D018320 Leishmania tropica major
% 221.25/221.44  |- skos__broader mesh__D018320smesh__D007891
% 221.25/221.44  |- mesh__dateRevised mesh__D018320 2003-07-09
% 221.25/221.44  |- mesh__historyNote mesh__D004300 78   
% 221.25/221.44  |- skos__hiddenLabel mesh__D004300 in Sport, Doping
% 221.25/221.44  |- skos__scopeNote mesh__D004300
% 221.25/221.44       Illegitimate use of drugs for a desired effect in competitive sports; includes humans and animals.%A%    
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D004300 1998
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D004300 2004
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D004300 1995
% 221.25/221.44  |- mesh__dateRevised mesh__D004300 1992-05-14
% 221.25/221.44  |- skos__annotation mesh__D004300
% 221.25/221.44       human %26% animal; coord IM with animal doped %28%IM%29%   
% 221.25/221.44  |- mesh__recordOriginator mesh__D004300 EC
% 221.25/221.44  |- skos__hiddenLabel mesh__D004300 Doping in Sport
% 221.25/221.44  |- skos__hiddenLabel mesh__D004300 Abuse, Sports Drug
% 221.25/221.44  |- mesh__recordAuthorizer mesh__D004300 PLS
% 221.25/221.44  |- mesh__recordMaintainer mesh__D004300 TGC
% 221.25/221.44  |- skos__hiddenLabel mesh__D004300 Dopings, Blood
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D004300 1999
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D004300 1996
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D004300 1993
% 221.25/221.44  |- skos__hiddenLabel mesh__D004300 Sport, Doping in
% 221.25/221.44  |- skos__hiddenLabel mesh__D004300 Sports, Doping in
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D004300 2000
% 221.25/221.44  |- mesh__dateEstablished mesh__D004300 1978-01-01
% 221.25/221.44  |- rdf__type mesh__D004300sskos__Concept
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D004300 1997
% 221.25/221.44  |- skos__hiddenLabel mesh__D004300 Doping, Blood
% 221.25/221.44  |- skos__hiddenLabel mesh__D004300 in Sports, Doping
% 221.25/221.44  |- skos__hiddenLabel mesh__D004300 Drug Abuses, Sports
% 221.25/221.44  |- mesh__publicMeSHNote mesh__D004300 78   
% 221.25/221.44  |- mesh__dateCreated mesh__D004300 1977-05-13
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D004300 2005
% 221.25/221.44  |- skos__hiddenLabel mesh__D004300 Sports Drug Abuse
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D004300 2001
% 221.25/221.44  |- skos__hiddenLabel mesh__D004300 Sports Drug Abuses
% 221.25/221.44  |- skos__hiddenLabel mesh__D004300 Blood Dopings
% 221.25/221.44  |- skos__hiddenLabel mesh__D004300 Abuses, Sports Drug
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D004300 2006
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D004300 2002
% 221.25/221.44  |- skos__broader mesh__D004300smesh__D012940
% 221.25/221.44  |- skos__prefLabel mesh__D004300 Doping in Sports
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D004300 2003
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D004300 1994
% 221.25/221.44  |- rdf__type mesh__D009594sskos__Concept
% 221.25/221.44  |- skos__historyNote mesh__D009594 Styrenes %28%1972-1974%29%
% 221.25/221.44  |- mesh__recordOriginator mesh__D009594 NLM
% 221.25/221.44  |- mesh__recordAuthorizer mesh__D009594 sjn
% 221.25/221.44  |- skos__altLabel mesh__D009594 CI628
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D009594 2005
% 221.25/221.44  |- skos__prefLabel mesh__D009594 Nitromifene
% 221.25/221.44  |- skos__broader mesh__D009594smesh__D011759
% 221.25/221.44  |- skos__scopeNote mesh__D009594
% 221.25/221.44       A non-steroidal estrogen antagonist %28%as the 1:1 citrate%29% most commonly used as a research tool in animal studies.%A%    
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D009594 2006
% 221.25/221.44  |- mesh__publicMeSHNote mesh__D009594
% 221.25/221.44       91; was see under PYRROLIDINES 1979-90; was CI 628 see under PYRROLIDINES 1975-78%A%  
% 221.25/221.44  |- mesh__dateCreated mesh__D009594 1974-11-11
% 221.25/221.44  |- skos__altLabel mesh__D009594 Nitromiphene
% 221.25/221.44  |- skos__altLabel mesh__D009594 CN-55945-27
% 221.25/221.44  |- skos__hiddenLabel mesh__D009594 CI 628
% 221.25/221.44  |- mesh__recordMaintainer mesh__D009594 jmp
% 221.25/221.44  |- mesh__dateRevised mesh__D009594 2004-07-07
% 221.25/221.44  |- skos__historyNote mesh__D009594 Anisoles %28%1972-1974%29%
% 221.25/221.44  |- mesh__historyNote mesh__D009594
% 221.25/221.44       91%28%79%29%; was see under PYRROLIDINES 1979-90; was CI 628 see under PYRROLIDINES 1975-78%A%  
% 221.25/221.44  |- mesh__dateEstablished mesh__D009594 1991-01-01
% 221.25/221.44  |- mesh__onlineNote mesh__D009594
% 221.25/221.44       use NITROMIFENE to search CI 628 1975-78   
% 221.25/221.44  |- skos__historyNote mesh__D009594 Pyrrolidines %28%1972-1974%29%
% 221.25/221.44  |- mesh__dateCreated mesh__D017228 1992-05-20
% 221.25/221.44  |- rdf__type mesh__D017228sskos__Concept
% 221.25/221.44  |- skos__historyNote mesh__D017228 Growth Substances %28%1992%29%
% 221.25/221.44  |- mesh__onlineNote mesh__D017228
% 221.25/221.44       use HEPATOCYTE GROWTH FACTOR %28%NM%29% to search HEPATOCYTE GROWTH FACTOR 1984-92 and SCATTER FACTOR 1987-92%A%  
% 221.25/221.44  |- skos__hiddenLabel mesh__D017228 Factor, Scatter
% 221.25/221.44  |- mesh__dateEstablished mesh__D017228 1993-01-01
% 221.25/221.44  |- mesh__recordOriginator mesh__D017228 AGS
% 221.25/221.44  |- mesh__recordAuthorizer mesh__D017228 sjn
% 221.25/221.44  |- mesh__dateRevised mesh__D017228 2005-07-01
% 221.25/221.44  |- skos__historyNote mesh__D017228 Blood Proteins %28%1984-1991%29%
% 221.25/221.44  |- mesh__recordMaintainer mesh__D017228 sjn
% 221.25/221.44  |- skos__broader mesh__D017228smesh__D016207
% 221.25/221.44  |- skos__hiddenLabel mesh__D017228 Growth Factor, Hepatocyte
% 221.25/221.44  |- skos__altLabel mesh__D017228 Scatter Factor
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D017228 2006
% 221.25/221.44  |- mesh__historyNote mesh__D017228
% 221.25/221.44       93; was HEPATOCYTE GROWTH FACTOR %28%NM%29% 1984-92 and SCATTER FACTOR %28%NM%29% 1987-92%A%  
% 221.25/221.44  |- skos__hiddenLabel mesh__D017228 Factor, Hepatocyte Growth
% 221.25/221.44  |- skos__altLabel mesh__D017228 Hepatopoietin
% 221.25/221.44  |- skos__prefLabel mesh__D017228 Hepatocyte Growth Factor
% 221.25/221.44  |- mesh__publicMeSHNote mesh__D017228
% 221.25/221.44       93; HEPATOCYTE GROWTH FACTOR was indexed under GROWTH SUBSTANCES 1992 and under BLOOD PROTEINS 1984-91; SCATTER FACTOR was indexed under CYTOKINES 1992 and under PROTEINS 1987-91%A%  
% 221.25/221.44  |- skos__scopeNote mesh__D017228
% 221.25/221.44       Multifunctional growth factor which regulates both cell growth and cell motility. It exerts a strong mitogenic effect on hepatocytes and primary epithelial cells. Its receptor is PROTO-ONCOGENE PROTEINS C-MET.%A%    
% 221.25/221.44  |- skos__altLabel mesh__D017228 Hepatopoietin A
% 221.25/221.44  |- skos__scopeNote mesh__D003208
% 221.25/221.44       A MANNOSE/GLUCOSE binding lectin isolated from the jack bean %28%Canavalia ensiformis%29%. It is a potent mitogen used to stimulate cell proliferation in lymphocytes, primarily T-lymphocyte, cultures.%A%    
% 221.25/221.44  |- mesh__dateEstablished mesh__D003208 1974-01-01
% 221.25/221.44  |- skos__annotation mesh__D003208 DF: CON A   
% 221.25/221.44  |- mesh__dateCreated mesh__D003208 1999-01-01
% 221.25/221.44  |- mesh__recordOriginator mesh__D003208 NLM
% 221.25/221.44  |- skos__hiddenLabel mesh__D003208 A, Concanavalin
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D003208 2006
% 221.25/221.44  |- skos__historyNote mesh__D003208 Lectins %28%1966-1970%29%
% 221.25/221.44  |- skos__related mesh__D003208smesh__D011952
% 221.25/221.44  |- rdf__type mesh__D003208sskos__Concept
% 221.25/221.44  |- skos__broader mesh__D003208smesh__D037121
% 221.25/221.44  |- mesh__historyNote mesh__D003208 74%28%71%29%   
% 221.25/221.44  |- skos__prefLabel mesh__D003208 Concanavalin A
% 221.25/221.44  |- mesh__publicMeSHNote mesh__D003208 74   
% 221.25/221.44  |- mesh__dateRevised mesh__D003208 2005-06-30
% 221.25/221.44  |- mesh__recordMaintainer mesh__D003208 ssb
% 221.25/221.44  |- mesh__recordAuthorizer mesh__D003208 sjn
% 221.25/221.44  |- skos__broader mesh__D011458Q000031smesh__D011458
% 221.25/221.44  |- mesh__preferredCombination mesh__D011458Q000031smesh__D011459
% 221.25/221.44  |- rdf__type mesh__D011458Q000031smesh__CompoundConcept
% 221.25/221.44  |- skos__prefLabel mesh__D046810 Gyrovirus
% 221.25/221.44  |- rdf__type mesh__D046810sskos__Concept
% 221.25/221.44  |- mesh__historyNote mesh__D046810 2005   
% 221.25/221.44  |- skos__scopeNote mesh__D046810
% 221.25/221.44       A genus in the family CIRCOVIRIDAE comprising the single species CHICKEN ANEMIA VIRUS.%A%    
% 221.25/221.44  |- mesh__activeMeSHYear mesh__D046810 2006
% 221.25/221.44  |- mesh__recordAuthorizer mesh__D046810 sjn
% 221.25/221.45  |- mesh__dateCreated mesh__D046810 2004-07-07
% 221.25/221.45  |- mesh__recordOriginator mesh__D046810 ags
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D046810 2005
% 221.25/221.45  |- mesh__publicMeSHNote mesh__D046810 2005   
% 221.25/221.45  |- mesh__recordMaintainer mesh__D046810 ags
% 221.25/221.45  |- mesh__dateEstablished mesh__D046810 2005-01-01
% 221.25/221.45  |- skos__hiddenLabel mesh__D046810 Gyroviruses
% 221.25/221.45  |- skos__broader mesh__D046810smesh__D018136
% 221.25/221.45  |- skos__annotation mesh__D046810
% 221.25/221.45       infection: coord IM with CIRCOVIRIDAE INFECTIONS %28%IM%29%   
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D013636 2000
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D013636 1998
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D013636 2005
% 221.25/221.45  |- skos__prefLabel mesh__D013636 Tanzania
% 221.25/221.45  |- skos__broader mesh__D013636smesh__D000351
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D013636 2001
% 221.25/221.45  |- rdf__type mesh__D013636sskos__Concept
% 221.25/221.45  |- skos__scopeNote mesh__D013636
% 221.25/221.45       A republic in eastern Africa, south of UGANDA and north of MOZAMBIQUE. Its capital is Dar es Salaam %28%House of Peace%29%. It was formed in 1964 by a merger of the countries of Tanganyika and Zanzibar. The country has been dominated successively by Arabs, Portugal, Oman, Zanzibar, Germany, and Britain. It became a British mandate in 1920 as Tanganyika and became independent in 1961. It united with Zanzibar in 1964 as Tanzania. Tanganyika was named for the lake of that name, kou tanganyika meaning to join, i.e., the place where waters met and Zanzibar, from Zeni or Zengj, the name of a local people, meaning black + the Arabic barr, coast or shore. %28%From Webster%27%s New Geographical Dictionary, 1988, p1186 %26% Room, Brewer%27%s Dictionary of Names, 1992, p533, 609%29%%A%    
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D013636 1999
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D013636 2006
% 221.25/221.45  |- mesh__dateCreated mesh__D013636 1999-01-01
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D013636 1996
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D013636 2003
% 221.25/221.45  |- mesh__recordMaintainer mesh__D013636 TGC
% 221.25/221.45  |- skos__annotation mesh__D013636
% 221.25/221.45       a republic in eastern Africa, from TANganyika + ZANzibar   
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D013636 2002
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D013636 1997
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D013636 2004
% 221.25/221.45  |- mesh__recordOriginator mesh__D013636 NLM
% 221.25/221.45  |- mesh__dateRevised mesh__D013636 1995-02-21
% 221.25/221.45  |- mesh__recordAuthorizer mesh__D013636 PLS
% 221.25/221.45  |- skos__altLabel mesh__D018321 Myxoma, Nerve Sheath
% 221.25/221.45  |- skos__prefLabel mesh__D018321 Neurothekeoma
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018321 1998
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018321 2005
% 221.25/221.45  |- mesh__recordOriginator mesh__D018321 PLS
% 221.25/221.45  |- skos__hiddenLabel mesh__D018321 Neurothekeomas
% 221.25/221.45  |- skos__broader mesh__D018321smesh__D009232
% 221.25/221.45  |- mesh__historyNote mesh__D018321 94   
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018321 2002
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018321 1999
% 221.25/221.45  |- mesh__dateRevised mesh__D018321 1995-06-08
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018321 2006
% 221.25/221.45  |- skos__altLabel mesh__D018321 Neurothecoma
% 221.25/221.45  |- skos__historyNote mesh__D018321 Skin Neoplasms %28%1980-1993%29%
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018321 1996
% 221.25/221.45  |- skos__hiddenLabel mesh__D018321 Myxomas, Nerve Sheath
% 221.25/221.45  |- rdf__type mesh__D018321sskos__Concept
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018321 2003
% 221.25/221.45  |- skos__hiddenLabel mesh__D018321 Neurotheceomas
% 221.25/221.45  |- skos__hiddenLabel mesh__D018321 Nerve Sheath Myxomas
% 221.25/221.45  |- mesh__recordAuthorizer mesh__D018321 PLS
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018321 2000
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018321 1997
% 221.25/221.45  |- skos__annotation mesh__D018321
% 221.25/221.45       a nerve sheath tumor: Greek neuro-, nerve + theke, sheath; /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018321 2004
% 221.25/221.45  |- skos__scopeNote mesh__D018321
% 221.25/221.45       A benign myxoma of cutaneous nerve sheath origin. Theke is from the Greek theke, sheath. %28%From Stedman, 25th ed%29%%A%    
% 221.25/221.45  |- skos__historyNote mesh__D018321
% 221.25/221.45       Nervous System Neoplasms %28%1990-1993%29%
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018321 2001
% 221.25/221.45  |- mesh__dateEstablished mesh__D018321 1994-01-01
% 221.25/221.45  |- mesh__dateCreated mesh__D018321 1993-06-25
% 221.25/221.45  |- mesh__publicMeSHNote mesh__D018321 94   
% 221.25/221.45  |- skos__hiddenLabel mesh__D018321 Nerve Sheath Myxoma
% 221.25/221.45  |- skos__altLabel mesh__D018321 Neurotheceoma
% 221.25/221.45  |- skos__broader mesh__D018321smesh__D018317
% 221.25/221.45  |- skos__hiddenLabel mesh__D018321 Neurothecomas
% 221.25/221.45  |- mesh__recordMaintainer mesh__D018321 KEV
% 221.25/221.45  |- skos__hiddenLabel mesh__D004301 Shift, Doppler
% 221.25/221.45  |- skos__altLabel mesh__D004301 Effect, Doppler
% 221.25/221.45  |- skos__broader mesh__D004301smesh__D010825
% 221.25/221.45  |- mesh__dateRevised mesh__D004301 2001-07-25
% 221.25/221.45  |- skos__altLabel mesh__D004301 Doppler Shift
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D004301 2003
% 221.25/221.45  |- mesh__historyNote mesh__D004301
% 221.25/221.45       91%28%75%29%; was see under PHYSICS 1975-90   
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D004301 2005
% 221.25/221.45  |- mesh__publicMeSHNote mesh__D004301 91; was see under PHYSICS 1975-90   
% 221.25/221.45  |- skos__annotation mesh__D004301
% 221.25/221.45       no qualif; note DOPPLER ULTRASOUND see ULTRASONICS; Doppler flowmetry goes under ULTRASONICS; ULTRASONOGRAPHY; their specifics or LASER-DOPPLER FLOWMETRY%A%  
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D004301 2004
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D004301 2002
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D004301 2006
% 221.25/221.45  |- skos__prefLabel mesh__D004301 Doppler Effect
% 221.25/221.45  |- mesh__dateCreated mesh__D004301 1974-12-12
% 221.25/221.45  |- mesh__recordMaintainer mesh__D004301 mdb
% 221.25/221.45  |- mesh__recordAuthorizer mesh__D004301 sjn
% 221.25/221.45  |- skos__scopeNote mesh__D004301
% 221.25/221.45       Changes in the observed frequency of waves %28%as sound, light, or radio waves%29% due to the relative motion of source and observer. The effect was named for the 19th century Austrian physicist Johann Christian Doppler.%A%    
% 221.25/221.45  |- mesh__recordOriginator mesh__D004301 NLM
% 221.25/221.45  |- rdf__type mesh__D004301sskos__Concept
% 221.25/221.45  |- mesh__dateEstablished mesh__D004301 1991-01-01
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009595 1994
% 221.25/221.45  |- mesh__recordAuthorizer mesh__D009595 PLS
% 221.25/221.45  |- skos__prefLabel mesh__D009595 Nitroparaffins
% 221.25/221.45  |- mesh__dateRevised mesh__D009595 1992-05-19
% 221.25/221.45  |- mesh__dateEstablished mesh__D009595 1991-01-01
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009595 2004
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009595 2001
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009595 1997
% 221.25/221.45  |- mesh__onlineNote mesh__D009595 search ALKANES 1968-74   
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009595 2000
% 221.25/221.45  |- rdf__type mesh__D009595sskos__Concept
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009595 1993
% 221.25/221.45  |- mesh__recordMaintainer mesh__D009595 TAP
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009595 2003
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009595 1996
% 221.25/221.45  |- mesh__dateCreated mesh__D009595 1999-01-01
% 221.25/221.45  |- skos__broader mesh__D009595smesh__D000473
% 221.25/221.45  |- mesh__historyNote mesh__D009595
% 221.25/221.45       91%28%75%29%; was see under ALKANES 1975-90   
% 221.25/221.45  |- mesh__recordOriginator mesh__D009595 NLM
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009595 2006
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009595 1999
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009595 2002
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009595 1995
% 221.25/221.45  |- skos__broader mesh__D009595smesh__D009574
% 221.25/221.45  |- mesh__publicMeSHNote mesh__D009595 91; was see under ALKANES 1975-90   
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009595 2005
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009595 1998
% 221.25/221.45  |- skos__historyNote mesh__D017229 Oxyuriasis %28%1966-1992%29%
% 221.25/221.45  |- skos__hiddenLabel mesh__D017229 Oxyuris vermicularis Infections
% 221.25/221.45  |- skos__broader mesh__D017229smesh__D010123
% 221.25/221.45  |- skos__hiddenLabel mesh__D017229 Infections, Oxyuris vermicularis
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D017229 2005
% 221.25/221.45  |- mesh__recordOriginator mesh__D017229 PXP
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D017229 2006
% 221.25/221.45  |- skos__scopeNote mesh__D017229
% 221.25/221.45       Infection with nematodes of the genus ENTEROBIUS; E. vermicularis, the pinworm of man, causes a crawling sensation and pruritus. This condition results in scratching the area, occasionally causing scarification.%A%    
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D017229 2003
% 221.25/221.45  |- skos__altLabel mesh__D017229 Infection, Enterobius vermicularis
% 221.25/221.45  |- mesh__dateRevised mesh__D017229 2001-07-25
% 221.25/221.45  |- mesh__recordMaintainer mesh__D017229 mdb
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D017229 2004
% 221.25/221.45  |- mesh__dateEstablished mesh__D017229 1993-01-01
% 221.25/221.45  |- mesh__historyNote mesh__D017229
% 221.25/221.45       93; was see OXYURIASIS 1975-92; was see under OXYURIASIS 1967-74%A%  
% 221.25/221.45  |- skos__hiddenLabel mesh__D017229 Enterobius vermicularis Infections
% 221.25/221.45  |- mesh__dateCreated mesh__D017229 1992-05-08
% 221.25/221.45  |- skos__hiddenLabel mesh__D017229 Enterobiases
% 221.25/221.45  |- rdf__type mesh__D017229sskos__Concept
% 221.25/221.45  |- skos__annotation mesh__D017229 nematode infect caused by Enterobius   
% 221.25/221.45  |- mesh__onlineNote mesh__D017229
% 221.25/221.45       use OXYURIASIS to search ENTEROBIASIS 1966-92   
% 221.25/221.45  |- skos__altLabel mesh__D017229 Oxyuris vermicularis Infection
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D017229 2002
% 221.25/221.45  |- mesh__recordAuthorizer mesh__D017229 sjn
% 221.25/221.45  |- mesh__publicMeSHNote mesh__D017229
% 221.25/221.45       93; was see OXYURIASIS 1975-92; was see under OXYURIASIS 1967-74%A%  
% 221.25/221.45  |- skos__hiddenLabel mesh__D017229 Infections, Enterobius vermicularis
% 221.25/221.45  |- skos__altLabel mesh__D017229 Infection, Oxyuris vermicularis
% 221.25/221.45  |- skos__altLabel mesh__D017229 Enterobius vermicularis Infection
% 221.25/221.45  |- skos__prefLabel mesh__D017229 Enterobiasis
% 221.25/221.45  |- mesh__publicMeSHNote mesh__D003209 91; was see under PRISONS 1975-90   
% 221.25/221.45  |- mesh__dateEstablished mesh__D003209 1991-01-01
% 221.25/221.45  |- mesh__dateRevised mesh__D003209 1999-11-03
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D003209 2005
% 221.25/221.45  |- mesh__recordMaintainer mesh__D003209 kle
% 221.25/221.45  |- skos__annotation mesh__D003209 specify geog if pertinent   
% 221.25/221.45  |- skos__broader mesh__D003209smesh__D011330
% 221.25/221.45  |- mesh__recordAuthorizer mesh__D003209 sjn
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D003209 2006
% 221.25/221.45  |- rdf__type mesh__D003209sskos__Concept
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D003209 2000
% 221.25/221.45  |- skos__hiddenLabel mesh__D003209 Camp, Concentration
% 221.25/221.45  |- skos__scopeNote mesh__D003209
% 221.25/221.45       Facilities in which war or political prisoners are confined.%A%    
% 221.25/221.45  |- skos__hiddenLabel mesh__D003209 Concentration Camp
% 221.25/221.45  |- skos__prefLabel mesh__D003209 Concentration Camps
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D003209 2001
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D003209 2003
% 221.25/221.45  |- mesh__recordOriginator mesh__D003209 NLM
% 221.25/221.45  |- mesh__historyNote mesh__D003209
% 221.25/221.45       91%28%75%29%; was see under PRISONS 1975-90   
% 221.25/221.45  |- skos__hiddenLabel mesh__D003209 Camps, Concentration
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D003209 2002
% 221.25/221.45  |- mesh__onlineNote mesh__D003209 search PRISONS 1966-74   
% 221.25/221.45  |- mesh__dateCreated mesh__D003209 1999-01-01
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D003209 2004
% 221.25/221.45  |- skos__hiddenLabel mesh__D013637 Recording, Tape
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D013637 2005
% 221.25/221.45  |- mesh__recordMaintainer mesh__D013637 ags
% 221.25/221.45  |- mesh__recordOriginator mesh__D013637 NLM
% 221.25/221.45  |- skos__prefLabel mesh__D013637 Tape Recording
% 221.25/221.45  |- mesh__dateEstablished mesh__D013637 1967-01-01
% 221.25/221.45  |- skos__altLabel mesh__D013637 Tape Recordings
% 221.25/221.45  |- mesh__recordAuthorizer mesh__D013637 sjn
% 221.25/221.45  |- rdf__type mesh__D013637sskos__Concept
% 221.25/221.45  |- skos__hiddenLabel mesh__D013637 Audiotape
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D013637 2006
% 221.25/221.45  |- mesh__dateCreated mesh__D013637 1999-01-01
% 221.25/221.45  |- skos__broader mesh__D013637smesh__D001296
% 221.25/221.45  |- mesh__dateRevised mesh__D013637 2004-07-07
% 221.25/221.45  |- mesh__publicMeSHNote mesh__D013637 67   
% 221.25/221.45  |- skos__broader mesh__D013637smesh__D003308
% 221.25/221.45  |- skos__scopeNote mesh__D013637
% 221.25/221.45       Recording of information on magnetic or punched paper tape.%A%    
% 221.25/221.45  |- mesh__historyNote mesh__D013637 67%28%64%29%   
% 221.25/221.45  |- skos__annotation mesh__D013637 IM   
% 221.25/221.45  |- mesh__recordAuthorizer mesh__D018322 PLS
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018322 2000
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018322 1996
% 221.25/221.45  |- mesh__dateEstablished mesh__D018322 1994-01-01
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018322 2003
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018322 2001
% 221.25/221.45  |- rdf__type mesh__D018322sskos__Concept
% 221.25/221.45  |- skos__prefLabel mesh__D018322 Angiofibroma
% 221.25/221.45  |- skos__hiddenLabel mesh__D018322 Angiofibromas
% 221.25/221.45  |- mesh__dateCreated mesh__D018322 1993-06-25
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018322 1997
% 221.25/221.45  |- mesh__publicMeSHNote mesh__D018322 94   
% 221.25/221.45  |- skos__annotation mesh__D018322
% 221.25/221.45       /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018322 2004
% 221.25/221.45  |- skos__scopeNote mesh__D018322
% 221.25/221.45       A benign neoplasm of fibrous tissue in which there are numerous small and large, frequently dilated, vascular channels. %28%Stedman, 25th ed%29%%A%    
% 221.25/221.45  |- mesh__recordMaintainer mesh__D018322 KEV
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018322 2002
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018322 1998
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018322 2005
% 221.25/221.45  |- skos__historyNote mesh__D018322 Dermatofibroma %28%1966-1993%29%
% 221.25/221.45  |- skos__broader mesh__D018322smesh__D009383
% 221.25/221.45  |- mesh__recordOriginator mesh__D018322 PLS
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018322 1999
% 221.25/221.45  |- mesh__historyNote mesh__D018322 94   
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018322 2006
% 221.25/221.45  |- mesh__dateRevised mesh__D018322 1995-06-08
% 221.25/221.45  |- mesh__publicMeSHNote mesh__D051756
% 221.25/221.45       2006; LEUCINE-RESPONSIVE REGULATORY PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1991-2005, %26% under BACTERIAL PROTEINS 1991-2004%A%  
% 221.25/221.45  |- skos__hiddenLabel mesh__D051756 Leucine Responsive Regulatory Protein
% 221.25/221.45  |- mesh__recordAuthorizer mesh__D051756 sjn
% 221.25/221.45  |- skos__scopeNote mesh__D051756
% 221.25/221.45       A LEUCINE and DNA-binding protein that is found primarily in BACTERIA and ARCHAEA. It regulates GENETIC TRANSCRIPTION involved in METABOLISM of AMINO ACIDS in response to the increased concentration of LEUCINE.%A%    
% 221.25/221.45  |- skos__prefLabel mesh__D051756 Leucine-Responsive Regulatory Protein
% 221.25/221.45  |- mesh__recordOriginator mesh__D051756 DRC
% 221.25/221.45  |- mesh__recordMaintainer mesh__D051756 DRC
% 221.25/221.45  |- mesh__dateEstablished mesh__D051756 2006-01-01
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D051756 2006
% 221.25/221.45  |- rdf__type mesh__D051756sskos__Concept
% 221.25/221.45  |- skos__broader mesh__D051756smesh__D014157
% 221.25/221.45  |- skos__broader mesh__D051756smesh__D004268
% 221.25/221.45  |- mesh__dateCreated mesh__D051756 2005-06-30
% 221.25/221.45  |- mesh__historyNote mesh__D051756 2006%28%1991%29%   
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D004302 1999
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D004302 1993
% 221.25/221.45  |- mesh__dateCreated mesh__D004302 1982-04-28
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D004302 2003
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D004302 2000
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D004302 1995
% 221.25/221.45  |- skos__altLabel mesh__D004302 Hypothalamic Nucleus, Dorsomedial
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D004302 2005
% 221.25/221.45  |- mesh__recordAuthorizer mesh__D004302 PLS
% 221.25/221.45  |- skos__historyNote mesh__D004302 Hypothalamus %28%1966-1982%29%
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D004302 2004
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D004302 2001
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D004302 2006
% 221.25/221.45  |- mesh__recordOriginator mesh__D004302 RC
% 221.25/221.45  |- mesh__historyNote mesh__D004302
% 221.25/221.45       91%28%83%29%; was see under HYPOTHALAMUS, MIDDLE 1983-90   
% 221.25/221.45  |- mesh__publicMeSHNote mesh__D004302
% 221.25/221.45       91; was see under HYPOTHALAMUS, MIDDLE 1983-90   
% 221.25/221.45  |- skos__hiddenLabel mesh__D004302 Nucleus, Dorsomedial Hypothalamic
% 221.25/221.45  |- skos__broader mesh__D004302smesh__D007033
% 221.25/221.45  |- mesh__recordMaintainer mesh__D004302 TAP
% 221.25/221.45  |- mesh__dateRevised mesh__D004302 1992-05-14
% 221.25/221.45  |- rdf__type mesh__D004302sskos__Concept
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D004302 2002
% 221.25/221.45  |- mesh__dateEstablished mesh__D004302 1991-01-01
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D004302 1996
% 221.25/221.45  |- skos__scopeNote mesh__D004302
% 221.25/221.45       An aggregation of cells in the middle hypothalamus dorsal to the ventromedial nucleus and bordering the third ventricle.%A%    
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D004302 1998
% 221.25/221.45  |- skos__prefLabel mesh__D004302 Dorsomedial Hypothalamic Nucleus
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D004302 1997
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D004302 1994
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009596 2004
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009596 1997
% 221.25/221.45  |- skos__broader mesh__D009596smesh__D009574
% 221.25/221.45  |- skos__prefLabel mesh__D009596 Nitrophenols
% 221.25/221.45  |- rdf__type mesh__D009596sskos__Concept
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009596 1993
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009596 2003
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009596 1996
% 221.25/221.45  |- mesh__recordAuthorizer mesh__D009596 PLS
% 221.25/221.45  |- mesh__dateCreated mesh__D009596 1999-01-01
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009596 2001
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009596 2006
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009596 1999
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009596 2000
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009596 1995
% 221.25/221.45  |- mesh__recordMaintainer mesh__D009596 TAP
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009596 2005
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009596 1998
% 221.25/221.45  |- skos__broader mesh__D009596smesh__D010636
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009596 1994
% 221.25/221.45  |- mesh__recordOriginator mesh__D009596 NLM
% 221.25/221.45  |- mesh__dateRevised mesh__D009596 1992-05-19
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D009596 2002
% 221.25/221.45  |- mesh__publicMeSHNote mesh__D042421 2004   
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D042421 2006
% 221.25/221.45  |- skos__prefLabel mesh__D042421 Histone Code
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D042421 2004
% 221.25/221.45  |- rdf__type mesh__D042421sskos__Concept
% 221.25/221.45  |- skos__scopeNote mesh__D042421
% 221.25/221.45       The specific patterns of POST-TRANSLATIONAL PROTEIN MODIFICATION of HISTONES, i.e. histone ACETYLATION; METHYLATION; PHOSPHORYLATION; and ubiquitination, at specific amino acid residues, that are involved in assembly, maintenance, and modification of different chromatin structural states, such as EUCHROMATIN and HETEROCHROMATIN.%A%    
% 221.25/221.45  |- skos__related mesh__D042421smesh__D005815
% 221.25/221.45  |- mesh__dateEstablished mesh__D042421 2004-01-01
% 221.25/221.45  |- skos__historyNote mesh__D042421 Histones %28%2000-2003%29%
% 221.25/221.45  |- skos__broader mesh__D042421smesh__D000595
% 221.25/221.45  |- mesh__dateCreated mesh__D042421 2003-07-09
% 221.25/221.45  |- skos__broader mesh__D042421smesh__D040342
% 221.25/221.45  |- skos__related mesh__D042421smesh__D011499
% 221.25/221.45  |- skos__hiddenLabel mesh__D042421 Code, Histone
% 221.25/221.45  |- skos__related mesh__D042421smesh__D042002
% 221.25/221.45  |- mesh__historyNote mesh__D042421 2004   
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D042421 2005
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D014730 1999
% 221.25/221.45  |- mesh__recordAuthorizer mesh__D014730 PLS
% 221.25/221.45  |- skos__related mesh__D014730smesh__D007756
% 221.25/221.45  |- mesh__dateCreated mesh__D014730 1999-01-01
% 221.25/221.45  |- skos__altLabel mesh__D014730 Medicine, Veterinary
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D014730 1995
% 221.25/221.45  |- mesh__recordOriginator mesh__D014730 NLM
% 221.25/221.45  |- skos__broader mesh__D014730smesh__D006281
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D014730 2003
% 221.25/221.45  |- skos__annotation mesh__D014730
% 221.25/221.45       SPEC only: SPEC qualif; prefer /vet with diseases %26% techniques: Manual 19.7+, 19.8.81; indexing policy: Manual 23.33+; /legislation %26% jurisprudence = LEGISLATION, VETERINARY or VETERINARY MEDICINE %28%IM%29% + JURISPRUDENCE %28%IM%29%; DF: VET MED%A%  
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D014730 1996
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D014730 2000
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D014730 2004
% 221.25/221.45  |- mesh__recordMaintainer mesh__D014730 TGC
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D014730 1997
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D014730 2001
% 221.25/221.45  |- rdf__type mesh__D014730sskos__Concept
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D014730 2005
% 221.25/221.45  |- skos__prefLabel mesh__D014730 Veterinary Medicine
% 221.25/221.45  |- skos__related mesh__D014730smesh__D017750
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D014730 1998
% 221.25/221.45  |- skos__scopeNote mesh__D014730
% 221.25/221.45       The medical science concerned with the prevention, diagnosis, and treatment of diseases in animals.%A%    
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D014730 2002
% 221.25/221.45  |- mesh__dateRevised mesh__D014730 1994-05-05
% 221.25/221.45  |- skos__related mesh__D014730smesh__D000820
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D014730 2006
% 221.25/221.45  |- skos__prefLabel mesh__D000710 Anaplasmataceae
% 221.25/221.45  |- skos__historyNote mesh__D000710 Bacteria %28%1966-1974%29%
% 221.25/221.45  |- mesh__dateEstablished mesh__D000710 1975-01-01
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D000710 2006
% 221.25/221.45  |- mesh__recordOriginator mesh__D000710 NLM
% 221.25/221.45  |- skos__altLabel mesh__D000710 Ehrlichieae
% 221.25/221.45  |- mesh__historyNote mesh__D000710 1975   
% 221.25/221.45  |- mesh__dateRevised mesh__D000710 2005-06-30
% 221.25/221.45  |- mesh__dateCreated mesh__D000710 1999-01-01
% 221.25/221.45  |- skos__annotation mesh__D000710 infection = ANAPLASMATACEAE INFECTIONS   
% 221.25/221.45  |- mesh__recordMaintainer mesh__D000710 SYSTEM
% 221.25/221.45  |- skos__broader mesh__D000710smesh__D020561
% 221.25/221.45  |- skos__scopeNote mesh__D000710
% 221.25/221.45       A family of bacteria which inhabit RED BLOOD CELLS and cause several animal diseases.%A%    
% 221.25/221.45  |- mesh__recordAuthorizer mesh__D000710 sjn
% 221.25/221.45  |- rdf__type mesh__D000710sskos__Concept
% 221.25/221.45  |- skos__broader mesh__D000710smesh__D006090
% 221.25/221.45  |- mesh__publicMeSHNote mesh__D000710 1975   
% 221.25/221.45  |- skos__broader mesh__D004042Q000737smesh__D004042
% 221.25/221.45  |- mesh__preferredCombination mesh__D004042Q000737smesh__D005224Q000737
% 221.25/221.45  |- rdf__type mesh__D004042Q000737smesh__CompoundConcept
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D013638 2004
% 221.25/221.45  |- skos__annotation mesh__D013638 D25-26 qualif   
% 221.25/221.45  |- mesh__dateRevised mesh__D013638 2003-07-09
% 221.25/221.45  |- mesh__recordMaintainer mesh__D013638 ssb
% 221.25/221.45  |- skos__broader mesh__D013638smesh__D045424
% 221.25/221.45  |- mesh__recordOriginator mesh__D013638 NLM
% 221.25/221.45  |- skos__prefLabel mesh__D013638 Tars
% 221.25/221.45  |- mesh__recordAuthorizer mesh__D013638 sjn
% 221.25/221.45  |- skos__scopeNote mesh__D013638
% 221.25/221.45       Viscous materials composed of complex, high-molecular-weight compounds derived from the distillation of petroleum or the destructive distillation of wood or coal. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D013638 2005
% 221.25/221.45  |- rdf__type mesh__D013638sskos__Concept
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D013638 2006
% 221.25/221.45  |- mesh__dateCreated mesh__D013638 1999-01-01
% 221.25/221.45  |- skos__broader mesh__D005223Q000737smesh__D005223
% 221.25/221.45  |- rdf__type mesh__D005223Q000737smesh__CompoundConcept
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018323 1997
% 221.25/221.45  |- skos__annotation mesh__D018323
% 221.25/221.45       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018323 2004
% 221.25/221.45  |- skos__prefLabel mesh__D018323 Hemangioendothelioma, Epithelioid
% 221.25/221.45  |- skos__hiddenLabel mesh__D018323 Epithelioid Hemangioendotheliomas
% 221.25/221.45  |- mesh__recordAuthorizer mesh__D018323 PLS
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018323 2000
% 221.25/221.45  |- mesh__dateEstablished mesh__D018323 1994-01-01
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018323 2001
% 221.25/221.45  |- mesh__recordMaintainer mesh__D018323 KEV
% 221.25/221.45  |- skos__broader mesh__D018323smesh__D006390
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018323 1998
% 221.25/221.45  |- mesh__dateCreated mesh__D018323 1993-06-25
% 221.25/221.45  |- mesh__publicMeSHNote mesh__D018323 94   
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018323 2005
% 221.25/221.45  |- skos__hiddenLabel mesh__D018323 Hemangioendotheliomas, Epithelioid
% 221.25/221.45  |- skos__historyNote mesh__D018323 Hemangioendothelioma %28%1982-1993%29%
% 221.25/221.45  |- mesh__recordOriginator mesh__D018323 PLS
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018323 1999
% 221.25/221.45  |- mesh__historyNote mesh__D018323 94   
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018323 2006
% 221.25/221.45  |- mesh__dateRevised mesh__D018323 1995-06-08
% 221.25/221.45  |- skos__scopeNote mesh__D018323
% 221.25/221.45       A tumor of medium-to-large veins, composed of plump-to-spindled endothelial cells that bulge into vascular spaces in a tombstone-like fashion. These tumors are thought to have %22%borderline%22% aggression, where one-third develop local recurrences, but only rarely metastasize. It is unclear whether the epithelioid hemangioendothelioma is truly neoplastic or an exuberant tissue reaction, nor is it clear if this is equivalent to Kimura%27%s disease %28%see ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA%29%. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018323 2002
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018323 1996
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D018323 2003
% 221.25/221.45  |- skos__hiddenLabel mesh__D018323 Epithelioid Hemangioendothelioma
% 221.25/221.45  |- rdf__type mesh__D018323sskos__Concept
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D010340 2006
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D010340 2001
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D010340 2005
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D010340 1999
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D010340 2000
% 221.25/221.45  |- skos__annotation mesh__D010340
% 221.25/221.45       SPEC only: SPEC qualif; DF: PATHOL SURG   
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D010340 2004
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D010340 1998
% 221.25/221.45  |- skos__broader mesh__D010340smesh__D010336
% 221.25/221.45  |- mesh__recordAuthorizer mesh__D010340 SJN
% 221.25/221.45  |- mesh__recordMaintainer mesh__D010340 PXP
% 221.25/221.45  |- rdf__type mesh__D010340sskos__Concept
% 221.25/221.45  |- mesh__activeMeSHYear mesh__D010340 2003
% 221.25/221.45  |- mesh__dateRevised mesh__D010340 1997-06-20
% 221.25/221.45  |- mesh__recordOriginator mesh__D010340 NLM
% 221.25/221.45  |- skos__scopeNote mesh__D010340
% 221.25/221.45       A field of anatomical pathology in which living tissue is surgically removed for the purpose of diagnosis and treatment.%A%    
% 221.25/221.46  |- mesh__dateCreated mesh__D010340 1999-01-01
% 221.25/221.46  |- skos__altLabel mesh__D010340 Surgical Pathology
% 221.25/221.46  |- skos__prefLabel mesh__D010340 Pathology, Surgical
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D010340 2002
% 221.25/221.46  |- mesh__dateRevised mesh__D051757 2005-07-13
% 221.25/221.46  |- skos__hiddenLabel mesh__D051757 B Cell Specific Activator Protein
% 221.25/221.46  |- mesh__dateEstablished mesh__D051757 2006-01-01
% 221.25/221.46  |- skos__prefLabel mesh__D051757 B-Cell-Specific Activator Protein
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D051757 2006A
% 221.25/221.46  |- mesh__recordOriginator mesh__D051757 DRC
% 221.25/221.46  |- mesh__recordMaintainer mesh__D051757 ags
% 221.25/221.46  |- skos__hiddenLabel mesh__D051757 Transcription Factor, PAX5
% 221.25/221.46  |- skos__hiddenLabel mesh__D051757 B Cell Specific Transcription Factor
% 221.25/221.46  |- mesh__historyNote mesh__D051757 2006%28%1992%29%   
% 221.25/221.46  |- skos__altLabel mesh__D051757 PAX5 Transcription Factor
% 221.25/221.46  |- skos__altLabel mesh__D051757 B Cell-Specific Transcription Factor
% 221.25/221.46  |- mesh__publicMeSHNote mesh__D051757
% 221.25/221.46       2006; B-CELL-SPECIFIC ACTIVATOR PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 2002-2005, %26% under NUCLEAR PROTEINS 1992-2001%A%  
% 221.25/221.46  |- mesh__dateCreated mesh__D051757 2005-06-30
% 221.25/221.46  |- skos__scopeNote mesh__D051757
% 221.25/221.46       A transcription factor that is essential for CELL DIFFERENTIATION of B-LYMPHOCYTES. It functions both as a transcriptional activator and repressor to mediate B-cell commitment.%A%    
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D051757 2006
% 221.25/221.46  |- mesh__recordAuthorizer mesh__D051757 ags
% 221.25/221.46  |- skos__hiddenLabel mesh__D051757 Early B Cell Specific Binding Protein 1
% 221.25/221.46  |- skos__altLabel mesh__D051757 Early B Cell-Specific Binding Protein-1
% 221.25/221.46  |- skos__broader mesh__D051757smesh__D051761
% 221.25/221.46  |- skos__hiddenLabel mesh__D051757 Transcription Factor, Pax5A
% 221.25/221.46  |- rdf__type mesh__D051757sskos__Concept
% 221.25/221.46  |- skos__hiddenLabel mesh__D004303 Genetic Dosage Compensation
% 221.25/221.46  |- mesh__dateRevised mesh__D004303 2005-06-30
% 221.25/221.46  |- mesh__recordOriginator mesh__D004303 AEP
% 221.25/221.46  |- skos__hiddenLabel mesh__D004303 Dosage Compensation, Gene
% 221.25/221.46  |- skos__hiddenLabel mesh__D004303 Compensation, Gene Dosage
% 221.25/221.46  |- skos__hiddenLabel mesh__D004303 Hypertranscription, X Chromosome
% 221.25/221.46  |- rdf__type mesh__D004303sskos__Concept
% 221.25/221.46  |- skos__scopeNote mesh__D004303
% 221.25/221.46       Genetic mechanisms that allow GENES to be expressed at a similar level irrespective of their GENE DOSAGE. This term is usually used in discussing genes that lie on the SEX CHROMOSOMES. Because the sex chromosomes are only partially homologous, there is a different copy number, i.e., dosage, of these genes in males vs. females. In DROSOPHILA, dosage compensation is accomplished by hypertranscription of genes located on the X CHROMOSOME. In mammals, dosage compensation of X chromosome genes is accomplished by random X CHROMOSOME INACTIVATION of one of the two X chromosomes in the female.%A%    
% 221.25/221.46  |- skos__prefLabel mesh__D004303 Dosage Compensation, Genetic
% 221.25/221.46  |- mesh__historyNote mesh__D004303 2006 %28%1982%29%   
% 221.25/221.46  |- mesh__recordMaintainer mesh__D004303 nns
% 221.25/221.46  |- skos__broader mesh__D004303smesh__D005786
% 221.25/221.46  |- skos__annotation mesh__D004303 do not confuse with GENE DOSAGE   
% 221.25/221.46  |- mesh__recordAuthorizer mesh__D004303 sjn
% 221.25/221.46  |- mesh__dateEstablished mesh__D004303 1982-01-01
% 221.25/221.46  |- mesh__dateCreated mesh__D004303 1981-02-23
% 221.25/221.46  |- skos__hiddenLabel mesh__D004303 Compensation, Dosage %28%Genetics%29%
% 221.25/221.46  |- mesh__publicMeSHNote mesh__D004303
% 221.25/221.46       2006; see DOSAGE COMPENSATION %28%GENETICS%29% 1982-2005   
% 221.25/221.46  |- skos__hiddenLabel mesh__D004303 X Chromosome Hypertranscription
% 221.25/221.46  |- skos__altLabel mesh__D004303 Dosage Compensation %28%Genetics%29%
% 221.25/221.46  |- skos__hiddenLabel mesh__D004303 Gene Dosage Compensations
% 221.25/221.46  |- skos__hiddenLabel mesh__D004303 Compensation, Genetic Dosage
% 221.25/221.46  |- skos__historyNote mesh__D004303 X Chromosome %28%1978-1981%29%
% 221.25/221.46  |- skos__hiddenLabel mesh__D004303 Genetic Dosage Compensations
% 221.25/221.46  |- skos__altLabel mesh__D004303 Gene Dosage Compensation
% 221.25/221.46  |- skos__historyNote mesh__D004303 Sex Chromosomes %28%1968-1981%29%
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D004303 2006
% 221.25/221.46  |- skos__altLabel mesh__D004303 Hypertranscription, X-Chromosome
% 221.25/221.46  |- skos__altLabel mesh__D009597 K+-NPPase
% 221.25/221.46  |- skos__hiddenLabel mesh__D009597 para Nitrophenylphosphatase
% 221.25/221.46  |- skos__altLabel mesh__D009597 K-Dependent p-Nitrophenylphosphatase
% 221.25/221.46  |- skos__altLabel mesh__D009597 para-Nitrophenyl Phosphatase
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D009597 2006
% 221.25/221.46  |- skos__altLabel mesh__D009597 para-Nitrophenylphosphatase
% 221.25/221.46  |- mesh__publicMeSHNote mesh__D009597
% 221.25/221.46       94; was 4-NITROPHENYL PHOSPHATASE 1992-93; was NITROPHENYL PHOSPHATASE 1975-91 %28%see under PHOSPHOMONOESTERASES 1975-90%29%%A%  
% 221.25/221.46  |- skos__hiddenLabel mesh__D009597 p NPPase
% 221.25/221.46  |- mesh__recordAuthorizer mesh__D009597 sjn
% 221.25/221.46  |- skos__broader mesh__D009597smesh__D010744
% 221.25/221.46  |- skos__historyNote mesh__D009597 Alkaline Phosphatase %28%1972-1974%29%
% 221.25/221.46  |- mesh__recordOriginator mesh__D009597 NLM
% 221.25/221.46  |- skos__altLabel mesh__D009597 4-Nitrophenyl Phosphatase
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D009597 2005
% 221.25/221.46  |- skos__prefLabel mesh__D009597 4-Nitrophenylphosphatase
% 221.25/221.46  |- skos__hiddenLabel mesh__D009597 K p NPPase
% 221.25/221.46  |- skos__hiddenLabel mesh__D009597 4 Nitrophenyl Phosphatase
% 221.25/221.46  |- skos__altLabel mesh__D009597 p-NPPase
% 221.25/221.46  |- skos__hiddenLabel mesh__D009597 p-Nitrophenylphosphatase, K-Dependent
% 221.25/221.46  |- mesh__recordMaintainer mesh__D009597 ssb
% 221.25/221.46  |- skos__hiddenLabel mesh__D009597 4 Nitrophenylphosphatase
% 221.25/221.46  |- skos__hiddenLabel mesh__D009597 K Dependent p Nitrophenylphosphatase
% 221.25/221.46  |- mesh__dateCreated mesh__D009597 1974-11-19
% 221.25/221.46  |- skos__hiddenLabel mesh__D009597 K+ NPPase
% 221.25/221.46  |- skos__scopeNote mesh__D009597
% 221.25/221.46       An enzyme that catalyzes the hydrolysis of nitrophenyl phosphates to nitrophenols. At acid pH it is probably ACID PHOSPHATASE %28%EC 3.1.3.2%29%; at alkaline pH it is probably ALKALINE PHOSPHATASE %28%EC 3.1.3.1%29%. EC 3.1.3.41.%A%    
% 221.25/221.46  |- skos__historyNote mesh__D009597
% 221.25/221.46       Organophosphorus Compounds %28%1973-1974%29%
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D009597 2004
% 221.25/221.46  |- skos__hiddenLabel mesh__D009597 p Nitrophenylphosphatase
% 221.25/221.46  |- mesh__dateEstablished mesh__D009597 1991-01-01
% 221.25/221.46  |- skos__hiddenLabel mesh__D009597 para Nitrophenyl Phosphatase
% 221.25/221.46  |- rdf__type mesh__D009597sskos__Concept
% 221.25/221.46  |- mesh__onlineNote mesh__D009597
% 221.25/221.46       use 4-NITROPHENYLPHOSPHATASE to search 4-NITROPHENYL PHOSPHATASE 1992-93 %26% NITROPHENYL PHOSPHATASE 1975-91%A%  
% 221.25/221.46  |- mesh__historyNote mesh__D009597
% 221.25/221.46       94; was 4-NITROPHENYL PHOSPHATASE 1992-93; was NITROPHENYL PHOSPHATASE 1975-91 %28%see under PHOSPHOMONOESTERASES 1975-90%29%%A%  
% 221.25/221.46  |- mesh__dateRevised mesh__D009597 2003-07-09
% 221.25/221.46  |- skos__altLabel mesh__D009597 p-Nitrophenylphosphatase
% 221.25/221.46  |- skos__historyNote mesh__D009597 Nitrophenols %28%1972-1974%29%
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D042422 2006
% 221.25/221.46  |- skos__prefLabel mesh__D042422 Achromobacter cycloclastes
% 221.25/221.46  |- rdf__type mesh__D042422sskos__Concept
% 221.25/221.46  |- mesh__historyNote mesh__D042422 2004   
% 221.25/221.46  |- mesh__recordAuthorizer mesh__D042422 sjn
% 221.25/221.46  |- mesh__recordOriginator mesh__D042422 ags
% 221.25/221.46  |- mesh__recordMaintainer mesh__D042422 SYSTEM
% 221.25/221.46  |- skos__broader mesh__D042422smesh__D042402
% 221.25/221.46  |- mesh__dateCreated mesh__D042422 2003-07-09
% 221.25/221.46  |- skos__annotation mesh__D042422
% 221.25/221.46       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 221.25/221.46  |- skos__scopeNote mesh__D042422
% 221.25/221.46       A species of gram negative, aerobic, denitrifying bacteria in the genus ACHROMOBACTER.%A%    
% 221.25/221.46  |- mesh__dateEstablished mesh__D042422 2004-01-01
% 221.25/221.46  |- mesh__dateRevised mesh__D042422 2005-06-30
% 221.25/221.46  |- skos__historyNote mesh__D042422 Alcaligenes %28%1972-2003%29%
% 221.25/221.46  |- mesh__publicMeSHNote mesh__D042422 2004   
% 221.25/221.46  |- skos__altLabel mesh__D014731 Service, Military Veterinary
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D014731 2002
% 221.25/221.46  |- skos__hiddenLabel mesh__D014731 Services, Military Veterinary
% 221.25/221.46  |- skos__annotation mesh__D014731
% 221.25/221.46       SPEC: SPEC qualif; specify country; DF: VET SERV MILITARY%A%  
% 221.25/221.46  |- skos__prefLabel mesh__D014731 Veterinary Service, Military
% 221.25/221.46  |- mesh__dateRevised mesh__D014731 1995-05-22
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D014731 2003
% 221.25/221.46  |- mesh__recordAuthorizer mesh__D014731 PLS
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D014731 1996
% 221.25/221.46  |- mesh__recordOriginator mesh__D014731 NLM
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D014731 2004
% 221.25/221.46  |- mesh__recordMaintainer mesh__D014731 KEV
% 221.25/221.46  |- skos__scopeNote mesh__D014731
% 221.25/221.46       A corps of the armed services concerned with animal medicine, the chief interest of which is the care of government-owned working dogs %28%as in the military police units%29%, working horses %28%as in state funerals%29%, and working military dolphins %28%as in undersea exploration and other activities%29%. In the United States Army Veterinary Corps animal medicine overlaps and interconnects with biomedical research using laboratory research animals. A related activity is laboratory animal care. The Corps provides limited care for privately owned animals of military personnel through non-appropriated funds. Military service veterinarians in the United States Army must be graduates of accredited veterinary schools and must have a state license. %28%Telephone communication with Lt. Col. William Inskeep II, U.S. Army Veterinary Corps, October 4, 1994%29%%A%    
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D014731 1997
% 221.25/221.46  |- skos__broader mesh__D014731smesh__D014730
% 221.25/221.46  |- skos__hiddenLabel mesh__D014731 Veterinary Services, Military
% 221.25/221.46  |- rdf__type mesh__D014731sskos__Concept
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D014731 2005
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D014731 1998
% 221.25/221.46  |- skos__altLabel mesh__D014731 Military Veterinary Service
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D014731 2006
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D014731 2000
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D014731 1999
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D014731 2001
% 221.25/221.46  |- mesh__dateCreated mesh__D014731 1999-01-01
% 221.25/221.46  |- skos__hiddenLabel mesh__D014731 Military Veterinary Services
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D000711 2004
% 221.25/221.46  |- mesh__recordAuthorizer mesh__D000711 sjn
% 221.25/221.46  |- skos__hiddenLabel mesh__D000711 Haemobartonelloses
% 221.25/221.46  |- skos__broader mesh__D000711smesh__D016905
% 221.25/221.46  |- skos__prefLabel mesh__D000711 Anaplasmataceae Infections
% 221.25/221.46  |- mesh__recordOriginator mesh__D000711 FPG
% 221.25/221.46  |- skos__historyNote mesh__D000711 Rickettsial Infections %28%1975-1976%29%
% 221.25/221.46  |- mesh__dateEstablished mesh__D000711 1977-01-01
% 221.25/221.46  |- mesh__recordMaintainer mesh__D000711 ags
% 221.25/221.46  |- skos__scopeNote mesh__D000711
% 221.25/221.46       Infections with bacteria of the family ANAPLASMATACEAE.%A%    
% 221.25/221.46  |- skos__historyNote mesh__D000711 Anaplasmosis %28%1966-1976%29%
% 221.25/221.46  |- skos__hiddenLabel mesh__D000711 Anaplasmataceae Infection
% 221.25/221.46  |- mesh__dateCreated mesh__D000711 1976-04-27
% 221.25/221.46  |- mesh__publicMeSHNote mesh__D000711
% 221.25/221.46       77; HAEMOBARTONELLOSIS was heading 1977-79   
% 221.25/221.46  |- skos__hiddenLabel mesh__D000711 Infection, Anaplasmataceae
% 221.25/221.46  |- rdf__type mesh__D000711sskos__Concept
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D000711 2005
% 221.25/221.46  |- skos__altLabel mesh__D000711 Infections, Anaplasmataceae
% 221.25/221.46  |- mesh__onlineNote mesh__D000711
% 221.25/221.46       use ANAPLASMATACEAE INFECTIONS to search HAEMOBARTONELLOSIS 1977-79%A%  
% 221.25/221.46  |- mesh__dateRevised mesh__D000711 2003-07-09
% 221.25/221.46  |- mesh__historyNote mesh__D000711
% 221.25/221.46       77; HAEMOBARTONELLOSIS was heading 1977-79   
% 221.25/221.46  |- skos__annotation mesh__D000711 rickettsial infect   
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D000711 2006
% 221.25/221.46  |- mesh__recordAuthorizer mesh__D038381 sjn
% 221.25/221.46  |- mesh__historyNote mesh__D038381 2003   
% 221.25/221.46  |- skos__prefLabel mesh__D038381 Neisseria meningitidis, Serogroup A
% 221.25/221.46  |- skos__broader mesh__D038381smesh__D009345
% 221.25/221.46  |- mesh__publicMeSHNote mesh__D038381 2003   
% 221.25/221.46  |- mesh__dateEstablished mesh__D038381 2003-01-01
% 221.25/221.46  |- skos__scopeNote mesh__D038381
% 221.25/221.46       Strains of Neisseria meningitidis responsible for most outbreaks of meningococcal disease in Western Europe and the United States in the first half of the 20th century. They continue to be a major cause of disease in Asia and Africa, and especially localized epidemics in Sub-Sahara Africa.%A%    
% 221.25/221.46  |- rdf__type mesh__D038381sskos__Concept
% 221.25/221.46  |- mesh__dateCreated mesh__D038381 2002-07-03
% 221.25/221.46  |- mesh__dateRevised mesh__D038381 2005-06-30
% 221.25/221.46  |- skos__altLabel mesh__D038381 Meningococci, Serogroup A
% 221.25/221.46  |- mesh__recordOriginator mesh__D038381 ags
% 221.25/221.46  |- mesh__recordMaintainer mesh__D038381 SYSTEM
% 221.25/221.46  |- skos__historyNote mesh__D038381 Neisseria meningitidis %28%1965-2002%29%
% 221.25/221.46  |- skos__altLabel mesh__D038381 Meningococcus, Serogroup A
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D038381 2006
% 221.25/221.46  |- skos__annotation mesh__D038381
% 221.25/221.46       infection: coord IM with MENINGITIS, MENINGOCOCCAL %28%IM%29% or, if not meningitis, MENINGOCOCCAL INFECTIONS %28%IM%29%%A%  
% 221.25/221.46  |- skos__hiddenLabel mesh__D013639 Bones, Tarsal
% 221.25/221.46  |- skos__hiddenLabel mesh__D013639 Cuboid Bones
% 221.25/221.46  |- skos__altLabel mesh__D013639 Tarsus Osseus
% 221.25/221.46  |- skos__hiddenLabel mesh__D013639 Bone, Tarsal
% 221.25/221.46  |- mesh__onlineNote mesh__D013639
% 221.25/221.46       use TARSUS to search TARSUS OSSEUS 1988-96   
% 221.25/221.46  |- skos__broader mesh__D013639smesh__D005529
% 221.25/221.46  |- skos__historyNote mesh__D013639 Ankle %28%1966-1971%29%
% 221.25/221.46  |- skos__hiddenLabel mesh__D013639 Foot Navicular Bone
% 221.25/221.46  |- skos__hiddenLabel mesh__D013639 Bones, Ankle
% 221.25/221.46  |- skos__altLabel mesh__D013639 Ankle Bones
% 221.25/221.46  |- mesh__dateEstablished mesh__D013639 1972-01-01
% 221.25/221.46  |- skos__hiddenLabel mesh__D013639 Bones, Cuneiform
% 221.25/221.46  |- skos__annotation mesh__D013639
% 221.25/221.46       TALUS %26% CALCANEUS are available; note X refs, the remaining bones; do not confuse with TARSUS see ANKLE %28%the area%29% or TARSAL JOINTS%A%  
% 221.25/221.46  |- mesh__historyNote mesh__D013639
% 221.25/221.46       72; TARSUS OSSEUS was see TARSUS 1988-96   
% 221.25/221.46  |- skos__related mesh__D013639smesh__D000842
% 221.25/221.46  |- rdf__type mesh__D013639sskos__Concept
% 221.25/221.46  |- skos__prefLabel mesh__D013639 Tarsal Bones
% 221.25/221.46  |- skos__hiddenLabel mesh__D013639 Bone, Cuneiform
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D013639 2006
% 221.25/221.46  |- mesh__recordMaintainer mesh__D013639 ags
% 221.25/221.46  |- mesh__publicMeSHNote mesh__D013639
% 221.25/221.46       72; TARSUS OSSEUS was see TARSUS 1988-96   
% 221.25/221.46  |- mesh__dateCreated mesh__D013639 1999-01-01
% 221.25/221.46  |- mesh__recordOriginator mesh__D013639 NLM
% 221.25/221.46  |- mesh__dateRevised mesh__D013639 2005-06-30
% 221.25/221.46  |- mesh__recordAuthorizer mesh__D013639 sjn
% 221.25/221.46  |- skos__hiddenLabel mesh__D013639 Cuneiform Bone
% 221.25/221.46  |- skos__hiddenLabel mesh__D013639 Bone, Cuboid
% 221.25/221.46  |- skos__hiddenLabel mesh__D013639 Bones, Cuboid
% 221.25/221.46  |- skos__hiddenLabel mesh__D013639 Foot Navicular Bones
% 221.25/221.46  |- skos__scopeNote mesh__D013639
% 221.25/221.46       The seven bones which form the tarsus - namely, CALCANEUS; TALUS; cuboid, navicular, and the internal, middle, and external cuneiforms.%A%    
% 221.25/221.46  |- skos__historyNote mesh__D013639 Ankle Joint %28%1966-1971%29%
% 221.25/221.46  |- skos__hiddenLabel mesh__D013639 Tarsal Bone
% 221.25/221.46  |- mesh__historyNote mesh__D024361 2002   
% 221.25/221.46  |- skos__prefLabel mesh__D024361 Amino Acids, Basic
% 221.25/221.46  |- skos__broader mesh__D024361smesh__D000596
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D024361 2004
% 221.25/221.46  |- skos__historyNote mesh__D024361 Amino Acids %28%1969-2001%29%
% 221.25/221.46  |- mesh__dateEstablished mesh__D024361 2002-01-01
% 221.25/221.46  |- skos__altLabel mesh__D024361 Basic Amino Acids
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D024361 2006
% 221.25/221.46  |- mesh__publicMeSHNote mesh__D024361 2002   
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D024361 2003
% 221.25/221.46  |- rdf__type mesh__D024361sskos__Concept
% 221.25/221.46  |- skos__hiddenLabel mesh__D024361 Amino Acid, Basic
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D024361 2005
% 221.25/221.46  |- skos__altLabel mesh__D024361 Basic Amino Acid
% 221.25/221.46  |- skos__historyNote mesh__D024361 specific amino acids %28%1969-2001%29%
% 221.25/221.46  |- mesh__dateCreated mesh__D024361 2001-07-25
% 221.25/221.46  |- skos__scopeNote mesh__D024361
% 221.25/221.46       Amino acids with side chains that are positively charged at physiological pH.%A%    
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D024361 2002
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D018324 2005
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D018324 2004
% 221.25/221.46  |- skos__annotation mesh__D018324
% 221.25/221.46       coord IM with precoord organ/neopl term %28%IM%29%; do not confuse with HEMANGIOMA, LOBULAR CAPILLARY see GRANULOMA, PYOGENIC; distinguish from PORT-WINE STAIN%A%  
% 221.25/221.46  |- rdf__type mesh__D018324sskos__Concept
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D018324 2003
% 221.25/221.46  |- skos__hiddenLabel mesh__D018324 Capillary Hemangioma
% 221.25/221.46  |- skos__hiddenLabel mesh__D018324 Hemangiomas, Capillary
% 221.25/221.46  |- skos__prefLabel mesh__D018324 Hemangioma, Capillary
% 221.25/221.46  |- mesh__dateEstablished mesh__D018324 1994-01-01
% 221.25/221.46  |- mesh__recordAuthorizer mesh__D018324 sjn
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D018324 2002
% 221.25/221.46  |- mesh__recordOriginator mesh__D018324 PLS
% 221.25/221.46  |- mesh__recordMaintainer mesh__D018324 nns
% 221.25/221.46  |- mesh__dateRevised mesh__D018324 2001-07-25
% 221.25/221.46  |- skos__hiddenLabel mesh__D018324 Capillary Hemangiomas
% 221.25/221.46  |- skos__broader mesh__D018324smesh__D006391
% 221.25/221.46  |- skos__historyNote mesh__D018324 Hemangioma %28%1966-1993%29%
% 221.25/221.46  |- mesh__dateCreated mesh__D018324 1993-06-25
% 221.25/221.46  |- mesh__historyNote mesh__D018324 94   
% 221.25/221.46  |- mesh__publicMeSHNote mesh__D018324 94   
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D018324 2006
% 221.25/221.46  |- skos__scopeNote mesh__D018324
% 221.25/221.46       A dull red, firm, dome-shaped hemangioma, sharply demarcated from surrounding skin, usually located on the head and neck, which grows rapidly and generally undergoes regression and involution without scarring. It is caused by proliferation of immature capillary vessels in active stroma, and is usually present at birth or occurs within the first two or three months of life. %28%Dorland, 27th ed%29%%A%    
% 221.25/221.46  |- skos__altLabel mesh__D010341 Veterinary Pathology
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D010341 2005
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D010341 1999
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D010341 2002
% 221.25/221.46  |- skos__scopeNote mesh__D010341
% 221.25/221.46       The field of veterinary medicine concerned with the causes of and changes produced in the body by disease.%A%    
% 221.25/221.46  |- skos__prefLabel mesh__D010341 Pathology, Veterinary
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D010341 2004
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D010341 1998
% 221.25/221.46  |- mesh__recordAuthorizer mesh__D010341 PLS
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D010341 2001
% 221.25/221.46  |- skos__broader mesh__D010341smesh__D014730
% 221.25/221.46  |- rdf__type mesh__D010341sskos__Concept
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D010341 2003
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D010341 1997
% 221.25/221.46  |- mesh__dateRevised mesh__D010341 1993-06-04
% 221.25/221.46  |- skos__annotation mesh__D010341
% 221.25/221.46       SPEC only; SPEC qualif; not a substitute for /pathol of organs or dis in vet animals nor for ANIMAL DISEASES or specific animal dis; DF: PATHOL VET%A%  
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D010341 2000
% 221.25/221.46  |- mesh__dateCreated mesh__D010341 1999-01-01
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D010341 1996
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D010341 1995
% 221.25/221.46  |- mesh__recordMaintainer mesh__D010341 JLS
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D010341 2006
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D010341 1994
% 221.25/221.46  |- mesh__recordOriginator mesh__D010341 NLM
% 221.25/221.46  |- mesh__dateRevised mesh__D051758 2005-08-03
% 221.25/221.46  |- mesh__dateCreated mesh__D051758 2005-06-30
% 221.25/221.46  |- mesh__recordOriginator mesh__D051758 DRC
% 221.25/221.46  |- mesh__recordMaintainer mesh__D051758 ags
% 221.25/221.46  |- skos__hiddenLabel mesh__D051758 BTF2, Transcription Factor
% 221.25/221.46  |- skos__altLabel mesh__D051758 BTF2 Transcription Factor
% 221.25/221.46  |- skos__altLabel mesh__D051758 Transcription Factor BTF2
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D051758 2006B
% 221.25/221.46  |- mesh__dateEstablished mesh__D051758 2006-01-01
% 221.25/221.46  |- skos__hiddenLabel mesh__D051758 Transcription Factor, TFIIH
% 221.25/221.46  |- skos__altLabel mesh__D051758 TFIIH Transcription Factor
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D051758 2006A
% 221.25/221.46  |- skos__broader mesh__D051758smesh__D019473
% 221.25/221.46  |- skos__hiddenLabel mesh__D051758 TFIIH, Transcription Factor
% 221.25/221.46  |- mesh__recordAuthorizer mesh__D051758 ags
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D051758 2006
% 221.25/221.46  |- skos__scopeNote mesh__D051758
% 221.25/221.46       A general transcription factor that is involved in basal GENETIC TRANSCRIPTION and NUCLEOTIDE EXCISION REPAIR. It consists of nine subunits including ATP-dependent DNA HELICASE; CYCLIN H; and XERODERMA PIGMENTOSUM GROUP D PROTEIN.%A%    
% 221.25/221.46  |- rdf__type mesh__D051758sskos__Concept
% 221.25/221.46  |- skos__altLabel mesh__D051758 Basic Transcription Factor 2
% 221.25/221.46  |- mesh__historyNote mesh__D051758 2006%28%1992%29%   
% 221.25/221.46  |- skos__hiddenLabel mesh__D051758 Transcription Factor, BTF2
% 221.25/221.46  |- skos__prefLabel mesh__D051758 Transcription Factor TFIIH
% 221.25/221.46  |- mesh__publicMeSHNote mesh__D051758
% 221.25/221.46       2006; TRANSCRIPTION FACTOR TFIIH was indexed under TRANSCRIPTION FACTORS, TFII 2003-2005, %26% under TRANSCRIPTION FACTORS 1992-2002%A%  
% 221.25/221.46  |- skos__altLabel mesh__D051758 Transcription Factor IIH
% 221.25/221.46  |- skos__related mesh__D004304smesh__D004333
% 221.25/221.46  |- rdf__type mesh__D004304sskos__Concept
% 221.25/221.46  |- skos__prefLabel mesh__D004304 Dosage Forms
% 221.25/221.46  |- skos__related mesh__D004304smesh__D016503
% 221.25/221.46  |- skos__hiddenLabel mesh__D004304 Form, Dosage
% 221.25/221.46  |- skos__broader mesh__D004304smesh__D013678
% 221.25/221.46  |- skos__annotation mesh__D004304
% 221.25/221.46       GEN only: prefer specific drug with qualif /admin; Manual 25.12.2; examine also indentions under DRUG ADMINISTRATION ROUTES in Cat E5%A%  
% 221.25/221.46  |- skos__hiddenLabel mesh__D004304 Forms, Dosage
% 221.25/221.46  |- mesh__dateRevised mesh__D004304 2003-07-09
% 221.25/221.46  |- mesh__recordMaintainer mesh__D004304 ssb
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D004304 2005
% 221.25/221.46  |- mesh__recordAuthorizer mesh__D004304 sjn
% 221.25/221.46  |- mesh__recordOriginator mesh__D004304 NLM
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D004304 2004
% 221.25/221.46  |- skos__broader mesh__D004304smesh__D020313
% 221.25/221.46  |- skos__hiddenLabel mesh__D004304 Dosage Form
% 221.25/221.46  |- mesh__dateCreated mesh__D004304 1999-01-01
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D004304 2006
% 221.25/221.46  |- skos__scopeNote mesh__D004304
% 221.25/221.46       Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect. They include CAPSULES; LINIMENTS; OINTMENTS; PHARMACEUTICAL SOLUTIONS; POWDERS; TABLETS; etc.%A%    
% 221.25/221.46  |- skos__broader mesh__D004304smesh__D004364
% 221.25/221.46  |- mesh__publicMeSHNote mesh__D009598
% 221.25/221.46       91; was see under GLYCOSIDES 1988-90; was NITROPHENYLGALACTOSIDE see under GLYCOSIDES 1975-87%A%  
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D009598 2005
% 221.25/221.46  |- mesh__dateRevised mesh__D009598 2004-07-07
% 221.25/221.46  |- skos__broader mesh__D009598smesh__D005697
% 221.25/221.46  |- mesh__onlineNote mesh__D009598
% 221.25/221.46       use NITROPHENYLGALACTOSIDES to search NITROPHENYLGALACTOSIDE 1975-87%A%  
% 221.25/221.46  |- skos__historyNote mesh__D009598 Nitrophenols %28%1973-1974%29%
% 221.25/221.46  |- mesh__recordAuthorizer mesh__D009598 sjn
% 221.25/221.46  |- mesh__recordOriginator mesh__D009598 NLM
% 221.25/221.46  |- mesh__historyNote mesh__D009598
% 221.25/221.46       91%28%88%29%; was see under GLYCOSIDES 1988-90; was NITROPHENYLGALACTOSIDE see under GLYCOSIDES 1975-87%A%  
% 221.25/221.46  |- mesh__dateEstablished mesh__D009598 1991-01-01
% 221.25/221.46  |- rdf__type mesh__D009598sskos__Concept
% 221.25/221.46  |- mesh__recordMaintainer mesh__D009598 ssb
% 221.25/221.46  |- skos__prefLabel mesh__D009598 Nitrophenylgalactosides
% 221.25/221.46  |- mesh__dateCreated mesh__D009598 1974-11-19
% 221.25/221.46  |- skos__historyNote mesh__D009598 Galactose %28%1970-1974%29%
% 221.25/221.46  |- skos__scopeNote mesh__D009598
% 221.25/221.46       Includes ortho-, meta-, and para-nitrophenylgalactosides.%A%    
% 221.25/221.46  |- skos__altLabel mesh__D009598 Nitrophenylgalactopyranosides
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D009598 2006
% 221.25/221.46  |- skos__historyNote mesh__D009598 Glycosides %28%1970-1974%29%
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D014732 2006
% 221.25/221.46  |- skos__broader mesh__D014732smesh__D001696
% 221.25/221.46  |- skos__broader mesh__D014732smesh__D019563
% 221.25/221.46  |- mesh__recordAuthorizer mesh__D014732 sjn
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D014732 2005
% 221.25/221.46  |- skos__prefLabel mesh__D014732 Vibration
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D014732 2004
% 221.25/221.46  |- mesh__recordMaintainer mesh__D014732 nns
% 221.25/221.46  |- skos__annotation mesh__D014732 biol %26% non-biol application   
% 221.25/221.46  |- skos__hiddenLabel mesh__D014732 Vibrations
% 221.25/221.46  |- mesh__dateRevised mesh__D014732 2003-07-09
% 221.25/221.46  |- mesh__recordOriginator mesh__D014732 NLM
% 221.25/221.46  |- mesh__dateCreated mesh__D014732 1999-01-01
% 221.25/221.46  |- rdf__type mesh__D014732sskos__Concept
% 221.25/221.46  |- skos__broader mesh__D000712smesh__D000820
% 221.25/221.46  |- rdf__type mesh__D000712sskos__Concept
% 221.25/221.46  |- mesh__publicMeSHNote mesh__D000712 68   
% 221.25/221.46  |- skos__hiddenLabel mesh__D000712 Anaplasmoses
% 221.25/221.46  |- mesh__recordMaintainer mesh__D000712 ags
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D000712 2005
% 221.25/221.46  |- mesh__recordAuthorizer mesh__D000712 sjn
% 221.25/221.46  |- skos__prefLabel mesh__D000712 Anaplasmosis
% 221.25/221.46  |- mesh__historyNote mesh__D000712 68%28%66%29%   
% 221.25/221.46  |- skos__scopeNote mesh__D000712
% 221.25/221.46       A disease of cattle caused by parasitization of the red blood cells by bacteria of the genus ANAPLASMA.%A%    
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D000712 2006
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D000712 2004
% 221.25/221.46  |- mesh__dateRevised mesh__D000712 2003-07-30
% 221.25/221.46  |- mesh__dateEstablished mesh__D000712 1968-01-01
% 221.25/221.46  |- mesh__recordOriginator mesh__D000712 NLM
% 221.25/221.46  |- mesh__dateCreated mesh__D000712 1999-01-01
% 221.25/221.46  |- skos__annotation mesh__D000712
% 221.25/221.46       tick-borne dis; usually animal; check tag ANIMALS   
% 221.25/221.46  |- skos__broader mesh__D000712smesh__D000711
% 221.25/221.46  |- skos__broader mesh__D000712smesh__D017282
% 221.25/221.46  |- skos__related mesh__D024362smesh__D016414
% 221.25/221.46  |- skos__hiddenLabel mesh__D024362 Adherences, Directive
% 221.25/221.46  |- skos__hiddenLabel mesh__D024362 Directive Adherence, Advance
% 221.25/221.46  |- skos__altLabel mesh__D024362 Advance Directive Compliance
% 221.25/221.46  |- skos__broader mesh__D024362smesh__D017531
% 221.25/221.46  |- mesh__dateCreated mesh__D024362 2001-07-25
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D024362 2004
% 221.25/221.46  |- skos__hiddenLabel mesh__D024362 Directive Compliance, Advance
% 221.25/221.46  |- mesh__dateEstablished mesh__D024362 2002-01-01
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D024362 2002
% 221.25/221.46  |- skos__hiddenLabel mesh__D024362 Adherence, Directive
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D024362 2006
% 221.25/221.46  |- skos__prefLabel mesh__D024362 Advance Directive Adherence
% 221.25/221.46  |- mesh__publicMeSHNote mesh__D024362 2002   
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D024362 2003
% 221.25/221.46  |- rdf__type mesh__D024362sskos__Concept
% 221.25/221.46  |- mesh__historyNote mesh__D024362 2002   
% 221.25/221.46  |- skos__hiddenLabel mesh__D024362 Directive Adherences
% 221.25/221.46  |- skos__historyNote mesh__D024362 Advance Directives %28%1991-2001%29%
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D024362 2005
% 221.25/221.46  |- skos__related mesh__D024362smesh__D016223
% 221.25/221.46  |- skos__hiddenLabel mesh__D024362 Adherence, Advance Directive
% 221.25/221.46  |- skos__scopeNote mesh__D024362
% 221.25/221.46       Compliance by health personnel or proxies with the stipulations of ADVANCE DIRECTIVES %28%or similar directives such as RESUSCITATION ORDERS%29% when patients are unable to direct their own care.%A%    
% 221.25/221.46  |- skos__related mesh__D024362smesh__D019983
% 221.25/221.46  |- skos__broader mesh__D024362smesh__D011787
% 221.25/221.46  |- skos__hiddenLabel mesh__D024362 Compliance, Advance Directive
% 221.25/221.46  |- mesh__dateCreated mesh__D018325 1993-06-25
% 221.25/221.46  |- mesh__publicMeSHNote mesh__D018325 94   
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D018325 2003
% 221.25/221.46  |- skos__hiddenLabel mesh__D018325 Hemangioblastomas, Multiple
% 221.25/221.46  |- mesh__recordMaintainer mesh__D018325 KEV
% 221.25/221.46  |- mesh__activeMeSHYear mesh__D018325 2001
% 221.25/221.46  |- skos__prefLabel mesh__D018325 Hemangioblastoma
% 221.25/221.47  |- skos__annotation mesh__D018325
% 221.25/221.47       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with CEREBELLAR NEOPLASMS %28%IM%29% or other precoord brain/neopl term %28%IM%29%%A%  
% 221.25/221.47  |- mesh__dateRevised mesh__D018325 1999-11-03
% 221.25/221.47  |- mesh__recordOriginator mesh__D018325 PLS
% 221.25/221.47  |- skos__hiddenLabel mesh__D018325 Hemangioblastoma, Multiple
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D018325 2000
% 221.25/221.47  |- skos__historyNote mesh__D018325 Hemangiosarcoma %28%1966-1993%29%
% 221.25/221.47  |- skos__hiddenLabel mesh__D018325 Hemangioblastomas
% 221.25/221.47  |- mesh__historyNote mesh__D018325 94   
% 221.25/221.47  |- mesh__dateEstablished mesh__D018325 1994-01-01
% 221.25/221.47  |- mesh__recordAuthorizer mesh__D018325 sjn
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D018325 2006
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D018325 2002
% 221.25/221.47  |- skos__broader mesh__D018325smesh__D018324
% 221.25/221.47  |- skos__scopeNote mesh__D018325
% 221.25/221.47       A benign tumor of the nervous system that may occur sporadically or in association with HIPPEL-LINDAU DISEASE. It accounts for approximately 2%25% of intracranial tumors, arising most frequently in the cerebellar hemispheres and vermis. Histologically, the tumors are composed of multiple capillary and sinusoidal channels lined with endothelial cells and clusters of lipid-laden pseudoxanthoma cells. Usually solitary, these tumors can be multiple and may also occur in the brain stem, spinal cord, retina, and supratentorial compartment. Cerebellar hemangioblastomas usually present in the third decade with INTRACRANIAL HYPERTENSION, and ataxia. %28%From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2071-2%29%%A%    
% 221.25/221.47  |- skos__hiddenLabel mesh__D018325 Multiple Hemangioblastoma
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D018325 2005
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D018325 2004
% 221.25/221.47  |- rdf__type mesh__D018325sskos__Concept
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D010342 2003
% 221.25/221.47  |- skos__hiddenLabel mesh__D010342 Characteristic, Acceptor
% 221.25/221.47  |- mesh__dateRevised mesh__D010342 2001-07-25
% 221.25/221.47  |- skos__hiddenLabel mesh__D010342 Acceptability, Program
% 221.25/221.47  |- skos__scopeNote mesh__D010342
% 221.25/221.47       The seeking and acceptance by patients of health service.%A%    
% 221.25/221.47  |- mesh__dateCreated mesh__D010342 1974-11-11
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D010342 2004
% 221.25/221.47  |- skos__hiddenLabel mesh__D010342 Healthcare Patient Acceptance
% 221.25/221.47  |- mesh__historyNote mesh__D010342 75   
% 221.25/221.47  |- mesh__publicMeSHNote mesh__D010342 75   
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D010342 2005
% 221.25/221.47  |- mesh__dateEstablished mesh__D010342 1975-09-01
% 221.25/221.47  |- skos__prefLabel mesh__D010342 Patient Acceptance of Health Care
% 221.25/221.47  |- skos__hiddenLabel mesh__D010342 Repeat Acceptors
% 221.25/221.47  |- skos__hiddenLabel mesh__D010342 New Acceptors
% 221.25/221.47  |- skos__historyNote mesh__D010342 Attitude to Health %28%1968-1974%29%
% 221.25/221.47  |- skos__hiddenLabel mesh__D010342 Healthcare Patient Acceptances
% 221.25/221.47  |- skos__hiddenLabel mesh__D010342 Characteristics, Nonacceptor
% 221.25/221.47  |- skos__hiddenLabel mesh__D010342 Acceptor Characteristic
% 221.25/221.47  |- skos__hiddenLabel mesh__D010342 Nonacceptor Characteristic
% 221.25/221.47  |- mesh__recordMaintainer mesh__D010342 jls
% 221.25/221.47  |- skos__hiddenLabel mesh__D010342 Acceptor, New
% 221.25/221.47  |- skos__hiddenLabel mesh__D010342 Healthcare Acceptability
% 221.25/221.47  |- skos__hiddenLabel mesh__D010342 New Acceptor
% 221.25/221.47  |- skos__hiddenLabel mesh__D010342 Acceptability, Method
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D010342 2006
% 221.25/221.47  |- skos__broader mesh__D010342smesh__D001294
% 221.25/221.47  |- skos__hiddenLabel mesh__D010342 Characteristic, Nonacceptor
% 221.25/221.47  |- skos__altLabel mesh__D010342 Acceptability of Healthcare
% 221.25/221.47  |- mesh__recordOriginator mesh__D010342 NLM
% 221.25/221.47  |- skos__hiddenLabel mesh__D010342 Repeat Acceptor
% 221.25/221.47  |- skos__altLabel mesh__D010342 Patient Acceptance of Healthcare
% 221.25/221.47  |- skos__hiddenLabel mesh__D010342 Acceptor, Repeat
% 221.25/221.47  |- mesh__recordAuthorizer mesh__D010342 sjn
% 221.25/221.47  |- skos__hiddenLabel mesh__D010342 Health Care Acceptability
% 221.25/221.47  |- skos__hiddenLabel mesh__D010342 Healthcare Acceptabilities
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D010342 2002
% 221.25/221.47  |- skos__hiddenLabel mesh__D010342 Nonacceptor
% 221.25/221.47  |- skos__annotation mesh__D010342 DF: PATIENT ACCEPT   
% 221.25/221.47  |- rdf__type mesh__D010342sskos__Concept
% 221.25/221.47  |- skos__hiddenLabel mesh__D010342 Characteristics, Acceptor
% 221.25/221.47  |- skos__altLabel mesh__D051759
% 221.25/221.47       Xeroderma Pigmentosum Complementation Group D Protein
% 221.25/221.47  |- mesh__recordMaintainer mesh__D051759 DRC
% 221.25/221.47  |- skos__altLabel mesh__D051759
% 221.25/221.47       Excision Repair Cross-Complementing Rodent Repair Deficiency, Group 2 Protein
% 221.25/221.47  |- mesh__recordAuthorizer mesh__D051759 sjn
% 221.25/221.47  |- mesh__historyNote mesh__D051759 2006%28%1992%29%   
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D051759 2006
% 221.25/221.47  |- skos__prefLabel mesh__D051759 Xeroderma Pigmentosum Group D Protein
% 221.25/221.47  |- skos__broader mesh__D051759smesh__D051758
% 221.25/221.47  |- rdf__type mesh__D051759sskos__Concept
% 221.25/221.47  |- mesh__publicMeSHNote mesh__D051759
% 221.25/221.47       2006; XERODERMA PIGMENTOSUM GROUP D PROTEIN was indexed under DNA HELICASES %26% DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1993-2005, %26% under PROTEINS 1992%A%  
% 221.25/221.47  |- mesh__dateCreated mesh__D051759 2005-06-30
% 221.25/221.47  |- skos__broader mesh__D051759smesh__D004265
% 221.25/221.47  |- skos__hiddenLabel mesh__D051759
% 221.25/221.47       Excision Repair Cross Complementing Rodent Repair Deficiency, Group 2 Protein
% 221.25/221.47  |- mesh__dateEstablished mesh__D051759 2006-01-01
% 221.25/221.47  |- mesh__recordOriginator mesh__D051759 DRC
% 221.25/221.47  |- skos__scopeNote mesh__D051759
% 221.25/221.47       A DNA helicase that is a component of TRANSCRIPTION FACTOR TFIIH. It plays an essential role in NUCLEOTIDE EXCISION REPAIR, and mutations in this protein are associated with XERODERMA PIGMENTOSUM.%A%    
% 221.25/221.47  |- skos__altLabel mesh__D051759 ERCC2 Protein
% 221.25/221.47  |- skos__hiddenLabel mesh__D004305 Dose-Response Relationships, Drug
% 221.25/221.47  |- rdf__type mesh__D004305sskos__Concept
% 221.25/221.47  |- mesh__publicMeSHNote mesh__D004305 73   
% 221.25/221.47  |- skos__scopeNote mesh__D004305
% 221.25/221.47       The relationship between the dose of an administered drug and the response of the organism to the drug.%A%    
% 221.25/221.47  |- skos__altLabel mesh__D004305 Dose Response Relationship, Drug
% 221.25/221.47  |- skos__hiddenLabel mesh__D004305 Drug Dose-Response Relationship
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004305 1991
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004305 1998
% 221.25/221.47  |- mesh__recordMaintainer mesh__D004305 TGC
% 221.25/221.47  |- mesh__dateRevised mesh__D004305 1990-06-08
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004305 1997
% 221.25/221.47  |- mesh__historyNote mesh__D004305 73   
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004305 2002
% 221.25/221.47  |- mesh__dateEstablished mesh__D004305 1973-01-01
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004305 1992
% 221.25/221.47  |- skos__hiddenLabel mesh__D004305 Drug Dose-Response Relationships
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004305 1999
% 221.25/221.47  |- skos__prefLabel mesh__D004305 Dose-Response Relationship, Drug
% 221.25/221.47  |- skos__annotation mesh__D004305
% 221.25/221.47       no qualif; IM if general, NIM when coord for specific drug; DF: DOSE RESPONSE RELAT DRUG%A%  
% 221.25/221.47  |- mesh__recordOriginator mesh__D004305 NLM
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004305 1994
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004305 2003
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004305 1993
% 221.25/221.47  |- mesh__dateCreated mesh__D004305 1999-01-01
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004305 2000
% 221.25/221.47  |- mesh__recordAuthorizer mesh__D004305 PLS
% 221.25/221.47  |- skos__hiddenLabel mesh__D004305 Relationship, Drug Dose-Response
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004305 2005
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004305 1995
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004305 2004
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004305 2001
% 221.25/221.47  |- skos__hiddenLabel mesh__D004305 Relationships, Drug Dose-Response
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004305 2006
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004305 1996
% 221.25/221.47  |- skos__broader mesh__D004305smesh__D002620
% 221.25/221.47  |- skos__historyNote mesh__D009599 Nitric Oxide %28%1966-1974%29%
% 221.25/221.47  |- skos__altLabel mesh__D009599
% 221.25/221.47       Fides Ecopharma Brand of Sodium Nitroprusside
% 221.25/221.47  |- mesh__recordMaintainer mesh__D009599 CCR
% 221.25/221.47  |- skos__altLabel mesh__D009599 Cyanonitrosylferrate
% 221.25/221.47  |- mesh__dateRevised mesh__D009599 2005-06-30
% 221.25/221.47  |- skos__scopeNote mesh__D009599
% 221.25/221.47       A powerful vasodilator used in emergencies to lower blood pressure or to improve cardiac function. It is also an indicator for free sulfhydryl groups in proteins.%A%    
% 221.25/221.47  |- skos__altLabel mesh__D009599 Nitroprusside, Disodium Salt
% 221.25/221.47  |- skos__broader mesh__D009599smesh__D005292
% 221.25/221.47  |- skos__hiddenLabel mesh__D009599 Disodium Salt Nitroprusside
% 221.25/221.47  |- skos__altLabel mesh__D009599 Abbott Brand of Sodium Nitroprusside
% 221.25/221.47  |- mesh__publicMeSHNote mesh__D009599
% 221.25/221.47       91; was see under FERRICYANIDES 1975-90   
% 221.25/221.47  |- skos__altLabel mesh__D009599 Bayer Brand of Sodium Nitroprusside
% 221.25/221.47  |- skos__hiddenLabel mesh__D009599 Nitroprusside, Sodium
% 221.25/221.47  |- skos__altLabel mesh__D009599 Roche Brand of Sodium Nitroprusside
% 221.25/221.47  |- rdf__type mesh__D009599sskos__Concept
% 221.25/221.47  |- skos__historyNote mesh__D009599 Ferricyanides %28%1966-1974%29%
% 221.25/221.47  |- skos__altLabel mesh__D009599 Nitroferricyanide
% 221.25/221.47  |- skos__prefLabel mesh__D009599 Nitroprusside
% 221.25/221.47  |- mesh__historyNote mesh__D009599
% 221.25/221.47       91%28%75%29%; was see under FERRICYANIDES 1975-90   
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D009599 2006
% 221.25/221.47  |- mesh__recordAuthorizer mesh__D009599 sjn
% 221.25/221.47  |- mesh__recordOriginator mesh__D009599 NLM
% 221.25/221.47  |- mesh__dateCreated mesh__D009599 1974-11-19
% 221.25/221.47  |- skos__altLabel mesh__D009599 Faulding Brand of Sodium Nitroprusside
% 221.25/221.47  |- skos__altLabel mesh__D009599 SERB Brand of Sodium Nitroprusside
% 221.25/221.47  |- skos__annotation mesh__D009599 D25-26 qualif   
% 221.25/221.47  |- mesh__dateEstablished mesh__D009599 1991-01-01
% 221.25/221.47  |- skos__hiddenLabel mesh__D020770 Polyacid Modified Composite Resins
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D020770 2005
% 221.25/221.47  |- skos__prefLabel mesh__D020770 Compomers
% 221.25/221.47  |- mesh__recordOriginator mesh__D020770 jmp
% 221.25/221.47  |- mesh__recordMaintainer mesh__D020770 ags
% 221.25/221.47  |- mesh__dateEstablished mesh__D020770 2000-01-01
% 221.25/221.47  |- mesh__historyNote mesh__D020770 2000   
% 221.25/221.47  |- mesh__recordAuthorizer mesh__D020770 ags
% 221.25/221.47  |- skos__broader mesh__D020770smesh__D003738
% 221.25/221.47  |- skos__broader mesh__D020770smesh__D003188
% 221.25/221.47  |- mesh__dateCreated mesh__D020770 1999-11-03
% 221.25/221.47  |- mesh__publicMeSHNote mesh__D020770 2000   
% 221.25/221.47  |- skos__historyNote mesh__D020770 Glass Ionomer Cements %28%1994-1999%29%
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D020770 2006A
% 221.25/221.47  |- skos__historyNote mesh__D020770 Composite Resins %28%1994-1999%29%
% 221.25/221.47  |- skos__altLabel mesh__D020770 Composite Resins, Polyacid-Modified
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D020770 2006
% 221.25/221.47  |- skos__hiddenLabel mesh__D020770 Resins, Polyacid-Modified Composite
% 221.25/221.47  |- mesh__dateRevised mesh__D020770 2005-07-15
% 221.25/221.47  |- rdf__type mesh__D020770sskos__Concept
% 221.25/221.47  |- skos__hiddenLabel mesh__D020770 Composite Resins, Polyacid Modified
% 221.25/221.47  |- skos__scopeNote mesh__D020770
% 221.25/221.47       Composite materials composed of an ion-leachable glass embedded in a polymeric matrix. They differ from GLASS IONOMER CEMENTS in that partially silanized glass particles are used to provide a direct bond to the resin matrix and the matrix is primarily formed by a light-activated, radical polymerization reaction.%A%    
% 221.25/221.47  |- skos__altLabel mesh__D020770 Polyacid-Modified Composite Resins
% 221.25/221.47  |- mesh__recordMaintainer mesh__D014733 ags
% 221.25/221.47  |- mesh__publicMeSHNote mesh__D014733
% 221.25/221.47       90; BENECKEA was see under VIBRIONACEAE 1978-89, was heading 1963-65%A%  
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D014733 2006
% 221.25/221.47  |- skos__annotation mesh__D014733
% 221.25/221.47       GEN or unspecified; prefer specifics; VIBRIO MARINUS and VIBRIO VISCOSUS see MORITELLA are also available; infection = VIBRIO INFECTIONS%A%  
% 221.25/221.47  |- mesh__recordAuthorizer mesh__D014733 ags
% 221.25/221.47  |- mesh__dateRevised mesh__D014733 2005-08-03
% 221.25/221.47  |- skos__prefLabel mesh__D014733 Vibrio
% 221.25/221.47  |- mesh__recordOriginator mesh__D014733 NLM
% 221.25/221.47  |- mesh__dateCreated mesh__D014733 1999-01-01
% 221.25/221.47  |- rdf__type mesh__D014733sskos__Concept
% 221.25/221.47  |- skos__broader mesh__D014733smesh__D014737
% 221.25/221.47  |- skos__scopeNote mesh__D014733
% 221.25/221.47       A genus of VIBRIONACEAE, made up of short, slightly curved, motile, gram-negative rods. Various species produce cholera and other gastrointestinal disorders as well as abortion in sheep and cattle.%A%    
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D014733 2006A
% 221.25/221.47  |- mesh__historyNote mesh__D014733
% 221.25/221.47       90; BENECKEA was see under VIBRIONACEAE l978-89, was heading 1963-65%A%  
% 221.25/221.47  |- mesh__onlineNote mesh__D014733
% 221.25/221.47       use VIBRIONACEAE to search BENECKEA 1978-89   
% 221.25/221.47  |- mesh__publicMeSHNote mesh__D000713 88   
% 221.25/221.47  |- skos__hiddenLabel mesh__D000713 Diversions, Roux-en-Y
% 221.25/221.47  |- rdf__type mesh__D000713sskos__Concept
% 221.25/221.47  |- mesh__dateCreated mesh__D000713 1987-03-18
% 221.25/221.47  |- skos__broader mesh__D000713smesh__D000714
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D000713 2005
% 221.25/221.47  |- mesh__dateEstablished mesh__D000713 1988-01-01
% 221.25/221.47  |- mesh__dateRevised mesh__D000713 1997-06-20
% 221.25/221.47  |- skos__hiddenLabel mesh__D000713 Roux-en-Y Loops
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D000713 2003
% 221.25/221.47  |- skos__altLabel mesh__D000713 Roux-en-Y Diversion
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D000713 2006
% 221.25/221.47  |- skos__altLabel mesh__D000713 Roux-en-Y Anastomosis
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D000713 2004
% 221.25/221.47  |- skos__hiddenLabel mesh__D000713 Loop, Roux-en-Y
% 221.25/221.47  |- skos__hiddenLabel mesh__D000713 Roux en Y Loop
% 221.25/221.47  |- skos__hiddenLabel mesh__D000713 Anastomoses, Roux-en-Y
% 221.25/221.47  |- mesh__recordOriginator mesh__D000713 SCD
% 221.25/221.47  |- skos__hiddenLabel mesh__D000713 Roux-en-Y Anastomoses
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D000713 2000
% 221.25/221.47  |- skos__altLabel mesh__D000713 Roux-en-Y Loop
% 221.25/221.47  |- skos__hiddenLabel mesh__D000713 Roux en Y Diversion
% 221.25/221.47  |- skos__prefLabel mesh__D000713 Anastomosis, Roux-en-Y
% 221.25/221.47  |- skos__broader mesh__D000713smesh__D013505
% 221.25/221.47  |- skos__hiddenLabel mesh__D000713 Roux-en-Y Diversions
% 221.25/221.47  |- mesh__recordAuthorizer mesh__D000713 SJN
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D000713 2001
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D000713 1998
% 221.25/221.47  |- skos__historyNote mesh__D000713
% 221.25/221.47       specific digestive system organ or disease/surgery %28%1966-1987%29%
% 221.25/221.47  |- skos__hiddenLabel mesh__D000713 Anastomosis, Roux en Y
% 221.25/221.47  |- mesh__historyNote mesh__D000713 88   
% 221.25/221.47  |- mesh__recordMaintainer mesh__D000713 PXP
% 221.25/221.47  |- skos__annotation mesh__D000713
% 221.25/221.47       usually the digestive tract; NIM with specific organ /surg %28%IM%29%; do not use /util except by MeSH definition; DF: ROUX EN Y%A%  
% 221.25/221.47  |- skos__scopeNote mesh__D000713
% 221.25/221.47       A Y-shaped surgical anastomosis of any part of the digestive system which includes the small intestine as the eventual drainage site.%A%    
% 221.25/221.47  |- skos__hiddenLabel mesh__D000713 Diversion, Roux-en-Y
% 221.25/221.47  |- skos__hiddenLabel mesh__D000713 Loops, Roux-en-Y
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D000713 2002
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D000713 1999
% 221.25/221.47  |- skos__hiddenLabel mesh__D000713 Roux en Y Anastomosis
% 221.25/221.47  |- skos__hiddenLabel mesh__D024363 Site, Transcription Start
% 221.25/221.47  |- skos__hiddenLabel mesh__D024363 Start Sites, Transcription
% 221.25/221.47  |- mesh__recordOriginator mesh__D024363 nns
% 221.25/221.47  |- mesh__dateCreated mesh__D024363 2001-07-25
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D024363 2006
% 221.25/221.47  |- mesh__publicMeSHNote mesh__D024363 2002   
% 221.25/221.47  |- skos__altLabel mesh__D024363 Transcription Start Site
% 221.25/221.47  |- skos__broader mesh__D024363smesh__D050436
% 221.25/221.47  |- rdf__type mesh__D024363sskos__Concept
% 221.25/221.47  |- skos__hiddenLabel mesh__D024363 Initiation Sites, Transcription
% 221.25/221.47  |- skos__prefLabel mesh__D024363 Transcription Initiation Site
% 221.25/221.47  |- skos__scopeNote mesh__D024363
% 221.25/221.47       The first nucleotide of a transcribed DNA sequence where RNA polymerase %28%DNA-DIRECTED RNA POLYMERASE%29% begins synthesizing the RNA transcript.%A%    
% 221.25/221.47  |- mesh__dateEstablished mesh__D024363 2002-01-01
% 221.25/221.47  |- skos__hiddenLabel mesh__D024363 Transcription Start Sites
% 221.25/221.47  |- skos__hiddenLabel mesh__D024363 Transcription Initiation Sites
% 221.25/221.47  |- skos__hiddenLabel mesh__D024363 Start Site, Transcription
% 221.25/221.47  |- mesh__historyNote mesh__D024363 2002   
% 221.25/221.47  |- skos__hiddenLabel mesh__D024363 Sites, Transcription Start
% 221.25/221.47  |- skos__hiddenLabel mesh__D024363 Sites, Transcription Initiation
% 221.25/221.47  |- skos__historyNote mesh__D024363 Transcription, Genetic %28%1974-2001%29%
% 221.25/221.47  |- mesh__dateRevised mesh__D024363 2005-06-30
% 221.25/221.47  |- mesh__recordMaintainer mesh__D024363 nns
% 221.25/221.47  |- mesh__recordAuthorizer mesh__D024363 sjn
% 221.25/221.47  |- skos__hiddenLabel mesh__D024363 Site, Transcription Initiation
% 221.25/221.47  |- skos__hiddenLabel mesh__D024363 Initiation Site, Transcription
% 221.25/221.47  |- mesh__recordOriginator mesh__D018326 PLS
% 221.25/221.47  |- mesh__dateEstablished mesh__D018326 1998-01-01
% 221.25/221.47  |- mesh__recordAuthorizer mesh__D018326 sjn
% 221.25/221.47  |- mesh__historyNote mesh__D018326 98; use explode 1994-97   
% 221.25/221.47  |- mesh__publicMeSHNote mesh__D018326 98   
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D018326 2006
% 221.25/221.47  |- mesh__dateRevised mesh__D018326 2004-07-13
% 221.25/221.47  |- mesh__dateCreated mesh__D018326 1993-06-25
% 221.25/221.47  |- skos__broader mesh__D018326smesh__D009370
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D018326 2005
% 221.25/221.47  |- rdf__type mesh__D018326sskos__Concept
% 221.25/221.47  |- mesh__recordMaintainer mesh__D018326 sjn
% 221.25/221.47  |- skos__annotation mesh__D018326
% 221.25/221.47       not used for indexing or cataloging; policy: Manual section 24; also TN Suppl:Tumor Key for human %26% corresponding vet tumors %28%does not contain exper tumors%29%; DF: NEVI MELANOMAS%A%  
% 221.25/221.47  |- skos__altLabel mesh__D018326 Melanomas and Nevi
% 221.25/221.47  |- skos__prefLabel mesh__D018326 Nevi and Melanomas
% 221.25/221.47  |- skos__scopeNote mesh__D018326
% 221.25/221.47       A collective term for the various types of nevi and melanomas.%A%    
% 221.25/221.47  |- skos__hiddenLabel mesh__D010343 Voluntary Admissions
% 221.25/221.47  |- mesh__publicMeSHNote mesh__D010343 78   
% 221.25/221.47  |- skos__scopeNote mesh__D010343
% 221.25/221.47       The process of accepting patients. The concept includes patients accepted for medical and nursing care in a hospital or other health care institution.%A%    
% 221.25/221.47  |- skos__hiddenLabel mesh__D010343 Patient Admissions
% 221.25/221.47  |- skos__hiddenLabel mesh__D010343 Admissions, Patient
% 221.25/221.47  |- skos__hiddenLabel mesh__D010343 Admissions, Voluntary
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D010343 2000
% 221.25/221.47  |- skos__historyNote mesh__D010343 Hospitalization %28%1966-1977%29%
% 221.25/221.47  |- mesh__recordOriginator mesh__D010343 EC
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D010343 2006
% 221.25/221.47  |- skos__related mesh__D010343smesh__D010359
% 221.25/221.47  |- mesh__historyNote mesh__D010343 78   
% 221.25/221.47  |- mesh__recordAuthorizer mesh__D010343 SJN
% 221.25/221.47  |- mesh__recordMaintainer mesh__D010343 PXP
% 221.25/221.47  |- skos__hiddenLabel mesh__D010343 Admission, Patient
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D010343 2005
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D010343 1999
% 221.25/221.47  |- mesh__dateRevised mesh__D010343 1997-06-20
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D010343 2004
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D010343 1998
% 221.25/221.47  |- mesh__dateCreated mesh__D010343 1977-05-12
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D010343 2002
% 221.25/221.47  |- skos__hiddenLabel mesh__D010343 Admission, Voluntary
% 221.25/221.47  |- skos__broader mesh__D010343smesh__D006760
% 221.25/221.47  |- rdf__type mesh__D010343sskos__Concept
% 221.25/221.47  |- mesh__dateEstablished mesh__D010343 1978-01-01
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D010343 2003
% 221.25/221.47  |- skos__prefLabel mesh__D010343 Patient Admission
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D010343 2001
% 221.25/221.47  |- skos__broader mesh__D004306smesh__D007109
% 221.25/221.47  |- skos__hiddenLabel mesh__D004306 Immunologic Dose Response Relationship
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004306 2002
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004306 1994
% 221.25/221.47  |- mesh__dateCreated mesh__D004306 1976-04-27
% 221.25/221.47  |- skos__hiddenLabel mesh__D004306 Relationships, Immunologic Dose-Response
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004306 2006
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004306 1997
% 221.25/221.47  |- mesh__dateRevised mesh__D004306 1993-06-18
% 221.25/221.47  |- mesh__recordOriginator mesh__D004306 MM
% 221.25/221.47  |- rdf__type mesh__D004306sskos__Concept
% 221.25/221.47  |- skos__annotation mesh__D004306
% 221.25/221.47       no qualif; IM if general, NIM when coord for specific immunol concept; DF: DOSE RESPONSE RELAT IMMUNOL%A%  
% 221.25/221.47  |- skos__hiddenLabel mesh__D004306 Dose-Response Relationships, Immunologic
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004306 2005
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004306 1996
% 221.25/221.47  |- skos__scopeNote mesh__D004306
% 221.25/221.47       A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell.%A%    
% 221.25/221.47  |- skos__altLabel mesh__D004306 Immunologic Dose-Response Relationship
% 221.25/221.47  |- mesh__historyNote mesh__D004306 77   
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004306 2001
% 221.25/221.47  |- skos__altLabel mesh__D004306 Relationship, Immunologic Dose-Response
% 221.25/221.47  |- mesh__recordMaintainer mesh__D004306 RAZ
% 221.25/221.47  |- mesh__publicMeSHNote mesh__D004306 77   
% 221.25/221.47  |- skos__hiddenLabel mesh__D004306 Relationship, Immunologic Dose Response
% 221.25/221.47  |- mesh__dateEstablished mesh__D004306 1977-01-01
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004306 1999
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004306 2000
% 221.25/221.47  |- mesh__recordAuthorizer mesh__D004306 PLS
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004306 2004
% 221.25/221.47  |- skos__hiddenLabel mesh__D004306 Immunologic Dose-Response Relationships
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004306 1998
% 221.25/221.47  |- skos__hiddenLabel mesh__D004306 Dose Response Relationship, Immunologic
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004306 2003
% 221.25/221.47  |- skos__prefLabel mesh__D004306 Dose-Response Relationship, Immunologic
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D004306 1995
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D020771 2004
% 221.25/221.47  |- skos__hiddenLabel mesh__D020771 Arteries, Anterior Cerebral
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D020771 2002
% 221.25/221.47  |- mesh__recordOriginator mesh__D020771 ags
% 221.25/221.47  |- skos__altLabel mesh__D020771 Cerebral Artery, Anterior
% 221.25/221.47  |- mesh__historyNote mesh__D020771 2000   
% 221.25/221.47  |- mesh__dateRevised mesh__D020771 2001-07-25
% 221.25/221.47  |- mesh__dateCreated mesh__D020771 1999-11-03
% 221.25/221.47  |- skos__broader mesh__D020771smesh__D002536
% 221.25/221.47  |- mesh__recordMaintainer mesh__D020771 mdb
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D020771 2005
% 221.25/221.47  |- skos__hiddenLabel mesh__D020771 Artery, Anterior Cerebral
% 221.25/221.47  |- mesh__publicMeSHNote mesh__D020771 2000   
% 221.25/221.47  |- skos__hiddenLabel mesh__D020771 Anterior Cerebral Arteries
% 221.25/221.47  |- mesh__recordAuthorizer mesh__D020771 sjn
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D020771 2006
% 221.25/221.47  |- skos__prefLabel mesh__D020771 Anterior Cerebral Artery
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D020771 2003
% 221.25/221.47  |- mesh__dateEstablished mesh__D020771 2000-01-01
% 221.25/221.47  |- skos__hiddenLabel mesh__D020771 Cerebral Arteries, Anterior
% 221.25/221.47  |- skos__scopeNote mesh__D020771
% 221.25/221.47       Artery formed by the bifurcation of the internal carotid artery %28%CAROTID ARTERY, INTERNAL%29%. Branches of the anterior cerebral artery supply the CAUDATE NUCLEUS; INTERNAL CAPSULE; PUTAMEN; SEPTAL NUCLEI; GYRUS CINGULI; and surfaces of the FRONTAL LOBE and PARIETAL LOBE.%A%    
% 221.25/221.47  |- skos__historyNote mesh__D020771 Cerebral Arteries %28%1966-1999%29%
% 221.25/221.47  |- rdf__type mesh__D020771sskos__Concept
% 221.25/221.47  |- skos__broader mesh__D005680Q000037smesh__D005680
% 221.25/221.47  |- mesh__preferredCombination mesh__D005680Q000037smesh__D018756
% 221.25/221.47  |- rdf__type mesh__D005680Q000037smesh__CompoundConcept
% 221.25/221.47  |- skos__related mesh__D014734smesh__D002772
% 221.25/221.47  |- skos__broader mesh__D014734smesh__D014733
% 221.25/221.47  |- mesh__dateRevised mesh__D014734 2005-06-30
% 221.25/221.47  |- skos__historyNote mesh__D014734 Vibrio %28%1966-1971%29%
% 221.25/221.47  |- mesh__recordMaintainer mesh__D014734 SYSTEM
% 221.25/221.47  |- mesh__recordAuthorizer mesh__D014734 sjn
% 221.25/221.47  |- mesh__recordOriginator mesh__D014734 JW
% 221.25/221.47  |- skos__prefLabel mesh__D014734 Vibrio cholerae
% 221.25/221.47  |- mesh__publicMeSHNote mesh__D014734 76; was VIBRIO COMMA 1974-75   
% 221.25/221.47  |- mesh__dateCreated mesh__D014734 1975-07-18
% 221.25/221.47  |- mesh__dateEstablished mesh__D014734 1976-01-01
% 221.25/221.47  |- rdf__type mesh__D014734sskos__Concept
% 221.25/221.47  |- mesh__onlineNote mesh__D014734
% 221.25/221.47       use VIBRIO CHOLERAE to search VIBRIO COMMA 1972-75 %28%as Prov 1972-73%29%%A%  
% 221.25/221.47  |- mesh__historyNote mesh__D014734
% 221.25/221.47       76; was VIBRIO COMMA 1972-75 %28%Prov 1972-73%29%   
% 221.25/221.47  |- skos__annotation mesh__D014734 infection = CHOLERA   
% 221.25/221.47  |- mesh__activeMeSHYear mesh__D014734 2006
% 221.25/221.47  |- skos__altLabel mesh__D014734 Vibrio comma
% 221.25/221.47  |- skos__scopeNote mesh__D014734 The etiologic agent of CHOLERA.     
% 221.25/221.47  |- mesh__publicMeSHNote mesh__D000714 88   
% 221.25/221.48  |- skos__annotation mesh__D000714
% 221.25/221.48       NIM with specific organ /surg %28%IM%29%; do not use /util except by MeSH definition; DF: ANASTOMOSIS SURG%A%  
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000714 1997
% 221.25/221.48  |- skos__altLabel mesh__D000714 Surgical Anastomosis
% 221.25/221.48  |- skos__scopeNote mesh__D000714
% 221.25/221.48       Surgical union or shunt between ducts, tubes or vessels. It may be end-to-end, end-to-side, side-to-end, or side-to-side.%A%    
% 221.25/221.48  |- rdf__type mesh__D000714sskos__Concept
% 221.25/221.48  |- mesh__dateRevised mesh__D000714 2004-08-03
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000714 1999
% 221.25/221.48  |- mesh__dateEstablished mesh__D000714 1988-01-01
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000714 1996
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000714 2004
% 221.25/221.48  |- skos__hiddenLabel mesh__D000714 Surgical Anastomoses
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000714 1993
% 221.25/221.48  |- mesh__recordOriginator mesh__D000714 SCD
% 221.25/221.48  |- skos__historyNote mesh__D000714 organ/disease/surgery %28%1966-1987%29%
% 221.25/221.48  |- skos__hiddenLabel mesh__D000714 Anastomoses, Surgical
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000714 1998
% 221.25/221.48  |- mesh__dateCreated mesh__D000714 1987-03-16
% 221.25/221.48  |- mesh__recordAuthorizer mesh__D000714 jls
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000714 2006
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000714 2003
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000714 1995
% 221.25/221.48  |- skos__broader mesh__D000714smesh__D013514
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000714 1992
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000714 2002
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000714 2005A
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000714 2005
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000714 1991
% 221.25/221.48  |- mesh__recordMaintainer mesh__D000714 jls
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000714 1994
% 221.25/221.48  |- skos__prefLabel mesh__D000714 Anastomosis, Surgical
% 221.25/221.48  |- skos__historyNote mesh__D000714
% 221.25/221.48       specific surgical technique %28%1966-1987%29%
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000714 2001
% 221.25/221.48  |- mesh__historyNote mesh__D000714 88   
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000714 2000
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D018327 2000
% 221.25/221.48  |- mesh__dateEstablished mesh__D018327 1994-01-01
% 221.25/221.48  |- mesh__historyNote mesh__D018327 94   
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D018327 2006
% 221.25/221.48  |- skos__broader mesh__D018327smesh__D008545
% 221.25/221.48  |- skos__hiddenLabel mesh__D018327 Freckles, Melanotic
% 221.25/221.48  |- skos__hiddenLabel mesh__D018327 Malignant Lentigo
% 221.25/221.48  |- mesh__recordAuthorizer mesh__D018327 sjn
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D018327 2004
% 221.25/221.48  |- skos__hiddenLabel mesh__D018327 Lentigos, Malignant
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D018327 2005
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D018327 2002
% 221.25/221.48  |- rdf__type mesh__D018327sskos__Concept
% 221.25/221.48  |- skos__hiddenLabel mesh__D018327 Melanotic Freckles
% 221.25/221.48  |- skos__hiddenLabel mesh__D018327 Hutchinson Melanotic Freckle
% 221.25/221.48  |- skos__altLabel mesh__D018327 Lentigo Maligna
% 221.25/221.48  |- skos__hiddenLabel mesh__D018327 Malignant Lentigos
% 221.25/221.48  |- skos__hiddenLabel mesh__D018327 Freckle, Hutchinson%27%s Melanotic
% 221.25/221.48  |- skos__annotation mesh__D018327
% 221.25/221.48       coord IM with SKIN NEOPLASMS %28%IM%29% + site %28%IM or NIM%29% if relevant%A%  
% 221.25/221.48  |- mesh__dateCreated mesh__D018327 1993-06-03
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D018327 2003
% 221.25/221.48  |- skos__altLabel mesh__D018327 Melanotic Freckle
% 221.25/221.48  |- mesh__recordMaintainer mesh__D018327 KEV
% 221.25/221.48  |- skos__prefLabel mesh__D018327 Hutchinson%27%s Melanotic Freckle
% 221.25/221.48  |- skos__hiddenLabel mesh__D018327 Hutchinsons Melanotic Freckle
% 221.25/221.48  |- mesh__publicMeSHNote mesh__D018327 94   
% 221.25/221.48  |- mesh__dateRevised mesh__D018327 1999-11-03
% 221.25/221.48  |- skos__altLabel mesh__D018327 Lentigo, Malignant
% 221.25/221.48  |- skos__hiddenLabel mesh__D018327 Melanotic Freckle, Hutchinson%27%s
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D018327 2001
% 221.25/221.48  |- skos__scopeNote mesh__D018327
% 221.25/221.48       A cellular subtype of malignant melanoma. It is a pigmented lesion composed of melanocytes occurring on sun-exposed skin, usually the face and neck. The melanocytes are commonly multinucleated with a %22%starburst%22% appearance. It is considered by many to be the in situ phase of lentigo maligna melanoma.%A%    
% 221.25/221.48  |- mesh__recordOriginator mesh__D018327 PLS
% 221.25/221.48  |- skos__altLabel mesh__D018327 Freckle, Melanotic
% 221.25/221.48  |- mesh__dateEstablished mesh__D010344 1978-01-01
% 221.25/221.48  |- skos__hiddenLabel mesh__D010344 Ombudsman, Clinical
% 221.25/221.48  |- mesh__recordAuthorizer mesh__D010344 sjn
% 221.25/221.48  |- mesh__dateCreated mesh__D010344 1975-07-23
% 221.25/221.48  |- skos__hiddenLabel mesh__D010344 Ombudsman, Patient
% 221.25/221.48  |- mesh__recordOriginator mesh__D010344 EC
% 221.25/221.48  |- skos__prefLabel mesh__D010344 Patient Advocacy
% 221.25/221.48  |- skos__related mesh__D010344smesh__D028701
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D010344 2006
% 221.25/221.48  |- skos__scopeNote mesh__D010344
% 221.25/221.48       Promotion and protection of the rights of patients, frequently through a legal process.%A%    
% 221.25/221.48  |- skos__hiddenLabel mesh__D010344 Patient Representative
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D010344 2005
% 221.25/221.48  |- skos__historyNote mesh__D010344 Human Rights %28%1973-1975%29%
% 221.25/221.48  |- skos__broader mesh__D010344smesh__D012926
% 221.25/221.48  |- rdf__type mesh__D010344sskos__Concept
% 221.25/221.48  |- skos__hiddenLabel mesh__D010344 Representative, Patient
% 221.25/221.48  |- mesh__historyNote mesh__D010344 76   
% 221.25/221.48  |- mesh__recordMaintainer mesh__D010344 jls
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D010344 2004
% 221.25/221.48  |- skos__altLabel mesh__D010344 Patient Ombudsman
% 221.25/221.48  |- skos__hiddenLabel mesh__D010344 Representatives, Patient
% 221.25/221.48  |- mesh__publicMeSHNote mesh__D010344 76   
% 221.25/221.48  |- mesh__dateRevised mesh__D010344 2003-07-09
% 221.25/221.48  |- skos__hiddenLabel mesh__D010344 Advocacy, Patient
% 221.25/221.48  |- skos__hiddenLabel mesh__D010344 Ombudsmen, Patient
% 221.25/221.48  |- rdf__type mesh__D004307sskos__Concept
% 221.25/221.48  |- mesh__historyNote mesh__D004307 73   
% 221.25/221.48  |- mesh__recordOriginator mesh__D004307 NLM
% 221.25/221.48  |- skos__broader mesh__D004307smesh__D011829
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D004307 2005
% 221.25/221.48  |- skos__hiddenLabel mesh__D004307 Dose Response Relationship, Radiation
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D004307 1996
% 221.25/221.48  |- skos__hiddenLabel mesh__D004307 Radiation Dose-Response Relationships
% 221.25/221.48  |- skos__historyNote mesh__D004307 Radiation Dosage %28%1972%29%
% 221.25/221.48  |- skos__hiddenLabel mesh__D004307 Relationship, Radiation Dose-Response
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D004307 2002
% 221.25/221.48  |- skos__hiddenLabel mesh__D004307 Radiation Dose-Response Relationship
% 221.25/221.48  |- mesh__recordMaintainer mesh__D004307 RAZ
% 221.25/221.48  |- mesh__dateEstablished mesh__D004307 1973-01-01
% 221.25/221.48  |- skos__historyNote mesh__D004307 Radiotherapy Dosage %28%1966-1972%29%
% 221.25/221.48  |- skos__hiddenLabel mesh__D004307 Relationships, Radiation Dose-Response
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D004307 1999
% 221.25/221.48  |- mesh__dateRevised mesh__D004307 1992-12-28
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D004307 2004
% 221.25/221.48  |- skos__annotation mesh__D004307
% 221.25/221.48       no qualif; IM if general, NIM when coord for specific radiation; DF: DOSE RESPONSE RELAT RAD%A%  
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D004307 1998
% 221.25/221.48  |- skos__prefLabel mesh__D004307 Dose-Response Relationship, Radiation
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D004307 2001
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D004307 2003
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D004307 1995
% 221.25/221.48  |- mesh__dateCreated mesh__D004307 1999-01-01
% 221.25/221.48  |- skos__scopeNote mesh__D004307
% 221.25/221.48       The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation.%A%    
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D004307 2000
% 221.25/221.48  |- mesh__publicMeSHNote mesh__D004307 73   
% 221.25/221.48  |- mesh__recordAuthorizer mesh__D004307 PLS
% 221.25/221.48  |- skos__hiddenLabel mesh__D004307 Dose-Response Relationships, Radiation
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D004307 1994
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D004307 2006
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D004307 1997
% 221.25/221.48  |- mesh__historyNote mesh__D020772 2000   
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D020772 2002
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D020772 2004
% 221.25/221.48  |- mesh__dateCreated mesh__D020772 1999-11-03
% 221.25/221.48  |- skos__broader mesh__D020772smesh__D013687
% 221.25/221.48  |- skos__hiddenLabel mesh__D020772 Internal Capsules
% 221.25/221.48  |- skos__hiddenLabel mesh__D020772 Capsule, Internal
% 221.25/221.48  |- skos__scopeNote mesh__D020772
% 221.25/221.48       White matter pathway, flanked by nuclear masses, consisting of both afferent and efferent fibers projecting between the cerebral cortex and the brainstem. It consists of three distinct parts: an anterior limb, posterior limb, and genu.%A%    
% 221.25/221.48  |- skos__prefLabel mesh__D020772 Internal Capsule
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D020772 2000
% 221.25/221.48  |- mesh__publicMeSHNote mesh__D020772 2000   
% 221.25/221.48  |- skos__broader mesh__D020772smesh__D009434
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D020772 2005
% 221.25/221.48  |- rdf__type mesh__D020772sskos__Concept
% 221.25/221.48  |- mesh__dateEstablished mesh__D020772 2000-01-01
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D020772 2001
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D020772 2003
% 221.25/221.48  |- skos__hiddenLabel mesh__D020772 Capsules, Internal
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D020772 2006
% 221.25/221.48  |- skos__broader mesh__D014735smesh__D016905
% 221.25/221.48  |- mesh__dateCreated mesh__D014735 1999-01-01
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D014735 2003
% 221.25/221.48  |- skos__prefLabel mesh__D014735 Vibrio Infections
% 221.25/221.48  |- rdf__type mesh__D014735sskos__Concept
% 221.25/221.48  |- skos__scopeNote mesh__D014735
% 221.25/221.48       Infections with bacteria of the genus VIBRIO.     
% 221.25/221.48  |- skos__historyNote mesh__D014735 Vibrio %28%1966-1967%29%
% 221.25/221.48  |- mesh__recordOriginator mesh__D014735 NLM
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D014735 1995
% 221.25/221.48  |- mesh__dateEstablished mesh__D014735 1968-01-01
% 221.25/221.48  |- mesh__dateRevised mesh__D014735 1993-06-03
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D014735 1999
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D014735 2002
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D014735 1994
% 221.25/221.48  |- skos__altLabel mesh__D014735 Infections, Vibrio
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D014735 2006
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D014735 1998
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D014735 2001
% 221.25/221.48  |- mesh__recordMaintainer mesh__D014735 TAP
% 221.25/221.48  |- skos__hiddenLabel mesh__D014735 Infection, Vibrio
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D014735 2005
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D014735 1997
% 221.25/221.48  |- mesh__historyNote mesh__D014735 68   
% 221.25/221.48  |- mesh__publicMeSHNote mesh__D014735 68   
% 221.25/221.48  |- mesh__recordAuthorizer mesh__D014735 PLS
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D014735 2000
% 221.25/221.48  |- skos__hiddenLabel mesh__D014735 Vibrio Infection
% 221.25/221.48  |- skos__annotation mesh__D014735
% 221.25/221.48       gram-neg bact infect; V. comma infection = CHOLERA   
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D014735 2004
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D014735 1996
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000715 2004
% 221.25/221.48  |- mesh__recordAuthorizer mesh__D000715 sjn
% 221.25/221.48  |- skos__broader mesh__D000715smesh__D001690
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000715 2006
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000715 2003
% 221.25/221.48  |- skos__annotation mesh__D000715
% 221.25/221.48       SPEC only: SPEC qualif; with organ or organism use /anat: Manual 19.8.7, 19.7+; DF: ANAT%A%  
% 221.25/221.48  |- mesh__dateCreated mesh__D000715 1999-01-01
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000715 2005
% 221.25/221.48  |- mesh__recordOriginator mesh__D000715 NLM
% 221.25/221.48  |- skos__hiddenLabel mesh__D000715 Anatomies
% 221.25/221.48  |- skos__prefLabel mesh__D000715 Anatomy
% 221.25/221.48  |- mesh__dateRevised mesh__D000715 2001-07-25
% 221.25/221.48  |- skos__related mesh__D000715smesh__D004210
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D000715 2002
% 221.25/221.48  |- rdf__type mesh__D000715sskos__Concept
% 221.25/221.48  |- mesh__recordMaintainer mesh__D000715 jls
% 221.25/221.48  |- mesh__dateCreated mesh__D005400 1999-01-01
% 221.25/221.48  |- rdf__type mesh__D005400sskos__Concept
% 221.25/221.48  |- mesh__historyNote mesh__D005400 68   
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D005400 2006
% 221.25/221.48  |- skos__related mesh__D005400smesh__D013779
% 221.25/221.48  |- skos__historyNote mesh__D005400 Fishes %28%1966-1967%29%
% 221.25/221.48  |- skos__broader mesh__D005400smesh__D000832
% 221.25/221.48  |- mesh__dateRevised mesh__D005400 2004-07-07
% 221.25/221.48  |- mesh__recordAuthorizer mesh__D005400 sjn
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D005400 2005
% 221.25/221.48  |- skos__related mesh__D005400smesh__D005397
% 221.25/221.48  |- skos__prefLabel mesh__D005400 Fishes, Poisonous
% 221.25/221.48  |- skos__broader mesh__D005400smesh__D005399
% 221.25/221.48  |- mesh__recordMaintainer mesh__D005400 nns
% 221.25/221.48  |- skos__hiddenLabel mesh__D005400 Poisonous Fishes
% 221.25/221.48  |- mesh__recordOriginator mesh__D005400 NLM
% 221.25/221.48  |- mesh__dateEstablished mesh__D005400 1968-01-01
% 221.25/221.48  |- mesh__publicMeSHNote mesh__D005400 68   
% 221.25/221.48  |- skos__annotation mesh__D005400 IM; qualif permitted   
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D018328 2000
% 221.25/221.48  |- mesh__recordAuthorizer mesh__D018328 PLS
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D018328 1999
% 221.25/221.48  |- skos__annotation mesh__D018328
% 221.25/221.48       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with SKIN NEOPLASMS %28%IM%29% + site %28%IM or NIM%29% if relevant%A%  
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D018328 1996
% 221.25/221.48  |- mesh__dateCreated mesh__D018328 1993-06-25
% 221.25/221.48  |- mesh__historyNote mesh__D018328 94   
% 221.25/221.48  |- mesh__publicMeSHNote mesh__D018328 94   
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D018328 2006
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D018328 2003
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D018328 2001
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D018328 1997
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D018328 2004
% 221.25/221.48  |- mesh__dateEstablished mesh__D018328 1994-01-01
% 221.25/221.48  |- skos__prefLabel mesh__D018328 Melanoma, Amelanotic
% 221.25/221.48  |- rdf__type mesh__D018328sskos__Concept
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D018328 2002
% 221.25/221.48  |- skos__hiddenLabel mesh__D018328 Amelanotic Melanomas
% 221.25/221.48  |- mesh__recordMaintainer mesh__D018328 KEV
% 221.25/221.48  |- skos__historyNote mesh__D018328 Melanoma %28%1966-1993%29%
% 221.25/221.48  |- skos__scopeNote mesh__D018328
% 221.25/221.48       An unpigmented malignant melanoma. It is an anaplastic melanoma consisting of cells derived from melanoblasts but not forming melanin. %28%Dorland, 27th ed; Stedman, 25th ed%29%%A%    
% 221.25/221.48  |- mesh__recordOriginator mesh__D018328 PLS
% 221.25/221.48  |- skos__hiddenLabel mesh__D018328 Melanomas, Amelanotic
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D018328 1998
% 221.25/221.48  |- mesh__dateRevised mesh__D018328 1995-06-08
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D018328 2005
% 221.25/221.48  |- skos__hiddenLabel mesh__D018328 Amelanotic Melanoma
% 221.25/221.48  |- skos__broader mesh__D018328smesh__D008545
% 221.25/221.48  |- mesh__historyNote mesh__D004308
% 221.25/221.48       91%28%79%29%; was see under DIBENZOTHIEPINS 1979-90; was PROTHIADENE see under DIBENZOTHIEPINS 1968-78; PROTHIADENE was see DOTHIEPIN 1979-94%A%  
% 221.25/221.48  |- mesh__recordMaintainer mesh__D004308 ssb
% 221.25/221.48  |- mesh__dateEstablished mesh__D004308 1991-01-01
% 221.25/221.48  |- mesh__dateRevised mesh__D004308 2005-06-30
% 221.25/221.48  |- mesh__dateCreated mesh__D004308 1999-01-01
% 221.25/221.48  |- mesh__recordOriginator mesh__D004308 NLM
% 221.25/221.48  |- mesh__recordAuthorizer mesh__D004308 sjn
% 221.25/221.48  |- skos__scopeNote mesh__D004308
% 221.25/221.48       A tricyclic antidepressant with some tranquilizing action.%A%    
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D004308 2006
% 221.25/221.48  |- rdf__type mesh__D004308sskos__Concept
% 221.25/221.48  |- skos__hiddenLabel mesh__D004308 Hydrochloride, Dothiepin
% 221.25/221.48  |- skos__historyNote mesh__D004308 Dibenzothiepins %28%1968-1974%29%
% 221.25/221.48  |- mesh__publicMeSHNote mesh__D004308
% 221.25/221.48       91; was see under DIBENZOTHIEPINS 1979-90; was PROTHIADENE see under DIBENZOTHIEPINS 1968-78; PROTHIADENE was see DOTHIEPIN 1979-94%A%  
% 221.25/221.48  |- skos__prefLabel mesh__D004308 Dothiepin
% 221.25/221.48  |- mesh__onlineNote mesh__D004308
% 221.25/221.48       use DOTHIEPIN to search PROTHIADENE 1975-94; use DIBENZOTHIEPINS 1968-74%A%  
% 221.25/221.48  |- skos__broader mesh__D004308smesh__D003988
% 221.25/221.48  |- skos__altLabel mesh__D004308 Dosulepin
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D015030 2002
% 221.25/221.48  |- mesh__onlineNote mesh__D015030
% 221.25/221.48       use ZIMBABWE to search ZIMBABWE RHODESIA 1980, RHODESIA 1967-79 %26% RHODESIA-NYASALAND 1966%A%  
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D015030 2006
% 221.25/221.48  |- skos__altLabel mesh__D015030 Southern Rhodesia
% 221.25/221.48  |- mesh__recordAuthorizer mesh__D015030 SJN
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D015030 2003
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D015030 2000
% 221.25/221.48  |- rdf__type mesh__D015030sskos__Concept
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D015030 1998
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D015030 2004
% 221.25/221.48  |- skos__altLabel mesh__D015030 Zimbabwe Rhodesia
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D015030 1999
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D015030 2001
% 221.25/221.48  |- mesh__historyNote mesh__D015030
% 221.25/221.48       81; was ZIMBABWE RHODESIA 1980, was RHODESIA 1967-79, was RHODESIA-NYASALAND 1963-66%A%  
% 221.25/221.48  |- mesh__dateRevised mesh__D015030 1997-06-20
% 221.25/221.48  |- skos__altLabel mesh__D015030 Rhodesia, Southern
% 221.25/221.48  |- skos__scopeNote mesh__D015030
% 221.25/221.48       A republic in southern Africa, east of ZAMBIA and BOTSWANA and west of MOZAMBIQUE. Its capital is Harare. It was formerly called Rhodesia and Southern Rhodesia. The region was under the administration of the British South Africa Company from 1889 to 1923 when it became a self-governing British colony. Zimbabwe was a member of the Federation of Rhodesia and Nyasaland 1953-63. It was granted independence by the British in 1980 when it became Zimbabwe. The name is from that of a famous archaeological site whose name is the Bantu zimba we bahwe, %28%house of stones%29% from zimba, the plural of imba %28%house%29% + bahwe %28%stones%29%. It refers to ruins comprising an acropolis with huge walls of monoliths fitted without mortar. %28%From Webster%27%s New Geographical Dictionary, 1988, p1013, 1374 %26% Room, Brewer%27%s Dictionary of Names, 1992, p610%29%%A%    
% 221.25/221.48  |- skos__annotation mesh__D015030
% 221.25/221.48       a republic in southern Africa; note X ref SOUTHERN RHODESIA: Northern Rhodesia is now ZAMBIA%A%  
% 221.25/221.48  |- skos__broader mesh__D015030smesh__D000353
% 221.25/221.48  |- mesh__recordOriginator mesh__D015030 NLM
% 221.25/221.48  |- mesh__dateCreated mesh__D015030 1999-01-01
% 221.25/221.48  |- skos__prefLabel mesh__D015030 Zimbabwe
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D015030 2005
% 221.25/221.48  |- mesh__recordMaintainer mesh__D015030 TGC
% 221.25/221.48  |- mesh__dateRevised mesh__D001010 1997-06-20
% 221.25/221.48  |- skos__historyNote mesh__D001010 Child Psychology %28%1966-1967%29%
% 221.25/221.48  |- mesh__historyNote mesh__D001010
% 221.25/221.48       68; HOMESICKNESS was see under ANXIETY, SEPARATION 1975-78, was see under EMOTIONS 1963-74%A%  
% 221.25/221.48  |- skos__historyNote mesh__D001010 Anxiety %28%1966-1967%29%
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D001010 1998
% 221.25/221.48  |- rdf__type mesh__D001010sskos__Concept
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D001010 2000
% 221.25/221.48  |- mesh__recordMaintainer mesh__D001010 JLS
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D001010 1999
% 221.25/221.48  |- mesh__dateEstablished mesh__D001010 1968-01-01
% 221.25/221.48  |- skos__broader mesh__D001010smesh__D019952
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D001010 2001
% 221.25/221.48  |- skos__prefLabel mesh__D001010 Anxiety, Separation
% 221.25/221.48  |- skos__hiddenLabel mesh__D001010 Anxiety Disorder, Separation
% 221.25/221.48  |- mesh__publicMeSHNote mesh__D001010
% 221.25/221.48       68; HOMESICKNESS was see under EMOTIONS 1963-74   
% 221.25/221.48  |- mesh__dateCreated mesh__D001010 1999-01-01
% 221.25/221.48  |- mesh__activeMeSHYear mesh__D001010 2003
% 221.34/221.48  |- mesh__onlineNote mesh__D001010
% 221.34/221.48       use ANXIETY, SEPARATION to search HOMESICKNESS 1975-78; use EMOTIONS 1966-74%A%  
% 221.34/221.48  |- mesh__activeMeSHYear mesh__D001010 2005
% 221.34/221.48  |- skos__hiddenLabel mesh__D001010 Separation Anxiety
% 221.34/221.48  |- mesh__recordOriginator mesh__D001010 NLM
% 221.34/221.48  |- mesh__activeMeSHYear mesh__D001010 2004
% 221.34/221.48  |- skos__scopeNote mesh__D001010
% 221.34/221.48       Anxiety experienced by an individual upon separation from a person or object of particular significance to him.%A%    
% 221.34/221.48  |- mesh__activeMeSHYear mesh__D001010 2002
% 221.34/221.48  |- mesh__activeMeSHYear mesh__D001010 2006
% 221.34/221.48  |- skos__historyNote mesh__D001010
% 221.34/221.48       Child Behavior Disorders %28%1966-1967%29%
% 221.34/221.48  |- mesh__recordAuthorizer mesh__D001010 SJN
% 221.34/221.48  |- mesh__dateCreated mesh__D020773 1999-11-08
% 221.34/221.48  |- skos__prefLabel mesh__D020773 Headache Disorders
% 221.34/221.48  |- skos__hiddenLabel mesh__D020773 Syndrome, Headache
% 221.34/221.48  |- skos__hiddenLabel mesh__D020773 Daily Headache, Chronic
% 221.34/221.48  |- skos__hiddenLabel mesh__D020773 Chronic Headaches
% 221.34/221.48  |- skos__scopeNote mesh__D020773
% 221.34/221.48       Various conditions with the symptom of HEADACHE. Headache disorders are classified into major groups, such as PRIMARY HEADACHE DISORDERS %28%based on characteristics of their headache symptoms%29% and SECONDARY HEADACHE DISORDERS %28%based on their etiologies%29%. %28%International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1%29%%A%    
% 221.34/221.48  |- skos__hiddenLabel mesh__D020773 Headache Syndrome
% 221.34/221.48  |- skos__hiddenLabel mesh__D020773 Headaches, Intractable
% 221.34/221.48  |- mesh__dateRevised mesh__D020773 2005-06-30
% 221.34/221.48  |- skos__hiddenLabel mesh__D020773 Cephalgia Syndrome
% 221.34/221.48  |- skos__related mesh__D020773smesh__D006261
% 221.34/221.48  |- skos__historyNote mesh__D020773 Headache %28%1978-1999%29%
% 221.34/221.48  |- skos__hiddenLabel mesh__D020773 Headache Disorder
% 221.34/221.48  |- skos__hiddenLabel mesh__D020773 Headaches, Chronic
% 221.34/221.48  |- skos__hiddenLabel mesh__D020773 Chronic Daily Headaches
% 221.34/221.48  |- rdf__type mesh__D020773sskos__Concept
% 221.34/221.48  |- mesh__dateEstablished mesh__D020773 2000-01-01
% 221.34/221.48  |- skos__hiddenLabel mesh__D020773 Intractable Headaches
% 221.34/221.48  |- mesh__recordOriginator mesh__D020773 KEV
% 221.34/221.48  |- skos__hiddenLabel mesh__D020773 Headaches, Chronic Daily
% 221.34/221.48  |- mesh__activeMeSHYear mesh__D020773 2006
% 221.34/221.48  |- mesh__publicMeSHNote mesh__D020773 2000   
% 221.34/221.48  |- mesh__historyNote mesh__D020773 2000   
% 221.34/221.48  |- skos__hiddenLabel mesh__D020773 Headache, Chronic
% 221.34/221.48  |- mesh__recordAuthorizer mesh__D020773 sjn
% 221.34/221.48  |- skos__hiddenLabel mesh__D020773 Headache, Chronic Daily
% 221.34/221.48  |- skos__altLabel mesh__D020773 Headache Syndromes
% 221.34/221.48  |- mesh__recordMaintainer mesh__D020773 lkt
% 221.34/221.48  |- skos__altLabel mesh__D020773 Cephalgia Syndromes
% 221.34/221.48  |- skos__broader mesh__D020773smesh__D001927
% 221.34/221.48  |- skos__hiddenLabel mesh__D020773 Daily Headaches, Chronic
% 221.34/221.48  |- skos__hiddenLabel mesh__D020773 Intractable Headache
% 221.34/221.48  |- mesh__publicMeSHNote mesh__D014736 76   
% 221.34/221.48  |- skos__scopeNote mesh__D014736
% 221.34/221.48       A species of bacteria found in the marine environment, sea foods, and the feces of patients with acute enteritis.%A%    
% 221.34/221.48  |- mesh__activeMeSHYear mesh__D014736 2006
% 221.34/221.48  |- skos__annotation mesh__D014736
% 221.34/221.48       infection: coord IM with VIBRIO INFECTIONS %28%IM%29%   
% 221.34/221.48  |- skos__historyNote mesh__D014736 Vibrio %28%1966-1975%29%
% 221.34/221.48  |- skos__broader mesh__D014736smesh__D014733
% 221.34/221.48  |- mesh__historyNote mesh__D014736 76   
% 221.34/221.48  |- mesh__dateRevised mesh__D014736 2005-06-30
% 221.34/221.48  |- mesh__dateCreated mesh__D014736 1975-07-23
% 221.34/221.48  |- mesh__recordMaintainer mesh__D014736 SYSTEM
% 221.34/221.48  |- mesh__recordOriginator mesh__D014736 JW
% 221.34/221.48  |- mesh__recordAuthorizer mesh__D014736 sjn
% 221.34/221.48  |- rdf__type mesh__D014736sskos__Concept
% 221.34/221.48  |- mesh__dateEstablished mesh__D014736 1976-01-01
% 221.34/221.48  |- skos__prefLabel mesh__D014736 Vibrio parahaemolyticus
% 221.34/221.48  |- skos__annotation mesh__D000716
% 221.34/221.48       SPEC: SPEC qualif; anatomical atlases go here %28%IM%29% + MEDICAL ILLUSTRATION %28%IM%29%%A%  
% 221.34/221.48  |- mesh__activeMeSHYear mesh__D000716 2005
% 221.34/221.48  |- mesh__recordOriginator mesh__D000716 NLM
% 221.34/221.48  |- skos__altLabel mesh__D000716 Artistic Anatomy
% 221.34/221.48  |- mesh__dateRevised mesh__D000716 2001-07-25
% 221.34/221.48  |- mesh__dateCreated mesh__D000716 1999-01-01
% 221.34/221.48  |- mesh__recordMaintainer mesh__D000716 jls
% 221.34/221.48  |- mesh__activeMeSHYear mesh__D000716 2002
% 221.34/221.48  |- skos__broader mesh__D000716smesh__D008488
% 221.34/221.48  |- skos__hiddenLabel mesh__D000716 Artistic Anatomies
% 221.34/221.48  |- skos__hiddenLabel mesh__D000716 Anatomies, Artistic
% 221.34/221.48  |- mesh__recordAuthorizer mesh__D000716 sjn
% 221.34/221.48  |- rdf__type mesh__D000716sskos__Concept
% 221.34/221.48  |- skos__broader mesh__D000716smesh__D000715
% 221.34/221.48  |- mesh__activeMeSHYear mesh__D000716 2004
% 221.34/221.48  |- skos__prefLabel mesh__D000716 Anatomy, Artistic
% 221.34/221.48  |- mesh__activeMeSHYear mesh__D000716 2006
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D000716 2003
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D005401 2002
% 221.34/221.49  |- skos__hiddenLabel mesh__D005401 Ulcers, Anal
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D005401 2006
% 221.34/221.49  |- skos__scopeNote mesh__D005401
% 221.34/221.49       A painful linear ulcer at the margin of the anus. It appears as a crack or slit in the mucous membrane of the anus and is very painful and difficult to heal. %28%Dorland, 27th ed %26% Stedman, 25th ed%29%%A%    
% 221.34/221.49  |- skos__hiddenLabel mesh__D005401 Ulcer, Anal
% 221.34/221.49  |- skos__broader mesh__D005401smesh__D001004
% 221.34/221.49  |- mesh__dateRevised mesh__D005401 1997-06-20
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D005401 2003
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D005401 2001
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D005401 2005
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D005401 1999
% 221.34/221.49  |- mesh__recordAuthorizer mesh__D005401 SJN
% 221.34/221.49  |- skos__hiddenLabel mesh__D005401 Anal Ulcers
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D005401 2000
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D005401 1998
% 221.34/221.49  |- skos__altLabel mesh__D005401 Anal Ulcer
% 221.34/221.49  |- mesh__dateCreated mesh__D005401 1999-01-01
% 221.34/221.49  |- skos__prefLabel mesh__D005401 Fissure in Ano
% 221.34/221.49  |- skos__altLabel mesh__D005401 Anal Fissure
% 221.34/221.49  |- rdf__type mesh__D005401sskos__Concept
% 221.34/221.49  |- skos__hiddenLabel mesh__D005401 Fissure, Anal
% 221.34/221.49  |- skos__annotation mesh__D005401
% 221.34/221.49       ulcer at margin of anus; do not confuse X ref ANAL FISSURE with ANAL FISTULA see RECTAL FISTULA%A%  
% 221.34/221.49  |- mesh__recordMaintainer mesh__D005401 TPW
% 221.34/221.49  |- mesh__recordOriginator mesh__D005401 NLM
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D005401 2004
% 221.34/221.49  |- skos__hiddenLabel mesh__D018329 Nevus, Cellular Blue
% 221.34/221.49  |- skos__altLabel mesh__D018329 Blue Nevus
% 221.34/221.49  |- skos__historyNote mesh__D018329 Nevus %28%1966-1993%29%
% 221.34/221.49  |- skos__altLabel mesh__D018329 Cellular Blue Nevi
% 221.34/221.49  |- skos__hiddenLabel mesh__D018329 Nevi, Blue
% 221.34/221.49  |- rdf__type mesh__D018329sskos__Concept
% 221.34/221.49  |- mesh__recordMaintainer mesh__D018329 ags
% 221.34/221.49  |- mesh__dateCreated mesh__D018329 1993-06-25
% 221.34/221.49  |- mesh__publicMeSHNote mesh__D018329 94   
% 221.34/221.49  |- skos__altLabel mesh__D018329 Blue Nevus, Cellular
% 221.34/221.49  |- mesh__dateRevised mesh__D018329 2004-07-07
% 221.34/221.49  |- skos__prefLabel mesh__D018329 Nevus, Blue
% 221.34/221.49  |- mesh__dateEstablished mesh__D018329 1994-01-01
% 221.34/221.49  |- mesh__recordOriginator mesh__D018329 PLS
% 221.34/221.49  |- skos__annotation mesh__D018329
% 221.34/221.49       coord IM with SKIN NEOPLASMS %28%IM%29% + site %28%IM or NIM%29% if relevant%A%  
% 221.34/221.49  |- skos__altLabel mesh__D018329 Blue Nevi
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D018329 2005
% 221.34/221.49  |- skos__hiddenLabel mesh__D018329 Nevi, Cellular Blue
% 221.34/221.49  |- skos__broader mesh__D018329smesh__D009508
% 221.34/221.49  |- skos__related mesh__D018329smesh__D049328
% 221.34/221.49  |- mesh__recordAuthorizer mesh__D018329 sjn
% 221.34/221.49  |- mesh__historyNote mesh__D018329 94   
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D018329 2006
% 221.34/221.49  |- skos__hiddenLabel mesh__D018329 Blue Nevi, Cellular
% 221.34/221.49  |- skos__historyNote mesh__D018329 Nevus, Pigmented %28%1967-1993%29%
% 221.34/221.49  |- skos__scopeNote mesh__D018329
% 221.34/221.49       Usually a benign tumor, that commonly presents as a solitary blue nodule with spindled MELANOCYTES covered by smooth SKIN. Several variants have been identified, one variant being malignant. The blue color is caused by large, densely packed melanocytes deep in the DERMIS of the nevus. In CHILDREN, they usually occur on the BUTTOCKS and LUMBOSACRAL REGION and are referred to as cellular blue nevi. Malignant blue nevi are more commonly found on the SCALP.%A%    
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D010346 2005
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D010346 1998
% 221.34/221.49  |- skos__scopeNote mesh__D010346
% 221.34/221.49       Generating, planning, organizing, and administering medical and nursing care and services for patients.%A%    
% 221.34/221.49  |- mesh__dateEstablished mesh__D010346 1998-01-01
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D010346 2006
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D010346 1999
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D010346 2000
% 221.34/221.49  |- skos__hiddenLabel mesh__D010346 Management, Patient Care
% 221.34/221.49  |- mesh__dateCreated mesh__D010346 1999-01-01
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D010346 2003
% 221.34/221.49  |- rdf__type mesh__D010346sskos__Concept
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D010346 2001
% 221.34/221.49  |- mesh__recordAuthorizer mesh__D010346 SJN
% 221.34/221.49  |- mesh__recordMaintainer mesh__D010346 TGC
% 221.34/221.49  |- skos__annotation mesh__D010346 GEN or unspecified; prefer specifics   
% 221.34/221.49  |- mesh__historyNote mesh__D010346 98; use explode 1970-97   
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D010346 2004
% 221.34/221.49  |- mesh__dateRevised mesh__D010346 1997-06-20
% 221.34/221.49  |- mesh__publicMeSHNote mesh__D010346 98   
% 221.34/221.49  |- skos__hiddenLabel mesh__D010346 Care Management, Patient
% 221.34/221.49  |- skos__broader mesh__D010346smesh__D006298
% 221.34/221.49  |- skos__prefLabel mesh__D010346 Patient Care Management
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D010346 2002
% 221.34/221.49  |- mesh__recordOriginator mesh__D010346 NLM
% 221.34/221.49  |- mesh__recordMaintainer mesh__D004309 jls
% 221.34/221.49  |- skos__broader mesh__D004309smesh__D011593
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D004309 2003
% 221.34/221.49  |- mesh__dateCreated mesh__D004309 1999-01-01
% 221.34/221.49  |- skos__annotation mesh__D004309 no qualif   
% 221.34/221.49  |- mesh__historyNote mesh__D004309 2000%28%1972%29%   
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D004309 2001
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D004309 2006
% 221.34/221.49  |- skos__hiddenLabel mesh__D004309 Double Bind Interactions
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D004309 2000
% 221.34/221.49  |- rdf__type mesh__D004309sskos__Concept
% 221.34/221.49  |- skos__hiddenLabel mesh__D004309 Theory, Double Bind
% 221.34/221.49  |- skos__scopeNote mesh__D004309
% 221.34/221.49       Simultaneous communication of conflicting messages in which the response to either message evokes rejection or disapproval. %28%APA, Thesaurus of Psychological Index Terms, 8th ed.%29%%A%    
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D004309 2005
% 221.34/221.49  |- skos__hiddenLabel mesh__D004309 Interactions, Double Bind
% 221.34/221.49  |- skos__hiddenLabel mesh__D004309 Double Bind Theories
% 221.34/221.49  |- skos__hiddenLabel mesh__D004309 Theories, Double Bind
% 221.34/221.49  |- mesh__recordAuthorizer mesh__D004309 sjn
% 221.34/221.49  |- mesh__publicMeSHNote mesh__D004309
% 221.34/221.49       2000; see DOUBLE BIND THEORY 1991-1999; see PSYCHOLOGICAL THEORY 1972-1990%A%  
% 221.34/221.49  |- mesh__recordOriginator mesh__D004309 NLM
% 221.34/221.49  |- skos__hiddenLabel mesh__D004309 Interaction, Double Bind
% 221.34/221.49  |- skos__prefLabel mesh__D004309 Double Bind Interaction
% 221.34/221.49  |- skos__historyNote mesh__D004309 Psychological Theory %28%1966-1971%29%
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D004309 2002
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D004309 2004
% 221.34/221.49  |- mesh__dateRevised mesh__D004309 1999-11-03
% 221.34/221.49  |- mesh__dateEstablished mesh__D004309 1991-01-01
% 221.34/221.49  |- skos__hiddenLabel mesh__D015031 Hydrochloride, Zimeldine
% 221.34/221.49  |- mesh__recordAuthorizer mesh__D015031 sjn
% 221.34/221.49  |- skos__hiddenLabel mesh__D015031 H10209
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D015031 2004
% 221.34/221.49  |- mesh__dateCreated mesh__D015031 1983-03-11
% 221.34/221.49  |- mesh__publicMeSHNote mesh__D015031 93; was ZIMELIDINE 1984-92   
% 221.34/221.49  |- skos__altLabel mesh__D015031 Zimeldine Hydrochloride
% 221.34/221.49  |- skos__broader mesh__D015031smesh__D001977
% 221.34/221.49  |- mesh__onlineNote mesh__D015031
% 221.34/221.49       use ZIMELDINE to search ZIMELIDINE 1984-92   
% 221.34/221.49  |- skos__altLabel mesh__D015031 Zimelidin
% 221.34/221.49  |- skos__hiddenLabel mesh__D015031 Hydrochloride, Zimelidine
% 221.34/221.49  |- skos__historyNote mesh__D015031 Brompheniramine %28%1966-1983%29%
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D015031 2002
% 221.34/221.49  |- mesh__historyNote mesh__D015031 93; was ZIMELIDINE 1984-92   
% 221.34/221.49  |- mesh__recordMaintainer mesh__D015031 ssb
% 221.34/221.49  |- skos__prefLabel mesh__D015031 Zimeldine
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D015031 2005
% 221.34/221.49  |- mesh__recordOriginator mesh__D015031 SH
% 221.34/221.49  |- mesh__dateRevised mesh__D015031 2001-07-25
% 221.34/221.49  |- skos__scopeNote mesh__D015031
% 221.34/221.49       One of the SEROTONIN UPTAKE INHIBITORS formerly used for depression but was withdrawn worldwide in September 1983 because of the risk of GUILLAIN-BARRE SYNDROME associated with its use. %28%From Martindale, The Extra Pharmacopoeia, 29th ed, p385%29%%A%    
% 221.34/221.49  |- mesh__dateEstablished mesh__D015031 1984-01-01
% 221.34/221.49  |- skos__hiddenLabel mesh__D015031 H 102 09
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D015031 2006
% 221.34/221.49  |- skos__altLabel mesh__D015031 Zimelidine
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D015031 2003
% 221.34/221.49  |- rdf__type mesh__D015031sskos__Concept
% 221.34/221.49  |- skos__historyNote mesh__D015031 Pyridines %28%1966-1983%29%
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D001011 1997
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D001011 1994
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D001011 2002
% 221.34/221.49  |- skos__altLabel mesh__D001011 Aorta, Ascending
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D001011 1999
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D001011 1993
% 221.34/221.49  |- mesh__recordMaintainer mesh__D001011 TAP
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D001011 1995
% 221.34/221.49  |- mesh__dateRevised mesh__D001011 1992-03-25
% 221.34/221.49  |- mesh__dateCreated mesh__D001011 1999-01-01
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D001011 2003
% 221.34/221.49  |- skos__annotation mesh__D001011
% 221.34/221.49       /surg: consider also CORONARY ARTERY BYPASS; inflammation = AORTITIS but note also AORTITIS, SYPHILITIC see SYPHILIS, CARDIOVASCULAR%A%  
% 221.34/221.49  |- skos__scopeNote mesh__D001011
% 221.34/221.49       The main trunk of the systemic arteries.     
% 221.34/221.49  |- skos__related mesh__D001011smesh__D001027
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D001011 2005
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D001011 2000
% 221.34/221.49  |- skos__broader mesh__D001011smesh__D001158
% 221.34/221.49  |- skos__hiddenLabel mesh__D001011 Aortas
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D001011 2004
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D001011 2001
% 221.34/221.49  |- skos__prefLabel mesh__D001011 Aorta
% 221.34/221.49  |- skos__hiddenLabel mesh__D001011 Aortas, Ascending
% 221.34/221.49  |- skos__hiddenLabel mesh__D001011 Ascending Aortas
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D001011 2006
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D001011 1996
% 221.34/221.49  |- mesh__recordAuthorizer mesh__D001011 PLS
% 221.34/221.49  |- skos__related mesh__D001011smesh__D001026
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D001011 1998
% 221.34/221.49  |- mesh__recordOriginator mesh__D001011 NLM
% 221.34/221.49  |- rdf__type mesh__D001011sskos__Concept
% 221.34/221.49  |- mesh__publicMeSHNote mesh__D020774
% 221.34/221.49       2000; for PICKS DISEASE OF BRAIN see DEMENTIA 1992-1999   
% 221.34/221.49  |- skos__hiddenLabel mesh__D020774 Disease, Pick%27%s
% 221.34/221.49  |- mesh__dateCreated mesh__D020774 1999-11-05
% 221.34/221.49  |- skos__hiddenLabel mesh__D020774 Atrophy, Lobar %28%Brain%29%
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D020774 2005
% 221.34/221.49  |- rdf__type mesh__D020774sskos__Concept
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D020774 2000
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D020774 2003
% 221.34/221.49  |- skos__historyNote mesh__D020774 Dementia %28%1966-1999%29%
% 221.34/221.49  |- mesh__historyNote mesh__D020774
% 221.34/221.49       2000; for PICKS DISEASE OF BRAIN use DEMENTIA 1992-1999   
% 221.34/221.49  |- skos__hiddenLabel mesh__D020774 Disease, Pick
% 221.34/221.49  |- skos__altLabel mesh__D020774 Lobar Atrophy %28%Brain%29%
% 221.34/221.49  |- skos__hiddenLabel mesh__D020774 Picks Disease
% 221.34/221.49  |- skos__altLabel mesh__D020774 Picks Disease of Brain
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D020774 2006
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D020774 2001
% 221.34/221.49  |- mesh__dateEstablished mesh__D020774 2000-01-01
% 221.34/221.49  |- skos__broader mesh__D020774smesh__D003704
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D020774 2004
% 221.34/221.49  |- skos__altLabel mesh__D020774 Circumscribed Lobar Atrophy of the Brain
% 221.34/221.49  |- skos__altLabel mesh__D020774 Brain Atrophy, Circumscribed Lobar
% 221.34/221.49  |- skos__prefLabel mesh__D020774 Pick Disease of the Brain
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D020774 2002
% 221.34/221.49  |- skos__scopeNote mesh__D020774
% 221.34/221.49       A rare form of DEMENTIA that is sometimes familial. Clinical features include APHASIA; APRAXIA; CONFUSION; ANOMIA; memory loss; and personality deterioration. This pattern is consistent with the pathologic findings of circumscribed atrophy of the poles of the FRONTAL LOBE and TEMPORAL LOBE. Neuronal loss is maximal in the HIPPOCAMPUS, entorhinal cortex, and AMYGDALA. Some ballooned cortical neurons contain argentophylic %28%Pick%29% bodies. %28%From Brain Pathol 1998 Apr;8%28%2%29%:339-54; Adams et al., Principles of Neurology, 6th ed, pp1057-9%29%%A%    
% 221.34/221.49  |- skos__hiddenLabel mesh__D020774 Atrophies, Lobar %28%Brain%29%
% 221.34/221.49  |- skos__hiddenLabel mesh__D020774 Lobar Atrophies %28%Brain%29%
% 221.34/221.49  |- skos__altLabel mesh__D020774 Pick Disease
% 221.34/221.49  |- skos__altLabel mesh__D020774 Pick%27%s Disease
% 221.34/221.49  |- mesh__recordAuthorizer mesh__D014737 ags
% 221.34/221.49  |- skos__annotation mesh__D014737
% 221.34/221.49       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 221.34/221.49  |- skos__broader mesh__D014737smesh__D020563
% 221.34/221.49  |- mesh__dateEstablished mesh__D014737 1976-01-01
% 221.34/221.49  |- mesh__recordMaintainer mesh__D014737 ags
% 221.34/221.49  |- mesh__recordOriginator mesh__D014737 CAB
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D014737 2006
% 221.34/221.49  |- skos__broader mesh__D014737smesh__D006092
% 221.34/221.49  |- skos__historyNote mesh__D014737 Spirillaceae %28%1975%29%
% 221.34/221.49  |- mesh__dateRevised mesh__D014737 2005-07-14
% 221.34/221.49  |- mesh__publicMeSHNote mesh__D014737 76   
% 221.34/221.49  |- skos__scopeNote mesh__D014737
% 221.34/221.49       A family of gram-negative bacteria whose members predominate in the bacterial flora of PLANKTON; FISHES; and SEAWATER. Some members are important pathogens for humans and animals.%A%    
% 221.34/221.49  |- mesh__historyNote mesh__D014737 76   
% 221.34/221.49  |- mesh__dateCreated mesh__D014737 1975-07-18
% 221.34/221.49  |- skos__prefLabel mesh__D014737 Vibrionaceae
% 221.34/221.49  |- skos__historyNote mesh__D014737 Bacteria %28%1966-1974%29%
% 221.34/221.49  |- skos__historyNote mesh__D014737 Pseudomonadaceae %28%1975%29%
% 221.34/221.49  |- rdf__type mesh__D014737sskos__Concept
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D014737 2006A
% 221.34/221.49  |- skos__hiddenLabel mesh__D000717 Comparative Anatomies
% 221.34/221.49  |- skos__altLabel mesh__D000717 Comparative Anatomy
% 221.34/221.49  |- mesh__recordOriginator mesh__D000717 NLM
% 221.34/221.49  |- mesh__dateRevised mesh__D000717 2001-07-25
% 221.34/221.49  |- skos__hiddenLabel mesh__D000717 Anatomies, Comparative
% 221.34/221.49  |- mesh__recordMaintainer mesh__D000717 jls
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D000717 2002
% 221.34/221.49  |- rdf__type mesh__D000717sskos__Concept
% 221.34/221.49  |- skos__annotation mesh__D000717
% 221.34/221.49       SPEC: IM, SPEC qualif; do not check COMPARATIVE STUDY for, as a field, it is not a substitute for a comparison of two or more anatomical concepts %28% = COMPARATIVE STUDY tag%29%; Manual 18.13.4: relation to COMPARATIVE STUDY%A%  
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D000717 2004
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D000717 2006
% 221.34/221.49  |- skos__prefLabel mesh__D000717 Anatomy, Comparative
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D000717 2003
% 221.34/221.49  |- mesh__recordAuthorizer mesh__D000717 sjn
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D000717 2005
% 221.34/221.49  |- skos__broader mesh__D000717smesh__D000715
% 221.34/221.49  |- skos__scopeNote mesh__D000717
% 221.34/221.49       The comparative study of animal structure with regard to homologous organs or parts. %28%Stedman, 25th ed%29%%A%    
% 221.34/221.49  |- mesh__dateCreated mesh__D000717 1999-01-01
% 221.34/221.49  |- mesh__dateCreated mesh__D019422 1996-06-10
% 221.34/221.49  |- skos__altLabel mesh__D019422 Sucrose, Dietary
% 221.34/221.49  |- rdf__type mesh__D019422sskos__Concept
% 221.34/221.49  |- skos__broader mesh__D019422smesh__D013395
% 221.34/221.49  |- skos__annotation mesh__D019422
% 221.34/221.49       /adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with specific dis /diet ther%A%  
% 221.34/221.49  |- mesh__historyNote mesh__D019422 97   
% 221.34/221.49  |- mesh__publicMeSHNote mesh__D019422 97   
% 221.34/221.49  |- mesh__dateEstablished mesh__D019422 1997-01-01
% 221.34/221.49  |- mesh__recordAuthorizer mesh__D019422 sjn
% 221.34/221.49  |- skos__historyNote mesh__D019422 Sucrose %28%1966-1996%29%
% 221.34/221.49  |- skos__altLabel mesh__D019422 Table Sugar
% 221.34/221.49  |- skos__altLabel mesh__D019422 Dietary Sugars
% 221.34/221.49  |- mesh__dateRevised mesh__D019422 2004-07-07
% 221.34/221.49  |- mesh__recordMaintainer mesh__D019422 ssb
% 221.34/221.49  |- mesh__recordOriginator mesh__D019422 TPW
% 221.34/221.49  |- skos__prefLabel mesh__D019422 Dietary Sucrose
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D019422 2005
% 221.34/221.49  |- skos__historyNote mesh__D019422 Dietary Carbohydrates %28%1966-1996%29%
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D019422 2006
% 221.34/221.49  |- skos__scopeNote mesh__D019422
% 221.34/221.49       Sucrose present in the diet. It is added to food and drinks as a sweetener.%A%    
% 221.34/221.49  |- skos__broader mesh__D019422smesh__D004040
% 221.34/221.49  |- mesh__recordAuthorizer mesh__D005402 sjn
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D005402 2002
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D005402 2006
% 221.34/221.49  |- skos__prefLabel mesh__D005402 Fistula
% 221.34/221.49  |- mesh__recordMaintainer mesh__D005402 jls
% 221.34/221.49  |- mesh__recordOriginator mesh__D005402 NLM
% 221.34/221.49  |- mesh__dateCreated mesh__D005402 1999-01-01
% 221.34/221.49  |- skos__annotation mesh__D005402
% 221.34/221.49       GEN or unspecified; prefer specifics; coord IM with organ %28%IM%29% or precoord organ/dis term %28%IM%29%; policy: Manual 23.19+; anal fistula or fistula in ano: index RECTAL FISTULA, not FISSURE IN ANO; artificial fistula: Manual 23.19.7; ECK FISTULA see PORTACAVAL SHUNT, SURGICAL is also available%A%  
% 221.34/221.49  |- skos__scopeNote mesh__D005402
% 221.34/221.49       Abnormal communication most commonly seen between two internal organs, or between an internal organ and the surface of the body.%A%    
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D005402 2000
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D005402 2001
% 221.34/221.49  |- mesh__dateRevised mesh__D005402 1999-11-09
% 221.34/221.49  |- skos__broader mesh__D005402smesh__D020763
% 221.34/221.49  |- skos__hiddenLabel mesh__D005402 Fistulas
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D005402 2003
% 221.34/221.49  |- rdf__type mesh__D005402sskos__Concept
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D005402 2005
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D005402 2004
% 221.34/221.49  |- skos__broader mesh__D052058smesh__D050438
% 221.34/221.49  |- skos__prefLabel mesh__D052058 Hinge Exons
% 221.34/221.49  |- mesh__dateRevised mesh__D052058 2005-11-09
% 221.34/221.49  |- rdf__type mesh__D052058sskos__Concept
% 221.34/221.49  |- mesh__recordMaintainer mesh__D052058 ags
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D052058 2006A
% 221.34/221.49  |- mesh__recordAuthorizer mesh__D052058 ags
% 221.34/221.49  |- skos__hiddenLabel mesh__D052058 Exons, Hinge
% 221.34/221.49  |- skos__historyNote mesh__D052058
% 221.34/221.49       Immunoglobulins, Heavy-Chain %28%1982-2005%29%
% 221.34/221.49  |- skos__broader mesh__D052058smesh__D005091
% 221.34/221.49  |- mesh__historyNote mesh__D052058 2006   
% 221.34/221.49  |- mesh__dateEstablished mesh__D052058 2006-01-01
% 221.34/221.49  |- mesh__publicMeSHNote mesh__D052058 2006; see EXONS 1988-2005   
% 221.34/221.49  |- mesh__dateCreated mesh__D052058 2005-06-30
% 221.34/221.49  |- skos__scopeNote mesh__D052058
% 221.34/221.49       Immunoglobulin heavy chain gene exons coding for the hinge region of the heavy chains between the first constant region %28%on the FAB FRAGMENTS%29% and the second constant region %28%on the FC FRAGMENTS%29%.%A%    
% 221.34/221.49  |- skos__altLabel mesh__D052058 Hinge Exon
% 221.34/221.49  |- skos__historyNote mesh__D052058
% 221.34/221.49       Immunoglobulin Constant Region %28%1982-2005%29%
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D052058 2006B
% 221.34/221.49  |- skos__hiddenLabel mesh__D052058 Exon, Hinge
% 221.34/221.49  |- mesh__recordOriginator mesh__D052058 nns
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D052058 2006
% 221.34/221.49  |- skos__hiddenLabel mesh__D010347 Nursing Care Plan
% 221.34/221.49  |- skos__hiddenLabel mesh__D010347 Care Plan, Nursing
% 221.34/221.49  |- mesh__historyNote mesh__D010347 68   
% 221.34/221.49  |- mesh__recordMaintainer mesh__D010347 kle
% 221.34/221.49  |- rdf__type mesh__D010347sskos__Concept
% 221.34/221.49  |- mesh__recordAuthorizer mesh__D010347 sjn
% 221.34/221.49  |- skos__hiddenLabel mesh__D010347 Planning, Patient Care
% 221.34/221.49  |- skos__broader mesh__D010347smesh__D003191
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D010347 2004
% 221.34/221.49  |- skos__hiddenLabel mesh__D010347 Plan, Nursing Care
% 221.34/221.49  |- mesh__dateEstablished mesh__D010347 1968-01-01
% 221.34/221.49  |- skos__scopeNote mesh__D010347
% 221.34/221.49       Usually a written medical and nursing care program designed for a particular patient.%A%    
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D010347 2002
% 221.34/221.49  |- mesh__recordOriginator mesh__D010347 NLM
% 221.34/221.49  |- skos__annotation mesh__D010347
% 221.34/221.49       for individual patient: do not confuse with PATIENT-CENTERED CARE which is institutional %26% admin management%A%  
% 221.34/221.49  |- mesh__dateRevised mesh__D010347 1999-11-03
% 221.34/221.49  |- skos__related mesh__D010347smesh__D000359
% 221.34/221.49  |- skos__altLabel mesh__D010347 Plans, Nursing Care
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D010347 2005
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D010347 2000
% 221.34/221.49  |- mesh__publicMeSHNote mesh__D010347 68   
% 221.34/221.49  |- skos__hiddenLabel mesh__D010347 Care Planning, Patient
% 221.34/221.49  |- skos__prefLabel mesh__D010347 Patient Care Planning
% 221.34/221.49  |- skos__hiddenLabel mesh__D010347 Care Plans, Nursing
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D010347 2006
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D010347 2001
% 221.34/221.49  |- mesh__dateCreated mesh__D010347 1999-01-01
% 221.34/221.49  |- skos__related mesh__D010347smesh__D003256
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D010347 2003
% 221.34/221.49  |- skos__related mesh__D015032smesh__D015037
% 221.34/221.49  |- skos__broader mesh__D015032smesh__D028561
% 221.34/221.49  |- skos__related mesh__D015032smesh__D015033
% 221.34/221.49  |- mesh__recordAuthorizer mesh__D015032 sjn
% 221.34/221.49  |- mesh__dateCreated mesh__D015032 1999-01-01
% 221.34/221.49  |- mesh__recordOriginator mesh__D015032 NLM
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D015032 2006
% 221.34/221.49  |- skos__scopeNote mesh__D015032
% 221.34/221.49       A metallic element of atomic number 30 and atomic weight 65.38. It is a necessary trace element in the diet, forming an essential part of many enzymes, and playing an important role in protein synthesis and in cell division. Zinc deficiency is associated with ANEMIA, short stature, HYPOGONADISM, impaired WOUND HEALING, and geophagia. It is known by the symbol Zn.%A%    
% 221.34/221.49  |- mesh__recordMaintainer mesh__D015032 ssb
% 221.34/221.49  |- rdf__type mesh__D015032sskos__Concept
% 221.34/221.49  |- mesh__dateRevised mesh__D015032 2005-06-30
% 221.34/221.49  |- skos__prefLabel mesh__D015032 Zinc
% 221.34/221.49  |- skos__broader mesh__D015032smesh__D019216
% 221.34/221.49  |- skos__related mesh__D001810smesh__D020896
% 221.34/221.49  |- mesh__recordOriginator mesh__D001810 NLM
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D001810 2006
% 221.34/221.49  |- skos__hiddenLabel mesh__D001810 Volume, Blood
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D001810 2004
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D001810 2005
% 221.34/221.49  |- mesh__dateRevised mesh__D001810 2003-07-09
% 221.34/221.49  |- skos__broader mesh__D001810smesh__D045122
% 221.34/221.49  |- skos__hiddenLabel mesh__D001810 Blood Volumes
% 221.34/221.49  |- skos__prefLabel mesh__D001810 Blood Volume
% 221.34/221.49  |- skos__broader mesh__D001810smesh__D045472
% 221.34/221.49  |- mesh__dateCreated mesh__D001810 1999-01-01
% 221.34/221.49  |- mesh__recordMaintainer mesh__D001810 nns
% 221.34/221.49  |- skos__hiddenLabel mesh__D001810 Volumes, Blood
% 221.34/221.49  |- skos__scopeNote mesh__D001810
% 221.34/221.49       Volume of circulating BLOOD. It is the sum of the PLASMA VOLUME and ERYTHROCYTE VOLUME.%A%    
% 221.34/221.49  |- mesh__recordAuthorizer mesh__D001810 sjn
% 221.34/221.49  |- skos__related mesh__D001810smesh__D018495
% 221.34/221.49  |- skos__annotation mesh__D001810
% 221.34/221.49       PLASMA VOLUME; ERYTHROCYTE VOLUME; %26% ERYTHROCYTE VOLUME, PACKED are also available; coord IM with disease /physiopathol %28%IM%29%, not /blood%A%  
% 221.34/221.49  |- rdf__type mesh__D001810sskos__Concept
% 221.34/221.49  |- skos__hiddenLabel mesh__D001012 Aortas, Abdominal
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D001012 2005
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D001012 2006
% 221.34/221.49  |- mesh__recordMaintainer mesh__D001012 ags
% 221.34/221.49  |- mesh__recordOriginator mesh__D001012 NLM
% 221.34/221.49  |- skos__altLabel mesh__D001012 Abdominal Aorta
% 221.34/221.49  |- mesh__dateRevised mesh__D001012 2004-07-07
% 221.34/221.49  |- skos__broader mesh__D001012smesh__D001011
% 221.34/221.49  |- skos__hiddenLabel mesh__D001012 Abdominal Aortas
% 221.34/221.49  |- rdf__type mesh__D001012sskos__Concept
% 221.34/221.49  |- skos__annotation mesh__D001012
% 221.34/221.49       coord NIM with aortic dis terms %28%IM%29%   
% 221.34/221.49  |- mesh__recordAuthorizer mesh__D001012 sjn
% 221.34/221.49  |- skos__scopeNote mesh__D001012
% 221.34/221.49       The aorta from the DIAPHRAGM to the bifurcation into the right and left common iliac arteries.%A%    
% 221.34/221.49  |- skos__prefLabel mesh__D001012 Aorta, Abdominal
% 221.34/221.49  |- mesh__dateCreated mesh__D001012 1999-01-01
% 221.34/221.49  |- rdf__type mesh__D020775sskos__Concept
% 221.34/221.49  |- skos__broader mesh__D020775smesh__D013906
% 221.34/221.49  |- skos__hiddenLabel mesh__D020775 Surgery, Video-Assisted Thoracoscopic
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D020775 2003
% 221.34/221.49  |- skos__altLabel mesh__D020775 Video-Assisted Thoracoscopic Surgery
% 221.34/221.49  |- skos__hiddenLabel mesh__D020775 VATSs
% 221.34/221.49  |- skos__hiddenLabel mesh__D020775 Thoracic Surgery, Video Assisted
% 221.34/221.49  |- skos__altLabel mesh__D020775 Surgery, Thoracic, Video-Assisted
% 221.34/221.49  |- skos__hiddenLabel mesh__D020775 Video-Assisted Thoracic Surgeries
% 221.34/221.49  |- skos__altLabel mesh__D020775 VATS
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D020775 2006
% 221.34/221.49  |- mesh__dateEstablished mesh__D020775 2000-01-01
% 221.34/221.49  |- mesh__historyNote mesh__D020775 2000   
% 221.34/221.49  |- skos__hiddenLabel mesh__D020775 Video-Assisted Thoracoscopic Surgeries
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D020775 2004
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D020775 2000
% 221.34/221.49  |- mesh__publicMeSHNote mesh__D020775 2000   
% 221.34/221.49  |- mesh__dateCreated mesh__D020775 1999-11-08
% 221.34/221.49  |- skos__hiddenLabel mesh__D020775 Thoracoscopic Surgery, Video-Assisted
% 221.34/221.49  |- skos__hiddenLabel mesh__D020775 Video Assisted Thoracoscopic Surgery
% 221.34/221.49  |- skos__scopeNote mesh__D020775
% 221.34/221.49       Endoscopic surgery of the pleural cavity performed with visualization via video transmission.%A%    
% 221.34/221.49  |- skos__hiddenLabel mesh__D020775 Surgeries, Video-Assisted Thoracic
% 221.34/221.49  |- skos__historyNote mesh__D020775 Thoracoscopy %28%1993-1999%29%
% 221.34/221.49  |- mesh__activeMeSHYear mesh__D020775 2001
% 221.34/221.49  |- skos__broader mesh__D020775smesh__D020535
% 221.34/221.49  |- skos__related mesh__D020775smesh__D014741
% 221.34/221.49  |- skos__hiddenLabel mesh__D020775 Surgeries, Video-Assisted Thoracoscopic
% 221.34/221.49  |- skos__hiddenLabel mesh__D020775 Video Assisted Thoracic Surgery
% 221.34/221.49  |- skos__historyNote mesh__D020775 Video Recording %28%1993-1999%29%
% 221.34/221.50  |- skos__hiddenLabel mesh__D020775 Thoracoscopic Surgeries, Video-Assisted
% 221.34/221.50  |- skos__hiddenLabel mesh__D020775 Thoracic Surgeries, Video-Assisted
% 221.34/221.50  |- skos__altLabel mesh__D020775 Video-Assisted Thoracic Surgery
% 221.34/221.50  |- mesh__activeMeSHYear mesh__D020775 2002
% 221.34/221.50  |- skos__hiddenLabel mesh__D020775 Surgery, Video-Assisted Thoracic
% 221.34/221.50  |- skos__prefLabel mesh__D020775 Thoracic Surgery, Video-Assisted
% 221.34/221.50  |- mesh__activeMeSHYear mesh__D020775 2005
% 221.34/221.50  |- skos__broader mesh__D013338Q000193smesh__D013338
% 221.34/221.50  |- mesh__preferredCombination mesh__D013338Q000193smesh__D004506
% 221.34/221.50  |- rdf__type mesh__D013338Q000193smesh__CompoundConcept
% 221.34/221.50  |- skos__historyNote mesh__D014738 Mechanoreceptors %28%1971-1984%29%
% 221.34/221.50  |- skos__scopeNote mesh__D014738
% 221.34/221.50       Stiff hairs projecting from the face around the nose of most mammals, acting as touch receptors.%A%    
% 221.34/221.50  |- skos__broader mesh__D014738smesh__D000825
% 221.34/221.50  |- mesh__activeMeSHYear mesh__D014738 2006
% 221.34/221.50  |- mesh__activeMeSHYear mesh__D014738 1996
% 221.34/221.50  |- mesh__recordAuthorizer mesh__D014738 PLS
% 221.34/221.50  |- mesh__activeMeSHYear mesh__D014738 2000
% 221.34/221.50  |- mesh__activeMeSHYear mesh__D014738 1993
% 221.34/221.50  |- mesh__activeMeSHYear mesh__D014738 2003
% 221.34/221.50  |- mesh__activeMeSHYear mesh__D014738 1997
% 221.34/221.50  |- skos__prefLabel mesh__D014738 Vibrissae
% 221.34/221.50  |- mesh__dateEstablished mesh__D014738 1985-01-01
% 221.34/221.50  |- mesh__activeMeSHYear mesh__D014738 2001
% 221.34/221.50  |- mesh__activeMeSHYear mesh__D014738 2004
% 221.34/221.50  |- mesh__recordMaintainer mesh__D014738 TAP
% 221.34/221.50  |- mesh__dateCreated mesh__D014738 1984-04-06
% 221.34/221.50  |- mesh__publicMeSHNote mesh__D014738 85   
% 221.34/221.50  |- skos__altLabel mesh__D014738 Whiskers
% 221.34/221.50  |- rdf__type mesh__D014738sskos__Concept
% 221.34/221.50  |- skos__historyNote mesh__D014738 Hair %28%1966-1984%29%
% 221.34/221.50  |- mesh__activeMeSHYear mesh__D014738 1994
% 221.34/221.50  |- skos__hiddenLabel mesh__D014738 Whisker
% 221.34/221.50  |- mesh__activeMeSHYear mesh__D014738 2002
% 221.34/221.50  |- mesh__activeMeSHYear mesh__D014738 1998
% 221.34/221.52  |- mesh__historyNote mesh__D014738 85   
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D014738 1995
% 221.34/221.52  |- mesh__recordOriginator mesh__D014738 RC
% 221.34/221.52  |- skos__historyNote mesh__D014738 Afferent Pathways %28%1976-1984%29%
% 221.34/221.52  |- mesh__dateRevised mesh__D014738 1992-05-18
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D014738 2005
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D014738 1999
% 221.34/221.52  |- mesh__dateRevised mesh__D019423 2001-07-25
% 221.34/221.52  |- skos__scopeNote mesh__D019423
% 221.34/221.52       An intermediate stage between polytheism and monotheism, which assumes a %22%Great Spirit%22%, with lesser deities subordinated. With the beginnings of shamanism there was the advent of the medicine man or witch doctor, who assumed a supervisory relation to disease and its cure. Formally, shamanism is a religion of Ural-Altaic peoples of Northern Asia and Europe, characterized by the belief that the unseen world of gods, demons, ancestral spirits is responsive only to shamans. The Indians of North and South America entertain religious practices similar to the Ural-Altaic shamanism. The word shaman comes from the Tungusic %28%Manchuria and Siberia%29% saman, meaning Buddhist monk. The shaman handles disease almost entirely by psychotherapeutic means; he frightens away the demons of disease by assuming a terrifying mien. %28%From Garrison, An Introduction to the History of Medicine, 4th ed, p22; from Webster, 3d ed%29%%A%    
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D019423 2002
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D019423 2005
% 221.34/221.52  |- skos__prefLabel mesh__D019423 Shamanism
% 221.34/221.52  |- mesh__recordOriginator mesh__D019423 TGC
% 221.34/221.52  |- mesh__dateCreated mesh__D019423 1996-06-10
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D019423 2006
% 221.34/221.52  |- mesh__dateEstablished mesh__D019423 1997-01-01
% 221.34/221.52  |- mesh__publicMeSHNote mesh__D019423 97   
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D019423 2003
% 221.34/221.52  |- skos__broader mesh__D019423smesh__D008519
% 221.34/221.52  |- rdf__type mesh__D019423sskos__Concept
% 221.34/221.52  |- skos__historyNote mesh__D019423 Medicine, Traditional %28%1970-1996%29%
% 221.34/221.52  |- mesh__historyNote mesh__D019423 97   
% 221.34/221.52  |- skos__broader mesh__D019423smesh__D026443
% 221.34/221.52  |- mesh__recordAuthorizer mesh__D019423 sjn
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D019423 2004
% 221.34/221.52  |- skos__annotation mesh__D019423
% 221.34/221.52       a form of traditional medicine; specify geog; not for African witch doctors: use instead MEDICINE, AFRICAN TRADITIONAL%A%  
% 221.34/221.52  |- mesh__recordMaintainer mesh__D019423 ssb
% 221.34/221.52  |- skos__prefLabel mesh__D000718 Anatomy, Regional
% 221.34/221.52  |- mesh__recordAuthorizer mesh__D000718 sjn
% 221.34/221.52  |- mesh__dateRevised mesh__D000718 2001-07-25
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D000718 2003
% 221.34/221.52  |- rdf__type mesh__D000718sskos__Concept
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D000718 2002
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D000718 2005
% 221.34/221.52  |- skos__annotation mesh__D000718 SPEC; no qualif   
% 221.34/221.52  |- skos__hiddenLabel mesh__D000718 Anatomies, Regional
% 221.34/221.52  |- mesh__dateCreated mesh__D000718 1999-01-01
% 221.34/221.52  |- skos__altLabel mesh__D000718 Regional Anatomy
% 221.34/221.52  |- mesh__recordMaintainer mesh__D000718 jls
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D000718 2004
% 221.34/221.52  |- mesh__recordOriginator mesh__D000718 NLM
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D000718 2006
% 221.34/221.52  |- skos__hiddenLabel mesh__D000718 Regional Anatomies
% 221.34/221.52  |- skos__broader mesh__D000718smesh__D000715
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D011440 2002
% 221.34/221.52  |- mesh__historyNote mesh__D011440
% 221.34/221.52       91%28%75%29%; was see under IODOPYRIDONES 1975-90; was see under CONTRAST MEDIA 1963-74%A%  
% 221.34/221.52  |- skos__broader mesh__D011440smesh__D007469
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D011440 2003
% 221.34/221.52  |- rdf__type mesh__D011440sskos__Concept
% 221.34/221.52  |- mesh__onlineNote mesh__D011440 search CONTRAST MEDIA 1966-74   
% 221.34/221.52  |- skos__prefLabel mesh__D011440 Propyliodone
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D011440 2004
% 221.34/221.52  |- skos__altLabel mesh__D011440 Propiodone
% 221.34/221.52  |- mesh__dateEstablished mesh__D011440 1991-01-01
% 221.34/221.52  |- mesh__dateRevised mesh__D011440 2001-07-25
% 221.34/221.52  |- mesh__dateCreated mesh__D011440 1999-01-01
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D011440 2005
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D011440 2006
% 221.34/221.52  |- skos__annotation mesh__D011440 D25-26 qualif   
% 221.34/221.52  |- mesh__recordOriginator mesh__D011440 NLM
% 221.34/221.52  |- mesh__recordMaintainer mesh__D011440 ssb
% 221.34/221.52  |- skos__scopeNote mesh__D011440
% 221.34/221.52       Radiopaque medium usually in oil; used in bronchography.%A%    
% 221.34/221.52  |- mesh__recordAuthorizer mesh__D011440 sjn
% 221.34/221.52  |- mesh__publicMeSHNote mesh__D011440
% 221.34/221.52       91; was see under IODOPYRIDONES 1975-90; was see under CONTRAST MEDIA 1963-74%A%  
% 221.34/221.52  |- mesh__dateEstablished mesh__D005403 1968-01-01
% 221.34/221.52  |- skos__altLabel mesh__D005403 Ocular Fixation
% 221.34/221.52  |- skos__scopeNote mesh__D005403
% 221.34/221.52       The positioning and accommodation of eyes that allows the image to be brought into place on the FOVEA CENTRALIS of each eye.%A%    
% 221.34/221.52  |- mesh__dateCreated mesh__D005403 1999-01-01
% 221.34/221.52  |- mesh__recordAuthorizer mesh__D005403 jls
% 221.34/221.52  |- mesh__publicMeSHNote mesh__D005403 68   
% 221.34/221.52  |- mesh__recordOriginator mesh__D005403 NLM
% 221.34/221.52  |- mesh__recordMaintainer mesh__D005403 jls
% 221.34/221.52  |- mesh__historyNote mesh__D005403 68%28%64%29%   
% 221.34/221.52  |- rdf__type mesh__D005403sskos__Concept
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D005403 2005A
% 221.34/221.52  |- skos__broader mesh__D005403smesh__D005133
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D005403 2005
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D005403 2004
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D005403 2006
% 221.34/221.52  |- skos__altLabel mesh__D005403 Focusing, Ocular
% 221.34/221.52  |- skos__prefLabel mesh__D005403 Fixation, Ocular
% 221.34/221.52  |- skos__hiddenLabel mesh__D005403 Ocular Focusing
% 221.34/221.52  |- mesh__dateRevised mesh__D005403 2004-07-27
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Care Team, Health
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D010348 2004
% 221.34/221.52  |- mesh__dateCreated mesh__D010348 1999-01-01
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Teams, Healthcare
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Care Team, Medical
% 221.34/221.52  |- skos__historyNote mesh__D010348
% 221.34/221.52       Progressive Patient Care %28%1966-1967%29%
% 221.34/221.52  |- skos__altLabel mesh__D010348 Health Care Team
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Team, Interdisciplinary Health
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Team, Patient Care
% 221.34/221.52  |- skos__historyNote mesh__D010348 Nursing, Team %28%1966-1967%29%
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Teams, Patient Care
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D010348 2002
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Healthcare Teams
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D010348 2003
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Team, Medical Care
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Interdisciplinary Health Teams
% 221.34/221.52  |- mesh__historyNote mesh__D010348 68   
% 221.34/221.52  |- skos__prefLabel mesh__D010348 Patient Care Team
% 221.34/221.52  |- skos__scopeNote mesh__D010348
% 221.34/221.52       Care of patients by a multidisciplinary team usually organized under the leadership of a physician; each member of the team has specific responsibilities and the whole team contributes to the care of the patient.%A%    
% 221.34/221.52  |- mesh__dateRevised mesh__D010348 2001-07-25
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Care Teams, Patient
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Medical Care Teams
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D010348 2006
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Health Care Teams
% 221.34/221.52  |- mesh__dateEstablished mesh__D010348 1968-01-01
% 221.34/221.52  |- skos__altLabel mesh__D010348 Interdisciplinary Health Team
% 221.34/221.52  |- mesh__recordOriginator mesh__D010348 NLM
% 221.34/221.52  |- skos__broader mesh__D010348smesh__D010346
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Care Teams, Medical
% 221.34/221.52  |- rdf__type mesh__D010348sskos__Concept
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Health Team, Interdisciplinary
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D010348 2005
% 221.34/221.52  |- mesh__recordAuthorizer mesh__D010348 sjn
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Care Teams, Health
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Teams, Interdisciplinary Health
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Team, Health Care
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Teams, Health Care
% 221.34/221.52  |- mesh__recordMaintainer mesh__D010348 jls
% 221.34/221.52  |- skos__annotation mesh__D010348 consider also NURSING, TEAM   
% 221.34/221.52  |- skos__altLabel mesh__D010348 Healthcare Team
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Team, Healthcare
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Health Teams, Interdisciplinary
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Patient Care Teams
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Teams, Medical Care
% 221.34/221.52  |- mesh__publicMeSHNote mesh__D010348 68   
% 221.34/221.52  |- skos__hiddenLabel mesh__D010348 Care Team, Patient
% 221.34/221.52  |- mesh__dateEstablished mesh__D015831 1990-01-01
% 221.34/221.52  |- skos__historyNote mesh__D015831 Chondroma %28%1966-1989%29%
% 221.34/221.52  |- skos__broader mesh__D015831smesh__D010009
% 221.34/221.52  |- skos__hiddenLabel mesh__D015831 Cartilaginous Exostoses
% 221.34/221.52  |- skos__altLabel mesh__D015831 Chondrosteoma
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D015831 1999
% 221.34/221.52  |- mesh__publicMeSHNote mesh__D015831 90   
% 221.34/221.52  |- skos__hiddenLabel mesh__D015831 Osteochondromas
% 221.34/221.52  |- skos__hiddenLabel mesh__D015831 Exostoses, Cartilaginous
% 221.34/221.52  |- skos__hiddenLabel mesh__D015831 Osteocartilaginous Exostosis
% 221.34/221.52  |- skos__hiddenLabel mesh__D015831 Exostoses, Osteocartilaginous
% 221.34/221.52  |- skos__scopeNote mesh__D015831
% 221.34/221.52       A cartilage-capped benign tumor that often appears as a stalk on the surface of bone. It is probably a developmental malformation rather than a true neoplasm and is usually found in the metaphysis of the distal femur, proximal tibia, or proximal humerus. Osteochondroma is the most common of benign bone tumors.%A%    
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D015831 2003
% 221.34/221.52  |- mesh__recordAuthorizer mesh__D015831 SJN
% 221.34/221.52  |- mesh__historyNote mesh__D015831 90   
% 221.34/221.52  |- mesh__recordMaintainer mesh__D015831 TGC
% 221.34/221.52  |- mesh__dateCreated mesh__D015831 1989-05-15
% 221.34/221.52  |- mesh__recordOriginator mesh__D015831 AGS
% 221.34/221.52  |- skos__annotation mesh__D015831
% 221.34/221.52       solitary; note OSTEOCHONDROMAS, MULTIPLE see EXOSTOSES, MULTIPLE HEREDITARY; /blood supply /chem /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS %28%IM%29% or specific precoord bone/neopl term %28%IM%29% or specific bone %28%IM%29% + BONE NEOPLASMS %28%IM%29%%A%  
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D015831 2000
% 221.34/221.52  |- rdf__type mesh__D015831sskos__Concept
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D015831 2004
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D015831 2001
% 221.34/221.52  |- mesh__dateRevised mesh__D015831 1997-06-20
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D015831 2005
% 221.34/221.52  |- skos__hiddenLabel mesh__D015831 Cartilaginous Exostosis
% 221.34/221.52  |- skos__hiddenLabel mesh__D015831 Chondrosteomas
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D015831 2002
% 221.34/221.52  |- skos__broader mesh__D015831smesh__D018213
% 221.34/221.52  |- skos__prefLabel mesh__D015831 Osteochondroma
% 221.34/221.52  |- skos__altLabel mesh__D015831 Exostosis, Osteocartilaginous
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D015831 2006
% 221.34/221.52  |- skos__hiddenLabel mesh__D015831 Osteocartilaginous Exostoses
% 221.34/221.52  |- skos__altLabel mesh__D015831 Exostosis, Cartilaginous
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D015831 1998
% 221.34/221.52  |- rdf__type mesh__D015033sskos__Concept
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D015033 2003
% 221.34/221.52  |- skos__broader mesh__D015033smesh__D007554
% 221.34/221.52  |- skos__scopeNote mesh__D015033
% 221.34/221.52       Stable zinc atoms that have the same atomic number as the element zinc, but differ in atomic weight. Zn-66-68, and 70 are stable zinc isotopes.%A%    
% 221.34/221.52  |- skos__hiddenLabel mesh__D015033 Isotopes, Zinc
% 221.34/221.52  |- mesh__recordMaintainer mesh__D015033 nns
% 221.34/221.52  |- mesh__activeMeSHYear mesh__D015033 2002
% 221.34/221.53  |- skos__prefLabel mesh__D015033 Zinc Isotopes
% 221.34/221.53  |- mesh__dateCreated mesh__D015033 1999-01-01
% 221.34/221.53  |- mesh__recordAuthorizer mesh__D015033 sjn
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D015033 2006
% 221.34/221.53  |- mesh__dateRevised mesh__D015033 2000-06-22
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D015033 2001
% 221.34/221.53  |- skos__annotation mesh__D015033 Zn-66, 67, 68, 70; NIM   
% 221.34/221.53  |- mesh__recordOriginator mesh__D015033 NLM
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D015033 2005
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D015033 2004
% 221.34/221.53  |- rdf__type mesh__D001811sskos__Concept
% 221.34/221.53  |- skos__hiddenLabel mesh__D001811 Volume Determinations, Blood
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001811 2005
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001811 2001
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001811 2003
% 221.34/221.53  |- skos__hiddenLabel mesh__D001811 Determination, Blood Volume
% 221.34/221.53  |- mesh__recordMaintainer mesh__D001811 PXP
% 221.34/221.53  |- skos__prefLabel mesh__D001811 Blood Volume Determination
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001811 2006
% 221.34/221.53  |- skos__hiddenLabel mesh__D001811 Blood Volume Determinations
% 221.34/221.53  |- mesh__dateRevised mesh__D001811 1997-06-20
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001811 2002
% 221.34/221.53  |- mesh__dateCreated mesh__D001811 1999-01-01
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001811 2004
% 221.34/221.53  |- skos__hiddenLabel mesh__D001811 Volume Determination, Blood
% 221.34/221.53  |- mesh__recordOriginator mesh__D001811 NLM
% 221.34/221.53  |- skos__broader mesh__D001811smesh__D003935
% 221.34/221.53  |- skos__scopeNote mesh__D001811
% 221.34/221.53       Method for determining the circulating blood volume by introducing a known quantity of foreign substance into the blood and determining its concentration some minutes later when thorough mixing has occurred. From these two values the blood volume can be calculated by dividing the quantity of injected material by its concentration in the blood at the time of uniform mixing. Generally expressed as cubic centimeters or liters per kilogram of body weight.%A%    
% 221.34/221.53  |- skos__annotation mesh__D001811
% 221.34/221.53       NIM; coord with disease /physiopathol, not /blood   
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001811 1998
% 221.34/221.53  |- mesh__recordAuthorizer mesh__D001811 SJN
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001811 1999
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001811 2000
% 221.34/221.53  |- skos__hiddenLabel mesh__D001811 Determinations, Blood Volume
% 221.34/221.53  |- skos__prefLabel mesh__D001013 Aorta, Thoracic
% 221.34/221.53  |- skos__altLabel mesh__D001013 Arch of the Aorta
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001013 2006
% 221.34/221.53  |- mesh__recordMaintainer mesh__D001013 ags
% 221.34/221.53  |- skos__scopeNote mesh__D001013
% 221.34/221.53       The portion of the descending aorta proceeding from the arch of the aorta and extending to the DIAPHRAGM, eventually connecting to the ABDOMINAL AORTA.%A%    
% 221.34/221.53  |- mesh__dateRevised mesh__D001013 2004-07-07
% 221.34/221.53  |- skos__hiddenLabel mesh__D001013 Descending Aorta
% 221.34/221.53  |- skos__broader mesh__D001013smesh__D001011
% 221.34/221.53  |- rdf__type mesh__D001013sskos__Concept
% 221.34/221.53  |- skos__annotation mesh__D001013
% 221.34/221.53       diseases: coordinate IM with AORTIC DISEASES %28%IM%29% OR specifics %28%IM%29%%A%  
% 221.34/221.53  |- mesh__recordOriginator mesh__D001013 NLM
% 221.34/221.53  |- skos__hiddenLabel mesh__D001013 Thoracic Aorta
% 221.34/221.53  |- mesh__dateCreated mesh__D001013 1999-01-01
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001013 2005
% 221.34/221.53  |- skos__hiddenLabel mesh__D001013 Arch, Aortic
% 221.34/221.53  |- mesh__recordAuthorizer mesh__D001013 sjn
% 221.34/221.53  |- skos__broader mesh__D020776smesh__D019723
% 221.34/221.53  |- skos__altLabel mesh__D020776 Gastrointestinal Endoscopes
% 221.34/221.53  |- skos__hiddenLabel mesh__D020776 Endoscope, Gastrointestinal
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D020776 2004
% 221.34/221.53  |- rdf__type mesh__D020776sskos__Concept
% 221.34/221.53  |- mesh__dateEstablished mesh__D020776 2000-01-01
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D020776 2006
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D020776 2003
% 221.34/221.53  |- skos__historyNote mesh__D020776
% 221.34/221.53       Endoscopy, Gastrointestinal/instrumentation %28%1991-1999%29%
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D020776 2002
% 221.34/221.53  |- skos__historyNote mesh__D020776
% 221.34/221.53       Gastroscopy/instrumentation %28%1966-1990%29%
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D020776 2005
% 221.34/221.53  |- mesh__historyNote mesh__D020776 2000   
% 221.34/221.53  |- skos__historyNote mesh__D020776
% 221.34/221.53       Endoscopy/instrumentation %28%1966-1990%29%
% 221.34/221.53  |- skos__hiddenLabel mesh__D020776 Gastrointestinal Endoscope
% 221.34/221.53  |- skos__prefLabel mesh__D020776 Endoscopes, Gastrointestinal
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D020776 2001
% 221.34/221.53  |- skos__scopeNote mesh__D020776
% 221.34/221.53       Instruments for the visual examination of the interior of the gastrointestinal tract.%A%    
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D020776 2000
% 221.34/221.53  |- mesh__publicMeSHNote mesh__D020776 2000   
% 221.34/221.53  |- mesh__dateCreated mesh__D020776 1999-11-03
% 221.34/221.53  |- skos__hiddenLabel mesh__D039481 Antigen, Mo1
% 221.34/221.53  |- skos__altLabel mesh__D039481 CD11b Antigen
% 221.34/221.53  |- skos__altLabel mesh__D039481 Integrin alphaM
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D039481 2006
% 221.34/221.53  |- mesh__dateRevised mesh__D039481 2005-07-12
% 221.34/221.53  |- mesh__recordAuthorizer mesh__D039481 ags
% 221.34/221.53  |- mesh__dateEstablished mesh__D039481 2003-01-01
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D039481 2006A
% 221.34/221.53  |- skos__historyNote mesh__D039481 Macrophage-1 Antigen %28%1990-2002%29%
% 221.34/221.53  |- mesh__publicMeSHNote mesh__D039481
% 221.34/221.53       2003; for ANTIGENS CD11B %26% CD11B ANTIGEN see MACROPHAGE-1 ANTIGEN 1995-2002;  for M01 ANTIGEN %26% MO1 GLYCOPROTEIN see MACROPHAGE-1 ANTIGEN 1991-2002%A%  
% 221.34/221.53  |- skos__hiddenLabel mesh__D039481 Antigen, CD11b
% 221.34/221.53  |- skos__altLabel mesh__D039481 alphaM Integrin
% 221.34/221.53  |- skos__altLabel mesh__D039481 Mo1 Glycoprotein
% 221.34/221.53  |- mesh__dateCreated mesh__D039481 2002-07-02
% 221.34/221.53  |- skos__broader mesh__D039481smesh__D039001
% 221.34/221.53  |- rdf__type mesh__D039481sskos__Concept
% 221.34/221.53  |- skos__hiddenLabel mesh__D039481 alphaM, Integrin
% 221.34/221.53  |- skos__prefLabel mesh__D039481 Antigens, CD11b
% 221.34/221.53  |- mesh__historyNote mesh__D039481
% 221.34/221.53       2003; for ANTIGENS CD11B %26% CD11B ANTIGEN use MACROPHAGE-1 ANTIGEN 1995-2002;  for M01 ANTIGEN %26% MO1 GLYCOPROTEIN use MACROPHAGE-1 ANTIGEN 1991-2002%A%  
% 221.34/221.53  |- skos__broader mesh__D039481smesh__D018845
% 221.34/221.53  |- mesh__recordOriginator mesh__D039481 MDJ
% 221.34/221.53  |- mesh__recordMaintainer mesh__D039481 ags
% 221.34/221.53  |- skos__hiddenLabel mesh__D039481 Integrin, alphaM
% 221.34/221.53  |- skos__altLabel mesh__D039481 Mo1 Antigen
% 221.34/221.53  |- skos__altLabel mesh__D039481 CD11b Antigens
% 221.34/221.53  |- skos__scopeNote mesh__D039481
% 221.34/221.53       A CD antigen that contains a conserved I domain which is involved in ligand binding.  When combined with CD18 the two subunits form MACROPHAGE-1 ANTIGEN.%A%    
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D014739 2004
% 221.34/221.53  |- skos__scopeNote mesh__D014739
% 221.34/221.53       A state in southeastern Australia, the southernmost state. Its capital is Melbourne. It was discovered in 1770 by Captain Cook and first settled by immigrants from Tasmania. In 1851 it was separated from New South Wales as a separate colony. Self-government was introduced in 1851; it became a state in 1901. It was named for Queen Victoria in 1851. %28%From Webster%27%s New Geographical Dictionary, 1988, p1295 %26% Room, Brewer%27%s Dictionary of Names, p574%29%%A%    
% 221.34/221.53  |- skos__broader mesh__D014739smesh__D001315
% 221.34/221.53  |- mesh__recordMaintainer mesh__D014739 TGC
% 221.34/221.53  |- mesh__dateCreated mesh__D014739 1987-03-09
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D014739 2002
% 221.34/221.53  |- rdf__type mesh__D014739sskos__Concept
% 221.34/221.53  |- mesh__dateEstablished mesh__D014739 1988-01-01
% 221.34/221.53  |- mesh__dateRevised mesh__D014739 1995-02-21
% 221.34/221.53  |- mesh__historyNote mesh__D014739 88   
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D014739 1998
% 221.34/221.53  |- mesh__recordAuthorizer mesh__D014739 PLS
% 221.34/221.53  |- skos__historyNote mesh__D014739 Australia %28%1966-1987%29%
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D014739 2000
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D014739 2005
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D014739 1999
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D014739 2006
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D014739 1996
% 221.34/221.53  |- skos__annotation mesh__D014739 a state of Australia   
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D014739 2001
% 221.34/221.53  |- skos__prefLabel mesh__D014739 Victoria
% 221.34/221.53  |- mesh__recordOriginator mesh__D014739 EC
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D014739 2003
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D014739 1997
% 221.34/221.53  |- skos__altLabel mesh__D025461 Feedback Stimulation, Biochemical
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D025461 2006
% 221.34/221.53  |- skos__altLabel mesh__D025461 Feedback Regulation, Biochemical
% 221.34/221.53  |- mesh__publicMeSHNote mesh__D025461 2002   
% 221.34/221.53  |- rdf__type mesh__D025461sskos__Concept
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D025461 2003
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D025461 2005
% 221.34/221.53  |- skos__broader mesh__D025461smesh__D006706
% 221.34/221.53  |- skos__altLabel mesh__D025461 Feedback Inhibition, Biochemical
% 221.34/221.53  |- mesh__dateCreated mesh__D025461 2001-08-03
% 221.34/221.53  |- skos__related mesh__D025461smesh__D015398
% 221.34/221.53  |- mesh__dateEstablished mesh__D025461 2002-01-01
% 221.34/221.53  |- mesh__recordMaintainer mesh__D025461 jls
% 221.34/221.53  |- skos__prefLabel mesh__D025461 Feedback, Biochemical
% 221.34/221.53  |- skos__historyNote mesh__D025461 Feedback %28%1964-2001%29%
% 221.34/221.53  |- mesh__historyNote mesh__D025461 2002   
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D025461 2002
% 221.34/221.53  |- mesh__recordAuthorizer mesh__D025461 sjn
% 221.34/221.53  |- skos__scopeNote mesh__D025461
% 221.34/221.53       A mechanism of communication among life processes to coordinate development, reproduction, and homeostasis. In humans, feedback loops are especially important for communication between organs that are spatially separated. Virtually all hormones from the nervous and endocrine systems are under feedback control: by peripheral hormones, cations, metabolites, osmolarity or extracellular fluid volume.%A%    
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D025461 2004
% 221.34/221.53  |- mesh__recordOriginator mesh__D025461 lkt
% 221.34/221.53  |- skos__hiddenLabel mesh__D025461 Feedback, Biochemical Positive
% 221.34/221.53  |- skos__related mesh__D025461smesh__D005246
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D019424 2005
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D019424 1997
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D019424 2006
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D019424 2002
% 221.34/221.53  |- rdf__type mesh__D019424sskos__Concept
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D019424 2003
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D019424 1998
% 221.34/221.53  |- skos__prefLabel mesh__D019424 Dominica
% 221.34/221.53  |- skos__broader mesh__D019424smesh__D014900
% 221.34/221.53  |- mesh__historyNote mesh__D019424 97   
% 221.34/221.53  |- skos__annotation mesh__D019424
% 221.34/221.53       an island in the West Indies; do not confuse with DOMINICAN REPUBLIC, also in the West Indies%A%  
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D019424 2004
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D019424 1999
% 221.34/221.53  |- skos__historyNote mesh__D019424 West Indies %28%1968-1996%29%
% 221.34/221.53  |- skos__scopeNote mesh__D019424
% 221.34/221.53       An island republic of the West Indies. Its capital is Roseau. It was discovered in 1493 by Columbus and held at different times by the French and the British in the 18th century. A member of the West Indies Federation, it achieved internal self-government in 1967 but became independent in 1978. It was named by Columbus who discovered it on Sunday, Domingo in Spanish, from the Latin Dominica dies, the Lord%27%s Day. %28%From Webster%27%s New Geographical Dictionary, 1988, p338 %26% Room, Brewer%27%s Dictionary of Names, 1992, p151%29%%A%    
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D019424 2000
% 221.34/221.53  |- mesh__dateEstablished mesh__D019424 1997-01-01
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D019424 2001
% 221.34/221.53  |- mesh__dateCreated mesh__D019424 1996-06-26
% 221.34/221.53  |- skos__hiddenLabel mesh__D000719 Veterinary Anatomies
% 221.34/221.53  |- skos__broader mesh__D000719smesh__D000715
% 221.34/221.53  |- skos__annotation mesh__D000719 SPEC   
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D000719 2003
% 221.34/221.53  |- rdf__type mesh__D000719sskos__Concept
% 221.34/221.53  |- skos__hiddenLabel mesh__D000719 Anatomies, Veterinary
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D000719 2005
% 221.34/221.53  |- mesh__dateCreated mesh__D000719 1999-01-01
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D000719 2004
% 221.34/221.53  |- mesh__recordAuthorizer mesh__D000719 sjn
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D000719 2006
% 221.34/221.53  |- skos__prefLabel mesh__D000719 Anatomy, Veterinary
% 221.34/221.53  |- mesh__dateRevised mesh__D000719 2001-07-25
% 221.34/221.53  |- skos__altLabel mesh__D000719 Veterinary Anatomy
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D000719 2002
% 221.34/221.53  |- mesh__recordMaintainer mesh__D000719 jls
% 221.34/221.53  |- mesh__recordOriginator mesh__D000719 NLM
% 221.34/221.53  |- mesh__recordMaintainer mesh__D011441 JRT
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D011441 2001
% 221.34/221.53  |- skos__annotation mesh__D011441 a thyroid antag   
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D011441 1996
% 221.34/221.53  |- mesh__recordOriginator mesh__D011441 NLM
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D011441 2005
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D011441 2000
% 221.34/221.53  |- skos__altLabel mesh__D011441 6-Propyl-2-Thiouracil
% 221.34/221.53  |- mesh__dateCreated mesh__D011441 1999-01-01
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D011441 2004
% 221.34/221.53  |- skos__scopeNote mesh__D011441
% 221.34/221.53       A thiourea antithyroid agent. Propythiouracil inhibits the synthesis of thyroxine and inhibits the peripheral conversion of throxine to tri-iodothyronine. It is used in the treatment of hyperthyroidism. %28%From Martindale, The Extra Pharmacopeoia, 30th ed, p534%29%%A%    
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D011441 1999
% 221.34/221.53  |- rdf__type mesh__D011441sskos__Concept
% 221.34/221.53  |- mesh__recordAuthorizer mesh__D011441 PLS
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D011441 2003
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D011441 1998
% 221.34/221.53  |- mesh__dateRevised mesh__D011441 1995-06-08
% 221.34/221.53  |- skos__broader mesh__D011441smesh__D013889
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D011441 2002
% 221.34/221.53  |- skos__hiddenLabel mesh__D011441 6 Propyl 2 Thiouracil
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D011441 1997
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D011441 2006
% 221.34/221.53  |- skos__prefLabel mesh__D011441 Propylthiouracil
% 221.34/221.53  |- skos__annotation mesh__D005404
% 221.34/221.53       do not restrict to histol techniques: may be microbiol techniques also; D25-26 qualif%A%  
% 221.34/221.53  |- skos__historyNote mesh__D005404
% 221.34/221.53       Histological Techniques %28%1966-1976%29%
% 221.34/221.53  |- mesh__recordMaintainer mesh__D005404 ssb
% 221.34/221.53  |- mesh__dateEstablished mesh__D005404 1977-01-01
% 221.34/221.53  |- rdf__type mesh__D005404sskos__Concept
% 221.34/221.53  |- mesh__onlineNote mesh__D005404 search HISTOLOGICAL TECHNIQUES 1974   
% 221.34/221.53  |- skos__broader mesh__D005404smesh__D020313
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D005404 2005
% 221.34/221.53  |- mesh__historyNote mesh__D005404
% 221.34/221.53       77; was see under HISTOLOGICAL TECHNIQUES 1974   
% 221.34/221.53  |- mesh__recordOriginator mesh__D005404 SH
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D005404 2004
% 221.34/221.53  |- mesh__publicMeSHNote mesh__D005404
% 221.34/221.53       77; was see under HISTOLOGICAL TECHNIQUES 1974   
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D005404 2006
% 221.34/221.53  |- skos__hiddenLabel mesh__D005404 Agents, Pickling
% 221.34/221.53  |- mesh__recordAuthorizer mesh__D005404 sjn
% 221.34/221.53  |- skos__prefLabel mesh__D005404 Fixatives
% 221.34/221.53  |- mesh__dateCreated mesh__D005404 1976-04-16
% 221.34/221.53  |- mesh__dateRevised mesh__D005404 2003-07-09
% 221.34/221.53  |- skos__scopeNote mesh__D005404
% 221.34/221.53       Agents employed in the preparation of histologic or pathologic specimens for the purpose of maintaining the existing form and structure of all of the constituent elements. Great numbers of different agents are used; some are also decalcifying and hardening agents. They must quickly kill and coagulate living tissue.%A%    
% 221.34/221.53  |- skos__broader mesh__D003558Q000295smesh__D003558
% 221.34/221.53  |- mesh__preferredCombination mesh__D003558Q000295smesh__D020684
% 221.34/221.53  |- rdf__type mesh__D003558Q000295smesh__CompoundConcept
% 221.34/221.53  |- rdf__type mesh__D043523sskos__Concept
% 221.34/221.53  |- mesh__historyNote mesh__D043523
% 221.34/221.53       2004; use BIOTINIDASE %28%NM%29% 1983 - 2003   
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D043523 2004
% 221.34/221.53  |- skos__related mesh__D043523smesh__D028921
% 221.34/221.53  |- mesh__dateCreated mesh__D043523 2003-07-09
% 221.34/221.53  |- skos__prefLabel mesh__D043523 Biotinidase
% 221.34/221.53  |- mesh__publicMeSHNote mesh__D043523
% 221.34/221.53       2004; BIOTINIDASE was indexed under AMIDOHYDROLASES 1983 - 2003%A%  
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D043523 2005
% 221.34/221.53  |- mesh__dateEstablished mesh__D043523 2004-01-01
% 221.34/221.53  |- skos__related mesh__D043523smesh__D009100
% 221.34/221.53  |- skos__hiddenLabel mesh__D043523 Hydrolase, Biocytin
% 221.34/221.53  |- skos__broader mesh__D043523smesh__D000581
% 221.34/221.53  |- skos__altLabel mesh__D043523 Biocytin Hydrolase
% 221.34/221.53  |- skos__historyNote mesh__D043523 Amidohydrolases %28%1983-2003%29%
% 221.34/221.53  |- skos__scopeNote mesh__D043523
% 221.34/221.53       An enzyme which catalyzes the release of BIOTIN from biocytin. In human, defects in the enzyme are the cause of the organic acidemia MULTIPLE CARBOXYLASE DEFICIENCY or BIOTINIDASE DEFICIENCY.%A%    
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D043523 2006
% 221.34/221.53  |- mesh__recordOriginator mesh__D010349 NLM
% 221.34/221.53  |- skos__hiddenLabel mesh__D010349 Cooperation, Patient
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D010349 2005
% 221.34/221.53  |- skos__scopeNote mesh__D010349
% 221.34/221.53       Voluntary cooperation of the patient in following a prescribed regimen.%A%    
% 221.34/221.53  |- rdf__type mesh__D010349sskos__Concept
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D010349 2003
% 221.34/221.53  |- skos__annotation mesh__D010349
% 221.34/221.53       for non-compliance, note PATIENT NONCOMPLIANCE see TREATMENT REFUSAL%A%  
% 221.34/221.53  |- skos__prefLabel mesh__D010349 Patient Compliance
% 221.34/221.53  |- skos__altLabel mesh__D010349 Patient Cooperation
% 221.34/221.53  |- mesh__dateRevised mesh__D010349 2002-07-03
% 221.34/221.53  |- mesh__historyNote mesh__D010349 75   
% 221.34/221.53  |- skos__broader mesh__D010349smesh__D010342
% 221.34/221.53  |- skos__broader mesh__D010349smesh__D015438
% 221.34/221.53  |- skos__related mesh__D010349smesh__D010352
% 221.34/221.53  |- skos__related mesh__D010349smesh__D016312
% 221.34/221.53  |- skos__hiddenLabel mesh__D010349 Compliance, User
% 221.34/221.53  |- mesh__recordAuthorizer mesh__D010349 sjn
% 221.34/221.53  |- skos__hiddenLabel mesh__D010349 Compliance, Patient
% 221.34/221.53  |- mesh__recordMaintainer mesh__D010349 lkt
% 221.34/221.53  |- mesh__dateCreated mesh__D010349 1974-11-11
% 221.34/221.53  |- skos__historyNote mesh__D010349 Cooperative Behavior %28%1971-1974%29%
% 221.34/221.53  |- skos__related mesh__D010349smesh__D023801
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D010349 2006
% 221.34/221.53  |- mesh__publicMeSHNote mesh__D010349 75   
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D010349 2004
% 221.34/221.53  |- mesh__dateEstablished mesh__D010349 1975-09-01
% 221.34/221.53  |- mesh__historyNote mesh__D015034
% 221.34/221.53       91%28%75%29%; was see under ZINC 1975-90   
% 221.34/221.53  |- skos__prefLabel mesh__D015034 Zinc Oxide
% 221.34/221.53  |- mesh__recordOriginator mesh__D015034 NLM
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D015034 1998
% 221.34/221.53  |- skos__annotation mesh__D015034 a dermatol agent   
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D015034 1997
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D015034 2000
% 221.34/221.53  |- mesh__recordMaintainer mesh__D015034 JRT
% 221.34/221.53  |- skos__historyNote mesh__D015034 Oxides %28%1966-1974%29%
% 221.34/221.53  |- mesh__publicMeSHNote mesh__D015034 91; was see under ZINC 1975-90   
% 221.34/221.53  |- mesh__dateEstablished mesh__D015034 1991-01-01
% 221.34/221.53  |- skos__hiddenLabel mesh__D015034 Paste, Lassar%27%s
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D015034 1996
% 221.34/221.53  |- skos__broader mesh__D015034smesh__D017967
% 221.34/221.53  |- skos__historyNote mesh__D015034 Zinc %28%1966-1974%29%
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D015034 2006
% 221.34/221.53  |- skos__altLabel mesh__D015034 Lassar%27%s Paste
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D015034 2002
% 221.34/221.53  |- skos__scopeNote mesh__D015034
% 221.34/221.53       A mild astringent and topical protectant with some antiseptic action. It is also used in bandages, pastes, ointments, dental cements, and as a sunblock.%A%    
% 221.34/221.53  |- skos__broader mesh__D015034smesh__D010087
% 221.34/221.53  |- skos__hiddenLabel mesh__D015034 Oxide, Zinc
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D015034 2005
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D015034 2004
% 221.34/221.53  |- mesh__dateRevised mesh__D015034 1995-06-09
% 221.34/221.53  |- mesh__dateCreated mesh__D015034 1974-11-19
% 221.34/221.53  |- mesh__recordAuthorizer mesh__D015034 PLS
% 221.34/221.53  |- rdf__type mesh__D015034sskos__Concept
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D015034 2003
% 221.34/221.53  |- skos__hiddenLabel mesh__D015034 Lassars Paste
% 221.34/221.53  |- skos__hiddenLabel mesh__D015034 Lassar Paste
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D015034 2001
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D015034 1999
% 221.34/221.53  |- skos__hiddenLabel mesh__D001812 Hemato Encephalic Barrier
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001812 2006
% 221.34/221.53  |- mesh__historyNote mesh__D001812
% 221.34/221.53       66; was HEMATO-ENCEPHALIC BARRIER 1963-65   
% 221.34/221.53  |- skos__related mesh__D001812smesh__D002199
% 221.34/221.53  |- mesh__publicMeSHNote mesh__D001812
% 221.34/221.53       66; was HEMATO-ENCEPHALIC BARRIER 1963-65   
% 221.34/221.53  |- mesh__dateCreated mesh__D001812 1999-01-01
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001812 2004
% 221.34/221.53  |- skos__altLabel mesh__D001812 Hemato-Encephalic Barrier
% 221.34/221.53  |- skos__hiddenLabel mesh__D001812 Brain-Blood Barriers
% 221.34/221.53  |- skos__hiddenLabel mesh__D001812 Hemato-Encephalic Barriers
% 221.34/221.53  |- mesh__recordMaintainer mesh__D001812 nns
% 221.34/221.53  |- skos__annotation mesh__D001812
% 221.34/221.53       coord IM with endogenous substance /metab %28%IM%29% or exogenous substance /pharmacokin %28%IM%29%%A%  
% 221.34/221.53  |- skos__hiddenLabel mesh__D001812 Barriers, Hemato-Encephalic
% 221.34/221.53  |- mesh__dateRevised mesh__D001812 2003-07-09
% 221.34/221.53  |- skos__hiddenLabel mesh__D001812 Barrier, Blood-Brain
% 221.34/221.53  |- skos__broader mesh__D001812smesh__D001921
% 221.34/221.53  |- skos__hiddenLabel mesh__D001812 Barriers, Brain-Blood
% 221.34/221.53  |- mesh__recordAuthorizer mesh__D001812 sjn
% 221.34/221.53  |- skos__scopeNote mesh__D001812
% 221.34/221.53       Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue.%A%    
% 221.34/221.53  |- skos__prefLabel mesh__D001812 Blood-Brain Barrier
% 221.34/221.53  |- skos__hiddenLabel mesh__D001812 Barrier, Hemato-Encephalic
% 221.34/221.53  |- mesh__recordOriginator mesh__D001812 NLM
% 221.34/221.53  |- skos__hiddenLabel mesh__D001812 Blood Brain Barrier
% 221.34/221.53  |- rdf__type mesh__D001812sskos__Concept
% 221.34/221.53  |- skos__hiddenLabel mesh__D001812 Blood-Brain Barriers
% 221.34/221.53  |- skos__hiddenLabel mesh__D001812 Barriers, Blood-Brain
% 221.34/221.53  |- skos__hiddenLabel mesh__D001812 Brain Blood Barrier
% 221.34/221.53  |- skos__hiddenLabel mesh__D001812 Barrier, Brain-Blood
% 221.34/221.53  |- mesh__dateEstablished mesh__D001812 1966-01-01
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001812 2005
% 221.34/221.53  |- skos__broader mesh__D001812smesh__D002319
% 221.34/221.53  |- skos__altLabel mesh__D001812 Brain-Blood Barrier
% 221.34/221.53  |- skos__scopeNote mesh__D001014 Aneurysm of the aorta.     
% 221.34/221.53  |- skos__prefLabel mesh__D001014 Aortic Aneurysm
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001014 2000
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001014 1994
% 221.34/221.53  |- mesh__dateCreated mesh__D001014 1999-01-01
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001014 2003
% 221.34/221.53  |- skos__annotation mesh__D001014
% 221.34/221.53       GEN or unspecified; prefer specific sites; ruptured aortic aneurysm = AORTIC RUPTURE; for dissecting aneurysm of aorta, coord IM with ANEURYSM, DISSECTING %28%IM%29%%A%  
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001014 2006
% 221.34/221.53  |- mesh__dateRevised mesh__D001014 1992-05-20
% 221.34/221.53  |- skos__hiddenLabel mesh__D001014 Aneurysm, Aortic
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001014 1997
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001014 2002
% 221.34/221.53  |- mesh__recordAuthorizer mesh__D001014 PLS
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001014 2005
% 221.34/221.53  |- mesh__recordMaintainer mesh__D001014 TGC
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001014 1993
% 221.34/221.53  |- rdf__type mesh__D001014sskos__Concept
% 221.34/221.53  |- skos__hiddenLabel mesh__D001014 Aneurysms, Aortic
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001014 1996
% 221.34/221.53  |- skos__hiddenLabel mesh__D001014 Aortic Aneurysms
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001014 1999
% 221.34/221.53  |- skos__broader mesh__D001014smesh__D001018
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001014 2001
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001014 1995
% 221.34/221.53  |- skos__broader mesh__D001014smesh__D000783
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001014 1998
% 221.34/221.53  |- mesh__recordOriginator mesh__D001014 NLM
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D001014 2004
% 221.34/221.53  |- skos__altLabel mesh__D039482 Antigens, CD49e
% 221.34/221.53  |- skos__altLabel mesh__D039482 alpha%28%5%29% Integrin
% 221.34/221.53  |- mesh__publicMeSHNote mesh__D039482
% 221.34/221.53       2003; INTEGRIN ALPHA5 was indexed under ANTIGENS, CD 1996-2002%A%  
% 221.34/221.53  |- skos__hiddenLabel mesh__D039482 Integrin, alpha5
% 221.34/221.53  |- skos__hiddenLabel mesh__D039482 Ic, Platelet Glycoprotein
% 221.34/221.53  |- skos__hiddenLabel mesh__D039482 VLA 5 alpha Chain
% 221.34/221.53  |- skos__hiddenLabel mesh__D039482 Chain, VLA-5 alpha
% 221.34/221.53  |- skos__hiddenLabel mesh__D039482 alphaF, Integrin
% 221.34/221.53  |- skos__altLabel mesh__D039482 CD49e Antigens
% 221.34/221.53  |- mesh__dateRevised mesh__D039482 2005-06-30
% 221.34/221.53  |- mesh__dateEstablished mesh__D039482 2003-01-01
% 221.34/221.53  |- skos__altLabel mesh__D039482 Integrin alphaF
% 221.34/221.53  |- rdf__type mesh__D039482sskos__Concept
% 221.34/221.53  |- skos__hiddenLabel mesh__D039482 Antigen, CD49e
% 221.34/221.53  |- skos__scopeNote mesh__D039482
% 221.34/221.53       This integrin alpha subunit combines with INTEGRIN BETA1 to form a receptor %28%INTEGRIN ALPHA5BETA1%29% that binds FIBRONECTIN and LAMININ. It undergoes posttranslational cleavage into a heavy and a light chain that are connected by disulfide bonds.%A%    
% 221.34/221.53  |- skos__altLabel mesh__D039482 Platelet Glycoprotein Ic
% 221.34/221.53  |- skos__altLabel mesh__D039482 CD49e Antigen
% 221.34/221.53  |- mesh__recordAuthorizer mesh__D039482 sjn
% 221.34/221.53  |- skos__hiddenLabel mesh__D039482 alpha5, Integrin
% 221.34/221.53  |- mesh__recordOriginator mesh__D039482 MDJ
% 221.34/221.53  |- mesh__dateCreated mesh__D039482 2002-07-02
% 221.34/221.53  |- skos__hiddenLabel mesh__D039482 alpha Chain, VLA-5
% 221.34/221.53  |- skos__historyNote mesh__D039482 Antigens, CD %28%1996-2002%29%
% 221.34/221.53  |- skos__broader mesh__D039482smesh__D015703
% 221.34/221.53  |- skos__altLabel mesh__D039482 VLA-5 alpha Chain
% 221.34/221.53  |- skos__prefLabel mesh__D039482 Integrin alpha5
% 221.34/221.53  |- skos__altLabel mesh__D039482 alpha5 Integrin
% 221.34/221.53  |- skos__broader mesh__D039482smesh__D039001
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D039482 2006
% 221.34/221.53  |- skos__hiddenLabel mesh__D039482 Glycoprotein Ic, Platelet
% 221.34/221.53  |- mesh__historyNote mesh__D039482
% 221.34/221.53       2003; use INTEGRIN ALPHA5 %28%NM%29% 1996-2002   
% 221.34/221.53  |- mesh__recordMaintainer mesh__D039482 ssb
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D019425 1998
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D019425 1997
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D019425 2002
% 221.34/221.53  |- skos__historyNote mesh__D019425 West Indies %28%1969-1996%29%
% 221.34/221.53  |- skos__prefLabel mesh__D019425 Grenada
% 221.34/221.53  |- skos__broader mesh__D019425smesh__D014900
% 221.34/221.53  |- mesh__dateCreated mesh__D019425 1996-06-26
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D019425 2006
% 221.34/221.53  |- skos__scopeNote mesh__D019425
% 221.34/221.53       An island of the West Indies. Its capital is St. George%27%s. It was discovered in 1498 by Columbus who called it Concepcion. It was held at different times by the French and the British during the 18th century. The British suppressed a native uprising in 1795. It was an associate state of Great Britain 1967-74 but became an independent nation within the British Commonwealth in 1974. The original name referred to the Feast of the Immaculate Conception but it was later renamed for the Spanish kingdom of Granada. %28%From Webster%27%s New Geographical Dictionary, 1988, p467 %26% Room, Brewer%27%s Dictionary of Names, 1992, p219%29%%A%    
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D019425 2001
% 221.34/221.53  |- skos__annotation mesh__D019425
% 221.34/221.53       an island in the West Indies; do not confuse with GRENADINES see SAINT VINCENT AND THE GRENADINES, also in the West Indies%A%  
% 221.34/221.53  |- mesh__dateEstablished mesh__D019425 1997-01-01
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D019425 2005
% 221.34/221.53  |- mesh__activeMeSHYear mesh__D019425 2004
% 221.34/221.54  |- rdf__type mesh__D019425sskos__Concept
% 221.34/221.54  |- mesh__historyNote mesh__D019425 97   
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D019425 2000
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D019425 2003
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D019425 1999
% 221.34/221.54  |- mesh__publicMeSHNote mesh__D011442
% 221.34/221.54       91; was see under BUFANOLIDES 1975-90   
% 221.34/221.54  |- skos__altLabel mesh__D011442 Knoll Brand of Proscillaridin
% 221.34/221.54  |- rdf__type mesh__D011442sskos__Concept
% 221.34/221.54  |- skos__scopeNote mesh__D011442
% 221.34/221.54       A cardiotonic glycoside isolated from Scilla maritima var. alba %28%Squill%29%.%A%    
% 221.34/221.54  |- skos__historyNote mesh__D011442 Plants, Medicinal %28%1970-1974%29%
% 221.34/221.54  |- skos__altLabel mesh__D011442 Ziethen Brand of Proscillaridin
% 221.34/221.54  |- skos__altLabel mesh__D011442 Abbott Brand of Proscillaridin
% 221.34/221.54  |- mesh__recordOriginator mesh__D011442 NLM
% 221.34/221.54  |- mesh__dateRevised mesh__D011442 2005-06-30
% 221.34/221.54  |- skos__altLabel mesh__D011442 Scillarenin Rhamnoside
% 221.34/221.54  |- mesh__recordMaintainer mesh__D011442 lkw
% 221.34/221.54  |- mesh__recordAuthorizer mesh__D011442 sjn
% 221.34/221.54  |- skos__prefLabel mesh__D011442 Proscillaridin
% 221.34/221.54  |- skos__historyNote mesh__D011442 Bufanolides %28%1970-1974%29%
% 221.34/221.54  |- skos__altLabel mesh__D011442 Proscillaridine
% 221.34/221.54  |- skos__hiddenLabel mesh__D011442 Rhamnoside, Scillarenin
% 221.34/221.54  |- skos__altLabel mesh__D011442 Desglucotransvaaline
% 221.34/221.54  |- skos__altLabel mesh__D011442 Ysatfabrik Brand of Proscillaridin
% 221.34/221.54  |- mesh__dateEstablished mesh__D011442 1991-01-01
% 221.34/221.54  |- mesh__historyNote mesh__D011442
% 221.34/221.54       91%28%75%29%; was see under BUFANOLIDES 1975-90   
% 221.34/221.54  |- skos__broader mesh__D011442smesh__D002301
% 221.34/221.54  |- skos__broader mesh__D011442smesh__D002018
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D011442 2006
% 221.34/221.54  |- mesh__dateCreated mesh__D011442 1974-11-19
% 221.34/221.54  |- skos__altLabel mesh__D011442 Proscillaridin A
% 221.34/221.54  |- skos__hiddenLabel mesh__D011442 A, Proscillaridin
% 221.34/221.54  |- mesh__publicMeSHNote mesh__D005405 84   
% 221.34/221.54  |- rdf__type mesh__D005405sskos__Concept
% 221.34/221.54  |- skos__historyNote mesh__D005405
% 221.34/221.54       Enkephalin, Methionine/analogs %26% derivatives %28%1983%29%
% 221.34/221.54  |- mesh__dateRevised mesh__D005405 2004-07-07
% 221.34/221.54  |- skos__annotation mesh__D005405 DF: note short X ref   
% 221.34/221.54  |- mesh__recordMaintainer mesh__D005405 jmp
% 221.34/221.54  |- skos__hiddenLabel mesh__D005405 Tyr Ala Gly MePhe Met OH
% 221.34/221.54  |- skos__altLabel mesh__D005405 FK-33824
% 221.34/221.54  |- mesh__historyNote mesh__D005405 84   
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D005405 2005
% 221.34/221.54  |- mesh__recordAuthorizer mesh__D005405 sjn
% 221.34/221.54  |- skos__historyNote mesh__D005405 Enkephalins %28%1978-1982%29%
% 221.34/221.54  |- mesh__dateEstablished mesh__D005405 1984-01-01
% 221.34/221.54  |- skos__broader mesh__D005405smesh__D004744
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D005405 2006
% 221.34/221.54  |- skos__hiddenLabel mesh__D005405 FK33824
% 221.34/221.54  |- skos__altLabel mesh__D005405 Tyr-Ala-Gly-MePhe-Met-OH
% 221.34/221.54  |- skos__hiddenLabel mesh__D005405 FK 33824
% 221.34/221.54  |- skos__hiddenLabel mesh__D005405 FK 33 824
% 221.34/221.54  |- skos__prefLabel mesh__D005405
% 221.34/221.54       D-Ala%28%2%29%,MePhe%28%4%29%,Met%28%0%29%-ol-enkephalin
% 221.34/221.54  |- skos__altLabel mesh__D005405 FK-33-824
% 221.34/221.54  |- skos__altLabel mesh__D005405 DAMME
% 221.34/221.54  |- mesh__recordOriginator mesh__D005405 RLS
% 221.34/221.54  |- skos__scopeNote mesh__D005405
% 221.34/221.54       A stable synthetic analog of methionine enkephalin %28%ENKEPHALIN, METHIONINE%29%. Actions are similar to those of methionine enkephalin. Its effects can be reversed by narcotic antagonists such as naloxone.%A%    
% 221.34/221.54  |- mesh__dateCreated mesh__D005405 1983-06-15
% 221.34/221.54  |- skos__hiddenLabel mesh__D043524 N Glycosidase A
% 221.34/221.54  |- mesh__recordMaintainer mesh__D043524 AKE
% 221.34/221.54  |- mesh__historyNote mesh__D043524
% 221.34/221.54       2004; use PEPTIDE-N4-%28%N-ACETYL-BETA-GLUCOSAMINYL%29% ASPARAGINE AMIDASE %28%NM%29% 1979 - 2003%A%  
% 221.34/221.54  |- skos__hiddenLabel mesh__D043524 N-Glycosidase, Peptide
% 221.34/221.54  |- skos__hiddenLabel mesh__D043524 N-glycosidase, Glycopeptide
% 221.34/221.54  |- rdf__type mesh__D043524sskos__Concept
% 221.34/221.54  |- skos__historyNote mesh__D043524 Amidohydrolases %28%1979-2003%29%
% 221.34/221.54  |- skos__altLabel mesh__D043524 Peptide N-glycohydrolase F
% 221.34/221.54  |- skos__broader mesh__D043524smesh__D000581
% 221.34/221.54  |- mesh__recordAuthorizer mesh__D043524 sjn
% 221.34/221.54  |- skos__altLabel mesh__D043524 PNGase F
% 221.34/221.54  |- skos__scopeNote mesh__D043524
% 221.34/221.54       An amidohydrolase that removes intact asparagine-linked oligosaccharide chains from glycoproteins. It requires the presence of more than two amino-acid residues in the substrate for activity. This enzyme was previously listed as EC 3.2.2.18.%A%    
% 221.34/221.54  |- skos__altLabel mesh__D043524 N-Oligosaccharide Glycopeptidase
% 221.34/221.54  |- skos__altLabel mesh__D043524 Glycopeptidase
% 221.34/221.54  |- skos__hiddenLabel mesh__D043524 Peptide N Glycanase
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D043524 2005
% 221.34/221.54  |- skos__altLabel mesh__D043524 Glycopeptide N-glycosidase
% 221.34/221.54  |- mesh__dateEstablished mesh__D043524 2004-01-01
% 221.34/221.54  |- skos__prefLabel mesh__D043524
% 221.34/221.54       Peptide-N4-%28%N-acetyl-beta-glucosaminyl%29% Asparagine Amidase
% 221.34/221.54  |- skos__altLabel mesh__D043524 N-Glycosidase F
% 221.34/221.54  |- skos__hiddenLabel mesh__D043524 Glycopeptide N glycosidase
% 221.34/221.54  |- skos__hiddenLabel mesh__D043524 Peptide N glycohydrolase F
% 221.34/221.54  |- skos__hiddenLabel mesh__D043524 Glycopeptidase, N-Oligosaccharide
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D043524 2006
% 221.34/221.54  |- skos__hiddenLabel mesh__D043524 N Glycosidase F
% 221.34/221.54  |- skos__altLabel mesh__D043524
% 221.34/221.54       Peptide-N%28%4%29%-%28%acetyl-beta-glucosaminyl%29%Asparagine Amidase
% 221.34/221.54  |- skos__hiddenLabel mesh__D043524 N Glycanase
% 221.34/221.54  |- skos__hiddenLabel mesh__D043524 N Oligosaccharide Glycopeptidase
% 221.34/221.54  |- skos__altLabel mesh__D043524 Peptide N-Glycosidase
% 221.34/221.54  |- skos__altLabel mesh__D043524 PNGase A
% 221.34/221.54  |- mesh__publicMeSHNote mesh__D043524
% 221.34/221.54       2004; PEPTIDE-N4-%28%N-ACETYL-BETA-GLUCOSAMINYL%29% ASPARAGINE AMIDASE was indexed under AMIDOHYDROLASES 1983-2003 %26% GLYCOPEPTIDES 1979-1984%A%  
% 221.34/221.54  |- skos__hiddenLabel mesh__D043524 Peptide N Glycosidase
% 221.34/221.54  |- skos__hiddenLabel mesh__D043524 N-Glycanase, Peptide
% 221.34/221.54  |- mesh__recordOriginator mesh__D043524 AKE
% 221.34/221.54  |- skos__altLabel mesh__D043524 Peptide-N-Glycanase
% 221.34/221.54  |- skos__altLabel mesh__D043524 N-Glycosidase A
% 221.34/221.54  |- skos__altLabel mesh__D043524 N-Glycanase
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D043524 2004
% 221.34/221.54  |- skos__altLabel mesh__D043524 Peptide N-Glycanase
% 221.34/221.54  |- skos__hiddenLabel mesh__D043524 N-glycohydrolase F, Peptide
% 221.34/221.54  |- mesh__dateCreated mesh__D043524 2003-07-09
% 221.34/221.54  |- mesh__dateCreated mesh__D015035 1999-01-01
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015035 2006
% 221.34/221.54  |- skos__broader mesh__D015035smesh__D003738
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015035 2005
% 221.34/221.54  |- mesh__recordAuthorizer mesh__D015035 sjn
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015035 2004
% 221.34/221.54  |- mesh__recordMaintainer mesh__D015035 ssb
% 221.34/221.54  |- mesh__dateRevised mesh__D015035 2001-07-25
% 221.34/221.54  |- skos__hiddenLabel mesh__D015035 Zinc Oxide Eugenol Cement
% 221.34/221.54  |- mesh__dateEstablished mesh__D015035 1965-01-01
% 221.34/221.54  |- skos__annotation mesh__D015035 D25-26 qualif   
% 221.34/221.54  |- skos__hiddenLabel mesh__D015035 Cement, Zinc Oxide-Eugenol
% 221.34/221.54  |- mesh__recordOriginator mesh__D015035 NLM
% 221.34/221.54  |- skos__prefLabel mesh__D015035 Zinc Oxide-Eugenol Cement
% 221.34/221.54  |- rdf__type mesh__D015035sskos__Concept
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015035 2003
% 221.34/221.54  |- skos__scopeNote mesh__D015035
% 221.34/221.54       Used as a dental cement this is mainly zinc oxide %28%with strengtheners and accelerators%29% and eugenol. %28%Boucher%27%s Clinical Dental Terminology, 4th ed, p50%29%%A%    
% 221.34/221.54  |- skos__hiddenLabel mesh__D015035 Oxide-Eugenol Cement, Zinc
% 221.34/221.54  |- mesh__publicMeSHNote mesh__D015035 65   
% 221.34/221.54  |- mesh__historyNote mesh__D015035 65   
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015035 2002
% 221.34/221.54  |- skos__historyNote mesh__D001813 Retinal Vessels %28%1966-1986%29%
% 221.34/221.54  |- skos__hiddenLabel mesh__D001813 Barriers, Retinal-Blood
% 221.34/221.54  |- skos__hiddenLabel mesh__D001813 Barriers, Blood-Retinal
% 221.34/221.54  |- skos__hiddenLabel mesh__D001813 Barrier, Retinal-Blood
% 221.34/221.54  |- mesh__recordOriginator mesh__D001813 RC
% 221.34/221.54  |- skos__annotation mesh__D001813
% 221.34/221.54       coord IM with endogenous substance /metab %28%IM%29% or exogenous substance /pharmacokin %28%IM%29%%A%  
% 221.34/221.54  |- mesh__dateEstablished mesh__D001813 1987-01-01
% 221.34/221.54  |- skos__hiddenLabel mesh__D001813 Barrier, Blood-Retinal
% 221.34/221.54  |- skos__hiddenLabel mesh__D001813 Retinal-Blood Barriers
% 221.34/221.54  |- skos__broader mesh__D001813smesh__D002319
% 221.34/221.54  |- skos__broader mesh__D001813smesh__D012160
% 221.34/221.54  |- rdf__type mesh__D001813sskos__Concept
% 221.34/221.54  |- skos__hiddenLabel mesh__D001813 Blood Retinal Barrier
% 221.34/221.54  |- mesh__recordMaintainer mesh__D001813 nns
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D001813 2005
% 221.34/221.54  |- mesh__historyNote mesh__D001813 87   
% 221.34/221.54  |- skos__scopeNote mesh__D001813
% 221.34/221.54       A specialized transport barrier, in the EYE, formed by the retinal pigment EPITHELIUM, and the ENDOTHELIUM of the BLOOD VESSELS of the RETINA. TIGHT JUNCTIONS joining adjacent cells keep the barrier between cells continuous.%A%    
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D001813 2006
% 221.34/221.54  |- skos__related mesh__D001813smesh__D002199
% 221.34/221.54  |- skos__prefLabel mesh__D001813 Blood-Retinal Barrier
% 221.34/221.54  |- skos__hiddenLabel mesh__D001813 Blood-Retinal Barriers
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D001813 2004
% 221.34/221.54  |- skos__historyNote mesh__D001813 Retina %28%1966-1986%29%
% 221.34/221.54  |- mesh__publicMeSHNote mesh__D001813 87   
% 221.34/221.54  |- skos__hiddenLabel mesh__D001813 Retinal Blood Barrier
% 221.34/221.54  |- skos__altLabel mesh__D001813 Retinal-Blood Barrier
% 221.34/221.54  |- mesh__recordAuthorizer mesh__D001813 sjn
% 221.34/221.54  |- mesh__dateCreated mesh__D001813 1986-04-07
% 221.34/221.54  |- mesh__dateRevised mesh__D001813 2003-07-09
% 221.34/221.54  |- mesh__dateRevised mesh__D001015 1993-05-24
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D001015 2001
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D001015 2006
% 221.34/221.54  |- skos__prefLabel mesh__D001015 Aortic Arch Syndromes
% 221.34/221.54  |- mesh__recordOriginator mesh__D001015 NLM
% 221.34/221.54  |- skos__hiddenLabel mesh__D001015 Aortitis Syndromes
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D001015 1997
% 221.34/221.54  |- skos__annotation mesh__D001015
% 221.34/221.54       occlusion of aortic arch from various causes   
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D001015 2000
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D001015 2005
% 221.34/221.54  |- mesh__recordMaintainer mesh__D001015 TGC
% 221.34/221.54  |- rdf__type mesh__D001015sskos__Concept
% 221.34/221.54  |- mesh__publicMeSHNote mesh__D001015 65   
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D001015 1996
% 221.34/221.54  |- mesh__historyNote mesh__D001015 65   
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D001015 1999
% 221.34/221.54  |- skos__hiddenLabel mesh__D001015 Syndromes, Aortitis
% 221.34/221.54  |- skos__hiddenLabel mesh__D001015 Syndrome, Aortic Arch
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D001015 2002
% 221.34/221.54  |- skos__hiddenLabel mesh__D001015 Syndrome, Aortitis
% 221.34/221.54  |- mesh__recordAuthorizer mesh__D001015 PLS
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D001015 1995
% 221.34/221.54  |- skos__scopeNote mesh__D001015
% 221.34/221.54       Any of a group of disorders leading to occlusion of the arteries arising from the aortic arch. Such occlusion may be caused by atherosclerosis, arterial embolism, syphilitic or tuberculous arteritis, etc. %28%Dorland, 27th ed%29%%A%    
% 221.34/221.54  |- mesh__dateEstablished mesh__D001015 1965-01-01
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D001015 1998
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D001015 2004
% 221.34/221.54  |- skos__hiddenLabel mesh__D001015 Syndromes, Aortic Arch
% 221.34/221.54  |- skos__hiddenLabel mesh__D001015 Aortic Arch Syndrome
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D001015 1994
% 221.34/221.54  |- mesh__dateCreated mesh__D001015 1999-01-01
% 221.34/221.54  |- skos__broader mesh__D001015smesh__D001018
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D001015 2003
% 221.34/221.54  |- skos__scopeNote mesh__D020778
% 221.34/221.54       A secreted endopeptidase homologous with INTERSTITIAL COLLAGENASE, but which possesses an additional fibronectin-like domain.%A%    
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D020778 2005
% 221.34/221.54  |- skos__altLabel mesh__D020778 72-kDa Gelatinase
% 221.34/221.54  |- skos__altLabel mesh__D020778 Matrix Metalloproteinase-2
% 221.34/221.54  |- skos__broader mesh__D020778smesh__D017364
% 221.34/221.54  |- skos__hiddenLabel mesh__D020778 MMP 2
% 221.34/221.54  |- skos__hiddenLabel mesh__D020778 Gelatinase, 72-kDa
% 221.34/221.54  |- skos__broader mesh__D020778smesh__D020782
% 221.34/221.54  |- skos__altLabel mesh__D020778 MMP-2
% 221.34/221.54  |- skos__hiddenLabel mesh__D020778 72 kDa Gelatinase
% 221.34/221.54  |- mesh__recordAuthorizer mesh__D020778 sjn
% 221.34/221.54  |- mesh__publicMeSHNote mesh__D020778
% 221.34/221.54       2000; GELATINASE A was indexed under GELATINASES %26% METALLOPROTEINASES 1992-1999%A%  
% 221.34/221.54  |- skos__historyNote mesh__D020778 Metalloendopeptidases %28%1992-1999%29%
% 221.34/221.54  |- mesh__recordOriginator mesh__D020778 adp
% 221.34/221.54  |- skos__historyNote mesh__D020778 Gelatinases %28%1992-1999%29%
% 221.34/221.54  |- skos__altLabel mesh__D020778 72-kDa Type IV Collagenase
% 221.34/221.54  |- skos__hiddenLabel mesh__D020778 Matrix Metalloproteinase 2
% 221.34/221.54  |- mesh__dateCreated mesh__D020778 1999-11-04
% 221.34/221.54  |- mesh__recordMaintainer mesh__D020778 sjn
% 221.34/221.54  |- rdf__type mesh__D020778sskos__Concept
% 221.34/221.54  |- skos__hiddenLabel mesh__D020778 72 kDa Type IV Collagenase
% 221.34/221.54  |- skos__annotation mesh__D020778
% 221.34/221.54        /antag is permitted but  TISSUE INHIBITOR OF METALLOPROTEINASE-2 is available%A%  
% 221.34/221.54  |- skos__broader mesh__D020778smesh__D018093
% 221.34/221.54  |- mesh__historyNote mesh__D020778
% 221.34/221.54       2000; use GELATINASE A %28%NM%29% 1992-1999   
% 221.34/221.54  |- skos__prefLabel mesh__D020778 Gelatinase A
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D020778 2006
% 221.34/221.54  |- mesh__dateEstablished mesh__D020778 2000-01-01
% 221.34/221.54  |- mesh__dateRevised mesh__D020778 2004-07-13
% 221.34/221.54  |- mesh__dateCreated mesh__D019426 1996-06-13
% 221.34/221.54  |- mesh__dateRevised mesh__D019426 2003-07-09
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D019426 2006
% 221.34/221.54  |- skos__altLabel mesh__D019426 Integrase
% 221.34/221.54  |- skos__historyNote mesh__D019426
% 221.34/221.54       DNA Nucleotidyltransferases %28%1974-1996%29%
% 221.34/221.54  |- skos__historyNote mesh__D019426 DNA Helicases %28%1974-1987%29%
% 221.34/221.54  |- mesh__recordOriginator mesh__D019426 AGS
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D019426 2004
% 221.34/221.54  |- skos__prefLabel mesh__D019426 Integrases
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D019426 2005
% 221.34/221.54  |- rdf__type mesh__D019426sskos__Concept
% 221.34/221.54  |- mesh__recordMaintainer mesh__D019426 jmp
% 221.34/221.54  |- mesh__recordAuthorizer mesh__D019426 sjn
% 221.34/221.54  |- skos__scopeNote mesh__D019426
% 221.34/221.54       Recombinases that insert exogenous DNA into the host genome. Examples include proteins encoded by the POL GENE of RETROVIRIDAE and also by temperate BACTERIOPHAGES, the best known being BACTERIOPHAGE LAMBDA.%A%    
% 221.34/221.54  |- skos__historyNote mesh__D019426 Viral Proteins %28%1980-1987%29%
% 221.34/221.54  |- mesh__publicMeSHNote mesh__D019426
% 221.34/221.54       2004; see INTEGRASE 1997-2003; INTEGRASE was indexed under DNA NUCLEOTIDYLTRANSFERASES 1974-96, DNA UNWINDING PROTEINS 1974-87, VIRAL PROTEINS 1980-87, %26% COLIPHAGES/enzymology 1974-80%A%  
% 221.34/221.54  |- mesh__dateEstablished mesh__D019426 1997-01-01
% 221.34/221.54  |- mesh__historyNote mesh__D019426
% 221.34/221.54       2004%28%1997%29%; use INTEGRASE %28%NM%29% 1974-1996   
% 221.34/221.54  |- skos__historyNote mesh__D019426 Coliphages/enzymology %28%1974-1980%29%
% 221.34/221.54  |- skos__annotation mesh__D019426 HIV INTEGRASE is also available   
% 221.34/221.54  |- skos__broader mesh__D019426smesh__D045522
% 221.34/221.54  |- mesh__dateCreated mesh__D011443 1974-11-19
% 221.34/221.54  |- mesh__onlineNote mesh__D011443
% 221.34/221.54       use STREPSIRHINI to search PROSIMII 1981-91 %26% PROSIMIANS 1975-80%A%  
% 221.34/221.54  |- mesh__dateEstablished mesh__D011443 1975-09-01
% 221.34/221.54  |- mesh__recordMaintainer mesh__D011443 ags
% 221.34/221.54  |- mesh__publicMeSHNote mesh__D011443
% 221.34/221.54       92; was PROSIMII 1981-91; was PROSIMIANS 1975-80   
% 221.34/221.54  |- skos__broader mesh__D011443smesh__D011323
% 221.34/221.54  |- mesh__historyNote mesh__D011443
% 221.34/221.54       92; was PROSIMII 1981-91; was PROSIMIANS 1975-80   
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D011443 2006
% 221.34/221.54  |- skos__historyNote mesh__D011443 Primates %28%1966-1974%29%
% 221.34/221.54  |- skos__altLabel mesh__D011443 Prosimii
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D011443 2005
% 221.34/221.54  |- mesh__recordOriginator mesh__D011443 NLM
% 221.34/221.54  |- skos__prefLabel mesh__D011443 Strepsirhini
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D011443 2004
% 221.34/221.54  |- mesh__recordAuthorizer mesh__D011443 sjn
% 221.34/221.54  |- skos__scopeNote mesh__D011443
% 221.34/221.54       A suborder of PRIMATES consisting of the following five families: CHEIROGALEIDAE; Daubentoniidae; Indriidae; LEMURIDAE; and LORISIDAE.%A%    
% 221.34/221.54  |- rdf__type mesh__D011443sskos__Concept
% 221.34/221.54  |- mesh__dateRevised mesh__D011443 2003-07-09
% 221.34/221.54  |- mesh__historyNote mesh__D005406
% 221.34/221.54       2002%28%1975%29%; use IMIDAZOLES 1975-1990   
% 221.34/221.54  |- skos__broader mesh__D005406smesh__D007093
% 221.34/221.54  |- mesh__dateCreated mesh__D005406 1974-11-19
% 221.34/221.54  |- skos__scopeNote mesh__D005406
% 221.34/221.54       An inhibitor of the last step of noradrenaline biosynthesis.%A%    
% 221.34/221.54  |- mesh__recordMaintainer mesh__D005406 ssb
% 221.34/221.54  |- skos__prefLabel mesh__D005406
% 221.34/221.54       Bis%28%4-Methyl-1-Homopiperazinylthiocarbonyl%29%disulfide
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D005406 2006
% 221.34/221.54  |- mesh__publicMeSHNote mesh__D005406
% 221.34/221.54       2002; see FLA 63 1991-2001 %26% IMIDAZOLES 1975-1990   
% 221.34/221.54  |- mesh__dateEstablished mesh__D005406 1991-01-01
% 221.34/221.54  |- mesh__recordAuthorizer mesh__D005406 sjn
% 221.34/221.54  |- skos__historyNote mesh__D005406 Imidazoles %28%1972-1990%29%
% 221.34/221.54  |- rdf__type mesh__D005406sskos__Concept
% 221.34/221.54  |- mesh__dateRevised mesh__D005406 2005-06-30
% 221.34/221.54  |- mesh__recordOriginator mesh__D005406 NLM
% 221.34/221.54  |- skos__historyNote mesh__D005406 Disulfides %28%1972-1974%29%
% 221.34/221.54  |- rdf__type mesh__D043525sskos__Concept
% 221.34/221.54  |- mesh__dateCreated mesh__D043525 2003-07-09
% 221.34/221.54  |- skos__prefLabel mesh__D043525 Cytosine Deaminase
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D043525 2005
% 221.34/221.54  |- mesh__recordOriginator mesh__D043525 AKE
% 221.34/221.54  |- mesh__recordMaintainer mesh__D043525 AKE
% 221.34/221.54  |- mesh__recordAuthorizer mesh__D043525 sjn
% 221.34/221.54  |- skos__scopeNote mesh__D043525
% 221.34/221.54       An enzyme which catalyzes the deamination of CYTOSINE resulting in the formation of URACIL. It can also act on 5-methylcytosine to form THYMIDINE.%A%    
% 221.34/221.54  |- skos__historyNote mesh__D043525 Cytosine %28%1978-1982%29%
% 221.34/221.54  |- skos__hiddenLabel mesh__D043525 Aminohydrolase, Cytosine
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D043525 2004
% 221.34/221.54  |- mesh__dateEstablished mesh__D043525 2004-01-01
% 221.34/221.54  |- skos__altLabel mesh__D043525 Cytosine Aminohydrolase
% 221.34/221.54  |- skos__broader mesh__D043525smesh__D009700
% 221.34/221.54  |- skos__annotation mesh__D043525 see SCR for organism specific terms   
% 221.34/221.54  |- mesh__publicMeSHNote mesh__D043525
% 221.34/221.54       2004; CYTOSINE DEAMINASE was indexed under NUCLEOSIDE DEAMINASES 1983- 2003 %26% CYTOSINE 1978-1982%A%  
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D043525 2006
% 221.34/221.54  |- skos__hiddenLabel mesh__D043525 Deaminase, Cytosine
% 221.34/221.54  |- skos__historyNote mesh__D043525 Nucleoside Deaminases %28%1978-2003%29%
% 221.34/221.54  |- mesh__historyNote mesh__D043525
% 221.34/221.54       2004; use CYTOSINE DEAMINASE %28%NM%29% 1983 - 2003   
% 221.34/221.54  |- skos__hiddenLabel mesh__D015834 Diseases, Cochlear
% 221.34/221.54  |- mesh__publicMeSHNote mesh__D015834 90   
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015834 2006
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015834 2000
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015834 1999
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015834 1994
% 221.34/221.54  |- skos__prefLabel mesh__D015834 Cochlear Diseases
% 221.34/221.54  |- skos__scopeNote mesh__D015834
% 221.34/221.54       Diseases of the cochlea, the part of the inner ear that is concerned with hearing.%A%    
% 221.34/221.54  |- mesh__dateCreated mesh__D015834 1989-05-15
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015834 2005
% 221.34/221.54  |- mesh__historyNote mesh__D015834 90   
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015834 1993
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015834 1998
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015834 2004
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015834 1992
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015834 1997
% 221.34/221.54  |- rdf__type mesh__D015834sskos__Concept
% 221.34/221.54  |- mesh__recordAuthorizer mesh__D015834 NLM
% 221.34/221.54  |- skos__broader mesh__D015834smesh__D007759
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015834 2003
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015834 1996
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015834 1991
% 221.34/221.54  |- skos__hiddenLabel mesh__D015834 Disease, Cochlear
% 221.34/221.54  |- mesh__dateEstablished mesh__D015834 1990-01-01
% 221.34/221.54  |- mesh__dateRevised mesh__D015834 1990-05-29
% 221.34/221.54  |- skos__hiddenLabel mesh__D015834 Cochlear Disease
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015834 2002
% 221.34/221.54  |- mesh__recordMaintainer mesh__D015834 PLS
% 221.34/221.54  |- skos__historyNote mesh__D015834 Labyrinth Diseases %28%1966-1989%29%
% 221.34/221.54  |- mesh__recordOriginator mesh__D015834 PXP
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015834 2001
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015834 1995
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D048210 2005
% 221.34/221.54  |- rdf__type mesh__D048210sskos__Concept
% 221.34/221.54  |- skos__scopeNote mesh__D048210
% 221.34/221.54       A north temperate species of tapeworm %28%CESTODA%29% whose adult form infects FOXES and wild RODENTS. The larval form can infect humans producing HEPATIC HYDATID CYSTS.%A%    
% 221.34/221.54  |- skos__prefLabel mesh__D048210 Echinococcus multilocularis
% 221.34/221.54  |- mesh__publicMeSHNote mesh__D048210 2005   
% 221.34/221.54  |- mesh__recordMaintainer mesh__D048210 ags
% 221.34/221.54  |- skos__annotation mesh__D048210
% 221.34/221.54       infection: coordinate %28%IM%29% with ECHINOCOCCOSIS %28%IM%29% or specifics %28%IM%29%; infection in humans = ECHINOCOCCOSIS, HEPATIC%A%  
% 221.34/221.54  |- mesh__dateEstablished mesh__D048210 2005-01-01
% 221.34/221.54  |- mesh__recordOriginator mesh__D048210 ags
% 221.34/221.54  |- skos__historyNote mesh__D048210 Echinococcus %28%1965-2004%29%
% 221.34/221.54  |- mesh__historyNote mesh__D048210 2005   
% 221.34/221.54  |- skos__broader mesh__D048210smesh__D004446
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D048210 2006
% 221.34/221.54  |- mesh__dateCreated mesh__D048210 2004-07-07
% 221.34/221.54  |- mesh__recordAuthorizer mesh__D048210 sjn
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015036 2005
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015036 2004
% 221.34/221.54  |- mesh__recordMaintainer mesh__D015036 ADP
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015036 2002
% 221.34/221.54  |- skos__hiddenLabel mesh__D015036 Cement, Zinc Phosphate
% 221.34/221.54  |- mesh__dateRevised mesh__D015036 1997-06-20
% 221.34/221.54  |- rdf__type mesh__D015036sskos__Concept
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015036 2003
% 221.34/221.54  |- skos__broader mesh__D015036smesh__D003738
% 221.34/221.54  |- skos__scopeNote mesh__D015036
% 221.34/221.54       A material used for cementation of inlays, crowns, bridges, and orthodontic appliances and occasionally as a temporary restoration. It is prepared by mixing zinc oxide and magnesium oxide powders with a liquid consisting principally of phosphoric acid, water, and buffers. %28%From Bouchers%27% Clinical Dental Terminology, 3d ed%29%%A%    
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015036 1999
% 221.34/221.54  |- skos__prefLabel mesh__D015036 Zinc Phosphate Cement
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015036 2001
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015036 1998
% 221.34/221.54  |- mesh__dateEstablished mesh__D015036 1965-01-01
% 221.34/221.54  |- mesh__recordOriginator mesh__D015036 NLM
% 221.34/221.54  |- mesh__recordAuthorizer mesh__D015036 SJN
% 221.34/221.54  |- mesh__historyNote mesh__D015036 65   
% 221.34/221.54  |- skos__annotation mesh__D015036 a dent cement; D25-26 qualif   
% 221.34/221.54  |- mesh__publicMeSHNote mesh__D015036 65   
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015036 2000
% 221.34/221.54  |- mesh__dateCreated mesh__D015036 1999-01-01
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D015036 2006
% 221.34/221.54  |- skos__hiddenLabel mesh__D001814 Testis-Blood Barriers
% 221.34/221.54  |- mesh__dateCreated mesh__D001814 1974-11-11
% 221.34/221.54  |- mesh__recordAuthorizer mesh__D001814 sjn
% 221.34/221.54  |- rdf__type mesh__D001814sskos__Concept
% 221.34/221.54  |- skos__hiddenLabel mesh__D001814 Testis Blood Barrier
% 221.34/221.54  |- skos__hiddenLabel mesh__D001814 Barriers, Blood-Testis
% 221.34/221.54  |- mesh__recordOriginator mesh__D001814 NLM
% 221.34/221.54  |- skos__broader mesh__D001814smesh__D012671
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D001814 2005
% 221.34/221.54  |- skos__hiddenLabel mesh__D001814 Barrier, Blood-Testis
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D001814 2006
% 221.34/221.54  |- skos__related mesh__D001814smesh__D002199
% 221.34/221.54  |- skos__broader mesh__D001814smesh__D002319
% 221.34/221.54  |- skos__historyNote mesh__D001814 Testis %28%1966-1974%29%
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D001814 2004
% 221.34/221.54  |- mesh__dateEstablished mesh__D001814 1976-01-01
% 221.34/221.54  |- skos__prefLabel mesh__D001814 Blood-Testis Barrier
% 221.34/221.54  |- mesh__recordMaintainer mesh__D001814 nns
% 221.34/221.54  |- mesh__historyNote mesh__D001814
% 221.34/221.54       76%28%75%29%; was see under TESTIS 1975   
% 221.34/221.54  |- skos__hiddenLabel mesh__D001814 Barriers, Testis-Blood
% 221.34/221.54  |- mesh__publicMeSHNote mesh__D001814 76; was see under TESTIS 1975   
% 221.34/221.54  |- mesh__dateRevised mesh__D001814 2003-07-09
% 221.34/221.54  |- skos__hiddenLabel mesh__D001814 Barrier, Testis-Blood
% 221.34/221.54  |- skos__hiddenLabel mesh__D001814 Blood-Testis Barriers
% 221.34/221.54  |- skos__scopeNote mesh__D001814
% 221.34/221.54       A specialized barrier, in the TESTIS, between the interstitial BLOOD compartment and the adluminal compartment of the SEMINIFEROUS TUBULES. The barrier is formed by layers of cells from the VASCULAR ENDOTHELIUM of the capillary BLOOD VESSELS, to the SEMINIFEROUS EPITHELIUM of the seminiferous tubules. TIGHT JUNCTIONS form between adjacent SERTOLI CELLS, as well as between the ENDOTHELIAL CELLS.%A%    
% 221.34/221.54  |- skos__annotation mesh__D001814
% 221.34/221.54       coord IM with endogenous substance /metab %28%IM%29% or exogenous substance /pharmacokin %28%IM%29%%A%  
% 221.34/221.54  |- skos__altLabel mesh__D001814 Testis-Blood Barrier
% 221.34/221.54  |- skos__hiddenLabel mesh__D001814 Blood Testis Barrier
% 221.34/221.54  |- skos__hiddenLabel mesh__D001016 Vagale, Glomus
% 221.34/221.54  |- skos__annotation mesh__D001016 do not confuse with PARA-AORTIC BODIES   
% 221.34/221.54  |- skos__hiddenLabel mesh__D001016 Body, Vagal
% 221.34/221.54  |- skos__hiddenLabel mesh__D001016 Glomus, Aortic
% 221.34/221.54  |- skos__altLabel mesh__D001016 Glomus Vagale
% 221.34/221.54  |- skos__hiddenLabel mesh__D001016 Bodies, Vagal
% 221.34/221.54  |- skos__altLabel mesh__D001016 Vagal Body
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D001016 2006
% 221.34/221.54  |- rdf__type mesh__D001016sskos__Concept
% 221.34/221.54  |- skos__prefLabel mesh__D001016 Aortic Bodies
% 221.34/221.54  |- skos__hiddenLabel mesh__D001016 Aorticum, Glomus
% 221.34/221.54  |- mesh__historyNote mesh__D001016
% 221.34/221.54       91%28%75%29%; was see under PARAGANGLIA, NONCHROMAFFIN 1975-90   
% 221.34/221.54  |- skos__broader mesh__D001016smesh__D010234
% 221.34/221.54  |- skos__scopeNote mesh__D001016
% 221.34/221.54       Small clusters of chemoreceptive and supporting cells located near the ARCH OF THE AORTA; the PULMONARY ARTERIES; and the coronary arteries. The aortic bodies sense PH; CARBON DIOXIDE; and oxygen concentrations in the BLOOD and participate in the control of RESPIRATION. The aortic bodies should not be confused with the PARA-AORTIC BODIES in the abdomen %28%which are sometimes also called aortic bodies%29%.%A%    
% 221.34/221.54  |- mesh__activeMeSHYear mesh__D001016 2005
% 221.34/221.54  |- mesh__dateEstablished mesh__D001016 1991-01-01
% 221.34/221.54  |- skos__hiddenLabel mesh__D001016 Body, Aortic
% 221.34/221.54  |- mesh__recordAuthorizer mesh__D001016 sjn
% 221.34/221.54  |- mesh__dateRevised mesh__D001016 2004-07-07
% 221.34/221.54  |- skos__altLabel mesh__D001016 Aortic Glomus
% 221.34/221.54  |- mesh__dateCreated mesh__D001016 1999-01-01
% 221.34/221.54  |- skos__hiddenLabel mesh__D001016 Vagal Bodies
% 221.34/221.54  |- skos__altLabel mesh__D001016 Glomus Aorticum
% 221.34/221.54  |- skos__hiddenLabel mesh__D001016 Aortic Body
% 221.34/221.54  |- skos__hiddenLabel mesh__D001016 Bodies, Aortic
% 221.34/221.55  |- mesh__publicMeSHNote mesh__D001016
% 221.34/221.55       91; was see under PARAGANGLIA, NONCHROMAFFIN 1975-90   
% 221.34/221.55  |- mesh__recordMaintainer mesh__D001016 ags
% 221.34/221.55  |- mesh__onlineNote mesh__D001016
% 221.34/221.55       search PARAGANGLIA, NONCHROMAFFIN 1966-74   
% 221.34/221.55  |- mesh__recordOriginator mesh__D001016 NLM
% 221.34/221.55  |- skos__historyNote mesh__D020779 Cranial Sinuses %28%1971-1999%29%
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D020779 2002
% 221.34/221.55  |- skos__historyNote mesh__D020779 Hemangioma %28%1971-1999%29%
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D020779 2004
% 221.34/221.55  |- rdf__type mesh__D020779sskos__Concept
% 221.34/221.55  |- skos__broader mesh__D020779smesh__D020785
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D020779 2001
% 221.34/221.55  |- mesh__dateCreated mesh__D020779 1999-11-03
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D020779 2006
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D020779 2003
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D020779 2000
% 221.34/221.55  |- skos__prefLabel mesh__D020779 Sinus Pericranii
% 221.34/221.55  |- mesh__publicMeSHNote mesh__D020779 2000   
% 221.34/221.55  |- mesh__dateEstablished mesh__D020779 2000-01-01
% 221.34/221.55  |- skos__scopeNote mesh__D020779
% 221.34/221.55       Rare vascular anomaly involving an abnormal communication between the extracranial and intracranial circulations involving the venous dura sinuses. It is often present in childhood and can be congenital or traumatic in origin.%A%    
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D020779 2005
% 221.34/221.55  |- mesh__historyNote mesh__D020779 2000   
% 221.34/221.55  |- skos__historyNote mesh__D019427
% 221.34/221.55       DNA Nucleotidyltransferases %28%1993-1996%29%
% 221.34/221.55  |- mesh__dateEstablished mesh__D019427 1997-01-01
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D019427 2005
% 221.34/221.55  |- rdf__type mesh__D019427sskos__Concept
% 221.34/221.55  |- skos__hiddenLabel mesh__D019427 Integration Protein, HIV
% 221.34/221.55  |- skos__altLabel mesh__D019427 HIV Integration Protein
% 221.34/221.55  |- skos__broader mesh__D019427smesh__D019895
% 221.34/221.55  |- mesh__publicMeSHNote mesh__D019427
% 221.34/221.55       97; HIV INTEGRASE was indexed under DNA NUCLEOTIDYLTRANSFERASES 1993-96%A%  
% 221.34/221.55  |- skos__hiddenLabel mesh__D019427 HIV 2 Integrase
% 221.34/221.55  |- skos__broader mesh__D019427smesh__D015684
% 221.34/221.55  |- skos__hiddenLabel mesh__D019427 Integrase, HIV-1
% 221.34/221.55  |- skos__prefLabel mesh__D019427 HIV Integrase
% 221.34/221.55  |- mesh__historyNote mesh__D019427
% 221.34/221.55       97; HIV INTEGRASE was SY to INTEGRASE %28%NM%29% 1993-96   
% 221.34/221.55  |- mesh__dateRevised mesh__D019427 2004-07-13
% 221.34/221.55  |- skos__scopeNote mesh__D019427
% 221.34/221.55       Enzyme of the HUMAN IMMUNODEFICIENCY VIRUS that is required to integrate viral DNA into cellular DNA in the nucleus of a host cell. HIV integrase is a DNA nucleotidyltransferase encoded by the pol gene.%A%    
% 221.34/221.55  |- mesh__dateCreated mesh__D019427 1996-06-13
% 221.34/221.55  |- skos__hiddenLabel mesh__D019427 Integrase, HIV
% 221.34/221.55  |- skos__hiddenLabel mesh__D019427 HIV 1 Integrase
% 221.34/221.55  |- mesh__recordOriginator mesh__D019427 AGS
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D019427 2006
% 221.34/221.55  |- mesh__onlineNote mesh__D019427
% 221.34/221.55       use INTEGRASE %28%NM%29% to search HIV INTEGRASE 1993-96   
% 221.34/221.55  |- mesh__recordMaintainer mesh__D019427 sjn
% 221.34/221.55  |- skos__hiddenLabel mesh__D019427 Integrase, HIV-2
% 221.34/221.55  |- mesh__recordAuthorizer mesh__D019427 sjn
% 221.34/221.55  |- skos__annotation mesh__D011444
% 221.34/221.55       specify geog; DF: note short X ref      CATALOG: use NAF entry%A%  
% 221.34/221.55  |- skos__broader mesh__D011444smesh__D011445
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D011444 2003
% 221.34/221.55  |- skos__prefLabel mesh__D011444 Prospective Payment Assessment Commission
% 221.34/221.55  |- mesh__publicMeSHNote mesh__D011444
% 221.34/221.55       91; was see under PROSPECTIVE PAYMENT SYSTEM 1987-90   
% 221.34/221.55  |- skos__historyNote mesh__D011444 Prospective Payment System %28%1986%29%
% 221.34/221.55  |- mesh__recordOriginator mesh__D011444 EC
% 221.34/221.55  |- mesh__historyNote mesh__D011444
% 221.34/221.55       91%28%87%29%; was see under PROSPECTIVE PAYMENT SYSTEM 1987-90   
% 221.34/221.55  |- mesh__dateEstablished mesh__D011444 1991-01-01
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D011444 2002
% 221.34/221.55  |- mesh__dateRevised mesh__D011444 1999-11-09
% 221.34/221.55  |- skos__related mesh__D011444smesh__D020406
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D011444 2006
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D011444 2001
% 221.34/221.55  |- mesh__dateCreated mesh__D011444 1986-05-30
% 221.34/221.55  |- mesh__recordAuthorizer mesh__D011444 sjn
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D011444 2005
% 221.34/221.55  |- mesh__recordMaintainer mesh__D011444 jls
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D011444 2000
% 221.34/221.55  |- skos__altLabel mesh__D011444 PROPAC
% 221.34/221.55  |- rdf__type mesh__D011444sskos__Concept
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D011444 2004
% 221.34/221.55  |- skos__scopeNote mesh__D011444
% 221.34/221.55       The commission charged with evaluating issues and factors which affect the implementation of the PROSPECTIVE PAYMENT SYSTEM.%A%    
% 221.34/221.55  |- mesh__recordAuthorizer mesh__D005407 sjn
% 221.34/221.55  |- rdf__type mesh__D005407sskos__Concept
% 221.34/221.55  |- skos__prefLabel mesh__D005407 Flagella
% 221.34/221.55  |- mesh__recordMaintainer mesh__D005407 ags
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D005407 2004
% 221.34/221.55  |- mesh__historyNote mesh__D005407 65%28%64%29%   
% 221.34/221.55  |- mesh__recordOriginator mesh__D005407 NLM
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D005407 2003
% 221.34/221.55  |- skos__annotation mesh__D005407
% 221.34/221.55       do not confuse with FLAGELLATA see MASTIGOPHORA, a subphylum of protozoa%A%  
% 221.34/221.55  |- mesh__publicMeSHNote mesh__D005407 65   
% 221.34/221.55  |- skos__broader mesh__D005407smesh__D022081
% 221.34/221.55  |- mesh__dateRevised mesh__D005407 2001-07-25
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D005407 2002
% 221.34/221.55  |- skos__scopeNote mesh__D005407
% 221.34/221.55       A whiplike motility appendage present on the surface cells. Prokaryote flagella are composed of a protein called FLAGELLIN. Bacteria can have a single flagellum, a tuft at one pole, or multiple flagella covering the entire surface. In eukaryotes, flagella are threadlike protoplasmic extensions used to propel flagellates and sperm. Flagella have the same basic structure as CILIA but are longer in proportion to the cell bearing them and present in much smaller numbers. %28%From King %26% Stansfield, A Dictionary of Genetics, 4th ed%29%%A%    
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D005407 2006
% 221.34/221.55  |- mesh__dateEstablished mesh__D005407 1965-01-01
% 221.34/221.55  |- skos__altLabel mesh__D005407 Flagellum
% 221.34/221.55  |- mesh__dateCreated mesh__D005407 1999-01-01
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D005407 2005
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Smooth Pursuit Deficiencies
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Insufficiency, Convergence
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Deviations, Skew
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Ophthalmoplegias, Internuclear
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Conjugate Gaze Spasms
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Ocular Dyskinesia, Paroxysmal
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015835 2002
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Dyskinesia, Paroxysmal Ocular
% 221.34/221.55  |- rdf__type mesh__D015835sskos__Concept
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015835 2004
% 221.34/221.55  |- mesh__dateRevised mesh__D015835 1999-12-08
% 221.34/221.55  |- skos__altLabel mesh__D015835 Brown%27%s Tendon Sheath Syndrome
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Convergence Excesses
% 221.34/221.55  |- skos__historyNote mesh__D015835 specific eye disease %28%1966-1989%29%
% 221.34/221.55  |- skos__altLabel mesh__D015835 Parinaud%27%s Syndrome
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Deficiencies, Smooth Pursuit
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Pseudoophthalmoplegias
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Pursuit Deficiency, Smooth
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Cyclophorias
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Parinauds Syndrome
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Excess, Convergence
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015835 2000A
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Internuclear Ophthalmoplegias
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015835 2005
% 221.34/221.55  |- skos__altLabel mesh__D015835 Syndrome, Brown%27%s Tendon Sheath
% 221.34/221.55  |- skos__scopeNote mesh__D015835
% 221.34/221.55       Disorders that feature impairment of eye movements as a primary manifestation of disease. These conditions may be divided into infranuclear, nuclear, and supranuclear disorders. Diseases of the eye muscles or oculomotor cranial nerves %28%III, IV, and VI%29% are considered infranuclear. Nuclear disorders are caused by disease of the oculomotor, trochlear, or abducens nuclei in the BRAIN STEM. Supranuclear disorders are produced by dysfunction of higher order sensory and motor systems that control eye movements, including neural networks in the CEREBRAL CORTEX; BASAL GANGLIA; CEREBELLUM; and BRAIN STEM. Ocular torticollis refers to a head tilt that is caused by an ocular misalignment. Opsoclonus refers to rapid, conjugate oscillations of the eyes in multiple directions, which may occur as a parainfectious or paraneoplastic condition %28%e.g., OPSOCLONUS-MYOCLONUS SYNDROME%29%. %28%Adams et al., Principles of Neurology, 6th ed, p240%29%%A%    
% 221.34/221.55  |- skos__altLabel mesh__D015835 Eye Motility Disorders
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Pursuit Deficiencies, Smooth
% 221.34/221.55  |- mesh__dateEstablished mesh__D015835 1990-01-01
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Syndrome, Parinaud
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Deviation, Skew
% 221.34/221.55  |- mesh__recordOriginator mesh__D015835 EGC
% 221.34/221.55  |- skos__prefLabel mesh__D015835 Ocular Motility Disorders
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015835 2006
% 221.34/221.55  |- skos__broader mesh__D015835smesh__D005128
% 221.34/221.55  |- mesh__recordMaintainer mesh__D015835 ags
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Paroxysmal Ocular Dyskinesias
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015835 2000
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Ocular Motility Disorder
% 221.34/221.55  |- skos__altLabel mesh__D015835 Eye Movement Disorders
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Ophthalmoplegia, Internuclear
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Convergence Insufficiencies
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Dyskinesias, Paroxysmal Ocular
% 221.34/221.55  |- skos__broader mesh__D015835smesh__D003389
% 221.34/221.55  |- skos__historyNote mesh__D015835 Ophthalmoplegia %28%1966-1989%29%
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Syndrome, Parinaud%27%s
% 221.34/221.55  |- skos__altLabel mesh__D015835 Tendon Sheath Syndrome of Brown
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Ocular Dyskinesias, Paroxysmal
% 221.34/221.55  |- skos__altLabel mesh__D015835 Deficiency, Smooth Pursuit
% 221.34/221.55  |- mesh__publicMeSHNote mesh__D015835 1990   
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Insufficiencies, Convergence
% 221.34/221.55  |- mesh__dateCreated mesh__D015835 1989-05-25
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015835 2001
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Eye Movement Disorder
% 221.34/221.55  |- mesh__recordAuthorizer mesh__D015835 ags
% 221.34/221.55  |- skos__annotation mesh__D015835 GEN: prefer specifics   
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Eye Motility Disorder
% 221.34/221.55  |- mesh__historyNote mesh__D015835 1990   
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015835 2003
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Skew Deviations
% 221.34/221.55  |- skos__broader mesh__D015835smesh__D002493
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Conjugate Gaze Spasm
% 221.34/221.55  |- skos__hiddenLabel mesh__D015835 Gaze Spasms, Conjugate
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015037 1995
% 221.34/221.55  |- mesh__recordOriginator mesh__D015037 NLM
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015037 2004
% 221.34/221.55  |- mesh__dateCreated mesh__D015037 1974-11-11
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015037 2002
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015037 1998
% 221.34/221.55  |- rdf__type mesh__D015037sskos__Concept
% 221.34/221.55  |- mesh__dateRevised mesh__D015037 1993-06-03
% 221.34/221.55  |- mesh__recordMaintainer mesh__D015037 TPW
% 221.34/221.55  |- skos__broader mesh__D015037smesh__D011868
% 221.34/221.55  |- skos__scopeNote mesh__D015037
% 221.34/221.55       Unstable isotopes of zinc that decay or disintegrate emitting radiation. Zn atoms with atomic weights 60-63, 65, 69, 71, and 72 are radioactive zinc isotopes.%A%    
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015037 1999
% 221.34/221.55  |- mesh__dateEstablished mesh__D015037 1975-09-01
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015037 1996
% 221.34/221.55  |- skos__hiddenLabel mesh__D015037 Radioisotopes, Zinc
% 221.34/221.55  |- mesh__recordAuthorizer mesh__D015037 PLS
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015037 1997
% 221.34/221.55  |- mesh__publicMeSHNote mesh__D015037 75   
% 221.34/221.55  |- skos__prefLabel mesh__D015037 Zinc Radioisotopes
% 221.34/221.55  |- skos__historyNote mesh__D015037 Zinc Isotopes %28%1966-1974%29%
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015037 2005
% 221.34/221.55  |- mesh__onlineNote mesh__D015037 search ZINC ISOTOPES 1966-74   
% 221.34/221.55  |- skos__historyNote mesh__D015037 Radioisotopes %28%1966-1974%29%
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015037 2000
% 221.34/221.55  |- skos__broader mesh__D015037smesh__D015033
% 221.34/221.55  |- skos__annotation mesh__D015037
% 221.34/221.55       Zn-60-63, 65, 69, 71, 72; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015037 1994
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015037 2006
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015037 2003
% 221.34/221.55  |- mesh__historyNote mesh__D015037 75   
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015037 2001
% 221.34/221.55  |- skos__prefLabel mesh__D001815 Bloodletting
% 221.34/221.55  |- mesh__dateRevised mesh__D001815 2001-07-25
% 221.34/221.55  |- skos__broader mesh__D001815smesh__D018962
% 221.34/221.55  |- skos__annotation mesh__D001815
% 221.34/221.55       restrict to hist articles or hist contexts: modern counterpart is PHLEBOTOMY%A%  
% 221.34/221.55  |- mesh__dateCreated mesh__D001815 1999-01-01
% 221.34/221.55  |- rdf__type mesh__D001815sskos__Concept
% 221.34/221.55  |- mesh__recordAuthorizer mesh__D001815 sjn
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D001815 2004
% 221.34/221.55  |- mesh__recordOriginator mesh__D001815 NLM
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D001815 2006
% 221.34/221.55  |- skos__related mesh__D001815smesh__D018962
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D001815 2003
% 221.34/221.55  |- skos__scopeNote mesh__D001815
% 221.34/221.55       Puncture of a vein to draw blood for therapeutic purposes. Bloodletting therapy has been used in Talmudic and Indian medicine since the medieval time, and was still practiced widely in the 18th and 19th centuries. Its modern counterpart is PHLEBOTOMY.%A%    
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D001815 2002
% 221.34/221.55  |- mesh__recordMaintainer mesh__D001815 lkt
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D001815 2005
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D001017 2005
% 221.34/221.55  |- skos__hiddenLabel mesh__D001017 Aortic Coarctations
% 221.34/221.55  |- skos__scopeNote mesh__D001017
% 221.34/221.55       Narrowing of the lumen of the aorta, caused by deformity of the aortic media.%A%    
% 221.34/221.55  |- mesh__dateRevised mesh__D001017 1999-11-03
% 221.34/221.55  |- mesh__recordMaintainer mesh__D001017 kle
% 221.34/221.55  |- skos__hiddenLabel mesh__D001017 Coarctation, Aortic
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D001017 2001
% 221.34/221.55  |- mesh__dateCreated mesh__D001017 1999-01-01
% 221.34/221.55  |- mesh__recordOriginator mesh__D001017 NLM
% 221.34/221.55  |- skos__annotation mesh__D001017
% 221.34/221.55       narrowing of the aorta lumen; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D001017 2004
% 221.34/221.55  |- skos__prefLabel mesh__D001017 Aortic Coarctation
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D001017 2000
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D001017 2003
% 221.34/221.55  |- skos__hiddenLabel mesh__D001017 Coarctations, Aortic
% 221.34/221.55  |- skos__broader mesh__D001017smesh__D006330
% 221.34/221.55  |- mesh__recordAuthorizer mesh__D001017 sjn
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D001017 2006
% 221.34/221.55  |- rdf__type mesh__D001017sskos__Concept
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D001017 2002
% 221.34/221.55  |- skos__hiddenLabel mesh__D006500 Duct, Hepatic
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D006500 2004
% 221.34/221.55  |- skos__hiddenLabel mesh__D006500 Ducts, Hepatic
% 221.34/221.55  |- mesh__historyNote mesh__D006500 80; was HEPATIC DUCT 1963-79   
% 221.34/221.55  |- skos__prefLabel mesh__D006500 Hepatic Duct, Common
% 221.34/221.55  |- mesh__dateRevised mesh__D006500 2003-07-25
% 221.34/221.55  |- skos__hiddenLabel mesh__D006500 Common Hepatic Ducts
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D006500 2006
% 221.34/221.55  |- mesh__recordOriginator mesh__D006500 NLM
% 221.34/221.55  |- skos__annotation mesh__D006500
% 221.34/221.55       an external bile duct formed by junction of right %26% left hepatic ducts; diseases: coord IM with BILE DUCT DISEASES %28%IM%29%; neopl: coord IM with BILE DUCT NEOPLASMS %28%IM%29%; inflammation: coord IM with CHOLANGITIS %28%IM%29%; obstruct: coord IM with CHOLESTASIS, EXTRAHEPATIC %28%IM%29%; calculi: coord %28%IM%29% with CHOLELITHIASIS %28%IM%29%%A%  
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D006500 2005
% 221.34/221.55  |- mesh__recordAuthorizer mesh__D006500 sjn
% 221.34/221.55  |- mesh__onlineNote mesh__D006500
% 221.34/221.55       use HEPATIC DUCT, COMMON to search HEPATIC DUCT 1966-79   
% 221.34/221.55  |- mesh__recordMaintainer mesh__D006500 sjn
% 221.34/221.55  |- skos__hiddenLabel mesh__D006500 Duct, Common Hepatic
% 221.34/221.55  |- skos__scopeNote mesh__D006500
% 221.34/221.55       Predominantly extrahepatic bile duct which is formed by the junction of the right and left hepatic ducts, which are predominantly intrahepatic, and, in turn, joins the cystic duct to form the common bile duct.%A%    
% 221.34/221.55  |- mesh__publicMeSHNote mesh__D006500 80; was HEPATIC DUCT 1963-79   
% 221.34/221.55  |- skos__altLabel mesh__D006500 Common Hepatic Duct
% 221.34/221.55  |- rdf__type mesh__D006500sskos__Concept
% 221.34/221.55  |- mesh__dateCreated mesh__D006500 1999-01-01
% 221.34/221.55  |- skos__hiddenLabel mesh__D006500 Ducts, Common Hepatic
% 221.34/221.55  |- skos__broader mesh__D006500smesh__D017734
% 221.34/221.55  |- skos__hiddenLabel mesh__D006500 Hepatic Ducts, Common
% 221.34/221.55  |- skos__hiddenLabel mesh__D006500 Hepatic Ducts
% 221.34/221.55  |- mesh__recordOriginator mesh__D019428 AGS
% 221.34/221.55  |- mesh__publicMeSHNote mesh__D019428 97   
% 221.34/221.55  |- skos__broader mesh__D019428smesh__D019380
% 221.34/221.55  |- mesh__dateCreated mesh__D019428 1996-06-10
% 221.34/221.55  |- skos__annotation mesh__D019428 DF: HIV INTEGRASE INHIB   
% 221.34/221.55  |- mesh__recordAuthorizer mesh__D019428 sjn
% 221.34/221.55  |- mesh__dateEstablished mesh__D019428 1997-01-01
% 221.34/221.55  |- mesh__dateRevised mesh__D019428 2005-06-30
% 221.34/221.55  |- skos__scopeNote mesh__D019428
% 221.34/221.55       Inhibitors of HIV INTEGRASE, an enzyme required for integration of viral DNA into cellular DNA.%A%    
% 221.34/221.55  |- skos__broader mesh__D019428smesh__D019429
% 221.34/221.55  |- skos__historyNote mesh__D019428
% 221.34/221.55       DNA Nucleotidyltransferases/antagonists %26% inhibitors %28%1994-1996%29%
% 221.34/221.55  |- skos__historyNote mesh__D019428 Antiviral Agents %28%1994-1996%29%
% 221.34/221.55  |- skos__prefLabel mesh__D019428 HIV Integrase Inhibitors
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D019428 2006
% 221.34/221.55  |- skos__altLabel mesh__D019428 Integrase Inhibitors, HIV
% 221.34/221.55  |- skos__hiddenLabel mesh__D019428 Inhibitors, HIV Integrase
% 221.34/221.55  |- rdf__type mesh__D019428sskos__Concept
% 221.34/221.55  |- mesh__recordMaintainer mesh__D019428 ssb
% 221.34/221.55  |- mesh__historyNote mesh__D019428 97   
% 221.34/221.55  |- mesh__dateRevised mesh__D011445 1999-11-03
% 221.34/221.55  |- skos__hiddenLabel mesh__D011445 Discretionary Adjustments
% 221.34/221.55  |- skos__hiddenLabel mesh__D011445 Reimbursements, Prospective
% 221.34/221.55  |- skos__broader mesh__D011445smesh__D012051
% 221.34/221.55  |- skos__hiddenLabel mesh__D011445 Payment Systems, Prospective
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D011445 2006
% 221.34/221.55  |- skos__prefLabel mesh__D011445 Prospective Payment System
% 221.34/221.55  |- skos__annotation mesh__D011445 specify geog   
% 221.34/221.55  |- skos__scopeNote mesh__D011445
% 221.34/221.55       A system wherein reimbursement rates are set, for a given period of time, prior to the circumstances giving rise to actual reimbursement claims.%A%    
% 221.34/221.55  |- skos__hiddenLabel mesh__D011445 Pricing, Prospective
% 221.34/221.55  |- skos__hiddenLabel mesh__D011445 Discretionary Adjustment Factors
% 221.34/221.55  |- mesh__recordOriginator mesh__D011445 EC
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D011445 2005
% 221.34/221.55  |- skos__hiddenLabel mesh__D011445 Adjustments, Discretionary
% 221.34/221.55  |- rdf__type mesh__D011445sskos__Concept
% 221.34/221.55  |- skos__hiddenLabel mesh__D011445 Adjustment Factors, Discretionary
% 221.34/221.55  |- mesh__dateEstablished mesh__D011445 1987-01-01
% 221.34/221.55  |- mesh__publicMeSHNote mesh__D011445
% 221.34/221.55       87; was see under REIMBURSEMENT MECHANISMS 1986; was REIMBURSEMENT, PROSPECTIVE see under REIMBURSEMENT MECHANISMS 1979-85%A%  
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D011445 2002
% 221.34/221.55  |- skos__hiddenLabel mesh__D011445 Prospective Reimbursements
% 221.34/221.55  |- skos__hiddenLabel mesh__D011445 Payment System, Prospective
% 221.34/221.55  |- skos__hiddenLabel mesh__D011445 Prospective Payment Systems
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D011445 2004
% 221.34/221.55  |- skos__hiddenLabel mesh__D011445 Adjustment Factor, Discretionary
% 221.34/221.55  |- mesh__dateCreated mesh__D011445 1978-05-10
% 221.34/221.55  |- mesh__recordMaintainer mesh__D011445 kle
% 221.34/221.55  |- skos__altLabel mesh__D011445 Reimbursement, Prospective
% 221.34/221.55  |- skos__hiddenLabel mesh__D011445 Factors, Discretionary Adjustment
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D011445 2001
% 221.34/221.55  |- skos__hiddenLabel mesh__D011445 Discretionary Adjustment
% 221.34/221.55  |- skos__hiddenLabel mesh__D011445 System, Prospective Payment
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D011445 2003
% 221.34/221.55  |- mesh__historyNote mesh__D011445
% 221.34/221.55       87%28%86%29%; was see under REIMBURSEMENT MECHANISMS 1986; was REIMBURSEMENT, PROSPECTIVE see under REIMBURSEMENT MECHANISMS 1979-85%A%  
% 221.34/221.55  |- mesh__recordAuthorizer mesh__D011445 sjn
% 221.34/221.55  |- mesh__onlineNote mesh__D011445
% 221.34/221.55       use PROSPECTIVE PAYMENT SYSTEM to search REIMBURSEMENT, PROSPECTIVE 1979-85%A%  
% 221.34/221.55  |- skos__hiddenLabel mesh__D011445 Systems, Prospective Payment
% 221.34/221.55  |- skos__hiddenLabel mesh__D011445 Factor, Discretionary Adjustment
% 221.34/221.55  |- skos__altLabel mesh__D011445 Prospective Reimbursement
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D011445 2000
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D005408 2004
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D005408 1997
% 221.34/221.55  |- mesh__recordMaintainer mesh__D005408 KEV
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D005408 2001
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D005408 2003
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D005408 1996
% 221.34/221.55  |- mesh__publicMeSHNote mesh__D005408
% 221.34/221.55       91; was see under BACTERIAL PROTEINS 1975-90   
% 221.34/221.55  |- mesh__dateCreated mesh__D005408 1974-11-19
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D005408 2000
% 221.34/221.55  |- mesh__historyNote mesh__D005408
% 221.34/221.55       91%28%75%29%; was see under BACTERIAL PROTEINS 1975-90   
% 221.34/221.55  |- mesh__dateRevised mesh__D005408 1995-05-19
% 221.34/221.55  |- skos__annotation mesh__D005408 a bact protein   
% 221.34/221.55  |- skos__historyNote mesh__D005408 Bacterial Proteins %28%1972-1974%29%
% 221.34/221.55  |- skos__prefLabel mesh__D005408 Flagellin
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D005408 2006
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D005408 1999
% 221.34/221.55  |- mesh__recordOriginator mesh__D005408 NLM
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D005408 2005
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D005408 1998
% 221.34/221.55  |- mesh__recordAuthorizer mesh__D005408 PLS
% 221.34/221.55  |- skos__scopeNote mesh__D005408
% 221.34/221.55       A protein with a molecular weight of 40,000 isolated from bacterial flagella. At appropriate pH and salt concentration, three flagellin monomers can spontaneously reaggregate to form structures which appear identical to intact flagella.%A%    
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D005408 2002
% 221.34/221.55  |- mesh__dateEstablished mesh__D005408 1991-01-01
% 221.34/221.55  |- rdf__type mesh__D005408sskos__Concept
% 221.34/221.55  |- skos__broader mesh__D005408smesh__D001426
% 221.34/221.55  |- mesh__dateRevised mesh__D016130 1993-06-02
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D016130 1995
% 221.34/221.55  |- mesh__historyNote mesh__D016130 91   
% 221.34/221.55  |- skos__hiddenLabel mesh__D016130 Lymphocyte Immunophenotypings
% 221.34/221.55  |- skos__altLabel mesh__D016130 Immunologic Subtyping
% 221.34/221.55  |- skos__hiddenLabel mesh__D016130 Immunophenotyping, Lymphocyte
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D016130 1998
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D016130 2000
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D016130 2005
% 221.34/221.55  |- skos__hiddenLabel mesh__D016130 Subtypings, Lymphocyte
% 221.34/221.55  |- skos__broader mesh__D016130smesh__D007158
% 221.34/221.55  |- skos__hiddenLabel mesh__D016130 Immunophenotypings, Lymphocyte
% 221.34/221.55  |- mesh__recordOriginator mesh__D016130 AGS
% 221.34/221.55  |- skos__prefLabel mesh__D016130 Immunophenotyping
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D016130 1999
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D016130 2006
% 221.34/221.55  |- skos__hiddenLabel mesh__D016130 Lymphocyte Subtypings
% 221.34/221.55  |- skos__hiddenLabel mesh__D016130 Immunophenotypings
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D016130 2001
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D016130 1996
% 221.34/221.55  |- skos__hiddenLabel mesh__D016130 Subtyping, Lymphocyte
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D016130 2003
% 221.34/221.55  |- skos__historyNote mesh__D016130 Phenotype %28%1979-1990%29%
% 221.34/221.55  |- mesh__dateCreated mesh__D016130 1990-03-23
% 221.34/221.55  |- rdf__type mesh__D016130sskos__Concept
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D016130 1997
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D016130 2004
% 221.34/221.55  |- mesh__dateEstablished mesh__D016130 1991-01-01
% 221.34/221.55  |- mesh__recordAuthorizer mesh__D016130 PLS
% 221.34/221.55  |- skos__scopeNote mesh__D016130
% 221.34/221.55       Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry.%A%    
% 221.34/221.55  |- skos__altLabel mesh__D016130 Subtypings, Immunologic
% 221.34/221.55  |- skos__altLabel mesh__D016130 Subtyping, Immunologic
% 221.34/221.55  |- skos__altLabel mesh__D016130 Immunologic Subtypings
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D016130 2002
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D016130 1994
% 221.34/221.55  |- mesh__publicMeSHNote mesh__D016130 91   
% 221.34/221.55  |- mesh__recordMaintainer mesh__D016130 TGC
% 221.34/221.55  |- mesh__dateRevised mesh__D002110 2005-06-30
% 221.34/221.55  |- mesh__recordMaintainer mesh__D002110 lkw
% 221.34/221.55  |- skos__altLabel mesh__D002110 Thompson Brand 1 of Caffeine
% 221.34/221.55  |- skos__altLabel mesh__D002110 Berlin-Chemie Brand of Caffeine
% 221.34/221.55  |- mesh__recordAuthorizer mesh__D002110 sjn
% 221.34/221.55  |- skos__altLabel mesh__D002110 Bristol-Myers Squibb Brand of Caffeine
% 221.34/221.55  |- skos__altLabel mesh__D002110 1,3,7-Trimethylxanthine
% 221.34/221.55  |- skos__altLabel mesh__D002110 Republic Drug Brand of Caffeine
% 221.34/221.55  |- skos__altLabel mesh__D002110 Passauer Brand of Caffeine
% 221.34/221.55  |- rdf__type mesh__D002110sskos__Concept
% 221.34/221.55  |- skos__altLabel mesh__D002110 Pierre Fabre Brand of Caffeine
% 221.34/221.55  |- skos__scopeNote mesh__D002110
% 221.34/221.55       A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine%27%s most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes smooth muscle, stimulates cardiac muscle, stimulates diuresis, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide phosphodiesterases, antagonism of adenosine receptors, and modulation of intracellular calcium handling.%A%    
% 221.34/221.55  |- mesh__recordOriginator mesh__D002110 NLM
% 221.34/221.55  |- skos__altLabel mesh__D002110 GlaxoSmithKline Brand of Caffeine
% 221.34/221.55  |- skos__prefLabel mesh__D002110 Caffeine
% 221.34/221.55  |- skos__altLabel mesh__D002110 Thompson Brand 2 of Caffeine
% 221.34/221.55  |- skos__altLabel mesh__D002110 Merck dura Brand of Caffeine
% 221.34/221.55  |- skos__broader mesh__D002110smesh__D014970
% 221.34/221.55  |- mesh__dateCreated mesh__D002110 1999-01-01
% 221.34/221.55  |- skos__altLabel mesh__D002110 Seid Brand of Caffeine
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D002110 2006
% 221.34/221.55  |- rdf__type mesh__D015038sskos__Concept
% 221.34/221.55  |- skos__hiddenLabel mesh__D015038 Dithane Z78
% 221.34/221.55  |- mesh__recordAuthorizer mesh__D015038 sjn
% 221.34/221.55  |- mesh__dateEstablished mesh__D015038 1991-01-01
% 221.34/221.55  |- skos__historyNote mesh__D015038 Zinc %28%1966-1971%29%
% 221.34/221.55  |- mesh__publicMeSHNote mesh__D015038
% 221.34/221.55       91; was see under THIOCARBAMATES 1972-90   
% 221.34/221.55  |- mesh__recordMaintainer mesh__D015038 sjn
% 221.34/221.55  |- skos__historyNote mesh__D015038 Pesticides %28%1966-1971%29%
% 221.34/221.55  |- mesh__historyNote mesh__D015038
% 221.34/221.55       91%28%72%29%; was see under THIOCARBAMATES 1972-90   
% 221.34/221.55  |- skos__broader mesh__D015038smesh__D005028
% 221.34/221.55  |- mesh__recordOriginator mesh__D015038 NLM
% 221.34/221.55  |- mesh__dateCreated mesh__D015038 1999-01-01
% 221.34/221.55  |- skos__prefLabel mesh__D015038 Zineb
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015038 2005
% 221.34/221.55  |- skos__broader mesh__D015038smesh__D009942
% 221.34/221.55  |- skos__altLabel mesh__D015038 Zinc Ethylenebis%28%dithiocarbamate%29%
% 221.34/221.55  |- skos__hiddenLabel mesh__D015038 Dithane Z 78
% 221.34/221.55  |- mesh__activeMeSHYear mesh__D015038 2006
% 221.34/221.55  |- skos__historyNote mesh__D015038 Thiocarbamates %28%1966-1971%29%
% 221.34/221.55  |- mesh__dateRevised mesh__D015038 2004-07-13
% 221.34/221.55  |- skos__historyNote mesh__D015038 Antifungal Agents %28%1966-1971%29%
% 221.34/221.55  |- skos__scopeNote mesh__D015038
% 221.34/221.55       An agricultural fungicide of the dithiocarbamate class. It has relatively low toxicity and there is little evidence of human injury from exposure.%A%    
% 221.34/221.55  |- skos__prefLabel mesh__D001816 Bloom Syndrome
% 221.34/221.55  |- skos__historyNote mesh__D001816
% 221.34/221.55       Abnormalities, Multiple %28%1968-1981%29%
% 221.34/221.56  |- skos__altLabel mesh__D001816 Bloom-Torre-Machacek Syndrome
% 221.34/221.56  |- skos__scopeNote mesh__D001816
% 221.34/221.56       An autosomal recessive disorder characterized by telangiectatic ERYTHEMA of the face, photosensitivity, DWARFISM and other abnormalities, and a predisposition toward developing cancer. The Bloom syndrome gene %28%BLM%29% encodes a RecQ-like DNA helicase.%A%    
% 221.34/221.56  |- skos__historyNote mesh__D001816 Telangiectasis %28%1966-1981%29%
% 221.34/221.56  |- rdf__type mesh__D001816sskos__Concept
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001816 2006
% 221.34/221.56  |- mesh__recordMaintainer mesh__D001816 nns
% 221.34/221.56  |- skos__hiddenLabel mesh__D001816 Syndrome, Bloom-Torre-Machacek
% 221.34/221.56  |- skos__hiddenLabel mesh__D001816 Syndrome, Bloom
% 221.34/221.56  |- mesh__dateRevised mesh__D001816 2005-06-30
% 221.34/221.56  |- skos__broader mesh__D001816smesh__D049914
% 221.34/221.56  |- mesh__recordAuthorizer mesh__D001816 sjn
% 221.34/221.56  |- mesh__historyNote mesh__D001816 82   
% 221.34/221.56  |- skos__hiddenLabel mesh__D001816 Bloom Torre Machacek Syndrome
% 221.34/221.56  |- skos__historyNote mesh__D001816 Dwarfism %28%1966-1981%29%
% 221.34/221.56  |- mesh__recordOriginator mesh__D001816 AEP
% 221.34/221.56  |- mesh__dateEstablished mesh__D001816 1982-01-01
% 221.34/221.56  |- mesh__dateCreated mesh__D001816 1981-02-23
% 221.34/221.56  |- skos__broader mesh__D001816smesh__D000015
% 221.34/221.56  |- skos__historyNote mesh__D001816 Facial Dermatoses %28%1966-1981%29%
% 221.34/221.56  |- mesh__publicMeSHNote mesh__D001816 82   
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001018 1998
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001018 2002
% 221.34/221.56  |- mesh__dateCreated mesh__D001018 1999-01-01
% 221.34/221.56  |- mesh__recordMaintainer mesh__D001018 PLS
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001018 2004
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001018 1995
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001018 2003
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001018 1994
% 221.34/221.56  |- skos__prefLabel mesh__D001018 Aortic Diseases
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001018 1997
% 221.34/221.56  |- mesh__recordOriginator mesh__D001018 NLM
% 221.34/221.56  |- skos__annotation mesh__D001018
% 221.34/221.56       locate as AORTA, ABDOMINAL or AORTA, THORACIC %28%NIM%29%; inflamm dis = AORTITIS but note AORTITIS, SYPHILITIC see SYPHILIS, CARDIOVASCULAR%A%  
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001018 2001
% 221.34/221.56  |- skos__hiddenLabel mesh__D001018 Disease, Aortic
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001018 1996
% 221.34/221.56  |- rdf__type mesh__D001018sskos__Concept
% 221.34/221.56  |- skos__hiddenLabel mesh__D001018 Diseases, Aortic
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001018 2006
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001018 2000
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001018 1991
% 221.34/221.56  |- skos__hiddenLabel mesh__D001018 Aortic Disease
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001018 1993
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001018 2005
% 221.34/221.56  |- skos__broader mesh__D001018smesh__D014652
% 221.34/221.56  |- mesh__dateRevised mesh__D001018 1990-05-29
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001018 1999
% 221.34/221.56  |- mesh__recordAuthorizer mesh__D001018 NLM
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001018 1992
% 221.34/221.56  |- mesh__publicMeSHNote mesh__D006501
% 221.34/221.56       1984; see HEPATIC COMA 1975-83; HEPATIC COMA was heading 1963-83%A%  
% 221.34/221.56  |- skos__hiddenLabel mesh__D006501 Portal Systemic Encephalopathy
% 221.34/221.56  |- skos__altLabel mesh__D006501 Encephalopathy, Portal-Systemic
% 221.34/221.56  |- skos__hiddenLabel mesh__D006501 Hepatocerebral Encephalopathies
% 221.34/221.56  |- skos__altLabel mesh__D006501 Encephalopathy, Hepatocerebral
% 221.34/221.56  |- skos__hiddenLabel mesh__D006501 Hepatic Comas
% 221.34/221.56  |- rdf__type mesh__D006501sskos__Concept
% 221.34/221.56  |- mesh__dateCreated mesh__D006501 1999-01-01
% 221.34/221.56  |- skos__broader mesh__D006501smesh__D001928
% 221.34/221.56  |- skos__hiddenLabel mesh__D006501 Encephalopathies, Hepatocerebral
% 221.34/221.56  |- skos__hiddenLabel mesh__D006501 Coma, Hepatic
% 221.34/221.56  |- mesh__historyNote mesh__D006501 1984; use HEPATIC COMA 1975-83   
% 221.34/221.56  |- skos__hiddenLabel mesh__D006501 Hepatic Stupors
% 221.34/221.56  |- skos__hiddenLabel mesh__D006501 Portosystemic Encephalopathies
% 221.34/221.56  |- skos__altLabel mesh__D006501 Encephalopathy, Portosystemic
% 221.34/221.56  |- skos__scopeNote mesh__D006501
% 221.34/221.56       A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION %28%frequently progressing to COMA%29%; ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes %28%see REFLEX, BABINSKI%29%. ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. %28%From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum %26% Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5%29%%A%    
% 221.34/221.56  |- skos__hiddenLabel mesh__D006501 Portal-Systemic Encephalopathies
% 221.34/221.56  |- skos__altLabel mesh__D006501 Portosystemic Encephalopathy
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D006501 2006B
% 221.34/221.56  |- skos__altLabel mesh__D006501 Encephalopathy, Hepatic
% 221.34/221.56  |- skos__hiddenLabel mesh__D006501 Stupors, Hepatic
% 221.34/221.56  |- mesh__recordMaintainer mesh__D006501 ags
% 221.34/221.56  |- skos__broader mesh__D006501smesh__D017093
% 221.34/221.56  |- mesh__recordOriginator mesh__D006501 NLM
% 221.34/221.56  |- skos__hiddenLabel mesh__D006501 Hepatic Encephalopathies
% 221.34/221.56  |- skos__altLabel mesh__D006501 Hepatocerebral Encephalopathy
% 221.34/221.56  |- mesh__dateRevised mesh__D006501 2005-07-22
% 221.34/221.56  |- skos__hiddenLabel mesh__D006501 Stupor, Hepatic
% 221.34/221.56  |- skos__hiddenLabel mesh__D006501 Encephalopathies, Portal-Systemic
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D006501 2006A
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D006501 2006
% 221.34/221.56  |- mesh__recordAuthorizer mesh__D006501 ags
% 221.34/221.56  |- skos__hiddenLabel mesh__D006501 Encephalopathy, Portal Systemic
% 221.34/221.56  |- skos__altLabel mesh__D006501 Portal-Systemic Encephalopathy
% 221.34/221.56  |- skos__hiddenLabel mesh__D006501 Encephalopathies, Hepatic
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D006501 2005
% 221.34/221.56  |- skos__hiddenLabel mesh__D006501 Comas, Hepatic
% 221.34/221.56  |- skos__prefLabel mesh__D006501 Hepatic Encephalopathy
% 221.34/221.56  |- skos__hiddenLabel mesh__D006501 Encephalopathies, Portosystemic
% 221.34/221.56  |- mesh__recordOriginator mesh__D019429 AGS
% 221.34/221.56  |- skos__prefLabel mesh__D019429 Integrase Inhibitors
% 221.34/221.56  |- skos__scopeNote mesh__D019429
% 221.34/221.56       Compounds which inhibit or antagonize biosynthesis or actions of integrase.%A%    
% 221.34/221.56  |- skos__broader mesh__D019429smesh__D004791
% 221.34/221.56  |- mesh__publicMeSHNote mesh__D019429 97   
% 221.34/221.56  |- mesh__dateCreated mesh__D019429 1996-06-10
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D019429 2005
% 221.34/221.56  |- skos__altLabel mesh__D019429 Inhibitors, Integrase
% 221.34/221.56  |- mesh__recordAuthorizer mesh__D019429 sjn
% 221.34/221.56  |- mesh__dateRevised mesh__D019429 2003-07-09
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D019429 2006
% 221.34/221.56  |- mesh__dateEstablished mesh__D019429 1997-01-01
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D019429 2004
% 221.34/221.56  |- rdf__type mesh__D019429sskos__Concept
% 221.34/221.56  |- mesh__recordMaintainer mesh__D019429 ssb
% 221.34/221.56  |- mesh__historyNote mesh__D019429 97   
% 221.34/221.56  |- skos__historyNote mesh__D019429
% 221.34/221.56       DNA Nucleotidyltransferases/antagonists %26% inhibitors %28%1993-1996%29%
% 221.34/221.56  |- skos__broader mesh__D011446smesh__D008137
% 221.34/221.56  |- skos__scopeNote mesh__D011446
% 221.34/221.56       Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.%A%    
% 221.34/221.56  |- skos__prefLabel mesh__D011446 Prospective Studies
% 221.34/221.56  |- mesh__dateCreated mesh__D011446 1999-01-01
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D011446 2005
% 221.34/221.56  |- mesh__recordOriginator mesh__D011446 NLM
% 221.34/221.56  |- mesh__historyNote mesh__D011446 67%28%65%29%   
% 221.34/221.56  |- mesh__publicMeSHNote mesh__D011446 67   
% 221.34/221.56  |- skos__broader mesh__D011446smesh__D015331
% 221.34/221.56  |- mesh__recordAuthorizer mesh__D011446 sjn
% 221.34/221.56  |- skos__hiddenLabel mesh__D011446 Study, Prospective
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D011446 2006
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D011446 2003
% 221.34/221.56  |- skos__hiddenLabel mesh__D011446 Prospective Study
% 221.34/221.56  |- rdf__type mesh__D011446sskos__Concept
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D011446 2002
% 221.34/221.56  |- skos__hiddenLabel mesh__D011446 Studies, Prospective
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D011446 2004
% 221.34/221.56  |- mesh__dateEstablished mesh__D011446 1967-01-01
% 221.34/221.56  |- skos__annotation mesh__D011446
% 221.34/221.56       IM GEN only; coord NIM with specific disease %28%IM%29%; no qualif; specify geog if pertinent%A%  
% 221.34/221.56  |- mesh__recordMaintainer mesh__D011446 ags
% 221.34/221.56  |- mesh__dateRevised mesh__D011446 2001-07-25
% 221.34/221.56  |- skos__historyNote mesh__D005409 Thoracic Injuries %28%1966-1979%29%
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D005409 2006
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D005409 1999
% 221.34/221.56  |- mesh__recordAuthorizer mesh__D005409 PLS
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D005409 2002
% 221.34/221.56  |- skos__prefLabel mesh__D005409 Flail Chest
% 221.34/221.56  |- mesh__historyNote mesh__D005409
% 221.34/221.56       91%28%80%29%; was see under THORACIC INJURIES 1980-90   
% 221.34/221.56  |- skos__broader mesh__D005409smesh__D013898
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D005409 2005
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D005409 1998
% 221.34/221.56  |- mesh__dateRevised mesh__D005409 1994-02-08
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D005409 1995
% 221.34/221.56  |- skos__hiddenLabel mesh__D005409 Chest, Stove-in
% 221.34/221.56  |- skos__hiddenLabel mesh__D005409 Stove in Chest
% 221.34/221.56  |- rdf__type mesh__D005409sskos__Concept
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D005409 2001
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D005409 2004
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D005409 1997
% 221.34/221.56  |- mesh__dateEstablished mesh__D005409 1991-01-01
% 221.34/221.56  |- skos__historyNote mesh__D005409 Rib Fractures %28%1966-1979%29%
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D005409 2000
% 221.34/221.56  |- skos__hiddenLabel mesh__D005409 Chest, Flail
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D005409 2003
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D005409 1996
% 221.34/221.56  |- skos__scopeNote mesh__D005409
% 221.34/221.56       A complication of multiple rib fractures, rib and sternum fractures, or thoracic surgery. A portion of the chest wall becomes isolated from the thoracic cage and exhibits paradoxical respiration.%A%    
% 221.34/221.56  |- mesh__dateCreated mesh__D005409 1978-12-21
% 221.34/221.56  |- skos__annotation mesh__D005409 compl of chest inj   
% 221.34/221.56  |- mesh__recordMaintainer mesh__D005409 TGC
% 221.34/221.56  |- skos__altLabel mesh__D005409 Stove-in Chest
% 221.34/221.56  |- mesh__publicMeSHNote mesh__D005409
% 221.34/221.56       91; was see under THORACIC INJURIES 1980-90   
% 221.34/221.56  |- mesh__recordOriginator mesh__D005409 AEP
% 221.34/221.56  |- mesh__recordAuthorizer mesh__D016131 sjn
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D016131 2005
% 221.34/221.56  |- mesh__publicMeSHNote mesh__D016131 91   
% 221.34/221.56  |- skos__altLabel mesh__D016131 Lymphocyte Subpopulations
% 221.34/221.56  |- skos__broader mesh__D016131smesh__D008214
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D016131 2006
% 221.34/221.56  |- skos__hiddenLabel mesh__D016131 Lymphocyte Subset
% 221.34/221.56  |- skos__hiddenLabel mesh__D016131 Subpopulations, Lymphocyte
% 221.34/221.56  |- skos__hiddenLabel mesh__D016131 Lymphocyte Subpopulation
% 221.34/221.56  |- rdf__type mesh__D016131sskos__Concept
% 221.34/221.56  |- skos__hiddenLabel mesh__D016131 Subpopulation, Lymphocyte
% 221.34/221.56  |- mesh__recordMaintainer mesh__D016131 jmp
% 221.34/221.56  |- mesh__recordOriginator mesh__D016131 AGS
% 221.34/221.56  |- skos__prefLabel mesh__D016131 Lymphocyte Subsets
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D016131 2004
% 221.34/221.56  |- mesh__dateEstablished mesh__D016131 1991-01-01
% 221.34/221.56  |- skos__historyNote mesh__D016131
% 221.34/221.56       Lymphocytes/classification %28%1977-1990%29%
% 221.34/221.56  |- skos__hiddenLabel mesh__D016131 Subsets, Lymphocyte
% 221.34/221.56  |- skos__scopeNote mesh__D016131
% 221.34/221.56       A classification of lymphocytes based on structurally or functionally different populations of cells.%A%    
% 221.34/221.56  |- skos__related mesh__D016131smesh__D016130
% 221.34/221.56  |- mesh__dateCreated mesh__D016131 1990-03-23
% 221.34/221.56  |- skos__hiddenLabel mesh__D016131 Subset, Lymphocyte
% 221.34/221.56  |- skos__annotation mesh__D016131
% 221.34/221.56       A 11 qualif; coord IM with specific lymphocyte %28%IM%29% but note that B-LYMPHOCYTE SUBSETS %26% T-LYMPHOCYTE SUBSETS are available%A%  
% 221.34/221.56  |- mesh__historyNote mesh__D016131 91   
% 221.34/221.56  |- mesh__dateRevised mesh__D016131 2003-07-09
% 221.34/221.56  |- skos__broader mesh__D002111smesh__D013639
% 221.34/221.56  |- skos__altLabel mesh__D002111 Heel Bone
% 221.34/221.56  |- rdf__type mesh__D002111sskos__Concept
% 221.34/221.56  |- skos__annotation mesh__D002111 do not confuse with HEEL, the area   
% 221.34/221.56  |- skos__prefLabel mesh__D002111 Calcaneus
% 221.34/221.56  |- mesh__dateCreated mesh__D002111 1999-01-01
% 221.34/221.56  |- mesh__dateRevised mesh__D002111 2005-06-30
% 221.34/221.56  |- skos__related mesh__D002111smesh__D006365
% 221.34/221.56  |- skos__scopeNote mesh__D002111
% 221.34/221.56       The largest of the TARSAL BONES which is situated at the lower and back part of the FOOT, forming the HEEL.%A%    
% 221.34/221.56  |- mesh__recordAuthorizer mesh__D002111 sjn
% 221.34/221.56  |- skos__hiddenLabel mesh__D002111 Bone, Heel
% 221.34/221.56  |- mesh__recordOriginator mesh__D002111 NLM
% 221.34/221.56  |- mesh__recordMaintainer mesh__D002111 ags
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D002111 2006
% 221.34/221.56  |- mesh__dateEstablished mesh__D015837 1990-01-01
% 221.34/221.56  |- skos__hiddenLabel mesh__D015837 Disease, Vestibular
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D015837 1995
% 221.34/221.56  |- skos__historyNote mesh__D015837 Labyrinth Diseases %28%1966-1989%29%
% 221.34/221.56  |- mesh__dateCreated mesh__D015837 1989-05-16
% 221.34/221.56  |- skos__scopeNote mesh__D015837
% 221.34/221.56       Diseases of the vestibule, the part of the inner ear that contains organs involved with balance.%A%    
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D015837 2006
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D015837 1999
% 221.34/221.56  |- mesh__recordOriginator mesh__D015837 PXP
% 221.34/221.56  |- skos__broader mesh__D015837smesh__D007759
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D015837 1994
% 221.34/221.56  |- skos__annotation mesh__D015837 inner ear dis   
% 221.34/221.56  |- mesh__recordAuthorizer mesh__D015837 PLS
% 221.34/221.56  |- skos__prefLabel mesh__D015837 Vestibular Diseases
% 221.34/221.56  |- mesh__publicMeSHNote mesh__D015837 90   
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D015837 2005
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D015837 1998
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D015837 2002
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D015837 2004
% 221.34/221.56  |- mesh__recordMaintainer mesh__D015837 TGC
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D015837 1997
% 221.34/221.56  |- rdf__type mesh__D015837sskos__Concept
% 221.34/221.56  |- skos__hiddenLabel mesh__D015837 Diseases, Vestibular
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D015837 2001
% 221.34/221.56  |- skos__hiddenLabel mesh__D015837 Vestibular Disease
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D015837 2003
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D015837 1996
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D015837 2000
% 221.34/221.56  |- mesh__historyNote mesh__D015837 90   
% 221.34/221.56  |- mesh__dateRevised mesh__D015837 1993-06-03
% 221.34/221.56  |- skos__altLabel mesh__D015039 Zinc Dimethyldithiocarbamate
% 221.34/221.56  |- mesh__dateRevised mesh__D015039 2000-06-22
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D015039 2005
% 221.34/221.56  |- skos__broader mesh__D015039smesh__D004125
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D015039 2006
% 221.34/221.56  |- skos__historyNote mesh__D015039 Thiocarbamates %28%1969-1974%29%
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D015039 2003
% 221.34/221.56  |- mesh__publicMeSHNote mesh__D015039
% 221.34/221.56       91; was see under THIOCARBAMATES 1975-90   
% 221.34/221.56  |- mesh__recordAuthorizer mesh__D015039 sjn
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D015039 2004
% 221.34/221.56  |- mesh__recordMaintainer mesh__D015039 CCR
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D015039 2001
% 221.34/221.56  |- skos__hiddenLabel mesh__D015039 Dimethyldithiocarbamate, Zinc
% 221.34/221.56  |- rdf__type mesh__D015039sskos__Concept
% 221.34/221.56  |- mesh__recordOriginator mesh__D015039 NLM
% 221.34/221.56  |- skos__scopeNote mesh__D015039
% 221.34/221.56       An industrial fungicide with low mammalian toxicity, although it does possess an irritant capacity for skin and mucous membranes.%A%    
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D015039 2002
% 221.34/221.56  |- skos__prefLabel mesh__D015039 Ziram
% 221.34/221.56  |- mesh__historyNote mesh__D015039
% 221.34/221.56       91%28%75%29%; was see under THIOCARBAMATES 1975-90   
% 221.34/221.56  |- mesh__dateCreated mesh__D015039 1974-11-19
% 221.34/221.56  |- skos__historyNote mesh__D015039 Zinc %28%1969-1974%29%
% 221.34/221.56  |- mesh__dateEstablished mesh__D015039 1991-01-01
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001817 2006
% 221.34/221.56  |- skos__prefLabel mesh__D001817 Blue Cross
% 221.34/221.56  |- mesh__recordAuthorizer mesh__D001817 PLS
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001817 2003
% 221.34/221.56  |- skos__broader mesh__D001817smesh__D007350
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001817 2005
% 221.34/221.56  |- mesh__recordOriginator mesh__D001817 NLM
% 221.34/221.56  |- mesh__dateRevised mesh__D001817 1994-04-19
% 221.34/221.56  |- skos__hiddenLabel mesh__D001817 Cross, Blue
% 221.34/221.56  |- skos__scopeNote mesh__D001817
% 221.34/221.56       A prepaid health insurance plan for hospital costs and related services. It usually excludes physicians%27% services %28%which are covered under BLUE SHIELD%29%.%A%    
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001817 2002
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001817 1997
% 221.34/221.56  |- skos__hiddenLabel mesh__D001817 Blue Crosses
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001817 1999
% 221.34/221.56  |- mesh__onlineNote mesh__D001817
% 221.34/221.56       search INSURANCE, HOSPITALIZATION 1968-74   
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001817 2001
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001817 1996
% 221.34/221.56  |- mesh__recordMaintainer mesh__D001817 JLS
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001817 1998
% 221.34/221.56  |- mesh__dateEstablished mesh__D001817 1991-01-01
% 221.34/221.56  |- skos__hiddenLabel mesh__D001817 Crosses, Blue
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001817 2000
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001817 1995
% 221.34/221.56  |- mesh__dateCreated mesh__D001817 1999-01-01
% 221.34/221.56  |- mesh__historyNote mesh__D001817
% 221.34/221.56       91%28%75%29%; was see under INSURANCE, HOSPITALIZATION 1975-90   
% 221.34/221.56  |- mesh__publicMeSHNote mesh__D001817
% 221.34/221.56       91; was see under INSURANCE, HOSPITALIZATION 1975-90   
% 221.34/221.56  |- skos__broader mesh__D001817smesh__D018588
% 221.34/221.56  |- skos__annotation mesh__D001817
% 221.34/221.56       for hosp %26% related costs: for physicians%27% costs see BLUE SHIELD; specify geog if possible      CATALOG: use NAF entry%A%  
% 221.34/221.56  |- rdf__type mesh__D001817sskos__Concept
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001817 2004
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001019 2003
% 221.34/221.56  |- skos__broader mesh__D001019smesh__D017542
% 221.34/221.56  |- mesh__dateRevised mesh__D001019 2000-06-21
% 221.34/221.56  |- skos__hiddenLabel mesh__D001019 Rupture, Aortic
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001019 2002
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001019 2004
% 221.34/221.56  |- skos__hiddenLabel mesh__D001019 Ruptures, Aortic
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001019 2005
% 221.34/221.56  |- mesh__recordAuthorizer mesh__D001019 sjn
% 221.34/221.56  |- skos__prefLabel mesh__D001019 Aortic Rupture
% 221.34/221.56  |- skos__hiddenLabel mesh__D001019 Aortic Aneurysms, Ruptured
% 221.34/221.56  |- mesh__recordMaintainer mesh__D001019 jmp
% 221.34/221.56  |- skos__hiddenLabel mesh__D001019 Ruptured Aortic Aneurysms
% 221.34/221.56  |- skos__hiddenLabel mesh__D001019 Ruptured Aortic Aneurysm
% 221.34/221.56  |- rdf__type mesh__D001019sskos__Concept
% 221.34/221.56  |- skos__hiddenLabel mesh__D001019 Aneurysms, Ruptured Aortic
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001019 2006
% 221.34/221.56  |- skos__annotation mesh__D001019
% 221.34/221.56       do not coord with RUPTURE, SPONTANEOUS unless particularly discussed %26% then only NIM%A%  
% 221.34/221.56  |- skos__broader mesh__D001019smesh__D012421
% 221.34/221.56  |- skos__hiddenLabel mesh__D001019 Aortic Ruptures
% 221.34/221.56  |- mesh__dateCreated mesh__D001019 1999-01-01
% 221.34/221.56  |- skos__hiddenLabel mesh__D001019 Aneurysm, Ruptured Aortic
% 221.34/221.56  |- skos__scopeNote mesh__D001019
% 221.34/221.56       Tearing of aortic tissue. It may be rupture of an aneurysm or it may be due to trauma.%A%    
% 221.34/221.56  |- skos__broader mesh__D001019smesh__D001014
% 221.34/221.56  |- mesh__recordOriginator mesh__D001019 NLM
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D001019 2001
% 221.34/221.56  |- skos__hiddenLabel mesh__D006502 Thromboses, Hepatic Vein
% 221.34/221.56  |- skos__hiddenLabel mesh__D006502 Chiari Syndrome
% 221.34/221.56  |- rdf__type mesh__D006502sskos__Concept
% 221.34/221.56  |- mesh__dateCreated mesh__D006502 1999-01-01
% 221.34/221.56  |- mesh__dateRevised mesh__D006502 2004-07-28
% 221.34/221.56  |- skos__hiddenLabel mesh__D006502 Thrombosis, Hepatic Vein
% 221.34/221.56  |- skos__hiddenLabel mesh__D006502 Hepatic Vein Thromboses
% 221.34/221.56  |- skos__hiddenLabel mesh__D006502 Chiaris Syndrome
% 221.34/221.56  |- skos__annotation mesh__D006502
% 221.34/221.56       do not confuse X ref CHIARI%27%S SYNDROME with ARNOLD-CHIARI SYNDROME see ARNOLD-CHIARI MALFORMATION%A%  
% 221.34/221.56  |- skos__scopeNote mesh__D006502
% 221.34/221.56       An acute or subacute blockage of the HEPATIC VEINS, usually extrahepatic and caused by blood clots %28%THROMBUS%29% or fibrous webs. Parenchymal FIBROSIS is uncommon.%A%    
% 221.34/221.56  |- skos__broader mesh__D006502smesh__D008107
% 221.34/221.56  |- skos__prefLabel mesh__D006502 Hepatic Vein Thrombosis
% 221.34/221.56  |- skos__altLabel mesh__D006502 Budd-Chiari Syndrome
% 221.34/221.56  |- skos__hiddenLabel mesh__D006502 Vein Thromboses, Hepatic
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D006502 2006
% 221.34/221.56  |- skos__broader mesh__D006502smesh__D020246
% 221.34/221.56  |- skos__hiddenLabel mesh__D006502 Budd Chiari Syndrome
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D006502 2005
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D006502 2005A
% 221.34/221.56  |- mesh__recordMaintainer mesh__D006502 jls
% 221.34/221.56  |- mesh__recordOriginator mesh__D006502 NLM
% 221.34/221.56  |- skos__altLabel mesh__D006502 Chiari%27%s Syndrome
% 221.34/221.56  |- skos__hiddenLabel mesh__D006502 Vein Thrombosis, Hepatic
% 221.34/221.56  |- mesh__recordAuthorizer mesh__D006502 jls
% 221.34/221.56  |- mesh__recordMaintainer mesh__D011447 TWD
% 221.34/221.56  |- skos__historyNote mesh__D011447 Piperazines %28%1971-1974%29%
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D011447 2006
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D011447 2003
% 221.34/221.56  |- skos__historyNote mesh__D011447 Alcohol, Propyl %28%1972-1974%29%
% 221.34/221.56  |- mesh__historyNote mesh__D011447
% 221.34/221.56       91%28%75%29%; was see under PIPERAZINES 1975-90   
% 221.34/221.56  |- mesh__recordOriginator mesh__D011447 NLM
% 221.34/221.56  |- rdf__type mesh__D011447sskos__Concept
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D011447 2001
% 221.34/221.56  |- mesh__dateEstablished mesh__D011447 1991-01-01
% 221.34/221.56  |- skos__hiddenLabel mesh__D011447 Chloride, Prospidium
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D011447 2004
% 221.34/221.56  |- mesh__recordAuthorizer mesh__D011447 sjn
% 221.34/221.56  |- mesh__dateCreated mesh__D011447 1974-11-19
% 221.34/221.56  |- skos__altLabel mesh__D011447 Prospidine
% 221.34/221.56  |- skos__broader mesh__D011447smesh__D013141
% 221.34/221.56  |- mesh__dateRevised mesh__D011447 2000-06-22
% 221.34/221.56  |- skos__historyNote mesh__D011447 Spiro Compounds %28%1971-1974%29%
% 221.34/221.56  |- skos__prefLabel mesh__D011447 Prospidium
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D011447 2002
% 221.34/221.56  |- skos__scopeNote mesh__D011447
% 221.34/221.56       An antineoplastic dispiropiperazine derivative.     
% 221.34/221.56  |- skos__broader mesh__D011447smesh__D010879
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D011447 2005
% 221.34/221.56  |- skos__altLabel mesh__D011447 Prospidin
% 221.34/221.56  |- mesh__publicMeSHNote mesh__D011447
% 221.34/221.56       91; was see under PIPERAZINES 1975-90   
% 221.34/221.56  |- mesh__recordMaintainer mesh__D016930 SYSTEM
% 221.34/221.56  |- mesh__dateEstablished mesh__D016930 1992-01-01
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D016930 2006
% 221.34/221.56  |- mesh__recordAuthorizer mesh__D016930 sjn
% 221.34/221.56  |- skos__scopeNote mesh__D016930
% 221.34/221.56       A genus of gram-positive bacteria whose spores are round to oval and covered by a sheath.%A%    
% 221.34/221.56  |- skos__broader mesh__D016930smesh__D000192
% 221.34/221.56  |- mesh__dateCreated mesh__D016930 1991-05-30
% 221.34/221.56  |- skos__historyNote mesh__D016930 Streptomyces %28%1988-1991%29%
% 221.34/221.56  |- mesh__dateRevised mesh__D016930 2005-06-30
% 221.34/221.56  |- mesh__recordOriginator mesh__D016930 PXP
% 221.34/221.56  |- skos__broader mesh__D016930smesh__D016937
% 221.34/221.56  |- skos__annotation mesh__D016930 a gram-pos bacterium   
% 221.34/221.56  |- rdf__type mesh__D016930sskos__Concept
% 221.34/221.56  |- skos__prefLabel mesh__D016930 Saccharopolyspora
% 221.34/221.56  |- mesh__historyNote mesh__D016930 92   
% 221.34/221.56  |- mesh__publicMeSHNote mesh__D016930 92   
% 221.34/221.56  |- mesh__historyNote mesh__D030601 2002   
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D030601 2003
% 221.34/221.56  |- mesh__dateCreated mesh__D030601 2001-07-25
% 221.34/221.56  |- skos__scopeNote mesh__D030601
% 221.34/221.56       A plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida. The common name of rock rose is used with several plants of this family.%A%    
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D030601 2006
% 221.34/221.56  |- mesh__recordMaintainer mesh__D030601 ssb
% 221.34/221.56  |- mesh__recordAuthorizer mesh__D030601 sjn
% 221.34/221.56  |- skos__annotation mesh__D030601
% 221.34/221.56       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D030601 2005
% 221.34/221.56  |- mesh__dateRevised mesh__D030601 2002-07-03
% 221.34/221.56  |- skos__prefLabel mesh__D030601 Cistaceae
% 221.34/221.56  |- rdf__type mesh__D030601sskos__Concept
% 221.34/221.56  |- mesh__dateEstablished mesh__D030601 2002-01-01
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D030601 2004
% 221.34/221.56  |- skos__broader mesh__D030601smesh__D019684
% 221.34/221.56  |- mesh__recordOriginator mesh__D030601 ssb
% 221.34/221.56  |- mesh__publicMeSHNote mesh__D030601 2002   
% 221.34/221.56  |- skos__broader mesh__D002910smesh__D013995
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D002910 2006
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D002910 2004
% 221.34/221.56  |- skos__prefLabel mesh__D002910 Chronology
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D002910 2005
% 221.34/221.56  |- mesh__recordMaintainer mesh__D002910 mdb
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D002910 2003
% 221.34/221.56  |- mesh__dateCreated mesh__D002910 1999-01-01
% 221.34/221.56  |- skos__broader mesh__D002910smesh__D007254
% 221.34/221.56  |- rdf__type mesh__D002910sskos__Concept
% 221.34/221.56  |- mesh__recordAuthorizer mesh__D002910 sjn
% 221.34/221.56  |- mesh__dateRevised mesh__D002910 2001-07-25
% 221.34/221.56  |- mesh__recordOriginator mesh__D002910 NLM
% 221.34/221.56  |- mesh__activeMeSHYear mesh__D002910 2002
% 221.34/221.56  |- skos__annotation mesh__D002910
% 221.34/221.56       no qualif; used more by Catalogers than Indexers; do not confuse with TIME; TIME FACTORS or TIME PERCEPTION: CHRONOLOGY is usually for data or events arranged in order of time or occurrence; DF: CHRONOL%A%  
% 221.34/221.56  |- mesh__historyNote mesh__D002112 83   
% 221.34/221.56  |- skos__altLabel mesh__D002112 Aventis Brand of Calcifediol
% 221.34/221.56  |- rdf__type mesh__D002112sskos__Concept
% 221.34/221.57  |- skos__altLabel mesh__D002112 25-Hydroxyvitamin D 3
% 221.34/221.57  |- skos__altLabel mesh__D002112 25-Hydroxyvitamin D3
% 221.34/221.57  |- mesh__dateCreated mesh__D002112 1982-05-04
% 221.34/221.57  |- skos__annotation mesh__D002112
% 221.34/221.57       deficiency: coordinate CALCIFEDIOL /defic %28%IM%29% with VITAMIN D DEFICIENCY %28%IM%29%%A%  
% 221.34/221.57  |- skos__altLabel mesh__D002112 Faes Brand of Calcifediol
% 221.34/221.57  |- mesh__recordOriginator mesh__D002112 RLS
% 221.34/221.57  |- mesh__recordMaintainer mesh__D002112 ssb
% 221.34/221.57  |- skos__hiddenLabel mesh__D002112 25 Hydroxycholecalciferol
% 221.34/221.57  |- skos__altLabel mesh__D002112 25-Hydroxycholecalciferol
% 221.34/221.57  |- skos__altLabel mesh__D002112 Calcidiol
% 221.34/221.57  |- skos__hiddenLabel mesh__D002112 25 Hydroxyvitamin D 3
% 221.34/221.57  |- skos__hiddenLabel mesh__D002112 Calcifediol Organon Brand
% 221.34/221.57  |- skos__hiddenLabel mesh__D002112 Calcifediol Faes Brand
% 221.34/221.57  |- skos__altLabel mesh__D002112 Organon Brand of Calcifediol
% 221.34/221.57  |- skos__hiddenLabel mesh__D002112 25 Hydroxyvitamin D3
% 221.34/221.57  |- mesh__dateRevised mesh__D002112 2005-06-30
% 221.34/221.57  |- skos__historyNote mesh__D002112
% 221.34/221.57       Hydroxycholecalciferols %28%1972-1982%29%
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D002112 2006
% 221.34/221.57  |- mesh__publicMeSHNote mesh__D002112 83   
% 221.34/221.57  |- skos__historyNote mesh__D002112 Cholecalciferols %28%1966-1972%29%
% 221.34/221.57  |- skos__prefLabel mesh__D002112 Calcifediol
% 221.34/221.57  |- mesh__recordAuthorizer mesh__D002112 sjn
% 221.34/221.57  |- mesh__dateEstablished mesh__D002112 1983-01-01
% 221.34/221.57  |- skos__scopeNote mesh__D002112
% 221.34/221.57       The major circulating metabolite of vitamin D3 %28%CALCIFEROL%29%.  It is produced in the LIVER and is the best indicator of the body%27%s vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties.%A%    
% 221.34/221.57  |- skos__hiddenLabel mesh__D002112 Calcifediol Aventis Brand
% 221.34/221.57  |- skos__broader mesh__D002112smesh__D006887
% 221.34/221.57  |- mesh__dateRevised mesh__D015838 1993-05-24
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D015838 1996
% 221.34/221.57  |- skos__hiddenLabel mesh__D015838 Osteochondromatoses, Synovial
% 221.34/221.57  |- skos__prefLabel mesh__D015838 Chondromatosis, Synovial
% 221.34/221.57  |- mesh__recordAuthorizer mesh__D015838 PLS
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D015838 2003
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D015838 2002
% 221.34/221.57  |- skos__altLabel mesh__D015838 Reichel%27%s Syndrome
% 221.34/221.57  |- skos__hiddenLabel mesh__D015838 Synovial Chondromatoses
% 221.34/221.57  |- skos__hiddenLabel mesh__D015838 Synovial Osteochondromatoses
% 221.34/221.57  |- skos__hiddenLabel mesh__D015838 Synovial Chondrometaplasias
% 221.34/221.57  |- skos__altLabel mesh__D015838 Synovial Chondromatosis
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D015838 1999
% 221.34/221.57  |- mesh__dateEstablished mesh__D015838 1990-01-01
% 221.34/221.57  |- mesh__recordMaintainer mesh__D015838 PLS
% 221.34/221.57  |- mesh__recordOriginator mesh__D015838 AGS
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D015838 2006
% 221.34/221.57  |- skos__hiddenLabel mesh__D015838 Reichel Syndrome
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D015838 1995
% 221.34/221.57  |- skos__scopeNote mesh__D015838
% 221.34/221.57       Rare, benign, chronic, progressive metaplasia in which cartilage is formed in the synovial membranes of joints, tendon sheaths, or bursae. Some of the metaplastic foci can become detached producing loose bodies. When the loose bodies undergo secondary calcification, the condition is called synovial osteochondromatosis.%A%    
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D015838 1998
% 221.34/221.57  |- skos__hiddenLabel mesh__D015838 Reichels Syndrome
% 221.34/221.57  |- skos__broader mesh__D015838smesh__D007592
% 221.34/221.57  |- skos__hiddenLabel mesh__D015838 Syndrome, Henderson-Jones
% 221.34/221.57  |- skos__altLabel mesh__D015838 Synovial Chondrometaplasia
% 221.34/221.57  |- skos__annotation mesh__D015838
% 221.34/221.57       non-neoplastic progressive joint metaplasia   
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D015838 2001
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D015838 2005
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D015838 1994
% 221.34/221.57  |- skos__altLabel mesh__D015838 Synovial Osteochondromatosis
% 221.34/221.57  |- mesh__historyNote mesh__D015838 90   
% 221.34/221.57  |- skos__altLabel mesh__D015838 Henderson-Jones Syndrome
% 221.34/221.57  |- skos__hiddenLabel mesh__D015838 Chondromatoses, Synovial
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D015838 2000
% 221.34/221.57  |- skos__historyNote mesh__D015838 Chondroma %28%1966-1989%29%
% 221.34/221.57  |- skos__hiddenLabel mesh__D015838 Chondrometaplasias, Synovial
% 221.34/221.57  |- mesh__dateCreated mesh__D015838 1989-05-15
% 221.34/221.57  |- skos__hiddenLabel mesh__D015838 Henderson Jones Syndrome
% 221.34/221.57  |- skos__hiddenLabel mesh__D015838 Chondrometaplasia, Synovial
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D015838 1997
% 221.34/221.57  |- rdf__type mesh__D015838sskos__Concept
% 221.34/221.57  |- mesh__publicMeSHNote mesh__D015838 90   
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D015838 2004
% 221.34/221.57  |- skos__hiddenLabel mesh__D015838 Syndrome, Reichel%27%s
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D001818 2005
% 221.34/221.57  |- mesh__onlineNote mesh__D001818
% 221.34/221.57       search INSURANCE, PHYSICIAN SERVICES 1968-74   
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D001818 2000
% 221.34/221.57  |- mesh__dateRevised mesh__D001818 1994-04-19
% 221.34/221.57  |- skos__scopeNote mesh__D001818
% 221.34/221.57       A prepaid health insurance plan for costs of physicians%27% services.%A%    
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D001818 1997
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D001818 1999
% 221.34/221.57  |- mesh__recordAuthorizer mesh__D001818 PLS
% 221.34/221.57  |- skos__hiddenLabel mesh__D001818 Shield, Blue
% 221.34/221.57  |- skos__hiddenLabel mesh__D001818 Blue Shields
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D001818 1996
% 221.34/221.57  |- mesh__recordOriginator mesh__D001818 NLM
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D001818 1998
% 221.34/221.57  |- skos__broader mesh__D001818smesh__D007357
% 221.34/221.57  |- mesh__dateEstablished mesh__D001818 1991-01-01
% 221.34/221.57  |- skos__prefLabel mesh__D001818 Blue Shield
% 221.34/221.57  |- mesh__historyNote mesh__D001818
% 221.34/221.57       91%28%75%29%; was see under INSURANCE, PHYSICIAN SERVICES 1975-90%A%  
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D001818 2002
% 221.34/221.57  |- mesh__publicMeSHNote mesh__D001818
% 221.34/221.57       91; was see under INSURANCE, PHYSICIAN SERVICES 1975-90   
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D001818 1995
% 221.34/221.57  |- mesh__dateCreated mesh__D001818 1999-01-01
% 221.34/221.57  |- skos__broader mesh__D001818smesh__D018588
% 221.34/221.57  |- rdf__type mesh__D001818sskos__Concept
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D001818 2004
% 221.34/221.57  |- mesh__recordMaintainer mesh__D001818 JLS
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D001818 2001
% 221.34/221.57  |- skos__hiddenLabel mesh__D001818 Shields, Blue
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D001818 2006
% 221.34/221.57  |- skos__annotation mesh__D001818
% 221.34/221.57       for physicians%27% costs: for hosp %26% related costs use BLUE CROSS; specify geog if possible      CATALOG: use NAF entry%A%  
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D001818 2003
% 221.34/221.57  |- skos__annotation mesh__D012540
% 221.34/221.57       fracture = SCAPULA /inj %28%IM%29% + FRACTURES, BONE %28%IM%29%: do not confuse with SHOULDER FRACTURES%A%  
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012540 2002
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012540 1996
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012540 2006
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012540 2006A
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012540 1992
% 221.34/221.57  |- mesh__dateRevised mesh__D012540 2005-07-14
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012540 1997
% 221.34/221.57  |- skos__hiddenLabel mesh__D012540 Scapulas
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012540 1993
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012540 1998
% 221.34/221.57  |- skos__broader mesh__D012540smesh__D001133
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012540 1990
% 221.34/221.57  |- mesh__recordMaintainer mesh__D012540 ags
% 221.34/221.57  |- rdf__type mesh__D012540sskos__Concept
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012540 1994
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012540 1999
% 221.34/221.57  |- mesh__dateCreated mesh__D012540 1999-01-01
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012540 2003
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012540 1991
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012540 1989
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012540 2000
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012540 1995
% 221.34/221.57  |- mesh__recordAuthorizer mesh__D012540 ags
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012540 2004
% 221.34/221.57  |- mesh__recordOriginator mesh__D012540 NLM
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012540 2001
% 221.34/221.57  |- skos__prefLabel mesh__D012540 Scapula
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012540 2005
% 221.34/221.57  |- rdf__type mesh__D006503sskos__Concept
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D006503 2001
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D006503 1995
% 221.34/221.57  |- mesh__recordOriginator mesh__D006503 NLM
% 221.34/221.57  |- skos__related mesh__D006503smesh__D008102
% 221.34/221.57  |- mesh__dateRevised mesh__D006503 1992-05-15
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D006503 2003
% 221.34/221.57  |- skos__hiddenLabel mesh__D006503 Veins, Hepatic
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D006503 2005
% 221.34/221.57  |- skos__prefLabel mesh__D006503 Hepatic Veins
% 221.34/221.57  |- mesh__recordAuthorizer mesh__D006503 PLS
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D006503 2004
% 221.34/221.57  |- skos__hiddenLabel mesh__D006503 Vein, Hepatic
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D006503 2002
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D006503 2006
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D006503 1996
% 221.34/221.57  |- mesh__recordMaintainer mesh__D006503 TAP
% 221.34/221.57  |- mesh__dateCreated mesh__D006503 1999-01-01
% 221.34/221.57  |- skos__broader mesh__D006503smesh__D014680
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D006503 1998
% 221.34/221.57  |- skos__hiddenLabel mesh__D006503 Hepatic Vein
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D006503 1997
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D006503 2000
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D006503 1994
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D006503 1999
% 221.34/221.57  |- skos__scopeNote mesh__D006503 Veins which drain the liver.     
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D006503 1993
% 221.34/221.57  |- skos__hiddenLabel mesh__D044622 Pellicle, Salivary
% 221.34/221.57  |- skos__altLabel mesh__D044622 Salivary Pellicle
% 221.34/221.57  |- skos__hiddenLabel mesh__D044622 Pellicle, Enamel
% 221.34/221.57  |- skos__scopeNote mesh__D044622
% 221.34/221.57       A thin protein film on the surface of DENTAL ENAMEL. It is widely believed to result from the selective adsorption of precursor proteins present in SALIVA onto tooth surfaces, and to reduce microbial adherence to the TEETH.%A%    
% 221.34/221.57  |- mesh__dateCreated mesh__D044622 2003-07-09
% 221.34/221.57  |- skos__hiddenLabel mesh__D044622 Pellicle, Salivary Acquired
% 221.34/221.57  |- mesh__dateEstablished mesh__D044622 2004-01-01
% 221.34/221.57  |- skos__hiddenLabel mesh__D044622 Pellicle, Dental
% 221.34/221.57  |- mesh__historyNote mesh__D044622 2004   
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D044622 2005
% 221.34/221.57  |- skos__altLabel mesh__D044622 Enamel Pellicle
% 221.34/221.57  |- skos__related mesh__D044622smesh__D012471
% 221.34/221.57  |- skos__hiddenLabel mesh__D044622 Acquired Pellicle, Salivary
% 221.34/221.57  |- mesh__publicMeSHNote mesh__D044622 2004   
% 221.34/221.57  |- skos__prefLabel mesh__D044622 Dental Pellicle
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D044622 2006
% 221.34/221.57  |- rdf__type mesh__D044622sskos__Concept
% 221.34/221.57  |- skos__altLabel mesh__D044622 Salivary Acquired Pellicle
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D044622 2004
% 221.34/221.57  |- skos__broader mesh__D044622smesh__D003743
% 221.34/221.57  |- skos__hiddenLabel mesh__D011448 Inhibitor, Prostaglandin
% 221.34/221.57  |- mesh__dateEstablished mesh__D011448 1975-09-01
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D011448 2004
% 221.34/221.57  |- mesh__recordMaintainer mesh__D011448 ssb
% 221.34/221.57  |- skos__scopeNote mesh__D011448
% 221.34/221.57       Compounds that inhibit the action of prostaglandins.     
% 221.34/221.57  |- mesh__historyNote mesh__D011448 75   
% 221.34/221.57  |- skos__altLabel mesh__D011448 Prostaglandin Inhibitors
% 221.34/221.57  |- skos__broader mesh__D011448smesh__D006727
% 221.34/221.57  |- skos__annotation mesh__D011448
% 221.34/221.57       /biosyn /physiol permitted if by living organism; DF: PG ANTAG%A%  
% 221.34/221.57  |- mesh__dateRevised mesh__D011448 2003-07-09
% 221.34/221.57  |- skos__altLabel mesh__D011448 Inhibitors, Prostaglandin
% 221.34/221.57  |- skos__historyNote mesh__D011448
% 221.34/221.57       Prostaglandins/antagonists %26% inhibitors %28%1968-1974%29%
% 221.34/221.57  |- skos__prefLabel mesh__D011448 Prostaglandin Antagonists
% 221.34/221.57  |- mesh__dateCreated mesh__D011448 1974-11-11
% 221.34/221.57  |- skos__hiddenLabel mesh__D011448 Antagonist, Prostaglandin
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D011448 2005
% 221.34/221.57  |- skos__altLabel mesh__D011448 Prostaglandin Inhibitor
% 221.34/221.57  |- skos__related mesh__D011448smesh__D016861
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D011448 2006
% 221.34/221.57  |- mesh__recordOriginator mesh__D011448 NLM
% 221.34/221.57  |- mesh__recordAuthorizer mesh__D011448 sjn
% 221.34/221.57  |- mesh__publicMeSHNote mesh__D011448 75   
% 221.34/221.57  |- skos__altLabel mesh__D011448 Antagonists, Prostaglandin
% 221.34/221.57  |- skos__altLabel mesh__D011448 Prostaglandin Antagonist
% 221.34/221.57  |- rdf__type mesh__D011448sskos__Concept
% 221.34/221.57  |- skos__annotation mesh__D016931
% 221.34/221.57       an order of the kingdom of Euryarchaeota, of the domain Archaea%A%  
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D016931 2006
% 221.34/221.57  |- mesh__publicMeSHNote mesh__D016931 92   
% 221.34/221.57  |- mesh__dateCreated mesh__D016931 1991-05-30
% 221.34/221.57  |- mesh__dateEstablished mesh__D016931 1992-01-01
% 221.34/221.57  |- skos__prefLabel mesh__D016931 Halobacteriales
% 221.34/221.57  |- mesh__recordOriginator mesh__D016931 PXP
% 221.34/221.57  |- skos__scopeNote mesh__D016931
% 221.34/221.57       An order of extremely halophilic archaea, in the kingdom EURYARCHAEOTA. They occur ubiquitously in nature where the salt concentration is high, and are chemoorganotrophic, using amino acids or carbohydrates as a carbon source.%A%    
% 221.34/221.57  |- mesh__recordAuthorizer mesh__D016931 sjn
% 221.34/221.57  |- rdf__type mesh__D016931sskos__Concept
% 221.34/221.57  |- mesh__historyNote mesh__D016931 92   
% 221.34/221.57  |- skos__broader mesh__D016931smesh__D019605
% 221.34/221.57  |- mesh__recordMaintainer mesh__D016931 SYSTEM
% 221.34/221.57  |- mesh__dateRevised mesh__D016931 2005-06-30
% 221.34/221.57  |- skos__broader mesh__D016133smesh__D021141
% 221.34/221.57  |- mesh__publicMeSHNote mesh__D016133
% 221.34/221.57       91; was see under GENE AMPLIFICATION 1990   
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D016133 2004
% 221.34/221.57  |- skos__hiddenLabel mesh__D016133 PCR, Nested
% 221.34/221.57  |- skos__hiddenLabel mesh__D016133 Reactions, Polymerase Chain
% 221.34/221.57  |- mesh__recordOriginator mesh__D016133 PLS
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D016133 2001
% 221.34/221.57  |- mesh__dateEstablished mesh__D016133 1991-01-01
% 221.34/221.57  |- skos__historyNote mesh__D016133 Gene Amplification %28%1988-1989%29%
% 221.34/221.57  |- skos__related mesh__D016133smesh__D016324
% 221.34/221.57  |- skos__related mesh__D016133smesh__D022521
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D016133 2005
% 221.34/221.57  |- mesh__recordMaintainer mesh__D016133 PXP
% 221.34/221.57  |- skos__altLabel mesh__D016133 Inverse Polymerase Chain Reaction
% 221.34/221.57  |- mesh__dateRevised mesh__D016133 2000-06-22
% 221.34/221.57  |- skos__hiddenLabel mesh__D016133 Polymerase Chain Reactions
% 221.34/221.57  |- skos__altLabel mesh__D016133 Nested PCR
% 221.34/221.57  |- skos__prefLabel mesh__D016133 Polymerase Chain Reaction
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D016133 2006
% 221.34/221.57  |- skos__hiddenLabel mesh__D016133 PCR, Inverse
% 221.34/221.57  |- skos__altLabel mesh__D016133 PCR
% 221.34/221.57  |- skos__altLabel mesh__D016133 Anchored Polymerase Chain Reaction
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D016133 2002
% 221.34/221.57  |- mesh__recordAuthorizer mesh__D016133 sjn
% 221.34/221.57  |- skos__scopeNote mesh__D016133
% 221.34/221.57       In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences %28%primers%29%. The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.%A%    
% 221.34/221.57  |- skos__hiddenLabel mesh__D016133 Reaction, Polymerase Chain
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D016133 2003
% 221.34/221.57  |- mesh__historyNote mesh__D016133
% 221.34/221.57       91%28%90%29%; was see under GENE AMPLIFICATION 1990   
% 221.34/221.57  |- mesh__dateCreated mesh__D016133 1990-01-11
% 221.34/221.57  |- rdf__type mesh__D016133sskos__Concept
% 221.34/221.57  |- skos__hiddenLabel mesh__D016133 PCR, Anchored
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D002911 2005
% 221.34/221.57  |- mesh__dateRevised mesh__D002911 2004-07-13
% 221.34/221.57  |- skos__annotation mesh__D002911 hydrocarbons from coal tar   
% 221.34/221.57  |- rdf__type mesh__D002911sskos__Concept
% 221.34/221.57  |- mesh__dateCreated mesh__D002911 1975-07-18
% 221.34/221.57  |- mesh__historyNote mesh__D002911
% 221.34/221.57       91%28%76%29%; was see under PHENANTHRENES 1976-90   
% 221.34/221.57  |- mesh__publicMeSHNote mesh__D002911
% 221.34/221.57       91; was see under PHENANTHRENES 1976-90   
% 221.34/221.57  |- skos__historyNote mesh__D002911 Phenanthrenes %28%1969-1975%29%
% 221.34/221.57  |- skos__broader mesh__D002911smesh__D010616
% 221.34/221.57  |- mesh__dateEstablished mesh__D002911 1991-01-01
% 221.34/221.57  |- skos__prefLabel mesh__D002911 Chrysenes
% 221.34/221.57  |- skos__scopeNote mesh__D002911
% 221.34/221.57        1,2-Benzphenanthrenes.  POLYCYCLIC COMPOUNDS obtained from coal tar.%A%    
% 221.34/221.57  |- mesh__recordAuthorizer mesh__D002911 sjn
% 221.34/221.57  |- mesh__recordMaintainer mesh__D002911 sjn
% 221.34/221.57  |- mesh__recordOriginator mesh__D002911 RLS
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D002911 2006
% 221.34/221.57  |- skos__hiddenLabel mesh__D002113 Mineralization, Bone
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D002113 2005
% 221.34/221.57  |- skos__altLabel mesh__D002113 Bone Mineralization
% 221.34/221.57  |- mesh__recordMaintainer mesh__D002113 lkt
% 221.34/221.57  |- skos__altLabel mesh__D002113 Calcification, Physiological
% 221.34/221.57  |- mesh__recordAuthorizer mesh__D002113 sjn
% 221.34/221.57  |- mesh__dateRevised mesh__D002113 2004-07-07
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D002113 2006
% 221.34/221.57  |- skos__prefLabel mesh__D002113 Calcification, Physiologic
% 221.34/221.57  |- skos__related mesh__D002113smesh__D010012
% 221.34/221.57  |- mesh__publicMeSHNote mesh__D002113 65; was CALCIFICATION 1963-64   
% 221.34/221.57  |- skos__related mesh__D002113smesh__D001846
% 221.34/221.57  |- skos__altLabel mesh__D002113 Physiologic Calcification
% 221.34/221.57  |- mesh__recordOriginator mesh__D002113 NLM
% 221.34/221.57  |- skos__hiddenLabel mesh__D002113 Physiological Calcification
% 221.34/221.57  |- skos__broader mesh__D002113smesh__D001846
% 221.34/221.57  |- skos__annotation mesh__D002113
% 221.34/221.57       TOOTH CALCIFICATION is also available; DF: CALCIFICATION PHYSIOL%A%  
% 221.34/221.57  |- skos__scopeNote mesh__D002113
% 221.34/221.57       Process by which organic tissue becomes hardened by the physiologic deposit of calcium salts.%A%    
% 221.34/221.57  |- mesh__historyNote mesh__D002113 65; was CALCIFICATION 1963-64   
% 221.34/221.57  |- skos__broader mesh__D002113smesh__D001669
% 221.34/221.57  |- rdf__type mesh__D002113sskos__Concept
% 221.34/221.57  |- mesh__dateEstablished mesh__D002113 1965-01-01
% 221.34/221.57  |- mesh__dateCreated mesh__D002113 1999-01-01
% 221.34/221.57  |- skos__altLabel mesh__D026561 Heymann Nephritis Antigen GP330
% 221.34/221.57  |- skos__broader mesh__D026561smesh__D026541
% 221.34/221.57  |- skos__altLabel mesh__D026561 Glycoprotein 330
% 221.34/221.57  |- mesh__recordAuthorizer mesh__D026561 ags
% 221.34/221.57  |- mesh__dateEstablished mesh__D026561 2002-01-01
% 221.34/221.57  |- mesh__publicMeSHNote mesh__D026561
% 221.34/221.57       2002;  HEYMAN%27%S NEPHRITIS ANTIGEN GP330 was indexed under MEMBRANE GLYCOPROTEINS 1989-2001 %26% ANTIGENS, SURFACE 1986-1988;  ANTIGEN GP330, NEPHRITIS was indexed under MEMBRANE GLYCOPROTEINS 1989-2001%26% ANTIGENS, SURFACE 1988;  RENAL GLYCOPROTEIN GP330 was indexed under MEMBRANE GLYCOPROTEINS 1991-2001;  GP330 ANTIGEN was indexed under MEMBRANE GLYCOPROTEINS 1991-2001;  LPR-2 was indexed under MEMBRANE GLYCOPROTEINS 1996-2001;  LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEINS 2 was indexed under MEMBRANE GLYCOPROTEINS 1994-2001;  MEGALIN was indexed under MEMBRANE GLYCOPROTEINS 1995-2001%A%  
% 221.34/221.57  |- skos__altLabel mesh__D026561 Antigen GP 330, Nephritis
% 221.34/221.57  |- skos__hiddenLabel mesh__D026561 LRP 2 Receptor
% 221.34/221.57  |- skos__altLabel mesh__D026561 Megalin
% 221.34/221.57  |- rdf__type mesh__D026561sskos__Concept
% 221.34/221.57  |- skos__historyNote mesh__D026561 Membrane Glycoproteins %28%1989-2001%29%
% 221.34/221.57  |- skos__altLabel mesh__D026561 Nephritis Antigen %28%GP330%29%
% 221.34/221.57  |- skos__scopeNote mesh__D026561
% 221.34/221.57       An LDL-RECEPTOR RELATED PROTEIN found in the neuroepithelium and in proximal tubular cells of the kidney. It is considered a multiligand receptor in that it binds to a variety of ligands with relatively high affinity and may function in mediating the uptake and lysosomal degradation of macromolecules such as: LIPOPROTEINS; ENDOPEPTIDASES; and PROTEASE INHIBITORS.%A%    
% 221.34/221.57  |- skos__prefLabel mesh__D026561 LDL-Receptor Related Protein 2
% 221.34/221.57  |- mesh__historyNote mesh__D026561
% 221.34/221.57       2002; for HEYMAN%27%S NEPHRITIS ANTIGEN GP330 use HEYMANN NEPHRITIS ANTIGENIC COMPLEX %28%NM%29% 1984-2001; for ANTIGEN GP330, NEPHRITIS use HEYMANN NEPHRITIS ANTIGENIC COMPLEX %28%NM%29% 1988-2001; for RENAL GLYCOPROTEIN GP330 use HEYMANN NEPHRITIS ANTIGENIC COMPLEX %28%NM%29% 1991-2001; for GP330 ANTIGEN use HEYMANN NEPHRITIS ANTIGENIC COMPLEX %28%NM%29% 1991-2001; for LPR-2 use HEYMANN NEPHRITIS ANTIGENIC COMPLEX %28%NM%29% 1996-2001; for LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEINS 2 use HEYMANN NEPHRITIS ANTIGENIC COMPLEX %28%NM%29% 1994-2001; for MEGALIN use HEYMANN NEPHRITIS ANTIGENIC COMPLEX %28%NM%29% 1995-2001%A%  
% 221.34/221.57  |- mesh__recordOriginator mesh__D026561 jmp
% 221.34/221.57  |- skos__hiddenLabel mesh__D026561 LRP 2
% 221.34/221.57  |- skos__altLabel mesh__D026561 Heyman%27%s Nephritis Antigen GP330
% 221.34/221.57  |- skos__hiddenLabel mesh__D026561 GP330, Renal Glycoprotein
% 221.34/221.57  |- skos__altLabel mesh__D026561
% 221.34/221.57       Low-Density Lipoprotein Receptor-Related Protein-2
% 221.34/221.57  |- skos__hiddenLabel mesh__D026561 Glycoprotein GP330, Renal
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D026561 2006A
% 221.34/221.57  |- skos__historyNote mesh__D026561 Antigens, Surface %28%1984-1988%29%
% 221.34/221.57  |- skos__annotation mesh__D026561
% 221.34/221.57       not X ref Heymann Nephritis Antigen GP330: HEYMANN NEPHRITIS ANTIGENIC COMPLEX is also available; DF: LRP 2%A%  
% 221.34/221.57  |- skos__hiddenLabel mesh__D026561
% 221.34/221.57       Low Density Lipoprotein Receptor Related Protein 2
% 221.34/221.57  |- mesh__recordMaintainer mesh__D026561 ags
% 221.34/221.57  |- skos__altLabel mesh__D026561 LRP-2 Receptor
% 221.34/221.57  |- mesh__dateRevised mesh__D026561 2005-07-19
% 221.34/221.57  |- skos__hiddenLabel mesh__D026561 LDL Receptor Related Protein 2
% 221.34/221.57  |- skos__altLabel mesh__D026561 GP330 Antigen
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D026561 2006
% 221.34/221.57  |- skos__altLabel mesh__D026561 Renal Glycoprotein GP330
% 221.34/221.57  |- mesh__dateCreated mesh__D026561 2001-07-25
% 221.34/221.57  |- skos__broader mesh__D026561smesh__D026502
% 221.34/221.57  |- skos__altLabel mesh__D026561 LRP-2
% 221.34/221.57  |- skos__broader mesh__D001819smesh__D001102
% 221.34/221.57  |- skos__altLabel mesh__D001819 Blue Tongue
% 221.34/221.57  |- mesh__dateEstablished mesh__D001819 1974-01-01
% 221.34/221.57  |- mesh__dateCreated mesh__D001819 1999-01-01
% 221.34/221.57  |- skos__historyNote mesh__D001819 Sheep Diseases %28%1966-1967%29%
% 221.34/221.57  |- skos__annotation mesh__D001819
% 221.34/221.57       caused by a reovirus; usually animal; check tag ANIMALS; don%27%t forget also SHEEP %28%NIM%29% but do not index under SHEEP DISEASES%A%  
% 221.34/221.57  |- mesh__publicMeSHNote mesh__D001819 94; was BLUE TONGUE 1974-93   
% 221.34/221.57  |- skos__broader mesh__D001819smesh__D012757
% 221.34/221.57  |- skos__broader mesh__D001819smesh__D012088
% 221.34/221.57  |- skos__hiddenLabel mesh__D001819 Tongue, Blue
% 221.34/221.57  |- mesh__dateRevised mesh__D001819 2003-07-30
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D001819 2005
% 221.34/221.57  |- rdf__type mesh__D001819sskos__Concept
% 221.34/221.57  |- skos__historyNote mesh__D001819
% 221.34/221.57       Virus Diseases/veterinary %28%1966-1967%29%
% 221.34/221.57  |- mesh__recordAuthorizer mesh__D001819 sjn
% 221.34/221.57  |- mesh__onlineNote mesh__D001819
% 221.34/221.57       use BLUETONGUE to search BLUE TONGUE 1968-93 %28%as Prov 1968-73%29%%A%  
% 221.34/221.57  |- skos__prefLabel mesh__D001819 Bluetongue
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D001819 2004
% 221.34/221.57  |- mesh__historyNote mesh__D001819
% 221.34/221.57       94; was BLUE TONGUE 1968-93 %28%Prov 1968-73%29%   
% 221.34/221.57  |- mesh__recordOriginator mesh__D001819 NLM
% 221.34/221.57  |- skos__scopeNote mesh__D001819
% 221.34/221.57       A reovirus infection, chiefly of sheep, characterized by a swollen blue tongue, catarrhal inflammation of upper respiratory and gastrointestinal tracts, and often by inflammation of sensitive laminae of the feet and coronet.%A%    
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D001819 2006
% 221.34/221.57  |- mesh__recordMaintainer mesh__D001819 ags
% 221.34/221.57  |- skos__annotation mesh__D012541 strep infect; also called scarlatina   
% 221.34/221.57  |- mesh__recordOriginator mesh__D012541 NLM
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012541 1997
% 221.34/221.57  |- skos__hiddenLabel mesh__D012541 Fevers, Scarlet
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012541 2001
% 221.34/221.57  |- mesh__dateRevised mesh__D012541 1993-06-03
% 221.34/221.57  |- skos__hiddenLabel mesh__D012541 Scarlet Fevers
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012541 1998
% 221.34/221.57  |- skos__hiddenLabel mesh__D012541 Fever, Scarlet
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012541 2002
% 221.34/221.57  |- skos__broader mesh__D012541smesh__D013290
% 221.34/221.57  |- rdf__type mesh__D012541sskos__Concept
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012541 1999
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012541 1994
% 221.34/221.57  |- mesh__dateCreated mesh__D012541 1999-01-01
% 221.34/221.57  |- skos__prefLabel mesh__D012541 Scarlet Fever
% 221.34/221.57  |- mesh__recordAuthorizer mesh__D012541 PLS
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012541 2003
% 221.34/221.57  |- skos__scopeNote mesh__D012541
% 221.34/221.57       Infection with group A streptococci that is characterized by tonsillitis and pharyngitis. An erythematous rash is commonly present.%A%    
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012541 1995
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012541 2004
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012541 2005
% 221.34/221.57  |- mesh__recordMaintainer mesh__D012541 TAP
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012541 1996
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012541 2006
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D012541 2000
% 221.34/221.57  |- skos__hiddenLabel mesh__D006504 Veno Occlusive Disease, Hepatic
% 221.34/221.57  |- skos__prefLabel mesh__D006504 Hepatic Veno-Occlusive Disease
% 221.34/221.57  |- skos__broader mesh__D006504smesh__D008107
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D006504 2005
% 221.34/221.57  |- mesh__dateRevised mesh__D006504 2004-07-07
% 221.34/221.57  |- mesh__publicMeSHNote mesh__D006504
% 221.34/221.57       87; VENO-OCCLUSIVE DISEASE OF LIVER was see HEPATIC VENO-OCCLUSIVE DISEASE 1987-93%A%  
% 221.34/221.57  |- skos__historyNote mesh__D006504 Liver/blood supply %28%1966-1986%29%
% 221.34/221.57  |- skos__historyNote mesh__D006504
% 221.34/221.57       Hepatic Vein Thrombosis %28%1966-1986%29%
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D006504 2006
% 221.34/221.57  |- skos__annotation mesh__D006504 DF: HVOD   
% 221.34/221.57  |- mesh__historyNote mesh__D006504
% 221.34/221.57       87; VENO-OCCLUSIVE DISEASE OF LIVER was see HEPATIC VENO-OCCLUSIVE DISEASE 1987-93%A%  
% 221.34/221.57  |- skos__hiddenLabel mesh__D006504 Disease, Hepatic Veno-Occlusive
% 221.34/221.57  |- mesh__recordAuthorizer mesh__D006504 sjn
% 221.34/221.57  |- mesh__dateEstablished mesh__D006504 1987-01-01
% 221.34/221.57  |- skos__scopeNote mesh__D006504
% 221.34/221.57       Liver disease that is caused by injuries to the ENDOTHELIAL CELLS of the vessels and subendothelial EDEMA, but not by THROMBOSIS. Extracellular matrix, rich in FIBRONECTINS, is usually deposited around the HEPATIC VEINS leading to venous outflow occlusion and sinusoidal obstruction.%A%    
% 221.34/221.57  |- skos__historyNote mesh__D006504 Hepatic Veins %28%1966-1986%29%
% 221.34/221.57  |- skos__hiddenLabel mesh__D006504 Hepatic Veno-Occlusive Diseases
% 221.34/221.57  |- skos__altLabel mesh__D006504 Hepatic Veno Occlusive Disease
% 221.34/221.57  |- mesh__recordOriginator mesh__D006504 VDK
% 221.34/221.57  |- mesh__dateCreated mesh__D006504 1986-06-24
% 221.34/221.57  |- skos__altLabel mesh__D006504 Sinusoidal Obstruction Syndrome
% 221.34/221.57  |- rdf__type mesh__D006504sskos__Concept
% 221.34/221.57  |- skos__related mesh__D006504smesh__D006502
% 221.34/221.57  |- mesh__recordMaintainer mesh__D006504 lkt
% 221.34/221.57  |- mesh__onlineNote mesh__D006504
% 221.34/221.57       use HEPATIC VENO-OCCLUSIVE DISEASE to search VENO-OCCLUSIVE DISEASE OF LIVER 1987-93%A%  
% 221.34/221.57  |- skos__broader mesh__D006504smesh__D014652
% 221.34/221.57  |- skos__hiddenLabel mesh__D006504 Syndrome, Sinusoidal Obstruction
% 221.34/221.57  |- skos__altLabel mesh__D006504 Veno-Occlusive Disease, Hepatic
% 221.34/221.57  |- mesh__historyNote mesh__D050660 2006%28%1997%29%   
% 221.34/221.57  |- skos__scopeNote mesh__D050660
% 221.34/221.57       Heterodimeric transcription factors containing a DNA-binding alpha subunits, %28%CORE BINDING FACTOR ALPHA SUBUNITS%29%, along with a non-DNA-binding beta subunits, CORE BINDING FACTOR BETA SUBUNIT. Core Binding Factor regulates GENETIC TRANSCRIPTION of a variety of GENES involved primarily in CELL DIFFERENTIATION and CELL CYCLE progression.%A%    
% 221.34/221.57  |- skos__annotation mesh__D050660 see SCR for organism-specific terms   
% 221.34/221.57  |- mesh__dateRevised mesh__D050660 2005-08-03
% 221.34/221.57  |- mesh__recordOriginator mesh__D050660 DRC
% 221.34/221.57  |- mesh__dateCreated mesh__D050660 2005-06-30
% 221.34/221.57  |- skos__hiddenLabel mesh__D050660 Core Binding Factor
% 221.34/221.57  |- skos__broader mesh__D050660smesh__D014157
% 221.34/221.57  |- skos__historyNote mesh__D050660 Transcription Factors %28%1997-2005%29%
% 221.34/221.57  |- mesh__activeMeSHYear mesh__D050660 2006
% 221.34/221.58  |- mesh__recordMaintainer mesh__D050660 ags
% 221.34/221.58  |- mesh__publicMeSHNote mesh__D050660
% 221.34/221.58       2006; CORE-BINDING FACTOR was indexed under NEOPLASM PROTEINS %26% TRANSCRIPTION FACTORS 1997-2005%A%  
% 221.34/221.58  |- skos__hiddenLabel mesh__D050660 Binding Factors, Core
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D050660 2006B
% 221.34/221.58  |- rdf__type mesh__D050660sskos__Concept
% 221.34/221.58  |- skos__prefLabel mesh__D050660 Core Binding Factors
% 221.34/221.58  |- skos__altLabel mesh__D050660 Core-Binding Factor
% 221.34/221.58  |- mesh__recordAuthorizer mesh__D050660 ags
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D050660 2006A
% 221.34/221.58  |- skos__altLabel mesh__D050660 PEBP2 Transcription Factor
% 221.34/221.58  |- mesh__dateEstablished mesh__D050660 2006-01-01
% 221.34/221.58  |- skos__hiddenLabel mesh__D050660 Factors, Core Binding
% 221.34/221.58  |- skos__altLabel mesh__D050660 Polyomavirus Enhancer Binding Protein 2
% 221.34/221.58  |- skos__historyNote mesh__D050660 Neoplasm Proteins %28%1997-2005%29%
% 221.34/221.58  |- skos__hiddenLabel mesh__D050660 Transcription Factor, PEBP2
% 221.34/221.58  |- skos__annotation mesh__D044623 GEN only; prefer specifics   
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D044623 2005
% 221.34/221.58  |- mesh__publicMeSHNote mesh__D044623 2004   
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D044623 2006
% 221.34/221.58  |- rdf__type mesh__D044623sskos__Concept
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D044623 2004
% 221.34/221.58  |- skos__hiddenLabel mesh__D044623 Nutrition Therapy, Medical
% 221.34/221.58  |- skos__prefLabel mesh__D044623 Nutrition Therapy
% 221.34/221.58  |- mesh__dateEstablished mesh__D044623 2004-01-01
% 221.34/221.58  |- skos__broader mesh__D044623smesh__D013812
% 221.34/221.58  |- skos__hiddenLabel mesh__D044623 Therapy, Medical Nutrition
% 221.34/221.58  |- skos__historyNote mesh__D044623 Nutrition %28%1974-2003%29%
% 221.34/221.58  |- mesh__dateCreated mesh__D044623 2003-07-09
% 221.34/221.58  |- skos__scopeNote mesh__D044623
% 221.34/221.58       Improving health status of an individual by adjusting the quantities, qualities, and methods of nutrient intake.%A%    
% 221.34/221.58  |- mesh__historyNote mesh__D044623 2004   
% 221.34/221.58  |- skos__hiddenLabel mesh__D044623 Therapy, Nutrition
% 221.34/221.58  |- skos__historyNote mesh__D011449 Peroxides %28%1966-1977%29%
% 221.34/221.58  |- skos__annotation mesh__D011449
% 221.34/221.58       /biosyn /physiol permitted; /chem syn permitted: do not convert to PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; DF: PG ENDOPEROXIDES%A%  
% 221.34/221.58  |- mesh__publicMeSHNote mesh__D011449 78   
% 221.34/221.58  |- mesh__recordAuthorizer mesh__D011449 sjn
% 221.34/221.58  |- skos__historyNote mesh__D011449 Prostaglandins %28%1966-1977%29%
% 221.34/221.58  |- mesh__historyNote mesh__D011449 78   
% 221.34/221.58  |- mesh__dateRevised mesh__D011449 2005-06-30
% 221.34/221.58  |- mesh__recordMaintainer mesh__D011449 ssb
% 221.34/221.58  |- skos__broader mesh__D011449smesh__D011453
% 221.34/221.58  |- skos__scopeNote mesh__D011449
% 221.34/221.58       Precursors in the biosynthesis of prostaglandins and thromboxanes from arachidonic acid. They are physiologically active compounds, having effect on vascular and airway smooth muscles, platelet aggregation, etc.%A%    
% 221.34/221.58  |- skos__hiddenLabel mesh__D011449 Endoperoxides, Prostaglandin
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D011449 2006
% 221.34/221.58  |- mesh__dateCreated mesh__D011449 1977-05-23
% 221.34/221.58  |- mesh__recordOriginator mesh__D011449 RLS
% 221.34/221.58  |- mesh__dateEstablished mesh__D011449 1978-01-01
% 221.34/221.58  |- rdf__type mesh__D011449sskos__Concept
% 221.34/221.58  |- skos__prefLabel mesh__D011449 Prostaglandin Endoperoxides
% 221.34/221.58  |- skos__altLabel mesh__D016134 Policies, Organizational
% 221.34/221.58  |- mesh__recordMaintainer mesh__D016134 tjk
% 221.34/221.58  |- skos__altLabel mesh__D016134 Institutional Policies
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D016134 2005
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D016134 2004
% 221.34/221.58  |- mesh__recordOriginator mesh__D016134 TGC
% 221.34/221.58  |- mesh__publicMeSHNote mesh__D016134 91   
% 221.34/221.58  |- skos__scopeNote mesh__D016134
% 221.34/221.58       A course or method of action selected, usually by an organization, institution, university, society, etc., from among alternatives to guide and determine present and future decisions and positions on matters of public interest or social concern. It does not include internal policy relating to organization and administration within the corporate body, for which ORGANIZATION AND ADMINISTRATION is available.%A%    
% 221.34/221.58  |- mesh__dateCreated mesh__D016134 1990-03-23
% 221.34/221.58  |- mesh__recordAuthorizer mesh__D016134 sjn
% 221.34/221.58  |- skos__altLabel mesh__D016134 Policy, Organizational
% 221.34/221.58  |- rdf__type mesh__D016134sskos__Concept
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D016134 2003
% 221.34/221.58  |- skos__broader mesh__D016134smesh__D011049
% 221.34/221.58  |- skos__annotation mesh__D016134
% 221.34/221.58       no qualif; specify corporate body if pertinent   
% 221.34/221.58  |- skos__historyNote mesh__D016134 Public Policy %28%1978-1990%29%
% 221.34/221.58  |- skos__prefLabel mesh__D016134 Organizational Policy
% 221.34/221.58  |- mesh__historyNote mesh__D016134 91   
% 221.34/221.58  |- mesh__dateRevised mesh__D016134 2002-07-03
% 221.34/221.58  |- skos__altLabel mesh__D016134 Policy, Institutional
% 221.34/221.58  |- mesh__dateEstablished mesh__D016134 1991-01-01
% 221.34/221.58  |- skos__altLabel mesh__D016134 Policies, Institutional
% 221.34/221.58  |- skos__altLabel mesh__D016134 Organizational Policies
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D016134 2006
% 221.34/221.58  |- skos__prefLabel mesh__D002912 Chrysosporium
% 221.34/221.58  |- skos__scopeNote mesh__D002912
% 221.34/221.58       A mitosporic Onygenaceae fungal genus which causes adiaspiromycosis, a pulmonary mycosis of man and rodents. One of its teleomorphs is Ajellomyces.%A%    
% 221.34/221.58  |- skos__altLabel mesh__D002912 Emmonsia
% 221.34/221.58  |- mesh__recordAuthorizer mesh__D002912 sjn
% 221.34/221.58  |- mesh__dateRevised mesh__D002912 2005-06-30
% 221.34/221.58  |- mesh__historyNote mesh__D002912
% 221.34/221.58       91%28%86%29%; for EMMONSIA use MITOSPORIC FUNGI 1975-85   
% 221.34/221.58  |- mesh__dateCreated mesh__D002912 1985-02-11
% 221.34/221.58  |- rdf__type mesh__D002912sskos__Concept
% 221.34/221.58  |- skos__related mesh__D002912smesh__D020036
% 221.34/221.58  |- skos__annotation mesh__D002912
% 221.34/221.58       infection: coord IM with MYCOSES %28%IM%29% or specific mycosis %28%IM%29%%A%  
% 221.34/221.58  |- mesh__publicMeSHNote mesh__D002912
% 221.34/221.58       91; see HYPHOMYCETES 1986-90; for EMMONSIA see MONILIALES 1975-85%A%  
% 221.34/221.58  |- mesh__recordOriginator mesh__D002912 RC
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D002912 2006
% 221.34/221.58  |- mesh__recordMaintainer mesh__D002912 SYSTEM
% 221.34/221.58  |- mesh__dateEstablished mesh__D002912 1991-01-01
% 221.34/221.58  |- skos__broader mesh__D002912smesh__D003904
% 221.34/221.58  |- skos__historyNote mesh__D002912 Hyphomycetes %28%1966-1985%29%
% 221.34/221.58  |- skos__historyNote mesh__D002912 Fungi %28%1966-1985%29%
% 221.34/221.58  |- skos__broader mesh__D002114smesh__D002128
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D002114 2006
% 221.34/221.58  |- skos__altLabel mesh__D002114 Calcification, Pathologic
% 221.34/221.58  |- mesh__dateRevised mesh__D002114 2004-07-13
% 221.34/221.58  |- mesh__recordAuthorizer mesh__D002114 sjn
% 221.34/221.58  |- mesh__publicMeSHNote mesh__D002114 CALCIPHYLAXIS was heading 1965-83   
% 221.34/221.58  |- mesh__recordMaintainer mesh__D002114 sjn
% 221.34/221.58  |- rdf__type mesh__D002114sskos__Concept
% 221.34/221.58  |- skos__annotation mesh__D002114
% 221.34/221.58        deposition of calcium salts in tissues; most texts will say %22%calcification%22%; coord IM with organ/diseases term %28%IM%29%; for calcinosis of the heart, coord IM with  CARDIOMYOPATHIES %28%IM%29%, not HEART DISEASES%A%  
% 221.34/221.58  |- skos__scopeNote mesh__D002114
% 221.34/221.58       Pathologic deposition of calcium salts in tissues.     
% 221.34/221.58  |- mesh__dateCreated mesh__D002114 1999-01-01
% 221.34/221.58  |- mesh__recordOriginator mesh__D002114 NLM
% 221.34/221.58  |- skos__altLabel mesh__D002114 Pathologic Calcification
% 221.34/221.58  |- skos__related mesh__D002114smesh__D002805
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D002114 2005
% 221.34/221.58  |- skos__prefLabel mesh__D002114 Calcinosis
% 221.34/221.58  |- skos__hiddenLabel mesh__D002114 Calcinoses
% 221.34/221.58  |- skos__historyNote mesh__D012542 Radiation %28%1966-1970%29%
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012542 2002
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012542 1997
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012542 1991
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012542 2006
% 221.34/221.58  |- skos__annotation mesh__D012542
% 221.34/221.58       NIM; no qualif; includes light scattering %28%coord with LIGHT %28%NIM%29% %29%%A%  
% 221.34/221.58  |- skos__prefLabel mesh__D012542 Scattering, Radiation
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012542 2001
% 221.34/221.58  |- mesh__dateCreated mesh__D012542 1999-01-01
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012542 1996
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012542 1995
% 221.34/221.58  |- mesh__onlineNote mesh__D012542
% 221.34/221.58       use SCATTERING, RADIATION to search SCATTERING 1971-73 %28%as Prov%29%%A%  
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012542 1990
% 221.34/221.58  |- mesh__historyNote mesh__D012542
% 221.34/221.58       74; was SCATTERING 1971-73 %28%Prov%29%   
% 221.34/221.58  |- skos__related mesh__D012542smesh__D009391
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012542 2005
% 221.34/221.58  |- skos__hiddenLabel mesh__D012542 Radiation Scatterings
% 221.34/221.58  |- mesh__recordOriginator mesh__D012542 NLM
% 221.34/221.58  |- mesh__recordAuthorizer mesh__D012542 PLS
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012542 2000
% 221.34/221.58  |- skos__scopeNote mesh__D012542
% 221.34/221.58       The process in which energy is removed from a beam of light or other electromagnetic radiation and emitted without appreciable change in wavelength. May be considered as the change in direction of a particle or photon owing to a collision with another particle or system.%A%    
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012542 1994
% 221.34/221.58  |- skos__broader mesh__D012542smesh__D011827
% 221.34/221.58  |- rdf__type mesh__D012542sskos__Concept
% 221.34/221.58  |- skos__historyNote mesh__D012542 specific radiation %28%1966-1970%29%
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012542 2004
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012542 1999
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012542 1993
% 221.34/221.58  |- mesh__dateRevised mesh__D012542 1989-07-14
% 221.34/221.58  |- mesh__recordMaintainer mesh__D012542 PLS
% 221.34/221.58  |- mesh__publicMeSHNote mesh__D012542 74   
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012542 2003
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012542 1998
% 221.34/221.58  |- skos__altLabel mesh__D012542 Radiation Scattering
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012542 1992
% 221.34/221.58  |- mesh__dateEstablished mesh__D012542 1974-01-01
% 221.34/221.58  |- skos__hiddenLabel mesh__D012542 Scatterings, Radiation
% 221.34/221.58  |- skos__scopeNote mesh__D006505 INFLAMMATION of the LIVER.     
% 221.34/221.58  |- mesh__recordOriginator mesh__D006505 NLM
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D006505 2005
% 221.34/221.58  |- mesh__dateRevised mesh__D006505 2004-07-13
% 221.34/221.58  |- skos__broader mesh__D006505smesh__D008107
% 221.34/221.58  |- mesh__recordAuthorizer mesh__D006505 sjn
% 221.34/221.58  |- mesh__recordMaintainer mesh__D006505 sjn
% 221.34/221.58  |- mesh__dateCreated mesh__D006505 1999-01-01
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D006505 2006
% 221.34/221.58  |- skos__prefLabel mesh__D006505 Hepatitis
% 221.34/221.58  |- rdf__type mesh__D006505sskos__Concept
% 221.34/221.58  |- skos__annotation mesh__D006505
% 221.34/221.58       GEN or unspecified; prefer specifics; probably non-viral; viral hepatitis = HEPATITIS, VIRAL, HUMAN %26% HEPATITIS, VIRAL, ANIMAL or their specifics; /chem ind = HEPATITIS, TOXIC but note HEPATITIS, ALCOHOLIC is also available%A%  
% 221.34/221.58  |- skos__hiddenLabel mesh__D006505 Hepatitides
% 221.34/221.58  |- skos__historyNote mesh__D050661 Whales %28%1974-2005%29%
% 221.34/221.58  |- mesh__dateEstablished mesh__D050661 2006-01-01
% 221.34/221.58  |- mesh__recordMaintainer mesh__D050661 ags
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D050661 2006
% 221.34/221.58  |- rdf__type mesh__D050661sskos__Concept
% 221.34/221.58  |- skos__prefLabel mesh__D050661 Sperm Whale
% 221.34/221.58  |- skos__annotation mesh__D050661
% 221.34/221.58       do not confuse with the Pygmy Sperm Whale or Dwarf Sperm Whale = WHALES%A%  
% 221.34/221.58  |- mesh__dateCreated mesh__D050661 2005-06-30
% 221.34/221.58  |- skos__hiddenLabel mesh__D050661 Whale, Sperm
% 221.34/221.58  |- skos__broader mesh__D050661smesh__D014907
% 221.34/221.58  |- skos__altLabel mesh__D050661 Physeter macrocephalus
% 221.34/221.58  |- mesh__publicMeSHNote mesh__D050661 2006; see WHALES 1998-2005   
% 221.34/221.58  |- skos__scopeNote mesh__D050661
% 221.34/221.58       The species Physeter catodon %28%also called Physeter macrocephalus%29%, in the family Physeteridae. The common name is derived from the milky wax substance in its head %28%spermaceti%29%. The species also produces an intestinal secretion AMBERGRIS,  which was previously used in perfumes. The sperm whale is the largest toothed MAMMAL in the world.%A%    
% 221.34/221.58  |- mesh__recordAuthorizer mesh__D050661 sjn
% 221.34/221.58  |- skos__historyNote mesh__D050661 Cetacea %28%1965-2005%29%
% 221.34/221.58  |- mesh__recordOriginator mesh__D050661 ags
% 221.34/221.58  |- mesh__historyNote mesh__D050661 2006; use WHALES 1998-2005   
% 221.34/221.58  |- skos__altLabel mesh__D050661 Physeter catodon
% 221.34/221.58  |- skos__related mesh__D050661smesh__D018648
% 221.34/221.58  |- skos__broader mesh__D002136Q000172smesh__D002136
% 221.34/221.58  |- mesh__preferredCombination mesh__D002136Q000172smesh__D002118Q000172
% 221.34/221.58  |- rdf__type mesh__D002136Q000172smesh__CompoundConcept
% 221.34/221.58  |- skos__hiddenLabel mesh__D016135 Dysraphicus, Status
% 221.34/221.58  |- skos__broader mesh__D016135smesh__D009436
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D016135 2003
% 221.34/221.58  |- skos__altLabel mesh__D016135 Schistorrhachis
% 221.34/221.58  |- mesh__recordOriginator mesh__D016135 AGS
% 221.34/221.58  |- skos__annotation mesh__D016135
% 221.34/221.58       GEN or unspecified; prefer specifics; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 221.34/221.58  |- skos__hiddenLabel mesh__D016135 Rachischises
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D016135 2001
% 221.34/221.58  |- skos__hiddenLabel mesh__D016135 Dysraphism, Spinal
% 221.34/221.58  |- skos__hiddenLabel mesh__D016135 Spinal Dysraphias
% 221.34/221.58  |- mesh__publicMeSHNote mesh__D016135
% 221.34/221.58       1991; see STATUS DYSRAPHICUS 1964-90 ; for SPINA BIFIDA see SPINA BIFIDA OCCULTA 1978-1990, see SPINAL DYSRAPHISM 1966-1977%A%  
% 221.34/221.58  |- mesh__recordAuthorizer mesh__D016135 sjn
% 221.34/221.58  |- skos__hiddenLabel mesh__D016135 Spina Bifidas
% 221.34/221.58  |- mesh__historyNote mesh__D016135
% 221.34/221.58       1991%28%1964%29%; for SPINA BIFIDA use SPINA BIFIDA OCCULTA 1978-1990, use SPINAL DYSRAPHISM 1966-1970%A%  
% 221.34/221.58  |- skos__hiddenLabel mesh__D016135 Spinal Dysraphisms
% 221.34/221.58  |- skos__prefLabel mesh__D016135 Spinal Dysraphism
% 221.34/221.58  |- mesh__dateRevised mesh__D016135 2000-06-22
% 221.34/221.58  |- mesh__dateEstablished mesh__D016135 1991-01-01
% 221.34/221.58  |- skos__altLabel mesh__D016135 Spinal Dysraphia
% 221.34/221.58  |- skos__hiddenLabel mesh__D016135 Bifida, Spina
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D016135 2006
% 221.34/221.58  |- skos__hiddenLabel mesh__D016135 Dysraphias, Spinal
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D016135 2002
% 221.34/221.58  |- skos__altLabel mesh__D016135 Spina Bifida
% 221.34/221.58  |- skos__scopeNote mesh__D016135
% 221.34/221.58       Congenital defects of closure of one or more vertebral arches, which may be associated with malformations of the spinal cord, nerve roots, congenital fibrous bands, lipomas, and congenital cysts. These malformations range from mild %28%e.g., SPINA BIFIDA OCCULTA%29% to severe, including rachischisis where there is complete failure of neural tube and spinal cord fusion, resulting in exposure of the spinal cord at the surface. Spinal dysraphism includes all forms of spina bifida. The open form is called SPINA BIFIDA CYSTICA and the closed form is SPINA BIFIDA OCCULTA. %28%From Joynt, Clinical Neurology, 1992, Ch55, p34%29%%A%    
% 221.34/221.58  |- mesh__dateCreated mesh__D016135 1990-07-27
% 221.34/221.58  |- skos__hiddenLabel mesh__D016135 Dysraphisms, Spinal
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D016135 2005
% 221.34/221.58  |- skos__hiddenLabel mesh__D016135 Dysraphia, Spinal
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D016135 2004
% 221.34/221.58  |- mesh__recordMaintainer mesh__D016135 jls
% 221.34/221.58  |- rdf__type mesh__D016135sskos__Concept
% 221.34/221.58  |- rdf__type mesh__D002913sskos__Concept
% 221.34/221.58  |- skos__annotation mesh__D002913
% 221.34/221.58       chyluria: index CHYLE %28%IM%29% + URINE %28%NIM%29%   
% 221.34/221.58  |- mesh__recordAuthorizer mesh__D002913 sjn
% 221.34/221.58  |- skos__prefLabel mesh__D002913 Chyle
% 221.34/221.58  |- skos__broader mesh__D002913smesh__D008196
% 221.34/221.58  |- skos__hiddenLabel mesh__D002913 Chyles
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D002913 2005
% 221.34/221.58  |- mesh__recordOriginator mesh__D002913 NLM
% 221.34/221.58  |- mesh__dateCreated mesh__D002913 1999-01-01
% 221.34/221.58  |- mesh__recordMaintainer mesh__D002913 jmp
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D002913 2006
% 221.34/221.58  |- mesh__dateRevised mesh__D002913 2003-07-09
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D002913 2004
% 221.34/221.58  |- skos__scopeNote mesh__D002913
% 221.34/221.58       An opaque, milky-white fluid consisting mainly of emulsified fats that passes through the lacteals of the small intestines into the lymphatic system.%A%    
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D002115 1996
% 221.34/221.58  |- skos__prefLabel mesh__D002115 Calciphylaxis
% 221.34/221.58  |- mesh__dateCreated mesh__D002115 1999-01-01
% 221.34/221.58  |- mesh__recordOriginator mesh__D002115 NLM
% 221.34/221.58  |- mesh__dateRevised mesh__D002115 1993-05-26
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D002115 1999
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D002115 2000
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D002115 2003
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D002115 1995
% 221.34/221.58  |- mesh__publicMeSHNote mesh__D002115
% 221.34/221.58       91,63-83; was see under CALCINOSIS 1984-90   
% 221.34/221.58  |- skos__annotation mesh__D002115
% 221.34/221.58       hypersensitivity with sudden local calcification   
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D002115 1998
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D002115 2006
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D002115 2002
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D002115 1994
% 221.34/221.58  |- mesh__recordMaintainer mesh__D002115 TGC
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D002115 2005
% 221.34/221.58  |- mesh__dateEstablished mesh__D002115 1965-01-01
% 221.34/221.58  |- skos__altLabel mesh__D002115 Calciphylaxes
% 221.34/221.58  |- mesh__historyNote mesh__D002115
% 221.34/221.58       91%28%84%29%63; was see under CALCINOSIS 1984-90   
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D002115 1997
% 221.34/221.58  |- rdf__type mesh__D002115sskos__Concept
% 221.34/221.58  |- skos__broader mesh__D002115smesh__D002114
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D002115 2001
% 221.34/221.58  |- skos__scopeNote mesh__D002115
% 221.34/221.58       Condition of induced systemic hypersensitivity in which tissues respond to appropriate challenging agents with a sudden local calcification.%A%    
% 221.34/221.58  |- mesh__recordAuthorizer mesh__D002115 PLS
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D002115 2004
% 221.34/221.58  |- skos__altLabel mesh__D026563 Heparin-Binding Protein, 39-kDa
% 221.34/221.58  |- skos__altLabel mesh__D026563 A2MRAP Protein
% 221.34/221.58  |- mesh__publicMeSHNote mesh__D026563
% 221.34/221.58       2002; HEPARIN-BINDING PROTEIN 44, 39-KDA RECEPTOR-ASSOCIATED PROTEIN %26% 39KDA-RAP were indexed under CARRIER PROTEINS %26% GLYCOPROTEINS 1992-2001; ALPHA2-MACROGLOBULIN RECEPTOR-ASSOCIATED PROTEIN %26% ALPHA2-MRAP were indexed under CARRIER PROTEINS %26% GLYCOPROTEINS 1994-2001; LDL RECEPTOR-ASSOCIATED PROTEIN was indexed under MEMBRANE GLYCOPROTEINS 1997-2001; LPRAP1 GENE PRODUCT was indexed under RECEPTORS, IMMUNOLOGIC 1997-2001%A%  
% 221.34/221.58  |- skos__broader mesh__D026563smesh__D008565
% 221.34/221.58  |- skos__hiddenLabel mesh__D026563
% 221.34/221.58       Receptor-Associated Protein, alpha2-Macroglobulin
% 221.34/221.58  |- skos__historyNote mesh__D026563 Membrane Glycoproteins %28%1997-2001%29%
% 221.34/221.58  |- skos__hiddenLabel mesh__D026563 39 kDa RAP
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D026563 2006
% 221.34/221.58  |- skos__altLabel mesh__D026563 39-kDa Receptor-Associated Protein
% 221.34/221.58  |- mesh__historyNote mesh__D026563
% 221.34/221.58       2002; for HEPARIN-BINDING PROTEIN 44, 39-KDA RECEPTOR-ASSOCIATED PROTEIN %26% 39KDA-RAP use LDL-RECEPTOR RELATED PROTEIN-ASSOCIATED PROTEIN %28%NM%29% 1992-2001; for ALPHA2-MACROGLOBULIN RECEPTOR-ASSOCIATED PROTEIN %26% ALPHA2-MRAP use LDL-RECEPTOR RELATED PROTEIN-ASSOCIATED PROTEIN %28%NM%29% 1994-2001; for LDL RECEPTOR-ASSOCIATED PROTEIN use HEYMANN NEPHRITIS ANTIGEN COMPLEX %28%NM%29% 1997-2001; for LPRAP1 GENE PRODUCT use LDL-RECEPTOR RELATED PROTEIN 1 %28%NM%29% 1997-2001%A%  
% 221.34/221.58  |- mesh__dateCreated mesh__D026563 2001-07-25
% 221.34/221.58  |- skos__prefLabel mesh__D026563
% 221.34/221.58       LDL-Receptor Related Protein-Associated Protein
% 221.34/221.58  |- skos__hiddenLabel mesh__D026563 39 kDa Receptor Associated Protein
% 221.34/221.58  |- skos__altLabel mesh__D026563
% 221.34/221.58       alpha2-Macroglobulin Receptor-Associated Protein
% 221.34/221.58  |- skos__altLabel mesh__D026563 39-kDa-RAP
% 221.34/221.58  |- skos__altLabel mesh__D026563
% 221.34/221.58       Low-Density Lipoprotein-Related Protein-Associated Protein 1
% 221.34/221.58  |- mesh__dateRevised mesh__D026563 2005-06-30
% 221.34/221.58  |- mesh__recordAuthorizer mesh__D026563 sjn
% 221.34/221.58  |- skos__historyNote mesh__D026563 Glycoproteins %28%1992-2001%29%
% 221.34/221.58  |- skos__hiddenLabel mesh__D026563 Heparin Binding Protein 44
% 221.34/221.58  |- skos__broader mesh__D026563smesh__D026541
% 221.34/221.58  |- skos__altLabel mesh__D026563 HBP44
% 221.34/221.58  |- skos__altLabel mesh__D026563 Heparin-Binding Protein 44
% 221.34/221.58  |- skos__historyNote mesh__D026563 Receptors, Immunologic %28%1997-2001%29%
% 221.34/221.58  |- skos__hiddenLabel mesh__D026563 39-kDa Heparin-Binding Protein
% 221.34/221.58  |- rdf__type mesh__D026563sskos__Concept
% 221.34/221.58  |- skos__altLabel mesh__D026563 LRPAP1 Gene Product
% 221.34/221.58  |- skos__hiddenLabel mesh__D026563
% 221.34/221.58       Low Density Lipoprotein Related Protein Associated Protein 1
% 221.34/221.58  |- skos__altLabel mesh__D026563 HBP-44
% 221.34/221.58  |- skos__hiddenLabel mesh__D026563 HBP 44
% 221.34/221.58  |- skos__altLabel mesh__D026563 LDL Receptor-Associated Protein
% 221.34/221.58  |- skos__hiddenLabel mesh__D026563 LDL Receptor Associated Protein
% 221.34/221.58  |- skos__historyNote mesh__D026563 Carrier Proteins %28%1992-2001%29%
% 221.34/221.58  |- skos__hiddenLabel mesh__D026563
% 221.34/221.58       alpha2 Macroglobulin Receptor Associated Protein
% 221.34/221.58  |- skos__hiddenLabel mesh__D026563 alpha2 MRAP
% 221.34/221.58  |- mesh__recordMaintainer mesh__D026563 ssb
% 221.34/221.58  |- skos__hiddenLabel mesh__D026563 Heparin Binding Protein, 39 kDa
% 221.34/221.58  |- skos__scopeNote mesh__D026563
% 221.34/221.58       A membrane protein found in the rough endoplasm reticulum %28%ENDOPLASMIC RETICULUM, ROUGH%29% that binds to LDL-RECEPTOR RELATED PROTEINS. It may function to prevent ligand binding of receptors during protein processing events within endosomal compartments.%A%    
% 221.34/221.58  |- mesh__dateEstablished mesh__D026563 2002-01-01
% 221.34/221.58  |- skos__hiddenLabel mesh__D026563
% 221.34/221.58       LDL Receptor Related Protein Associated Protein
% 221.34/221.58  |- skos__altLabel mesh__D026563 Receptor-Associated Protein %28%LDL%29%
% 221.34/221.58  |- skos__hiddenLabel mesh__D026563 Receptor-Associated Protein, 39-kDa
% 221.34/221.58  |- skos__altLabel mesh__D026563 alpha2-MRAP
% 221.34/221.58  |- mesh__recordOriginator mesh__D026563 jmp
% 221.34/221.58  |- mesh__dateRevised mesh__D012543 1990-04-13
% 221.34/221.58  |- mesh__historyNote mesh__D012543
% 221.34/221.58       91%28%75%29%; was see under EXOCRINE GLANDS 1975-90   
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012543 1996
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012543 1995
% 221.34/221.58  |- mesh__recordMaintainer mesh__D012543 NLM
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012543 2005
% 221.34/221.58  |- skos__prefLabel mesh__D012543 Scent Glands
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012543 2002
% 221.34/221.58  |- skos__hiddenLabel mesh__D012543 Scent Gland
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012543 1994
% 221.34/221.58  |- mesh__dateCreated mesh__D012543 1974-11-11
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012543 1991
% 221.34/221.58  |- rdf__type mesh__D012543sskos__Concept
% 221.34/221.58  |- skos__scopeNote mesh__D012543
% 221.34/221.58       Exocrine glands in animals which secrete scents which either repel or attract other animals, e.g. perianal glands of skunks, anal glands of weasels, musk glands of foxes, ventral glands of wood rats, and dorsal glands of peccaries.%A%    
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012543 2004
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012543 1999
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012543 2001
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012543 1993
% 221.34/221.58  |- mesh__publicMeSHNote mesh__D012543
% 221.34/221.58       91; was see under EXOCRINE GLANDS 1975-90   
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012543 2003
% 221.34/221.58  |- mesh__recordOriginator mesh__D012543 NLM
% 221.34/221.58  |- mesh__recordAuthorizer mesh__D012543 PLS
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012543 1998
% 221.34/221.58  |- skos__annotation mesh__D012543
% 221.34/221.58       animal only; includes skunk perianal glands, weasel anal glands, fox musk glands, wood rat ventral glands, peccary dorsal glands%A%  
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012543 2000
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012543 1992
% 221.34/221.58  |- skos__hiddenLabel mesh__D012543 Gland, Scent
% 221.34/221.58  |- skos__broader mesh__D012543smesh__D000825
% 221.34/221.58  |- mesh__dateEstablished mesh__D012543 1991-01-01
% 221.34/221.58  |- skos__hiddenLabel mesh__D012543 Glands, Scent
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012543 1997
% 221.34/221.58  |- mesh__activeMeSHYear mesh__D012543 2006
% 221.44/221.58  |- mesh__activeMeSHYear mesh__D006506 2006
% 221.44/221.58  |- mesh__historyNote mesh__D006506 77; was HEPATITIS, INFECTIOUS 1963-76   
% 221.44/221.58  |- skos__altLabel mesh__D006506 Infectious Hepatitis
% 221.44/221.58  |- skos__altLabel mesh__D006506 Hepatitis, Infectious
% 221.44/221.58  |- skos__hiddenLabel mesh__D006506 Infectious Hepatitides
% 221.44/221.58  |- skos__broader mesh__D006506smesh__D004769
% 221.44/221.58  |- rdf__type mesh__D006506sskos__Concept
% 221.44/221.58  |- mesh__onlineNote mesh__D006506
% 221.44/221.58       use HEPATITIS A to search HEPATITIS, INFECTIOUS 1966-76   
% 221.44/221.58  |- skos__prefLabel mesh__D006506 Hepatitis A
% 221.44/221.58  |- mesh__recordMaintainer mesh__D006506 sjn
% 221.44/221.58  |- mesh__recordOriginator mesh__D006506 NLM
% 221.44/221.58  |- mesh__dateRevised mesh__D006506 2004-07-13
% 221.44/221.58  |- mesh__recordAuthorizer mesh__D006506 sjn
% 221.44/221.58  |- mesh__activeMeSHYear mesh__D006506 2005
% 221.44/221.58  |- skos__broader mesh__D006506smesh__D006525
% 221.44/221.58  |- skos__hiddenLabel mesh__D006506 Hepatitides, Infectious
% 221.44/221.58  |- skos__scopeNote mesh__D006506
% 221.44/221.58       INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water.%A%    
% 221.44/221.58  |- mesh__publicMeSHNote mesh__D006506
% 221.44/221.58       77; was HEPATITIS, INFECTIOUS 1963-76   
% 221.44/221.58  |- mesh__dateCreated mesh__D006506 1999-01-01
% 221.44/221.58  |- rdf__type mesh__D016934sskos__Concept
% 221.44/221.58  |- mesh__recordAuthorizer mesh__D016934 sjn
% 221.44/221.58  |- mesh__historyNote mesh__D016934 92   
% 221.44/221.58  |- skos__prefLabel mesh__D016934 Caulobacter
% 221.44/221.58  |- mesh__dateRevised mesh__D016934 2005-06-30
% 221.44/221.58  |- mesh__recordMaintainer mesh__D016934 SYSTEM
% 221.44/221.58  |- skos__historyNote mesh__D016934 Bacteria %28%1966-1991%29%
% 221.44/221.58  |- skos__scopeNote mesh__D016934
% 221.44/221.58       A genus of gram-negative, aerobic, rod- or vibroid-shaped or fusiform bacteria that commonly produce a stalk. They are found in fresh water and soil and divide by binary transverse fission.%A%    
% 221.44/221.58  |- mesh__activeMeSHYear mesh__D016934 2006
% 221.44/221.58  |- skos__broader mesh__D016934smesh__D042063
% 221.44/221.58  |- mesh__dateCreated mesh__D016934 1991-05-30
% 221.44/221.58  |- mesh__publicMeSHNote mesh__D016934 92   
% 221.44/221.58  |- skos__broader mesh__D016934smesh__D006088
% 221.44/221.58  |- mesh__dateEstablished mesh__D016934 1992-01-01
% 221.44/221.58  |- mesh__recordOriginator mesh__D016934 PXP
% 221.44/221.58  |- mesh__recordMaintainer mesh__D049310 lkt
% 221.44/221.58  |- mesh__recordAuthorizer mesh__D049310 sjn
% 221.44/221.58  |- skos__altLabel mesh__D049310 Distal Myopathy
% 221.44/221.58  |- skos__historyNote mesh__D049310 Muscular Diseases %28%1965-2004%29%
% 221.44/221.58  |- skos__hiddenLabel mesh__D049310 Myopathy, Distal
% 221.44/221.58  |- skos__hiddenLabel mesh__D049310 Muscular Dystrophies, Distal
% 221.44/221.58  |- mesh__recordOriginator mesh__D049310 lkt
% 221.44/221.58  |- mesh__dateCreated mesh__D049310 2004-07-07
% 221.44/221.58  |- skos__altLabel mesh__D049310 Distal Muscular Dystrophies
% 221.44/221.58  |- skos__hiddenLabel mesh__D049310 Finnish Markesbery Muscular Dystrophy
% 221.44/221.58  |- skos__hiddenLabel mesh__D049310 Muscular Dystrophy, Tibial
% 221.44/221.58  |- mesh__activeMeSHYear mesh__D049310 2006
% 221.44/221.58  |- skos__hiddenLabel mesh__D049310 Udd Markesbery Muscular Dystrophy
% 221.44/221.58  |- mesh__publicMeSHNote mesh__D049310
% 221.44/221.58       2005; see MUSCULAR DYSTROPHIES 2000-2004   
% 221.44/221.58  |- skos__broader mesh__D049310smesh__D009136
% 221.44/221.58  |- skos__historyNote mesh__D049310 Muscular Dystrophies %28%1966-2004%29%
% 221.44/221.58  |- skos__hiddenLabel mesh__D049310 Muscular Dystrophy, Finnish-Markesbery
% 221.44/221.58  |- rdf__type mesh__D049310sskos__Concept
% 221.44/221.58  |- mesh__activeMeSHYear mesh__D049310 2005
% 221.44/221.58  |- skos__hiddenLabel mesh__D049310 Muscular Dystrophy, Udd-Markesbery
% 221.44/221.58  |- mesh__historyNote mesh__D049310
% 221.44/221.58       2005; use MUSCULAR DYSTROPHIES 2000-2004   
% 221.44/221.58  |- skos__altLabel mesh__D049310 Muscular Dystrophy, Distal
% 221.44/221.58  |- skos__scopeNote mesh__D049310
% 221.44/221.58       A heterogeneous group of genetic disorders characterized by progressive MUSCULAR ATROPHY and MUSCLE WEAKNESS beginning in the hands, the legs, or the feet. Most are adult-onset autosomal dominant forms. Others are autosomal recessive.%A%    
% 221.44/221.58  |- skos__hiddenLabel mesh__D049310 Myopathies, Distal
% 221.44/221.58  |- skos__altLabel mesh__D049310 Udd-Markesbery Muscular Dystrophy
% 221.44/221.58  |- skos__hiddenLabel mesh__D049310 Distal Muscular Dystrophy
% 221.44/221.58  |- skos__hiddenLabel mesh__D049310 Distal Myopathy, Welander
% 221.44/221.58  |- mesh__dateEstablished mesh__D049310 2005-01-01
% 221.44/221.58  |- skos__prefLabel mesh__D049310 Distal Myopathies
% 221.44/221.59  |- skos__altLabel mesh__D049310 Finnish-Markesbery Muscular Dystrophy
% 221.44/221.59  |- skos__hiddenLabel mesh__D016136 Spina Bifida, Occult
% 221.44/221.59  |- mesh__dateCreated mesh__D016136 1990-06-05
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D016136 2002
% 221.44/221.59  |- skos__altLabel mesh__D016136 Spinal Bifida, Closed
% 221.44/221.59  |- skos__altLabel mesh__D016136 Occult Spina Bifida
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D016136 2006
% 221.44/221.59  |- skos__scopeNote mesh__D016136
% 221.44/221.59       A common congenital midline defect of fusion of the vertebral arch without protrusion of the spinal cord or meninges. The lesion is also covered by skin. L5 and S1 are the most common vertebrae involved. The condition may be associated with an overlying area of hyperpigmented skin, a dermal sinus, or an abnormal patch of hair. The majority of individuals with this malformation are asymptomatic although there is an increased incidence of tethered cord syndrome and lumbar SPONDYLOSIS. %28%From Joynt, Clinical Neurology, 1992, Ch55, p34%29%%A%    
% 221.44/221.59  |- mesh__dateEstablished mesh__D016136 1991-01-01
% 221.44/221.59  |- mesh__dateRevised mesh__D016136 1999-12-08
% 221.44/221.59  |- mesh__publicMeSHNote mesh__D016136
% 221.44/221.59       1991; was SPINA BIFIDA 1978-1990; for DERMAL SINUS see NEURAL TUBE DEFECTS 1979-1990%A%  
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D016136 2005
% 221.44/221.59  |- mesh__recordOriginator mesh__D016136 AGS
% 221.44/221.59  |- skos__broader mesh__D016136smesh__D016135
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D016136 2004
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D016136 2001
% 221.44/221.59  |- skos__hiddenLabel mesh__D016136 Closed Spinal Bifida
% 221.44/221.59  |- rdf__type mesh__D016136sskos__Concept
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D016136 2003
% 221.44/221.59  |- mesh__recordAuthorizer mesh__D016136 ags
% 221.44/221.59  |- skos__historyNote mesh__D016136 Spinal Dysraphism %28%1966-1977%29%
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D016136 2000
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D016136 2000A
% 221.44/221.59  |- mesh__historyNote mesh__D016136
% 221.44/221.59       1991; was SPINA BIFIDA 1978-1990; for DERMAL SINUS use NEURAL TUBE DEFECTS 1979-1990%A%  
% 221.44/221.59  |- skos__prefLabel mesh__D016136 Spina Bifida Occulta
% 221.44/221.59  |- mesh__recordMaintainer mesh__D016136 ags
% 221.44/221.59  |- skos__hiddenLabel mesh__D016136 Sinus, Dermal
% 221.44/221.59  |- mesh__dateCreated mesh__D002914 1999-01-01
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D002914 2006
% 221.44/221.59  |- skos__prefLabel mesh__D002914 Chylomicrons
% 221.44/221.59  |- skos__broader mesh__D002914smesh__D008074
% 221.44/221.59  |- mesh__recordMaintainer mesh__D002914 SYSTEM
% 221.44/221.59  |- rdf__type mesh__D002914sskos__Concept
% 221.44/221.59  |- mesh__recordAuthorizer mesh__D002914 sjn
% 221.44/221.59  |- mesh__dateRevised mesh__D002914 2005-06-30
% 221.44/221.59  |- skos__scopeNote mesh__D002914
% 221.44/221.59       A class of lipoproteins that carry dietary cholesterol and triglycerides from the small intestines to the tissues.%A%    
% 221.44/221.59  |- mesh__recordOriginator mesh__D002914 NLM
% 221.44/221.59  |- skos__altLabel mesh__D002116 Calcitrin
% 221.44/221.59  |- skos__broader mesh__D002116smesh__D036361
% 221.44/221.59  |- skos__hiddenLabel mesh__D002116 Ciba 47175BA
% 221.44/221.59  |- mesh__historyNote mesh__D002116
% 221.44/221.59       74,66-67; was THYROCALCITONIN 1968-73 %26% 1964-65 %28%Prov 1964-65%29%%A%  
% 221.44/221.59  |- skos__broader mesh__D002116smesh__D009479
% 221.44/221.59  |- mesh__onlineNote mesh__D002116
% 221.44/221.59       use CALCITONIN to search THYROCALCITONIN 1966-73   
% 221.44/221.59  |- skos__altLabel mesh__D002116 Thyrocalcitonin
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D002116 2006
% 221.44/221.59  |- skos__hiddenLabel mesh__D002116 Ciba 47175 BA
% 221.44/221.59  |- skos__hiddenLabel mesh__D002116 Calcitonin, Eel
% 221.44/221.59  |- mesh__publicMeSHNote mesh__D002116
% 221.44/221.59       74,66-67; was THYROCALCITONIN 1968-73   
% 221.44/221.59  |- rdf__type mesh__D002116sskos__Concept
% 221.44/221.59  |- mesh__recordAuthorizer mesh__D002116 sjn
% 221.44/221.59  |- mesh__dateRevised mesh__D002116 2005-06-30
% 221.44/221.59  |- mesh__recordMaintainer mesh__D002116 ssb
% 221.44/221.59  |- skos__prefLabel mesh__D002116 Calcitonin
% 221.44/221.59  |- mesh__dateCreated mesh__D002116 1999-01-01
% 221.44/221.59  |- mesh__recordOriginator mesh__D002116 NLM
% 221.44/221.59  |- skos__altLabel mesh__D002116 Calcitonin%28%1-32%29%
% 221.44/221.59  |- skos__related mesh__D002116smesh__D018003
% 221.44/221.59  |- mesh__dateEstablished mesh__D002116 1974-01-01
% 221.44/221.59  |- skos__scopeNote mesh__D002116
% 221.44/221.59       A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults.%A%    
% 221.44/221.59  |- mesh__recordMaintainer mesh__D012544 PLS
% 221.44/221.59  |- skos__hiddenLabel mesh__D012544 Disease, Scheuermann%27%s
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012544 2006
% 221.44/221.59  |- skos__broader mesh__D012544smesh__D010007
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012544 2002
% 221.44/221.59  |- rdf__type mesh__D012544sskos__Concept
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012544 1995
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012544 2005
% 221.44/221.59  |- skos__hiddenLabel mesh__D012544 Scheuermanns Disease
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012544 2001
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012544 1999
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012544 2004
% 221.44/221.59  |- mesh__recordOriginator mesh__D012544 NLM
% 221.44/221.59  |- skos__annotation mesh__D012544 a spinal osteochondritis in children   
% 221.44/221.59  |- mesh__recordAuthorizer mesh__D012544 PLS
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012544 2000
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012544 1998
% 221.44/221.59  |- skos__hiddenLabel mesh__D012544 Disease, Scheuermann
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012544 2003
% 221.44/221.59  |- skos__scopeNote mesh__D012544
% 221.44/221.59       Osteochondrosis of the vertebral epiphyses in children.%A%    
% 221.44/221.59  |- skos__broader mesh__D012544smesh__D013122
% 221.44/221.59  |- skos__altLabel mesh__D012544 Scheuermann Disease
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012544 1997
% 221.44/221.59  |- mesh__dateRevised mesh__D012544 1994-04-11
% 221.44/221.59  |- skos__prefLabel mesh__D012544 Scheuermann%27%s Disease
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012544 1996
% 221.44/221.59  |- mesh__dateCreated mesh__D012544 1999-01-01
% 221.44/221.59  |- mesh__publicMeSHNote mesh__D006507
% 221.44/221.59       94; was HEPATITIS A VIRUS 1977-93; was HEPATITIS VIRUS, INFECTIOUS 1966-76%A%  
% 221.44/221.59  |- skos__hiddenLabel mesh__D006507 Infectious Hepatitis Viruses
% 221.44/221.59  |- rdf__type mesh__D006507sskos__Concept
% 221.44/221.59  |- skos__altLabel mesh__D006507 Hepatitis Virus, Infectious
% 221.44/221.59  |- skos__prefLabel mesh__D006507 Hepatovirus
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D006507 2002
% 221.44/221.59  |- mesh__historyNote mesh__D006507
% 221.44/221.59       94; was HEPATITIS A VIRUS 1977-93; was HEPATITIS VIRUS, INFECTIOUS 1966-76%A%  
% 221.44/221.59  |- mesh__dateRevised mesh__D006507 2001-07-25
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D006507 2003
% 221.44/221.59  |- skos__broader mesh__D006507smesh__D010849
% 221.44/221.59  |- skos__broader mesh__D006507smesh__D006518
% 221.44/221.59  |- mesh__onlineNote mesh__D006507
% 221.44/221.59       use HEPATOVIRUS to search HEPATITIS A VIRUS 1977-93 %26% HEPATITIS VIRUS, INFECTIOUS 1966-76%A%  
% 221.44/221.59  |- mesh__recordMaintainer mesh__D006507 ags
% 221.44/221.59  |- skos__hiddenLabel mesh__D006507 Hepatoviruses
% 221.44/221.59  |- skos__hiddenLabel mesh__D006507 Hepatitis Viruses, Infectious
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D006507 2005
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D006507 2004
% 221.44/221.59  |- mesh__dateCreated mesh__D006507 1999-01-01
% 221.44/221.59  |- mesh__recordOriginator mesh__D006507 NLM
% 221.44/221.59  |- skos__annotation mesh__D006507
% 221.44/221.59       a genus of the family Picornaviridae; infection = HEPATITIS A%A%  
% 221.44/221.59  |- skos__altLabel mesh__D006507 Infectious Hepatitis Virus
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D006507 2006
% 221.44/221.59  |- skos__scopeNote mesh__D006507
% 221.44/221.59       A genus of PICORNAVIRIDAE causing infectious hepatitis naturally in humans and experimentally in other primates. It is transmitted through fecal contamination of food or water. HEPATITIS A VIRUS is the type species.%A%    
% 221.44/221.59  |- mesh__dateEstablished mesh__D006507 1966-01-01
% 221.44/221.59  |- mesh__recordAuthorizer mesh__D006507 sjn
% 221.44/221.59  |- mesh__recordOriginator mesh__D016935 PXP
% 221.44/221.59  |- rdf__type mesh__D016935sskos__Concept
% 221.44/221.59  |- skos__scopeNote mesh__D016935
% 221.44/221.59       A species of gram-negative, aerobic bacteria that consist of slender vibroid cells.%A%    
% 221.44/221.59  |- mesh__recordAuthorizer mesh__D016935 sjn
% 221.44/221.59  |- mesh__historyNote mesh__D016935 92   
% 221.44/221.59  |- mesh__recordMaintainer mesh__D016935 SYSTEM
% 221.44/221.59  |- skos__broader mesh__D016935smesh__D016934
% 221.44/221.59  |- mesh__publicMeSHNote mesh__D016935 92   
% 221.44/221.59  |- mesh__dateCreated mesh__D016935 1991-05-30
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D016935 2006
% 221.44/221.59  |- skos__historyNote mesh__D016935 Bacteria %28%1966-1991%29%
% 221.44/221.59  |- mesh__dateEstablished mesh__D016935 1992-01-01
% 221.44/221.59  |- mesh__dateRevised mesh__D016935 2005-06-30
% 221.44/221.59  |- skos__prefLabel mesh__D016935 Caulobacter crescentus
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D016137 2006
% 221.44/221.59  |- skos__altLabel mesh__D016137 Spina Bifida Manifesta
% 221.44/221.59  |- mesh__dateRevised mesh__D016137 1999-11-03
% 221.44/221.59  |- mesh__dateEstablished mesh__D016137 1991-01-01
% 221.44/221.59  |- mesh__onlineNote mesh__D016137 search MENINGOMYELOCELE 1978-90   
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D016137 2004
% 221.44/221.59  |- mesh__dateCreated mesh__D016137 1990-06-05
% 221.44/221.59  |- skos__broader mesh__D016137smesh__D016135
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D016137 2005
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D016137 2002
% 221.44/221.59  |- skos__prefLabel mesh__D016137 Spina Bifida Cystica
% 221.44/221.59  |- rdf__type mesh__D016137sskos__Concept
% 221.44/221.59  |- mesh__historyNote mesh__D016137 91; was see MENINGOMYELOCELE 1978-90   
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D016137 2003
% 221.44/221.59  |- mesh__publicMeSHNote mesh__D016137
% 221.44/221.59       91; was see MENINGOMYELOCELE 1978-90   
% 221.44/221.59  |- skos__scopeNote mesh__D016137
% 221.44/221.59       A form of spinal dysraphism associated with a protruding cyst made up of either meninges %28%i.e., a MENINGOCELE%29% or meninges in combination with spinal cord tissue %28%i.e., a MENINGOMYELOCELE%29%. These lesions are frequently associated with spinal cord dysfunction, HYDROCEPHALUS, and SYRINGOMYELIA. %28%From Davis et al., Textbook of Neuropathology, 2nd ed, pp224-5%29%%A%    
% 221.44/221.59  |- mesh__recordOriginator mesh__D016137 AGS
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D016137 2001
% 221.44/221.59  |- skos__altLabel mesh__D016137 Spina Bifida Aperta
% 221.44/221.59  |- mesh__recordMaintainer mesh__D016137 KEV
% 221.44/221.59  |- skos__historyNote mesh__D016137 Meningomyelocele %28%1978-1990%29%
% 221.44/221.59  |- skos__historyNote mesh__D016137 Spinal Dysraphism %28%1966-1977%29%
% 221.44/221.59  |- skos__hiddenLabel mesh__D016137 Open Spina Bifida
% 221.44/221.59  |- mesh__recordAuthorizer mesh__D016137 sjn
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D016137 2000
% 221.44/221.59  |- mesh__dateCreated mesh__D002915 1999-01-01
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D002915 2006
% 221.44/221.59  |- skos__prefLabel mesh__D002915 Chylous Ascites
% 221.44/221.59  |- skos__broader mesh__D002915smesh__D010532
% 221.44/221.59  |- mesh__recordOriginator mesh__D002915 NLM
% 221.44/221.59  |- mesh__historyNote mesh__D002915 2005 %28%1966%29%   
% 221.44/221.59  |- mesh__recordMaintainer mesh__D002915 lkt
% 221.44/221.59  |- skos__altLabel mesh__D002915 Ascites, Chylous
% 221.44/221.59  |- skos__altLabel mesh__D002915 Peritonitis, Chylous
% 221.44/221.59  |- skos__altLabel mesh__D002915 Chyloperitoneum
% 221.44/221.59  |- rdf__type mesh__D002915sskos__Concept
% 221.44/221.59  |- skos__scopeNote mesh__D002915
% 221.44/221.59       Presence of milky lymph %28%CHYLE%29% in the PERITONEAL CAVITY, with or without infection.%A%    
% 221.44/221.59  |- mesh__dateRevised mesh__D002915 2004-07-07
% 221.44/221.59  |- mesh__publicMeSHNote mesh__D002915
% 221.44/221.59       2005; see CHYLOPERITONEUM 1966-2004   
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D002915 2005
% 221.44/221.59  |- mesh__recordAuthorizer mesh__D002915 sjn
% 221.44/221.59  |- skos__altLabel mesh__D002117 Roche Brand of Calcitriol
% 221.44/221.59  |- skos__altLabel mesh__D002117 1,25-Dihydroxycholecalciferol
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 Calcitriol Galderma Brand
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 Calcitriol Medice Brand
% 221.44/221.59  |- mesh__dateCreated mesh__D002117 1981-05-12
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 Calcitriol Leo Brand
% 221.44/221.59  |- skos__altLabel mesh__D002117 Alphapharm Brand of Calcitriol
% 221.44/221.59  |- mesh__recordOriginator mesh__D002117 RLS
% 221.44/221.59  |- mesh__recordAuthorizer mesh__D002117 sjn
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 Calcitriol RenaCare Brand
% 221.44/221.59  |- skos__altLabel mesh__D002117 Abbott Brand of Calcitriol
% 221.44/221.59  |- rdf__type mesh__D002117sskos__Concept
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 1 alpha,25 Dihydroxycholecalciferol
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 Calcitriol KyraMed Brand
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 D3, 1,25-dihydroxy-20-epi-Vitamin
% 221.44/221.59  |- mesh__dateRevised mesh__D002117 2005-06-30
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 D3, 1,25-Dihydroxyvitamin
% 221.44/221.59  |- skos__altLabel mesh__D002117 1,25%28%OH%29%2-20epi-D3
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D002117 2006
% 221.44/221.59  |- skos__altLabel mesh__D002117 Gry Brand of Calcitriol
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 1 alpha,25 Dihydroxyvitamin D3
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 CalcitriolNefro
% 221.44/221.59  |- skos__annotation mesh__D002117
% 221.44/221.59       deficiency: coordinate CALCITRIOL /defic %28%IM%29% with VITAMIN D DEFICIENCY %28%IM%29%%A%  
% 221.44/221.59  |- skos__altLabel mesh__D002117 1,25-Dihydroxyvitamin D3
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 1,25 Dihydroxycholecalciferol
% 221.44/221.59  |- skos__historyNote mesh__D002117
% 221.44/221.59       Dihydroxycholecalciferols %28%1973-1981%29%
% 221.44/221.59  |- skos__altLabel mesh__D002117 Medice Brand of Calcitriol
% 221.44/221.59  |- skos__historyNote mesh__D002117 Cholecalciferols %28%1966-1972%29%
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 Calcitriol Alphapharm Brand
% 221.44/221.59  |- skos__altLabel mesh__D002117 Galderma Brand of Calcitriol
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 Calcitriol Jenapharm Brand
% 221.44/221.59  |- skos__related mesh__D002117smesh__D018167
% 221.44/221.59  |- mesh__publicMeSHNote mesh__D002117 82   
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 1,25 Dihydroxyvitamin D3
% 221.44/221.59  |- skos__altLabel mesh__D002117 Leo Brand of Calcitriol
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 Hoffmann La Roche Brand of Calcitriol
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 MC 1288
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 Calcitriol Roche Brand
% 221.44/221.59  |- mesh__historyNote mesh__D002117 82   
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 Calcitriol Gry Brand
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 1 alpha, 25 dihydroxy 20 epi Vitamin D3
% 221.44/221.59  |- skos__historyNote mesh__D002117
% 221.44/221.59       Hydroxycholecalciferols %28%1972-1973%29%
% 221.44/221.59  |- skos__altLabel mesh__D002117 1,25-dihydroxy-20-epi-Vitamin D3
% 221.44/221.59  |- skos__altLabel mesh__D002117 MC-1288
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 Calcitriol Abbott Brand
% 221.44/221.59  |- skos__altLabel mesh__D002117 Jenapharm Brand of Calcitriol
% 221.44/221.59  |- skos__altLabel mesh__D002117 KyraMed Brand of Calcitriol
% 221.44/221.59  |- mesh__dateEstablished mesh__D002117 1982-01-01
% 221.44/221.59  |- skos__altLabel mesh__D002117 1 alpha, 25-dihydroxy-20-epi-Vitamin D3
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 KyraMed, Calcitriol
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 Calcitriol Cryopharma Brand
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 1,25 dihydroxy 20 epi Vitamin D3
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 Calcitriol Nefro
% 221.44/221.59  |- skos__altLabel mesh__D002117 Hoffmann-La Roche Brand of Calcitriol
% 221.44/221.59  |- skos__altLabel mesh__D002117 1 alpha,25-Dihydroxyvitamin D3
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 20 epi 1alpha,25 dihydroxycholecaliferol
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 D3, 1 alpha,25-Dihydroxyvitamin
% 221.44/221.59  |- skos__altLabel mesh__D002117 Cryopharma Brand of Calcitriol
% 221.44/221.59  |- mesh__recordMaintainer mesh__D002117 ssb
% 221.44/221.59  |- skos__prefLabel mesh__D002117 Calcitriol
% 221.44/221.59  |- skos__broader mesh__D002117smesh__D004100
% 221.44/221.59  |- skos__scopeNote mesh__D002117
% 221.44/221.59       The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol %28%CALCIFEDIOL%29%. Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption.%A%    
% 221.44/221.59  |- skos__hiddenLabel mesh__D002117 alpha,25-Dihydroxyvitamin D3, 1
% 221.44/221.59  |- skos__altLabel mesh__D002117 1 alpha,25-Dihydroxycholecalciferol
% 221.44/221.59  |- skos__altLabel mesh__D002117 RenaCare Brand of Calcitriol
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D007600 1996
% 221.44/221.59  |- mesh__dateRevised mesh__D007600 1992-05-14
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D007600 1993
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D007600 2004
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D007600 1995
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D007600 1998
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D007600 2006
% 221.44/221.59  |- skos__hiddenLabel mesh__D007600 Judgments
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D007600 2003
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D007600 1994
% 221.44/221.59  |- mesh__recordOriginator mesh__D007600 NLM
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D007600 2005
% 221.44/221.59  |- mesh__dateCreated mesh__D007600 1999-01-01
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D007600 2002
% 221.44/221.59  |- mesh__recordAuthorizer mesh__D007600 PLS
% 221.44/221.59  |- skos__scopeNote mesh__D007600
% 221.44/221.59       The process of discovering or asserting an objective or intrinsic relation between two objects or concepts; a faculty or power that enables a person to make judgments; the process of bringing to light and asserting the implicit meaning of a concept; a critical evaluation of a person or situation.%A%    
% 221.44/221.59  |- mesh__dateEstablished mesh__D007600 1966-01-01
% 221.44/221.59  |- mesh__recordMaintainer mesh__D007600 TAP
% 221.44/221.59  |- skos__broader mesh__D007600smesh__D013850
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D007600 2001
% 221.44/221.59  |- skos__prefLabel mesh__D007600 Judgment
% 221.44/221.59  |- rdf__type mesh__D007600sskos__Concept
% 221.44/221.59  |- mesh__publicMeSHNote mesh__D007600 66   
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D007600 1997
% 221.44/221.59  |- mesh__historyNote mesh__D007600 66   
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D007600 1999
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D007600 2000
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012545 1999
% 221.44/221.59  |- mesh__publicMeSHNote mesh__D012545 73   
% 221.44/221.59  |- skos__annotation mesh__D012545
% 221.44/221.59       IM general only; an imine: do not confuse with Schiff reagent nor PERIODIC ACID-SCHIFF REACTION%A%  
% 221.44/221.59  |- mesh__historyNote mesh__D012545
% 221.44/221.59       73; was SCHIFF BASE 1971-72 %28%Prov%29%   
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012545 2004
% 221.44/221.59  |- skos__scopeNote mesh__D012545
% 221.44/221.59       Condensation products of aromatic amines and aldehydes forming azomethines substituted on the N atom, containing the general formula R-N:CHR. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012545 1998
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012545 2003
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012545 1997
% 221.44/221.59  |- skos__historyNote mesh__D012545 Amines %28%1966-1970%29%
% 221.44/221.59  |- mesh__onlineNote mesh__D012545
% 221.44/221.59       use SCHIFF BASES to search SCHIFF BASE 1971-72 %28%as Prov 1971-72%29%%A%  
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012545 1996
% 221.44/221.59  |- mesh__dateCreated mesh__D012545 1999-01-01
% 221.44/221.59  |- mesh__dateEstablished mesh__D012545 1973-01-01
% 221.44/221.59  |- skos__prefLabel mesh__D012545 Schiff Bases
% 221.44/221.59  |- skos__hiddenLabel mesh__D012545 Bases, Schiff
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012545 2002
% 221.44/221.59  |- skos__hiddenLabel mesh__D012545 Base, Schiff
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012545 2006
% 221.44/221.59  |- mesh__dateRevised mesh__D012545 1995-05-22
% 221.44/221.59  |- mesh__recordMaintainer mesh__D012545 KEV
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012545 2001
% 221.44/221.59  |- skos__altLabel mesh__D012545 Schiff Base
% 221.44/221.59  |- rdf__type mesh__D012545sskos__Concept
% 221.44/221.59  |- skos__broader mesh__D012545smesh__D007097
% 221.44/221.59  |- mesh__recordOriginator mesh__D012545 NLM
% 221.44/221.59  |- mesh__recordAuthorizer mesh__D012545 PLS
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012545 2005
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D012545 2000
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D006508 2006
% 221.44/221.59  |- skos__prefLabel mesh__D006508 Hepatitis Antibodies
% 221.44/221.59  |- mesh__dateEstablished mesh__D006508 1985-01-01
% 221.44/221.59  |- skos__scopeNote mesh__D006508
% 221.44/221.59       Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis.%A%    
% 221.44/221.59  |- rdf__type mesh__D006508sskos__Concept
% 221.44/221.59  |- mesh__recordAuthorizer mesh__D006508 sjn
% 221.44/221.59  |- skos__historyNote mesh__D006508 Antibodies, Viral %28%1973-1984%29%
% 221.44/221.59  |- mesh__dateRevised mesh__D006508 2005-06-30
% 221.44/221.59  |- mesh__historyNote mesh__D006508 85   
% 221.44/221.59  |- skos__annotation mesh__D006508
% 221.44/221.59       coordinate IM with specific hepatitis virus /immunol %28%IM%29%; do not coord with ANTIBODY FORMATION for /biosyn%A%  
% 221.44/221.59  |- skos__broader mesh__D006508smesh__D000914
% 221.44/221.59  |- mesh__recordOriginator mesh__D006508 SH
% 221.44/221.59  |- mesh__dateCreated mesh__D006508 1984-05-01
% 221.44/221.59  |- skos__altLabel mesh__D006508 Antibodies, Hepatitis
% 221.44/221.59  |- mesh__publicMeSHNote mesh__D006508 85   
% 221.44/221.59  |- mesh__recordMaintainer mesh__D006508 ssb
% 221.44/221.59  |- mesh__recordMaintainer mesh__D003210 TAP
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D003210 2001
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D003210 1999
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D003210 1993
% 221.44/221.59  |- skos__hiddenLabel mesh__D003210 Concept Formations
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D003210 1996
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D003210 1995
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D003210 1998
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D003210 2004
% 221.44/221.59  |- skos__scopeNote mesh__D003210
% 221.44/221.59       A cognitive process involving the formation of ideas generalized from the knowledge of qualities, aspects, and relations of objects.%A%    
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D003210 2000
% 221.44/221.59  |- skos__prefLabel mesh__D003210 Concept Formation
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D003210 2006
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D003210 1994
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D003210 2003
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D003210 2005
% 221.44/221.59  |- mesh__recordOriginator mesh__D003210 NLM
% 221.44/221.59  |- rdf__type mesh__D003210sskos__Concept
% 221.44/221.59  |- skos__hiddenLabel mesh__D003210 Formations, Concept
% 221.44/221.59  |- skos__hiddenLabel mesh__D003210 Formation, Concept
% 221.44/221.59  |- mesh__recordAuthorizer mesh__D003210 PLS
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D003210 2002
% 221.44/221.59  |- mesh__dateRevised mesh__D003210 1992-05-07
% 221.44/221.59  |- skos__broader mesh__D003210smesh__D013850
% 221.44/221.59  |- mesh__dateCreated mesh__D003210 1999-01-01
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D003210 1997
% 221.44/221.59  |- rdf__type mesh__D016936sskos__Concept
% 221.44/221.59  |- mesh__dateEstablished mesh__D016936 1992-01-01
% 221.44/221.59  |- mesh__dateRevised mesh__D016936 2005-06-30
% 221.44/221.59  |- mesh__recordMaintainer mesh__D016936 SYSTEM
% 221.44/221.59  |- mesh__historyNote mesh__D016936 92   
% 221.44/221.59  |- skos__prefLabel mesh__D016936 Gram-Positive Endospore-Forming Bacteria
% 221.44/221.59  |- skos__broader mesh__D016936smesh__D004725
% 221.44/221.59  |- mesh__dateCreated mesh__D016936 1991-05-30
% 221.44/221.59  |- skos__altLabel mesh__D016936 Gram Positive Endospore Forming Bacteria
% 221.44/221.59  |- mesh__recordAuthorizer mesh__D016936 sjn
% 221.44/221.59  |- skos__broader mesh__D016936smesh__D006094
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D016936 2006
% 221.44/221.59  |- skos__scopeNote mesh__D016936
% 221.44/221.59       Bacteria that form endospores and are gram-positive. Representative genera include BACILLUS; CLOSTRIDIUM; MICROMONOSPORA; SACCHAROPOLYSPORA; and STREPTOMYCES.%A%    
% 221.44/221.59  |- skos__annotation mesh__D016936
% 221.44/221.59       do not confuse with GRAM-POSITIVE ENDOSPORE-FORMING RODS; avoid: too general; prefer specific families %26% genera; infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS %28%IM%29%; DF: GRAM POS ENDOSPORE FORMING BACT%A%  
% 221.44/221.59  |- mesh__recordOriginator mesh__D016936 PXP
% 221.44/221.59  |- mesh__publicMeSHNote mesh__D016936 92   
% 221.44/221.59  |- rdf__type mesh__D049312sskos__Concept
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D049312 2005
% 221.44/221.59  |- mesh__recordMaintainer mesh__D049312 jmp
% 221.44/221.59  |- skos__broader mesh__D049312smesh__D043562
% 221.44/221.59  |- skos__historyNote mesh__D049312
% 221.44/221.59       Receptors, G-Protein-Coupled %28%2004%29%
% 221.44/221.59  |- skos__prefLabel mesh__D049312 Receptors, Lysophospholipid
% 221.44/221.59  |- mesh__historyNote mesh__D049312 2005%28%1996%29%   
% 221.44/221.59  |- mesh__dateEstablished mesh__D049312 2005-01-01
% 221.44/221.59  |- mesh__recordOriginator mesh__D049312 jmp
% 221.44/221.59  |- skos__scopeNote mesh__D049312
% 221.44/221.59       A family of G-protein-coupled receptors that bind to specific LYSOPHOSPHOLIPIDS such as lysophosphatidic acid and lysosphinglipids such as sphingosine-1-phosphate. They play an important role in the formation and function of the CARDIOVASCULAR SYSTEM.%A%    
% 221.44/221.59  |- mesh__recordAuthorizer mesh__D049312 sjn
% 221.44/221.59  |- mesh__publicMeSHNote mesh__D049312
% 221.44/221.59       2005; RECEPTORS, LYSOPHOSPHOLIPID was indexed under RECEPTORS, G-PROTEIN-COUPLED 2004 %26% under RECEPTORS, CELL SURFACE 1996-2003%A%  
% 221.44/221.59  |- mesh__dateCreated mesh__D049312 2004-07-07
% 221.44/221.59  |- skos__altLabel mesh__D049312 Lysophospholipid Receptors
% 221.44/221.59  |- skos__historyNote mesh__D049312
% 221.44/221.59       Receptors, Cell Surface %28%1996-2003%29%
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D049312 2006
% 221.44/221.59  |- mesh__dateCreated mesh__D016138 1990-03-23
% 221.44/221.59  |- skos__related mesh__D016138smesh__D005684
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D016138 2006
% 221.44/221.59  |- skos__historyNote mesh__D016138 Exercise %28%1989-1990%29%
% 221.44/221.59  |- skos__broader mesh__D016138smesh__D026241
% 221.44/221.59  |- skos__prefLabel mesh__D016138 Walking
% 221.44/221.59  |- mesh__recordMaintainer mesh__D016138 lkt
% 221.44/221.59  |- skos__historyNote mesh__D016138 Exertion %28%1966-1990%29%
% 221.44/221.59  |- mesh__publicMeSHNote mesh__D016138 91   
% 221.44/221.59  |- mesh__recordAuthorizer mesh__D016138 sjn
% 221.44/221.59  |- mesh__dateRevised mesh__D016138 2005-06-30
% 221.44/221.59  |- rdf__type mesh__D016138sskos__Concept
% 221.44/221.59  |- skos__scopeNote mesh__D016138
% 221.44/221.59       An activity in which the body advances at a slow to moderate pace by moving the feet in a coordinated fashion. This includes recreational walking, walking for fitness, and competitive race-walking.%A%    
% 221.44/221.59  |- skos__broader mesh__D016138smesh__D013177
% 221.44/221.59  |- mesh__dateEstablished mesh__D016138 1991-01-01
% 221.44/221.59  |- skos__broader mesh__D016138smesh__D009043
% 221.44/221.59  |- mesh__recordOriginator mesh__D016138 PXP
% 221.44/221.59  |- mesh__historyNote mesh__D016138 91   
% 221.44/221.59  |- skos__annotation mesh__D016138
% 221.44/221.59       human %26% animal; /inj: coordinate IM with specific injury %28%IM%29%; /physiol permitted; differentiate from GAIT, the way one walks%A%  
% 221.44/221.59  |- skos__broader mesh__D016138smesh__D008124
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D002916 1994
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D002916 2004
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D002916 2006
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D002916 2003
% 221.44/221.59  |- mesh__recordAuthorizer mesh__D002916 sjn
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D002916 2005
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D002916 2002
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D002916 2003A
% 221.44/221.59  |- mesh__activeMeSHYear mesh__D002916 1997
% 221.44/221.59  |- skos__annotation mesh__D002916 chyle in thoracic cavity   
% 221.44/221.59  |- mesh__recordOriginator mesh__D002916 NLM
% 221.44/221.59  |- skos__prefLabel mesh__D002916 Chylothorax
% 221.44/221.60  |- skos__scopeNote mesh__D002916
% 221.44/221.60       The presence of chyle in the thoracic cavity. %28%Dorland, 27th ed%29%%A%    
% 221.44/221.60  |- mesh__recordMaintainer mesh__D002916 sjn
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D002916 1999
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D002916 2001
% 221.44/221.60  |- mesh__dateRevised mesh__D002916 2002-10-23
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D002916 1996
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D002916 1998
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D002916 2000
% 221.44/221.60  |- rdf__type mesh__D002916sskos__Concept
% 221.44/221.60  |- mesh__dateCreated mesh__D002916 1999-01-01
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D002916 1995
% 221.44/221.60  |- skos__broader mesh__D002916smesh__D010995
% 221.44/221.60  |- rdf__type mesh__D002118sskos__Concept
% 221.44/221.60  |- skos__related mesh__D002118smesh__D006934
% 221.44/221.60  |- skos__prefLabel mesh__D002118 Calcium
% 221.44/221.60  |- skos__related mesh__D002118smesh__D002132
% 221.44/221.60  |- skos__annotation mesh__D002118
% 221.44/221.60       Ca-40; /antag permitted but consider also CALCIUM CHANNEL BLOCKERS; /blood: note see related terms; /defic: consider also HYPOCALCEMIA %26% note that CALCIUM, DIETARY is also available; /metab: consider also CALCIUM CHANNELS %26% CALCIUM PUMP: see CA%28%2+%29%-TRANSPORTING ATPASE; metab disord = CALCIUM METABOLISM DISORDERS; CALCIUM SIGNALING is available for calcium mobilization in the context of signal transduction%A%  
% 221.44/221.60  |- mesh__dateCreated mesh__D002118 1999-01-01
% 221.44/221.60  |- mesh__recordAuthorizer mesh__D002118 sjn
% 221.44/221.60  |- mesh__dateRevised mesh__D002118 2005-06-30
% 221.44/221.60  |- skos__hiddenLabel mesh__D002118 IV, Coagulation Factor
% 221.44/221.60  |- skos__related mesh__D002118smesh__D006996
% 221.44/221.60  |- mesh__recordMaintainer mesh__D002118 ssb
% 221.44/221.60  |- skos__related mesh__D002118smesh__D002127
% 221.44/221.60  |- skos__altLabel mesh__D002118 Factor IV
% 221.44/221.60  |- skos__broader mesh__D002118smesh__D008673
% 221.44/221.60  |- skos__altLabel mesh__D002118 Coagulation Factor IV
% 221.44/221.60  |- mesh__recordOriginator mesh__D002118 NLM
% 221.44/221.60  |- skos__altLabel mesh__D002118 Blood Coagulation Factor IV
% 221.44/221.60  |- skos__broader mesh__D002118smesh__D001779
% 221.44/221.60  |- skos__hiddenLabel mesh__D002118 Factor IV, Coagulation
% 221.44/221.60  |- mesh__historyNote mesh__D002118
% 221.44/221.60       /metabolism was CALCIUM METABOLISM 1965   
% 221.44/221.60  |- skos__scopeNote mesh__D002118
% 221.44/221.60       A basic element found in nearly all organized tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation %28%as factor IV%29% and in many enzymatic processes.%A%    
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D002118 2006
% 221.44/221.60  |- mesh__publicMeSHNote mesh__D002118
% 221.44/221.60       /metabolism was CALCIUM METABOLISM 1965   
% 221.44/221.60  |- skos__hiddenLabel mesh__D007601 Vein, Jugular
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D007601 2003
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D007601 2000
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D007601 2005
% 221.44/221.60  |- mesh__dateCreated mesh__D007601 1999-01-01
% 221.44/221.60  |- mesh__historyNote mesh__D007601 78; was JUGULAR VEIN 1963-77   
% 221.44/221.60  |- skos__broader mesh__D007601smesh__D014680
% 221.44/221.60  |- mesh__publicMeSHNote mesh__D007601 78; was JUGULAR VEIN 1963-77   
% 221.44/221.60  |- skos__hiddenLabel mesh__D007601 Veins, Jugular
% 221.44/221.60  |- skos__scopeNote mesh__D007601
% 221.44/221.60       Veins in the neck which drain the brain, face, and neck into the brachiocephalic or subclavian veins.%A%    
% 221.44/221.60  |- rdf__type mesh__D007601sskos__Concept
% 221.44/221.60  |- mesh__recordOriginator mesh__D007601 NLM
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D007601 1997
% 221.44/221.60  |- mesh__onlineNote mesh__D007601
% 221.44/221.60       use JUGULAR VEINS to search JUGULAR VEIN 1966-77   
% 221.44/221.60  |- skos__hiddenLabel mesh__D007601 Jugular Vein
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D007601 2002
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D007601 1999
% 221.44/221.60  |- mesh__recordAuthorizer mesh__D007601 PLS
% 221.44/221.60  |- skos__prefLabel mesh__D007601 Jugular Veins
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D007601 2004
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D007601 1996
% 221.44/221.60  |- mesh__recordMaintainer mesh__D007601 TAP
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D007601 2001
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D007601 1998
% 221.44/221.60  |- mesh__dateRevised mesh__D007601 1995-05-18
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D007601 2006
% 221.44/221.60  |- mesh__dateRevised mesh__D012546 1999-11-03
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D012546 2003
% 221.44/221.60  |- mesh__recordOriginator mesh__D012546 NLM
% 221.44/221.60  |- mesh__dateEstablished mesh__D012546 1966-01-01
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D012546 2000
% 221.44/221.60  |- mesh__dateCreated mesh__D012546 1999-01-01
% 221.44/221.60  |- skos__prefLabel mesh__D012546 Schilling Test
% 221.44/221.60  |- mesh__recordMaintainer mesh__D012546 KEV
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D012546 2006
% 221.44/221.60  |- rdf__type mesh__D012546sskos__Concept
% 221.44/221.60  |- mesh__publicMeSHNote mesh__D012546 66   
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D012546 2005
% 221.44/221.60  |- skos__hiddenLabel mesh__D012546 Test, Schilling
% 221.44/221.60  |- skos__broader mesh__D012546smesh__D006403
% 221.44/221.60  |- skos__scopeNote mesh__D012546
% 221.44/221.60       A diagnostic test in which vitamin B12 is tagged with radioactive cobalt, taken orally, and gastrointestinal absorption is determined via measurement of the amount of radioactivity in a 24-hour urine collection.%A%    
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D012546 2002
% 221.44/221.60  |- mesh__recordAuthorizer mesh__D012546 sjn
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D012546 2004
% 221.44/221.60  |- mesh__historyNote mesh__D012546 66%28%63%29%   
% 221.44/221.60  |- skos__broader mesh__D012546smesh__D003947
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D012546 2001
% 221.44/221.60  |- skos__broader mesh__D006509smesh__D018347
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D006509 2005
% 221.44/221.60  |- mesh__onlineNote mesh__D006509
% 221.44/221.60       use HEPATITIS B to search HEPATITIS, HOMOLOGOUS SERUM 1966-76%A%  
% 221.44/221.60  |- rdf__type mesh__D006509sskos__Concept
% 221.44/221.60  |- mesh__recordMaintainer mesh__D006509 lkt
% 221.44/221.60  |- skos__scopeNote mesh__D006509
% 221.44/221.60       INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.%A%    
% 221.44/221.60  |- mesh__historyNote mesh__D006509
% 221.44/221.60       77; was HEPATITIS, HOMOLOGOUS SERUM 1963-76   
% 221.44/221.60  |- mesh__recordOriginator mesh__D006509 NLM
% 221.44/221.60  |- mesh__recordAuthorizer mesh__D006509 sjn
% 221.44/221.60  |- skos__broader mesh__D006509smesh__D006525
% 221.44/221.60  |- skos__annotation mesh__D006509 chronic = HEPATITIS B, CHRONIC   
% 221.44/221.60  |- mesh__dateRevised mesh__D006509 2004-07-07
% 221.44/221.60  |- mesh__publicMeSHNote mesh__D006509
% 221.44/221.60       77; was HEPATITIS, HOMOLOGOUS SERUM 1963-76   
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D006509 2006
% 221.44/221.60  |- skos__prefLabel mesh__D006509 Hepatitis B
% 221.44/221.60  |- mesh__dateCreated mesh__D006509 1999-01-01
% 221.44/221.60  |- skos__hiddenLabel mesh__D017231 c-mos, Proto-Oncogene Proteins
% 221.44/221.60  |- skos__altLabel mesh__D017231 pp39%28%c-mos%29%
% 221.44/221.60  |- skos__hiddenLabel mesh__D017231 c mos Proteins
% 221.44/221.60  |- skos__altLabel mesh__D017231 pp39 c-mos
% 221.44/221.60  |- skos__annotation mesh__D017231
% 221.44/221.60       /drug eff /ultrastruct permitted; DF: note short X refs   
% 221.44/221.60  |- skos__broader mesh__D017231smesh__D011518
% 221.44/221.60  |- skos__scopeNote mesh__D017231
% 221.44/221.60       Cellular proteins encoded by the c-mos genes %28%GENES, MOS%29%. They function in the cell cycle to maintain MATURATION PROMOTING FACTOR in the active state and have protein-serine/threonine kinase activity. Oncogenic transformation can take place when c-mos proteins are expressed at the wrong time.%A%    
% 221.44/221.60  |- skos__hiddenLabel mesh__D017231 Proto Oncogene Products c mos
% 221.44/221.60  |- skos__hiddenLabel mesh__D017231 Proteins c-mos, Proto-Oncogene
% 221.44/221.60  |- skos__hiddenLabel mesh__D017231 mos Proto Oncogene Proteins
% 221.44/221.60  |- skos__historyNote mesh__D017231
% 221.44/221.60       Proto-Oncogene Proteins %28%1987-1992%29%
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D017231 2006
% 221.44/221.60  |- rdf__type mesh__D017231sskos__Concept
% 221.44/221.60  |- skos__hiddenLabel mesh__D017231 c-mos, pp39
% 221.44/221.60  |- skos__altLabel mesh__D017231 mos Proto-Oncogene Product pp39
% 221.44/221.60  |- skos__hiddenLabel mesh__D017231 Proto Oncogene Proteins mos
% 221.44/221.60  |- skos__hiddenLabel mesh__D017231 Proteins, mos Proto-Oncogene
% 221.44/221.60  |- mesh__historyNote mesh__D017231
% 221.44/221.60       93; was PROTO-ONCOGENE PROTEIN C-MOS %28%NM%29% 1987-92   
% 221.44/221.60  |- skos__hiddenLabel mesh__D017231 Proto-Oncogene Proteins, mos
% 221.44/221.60  |- skos__altLabel mesh__D017231 c-mos Proteins
% 221.44/221.60  |- skos__hiddenLabel mesh__D017231 Products c-mos, Proto-Oncogene
% 221.44/221.60  |- skos__hiddenLabel mesh__D017231 Proto Oncogene Proteins c mos
% 221.44/221.60  |- skos__altLabel mesh__D017231 Proto-Oncogene Proteins mos
% 221.44/221.60  |- mesh__dateEstablished mesh__D017231 1993-01-01
% 221.44/221.60  |- skos__prefLabel mesh__D017231 Proto-Oncogene Proteins c-mos
% 221.44/221.60  |- skos__broader mesh__D017231smesh__D020930
% 221.44/221.60  |- skos__hiddenLabel mesh__D017231 Proteins, c-mos
% 221.44/221.60  |- mesh__recordOriginator mesh__D017231 AGS
% 221.44/221.60  |- mesh__publicMeSHNote mesh__D017231
% 221.44/221.60       93; PROTO-ONCOGENE PROTEIN C-MOS %28%NM%29% was indexed under PROTO-ONCOGENE PROTEINS 1987-92%A%  
% 221.44/221.60  |- skos__hiddenLabel mesh__D017231 c-mos, Proto-Oncogene Products
% 221.44/221.60  |- mesh__recordMaintainer mesh__D017231 DRC
% 221.44/221.60  |- skos__altLabel mesh__D017231 Cytostatic Factor
% 221.44/221.60  |- skos__altLabel mesh__D017231 mos Proto-Oncogene Proteins
% 221.44/221.60  |- skos__hiddenLabel mesh__D017231 Proteins mos, Proto-Oncogene
% 221.44/221.60  |- mesh__onlineNote mesh__D017231
% 221.44/221.60       use PROTO-ONCOGENE PROTEINS C-MOS %28%NM%29% to search PROTO-ONCOGENE PROTEIN C-MOS 1987-92%A%  
% 221.44/221.60  |- mesh__dateCreated mesh__D017231 1992-05-22
% 221.44/221.60  |- skos__hiddenLabel mesh__D017231 mos Proto Oncogene Product pp39
% 221.44/221.60  |- skos__hiddenLabel mesh__D017231 pp39 c mos
% 221.44/221.60  |- skos__altLabel mesh__D017231 Proto-Oncogene Products c-mos
% 221.44/221.60  |- mesh__recordAuthorizer mesh__D017231 sjn
% 221.44/221.60  |- mesh__dateRevised mesh__D017231 2005-06-30
% 221.44/221.60  |- mesh__recordAuthorizer mesh__D003211 PLS
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D003211 2004
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D003211 2002
% 221.44/221.60  |- skos__altLabel mesh__D003211 Review, Concurrent
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D003211 2006
% 221.44/221.60  |- mesh__dateCreated mesh__D003211 1977-05-12
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D003211 2003
% 221.44/221.60  |- mesh__publicMeSHNote mesh__D003211
% 221.44/221.60       91; was see under UTILIZATION REVIEW Aug 1977-90   
% 221.44/221.60  |- skos__broader mesh__D003211smesh__D014600
% 221.44/221.60  |- skos__historyNote mesh__D003211
% 221.44/221.60       Professional Standards Review Organizations %28%1974-Jul 1977%29%
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D003211 2001
% 221.44/221.60  |- skos__scopeNote mesh__D003211
% 221.44/221.60       Review of the medical necessity of hospital or other health facility admissions, upon or within a short time following an admission, and periodic review of services provided during the course of treatment.%A%    
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D003211 2005
% 221.44/221.60  |- skos__historyNote mesh__D003211 Utilization Review %28%1968-Jul 1977%29%
% 221.44/221.60  |- skos__hiddenLabel mesh__D003211 Reviews, Continued Stay
% 221.44/221.60  |- mesh__recordMaintainer mesh__D003211 TGC
% 221.44/221.60  |- rdf__type mesh__D003211sskos__Concept
% 221.44/221.60  |- skos__hiddenLabel mesh__D003211 Continued Stay Reviews
% 221.44/221.60  |- skos__annotation mesh__D003211
% 221.44/221.60       a type of hosp %26% health facility utilization review; DF: CONCURRENT REV%A%  
% 221.44/221.60  |- skos__hiddenLabel mesh__D003211 Concurrent Reviews
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D003211 2000
% 221.44/221.60  |- skos__prefLabel mesh__D003211 Concurrent Review
% 221.44/221.60  |- skos__hiddenLabel mesh__D003211 Reviews, Concurrent
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D003211 1997
% 221.44/221.60  |- mesh__dateEstablished mesh__D003211 1991-01-01
% 221.44/221.60  |- mesh__historyNote mesh__D003211
% 221.44/221.60       91%28%Aug 77%29%; was see under UTILIZATION REVIEW 1977-90   
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D003211 1999
% 221.44/221.60  |- skos__altLabel mesh__D003211 Continued Stay Review
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D003211 1996
% 221.44/221.60  |- mesh__recordOriginator mesh__D003211 EC
% 221.44/221.60  |- mesh__dateRevised mesh__D003211 1994-05-05
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D003211 1995
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D003211 1998
% 221.44/221.60  |- mesh__recordAuthorizer mesh__D016937 sjn
% 221.44/221.60  |- mesh__dateCreated mesh__D016937 1991-08-23
% 221.44/221.60  |- mesh__recordMaintainer mesh__D016937 SYSTEM
% 221.44/221.60  |- skos__annotation mesh__D016937
% 221.44/221.60       do not confuse with GRAM-POSITIVE ENDOSPORE-FORMING BACTERIA; avoid: too general; prefer specific families %26% genera; infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS %28%IM%29%; DF: GRAM POS ENDOSPORE FORMING RODS%A%  
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D016937 2006
% 221.44/221.60  |- mesh__historyNote mesh__D016937 98; use explode 1992-97   
% 221.44/221.60  |- mesh__dateRevised mesh__D016937 2005-06-30
% 221.44/221.60  |- skos__broader mesh__D016937smesh__D016936
% 221.44/221.60  |- rdf__type mesh__D016937sskos__Concept
% 221.44/221.60  |- mesh__publicMeSHNote mesh__D016937 98   
% 221.44/221.60  |- mesh__dateEstablished mesh__D016937 1998-01-01
% 221.44/221.60  |- skos__broader mesh__D016937smesh__D016987
% 221.44/221.60  |- mesh__recordOriginator mesh__D016937 PXP
% 221.44/221.60  |- skos__altLabel mesh__D016937 Gram Positive Endospore Forming Rods
% 221.44/221.60  |- skos__scopeNote mesh__D016937
% 221.44/221.60       Rod-shaped bacteria that form endospores and are gram-positive. Representative genera include BACILLUS and CLOSTRIDIUM.%A%    
% 221.44/221.60  |- skos__prefLabel mesh__D016937 Gram-Positive Endospore-Forming Rods
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D016139 2004
% 221.44/221.60  |- skos__hiddenLabel mesh__D016139 Fu, Gong
% 221.44/221.60  |- rdf__type mesh__D016139sskos__Concept
% 221.44/221.60  |- mesh__dateCreated mesh__D016139 1990-03-23
% 221.44/221.60  |- skos__annotation mesh__D016139
% 221.44/221.60       /inj: coord IM with specific inj %28%IM%29%; Manual 30.15.1   
% 221.44/221.60  |- skos__broader mesh__D016139smesh__D013177
% 221.44/221.60  |- skos__historyNote mesh__D016139 Sports %28%1968-1990%29%
% 221.44/221.60  |- mesh__dateEstablished mesh__D016139 1991-01-01
% 221.44/221.60  |- skos__altLabel mesh__D016139 Gong Fu
% 221.44/221.60  |- skos__related mesh__D016139smesh__D014952
% 221.44/221.60  |- mesh__recordOriginator mesh__D016139 PXP
% 221.44/221.60  |- mesh__dateRevised mesh__D016139 2002-07-02
% 221.44/221.60  |- skos__scopeNote mesh__D016139
% 221.44/221.60       Activities in which participants learn self-defense mainly through the use of hand-to-hand combat. Judo involves throwing an opponent to the ground while karate %28%which includes kung fu and tae kwon do%29% involves kicking and punching an opponent.%A%    
% 221.44/221.60  |- mesh__publicMeSHNote mesh__D016139 91   
% 221.44/221.60  |- mesh__historyNote mesh__D016139 91   
% 221.44/221.60  |- mesh__recordAuthorizer mesh__D016139 sjn
% 221.44/221.60  |- skos__prefLabel mesh__D016139 Martial Arts
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D016139 2005
% 221.44/221.60  |- mesh__recordMaintainer mesh__D016139 mdb
% 221.44/221.60  |- skos__altLabel mesh__D016139 Gongfu
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D016139 2006
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D016139 2003
% 221.44/221.60  |- skos__hiddenLabel mesh__D016139 Arts, Martial
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D002917 2006
% 221.44/221.60  |- skos__scopeNote mesh__D002917
% 221.44/221.60       A cysteine endopeptidase isolated from papaya latex. Preferential cleavage at glutamic and aspartic acid residues. EC 3.4.22.6.%A%    
% 221.44/221.60  |- skos__prefLabel mesh__D002917 Chymopapain
% 221.44/221.60  |- skos__historyNote mesh__D002917 Papain %28%1973-1974%29%
% 221.44/221.60  |- mesh__recordAuthorizer mesh__D002917 sjn
% 221.44/221.60  |- mesh__dateEstablished mesh__D002917 1986-01-01
% 221.44/221.60  |- mesh__dateCreated mesh__D002917 1974-11-19
% 221.44/221.60  |- mesh__dateRevised mesh__D002917 2005-06-30
% 221.44/221.60  |- rdf__type mesh__D002917sskos__Concept
% 221.44/221.60  |- mesh__recordOriginator mesh__D002917 NLM
% 221.44/221.60  |- mesh__publicMeSHNote mesh__D002917
% 221.44/221.60       86; was see under PEPTIDE PEPTIDOHYDROLASES 1975-85   
% 221.44/221.60  |- mesh__recordMaintainer mesh__D002917 lkw
% 221.44/221.60  |- mesh__historyNote mesh__D002917
% 221.44/221.60       86%28%75%29%; was see under PEPTIDE PEPTIDOHYDROLASES 1975-85   
% 221.44/221.60  |- skos__altLabel mesh__D002917 Farmamed Brand of Chymopapain
% 221.44/221.60  |- skos__broader mesh__D002917smesh__D003546
% 221.44/221.60  |- skos__altLabel mesh__D002917 Link Brand of Chymopapain
% 221.44/221.60  |- mesh__dateRevised mesh__D002119 1995-06-08
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D002119 1996
% 221.44/221.60  |- mesh__dateEstablished mesh__D002119 1965-01-01
% 221.44/221.60  |- skos__scopeNote mesh__D002119
% 221.44/221.60       Carbonic acid calcium salt %28%CaCO3%29%. An odorless, tasteless powder or crystal that occurs in nature. It is used therapeutically as a phosphate buffer in hemodialysis patients and as a calcium supplement.%A%    
% 221.44/221.60  |- mesh__dateCreated mesh__D002119 1999-01-01
% 221.44/221.60  |- mesh__recordMaintainer mesh__D002119 JRT
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D002119 2002
% 221.44/221.60  |- mesh__publicMeSHNote mesh__D002119 65   
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D002119 2004
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D002119 1999
% 221.44/221.60  |- skos__hiddenLabel mesh__D002119 Carbonate, Calcium
% 221.44/221.60  |- mesh__historyNote mesh__D002119 65   
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D002119 2003
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D002119 1998
% 221.44/221.60  |- skos__annotation mesh__D002119
% 221.44/221.60       occurs in nature as chalk, limestone or marble; used in med as a buffer in hemodialysis%A%  
% 221.44/221.60  |- skos__prefLabel mesh__D002119 Calcium Carbonate
% 221.44/221.60  |- mesh__recordAuthorizer mesh__D002119 PLS
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D002119 2001
% 221.44/221.60  |- mesh__recordOriginator mesh__D002119 NLM
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D002119 2006
% 221.44/221.60  |- skos__hiddenLabel mesh__D002119 Calcium Milk
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D002119 2000
% 221.44/221.60  |- skos__broader mesh__D002119smesh__D017610
% 221.44/221.60  |- skos__broader mesh__D002119smesh__D008903
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D002119 1997
% 221.44/221.60  |- rdf__type mesh__D002119sskos__Concept
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D002119 2005
% 221.44/221.60  |- skos__broader mesh__D002119smesh__D002254
% 221.44/221.60  |- mesh__historyNote mesh__D007602
% 221.44/221.60       91%28%75%29%; was see under PSYCHOANALYTIC THEORY 1975-90   
% 221.44/221.60  |- skos__hiddenLabel mesh__D007602 Theory, Jungian
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D007602 2002
% 221.44/221.60  |- rdf__type mesh__D007602sskos__Concept
% 221.44/221.60  |- skos__scopeNote mesh__D007602
% 221.44/221.60       A theoretical psychoanalytical system centered around symbols of the unconscious with the unconscious material derived from two sources - the personal unconscious %28%repressed or forgotten experiences, thoughts and feelings%29% and the collective or objective unconscious %28%the universal inherited qualities which dispose individuals to behave in ways similar to their ancestors%29%.%A%    
% 221.44/221.60  |- mesh__onlineNote mesh__D007602 search PSYCHOANALYTIC THEORY 1969-74   
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D007602 2001
% 221.44/221.60  |- mesh__dateRevised mesh__D007602 2004-07-28
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D007602 2004
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D007602 2000
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D007602 2006
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D007602 2005A
% 221.44/221.60  |- skos__broader mesh__D007602smesh__D011574
% 221.44/221.60  |- mesh__recordMaintainer mesh__D007602 jls
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D007602 2003
% 221.44/221.60  |- mesh__dateEstablished mesh__D007602 1991-01-01
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D007602 2005
% 221.44/221.60  |- skos__prefLabel mesh__D007602 Jungian Theory
% 221.44/221.60  |- mesh__recordAuthorizer mesh__D007602 jls
% 221.44/221.60  |- mesh__publicMeSHNote mesh__D007602
% 221.44/221.60       91; was see under PSYCHOANALYTIC THEORY 1975-90   
% 221.44/221.60  |- mesh__dateCreated mesh__D007602 1999-01-01
% 221.44/221.60  |- mesh__recordOriginator mesh__D007602 NLM
% 221.44/221.60  |- mesh__recordMaintainer mesh__D012547 ags
% 221.44/221.60  |- skos__annotation mesh__D012547
% 221.44/221.60       GEN or unspecified; prefer specifics; /drug eff: consider also SCHISTOSOMICIDES; infection = SCHISTOSOMIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 221.44/221.60  |- mesh__recordAuthorizer mesh__D012547 sjn
% 221.44/221.60  |- skos__altLabel mesh__D012547 Bilharzia
% 221.44/221.60  |- skos__scopeNote mesh__D012547
% 221.44/221.60       A genus of trematode flukes belonging to the family Schistosomatidae. There are over a dozen species. These parasites are found in man and other mammals. Snails are the intermediate hosts.%A%    
% 221.44/221.60  |- skos__related mesh__D012547smesh__D012556
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D012547 2005
% 221.44/221.60  |- mesh__recordOriginator mesh__D012547 NLM
% 221.44/221.60  |- skos__prefLabel mesh__D012547 Schistosoma
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D012547 2006
% 221.44/221.60  |- skos__broader mesh__D012547smesh__D012551
% 221.44/221.60  |- rdf__type mesh__D012547sskos__Concept
% 221.44/221.60  |- mesh__dateRevised mesh__D012547 2003-07-09
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D012547 2004
% 221.44/221.60  |- mesh__dateCreated mesh__D012547 1999-01-01
% 221.44/221.60  |- mesh__dateCreated mesh__D031701 2002-07-03
% 221.44/221.60  |- skos__prefLabel mesh__D031701 Piper
% 221.44/221.60  |- mesh__dateEstablished mesh__D031701 2003-01-01
% 221.44/221.60  |- rdf__type mesh__D031701sskos__Concept
% 221.44/221.60  |- skos__annotation mesh__D031701
% 221.44/221.60       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D031701 2004
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D031701 2003
% 221.44/221.60  |- skos__altLabel mesh__D031701 Pepper, Jaborandi
% 221.44/221.60  |- skos__scopeNote mesh__D031701
% 221.44/221.60       A plant genus of the family PIPERACEAE that includes species used for spicy and stimulating qualities.%A%    
% 221.44/221.60  |- skos__altLabel mesh__D031701 Pepper, Cubeb
% 221.44/221.60  |- mesh__historyNote mesh__D031701 2003   
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D031701 2006
% 221.44/221.60  |- skos__altLabel mesh__D031701 Cubeb Pepper
% 221.44/221.60  |- skos__altLabel mesh__D031701 Pepper, Ashanti
% 221.44/221.60  |- skos__broader mesh__D031701smesh__D026321
% 221.44/221.60  |- mesh__publicMeSHNote mesh__D031701 2003   
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D031701 2005
% 221.44/221.60  |- skos__historyNote mesh__D017232
% 221.44/221.60       Retroviridae Proteins, Oncogenic %28%1990-1992%29%
% 221.44/221.60  |- mesh__recordAuthorizer mesh__D017232 sjn
% 221.44/221.60  |- skos__altLabel mesh__D017232 v-mos Proteins
% 221.44/221.60  |- mesh__dateRevised mesh__D017232 2005-06-30
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D017232 2006
% 221.44/221.60  |- skos__hiddenLabel mesh__D017232 Products v-mos, Oncogene
% 221.44/221.60  |- rdf__type mesh__D017232sskos__Concept
% 221.44/221.60  |- skos__hiddenLabel mesh__D017232 v mos Proteins
% 221.44/221.60  |- skos__altLabel mesh__D017232 p85 gag-mos
% 221.44/221.60  |- mesh__publicMeSHNote mesh__D017232
% 221.44/221.60       93; ONCOGENE PROTEIN P37%28%MOS%29% was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1989-92; ONCOGENE PROTEIN MOS was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1989-92 %26% under RETROVIRIDAE PROTEINS 1987-89%A%  
% 221.44/221.60  |- skos__hiddenLabel mesh__D017232 v-mos, Oncogene Proteins
% 221.44/221.60  |- skos__broader mesh__D017232smesh__D015682
% 221.44/221.60  |- skos__hiddenLabel mesh__D017232 Proteins mos, Oncogene
% 221.44/221.60  |- skos__hiddenLabel mesh__D017232 v-mos, Oncogene Products
% 221.44/221.60  |- skos__hiddenLabel mesh__D017232 gag-mos Fusion Proteins
% 221.44/221.60  |- skos__annotation mesh__D017232
% 221.44/221.60       IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted; DF: note short X ref%A%  
% 221.44/221.60  |- skos__altLabel mesh__D017232 mos Oncogene Proteins
% 221.44/221.60  |- skos__hiddenLabel mesh__D017232 mos, Oncogene Proteins
% 221.44/221.60  |- skos__altLabel mesh__D017232 p37%28%v-mos%29%
% 221.44/221.60  |- skos__altLabel mesh__D017232 Oncogene Protein p85%28%gag-mos%29%
% 221.44/221.60  |- mesh__dateEstablished mesh__D017232 1993-01-01
% 221.44/221.60  |- mesh__onlineNote mesh__D017232
% 221.44/221.60       use ONCOGENE PROTEINS V-MOS %28%NM%29% to search ONCOGENE PROTEIN P37%28%MOS%29% 1989-92 %26% ONCOGENE PROTEIN MOS 1987-92%A%  
% 221.44/221.60  |- skos__hiddenLabel mesh__D017232 Proteins v-mos, Oncogene
% 221.44/221.60  |- skos__hiddenLabel mesh__D017232 Oncogene Proteins, mos
% 221.44/221.60  |- skos__hiddenLabel mesh__D017232 Fusion Proteins, gag mos
% 221.44/221.60  |- skos__altLabel mesh__D017232 Oncogene Products v-mos
% 221.44/221.60  |- skos__hiddenLabel mesh__D017232 v-mos, p37
% 221.44/221.60  |- skos__hiddenLabel mesh__D017232 p85 gag mos
% 221.44/221.60  |- mesh__recordOriginator mesh__D017232 AGS
% 221.44/221.60  |- skos__historyNote mesh__D017232 Retroviridae Proteins %28%1987-1989%29%
% 221.44/221.60  |- skos__prefLabel mesh__D017232 Oncogene Proteins v-mos
% 221.44/221.60  |- skos__scopeNote mesh__D017232
% 221.44/221.60       Transforming proteins coded by mos oncogenes. The v-mos proteins were originally isolated from the Moloney murine sarcoma virus %28%Mo-MSV%29%.%A%    
% 221.44/221.60  |- mesh__recordMaintainer mesh__D017232 SYSTEM
% 221.44/221.60  |- skos__hiddenLabel mesh__D017232 gag-mos, p85
% 221.44/221.60  |- mesh__historyNote mesh__D017232
% 221.44/221.60       93; was ONCOGENE PROTEIN P37%28%MOS%29% %28%NM%29% 1989-92 and ONCOGENE PROTEIN MOS %28%NM%29% 1987-92%A%  
% 221.44/221.60  |- skos__hiddenLabel mesh__D017232 Oncogene Products v mos
% 221.44/221.60  |- skos__altLabel mesh__D017232 Oncogene Proteins mos
% 221.44/221.60  |- skos__hiddenLabel mesh__D017232 Oncogene Proteins v mos
% 221.44/221.60  |- mesh__dateCreated mesh__D017232 1992-05-22
% 221.44/221.60  |- skos__hiddenLabel mesh__D017232 p37 v mos
% 221.44/221.60  |- skos__altLabel mesh__D017232 p37 v-mos
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D003212 2002
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D003212 2006
% 221.44/221.60  |- mesh__recordOriginator mesh__D003212 NLM
% 221.44/221.60  |- skos__scopeNote mesh__D003212
% 221.44/221.60       Aromatic substances added to food before or after cooking to enhance its flavor. These are usually of vegetable origin.%A%    
% 221.44/221.60  |- mesh__dateRevised mesh__D003212 1997-06-20
% 221.44/221.60  |- mesh__recordMaintainer mesh__D003212 JLS
% 221.44/221.60  |- mesh__dateCreated mesh__D003212 1999-01-01
% 221.44/221.60  |- rdf__type mesh__D003212sskos__Concept
% 221.44/221.60  |- skos__hiddenLabel mesh__D003212 Condiment
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D003212 2000
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D003212 1998
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D003212 2001
% 221.44/221.60  |- skos__broader mesh__D003212smesh__D005502
% 221.44/221.60  |- skos__annotation mesh__D003212
% 221.44/221.60       SPICES %26% other condiments are also available   
% 221.44/221.60  |- skos__prefLabel mesh__D003212 Condiments
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D003212 1999
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D003212 2003
% 221.44/221.60  |- mesh__recordAuthorizer mesh__D003212 SJN
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D003212 2005
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D003212 2004
% 221.44/221.60  |- mesh__recordAuthorizer mesh__D002918 sjn
% 221.44/221.60  |- skos__altLabel mesh__D002918 Sanofi Synthelabo Brand of Chymotrypsin
% 221.44/221.60  |- mesh__dateRevised mesh__D002918 2005-06-30
% 221.44/221.60  |- mesh__recordOriginator mesh__D002918 NLM
% 221.44/221.60  |- skos__altLabel mesh__D002918 Wampole Brand of Chymotrypsin
% 221.44/221.60  |- skos__altLabel mesh__D002918 Leurquin Brand of Chymotrypsin
% 221.44/221.60  |- rdf__type mesh__D002918sskos__Concept
% 221.44/221.60  |- mesh__dateCreated mesh__D002918 1999-01-01
% 221.44/221.60  |- skos__prefLabel mesh__D002918 Chymotrypsin
% 221.44/221.60  |- skos__broader mesh__D002918smesh__D012697
% 221.44/221.60  |- skos__altLabel mesh__D002918 Delalande Brand of Chymotrypsin
% 221.44/221.60  |- skos__annotation mesh__D002918
% 221.44/221.60       /antag: consider also ALPHA 1-ANTICHYMOTRYPSIN   
% 221.44/221.60  |- skos__scopeNote mesh__D002918
% 221.44/221.60       A serine endopeptidase secreted by the pancreas as its zymogen, CHYMOTRYPSINOGEN and carried in the pancreatic juice to the duodenum where it is activated by TRYPSIN. It selectively cleaves aromatic amino acids on the carboxyl side.%A%    
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D002918 2006
% 221.44/221.60  |- mesh__recordMaintainer mesh__D002918 lkw
% 221.44/221.60  |- mesh__recordAuthorizer mesh__D013640 ags
% 221.44/221.60  |- mesh__dateCreated mesh__D013640 1999-01-01
% 221.44/221.60  |- skos__hiddenLabel mesh__D013640 Joints, Tarsal
% 221.44/221.60  |- mesh__publicMeSHNote mesh__D013640 2002; see TARSAL JOINT 1965-2001   
% 221.44/221.60  |- skos__hiddenLabel mesh__D013640 Joint, Tarsal
% 221.44/221.60  |- skos__hiddenLabel mesh__D013640 Intertarsal Joints
% 221.44/221.60  |- skos__hiddenLabel mesh__D013640 Joint, Intertarsal
% 221.44/221.60  |- rdf__type mesh__D013640sskos__Concept
% 221.44/221.60  |- skos__scopeNote mesh__D013640
% 221.44/221.60       The articulations between the various TARSAL BONES. This does not include the ANKLE JOINT which consists of the articulations between the TIBIA; FIBULA; and TALUS.%A%    
% 221.44/221.60  |- skos__altLabel mesh__D013640 Articulationes intertarseae
% 221.44/221.60  |- mesh__recordOriginator mesh__D013640 NLM
% 221.44/221.60  |- mesh__recordMaintainer mesh__D013640 ags
% 221.44/221.60  |- mesh__activeMeSHYear mesh__D013640 2006A
% 221.44/221.60  |- mesh__historyNote mesh__D013640 2002 %28%1965%29%   
% 221.44/221.61  |- mesh__dateEstablished mesh__D013640 1965-01-01
% 221.44/221.61  |- mesh__dateRevised mesh__D013640 2005-08-02
% 221.44/221.61  |- skos__annotation mesh__D013640
% 221.44/221.61       do not confuse with TARSUS see ANKLE; tarsal joints of animals goes here not under TARSUS, ANIMAL%A%  
% 221.44/221.61  |- skos__altLabel mesh__D013640 Articulationes intertarsales
% 221.44/221.61  |- skos__altLabel mesh__D013640 Tarsal Joint
% 221.44/221.61  |- skos__prefLabel mesh__D013640 Tarsal Joints
% 221.44/221.61  |- skos__broader mesh__D013640smesh__D033023
% 221.44/221.61  |- skos__hiddenLabel mesh__D013640 Joints, Intertarsal
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D013640 2006
% 221.44/221.61  |- skos__hiddenLabel mesh__D007603 Status, Legal
% 221.44/221.61  |- skos__hiddenLabel mesh__D007603 Litigations
% 221.44/221.61  |- mesh__recordAuthorizer mesh__D007603 sjn
% 221.44/221.61  |- skos__hiddenLabel mesh__D007603 Law, Constitutional
% 221.44/221.61  |- skos__hiddenLabel mesh__D007603 Interests, State
% 221.44/221.61  |- skos__hiddenLabel mesh__D007603 Decisions, Court
% 221.44/221.61  |- mesh__recordOriginator mesh__D007603 NLM
% 221.44/221.61  |- skos__prefLabel mesh__D007603 Jurisprudence
% 221.44/221.61  |- skos__hiddenLabel mesh__D007603 Laws
% 221.44/221.61  |- skos__annotation mesh__D007603
% 221.44/221.61       GEN only: prefer /legis %28%for /legislation %26% jurisprudence%29%: Manual 19.7+, 19.8.42;  specify geog;  do not coord with MEDICINE; for civil suits: differentiate from FORENSIC MEDICINE which is for crime %26% identification%A%  
% 221.44/221.61  |- mesh__dateRevised mesh__D007603 2002-07-02
% 221.44/221.61  |- skos__hiddenLabel mesh__D007603 Interest, State
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007603 2004
% 221.44/221.61  |- skos__hiddenLabel mesh__D007603 Legal Aspect
% 221.44/221.61  |- skos__hiddenLabel mesh__D007603 Jurisprudence, Medical
% 221.44/221.61  |- skos__hiddenLabel mesh__D007603 Decision, Court
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007603 2006
% 221.44/221.61  |- skos__hiddenLabel mesh__D007603 State Interests
% 221.44/221.61  |- skos__related mesh__D007603smesh__D033241
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007603 2003
% 221.44/221.61  |- skos__scopeNote mesh__D007603
% 221.44/221.61       The science or philosophy of law. Also, the application of the principles of law and justice to health and medicine.%A%    
% 221.44/221.61  |- skos__hiddenLabel mesh__D007603 Obligations, Legal
% 221.44/221.61  |- skos__hiddenLabel mesh__D007603 Aspect, Legal
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007603 2005
% 221.44/221.61  |- mesh__dateCreated mesh__D007603 1999-01-01
% 221.44/221.61  |- skos__related mesh__D007603smesh__D005553
% 221.44/221.61  |- skos__hiddenLabel mesh__D007603 Court Decisions
% 221.44/221.61  |- skos__hiddenLabel mesh__D007603 Aspects, Legal
% 221.44/221.61  |- skos__hiddenLabel mesh__D007603 Obligation, Legal
% 221.44/221.61  |- skos__altLabel mesh__D007603 Legal Aspects
% 221.44/221.61  |- skos__related mesh__D007603smesh__D005554
% 221.44/221.61  |- skos__hiddenLabel mesh__D007603 Legal Obligation
% 221.44/221.61  |- skos__hiddenLabel mesh__D007603 Laws, Constitutional
% 221.44/221.61  |- mesh__recordMaintainer mesh__D007603 hjn
% 221.44/221.61  |- rdf__type mesh__D007603sskos__Concept
% 221.44/221.61  |- skos__broader mesh__D007603smesh__D012926
% 221.44/221.61  |- skos__hiddenLabel mesh__D007603 Constitutional Laws
% 221.44/221.61  |- skos__historyNote mesh__D045722 Coronaviridae %28%1990-2003%29%
% 221.44/221.61  |- mesh__historyNote mesh__D045722 2004   
% 221.44/221.61  |- mesh__publicMeSHNote mesh__D045722 2004   
% 221.44/221.61  |- skos__broader mesh__D045722smesh__D005760
% 221.44/221.61  |- skos__prefLabel mesh__D045722 Porcine Respiratory Coronavirus
% 221.44/221.61  |- skos__scopeNote mesh__D045722
% 221.44/221.61       A mutant strain of TRANSMISSIBLE GASTROENTERITIS VIRUS causing mild or subclinical respiratory infections in young SWINE. It may also play a role in post-weaning porcine respiratory disease complex, especially when combined with other respiratory agents.%A%    
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D045722 2005
% 221.44/221.61  |- mesh__dateEstablished mesh__D045722 2004-01-01
% 221.44/221.61  |- rdf__type mesh__D045722sskos__Concept
% 221.44/221.61  |- skos__hiddenLabel mesh__D045722 Respiratory Coronavirus, Porcine
% 221.44/221.61  |- skos__annotation mesh__D045722
% 221.44/221.61       infection: coord IM with CORONAVIRUS INFECTIONS %28%IM%29%   
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D045722 2006
% 221.44/221.61  |- skos__historyNote mesh__D045722
% 221.44/221.61       Transmissible gastroenteritis virus %28%1986-2003%29%
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D045722 2004
% 221.44/221.61  |- mesh__dateCreated mesh__D045722 2003-07-09
% 221.44/221.61  |- skos__hiddenLabel mesh__D045722 Coronavirus, Porcine Respiratory
% 221.44/221.61  |- skos__prefLabel mesh__D012548 Schistosoma haematobium
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D012548 2005
% 221.44/221.61  |- mesh__publicMeSHNote mesh__D012548 72   
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D012548 2006
% 221.44/221.61  |- rdf__type mesh__D012548sskos__Concept
% 221.44/221.61  |- mesh__recordAuthorizer mesh__D012548 sjn
% 221.44/221.61  |- skos__broader mesh__D012548smesh__D012547
% 221.44/221.61  |- skos__historyNote mesh__D012548 Schistosoma %28%1966-1971%29%
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D012548 2004
% 221.44/221.61  |- mesh__recordOriginator mesh__D012548 NLM
% 221.44/221.61  |- mesh__dateRevised mesh__D012548 2003-07-09
% 221.44/221.61  |- mesh__dateCreated mesh__D012548 1999-01-01
% 221.44/221.61  |- skos__scopeNote mesh__D012548
% 221.44/221.61       A species of trematode blood flukes of the family Schistosomatidae which occurs at different stages in development in veins of the pulmonary and hepatic system and finally the bladder lumen. This parasite causes urinary schistosomiasis.%A%    
% 221.44/221.61  |- mesh__dateEstablished mesh__D012548 1972-01-01
% 221.44/221.61  |- mesh__recordMaintainer mesh__D012548 ags
% 221.44/221.61  |- skos__annotation mesh__D012548
% 221.44/221.61       infection = SCHISTOSOMIASIS HAEMATOBIA; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 221.44/221.61  |- mesh__historyNote mesh__D012548 72   
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D031702 2004
% 221.44/221.61  |- mesh__dateCreated mesh__D031702 2002-07-02
% 221.44/221.61  |- skos__annotation mesh__D031702
% 221.44/221.61       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D031702 2003
% 221.44/221.61  |- skos__prefLabel mesh__D031702 Agropyron
% 221.44/221.61  |- mesh__dateEstablished mesh__D031702 2003-01-01
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D031702 2006
% 221.44/221.61  |- mesh__publicMeSHNote mesh__D031702 2003   
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D031702 2005
% 221.44/221.61  |- skos__scopeNote mesh__D031702
% 221.44/221.61       A plant genus of the family POACEAE. The common name of wheatgrass is also used for other plants in the family.%A%    
% 221.44/221.61  |- skos__broader mesh__D031702smesh__D006109
% 221.44/221.61  |- mesh__historyNote mesh__D031702 2003   
% 221.44/221.61  |- rdf__type mesh__D031702sskos__Concept
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D017233 1998
% 221.44/221.61  |- mesh__recordAuthorizer mesh__D017233 SJN
% 221.44/221.61  |- skos__related mesh__D017233smesh__D017234
% 221.44/221.61  |- mesh__recordOriginator mesh__D017233 TGC
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D017233 2006
% 221.44/221.61  |- mesh__recordMaintainer mesh__D017233 PXP
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D017233 1999
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D017233 2000
% 221.44/221.61  |- skos__hiddenLabel mesh__D017233 Eviscerations, Orbital
% 221.44/221.61  |- skos__hiddenLabel mesh__D017233 Eviscerations, Orbit
% 221.44/221.61  |- mesh__dateEstablished mesh__D017233 1993-01-01
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D017233 2003
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D017233 2001
% 221.44/221.61  |- skos__historyNote mesh__D017233 Orbit/surgery %28%1966-1992%29%
% 221.44/221.61  |- skos__broader mesh__D017233smesh__D013508
% 221.44/221.61  |- skos__altLabel mesh__D017233 Orbital Evisceration
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D017233 2004
% 221.44/221.61  |- skos__prefLabel mesh__D017233 Orbit Evisceration
% 221.44/221.61  |- rdf__type mesh__D017233sskos__Concept
% 221.44/221.61  |- mesh__dateRevised mesh__D017233 1997-06-20
% 221.44/221.61  |- skos__hiddenLabel mesh__D017233 Orbit Eviscerations
% 221.44/221.61  |- skos__hiddenLabel mesh__D017233 Evisceration, Orbital
% 221.44/221.61  |- mesh__dateCreated mesh__D017233 1992-05-22
% 221.44/221.61  |- mesh__publicMeSHNote mesh__D017233 93   
% 221.44/221.61  |- skos__scopeNote mesh__D017233
% 221.44/221.61       The surgical removal of the contents of the orbit. This includes the eyeball, blood vessels, muscles, fat, nerve supply, and periosteum. It should be differentiated from EYE EVISCERATION which removes the inner contents of the eye, leaving the sclera intact.%A%    
% 221.44/221.61  |- skos__annotation mesh__D017233
% 221.44/221.61       %22%removal of the contents of the orbit%22% %28%see MeSH definition%29%: do not confuse with EYE EVISCERATION, %22%removal of the inner contents of the eye, leaving the sclera intact%22%; do not use /util except by MeSH definition%A%  
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D017233 2002
% 221.44/221.61  |- skos__hiddenLabel mesh__D017233 Orbital Eviscerations
% 221.44/221.61  |- skos__hiddenLabel mesh__D017233 Evisceration, Orbit
% 221.44/221.61  |- mesh__historyNote mesh__D017233 93   
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D017233 2005
% 221.44/221.61  |- mesh__dateCreated mesh__D003213 1999-01-01
% 221.44/221.61  |- mesh__recordAuthorizer mesh__D003213 PLS
% 221.44/221.61  |- rdf__type mesh__D003213sskos__Concept
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003213 2002
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003213 1996
% 221.44/221.61  |- mesh__recordOriginator mesh__D003213 NLM
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003213 1998
% 221.44/221.61  |- mesh__historyNote mesh__D003213 65; was CONDITIONED LEARNING 1963-64   
% 221.44/221.61  |- mesh__dateRevised mesh__D003213 1992-05-07
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003213 1997
% 221.44/221.61  |- mesh__publicMeSHNote mesh__D003213
% 221.44/221.61       65; was CONDITIONED LEARNING 1963-64   
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003213 1994
% 221.44/221.61  |- skos__hiddenLabel mesh__D003213 Conditionings %28%Psychology%29%
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003213 1999
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003213 2003
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003213 1993
% 221.44/221.61  |- skos__scopeNote mesh__D003213
% 221.44/221.61       A general term referring to the learning of some particular response.%A%    
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003213 2000
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003213 2005
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003213 1995
% 221.44/221.61  |- skos__broader mesh__D003213smesh__D007858
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003213 2004
% 221.44/221.61  |- mesh__dateEstablished mesh__D003213 1965-01-01
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003213 2001
% 221.44/221.61  |- mesh__recordMaintainer mesh__D003213 TAP
% 221.44/221.61  |- skos__prefLabel mesh__D003213 Conditioning %28%Psychology%29%
% 221.44/221.61  |- skos__annotation mesh__D003213 human %26% animal; DF: CONDITIONING   
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003213 2006
% 221.44/221.61  |- skos__altLabel mesh__D003213 Conditioning
% 221.44/221.61  |- skos__hiddenLabel mesh__D002919 A, Chymotrypsinogen
% 221.44/221.61  |- mesh__dateEstablished mesh__D002919 1972-01-01
% 221.44/221.61  |- skos__historyNote mesh__D002919 Chymotrypsin %28%1966-1971%29%
% 221.44/221.61  |- rdf__type mesh__D002919sskos__Concept
% 221.44/221.61  |- mesh__historyNote mesh__D002919 72   
% 221.44/221.61  |- mesh__dateCreated mesh__D002919 1999-01-01
% 221.44/221.61  |- skos__hiddenLabel mesh__D002919 Alpha Chymotrypsinogen
% 221.44/221.61  |- mesh__recordAuthorizer mesh__D002919 sjn
% 221.44/221.61  |- mesh__publicMeSHNote mesh__D002919 72   
% 221.44/221.61  |- mesh__recordOriginator mesh__D002919 NLM
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D002919 2004
% 221.44/221.61  |- skos__prefLabel mesh__D002919 Chymotrypsinogen
% 221.44/221.61  |- mesh__recordMaintainer mesh__D002919 ssb
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D002919 2006
% 221.44/221.61  |- skos__hiddenLabel mesh__D002919 beta, Chymotrypsinogen
% 221.44/221.61  |- skos__annotation mesh__D002919 an enzyme precursor   
% 221.44/221.61  |- skos__broader mesh__D002919smesh__D004792
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D002919 2005
% 221.44/221.61  |- skos__historyNote mesh__D002919 Enzyme Precursors %28%1966-1971%29%
% 221.44/221.61  |- mesh__dateRevised mesh__D002919 2003-07-09
% 221.44/221.61  |- skos__hiddenLabel mesh__D013641 Syndrome, Tarsal Tunnel
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D013641 2003
% 221.44/221.61  |- skos__hiddenLabel mesh__D013641 Tunnel Syndromes, Tarsal
% 221.44/221.61  |- skos__prefLabel mesh__D013641 Tarsal Tunnel Syndrome
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D013641 2000
% 221.44/221.61  |- mesh__recordMaintainer mesh__D013641 ags
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D013641 2004
% 221.44/221.61  |- skos__hiddenLabel mesh__D013641 Tarsal Tunnel Syndromes
% 221.44/221.61  |- mesh__dateEstablished mesh__D013641 1972-01-01
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D013641 2001
% 221.44/221.61  |- skos__altLabel mesh__D013641 Tarsal Tunnel Entrapment Neuropathy
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D013641 2005
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D013641 2000A
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D013641 2002
% 221.44/221.61  |- skos__scopeNote mesh__D013641
% 221.44/221.61       Entrapment of the distal branches of the posterior TIBIAL NERVE %28%which divides into the medial plantar, lateral plantar, and calcanial nerves%29% in the tarsal tunnel, which lies posterior to the internal malleolus and beneath the retinaculum of the flexor muscles of the foot. Symptoms include ankle pain radiating into the foot which tends to be aggravated by walking. Examination may reveal Tinel%27%s sign %28%radiating pain following nerve percussion%29% over the tibial nerve at the ankle, weakness and atrophy of the small foot muscles, or loss of sensation in the foot. %28%From Foot Ankle 1990;11%28%1%29%:47-52%29%%A%    
% 221.44/221.61  |- skos__hiddenLabel mesh__D013641 Syndromes, Tarsal Tunnel
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D013641 2006
% 221.44/221.61  |- skos__altLabel mesh__D013641 Tibial Neuropathy, Tarsal Tunnel
% 221.44/221.61  |- skos__altLabel mesh__D013641 Tarsal Tunnel Tibial Neuropathy
% 221.44/221.61  |- mesh__publicMeSHNote mesh__D013641 1972   
% 221.44/221.61  |- skos__altLabel mesh__D013641 Entrapment Neuropathy, Tarsal Tunnel
% 221.44/221.61  |- mesh__recordAuthorizer mesh__D013641 ags
% 221.44/221.61  |- mesh__dateCreated mesh__D013641 1999-01-01
% 221.44/221.61  |- mesh__dateRevised mesh__D013641 1999-12-08
% 221.44/221.61  |- mesh__recordOriginator mesh__D013641 NLM
% 221.44/221.61  |- skos__broader mesh__D013641smesh__D020429
% 221.44/221.61  |- mesh__historyNote mesh__D013641 1972%28%1964%29%   
% 221.44/221.61  |- rdf__type mesh__D013641sskos__Concept
% 221.44/221.61  |- skos__broader mesh__D013641smesh__D009408
% 221.44/221.61  |- skos__hiddenLabel mesh__D013641 Tunnel Syndrome, Tarsal
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007604 2003
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007604 2005
% 221.44/221.61  |- mesh__dateCreated mesh__D007604 1999-01-01
% 221.44/221.61  |- skos__annotation mesh__D007604 IM   
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007604 2004
% 221.44/221.61  |- skos__broader mesh__D007604smesh__D012940
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007604 2002
% 221.44/221.61  |- skos__prefLabel mesh__D007604 Juvenile Delinquency
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007604 2006
% 221.44/221.61  |- mesh__recordAuthorizer mesh__D007604 sjn
% 221.44/221.61  |- skos__hiddenLabel mesh__D007604 Delinquency, Juvenile
% 221.44/221.61  |- mesh__recordOriginator mesh__D007604 NLM
% 221.44/221.61  |- mesh__recordMaintainer mesh__D007604 kle
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007604 2000
% 221.44/221.61  |- skos__scopeNote mesh__D007604
% 221.44/221.61       The antisocial acts of children or persons under age which are illegal or lawfully interpreted as constituting delinquency.%A%    
% 221.44/221.61  |- mesh__dateRevised mesh__D007604 1999-11-03
% 221.44/221.61  |- rdf__type mesh__D007604sskos__Concept
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007604 2001
% 221.44/221.61  |- skos__broader mesh__D051760smesh__D004268
% 221.44/221.61  |- skos__hiddenLabel mesh__D051760 Xeroderma Pigmentosum A Protein
% 221.44/221.61  |- mesh__dateCreated mesh__D051760 2005-06-30
% 221.44/221.61  |- mesh__recordAuthorizer mesh__D051760 sjn
% 221.44/221.61  |- mesh__recordMaintainer mesh__D051760 DRC
% 221.44/221.61  |- skos__altLabel mesh__D051760
% 221.44/221.61       Xeroderma Pigmentosum Group A Complementing Protein
% 221.44/221.61  |- skos__prefLabel mesh__D051760 Xeroderma Pigmentosum Group A Protein
% 221.44/221.61  |- skos__altLabel mesh__D051760 XPA Repair Protein
% 221.44/221.61  |- mesh__publicMeSHNote mesh__D051760
% 221.44/221.61       2006; XERODERMA PIGMENTOSUM GROUP A PROTEIN was indexed under DNA-BINDING PROTEINS 1990-2005%A%  
% 221.44/221.61  |- skos__altLabel mesh__D051760 XPA Nucleotide Excision Repair Protein
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D051760 2006
% 221.44/221.61  |- rdf__type mesh__D051760sskos__Concept
% 221.44/221.61  |- mesh__historyNote mesh__D051760 2006%28%1990%29%   
% 221.44/221.61  |- mesh__recordOriginator mesh__D051760 DRC
% 221.44/221.61  |- mesh__dateEstablished mesh__D051760 2006-01-01
% 221.44/221.61  |- skos__altLabel mesh__D051760 Xeroderma Pigmentosum-A Protein
% 221.44/221.61  |- skos__scopeNote mesh__D051760
% 221.44/221.61       A ZINC FINGER MOTIF protein that recognizes and interacts with damaged DNA. It is a DNA-binding protein that plays an essential role in NUCLEOTIDE EXCISION REPAIR. Mutations in this protein are associated with the most severe form of XERODERMA PIGMENTOSUM.%A%    
% 221.44/221.61  |- skos__prefLabel mesh__D045723 Diverticulosis, Esophageal
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D045723 2005
% 221.44/221.61  |- rdf__type mesh__D045723sskos__Concept
% 221.44/221.61  |- skos__scopeNote mesh__D045723
% 221.44/221.61       A pathological condition characterized by the presence of a number of ESOPHAGEAL DIVERTICULA in the ESOPHAGUS.%A%    
% 221.44/221.61  |- mesh__historyNote mesh__D045723
% 221.44/221.61       2004; use DIVERTICULUM, ESOPHAGEAL 1980-2003   
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D045723 2006
% 221.44/221.61  |- skos__historyNote mesh__D045723
% 221.44/221.61       Diverticulum, Esophageal %28%1967-2003%29%
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D045723 2004
% 221.44/221.61  |- mesh__dateEstablished mesh__D045723 2004-01-01
% 221.44/221.61  |- skos__broader mesh__D045723smesh__D004935
% 221.44/221.61  |- mesh__dateCreated mesh__D045723 2003-07-09
% 221.44/221.61  |- skos__related mesh__D045723smesh__D004936
% 221.44/221.61  |- skos__altLabel mesh__D045723 Esophageal Diverticulosis
% 221.44/221.61  |- mesh__publicMeSHNote mesh__D045723
% 221.44/221.61       2004; see DIVERTICULUM, ESOPHAGEAL 1980-2003   
% 221.44/221.61  |- rdf__type mesh__D012549sskos__Concept
% 221.44/221.61  |- mesh__historyNote mesh__D012549 79   
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D012549 2004
% 221.44/221.61  |- skos__scopeNote mesh__D012549
% 221.44/221.61       A species of trematode blood flukes belonging to the family Schistosomatidae whose distribution is confined to areas of the Far East. The intermediate host is a snail. It occurs in man and other mammals.%A%    
% 221.44/221.61  |- mesh__dateRevised mesh__D012549 2003-07-09
% 221.44/221.61  |- skos__prefLabel mesh__D012549 Schistosoma japonicum
% 221.44/221.61  |- mesh__publicMeSHNote mesh__D012549 79   
% 221.44/221.61  |- mesh__dateCreated mesh__D012549 1978-03-06
% 221.44/221.61  |- mesh__recordOriginator mesh__D012549 AEP
% 221.44/221.61  |- skos__historyNote mesh__D012549 Schistosoma %28%1966-1978%29%
% 221.44/221.61  |- mesh__recordMaintainer mesh__D012549 ags
% 221.44/221.61  |- mesh__dateEstablished mesh__D012549 1979-01-01
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D012549 2005
% 221.44/221.61  |- mesh__recordAuthorizer mesh__D012549 sjn
% 221.44/221.61  |- skos__broader mesh__D012549smesh__D012547
% 221.44/221.61  |- skos__annotation mesh__D012549
% 221.44/221.61       infection = SCHISTOSOMIASIS JAPONICA; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D012549 2006
% 221.44/221.61  |- rdf__type mesh__D031703sskos__Concept
% 221.44/221.61  |- mesh__dateCreated mesh__D031703 2002-07-02
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D031703 2004
% 221.44/221.61  |- skos__altLabel mesh__D031703 Bentgrass
% 221.44/221.61  |- mesh__historyNote mesh__D031703 2003   
% 221.44/221.61  |- skos__scopeNote mesh__D031703 A plant genus of the family POACEAE.     
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D031703 2005
% 221.44/221.61  |- skos__annotation mesh__D031703
% 221.44/221.61       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D031703 2006
% 221.44/221.61  |- mesh__dateEstablished mesh__D031703 2003-01-01
% 221.44/221.61  |- mesh__publicMeSHNote mesh__D031703 2003   
% 221.44/221.61  |- skos__prefLabel mesh__D031703 Agrostis
% 221.44/221.61  |- skos__broader mesh__D031703smesh__D006109
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D031703 2003
% 221.44/221.61  |- skos__broader mesh__D004848Q000166smesh__D004848
% 221.44/221.61  |- mesh__preferredCombination mesh__D004848Q000166smesh__D004847
% 221.44/221.61  |- rdf__type mesh__D004848Q000166smesh__CompoundConcept
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D017234 2006
% 221.44/221.61  |- mesh__publicMeSHNote mesh__D017234 93   
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D017234 1999
% 221.44/221.61  |- skos__hiddenLabel mesh__D017234 Eye Eviscerations
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D017234 2002
% 221.44/221.61  |- skos__annotation mesh__D017234
% 221.44/221.61       %22%removal of the inner contents of the eye, leaving the sclera intact%22%: do not confuse with EYE ENUCLEATION %28%%22%removal of eyeball leaving eye musc %26% remaining orbital contents intact%22%%29% or ORBIT EVISCERATION %28%%22%removal of contents of orbit, including eyeball, blood vessels, muscles, fat, nerve supply %26% periosteum%22%%29%; do not use /util except by MeSH definition%A%  
% 221.44/221.61  |- skos__related mesh__D017234smesh__D017233
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D017234 2003
% 221.44/221.61  |- mesh__recordAuthorizer mesh__D017234 SJN
% 221.44/221.61  |- skos__historyNote mesh__D017234 Eye Enucleation %28%1989-1992%29%
% 221.44/221.61  |- skos__prefLabel mesh__D017234 Eye Evisceration
% 221.44/221.61  |- mesh__dateCreated mesh__D017234 1992-05-08
% 221.44/221.61  |- mesh__recordOriginator mesh__D017234 TGC
% 221.44/221.61  |- skos__related mesh__D017234smesh__D015353
% 221.44/221.61  |- mesh__recordMaintainer mesh__D017234 PXP
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D017234 2004
% 221.44/221.61  |- rdf__type mesh__D017234sskos__Concept
% 221.44/221.61  |- skos__historyNote mesh__D017234 Eye/surgery %28%1966-1988%29%
% 221.44/221.61  |- skos__hiddenLabel mesh__D017234 Eviscerations, Eye
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D017234 2000
% 221.44/221.61  |- mesh__dateEstablished mesh__D017234 1993-01-01
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D017234 2001
% 221.44/221.61  |- skos__scopeNote mesh__D017234
% 221.44/221.61       The surgical removal of the inner contents of the eye, leaving the sclera intact. It should be differentiated from ORBIT EVISCERATION which removes the entire contents of the orbit, including eyeball, blood vessels, muscles, fat, nerve supply, and periosteum.%A%    
% 221.44/221.61  |- skos__broader mesh__D017234smesh__D013508
% 221.44/221.61  |- mesh__historyNote mesh__D017234 93   
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D017234 2005
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D017234 1998
% 221.44/221.61  |- mesh__dateRevised mesh__D017234 1997-06-20
% 221.44/221.61  |- skos__hiddenLabel mesh__D017234 Evisceration, Eye
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003214 2000
% 221.44/221.61  |- mesh__dateRevised mesh__D003214 1998-06-10
% 221.44/221.61  |- skos__broader mesh__D003214smesh__D003213
% 221.44/221.61  |- mesh__dateEstablished mesh__D003214 1973-01-01
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003214 1999
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003214 2003
% 221.44/221.61  |- skos__prefLabel mesh__D003214 Conditioning, Classical
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003214 2001
% 221.44/221.61  |- skos__scopeNote mesh__D003214
% 221.44/221.61       Learning that takes place when a conditioned stimulus is paired with an unconditioned stimulus.%A%    
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003214 2005
% 221.44/221.61  |- skos__hiddenLabel mesh__D003214 Classical Conditionings
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003214 2004
% 221.44/221.61  |- skos__hiddenLabel mesh__D003214 Conditioned Reflex
% 221.44/221.61  |- mesh__recordAuthorizer mesh__D003214 SJN
% 221.44/221.61  |- mesh__publicMeSHNote mesh__D003214
% 221.44/221.61       73; was REFLEX, CONDITIONED 1963-72   
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003214 2006
% 221.44/221.61  |- skos__historyNote mesh__D003214 REFLEX, CONDITIONED
% 221.44/221.61  |- mesh__historyNote mesh__D003214
% 221.44/221.61       73%28%66%29%; REFLEX, CONDITIONED was heading 1963-72   
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D003214 2002
% 221.44/221.61  |- mesh__recordMaintainer mesh__D003214 MSR
% 221.44/221.61  |- mesh__dateCreated mesh__D003214 1999-01-01
% 221.44/221.61  |- mesh__recordOriginator mesh__D003214 NLM
% 221.44/221.61  |- rdf__type mesh__D003214sskos__Concept
% 221.44/221.61  |- skos__hiddenLabel mesh__D003214 Classical Conditioning
% 221.44/221.61  |- skos__hiddenLabel mesh__D003214 Conditionings, Classical
% 221.44/221.61  |- mesh__onlineNote mesh__D003214
% 221.44/221.61       use CONDITIONING, CLASSICAL to search REFLEX, CONDITIONED 1966-72%A%  
% 221.44/221.61  |- skos__annotation mesh__D007605
% 221.44/221.61       insects only; coord IM with specific insect %28%IM%29%   
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007605 1999
% 221.44/221.61  |- mesh__dateCreated mesh__D007605 1999-01-01
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007605 2003
% 221.44/221.61  |- skos__prefLabel mesh__D007605 Juvenile Hormones
% 221.44/221.61  |- mesh__recordAuthorizer mesh__D007605 PLS
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007605 1994
% 221.44/221.61  |- skos__altLabel mesh__D007605 Regulators, Insect Growth
% 221.44/221.61  |- skos__altLabel mesh__D007605 Insect Growth Regulators
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007605 1993
% 221.44/221.61  |- mesh__historyNote mesh__D007605 72%28%66%29%   
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007605 2002
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007605 2005
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007605 2004
% 221.44/221.61  |- mesh__recordOriginator mesh__D007605 NLM
% 221.44/221.61  |- skos__altLabel mesh__D007605 Growth Regulators, Insect
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007605 1995
% 221.44/221.61  |- mesh__dateRevised mesh__D007605 1992-05-18
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007605 2006
% 221.44/221.61  |- skos__scopeNote mesh__D007605
% 221.44/221.61       Compounds, either natural or synthetic, which block development of the growing insect.%A%    
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007605 2000
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007605 1996
% 221.44/221.61  |- mesh__recordMaintainer mesh__D007605 TAP
% 221.44/221.61  |- rdf__type mesh__D007605sskos__Concept
% 221.44/221.61  |- skos__hiddenLabel mesh__D007605 Hormones, Juvenile
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007605 2001
% 221.44/221.61  |- mesh__publicMeSHNote mesh__D007605 72   
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007605 1998
% 221.44/221.61  |- mesh__activeMeSHYear mesh__D007605 1997
% 221.44/221.61  |- mesh__dateEstablished mesh__D007605 1972-01-01
% 221.44/221.61  |- skos__broader mesh__D007605smesh__D007301
% 221.44/221.61  |- skos__broader mesh__D013116Q000293smesh__D013116
% 221.44/221.61  |- mesh__preferredCombination mesh__D013116Q000293smesh__D013119
% 221.44/221.61  |- rdf__type mesh__D013116Q000293smesh__CompoundConcept
% 221.44/221.61  |- mesh__recordOriginator mesh__D051761 DRC
% 221.47/221.61  |- skos__broader mesh__D051761smesh__D004268
% 221.47/221.61  |- skos__prefLabel mesh__D051761 Paired Box Transcription Factors
% 221.47/221.61  |- mesh__historyNote mesh__D051761 2006   
% 221.47/221.61  |- mesh__dateEstablished mesh__D051761 2006-01-01
% 221.47/221.61  |- skos__broader mesh__D051761smesh__D014157
% 221.47/221.61  |- mesh__recordMaintainer mesh__D051761 DRC
% 221.47/221.61  |- mesh__dateCreated mesh__D051761 2005-06-30
% 221.47/221.61  |- mesh__recordAuthorizer mesh__D051761 sjn
% 221.47/221.61  |- mesh__publicMeSHNote mesh__D051761 2006   
% 221.47/221.61  |- mesh__activeMeSHYear mesh__D051761 2006
% 221.47/221.61  |- rdf__type mesh__D051761sskos__Concept
% 221.47/221.61  |- skos__scopeNote mesh__D051761
% 221.47/221.61       A family of transcription factors that control EMBRYONIC DEVELOPMENT within a variety of cell lineages. They are characterized by a highly conserved paired DNA-binding domain that was first identified in DROSOPHILA segmentation genes.%A%    
% 221.47/221.61  |- skos__hiddenLabel mesh__D051761 Transcription Factors, Pax
% 221.47/221.61  |- skos__altLabel mesh__D051761 Pax Transcription Factors
% 221.47/221.61  |- mesh__activeMeSHYear mesh__D045724 2004
% 221.47/221.61  |- skos__altLabel mesh__D045724 Diverticulosis, Gastric
% 221.47/221.61  |- skos__altLabel mesh__D045724 Gastric Diverticulosis
% 221.47/221.61  |- mesh__dateCreated mesh__D045724 2003-07-09
% 221.47/221.61  |- skos__scopeNote mesh__D045724
% 221.47/221.61       A pathological condition characterized by the presence of a number of GASTRIC DIVERTICULA in the STOMACH.%A%    
% 221.47/221.61  |- mesh__historyNote mesh__D045724
% 221.47/221.61       2004; use DIVERTICULUM, STOMACH 1980-2003   
% 221.47/221.61  |- skos__historyNote mesh__D045724 Diverticulum, Stomach %28%1968-2003%29%
% 221.47/221.61  |- skos__prefLabel mesh__D045724 Diverticulosis, Stomach
% 221.47/221.61  |- mesh__dateEstablished mesh__D045724 2004-01-01
% 221.47/221.61  |- mesh__activeMeSHYear mesh__D045724 2005
% 221.47/221.61  |- rdf__type mesh__D045724sskos__Concept
% 221.47/221.61  |- skos__altLabel mesh__D045724 Stomach Diverticulosis
% 221.47/221.61  |- skos__broader mesh__D045724smesh__D013272
% 221.47/221.61  |- mesh__publicMeSHNote mesh__D045724
% 221.47/221.61       2004; see DIVERTICULUM, STOMACH 1980-2003   
% 221.47/221.61  |- mesh__activeMeSHYear mesh__D045724 2006
% 221.47/221.61  |- mesh__activeMeSHYear mesh__D003215 1999
% 221.47/221.61  |- skos__scopeNote mesh__D003215
% 221.47/221.61       Reflex closure of the eyelid occurring as a result of classical conditioning.%A%    
% 221.47/221.62  |- skos__hiddenLabel mesh__D003215 Eyelid Conditionings
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003215 2003
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003215 1993
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003215 2005
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003215 1995
% 221.47/221.62  |- skos__historyNote mesh__D003215
% 221.47/221.62       Conditioning, Classical %28%1966-1968%29%
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003215 2004
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003215 2006
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003215 2000
% 221.47/221.62  |- mesh__dateEstablished mesh__D003215 1969-01-01
% 221.47/221.62  |- mesh__recordMaintainer mesh__D003215 ags
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003215 2001
% 221.47/221.62  |- mesh__recordAuthorizer mesh__D003215 ags
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003215 2000A
% 221.47/221.62  |- mesh__dateCreated mesh__D003215 1999-01-01
% 221.47/221.62  |- rdf__type mesh__D003215sskos__Concept
% 221.47/221.62  |- skos__hiddenLabel mesh__D003215 Conditionings, Eyelid
% 221.47/221.62  |- skos__historyNote mesh__D003215
% 221.47/221.62       Conditioning %28%Psychology%29% %28%1966-1968%29%
% 221.47/221.62  |- mesh__publicMeSHNote mesh__D003215 69   
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003215 1996
% 221.47/221.62  |- skos__historyNote mesh__D003215 Eyelids %28%1966-1968%29%
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003215 1998
% 221.47/221.62  |- skos__prefLabel mesh__D003215 Conditioning, Eyelid
% 221.47/221.62  |- skos__altLabel mesh__D003215 Eyelid Conditioning
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003215 2002
% 221.47/221.62  |- mesh__dateRevised mesh__D003215 1999-12-13
% 221.47/221.62  |- skos__broader mesh__D003215smesh__D003213
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003215 1997
% 221.47/221.62  |- mesh__historyNote mesh__D003215 69   
% 221.47/221.62  |- mesh__recordOriginator mesh__D003215 NLM
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003215 1994
% 221.47/221.62  |- skos__broader mesh__D000005Q000530smesh__D000005
% 221.47/221.62  |- mesh__preferredCombination mesh__D000005Q000530smesh__D011860
% 221.47/221.62  |- rdf__type mesh__D000005Q000530smesh__CompoundConcept
% 221.47/221.62  |- mesh__dateEstablished mesh__D013643 1988-01-01
% 221.47/221.62  |- mesh__historyNote mesh__D013643
% 221.47/221.62       1988%28%1968%29%; for HOCK see HINDLIMB 1975-2001   
% 221.47/221.62  |- skos__broader mesh__D013643smesh__D006614
% 221.47/221.62  |- mesh__dateCreated mesh__D013643 1999-01-01
% 221.47/221.62  |- skos__prefLabel mesh__D013643 Tarsus, Animal
% 221.47/221.62  |- mesh__recordOriginator mesh__D013643 NLM
% 221.47/221.62  |- mesh__recordAuthorizer mesh__D013643 sjn
% 221.47/221.62  |- skos__altLabel mesh__D013643 Hock
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D013643 2006
% 221.47/221.62  |- mesh__publicMeSHNote mesh__D013643
% 221.47/221.62       1988;  see HINDLIMB 1968-87; for HOCK see HINDLIMB 1997-2001, see HOCK 1991-1996, see HINDLIMB 1975-1990%A%  
% 221.47/221.62  |- skos__hiddenLabel mesh__D013643 Hocks
% 221.47/221.62  |- skos__annotation mesh__D013643
% 221.47/221.62       use for ankle of non-primate vertebrates; tarsal joints of animals does not go here: use TARSAL JOINTS%A%  
% 221.47/221.62  |- skos__hiddenLabel mesh__D013643 Animal Tarsus
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D013643 2005
% 221.47/221.62  |- skos__scopeNote mesh__D013643
% 221.47/221.62       The region in the hindlimb of a quadruped, corresponding to the human ANKLE.%A%    
% 221.47/221.62  |- mesh__recordMaintainer mesh__D013643 sjn
% 221.47/221.62  |- rdf__type mesh__D013643sskos__Concept
% 221.47/221.62  |- mesh__dateRevised mesh__D013643 2004-07-13
% 221.47/221.62  |- mesh__dateRevised mesh__D007606 2005-06-30
% 221.47/221.62  |- skos__hiddenLabel mesh__D007606 Apparatus, Juxtaglomerular
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D007606 2006
% 221.47/221.62  |- skos__prefLabel mesh__D007606 Juxtaglomerular Apparatus
% 221.47/221.62  |- mesh__dateEstablished mesh__D007606 1966-01-01
% 221.47/221.62  |- mesh__historyNote mesh__D007606 66%28%64%29%   
% 221.47/221.62  |- mesh__recordAuthorizer mesh__D007606 sjn
% 221.47/221.62  |- mesh__recordOriginator mesh__D007606 NLM
% 221.47/221.62  |- rdf__type mesh__D007606sskos__Concept
% 221.47/221.62  |- skos__broader mesh__D007606smesh__D007678
% 221.47/221.62  |- skos__related mesh__D007606smesh__D012083
% 221.47/221.62  |- skos__scopeNote mesh__D007606
% 221.47/221.62       A complex of cells consisting of juxtaglomerular cells, extraglomerular mesangium lacis cells, the macula densa of the distal convoluted tubule, and granular epithelial peripolar cells. Juxtaglomerular cells are modified smooth muscle cells found in the walls of afferent glomerular arterioles and sometimes the efferent arterioles. Extraglomerular mesangium lacis cells are located in the angle between the afferent and efferent glomerular arterioles. Granular epithelial peripolar cells are located at the angle of reflection of the parietal to visceral angle of the renal corpuscle.%A%    
% 221.47/221.62  |- mesh__recordMaintainer mesh__D007606 nns
% 221.47/221.62  |- mesh__dateCreated mesh__D007606 1999-01-01
% 221.47/221.62  |- mesh__publicMeSHNote mesh__D007606 66   
% 221.47/221.62  |- skos__prefLabel mesh__D051762 PAX2 Transcription Factor
% 221.47/221.62  |- skos__altLabel mesh__D051762 Paired Box Transcription Factor 2
% 221.47/221.62  |- skos__hiddenLabel mesh__D051762 Factor PAX2, Transcription
% 221.47/221.62  |- skos__altLabel mesh__D051762 Paired Box Protein Pax-2
% 221.47/221.62  |- skos__hiddenLabel mesh__D051762 PAX2, Transcription Factor
% 221.47/221.62  |- skos__altLabel mesh__D051762 Paired Box Gene 2 Protein
% 221.47/221.62  |- mesh__dateEstablished mesh__D051762 2006-01-01
% 221.47/221.62  |- rdf__type mesh__D051762sskos__Concept
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D051762 2006
% 221.47/221.62  |- mesh__publicMeSHNote mesh__D051762
% 221.47/221.62       2006; PAX2 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1992-2005%A%  
% 221.47/221.62  |- skos__altLabel mesh__D051762 Transcription Factor PAX2
% 221.47/221.62  |- skos__broader mesh__D051762smesh__D051761
% 221.47/221.62  |- mesh__recordMaintainer mesh__D051762 DRC
% 221.47/221.62  |- mesh__dateCreated mesh__D051762 2005-06-30
% 221.47/221.62  |- skos__scopeNote mesh__D051762
% 221.47/221.62       A paired box transcription factor that is essential for ORGANOGENESIS of the CENTRAL NERVOUS SYSTEM and KIDNEY.%A%    
% 221.47/221.62  |- skos__hiddenLabel mesh__D051762 Transcription Factor, PAX2
% 221.47/221.62  |- mesh__recordAuthorizer mesh__D051762 sjn
% 221.47/221.62  |- mesh__recordOriginator mesh__D051762 DRC
% 221.47/221.62  |- skos__hiddenLabel mesh__D051762 Paired Box Protein Pax 2
% 221.47/221.62  |- mesh__historyNote mesh__D051762 2006%28%1992%29%   
% 221.47/221.62  |- mesh__recordMaintainer mesh__D045725 ssb
% 221.47/221.62  |- skos__broader mesh__D045725smesh__D047028
% 221.47/221.62  |- mesh__publicMeSHNote mesh__D045725
% 221.47/221.62       2004; TETRAPYRROLES was indexed under PYRROLES 1978-2003   
% 221.47/221.62  |- mesh__dateCreated mesh__D045725 2003-07-09
% 221.47/221.62  |- skos__broader mesh__D045725smesh__D006576
% 221.47/221.62  |- mesh__recordOriginator mesh__D045725 ssb
% 221.47/221.62  |- skos__scopeNote mesh__D045725
% 221.47/221.62       Four PYRROLES joined by one-carbon units linking position 2 of one to position 5 of the next. The conjugated bond system results in PIGMENTATION.%A%    
% 221.47/221.62  |- mesh__recordAuthorizer mesh__D045725 sjn
% 221.47/221.62  |- skos__historyNote mesh__D045725 Pyrroles %28%1966-2003%29%
% 221.47/221.62  |- mesh__historyNote mesh__D045725
% 221.47/221.62       2004; use TETRAPYRROLES %28%NM%29% 1978-2003   
% 221.47/221.62  |- skos__prefLabel mesh__D045725 Tetrapyrroles
% 221.47/221.62  |- mesh__dateRevised mesh__D045725 2005-06-30
% 221.47/221.62  |- rdf__type mesh__D045725sskos__Concept
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D045725 2006
% 221.47/221.62  |- skos__broader mesh__D045725smesh__D011758
% 221.47/221.62  |- mesh__dateEstablished mesh__D045725 2004-01-01
% 221.47/221.62  |- skos__hiddenLabel mesh__D017236 Suicides, Physician-Assisted
% 221.47/221.62  |- mesh__dateRevised mesh__D017236 2003-07-09
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D017236 2006
% 221.47/221.62  |- skos__related mesh__D017236smesh__D033101
% 221.47/221.62  |- skos__related mesh__D017236smesh__D028601
% 221.47/221.62  |- skos__broader mesh__D017236smesh__D013405
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D017236 2005
% 221.47/221.62  |- mesh__recordOriginator mesh__D017236 TGC
% 221.47/221.62  |- skos__historyNote mesh__D017236 Euthanasia %28%1976-1992%29%
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D017236 2004
% 221.47/221.62  |- skos__prefLabel mesh__D017236 Suicide, Assisted
% 221.47/221.62  |- skos__hiddenLabel mesh__D017236 Assisted Death
% 221.47/221.62  |- skos__broader mesh__D017236smesh__D013727
% 221.47/221.62  |- skos__hiddenLabel mesh__D017236 Deaths, Assisted
% 221.47/221.62  |- rdf__type mesh__D017236sskos__Concept
% 221.47/221.62  |- skos__hiddenLabel mesh__D017236 Suicides, Assisted
% 221.47/221.62  |- skos__altLabel mesh__D017236 Death, Assisted
% 221.47/221.62  |- mesh__publicMeSHNote mesh__D017236 93   
% 221.47/221.62  |- mesh__dateEstablished mesh__D017236 1993-01-01
% 221.47/221.62  |- skos__altLabel mesh__D017236 Suicides, Medically Assisted
% 221.47/221.62  |- skos__altLabel mesh__D017236 Medically Assisted Suicides
% 221.47/221.62  |- mesh__recordAuthorizer mesh__D017236 sjn
% 221.47/221.62  |- skos__related mesh__D017236smesh__D005065
% 221.47/221.62  |- skos__hiddenLabel mesh__D017236 Physician Assisted Suicide
% 221.47/221.62  |- skos__hiddenLabel mesh__D017236 Physician-Assisted Suicides
% 221.47/221.62  |- skos__hiddenLabel mesh__D017236 Suicide, Physician-Assisted
% 221.47/221.62  |- skos__hiddenLabel mesh__D017236 Assisted Suicides
% 221.47/221.62  |- skos__altLabel mesh__D017236 Suicide, Medically Assisted
% 221.47/221.62  |- mesh__historyNote mesh__D017236 93   
% 221.47/221.62  |- skos__altLabel mesh__D017236 Assisted Suicide
% 221.47/221.62  |- mesh__dateCreated mesh__D017236 1992-05-22
% 221.47/221.62  |- mesh__recordMaintainer mesh__D017236 ssb
% 221.47/221.62  |- skos__historyNote mesh__D017236 Suicide %28%1976-1992%29%
% 221.47/221.62  |- skos__scopeNote mesh__D017236
% 221.47/221.62       Provision %28%by a physician or other health professional, or by a family member or friend%29% of support and/or means that gives a patient the power to terminate his or her own life. %28%from APA, Thesaurus of Psychological Index Terms, 8th ed%29%.%A%    
% 221.47/221.62  |- skos__hiddenLabel mesh__D017236 Assisted Deaths
% 221.47/221.62  |- skos__hiddenLabel mesh__D003216 Operant Conditionings
% 221.47/221.62  |- skos__broader mesh__D003216smesh__D003213
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003216 2003
% 221.47/221.62  |- skos__prefLabel mesh__D003216 Conditioning, Operant
% 221.47/221.62  |- mesh__dateRevised mesh__D003216 2002-07-03
% 221.47/221.62  |- skos__hiddenLabel mesh__D003216 Conditionings, Operant
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003216 2005
% 221.47/221.62  |- mesh__recordAuthorizer mesh__D003216 sjn
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003216 2004
% 221.47/221.62  |- mesh__dateCreated mesh__D003216 1999-01-01
% 221.47/221.62  |- mesh__dateEstablished mesh__D003216 1968-01-01
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003216 2006
% 221.47/221.62  |- rdf__type mesh__D003216sskos__Concept
% 221.47/221.62  |- skos__related mesh__D003216smesh__D032763
% 221.47/221.62  |- skos__altLabel mesh__D003216 Learning, Instrumental
% 221.47/221.62  |- mesh__recordMaintainer mesh__D003216 jrf
% 221.47/221.62  |- skos__scopeNote mesh__D003216
% 221.47/221.62       Learning situations in which the sequence responses of the subject are instrumental in producing reinforcement. When the correct response occurs, which involves the selection from among a repertoire of responses, the subject is immediately reinforced.%A%    
% 221.47/221.62  |- skos__hiddenLabel mesh__D003216 Learnings, Instrumental
% 221.47/221.62  |- skos__annotation mesh__D003216 human %26% animal   
% 221.47/221.62  |- skos__hiddenLabel mesh__D003216 Instrumental Learnings
% 221.47/221.62  |- skos__altLabel mesh__D003216 Operant Conditioning
% 221.47/221.62  |- mesh__historyNote mesh__D003216 68%28%65%29%   
% 221.47/221.62  |- mesh__recordOriginator mesh__D003216 NLM
% 221.47/221.62  |- mesh__publicMeSHNote mesh__D003216 68   
% 221.47/221.62  |- skos__altLabel mesh__D003216 Instrumental Learning
% 221.47/221.62  |- skos__broader mesh__D013644smesh__D003998
% 221.47/221.62  |- mesh__dateCreated mesh__D013644 1999-01-01
% 221.47/221.62  |- mesh__recordOriginator mesh__D013644 NLM
% 221.47/221.62  |- mesh__dateRevised mesh__D013644 2004-07-07
% 221.47/221.62  |- mesh__recordAuthorizer mesh__D013644 sjn
% 221.47/221.62  |- mesh__recordMaintainer mesh__D013644 ssb
% 221.47/221.62  |- skos__prefLabel mesh__D013644 Tartrates
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D013644 2006
% 221.47/221.62  |- rdf__type mesh__D013644sskos__Concept
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D013644 2005
% 221.47/221.62  |- skos__broader mesh__D013644smesh__D013400
% 221.47/221.62  |- skos__broader mesh__D051763smesh__D051761
% 221.47/221.62  |- mesh__dateCreated mesh__D051763 2005-06-30
% 221.47/221.62  |- skos__hiddenLabel mesh__D051763 Paired Box Protein Pax 7
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D051763 2006
% 221.47/221.62  |- mesh__recordAuthorizer mesh__D051763 sjn
% 221.47/221.62  |- rdf__type mesh__D051763sskos__Concept
% 221.47/221.62  |- mesh__publicMeSHNote mesh__D051763
% 221.47/221.62       2006; PAX7 TRANSCRIPTION FACTOR was indexed under HOMEODOMAIN PROTEINS 2001-2005, %26% under MUSCLE PROTEINS %26% NERVE TISSUE PROTEINS 1993-2000%A%  
% 221.47/221.62  |- skos__altLabel mesh__D051763 Transcription Factor PAX7
% 221.47/221.62  |- skos__prefLabel mesh__D051763 PAX7 Transcription Factor
% 221.47/221.62  |- skos__hiddenLabel mesh__D051763 Factor PAX7, Transcription
% 221.47/221.62  |- mesh__historyNote mesh__D051763 2006%28%1993%29%   
% 221.47/221.62  |- mesh__recordOriginator mesh__D051763 DRC
% 221.47/221.62  |- skos__scopeNote mesh__D051763
% 221.47/221.62       A paired box transcription factor that is involved in EMBRYONIC DEVELOPMENT of the CENTRAL NERVOUS SYSTEM and SKELETAL MUSCLE.%A%    
% 221.47/221.62  |- skos__altLabel mesh__D051763 Paired Box Protein Pax-7
% 221.47/221.62  |- mesh__dateEstablished mesh__D051763 2006-01-01
% 221.47/221.62  |- skos__altLabel mesh__D051763 Paired Box Transcription Factor 7
% 221.47/221.62  |- skos__hiddenLabel mesh__D051763 PAX7, Transcription Factor
% 221.47/221.62  |- skos__broader mesh__D051763smesh__D018398
% 221.47/221.62  |- skos__hiddenLabel mesh__D051763 Transcription Factor, PAX7
% 221.47/221.62  |- mesh__recordMaintainer mesh__D051763 DRC
% 221.47/221.62  |- skos__annotation mesh__D045726 GEN; prefer specifics   
% 221.47/221.62  |- mesh__dateCreated mesh__D045726 2003-07-09
% 221.47/221.62  |- skos__historyNote mesh__D045726 Metalloendopeptidases %28%1987-2003%29%
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D045726 2005
% 221.47/221.62  |- mesh__historyNote mesh__D045726
% 221.47/221.62       2004; use METALLOENDOPEPTIDASES 1988-2003   
% 221.47/221.62  |- mesh__publicMeSHNote mesh__D045726
% 221.47/221.62       2004; see METALLOENDOPEPTIDASES 1988-2003   
% 221.47/221.62  |- skos__scopeNote mesh__D045726
% 221.47/221.62       Proteases which use a metal, normally ZINC, in the catalytic mechanism. This group of enzymes is inactivated by metal CHELATORS.%A%    
% 221.47/221.62  |- skos__broader mesh__D045726smesh__D010447
% 221.47/221.62  |- skos__altLabel mesh__D045726 Metalloproteinases
% 221.47/221.62  |- mesh__recordMaintainer mesh__D045726 jmp
% 221.47/221.62  |- skos__altLabel mesh__D045726 Metallopeptidases
% 221.47/221.62  |- skos__prefLabel mesh__D045726 Metalloproteases
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D045726 2004
% 221.47/221.62  |- mesh__dateEstablished mesh__D045726 2004-01-01
% 221.47/221.62  |- mesh__recordOriginator mesh__D045726 jmp
% 221.47/221.62  |- mesh__recordAuthorizer mesh__D045726 sjn
% 221.47/221.62  |- rdf__type mesh__D045726sskos__Concept
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D045726 2006
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D017237 2003
% 221.47/221.62  |- mesh__recordAuthorizer mesh__D017237 sjn
% 221.47/221.62  |- skos__prefLabel mesh__D017237 Mitochondrial Encephalomyopathies
% 221.47/221.62  |- skos__broader mesh__D017237smesh__D017240
% 221.47/221.62  |- mesh__dateRevised mesh__D017237 2001-07-25
% 221.47/221.62  |- rdf__type mesh__D017237sskos__Concept
% 221.47/221.62  |- skos__historyNote mesh__D017237 Mitochondria, Muscle %28%1977-1992%29%
% 221.47/221.62  |- mesh__dateCreated mesh__D017237 1992-05-22
% 221.47/221.62  |- mesh__publicMeSHNote mesh__D017237 1993   
% 221.47/221.62  |- skos__historyNote mesh__D017237
% 221.47/221.62       Brain Diseases, Metabolic %28%1977-1992%29%
% 221.47/221.62  |- skos__hiddenLabel mesh__D017237 Mitochondrial Encephalomyopathy
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D017237 2002
% 221.47/221.62  |- skos__altLabel mesh__D017237 Encephalomyopathies, Mitochondrial
% 221.47/221.62  |- mesh__recordMaintainer mesh__D017237 nns
% 221.47/221.62  |- skos__historyNote mesh__D017237 Neuromuscular Diseases %28%1977-1992%29%
% 221.47/221.62  |- mesh__recordOriginator mesh__D017237 TGC
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D017237 2006
% 221.47/221.62  |- mesh__historyNote mesh__D017237 1993   
% 221.47/221.62  |- skos__annotation mesh__D017237
% 221.47/221.62       GEN or unspecified; prefer specifics; coord with specific dysfunction if pertinent; DF: MITOCHONDRIAL ENCEPH%A%  
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D017237 2004
% 221.47/221.62  |- mesh__dateEstablished mesh__D017237 1993-01-01
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D017237 2005
% 221.47/221.62  |- skos__broader mesh__D017237smesh__D001928
% 221.47/221.62  |- skos__scopeNote mesh__D017237
% 221.47/221.62       A heterogenous group of disorders characterized by alterations of mitochondrial metabolism that result in muscle and nervous system dysfunction. These are often multisystemic and vary considerably in age at onset %28%usually in the first or second decade of life%29%, distribution of affected muscles, severity, and course. %28%From Adams et al., Principles of Neurology, 6th ed, pp984-5%29%%A%    
% 221.47/221.62  |- skos__hiddenLabel mesh__D017237 Encephalomyopathy, Mitochondrial
% 221.47/221.62  |- skos__annotation mesh__D003217
% 221.47/221.62       a titrimetric %26% electrochem technique; NIM   
% 221.47/221.62  |- mesh__publicMeSHNote mesh__D003217 68   
% 221.47/221.62  |- mesh__dateEstablished mesh__D003217 1968-01-01
% 221.47/221.62  |- skos__broader mesh__D003217smesh__D017186
% 221.47/221.62  |- mesh__recordOriginator mesh__D003217 NLM
% 221.47/221.62  |- skos__hiddenLabel mesh__D003217 Titrations, Conductometric
% 221.47/221.62  |- mesh__recordMaintainer mesh__D003217 lkt
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003217 2004
% 221.47/221.62  |- skos__prefLabel mesh__D003217 Conductometry
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003217 2003
% 221.47/221.62  |- skos__broader mesh__D003217smesh__D004563
% 221.47/221.62  |- skos__hiddenLabel mesh__D003217 Conductometric Titration
% 221.47/221.62  |- skos__altLabel mesh__D003217 Titration, Conductometric
% 221.47/221.62  |- mesh__dateRevised mesh__D003217 2002-07-03
% 221.47/221.62  |- mesh__recordAuthorizer mesh__D003217 sjn
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003217 2006
% 221.47/221.62  |- rdf__type mesh__D003217sskos__Concept
% 221.47/221.62  |- mesh__dateCreated mesh__D003217 1999-01-01
% 221.47/221.62  |- mesh__historyNote mesh__D003217 68   
% 221.47/221.62  |- skos__scopeNote mesh__D003217
% 221.47/221.62       Determination of the quantity of a material present in a mixture by measurement of its effect on the electrical conductivity of the mixture. %28%Webster, 3d ed%29%%A%    
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D003217 2005
% 221.47/221.62  |- skos__hiddenLabel mesh__D003217 Conductometric Titrations
% 221.47/221.62  |- mesh__dateEstablished mesh__D013645 1991-01-01
% 221.47/221.62  |- skos__broader mesh__D013645smesh__D001391
% 221.47/221.62  |- skos__historyNote mesh__D013645 Pyrazoles %28%1969-1976%29%
% 221.47/221.62  |- skos__scopeNote mesh__D013645
% 221.47/221.62       An anionic, hydrophilic azo dye with an orange-yellow color used in fabrics, foods and cosmetics, and as a biological stain.%A%    
% 221.47/221.62  |- mesh__historyNote mesh__D013645
% 221.47/221.62       91%28%77%29%; was see under AZO COMPOUNDS 1977-90   
% 221.47/221.62  |- skos__annotation mesh__D013645 D25-26 qualif   
% 221.47/221.62  |- skos__altLabel mesh__D013645 FD%26%C Yellow No. 5
% 221.47/221.62  |- skos__historyNote mesh__D013645 Azo Compounds %28%1969-1976%29%
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D013645 2006
% 221.47/221.62  |- rdf__type mesh__D013645sskos__Concept
% 221.47/221.62  |- mesh__recordAuthorizer mesh__D013645 NLM
% 221.47/221.62  |- mesh__recordOriginator mesh__D013645 SH
% 221.47/221.62  |- skos__hiddenLabel mesh__D013645 Barium, Tartrazine
% 221.47/221.62  |- mesh__dateCreated mesh__D013645 1976-04-16
% 221.47/221.62  |- skos__prefLabel mesh__D013645 Tartrazine
% 221.47/221.62  |- mesh__dateRevised mesh__D013645 2005-07-06
% 221.47/221.62  |- skos__historyNote mesh__D013645 Benzenesulfonates %28%1974-1976%29%
% 221.47/221.62  |- mesh__publicMeSHNote mesh__D013645
% 221.47/221.62       91; was see under AZO COMPOUNDS 1977-90   
% 221.47/221.62  |- mesh__recordMaintainer mesh__D013645 NLM
% 221.47/221.62  |- mesh__recordAuthorizer mesh__D007608 PLS
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D007608 1998
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D007608 2002
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D007608 1997
% 221.47/221.62  |- mesh__recordMaintainer mesh__D007608 JRT
% 221.47/221.62  |- mesh__dateEstablished mesh__D007608 1986-01-01
% 221.47/221.62  |- skos__hiddenLabel mesh__D007608 Acid, Digenic
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D007608 1999
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D007608 2003
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D007608 2000
% 221.47/221.62  |- mesh__dateCreated mesh__D007608 1977-04-22
% 221.47/221.62  |- skos__annotation mesh__D007608
% 221.47/221.62       an antinematodal agent %26% excitatory amino acid agonist   
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D007608 2005
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D007608 2004
% 221.47/221.62  |- mesh__dateRevised mesh__D007608 1995-06-16
% 221.47/221.62  |- skos__prefLabel mesh__D007608 Kainic Acid
% 221.47/221.62  |- skos__historyNote mesh__D007608 Pyrrolidines %28%1966-1977%29%
% 221.47/221.62  |- mesh__publicMeSHNote mesh__D007608
% 221.47/221.62       86; was see under PYRROLIDINES 1978-85   
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D007608 2001
% 221.47/221.62  |- skos__altLabel mesh__D007608 Digenic Acid
% 221.47/221.62  |- skos__hiddenLabel mesh__D007608 Acid, Kainic
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D007608 2006
% 221.47/221.62  |- mesh__recordOriginator mesh__D007608 SH
% 221.47/221.62  |- skos__broader mesh__D007608smesh__D011759
% 221.47/221.62  |- mesh__historyNote mesh__D007608
% 221.47/221.62       86%28%78%29%; was see under PYRROLIDINES 1978-85   
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D007608 1996
% 221.47/221.62  |- skos__scopeNote mesh__D007608
% 221.47/221.62       %28%2S-%28%2 alpha,3 beta,4 beta%29%%29%-2-Carboxy-4-%28%1-methylethenyl%29%-3-pyrrolidineacetic acid. Ascaricide obtained from the red alga Digenea simplex. It is a potent excitatory amino acid agonist at some types of excitatory amino acid receptors and has been used to discriminate among receptor types. Like many excitatory amino acid agonists it can cause neurotoxicity and has been used experimentally for that purpose.%A%    
% 221.47/221.62  |- skos__related mesh__D007608smesh__D018092
% 221.47/221.62  |- rdf__type mesh__D007608sskos__Concept
% 221.47/221.62  |- skos__altLabel mesh__D018330 Nevi, Intradermal
% 221.47/221.62  |- skos__scopeNote mesh__D018330
% 221.47/221.62       A nevus in which nests of melanocytes are found in the dermis, but not at the epidermal-dermal junction. Benign pigmented nevi in adults are most commonly intradermal. %28%Stedman, 25th ed%29%%A%    
% 221.47/221.62  |- mesh__recordOriginator mesh__D018330 PLS
% 221.47/221.62  |- skos__prefLabel mesh__D018330 Nevus, Intradermal
% 221.47/221.62  |- mesh__historyNote mesh__D018330 94   
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D018330 2006
% 221.47/221.62  |- mesh__dateRevised mesh__D018330 1995-06-08
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D018330 1999
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D018330 2002
% 221.47/221.62  |- rdf__type mesh__D018330sskos__Concept
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D018330 2005
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D018330 1998
% 221.47/221.62  |- skos__broader mesh__D018330smesh__D009506
% 221.47/221.62  |- skos__historyNote mesh__D018330 Nevus, Pigmented %28%1967-1993%29%
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D018330 2001
% 221.47/221.62  |- mesh__dateCreated mesh__D018330 1993-06-25
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D018330 2004
% 221.47/221.62  |- mesh__publicMeSHNote mesh__D018330 94   
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D018330 1997
% 221.47/221.62  |- mesh__recordAuthorizer mesh__D018330 PLS
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D018330 2000
% 221.47/221.62  |- mesh__dateEstablished mesh__D018330 1994-01-01
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D018330 2003
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D018330 1996
% 221.47/221.62  |- skos__hiddenLabel mesh__D018330 Intradermal Nevi
% 221.47/221.62  |- skos__annotation mesh__D018330
% 221.47/221.62       /blood supply /chem /secret /ultrastruct permitted; coord IM with SKIN NEOPLASMS %28%IM%29% + site %28%IM or NIM%29% if permitted%A%  
% 221.47/221.62  |- skos__hiddenLabel mesh__D018330 Intradermal Nevus
% 221.47/221.62  |- mesh__recordMaintainer mesh__D018330 KEV
% 221.47/221.62  |- rdf__type mesh__D051764sskos__Concept
% 221.47/221.62  |- skos__altLabel mesh__D051764 Paired Box 9 Protein
% 221.47/221.62  |- mesh__recordMaintainer mesh__D051764 DRC
% 221.47/221.62  |- mesh__recordOriginator mesh__D051764 DRC
% 221.47/221.62  |- skos__broader mesh__D051764smesh__D051761
% 221.47/221.62  |- mesh__dateCreated mesh__D051764 2005-06-30
% 221.47/221.62  |- skos__prefLabel mesh__D051764 PAX9 Transcription Factor
% 221.47/221.62  |- mesh__recordAuthorizer mesh__D051764 sjn
% 221.47/221.62  |- skos__scopeNote mesh__D051764
% 221.47/221.62       A paired box transcription factor that is involved in ODONTOGENESIS.%A%    
% 221.47/221.62  |- mesh__historyNote mesh__D051764 2006%28%1993%29%   
% 221.47/221.62  |- mesh__publicMeSHNote mesh__D051764
% 221.47/221.62       2006; PAX9 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1993-2005%A%  
% 221.47/221.62  |- skos__hiddenLabel mesh__D051764 Transcription Factor, PAX9
% 221.47/221.62  |- mesh__dateEstablished mesh__D051764 2006-01-01
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D051764 2006
% 221.47/221.62  |- skos__altLabel mesh__D051764 Paired Box Transcription Factor 9
% 221.47/221.62  |- skos__altLabel mesh__D004310 Taussig-Bing Anomaly
% 221.47/221.62  |- skos__annotation mesh__D004310
% 221.47/221.62       incomplete transposition of great vessels; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 221.47/221.62  |- skos__hiddenLabel mesh__D004310 Anomaly, Taussig-Bing
% 221.47/221.62  |- mesh__onlineNote mesh__D004310
% 221.47/221.62       search TRANSPOSITION OF GREAT VESSELS 1984-86   
% 221.47/221.62  |- rdf__type mesh__D004310sskos__Concept
% 221.47/221.62  |- skos__hiddenLabel mesh__D004310 Taussig Bing Anomaly
% 221.47/221.62  |- skos__scopeNote mesh__D004310
% 221.47/221.62       Incomplete transposition of the great vessels in which both the aorta and the pulmonary artery arise from the right ventricle, often associated with a subaortic ventricular septal defect.%A%    
% 221.47/221.62  |- mesh__publicMeSHNote mesh__D004310
% 221.47/221.62       87; was see TRANSPOSITION OF GREAT VESSELS 1984-86   
% 221.47/221.62  |- mesh__dateCreated mesh__D004310 1986-06-24
% 221.47/221.62  |- mesh__recordAuthorizer mesh__D004310 sjn
% 221.47/221.62  |- skos__historyNote mesh__D004310
% 221.47/221.62       Transposition of Great Vessels %28%1966-1986%29%
% 221.47/221.62  |- mesh__dateEstablished mesh__D004310 1987-01-01
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D004310 2002
% 221.47/221.62  |- skos__prefLabel mesh__D004310 Double Outlet Right Ventricle
% 221.47/221.62  |- mesh__recordMaintainer mesh__D004310 kle
% 221.47/221.62  |- mesh__dateRevised mesh__D004310 1999-11-03
% 221.47/221.62  |- mesh__historyNote mesh__D004310
% 221.47/221.62       87; was see TRANSPOSITION OF GREAT VESSELS 1984-86   
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D004310 2004
% 221.47/221.62  |- mesh__recordOriginator mesh__D004310 VDK
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D004310 2001
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D004310 2006
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D004310 2003
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D004310 2005
% 221.47/221.62  |- skos__broader mesh__D004310smesh__D014188
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D004310 2000
% 221.47/221.62  |- mesh__dateEstablished mesh__D045727 2004-01-01
% 221.47/221.62  |- skos__altLabel mesh__D045727 Metalloexopeptidase
% 221.47/221.62  |- skos__broader mesh__D045727smesh__D020689
% 221.47/221.62  |- mesh__historyNote mesh__D045727 2004   
% 221.47/221.62  |- skos__altLabel mesh__D045727 Metalloexoproteinases
% 221.47/221.62  |- skos__scopeNote mesh__D045727
% 221.47/221.62       EXOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism.%A%    
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D045727 2004
% 221.47/221.62  |- rdf__type mesh__D045727sskos__Concept
% 221.47/221.62  |- skos__prefLabel mesh__D045727 Metalloexopeptidases
% 221.47/221.62  |- skos__altLabel mesh__D045727 Metalloexoproteinase
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D045727 2006
% 221.47/221.62  |- mesh__publicMeSHNote mesh__D045727 2004   
% 221.47/221.62  |- skos__broader mesh__D045727smesh__D045726
% 221.47/221.62  |- mesh__dateCreated mesh__D045727 2003-07-09
% 221.47/221.62  |- mesh__activeMeSHYear mesh__D045727 2005
% 221.47/221.63  |- mesh__dateEstablished mesh__D017238 1993-01-01
% 221.47/221.63  |- mesh__dateCreated mesh__D017238 1992-05-20
% 221.47/221.63  |- skos__annotation mesh__D017238
% 221.47/221.63       coordinate IM with specific helminth /genet %28%IM%29%   
% 221.47/221.63  |- skos__altLabel mesh__D017238 Helminth Genes
% 221.47/221.63  |- skos__broader mesh__D017238smesh__D049751
% 221.47/221.63  |- skos__hiddenLabel mesh__D017238 Gene, Helminth
% 221.47/221.63  |- skos__scopeNote mesh__D017238
% 221.47/221.63       The functional hereditary units of HELMINTHS.     
% 221.47/221.63  |- mesh__historyNote mesh__D017238 93   
% 221.47/221.63  |- mesh__publicMeSHNote mesh__D017238 93   
% 221.47/221.63  |- skos__historyNote mesh__D017238 specific helminths %28%1974-1992%29%
% 221.47/221.63  |- mesh__recordAuthorizer mesh__D017238 sjn
% 221.47/221.63  |- skos__historyNote mesh__D017238 Genes %28%1974-1992%29%
% 221.47/221.63  |- skos__related mesh__D017238smesh__D049751
% 221.47/221.63  |- mesh__activeMeSHYear mesh__D017238 2006
% 221.47/221.63  |- mesh__recordMaintainer mesh__D017238 nns
% 221.47/221.63  |- skos__hiddenLabel mesh__D017238 Helminth Gene
% 221.47/221.63  |- mesh__recordOriginator mesh__D017238 PXP
% 221.47/221.63  |- mesh__dateRevised mesh__D017238 2005-06-30
% 221.47/221.63  |- skos__broader mesh__D017238smesh__D005796
% 221.47/221.63  |- rdf__type mesh__D017238sskos__Concept
% 221.47/221.63  |- skos__prefLabel mesh__D017238 Genes, Helminth
% 221.47/221.63  |- skos__prefLabel mesh__D003218 Condylomata Acuminata
% 221.47/221.63  |- skos__hiddenLabel mesh__D003218 Wart, Genital
% 221.47/221.63  |- mesh__dateEstablished mesh__D003218 1972-01-01
% 221.47/221.63  |- skos__hiddenLabel mesh__D003218 Genital Wart
% 221.47/221.63  |- skos__altLabel mesh__D003218 Genital Warts
% 221.47/221.63  |- mesh__recordOriginator mesh__D003218 NLM
% 221.47/221.63  |- skos__broader mesh__D003218smesh__D014860
% 221.47/221.63  |- skos__altLabel mesh__D003218 Warts, Genital
% 221.47/221.63  |- skos__broader mesh__D003218smesh__D015229
% 221.47/221.63  |- rdf__type mesh__D003218sskos__Concept
% 221.47/221.63  |- skos__scopeNote mesh__D003218
% 221.47/221.63       Sexually transmitted form of anogenital warty growth caused by the human papillomaviruses.%A%    
% 221.47/221.63  |- mesh__activeMeSHYear mesh__D003218 2006
% 221.47/221.63  |- mesh__dateCreated mesh__D003218 1999-01-01
% 221.47/221.63  |- skos__altLabel mesh__D003218 Venereal Warts
% 221.47/221.63  |- skos__hiddenLabel mesh__D003218 Wart, Venereal
% 221.47/221.63  |- mesh__activeMeSHYear mesh__D003218 2005
% 221.47/221.63  |- mesh__historyNote mesh__D003218 72%28%64%29%   
% 221.47/221.63  |- skos__hiddenLabel mesh__D003218 Venereal Wart
% 221.47/221.63  |- skos__annotation mesh__D003218
% 221.47/221.63       a non-neoplastic tumor virus infect; coord IM with precoord organ/dis term %28%IM%29%%A%  
% 221.47/221.63  |- mesh__recordAuthorizer mesh__D003218 sjn
% 221.47/221.63  |- skos__altLabel mesh__D003218 Warts, Venereal
% 221.47/221.63  |- mesh__publicMeSHNote mesh__D003218 72   
% 221.47/221.63  |- mesh__dateRevised mesh__D003218 2004-07-13
% 221.47/221.63  |- mesh__recordMaintainer mesh__D003218 sjn
% 221.47/221.63  |- skos__altLabel mesh__D008701
% 221.47/221.63       N,N-Dimethyl-N%27%-2-pyridinyl-N%27%-%28%2-thienylmethyl%29%-1,2-ethanediamine
% 221.47/221.63  |- skos__broader mesh__D008701smesh__D000631
% 221.47/221.63  |- mesh__activeMeSHYear mesh__D008701 2004
% 221.47/221.63  |- mesh__historyNote mesh__D008701
% 221.47/221.63       91%28%75%29%; was see under AMINOPYRIDINES 1979-90; was see under PYRIDINES 1975-78; was see under ANTIHISTAMINICS 1963-74%A%  
% 221.47/221.63  |- mesh__dateCreated mesh__D008701 1977-12-08
% 221.47/221.63  |- mesh__activeMeSHYear mesh__D008701 2006
% 221.47/221.63  |- mesh__dateEstablished mesh__D008701 1991-01-01
% 221.47/221.63  |- mesh__recordMaintainer mesh__D008701 ssb
% 221.47/221.63  |- skos__scopeNote mesh__D008701
% 221.47/221.63       Histamine H1 antagonist with sedative action used as a hypnotic and in allergies.%A%    
% 221.47/221.63  |- mesh__activeMeSHYear mesh__D008701 2005
% 221.47/221.63  |- skos__altLabel mesh__D008701 Thenylpyramine
% 221.47/221.63  |- mesh__publicMeSHNote mesh__D008701
% 221.47/221.63       91; was see under AMINOPYRIDINES 1979-90; was see under PYRIDINES 1975-78; was see under ANTIHISTAMINICS 1963-74%A%  
% 221.47/221.63  |- skos__prefLabel mesh__D008701 Methapyrilene
% 221.47/221.63  |- mesh__onlineNote mesh__D008701
% 221.47/221.63       use HISTAMINE H1 RECEPTOR BLOCKADERS to search METHAPYRILENE 1966-74%A%  
% 221.47/221.63  |- skos__broader mesh__D008701smesh__D005029
% 221.48/221.63  |- mesh__recordAuthorizer mesh__D008701 sjn
% 221.48/221.63  |- mesh__recordOriginator mesh__D008701 SH
% 221.48/221.63  |- rdf__type mesh__D008701sskos__Concept
% 221.48/221.63  |- mesh__dateRevised mesh__D008701 2003-07-09
% 221.48/221.63  |- mesh__recordMaintainer mesh__D013646 ssb
% 221.48/221.63  |- skos__altLabel mesh__D013646 Hydroxymalonic Acids
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D013646 2006
% 221.48/221.63  |- rdf__type mesh__D013646sskos__Concept
% 221.48/221.63  |- skos__broader mesh__D013646smesh__D013400
% 221.48/221.63  |- skos__hiddenLabel mesh__D013646 Acids, Hydroxymalonic
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D013646 2005
% 221.48/221.63  |- mesh__dateCreated mesh__D013646 1999-01-01
% 221.48/221.63  |- mesh__dateRevised mesh__D013646 2004-07-07
% 221.48/221.63  |- skos__broader mesh__D013646smesh__D003998
% 221.48/221.63  |- mesh__recordOriginator mesh__D013646 NLM
% 221.48/221.63  |- skos__prefLabel mesh__D013646 Tartronates
% 221.48/221.63  |- mesh__recordAuthorizer mesh__D013646 sjn
% 221.48/221.63  |- skos__hiddenLabel mesh__D007609 Bradykinin, Lysine
% 221.48/221.63  |- skos__hiddenLabel mesh__D007609 Bradykinin, Lysyl
% 221.48/221.63  |- skos__annotation mesh__D007609 /biosyn /drug eff /physiol permitted   
% 221.48/221.63  |- skos__hiddenLabel mesh__D007609 Tetraacetate, Kallidin
% 221.48/221.63  |- mesh__dateRevised mesh__D007609 2005-06-30
% 221.48/221.63  |- rdf__type mesh__D007609sskos__Concept
% 221.48/221.63  |- skos__altLabel mesh__D007609 Lysyl Bradykinin
% 221.48/221.63  |- skos__scopeNote mesh__D007609
% 221.48/221.63       A decapeptide bradykinin homolog cleaved from kininogen by kallikreins. It is a smooth-muscle stimulant and hypotensive agent that acts by vasodilatation.%A%    
% 221.48/221.63  |- skos__hiddenLabel mesh__D007609 Lys Bradykinin
% 221.48/221.63  |- mesh__historyNote mesh__D007609 66%28%64%29%   
% 221.48/221.63  |- mesh__recordAuthorizer mesh__D007609 sjn
% 221.48/221.63  |- mesh__publicMeSHNote mesh__D007609 66   
% 221.48/221.63  |- mesh__recordMaintainer mesh__D007609 ssb
% 221.48/221.63  |- skos__altLabel mesh__D007609 N2-L-Lysylbradykinin
% 221.48/221.63  |- mesh__recordOriginator mesh__D007609 NLM
% 221.48/221.63  |- mesh__dateCreated mesh__D007609 1999-01-01
% 221.48/221.63  |- skos__altLabel mesh__D007609 Lysine Bradykinin
% 221.48/221.63  |- skos__broader mesh__D007609smesh__D001920
% 221.48/221.63  |- mesh__dateEstablished mesh__D007609 1966-01-01
% 221.48/221.63  |- skos__altLabel mesh__D007609 Lys-Bradykinin
% 221.48/221.63  |- skos__hiddenLabel mesh__D007609 N2 L Lysylbradykinin
% 221.48/221.63  |- skos__prefLabel mesh__D007609 Kallidin
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D007609 2006
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018331 2006
% 221.48/221.63  |- mesh__dateRevised mesh__D018331 1995-06-08
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018331 1999
% 221.48/221.63  |- skos__scopeNote mesh__D018331
% 221.48/221.63       A form of pigmented nevus showing intense melanocytic activity around the dermo-epidermal junction. Large numbers of spindle-shaped melanocytes proliferate downward toward the dermis and usually a large amount of pigment is present. It was first described in 1976 and the bulk of patients reported have been young females with the lesions presenting on the thighs. %28%From Rook et al., Textbook of Dermatology, 4th ed, 1992, p185%29%%A%    
% 221.48/221.63  |- skos__annotation mesh__D018331
% 221.48/221.63       /blood supply /chem /secret /ultrastruct permitted; coord IM with SKIN NEOPLASMS %28%IM%29% + site %28%IM or NIM%29% if relevant%A%  
% 221.48/221.63  |- skos__hiddenLabel mesh__D018331 Spindle Cell Nevus
% 221.48/221.63  |- rdf__type mesh__D018331sskos__Concept
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018331 2005
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018331 1998
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018331 2004
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018331 1997
% 221.48/221.63  |- skos__broader mesh__D018331smesh__D009508
% 221.48/221.63  |- skos__altLabel mesh__D018331 Nevi, Spindle Cell
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018331 2002
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018331 2003
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018331 1996
% 221.48/221.63  |- skos__historyNote mesh__D018331 Nevus, Pigmented %28%1973-1993%29%
% 221.48/221.63  |- skos__hiddenLabel mesh__D018331 Spindle Cell Nevi
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018331 2001
% 221.48/221.63  |- mesh__dateCreated mesh__D018331 1993-06-25
% 221.48/221.63  |- mesh__publicMeSHNote mesh__D018331 94   
% 221.48/221.63  |- mesh__recordMaintainer mesh__D018331 KEV
% 221.48/221.63  |- skos__prefLabel mesh__D018331 Nevus, Spindle Cell
% 221.48/221.63  |- mesh__recordAuthorizer mesh__D018331 PLS
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018331 2000
% 221.48/221.63  |- mesh__recordOriginator mesh__D018331 PLS
% 221.48/221.63  |- mesh__dateEstablished mesh__D018331 1994-01-01
% 221.48/221.63  |- mesh__historyNote mesh__D018331 94   
% 221.48/221.63  |- skos__broader mesh__D051765smesh__D014157
% 221.48/221.63  |- skos__broader mesh__D051765smesh__D004268
% 221.48/221.63  |- skos__broader mesh__D051765smesh__D017874
% 221.48/221.63  |- skos__prefLabel mesh__D051765
% 221.48/221.63       Early Growth Response Transcription Factors
% 221.48/221.63  |- mesh__recordMaintainer mesh__D051765 DRC
% 221.48/221.63  |- mesh__dateEstablished mesh__D051765 2006-01-01
% 221.48/221.63  |- mesh__historyNote mesh__D051765 2006   
% 221.48/221.63  |- mesh__dateCreated mesh__D051765 2005-06-30
% 221.48/221.63  |- mesh__recordAuthorizer mesh__D051765 sjn
% 221.48/221.63  |- mesh__publicMeSHNote mesh__D051765 2006   
% 221.48/221.63  |- skos__altLabel mesh__D051765 EGR Transcription Factors
% 221.48/221.63  |- skos__scopeNote mesh__D051765
% 221.48/221.63       A family of transcription factors that are induced by GROWTH FACTORS and contain a highly conserved DNA-binding domain composed of three ZINC FINGER MOTIFS.%A%    
% 221.48/221.63  |- mesh__recordOriginator mesh__D051765 DRC
% 221.48/221.63  |- skos__hiddenLabel mesh__D051765 Transcription Factors, EGR
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D051765 2006
% 221.48/221.63  |- rdf__type mesh__D051765sskos__Concept
% 221.48/221.63  |- mesh__dateCreated mesh__D004311 1977-05-12
% 221.48/221.63  |- mesh__recordOriginator mesh__D004311 EC
% 221.48/221.63  |- skos__broader mesh__D004311smesh__D015340
% 221.48/221.63  |- skos__altLabel mesh__D004311 Double-Masked Method
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D004311 2004
% 221.48/221.63  |- skos__hiddenLabel mesh__D004311 Studies, Double-Masked
% 221.48/221.63  |- skos__altLabel mesh__D004311 Double-Blind Study
% 221.48/221.63  |- mesh__historyNote mesh__D004311
% 221.48/221.63       90%28%Aug 77%29%; was in Cat E %26% H Aug 77-79; was see under RESEARCH DESIGN 1977-89%A%  
% 221.48/221.63  |- skos__altLabel mesh__D004311 Double-Masked Study
% 221.48/221.63  |- skos__hiddenLabel mesh__D004311 Double-Blind Methods
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D004311 2006
% 221.48/221.63  |- skos__hiddenLabel mesh__D004311 Double Masked Study
% 221.48/221.63  |- mesh__publicMeSHNote mesh__D004311
% 221.48/221.63       90; was see under RESEARCH DESIGN 1977-89   
% 221.48/221.63  |- skos__annotation mesh__D004311
% 221.48/221.63       IM GEN only; coord NIM with specific disease %28%IM%29%; when pertinent add CLINICAL TRIAL %28%PT%29% or RANDOMIZED CONTROLLED TRIAL %28%PT%29%; do not index also under PLACEBOS unless particularly discussed; no qualif%A%  
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D004311 2003
% 221.48/221.63  |- skos__hiddenLabel mesh__D004311 Double Masked Method
% 221.48/221.63  |- mesh__dateRevised mesh__D004311 2001-07-25
% 221.48/221.63  |- skos__hiddenLabel mesh__D004311 Methods, Double-Blind
% 221.48/221.63  |- skos__hiddenLabel mesh__D004311 Method, Double-Blind
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D004311 2005
% 221.48/221.63  |- skos__scopeNote mesh__D004311
% 221.48/221.63       A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.%A%    
% 221.48/221.63  |- skos__hiddenLabel mesh__D004311 Double-Masked Studies
% 221.48/221.63  |- mesh__recordMaintainer mesh__D004311 ags
% 221.48/221.63  |- skos__hiddenLabel mesh__D004311 Study, Double-Masked
% 221.48/221.63  |- mesh__dateEstablished mesh__D004311 1990-01-01
% 221.48/221.63  |- skos__hiddenLabel mesh__D004311 Double Blind Study
% 221.48/221.63  |- skos__hiddenLabel mesh__D004311 Double-Blind Studies
% 221.48/221.63  |- skos__broader mesh__D004311smesh__D012107
% 221.48/221.63  |- skos__hiddenLabel mesh__D004311 Method, Double-Masked
% 221.48/221.63  |- rdf__type mesh__D004311sskos__Concept
% 221.48/221.63  |- skos__hiddenLabel mesh__D004311 Study, Double-Blind
% 221.48/221.63  |- skos__prefLabel mesh__D004311 Double-Blind Method
% 221.48/221.63  |- mesh__recordAuthorizer mesh__D004311 sjn
% 221.48/221.63  |- skos__hiddenLabel mesh__D004311 Studies, Double-Blind
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D004311 2002
% 221.48/221.63  |- skos__hiddenLabel mesh__D004311 Methods, Double-Masked
% 221.48/221.63  |- skos__hiddenLabel mesh__D004311 Double Blind Method
% 221.48/221.63  |- skos__hiddenLabel mesh__D004311 Double-Masked Methods
% 221.48/221.63  |- skos__prefLabel mesh__D045728 Corrinoids
% 221.48/221.63  |- mesh__historyNote mesh__D045728
% 221.48/221.63       2004; use CORRINOIDS %28%NM%29% 1975-2003   
% 221.48/221.63  |- mesh__dateEstablished mesh__D045728 2004-01-01
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D045728 2006
% 221.48/221.63  |- rdf__type mesh__D045728sskos__Concept
% 221.48/221.63  |- skos__scopeNote mesh__D045728
% 221.48/221.63       Cyclic TETRAPYRROLES based on the corrin skeleton.     
% 221.48/221.63  |- mesh__recordAuthorizer mesh__D045728 sjn
% 221.48/221.63  |- mesh__dateCreated mesh__D045728 2003-07-09
% 221.48/221.63  |- skos__historyNote mesh__D045728 Porphyrins %28%1965-2003%29%
% 221.48/221.63  |- mesh__recordOriginator mesh__D045728 ssb
% 221.48/221.63  |- skos__broader mesh__D045728smesh__D045725
% 221.48/221.63  |- mesh__publicMeSHNote mesh__D045728
% 221.48/221.63       2004; CORRINOID was indexed under PORPHYRINS 1975-2003   
% 221.48/221.63  |- mesh__dateRevised mesh__D045728 2005-06-30
% 221.48/221.63  |- mesh__recordMaintainer mesh__D045728 ssb
% 221.48/221.63  |- skos__broader mesh__D017239smesh__D043823
% 221.48/221.63  |- skos__scopeNote mesh__D017239
% 221.48/221.63       A cyclodecane isolated from the bark of the Pacific yew tree, TAXUS BREVIFOLIA. It stabilizes MICROTUBULES in their polymerized form leading to cell death.%A%    
% 221.48/221.63  |- skos__altLabel mesh__D017239 Taxol A
% 221.48/221.63  |- mesh__publicMeSHNote mesh__D017239
% 221.48/221.63       95; was TAXOL 1993-94; TAXOL A was indexed under ALKALOIDS 1982-92 %26% TERPENES 1977-81%A%  
% 221.48/221.63  |- mesh__dateRevised mesh__D017239 2005-06-30
% 221.48/221.63  |- skos__historyNote mesh__D017239 Terpenes %28%1977-1981%29%
% 221.48/221.63  |- skos__altLabel mesh__D017239 Bristol-Myers Brand of Paclitaxel
% 221.48/221.63  |- skos__altLabel mesh__D017239 Bull Brand of Paclitaxel
% 221.48/221.63  |- mesh__historyNote mesh__D017239
% 221.48/221.63       95; was TAXOL 1993-94; was TAXOL A %28%NM%29% 1977-92   
% 221.48/221.63  |- skos__prefLabel mesh__D017239 Paclitaxel
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D017239 2006
% 221.48/221.63  |- skos__altLabel mesh__D017239 Bristol-Myers Squibb Brand of Paclitaxel
% 221.48/221.63  |- skos__altLabel mesh__D017239 Ivax Brand of Paclitaxel
% 221.48/221.63  |- mesh__dateEstablished mesh__D017239 1993-01-01
% 221.48/221.63  |- mesh__recordOriginator mesh__D017239 AGS
% 221.48/221.63  |- mesh__recordAuthorizer mesh__D017239 sjn
% 221.48/221.63  |- skos__altLabel mesh__D017239 Lemery Brand of Paclitaxel
% 221.48/221.63  |- skos__hiddenLabel mesh__D017239 NSC 125973
% 221.48/221.63  |- skos__historyNote mesh__D017239 Alkaloids %28%1982-1992%29%
% 221.48/221.63  |- skos__altLabel mesh__D017239 Bris Taxol
% 221.48/221.63  |- mesh__recordMaintainer mesh__D017239 CCR
% 221.48/221.63  |- skos__hiddenLabel mesh__D017239 7 epi Taxol
% 221.48/221.63  |- mesh__onlineNote mesh__D017239
% 221.48/221.63       use PACLITAXEL to search TAXOL 1993-94; use PACLITAXEL %28%NM%29% to search TAXOL A 1977-92%A%  
% 221.48/221.63  |- skos__hiddenLabel mesh__D017239 NSC125973
% 221.48/221.63  |- rdf__type mesh__D017239sskos__Concept
% 221.48/221.63  |- mesh__dateCreated mesh__D017239 1999-11-04
% 221.48/221.63  |- skos__related mesh__D003219smesh__D017007
% 221.48/221.63  |- skos__hiddenLabel mesh__D003219 Privileged Communications
% 221.48/221.63  |- skos__hiddenLabel mesh__D003219 Privacy, Patient Data
% 221.48/221.63  |- skos__prefLabel mesh__D003219 Confidentiality
% 221.48/221.63  |- mesh__onlineNote mesh__D003219
% 221.48/221.63       use CONFIDENTIALITY to search PRIVILEGED COMMUNICATION 1975-79; use JURISPRUDENCE 1968-74%A%  
% 221.48/221.63  |- rdf__type mesh__D003219sskos__Concept
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D003219 2006
% 221.48/221.63  |- skos__altLabel mesh__D003219 Patient Data Privacy
% 221.48/221.63  |- skos__broader mesh__D003219smesh__D028701
% 221.48/221.63  |- mesh__dateEstablished mesh__D003219 1975-01-01
% 221.48/221.63  |- mesh__dateCreated mesh__D003219 1999-01-01
% 221.48/221.63  |- mesh__recordMaintainer mesh__D003219 sjn
% 221.48/221.63  |- skos__related mesh__D003219smesh__D035041
% 221.48/221.63  |- skos__hiddenLabel mesh__D003219 Data Privacy, Patient
% 221.48/221.63  |- mesh__recordAuthorizer mesh__D003219 sjn
% 221.48/221.63  |- skos__related mesh__D003219smesh__D030881
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D003219 2005
% 221.48/221.63  |- skos__scopeNote mesh__D003219
% 221.48/221.63       The privacy of information and its protection against unauthorized disclosure.%A%    
% 221.48/221.63  |- skos__related mesh__D003219smesh__D018907
% 221.48/221.63  |- skos__broader mesh__D003219smesh__D007603
% 221.48/221.63  |- skos__hiddenLabel mesh__D003219 Communication, Privileged
% 221.48/221.63  |- mesh__publicMeSHNote mesh__D003219
% 221.48/221.63       80; was PRIVILEGED COMMUNICATION 1975-79; was PRIVILEGED COMMUNICATION see under JURISPRUDENCE 1968-74%A%  
% 221.48/221.63  |- skos__related mesh__D003219smesh__D030661
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D003219 2004
% 221.48/221.63  |- skos__broader mesh__D003219smesh__D005555
% 221.48/221.63  |- skos__related mesh__D003219smesh__D035622
% 221.48/221.63  |- skos__hiddenLabel mesh__D003219 Communications, Privileged
% 221.48/221.63  |- skos__annotation mesh__D003219 secrecy goes here   
% 221.48/221.63  |- mesh__recordOriginator mesh__D003219 NLM
% 221.48/221.63  |- skos__historyNote mesh__D003219 Jurisprudence %28%1966-1974%29%
% 221.48/221.63  |- mesh__dateRevised mesh__D003219 2003-07-25
% 221.48/221.63  |- skos__hiddenLabel mesh__D003219 Information, Confidential
% 221.48/221.63  |- mesh__historyNote mesh__D003219
% 221.48/221.63       80; was PRIVILEGED COMMUNICATION 1975-79; was PRIVILEGED COMMUNICATION see under JURISPRUDENCE 1968-74%A%  
% 221.48/221.63  |- skos__broader mesh__D008702smesh__D011799
% 221.48/221.63  |- skos__altLabel mesh__D008702 Wallace Brand of Methaqualone Hydrochloride
% 221.48/221.63  |- skos__altLabel mesh__D008702 Ortonal
% 221.48/221.63  |- skos__prefLabel mesh__D008702 Methaqualone
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D008702 2006
% 221.48/221.63  |- mesh__historyNote mesh__D008702 68   
% 221.48/221.63  |- skos__altLabel mesh__D008702 Metolquizolone
% 221.48/221.63  |- skos__scopeNote mesh__D008702
% 221.48/221.63       A quinazoline derivative with hypnotic and sedative properties. It has been withdrawn from the market in many countries because of problems with abuse. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p604%29%%A%    
% 221.48/221.63  |- mesh__dateEstablished mesh__D008702 1968-01-01
% 221.48/221.63  |- skos__hiddenLabel mesh__D008702 Hydrochloride, Methaqualone
% 221.48/221.63  |- rdf__type mesh__D008702sskos__Concept
% 221.48/221.63  |- mesh__dateCreated mesh__D008702 1999-01-01
% 221.48/221.63  |- mesh__dateRevised mesh__D008702 2005-06-30
% 221.48/221.63  |- mesh__recordOriginator mesh__D008702 NLM
% 221.48/221.63  |- skos__historyNote mesh__D008702 Tranquilizing Agents %28%1966-1967%29%
% 221.48/221.63  |- skos__historyNote mesh__D008702
% 221.48/221.63       Hypnotics and Sedatives %28%1966-1967%29%
% 221.48/221.63  |- mesh__recordMaintainer mesh__D008702 CCR
% 221.48/221.63  |- mesh__recordAuthorizer mesh__D008702 sjn
% 221.48/221.63  |- mesh__publicMeSHNote mesh__D008702 68   
% 221.48/221.63  |- rdf__type mesh__D052060sskos__Concept
% 221.48/221.63  |- mesh__historyNote mesh__D052060 2005   
% 221.48/221.63  |- skos__prefLabel mesh__D052060 Research Support, N.I.H., Intramural
% 221.48/221.63  |- mesh__recordAuthorizer mesh__D052060 sjn
% 221.48/221.63  |- skos__altLabel mesh__D052060 Research, NIH, Intramural
% 221.48/221.63  |- mesh__recordOriginator mesh__D052060 jls
% 221.48/221.63  |- mesh__dateCreated mesh__D052060 2005-04-04
% 221.48/221.63  |- mesh__dateEstablished mesh__D052060 2005-04-04
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D052060 2006
% 221.48/221.63  |- skos__annotation mesh__D052060
% 221.48/221.63       for all articles noted as resulting from intramural research at any NIH institute; CATALOG: do not use%A%  
% 221.48/221.63  |- skos__scopeNote mesh__D052060
% 221.48/221.63       A designation for publications of research resulting from intramural research at the National Institutes of Health.%A%    
% 221.48/221.63  |- skos__broader mesh__D052060smesh__D013487
% 221.48/221.63  |- mesh__recordMaintainer mesh__D052060 jls
% 221.48/221.63  |- mesh__dateRevised mesh__D052060 2005-06-30
% 221.48/221.63  |- skos__altLabel mesh__D052060
% 221.48/221.63       United States Gov%27%t Supported, P.H.S., N.I.H., Intramural
% 221.48/221.63  |- skos__hiddenLabel mesh__D013647 Incident Techniques, Critical
% 221.48/221.63  |- mesh__dateRevised mesh__D013647 2001-07-25
% 221.48/221.63  |- skos__hiddenLabel mesh__D013647 Critical Incident Technics
% 221.48/221.63  |- skos__hiddenLabel mesh__D013647 Techniques, Critical Incident
% 221.48/221.63  |- mesh__recordAuthorizer mesh__D013647 sjn
% 221.48/221.63  |- skos__hiddenLabel mesh__D013647 Incident Technique, Critical
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D013647 2005
% 221.48/221.63  |- skos__hiddenLabel mesh__D013647 Technique, Critical Incident
% 221.48/221.63  |- skos__hiddenLabel mesh__D013647 Technic, Critical Incident
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D013647 2002
% 221.48/221.63  |- skos__altLabel mesh__D013647 Task Performance, Analysis
% 221.48/221.63  |- skos__hiddenLabel mesh__D013647 Technics, Critical Incident
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D013647 2004
% 221.48/221.63  |- skos__broader mesh__D013647smesh__D006804
% 221.48/221.63  |- skos__broader mesh__D013647smesh__D011597
% 221.48/221.63  |- mesh__publicMeSHNote mesh__D013647 73   
% 221.48/221.63  |- mesh__dateCreated mesh__D013647 1999-01-01
% 221.48/221.63  |- skos__scopeNote mesh__D013647
% 221.48/221.63       The detailed examination of observable activity or behavior associated with the execution or completion of a required function or unit of work.%A%    
% 221.48/221.63  |- skos__annotation mesh__D013647
% 221.48/221.63       do not use for anal of performance on individual tasks in learning exper; no qualif; DF: TASK PERFORMANCE%A%  
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D013647 2003
% 221.48/221.63  |- skos__hiddenLabel mesh__D013647 Incident Technics, Critical
% 221.48/221.63  |- skos__hiddenLabel mesh__D013647 Performance, Task
% 221.48/221.63  |- skos__hiddenLabel mesh__D013647 Performance, Analysis Task
% 221.48/221.63  |- skos__hiddenLabel mesh__D013647 Performances, Task
% 221.48/221.63  |- skos__related mesh__D013647smesh__D016526
% 221.48/221.63  |- skos__hiddenLabel mesh__D013647 Performances, Analysis Task
% 221.48/221.63  |- mesh__historyNote mesh__D013647 73%28%72%29%   
% 221.48/221.63  |- skos__altLabel mesh__D013647 Critical Incident Technic
% 221.48/221.63  |- mesh__recordMaintainer mesh__D013647 nns
% 221.48/221.63  |- mesh__dateEstablished mesh__D013647 1973-01-01
% 221.48/221.63  |- skos__hiddenLabel mesh__D013647 Task Performances, Analysis
% 221.48/221.63  |- skos__hiddenLabel mesh__D013647 Incident Technic, Critical
% 221.48/221.63  |- skos__prefLabel mesh__D013647 Task Performance and Analysis
% 221.48/221.63  |- skos__hiddenLabel mesh__D013647 Task Performances
% 221.48/221.63  |- skos__hiddenLabel mesh__D013647 Critical Incident Techniques
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D013647 2006
% 221.48/221.63  |- mesh__recordOriginator mesh__D013647 NLM
% 221.48/221.63  |- skos__broader mesh__D013647smesh__D011590
% 221.48/221.63  |- rdf__type mesh__D013647sskos__Concept
% 221.48/221.63  |- skos__broader mesh__D032801smesh__D013508
% 221.48/221.63  |- mesh__publicMeSHNote mesh__D032801 2003   
% 221.48/221.63  |- skos__prefLabel mesh__D032801 Iridectomy
% 221.48/221.63  |- skos__historyNote mesh__D032801 Iris/surgery %28%1964-2002%29%
% 221.48/221.63  |- skos__scopeNote mesh__D032801
% 221.48/221.63       Surgical removal of a section of the iris.     
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D032801 2005
% 221.48/221.63  |- skos__hiddenLabel mesh__D032801 Iridectomies
% 221.48/221.63  |- rdf__type mesh__D032801sskos__Concept
% 221.48/221.63  |- mesh__dateCreated mesh__D032801 2002-07-03
% 221.48/221.63  |- mesh__historyNote mesh__D032801 2003   
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D032801 2004
% 221.48/221.63  |- skos__hiddenLabel mesh__D032801 Corectomies
% 221.48/221.63  |- skos__altLabel mesh__D032801 Corectomy
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D032801 2003
% 221.48/221.63  |- mesh__dateEstablished mesh__D032801 2003-01-01
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D032801 2006
% 221.48/221.63  |- mesh__dateRevised mesh__D018332 1995-06-08
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018332 1999
% 221.48/221.63  |- skos__altLabel mesh__D018332 Nevus, Spindle Cell and Epithelioid
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018332 2001
% 221.48/221.63  |- mesh__dateCreated mesh__D018332 1993-06-25
% 221.48/221.63  |- mesh__publicMeSHNote mesh__D018332 94   
% 221.48/221.63  |- mesh__dateEstablished mesh__D018332 1994-01-01
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018332 2003
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018332 1996
% 221.48/221.63  |- rdf__type mesh__D018332sskos__Concept
% 221.48/221.63  |- skos__annotation mesh__D018332
% 221.48/221.63       /blood supply /chem /secret /ultrastruct permitted; coord IM with SKIN NEOPLASMS %28%IM%29% + site %28%IM or NIM%29% if relevant%A%  
% 221.48/221.63  |- skos__altLabel mesh__D018332 Spitz Nevus
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018332 2004
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018332 1997
% 221.48/221.63  |- skos__broader mesh__D018332smesh__D018331
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018332 2002
% 221.48/221.63  |- skos__prefLabel mesh__D018332 Nevus, Epithelioid and Spindle Cell
% 221.48/221.63  |- skos__hiddenLabel mesh__D018332 Nevus, Spitz
% 221.48/221.63  |- mesh__recordMaintainer mesh__D018332 KEV
% 221.48/221.63  |- skos__scopeNote mesh__D018332
% 221.48/221.63       A benign compound nevus occurring most often in children before puberty, composed of spindle and epithelioid cells located mainly in the dermis, sometimes in association with large atypical cells and multinucleate cells, and having a close histopathological resemblance to malignant melanoma. The tumor presents as a smooth to slightly scaly, round to oval, raised, firm papule or nodule, ranging in color from pink-tan to purplish red, often with surface telangiectasia. %28%Dorland, 27th ed%29%%A%    
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018332 2005
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018332 2000
% 221.48/221.63  |- mesh__recordAuthorizer mesh__D018332 PLS
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018332 1998
% 221.48/221.63  |- skos__historyNote mesh__D018332 Nevus, Pigmented %28%1977-1993%29%
% 221.48/221.63  |- mesh__recordOriginator mesh__D018332 PLS
% 221.48/221.63  |- mesh__historyNote mesh__D018332 94   
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D018332 2006
% 221.48/221.63  |- skos__altLabel mesh__D051766 EGR1 Transcription Factor
% 221.48/221.63  |- skos__scopeNote mesh__D051766
% 221.48/221.63       An early growth response transcription factor that has been implicated in regulation of CELL PROLIFERATION and APOPTOSIS.%A%    
% 221.48/221.63  |- skos__broader mesh__D051766smesh__D051765
% 221.48/221.63  |- skos__hiddenLabel mesh__D051766 Transcription Factor, EGR1
% 221.48/221.63  |- mesh__recordMaintainer mesh__D051766 DRC
% 221.48/221.63  |- mesh__historyNote mesh__D051766 2006%28%1988%29%   
% 221.48/221.63  |- mesh__dateEstablished mesh__D051766 2006-01-01
% 221.48/221.63  |- mesh__recordOriginator mesh__D051766 DRC
% 221.48/221.63  |- skos__altLabel mesh__D051766
% 221.48/221.63       Early Growth Response Transcription Factor 1
% 221.48/221.63  |- mesh__activeMeSHYear mesh__D051766 2006
% 221.48/221.63  |- rdf__type mesh__D051766sskos__Concept
% 221.48/221.63  |- skos__prefLabel mesh__D051766 Early Growth Response Protein 1
% 221.48/221.63  |- mesh__publicMeSHNote mesh__D051766
% 221.48/221.63       2006; EARLY GROWTH RESPONSE PROTEIN 1 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS %26% IMMEDIATE-EARLY PROTEINS 1988-2005%A%  
% 221.48/221.63  |- mesh__dateCreated mesh__D051766 2005-06-30
% 221.48/221.63  |- mesh__recordAuthorizer mesh__D051766 sjn
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D004312 2006
% 221.48/221.64  |- skos__annotation mesh__D004312
% 221.48/221.64       a sac formed by a fold of the peritoneum; diseases: coord IM with PERITONEAL DISEASES %28%NIM%29%%A%  
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D004312 2003
% 221.48/221.64  |- skos__altLabel mesh__D004312 Rectouterine Pouch
% 221.48/221.64  |- skos__altLabel mesh__D004312 Cul-de-Sac, Douglas%27%
% 221.48/221.64  |- skos__hiddenLabel mesh__D004312 Douglas%27% Cul-de-Sac
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D004312 2005
% 221.48/221.64  |- mesh__recordMaintainer mesh__D004312 TGC
% 221.48/221.64  |- skos__hiddenLabel mesh__D004312 Pouch, Rectouterine
% 221.48/221.64  |- mesh__dateCreated mesh__D004312 1999-01-01
% 221.48/221.64  |- rdf__type mesh__D004312sskos__Concept
% 221.48/221.64  |- skos__hiddenLabel mesh__D004312 Cul de Sac of Douglas
% 221.48/221.64  |- skos__hiddenLabel mesh__D004312 Douglas Cul-de-Sac
% 221.48/221.64  |- skos__hiddenLabel mesh__D004312 Pouch, Douglas%27%
% 221.48/221.64  |- skos__broader mesh__D004312smesh__D010537
% 221.48/221.64  |- skos__prefLabel mesh__D004312 Douglas%27% Pouch
% 221.48/221.64  |- skos__hiddenLabel mesh__D004312 Cul-de-Sac, Douglas
% 221.48/221.64  |- skos__scopeNote mesh__D004312
% 221.48/221.64       A sac or recess formed by a fold of the peritoneum.     
% 221.48/221.64  |- mesh__dateRevised mesh__D004312 2002-07-03
% 221.48/221.64  |- skos__hiddenLabel mesh__D004312 Cul de Sac, Douglas%27%
% 221.48/221.64  |- mesh__recordAuthorizer mesh__D004312 sjn
% 221.48/221.64  |- skos__altLabel mesh__D004312 Cul-de-Sac of Douglas
% 221.48/221.64  |- skos__related mesh__D004312smesh__D003464
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D004312 2004
% 221.48/221.64  |- skos__hiddenLabel mesh__D004312 Douglas Pouch
% 221.48/221.64  |- mesh__recordOriginator mesh__D004312 NLM
% 221.48/221.64  |- mesh__historyNote mesh__D045729 2004   
% 221.48/221.64  |- skos__hiddenLabel mesh__D045729 Swine Mycoplasmal Pneumonia
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D045729 2004
% 221.48/221.64  |- skos__altLabel mesh__D045729 Pneumonia of Swine, Enzootic
% 221.48/221.64  |- skos__prefLabel mesh__D045729 Pneumonia of Swine, Mycoplasmal
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D045729 2006
% 221.48/221.64  |- rdf__type mesh__D045729sskos__Concept
% 221.48/221.64  |- mesh__publicMeSHNote mesh__D045729 2004   
% 221.48/221.64  |- skos__annotation mesh__D045729
% 221.48/221.64       do not confuse with PNEUMONIA, MYCOPLASMA   
% 221.48/221.64  |- mesh__dateCreated mesh__D045729 2003-07-09
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D045729 2005
% 221.48/221.64  |- mesh__dateEstablished mesh__D045729 2004-01-01
% 221.48/221.64  |- skos__hiddenLabel mesh__D045729 Swine Mycoplasma Pneumonia
% 221.48/221.64  |- skos__altLabel mesh__D045729 Enzootic Pneumonia of Swine
% 221.48/221.64  |- skos__broader mesh__D045729smesh__D018410
% 221.48/221.64  |- skos__hiddenLabel mesh__D045729 Swine Enzootic Pneumonia
% 221.48/221.64  |- skos__broader mesh__D045729smesh__D013553
% 221.48/221.64  |- skos__altLabel mesh__D045729 Mycoplasma Pneumonia of Pigs
% 221.48/221.64  |- skos__altLabel mesh__D045729 Enzootic Pneumonia of Pigs
% 221.48/221.64  |- skos__altLabel mesh__D045729 Mycoplasmal Pneumonia of Swine
% 221.48/221.64  |- skos__altLabel mesh__D045729 Mycoplasma Pneumonia of Swine
% 221.48/221.64  |- skos__scopeNote mesh__D045729
% 221.48/221.64       A chronic, clinically mild, infectious pneumonia of PIGS caused by MYCOPLASMA HYOPNEUMONIAE. Ninety percent of swine herds worldwide are infected with this economically costly disease that primarily affects animals aged two to six months old. The disease can be associated with porcine respiratory disease complex. PASTEURELLA MULTOCIDA is often found as a secondary infection.%A%    
% 221.48/221.64  |- skos__altLabel mesh__D014740 Parke Davis Brand of Vidarabine
% 221.48/221.64  |- skos__altLabel mesh__D014740 beta-Ara A
% 221.48/221.64  |- rdf__type mesh__D014740sskos__Concept
% 221.48/221.64  |- skos__altLabel mesh__D014740 Monarch Brand of Vidarabine
% 221.48/221.64  |- skos__altLabel mesh__D014740 Arabinofuranosyladenine
% 221.48/221.64  |- skos__hiddenLabel mesh__D014740 Vira A
% 221.48/221.64  |- skos__prefLabel mesh__D014740 Vidarabine
% 221.48/221.64  |- skos__scopeNote mesh__D014740
% 221.48/221.64       A nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the VACCINIA VIRUS and varicella zoster virus.%A%    
% 221.48/221.64  |- skos__altLabel mesh__D014740 9-beta-Arabinofuranosyladenine
% 221.48/221.64  |- skos__hiddenLabel mesh__D014740 Arabinoside, Adenine
% 221.48/221.64  |- skos__altLabel mesh__D014740 alpha-Ara A
% 221.48/221.64  |- mesh__historyNote mesh__D014740
% 221.48/221.64       79; was ARABINOFURANOSYLADENINE 1977-78, was ARABINOFURANOSYLADENINE see under PURINE NUCLEOSIDES 1975-76%A%  
% 221.48/221.64  |- skos__hiddenLabel mesh__D014740 beta Ara A
% 221.48/221.64  |- skos__hiddenLabel mesh__D014740 ViraA
% 221.48/221.64  |- skos__altLabel mesh__D014740 9-beta-D-Arabinofuranosyladenine
% 221.48/221.64  |- mesh__recordAuthorizer mesh__D014740 sjn
% 221.48/221.64  |- mesh__dateCreated mesh__D014740 1974-11-19
% 221.48/221.64  |- skos__hiddenLabel mesh__D014740 alpha Ara A
% 221.48/221.64  |- mesh__onlineNote mesh__D014740
% 221.48/221.64       use VIDARABINE to search ARABINOFURANOSYLADENINE 1975-78   
% 221.48/221.64  |- mesh__dateRevised mesh__D014740 2005-06-30
% 221.48/221.64  |- skos__annotation mesh__D014740 an antiviral %26% antimetabolite   
% 221.48/221.64  |- skos__altLabel mesh__D014740 Adenine Arabinoside
% 221.48/221.64  |- mesh__recordMaintainer mesh__D014740 lkw
% 221.48/221.64  |- skos__altLabel mesh__D014740 Ara-A
% 221.48/221.64  |- skos__altLabel mesh__D014740 alpha-D-Arabinofuranosyladenine
% 221.48/221.64  |- skos__broader mesh__D014740smesh__D000241
% 221.48/221.64  |- skos__historyNote mesh__D014740 Nucleosides %28%1972-1974%29%
% 221.48/221.64  |- mesh__dateEstablished mesh__D014740 1977-01-01
% 221.48/221.64  |- skos__broader mesh__D014740smesh__D001087
% 221.48/221.64  |- skos__altLabel mesh__D014740 Ara A
% 221.48/221.64  |- mesh__publicMeSHNote mesh__D014740
% 221.48/221.64       79; was ARABINOFURANOSYLADENINE 1977-78, was ARABINOFURANOSYLADENINE see under PURINE NUCLEOSIDES 1975-76%A%  
% 221.48/221.64  |- skos__hiddenLabel mesh__D014740 9 beta Arabinofuranosyladenine
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D014740 2006
% 221.48/221.64  |- skos__altLabel mesh__D014740 Arabinosyladenine
% 221.48/221.64  |- mesh__recordOriginator mesh__D014740 NLM
% 221.48/221.64  |- skos__hiddenLabel mesh__D014740 A, alpha-Ara
% 221.48/221.64  |- skos__hiddenLabel mesh__D014740 A, beta-Ara
% 221.48/221.64  |- skos__historyNote mesh__D014740 Adenine %28%1972-1974%29%
% 221.48/221.64  |- skos__historyNote mesh__D014740 Arabinose %28%1972-1974%29%
% 221.48/221.64  |- skos__hiddenLabel mesh__D014740 alpha D Arabinofuranosyladenine
% 221.48/221.64  |- skos__hiddenLabel mesh__D014740 A, Ara
% 221.48/221.64  |- skos__historyNote mesh__D014740 Purines %28%1966-1973%29%
% 221.48/221.64  |- skos__hiddenLabel mesh__D014740 9 beta D Arabinofuranosyladenine
% 221.48/221.64  |- mesh__dateRevised mesh__D000720 1995-05-22
% 221.48/221.64  |- skos__hiddenLabel mesh__D000720 Hospital Ancillary Service
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D000720 2003
% 221.48/221.64  |- mesh__dateEstablished mesh__D000720 1991-01-01
% 221.48/221.64  |- mesh__recordOriginator mesh__D000720 EC
% 221.48/221.64  |- skos__altLabel mesh__D000720 Hospital Ancillary Services
% 221.48/221.64  |- mesh__recordMaintainer mesh__D000720 KEV
% 221.48/221.64  |- skos__annotation mesh__D000720 DF: ANCILLARY SERV HOSP   
% 221.48/221.64  |- skos__altLabel mesh__D000720 Services, Hospital Ancillary
% 221.48/221.64  |- mesh__historyNote mesh__D000720
% 221.48/221.64       91%28%84%29%; was see under HOSPITAL ADMINISTRATION 1984-90   
% 221.48/221.64  |- skos__prefLabel mesh__D000720 Ancillary Services, Hospital
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D000720 2002
% 221.48/221.64  |- skos__hiddenLabel mesh__D000720 Service, Hospital Ancillary
% 221.48/221.64  |- rdf__type mesh__D000720sskos__Concept
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D000720 1999
% 221.48/221.64  |- mesh__publicMeSHNote mesh__D000720
% 221.48/221.64       91; was see under HOSPITAL ADMINISTRATION 1984-90   
% 221.48/221.64  |- mesh__dateCreated mesh__D000720 1983-06-10
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D000720 1997
% 221.48/221.64  |- mesh__recordAuthorizer mesh__D000720 PLS
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D000720 1998
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D000720 1996
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D000720 2006
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D000720 2001
% 221.48/221.64  |- skos__scopeNote mesh__D000720
% 221.48/221.64       Those support services other than room, board, and medical and nursing services that are provided to hospital patients in the course of care. They include such services as laboratory, radiology, pharmacy, and physical therapy services.%A%    
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D000720 2004
% 221.48/221.64  |- skos__broader mesh__D000720smesh__D006739
% 221.48/221.64  |- skos__hiddenLabel mesh__D000720 Ancillary Service, Hospital
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D000720 2005
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D000720 2000
% 221.48/221.64  |- skos__broader mesh__D002241Q000172smesh__D002241
% 221.48/221.64  |- rdf__type mesh__D002241Q000172smesh__CompoundConcept
% 221.48/221.64  |- skos__scopeNote mesh__D052061
% 221.48/221.64       A designation for publications of research resulting from extramural research funded by the National Institutes of Health.%A%    
% 221.48/221.64  |- skos__altLabel mesh__D052061 Research, NIH, Extramural
% 221.48/221.64  |- mesh__dateCreated mesh__D052061 2005-04-04
% 221.48/221.64  |- rdf__type mesh__D052061sskos__Concept
% 221.48/221.64  |- skos__annotation mesh__D052061
% 221.48/221.64       for all articles noted as resulting  from extramural research at any NIH institute; CATALOG: do not use%A%  
% 221.48/221.64  |- mesh__dateRevised mesh__D052061 2005-06-30
% 221.48/221.64  |- skos__broader mesh__D052061smesh__D013487
% 221.48/221.64  |- mesh__recordAuthorizer mesh__D052061 sjn
% 221.48/221.64  |- mesh__recordMaintainer mesh__D052061 jls
% 221.48/221.64  |- mesh__recordOriginator mesh__D052061 jls
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D052061 2006
% 221.48/221.64  |- skos__altLabel mesh__D052061
% 221.48/221.64       United States Gov%27%t Supported, P.H.S., N.I.H., Extramural
% 221.48/221.64  |- mesh__historyNote mesh__D052061 2005   
% 221.48/221.64  |- skos__prefLabel mesh__D052061 Research Support, N.I.H., Extramural
% 221.48/221.64  |- mesh__dateEstablished mesh__D052061 2005-04-04
% 221.48/221.64  |- skos__broader mesh__D006282Q000600smesh__D006282
% 221.48/221.64  |- mesh__preferredCombination mesh__D006282Q000600smesh__D006280
% 221.48/221.64  |- rdf__type mesh__D006282Q000600smesh__CompoundConcept
% 221.48/221.64  |- mesh__dateCreated mesh__D013648 1987-03-09
% 221.48/221.64  |- skos__historyNote mesh__D013648 Australia %28%1966-1987%29%
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D013648 1996
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D013648 2003
% 221.48/221.64  |- skos__scopeNote mesh__D013648
% 221.48/221.64       An island south of Australia and the smallest state of the Commonwealth. Its capital is Hobart. It was discovered and named Van Diemen%27%s Island in 1642 by Abel Tasman, a Dutch navigator, in honor of the Dutch governor-general of the Dutch East Indian colonies. It was renamed for the discoverer in 1853. In 1803 it was taken over by Great Britain and was used as a penal colony. It was granted government in 1856 and federated as a state in 1901. %28%From Webster%27%s New Geographical Dictionary, 1988, p1190 %26% Room, Brewer%27%s Dictionary of Names, p535%29%%A%    
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D013648 2004
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D013648 2002
% 221.48/221.64  |- mesh__recordMaintainer mesh__D013648 PLS
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D013648 1997
% 221.48/221.64  |- skos__prefLabel mesh__D013648 Tasmania
% 221.48/221.64  |- mesh__dateRevised mesh__D013648 1995-02-21
% 221.48/221.64  |- mesh__recordAuthorizer mesh__D013648 PLS
% 221.48/221.64  |- mesh__historyNote mesh__D013648 88   
% 221.48/221.64  |- skos__broader mesh__D013648smesh__D001315
% 221.48/221.64  |- skos__annotation mesh__D013648 an island state of Australia   
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D013648 2000
% 221.48/221.64  |- mesh__dateEstablished mesh__D013648 1988-01-01
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D013648 1998
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D013648 2005
% 221.48/221.64  |- mesh__recordOriginator mesh__D013648 EC
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D013648 2001
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D013648 1999
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D013648 2006
% 221.48/221.64  |- rdf__type mesh__D013648sskos__Concept
% 221.48/221.64  |- mesh__dateEstablished mesh__D032802 2003-01-01
% 221.48/221.64  |- mesh__recordMaintainer mesh__D032802 sjn
% 221.48/221.64  |- mesh__dateRevised mesh__D032802 2003-07-25
% 221.48/221.64  |- skos__scopeNote mesh__D032802
% 221.48/221.64       The composition of a committee; the state or status of being a member of a committee.%A%    
% 221.48/221.64  |- skos__hiddenLabel mesh__D032802 Members, Committee
% 221.48/221.64  |- skos__hiddenLabel mesh__D032802 Committee Member
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D032802 2004
% 221.48/221.64  |- skos__hiddenLabel mesh__D032802 Memberships, Committee
% 221.48/221.64  |- skos__hiddenLabel mesh__D032802 Committee Memberships
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D032802 2006
% 221.48/221.64  |- skos__prefLabel mesh__D032802 Committee Membership
% 221.48/221.64  |- mesh__publicMeSHNote mesh__D032802 2003   
% 221.48/221.64  |- mesh__recordAuthorizer mesh__D032802 sjn
% 221.48/221.64  |- mesh__dateCreated mesh__D032802 2002-07-03
% 221.48/221.64  |- skos__hiddenLabel mesh__D032802 Member, Committee
% 221.48/221.64  |- skos__broader mesh__D032802smesh__D009934
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D032802 2005
% 221.48/221.64  |- skos__historyNote mesh__D032802
% 221.48/221.64       Organization and Administration %28%1990-2002%29%
% 221.48/221.64  |- mesh__recordOriginator mesh__D032802 jrf
% 221.48/221.64  |- skos__annotation mesh__D032802
% 221.48/221.64       coord with specific committee if pertinent   
% 221.48/221.64  |- skos__hiddenLabel mesh__D032802 Membership, Committee
% 221.48/221.64  |- mesh__historyNote mesh__D032802 2003   
% 221.48/221.64  |- rdf__type mesh__D032802sskos__Concept
% 221.48/221.64  |- rdf__type mesh__D018333sskos__Concept
% 221.48/221.64  |- skos__scopeNote mesh__D018333
% 221.48/221.64       A mixed radiolucent-radiopaque lesion of the jaws with features of both a cyst and a solid neoplasm. It is characterized microscopically by an epithelial lining showing a palisaded layer of columnar basal cells, presence of ghost cell keratinization, dentinoid, and calcification. %28%Stedman, 25th ed%29%%A%    
% 221.48/221.64  |- mesh__recordAuthorizer mesh__D018333 PLS
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D018333 2000
% 221.48/221.64  |- skos__broader mesh__D018333smesh__D009808
% 221.48/221.64  |- skos__hiddenLabel mesh__D018333 Odontogenic Cysts, Calcifying
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D018333 2004
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D018333 1997
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D018333 2001
% 221.48/221.64  |- skos__historyNote mesh__D018333 Odontogenic Cysts %28%1967-1993%29%
% 221.48/221.64  |- skos__broader mesh__D018333smesh__D009807
% 221.48/221.64  |- mesh__dateCreated mesh__D018333 1993-06-25
% 221.48/221.64  |- mesh__publicMeSHNote mesh__D018333 94   
% 221.48/221.64  |- mesh__dateEstablished mesh__D018333 1994-01-01
% 221.48/221.64  |- skos__prefLabel mesh__D018333 Odontogenic Cyst, Calcifying
% 221.48/221.64  |- skos__annotation mesh__D018333
% 221.48/221.64       neoplastic; /blood supply /chem /secret /ultrastruct permitted; coord IM with probably JAW NEOPLASMS %28%IM%29% or precoord jaw/neopl term %28%IM%29%%A%  
% 221.48/221.64  |- mesh__recordMaintainer mesh__D018333 KEV
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D018333 2005
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D018333 1998
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D018333 2002
% 221.48/221.64  |- skos__historyNote mesh__D018333 Odontogenic Tumors %28%1966-1993%29%
% 221.48/221.64  |- mesh__recordOriginator mesh__D018333 PLS
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D018333 2006
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D018333 1999
% 221.48/221.64  |- mesh__historyNote mesh__D018333 94   
% 221.48/221.64  |- skos__hiddenLabel mesh__D018333 Cysts, Calcifying Odontogenic
% 221.48/221.64  |- skos__hiddenLabel mesh__D018333 Cyst, Calcifying Odontogenic
% 221.48/221.64  |- skos__hiddenLabel mesh__D018333 Calcifying Odontogenic Cyst
% 221.48/221.64  |- mesh__dateRevised mesh__D018333 1995-06-08
% 221.48/221.64  |- skos__hiddenLabel mesh__D018333 Calcifying Odontogenic Cysts
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D018333 2003
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D018333 1996
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D010350 2003
% 221.48/221.64  |- mesh__dateEstablished mesh__D010350 1991-01-01
% 221.48/221.64  |- skos__annotation mesh__D010350 DF: PATIENT CREDIT   
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D010350 2000
% 221.48/221.64  |- rdf__type mesh__D010350sskos__Concept
% 221.48/221.64  |- mesh__historyNote mesh__D010350
% 221.48/221.64       91%28%78%29%; was see under ACCOUNTING 1978-90   
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D010350 2004
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D010350 1996
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D010350 2001
% 221.48/221.64  |- skos__prefLabel mesh__D010350 Patient Credit and Collection
% 221.48/221.64  |- skos__hiddenLabel mesh__D010350 Credit, Patient
% 221.48/221.64  |- mesh__recordAuthorizer mesh__D010350 NLM
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D010350 2005
% 221.48/221.64  |- mesh__recordMaintainer mesh__D010350 PLS
% 221.48/221.64  |- skos__altLabel mesh__D010350 Credit and Collection, Patient
% 221.48/221.64  |- mesh__dateCreated mesh__D010350 1977-05-11
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D010350 1997
% 221.48/221.64  |- skos__hiddenLabel mesh__D010350 Patient Credits
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D010350 2002
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D010350 2006
% 221.48/221.64  |- mesh__publicMeSHNote mesh__D010350
% 221.48/221.64       91; was see under ACCOUNTING 1978-90   
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D010350 1998
% 221.48/221.64  |- mesh__recordOriginator mesh__D010350 EC
% 221.48/221.64  |- skos__scopeNote mesh__D010350
% 221.48/221.64       Accounting procedures for determining credit status and methods of obtaining payment.%A%    
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D010350 1999
% 221.48/221.64  |- mesh__dateRevised mesh__D010350 1993-09-16
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D010350 1995
% 221.48/221.64  |- skos__broader mesh__D010350smesh__D000066
% 221.48/221.64  |- skos__hiddenLabel mesh__D010350 Credits, Patient
% 221.48/221.64  |- mesh__historyNote mesh__D051767 2006%28%1988%29%   
% 221.48/221.64  |- mesh__recordOriginator mesh__D051767 DRC
% 221.48/221.64  |- mesh__publicMeSHNote mesh__D051767
% 221.48/221.64       2006; EARLY GROWTH RESPONSE PROTEIN 2 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1988-2005%A%  
% 221.48/221.64  |- mesh__dateCreated mesh__D051767 2005-06-30
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D051767 2006
% 221.48/221.64  |- skos__scopeNote mesh__D051767
% 221.48/221.64       An early growth response transcription factor that controls the formation of the MYELIN SHEATH around peripheral AXONS by SCHWANN CELLS.  Mutations in EGR2 transcription factor have been associated with HEREDITARY MOTOR AND SENSORY NEUROPATHIES such as CHARCOT-MARIE-TOOTH DISEASE.%A%    
% 221.48/221.64  |- skos__hiddenLabel mesh__D051767 Transcription Factor, EGR2
% 221.48/221.64  |- mesh__recordAuthorizer mesh__D051767 sjn
% 221.48/221.64  |- rdf__type mesh__D051767sskos__Concept
% 221.48/221.64  |- skos__hiddenLabel mesh__D051767 Transcription Factor, Krox-20
% 221.48/221.64  |- skos__altLabel mesh__D051767 Krox20 Protein
% 221.48/221.64  |- skos__broader mesh__D051767smesh__D051765
% 221.48/221.64  |- skos__hiddenLabel mesh__D051767 Krox 20 Transcription Factor
% 221.48/221.64  |- skos__related mesh__D051767smesh__D002607
% 221.48/221.64  |- mesh__recordMaintainer mesh__D051767 DRC
% 221.48/221.64  |- skos__altLabel mesh__D051767 EGR2 Transcription Factor
% 221.48/221.64  |- mesh__dateEstablished mesh__D051767 2006-01-01
% 221.48/221.64  |- skos__altLabel mesh__D051767 Krox-20 Transcription Factor
% 221.48/221.64  |- skos__prefLabel mesh__D051767 Early Growth Response Protein 2
% 221.48/221.64  |- mesh__dateCreated mesh__D004313 1999-01-01
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D004313 2006
% 221.48/221.64  |- mesh__recordMaintainer mesh__D004313 ags
% 221.48/221.64  |- skos__hiddenLabel mesh__D004313 Dourines
% 221.48/221.64  |- mesh__dateRevised mesh__D004313 2003-07-30
% 221.48/221.64  |- mesh__recordAuthorizer mesh__D004313 sjn
% 221.48/221.64  |- mesh__recordOriginator mesh__D004313 NLM
% 221.48/221.64  |- mesh__dateEstablished mesh__D004313 1991-01-01
% 221.48/221.64  |- rdf__type mesh__D004313sskos__Concept
% 221.48/221.64  |- mesh__onlineNote mesh__D004313 search TRYPANOSOMIASIS 1968-74   
% 221.48/221.64  |- skos__scopeNote mesh__D004313
% 221.48/221.64       A disease of horses and donkeys caused by Trypanosoma equiperdum. The disease occurs in Africa, the Americas, and Asia.%A%    
% 221.48/221.64  |- skos__annotation mesh__D004313
% 221.48/221.64       trypanosome infect in horses; coord IM with HORSE DISEASES %28%IM%29% + HORSES %28%NIM%29%; if in donkeys, coord IM with PERISSODACTYLA %28%IM%29%; check tag ANIMALS%A%  
% 221.48/221.64  |- skos__broader mesh__D004313smesh__D011529
% 221.48/221.64  |- mesh__publicMeSHNote mesh__D004313
% 221.48/221.64       91; was see under TRYPANOSOMIASIS 1975-90   
% 221.48/221.64  |- skos__prefLabel mesh__D004313 Dourine
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D004313 2005
% 221.48/221.64  |- mesh__historyNote mesh__D004313
% 221.48/221.64       91%28%75%29%; was see under TRYPANOSOMIASIS 1975-90   
% 221.48/221.64  |- skos__broader mesh__D004313smesh__D014352
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D004313 2004
% 221.48/221.64  |- skos__hiddenLabel mesh__D028761 Treatments, Withholding
% 221.48/221.64  |- skos__prefLabel mesh__D028761 Withholding Treatment
% 221.48/221.64  |- skos__hiddenLabel mesh__D028761 Withholding Treatments
% 221.48/221.64  |- skos__scopeNote mesh__D028761
% 221.48/221.64       Withholding or withdrawal of a particular treatment or treatments, often %28%but not necessarily%29% life-prolonging treatment, from a patient or from a research subject as part of a research protocol. The concept is differentiated from REFUSAL TO TREAT, where the emphasis is on the health professional%27%s or health facility%27%s refusal to treat a patient or group of patients when the patient or the patient%27%s representative requests treatment. Withholding of life-prolonging treatment is usually indexed only with EUTHANASIA, PASSIVE, unless the distinction between withholding and withdrawing treatment, or the issue of withholding palliative rather than curative treatment, is discussed.%A%    
% 221.48/221.64  |- skos__hiddenLabel mesh__D028761 Treatment Cessation
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D028761 2005
% 221.48/221.64  |- skos__hiddenLabel mesh__D028761 Treatments, Withdrawing
% 221.48/221.64  |- mesh__recordAuthorizer mesh__D028761 sjn
% 221.48/221.64  |- skos__hiddenLabel mesh__D028761 Treatment Cessations
% 221.48/221.64  |- skos__related mesh__D028761smesh__D016414
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D028761 2003
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D028761 2006
% 221.48/221.64  |- mesh__dateEstablished mesh__D028761 2002-01-01
% 221.48/221.64  |- skos__altLabel mesh__D028761 Cessation of Treatment
% 221.48/221.64  |- skos__broader mesh__D028761smesh__D005791
% 221.48/221.64  |- mesh__recordOriginator mesh__D028761 con
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D028761 2004
% 221.48/221.64  |- skos__hiddenLabel mesh__D028761 Care, Withdrawing
% 221.48/221.64  |- skos__annotation mesh__D028761
% 221.48/221.64       human only; EUTHANASIA, PASSIVE: do not coord with WITHHOLDING TREATMENT unless particularly discussed%A%  
% 221.48/221.64  |- mesh__historyNote mesh__D028761
% 221.48/221.64       2002; for WITHDRAWING CARE use EUTHANASIA, PASSIVE 1999-2001%A%  
% 221.48/221.64  |- mesh__recordMaintainer mesh__D028761 tjk
% 221.48/221.64  |- mesh__publicMeSHNote mesh__D028761
% 221.48/221.64       2002; for WITHDRAWING CARE see EUTHANASIA, PASSIVE 1999-2001%A%  
% 221.48/221.64  |- rdf__type mesh__D028761sskos__Concept
% 221.48/221.64  |- skos__hiddenLabel mesh__D028761 Treatment, Withdrawing
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D028761 2002
% 221.48/221.64  |- skos__hiddenLabel mesh__D028761 Withdrawing Treatments
% 221.48/221.64  |- skos__hiddenLabel mesh__D028761 Treatment, Withholding
% 221.48/221.64  |- mesh__dateCreated mesh__D028761 2001-07-25
% 221.48/221.64  |- mesh__historyNote mesh__D014741 84   
% 221.48/221.64  |- skos__historyNote mesh__D014741 Videotape Recording %28%1974-1983%29%
% 221.48/221.64  |- skos__scopeNote mesh__D014741
% 221.48/221.64       The storing or preserving of video signals for television to be played back later via a transmitter or receiver. Recordings may be made on magnetic tape or discs %28%VIDEODISC RECORDING%29%.%A%    
% 221.48/221.64  |- skos__hiddenLabel mesh__D014741 Videorecordings
% 221.48/221.64  |- skos__hiddenLabel mesh__D014741 Recordings, Video
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D014741 2003
% 221.48/221.64  |- mesh__dateRevised mesh__D014741 1999-11-03
% 221.48/221.64  |- mesh__dateCreated mesh__D014741 1983-06-13
% 221.48/221.64  |- mesh__publicMeSHNote mesh__D014741 84   
% 221.48/221.64  |- skos__prefLabel mesh__D014741 Video Recording
% 221.48/221.64  |- mesh__recordOriginator mesh__D014741 EC
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D014741 2004
% 221.48/221.64  |- rdf__type mesh__D014741sskos__Concept
% 221.48/221.64  |- skos__annotation mesh__D014741
% 221.48/221.64       IM; VIDEODISC RECORDING %26% VIDEOTAPE RECORDING are also available%A%  
% 221.48/221.64  |- skos__related mesh__D014741smesh__D020535
% 221.48/221.64  |- skos__hiddenLabel mesh__D014741 Video Recordings
% 221.48/221.64  |- mesh__recordAuthorizer mesh__D014741 sjn
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D014741 2000
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D014741 2005
% 221.48/221.64  |- skos__broader mesh__D014741smesh__D003308
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D014741 2001
% 221.48/221.64  |- skos__related mesh__D014741smesh__D020775
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D014741 2006
% 221.48/221.64  |- mesh__recordMaintainer mesh__D014741 nns
% 221.48/221.64  |- skos__hiddenLabel mesh__D014741 Recording, Video
% 221.48/221.64  |- mesh__dateEstablished mesh__D014741 1984-01-01
% 221.48/221.64  |- skos__altLabel mesh__D014741 Videorecording
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D014741 2002
% 221.48/221.64  |- rdf__type mesh__D008704sskos__Concept
% 221.48/221.64  |- mesh__dateCreated mesh__D008704 1999-01-01
% 221.48/221.64  |- mesh__historyNote mesh__D008704
% 221.48/221.64       91%28%63%29%; was see under THIADIAZOLES 1975-90; was see under CARBONIC ANHYDRASE INHIBITORS 1965-74%A%  
% 221.48/221.64  |- mesh__recordMaintainer mesh__D008704 ssb
% 221.48/221.64  |- skos__hiddenLabel mesh__D008704 N Methylacetazolamide
% 221.48/221.64  |- mesh__recordOriginator mesh__D008704 NLM
% 221.48/221.64  |- mesh__dateRevised mesh__D008704 2005-06-30
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D008704 2006
% 221.48/221.64  |- mesh__publicMeSHNote mesh__D008704
% 221.48/221.64       91; was see under THIADIAZOLES 1975-90; was see under CARBONIC ANHYDRASE INHIBITORS 1965-74%A%  
% 221.48/221.64  |- skos__prefLabel mesh__D008704 Methazolamide
% 221.48/221.64  |- mesh__recordAuthorizer mesh__D008704 sjn
% 221.48/221.64  |- skos__broader mesh__D008704smesh__D013830
% 221.48/221.64  |- skos__annotation mesh__D008704 a carbonic anhydrase inhib   
% 221.48/221.64  |- mesh__dateEstablished mesh__D008704 1991-01-01
% 221.48/221.64  |- skos__scopeNote mesh__D008704
% 221.48/221.64       A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.%A%    
% 221.48/221.64  |- skos__altLabel mesh__D008704 N-Methylacetazolamide
% 221.48/221.64  |- skos__scopeNote mesh__D000721
% 221.48/221.64       An enzyme fraction from the venom of the Malayan pit viper, Agkistrodon rhodostoma. It catalyzes the hydrolysis of a number of amino acid esters and a limited proteolysis of fibrinogen. It is used clinically to produce controlled defibrination in patients requiring anticoagulant therapy. EC 3.4.21.-.%A%    
% 221.48/221.64  |- skos__altLabel mesh__D000721 Agkistrodon Serine Proteinase
% 221.48/221.64  |- skos__prefLabel mesh__D000721 Ancrod
% 221.48/221.64  |- mesh__historyNote mesh__D000721
% 221.48/221.64       78; was ARVIN see under ENDOPEPTIDASES 1975-77; ARVIN was see ANCROD 1978-95%A%  
% 221.48/221.64  |- skos__historyNote mesh__D000721 Venoms %28%1972-1974%29%
% 221.48/221.64  |- mesh__publicMeSHNote mesh__D000721
% 221.48/221.64       78; was ARVIN see under PEPTIDE PEPTIDOHYDROLASES 1975-77; ARVIN was see ANCROD 1978-95%A%  
% 221.48/221.64  |- rdf__type mesh__D000721sskos__Concept
% 221.48/221.64  |- skos__altLabel mesh__D000721 Knoll Brand of Ancrod
% 221.48/221.64  |- skos__altLabel mesh__D000721 Berk Brand of Ancrod
% 221.48/221.64  |- mesh__recordOriginator mesh__D000721 NLM
% 221.48/221.64  |- skos__hiddenLabel mesh__D000721 Ancrod Knoll Brand
% 221.48/221.64  |- mesh__onlineNote mesh__D000721 use ANCROD to search ARVIN 1975-77   
% 221.48/221.64  |- mesh__dateEstablished mesh__D000721 1978-01-01
% 221.48/221.64  |- mesh__dateRevised mesh__D000721 2005-06-30
% 221.48/221.64  |- mesh__recordMaintainer mesh__D000721 ssb
% 221.48/221.64  |- skos__broader mesh__D000721smesh__D003435
% 221.48/221.64  |- skos__altLabel mesh__D000721 Arwin
% 221.48/221.64  |- skos__hiddenLabel mesh__D000721 Ancrod Berk Brand
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D000721 2006
% 221.48/221.64  |- skos__historyNote mesh__D000721 Peptide Hydrolases %28%1972-1974%29%
% 221.48/221.64  |- skos__broader mesh__D000721smesh__D020791
% 221.48/221.64  |- skos__altLabel mesh__D000721 Agkistrodon rhodostoma Venom Protease
% 221.48/221.64  |- skos__hiddenLabel mesh__D000721 Arvin IRC 50
% 221.48/221.64  |- skos__hiddenLabel mesh__D000721 Arvin IRC50
% 221.48/221.64  |- skos__historyNote mesh__D000721
% 221.48/221.64       Peptide Peptidohydrolases %28%1966-1974%29%
% 221.48/221.64  |- mesh__recordAuthorizer mesh__D000721 sjn
% 221.48/221.64  |- mesh__dateCreated mesh__D000721 1974-11-11
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D013649 2001
% 221.48/221.64  |- skos__prefLabel mesh__D013649 Taste
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D013649 1997
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D013649 2004
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D013649 1994
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D013649 2002
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D013649 2005
% 221.48/221.64  |- mesh__activeMeSHYear mesh__D013649 1998
% 221.48/221.65  |- mesh__dateRevised mesh__D013649 1992-05-18
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D013649 1995
% 221.48/221.65  |- mesh__recordOriginator mesh__D013649 NLM
% 221.48/221.65  |- mesh__recordAuthorizer mesh__D013649 PLS
% 221.48/221.65  |- skos__broader mesh__D013649smesh__D012677
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D013649 1999
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D013649 2006
% 221.48/221.65  |- mesh__dateCreated mesh__D013649 1999-01-01
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D013649 2000
% 221.48/221.65  |- rdf__type mesh__D013649sskos__Concept
% 221.48/221.65  |- skos__scopeNote mesh__D013649
% 221.48/221.65       The sensation or perception of certain qualities of substances put in the mouth, primarily sweet, sour, salt and bitter.%A%    
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D013649 2003
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D013649 1996
% 221.48/221.65  |- mesh__recordMaintainer mesh__D013649 TAP
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D013649 1993
% 221.48/221.65  |- skos__hiddenLabel mesh__D013649 Tastes
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018334 2005
% 221.48/221.65  |- mesh__dateCreated mesh__D018334 1993-06-03
% 221.48/221.65  |- skos__altLabel mesh__D018334 Leishmania brasiliensis guyanensis
% 221.48/221.65  |- skos__altLabel mesh__D018334 Leishmania %28%Viannia%29% guyanensis
% 221.48/221.65  |- mesh__historyNote mesh__D018334
% 221.48/221.65       94; was LEISHMANIA BRAZILIENSIS GUYANENSIS see LEISHMANIA BRAZILIENSIS 1992-93%A%  
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018334 2006
% 221.48/221.65  |- skos__annotation mesh__D018334
% 221.48/221.65       infection: coord IM with LEISHMANIASIS, MUCOCUTANEOUS %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 221.48/221.65  |- skos__altLabel mesh__D018334 Leishmania viannia panamensis
% 221.48/221.65  |- skos__prefLabel mesh__D018334 Leishmania guyanensis
% 221.48/221.65  |- skos__altLabel mesh__D018334 Leishmania braziliensis guyanensis
% 221.48/221.65  |- mesh__dateEstablished mesh__D018334 1994-01-01
% 221.48/221.65  |- skos__altLabel mesh__D018334 Leishmania viannia guyanensis
% 221.48/221.65  |- skos__broader mesh__D018334smesh__D007891
% 221.48/221.65  |- rdf__type mesh__D018334sskos__Concept
% 221.48/221.65  |- mesh__publicMeSHNote mesh__D018334
% 221.48/221.65       94; was LEISHMANIA BRAZILIENSIS GUYANENSIS see LEISHMANIA BRAZILIENSIS 1992-93%A%  
% 221.48/221.65  |- skos__scopeNote mesh__D018334
% 221.48/221.65       A parasitic hemoflagellate of the subgenus Leishmania viannia that infects man and animals and causes mucocutaneous leishmaniasis %28%LEISHMANIASIS, MUCOCUTANEOUS%29%. Transmission is by Lutzomyia sandflies.%A%    
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018334 2004
% 221.48/221.65  |- mesh__onlineNote mesh__D018334
% 221.48/221.65       use LEISHMANIA BRAZILIENSIS to search LEISHMANIA BRAZILIENSIS GUYANENSIS 1992-93%A%  
% 221.48/221.65  |- mesh__dateRevised mesh__D018334 2003-07-09
% 221.48/221.65  |- skos__historyNote mesh__D018334
% 221.48/221.65       Leishmania braziliensis %28%1986-1993%29%
% 221.48/221.65  |- skos__historyNote mesh__D018334 Leishmania %28%1976-1985%29%
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D010351 2004
% 221.48/221.65  |- skos__hiddenLabel mesh__D010351 Discharges, Patient
% 221.48/221.65  |- skos__historyNote mesh__D010351 Hospitalization %28%1966-1977%29%
% 221.48/221.65  |- mesh__historyNote mesh__D010351 78   
% 221.48/221.65  |- mesh__recordAuthorizer mesh__D010351 SJN
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D010351 2005
% 221.48/221.65  |- skos__hiddenLabel mesh__D010351 Discharge, Patient
% 221.48/221.65  |- mesh__dateCreated mesh__D010351 1977-05-12
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D010351 2006
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D010351 2000
% 221.48/221.65  |- skos__hiddenLabel mesh__D010351 Plannings, Discharge
% 221.48/221.65  |- mesh__publicMeSHNote mesh__D010351 78   
% 221.48/221.65  |- skos__broader mesh__D010351smesh__D006760
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D010351 2001
% 221.48/221.65  |- mesh__recordMaintainer mesh__D010351 JLS
% 221.48/221.65  |- skos__scopeNote mesh__D010351
% 221.48/221.65       The administrative process of discharging the patient, live or dead, from hospitals or other health facilities.%A%    
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D010351 1999
% 221.48/221.65  |- mesh__dateEstablished mesh__D010351 1978-01-01
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D010351 2002
% 221.48/221.65  |- skos__hiddenLabel mesh__D010351 Patient Discharges
% 221.48/221.65  |- mesh__recordOriginator mesh__D010351 EC
% 221.48/221.65  |- skos__hiddenLabel mesh__D010351 Planning, Discharge
% 221.48/221.65  |- skos__prefLabel mesh__D010351 Patient Discharge
% 221.48/221.65  |- skos__hiddenLabel mesh__D010351 Discharge Plannings
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D010351 2003
% 221.48/221.65  |- mesh__dateRevised mesh__D010351 1998-06-10
% 221.48/221.65  |- rdf__type mesh__D010351sskos__Concept
% 221.48/221.65  |- skos__scopeNote mesh__D004314
% 221.48/221.65       A chromosome disorder associated either with an extra chromosome 21 or an effective trisomy for chromosome 21. Clinical manifestations include hypotonia, short stature, brachycephaly, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, Simian crease, and moderate to severe MENTAL RETARDATION. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. %28%Menkes, Textbook of Child Neurology, 5th ed, p213%29%%A%    
% 221.48/221.65  |- skos__broader mesh__D004314smesh__D000015
% 221.48/221.65  |- skos__altLabel mesh__D004314 Partial Trisomy 21 Down Syndrome
% 221.48/221.65  |- mesh__publicMeSHNote mesh__D004314
% 221.48/221.65       93; was DOWN%27%S SYNDROME 1975-92 %26% 1963-64; was MONGOLISM 1965-74%A%  
% 221.48/221.65  |- skos__broader mesh__D004314smesh__D008607
% 221.48/221.65  |- skos__hiddenLabel mesh__D004314 Syndrome, Down
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D004314 2002
% 221.48/221.65  |- rdf__type mesh__D004314sskos__Concept
% 221.48/221.65  |- skos__prefLabel mesh__D004314 Down Syndrome
% 221.48/221.65  |- mesh__onlineNote mesh__D004314
% 221.48/221.65       use DOWN SYNDROME to search DOWN%27%S SYNDROME 1975-92 %26% MONGOLISM 1966-74%A%  
% 221.48/221.65  |- skos__altLabel mesh__D004314 Down%27%s Syndrome
% 221.48/221.65  |- mesh__historyNote mesh__D004314
% 221.48/221.65       93; was DOWN%27%S SYNDROME 1975-92 %26% 1963-64; was MONGOLISM 1965-74%A%  
% 221.48/221.65  |- mesh__recordAuthorizer mesh__D004314 sjn
% 221.48/221.65  |- mesh__recordOriginator mesh__D004314 NLM
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D004314 2003
% 221.48/221.65  |- mesh__recordMaintainer mesh__D004314 nns
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D004314 2005
% 221.48/221.65  |- skos__hiddenLabel mesh__D004314 Syndrome, Down%27%s
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D004314 2004
% 221.48/221.65  |- skos__altLabel mesh__D004314 Trisomy 21
% 221.48/221.65  |- mesh__dateRevised mesh__D004314 2001-07-25
% 221.48/221.65  |- mesh__dateCreated mesh__D004314 1999-01-01
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D004314 2006
% 221.48/221.65  |- skos__hiddenLabel mesh__D004314 Downs Syndrome
% 221.48/221.65  |- skos__broader mesh__D004314smesh__D025063
% 221.48/221.65  |- skos__altLabel mesh__D004314 Mongolism
% 221.48/221.65  |- skos__broader mesh__D014742smesh__D013690
% 221.48/221.65  |- mesh__recordAuthorizer mesh__D014742 sjn
% 221.48/221.65  |- mesh__recordMaintainer mesh__D014742 ags
% 221.48/221.65  |- mesh__dateEstablished mesh__D014742 1991-01-01
% 221.48/221.65  |- skos__hiddenLabel mesh__D014742 Recording, Videodisk
% 221.48/221.65  |- mesh__publicMeSHNote mesh__D014742
% 221.48/221.65       91; was see under VIDEO RECORDING 1984-90   
% 221.48/221.65  |- rdf__type mesh__D014742sskos__Concept
% 221.48/221.65  |- skos__annotation mesh__D014742
% 221.48/221.65       IM; do not confuse with VIDEO RECORDING or VIDEOTAPE RECORDING%A%  
% 221.48/221.65  |- skos__hiddenLabel mesh__D014742 Recording, Videodisc
% 221.48/221.65  |- skos__historyNote mesh__D014742 Audio-Visual Aids %28%1966-1983%29%
% 221.48/221.65  |- mesh__historyNote mesh__D014742
% 221.48/221.65       91%28%84%29%; was see under VIDEO RECORDING 1984-90   
% 221.48/221.65  |- skos__hiddenLabel mesh__D014742 Videodisk Recordings
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D014742 2005
% 221.48/221.65  |- skos__prefLabel mesh__D014742 Videodisc Recording
% 221.48/221.65  |- skos__hiddenLabel mesh__D014742 Recordings, Videodisc
% 221.48/221.65  |- skos__hiddenLabel mesh__D014742 Videodisc Recordings
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D014742 2006
% 221.48/221.65  |- skos__broader mesh__D014742smesh__D016249
% 221.48/221.65  |- skos__historyNote mesh__D014742 Videotape Recording %28%1974-1983%29%
% 221.48/221.65  |- mesh__recordOriginator mesh__D014742 EC
% 221.48/221.65  |- skos__scopeNote mesh__D014742
% 221.48/221.65       The storing of visual and usually sound signals on discs for later reproduction on a television screen or monitor.%A%    
% 221.48/221.65  |- mesh__dateCreated mesh__D014742 1983-06-13
% 221.48/221.65  |- skos__hiddenLabel mesh__D014742 Recordings, Videodisk
% 221.48/221.65  |- skos__broader mesh__D014742smesh__D014741
% 221.48/221.65  |- skos__altLabel mesh__D014742 Videodisk Recording
% 221.48/221.65  |- mesh__dateRevised mesh__D014742 2004-07-07
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008705 1995
% 221.48/221.65  |- skos__annotation mesh__D008705 a serum albumin   
% 221.48/221.65  |- skos__historyNote mesh__D008705 Heme %28%1966-1976%29%
% 221.48/221.65  |- skos__broader mesh__D008705smesh__D012709
% 221.48/221.65  |- skos__prefLabel mesh__D008705 Methemalbumin
% 221.48/221.65  |- skos__broader mesh__D008705smesh__D006420
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008705 1994
% 221.48/221.65  |- mesh__recordOriginator mesh__D008705 RLS
% 221.48/221.65  |- mesh__recordAuthorizer mesh__D008705 PLS
% 221.48/221.65  |- skos__historyNote mesh__D008705 Hemeproteins %28%1973-1976%29%
% 221.48/221.65  |- mesh__dateCreated mesh__D008705 1976-04-27
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008705 2002
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008705 2004
% 221.48/221.65  |- mesh__publicMeSHNote mesh__D008705
% 221.48/221.65       91; was see under HEMEPROTEINS 1977-90   
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008705 1997
% 221.48/221.65  |- mesh__dateRevised mesh__D008705 1992-05-18
% 221.48/221.65  |- mesh__dateEstablished mesh__D008705 1991-01-01
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008705 2001
% 221.48/221.65  |- mesh__recordMaintainer mesh__D008705 TAP
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008705 2003
% 221.48/221.65  |- mesh__historyNote mesh__D008705
% 221.48/221.65       91%28%77%29%; was see under HEMEPROTEINS 1977-90   
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008705 2006
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008705 1996
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008705 1999
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008705 2000
% 221.48/221.65  |- skos__scopeNote mesh__D008705
% 221.48/221.65       A 1:1 molar complex of heme or hematin and albumin formed after the dissociation of methemoglobin into heme or hematin and globin in plasma. This complex, which imparts a coffee-brown color to plasma, occurs in hemolytic and hemorrhagic disorders. Its presence in plasma is used as a test to differentiate between hemorrhagic and edematous pancreatitis.%A%    
% 221.48/221.65  |- skos__historyNote mesh__D008705 Serum Albumin %28%1966-1976%29%
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008705 2005
% 221.48/221.65  |- rdf__type mesh__D008705sskos__Concept
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008705 1993
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008705 1998
% 221.48/221.65  |- mesh__recordMaintainer mesh__D000722 ags
% 221.48/221.65  |- mesh__dateCreated mesh__D000722 1999-01-01
% 221.48/221.65  |- rdf__type mesh__D000722sskos__Concept
% 221.48/221.65  |- skos__annotation mesh__D000722
% 221.48/221.65       a genus of nematodes; infection = ANCYLOSTOMIASIS; coord with specific pre-coordinated helminth terms %28%e.g., ANTIGENS, HELMINTH%29% if pertinent%A%  
% 221.48/221.65  |- mesh__recordAuthorizer mesh__D000722 sjn
% 221.48/221.65  |- skos__altLabel mesh__D000722 Hookworm, Old World
% 221.48/221.65  |- mesh__publicMeSHNote mesh__D000722
% 221.48/221.65       ANCYLOSTOMA DUODENALE was UNCINARIA DUODENALE 1979-92   
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D000722 2005
% 221.48/221.65  |- skos__scopeNote mesh__D000722
% 221.48/221.65       A genus of nematode intestinal parasites that consists of several species. A. duodenale is the common hookworm in humans. A. braziliense, A. ceylonicum, and A. caninum occur primarily in cats and dogs, but all have been known to occur in humans.%A%    
% 221.48/221.65  |- mesh__onlineNote mesh__D000722
% 221.48/221.65       use ANCYLOSTOMA to search UNCINARIA DUODENALE 1979-92   
% 221.48/221.65  |- mesh__dateRevised mesh__D000722 2003-07-09
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D000722 2006
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D000722 2004
% 221.48/221.65  |- mesh__recordOriginator mesh__D000722 NLM
% 221.48/221.65  |- skos__prefLabel mesh__D000722 Ancylostoma
% 221.48/221.65  |- skos__broader mesh__D000722smesh__D000723
% 221.48/221.65  |- mesh__historyNote mesh__D000722
% 221.48/221.65       ANCYLOSTOMA DUODENALE was UNCINARIA DUODENALE 1979-92   
% 221.48/221.65  |- mesh__recordOriginator mesh__D018335 PLS
% 221.48/221.65  |- skos__hiddenLabel mesh__D018335 Rhabdoid Tumors
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018335 2006
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018335 1999
% 221.48/221.65  |- mesh__historyNote mesh__D018335 94   
% 221.48/221.65  |- skos__annotation mesh__D018335
% 221.48/221.65       /blood supply /chem /second /secret /ultrastruct permitted%A%  
% 221.48/221.65  |- skos__hiddenLabel mesh__D018335 Tumors, Rhabdoid
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018335 2002
% 221.48/221.65  |- mesh__dateRevised mesh__D018335 1995-06-08
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018335 2003
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018335 1996
% 221.48/221.65  |- rdf__type mesh__D018335sskos__Concept
% 221.48/221.65  |- mesh__dateCreated mesh__D018335 1993-06-03
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018335 2004
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018335 1997
% 221.48/221.65  |- mesh__recordAuthorizer mesh__D018335 PLS
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018335 2000
% 221.48/221.65  |- skos__broader mesh__D018335smesh__D018193
% 221.48/221.65  |- mesh__dateEstablished mesh__D018335 1994-01-01
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018335 2001
% 221.48/221.65  |- skos__hiddenLabel mesh__D018335 Tumor, Rhabdoid
% 221.48/221.65  |- skos__scopeNote mesh__D018335
% 221.48/221.65       A rare but highly lethal childhood tumor found almost exclusively in infants. Histopathologically, it resembles RHABDOMYOSARCOMA but the tumor cells are not of myogenic origin. Although it arises primarily in the kidney, it may be found in other parts of the body. The rhabdoid cytomorphology is believed to be the expression of a very primitive malignant cell. %28%From Holland et al., Cancer Medicine, 3d ed, p2210%29%%A%    
% 221.48/221.65  |- mesh__recordMaintainer mesh__D018335 KEV
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018335 2005
% 221.48/221.65  |- mesh__publicMeSHNote mesh__D018335 94   
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018335 1998
% 221.48/221.65  |- skos__prefLabel mesh__D018335 Rhabdoid Tumor
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D010352 1998
% 221.48/221.65  |- skos__hiddenLabel mesh__D010352 Characteristic, Dropout
% 221.48/221.65  |- mesh__publicMeSHNote mesh__D010352 74   
% 221.48/221.65  |- skos__hiddenLabel mesh__D010352 Patient Dropout
% 221.48/221.65  |- rdf__type mesh__D010352sskos__Concept
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D010352 2003
% 221.48/221.65  |- mesh__dateEstablished mesh__D010352 1974-01-01
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D010352 1997
% 221.48/221.65  |- mesh__historyNote mesh__D010352 74   
% 221.48/221.65  |- mesh__recordOriginator mesh__D010352 NLM
% 221.48/221.65  |- mesh__dateCreated mesh__D010352 1999-01-01
% 221.48/221.65  |- skos__hiddenLabel mesh__D010352 Dropout, Patient
% 221.48/221.65  |- skos__hiddenLabel mesh__D010352 Dropouts, Patient
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D010352 2002
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D010352 1996
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D010352 1995
% 221.48/221.65  |- mesh__recordMaintainer mesh__D010352 PLS
% 221.48/221.65  |- skos__broader mesh__D010352smesh__D010361
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D010352 2006
% 221.48/221.65  |- mesh__recordAuthorizer mesh__D010352 PLS
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D010352 2001
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D010352 1994
% 221.48/221.65  |- mesh__dateRevised mesh__D010352 1993-06-03
% 221.48/221.65  |- skos__hiddenLabel mesh__D010352 Dropout Characteristic
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D010352 2005
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D010352 1999
% 221.48/221.65  |- skos__hiddenLabel mesh__D010352 Dropout
% 221.48/221.65  |- skos__prefLabel mesh__D010352 Patient Dropouts
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D010352 2000
% 221.48/221.65  |- skos__hiddenLabel mesh__D010352 Characteristics, Dropout
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D010352 2004
% 221.48/221.65  |- skos__altLabel mesh__D004315 Wyeth Brand of Doxapram Hydrochloride
% 221.48/221.65  |- skos__prefLabel mesh__D004315 Doxapram
% 221.48/221.65  |- mesh__historyNote mesh__D004315 73%28%65%29%   
% 221.48/221.65  |- mesh__publicMeSHNote mesh__D004315 73   
% 221.48/221.65  |- skos__altLabel mesh__D004315 Genopharm Brand of Doxapram Hydrochloride
% 221.48/221.65  |- mesh__dateCreated mesh__D004315 1999-01-01
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D004315 2006
% 221.48/221.65  |- mesh__recordMaintainer mesh__D004315 exl
% 221.48/221.65  |- skos__altLabel mesh__D004315 Antigen Brand of Doxapram Hydrochloride
% 221.48/221.65  |- mesh__dateEstablished mesh__D004315 1973-01-01
% 221.48/221.65  |- mesh__dateRevised mesh__D004315 2005-06-30
% 221.48/221.65  |- skos__scopeNote mesh__D004315
% 221.48/221.65       A central respiratory stimulant with a brief duration of action. %28%From Martindale, The Extra Pharmocopoeia, 30th ed, p1225%29%%A%    
% 221.48/221.65  |- skos__altLabel mesh__D004315 Wyeth Brand of Doxapram
% 221.48/221.65  |- skos__hiddenLabel mesh__D004315 Hydrochloride, Doxapram
% 221.48/221.65  |- skos__altLabel mesh__D004315 Riemser Brand of Doxapram Hydrochloride
% 221.48/221.65  |- rdf__type mesh__D004315sskos__Concept
% 221.48/221.65  |- skos__altLabel mesh__D004315 AHP Brand of Doxapram Hydrochloride
% 221.48/221.65  |- mesh__recordAuthorizer mesh__D004315 sjn
% 221.48/221.65  |- mesh__recordOriginator mesh__D004315 NLM
% 221.48/221.65  |- skos__broader mesh__D004315smesh__D011760
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D009000 2006
% 221.48/221.65  |- skos__scopeNote mesh__D009000
% 221.48/221.65       Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles.%A%    
% 221.48/221.65  |- skos__broader mesh__D009000smesh__D007963
% 221.48/221.65  |- mesh__dateCreated mesh__D009000 1999-01-01
% 221.48/221.65  |- skos__altLabel mesh__D009000 Monocyte
% 221.48/221.65  |- skos__broader mesh__D009000smesh__D001854
% 221.48/221.65  |- skos__broader mesh__D009000smesh__D012157
% 221.48/221.65  |- mesh__recordOriginator mesh__D009000 NLM
% 221.48/221.65  |- rdf__type mesh__D009000sskos__Concept
% 221.48/221.65  |- mesh__recordMaintainer mesh__D009000 nns
% 221.48/221.65  |- mesh__recordAuthorizer mesh__D009000 sjn
% 221.48/221.65  |- skos__broader mesh__D009000smesh__D022423
% 221.48/221.65  |- skos__annotation mesh__D009000
% 221.48/221.65       do not confuse with LEUKOCYTES, MONONUCLEAR   
% 221.48/221.65  |- mesh__dateRevised mesh__D009000 2003-07-09
% 221.48/221.65  |- skos__broader mesh__D009000smesh__D010586
% 221.48/221.65  |- skos__prefLabel mesh__D009000 Monocytes
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D009000 2005
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D009000 2004
% 221.48/221.65  |- rdf__type mesh__D020780sskos__Concept
% 221.48/221.65  |- skos__broader mesh__D020780smesh__D017364
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D020780 2005
% 221.48/221.65  |- skos__altLabel mesh__D020780 92-kDa Gelatinase
% 221.48/221.65  |- mesh__recordMaintainer mesh__D020780 ags
% 221.48/221.65  |- skos__scopeNote mesh__D020780
% 221.48/221.65       An endopeptidase that is structurally similar to GELATINASE A. It degrades GELATIN types I and V; COLLAGEN TYPE IV; and COLLAGEN TYPE V. EC 3.4.24.35.%A%    
% 221.48/221.65  |- mesh__dateEstablished mesh__D020780 2000-01-01
% 221.48/221.65  |- skos__hiddenLabel mesh__D020780 Matrix Metalloproteinase 9
% 221.48/221.65  |- skos__altLabel mesh__D020780 Matrix Metalloproteinase-9
% 221.48/221.65  |- skos__historyNote mesh__D020780 Collagenases %28%1989-1999%29%
% 221.48/221.65  |- mesh__historyNote mesh__D020780
% 221.48/221.65       2000; use GELATINASE B %28%NM%29% 1989-1999   
% 221.48/221.65  |- skos__hiddenLabel mesh__D020780 92 kDa Gelatinase
% 221.48/221.65  |- skos__prefLabel mesh__D020780 Gelatinase B
% 221.48/221.65  |- skos__altLabel mesh__D020780 92-kDa Type IV Collagenase
% 221.48/221.65  |- skos__broader mesh__D020780smesh__D020782
% 221.48/221.65  |- mesh__dateRevised mesh__D020780 2005-08-03
% 221.48/221.65  |- mesh__recordOriginator mesh__D020780 adp
% 221.48/221.65  |- skos__broader mesh__D020780smesh__D018093
% 221.48/221.65  |- mesh__recordAuthorizer mesh__D020780 ags
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D020780 2006A
% 221.48/221.65  |- skos__hiddenLabel mesh__D020780 92 kDa Type IV Collagenase
% 221.48/221.65  |- mesh__dateCreated mesh__D020780 1999-11-08
% 221.48/221.65  |- skos__hiddenLabel mesh__D020780 MMP 9
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D020780 2006
% 221.48/221.65  |- mesh__publicMeSHNote mesh__D020780
% 221.48/221.65       2000; GELATINASE B was indexed under COLLAGENASES 1989-1999%A%  
% 221.48/221.65  |- skos__altLabel mesh__D020780 MMP-9
% 221.48/221.65  |- skos__scopeNote mesh__D014743
% 221.48/221.65       Recording of visual and sometimes sound signals on magnetic tape.%A%    
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D014743 2005
% 221.48/221.65  |- skos__broader mesh__D014743smesh__D013690
% 221.48/221.65  |- mesh__historyNote mesh__D014743 74   
% 221.48/221.65  |- skos__hiddenLabel mesh__D014743 Video Tape Recordings
% 221.48/221.65  |- mesh__recordAuthorizer mesh__D014743 sjn
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D014743 2006
% 221.48/221.65  |- skos__broader mesh__D014743smesh__D013637
% 221.48/221.65  |- skos__annotation mesh__D014743
% 221.48/221.65       IM; do not confuse with VIDEO RECORDING or VIDEODISC RECORDING%A%  
% 221.48/221.65  |- skos__hiddenLabel mesh__D014743 Tape Recordings, Video
% 221.48/221.65  |- skos__hiddenLabel mesh__D014743 Videotape
% 221.48/221.65  |- skos__hiddenLabel mesh__D014743 Recordings, Videotape
% 221.48/221.65  |- skos__hiddenLabel mesh__D014743 Recording, Video Tape
% 221.48/221.65  |- mesh__dateEstablished mesh__D014743 1974-01-01
% 221.48/221.65  |- mesh__dateCreated mesh__D014743 1999-01-01
% 221.48/221.65  |- skos__hiddenLabel mesh__D014743 Video Tape Recording
% 221.48/221.65  |- skos__altLabel mesh__D014743 Tape Recording, Video
% 221.48/221.65  |- skos__broader mesh__D014743smesh__D014741
% 221.48/221.65  |- skos__hiddenLabel mesh__D014743 Recording, Videotape
% 221.48/221.65  |- skos__hiddenLabel mesh__D014743 Recordings, Video Tape
% 221.48/221.65  |- mesh__dateRevised mesh__D014743 2004-07-07
% 221.48/221.65  |- mesh__recordMaintainer mesh__D014743 ags
% 221.48/221.65  |- mesh__publicMeSHNote mesh__D014743 74   
% 221.48/221.65  |- skos__prefLabel mesh__D014743 Videotape Recording
% 221.48/221.65  |- rdf__type mesh__D014743sskos__Concept
% 221.48/221.65  |- mesh__recordOriginator mesh__D014743 NLM
% 221.48/221.65  |- skos__hiddenLabel mesh__D014743 Videotape Recordings
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008706 2001
% 221.48/221.65  |- mesh__recordMaintainer mesh__D008706 TAP
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008706 1995
% 221.48/221.65  |- skos__prefLabel mesh__D008706 Methemoglobin
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008706 2003
% 221.48/221.65  |- mesh__recordAuthorizer mesh__D008706 PLS
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008706 1996
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008706 2002
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008706 2005
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008706 2004
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008706 1998
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008706 1997
% 221.48/221.65  |- skos__broader mesh__D008706smesh__D006454
% 221.48/221.65  |- mesh__dateCreated mesh__D008706 1999-01-01
% 221.48/221.65  |- mesh__recordOriginator mesh__D008706 NLM
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008706 2006
% 221.48/221.65  |- mesh__dateRevised mesh__D008706 1992-05-15
% 221.48/221.65  |- skos__altLabel mesh__D008706 Ferrihemoglobin
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008706 1999
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008706 2000
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008706 1994
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D008706 1993
% 221.48/221.65  |- rdf__type mesh__D008706sskos__Concept
% 221.48/221.65  |- rdf__type mesh__D000723sskos__Concept
% 221.48/221.65  |- mesh__onlineNote mesh__D000723
% 221.48/221.65       use ANCYLOSTOMATOIDEA to search HOOKWORMS 1966-85   
% 221.48/221.65  |- skos__scopeNote mesh__D000723
% 221.48/221.65       A superfamily of nematode parasitic hookworms consisting of four genera: ANCYLOSTOMA, NECATOR, Bunostomum, and Uncinaria. ANCYLOSTOMA and NECATOR occur in humans and other mammals. Bunostomum is common in ruminants and Uncinaria in wolves, foxes, and dogs.%A%    
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D000723 2005
% 221.48/221.65  |- mesh__historyNote mesh__D000723 86; was HOOKWORMS 1963-85   
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D000723 2006
% 221.48/221.65  |- mesh__dateRevised mesh__D000723 2003-07-09
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D000723 2004
% 221.48/221.65  |- mesh__recordAuthorizer mesh__D000723 sjn
% 221.48/221.65  |- mesh__recordMaintainer mesh__D000723 ags
% 221.48/221.65  |- skos__altLabel mesh__D000723 Hookworms
% 221.48/221.65  |- skos__annotation mesh__D000723
% 221.48/221.65       a superfamily of nematodes %28%hookworms%29%: HOOKWORM, NEW WORLD see NECATOR %26% HOOKWORM, OLD WORLD see ANCYLOSTOMA are available; infection = HOOKWORM INFECTIONS but see note under ANCYLOSTOMA; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 221.48/221.65  |- mesh__dateCreated mesh__D000723 1999-01-01
% 221.48/221.65  |- skos__broader mesh__D000723smesh__D017183
% 221.48/221.65  |- mesh__publicMeSHNote mesh__D000723 86; was HOOKWORMS 1963-85   
% 221.48/221.65  |- skos__prefLabel mesh__D000723 Ancylostomatoidea
% 221.48/221.65  |- mesh__recordOriginator mesh__D000723 NLM
% 221.48/221.65  |- skos__altLabel mesh__D018336 Aryl Hydrocarbon Receptors
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018336 1996
% 221.48/221.65  |- rdf__type mesh__D018336sskos__Concept
% 221.48/221.65  |- skos__hiddenLabel mesh__D018336 Receptor, AH
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018336 2003
% 221.48/221.65  |- skos__altLabel mesh__D018336 Receptors, Polyaromatic Hydrocarbon
% 221.48/221.65  |- skos__prefLabel mesh__D018336 Receptors, Aryl Hydrocarbon
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018336 1997
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018336 1998
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018336 2002
% 221.48/221.65  |- skos__historyNote mesh__D018336 Receptors, Drug %28%1979-1993%29%
% 221.48/221.65  |- skos__altLabel mesh__D018336 Polyaromatic Hydrocarbon Receptor
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018336 2004
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018336 2005
% 221.48/221.65  |- mesh__dateEstablished mesh__D018336 1994-01-01
% 221.48/221.65  |- skos__annotation mesh__D018336 DF: RECEPT AH   
% 221.48/221.65  |- mesh__recordOriginator mesh__D018336 RAZ
% 221.48/221.65  |- mesh__activeMeSHYear mesh__D018336 1999
% 221.48/221.65  |- mesh__onlineNote mesh__D018336
% 221.48/221.65       use RECEPTORS, ARYL HYDROCARBON %28%NM%29% to search 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN RECEPTOR 1980-93 %26% ARYL HYDROCARBON RECEPTOR 1981-93%A%  
% 221.48/221.65  |- skos__broader mesh__D018336smesh__D014157
% 221.48/221.65  |- skos__hiddenLabel mesh__D018336 Receptor, Polyaromatic Hydrocarbon
% 221.48/221.65  |- skos__altLabel mesh__D018336 AH Receptors
% 221.48/221.65  |- skos__altLabel mesh__D018336
% 221.48/221.65       Receptors, 2,3,7,8-Tetrachlorodibenzo-p-dioxin
% 221.48/221.65  |- skos__broader mesh__D018336smesh__D018160
% 221.48/221.66  |- mesh__dateCreated mesh__D018336 1993-07-09
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D018336 2006
% 221.48/221.66  |- skos__altLabel mesh__D018336 TCDD Receptors
% 221.48/221.66  |- skos__altLabel mesh__D018336 Dioxin Receptors
% 221.48/221.66  |- skos__altLabel mesh__D018336 Receptors, Dioxin
% 221.48/221.66  |- skos__altLabel mesh__D018336 AH Receptor
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D018336 2000
% 221.48/221.66  |- skos__hiddenLabel mesh__D018336 Receptor, TCDD
% 221.48/221.66  |- skos__altLabel mesh__D018336 TCDD Receptor
% 221.48/221.66  |- skos__altLabel mesh__D018336 Polyaromatic Hydrocarbon Receptors
% 221.48/221.66  |- mesh__recordAuthorizer mesh__D018336 PLS
% 221.48/221.66  |- mesh__historyNote mesh__D018336
% 221.48/221.66       94; was ARYL HYDROCARBON RECEPTOR %28%NM%29% 1981-93; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN RECEPTOR was %28%NM%29% 1979-93%A%  
% 221.48/221.66  |- skos__hiddenLabel mesh__D018336 Receptor, Dioxin
% 221.48/221.66  |- mesh__dateRevised mesh__D018336 1995-06-08
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D018336 2001
% 221.48/221.66  |- skos__altLabel mesh__D018336 Dioxin Receptor
% 221.48/221.66  |- skos__altLabel mesh__D018336 Aryl Hydrocarbon Receptor
% 221.48/221.66  |- mesh__publicMeSHNote mesh__D018336
% 221.48/221.66       94; ARYL HYDROCARBON RECEPTOR was indexed under RECEPTORS, DRUG 1981-93; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN RECEPTOR was indexed under RECEPTORS, DRUG 1979-93%A%  
% 221.48/221.66  |- skos__hiddenLabel mesh__D018336 Receptor, Aryl Hydrocarbon
% 221.48/221.66  |- skos__altLabel mesh__D018336 Receptors, TCDD
% 221.48/221.66  |- mesh__recordMaintainer mesh__D018336 KEV
% 221.48/221.66  |- skos__scopeNote mesh__D018336
% 221.48/221.66       Cytoplasmic proteins that bind certain aryl hydrocarbons, translocate to the nucleus, and activate transcription of particular DNA segments. AH receptors are identified by their high-affinity binding to several carcinogenic or teratogenic environmental chemicals including polycyclic aromatic hydrocarbons found in cigarette smoke and smog, heterocyclic amines found in cooked foods, and halogenated hydrocarbons including dioxins and polychlorinated biphenyls. No endogenous ligand has been identified, but an unknown natural messenger with a role in cell differentiation and development is suspected.%A%    
% 221.48/221.66  |- skos__altLabel mesh__D018336 Receptors, AH
% 221.48/221.66  |- mesh__dateEstablished mesh__D010353 1980-01-01
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D010353 2003
% 221.48/221.66  |- mesh__recordMaintainer mesh__D010353 kle
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D010353 2000
% 221.48/221.66  |- mesh__historyNote mesh__D010353 80; was PATIENTS/education 1966-79   
% 221.48/221.66  |- skos__prefLabel mesh__D010353 Patient Education
% 221.48/221.66  |- mesh__recordAuthorizer mesh__D010353 sjn
% 221.48/221.66  |- mesh__onlineNote mesh__D010353
% 221.48/221.66       use PATIENT EDUCATION %28%with no qualif%29% to search PATIENTS/education 1966-79%A%  
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D010353 2006
% 221.48/221.66  |- mesh__recordOriginator mesh__D010353 EC
% 221.48/221.66  |- mesh__dateCreated mesh__D010353 1979-06-01
% 221.48/221.66  |- mesh__dateRevised mesh__D010353 1999-11-03
% 221.48/221.66  |- mesh__publicMeSHNote mesh__D010353 80; was PATIENTS/education 1966-79   
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D010353 2005
% 221.48/221.66  |- skos__broader mesh__D010353smesh__D006266
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D010353 2002
% 221.48/221.66  |- skos__altLabel mesh__D010353 Education, Patient
% 221.48/221.66  |- skos__annotation mesh__D010353 IM; DF: PATIENT EDUC   
% 221.48/221.66  |- skos__hiddenLabel mesh__D010353 Patients Education
% 221.48/221.66  |- skos__scopeNote mesh__D010353
% 221.48/221.66       The teaching or training of patients concerning their own health needs.%A%    
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D010353 2004
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D010353 2001
% 221.48/221.66  |- skos__altLabel mesh__D010353 Education of Patients
% 221.48/221.66  |- rdf__type mesh__D010353sskos__Concept
% 221.48/221.66  |- skos__broader mesh__D004316smesh__D003990
% 221.48/221.66  |- skos__altLabel mesh__D004316 Doxepin-ratiopharm
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 beta, Doxepin
% 221.48/221.66  |- skos__altLabel mesh__D004316 Apotex Brand of Doxepin Hydrochloride
% 221.48/221.66  |- skos__altLabel mesh__D004316 Doxepin Lindo
% 221.48/221.66  |- skos__altLabel mesh__D004316 Doxepin Holsten
% 221.48/221.66  |- skos__altLabel mesh__D004316 Sinquan
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 ApoDoxepin
% 221.48/221.66  |- skos__altLabel mesh__D004316 Alphapharm Brand of Doxepin Hydrochloride
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 AL, Doxepin
% 221.48/221.66  |- mesh__dateCreated mesh__D004316 1999-01-01
% 221.48/221.66  |- skos__altLabel mesh__D004316 Doxepin beta
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 Hydrochloride, Doxepin
% 221.48/221.66  |- skos__altLabel mesh__D004316 Doxepia
% 221.48/221.66  |- skos__altLabel mesh__D004316 Xepin
% 221.48/221.66  |- skos__altLabel mesh__D004316 Espadox
% 221.48/221.66  |- skos__prefLabel mesh__D004316 Doxepin
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 AZU, Doxepin
% 221.48/221.66  |- skos__altLabel mesh__D004316
% 221.48/221.66       Doxepin Hydrochloride, Cis-Trans Isomer Mixture %28%approximately 1:5%29%
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 Doxepinneuraxpharm
% 221.48/221.66  |- skos__altLabel mesh__D004316 Roche Brand of Doxepin Hydrochloride
% 221.48/221.66  |- skos__altLabel mesh__D004316 Doxepin-RPh
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 DoxepinTEVA
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 DoxepinRPh
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 Apo Doxepin
% 221.48/221.66  |- skos__altLabel mesh__D004316 Doxepin Stada
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 NovoDoxepin
% 221.48/221.66  |- skos__altLabel mesh__D004316 Doneurin
% 221.48/221.66  |- skos__altLabel mesh__D004316 doxepin-biomo
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D004316 2006
% 221.48/221.66  |- skos__altLabel mesh__D004316 Doxepin dura
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 doxepinbiomo
% 221.48/221.66  |- skos__altLabel mesh__D004316 Doxepin AL
% 221.48/221.66  |- skos__altLabel mesh__D004316 Mareen
% 221.48/221.66  |- mesh__recordAuthorizer mesh__D004316 sjn
% 221.48/221.66  |- skos__broader mesh__D004316smesh__D010082
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 Holsten, Doxepin
% 221.48/221.66  |- skos__altLabel mesh__D004316 Desitin Brand of Doxepin Hydrochloride
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 Doxepin ratiopharm
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 Doxepinratiopharm
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 doxepin biomo
% 221.48/221.66  |- skos__scopeNote mesh__D004316
% 221.48/221.66       A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H%28%1%29%- and H%28%2%29%-receptors.%A%    
% 221.48/221.66  |- skos__altLabel mesh__D004316 Doxepin AZU
% 221.48/221.66  |- skos__altLabel mesh__D004316 Doxepin-neuraxpharm
% 221.48/221.66  |- skos__altLabel mesh__D004316 Prudoxin
% 221.48/221.66  |- mesh__recordMaintainer mesh__D004316 exl
% 221.48/221.66  |- mesh__dateEstablished mesh__D004316 1974-01-01
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 Doxepin neuraxpharm
% 221.48/221.66  |- skos__altLabel mesh__D004316 Doxepin-TEVA
% 221.48/221.66  |- rdf__type mesh__D004316sskos__Concept
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 Doxepin RPh
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 Novo Doxepin
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 dura, Doxepin
% 221.48/221.66  |- mesh__dateRevised mesh__D004316 2005-06-30
% 221.48/221.66  |- skos__altLabel mesh__D004316 Novo-Doxepin
% 221.48/221.66  |- skos__altLabel mesh__D004316 Quitaxon
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 Stada, Doxepin
% 221.48/221.66  |- mesh__historyNote mesh__D004316 74   
% 221.48/221.66  |- mesh__publicMeSHNote mesh__D004316 74   
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 Doxepin TEVA
% 221.48/221.66  |- mesh__recordOriginator mesh__D004316 NLM
% 221.48/221.66  |- skos__hiddenLabel mesh__D004316 Lindo, Doxepin
% 221.48/221.66  |- mesh__publicMeSHNote mesh__D020781 2000   
% 221.48/221.66  |- skos__broader mesh__D020781smesh__D020782
% 221.48/221.66  |- skos__scopeNote mesh__D020781
% 221.48/221.66       A member of the metalloproteinase family of enzymes that is principally responsible for cleaving fibrillar collagen. It can degrade interstitial collagens, types I, II and III. EC 3.4.24.7.%A%    
% 221.48/221.66  |- mesh__historyNote mesh__D020781
% 221.48/221.66       2000; use INTERSTITIAL COLLAGENASE %28%NM%29% 1991-1999   
% 221.48/221.66  |- skos__historyNote mesh__D020781 Collagenases %28%1991-1999%29%
% 221.48/221.66  |- mesh__dateEstablished mesh__D020781 2000-01-01
% 221.48/221.66  |- skos__broader mesh__D020781smesh__D017364
% 221.48/221.66  |- skos__prefLabel mesh__D020781 Interstitial Collagenase
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D020781 2006
% 221.48/221.66  |- skos__annotation mesh__D020781
% 221.48/221.66       /antag is permitted but TISSUE INHIBITOR OF METALLOPROTEINASE-1 is available%A%  
% 221.48/221.66  |- skos__altLabel mesh__D020781 Matrix Metalloproteinase-1
% 221.48/221.66  |- rdf__type mesh__D020781sskos__Concept
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D020781 2004
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D020781 2005
% 221.48/221.66  |- skos__hiddenLabel mesh__D020781 Matrix Metalloproteinase 1
% 221.48/221.66  |- skos__hiddenLabel mesh__D020781 MMP 1
% 221.48/221.66  |- mesh__dateRevised mesh__D020781 2003-07-09
% 221.48/221.66  |- skos__altLabel mesh__D020781 MMP-1
% 221.48/221.66  |- mesh__dateCreated mesh__D020781 1999-11-08
% 221.48/221.66  |- mesh__recordMaintainer mesh__D014744 KEV
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D014744 2000
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D014744 1998
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D014744 2005
% 221.48/221.66  |- mesh__dateRevised mesh__D014744 1995-05-23
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D014744 2001
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D014744 1999
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D014744 2006
% 221.48/221.66  |- mesh__dateCreated mesh__D014744 1999-01-01
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D014744 2002
% 221.48/221.66  |- skos__altLabel mesh__D014744 Vietnam, Republic of
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D014744 1996
% 221.48/221.66  |- skos__broader mesh__D014744smesh__D001210
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D014744 2003
% 221.48/221.66  |- mesh__recordAuthorizer mesh__D014744 PLS
% 221.48/221.66  |- skos__prefLabel mesh__D014744 Vietnam
% 221.48/221.66  |- mesh__recordOriginator mesh__D014744 NLM
% 221.48/221.66  |- rdf__type mesh__D014744sskos__Concept
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D014744 1997
% 221.48/221.66  |- skos__altLabel mesh__D014744 Viet Nam
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D014744 2004
% 221.48/221.66  |- mesh__historyNote mesh__D000724
% 221.48/221.66       68; was see under HOOKWORM INFECTION 1963-67   
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D000724 2001
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D000724 2004
% 221.48/221.66  |- mesh__recordMaintainer mesh__D000724 JLS
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D000724 2002
% 221.48/221.66  |- skos__prefLabel mesh__D000724 Ancylostomiasis
% 221.48/221.66  |- mesh__dateEstablished mesh__D000724 1968-01-01
% 221.48/221.66  |- skos__scopeNote mesh__D000724
% 221.48/221.66       Infection of humans or animals with hookworms of the genus ANCYLOSTOMA. Characteristics include anemia, dyspepsia, eosinophilia, and abdominal swelling.%A%    
% 221.48/221.66  |- skos__annotation mesh__D000724
% 221.48/221.66       hookworm infect; Ancylostoma americanum infection = NECATORIASIS, not ANCYLOSTOMIASIS%A%  
% 221.48/221.66  |- skos__historyNote mesh__D000724 Hookworm Infections %28%1966-1967%29%
% 221.48/221.66  |- mesh__recordOriginator mesh__D000724 NLM
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D000724 1994
% 221.48/221.66  |- mesh__recordAuthorizer mesh__D000724 PLS
% 221.48/221.66  |- mesh__dateCreated mesh__D000724 1999-01-01
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D000724 1998
% 221.48/221.66  |- skos__broader mesh__D000724smesh__D006725
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D000724 1995
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D000724 1996
% 221.48/221.66  |- rdf__type mesh__D000724sskos__Concept
% 221.48/221.66  |- mesh__onlineNote mesh__D000724 search HOOKWORM INFECTIONS 1966-67   
% 221.48/221.66  |- mesh__publicMeSHNote mesh__D000724
% 221.48/221.66       68; was see under HOOKWORM INFECTION 1963-67   
% 221.48/221.66  |- skos__hiddenLabel mesh__D000724 Ancylostomiases
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D000724 1999
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D000724 2000
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D000724 1997
% 221.48/221.66  |- mesh__dateRevised mesh__D000724 1993-06-04
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D000724 2005
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D000724 2003
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D000724 2006
% 221.48/221.66  |- skos__historyNote mesh__D052065
% 221.48/221.66       Sexual Dysfunctions, Psychological %28%1969-2005%29%
% 221.48/221.66  |- mesh__recordOriginator mesh__D052065 lkt
% 221.48/221.66  |- skos__historyNote mesh__D052065 Vaginal Diseases %28%1965-2005%29%
% 221.48/221.66  |- mesh__recordMaintainer mesh__D052065 lkt
% 221.48/221.66  |- skos__prefLabel mesh__D052065 Vaginismus
% 221.48/221.66  |- skos__broader mesh__D052065smesh__D012735
% 221.48/221.66  |- skos__scopeNote mesh__D052065
% 221.48/221.66       Recurrent or persistent involuntary SPASM of the outer muscles of the VAGINA, occurring during vaginal penetration.%A%    
% 221.48/221.66  |- rdf__type mesh__D052065sskos__Concept
% 221.48/221.66  |- skos__broader mesh__D052065smesh__D020018
% 221.48/221.66  |- mesh__historyNote mesh__D052065
% 221.48/221.66       2006; use SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL 1998-2005   
% 221.48/221.66  |- mesh__dateEstablished mesh__D052065 2006-01-01
% 221.48/221.66  |- mesh__publicMeSHNote mesh__D052065
% 221.48/221.66       2006; see SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL 1998-2005   
% 221.48/221.66  |- mesh__recordAuthorizer mesh__D052065 sjn
% 221.48/221.66  |- mesh__dateCreated mesh__D052065 2005-06-30
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D052065 2006
% 221.48/221.66  |- skos__broader mesh__D052065smesh__D014623
% 221.48/221.66  |- mesh__recordMaintainer mesh__D046028 ags
% 221.48/221.66  |- skos__broader mesh__D046028smesh__D002335
% 221.48/221.66  |- mesh__recordOriginator mesh__D046028 ags
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D046028 2006
% 221.48/221.66  |- mesh__recordAuthorizer mesh__D046028 sjn
% 221.48/221.66  |- rdf__type mesh__D046028sskos__Concept
% 221.48/221.66  |- skos__scopeNote mesh__D046028
% 221.48/221.66       A family of terrestrial carnivores with long snouts and non-retractable claws. Members include COYOTES; DOGS; FOXES; JACKALS; RACCOON DOGS; and WOLVES.%A%    
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D046028 2005
% 221.48/221.66  |- mesh__historyNote mesh__D046028 2005; use CARNIVORA 1998-2004   
% 221.48/221.66  |- skos__altLabel mesh__D046028 Chrysocyon brachyurus
% 221.48/221.66  |- skos__historyNote mesh__D046028 Carnivora %28%1965-2004%29%
% 221.48/221.66  |- mesh__dateCreated mesh__D046028 2004-07-07
% 221.48/221.66  |- skos__prefLabel mesh__D046028 Canidae
% 221.48/221.66  |- mesh__dateEstablished mesh__D046028 2005-01-01
% 221.48/221.66  |- mesh__publicMeSHNote mesh__D046028 2005; see CARNIVORA 1998-2004   
% 221.48/221.66  |- skos__hiddenLabel mesh__D046028 Wolf, Maned
% 221.48/221.66  |- skos__scopeNote mesh__D010354
% 221.48/221.66       A special service provided by volunteers to accompany patients who need help in moving about the health facility.%A%    
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D010354 2002
% 221.48/221.66  |- mesh__recordMaintainer mesh__D010354 KEV
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D010354 2005
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D010354 1999
% 221.48/221.66  |- mesh__recordAuthorizer mesh__D010354 PLS
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D010354 2001
% 221.48/221.66  |- skos__hiddenLabel mesh__D010354 Escort Services, Patient
% 221.48/221.66  |- skos__hiddenLabel mesh__D010354 Patient Escort Services
% 221.48/221.66  |- skos__broader mesh__D010354smesh__D006758
% 221.48/221.66  |- skos__prefLabel mesh__D010354 Patient Escort Service
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D010354 2004
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D010354 1998
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D010354 2000
% 221.48/221.66  |- skos__annotation mesh__D010354 DF: PATIENT ESCORT SERV   
% 221.48/221.66  |- mesh__dateCreated mesh__D010354 1977-05-11
% 221.48/221.66  |- rdf__type mesh__D010354sskos__Concept
% 221.48/221.66  |- mesh__recordOriginator mesh__D010354 EC
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D010354 2003
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D010354 1997
% 221.48/221.66  |- skos__hiddenLabel mesh__D010354 Services, Patient Escort
% 221.48/221.66  |- skos__altLabel mesh__D010354 Service, Patient Escort
% 221.48/221.66  |- mesh__dateEstablished mesh__D010354 1991-01-01
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D010354 1996
% 221.48/221.66  |- mesh__dateRevised mesh__D010354 1995-05-22
% 221.48/221.66  |- mesh__publicMeSHNote mesh__D010354
% 221.48/221.66       91; was see under HOSPITAL VOLUNTEERS Aug 1977-90   
% 221.48/221.66  |- skos__altLabel mesh__D010354 Escort Service, Patient
% 221.48/221.66  |- mesh__historyNote mesh__D010354
% 221.48/221.66       91%28%Aug 77%29%; was see under HOSPITAL VOLUNTEERS 1977-90   
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D010354 2006
% 221.48/221.66  |- skos__broader mesh__D043523Q000172smesh__D043523
% 221.48/221.66  |- mesh__preferredCombination mesh__D043523Q000172smesh__D028921
% 221.48/221.66  |- rdf__type mesh__D043523Q000172smesh__CompoundConcept
% 221.48/221.66  |- mesh__recordOriginator mesh__D004317 NLM
% 221.48/221.66  |- skos__historyNote mesh__D004317
% 221.48/221.66       Antibiotics, Antineoplastic %28%1967-1972%29%
% 221.48/221.66  |- skos__hiddenLabel mesh__D004317 Doxorubicin, Liposomal
% 221.48/221.66  |- skos__hiddenLabel mesh__D004317 DOX SL
% 221.48/221.66  |- mesh__publicMeSHNote mesh__D004317 78; see ADRIAMYCIN 1973-77   
% 221.48/221.66  |- mesh__dateCreated mesh__D004317 1999-01-01
% 221.48/221.66  |- mesh__dateEstablished mesh__D004317 1973-01-01
% 221.48/221.66  |- skos__broader mesh__D004317smesh__D003630
% 221.48/221.66  |- skos__altLabel mesh__D004317
% 221.48/221.66       Tedec Meiji Brand of Doxorubicin Hydrochloride
% 221.48/221.66  |- skos__hiddenLabel mesh__D004317 Hydrochloride, Doxorubicin
% 221.48/221.66  |- skos__altLabel mesh__D004317 Adriblastine
% 221.48/221.66  |- skos__altLabel mesh__D004317 Schering Brand of Doxorubicin Hydrochloride
% 221.48/221.66  |- skos__altLabel mesh__D004317
% 221.48/221.66       Onkoworks Brand of Doxorubicin Hydrochloride
% 221.48/221.66  |- mesh__historyNote mesh__D004317 78%28%73%29%   
% 221.48/221.66  |- skos__altLabel mesh__D004317
% 221.48/221.66       Schering-Plough Brand of Doxorubicin Hydrochloride
% 221.48/221.66  |- skos__altLabel mesh__D004317 Baxter Brand of Doxorubicin Hydrochloride
% 221.48/221.66  |- skos__altLabel mesh__D004317 Elan Brand of Doxorubicin Hydrochloride
% 221.48/221.66  |- skos__altLabel mesh__D004317 Ferrer Brand of Doxorubicin Hydrochloride
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D004317 2006
% 221.48/221.66  |- skos__altLabel mesh__D004317 Adriblastin
% 221.48/221.66  |- skos__scopeNote mesh__D004317
% 221.48/221.66       Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN.%A%    
% 221.48/221.66  |- skos__altLabel mesh__D004317 Essex Brand of Doxorubicin Hydrochloride
% 221.48/221.66  |- skos__hiddenLabel mesh__D004317 DOXO cell
% 221.48/221.66  |- skos__altLabel mesh__D004317 Urokit Doxo-cell
% 221.48/221.66  |- mesh__recordAuthorizer mesh__D004317 sjn
% 221.48/221.66  |- skos__altLabel mesh__D004317
% 221.48/221.66       Pharmacia Brand of Doxorubicin Hydrochloride
% 221.48/221.66  |- skos__altLabel mesh__D004317
% 221.48/221.66       Bristol-Myers Squibb Brand of Doxorubicin Hydrochloride
% 221.48/221.66  |- skos__hiddenLabel mesh__D004317 Urokit Doxo cell
% 221.48/221.66  |- skos__altLabel mesh__D004317 medac Brand of Doxorubicin Hydrochloride
% 221.48/221.66  |- skos__altLabel mesh__D004317
% 221.48/221.66       cell pharm Brand of Doxorubicin Hydrochloride
% 221.48/221.66  |- skos__altLabel mesh__D004317 Kenfarma Brand of Doxorubicin Hydrochloride
% 221.48/221.66  |- rdf__type mesh__D004317sskos__Concept
% 221.48/221.66  |- skos__altLabel mesh__D004317 Adriablastin
% 221.48/221.66  |- skos__altLabel mesh__D004317
% 221.48/221.66       ribosepharm Brand of Doxorubicin Hydrochloride
% 221.48/221.66  |- skos__altLabel mesh__D004317 Columbia Brand of Doxorubicin Hydrochloride
% 221.48/221.66  |- skos__annotation mesh__D004317
% 221.48/221.66       Xref CAELYX or LIPOSOMAL DOXRUBICIN coord with LIPOSOMES %28%NIM%29%%A%  
% 221.48/221.66  |- skos__altLabel mesh__D004317
% 221.48/221.66       Ortho Biotech Brand of Doxorubicin Hydrochloride
% 221.48/221.66  |- mesh__recordMaintainer mesh__D004317 lkw
% 221.48/221.66  |- skos__prefLabel mesh__D004317 Doxorubicin
% 221.48/221.66  |- skos__altLabel mesh__D004317 Lemery Brand of Doxorubicin Hydrochloride
% 221.48/221.66  |- skos__altLabel mesh__D004317 Neocorp Brand of Doxorubicin Hydrochloride
% 221.48/221.66  |- skos__altLabel mesh__D004317 Hexal Brand of Doxorubicin Hydrochloride
% 221.48/221.66  |- skos__altLabel mesh__D004317
% 221.48/221.66       Prasfarma Brand of Doxorubicin Hydrochloride
% 221.48/221.66  |- mesh__dateRevised mesh__D004317 2005-06-30
% 221.48/221.66  |- skos__altLabel mesh__D004317 Adriblastina
% 221.48/221.66  |- skos__broader mesh__D009800smesh__D020157
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D009800 2005A
% 221.48/221.66  |- skos__hiddenLabel mesh__D009800 Renal-Oculocerebrodystrophies
% 221.48/221.66  |- skos__hiddenLabel mesh__D009800 Oculocerebrorenal Dystrophies
% 221.48/221.66  |- skos__historyNote mesh__D009800 Eye Diseases %28%1966-1976%29%
% 221.48/221.66  |- mesh__dateRevised mesh__D009800 2004-07-29
% 221.48/221.66  |- skos__altLabel mesh__D009800 Lowe-Bickel Syndrome
% 221.48/221.66  |- skos__broader mesh__D009800smesh__D040181
% 221.48/221.66  |- skos__historyNote mesh__D009800 Kidney Diseases %28%1966-1976%29%
% 221.48/221.66  |- skos__altLabel mesh__D009800 Lowe Oculocerebrorenal Syndrome
% 221.48/221.66  |- skos__broader mesh__D009800smesh__D020739
% 221.48/221.66  |- skos__hiddenLabel mesh__D009800 Cerebrooculorenal Syndromes
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D009800 2004
% 221.48/221.66  |- skos__broader mesh__D009800smesh__D015499
% 221.48/221.66  |- skos__altLabel mesh__D009800 Lowe-Terrey-MacLachlan Syndrome
% 221.48/221.66  |- skos__altLabel mesh__D009800 Renal-Oculocerebrodystrophy
% 221.48/221.66  |- skos__hiddenLabel mesh__D009800 Lowe Bickel Syndrome
% 221.48/221.66  |- mesh__dateEstablished mesh__D009800 1991-01-01
% 221.48/221.66  |- mesh__publicMeSHNote mesh__D009800
% 221.48/221.66       1991; see RENAL TUBULAR TRANSPORT, INBORN ERRORS 1977-90   
% 221.48/221.66  |- skos__hiddenLabel mesh__D009800 Cerebro-Oculo-Renal Syndromes
% 221.48/221.66  |- skos__hiddenLabel mesh__D009800 Dystrophies, Oculocerebrorenal
% 221.48/221.66  |- skos__historyNote mesh__D009800
% 221.48/221.66       Abnormalities, Multiple %28%1968-1976%29%
% 221.48/221.66  |- skos__altLabel mesh__D009800 Lowe Syndrome
% 221.48/221.66  |- skos__hiddenLabel mesh__D009800 Renal Oculocerebrodystrophy
% 221.48/221.66  |- skos__broader mesh__D009800smesh__D000015
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D009800 2003
% 221.48/221.66  |- mesh__dateCreated mesh__D009800 1976-05-19
% 221.48/221.66  |- skos__hiddenLabel mesh__D009800 Cerebro Oculo Renal Syndrome
% 221.48/221.66  |- skos__hiddenLabel mesh__D009800 Lowe Terrey MacLachlan Syndrome
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D009800 2006
% 221.48/221.66  |- skos__altLabel mesh__D009800 Cerebro-Oculo-Renal Syndrome
% 221.48/221.66  |- skos__scopeNote mesh__D009800
% 221.48/221.66       A sex-linked recessive disorder of amino acid transport which affects the EYE; NERVOUS SYSTEM; and KIDNEY. Clinical manifestations include CATARACT; GLAUCOMA; developmental delay %28%which eventually leads to profound cognitive deficits%29%; myopathy; peripheral neuropathy; and hypotonia. There is an associated generalized aminoaciduria of the FANCONI SYNDROME type; renal tubular acidosis %28%ACIDOSIS, RENAL TUBULAR%29%; and hypophosphatemic RICKETS. This condition has been associated with deficient activity of the enzyme phosphatidylinositol 4,5-bisphosphate-5-phosphatase. %28%Menkes, Textbook of Child Neurology, 5th ed, p60; Am J Hum Genet 1997 Jun;60%28%6%29%:1384-8%29%%A%    
% 221.48/221.66  |- skos__hiddenLabel mesh__D009800 Dystrophy, Oculocerebrorenal
% 221.48/221.66  |- skos__altLabel mesh__D009800 Lowe Disease
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D009800 2005
% 221.48/221.66  |- mesh__recordOriginator mesh__D009800 SMH
% 221.48/221.66  |- mesh__recordAuthorizer mesh__D009800 jls
% 221.48/221.66  |- skos__altLabel mesh__D009800 Oculocerebrorenal Dystrophy
% 221.48/221.66  |- skos__altLabel mesh__D009800 Cerebrooculorenal Syndrome
% 221.48/221.66  |- skos__prefLabel mesh__D009800 Oculocerebrorenal Syndrome
% 221.48/221.66  |- mesh__recordMaintainer mesh__D009800 jls
% 221.48/221.66  |- mesh__historyNote mesh__D009800 1991%28%1977%29%   
% 221.48/221.66  |- rdf__type mesh__D009800sskos__Concept
% 221.48/221.66  |- skos__prefLabel mesh__D009002 Monomethylhydrazine
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D009002 1996
% 221.48/221.66  |- mesh__dateEstablished mesh__D009002 1991-01-01
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D009002 2006
% 221.48/221.66  |- mesh__recordOriginator mesh__D009002 NLM
% 221.48/221.66  |- skos__broader mesh__D009002smesh__D008763
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D009002 2002
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D009002 1999
% 221.48/221.66  |- mesh__publicMeSHNote mesh__D009002
% 221.48/221.66       91; was see under METHYLHYDRAZINES 1978-90; was METHYLHYDRAZINE see under HYDRAZINES 1966-77%A%  
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D009002 2005
% 221.48/221.66  |- mesh__recordMaintainer mesh__D009002 TAP
% 221.48/221.66  |- skos__scopeNote mesh__D009002
% 221.48/221.66       Hydrazine substituted by one methyl group.     
% 221.48/221.66  |- mesh__dateCreated mesh__D009002 1999-01-01
% 221.48/221.66  |- mesh__dateRevised mesh__D009002 1995-05-18
% 221.48/221.66  |- mesh__onlineNote mesh__D009002
% 221.48/221.66       to search METHYLHYDRAZINE use MONOMETHYLHYDRAZINE 1975-77 %26% HYDRAZINES 1966-74%A%  
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D009002 1998
% 221.48/221.66  |- rdf__type mesh__D009002sskos__Concept
% 221.48/221.66  |- skos__altLabel mesh__D009002 Methylhydrazine
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D009002 2004
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D009002 2001
% 221.48/221.66  |- mesh__historyNote mesh__D009002
% 221.48/221.66       91%28%78%29%; was see under METHYLHYDRAZINES 1978-90; was METHYLHYDRAZINE see under HYDRAZINES 1966-77%A%  
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D009002 2000
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D009002 1997
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D009002 2003
% 221.48/221.66  |- mesh__recordAuthorizer mesh__D009002 PLS
% 221.48/221.66  |- skos__historyNote mesh__D020782 Metalloendopeptidases %28%1988-1999%29%
% 221.48/221.66  |- mesh__recordAuthorizer mesh__D020782 ags
% 221.48/221.66  |- mesh__historyNote mesh__D020782 2000   
% 221.48/221.66  |- mesh__recordOriginator mesh__D020782 adp
% 221.48/221.66  |- mesh__dateCreated mesh__D020782 1999-11-08
% 221.48/221.66  |- skos__annotation mesh__D020782
% 221.48/221.66       /antag is permitted but TISSUE INHIBITOR OF METALLOPROTEINASES is available; check MeSH for specific matrix metalloproteinases%A%  
% 221.48/221.66  |- mesh__publicMeSHNote mesh__D020782 2000   
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D020782 2006A
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D020782 2006
% 221.48/221.66  |- skos__prefLabel mesh__D020782 Matrix Metalloproteinases
% 221.48/221.66  |- rdf__type mesh__D020782sskos__Concept
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D020782 2004
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D020782 2005
% 221.48/221.66  |- mesh__dateRevised mesh__D020782 2005-07-20
% 221.48/221.66  |- skos__broader mesh__D020782smesh__D008666
% 221.48/221.66  |- mesh__recordMaintainer mesh__D020782 ags
% 221.48/221.66  |- skos__altLabel mesh__D020782 MMPs
% 221.48/221.66  |- mesh__dateEstablished mesh__D020782 2000-01-01
% 221.48/221.66  |- skos__scopeNote mesh__D020782
% 221.48/221.66       A family of zinc-dependent metalloendopeptidases that are involved in the degradation of EXTRACELLULAR MATRIX components. EC 3.4.24.-.%A%    
% 221.48/221.66  |- skos__scopeNote mesh__D014745
% 221.48/221.66       A morpholine derivative used as an antidepressant. It is similar in action to IMIPRAMINE.%A%    
% 221.48/221.66  |- rdf__type mesh__D014745sskos__Concept
% 221.48/221.66  |- skos__altLabel mesh__D014745
% 221.48/221.66       AstraZeneca Brand of Viloxazine Hydrochloride
% 221.48/221.66  |- skos__historyNote mesh__D014745 Ethers %28%1972-1975%29%
% 221.48/221.66  |- mesh__historyNote mesh__D014745
% 221.48/221.66       91%28%77%29%; was see under MORPHOLINES 1977-90   
% 221.48/221.66  |- mesh__dateEstablished mesh__D014745 1991-01-01
% 221.48/221.66  |- mesh__dateCreated mesh__D014745 1976-04-13
% 221.48/221.66  |- skos__broader mesh__D014745smesh__D009025
% 221.48/221.66  |- mesh__recordOriginator mesh__D014745 SH
% 221.48/221.66  |- mesh__dateRevised mesh__D014745 2005-06-30
% 221.48/221.66  |- skos__hiddenLabel mesh__D014745 ICI58,834
% 221.48/221.66  |- skos__historyNote mesh__D014745 Morpholines %28%1976%29%
% 221.48/221.66  |- mesh__recordAuthorizer mesh__D014745 sjn
% 221.48/221.66  |- mesh__recordMaintainer mesh__D014745 lkw
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D014745 2006
% 221.48/221.66  |- skos__prefLabel mesh__D014745 Viloxazine
% 221.48/221.66  |- skos__altLabel mesh__D014745 Astra Brand of Viloxazine Hydrochloride
% 221.48/221.66  |- mesh__publicMeSHNote mesh__D014745
% 221.48/221.66       91; was see under MORPHOLINES 1977-90   
% 221.48/221.66  |- skos__historyNote mesh__D014745 Oxazines %28%1972-1975%29%
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D008708 1997
% 221.48/221.66  |- mesh__dateCreated mesh__D008708 1999-01-01
% 221.48/221.66  |- mesh__activeMeSHYear mesh__D008708 2002
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D008708 2006
% 221.48/221.67  |- skos__annotation mesh__D008708 presence of methemoglobin in blood   
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D008708 1999
% 221.48/221.67  |- mesh__recordOriginator mesh__D008708 NLM
% 221.48/221.67  |- skos__broader mesh__D008708smesh__D006402
% 221.48/221.67  |- skos__scopeNote mesh__D008708
% 221.48/221.67       The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase %28%an autosomal recessive trait%29% or to an abnormality in hemoglobin M %28%an autosomal dominant trait%29%. %28%Dorland, 27th ed%29%%A%    
% 221.48/221.67  |- skos__prefLabel mesh__D008708 Methemoglobinemia
% 221.48/221.67  |- rdf__type mesh__D008708sskos__Concept
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D008708 2000
% 221.48/221.67  |- mesh__recordMaintainer mesh__D008708 PLS
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D008708 1995
% 221.48/221.67  |- skos__hiddenLabel mesh__D008708 Methemoglobinemias
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D008708 2001
% 221.48/221.67  |- mesh__dateRevised mesh__D008708 1994-06-28
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D008708 2003
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D008708 1996
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D008708 2005
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D008708 2004
% 221.48/221.67  |- mesh__recordAuthorizer mesh__D008708 PLS
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D008708 1998
% 221.48/221.67  |- mesh__recordMaintainer mesh__D000725 TGC
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D000725 2001
% 221.48/221.67  |- mesh__dateCreated mesh__D000725 1999-01-01
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D000725 1998
% 221.48/221.67  |- rdf__type mesh__D000725sskos__Concept
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D000725 2002
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D000725 1996
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D000725 1999
% 221.48/221.67  |- mesh__recordOriginator mesh__D000725 NLM
% 221.48/221.67  |- skos__scopeNote mesh__D000725
% 221.48/221.67       A principality in the Pyrenees between France and Spain. Its capital is also called Andorra. %28%From Webster%27%s New Geographical Dictionary, 1988, p50%29%%A%    
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D000725 1997
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D000725 2005
% 221.48/221.67  |- skos__annotation mesh__D000725
% 221.48/221.67       a country lying between France %26% Spain   
% 221.48/221.67  |- mesh__recordAuthorizer mesh__D000725 PLS
% 221.48/221.67  |- skos__prefLabel mesh__D000725 Andorra
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D000725 2003
% 221.48/221.67  |- skos__broader mesh__D000725smesh__D005060
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D000725 2006
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D000725 2004
% 221.48/221.67  |- mesh__dateRevised mesh__D000725 1995-02-17
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D000725 2000
% 221.48/221.67  |- skos__prefLabel mesh__D019430 Guadeloupe
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D019430 2006
% 221.48/221.67  |- skos__annotation mesh__D019430
% 221.48/221.67       two islands in the West Indies separated by a narrow channel%A%  
% 221.48/221.67  |- mesh__dateCreated mesh__D019430 1996-06-26
% 221.48/221.67  |- rdf__type mesh__D019430sskos__Concept
% 221.48/221.67  |- mesh__historyNote mesh__D019430 97   
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D019430 2005
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D019430 2002
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D019430 2004
% 221.48/221.67  |- skos__broader mesh__D019430smesh__D014900
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D019430 1999
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D019430 2001
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D019430 2003
% 221.48/221.67  |- mesh__dateEstablished mesh__D019430 1997-01-01
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D019430 2000
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D019430 1998
% 221.48/221.67  |- skos__scopeNote mesh__D019430
% 221.48/221.67       The name of two islands of the West Indies, separated by a narrow channel. Their capital is Basse-Terre. They were discovered by Columbus in 1493, occupied by the French in 1635, held by the British at various times between 1759 and 1813, transferred to Sweden in 1813, and restored to France in 1816. Its status was changed from colony to a French overseas department in 1946. Columbus named it in honor of the monastery of Santa Maria de Guadalupe in Spain. %28%From Webster%27%s New Geographical Dictionary, 1988, p470 %26% Room, Brewer%27%s Dictionary of Names, 1992, p221%29%%A%    
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D019430 1997
% 221.48/221.67  |- skos__historyNote mesh__D019430 West Indies %28%1966-1996%29%
% 221.48/221.67  |- mesh__recordAuthorizer mesh__D033101 jls
% 221.48/221.67  |- mesh__publicMeSHNote mesh__D033101
% 221.48/221.67       2003; for VOLUNTARY EUTHANASIA see EUTHANASIA 1978-2002   
% 221.48/221.67  |- skos__prefLabel mesh__D033101 Euthanasia, Active, Voluntary
% 221.48/221.67  |- mesh__recordOriginator mesh__D033101 jrf
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D033101 2003
% 221.48/221.67  |- rdf__type mesh__D033101sskos__Concept
% 221.48/221.67  |- mesh__dateRevised mesh__D033101 2002-10-31
% 221.48/221.67  |- skos__scopeNote mesh__D033101
% 221.48/221.67       Active euthanasia of a patient at the patient%27%s request and/or with the patient%27%s consent.%A%    
% 221.48/221.67  |- skos__historyNote mesh__D033101 Euthanasia %28%1974-2002%29%
% 221.48/221.67  |- skos__broader mesh__D033101smesh__D028601
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D033101 2006
% 221.48/221.67  |- skos__related mesh__D033101smesh__D017236
% 221.48/221.67  |- mesh__dateEstablished mesh__D033101 2003-01-01
% 221.48/221.67  |- mesh__historyNote mesh__D033101
% 221.48/221.67       2003; for VOLUNTARY EUTHANASIA use EUTHANASIA 1978-2002   
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D033101 2003A
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D033101 2005
% 221.48/221.67  |- mesh__recordMaintainer mesh__D033101 jls
% 221.48/221.67  |- skos__altLabel mesh__D033101 Euthanasia, Voluntary
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D033101 2004
% 221.48/221.67  |- mesh__dateCreated mesh__D033101 2002-07-03
% 221.48/221.67  |- skos__broader mesh__D005410smesh__D002849
% 221.48/221.67  |- mesh__dateCreated mesh__D005410 1974-11-11
% 221.48/221.67  |- skos__hiddenLabel mesh__D005410 Ionization, Flame
% 221.48/221.67  |- mesh__historyNote mesh__D005410
% 221.48/221.67       91%28%75%29%; was see under CHROMATOGRAPHY, GAS 1975-90   
% 221.48/221.67  |- rdf__type mesh__D005410sskos__Concept
% 221.48/221.67  |- mesh__dateEstablished mesh__D005410 1991-01-01
% 221.48/221.67  |- skos__annotation mesh__D005410 a type of gas chromatogr; NIM   
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D005410 2004
% 221.48/221.67  |- mesh__recordAuthorizer mesh__D005410 sjn
% 221.48/221.67  |- mesh__dateRevised mesh__D005410 2002-07-03
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D005410 2006
% 221.48/221.67  |- skos__scopeNote mesh__D005410
% 221.48/221.67       Pyrolysis of organic compounds at the temperature of a hydrogen-air flame to produce ionic intermediates which can be collected and the resulting ion current measured by gas chromatography.%A%    
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D005410 2003
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D005410 2005
% 221.48/221.67  |- mesh__recordOriginator mesh__D005410 NLM
% 221.48/221.67  |- skos__hiddenLabel mesh__D005410 Ionizations, Flame
% 221.48/221.67  |- mesh__publicMeSHNote mesh__D005410
% 221.48/221.67       91; was see under CHROMATOGRAPHY, GAS 1975-90   
% 221.48/221.67  |- skos__prefLabel mesh__D005410 Flame Ionization
% 221.48/221.67  |- skos__hiddenLabel mesh__D005410 Flame Ionizations
% 221.48/221.67  |- mesh__recordMaintainer mesh__D005410 lkt
% 221.48/221.67  |- skos__related mesh__D052066smesh__D050576
% 221.48/221.67  |- skos__hiddenLabel mesh__D052066
% 221.48/221.67       Fusion Protein, N-Ethylmaleimide-Sensitive
% 221.48/221.67  |- skos__hiddenLabel mesh__D052066 Protein, N-Ethylmaleimide-Sensitive
% 221.48/221.67  |- skos__hiddenLabel mesh__D052066 ATPase, N-Ethylmaleimide-Sensitive
% 221.48/221.67  |- skos__hiddenLabel mesh__D052066
% 221.48/221.67       N Ethylmaleimide Sensitive Fusion Protein
% 221.48/221.67  |- mesh__recordMaintainer mesh__D052066 nns
% 221.48/221.67  |- skos__hiddenLabel mesh__D052066 N Ethylmaleimide Sensitive ATPase
% 221.48/221.67  |- rdf__type mesh__D052066sskos__Concept
% 221.48/221.67  |- skos__hiddenLabel mesh__D052066
% 221.48/221.67       Protein, N-Ethylmaleimide-Sensitive Fusion
% 221.48/221.67  |- skos__altLabel mesh__D052066 N-Ethylmaleimide-Sensitive Factors
% 221.48/221.67  |- mesh__publicMeSHNote mesh__D052066 2006   
% 221.48/221.67  |- skos__hiddenLabel mesh__D052066 Proteins, NEM-Sensitive Fusion
% 221.48/221.67  |- skos__altLabel mesh__D052066 N-Ethylmaleimide-Sensitive ATPase
% 221.48/221.67  |- skos__scopeNote mesh__D052066
% 221.48/221.67       ATPases that are members of the AAA protein superfamily %28%ATPase family Associated with various cellular Activities%29%. The NSFs functions, acting in conjunction with SOLUBLE NSF ATTACHMENT PROTEINS %28%i.e. SNAPs, which have no relation to SNAP 25%29%, are to dissociate SNARE complexes.%A%    
% 221.48/221.67  |- skos__altLabel mesh__D052066 N-Ethylmaleimide-Sensitive Fusion Protein
% 221.48/221.67  |- skos__prefLabel mesh__D052066 N-Ethylmaleimide-Sensitive Proteins
% 221.48/221.67  |- skos__broader mesh__D052066smesh__D000251
% 221.48/221.67  |- skos__hiddenLabel mesh__D052066 N Ethylmaleimide Sensitive Protein
% 221.48/221.67  |- skos__hiddenLabel mesh__D052066 Fusion Proteins, NEM-Sensitive
% 221.48/221.67  |- skos__altLabel mesh__D052066 NEM-Sensitive Fusion Proteins
% 221.48/221.67  |- skos__hiddenLabel mesh__D052066 N Ethylmaleimide Sensitive Factors
% 221.48/221.67  |- skos__hiddenLabel mesh__D052066 N Ethylmaleimide Sensitive Factor
% 221.48/221.67  |- skos__hiddenLabel mesh__D052066 Proteins, N-Ethylmaleimide-Sensitive
% 221.48/221.67  |- skos__hiddenLabel mesh__D052066 NEM Sensitive Fusion Proteins
% 221.48/221.67  |- skos__hiddenLabel mesh__D052066 N Ethylmaleimide Sensitive Proteins
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D052066 2006
% 221.48/221.67  |- skos__hiddenLabel mesh__D052066 Factors, N-Ethylmaleimide-Sensitive
% 221.48/221.67  |- skos__hiddenLabel mesh__D052066 ATPase, NSF
% 221.48/221.67  |- mesh__recordOriginator mesh__D052066 nns
% 221.48/221.67  |- skos__altLabel mesh__D052066 N-Ethylmaleimide-Sensitive Protein
% 221.48/221.67  |- mesh__dateEstablished mesh__D052066 2006-01-01
% 221.48/221.67  |- skos__hiddenLabel mesh__D052066 Factor, N-Ethylmaleimide-Sensitive
% 221.48/221.67  |- mesh__historyNote mesh__D052066 2006   
% 221.48/221.67  |- mesh__recordAuthorizer mesh__D052066 sjn
% 221.48/221.67  |- mesh__dateCreated mesh__D052066 2005-06-30
% 221.48/221.67  |- skos__related mesh__D052066smesh__D008561
% 221.48/221.67  |- skos__altLabel mesh__D052066 N-Ethylmaleimide-Sensitive Factor
% 221.48/221.67  |- skos__prefLabel mesh__D046029 Coyotes
% 221.48/221.67  |- mesh__publicMeSHNote mesh__D046029 2005; see CARNIVORA 1998-2004   
% 221.48/221.67  |- skos__broader mesh__D046029smesh__D046028
% 221.48/221.67  |- skos__hiddenLabel mesh__D046029 Coyote
% 221.48/221.67  |- mesh__dateCreated mesh__D046029 2004-07-07
% 221.48/221.67  |- skos__altLabel mesh__D046029 Canis latrans
% 221.48/221.67  |- mesh__recordOriginator mesh__D046029 ags
% 221.48/221.67  |- skos__historyNote mesh__D046029 Carnivora %28%1966-2004%29%
% 221.48/221.67  |- mesh__recordAuthorizer mesh__D046029 sjn
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D046029 2006
% 221.48/221.67  |- rdf__type mesh__D046029sskos__Concept
% 221.48/221.67  |- mesh__recordMaintainer mesh__D046029 ags
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D046029 2005
% 221.48/221.67  |- skos__scopeNote mesh__D046029
% 221.48/221.67       The species Canis latrans in the family CANIDAE, a smaller relative of WOLVES. It is found in the Western hemisphere from Costa Rica to Alaska.%A%    
% 221.48/221.67  |- mesh__dateEstablished mesh__D046029 2005-01-01
% 221.48/221.67  |- mesh__historyNote mesh__D046029 2005; use CARNIVORA 1998-2004   
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D010355 2002
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D010355 1995
% 221.48/221.67  |- skos__hiddenLabel mesh__D010355 Systems, Patient Identification
% 221.48/221.67  |- mesh__recordAuthorizer mesh__D010355 PLS
% 221.48/221.67  |- skos__hiddenLabel mesh__D010355 Identification System, Patient
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D010355 2006
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D010355 1999
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D010355 2001
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D010355 1994
% 221.48/221.67  |- skos__broader mesh__D010355smesh__D009934
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D010355 2005
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D010355 1998
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D010355 2000
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D010355 1993
% 221.48/221.67  |- skos__scopeNote mesh__D010355
% 221.48/221.67       Organized procedures for establishing patient identity, including use of bracelets, etc.%A%    
% 221.48/221.67  |- rdf__type mesh__D010355sskos__Concept
% 221.48/221.67  |- skos__annotation mesh__D010355 DF: PATIENT ID SYSTEMS   
% 221.48/221.67  |- skos__hiddenLabel mesh__D010355 System, Patient Identification
% 221.48/221.67  |- skos__hiddenLabel mesh__D010355 Patient Identification System
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D010355 2004
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D010355 1997
% 221.48/221.67  |- mesh__dateCreated mesh__D010355 1977-05-12
% 221.48/221.67  |- mesh__recordOriginator mesh__D010355 EC
% 221.48/221.67  |- mesh__recordMaintainer mesh__D010355 TGC
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D010355 2003
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D010355 1996
% 221.48/221.67  |- mesh__dateEstablished mesh__D010355 1978-01-01
% 221.48/221.67  |- mesh__historyNote mesh__D010355 78   
% 221.48/221.67  |- mesh__publicMeSHNote mesh__D010355 78   
% 221.48/221.67  |- mesh__dateRevised mesh__D010355 1992-05-15
% 221.48/221.67  |- skos__hiddenLabel mesh__D010355 Identification Systems, Patient
% 221.48/221.67  |- skos__prefLabel mesh__D010355 Patient Identification Systems
% 221.48/221.67  |- mesh__recordMaintainer mesh__D004318 ssb
% 221.48/221.67  |- skos__hiddenLabel mesh__D004318 BU 3839T
% 221.48/221.67  |- skos__hiddenLabel mesh__D004318 BMY 28689
% 221.48/221.67  |- skos__altLabel mesh__D004318 alpha-6-Deoxyoxytetracycline
% 221.48/221.67  |- skos__broader mesh__D004318smesh__D013754
% 221.48/221.67  |- skos__scopeNote mesh__D004318
% 221.48/221.67       A synthetic TETRACYCLINE derivative with similar antimicrobial activity. Animal studies suggest that it may cause less tooth staining than other tetracyclines. It is used in some areas for the treatment of chloroquine-resistant falciparum malaria %28%MALARIA, FALCIPARUM%29%.%A%    
% 221.48/221.67  |- skos__historyNote mesh__D004318 Oxytetracycline %28%1966-1970%29%
% 221.48/221.67  |- mesh__dateRevised mesh__D004318 2004-07-07
% 221.48/221.67  |- skos__hiddenLabel mesh__D004318 Calcium, Doxycycline
% 221.48/221.67  |- mesh__recordAuthorizer mesh__D004318 sjn
% 221.48/221.67  |- mesh__recordOriginator mesh__D004318 NLM
% 221.48/221.67  |- skos__prefLabel mesh__D004318 Doxycycline
% 221.48/221.67  |- skos__hiddenLabel mesh__D004318 Doxycycline Monohydrochloride, 6 epimer
% 221.48/221.67  |- skos__hiddenLabel mesh__D004318 alpha 6 Deoxyoxytetracycline
% 221.48/221.67  |- mesh__dateCreated mesh__D004318 1999-01-01
% 221.48/221.67  |- skos__hiddenLabel mesh__D004318 Monohydrate, Doxycycline
% 221.48/221.67  |- skos__hiddenLabel mesh__D004318 Dihydrate Doxycycline Monohydrochloride
% 221.48/221.67  |- skos__hiddenLabel mesh__D004318 Doxycycline Chinoin
% 221.48/221.67  |- mesh__onlineNote mesh__D004318
% 221.48/221.67       use DOXYCYCLINE %28%NM%29% to search HYDRAMYCIN 1991-92   
% 221.48/221.67  |- mesh__dateEstablished mesh__D004318 1973-01-01
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D004318 2006
% 221.48/221.67  |- mesh__historyNote mesh__D004318 73; HYDRAMYCIN was NM 1991-92   
% 221.48/221.67  |- skos__hiddenLabel mesh__D004318 BMY28689
% 221.48/221.67  |- rdf__type mesh__D004318sskos__Concept
% 221.48/221.67  |- skos__hiddenLabel mesh__D004318 BU3839T
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D004318 2005
% 221.48/221.67  |- mesh__publicMeSHNote mesh__D004318
% 221.48/221.67       73; HYDRAMYCIN was indexed under ANTHRAQUINONES 1991-92   
% 221.48/221.67  |- skos__hiddenLabel mesh__D004318 Novum, Vibramycin
% 221.48/221.67  |- skos__hiddenLabel mesh__D004318 Monohydrochloride, Dihydrate Doxycycline
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D015040 2005
% 221.48/221.67  |- rdf__type mesh__D015040sskos__Concept
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D015040 2004
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D015040 2002
% 221.48/221.67  |- skos__scopeNote mesh__D015040
% 221.48/221.67       Zirconium. A rather rare metallic element, atomic number 40, atomic weight 91.22, symbol Zr. %28%From Dorland, 28th ed%29%%A%    
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D015040 2003
% 221.48/221.67  |- skos__prefLabel mesh__D015040 Zirconium
% 221.48/221.67  |- skos__broader mesh__D015040smesh__D028561
% 221.48/221.67  |- mesh__dateRevised mesh__D015040 2001-07-25
% 221.48/221.67  |- mesh__recordAuthorizer mesh__D015040 sjn
% 221.48/221.67  |- skos__broader mesh__D015040smesh__D019216
% 221.48/221.67  |- mesh__recordOriginator mesh__D015040 NLM
% 221.48/221.67  |- skos__annotation mesh__D015040
% 221.48/221.67       Zr-90; Zr-91, 92, 94, 96 = ZIRCONIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Zr-81-89, 93, 95, 97, 98 = ZIRCONIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D015040 2006
% 221.48/221.67  |- mesh__recordMaintainer mesh__D015040 jmp
% 221.48/221.67  |- mesh__dateCreated mesh__D015040 1999-01-01
% 221.48/221.67  |- skos__annotation mesh__D009801
% 221.48/221.67       /innerv = probably OCULOMOTOR NERVE but consider also ABDUCENS NERVE %26% TROCHLEAR NERVE; paralysis = OCULOMOTOR PARALYSIS see OPHTHALMOPLEGIA; /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D009801 2006
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D009801 2003
% 221.48/221.67  |- mesh__dateRevised mesh__D009801 2001-07-25
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D009801 2004
% 221.48/221.67  |- rdf__type mesh__D009801sskos__Concept
% 221.48/221.67  |- skos__hiddenLabel mesh__D009801 Muscle, Oculomotor
% 221.48/221.67  |- mesh__recordAuthorizer mesh__D009801 sjn
% 221.48/221.67  |- skos__scopeNote mesh__D009801
% 221.48/221.67       The muscles that move the eye. Included in this group are the medial rectus, lateral rectus, superior rectus, inferior rectus, inferior oblique, superior oblique, musculus orbitalis, and levator palpebrae superioris.%A%    
% 221.48/221.67  |- mesh__recordOriginator mesh__D009801 NLM
% 221.48/221.67  |- skos__broader mesh__D009801smesh__D018482
% 221.48/221.67  |- skos__hiddenLabel mesh__D009801 Muscles, Oculomotor
% 221.48/221.67  |- skos__hiddenLabel mesh__D009801 Oculomotor Muscle
% 221.48/221.67  |- skos__prefLabel mesh__D009801 Oculomotor Muscles
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D009801 2005
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D009801 2002
% 221.48/221.67  |- mesh__recordMaintainer mesh__D009801 nns
% 221.48/221.67  |- skos__broader mesh__D009801smesh__D005123
% 221.48/221.67  |- mesh__dateCreated mesh__D009801 1999-01-01
% 221.48/221.67  |- mesh__publicMeSHNote mesh__D001020
% 221.48/221.67       91; was see under CARDIOMYOPATHY, HYPERTROPHIC 1986-90; was see under IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1967-85%A%  
% 221.48/221.67  |- mesh__recordMaintainer mesh__D001020 nns
% 221.48/221.67  |- mesh__recordAuthorizer mesh__D001020 sjn
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D001020 2002
% 221.48/221.67  |- mesh__historyNote mesh__D001020
% 221.48/221.67       91%28%75%29%; was see under CARDIOMYOPATHY, HYPERTROPHIC 1986-90; was see under IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1967-85%A%  
% 221.48/221.67  |- mesh__dateEstablished mesh__D001020 1991-01-01
% 221.48/221.67  |- skos__hiddenLabel mesh__D001020 Stenoses, Subvalvular Aortic
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D001020 2001
% 221.48/221.67  |- skos__broader mesh__D001020smesh__D001024
% 221.48/221.67  |- skos__hiddenLabel mesh__D001020 Stenosis, Aortic Subvalvular
% 221.48/221.67  |- skos__hiddenLabel mesh__D001020 Stenoses, Aortic Subvalvular
% 221.48/221.67  |- skos__hiddenLabel mesh__D001020 Subvalvular Stenoses, Aortic
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D001020 2004
% 221.48/221.67  |- skos__hiddenLabel mesh__D001020 Subvalvular Stenosis, Aortic
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D001020 2006
% 221.48/221.67  |- skos__prefLabel mesh__D001020 Aortic Stenosis, Subvalvular
% 221.48/221.67  |- skos__hiddenLabel mesh__D001020 Subvalvular Aortic Stenoses
% 221.48/221.67  |- skos__hiddenLabel mesh__D001020 Aortic Subvalvular Stenoses
% 221.48/221.67  |- mesh__dateCreated mesh__D001020 1999-01-01
% 221.48/221.67  |- skos__hiddenLabel mesh__D001020 Stenosis, Subvalvular Aortic
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D001020 2003
% 221.48/221.67  |- mesh__recordOriginator mesh__D001020 NLM
% 221.48/221.67  |- mesh__dateRevised mesh__D001020 2000-06-21
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D001020 2005
% 221.48/221.67  |- skos__altLabel mesh__D001020 Aortic Subvalvular Stenosis
% 221.48/221.67  |- skos__hiddenLabel mesh__D001020 Aortic Stenoses, Subvalvular
% 221.48/221.67  |- mesh__onlineNote mesh__D001020
% 221.48/221.67       search CARDIOMYOPATHY, HYPERTROPHIC 1967-74   
% 221.48/221.67  |- rdf__type mesh__D001020sskos__Concept
% 221.48/221.67  |- skos__scopeNote mesh__D001020
% 221.48/221.67       A narrowing of the aorta in the region below the aortic valve.%A%    
% 221.48/221.67  |- skos__altLabel mesh__D001020 Subvalvular Aortic Stenosis
% 221.48/221.67  |- mesh__recordOriginator mesh__D020783 adp
% 221.48/221.67  |- skos__scopeNote mesh__D020783
% 221.48/221.67       The smallest member of the MATRIX METALLOPROTEINASES. It plays a role in tumor progression. EC 3.4.24.23.%A%    
% 221.48/221.67  |- skos__hiddenLabel mesh__D020783 PUMP 1
% 221.48/221.67  |- mesh__recordMaintainer mesh__D020783 jmp
% 221.48/221.67  |- mesh__dateCreated mesh__D020783 1999-11-03
% 221.48/221.67  |- mesh__publicMeSHNote mesh__D020783
% 221.48/221.67       2000; MATRILYSIN was indexed under METALLOPROTEINASES 1992-1999%A%  
% 221.48/221.67  |- skos__prefLabel mesh__D020783 Matrilysin
% 221.48/221.67  |- skos__altLabel mesh__D020783 Matrix Metalloproteinase-7
% 221.48/221.67  |- skos__hiddenLabel mesh__D020783 Matrix Metalloproteinase 7
% 221.48/221.67  |- rdf__type mesh__D020783sskos__Concept
% 221.48/221.67  |- skos__historyNote mesh__D020783 Metalloendopeptidases %28%1992-1999%29%
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D020783 2006
% 221.48/221.67  |- skos__hiddenLabel mesh__D020783 Metalloproteinase-7, Matrix
% 221.48/221.67  |- skos__altLabel mesh__D020783 PUMP-1
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D020783 2004
% 221.48/221.67  |- skos__altLabel mesh__D020783 MMP-7
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D020783 2005
% 221.48/221.67  |- mesh__dateRevised mesh__D020783 2003-07-09
% 221.48/221.67  |- mesh__recordAuthorizer mesh__D020783 sjn
% 221.48/221.67  |- mesh__dateEstablished mesh__D020783 2000-01-01
% 221.48/221.67  |- mesh__historyNote mesh__D020783
% 221.48/221.67       2000; use MATRILYSIN %28%NM%29% 1992-1999   
% 221.48/221.67  |- skos__broader mesh__D020783smesh__D020782
% 221.48/221.67  |- skos__hiddenLabel mesh__D020783 MMP 7
% 221.48/221.67  |- skos__altLabel mesh__D020783 Matrin
% 221.48/221.67  |- mesh__dateRevised mesh__D014746 2004-07-07
% 221.48/221.67  |- skos__scopeNote mesh__D014746
% 221.48/221.67       An intermediate filament protein found in most differentiating cells, in cells grown in tissue culture, and in certain fully differentiated cells. Its insolubility suggests that it serves a structural function in the cytoplasm. MW 52,000.%A%    
% 221.48/221.67  |- skos__annotation mesh__D014746
% 221.48/221.67       an intermediate filament protein; /biosyn /physiol permitted%A%  
% 221.48/221.67  |- skos__historyNote mesh__D014746 Muscle Proteins %28%1966-1982%29%
% 221.48/221.67  |- mesh__recordOriginator mesh__D014746 RLS
% 221.48/221.67  |- mesh__publicMeSHNote mesh__D014746 85   
% 221.48/221.67  |- skos__prefLabel mesh__D014746 Vimentin
% 221.48/221.67  |- mesh__dateCreated mesh__D014746 1984-04-06
% 221.48/221.67  |- skos__historyNote mesh__D014746
% 221.48/221.67       Intermediate Filament Proteins %28%1983-1984%29%
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D014746 2006
% 221.48/221.67  |- mesh__historyNote mesh__D014746 85   
% 221.48/221.67  |- mesh__dateEstablished mesh__D014746 1985-01-01
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D014746 2005
% 221.48/221.67  |- mesh__recordAuthorizer mesh__D014746 sjn
% 221.48/221.67  |- skos__broader mesh__D014746smesh__D007381
% 221.48/221.67  |- mesh__recordMaintainer mesh__D014746 jmp
% 221.48/221.67  |- rdf__type mesh__D014746sskos__Concept
% 221.48/221.67  |- rdf__type mesh__D008709sskos__Concept
% 221.48/221.67  |- skos__broader mesh__D008709smesh__D011073
% 221.48/221.67  |- skos__hiddenLabel mesh__D008709 Methenamine, Silver
% 221.48/221.67  |- skos__broader mesh__D008709smesh__D000218
% 221.48/221.67  |- skos__altLabel mesh__D008709 Hexamethylenetetramine
% 221.48/221.67  |- mesh__recordOriginator mesh__D008709 NLM
% 221.48/221.67  |- skos__altLabel mesh__D008709 Silver Methenamine
% 221.48/221.67  |- skos__altLabel mesh__D008709 Hexamine
% 221.48/221.67  |- mesh__recordAuthorizer mesh__D008709 sjn
% 221.48/221.67  |- mesh__dateRevised mesh__D008709 2004-07-07
% 221.48/221.67  |- skos__prefLabel mesh__D008709 Methenamine
% 221.48/221.67  |- skos__scopeNote mesh__D008709
% 221.48/221.67       An anti-infective agent most commonly used in the treatment of urinary tract infections. Its anti-infective action derives from the slow release of formaldehyde by hydrolysis at acidic pH. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p173%29%%A%    
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D008709 2005
% 221.48/221.67  |- skos__altLabel mesh__D008709 Methenamine Silver
% 221.48/221.67  |- skos__hiddenLabel mesh__D008709 Silver, Methenamine
% 221.48/221.67  |- mesh__dateCreated mesh__D008709 1999-01-01
% 221.48/221.67  |- skos__hiddenLabel mesh__D008709 Silver, Hexamine
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D008709 2006
% 221.48/221.67  |- mesh__recordMaintainer mesh__D008709 ssb
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D000726 2006
% 221.48/221.67  |- skos__historyNote mesh__D000726 specific androgen %28%1966-1977%29%
% 221.48/221.67  |- skos__broader mesh__D000726smesh__D006727
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D000726 2005
% 221.48/221.67  |- skos__annotation mesh__D000726 DF: ANDROGEN ANTAG   
% 221.48/221.67  |- skos__scopeNote mesh__D000726
% 221.48/221.67       Compounds which inhibit or antagonize the biosynthesis or actions of androgens.%A%    
% 221.48/221.67  |- mesh__dateRevised mesh__D000726 2003-07-09
% 221.48/221.67  |- mesh__recordMaintainer mesh__D000726 ssb
% 221.48/221.67  |- mesh__publicMeSHNote mesh__D000726 78   
% 221.48/221.67  |- mesh__recordAuthorizer mesh__D000726 sjn
% 221.48/221.67  |- mesh__recordOriginator mesh__D000726 RLS
% 221.48/221.67  |- rdf__type mesh__D000726sskos__Concept
% 221.48/221.67  |- skos__prefLabel mesh__D000726 Androgen Antagonists
% 221.48/221.67  |- skos__hiddenLabel mesh__D000726 Antagonists, Androgen
% 221.48/221.67  |- skos__altLabel mesh__D000726 Antiandrogens
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D000726 2004
% 221.48/221.67  |- mesh__historyNote mesh__D000726 78   
% 221.48/221.67  |- mesh__dateCreated mesh__D000726 1977-05-17
% 221.48/221.67  |- mesh__dateEstablished mesh__D000726 1978-01-01
% 221.48/221.67  |- skos__historyNote mesh__D000726 Androgens %28%1966-1977%29%
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D019431 2005
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D019431 2001
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D019431 2004
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D019431 2000
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D019431 1999
% 221.48/221.67  |- skos__annotation mesh__D019431 an island in the West Indies   
% 221.48/221.67  |- skos__prefLabel mesh__D019431 Saint Lucia
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D019431 2003
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D019431 1998
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D019431 1997
% 221.48/221.67  |- skos__historyNote mesh__D019431 West Indies %28%1966-1996%29%
% 221.48/221.67  |- skos__altLabel mesh__D019431 St. Lucia
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D019431 2006
% 221.48/221.67  |- mesh__dateCreated mesh__D019431 1996-06-10
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D019431 2002
% 221.48/221.67  |- skos__scopeNote mesh__D019431
% 221.48/221.67       An independent state in the West Indies. Its capital is Castries. It was probably discovered by Columbus in 1502 and first settled by the English in 1605. Contended for by the French and English in the 17th century, it was regarded as neutral in 1748 but changed hands many times in the wars of the 19th century. It became a self-governing state in association with Great Britain in 1967 and achieved independence in 1979. Columbus named it for the day on which he discovered it, the feast of St. Lucy, a Sicilian virgin martyr. %28%From Webster%27%s New Geographical Dictionary, 1988, p1051 %26% Room, Brewer%27%s Dictionary of Names, 1992, p477%29%%A%    
% 221.48/221.67  |- rdf__type mesh__D019431sskos__Concept
% 221.48/221.67  |- skos__broader mesh__D019431smesh__D014900
% 221.48/221.67  |- mesh__dateEstablished mesh__D019431 1997-01-01
% 221.48/221.67  |- mesh__historyNote mesh__D019431 97   
% 221.48/221.67  |- skos__hiddenLabel mesh__D005411 Retardants, Fire
% 221.48/221.67  |- mesh__dateCreated mesh__D005411 1977-04-22
% 221.48/221.67  |- mesh__publicMeSHNote mesh__D005411 78   
% 221.48/221.67  |- mesh__recordOriginator mesh__D005411 SH
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D005411 2004
% 221.48/221.67  |- skos__prefLabel mesh__D005411 Flame Retardants
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D005411 2006
% 221.48/221.67  |- skos__hiddenLabel mesh__D005411 Retardants, Flame
% 221.48/221.67  |- skos__hiddenLabel mesh__D005411 Agents, Fireproofing
% 221.48/221.67  |- skos__historyNote mesh__D005411 Fires %28%1966-1977%29%
% 221.48/221.67  |- mesh__activeMeSHYear mesh__D005411 2005
% 221.48/221.67  |- mesh__recordMaintainer mesh__D005411 ssb
% 221.48/221.67  |- skos__broader mesh__D005411smesh__D020313
% 221.48/221.67  |- mesh__recordAuthorizer mesh__D005411 sjn
% 221.48/221.67  |- skos__scopeNote mesh__D005411
% 221.48/221.67       Materials applied to fabrics, bedding, furniture, plastics, etc. to retard their burning; many may leach out and cause allergies or other harm.%A%    
% 221.48/221.67  |- skos__historyNote mesh__D005411 specific substance %28%1966-1977%29%
% 221.48/221.67  |- mesh__dateRevised mesh__D005411 2003-07-09
% 221.48/221.67  |- mesh__historyNote mesh__D005411 78; was in Cat D %26% J 1978-82   
% 221.48/221.67  |- skos__altLabel mesh__D005411 Fire Retardants
% 221.48/221.67  |- mesh__dateEstablished mesh__D005411 1978-01-01
% 221.48/221.67  |- rdf__type mesh__D005411sskos__Concept
% 221.48/221.67  |- rdf__type mesh__D052067sskos__Concept
% 221.48/221.67  |- skos__hiddenLabel mesh__D052067 beta SNAP
% 221.48/221.67  |- skos__hiddenLabel mesh__D052067
% 221.48/221.67       Soluble N Ethylmaleimide Sensitive Fusion Attachment Protein
% 221.48/221.67  |- mesh__recordMaintainer mesh__D052067 nns
% 221.48/221.67  |- skos__hiddenLabel mesh__D052067 Attachment Protein, NSF
% 221.48/221.67  |- mesh__dateCreated mesh__D052067 2005-06-30
% 221.48/221.68  |- skos__altLabel mesh__D052067 Soluble NSF Attachment Protein
% 221.48/221.68  |- skos__scopeNote mesh__D052067
% 221.48/221.68       SNARE binding proteins that facilitate the ATP hydrolysis-driven dissociation of the SNARE complex. They are required for the binding of  N-ETHYLMALEIMIDE-SENSITIVE PROTEIN %28%NSF%29% to the SNARE complex which also stimulates the ATPASE activity of NSF. They are unrelated structurally to SNAP-25 PROTEIN.%A%    
% 221.48/221.68  |- mesh__publicMeSHNote mesh__D052067 2006   
% 221.48/221.68  |- skos__hiddenLabel mesh__D052067
% 221.48/221.68       Soluble N Ethylmaleimide Sensitive Factor Attachment Protein
% 221.48/221.68  |- skos__broader mesh__D052067smesh__D033921
% 221.48/221.68  |- skos__altLabel mesh__D052067 NSF Attachment Protein
% 221.48/221.68  |- skos__hiddenLabel mesh__D052067 alpha SNAP
% 221.48/221.68  |- skos__hiddenLabel mesh__D052067 Protein, NSF Attachment
% 221.48/221.68  |- skos__altLabel mesh__D052067
% 221.48/221.68       Soluble N-Ethylmaleimide-Sensitive Fusion Attachment Protein
% 221.48/221.68  |- skos__hiddenLabel mesh__D052067 gamma SNAP
% 221.48/221.68  |- mesh__recordOriginator mesh__D052067 nns
% 221.48/221.68  |- skos__prefLabel mesh__D052067
% 221.48/221.68       Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins
% 221.48/221.68  |- mesh__recordAuthorizer mesh__D052067 sjn
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D052067 2006
% 221.48/221.68  |- mesh__historyNote mesh__D052067 2006   
% 221.48/221.68  |- mesh__dateEstablished mesh__D052067 2006-01-01
% 221.48/221.68  |- skos__hiddenLabel mesh__D052067
% 221.48/221.68       Soluble N Ethylmaleimide Sensitive Factor Attachment Proteins
% 221.48/221.68  |- skos__altLabel mesh__D052067
% 221.48/221.68       Soluble N-Ethylmaleimide-Sensitive Factor Attachment Protein
% 221.48/221.68  |- skos__hiddenLabel mesh__D046828 Yellow head virus
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D046828 2005
% 221.48/221.68  |- mesh__dateCreated mesh__D046828 2004-07-07
% 221.48/221.68  |- skos__scopeNote mesh__D046828
% 221.48/221.68       A family of rod-shaped viruses, in the order NIDOVIRALES. It includes one genus: Okavirus.%A%    
% 221.48/221.68  |- mesh__dateEstablished mesh__D046828 2005-01-01
% 221.48/221.68  |- mesh__publicMeSHNote mesh__D046828 2005   
% 221.48/221.68  |- skos__hiddenLabel mesh__D046828 Okaviruses
% 221.48/221.68  |- skos__prefLabel mesh__D046828 Roniviridae
% 221.48/221.68  |- mesh__recordAuthorizer mesh__D046828 sjn
% 221.48/221.68  |- skos__hiddenLabel mesh__D046828 Gill-associated viruses
% 221.48/221.68  |- mesh__recordOriginator mesh__D046828 ags
% 221.48/221.68  |- skos__annotation mesh__D046828
% 221.48/221.68       infection: coord IM with RNA VIRUS INFECTIONS %28%IM%29%   
% 221.48/221.68  |- mesh__recordMaintainer mesh__D046828 ags
% 221.48/221.68  |- skos__historyNote mesh__D046828 Nidovirales %28%2003-2004%29%
% 221.48/221.68  |- skos__hiddenLabel mesh__D046828 Yellow-head viruses
% 221.48/221.68  |- skos__broader mesh__D046828smesh__D028381
% 221.48/221.68  |- mesh__historyNote mesh__D046828 2005   
% 221.48/221.68  |- rdf__type mesh__D046828sskos__Concept
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D046828 2006
% 221.48/221.68  |- skos__hiddenLabel mesh__D046828 Gill associated virus
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D010356 2005
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D010356 1998
% 221.48/221.68  |- skos__altLabel mesh__D010356 Isolation, Patient
% 221.48/221.68  |- skos__prefLabel mesh__D010356 Patient Isolation
% 221.48/221.68  |- skos__broader mesh__D010356smesh__D013812
% 221.48/221.68  |- skos__scopeNote mesh__D010356
% 221.48/221.68       The segregation of patients with communicable or other diseases for a specified time. Isolation may be strict, in which movement and social contacts are limited; modified, where an effort to control specified aspects of care is made in order to prevent cross infection; or reverse, where the patient is secluded in a controlled or germ-free environment in order to protect him or her from cross infection.%A%    
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D010356 2002
% 221.48/221.68  |- rdf__type mesh__D010356sskos__Concept
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D010356 2004
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D010356 1997
% 221.48/221.68  |- mesh__publicMeSHNote mesh__D010356 77   
% 221.48/221.68  |- mesh__recordOriginator mesh__D010356 SMH
% 221.48/221.68  |- mesh__recordAuthorizer mesh__D010356 PLS
% 221.48/221.68  |- skos__historyNote mesh__D010356 Patient Isolators %28%1966-1976%29%
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D010356 2001
% 221.48/221.68  |- mesh__dateRevised mesh__D010356 1996-06-10
% 221.48/221.68  |- mesh__recordMaintainer mesh__D010356 TGC
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D010356 2003
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D010356 2000
% 221.48/221.68  |- mesh__dateEstablished mesh__D010356 1977-01-01
% 221.48/221.68  |- skos__broader mesh__D010356smesh__D017053
% 221.48/221.68  |- skos__historyNote mesh__D010356 Cross Infection %28%1966-1976%29%
% 221.48/221.68  |- skos__annotation mesh__D010356
% 221.48/221.68       do not confuse with PATIENT ISOLATORS; DF: PATIENT ISOL   
% 221.48/221.68  |- skos__historyNote mesh__D010356
% 221.48/221.68       Bacterial Infections/prevention %26% control %28%1972-1976%29%
% 221.48/221.68  |- mesh__dateCreated mesh__D010356 1976-05-19
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D010356 2006
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D010356 1999
% 221.48/221.68  |- mesh__historyNote mesh__D010356 77   
% 221.48/221.68  |- skos__broader mesh__D029061smesh__D019684
% 221.48/221.68  |- skos__annotation mesh__D029061
% 221.48/221.68       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.48/221.68  |- skos__altLabel mesh__D029061 Yingzhao
% 221.48/221.68  |- skos__prefLabel mesh__D029061 Annonaceae
% 221.48/221.68  |- skos__scopeNote mesh__D029061
% 221.48/221.68       The custard-apple plant family of the order Magnoliales, subclass Magnoliidae, class Magnoliopsida. Some members provide large pulpy fruits and commercial timber. Leaves and wood are often fragrant. Leaves are simple, with smooth margins, and alternately arranged in two rows along the stems.%A%    
% 221.48/221.68  |- mesh__dateEstablished mesh__D029061 2002-01-01
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D029061 2005
% 221.48/221.68  |- mesh__recordAuthorizer mesh__D029061 sjn
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D029061 2004
% 221.48/221.68  |- mesh__dateCreated mesh__D029061 2001-07-25
% 221.48/221.68  |- skos__altLabel mesh__D029061 Ylang-Ylang
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D029061 2006
% 221.48/221.68  |- mesh__recordMaintainer mesh__D029061 ssb
% 221.48/221.68  |- mesh__publicMeSHNote mesh__D029061 2002   
% 221.48/221.68  |- mesh__historyNote mesh__D029061 2002   
% 221.48/221.68  |- rdf__type mesh__D029061sskos__Concept
% 221.48/221.68  |- mesh__dateRevised mesh__D029061 2003-07-09
% 221.48/221.68  |- mesh__recordOriginator mesh__D029061 ssb
% 221.48/221.68  |- mesh__historyNote mesh__D004319
% 221.48/221.68       91%28%72%29%; was see under PYRIDINES 1972-90   
% 221.48/221.68  |- skos__prefLabel mesh__D004319 Doxylamine
% 221.48/221.68  |- mesh__recordMaintainer mesh__D004319 exl
% 221.48/221.68  |- skos__historyNote mesh__D004319 Pyridines %28%1972%29%
% 221.48/221.68  |- mesh__dateCreated mesh__D004319 1999-01-01
% 221.48/221.68  |- skos__scopeNote mesh__D004319
% 221.48/221.68       Histamine H1 antagonist with pronounced sedative properties. It is used in allergies and as an antitussive, antiemetic, and hypnotic. Doxylamine has also been administered in veterinary applications and was formerly used in PARKINSONISM.%A%    
% 221.48/221.68  |- skos__historyNote mesh__D004319 Antiparkinson Agents %28%1972%29%
% 221.48/221.68  |- skos__broader mesh__D004319smesh__D011725
% 221.48/221.68  |- mesh__dateRevised mesh__D004319 2005-06-30
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D004319 2006
% 221.48/221.68  |- rdf__type mesh__D004319sskos__Concept
% 221.48/221.68  |- mesh__recordAuthorizer mesh__D004319 sjn
% 221.48/221.68  |- mesh__recordOriginator mesh__D004319 NLM
% 221.48/221.68  |- mesh__dateEstablished mesh__D004319 1991-01-01
% 221.48/221.68  |- mesh__publicMeSHNote mesh__D004319
% 221.48/221.68       91; was see under PYRIDINES 1972-90   
% 221.48/221.68  |- skos__broader mesh__D015041smesh__D001381
% 221.48/221.68  |- rdf__type mesh__D015041sskos__Concept
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D015041 2004
% 221.48/221.68  |- mesh__dateRevised mesh__D015041 2003-07-09
% 221.48/221.68  |- mesh__dateEstablished mesh__D015041 1991-01-01
% 221.48/221.68  |- skos__altLabel mesh__D015041 Zolasepam
% 221.48/221.68  |- mesh__recordMaintainer mesh__D015041 ssb
% 221.48/221.68  |- skos__hiddenLabel mesh__D015041 CI 716
% 221.48/221.68  |- skos__scopeNote mesh__D015041
% 221.48/221.68       A pyrazolodiazepinone with pharmacological actions similar to ANTI-ANXIETY AGENTS. It is commonly used in combination with TILETAMINE to obtain immobilization and anesthesia in animals.%A%    
% 221.48/221.68  |- mesh__publicMeSHNote mesh__D015041 91; was see under AZEPINES 1977-90   
% 221.48/221.68  |- mesh__dateCreated mesh__D015041 1976-04-16
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D015041 2005
% 221.48/221.68  |- skos__prefLabel mesh__D015041 Zolazepam
% 221.48/221.68  |- mesh__recordOriginator mesh__D015041 SH
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D015041 2006
% 221.48/221.68  |- mesh__historyNote mesh__D015041
% 221.48/221.68       91%28%77%29%; was see under AZEPINES 1977-90   
% 221.48/221.68  |- mesh__recordAuthorizer mesh__D015041 sjn
% 221.48/221.68  |- skos__historyNote mesh__D015041 Pyrazoles %28%1974-1975%29%
% 221.48/221.68  |- skos__hiddenLabel mesh__D015041 CI716
% 221.48/221.68  |- skos__hiddenLabel mesh__D015041 Hydrochloride, Zolazepam
% 221.48/221.68  |- skos__historyNote mesh__D015041 Fluorobenzenes %28%1974-1975%29%
% 221.48/221.68  |- skos__historyNote mesh__D015041 Azepines %28%1973-1976%29%
% 221.48/221.68  |- skos__altLabel mesh__D009802 Third Cranial Nerve
% 221.48/221.68  |- mesh__recordOriginator mesh__D009802 NLM
% 221.48/221.68  |- skos__hiddenLabel mesh__D009802 Nerves, Oculomotor
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D009802 2000
% 221.48/221.68  |- skos__hiddenLabel mesh__D009802 Nerve, Oculomotor
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D009802 2004
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D009802 2006
% 221.48/221.68  |- skos__hiddenLabel mesh__D009802 Cranial Nerve IIIs
% 221.48/221.68  |- skos__hiddenLabel mesh__D009802 III, Cranial Nerve
% 221.48/221.68  |- skos__altLabel mesh__D009802 Cranial Nerve III
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D009802 2003
% 221.48/221.68  |- skos__broader mesh__D009802smesh__D003391
% 221.48/221.68  |- skos__scopeNote mesh__D009802
% 221.48/221.68       The 3d cranial nerve. The oculomotor nerve sends motor fibers to the levator muscles of the eyelid and to the superior rectus, inferior rectus, and inferior oblique muscles of the eye. It also sends parasympathetic efferents %28%via the ciliary ganglion%29% to the muscles controlling pupillary constriction and accommodation. The motor fibers originate in the oculomotor nuclei of the midbrain.%A%    
% 221.48/221.68  |- skos__hiddenLabel mesh__D009802 Oculomotor Nerves
% 221.48/221.68  |- skos__annotation mesh__D009802
% 221.48/221.68       neopl = OCULOMOTOR NERVE DISEASES %28%IM%29% + CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 221.48/221.68  |- skos__hiddenLabel mesh__D009802 Third Cranial Nerves
% 221.48/221.68  |- skos__prefLabel mesh__D009802 Oculomotor Nerve
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D009802 2005
% 221.48/221.68  |- skos__hiddenLabel mesh__D009802 IIIs, Cranial Nerve
% 221.48/221.68  |- skos__hiddenLabel mesh__D009802 Cranial Nerves, Third
% 221.48/221.68  |- rdf__type mesh__D009802sskos__Concept
% 221.48/221.68  |- skos__hiddenLabel mesh__D009802 Nerve, Third Cranial
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D009802 2002
% 221.48/221.68  |- skos__hiddenLabel mesh__D009802 Nerves, Third Cranial
% 221.48/221.68  |- skos__hiddenLabel mesh__D009802 Nerve III, Cranial
% 221.48/221.68  |- skos__hiddenLabel mesh__D009802 Cranial Nerve, Third
% 221.48/221.68  |- skos__hiddenLabel mesh__D009802 Nerve IIIs, Cranial
% 221.48/221.68  |- mesh__recordMaintainer mesh__D009802 ags
% 221.48/221.68  |- mesh__dateCreated mesh__D009802 1999-01-01
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D009802 2001
% 221.48/221.68  |- mesh__recordAuthorizer mesh__D009802 sjn
% 221.48/221.68  |- mesh__dateRevised mesh__D009802 1999-11-03
% 221.48/221.68  |- mesh__recordOriginator mesh__D009004 RLS
% 221.48/221.68  |- skos__hiddenLabel mesh__D009004 Proteins, Monosaccharide Transport
% 221.48/221.68  |- skos__hiddenLabel mesh__D009004 Transport-Inducing Protein, Glucose
% 221.48/221.68  |- mesh__dateRevised mesh__D009004 2005-06-30
% 221.48/221.68  |- mesh__dateEstablished mesh__D009004 1986-01-01
% 221.48/221.68  |- mesh__historyNote mesh__D009004 86   
% 221.48/221.68  |- skos__hiddenLabel mesh__D009004 4.5 Preactin, Band
% 221.48/221.68  |- mesh__publicMeSHNote mesh__D009004 86   
% 221.48/221.68  |- mesh__dateCreated mesh__D009004 1985-06-05
% 221.48/221.68  |- skos__hiddenLabel mesh__D009004 Glucose Transport Inducing Protein
% 221.48/221.68  |- skos__prefLabel mesh__D009004 Monosaccharide Transport Proteins
% 221.48/221.68  |- skos__historyNote mesh__D009004 Glucose %28%1966-1985%29%
% 221.48/221.68  |- skos__scopeNote mesh__D009004
% 221.48/221.68       A large group of membrane transport proteins that shuttle MONOSACCHARIDES across CELL MEMBRANES.%A%    
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D009004 2006
% 221.48/221.68  |- skos__historyNote mesh__D009004 Carrier Proteins %28%1973-1985%29%
% 221.48/221.68  |- skos__altLabel mesh__D009004 Hexose Transporter
% 221.48/221.68  |- skos__hiddenLabel mesh__D009004 Transport Proteins, Monosaccharide
% 221.48/221.68  |- skos__hiddenLabel mesh__D009004 Preactin, Band 4.5
% 221.48/221.68  |- mesh__recordMaintainer mesh__D009004 DRC
% 221.48/221.68  |- skos__hiddenLabel mesh__D009004 Transport Proteins, Hexose
% 221.48/221.68  |- mesh__recordAuthorizer mesh__D009004 sjn
% 221.48/221.68  |- skos__historyNote mesh__D009004 Galactose %28%1966-1985%29%
% 221.48/221.68  |- skos__altLabel mesh__D009004 Band 4.5 Preactin
% 221.48/221.68  |- skos__broader mesh__D009004smesh__D026901
% 221.48/221.68  |- skos__historyNote mesh__D009004 Monosaccharides %28%1966-1985%29%
% 221.48/221.68  |- rdf__type mesh__D009004sskos__Concept
% 221.48/221.68  |- skos__scopeNote mesh__D001021
% 221.48/221.68       The valve between the left ventricle and the ascending aorta which prevents backflow into the left ventricle.%A%    
% 221.48/221.68  |- skos__broader mesh__D001021smesh__D006351
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D001021 2004
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D001021 2002
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D001021 2006
% 221.48/221.68  |- skos__hiddenLabel mesh__D001021 Valve, Aortic
% 221.48/221.68  |- mesh__dateCreated mesh__D001021 1999-01-01
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D001021 2003
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D001021 2001
% 221.48/221.68  |- mesh__recordAuthorizer mesh__D001021 SJN
% 221.48/221.68  |- mesh__dateRevised mesh__D001021 1998-06-10
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D001021 2005
% 221.48/221.68  |- skos__annotation mesh__D001021
% 221.48/221.68       dis: coord IM with HEART VALVE DISEASES %28%IM%29% but note specific aortic valve dis; atresia: index AORTIC VALVE /abnorm%A%  
% 221.48/221.68  |- mesh__historyNote mesh__D001021
% 221.48/221.68       AORTIC VALVE DISEASES was heading 1963-66   
% 221.48/221.68  |- mesh__onlineNote mesh__D001021
% 221.48/221.68       search AORTIC VALVE DISEASES under HEART VALVE DISEASES 1966%A%  
% 221.48/221.68  |- mesh__recordMaintainer mesh__D001021 MSR
% 221.48/221.68  |- skos__hiddenLabel mesh__D001021 Aortic Valves
% 221.48/221.68  |- rdf__type mesh__D001021sskos__Concept
% 221.48/221.68  |- skos__prefLabel mesh__D001021 Aortic Valve
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D001021 2000
% 221.48/221.68  |- skos__hiddenLabel mesh__D001021 Valves, Aortic
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D001021 1999
% 221.48/221.68  |- mesh__publicMeSHNote mesh__D001021
% 221.48/221.68       AORTIC VALVE DISEASES was heading 1963-66   
% 221.48/221.68  |- mesh__recordOriginator mesh__D001021 NLM
% 221.48/221.68  |- mesh__recordOriginator mesh__D020784 adp
% 221.48/221.68  |- skos__hiddenLabel mesh__D020784 Collagenase, Fibroblast
% 221.48/221.68  |- skos__broader mesh__D020784smesh__D017364
% 221.48/221.68  |- skos__altLabel mesh__D020784 MMP-8
% 221.48/221.68  |- mesh__recordAuthorizer mesh__D020784 sjn
% 221.48/221.68  |- skos__hiddenLabel mesh__D020784 Metalloproteinase-8, Matrix
% 221.48/221.68  |- skos__altLabel mesh__D020784 Matrix Metalloproteinase-8
% 221.48/221.68  |- skos__hiddenLabel mesh__D020784 Matrix Metalloproteinase 8
% 221.48/221.68  |- skos__hiddenLabel mesh__D020784 MMP 8
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D020784 2005
% 221.48/221.68  |- mesh__dateEstablished mesh__D020784 2000-01-01
% 221.48/221.68  |- rdf__type mesh__D020784sskos__Concept
% 221.48/221.68  |- skos__hiddenLabel mesh__D020784 Collagenase, Neutrophil
% 221.48/221.68  |- skos__altLabel mesh__D020784 Fibroblast Collagenase
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D020784 2006
% 221.48/221.68  |- skos__broader mesh__D020784smesh__D020782
% 221.48/221.68  |- mesh__publicMeSHNote mesh__D020784
% 221.48/221.68       2000; NEUTROPHIL COLLAGENASE was indexed under COLLAGENASES 1992-1999%A%  
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D020784 2004
% 221.48/221.68  |- skos__scopeNote mesh__D020784
% 221.48/221.68       A member of the MATRIX METALLOPROTEINASES that cleaves triple-helical collagens types I, II, and III. EC 3.4.24.34.%A%    
% 221.48/221.68  |- mesh__dateRevised mesh__D020784 2003-07-09
% 221.48/221.68  |- skos__historyNote mesh__D020784 Collagenases %28%1992-1999%29%
% 221.48/221.68  |- mesh__dateCreated mesh__D020784 1999-11-03
% 221.48/221.68  |- skos__prefLabel mesh__D020784 Neutrophil Collagenase
% 221.48/221.68  |- mesh__historyNote mesh__D020784
% 221.48/221.68       2000; use NEUTROPHIL COLLAGENASE %28%NM%29% 1992-1999   
% 221.48/221.68  |- mesh__recordMaintainer mesh__D020784 jmp
% 221.48/221.68  |- skos__altLabel mesh__D014747 Vinblastina Lilly
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D014747 2006
% 221.48/221.68  |- skos__prefLabel mesh__D014747 Vinblastine
% 221.48/221.68  |- mesh__recordAuthorizer mesh__D014747 sjn
% 221.48/221.68  |- skos__broader mesh__D014747smesh__D014748
% 221.48/221.68  |- skos__scopeNote mesh__D014747
% 221.48/221.68       Antitumor alkaloid isolated from Vinca rosea. %28%Merck, 11th ed.%29%%A%    
% 221.48/221.68  |- skos__altLabel mesh__D014747 Vincaleukoblastine
% 221.48/221.68  |- skos__altLabel mesh__D014747 Velbe
% 221.48/221.68  |- rdf__type mesh__D014747sskos__Concept
% 221.48/221.68  |- skos__altLabel mesh__D014747 Gry Brand of Vinblastine Sulfate
% 221.48/221.68  |- skos__altLabel mesh__D014747 Lilly Brand of Vinblastine Sulfate
% 221.48/221.68  |- skos__altLabel mesh__D014747 Faulding Brand of Vinblastine Sulfate
% 221.48/221.68  |- skos__altLabel mesh__D014747 Hexal Brand of Vinblastine Sulfate
% 221.48/221.68  |- skos__altLabel mesh__D014747 cell pharm Brand of Vinblastine Sulfate
% 221.48/221.68  |- skos__altLabel mesh__D014747 Lemery Brand of Vinblastine Sulfate
% 221.48/221.68  |- mesh__dateCreated mesh__D014747 1999-01-01
% 221.48/221.68  |- skos__altLabel mesh__D014747 EG Labo Brand of Vinblastine Sulfate
% 221.48/221.68  |- mesh__recordOriginator mesh__D014747 NLM
% 221.48/221.68  |- mesh__dateRevised mesh__D014747 2005-06-30
% 221.48/221.68  |- skos__annotation mesh__D014747 /biosyn permitted if by plant   
% 221.48/221.68  |- mesh__recordMaintainer mesh__D014747 lkw
% 221.48/221.68  |- skos__hiddenLabel mesh__D014747 Sulfate, Vinblastine
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D033901 2006
% 221.48/221.68  |- skos__broader mesh__D033901smesh__D011990
% 221.48/221.68  |- rdf__type mesh__D033901sskos__Concept
% 221.48/221.68  |- skos__historyNote mesh__D033901 Iron-Binding Proteins %28%1980-2002%29%
% 221.48/221.68  |- skos__scopeNote mesh__D033901
% 221.48/221.68       A complex of proteins that forms a receptor for TRANSFERRIN in BACTERIA. Many pathogenic bacteria utilize the transferrin-binding complex to acquire their supply of iron from serum.%A%    
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D033901 2005
% 221.48/221.68  |- skos__altLabel mesh__D033901
% 221.48/221.68       Transferrin-Binding Protein Complex, Bacterial
% 221.48/221.68  |- mesh__dateCreated mesh__D033901 2002-07-02
% 221.48/221.68  |- skos__broader mesh__D033901smesh__D001425
% 221.48/221.68  |- skos__prefLabel mesh__D033901 Bacterial Transferrin Receptor Complex
% 221.48/221.68  |- mesh__publicMeSHNote mesh__D033901 2003   
% 221.48/221.68  |- skos__broader mesh__D033901smesh__D001426
% 221.48/221.68  |- mesh__historyNote mesh__D033901 2003   
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D033901 2004
% 221.48/221.68  |- skos__hiddenLabel mesh__D033901
% 221.48/221.68       Transferrin Binding Protein Complex, Bacterial
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D033901 2003
% 221.48/221.68  |- mesh__dateEstablished mesh__D033901 2003-01-01
% 221.48/221.68  |- mesh__historyNote mesh__D000727 2000%28%1980%29%   
% 221.48/221.68  |- skos__historyNote mesh__D000727 Proteins %28%1966-1970%29%
% 221.48/221.68  |- skos__historyNote mesh__D000727 Carrier Proteins %28%1971-1979%29%
% 221.48/221.68  |- skos__prefLabel mesh__D000727 Androgen-Binding Protein
% 221.48/221.68  |- skos__historyNote mesh__D000727
% 221.48/221.68       Receptors, Endogenous Substances %28%1973-1976%29%
% 221.48/221.68  |- mesh__publicMeSHNote mesh__D000727
% 221.48/221.68       2000; see ANDROGEN-BINDING PROTEINS 1986-1999, see CARRIER PROTEINS 1980-85%A%  
% 221.48/221.68  |- skos__hiddenLabel mesh__D000727 Binding Protein, Androgen
% 221.48/221.68  |- skos__altLabel mesh__D000727 Androgen Binding Protein
% 221.48/221.68  |- skos__related mesh__D000727smesh__D012738
% 221.48/221.68  |- skos__historyNote mesh__D000727 Receptors, Androgen %28%1977-1979%29%
% 221.48/221.68  |- rdf__type mesh__D000727sskos__Concept
% 221.48/221.68  |- mesh__recordAuthorizer mesh__D000727 ags
% 221.48/221.68  |- mesh__dateCreated mesh__D000727 1979-05-23
% 221.48/221.68  |- mesh__recordOriginator mesh__D000727 RLS
% 221.48/221.68  |- skos__hiddenLabel mesh__D000727 Protein, Androgen-Binding
% 221.48/221.68  |- mesh__dateRevised mesh__D000727 2005-07-29
% 221.48/221.68  |- skos__hiddenLabel mesh__D000727 Protein, Androgen Binding
% 221.48/221.68  |- mesh__dateEstablished mesh__D000727 1986-01-01
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D000727 2006
% 221.48/221.68  |- skos__broader mesh__D000727smesh__D002352
% 221.48/221.68  |- skos__scopeNote mesh__D000727
% 221.48/221.68       Carrier proteins produced in the Sertoli cells of the testis, secreted into the seminiferous tubules, and transported via the efferent ducts to the epididymis. They participate in the transport of androgens. Androgen-binding protein has the same amino acid sequence as SEX HORMONE-BINDING GLOBULIN. They differ by their sites of synthesis and post-translational oligosaccharide modifications.%A%    
% 221.48/221.68  |- mesh__recordMaintainer mesh__D000727 ags
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D000727 2006A
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D019432 1999
% 221.48/221.68  |- skos__annotation mesh__D019432 a Brit colony in the Atlantic Islands   
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D019432 2002
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D019432 2003
% 221.48/221.68  |- mesh__dateEstablished mesh__D019432 1997-01-01
% 221.48/221.68  |- skos__prefLabel mesh__D019432 Falkland Islands
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D019432 1998
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D019432 2001
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D019432 1997
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D019432 2000
% 221.48/221.68  |- skos__historyNote mesh__D019432 Atlantic Islands %28%1982-1996%29%
% 221.48/221.68  |- skos__broader mesh__D019432smesh__D001266
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D019432 2006
% 221.48/221.68  |- skos__altLabel mesh__D019432 Malvinas
% 221.48/221.68  |- mesh__dateCreated mesh__D019432 1996-06-26
% 221.48/221.68  |- rdf__type mesh__D019432sskos__Concept
% 221.48/221.68  |- mesh__historyNote mesh__D019432 97   
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D019432 2005
% 221.48/221.68  |- skos__scopeNote mesh__D019432
% 221.48/221.68       A British colony in the Atlantic Islands, comprising two principal islands, East Falkland and West Falkland. Its capital is Stanley. Discovered in 1592, it was not occupied until the French settled there briefly in 1764. Later the English settled there but were expelled by the Spanish in 1770. The Falklands were claimed by Argentina but were occupied in 1833 by the British who, after an April 1982 invasion by Argentina, regained them in June. The islands were named by British Captain John Strong in 1690 for the fifth Viscount Falkland who financed Strong%27%s expedition. The Spanish name for the islands, Malvinas, is from the French Malouins, inhabitants of St. Malo who attempted to colonize the islands in 1764. %28%From Webster%27%s New Geographical Dictionary, 1988, p389 %26% Room, Brewer%27%s Dictionary of Names, 1992, p182%29%%A%    
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D019432 2004
% 221.48/221.68  |- skos__broader mesh__D013199Q000601smesh__D013199
% 221.48/221.68  |- mesh__preferredCombination mesh__D013199Q000601smesh__D013201
% 221.48/221.68  |- rdf__type mesh__D013199Q000601smesh__CompoundConcept
% 221.48/221.68  |- skos__broader mesh__D005412smesh__D005399
% 221.48/221.68  |- skos__scopeNote mesh__D005412
% 221.48/221.68       Common name for the order Pleuronectiformes. A very distinctive group in that during development they become asymmetrical, i.e., one eye migrates to lie adjacent to the other. They swim on the eyeless side. FLOUNDER, sole, and turbot, along with several others, are included in this order.%A%    
% 221.48/221.68  |- skos__altLabel mesh__D005412 Psetta maxima
% 221.48/221.68  |- skos__prefLabel mesh__D005412 Flatfishes
% 221.48/221.68  |- mesh__dateRevised mesh__D005412 2003-07-09
% 221.48/221.68  |- skos__altLabel mesh__D005412 Pleuronectiformes
% 221.48/221.68  |- skos__historyNote mesh__D005412 Fishes %28%1966-1986%29%
% 221.48/221.68  |- mesh__recordOriginator mesh__D005412 EC
% 221.48/221.68  |- skos__annotation mesh__D005412
% 221.48/221.68       sole may be SOLEA see FLATFISHES or FLOUNDER %28%Pleuronectidae%29%; check text%A%  
% 221.48/221.68  |- mesh__publicMeSHNote mesh__D005412 1987   
% 221.48/221.68  |- mesh__dateEstablished mesh__D005412 1987-01-01
% 221.48/221.68  |- rdf__type mesh__D005412sskos__Concept
% 221.48/221.68  |- skos__altLabel mesh__D005412 Scophthalmus maximus
% 221.48/221.68  |- mesh__historyNote mesh__D005412 1987   
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D005412 2004
% 221.48/221.68  |- mesh__recordMaintainer mesh__D005412 ags
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D005412 2006
% 221.48/221.68  |- skos__hiddenLabel mesh__D005412 Turbots
% 221.48/221.68  |- mesh__recordAuthorizer mesh__D005412 sjn
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D005412 2005
% 221.48/221.68  |- mesh__dateCreated mesh__D005412 1986-04-15
% 221.48/221.68  |- mesh__recordOriginator mesh__D046829 ags
% 221.48/221.68  |- skos__hiddenLabel mesh__D046829 Isaviruses
% 221.48/221.68  |- skos__annotation mesh__D046829
% 221.48/221.68       infection: coord IM with ORTHOMYXOVIRIDAE INFECTIONS %28%IM%29%%A%  
% 221.48/221.68  |- mesh__historyNote mesh__D046829 2005   
% 221.48/221.68  |- mesh__recordMaintainer mesh__D046829 ags
% 221.48/221.68  |- rdf__type mesh__D046829sskos__Concept
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D046829 2006
% 221.48/221.68  |- mesh__dateEstablished mesh__D046829 2005-01-01
% 221.48/221.68  |- skos__broader mesh__D046829smesh__D009975
% 221.48/221.68  |- skos__prefLabel mesh__D046829 Isavirus
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D046829 2005
% 221.48/221.68  |- skos__scopeNote mesh__D046829
% 221.48/221.68       A genus in the family ORTHOMYXOVIRIDAE containing one species: Infectious salmon anemia virus.%A%    
% 221.48/221.68  |- mesh__dateCreated mesh__D046829 2004-07-07
% 221.48/221.68  |- mesh__publicMeSHNote mesh__D046829 2005   
% 221.48/221.68  |- mesh__recordAuthorizer mesh__D046829 sjn
% 221.48/221.68  |- skos__broader mesh__D010357smesh__D004865
% 221.48/221.68  |- mesh__dateCreated mesh__D010357 1999-01-01
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D010357 2003
% 221.48/221.68  |- skos__annotation mesh__D010357
% 221.48/221.68       DF: do NOT shorten: short form can be confused with PATIENT ISOL for PATIENT ISOLATION%A%  
% 221.48/221.68  |- skos__hiddenLabel mesh__D010357 Life Island
% 221.48/221.68  |- mesh__recordMaintainer mesh__D010357 TGC
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D010357 2002
% 221.48/221.68  |- rdf__type mesh__D010357sskos__Concept
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D010357 2004
% 221.48/221.68  |- mesh__recordOriginator mesh__D010357 NLM
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D010357 1997
% 221.48/221.68  |- mesh__recordAuthorizer mesh__D010357 PLS
% 221.48/221.68  |- skos__historyNote mesh__D010357
% 221.48/221.68       Cross Infection/prevention %26% control %28%1966-1967%29%
% 221.48/221.68  |- mesh__dateEstablished mesh__D010357 1968-01-01
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D010357 2000
% 221.48/221.68  |- skos__hiddenLabel mesh__D010357 Patient Isolator
% 221.48/221.68  |- skos__scopeNote mesh__D010357
% 221.48/221.68       Equipment used to prevent contamination of and by patients, especially those with bacterial infections. This includes plastic surgical isolators and isolators used to protect immunocompromised patients.%A%    
% 221.48/221.68  |- skos__hiddenLabel mesh__D010357 Island, Life
% 221.48/221.68  |- skos__prefLabel mesh__D010357 Patient Isolators
% 221.48/221.68  |- skos__historyNote mesh__D010357 Germ-Free Life %28%1966-1967%29%
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D010357 2005
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D010357 1998
% 221.48/221.68  |- skos__hiddenLabel mesh__D010357 Isolators, Patient
% 221.48/221.68  |- skos__hiddenLabel mesh__D010357 Islands, Life
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D010357 2001
% 221.48/221.68  |- mesh__publicMeSHNote mesh__D010357 68   
% 221.48/221.68  |- mesh__dateRevised mesh__D010357 1996-06-10
% 221.48/221.68  |- skos__historyNote mesh__D010357
% 221.48/221.68       Equipment and Supplies, Hospital %28%1966-1967%29%
% 221.48/221.68  |- skos__hiddenLabel mesh__D010357 Isolator, Patient
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D010357 2006
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D010357 1999
% 221.48/221.68  |- mesh__historyNote mesh__D010357 68   
% 221.48/221.68  |- skos__annotation mesh__D029062
% 221.48/221.68       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.48/221.68  |- mesh__recordMaintainer mesh__D029062 ssb
% 221.48/221.68  |- mesh__historyNote mesh__D029062 2002   
% 221.48/221.68  |- mesh__dateEstablished mesh__D029062 2002-01-01
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D029062 2006
% 221.48/221.68  |- mesh__publicMeSHNote mesh__D029062 2002   
% 221.48/221.68  |- skos__broader mesh__D029062smesh__D019684
% 221.48/221.68  |- rdf__type mesh__D029062sskos__Concept
% 221.48/221.68  |- skos__scopeNote mesh__D029062
% 221.48/221.68       The dogbane plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida.  Members of the family have milky, often poisonous juice, smooth-margined leaves, and flowers in clusters.%A%    
% 221.48/221.68  |- mesh__dateRevised mesh__D029062 2002-07-02
% 221.48/221.68  |- mesh__recordAuthorizer mesh__D029062 sjn
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D029062 2003
% 221.48/221.68  |- mesh__recordOriginator mesh__D029062 ssb
% 221.48/221.68  |- skos__prefLabel mesh__D029062 Apocynaceae
% 221.48/221.68  |- mesh__dateCreated mesh__D029062 2001-07-25
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D029062 2005
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D029062 2004
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D015840 2002
% 221.48/221.68  |- skos__hiddenLabel mesh__D015840 Third-Nerve Palsy, Total
% 221.48/221.68  |- mesh__recordMaintainer mesh__D015840 ags
% 221.48/221.68  |- skos__hiddenLabel mesh__D015840 Partial Third-Nerve Palsies
% 221.48/221.68  |- mesh__activeMeSHYear mesh__D015840 2003
% 221.48/221.68  |- skos__hiddenLabel mesh__D015840 Nerve Paralyses, Oculomotor
% 221.48/221.68  |- rdf__type mesh__D015840sskos__Concept
% 221.48/221.68  |- skos__historyNote mesh__D015840 Oculomotor Nerve %28%1969-1989%29%
% 221.48/221.69  |- skos__altLabel mesh__D015840 Third-Nerve Paralysis
% 221.48/221.69  |- skos__broader mesh__D015840smesh__D015835
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Third Nerve Palsy
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Palsies, Total Third-Nerve
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Paralysis, Third-Nerve
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Palsies, Oculomotor Nerve
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Oculomotor Neuropathies
% 221.48/221.69  |- skos__altLabel mesh__D015840 Oculomotor Nerve Disorders
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Palsy, Partial Third-Nerve
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Third-Nerve Palsy, Partial
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D015840 2004
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Palsies, Third-Nerve
% 221.48/221.69  |- mesh__dateEstablished mesh__D015840 1990-01-01
% 221.48/221.69  |- skos__historyNote mesh__D015840 Ophthalmoplegia %28%1966-1989%29%
% 221.48/221.69  |- skos__annotation mesh__D015840
% 221.48/221.69       do not confuse X-ref OCULOMOTOR NERVE PALSY with oculomotor palsies caused by weakened 4th or 5th cranial nerves which are indexed: 4th=TROCHLEAR NERVE DIS and 6th=ABDUCENS NERVE DIS, if not specified use CRANIAL NERVE DIS; neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%; do not confuse with OCULOMOTOR PARALYSIS see OPHTHALMOPLEGIA%A%  
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Palsy, Oculomotor Nerve
% 221.48/221.69  |- skos__related mesh__D015840smesh__D009886
% 221.48/221.69  |- skos__altLabel mesh__D015840 Oculomotor Nerve Palsy
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Oculomotor Nerve Disorder
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Oculomotor Nerve Palsies
% 221.48/221.69  |- skos__altLabel mesh__D015840 Cranial Nerve III Diseases
% 221.48/221.69  |- skos__prefLabel mesh__D015840 Oculomotor Nerve Diseases
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Partial Third Nerve Palsy
% 221.48/221.69  |- mesh__historyNote mesh__D015840 2000%28%1990%29%   
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Oculomotor Nerve Paralyses
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Neuropathy, Oculomotor
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Total Third Nerve Palsy
% 221.48/221.69  |- mesh__dateCreated mesh__D015840 1989-05-26
% 221.48/221.69  |- mesh__recordAuthorizer mesh__D015840 sjn
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Nerve Diseases, Oculomotor
% 221.48/221.69  |- skos__altLabel mesh__D015840 Oculomotor Neuropathy
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Palsy, Total Third-Nerve
% 221.48/221.69  |- mesh__publicMeSHNote mesh__D015840
% 221.48/221.69       2000; see OCULOMOTOR NERVE PARALYSIS 1990-1999   
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Paralysis, Oculomotor Nerve
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Nerve Disorder, Oculomotor
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Oculomotor Nerve Disease
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Nerve Paralysis, Oculomotor
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Third-Nerve Palsies, Partial
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Nerve Disease, Oculomotor
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Third Nerve Paralysis
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Third-Nerve Palsies
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D015840 2005
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Nerve Disorders, Oculomotor
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Neuropathies, Oculomotor
% 221.48/221.69  |- skos__altLabel mesh__D015840 Third-Nerve Palsy
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Nerve Palsies, Oculomotor
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Total Third-Nerve Palsies
% 221.48/221.69  |- mesh__recordOriginator mesh__D015840 EGC
% 221.48/221.69  |- skos__scopeNote mesh__D015840
% 221.48/221.69       Diseases of the oculomotor nerve or nucleus that result in weakness or paralysis of the superior rectus, inferior rectus, medial rectus, inferior oblique, or levator palpebrae muscles, or impaired parasympathetic innervation to the pupil. With a complete oculomotor palsy, the eyelid will be paralyzed, the eye will be in an abducted and inferior position, and the pupil will be markedly dilated. Commonly associated conditions include neoplasms, CRANIOCEREBRAL TRAUMA, ischemia %28%especially in association with DIABETES MELLITUS%29%, and aneurysmal compression. %28%From Adams et al., Principles of Neurology, 6th ed, p270%29%%A%    
% 221.48/221.69  |- skos__altLabel mesh__D015840 Oculomotor Nerve Paralysis
% 221.48/221.69  |- skos__altLabel mesh__D015840 Third Cranial Nerve Diseases
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Nerve Palsy, Oculomotor
% 221.48/221.69  |- mesh__dateRevised mesh__D015840 2001-07-25
% 221.48/221.69  |- skos__broader mesh__D015840smesh__D003389
% 221.48/221.69  |- skos__related mesh__D015840smesh__D020209
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D015840 2006
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Palsy, Third-Nerve
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Paralyses, Oculomotor Nerve
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Third-Nerve Palsies, Total
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Palsies, Partial Third-Nerve
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Paralyses, Third-Nerve
% 221.48/221.69  |- skos__hiddenLabel mesh__D015840 Third-Nerve Paralyses
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D009803 2004
% 221.48/221.69  |- skos__related mesh__D009803smesh__D016717
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D009803 2006
% 221.48/221.69  |- mesh__recordAuthorizer mesh__D009803 sjn
% 221.48/221.69  |- mesh__recordOriginator mesh__D009803 NLM
% 221.48/221.69  |- mesh__publicMeSHNote mesh__D009803
% 221.48/221.69       2004; see ODD%27%S SPHINCTER 1991-2003, see VATER%27%S AMPULLA 1975-1990%A%  
% 221.48/221.69  |- skos__altLabel mesh__D009803 Oddi%27%s Sphincter
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D009803 2005
% 221.48/221.69  |- skos__hiddenLabel mesh__D009803 Sphincter, Oddi%27%s
% 221.48/221.69  |- rdf__type mesh__D009803sskos__Concept
% 221.48/221.69  |- mesh__historyNote mesh__D009803 2004 %28%1975%29%   
% 221.48/221.69  |- skos__scopeNote mesh__D009803
% 221.48/221.69       The sphincter of the hepatopancreatic ampulla within the duodenal papilla. The COMMON BILE DUCT and main pancreatic duct pass through this sphincter.%A%    
% 221.48/221.69  |- mesh__dateRevised mesh__D009803 2003-07-09
% 221.48/221.69  |- mesh__dateCreated mesh__D009803 1999-01-01
% 221.48/221.69  |- skos__related mesh__D009803smesh__D013105
% 221.48/221.69  |- mesh__recordMaintainer mesh__D009803 lkt
% 221.48/221.69  |- skos__broader mesh__D009803smesh__D014670
% 221.48/221.69  |- skos__related mesh__D009803smesh__D002760
% 221.48/221.69  |- skos__hiddenLabel mesh__D009803 Oddis Sphincter
% 221.48/221.69  |- skos__hiddenLabel mesh__D009803 Oddi Sphincter
% 221.48/221.69  |- skos__annotation mesh__D009803
% 221.48/221.69       diseases: coord IM with COMMON BILE DUCT DISEASES %28%IM%29%; inflammation: coord IM with CHOLANGITIS %28%IM%29%; neopl: coord IM with COMMON BILE DUCT NEOPLASMS %28%IM%29%%A%  
% 221.48/221.69  |- skos__prefLabel mesh__D009803 Sphincter of Oddi
% 221.48/221.69  |- mesh__dateEstablished mesh__D009803 1991-01-01
% 221.48/221.69  |- skos__altLabel mesh__D001820 Ovine Catarrhal Fever Virus
% 221.48/221.69  |- mesh__publicMeSHNote mesh__D001820
% 221.48/221.69       94; was BLUE TONGUE VIRUS 1975-93 %28%see under REOVIRIDAE 1981-90, see under REOVIRUSES 1975-80%29%%A%  
% 221.48/221.69  |- mesh__onlineNote mesh__D001820
% 221.48/221.69       use BLUETONGUE VIRUS to search BLUE TONGUE VIRUS 1975-93   
% 221.48/221.69  |- rdf__type mesh__D001820sskos__Concept
% 221.48/221.69  |- skos__hiddenLabel mesh__D001820 Bluetongue Viruses
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D001820 2002
% 221.48/221.69  |- skos__hiddenLabel mesh__D001820 Blue Tongue Viruses
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D001820 2006
% 221.48/221.69  |- skos__prefLabel mesh__D001820 Bluetongue virus
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D001820 2004
% 221.48/221.69  |- mesh__historyNote mesh__D001820
% 221.48/221.69       94; was BLUE TONGUE VIRUS 1975-93 %28%see under REOVIRIDAE 1981-90, see under REOVIRUSES 1975-80%29%%A%  
% 221.48/221.69  |- skos__altLabel mesh__D001820 Blue Tongue Virus
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D001820 2005
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D001820 2003
% 221.48/221.69  |- mesh__dateRevised mesh__D001820 2001-07-25
% 221.48/221.69  |- mesh__dateCreated mesh__D001820 1974-12-12
% 221.48/221.69  |- skos__scopeNote mesh__D001820
% 221.48/221.69       The type species of ORBIVIRUS causing a serious disease in sheep, especially lambs. It may also infect wild ruminants and other domestic animals.%A%    
% 221.48/221.69  |- skos__annotation mesh__D001820 infection = BLUETONGUE: see note there   
% 221.48/221.69  |- mesh__dateEstablished mesh__D001820 1991-01-01
% 221.48/221.69  |- mesh__recordAuthorizer mesh__D001820 sjn
% 221.48/221.69  |- mesh__recordMaintainer mesh__D001820 ags
% 221.48/221.69  |- mesh__recordOriginator mesh__D001820 NLM
% 221.48/221.69  |- skos__broader mesh__D001820smesh__D018163
% 221.48/221.69  |- skos__broader mesh__D009005smesh__D002241
% 221.48/221.69  |- skos__prefLabel mesh__D009005 Monosaccharides
% 221.48/221.69  |- mesh__recordAuthorizer mesh__D009005 sjn
% 221.48/221.69  |- skos__scopeNote mesh__D009005
% 221.48/221.69       Simple sugars, carbohydrates which cannot be decomposed by hydrolysis. They are colorless crystalline substances with a sweet taste and have the same general formula CnH2nOn. %28%From Dorland, 28th ed%29%%A%    
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D009005 2006
% 221.48/221.69  |- skos__annotation mesh__D009005 GEN; prefer specifics   
% 221.48/221.69  |- mesh__recordMaintainer mesh__D009005 ssb
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D009005 2005
% 221.48/221.69  |- mesh__dateRevised mesh__D009005 2004-07-07
% 221.48/221.69  |- mesh__dateCreated mesh__D009005 1999-01-01
% 221.48/221.69  |- rdf__type mesh__D009005sskos__Concept
% 221.48/221.69  |- mesh__recordOriginator mesh__D009005 NLM
% 221.48/221.69  |- mesh__dateCreated mesh__D001022 1999-01-01
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D001022 2003
% 221.48/221.69  |- mesh__recordAuthorizer mesh__D001022 PLS
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D001022 2005
% 221.48/221.69  |- mesh__publicMeSHNote mesh__D001022
% 221.48/221.69       67; AORTIC REGURGITATION was REGURGITATION, AORTIC VALVE 1963-92%A%  
% 221.48/221.69  |- skos__altLabel mesh__D001022 Regurgitation, Aortic Valve
% 221.48/221.69  |- skos__hiddenLabel mesh__D001022 Regurgitation, Aortic
% 221.48/221.69  |- mesh__recordOriginator mesh__D001022 NLM
% 221.48/221.69  |- skos__broader mesh__D001022smesh__D006349
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D001022 2004
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D001022 2002
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D001022 2006
% 221.48/221.69  |- mesh__dateEstablished mesh__D001022 1967-01-01
% 221.48/221.69  |- skos__altLabel mesh__D001022 Aortic Incompetence
% 221.48/221.69  |- skos__altLabel mesh__D001022 Aortic Valve Incompetence
% 221.48/221.69  |- skos__scopeNote mesh__D001022
% 221.48/221.69       Backflow of blood from the aorta into the left ventricle, owing to imperfect functioning of the aortic semilunar valve.%A%    
% 221.48/221.69  |- mesh__recordMaintainer mesh__D001022 PLS
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D001022 1996
% 221.48/221.69  |- skos__hiddenLabel mesh__D001022 Insufficiency, Aortic Valve
% 221.48/221.69  |- mesh__historyNote mesh__D001022
% 221.48/221.69       67; AORTIC REGURGITATION was REGURGITATION, AORTIC VALVE 1963-92%A%  
% 221.48/221.69  |- skos__hiddenLabel mesh__D001022 Incompetence, Aortic
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D001022 1998
% 221.48/221.69  |- rdf__type mesh__D001022sskos__Concept
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D001022 1997
% 221.48/221.69  |- skos__historyNote mesh__D001022 Heart Valve Diseases %28%1966%29%
% 221.48/221.69  |- skos__prefLabel mesh__D001022 Aortic Valve Insufficiency
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D001022 1994
% 221.48/221.69  |- skos__hiddenLabel mesh__D001022 Incompetence, Aortic Valve
% 221.48/221.69  |- skos__altLabel mesh__D001022 Aortic Regurgitation
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D001022 2000
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D001022 1999
% 221.48/221.69  |- mesh__dateRevised mesh__D001022 1992-05-07
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D001022 2001
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D001022 1993
% 221.48/221.69  |- skos__annotation mesh__D001022 imperfect closing of valve   
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D001022 1995
% 221.48/221.69  |- mesh__dateRevised mesh__D020785 2005-08-02
% 221.48/221.69  |- skos__annotation mesh__D020785
% 221.48/221.69       do not confuse x-refs CAPILLARY TELANGIECTASIA, BRAIN and PONTINE CAPILLARY TELANGIECTASIAS with TELANGIECTASIS%A%  
% 221.48/221.69  |- skos__historyNote mesh__D020785
% 221.48/221.69       Cerebral Arteries/abnormalities %28%1966-1999%29%
% 221.48/221.69  |- mesh__recordAuthorizer mesh__D020785 ags
% 221.48/221.69  |- skos__altLabel mesh__D020785
% 221.48/221.69       Vascular Malformations, Central Nervous System
% 221.48/221.69  |- skos__hiddenLabel mesh__D020785 Telangiectasias, Brain Capillary
% 221.48/221.69  |- skos__hiddenLabel mesh__D020785 Malformations, Brain Vascular
% 221.48/221.69  |- mesh__recordMaintainer mesh__D020785 ags
% 221.48/221.69  |- mesh__recordOriginator mesh__D020785 KEV
% 221.48/221.69  |- skos__hiddenLabel mesh__D020785 Malformation, Brain Vascular
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D020785 2005A
% 221.48/221.69  |- skos__hiddenLabel mesh__D020785 Brain Capillary Telangiectasia
% 221.48/221.69  |- skos__hiddenLabel mesh__D020785 Telangiectasia, Pontine Capillary
% 221.48/221.69  |- skos__hiddenLabel mesh__D020785 Pontine Capillary Telangiectasia
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D020785 2004
% 221.48/221.69  |- skos__historyNote mesh__D020785 Brain/abnormalities %28%1967-1999%29%
% 221.48/221.69  |- mesh__publicMeSHNote mesh__D020785 2000   
% 221.48/221.69  |- skos__hiddenLabel mesh__D020785 Dural Arteriovenous Fistulas
% 221.48/221.69  |- skos__scopeNote mesh__D020785
% 221.48/221.69       Congenital or acquired malformations involving arteries, veins, or venous sinuses of the brain, spinal cord, and meninges.%A%    
% 221.48/221.69  |- skos__historyNote mesh__D020785 Veins/abnormalities %28%1966-1999%29%
% 221.48/221.69  |- skos__broader mesh__D020785smesh__D018376
% 221.48/221.69  |- skos__altLabel mesh__D020785 Persistent Cerebral Embyronic Artery
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D020785 2006
% 221.48/221.69  |- skos__altLabel mesh__D020785 Vascular Anomalies, Central Nervous System
% 221.48/221.69  |- skos__hiddenLabel mesh__D020785 Capillary Telangiectasias, Brain
% 221.48/221.69  |- skos__hiddenLabel mesh__D020785 Brain Vascular Malformation
% 221.48/221.69  |- skos__altLabel mesh__D020785
% 221.48/221.69       Vascular Malformations, Congenital, Nervous System
% 221.48/221.69  |- skos__broader mesh__D020785smesh__D009421
% 221.48/221.69  |- mesh__dateEstablished mesh__D020785 2000-01-01
% 221.48/221.69  |- skos__hiddenLabel mesh__D020785 Telangiectasia, Brain Capillary
% 221.48/221.69  |- skos__hiddenLabel mesh__D020785 Capillary Telangiectasia, Pontine
% 221.48/221.69  |- skos__altLabel mesh__D020785
% 221.48/221.69       Congenital Vascular Malformations, Central Nevous System
% 221.48/221.69  |- skos__prefLabel mesh__D020785
% 221.48/221.69       Central Nervous System Vascular Malformations
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D020785 2005
% 221.48/221.69  |- skos__hiddenLabel mesh__D020785 Arteriovenous Fistulas, Dural
% 221.48/221.69  |- skos__historyNote mesh__D020785 Hemangioma, Cavernous %28%1964-1999%29%
% 221.48/221.69  |- skos__altLabel mesh__D020785 Embyonic Artery, Persistent, Cerebral
% 221.48/221.69  |- skos__hiddenLabel mesh__D020785 Brain Vascular Malformations
% 221.48/221.69  |- skos__hiddenLabel mesh__D020785 Arteriovenous Fistula, Dural
% 221.48/221.69  |- skos__hiddenLabel mesh__D020785 Brain Capillary Telangiectasias
% 221.48/221.69  |- rdf__type mesh__D020785sskos__Concept
% 221.48/221.69  |- skos__hiddenLabel mesh__D020785 Capillary Telangiectasias, Pontine
% 221.48/221.69  |- skos__hiddenLabel mesh__D020785 Telangiectasias, Pontine Capillary
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D020785 2006A
% 221.48/221.69  |- mesh__dateCreated mesh__D020785 1999-11-04
% 221.48/221.69  |- skos__hiddenLabel mesh__D020785 Vascular Malformation, Brain
% 221.48/221.69  |- mesh__historyNote mesh__D020785 2000   
% 221.48/221.69  |- skos__altLabel mesh__D020785 Central Nervous System Vascular Anomalies
% 221.48/221.69  |- mesh__recordOriginator mesh__D014748 NLM
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D014748 2005
% 221.48/221.69  |- skos__prefLabel mesh__D014748 Vinca Alkaloids
% 221.48/221.69  |- skos__scopeNote mesh__D014748
% 221.48/221.69       A group of indole-indoline dimers which are ALKALOIDS obtained from the VINCA genus of plants. They inhibit polymerization of TUBULIN into MICROTUBULES thus blocking spindle formation and arresting cells in METAPHASE. They are some of the most useful ANTINEOPLASTIC AGENTS.%A%    
% 221.48/221.69  |- rdf__type mesh__D014748sskos__Concept
% 221.48/221.69  |- mesh__recordAuthorizer mesh__D014748 sjn
% 221.48/221.69  |- mesh__recordMaintainer mesh__D014748 ssb
% 221.48/221.69  |- mesh__publicMeSHNote mesh__D014748 73   
% 221.48/221.69  |- mesh__dateRevised mesh__D014748 2004-07-07
% 221.48/221.69  |- mesh__dateCreated mesh__D014748 1999-01-01
% 221.48/221.69  |- skos__historyNote mesh__D014748 Alkaloids %28%1966-1972%29%
% 221.48/221.69  |- skos__hiddenLabel mesh__D014748 Alkaloids, Vinca
% 221.48/221.69  |- mesh__dateEstablished mesh__D014748 1973-01-01
% 221.48/221.69  |- skos__broader mesh__D014748smesh__D046948
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D014748 2006
% 221.48/221.69  |- mesh__historyNote mesh__D014748 73   
% 221.48/221.69  |- rdf__type mesh__D033902sskos__Concept
% 221.48/221.69  |- mesh__recordOriginator mesh__D033902 jmp
% 221.48/221.69  |- mesh__recordAuthorizer mesh__D033902 sjn
% 221.48/221.69  |- mesh__dateEstablished mesh__D033902 2003-01-01
% 221.48/221.69  |- skos__broader mesh__D033902smesh__D033903
% 221.48/221.69  |- skos__scopeNote mesh__D033902
% 221.48/221.69       Periplasmic proteins that scavenge or sense diverse nutrients. In the bacterial environment they usually couple to transporters or chemotaxis receptors on the inner bacterial membrane.%A%    
% 221.48/221.69  |- skos__prefLabel mesh__D033902 Periplasmic Binding Proteins
% 221.48/221.69  |- mesh__recordMaintainer mesh__D033902 SYSTEM
% 221.48/221.69  |- skos__broader mesh__D033902smesh__D002352
% 221.48/221.69  |- skos__hiddenLabel mesh__D033902 Binding Proteins, Periplasmic
% 221.48/221.69  |- mesh__historyNote mesh__D033902 2003; use CARRIER PROTEINS 1983-2002   
% 221.48/221.69  |- mesh__dateCreated mesh__D033902 2002-07-02
% 221.48/221.69  |- mesh__publicMeSHNote mesh__D033902
% 221.48/221.69       2003; see CARRIER PROTEINS 1983-2002   
% 221.48/221.69  |- mesh__dateRevised mesh__D033902 2005-06-30
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D033902 2006
% 221.48/221.69  |- skos__historyNote mesh__D019433 Viral Vaccines %28%1970-1996%29%
% 221.48/221.69  |- skos__hiddenLabel mesh__D019433 Vaccine, Chickenpox
% 221.48/221.69  |- skos__broader mesh__D019433smesh__D022283
% 221.48/221.69  |- skos__prefLabel mesh__D019433 Chickenpox Vaccine
% 221.48/221.69  |- mesh__recordOriginator mesh__D019433 AGS
% 221.48/221.69  |- skos__altLabel mesh__D019433 Oka Varicella Vaccine
% 221.48/221.69  |- skos__scopeNote mesh__D019433
% 221.48/221.69       A live, attenuated varicella virus vaccine used for immunization against chickenpox. It is recommended for children between the ages of 12 months and 13 years.%A%    
% 221.48/221.69  |- mesh__historyNote mesh__D019433
% 221.48/221.69       97; was VARICELLA VACCINE %28%NM%29% 1985-96   
% 221.48/221.69  |- skos__hiddenLabel mesh__D019433 Vaccine, Oka Varicella
% 221.48/221.69  |- mesh__dateCreated mesh__D019433 1996-06-10
% 221.48/221.69  |- skos__historyNote mesh__D019433 Vaccines, Attenuated %28%1984-1996%29%
% 221.48/221.69  |- skos__altLabel mesh__D019433 Varicella Vaccine
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D019433 2006
% 221.48/221.69  |- skos__hiddenLabel mesh__D019433 Varicella Vaccine, Oka
% 221.48/221.69  |- mesh__publicMeSHNote mesh__D019433
% 221.48/221.69       97; VARICELLA VACCINE was indexed under VIRAL VACCINES 1985-96%A%  
% 221.48/221.69  |- skos__hiddenLabel mesh__D019433 Vaccine, Varicella
% 221.48/221.69  |- mesh__recordAuthorizer mesh__D019433 sjn
% 221.48/221.69  |- mesh__dateEstablished mesh__D019433 1997-01-01
% 221.48/221.69  |- rdf__type mesh__D019433sskos__Concept
% 221.48/221.69  |- mesh__onlineNote mesh__D019433
% 221.48/221.69       use CHICKENPOX VACCINE %28%NM%29% to search VARICELLA VACCINE 1985-96%A%  
% 221.48/221.69  |- mesh__dateRevised mesh__D019433 2005-06-30
% 221.48/221.69  |- mesh__recordMaintainer mesh__D019433 ssb
% 221.48/221.69  |- skos__scopeNote mesh__D000728
% 221.48/221.69       Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power.%A%    
% 221.48/221.69  |- rdf__type mesh__D000728sskos__Concept
% 221.48/221.69  |- skos__altLabel mesh__D000728 Androgenic Agents
% 221.48/221.69  |- mesh__recordAuthorizer mesh__D000728 ags
% 221.48/221.69  |- skos__prefLabel mesh__D000728 Androgens
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D000728 2004
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D000728 2006A
% 221.48/221.69  |- mesh__dateRevised mesh__D000728 2005-07-29
% 221.48/221.69  |- skos__hiddenLabel mesh__D000728 Agents, Androgenic
% 221.48/221.69  |- mesh__historyNote mesh__D000728 1963   
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D000728 2006
% 221.48/221.69  |- skos__related mesh__D000728smesh__D000726
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D000728 2005
% 221.48/221.69  |- mesh__recordOriginator mesh__D000728 NLM
% 221.48/221.69  |- skos__hiddenLabel mesh__D000728 Compounds, Androgenic
% 221.48/221.69  |- mesh__recordMaintainer mesh__D000728 ags
% 221.48/221.69  |- mesh__dateCreated mesh__D000728 1999-01-01
% 221.48/221.69  |- skos__annotation mesh__D000728
% 221.48/221.69       /defic: consider also HYPOGONADISM %26% other gonadal disord in Cat C19%A%  
% 221.48/221.69  |- mesh__publicMeSHNote mesh__D000728 1963   
% 221.48/221.69  |- skos__altLabel mesh__D000728 Androgenic Compounds
% 221.48/221.69  |- skos__broader mesh__D000728smesh__D006728
% 221.48/221.69  |- skos__related mesh__D000728smesh__D011944
% 221.48/221.69  |- skos__hiddenLabel mesh__D011450 Analogues, Prostaglandin Endoperoxide
% 221.48/221.69  |- skos__altLabel mesh__D011450 Prostaglandin Endoperoxide Analogues
% 221.48/221.69  |- skos__hiddenLabel mesh__D011450 Endoperoxide Analogues, Prostaglandin
% 221.48/221.69  |- skos__historyNote mesh__D011450 Prostaglandins, Synthetic %28%1977%29%
% 221.48/221.69  |- mesh__publicMeSHNote mesh__D011450 78   
% 221.48/221.69  |- skos__historyNote mesh__D011450 Ethers, Cyclic %28%1966-1977%29%
% 221.48/221.69  |- skos__altLabel mesh__D011450 Synthetic Prostaglandin Endoperoxides
% 221.48/221.69  |- mesh__historyNote mesh__D011450 78   
% 221.48/221.69  |- mesh__recordOriginator mesh__D011450 RLS
% 221.48/221.69  |- skos__prefLabel mesh__D011450 Prostaglandin Endoperoxides, Synthetic
% 221.48/221.69  |- rdf__type mesh__D011450sskos__Concept
% 221.48/221.69  |- skos__scopeNote mesh__D011450
% 221.48/221.69       Synthetic compounds that are analogs of the naturally occurring prostaglandin endoperoxides and that mimic their pharmacologic and physiologic activities. They are usually more stable than the naturally occurring compounds.%A%    
% 221.48/221.69  |- skos__broader mesh__D011450smesh__D011465
% 221.48/221.69  |- mesh__dateRevised mesh__D011450 2005-06-30
% 221.48/221.69  |- skos__historyNote mesh__D011450 Peroxides %28%1966-1977%29%
% 221.48/221.69  |- skos__hiddenLabel mesh__D011450 Endoperoxides, Synthetic Prostaglandin
% 221.48/221.69  |- mesh__recordMaintainer mesh__D011450 ssb
% 221.48/221.69  |- skos__historyNote mesh__D011450 Prostaglandins %28%1966-1976%29%
% 221.48/221.69  |- skos__annotation mesh__D011450
% 221.48/221.69       coord IM with specific syn prostaglandin %28%NIM%29%; DF: PG ENDOPEROXIDES SYN%A%  
% 221.48/221.69  |- mesh__recordAuthorizer mesh__D011450 sjn
% 221.48/221.69  |- mesh__dateCreated mesh__D011450 1977-05-23
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D011450 2006
% 221.48/221.69  |- skos__altLabel mesh__D011450 Prostaglandin Endoperoxide Analogs
% 221.48/221.69  |- mesh__dateEstablished mesh__D011450 1978-01-01
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D005413 1998
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D005413 1992
% 221.48/221.69  |- skos__altLabel mesh__D005413 Pes Planus
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D005413 1994
% 221.48/221.69  |- skos__annotation mesh__D005413 congen or acquired   
% 221.48/221.69  |- mesh__dateCreated mesh__D005413 1999-01-01
% 221.48/221.69  |- mesh__dateRevised mesh__D005413 1991-06-18
% 221.48/221.69  |- mesh__recordAuthorizer mesh__D005413 PLS
% 221.48/221.69  |- skos__altLabel mesh__D005413 Flat Feet
% 221.48/221.69  |- skos__altLabel mesh__D005413 Flatfeet
% 221.48/221.69  |- rdf__type mesh__D005413sskos__Concept
% 221.48/221.69  |- mesh__recordOriginator mesh__D005413 NLM
% 221.48/221.69  |- skos__hiddenLabel mesh__D005413 Feet, Flat
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D005413 2004
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D005413 2002
% 221.48/221.69  |- skos__altLabel mesh__D005413 Flat Foot
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D005413 2006
% 221.48/221.69  |- skos__broader mesh__D005413smesh__D005530
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D005413 2003
% 221.48/221.69  |- skos__hiddenLabel mesh__D005413 Foot, Flat
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D005413 2001
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D005413 1997
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D005413 2005
% 221.48/221.69  |- skos__scopeNote mesh__D005413
% 221.48/221.69       A condition in which one or more of the arches of the foot have flattened out.%A%    
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D005413 1999
% 221.48/221.69  |- skos__prefLabel mesh__D005413 Flatfoot
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D005413 1993
% 221.48/221.69  |- mesh__recordMaintainer mesh__D005413 PLS
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D005413 2000
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D005413 1996
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D005413 1995
% 221.48/221.69  |- mesh__dateCreated mesh__D029861 2001-07-25
% 221.48/221.69  |- skos__annotation mesh__D029861
% 221.48/221.69       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D029861 2002
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D029861 2005
% 221.48/221.69  |- mesh__dateEstablished mesh__D029861 2002-01-01
% 221.48/221.69  |- skos__altLabel mesh__D029861 Tamarind
% 221.48/221.69  |- mesh__historyNote mesh__D029861 2002   
% 221.48/221.69  |- skos__broader mesh__D029861smesh__D007887
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D029861 2003
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D029861 2006
% 221.48/221.69  |- skos__scopeNote mesh__D029861
% 221.48/221.69       A plant genus of the family FABACEAE known for its sour fruit.%A%    
% 221.48/221.69  |- mesh__publicMeSHNote mesh__D029861 2002   
% 221.48/221.69  |- rdf__type mesh__D029861sskos__Concept
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D029861 2004
% 221.48/221.69  |- skos__prefLabel mesh__D029861 Tamarindus
% 221.48/221.69  |- skos__broader mesh__D020160Q000031smesh__D020160
% 221.48/221.69  |- mesh__preferredCombination mesh__D020160Q000031smesh__D001565
% 221.48/221.69  |- rdf__type mesh__D020160Q000031smesh__CompoundConcept
% 221.48/221.69  |- mesh__dateCreated mesh__D010358 1977-04-22
% 221.48/221.69  |- rdf__type mesh__D010358sskos__Concept
% 221.48/221.69  |- mesh__publicMeSHNote mesh__D010358 78   
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D010358 2004
% 221.48/221.69  |- mesh__dateRevised mesh__D010358 2003-07-09
% 221.48/221.69  |- mesh__recordOriginator mesh__D010358 EC
% 221.48/221.69  |- skos__hiddenLabel mesh__D010358 Patient Participation Rate
% 221.48/221.69  |- mesh__recordAuthorizer mesh__D010358 sjn
% 221.48/221.69  |- skos__broader mesh__D010358smesh__D010342
% 221.48/221.69  |- skos__hiddenLabel mesh__D010358 Participation Rates, Patient
% 221.48/221.69  |- mesh__historyNote mesh__D010358 78   
% 221.48/221.69  |- mesh__recordMaintainer mesh__D010358 hjn
% 221.48/221.69  |- skos__prefLabel mesh__D010358 Patient Participation
% 221.48/221.69  |- skos__related mesh__D010358smesh__D045808
% 221.48/221.69  |- skos__hiddenLabel mesh__D010358 Rate, Patient Participation
% 221.48/221.69  |- skos__hiddenLabel mesh__D010358 Participation, Patient
% 221.48/221.69  |- skos__hiddenLabel mesh__D010358 Participation Rate, Patient
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D010358 2005
% 221.48/221.69  |- skos__broader mesh__D010358smesh__D003256
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D010358 2006
% 221.48/221.69  |- skos__hiddenLabel mesh__D010358 Rates, Patient Participation
% 221.48/221.69  |- skos__scopeNote mesh__D010358
% 221.48/221.69       Patient involvement in the decision-making process in matters pertaining to health.%A%    
% 221.48/221.69  |- skos__annotation mesh__D010358
% 221.48/221.69       %22%patient involvement in the decision-making process in matters pertaining to health%22%; do not confuse with PATIENT COMPLIANCE %28%see note there%29%%A%  
% 221.48/221.69  |- mesh__dateEstablished mesh__D010358 1978-01-01
% 221.48/221.69  |- mesh__publicMeSHNote mesh__D029063 2002   
% 221.48/221.69  |- mesh__dateCreated mesh__D029063 2001-07-25
% 221.48/221.69  |- rdf__type mesh__D029063sskos__Concept
% 221.48/221.69  |- mesh__historyNote mesh__D029063 2002   
% 221.48/221.69  |- skos__annotation mesh__D029063
% 221.48/221.69       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.48/221.69  |- skos__prefLabel mesh__D029063 Aquifoliaceae
% 221.48/221.69  |- skos__broader mesh__D029063smesh__D019684
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D029063 2002
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D029063 2003
% 221.48/221.69  |- skos__scopeNote mesh__D029063
% 221.48/221.69       The holly plant family of the order Celastrales, subclass Rosidae, class Magnoliopsida.%A%    
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D029063 2005
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D029063 2004
% 221.48/221.69  |- mesh__dateEstablished mesh__D029063 2002-01-01
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D029063 2006
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D015841 1998
% 221.48/221.69  |- mesh__publicMeSHNote mesh__D015841 90   
% 221.48/221.69  |- skos__annotation mesh__D015841
% 221.48/221.69       recession of eye into orbit: do not confuse with EXOPHTHALMOS, protrusion%A%  
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D015841 1994
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D015841 1999
% 221.48/221.69  |- skos__scopeNote mesh__D015841
% 221.48/221.69       Recession of the eyeball into the orbit.     
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D015841 1995
% 221.48/221.69  |- mesh__recordMaintainer mesh__D015841 TGC
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D015841 2000
% 221.48/221.69  |- skos__broader mesh__D015841smesh__D009916
% 221.48/221.69  |- mesh__recordAuthorizer mesh__D015841 PLS
% 221.48/221.69  |- mesh__activeMeSHYear mesh__D015841 2003
% 221.48/221.69  |- mesh__historyNote mesh__D015841 90   
% 221.48/221.69  |- skos__historyNote mesh__D015841 Eye Diseases %28%1967-1989%29%
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D015841 2001
% 221.48/221.70  |- skos__historyNote mesh__D015841 Orbit %28%1966-1989%29%
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D015841 2004
% 221.48/221.70  |- rdf__type mesh__D015841sskos__Concept
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D015841 1996
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D015841 2002
% 221.48/221.70  |- mesh__recordOriginator mesh__D015841 EGC
% 221.48/221.70  |- skos__prefLabel mesh__D015841 Enophthalmos
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D015841 2005
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D015841 1997
% 221.48/221.70  |- mesh__dateEstablished mesh__D015841 1990-01-01
% 221.48/221.70  |- mesh__dateCreated mesh__D015841 1989-05-25
% 221.48/221.70  |- mesh__dateRevised mesh__D015841 1993-05-27
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D015841 2006
% 221.48/221.70  |- skos__broader mesh__D015043smesh__D009384
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D015043 2005
% 221.48/221.70  |- skos__broader mesh__D015043smesh__D007410
% 221.48/221.70  |- skos__scopeNote mesh__D015043
% 221.48/221.70       A syndrome that is characterized by the triad of severe PEPTIC ULCER, hypersecretion of GASTRIC ACID, and GASTRIN-producing tumors of the PANCREAS or other tissue %28%GASTRINOMA%29%. This syndrome may be sporadic or be associated with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1.%A%    
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D015043 2006
% 221.48/221.70  |- skos__broader mesh__D015043smesh__D010437
% 221.48/221.70  |- skos__broader mesh__D015043smesh__D013272
% 221.48/221.70  |- skos__related mesh__D015043smesh__D018761
% 221.48/221.70  |- rdf__type mesh__D015043sskos__Concept
% 221.48/221.70  |- mesh__recordAuthorizer mesh__D015043 sjn
% 221.48/221.70  |- mesh__recordOriginator mesh__D015043 NLM
% 221.48/221.70  |- skos__hiddenLabel mesh__D015043 Syndrome, Zollinger-Ellison
% 221.48/221.70  |- skos__broader mesh__D015043smesh__D005770
% 221.48/221.70  |- mesh__recordMaintainer mesh__D015043 lkt
% 221.48/221.70  |- mesh__dateRevised mesh__D015043 2004-07-07
% 221.48/221.70  |- skos__hiddenLabel mesh__D015043 Zollinger Ellison Syndrome
% 221.48/221.70  |- skos__prefLabel mesh__D015043 Zollinger-Ellison Syndrome
% 221.48/221.70  |- mesh__dateCreated mesh__D015043 1999-01-01
% 221.48/221.70  |- mesh__publicMeSHNote mesh__D009804 65   
% 221.48/221.70  |- rdf__type mesh__D009804sskos__Concept
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D009804 1999
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D009804 1993
% 221.48/221.70  |- mesh__recordMaintainer mesh__D009804 PLS
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D009804 1996
% 221.48/221.70  |- skos__hiddenLabel mesh__D009804 Odontoblast
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D009804 1995
% 221.48/221.70  |- mesh__historyNote mesh__D009804 65   
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D009804 2002
% 221.48/221.70  |- mesh__dateCreated mesh__D009804 1999-01-01
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D009804 1998
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D009804 1992
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D009804 1994
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D009804 2001
% 221.48/221.70  |- mesh__dateEstablished mesh__D009804 1965-01-01
% 221.48/221.70  |- skos__prefLabel mesh__D009804 Odontoblasts
% 221.48/221.70  |- mesh__recordOriginator mesh__D009804 NLM
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D009804 2004
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D009804 2000
% 221.48/221.70  |- mesh__recordAuthorizer mesh__D009804 NLM
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D009804 2006
% 221.48/221.70  |- skos__annotation mesh__D009804 A 11 qualif   
% 221.48/221.70  |- mesh__dateRevised mesh__D009804 1990-05-26
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D009804 1991
% 221.48/221.70  |- skos__broader mesh__D009804smesh__D003239
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D009804 2003
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D009804 2005
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D009804 1997
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D001821 2004
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D001821 2005
% 221.48/221.70  |- mesh__recordAuthorizer mesh__D001821 sjn
% 221.48/221.70  |- skos__broader mesh__D001821smesh__D009633
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D001821 2003
% 221.48/221.70  |- mesh__recordOriginator mesh__D001821 NLM
% 221.48/221.70  |- skos__annotation mesh__D001821
% 221.48/221.70       note category: do not confuse with FLUSHING %28%C23%29%   
% 221.48/221.70  |- mesh__dateCreated mesh__D001821 1999-01-01
% 221.48/221.70  |- skos__hiddenLabel mesh__D001821 Blushings
% 221.48/221.70  |- mesh__dateRevised mesh__D001821 2002-07-02
% 221.48/221.70  |- skos__prefLabel mesh__D001821 Blushing
% 221.48/221.70  |- skos__broader mesh__D001821smesh__D011603
% 221.48/221.70  |- skos__scopeNote mesh__D001821
% 221.48/221.70       Involuntary reddening, especially of the face, associated with feelings of embarrassment, confusion or shame.%A%    
% 221.48/221.70  |- mesh__recordMaintainer mesh__D001821 TAP
% 221.48/221.70  |- rdf__type mesh__D001821sskos__Concept
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D001821 2006
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D009006 2005
% 221.48/221.70  |- mesh__publicMeSHNote mesh__D009006
% 221.48/221.70       91; was see under CHROMOSOME DELETION 1985-90   
% 221.48/221.70  |- skos__historyNote mesh__D009006 Chromosome Aberrations %28%1968-1984%29%
% 221.48/221.70  |- skos__prefLabel mesh__D009006 Monosomy
% 221.48/221.70  |- skos__annotation mesh__D009006
% 221.48/221.70       %22%one chromosome of a pair is missing%22%   
% 221.48/221.70  |- mesh__recordOriginator mesh__D009006 AEP
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D009006 2006
% 221.48/221.70  |- skos__hiddenLabel mesh__D009006 Monosomies
% 221.48/221.70  |- mesh__recordAuthorizer mesh__D009006 sjn
% 221.48/221.70  |- mesh__dateCreated mesh__D009006 1984-04-05
% 221.48/221.70  |- skos__scopeNote mesh__D009006
% 221.48/221.70       The condition in which one chromosome of a pair is missing. In a normally diploid cell it is represented symbolically as 2N-1.%A%    
% 221.48/221.70  |- skos__historyNote mesh__D009006 Aneuploidy %28%1968-1984%29%
% 221.48/221.70  |- mesh__dateRevised mesh__D009006 2003-07-09
% 221.48/221.70  |- mesh__historyNote mesh__D009006
% 221.48/221.70       91%28%85%29%; was see under CHROMOSOME DELETION 1985-90   
% 221.48/221.70  |- skos__historyNote mesh__D009006 Chromosome Deletion %28%1975-1984%29%
% 221.48/221.70  |- rdf__type mesh__D009006sskos__Concept
% 221.48/221.70  |- mesh__recordMaintainer mesh__D009006 nns
% 221.48/221.70  |- skos__broader mesh__D009006smesh__D000782
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D009006 2004
% 221.48/221.70  |- mesh__dateEstablished mesh__D009006 1991-01-01
% 221.48/221.70  |- skos__historyNote mesh__D009006
% 221.48/221.70       Chromosome Abnormalities %28%1966-1984%29%
% 221.48/221.70  |- mesh__historyNote mesh__D001023 88   
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D001023 2004
% 221.48/221.70  |- skos__historyNote mesh__D001023 Aortic Valve %28%1966-1987%29%
% 221.48/221.70  |- mesh__dateCreated mesh__D001023 1987-04-30
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D001023 2006
% 221.48/221.70  |- mesh__recordMaintainer mesh__D001023 lkt
% 221.48/221.70  |- skos__broader mesh__D001023smesh__D016127
% 221.48/221.70  |- skos__hiddenLabel mesh__D001023 Prolapse, Aortic Valve
% 221.48/221.70  |- mesh__dateEstablished mesh__D001023 1988-01-01
% 221.48/221.70  |- skos__historyNote mesh__D001023
% 221.48/221.70       Aortic Valve Insufficiency %28%1967-1987%29%
% 221.48/221.70  |- skos__hiddenLabel mesh__D001023 Valve Prolapses, Aortic
% 221.48/221.70  |- mesh__dateRevised mesh__D001023 2003-07-09
% 221.48/221.70  |- rdf__type mesh__D001023sskos__Concept
% 221.48/221.70  |- mesh__publicMeSHNote mesh__D001023 88   
% 221.48/221.70  |- skos__hiddenLabel mesh__D001023 Valve Prolapse, Aortic
% 221.48/221.70  |- skos__prefLabel mesh__D001023 Aortic Valve Prolapse
% 221.48/221.70  |- mesh__recordOriginator mesh__D001023 EC
% 221.48/221.70  |- skos__hiddenLabel mesh__D001023 Aortic Valve Prolapses
% 221.48/221.70  |- skos__hiddenLabel mesh__D001023 Prolapses, Aortic Valve
% 221.48/221.70  |- mesh__recordAuthorizer mesh__D001023 sjn
% 221.48/221.70  |- skos__scopeNote mesh__D001023
% 221.48/221.70       The downward displacement of the cuspal material %28%misalignment of the cusps%29% below a line joining points of attachment of the aortic valve leaflets. The prolapsed cusp may occlude the ventricular septal defect during ventricular diastole.%A%    
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D001023 2005
% 221.48/221.70  |- skos__hiddenLabel mesh__D020786 Intracerebral Cavernous Hemangiomas
% 221.48/221.70  |- skos__hiddenLabel mesh__D020786 Extracerebral Cavernous Hemangiomas
% 221.48/221.70  |- skos__hiddenLabel mesh__D020786 Hemangiomas, Cerebral Cavernous
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D020786 2002
% 221.48/221.70  |- skos__hiddenLabel mesh__D020786 Intracerebral Cavernous Hemangioma
% 221.48/221.70  |- skos__hiddenLabel mesh__D020786 Hemangiomas, Intracerebral Cavernous
% 221.48/221.70  |- skos__broader mesh__D020786smesh__D006392
% 221.48/221.70  |- skos__hiddenLabel mesh__D020786 Cerebral Cavernous Hemangiomas
% 221.48/221.70  |- skos__hiddenLabel mesh__D020786 Hemangiomas, Extracerebral Cavernous
% 221.48/221.70  |- skos__broader mesh__D020786smesh__D020785
% 221.48/221.70  |- skos__hiddenLabel mesh__D020786 Hemangioma, Intracerebral Cavernous
% 221.48/221.70  |- skos__hiddenLabel mesh__D020786 Hemangioma, Extracerebral Cavernous
% 221.48/221.70  |- skos__hiddenLabel mesh__D020786 Extracerebral Cavernous Hemangioma
% 221.48/221.70  |- skos__hiddenLabel mesh__D020786 Cavernous Hemangiomas, Intracerebral
% 221.48/221.70  |- skos__hiddenLabel mesh__D020786 Cavernous Hemangioma, Cerebral
% 221.48/221.70  |- mesh__dateCreated mesh__D020786 1999-11-05
% 221.48/221.70  |- skos__altLabel mesh__D020786 Cavernous Angioma, Central Nervous System
% 221.48/221.70  |- skos__hiddenLabel mesh__D020786 Cavernous Hemangiomas, Cerebral
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D020786 2005
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D020786 2000
% 221.48/221.70  |- mesh__publicMeSHNote mesh__D020786 2000   
% 221.48/221.70  |- skos__hiddenLabel mesh__D020786 Hemangioma, Cerebral Cavernous
% 221.48/221.70  |- skos__historyNote mesh__D020786 Hemangioma, Cavernous %28%1966-1999%29%
% 221.48/221.70  |- rdf__type mesh__D020786sskos__Concept
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D020786 2003
% 221.48/221.70  |- skos__prefLabel mesh__D020786
% 221.48/221.70       Hemangioma, Cavernous, Central Nervous System
% 221.48/221.70  |- skos__hiddenLabel mesh__D020786 Cavernous Hemangiomas, Extracerebral
% 221.48/221.70  |- mesh__dateEstablished mesh__D020786 2000-01-01
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D020786 2006
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D020786 2001
% 221.48/221.70  |- skos__scopeNote mesh__D020786
% 221.48/221.70       A vascular malformation composed of clusters of large, thin walled veins lacking intervening nervous tissue. They are most common in the BRAIN STEM but may also occur in the cerebral hemispheres, diencephalon, cerebellum, and spinal cord. The lesions have a tendency to rupture and cause a variety of clinical deficits %28%e.g., SEIZURES; hemiparesis%29% that depend upon the location of the hemorrhage. %28%From Adams et al., Principles of Neurology, 6th ed, pp851-2%29%%A%    
% 221.48/221.70  |- skos__annotation mesh__D020786
% 221.48/221.70       coord %28%IM%29% with CENTRAL NERVOUS SYSTEM NEOPLASMS or specific %28%IM%29%%A%  
% 221.48/221.70  |- skos__altLabel mesh__D020786 Central Nervous System Cavernous Hemangioma
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D020786 2004
% 221.48/221.70  |- skos__altLabel mesh__D020786
% 221.48/221.70       Cavernous Hemangioma, Central Nervous System
% 221.48/221.70  |- mesh__historyNote mesh__D020786 2000   
% 221.48/221.70  |- skos__annotation mesh__D014749 /biosyn permitted if by plant   
% 221.48/221.70  |- mesh__publicMeSHNote mesh__D014749
% 221.48/221.70       91; was see under VINCA ALKALOIDS 1979-90   
% 221.48/221.70  |- mesh__recordOriginator mesh__D014749 RLS
% 221.48/221.70  |- skos__historyNote mesh__D014749 Vinca Alkaloids %28%1973-1978%29%
% 221.48/221.70  |- rdf__type mesh__D014749sskos__Concept
% 221.48/221.70  |- skos__scopeNote mesh__D014749
% 221.48/221.70       A major alkaloid of Vinca minor L., Apocynaceae. It has been used therapeutically as a vasodilator and antihypertensive agent, particularly in cerebrovascular disorders.%A%    
% 221.48/221.70  |- mesh__recordMaintainer mesh__D014749 ssb
% 221.48/221.70  |- skos__broader mesh__D014749smesh__D014748
% 221.48/221.70  |- skos__historyNote mesh__D014749 Alkaloids %28%1966-1972%29%
% 221.48/221.70  |- skos__prefLabel mesh__D014749 Vincamine
% 221.48/221.70  |- mesh__historyNote mesh__D014749
% 221.48/221.70       91%28%79%29%; was see under VINCA ALKALOIDS 1979-90   
% 221.48/221.70  |- mesh__dateCreated mesh__D014749 1978-05-19
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D014749 2005
% 221.48/221.70  |- mesh__recordAuthorizer mesh__D014749 sjn
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D014749 2006
% 221.48/221.70  |- mesh__dateEstablished mesh__D014749 1991-01-01
% 221.48/221.70  |- mesh__dateRevised mesh__D014749 2004-07-07
% 221.48/221.70  |- skos__historyNote mesh__D033903 Protein Binding %28%1966-1970%29%
% 221.48/221.70  |- skos__historyNote mesh__D033903 Carrier Proteins %28%1971-2002%29%
% 221.48/221.70  |- mesh__historyNote mesh__D033903 2003   
% 221.48/221.70  |- mesh__recordMaintainer mesh__D033903 SYSTEM
% 221.48/221.70  |- mesh__dateCreated mesh__D033903 2002-07-03
% 221.48/221.70  |- skos__broader mesh__D033903smesh__D001426
% 221.48/221.70  |- mesh__dateRevised mesh__D033903 2005-06-30
% 221.48/221.70  |- mesh__dateEstablished mesh__D033903 2003-01-01
% 221.48/221.70  |- skos__broader mesh__D033903smesh__D010940
% 221.48/221.70  |- mesh__recordOriginator mesh__D033903 jmp
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D033903 2006
% 221.48/221.70  |- skos__historyNote mesh__D033903 Proteins %28%1966-2002%29%
% 221.48/221.70  |- skos__prefLabel mesh__D033903 Periplasmic Proteins
% 221.48/221.70  |- skos__broader mesh__D033903smesh__D019843
% 221.48/221.70  |- mesh__recordAuthorizer mesh__D033903 sjn
% 221.48/221.70  |- rdf__type mesh__D033903sskos__Concept
% 221.48/221.70  |- mesh__publicMeSHNote mesh__D033903 2003   
% 221.48/221.70  |- skos__scopeNote mesh__D033903
% 221.48/221.70       Proteins found in the PERIPLASM of organisms with cell walls.%A%    
% 221.48/221.70  |- mesh__historyNote mesh__D019434
% 221.48/221.70       97; was HIV-1 REVERSE TRANSCRIPTASE %28%NM%29% 1992-96   
% 221.48/221.70  |- mesh__recordMaintainer mesh__D019434 ssb
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D019434 2005
% 221.48/221.70  |- skos__hiddenLabel mesh__D019434 HIV 1 Reverse Transcriptase p51
% 221.48/221.70  |- mesh__publicMeSHNote mesh__D019434
% 221.48/221.70       97; HIV-1 REVERSE TRANSCRIPTASE was indexed under RNA-DIRECTED DNA POLYMERASE 1992-96%A%  
% 221.48/221.70  |- skos__hiddenLabel mesh__D019434 HIV 1 Reverse Transcriptase
% 221.48/221.70  |- mesh__recordOriginator mesh__D019434 AGS
% 221.48/221.70  |- skos__prefLabel mesh__D019434 HIV-1 Reverse Transcriptase
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D019434 2006
% 221.48/221.70  |- mesh__dateCreated mesh__D019434 1996-06-27
% 221.48/221.70  |- mesh__dateRevised mesh__D019434 2003-07-09
% 221.48/221.70  |- skos__hiddenLabel mesh__D019434 HIV 1 Reverse Transcriptase p66
% 221.48/221.70  |- rdf__type mesh__D019434sskos__Concept
% 221.48/221.70  |- skos__scopeNote mesh__D019434
% 221.48/221.70       HIV-1 enzyme responsible for the synthesis of DNA from genomic RNA of the virus. It exists as a heterodimer of a 66 kDa %28%p66%29% subunit and a 51 kDa %28%p51%29% subunit. It is encoded by the pol gene of HIV-1. EC 2.7.7.-.%A%    
% 221.48/221.70  |- skos__hiddenLabel mesh__D019434 Reverse Transcriptase, HIV 1
% 221.48/221.70  |- mesh__onlineNote mesh__D019434
% 221.48/221.70       use HIV-1 REVERSE TRANSCRIPTASE %28%NM%29% to search HIV-1 REVERSE TRANSCRIPTASE 1992-96%A%  
% 221.48/221.70  |- skos__broader mesh__D019434smesh__D012194
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D019434 2004
% 221.48/221.70  |- skos__historyNote mesh__D019434
% 221.48/221.70       RNA-Directed DNA Polymerase %28%1992-1996%29%
% 221.48/221.70  |- skos__altLabel mesh__D019434 Reverse Transcriptase, HIV-1
% 221.48/221.70  |- skos__annotation mesh__D019434
% 221.48/221.70       /antag: coord IM with specific inhibitor %28%IM%29% + REVERSE TRANSCRIPTASE INHIBITORS %28%IM%29%%A%  
% 221.48/221.70  |- mesh__recordAuthorizer mesh__D019434 sjn
% 221.48/221.70  |- mesh__dateEstablished mesh__D019434 1997-01-01
% 221.48/221.70  |- skos__altLabel mesh__D011451 Prostaglandin H2 Synthetase
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 Synthetase, PGH2
% 221.48/221.70  |- skos__historyNote mesh__D011451 Oxygenases %28%1971-1973%29%
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 Prostaglandin G H Synthase
% 221.48/221.70  |- skos__broader mesh__D011451smesh__D009097
% 221.48/221.70  |- rdf__type mesh__D011451sskos__Concept
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 Cyclo-Oxygenase, Prostaglandin
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 Prostaglandin Cyclo Oxygenase
% 221.48/221.70  |- skos__historyNote mesh__D011451 Hydroxylases %28%1974-1977%29%
% 221.48/221.70  |- skos__altLabel mesh__D011451 PGH Synthase
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 Synthase, Prostaglandin H
% 221.48/221.70  |- mesh__dateRevised mesh__D011451 2005-06-30
% 221.48/221.70  |- mesh__dateCreated mesh__D011451 1974-11-11
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 G-H Synthase, Prostaglandin
% 221.48/221.70  |- skos__altLabel mesh__D011451 Prostaglandin Endoperoxide Synthetase
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 Cyclooxygenase, Prostaglandin
% 221.48/221.70  |- skos__altLabel mesh__D011451 Cyclooxygenase
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 Cyclo Oxygenase
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 Synthetase, Prostaglandin Endoperoxide
% 221.48/221.70  |- skos__altLabel mesh__D011451 PGH2 Synthetase
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 Cyclase, Hydroperoxide
% 221.48/221.70  |- skos__altLabel mesh__D011451 Arachidonic Acid Cyclooxygenase
% 221.48/221.70  |- skos__historyNote mesh__D011451 Prostaglandins %28%1971-1974%29%
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 Synthetase, Prostaglandin H2
% 221.48/221.70  |- skos__altLabel mesh__D011451 Hydroperoxide Cyclase
% 221.48/221.70  |- skos__altLabel mesh__D011451 Prostaglandin Cyclo-Oxygenase
% 221.48/221.70  |- skos__annotation mesh__D011451 DF: PG SYNTHASE   
% 221.48/221.70  |- mesh__dateEstablished mesh__D011451 1978-01-01
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 Cyclooxygenase, Arachidonic Acid
% 221.48/221.70  |- mesh__recordAuthorizer mesh__D011451 sjn
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 Synthase, PGH
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 Synthase, Prostaglandin
% 221.48/221.70  |- mesh__recordOriginator mesh__D011451 NLM
% 221.48/221.70  |- mesh__historyNote mesh__D011451 2006%28%1992%29%;   
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 Endoperoxide Synthetase, Prostaglandin
% 221.48/221.70  |- skos__altLabel mesh__D011451 Prostaglandin H Synthase
% 221.48/221.70  |- skos__altLabel mesh__D011451 Cyclo-Oxygenase
% 221.48/221.70  |- skos__prefLabel mesh__D011451 Prostaglandin-Endoperoxide Synthases
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 Synthetase, Prostaglandin
% 221.48/221.70  |- skos__scopeNote mesh__D011451
% 221.48/221.70       Enzyme complexes that catalyze the formation of PROSTAGLANDINS from the appropriate unsaturated FATTY ACIDS, molecular OXYGEN, and a reduced acceptor.%A%    
% 221.48/221.70  |- skos__altLabel mesh__D011451 Fatty Acid Cyclo-Oxygenase
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 Synthase, Prostaglandin-Endoperoxide
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D011451 2006
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 Cyclo-Oxygenase, Fatty Acid
% 221.48/221.70  |- skos__altLabel mesh__D011451 Prostaglandin Synthase
% 221.48/221.70  |- skos__altLabel mesh__D011451 Prostaglandin Synthetase
% 221.48/221.70  |- skos__altLabel mesh__D011451 Prostaglandin-Endoperoxide Synthase
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 Prostaglandin Endoperoxide Synthases
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 Fatty Acid Cyclo Oxygenase
% 221.48/221.70  |- skos__altLabel mesh__D011451 Prostaglandin G-H Synthase
% 221.48/221.70  |- mesh__publicMeSHNote mesh__D011451
% 221.48/221.70       2006; see PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1978-2005, see PROSTAGLANDIN SYNTHASE 1978-1991, see under HYDROXYLASES 1975-1977%A%  
% 221.48/221.70  |- skos__altLabel mesh__D011451 Cyclooxygenases
% 221.48/221.70  |- mesh__recordMaintainer mesh__D011451 jmp
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 Synthases, Prostaglandin-Endoperoxide
% 221.48/221.70  |- skos__hiddenLabel mesh__D011451 Synthase, Prostaglandin G-H
% 221.48/221.70  |- skos__broader mesh__D011451smesh__D006899
% 221.48/221.70  |- skos__historyNote mesh__D011451 Multienzyme Complexes %28%1973-1974%29%
% 221.48/221.70  |- skos__altLabel mesh__D011451 Prostaglandin Cyclooxygenase
% 221.48/221.70  |- skos__annotation mesh__D005414
% 221.48/221.70       /drug ther: consider also ANTIFOAMING AGENTS; see note on %22%intestinal gases%22% under GASES%A%  
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D005414 2001
% 221.48/221.70  |- skos__related mesh__D005414smesh__D000934
% 221.48/221.70  |- skos__altLabel mesh__D005414 Flatus
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D005414 2003
% 221.48/221.70  |- skos__broader mesh__D005414smesh__D012817
% 221.48/221.70  |- skos__prefLabel mesh__D005414 Flatulence
% 221.48/221.70  |- rdf__type mesh__D005414sskos__Concept
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D005414 2005
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D005414 2004
% 221.48/221.70  |- mesh__recordAuthorizer mesh__D005414 sjn
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D005414 2002
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D005414 2006
% 221.48/221.70  |- mesh__recordMaintainer mesh__D005414 KEV
% 221.48/221.70  |- skos__scopeNote mesh__D005414
% 221.48/221.70       Production or presence of gas in the gastrointestinal tract which may be expelled through the anus.%A%    
% 221.48/221.70  |- mesh__dateRevised mesh__D005414 1999-11-03
% 221.48/221.70  |- mesh__recordOriginator mesh__D005414 NLM
% 221.48/221.70  |- mesh__dateCreated mesh__D005414 1999-01-01
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D005414 2000
% 221.48/221.70  |- mesh__historyNote mesh__D029862 2002   
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D029862 2005
% 221.48/221.70  |- skos__annotation mesh__D029862
% 221.48/221.70       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.48/221.70  |- skos__broader mesh__D029862smesh__D007887
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D029862 2003
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D029862 2006
% 221.48/221.70  |- mesh__dateCreated mesh__D029862 2001-07-25
% 221.48/221.70  |- mesh__publicMeSHNote mesh__D029862 2002   
% 221.48/221.70  |- mesh__dateEstablished mesh__D029862 2002-01-01
% 221.48/221.70  |- rdf__type mesh__D029862sskos__Concept
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D029862 2004
% 221.48/221.70  |- skos__altLabel mesh__D029862 Algarrobo
% 221.48/221.70  |- skos__prefLabel mesh__D029862 Prosopis
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D029862 2002
% 221.48/221.70  |- skos__scopeNote mesh__D029862
% 221.48/221.70       A plant genus of the family FABACEAE that is a source of prosopis gum.%A%    
% 221.48/221.70  |- skos__altLabel mesh__D029064 Aroids
% 221.48/221.70  |- mesh__dateCreated mesh__D029064 2001-07-25
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D029064 2006
% 221.48/221.70  |- skos__altLabel mesh__D029064 Skunk Cabbage
% 221.48/221.70  |- mesh__recordMaintainer mesh__D029064 ssb
% 221.48/221.70  |- mesh__publicMeSHNote mesh__D029064 2002   
% 221.48/221.70  |- skos__altLabel mesh__D029064 Lettuce, Water
% 221.48/221.70  |- mesh__dateEstablished mesh__D029064 2002-01-01
% 221.48/221.70  |- mesh__recordAuthorizer mesh__D029064 sjn
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D029064 2005
% 221.48/221.70  |- skos__broader mesh__D029064smesh__D019684
% 221.48/221.70  |- skos__prefLabel mesh__D029064 Araceae
% 221.48/221.70  |- rdf__type mesh__D029064sskos__Concept
% 221.48/221.70  |- mesh__historyNote mesh__D029064 2002   
% 221.48/221.70  |- mesh__recordOriginator mesh__D029064 ssb
% 221.48/221.70  |- skos__altLabel mesh__D029064 Cabbage, Skunk
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D029064 2004
% 221.48/221.70  |- skos__annotation mesh__D029064
% 221.48/221.70       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.48/221.70  |- mesh__dateRevised mesh__D029064 2002-07-02
% 221.48/221.70  |- skos__scopeNote mesh__D029064
% 221.48/221.70       A plant family of the order Arales, subclass Arecidae, class Liliopsida %28%monocot%29%. Many members contain OXALIC ACID and calcium oxalate %28%OXALATES%29%.%A%    
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D029064 2003
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D010359 2000
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D010359 2005
% 221.48/221.70  |- skos__prefLabel mesh__D010359 Patient Readmission
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D010359 1998
% 221.48/221.70  |- mesh__publicMeSHNote mesh__D010359
% 221.48/221.70       78; was HOSPITAL READMISSION 1972-77; HOSPITAL READMISSIONS was see PATIENT READMISSION 1997%A%  
% 221.48/221.70  |- skos__altLabel mesh__D010359 Readmissions, Hospital
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D010359 2006
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D010359 1999
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D010359 2001
% 221.48/221.70  |- mesh__recordAuthorizer mesh__D010359 SJN
% 221.48/221.70  |- mesh__dateCreated mesh__D010359 1999-01-01
% 221.48/221.70  |- mesh__historyNote mesh__D010359
% 221.48/221.70       78; was HOSPITAL READMISSION 1970-77 %28%Prov 1970-71%29%; HOSPITAL READMISSIONS was see PATIENT READMISSION 1997%A%  
% 221.48/221.70  |- skos__altLabel mesh__D010359 Hospital Readmission
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D010359 2003
% 221.48/221.70  |- skos__hiddenLabel mesh__D010359 Patient Readmissions
% 221.48/221.70  |- mesh__dateRevised mesh__D010359 1997-06-20
% 221.48/221.70  |- rdf__type mesh__D010359sskos__Concept
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D010359 2004
% 221.48/221.70  |- mesh__onlineNote mesh__D010359
% 221.48/221.70       use PATIENT READMISSION to search HOSPITAL READMISSION 1970-77 %28%as Prov 1970-71%29%%A%  
% 221.48/221.70  |- mesh__recordMaintainer mesh__D010359 PXP
% 221.48/221.70  |- mesh__dateEstablished mesh__D010359 1972-01-01
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D010359 2002
% 221.48/221.70  |- skos__hiddenLabel mesh__D010359 Readmissions, Patient
% 221.48/221.70  |- skos__altLabel mesh__D010359 Readmission, Hospital
% 221.48/221.70  |- mesh__recordOriginator mesh__D010359 NLM
% 221.48/221.70  |- skos__hiddenLabel mesh__D010359 Readmission, Patient
% 221.48/221.70  |- skos__scopeNote mesh__D010359
% 221.48/221.70       Subsequent admissions of a patient to a hospital or other health care institution for treatment.%A%    
% 221.48/221.70  |- skos__broader mesh__D010359smesh__D006760
% 221.48/221.70  |- skos__historyNote mesh__D010359 Hospitalization %28%1966-1969%29%
% 221.48/221.70  |- skos__hiddenLabel mesh__D021081 Biological Clock Disturbance
% 221.48/221.70  |- skos__hiddenLabel mesh__D021081 Circadian Rhythm Disorder
% 221.48/221.70  |- mesh__publicMeSHNote mesh__D021081
% 221.48/221.70       2001; see SLEEP DISORDERS, CIRCADIAN RHYTHM 2000; for CHRONOBIOLOGY DISORDERS see SLEEP DISORDERS, CIRCADIAN RHYTHM 2000%A%  
% 221.48/221.70  |- mesh__recordMaintainer mesh__D021081 nns
% 221.48/221.70  |- skos__broader mesh__D021081smesh__D009422
% 221.48/221.70  |- mesh__historyNote mesh__D021081
% 221.48/221.70       2001; use SLEEP DISORDERS, CIRCADIAN RHYTHM 2000; for CHRONOBIOLOGY DISORDERS use SLEEP DISORDERS, CIRCADIAN RHYTHM 2000%A%  
% 221.48/221.70  |- skos__hiddenLabel mesh__D021081 Chronobiology Disorder
% 221.48/221.70  |- skos__altLabel mesh__D021081 Inversion of Circadian Rhythm, Psychogenic
% 221.48/221.70  |- skos__scopeNote mesh__D021081
% 221.48/221.70       Disruptions of the rhythmic cycle of bodily functions or activities.%A%    
% 221.48/221.70  |- mesh__recordAuthorizer mesh__D021081 ags
% 221.48/221.70  |- mesh__dateEstablished mesh__D021081 2001-01-01
% 221.48/221.70  |- skos__altLabel mesh__D021081 Circadian Dysregulation
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D021081 2002
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D021081 2004
% 221.48/221.70  |- skos__prefLabel mesh__D021081 Chronobiology Disorders
% 221.48/221.70  |- skos__hiddenLabel mesh__D021081 Disturbances, Biological Clock
% 221.48/221.70  |- skos__hiddenLabel mesh__D021081 Dysregulation, Circadian
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D021081 2001
% 221.48/221.70  |- skos__altLabel mesh__D021081 Biological Clock Disturbances
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D021081 2006
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D021081 2003
% 221.48/221.70  |- mesh__recordOriginator mesh__D021081 nns
% 221.48/221.70  |- mesh__dateCreated mesh__D021081 2000-07-05
% 221.48/221.70  |- skos__hiddenLabel mesh__D021081 Disturbance, Biological Clock
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D021081 2005
% 221.48/221.70  |- rdf__type mesh__D021081sskos__Concept
% 221.48/221.70  |- skos__scopeNote mesh__D015842
% 221.48/221.70       Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES.%A%    
% 221.48/221.70  |- mesh__recordOriginator mesh__D015842 RLS
% 221.48/221.70  |- skos__historyNote mesh__D015842 Protease Inhibitors %28%1979-1989%29%
% 221.48/221.70  |- skos__historyNote mesh__D015842 Enzyme Inhibitors %28%1968-1978%29%
% 221.48/221.70  |- skos__annotation mesh__D015842 DF: SERINE PROTEINASE INHIB   
% 221.48/221.70  |- skos__broader mesh__D015842smesh__D011480
% 221.48/221.70  |- skos__altLabel mesh__D015842 Serine Protease Inhibitors
% 221.48/221.70  |- mesh__recordMaintainer mesh__D015842 ssb
% 221.48/221.70  |- skos__altLabel mesh__D015842 Serine Proteinase Antagonists
% 221.48/221.70  |- mesh__recordAuthorizer mesh__D015842 sjn
% 221.48/221.70  |- skos__altLabel mesh__D015842 Serine Protease Inhibitors, Endogenous
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D015842 2004
% 221.48/221.70  |- rdf__type mesh__D015842sskos__Concept
% 221.48/221.70  |- skos__related mesh__D015842smesh__D015843
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D015842 2005
% 221.48/221.70  |- mesh__historyNote mesh__D015842 90   
% 221.48/221.70  |- mesh__dateRevised mesh__D015842 2003-07-09
% 221.48/221.70  |- mesh__dateEstablished mesh__D015842 1990-01-01
% 221.48/221.70  |- skos__prefLabel mesh__D015842 Serine Proteinase Inhibitors
% 221.48/221.70  |- mesh__dateCreated mesh__D015842 1989-05-25
% 221.48/221.70  |- mesh__activeMeSHYear mesh__D015842 2006
% 221.48/221.70  |- mesh__publicMeSHNote mesh__D015842 90   
% 221.48/221.71  |- skos__altLabel mesh__D015842 Serine Endopeptidase Inhibitors
% 221.48/221.71  |- skos__altLabel mesh__D015842 Serine Protease Inhibitors, Exogenous
% 221.48/221.71  |- mesh__recordMaintainer mesh__D015044 lkt
% 221.48/221.71  |- skos__broader mesh__D015044smesh__D010063
% 221.48/221.71  |- skos__scopeNote mesh__D015044
% 221.48/221.71       A tough transparent membrane surrounding the OVUM. It is penetrated by the sperm during FERTILIZATION.%A%    
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D015044 2003
% 221.48/221.71  |- rdf__type mesh__D015044sskos__Concept
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D015044 2004
% 221.48/221.71  |- mesh__dateCreated mesh__D015044 1974-11-11
% 221.48/221.71  |- mesh__publicMeSHNote mesh__D015044 91; was see under OVUM 1975-90   
% 221.48/221.71  |- skos__broader mesh__D015044smesh__D005109
% 221.48/221.71  |- mesh__dateEstablished mesh__D015044 1991-01-01
% 221.48/221.71  |- mesh__historyNote mesh__D015044
% 221.48/221.71       91%28%75%29%; was see under OVUM 1975-90   
% 221.48/221.71  |- mesh__dateRevised mesh__D015044 2002-07-03
% 221.48/221.71  |- skos__prefLabel mesh__D015044 Zona Pellucida
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D015044 2005
% 221.48/221.71  |- mesh__recordAuthorizer mesh__D015044 sjn
% 221.48/221.71  |- mesh__recordOriginator mesh__D015044 NLM
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D015044 2006
% 221.48/221.71  |- skos__broader mesh__D009805smesh__D038081
% 221.48/221.71  |- mesh__historyNote mesh__D009805 65   
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D009805 2005
% 221.48/221.71  |- mesh__dateRevised mesh__D009805 2004-07-07
% 221.48/221.71  |- mesh__dateCreated mesh__D009805 1999-01-01
% 221.48/221.71  |- skos__hiddenLabel mesh__D009805 Odontogeneses
% 221.48/221.71  |- mesh__dateEstablished mesh__D009805 1965-01-01
% 221.48/221.71  |- mesh__recordAuthorizer mesh__D009805 sjn
% 221.48/221.71  |- mesh__recordOriginator mesh__D009805 NLM
% 221.48/221.71  |- skos__scopeNote mesh__D009805
% 221.48/221.71       The process of TOOTH formation. It is divided into several stages including: the dental lamina stage, the bud stage, the cap stage, and the bell stage. Odontogenesis includes the production of tooth enamel %28%AMELOGENESIS%29%, dentin %28%DENTINOGENESIS%29%, and dental cementum %28%CEMENTOGENESIS%29%.%A%    
% 221.48/221.71  |- mesh__publicMeSHNote mesh__D009805 65   
% 221.48/221.71  |- skos__prefLabel mesh__D009805 Odontogenesis
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D009805 2006
% 221.48/221.71  |- mesh__recordMaintainer mesh__D009805 lkt
% 221.48/221.71  |- rdf__type mesh__D009805sskos__Concept
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D001822 2003
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D001822 1995
% 221.48/221.71  |- mesh__dateEstablished mesh__D001822 1973-01-01
% 221.48/221.71  |- skos__prefLabel mesh__D001822 Body Burden
% 221.48/221.71  |- skos__related mesh__D001822smesh__D010573
% 221.48/221.71  |- mesh__recordAuthorizer mesh__D001822 PLS
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D001822 1993
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D001822 2001
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D001822 1999
% 221.48/221.71  |- mesh__dateCreated mesh__D001822 1999-01-01
% 221.48/221.71  |- skos__scopeNote mesh__D001822
% 221.48/221.71       The total amount of a chemical, metal or radioactive substance present at any time after absorption in the body of man or animal.%A%    
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D001822 1994
% 221.48/221.71  |- skos__annotation mesh__D001822
% 221.48/221.71       NIM; not restricted to radioactive substances: applicable to chemical, metal or radioactive substances; no qualif%A%  
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D001822 1997
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D001822 1992
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D001822 2000
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D001822 1998
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D001822 1996
% 221.48/221.71  |- rdf__type mesh__D001822sskos__Concept
% 221.48/221.71  |- mesh__recordOriginator mesh__D001822 NLM
% 221.48/221.71  |- skos__historyNote mesh__D001822 Radiation Monitoring %28%1966-1970%29%
% 221.48/221.71  |- skos__hiddenLabel mesh__D001822 Burden, Body
% 221.48/221.71  |- mesh__historyNote mesh__D001822
% 221.48/221.71       73%28%71%29%; only radioactive substances 1971-77   
% 221.48/221.71  |- skos__related mesh__D001822smesh__D004350
% 221.48/221.71  |- mesh__publicMeSHNote mesh__D001822
% 221.48/221.71       73; only radioactive substances 1973-77   
% 221.48/221.71  |- skos__broader mesh__D001822smesh__D004787
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D001822 2006
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D001822 2002
% 221.48/221.71  |- skos__hiddenLabel mesh__D001822 Body Burdens
% 221.48/221.71  |- skos__hiddenLabel mesh__D001822 Burdens, Body
% 221.48/221.71  |- skos__broader mesh__D001822smesh__D011834
% 221.48/221.71  |- mesh__dateRevised mesh__D001822 1991-06-20
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D001822 2004
% 221.48/221.71  |- mesh__recordMaintainer mesh__D001822 TGC
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D001822 2005
% 221.48/221.71  |- mesh__dateCreated mesh__D009007 1999-01-01
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D009007 2006
% 221.48/221.71  |- mesh__recordMaintainer mesh__D009007 ags
% 221.48/221.71  |- skos__historyNote mesh__D009007 Mammals %28%1966-1972%29%
% 221.48/221.71  |- mesh__onlineNote mesh__D009007 search MAMMALS 1966-67   
% 221.48/221.71  |- mesh__publicMeSHNote mesh__D009007 75,63-67   
% 221.48/221.71  |- mesh__historyNote mesh__D009007 75%28%73%29%63-67   
% 221.48/221.71  |- skos__annotation mesh__D009007
% 221.48/221.71       GEN or unspecified; prefer ECHIDNA %26% PLATYPUS; IM; qualif permitted%A%  
% 221.48/221.71  |- mesh__dateRevised mesh__D009007 2003-07-09
% 221.48/221.71  |- mesh__recordOriginator mesh__D009007 NLM
% 221.48/221.71  |- skos__hiddenLabel mesh__D009007 Monotrematas
% 221.48/221.71  |- rdf__type mesh__D009007sskos__Concept
% 221.48/221.71  |- skos__broader mesh__D009007smesh__D008322
% 221.48/221.71  |- mesh__recordAuthorizer mesh__D009007 sjn
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D009007 2004
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D009007 2005
% 221.48/221.71  |- skos__prefLabel mesh__D009007 Monotremata
% 221.48/221.71  |- mesh__dateEstablished mesh__D009007 1975-01-01
% 221.48/221.71  |- skos__prefLabel mesh__D001024 Aortic Valve Stenosis
% 221.48/221.71  |- rdf__type mesh__D001024sskos__Concept
% 221.48/221.71  |- mesh__historyNote mesh__D001024
% 221.48/221.71       67; was AORTIC STENOSIS 1963-66; AORTIC VALVE DISEASES was heading 1963-66%A%  
% 221.48/221.71  |- mesh__recordAuthorizer mesh__D001024 sjn
% 221.48/221.71  |- skos__hiddenLabel mesh__D001024 Stenosis, Aortic Valve
% 221.48/221.71  |- skos__hiddenLabel mesh__D001024 Aortic Valve Stenoses
% 221.48/221.71  |- skos__hiddenLabel mesh__D001024 Valve Stenoses, Aortic
% 221.48/221.71  |- skos__hiddenLabel mesh__D001024 Stenosis, Aortic
% 221.48/221.71  |- mesh__dateCreated mesh__D001024 1999-01-01
% 221.48/221.71  |- skos__hiddenLabel mesh__D001024 Valve Stenosis, Aortic
% 221.48/221.71  |- skos__scopeNote mesh__D001024
% 221.48/221.71       Constriction in the opening of the aortic valve or of the supravalvular or subvalvular regions.%A%    
% 221.48/221.71  |- skos__hiddenLabel mesh__D001024 Stenoses, Aortic
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D001024 2003
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D001024 2001
% 221.48/221.71  |- skos__annotation mesh__D001024
% 221.48/221.71       aortic valve atresia = AORTIC VALVE /abnorm   
% 221.48/221.71  |- mesh__onlineNote mesh__D001024
% 221.48/221.71       use AORTIC VALVE STENOSIS to search AORTIC STENOSIS 1966; search AORTIC VALVE DISEASES under HEART VALVE DISEASES 1966%A%  
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D001024 2005
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D001024 2004
% 221.48/221.71  |- skos__broader mesh__D001024smesh__D006349
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D001024 2006
% 221.48/221.71  |- mesh__publicMeSHNote mesh__D001024
% 221.48/221.71       67; was AORTIC STENOSIS 1963-66; AORTIC VALVE DISEASES was heading 1963-66%A%  
% 221.48/221.71  |- mesh__dateEstablished mesh__D001024 1967-01-01
% 221.48/221.71  |- skos__altLabel mesh__D001024 Aortic Stenosis
% 221.48/221.71  |- mesh__recordOriginator mesh__D001024 NLM
% 221.48/221.71  |- skos__related mesh__D001024smesh__D002312
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D001024 2002
% 221.48/221.71  |- mesh__recordMaintainer mesh__D001024 nns
% 221.48/221.71  |- mesh__dateRevised mesh__D001024 2000-06-21
% 221.48/221.71  |- skos__hiddenLabel mesh__D001024 Stenoses, Aortic Valve
% 221.48/221.71  |- skos__altLabel mesh__D020787 Angioma, Venous, Central Nervous System
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D020787 2001
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D020787 2002
% 221.48/221.71  |- skos__prefLabel mesh__D020787 Central Nervous System Venous Angioma
% 221.48/221.71  |- mesh__dateCreated mesh__D020787 1999-11-03
% 221.48/221.71  |- skos__scopeNote mesh__D020787
% 221.48/221.71       A congenital anomaly characterized by clusters of dilated hypertrophic veins surrounded by normal nervous system tissue. The blood vessels have thin walls composed of a single layer of fibromuscular tissue lined by epithelium. These lesions may occur in the brain, but are more frequent in the spinal cord and spinal meninges. The incidence of hemorrhage is relatively low, but when it occurs it may be associated with venous infarctions of the nervous system. %28%From Davis et al., Textbook of Neuropathology, 2nd ed, pp628-9%29%%A%    
% 221.48/221.71  |- mesh__activeMeSHYear mesh__D020787 2005
% 221.48/221.71  |- rdf__type mesh__D020787sskos__Concept
% 221.57/221.71  |- skos__broader mesh__D020787smesh__D020785
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D020787 2003
% 221.57/221.71  |- skos__altLabel mesh__D020787 Venous Angioma, Central Nervous System
% 221.57/221.71  |- mesh__dateEstablished mesh__D020787 2000-01-01
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D020787 2006
% 221.57/221.71  |- skos__broader mesh__D020787smesh__D006391
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D020787 2004
% 221.57/221.71  |- mesh__historyNote mesh__D020787 2000   
% 221.57/221.71  |- skos__historyNote mesh__D020787
% 221.57/221.71       Intracranial Arteriovenous Malformations %28%1978-1999%29%
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D020787 2000
% 221.57/221.71  |- mesh__publicMeSHNote mesh__D020787 2000   
% 221.57/221.71  |- skos__historyNote mesh__D020787 Hemangioma %28%1969-1999%29%
% 221.57/221.71  |- mesh__historyNote mesh__D019435
% 221.57/221.71       97; GUERNSEY ISLAND was see CHANNEL ISLANDS 1975-96   
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D019435 2000
% 221.57/221.71  |- skos__historyNote mesh__D019435 Channel Islands %28%1967-1996%29%
% 221.57/221.71  |- skos__annotation mesh__D019435 one of the Channel Islands   
% 221.57/221.71  |- mesh__dateEstablished mesh__D019435 1997-01-01
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D019435 2003
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D019435 1998
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D019435 2001
% 221.57/221.71  |- rdf__type mesh__D019435sskos__Concept
% 221.57/221.71  |- skos__altLabel mesh__D019435 Guernsey Island
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D019435 2004
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D019435 1999
% 221.57/221.71  |- skos__broader mesh__D019435smesh__D002603
% 221.57/221.71  |- mesh__onlineNote mesh__D019435
% 221.57/221.71       use CHANNEL ISLANDS to search GUERNSEY ISLAND 1975-96   
% 221.57/221.71  |- skos__prefLabel mesh__D019435 Guernsey
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D019435 2002
% 221.57/221.71  |- skos__scopeNote mesh__D019435
% 221.57/221.71       The second largest of the Channel Islands in the English Channel. It covers about 30 square miles and is where the Guernsey breed of cattle originated. The name is Scandinavian, Grani%27%s island %28%ey means island%29%. %28%From Webster%27%s New Geographical Dictionary, 1988, p474 %26% Room, Brewer%27%s Dictionary of Names, 1992, p222%29%%A%    
% 221.57/221.71  |- mesh__dateCreated mesh__D019435 1996-06-26
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D019435 2005
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D019435 1997
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D019435 2006
% 221.57/221.71  |- mesh__historyNote mesh__D011452
% 221.57/221.71       94; was PROSTAGLANDIN-13,14-REDUCTASE 1978-93 %28%see under OXIDOREDUCTASES 1978-90%29%; DELTA 13-15-KETOPROSTAGLANDIN REDUCTASE was %28%NM%29% 1976-93; PROSTAGLANDIN DELTA 13 REDUCTASE was %28%NM%29% 1981-93%A%  
% 221.57/221.71  |- skos__altLabel mesh__D011452 Prostaglandin-13,14-Reductase
% 221.57/221.71  |- mesh__dateEstablished mesh__D011452 1991-01-01
% 221.57/221.71  |- skos__historyNote mesh__D011452 specific prostaglandin %28%1975-1977%29%
% 221.57/221.71  |- mesh__dateRevised mesh__D011452 2005-06-30
% 221.57/221.71  |- mesh__dateCreated mesh__D011452 1977-05-23
% 221.57/221.71  |- skos__historyNote mesh__D011452 Oxidoreductases %28%1966-1977%29%
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D011452 2006
% 221.57/221.71  |- skos__altLabel mesh__D011452 delta 13-15-Ketoprostaglandin Reductase
% 221.57/221.71  |- mesh__recordAuthorizer mesh__D011452 sjn
% 221.57/221.71  |- skos__hiddenLabel mesh__D011452 Reductase, delta 13-15-Ketoprostaglandin
% 221.57/221.71  |- skos__hiddenLabel mesh__D011452 13-Reductase, 15-Ketoprostaglandin delta
% 221.57/221.71  |- skos__hiddenLabel mesh__D011452 15 Ketoprostaglandin delta 13 Reductase
% 221.57/221.71  |- mesh__onlineNote mesh__D011452
% 221.57/221.71       use 15-OXOPROSTAGLANDIN 13-REDUCTASE to search PROSTAGLANDIN-13,14-REDUCTASE 1978-93; use 15-OXOPROSTAGLANDIN 13-REDUCTASE %28%NM%29% to search DELTA 13-15-KETOPROSTAGLANDIN REDUCTASE 1980-93 %26% PROSTAGLANDIN DELTA 13 REDUCTASE 1981-93%A%  
% 221.57/221.71  |- skos__altLabel mesh__D011452 15-Ketoprostaglandin delta 13-Reductase
% 221.57/221.71  |- skos__hiddenLabel mesh__D011452 delta 13 PG Reductase
% 221.57/221.71  |- skos__hiddenLabel mesh__D011452 Prostaglandin 13,14 Reductase
% 221.57/221.71  |- mesh__recordMaintainer mesh__D011452 jmp
% 221.57/221.71  |- mesh__publicMeSHNote mesh__D011452
% 221.57/221.71       94; was PROSTAGLANDIN-13,14-REDUCTASE 1978-93 %28%see under OXIDOREDUCTASES 1978-90%29%; DELTA 13-15-KETOPROSTAGLANDIN REDUCTASE was indexed under PROSTAGLANDIN-13,14-REDUCTASE 1981-93 and OXIDOREDUCTASES %26% PROSTAGLANDINS 1976-80; PROSTAGLANDIN DELTA 13 REDUCTASE was indexed under OXIDOREDUCTASES 1981-93%A%  
% 221.57/221.71  |- skos__hiddenLabel mesh__D011452 delta 13-Reductase, 15-Ketoprostaglandin
% 221.57/221.71  |- skos__hiddenLabel mesh__D011452 delta 13 15 Ketoprostaglandin Reductase
% 221.57/221.71  |- skos__altLabel mesh__D011452 Prostaglandin delta-13-Reductase
% 221.57/221.71  |- skos__hiddenLabel mesh__D011452 Prostaglandin delta 13 Reductase
% 221.57/221.71  |- skos__hiddenLabel mesh__D011452 13-15-Ketoprostaglandin Reductase, delta
% 221.57/221.71  |- mesh__recordOriginator mesh__D011452 RLS
% 221.57/221.71  |- rdf__type mesh__D011452sskos__Concept
% 221.57/221.71  |- skos__scopeNote mesh__D011452
% 221.57/221.71       %28%5Z%29%-%28%15S%29%-11 alpha-Hydroxy-9,15-dioxoprostanoate:NAD%28%P%29%+ delta%28%13%29%-oxidoreductase. An enzyme active in prostaglandin E and F catabolism. It catalyzes the reduction of the double bond at the 13-14 position of the 15-ketoprostaglandins and uses NADPH as cofactor. EC 1.3.1.48.%A%    
% 221.57/221.71  |- skos__hiddenLabel mesh__D011452 delta-13-Reductase, Prostaglandin
% 221.57/221.71  |- skos__prefLabel mesh__D011452 15-Oxoprostaglandin 13-Reductase
% 221.57/221.71  |- skos__historyNote mesh__D011452 Prostaglandins %28%1966-1977%29%
% 221.57/221.71  |- skos__hiddenLabel mesh__D011452 15 Oxoprostaglandin 13 Reductase
% 221.57/221.71  |- skos__hiddenLabel mesh__D011452 13-Reductase, 15-Oxoprostaglandin
% 221.57/221.71  |- skos__annotation mesh__D011452 DF: OXOPG REDUCTASE   
% 221.57/221.71  |- skos__altLabel mesh__D011452 delta-13-PG-Reductase
% 221.57/221.71  |- skos__broader mesh__D011452smesh__D044925
% 221.57/221.71  |- skos__broader mesh__D005415smesh__D006575
% 221.57/221.71  |- rdf__type mesh__D005415sskos__Concept
% 221.57/221.71  |- mesh__recordMaintainer mesh__D005415 ssb
% 221.57/221.71  |- skos__broader mesh__D005415smesh__D003067
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D005415 2006
% 221.57/221.71  |- skos__annotation mesh__D005415 do not confuse with FLAVONES   
% 221.57/221.71  |- skos__broader mesh__D005415smesh__D011621
% 221.57/221.71  |- mesh__dateCreated mesh__D005415 1999-01-01
% 221.57/221.71  |- mesh__recordAuthorizer mesh__D005415 sjn
% 221.57/221.71  |- skos__scopeNote mesh__D005415
% 221.57/221.71       Derivatives of the dimethylisoalloxazine %28%7,8-dimethylbenzo%5B%g%5D%pteridine-2,4%28%3H,10H%29%-dione%29% skeleton. Flavin derivatives serve an electron transfer function as ENZYME COFACTORS in FLAVOPROTEINS.%A%    
% 221.57/221.71  |- mesh__dateRevised mesh__D005415 2005-06-30
% 221.57/221.71  |- skos__prefLabel mesh__D005415 Flavins
% 221.57/221.71  |- skos__broader mesh__D005415smesh__D010860
% 221.57/221.71  |- mesh__recordOriginator mesh__D005415 NLM
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D029863 2002
% 221.57/221.71  |- skos__broader mesh__D029863smesh__D007887
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D029863 2003
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D029863 2006
% 221.57/221.71  |- mesh__publicMeSHNote mesh__D029863 2002   
% 221.57/221.71  |- mesh__dateEstablished mesh__D029863 2002-01-01
% 221.57/221.71  |- mesh__historyNote mesh__D029863 2002   
% 221.57/221.71  |- rdf__type mesh__D029863sskos__Concept
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D029863 2004
% 221.57/221.71  |- skos__annotation mesh__D029863
% 221.57/221.71       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.57/221.71  |- skos__prefLabel mesh__D029863 Cicer
% 221.57/221.71  |- mesh__dateCreated mesh__D029863 2001-07-25
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D029863 2005
% 221.57/221.71  |- skos__altLabel mesh__D029863 Garbanzo
% 221.57/221.71  |- skos__scopeNote mesh__D029863
% 221.57/221.71       A plant genus of the family FABACEAE known for the edible beans.%A%    
% 221.57/221.71  |- skos__scopeNote mesh__D029065
% 221.57/221.71       A plant family of the order Aristolochiales subclass Magnoliidae class Magnoliopsida.  They are mostly tropical woody vines and a few temperate-zone species.  The flowers are 3-parted; some species lack petals while others are large and foul smelling.%A%    
% 221.57/221.71  |- mesh__publicMeSHNote mesh__D029065 2002   
% 221.57/221.71  |- skos__annotation mesh__D029065
% 221.57/221.71       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.57/221.71  |- mesh__dateRevised mesh__D029065 2002-07-02
% 221.57/221.71  |- mesh__dateEstablished mesh__D029065 2002-01-01
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D029065 2005
% 221.57/221.71  |- rdf__type mesh__D029065sskos__Concept
% 221.57/221.71  |- mesh__dateCreated mesh__D029065 2001-07-25
% 221.57/221.71  |- mesh__recordMaintainer mesh__D029065 ssb
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D029065 2004
% 221.57/221.71  |- mesh__recordAuthorizer mesh__D029065 sjn
% 221.57/221.71  |- mesh__recordOriginator mesh__D029065 ssb
% 221.57/221.71  |- skos__broader mesh__D029065smesh__D019684
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D029065 2003
% 221.57/221.71  |- mesh__historyNote mesh__D029065 2002   
% 221.57/221.71  |- skos__prefLabel mesh__D029065 Aristolochiaceae
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D029065 2006
% 221.57/221.71  |- rdf__type mesh__D015843sskos__Concept
% 221.57/221.71  |- skos__broader mesh__D015843smesh__D011506
% 221.57/221.71  |- skos__hiddenLabel mesh__D015843 Superfamily, Serpin
% 221.57/221.71  |- mesh__recordOriginator mesh__D015843 RLS
% 221.57/221.71  |- mesh__dateCreated mesh__D015843 1989-05-26
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D015843 2006
% 221.57/221.71  |- mesh__dateRevised mesh__D015843 2005-06-30
% 221.57/221.71  |- skos__annotation mesh__D015843
% 221.57/221.71       %22%a family of SERine Proteinase INhibitors%22%, thus the source of the name%A%  
% 221.57/221.71  |- mesh__dateEstablished mesh__D015843 1990-01-01
% 221.57/221.71  |- skos__prefLabel mesh__D015843 Serpins
% 221.57/221.71  |- mesh__publicMeSHNote mesh__D015843 90   
% 221.57/221.71  |- mesh__recordMaintainer mesh__D015843 SYSTEM
% 221.57/221.71  |- mesh__recordAuthorizer mesh__D015843 sjn
% 221.57/221.71  |- skos__scopeNote mesh__D015843
% 221.57/221.71       A family of serine proteinase inhibitors which are similar in amino acid sequence and mechanism of inhibition, but differ in their specificity toward proteolytic enzymes. This family includes alpha 1-antitrypsin, angiotensinogen, ovalbumin, antiplasmin, alpha 1-antichymotrypsin, thyroxine-binding protein, complement 1 inactivators, antithrombin III, heparin cofactor II, plasminogen inactivators, gene Y protein, placental plasminogen activator inhibitor, and barley Z protein. Some members of the serpin family may be substrates rather than inhibitors of SERINE ENDOPEPTIDASES, and some serpins occur in plants where their function is not known.%A%    
% 221.57/221.71  |- skos__historyNote mesh__D015843 Enzyme Inhibitors %28%1968-1978%29%
% 221.57/221.71  |- skos__historyNote mesh__D015843 Protease Inhibitors %28%1979-1989%29%
% 221.57/221.71  |- mesh__historyNote mesh__D015843 90   
% 221.57/221.71  |- mesh__onlineNote mesh__D015045 use ZOOGLOEA to search ZOOGLEA 1972-78   
% 221.57/221.71  |- mesh__dateCreated mesh__D015045 1999-01-01
% 221.57/221.71  |- mesh__recordAuthorizer mesh__D015045 sjn
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D015045 2006
% 221.57/221.71  |- skos__altLabel mesh__D015045 Zooglea
% 221.57/221.71  |- mesh__recordMaintainer mesh__D015045 SYSTEM
% 221.57/221.71  |- mesh__recordOriginator mesh__D015045 NLM
% 221.57/221.71  |- skos__historyNote mesh__D015045 Bacteria %28%1966-1971%29%
% 221.57/221.71  |- mesh__dateEstablished mesh__D015045 1972-01-01
% 221.57/221.71  |- rdf__type mesh__D015045sskos__Concept
% 221.57/221.71  |- mesh__publicMeSHNote mesh__D015045 79,63-65; was ZOOGLEA 1972-78   
% 221.57/221.71  |- mesh__historyNote mesh__D015045 79,63-65; was ZOOGLEA 1972-78   
% 221.57/221.71  |- skos__broader mesh__D015045smesh__D016946
% 221.57/221.71  |- skos__scopeNote mesh__D015045
% 221.57/221.71       A genus of RHODOCYCLACEAE occurring as rod-shaped cells embedded in a gelatinous matrix. It includes Z. filipendula.%A%    
% 221.57/221.71  |- mesh__dateRevised mesh__D015045 2005-06-30
% 221.57/221.71  |- skos__prefLabel mesh__D015045 Zoogloea
% 221.57/221.71  |- skos__broader mesh__D015045smesh__D043362
% 221.57/221.71  |- skos__hiddenLabel mesh__D001823 Body Compositions
% 221.57/221.71  |- skos__related mesh__D001823smesh__D000886
% 221.57/221.71  |- skos__hiddenLabel mesh__D001823 Compositions, Body
% 221.57/221.71  |- skos__scopeNote mesh__D001823
% 221.57/221.71       The relative amounts of various components in the body, such as percent body fat.%A%    
% 221.57/221.71  |- mesh__dateRevised mesh__D001823 2000-06-22
% 221.57/221.71  |- skos__hiddenLabel mesh__D001823 Composition, Body
% 221.57/221.71  |- rdf__type mesh__D001823sskos__Concept
% 221.57/221.71  |- mesh__recordMaintainer mesh__D001823 adp
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D001823 2005
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D001823 2001
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D001823 2003
% 221.57/221.71  |- skos__prefLabel mesh__D001823 Body Composition
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D001823 2006
% 221.57/221.71  |- mesh__recordAuthorizer mesh__D001823 sjn
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D001823 2002
% 221.57/221.71  |- mesh__dateCreated mesh__D001823 1999-01-01
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D001823 2004
% 221.57/221.71  |- skos__broader mesh__D001823smesh__D001669
% 221.57/221.71  |- mesh__recordOriginator mesh__D001823 NLM
% 221.57/221.71  |- skos__broader mesh__D002129Q000031smesh__D002129
% 221.57/221.71  |- mesh__preferredCombination mesh__D002129Q000031smesh__D010070
% 221.57/221.71  |- rdf__type mesh__D002129Q000031smesh__CompoundConcept
% 221.57/221.71  |- skos__hiddenLabel mesh__D009008 Monster
% 221.57/221.71  |- mesh__recordAuthorizer mesh__D009008 sjn
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D009008 2003
% 221.57/221.71  |- rdf__type mesh__D009008sskos__Concept
% 221.57/221.71  |- mesh__dateRevised mesh__D009008 1999-11-03
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D009008 2000
% 221.57/221.71  |- skos__scopeNote mesh__D009008
% 221.57/221.71       A fetus or infant with such pronounced developmental anomalies as to be grotesque and usually nonviable. %28%Dorland, 27th ed%29%%A%    
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D009008 2004
% 221.57/221.71  |- mesh__recordMaintainer mesh__D009008 kle
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D009008 2001
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D009008 2005
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D009008 2002
% 221.57/221.71  |- mesh__dateCreated mesh__D009008 1999-01-01
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D009008 2006
% 221.57/221.71  |- skos__annotation mesh__D009008
% 221.57/221.71       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; fetus in fetu: index under FETUS /abnorm%A%  
% 221.57/221.71  |- skos__prefLabel mesh__D009008 Monsters
% 221.57/221.71  |- skos__broader mesh__D009008smesh__D000013
% 221.57/221.71  |- mesh__recordOriginator mesh__D009008 NLM
% 221.57/221.71  |- mesh__dateEstablished mesh__D001025 1980-01-01
% 221.57/221.71  |- mesh__recordOriginator mesh__D001025 VDK
% 221.57/221.71  |- skos__historyNote mesh__D001025 Arteritis %28%1966-1979%29%
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D001025 2002
% 221.57/221.71  |- mesh__recordMaintainer mesh__D001025 TGC
% 221.57/221.71  |- skos__broader mesh__D001025smesh__D001018
% 221.57/221.71  |- mesh__recordAuthorizer mesh__D001025 SJN
% 221.57/221.71  |- mesh__dateRevised mesh__D001025 1997-06-20
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D001025 2003
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D001025 2005
% 221.57/221.71  |- skos__annotation mesh__D001025 inflamm of aorta   
% 221.57/221.71  |- skos__hiddenLabel mesh__D001025 Aortitides
% 221.57/221.71  |- mesh__dateCreated mesh__D001025 1979-04-24
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D001025 2004
% 221.57/221.71  |- skos__scopeNote mesh__D001025
% 221.57/221.71       Inflammation of the wall of the aorta.     
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D001025 2006
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D001025 2000
% 221.57/221.71  |- mesh__historyNote mesh__D001025 80   
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D001025 2001
% 221.57/221.71  |- skos__broader mesh__D001025smesh__D014657
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D001025 1998
% 221.57/221.71  |- skos__prefLabel mesh__D001025 Aortitis
% 221.57/221.71  |- mesh__publicMeSHNote mesh__D001025 80   
% 221.57/221.71  |- rdf__type mesh__D001025sskos__Concept
% 221.57/221.71  |- skos__historyNote mesh__D001025 Aortic Diseases %28%1966-1979%29%
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D001025 1999
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D020788 2002
% 221.57/221.71  |- skos__scopeNote mesh__D020788
% 221.57/221.71       An autosomal recessive disorder characterized by RETINITIS PIGMENTOSA; POLYDACTYLY; OBESITY; MENTAL RETARDATION; hypogenitalism; renal dysplasia; and short stature. This syndrome has been distinguished as a separate entity from LAURENCE-MOON SYNDROME. %28%From J Med Genet 1997 Feb;34%28%2%29%:92-8%29%%A%    
% 221.57/221.71  |- skos__annotation mesh__D020788
% 221.57/221.71       note X ref: do not confuse with LAURENCE-MOON-BARDET-BIEDL SYNDROME see BARDET-BIEDL SYNDROME%A%  
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D020788 2005
% 221.57/221.71  |- mesh__historyNote mesh__D020788 2000   
% 221.57/221.71  |- skos__hiddenLabel mesh__D020788 Laurence Moon Bardet Biedl Syndrome
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D020788 2001
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D020788 2000
% 221.57/221.71  |- mesh__publicMeSHNote mesh__D020788 2000   
% 221.57/221.71  |- skos__altLabel mesh__D020788 Laurence-Moon-Bardet-Biedl Syndrome
% 221.57/221.71  |- skos__related mesh__D020788smesh__D008607
% 221.57/221.71  |- skos__broader mesh__D020788smesh__D000015
% 221.57/221.71  |- skos__hiddenLabel mesh__D020788 Bardet Biedl Syndrome
% 221.57/221.71  |- skos__historyNote mesh__D020788 Bardet-Biedl Syndrome %28%1966-1999%29%
% 221.57/221.71  |- skos__hiddenLabel mesh__D020788 Syndrome, Bardet-Biedl
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D020788 2004
% 221.57/221.71  |- skos__broader mesh__D020788smesh__D007027
% 221.57/221.71  |- skos__prefLabel mesh__D020788 Bardet-Biedl Syndrome
% 221.57/221.71  |- rdf__type mesh__D020788sskos__Concept
% 221.57/221.71  |- mesh__dateCreated mesh__D020788 1999-11-08
% 221.57/221.71  |- mesh__dateEstablished mesh__D020788 2000-01-01
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D020788 2006
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D020788 2003
% 221.57/221.71  |- skos__hiddenLabel mesh__D020788 Syndrome, Laurence-Moon-Bardet-Biedl
% 221.57/221.71  |- rdf__type mesh__D019436sskos__Concept
% 221.57/221.71  |- skos__altLabel mesh__D019436 St. Vincent and the Grenadines
% 221.57/221.71  |- skos__broader mesh__D019436smesh__D014900
% 221.57/221.71  |- mesh__historyNote mesh__D019436 97   
% 221.57/221.71  |- skos__annotation mesh__D019436
% 221.57/221.71       self-governing islands in the West Indies; do not confuse X ref GRENADINES with GRENADA, also in the West Indies; DF: ST VINCENT%A%  
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D019436 2004
% 221.57/221.71  |- mesh__dateCreated mesh__D019436 1996-06-10
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D019436 1999
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D019436 2000
% 221.57/221.71  |- mesh__dateEstablished mesh__D019436 1997-01-01
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D019436 2001
% 221.57/221.71  |- skos__scopeNote mesh__D019436
% 221.57/221.71       A self-governing state of the Windward Islands in the West Indies, comprising Saint Vincent and the northern islets of the Grenadines. Its capital is Kingstown. It is one of the original homes of the Carib Indians supposed to have been sighted by Columbus in 1498. It was in English hands from 1627 till held by the French 1779-83. Saint Vincent subsequently became a British possession and, with other nearby British territories, was administered by the Governor of the Windward Islands till 1959. It attained a measure of independence in 1969 but achieved full independence as Saint Vincent and the Grenadines in 1979. Saint Vincent was the 4th century Spanish martyr on whose feast day Columbus discovered the island. Grenadines is derived from the Spanish kingdom of Granada. %28%From Webster%27%s New Geographical Dictionary, 1988, p1054 %26% The Europa World Year Book 1993, p2441%29%%A%    
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D019436 2005
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D019436 1997
% 221.57/221.71  |- skos__historyNote mesh__D019436 West Indies %28%1969-1996%29%
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D019436 2006
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D019436 2002
% 221.57/221.71  |- skos__prefLabel mesh__D019436 Saint Vincent and the Grenadines
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D019436 2003
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D019436 1998
% 221.57/221.71  |- mesh__dateCreated mesh__D011453 1999-01-01
% 221.57/221.71  |- skos__broader mesh__D011453smesh__D015777
% 221.57/221.71  |- mesh__dateEstablished mesh__D011453 1966-01-01
% 221.57/221.71  |- mesh__recordMaintainer mesh__D011453 ssb
% 221.57/221.71  |- skos__scopeNote mesh__D011453
% 221.57/221.71       A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes.%A%    
% 221.57/221.71  |- mesh__activeMeSHYear mesh__D011453 2006
% 221.57/221.71  |- mesh__dateRevised mesh__D011453 2005-06-30
% 221.57/221.72  |- skos__annotation mesh__D011453
% 221.57/221.72       GEN or unspecified only: prefer specifics; /biosyn /physiol permitted; /chem syn permitted: do not convert to PROSTAGLANDINS, SYNTHETIC%A%  
% 221.57/221.72  |- mesh__historyNote mesh__D011453 66%28%63%29%   
% 221.57/221.72  |- skos__related mesh__D011453smesh__D011448
% 221.57/221.72  |- skos__related mesh__D011453smesh__D011982
% 221.57/221.72  |- mesh__recordAuthorizer mesh__D011453 sjn
% 221.57/221.72  |- mesh__recordOriginator mesh__D011453 NLM
% 221.57/221.72  |- skos__altLabel mesh__D011453 Prostanoids
% 221.57/221.72  |- skos__prefLabel mesh__D011453 Prostaglandins
% 221.57/221.72  |- skos__broader mesh__D011453smesh__D001095
% 221.57/221.72  |- mesh__publicMeSHNote mesh__D011453 66   
% 221.57/221.72  |- rdf__type mesh__D011453sskos__Concept
% 221.57/221.72  |- rdf__type mesh__D005416sskos__Concept
% 221.57/221.72  |- skos__hiddenLabel mesh__D005416 Group B Arboviruses
% 221.57/221.72  |- skos__hiddenLabel mesh__D005416 Flaviviruses
% 221.57/221.72  |- mesh__historyNote mesh__D005416
% 221.57/221.72       94; was FLAVIVIRUSES 1981-93, was see ARBOVIRUSES 1978-80; ARBOVIRUS GROUP B was ARBOVIRUSES GROUP B see FLAVIVIRUSES 1981-93%A%  
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D005416 2003
% 221.57/221.72  |- mesh__recordMaintainer mesh__D005416 ags
% 221.57/221.72  |- skos__altLabel mesh__D005416 Arbovirus, Group B
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D005416 2005
% 221.57/221.72  |- mesh__publicMeSHNote mesh__D005416
% 221.57/221.72       94; was FLAVIVIRUSES 1981-93, was see ARBOVIRUSES 1978-80; ARBOVIRUS GROUP B was ARBOVIRUSES GROUP B see FLAVIVIRUSES 1981-93%A%  
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D005416 2004
% 221.57/221.72  |- skos__prefLabel mesh__D005416 Flavivirus
% 221.57/221.72  |- skos__broader mesh__D005416smesh__D018067
% 221.57/221.72  |- mesh__dateRevised mesh__D005416 2001-07-25
% 221.57/221.72  |- skos__historyNote mesh__D005416 Arboviruses %28%1966-1980%29%
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D005416 2006
% 221.57/221.72  |- mesh__recordOriginator mesh__D005416 RC
% 221.57/221.72  |- mesh__dateEstablished mesh__D005416 1981-01-01
% 221.57/221.72  |- mesh__recordAuthorizer mesh__D005416 sjn
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D005416 2002
% 221.57/221.72  |- skos__annotation mesh__D005416 infection = FLAVIVIRUS INFECTIONS   
% 221.57/221.72  |- skos__hiddenLabel mesh__D005416 Arboviruses, Group B
% 221.57/221.72  |- skos__scopeNote mesh__D005416
% 221.57/221.72       A genus of FLAVIVIRIDAE containing several subgroups and many species. Most are arboviruses transmitted by mosquitoes or ticks. The type species is YELLOW FEVER VIRUS.%A%    
% 221.57/221.72  |- mesh__dateCreated mesh__D005416 1980-05-14
% 221.57/221.72  |- skos__hiddenLabel mesh__D005416 Group B Arbovirus
% 221.57/221.72  |- mesh__onlineNote mesh__D005416
% 221.57/221.72       use FLAVIVIRUS to search FLAVIVIRUSES %26% ARBOVIRUSES GROUP B 1981-93; use ARBOVIRUSES 1978-80%A%  
% 221.57/221.72  |- skos__scopeNote mesh__D029864
% 221.57/221.72       A plant genus of the family FABACEAE that contains crotalarin.%A%    
% 221.57/221.72  |- skos__prefLabel mesh__D029864 Crotalaria
% 221.57/221.72  |- mesh__recordAuthorizer mesh__D029864 sjn
% 221.57/221.72  |- mesh__recordMaintainer mesh__D029864 ssb
% 221.57/221.72  |- mesh__recordOriginator mesh__D029864 ssb
% 221.57/221.72  |- mesh__dateEstablished mesh__D029864 2002-01-01
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D029864 2004
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D029864 2006
% 221.57/221.72  |- skos__broader mesh__D029864smesh__D007887
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D029864 2003
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D029864 2005
% 221.57/221.72  |- rdf__type mesh__D029864sskos__Concept
% 221.57/221.72  |- mesh__dateCreated mesh__D029864 2001-07-25
% 221.57/221.72  |- mesh__historyNote mesh__D029864 2002   
% 221.57/221.72  |- skos__annotation mesh__D029864
% 221.57/221.72       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.57/221.72  |- mesh__dateRevised mesh__D029864 2002-07-03
% 221.57/221.72  |- mesh__publicMeSHNote mesh__D029864 2002   
% 221.57/221.72  |- mesh__recordOriginator mesh__D021881 jmp
% 221.57/221.72  |- skos__altLabel mesh__D021881 Deoxyribozymes
% 221.57/221.72  |- skos__broader mesh__D021881smesh__D004798
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D021881 2006A
% 221.57/221.72  |- mesh__historyNote mesh__D021881
% 221.57/221.72       2001; use DNA, CATALYTIC %28%NM%29% 1997-2000   
% 221.57/221.72  |- skos__altLabel mesh__D021881 Catalytic DNA
% 221.57/221.72  |- skos__scopeNote mesh__D021881
% 221.57/221.72       Molecules of DNA that possess enzymatic activity.     
% 221.57/221.72  |- skos__broader mesh__D021881smesh__D012316
% 221.57/221.72  |- skos__altLabel mesh__D021881 Deoxyribozyme
% 221.57/221.72  |- mesh__recordMaintainer mesh__D021881 ags
% 221.57/221.72  |- mesh__dateCreated mesh__D021881 2000-06-22
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D021881 2006
% 221.57/221.72  |- skos__altLabel mesh__D021881 DNAzymes
% 221.57/221.72  |- rdf__type mesh__D021881sskos__Concept
% 221.57/221.72  |- skos__broader mesh__D021881smesh__D004247
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D021881 2004
% 221.57/221.72  |- skos__prefLabel mesh__D021881 DNA, Catalytic
% 221.57/221.72  |- mesh__recordAuthorizer mesh__D021881 ags
% 221.57/221.72  |- skos__historyNote mesh__D021881 DNA, Single-Stranded %28%1997-2000%29%
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D021881 2005
% 221.57/221.72  |- skos__altLabel mesh__D021881 DNAzyme
% 221.57/221.72  |- mesh__dateEstablished mesh__D021881 2001-01-01
% 221.57/221.72  |- mesh__dateRevised mesh__D021881 2005-07-13
% 221.57/221.72  |- mesh__publicMeSHNote mesh__D021881
% 221.57/221.72       2001; Deoxyribozyme %28%now DNA, CATALYTIC%29% was indexed under DNA, SINGLE-STRANDED 1997-2000%A%  
% 221.57/221.72  |- skos__broader mesh__D015844smesh__D000510
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D015844 2001
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D015844 2004
% 221.57/221.72  |- skos__hiddenLabel mesh__D015844 Cofactor II, Heparin
% 221.57/221.72  |- mesh__dateCreated mesh__D015844 1989-05-25
% 221.57/221.72  |- mesh__recordMaintainer mesh__D015844 ADP
% 221.57/221.72  |- mesh__dateRevised mesh__D015844 1998-06-10
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D015844 2002
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D015844 2005
% 221.57/221.72  |- mesh__dateEstablished mesh__D015844 1990-01-01
% 221.57/221.72  |- mesh__recordOriginator mesh__D015844 RLS
% 221.57/221.72  |- skos__scopeNote mesh__D015844
% 221.57/221.72       A sulfated plasma protein with the MW of approximately 66kDa that resembles ANTITHROMBIN III. The protein is an inhibitor of thrombin in plasma and is activated by dermatan sulfate or heparin. It is a member of the serpin superfamily.%A%    
% 221.57/221.72  |- skos__prefLabel mesh__D015844 Heparin Cofactor II
% 221.57/221.72  |- skos__altLabel mesh__D015844 Heparin Co-Factor II
% 221.57/221.72  |- mesh__publicMeSHNote mesh__D015844 90   
% 221.57/221.72  |- skos__related mesh__D015844smesh__D000990
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D015844 2006
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D015844 1999
% 221.57/221.72  |- skos__hiddenLabel mesh__D015844 Co-Factor II, Heparin
% 221.57/221.72  |- mesh__historyNote mesh__D015844 90   
% 221.57/221.72  |- skos__hiddenLabel mesh__D015844 Heparin Co Factor II
% 221.57/221.72  |- skos__historyNote mesh__D015844 Antithrombins %28%1966-1989%29%
% 221.57/221.72  |- mesh__recordAuthorizer mesh__D015844 SJN
% 221.57/221.72  |- skos__historyNote mesh__D015844 Glycoproteins %28%1966-1989%29%
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D015844 2000
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D015844 2003
% 221.57/221.72  |- skos__broader mesh__D015844smesh__D000991
% 221.57/221.72  |- rdf__type mesh__D015844sskos__Concept
% 221.57/221.72  |- skos__related mesh__D015046smesh__D000828
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D015046 2006
% 221.57/221.72  |- mesh__recordMaintainer mesh__D015046 SYSTEM
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D015046 2005
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D015046 2004
% 221.57/221.72  |- rdf__type mesh__D015046sskos__Concept
% 221.57/221.72  |- skos__prefLabel mesh__D015046 Zoology
% 221.57/221.72  |- mesh__recordOriginator mesh__D015046 NLM
% 221.57/221.72  |- mesh__dateRevised mesh__D015046 2003-07-30
% 221.57/221.72  |- skos__annotation mesh__D015046 SPEC: SPEC qualif; DF: ZOOL   
% 221.57/221.72  |- mesh__recordAuthorizer mesh__D015046 NLM
% 221.57/221.72  |- skos__broader mesh__D015046smesh__D001695
% 221.57/221.72  |- mesh__dateCreated mesh__D015046 1999-01-01
% 221.57/221.72  |- mesh__recordOriginator mesh__D009807 NLM
% 221.57/221.72  |- mesh__dateEstablished mesh__D009807 1965-01-01
% 221.57/221.72  |- mesh__publicMeSHNote mesh__D009807 65   
% 221.57/221.72  |- skos__hiddenLabel mesh__D009807 Odontogenic Cyst
% 221.57/221.72  |- mesh__dateRevised mesh__D009807 1996-06-10
% 221.57/221.72  |- skos__annotation mesh__D009807
% 221.57/221.72       non-neoplastic but calcifying odontogenic cyst = ODONTOGENIC CYST, CALCIFYING %28%neoplastic%29%; /blood supply /chem /secret /ultrastruct permitted; coord IM with MANDIBULAR DISEASES or MAXILLARY DISEASES %28%IM%29%%A%  
% 221.57/221.72  |- skos__hiddenLabel mesh__D009807 Cysts, Odontogenic
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D009807 2003
% 221.57/221.72  |- mesh__recordMaintainer mesh__D009807 JLS
% 221.57/221.72  |- skos__hiddenLabel mesh__D009807 Keratocyst
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D009807 2002
% 221.57/221.72  |- mesh__historyNote mesh__D009807 65   
% 221.57/221.72  |- mesh__recordAuthorizer mesh__D009807 PLS
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D009807 2005
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D009807 2004
% 221.57/221.72  |- skos__hiddenLabel mesh__D009807 Cyst, Odontogenic
% 221.57/221.72  |- mesh__dateCreated mesh__D009807 1999-01-01
% 221.57/221.72  |- skos__broader mesh__D009807smesh__D007570
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D009807 1998
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D009807 1997
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D009807 2006
% 221.57/221.72  |- rdf__type mesh__D009807sskos__Concept
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D009807 2000
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D009807 1999
% 221.57/221.72  |- skos__scopeNote mesh__D009807
% 221.57/221.72       Cysts found in the jaws and arising from epithelium involved in tooth formation. They include follicular cysts %28%e.g., primordial cyst, dentigerous cyst, multilocular cyst%29%, lateral periodontal cysts, and radicular cysts. They may become keratinized %28%odontogenic keratocysts%29%. Follicular cysts may give rise to ameloblastomas and, in rare cases, undergo malignant transformation.%A%    
% 221.57/221.72  |- skos__prefLabel mesh__D009807 Odontogenic Cysts
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D009807 2001
% 221.57/221.72  |- skos__scopeNote mesh__D001824
% 221.57/221.72       The physical characteristics of the body, including the mode of performance of functions, the activity of  metabolic processes, the manner and degree of reactions to stimuli, and power of resistance to the attack of pathogenic organisms.%A%    
% 221.57/221.72  |- mesh__recordOriginator mesh__D001824 NLM
% 221.57/221.72  |- skos__broader mesh__D001824smesh__D010808
% 221.57/221.72  |- mesh__dateRevised mesh__D001824 2004-07-07
% 221.57/221.72  |- rdf__type mesh__D001824sskos__Concept
% 221.57/221.72  |- skos__prefLabel mesh__D001824 Body Constitution
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D001824 2005
% 221.57/221.72  |- skos__broader mesh__D001824smesh__D010829
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D001824 2006
% 221.57/221.72  |- mesh__dateCreated mesh__D001824 1999-01-01
% 221.57/221.72  |- skos__hiddenLabel mesh__D001824 Constitution, Body
% 221.57/221.72  |- mesh__recordMaintainer mesh__D001824 nns
% 221.57/221.72  |- skos__hiddenLabel mesh__D001824 Constitutions, Body
% 221.57/221.72  |- skos__hiddenLabel mesh__D001824 Body Constitutions
% 221.57/221.72  |- mesh__recordAuthorizer mesh__D001824 sjn
% 221.57/221.72  |- rdf__type mesh__D009009sskos__Concept
% 221.57/221.72  |- mesh__recordAuthorizer mesh__D009009 SJN
% 221.57/221.72  |- mesh__dateRevised mesh__D009009 1997-06-20
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D009009 2004
% 221.57/221.72  |- mesh__recordMaintainer mesh__D009009 PXP
% 221.57/221.72  |- mesh__recordOriginator mesh__D009009 NLM
% 221.57/221.72  |- skos__broader mesh__D009009smesh__D015205
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D009009 2005
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D009009 2006
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D009009 1998
% 221.57/221.72  |- mesh__dateCreated mesh__D009009 1999-01-01
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D009009 2000
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D009009 1999
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D009009 2001
% 221.57/221.72  |- skos__prefLabel mesh__D009009 Montana
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D009009 2002
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D009009 2003
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D001026 2005
% 221.57/221.72  |- mesh__dateEstablished mesh__D001026 1973-01-01
% 221.57/221.72  |- skos__altLabel mesh__D001026 Aortocoronary Bypass
% 221.57/221.72  |- rdf__type mesh__D001026sskos__Concept
% 221.57/221.72  |- skos__hiddenLabel mesh__D001026 Aortocoronary Bypasses
% 221.57/221.72  |- skos__hiddenLabel mesh__D001026 Bypass, Aortocoronary
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D001026 1999
% 221.57/221.72  |- skos__scopeNote mesh__D001026
% 221.57/221.72       Surgical therapy of ischemic coronary artery disease achieved by grafting a section of saphenous vein, internal mammary artery, or other substitute between the aorta and the obstructed coronary artery distal to the obstructive lesion.%A%    
% 221.57/221.72  |- skos__historyNote mesh__D001026
% 221.57/221.72       Coronary Disease/surgery %28%1966-1971%29%
% 221.57/221.72  |- mesh__dateRevised mesh__D001026 1997-06-20
% 221.57/221.72  |- mesh__recordAuthorizer mesh__D001026 SJN
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D001026 2001
% 221.57/221.72  |- skos__historyNote mesh__D001026
% 221.57/221.72       Myocardial Infarct/surgery %28%1966-1971%29%
% 221.57/221.72  |- skos__altLabel mesh__D001026 Coronary Artery Bypass Grafting
% 221.57/221.72  |- skos__hiddenLabel mesh__D001026 Artery Bypasses, Coronary
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D001026 1998
% 221.57/221.72  |- mesh__publicMeSHNote mesh__D001026
% 221.57/221.72       90; was AORTOCORONARY BYPASS 1973-89   
% 221.57/221.72  |- skos__altLabel mesh__D001026 Bypass Surgery, Coronary Artery
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D001026 2004
% 221.57/221.72  |- mesh__recordOriginator mesh__D001026 NLM
% 221.57/221.72  |- mesh__onlineNote mesh__D001026
% 221.57/221.72       use CORONARY ARTERY BYPASS to search AORTOCORONARY BYPASS 1972-89 %28%Prov 1972%29%%A%  
% 221.57/221.72  |- skos__prefLabel mesh__D001026 Coronary Artery Bypass
% 221.57/221.72  |- skos__hiddenLabel mesh__D001026 Coronary Artery Bypasses
% 221.57/221.72  |- skos__annotation mesh__D001026
% 221.57/221.72       do not use /util except by MeSH definition   
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D001026 2000
% 221.57/221.72  |- mesh__recordMaintainer mesh__D001026 PXP
% 221.57/221.72  |- mesh__dateCreated mesh__D001026 1999-01-01
% 221.57/221.72  |- skos__altLabel mesh__D001026 Bypass, Coronary Artery
% 221.57/221.72  |- skos__historyNote mesh__D001026
% 221.57/221.72       Coronary Vessels/surgery %28%1966-1971%29%
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D001026 2003
% 221.57/221.72  |- skos__hiddenLabel mesh__D001026 Artery Bypass, Coronary
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D001026 2006
% 221.57/221.72  |- mesh__historyNote mesh__D001026
% 221.57/221.72       90; was AORTOCORONARY BYPASS 1973-89 %28%Prov 1972%29%   
% 221.57/221.72  |- skos__altLabel mesh__D001026 Coronary Artery Bypass Surgery
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D001026 2002
% 221.57/221.72  |- skos__hiddenLabel mesh__D001026 Bypasses, Aortocoronary
% 221.57/221.72  |- skos__broader mesh__D001026smesh__D009204
% 221.57/221.72  |- skos__hiddenLabel mesh__D001026 Bypasses, Coronary Artery
% 221.57/221.72  |- mesh__historyNote mesh__D020789
% 221.57/221.72       2000; use DIPEPTIDYL PEPTIDASE I %28%NM%29% 1984-1999; use CATHEPSINS 1981-1984%A%  
% 221.57/221.72  |- mesh__dateRevised mesh__D020789 2003-07-09
% 221.57/221.72  |- skos__broader mesh__D020789smesh__D004152
% 221.57/221.72  |- skos__hiddenLabel mesh__D020789 I, Dipeptidyl Aminopeptidase
% 221.57/221.72  |- mesh__dateCreated mesh__D020789 1999-11-05
% 221.57/221.72  |- skos__hiddenLabel mesh__D020789 Transferase, Dipeptidyl
% 221.57/221.72  |- skos__broader mesh__D020789smesh__D002403
% 221.57/221.72  |- skos__scopeNote mesh__D020789
% 221.57/221.72       A cysteine-type peptidase that is CHLORINE dependent and functions maximally at acidic pHs. At neutral pH, it polymerizes esters, aryl- and dipeptide amides. EC 3.4.14.1.%A%    
% 221.57/221.72  |- skos__altLabel mesh__D020789 Cathepsin C
% 221.57/221.72  |- skos__altLabel mesh__D020789 Dipeptidyl Transferase
% 221.57/221.72  |- mesh__recordAuthorizer mesh__D020789 sjn
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D020789 2004
% 221.57/221.72  |- rdf__type mesh__D020789sskos__Concept
% 221.57/221.72  |- mesh__publicMeSHNote mesh__D020789
% 221.57/221.72       2000; DIPEPTIDYL PEPTIDASE I was indexed under DIPEPTIDYL PEPTIDASES 1984-1999; CATHEPSINS 1981-1984%A%  
% 221.57/221.72  |- mesh__recordOriginator mesh__D020789 adp
% 221.57/221.72  |- mesh__dateEstablished mesh__D020789 2000-01-01
% 221.57/221.72  |- mesh__recordMaintainer mesh__D020789 ssb
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D020789 2006
% 221.57/221.72  |- skos__hiddenLabel mesh__D020789 Peptidase I, Dipeptidyl
% 221.57/221.72  |- skos__hiddenLabel mesh__D020789 Aminopeptidase I, Dipeptidyl
% 221.57/221.72  |- skos__prefLabel mesh__D020789 Dipeptidyl Peptidase I
% 221.57/221.72  |- skos__hiddenLabel mesh__D020789 I, Dipeptidyl Peptidase
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D020789 2005
% 221.57/221.72  |- skos__hiddenLabel mesh__D020789 C, Cathepsin
% 221.57/221.72  |- skos__historyNote mesh__D020789 Dipeptidyl Peptidases %28%1984-1999%29%
% 221.57/221.72  |- skos__altLabel mesh__D020789 Dipeptidyl Aminopeptidase I
% 221.57/221.72  |- mesh__recordOriginator mesh__D047128 ags
% 221.57/221.72  |- mesh__historyNote mesh__D047128 2005   
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D047128 2005
% 221.57/221.72  |- skos__broader mesh__D047128smesh__D011161
% 221.57/221.72  |- skos__prefLabel mesh__D047128 Callyspongia
% 221.57/221.72  |- mesh__dateCreated mesh__D047128 2004-07-07
% 221.57/221.72  |- skos__scopeNote mesh__D047128
% 221.57/221.72       A genus of SPONGES in the family Callyspongiidae comprised of a regular ectosomal reticulate skeleton.%A%    
% 221.57/221.72  |- mesh__recordMaintainer mesh__D047128 ags
% 221.57/221.72  |- mesh__publicMeSHNote mesh__D047128 2005   
% 221.57/221.72  |- mesh__dateEstablished mesh__D047128 2005-01-01
% 221.57/221.72  |- skos__historyNote mesh__D047128 Porifera %28%1980-2004%29%
% 221.57/221.72  |- rdf__type mesh__D047128sskos__Concept
% 221.57/221.72  |- mesh__recordAuthorizer mesh__D047128 sjn
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D047128 2006
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D019437 2001
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D019437 2004
% 221.57/221.72  |- mesh__dateEstablished mesh__D019437 1997-01-01
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D019437 2005
% 221.57/221.72  |- skos__prefLabel mesh__D019437 Saint Kitts and Nevis
% 221.57/221.72  |- rdf__type mesh__D019437sskos__Concept
% 221.57/221.72  |- mesh__historyNote mesh__D019437 97   
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D019437 2000
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D019437 2003
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D019437 1999
% 221.57/221.72  |- skos__annotation mesh__D019437
% 221.57/221.72       an independent federation in the West Indies   
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D019437 2002
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D019437 1997
% 221.57/221.72  |- skos__historyNote mesh__D019437 West Indies %28%1966-1996%29%
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D019437 1998
% 221.57/221.72  |- skos__altLabel mesh__D019437 St. Kitts and Nevis
% 221.57/221.72  |- skos__broader mesh__D019437smesh__D014900
% 221.57/221.72  |- skos__scopeNote mesh__D019437
% 221.57/221.72       An independent federation of the Leeward Islands in the West Indies, consisting of Saint Christopher, Nevis, and Sombrero. Its capital is Basseterre. It was discovered by Columbus in 1493, settled by the British in 1625, the first of the Leeward Islands to be colonized by them. It was held jointly by the French and English 1628-1713, but returned to Great Britain by the Treaty of Utrecht in 1713. It was held by the French 1782-83. Under the British for the next 200 years, it gained its independence in 1983. %28%From Webster%27%s New Geographical Dictionary, 1988, p1045; Embassy, telephone 202-686-2636%29%%A%    
% 221.57/221.72  |- mesh__dateCreated mesh__D019437 1996-06-26
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D019437 2006
% 221.57/221.72  |- skos__annotation mesh__D011454
% 221.57/221.72       /chem syn permitted: do not convert to PROSTAGLANDINS A, SYNTHETIC; DF: PGA%A%  
% 221.57/221.72  |- mesh__historyNote mesh__D011454 75   
% 221.57/221.72  |- skos__altLabel mesh__D011454 PGA
% 221.57/221.72  |- skos__scopeNote mesh__D011454
% 221.57/221.72       %28%13E,15S%29%-15-Hydroxy-9-oxoprosta-10,13-dien-1-oic acid %28%PGA%28%1%29%%29%; %28%5Z,13E,15S%29%-15-hydroxy-9-oxoprosta-5,10,13-trien-1-oic acid %28%PGA%28%2%29%%29%; %28%5Z,13E,15S,17Z%29%-15-hydroxy-9-oxoprosta-5,10,13,17-tetraen-1-oic acid %28%PGA%28%3%29%%29%. A group of naturally occurring secondary prostaglandins derived from PGE; PGA%28%1%29% and PGA%28%2%29% as well as their 19-hydroxy derivatives are found in many organs and tissues.%A%    
% 221.57/221.72  |- mesh__publicMeSHNote mesh__D011454 75   
% 221.57/221.72  |- skos__broader mesh__D011454smesh__D011453
% 221.57/221.72  |- skos__hiddenLabel mesh__D011454 A, Prostaglandins
% 221.57/221.72  |- skos__prefLabel mesh__D011454 Prostaglandins A
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D011454 2006
% 221.57/221.72  |- mesh__recordMaintainer mesh__D011454 ssb
% 221.57/221.72  |- skos__historyNote mesh__D011454 Prostaglandins %28%1966-1974%29%
% 221.57/221.72  |- mesh__dateCreated mesh__D011454 1974-11-11
% 221.57/221.72  |- rdf__type mesh__D011454sskos__Concept
% 221.57/221.72  |- mesh__dateRevised mesh__D011454 2005-06-30
% 221.57/221.72  |- mesh__recordAuthorizer mesh__D011454 sjn
% 221.57/221.72  |- mesh__recordOriginator mesh__D011454 NLM
% 221.57/221.72  |- mesh__dateEstablished mesh__D011454 1975-09-01
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D005417 2006
% 221.57/221.72  |- mesh__dateCreated mesh__D005417 1999-01-01
% 221.57/221.72  |- mesh__recordOriginator mesh__D005417 NLM
% 221.57/221.72  |- skos__scopeNote mesh__D005417
% 221.57/221.72       A genus of gram-negative, aerobic, rod-shaped bacteria widely distributed in SOIL and WATER. Its organisms are also found in raw meats, MILK and other FOOD, hospital environments, and human clinical specimens. Some species are pathogenic in humans.%A%    
% 221.57/221.72  |- mesh__dateRevised mesh__D005417 2005-06-30
% 221.57/221.72  |- mesh__recordMaintainer mesh__D005417 SYSTEM
% 221.57/221.72  |- skos__prefLabel mesh__D005417 Flavobacterium
% 221.57/221.72  |- rdf__type mesh__D005417sskos__Concept
% 221.57/221.72  |- skos__annotation mesh__D005417
% 221.57/221.72       infection: coord IM with FLAVOBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 221.57/221.72  |- skos__broader mesh__D005417smesh__D041965
% 221.57/221.72  |- mesh__recordAuthorizer mesh__D005417 sjn
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D029865 2004
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D029865 2006
% 221.57/221.72  |- mesh__recordAuthorizer mesh__D029865 sjn
% 221.57/221.72  |- skos__prefLabel mesh__D029865 Cytisus
% 221.57/221.72  |- skos__broader mesh__D029865smesh__D007887
% 221.57/221.72  |- mesh__recordMaintainer mesh__D029865 ssb
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D029865 2003
% 221.57/221.72  |- skos__annotation mesh__D029865
% 221.57/221.72       X ref BROOM, DESERT: several other Broom terms are also available; check text and MeSH; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.57/221.72  |- rdf__type mesh__D029865sskos__Concept
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D029865 2005
% 221.57/221.72  |- skos__altLabel mesh__D029865 Broom, Scotch
% 221.57/221.72  |- skos__altLabel mesh__D029865 Sarothamnus scoparius
% 221.57/221.72  |- mesh__dateRevised mesh__D029865 2002-07-02
% 221.57/221.72  |- mesh__publicMeSHNote mesh__D029865 2002   
% 221.57/221.72  |- skos__scopeNote mesh__D029865
% 221.57/221.72       A plant genus of the family FABACEAE that is sometimes called broom because of the shape of the plant. Members produce SPARTEINE.%A%    
% 221.57/221.72  |- mesh__dateCreated mesh__D029865 2001-07-25
% 221.57/221.72  |- mesh__historyNote mesh__D029865 2002   
% 221.57/221.72  |- mesh__dateEstablished mesh__D029865 2002-01-01
% 221.57/221.72  |- skos__altLabel mesh__D029865 Broom
% 221.57/221.72  |- mesh__recordOriginator mesh__D029865 ssb
% 221.57/221.72  |- skos__broader mesh__D029067smesh__D019684
% 221.57/221.72  |- skos__scopeNote mesh__D029067
% 221.57/221.72       The milkweed plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida.  It includes many tropical herbs and shrubby climbers; most with milky juice. Flowers have five united petals.  Fruits are podlike, usually with tufted seeds.%A%    
% 221.57/221.72  |- mesh__recordOriginator mesh__D029067 ssb
% 221.57/221.72  |- mesh__recordAuthorizer mesh__D029067 sjn
% 221.57/221.72  |- skos__annotation mesh__D029067
% 221.57/221.72       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D029067 2006
% 221.57/221.72  |- mesh__historyNote mesh__D029067 2002   
% 221.57/221.72  |- mesh__publicMeSHNote mesh__D029067 2002   
% 221.57/221.72  |- mesh__dateRevised mesh__D029067 2003-07-09
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D029067 2005
% 221.57/221.72  |- rdf__type mesh__D029067sskos__Concept
% 221.57/221.72  |- mesh__dateEstablished mesh__D029067 2002-01-01
% 221.57/221.72  |- skos__prefLabel mesh__D029067 Asclepiadaceae
% 221.57/221.72  |- mesh__dateCreated mesh__D029067 2001-07-25
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D029067 2004
% 221.57/221.72  |- mesh__recordMaintainer mesh__D029067 ssb
% 221.57/221.72  |- skos__hiddenLabel mesh__D015845 Pupils, Local Tonic
% 221.57/221.72  |- skos__scopeNote mesh__D015845
% 221.57/221.72       A pupillary abnormality characterized by a poor pupillary light reaction, reduced accommodation, iris sector palsies, an enhanced pupillary response to near effort that results in a prolonged, %22%tonic%22% constriction, and slow pupillary redilation. This condition is associated with injury to the postganglionic parasympathetic innervation to the pupil. %28%From Miller et al., Clinical Neuro-Ophthalmology, 4th ed, pp492-500%29%%A%    
% 221.57/221.72  |- mesh__dateEstablished mesh__D015845 1990-01-01
% 221.57/221.72  |- mesh__dateRevised mesh__D015845 2001-07-25
% 221.57/221.72  |- skos__historyNote mesh__D015845 Photic Stimulation %28%1972-1989%29%
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D015845 2004
% 221.57/221.72  |- skos__altLabel mesh__D015845 Adie%27%s Pupil
% 221.57/221.72  |- skos__altLabel mesh__D015845 Pupil, Tonic
% 221.57/221.72  |- mesh__dateCreated mesh__D015845 1989-05-25
% 221.57/221.72  |- skos__hiddenLabel mesh__D015845 Pupil, Myotonic
% 221.57/221.72  |- skos__hiddenLabel mesh__D015845 Neuropathic Tonic Pupils
% 221.57/221.72  |- mesh__recordAuthorizer mesh__D015845 sjn
% 221.57/221.72  |- skos__altLabel mesh__D015845 Pupillotonia
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D015845 2002
% 221.57/221.72  |- skos__hiddenLabel mesh__D015845 Pupil, Adie%27%s
% 221.57/221.72  |- mesh__historyNote mesh__D015845 1990   
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D015845 2003
% 221.57/221.72  |- skos__broader mesh__D015845smesh__D011681
% 221.57/221.72  |- skos__hiddenLabel mesh__D015845 Myotonic Pupils
% 221.57/221.72  |- skos__hiddenLabel mesh__D015845 Pupils, Tonic
% 221.57/221.72  |- skos__hiddenLabel mesh__D015845 Adie Pupil
% 221.57/221.72  |- skos__altLabel mesh__D015845 Myotonic Pupil
% 221.57/221.72  |- skos__hiddenLabel mesh__D015845 Pupil, Neuropathic Tonic
% 221.57/221.72  |- skos__hiddenLabel mesh__D015845 Pupils, Adie%27%s
% 221.57/221.72  |- skos__hiddenLabel mesh__D015845 Pupils, Myotonic
% 221.57/221.72  |- skos__hiddenLabel mesh__D015845 Adies Pupil
% 221.57/221.72  |- skos__hiddenLabel mesh__D015845 Pupillotonias
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D015845 2006
% 221.57/221.72  |- skos__hiddenLabel mesh__D015845 Tonic Pupils, Local
% 221.57/221.72  |- skos__hiddenLabel mesh__D015845 Tonic Pupils, Neuropathic
% 221.57/221.72  |- mesh__publicMeSHNote mesh__D015845 1990   
% 221.57/221.72  |- skos__hiddenLabel mesh__D015845 Pupils, Neuropathic Tonic
% 221.57/221.72  |- skos__hiddenLabel mesh__D015845 Pupil, Local Tonic
% 221.57/221.72  |- skos__hiddenLabel mesh__D015845 Neuropathic Tonic Pupil
% 221.57/221.72  |- mesh__recordMaintainer mesh__D015845 ags
% 221.57/221.72  |- rdf__type mesh__D015845sskos__Concept
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D015845 2005
% 221.57/221.72  |- skos__historyNote mesh__D015845 Pupil %28%1967-1989%29%
% 221.57/221.72  |- skos__hiddenLabel mesh__D015845 Tonic Pupils
% 221.57/221.72  |- skos__prefLabel mesh__D015845 Tonic Pupil
% 221.57/221.72  |- mesh__recordOriginator mesh__D015845 EGC
% 221.57/221.72  |- mesh__recordMaintainer mesh__D015047 ags
% 221.57/221.72  |- mesh__dateRevised mesh__D015047 2005-06-30
% 221.57/221.72  |- skos__prefLabel mesh__D015047 Zoonoses
% 221.57/221.72  |- skos__broader mesh__D015047smesh__D001423
% 221.57/221.72  |- skos__broader mesh__D015047smesh__D014777
% 221.57/221.72  |- skos__scopeNote mesh__D015047
% 221.57/221.72       Diseases of non-human animals that may be transmitted to HUMANS or may be transmitted from humans to non-human animals.%A%    
% 221.57/221.72  |- mesh__dateCreated mesh__D015047 1999-01-01
% 221.57/221.72  |- skos__broader mesh__D015047smesh__D000820
% 221.57/221.72  |- mesh__activeMeSHYear mesh__D015047 2006
% 221.57/221.72  |- skos__broader mesh__D015047smesh__D010272
% 221.57/221.72  |- mesh__recordAuthorizer mesh__D015047 sjn
% 221.57/221.72  |- skos__related mesh__D015047smesh__D004197
% 221.57/221.72  |- mesh__recordOriginator mesh__D015047 NLM
% 221.57/221.72  |- skos__annotation mesh__D015047
% 221.57/221.72       not a routine coordinate for every zoonotic disease; index only when discussed%A%  
% 221.57/221.72  |- rdf__type mesh__D015047sskos__Concept
% 221.57/221.73  |- skos__broader mesh__D009808smesh__D009370
% 221.57/221.73  |- skos__prefLabel mesh__D009808 Odontogenic Tumors
% 221.57/221.73  |- mesh__activeMeSHYear mesh__D009808 2003
% 221.57/221.73  |- skos__hiddenLabel mesh__D009808 Dental Tissue Neoplasm
% 221.57/221.75  |- mesh__onlineNote mesh__D009808
% 221.57/221.75       use ODONTOGENIC TUMORS to search ODONTOGENIC TUMOR %26% NEOPLASMS, DENTAL TISSUE 1966-79%A%  
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D009808 2001
% 221.57/221.75  |- skos__scopeNote mesh__D009808
% 221.57/221.75       Neoplasms produced from tooth-forming tissues.     
% 221.57/221.75  |- skos__altLabel mesh__D009808 Dental Tissue Neoplasms
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D009808 1996
% 221.57/221.75  |- mesh__recordOriginator mesh__D009808 NLM
% 221.57/221.75  |- skos__hiddenLabel mesh__D009808 Neoplasm, Dental Tissue
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D009808 2005
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D009808 2004
% 221.57/221.75  |- mesh__dateRevised mesh__D009808 1995-06-08
% 221.57/221.75  |- mesh__dateCreated mesh__D009808 1999-01-01
% 221.57/221.75  |- skos__hiddenLabel mesh__D009808 Odontogenic Tumor
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D009808 1998
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D009808 1997
% 221.57/221.75  |- mesh__historyNote mesh__D009808
% 221.57/221.75       80; was ODONTOGENIC TUMOR 1963-79; NEOPLASMS, DENTAL TISSUE was heading 1963-79%A%  
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D009808 2006
% 221.57/221.75  |- mesh__recordMaintainer mesh__D009808 KEV
% 221.57/221.75  |- rdf__type mesh__D009808sskos__Concept
% 221.57/221.75  |- mesh__publicMeSHNote mesh__D009808
% 221.57/221.75       80; was ODONTOGENIC TUMOR 1963-79; NEOPLASMS, DENTAL TISSUE was heading 1963-79%A%  
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D009808 1999
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D009808 2002
% 221.57/221.75  |- mesh__recordAuthorizer mesh__D009808 PLS
% 221.57/221.75  |- skos__hiddenLabel mesh__D009808 Tissue Neoplasm, Dental
% 221.57/221.75  |- skos__hiddenLabel mesh__D009808 Tumors, Odontogenic
% 221.57/221.75  |- skos__hiddenLabel mesh__D009808 Tumor, Odontogenic
% 221.57/221.75  |- skos__annotation mesh__D009808
% 221.57/221.75       benign or malignant; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D009808 2000
% 221.57/221.75  |- skos__hiddenLabel mesh__D009808 Tissue Neoplasms, Dental
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001825 2003
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001825 2006
% 221.57/221.75  |- skos__hiddenLabel mesh__D001825 Compartment, Body Fluid
% 221.57/221.75  |- mesh__dateCreated mesh__D001825 1977-03-01
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001825 2001
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001825 2004
% 221.57/221.75  |- skos__scopeNote mesh__D001825
% 221.57/221.75       The two phases between which water and other body fluids are distributed: extracellular and intracellular.%A%    
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001825 1994
% 221.57/221.75  |- skos__hiddenLabel mesh__D001825 Body Fluid Compartment
% 221.57/221.75  |- skos__historyNote mesh__D001825 Body Water %28%1974-1977%29%
% 221.57/221.75  |- mesh__dateEstablished mesh__D001825 1991-01-01
% 221.57/221.75  |- skos__broader mesh__D001825smesh__D001826
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001825 2002
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001825 1998
% 221.57/221.75  |- mesh__publicMeSHNote mesh__D001825
% 221.57/221.75       91; was see under BODY FLUIDS 1978-90   
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001825 1995
% 221.57/221.75  |- skos__prefLabel mesh__D001825 Body Fluid Compartments
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001825 1996
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001825 1993
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001825 1999
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001825 1997
% 221.57/221.75  |- mesh__recordOriginator mesh__D001825 AEP
% 221.57/221.75  |- mesh__historyNote mesh__D001825
% 221.57/221.75       91%28%78%29%; was see under BODY FLUIDS 1978-90   
% 221.57/221.75  |- mesh__dateRevised mesh__D001825 1992-03-25
% 221.57/221.75  |- mesh__recordAuthorizer mesh__D001825 PLS
% 221.57/221.75  |- skos__hiddenLabel mesh__D001825 Compartments, Body Fluid
% 221.57/221.75  |- skos__historyNote mesh__D001825 Body Fluids %28%1966-1977%29%
% 221.57/221.75  |- rdf__type mesh__D001825sskos__Concept
% 221.57/221.75  |- skos__hiddenLabel mesh__D001825 Fluid Compartment, Body
% 221.57/221.75  |- skos__hiddenLabel mesh__D001825 Fluid Compartments, Body
% 221.57/221.75  |- mesh__recordMaintainer mesh__D001825 TAP
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001825 2000
% 221.57/221.75  |- skos__broader mesh__D001825smesh__D001823
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001825 2005
% 221.57/221.75  |- skos__hiddenLabel mesh__D034201 Computers, Palm Top
% 221.57/221.75  |- mesh__dateEstablished mesh__D034201 2003-01-01
% 221.57/221.75  |- mesh__recordMaintainer mesh__D034201 jls
% 221.57/221.75  |- skos__hiddenLabel mesh__D034201 Palmtop Computers
% 221.57/221.75  |- skos__hiddenLabel mesh__D034201 Palm-Top Computers
% 221.57/221.75  |- skos__hiddenLabel mesh__D034201 Computer, Palm-Top
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D034201 2006
% 221.57/221.75  |- skos__hiddenLabel mesh__D034201 Palm-Top Computer
% 221.57/221.75  |- mesh__recordAuthorizer mesh__D034201 sjn
% 221.57/221.75  |- skos__historyNote mesh__D034201 Microcomputers %28%1992-2002%29%
% 221.57/221.75  |- mesh__dateCreated mesh__D034201 2002-07-03
% 221.57/221.75  |- skos__hiddenLabel mesh__D034201 Digital Assistant, Personal
% 221.57/221.75  |- mesh__publicMeSHNote mesh__D034201 2003   
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D034201 2005
% 221.57/221.75  |- mesh__historyNote mesh__D034201 2003   
% 221.57/221.75  |- skos__hiddenLabel mesh__D034201 Palmtop Computer
% 221.57/221.75  |- skos__altLabel mesh__D034201 Computers, Palm-Top
% 221.57/221.75  |- skos__hiddenLabel mesh__D034201 Pocket PCs
% 221.57/221.75  |- skos__hiddenLabel mesh__D034201 Pilots, Palm
% 221.57/221.75  |- skos__hiddenLabel mesh__D034201 PDA Computers
% 221.57/221.75  |- mesh__dateRevised mesh__D034201 2004-07-07
% 221.57/221.75  |- skos__hiddenLabel mesh__D034201 Handheld Computer
% 221.57/221.75  |- skos__hiddenLabel mesh__D034201 Computer, Handheld
% 221.57/221.75  |- skos__prefLabel mesh__D034201 Computers, Handheld
% 221.57/221.75  |- skos__altLabel mesh__D034201 PDA Computer
% 221.57/221.75  |- skos__hiddenLabel mesh__D034201 Computers, PDA
% 221.57/221.75  |- skos__hiddenLabel mesh__D034201 Computer, PDA
% 221.57/221.75  |- mesh__recordOriginator mesh__D034201 ssb
% 221.57/221.75  |- skos__hiddenLabel mesh__D034201 Pilot, Palm
% 221.57/221.75  |- skos__hiddenLabel mesh__D034201 PCs, Pocket
% 221.57/221.75  |- rdf__type mesh__D034201sskos__Concept
% 221.57/221.75  |- skos__hiddenLabel mesh__D034201 Palm Pilots
% 221.57/221.75  |- skos__hiddenLabel mesh__D034201 PC, Pocket
% 221.57/221.75  |- skos__broader mesh__D034201smesh__D008838
% 221.57/221.75  |- skos__hiddenLabel mesh__D034201 Computer, Palmtop
% 221.57/221.75  |- skos__hiddenLabel mesh__D034201 Handheld Computers
% 221.57/221.75  |- skos__scopeNote mesh__D034201
% 221.57/221.75       MICROCOMPUTERS, sometimes called PDA, that are very small and portable, fitting in a hand, and that have much more function than a calculator. They are convenient to use in clinical and other field situations for quick data management. They usually require docking with MICROCOMPUTERS for updates.%A%    
% 221.57/221.75  |- rdf__type mesh__D001027sskos__Concept
% 221.57/221.75  |- mesh__historyNote mesh__D001027 66; was see under ANGIOGRAPHY 1963-65   
% 221.57/221.75  |- skos__prefLabel mesh__D001027 Aortography
% 221.57/221.75  |- skos__annotation mesh__D001027
% 221.57/221.75       NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: AORTOGR%A%  
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001027 2005
% 221.57/221.75  |- mesh__recordAuthorizer mesh__D001027 SJN
% 221.57/221.75  |- mesh__publicMeSHNote mesh__D001027
% 221.57/221.75       66; was see under ANGIOGRAPHY 1963-65   
% 221.57/221.75  |- mesh__dateRevised mesh__D001027 1997-06-20
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001027 1999
% 221.57/221.75  |- skos__hiddenLabel mesh__D001027 Aortographies
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001027 2001
% 221.57/221.75  |- mesh__recordOriginator mesh__D001027 NLM
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001027 1998
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001027 2000
% 221.57/221.75  |- mesh__dateCreated mesh__D001027 1999-01-01
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001027 2004
% 221.57/221.75  |- mesh__dateEstablished mesh__D001027 1966-01-01
% 221.57/221.75  |- skos__broader mesh__D001027smesh__D000792
% 221.57/221.75  |- skos__scopeNote mesh__D001027
% 221.57/221.75       Radiographic visualization of the aorta and its branches by injection of contrast media, using percutaneous puncture or catheterization procedures.%A%    
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001027 2003
% 221.57/221.75  |- mesh__recordMaintainer mesh__D001027 PXP
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001027 2002
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D001027 2006
% 221.57/221.75  |- skos__altLabel mesh__D006510 Hepatitis B Virus Antibodies
% 221.57/221.75  |- skos__broader mesh__D006510smesh__D006508
% 221.57/221.75  |- mesh__recordOriginator mesh__D006510 NLM
% 221.57/221.75  |- mesh__historyNote mesh__D006510
% 221.57/221.75       84%28%78%29%; was see under ANTIBODIES, VIRAL 1978-83; was ANTI-AUSTRALIA ANTIGEN see under ANTIBODIES, VIRAL 1975-77, was ANTI-AUSTRALIA ANTIGEN 1973-74 %28%Prov%29%%A%  
% 221.57/221.75  |- mesh__dateEstablished mesh__D006510 1984-01-01
% 221.57/221.75  |- rdf__type mesh__D006510sskos__Concept
% 221.57/221.75  |- mesh__dateRevised mesh__D006510 2005-06-30
% 221.57/221.75  |- skos__historyNote mesh__D006510 Immune Sera %28%1966-1972%29%
% 221.57/221.75  |- skos__hiddenLabel mesh__D006510 B Antigens, Anti-Hepatitis
% 221.57/221.75  |- mesh__recordAuthorizer mesh__D006510 sjn
% 221.57/221.75  |- skos__historyNote mesh__D006510 Hepatitis B %28%1966%29%
% 221.57/221.75  |- mesh__onlineNote mesh__D006510
% 221.57/221.75       use HEPATITIS B ANTIBODIES to search ANTI-AUSTRALIA ANTIGEN 1973-77 %28%as Prov 1973-74%29%%A%  
% 221.57/221.75  |- skos__altLabel mesh__D006510 Anti HBAg
% 221.57/221.75  |- skos__hiddenLabel mesh__D006510 B Antibodies, Hepatitis
% 221.57/221.75  |- skos__altLabel mesh__D006510 Anti-HBAg
% 221.57/221.75  |- mesh__dateCreated mesh__D006510 1999-01-01
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D006510 2006
% 221.57/221.75  |- skos__hiddenLabel mesh__D006510 Anti Australia Antigens
% 221.57/221.75  |- skos__scopeNote mesh__D006510
% 221.57/221.75       Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface %28%Australia%29% and core of the Dane particle and those to the %22%e%22% antigens.%A%    
% 221.57/221.75  |- skos__hiddenLabel mesh__D006510 HBAg, Anti
% 221.57/221.75  |- skos__hiddenLabel mesh__D006510 Antigens, Anti-Australia
% 221.57/221.75  |- skos__prefLabel mesh__D006510 Hepatitis B Antibodies
% 221.57/221.75  |- mesh__publicMeSHNote mesh__D006510
% 221.57/221.75       84; was see under ANTIBODIES, VIRAL 1978-83, was ANTI-AUSTRALIA ANTIGEN see under ANTIBODIES, VIRAL 1975-77%A%  
% 221.57/221.75  |- skos__altLabel mesh__D006510 Anti-Australia Antigens
% 221.57/221.75  |- skos__altLabel mesh__D006510 Anti-Hepatitis B Antigens
% 221.57/221.75  |- skos__historyNote mesh__D006510 Hepatitis B Virus %28%1967-1972%29%
% 221.57/221.75  |- skos__hiddenLabel mesh__D006510 Antigens, Anti-Hepatitis B
% 221.57/221.75  |- skos__hiddenLabel mesh__D006510 Anti Hepatitis B Antigens
% 221.57/221.75  |- skos__hiddenLabel mesh__D006510 Antibodies, Hepatitis B
% 221.57/221.75  |- mesh__recordMaintainer mesh__D006510 ssb
% 221.57/221.75  |- mesh__recordAuthorizer mesh__D047129 sjn
% 221.57/221.75  |- mesh__dateCreated mesh__D047129 2004-07-07
% 221.57/221.75  |- skos__historyNote mesh__D047129 Porifera %28%1967-2004%29%
% 221.57/221.75  |- skos__scopeNote mesh__D047129
% 221.57/221.75       A genus of SPONGES in the family Chalinidae characterized by unispicular secondary lines in the choanosomal skeleton.%A%    
% 221.57/221.75  |- mesh__recordOriginator mesh__D047129 ags
% 221.57/221.75  |- mesh__historyNote mesh__D047129 2005   
% 221.57/221.75  |- mesh__recordMaintainer mesh__D047129 ags
% 221.57/221.75  |- mesh__publicMeSHNote mesh__D047129 2005   
% 221.57/221.75  |- rdf__type mesh__D047129sskos__Concept
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D047129 2006
% 221.57/221.75  |- mesh__dateEstablished mesh__D047129 2005-01-01
% 221.57/221.75  |- mesh__activeMeSHYear mesh__D047129 2005
% 221.57/221.75  |- skos__broader mesh__D047129smesh__D011161
% 221.57/221.75  |- skos__prefLabel mesh__D047129 Haliclona
% 221.57/221.75  |- rdf__type mesh__D019438sskos__Concept
% 221.57/221.76  |- skos__historyNote mesh__D019438 Thiazoles %28%1996%29%
% 221.57/221.76  |- mesh__recordAuthorizer mesh__D019438 sjn
% 221.57/221.76  |- mesh__dateRevised mesh__D019438 2005-06-30
% 221.57/221.76  |- skos__hiddenLabel mesh__D019438 538, ABT
% 221.57/221.76  |- mesh__historyNote mesh__D019438 97; was ABT 538 %28%NM%29% 1995-96   
% 221.57/221.76  |- mesh__dateEstablished mesh__D019438 1997-01-01
% 221.57/221.76  |- skos__scopeNote mesh__D019438
% 221.57/221.76       An HIV protease inhibitor that works by interfering with the reproductive cycle of HIV.%A%    
% 221.57/221.76  |- skos__altLabel mesh__D019438 ABT-538
% 221.57/221.76  |- skos__historyNote mesh__D019438
% 221.57/221.76       Valine/analogs %26% derivatives %28%1996%29%
% 221.57/221.76  |- skos__prefLabel mesh__D019438 Ritonavir
% 221.57/221.76  |- skos__hiddenLabel mesh__D019438 ABT538
% 221.57/221.76  |- skos__historyNote mesh__D019438 HIV Protease Inhibitors %28%1995%29%
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D019438 2006
% 221.57/221.76  |- mesh__publicMeSHNote mesh__D019438
% 221.57/221.76       97; ABT 538 was indexed under THIAZOLES %26% VALINE/analogs %26% derivatives 1996 %26% HIV PROTEASE INHIBITORS 1995%A%  
% 221.57/221.76  |- mesh__recordMaintainer mesh__D019438 ssb
% 221.57/221.76  |- mesh__recordOriginator mesh__D019438 AGS
% 221.57/221.76  |- mesh__dateCreated mesh__D019438 1996-06-10
% 221.57/221.76  |- mesh__onlineNote mesh__D019438
% 221.57/221.76       use RITONAVIR %28%NM%29% to search ABT 538 1995-96   
% 221.57/221.76  |- skos__broader mesh__D019438smesh__D013844
% 221.57/221.76  |- skos__scopeNote mesh__D011455
% 221.57/221.76       Analogs or derivatives of prostaglandin A that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGA.%A%    
% 221.57/221.76  |- skos__hiddenLabel mesh__D011455 Analogues, Prostaglandin A
% 221.57/221.76  |- mesh__historyNote mesh__D011455 78   
% 221.57/221.76  |- skos__broader mesh__D011455smesh__D011465
% 221.57/221.76  |- skos__hiddenLabel mesh__D011455 Analogs, Prostaglandin A
% 221.57/221.76  |- mesh__recordMaintainer mesh__D011455 ssb
% 221.57/221.76  |- mesh__recordOriginator mesh__D011455 RLS
% 221.57/221.76  |- mesh__publicMeSHNote mesh__D011455 78   
% 221.57/221.76  |- skos__altLabel mesh__D011455 Synthetic Prostaglandins A
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D011455 2006
% 221.57/221.76  |- skos__annotation mesh__D011455 DF: PGA SYN   
% 221.57/221.76  |- skos__altLabel mesh__D011455 Prostaglandin A Analogues
% 221.57/221.76  |- skos__altLabel mesh__D011455 PGA Synthetic
% 221.57/221.76  |- skos__prefLabel mesh__D011455 Prostaglandins A, Synthetic
% 221.57/221.76  |- rdf__type mesh__D011455sskos__Concept
% 221.57/221.76  |- skos__altLabel mesh__D011455 Prostaglandin A Analogs
% 221.57/221.76  |- mesh__recordAuthorizer mesh__D011455 sjn
% 221.57/221.76  |- mesh__dateRevised mesh__D011455 2005-06-30
% 221.57/221.76  |- skos__historyNote mesh__D011455 Prostaglandins, Synthetic %28%1977%29%
% 221.57/221.76  |- skos__historyNote mesh__D011455 Prostaglandins A %28%1975-1977%29%
% 221.57/221.76  |- mesh__dateEstablished mesh__D011455 1978-01-01
% 221.57/221.76  |- skos__hiddenLabel mesh__D011455 Synthetic, PGA
% 221.57/221.76  |- mesh__dateCreated mesh__D011455 1977-05-23
% 221.57/221.76  |- mesh__recordAuthorizer mesh__D005418 PLS
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D005418 1999
% 221.57/221.76  |- mesh__publicMeSHNote mesh__D005418
% 221.57/221.76       91; was see under FLAVOPROTEINS 1977-90   
% 221.57/221.76  |- skos__annotation mesh__D005418 a bact protein   
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D005418 1994
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D005418 1993
% 221.57/221.76  |- skos__broader mesh__D005418smesh__D001426
% 221.57/221.76  |- mesh__historyNote mesh__D005418
% 221.57/221.76       91%28%77%29%; was see under FLAVOPROTEINS 1977-90   
% 221.57/221.76  |- mesh__dateEstablished mesh__D005418 1991-01-01
% 221.57/221.76  |- skos__broader mesh__D005418smesh__D005420
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D005418 2002
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D005418 1995
% 221.57/221.76  |- rdf__type mesh__D005418sskos__Concept
% 221.57/221.76  |- skos__historyNote mesh__D005418 Flavoproteins %28%1970-1976%29%
% 221.57/221.76  |- skos__prefLabel mesh__D005418 Flavodoxin
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D005418 2003
% 221.57/221.76  |- mesh__dateRevised mesh__D005418 1992-05-19
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D005418 1996
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D005418 2000
% 221.57/221.76  |- mesh__recordOriginator mesh__D005418 RLS
% 221.57/221.76  |- skos__historyNote mesh__D005418 Bacterial Proteins %28%1972-1976%29%
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D005418 2005
% 221.57/221.76  |- mesh__dateCreated mesh__D005418 1976-04-13
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D005418 2004
% 221.57/221.76  |- mesh__recordMaintainer mesh__D005418 TAP
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D005418 1998
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D005418 1997
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D005418 2001
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D005418 2006
% 221.57/221.76  |- skos__scopeNote mesh__D005418
% 221.57/221.76       A low-molecular-weight %28%16,000%29% iron-free flavoprotein containing one molecule of flavin mononucleotide %28%FMN%29% and isolated from bacteria grown on an iron-deficient medium. It can replace ferredoxin in all the electron-transfer functions in which the latter is known to serve in bacterial cells.%A%    
% 221.57/221.76  |- mesh__dateRevised mesh__D002120 2005-06-30
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D002120 2006
% 221.57/221.76  |- skos__prefLabel mesh__D002120 Calcium Channel Agonists
% 221.57/221.76  |- mesh__dateEstablished mesh__D002120 1988-01-01
% 221.57/221.76  |- skos__hiddenLabel mesh__D002120 Agonist, Calcium Channel
% 221.57/221.76  |- skos__broader mesh__D002120smesh__D049990
% 221.57/221.76  |- skos__hiddenLabel mesh__D002120 Channel Agonist, Calcium
% 221.57/221.76  |- skos__hiddenLabel mesh__D002120 Channel Agonists, Calcium
% 221.57/221.76  |- mesh__recordAuthorizer mesh__D002120 sjn
% 221.57/221.76  |- skos__hiddenLabel mesh__D002120 Agonists, Calcium Channel
% 221.57/221.76  |- skos__altLabel mesh__D002120 Calcium Channel Agonists, Exogenous
% 221.57/221.76  |- skos__hiddenLabel mesh__D002120 Channel Activators, Calcium
% 221.57/221.76  |- skos__altLabel mesh__D002120 Calcium Channel Agonist
% 221.57/221.76  |- skos__scopeNote mesh__D002120
% 221.57/221.76       Agents that increase calcium influx into calcium channels of excitable tissues. This causes vasoconstriction in vascular smooth muscle and/or cardiac muscle cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-selective calcium agonists have the potential to combat cardiac failure and endocrinological disorders. They have been used primarily in experimental studies in cell and tissue culture.%A%    
% 221.57/221.76  |- skos__hiddenLabel mesh__D002120 Activators, Calcium Channel
% 221.57/221.76  |- skos__broader mesh__D002120smesh__D014662
% 221.57/221.76  |- skos__historyNote mesh__D002120 Calcium/metab %28%1966-1987%29%
% 221.57/221.76  |- mesh__publicMeSHNote mesh__D002120 88   
% 221.57/221.76  |- rdf__type mesh__D002120sskos__Concept
% 221.57/221.76  |- mesh__historyNote mesh__D002120 88   
% 221.57/221.76  |- mesh__recordOriginator mesh__D002120 RLS
% 221.57/221.76  |- mesh__dateCreated mesh__D002120 1987-03-23
% 221.57/221.76  |- skos__altLabel mesh__D002120 Calcium Channel Activators
% 221.57/221.76  |- skos__annotation mesh__D002120
% 221.57/221.76       vasoconstrictors; DF: CALCIUM CHANNEL AGON or CALCIUM CHANNEL AG%A%  
% 221.57/221.76  |- skos__historyNote mesh__D002120 Ion Channels %28%1979-1987%29%
% 221.57/221.76  |- mesh__recordMaintainer mesh__D002120 ssb
% 221.57/221.76  |- skos__annotation mesh__D029866
% 221.57/221.76       X ref PONGAMIA ULIGINOSA: Pongamia unspecified, PONGAMIA see FABACEAE is available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.57/221.76  |- mesh__historyNote mesh__D029866 2002   
% 221.57/221.76  |- mesh__dateCreated mesh__D029866 2001-07-25
% 221.57/221.76  |- mesh__publicMeSHNote mesh__D029866 2002   
% 221.57/221.76  |- skos__prefLabel mesh__D029866 Derris
% 221.57/221.76  |- mesh__recordAuthorizer mesh__D029866 sjn
% 221.57/221.76  |- mesh__recordMaintainer mesh__D029866 ssb
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D029866 2004
% 221.57/221.76  |- mesh__dateEstablished mesh__D029866 2002-01-01
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D029866 2006
% 221.57/221.76  |- mesh__recordOriginator mesh__D029866 ssb
% 221.57/221.76  |- skos__broader mesh__D029866smesh__D007887
% 221.57/221.76  |- skos__scopeNote mesh__D029866
% 221.57/221.76       A plant genus of the family FABACEAE. The root is a source of rotenoids %28%ROTENONE%29% and flavonoids. Some species of Pongamia have been reclassified to this genus and some to MILLETTIA. Some species of Deguelia have been reclassified to this genus.%A%    
% 221.57/221.76  |- rdf__type mesh__D029866sskos__Concept
% 221.57/221.76  |- skos__altLabel mesh__D029866 Lonchocarpus urucu
% 221.57/221.76  |- skos__altLabel mesh__D029866 Pongamia uliginosa
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D029866 2005
% 221.57/221.76  |- mesh__dateRevised mesh__D029866 2003-07-09
% 221.57/221.76  |- skos__annotation mesh__D029068
% 221.57/221.76       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D029068 2002
% 221.57/221.76  |- mesh__dateEstablished mesh__D029068 2002-01-01
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D029068 2005
% 221.57/221.76  |- skos__broader mesh__D029068smesh__D019684
% 221.57/221.76  |- skos__scopeNote mesh__D029068
% 221.57/221.76       A plant family of the order Geraniales %28%or Ericales in APG system%29%, subclass Rosidae, class Magnoliopsida.%A%    
% 221.57/221.76  |- skos__prefLabel mesh__D029068 Balsaminaceae
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D029068 2006
% 221.57/221.76  |- mesh__publicMeSHNote mesh__D029068 2002   
% 221.57/221.76  |- rdf__type mesh__D029068sskos__Concept
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D029068 2003
% 221.57/221.76  |- mesh__historyNote mesh__D029068 2002   
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D029068 2004
% 221.57/221.76  |- mesh__dateCreated mesh__D029068 2001-07-25
% 221.57/221.76  |- mesh__dateRevised mesh__D015846 2005-06-30
% 221.57/221.76  |- mesh__dateEstablished mesh__D015846 1990-01-01
% 221.57/221.76  |- mesh__recordAuthorizer mesh__D015846 sjn
% 221.57/221.76  |- skos__scopeNote mesh__D015846
% 221.57/221.76       Soluble mediators of the immune response that are neither antibodies nor complement. They are produced largely, but not exclusively, by monocytes and macrophages.%A%    
% 221.57/221.76  |- skos__annotation mesh__D015846
% 221.57/221.76       /biosyn /drug eff /physiol /ultrastruct permitted   
% 221.57/221.76  |- skos__historyNote mesh__D015846 Biological Factors %28%1988-1989%29%
% 221.57/221.76  |- mesh__publicMeSHNote mesh__D015846 90   
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D015846 2006
% 221.57/221.76  |- skos__broader mesh__D015846smesh__D016207
% 221.57/221.76  |- skos__historyNote mesh__D015846 Biological Products %28%1987-1988%29%
% 221.57/221.76  |- mesh__historyNote mesh__D015846 90   
% 221.57/221.76  |- mesh__recordMaintainer mesh__D015846 ssb
% 221.57/221.76  |- skos__historyNote mesh__D015846 Proteins %28%1981-1987%29%
% 221.57/221.76  |- mesh__dateCreated mesh__D015846 1989-05-25
% 221.57/221.76  |- mesh__recordOriginator mesh__D015846 AGS
% 221.57/221.76  |- skos__prefLabel mesh__D015846 Monokines
% 221.57/221.76  |- rdf__type mesh__D015846sskos__Concept
% 221.57/221.76  |- skos__prefLabel mesh__D015048 Zooplankton
% 221.57/221.76  |- skos__scopeNote mesh__D015048
% 221.57/221.76       Minute free-floating animal organisms which live in practically all natural waters.%A%    
% 221.57/221.76  |- mesh__recordOriginator mesh__D015048 NLM
% 221.57/221.76  |- mesh__historyNote mesh__D015048
% 221.57/221.76       91%28%71%29%; was see under PLANKTON 1971-90   
% 221.57/221.76  |- mesh__dateCreated mesh__D015048 1999-01-01
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D015048 2006
% 221.57/221.76  |- mesh__dateEstablished mesh__D015048 1991-01-01
% 221.57/221.76  |- mesh__dateRevised mesh__D015048 2005-06-30
% 221.57/221.76  |- mesh__publicMeSHNote mesh__D015048 91; was see under PLANKTON 1971-90   
% 221.57/221.76  |- skos__broader mesh__D015048smesh__D010933
% 221.57/221.76  |- mesh__recordMaintainer mesh__D015048 SYSTEM
% 221.57/221.76  |- rdf__type mesh__D015048sskos__Concept
% 221.57/221.76  |- skos__annotation mesh__D015048 live in almost all natural waters   
% 221.57/221.76  |- mesh__recordAuthorizer mesh__D015048 sjn
% 221.57/221.76  |- skos__historyNote mesh__D015048 Plankton %28%1966-1970%29%
% 221.57/221.76  |- mesh__recordAuthorizer mesh__D009809 PLS
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D009809 1998
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D009809 2006
% 221.57/221.76  |- rdf__type mesh__D009809sskos__Concept
% 221.57/221.76  |- skos__scopeNote mesh__D009809
% 221.57/221.76       The toothlike process on the upper surface of the axis, which articulates with the atlas above.%A%    
% 221.57/221.76  |- mesh__historyNote mesh__D009809
% 221.57/221.76       91%28%85%29%; was see under AXIS 1985-90   
% 221.57/221.76  |- skos__hiddenLabel mesh__D009809 Odontoid Processes
% 221.57/221.76  |- mesh__dateCreated mesh__D009809 1984-04-06
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D009809 1999
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D009809 1992
% 221.57/221.76  |- skos__historyNote mesh__D009809 Axis %28%1966-1984%29%
% 221.57/221.76  |- mesh__recordOriginator mesh__D009809 RC
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D009809 2000
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D009809 1994
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D009809 1993
% 221.57/221.76  |- mesh__dateEstablished mesh__D009809 1991-01-01
% 221.57/221.76  |- skos__altLabel mesh__D009809 Dens Axis
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D009809 1995
% 221.57/221.76  |- skos__hiddenLabel mesh__D009809 Processes, Odontoid
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D009809 2001
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D009809 2003
% 221.57/221.76  |- skos__hiddenLabel mesh__D009809 Process, Odontoid
% 221.57/221.76  |- skos__broader mesh__D009809smesh__D001368
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D009809 1996
% 221.57/221.76  |- skos__prefLabel mesh__D009809 Odontoid Process
% 221.57/221.76  |- mesh__dateRevised mesh__D009809 1991-01-07
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D009809 2004
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D009809 2005
% 221.57/221.76  |- mesh__publicMeSHNote mesh__D009809 91; was see under AXIS 1985-90   
% 221.57/221.76  |- skos__hiddenLabel mesh__D009809 Axis, Dens
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D009809 2002
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D009809 1997
% 221.57/221.76  |- skos__annotation mesh__D009809 a part of the AXIS; not a dental term   
% 221.57/221.76  |- mesh__recordMaintainer mesh__D009809 TGC
% 221.57/221.76  |- mesh__dateCreated mesh__D001826 1999-01-01
% 221.57/221.76  |- skos__annotation mesh__D001826
% 221.57/221.76       interstitial fluid: index EXTRACELLULAR FLUID %28%see EXTRACELLULAR SPACE%29%%A%  
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D001826 2004
% 221.57/221.76  |- mesh__recordMaintainer mesh__D001826 JLS
% 221.57/221.76  |- skos__scopeNote mesh__D001826
% 221.57/221.76       Liquid components of living organisms.     
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D001826 2000
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D001826 1998
% 221.57/221.76  |- skos__hiddenLabel mesh__D001826 Fluid, Body
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D001826 1995
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D001826 1996
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D001826 1999
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D001826 2001
% 221.57/221.76  |- skos__related mesh__D001826smesh__D011865
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D001826 1997
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D001826 2002
% 221.57/221.76  |- skos__broader mesh__D001826smesh__D005441
% 221.57/221.76  |- skos__related mesh__D001826smesh__D018495
% 221.57/221.76  |- rdf__type mesh__D001826sskos__Concept
% 221.57/221.76  |- skos__hiddenLabel mesh__D001826 Fluids, Body
% 221.57/221.76  |- mesh__dateRevised mesh__D001826 1994-06-07
% 221.57/221.76  |- skos__hiddenLabel mesh__D001826 Body Fluid
% 221.57/221.76  |- mesh__recordOriginator mesh__D001826 NLM
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D001826 2005
% 221.57/221.76  |- skos__related mesh__D001826smesh__D003681
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D001826 2003
% 221.57/221.76  |- skos__prefLabel mesh__D001826 Body Fluids
% 221.57/221.76  |- mesh__recordAuthorizer mesh__D001826 PLS
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D001826 2006
% 221.57/221.76  |- skos__altLabel mesh__D001028 Defects, Aorticopulmonary Septal
% 221.57/221.76  |- mesh__recordOriginator mesh__D001028 VDK
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D001028 2002
% 221.57/221.76  |- skos__scopeNote mesh__D001028
% 221.57/221.76       A congenital anomaly in which there is abnormal communication between the ascending aorta and pulmonary artery just above the semilunar valves.%A%    
% 221.57/221.76  |- skos__altLabel mesh__D001028 Defect, Aortopulmonary Septal
% 221.57/221.76  |- skos__historyNote mesh__D001028
% 221.57/221.76       Heart Defects, Congenital %28%1966-1983%29%
% 221.57/221.76  |- skos__altLabel mesh__D001028 Septal Defects, Aorticopulmonary
% 221.57/221.76  |- skos__altLabel mesh__D001028 Defect, Aorticopulmonary Septal
% 221.57/221.76  |- mesh__publicMeSHNote mesh__D001028
% 221.57/221.76       91; was see under HEART DEFECTS, CONGENITAL 1984-90   
% 221.57/221.76  |- mesh__recordMaintainer mesh__D001028 kle
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D001028 2004
% 221.57/221.76  |- mesh__dateCreated mesh__D001028 1983-05-31
% 221.57/221.76  |- skos__altLabel mesh__D001028 Aorticopulmonary Septal Defects
% 221.57/221.76  |- skos__broader mesh__D001028smesh__D006343
% 221.57/221.76  |- skos__historyNote mesh__D001028 Aorta/abnormalities %28%1966-1983%29%
% 221.57/221.76  |- skos__altLabel mesh__D001028 Septal Defect, Aorticopulmonary
% 221.57/221.76  |- skos__altLabel mesh__D001028 Defects, Aortopulmonary Septal
% 221.57/221.76  |- mesh__historyNote mesh__D001028
% 221.57/221.76       91%28%84%29%; was see under HEART DEFECTS, CONGENITAL 1984-90   
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D001028 2001
% 221.57/221.76  |- mesh__dateRevised mesh__D001028 1999-11-03
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D001028 2003
% 221.57/221.76  |- skos__altLabel mesh__D001028 Septal Defect, Aortopulmonary
% 221.57/221.76  |- skos__altLabel mesh__D001028 Aortopulmonary Septal Defects
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D001028 2000
% 221.57/221.76  |- skos__prefLabel mesh__D001028 Aortopulmonary Septal Defect
% 221.57/221.76  |- skos__historyNote mesh__D001028
% 221.57/221.76       Aorta, Thoracic/abnormalities %28%1966-1983%29%
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D001028 2006
% 221.57/221.76  |- skos__annotation mesh__D001028
% 221.57/221.76       abnorm commun between aorta %26% pulm artery; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: AORTOPULM SEPTAL DEFECT%A%  
% 221.57/221.76  |- rdf__type mesh__D001028sskos__Concept
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D001028 2005
% 221.57/221.76  |- mesh__dateEstablished mesh__D001028 1991-01-01
% 221.57/221.76  |- skos__altLabel mesh__D001028 Septal Defects, Aortopulmonary
% 221.57/221.76  |- mesh__recordAuthorizer mesh__D001028 sjn
% 221.57/221.76  |- skos__historyNote mesh__D001028
% 221.57/221.76       Pulmonary Artery/abnormalities %28%1966-1983%29%
% 221.57/221.76  |- skos__altLabel mesh__D001028 Aorticopulmonary Septal Defect
% 221.57/221.76  |- skos__broader mesh__D006511smesh__D018963
% 221.57/221.76  |- mesh__recordMaintainer mesh__D006511 ssb
% 221.57/221.76  |- mesh__dateEstablished mesh__D006511 1973-01-01
% 221.57/221.76  |- skos__historyNote mesh__D006511 Hepatitis B Virus %28%1966-1972%29%
% 221.57/221.76  |- skos__scopeNote mesh__D006511
% 221.57/221.76       Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface %28%HEPATITIS B SURFACE ANTIGENS%29%, core %28%HEPATITIS B CORE ANTIGENS%29%, and other associated antigens, including the HEPATITIS B E ANTIGENS.%A%    
% 221.57/221.76  |- rdf__type mesh__D006511sskos__Concept
% 221.57/221.76  |- mesh__dateCreated mesh__D006511 1999-01-01
% 221.57/221.76  |- mesh__recordOriginator mesh__D006511 NLM
% 221.57/221.76  |- mesh__historyNote mesh__D006511
% 221.57/221.76       77; HEPATITIS B ANTIGEN was see AUSTRALIA ANTIGEN 1974-76%A%  
% 221.57/221.76  |- mesh__dateRevised mesh__D006511 2005-06-30
% 221.57/221.76  |- mesh__publicMeSHNote mesh__D006511
% 221.57/221.76       77; HEPATITIS B ANTIGEN was see AUSTRALIA ANTIGEN 1974-76%A%  
% 221.57/221.76  |- mesh__recordAuthorizer mesh__D006511 sjn
% 221.57/221.76  |- skos__prefLabel mesh__D006511 Hepatitis B Antigens
% 221.57/221.76  |- skos__hiddenLabel mesh__D006511 B Antigens, Hepatitis
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D006511 2006
% 221.57/221.76  |- skos__altLabel mesh__D006511 HBAg
% 221.57/221.76  |- skos__hiddenLabel mesh__D006511 Antigens, Hepatitis B
% 221.57/221.76  |- mesh__dateEstablished mesh__D047928 2005-01-01
% 221.57/221.76  |- mesh__dateCreated mesh__D047928 2004-07-07
% 221.57/221.76  |- skos__hiddenLabel mesh__D047928 Birth, Preterm
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D047928 2006
% 221.57/221.76  |- mesh__recordMaintainer mesh__D047928 sjn
% 221.57/221.76  |- skos__broader mesh__D047928smesh__D007752
% 221.57/221.76  |- skos__hiddenLabel mesh__D047928 Premature Births
% 221.57/221.76  |- skos__historyNote mesh__D047928 Labor, Premature %28%1966-2004%29%
% 221.57/221.76  |- skos__hiddenLabel mesh__D047928 Births, Preterm
% 221.57/221.76  |- skos__historyNote mesh__D047928 Infant, Premature %28%1965-2004%29%
% 221.57/221.76  |- mesh__historyNote mesh__D047928 2005; use LABOR, PREMATURE 1995-2004   
% 221.57/221.76  |- skos__annotation mesh__D047928
% 221.57/221.76       check tags FEMALE %26% PREGNANCY; OBSTETRIC LABOR, PREMATURE is also available%A%  
% 221.57/221.76  |- skos__hiddenLabel mesh__D047928 Birth, Premature
% 221.57/221.76  |- mesh__recordOriginator mesh__D047928 lkt
% 221.57/221.76  |- skos__prefLabel mesh__D047928 Premature Birth
% 221.57/221.76  |- skos__hiddenLabel mesh__D047928 Births, Premature
% 221.57/221.76  |- mesh__recordAuthorizer mesh__D047928 sjn
% 221.57/221.76  |- skos__hiddenLabel mesh__D047928 Preterm Births
% 221.57/221.76  |- skos__scopeNote mesh__D047928
% 221.57/221.76       CHILDBIRTH before 37 weeks of PREGNANCY %28%259 days from the first day of the mother%27%s last menstrual period, or 245 days after FERTILIZATION%29%.%A%    
% 221.57/221.76  |- mesh__dateRevised mesh__D047928 2005-07-01
% 221.57/221.76  |- mesh__publicMeSHNote mesh__D047928
% 221.57/221.76       2005; see LABOR, PREMATURE 1995-2004   
% 221.57/221.76  |- rdf__type mesh__D047928sskos__Concept
% 221.57/221.76  |- skos__altLabel mesh__D047928 Preterm Birth
% 221.57/221.76  |- skos__related mesh__D047928smesh__D007234
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D019439 1998
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D019439 2002
% 221.57/221.76  |- skos__hiddenLabel mesh__D019439 Chromaffin Cell
% 221.57/221.76  |- skos__historyNote mesh__D019439 Enterochromaffin Cells %28%1977-1995%29%
% 221.57/221.76  |- mesh__publicMeSHNote mesh__D019439 97   
% 221.57/221.76  |- skos__annotation mesh__D019439
% 221.57/221.76       located in adrenal medulla %26% sympath paraganglia; store epinephrine%A%  
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D019439 2006
% 221.57/221.76  |- mesh__dateCreated mesh__D019439 1996-06-10
% 221.57/221.76  |- skos__prefLabel mesh__D019439 Chromaffin Cells
% 221.57/221.76  |- skos__broader mesh__D019439smesh__D002477
% 221.57/221.76  |- skos__broader mesh__D019439smesh__D002838
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D019439 2004
% 221.57/221.76  |- mesh__dateEstablished mesh__D019439 1997-01-01
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D019439 2005
% 221.57/221.76  |- skos__historyNote mesh__D019439 Chromaffin System %28%1967-1996%29%
% 221.57/221.76  |- rdf__type mesh__D019439sskos__Concept
% 221.57/221.76  |- skos__scopeNote mesh__D019439
% 221.57/221.76       Cells that store epinephrine secretory vesicles. During times of stress, the nervous system signals the vesicles to secrete their hormonal content. Their name derives from their ability to stain a brownish color with chromic salts. Characteristically, they are located in the adrenal medulla and paraganglia %28%PARAGANGLIA, CHROMAFFIN%29% of the sympathetic nervous system.%A%    
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D019439 2001
% 221.57/221.76  |- mesh__historyNote mesh__D019439 97   
% 221.57/221.76  |- skos__hiddenLabel mesh__D019439 Cells, Chromaffin
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D019439 2003
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D019439 1999
% 221.57/221.76  |- skos__hiddenLabel mesh__D019439 Cell, Chromaffin
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D019439 2000
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D019439 1997
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D011456 2006
% 221.57/221.76  |- mesh__dateRevised mesh__D011456 2005-06-30
% 221.57/221.76  |- mesh__recordAuthorizer mesh__D011456 sjn
% 221.57/221.76  |- rdf__type mesh__D011456sskos__Concept
% 221.57/221.76  |- skos__annotation mesh__D011456
% 221.57/221.76       /biosyn /physiol permitted; for analogs, coord NIM with PROSTAGLANDINS, SYNTHETIC %28%IM%29%; /chem syn permitted: do not convert to PROSTAGLANDINS, SYNTHETIC: DF: PGB%A%  
% 221.57/221.76  |- mesh__historyNote mesh__D011456
% 221.57/221.76       91%28%78%29%; was see under PROSTAGLANDINS 1978-90   
% 221.57/221.76  |- skos__prefLabel mesh__D011456 Prostaglandins B
% 221.57/221.76  |- skos__historyNote mesh__D011456 Prostaglandins %28%1966-1977%29%
% 221.57/221.76  |- mesh__dateCreated mesh__D011456 1977-05-23
% 221.57/221.76  |- mesh__recordOriginator mesh__D011456 RLS
% 221.57/221.76  |- skos__altLabel mesh__D011456 PGB
% 221.57/221.76  |- skos__hiddenLabel mesh__D011456 B, Prostaglandins
% 221.57/221.76  |- mesh__recordMaintainer mesh__D011456 ssb
% 221.57/221.76  |- skos__broader mesh__D011456smesh__D011453
% 221.57/221.76  |- skos__scopeNote mesh__D011456
% 221.57/221.76       Physiologically active prostaglandins found in many tissues and organs. They are potent pressor substances and have many other physiological activities.%A%    
% 221.57/221.76  |- mesh__dateEstablished mesh__D011456 1991-01-01
% 221.57/221.76  |- mesh__publicMeSHNote mesh__D011456
% 221.57/221.76       91; was see under PROSTAGLANDINS 1978-90   
% 221.57/221.76  |- skos__scopeNote mesh__D005419
% 221.57/221.76       A group of phenyl benzopyrans named for having structures like FLAVONES.%A%    
% 221.57/221.76  |- mesh__publicMeSHNote mesh__D005419
% 221.57/221.76       2004; see FLAVONES 1963-2003; for BIOFLAVONOIDS see BIOFLAVONOIDS 1963-2003; QUERCETIN was under BIOFLAVONOIDS 1963-1974%A%  
% 221.57/221.76  |- skos__altLabel mesh__D005419 2-Phenyl-Benzopyrans
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D005419 2006
% 221.57/221.76  |- mesh__dateCreated mesh__D005419 1999-01-01
% 221.57/221.76  |- mesh__recordAuthorizer mesh__D005419 sjn
% 221.57/221.76  |- skos__prefLabel mesh__D005419 Flavonoids
% 221.57/221.76  |- skos__broader mesh__D005419smesh__D002867
% 221.57/221.76  |- rdf__type mesh__D005419sskos__Concept
% 221.57/221.76  |- skos__annotation mesh__D005419 do not confuse with FLAVINS, pigments   
% 221.57/221.76  |- mesh__recordMaintainer mesh__D005419 ssb
% 221.57/221.76  |- mesh__historyNote mesh__D005419 2004%28%1963%29%   
% 221.57/221.76  |- skos__altLabel mesh__D005419 2-Phenyl-Chromenes
% 221.57/221.76  |- skos__hiddenLabel mesh__D005419 2 Phenyl Benzopyrans
% 221.57/221.76  |- mesh__recordOriginator mesh__D005419 NLM
% 221.57/221.76  |- skos__hiddenLabel mesh__D005419 2 Phenyl Chromenes
% 221.57/221.76  |- mesh__dateRevised mesh__D005419 2005-06-30
% 221.57/221.76  |- skos__hiddenLabel mesh__D002121 Blockaders, Exogenous Calcium
% 221.57/221.76  |- skos__altLabel mesh__D002121 Calcium Inhibitors, Exogenous
% 221.57/221.76  |- skos__altLabel mesh__D002121 Exogenous Calcium Antagonists
% 221.57/221.76  |- rdf__type mesh__D002121sskos__Concept
% 221.57/221.76  |- skos__historyNote mesh__D002121 Ion Channels %28%1979-1981%29%
% 221.57/221.76  |- skos__altLabel mesh__D002121 Exogenous Calcium Blockaders
% 221.57/221.76  |- skos__altLabel mesh__D002121 Calcium Blockaders, Exogenous
% 221.57/221.76  |- skos__hiddenLabel mesh__D002121 Inhibitors, Exogenous Calcium
% 221.57/221.76  |- skos__altLabel mesh__D002121 Calcium Channel Blocking Drugs
% 221.57/221.76  |- mesh__dateCreated mesh__D002121 1981-05-12
% 221.57/221.76  |- skos__related mesh__D002121smesh__D014665
% 221.57/221.76  |- skos__broader mesh__D002121smesh__D049990
% 221.57/221.76  |- mesh__publicMeSHNote mesh__D002121
% 221.57/221.76       83; was CALCIUM ANTAGONISTS, EXOGENOUS 1982   
% 221.57/221.76  |- mesh__historyNote mesh__D002121
% 221.57/221.76       83; was CALCIUM ANTAGONISTS, EXOGENOUS 1982   
% 221.57/221.76  |- skos__hiddenLabel mesh__D002121 Antagonists, Exogenous Calcium
% 221.57/221.76  |- skos__altLabel mesh__D002121 Channel Blockers, Calcium
% 221.57/221.76  |- mesh__recordMaintainer mesh__D002121 ssb
% 221.57/221.76  |- skos__historyNote mesh__D002121
% 221.57/221.76       Calcium %28%1966-1967%29% /antagonists %26% inhibitors %28%1968-1981%29%
% 221.57/221.76  |- skos__related mesh__D002121smesh__D000959
% 221.57/221.76  |- mesh__dateRevised mesh__D002121 2005-06-30
% 221.57/221.76  |- skos__broader mesh__D002121smesh__D002317
% 221.57/221.76  |- skos__prefLabel mesh__D002121 Calcium Channel Blockers
% 221.57/221.76  |- skos__hiddenLabel mesh__D002121 Blockers, Calcium Channel
% 221.57/221.76  |- mesh__recordAuthorizer mesh__D002121 sjn
% 221.57/221.76  |- mesh__onlineNote mesh__D002121
% 221.57/221.76       use CALCIUM CHANNEL BLOCKERS to search CALCIUM ANTAGONISTS, EXOGENOUS 1982%A%  
% 221.57/221.76  |- mesh__activeMeSHYear mesh__D002121 2006
% 221.57/221.76  |- skos__altLabel mesh__D002121 Calcium Antagonists, Exogenous
% 221.57/221.76  |- skos__annotation mesh__D002121
% 221.57/221.76       vasodilators; D25-26 qualif; DF: CA CHANNEL BLOCK   
% 221.57/221.76  |- skos__related mesh__D002121smesh__D000889
% 221.57/221.76  |- mesh__recordOriginator mesh__D002121 RLS
% 221.57/221.76  |- skos__scopeNote mesh__D002121
% 221.57/221.76       A class of drugs that act by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools. Since they are inducers of vascular and other smooth muscle relaxation, they are used in the drug therapy of hypertension and cerebrovascular spasms, as myocardial protective agents, and in the relaxation of uterine spasms.%A%    
% 221.57/221.76  |- skos__altLabel mesh__D002121 Exogenous Calcium Inhibitors
% 221.57/221.76  |- mesh__dateEstablished mesh__D002121 1982-01-01
% 221.57/221.76  |- skos__related mesh__D029867smesh__D014982
% 221.57/221.76  |- mesh__recordOriginator mesh__D029867 jmp
% 221.57/221.76  |- mesh__publicMeSHNote mesh__D029867 2002   
% 221.57/221.76  |- skos__broader mesh__D029867smesh__D029845
% 221.57/221.76  |- skos__prefLabel mesh__D029867 Xenopus Proteins
% 221.57/221.76  |- mesh__historyNote mesh__D029867 2002   
% 221.57/221.77  |- mesh__recordMaintainer mesh__D029867 SYSTEM
% 221.57/221.77  |- mesh__dateCreated mesh__D029867 2001-07-25
% 221.57/221.77  |- mesh__dateEstablished mesh__D029867 2002-01-01
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D029867 2006
% 221.57/221.77  |- skos__scopeNote mesh__D029867
% 221.57/221.77       Proteins obtained from various species of  Xenopus. Included here are proteins from the African clawed frog %28%XENOPUS LAEVIS%29%. Many of these proteins have been the subject of scientific investigations in the area of MORPHOGENESIS and development.%A%    
% 221.57/221.77  |- rdf__type mesh__D029867sskos__Concept
% 221.57/221.77  |- mesh__recordAuthorizer mesh__D029867 sjn
% 221.57/221.77  |- skos__annotation mesh__D029867 coord IM with specific protein   
% 221.57/221.77  |- mesh__dateRevised mesh__D029867 2005-06-30
% 221.57/221.77  |- skos__altLabel mesh__D029069 Jewelweed
% 221.57/221.77  |- mesh__historyNote mesh__D029069 2002   
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D029069 2006
% 221.57/221.77  |- mesh__dateCreated mesh__D029069 2001-07-25
% 221.57/221.77  |- mesh__publicMeSHNote mesh__D029069 2002   
% 221.57/221.77  |- skos__scopeNote mesh__D029069
% 221.57/221.77       A plant genus of subsucculent annual or perennial plants in the family BALSAMINACEAE, order Geraniales.%A%    
% 221.57/221.77  |- mesh__recordMaintainer mesh__D029069 ssb
% 221.57/221.77  |- mesh__recordOriginator mesh__D029069 ssb
% 221.57/221.77  |- mesh__dateRevised mesh__D029069 2002-07-03
% 221.57/221.77  |- skos__prefLabel mesh__D029069 Impatiens
% 221.57/221.77  |- skos__broader mesh__D029069smesh__D029068
% 221.57/221.77  |- rdf__type mesh__D029069sskos__Concept
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D029069 2003
% 221.57/221.77  |- skos__annotation mesh__D029069
% 221.57/221.77       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.57/221.77  |- skos__altLabel mesh__D029069 Touch-me-not
% 221.57/221.77  |- mesh__recordAuthorizer mesh__D029069 sjn
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D029069 2004
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D029069 2005
% 221.57/221.77  |- mesh__dateEstablished mesh__D029069 2002-01-01
% 221.57/221.77  |- mesh__historyNote mesh__D015847
% 221.57/221.77       90; B-CELL GROWTH FACTOR was see INTERLEUKIN-4 1990-96   
% 221.57/221.77  |- skos__scopeNote mesh__D015847
% 221.57/221.77       Soluble factor produced by activated T-lymphocytes that causes proliferation and differentiation of B-cells. Interleukin-4 induces the expression of class II major histocompatibility complex and Fc receptors on B-cells. It also acts on T-lymphocytes, mast cell lines, and several other hematopoietic lineage cells including granulocyte, megakaryocyte, and erythroid precursors, as well as macrophages.%A%    
% 221.57/221.77  |- skos__altLabel mesh__D015847 IL-4
% 221.57/221.77  |- mesh__recordOriginator mesh__D015847 AGS
% 221.57/221.77  |- skos__altLabel mesh__D015847 IL4
% 221.57/221.77  |- skos__altLabel mesh__D015847 BCGF-1
% 221.57/221.77  |- skos__annotation mesh__D015847 DF: IL 4 or IL4   
% 221.57/221.77  |- skos__hiddenLabel mesh__D015847 Interleukin 4
% 221.57/221.77  |- skos__altLabel mesh__D015847 Binetrakin
% 221.57/221.77  |- skos__altLabel mesh__D015847 B Cell Stimulatory Factor-1
% 221.57/221.77  |- skos__hiddenLabel mesh__D015847 B Cell Growth Factor 1
% 221.57/221.77  |- mesh__dateRevised mesh__D015847 2005-06-30
% 221.57/221.77  |- skos__historyNote mesh__D015847 Interleukins %28%1988-1989%29%
% 221.57/221.77  |- skos__related mesh__D015847smesh__D000949
% 221.57/221.77  |- skos__altLabel mesh__D015847 BSF-1
% 221.57/221.77  |- skos__broader mesh__D015847smesh__D007378
% 221.57/221.77  |- skos__hiddenLabel mesh__D015847 B Cell Proliferating Factor
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D015847 2006
% 221.57/221.77  |- mesh__recordAuthorizer mesh__D015847 sjn
% 221.57/221.77  |- skos__hiddenLabel mesh__D015847 B Cell Stimulatory Factor 1
% 221.57/221.77  |- skos__historyNote mesh__D015847 Lymphokines %28%1974-1987%29%
% 221.57/221.77  |- skos__altLabel mesh__D015847 B-Cell Stimulating Factor-1
% 221.57/221.77  |- mesh__dateCreated mesh__D015847 1989-05-25
% 221.57/221.77  |- skos__altLabel mesh__D015847 B-Cell Stimulatory Factor-1
% 221.57/221.77  |- skos__hiddenLabel mesh__D015847 Mast Cell Growth Factor 2
% 221.57/221.77  |- mesh__onlineNote mesh__D015847
% 221.57/221.77       use INTERLEUKIN-4 to search B-CELL GROWTH FACTOR 1990-96   
% 221.57/221.77  |- skos__prefLabel mesh__D015847 Interleukin-4
% 221.57/221.77  |- rdf__type mesh__D015847sskos__Concept
% 221.57/221.77  |- skos__hiddenLabel mesh__D015847 B Cell Growth Factor I
% 221.57/221.77  |- skos__altLabel mesh__D015847 Mast Cell Growth Factor-2
% 221.57/221.77  |- skos__altLabel mesh__D015847 B-Cell Proliferating Factor
% 221.57/221.77  |- skos__hiddenLabel mesh__D015847 B Cell Stimulating Factor 1
% 221.57/221.77  |- skos__altLabel mesh__D015847 B-Cell Growth Factor-I
% 221.57/221.77  |- skos__altLabel mesh__D015847 B-Cell Growth Factor-1
% 221.57/221.77  |- skos__altLabel mesh__D015847 MCGF-2
% 221.57/221.77  |- skos__altLabel mesh__D015847 B-Cell Stimulatory Factor 1
% 221.57/221.77  |- mesh__dateEstablished mesh__D015847 1990-01-01
% 221.57/221.77  |- mesh__publicMeSHNote mesh__D015847
% 221.57/221.77       90; B-CELL GROWTH FACTOR was see INTERLEUKIN-4 1990-96   
% 221.57/221.77  |- mesh__recordMaintainer mesh__D015847 ssb
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D015049 1997
% 221.57/221.77  |- skos__broader mesh__D015049smesh__D001583
% 221.57/221.77  |- skos__prefLabel mesh__D015049 Zoxazolamine
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D015049 2005
% 221.57/221.77  |- skos__scopeNote mesh__D015049
% 221.57/221.77       A uricosuric and muscle relaxant. Zoxazolamine acts centrally as a muscle relaxant, but the mechanism of its action is not understood.%A%    
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D015049 2000
% 221.57/221.77  |- mesh__dateRevised mesh__D015049 1995-06-09
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D015049 2006
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D015049 2003
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D015049 2001
% 221.57/221.77  |- skos__annotation mesh__D015049
% 221.57/221.77       a uricosuric %26% central muscle relaxant   
% 221.57/221.77  |- mesh__recordOriginator mesh__D015049 NLM
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D015049 2004
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D015049 2002
% 221.57/221.77  |- rdf__type mesh__D015049sskos__Concept
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D015049 1998
% 221.57/221.77  |- mesh__recordMaintainer mesh__D015049 JRT
% 221.57/221.77  |- mesh__recordAuthorizer mesh__D015049 PLS
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D015049 1999
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D015049 1996
% 221.57/221.77  |- mesh__dateCreated mesh__D015049 1999-01-01
% 221.57/221.77  |- skos__hiddenLabel mesh__D001827 Height, Body
% 221.57/221.77  |- skos__hiddenLabel mesh__D001827 Heights, Body
% 221.57/221.77  |- skos__prefLabel mesh__D001827 Body Height
% 221.57/221.77  |- skos__annotation mesh__D001827
% 221.57/221.77       human only; for height or length of animals use animal /anat %28%IM%29% + BIOMETRY %28%NIM%29%%A%  
% 221.57/221.77  |- skos__broader mesh__D001827smesh__D049628
% 221.57/221.77  |- skos__scopeNote mesh__D001827
% 221.57/221.77       The distance from the sole to the crown of the head with body standing on a flat surface and fully extended.%A%    
% 221.57/221.77  |- mesh__recordMaintainer mesh__D001827 lkt
% 221.57/221.77  |- rdf__type mesh__D001827sskos__Concept
% 221.57/221.77  |- mesh__recordOriginator mesh__D001827 NLM
% 221.57/221.77  |- mesh__dateRevised mesh__D001827 2004-07-07
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D001827 2006
% 221.57/221.77  |- mesh__dateCreated mesh__D001827 1999-01-01
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D001827 2005
% 221.57/221.77  |- skos__hiddenLabel mesh__D001827 Body Heights
% 221.57/221.77  |- mesh__recordAuthorizer mesh__D001827 sjn
% 221.57/221.77  |- skos__hiddenLabel mesh__D001029 Night Monkeys, Northern
% 221.57/221.77  |- mesh__publicMeSHNote mesh__D001029
% 221.57/221.77       91; was see under CEBIDAE 1981-90; was NIGHT MONKEYS see under MONKEYS 1975-80%A%  
% 221.57/221.77  |- skos__altLabel mesh__D001029 Monkey, Northern Night
% 221.57/221.77  |- skos__broader mesh__D001029smesh__D016645
% 221.57/221.77  |- mesh__recordMaintainer mesh__D001029 ags
% 221.57/221.77  |- mesh__onlineNote mesh__D001029
% 221.57/221.77       use AOTUS TRIVIRGATUS to search NIGHT MONKEYS 1975-80   
% 221.57/221.77  |- skos__scopeNote mesh__D001029
% 221.57/221.77       A species of the subfamily AOTINAE, family CEBIDAE, inhabiting the forested regions of Central and South America %28%from Panama to the Amazon%29%. Vocalizations occur primarily at night when they are active, thus they are also known as Northern night monkeys.%A%    
% 221.57/221.77  |- mesh__recordAuthorizer mesh__D001029 sjn
% 221.57/221.77  |- skos__hiddenLabel mesh__D001029 trivirgatus, Aotus
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D001029 2006
% 221.57/221.77  |- rdf__type mesh__D001029sskos__Concept
% 221.57/221.77  |- mesh__historyNote mesh__D001029
% 221.57/221.77       91%28%81%29%; was see under CEBIDAE 1981-90; was NIGHT MONKEYS see under MONKEYS 1975-80%A%  
% 221.57/221.77  |- mesh__dateCreated mesh__D001029 1974-11-11
% 221.57/221.77  |- skos__altLabel mesh__D001029 Night Monkey, Northern
% 221.57/221.77  |- mesh__dateRevised mesh__D001029 2005-06-30
% 221.57/221.77  |- skos__hiddenLabel mesh__D001029 Northern Night Monkeys
% 221.57/221.77  |- mesh__dateEstablished mesh__D001029 1991-01-01
% 221.57/221.77  |- skos__prefLabel mesh__D001029 Aotus trivirgatus
% 221.57/221.77  |- mesh__recordOriginator mesh__D001029 NLM
% 221.57/221.77  |- skos__hiddenLabel mesh__D001029 Monkeys, Northern Night
% 221.57/221.77  |- skos__annotation mesh__D001029
% 221.57/221.77       New World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%; DF: AOTUS%A%  
% 221.57/221.77  |- skos__hiddenLabel mesh__D001029 Northern Night Monkey
% 221.57/221.77  |- mesh__dateCreated mesh__D006512 1976-05-19
% 221.57/221.77  |- skos__scopeNote mesh__D006512
% 221.57/221.77       The hepatitis B antigen within the core of the Dane particle, the infectious hepatitis virion.%A%    
% 221.57/221.77  |- skos__historyNote mesh__D006512 Hepatitis B Virus %28%1970-1972%29%
% 221.57/221.77  |- skos__broader mesh__D006512smesh__D006511
% 221.57/221.77  |- rdf__type mesh__D006512sskos__Concept
% 221.57/221.77  |- mesh__onlineNote mesh__D006512
% 221.57/221.77       use HEPATITIS B CORE ANTIGENS to search HEPATITIS B CORE ANTIGEN 1977-84%A%  
% 221.57/221.77  |- mesh__recordMaintainer mesh__D006512 ssb
% 221.57/221.77  |- mesh__dateEstablished mesh__D006512 1977-01-01
% 221.57/221.77  |- skos__historyNote mesh__D006512 Hepatitis B Antigens %28%1973-1976%29%
% 221.57/221.77  |- skos__altLabel mesh__D006512 Hepatitis B Core Antigen
% 221.57/221.77  |- skos__annotation mesh__D006512 DF: note short X ref   
% 221.57/221.77  |- mesh__publicMeSHNote mesh__D006512
% 221.57/221.77       85; was HEPATITIS B CORE ANTIGEN 1977-84   
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D006512 2006
% 221.57/221.77  |- mesh__historyNote mesh__D006512
% 221.57/221.77       85; was HEPATITIS B CORE ANTIGEN 1977-84   
% 221.57/221.77  |- skos__altLabel mesh__D006512 HBcAg
% 221.57/221.77  |- mesh__dateRevised mesh__D006512 2005-06-30
% 221.57/221.77  |- skos__prefLabel mesh__D006512 Hepatitis B Core Antigens
% 221.57/221.77  |- mesh__recordAuthorizer mesh__D006512 sjn
% 221.57/221.77  |- mesh__recordOriginator mesh__D006512 FPG
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D047929 2005
% 221.57/221.77  |- skos__scopeNote mesh__D047929
% 221.57/221.77       CHILDBIRTH at the end of a normal duration of PREGNANCY, between 37 to 40 weeks of gestation or about 280 days from the first day of the mother%27%s last menstrual period.%A%    
% 221.57/221.77  |- mesh__publicMeSHNote mesh__D047929 2005   
% 221.57/221.77  |- skos__hiddenLabel mesh__D047929 Births, Fullterm
% 221.57/221.77  |- skos__hiddenLabel mesh__D047929 Fullterm Births
% 221.57/221.77  |- skos__hiddenLabel mesh__D047929 Birth, Fullterm
% 221.57/221.77  |- mesh__historyNote mesh__D047929 2005   
% 221.57/221.77  |- mesh__dateEstablished mesh__D047929 2005-01-01
% 221.57/221.77  |- skos__hiddenLabel mesh__D047929 Full-Term Infant Births
% 221.57/221.77  |- mesh__recordOriginator mesh__D047929 lkt
% 221.57/221.77  |- mesh__recordMaintainer mesh__D047929 lkt
% 221.57/221.77  |- skos__altLabel mesh__D047929 Birth of Full-Term Newborn
% 221.57/221.77  |- skos__broader mesh__D047929smesh__D036801
% 221.57/221.77  |- skos__hiddenLabel mesh__D047929 Birth of Full Term Infant
% 221.57/221.77  |- rdf__type mesh__D047929sskos__Concept
% 221.57/221.77  |- skos__hiddenLabel mesh__D047929 Birth, Term
% 221.57/221.77  |- skos__related mesh__D047929smesh__D005865
% 221.57/221.77  |- mesh__recordAuthorizer mesh__D047929 sjn
% 221.57/221.77  |- mesh__dateCreated mesh__D047929 2004-07-07
% 221.57/221.77  |- skos__altLabel mesh__D047929 Birth of Full-Term Infant
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D047929 2006
% 221.57/221.77  |- skos__historyNote mesh__D047929 Pregnancy %28%1973-2004%29%
% 221.57/221.77  |- skos__altLabel mesh__D047929 Fullterm Birth
% 221.57/221.77  |- skos__hiddenLabel mesh__D047929 Term Births
% 221.57/221.77  |- skos__hiddenLabel mesh__D047929 Birth of Full Term Newborn
% 221.57/221.77  |- skos__prefLabel mesh__D047929 Term Birth
% 221.57/221.77  |- skos__annotation mesh__D011457
% 221.57/221.77       /biosyn /physiol permitted; for analogs, coord NIM with PROSTAGLANDINS, SYNTHETIC %28%IM%29%; /chem syn permitted: do not convert to PROSTAGLANDINS, SYNTHETIC; DF: PGD%A%  
% 221.57/221.77  |- mesh__historyNote mesh__D011457
% 221.57/221.77       84%28%78%29%; was see under PROSTAGLANDINS 1978-83   
% 221.57/221.77  |- skos__scopeNote mesh__D011457
% 221.57/221.77       Physiologically active prostaglandins found in many tissues and organs. They show pressor activity, are mediators of inflammation, and have potential antithrombotic effects.%A%    
% 221.57/221.77  |- mesh__dateCreated mesh__D011457 1977-05-23
% 221.57/221.77  |- mesh__recordAuthorizer mesh__D011457 sjn
% 221.57/221.77  |- mesh__dateRevised mesh__D011457 2005-06-30
% 221.57/221.77  |- skos__prefLabel mesh__D011457 Prostaglandins D
% 221.57/221.77  |- mesh__publicMeSHNote mesh__D011457
% 221.57/221.77       84; was see under PROSTAGLANDINS 1978-83   
% 221.57/221.77  |- skos__hiddenLabel mesh__D011457 D, Prostaglandins
% 221.57/221.77  |- skos__broader mesh__D011457smesh__D011453
% 221.57/221.77  |- mesh__recordOriginator mesh__D011457 RLS
% 221.57/221.77  |- mesh__dateEstablished mesh__D011457 1984-01-01
% 221.57/221.77  |- skos__historyNote mesh__D011457 Prostaglandins %28%1966-1977%29%
% 221.57/221.77  |- skos__altLabel mesh__D011457 PGD
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D011457 2006
% 221.57/221.77  |- mesh__recordMaintainer mesh__D011457 ssb
% 221.57/221.77  |- rdf__type mesh__D011457sskos__Concept
% 221.57/221.77  |- mesh__recordOriginator mesh__D016940 PXP
% 221.57/221.77  |- skos__prefLabel mesh__D016940 Myxococcus
% 221.57/221.77  |- skos__scopeNote mesh__D016940
% 221.57/221.77       A genus of gliding bacteria that are common inhabitants on tree bark and decomposing vegetation. The cells are slender rods with tapering ends.%A%    
% 221.57/221.77  |- mesh__dateEstablished mesh__D016940 1992-01-01
% 221.57/221.77  |- mesh__recordAuthorizer mesh__D016940 sjn
% 221.57/221.77  |- mesh__recordMaintainer mesh__D016940 SYSTEM
% 221.57/221.77  |- skos__broader mesh__D016940smesh__D009231
% 221.57/221.77  |- skos__historyNote mesh__D016940 Bacteria %28%1966-1973%29%
% 221.57/221.77  |- mesh__historyNote mesh__D016940 92   
% 221.57/221.77  |- mesh__dateRevised mesh__D016940 2005-06-30
% 221.57/221.77  |- rdf__type mesh__D016940sskos__Concept
% 221.57/221.77  |- skos__historyNote mesh__D016940 Myxococcales %28%1974-1991%29%
% 221.57/221.77  |- mesh__publicMeSHNote mesh__D016940 92   
% 221.57/221.77  |- mesh__dateCreated mesh__D016940 1991-05-30
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D016940 2006
% 221.57/221.77  |- skos__prefLabel mesh__D016142 Holoprosencephaly
% 221.57/221.77  |- skos__broader mesh__D016142smesh__D009421
% 221.57/221.77  |- skos__hiddenLabel mesh__D016142 Holoprosencephalies, Semilobar
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D016142 2003
% 221.57/221.77  |- skos__hiddenLabel mesh__D016142 Arhinencephalies
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D016142 2005A
% 221.57/221.77  |- rdf__type mesh__D016142sskos__Concept
% 221.57/221.77  |- skos__hiddenLabel mesh__D016142 Holoprosencephaly, Lobar
% 221.57/221.77  |- skos__historyNote mesh__D016142
% 221.57/221.77       Abnormalities, Multiple %28%1966-1990%29%
% 221.57/221.77  |- skos__hiddenLabel mesh__D016142 Lobar Holoprosencephalies
% 221.57/221.77  |- skos__hiddenLabel mesh__D016142 Holoprosencephalies, Lobar
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D016142 2004
% 221.57/221.77  |- mesh__dateEstablished mesh__D016142 1991-01-01
% 221.57/221.77  |- skos__broader mesh__D016142smesh__D019465
% 221.57/221.77  |- skos__historyNote mesh__D016142 Brain/abnormalities %28%1966-1990%29%
% 221.57/221.77  |- mesh__recordMaintainer mesh__D016142 jls
% 221.57/221.77  |- skos__hiddenLabel mesh__D016142 Alobar Holoprosencephalies
% 221.57/221.77  |- mesh__dateCreated mesh__D016142 1990-04-24
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D016142 2002
% 221.57/221.77  |- mesh__publicMeSHNote mesh__D016142 91   
% 221.57/221.77  |- skos__broader mesh__D016142smesh__D025063
% 221.57/221.77  |- skos__broader mesh__D016142smesh__D000015
% 221.57/221.77  |- skos__hiddenLabel mesh__D016142 Holoprosencephaly, Alobar
% 221.57/221.77  |- skos__hiddenLabel mesh__D016142 Holoprosencephalies, Alobar
% 221.57/221.77  |- mesh__recordAuthorizer mesh__D016142 jls
% 221.57/221.77  |- mesh__historyNote mesh__D016142 91   
% 221.57/221.77  |- mesh__dateRevised mesh__D016142 2004-07-28
% 221.57/221.77  |- skos__hiddenLabel mesh__D016142 Semilobar Holoprosencephalies
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D016142 2005
% 221.57/221.77  |- mesh__recordOriginator mesh__D016142 AGS
% 221.57/221.77  |- skos__hiddenLabel mesh__D016142 Holoprosencephaly, Semilobar
% 221.57/221.77  |- skos__scopeNote mesh__D016142
% 221.57/221.77       Anterior midline brain, cranial, and facial malformations resulting from the failure of the embryonic prosencephalon to undergo segmentation and cleavage. Alobar prosencephaly is the most severe form and features anophthalmia; cyclopia; severe MENTAL RETARDATION; CLEFT LIP; CLEFT PALATE; SEIZURES; and microcephaly. Semilobar holoprosencepaly is characterized by hypotelorism, microphthalmia, coloboma, nasal malformations, and variable degrees of mental retardation. Lobar holoprosencephaly is associated with mild %28%or absent%29% facial malformations and intellectual abilities that range from mild mental retardation to normal. Holoprosencephaly is associated with CHROMOSOME ABNORMALITIES.%A%    
% 221.57/221.77  |- skos__hiddenLabel mesh__D016142 Holoprosencephalies
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D016142 2006
% 221.57/221.77  |- skos__historyNote mesh__D002920 Ethylmercury Compounds %28%1972-1974%29%
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D002920 2001
% 221.57/221.77  |- skos__scopeNote mesh__D002920 Tissue preservative.     
% 221.57/221.77  |- mesh__recordMaintainer mesh__D002920 TWD
% 221.57/221.77  |- skos__prefLabel mesh__D002920 Cialit
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D002920 2006
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D002920 2004
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D002920 2005
% 221.57/221.77  |- mesh__historyNote mesh__D002920
% 221.57/221.77       91%28%75%29%; was see under ETHYLMERCURY COMPOUNDS 1980-90; was see under ETHYL MERCURY COMPOUNDS 1975-79%A%  
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D002920 2003
% 221.57/221.77  |- mesh__recordAuthorizer mesh__D002920 sjn
% 221.57/221.77  |- skos__historyNote mesh__D002920 Benzoxazoles %28%1972-1974%29%
% 221.57/221.77  |- mesh__dateCreated mesh__D002920 1974-11-27
% 221.57/221.77  |- mesh__recordOriginator mesh__D002920 NLM
% 221.57/221.77  |- skos__broader mesh__D002920smesh__D005035
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D002920 2002
% 221.57/221.77  |- mesh__publicMeSHNote mesh__D002920
% 221.57/221.77       91; was see under ETHYLMERCURY COMPOUNDS 1980-90; was see under ETHYL MERCURY COMPOUNDS 1975-79%A%  
% 221.57/221.77  |- mesh__dateEstablished mesh__D002920 1991-01-01
% 221.57/221.77  |- rdf__type mesh__D002920sskos__Concept
% 221.57/221.77  |- skos__historyNote mesh__D002920 Sulfides %28%1972-1974%29%
% 221.57/221.77  |- mesh__dateRevised mesh__D002920 2000-06-22
% 221.57/221.77  |- skos__broader mesh__D002920smesh__D001583
% 221.57/221.77  |- skos__hiddenLabel mesh__D002122 Anhydrous Calcium Chloride
% 221.57/221.77  |- mesh__recordMaintainer mesh__D002122 sjn
% 221.57/221.77  |- mesh__dateEstablished mesh__D002122 1965-01-01
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D002122 2004
% 221.57/221.77  |- mesh__publicMeSHNote mesh__D002122 65   
% 221.57/221.77  |- skos__prefLabel mesh__D002122 Calcium Chloride
% 221.57/221.77  |- mesh__dateCreated mesh__D002122 1999-01-01
% 221.57/221.77  |- skos__hiddenLabel mesh__D002122 Chloride, Anhydrous Calcium
% 221.57/221.77  |- skos__hiddenLabel mesh__D002122 Chloride, Calcium
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D002122 2006
% 221.57/221.77  |- mesh__dateRevised mesh__D002122 2003-07-25
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D002122 2005
% 221.57/221.77  |- mesh__historyNote mesh__D002122 65   
% 221.57/221.77  |- skos__hiddenLabel mesh__D002122 Dihydrate, Calcium Chloride
% 221.57/221.77  |- skos__hiddenLabel mesh__D002122 Chloride Dihydrate, Calcium
% 221.57/221.77  |- mesh__recordAuthorizer mesh__D002122 sjn
% 221.57/221.77  |- skos__scopeNote mesh__D002122
% 221.57/221.77       A salt used to replenish calcium levels, as an acid-producing diuretic, and as an antidote for magnesium poisoning.%A%    
% 221.57/221.77  |- mesh__recordOriginator mesh__D002122 NLM
% 221.57/221.77  |- skos__broader mesh__D002122smesh__D017610
% 221.57/221.77  |- rdf__type mesh__D002122sskos__Concept
% 221.57/221.77  |- skos__altLabel mesh__D002122 Calcium Chloride, Anhydrous
% 221.57/221.77  |- skos__broader mesh__D002122smesh__D002712
% 221.57/221.77  |- skos__broader mesh__D015848smesh__D007378
% 221.57/221.77  |- skos__altLabel mesh__D015848 Eosinophil Differentiation Factor
% 221.57/221.77  |- skos__scopeNote mesh__D015848
% 221.57/221.77       Factor promoting eosinophil differentiation and activation in hematopoiesis. It also triggers activated B-cells for a terminal differentiation into Ig-secreting cells.%A%    
% 221.57/221.77  |- mesh__publicMeSHNote mesh__D015848 90   
% 221.57/221.77  |- mesh__historyNote mesh__D015848 90   
% 221.57/221.77  |- skos__hiddenLabel mesh__D015848 T Cell Replacing Factor
% 221.57/221.77  |- skos__annotation mesh__D015848 DF: IL 5 or IL5   
% 221.57/221.77  |- mesh__dateCreated mesh__D015848 1989-05-25
% 221.57/221.77  |- skos__prefLabel mesh__D015848 Interleukin-5
% 221.57/221.77  |- mesh__recordMaintainer mesh__D015848 ssb
% 221.57/221.77  |- rdf__type mesh__D015848sskos__Concept
% 221.57/221.77  |- skos__hiddenLabel mesh__D015848 Interleukin 5
% 221.57/221.77  |- skos__altLabel mesh__D015848 IL-5
% 221.57/221.77  |- mesh__recordOriginator mesh__D015848 AGS
% 221.57/221.77  |- skos__historyNote mesh__D015848 Interleukins %28%1988-1989%29%
% 221.57/221.77  |- skos__altLabel mesh__D015848 T-Cell Replacing Factor
% 221.57/221.77  |- skos__altLabel mesh__D015848 BCGF-II
% 221.57/221.77  |- skos__hiddenLabel mesh__D015848 Replacing Factor, T-Cell
% 221.57/221.77  |- mesh__dateRevised mesh__D015848 2005-06-30
% 221.57/221.77  |- skos__hiddenLabel mesh__D015848 B Cell Growth Factor II
% 221.57/221.77  |- skos__altLabel mesh__D015848 B-Cell Growth Factor-II
% 221.57/221.77  |- mesh__recordAuthorizer mesh__D015848 sjn
% 221.57/221.77  |- mesh__dateEstablished mesh__D015848 1990-01-01
% 221.57/221.77  |- skos__altLabel mesh__D015848 T-Cell-Replacing Factor
% 221.57/221.77  |- skos__altLabel mesh__D015848 IL5
% 221.57/221.77  |- skos__altLabel mesh__D015848 Differentiation Factor, Eosinophil
% 221.57/221.77  |- skos__historyNote mesh__D015848 Lymphokines %28%1977-1987%29%
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D015848 2006
% 221.57/221.77  |- skos__scopeNote mesh__D040241
% 221.57/221.77       Use of marketing principles also used to sell products to consumers to promote ideas, attitudes and behaviors. Design and use of programs seeking to increase the acceptance of a social idea or practice by target groups, not for the benefit of the marketer, but to benefit the target audience and the general society.%A%    
% 221.57/221.77  |- mesh__historyNote mesh__D040241
% 221.57/221.77       2003; use Marketing of Health Services 1980-2002   
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D040241 2006
% 221.57/221.77  |- skos__prefLabel mesh__D040241 Social Marketing
% 221.57/221.77  |- mesh__publicMeSHNote mesh__D040241
% 221.57/221.77       2003; see Marketing of Health Services 1980-2002   
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D040241 2003
% 221.57/221.77  |- rdf__type mesh__D040241sskos__Concept
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D040241 2004
% 221.57/221.77  |- skos__hiddenLabel mesh__D040241 Marketing, Social
% 221.57/221.77  |- skos__broader mesh__D040241smesh__D008389
% 221.57/221.77  |- skos__broader mesh__D040241smesh__D040541
% 221.57/221.77  |- mesh__dateCreated mesh__D040241 2002-07-03
% 221.57/221.77  |- mesh__dateEstablished mesh__D040241 2003-01-01
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D040241 2005
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D001828 2002
% 221.57/221.77  |- mesh__recordAuthorizer mesh__D001828 sjn
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D001828 2001
% 221.57/221.77  |- mesh__recordMaintainer mesh__D001828 adp
% 221.57/221.77  |- rdf__type mesh__D001828sskos__Concept
% 221.57/221.77  |- skos__hiddenLabel mesh__D001828 Image, Body
% 221.57/221.77  |- skos__prefLabel mesh__D001828 Body Image
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D001828 2004
% 221.57/221.77  |- skos__annotation mesh__D001828 no qualif   
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D001828 2000
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D001828 2006
% 221.57/221.77  |- mesh__dateRevised mesh__D001828 1999-11-08
% 221.57/221.77  |- mesh__dateCreated mesh__D001828 1999-01-01
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D001828 2003
% 221.57/221.77  |- skos__hiddenLabel mesh__D001828 Images, Body
% 221.57/221.77  |- skos__scopeNote mesh__D001828
% 221.57/221.77       Individuals%27% personal concept of their bodies as objects in and bound by space, independently and apart from all other objects.%A%    
% 221.57/221.77  |- skos__hiddenLabel mesh__D001828 Body Images
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D001828 2005
% 221.57/221.77  |- skos__broader mesh__D001828smesh__D010465
% 221.57/221.77  |- mesh__recordOriginator mesh__D001828 NLM
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D012550 2005
% 221.57/221.77  |- skos__prefLabel mesh__D012550 Schistosoma mansoni
% 221.57/221.77  |- skos__annotation mesh__D012550
% 221.57/221.77       infection = SCHISTOSOMIASIS MANSONI; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 221.57/221.77  |- skos__scopeNote mesh__D012550
% 221.57/221.77       A species of trematode blood flukes of the family Schistosomatidae. It is common in the Nile delta. The intermediate host is the planorbid snail. This parasite causes schistosomiasis mansoni and intestinal bilharziasis.%A%    
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D012550 2006
% 221.57/221.77  |- mesh__dateRevised mesh__D012550 2003-07-09
% 221.57/221.77  |- skos__historyNote mesh__D012550 Schistosoma %28%1966-1971%29%
% 221.57/221.77  |- mesh__recordMaintainer mesh__D012550 ags
% 221.57/221.77  |- skos__broader mesh__D012550smesh__D012547
% 221.57/221.77  |- mesh__recordAuthorizer mesh__D012550 sjn
% 221.57/221.77  |- rdf__type mesh__D012550sskos__Concept
% 221.57/221.77  |- mesh__historyNote mesh__D012550 72   
% 221.57/221.77  |- mesh__dateCreated mesh__D012550 1999-01-01
% 221.57/221.77  |- mesh__recordOriginator mesh__D012550 NLM
% 221.57/221.77  |- mesh__publicMeSHNote mesh__D012550 72   
% 221.57/221.77  |- mesh__dateEstablished mesh__D012550 1972-01-01
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D012550 2004
% 221.57/221.77  |- mesh__recordOriginator mesh__D006513 SH
% 221.57/221.77  |- mesh__dateEstablished mesh__D006513 1987-01-01
% 221.57/221.77  |- mesh__dateRevised mesh__D006513 2005-06-30
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D006513 2006
% 221.57/221.77  |- mesh__recordAuthorizer mesh__D006513 sjn
% 221.57/221.77  |- skos__altLabel mesh__D006513 e Antigens
% 221.57/221.77  |- mesh__publicMeSHNote mesh__D006513
% 221.57/221.77       87; was see under HEPATITIS B ANTIGENS 1981-86   
% 221.57/221.77  |- skos__prefLabel mesh__D006513 Hepatitis B e Antigens
% 221.57/221.77  |- skos__altLabel mesh__D006513 HBeAg
% 221.57/221.77  |- skos__altLabel mesh__D006513 Hepatitis Be Antigens
% 221.57/221.77  |- skos__historyNote mesh__D006513 Hepatitis B Antigens %28%1973-1980%29%
% 221.57/221.77  |- skos__historyNote mesh__D006513 Hepatitis B Virus %28%1966-1972%29%
% 221.57/221.77  |- mesh__dateCreated mesh__D006513 1980-05-13
% 221.57/221.77  |- skos__hiddenLabel mesh__D006513 Antigens, e
% 221.57/221.77  |- mesh__recordMaintainer mesh__D006513 ssb
% 221.57/221.77  |- skos__scopeNote mesh__D006513
% 221.57/221.77       A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G.%A%    
% 221.57/221.77  |- skos__hiddenLabel mesh__D006513 Antigens, Hepatitis Be
% 221.57/221.77  |- skos__annotation mesh__D006513 DF: note short X refs   
% 221.57/221.77  |- skos__broader mesh__D006513smesh__D006511
% 221.57/221.77  |- rdf__type mesh__D006513sskos__Concept
% 221.57/221.77  |- mesh__historyNote mesh__D006513
% 221.57/221.77       87%28%81%29%; was see under HEPATITIS B ANTIGENS 1981-86   
% 221.57/221.77  |- skos__hiddenLabel mesh__D006513 Be Antigens, Hepatitis
% 221.57/221.77  |- skos__prefLabel mesh__D011458 Prostaglandins E
% 221.57/221.77  |- skos__historyNote mesh__D011458 Prostaglandins %28%1966-1974%29%
% 221.57/221.77  |- skos__altLabel mesh__D011458 PGE
% 221.57/221.77  |- mesh__historyNote mesh__D011458 75   
% 221.57/221.77  |- skos__hiddenLabel mesh__D011458 E, Prostaglandins
% 221.57/221.77  |- skos__annotation mesh__D011458
% 221.57/221.77       /biosyn /physiol permitted; /chem syn permitted: do not convert to PROSTAGLANDINS E, SYNTHETIC: DF: PGE%A%  
% 221.57/221.77  |- skos__broader mesh__D011458smesh__D011453
% 221.57/221.77  |- mesh__dateCreated mesh__D011458 1974-11-11
% 221.57/221.77  |- mesh__recordOriginator mesh__D011458 NLM
% 221.57/221.77  |- mesh__recordAuthorizer mesh__D011458 sjn
% 221.57/221.77  |- mesh__dateRevised mesh__D011458 2005-06-30
% 221.57/221.77  |- mesh__activeMeSHYear mesh__D011458 2006
% 221.57/221.77  |- skos__scopeNote mesh__D011458
% 221.57/221.77       %28%11 alpha,13E,15S%29%-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid %28%PGE%28%1%29%%29%; %28%5Z,11 alpha,13E,15S%29%-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid %28%PGE%28%2%29%%29%; and %28%5Z,11 alpha,13E,15S,17Z%29%-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid %28%PGE%28%3%29%%29%. Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities.%A%    
% 221.57/221.77  |- mesh__publicMeSHNote mesh__D011458 75   
% 221.57/221.77  |- mesh__recordMaintainer mesh__D011458 ssb
% 221.57/221.77  |- mesh__dateEstablished mesh__D011458 1975-09-01
% 221.57/221.77  |- rdf__type mesh__D011458sskos__Concept
% 221.57/221.77  |- skos__prefLabel mesh__D016941 Myxococcus xanthus
% 221.57/221.77  |- mesh__publicMeSHNote mesh__D016941 92   
% 221.57/221.77  |- mesh__recordMaintainer mesh__D016941 SYSTEM
% 221.57/221.77  |- skos__historyNote mesh__D016941 Bacteria %28%1966-1973%29%
% 221.57/221.77  |- skos__scopeNote mesh__D016941
% 221.57/221.77       A species of gliding bacteria found on soil as well as in surface fresh water and coastal seawater.%A%    
% 221.57/221.78  |- mesh__historyNote mesh__D016941 92   
% 221.57/221.78  |- rdf__type mesh__D016941sskos__Concept
% 221.57/221.78  |- mesh__dateEstablished mesh__D016941 1992-01-01
% 221.57/221.78  |- mesh__recordAuthorizer mesh__D016941 sjn
% 221.57/221.78  |- mesh__dateCreated mesh__D016941 1991-05-30
% 221.57/221.78  |- skos__broader mesh__D016941smesh__D016940
% 221.57/221.78  |- mesh__recordOriginator mesh__D016941 PXP
% 221.57/221.78  |- mesh__activeMeSHYear mesh__D016941 2006
% 221.57/221.78  |- mesh__dateRevised mesh__D016941 2005-06-30
% 221.57/221.78  |- skos__historyNote mesh__D016941 Myxococcales %28%1974-1991%29%
% 221.57/221.78  |- mesh__activeMeSHYear mesh__D002921 2006
% 221.57/221.78  |- mesh__recordMaintainer mesh__D002921 TGC
% 221.57/221.78  |- mesh__activeMeSHYear mesh__D002921 2004
% 221.57/221.78  |- mesh__activeMeSHYear mesh__D002921 2005
% 221.57/221.78  |- mesh__activeMeSHYear mesh__D002921 2003
% 221.57/221.78  |- mesh__dateCreated mesh__D002921 1999-01-01
% 221.57/221.78  |- skos__scopeNote mesh__D002921
% 221.57/221.78       The formation of new tissue in the process of wound healing.%A%    
% 221.57/221.78  |- skos__annotation mesh__D002921
% 221.57/221.78       only Cat C qualif; CICATRIX, HYPERTROPHIC is also available%A%  
% 221.57/221.78  |- skos__hiddenLabel mesh__D002921 Scar
% 221.57/221.78  |- skos__broader mesh__D002921smesh__D012871
% 221.57/221.78  |- skos__broader mesh__D002921smesh__D006097
% 221.57/221.78  |- skos__hiddenLabel mesh__D002921 Cicatrices
% 221.57/221.78  |- rdf__type mesh__D002921sskos__Concept
% 221.57/221.78  |- skos__altLabel mesh__D002921 Scars
% 221.57/221.78  |- mesh__recordAuthorizer mesh__D002921 sjn
% 221.57/221.78  |- skos__related mesh__D002921smesh__D007627
% 221.57/221.78  |- mesh__recordOriginator mesh__D002921 NLM
% 221.57/221.78  |- skos__prefLabel mesh__D002921 Cicatrix
% 221.57/221.78  |- mesh__dateRevised mesh__D002921 2002-07-03
% 221.57/221.78  |- skos__historyNote mesh__D002123 Benzenesulfonates %28%1974%29%
% 221.57/221.78  |- skos__altLabel mesh__D002123
% 221.57/221.78       Sanofi Synthelabo Brand of Calcium Dobesilate
% 221.57/221.78  |- mesh__recordAuthorizer mesh__D002123 sjn
% 221.57/221.78  |- skos__hiddenLabel mesh__D002123 2,5 Dihydroxybenzenesulfonic Acid
% 221.57/221.78  |- skos__hiddenLabel mesh__D002123 Calcium, Dobesilate
% 221.57/221.78  |- mesh__activeMeSHYear mesh__D002123 2005
% 221.57/221.78  |- skos__hiddenLabel mesh__D002123 2,5 Dihydroxybenzenesulfonate
% 221.57/221.78  |- mesh__recordMaintainer mesh__D002123 mdb
% 221.57/221.78  |- skos__altLabel mesh__D002123 Esteve Brand of Calcium Dobesilate
% 221.57/221.78  |- mesh__recordOriginator mesh__D002123 NLM
% 221.57/221.78  |- skos__scopeNote mesh__D002123
% 221.57/221.78       A drug used to reduce hemorrhage in diabetic retinopathy.%A%    
% 221.57/221.78  |- mesh__activeMeSHYear mesh__D002123 2006
% 221.57/221.78  |- mesh__dateRevised mesh__D002123 2004-07-07
% 221.57/221.78  |- skos__broader mesh__D002123smesh__D001557
% 221.57/221.78  |- skos__historyNote mesh__D002123 Hydroquinones %28%1972-1974%29%
% 221.57/221.78  |- skos__altLabel mesh__D002123 Knoll Brand of Calcium Dobesilate
% 221.57/221.78  |- mesh__historyNote mesh__D002123
% 221.57/221.78       91%28%75%29%; was see under BENZENESULFONATES 1975-90   
% 221.57/221.78  |- mesh__dateEstablished mesh__D002123 1991-01-01
% 221.57/221.78  |- mesh__publicMeSHNote mesh__D002123
% 221.57/221.78       91; was see under BENZENESULFONATES 1975-90   
% 221.57/221.78  |- skos__altLabel mesh__D002123 Dobesilate Calcium
% 221.57/221.78  |- skos__hiddenLabel mesh__D002123 Dobesilate, Calcium
% 221.57/221.78  |- skos__prefLabel mesh__D002123 Calcium Dobesilate
% 221.57/221.78  |- mesh__dateCreated mesh__D002123 1974-11-19
% 221.57/221.78  |- skos__altLabel mesh__D002123
% 221.57/221.78       Altana Pharma Oranienburg Brand of Calcium Dobesilate Monohydrate
% 221.57/221.78  |- rdf__type mesh__D002123sskos__Concept
% 221.57/221.78  |- mesh__activeMeSHYear mesh__D015849 2002
% 221.57/221.78  |- mesh__dateCreated mesh__D015849 1989-05-25
% 221.57/221.78  |- skos__historyNote mesh__D015849
% 221.57/221.78       Plasminogen Activators/antagonists %26% inhibitors %28%1976-1989%29%
% 221.57/221.78  |- mesh__activeMeSHYear mesh__D015849 2004
% 221.57/221.78  |- skos__altLabel mesh__D015849 Placental Plasminogen Activator Inhibitors
% 221.57/221.78  |- rdf__type mesh__D015849sskos__Concept
% 221.57/221.78  |- skos__prefLabel mesh__D015849 Plasminogen Inactivators
% 221.57/221.78  |- skos__hiddenLabel mesh__D015849 Inactivators, Plasminogen
% 221.57/221.78  |- mesh__activeMeSHYear mesh__D015849 2003
% 221.57/221.78  |- mesh__recordMaintainer mesh__D015849 mdb
% 221.57/221.78  |- mesh__historyNote mesh__D015849 90   
% 221.57/221.78  |- skos__altLabel mesh__D015849 Plasminogen Activator Inhibitors
% 221.57/221.78  |- skos__altLabel mesh__D015849
% 221.57/221.78       Endothelial Plasminogen Activator Inhibitors
% 221.57/221.78  |- skos__hiddenLabel mesh__D015849 Inhibitors, Plasminogen Activator
% 221.57/221.78  |- mesh__recordOriginator mesh__D015849 RLS
% 221.57/221.78  |- mesh__dateEstablished mesh__D015849 1990-01-01
% 221.57/221.78  |- mesh__dateRevised mesh__D015849 2001-07-25
% 221.57/221.78  |- mesh__activeMeSHYear mesh__D015849 2006
% 221.57/221.78  |- skos__historyNote mesh__D015849 Glycoproteins %28%1966-1989%29%
% 221.57/221.78  |- skos__scopeNote mesh__D015849
% 221.57/221.78       Important modulators of the activity of plasminogen activators. Four inhibitors, all belonging to the serpin family of proteins, have been implicated in plasminogen activation inhibition. They are PAI-1, PAI-2, protease-nexin, and PROTEIN C INHIBITOR; %28%PAI-3%29%. All inhibit both the tissue-type and urokinase-type plasminogen activators.%A%    
% 221.57/221.78  |- skos__annotation mesh__D015849 serpins; DF: PLASMINOGEN INACT   
% 221.57/221.78  |- skos__broader mesh__D015849smesh__D015843
% 221.57/221.78  |- mesh__publicMeSHNote mesh__D015849 90   
% 221.57/221.78  |- mesh__activeMeSHYear mesh__D015849 2005
% 221.57/221.78  |- mesh__recordAuthorizer mesh__D015849 sjn
% 221.57/221.78  |- mesh__dateEstablished mesh__D040242 2003-01-01
% 221.57/221.78  |- mesh__activeMeSHYear mesh__D040242 2005
% 221.57/221.78  |- rdf__type mesh__D040242sskos__Concept
% 221.57/221.78  |- mesh__recordAuthorizer mesh__D040242 sjn
% 221.57/221.78  |- skos__scopeNote mesh__D040242
% 221.57/221.78       Reduction of high-risk choices and adoption of low-risk quantity and frequency alternatives.%A%    
% 221.57/221.78  |- mesh__activeMeSHYear mesh__D040242 2003
% 221.57/221.78  |- skos__altLabel mesh__D040242 Lifestyle Risk Reduction
% 221.57/221.78  |- mesh__activeMeSHYear mesh__D040242 2006
% 221.63/221.78  |- skos__broader mesh__D040242smesh__D001519
% 221.63/221.78  |- mesh__dateCreated mesh__D040242 2002-07-02
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D040242 2004
% 221.63/221.78  |- skos__hiddenLabel mesh__D040242 Risk Reduction Behaviors
% 221.63/221.78  |- skos__hiddenLabel mesh__D040242 Behaviors, Risk Reduction
% 221.63/221.78  |- skos__hiddenLabel mesh__D040242 Behavior, Risk Reduction
% 221.63/221.78  |- skos__prefLabel mesh__D040242 Risk Reduction Behavior
% 221.63/221.78  |- mesh__historyNote mesh__D040242 2003; use Health Behavior 1995-2002   
% 221.63/221.78  |- mesh__publicMeSHNote mesh__D040242
% 221.63/221.78       2003;  see Health Behavior 1995-2002   
% 221.63/221.78  |- mesh__recordMaintainer mesh__D040242 jls
% 221.63/221.78  |- skos__related mesh__D040242smesh__D012306
% 221.63/221.78  |- mesh__recordOriginator mesh__D040242 jls
% 221.63/221.78  |- skos__hiddenLabel mesh__D040242 Lifestyle Risk Reductions
% 221.63/221.78  |- skos__scopeNote mesh__D001829 Anatomical areas of the body.     
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D001829 2004
% 221.63/221.78  |- mesh__recordMaintainer mesh__D001829 MSR
% 221.63/221.78  |- mesh__runningHead mesh__D001829 A1 - ANATOMY-BODY REGIONS   
% 221.63/221.78  |- mesh__dateRevised mesh__D001829 1998-06-17
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D001829 2006
% 221.63/221.78  |- mesh__dateCreated mesh__D001829 1999-01-01
% 221.63/221.78  |- mesh__recordOriginator mesh__D001829 NLM
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D001829 2003
% 221.63/221.78  |- skos__annotation mesh__D001829 not used for indexing   
% 221.63/221.78  |- mesh__publicMeSHNote mesh__D001829 98   
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D001829 2005
% 221.63/221.78  |- skos__hiddenLabel mesh__D001829 Regions, Body
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D001829 1999
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D001829 2002
% 221.63/221.78  |- skos__prefLabel mesh__D001829 Body Regions
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D001829 2001
% 221.63/221.78  |- mesh__historyNote mesh__D001829 98; use explode 1971-97   
% 221.63/221.78  |- mesh__recordAuthorizer mesh__D001829 SJN
% 221.63/221.78  |- skos__hiddenLabel mesh__D001829 Body Region
% 221.63/221.78  |- rdf__type mesh__D001829sskos__Concept
% 221.63/221.78  |- skos__historyNote mesh__D001829 specific region %28%1966-1997%29%
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D001829 2000
% 221.63/221.78  |- mesh__dateEstablished mesh__D001829 1998-01-01
% 221.63/221.78  |- skos__hiddenLabel mesh__D001829 Region, Body
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D012551 2006
% 221.63/221.78  |- skos__prefLabel mesh__D012551 Schistosomatidae
% 221.63/221.78  |- mesh__dateRevised mesh__D012551 2003-07-09
% 221.63/221.78  |- skos__broader mesh__D012551smesh__D014200
% 221.63/221.78  |- mesh__recordMaintainer mesh__D012551 ags
% 221.63/221.78  |- skos__annotation mesh__D012551
% 221.63/221.78       a family of trematodes; infection: coord IM with TREMATODE INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 221.63/221.78  |- mesh__dateCreated mesh__D012551 1981-05-15
% 221.63/221.78  |- skos__scopeNote mesh__D012551
% 221.63/221.78       A family of blood flukes of the class Trematoda which is found in animals and man. It Includes the genera Heterobilharzia, Schistosomatium, Schistosoma, Ornithobilharzia, Bilharziella, Trichobilharzia, Pseudobilharzia, and Austrobilharzia.%A%    
% 221.63/221.78  |- mesh__historyNote mesh__D012551 82   
% 221.63/221.78  |- rdf__type mesh__D012551sskos__Concept
% 221.63/221.78  |- skos__historyNote mesh__D012551 Trematoda %28%1966-1981%29%
% 221.63/221.78  |- mesh__recordOriginator mesh__D012551 EC
% 221.63/221.78  |- mesh__recordAuthorizer mesh__D012551 sjn
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D012551 2004
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D012551 2005
% 221.63/221.78  |- mesh__dateEstablished mesh__D012551 1982-01-01
% 221.63/221.78  |- mesh__publicMeSHNote mesh__D012551 82   
% 221.63/221.78  |- mesh__recordOriginator mesh__D006514 FPG
% 221.63/221.78  |- mesh__onlineNote mesh__D006514
% 221.63/221.78       use HEPATITIS B SURFACE ANTIGENS to search HEPATITIS B SURFACE ANTIGEN 1977-80; to search AUSTRALIA ANTIGEN use HEPATITIS B ANTIGENS 1973-77 %26% HEPATITIS VIRUS, HOMOLOGOUS SERUM 1971-72%A%  
% 221.63/221.78  |- mesh__dateRevised mesh__D006514 2005-06-30
% 221.63/221.78  |- mesh__historyNote mesh__D006514
% 221.63/221.78       81; was HEPATITIS B SURFACE ANTIGEN 1977-80; AUSTRALIA ANTIGEN was see HEPATITIS B ANTIGENS 1977, was heading 1973-76, was see HEPATITIS VIRUS, HOMOLOGOUS SERUM 1971-72; HEPATITIS ASSOCIATED ANTIGEN was see AUSTRALIA ANTIGEN 1973-75, was see under HEPATITIS VIRUS, HOMOLOGOUS SERUM 1970-72%A%  
% 221.63/221.78  |- skos__hiddenLabel mesh__D006514 Antigen, Australia
% 221.63/221.78  |- mesh__recordAuthorizer mesh__D006514 sjn
% 221.63/221.78  |- skos__prefLabel mesh__D006514 Hepatitis B Surface Antigens
% 221.63/221.78  |- skos__altLabel mesh__D006514 HBsAg
% 221.63/221.78  |- mesh__dateCreated mesh__D006514 1976-05-19
% 221.63/221.78  |- skos__broader mesh__D006514smesh__D006511
% 221.63/221.78  |- skos__scopeNote mesh__D006514
% 221.63/221.78       Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen.%A%    
% 221.63/221.78  |- rdf__type mesh__D006514sskos__Concept
% 221.63/221.78  |- mesh__dateEstablished mesh__D006514 1977-01-01
% 221.63/221.78  |- skos__altLabel mesh__D006514 Hepatitis B Surface Antigen
% 221.63/221.78  |- skos__historyNote mesh__D006514 Hepatitis B Virus %28%1970-1972%29%
% 221.63/221.78  |- mesh__recordMaintainer mesh__D006514 ssb
% 221.63/221.78  |- skos__historyNote mesh__D006514 Hepatitis B Antigens %28%1973-1977%29%
% 221.63/221.78  |- skos__annotation mesh__D006514 DF: note short X refs   
% 221.63/221.78  |- mesh__publicMeSHNote mesh__D006514
% 221.63/221.78       81; was HEPATITIS B SURFACE ANTIGEN 1977-80; AUSTRALIA ANTIGEN was see HEPATITIS B ANTIGENS 1977, was heading 1973-76, was see HEPATITIS VIRUS, HOMOLOGOUS SERUM 1971-72; HEPATITIS ASSOCIATED ANTIGEN was see AUSTRALIA ANTIGEN 1973-75, was see under HEPATITIS VIRUS, HOMOLOGOUS SERUM 1970-72%A%  
% 221.63/221.78  |- skos__altLabel mesh__D006514 Australia Antigen
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D006514 2006
% 221.63/221.78  |- mesh__historyNote mesh__D011459 78   
% 221.63/221.78  |- mesh__recordMaintainer mesh__D011459 ssb
% 221.63/221.78  |- mesh__publicMeSHNote mesh__D011459 78   
% 221.63/221.78  |- skos__annotation mesh__D011459 DF: PGE SYN   
% 221.63/221.78  |- skos__hiddenLabel mesh__D011459 Synthetic, PGE
% 221.63/221.78  |- skos__broader mesh__D011459smesh__D011465
% 221.63/221.78  |- skos__hiddenLabel mesh__D011459 Analogs, Prostaglandin E
% 221.63/221.78  |- skos__altLabel mesh__D011459 Synthetic Prostaglandins E
% 221.63/221.78  |- skos__altLabel mesh__D011459 PGE Synthetic
% 221.63/221.78  |- mesh__recordOriginator mesh__D011459 RLS
% 221.63/221.78  |- skos__historyNote mesh__D011459 Prostaglandins, Synthetic %28%1977%29%
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D011459 2006
% 221.63/221.78  |- mesh__dateEstablished mesh__D011459 1978-01-01
% 221.63/221.78  |- mesh__dateCreated mesh__D011459 1977-05-23
% 221.63/221.78  |- skos__hiddenLabel mesh__D011459 Analogues, Prostaglandin E
% 221.63/221.78  |- rdf__type mesh__D011459sskos__Concept
% 221.63/221.78  |- skos__altLabel mesh__D011459 Prostaglandin E Analogues
% 221.63/221.78  |- skos__historyNote mesh__D011459 Prostaglandins E %28%1975-1977%29%
% 221.63/221.78  |- skos__altLabel mesh__D011459 Prostaglandin E Analogs
% 221.63/221.78  |- mesh__dateRevised mesh__D011459 2005-06-30
% 221.63/221.78  |- mesh__recordAuthorizer mesh__D011459 sjn
% 221.63/221.78  |- skos__prefLabel mesh__D011459 Prostaglandins E, Synthetic
% 221.63/221.78  |- skos__scopeNote mesh__D011459
% 221.63/221.78       Analogs or derivatives of prostaglandins E that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGE.%A%    
% 221.63/221.78  |- skos__hiddenLabel mesh__D022181 Coat Protein Complex Coated Vesicles
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D022181 2006
% 221.63/221.78  |- skos__hiddenLabel mesh__D022181 Vesicle, COPI-Coated
% 221.63/221.78  |- skos__hiddenLabel mesh__D022181 COPI-Coated Vesicle
% 221.63/221.78  |- rdf__type mesh__D022181sskos__Concept
% 221.63/221.78  |- skos__hiddenLabel mesh__D022181 COP-Coated Vesicle
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D022181 2005
% 221.63/221.78  |- mesh__dateCreated mesh__D022181 2000-06-22
% 221.63/221.78  |- skos__hiddenLabel mesh__D022181 COPII Coated Vesicles
% 221.63/221.78  |- skos__hiddenLabel mesh__D022181 Coatomer-Coated Vesicle
% 221.63/221.78  |- skos__prefLabel mesh__D022181 COP-Coated Vesicles
% 221.63/221.78  |- skos__scopeNote mesh__D022181
% 221.63/221.78       TRANSPORT VESICLES formed when cell-membrane coated pits %28%COATED PITS, CELL-MEMBRANE%29% invaginate and pinch off. The outer surface of these vesicles is covered with a lattice-like network of COP %28%coat protein complex%29% proteins, either COPI or COPII. COPI coated vesicles transport backwards from the cisternae of the GOLGI APPARATUS to the rough endoplasmic reticulum %28%ENDOPLASMIC RETICULUM, ROUGH%29%, while COPII coated vesicles transport forward from the rough endoplasmic reticulum to the Golgi apparatus.%A%    
% 221.63/221.78  |- mesh__dateEstablished mesh__D022181 2001-01-01
% 221.63/221.78  |- skos__hiddenLabel mesh__D022181 Vesicles, Coatomer-Coated
% 221.63/221.78  |- mesh__publicMeSHNote mesh__D022181 2001   
% 221.63/221.78  |- skos__broader mesh__D022181smesh__D018699
% 221.63/221.78  |- skos__hiddenLabel mesh__D022181 Vesicle, COP-Coated
% 221.63/221.78  |- skos__hiddenLabel mesh__D022181 Vesicles, COPI-Coated
% 221.63/221.78  |- skos__hiddenLabel mesh__D022181 Vesicle, Coatomer-Coated
% 221.63/221.78  |- mesh__dateRevised mesh__D022181 2003-07-09
% 221.63/221.78  |- mesh__historyNote mesh__D022181 2001   
% 221.63/221.78  |- skos__altLabel mesh__D022181 Coatomer-Coated Vesicles
% 221.63/221.78  |- skos__altLabel mesh__D022181 Coat Protein Complex-Coated Vesicles
% 221.63/221.78  |- skos__hiddenLabel mesh__D022181 Vesicles, COPII-Coated
% 221.63/221.78  |- skos__hiddenLabel mesh__D022181 COPII-Coated Vesicle
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D022181 2004
% 221.63/221.78  |- skos__hiddenLabel mesh__D022181 Vesicles, COP-Coated
% 221.63/221.78  |- skos__hiddenLabel mesh__D022181 Coatomer Coated Vesicles
% 221.63/221.78  |- skos__hiddenLabel mesh__D022181 COP Coated Vesicles
% 221.63/221.78  |- skos__historyNote mesh__D022181 Coated Vesicles %28%1995-2000%29%
% 221.63/221.78  |- skos__hiddenLabel mesh__D022181 COPI Coated Vesicles
% 221.63/221.78  |- skos__hiddenLabel mesh__D022181 Vesicle, COPII-Coated
% 221.63/221.78  |- skos__scopeNote mesh__D016942
% 221.63/221.78       An order of CRENARCHAEOTA consisting of aerobic or facultatively aerobic, chemolithotrophic cocci which are extreme thermoacidophiles. They lack peptidoglycan in their cell walls.%A%    
% 221.63/221.78  |- skos__broader mesh__D016942smesh__D019615
% 221.63/221.78  |- mesh__dateCreated mesh__D016942 1991-05-30
% 221.63/221.78  |- skos__annotation mesh__D016942
% 221.63/221.78       an order of Crenarchaeota, of the domain Archaea   
% 221.63/221.78  |- mesh__dateRevised mesh__D016942 2005-06-30
% 221.63/221.78  |- mesh__recordOriginator mesh__D016942 PXP
% 221.63/221.78  |- mesh__historyNote mesh__D016942 92   
% 221.63/221.78  |- rdf__type mesh__D016942sskos__Concept
% 221.63/221.78  |- mesh__publicMeSHNote mesh__D016942 92   
% 221.63/221.78  |- mesh__recordMaintainer mesh__D016942 SYSTEM
% 221.63/221.78  |- skos__prefLabel mesh__D016942 Sulfolobales
% 221.63/221.78  |- mesh__dateEstablished mesh__D016942 1992-01-01
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D016942 2006
% 221.63/221.78  |- mesh__recordAuthorizer mesh__D016942 sjn
% 221.63/221.78  |- skos__prefLabel mesh__D002922 Ciguatoxins
% 221.63/221.78  |- rdf__type mesh__D002922sskos__Concept
% 221.63/221.78  |- mesh__publicMeSHNote mesh__D002922
% 221.63/221.78       2003; see CIGUATOXIN 1991-2002, see MARINE TOXINS 1978-1990%A%  
% 221.63/221.78  |- skos__altLabel mesh__D002922 Ciguatoxin
% 221.63/221.78  |- mesh__recordAuthorizer mesh__D002922 sjn
% 221.63/221.78  |- mesh__historyNote mesh__D002922 1991%28%1978%29%   
% 221.63/221.78  |- mesh__recordMaintainer mesh__D002922 ssb
% 221.63/221.78  |- mesh__dateRevised mesh__D002922 2005-06-30
% 221.63/221.78  |- skos__historyNote mesh__D002922 Fishes, Poisonous %28%1968-1977%29%
% 221.63/221.78  |- skos__annotation mesh__D002922
% 221.63/221.78       /antag permitted but consider also ANTITOXINS; coordinate IM with source of ciguatoxin%A%  
% 221.63/221.78  |- mesh__dateEstablished mesh__D002922 1991-01-01
% 221.63/221.78  |- skos__broader mesh__D002922smesh__D008387
% 221.63/221.78  |- skos__broader mesh__D002922smesh__D004988
% 221.63/221.78  |- skos__historyNote mesh__D002922 Marine Toxins %28%1974-1977%29%
% 221.63/221.78  |- skos__historyNote mesh__D002922 Toxins %28%1966-1973%29%
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D002922 2006
% 221.63/221.78  |- mesh__recordOriginator mesh__D002922 SH
% 221.63/221.78  |- mesh__dateCreated mesh__D002922 1977-04-22
% 221.63/221.78  |- skos__scopeNote mesh__D002922
% 221.63/221.78       Polycyclic ethers produced by Gambierdiscus %28%DINOFLAGELLATES%29% from gambiertoxins, which are ingested by fish which in turn may be ingested by humans who are susceptible to the CIGUATERA POISONING.%A%    
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D002124 1994
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D002124 1999
% 221.63/221.78  |- mesh__historyNote mesh__D002124 65   
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D002124 2004
% 221.63/221.78  |- mesh__dateEstablished mesh__D002124 1965-01-01
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D002124 2001
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D002124 1995
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D002124 2006
% 221.63/221.78  |- skos__broader mesh__D002124smesh__D005459
% 221.63/221.78  |- mesh__dateRevised mesh__D002124 1993-06-04
% 221.63/221.78  |- skos__prefLabel mesh__D002124 Calcium Fluoride
% 221.63/221.78  |- skos__scopeNote mesh__D002124
% 221.63/221.78       Calcium fluoride. Occurring in nature as the mineral fluorite or fluorspar. It is the primary source of fluorine and its compounds. Pure calcium fluoride is used as a catalyst in dehydration and dehydrogenation and is used to fluoridate drinking water. %28%From Merck Index, 11th ed%29%%A%    
% 221.63/221.78  |- mesh__recordMaintainer mesh__D002124 TPW
% 221.63/221.78  |- skos__broader mesh__D002124smesh__D017610
% 221.63/221.78  |- mesh__recordOriginator mesh__D002124 NLM
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D002124 2002
% 221.63/221.78  |- mesh__publicMeSHNote mesh__D002124 65   
% 221.63/221.78  |- rdf__type mesh__D002124sskos__Concept
% 221.63/221.78  |- mesh__dateCreated mesh__D002124 1999-01-01
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D002124 1996
% 221.63/221.78  |- mesh__recordAuthorizer mesh__D002124 PLS
% 221.63/221.78  |- skos__annotation mesh__D002124
% 221.63/221.78       in nature as mineral fluorite or fluorspar; used in fluoridation of drinking water%A%  
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D002124 1998
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D002124 2003
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D002124 1997
% 221.63/221.78  |- skos__hiddenLabel mesh__D002124 Fluoride, Calcium
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D002124 2005
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D002124 2000
% 221.63/221.78  |- rdf__type mesh__D012552sskos__Concept
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D012552 1999
% 221.63/221.78  |- mesh__dateCreated mesh__D012552 1999-01-01
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D012552 2003
% 221.63/221.78  |- mesh__dateRevised mesh__D012552 1996-06-10
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D012552 2000
% 221.63/221.78  |- skos__hiddenLabel mesh__D012552 Schistosomiases
% 221.63/221.78  |- skos__scopeNote mesh__D012552
% 221.63/221.78       Infection with flukes %28%trematodes%29% of the genus SCHISTOSOMA. Three species produce the most frequent clinical diseases: SCHISTOSOMA HAEMATOBIUM %28%endemic in Africa and the Middle East%29%, SCHISTOSOMA MANSONI %28%in Egypt, northern and southern Africa, some West Indies islands, northern 2/3 of South America%29%, and SCHISTOSOMA JAPONICUM %28%in Japan, China, the Philippines, Celebes, Thailand, Laos%29%. S. mansoni is often seen in Puerto Ricans living in the United States. %28%Merck Manual, 15th ed%29%%A%    
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D012552 2004
% 221.63/221.78  |- mesh__recordOriginator mesh__D012552 NLM
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D012552 2001
% 221.63/221.78  |- skos__broader mesh__D012552smesh__D014201
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D012552 2005
% 221.63/221.78  |- skos__hiddenLabel mesh__D012552 Bilharziases
% 221.63/221.78  |- skos__related mesh__D012552smesh__D012556
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D012552 2002
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D012552 2006
% 221.63/221.78  |- mesh__recordAuthorizer mesh__D012552 PLS
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D012552 1997
% 221.63/221.78  |- skos__prefLabel mesh__D012552 Schistosomiasis
% 221.63/221.78  |- skos__altLabel mesh__D012552 Bilharziasis
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D012552 1998
% 221.63/221.78  |- mesh__recordMaintainer mesh__D012552 TGC
% 221.63/221.78  |- skos__annotation mesh__D012552
% 221.63/221.78       trematode infect; GEN or unspecified; prefer specifics; /drug ther: consider also SCHISTOSOMICIDES%A%  
% 221.63/221.78  |- mesh__onlineNote mesh__D006515
% 221.63/221.78       use HEPATITIS B VIRUS to search HEPATITIS VIRUS, HOMOLOGOUS SERUM 1966-76; use HEPATITIS B VIRUS to search DANE PARTICLE 1981 %26% use HEPATITIS B ANTIGENS 1977-80%A%  
% 221.63/221.78  |- skos__prefLabel mesh__D006515 Hepatitis B virus
% 221.63/221.78  |- skos__hiddenLabel mesh__D006515 Particle, Dane
% 221.63/221.78  |- mesh__dateCreated mesh__D006515 1999-01-01
% 221.63/221.78  |- skos__related mesh__D006515smesh__D006514
% 221.63/221.78  |- skos__broader mesh__D006515smesh__D017918
% 221.63/221.78  |- skos__hiddenLabel mesh__D006515 Hepatitis B viruses
% 221.63/221.78  |- mesh__recordMaintainer mesh__D006515 sjn
% 221.63/221.78  |- mesh__publicMeSHNote mesh__D006515
% 221.63/221.78       77; was HEPATITIS VIRUS, HOMOLOGOUS SERUM 1966-76; DANE PARTICLE was see HEPATITIS B ANTIGENS 1977-80%A%  
% 221.63/221.78  |- rdf__type mesh__D006515sskos__Concept
% 221.63/221.78  |- skos__scopeNote mesh__D006515
% 221.63/221.78       The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum.%A%    
% 221.63/221.78  |- skos__hiddenLabel mesh__D006515 virus, Hepatitis B
% 221.63/221.78  |- mesh__recordOriginator mesh__D006515 NLM
% 221.63/221.78  |- mesh__dateRevised mesh__D006515 2004-07-13
% 221.63/221.78  |- mesh__historyNote mesh__D006515
% 221.63/221.78       77; was HEPATITIS VIRUS, HOMOLOGOUS SERUM 1966-76; DANE PARTICLE was see HEPATITIS B ANTIGENS 1977-80%A%  
% 221.63/221.78  |- mesh__recordAuthorizer mesh__D006515 sjn
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D006515 2005
% 221.63/221.78  |- skos__altLabel mesh__D006515 Hepatitis Virus, Homologous Serum
% 221.63/221.78  |- skos__hiddenLabel mesh__D006515 B virus, Hepatitis
% 221.63/221.78  |- skos__hiddenLabel mesh__D006515 viruses, Hepatitis B
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D006515 2006
% 221.63/221.78  |- skos__annotation mesh__D006515
% 221.63/221.78       infection = HEPATITIS B or HEPATITIS B, CHRONIC   
% 221.63/221.78  |- mesh__dateEstablished mesh__D006515 1966-01-01
% 221.63/221.78  |- skos__broader mesh__D008628Q000506smesh__D008628
% 221.63/221.78  |- mesh__preferredCombination mesh__D008628Q000506smesh__D008630
% 221.63/221.78  |- rdf__type mesh__D008628Q000506smesh__CompoundConcept
% 221.63/221.78  |- mesh__recordOriginator mesh__D016943 PXP
% 221.63/221.78  |- mesh__recordAuthorizer mesh__D016943 sjn
% 221.63/221.78  |- skos__broader mesh__D016943smesh__D016942
% 221.63/221.78  |- rdf__type mesh__D016943sskos__Concept
% 221.63/221.78  |- mesh__publicMeSHNote mesh__D016943 1992   
% 221.63/221.78  |- mesh__recordMaintainer mesh__D016943 SYSTEM
% 221.63/221.78  |- mesh__dateRevised mesh__D016943 2005-06-30
% 221.63/221.78  |- mesh__historyNote mesh__D016943 1992   
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D016943 2006
% 221.63/221.78  |- skos__scopeNote mesh__D016943
% 221.63/221.78       A family of SULFOLOBALES consisting of aerobic or facultatively anaerobic chemolithotrophic cocci, usually occurring singly. They grow best at a pH of about 2.%A%    
% 221.63/221.78  |- skos__prefLabel mesh__D016943 Sulfolobaceae
% 221.63/221.78  |- mesh__dateEstablished mesh__D016943 1992-01-01
% 221.63/221.78  |- mesh__dateCreated mesh__D016943 1991-05-30
% 221.63/221.78  |- skos__broader mesh__D016145smesh__D013505
% 221.63/221.78  |- skos__altLabel mesh__D016145
% 221.63/221.78       Procedure, Endoscopic, Digestive System, Surgical
% 221.63/221.78  |- skos__altLabel mesh__D016145 Surgery, Endoscopic, Digestive System
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D016145 2006
% 221.63/221.78  |- skos__hiddenLabel mesh__D016145 Esophagogastroduodenoscopies
% 221.63/221.78  |- skos__altLabel mesh__D016145
% 221.63/221.78       Surgical Procedures, Endoscopic, Digestive System
% 221.63/221.78  |- skos__altLabel mesh__D016145 Digestive System Endoscopic Surgery
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D016145 2002
% 221.63/221.78  |- mesh__publicMeSHNote mesh__D016145 91   
% 221.63/221.78  |- mesh__recordAuthorizer mesh__D016145 sjn
% 221.63/221.78  |- skos__annotation mesh__D016145
% 221.63/221.78       GEN only: prefer specifics but note 3-organ X ref; /instrum permitted but consider ENDOSCOPES, GASTROINTESTINAL or specifics%A%  
% 221.63/221.78  |- skos__scopeNote mesh__D016145
% 221.63/221.78       Endoscopic examination, therapy or surgery of the digestive tract.%A%    
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D016145 2003
% 221.63/221.78  |- skos__altLabel mesh__D016145
% 221.63/221.78       Procedure, Digestive System, Endoscopic, Surgical
% 221.63/221.78  |- skos__prefLabel mesh__D016145 Endoscopy, Digestive System
% 221.63/221.78  |- mesh__dateRevised mesh__D016145 1999-11-03
% 221.63/221.78  |- skos__hiddenLabel mesh__D016145 Digestive System Endoscopies
% 221.63/221.78  |- skos__altLabel mesh__D016145
% 221.63/221.78       Endoscopic, Digestive System, Surgical Procedure
% 221.63/221.78  |- skos__altLabel mesh__D016145 Endoscopic, Digestive System, Surgery
% 221.63/221.78  |- skos__hiddenLabel mesh__D016145 Digestive System Endoscopy
% 221.63/221.78  |- skos__altLabel mesh__D016145 Surgery, Digestive System Endoscopic
% 221.63/221.78  |- skos__broader mesh__D016145smesh__D003938
% 221.63/221.78  |- rdf__type mesh__D016145sskos__Concept
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D016145 2004
% 221.63/221.78  |- skos__altLabel mesh__D016145
% 221.63/221.78       Procedures, Endoscopic, Digestive System, Surgical
% 221.63/221.78  |- mesh__recordOriginator mesh__D016145 AGS
% 221.63/221.78  |- skos__broader mesh__D016145smesh__D004724
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D016145 2000
% 221.63/221.78  |- skos__altLabel mesh__D016145
% 221.63/221.78       Procedures, Digestive System, Endoscopic, Surgical
% 221.63/221.78  |- mesh__activeMeSHYear mesh__D016145 2001
% 221.63/221.78  |- mesh__dateEstablished mesh__D016145 1991-01-01
% 221.63/221.78  |- skos__historyNote mesh__D016145 Endoscopy %28%1966-1990%29%
% 221.63/221.78  |- mesh__historyNote mesh__D016145 91   
% 221.63/221.78  |- mesh__recordMaintainer mesh__D016145 nns
% 221.63/221.78  |- skos__altLabel mesh__D016145
% 221.63/221.78       Surgical Procedure, Endoscopic, Digestive System
% 221.63/221.78  |- skos__hiddenLabel mesh__D016145 Endoscopies, Digestive System
% 221.63/221.78  |- mesh__dateCreated mesh__D016145 1990-03-23
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D016145 2005
% 221.63/221.79  |- skos__scopeNote mesh__D002923
% 221.63/221.79       Populations of thin, motile processes found covering the surface of ciliates %28%CILIOPHORA%29% or the free surface of the cells making up ciliated EPITHELIUM. Each cilium arises from a basic granule in the superficial layer of CYTOPLASM. The movement of cilia propels ciliates through the liquid in which they live. The movement of cilia on a ciliated epithelium serves to propel a surface layer of mucus or fluid. %28%King %26% Stansfield, A Dictionary of Genetics, 4th ed%29%%A%    
% 221.63/221.79  |- mesh__historyNote mesh__D002923 65%28%64%29%   
% 221.63/221.79  |- skos__prefLabel mesh__D002923 Cilia
% 221.63/221.79  |- mesh__dateRevised mesh__D002923 2000-06-22
% 221.63/221.79  |- mesh__recordAuthorizer mesh__D002923 sjn
% 221.63/221.79  |- skos__altLabel mesh__D002923 Cilium
% 221.63/221.79  |- mesh__publicMeSHNote mesh__D002923 65   
% 221.63/221.79  |- skos__broader mesh__D002923smesh__D022081
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002923 2006
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002923 2002
% 221.63/221.79  |- mesh__recordOriginator mesh__D002923 NLM
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002923 2004
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002923 2005
% 221.63/221.79  |- mesh__dateCreated mesh__D002923 1999-01-01
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002923 2003
% 221.63/221.79  |- mesh__dateEstablished mesh__D002923 1965-01-01
% 221.63/221.79  |- skos__related mesh__D002923smesh__D004848
% 221.63/221.79  |- skos__annotation mesh__D002923
% 221.63/221.79       IM GEN only; NIM when specific organ is IM; A 11 qualif except /cytol; /genet permitted; do not confuse with the protozoa CILIATA see CILIOPHORA or with the Latin plural of EYELASHES%A%  
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002923 2001
% 221.63/221.79  |- mesh__recordMaintainer mesh__D002923 NDW
% 221.63/221.79  |- rdf__type mesh__D002923sskos__Concept
% 221.63/221.79  |- mesh__recordOriginator mesh__D002125 RLS
% 221.63/221.79  |- skos__altLabel mesh__D002125 Fresenius Kabi Brand of Calcium Gluconate
% 221.63/221.79  |- mesh__historyNote mesh__D002125
% 221.63/221.79       91%28%79%29%; was see under GLUCONATES 1979-90   
% 221.63/221.79  |- skos__altLabel mesh__D002125 Coophavet Brand of Calcium Gluconate
% 221.63/221.79  |- skos__prefLabel mesh__D002125 Calcium Gluconate
% 221.63/221.79  |- skos__altLabel mesh__D002125
% 221.63/221.79       Chaix et du Marais Brand of Calcium Gluconate
% 221.63/221.79  |- mesh__dateEstablished mesh__D002125 1991-01-01
% 221.63/221.79  |- skos__scopeNote mesh__D002125
% 221.63/221.79       The calcium salt of gluconic acid. The compound has a variety of uses, including its use as a calcium replenisher in hypocalcemic states.%A%    
% 221.63/221.79  |- skos__historyNote mesh__D002125 Calcium %28%1966-1978%29%
% 221.63/221.79  |- mesh__recordMaintainer mesh__D002125 lkw
% 221.63/221.79  |- mesh__dateCreated mesh__D002125 1977-12-09
% 221.63/221.79  |- rdf__type mesh__D002125sskos__Concept
% 221.63/221.79  |- skos__altLabel mesh__D002125 3M Brand of Calcium Gluconate Monohydrate
% 221.63/221.79  |- skos__altLabel mesh__D002125 Pharmtech Brand of Calcium Gluconate
% 221.63/221.79  |- mesh__dateRevised mesh__D002125 2005-06-30
% 221.63/221.79  |- mesh__publicMeSHNote mesh__D002125
% 221.63/221.79       91; was see under GLUCONATES 1979-90   
% 221.63/221.79  |- skos__altLabel mesh__D002125 Braun Brand of Calcium Gluconate
% 221.63/221.79  |- mesh__recordAuthorizer mesh__D002125 sjn
% 221.63/221.79  |- skos__broader mesh__D002125smesh__D005942
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002125 2006
% 221.63/221.79  |- skos__hiddenLabel mesh__D002125 Gluconate, Calcium
% 221.63/221.79  |- skos__historyNote mesh__D002125 Gluconates %28%1966-1978%29%
% 221.63/221.79  |- skos__altLabel mesh__D002125 Merial Brand of Calcium Gluconate
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012553 1995
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012553 2004
% 221.63/221.79  |- skos__hiddenLabel mesh__D012553 Urinary Schistosomiases
% 221.63/221.79  |- skos__historyNote mesh__D012553 Schistosomiasis %28%1966-1985%29%
% 221.63/221.79  |- skos__prefLabel mesh__D012553 Schistosomiasis haematobia
% 221.63/221.79  |- mesh__recordMaintainer mesh__D012553 PXP
% 221.63/221.79  |- skos__broader mesh__D012553smesh__D014552
% 221.63/221.79  |- skos__hiddenLabel mesh__D012553 Urinary Schistosomiasis
% 221.63/221.79  |- skos__altLabel mesh__D012553 Schistosomiasis haematobium
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012553 2005
% 221.63/221.79  |- mesh__dateEstablished mesh__D012553 1986-01-01
% 221.63/221.79  |- skos__altLabel mesh__D012553 Schistosomiasis, Urinary
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012553 1996
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012553 2006
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012553 2000
% 221.63/221.79  |- mesh__historyNote mesh__D012553 86   
% 221.63/221.79  |- skos__annotation mesh__D012553
% 221.63/221.79       for X ref SCHISTOSOMIASIS, URINARY do not coord with URINARY TRACT INFECTIONS; in titles %26% translations do not capitalize haematobia%A%  
% 221.63/221.79  |- skos__historyNote mesh__D012553
% 221.63/221.79       Schistosoma haematobium %28%1972-1985%29%
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012553 1997
% 221.63/221.79  |- skos__broader mesh__D012553smesh__D012552
% 221.63/221.79  |- skos__hiddenLabel mesh__D012553 Schistosomiases, Urinary
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012553 2001
% 221.63/221.79  |- skos__scopeNote mesh__D012553
% 221.63/221.79       Schistosomiasis caused by SCHISTOSOMA HAEMATOBIUM. It is endemic in Africa and parts of the Middle East, and affects the urinary tract.%A%    
% 221.63/221.79  |- mesh__dateCreated mesh__D012553 1985-05-07
% 221.63/221.79  |- mesh__dateRevised mesh__D012553 1993-06-03
% 221.63/221.79  |- mesh__recordOriginator mesh__D012553 RC
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012553 1998
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012553 2002
% 221.63/221.79  |- rdf__type mesh__D012553sskos__Concept
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012553 1994
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012553 1999
% 221.63/221.79  |- mesh__recordAuthorizer mesh__D012553 PLS
% 221.63/221.79  |- mesh__publicMeSHNote mesh__D012553 86   
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012553 2003
% 221.63/221.79  |- skos__hiddenLabel mesh__D006516 Canine Hepatitis Virus
% 221.63/221.79  |- mesh__dateCreated mesh__D006516 1999-01-01
% 221.63/221.79  |- skos__altLabel mesh__D006516 Hepatitis Virus, Infectious Canine
% 221.63/221.79  |- mesh__dateRevised mesh__D006516 2001-07-25
% 221.63/221.79  |- skos__hiddenLabel mesh__D006516 Hepatitis Viruses, Canine
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D006516 2006
% 221.63/221.79  |- skos__altLabel mesh__D006516 Canine Infectious Hepatitis Virus
% 221.63/221.79  |- skos__hiddenLabel mesh__D006516 Viruses, Canine Hepatitis
% 221.63/221.79  |- skos__broader mesh__D006516smesh__D006518
% 221.63/221.79  |- skos__annotation mesh__D006516
% 221.63/221.79       infection: coord IM with ADENOVIRIDAE INFECTIONS %28%IM%29% or HEPATITIS, INFECTIOUS CANINE %28%IM%29% if pertinent%A%  
% 221.63/221.79  |- mesh__publicMeSHNote mesh__D006516
% 221.63/221.79       94; was HEPATITIS VIRUS, INFECTIOUS CANINE 1966-93   
% 221.63/221.79  |- skos__scopeNote mesh__D006516
% 221.63/221.79       Species of the genus MASTADENOVIRUS that causes fever, edema, vomiting, and diarrhea in dogs and encephalitis in foxes. Epizootics have also been caused in bears, wolves, coyotes, and skunks. The official species name is Canine adenovirus and it contains two serotypes.%A%    
% 221.63/221.79  |- skos__hiddenLabel mesh__D006516 Canine Hepatitis Viruses
% 221.63/221.79  |- rdf__type mesh__D006516sskos__Concept
% 221.63/221.79  |- skos__altLabel mesh__D006516 Canine adenovirus
% 221.63/221.79  |- mesh__recordOriginator mesh__D006516 NLM
% 221.63/221.79  |- skos__hiddenLabel mesh__D006516 adenovirus, Canine
% 221.63/221.79  |- mesh__historyNote mesh__D006516
% 221.63/221.79       94; was HEPATITIS VIRUS, INFECTIOUS CANINE 1966-93   
% 221.63/221.79  |- mesh__recordAuthorizer mesh__D006516 sjn
% 221.63/221.79  |- mesh__recordMaintainer mesh__D006516 ags
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D006516 2003
% 221.63/221.79  |- skos__altLabel mesh__D006516 Hepatitis Virus, Canine
% 221.63/221.79  |- skos__prefLabel mesh__D006516 Adenoviruses, Canine
% 221.63/221.79  |- skos__altLabel mesh__D006516 Infectious Canine Hepatitis Virus
% 221.63/221.79  |- mesh__dateEstablished mesh__D006516 1966-01-01
% 221.63/221.79  |- skos__broader mesh__D006516smesh__D017921
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D006516 2002
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D006516 2005
% 221.63/221.79  |- mesh__onlineNote mesh__D006516
% 221.63/221.79       use ADENOVIRUSES, CANINE to search HEPATITIS VIRUS, INFECTIOUS CANINE 1966-93%A%  
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D006516 2004
% 221.63/221.79  |- skos__altLabel mesh__D006516 Canine Adenoviruses
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D022981 2004
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D022981 2005
% 221.63/221.79  |- mesh__publicMeSHNote mesh__D022981 2001   
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D022981 2003
% 221.63/221.79  |- mesh__dateRevised mesh__D022981 2002-07-02
% 221.63/221.79  |- skos__hiddenLabel mesh__D022981 Imbalances, Allelic
% 221.63/221.79  |- mesh__dateCreated mesh__D022981 2000-06-21
% 221.63/221.79  |- skos__prefLabel mesh__D022981 Allelic Imbalance
% 221.63/221.79  |- skos__hiddenLabel mesh__D022981 Imbalance, Allelic
% 221.63/221.79  |- skos__scopeNote mesh__D022981
% 221.63/221.79       A situation where one member %28%allele%29% of a gene pair is lost %28%LOSS OF HETEROZYGOSITY%29% or amplified.%A%    
% 221.63/221.79  |- skos__hiddenLabel mesh__D022981 Allelic Imbalances
% 221.63/221.79  |- skos__broader mesh__D022981smesh__D009154
% 221.63/221.79  |- rdf__type mesh__D022981sskos__Concept
% 221.63/221.79  |- mesh__historyNote mesh__D022981 2001   
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D022981 2006
% 221.63/221.79  |- skos__annotation mesh__D022981
% 221.63/221.79       do not confuse with ALLELIC LOSS see LOSS OF HETEROZYGOSITY%A%  
% 221.63/221.79  |- mesh__dateEstablished mesh__D022981 2001-01-01
% 221.63/221.79  |- mesh__dateEstablished mesh__D016944 1992-01-01
% 221.63/221.79  |- skos__broader mesh__D016944smesh__D016943
% 221.63/221.79  |- rdf__type mesh__D016944sskos__Concept
% 221.63/221.79  |- skos__historyNote mesh__D016944 Bacteria %28%1972-1991%29%
% 221.63/221.79  |- mesh__historyNote mesh__D016944 92   
% 221.63/221.79  |- skos__scopeNote mesh__D016944
% 221.63/221.79       A genus of aerobic, chemolithotrophic, coccoid ARCHAEA whose organisms are thermoacidophilic. Its cells are highly irregular in shape, often lobed, but occasionally spherical. It has worldwide distribution with organisms isolated from hot acidic soils and water. Sulfur is used as an energy source.%A%    
% 221.63/221.79  |- mesh__recordMaintainer mesh__D016944 SYSTEM
% 221.63/221.79  |- mesh__dateRevised mesh__D016944 2005-06-30
% 221.63/221.79  |- skos__annotation mesh__D016944
% 221.63/221.79       a genus of archaea found in %22%hot acid soils %26% water%22%   
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D016944 2006
% 221.63/221.79  |- mesh__publicMeSHNote mesh__D016944 92   
% 221.63/221.79  |- mesh__dateCreated mesh__D016944 1991-05-30
% 221.63/221.79  |- skos__prefLabel mesh__D016944 Sulfolobus
% 221.63/221.79  |- mesh__recordOriginator mesh__D016944 PXP
% 221.63/221.79  |- mesh__recordAuthorizer mesh__D016944 sjn
% 221.63/221.79  |- skos__historyNote mesh__D016146 Urologic Diseases %28%1966-1990%29%
% 221.63/221.79  |- mesh__historyNote mesh__D016146 91   
% 221.63/221.79  |- skos__broader mesh__D016146smesh__D005831
% 221.63/221.79  |- skos__hiddenLabel mesh__D016146 Urogenital Disease
% 221.63/221.79  |- mesh__dateEstablished mesh__D016146 1991-01-01
% 221.63/221.79  |- skos__hiddenLabel mesh__D016146 Disease, Genitourinary
% 221.63/221.79  |- skos__historyNote mesh__D016146
% 221.63/221.79       specific urologic and genital diseases %28%1966-1990%29%
% 221.63/221.79  |- skos__altLabel mesh__D016146 Genitourinary Diseases
% 221.63/221.79  |- mesh__recordOriginator mesh__D016146 AGS
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D016146 2006
% 221.63/221.79  |- skos__hiddenLabel mesh__D016146 Diseases, Genitourinary
% 221.63/221.79  |- skos__annotation mesh__D016146 general or unspecified   
% 221.63/221.79  |- mesh__recordMaintainer mesh__D016146 lkt
% 221.63/221.79  |- skos__hiddenLabel mesh__D016146 Genitourinary Disease
% 221.63/221.79  |- skos__hiddenLabel mesh__D016146 Diseases, Urogenital
% 221.63/221.79  |- mesh__publicMeSHNote mesh__D016146 91   
% 221.63/221.79  |- mesh__recordAuthorizer mesh__D016146 sjn
% 221.63/221.79  |- skos__prefLabel mesh__D016146 Urogenital Diseases
% 221.63/221.79  |- mesh__dateRevised mesh__D016146 2005-06-30
% 221.63/221.79  |- rdf__type mesh__D016146sskos__Concept
% 221.63/221.79  |- skos__scopeNote mesh__D016146
% 221.63/221.79       Pathological processes involving any part of the UROGENITAL SYSTEM in either the male or the female.%A%    
% 221.63/221.79  |- mesh__dateCreated mesh__D016146 1990-02-12
% 221.63/221.79  |- skos__hiddenLabel mesh__D016146 Disease, Urogenital
% 221.63/221.79  |- skos__broader mesh__D016146smesh__D014569
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002924 2000
% 221.63/221.79  |- mesh__dateRevised mesh__D002924 1998-06-10
% 221.63/221.79  |- skos__related mesh__D002924smesh__D014130
% 221.63/221.79  |- skos__hiddenLabel mesh__D002924 Bodies, Ciliary
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002924 2005
% 221.63/221.79  |- mesh__dateCreated mesh__D002924 1999-01-01
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002924 2001
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002924 2003
% 221.63/221.79  |- mesh__recordAuthorizer mesh__D002924 SJN
% 221.63/221.79  |- skos__prefLabel mesh__D002924 Ciliary Body
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002924 2006
% 221.63/221.79  |- skos__broader mesh__D002924smesh__D014602
% 221.63/221.79  |- skos__scopeNote mesh__D002924
% 221.63/221.79       A ring of tissue extending from the scleral spur to the ora serrata of the retina. It consists of the uveal portion and the epithelial portion. The ciliary muscle is in the uveal portion and the ciliary processes are in the epithelial portion.%A%    
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002924 2002
% 221.63/221.79  |- skos__hiddenLabel mesh__D002924 Ciliary Bodies
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002924 2004
% 221.63/221.79  |- skos__annotation mesh__D002924
% 221.63/221.79       inflammation: consider CILIARY BODY %28%IM%29% + UVEITIS %28%IM%29% or UVEITIS, ANTERIOR %28%IM%29%; dis = CILIARY BODY %28%IM%29% + UVEAL DISEASES %28%IM%29%; neopl = CILIARY BODY %28%IM%29% + UVEAL NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%; /blood supply consider also CILIARY ARTERIES; pigmented ciliary epithelium: coord CILIARY BODY with PIGMENT EPITHELIUM OF EYE%A%  
% 221.63/221.79  |- skos__hiddenLabel mesh__D002924 Body, Ciliary
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002924 1999
% 221.63/221.79  |- mesh__recordOriginator mesh__D002924 NLM
% 221.63/221.79  |- mesh__recordMaintainer mesh__D002924 PXP
% 221.63/221.79  |- rdf__type mesh__D002924sskos__Concept
% 221.63/221.79  |- rdf__type mesh__D002126sskos__Concept
% 221.63/221.79  |- mesh__recordOriginator mesh__D002126 NLM
% 221.63/221.79  |- mesh__dateCreated mesh__D002126 1999-01-01
% 221.63/221.79  |- mesh__historyNote mesh__D002126 67   
% 221.63/221.79  |- skos__prefLabel mesh__D002126 Calcium Hydroxide
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002126 2003
% 221.63/221.79  |- mesh__recordMaintainer mesh__D002126 ssb
% 221.63/221.79  |- mesh__dateEstablished mesh__D002126 1967-01-01
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002126 2005
% 221.63/221.79  |- skos__broader mesh__D002126smesh__D006878
% 221.63/221.79  |- skos__hiddenLabel mesh__D002126 Hydroxide, Calcium
% 221.63/221.79  |- skos__historyNote mesh__D002126 Hydroxides %28%1966%29%
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002126 2004
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002126 2006
% 221.63/221.79  |- skos__historyNote mesh__D002126 Calcium %28%1966%29%
% 221.63/221.79  |- skos__broader mesh__D002126smesh__D017610
% 221.63/221.79  |- mesh__publicMeSHNote mesh__D002126 67   
% 221.63/221.79  |- mesh__dateRevised mesh__D002126 2002-07-31
% 221.63/221.79  |- skos__scopeNote mesh__D002126
% 221.63/221.79       A white powder prepared from lime that has many medical and industrial uses. It is in many dental formulations, especially for root canal filling.%A%    
% 221.63/221.79  |- mesh__recordAuthorizer mesh__D002126 sjn
% 221.63/221.79  |- skos__annotation mesh__D048228
% 221.63/221.79       do not confuse with CONTINUOUS PASSIVE MOTION THERAPY   
% 221.63/221.79  |- skos__historyNote mesh__D048228
% 221.63/221.79       Postoperative Complications/prevention %26% control %28%1972-2004%29%
% 221.63/221.79  |- mesh__dateCreated mesh__D048228 2004-07-07
% 221.63/221.79  |- skos__broader mesh__D048228smesh__D004864
% 221.63/221.79  |- mesh__dateEstablished mesh__D048228 2005-01-01
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D048228 2005
% 221.63/221.79  |- skos__prefLabel mesh__D048228 Intermittent Pneumatic Compression Devices
% 221.63/221.79  |- rdf__type mesh__D048228sskos__Concept
% 221.63/221.79  |- skos__scopeNote mesh__D048228
% 221.63/221.79       Instruments that generate intermittent forces, uniformed or graduated, to facilitate the emptying of VEINS. These devices are used to reduce limb EDEMA and prevent venous THROMBOEMBOLISM, such as deep vein thrombosis in the legs.%A%    
% 221.63/221.79  |- skos__altLabel mesh__D048228 Pneumatic Intermittent Impulse Device
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D048228 2006
% 221.63/221.79  |- mesh__recordAuthorizer mesh__D048228 sjn
% 221.63/221.79  |- mesh__historyNote mesh__D048228 2005   
% 221.63/221.79  |- skos__historyNote mesh__D048228
% 221.63/221.79       Thrombophlebitis/prevention %26% control %28%1972-2004%29%
% 221.63/221.79  |- mesh__publicMeSHNote mesh__D048228 2005   
% 221.63/221.79  |- mesh__recordMaintainer mesh__D048228 lkt
% 221.63/221.79  |- mesh__recordOriginator mesh__D048228 lkt
% 221.63/221.79  |- skos__annotation mesh__D012554
% 221.63/221.79       in titles and translations do not capitalize japonica   
% 221.63/221.79  |- rdf__type mesh__D012554sskos__Concept
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012554 2004
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012554 1999
% 221.63/221.79  |- mesh__recordMaintainer mesh__D012554 PLS
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012554 1993
% 221.63/221.79  |- skos__altLabel mesh__D012554 Schistosomiasis japonicum
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012554 2003
% 221.63/221.79  |- skos__prefLabel mesh__D012554 Schistosomiasis japonica
% 221.63/221.79  |- skos__broader mesh__D012554smesh__D012552
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012554 1998
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012554 1992
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012554 2002
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012554 1997
% 221.63/221.79  |- mesh__historyNote mesh__D012554 86   
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012554 2006
% 221.63/221.79  |- skos__historyNote mesh__D012554 Schistosomiasis %28%1966-1985%29%
% 221.63/221.79  |- mesh__publicMeSHNote mesh__D012554 86   
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012554 2001
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012554 1996
% 221.63/221.79  |- mesh__dateRevised mesh__D012554 1991-06-19
% 221.63/221.79  |- mesh__dateCreated mesh__D012554 1985-05-07
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012554 1995
% 221.63/221.79  |- mesh__dateEstablished mesh__D012554 1986-01-01
% 221.63/221.79  |- mesh__recordOriginator mesh__D012554 RC
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012554 2005
% 221.63/221.79  |- mesh__recordAuthorizer mesh__D012554 PLS
% 221.63/221.79  |- skos__historyNote mesh__D012554 Schistosoma japonicum %28%1979-1985%29%
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012554 2000
% 221.63/221.79  |- skos__scopeNote mesh__D012554
% 221.63/221.79       Schistosomiasis caused by Schistosoma japonicum. It is endemic in the Far East and affects the bowel, liver, and spleen,%A%    
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D012554 1994
% 221.63/221.79  |- skos__scopeNote mesh__D006517
% 221.63/221.79       A species of the CORONAVIRUS genus causing hepatitis in mice. Four strains have been identified as MHV 1, MHV 2, MHV 3, and MHV 4 %28%also known as MHV-JHM, which is neurotropic and causes disseminated encephalomyelitis with demyelination as well as focal liver necrosis%29%.%A%    
% 221.63/221.79  |- skos__hiddenLabel mesh__D006517 Mouse Hepatitis Viruses
% 221.63/221.79  |- mesh__historyNote mesh__D006517 2002 %28%1966%29%   
% 221.63/221.79  |- mesh__dateEstablished mesh__D006517 1966-01-01
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D006517 2002
% 221.63/221.79  |- skos__hiddenLabel mesh__D006517 Murine hepatitis viruses
% 221.63/221.79  |- rdf__type mesh__D006517sskos__Concept
% 221.63/221.79  |- mesh__dateRevised mesh__D006517 2001-07-25
% 221.63/221.79  |- skos__broader mesh__D006517smesh__D017934
% 221.63/221.79  |- skos__hiddenLabel mesh__D006517 hepatitis virus, Murine
% 221.63/221.79  |- skos__altLabel mesh__D006517 Hepatitis Virus, Mouse
% 221.63/221.79  |- skos__annotation mesh__D006517
% 221.63/221.79       infection: coord IM with CORONAVIRUS INFECTIONS %28%IM%29%; since formerly called murine hepatitis virus %26% causing hepatitis in mice, coord IM with HEPATITIS, VIRAL, ANIMAL %28%IM%29% if pertinent%A%  
% 221.63/221.79  |- skos__altLabel mesh__D006517 Murine Gastroenteritis Virus
% 221.63/221.79  |- skos__broader mesh__D006517smesh__D006518
% 221.63/221.79  |- skos__hiddenLabel mesh__D006517 Hepatitis Viruses, Mouse
% 221.63/221.79  |- mesh__recordMaintainer mesh__D006517 ags
% 221.63/221.79  |- mesh__publicMeSHNote mesh__D006517
% 221.63/221.79       2002; see GASTROENTERITIS VIRUS, MURINE 1994-2001, see HEPATITIS VIRUS, MOUSE 1966-1993%A%  
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D006517 2003
% 221.63/221.79  |- skos__hiddenLabel mesh__D006517 Murine Gastroenteritis Viruses
% 221.63/221.79  |- skos__hiddenLabel mesh__D006517 Gastroenteritis Viruses, Murine
% 221.63/221.79  |- skos__altLabel mesh__D006517 Gastroenteritis Virus, Murine
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D006517 2005
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D006517 2004
% 221.63/221.79  |- mesh__recordOriginator mesh__D006517 NLM
% 221.63/221.79  |- skos__altLabel mesh__D006517 Mouse Hepatitis Virus
% 221.63/221.79  |- mesh__recordAuthorizer mesh__D006517 sjn
% 221.63/221.79  |- mesh__dateCreated mesh__D006517 1999-01-01
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D006517 2006
% 221.63/221.79  |- skos__prefLabel mesh__D006517 Murine hepatitis virus
% 221.63/221.79  |- skos__broader mesh__D016945smesh__D016944
% 221.63/221.79  |- skos__historyNote mesh__D016945 Bacteria %28%1973-1991%29%
% 221.63/221.79  |- mesh__publicMeSHNote mesh__D016945 92   
% 221.63/221.79  |- skos__annotation mesh__D016945 a species of archaea   
% 221.63/221.79  |- mesh__dateEstablished mesh__D016945 1992-01-01
% 221.63/221.79  |- mesh__recordMaintainer mesh__D016945 SYSTEM
% 221.63/221.79  |- skos__scopeNote mesh__D016945
% 221.63/221.79       A species of aerobic, chemolithotrophic ARCHAEA consisting of coccoid cells that utilize sulfur as an energy source. The optimum temperature for growth is 70-75 degrees C. They are isolated from acidic fields.%A%    
% 221.63/221.79  |- mesh__recordAuthorizer mesh__D016945 sjn
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D016945 2006
% 221.63/221.79  |- mesh__dateCreated mesh__D016945 1991-05-30
% 221.63/221.79  |- mesh__recordOriginator mesh__D016945 PXP
% 221.63/221.79  |- rdf__type mesh__D016945sskos__Concept
% 221.63/221.79  |- skos__prefLabel mesh__D016945 Sulfolobus acidocaldarius
% 221.63/221.79  |- mesh__dateRevised mesh__D016945 2005-06-30
% 221.63/221.79  |- mesh__historyNote mesh__D016945 92   
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Suppressor Genes, Cancer
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Suppressor Gene, Growth
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D016147 2006
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Metastasis Suppressor Gene
% 221.63/221.79  |- mesh__recordMaintainer mesh__D016147 nns
% 221.63/221.79  |- mesh__recordAuthorizer mesh__D016147 sjn
% 221.63/221.79  |- rdf__type mesh__D016147sskos__Concept
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Onco-Suppressor Gene
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Gene, Growth Suppressor
% 221.63/221.79  |- skos__altLabel mesh__D016147 Genes, Cancer Suppressor
% 221.63/221.79  |- skos__altLabel mesh__D016147 Genes, Growth Suppressor
% 221.63/221.79  |- skos__altLabel mesh__D016147 Tumor Suppressor Genes
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Genes, Tumor Suppressing
% 221.63/221.79  |- mesh__dateRevised mesh__D016147 2005-06-30
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Anti-Oncogene
% 221.63/221.79  |- skos__scopeNote mesh__D016147
% 221.63/221.79       Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When tumor suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible.%A%    
% 221.63/221.79  |- mesh__publicMeSHNote mesh__D016147
% 221.63/221.79       2002; see GENES, SUPPRESSOR, TUMOR 1991-2001   
% 221.63/221.79  |- skos__altLabel mesh__D016147 Antioncogenes
% 221.63/221.79  |- mesh__dateCreated mesh__D016147 1990-05-07
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Anti Oncogenes
% 221.63/221.79  |- skos__altLabel mesh__D016147 Tumor Suppressing Genes
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Suppressor Gene, Metastasis
% 221.63/221.79  |- skos__altLabel mesh__D016147 Cancer Suppressor Genes
% 221.63/221.79  |- skos__broader mesh__D016147smesh__D052138
% 221.63/221.79  |- skos__prefLabel mesh__D016147 Genes, Tumor Suppressor
% 221.63/221.79  |- skos__broader mesh__D016147smesh__D005808
% 221.63/221.79  |- mesh__historyNote mesh__D016147 2002 %28%1991%29%   
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Gene, Tumor Suppressor
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Emerogene
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Gene, Onco-Suppressor
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Suppressor Gene, Cancer
% 221.63/221.79  |- skos__annotation mesh__D016147 Manual 24.4.4.3   
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Gene, Metastasis Suppressor
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Recessive Oncogenes
% 221.63/221.79  |- skos__altLabel mesh__D016147 Emerogenes
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Growth Suppressor Gene
% 221.63/221.79  |- skos__altLabel mesh__D016147 Genes, Onco-Suppressor
% 221.63/221.79  |- skos__altLabel mesh__D016147 Oncogenes, Recessive
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Suppressor Genes, Metastasis
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Cancer Suppressor Gene
% 221.63/221.79  |- skos__related mesh__D016147smesh__D025521
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Oncogene, Recessive
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Onco-Suppressor Genes
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Recessive Oncogene
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Gene, Tumor Suppressing
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Suppressor Genes, Growth
% 221.63/221.79  |- skos__historyNote mesh__D016147 Suppression, Genetic %28%1986-1990%29%
% 221.63/221.79  |- mesh__dateEstablished mesh__D016147 1991-01-01
% 221.63/221.79  |- skos__altLabel mesh__D016147 Anti-Oncogenes
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Tumor Suppressor Gene
% 221.63/221.79  |- skos__altLabel mesh__D016147 Genes, Metastasis Suppressor
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Genes, Onco Suppressor
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Gene, Cancer Suppressor
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Tumor Suppressing Gene
% 221.63/221.79  |- skos__hiddenLabel mesh__D016147 Antioncogene
% 221.63/221.79  |- mesh__recordOriginator mesh__D016147 AGS
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002925 2005
% 221.63/221.79  |- skos__scopeNote mesh__D002925
% 221.63/221.79       Disorders characterized by abnormal ciliary movement in the nose, paranasal sinuses, respiratory tract, and spermatozoa. Electron microscopy of the CILIA shows that dynein arms are missing. The disorders manifest as KARTAGENER SYNDROME, chronic respiratory disorders, chronic sinusitis, and/or chronic otitis.%A%    
% 221.63/221.79  |- mesh__recordOriginator mesh__D002925 RC
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002925 2003
% 221.63/221.79  |- mesh__dateEstablished mesh__D002925 1984-01-01
% 221.63/221.79  |- skos__broader mesh__D002925smesh__D010038
% 221.63/221.79  |- skos__prefLabel mesh__D002925 Ciliary Motility Disorders
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002925 2006
% 221.63/221.79  |- skos__historyNote mesh__D002925 Kartagener Triad %28%1966-1983%29%
% 221.63/221.79  |- skos__hiddenLabel mesh__D002925 Ciliary Dyskinesias
% 221.63/221.79  |- skos__hiddenLabel mesh__D002925 Immotile Cilia Syndromes
% 221.63/221.79  |- skos__altLabel mesh__D002925 Immotile Cilia Syndrome
% 221.63/221.79  |- skos__hiddenLabel mesh__D002925 Disorders, Ciliary Motility
% 221.63/221.79  |- skos__hiddenLabel mesh__D002925 Ciliary Motility Disorder
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002925 2004
% 221.63/221.79  |- mesh__historyNote mesh__D002925 84   
% 221.63/221.79  |- skos__hiddenLabel mesh__D002925 Syndromes, Immotile Cilia
% 221.63/221.79  |- skos__hiddenLabel mesh__D002925 Cilia Syndromes, Immotile
% 221.63/221.79  |- skos__hiddenLabel mesh__D002925 Cilia Syndrome, Immotile
% 221.63/221.79  |- skos__historyNote mesh__D002925 Cilia %28%1966-1983%29%
% 221.63/221.79  |- skos__hiddenLabel mesh__D002925 Syndrome, Immotile Cilia
% 221.63/221.79  |- mesh__dateRevised mesh__D002925 2001-07-25
% 221.63/221.79  |- mesh__publicMeSHNote mesh__D002925 84   
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D002925 2002
% 221.63/221.79  |- rdf__type mesh__D002925sskos__Concept
% 221.63/221.79  |- skos__hiddenLabel mesh__D002925 Dyskinesias, Ciliary
% 221.63/221.79  |- mesh__recordMaintainer mesh__D002925 nns
% 221.63/221.79  |- skos__hiddenLabel mesh__D002925 Disorder, Ciliary Motility
% 221.63/221.79  |- skos__hiddenLabel mesh__D002925 Dyskinesia, Ciliary
% 221.63/221.79  |- skos__altLabel mesh__D002925 Ciliary Dyskinesia
% 221.63/221.79  |- skos__broader mesh__D002925smesh__D012140
% 221.63/221.79  |- skos__historyNote mesh__D002925 Nasal Mucosa %28%1966-1983%29%
% 221.63/221.79  |- mesh__recordAuthorizer mesh__D002925 sjn
% 221.63/221.79  |- mesh__dateCreated mesh__D002925 1983-03-11
% 221.63/221.79  |- mesh__activeMeSHYear mesh__D035301 2006
% 221.63/221.79  |- skos__altLabel mesh__D035301 Middle Cranial Fossa
% 221.63/221.79  |- mesh__recordMaintainer mesh__D035301 jls
% 221.63/221.79  |- mesh__publicMeSHNote mesh__D035301 2003   
% 221.63/221.80  |- skos__prefLabel mesh__D035301 Cranial Fossa, Middle
% 221.63/221.80  |- mesh__dateRevised mesh__D035301 2002-09-19
% 221.63/221.80  |- mesh__recordOriginator mesh__D035301 ags
% 221.63/221.80  |- mesh__dateCreated mesh__D035301 2002-07-03
% 221.63/221.80  |- skos__hiddenLabel mesh__D035301 Fossa, Middle Cranial
% 221.63/221.80  |- skos__broader mesh__D035301smesh__D019291
% 221.63/221.80  |- skos__annotation mesh__D035301
% 221.63/221.80       NIM when merely locational; neopl: coord IM with SKULL BASE NEOPLASMS %28%IM%29%%A%  
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D035301 2003A
% 221.63/221.80  |- mesh__dateEstablished mesh__D035301 2003-01-01
% 221.63/221.80  |- mesh__historyNote mesh__D035301 2003   
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D035301 2003
% 221.63/221.80  |- rdf__type mesh__D035301sskos__Concept
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D035301 2004
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D035301 2005
% 221.63/221.80  |- mesh__recordAuthorizer mesh__D035301 jls
% 221.63/221.80  |- skos__scopeNote mesh__D035301
% 221.63/221.80       The compartment containing the anterior extremities and half the inferior surface of the temporal lobes %28%TEMPORAL LOBE%29% of the cerebral hemispheres. Lying posterior and inferior to the anterior cranial fossa %28%CRANIAL FOSSA, ANTERIOR%29%, it is formed by part of the TEMPORAL BONE and SPHENOID BONE. It is separated from the posterior cranial fossa %28%CRANIAL FOSSA, POSTERIOR%29% by crests formed by the superior borders of the petrous parts of the temporal bones.%A%    
% 221.63/221.80  |- mesh__dateCreated mesh__D002127 1999-01-01
% 221.63/221.80  |- skos__scopeNote mesh__D002127
% 221.63/221.80       Stable calcium atoms that have the same atomic number as the element calcium, but differ in atomic weight. Ca-42-44, 46, and 48 are stable calcium isotopes.%A%    
% 221.63/221.80  |- mesh__recordMaintainer mesh__D002127 nns
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D002127 2002
% 221.63/221.80  |- mesh__dateRevised mesh__D002127 2000-06-22
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D002127 2003
% 221.63/221.80  |- skos__prefLabel mesh__D002127 Calcium Isotopes
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D002127 2005
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D002127 2004
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D002127 2001
% 221.63/221.80  |- skos__hiddenLabel mesh__D002127 Isotopes, Calcium
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D002127 2006
% 221.63/221.80  |- mesh__recordAuthorizer mesh__D002127 sjn
% 221.63/221.80  |- skos__annotation mesh__D002127 Ca-42-44, 46, 48; NIM   
% 221.63/221.80  |- skos__broader mesh__D002127smesh__D007554
% 221.63/221.80  |- mesh__recordOriginator mesh__D002127 NLM
% 221.63/221.80  |- rdf__type mesh__D002127sskos__Concept
% 221.63/221.80  |- skos__altLabel mesh__D007610 Kininogenase
% 221.63/221.80  |- skos__hiddenLabel mesh__D007610 beta Kallikrein
% 221.63/221.80  |- skos__related mesh__D007610smesh__D003029
% 221.63/221.80  |- skos__hiddenLabel mesh__D007610 Light Chain, Kallikrein
% 221.63/221.80  |- rdf__type mesh__D007610sskos__Concept
% 221.63/221.80  |- mesh__recordAuthorizer mesh__D007610 sjn
% 221.63/221.80  |- mesh__recordOriginator mesh__D007610 NLM
% 221.63/221.80  |- skos__altLabel mesh__D007610 Kallidinogenase
% 221.63/221.80  |- mesh__dateCreated mesh__D007610 1999-01-01
% 221.63/221.80  |- mesh__recordMaintainer mesh__D007610 ssb
% 221.63/221.80  |- skos__altLabel mesh__D007610 Callicrein
% 221.63/221.80  |- skos__altLabel mesh__D007610 Kalliginogenase
% 221.63/221.80  |- skos__prefLabel mesh__D007610 Kallikreins
% 221.63/221.80  |- skos__altLabel mesh__D007610 Kallikrein
% 221.63/221.80  |- skos__annotation mesh__D007610
% 221.63/221.80       /antag permitted but consider KALLIKREIN-TRYPSIN INACTIVATOR%A%  
% 221.63/221.80  |- skos__hiddenLabel mesh__D007610 Kinin Forming Enzyme
% 221.63/221.80  |- skos__broader mesh__D007610smesh__D001779
% 221.63/221.80  |- mesh__dateRevised mesh__D007610 2005-06-30
% 221.63/221.80  |- mesh__historyNote mesh__D007610 2000%28%1963%29%   
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D007610 2006
% 221.63/221.80  |- skos__broader mesh__D007610smesh__D012697
% 221.63/221.80  |- skos__hiddenLabel mesh__D007610 Enzyme, Kinin-Forming
% 221.63/221.80  |- skos__scopeNote mesh__D007610
% 221.63/221.80       Proteolytic enzymes from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increase vascular permeability and affect smooth muscle. They act as infertility agents in men. Three forms are recognized, PLASMA KALLIKREIN %28%EC 3.4.21.34%29%, TISSUE KALLIKREIN %28%EC 3.4.21.35%29%, and PROSTATE-SPECIFIC ANTIGEN %28%EC 3.4.21.77%29%.%A%    
% 221.63/221.80  |- skos__altLabel mesh__D007610 Kinin-Forming Enzyme
% 221.63/221.80  |- mesh__publicMeSHNote mesh__D007610 2000; see KALLIKREIN 1963-1999   
% 221.63/221.80  |- skos__hiddenLabel mesh__D007610 alpha Kallikrein
% 221.63/221.80  |- skos__hiddenLabel mesh__D007610 beta Kallikrein B
% 221.63/221.80  |- mesh__publicMeSHNote mesh__D048229 2005   
% 221.63/221.80  |- mesh__recordAuthorizer mesh__D048229 sjn
% 221.63/221.80  |- mesh__historyNote mesh__D048229 2005   
% 221.63/221.80  |- skos__historyNote mesh__D048229 Sulfolobus %28%1992-2004%29%
% 221.63/221.80  |- mesh__recordMaintainer mesh__D048229 SYSTEM
% 221.63/221.80  |- mesh__dateEstablished mesh__D048229 2005-01-01
% 221.63/221.80  |- mesh__dateRevised mesh__D048229 2005-06-30
% 221.63/221.80  |- skos__prefLabel mesh__D048229 Sulfolobus solfataricus
% 221.63/221.80  |- mesh__dateCreated mesh__D048229 2004-07-07
% 221.63/221.80  |- skos__broader mesh__D048229smesh__D016944
% 221.63/221.80  |- skos__historyNote mesh__D048229 Archaea %28%1983-1991%29%
% 221.63/221.80  |- rdf__type mesh__D048229sskos__Concept
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D048229 2006
% 221.63/221.80  |- skos__scopeNote mesh__D048229
% 221.63/221.80       A species of thermoacidophilic ARCHAEA in the family Sulfolobaceae, found in volcanic areas where the temperature is about 80 degrees C and SULFUR is present.%A%    
% 221.63/221.80  |- mesh__recordOriginator mesh__D048229 ags
% 221.63/221.80  |- skos__hiddenLabel mesh__D012555 Schistosomiases, Intestinal
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D012555 1999
% 221.63/221.80  |- mesh__dateCreated mesh__D012555 1985-05-09
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D012555 2004
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D012555 1998
% 221.63/221.80  |- mesh__dateRevised mesh__D012555 1995-06-08
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D012555 2003
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D012555 1997
% 221.63/221.80  |- mesh__historyNote mesh__D012555 86   
% 221.63/221.80  |- skos__broader mesh__D012555smesh__D012552
% 221.63/221.80  |- skos__historyNote mesh__D012555 Schistosomiasis %28%1966-1985%29%
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D012555 2002
% 221.63/221.80  |- skos__historyNote mesh__D012555 Schistosoma mansoni %28%1972-1985%29%
% 221.63/221.80  |- skos__hiddenLabel mesh__D012555 Intestinal Schistosomiases
% 221.63/221.80  |- mesh__publicMeSHNote mesh__D012555 86   
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D012555 1996
% 221.63/221.80  |- skos__annotation mesh__D012555
% 221.63/221.80       for X ref SCHISTOSOMIASIS, INTESTINAL do not coord with INTESTINAL DISEASES, PARASITIC; in titles %26% translations do not capitalize mansoni%A%  
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D012555 2001
% 221.63/221.80  |- skos__hiddenLabel mesh__D012555 Intestinal Schistosomiasis
% 221.63/221.80  |- mesh__dateEstablished mesh__D012555 1986-01-01
% 221.63/221.80  |- mesh__recordAuthorizer mesh__D012555 PLS
% 221.63/221.80  |- skos__scopeNote mesh__D012555
% 221.63/221.80       Schistosomiasis caused by Schistosoma mansoni. It is endemic in Africa, the Middle East, South America, and the Caribbean and affects mainly the bowel, spleen, and liver.%A%    
% 221.63/221.80  |- mesh__recordMaintainer mesh__D012555 RAZ
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D012555 2006
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D012555 2000
% 221.63/221.80  |- skos__prefLabel mesh__D012555 Schistosomiasis mansoni
% 221.63/221.80  |- rdf__type mesh__D012555sskos__Concept
% 221.63/221.80  |- mesh__recordOriginator mesh__D012555 RC
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D012555 2005
% 221.63/221.80  |- mesh__recordMaintainer mesh__D006518 sjn
% 221.63/221.80  |- skos__scopeNote mesh__D006518
% 221.63/221.80       Any of the viruses that cause inflammation of the liver. They include both DNA and RNA viruses as well viruses from humans and animals.%A%    
% 221.63/221.80  |- mesh__recordOriginator mesh__D006518 NLM
% 221.63/221.80  |- skos__hiddenLabel mesh__D006518 Hepatitis Virus
% 221.63/221.80  |- mesh__dateRevised mesh__D006518 2004-07-13
% 221.63/221.80  |- skos__hiddenLabel mesh__D006518 Marmoset Hepatitis Viruses
% 221.63/221.80  |- mesh__recordAuthorizer mesh__D006518 sjn
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D006518 2005
% 221.63/221.80  |- skos__broader mesh__D006518smesh__D014780
% 221.63/221.80  |- mesh__onlineNote mesh__D006518
% 221.63/221.80       use HEPATITIS VIRUSES to search HEPATITIS VIRUS, MARMOSET 1975-85%A%  
% 221.63/221.80  |- mesh__publicMeSHNote mesh__D006518
% 221.63/221.80       HEPATITIS VIRUS, MARMOSET was see under HEPATITIS VIRUSES 1975-85%A%  
% 221.63/221.80  |- mesh__dateCreated mesh__D006518 1999-01-01
% 221.63/221.80  |- skos__hiddenLabel mesh__D006518 Viruses, Marmoset Hepatitis
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D006518 2006
% 221.63/221.80  |- skos__annotation mesh__D006518
% 221.63/221.80       GEN or unspecified; prefer specifics; infection = HEPATITIS, VIRAL, HUMAN or HEPATITIS, VIRAL, ANIMAL or their specifics: see notes there%A%  
% 221.63/221.80  |- mesh__historyNote mesh__D006518
% 221.63/221.80       HEPATITIS VIRUS, MARMOSET was see under HEPATITIS VIRUSES 1975-85%A%  
% 221.63/221.80  |- skos__hiddenLabel mesh__D006518 Hepatitis Viruses, Marmoset
% 221.63/221.80  |- skos__hiddenLabel mesh__D006518 Viruses, Hepatitis
% 221.63/221.80  |- skos__hiddenLabel mesh__D006518 Marmoset Hepatitis Virus
% 221.63/221.80  |- skos__hiddenLabel mesh__D006518 Virus, Hepatitis
% 221.63/221.80  |- rdf__type mesh__D006518sskos__Concept
% 221.63/221.80  |- skos__hiddenLabel mesh__D006518 Virus, Marmoset Hepatitis
% 221.63/221.80  |- skos__prefLabel mesh__D006518 Hepatitis Viruses
% 221.63/221.80  |- skos__hiddenLabel mesh__D017240 Megaconial Myopathy
% 221.63/221.80  |- mesh__recordOriginator mesh__D017240 TGC
% 221.63/221.80  |- skos__hiddenLabel mesh__D017240 Myopathy, Megaconial
% 221.63/221.80  |- skos__hiddenLabel mesh__D017240 Disease, Luft%27%s
% 221.63/221.80  |- skos__hiddenLabel mesh__D017240 Disease, Luft
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D017240 2005
% 221.63/221.80  |- skos__broader mesh__D017240smesh__D028361
% 221.63/221.80  |- mesh__recordMaintainer mesh__D017240 nns
% 221.63/221.80  |- rdf__type mesh__D017240sskos__Concept
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D017240 2002
% 221.63/221.80  |- skos__annotation mesh__D017240
% 221.63/221.80       GEN or unspecified; prefer specifics; NARP syndrome %28%neuropathy, ataxia and retinitis pigmentosa%29% = MITOCHONDRIAL MYOPATHIES + ATAXIA + RETINITIS PIGMENTOSA + SYNDROME%A%  
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D017240 2004
% 221.63/221.80  |- skos__scopeNote mesh__D017240
% 221.63/221.80       A group of muscle diseases associated with abnormal mitochondria function.%A%    
% 221.63/221.80  |- mesh__publicMeSHNote mesh__D017240 1993   
% 221.63/221.80  |- skos__hiddenLabel mesh__D017240 Mitochondrial Myopathy
% 221.63/221.80  |- skos__prefLabel mesh__D017240 Mitochondrial Myopathies
% 221.63/221.80  |- mesh__historyNote mesh__D017240 1993   
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D017240 2003
% 221.63/221.80  |- mesh__dateEstablished mesh__D017240 1993-01-01
% 221.63/221.80  |- skos__hiddenLabel mesh__D017240 Myopathy, Mitochondrial
% 221.63/221.80  |- skos__historyNote mesh__D017240 Muscular Diseases %28%1968-1992%29%
% 221.63/221.80  |- skos__historyNote mesh__D017240 Mitochondria, Muscle %28%1968-1992%29%
% 221.63/221.80  |- mesh__dateCreated mesh__D017240 1992-05-22
% 221.63/221.80  |- mesh__dateRevised mesh__D017240 2001-07-25
% 221.63/221.80  |- skos__hiddenLabel mesh__D017240 Pleoconial Myopathy
% 221.63/221.80  |- skos__broader mesh__D017240smesh__D009135
% 221.63/221.80  |- mesh__recordAuthorizer mesh__D017240 sjn
% 221.63/221.80  |- skos__altLabel mesh__D017240 Luft%27%s Disease
% 221.63/221.80  |- skos__hiddenLabel mesh__D017240 Myopathies, Pleoconial
% 221.63/221.80  |- skos__hiddenLabel mesh__D017240 Myopathy, Pleoconial
% 221.63/221.80  |- skos__hiddenLabel mesh__D017240 Lufts Disease
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D017240 2006
% 221.63/221.80  |- skos__altLabel mesh__D017240 Myopathies, Mitochondrial
% 221.63/221.80  |- mesh__dateCreated mesh__D003220 1999-01-01
% 221.63/221.80  |- skos__annotation mesh__D003220
% 221.63/221.80       human %26% animal; individual %26% group; no qualif; DF: CONFLICT%A%  
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D003220 2004
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D003220 2006
% 221.63/221.80  |- skos__hiddenLabel mesh__D003220 Conflicts
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D003220 2003
% 221.63/221.80  |- mesh__recordOriginator mesh__D003220 NLM
% 221.63/221.80  |- skos__scopeNote mesh__D003220
% 221.63/221.80       The internal individual struggle resulting from incompatible or opposing needs, drives, or external and internal demands. In group interactions, competitive or opposing action of incompatibles: antagonistic state or action %28%as of divergent ideas, interests, or persons%29%. %28%from Merriam-Webster%27%s Collegiate Dictionary, 10th ed%29%%A%    
% 221.63/221.80  |- mesh__dateRevised mesh__D003220 2002-07-03
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D003220 2005
% 221.63/221.80  |- skos__altLabel mesh__D003220 Conflict
% 221.63/221.80  |- mesh__historyNote mesh__D003220 68%28%65%29%   
% 221.63/221.80  |- skos__prefLabel mesh__D003220 Conflict %28%Psychology%29%
% 221.63/221.80  |- rdf__type mesh__D003220sskos__Concept
% 221.63/221.80  |- skos__hiddenLabel mesh__D003220 Conflicts %28%Psychology%29%
% 221.63/221.80  |- mesh__dateEstablished mesh__D003220 1968-01-01
% 221.63/221.80  |- mesh__publicMeSHNote mesh__D003220 68   
% 221.63/221.80  |- mesh__recordAuthorizer mesh__D003220 sjn
% 221.63/221.80  |- skos__broader mesh__D003220smesh__D009042
% 221.63/221.80  |- skos__related mesh__D003220smesh__D034462
% 221.63/221.80  |- mesh__recordMaintainer mesh__D003220 jrf
% 221.63/221.80  |- skos__prefLabel mesh__D016946 Gram-Negative Aerobic Rods and Cocci
% 221.63/221.80  |- mesh__recordMaintainer mesh__D016946 SYSTEM
% 221.63/221.80  |- skos__scopeNote mesh__D016946
% 221.63/221.80       A group of gram-negative bacteria consisting of rod- and coccus-shaped cells. They are both aerobic %28%able to grow under an air atmosphere%29% and microaerophilic %28%grow better in low concentrations of oxygen%29% under nitrogen-fixing conditions but, when supplied with a source of fixed nitrogen, they grow as aerobes.%A%    
% 221.63/221.80  |- mesh__dateRevised mesh__D016946 2005-06-30
% 221.63/221.80  |- skos__altLabel mesh__D016946 Gram Negative Aerobic Rods and Cocci
% 221.63/221.80  |- skos__annotation mesh__D016946
% 221.63/221.80       avoid: too general; prefer specific families %26% genera; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%; DF: GRAM NEG AEROBIC RODS%A%  
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D016946 2006
% 221.63/221.80  |- skos__historyNote mesh__D016946
% 221.63/221.80       Gram-Negative Aerobic Bacteria %28%1992-1997%29%
% 221.63/221.80  |- skos__broader mesh__D016946smesh__D006088
% 221.63/221.80  |- mesh__dateCreated mesh__D016946 1991-08-23
% 221.63/221.80  |- mesh__dateEstablished mesh__D016946 1998-01-01
% 221.63/221.80  |- mesh__recordOriginator mesh__D016946 PXP
% 221.63/221.80  |- rdf__type mesh__D016946sskos__Concept
% 221.63/221.80  |- mesh__recordAuthorizer mesh__D016946 sjn
% 221.63/221.80  |- mesh__historyNote mesh__D016946 98; use explode 1992-97   
% 221.63/221.80  |- mesh__publicMeSHNote mesh__D016946 98   
% 221.63/221.80  |- skos__hiddenLabel mesh__D002128 Disorders, Calcium Metabolism
% 221.63/221.80  |- mesh__dateRevised mesh__D002128 1996-06-10
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D002128 2005
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D002128 1997
% 221.63/221.80  |- rdf__type mesh__D002128sskos__Concept
% 221.63/221.80  |- skos__prefLabel mesh__D002128 Calcium Metabolism Disorders
% 221.63/221.80  |- mesh__recordAuthorizer mesh__D002128 PLS
% 221.63/221.80  |- mesh__recordMaintainer mesh__D002128 TGC
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D002128 2001
% 221.63/221.80  |- mesh__recordOriginator mesh__D002128 NLM
% 221.63/221.80  |- mesh__dateCreated mesh__D002128 1999-01-01
% 221.63/221.80  |- skos__hiddenLabel mesh__D002128 Calcium Metabolism Disorder
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D002128 2000
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D002128 2004
% 221.63/221.80  |- skos__annotation mesh__D002128
% 221.63/221.80       GEN or unspecified; prefer specifics; DF: CALCIUM METAB DIS%A%  
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D002128 1999
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D002128 2003
% 221.63/221.80  |- skos__scopeNote mesh__D002128
% 221.63/221.80       Disorders in the processing of calcium in the body: its absorption, transport, storage, and utilization.%A%    
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D002128 1998
% 221.63/221.80  |- skos__hiddenLabel mesh__D002128 Disorder, Calcium Metabolism
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D002128 2002
% 221.63/221.80  |- skos__broader mesh__D002128smesh__D008659
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D002128 2006
% 221.63/221.80  |- mesh__recordMaintainer mesh__D007611 lkw
% 221.63/221.80  |- mesh__dateCreated mesh__D007611 1999-01-01
% 221.63/221.80  |- skos__altLabel mesh__D007611 Kontrikal
% 221.63/221.80  |- skos__prefLabel mesh__D007611 Aprotinin
% 221.63/221.80  |- mesh__onlineNote mesh__D007611
% 221.63/221.80       use APROTININ to search KALLIKREIN-TRYPSIN INACTIVATOR 1966-89%A%  
% 221.63/221.80  |- skos__altLabel mesh__D007611 BPTI, Basic Pancreatic Trypsin Inhibitor
% 221.63/221.80  |- skos__altLabel mesh__D007611 Contrical
% 221.63/221.80  |- skos__hiddenLabel mesh__D007611 Inactivator, Kallikrein-Trypsin
% 221.63/221.80  |- skos__altLabel mesh__D007611 Trypsin Inhibitor, Basic, Pancreatic
% 221.63/221.80  |- skos__broader mesh__D007611smesh__D011506
% 221.63/221.80  |- skos__altLabel mesh__D007611 Bovine Kunitz Pancreatic Trypsin Inhibitor
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D007611 2006
% 221.63/221.80  |- mesh__recordAuthorizer mesh__D007611 sjn
% 221.63/221.80  |- mesh__recordOriginator mesh__D007611 NLM
% 221.63/221.80  |- skos__altLabel mesh__D007611 Arzneimittelwerk Dresden Brand of Aprotinin
% 221.63/221.80  |- mesh__publicMeSHNote mesh__D007611
% 221.63/221.80       90; was KALLIKREIN-TRYPSIN INACTIVATOR 1966-89   
% 221.63/221.80  |- skos__altLabel mesh__D007611 Kallikrein-Trypsin Inactivator
% 221.63/221.80  |- skos__altLabel mesh__D007611 Bovine Pancreatic Trypsin Inhibitor
% 221.63/221.80  |- skos__altLabel mesh__D007611 Bayer Brand of Aprotinin
% 221.63/221.80  |- skos__altLabel mesh__D007611 Sanofi Winthrop Brand of Aprotinin
% 221.63/221.80  |- mesh__historyNote mesh__D007611
% 221.63/221.80       90; was KALLIKREIN-TRYPSIN INACTIVATOR 1966-89   
% 221.63/221.80  |- mesh__dateEstablished mesh__D007611 1966-01-01
% 221.63/221.80  |- skos__altLabel mesh__D007611 Kunitz Pancreatic Trypsin Inhibitor
% 221.63/221.80  |- skos__altLabel mesh__D007611 Basic Pancreatic Trypsin Inhibitor
% 221.63/221.80  |- skos__hiddenLabel mesh__D007611 Kallikrein Trypsin Inactivator
% 221.63/221.80  |- skos__annotation mesh__D007611 /drug eff /ultrastruct permitted   
% 221.63/221.80  |- mesh__dateRevised mesh__D007611 2005-06-30
% 221.63/221.80  |- skos__scopeNote mesh__D007611
% 221.63/221.80       A single-chain polypeptide derived from bovine tissues consisting of 58 amino-acid residues. It is an inhibitor of proteolytic enzymes including chymotrypsin, kallikrein, plasmin, and trypsin. It is used in the treatment of hemorrhage associated with raised plasma concentrations of plasmin. It is also used to reduce blood loss and transfusion requirements in patients at high risk of major blood loss during and following open heart surgery with extracorporeal circulation. %28%Reynolds JEF%28%Ed%29%: Martindale: The Extra Pharmacopoeia %28%electronic version%29%. Micromedex, Inc, Englewood, CO, 1995%29%%A%    
% 221.63/221.80  |- skos__altLabel mesh__D007611 Kontrykal
% 221.63/221.80  |- skos__altLabel mesh__D007611 Trypsin Inhibitor, Kunitz, Pancreatic
% 221.63/221.80  |- rdf__type mesh__D007611sskos__Concept
% 221.63/221.80  |- skos__hiddenLabel mesh__D045730 Curd, Soy Bean
% 221.63/221.80  |- mesh__publicMeSHNote mesh__D045730 2004   
% 221.63/221.80  |- skos__hiddenLabel mesh__D045730 Soy Food
% 221.63/221.80  |- skos__hiddenLabel mesh__D045730 Protein, Texturized Soy
% 221.63/221.80  |- skos__hiddenLabel mesh__D045730 Soy Bean Curds
% 221.63/221.80  |- skos__hiddenLabel mesh__D045730 Soy Protein, Texturized
% 221.63/221.80  |- skos__hiddenLabel mesh__D045730 Sauce, Soy
% 221.63/221.80  |- skos__hiddenLabel mesh__D045730 Proteins, Texturized Soy
% 221.63/221.80  |- skos__hiddenLabel mesh__D045730 Vegetable Proteins, Texturized
% 221.63/221.80  |- skos__hiddenLabel mesh__D045730 Vegetable Protein, Texturized
% 221.63/221.80  |- skos__hiddenLabel mesh__D045730 Bean Curds, Soy
% 221.63/221.80  |- skos__hiddenLabel mesh__D045730 Cheeses, Soy
% 221.63/221.80  |- skos__hiddenLabel mesh__D045730 Texturized Soy Proteins
% 221.63/221.80  |- skos__hiddenLabel mesh__D045730 Soy Cheeses
% 221.63/221.80  |- mesh__historyNote mesh__D045730 2004   
% 221.63/221.80  |- skos__hiddenLabel mesh__D045730 Protein, Texturized Vegetable
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D045730 2006
% 221.63/221.80  |- skos__altLabel mesh__D045730 Bean Curd, Soy
% 221.63/221.80  |- skos__hiddenLabel mesh__D045730 Foods, Soy
% 221.63/221.80  |- skos__prefLabel mesh__D045730 Soy Foods
% 221.63/221.80  |- skos__hiddenLabel mesh__D045730 Soy Bean Curd
% 221.63/221.80  |- skos__hiddenLabel mesh__D045730 Curds, Soy Bean
% 221.63/221.80  |- rdf__type mesh__D045730sskos__Concept
% 221.63/221.80  |- skos__hiddenLabel mesh__D045730 Cheese, Soy
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D045730 2004
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D045730 2005
% 221.63/221.80  |- mesh__dateEstablished mesh__D045730 2004-01-01
% 221.63/221.80  |- skos__historyNote mesh__D045730 Soybeans %28%1963-2003%29%
% 221.63/221.80  |- skos__hiddenLabel mesh__D045730 Food, Soy
% 221.63/221.80  |- skos__broader mesh__D045730smesh__D013025
% 221.63/221.80  |- skos__scopeNote mesh__D045730
% 221.63/221.80       Foods made from SOYBEANS. Health benefits are ascribed to the high levels of DIETARY PROTEINS and ISOFLAVONES.%A%    
% 221.63/221.80  |- skos__altLabel mesh__D045730 Texturized Vegetable Protein
% 221.63/221.80  |- skos__hiddenLabel mesh__D045730 Soy Proteins, Texturized
% 221.63/221.80  |- mesh__dateCreated mesh__D045730 2003-07-09
% 221.63/221.80  |- skos__broader mesh__D012556smesh__D000980
% 221.63/221.80  |- mesh__recordMaintainer mesh__D012556 ssb
% 221.63/221.80  |- mesh__dateEstablished mesh__D012556 1975-01-01
% 221.63/221.80  |- skos__hiddenLabel mesh__D012556 Agents, Antischistosomal
% 221.63/221.80  |- mesh__dateCreated mesh__D012556 1999-01-01
% 221.63/221.80  |- mesh__historyNote mesh__D012556 75%28%73%29%   
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D012556 2006
% 221.63/221.80  |- skos__historyNote mesh__D012556
% 221.63/221.80       Schistosomiasis/drug therapy %28%1966-1972%29%
% 221.63/221.80  |- mesh__recordAuthorizer mesh__D012556 sjn
% 221.63/221.80  |- rdf__type mesh__D012556sskos__Concept
% 221.63/221.80  |- skos__annotation mesh__D012556
% 221.63/221.80       -cidal or -static; consider also SCHISTOSOMA /drug eff %26% SCHISTOSOMIASIS /drug ther or pertinent specifics%A%  
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D012556 2005
% 221.63/221.80  |- skos__scopeNote mesh__D012556
% 221.63/221.80       Agents that act systemically to kill adult schistosomes.%A%    
% 221.63/221.80  |- skos__prefLabel mesh__D012556 Schistosomicides
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D012556 2004
% 221.63/221.80  |- mesh__dateRevised mesh__D012556 2003-07-09
% 221.63/221.80  |- mesh__publicMeSHNote mesh__D012556 75   
% 221.63/221.80  |- mesh__recordOriginator mesh__D012556 NLM
% 221.63/221.80  |- skos__hiddenLabel mesh__D006519 Chronic Alcoholic Hepatitides
% 221.63/221.80  |- skos__scopeNote mesh__D006519
% 221.63/221.80       INFLAMMATION of the LIVER due to ALCOHOL ABUSE. It is characterized by NECROSIS of HEPATOCYTES, infiltration by NEUTROPHILS, and deposit of Mallory hyaline bodies. Depending on its severity, the inflammatory lesion may be reversible or progress to LIVER CIRRHOSIS.%A%    
% 221.63/221.80  |- skos__altLabel mesh__D006519 Alcoholic Hepatitis
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D006519 2005
% 221.63/221.80  |- mesh__publicMeSHNote mesh__D006519 78   
% 221.63/221.80  |- mesh__dateRevised mesh__D006519 2004-07-07
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D006519 2006
% 221.63/221.80  |- mesh__recordOriginator mesh__D006519 SMH
% 221.63/221.80  |- skos__prefLabel mesh__D006519 Hepatitis, Alcoholic
% 221.63/221.80  |- mesh__dateCreated mesh__D006519 1977-04-22
% 221.63/221.80  |- skos__broader mesh__D006519smesh__D006505
% 221.63/221.80  |- mesh__recordAuthorizer mesh__D006519 sjn
% 221.63/221.80  |- mesh__dateEstablished mesh__D006519 1978-01-01
% 221.63/221.80  |- rdf__type mesh__D006519sskos__Concept
% 221.63/221.80  |- skos__historyNote mesh__D006519 Hepatitis, Toxic %28%1966-1977%29%
% 221.63/221.80  |- mesh__historyNote mesh__D006519 78   
% 221.63/221.80  |- skos__historyNote mesh__D006519 Alcoholism %28%1966-1977%29%
% 221.63/221.80  |- skos__historyNote mesh__D006519 Hepatitis %28%1966-1977%29%
% 221.63/221.80  |- mesh__recordMaintainer mesh__D006519 lkt
% 221.63/221.80  |- skos__altLabel mesh__D006519 Hepatitis, Alcoholic, Chronic
% 221.63/221.80  |- skos__annotation mesh__D006519
% 221.63/221.80       considered chronic so do not coord with CHRONIC DISEASE   
% 221.63/221.80  |- skos__broader mesh__D006519smesh__D008108
% 221.63/221.80  |- skos__hiddenLabel mesh__D006519 Alcoholic Hepatitis, Chronic
% 221.63/221.80  |- mesh__dateRevised mesh__D017241 2001-07-25
% 221.63/221.80  |- skos__historyNote mesh__D017241 Mitochondria, Muscle %28%1984-1992%29%
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D017241 2003
% 221.63/221.80  |- mesh__recordAuthorizer mesh__D017241 sjn
% 221.63/221.80  |- skos__historyNote mesh__D017241 Lactates %28%1985-1986%29%
% 221.63/221.80  |- skos__historyNote mesh__D017241
% 221.63/221.80       Cerebrovascular Disorders %28%1987-1992%29%
% 221.63/221.80  |- mesh__recordMaintainer mesh__D017241 nns
% 221.63/221.80  |- mesh__recordOriginator mesh__D017241 TGC
% 221.63/221.80  |- skos__hiddenLabel mesh__D017241 Syndrome, MELAS
% 221.63/221.80  |- skos__prefLabel mesh__D017241 MELAS Syndrome
% 221.63/221.80  |- skos__scopeNote mesh__D017241
% 221.63/221.80       A mitochondrial disorder characterized by focal or generalized seizures, episodes of transient or persistent neurologic dysfunction resembling strokes, and ragged-red fibers on muscle biopsy. Affected individuals tend to be normal at birth through early childhood, then experience growth failure, episodic vomiting, and recurrent cerebral insults resulting in visual loss and hemiparesis. The cortical lesions tend to occur in the parietal and occipital lobes and are not associated with vascular occlusion. VASCULAR HEADACHE is frequently associated and the disorder tends to be familial. %28%From Joynt, Clinical Neurology, 1992, Ch56, p117%29%%A%    
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D017241 2006
% 221.63/221.80  |- skos__historyNote mesh__D017241
% 221.63/221.80       Brain Diseases, Metabolic %28%1987-1992%29%
% 221.63/221.80  |- skos__historyNote mesh__D017241 Acidosis %28%1985-1986%29%
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D017241 2002
% 221.63/221.80  |- skos__broader mesh__D017241smesh__D017237
% 221.63/221.80  |- mesh__dateEstablished mesh__D017241 1993-01-01
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D017241 2005
% 221.63/221.80  |- rdf__type mesh__D017241sskos__Concept
% 221.63/221.80  |- mesh__historyNote mesh__D017241 1993   
% 221.63/221.80  |- skos__broader mesh__D017241smesh__D020739
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D017241 2004
% 221.63/221.80  |- skos__annotation mesh__D017241 DF: MELAS   
% 221.63/221.80  |- mesh__publicMeSHNote mesh__D017241 1993   
% 221.63/221.80  |- skos__altLabel mesh__D017241
% 221.63/221.80       Mitochondrial Myopathy, Lactic Acidosis, Stroke-Like Episode
% 221.63/221.80  |- skos__historyNote mesh__D017241 Neuromuscular Diseases %28%1987-1992%29%
% 221.63/221.80  |- skos__historyNote mesh__D017241 Brain Diseases %28%1985-1987%29%
% 221.63/221.80  |- skos__historyNote mesh__D017241 Acidosis, Lactic %28%1987-1992%29%
% 221.63/221.80  |- mesh__dateCreated mesh__D017241 1992-05-22
% 221.63/221.80  |- skos__hiddenLabel mesh__D003221 Post-Ictal Confusion
% 221.63/221.80  |- skos__broader mesh__D003221smesh__D019954
% 221.63/221.80  |- skos__prefLabel mesh__D003221 Confusion
% 221.63/221.80  |- skos__hiddenLabel mesh__D003221 Confusional States
% 221.63/221.80  |- mesh__recordAuthorizer mesh__D003221 sjn
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D003221 2004
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D003221 2006
% 221.63/221.80  |- skos__altLabel mesh__D003221 Confusional State
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D003221 2003
% 221.63/221.80  |- skos__scopeNote mesh__D003221
% 221.63/221.80       A mental state characterized by bewilderment, emotional disturbance, lack of clear thinking, and perceptual disorientation.%A%    
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D003221 2005
% 221.63/221.80  |- rdf__type mesh__D003221sskos__Concept
% 221.63/221.80  |- mesh__historyNote mesh__D003221
% 221.63/221.80       91%28%75%29%; was see under COGNITION DISORDERS 1975-90   
% 221.63/221.80  |- mesh__recordOriginator mesh__D003221 NLM
% 221.63/221.80  |- mesh__dateEstablished mesh__D003221 1991-01-01
% 221.63/221.80  |- mesh__dateRevised mesh__D003221 2001-07-25
% 221.63/221.80  |- mesh__onlineNote mesh__D003221 search COGNITION DISORDERS 1969-74   
% 221.63/221.80  |- mesh__dateCreated mesh__D003221 1999-01-01
% 221.63/221.80  |- skos__hiddenLabel mesh__D003221 Reactive Confusion
% 221.63/221.80  |- skos__hiddenLabel mesh__D003221 Confusion, Post Ictal
% 221.63/221.80  |- skos__hiddenLabel mesh__D003221 State, Confusional
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D003221 2002
% 221.63/221.80  |- mesh__publicMeSHNote mesh__D003221
% 221.63/221.80       91; was see under COGNITION DISORDERS 1975-90   
% 221.63/221.80  |- mesh__recordMaintainer mesh__D003221 nns
% 221.63/221.80  |- skos__hiddenLabel mesh__D003221 States, Confusional
% 221.63/221.80  |- skos__broader mesh__D016947smesh__D012245
% 221.63/221.80  |- skos__scopeNote mesh__D016947
% 221.63/221.80       A family of gram-negative aerobic bacteria consisting of ellipsoidal to rod-shaped cells that occur singly, in pairs, or in chains.%A%    
% 221.63/221.80  |- mesh__publicMeSHNote mesh__D016947 92   
% 221.63/221.80  |- mesh__dateCreated mesh__D016947 1991-05-30
% 221.63/221.80  |- skos__broader mesh__D016947smesh__D016946
% 221.63/221.80  |- mesh__dateEstablished mesh__D016947 1992-01-01
% 221.63/221.80  |- mesh__activeMeSHYear mesh__D016947 2006
% 221.63/221.80  |- skos__prefLabel mesh__D016947 Acetobacteraceae
% 221.63/221.80  |- mesh__dateRevised mesh__D016947 2005-06-30
% 221.63/221.80  |- mesh__recordOriginator mesh__D016947 PXP
% 221.63/221.80  |- rdf__type mesh__D016947sskos__Concept
% 221.63/221.80  |- mesh__historyNote mesh__D016947 92   
% 221.63/221.80  |- mesh__recordMaintainer mesh__D016947 ags
% 221.63/221.80  |- mesh__recordAuthorizer mesh__D016947 sjn
% 221.63/221.80  |- skos__hiddenLabel mesh__D002927 SK%26%F92334
% 221.63/221.80  |- skos__historyNote mesh__D002927 Imidazoles %28%1966-1977%29%
% 221.63/221.80  |- rdf__type mesh__D002927sskos__Concept
% 221.63/221.80  |- mesh__recordMaintainer mesh__D002927 ssb
% 221.63/221.81  |- skos__altLabel mesh__D002927 SKF-92334
% 221.63/221.81  |- mesh__publicMeSHNote mesh__D002927
% 221.63/221.81       84; was see under GUANIDINES 1978-83   
% 221.63/221.81  |- skos__broader mesh__D002927smesh__D006146
% 221.63/221.81  |- skos__broader mesh__D002927smesh__D007093
% 221.63/221.81  |- skos__historyNote mesh__D002927 Guanidines %28%1966-1977%29%
% 221.63/221.81  |- skos__hiddenLabel mesh__D002927 SKF92334
% 221.63/221.81  |- mesh__recordAuthorizer mesh__D002927 sjn
% 221.63/221.81  |- skos__hiddenLabel mesh__D002927 SK%26%F 92334
% 221.63/221.81  |- mesh__historyNote mesh__D002927
% 221.63/221.81       84%28%78%29%; was see under GUANIDINES 1978-83   
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D002927 2006
% 221.63/221.81  |- mesh__dateEstablished mesh__D002927 1984-01-01
% 221.63/221.81  |- mesh__dateRevised mesh__D002927 2005-06-30
% 221.63/221.81  |- skos__prefLabel mesh__D002927 Cimetidine
% 221.63/221.81  |- mesh__recordOriginator mesh__D002927 SH
% 221.63/221.81  |- skos__altLabel mesh__D002927 Cimetidine HCl
% 221.63/221.81  |- skos__scopeNote mesh__D002927
% 221.63/221.81       A histamine congener, it competitively inhibits histamine binding to H2 receptors. Cimetidine has a range of pharmacological actions. It inhibits gastric acid secretion, as well as pepsin and gastrin output. It also blocks the activity of cytochrome P-450.%A%    
% 221.63/221.81  |- skos__hiddenLabel mesh__D002927 HCl, Cimetidine
% 221.63/221.81  |- skos__hiddenLabel mesh__D002927 SKF 92334
% 221.63/221.81  |- skos__altLabel mesh__D002927
% 221.63/221.81       N-Cyano-N%27%-methyl-N%27%%27%-%28%2-%28%%28%%28%5-methyl-1H-imidazol-4-yl%29%methyl%29%thio%29%ethyl%29%guanidine
% 221.63/221.81  |- mesh__dateCreated mesh__D002927 1977-04-22
% 221.63/221.81  |- skos__hiddenLabel mesh__D002927 Hydrochloride, Cimetidine
% 221.63/221.81  |- rdf__type mesh__D002129sskos__Concept
% 221.63/221.81  |- skos__historyNote mesh__D002129 Oxalates %28%1966-1978%29%
% 221.63/221.81  |- mesh__historyNote mesh__D002129 79   
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D002129 2002
% 221.63/221.81  |- mesh__publicMeSHNote mesh__D002129 79   
% 221.63/221.81  |- mesh__dateCreated mesh__D002129 1977-12-09
% 221.63/221.81  |- skos__hiddenLabel mesh__D002129 Monohydrate, Calcium Oxalate
% 221.63/221.81  |- skos__historyNote mesh__D002129 Calcium %28%1966-1978%29%
% 221.63/221.81  |- skos__hiddenLabel mesh__D002129 Trihydrate, Calcium Oxalate
% 221.63/221.81  |- mesh__recordMaintainer mesh__D002129 sjn
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D002129 2004
% 221.63/221.81  |- mesh__recordOriginator mesh__D002129 RLS
% 221.63/221.81  |- mesh__recordAuthorizer mesh__D002129 sjn
% 221.63/221.81  |- skos__prefLabel mesh__D002129 Calcium Oxalate
% 221.63/221.81  |- skos__altLabel mesh__D002129 Calcium Oxalate Dihydrate
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D002129 2001
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D002129 2003
% 221.63/221.81  |- mesh__dateEstablished mesh__D002129 1979-01-01
% 221.63/221.81  |- skos__annotation mesh__D002129 OXALATES is also available   
% 221.63/221.81  |- skos__scopeNote mesh__D002129
% 221.63/221.81       The calcium salt of oxalic acid, occurring in the urine as crystals and in certain calculi.%A%    
% 221.63/221.81  |- skos__broader mesh__D002129smesh__D010070
% 221.63/221.81  |- mesh__dateRevised mesh__D002129 2001-11-27
% 221.63/221.81  |- skos__hiddenLabel mesh__D002129 Oxalate, Calcium
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D002129 2006
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D002129 2002A
% 221.63/221.81  |- skos__hiddenLabel mesh__D002129 Dihydrate, Calcium Oxalate
% 221.63/221.81  |- skos__altLabel mesh__D002129 Calcium Oxalate Monohydrate
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D002129 2005
% 221.63/221.81  |- rdf__type mesh__D007612sskos__Concept
% 221.63/221.81  |- mesh__dateRevised mesh__D007612 2005-06-30
% 221.63/221.81  |- skos__broader mesh__D007612smesh__D000617
% 221.63/221.81  |- mesh__recordMaintainer mesh__D007612 lkw
% 221.63/221.81  |- skos__prefLabel mesh__D007612 Kanamycin
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D007612 2006
% 221.63/221.81  |- skos__scopeNote mesh__D007612
% 221.63/221.81       Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components.%A%    
% 221.63/221.81  |- mesh__dateCreated mesh__D007612 1999-01-01
% 221.63/221.81  |- mesh__recordAuthorizer mesh__D007612 sjn
% 221.63/221.81  |- mesh__recordOriginator mesh__D007612 NLM
% 221.63/221.81  |- mesh__dateCreated mesh__D012557 1999-01-01
% 221.63/221.81  |- mesh__dateEstablished mesh__D012557 1973-01-01
% 221.63/221.81  |- skos__hiddenLabel mesh__D012557 Disorders, Schizoid Personality
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D012557 2002
% 221.63/221.81  |- skos__broader mesh__D012557smesh__D010554
% 221.63/221.81  |- skos__altLabel mesh__D012557 Personality Disorder, Schizoid
% 221.63/221.81  |- mesh__recordAuthorizer mesh__D012557 SJN
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D012557 2006
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D012557 2001
% 221.63/221.81  |- skos__hiddenLabel mesh__D012557 Schizoid Personalities
% 221.63/221.81  |- rdf__type mesh__D012557sskos__Concept
% 221.63/221.81  |- skos__altLabel mesh__D012557 Schizoid Personality
% 221.63/221.81  |- mesh__recordOriginator mesh__D012557 NLM
% 221.63/221.81  |- skos__prefLabel mesh__D012557 Schizoid Personality Disorder
% 221.63/221.81  |- skos__hiddenLabel mesh__D012557 Schizoid Personality Disorders
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D012557 2005
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D012557 2000
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D012557 1999
% 221.63/221.81  |- mesh__publicMeSHNote mesh__D012557
% 221.63/221.81       81; was SCHIZOID PERSONALITY 1973-80, was SCHIZOID PERSONALITY see under PERSONALITY DISORDERS 1969-72%A%  
% 221.63/221.81  |- mesh__recordMaintainer mesh__D012557 JLS
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D012557 2004
% 221.63/221.81  |- skos__historyNote mesh__D012557 Personality Disorders %28%1968-1971%29%
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D012557 1998
% 221.63/221.81  |- skos__hiddenLabel mesh__D012557 Personality, Schizoid
% 221.63/221.81  |- skos__hiddenLabel mesh__D012557 Personality Disorders, Schizoid
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D012557 2003
% 221.63/221.81  |- skos__hiddenLabel mesh__D012557 Personalities, Schizoid
% 221.63/221.81  |- mesh__dateRevised mesh__D012557 1997-06-20
% 221.63/221.81  |- mesh__onlineNote mesh__D012557
% 221.63/221.81       use SCHIZOID PERSONALITY DISORDER to search SCHIZOID PERSONALITY 1972-80 %28%as Prov 1972%29%; use PERSONALITY DISORDERS 1969-71%A%  
% 221.63/221.81  |- skos__scopeNote mesh__D012557
% 221.63/221.81       A personality disorder manifested by a profound defect in the ability to form social relationships, no desire for social involvement, and an indifference to praise or criticism.%A%    
% 221.63/221.81  |- skos__hiddenLabel mesh__D012557 Disorder, Schizoid Personality
% 221.63/221.81  |- mesh__historyNote mesh__D012557
% 221.63/221.81       81; was SCHIZOID PERSONALITY 1972-80 %28%Prov 1972%29%, was SCHIZOID PERSONALITY see under PERSONALITY DISORDERS 1969-72%A%  
% 221.63/221.81  |- skos__historyNote mesh__D017242 Beta Globulins %28%1978-1979%29%
% 221.63/221.81  |- mesh__onlineNote mesh__D017242
% 221.63/221.81       use COMPLEMENT FACTOR H %28%NM%29% to search COMPLEMENT FACTOR H 1978-92%A%  
% 221.63/221.81  |- skos__historyNote mesh__D017242
% 221.63/221.81       Complement 3b Inactivators %28%1980-1992%29%
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D017242 2006
% 221.63/221.81  |- mesh__recordAuthorizer mesh__D017242 ags
% 221.63/221.81  |- mesh__dateRevised mesh__D017242 2005-07-07
% 221.63/221.81  |- skos__scopeNote mesh__D017242
% 221.63/221.81       An important soluble regulator of the alternative pathway of complement activation %28%COMPLEMENT ACTIVATION PATHWAY, ALTERNATIVE%29%. It is a 139-kDa glycoprotein expressed by the liver and secreted into the blood. It binds to COMPLEMENT C3B and makes iC3b %28%inactivated complement 3b%29% susceptible to cleavage by COMPLEMENT FACTOR I. Complement factor H also inhibits the association of C3b with COMPLEMENT FACTOR B to form the C3bB proenzyme, and promotes the dissociation of Bb from the C3bBb complex %28%COMPLEMENT C3 CONVERTASE, ALTERNATIVE PATHWAY%29%.%A%    
% 221.63/221.81  |- rdf__type mesh__D017242sskos__Concept
% 221.63/221.81  |- skos__historyNote mesh__D017242 Glycoproteins %28%1978-1979%29%
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D017242 2006A
% 221.63/221.81  |- mesh__recordMaintainer mesh__D017242 ags
% 221.63/221.81  |- mesh__publicMeSHNote mesh__D017242
% 221.63/221.81       93; COMPLEMENT FACTOR H was indexed under COMPLEMENT 3B INACTIVATORS 1980-92 %26% under BETA GLOBULINS and GLYCOPROTEINS 1978-79%A%  
% 221.63/221.81  |- mesh__dateCreated mesh__D017242 1992-05-07
% 221.63/221.81  |- mesh__recordOriginator mesh__D017242 AGS
% 221.63/221.81  |- mesh__historyNote mesh__D017242
% 221.63/221.81       93; was COMPLEMENT FACTOR H %28%NM%29% 1978-92   
% 221.63/221.81  |- skos__altLabel mesh__D017242 Factor H
% 221.63/221.81  |- skos__prefLabel mesh__D017242 Complement Factor H
% 221.63/221.81  |- skos__broader mesh__D017242smesh__D003180
% 221.63/221.81  |- skos__hiddenLabel mesh__D017242 Factor H, Complement
% 221.63/221.81  |- mesh__dateEstablished mesh__D017242 1993-01-01
% 221.63/221.81  |- skos__broader mesh__D017242smesh__D001609
% 221.63/221.81  |- skos__hiddenLabel mesh__D050676 Runt Related Transcription Factor 1
% 221.63/221.81  |- mesh__historyNote mesh__D050676 2006%28%1993%29%   
% 221.63/221.81  |- rdf__type mesh__D050676sskos__Concept
% 221.63/221.81  |- mesh__recordAuthorizer mesh__D050676 sjn
% 221.63/221.81  |- skos__hiddenLabel mesh__D050676 Core Binding Factor Alpha 2 Protein
% 221.63/221.81  |- mesh__publicMeSHNote mesh__D050676
% 221.63/221.81       2006; RUNX1 PROTEIN was indexed under DNA-BINDING PROTEINS 1996-2005, NEOPLASM PROTEINS 1993-1996, PROTO-ONCOGENE PROTEINS 1996-2005, %26% TRANSCRIPTION FACTORS 1996-2005%A%  
% 221.63/221.81  |- skos__historyNote mesh__D050676 Neoplasm Proteins %28%1993-1996%29%
% 221.63/221.81  |- skos__altLabel mesh__D050676 Pebp2a2 Protein
% 221.63/221.81  |- skos__altLabel mesh__D050676 Runx1 Protein
% 221.63/221.81  |- skos__altLabel mesh__D050676 AML1D Protein
% 221.63/221.81  |- skos__historyNote mesh__D050676
% 221.63/221.81       Proto-Oncogene Proteins %28%1996-2005%29%
% 221.63/221.81  |- skos__altLabel mesh__D050676 Core-Binding Factor Alpha 2 Protein
% 221.63/221.81  |- skos__altLabel mesh__D050676 Acute Myeloid Leukemia 1 Protein
% 221.63/221.81  |- skos__altLabel mesh__D050676 Runt-Related Transcription Factor 1
% 221.63/221.81  |- skos__prefLabel mesh__D050676 Core Binding Factor Alpha 2 Subunit
% 221.63/221.81  |- mesh__recordMaintainer mesh__D050676 DRC
% 221.63/221.81  |- mesh__recordOriginator mesh__D050676 DRC
% 221.63/221.81  |- skos__altLabel mesh__D050676 AML1A Protein
% 221.63/221.81  |- mesh__dateEstablished mesh__D050676 2006-01-01
% 221.63/221.81  |- skos__broader mesh__D050676smesh__D050657
% 221.63/221.81  |- skos__altLabel mesh__D050676 AML1C Protein
% 221.63/221.81  |- skos__historyNote mesh__D050676 Transcription Factors %28%1996-2005%29%
% 221.63/221.81  |- skos__scopeNote mesh__D050676
% 221.63/221.81       A transcription factor that dimerizes with the cofactor CORE BINDING FACTOR BETA SUBUNIT to form core binding factor. It contains a highly conserved DNA-binding domain known as the runt domain. Runx1 is frequently mutated in human LEUKEMIAS.%A%    
% 221.63/221.81  |- skos__historyNote mesh__D050676 DNA-Binding Proteins %28%1996-2005%29%
% 221.63/221.81  |- skos__annotation mesh__D050676 see SCR for organism-specific terms   
% 221.63/221.81  |- skos__altLabel mesh__D050676 AML1B Protein
% 221.63/221.81  |- mesh__dateCreated mesh__D050676 2005-06-30
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D050676 2006
% 221.63/221.81  |- mesh__dateCreated mesh__D016948 1991-05-30
% 221.63/221.81  |- mesh__recordAuthorizer mesh__D016948 sjn
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D016948 2006
% 221.63/221.81  |- skos__broader mesh__D016948smesh__D001395
% 221.63/221.81  |- mesh__recordOriginator mesh__D016948 PXP
% 221.63/221.81  |- skos__scopeNote mesh__D016948
% 221.63/221.81       A species of gram-negative, aerobic bacteria first isolated from soil in Vineland, New Jersey. Ammonium and nitrate are used as nitrogen sources by this bacterium. It is distinguished from other members of its genus by the ability to use rhamnose as a carbon source. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A%    
% 221.63/221.81  |- mesh__publicMeSHNote mesh__D016948 92   
% 221.63/221.81  |- rdf__type mesh__D016948sskos__Concept
% 221.63/221.81  |- skos__prefLabel mesh__D016948 Azotobacter vinelandii
% 221.63/221.81  |- skos__historyNote mesh__D016948 Azotobacter %28%1966-1991%29%
% 221.63/221.81  |- mesh__dateEstablished mesh__D016948 1992-01-01
% 221.63/221.81  |- mesh__dateRevised mesh__D016948 2005-06-30
% 221.63/221.81  |- mesh__historyNote mesh__D016948 92   
% 221.63/221.81  |- mesh__recordMaintainer mesh__D016948 SYSTEM
% 221.63/221.81  |- mesh__publicMeSHNote mesh__D041341 2003   
% 221.63/221.81  |- mesh__recordAuthorizer mesh__D041341 sjn
% 221.63/221.81  |- mesh__dateEstablished mesh__D041341 2003-01-01
% 221.63/221.81  |- mesh__recordOriginator mesh__D041341 ags
% 221.63/221.81  |- skos__annotation mesh__D041341
% 221.63/221.81       do not confuse with the seroGROUP canicola, sometimes termed Leptospira canicola %28%index LEPTOSPIRA INTERROGANS%29%; infection: coord IM with probably LEPTOSPIROSIS %28%IM%29%%A%  
% 221.63/221.81  |- skos__historyNote mesh__D041341 Leptospira interrogans %28%1966-2002%29%
% 221.63/221.81  |- mesh__historyNote mesh__D041341 2003   
% 221.63/221.81  |- rdf__type mesh__D041341sskos__Concept
% 221.63/221.81  |- mesh__dateRevised mesh__D041341 2005-06-30
% 221.63/221.81  |- skos__scopeNote mesh__D041341
% 221.63/221.81       A serovar of the bacterial species LEPTOSPIRA INTERROGANS, whose natural host is DOGS where disease is characterized by GASTROENTERITIS, and INTERSTITIAL NEPHRITIS.%A%    
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D041341 2006
% 221.63/221.81  |- mesh__recordMaintainer mesh__D041341 SYSTEM
% 221.63/221.81  |- skos__prefLabel mesh__D041341 Leptospira Interrogans serovar canicola
% 221.63/221.81  |- skos__broader mesh__D041341smesh__D007921
% 221.63/221.81  |- mesh__dateCreated mesh__D041341 2002-07-03
% 221.63/221.81  |- skos__historyNote mesh__D002928 Cinnamates %28%1969-1974%29%
% 221.63/221.81  |- skos__hiddenLabel mesh__D002928 Monohydrochloride, Cinanserin
% 221.63/221.81  |- mesh__recordOriginator mesh__D002928 NLM
% 221.63/221.81  |- skos__hiddenLabel mesh__D002928 SQ10,643
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D002928 2001
% 221.63/221.81  |- mesh__recordMaintainer mesh__D002928 CCR
% 221.63/221.81  |- mesh__dateRevised mesh__D002928 2000-06-22
% 221.63/221.81  |- skos__prefLabel mesh__D002928 Cinanserin
% 221.63/221.81  |- mesh__dateEstablished mesh__D002928 1991-01-01
% 221.63/221.81  |- rdf__type mesh__D002928sskos__Concept
% 221.63/221.81  |- mesh__historyNote mesh__D002928
% 221.63/221.81       91%28%75%29%; was see under CINNAMATES 1975-90   
% 221.63/221.81  |- skos__hiddenLabel mesh__D002928 SQ 16,167
% 221.63/221.81  |- skos__hiddenLabel mesh__D002928 SQ16,167
% 221.63/221.81  |- mesh__dateCreated mesh__D002928 1974-11-11
% 221.63/221.81  |- skos__altLabel mesh__D002928 Cinanserin Monohydrochloride
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D002928 2004
% 221.63/221.81  |- skos__scopeNote mesh__D002928
% 221.63/221.81       A serotonin antagonist with limited antihistaminic, anticholinergic, and immunosuppressive activity.%A%    
% 221.63/221.81  |- skos__hiddenLabel mesh__D002928 SQ 10,643
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D002928 2006
% 221.63/221.81  |- skos__historyNote mesh__D002928 Sulfides %28%1974%29%
% 221.63/221.81  |- skos__broader mesh__D002928smesh__D002934
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D002928 2003
% 221.63/221.81  |- mesh__recordAuthorizer mesh__D002928 sjn
% 221.63/221.81  |- mesh__publicMeSHNote mesh__D002928
% 221.63/221.81       91; was see under CINNAMATES 1975-90   
% 221.63/221.81  |- skos__historyNote mesh__D002928 Anilides %28%1969-1974%29%
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D002928 2002
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D002928 2005
% 221.63/221.81  |- skos__hiddenLabel mesh__D002928 Hydrochloride, Cinanserin
% 221.63/221.81  |- rdf__type mesh__D013650sskos__Concept
% 221.63/221.81  |- mesh__dateCreated mesh__D013650 1999-01-01
% 221.63/221.81  |- skos__hiddenLabel mesh__D013650 Bud, Taste
% 221.63/221.81  |- mesh__recordOriginator mesh__D013650 NLM
% 221.63/221.81  |- skos__annotation mesh__D013650
% 221.63/221.81       chemoreceptors on the tongue, palate %26% pharynx   
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D013650 2004
% 221.63/221.81  |- mesh__recordAuthorizer mesh__D013650 sjn
% 221.63/221.81  |- skos__prefLabel mesh__D013650 Taste Buds
% 221.63/221.81  |- skos__broader mesh__D013650smesh__D002628
% 221.63/221.81  |- mesh__recordMaintainer mesh__D013650 lkt
% 221.63/221.81  |- skos__hiddenLabel mesh__D013650 Buds, Taste
% 221.63/221.81  |- skos__broader mesh__D013650smesh__D014059
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D013650 2006
% 221.63/221.81  |- skos__hiddenLabel mesh__D013650 Taste Bud
% 221.63/221.81  |- skos__broader mesh__D013650smesh__D012679
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D013650 2005
% 221.63/221.81  |- skos__scopeNote mesh__D013650
% 221.63/221.81       Small sensory organs which contain gustatory receptor cells, basal cells, and supporting cells. Taste buds in humans are found in the epithelia of the tongue, palate, and pharynx. They are innervated by the CHORDA TYMPANI NERVE %28%a branch of the facial nerve%29% and the GLOSSOPHARYNGEAL NERVE.%A%    
% 221.63/221.81  |- mesh__dateRevised mesh__D013650 2003-07-09
% 221.63/221.81  |- skos__scopeNote mesh__D007613
% 221.63/221.81       Nonsusceptibility of bacteria to the antibiotic KANAMYCIN, which can bind to their 70S ribosomes and cause misreading of messenger RNA.%A%    
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D007613 2004
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D007613 2006
% 221.63/221.81  |- skos__broader mesh__D007613smesh__D024881
% 221.63/221.81  |- mesh__dateCreated mesh__D007613 1987-05-09
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D007613 2005
% 221.63/221.81  |- skos__historyNote mesh__D007613
% 221.63/221.81       Drug Resistance, Microbial %28%1966-1987%29%
% 221.63/221.81  |- mesh__recordOriginator mesh__D007613 SCD
% 221.63/221.81  |- mesh__dateRevised mesh__D007613 2003-07-09
% 221.63/221.81  |- mesh__recordMaintainer mesh__D007613 ssb
% 221.63/221.81  |- mesh__dateEstablished mesh__D007613 1988-01-01
% 221.63/221.81  |- mesh__historyNote mesh__D007613 88   
% 221.63/221.81  |- skos__historyNote mesh__D007613 Kanamycin %28%1966-1987%29%
% 221.63/221.81  |- skos__prefLabel mesh__D007613 Kanamycin Resistance
% 221.63/221.81  |- mesh__publicMeSHNote mesh__D007613 88   
% 221.63/221.81  |- rdf__type mesh__D007613sskos__Concept
% 221.63/221.81  |- mesh__recordAuthorizer mesh__D007613 sjn
% 221.63/221.81  |- skos__hiddenLabel mesh__D017243 Syndrome, Fukuhara
% 221.63/221.81  |- mesh__recordOriginator mesh__D017243 TGC
% 221.63/221.81  |- skos__broader mesh__D017243smesh__D020739
% 221.63/221.81  |- skos__prefLabel mesh__D017243 MERRF Syndrome
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D017243 2005
% 221.63/221.81  |- skos__hiddenLabel mesh__D017243 Syndrome, MERRF
% 221.63/221.81  |- mesh__dateRevised mesh__D017243 2001-07-25
% 221.63/221.81  |- skos__historyNote mesh__D017243 Mitochondria, Muscle %28%1980-1992%29%
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D017243 2006
% 221.63/221.81  |- skos__scopeNote mesh__D017243
% 221.63/221.81       A mitochondrial encephalomyopathy characterized clinically by a mixed seizure disorder, myoclonus, progressive ataxia, spasticity, and a mild myopathy. Dysarthria, optic atrophy, growth retardation, deafness, and dementia may also occur. This condition tends to present in childhood and to be transmitted via maternal lineage. Muscle biopsies reveal ragged-red fibers and respiratory chain enzymatic defects. %28%From Adams et al., Principles of Neurology, 6th ed, p986%29%%A%    
% 221.63/221.81  |- mesh__historyNote mesh__D017243 1993   
% 221.63/221.81  |- skos__broader mesh__D017243smesh__D017237
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D017243 2003
% 221.63/221.81  |- skos__altLabel mesh__D017243 Fukuhara Syndrome
% 221.63/221.81  |- mesh__dateEstablished mesh__D017243 1993-01-01
% 221.63/221.81  |- rdf__type mesh__D017243sskos__Concept
% 221.63/221.81  |- mesh__dateCreated mesh__D017243 1992-05-22
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D017243 2004
% 221.63/221.81  |- skos__annotation mesh__D017243 DF: MERRF   
% 221.63/221.81  |- mesh__publicMeSHNote mesh__D017243 1993   
% 221.63/221.81  |- mesh__recordAuthorizer mesh__D017243 sjn
% 221.63/221.81  |- mesh__recordMaintainer mesh__D017243 nns
% 221.63/221.81  |- skos__altLabel mesh__D017243 Fukuhara Disease
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D017243 2002
% 221.63/221.81  |- skos__broader mesh__D017243smesh__D020191
% 221.63/221.81  |- skos__historyNote mesh__D017243 Epilepsy, Myoclonic %28%1980-1992%29%
% 221.63/221.81  |- skos__altLabel mesh__D017243 Myoclonic Epilepsy with Ragged Red Fibers
% 221.63/221.81  |- skos__altLabel mesh__D017243 Myoclonic Epilepsy and Ragged Red Fibers
% 221.63/221.81  |- skos__hiddenLabel mesh__D050677
% 221.63/221.81       Runt Related Transcription Factor 3 Protein
% 221.63/221.81  |- mesh__dateCreated mesh__D050677 2005-06-30
% 221.63/221.81  |- skos__altLabel mesh__D050677 Runt-Related Transcription Factor 3 Protein
% 221.63/221.81  |- skos__scopeNote mesh__D050677
% 221.63/221.81       A transcription factor that dimerizes with the cofactor CORE BINDING FACTOR BETA SUBUNIT to form core binding factor. It contains a highly conserved DNA-binding domain known as the runt domain.%A%    
% 221.63/221.81  |- skos__altLabel mesh__D050677 CBFA3 Protein
% 221.63/221.81  |- skos__historyNote mesh__D050677 Transcription Factors %28%2001-2005%29%
% 221.63/221.81  |- mesh__recordOriginator mesh__D050677 DRC
% 221.63/221.81  |- skos__altLabel mesh__D050677 PEBP2A3 Protein
% 221.63/221.81  |- mesh__recordAuthorizer mesh__D050677 sjn
% 221.63/221.81  |- skos__broader mesh__D050677smesh__D050657
% 221.63/221.81  |- skos__altLabel mesh__D050677 Runx3 Protein
% 221.63/221.81  |- skos__altLabel mesh__D050677 Acute Myeloid Leukemia 2 Protein
% 221.63/221.81  |- mesh__publicMeSHNote mesh__D050677
% 221.63/221.81       2006; RUNX3 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 2001-2005%A%  
% 221.63/221.81  |- skos__hiddenLabel mesh__D050677 Core Binding Factor Alpha 3 Protein
% 221.63/221.81  |- skos__altLabel mesh__D050677 Runt Domain Transcription Factor AML-2
% 221.63/221.81  |- skos__historyNote mesh__D050677 DNA-Binding Proteins %28%2001-2005%29%
% 221.63/221.81  |- skos__prefLabel mesh__D050677 Core Binding Factor Alpha 3 Subunit
% 221.63/221.81  |- mesh__recordMaintainer mesh__D050677 DRC
% 221.63/221.81  |- mesh__dateEstablished mesh__D050677 2006-01-01
% 221.63/221.81  |- mesh__historyNote mesh__D050677 2006%28%2001%29%   
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D050677 2006
% 221.63/221.81  |- rdf__type mesh__D050677sskos__Concept
% 221.63/221.81  |- skos__altLabel mesh__D050677 AML2 Protein
% 221.63/221.81  |- skos__annotation mesh__D050677 see SCR for organism-specific terms   
% 221.63/221.81  |- skos__altLabel mesh__D050677 Core-Binding Factor Alpha 3 Protein
% 221.63/221.81  |- skos__broader mesh__D003223smesh__D000350
% 221.63/221.81  |- skos__prefLabel mesh__D003223 Congo
% 221.63/221.81  |- skos__altLabel mesh__D003223 Congo %28%Brazzaville%29%
% 221.63/221.81  |- mesh__recordMaintainer mesh__D003223 AGS
% 221.63/221.81  |- mesh__dateCreated mesh__D003223 1999-01-01
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D003223 1999
% 221.63/221.81  |- mesh__recordOriginator mesh__D003223 NLM
% 221.63/221.81  |- mesh__recordAuthorizer mesh__D003223 SJN
% 221.63/221.81  |- skos__scopeNote mesh__D003223
% 221.63/221.81       A republic in central Africa lying between GABON and DEMOCRATIC REPUBLIC OF THE CONGO. Its capital is Brazzaville. It became a territory of French Equatorial Africa in 1910, a French overseas territory in 1946, an autonomous republic within the French Community in 1958, and achieved independence in 1960. The country takes its name from the Congo River running through it: the Bantu name for the river means mountain, with reference to the local topography. %28%From Webster%27%s New Geographical Dictionary, 1988, p285 %26% Room, Brewer%27%s Dictionary of Names, 1992, p123%29%%A%    
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D003223 2004
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D003223 1998
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D003223 2002
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D003223 2006
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D003223 2003
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D003223 2001
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D003223 2005
% 221.63/221.81  |- mesh__dateRevised mesh__D003223 1997-06-20
% 221.63/221.81  |- skos__annotation mesh__D003223
% 221.63/221.81       Republic of Congo %28%capital at Brazzaville%29%; do not confuse with DEMOCRATIC REPUBLIC OF THE CONGO %28%capital at Kinshasa, formerly Leopoldville%29%%A%  
% 221.63/221.81  |- rdf__type mesh__D003223sskos__Concept
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D003223 2000
% 221.63/221.81  |- mesh__dateRevised mesh__D016949 2005-06-30
% 221.63/221.81  |- skos__prefLabel mesh__D016949 Azospirillum
% 221.63/221.81  |- rdf__type mesh__D016949sskos__Concept
% 221.63/221.81  |- mesh__recordOriginator mesh__D016949 PXP
% 221.63/221.81  |- mesh__historyNote mesh__D016949 92   
% 221.63/221.81  |- skos__broader mesh__D016949smesh__D012244
% 221.63/221.81  |- mesh__recordAuthorizer mesh__D016949 sjn
% 221.63/221.81  |- skos__scopeNote mesh__D016949
% 221.63/221.81       A genus of gram-negative aerobic bacteria that occurs free-living in the soil or associated with the roots of cereal crops or grasses %28%POACEAE%29%.%A%    
% 221.63/221.81  |- mesh__recordMaintainer mesh__D016949 ags
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D016949 2006
% 221.63/221.81  |- mesh__dateEstablished mesh__D016949 1992-01-01
% 221.63/221.81  |- mesh__publicMeSHNote mesh__D016949 92   
% 221.63/221.81  |- mesh__dateCreated mesh__D016949 1991-05-30
% 221.63/221.81  |- skos__historyNote mesh__D041342 Bedding and Linens %28%1988-1991%29%
% 221.63/221.81  |- skos__historyNote mesh__D041342 Incontinence Pads %28%1992-2002%29%
% 221.63/221.81  |- mesh__recordOriginator mesh__D041342 lkt
% 221.63/221.81  |- mesh__recordAuthorizer mesh__D041342 sjn
% 221.63/221.81  |- skos__hiddenLabel mesh__D041342 Pads, Absorbent
% 221.63/221.81  |- skos__broader mesh__D041342smesh__D004865
% 221.63/221.81  |- mesh__dateCreated mesh__D041342 2002-07-02
% 221.63/221.81  |- skos__hiddenLabel mesh__D041342 Liners, Pants
% 221.63/221.81  |- rdf__type mesh__D041342sskos__Concept
% 221.63/221.81  |- mesh__dateEstablished mesh__D041342 2003-01-01
% 221.63/221.81  |- skos__hiddenLabel mesh__D041342 Pad, Absorbent
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D041342 2005
% 221.63/221.81  |- skos__hiddenLabel mesh__D041342 Liner, Pants
% 221.63/221.81  |- skos__hiddenLabel mesh__D041342 Pants Liner
% 221.63/221.81  |- skos__hiddenLabel mesh__D041342 Underpad
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D041342 2003
% 221.63/221.81  |- skos__hiddenLabel mesh__D041342 Absorbent Pad
% 221.63/221.81  |- mesh__historyNote mesh__D041342 2003; use INCONTINENCE PADS 1992-2002   
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D041342 2006
% 221.63/221.81  |- mesh__recordMaintainer mesh__D041342 lkt
% 221.63/221.81  |- skos__prefLabel mesh__D041342 Absorbent Pads
% 221.63/221.81  |- mesh__publicMeSHNote mesh__D041342
% 221.63/221.81       2003; see INCONTINENCE PADS 1992-2002   
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D041342 2004
% 221.63/221.81  |- skos__scopeNote mesh__D041342
% 221.63/221.81       Pads made of various materials used for personal hygiene usually for absorbing URINE or FECES. They can be worn as underpants or pants liners by various age groups, from NEWBORNS to the ELDERLY. Absorbent pads can be made of fluff wood pulp and HYDROGEL absorbent covered with viscose rayon, polyester, polypropylene, or POLYETHYLENE coverstock.%A%    
% 221.63/221.81  |- mesh__recordAuthorizer mesh__D002929 sjn
% 221.63/221.81  |- skos__scopeNote mesh__D002929
% 221.63/221.81       A genus of rubiaceous South American trees that yields the toxic CINCHONA ALKALOIDS from their bark; QUININE; QUINIDINE; chinconine, cinchonidine and others are used to treat malaria and cardiac arrhythmias.%A%    
% 221.63/221.81  |- rdf__type mesh__D002929sskos__Concept
% 221.63/221.81  |- mesh__dateCreated mesh__D002929 1999-01-01
% 221.63/221.81  |- mesh__dateRevised mesh__D002929 2005-06-30
% 221.63/221.81  |- mesh__recordOriginator mesh__D002929 NLM
% 221.63/221.81  |- skos__broader mesh__D002929smesh__D019666
% 221.63/221.81  |- skos__related mesh__D002929smesh__D002930
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D002929 2006
% 221.63/221.81  |- skos__annotation mesh__D002929
% 221.63/221.81       plant only: alkaloids = CINCHONA ALKALOIDS; coordinate with specific PLANT COMPONENTS term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.63/221.81  |- skos__prefLabel mesh__D002929 Cinchona
% 221.63/221.81  |- mesh__recordMaintainer mesh__D002929 ags
% 221.63/221.81  |- mesh__historyNote mesh__D002929 was in Cat B %26% D 1963-76   
% 221.63/221.81  |- skos__broader mesh__D013651smesh__D012678
% 221.63/221.81  |- rdf__type mesh__D013651sskos__Concept
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D013651 2000
% 221.63/221.81  |- skos__hiddenLabel mesh__D013651 Taste Disorders, Primary
% 221.63/221.81  |- skos__hiddenLabel mesh__D013651 Taste Disorder
% 221.63/221.81  |- mesh__recordMaintainer mesh__D013651 ags
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D013651 2003
% 221.63/221.81  |- skos__hiddenLabel mesh__D013651 Taste Disorders, Secondary
% 221.63/221.81  |- skos__scopeNote mesh__D013651
% 221.63/221.81       Conditions characterized by an alteration in gustatory function or perception. Taste disorders are frequently associated with OLFACTION DISORDERS. Additional potential etiologies include METABOLIC DISEASES; DRUG TOXICITY; and taste pathway disorders %28%e.g., TASTE BUD diseases; FACIAL NERVE DISEASES; GLOSSOPHARYNGEAL NERVE DISEASES; and BRAIN STEM diseases%29%.%A%    
% 221.63/221.81  |- skos__hiddenLabel mesh__D013651 Secondary Taste Disorder
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D013651 2001
% 221.63/221.81  |- mesh__publicMeSHNote mesh__D013651 1973   
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D013651 2004
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D013651 2002
% 221.63/221.81  |- skos__hiddenLabel mesh__D013651 Metallic Tastes
% 221.63/221.81  |- skos__historyNote mesh__D013651 Taste %28%1966-1970%29%
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D013651 2005
% 221.63/221.81  |- skos__hiddenLabel mesh__D013651 Tastes, Metallic
% 221.63/221.81  |- skos__hiddenLabel mesh__D013651 Secondary Taste Disorders
% 221.63/221.81  |- skos__hiddenLabel mesh__D013651 Primary Taste Disorders
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D013651 2000A
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D013651 2006
% 221.63/221.81  |- mesh__recordOriginator mesh__D013651 NLM
% 221.63/221.81  |- mesh__dateEstablished mesh__D013651 1973-01-01
% 221.63/221.81  |- mesh__recordAuthorizer mesh__D013651 ags
% 221.63/221.81  |- skos__hiddenLabel mesh__D013651 Primary Taste Disorder
% 221.63/221.81  |- mesh__dateCreated mesh__D013651 1999-01-01
% 221.63/221.81  |- mesh__dateRevised mesh__D013651 1999-12-08
% 221.63/221.81  |- skos__hiddenLabel mesh__D013651 Metallic Taste
% 221.63/221.81  |- skos__prefLabel mesh__D013651 Taste Disorders
% 221.63/221.81  |- mesh__historyNote mesh__D013651 1973%28%1971%29%   
% 221.63/221.81  |- skos__broader mesh__D007614smesh__D008394
% 221.63/221.81  |- skos__prefLabel mesh__D007614 Macropodidae
% 221.63/221.81  |- skos__scopeNote mesh__D007614
% 221.63/221.81       A family of herbivorous leaping MAMMALS of Australia, New Guinea, and adjacent islands. Members include kangaroos, wallabies, quokkas, and wallaroos.%A%    
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D007614 2006
% 221.63/221.81  |- skos__altLabel mesh__D007614 Setonix
% 221.63/221.81  |- mesh__activeMeSHYear mesh__D007614 2005
% 221.63/221.81  |- mesh__dateCreated mesh__D007614 1974-12-12
% 221.63/221.81  |- mesh__publicMeSHNote mesh__D007614
% 221.63/221.81       2005; see KANGAROOS 1991-2004, see  MARSUPIALIA 1975-1990%A%  
% 221.63/221.81  |- skos__hiddenLabel mesh__D007614 Wallaroos
% 221.63/221.82  |- mesh__historyNote mesh__D007614 2005 %28%1975%29%   
% 221.63/221.82  |- mesh__recordAuthorizer mesh__D007614 sjn
% 221.63/221.82  |- skos__hiddenLabel mesh__D007614 Petrogales
% 221.63/221.82  |- rdf__type mesh__D007614sskos__Concept
% 221.63/221.82  |- skos__hiddenLabel mesh__D007614 Wallaby
% 221.63/221.82  |- skos__hiddenLabel mesh__D007614 Wallaby, Rock
% 221.63/221.82  |- mesh__recordOriginator mesh__D007614 NLM
% 221.63/221.82  |- mesh__recordMaintainer mesh__D007614 ags
% 221.63/221.82  |- skos__altLabel mesh__D007614 Wallabies, Rock
% 221.63/221.82  |- mesh__dateRevised mesh__D007614 2004-07-07
% 221.63/221.82  |- skos__hiddenLabel mesh__D007614 Rock Wallabies
% 221.63/221.82  |- skos__hiddenLabel mesh__D007614 Kangaroo
% 221.63/221.82  |- skos__altLabel mesh__D007614 Macropus robustus
% 221.63/221.82  |- skos__hiddenLabel mesh__D007614 Quokka
% 221.63/221.82  |- mesh__dateEstablished mesh__D007614 1991-01-01
% 221.63/221.82  |- skos__hiddenLabel mesh__D007614 Rock Wallaby
% 221.63/221.82  |- mesh__recordOriginator mesh__D012559 NLM
% 221.63/221.82  |- rdf__type mesh__D012559sskos__Concept
% 221.63/221.82  |- mesh__dateRevised mesh__D012559 1999-11-03
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D012559 2003
% 221.63/221.82  |- skos__prefLabel mesh__D012559 Schizophrenia
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D012559 2002
% 221.63/221.82  |- skos__hiddenLabel mesh__D012559 Disorder, Schizophrenic
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D012559 2004
% 221.63/221.82  |- skos__hiddenLabel mesh__D012559 Schizophrenias
% 221.63/221.82  |- mesh__dateCreated mesh__D012559 1999-01-01
% 221.63/221.82  |- skos__hiddenLabel mesh__D012559 Schizophrenic Disorder
% 221.63/221.82  |- mesh__recordMaintainer mesh__D012559 kle
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D012559 2000
% 221.63/221.82  |- skos__scopeNote mesh__D012559
% 221.63/221.82       A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, hallucinations, emotional disharmony, and regressive behavior.%A%    
% 221.63/221.82  |- skos__annotation mesh__D012559 GEN or unspecified; prefer specifics   
% 221.63/221.82  |- mesh__recordAuthorizer mesh__D012559 sjn
% 221.63/221.82  |- skos__broader mesh__D012559smesh__D019967
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D012559 2005
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D012559 2001
% 221.63/221.82  |- skos__hiddenLabel mesh__D012559 Disorders, Schizophrenic
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D012559 2006
% 221.63/221.82  |- skos__altLabel mesh__D012559 Schizophrenic Disorders
% 221.63/221.82  |- skos__scopeNote mesh__D023281
% 221.63/221.82       The systematic study of the complete DNA sequences %28%GENOME%29% of organisms.%A%    
% 221.63/221.82  |- mesh__historyNote mesh__D023281 2001   
% 221.63/221.82  |- mesh__recordMaintainer mesh__D023281 jls
% 221.63/221.82  |- skos__related mesh__D023281smesh__D017422
% 221.63/221.82  |- skos__related mesh__D023281smesh__D016045
% 221.63/221.82  |- mesh__recordOriginator mesh__D023281 nns
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D023281 2005
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D023281 2003
% 221.63/221.82  |- skos__related mesh__D023281smesh__D019295
% 221.63/221.82  |- mesh__dateEstablished mesh__D023281 2001-01-01
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D023281 2006
% 221.63/221.82  |- skos__prefLabel mesh__D023281 Genomics
% 221.63/221.82  |- mesh__publicMeSHNote mesh__D023281 2001   
% 221.63/221.82  |- mesh__dateCreated mesh__D023281 2000-06-22
% 221.63/221.82  |- rdf__type mesh__D023281sskos__Concept
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D023281 2004
% 221.63/221.82  |- mesh__dateRevised mesh__D023281 2002-07-03
% 221.63/221.82  |- skos__broader mesh__D023281smesh__D005823
% 221.63/221.82  |- skos__related mesh__D023281smesh__D040901
% 221.63/221.82  |- mesh__recordAuthorizer mesh__D023281 sjn
% 221.63/221.82  |- skos__hiddenLabel mesh__D017244 Inactivator, Complement C4b-C3b
% 221.63/221.82  |- skos__altLabel mesh__D017244 C3b Inactivator
% 221.63/221.82  |- skos__altLabel mesh__D017244 C4bC3bINA
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D017244 2006
% 221.63/221.82  |- skos__hiddenLabel mesh__D017244 Complement 3b Complement 4b Inactivator
% 221.63/221.82  |- skos__hiddenLabel mesh__D017244 C4b C3b INA
% 221.63/221.82  |- skos__scopeNote mesh__D017244
% 221.63/221.82       A plasma serine proteinase that cleaves the alpha-chains of C3b and C4b in the presence of the cofactors COMPLEMENT FACTOR H and C4-binding protein, respectively. It is a 66-kDa glycoprotein that converts C3b to inactivated C3b %28%iC3b%29% followed by the release of two fragments, C3c %28%150-kDa%29% and C3dg %28%41-kDa%29%. It was formerly called KAF, C3bINF, or enzyme 3b inactivator.%A%    
% 221.63/221.82  |- skos__hiddenLabel mesh__D017244 Inactivator, C3b
% 221.63/221.82  |- skos__broader mesh__D017244smesh__D012697
% 221.63/221.82  |- skos__altLabel mesh__D017244 Complement C4b-C3b Inactivator
% 221.63/221.82  |- skos__historyNote mesh__D017244 Serine Proteinases %28%1988-1992%29%
% 221.63/221.82  |- skos__broader mesh__D017244smesh__D003180
% 221.63/221.82  |- mesh__dateRevised mesh__D017244 2005-06-30
% 221.63/221.82  |- mesh__recordMaintainer mesh__D017244 lkt
% 221.63/221.82  |- skos__hiddenLabel mesh__D017244 C4b-C3b Inactivator, Complement
% 221.63/221.82  |- rdf__type mesh__D017244sskos__Concept
% 221.63/221.82  |- mesh__publicMeSHNote mesh__D017244
% 221.63/221.82       93; COMPLEMENT FACTOR I was indexed under SERINE PROTEINASES 1988-92 %26% under PEPTIDE PEPTIDOHYDROLASES 1983-87%A%  
% 221.63/221.82  |- skos__hiddenLabel mesh__D017244 C3b C4b Inactivator
% 221.63/221.82  |- mesh__onlineNote mesh__D017244
% 221.63/221.82       use COMPLEMENT FACTOR I %28%NM%29% to search FACTOR I, C 3B INACTIVATOR 1983-92%A%  
% 221.63/221.82  |- mesh__dateCreated mesh__D017244 1992-05-07
% 221.63/221.82  |- skos__prefLabel mesh__D017244 Complement Factor I
% 221.63/221.82  |- skos__hiddenLabel mesh__D017244 Inactivator, C3b-C4b
% 221.63/221.82  |- mesh__dateEstablished mesh__D017244 1993-01-01
% 221.63/221.82  |- skos__annotation mesh__D017244
% 221.63/221.82       do not confuse with FACTOR I see FIBRINOGEN   
% 221.63/221.82  |- mesh__historyNote mesh__D017244
% 221.63/221.82       93; was FACTOR I, C 3B INACTIVATOR %28%NM%29% 1983-92   
% 221.63/221.82  |- skos__historyNote mesh__D017244
% 221.63/221.82       Peptide Peptidohydrolases %28%1983-1987%29%
% 221.63/221.82  |- skos__altLabel mesh__D017244 Complement 3b-Complement 4b Inactivator
% 221.63/221.82  |- skos__altLabel mesh__D017244 C4b-C3b-INA
% 221.63/221.82  |- skos__hiddenLabel mesh__D017244 Complement C4b C3b Inactivator
% 221.63/221.82  |- skos__altLabel mesh__D017244 C3b-C4b Inactivator
% 221.63/221.82  |- mesh__recordAuthorizer mesh__D017244 sjn
% 221.63/221.82  |- mesh__recordOriginator mesh__D017244 AGS
% 221.63/221.82  |- mesh__dateEstablished mesh__D050678 2006-01-01
% 221.63/221.82  |- skos__altLabel mesh__D050678 C2a Complement
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D050678 2006
% 221.63/221.82  |- mesh__publicMeSHNote mesh__D050678
% 221.63/221.82       2006; COMPLEMENT C2A was indexed under COMPLEMENT 2 1986-2005%A%  
% 221.63/221.82  |- mesh__dateCreated mesh__D050678 2005-06-30
% 221.63/221.82  |- skos__altLabel mesh__D050678 Complement C2a Fragment
% 221.63/221.82  |- skos__prefLabel mesh__D050678 Complement C2a
% 221.63/221.82  |- skos__hiddenLabel mesh__D050678 C2a, Complement
% 221.63/221.82  |- rdf__type mesh__D050678sskos__Concept
% 221.63/221.82  |- skos__scopeNote mesh__D050678
% 221.63/221.82       The COOH-terminal fragment of COMPLEMENT 2, released by the action of activated COMPLEMENT C1S. It is a SERINE PROTEASE. C2a combines with COMPLEMENT C4B to form C4b2a %28%CLASSICAL PATHWAY C3 CONVERTASE%29% and subsequent C4b2a3b %28%CLASSICAL PATHWAY C5 CONVERTASE%29%.%A%    
% 221.63/221.82  |- skos__broader mesh__D050678smesh__D003175
% 221.63/221.82  |- skos__hiddenLabel mesh__D050678 C2a Fragment, Complement
% 221.63/221.82  |- mesh__recordOriginator mesh__D050678 lkt
% 221.63/221.82  |- mesh__historyNote mesh__D050678 2006 %28%1986%29%   
% 221.63/221.82  |- skos__altLabel mesh__D050678 Complement C2 Fragment a
% 221.63/221.82  |- mesh__recordAuthorizer mesh__D050678 sjn
% 221.63/221.82  |- skos__altLabel mesh__D050678 Complement 2a
% 221.63/221.82  |- skos__hiddenLabel mesh__D050678 Complement, C2a
% 221.63/221.82  |- mesh__recordMaintainer mesh__D050678 lkt
% 221.63/221.82  |- mesh__dateRevised mesh__D003224 2005-07-06
% 221.63/221.82  |- mesh__recordAuthorizer mesh__D003224 NLM
% 221.63/221.82  |- skos__broader mesh__D003224smesh__D009282
% 221.63/221.82  |- mesh__recordMaintainer mesh__D003224 NLM
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D003224 2006
% 221.63/221.82  |- mesh__recordOriginator mesh__D003224 NLM
% 221.63/221.82  |- skos__scopeNote mesh__D003224
% 221.63/221.82       An acid dye used in testing for hydrochloric acid in gastric contents. It is also used histologically to test for AMYLOIDOSIS.%A%    
% 221.63/221.82  |- mesh__dateCreated mesh__D003224 1999-01-01
% 221.63/221.82  |- skos__hiddenLabel mesh__D003224 Red, Congo
% 221.63/221.82  |- skos__prefLabel mesh__D003224 Congo Red
% 221.63/221.82  |- rdf__type mesh__D003224sskos__Concept
% 221.63/221.82  |- skos__scopeNote mesh__D041343
% 221.63/221.82       A serovar of the bacterial species LEPTOSPIRA INTERROGANS, whose frequent host is CATTLE.%A%    
% 221.63/221.82  |- mesh__dateCreated mesh__D041343 2002-07-03
% 221.63/221.82  |- rdf__type mesh__D041343sskos__Concept
% 221.63/221.82  |- skos__annotation mesh__D041343
% 221.63/221.82       do not confuse with the seroGROUP hebdomadis, sometimes termed Leptospira hebdomadis %28%index LEPTOSPIRA INTERROGANS%29%; infection: coord IM with probably LEPTOSPIROSIS %28%IM%29%%A%  
% 221.63/221.82  |- skos__historyNote mesh__D041343 Leptospira interrogans %28%1964-2002%29%
% 221.63/221.82  |- mesh__recordAuthorizer mesh__D041343 sjn
% 221.63/221.82  |- mesh__recordOriginator mesh__D041343 ags
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D041343 2006
% 221.63/221.82  |- mesh__dateEstablished mesh__D041343 2003-01-01
% 221.63/221.82  |- mesh__recordMaintainer mesh__D041343 SYSTEM
% 221.63/221.82  |- skos__prefLabel mesh__D041343 Leptospira interrogans serovar hebdomadis
% 221.63/221.82  |- mesh__historyNote mesh__D041343 2003   
% 221.63/221.82  |- mesh__dateRevised mesh__D041343 2005-06-30
% 221.63/221.82  |- skos__broader mesh__D041343smesh__D007921
% 221.63/221.82  |- mesh__publicMeSHNote mesh__D041343 2003   
% 221.63/221.82  |- skos__broader mesh__D013652smesh__D013649
% 221.63/221.82  |- mesh__dateRevised mesh__D013652 1992-05-18
% 221.63/221.82  |- mesh__recordMaintainer mesh__D013652 TAP
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D013652 2004
% 221.63/221.82  |- skos__hiddenLabel mesh__D013652 Taste Thresholds
% 221.63/221.82  |- skos__hiddenLabel mesh__D013652 Threshold, Taste
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D013652 1996
% 221.63/221.82  |- skos__historyNote mesh__D013652 Taste %28%1966-1975%29%
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D013652 2000
% 221.63/221.82  |- mesh__dateCreated mesh__D013652 1975-07-25
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D013652 2005
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D013652 1997
% 221.63/221.82  |- skos__broader mesh__D013652smesh__D012684
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D013652 2001
% 221.63/221.82  |- skos__scopeNote mesh__D013652
% 221.63/221.82       The minimum concentration at which taste sensitivity to a particular substance or food can be perceived.%A%    
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D013652 2006
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D013652 1998
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D013652 1993
% 221.63/221.82  |- mesh__historyNote mesh__D013652
% 221.63/221.82       91%28%76%29%; was see under TASTE 1976-90   
% 221.63/221.82  |- skos__prefLabel mesh__D013652 Taste Threshold
% 221.63/221.82  |- mesh__publicMeSHNote mesh__D013652 91; was see under TASTE 1976-90   
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D013652 2002
% 221.63/221.82  |- mesh__recordOriginator mesh__D013652 EC
% 221.63/221.82  |- mesh__recordAuthorizer mesh__D013652 PLS
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D013652 1994
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D013652 1999
% 221.63/221.82  |- skos__hiddenLabel mesh__D013652 Thresholds, Taste
% 221.63/221.82  |- rdf__type mesh__D013652sskos__Concept
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D013652 1995
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D013652 2003
% 221.63/221.82  |- mesh__dateEstablished mesh__D013652 1991-01-01
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D007615 2001
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D007615 2005
% 221.63/221.82  |- skos__broader mesh__D007615smesh__D015146
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D007615 2000
% 221.63/221.82  |- rdf__type mesh__D007615sskos__Concept
% 221.63/221.82  |- mesh__dateRevised mesh__D007615 1997-06-20
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D007615 1999
% 221.63/221.82  |- skos__prefLabel mesh__D007615 Kansas
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D007615 1998
% 221.63/221.82  |- mesh__recordMaintainer mesh__D007615 PXP
% 221.63/221.82  |- mesh__recordOriginator mesh__D007615 NLM
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D007615 2004
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D007615 2002
% 221.63/221.82  |- mesh__recordAuthorizer mesh__D007615 SJN
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D007615 2006
% 221.63/221.82  |- mesh__dateCreated mesh__D007615 1999-01-01
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D007615 2003
% 221.63/221.82  |- rdf__type mesh__D023282sskos__Concept
% 221.63/221.82  |- mesh__historyNote mesh__D023282 2001   
% 221.63/221.82  |- skos__broader mesh__D023282smesh__D005821
% 221.63/221.82  |- skos__hiddenLabel mesh__D023282 Assays, Nuclease Protection
% 221.63/221.82  |- skos__prefLabel mesh__D023282 Nuclease Protection Assays
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D023282 2005
% 221.63/221.82  |- mesh__dateEstablished mesh__D023282 2001-01-01
% 221.63/221.82  |- mesh__recordAuthorizer mesh__D023282 sjn
% 221.63/221.82  |- mesh__dateCreated mesh__D023282 2000-06-21
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D023282 2002
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D023282 2001
% 221.63/221.82  |- skos__hiddenLabel mesh__D023282 Assay, Nuclease Protection
% 221.63/221.82  |- skos__scopeNote mesh__D023282
% 221.63/221.82       Techniques for measuring specific nucleic acid interaction with another nucleic acid or with a protein by digestion of the non-interacting nucleic acid by various nucleases.  After all non-interacting regions are eliminated by nuclease digestion, the protected nucleic acid that remains is analyzed. DNA FOOTPRINTING utilizes this technique to analyze the DNA contact sites of DNA-BINDING PROTEINS.%A%    
% 221.63/221.82  |- mesh__publicMeSHNote mesh__D023282 2001   
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D023282 2004
% 221.63/221.82  |- mesh__recordOriginator mesh__D023282 nns
% 221.63/221.82  |- skos__hiddenLabel mesh__D023282 Nuclease Protection Assay
% 221.63/221.82  |- mesh__recordMaintainer mesh__D023282 nns
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D023282 2006
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D023282 2003
% 221.63/221.82  |- mesh__historyNote mesh__D017245
% 221.63/221.82       93; FOSCARNET was SY to PHOSPHONOFORMIC ACID %28%NM%29% 1983-92%A%  
% 221.63/221.82  |- skos__hiddenLabel mesh__D017245 Sodium, Foscarnet
% 221.63/221.82  |- rdf__type mesh__D017245sskos__Concept
% 221.63/221.82  |- skos__broader mesh__D017245smesh__D010746
% 221.63/221.82  |- skos__historyNote mesh__D017245 Formates %28%1978-1980%29%
% 221.63/221.82  |- skos__hiddenLabel mesh__D017245 Tripotassium Salt, Foscarnet
% 221.63/221.82  |- skos__hiddenLabel mesh__D017245 Phosphonoformate, Trisodium
% 221.63/221.82  |- skos__hiddenLabel mesh__D017245 Trisodium Salt, Foscarnet
% 221.63/221.82  |- skos__historyNote mesh__D017245 Phosphonoacetic Acid %28%1981-1992%29%
% 221.63/221.82  |- skos__scopeNote mesh__D017245
% 221.63/221.82       An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.%A%    
% 221.63/221.82  |- mesh__recordMaintainer mesh__D017245 sjn
% 221.63/221.82  |- mesh__recordAuthorizer mesh__D017245 sjn
% 221.63/221.82  |- mesh__recordOriginator mesh__D017245 AGS
% 221.63/221.82  |- mesh__dateCreated mesh__D017245 1992-05-19
% 221.63/221.82  |- skos__hiddenLabel mesh__D017245 Trilithium Salt, Foscarnet
% 221.63/221.82  |- mesh__dateRevised mesh__D017245 2004-07-13
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D017245 2005
% 221.63/221.82  |- skos__prefLabel mesh__D017245 Foscarnet
% 221.63/221.82  |- skos__altLabel mesh__D017245 Foscarnet Sodium
% 221.63/221.82  |- mesh__onlineNote mesh__D017245
% 221.63/221.82       use FOSCARNET %28%NM%29% to search FOSCARNET 1980-92   
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D017245 2006
% 221.63/221.82  |- skos__historyNote mesh__D017245
% 221.63/221.82       Organophosphorus Compounds %28%1978-1980%29%
% 221.63/221.82  |- skos__altLabel mesh__D017245 Phosphonoformic Acid
% 221.63/221.82  |- mesh__publicMeSHNote mesh__D017245
% 221.63/221.82       93; FOSCARNET was indexed under PHOSPHONOACETIC ACID 1981-92 %26% under ORGANOPHOSPHORUS COMPOUNDS and FORMATES 1978-80%A%  
% 221.63/221.82  |- mesh__dateEstablished mesh__D017245 1993-01-01
% 221.63/221.82  |- skos__hiddenLabel mesh__D017245 Disodium Salt, Foscarnet
% 221.63/221.82  |- skos__hiddenLabel mesh__D050679 C2b Fragment, Complement
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D050679 2006
% 221.63/221.82  |- mesh__recordMaintainer mesh__D050679 lkt
% 221.63/221.82  |- mesh__dateEstablished mesh__D050679 2006-01-01
% 221.63/221.82  |- skos__altLabel mesh__D050679 Complement C2b Fragment
% 221.63/221.82  |- skos__historyNote mesh__D050679 Complement 2 %28%1985-2005%29%
% 221.63/221.82  |- mesh__historyNote mesh__D050679 2006 %28%1985%29%   
% 221.63/221.82  |- mesh__publicMeSHNote mesh__D050679
% 221.63/221.82       2006; COMPLEMENT C2B was indexed under COMPLEMENT 2 1985-2005%A%  
% 221.63/221.82  |- rdf__type mesh__D050679sskos__Concept
% 221.63/221.82  |- skos__altLabel mesh__D050679 Complement Component 2b
% 221.63/221.82  |- skos__broader mesh__D050679smesh__D003175
% 221.63/221.82  |- mesh__recordOriginator mesh__D050679 lkt
% 221.63/221.82  |- skos__prefLabel mesh__D050679 Complement C2b
% 221.63/221.82  |- skos__hiddenLabel mesh__D050679 Fragment, Complement C2b
% 221.63/221.82  |- skos__scopeNote mesh__D050679
% 221.63/221.82       The N-terminal fragment of COMPLEMENT 2, released by the action of activated COMPLEMENT C1S.%A%    
% 221.63/221.82  |- mesh__dateCreated mesh__D050679 2005-06-30
% 221.63/221.82  |- skos__altLabel mesh__D050679 C2b Complement
% 221.63/221.82  |- skos__altLabel mesh__D050679 Complement 2b
% 221.63/221.82  |- mesh__recordAuthorizer mesh__D050679 sjn
% 221.63/221.82  |- skos__hiddenLabel mesh__D050679 Complement, C2b
% 221.63/221.82  |- skos__hiddenLabel mesh__D050679 C2b, Complement
% 221.63/221.82  |- skos__hiddenLabel mesh__D050679 Component 2b, Complement
% 221.63/221.82  |- skos__altLabel mesh__D003225 Congo Virus
% 221.63/221.82  |- skos__annotation mesh__D003225
% 221.63/221.82       infection = HEMORRHAGIC FEVER, CRIMEAN; DF: CCHF VIRUS   
% 221.63/221.82  |- skos__scopeNote mesh__D003225
% 221.63/221.82       A species of NAIROVIRUS of the family BUNYAVIRIDAE. It is primarily transmitted by ticks and causes a severe, often fatal disease in humans.%A%    
% 221.63/221.82  |- skos__prefLabel mesh__D003225 Hemorrhagic Fever Virus, Crimean-Congo
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D003225 2003
% 221.63/221.82  |- mesh__dateCreated mesh__D003225 1974-12-12
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D003225 2005
% 221.63/221.82  |- mesh__recordAuthorizer mesh__D003225 sjn
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D003225 2004
% 221.63/221.82  |- skos__altLabel mesh__D003225 Crimean-Congo hemorrhagic fever virus
% 221.63/221.82  |- mesh__recordMaintainer mesh__D003225 ags
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D003225 2006
% 221.63/221.82  |- mesh__dateEstablished mesh__D003225 1991-01-01
% 221.63/221.82  |- skos__broader mesh__D003225smesh__D016855
% 221.63/221.82  |- mesh__dateRevised mesh__D003225 2001-07-25
% 221.63/221.82  |- mesh__onlineNote mesh__D003225
% 221.63/221.82       use HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO to search CONGO VIRUS 1975-91%A%  
% 221.63/221.82  |- rdf__type mesh__D003225sskos__Concept
% 221.63/221.82  |- mesh__historyNote mesh__D003225
% 221.63/221.82       92; was CONGO VIRUS 1975-91 %28%see under BUNYAVIRIDAE 1981-90, see under ARBOVIRUSES 1975-80%29%%A%  
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D003225 2002
% 221.63/221.82  |- mesh__publicMeSHNote mesh__D003225
% 221.63/221.82       92; was CONGO VIRUS 1975-91 %28%see under BUNYAVIRIDAE 1981-90, see under ARBOVIRUSES 1975-80%29%%A%  
% 221.63/221.82  |- skos__altLabel mesh__D003225 Hemorrhagic Fever Virus, Crimean
% 221.63/221.82  |- skos__hiddenLabel mesh__D003225 Crimean Congo hemorrhagic fever virus
% 221.63/221.82  |- mesh__recordOriginator mesh__D003225 NLM
% 221.63/221.82  |- skos__hiddenLabel mesh__D003225 Hemorrhagic Fever Virus, Crimean Congo
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D013653 2006
% 221.63/221.82  |- mesh__dateCreated mesh__D013653 1999-01-01
% 221.63/221.82  |- mesh__recordOriginator mesh__D013653 NLM
% 221.63/221.82  |- skos__hiddenLabel mesh__D013653 Tattooings
% 221.63/221.82  |- mesh__recordMaintainer mesh__D013653 sjn
% 221.63/221.82  |- mesh__dateRevised mesh__D013653 2005-07-01
% 221.63/221.82  |- mesh__recordAuthorizer mesh__D013653 sjn
% 221.63/221.82  |- rdf__type mesh__D013653sskos__Concept
% 221.63/221.82  |- skos__scopeNote mesh__D013653
% 221.63/221.82       The indelible marking of TISSUES, primarily SKIN, by pricking it with NEEDLES to imbed various COLORING AGENTS. Tattooing of the CORNEA is done to colorize LEUKOMA spots.%A%    
% 221.63/221.82  |- skos__broader mesh__D013653smesh__D046289
% 221.63/221.82  |- skos__annotation mesh__D013653
% 221.63/221.82       includes tattooing as body decoration among various cultures and as an aid in endoscopic procedures%A%  
% 221.63/221.82  |- skos__prefLabel mesh__D013653 Tattooing
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D007616 2003
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D007616 2006
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D007616 2000
% 221.63/221.82  |- rdf__type mesh__D007616sskos__Concept
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D007616 2005
% 221.63/221.82  |- skos__broader mesh__D007616smesh__D000538
% 221.63/221.82  |- mesh__recordMaintainer mesh__D007616 adp
% 221.63/221.82  |- mesh__recordAuthorizer mesh__D007616 sjn
% 221.63/221.82  |- skos__annotation mesh__D007616 an antidiarrheal   
% 221.63/221.82  |- skos__scopeNote mesh__D007616
% 221.63/221.82       The most common mineral of a group of hydrated aluminum silicates, approximately H2Al2Si2O8-H2O. It is prepared for pharmaceutical and medicinal purposes by levigating with water to remove sand, etc. %28%From Merck Index, 11th ed%29% The name is derived from Kao-ling %28%Chinese: %22%high ridge%22%%29%, the original site. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 221.63/221.82  |- mesh__recordOriginator mesh__D007616 NLM
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D007616 2002
% 221.63/221.82  |- mesh__dateRevised mesh__D007616 1999-11-03
% 221.63/221.82  |- mesh__dateCreated mesh__D007616 1999-01-01
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D007616 2004
% 221.63/221.82  |- skos__prefLabel mesh__D007616 Kaolin
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D007616 2001
% 221.63/221.82  |- skos__broader mesh__D017246smesh__D017240
% 221.63/221.82  |- skos__altLabel mesh__D017246 Graefe Disease
% 221.63/221.82  |- mesh__publicMeSHNote mesh__D017246 93   
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D017246 2005
% 221.63/221.82  |- skos__historyNote mesh__D017246 Mitochondria, Muscle %28%1972-1992%29%
% 221.63/221.82  |- skos__hiddenLabel mesh__D017246 External Ophthalmoplegia, Progressive
% 221.63/221.82  |- skos__prefLabel mesh__D017246
% 221.63/221.82       Ophthalmoplegia, Chronic Progressive External
% 221.63/221.82  |- skos__historyNote mesh__D017246 Ophthalmoplegia %28%1966-1992%29%
% 221.63/221.82  |- skos__hiddenLabel mesh__D017246 Progressive External Ophthalmoplegias
% 221.63/221.82  |- mesh__recordOriginator mesh__D017246 TGC
% 221.63/221.82  |- skos__hiddenLabel mesh__D017246 Dystrophies, Ocular Muscular
% 221.63/221.82  |- mesh__dateEstablished mesh__D017246 1993-01-01
% 221.63/221.82  |- skos__altLabel mesh__D017246 Graefe%27%s Disease
% 221.63/221.82  |- skos__altLabel mesh__D017246 Ocular Muscular Dystrophy
% 221.63/221.82  |- skos__annotation mesh__D017246
% 221.63/221.82       this opthalmoplegia with cardiomyopathy %26% retinitis pigmentosa = KEARNS SYNDROME; DF: note short X ref%A%  
% 221.63/221.82  |- skos__hiddenLabel mesh__D017246 Myopathies, Mitochondrial Ocular
% 221.63/221.82  |- skos__broader mesh__D017246smesh__D009886
% 221.63/221.82  |- skos__broader mesh__D017246smesh__D015835
% 221.63/221.82  |- skos__altLabel mesh__D017246 Ocular Myopathy of Von Graefe-Fuchs
% 221.63/221.82  |- mesh__dateRevised mesh__D017246 2001-07-25
% 221.63/221.82  |- skos__hiddenLabel mesh__D017246 Ocular Myopathies, Mitochondrial
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D017246 2004
% 221.63/221.82  |- skos__hiddenLabel mesh__D017246 Myopathy, Mitochondrial Ocular
% 221.63/221.82  |- skos__hiddenLabel mesh__D017246 Graefes Disease
% 221.63/221.82  |- mesh__dateCreated mesh__D017246 1992-05-22
% 221.63/221.82  |- skos__altLabel mesh__D017246 CPEO
% 221.63/221.82  |- skos__hiddenLabel mesh__D017246 Ocular Muscular Dystrophies
% 221.63/221.82  |- mesh__recordAuthorizer mesh__D017246 sjn
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D017246 2002
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D017246 2003
% 221.63/221.82  |- skos__hiddenLabel mesh__D017246 Muscular Dystrophy, Ocular
% 221.63/221.82  |- skos__hiddenLabel mesh__D017246 External Ophthalmoplegias, Progressive
% 221.63/221.82  |- skos__altLabel mesh__D017246 Ophthalmoplegia, Progressive External
% 221.63/221.82  |- skos__scopeNote mesh__D017246
% 221.63/221.82       A mitochondrial myopathy characterized by slowly progressive paralysis of the levator palpebrae, orbicularis oculi, and extraocular muscles. Ragged-red fibers and atrophy are found on muscle biopsy. Familial and sporadic forms may occur. Disease onset is usually in the first or second decade of life, and the illness slowly progresses until usually all ocular motility is lost. %28%From Adams et al., Principles of Neurology, 6th ed, p1422%29%%A%    
% 221.63/221.82  |- skos__altLabel mesh__D017246 Progressive External Ophthalmoplegia
% 221.63/221.82  |- mesh__historyNote mesh__D017246 93   
% 221.63/221.82  |- skos__altLabel mesh__D017246 Mitochondrial Ocular Myopathy
% 221.63/221.82  |- skos__hiddenLabel mesh__D017246 Ophthalmoplegias, Progressive External
% 221.63/221.82  |- skos__hiddenLabel mesh__D017246 Ocular Myopathy of Von Graefe Fuchs
% 221.63/221.82  |- skos__hiddenLabel mesh__D017246 Dystrophy, Ocular Muscular
% 221.63/221.82  |- mesh__recordMaintainer mesh__D017246 nns
% 221.63/221.82  |- skos__hiddenLabel mesh__D017246 Mitochondrial Ocular Myopathies
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D017246 2006
% 221.63/221.82  |- rdf__type mesh__D017246sskos__Concept
% 221.63/221.82  |- skos__historyNote mesh__D017246 DNA, Mitochondrial %28%1988-1992%29%
% 221.63/221.82  |- skos__hiddenLabel mesh__D017246 Muscular Dystrophies, Ocular
% 221.63/221.82  |- skos__hiddenLabel mesh__D017246 Ocular Myopathy, Mitochondrial
% 221.63/221.82  |- skos__hiddenLabel mesh__D017246 Disease, Graefe
% 221.63/221.82  |- mesh__dateRevised mesh__D003226 1999-11-03
% 221.63/221.82  |- skos__hiddenLabel mesh__D003226 Proceedings, Conference
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D003226 2002
% 221.63/221.82  |- mesh__dateCreated mesh__D003226 1999-01-01
% 221.63/221.82  |- skos__annotation mesh__D003226
% 221.63/221.82       Manual 35.8+; for congresses as a means of scientific communication; TN 112: INTERNATIONAL COOPERATION not for international congresses%A%  
% 221.63/221.82  |- mesh__recordOriginator mesh__D003226 NLM
% 221.63/221.82  |- skos__prefLabel mesh__D003226 Congresses
% 221.63/221.82  |- rdf__type mesh__D003226sskos__Concept
% 221.63/221.82  |- skos__altLabel mesh__D003226 Congresses and Conferences
% 221.63/221.82  |- mesh__historyNote mesh__D003226
% 221.63/221.82       CONFERENCES was see under CONGRESSES 1963-77   
% 221.63/221.82  |- mesh__recordMaintainer mesh__D003226 kle
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D003226 2000
% 221.63/221.82  |- mesh__recordAuthorizer mesh__D003226 sjn
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D003226 2003
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D003226 2001
% 221.63/221.82  |- mesh__onlineNote mesh__D003226
% 221.63/221.82       use CONGRESSES to search CONFERENCES 1966-77   
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D003226 2005
% 221.63/221.82  |- skos__scopeNote mesh__D003226
% 221.63/221.82       Conferences, conventions or formal meetings usually attended by delegates representing a special field of interest.%A%    
% 221.63/221.82  |- skos__broader mesh__D003226smesh__D009938
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D003226 2004
% 221.63/221.82  |- skos__hiddenLabel mesh__D003226 Proceedings and Conferences
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D003226 2006
% 221.63/221.82  |- skos__hiddenLabel mesh__D049328 Spot, Mongolian
% 221.63/221.82  |- skos__hiddenLabel mesh__D049328 Blue Spot, Mongolian
% 221.63/221.82  |- skos__related mesh__D049328smesh__D018329
% 221.63/221.82  |- skos__annotation mesh__D049328
% 221.63/221.82       coordinate IM with SKIN NEOPLASMS %28%IM%29% + site %28%IM or NIM%29% if relevant%A%  
% 221.63/221.82  |- mesh__recordMaintainer mesh__D049328 ags
% 221.63/221.82  |- skos__scopeNote mesh__D049328
% 221.63/221.82       A bluish-gray to gray-brown benign, melanocytic nevus found usually in the LUMBOSACRAL REGION of dark-skinned people, especially those of East Asian ancestry. It is usually congenital or appears shortly after birth, and disappears in childhood.%A%    
% 221.63/221.82  |- mesh__historyNote mesh__D049328 2005   
% 221.63/221.82  |- mesh__publicMeSHNote mesh__D049328 2005   
% 221.63/221.82  |- skos__historyNote mesh__D049328 Nevus, Pigmented %28%1969-2004%29%
% 221.63/221.82  |- mesh__dateCreated mesh__D049328 2004-07-07
% 221.63/221.82  |- skos__altLabel mesh__D049328 Mongolian Blue Spot
% 221.63/221.82  |- mesh__dateEstablished mesh__D049328 2005-01-01
% 221.63/221.82  |- skos__broader mesh__D049328smesh__D009508
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D049328 2005
% 221.63/221.82  |- rdf__type mesh__D049328sskos__Concept
% 221.63/221.82  |- skos__prefLabel mesh__D049328 Mongolian Spot
% 221.63/221.82  |- mesh__recordOriginator mesh__D049328 ags
% 221.63/221.82  |- mesh__activeMeSHYear mesh__D049328 2006
% 221.63/221.82  |- mesh__recordAuthorizer mesh__D049328 sjn
% 221.63/221.82  |- mesh__dateRevised mesh__D013654 2001-07-25
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D013654 2002
% 221.63/221.83  |- rdf__type mesh__D013654sskos__Concept
% 221.63/221.83  |- skos__broader mesh__D013654smesh__D017738
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D013654 2003
% 221.63/221.83  |- skos__prefLabel mesh__D013654 Taurine
% 221.63/221.83  |- skos__altLabel mesh__D013654 Taufon
% 221.63/221.83  |- mesh__recordOriginator mesh__D013654 NLM
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D013654 2004
% 221.63/221.83  |- mesh__recordAuthorizer mesh__D013654 sjn
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D013654 2005
% 221.63/221.83  |- mesh__recordMaintainer mesh__D013654 jmp
% 221.63/221.83  |- skos__annotation mesh__D013654 /biosyn /physiol permitted   
% 221.63/221.83  |- skos__altLabel mesh__D013654 Tauphon
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D013654 2006
% 221.63/221.83  |- mesh__dateCreated mesh__D013654 1999-01-01
% 221.63/221.83  |- skos__scopeNote mesh__D013654
% 221.63/221.83       A conditionally essential nutrient, important during mammalian development. It is present in milk but is isolated mostly from ox bile and strongly conjugates bile acids.%A%    
% 221.63/221.83  |- mesh__recordMaintainer mesh__D046030 ags
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D046030 2006
% 221.63/221.83  |- mesh__recordAuthorizer mesh__D046030 sjn
% 221.63/221.83  |- skos__historyNote mesh__D046030 Carnivora %28%1967-2004%29%
% 221.63/221.83  |- mesh__recordOriginator mesh__D046030 ags
% 221.63/221.83  |- skos__scopeNote mesh__D046030
% 221.63/221.83       Medium-sized terrestrial carnivores, in the genus Canis, family CANIDAE. Three species are recognized, two found only in Africa and one found in Africa, Europe, and Asia.%A%    
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D046030 2005
% 221.63/221.83  |- mesh__dateEstablished mesh__D046030 2005-01-01
% 221.63/221.83  |- rdf__type mesh__D046030sskos__Concept
% 221.63/221.83  |- skos__prefLabel mesh__D046030 Jackals
% 221.63/221.83  |- mesh__publicMeSHNote mesh__D046030 2005; see CARNIVORA 1998-2004   
% 221.63/221.83  |- skos__hiddenLabel mesh__D046030 Jackal
% 221.63/221.83  |- mesh__historyNote mesh__D046030 2005; use CARNIVORA 1998-2004   
% 221.63/221.83  |- skos__broader mesh__D046030smesh__D046028
% 221.63/221.83  |- mesh__dateCreated mesh__D046030 2004-07-07
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D007617 2006
% 221.63/221.83  |- skos__hiddenLabel mesh__D007617 Varicelliform Eruption, Kaposi
% 221.63/221.83  |- skos__hiddenLabel mesh__D007617 Kaposis Varicelliform Eruption
% 221.63/221.83  |- skos__hiddenLabel mesh__D007617 Eruption, Kaposi Varicelliform
% 221.63/221.83  |- rdf__type mesh__D007617sskos__Concept
% 221.63/221.83  |- skos__broader mesh__D007617smesh__D006561
% 221.63/221.83  |- mesh__publicMeSHNote mesh__D007617
% 221.63/221.83       98; was KAPOSI%27%S VARICELLIFORM ERUPTION 1963-97   
% 221.63/221.83  |- mesh__recordMaintainer mesh__D007617 ags
% 221.63/221.83  |- mesh__historyNote mesh__D007617
% 221.63/221.83       98; was KAPOSI%27%S VARICELLIFORM ERUPTION 1963-97   
% 221.63/221.83  |- skos__scopeNote mesh__D007617
% 221.63/221.83       A disseminated vesicular-pustular eruption caused by the herpes simplex virus %28%HERPESVIRUS HOMINIS%29%, the VACCINIA VIRUS, or Varicella zoster %28%HERPESVIRUS 3, HUMAN%29%. It is usually superimposed on a preexisting, inactive or active, atopic dermatitis %28%DERMATITIS, ATOPIC%29%.%A%    
% 221.63/221.83  |- skos__altLabel mesh__D007617 Kaposi%27%s Varicelliform Eruption
% 221.63/221.83  |- skos__prefLabel mesh__D007617 Kaposi Varicelliform Eruption
% 221.63/221.83  |- mesh__dateCreated mesh__D007617 1999-01-01
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D007617 2003
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D007617 2005
% 221.63/221.83  |- mesh__dateRevised mesh__D007617 2002-07-03
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D007617 2004
% 221.63/221.83  |- mesh__recordAuthorizer mesh__D007617 sjn
% 221.63/221.83  |- skos__hiddenLabel mesh__D007617 Varicelliform Eruption, Kaposi%27%s
% 221.63/221.83  |- skos__hiddenLabel mesh__D007617 Eruption, Kaposi%27%s Varicelliform
% 221.63/221.83  |- mesh__recordOriginator mesh__D007617 NLM
% 221.63/221.83  |- skos__hiddenLabel mesh__D017247 Therapy, Neutron Capturing
% 221.63/221.83  |- rdf__type mesh__D017247sskos__Concept
% 221.63/221.83  |- mesh__dateCreated mesh__D017247 1992-05-22
% 221.63/221.83  |- skos__historyNote mesh__D017247
% 221.63/221.83       Radiotherapy, High-Energy %28%1966-1992%29%
% 221.63/221.83  |- skos__prefLabel mesh__D017247 Neutron Capture Therapy
% 221.63/221.83  |- mesh__recordMaintainer mesh__D017247 lkt
% 221.63/221.83  |- mesh__dateRevised mesh__D017247 2005-06-30
% 221.63/221.83  |- skos__altLabel mesh__D017247 Therapy, Neutron Capture
% 221.63/221.83  |- mesh__historyNote mesh__D017247 93   
% 221.63/221.83  |- skos__historyNote mesh__D017247 Neutrons %28%1966-1992%29%
% 221.63/221.83  |- mesh__recordOriginator mesh__D017247 JLS
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D017247 2006
% 221.63/221.83  |- skos__altLabel mesh__D017247 Neutron Capturing Therapy
% 221.63/221.83  |- skos__scopeNote mesh__D017247
% 221.63/221.83       A technique for the treatment of neoplasms in which an isotope is introduced into target cells followed by irradiation with thermal neutrons.%A%    
% 221.63/221.83  |- skos__annotation mesh__D017247
% 221.63/221.83       do not use /util except by MeSH definition; coord IM with disease /radiother %28%IM%29%; DF: NCT%A%  
% 221.63/221.83  |- mesh__publicMeSHNote mesh__D017247 93   
% 221.63/221.83  |- mesh__dateEstablished mesh__D017247 1993-01-01
% 221.63/221.83  |- skos__broader mesh__D017247smesh__D011882
% 221.63/221.83  |- mesh__recordAuthorizer mesh__D017247 sjn
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D036401 2006
% 221.63/221.83  |- skos__hiddenLabel mesh__D036401 Test, Chronic Toxicity
% 221.63/221.83  |- skos__scopeNote mesh__D036401
% 221.63/221.83       Experiments designed to determine the potential toxic effects of a long-term exposure to a chemical or chemicals.%A%    
% 221.63/221.83  |- mesh__dateCreated mesh__D036401 2002-07-03
% 221.63/221.83  |- skos__altLabel mesh__D036401 Chronic Toxicity Tests
% 221.63/221.83  |- mesh__dateEstablished mesh__D036401 2003-01-01
% 221.63/221.83  |- rdf__type mesh__D036401sskos__Concept
% 221.63/221.83  |- skos__hiddenLabel mesh__D036401 Tests, Chronic Toxicity
% 221.63/221.83  |- mesh__publicMeSHNote mesh__D036401 2003   
% 221.63/221.83  |- mesh__historyNote mesh__D036401 2003   
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D036401 2003
% 221.63/221.83  |- skos__hiddenLabel mesh__D036401 Chronic Toxicity Test
% 221.63/221.83  |- skos__historyNote mesh__D036401 Toxicity Tests %28%1995-2002%29%
% 221.63/221.83  |- skos__broader mesh__D036401smesh__D018675
% 221.63/221.83  |- skos__hiddenLabel mesh__D036401 Toxicity Test, Chronic
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D036401 2004
% 221.63/221.83  |- skos__prefLabel mesh__D036401 Toxicity Tests, Chronic
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D036401 2005
% 221.63/221.83  |- mesh__dateCreated mesh__D003227 1999-01-01
% 221.63/221.83  |- mesh__recordOriginator mesh__D003227 NLM
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D003227 2006
% 221.63/221.83  |- mesh__dateEstablished mesh__D003227 1968-01-01
% 221.63/221.83  |- rdf__type mesh__D003227sskos__Concept
% 221.63/221.83  |- mesh__recordMaintainer mesh__D003227 ags
% 221.63/221.83  |- mesh__dateRevised mesh__D003227 2005-06-30
% 221.63/221.83  |- skos__broader mesh__D003227smesh__D011995
% 221.63/221.83  |- skos__altLabel mesh__D003227 Genetic Conjugation
% 221.63/221.83  |- skos__altLabel mesh__D003227 Conjugation, Bacterial
% 221.63/221.83  |- skos__historyNote mesh__D003227 Genetics %28%1966-1967%29%
% 221.63/221.83  |- mesh__publicMeSHNote mesh__D003227 68   
% 221.63/221.83  |- mesh__recordAuthorizer mesh__D003227 sjn
% 221.63/221.83  |- skos__scopeNote mesh__D003227
% 221.63/221.83       A parasexual process in BACTERIA; ALGAE; FUNGI; and ciliate PROTOZOA for achieving exchange of chromosome material during fusion of two cells. In bacteria, this is a uni-directional transfer of genetic material; in protozoa it is a bi-directional exchange. In algae and fungi, it is a form of sexual reproduction, with the union of male and female gametes.%A%    
% 221.63/221.83  |- mesh__historyNote mesh__D003227 68   
% 221.63/221.83  |- skos__prefLabel mesh__D003227 Conjugation, Genetic
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D008710 2005
% 221.63/221.83  |- skos__scopeNote mesh__D008710
% 221.63/221.83       A synthetic steroid that has been used for its anabolic action.%A%    
% 221.63/221.83  |- skos__prefLabel mesh__D008710 Methenolone
% 221.63/221.83  |- mesh__publicMeSHNote mesh__D008710 66   
% 221.63/221.83  |- skos__altLabel mesh__D008710 Metenolone
% 221.63/221.83  |- mesh__recordOriginator mesh__D008710 NLM
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D008710 2006
% 221.63/221.83  |- mesh__dateCreated mesh__D008710 1999-01-01
% 221.63/221.83  |- mesh__recordAuthorizer mesh__D008710 sjn
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D008710 2004
% 221.63/221.83  |- mesh__historyNote mesh__D008710 66   
% 221.63/221.83  |- mesh__dateRevised mesh__D008710 2003-07-09
% 221.63/221.83  |- mesh__recordMaintainer mesh__D008710 lkt
% 221.63/221.83  |- mesh__dateEstablished mesh__D008710 1966-01-01
% 221.63/221.83  |- rdf__type mesh__D008710sskos__Concept
% 221.63/221.83  |- skos__broader mesh__D008710smesh__D013739
% 221.63/221.83  |- skos__broader mesh__D049329smesh__D008420
% 221.63/221.83  |- mesh__publicMeSHNote mesh__D049329 2005   
% 221.63/221.83  |- mesh__dateCreated mesh__D049329 2004-07-07
% 221.63/221.83  |- mesh__recordAuthorizer mesh__D049329 sjn
% 221.63/221.83  |- skos__hiddenLabel mesh__D049329 Nanoparticle
% 221.63/221.83  |- skos__related mesh__D049329smesh__D036103
% 221.63/221.83  |- skos__scopeNote mesh__D049329 Nanometer-sized objects.     
% 221.63/221.83  |- mesh__historyNote mesh__D049329 2005   
% 221.63/221.83  |- mesh__recordMaintainer mesh__D049329 ssb
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D049329 2005
% 221.63/221.83  |- rdf__type mesh__D049329sskos__Concept
% 221.63/221.83  |- skos__hiddenLabel mesh__D049329 Nanostructure
% 221.63/221.83  |- skos__prefLabel mesh__D049329 Nanostructures
% 221.63/221.83  |- mesh__dateEstablished mesh__D049329 2005-01-01
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D049329 2006
% 221.63/221.83  |- skos__historyNote mesh__D049329 Nanotechnology %28%2002-2004%29%
% 221.63/221.83  |- mesh__recordOriginator mesh__D049329 ssb
% 221.63/221.83  |- skos__broader mesh__D019805Q000031smesh__D019805
% 221.63/221.83  |- mesh__preferredCombination mesh__D019805Q000031smesh__D008781
% 221.63/221.83  |- rdf__type mesh__D019805Q000031smesh__CompoundConcept
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D013655 2006
% 221.63/221.83  |- mesh__recordMaintainer mesh__D013655 CCR
% 221.63/221.83  |- skos__historyNote mesh__D013655 Taurine %28%1966-1972%29%
% 221.63/221.83  |- skos__scopeNote mesh__D013655
% 221.63/221.83       A bile salt formed in the liver by conjugation of chenodeoxycholate with taurine, usually as the sodium salt. It acts as detergent to solubilize fats in the small intestine and is itself absorbed. It is used as a cholagogue and choleretic.%A%    
% 221.63/221.83  |- rdf__type mesh__D013655sskos__Concept
% 221.63/221.83  |- skos__prefLabel mesh__D013655 Taurochenodeoxycholic Acid
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D013655 2002
% 221.63/221.83  |- mesh__recordOriginator mesh__D013655 SH
% 221.63/221.83  |- mesh__dateCreated mesh__D013655 1977-03-04
% 221.63/221.83  |- mesh__historyNote mesh__D013655
% 221.63/221.83       91%28%78%29%; was see under CHENODEOXYCHOLIC ACID 1978-90   
% 221.63/221.83  |- skos__broader mesh__D013655smesh__D013657
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D013655 2003
% 221.63/221.83  |- mesh__dateRevised mesh__D013655 2000-06-21
% 221.63/221.83  |- mesh__recordAuthorizer mesh__D013655 sjn
% 221.63/221.83  |- skos__altLabel mesh__D013655 Chenodeoxycholyltaurine
% 221.63/221.83  |- mesh__dateEstablished mesh__D013655 1991-01-01
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D013655 2004
% 221.63/221.83  |- skos__hiddenLabel mesh__D013655 Chenodeoxycholate, Taurine
% 221.63/221.83  |- skos__broader mesh__D013655smesh__D002635
% 221.63/221.83  |- mesh__publicMeSHNote mesh__D013655
% 221.63/221.83       91; was see under CHENODEOXYCHOLIC ACID 1978-90   
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D013655 2005
% 221.63/221.83  |- skos__historyNote mesh__D013655 Chenodeoxycholic Acid %28%1973-1977%29%
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D013655 2001
% 221.63/221.83  |- skos__annotation mesh__D013655 /biosyn /physiol permitted   
% 221.63/221.83  |- skos__historyNote mesh__D013655 Taurocholic Acid %28%1973-1977%29%
% 221.63/221.83  |- skos__hiddenLabel mesh__D013655 Acid, Taurochenodeoxycholic
% 221.63/221.83  |- skos__historyNote mesh__D013655 Bile Acids and Salts %28%1966-1972%29%
% 221.63/221.83  |- skos__altLabel mesh__D013655 Taurochenodeoxycholate
% 221.63/221.83  |- skos__annotation mesh__D046031 do not confuse with RACCOONS   
% 221.63/221.83  |- rdf__type mesh__D046031sskos__Concept
% 221.63/221.83  |- mesh__recordOriginator mesh__D046031 ags
% 221.63/221.83  |- skos__hiddenLabel mesh__D046031 Raccoon Dog
% 221.63/221.83  |- mesh__recordAuthorizer mesh__D046031 sjn
% 221.63/221.83  |- skos__hiddenLabel mesh__D046031 Dogs, Raccoon
% 221.63/221.83  |- mesh__dateEstablished mesh__D046031 2005-01-01
% 221.63/221.83  |- mesh__historyNote mesh__D046031
% 221.63/221.83       2005; use CARNIVORA 1990-2004; for NYCTEREUTES use CARNIVORA 1998-2004%A%  
% 221.63/221.83  |- skos__altLabel mesh__D046031 Nyctereutes procyonoides
% 221.63/221.83  |- mesh__dateCreated mesh__D046031 2004-07-07
% 221.63/221.83  |- mesh__publicMeSHNote mesh__D046031
% 221.63/221.83       2005; see CARNIVORA 1990-2004; for NYCTEREUTES see CARNIVORA 1998-2004%A%  
% 221.63/221.83  |- skos__historyNote mesh__D046031 Carnivora %28%1974-2004%29%
% 221.63/221.83  |- skos__hiddenLabel mesh__D046031 Dog, Raccoon
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D046031 2006
% 221.63/221.83  |- mesh__recordMaintainer mesh__D046031 ags
% 221.63/221.83  |- skos__scopeNote mesh__D046031
% 221.63/221.83       The lone species in the genus Nyctereutes, family CANIDAE. It is found in the woodland zone from southeastern Siberia to Vietnam and on the main islands of Japan.%A%    
% 221.63/221.83  |- skos__prefLabel mesh__D046031 Raccoon Dogs
% 221.63/221.83  |- skos__broader mesh__D046031smesh__D046028
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D046031 2005
% 221.63/221.83  |- skos__broader mesh__D005340Q000172smesh__D005340
% 221.63/221.83  |- mesh__preferredCombination mesh__D005340Q000172smesh__D000347
% 221.63/221.83  |- rdf__type mesh__D005340Q000172smesh__CompoundConcept
% 221.63/221.83  |- skos__broader mesh__D007618smesh__D011134
% 221.63/221.83  |- mesh__recordAuthorizer mesh__D007618 sjn
% 221.63/221.83  |- skos__prefLabel mesh__D007618 Karaya Gum
% 221.63/221.83  |- skos__altLabel mesh__D007618 Gum Karaya
% 221.63/221.83  |- skos__hiddenLabel mesh__D007618 Karaya, Gum
% 221.63/221.83  |- skos__broader mesh__D007618smesh__D010936
% 221.63/221.83  |- skos__hiddenLabel mesh__D007618 Gum, Karaya
% 221.63/221.83  |- skos__scopeNote mesh__D007618
% 221.63/221.83       Polysaccharide gum from Sterculia urens %28%STERCULIA%29%.  It is used as a suspending or stabilizing agent in foods, cosmetics and pharmaceuticals; a bulk-forming laxative; a surgical lubricant and adhesive; and in the treatment of skin ulcers.%A%    
% 221.63/221.83  |- mesh__publicMeSHNote mesh__D007618
% 221.63/221.83       91; was see under POLYSACCHARIDES 1978-90   
% 221.63/221.83  |- mesh__recordMaintainer mesh__D007618 ssb
% 221.63/221.83  |- skos__historyNote mesh__D007618 Polysaccharides %28%1966-1977%29%
% 221.63/221.83  |- skos__altLabel mesh__D007618 Tragacanth, Indian
% 221.63/221.83  |- skos__broader mesh__D007618smesh__D001704
% 221.63/221.83  |- mesh__recordOriginator mesh__D007618 SH
% 221.63/221.83  |- mesh__dateCreated mesh__D007618 1977-03-01
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D007618 2006
% 221.63/221.83  |- mesh__dateRevised mesh__D007618 2005-06-30
% 221.63/221.83  |- skos__historyNote mesh__D007618 Resins %28%1966-1977%29%
% 221.63/221.83  |- mesh__dateEstablished mesh__D007618 1991-01-01
% 221.63/221.83  |- rdf__type mesh__D007618sskos__Concept
% 221.63/221.83  |- skos__hiddenLabel mesh__D007618 Indian Tragacanth
% 221.63/221.83  |- mesh__historyNote mesh__D007618
% 221.63/221.83       91%28%78%29%; was see under POLYSACCHARIDES 1978-90   
% 221.63/221.83  |- mesh__recordAuthorizer mesh__D018340 sjn
% 221.63/221.83  |- skos__hiddenLabel mesh__D018340 Adrenergic alpha 1 Receptors
% 221.63/221.83  |- skos__altLabel mesh__D018340 alpha 1 Adrenergic Receptor
% 221.63/221.83  |- skos__hiddenLabel mesh__D018340 alpha-1 Receptors, Adrenergic
% 221.63/221.83  |- skos__altLabel mesh__D018340 Adrenergic Receptor, alpha-1
% 221.63/221.83  |- skos__broader mesh__D018340smesh__D011942
% 221.63/221.83  |- skos__hiddenLabel mesh__D018340 Adrenergic Receptors, alpha-1
% 221.63/221.83  |- skos__hiddenLabel mesh__D018340 Adrenergic Receptor, alpha 1
% 221.63/221.83  |- mesh__historyNote mesh__D018340 94   
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D018340 2006
% 221.63/221.83  |- mesh__recordMaintainer mesh__D018340 jmp
% 221.63/221.83  |- skos__altLabel mesh__D018340 alpha-1 Adrenergic Receptors
% 221.63/221.83  |- skos__altLabel mesh__D018340 Receptors, alpha-1 Adrenergic
% 221.63/221.83  |- skos__altLabel mesh__D018340 Receptor, Adrenergic, alpha-1
% 221.63/221.83  |- skos__altLabel mesh__D018340 Adrenergic alpha-1 Receptors
% 221.63/221.83  |- mesh__publicMeSHNote mesh__D018340 94   
% 221.63/221.83  |- skos__prefLabel mesh__D018340 Receptors, Adrenergic, alpha-1
% 221.63/221.83  |- skos__historyNote mesh__D018340
% 221.63/221.83       Receptors, Adrenergic, alpha %28%1977-1993%29%
% 221.63/221.83  |- rdf__type mesh__D018340sskos__Concept
% 221.63/221.83  |- skos__scopeNote mesh__D018340
% 221.63/221.83       A subclass of alpha-adrenergic receptors %28%RECEPTORS, ADRENERGIC, ALPHA%29%. alpha-1 Adrenergic receptors can be pharmacologically discriminated, e.g., by their high affinity for the agonist phenylephrine and the antagonist prazosin. They are widespread, with clinically important concentrations in the liver, the heart, vascular, intestinal, and genitourinary smooth muscle, and the central and peripheral nervous systems.%A%    
% 221.63/221.83  |- skos__hiddenLabel mesh__D018340 Receptor, alpha-1 Adrenergic
% 221.63/221.83  |- skos__hiddenLabel mesh__D018340 alpha 1 Adrenergic Receptors
% 221.63/221.83  |- skos__hiddenLabel mesh__D018340 alpha-1 Adrenergic Receptor
% 221.63/221.83  |- skos__hiddenLabel mesh__D018340 Receptors, alpha 1 Adrenergic
% 221.63/221.83  |- skos__hiddenLabel mesh__D018340 Receptors, Adrenergic alpha-1
% 221.63/221.83  |- mesh__dateCreated mesh__D018340 1993-06-16
% 221.63/221.83  |- mesh__dateRevised mesh__D018340 2005-06-30
% 221.63/221.83  |- mesh__dateEstablished mesh__D018340 1994-01-01
% 221.63/221.83  |- mesh__recordOriginator mesh__D018340 TPW
% 221.63/221.83  |- skos__broader mesh__D004320smesh__D017205
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D004320 2003
% 221.63/221.83  |- mesh__dateRevised mesh__D004320 2005-07-13
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D004320 2006
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D004320 1994
% 221.63/221.83  |- skos__hiddenLabel mesh__D004320 Infection, Guinea Worm
% 221.63/221.83  |- mesh__publicMeSHNote mesh__D004320 93; was DRACUNCULOSIS 1963-92   
% 221.63/221.83  |- mesh__recordOriginator mesh__D004320 NLM
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D004320 2004
% 221.63/221.83  |- skos__altLabel mesh__D004320 Dracunculosis
% 221.63/221.83  |- skos__hiddenLabel mesh__D004320 Dracunculiases
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D004320 1995
% 221.63/221.83  |- skos__prefLabel mesh__D004320 Dracunculiasis
% 221.63/221.83  |- skos__altLabel mesh__D004320 Guinea Worm Infection
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D004320 2006A
% 221.63/221.83  |- mesh__onlineNote mesh__D004320
% 221.63/221.83       use DRACUNCULIASIS to search DRACUNCULOSIS 1966-92   
% 221.63/221.83  |- rdf__type mesh__D004320sskos__Concept
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D004320 1998
% 221.63/221.83  |- skos__scopeNote mesh__D004320
% 221.63/221.83       Infection with nematodes of the genus Dracunculus. One or more worms may be seen at a time, with the legs and feet being the most commonly infected areas. Symptoms include pruritus, nausea, vomiting, diarrhea, or asthmatic attacks.%A%    
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D004320 2000
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D004320 2001
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D004320 1996
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D004320 1999
% 221.63/221.83  |- mesh__historyNote mesh__D004320 93; was DRACUNCULOSIS 1963-92   
% 221.63/221.83  |- mesh__recordMaintainer mesh__D004320 ags
% 221.63/221.83  |- mesh__dateCreated mesh__D004320 1999-01-01
% 221.63/221.83  |- skos__annotation mesh__D004320 nematode infect   
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D004320 2005
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D004320 2002
% 221.63/221.83  |- mesh__recordAuthorizer mesh__D004320 ags
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D004320 1997
% 221.63/221.83  |- skos__hiddenLabel mesh__D004320 Dracunculoses
% 221.63/221.83  |- skos__broader mesh__D011950Q000819smesh__D011950
% 221.63/221.83  |- mesh__preferredCombination mesh__D011950Q000819smesh__D018679
% 221.63/221.83  |- rdf__type mesh__D011950Q000819smesh__CompoundConcept
% 221.63/221.83  |- skos__prefLabel mesh__D017248 Enzyme Multiplied Immunoassay Technique
% 221.63/221.83  |- mesh__publicMeSHNote mesh__D017248 93   
% 221.63/221.83  |- mesh__dateEstablished mesh__D017248 1993-01-01
% 221.63/221.83  |- skos__historyNote mesh__D017248
% 221.63/221.83       Immunoenzyme Techniques %28%1976-1992%29%
% 221.63/221.83  |- mesh__recordAuthorizer mesh__D017248 sjn
% 221.63/221.83  |- mesh__dateCreated mesh__D017248 1992-05-08
% 221.63/221.83  |- mesh__dateRevised mesh__D017248 2001-07-25
% 221.63/221.83  |- skos__annotation mesh__D017248 DF: EMIT   
% 221.63/221.83  |- mesh__recordMaintainer mesh__D017248 ssb
% 221.63/221.83  |- skos__broader mesh__D017248smesh__D007124
% 221.63/221.83  |- mesh__historyNote mesh__D017248 93   
% 221.63/221.83  |- skos__scopeNote mesh__D017248
% 221.63/221.83       An immunoenzyme test for the presence of drugs and other substances in urine and blood. The test uses enzyme linked antibodies that react only with the particular drug for which the sample is being tested.%A%    
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D017248 2006
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D017248 2002
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D017248 2004
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D017248 2005
% 221.63/221.83  |- mesh__recordOriginator mesh__D017248 TGC
% 221.63/221.83  |- rdf__type mesh__D017248sskos__Concept
% 221.63/221.83  |- skos__related mesh__D017248smesh__D015813
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D017248 2003
% 221.63/221.83  |- skos__scopeNote mesh__D003228
% 221.63/221.83       The mucous membrane that lines the inner surface of the eyelids and the anterior part of the sclera.%A%    
% 221.63/221.83  |- mesh__recordOriginator mesh__D003228 NLM
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D003228 2002
% 221.63/221.83  |- mesh__dateRevised mesh__D003228 1999-11-03
% 221.63/221.83  |- skos__broader mesh__D003228smesh__D005123
% 221.63/221.83  |- skos__prefLabel mesh__D003228 Conjunctiva
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D003228 2003
% 221.63/221.83  |- mesh__recordMaintainer mesh__D003228 KEV
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D003228 2000
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D003228 2005
% 221.63/221.83  |- mesh__recordAuthorizer mesh__D003228 sjn
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D003228 2004
% 221.63/221.83  |- skos__annotation mesh__D003228
% 221.63/221.83       inflammation = CONJUNCTIVITIS %28%consider also KERATOCONJUNCTIVITIS%29%; do not confuse with %22%conjunctive tissue%22% in poorly translated texts %28%as for French %22%tissu conjonctif%22%%29%: this is CONNECTIVE TISSUE, not CONJUNCTIVA; /blood supply consider also CILIARY ARTERIES%A%  
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D003228 2001
% 221.63/221.83  |- mesh__dateCreated mesh__D003228 1999-01-01
% 221.63/221.83  |- skos__hiddenLabel mesh__D003228 Conjunctivas
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D003228 2006
% 221.63/221.83  |- rdf__type mesh__D003228sskos__Concept
% 221.63/221.83  |- mesh__dateRevised mesh__D008711 2005-07-01
% 221.63/221.83  |- skos__altLabel mesh__D008711 Teofarma Brand of Metergoline
% 221.63/221.83  |- skos__hiddenLabel mesh__D008711 Metergoline Teofarma Brand
% 221.63/221.83  |- mesh__dateCreated mesh__D008711 1974-11-19
% 221.63/221.83  |- rdf__type mesh__D008711sskos__Concept
% 221.63/221.83  |- mesh__publicMeSHNote mesh__D008711
% 221.63/221.83       2002; see METHERGOLINE 1991-2001, see ERGOLINES 1975-1990%A%  
% 221.63/221.83  |- skos__historyNote mesh__D008711 Ergolines %28%1971-1974%29%
% 221.63/221.83  |- mesh__recordMaintainer mesh__D008711 sjn
% 221.63/221.83  |- mesh__recordOriginator mesh__D008711 NLM
% 221.63/221.83  |- mesh__historyNote mesh__D008711 2002%28%1975%29%   
% 221.63/221.83  |- skos__scopeNote mesh__D008711
% 221.63/221.83       A dopamine agonist and serotonin antagonist. It has been used similarly to BROMOCRIPTINE as a dopamine agonist and also for MIGRAINE DISORDERS therapy.%A%    
% 221.63/221.83  |- mesh__dateEstablished mesh__D008711 1991-01-01
% 221.63/221.83  |- skos__broader mesh__D008711smesh__D004873
% 221.63/221.83  |- mesh__recordAuthorizer mesh__D008711 sjn
% 221.63/221.83  |- skos__prefLabel mesh__D008711 Metergoline
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D008711 2006
% 221.63/221.83  |- skos__altLabel mesh__D008711 Methergoline
% 221.63/221.83  |- rdf__type mesh__D046830sskos__Concept
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D046830 2005
% 221.63/221.83  |- skos__broader mesh__D046830smesh__D010942
% 221.63/221.83  |- mesh__recordMaintainer mesh__D046830 ags
% 221.63/221.83  |- skos__prefLabel mesh__D046830 Tymoviridae
% 221.63/221.83  |- mesh__historyNote mesh__D046830 2005   
% 221.63/221.83  |- mesh__publicMeSHNote mesh__D046830 2005   
% 221.63/221.83  |- skos__hiddenLabel mesh__D046830 Maculaviruses
% 221.63/221.83  |- mesh__recordAuthorizer mesh__D046830 sjn
% 221.63/221.83  |- mesh__recordOriginator mesh__D046830 ags
% 221.63/221.83  |- skos__hiddenLabel mesh__D046830 Marafiviruses
% 221.63/221.83  |- skos__scopeNote mesh__D046830
% 221.63/221.83       A family of icosahedral, non-enveloped, RNA plant viruses comprised of three genera: TYMOVIRUS, Marafivirus and Maculavirus.%A%    
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D046830 2006
% 221.63/221.83  |- mesh__dateEstablished mesh__D046830 2005-01-01
% 221.63/221.83  |- skos__broader mesh__D046830smesh__D012328
% 221.63/221.83  |- mesh__dateCreated mesh__D046830 2004-07-07
% 221.63/221.83  |- skos__broader mesh__D013656smesh__D013654
% 221.63/221.83  |- skos__historyNote mesh__D013656 Bile Acids and Salts %28%1966-1972%29%
% 221.63/221.83  |- mesh__historyNote mesh__D013656 74%28%73%29%   
% 221.63/221.83  |- skos__hiddenLabel mesh__D013656 Taurocholate, Sodium
% 221.63/221.83  |- skos__altLabel mesh__D013656 Cholyltaurine
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D013656 2006
% 221.63/221.83  |- rdf__type mesh__D013656sskos__Concept
% 221.63/221.83  |- skos__altLabel mesh__D013656 Taurine Cholate
% 221.63/221.83  |- skos__prefLabel mesh__D013656 Taurocholic Acid
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D013656 2005
% 221.63/221.83  |- skos__altLabel mesh__D013656 Taurocholate Sodium
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D013656 2004
% 221.63/221.83  |- skos__altLabel mesh__D013656 Sodium Taurocholate
% 221.63/221.83  |- mesh__dateEstablished mesh__D013656 1974-01-01
% 221.63/221.83  |- mesh__dateCreated mesh__D013656 1999-01-01
% 221.63/221.83  |- mesh__recordOriginator mesh__D013656 NLM
% 221.63/221.83  |- skos__broader mesh__D013656smesh__D002793
% 221.63/221.83  |- skos__historyNote mesh__D013656 Taurine %28%1966-1972%29%
% 221.63/221.83  |- mesh__publicMeSHNote mesh__D013656 74   
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D013656 2003
% 221.63/221.83  |- mesh__dateRevised mesh__D013656 2001-07-25
% 221.63/221.83  |- mesh__recordAuthorizer mesh__D013656 sjn
% 221.63/221.83  |- mesh__recordMaintainer mesh__D013656 jmp
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D013656 2002
% 221.63/221.83  |- skos__scopeNote mesh__D013656
% 221.63/221.83       The product of conjugation of cholic acid with taurine. Its sodium salt is the chief ingredient of the bile of carnivorous animals. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and cholerectic.%A%    
% 221.63/221.83  |- skos__annotation mesh__D013656 /biosyn /physiol permitted   
% 221.63/221.83  |- skos__historyNote mesh__D046032 Microscopy, Electron %28%1993-2004%29%
% 221.63/221.83  |- skos__scopeNote mesh__D046032
% 221.63/221.83       An analytical transmission electron microscopy method using an electron microscope fitted with an energy filtering lens. The method is based on the principle that some of the ELECTRONS passing through the specimen will lose energy when they ionize inner shell electrons of the atoms in the specimen. The amount of energy loss is dependent upon the element. Analysis of the energy loss spectrum %28%ELECTRON ENERGY-LOSS SPECTROSCOPY%29% reveals the elemental composition of a specimen. It is used analytically and quantitatively to determine which, how much of, and where specific ELEMENTS are in a sample. For example, it is used for elemental mapping of PHOSPHORUS to trace the strands of NUCLEIC ACIDS in nucleoprotein complexes.%A%    
% 221.63/221.83  |- skos__hiddenLabel mesh__D046032
% 221.63/221.83       Energy Filtering Transmission Electron Microscopy
% 221.63/221.83  |- skos__altLabel mesh__D046032
% 221.63/221.83       Energy-Filtered Transmission Electron Microscopy
% 221.63/221.83  |- mesh__publicMeSHNote mesh__D046032 2005   
% 221.63/221.83  |- skos__hiddenLabel mesh__D046032
% 221.63/221.83       Energy Filtered Transmission Electron Microscopy
% 221.63/221.83  |- mesh__dateCreated mesh__D046032 2004-07-07
% 221.63/221.83  |- mesh__recordAuthorizer mesh__D046032 ags
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D046032 2006
% 221.63/221.83  |- skos__broader mesh__D046032smesh__D046529
% 221.63/221.83  |- skos__hiddenLabel mesh__D046032 Imaging, Electron Spectroscopic
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D046032 2005
% 221.63/221.83  |- skos__hiddenLabel mesh__D046032
% 221.63/221.83       Microscopy, Energy Filtering Transmission Electron
% 221.63/221.83  |- skos__broader mesh__D046032smesh__D046590
% 221.63/221.83  |- mesh__dateRevised mesh__D046032 2005-07-21
% 221.63/221.83  |- skos__altLabel mesh__D046032 EFTEM
% 221.63/221.83  |- skos__altLabel mesh__D046032 EF-TEM
% 221.63/221.83  |- mesh__recordMaintainer mesh__D046032 ags
% 221.63/221.83  |- skos__altLabel mesh__D046032 Energy-Filtered TEM
% 221.63/221.83  |- skos__hiddenLabel mesh__D046032 Spectroscopic Imaging, Electron
% 221.63/221.83  |- mesh__dateEstablished mesh__D046032 2005-01-01
% 221.63/221.83  |- mesh__recordOriginator mesh__D046032 nns
% 221.63/221.83  |- skos__altLabel mesh__D046032 Electron Spectroscopic Imaging
% 221.63/221.83  |- mesh__historyNote mesh__D046032 2005   
% 221.63/221.83  |- mesh__activeMeSHYear mesh__D046032 2006A
% 221.63/221.83  |- rdf__type mesh__D046032sskos__Concept
% 221.63/221.83  |- skos__prefLabel mesh__D046032
% 221.63/221.83       Microscopy, Energy-Filtering Transmission Electron
% 221.63/221.83  |- skos__hiddenLabel mesh__D046032 Energy Filtered TEM
% 221.63/221.84  |- skos__hiddenLabel mesh__D046032 TEM, Energy-Filtered
% 221.63/221.84  |- skos__altLabel mesh__D046032
% 221.63/221.84       Energy-Filtering Transmission Electron Microscopy
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D007619 2003
% 221.63/221.84  |- skos__hiddenLabel mesh__D007619 Syndromes, Kartagener
% 221.63/221.84  |- mesh__historyNote mesh__D007619
% 221.63/221.84       2002 %28%1963%29%; for CILARY DYSKINESIA, PRIMARY use CILIARY MOTILITY DISORDERS 1992-2001%A%  
% 221.63/221.84  |- skos__hiddenLabel mesh__D007619 Triads, Kartagener
% 221.63/221.84  |- skos__hiddenLabel mesh__D007619 Triad, Kartagener%27%s
% 221.63/221.84  |- skos__hiddenLabel mesh__D007619 Kartageners Triad
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D007619 2005
% 221.63/221.84  |- skos__hiddenLabel mesh__D007619 Syndrome, Kartagener%27%s
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D007619 2004
% 221.63/221.84  |- skos__broader mesh__D007619smesh__D003914
% 221.63/221.84  |- skos__hiddenLabel mesh__D007619 Syndrome, Kartagener
% 221.63/221.84  |- skos__hiddenLabel mesh__D007619 Kartagener Syndromes
% 221.63/221.84  |- skos__altLabel mesh__D007619 Kartagener Triad
% 221.63/221.84  |- skos__scopeNote mesh__D007619
% 221.63/221.84       An autosomal recessive disorder characterized by BRONCHIECTASIS; SINUSITIS; DEXTROCARDIA; and INFERTILITY. In vitro studies of tissues from these patients, have shown various patterns of abnormal ciliary beating. %28%Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/OMIM, MIM %23% 244400, April 24, 2001%29%%A%    
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D007619 2002
% 221.63/221.84  |- mesh__publicMeSHNote mesh__D007619
% 221.63/221.84       2002; see KARTAGENER%27%S SYNDROME 1990-2001; see KARTAGENER TRIAD 1963-1989; for CILARY DYSKINESIA, PRIMARY see CILIARY MOTILITY DISORDERS 1992-2001%A%  
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D007619 2006
% 221.63/221.84  |- skos__prefLabel mesh__D007619 Kartagener Syndrome
% 221.63/221.84  |- mesh__recordAuthorizer mesh__D007619 sjn
% 221.63/221.84  |- skos__hiddenLabel mesh__D007619 Dyskinesias, Primary Ciliary
% 221.63/221.84  |- skos__broader mesh__D007619smesh__D030342
% 221.63/221.84  |- skos__broader mesh__D007619smesh__D001987
% 221.63/221.84  |- rdf__type mesh__D007619sskos__Concept
% 221.63/221.84  |- skos__hiddenLabel mesh__D007619 Triad, Kartagener
% 221.63/221.84  |- skos__hiddenLabel mesh__D007619 Primary Ciliary Dyskinesia
% 221.63/221.84  |- mesh__recordOriginator mesh__D007619 NLM
% 221.63/221.84  |- skos__hiddenLabel mesh__D007619 Ciliary Dyskinesias, Primary
% 221.63/221.84  |- skos__hiddenLabel mesh__D007619 Kartageners Syndrome
% 221.63/221.84  |- skos__hiddenLabel mesh__D007619 Dyskinesia, Primary Ciliary
% 221.63/221.84  |- skos__broader mesh__D007619smesh__D002925
% 221.63/221.84  |- skos__broader mesh__D007619smesh__D015619
% 221.63/221.84  |- skos__hiddenLabel mesh__D007619 Primary Ciliary Dyskinesias
% 221.63/221.84  |- skos__hiddenLabel mesh__D007619 Kartagener Triads
% 221.63/221.84  |- skos__altLabel mesh__D007619 Kartagener%27%s Triad
% 221.63/221.84  |- mesh__dateCreated mesh__D007619 1999-01-01
% 221.63/221.84  |- skos__altLabel mesh__D007619 Ciliary Dyskinesia, Primary
% 221.63/221.84  |- mesh__recordMaintainer mesh__D007619 nns
% 221.63/221.84  |- mesh__dateRevised mesh__D007619 2001-07-25
% 221.63/221.84  |- skos__altLabel mesh__D007619 Kartagener%27%s Syndrome
% 221.63/221.84  |- mesh__historyNote mesh__D018341 94   
% 221.63/221.84  |- mesh__dateEstablished mesh__D018341 1994-01-01
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D018341 2006
% 221.63/221.84  |- mesh__recordOriginator mesh__D018341 TPW
% 221.63/221.84  |- skos__altLabel mesh__D018341 Receptors, alpha-2 Adrenergic
% 221.63/221.84  |- mesh__recordMaintainer mesh__D018341 jmp
% 221.63/221.84  |- skos__scopeNote mesh__D018341
% 221.63/221.84       A subclass of alpha-adrenergic receptors %28%RECEPTORS, ADRENERGIC, ALPHA%29%. alpha-2 Adrenergic receptors can be pharmacologically discriminated, e.g., by their high affinity for the agonist clonidine and the antagonist yohimbine. They are found on pancreatic beta cells, platelets, and vascular smooth muscle, as well as both pre- and postsynaptically in the central and peripheral nervous systems.%A%    
% 221.63/221.84  |- mesh__recordAuthorizer mesh__D018341 sjn
% 221.63/221.84  |- skos__hiddenLabel mesh__D018341 Receptors, alpha 2 Adrenergic
% 221.63/221.84  |- skos__hiddenLabel mesh__D018341 Adrenergic Receptors, alpha-2
% 221.63/221.84  |- skos__historyNote mesh__D018341
% 221.63/221.84       Receptors, Adrenergic, alpha %28%1977-1993%29%
% 221.63/221.84  |- skos__hiddenLabel mesh__D018341 Adrenergic Receptor, alpha 2
% 221.63/221.84  |- skos__prefLabel mesh__D018341 Receptors, Adrenergic, alpha-2
% 221.63/221.84  |- rdf__type mesh__D018341sskos__Concept
% 221.63/221.84  |- skos__hiddenLabel mesh__D018341 alpha-2 Receptors, Adrenergic
% 221.63/221.84  |- skos__broader mesh__D018341smesh__D011942
% 221.63/221.84  |- skos__hiddenLabel mesh__D018341 Adrenergic alpha 2 Receptors
% 221.63/221.84  |- skos__altLabel mesh__D018341 alpha-2 Adrenergic Receptors
% 221.63/221.84  |- mesh__publicMeSHNote mesh__D018341 94   
% 221.63/221.84  |- skos__altLabel mesh__D018341 Adrenergic Receptor, alpha-2
% 221.63/221.84  |- skos__hiddenLabel mesh__D018341 Receptors, Adrenergic alpha-2
% 221.63/221.84  |- skos__hiddenLabel mesh__D018341 Receptor, alpha-2 Adrenergic
% 221.63/221.84  |- mesh__dateCreated mesh__D018341 1993-06-21
% 221.63/221.84  |- skos__altLabel mesh__D018341 alpha 2 Adrenergic Receptors
% 221.63/221.84  |- skos__altLabel mesh__D018341 Receptor, Adrenergic, alpha-2
% 221.63/221.84  |- skos__hiddenLabel mesh__D018341 alpha-2 Adrenergic Receptor
% 221.63/221.84  |- skos__altLabel mesh__D018341 Adrenergic alpha-2 Receptors
% 221.63/221.84  |- mesh__dateRevised mesh__D018341 2005-06-30
% 221.63/221.84  |- skos__prefLabel mesh__D004321 Dracunculus Nematode
% 221.63/221.84  |- mesh__publicMeSHNote mesh__D004321
% 221.63/221.84       2003; see DRACUNCULUS 1963-2002; for DRACUNCULUS MEDINENSIS see DRACUNCULUS 1963-1985; for GUINEA WORM see DRACUNCULUS MEDINENSIS 1979-1985, see DRACUNCULUS 1968-1978; for MEDINA WORM see DRACUNCULUS MEDINENSIS 1979-1985%A%  
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D004321 2005
% 221.63/221.84  |- mesh__recordOriginator mesh__D004321 NLM
% 221.63/221.84  |- mesh__dateRevised mesh__D004321 2003-07-09
% 221.63/221.84  |- rdf__type mesh__D004321sskos__Concept
% 221.63/221.84  |- skos__scopeNote mesh__D004321
% 221.63/221.84       A genus of nematode parasites which inhabit the body cavity, serous membranes, and connective tissues of vertebrates. The parasitic species in humans is Dracunculus medinensis.%A%    
% 221.63/221.84  |- skos__broader mesh__D004321smesh__D017176
% 221.63/221.84  |- mesh__recordMaintainer mesh__D004321 ags
% 221.63/221.84  |- mesh__historyNote mesh__D004321 2003%28%1963%29%   
% 221.63/221.84  |- mesh__dateCreated mesh__D004321 1999-01-01
% 221.63/221.84  |- mesh__recordAuthorizer mesh__D004321 sjn
% 221.63/221.84  |- skos__altLabel mesh__D004321 Guinea Worm
% 221.63/221.84  |- skos__altLabel mesh__D004321 Medina Worm
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D004321 2004
% 221.63/221.84  |- skos__annotation mesh__D004321
% 221.63/221.84       infection = DRACUNCULIASIS; coord with specific helminth terms %28%ANTIGENS, HELMINTH, etc if pertinent%29%%A%  
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D004321 2006
% 221.63/221.84  |- mesh__publicMeSHNote mesh__D003229 81   
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D003229 1995
% 221.63/221.84  |- mesh__recordOriginator mesh__D003229 RC
% 221.63/221.84  |- skos__hiddenLabel mesh__D003229 Diseases, Conjunctival
% 221.63/221.84  |- mesh__recordAuthorizer mesh__D003229 NLM
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D003229 2002
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D003229 2006
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D003229 1994
% 221.63/221.84  |- rdf__type mesh__D003229sskos__Concept
% 221.63/221.84  |- mesh__dateEstablished mesh__D003229 1981-01-01
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D003229 1997
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D003229 2005
% 221.63/221.84  |- skos__prefLabel mesh__D003229 Conjunctival Diseases
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D003229 1996
% 221.63/221.84  |- skos__historyNote mesh__D003229 Eye Diseases %28%1966-1980%29%
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D003229 2001
% 221.63/221.84  |- mesh__dateCreated mesh__D003229 1980-04-04
% 221.63/221.84  |- mesh__historyNote mesh__D003229 81   
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D003229 1993
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D003229 2000
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D003229 1999
% 221.63/221.84  |- mesh__dateRevised mesh__D003229 1990-05-29
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D003229 2004
% 221.63/221.84  |- skos__historyNote mesh__D003229 Conjunctiva %28%1966-1980%29%
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D003229 1992
% 221.63/221.84  |- skos__broader mesh__D003229smesh__D005128
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D003229 1998
% 221.63/221.84  |- mesh__recordMaintainer mesh__D003229 PLS
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D003229 2003
% 221.63/221.84  |- skos__hiddenLabel mesh__D003229 Conjunctival Disease
% 221.63/221.84  |- skos__hiddenLabel mesh__D003229 Disease, Conjunctival
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D003229 1991
% 221.63/221.84  |- skos__altLabel mesh__D008712 Meticillin
% 221.63/221.84  |- rdf__type mesh__D008712sskos__Concept
% 221.63/221.84  |- mesh__recordMaintainer mesh__D008712 CCR
% 221.63/221.84  |- skos__prefLabel mesh__D008712 Methicillin
% 221.63/221.84  |- skos__broader mesh__D008712smesh__D010406
% 221.63/221.84  |- skos__altLabel mesh__D008712 Methicillin Monohydrate, Monosodium Salt
% 221.63/221.84  |- skos__altLabel mesh__D008712 Penicillin, Dimethoxyphenyl
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D008712 2006
% 221.63/221.84  |- mesh__dateCreated mesh__D008712 1999-01-01
% 221.63/221.84  |- skos__altLabel mesh__D008712 CSL Brand of Methicillin Sodium
% 221.63/221.84  |- skos__scopeNote mesh__D008712
% 221.63/221.84       One of the PENICILLINS which is resistant to PENICILLINASE but susceptible to a penicillin-binding protein. It is inactivated by gastric acid so administered by injection.%A%    
% 221.63/221.84  |- skos__hiddenLabel mesh__D008712 Dimethoxyphenyl Penicillin
% 221.63/221.84  |- skos__related mesh__D008712smesh__D016106
% 221.63/221.84  |- mesh__dateRevised mesh__D008712 2005-06-30
% 221.63/221.84  |- mesh__recordOriginator mesh__D008712 NLM
% 221.63/221.84  |- mesh__recordAuthorizer mesh__D008712 sjn
% 221.63/221.84  |- skos__scopeNote mesh__D013657
% 221.63/221.84       A bile salt formed in the liver by conjugation of deoxycholate with taurine, usually as the sodium salt. It is used as a cholagogue and choleretic, also industrially as a fat emulsifier.%A%    
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D013657 2006
% 221.63/221.84  |- rdf__type mesh__D013657sskos__Concept
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D013657 2002
% 221.63/221.84  |- skos__altLabel mesh__D013657 Taurodeoxycholate
% 221.63/221.84  |- mesh__recordOriginator mesh__D013657 SH
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D013657 2005
% 221.63/221.84  |- mesh__dateCreated mesh__D013657 1977-06-02
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D013657 2001
% 221.63/221.84  |- skos__historyNote mesh__D013657 Bile Acids and Salts %28%1966-1972%29%
% 221.63/221.84  |- skos__annotation mesh__D013657
% 221.63/221.84       a bile acid; /biosyn /physiol permitted   
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D013657 2004
% 221.63/221.84  |- mesh__historyNote mesh__D013657
% 221.63/221.84       91%28%78%29%; was see under DEOXYCHOLIC ACID 1978-90   
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D013657 2000
% 221.63/221.84  |- skos__historyNote mesh__D013657 Taurine %28%1966-1972%29%
% 221.63/221.84  |- mesh__dateRevised mesh__D013657 1999-11-03
% 221.63/221.84  |- skos__hiddenLabel mesh__D013657 Taurodeoxycholate, Sodium
% 221.63/221.84  |- skos__hiddenLabel mesh__D013657 Acid, Taurodeoxycholic
% 221.63/221.84  |- skos__broader mesh__D013657smesh__D013656
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D013657 2003
% 221.63/221.84  |- skos__historyNote mesh__D013657 Taurocholic Acid %28%1973-1977%29%
% 221.63/221.84  |- skos__altLabel mesh__D013657 Deoxycholyltaurine
% 221.63/221.84  |- skos__prefLabel mesh__D013657 Taurodeoxycholic Acid
% 221.63/221.84  |- mesh__recordMaintainer mesh__D013657 jmp
% 221.63/221.84  |- mesh__publicMeSHNote mesh__D013657
% 221.63/221.84       91; was see under DEOXYCHOLIC ACID 1978-90   
% 221.63/221.84  |- mesh__dateEstablished mesh__D013657 1991-01-01
% 221.63/221.84  |- skos__hiddenLabel mesh__D013657 Deoxycholate, Taurine
% 221.63/221.84  |- skos__historyNote mesh__D013657 Deoxycholic Acid %28%1973-1977%29%
% 221.63/221.84  |- skos__broader mesh__D013657smesh__D003840
% 221.63/221.84  |- mesh__recordAuthorizer mesh__D013657 sjn
% 221.63/221.84  |- skos__broader mesh__D018342smesh__D011943
% 221.63/221.84  |- mesh__publicMeSHNote mesh__D018342 94   
% 221.63/221.84  |- skos__hiddenLabel mesh__D018342 Adrenergic Receptors, beta-1
% 221.63/221.84  |- skos__hiddenLabel mesh__D018342 Receptor, beta-1 Adrenergic
% 221.63/221.84  |- skos__altLabel mesh__D018342 beta-1 Adrenergic Receptors
% 221.63/221.84  |- skos__altLabel mesh__D018342 Adrenergic beta-1 Receptors
% 221.63/221.84  |- skos__hiddenLabel mesh__D018342 beta-1 Receptors, Adrenergic
% 221.63/221.84  |- skos__hiddenLabel mesh__D018342 beta 1 Adrenergic Receptors
% 221.63/221.84  |- skos__hiddenLabel mesh__D018342 Adrenergic Receptor, beta 1
% 221.63/221.84  |- mesh__dateEstablished mesh__D018342 1994-01-01
% 221.63/221.84  |- skos__altLabel mesh__D018342 Receptors, beta-1 Adrenergic
% 221.63/221.84  |- skos__altLabel mesh__D018342 Receptor, Adrenergic, beta-1
% 221.63/221.84  |- mesh__recordOriginator mesh__D018342 TPW
% 221.63/221.84  |- skos__altLabel mesh__D018342 beta 1 Adrenergic Receptor
% 221.63/221.84  |- mesh__dateRevised mesh__D018342 2005-06-30
% 221.63/221.84  |- skos__altLabel mesh__D018342 Adrenergic Receptor, beta-1
% 221.63/221.84  |- skos__prefLabel mesh__D018342 Receptors, Adrenergic, beta-1
% 221.63/221.84  |- mesh__recordAuthorizer mesh__D018342 sjn
% 221.63/221.84  |- skos__historyNote mesh__D018342
% 221.63/221.84       Receptors, Adrenergic, beta %28%1977-1993%29%
% 221.63/221.84  |- mesh__historyNote mesh__D018342 94   
% 221.63/221.84  |- skos__scopeNote mesh__D018342
% 221.63/221.84       A subclass of beta-adrenergic receptors %28%RECEPTORS, ADRENERGIC, BETA%29%. beta-1 Adrenergic receptors are equally sensitive to epinephrine and norepinephrine and bind the agonist dobutamine and the antagonist metoprolol with high affinity. They are found in the heart, juxtaglomerular cells, and in the central and peripheral nervous systems.%A%    
% 221.63/221.84  |- skos__hiddenLabel mesh__D018342 Receptors, Adrenergic beta-1
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D018342 2006
% 221.63/221.84  |- mesh__dateCreated mesh__D018342 1993-06-04
% 221.63/221.84  |- skos__hiddenLabel mesh__D018342 Receptors, beta 1 Adrenergic
% 221.63/221.84  |- skos__hiddenLabel mesh__D018342 beta-1 Adrenergic Receptor
% 221.63/221.84  |- skos__hiddenLabel mesh__D018342 Adrenergic beta 1 Receptors
% 221.63/221.84  |- mesh__recordMaintainer mesh__D018342 jmp
% 221.63/221.84  |- rdf__type mesh__D018342sskos__Concept
% 221.63/221.84  |- mesh__publicMeSHNote mesh__D051776
% 221.63/221.84       2006; EARLY GROWTH RESPONSE PROTEIN 3 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1991-2005%A%  
% 221.63/221.84  |- skos__altLabel mesh__D051776 EGR3 Transcription Factor
% 221.63/221.84  |- skos__hiddenLabel mesh__D051776 Transcription Factor, EGR3
% 221.63/221.84  |- skos__broader mesh__D051776smesh__D051765
% 221.63/221.84  |- mesh__dateEstablished mesh__D051776 2006-01-01
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D051776 2006
% 221.63/221.84  |- skos__altLabel mesh__D051776
% 221.63/221.84       Early Growth Response Transcription Factor 3
% 221.63/221.84  |- rdf__type mesh__D051776sskos__Concept
% 221.63/221.84  |- skos__prefLabel mesh__D051776 Early Growth Response Protein 3
% 221.63/221.84  |- mesh__recordMaintainer mesh__D051776 DRC
% 221.63/221.84  |- mesh__recordOriginator mesh__D051776 DRC
% 221.63/221.84  |- skos__scopeNote mesh__D051776
% 221.63/221.84       An early growth response transcription factor that is essential for the development of MUSCLE SPINDLES.%A%    
% 221.63/221.84  |- mesh__dateCreated mesh__D051776 2005-06-30
% 221.63/221.84  |- mesh__recordAuthorizer mesh__D051776 sjn
% 221.63/221.84  |- mesh__historyNote mesh__D051776 2006%28%1991%29%   
% 221.63/221.84  |- rdf__type mesh__D004322sskos__Concept
% 221.63/221.84  |- mesh__dateRevised mesh__D004322 2005-06-30
% 221.63/221.84  |- mesh__recordOriginator mesh__D004322 NLM
% 221.63/221.84  |- mesh__dateCreated mesh__D004322 1999-01-01
% 221.63/221.84  |- skos__scopeNote mesh__D004322
% 221.63/221.84       The removal of fluids or discharges from the body, such as from a wound, sore, or cavity.%A%    
% 221.63/221.84  |- skos__broader mesh__D004322smesh__D013514
% 221.63/221.84  |- mesh__recordMaintainer mesh__D004322 lkt
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D004322 2006
% 221.63/221.84  |- mesh__recordAuthorizer mesh__D004322 sjn
% 221.63/221.84  |- skos__broader mesh__D004322smesh__D013812
% 221.63/221.84  |- skos__annotation mesh__D004322
% 221.63/221.84       DRAINAGE, SUCTION see SUCTION is also available   
% 221.63/221.84  |- skos__prefLabel mesh__D004322 Drainage
% 221.63/221.84  |- skos__scopeNote mesh__D042441
% 221.63/221.84       The type species of gram negative, aerobic bacteria in the genus ACHROMOBACTER. Previously in the genus ALCALIGENES, the classification and nomenclature of this species has been frequently emended. The two subspecies, Achromobacter xylosoxidans subsp. denitrificans and Achromobacter xylosoxidans subsp. xylosoxidans are associated with infections.%A%    
% 221.63/221.84  |- rdf__type mesh__D042441sskos__Concept
% 221.63/221.84  |- mesh__recordAuthorizer mesh__D042441 sjn
% 221.63/221.84  |- mesh__recordOriginator mesh__D042441 ags
% 221.63/221.84  |- mesh__historyNote mesh__D042441 2006 %28%2004%29%   
% 221.63/221.84  |- mesh__dateCreated mesh__D042441 2003-07-09
% 221.63/221.84  |- mesh__dateEstablished mesh__D042441 2004-01-01
% 221.63/221.84  |- skos__broader mesh__D042441smesh__D042402
% 221.63/221.84  |- mesh__publicMeSHNote mesh__D042441
% 221.63/221.84       2006; see ACHROMOBACTER XYLOSOXIDANS 2004-2005   
% 221.63/221.84  |- mesh__dateRevised mesh__D042441 2005-06-30
% 221.63/221.84  |- skos__altLabel mesh__D042441
% 221.63/221.84       Alcaligenes denitrificans subsp. xylosoxydans
% 221.63/221.84  |- skos__historyNote mesh__D042441 Alcaligenes %28%1971-2003%29%
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D042441 2006
% 221.63/221.84  |- skos__annotation mesh__D042441
% 221.63/221.84       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 221.63/221.84  |- skos__altLabel mesh__D042441
% 221.63/221.84       Alcaligenes denitrificans subsp. xylosoxidans
% 221.63/221.84  |- skos__altLabel mesh__D042441 Achromobacter xylosoxidans
% 221.63/221.84  |- mesh__recordMaintainer mesh__D042441 ags
% 221.63/221.84  |- skos__prefLabel mesh__D042441 Achromobacter denitrificans
% 221.63/221.84  |- skos__prefLabel mesh__D014750 Vincristine
% 221.63/221.84  |- skos__altLabel mesh__D014750 Vincristin Liquid, Lilly
% 221.63/221.84  |- mesh__recordOriginator mesh__D014750 NLM
% 221.63/221.84  |- mesh__historyNote mesh__D014750 66%28%63%29%   
% 221.63/221.84  |- skos__scopeNote mesh__D014750
% 221.63/221.84       Antitumor alkaloid isolated from Vinca Rosea. %28%Merck, 11th ed.%29%%A%    
% 221.63/221.84  |- skos__altLabel mesh__D014750 Onkoworks Brand of Vincristine Sulfate
% 221.63/221.84  |- skos__altLabel mesh__D014750 Farmistin
% 221.63/221.84  |- skos__altLabel mesh__D014750 Columbia Brand of Vincristine Sulfate
% 221.63/221.84  |- mesh__publicMeSHNote mesh__D014750 66   
% 221.63/221.84  |- skos__altLabel mesh__D014750 Leurocristine
% 221.63/221.84  |- mesh__recordAuthorizer mesh__D014750 sjn
% 221.63/221.84  |- skos__altLabel mesh__D014750 Lilly Brand of Vincristine Sulfate
% 221.63/221.84  |- skos__altLabel mesh__D014750 cell pharm Brand of Vincristine Sulfate
% 221.63/221.84  |- mesh__dateCreated mesh__D014750 1999-01-01
% 221.63/221.84  |- rdf__type mesh__D014750sskos__Concept
% 221.63/221.84  |- skos__altLabel mesh__D014750 Vincristina Pharmacia
% 221.63/221.84  |- skos__altLabel mesh__D014750 Lemery Brand of Vincristine Sulfate
% 221.63/221.84  |- skos__annotation mesh__D014750 /biosyn permitted if by plant   
% 221.63/221.84  |- skos__altLabel mesh__D014750 medac Brand of Vincristine Sulfate
% 221.63/221.84  |- skos__altLabel mesh__D014750 Irisfarma Brand of Vincristine Sulfate
% 221.63/221.84  |- skos__hiddenLabel mesh__D014750 Sulfate, Vincristine
% 221.63/221.84  |- mesh__recordMaintainer mesh__D014750 lkw
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D014750 2006
% 221.63/221.84  |- skos__altLabel mesh__D014750 EG Labo Brand of Vincristine Sulfate
% 221.63/221.84  |- skos__broader mesh__D014750smesh__D014748
% 221.63/221.84  |- mesh__dateEstablished mesh__D014750 1966-01-01
% 221.63/221.84  |- skos__altLabel mesh__D014750
% 221.63/221.84       Bristol-Myers Squibb Brand of Vincristine Sulfate
% 221.63/221.84  |- skos__altLabel mesh__D014750 Oncovine
% 221.63/221.84  |- skos__altLabel mesh__D014750 Pharmacia Brand of Vincristine Sulfate
% 221.63/221.84  |- mesh__dateRevised mesh__D014750 2005-06-30
% 221.63/221.84  |- skos__altLabel mesh__D008713 Sanofi Synthelabo Brand of Methimazole
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D008713 2006
% 221.63/221.84  |- skos__altLabel mesh__D008713 Jones Brand of Methimazole
% 221.63/221.84  |- skos__altLabel mesh__D008713 Mercazole
% 221.63/221.84  |- skos__altLabel mesh__D008713 Hexal Brand of Methimazole
% 221.63/221.84  |- mesh__recordAuthorizer mesh__D008713 sjn
% 221.63/221.84  |- skos__broader mesh__D008713smesh__D013438
% 221.63/221.84  |- skos__altLabel mesh__D008713 1-Methyl-2-mercaptoimidazole
% 221.63/221.84  |- skos__altLabel mesh__D008713 Philopharm Brand of Methimazole
% 221.63/221.84  |- skos__historyNote mesh__D008713 Thyroid Antagonists %28%1966-1967%29%
% 221.63/221.84  |- skos__historyNote mesh__D008713 Imidazoles %28%1966-1967%29%
% 221.63/221.84  |- skos__altLabel mesh__D008713 Thimazol
% 221.63/221.84  |- skos__altLabel mesh__D008713 Mercasolyl
% 221.63/221.84  |- skos__altLabel mesh__D008713 Mercazolyl
% 221.63/221.84  |- rdf__type mesh__D008713sskos__Concept
% 221.63/221.84  |- skos__altLabel mesh__D008713 Nourypharma Brand of Methimazole
% 221.63/221.84  |- skos__altLabel mesh__D008713 Methymazol
% 221.63/221.84  |- mesh__dateRevised mesh__D008713 2005-06-30
% 221.63/221.84  |- mesh__recordMaintainer mesh__D008713 ssb
% 221.63/221.84  |- mesh__historyNote mesh__D008713
% 221.63/221.84       73%28%68%29%; was see under THYROID ANTAGONISTS 1963-72   
% 221.63/221.84  |- mesh__recordOriginator mesh__D008713 NLM
% 221.63/221.84  |- skos__altLabel mesh__D008713 Estedi Brand of Methimazole
% 221.63/221.84  |- mesh__dateCreated mesh__D008713 1999-01-01
% 221.63/221.84  |- skos__scopeNote mesh__D008713
% 221.63/221.84       A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme.%A%    
% 221.63/221.84  |- skos__hiddenLabel mesh__D008713 1 Methyl 2 mercaptoimidazole
% 221.63/221.84  |- skos__hiddenLabel mesh__D008713 Henning, Thiamazol
% 221.63/221.84  |- skos__broader mesh__D008713smesh__D007093
% 221.63/221.84  |- skos__altLabel mesh__D008713 Henning Berlin Brand of Methimazole
% 221.63/221.84  |- mesh__publicMeSHNote mesh__D008713
% 221.63/221.84       73; was see under THYROID ANTAGONISTS 1963-72   
% 221.63/221.84  |- skos__prefLabel mesh__D008713 Methimazole
% 221.63/221.84  |- skos__altLabel mesh__D008713 Tiamazol
% 221.63/221.84  |- mesh__dateEstablished mesh__D008713 1973-01-01
% 221.63/221.84  |- skos__altLabel mesh__D008713 Thiamazole
% 221.63/221.84  |- mesh__onlineNote mesh__D008713 search THYROID ANTAGONISTS 1966-67   
% 221.63/221.84  |- skos__altLabel mesh__D008713 Merck Brand of Methimazole
% 221.63/221.84  |- skos__altLabel mesh__D008713 Temmler Brand of Methimazole
% 221.63/221.84  |- skos__altLabel mesh__D008713 Metizol
% 221.63/221.84  |- skos__altLabel mesh__D008713 Methylmercaptoimidazole
% 221.63/221.84  |- skos__altLabel mesh__D008713 Eli Lilly Brand of Methimazole
% 221.63/221.84  |- skos__altLabel mesh__D008713 Merkazolil
% 221.63/221.84  |- skos__hiddenLabel mesh__D008713 Hexal, Thiamazol
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D000730 2005
% 221.63/221.84  |- mesh__historyNote mesh__D000730 75; was see under ANDROSTENES 1973-74   
% 221.63/221.84  |- mesh__recordOriginator mesh__D000730 NLM
% 221.63/221.84  |- mesh__publicMeSHNote mesh__D000730
% 221.63/221.84       75; was see under ANDROSTENES 1973-74   
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D000730 2003
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D000730 2002
% 221.63/221.84  |- skos__scopeNote mesh__D000730
% 221.63/221.84       Derivatives of the steroid androstane having two double bonds at any site in any of the rings.%A%    
% 221.63/221.84  |- skos__prefLabel mesh__D000730 Androstadienes
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D000730 1995
% 221.63/221.84  |- mesh__recordAuthorizer mesh__D000730 PLS
% 221.63/221.84  |- rdf__type mesh__D000730sskos__Concept
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D000730 1999
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D000730 1994
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D000730 2001
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D000730 1997
% 221.63/221.84  |- mesh__dateRevised mesh__D000730 1993-06-03
% 221.63/221.84  |- mesh__onlineNote mesh__D000730 search ANDROSTENES 1973-74   
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D000730 1998
% 221.63/221.84  |- mesh__dateCreated mesh__D000730 1999-01-01
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D000730 1996
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D000730 2006
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D000730 2000
% 221.63/221.84  |- mesh__recordMaintainer mesh__D000730 PLS
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D000730 2004
% 221.63/221.84  |- skos__broader mesh__D000730smesh__D000736
% 221.63/221.84  |- mesh__dateEstablished mesh__D000730 1975-01-01
% 221.63/221.84  |- skos__prefLabel mesh__D013658 Taurolithocholic Acid
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D013658 2003
% 221.63/221.84  |- skos__broader mesh__D013658smesh__D008095
% 221.63/221.84  |- skos__historyNote mesh__D013658 Taurine %28%1966-1972%29%
% 221.63/221.84  |- skos__historyNote mesh__D013658 Taurocholic Acid %28%1973-1977%29%
% 221.63/221.84  |- mesh__dateCreated mesh__D013658 1977-06-01
% 221.63/221.84  |- mesh__recordAuthorizer mesh__D013658 sjn
% 221.63/221.84  |- skos__hiddenLabel mesh__D013658 Lithocholate, Taurine
% 221.63/221.84  |- skos__altLabel mesh__D013658 Taurolithocholate
% 221.63/221.84  |- skos__historyNote mesh__D013658 Lithocholic Acid %28%1973-1977%29%
% 221.63/221.84  |- mesh__dateEstablished mesh__D013658 1991-01-01
% 221.63/221.84  |- mesh__recordMaintainer mesh__D013658 CCR
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D013658 2002
% 221.63/221.84  |- skos__annotation mesh__D013658 /biosyn /physiol permitted   
% 221.63/221.84  |- mesh__historyNote mesh__D013658
% 221.63/221.84       91%28%78%29%; was see under LITHOCHOLIC ACID 1978-90   
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D013658 2006
% 221.63/221.84  |- skos__hiddenLabel mesh__D013658 Acid, Taurolithocholic
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D013658 2001
% 221.63/221.84  |- rdf__type mesh__D013658sskos__Concept
% 221.63/221.84  |- skos__scopeNote mesh__D013658
% 221.63/221.84       A bile salt formed in the liver from lithocholic acid conjugation with taurine, usually as the sodium salt. It solubilizes fats for absorption and is itself absorbed. It is a cholagogue and choleretic.%A%    
% 221.63/221.84  |- skos__historyNote mesh__D013658 Bile Acids and Salts %28%1966-1972%29%
% 221.63/221.84  |- mesh__dateRevised mesh__D013658 2000-06-21
% 221.63/221.84  |- mesh__recordOriginator mesh__D013658 SH
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D013658 2005
% 221.63/221.84  |- skos__broader mesh__D013658smesh__D013656
% 221.63/221.84  |- skos__altLabel mesh__D013658 Lithocholyltaurine
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D013658 2004
% 221.63/221.84  |- mesh__publicMeSHNote mesh__D013658
% 221.63/221.84       91; was see under LITHOCHOLIC ACID 1978-90   
% 221.63/221.84  |- skos__hiddenLabel mesh__D018343 Adrenergic Receptors, beta-2
% 221.63/221.84  |- skos__hiddenLabel mesh__D018343 Receptor, beta-2 Adrenergic
% 221.63/221.84  |- skos__hiddenLabel mesh__D018343 Receptors, beta 2 Adrenergic
% 221.63/221.84  |- skos__broader mesh__D018343smesh__D011943
% 221.63/221.84  |- mesh__publicMeSHNote mesh__D018343 94   
% 221.63/221.84  |- skos__hiddenLabel mesh__D018343 beta-2 Adrenergic Receptor
% 221.63/221.84  |- mesh__historyNote mesh__D018343 94   
% 221.63/221.84  |- mesh__dateEstablished mesh__D018343 1994-01-01
% 221.63/221.84  |- skos__altLabel mesh__D018343 Receptors, beta-2 Adrenergic
% 221.63/221.84  |- mesh__recordOriginator mesh__D018343 TPW
% 221.63/221.84  |- mesh__activeMeSHYear mesh__D018343 2006
% 221.63/221.84  |- skos__prefLabel mesh__D018343 Receptors, Adrenergic, beta-2
% 221.63/221.84  |- mesh__dateRevised mesh__D018343 2005-06-30
% 221.63/221.84  |- skos__altLabel mesh__D018343 Adrenergic Receptor, beta-2
% 221.63/221.84  |- skos__hiddenLabel mesh__D018343 Receptors, Adrenergic beta-2
% 221.63/221.84  |- skos__hiddenLabel mesh__D018343 Adrenergic Receptor, beta 2
% 221.63/221.84  |- skos__altLabel mesh__D018343 Adrenergic beta-2 Receptors
% 221.63/221.84  |- mesh__recordMaintainer mesh__D018343 jmp
% 221.63/221.84  |- rdf__type mesh__D018343sskos__Concept
% 221.63/221.84  |- skos__scopeNote mesh__D018343
% 221.63/221.84       A subclass of beta-adrenergic receptors %28%RECEPTORS, ADRENERGIC, BETA%29%. beta-2 Adrenergic receptors are more sensitive to epinephrine than to norepinephrine and have a high affinity for the agonist terbutaline. They are widespread, with clinically important roles in skeletal muscle, liver, and vascular, bronchial, gastrointestinal, and genitourinary smooth muscle.%A%    
% 221.63/221.84  |- skos__hiddenLabel mesh__D018343 Adrenergic beta 2 Receptors
% 221.63/221.84  |- mesh__recordAuthorizer mesh__D018343 sjn
% 221.63/221.84  |- skos__hiddenLabel mesh__D018343 beta-2 Receptors, Adrenergic
% 221.63/221.84  |- skos__historyNote mesh__D018343
% 221.63/221.84       Receptors, Adrenergic, beta %28%1977-1993%29%
% 221.72/221.87  |- mesh__dateCreated mesh__D018343 1993-06-16
% 221.72/221.87  |- skos__altLabel mesh__D018343 beta 2 Adrenergic Receptors
% 221.72/221.87  |- skos__altLabel mesh__D018343 Receptor, Adrenergic, beta-2
% 221.72/221.87  |- skos__altLabel mesh__D018343 beta-2 Adrenergic Receptors
% 221.72/221.87  |- mesh__dateRevised mesh__D010360 1997-06-20
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D010360 2000
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D010360 2003
% 221.72/221.87  |- skos__hiddenLabel mesh__D010360 Dumping, Patient
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D010360 2001
% 221.72/221.87  |- skos__related mesh__D010360smesh__D014164
% 221.72/221.87  |- mesh__publicMeSHNote mesh__D010360 87   
% 221.72/221.87  |- skos__broader mesh__D010360smesh__D006760
% 221.72/221.87  |- rdf__type mesh__D010360sskos__Concept
% 221.72/221.87  |- skos__hiddenLabel mesh__D010360 Transfers, Patient
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D010360 2004
% 221.72/221.87  |- skos__hiddenLabel mesh__D010360 Patient Transfers
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D010360 2002
% 221.72/221.87  |- mesh__recordMaintainer mesh__D010360 PXP
% 221.72/221.87  |- skos__annotation mesh__D010360
% 221.72/221.87       %22%interfacility or intrahospital transfer%22%: read MeSH definition %26% do not confuse with TRANSPORTATION OF PATIENTS %28% = bed to bed or outside hosp or elsewhere%29%%A%  
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D010360 2005
% 221.72/221.87  |- mesh__historyNote mesh__D010360 87   
% 221.72/221.87  |- mesh__dateEstablished mesh__D010360 1987-01-01
% 221.72/221.87  |- mesh__recordOriginator mesh__D010360 EC
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D010360 2006
% 221.72/221.87  |- skos__prefLabel mesh__D010360 Patient Transfer
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D010360 1998
% 221.72/221.87  |- skos__scopeNote mesh__D010360
% 221.72/221.87       Interfacility or intrahospital transfer of patients. Intrahospital transfer is usually to obtain a specific kind of care and interfacility transfer is usually for economic reasons as well as type of care provided.%A%    
% 221.72/221.87  |- skos__hiddenLabel mesh__D010360 Transfer, Patient
% 221.72/221.87  |- mesh__recordAuthorizer mesh__D010360 SJN
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D010360 1999
% 221.72/221.87  |- mesh__dateCreated mesh__D010360 1986-05-30
% 221.72/221.87  |- skos__altLabel mesh__D051777 AraC Repressor
% 221.72/221.87  |- skos__hiddenLabel mesh__D051777 Transcriptional Regulator, AraC
% 221.72/221.87  |- skos__altLabel mesh__D051777 AraC Transcription Regulator
% 221.72/221.87  |- skos__prefLabel mesh__D051777 AraC Transcription Factor
% 221.72/221.87  |- skos__hiddenLabel mesh__D051777 Repressor, AraC
% 221.72/221.87  |- mesh__dateCreated mesh__D051777 2005-06-30
% 221.72/221.87  |- mesh__historyNote mesh__D051777 2006%28%1980%29%   
% 221.72/221.87  |- mesh__recordOriginator mesh__D051777 DRC
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D051777 2006
% 221.72/221.87  |- skos__hiddenLabel mesh__D051777 Transcription Factor, AraC
% 221.72/221.87  |- mesh__recordMaintainer mesh__D051777 ags
% 221.72/221.87  |- skos__broader mesh__D051777smesh__D001426
% 221.72/221.87  |- rdf__type mesh__D051777sskos__Concept
% 221.72/221.87  |- mesh__recordAuthorizer mesh__D051777 ags
% 221.72/221.87  |- skos__altLabel mesh__D051777 Ara-C Transcription Regulator
% 221.72/221.87  |- skos__broader mesh__D051777smesh__D004268
% 221.72/221.87  |- mesh__publicMeSHNote mesh__D051777
% 221.72/221.87       2006; ARAC TRANSCRIPTION REGULATOR was indexed under DNA-BINDING PROTEINS, REPRESSOR PROTEINS, %26% TRANSCRIPTION FACTORS 1980-2005%A%  
% 221.72/221.87  |- skos__hiddenLabel mesh__D051777 Transcription Regulator, AraC
% 221.72/221.87  |- skos__altLabel mesh__D051777 AraC Transcriptional Regulator
% 221.72/221.87  |- skos__hiddenLabel mesh__D051777 Transcription Regulator, Ara-C
% 221.72/221.87  |- skos__broader mesh__D051777smesh__D012097
% 221.72/221.87  |- skos__scopeNote mesh__D051777
% 221.72/221.87       A transcription factor found in BACTERIA that positively and negatively regulates the expression of proteins required for the uptake and catabolism of L-ARABINOSE.%A%    
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D051777 2006A
% 221.72/221.87  |- skos__hiddenLabel mesh__D051777 Regulator, AraC Transcriptional
% 221.72/221.87  |- mesh__dateEstablished mesh__D051777 2006-01-01
% 221.72/221.87  |- mesh__dateRevised mesh__D051777 2005-07-11
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D004323 2001
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D004323 1994
% 221.72/221.87  |- skos__historyNote mesh__D004323 Sanitary Engineering %28%1966-1974%29%
% 221.72/221.87  |- mesh__publicMeSHNote mesh__D004323
% 221.72/221.87       75; was see under SANITARY ENGINEERING 1963-74   
% 221.72/221.87  |- skos__hiddenLabel mesh__D004323 Sanitary Drainage
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D004323 2004
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D004323 2000
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D004323 2006
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D004323 2003
% 221.72/221.87  |- skos__broader mesh__D004323smesh__D012498
% 221.72/221.87  |- skos__scopeNote mesh__D004323
% 221.72/221.87       A system of artificial or natural drains, generally used for the disposal of liquid wastes.%A%    
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D004323 2005
% 221.72/221.87  |- mesh__recordAuthorizer mesh__D004323 PLS
% 221.72/221.87  |- skos__hiddenLabel mesh__D004323 Drainages, Sanitary
% 221.72/221.87  |- rdf__type mesh__D004323sskos__Concept
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D004323 1997
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D004323 1999
% 221.72/221.87  |- mesh__recordOriginator mesh__D004323 NLM
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D004323 2002
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D004323 1993
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D004323 1996
% 221.72/221.87  |- mesh__recordMaintainer mesh__D004323 TAP
% 221.72/221.87  |- mesh__dateRevised mesh__D004323 1992-05-14
% 221.72/221.87  |- mesh__onlineNote mesh__D004323 search SANITARY ENGINEERING 1966-74   
% 221.72/221.87  |- mesh__dateEstablished mesh__D004323 1975-01-01
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D004323 1995
% 221.72/221.87  |- mesh__historyNote mesh__D004323
% 221.72/221.87       75; was see under SANITARY ENGINEERING 1963-74   
% 221.72/221.87  |- skos__prefLabel mesh__D004323 Drainage, Sanitary
% 221.72/221.87  |- mesh__dateCreated mesh__D004323 1999-01-01
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D004323 1998
% 221.72/221.87  |- skos__hiddenLabel mesh__D004323 Sanitary Drainages
% 221.72/221.87  |- skos__broader mesh__D042442smesh__D042501
% 221.72/221.87  |- skos__scopeNote mesh__D042442
% 221.72/221.87       A family of angiogenic proteins that are closely-related to VASCULAR ENDOTHELIAL GROWTH FACTOR A. They play an important role in the growth and differentiation of vascular as well as lymphatic endothelial cells.%A%    
% 221.72/221.87  |- mesh__dateCreated mesh__D042442 2003-07-09
% 221.72/221.87  |- mesh__recordMaintainer mesh__D042442 ssb
% 221.72/221.87  |- skos__historyNote mesh__D042442 Angiogenesis Factor %28%1981-2003%29%
% 221.72/221.87  |- mesh__dateEstablished mesh__D042442 2004-01-01
% 221.72/221.87  |- mesh__dateRevised mesh__D042442 2005-06-30
% 221.72/221.87  |- skos__historyNote mesh__D042442
% 221.72/221.87       Endothelial Growth Factors %28%1991-2003%29%
% 221.72/221.87  |- skos__annotation mesh__D042442 GEN; prefer specifics   
% 221.72/221.87  |- skos__altLabel mesh__D042442 VEGFs
% 221.72/221.87  |- mesh__publicMeSHNote mesh__D042442 2004   
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D042442 2006
% 221.72/221.87  |- mesh__recordOriginator mesh__D042442 jmp
% 221.72/221.87  |- skos__prefLabel mesh__D042442 Vascular Endothelial Growth Factors
% 221.72/221.87  |- mesh__historyNote mesh__D042442 2004   
% 221.72/221.87  |- rdf__type mesh__D042442sskos__Concept
% 221.72/221.87  |- mesh__recordAuthorizer mesh__D042442 sjn
% 221.72/221.87  |- skos__broader mesh__D014751smesh__D014748
% 221.72/221.87  |- skos__historyNote mesh__D014751
% 221.72/221.87       Vinblastine/analogs %26% derivatives %28%1980-1985%29%
% 221.72/221.87  |- mesh__dateRevised mesh__D014751 2005-06-30
% 221.72/221.87  |- skos__scopeNote mesh__D014751
% 221.72/221.87       Vinblastine derivative with antineoplastic activity against acute leukemia, lung cancer, carcinoma of the breast, squamous cell carcinoma of the esophagus, head, and neck, and Hodgkin%27%s and non-Hodgkin%27%s lymphomas. Major side effects are myelosuppression and neurotoxicity. Vindesine is used extensively in chemotherapy protocols.%A%    
% 221.72/221.87  |- skos__altLabel mesh__D014751 Vindesin
% 221.72/221.87  |- mesh__dateCreated mesh__D014751 1985-04-24
% 221.72/221.87  |- rdf__type mesh__D014751sskos__Concept
% 221.72/221.87  |- mesh__historyNote mesh__D014751 86   
% 221.72/221.87  |- skos__hiddenLabel mesh__D014751 NSC245467
% 221.72/221.87  |- skos__hiddenLabel mesh__D014751 NSC 245467
% 221.72/221.87  |- mesh__recordAuthorizer mesh__D014751 sjn
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D014751 2006
% 221.72/221.87  |- skos__altLabel mesh__D014751 EG Labo Brand of Vindesine Sulfate
% 221.72/221.87  |- mesh__dateEstablished mesh__D014751 1986-01-01
% 221.72/221.87  |- skos__hiddenLabel mesh__D014751 Sulfate, Vindesine
% 221.72/221.87  |- skos__altLabel mesh__D014751 Desacetylvinblastine Amide
% 221.72/221.87  |- skos__altLabel mesh__D014751 Enison
% 221.72/221.87  |- skos__prefLabel mesh__D014751 Vindesine
% 221.72/221.87  |- skos__historyNote mesh__D014751 Vinca Alkaloids %28%1973-1979%29%
% 221.72/221.87  |- mesh__recordOriginator mesh__D014751 RLS
% 221.72/221.87  |- mesh__recordMaintainer mesh__D014751 lkw
% 221.72/221.87  |- skos__altLabel mesh__D014751 Lilly Brand of Vindesine Sulfate
% 221.72/221.87  |- mesh__publicMeSHNote mesh__D014751 86   
% 221.72/221.87  |- skos__prefLabel mesh__D008714 Methiocarb
% 221.72/221.87  |- skos__historyNote mesh__D008714 Carbamates %28%1969-1974%29%
% 221.72/221.87  |- mesh__recordMaintainer mesh__D008714 ssb
% 221.72/221.87  |- rdf__type mesh__D008714sskos__Concept
% 221.72/221.87  |- mesh__dateCreated mesh__D008714 1974-11-19
% 221.72/221.87  |- mesh__publicMeSHNote mesh__D008714
% 221.72/221.87       91; was see under INSECTICIDES, CARBAMATE 1975-90   
% 221.72/221.87  |- skos__historyNote mesh__D008714 Xylenes %28%1973-1974%29%
% 221.72/221.87  |- skos__scopeNote mesh__D008714 Insecticide, molluscacide, acaricide.     
% 221.72/221.87  |- skos__broader mesh__D008714smesh__D048448
% 221.72/221.87  |- mesh__recordOriginator mesh__D008714 NLM
% 221.72/221.87  |- mesh__recordAuthorizer mesh__D008714 sjn
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D008714 2006
% 221.72/221.87  |- mesh__dateEstablished mesh__D008714 1991-01-01
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D008714 2005
% 221.72/221.87  |- mesh__historyNote mesh__D008714
% 221.72/221.87       91%28%75%29%; was see under INSECTICIDES, CARBAMATE 1975-90   
% 221.72/221.87  |- mesh__dateRevised mesh__D008714 2004-07-07
% 221.72/221.87  |- skos__annotation mesh__D008714 TN 111 for eff on insects   
% 221.72/221.87  |- skos__broader mesh__D000731smesh__D013256
% 221.72/221.87  |- mesh__historyNote mesh__D000731 68   
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D000731 2000
% 221.72/221.87  |- mesh__recordMaintainer mesh__D000731 PLS
% 221.72/221.87  |- skos__annotation mesh__D000731 do not confuse with ANDROSTENES   
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D000731 1995
% 221.72/221.87  |- mesh__recordOriginator mesh__D000731 NLM
% 221.72/221.87  |- rdf__type mesh__D000731sskos__Concept
% 221.72/221.87  |- mesh__dateEstablished mesh__D000731 1968-01-01
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D000731 1999
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D000731 1994
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D000731 1997
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D000731 2002
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D000731 1998
% 221.72/221.87  |- mesh__publicMeSHNote mesh__D000731 68   
% 221.72/221.87  |- mesh__dateCreated mesh__D000731 1999-01-01
% 221.72/221.87  |- skos__scopeNote mesh__D000731
% 221.72/221.87       The family of steroids from which the androgens are derived.%A%    
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D000731 1996
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D000731 2006
% 221.72/221.87  |- mesh__recordAuthorizer mesh__D000731 PLS
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D000731 2004
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D000731 2005
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D000731 2001
% 221.72/221.87  |- mesh__dateRevised mesh__D000731 1993-06-03
% 221.72/221.87  |- skos__prefLabel mesh__D000731 Androstanes
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D000731 2003
% 221.72/221.87  |- mesh__recordOriginator mesh__D013659 EC
% 221.72/221.87  |- skos__broader mesh__D013659smesh__D013660
% 221.72/221.87  |- mesh__dateCreated mesh__D013659 1984-04-11
% 221.72/221.87  |- skos__annotation mesh__D013659
% 221.72/221.87       specify state if given      CATALOG: use NAF entry   
% 221.72/221.87  |- skos__altLabel mesh__D013659
% 221.72/221.87       United States Tax Equity and Fiscal Responsibility Act
% 221.72/221.87  |- skos__altLabel mesh__D013659 Public Law 97-248
% 221.72/221.87  |- mesh__dateEstablished mesh__D013659 1991-01-01
% 221.72/221.87  |- skos__scopeNote mesh__D013659
% 221.72/221.87       PL97-248. Title II of the Act specifies %22%provisions relating to savings in health and income security programs.%22% This includes changes in payment for services, benefits and premiums of Medicare as well as changes in provisions under Medicaid and other specific programs covered by Social Security. Title II includes various revenue measures.%A%    
% 221.72/221.87  |- skos__hiddenLabel mesh__D013659 Act, Tax Equity
% 221.72/221.87  |- skos__altLabel mesh__D013659 PL 97-248
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D013659 2006
% 221.72/221.87  |- skos__altLabel mesh__D013659 PL97-248
% 221.72/221.87  |- rdf__type mesh__D013659sskos__Concept
% 221.72/221.87  |- mesh__recordAuthorizer mesh__D013659 sjn
% 221.72/221.87  |- mesh__dateRevised mesh__D013659 2001-07-25
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D013659 2005
% 221.72/221.87  |- skos__prefLabel mesh__D013659 Tax Equity and Fiscal Responsibility Act
% 221.72/221.87  |- skos__altLabel mesh__D013659 Tax Equity Act
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D013659 2002
% 221.72/221.87  |- skos__altLabel mesh__D013659 TEFRA
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D013659 2004
% 221.72/221.87  |- mesh__recordMaintainer mesh__D013659 jls
% 221.72/221.87  |- mesh__publicMeSHNote mesh__D013659 91; was see under TAXES 1985-90   
% 221.72/221.87  |- mesh__historyNote mesh__D013659
% 221.72/221.87       91%28%85%29%; was see under TAXES 1985-90   
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D013659 2003
% 221.72/221.87  |- skos__broader mesh__D018344smesh__D008231
% 221.72/221.87  |- mesh__recordOriginator mesh__D018344 AGS
% 221.72/221.87  |- mesh__historyNote mesh__D018344 94   
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D018344 1997
% 221.72/221.87  |- skos__hiddenLabel mesh__D018344
% 221.72/221.87       T Lymphocytopenia, Idiopathic CD4 Positive
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D018344 2000
% 221.72/221.87  |- mesh__publicMeSHNote mesh__D018344 94   
% 221.72/221.87  |- skos__hiddenLabel mesh__D018344
% 221.72/221.87       Idiopathic CD4 Positive T Lymphocytopenia
% 221.72/221.87  |- skos__hiddenLabel mesh__D018344 Idiopathic CD4+ T Lymphocytopenia
% 221.72/221.87  |- skos__hiddenLabel mesh__D018344
% 221.72/221.87       CD4 Positive T Lymphocytopenia, Idiopathic
% 221.72/221.87  |- skos__hiddenLabel mesh__D018344 T-Lymphocytopenia, CD4+
% 221.72/221.87  |- mesh__recordAuthorizer mesh__D018344 PLS
% 221.72/221.87  |- skos__altLabel mesh__D018344 CD4+ T-Lymphocytopenia
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D018344 2004
% 221.72/221.87  |- skos__hiddenLabel mesh__D018344 CD4+ T Lymphocytopenia
% 221.72/221.87  |- skos__hiddenLabel mesh__D018344 T-Lymphocytopenias, CD4+
% 221.72/221.87  |- skos__prefLabel mesh__D018344 T-Lymphocytopenia, Idiopathic CD4-Positive
% 221.72/221.87  |- skos__altLabel mesh__D018344 CD4+ T-Lymphocytopenia, Idiopathic
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D018344 1996
% 221.72/221.87  |- skos__altLabel mesh__D018344 Idiopathic CD4-Positive T-Lymphocytopenia
% 221.72/221.87  |- mesh__dateCreated mesh__D018344 1993-06-15
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D018344 2003
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D018344 1999
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D018344 2002
% 221.72/221.87  |- mesh__dateEstablished mesh__D018344 1994-01-01
% 221.72/221.87  |- skos__altLabel mesh__D018344 T-Lymphocytopenia, Idiopathic CD4+
% 221.72/221.87  |- skos__hiddenLabel mesh__D018344 CD4+ T Lymphocytopenia, Idiopathic
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D018344 1995
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D018344 2006
% 221.72/221.87  |- skos__hiddenLabel mesh__D018344 CD4+ T-Lymphocytopenias
% 221.72/221.87  |- skos__historyNote mesh__D018344 Lymphopenia %28%1990-1993%29%
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D018344 1998
% 221.72/221.87  |- skos__altLabel mesh__D018344 CD4-Positive T-Lymphocytopenia, Idiopathic
% 221.72/221.87  |- rdf__type mesh__D018344sskos__Concept
% 221.72/221.87  |- mesh__dateRevised mesh__D018344 1994-05-23
% 221.72/221.87  |- skos__annotation mesh__D018344 DF: CD4 LYMPHOCYTOPENIA   
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D018344 2005
% 221.72/221.87  |- skos__altLabel mesh__D018344 Idiopathic CD4+ T-Lymphocytopenia
% 221.72/221.87  |- mesh__activeMeSHYear mesh__D018344 2001
% 221.72/221.87  |- mesh__recordMaintainer mesh__D018344 TGC
% 221.72/221.87  |- skos__scopeNote mesh__D018344
% 221.72/221.87       Reproducible depletion of CD4+ lymphocytes below 300 per cubic millimeter in the absence of HIV infection or other known causes of immunodeficiency. This is a rare, heterogeneous syndrome and does not appear to be caused by a transmissible agent.%A%    
% 221.72/221.87  |- skos__historyNote mesh__D018344
% 221.72/221.87       Immunologic Deficiency Syndromes %28%1991-1993%29%
% 221.72/221.87  |- skos__hiddenLabel mesh__D018344 T Lymphocytopenia, Idiopathic CD4+
% 221.72/221.87  |- skos__prefLabel mesh__D010361 Patients
% 221.72/221.88  |- mesh__publicMeSHNote mesh__D010361
% 221.72/221.88       /education %28% = PATIENT EDUCATION as of 1980%29% was used for indexing 1966-79; OUTPATIENTS was see AMBULATORY CARE 1978-79%A%  
% 221.72/221.88  |- rdf__type mesh__D010361sskos__Concept
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D010361 2004
% 221.72/221.88  |- skos__related mesh__D010361smesh__D007297
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D010361 2005
% 221.72/221.88  |- mesh__historyNote mesh__D010361
% 221.72/221.88       /education was used for indexing 1966-79; was in Cat G %26% M 1963-67%A%  
% 221.72/221.88  |- skos__scopeNote mesh__D010361
% 221.72/221.88       Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.%A%    
% 221.72/221.88  |- skos__hiddenLabel mesh__D010361 Client
% 221.72/221.88  |- mesh__dateRevised mesh__D010361 2001-07-25
% 221.72/221.88  |- skos__annotation mesh__D010361
% 221.72/221.88       GEN only, irrespective of disease; patients as people or as a social, sociol, psychol, etc., group; do not confuse the patient with the disease: the %22%tuberculotic patient%22% = TUBERCULOSIS %26% not also PATIENTS; Manual 34.13%A%  
% 221.72/221.88  |- skos__broader mesh__D010361smesh__D009272
% 221.72/221.88  |- skos__hiddenLabel mesh__D010361 Patient
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D010361 2006
% 221.72/221.88  |- mesh__recordAuthorizer mesh__D010361 sjn
% 221.72/221.88  |- mesh__recordMaintainer mesh__D010361 hjn
% 221.72/221.88  |- skos__related mesh__D010361smesh__D010045
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D010361 2002
% 221.72/221.88  |- mesh__dateCreated mesh__D010361 1999-01-01
% 221.72/221.88  |- mesh__onlineNote mesh__D010361
% 221.72/221.88       search PATIENTS/ED under PATIENT EDUCATION 1966-79   
% 221.72/221.88  |- mesh__recordOriginator mesh__D010361 NLM
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D010361 2003
% 221.72/221.88  |- mesh__historyNote mesh__D051778 2006   
% 221.72/221.88  |- mesh__publicMeSHNote mesh__D051778 2006   
% 221.72/221.88  |- mesh__recordOriginator mesh__D051778 DRC
% 221.72/221.88  |- mesh__recordMaintainer mesh__D051778 DRC
% 221.72/221.88  |- mesh__dateEstablished mesh__D051778 2006-01-01
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D051778 2006
% 221.72/221.88  |- skos__broader mesh__D051778smesh__D051792
% 221.72/221.88  |- skos__altLabel mesh__D051778 BHLHLZ Transcription Factors
% 221.72/221.88  |- skos__altLabel mesh__D051778 BHLH-Zip Transcription Factors
% 221.72/221.88  |- skos__hiddenLabel mesh__D051778 Transcription Factors, BHLHLZ
% 221.72/221.88  |- skos__hiddenLabel mesh__D051778 BHLH Zip Transcription Factors
% 221.72/221.88  |- rdf__type mesh__D051778sskos__Concept
% 221.72/221.88  |- mesh__dateCreated mesh__D051778 2005-06-30
% 221.72/221.88  |- mesh__recordAuthorizer mesh__D051778 sjn
% 221.72/221.88  |- skos__prefLabel mesh__D051778
% 221.72/221.88       Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
% 221.72/221.88  |- skos__hiddenLabel mesh__D051778 Transcription Factors, BHLH-Zip
% 221.72/221.88  |- skos__broader mesh__D051778smesh__D050976
% 221.72/221.88  |- skos__related mesh__D051778smesh__D018257
% 221.72/221.88  |- skos__related mesh__D051778smesh__D016350
% 221.72/221.88  |- skos__hiddenLabel mesh__D051778
% 221.72/221.88       Basic Helix Loop Helix Leucine Zipper Transcription Factors
% 221.72/221.88  |- skos__scopeNote mesh__D051778
% 221.72/221.88       A family of transcription factors that contain regions rich in basic residues, LEUCINE ZIPPER domains, and HELIX-LOOP-HELIX MOTIFS.%A%    
% 221.72/221.88  |- skos__broader mesh__D004324smesh__D008091
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004324 2004
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004324 2002
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004324 2006
% 221.72/221.88  |- mesh__publicMeSHNote mesh__D004324
% 221.72/221.88       91; was see under LITERATURE 1975-90   
% 221.72/221.88  |- skos__prefLabel mesh__D004324 Drama
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004324 2003
% 221.72/221.88  |- mesh__dateEstablished mesh__D004324 1991-01-01
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004324 2001
% 221.72/221.88  |- mesh__recordMaintainer mesh__D004324 TGC
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004324 2005
% 221.72/221.88  |- skos__annotation mesh__D004324
% 221.72/221.88       coord IM with LITERATURE, MEDIEVAL %28%IM%29% or LITERATURE, MODERN %28%IM%29%; docudrama as a stage presentation goes here%A%  
% 221.72/221.88  |- mesh__dateRevised mesh__D004324 1996-06-10
% 221.72/221.88  |- rdf__type mesh__D004324sskos__Concept
% 221.72/221.88  |- mesh__onlineNote mesh__D004324 search LITERATURE 1966-74   
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004324 1997
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004324 2000
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004324 1999
% 221.72/221.88  |- mesh__historyNote mesh__D004324
% 221.72/221.88       91%28%75%29%; was see under LITERATURE 1975-90   
% 221.72/221.88  |- mesh__dateCreated mesh__D004324 1999-01-01
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004324 1998
% 221.72/221.88  |- mesh__recordAuthorizer mesh__D004324 PLS
% 221.72/221.88  |- skos__scopeNote mesh__D004324
% 221.72/221.88       A composition in prose or verse presenting in dialogue or pantomime a story involving various characters, usually intended to be acted on a stage and to be regarded as a form of entertainment. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 221.72/221.88  |- mesh__recordOriginator mesh__D004324 NLM
% 221.72/221.88  |- skos__hiddenLabel mesh__D004324 Dramas
% 221.72/221.88  |- mesh__dateCreated mesh__D014752 1974-11-11
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D014752 2003
% 221.72/221.88  |- skos__broader mesh__D014752smesh__D014753
% 221.72/221.88  |- skos__broader mesh__D014752smesh__D006843
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D014752 2001
% 221.72/221.88  |- mesh__publicMeSHNote mesh__D014752
% 221.72/221.88       91; was see under VINYL COMPOUNDS 1975-90; was in Cat D %26% J 1975-79%A%  
% 221.72/221.88  |- mesh__dateRevised mesh__D014752 2000-06-22
% 221.72/221.88  |- skos__historyNote mesh__D014752 Hydrocarbons, Chlorinated %28%1974%29%
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D014752 2004
% 221.72/221.88  |- skos__hiddenLabel mesh__D014752 Chloride, Vinyl
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D014752 2002
% 221.72/221.88  |- rdf__type mesh__D014752sskos__Concept
% 221.72/221.88  |- skos__altLabel mesh__D014752 Chloroethylene
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D014752 2005
% 221.72/221.88  |- skos__historyNote mesh__D014752 Vinyl Compounds %28%1974%29%
% 221.72/221.88  |- skos__prefLabel mesh__D014752 Vinyl Chloride
% 221.72/221.88  |- skos__scopeNote mesh__D014752
% 221.72/221.88       A gas that has been used as an aerosol propellant and is the starting material for polyvinyl resins. Toxicity studies have shown various adverse effects, particularly the occurrence of liver neoplasms.%A%    
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D014752 2006
% 221.72/221.88  |- mesh__recordMaintainer mesh__D014752 CCR
% 221.72/221.88  |- mesh__recordOriginator mesh__D014752 NLM
% 221.72/221.88  |- mesh__historyNote mesh__D014752
% 221.72/221.88       91%28%75%29%; was see under VINYL COMPOUNDS 1975-90; was in Cat D %26% J 1975-79%A%  
% 221.72/221.88  |- skos__annotation mesh__D014752
% 221.72/221.88       D25-26 qualif; POLYVINYL CHLORIDE is available   
% 221.72/221.88  |- mesh__recordAuthorizer mesh__D014752 sjn
% 221.72/221.88  |- mesh__dateEstablished mesh__D014752 1991-01-01
% 221.72/221.88  |- skos__altLabel mesh__D008715 L-Methionine
% 221.72/221.88  |- skos__scopeNote mesh__D008715
% 221.72/221.88       A sulfur containing essential amino acid that is important in many body functions. It is a chelating agent for heavy metals.%A%    
% 221.72/221.88  |- skos__altLabel mesh__D008715 Methionine, L-Isomer
% 221.72/221.88  |- skos__hiddenLabel mesh__D008715 DL-Isomer Methionine
% 221.72/221.88  |- skos__broader mesh__D008715smesh__D000601
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D008715 2006
% 221.72/221.88  |- skos__hiddenLabel mesh__D008715 Methionine, L Isomer
% 221.72/221.88  |- skos__annotation mesh__D008715 /biosyn /defic /physiol permitted   
% 221.72/221.88  |- skos__broader mesh__D008715smesh__D000603
% 221.72/221.88  |- skos__prefLabel mesh__D008715 Methionine
% 221.72/221.88  |- skos__broader mesh__D008715smesh__D021542
% 221.72/221.88  |- mesh__recordMaintainer mesh__D008715 ssb
% 221.72/221.88  |- skos__hiddenLabel mesh__D008715 L-Isomer Methionine
% 221.72/221.88  |- mesh__recordOriginator mesh__D008715 NLM
% 221.72/221.88  |- mesh__dateRevised mesh__D008715 2005-06-30
% 221.72/221.88  |- rdf__type mesh__D008715sskos__Concept
% 221.72/221.88  |- mesh__recordAuthorizer mesh__D008715 sjn
% 221.72/221.88  |- mesh__dateCreated mesh__D008715 1999-01-01
% 221.72/221.88  |- skos__hiddenLabel mesh__D008715 Methionine, DL Isomer
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D000732 1999
% 221.72/221.88  |- skos__historyNote mesh__D000732 Hydroxysteroids %28%1972-1979%29%
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D000732 1994
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D000732 1997
% 221.72/221.88  |- skos__altLabel mesh__D000732 Hydroxyandrostanes
% 221.72/221.88  |- mesh__recordAuthorizer mesh__D000732 PLS
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D000732 1998
% 221.72/221.88  |- mesh__dateCreated mesh__D000732 1979-05-23
% 221.72/221.88  |- skos__broader mesh__D000732smesh__D000731
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D000732 1996
% 221.72/221.88  |- skos__annotation mesh__D000732 do not confuse with ANDROSTENOLS   
% 221.72/221.88  |- mesh__recordOriginator mesh__D000732 RLS
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D000732 2006
% 221.72/221.88  |- mesh__dateRevised mesh__D000732 1993-06-03
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D000732 2001
% 221.72/221.88  |- mesh__recordMaintainer mesh__D000732 PLS
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D000732 2004
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D000732 2005
% 221.72/221.88  |- skos__historyNote mesh__D000732 Androstanes %28%1968-1979%29%
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D000732 2000
% 221.72/221.88  |- mesh__dateEstablished mesh__D000732 1980-01-01
% 221.72/221.88  |- skos__historyNote mesh__D000732 Steroids %28%1966-1967%29%
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D000732 2003
% 221.72/221.88  |- mesh__publicMeSHNote mesh__D000732 80   
% 221.72/221.88  |- skos__scopeNote mesh__D000732
% 221.72/221.88       Androstanes and androstane derivatives which are substituted in any position with one or more hydroxyl groups.%A%    
% 221.72/221.88  |- skos__prefLabel mesh__D000732 Androstanols
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D000732 1995
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D000732 2002
% 221.72/221.88  |- mesh__historyNote mesh__D000732 80   
% 221.72/221.88  |- rdf__type mesh__D000732sskos__Concept
% 221.72/221.88  |- skos__scopeNote mesh__D024382
% 221.72/221.88       The expected function of a member of  a particular profession.%A%    
% 221.72/221.88  |- mesh__historyNote mesh__D024382 2002   
% 221.72/221.88  |- skos__hiddenLabel mesh__D024382 Professional Roles
% 221.72/221.88  |- mesh__dateCreated mesh__D024382 2001-07-25
% 221.72/221.88  |- mesh__publicMeSHNote mesh__D024382 2002   
% 221.72/221.88  |- skos__broader mesh__D024382smesh__D012380
% 221.72/221.88  |- skos__prefLabel mesh__D024382 Professional Role
% 221.72/221.88  |- skos__hiddenLabel mesh__D024382 Role, Professional
% 221.72/221.88  |- skos__hiddenLabel mesh__D024382 Roles, Professional
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D024382 2005
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D024382 2002
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D024382 2003
% 221.72/221.88  |- rdf__type mesh__D024382sskos__Concept
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D024382 2006
% 221.72/221.88  |- mesh__dateEstablished mesh__D024382 2002-01-01
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D024382 2004
% 221.72/221.88  |- skos__historyNote mesh__D018345 Mice %28%1992-1993%29%
% 221.72/221.88  |- mesh__dateRevised mesh__D018345 2005-06-30
% 221.72/221.88  |- skos__annotation mesh__D018345
% 221.72/221.88       NIM no qualif when exper animal; do not forget also to check MICE%A%  
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D018345 2006
% 221.72/221.88  |- mesh__historyNote mesh__D018345 94   
% 221.72/221.88  |- skos__scopeNote mesh__D018345
% 221.72/221.88       Strains of mice in which certain GENES of their GENOMES have been disrupted, or %22%knocked-out%22%. To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases %28%DISEASE MODELS, ANIMAL%29% and to clarify the functions of the genes.%A%    
% 221.72/221.88  |- skos__hiddenLabel mesh__D018345 Knockout Mouse
% 221.72/221.88  |- skos__hiddenLabel mesh__D018345 Knock-out Mice
% 221.72/221.88  |- skos__altLabel mesh__D018345 Mouse, Knockout
% 221.72/221.88  |- mesh__dateCreated mesh__D018345 1993-06-03
% 221.72/221.88  |- mesh__recordAuthorizer mesh__D018345 sjn
% 221.72/221.88  |- skos__altLabel mesh__D018345 Mice, Knock-out
% 221.72/221.88  |- mesh__recordMaintainer mesh__D018345 ags
% 221.72/221.88  |- skos__hiddenLabel mesh__D018345 Mice, Knock out
% 221.72/221.88  |- rdf__type mesh__D018345sskos__Concept
% 221.72/221.88  |- mesh__recordOriginator mesh__D018345 PXP
% 221.72/221.88  |- skos__prefLabel mesh__D018345 Mice, Knockout
% 221.72/221.88  |- skos__broader mesh__D018345smesh__D008817
% 221.72/221.88  |- mesh__publicMeSHNote mesh__D018345 94   
% 221.72/221.88  |- mesh__dateEstablished mesh__D018345 1994-01-01
% 221.72/221.88  |- skos__altLabel mesh__D018345 Knockout Mice
% 221.72/221.88  |- skos__broader mesh__D018345smesh__D008822
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D010362 2003
% 221.72/221.88  |- skos__hiddenLabel mesh__D010362 General Ward
% 221.72/221.88  |- skos__annotation mesh__D010362
% 221.72/221.88       note X ref WARDS, GENERAL but special care wards = HOSPITAL UNITS or specific%A%  
% 221.72/221.88  |- mesh__dateCreated mesh__D010362 1979-05-29
% 221.72/221.88  |- skos__hiddenLabel mesh__D010362 Patients Rooms
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D010362 2001
% 221.72/221.88  |- mesh__recordOriginator mesh__D010362 EC
% 221.72/221.88  |- skos__hiddenLabel mesh__D010362 Room, Patient
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D010362 1998
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D010362 1993
% 221.72/221.88  |- skos__hiddenLabel mesh__D010362 Patient%27%s Rooms
% 221.72/221.88  |- skos__hiddenLabel mesh__D010362 Room, Semi-Private
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D010362 2000
% 221.72/221.88  |- skos__hiddenLabel mesh__D010362 Private Room
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D010362 1997
% 221.72/221.88  |- mesh__dateEstablished mesh__D010362 1991-01-01
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D010362 2006
% 221.72/221.88  |- skos__hiddenLabel mesh__D010362 Rooms, Patients%27%
% 221.72/221.88  |- skos__hiddenLabel mesh__D010362 Rooms, Semi-Private
% 221.72/221.88  |- skos__broader mesh__D010362smesh__D006272
% 221.72/221.88  |- skos__hiddenLabel mesh__D010362 Room, Patients%27%
% 221.72/221.88  |- skos__hiddenLabel mesh__D010362 Rooms, Private
% 221.72/221.88  |- mesh__publicMeSHNote mesh__D010362
% 221.72/221.88       91; was see under HEALTH FACILITIES 1980-90   
% 221.72/221.88  |- skos__hiddenLabel mesh__D010362 General Wards
% 221.72/221.88  |- mesh__historyNote mesh__D010362
% 221.72/221.88       91%28%80%29%; was see under HEALTH FACILITIES 1980-90   
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D010362 1996
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D010362 2005
% 221.72/221.88  |- skos__scopeNote mesh__D010362
% 221.72/221.88       Rooms occupied by one or more individuals during a stay in a health facility. The concept includes aspects of environment, design, care, or economics.%A%    
% 221.72/221.88  |- skos__hiddenLabel mesh__D010362 Patient Rooms
% 221.72/221.88  |- skos__prefLabel mesh__D010362 Patients%27% Rooms
% 221.72/221.88  |- skos__hiddenLabel mesh__D010362 Patients%27% Room
% 221.72/221.88  |- skos__hiddenLabel mesh__D010362 Semi Private Rooms
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D010362 1995
% 221.72/221.88  |- mesh__recordMaintainer mesh__D010362 TGC
% 221.72/221.88  |- skos__historyNote mesh__D010362 Hospital Units %28%1974-1979%29%
% 221.72/221.88  |- skos__altLabel mesh__D010362 Rooms, Patient
% 221.72/221.88  |- skos__hiddenLabel mesh__D010362 Patient Room
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D010362 2004
% 221.72/221.88  |- skos__hiddenLabel mesh__D010362 Semi-Private Room
% 221.72/221.88  |- mesh__dateRevised mesh__D010362 1992-05-15
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D010362 2002
% 221.72/221.88  |- mesh__recordAuthorizer mesh__D010362 PLS
% 221.72/221.88  |- skos__hiddenLabel mesh__D010362 Room, Private
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D010362 1999
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D010362 1994
% 221.72/221.88  |- rdf__type mesh__D010362sskos__Concept
% 221.72/221.88  |- skos__hiddenLabel mesh__D010362 Ward, General
% 221.72/221.88  |- skos__prefLabel mesh__D051779 Sterol Regulatory Element Binding Proteins
% 221.72/221.88  |- skos__broader mesh__D051779smesh__D051778
% 221.72/221.88  |- mesh__recordMaintainer mesh__D051779 DRC
% 221.72/221.88  |- mesh__dateEstablished mesh__D051779 2006-01-01
% 221.72/221.88  |- mesh__historyNote mesh__D051779 2006   
% 221.72/221.88  |- skos__scopeNote mesh__D051779
% 221.72/221.88       Sterol regulatory element binding proteins are basic helix-loop-helix leucine zipper transcription factors that bind the sterol regulatory element TCACNCCAC. They are synthesized as precursors that are threaded into the MEMBRANES of the ENDOPLASMIC RETICULUM.%A%    
% 221.72/221.88  |- skos__altLabel mesh__D051779 SREBP Proteins
% 221.72/221.88  |- mesh__publicMeSHNote mesh__D051779 2006   
% 221.72/221.88  |- mesh__recordOriginator mesh__D051779 DRC
% 221.72/221.88  |- mesh__dateCreated mesh__D051779 2005-06-30
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D051779 2006
% 221.72/221.88  |- mesh__recordAuthorizer mesh__D051779 sjn
% 221.72/221.88  |- rdf__type mesh__D051779sskos__Concept
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004325 2004
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004325 2002
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004325 2006
% 221.72/221.88  |- skos__prefLabel mesh__D004325 Dreams
% 221.72/221.88  |- skos__annotation mesh__D004325
% 221.72/221.88       consider also NIGHT TERRORS %26% PAVOR NOCTURNUS %28%both see SLEEP DISORDERS%29%%A%  
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004325 1996
% 221.72/221.88  |- mesh__recordOriginator mesh__D004325 NLM
% 221.72/221.88  |- mesh__dateCreated mesh__D004325 1999-01-01
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004325 1998
% 221.72/221.88  |- skos__hiddenLabel mesh__D004325 Nightmare
% 221.72/221.88  |- rdf__type mesh__D004325sskos__Concept
% 221.72/221.88  |- mesh__recordMaintainer mesh__D004325 TAP
% 221.72/221.88  |- mesh__dateRevised mesh__D004325 1992-05-14
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004325 1997
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004325 2000
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004325 1994
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004325 1999
% 221.72/221.88  |- skos__broader mesh__D004325smesh__D012890
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004325 1993
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004325 2001
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004325 1995
% 221.72/221.88  |- skos__hiddenLabel mesh__D004325 Dream
% 221.72/221.88  |- skos__broader mesh__D004325smesh__D007092
% 221.72/221.88  |- mesh__recordAuthorizer mesh__D004325 PLS
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004325 2003
% 221.72/221.88  |- skos__scopeNote mesh__D004325
% 221.72/221.88       A series of thoughts, images, or emotions occurring during sleep which are dissociated from the usual stream of consciousness of the waking state.%A%    
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D004325 2005
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D009010 2004
% 221.72/221.88  |- mesh__publicMeSHNote mesh__D009010
% 221.72/221.88       91; was see under OPERATIONS RESEARCH 1975-90   
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D009010 1998
% 221.72/221.88  |- skos__broader mesh__D009010smesh__D013223
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D009010 1997
% 221.72/221.88  |- skos__broader mesh__D009010smesh__D009874
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D009010 2002
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D009010 2006
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D009010 1999
% 221.72/221.88  |- mesh__dateCreated mesh__D009010 1999-01-01
% 221.72/221.88  |- skos__prefLabel mesh__D009010 Monte Carlo Method
% 221.72/221.88  |- mesh__recordOriginator mesh__D009010 NLM
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D009010 2000
% 221.72/221.88  |- mesh__dateRevised mesh__D009010 1995-05-18
% 221.72/221.88  |- mesh__recordAuthorizer mesh__D009010 PLS
% 221.72/221.88  |- rdf__type mesh__D009010sskos__Concept
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D009010 2001
% 221.72/221.88  |- mesh__historyNote mesh__D009010
% 221.72/221.88       91%28%75%29%; was see under OPERATIONS RESEARCH 1975-90   
% 221.72/221.88  |- mesh__recordMaintainer mesh__D009010 TGC
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D009010 2003
% 221.72/221.88  |- mesh__dateEstablished mesh__D009010 1991-01-01
% 221.72/221.88  |- skos__hiddenLabel mesh__D009010 Method, Monte Carlo
% 221.72/221.88  |- skos__annotation mesh__D009010 a statist method; no qualif   
% 221.72/221.88  |- skos__scopeNote mesh__D009010
% 221.72/221.88       In statistics, a technique for numerically approximating the solution of a mathematical problem by studying the distribution of some random variable, often generated by a computer. The name alludes to the randomness characteristic of the games of chance played at the gambling casinos in Monte Carlo. %28%From Random House Unabridged Dictionary, 2d ed, 1993%29%%A%    
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D009010 1996
% 221.72/221.88  |- mesh__onlineNote mesh__D009010 search OPERATIONS RESEARCH 1966-74   
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D009010 2005
% 221.72/221.88  |- mesh__historyNote mesh__D020790 2000   
% 221.72/221.88  |- skos__hiddenLabel mesh__D020790 Pituitary Diabetes Insipidus
% 221.72/221.88  |- mesh__dateRevised mesh__D020790 2005-07-08
% 221.72/221.88  |- skos__broader mesh__D020790smesh__D003919
% 221.72/221.88  |- skos__altLabel mesh__D020790 Diabetes Insipidus, Central
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D020790 2006A
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D020790 2006
% 221.72/221.88  |- skos__annotation mesh__D020790
% 221.72/221.88       do not confuse with DIABETES INSIPIDUS, NEPHROGENIC   
% 221.72/221.88  |- mesh__recordOriginator mesh__D020790 KEV
% 221.72/221.88  |- skos__hiddenLabel mesh__D020790 Central Diabetes Insipidus
% 221.72/221.88  |- mesh__dateCreated mesh__D020790 1999-11-03
% 221.72/221.88  |- skos__altLabel mesh__D020790 Neurogenic Diabetes Insipidus
% 221.72/221.88  |- rdf__type mesh__D020790sskos__Concept
% 221.72/221.88  |- skos__altLabel mesh__D020790 Diabetes Insipidus, Neurohypophyseal
% 221.72/221.88  |- skos__scopeNote mesh__D020790
% 221.72/221.88       A genetic or acquired polyuric disorder caused by a deficiency of VASOPRESSINS secreted by the NEUROHYPOPHYSIS. Clinical signs include the excretion of large volumes of dilute URINE; HYPERNATREMIA; THIRST; and polydipsia. Etiologies include HEAD TRAUMA; surgeries and diseases involving the HYPOTHALAMUS and the PITUITARY GLAND. This disorder may also be caused by mutations of genes such as ARVP encoding vasopressin and its corresponding neurophysin %28%NEUROPHYSINS%29%.%A%    
% 221.72/221.88  |- skos__hiddenLabel mesh__D020790 Neurohypophyseal Diabetes Insipidus
% 221.72/221.88  |- mesh__recordAuthorizer mesh__D020790 ags
% 221.72/221.88  |- skos__prefLabel mesh__D020790 Diabetes Insipidus, Neurogenic
% 221.72/221.88  |- mesh__dateEstablished mesh__D020790 2000-01-01
% 221.72/221.88  |- skos__historyNote mesh__D020790 Diabetes Insipidus %28%1966-1999%29%
% 221.72/221.88  |- mesh__publicMeSHNote mesh__D020790 2000   
% 221.72/221.88  |- mesh__recordMaintainer mesh__D020790 ags
% 221.72/221.88  |- skos__altLabel mesh__D020790 Diabetes Insipidus, Pituitary
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D014753 2004
% 221.72/221.88  |- rdf__type mesh__D014753sskos__Concept
% 221.72/221.88  |- skos__prefLabel mesh__D014753 Vinyl Compounds
% 221.72/221.88  |- skos__broader mesh__D014753smesh__D000475
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D014753 1997
% 221.72/221.88  |- mesh__recordAuthorizer mesh__D014753 sjn
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D014753 2000
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D014753 2005
% 221.72/221.88  |- skos__historyNote mesh__D014753
% 221.72/221.88       specific component in the molecule %28%1971-1973%29%
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D014753 2001
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D014753 1998
% 221.72/221.88  |- mesh__historyNote mesh__D014753 73%28%71%29%   
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D014753 1993
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D014753 2006
% 221.72/221.88  |- mesh__publicMeSHNote mesh__D014753 73   
% 221.72/221.88  |- skos__annotation mesh__D014753 DF: VINYL CPDS   
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D014753 1994
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D014753 1999
% 221.72/221.88  |- mesh__activeMeSHYear mesh__D014753 2002
% 221.74/221.88  |- mesh__activeMeSHYear mesh__D014753 1995
% 221.74/221.88  |- mesh__dateCreated mesh__D014753 1999-01-01
% 221.74/221.88  |- skos__historyNote mesh__D014753 Alkenes %28%1966-1970%29%
% 221.74/221.88  |- mesh__dateEstablished mesh__D014753 1973-01-01
% 221.74/221.88  |- mesh__activeMeSHYear mesh__D014753 2003
% 221.74/221.88  |- skos__hiddenLabel mesh__D014753 Compounds, Vinyl
% 221.74/221.88  |- mesh__recordOriginator mesh__D014753 NLM
% 221.74/221.88  |- mesh__recordMaintainer mesh__D014753 sjn
% 221.74/221.88  |- mesh__activeMeSHYear mesh__D014753 2001A
% 221.74/221.88  |- mesh__dateRevised mesh__D014753 2001-02-22
% 221.74/221.88  |- mesh__activeMeSHYear mesh__D014753 1996
% 221.74/221.88  |- skos__prefLabel mesh__D008716 Methionine Adenosyltransferase
% 221.74/221.88  |- mesh__activeMeSHYear mesh__D008716 2004
% 221.74/221.88  |- skos__historyNote mesh__D008716 S-Adenosylmethionine %28%1973-1974%29%
% 221.74/221.88  |- mesh__publicMeSHNote mesh__D008716
% 221.74/221.88       91; was see under TRANSFERASES 1975-90   
% 221.74/221.88  |- mesh__dateEstablished mesh__D008716 1991-01-01
% 221.74/221.88  |- mesh__dateCreated mesh__D008716 1974-11-19
% 221.74/221.88  |- skos__historyNote mesh__D008716 Adenosine Triphosphate %28%1972-1974%29%
% 221.74/221.88  |- skos__hiddenLabel mesh__D008716 Synthetase, S-Adenosylmethionine
% 221.74/221.88  |- skos__hiddenLabel mesh__D008716 S-Adenosyltransferase, ATP-Methionine
% 221.74/221.88  |- mesh__activeMeSHYear mesh__D008716 2006
% 221.74/221.88  |- mesh__recordMaintainer mesh__D008716 ssb
% 221.74/221.88  |- skos__hiddenLabel mesh__D008716 Adenosyltransferase, Methionine
% 221.74/221.88  |- skos__scopeNote mesh__D008716
% 221.74/221.88       An enzyme that catalyzes the synthesis of S-adenosylmethionine from methionine and ATP. EC 2.5.1.6.%A%    
% 221.74/221.88  |- skos__historyNote mesh__D008716 Transferases %28%1972-1974%29%
% 221.74/221.88  |- mesh__activeMeSHYear mesh__D008716 2005
% 221.74/221.88  |- skos__broader mesh__D008716smesh__D019883
% 221.74/221.88  |- mesh__recordOriginator mesh__D008716 NLM
% 221.74/221.88  |- skos__altLabel mesh__D008716 S-Adenosylmethionine Synthetase
% 221.74/221.88  |- rdf__type mesh__D008716sskos__Concept
% 221.74/221.88  |- mesh__recordAuthorizer mesh__D008716 sjn
% 221.74/221.88  |- skos__hiddenLabel mesh__D008716 ATP Methionine S Adenosyltransferase
% 221.74/221.88  |- mesh__historyNote mesh__D008716
% 221.74/221.88       91%28%75%29%; was see under TRANSFERASES 1975-90   
% 221.74/221.88  |- skos__altLabel mesh__D008716 ATP-Methionine S-Adenosyltransferase
% 221.74/221.88  |- skos__hiddenLabel mesh__D008716 S Adenosylmethionine Synthetase
% 221.74/221.88  |- mesh__dateRevised mesh__D008716 2003-07-09
% 221.74/221.88  |- skos__historyNote mesh__D008716 Methionine %28%1972%29%
% 221.74/221.88  |- mesh__dateCreated mesh__D000733 1999-01-01
% 221.74/221.88  |- mesh__activeMeSHYear mesh__D000733 1996
% 221.74/221.88  |- mesh__activeMeSHYear mesh__D000733 2006
% 221.74/221.88  |- mesh__activeMeSHYear mesh__D000733 2002
% 221.74/221.88  |- mesh__activeMeSHYear mesh__D000733 2004
% 221.74/221.88  |- skos__prefLabel mesh__D000733 Androstatrienes
% 221.74/221.88  |- mesh__activeMeSHYear mesh__D000733 2005
% 221.74/221.88  |- mesh__publicMeSHNote mesh__D000733
% 221.74/221.88       75; was see under ANDROSTENES 1973-74   
% 221.74/221.88  |- mesh__activeMeSHYear mesh__D000733 2003
% 221.74/221.88  |- mesh__recordAuthorizer mesh__D000733 PLS
% 221.74/221.88  |- mesh__onlineNote mesh__D000733 search ANDROSTENES 1973-74   
% 221.74/221.88  |- mesh__dateRevised mesh__D000733 1993-06-03
% 221.74/221.88  |- mesh__activeMeSHYear mesh__D000733 2001
% 221.74/221.88  |- mesh__recordMaintainer mesh__D000733 PLS
% 221.74/221.88  |- mesh__dateEstablished mesh__D000733 1975-01-01
% 221.74/221.88  |- mesh__activeMeSHYear mesh__D000733 1995
% 221.74/221.88  |- mesh__activeMeSHYear mesh__D000733 2000
% 221.74/221.88  |- skos__broader mesh__D000733smesh__D000736
% 221.74/221.88  |- rdf__type mesh__D000733sskos__Concept
% 221.74/221.88  |- mesh__activeMeSHYear mesh__D000733 1999
% 221.74/221.88  |- mesh__activeMeSHYear mesh__D000733 1994
% 221.74/221.88  |- mesh__recordOriginator mesh__D000733 NLM
% 221.74/221.88  |- mesh__historyNote mesh__D000733 75; was see under ANDROSTENES 1973-74   
% 221.74/221.88  |- mesh__activeMeSHYear mesh__D000733 1997
% 221.74/221.88  |- skos__scopeNote mesh__D000733
% 221.74/221.88       Derivatives of the steroid androstane having three double bonds at any site in any of the rings.%A%    
% 221.74/221.88  |- mesh__activeMeSHYear mesh__D000733 1998
% 221.74/221.88  |- mesh__recordAuthorizer mesh__D010363 sjn
% 221.74/221.89  |- skos__broader mesh__D010363smesh__D007254
% 221.74/221.89  |- skos__hiddenLabel mesh__D010363 Pattern Recognition Systems
% 221.74/221.89  |- skos__annotation mesh__D010363
% 221.74/221.89       not physiological: physiol pattern recognition is PATTERN RECOGNITION, PHYSIOLOGICAL%A%  
% 221.74/221.89  |- mesh__publicMeSHNote mesh__D010363
% 221.74/221.89       2005; see PATTERN RECOGNITION 1973-2004, see AUTOMATIC DATA PROCESSING 1968-1972%A%  
% 221.74/221.89  |- mesh__historyNote mesh__D010363
% 221.74/221.89       2005; use PATTERN RECOGNITION 1973-2004, see AUTOMATIC DATA PROCESSING 1968-1972%A%  
% 221.74/221.89  |- skos__altLabel mesh__D010363 Automated Pattern Recognition
% 221.74/221.89  |- mesh__recordOriginator mesh__D010363 NLM
% 221.74/221.89  |- rdf__type mesh__D010363sskos__Concept
% 221.74/221.89  |- mesh__dateRevised mesh__D010363 2004-07-13
% 221.74/221.89  |- mesh__dateEstablished mesh__D010363 1973-01-01
% 221.74/221.89  |- skos__scopeNote mesh__D010363
% 221.74/221.89       In INFORMATION RETRIEVAL, machine-sensing or identification of visible patterns %28%shapes, forms, and configurations%29%. %28%Harrod%27%s Librarians%27% Glossary, 7th ed%29%%A%    
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D010363 2005
% 221.74/221.89  |- mesh__recordMaintainer mesh__D010363 sjn
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D010363 2006
% 221.74/221.89  |- skos__prefLabel mesh__D010363 Pattern Recognition, Automated
% 221.74/221.89  |- mesh__dateCreated mesh__D010363 1999-01-01
% 221.74/221.89  |- mesh__recordAuthorizer mesh__D004326 PLS
% 221.74/221.89  |- mesh__historyNote mesh__D004326 70%28%66%29%   
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D004326 1996
% 221.74/221.89  |- skos__annotation mesh__D004326
% 221.74/221.89       not for drinking alcohol or alcohol consumption %28% = ALCOHOL DRINKING%29%; when IM, qualif permitted; when NIM in psychol articles, usually no qualif but consider also DRINKING BEHAVIOR; TN 55: differentiate from DRINKING BEHAVIOR%A%  
% 221.74/221.89  |- skos__prefLabel mesh__D004326 Drinking
% 221.74/221.89  |- mesh__dateCreated mesh__D004326 1999-01-01
% 221.74/221.89  |- mesh__publicMeSHNote mesh__D004326 70   
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D004326 1998
% 221.74/221.89  |- rdf__type mesh__D004326sskos__Concept
% 221.74/221.89  |- mesh__dateRevised mesh__D004326 1992-05-08
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D004326 1997
% 221.74/221.89  |- skos__altLabel mesh__D004326 Water Intake
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D004326 2002
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D004326 1994
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D004326 1999
% 221.74/221.89  |- skos__related mesh__D004326smesh__D000428
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D004326 1993
% 221.74/221.89  |- skos__broader mesh__D004326smesh__D004068
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D004326 1995
% 221.74/221.89  |- skos__hiddenLabel mesh__D004326 Intake, Water
% 221.74/221.89  |- mesh__recordOriginator mesh__D004326 NLM
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D004326 2003
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D004326 2000
% 221.74/221.89  |- skos__hiddenLabel mesh__D004326 Consumption, Water
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D004326 2005
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D004326 2004
% 221.74/221.89  |- mesh__recordMaintainer mesh__D004326 TGC
% 221.74/221.89  |- mesh__dateEstablished mesh__D004326 1970-01-01
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D004326 2001
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D004326 2006
% 221.74/221.89  |- skos__altLabel mesh__D004326 Water Consumption
% 221.74/221.89  |- skos__hiddenLabel mesh__D004326 Drinkings
% 221.74/221.89  |- skos__prefLabel mesh__D009011 Monteggia%27%s Fracture
% 221.74/221.89  |- mesh__dateRevised mesh__D009011 2005-06-30
% 221.74/221.89  |- mesh__dateCreated mesh__D009011 1999-01-01
% 221.74/221.89  |- mesh__onlineNote mesh__D009011 search ULNA FRACTURES 1973-74   
% 221.74/221.89  |- skos__annotation mesh__D009011 ulna fract with radius disloc   
% 221.74/221.89  |- mesh__recordMaintainer mesh__D009011 ssb
% 221.74/221.89  |- mesh__publicMeSHNote mesh__D009011
% 221.74/221.89       91; was see under ULNA FRACTURES 1975-90   
% 221.74/221.89  |- rdf__type mesh__D009011sskos__Concept
% 221.74/221.89  |- mesh__historyNote mesh__D009011
% 221.74/221.89       91%28%75%29%; was see under ULNA FRACTURES 1975-90   
% 221.74/221.89  |- mesh__dateEstablished mesh__D009011 1991-01-01
% 221.74/221.89  |- skos__hiddenLabel mesh__D009011 Monteggias Fracture
% 221.74/221.89  |- mesh__recordOriginator mesh__D009011 NLM
% 221.74/221.89  |- skos__hiddenLabel mesh__D009011 Fracture, Monteggia%27%s
% 221.74/221.89  |- skos__hiddenLabel mesh__D009011 Monteggia Fracture
% 221.74/221.89  |- mesh__recordAuthorizer mesh__D009011 sjn
% 221.74/221.89  |- skos__broader mesh__D009011smesh__D014458
% 221.74/221.89  |- skos__scopeNote mesh__D009011
% 221.74/221.89       Fracture in the proximal half of the shaft of the ulna, with dislocation of the head of the radius.%A%    
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D009011 2006
% 221.74/221.89  |- mesh__dateCreated mesh__D020791 1999-11-03
% 221.74/221.89  |- mesh__historyNote mesh__D020791 2000   
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D020791 2006
% 221.74/221.89  |- skos__scopeNote mesh__D020791
% 221.74/221.89       A thrombin-like enzyme from the venom of snakes of the viper/rattlesnake group. Species variants of the enzyme include ANCROD %28%Agkistrodon rhodostoma %28%Malayan pit viper%29%%29%; BATROXOBIN from Bothrops atrox; and crotalase from Crotalus adamanteus %28%Eastern diamondback rattlesnake%29%. EC 3.4.21.74.%A%    
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D020791 2004
% 221.74/221.89  |- rdf__type mesh__D020791sskos__Concept
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D020791 2005
% 221.74/221.89  |- mesh__publicMeSHNote mesh__D020791 2000   
% 221.74/221.89  |- mesh__dateRevised mesh__D020791 2003-07-09
% 221.74/221.89  |- skos__broader mesh__D020791smesh__D012697
% 221.74/221.89  |- mesh__dateEstablished mesh__D020791 2000-01-01
% 221.74/221.89  |- skos__prefLabel mesh__D020791 Venombin A
% 221.74/221.89  |- skos__historyNote mesh__D014754 Aggression %28%1966-1967%29%
% 221.74/221.89  |- mesh__publicMeSHNote mesh__D014754 70; ATROCITIES was heading 1963-67   
% 221.74/221.89  |- mesh__dateCreated mesh__D014754 1999-01-01
% 221.74/221.89  |- skos__altLabel mesh__D014754 Behavior, Assaultive
% 221.74/221.89  |- skos__related mesh__D014754smesh__D001694
% 221.74/221.89  |- mesh__recordOriginator mesh__D014754 NLM
% 221.74/221.89  |- mesh__onlineNote mesh__D014754
% 221.74/221.89       search ATROCITIES under WAR CRIMES 1966-67   
% 221.74/221.89  |- mesh__historyNote mesh__D014754
% 221.74/221.89       70%28%68%29%; ATROCITIES was heading 1963-67   
% 221.74/221.89  |- skos__broader mesh__D014754smesh__D003415
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D014754 2003
% 221.74/221.89  |- mesh__recordAuthorizer mesh__D014754 sjn
% 221.74/221.89  |- mesh__recordMaintainer mesh__D014754 ags
% 221.74/221.89  |- skos__related mesh__D014754smesh__D014857
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D014754 2004
% 221.74/221.89  |- skos__related mesh__D014754smesh__D001497
% 221.74/221.89  |- skos__related mesh__D014754smesh__D018585
% 221.74/221.89  |- rdf__type mesh__D014754sskos__Concept
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D014754 2001
% 221.74/221.89  |- skos__broader mesh__D014754smesh__D012940
% 221.74/221.89  |- mesh__dateRevised mesh__D014754 2000-06-22
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D014754 2005
% 221.74/221.89  |- skos__scopeNote mesh__D014754
% 221.74/221.89       Individual or group aggressive behavior which is socially non-acceptable, turbulent, and often destructive. It is precipitated by frustrations, hostility, prejudices, etc.%A%    
% 221.74/221.89  |- skos__historyNote mesh__D014754 Psychology, Social %28%1966-1967%29%
% 221.74/221.89  |- skos__prefLabel mesh__D014754 Violence
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D014754 2002
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D014754 2006
% 221.74/221.89  |- mesh__dateEstablished mesh__D014754 1970-01-01
% 221.74/221.89  |- mesh__publicMeSHNote mesh__D047130 2005   
% 221.74/221.89  |- mesh__historyNote mesh__D047130 2005   
% 221.74/221.89  |- mesh__dateEstablished mesh__D047130 2005-01-01
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D047130 2005
% 221.74/221.89  |- skos__scopeNote mesh__D047130
% 221.74/221.89       A genus of SPONGES in the family Petrosiidae, characterized by an ectosomal triangular or polygonal reticulation of spicule tracts or single spicules.%A%    
% 221.74/221.89  |- skos__broader mesh__D047130smesh__D011161
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D047130 2006
% 221.74/221.89  |- skos__historyNote mesh__D047130 Porifera %28%1980-2004%29%
% 221.74/221.89  |- skos__prefLabel mesh__D047130 Petrosia
% 221.74/221.89  |- mesh__dateCreated mesh__D047130 2004-07-07
% 221.74/221.89  |- rdf__type mesh__D047130sskos__Concept
% 221.74/221.89  |- mesh__recordAuthorizer mesh__D047130 sjn
% 221.74/221.89  |- mesh__recordMaintainer mesh__D047130 ags
% 221.74/221.89  |- mesh__recordOriginator mesh__D047130 ags
% 221.74/221.89  |- mesh__dateRevised mesh__D008717 2005-06-30
% 221.74/221.89  |- skos__hiddenLabel mesh__D008717 Sulfoximine, Methionine
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D008717 2006
% 221.74/221.89  |- skos__prefLabel mesh__D008717 Methionine Sulfoximine
% 221.74/221.89  |- mesh__dateEstablished mesh__D008717 1973-01-01
% 221.74/221.89  |- rdf__type mesh__D008717sskos__Concept
% 221.74/221.89  |- mesh__historyNote mesh__D008717 73%28%64%29%   
% 221.74/221.89  |- mesh__dateCreated mesh__D008717 1999-01-01
% 221.74/221.89  |- skos__broader mesh__D008717smesh__D008715
% 221.74/221.89  |- mesh__recordMaintainer mesh__D008717 ssb
% 221.74/221.89  |- mesh__publicMeSHNote mesh__D008717 73   
% 221.74/221.89  |- mesh__recordOriginator mesh__D008717 NLM
% 221.74/221.89  |- mesh__recordAuthorizer mesh__D008717 sjn
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D000734 2006
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D000734 2002
% 221.74/221.89  |- skos__historyNote mesh__D000734 Androstenols %28%1974%29%
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D000734 2004
% 221.74/221.89  |- mesh__recordMaintainer mesh__D000734 PLS
% 221.74/221.89  |- mesh__recordOriginator mesh__D000734 NLM
% 221.74/221.89  |- mesh__recordAuthorizer mesh__D000734 PLS
% 221.74/221.89  |- mesh__onlineNote mesh__D000734
% 221.74/221.89       search ANDROSTENOLS 1974 %26% ANDROSTENES 1973   
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D000734 1994
% 221.74/221.89  |- skos__historyNote mesh__D000734 Androstenes %28%1973%29%
% 221.74/221.89  |- mesh__dateCreated mesh__D000734 1999-01-01
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D000734 1998
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D000734 1995
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D000734 2000
% 221.74/221.89  |- skos__annotation mesh__D000734 do not confuse with ANDROSTANEDIOL   
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D000734 1996
% 221.74/221.89  |- mesh__publicMeSHNote mesh__D000734
% 221.74/221.89       75; was see under ANDROSTENOLS 1974; was see under ANDROSTENES 1973%A%  
% 221.74/221.89  |- rdf__type mesh__D000734sskos__Concept
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D000734 1999
% 221.74/221.89  |- skos__scopeNote mesh__D000734
% 221.74/221.89       Unsaturated androstane derivatives which are substituted with two hydroxy groups in any position in the ring system.%A%    
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D000734 1997
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D000734 2005
% 221.74/221.89  |- skos__prefLabel mesh__D000734 Androstenediols
% 221.74/221.89  |- mesh__dateRevised mesh__D000734 1993-06-03
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D000734 2001
% 221.74/221.89  |- skos__broader mesh__D000734smesh__D000737
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D000734 2003
% 221.74/221.89  |- mesh__dateEstablished mesh__D000734 1975-09-01
% 221.74/221.89  |- mesh__historyNote mesh__D000734
% 221.74/221.89       75; was see under ANDROSTENOLS 1974; was see under ANDROSTENES 1973%A%  
% 221.74/221.89  |- rdf__type mesh__D018347sskos__Concept
% 221.74/221.89  |- skos__hiddenLabel mesh__D018347 Infection, Hepadnaviridae
% 221.74/221.89  |- mesh__recordOriginator mesh__D018347 AGS
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D018347 2004
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D018347 1997
% 221.74/221.89  |- mesh__recordAuthorizer mesh__D018347 PLS
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D018347 2000
% 221.74/221.89  |- skos__scopeNote mesh__D018347
% 221.74/221.89       Virus diseases caused by the HEPADNAVIRIDAE.     
% 221.74/221.89  |- skos__hiddenLabel mesh__D018347 Hepadnaviridae Infection
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D018347 2001
% 221.74/221.89  |- skos__altLabel mesh__D018347 Infections, Hepadnaviridae
% 221.74/221.89  |- mesh__dateRevised mesh__D018347 1996-06-10
% 221.74/221.89  |- mesh__dateEstablished mesh__D018347 1994-01-01
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D018347 2005
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D018347 1998
% 221.74/221.89  |- mesh__publicMeSHNote mesh__D018347 94   
% 221.74/221.89  |- mesh__recordMaintainer mesh__D018347 AGS
% 221.74/221.89  |- skos__annotation mesh__D018347 GEN or unspecified; prefer specific   
% 221.74/221.89  |- skos__broader mesh__D018347smesh__D004266
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D018347 2006
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D018347 1999
% 221.74/221.89  |- mesh__historyNote mesh__D018347 94   
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D018347 2002
% 221.74/221.89  |- mesh__dateCreated mesh__D018347 1993-06-04
% 221.74/221.89  |- skos__prefLabel mesh__D018347 Hepadnaviridae Infections
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D018347 2003
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D010364 2006
% 221.74/221.89  |- skos__broader mesh__D010364smesh__D014796
% 221.74/221.89  |- skos__hiddenLabel mesh__D010364 Visual Pattern Recognition
% 221.74/221.89  |- skos__prefLabel mesh__D010364 Pattern Recognition, Visual
% 221.74/221.89  |- mesh__historyNote mesh__D010364
% 221.74/221.89       91%28%75%29%; was see under FORM PERCEPTION 1975-90   
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D010364 2005
% 221.74/221.89  |- mesh__onlineNote mesh__D010364 search FORM PERCEPTION 1968-74   
% 221.74/221.89  |- mesh__recordMaintainer mesh__D010364 lkt
% 221.74/221.89  |- mesh__recordAuthorizer mesh__D010364 sjn
% 221.74/221.89  |- mesh__dateRevised mesh__D010364 2004-07-07
% 221.74/221.89  |- skos__broader mesh__D010364smesh__D046709
% 221.74/221.89  |- rdf__type mesh__D010364sskos__Concept
% 221.74/221.89  |- skos__scopeNote mesh__D010364
% 221.74/221.89       Mental process to visually perceive a critical number of facts %28%the pattern%29%, such as characters, shapes, displays, or designs.%A%    
% 221.74/221.89  |- mesh__recordOriginator mesh__D010364 NLM
% 221.74/221.89  |- mesh__dateEstablished mesh__D010364 1991-01-01
% 221.74/221.89  |- skos__hiddenLabel mesh__D010364 Recognition, Visual Pattern
% 221.74/221.89  |- mesh__dateCreated mesh__D010364 1999-01-01
% 221.74/221.89  |- mesh__publicMeSHNote mesh__D010364
% 221.74/221.89       91; was see under FORM PERCEPTION 1975-90   
% 221.74/221.89  |- skos__broader mesh__D010364smesh__D005556
% 221.74/221.89  |- mesh__recordAuthorizer mesh__D037501 sjn
% 221.74/221.89  |- skos__altLabel mesh__D037501 Galactoside-Binding Lectin 2
% 221.74/221.89  |- mesh__recordMaintainer mesh__D037501 jmp
% 221.74/221.89  |- skos__hiddenLabel mesh__D037501 Galactoside Binding Lectin 2
% 221.74/221.89  |- mesh__dateEstablished mesh__D037501 2003-01-01
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D037501 2005
% 221.74/221.89  |- mesh__historyNote mesh__D037501
% 221.74/221.89       2003; use GALECTIN 2 %28%NM%29% 1996-2002   
% 221.74/221.89  |- skos__broader mesh__D037501smesh__D037161
% 221.74/221.89  |- mesh__recordOriginator mesh__D037501 jmp
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D037501 2006
% 221.74/221.89  |- skos__prefLabel mesh__D037501 Galectin 2
% 221.74/221.89  |- skos__historyNote mesh__D037501 Hemagglutinins %28%1996-2002%29%
% 221.74/221.89  |- skos__altLabel mesh__D037501 Galectin-2
% 221.74/221.89  |- skos__scopeNote mesh__D037501
% 221.74/221.89       A galectin found preferentially expressed in the gastrointestinal tract.  The protein occurs as a homodimer with two 14-kDa subunits.%A%    
% 221.74/221.89  |- skos__altLabel mesh__D037501 LGALS2
% 221.74/221.89  |- skos__hiddenLabel mesh__D037501 Lectin 2, Galactoside-Binding
% 221.74/221.89  |- mesh__dateRevised mesh__D037501 2004-07-07
% 221.74/221.89  |- rdf__type mesh__D037501sskos__Concept
% 221.74/221.89  |- mesh__dateCreated mesh__D037501 2002-07-03
% 221.74/221.89  |- mesh__publicMeSHNote mesh__D037501
% 221.74/221.89       2003; GALECTIN 2 was indexed under HEMAGGLUTININS 1996-2002%A%  
% 221.74/221.89  |- mesh__dateCreated mesh__D004327 1999-01-01
% 221.74/221.89  |- mesh__historyNote mesh__D004327 69   
% 221.74/221.89  |- mesh__publicMeSHNote mesh__D004327 69   
% 221.74/221.89  |- rdf__type mesh__D004327sskos__Concept
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D004327 2006
% 221.74/221.89  |- skos__historyNote mesh__D004327 Behavior %28%1966-1968%29%
% 221.74/221.89  |- mesh__recordMaintainer mesh__D004327 sjn
% 221.74/221.89  |- skos__hiddenLabel mesh__D004327 Behavior, Drinking
% 221.74/221.89  |- skos__historyNote mesh__D004327 Thirst %28%1966-1968%29%
% 221.74/221.89  |- mesh__recordOriginator mesh__D004327 NLM
% 221.74/221.89  |- mesh__dateRevised mesh__D004327 2004-07-13
% 221.74/221.89  |- skos__scopeNote mesh__D004327
% 221.74/221.89       Behaviors associated with the ingesting of water and other liquids; includes rhythmic patterns of drinking %28%time intervals - onset and duration%29%, frequency and satiety.%A%    
% 221.74/221.89  |- mesh__dateEstablished mesh__D004327 1969-01-01
% 221.74/221.89  |- skos__hiddenLabel mesh__D004327 Drinking Behaviors
% 221.74/221.89  |- skos__broader mesh__D004327smesh__D001519
% 221.74/221.89  |- skos__annotation mesh__D004327
% 221.74/221.89       does not refer to drinking alcohol %28% = ALCOHOL DRINKING%29%; human %26% animal; TN 55: differentiate from DRINKING%A%  
% 221.74/221.89  |- mesh__recordAuthorizer mesh__D004327 sjn
% 221.74/221.89  |- skos__prefLabel mesh__D004327 Drinking Behavior
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D004327 2005
% 221.74/221.89  |- skos__hiddenLabel mesh__D004327 Behaviors, Drinking
% 221.74/221.89  |- skos__scopeNote mesh__D009810
% 221.74/221.89       A mixed tumor of odontogenic origin, in which both the epithelial and mesenchymal cells exhibit complete differentiation, resulting in the formation of tooth structures. %28%Jablonski, Illustrated Dictionary of Dentistry, 1982%29%%A%    
% 221.74/221.89  |- skos__hiddenLabel mesh__D009810 Compound Odontomas
% 221.74/221.89  |- skos__broader mesh__D009810smesh__D009808
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D009810 2005
% 221.74/221.89  |- skos__altLabel mesh__D009810 Fibroodontoma
% 221.74/221.89  |- skos__hiddenLabel mesh__D009810 Odontomas
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D009810 2000
% 221.74/221.89  |- mesh__dateCreated mesh__D009810 1999-01-01
% 221.74/221.89  |- mesh__recordOriginator mesh__D009810 NLM
% 221.74/221.89  |- skos__hiddenLabel mesh__D009810 Fibroodontomas
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D009810 2003
% 221.74/221.89  |- mesh__recordMaintainer mesh__D009810 KEV
% 221.74/221.89  |- skos__hiddenLabel mesh__D009810 Ameloblastic Fibro-odontoma
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D009810 2006
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D009810 2001
% 221.74/221.89  |- skos__hiddenLabel mesh__D009810 Fibro-Odontomas
% 221.74/221.89  |- mesh__recordAuthorizer mesh__D009810 PLS
% 221.74/221.89  |- skos__hiddenLabel mesh__D009810 Ameloblastic Fibro-odontomas
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D009810 1998
% 221.74/221.89  |- skos__historyNote mesh__D009810 Odontogenic Tumors %28%1966-1974%29%
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D009810 2004
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D009810 2002
% 221.74/221.89  |- rdf__type mesh__D009810sskos__Concept
% 221.74/221.89  |- skos__hiddenLabel mesh__D009810 Odontomas, Compound
% 221.74/221.89  |- skos__hiddenLabel mesh__D009810 Fibro-odontomas, Ameloblastic
% 221.74/221.89  |- skos__annotation mesh__D009810
% 221.74/221.89       /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; French %22%odontome%22% %28%a form of developmental anomaly%29%: index under TOOTH ABNORMALITIES%A%  
% 221.74/221.89  |- mesh__onlineNote mesh__D009810 search ODONTOGENIC TUMORS 1966-74   
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D009810 1996
% 221.74/221.89  |- skos__hiddenLabel mesh__D009810 Compound Odontoma
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D009810 1999
% 221.74/221.89  |- mesh__historyNote mesh__D009810
% 221.74/221.89       91%28%75%29%; was see under ODONTOGENIC TUMORS 1980-90; was see under ODONTOGENIC TUMOR 1975-79%A%  
% 221.74/221.89  |- mesh__dateRevised mesh__D009810 1995-06-08
% 221.74/221.89  |- skos__hiddenLabel mesh__D009810 Fibro odontoma, Ameloblastic
% 221.74/221.89  |- skos__altLabel mesh__D009810 Fibro-Odontoma
% 221.74/221.89  |- mesh__publicMeSHNote mesh__D009810
% 221.74/221.89       91; was see under ODONTOGENIC TUMORS 1980-90; was see under ODONTOGENIC TUMOR 1975-79%A%  
% 221.74/221.89  |- mesh__dateEstablished mesh__D009810 1991-01-01
% 221.74/221.89  |- skos__hiddenLabel mesh__D009810 Fibro Odontoma
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D009810 1997
% 221.74/221.89  |- skos__prefLabel mesh__D009810 Odontoma
% 221.74/221.89  |- rdf__type mesh__D009012sskos__Concept
% 221.74/221.89  |- mesh__recordOriginator mesh__D009012 NLM
% 221.74/221.89  |- mesh__onlineNote mesh__D009012 use MOPIDAMOL to search RA 233 1975-84   
% 221.74/221.89  |- mesh__dateCreated mesh__D009012 1974-11-19
% 221.74/221.89  |- mesh__recordAuthorizer mesh__D009012 sjn
% 221.74/221.89  |- mesh__historyNote mesh__D009012
% 221.74/221.89       91%28%85%29%; was see under PYRIMIDINES 1985-90; was RA 233 see under PYRIMIDINES 1975-84%A%  
% 221.74/221.89  |- skos__prefLabel mesh__D009012 Mopidamol
% 221.74/221.89  |- mesh__dateEstablished mesh__D009012 1991-01-01
% 221.74/221.89  |- mesh__recordMaintainer mesh__D009012 jmp
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D009012 2005
% 221.74/221.89  |- skos__historyNote mesh__D009012 Pyrimidines %28%1971-1974%29%
% 221.74/221.89  |- skos__broader mesh__D009012smesh__D011743
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D009012 2006
% 221.74/221.89  |- mesh__dateRevised mesh__D009012 2004-07-07
% 221.74/221.89  |- skos__scopeNote mesh__D009012
% 221.74/221.89       A phosphodiesterase inhibitor which inhibits platelet aggregation. Formerly used as an antineoplastic.%A%    
% 221.74/221.89  |- skos__historyNote mesh__D009012 Piperidines %28%1971-1974%29%
% 221.74/221.89  |- skos__historyNote mesh__D009012 Ethanolamines %28%1973-1974%29%
% 221.74/221.89  |- mesh__publicMeSHNote mesh__D009012
% 221.74/221.89       91; was see under PYRIMIDINES 1985-90; was RA 233 see under PYRIMIDINES 1975-84%A%  
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D020792 2000
% 221.74/221.89  |- mesh__publicMeSHNote mesh__D020792 2000   
% 221.74/221.89  |- skos__annotation mesh__D020792
% 221.74/221.89       chem composition of calculi: use/chem; /ultrastruc permitted%A%  
% 221.74/221.89  |- mesh__historyNote mesh__D020792 2000   
% 221.74/221.89  |- mesh__dateCreated mesh__D020792 1999-11-03
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D020792 2006
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D020792 2002
% 221.74/221.89  |- skos__historyNote mesh__D020792 Salivary Duct Calculi %28%1965-1999%29%
% 221.74/221.89  |- skos__prefLabel mesh__D020792 Salivary Calculi
% 221.74/221.89  |- rdf__type mesh__D020792sskos__Concept
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D020792 2004
% 221.74/221.89  |- skos__scopeNote mesh__D020792
% 221.74/221.89       The presence of calculi in a salivary duct or gland.     
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D020792 2005
% 221.74/221.89  |- skos__hiddenLabel mesh__D020792 Calculus, Salivary
% 221.74/221.89  |- skos__broader mesh__D020792smesh__D002137
% 221.74/221.89  |- skos__altLabel mesh__D020792 Salivary Calculus
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D020792 2003
% 221.74/221.89  |- mesh__dateEstablished mesh__D020792 2000-01-01
% 221.74/221.89  |- skos__altLabel mesh__D020792 Calculi, Salivary
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D020792 2001
% 221.74/221.89  |- skos__annotation mesh__D014755 oxidation-reduction indicators   
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D014755 1999
% 221.74/221.89  |- mesh__recordAuthorizer mesh__D014755 PLS
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D014755 2006
% 221.74/221.89  |- mesh__historyNote mesh__D014755
% 221.74/221.89       91%28%75%29%; was see under PYRIDINIUM COMPOUNDS 1975-90   
% 221.74/221.89  |- mesh__recordOriginator mesh__D014755 NLM
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D014755 1994
% 221.74/221.89  |- mesh__publicMeSHNote mesh__D014755
% 221.74/221.89       91; was see under PYRIDINIUM COMPOUNDS 1975-90   
% 221.74/221.89  |- skos__scopeNote mesh__D014755
% 221.74/221.89       A group of dipyridinium chloride derivatives that are used as oxidation-reduction indicators. The general formula is 1,1%27%-di-R-4,4%27%-bipyridinium chloride, where R = methyl, ethyl, benzyl or, betaine.%A%    
% 221.74/221.89  |- skos__historyNote mesh__D014755 Pyridinium Compounds %28%1968-1974%29%
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D014755 2000
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D014755 1995
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D014755 1996
% 221.74/221.89  |- mesh__dateEstablished mesh__D014755 1991-01-01
% 221.74/221.89  |- skos__broader mesh__D014755smesh__D011726
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D014755 2003
% 221.74/221.89  |- mesh__recordMaintainer mesh__D014755 TAP
% 221.74/221.89  |- rdf__type mesh__D014755sskos__Concept
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D014755 1997
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D014755 2001
% 221.74/221.89  |- mesh__dateCreated mesh__D014755 1974-11-19
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D014755 2004
% 221.74/221.89  |- mesh__dateRevised mesh__D014755 1992-05-20
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D014755 1998
% 221.74/221.89  |- skos__prefLabel mesh__D014755 Viologens
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D014755 2002
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D014755 2005
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D014755 1993
% 221.74/221.89  |- skos__broader mesh__D047131smesh__D011161
% 221.74/221.89  |- mesh__historyNote mesh__D047131 2005   
% 221.74/221.89  |- skos__historyNote mesh__D047131 Porifera %28%1981-2004%29%
% 221.74/221.89  |- mesh__recordAuthorizer mesh__D047131 sjn
% 221.74/221.89  |- mesh__recordOriginator mesh__D047131 ags
% 221.74/221.89  |- mesh__recordMaintainer mesh__D047131 ags
% 221.74/221.89  |- skos__prefLabel mesh__D047131 Xestospongia
% 221.74/221.89  |- mesh__dateCreated mesh__D047131 2004-07-07
% 221.74/221.89  |- mesh__publicMeSHNote mesh__D047131 2005   
% 221.74/221.89  |- skos__scopeNote mesh__D047131
% 221.74/221.89       A genus of SPONGES in the family Petrosiidae, characterized by an ectosomal skeleton consisting only of an isotropic reticulation of single spicules or spicule tracts.%A%    
% 221.74/221.89  |- mesh__dateEstablished mesh__D047131 2005-01-01
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D047131 2006
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D047131 2005
% 221.74/221.89  |- rdf__type mesh__D047131sskos__Concept
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D008718 2004
% 221.74/221.89  |- skos__hiddenLabel mesh__D008718 Ligase, Methionine-tRNA
% 221.74/221.89  |- skos__hiddenLabel mesh__D008718 Met tRNA Ligase
% 221.74/221.89  |- mesh__recordOriginator mesh__D008718 NLM
% 221.74/221.89  |- mesh__activeMeSHYear mesh__D008718 2006
% 221.74/221.89  |- skos__hiddenLabel mesh__D008718 Synthetase, Methionyl-tRNA
% 221.74/221.89  |- skos__altLabel mesh__D008718 Methionyl-tRNA Synthetase
% 221.74/221.89  |- skos__prefLabel mesh__D008718 Methionine-tRNA Ligase
% 221.74/221.89  |- mesh__recordAuthorizer mesh__D008718 sjn
% 221.74/221.89  |- skos__hiddenLabel mesh__D008718 Ligase, Met-tRNA
% 221.74/221.89  |- rdf__type mesh__D008718sskos__Concept
% 221.74/221.89  |- skos__hiddenLabel mesh__D008718 Methionyl tRNA Synthetase
% 221.74/221.89  |- mesh__dateEstablished mesh__D008718 1991-01-01
% 221.74/221.89  |- skos__altLabel mesh__D008718 Met-tRNA Ligase
% 221.74/221.89  |- mesh__recordMaintainer mesh__D008718 ssb
% 221.74/221.89  |- skos__historyNote mesh__D008718
% 221.74/221.89       Amino Acyl T RNA Synthetases %28%1972-1974%29%
% 221.74/221.89  |- skos__altLabel mesh__D008718 Methionyl T RNA Synthetase
% 221.74/221.89  |- skos__historyNote mesh__D008718 Methionine %28%1972-1974%29%
% 221.74/221.89  |- mesh__historyNote mesh__D008718 98%28%75%29%   
% 221.74/221.89  |- mesh__dateRevised mesh__D008718 2003-07-09
% 221.74/221.89  |- mesh__dateCreated mesh__D008718 1974-11-19
% 221.74/221.89  |- mesh__publicMeSHNote mesh__D008718
% 221.74/221.89       98; see METHIONYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A%  
% 221.74/221.89  |- skos__broader mesh__D008718smesh__D000604
% 221.74/221.89  |- skos__hiddenLabel mesh__D008718 Methionine tRNA Ligase
% 221.74/221.89  |- skos__scopeNote mesh__D008718
% 221.74/221.89       An enzyme that activates methionine with its specific transfer RNA. EC 6.1.1.10.%A%    
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D008718 2005
% 221.74/221.90  |- skos__annotation mesh__D000735
% 221.74/221.90       note double bond at the C4 position; do not confuse with androstanedione which is without the double bond%A%  
% 221.74/221.90  |- skos__hiddenLabel mesh__D000735 4 Androstene 3,17 dione
% 221.74/221.90  |- skos__broader mesh__D000735smesh__D015068
% 221.74/221.90  |- skos__hiddenLabel mesh__D000735 delta 4 Androstenedione
% 221.74/221.90  |- mesh__publicMeSHNote mesh__D000735 74   
% 221.74/221.90  |- skos__broader mesh__D000735smesh__D045165
% 221.74/221.90  |- skos__broader mesh__D000735smesh__D000736
% 221.74/221.90  |- mesh__dateCreated mesh__D000735 1999-01-01
% 221.74/221.90  |- skos__prefLabel mesh__D000735 Androstenedione
% 221.74/221.90  |- mesh__recordOriginator mesh__D000735 NLM
% 221.74/221.90  |- skos__altLabel mesh__D000735 4-Androstene-3,17-dione
% 221.74/221.90  |- skos__scopeNote mesh__D000735
% 221.74/221.90       A delta-4 C19 steroid that is produced not only in the TESTIS, but also in the OVARY and the ADRENAL CORTEX.  Depending on the tissue type, androstenedione can serve as a precursor to TESTOSTERONE as well as ESTRONE and ESTRADIOL.%A%    
% 221.74/221.90  |- rdf__type mesh__D000735sskos__Concept
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D000735 2005
% 221.74/221.90  |- skos__altLabel mesh__D000735 delta-4-Androstenedione
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D000735 2006
% 221.74/221.90  |- mesh__dateRevised mesh__D000735 2003-07-09
% 221.74/221.90  |- mesh__recordMaintainer mesh__D000735 lkt
% 221.74/221.90  |- mesh__dateEstablished mesh__D000735 1974-01-01
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D000735 2004
% 221.74/221.90  |- mesh__recordAuthorizer mesh__D000735 sjn
% 221.74/221.90  |- mesh__historyNote mesh__D000735 74%28%73%29%   
% 221.74/221.90  |- skos__hiddenLabel mesh__D019440 Anti Obesity Agents
% 221.74/221.90  |- skos__historyNote mesh__D019440 Obesity/drug therapy %28%1992-1996%29%
% 221.74/221.90  |- skos__hiddenLabel mesh__D019440 Weight Loss Drugs
% 221.74/221.90  |- skos__hiddenLabel mesh__D019440 Weight Loss Agents
% 221.74/221.90  |- skos__hiddenLabel mesh__D019440 Anti Obesity Drugs
% 221.74/221.90  |- mesh__dateEstablished mesh__D019440 1997-01-01
% 221.74/221.90  |- skos__hiddenLabel mesh__D019440 Agents, Antiobesity
% 221.74/221.90  |- skos__annotation mesh__D019440 consider also OBESITY /drug ther   
% 221.74/221.90  |- mesh__historyNote mesh__D019440 97   
% 221.74/221.90  |- skos__altLabel mesh__D019440 Antiobesity Agents
% 221.74/221.90  |- mesh__recordOriginator mesh__D019440 ADP
% 221.74/221.90  |- skos__historyNote mesh__D019440 Appetite Depressants %28%1982-1996%29%
% 221.74/221.90  |- skos__hiddenLabel mesh__D019440 Agents, Weight-Loss
% 221.74/221.90  |- skos__altLabel mesh__D019440 Anti-Obesity Drugs
% 221.74/221.90  |- mesh__publicMeSHNote mesh__D019440 97   
% 221.74/221.90  |- mesh__recordMaintainer mesh__D019440 ssb
% 221.74/221.90  |- skos__scopeNote mesh__D019440
% 221.74/221.90       Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus %28%NIDDM%29% to treat obesity.%A%    
% 221.74/221.90  |- skos__altLabel mesh__D019440 Antiobesity Drugs
% 221.74/221.90  |- skos__historyNote mesh__D019440 Obesity %28%1992-1996%29%
% 221.74/221.90  |- skos__hiddenLabel mesh__D019440 Agents, Anti-Obesity
% 221.74/221.90  |- mesh__recordAuthorizer mesh__D019440 sjn
% 221.74/221.90  |- mesh__dateCreated mesh__D019440 1996-06-13
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D019440 2006
% 221.74/221.90  |- skos__hiddenLabel mesh__D019440 Drugs, Anti-Obesity
% 221.74/221.90  |- skos__hiddenLabel mesh__D019440 Drugs, Weight-Loss
% 221.74/221.90  |- skos__broader mesh__D019440smesh__D002491
% 221.74/221.90  |- mesh__dateRevised mesh__D019440 2005-06-30
% 221.74/221.90  |- skos__altLabel mesh__D019440 Weight-Loss Drugs
% 221.74/221.90  |- rdf__type mesh__D019440sskos__Concept
% 221.74/221.90  |- skos__hiddenLabel mesh__D019440 Drugs, Antiobesity
% 221.74/221.90  |- skos__prefLabel mesh__D019440 Anti-Obesity Agents
% 221.74/221.90  |- skos__broader mesh__D005420smesh__D011506
% 221.74/221.90  |- mesh__recordAuthorizer mesh__D005420 sjn
% 221.74/221.90  |- skos__historyNote mesh__D005420 FAD %28%1966-1970%29%
% 221.74/221.90  |- skos__prefLabel mesh__D005420 Flavoproteins
% 221.74/221.90  |- mesh__dateRevised mesh__D005420 2005-06-30
% 221.74/221.90  |- skos__altLabel mesh__D005420 Flavoprotein
% 221.74/221.90  |- mesh__publicMeSHNote mesh__D005420 73   
% 221.74/221.90  |- mesh__historyNote mesh__D005420 73%28%71%29%   
% 221.74/221.90  |- skos__historyNote mesh__D005420 Proteins %28%1966-1970%29%
% 221.74/221.90  |- mesh__recordOriginator mesh__D005420 NLM
% 221.74/221.90  |- mesh__recordMaintainer mesh__D005420 SYSTEM
% 221.74/221.90  |- mesh__dateEstablished mesh__D005420 1973-01-01
% 221.74/221.90  |- rdf__type mesh__D005420sskos__Concept
% 221.74/221.90  |- skos__historyNote mesh__D005420 FMN %28%1966-1970%29%
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D005420 2006
% 221.74/221.90  |- mesh__dateCreated mesh__D005420 1999-01-01
% 221.74/221.90  |- skos__annotation mesh__D018348 GEN or unspecified; prefer specifics   
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D018348 2004
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D018348 1997
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D018348 2005
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D018348 1998
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D018348 2000
% 221.74/221.90  |- skos__prefLabel mesh__D018348 Papovaviridae Infections
% 221.74/221.90  |- rdf__type mesh__D018348sskos__Concept
% 221.74/221.90  |- mesh__recordMaintainer mesh__D018348 ags
% 221.74/221.90  |- skos__hiddenLabel mesh__D018348 Infection, Papovaviridae
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D018348 2003
% 221.74/221.90  |- skos__hiddenLabel mesh__D018348 Papovaviridae Infection
% 221.74/221.90  |- mesh__dateCreated mesh__D018348 1993-06-17
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D018348 2006A
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D018348 2002
% 221.74/221.90  |- mesh__dateEstablished mesh__D018348 1994-01-01
% 221.74/221.90  |- skos__scopeNote mesh__D018348
% 221.74/221.90       Virus diseases caused by the Papovaviridae. This includes both papillomavirus infections and polyomavirus infections.%A%    
% 221.74/221.90  |- mesh__dateRevised mesh__D018348 2005-07-22
% 221.74/221.90  |- skos__altLabel mesh__D018348 Infections, Papovaviridae
% 221.74/221.90  |- mesh__recordAuthorizer mesh__D018348 ags
% 221.74/221.90  |- skos__historyNote mesh__D018348 Tumor Virus Infections %28%1966-1993%29%
% 221.74/221.90  |- skos__broader mesh__D018348smesh__D004266
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D018348 2006
% 221.74/221.90  |- mesh__publicMeSHNote mesh__D018348 94   
% 221.74/221.90  |- mesh__recordOriginator mesh__D018348 AGS
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D018348 1999
% 221.74/221.90  |- mesh__historyNote mesh__D018348 94   
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D018348 2001
% 221.74/221.90  |- mesh__dateCreated mesh__D010365 1974-11-11
% 221.74/221.90  |- skos__historyNote mesh__D010365 Pyrans %28%1966-1974%29%
% 221.74/221.90  |- skos__broader mesh__D010365smesh__D011714
% 221.74/221.90  |- mesh__historyNote mesh__D010365
% 221.74/221.90       91%28%75%29%; was see under PYRANS 1975-90   
% 221.74/221.90  |- skos__scopeNote mesh__D010365
% 221.74/221.90       4-Hydroxy-4H-furo%28%3,2-c%29%pyran-2%28%6H%29%-one. A mycotoxin produced by several species of Aspergillus and Penicillium. It is found in unfermented apple and grape juice and field crops. It has antibiotic properties and has been shown to be carcinogenic and mutagenic and causes chromosome damage in biological systems.%A%    
% 221.74/221.90  |- rdf__type mesh__D010365sskos__Concept
% 221.74/221.90  |- mesh__dateEstablished mesh__D010365 1991-01-01
% 221.74/221.90  |- mesh__recordAuthorizer mesh__D010365 sjn
% 221.74/221.90  |- mesh__publicMeSHNote mesh__D010365 91; was see under PYRANS 1975-90   
% 221.74/221.90  |- mesh__dateRevised mesh__D010365 2005-06-30
% 221.74/221.90  |- skos__prefLabel mesh__D010365 Patulin
% 221.74/221.90  |- skos__broader mesh__D010365smesh__D009183
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D010365 2006
% 221.74/221.90  |- mesh__recordOriginator mesh__D010365 NLM
% 221.74/221.90  |- mesh__recordMaintainer mesh__D010365 ssb
% 221.74/221.90  |- skos__historyNote mesh__D010365 Furans %28%1966-1974%29%
% 221.74/221.90  |- skos__altLabel mesh__D037502 Epsilon-Binding Protein
% 221.74/221.90  |- skos__altLabel mesh__D037502 Mac-2 Antigen
% 221.74/221.90  |- skos__prefLabel mesh__D037502 Galectin 3
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D037502 2006
% 221.74/221.90  |- skos__altLabel mesh__D037502 IgE Binding Protein
% 221.74/221.90  |- skos__altLabel mesh__D037502 HL-29
% 221.74/221.90  |- skos__hiddenLabel mesh__D037502 Mac 2 Antigen
% 221.74/221.90  |- skos__scopeNote mesh__D037502
% 221.74/221.90       A multifunctional galactin initially discovered as a macrophage antigen that binds to IMMUNOGLOBULIN E, and as 29-35-kDa lectin that binds LAMININ. It is involved in a variety of biological events including interactions with galactose-containing glycoconjugates, cell proliferation, CELL DIFFERENTIATION, and APOPTOSIS.%A%    
% 221.74/221.90  |- skos__altLabel mesh__D037502 L-29 Lectin
% 221.74/221.90  |- skos__altLabel mesh__D037502 Carbohydrate-Binding Protein 35
% 221.74/221.90  |- skos__hiddenLabel mesh__D037502 Antigen, Macrophage-2
% 221.74/221.90  |- mesh__dateRevised mesh__D037502 2004-07-07
% 221.74/221.90  |- skos__hiddenLabel mesh__D037502 Antigen, Mac-2
% 221.74/221.90  |- rdf__type mesh__D037502sskos__Concept
% 221.74/221.90  |- skos__hiddenLabel mesh__D037502 Protein, IgE Binding
% 221.74/221.90  |- skos__altLabel mesh__D037502 L30 Lectin
% 221.74/221.90  |- mesh__recordAuthorizer mesh__D037502 sjn
% 221.74/221.90  |- skos__hiddenLabel mesh__D037502 L 29 Lectin
% 221.74/221.90  |- mesh__historyNote mesh__D037502
% 221.74/221.90       2003; use GALECTIN 3 %28%NM%29% 1994-2002   
% 221.74/221.90  |- mesh__dateEstablished mesh__D037502 2003-01-01
% 221.74/221.90  |- skos__altLabel mesh__D037502 Galectin-3
% 221.74/221.90  |- mesh__publicMeSHNote mesh__D037502
% 221.74/221.90       2003; MAC-2 ANTIGEN %28%now GALECTIN 3 %29% was indexed under ANTIGENS, DIFFERENTIATION 1994-2002%A%  
% 221.74/221.90  |- skos__altLabel mesh__D037502 L-34
% 221.74/221.90  |- skos__altLabel mesh__D037502 Macrophage-2 Antigen
% 221.74/221.90  |- skos__hiddenLabel mesh__D037502 Epsilon Binding Protein
% 221.74/221.90  |- skos__broader mesh__D037502smesh__D037161
% 221.74/221.90  |- skos__hiddenLabel mesh__D037502 Binding Protein, IgE
% 221.74/221.90  |- mesh__dateCreated mesh__D037502 2002-07-02
% 221.74/221.90  |- skos__altLabel mesh__D037502 IgEBP
% 221.74/221.90  |- skos__altLabel mesh__D037502 CBP-35
% 221.74/221.90  |- skos__hiddenLabel mesh__D037502 Macrophage 2 Antigen
% 221.74/221.90  |- skos__altLabel mesh__D037502 L-31
% 221.74/221.90  |- mesh__recordMaintainer mesh__D037502 jmp
% 221.74/221.90  |- mesh__recordOriginator mesh__D037502 jmp
% 221.74/221.90  |- skos__altLabel mesh__D037502 CBP-30
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D037502 2005
% 221.74/221.90  |- skos__altLabel mesh__D037502 LGALS3
% 221.74/221.90  |- skos__altLabel mesh__D037502 CBP35
% 221.74/221.90  |- skos__hiddenLabel mesh__D037502 Carbohydrate Binding Protein 35
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D004328 1994
% 221.74/221.90  |- skos__scopeNote mesh__D004328
% 221.74/221.90       A state of internal activity of an organism that is a necessary condition before a given stimulus will elicit a class of responses; e.g., a certain level of hunger %28%drive%29% must be present before food will elicit an eating response.%A%    
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D004328 1993
% 221.74/221.90  |- skos__broader mesh__D004328smesh__D009042
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D004328 2001
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D004328 1995
% 221.74/221.90  |- mesh__dateEstablished mesh__D004328 1969-01-01
% 221.74/221.90  |- mesh__recordAuthorizer mesh__D004328 PLS
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D004328 2003
% 221.74/221.90  |- skos__prefLabel mesh__D004328 Drive
% 221.74/221.90  |- skos__annotation mesh__D004328 human %26% animal; no qualif   
% 221.74/221.90  |- mesh__historyNote mesh__D004328
% 221.74/221.90       69%28%65%29%; was see under MOTIVATION 1963-68   
% 221.74/221.90  |- skos__hiddenLabel mesh__D004328 Drives
% 221.74/221.90  |- mesh__dateRevised mesh__D004328 1991-06-20
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D004328 2005
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D004328 2004
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D004328 1996
% 221.74/221.90  |- skos__related mesh__D004328smesh__D007323
% 221.74/221.90  |- skos__related mesh__D004328smesh__D009042
% 221.74/221.90  |- mesh__dateCreated mesh__D004328 1999-01-01
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D004328 2002
% 221.74/221.90  |- rdf__type mesh__D004328sskos__Concept
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D004328 2006
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D004328 1998
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D004328 1997
% 221.74/221.90  |- mesh__recordOriginator mesh__D004328 NLM
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D004328 1992
% 221.74/221.90  |- mesh__recordMaintainer mesh__D004328 TGC
% 221.74/221.90  |- mesh__publicMeSHNote mesh__D004328
% 221.74/221.90       69; was see under MOTIVATION 1963-68   
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D004328 1999
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D004328 2000
% 221.74/221.90  |- mesh__dateCreated mesh__D015050 1999-01-01
% 221.74/221.90  |- mesh__dateRevised mesh__D015050 2002-07-02
% 221.74/221.90  |- skos__altLabel mesh__D015050 Zygomatic Arch
% 221.74/221.90  |- skos__prefLabel mesh__D015050 Zygoma
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D015050 2005
% 221.74/221.90  |- skos__altLabel mesh__D015050 Zygomatic Arches
% 221.74/221.90  |- skos__hiddenLabel mesh__D015050 Bones, Malar
% 221.74/221.90  |- skos__hiddenLabel mesh__D015050 Cheek Bones
% 221.74/221.90  |- rdf__type mesh__D015050sskos__Concept
% 221.74/221.90  |- skos__altLabel mesh__D015050 Cheek Bone
% 221.74/221.90  |- skos__hiddenLabel mesh__D015050 Bones, Jugal
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D015050 2004
% 221.74/221.90  |- skos__hiddenLabel mesh__D015050 Malar Bones
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D015050 2003
% 221.74/221.90  |- mesh__recordAuthorizer mesh__D015050 sjn
% 221.74/221.90  |- skos__hiddenLabel mesh__D015050 Bones, Cheek
% 221.74/221.90  |- skos__altLabel mesh__D015050 Jugal Bone
% 221.74/221.90  |- mesh__recordOriginator mesh__D015050 NLM
% 221.74/221.90  |- skos__broader mesh__D015050smesh__D005147
% 221.74/221.90  |- skos__hiddenLabel mesh__D015050 Zygomas
% 221.74/221.90  |- skos__hiddenLabel mesh__D015050 Bone, Malar
% 221.74/221.90  |- skos__hiddenLabel mesh__D015050 Bone, Jugal
% 221.74/221.90  |- skos__altLabel mesh__D015050 Malar Bone
% 221.74/221.90  |- skos__hiddenLabel mesh__D015050 Bone, Cheek
% 221.74/221.90  |- skos__hiddenLabel mesh__D015050 Jugal Bones
% 221.74/221.90  |- mesh__recordMaintainer mesh__D015050 mdb
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D015050 2006
% 221.74/221.90  |- skos__hiddenLabel mesh__D015050 Arch, Zygomatic
% 221.74/221.90  |- skos__historyNote mesh__D009811 Dentition %28%1966-1972%29%
% 221.74/221.90  |- mesh__publicMeSHNote mesh__D009811
% 221.74/221.90       79; was see under CEPHALOMETRY 1969-78   
% 221.74/221.90  |- skos__prefLabel mesh__D009811 Odontometry
% 221.74/221.90  |- mesh__dateCreated mesh__D009811 1999-01-01
% 221.74/221.90  |- mesh__dateEstablished mesh__D009811 1979-01-01
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D009811 2006
% 221.74/221.90  |- mesh__historyNote mesh__D009811
% 221.74/221.90       79%28%73%29%; was see under CEPHALOMETRY 1969-78   
% 221.74/221.90  |- skos__hiddenLabel mesh__D009811 Odontometries
% 221.74/221.90  |- mesh__dateRevised mesh__D009811 2004-07-07
% 221.74/221.90  |- mesh__onlineNote mesh__D009811 search CEPHALOMETRY 1969-72   
% 221.74/221.90  |- rdf__type mesh__D009811sskos__Concept
% 221.74/221.90  |- mesh__recordAuthorizer mesh__D009811 sjn
% 221.74/221.90  |- mesh__recordOriginator mesh__D009811 NLM
% 221.74/221.90  |- skos__historyNote mesh__D009811 Cephalometry %28%1966-1972%29%
% 221.74/221.90  |- skos__historyNote mesh__D009811 Tooth %28%1966-1972%29%
% 221.74/221.90  |- skos__historyNote mesh__D009811 specific tooth heading
% 221.74/221.90  |- skos__broader mesh__D009811smesh__D003813
% 221.74/221.90  |- skos__broader mesh__D009811smesh__D000886
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D009811 2005
% 221.74/221.90  |- mesh__recordMaintainer mesh__D009811 nns
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D009013 2003
% 221.74/221.90  |- mesh__recordMaintainer mesh__D009013 TGC
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D009013 1996
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D009013 2004
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D009013 2005
% 221.74/221.90  |- mesh__dateRevised mesh__D009013 1989-05-02
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D009013 1991
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D009013 2000
% 221.74/221.90  |- mesh__recordOriginator mesh__D009013 NLM
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D009013 1997
% 221.74/221.90  |- skos__prefLabel mesh__D009013 Morale
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D009013 1992
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D009013 1998
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D009013 2006
% 221.74/221.90  |- mesh__recordAuthorizer mesh__D009013 PLS
% 221.74/221.90  |- skos__broader mesh__D009013smesh__D011593
% 221.74/221.90  |- skos__scopeNote mesh__D009013
% 221.74/221.90       The prevailing temper or spirit of an individual or group in relation to the tasks or functions which are expected.%A%    
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D009013 1994
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D009013 1993
% 221.74/221.90  |- mesh__dateCreated mesh__D009013 1999-01-01
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D009013 1999
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D009013 2001
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D009013 1995
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D009013 1990
% 221.74/221.90  |- rdf__type mesh__D009013sskos__Concept
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D009013 2002
% 221.74/221.90  |- skos__hiddenLabel mesh__D009013 Morales
% 221.74/221.90  |- skos__annotation mesh__D009013 no qualif   
% 221.74/221.90  |- mesh__historyNote mesh__D001030
% 221.74/221.90       91%28%78%29%; was see under BEE VENOMS 1978-90   
% 221.74/221.90  |- mesh__dateCreated mesh__D001030 1977-04-27
% 221.74/221.90  |- mesh__dateRevised mesh__D001030 2005-06-30
% 221.74/221.90  |- mesh__recordOriginator mesh__D001030 SH
% 221.74/221.90  |- skos__broader mesh__D001030smesh__D001514
% 221.74/221.90  |- skos__scopeNote mesh__D001030
% 221.74/221.90       A highly neurotoxic polypeptide from the venom of the honey bee %28%Apis mellifera%29%. It consists of 18 amino acids with two disulfide bridges and causes hyperexcitability resulting in convulsions and respiratory paralysis.%A%    
% 221.74/221.90  |- skos__annotation mesh__D001030
% 221.74/221.90       a bee venom; /antag permitted but consider also ANTIVENINS; do not confuse with drug Apamide %28% = METHAMPHETAMINE%29%%A%  
% 221.74/221.90  |- mesh__recordMaintainer mesh__D001030 ssb
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D001030 2006
% 221.74/221.90  |- skos__historyNote mesh__D001030 Bees %28%1966-1977%29%
% 221.74/221.90  |- skos__historyNote mesh__D001030 Venoms %28%1966-1977%29%
% 221.74/221.90  |- skos__prefLabel mesh__D001030 Apamin
% 221.74/221.90  |- mesh__publicMeSHNote mesh__D001030
% 221.74/221.90       91; was see under BEE VENOMS 1978-90   
% 221.74/221.90  |- rdf__type mesh__D001030sskos__Concept
% 221.74/221.90  |- mesh__dateEstablished mesh__D001030 1991-01-01
% 221.74/221.90  |- mesh__recordAuthorizer mesh__D001030 sjn
% 221.74/221.90  |- mesh__recordMaintainer mesh__D020793 sjn
% 221.74/221.90  |- mesh__recordAuthorizer mesh__D020793 sjn
% 221.74/221.90  |- rdf__type mesh__D020793sskos__Concept
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D020793 2004
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D020793 2005
% 221.74/221.90  |- skos__scopeNote mesh__D020793
% 221.74/221.90       The controlling of access to health services, usually by primary care providers; often used in managed care settings to reduce utilization of expensive services and reduce referrals. %28%From BIOETHICS Thesaurus, 1999%29%%A%    
% 221.74/221.90  |- mesh__dateCreated mesh__D020793 1999-11-03
% 221.74/221.90  |- mesh__publicMeSHNote mesh__D020793 2000   
% 221.74/221.90  |- mesh__recordOriginator mesh__D020793 jls
% 221.74/221.90  |- mesh__dateRevised mesh__D020793 2003-07-22
% 221.74/221.90  |- mesh__dateEstablished mesh__D020793 2000-01-01
% 221.74/221.90  |- skos__prefLabel mesh__D020793 Gatekeeping
% 221.74/221.90  |- skos__broader mesh__D020793smesh__D012017
% 221.74/221.90  |- mesh__historyNote mesh__D020793 2000   
% 221.74/221.90  |- skos__historyNote mesh__D020793
% 221.74/221.90       Referral and Consultation %28%1990-1999%29%
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D020793 2006
% 221.74/221.90  |- mesh__recordMaintainer mesh__D014756 ssb
% 221.74/221.90  |- skos__altLabel mesh__D014756 Florimycin
% 221.74/221.90  |- skos__prefLabel mesh__D014756 Viomycin
% 221.74/221.90  |- mesh__recordOriginator mesh__D014756 NLM
% 221.74/221.90  |- skos__broader mesh__D014756smesh__D010456
% 221.74/221.90  |- rdf__type mesh__D014756sskos__Concept
% 221.74/221.90  |- mesh__dateRevised mesh__D014756 2004-07-07
% 221.74/221.90  |- mesh__publicMeSHNote mesh__D014756
% 221.74/221.90       94,63-80; was VIOMYCINS 1981-93; was VIOMYCIN 1963-80   
% 221.74/221.90  |- mesh__historyNote mesh__D014756
% 221.74/221.90       94,63-80; was VIOMYCINS 1981-93; was VIOMYCIN 1963-80   
% 221.74/221.90  |- skos__altLabel mesh__D014756 Viomicin
% 221.74/221.90  |- mesh__recordAuthorizer mesh__D014756 sjn
% 221.74/221.90  |- skos__scopeNote mesh__D014756
% 221.74/221.90       A strongly basic peptide, antibiotic complex from several strains of Streptomyces. It is allergenic and toxic to kidneys and the labyrinth. Viomycin is used in tuberculosis as several different salts and in combination with other agents.%A%    
% 221.74/221.90  |- skos__altLabel mesh__D014756 Tuberactinomycin B
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D014756 2005
% 221.74/221.90  |- mesh__onlineNote mesh__D014756
% 221.74/221.90       use VIOMYCIN to search VIOMYCINS 1981-93   
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D014756 2006
% 221.74/221.90  |- mesh__dateCreated mesh__D014756 1999-01-01
% 221.74/221.90  |- mesh__recordMaintainer mesh__D047132 ags
% 221.74/221.90  |- mesh__dateCreated mesh__D047132 2004-07-07
% 221.74/221.90  |- mesh__publicMeSHNote mesh__D047132 2005   
% 221.74/221.90  |- mesh__historyNote mesh__D047132 2005   
% 221.74/221.90  |- mesh__recordAuthorizer mesh__D047132 sjn
% 221.74/221.90  |- skos__prefLabel mesh__D047132 Crambe Sponge
% 221.74/221.90  |- mesh__recordOriginator mesh__D047132 ags
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D047132 2006
% 221.74/221.90  |- skos__scopeNote mesh__D047132
% 221.74/221.90       A genus of SPONGES in the family Crambeidae characterized by desmoid spicules. The type species is Crambe crambe.%A%    
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D047132 2005
% 221.74/221.90  |- mesh__dateEstablished mesh__D047132 2005-01-01
% 221.74/221.90  |- rdf__type mesh__D047132sskos__Concept
% 221.74/221.90  |- skos__broader mesh__D047132smesh__D011161
% 221.74/221.90  |- skos__historyNote mesh__D047132 Porifera %28%1966-2004%29%
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D008719 2006
% 221.74/221.90  |- skos__altLabel mesh__D008719 Methiothepine
% 221.74/221.90  |- skos__broader mesh__D008719smesh__D003988
% 221.74/221.90  |- skos__hiddenLabel mesh__D008719 Maleate, Methiothepin
% 221.74/221.90  |- mesh__publicMeSHNote mesh__D008719
% 221.74/221.90       91; was see under DIBENZOTHIEPINS 1976-90   
% 221.74/221.90  |- mesh__recordOriginator mesh__D008719 SH
% 221.74/221.90  |- rdf__type mesh__D008719sskos__Concept
% 221.74/221.90  |- skos__historyNote mesh__D008719 Sulfides %28%1973-1975%29%
% 221.74/221.90  |- mesh__dateEstablished mesh__D008719 1991-01-01
% 221.74/221.90  |- mesh__recordAuthorizer mesh__D008719 sjn
% 221.74/221.90  |- skos__prefLabel mesh__D008719 Methiothepin
% 221.74/221.90  |- mesh__dateRevised mesh__D008719 2005-06-30
% 221.74/221.90  |- skos__altLabel mesh__D008719 Metitepine
% 221.74/221.90  |- skos__historyNote mesh__D008719 Dibenzothiepins %28%1968-1975%29%
% 221.74/221.90  |- mesh__recordMaintainer mesh__D008719 ssb
% 221.74/221.90  |- skos__scopeNote mesh__D008719
% 221.74/221.90       A serotonin receptor antagonist in the CENTRAL NERVOUS SYSTEM used as an antipsychotic.%A%    
% 221.74/221.90  |- skos__historyNote mesh__D008719 Piperazines %28%1973-1975%29%
% 221.74/221.90  |- mesh__historyNote mesh__D008719
% 221.74/221.90       91%28%76%29%; was see under DIBENZOTHIEPINS 1976-90   
% 221.74/221.90  |- mesh__dateCreated mesh__D008719 1975-07-23
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D000736 1998
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D000736 1995
% 221.74/221.90  |- mesh__publicMeSHNote mesh__D000736 73   
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D000736 1996
% 221.74/221.90  |- skos__broader mesh__D000736smesh__D000731
% 221.74/221.90  |- rdf__type mesh__D000736sskos__Concept
% 221.74/221.90  |- skos__historyNote mesh__D000736 Androstanes %28%1968-1972%29%
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D000736 1999
% 221.74/221.90  |- mesh__dateEstablished mesh__D000736 1973-01-01
% 221.74/221.90  |- skos__scopeNote mesh__D000736
% 221.74/221.90       Unsaturated derivatives of the steroid androstane containing at least one double bond at any site in any of the rings.%A%    
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D000736 2000
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D000736 1997
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D000736 2005
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D000736 2003
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D000736 2006
% 221.74/221.90  |- mesh__historyNote mesh__D000736 73   
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D000736 2004
% 221.74/221.90  |- mesh__dateRevised mesh__D000736 1993-06-03
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D000736 2001
% 221.74/221.90  |- mesh__recordMaintainer mesh__D000736 PLS
% 221.74/221.90  |- skos__annotation mesh__D000736 do not confuse with ANDROSTANES   
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D000736 2002
% 221.74/221.90  |- mesh__recordOriginator mesh__D000736 NLM
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D000736 1994
% 221.74/221.90  |- mesh__recordAuthorizer mesh__D000736 PLS
% 221.74/221.90  |- skos__prefLabel mesh__D000736 Androstenes
% 221.74/221.90  |- mesh__dateCreated mesh__D000736 1999-01-01
% 221.74/221.90  |- mesh__dateEstablished mesh__D019441 1997-01-01
% 221.74/221.90  |- skos__historyNote mesh__D019441 Plants %28%1966-1996%29%
% 221.74/221.90  |- mesh__historyNote mesh__D019441 97   
% 221.74/221.90  |- rdf__type mesh__D019441sskos__Concept
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D019441 2005
% 221.74/221.90  |- skos__annotation mesh__D019441
% 221.74/221.90       outer integument of plants; IM; coord with specific plant if pertinent %28%IM%29%%A%  
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D019441 2004
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D019441 2003
% 221.74/221.90  |- skos__scopeNote mesh__D019441
% 221.74/221.90       A thin layer of cells forming the outer integument of seed plants and ferns. %28%Random House Unabridged Dictionary, 2d ed%29%%A%    
% 221.74/221.90  |- skos__broader mesh__D019441smesh__D035261
% 221.74/221.90  |- skos__altLabel mesh__D019441 Epidermis, Plant
% 221.74/221.90  |- mesh__dateCreated mesh__D019441 1996-06-10
% 221.74/221.90  |- skos__prefLabel mesh__D019441 Plant Epidermis
% 221.74/221.90  |- mesh__publicMeSHNote mesh__D019441 97   
% 221.74/221.90  |- mesh__dateRevised mesh__D019441 2002-07-03
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D019441 2006
% 221.74/221.90  |- skos__broader mesh__D005421smesh__D020313
% 221.74/221.90  |- skos__broader mesh__D005421smesh__D005503
% 221.74/221.90  |- skos__hiddenLabel mesh__D005421 Agent, Flavoring
% 221.74/221.90  |- mesh__publicMeSHNote mesh__D005421
% 221.74/221.90       VANILLIN was see FLAVORING AGENTS 1983, was heading 1963-82%A%  
% 221.74/221.90  |- skos__annotation mesh__D005421
% 221.74/221.90       IM; coord with specific substance if pertinent %28%IM%29%   
% 221.74/221.90  |- skos__related mesh__D005421smesh__D010592
% 221.74/221.90  |- rdf__type mesh__D005421sskos__Concept
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D005421 2005
% 221.74/221.90  |- mesh__recordAuthorizer mesh__D005421 sjn
% 221.74/221.90  |- mesh__historyNote mesh__D005421
% 221.74/221.90       VANILLIN was see FLAVORING AGENTS 1983, was heading 1963-82%A%  
% 221.74/221.90  |- mesh__onlineNote mesh__D005421
% 221.74/221.90       use FLAVORING AGENTS to search VANILLIN 1966-83   
% 221.74/221.90  |- skos__scopeNote mesh__D005421
% 221.74/221.90       Substances added to foods and medicine to improve the quality of taste.%A%    
% 221.74/221.90  |- skos__hiddenLabel mesh__D005421 Agents, Flavoring
% 221.74/221.90  |- mesh__activeMeSHYear mesh__D005421 2006
% 221.74/221.90  |- mesh__recordMaintainer mesh__D005421 ssb
% 221.74/221.90  |- mesh__recordOriginator mesh__D005421 NLM
% 221.74/221.91  |- mesh__dateCreated mesh__D005421 1999-01-01
% 221.74/221.91  |- skos__prefLabel mesh__D005421 Flavoring Agents
% 221.74/221.91  |- skos__hiddenLabel mesh__D005421 Flavoring Agent
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D005421 2004
% 221.74/221.91  |- mesh__dateRevised mesh__D005421 2003-07-09
% 221.74/221.91  |- rdf__type mesh__D018349sskos__Concept
% 221.74/221.91  |- mesh__dateCreated mesh__D018349 1993-06-04
% 221.74/221.91  |- mesh__recordOriginator mesh__D018349 AGS
% 221.74/221.91  |- mesh__publicMeSHNote mesh__D018349 94   
% 221.74/221.91  |- skos__broader mesh__D018349smesh__D005416
% 221.74/221.91  |- skos__altLabel mesh__D018349 Japanese encephalitis virus group
% 221.74/221.91  |- skos__scopeNote mesh__D018349
% 221.74/221.91       A subgroup of the genus FLAVIVIRUS which comprises a number of viral species that are the etiologic agents of human encephalitis in many different geographical regions. These include Japanese encephalitis virus %28%ENCEPHALITIS VIRUS, JAPANESE%29%, St. Louis encephalitis virus %28%ENCEPHALITIS VIRUS, ST. LOUIS%29%, Murray Valley encephalitis virus %28%ENCEPHALITIS VIRUS, MURRAY VALLEY%29%, and WEST NILE VIRUS.%A%    
% 221.74/221.91  |- skos__annotation mesh__D018349
% 221.74/221.91       do not confuse with ENCEPHALITIS VIRUS, JAPANESE, a species of Flavivirus; infection: coord IM with ENCEPHALITIS, ARBOVIRUS, %28%IM%29% + FLAVIVIRUS INFECTIONS %28%IM%29%%A%  
% 221.74/221.91  |- mesh__recordMaintainer mesh__D018349 sjn
% 221.74/221.91  |- skos__broader mesh__D018349smesh__D004668
% 221.74/221.91  |- mesh__recordAuthorizer mesh__D018349 sjn
% 221.74/221.91  |- skos__prefLabel mesh__D018349 Encephalitis Viruses, Japanese
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D018349 2006
% 221.74/221.91  |- skos__altLabel mesh__D018349 Viruses, Japanese Encephalitis
% 221.74/221.91  |- mesh__historyNote mesh__D018349 94   
% 221.74/221.91  |- mesh__dateEstablished mesh__D018349 1994-01-01
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D018349 2005
% 221.74/221.91  |- skos__altLabel mesh__D018349 Japanese Encephalitis Viruses
% 221.74/221.91  |- mesh__dateRevised mesh__D018349 2004-07-13
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D010366 2006
% 221.74/221.91  |- skos__prefLabel mesh__D010366 Peak Expiratory Flow Rate
% 221.74/221.91  |- mesh__dateCreated mesh__D010366 1974-12-12
% 221.74/221.91  |- skos__scopeNote mesh__D010366
% 221.74/221.91       Measurement of the maximum rate of airflow attained during a FORCED VITAL CAPACITY determination. Common abbreviations are PEFR and PFR.%A%    
% 221.74/221.91  |- skos__altLabel mesh__D010366 Expiratory Peak Flow Rate
% 221.74/221.91  |- mesh__recordMaintainer mesh__D010366 nns
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D010366 2005
% 221.74/221.91  |- mesh__historyNote mesh__D010366
% 221.74/221.91       91%28%75%29%; was see under FORCED EXPIRATORY FLOW RATES 1975-90%A%  
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D010366 2004
% 221.74/221.91  |- rdf__type mesh__D010366sskos__Concept
% 221.74/221.91  |- mesh__dateEstablished mesh__D010366 1991-01-01
% 221.74/221.91  |- mesh__dateRevised mesh__D010366 2003-07-09
% 221.74/221.91  |- mesh__recordAuthorizer mesh__D010366 sjn
% 221.74/221.91  |- mesh__publicMeSHNote mesh__D010366
% 221.74/221.91       91; was see under FORCED EXPIRATORY FLOW RATES 1975-90   
% 221.74/221.91  |- skos__altLabel mesh__D010366 PEFR
% 221.74/221.91  |- mesh__recordOriginator mesh__D010366 NLM
% 221.74/221.91  |- skos__annotation mesh__D010366
% 221.74/221.91       usually NIM; do not confuse with MAXIMAL EXPIRATORY FLOW RATE; %28%MEFR%29%%A%  
% 221.74/221.91  |- skos__broader mesh__D010366smesh__D005540
% 221.74/221.91  |- skos__altLabel mesh__D010366 Flow Rate, Peak Expiratory
% 221.74/221.91  |- skos__scopeNote mesh__D004329
% 221.74/221.91       A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in conjunction with an opioid analgesic such as FENTANYL to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. It is also used as a premedicant, as an antiemetic, and for the control of agitation in acute psychoses. %28%From Martindale, The Extra  Pharmacopoeia, 29th ed, p593%29%%A%    
% 221.74/221.91  |- mesh__dateEstablished mesh__D004329 1974-01-01
% 221.74/221.91  |- skos__prefLabel mesh__D004329 Droperidol
% 221.74/221.91  |- mesh__publicMeSHNote mesh__D004329 74   
% 221.74/221.91  |- skos__altLabel mesh__D004329 Kern Brand of Droperidol
% 221.74/221.91  |- mesh__historyNote mesh__D004329 74%28%73%29%   
% 221.74/221.91  |- mesh__recordMaintainer mesh__D004329 exl
% 221.74/221.91  |- skos__broader mesh__D004329smesh__D001562
% 221.74/221.91  |- skos__broader mesh__D004329smesh__D002090
% 221.74/221.91  |- mesh__dateCreated mesh__D004329 1999-01-01
% 221.74/221.91  |- mesh__recordAuthorizer mesh__D004329 sjn
% 221.74/221.91  |- rdf__type mesh__D004329sskos__Concept
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D004329 2006
% 221.74/221.91  |- skos__altLabel mesh__D004329 Droleptan
% 221.74/221.91  |- skos__altLabel mesh__D004329 Janssen Brand of Droperidol
% 221.74/221.91  |- skos__altLabel mesh__D004329 Taylor Brand of Droperidol
% 221.74/221.91  |- mesh__dateRevised mesh__D004329 2005-06-30
% 221.74/221.91  |- mesh__recordOriginator mesh__D004329 NLM
% 221.74/221.91  |- mesh__recordOriginator mesh__D015051 NLM
% 221.74/221.91  |- mesh__dateEstablished mesh__D015051 1972-01-01
% 221.74/221.91  |- skos__historyNote mesh__D015051 Fractures %28%1966-1970%29%
% 221.74/221.91  |- skos__scopeNote mesh__D015051 Fractures of the zygoma.     
% 221.74/221.91  |- mesh__historyNote mesh__D015051 72%28%71%29%   
% 221.74/221.91  |- skos__hiddenLabel mesh__D015051 Fracture, Zygomatic
% 221.74/221.91  |- skos__hiddenLabel mesh__D015051 Zygomatic Fracture
% 221.74/221.91  |- mesh__dateRevised mesh__D015051 2005-06-30
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D015051 2006
% 221.74/221.91  |- skos__broader mesh__D015051smesh__D008446
% 221.74/221.91  |- skos__prefLabel mesh__D015051 Zygomatic Fractures
% 221.74/221.91  |- mesh__dateCreated mesh__D015051 1999-01-01
% 221.74/221.91  |- mesh__recordMaintainer mesh__D015051 ssb
% 221.74/221.91  |- skos__broader mesh__D015051smesh__D012887
% 221.74/221.91  |- mesh__recordAuthorizer mesh__D015051 sjn
% 221.74/221.91  |- mesh__publicMeSHNote mesh__D015051 72   
% 221.74/221.91  |- rdf__type mesh__D015051sskos__Concept
% 221.74/221.91  |- skos__hiddenLabel mesh__D015051 Fractures, Zygomatic
% 221.74/221.91  |- skos__related mesh__D009812smesh__D012903
% 221.74/221.91  |- mesh__recordAuthorizer mesh__D009812 PLS
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D009812 2001
% 221.74/221.91  |- rdf__type mesh__D009812sskos__Concept
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D009812 1999
% 221.74/221.91  |- mesh__dateRevised mesh__D009812 1996-06-13
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D009812 2002
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D009812 1997
% 221.74/221.91  |- skos__prefLabel mesh__D009812 Odors
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D009812 2005
% 221.74/221.91  |- skos__hiddenLabel mesh__D009812 Odor
% 221.74/221.91  |- skos__scopeNote mesh__D009812
% 221.74/221.91       The volatile portions of substances perceptible by the sense of smell. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 221.74/221.91  |- mesh__dateCreated mesh__D009812 1999-01-01
% 221.74/221.91  |- skos__broader mesh__D009812smesh__D004777
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D009812 2006
% 221.74/221.91  |- skos__annotation mesh__D009812
% 221.74/221.91       mouth odors = HALITOSIS; AROMATHERAPY %28%use of essential oils to treat dis in alternative med%29% is also available%A%  
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D009812 2003
% 221.74/221.91  |- skos__related mesh__D009812smesh__D019341
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D009812 2000
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D009812 2004
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D009812 1998
% 221.74/221.91  |- mesh__recordOriginator mesh__D009812 NLM
% 221.74/221.91  |- mesh__recordMaintainer mesh__D009812 TGC
% 221.74/221.91  |- skos__broader mesh__D004560Q000627smesh__D004560
% 221.74/221.91  |- mesh__preferredCombination mesh__D004560Q000627smesh__D004599
% 221.74/221.91  |- rdf__type mesh__D004560Q000627smesh__CompoundConcept
% 221.74/221.91  |- mesh__dateRevised mesh__D009014 2003-07-09
% 221.74/221.91  |- skos__broader mesh__D009014smesh__D011593
% 221.74/221.91  |- rdf__type mesh__D009014sskos__Concept
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D009014 2004
% 221.74/221.91  |- skos__prefLabel mesh__D009014 Morals
% 221.74/221.91  |- skos__related mesh__D009014smesh__D035481
% 221.74/221.91  |- skos__related mesh__D009014smesh__D016265
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D009014 2006
% 221.74/221.91  |- mesh__recordOriginator mesh__D009014 NLM
% 221.74/221.91  |- mesh__recordMaintainer mesh__D009014 lkt
% 221.74/221.91  |- mesh__recordAuthorizer mesh__D009014 sjn
% 221.74/221.91  |- skos__scopeNote mesh__D009014
% 221.74/221.91       Standards of conduct that distinguish right from wrong.%A%    
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D009014 2005
% 221.74/221.91  |- mesh__dateCreated mesh__D009014 1999-01-01
% 221.74/221.91  |- skos__broader mesh__D009014smesh__D004989
% 221.74/221.91  |- skos__annotation mesh__D001031 a group of phosphate minerals   
% 221.74/221.91  |- skos__scopeNote mesh__D001031
% 221.74/221.91       A group of phosphate minerals that includes ten mineral species and has the general formula X5%28%YO4%29%3Z, where X is usually calcium or lead, Y is phosphorus or arsenic, and Z is chlorine, fluorine, or OH-. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 221.74/221.91  |- skos__broader mesh__D001031smesh__D002130
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D001031 2002
% 221.74/221.91  |- mesh__historyNote mesh__D001031 66%28%64%29%   
% 221.74/221.91  |- mesh__dateCreated mesh__D001031 1999-01-01
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D001031 2004
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D001031 2001
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D001031 2006
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D001031 2003
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D001031 1997
% 221.74/221.91  |- mesh__publicMeSHNote mesh__D001031 66   
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D001031 2005
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D001031 2000
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D001031 1999
% 221.74/221.91  |- rdf__type mesh__D001031sskos__Concept
% 221.74/221.91  |- mesh__dateRevised mesh__D001031 1993-06-04
% 221.74/221.91  |- mesh__recordMaintainer mesh__D001031 TPW
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D001031 1996
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D001031 1995
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D001031 1998
% 221.74/221.91  |- mesh__recordAuthorizer mesh__D001031 PLS
% 221.74/221.91  |- mesh__recordOriginator mesh__D001031 NLM
% 221.74/221.91  |- mesh__dateEstablished mesh__D001031 1966-01-01
% 221.74/221.91  |- skos__broader mesh__D001031smesh__D008903
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D001031 1994
% 221.74/221.91  |- skos__prefLabel mesh__D001031 Apatites
% 221.74/221.91  |- mesh__recordAuthorizer mesh__D020794 sjn
% 221.74/221.91  |- skos__broader mesh__D020794smesh__D011505
% 221.74/221.91  |- rdf__type mesh__D020794sskos__Concept
% 221.74/221.91  |- skos__historyNote mesh__D020794
% 221.74/221.91       Receptor Protein-Tyrosine Kinase %28%1994-1999%29%
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D020794 2006
% 221.74/221.91  |- skos__hiddenLabel mesh__D020794 Protein-Tyrosine Kinase Receptors
% 221.74/221.91  |- skos__altLabel mesh__D020794 Tyrosine Kinase Receptors
% 221.74/221.91  |- skos__hiddenLabel mesh__D020794 Receptors, PTK
% 221.74/221.91  |- mesh__publicMeSHNote mesh__D020794
% 221.74/221.91       2000; for RECEPTOR PROTEIN-TYROSINE KINASE see RECEPTOR PROTEIN-TYROSINE KINASE 1994-1999%A%  
% 221.74/221.91  |- skos__scopeNote mesh__D020794
% 221.74/221.91       A class of cellular receptors that have an intrinsic PROTEIN-TYROSINE KINASE activity.%A%    
% 221.74/221.91  |- skos__hiddenLabel mesh__D020794 Receptors, Protein Tyrosine Kinase
% 221.74/221.91  |- mesh__dateRevised mesh__D020794 2005-06-30
% 221.74/221.91  |- skos__hiddenLabel mesh__D020794 Receptor, Protein-Tyrosine Kinase
% 221.74/221.91  |- skos__altLabel mesh__D020794 Tyrosine Kinase Linked Receptors
% 221.74/221.91  |- mesh__dateEstablished mesh__D020794 2000-01-01
% 221.74/221.91  |- skos__hiddenLabel mesh__D020794 Protein-Tyrosine Kinases, Receptor
% 221.74/221.91  |- skos__hiddenLabel mesh__D020794 Receptor Protein Tyrosine Kinases
% 221.74/221.91  |- skos__altLabel mesh__D020794 Receptors, Protein-Tyrosine Kinase
% 221.74/221.91  |- mesh__historyNote mesh__D020794 2000   
% 221.74/221.91  |- skos__hiddenLabel mesh__D020794 Kinase, Receptor Protein-Tyrosine
% 221.74/221.91  |- skos__broader mesh__D020794smesh__D011956
% 221.74/221.91  |- skos__altLabel mesh__D020794 Receptor Protein-Tyrosine Kinase
% 221.74/221.91  |- skos__historyNote mesh__D020794 specific receptors %28%1983-1993%29%
% 221.74/221.91  |- mesh__dateCreated mesh__D020794 1999-11-05
% 221.74/221.91  |- skos__prefLabel mesh__D020794 Receptor Protein-Tyrosine Kinases
% 221.74/221.91  |- skos__hiddenLabel mesh__D020794 Receptor Protein Tyrosine Kinase
% 221.74/221.91  |- skos__hiddenLabel mesh__D020794 Protein-Tyrosine Kinase, Receptor
% 221.74/221.91  |- skos__altLabel mesh__D020794 PTK Receptors
% 221.74/221.91  |- mesh__recordMaintainer mesh__D020794 jmp
% 221.74/221.91  |- mesh__recordOriginator mesh__D020794 jmp
% 221.74/221.91  |- skos__hiddenLabel mesh__D020794 Kinases, Receptor Protein-Tyrosine
% 221.74/221.91  |- skos__annotation mesh__D020794 DF: PTK RECEPT   
% 221.74/221.91  |- skos__historyNote mesh__D020794
% 221.74/221.91       Protein-Tyrosine Kinase %28%1983-1993%29%
% 221.74/221.91  |- skos__altLabel mesh__D020794 Protein-Tyrosine Kinase Receptor
% 221.74/221.91  |- skos__altLabel mesh__D014757 Viper Venom
% 221.74/221.91  |- mesh__recordMaintainer mesh__D014757 ssb
% 221.74/221.91  |- mesh__onlineNote mesh__D014757
% 221.74/221.91       use VIPER VENOMS to search CERASTES VENOM 1986-93   
% 221.74/221.91  |- mesh__dateEstablished mesh__D014757 1978-01-01
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D014757 2006
% 221.74/221.91  |- skos__historyNote mesh__D014757 Snake Venoms %28%1975-1977%29%
% 221.74/221.91  |- skos__broader mesh__D014757smesh__D012910
% 221.74/221.91  |- mesh__dateCreated mesh__D014757 1977-04-22
% 221.74/221.91  |- skos__historyNote mesh__D014757 Venoms %28%1966-1974%29%
% 221.74/221.91  |- mesh__historyNote mesh__D014757
% 221.74/221.91       78; CERASTES VENOM was %28%NM%29% 1986-93   
% 221.74/221.91  |- skos__hiddenLabel mesh__D014757 Venom, Viper
% 221.74/221.91  |- skos__hiddenLabel mesh__D014757 Venoms, Viper
% 221.74/221.91  |- skos__hiddenLabel mesh__D014757 Venoms, Cerastes
% 221.74/221.91  |- rdf__type mesh__D014757sskos__Concept
% 221.74/221.91  |- skos__prefLabel mesh__D014757 Viper Venoms
% 221.74/221.91  |- mesh__recordOriginator mesh__D014757 SH
% 221.74/221.91  |- skos__historyNote mesh__D014757 Snakes %28%1966-1974%29%
% 221.74/221.91  |- skos__altLabel mesh__D014757 Cerastes Venom
% 221.74/221.91  |- mesh__dateRevised mesh__D014757 2005-06-30
% 221.74/221.91  |- skos__scopeNote mesh__D014757
% 221.74/221.91       Venoms from SNAKES of the viperid family. They tend to be less toxic than elapid or hydrophid venoms and act mainly on the vascular system, interfering with coagulation and capillary membrane integrity and are highly cytotoxic. They contain large amounts of several enzymes, other factors, and some toxins.%A%    
% 221.74/221.91  |- skos__annotation mesh__D014757
% 221.74/221.91       /antag permitted but consider also ANTIVENINS; /enzymol permitted; includes adder venoms %26% viperotoxin; TN 241: common %26% scientific names of various viperids; note PIT VIPER VENOMS see CROTALID VENOMS%A%  
% 221.74/221.91  |- skos__hiddenLabel mesh__D014757 Venom, Cerastes
% 221.74/221.91  |- mesh__publicMeSHNote mesh__D014757
% 221.74/221.91       78; CERASTES VENOM was indexed under VIPER VENOMS 1986-93%A%  
% 221.74/221.91  |- mesh__recordAuthorizer mesh__D014757 sjn
% 221.74/221.91  |- mesh__dateRevised mesh__D000737 1992-05-07
% 221.74/221.91  |- mesh__recordOriginator mesh__D000737 NLM
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D000737 1997
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D000737 2005
% 221.74/221.91  |- mesh__recordAuthorizer mesh__D000737 PLS
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D000737 2003
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D000737 2006
% 221.74/221.91  |- mesh__dateEstablished mesh__D000737 1974-01-01
% 221.74/221.91  |- mesh__historyNote mesh__D000737
% 221.74/221.91       74; was ANDROSTENOL 1963-73 %28%Prov%29%   
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D000737 2004
% 221.74/221.91  |- skos__scopeNote mesh__D000737
% 221.74/221.91       Unsaturated androstanes which are substituted with one or more hydroxyl groups in any position in the ring system.%A%    
% 221.74/221.91  |- skos__prefLabel mesh__D000737 Androstenols
% 221.74/221.91  |- skos__altLabel mesh__D000737 Hydroxyandrostenes
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D000737 2000
% 221.74/221.91  |- mesh__onlineNote mesh__D000737
% 221.74/221.91       use ANDROSTENOLS to search ANDROSTENOL 1966-73 %28%as Prov%29%   
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D000737 1994
% 221.74/221.91  |- mesh__recordMaintainer mesh__D000737 TGC
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D000737 2001
% 221.74/221.91  |- mesh__dateCreated mesh__D000737 1999-01-01
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D000737 1998
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D000737 1995
% 221.74/221.91  |- skos__broader mesh__D000737smesh__D000736
% 221.74/221.91  |- mesh__publicMeSHNote mesh__D000737 74   
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D000737 2002
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D000737 1996
% 221.74/221.91  |- rdf__type mesh__D000737sskos__Concept
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D000737 1993
% 221.74/221.91  |- skos__annotation mesh__D000737 do not confuse with ANDROSTANOLS   
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D000737 1999
% 221.74/221.91  |- mesh__publicMeSHNote mesh__D019442 97   
% 221.74/221.91  |- skos__hiddenLabel mesh__D019442 Suits, Flight
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D019442 2001
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D019442 1999
% 221.74/221.91  |- skos__hiddenLabel mesh__D019442 Suit, Space
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D019442 2003
% 221.74/221.91  |- mesh__dateEstablished mesh__D019442 1997-01-01
% 221.74/221.91  |- skos__broader mesh__D019442smesh__D011481
% 221.74/221.91  |- skos__annotation mesh__D019442 G SUITS is also available   
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D019442 2000
% 221.74/221.91  |- skos__historyNote mesh__D019442 G Suits %28%1975-1996%29%
% 221.74/221.91  |- mesh__dateRevised mesh__D019442 1997-06-20
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D019442 1998
% 221.74/221.91  |- skos__prefLabel mesh__D019442 Space Suits
% 221.74/221.91  |- mesh__recordMaintainer mesh__D019442 JLS
% 221.74/221.91  |- skos__hiddenLabel mesh__D019442 Space Suit
% 221.74/221.91  |- mesh__recordOriginator mesh__D019442 JLS
% 221.74/221.91  |- skos__scopeNote mesh__D019442
% 221.74/221.91       Pressure suits for wear in space or at very low ambient pressures within the atmosphere, designed to permit the wearer to leave the protection of a pressurized cabin. %28%NASA Thesaurus, 1994%29%%A%    
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D019442 2006
% 221.74/221.91  |- skos__hiddenLabel mesh__D019442 Suit, Flight
% 221.74/221.91  |- skos__hiddenLabel mesh__D019442 Flight Suit
% 221.74/221.91  |- skos__hiddenLabel mesh__D019442 Suits, Space
% 221.74/221.91  |- rdf__type mesh__D019442sskos__Concept
% 221.74/221.91  |- mesh__historyNote mesh__D019442 97   
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D019442 2005
% 221.74/221.91  |- mesh__dateCreated mesh__D019442 1996-06-10
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D019442 2002
% 221.74/221.91  |- skos__altLabel mesh__D019442 Spacesuits
% 221.74/221.91  |- skos__hiddenLabel mesh__D019442 Spacesuit
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D019442 2004
% 221.74/221.91  |- mesh__recordAuthorizer mesh__D019442 SJN
% 221.74/221.91  |- skos__scopeNote mesh__D005422
% 221.74/221.91       A drug that has been used in various urinary syndromes and as an antispasmodic. Its therapeutic usefulness and its mechanism of action are not clear. It may have local anesthetic activity and direct relaxing effects on smooth muscle as well as some activity as a muscarinic antagonist.%A%    
% 221.74/221.91  |- mesh__publicMeSHNote mesh__D005422 91; was see under FLAVONES 1977-90   
% 221.74/221.91  |- skos__broader mesh__D005422smesh__D047309
% 221.74/221.91  |- skos__altLabel mesh__D005422 Negma Brand of Flavoxate Hydrochloride
% 221.74/221.91  |- skos__altLabel mesh__D005422
% 221.74/221.91       Cahill May Roberts Brand of Flavoxate Hydrochloride
% 221.74/221.91  |- skos__historyNote mesh__D005422 Flavones %28%1969-1976%29%
% 221.74/221.91  |- skos__altLabel mesh__D005422
% 221.74/221.91       Pierre Fabre Brand of Flavoxate Hydrochloride
% 221.74/221.91  |- skos__historyNote mesh__D005422 Carboxylic Acids %28%1972-1974%29%
% 221.74/221.91  |- skos__prefLabel mesh__D005422 Flavoxate
% 221.74/221.91  |- skos__altLabel mesh__D005422 Ortho Brand of Flavoxate Hydrochloride
% 221.74/221.91  |- skos__altLabel mesh__D005422 Shire Brand of Flavoxate Hydrochloride
% 221.74/221.91  |- mesh__dateEstablished mesh__D005422 1991-01-01
% 221.74/221.91  |- rdf__type mesh__D005422sskos__Concept
% 221.74/221.91  |- mesh__recordMaintainer mesh__D005422 ssb
% 221.74/221.91  |- mesh__recordOriginator mesh__D005422 SH
% 221.74/221.91  |- skos__historyNote mesh__D005422 Piperidines %28%1972-1976%29%
% 221.74/221.91  |- mesh__recordAuthorizer mesh__D005422 sjn
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D005422 2006
% 221.74/221.91  |- mesh__dateCreated mesh__D005422 1976-04-13
% 221.74/221.91  |- skos__altLabel mesh__D005422 Hoechst Brand of Flavoxate Hydrochloride
% 221.74/221.91  |- skos__altLabel mesh__D005422 Byk Brand of Flavoxate Hydrochloride
% 221.74/221.91  |- skos__altLabel mesh__D005422 Recordati Brand of Flavoxate Hydrochloride
% 221.74/221.91  |- mesh__historyNote mesh__D005422
% 221.74/221.91       91%28%77%29%; was see under FLAVONES 1977-90   
% 221.74/221.91  |- mesh__dateRevised mesh__D005422 2005-06-30
% 221.74/221.91  |- skos__hiddenLabel mesh__D005422 Hydrochloride, Flavoxate
% 221.74/221.91  |- mesh__recordMaintainer mesh__D052078 ags
% 221.74/221.91  |- mesh__recordOriginator mesh__D052078 ags
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D052078 2006
% 221.74/221.91  |- skos__prefLabel mesh__D052078 Conus Snail
% 221.74/221.91  |- skos__broader mesh__D052078smesh__D049851
% 221.74/221.91  |- skos__historyNote mesh__D052078 Mollusca %28%1966-2005%29%
% 221.74/221.91  |- skos__altLabel mesh__D052078 Conus
% 221.74/221.91  |- rdf__type mesh__D052078sskos__Concept
% 221.74/221.91  |- mesh__dateEstablished mesh__D052078 2006-01-01
% 221.74/221.91  |- skos__related mesh__D052078smesh__D020916
% 221.74/221.91  |- mesh__historyNote mesh__D052078 2006   
% 221.74/221.91  |- skos__scopeNote mesh__D052078
% 221.74/221.91       A genus of cone-shaped marine snails in the family Conidae, class GASTROPODA. It comprises more than 600 species, many containing unique venoms %28%CONUS VENOMS%29% with which they immobilize their prey.%A%    
% 221.74/221.91  |- mesh__recordAuthorizer mesh__D052078 sjn
% 221.74/221.91  |- mesh__publicMeSHNote mesh__D052078 2006   
% 221.74/221.91  |- mesh__dateCreated mesh__D052078 2005-06-30
% 221.74/221.91  |- rdf__type mesh__D010367sskos__Concept
% 221.74/221.91  |- mesh__dateCreated mesh__D010367 1999-01-01
% 221.74/221.91  |- skos__broader mesh__D010367smesh__D007887
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D010367 2003
% 221.74/221.91  |- mesh__recordOriginator mesh__D010367 NLM
% 221.74/221.91  |- skos__annotation mesh__D010367
% 221.74/221.91       as plant %26% food;  /adv eff: consider also PEANUT HYPERSENSITIVITY; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.74/221.91  |- mesh__recordMaintainer mesh__D010367 ssb
% 221.74/221.91  |- mesh__historyNote mesh__D010367 2002%28%1963%29%   
% 221.74/221.91  |- mesh__dateRevised mesh__D010367 2001-07-25
% 221.74/221.91  |- mesh__publicMeSHNote mesh__D010367 2002: see PEANUTS 1963-2001   
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D010367 2002
% 221.74/221.91  |- skos__scopeNote mesh__D010367
% 221.74/221.91       A plant species of the family FABACEAE that yields edible seeds, the familiar peanuts, which contain protein, oil and lectins.%A%    
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D010367 2006
% 221.74/221.91  |- skos__altLabel mesh__D010367 Peanuts
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D010367 2005
% 221.74/221.91  |- skos__prefLabel mesh__D010367 Arachis hypogaea
% 221.74/221.91  |- mesh__recordAuthorizer mesh__D010367 sjn
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D010367 2004
% 221.74/221.91  |- skos__altLabel mesh__D015850 B-Cell Stimulatory Factor-2
% 221.74/221.91  |- skos__hiddenLabel mesh__D015850 B Cell Differentiation Factor
% 221.74/221.91  |- mesh__activeMeSHYear mesh__D015850 2006
% 221.74/221.91  |- skos__altLabel mesh__D015850 B-Cell Stimulatory Factor 2
% 221.74/221.91  |- skos__altLabel mesh__D015850 B Cell Stimulatory Factor-2
% 221.74/221.91  |- skos__annotation mesh__D015850 DF: IL 6 or IL6   
% 221.74/221.91  |- skos__altLabel mesh__D015850 Hybridoma Growth Factor
% 221.74/221.91  |- skos__broader mesh__D015850smesh__D007378
% 221.74/221.91  |- skos__altLabel mesh__D015850 Hepatocyte-Stimulating Factor
% 221.74/221.91  |- skos__hiddenLabel mesh__D015850 B Cell Stimulatory Factor 2
% 221.74/221.91  |- skos__prefLabel mesh__D015850 Interleukin-6
% 221.74/221.91  |- skos__altLabel mesh__D015850 MGI-2
% 221.74/221.91  |- skos__historyNote mesh__D015850 Lymphokines %28%1987%29%
% 221.74/221.91  |- mesh__dateRevised mesh__D015850 2005-06-30
% 221.74/221.91  |- skos__historyNote mesh__D015850 Interleukins %28%1988-1989%29%
% 221.74/221.91  |- skos__hiddenLabel mesh__D015850 Interleukin 6
% 221.74/221.91  |- skos__altLabel mesh__D015850 B-Cell Differentiation Factor
% 221.74/221.91  |- mesh__recordOriginator mesh__D015850 AGS
% 221.74/221.91  |- skos__altLabel mesh__D015850 B-Cell Differentiation Factor-2
% 221.74/221.91  |- rdf__type mesh__D015850sskos__Concept
% 221.74/221.91  |- skos__altLabel mesh__D015850 Differentiation Factor, B-Cell
% 221.74/221.91  |- skos__altLabel mesh__D015850 IL6
% 221.74/221.91  |- skos__scopeNote mesh__D015850
% 221.74/221.91       Factor that stimulates the growth and differentiation of human B-cells and is also a growth factor for hybridomas and plasmacytomas. It is produced by many different cells including T-cells, monocytes, and fibroblasts.%A%    
% 221.74/221.91  |- skos__hiddenLabel mesh__D015850 Myeloid Differentiation Inducing Protein
% 221.74/221.91  |- skos__hiddenLabel mesh__D015850
% 221.74/221.91       Differentiation-Inducing Protein, Myeloid
% 221.74/221.91  |- mesh__dateEstablished mesh__D015850 1990-01-01
% 221.74/221.91  |- skos__hiddenLabel mesh__D015850 Differentiation Factor, B Cell
% 221.74/221.91  |- skos__related mesh__D015850smesh__D006825
% 221.74/221.91  |- skos__altLabel mesh__D015850 IL-6
% 221.74/221.91  |- mesh__recordAuthorizer mesh__D015850 sjn
% 221.74/221.91  |- skos__hiddenLabel mesh__D015850 B Cell Differentiation Factor 2
% 221.74/221.91  |- skos__hiddenLabel mesh__D015850 Growth Factor, Plasmacytoma
% 221.74/221.91  |- skos__altLabel mesh__D015850 Myeloid Differentiation-Inducing Protein
% 221.74/221.91  |- skos__hiddenLabel mesh__D015850 Differentiation Factor 2, B Cell
% 221.74/221.91  |- mesh__recordMaintainer mesh__D015850 ssb
% 221.74/221.91  |- skos__altLabel mesh__D015850 Differentiation Factor-2, B-Cell
% 221.74/221.91  |- skos__hiddenLabel mesh__D015850 Growth Factor, Hybridoma
% 221.74/221.91  |- skos__altLabel mesh__D015850 Plasmacytoma Growth Factor
% 221.74/221.91  |- skos__related mesh__D015850smesh__D010954
% 221.74/221.91  |- skos__hiddenLabel mesh__D015850 Hepatocyte Stimulating Factor
% 221.74/221.91  |- skos__altLabel mesh__D015850 BSF-2
% 221.74/221.91  |- skos__altLabel mesh__D015850 IFN-beta 2
% 221.78/221.91  |- mesh__historyNote mesh__D015850 90   
% 221.78/221.91  |- mesh__publicMeSHNote mesh__D015850 90   
% 221.78/221.91  |- mesh__dateCreated mesh__D015850 1989-05-25
% 221.78/221.91  |- mesh__dateEstablished mesh__D015052 1979-01-01
% 221.78/221.91  |- skos__prefLabel mesh__D015052 Zygomycota
% 221.78/221.91  |- mesh__recordOriginator mesh__D015052 NLM
% 221.78/221.91  |- skos__scopeNote mesh__D015052
% 221.78/221.91       A phylum of fungi, formerly included in the Phycomycetes, usually saprophytic or parasitic, especially for insects.%A%    
% 221.78/221.91  |- mesh__activeMeSHYear mesh__D015052 2006
% 221.78/221.91  |- mesh__dateCreated mesh__D015052 1999-01-01
% 221.78/221.91  |- skos__broader mesh__D015052smesh__D005658
% 221.78/221.91  |- mesh__publicMeSHNote mesh__D015052
% 221.78/221.91       99; see ZYGOMYCOTINA 1986-98, see ZYGOMYCETES 1979-85, see PHYCOMYCETES 1971-78%A%  
% 221.78/221.91  |- skos__altLabel mesh__D015052 Zygomycotina
% 221.78/221.91  |- mesh__dateRevised mesh__D015052 2005-06-30
% 221.78/221.91  |- mesh__recordMaintainer mesh__D015052 SYSTEM
% 221.78/221.91  |- mesh__historyNote mesh__D015052 99%28%79%29%; use FUNGI 1971-78   
% 221.78/221.91  |- rdf__type mesh__D015052sskos__Concept
% 221.78/221.91  |- skos__historyNote mesh__D015052 Fungi %28%1966-1974%29%
% 221.78/221.91  |- mesh__recordAuthorizer mesh__D015052 sjn
% 221.78/221.91  |- mesh__historyNote mesh__D009813
% 221.78/221.91       91%28%75%29%; was see under PSYCHOANALYTIC THEORY 1975-90   
% 221.78/221.91  |- skos__broader mesh__D009813smesh__D011574
% 221.78/221.91  |- mesh__activeMeSHYear mesh__D009813 2000
% 221.78/221.91  |- mesh__onlineNote mesh__D009813 search PSYCHOANALYTIC THEORY 1966-74   
% 221.78/221.91  |- mesh__recordOriginator mesh__D009813 NLM
% 221.78/221.91  |- mesh__activeMeSHYear mesh__D009813 2001
% 221.78/221.91  |- mesh__dateEstablished mesh__D009813 1991-01-01
% 221.78/221.91  |- mesh__activeMeSHYear mesh__D009813 2005
% 221.78/221.91  |- mesh__activeMeSHYear mesh__D009813 2002
% 221.78/221.91  |- mesh__dateCreated mesh__D009813 1999-01-01
% 221.78/221.91  |- mesh__dateRevised mesh__D009813 1998-06-10
% 221.78/221.91  |- mesh__publicMeSHNote mesh__D009813
% 221.78/221.91       91; was see under PSYCHOANALYTIC THEORY 1975-90   
% 221.78/221.91  |- mesh__activeMeSHYear mesh__D009813 2006
% 221.78/221.91  |- mesh__activeMeSHYear mesh__D009813 2003
% 221.78/221.91  |- mesh__recordAuthorizer mesh__D009813 SJN
% 221.78/221.91  |- mesh__activeMeSHYear mesh__D009813 2004
% 221.78/221.92  |- skos__hiddenLabel mesh__D009813 Complex, Oedipus
% 221.78/221.92  |- skos__prefLabel mesh__D009813 Oedipus Complex
% 221.78/221.92  |- mesh__recordMaintainer mesh__D009813 MSR
% 221.78/221.92  |- rdf__type mesh__D009813sskos__Concept
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D009813 1999
% 221.78/221.92  |- skos__annotation mesh__D009813 no qualif   
% 221.78/221.92  |- skos__scopeNote mesh__D009813
% 221.78/221.92       Attachment of the child to the parent of the opposite sex, accompanied by envious and aggressive feelings toward the parent of the same sex.%A%    
% 221.78/221.92  |- rdf__type mesh__D001830sskos__Concept
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D001830 2005
% 221.78/221.92  |- skos__hiddenLabel mesh__D001830 Areas, Body Surface
% 221.78/221.92  |- mesh__recordMaintainer mesh__D001830 nns
% 221.78/221.92  |- skos__hiddenLabel mesh__D001830 Area, Body Surface
% 221.78/221.92  |- skos__broader mesh__D001830smesh__D001837
% 221.78/221.92  |- mesh__recordOriginator mesh__D001830 NLM
% 221.78/221.92  |- skos__hiddenLabel mesh__D001830 Surface Area, Body
% 221.78/221.92  |- mesh__dateRevised mesh__D001830 2004-07-07
% 221.78/221.92  |- mesh__dateEstablished mesh__D001830 1970-01-01
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D001830 2006
% 221.78/221.92  |- mesh__historyNote mesh__D001830 70%28%67%29%   
% 221.78/221.92  |- skos__historyNote mesh__D001830 Anthropometry %28%1966%29%
% 221.78/221.92  |- mesh__publicMeSHNote mesh__D001830 70   
% 221.78/221.92  |- skos__hiddenLabel mesh__D001830 Body Surface Areas
% 221.78/221.92  |- skos__prefLabel mesh__D001830 Body Surface Area
% 221.78/221.92  |- mesh__recordAuthorizer mesh__D001830 sjn
% 221.78/221.92  |- skos__hiddenLabel mesh__D001830 Surface Areas, Body
% 221.78/221.92  |- mesh__dateCreated mesh__D001830 1999-01-01
% 221.78/221.92  |- mesh__historyNote mesh__D009015
% 221.78/221.92       91%28%75%29%; was see under PYRIMIDINES 1975-90   
% 221.78/221.92  |- skos__broader mesh__D009015smesh__D013876
% 221.78/221.92  |- mesh__recordMaintainer mesh__D009015 ssb
% 221.78/221.92  |- mesh__dateRevised mesh__D009015 2005-06-30
% 221.78/221.92  |- mesh__publicMeSHNote mesh__D009015
% 221.78/221.92       91; was see under PYRIMIDINES 1975-90   
% 221.78/221.92  |- skos__hiddenLabel mesh__D009015 Tartrate, Morantel
% 221.78/221.92  |- mesh__dateEstablished mesh__D009015 1991-01-01
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D009015 2006
% 221.78/221.92  |- mesh__dateCreated mesh__D009015 1974-11-19
% 221.78/221.92  |- skos__broader mesh__D009015smesh__D011743
% 221.78/221.92  |- skos__historyNote mesh__D009015 Pyrimidines %28%1972-1974%29%
% 221.78/221.92  |- skos__historyNote mesh__D009015 Thiophenes %28%1972-1974%29%
% 221.78/221.92  |- skos__prefLabel mesh__D009015 Morantel
% 221.78/221.92  |- mesh__recordOriginator mesh__D009015 NLM
% 221.78/221.92  |- skos__scopeNote mesh__D009015
% 221.78/221.92       Antinematodal agent used mainly for livestock.     
% 221.78/221.92  |- rdf__type mesh__D009015sskos__Concept
% 221.78/221.92  |- mesh__recordAuthorizer mesh__D009015 sjn
% 221.78/221.92  |- skos__altLabel mesh__D001032 Azapropazone
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D001032 2006
% 221.78/221.92  |- mesh__publicMeSHNote mesh__D001032
% 221.78/221.92       91; was see under TRIAZINES 1975-90   
% 221.78/221.92  |- mesh__recordMaintainer mesh__D001032 ssb
% 221.78/221.92  |- skos__altLabel mesh__D001032 ASTA Medica Brand of Azapropazone
% 221.78/221.92  |- skos__altLabel mesh__D001032
% 221.78/221.92       5-%28%Dimethylamino%29%-9-methyl-2-propyl-1H-pyrazolo%28%1,2-a%29%%28%1,2,4%29%benzotriazine-1,3%28%2H%29%-dione
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D001032 2005
% 221.78/221.92  |- mesh__recordOriginator mesh__D001032 NLM
% 221.78/221.92  |- rdf__type mesh__D001032sskos__Concept
% 221.78/221.92  |- skos__historyNote mesh__D001032 Dimethylamines %28%1973-1974%29%
% 221.78/221.92  |- skos__altLabel mesh__D001032 Du Pont Brand of Azapropazone Dihydrate
% 221.78/221.92  |- skos__historyNote mesh__D001032 Malonates %28%1973-1974%29%
% 221.78/221.92  |- mesh__dateRevised mesh__D001032 2003-07-09
% 221.78/221.92  |- skos__historyNote mesh__D001032 Triazines %28%1971-1974%29%
% 221.78/221.92  |- skos__altLabel mesh__D001032 Wyeth Brand of Azapropazone Dihydrate
% 221.78/221.92  |- mesh__dateEstablished mesh__D001032 1991-01-01
% 221.78/221.92  |- skos__prefLabel mesh__D001032 Apazone
% 221.78/221.92  |- mesh__recordAuthorizer mesh__D001032 sjn
% 221.78/221.92  |- skos__altLabel mesh__D001032 Dagra Brand of Azapropazone Dihydrate
% 221.78/221.92  |- mesh__dateCreated mesh__D001032 1974-11-19
% 221.78/221.92  |- mesh__historyNote mesh__D001032
% 221.78/221.92       91%28%75%29%; was see under TRIAZINES 1975-90   
% 221.78/221.92  |- skos__hiddenLabel mesh__D001032 Dihydrate, Apazone
% 221.78/221.92  |- skos__scopeNote mesh__D001032
% 221.78/221.92       An anti-inflammatory agent used in the treatment of rheumatoid arthritis. It also has uricosuric properties and has been used to treat gout.%A%    
% 221.78/221.92  |- skos__altLabel mesh__D001032 Robins Brand of Azapropazone Dihydrate
% 221.78/221.92  |- skos__broader mesh__D001032smesh__D014227
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D001032 2004
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D020795 2004
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D020795 2005
% 221.78/221.92  |- skos__broader mesh__D020795smesh__D014786
% 221.78/221.92  |- skos__historyNote mesh__D020795 Vision Disorders %28%1968-1999%29%
% 221.78/221.92  |- skos__historyNote mesh__D020795 Eye Diseases %28%1968-1999%29%
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D020795 2003
% 221.78/221.92  |- skos__hiddenLabel mesh__D020795 Sensitivity, Light
% 221.78/221.92  |- mesh__dateEstablished mesh__D020795 2000-01-01
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D020795 2001
% 221.78/221.92  |- mesh__historyNote mesh__D020795 2000   
% 221.78/221.92  |- skos__hiddenLabel mesh__D020795 Light Sensitivities
% 221.78/221.92  |- skos__scopeNote mesh__D020795
% 221.78/221.92       Abnormal sensitivity to light. This may occur as a manifestation of EYE DISEASES; MIGRAINE; SUBARACHNOID HEMORRHAGE; MENINGITIS; and other disorders. Photophobia may also occur in association with DEPRESSION and other MENTAL DISORDERS.%A%    
% 221.78/221.92  |- skos__hiddenLabel mesh__D020795 Photophobias
% 221.78/221.92  |- mesh__publicMeSHNote mesh__D020795 2000   
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D020795 2000
% 221.78/221.92  |- skos__altLabel mesh__D020795 Light Sensitivity
% 221.78/221.92  |- mesh__dateCreated mesh__D020795 1999-11-03
% 221.78/221.92  |- skos__prefLabel mesh__D020795 Photophobia
% 221.78/221.92  |- skos__hiddenLabel mesh__D020795 Sensitivities, Light
% 221.78/221.92  |- rdf__type mesh__D020795sskos__Concept
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D020795 2006
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D020795 2002
% 221.78/221.92  |- skos__broader mesh__D008659Q000151smesh__D008659
% 221.78/221.92  |- mesh__preferredCombination mesh__D008659Q000151smesh__D008661
% 221.78/221.92  |- rdf__type mesh__D008659Q000151smesh__CompoundConcept
% 221.78/221.92  |- mesh__dateRevised mesh__D014758 2005-06-30
% 221.78/221.92  |- skos__altLabel mesh__D014758 Major Core Protein sigma 2
% 221.78/221.92  |- skos__hiddenLabel mesh__D014758 Core Proteins, P30
% 221.78/221.92  |- skos__hiddenLabel mesh__D014758 Core Protein, Major
% 221.78/221.92  |- skos__historyNote mesh__D014758 Capsid %28%1975-1985%29%
% 221.78/221.92  |- mesh__recordAuthorizer mesh__D014758 sjn
% 221.78/221.92  |- skos__scopeNote mesh__D014758
% 221.78/221.92       Proteins found mainly in icosahedral DNA and RNA viruses. They consist of proteins directly associated with the nucleic acid inside the NUCLEOCAPSID.%A%    
% 221.78/221.92  |- skos__altLabel mesh__D014758 Core Proteins, Viral
% 221.78/221.92  |- skos__hiddenLabel mesh__D014758 Protein P19, Oncornaviral
% 221.78/221.92  |- skos__altLabel mesh__D014758 Major Core Protein lambda 1
% 221.78/221.92  |- mesh__recordMaintainer mesh__D014758 SYSTEM
% 221.78/221.92  |- rdf__type mesh__D014758sskos__Concept
% 221.78/221.92  |- skos__altLabel mesh__D014758 OVP 19
% 221.78/221.92  |- skos__altLabel mesh__D014758 Oncornaviral Protein P19
% 221.78/221.92  |- mesh__publicMeSHNote mesh__D014758 86   
% 221.78/221.92  |- skos__altLabel mesh__D014758 Major Core Protein
% 221.78/221.92  |- mesh__recordOriginator mesh__D014758 RLS
% 221.78/221.92  |- skos__hiddenLabel mesh__D014758 Proteins, P30 Core
% 221.78/221.92  |- skos__prefLabel mesh__D014758 Viral Core Proteins
% 221.78/221.92  |- skos__hiddenLabel mesh__D014758 Protein P19, Viral
% 221.78/221.92  |- skos__hiddenLabel mesh__D014758 Protein, Major Core
% 221.78/221.92  |- skos__broader mesh__D014758smesh__D019590
% 221.78/221.92  |- skos__annotation mesh__D014758
% 221.78/221.92       IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 221.78/221.92  |- skos__historyNote mesh__D014758 Viral Proteins %28%1966-1985%29%
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D014758 2006
% 221.78/221.92  |- skos__hiddenLabel mesh__D014758 Proteins, Viral Core
% 221.78/221.92  |- mesh__historyNote mesh__D014758 86   
% 221.78/221.92  |- mesh__dateCreated mesh__D014758 1985-04-25
% 221.78/221.92  |- mesh__dateEstablished mesh__D014758 1986-01-01
% 221.78/221.92  |- skos__hiddenLabel mesh__D019443 Dust, Interstellar
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D019443 1997
% 221.78/221.92  |- skos__scopeNote mesh__D019443
% 221.78/221.92       Finely divided solid matter with particle sizes smaller than a micrometeorite, thus with diameters much smaller than a millimeter, moving in interplanetary space. %28%NASA Thesaurus, 1994%29%%A%    
% 221.78/221.92  |- skos__hiddenLabel mesh__D019443 Interstellar Dusts
% 221.78/221.92  |- skos__altLabel mesh__D019443 Interplanetary Dust
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D019443 2006
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D019443 2002
% 221.78/221.92  |- mesh__dateCreated mesh__D019443 1996-06-10
% 221.78/221.92  |- skos__prefLabel mesh__D019443 Cosmic Dust
% 221.78/221.92  |- mesh__dateEstablished mesh__D019443 1997-01-01
% 221.78/221.92  |- mesh__publicMeSHNote mesh__D019443 97   
% 221.78/221.92  |- rdf__type mesh__D019443sskos__Concept
% 221.78/221.92  |- mesh__historyNote mesh__D019443 97   
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D019443 2005
% 221.78/221.92  |- skos__hiddenLabel mesh__D019443 Dusts, Interstellar
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D019443 2001
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D019443 2004
% 221.78/221.92  |- skos__hiddenLabel mesh__D019443 Interplanetary Dusts
% 221.78/221.92  |- skos__hiddenLabel mesh__D019443 Dusts, Interplanetary
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D019443 2000
% 221.78/221.92  |- skos__altLabel mesh__D019443 Interstellar Dust
% 221.78/221.92  |- skos__hiddenLabel mesh__D019443 Dust, Interplanetary
% 221.78/221.92  |- skos__broader mesh__D019443smesh__D004391
% 221.78/221.92  |- skos__hiddenLabel mesh__D019443 Dust, Cosmic
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D019443 1999
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D019443 2003
% 221.78/221.92  |- skos__broader mesh__D019443smesh__D005118
% 221.78/221.92  |- skos__hiddenLabel mesh__D019443 Dusts, Cosmic
% 221.78/221.92  |- skos__hiddenLabel mesh__D019443 Cosmic Dusts
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D019443 1998
% 221.78/221.92  |- skos__prefLabel mesh__D000738 Androsterone
% 221.78/221.92  |- skos__altLabel mesh__D000738 5 alpha-Androstan-3 alpha-ol-17-one
% 221.78/221.92  |- skos__scopeNote mesh__D000738
% 221.78/221.92       A metabolite of TESTOSTERONE or ANDROSTENEDIONE with a 3-alpha-hydroxyl group and without the double bond. The 3-beta hydroxyl isomer is epiandrosterone.%A%    
% 221.78/221.92  |- skos__hiddenLabel mesh__D000738 5 alpha Androstan 3 alpha ol 17 one
% 221.78/221.92  |- rdf__type mesh__D000738sskos__Concept
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D000738 2004
% 221.78/221.92  |- mesh__recordOriginator mesh__D000738 NLM
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D000738 2006
% 221.78/221.92  |- skos__broader mesh__D000738smesh__D045165
% 221.78/221.92  |- skos__hiddenLabel mesh__D000738 3 alpha Hydroxy 5 alpha Androstan 17 One
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D000738 2005
% 221.78/221.92  |- skos__altLabel mesh__D000738 3-alpha-Hydroxy-5-alpha-Androstan-17-One
% 221.78/221.92  |- skos__broader mesh__D000738smesh__D015068
% 221.78/221.92  |- mesh__dateCreated mesh__D000738 1999-01-01
% 221.78/221.92  |- mesh__dateRevised mesh__D000738 2003-07-09
% 221.78/221.92  |- skos__broader mesh__D000738smesh__D000732
% 221.78/221.92  |- mesh__recordMaintainer mesh__D000738 lkt
% 221.78/221.92  |- mesh__recordAuthorizer mesh__D000738 sjn
% 221.78/221.92  |- rdf__type mesh__D011460sskos__Concept
% 221.78/221.92  |- mesh__publicMeSHNote mesh__D011460 75   
% 221.78/221.92  |- skos__altLabel mesh__D011460 PGF
% 221.78/221.92  |- skos__broader mesh__D011460smesh__D011453
% 221.78/221.92  |- skos__scopeNote mesh__D011460
% 221.78/221.92       %28%9 alpha,11 alpha,13E,15S%29%-9,11,15-Trihydroxyprost-13-en-1-oic acid %28%PGF%28%1 alpha%29%%29%; %28%5Z,9 alpha,11,alpha,13E,15S%29%-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid %28%PGF%28%2 alpha%29%%29%; %28%5Z,9 alpha,11 alpha,13E,15S,17Z%29%-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid %28%PGF%28%3 alpha%29%%29%. A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics.%A%    
% 221.78/221.92  |- skos__annotation mesh__D011460
% 221.78/221.92       /biosyn /physiol permitted; /chem syn permitted: do not convert to PROSTAGLANDINS F, SYNTHETIC; DF: PGF%A%  
% 221.78/221.92  |- skos__historyNote mesh__D011460 Prostaglandins %28%1966-1974%29%
% 221.78/221.92  |- mesh__dateRevised mesh__D011460 2005-06-30
% 221.78/221.92  |- mesh__historyNote mesh__D011460 75   
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D011460 2006
% 221.78/221.92  |- skos__hiddenLabel mesh__D011460 F, Prostaglandins
% 221.78/221.92  |- mesh__recordOriginator mesh__D011460 NLM
% 221.78/221.92  |- mesh__recordAuthorizer mesh__D011460 sjn
% 221.78/221.92  |- skos__prefLabel mesh__D011460 Prostaglandins F
% 221.78/221.92  |- mesh__dateCreated mesh__D011460 1974-11-11
% 221.78/221.92  |- mesh__dateEstablished mesh__D011460 1975-09-01
% 221.78/221.92  |- mesh__recordMaintainer mesh__D011460 ssb
% 221.78/221.92  |- mesh__historyNote mesh__D005423 SIPHONAPTERA was heading 1975-79   
% 221.78/221.92  |- skos__broader mesh__D005423smesh__D007313
% 221.78/221.92  |- mesh__onlineNote mesh__D005423
% 221.78/221.92       use FLEAS to search SIPHONAPTERA 1975-79   
% 221.78/221.92  |- mesh__dateRevised mesh__D005423 2003-07-09
% 221.78/221.92  |- skos__prefLabel mesh__D005423 Fleas
% 221.78/221.92  |- skos__altLabel mesh__D005423 Aphaniptera
% 221.78/221.92  |- mesh__recordOriginator mesh__D005423 NLM
% 221.78/221.92  |- mesh__dateCreated mesh__D005423 1999-01-01
% 221.78/221.92  |- skos__scopeNote mesh__D005423
% 221.78/221.92       Parasitic, blood-sucking, wingless insects comprising the order Siphonaptera.%A%    
% 221.78/221.92  |- mesh__recordMaintainer mesh__D005423 ags
% 221.78/221.92  |- rdf__type mesh__D005423sskos__Concept
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D005423 2004
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D005423 2006
% 221.78/221.92  |- skos__annotation mesh__D005423
% 221.78/221.92       do not use /drug eff for insecticides: TN 111; /microbiol /parasitol /virol permitted%A%  
% 221.78/221.92  |- mesh__publicMeSHNote mesh__D005423 SIPHONAPTERA was heading 1975-79   
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D005423 2005
% 221.78/221.92  |- skos__altLabel mesh__D005423 Siphonaptera
% 221.78/221.92  |- mesh__recordAuthorizer mesh__D005423 sjn
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D043542 2004
% 221.78/221.92  |- rdf__type mesh__D043542sskos__Concept
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D043542 2005
% 221.78/221.92  |- mesh__publicMeSHNote mesh__D043542 2004; see DNA 1985-2003   
% 221.78/221.92  |- skos__prefLabel mesh__D043542 DNA, Z-Form
% 221.78/221.92  |- mesh__dateCreated mesh__D043542 2003-07-09
% 221.78/221.92  |- skos__historyNote mesh__D043542 DNA %28%1977-2003%29%
% 221.78/221.92  |- mesh__dateEstablished mesh__D043542 2004-01-01
% 221.78/221.92  |- skos__altLabel mesh__D043542 Z-DNA
% 221.78/221.92  |- skos__scopeNote mesh__D043542
% 221.78/221.92       A left-handed double helix of DNA. Its name derives from its narrow zigzag structure that is the least twisted and thinnest form of DNA. Z-DNA forming regions within the GENOME may play an important role in GENE EXPRESSION REGULATION.%A%    
% 221.78/221.92  |- skos__related mesh__D043542smesh__D044705
% 221.78/221.92  |- mesh__historyNote mesh__D043542 2004; use DNA 1985-2003   
% 221.78/221.92  |- skos__broader mesh__D043542smesh__D004247
% 221.78/221.92  |- skos__hiddenLabel mesh__D043542 Z-Form DNA
% 221.78/221.92  |- skos__hiddenLabel mesh__D043542 DNA, Z Form
% 221.78/221.92  |- skos__hiddenLabel mesh__D043542 DNA, Left-Handed
% 221.78/221.92  |- skos__altLabel mesh__D043542 Left-Handed DNA
% 221.78/221.92  |- skos__hiddenLabel mesh__D043542 Left Handed DNA
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D043542 2006
% 221.78/221.92  |- skos__related mesh__D043542smesh__D044704
% 221.78/221.92  |- mesh__recordAuthorizer mesh__D010368 sjn
% 221.78/221.92  |- skos__broader mesh__D010368smesh__D010936
% 221.78/221.92  |- skos__broader mesh__D010368smesh__D001704
% 221.78/221.92  |- mesh__recordOriginator mesh__D010368 NLM
% 221.78/221.92  |- skos__prefLabel mesh__D010368 Pectins
% 221.78/221.92  |- skos__scopeNote mesh__D010368
% 221.78/221.92       High molecular weight polysaccharides present in the cell walls of all plants. Pectins cement cell walls together. They are used as emulsifiers and stabilizers in the food industry. They have been tried for a variety of therapeutic uses including as antidiarrheals, where they are now generally considered ineffective, and in the treatment of hypercholesterolemia.%A%    
% 221.78/221.92  |- mesh__dateRevised mesh__D010368 2005-06-30
% 221.78/221.92  |- mesh__recordMaintainer mesh__D010368 ssb
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D010368 2006
% 221.78/221.92  |- skos__broader mesh__D010368smesh__D011134
% 221.78/221.92  |- rdf__type mesh__D010368sskos__Concept
% 221.78/221.92  |- mesh__dateCreated mesh__D010368 1999-01-01
% 221.78/221.92  |- skos__altLabel mesh__D015851 IL-7
% 221.78/221.92  |- mesh__dateEstablished mesh__D015851 1990-01-01
% 221.78/221.92  |- skos__hiddenLabel mesh__D015851 Lymphopoietin 1
% 221.78/221.92  |- skos__annotation mesh__D015851 DF: IL 7 or IL7   
% 221.78/221.92  |- mesh__recordAuthorizer mesh__D015851 sjn
% 221.78/221.92  |- skos__broader mesh__D015851smesh__D007378
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D015851 2006
% 221.78/221.92  |- mesh__dateRevised mesh__D015851 2005-06-30
% 221.78/221.92  |- skos__hiddenLabel mesh__D015851 Interleukin 7
% 221.78/221.92  |- mesh__historyNote mesh__D015851 90   
% 221.78/221.92  |- skos__prefLabel mesh__D015851 Interleukin-7
% 221.78/221.92  |- mesh__recordMaintainer mesh__D015851 ssb
% 221.78/221.92  |- skos__altLabel mesh__D015851 Lymphopoietin-1
% 221.78/221.92  |- mesh__recordOriginator mesh__D015851 AGS
% 221.78/221.92  |- skos__historyNote mesh__D015851 Interleukins %28%1988-1989%29%
% 221.78/221.92  |- skos__scopeNote mesh__D015851
% 221.78/221.92       Hematopoietic growth factor that promotes growth of B-cell precursors and also is co-mitogenic with Interleukin-2 for mature T-cell activation. It is produced by bone marrow stromal cells.%A%    
% 221.78/221.92  |- skos__altLabel mesh__D015851 IL7
% 221.78/221.92  |- mesh__dateCreated mesh__D015851 1989-05-25
% 221.78/221.92  |- rdf__type mesh__D015851sskos__Concept
% 221.78/221.92  |- mesh__publicMeSHNote mesh__D015851 90   
% 221.78/221.92  |- skos__hiddenLabel mesh__D015053 Fertilized Eggs
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D015053 2005
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D015053 2006
% 221.78/221.92  |- skos__broader mesh__D015053smesh__D004628
% 221.78/221.92  |- skos__prefLabel mesh__D015053 Zygote
% 221.78/221.92  |- skos__broader mesh__D015053smesh__D010063
% 221.78/221.92  |- mesh__recordAuthorizer mesh__D015053 sjn
% 221.78/221.92  |- skos__hiddenLabel mesh__D015053 Egg, Fertilized
% 221.78/221.92  |- skos__altLabel mesh__D015053 Ovum, Fertilized
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D015053 2003
% 221.78/221.92  |- mesh__dateRevised mesh__D015053 2002-07-03
% 221.78/221.92  |- mesh__historyNote mesh__D015053 75   
% 221.78/221.92  |- rdf__type mesh__D015053sskos__Concept
% 221.78/221.92  |- mesh__recordOriginator mesh__D015053 NLM
% 221.78/221.92  |- skos__hiddenLabel mesh__D015053 Eggs, Fertilized
% 221.78/221.92  |- skos__scopeNote mesh__D015053
% 221.78/221.92       The fertilized OVUM resulting from the fusion of a male and a female gamete.%A%    
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D015053 2004
% 221.78/221.92  |- skos__altLabel mesh__D015053 Fertilized Egg
% 221.78/221.92  |- skos__altLabel mesh__D015053 Fertilized Ovum
% 221.78/221.92  |- mesh__dateEstablished mesh__D015053 1975-09-01
% 221.78/221.92  |- skos__historyNote mesh__D015053 Ovum %28%1966-1974%29%
% 221.78/221.92  |- mesh__dateCreated mesh__D015053 1974-11-11
% 221.78/221.92  |- mesh__recordMaintainer mesh__D015053 lkt
% 221.78/221.92  |- skos__hiddenLabel mesh__D015053 Zygotes
% 221.78/221.92  |- mesh__publicMeSHNote mesh__D015053 75   
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D009814 2005
% 221.78/221.92  |- skos__broader mesh__D009814smesh__D017206
% 221.78/221.92  |- mesh__publicMeSHNote mesh__D009814 67   
% 221.78/221.92  |- mesh__historyNote mesh__D009814 67   
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D009814 1997
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D009814 2002
% 221.78/221.92  |- rdf__type mesh__D009814sskos__Concept
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D009814 1999
% 221.78/221.92  |- mesh__recordAuthorizer mesh__D009814 PLS
% 221.78/221.92  |- skos__hiddenLabel mesh__D009814 Oesophagostomiases
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D009814 2001
% 221.78/221.92  |- mesh__dateCreated mesh__D009814 1999-01-01
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D009814 1996
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D009814 1995
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D009814 1998
% 221.78/221.92  |- mesh__recordOriginator mesh__D009814 NLM
% 221.78/221.92  |- skos__scopeNote mesh__D009814
% 221.78/221.92       Infection of the intestinal tract with worms of the genus OESOPHAGOSTOMUM. This condition occurs mainly in animals other than man.%A%    
% 221.78/221.92  |- skos__prefLabel mesh__D009814 Oesophagostomiasis
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D009814 2000
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D009814 1994
% 221.78/221.92  |- mesh__recordMaintainer mesh__D009814 TGC
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D009814 2004
% 221.78/221.92  |- skos__annotation mesh__D009814 nematode infect of intestines   
% 221.78/221.92  |- skos__historyNote mesh__D009814 Hookworm Infections %28%1966%29%
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D009814 2006
% 221.78/221.92  |- mesh__dateEstablished mesh__D009814 1967-01-01
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D009814 2003
% 221.78/221.92  |- mesh__dateRevised mesh__D009814 1993-06-02
% 221.78/221.92  |- skos__broader mesh__D001831smesh__D010829
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D001831 1998
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D001831 2002
% 221.78/221.92  |- skos__hiddenLabel mesh__D001831 Temperature, Organ
% 221.78/221.92  |- skos__broader mesh__D001831smesh__D010808
% 221.78/221.92  |- skos__prefLabel mesh__D001831 Body Temperature
% 221.78/221.92  |- rdf__type mesh__D001831sskos__Concept
% 221.78/221.92  |- mesh__recordMaintainer mesh__D001831 PXP
% 221.78/221.92  |- mesh__dateCreated mesh__D001831 1999-01-01
% 221.78/221.92  |- skos__hiddenLabel mesh__D001831 Temperatures, Body
% 221.78/221.92  |- skos__related mesh__D001831smesh__D013817
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D001831 2001
% 221.78/221.92  |- skos__hiddenLabel mesh__D001831 Temperature, Body
% 221.78/221.92  |- skos__hiddenLabel mesh__D001831 Body Temperatures
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D001831 2006
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D001831 2000
% 221.78/221.92  |- skos__related mesh__D001831smesh__D005334
% 221.78/221.92  |- mesh__recordOriginator mesh__D001831 NLM
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D001831 2004
% 221.78/221.92  |- skos__hiddenLabel mesh__D001831 Temperatures, Organ
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D001831 2005
% 221.78/221.92  |- skos__related mesh__D001831smesh__D013821
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D001831 1999
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D001831 2003
% 221.78/221.92  |- mesh__dateRevised mesh__D001831 1997-06-20
% 221.78/221.92  |- skos__hiddenLabel mesh__D001831 Organ Temperatures
% 221.78/221.92  |- mesh__recordAuthorizer mesh__D001831 SJN
% 221.78/221.92  |- skos__prefLabel mesh__D009016 Moraxella
% 221.78/221.92  |- skos__broader mesh__D009016smesh__D044007
% 221.78/221.92  |- mesh__recordOriginator mesh__D009016 NLM
% 221.78/221.92  |- mesh__dateCreated mesh__D009016 1999-01-01
% 221.78/221.92  |- mesh__recordMaintainer mesh__D009016 SYSTEM
% 221.78/221.92  |- mesh__recordAuthorizer mesh__D009016 sjn
% 221.78/221.92  |- rdf__type mesh__D009016sskos__Concept
% 221.78/221.92  |- skos__annotation mesh__D009016
% 221.78/221.92       infection: coord IM with MORAXELLACEAE INFECTIONS %28%IM%29%; note specifics but MORAXELLA KINGAE see KINGELLA KINGAE is available%A%  
% 221.78/221.92  |- mesh__dateRevised mesh__D009016 2005-06-30
% 221.78/221.92  |- skos__scopeNote mesh__D009016
% 221.78/221.92       A genus of gram-negative, aerobic bacteria occurring as rods %28%subgenus Moraxella%29% or cocci %28%subgenus Branhamella%29%. Its organisms are parasitic on the mucous membranes of humans and other warm-blooded animals.%A%    
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D009016 2006
% 221.78/221.92  |- skos__altLabel mesh__D020796
% 221.78/221.92       Platelet-Derived Growth Factor alpha Receptor
% 221.78/221.92  |- skos__altLabel mesh__D020796 Antigens, CD140a
% 221.78/221.92  |- mesh__dateRevised mesh__D020796 2005-06-30
% 221.78/221.92  |- skos__altLabel mesh__D020796 PDGF-R-alpha
% 221.78/221.92  |- mesh__historyNote mesh__D020796
% 221.78/221.92       2000; use RECEPTOR, PDGF ALPHA %28%NM%29% 1994-1999   
% 221.78/221.92  |- skos__altLabel mesh__D020796 PDGF alpha Receptor
% 221.78/221.92  |- skos__hiddenLabel mesh__D020796
% 221.78/221.92       Platelet Derived Growth Factor alpha Receptor
% 221.78/221.92  |- mesh__dateCreated mesh__D020796 1999-11-03
% 221.78/221.92  |- skos__historyNote mesh__D020796
% 221.78/221.92       Receptors, Platelet-Derived Growth Factor %28%1994-1999%29%
% 221.78/221.92  |- skos__prefLabel mesh__D020796
% 221.78/221.92       Receptor, Platelet-Derived Growth Factor alpha
% 221.78/221.92  |- mesh__recordMaintainer mesh__D020796 jmp
% 221.78/221.92  |- mesh__recordOriginator mesh__D020796 jmp
% 221.78/221.92  |- skos__altLabel mesh__D020796 CD140a Antigen
% 221.78/221.92  |- mesh__recordAuthorizer mesh__D020796 sjn
% 221.78/221.92  |- mesh__publicMeSHNote mesh__D020796
% 221.78/221.92       2000; PLATELET-DERIVED GROWTH FACTOR ALPHA RECEPTOR %28%now RECEPTOR, PDGF ALPHA%29% was indexed under RECEPTORS, PLATELET-DERIVED GROWTH FACTOR 1994-1999%A%  
% 221.78/221.92  |- skos__annotation mesh__D020796 DF: PDGF ALPHA RECEPT   
% 221.78/221.92  |- skos__altLabel mesh__D020796 PDGFR2
% 221.78/221.92  |- skos__altLabel mesh__D020796 CD140a Antigens
% 221.78/221.92  |- mesh__dateEstablished mesh__D020796 2000-01-01
% 221.78/221.92  |- skos__broader mesh__D020796smesh__D017479
% 221.78/221.92  |- skos__scopeNote mesh__D020796
% 221.78/221.92       A PDGF receptor that binds specifically to both PDGF-A chains and PDGF-B chains. It contains a protein-tyrosine kinase activity that is involved in SIGNAL TRANSDUCTION.%A%    
% 221.78/221.92  |- rdf__type mesh__D020796sskos__Concept
% 221.78/221.92  |- skos__altLabel mesh__D020796 Receptor, PDGF alpha
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D020796 2006
% 221.78/221.92  |- skos__hiddenLabel mesh__D020796 Antigen, CD140a
% 221.78/221.92  |- skos__altLabel mesh__D014759 Envelope Proteins, Viral
% 221.78/221.92  |- skos__hiddenLabel mesh__D014759 Peplomer Proteins, Virus
% 221.78/221.92  |- mesh__recordMaintainer mesh__D014759 SYSTEM
% 221.78/221.92  |- skos__scopeNote mesh__D014759
% 221.78/221.92       Layers of protein which surround the capsid in animal viruses with tubular nucleocapsids. The envelope consists of an inner layer of lipids and virus specified proteins also called membrane or matrix proteins. The outer layer consists of one or more types of morphological subunits called peplomers which project from the viral envelope; this layer always consists of glycoproteins.%A%    
% 221.78/221.92  |- mesh__dateRevised mesh__D014759 2005-06-30
% 221.78/221.92  |- skos__broader mesh__D014759smesh__D015678
% 221.78/221.92  |- skos__prefLabel mesh__D014759 Viral Envelope Proteins
% 221.78/221.92  |- mesh__activeMeSHYear mesh__D014759 2006
% 221.78/221.92  |- mesh__recordAuthorizer mesh__D014759 sjn
% 221.78/221.92  |- skos__hiddenLabel mesh__D014759 Proteins, Virus Peplomer
% 221.78/221.92  |- mesh__historyNote mesh__D014759 84   
% 221.78/221.92  |- skos__annotation mesh__D014759
% 221.78/221.92       IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 221.78/221.92  |- skos__hiddenLabel mesh__D014759 Proteins, Viral Envelope
% 221.78/221.92  |- mesh__dateCreated mesh__D014759 1983-06-16
% 221.78/221.92  |- mesh__publicMeSHNote mesh__D014759 84   
% 221.78/221.92  |- skos__historyNote mesh__D014759 Viral Proteins %28%1966-1983%29%
% 221.78/221.92  |- mesh__recordOriginator mesh__D014759 RLS
% 221.78/221.92  |- rdf__type mesh__D014759sskos__Concept
% 221.78/221.93  |- mesh__dateEstablished mesh__D014759 1984-01-01
% 221.78/221.93  |- skos__altLabel mesh__D025481 Fructose-6-phosphate,2-kinase
% 221.78/221.93  |- mesh__recordOriginator mesh__D025481 lkt
% 221.78/221.93  |- mesh__dateRevised mesh__D025481 2003-07-09
% 221.78/221.93  |- skos__altLabel mesh__D025481 F Kinase-F-bisphosphatase
% 221.78/221.93  |- mesh__dateEstablished mesh__D025481 2002-01-01
% 221.78/221.93  |- skos__altLabel mesh__D025481 Fructose 2,6-bisphosphatase
% 221.78/221.93  |- skos__altLabel mesh__D025481 Fru-kinase-Fru-bisphosphatase
% 221.78/221.93  |- skos__altLabel mesh__D025481 Fructose-2,6-bisphosphate 2-phosphatase
% 221.78/221.93  |- skos__historyNote mesh__D025481
% 221.78/221.93       Phosphoric Monoester Hydrolases %28%1983-2001%29%
% 221.78/221.93  |- mesh__publicMeSHNote mesh__D025481
% 221.78/221.93       2002; 6-PHOSPHOFRUCTO-2-KINASE was indexed under PHOSPHOTRANSFERASES %28%NM%29% 1993-2001, under PHOSPHOTRANSFERASES, ATP %28%NM%29% 1981-1993; FRUCTOSE-2,6-BISPHOSPATASE was indexed under PHOSPHORIC MONOESTER HYDROLASES %28%NM%29% 1983-2001; 6-PHOSPHOFRUCTO-2-KINASE-FRUCTOSE-2,6-BISPHOSPHATASE was indexed under FRUCTOSE-BISPHOSPHATASE %28%NM%29% 1990-2001, under MULTIENZYME COMPLEXES %28%NM%29% 1990-2001, under PHOSPHOFRUCTOKINASE-1 %28%NM%29% 1990-2001%A%  
% 221.78/221.93  |- skos__historyNote mesh__D025481 Phosphofructokinase-1 %28%1981-2001%29%
% 221.78/221.93  |- skos__altLabel mesh__D025481
% 221.78/221.93       Fructose-6-phosphate,2-kinase-fructose-2,6-bisphosphatase
% 221.78/221.93  |- skos__broader mesh__D025481smesh__D025221
% 221.78/221.93  |- skos__broader mesh__D025481smesh__D010744
% 221.78/221.93  |- rdf__type mesh__D025481sskos__Concept
% 221.78/221.93  |- mesh__activeMeSHYear mesh__D025481 2005
% 221.78/221.93  |- skos__altLabel mesh__D025481 6-PF-2-K-Fru-2,6-P%28%2%29%ase
% 221.78/221.93  |- mesh__recordMaintainer mesh__D025481 ssb
% 221.78/221.93  |- mesh__historyNote mesh__D025481
% 221.78/221.93       2002; for 6-PHOSPHOFRUCTO-2-KINASE use PHOSPHOTRANSFERASES %28%NM%29% 1993-2001, use PHOSPHOTRANSFERASES, ATP %28%NM%29% 1981-1993; for FRUCTOSE-2,6-BISPHOSPATASE use PHOSPHORIC MONOESTER HYDROLASES %28%NM%29% 1983-2001; for 6-PHOSPHOFRUCTO-2-KINASE-FRUCTOSE-2,6-BISPHOSPHATASE use FRUCTOSE-BISPHOSPHATASE %28%NM%29% 1990-2001, use MULTIENZYME COMPLEXES %28%NM%29% 1990-2001, use PHOSPHOFRUCTOKINASE-1 %28%NM%29% 1990-2001%A%  
% 221.78/221.93  |- skos__historyNote mesh__D025481 Phosphotransferases %28%1981-2001%29%
% 221.78/221.93  |- skos__altLabel mesh__D025481 6PF2K
% 221.78/221.93  |- skos__altLabel mesh__D025481 6-Phosphofructo-2-kinase
% 221.78/221.93  |- mesh__dateCreated mesh__D025481 2001-07-25
% 221.78/221.93  |- mesh__recordAuthorizer mesh__D025481 sjn
% 221.78/221.93  |- mesh__activeMeSHYear mesh__D025481 2006
% 221.78/221.93  |- mesh__activeMeSHYear mesh__D025481 2004
% 221.78/221.93  |- skos__altLabel mesh__D025481 fructose-2,6-diphosphatase
% 221.78/221.93  |- skos__related mesh__D025481smesh__D010732
% 221.78/221.93  |- skos__altLabel mesh__D025481
% 221.78/221.93       ATP-D-Fructose-6-phosphate 2-phosphotransferase
% 221.78/221.93  |- skos__altLabel mesh__D025481 Fructose-6-P,2-kinase
% 221.78/221.93  |- skos__hiddenLabel mesh__D025481 Phosphofructokinase 2
% 221.78/221.93  |- skos__prefLabel mesh__D025481 Phosphofructokinase-2
% 221.78/221.93  |- skos__altLabel mesh__D025481
% 221.78/221.93       6-Phosphofructo 2-kinase-fructose 2,6-bisphosphatase
% 221.78/221.93  |- skos__altLabel mesh__D025481 Fru-6-P,2-kinase
% 221.78/221.93  |- skos__scopeNote mesh__D025481
% 221.78/221.93       An allosteric enzyme that regulates glycolysis and gluconeogenesis by catalyzing the transfer of a phosphate group from ATP to fructose-6-phosphate to yield fructose-2,6-bisphosphate, an allosteric effector for the other 6-phosphofructokinase, PHOSPHOFRUCTOKINASE-1. Phosphofructokinase-2 is bifunctional: the dephosphorylated form is a kinase and the phosphorylated form is a phosphatase that breaks down fructose-2,6-bisphosphate to yield fructose-6-phosphate.%A%    
% 221.78/221.93  |- mesh__dateRevised mesh__D019444 2005-06-30
% 221.78/221.93  |- mesh__activeMeSHYear mesh__D019444 2006
% 221.78/221.93  |- skos__broader mesh__D019444smesh__D014614
% 221.78/221.93  |- skos__scopeNote mesh__D019444
% 221.78/221.93       Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers.%A%    
% 221.78/221.93  |- skos__hiddenLabel mesh__D019444 DNA Vaccines, Naked
% 221.78/221.93  |- skos__altLabel mesh__D019444 Vaccines, Recombinant DNA
% 221.78/221.93  |- mesh__historyNote mesh__D019444 97   
% 221.78/221.93  |- mesh__recordMaintainer mesh__D019444 ssb
% 221.78/221.93  |- rdf__type mesh__D019444sskos__Concept
% 221.78/221.93  |- skos__hiddenLabel mesh__D019444 DNA Vaccines, Recombinant
% 221.78/221.93  |- skos__hiddenLabel mesh__D019444 Vaccines, Naked DNA
% 221.78/221.93  |- mesh__dateCreated mesh__D019444 1996-06-10
% 221.78/221.93  |- skos__annotation mesh__D019444
% 221.78/221.93       vaccines composed of recombinant DNA vectors encoding antigens%A%  
% 221.78/221.93  |- mesh__dateEstablished mesh__D019444 1997-01-01
% 221.78/221.93  |- mesh__recordOriginator mesh__D019444 AGS
% 221.78/221.93  |- mesh__publicMeSHNote mesh__D019444 97   
% 221.79/221.93  |- skos__altLabel mesh__D019444 DNA Vaccines
% 221.79/221.93  |- skos__altLabel mesh__D019444 Recombinant DNA Vaccines
% 221.79/221.93  |- mesh__recordAuthorizer mesh__D019444 sjn
% 221.79/221.93  |- skos__hiddenLabel mesh__D019444 Vaccines, Nucleic Acid
% 221.79/221.93  |- skos__prefLabel mesh__D019444 Vaccines, DNA
% 221.79/221.93  |- skos__hiddenLabel mesh__D019444 Vaccines, Polynucleotide
% 221.79/221.93  |- skos__historyNote mesh__D019444 Vaccines, Synthetic %28%1986-1996%29%
% 221.79/221.93  |- skos__altLabel mesh__D019444 Naked DNA Vaccines
% 221.79/221.93  |- skos__scopeNote mesh__D000739
% 221.79/221.93       Brief accounts or narratives of an incident or event.     
% 221.79/221.93  |- rdf__type mesh__D000739sskos__Concept
% 221.79/221.93  |- skos__annotation mesh__D000739 no qualif   
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D000739 2004
% 221.79/221.93  |- mesh__recordAuthorizer mesh__D000739 sjn
% 221.79/221.93  |- skos__hiddenLabel mesh__D000739 Anecdote
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D000739 2006
% 221.79/221.93  |- skos__broader mesh__D000739smesh__D008091
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D000739 2003
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D000739 2005
% 221.79/221.93  |- skos__related mesh__D000739smesh__D033262
% 221.79/221.93  |- mesh__dateRevised mesh__D000739 2002-07-31
% 221.79/221.93  |- mesh__dateCreated mesh__D000739 1999-01-01
% 221.79/221.93  |- mesh__recordOriginator mesh__D000739 NLM
% 221.79/221.93  |- skos__prefLabel mesh__D000739 Anecdotes
% 221.79/221.93  |- mesh__recordMaintainer mesh__D000739 jls
% 221.79/221.93  |- rdf__type mesh__D011461sskos__Concept
% 221.79/221.93  |- mesh__recordAuthorizer mesh__D011461 sjn
% 221.79/221.93  |- skos__altLabel mesh__D011461 Prostaglandin F Analogues
% 221.79/221.93  |- skos__broader mesh__D011461smesh__D011465
% 221.79/221.93  |- skos__historyNote mesh__D011461 Prostaglandins F %28%1975-1977%29%
% 221.79/221.93  |- skos__prefLabel mesh__D011461 Prostaglandins F, Synthetic
% 221.79/221.93  |- skos__historyNote mesh__D011461 Prostaglandins, Synthetic %28%1977%29%
% 221.79/221.93  |- skos__altLabel mesh__D011461 Synthetic Prostaglandins F
% 221.79/221.93  |- mesh__historyNote mesh__D011461 78   
% 221.79/221.93  |- mesh__dateCreated mesh__D011461 1977-05-23
% 221.79/221.93  |- mesh__recordOriginator mesh__D011461 RLS
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D011461 2006
% 221.79/221.93  |- skos__hiddenLabel mesh__D011461 Analogues, Prostaglandin F
% 221.79/221.93  |- mesh__dateEstablished mesh__D011461 1978-01-01
% 221.79/221.93  |- skos__altLabel mesh__D011461 Prostaglandin F Analogs
% 221.79/221.93  |- skos__scopeNote mesh__D011461
% 221.79/221.93       Analogs or derivatives of prostaglandins F that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGF.%A%    
% 221.79/221.93  |- skos__annotation mesh__D011461 DF: PGF SYN   
% 221.79/221.93  |- skos__altLabel mesh__D011461 PGF Synthetic
% 221.79/221.93  |- mesh__dateRevised mesh__D011461 2005-06-30
% 221.79/221.93  |- mesh__publicMeSHNote mesh__D011461 78   
% 221.79/221.93  |- skos__hiddenLabel mesh__D011461 Analogs, Prostaglandin F
% 221.79/221.93  |- mesh__recordMaintainer mesh__D011461 ssb
% 221.79/221.93  |- skos__hiddenLabel mesh__D011461 Synthetic, PGF
% 221.79/221.93  |- mesh__dateEstablished mesh__D005424 1987-01-01
% 221.79/221.93  |- mesh__publicMeSHNote mesh__D005424
% 221.79/221.93       92; was FLECAINIDE ACETATE 1991; was FLECAINIDE 1987-90   
% 221.79/221.93  |- skos__altLabel mesh__D005424 Merck dura Brand of Flecainide Acetate
% 221.79/221.93  |- rdf__type mesh__D005424sskos__Concept
% 221.79/221.93  |- mesh__dateCreated mesh__D005424 1986-06-02
% 221.79/221.93  |- mesh__historyNote mesh__D005424
% 221.79/221.93       92; was FLECAINIDE ACETATE 1991; was FLECAINIDE 1987-90   
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D005424 2006
% 221.79/221.93  |- skos__altLabel mesh__D005424 Alpharma Brand of Flecainide Acetate
% 221.79/221.93  |- mesh__recordAuthorizer mesh__D005424 sjn
% 221.79/221.93  |- mesh__dateRevised mesh__D005424 2005-06-30
% 221.79/221.93  |- skos__altLabel mesh__D005424 Apocard
% 221.79/221.93  |- skos__altLabel mesh__D005424 3M Brand of Flecainide Acetate
% 221.79/221.93  |- skos__altLabel mesh__D005424 United Drug Brand of Flecainide Acetate
% 221.79/221.93  |- skos__altLabel mesh__D005424 Riker Brand of Flecainide Acetate
% 221.79/221.93  |- mesh__recordOriginator mesh__D005424 RLS
% 221.79/221.93  |- mesh__onlineNote mesh__D005424
% 221.79/221.93       use FLECAINIDE to search FLECAINIDE ACETATE 1991   
% 221.79/221.93  |- skos__hiddenLabel mesh__D005424 Flecainid Isis
% 221.79/221.93  |- skos__altLabel mesh__D005424 Alphapharm Brand of Flecainide Acetate
% 221.79/221.93  |- skos__prefLabel mesh__D005424 Flecainide
% 221.79/221.93  |- mesh__recordMaintainer mesh__D005424 CCR
% 221.79/221.93  |- skos__scopeNote mesh__D005424
% 221.79/221.93       A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial arrhythmias and tachycardias. Paradoxically, however, in myocardial infarct patients with either symptomatic or asymptomatic arrhythmia, flecainide exacerbates the arrhythmia and is not recommended for use in these patients.%A%    
% 221.79/221.93  |- skos__hiddenLabel mesh__D005424 Acetate, Flecainide
% 221.79/221.93  |- skos__altLabel mesh__D005424 Fl%C3%%A9%ca%C3%%AF%ne
% 221.79/221.93  |- skos__altLabel mesh__D005424 Flecainide Monoacetate
% 221.79/221.93  |- skos__broader mesh__D005424smesh__D010880
% 221.79/221.93  |- skos__historyNote mesh__D005424 Piperidines %28%1966-1986%29%
% 221.79/221.93  |- skos__broader mesh__D007328Q000037smesh__D007328
% 221.79/221.93  |- mesh__preferredCombination mesh__D007328Q000037smesh__D007329
% 221.79/221.93  |- rdf__type mesh__D007328Q000037smesh__CompoundConcept
% 221.79/221.93  |- skos__scopeNote mesh__D010369
% 221.79/221.93       The pectoralis major and pectoralis minor muscles that make up the upper and fore part of the chest in front of the AXILLA.%A%    
% 221.79/221.93  |- skos__hiddenLabel mesh__D010369 Pectoralis Muscle
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D010369 2005
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D010369 2006
% 221.79/221.93  |- skos__annotation mesh__D010369
% 221.79/221.93       /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 221.79/221.93  |- mesh__dateRevised mesh__D010369 2001-07-25
% 221.79/221.93  |- mesh__recordAuthorizer mesh__D010369 sjn
% 221.79/221.93  |- mesh__dateCreated mesh__D010369 1999-01-01
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D010369 2003
% 221.79/221.93  |- skos__broader mesh__D010369smesh__D018482
% 221.79/221.93  |- skos__hiddenLabel mesh__D010369 Muscle, Pectoralis
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D010369 2002
% 221.79/221.93  |- mesh__recordOriginator mesh__D010369 NLM
% 221.79/221.93  |- rdf__type mesh__D010369sskos__Concept
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D010369 2004
% 221.79/221.93  |- mesh__recordMaintainer mesh__D010369 nns
% 221.79/221.93  |- skos__hiddenLabel mesh__D010369 Muscles, Pectoralis
% 221.79/221.93  |- skos__prefLabel mesh__D010369 Pectoralis Muscles
% 221.79/221.93  |- skos__hiddenLabel mesh__D015852 EIF 2 alpha
% 221.79/221.93  |- mesh__dateCreated mesh__D015852 1989-05-25
% 221.79/221.93  |- skos__altLabel mesh__D015852 EIF-2
% 221.79/221.93  |- skos__altLabel mesh__D015852 EIF-2 beta
% 221.79/221.93  |- skos__broader mesh__D015852smesh__D039642
% 221.79/221.93  |- mesh__publicMeSHNote mesh__D015852 2003; see EIF-2 1990-2002   
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D015852 2006
% 221.79/221.93  |- skos__altLabel mesh__D015852 Eukaryotic Peptide Initiation Factor-2
% 221.79/221.93  |- mesh__recordOriginator mesh__D015852 AGS
% 221.79/221.93  |- mesh__historyNote mesh__D015852 2003%28%1990%29%   
% 221.79/221.93  |- skos__hiddenLabel mesh__D015852 Eukaryotic Peptide Initiation Factor 2
% 221.79/221.93  |- skos__altLabel mesh__D015852 EIF-2 gamma
% 221.79/221.93  |- skos__hiddenLabel mesh__D015852 EIF 2gamma
% 221.79/221.93  |- mesh__dateEstablished mesh__D015852 1990-01-01
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D015852 2003
% 221.79/221.93  |- skos__hiddenLabel mesh__D015852 EIF 2beta
% 221.79/221.93  |- mesh__recordAuthorizer mesh__D015852 sjn
% 221.79/221.93  |- rdf__type mesh__D015852sskos__Concept
% 221.79/221.93  |- skos__hiddenLabel mesh__D015852 Initiation Factor-2, Eukaryotic
% 221.79/221.93  |- skos__hiddenLabel mesh__D015852 EIF 2 gamma
% 221.79/221.93  |- skos__altLabel mesh__D015852 Peptide Initiation Factor EIF-2
% 221.79/221.93  |- skos__hiddenLabel mesh__D015852 EIF 2alpha
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D015852 2004
% 221.79/221.93  |- skos__historyNote mesh__D015852
% 221.79/221.93       Peptide Initiation Factors %28%1978-1989%29%
% 221.79/221.93  |- skos__hiddenLabel mesh__D015852
% 221.79/221.93       Eukaryotic Initiation Factor 2, gamma Subunit
% 221.79/221.93  |- skos__prefLabel mesh__D015852 Eukaryotic Initiation Factor-2
% 221.79/221.93  |- skos__scopeNote mesh__D015852
% 221.79/221.93       Eukaryotic initiation factor of protein synthesis. In higher eukaryotes the factor consists of three subunits: alpha, beta, and gamma. As initiation proceeds, eIF-2 forms a ternary complex with Met-tRNAi and GTP.%A%    
% 221.79/221.93  |- skos__hiddenLabel mesh__D015852
% 221.79/221.93       Eukaryotic Initiation Factor 2, alpha Subunit
% 221.79/221.93  |- skos__hiddenLabel mesh__D015852
% 221.79/221.93       Eukaryotic Initiation Factor 2, beta Subunit
% 221.79/221.93  |- skos__hiddenLabel mesh__D015852 EIF 2 beta
% 221.79/221.93  |- skos__altLabel mesh__D015852 EIF-2 alpha
% 221.79/221.93  |- mesh__dateRevised mesh__D015852 2002-07-03
% 221.79/221.93  |- skos__altLabel mesh__D015852 EIF-2alpha
% 221.79/221.93  |- skos__altLabel mesh__D015852 EIF2
% 221.79/221.93  |- mesh__recordMaintainer mesh__D015852 jmp
% 221.79/221.93  |- skos__altLabel mesh__D015852 EIF-2gamma
% 221.79/221.93  |- skos__hiddenLabel mesh__D015852 EIF 2
% 221.79/221.93  |- skos__hiddenLabel mesh__D015852 Eukaryotic Initiation Factor 2
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D015852 2005
% 221.79/221.93  |- skos__altLabel mesh__D015852 EIF-2beta
% 221.79/221.93  |- skos__hiddenLabel mesh__D015852 Peptide Initiation Factor EIF 2
% 221.79/221.93  |- mesh__recordMaintainer mesh__D015054 ssb
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D015054 2006
% 221.79/221.93  |- skos__hiddenLabel mesh__D015054 A, Zymosan
% 221.79/221.93  |- skos__broader mesh__D015054smesh__D047071
% 221.79/221.93  |- rdf__type mesh__D015054sskos__Concept
% 221.79/221.93  |- mesh__recordAuthorizer mesh__D015054 sjn
% 221.79/221.93  |- skos__prefLabel mesh__D015054 Zymosan
% 221.79/221.93  |- mesh__dateRevised mesh__D015054 2004-07-07
% 221.79/221.93  |- mesh__recordOriginator mesh__D015054 NLM
% 221.79/221.93  |- mesh__dateCreated mesh__D015054 1999-01-01
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D015054 2005
% 221.79/221.93  |- mesh__recordMaintainer mesh__D009815 ags
% 221.79/221.93  |- skos__historyNote mesh__D009815 Ancylostomatoidea %28%1966%29%
% 221.79/221.93  |- mesh__dateCreated mesh__D009815 1999-01-01
% 221.79/221.93  |- skos__broader mesh__D009815smesh__D013320
% 221.79/221.93  |- mesh__dateRevised mesh__D009815 2003-07-09
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D009815 2004
% 221.79/221.93  |- mesh__publicMeSHNote mesh__D009815
% 221.79/221.93       67; was see under HOOKWORMS 1963-66   
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D009815 2006
% 221.79/221.93  |- mesh__dateEstablished mesh__D009815 1967-01-01
% 221.79/221.93  |- mesh__recordAuthorizer mesh__D009815 sjn
% 221.79/221.93  |- mesh__recordOriginator mesh__D009815 NLM
% 221.79/221.93  |- mesh__onlineNote mesh__D009815 search ANCYLOSTOMATOIDEA 1966   
% 221.79/221.93  |- skos__scopeNote mesh__D009815
% 221.79/221.93       A genus of nematodes of the superfamily STRONGYLOIDEA, parasitic in the intestines of animals. The adults are usually free in the intestinal lumen; the larvae encyst in the wall.%A%    
% 221.79/221.93  |- skos__annotation mesh__D009815
% 221.79/221.93       a genus of nematodes; infection = OESOPHAGOSTOMIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D009815 2005
% 221.79/221.93  |- skos__prefLabel mesh__D009815 Oesophagostomum
% 221.79/221.93  |- mesh__historyNote mesh__D009815 67; was see under HOOKWORMS 1963-66   
% 221.79/221.93  |- rdf__type mesh__D009815sskos__Concept
% 221.79/221.93  |- skos__scopeNote mesh__D001832
% 221.79/221.93       Significant alterations in temperature of the human body, above or below 98.6 degrees F. or 37 degrees C. when taken orally.%A%    
% 221.79/221.93  |- rdf__type mesh__D001832sskos__Concept
% 221.79/221.93  |- skos__broader mesh__D001832smesh__D012816
% 221.79/221.93  |- mesh__dateCreated mesh__D001832 1999-01-01
% 221.79/221.93  |- mesh__historyNote mesh__D001832 98; use explode 1975-97   
% 221.79/221.93  |- skos__hiddenLabel mesh__D001832 Temperature Changes, Body
% 221.79/221.93  |- skos__annotation mesh__D001832 not used for indexing   
% 221.79/221.93  |- skos__hiddenLabel mesh__D001832 Temperature Change, Body
% 221.79/221.93  |- skos__hiddenLabel mesh__D001832 Body Temperature Change
% 221.79/221.93  |- mesh__recordAuthorizer mesh__D001832 sjn
% 221.79/221.93  |- skos__hiddenLabel mesh__D001832 Changes, Body Temperature
% 221.79/221.93  |- mesh__publicMeSHNote mesh__D001832 98   
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D001832 2006
% 221.79/221.93  |- mesh__dateRevised mesh__D001832 2004-07-13
% 221.79/221.93  |- mesh__dateEstablished mesh__D001832 1998-01-01
% 221.79/221.93  |- skos__hiddenLabel mesh__D001832 Change, Body Temperature
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D001832 2005
% 221.79/221.93  |- mesh__recordMaintainer mesh__D001832 sjn
% 221.79/221.93  |- skos__historyNote mesh__D001832 Body Temperature %28%1966-1997%29%
% 221.79/221.93  |- skos__prefLabel mesh__D001832 Body Temperature Changes
% 221.79/221.93  |- mesh__recordOriginator mesh__D001832 NLM
% 221.79/221.93  |- mesh__recordMaintainer mesh__D009017 ags
% 221.79/221.93  |- skos__broader mesh__D009017smesh__D014798
% 221.79/221.93  |- mesh__dateCreated mesh__D009017 1999-01-01
% 221.79/221.93  |- skos__hiddenLabel mesh__D009017 Morbidities
% 221.79/221.93  |- skos__prefLabel mesh__D009017 Morbidity
% 221.79/221.93  |- rdf__type mesh__D009017sskos__Concept
% 221.79/221.93  |- mesh__recordOriginator mesh__D009017 NLM
% 221.79/221.93  |- mesh__recordAuthorizer mesh__D009017 sjn
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D009017 2006
% 221.79/221.93  |- mesh__dateRevised mesh__D009017 2005-06-30
% 221.79/221.93  |- skos__scopeNote mesh__D009017
% 221.79/221.93       The proportion of patients with a particular disease during a given year per given unit of population.%A%    
% 221.79/221.93  |- skos__annotation mesh__D009017
% 221.79/221.93       IM GEN only; coord NIM with disease /epidemiol %28%IM%29%; specify geog if possible%A%  
% 221.79/221.93  |- skos__broader mesh__D001034smesh__D010808
% 221.79/221.93  |- rdf__type mesh__D001034sskos__Concept
% 221.79/221.93  |- mesh__publicMeSHNote mesh__D001034 73   
% 221.79/221.93  |- skos__historyNote mesh__D001034 Physical Examination %28%1966-1970%29%
% 221.79/221.93  |- mesh__recordMaintainer mesh__D001034 sjn
% 221.79/221.93  |- mesh__recordAuthorizer mesh__D001034 sjn
% 221.79/221.93  |- mesh__dateRevised mesh__D001034 2004-07-19
% 221.79/221.93  |- skos__hiddenLabel mesh__D001034 Score, Apgar
% 221.79/221.93  |- mesh__historyNote mesh__D001034 73%28%71%29%   
% 221.79/221.93  |- mesh__dateEstablished mesh__D001034 1973-01-01
% 221.79/221.93  |- mesh__dateCreated mesh__D001034 1999-01-01
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D001034 2005
% 221.79/221.93  |- skos__historyNote mesh__D001034 Infant, Newborn %28%1966-1970%29%
% 221.79/221.93  |- skos__prefLabel mesh__D001034 Apgar Score
% 221.79/221.93  |- skos__annotation mesh__D001034
% 221.79/221.93        check the tags  HUMANS %26% INFANT, NEWBORN   
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D001034 2006
% 221.79/221.93  |- skos__scopeNote mesh__D001034
% 221.79/221.93       A method, developed by Dr. Virginia Apgar, to evaluate a newborn%27%s adjustment to extrauterine life. Five items - heart rate, respiratory effort, muscle tone, reflex irritability, and color - are evaluated 60 seconds after birth and again five minutes later on a scale from 0-2, 0 being the lowest, 2 being normal. The five numbers are added for the Apgar score. A score of 0-3 represents severe distress, 4-7 indicates moderate distress, and a score of 7-10 predicts an absence of difficulty in adjusting to extrauterine life.%A%    
% 221.79/221.93  |- mesh__recordOriginator mesh__D001034 NLM
% 221.79/221.93  |- mesh__publicMeSHNote mesh__D020797
% 221.79/221.93       2000; PLATELET-DERIVED GROWTH FACTOR BETA RECEPTOR %28%now RECEPTOR PDGF BETA%29% was indexed under RECEPTORS, PLATELET-DERIVED GROWTH FACTOR 1994-1999%A%  
% 221.79/221.93  |- mesh__historyNote mesh__D020797
% 221.79/221.93       2000; use RECEPTOR, PDGF BETA %28%NM%29% 1994-1999   
% 221.79/221.93  |- skos__scopeNote mesh__D020797
% 221.79/221.93       A PDGF receptor that binds specifically to the PDGF-B chain. It contains a protein-tyrosine kinase activity that is involved in SIGNAL TRANSDUCTION.%A%    
% 221.79/221.93  |- skos__altLabel mesh__D020797
% 221.79/221.93       Platelet-Derived Growth Factor beta Receptor
% 221.79/221.93  |- skos__altLabel mesh__D020797 Antigens, CD140b
% 221.79/221.93  |- mesh__dateRevised mesh__D020797 2005-06-30
% 221.79/221.93  |- skos__annotation mesh__D020797 DF: PDGF BETA RECEPT   
% 221.79/221.93  |- mesh__recordMaintainer mesh__D020797 jmp
% 221.79/221.93  |- skos__altLabel mesh__D020797 Receptor, PDGF beta
% 221.79/221.93  |- skos__hiddenLabel mesh__D020797
% 221.79/221.93       Receptor, Platelet Derived Growth Factor beta
% 221.79/221.93  |- skos__altLabel mesh__D020797 CD140b Antigen
% 221.79/221.93  |- skos__altLabel mesh__D020797 CD140b Antigens
% 221.79/221.93  |- skos__hiddenLabel mesh__D020797 beta, PDGFR
% 221.79/221.93  |- skos__altLabel mesh__D020797 PDGF beta Receptor
% 221.79/221.93  |- skos__hiddenLabel mesh__D020797 Antigen, CD140b
% 221.79/221.93  |- mesh__dateCreated mesh__D020797 1999-11-03
% 221.79/221.93  |- skos__altLabel mesh__D020797 PDGFRB
% 221.79/221.93  |- skos__hiddenLabel mesh__D020797
% 221.79/221.93       Platelet Derived Growth Factor beta Receptor
% 221.79/221.93  |- mesh__dateEstablished mesh__D020797 2000-01-01
% 221.79/221.93  |- skos__broader mesh__D020797smesh__D017479
% 221.79/221.93  |- skos__historyNote mesh__D020797
% 221.79/221.93       Receptors, Platelet-Derived Growth Factor %28%1994-1999%29%
% 221.79/221.93  |- rdf__type mesh__D020797sskos__Concept
% 221.79/221.93  |- skos__altLabel mesh__D020797 PDGFR beta
% 221.79/221.93  |- skos__altLabel mesh__D020797 PDGFR1
% 221.79/221.93  |- mesh__recordOriginator mesh__D020797 jmp
% 221.79/221.93  |- skos__prefLabel mesh__D020797
% 221.79/221.93       Receptor, Platelet-Derived Growth Factor beta
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D020797 2006
% 221.79/221.93  |- mesh__recordAuthorizer mesh__D020797 sjn
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D019445 2006
% 221.79/221.93  |- mesh__dateRevised mesh__D019445 1997-06-20
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D019445 2001
% 221.79/221.93  |- skos__broader mesh__D019445smesh__D016082
% 221.79/221.93  |- mesh__publicMeSHNote mesh__D019445 97   
% 221.79/221.93  |- skos__related mesh__D019445smesh__D003359
% 221.79/221.93  |- skos__hiddenLabel mesh__D019445 Flare, Solar
% 221.79/221.93  |- skos__hiddenLabel mesh__D019445 Event, Solar Particle
% 221.79/221.93  |- mesh__dateEstablished mesh__D019445 1997-01-01
% 221.79/221.93  |- mesh__dateCreated mesh__D019445 1996-06-13
% 221.79/221.93  |- skos__hiddenLabel mesh__D019445 Solar Flare
% 221.79/221.93  |- skos__hiddenLabel mesh__D019445 Particle Events, Solar
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D019445 2003
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D019445 1998
% 221.79/221.93  |- mesh__historyNote mesh__D019445 97   
% 221.79/221.93  |- skos__hiddenLabel mesh__D019445 Activity, Solar
% 221.79/221.93  |- rdf__type mesh__D019445sskos__Concept
% 221.79/221.93  |- skos__historyNote mesh__D019445 Solar Energy %28%1990-1996%29%
% 221.79/221.93  |- skos__scopeNote mesh__D019445
% 221.79/221.93       Any type of variation in the appearance of energy output of the sun. %28%NASA Thesaurus, 1994%29%%A%    
% 221.79/221.93  |- mesh__recordMaintainer mesh__D019445 JLS
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D019445 2004
% 221.79/221.93  |- skos__hiddenLabel mesh__D019445 Solar Particle Event
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D019445 2002
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D019445 1999
% 221.79/221.93  |- skos__hiddenLabel mesh__D019445 Flares, Solar
% 221.79/221.93  |- skos__hiddenLabel mesh__D019445 Activities, Solar
% 221.79/221.93  |- skos__hiddenLabel mesh__D019445 Sunspot
% 221.79/221.93  |- skos__prefLabel mesh__D019445 Solar Activity
% 221.79/221.93  |- mesh__recordAuthorizer mesh__D019445 SJN
% 221.79/221.93  |- skos__annotation mesh__D019445 no qualif   
% 221.79/221.93  |- skos__hiddenLabel mesh__D019445 Particle Event, Solar
% 221.79/221.93  |- skos__hiddenLabel mesh__D019445 Events, Solar Particle
% 221.79/221.93  |- skos__hiddenLabel mesh__D019445 Solar Activities
% 221.79/221.93  |- mesh__recordOriginator mesh__D019445 JLS
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D019445 2005
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D019445 2000
% 221.79/221.93  |- mesh__dateRevised mesh__D011462 2005-06-30
% 221.79/221.93  |- skos__historyNote mesh__D011462 Peroxides %28%1966-1977%29%
% 221.79/221.93  |- skos__hiddenLabel mesh__D011462 G, Prostaglandins
% 221.79/221.93  |- skos__broader mesh__D011462smesh__D011449
% 221.79/221.93  |- mesh__recordMaintainer mesh__D011462 ssb
% 221.79/221.93  |- mesh__publicMeSHNote mesh__D011462
% 221.79/221.93       91; was see under PROSTAGLANDIN ENDOPEROXIDES 1978-90   
% 221.79/221.93  |- mesh__recordAuthorizer mesh__D011462 sjn
% 221.79/221.93  |- skos__altLabel mesh__D011462 PGG
% 221.79/221.93  |- skos__prefLabel mesh__D011462 Prostaglandins G
% 221.79/221.93  |- mesh__dateCreated mesh__D011462 1977-05-23
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D011462 2006
% 221.79/221.93  |- skos__scopeNote mesh__D011462
% 221.79/221.93       A group of physiologically active prostaglandin endoperoxides. They are precursors in the biosynthesis of prostaglandins and thromboxanes. Most frequently encountered member of this group is the prostaglandin G2.%A%    
% 221.79/221.93  |- skos__annotation mesh__D011462
% 221.79/221.93       /biosyn /physiol permitted; for analogs, coord NIM with PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC %28%IM%29%; /chem syn permitted: do not convert to PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; DF: PGG%A%  
% 221.79/221.93  |- skos__historyNote mesh__D011462 Prostaglandins %28%1966-1977%29%
% 221.79/221.93  |- mesh__recordOriginator mesh__D011462 RLS
% 221.79/221.93  |- rdf__type mesh__D011462sskos__Concept
% 221.79/221.93  |- mesh__historyNote mesh__D011462
% 221.79/221.93       91%28%78%29%; was see under PROSTAGLANDIN ENDOPEROXIDES 1978-90%A%  
% 221.79/221.93  |- mesh__dateEstablished mesh__D011462 1991-01-01
% 221.79/221.93  |- skos__broader mesh__D004364Q000627smesh__D004364
% 221.79/221.93  |- mesh__preferredCombination mesh__D004364Q000627smesh__D004358
% 221.79/221.93  |- rdf__type mesh__D004364Q000627smesh__CompoundConcept
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D005425 2006
% 221.79/221.93  |- skos__annotation mesh__D005425
% 221.79/221.93       also called flicker fusion frequency %28%FFF%29%   
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D005425 2005
% 221.79/221.93  |- skos__hiddenLabel mesh__D005425 Fusion, Flicker
% 221.79/221.93  |- skos__hiddenLabel mesh__D005425 Fusions, Flicker
% 221.79/221.93  |- skos__hiddenLabel mesh__D005425 Flicker Fusions
% 221.79/221.93  |- skos__broader mesh__D005425smesh__D003941
% 221.79/221.93  |- mesh__recordAuthorizer mesh__D005425 sjn
% 221.79/221.93  |- mesh__dateRevised mesh__D005425 2003-07-09
% 221.79/221.93  |- skos__scopeNote mesh__D005425
% 221.79/221.93       The point or frequency at which all flicker of an intermittent light stimulus disappears.%A%    
% 221.79/221.93  |- skos__broader mesh__D005425smesh__D043722
% 221.79/221.93  |- mesh__dateCreated mesh__D005425 1999-01-01
% 221.79/221.93  |- mesh__recordMaintainer mesh__D005425 nns
% 221.79/221.93  |- skos__prefLabel mesh__D005425 Flicker Fusion
% 221.79/221.93  |- rdf__type mesh__D005425sskos__Concept
% 221.79/221.93  |- mesh__recordOriginator mesh__D005425 NLM
% 221.79/221.93  |- skos__broader mesh__D005425smesh__D014796
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D005425 2004
% 221.79/221.93  |- mesh__activeMeSHYear mesh__D015853 2006
% 221.79/221.93  |- skos__hiddenLabel mesh__D015853 Inhibitors, Cysteine Proteinase
% 221.79/221.93  |- skos__hiddenLabel mesh__D015853 Proteinase Inhibitors, Cysteine
% 221.79/221.93  |- skos__altLabel mesh__D015853 Cysteine Proteinase Antagonists
% 221.79/221.93  |- skos__broader mesh__D015853smesh__D011480
% 221.79/221.93  |- mesh__dateCreated mesh__D015853 1989-05-25
% 221.79/221.93  |- mesh__recordOriginator mesh__D015853 RLS
% 221.79/221.93  |- mesh__dateRevised mesh__D015853 2003-07-09
% 221.79/221.93  |- skos__hiddenLabel mesh__D015853 Protease Inhibitors, alpha-Cysteine
% 221.79/221.93  |- skos__hiddenLabel mesh__D015853 alpha Cysteine Protease Inhibitors
% 221.79/221.93  |- skos__hiddenLabel mesh__D015853 Protease Inhibitors, Cysteine
% 221.79/221.93  |- mesh__historyNote mesh__D015853 90   
% 221.79/221.93  |- skos__prefLabel mesh__D015853 Cysteine Proteinase Inhibitors
% 221.79/221.93  |- mesh__publicMeSHNote mesh__D015853 90   
% 221.79/221.94  |- skos__hiddenLabel mesh__D015853 Antagonists, Cysteine Proteinase
% 221.79/221.94  |- rdf__type mesh__D015853sskos__Concept
% 221.79/221.94  |- skos__historyNote mesh__D015853 Protease Inhibitors %28%1979-1989%29%
% 221.79/221.94  |- skos__hiddenLabel mesh__D015853 Inhibitors, Cysteine Protease
% 221.79/221.94  |- mesh__dateEstablished mesh__D015853 1990-01-01
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D015853 2004
% 221.79/221.94  |- skos__altLabel mesh__D015853 Cysteine Protease Inhibitors
% 221.79/221.94  |- skos__hiddenLabel mesh__D015853 Proteinase Antagonists, Cysteine
% 221.79/221.94  |- skos__historyNote mesh__D015853 Enzyme Inhibitors %28%1968-1978%29%
% 221.79/221.94  |- skos__scopeNote mesh__D015853
% 221.79/221.94       Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES.%A%    
% 221.79/221.94  |- mesh__recordAuthorizer mesh__D015853 sjn
% 221.79/221.94  |- skos__annotation mesh__D015853
% 221.79/221.94       /biosyn /physiol permitted only with endogenous proteinase inhib; DF: CYSTEINE PROTEINASE INHIB%A%  
% 221.79/221.94  |- skos__hiddenLabel mesh__D015853 Inhibitors, alpha-Cysteine Protease
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D015853 2005
% 221.79/221.94  |- mesh__recordMaintainer mesh__D015853 ssb
% 221.79/221.94  |- skos__broader mesh__D015055smesh__D014233
% 221.79/221.94  |- mesh__publicMeSHNote mesh__D015055
% 221.79/221.94       87; was see under GLUTAMATES 1979-86   
% 221.79/221.94  |- mesh__recordAuthorizer mesh__D015055 sjn
% 221.79/221.94  |- rdf__type mesh__D015055sskos__Concept
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D015055 2004
% 221.79/221.94  |- mesh__dateCreated mesh__D015055 1978-05-18
% 221.79/221.94  |- skos__annotation mesh__D015055 /biosyn /physiol permitted   
% 221.79/221.94  |- skos__hiddenLabel mesh__D015055 1 Carboxyglutamic Acid
% 221.79/221.94  |- skos__altLabel mesh__D015055 gamma-Carboxyglutamic Acid
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D015055 2002
% 221.79/221.94  |- mesh__historyNote mesh__D015055
% 221.79/221.94       87%28%79%29%; was see under GLUTAMATES 1979-86   
% 221.79/221.94  |- skos__hiddenLabel mesh__D015055 gamma Carboxyglutamate
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D015055 2005
% 221.79/221.94  |- mesh__recordOriginator mesh__D015055 RLS
% 221.79/221.94  |- mesh__dateRevised mesh__D015055 2001-07-25
% 221.79/221.94  |- mesh__dateEstablished mesh__D015055 1987-01-01
% 221.79/221.94  |- skos__broader mesh__D015055smesh__D018698
% 221.79/221.94  |- skos__prefLabel mesh__D015055 1-Carboxyglutamic Acid
% 221.79/221.94  |- skos__historyNote mesh__D015055 Glutamates %28%1966-1978%29%
% 221.79/221.94  |- skos__hiddenLabel mesh__D015055 gamma Carboxyglutamic Acid
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D015055 2006
% 221.79/221.94  |- skos__altLabel mesh__D015055 3-Amino-1,1,3-propanetricarboxylic Acid
% 221.79/221.94  |- mesh__recordMaintainer mesh__D015055 nns
% 221.79/221.94  |- skos__scopeNote mesh__D015055
% 221.79/221.94       Found in various tissues, particularly in four blood-clotting proteins including prothrombin, in kidney protein, in bone protein, and in the protein present in various ectopic calcifications.%A%    
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D015055 2003
% 221.79/221.94  |- mesh__publicMeSHNote mesh__D009816 87   
% 221.79/221.94  |- mesh__dateEstablished mesh__D009816 1987-01-01
% 221.79/221.94  |- skos__scopeNote mesh__D009816
% 221.79/221.94       Use of computers or computer systems for doing routine clerical work, e.g., billing, records pertaining to the administration of the office, etc.%A%    
% 221.79/221.94  |- mesh__dateCreated mesh__D009816 1986-06-17
% 221.79/221.94  |- skos__annotation mesh__D009816 IM   
% 221.79/221.94  |- skos__altLabel mesh__D009816 Automation, Office
% 221.79/221.94  |- skos__hiddenLabel mesh__D009816 Office Automations
% 221.79/221.94  |- mesh__recordAuthorizer mesh__D009816 sjn
% 221.79/221.94  |- mesh__recordMaintainer mesh__D009816 jls
% 221.79/221.94  |- mesh__recordOriginator mesh__D009816 EC
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009816 2006
% 221.79/221.94  |- skos__prefLabel mesh__D009816 Office Automation
% 221.79/221.94  |- skos__broader mesh__D009816smesh__D008331
% 221.79/221.94  |- rdf__type mesh__D009816sskos__Concept
% 221.79/221.94  |- skos__hiddenLabel mesh__D009816 Automations, Office
% 221.79/221.94  |- mesh__historyNote mesh__D009816 87   
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009816 2005
% 221.79/221.94  |- mesh__dateRevised mesh__D009816 2004-07-07
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001833 2006
% 221.79/221.94  |- skos__broader mesh__D001833smesh__D001831
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001833 2001
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001833 2004
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001833 2005
% 221.79/221.94  |- skos__hiddenLabel mesh__D001833 Regulations, Body Temperature
% 221.79/221.94  |- mesh__recordOriginator mesh__D001833 NLM
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001833 2003
% 221.79/221.94  |- skos__hiddenLabel mesh__D001833 Thermoregulations
% 221.79/221.94  |- skos__hiddenLabel mesh__D001833 Heat Losses
% 221.79/221.94  |- skos__hiddenLabel mesh__D001833 Losses, Heat
% 221.79/221.94  |- skos__altLabel mesh__D001833 Thermoregulation
% 221.79/221.94  |- skos__scopeNote mesh__D001833
% 221.79/221.94       The processes of heating and cooling that an organism uses to control its temperature.%A%    
% 221.79/221.94  |- mesh__recordMaintainer mesh__D001833 jmp
% 221.79/221.94  |- skos__altLabel mesh__D001833 Regulation, Body Temperature
% 221.79/221.94  |- rdf__type mesh__D001833sskos__Concept
% 221.79/221.94  |- mesh__recordAuthorizer mesh__D001833 sjn
% 221.79/221.94  |- skos__prefLabel mesh__D001833 Body Temperature Regulation
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001833 2002
% 221.79/221.94  |- skos__hiddenLabel mesh__D001833 Body Temperature Regulations
% 221.79/221.94  |- mesh__dateCreated mesh__D001833 1999-01-01
% 221.79/221.94  |- skos__hiddenLabel mesh__D001833 Loss, Heat
% 221.79/221.94  |- skos__broader mesh__D001833smesh__D006706
% 221.79/221.94  |- skos__hiddenLabel mesh__D001833 Temperature Regulations, Body
% 221.79/221.94  |- skos__altLabel mesh__D001833 Temperature Regulation, Body
% 221.79/221.94  |- mesh__dateRevised mesh__D001833 2000-06-22
% 221.79/221.94  |- skos__annotation mesh__D009018 a kingdom in northern Africa   
% 221.79/221.94  |- mesh__recordMaintainer mesh__D009018 TGC
% 221.79/221.94  |- skos__prefLabel mesh__D009018 Morocco
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009018 2000
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009018 2003
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009018 2001
% 221.79/221.94  |- mesh__dateRevised mesh__D009018 1995-02-21
% 221.79/221.94  |- mesh__recordAuthorizer mesh__D009018 PLS
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009018 1996
% 221.79/221.94  |- rdf__type mesh__D009018sskos__Concept
% 221.79/221.94  |- skos__broader mesh__D009018smesh__D000352
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009018 2004
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009018 2002
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009018 2005
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009018 1997
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009018 1998
% 221.79/221.94  |- mesh__dateCreated mesh__D009018 1999-01-01
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009018 2006
% 221.79/221.94  |- skos__scopeNote mesh__D009018
% 221.79/221.94       A kingdom in northern Africa, west of ALGERIA. Its capital is Rabat. It was known to the Romans as Mauretania, part of the Carthaginian empire %28%not to be confused with the modern MAURITANIA, a country of western Africa%29%. Morocco was invaded by the Muslims in the 7th century A.D. It engaged in hostilities with England, France, and Spain from 1662 to 1911. The country gained independence in 1956. The name is from the Arabic marukus, the name of the former capital Marrakech, from a Berber word meaning fortified. The Arabic name for Morocco is al-magrib al-aasa, the far west. %28%From Webster%27%s New Geographical Dictionary, 1988, p708, 792 %26% Room, Brewer%27%s Dictionary of Names, 1992, p362%29%%A%    
% 221.79/221.94  |- mesh__recordOriginator mesh__D009018 NLM
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009018 1999
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001035 2002
% 221.79/221.94  |- mesh__recordMaintainer mesh__D001035 TGC
% 221.79/221.94  |- skos__prefLabel mesh__D001035 Aphakia
% 221.79/221.94  |- skos__hiddenLabel mesh__D001035 Aphakias
% 221.79/221.94  |- mesh__publicMeSHNote mesh__D001035 78   
% 221.79/221.94  |- mesh__dateRevised mesh__D001035 1997-06-20
% 221.79/221.94  |- mesh__recordAuthorizer mesh__D001035 SJN
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001035 2003
% 221.79/221.94  |- mesh__dateEstablished mesh__D001035 1978-01-01
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001035 2000
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001035 2005
% 221.79/221.94  |- mesh__recordOriginator mesh__D001035 RC
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001035 2004
% 221.79/221.94  |- skos__broader mesh__D001035smesh__D007905
% 221.79/221.94  |- skos__scopeNote mesh__D001035
% 221.79/221.94       Absence of crystalline lens totally or partially from field of vision, from any cause except after cataract extraction. Aphakia is mainly congenital or as result of LENS DISLOCATION AND SUBLUXATION.%A%    
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001035 2001
% 221.79/221.94  |- mesh__dateCreated mesh__D001035 1977-04-11
% 221.79/221.94  |- mesh__historyNote mesh__D001035 78   
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001035 2006
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001035 1998
% 221.79/221.94  |- skos__annotation mesh__D001035
% 221.79/221.94       absence of lens from any cause %28%congen, inj, dis%29%; /congen permitted; after cataract extract = APHAKIA, POSTCATARACT; %22%aphakic eye%22% is probably APHAKIA, POSTCATARACT but PSEUDOPHAKIA is available for the postcataract eye fitted with an intraocular lens%A%  
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001035 1999
% 221.79/221.94  |- rdf__type mesh__D001035sskos__Concept
% 221.79/221.94  |- skos__historyNote mesh__D001035 Lens, Crystalline %28%1966-1977%29%
% 221.79/221.94  |- skos__broader mesh__D020798smesh__D003001
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 One-Hybrid System Technic
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D020798 2004
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Two Hybrid System Technics
% 221.79/221.94  |- skos__altLabel mesh__D020798 Two-Hybrid Assay
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Technics, Three-Hybrid System
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D020798 2002
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Two Hybrid System Techniques
% 221.79/221.94  |- mesh__dateCreated mesh__D020798 1999-11-03
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Reverse Two Hybrid System Techniques
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Techniques, Three-Hybrid System
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 System Technic, One-Hybrid
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 System Technics, Two-Hybrid
% 221.79/221.94  |- skos__altLabel mesh__D020798 Three-Hybrid System Technics
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 System Techniques, Tri-Hybrid
% 221.79/221.94  |- skos__altLabel mesh__D020798 One-Hybrid System Technics
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Two Hybrid Assay
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Technique, Three-Hybrid System
% 221.79/221.94  |- skos__broader mesh__D020798smesh__D025941
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D020798 2003
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 System Technics, One-Hybrid
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D020798 2006
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Tri-Hybrid System Technique
% 221.79/221.94  |- skos__altLabel mesh__D020798 Two-Hybrid Method
% 221.79/221.94  |- mesh__recordMaintainer mesh__D020798 nns
% 221.79/221.94  |- rdf__type mesh__D020798sskos__Concept
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Three Hybrid System Techniques
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Assay, Two-Hybrid
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 System Technic, Three-Hybrid
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Method, Two-Hybrid
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Methods, Two-Hybrid
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Reverse One Hybrid System Techniques
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Two Hybrid Method
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D020798 2005
% 221.79/221.94  |- mesh__recordOriginator mesh__D020798 nns
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Tri Hybrid System Techniques
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Two-Hybrid Methods
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Three-Hybrid System Technique
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Three-Hybrid System Technic
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 System Technic, Two-Hybrid
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 System Technics, Three-Hybrid
% 221.79/221.94  |- mesh__dateRevised mesh__D020798 2001-07-25
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Technics, One-Hybrid System
% 221.79/221.94  |- skos__altLabel mesh__D020798 Two-Hybrid System Technics
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Two-Hybrid System Technic
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Assays, Two-Hybrid
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 One-Hybrid System Technique
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Technic, One-Hybrid System
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Techniques, Two-Hybrid System
% 221.79/221.94  |- skos__prefLabel mesh__D020798 Two-Hybrid System Techniques
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Two-Hybrid Assays
% 221.79/221.94  |- skos__scopeNote mesh__D020798
% 221.79/221.94       Screening techniques used to identify genes encoding interacting proteins. Variations are used to evaluate complex interplay between proteins and other molecules.%A%    
% 221.79/221.94  |- skos__altLabel mesh__D020798 Tri-Hybrid System Techniques
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 One Hybrid System Techniques
% 221.79/221.94  |- mesh__historyNote mesh__D020798 2000   
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Techniques, One-Hybrid System
% 221.79/221.94  |- mesh__recordAuthorizer mesh__D020798 sjn
% 221.79/221.94  |- mesh__publicMeSHNote mesh__D020798 2000   
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Technic, Two-Hybrid System
% 221.79/221.94  |- mesh__dateEstablished mesh__D020798 2000-01-01
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Technique, Two-Hybrid System
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Techniques, Tri-Hybrid System
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Three Hybrid System Technics
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Technic, Three-Hybrid System
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 System Technique, Tri-Hybrid
% 221.79/221.94  |- skos__related mesh__D020798smesh__D026481
% 221.79/221.94  |- skos__broader mesh__D020798smesh__D015336
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 One Hybrid System Technics
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Two-Hybrid System Technique
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Technique, Tri-Hybrid System
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Technique, One-Hybrid System
% 221.79/221.94  |- skos__hiddenLabel mesh__D020798 Technics, Two-Hybrid System
% 221.79/221.94  |- skos__broader mesh__D019446smesh__D014115
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D019446 2003
% 221.79/221.94  |- rdf__type mesh__D019446sskos__Concept
% 221.79/221.94  |- skos__historyNote mesh__D019446 Septicemia %28%1966-1996%29%
% 221.79/221.94  |- skos__related mesh__D019446smesh__D012772
% 221.79/221.94  |- mesh__dateCreated mesh__D019446 1996-06-10
% 221.79/221.94  |- mesh__historyNote mesh__D019446 97   
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D019446 1998
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D019446 2000
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D019446 2004
% 221.79/221.94  |- skos__prefLabel mesh__D019446 Endotoxemia
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D019446 2001
% 221.79/221.94  |- skos__scopeNote mesh__D019446
% 221.79/221.94       A condition characterized by the presence of endotoxins in the blood. If endotoxemia is the result of gram-negative rod-shaped bacteria, shock may occur.%A%    
% 221.79/221.94  |- mesh__publicMeSHNote mesh__D019446 97   
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D019446 1999
% 221.79/221.94  |- skos__historyNote mesh__D019446 Toxemia %28%1966-1996%29%
% 221.79/221.94  |- skos__hiddenLabel mesh__D019446 Endotoxemias
% 221.79/221.94  |- mesh__dateEstablished mesh__D019446 1997-01-01
% 221.79/221.94  |- skos__annotation mesh__D019446
% 221.79/221.94       coord IM with specific bact/infect heading %28%IM%29% or specific bacterium %28%IM%29% if precoord bact/infect heading is not in MeSH; do not use /blood to cover -emia%A%  
% 221.79/221.94  |- skos__historyNote mesh__D019446 Endotoxins %28%1966-1996%29%
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D019446 2005
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D019446 2002
% 221.79/221.94  |- skos__historyNote mesh__D019446 Shock, Septic %28%1968-1996%29%
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D019446 1997
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D019446 2006
% 221.79/221.94  |- skos__hiddenLabel mesh__D011463 H, Prostaglandins
% 221.79/221.94  |- skos__historyNote mesh__D011463 Prostaglandins %28%1966-1977%29%
% 221.79/221.94  |- mesh__historyNote mesh__D011463
% 221.79/221.94       91%28%78%29%; was see under PROSTAGLANDIN ENDOPEROXIDES 1978-90%A%  
% 221.79/221.94  |- rdf__type mesh__D011463sskos__Concept
% 221.79/221.94  |- mesh__dateRevised mesh__D011463 2005-06-30
% 221.79/221.94  |- skos__annotation mesh__D011463
% 221.79/221.94       for analogs: coord with PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC if pertinant; /chem syn permitted: do not convert to PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; PROSTAGLANDIN H2 is also available; DF: PGH%A%  
% 221.79/221.94  |- skos__historyNote mesh__D011463 Peroxides %28%1966-1977%29%
% 221.79/221.94  |- skos__prefLabel mesh__D011463 Prostaglandins H
% 221.79/221.94  |- skos__broader mesh__D011463smesh__D011449
% 221.79/221.94  |- mesh__recordMaintainer mesh__D011463 ssb
% 221.79/221.94  |- mesh__recordAuthorizer mesh__D011463 sjn
% 221.79/221.94  |- skos__scopeNote mesh__D011463
% 221.79/221.94       A group of physiologically active prostaglandin endoperoxides. They are precursors in the biosynthesis of prostaglandins and thromboxanes. The most frequently encountered member of this group is the prostaglandin H2.%A%    
% 221.79/221.94  |- mesh__dateEstablished mesh__D011463 1991-01-01
% 221.79/221.94  |- mesh__dateCreated mesh__D011463 1977-05-23
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D011463 2006
% 221.79/221.94  |- mesh__recordOriginator mesh__D011463 RLS
% 221.79/221.94  |- mesh__publicMeSHNote mesh__D011463
% 221.79/221.94       91; was see under PROSTAGLANDIN ENDOPEROXIDES 1978-90   
% 221.79/221.94  |- skos__broader mesh__D005426smesh__D009068
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D005426 2006
% 221.79/221.94  |- skos__historyNote mesh__D005426 Locomotion %28%1966-1971%29%
% 221.79/221.94  |- skos__prefLabel mesh__D005426 Flight, Animal
% 221.79/221.94  |- skos__hiddenLabel mesh__D005426 Flights, Animal
% 221.79/221.94  |- skos__annotation mesh__D005426
% 221.79/221.94       flight is the use of wings to pass through air: do not confuse with FLIGHT REACTION see ESCAPE REACTION%A%  
% 221.79/221.94  |- skos__historyNote mesh__D005426 specific animal
% 221.79/221.94  |- mesh__recordOriginator mesh__D005426 NLM
% 221.79/221.94  |- mesh__dateCreated mesh__D005426 1999-01-01
% 221.79/221.94  |- skos__hiddenLabel mesh__D005426 Animal Flight
% 221.79/221.94  |- mesh__dateRevised mesh__D005426 2003-07-09
% 221.79/221.94  |- mesh__publicMeSHNote mesh__D005426 74   
% 221.79/221.94  |- mesh__dateEstablished mesh__D005426 1974-01-01
% 221.79/221.94  |- mesh__historyNote mesh__D005426 74%28%72%29%   
% 221.79/221.94  |- rdf__type mesh__D005426sskos__Concept
% 221.79/221.94  |- skos__hiddenLabel mesh__D005426 Animal Flights
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D005426 2005
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D005426 2004
% 221.79/221.94  |- mesh__recordAuthorizer mesh__D005426 sjn
% 221.79/221.94  |- mesh__recordMaintainer mesh__D005426 nns
% 221.79/221.94  |- skos__broader mesh__D015854smesh__D002620
% 221.79/221.94  |- skos__prefLabel mesh__D015854 Up-Regulation
% 221.79/221.94  |- mesh__dateCreated mesh__D015854 1989-05-26
% 221.79/221.94  |- skos__related mesh__D015854smesh__D015536
% 221.79/221.94  |- mesh__recordOriginator mesh__D015854 AGS
% 221.79/221.94  |- skos__hiddenLabel mesh__D015854 Up Regulation
% 221.79/221.94  |- rdf__type mesh__D015854sskos__Concept
% 221.79/221.94  |- mesh__historyNote mesh__D015854 2002 %28%1990%29%   
% 221.79/221.94  |- skos__broader mesh__D015854smesh__D025461
% 221.79/221.94  |- mesh__recordAuthorizer mesh__D015854 jls
% 221.79/221.94  |- mesh__dateEstablished mesh__D015854 1990-01-01
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D015854 2004
% 221.79/221.94  |- skos__altLabel mesh__D015854 Up-Regulation %28%Physiology%29%
% 221.79/221.94  |- skos__altLabel mesh__D015854 Upregulation
% 221.79/221.94  |- skos__scopeNote mesh__D015854
% 221.79/221.94       A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes %28%GENE EXPRESSION REGULATION%29%, mRNAs %28%RNA, MESSENGER%29%, and proteins.%A%    
% 221.79/221.94  |- mesh__dateRevised mesh__D015854 2004-08-03
% 221.79/221.94  |- mesh__publicMeSHNote mesh__D015854
% 221.79/221.94       2002; see Up-Regulation %28%Physiology%29% 1990-2001   
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D015854 2005
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D015854 2005B
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D015854 2005A
% 221.79/221.94  |- skos__annotation mesh__D015854 DF: UP REG   
% 221.79/221.94  |- mesh__recordMaintainer mesh__D015854 jls
% 221.79/221.94  |- skos__broader mesh__D015854smesh__D001669
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D015854 2006
% 221.79/221.94  |- skos__broader mesh__D015854smesh__D005786
% 221.79/221.94  |- skos__related mesh__D015854smesh__D025461
% 221.79/221.94  |- mesh__historyNote mesh__D048230 2005   
% 221.79/221.94  |- skos__prefLabel mesh__D048230 Corynebacterium glutamicum
% 221.79/221.94  |- skos__historyNote mesh__D048230 Corynebacterium %28%1969-2004%29%
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D048230 2006
% 221.79/221.94  |- mesh__recordMaintainer mesh__D048230 SYSTEM
% 221.79/221.94  |- skos__broader mesh__D048230smesh__D003352
% 221.79/221.94  |- rdf__type mesh__D048230sskos__Concept
% 221.79/221.94  |- mesh__recordOriginator mesh__D048230 ags
% 221.79/221.94  |- skos__scopeNote mesh__D048230
% 221.79/221.94       A species of gram-positive, asporogenous, non-pathogenic, soil bacteria that produces GLUTAMIC ACID.%A%    
% 221.79/221.94  |- mesh__recordAuthorizer mesh__D048230 sjn
% 221.79/221.94  |- mesh__publicMeSHNote mesh__D048230 2005   
% 221.79/221.94  |- mesh__dateEstablished mesh__D048230 2005-01-01
% 221.79/221.94  |- mesh__dateCreated mesh__D048230 2004-07-07
% 221.79/221.94  |- mesh__dateRevised mesh__D048230 2005-06-30
% 221.79/221.94  |- mesh__publicMeSHNote mesh__D015056
% 221.79/221.94       91; was see under THEOPHYLLINE 1979-90   
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D015056 2001
% 221.79/221.94  |- skos__annotation mesh__D015056 DF: MIBX   
% 221.79/221.94  |- mesh__dateEstablished mesh__D015056 1991-01-01
% 221.79/221.94  |- skos__historyNote mesh__D015056 Xanthines %28%1966-1978%29%
% 221.79/221.94  |- skos__altLabel mesh__D015056 IBMX
% 221.79/221.94  |- skos__historyNote mesh__D015056
% 221.79/221.94       Phosphodiesterases/antagonists %26% inhibitors %28%1972-1977%29%
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D015056 2005
% 221.79/221.94  |- mesh__recordAuthorizer mesh__D015056 sjn
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D015056 2006
% 221.79/221.94  |- skos__broader mesh__D015056smesh__D013806
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D015056 2002
% 221.79/221.94  |- mesh__dateRevised mesh__D015056 2000-06-22
% 221.79/221.94  |- skos__altLabel mesh__D015056 Isobutyltheophylline
% 221.79/221.94  |- mesh__recordOriginator mesh__D015056 RLS
% 221.79/221.94  |- skos__prefLabel mesh__D015056 1-Methyl-3-isobutylxanthine
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D015056 2003
% 221.79/221.94  |- skos__scopeNote mesh__D015056
% 221.79/221.94       A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES%A%    
% 221.79/221.94  |- rdf__type mesh__D015056sskos__Concept
% 221.79/221.94  |- skos__hiddenLabel mesh__D015056 3 Isobutyl 1 methylxanthine
% 221.79/221.94  |- mesh__dateCreated mesh__D015056 1978-03-09
% 221.79/221.94  |- skos__historyNote mesh__D015056
% 221.79/221.94       Phosphodiesterase Inhibitors %28%1978%29%
% 221.79/221.94  |- skos__hiddenLabel mesh__D015056 1 Methyl 3 isobutylxanthine
% 221.79/221.94  |- skos__altLabel mesh__D015056 3-Isobutyl-1-methylxanthine
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D015056 2004
% 221.79/221.94  |- mesh__recordMaintainer mesh__D015056 TWD
% 221.79/221.94  |- mesh__historyNote mesh__D015056
% 221.79/221.94       91%28%79%29%; was see under THEOPHYLLINE 1979-90   
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009817 2000
% 221.79/221.94  |- skos__prefLabel mesh__D009817 Office Management
% 221.79/221.94  |- skos__scopeNote mesh__D009817
% 221.79/221.94       Planning, organizing, and administering activities in an office.%A%    
% 221.79/221.94  |- skos__hiddenLabel mesh__D009817 Management, Office
% 221.79/221.94  |- skos__broader mesh__D009817smesh__D011364
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009817 2004
% 221.79/221.94  |- mesh__recordAuthorizer mesh__D009817 SJN
% 221.79/221.94  |- skos__annotation mesh__D009817 med or non-med offices   
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009817 2003
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009817 2006
% 221.79/221.94  |- rdf__type mesh__D009817sskos__Concept
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009817 2005
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009817 1999
% 221.79/221.94  |- mesh__dateCreated mesh__D009817 1999-01-01
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009817 2002
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009817 2001
% 221.79/221.94  |- mesh__recordOriginator mesh__D009817 NLM
% 221.79/221.94  |- mesh__dateRevised mesh__D009817 1998-06-10
% 221.79/221.94  |- skos__broader mesh__D009817smesh__D020399
% 221.79/221.94  |- mesh__recordMaintainer mesh__D009817 JLS
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001834 2005
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001834 1999
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001834 2003
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001834 1994
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001834 1997
% 221.79/221.94  |- mesh__dateRevised mesh__D001834 1992-03-25
% 221.79/221.94  |- skos__historyNote mesh__D001834 Body Fluids %28%1966-1971%29%
% 221.79/221.94  |- mesh__dateEstablished mesh__D001834 1974-01-01
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001834 1998
% 221.79/221.94  |- skos__historyNote mesh__D001834 Water %28%1966-1971%29%
% 221.79/221.94  |- skos__hiddenLabel mesh__D001834 Waters, Body
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001834 2001
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001834 1996
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001834 2000
% 221.79/221.94  |- mesh__recordAuthorizer mesh__D001834 PLS
% 221.79/221.94  |- mesh__recordMaintainer mesh__D001834 TAP
% 221.79/221.94  |- rdf__type mesh__D001834sskos__Concept
% 221.79/221.94  |- mesh__publicMeSHNote mesh__D001834 74   
% 221.79/221.94  |- mesh__dateCreated mesh__D001834 1999-01-01
% 221.79/221.94  |- mesh__recordOriginator mesh__D001834 NLM
% 221.79/221.94  |- skos__annotation mesh__D001834
% 221.79/221.94       do not confuse with EXTRACELLULAR FLUID see EXTRACELLULAR SPACE%A%  
% 221.79/221.94  |- skos__hiddenLabel mesh__D001834 Water, Body
% 221.79/221.94  |- skos__prefLabel mesh__D001834 Body Water
% 221.79/221.94  |- skos__broader mesh__D001834smesh__D001826
% 221.79/221.94  |- skos__hiddenLabel mesh__D001834 Body Waters
% 221.79/221.94  |- mesh__historyNote mesh__D001834 74%28%72%29%   
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001834 2006
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001834 2002
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001834 1995
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001834 2004
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D001834 1993
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009019 2003
% 221.79/221.94  |- mesh__dateRevised mesh__D009019 1992-05-18
% 221.79/221.94  |- mesh__recordOriginator mesh__D009019 NLM
% 221.79/221.94  |- rdf__type mesh__D009019sskos__Concept
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009019 1996
% 221.79/221.94  |- mesh__recordMaintainer mesh__D009019 TAP
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009019 2004
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009019 2005
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009019 2000
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009019 1997
% 221.79/221.94  |- mesh__publicMeSHNote mesh__D009019
% 221.79/221.94       69; BENZOMORPHAN was see under BRIDGED COMPOUNDS 1966-72   
% 221.79/221.94  |- skos__broader mesh__D009019smesh__D006572
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009019 2001
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009019 1998
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009019 2006
% 221.79/221.94  |- mesh__dateCreated mesh__D009019 1999-01-01
% 221.79/221.94  |- mesh__recordAuthorizer mesh__D009019 PLS
% 221.79/221.94  |- mesh__activeMeSHYear mesh__D009019 1993
% 221.79/221.95  |- mesh__dateEstablished mesh__D009019 1969-01-01
% 221.79/221.95  |- skos__broader mesh__D009019smesh__D009892
% 221.79/221.95  |- skos__broader mesh__D009019smesh__D006576
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D009019 1994
% 221.79/221.95  |- skos__historyNote mesh__D009019 Morphine %28%1966-1968%29%
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D009019 2002
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D009019 1999
% 221.79/221.95  |- skos__historyNote mesh__D009019 Thebaine %28%1966-1968%29%
% 221.79/221.95  |- skos__historyNote mesh__D009019 Opium %28%1966-1968%29%
% 221.79/221.95  |- skos__prefLabel mesh__D009019 Morphinans
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D009019 1995
% 221.79/221.95  |- skos__historyNote mesh__D009019 Diacetylmorphine %28%1966-1968%29%
% 221.79/221.95  |- skos__historyNote mesh__D009019 Codeine %28%1966-1968%29%
% 221.79/221.95  |- mesh__historyNote mesh__D009019 69   
% 221.79/221.95  |- skos__historyNote mesh__D009019 Dihydromorphinone %28%1966-1968%29%
% 221.79/221.95  |- mesh__historyNote mesh__D001036 78   
% 221.79/221.95  |- mesh__dateEstablished mesh__D001036 1978-01-01
% 221.79/221.95  |- mesh__recordOriginator mesh__D001036 RC
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D001036 2005
% 221.79/221.95  |- skos__broader mesh__D001036smesh__D001035
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D001036 2004
% 221.79/221.95  |- mesh__dateCreated mesh__D001036 1977-04-11
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D001036 2006
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D001036 1998
% 221.79/221.95  |- skos__hiddenLabel mesh__D001036 Postcataract Aphakia
% 221.79/221.95  |- skos__related mesh__D001036smesh__D019591
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D001036 2002
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D001036 1999
% 221.79/221.95  |- rdf__type mesh__D001036sskos__Concept
% 221.79/221.95  |- skos__scopeNote mesh__D001036
% 221.79/221.95       Absence of the crystalline lens resulting from cataract extraction.%A%    
% 221.79/221.95  |- mesh__dateRevised mesh__D001036 1997-06-20
% 221.79/221.95  |- skos__hiddenLabel mesh__D001036 Postcataract Aphakias
% 221.79/221.95  |- skos__annotation mesh__D001036
% 221.79/221.95       %22%aphakic eye%22% probably goes here unless truly congen %28% = APHAKIA /congen%29%; do not coord with CATARACT EXTRACTION unless particularly discussed; PSEUDOPHAKIA is available for the postcataract eye with an intraocular lens%A%  
% 221.79/221.95  |- skos__prefLabel mesh__D001036 Aphakia, Postcataract
% 221.79/221.95  |- mesh__recordAuthorizer mesh__D001036 SJN
% 221.79/221.95  |- skos__historyNote mesh__D001036 Lens, Crystalline %28%1966-1977%29%
% 221.79/221.95  |- mesh__publicMeSHNote mesh__D001036 78   
% 221.79/221.95  |- mesh__recordMaintainer mesh__D001036 TGC
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D001036 2000
% 221.79/221.95  |- skos__hiddenLabel mesh__D001036 Aphakias, Postcataract
% 221.79/221.95  |- skos__historyNote mesh__D001036 Cataract Extraction %28%1966-1977%29%
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D001036 2003
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D001036 2001
% 221.79/221.95  |- skos__altLabel mesh__D020799 Pecos Brand of Pancrelipase
% 221.79/221.95  |- rdf__type mesh__D020799sskos__Concept
% 221.79/221.95  |- skos__scopeNote mesh__D020799
% 221.79/221.95       A preparation of hog pancreatic enzymes standardized for lipase content.%A%    
% 221.79/221.95  |- skos__hiddenLabel mesh__D020799 Ku Zyme
% 221.79/221.95  |- skos__altLabel mesh__D020799 Ortho Brand of Pancrelipase
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D020799 2006
% 221.79/221.95  |- skos__altLabel mesh__D020799 Global Pharmaceutical Brand of Pancrelipase
% 221.79/221.95  |- mesh__dateEstablished mesh__D020799 2000-01-01
% 221.79/221.95  |- skos__historyNote mesh__D020799 Lipase %28%1980-1999%29%
% 221.79/221.95  |- skos__altLabel mesh__D020799 Axcan Brand 1 of Pancrelipase
% 221.79/221.95  |- skos__historyNote mesh__D020799 Pancreatin %28%1970-1979%29%
% 221.79/221.95  |- skos__broader mesh__D020799smesh__D008049
% 221.79/221.95  |- skos__altLabel mesh__D020799 Organon Brand 1 of Pancrelipase
% 221.79/221.95  |- skos__altLabel mesh__D020799 Rugby Brand 2 of Pancrelipase
% 221.79/221.95  |- mesh__recordOriginator mesh__D020799 adp
% 221.79/221.95  |- skos__altLabel mesh__D020799 Rugby Brand 1 of Pancrelipase
% 221.79/221.95  |- mesh__recordAuthorizer mesh__D020799 sjn
% 221.79/221.95  |- mesh__historyNote mesh__D020799
% 221.79/221.95       2000; for PANCREASE use PANCREATIN 1989-1999; use PANCRELIPASE %28%NM%29% 1970-1999%A%  
% 221.79/221.95  |- skos__prefLabel mesh__D020799 Pancrelipase
% 221.79/221.95  |- skos__altLabel mesh__D020799 Digestive Brand of Pancrelipase
% 221.79/221.95  |- skos__altLabel mesh__D020799 Organon Brand 2 of Pancrelipase
% 221.79/221.95  |- skos__historyNote mesh__D020799 Pancreatic Extracts %28%1980-1999%29%
% 221.79/221.95  |- skos__altLabel mesh__D020799 Janssen Brand of Pancrelipase
% 221.79/221.95  |- skos__altLabel mesh__D020799 Savage Brand of Pancrelipase
% 221.79/221.95  |- skos__altLabel mesh__D020799 Breckenridge Brand of Pancrelipase
% 221.79/221.95  |- skos__broader mesh__D020799smesh__D010184
% 221.79/221.95  |- skos__altLabel mesh__D020799 Solvay Brand of Pancrelipase
% 221.79/221.95  |- mesh__dateCreated mesh__D020799 1999-11-04
% 221.79/221.95  |- skos__altLabel mesh__D020799 Axcan Brand 2 of Pancrelipase
% 221.79/221.95  |- mesh__dateRevised mesh__D020799 2005-06-30
% 221.79/221.95  |- skos__hiddenLabel mesh__D020799 Cotazym S
% 221.79/221.95  |- mesh__publicMeSHNote mesh__D020799
% 221.79/221.95       2000; for PANCREASE see PANCREATIN 1989-1999; PANCRELIPSASE was indexed under LIPASE %26% PANCREATIC EXTRACTS 1980-1999 %26%  PANCREATIN 1970-1979%A%  
% 221.79/221.95  |- skos__altLabel mesh__D020799 Schwarz Brand of Pancrelipase
% 221.79/221.95  |- mesh__recordMaintainer mesh__D020799 ssb
% 221.79/221.95  |- skos__altLabel mesh__D020799 Organon Brand 3 of Pancrelipase
% 221.79/221.95  |- mesh__historyNote mesh__D011464
% 221.79/221.95       91%28%78%29%; was PROSTAGLANDINS X 1978-90 %28%see under PROSTAGLANDINS 1978-83%29%; PROSTACYCLIN was PROSTACYCLINS 1978-93;  PROSTAGLANDIN I2 was PROSTAGLANDINS I2 1982-93; PROSTAGLANDIN X was PROSTAGLANDINS X 1991-93%A%  
% 221.79/221.95  |- skos__altLabel mesh__D011464 PGX
% 221.79/221.95  |- mesh__recordOriginator mesh__D011464 RLS
% 221.79/221.95  |- skos__altLabel mesh__D011464 PGI2
% 221.79/221.95  |- rdf__type mesh__D011464sskos__Concept
% 221.79/221.95  |- skos__altLabel mesh__D011464 Epoprostanol
% 221.79/221.95  |- skos__altLabel mesh__D011464 Prostaglandin I2
% 221.79/221.95  |- skos__historyNote mesh__D011464 Prostaglandins %28%1966-1977%29%
% 221.79/221.95  |- mesh__publicMeSHNote mesh__D011464
% 221.79/221.95       91; was PROSTAGLANDINS X 1978-90 %28%see under PROSTAGLANDINS 1978-83%29%; PROSTACYCLIN was PROSTACYCLINS 1978-93;  PROSTAGLANDIN I2 was PROSTAGLANDINS I2 1982-93; PROSTAGLANDIN X was PROSTAGLANDINS X 1991-93%A%  
% 221.79/221.95  |- skos__scopeNote mesh__D011464
% 221.79/221.95       A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation.  It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue.  The sodium salt has been also used to treat primary pulmonary hypertension %28%HYPERTENSION, PULMONARY%29%.%A%    
% 221.79/221.95  |- mesh__dateRevised mesh__D011464 2005-06-30
% 221.79/221.95  |- skos__altLabel mesh__D011464 Prostaglandin I%28%2%29%
% 221.79/221.95  |- mesh__dateCreated mesh__D011464 1977-05-23
% 221.79/221.95  |- skos__annotation mesh__D011464
% 221.79/221.95       /chem syn permitted: do not convert to PROSTAGLANDINS, SYNTHETIC; DF: PGX%A%  
% 221.79/221.95  |- mesh__onlineNote mesh__D011464
% 221.79/221.95       use EPOPROSTENOL to search PROSTAGLANDINS I 1979-93 %26% PROSTAGLANDINS X 1978-90%A%  
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D011464 2006
% 221.79/221.95  |- mesh__recordMaintainer mesh__D011464 ssb
% 221.79/221.95  |- skos__altLabel mesh__D011464 Prostacyclin
% 221.79/221.95  |- mesh__recordAuthorizer mesh__D011464 sjn
% 221.79/221.95  |- mesh__dateEstablished mesh__D011464 1984-01-01
% 221.79/221.95  |- skos__prefLabel mesh__D011464 Epoprostenol
% 221.79/221.95  |- skos__broader mesh__D011464smesh__D044062
% 221.79/221.95  |- mesh__recordMaintainer mesh__D038601 jmp
% 221.79/221.95  |- skos__historyNote mesh__D038601 Ribosomal Proteins %28%1981-2002%29%
% 221.79/221.95  |- rdf__type mesh__D038601sskos__Concept
% 221.79/221.95  |- mesh__dateCreated mesh__D038601 2002-07-03
% 221.79/221.95  |- mesh__publicMeSHNote mesh__D038601
% 221.79/221.95       2003; RIBOSOMAL PROTEIN S6 was indexed under RIBOSOMAL PROTEINS 1981-2002%A%  
% 221.79/221.95  |- mesh__recordAuthorizer mesh__D038601 sjn
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D038601 2003
% 221.79/221.95  |- skos__scopeNote mesh__D038601
% 221.79/221.95       A ribosomal protein that may play a role in controlling cell growth and proliferation. It is a major substrate of RIBOSOMAL PROTEIN S6 KINASES and plays a role in regulating the translation %28%TRANSLATION, GENETIC%29% of RNAs that contain an RNA 5%27% TERMINAL OLIGOPYRIMIDINE SEQUENCE.%A%    
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D038601 2004
% 221.79/221.95  |- mesh__dateEstablished mesh__D038601 2003-01-01
% 221.79/221.95  |- skos__prefLabel mesh__D038601 Ribosomal Protein S6
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D038601 2005
% 221.79/221.95  |- skos__hiddenLabel mesh__D038601 Protein S6, Ribosomal
% 221.79/221.95  |- mesh__recordOriginator mesh__D038601 jmp
% 221.79/221.95  |- mesh__historyNote mesh__D038601
% 221.79/221.95       2003; use RIBOSOMAL PROTEIN S6 %28%NM%29% 1981-2002   
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D038601 2006
% 221.79/221.95  |- skos__broader mesh__D038601smesh__D012269
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D005427 2004
% 221.79/221.95  |- mesh__publicMeSHNote mesh__D005427
% 221.79/221.95       91; was see under PRECIPITATION 1972-90   
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D005427 1998
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D005427 1997
% 221.79/221.95  |- mesh__recordOriginator mesh__D005427 NLM
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D005427 2006
% 221.79/221.95  |- mesh__dateCreated mesh__D005427 1999-01-01
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D005427 1992
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D005427 1999
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D005427 2000
% 221.79/221.95  |- mesh__dateEstablished mesh__D005427 1991-01-01
% 221.79/221.95  |- skos__historyNote mesh__D005427 Precipitation %28%1966-1971%29%
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D005427 1994
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D005427 1991
% 221.79/221.95  |- mesh__dateRevised mesh__D005427 1990-04-13
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D005427 1993
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D005427 2001
% 221.79/221.95  |- skos__annotation mesh__D005427 almost never IM; no qualif   
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D005427 1995
% 221.79/221.95  |- mesh__recordMaintainer mesh__D005427 NLM
% 221.79/221.95  |- mesh__recordAuthorizer mesh__D005427 PLS
% 221.79/221.95  |- rdf__type mesh__D005427sskos__Concept
% 221.79/221.95  |- skos__prefLabel mesh__D005427 Flocculation
% 221.79/221.95  |- mesh__historyNote mesh__D005427
% 221.79/221.95       91%28%72%29%; was see under PRECIPITATION 1972-90   
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D005427 2003
% 221.79/221.95  |- skos__broader mesh__D005427smesh__D011232
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D005427 1996
% 221.79/221.95  |- skos__hiddenLabel mesh__D005427 Flocculations
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D005427 2002
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D005427 2005
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D015057 2000
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D015057 2003
% 221.79/221.95  |- skos__hiddenLabel mesh__D015057 1 Naphthylamine
% 221.79/221.95  |- rdf__type mesh__D015057sskos__Concept
% 221.79/221.95  |- skos__hiddenLabel mesh__D015057 8 Aminonaphthalene
% 221.79/221.95  |- skos__prefLabel mesh__D015057 1-Naphthylamine
% 221.79/221.95  |- skos__altLabel mesh__D015057 Naphthalidine
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D015057 1999
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D015057 2002
% 221.79/221.95  |- mesh__publicMeSHNote mesh__D015057
% 221.79/221.95       91; was see under NAPHTHALENES 1976-90   
% 221.79/221.95  |- mesh__dateCreated mesh__D015057 1975-07-18
% 221.79/221.95  |- skos__hiddenLabel mesh__D015057 1 Aminonaphthalene
% 221.79/221.95  |- skos__historyNote mesh__D015057 Naphthalenes %28%1969-1975%29%
% 221.79/221.95  |- mesh__recordOriginator mesh__D015057 SH
% 221.79/221.95  |- mesh__historyNote mesh__D015057
% 221.79/221.95       91%28%76%29%; was see under NAPHTHALENES 1976-90   
% 221.79/221.95  |- mesh__dateEstablished mesh__D015057 1991-01-01
% 221.79/221.95  |- skos__historyNote mesh__D015057 Amines %28%1969-1975%29%
% 221.79/221.95  |- skos__altLabel mesh__D015057 1-Aminonaphthalene
% 221.79/221.95  |- skos__broader mesh__D015057smesh__D009281
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D015057 2006
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D015057 2001
% 221.79/221.95  |- skos__scopeNote mesh__D015057
% 221.79/221.95       A suspected industrial carcinogen %28%and listed as such by OSHA%29%. Its N-hydroxy metabolite is strongly carcinogenic and mutagenic.%A%    
% 221.79/221.95  |- mesh__recordMaintainer mesh__D015057 ADP
% 221.79/221.95  |- skos__altLabel mesh__D015057 alpha-Naphthylamine
% 221.79/221.95  |- mesh__dateRevised mesh__D015057 1998-06-11
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D015057 2005
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D015057 2004
% 221.79/221.95  |- mesh__recordAuthorizer mesh__D015057 SJN
% 221.79/221.95  |- skos__annotation mesh__D015057 a carcinogen; D25-26 qualif   
% 221.79/221.95  |- skos__altLabel mesh__D015057 8-Aminonaphthalene
% 221.79/221.95  |- skos__broader mesh__D015057smesh__D000588
% 221.79/221.95  |- skos__hiddenLabel mesh__D015057 alpha Naphthylamine
% 221.79/221.95  |- skos__hiddenLabel mesh__D009818 Office Nursings
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D009818 2001
% 221.79/221.95  |- mesh__recordOriginator mesh__D009818 NLM
% 221.79/221.95  |- mesh__recordAuthorizer mesh__D009818 sjn
% 221.79/221.95  |- skos__prefLabel mesh__D009818 Office Nursing
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D009818 2003
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D009818 2006
% 221.79/221.95  |- mesh__dateEstablished mesh__D009818 1973-01-01
% 221.79/221.95  |- mesh__dateRevised mesh__D009818 1999-11-03
% 221.79/221.95  |- rdf__type mesh__D009818sskos__Concept
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D009818 2000
% 221.79/221.95  |- skos__broader mesh__D009818smesh__D009729
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D009818 2005
% 221.79/221.95  |- mesh__historyNote mesh__D009818 73%28%66%29%   
% 221.79/221.95  |- skos__altLabel mesh__D009818 Nursing, Office
% 221.79/221.95  |- mesh__dateCreated mesh__D009818 1999-01-01
% 221.79/221.95  |- skos__hiddenLabel mesh__D009818 Nursings, Office
% 221.79/221.95  |- mesh__publicMeSHNote mesh__D009818 73   
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D009818 2002
% 221.79/221.95  |- mesh__recordMaintainer mesh__D009818 jls
% 221.79/221.95  |- skos__scopeNote mesh__D009818
% 221.79/221.95       Nursing practice limited to an office setting.     
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D009818 2004
% 221.79/221.95  |- skos__scopeNote mesh__D001835
% 221.79/221.95       The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.%A%    
% 221.79/221.95  |- mesh__dateCreated mesh__D001835 1999-01-01
% 221.79/221.95  |- mesh__recordAuthorizer mesh__D001835 sjn
% 221.79/221.95  |- skos__hiddenLabel mesh__D001835 Weight, Body
% 221.79/221.95  |- skos__prefLabel mesh__D001835 Body Weight
% 221.79/221.95  |- skos__hiddenLabel mesh__D001835 Weights, Body
% 221.79/221.95  |- skos__broader mesh__D001835smesh__D049628
% 221.79/221.95  |- rdf__type mesh__D001835sskos__Concept
% 221.79/221.95  |- skos__broader mesh__D001835smesh__D012816
% 221.79/221.95  |- skos__related mesh__D001835smesh__D009765
% 221.79/221.95  |- mesh__dateRevised mesh__D001835 2004-07-07
% 221.79/221.95  |- mesh__recordMaintainer mesh__D001835 lkt
% 221.79/221.95  |- skos__hiddenLabel mesh__D001835 Body Weights
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D001835 2005
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D001835 2006
% 221.79/221.95  |- mesh__recordOriginator mesh__D001835 NLM
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Mixed Aphasias
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Mixed Aphasia
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Dysphasias, Global
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Commisural Aphasia
% 221.79/221.95  |- mesh__dateCreated mesh__D001037 1999-01-01
% 221.79/221.95  |- mesh__publicMeSHNote mesh__D001037
% 221.79/221.95       1963; for APHASIA, ACQUIRED see APHASIA, ACQUIRED 1991-1995, see APHASIA 1980-1990%A%  
% 221.79/221.95  |- skos__altLabel mesh__D001037 Logamnesia
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Aphasias, Progressive
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Lichtheim Sign
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Functional Aphasias
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Dejerine Lichtheim Phenomenon
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Aphasias, Global
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Lichtheims Sign
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Post-Ictal Aphasia
% 221.79/221.95  |- skos__altLabel mesh__D001037 Logagnosia
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Global Dysphasia
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Aphasias, Post-Traumatic
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Global Dysphasias
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Aphasias, Functional
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D001037 2001
% 221.79/221.95  |- skos__altLabel mesh__D001037 Alogia
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Post-Ictal Aphasias
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Graphomotor Aphasia
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Aphasias, Commisural
% 221.79/221.95  |- mesh__historyNote mesh__D001037 1963   
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Sign, Lichtheim%27%s
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Semantic Aphasia
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Phenomenon, Dejerine-Lichtheim
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Aphasias, Ageusic
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Aphasias, Graphomotor
% 221.79/221.95  |- skos__annotation mesh__D001037 GEN or unspecified; prefer specifics   
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Aphasia, Post Traumatic
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Aphasias, Syntactical
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Global Aphasias
% 221.79/221.95  |- skos__prefLabel mesh__D001037 Aphasia
% 221.79/221.95  |- skos__altLabel mesh__D001037 Dysphasia, Global
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D001037 2006
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D001037 2000
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Intellectual Aphasias
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Ageusic Aphasia
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Aphasias, Post-Ictal
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Global Aphasia
% 221.79/221.95  |- skos__scopeNote mesh__D001037
% 221.79/221.95       A cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form. This condition is caused by diseases which affect the language areas of the dominant hemisphere. Clinical features are used to classify the various subtypes of this condition. General categories include receptive, expressive, and mixed forms of aphasia.%A%    
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Post-Traumatic Aphasia
% 221.79/221.95  |- mesh__recordAuthorizer mesh__D001037 sjn
% 221.79/221.95  |- skos__altLabel mesh__D001037 Lichtheim%27%s Sign
% 221.79/221.95  |- rdf__type mesh__D001037sskos__Concept
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Alogias
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Auditory Discriminatory Aphasias
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Logamnesias
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Syntactical Aphasias
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Acquired Aphasia
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Logasthenias
% 221.79/221.95  |- mesh__dateRevised mesh__D001037 1999-11-03
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Intellectual Aphasia
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Graphomotor Aphasias
% 221.79/221.95  |- skos__broader mesh__D001037smesh__D013064
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Anepias
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Post-Traumatic Aphasias
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Logagnosias
% 221.79/221.95  |- skos__related mesh__D001037smesh__D018887
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D001037 2005
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Aphasias, Intellectual
% 221.79/221.95  |- skos__altLabel mesh__D001037 Logasthenia
% 221.79/221.95  |- mesh__recordMaintainer mesh__D001037 KEV
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Aphasias, Semantic
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Aphasias, Mixed
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D001037 2004
% 221.79/221.95  |- skos__altLabel mesh__D001037 Anepia
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Progressive Aphasia
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Functional Aphasia
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Commisural Aphasias
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Discriminatory Aphasia, Auditory
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Aphasia, Post Ictal
% 221.79/221.95  |- mesh__recordOriginator mesh__D001037 HMM
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D001037 2002
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Syntactical Aphasia
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Semantic Aphasias
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Progressive Aphasias
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Aphasias, Auditory Discriminatory
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Ageusic Aphasias
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D001037 2003
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Auditory Discriminatory Aphasia
% 221.79/221.95  |- skos__hiddenLabel mesh__D001037 Discriminatory Aphasias, Auditory
% 221.79/221.95  |- mesh__recordOriginator mesh__D006520 NLM
% 221.79/221.95  |- skos__broader mesh__D006520smesh__D006505
% 221.79/221.95  |- mesh__recordAuthorizer mesh__D006520 sjn
% 221.79/221.95  |- rdf__type mesh__D006520sskos__Concept
% 221.79/221.95  |- skos__prefLabel mesh__D006520 Hepatitis, Animal
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D006520 2005
% 221.79/221.95  |- mesh__recordMaintainer mesh__D006520 lkt
% 221.79/221.95  |- mesh__dateCreated mesh__D006520 1999-01-01
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D006520 2006
% 221.79/221.95  |- skos__broader mesh__D006520smesh__D000820
% 221.79/221.95  |- skos__annotation mesh__D006520
% 221.79/221.95       Experimental or veterinary; general or unspecified only; for specific experimental hepatitis, index the specific hepatitis term + ANIMALS check tag; for specific veterinary hepatitis, index the specific hepatitis term /vet + pre-coordinated animal disease term + ANIMALS check tag and do not coordinate with HEPATITIS, ANIMAL%A%  
% 221.79/221.95  |- skos__hiddenLabel mesh__D006520 Hepatitides, Animal
% 221.79/221.95  |- skos__hiddenLabel mesh__D006520 Animal Hepatitis
% 221.79/221.95  |- skos__hiddenLabel mesh__D006520 Animal Hepatitides
% 221.79/221.95  |- skos__scopeNote mesh__D006520
% 221.79/221.95       INFLAMMATION of the LIVER in non-human animals.     
% 221.79/221.95  |- mesh__dateRevised mesh__D006520 2004-07-07
% 221.79/221.95  |- mesh__recordMaintainer mesh__D019448 ssb
% 221.79/221.95  |- mesh__dateRevised mesh__D019448 2005-06-30
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D019448 2006
% 221.79/221.95  |- skos__prefLabel mesh__D019448 Ethnobotany
% 221.79/221.95  |- skos__broader mesh__D019448smesh__D001901
% 221.79/221.95  |- skos__historyNote mesh__D019448 Medicine, Traditional %28%1979-1996%29%
% 221.79/221.95  |- skos__annotation mesh__D019448
% 221.79/221.95       specialty; coordinate with geographic term or ethnic group if pertinent; coordinate NIM with specific drug or plant %28%IM%29% for ethnobotany aspects of the plant%A%  
% 221.79/221.95  |- mesh__historyNote mesh__D019448 97   
% 221.79/221.95  |- rdf__type mesh__D019448sskos__Concept
% 221.79/221.95  |- skos__scopeNote mesh__D019448
% 221.79/221.95       The plant lore and agricultural customs of a people. In the fields of ETHNOMEDICINE and ETHNOPHARMACOLOGY, the emphasis is on traditional medicine and the existence and medicinal uses of PLANTS and PLANT EXTRACTS and their constituents, both historically and in modern times.%A%    
% 221.79/221.95  |- skos__related mesh__D019448smesh__D020834
% 221.79/221.95  |- mesh__recordOriginator mesh__D019448 TGC
% 221.79/221.95  |- skos__related mesh__D019448smesh__D010944
% 221.79/221.95  |- mesh__dateCreated mesh__D019448 1996-06-10
% 221.79/221.95  |- skos__historyNote mesh__D019448 Plants, Medicinal %28%1970-1996%29%
% 221.79/221.95  |- mesh__dateEstablished mesh__D019448 1997-01-01
% 221.79/221.95  |- mesh__publicMeSHNote mesh__D019448 97   
% 221.79/221.95  |- mesh__recordAuthorizer mesh__D019448 sjn
% 221.79/221.95  |- skos__altLabel mesh__D011465 Synthetic Prostaglandins
% 221.79/221.95  |- mesh__dateRevised mesh__D011465 2005-06-30
% 221.79/221.95  |- skos__scopeNote mesh__D011465
% 221.79/221.95       Compounds obtained by chemical synthesis that are analogs or derivatives of naturally occurring prostaglandins and that have similar activity.%A%    
% 221.79/221.95  |- skos__historyNote mesh__D011465 Prostaglandins %28%1966-1976%29%
% 221.79/221.95  |- skos__hiddenLabel mesh__D011465 Analogs, Prostaglandin
% 221.79/221.95  |- skos__altLabel mesh__D011465 Prostaglandin Analogues
% 221.79/221.95  |- skos__altLabel mesh__D011465 PG Analogs
% 221.79/221.95  |- mesh__dateCreated mesh__D011465 1976-05-19
% 221.79/221.95  |- mesh__recordAuthorizer mesh__D011465 sjn
% 221.79/221.95  |- skos__annotation mesh__D011465
% 221.79/221.95       GEN or unspecified only: prefer specifics; for synthetic prostaglandins not precoord, coord specific non-synthetic %28%natural%29% prostaglandin term %28%NIM%29% + PROSTAGLANDINS, SYNTHETIC %28%IM%29%; DF: PG SYN%A%  
% 221.79/221.95  |- skos__altLabel mesh__D011465 Prostaglandin Analogs
% 221.79/221.95  |- rdf__type mesh__D011465sskos__Concept
% 221.79/221.95  |- skos__broader mesh__D011465smesh__D018836
% 221.79/221.95  |- mesh__recordOriginator mesh__D011465 RLS
% 221.79/221.95  |- skos__hiddenLabel mesh__D011465 Analogues, Prostaglandin
% 221.79/221.95  |- skos__historyNote mesh__D011465
% 221.79/221.95       Fatty Acids, Unsaturated %28%1975-1976%29%
% 221.79/221.95  |- mesh__recordMaintainer mesh__D011465 ssb
% 221.79/221.95  |- skos__prefLabel mesh__D011465 Prostaglandins, Synthetic
% 221.79/221.95  |- skos__broader mesh__D011465smesh__D011453
% 221.79/221.95  |- skos__hiddenLabel mesh__D011465 Analogs, PG
% 221.79/221.95  |- mesh__publicMeSHNote mesh__D011465 77   
% 221.79/221.95  |- mesh__dateEstablished mesh__D011465 1977-01-01
% 221.79/221.95  |- mesh__historyNote mesh__D011465 77   
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D011465 2006
% 221.79/221.95  |- mesh__dateRevised mesh__D038602 2005-06-30
% 221.79/221.95  |- rdf__type mesh__D038602sskos__Concept
% 221.79/221.95  |- skos__prefLabel mesh__D038602 Mice, Biozzi
% 221.79/221.95  |- skos__hiddenLabel mesh__D038602 Biozzi Mice
% 221.79/221.95  |- mesh__recordMaintainer mesh__D038602 ags
% 221.79/221.95  |- skos__scopeNote mesh__D038602
% 221.79/221.95       A strain of mice bred specifically as high or low antibody responders.%A%    
% 221.79/221.95  |- mesh__recordOriginator mesh__D038602 ags
% 221.79/221.95  |- mesh__recordAuthorizer mesh__D038602 sjn
% 221.79/221.95  |- skos__broader mesh__D038602smesh__D008817
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D038602 2006
% 221.79/221.95  |- mesh__historyNote mesh__D038602 2003   
% 221.79/221.95  |- skos__historyNote mesh__D038602 Mice, Inbred Strains %28%1972-2002%29%
% 221.79/221.95  |- mesh__publicMeSHNote mesh__D038602 2003   
% 221.79/221.95  |- mesh__dateEstablished mesh__D038602 2003-01-01
% 221.79/221.95  |- mesh__dateCreated mesh__D038602 2002-07-02
% 221.79/221.95  |- mesh__dateCreated mesh__D005428 1999-01-01
% 221.79/221.95  |- mesh__recordAuthorizer mesh__D005428 sjn
% 221.79/221.95  |- skos__annotation mesh__D005428 NIM   
% 221.79/221.95  |- mesh__publicMeSHNote mesh__D005428 73   
% 221.79/221.95  |- skos__historyNote mesh__D005428 Precipitin Tests %28%1966-1972%29%
% 221.79/221.95  |- mesh__recordMaintainer mesh__D005428 nns
% 221.79/221.95  |- skos__broader mesh__D005428smesh__D011233
% 221.79/221.95  |- skos__hiddenLabel mesh__D005428 Flocculation Test
% 221.79/221.95  |- skos__hiddenLabel mesh__D005428 Tests, Flocculation
% 221.79/221.95  |- mesh__recordOriginator mesh__D005428 NLM
% 221.79/221.95  |- skos__hiddenLabel mesh__D005428 Test, Flocculation
% 221.79/221.95  |- rdf__type mesh__D005428sskos__Concept
% 221.79/221.95  |- mesh__dateEstablished mesh__D005428 1973-01-01
% 221.79/221.95  |- skos__scopeNote mesh__D005428
% 221.79/221.95       Precipitin tests in which precipitation occurs over a narrow range of antigen-antibody ratio, due chiefly to peculiarities of the antibody %28%precipitin%29%. %28%From Stedman, 26th ed%29%%A%    
% 221.79/221.95  |- mesh__dateRevised mesh__D005428 2004-07-07
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D005428 2005
% 221.79/221.95  |- skos__historyNote mesh__D005428 Serodiagnosis %28%1966-1972%29%
% 221.79/221.95  |- skos__prefLabel mesh__D005428 Flocculation Tests
% 221.79/221.95  |- mesh__historyNote mesh__D005428 73   
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D005428 2006
% 221.79/221.95  |- rdf__type mesh__D002130sskos__Concept
% 221.79/221.95  |- mesh__publicMeSHNote mesh__D002130 65   
% 221.79/221.95  |- skos__hiddenLabel mesh__D002130 Phosphates, Calcium
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D002130 2001
% 221.79/221.95  |- mesh__dateEstablished mesh__D002130 1965-01-01
% 221.79/221.95  |- mesh__activeMeSHYear mesh__D002130 1998
% 221.79/221.95  |- skos__prefLabel mesh__D002130 Calcium Phosphates
% 221.79/221.95  |- mesh__historyNote mesh__D002130 65%28%64%29%   
% 221.79/221.96  |- mesh__dateRevised mesh__D002130 1993-06-04
% 221.79/221.96  |- skos__annotation mesh__D002130
% 221.79/221.96       GEN or unspecified; prefer specifics; often used as calcium supplement%A%  
% 221.79/221.96  |- mesh__recordOriginator mesh__D002130 NLM
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D002130 2005
% 221.79/221.96  |- skos__scopeNote mesh__D002130
% 221.79/221.96       Calcium salts of phosphoric acid. These compounds are frequently used as calcium supplements.%A%    
% 221.79/221.96  |- mesh__recordAuthorizer mesh__D002130 PLS
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D002130 1996
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D002130 2002
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D002130 1999
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D002130 2003
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D002130 2006
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D002130 1997
% 221.79/221.96  |- mesh__recordMaintainer mesh__D002130 TPW
% 221.79/221.96  |- skos__broader mesh__D002130smesh__D017610
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D002130 2004
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D002130 1994
% 221.79/221.96  |- mesh__dateCreated mesh__D002130 1999-01-01
% 221.79/221.96  |- skos__broader mesh__D002130smesh__D010710
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D002130 1995
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D002130 2000
% 221.79/221.96  |- skos__altLabel mesh__D015058 alpha-Naphthylisothiocyanate
% 221.79/221.96  |- mesh__recordMaintainer mesh__D015058 CCR
% 221.79/221.96  |- skos__hiddenLabel mesh__D015058 alpha Naphthylisothiocyanate
% 221.79/221.96  |- mesh__dateCreated mesh__D015058 1975-07-25
% 221.79/221.96  |- skos__historyNote mesh__D015058 Thiocyanates %28%1972-1975%29%
% 221.79/221.96  |- mesh__dateEstablished mesh__D015058 1991-01-01
% 221.79/221.96  |- mesh__recordOriginator mesh__D015058 SH
% 221.79/221.96  |- mesh__dateRevised mesh__D015058 2000-06-21
% 221.79/221.96  |- mesh__publicMeSHNote mesh__D015058
% 221.79/221.96       91; was see under THIOCYANATES 1977-90; was ALPHA-NAPHTHYLISOTHIOCYANATE %28%see under THIOCYANATES 1976%29%; ANIT was see 1-NAPHTHYLISOTHIOCYANATE 1976-93%A%  
% 221.79/221.96  |- skos__broader mesh__D015058smesh__D009281
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D015058 2006
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D015058 2002
% 221.79/221.96  |- mesh__historyNote mesh__D015058
% 221.79/221.96       91%28%77%29%; was see under THIOCYANATES 1977-90; was ALPHA-NAPHTHYLISOTHIOCYANATE %28%see under THIOCYANATES 1976%29%; ANIT was see 1-NAPHTHYLISOTHIOCYANATE 1976-93%A%  
% 221.79/221.96  |- skos__broader mesh__D015058smesh__D017879
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D015058 2005
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D015058 2004
% 221.79/221.96  |- skos__historyNote mesh__D015058 Naphthalenes %28%1972-1975%29%
% 221.79/221.96  |- skos__prefLabel mesh__D015058 1-Naphthylisothiocyanate
% 221.79/221.96  |- skos__hiddenLabel mesh__D015058 1 Naphthylisothiocyanate
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D015058 2003
% 221.79/221.96  |- mesh__recordAuthorizer mesh__D015058 sjn
% 221.79/221.96  |- skos__scopeNote mesh__D015058
% 221.79/221.96       A tool for the study of liver damage which causes bile stasis and hyperbilirubinemia acutely and bile duct hyperplasia and biliary cirrhosis chronically, with changes in hepatocyte function. It may cause skin and kidney damage.%A%    
% 221.79/221.96  |- mesh__onlineNote mesh__D015058
% 221.79/221.96       use 1-NAPHTHYLISOTHIOCYANATE to search   ALPHA-NAPHTHYLISOTHIOCYANATE 1976 %26% ANIT 1976-93%A%  
% 221.79/221.96  |- rdf__type mesh__D015058sskos__Concept
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D015058 2001
% 221.79/221.96  |- skos__hiddenLabel mesh__D009819 Office Visit
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D009819 2006
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D009819 1998
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D009819 1997
% 221.79/221.96  |- rdf__type mesh__D009819sskos__Concept
% 221.79/221.96  |- mesh__dateEstablished mesh__D009819 1984-01-01
% 221.79/221.96  |- skos__scopeNote mesh__D009819
% 221.79/221.96       Visits made by patients to health service providers%27% offices for diagnosis, treatment, and follow-up.%A%    
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D009819 2000
% 221.79/221.96  |- mesh__dateRevised mesh__D009819 1992-05-15
% 221.79/221.96  |- skos__hiddenLabel mesh__D009819 Visits, Office
% 221.79/221.96  |- mesh__recordOriginator mesh__D009819 EC
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D009819 1999
% 221.79/221.96  |- mesh__publicMeSHNote mesh__D009819 84   
% 221.79/221.96  |- mesh__historyNote mesh__D009819 84   
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D009819 2001
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D009819 1994
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D009819 1993
% 221.79/221.96  |- mesh__dateCreated mesh__D009819 1983-06-06
% 221.79/221.96  |- skos__prefLabel mesh__D009819 Office Visits
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D009819 1995
% 221.79/221.96  |- mesh__recordMaintainer mesh__D009819 TAP
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D009819 2003
% 221.79/221.96  |- skos__broader mesh__D009819smesh__D011364
% 221.79/221.96  |- skos__hiddenLabel mesh__D009819 Visit, Office
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D009819 2002
% 221.79/221.96  |- mesh__recordAuthorizer mesh__D009819 PLS
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D009819 2005
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D009819 2004
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D009819 1996
% 221.79/221.96  |- mesh__recordOriginator mesh__D001836 NLM
% 221.79/221.96  |- skos__hiddenLabel mesh__D001836 Changes, Body Weight
% 221.79/221.96  |- skos__hiddenLabel mesh__D001836 Body Weight Change
% 221.79/221.96  |- rdf__type mesh__D001836sskos__Concept
% 221.79/221.96  |- skos__historyNote mesh__D001836 Body Weight %28%1966-1997%29%
% 221.79/221.96  |- mesh__dateRevised mesh__D001836 2004-07-07
% 221.79/221.96  |- mesh__dateEstablished mesh__D001836 1998-01-01
% 221.79/221.96  |- mesh__historyNote mesh__D001836 98; use explode 1975-97   
% 221.79/221.96  |- skos__annotation mesh__D001836 not used for indexing   
% 221.79/221.96  |- mesh__recordAuthorizer mesh__D001836 sjn
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D001836 2005
% 221.79/221.96  |- mesh__recordMaintainer mesh__D001836 nns
% 221.79/221.96  |- skos__prefLabel mesh__D001836 Body Weight Changes
% 221.79/221.96  |- skos__hiddenLabel mesh__D001836 Weight Changes, Body
% 221.79/221.96  |- skos__scopeNote mesh__D001836
% 221.79/221.96       A clinical manifestation consisting of alterations in an individual%27%s weight from his or her norm.%A%    
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D001836 2006
% 221.79/221.96  |- mesh__publicMeSHNote mesh__D001836 98   
% 221.79/221.96  |- skos__hiddenLabel mesh__D001836 Change, Body Weight
% 221.79/221.96  |- skos__broader mesh__D001836smesh__D001835
% 221.79/221.96  |- skos__hiddenLabel mesh__D001836 Weight Change, Body
% 221.79/221.96  |- mesh__dateCreated mesh__D001836 1999-01-01
% 221.79/221.96  |- skos__historyNote mesh__D006521 Hepatitis %28%1966-1982%29%
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D006521 2005
% 221.79/221.96  |- skos__prefLabel mesh__D006521 Hepatitis, Chronic
% 221.79/221.96  |- mesh__publicMeSHNote mesh__D006521
% 221.79/221.96       98; was HEPATITIS, CHRONIC ACTIVE 1983-97   
% 221.79/221.96  |- mesh__dateEstablished mesh__D006521 1983-01-01
% 221.79/221.96  |- skos__historyNote mesh__D006521 Hepatitis B %28%1966-1982%29%
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D006521 2006
% 221.79/221.96  |- skos__hiddenLabel mesh__D006521 Chronic Hepatitis, Cryptogenic
% 221.79/221.96  |- skos__hiddenLabel mesh__D006521 Chronic Active Hepatitis
% 221.79/221.96  |- skos__broader mesh__D006521smesh__D006505
% 221.79/221.96  |- mesh__dateRevised mesh__D006521 2004-07-07
% 221.79/221.96  |- mesh__recordOriginator mesh__D006521 RC
% 221.79/221.96  |- mesh__historyNote mesh__D006521
% 221.79/221.96       98; was HEPATITIS, CHRONIC ACTIVE 1983-97   
% 221.79/221.96  |- mesh__recordAuthorizer mesh__D006521 sjn
% 221.79/221.96  |- skos__hiddenLabel mesh__D006521 Hepatitis, Cryptogenic Chronic
% 221.79/221.96  |- skos__hiddenLabel mesh__D006521 Chronic Persistent Hepatitis
% 221.79/221.96  |- skos__altLabel mesh__D006521 Hepatitis, Chronic, Cryptogenic
% 221.79/221.96  |- skos__scopeNote mesh__D006521
% 221.79/221.96       INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell %28%LEUKOCYTES%29% infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors.%A%    
% 221.79/221.96  |- mesh__recordMaintainer mesh__D006521 lkt
% 221.79/221.96  |- skos__hiddenLabel mesh__D006521 Chronic Persistent Hepatitides
% 221.79/221.96  |- mesh__dateCreated mesh__D006521 1982-04-27
% 221.79/221.96  |- skos__altLabel mesh__D006521 Chronic Hepatitis
% 221.79/221.96  |- rdf__type mesh__D006521sskos__Concept
% 221.79/221.96  |- skos__annotation mesh__D006521
% 221.79/221.96       GEN or unspecified; prefer specifics; chronic alcoholic hepatitis = HEPATITIS, ALCOHOLIC%A%  
% 221.79/221.96  |- skos__historyNote mesh__D019449 Ileitis %28%1986-1996%29%
% 221.79/221.96  |- skos__altLabel mesh__D019449 Pouch Ileitis
% 221.79/221.96  |- mesh__publicMeSHNote mesh__D019449 97   
% 221.79/221.96  |- mesh__dateCreated mesh__D019449 1996-06-10
% 221.79/221.96  |- skos__scopeNote mesh__D019449
% 221.79/221.96       Acute INFLAMMATION in the INTESTINAL MUCOSA of the continent ileal reservoir %28%or pouch%29% in patients who have undergone ILEOSTOMY and restorative proctocolectomy %28%PROCTOCOLECTOMY, RESTORATIVE%29%.%A%    
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D019449 2006
% 221.79/221.96  |- mesh__dateRevised mesh__D019449 2003-07-09
% 221.79/221.96  |- mesh__dateEstablished mesh__D019449 1997-01-01
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D019449 2004
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D019449 2005
% 221.79/221.96  |- skos__annotation mesh__D019449
% 221.79/221.96       do not index under PROCTOCOLECTOMY, RESTORATIVE unless particularly discussed%A%  
% 221.79/221.96  |- skos__prefLabel mesh__D019449 Pouchitis
% 221.79/221.96  |- skos__historyNote mesh__D019449
% 221.79/221.96       Proctocolectomy, Restorative %28%1992-1996%29%
% 221.79/221.96  |- skos__broader mesh__D019449smesh__D007079
% 221.79/221.96  |- mesh__historyNote mesh__D019449 97   
% 221.79/221.96  |- rdf__type mesh__D019449sskos__Concept
% 221.79/221.96  |- skos__hiddenLabel mesh__D019449 Ileitis, Pouch
% 221.79/221.96  |- skos__scopeNote mesh__D011466
% 221.79/221.96       2-Octylcyclopentaneheptanoic acids. The family of saturated carbon-20 cyclic fatty acids that represent the parent compounds of the prostaglandins.%A%    
% 221.79/221.96  |- mesh__recordAuthorizer mesh__D011466 sjn
% 221.79/221.96  |- skos__historyNote mesh__D011466 Prostaglandins %28%1971-1974%29%
% 221.79/221.96  |- mesh__recordOriginator mesh__D011466 NLM
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D011466 2006
% 221.79/221.96  |- mesh__dateCreated mesh__D011466 1974-11-11
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D011466 2005
% 221.79/221.96  |- skos__hiddenLabel mesh__D011466 Acids, Prostanoic
% 221.79/221.96  |- rdf__type mesh__D011466sskos__Concept
% 221.79/221.96  |- skos__annotation mesh__D011466
% 221.79/221.96       do not confuse with %22%prostenoic acids%22%; /biosyn /physiol permitted%A%  
% 221.79/221.96  |- mesh__historyNote mesh__D011466
% 221.79/221.96       91%28%75%29%; was see under FATTY ACIDS 1975-90   
% 221.79/221.96  |- skos__prefLabel mesh__D011466 Prostanoic Acids
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D011466 2004
% 221.79/221.96  |- skos__historyNote mesh__D011466 Fatty Acids %28%1971-1974%29%
% 221.79/221.96  |- skos__historyNote mesh__D011466 Cyclopentanes %28%1971-1974%29%
% 221.79/221.96  |- mesh__recordMaintainer mesh__D011466 ssb
% 221.79/221.96  |- mesh__dateRevised mesh__D011466 2003-07-09
% 221.79/221.96  |- mesh__publicMeSHNote mesh__D011466
% 221.79/221.96       91; was see under FATTY ACIDS 1975-90   
% 221.79/221.96  |- mesh__dateEstablished mesh__D011466 1991-01-01
% 221.79/221.96  |- skos__broader mesh__D011466smesh__D005227
% 221.79/221.96  |- mesh__recordMaintainer mesh__D002131 sjn
% 221.79/221.96  |- mesh__historyNote mesh__D002131
% 221.79/221.96       91%28%77%29%; was see under PYROPHOSPHATES 1977-90   
% 221.79/221.96  |- skos__annotation mesh__D002131
% 221.79/221.96       deposition = CALCIUM PYROPHOSPHATE DIHYDRATE DEPOSITION see CHONDROCALCINOSIS%A%  
% 221.79/221.96  |- rdf__type mesh__D002131sskos__Concept
% 221.79/221.96  |- mesh__publicMeSHNote mesh__D002131
% 221.79/221.96       91; was see under PYROPHOSPHATES 1977-90   
% 221.79/221.96  |- skos__broader mesh__D002131smesh__D011756
% 221.79/221.96  |- mesh__dateEstablished mesh__D002131 1991-01-01
% 221.79/221.96  |- skos__hiddenLabel mesh__D002131 Monohydrate Calcium Pyrophosphate
% 221.79/221.96  |- skos__prefLabel mesh__D002131 Calcium Pyrophosphate
% 221.79/221.96  |- mesh__dateRevised mesh__D002131 2004-07-13
% 221.79/221.96  |- skos__hiddenLabel mesh__D002131 Diphosphate, Calcium
% 221.79/221.96  |- mesh__recordAuthorizer mesh__D002131 sjn
% 221.79/221.96  |- skos__hiddenLabel mesh__D002131 Pyrophosphate, Calcium
% 221.79/221.96  |- skos__scopeNote mesh__D002131
% 221.79/221.96       An inorganic pyrophosphate which affects calcium metabolism in mammals. Abnormalities in its metabolism occur in some human diseases, notably HYPOPHOSPHATASIA and pseudogout %28%CHONDROCALCINOSIS%29%.%A%    
% 221.79/221.96  |- skos__hiddenLabel mesh__D002131 Pyrophosphate Dihydrate, Calcium
% 221.79/221.96  |- skos__hiddenLabel mesh__D002131 Pyrophosphate, Monohydrate Calcium
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D002131 2006
% 221.79/221.96  |- skos__broader mesh__D002131smesh__D002130
% 221.79/221.96  |- skos__altLabel mesh__D002131 Calcium Diphosphate
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D002131 2005
% 221.79/221.96  |- skos__related mesh__D002131smesh__D002805
% 221.79/221.96  |- mesh__recordOriginator mesh__D002131 RLS
% 221.79/221.96  |- skos__historyNote mesh__D002131 Pyrophosphates %28%1966-1976%29%
% 221.79/221.96  |- mesh__dateCreated mesh__D002131 1976-04-16
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D015059 2006
% 221.79/221.96  |- mesh__dateEstablished mesh__D015059 1991-01-01
% 221.79/221.96  |- skos__historyNote mesh__D015059
% 221.79/221.96       Isoleucine %28%1966-1974%29%/analogs %26% derivatives %28%1975-1979%29%
% 221.79/221.96  |- skos__hiddenLabel mesh__D015059 1 Sar 8 Ile Angiotensin II
% 221.79/221.96  |- skos__historyNote mesh__D015059
% 221.79/221.96       Angiotensin II %28%1966-1974%29%/analogs %26% derivatives %28%1975-1979%29%
% 221.79/221.96  |- mesh__recordAuthorizer mesh__D015059 sjn
% 221.79/221.96  |- skos__hiddenLabel mesh__D015059 Angiotensin II, 1-Sarcosine-8-Isoleucine
% 221.79/221.96  |- skos__historyNote mesh__D015059
% 221.79/221.96       Sarcosine %28%1968-1974%29%/analogs %26% derivatives %28%1975-1979%29%
% 221.79/221.96  |- skos__hiddenLabel mesh__D015059 1 Sarcosine 8 Isoleucine Angiotensin II
% 221.79/221.96  |- mesh__recordMaintainer mesh__D015059 ssb
% 221.79/221.96  |- skos__prefLabel mesh__D015059 1-Sarcosine-8-Isoleucine Angiotensin II
% 221.79/221.96  |- mesh__publicMeSHNote mesh__D015059
% 221.79/221.96       91; was see under ANGIOTENSIN II 1980-90   
% 221.79/221.96  |- rdf__type mesh__D015059sskos__Concept
% 221.79/221.96  |- skos__annotation mesh__D015059 DF: SAR ISO ANG   
% 221.79/221.96  |- mesh__historyNote mesh__D015059
% 221.79/221.96       91%28%80%29%; was see under ANGIOTENSIN II 1980-90   
% 221.79/221.96  |- skos__altLabel mesh__D015059 Sarile
% 221.79/221.96  |- mesh__dateCreated mesh__D015059 1979-05-25
% 221.79/221.96  |- skos__broader mesh__D015059smesh__D000804
% 221.79/221.96  |- skos__altLabel mesh__D015059
% 221.79/221.96       1-%28%N-Methylglycine%29%-8-L-Isoleucine-Angiotensin II
% 221.79/221.96  |- skos__scopeNote mesh__D015059
% 221.79/221.96       An ANGIOTENSIN II analog which acts as a highly specific inhibitor of ANGIOTENSIN TYPE 1 RECEPTOR.%A%    
% 221.79/221.96  |- mesh__dateRevised mesh__D015059 2005-06-30
% 221.79/221.96  |- skos__historyNote mesh__D015059 Glycine %28%1966-1967%29%
% 221.79/221.96  |- skos__hiddenLabel mesh__D015059 Angiotensin II, 1-Sar-8-Ile
% 221.79/221.96  |- mesh__recordOriginator mesh__D015059 RLS
% 221.79/221.96  |- skos__altLabel mesh__D015059 1-Sar-8-Ile Angiotensin II
% 221.79/221.96  |- mesh__publicMeSHNote mesh__D001837 98   
% 221.79/221.96  |- skos__annotation mesh__D001837
% 221.79/221.96       GEN or unspecified; prefer specifics; do not confuse with BODY WEIGHT; DF: BODY WEIGHTS MEASURES%A%  
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D001837 2005
% 221.79/221.96  |- mesh__dateRevised mesh__D001837 2004-07-13
% 221.79/221.96  |- mesh__historyNote mesh__D001837 98; use explode 1975-97   
% 221.79/221.96  |- skos__prefLabel mesh__D001837 Body Weights and Measures
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D001837 2006
% 221.79/221.96  |- mesh__recordOriginator mesh__D001837 NLM
% 221.79/221.96  |- mesh__dateCreated mesh__D001837 1999-01-01
% 221.79/221.96  |- mesh__dateEstablished mesh__D001837 1998-01-01
% 221.79/221.96  |- skos__hiddenLabel mesh__D001837 Body Measure
% 221.79/221.96  |- skos__broader mesh__D001837smesh__D001824
% 221.79/221.96  |- mesh__recordMaintainer mesh__D001837 sjn
% 221.79/221.96  |- skos__hiddenLabel mesh__D001837 Measures, Body
% 221.79/221.96  |- skos__related mesh__D001837smesh__D000886
% 221.79/221.96  |- mesh__recordAuthorizer mesh__D001837 sjn
% 221.79/221.96  |- rdf__type mesh__D001837sskos__Concept
% 221.79/221.96  |- skos__scopeNote mesh__D001837
% 221.79/221.96       Measurements of the height, weight, length, area, etc., of the human and animal body or its parts.%A%    
% 221.79/221.96  |- skos__hiddenLabel mesh__D001837 Measure, Body
% 221.79/221.96  |- skos__broader mesh__D001837smesh__D008919
% 221.79/221.96  |- skos__historyNote mesh__D001837 Anthropometry %28%1966-1997%29%
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Ataxic Aphasias
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Expressive Aphasia
% 221.79/221.96  |- skos__altLabel mesh__D001039 Dysphasia, Broca
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Aphasia Syndromes, Verbal
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Aphasias, Frontocortical
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D001039 2006
% 221.79/221.96  |- rdf__type mesh__D001039sskos__Concept
% 221.79/221.96  |- mesh__dateEstablished mesh__D001039 1991-01-01
% 221.79/221.96  |- skos__altLabel mesh__D001039 Verbal Aphasia Syndrome
% 221.79/221.96  |- mesh__recordOriginator mesh__D001039 RC
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Motor Aphasia
% 221.79/221.96  |- skos__altLabel mesh__D001039 Aphasia, Frontocortical
% 221.79/221.96  |- mesh__dateRevised mesh__D001039 1999-11-08
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Aphasias, Broca
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D001039 2003
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Aphasias, Ataxic
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D001039 2002
% 221.79/221.96  |- mesh__recordAuthorizer mesh__D001039 sjn
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Verbal Aphasia Syndromes
% 221.79/221.96  |- skos__altLabel mesh__D001039 Broca Aphasia
% 221.79/221.96  |- skos__broader mesh__D001039smesh__D001037
% 221.79/221.96  |- skos__scopeNote mesh__D001039
% 221.79/221.96       An aphasia characterized by impairment of expressive language %28%speech, writing, signs%29% and relative preservation of receptive language abilities %28%i.e., comprehension%29%. This condition is caused by lesions of the motor association cortex in the frontal lobe %28%Broca%27%s area and adjacent cortical and white matter regions%29%. The deficits range from almost complete muteness to a reduction in the fluency and rate of speech. CEREBROVASCULAR ACCIDENTS %28%in particular INFARCTION, MIDDLE CEREBRAL ARTERY%29% are a relatively common cause of this condition. %28%From Adams et al., Principles of Neurology, 6th ed, pp478-9%29%%A%    
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Dysphasia, Brocas
% 221.79/221.96  |- mesh__publicMeSHNote mesh__D001039 1991; see APHASIA 1980-1990   
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Anterior Aphasia
% 221.79/221.96  |- skos__altLabel mesh__D001039 Aphasia, Motor
% 221.79/221.96  |- mesh__recordMaintainer mesh__D001039 KEV
% 221.79/221.96  |- mesh__historyNote mesh__D001039 1991%28%1980%29%   
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D001039 2004
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Broca%27%s Dysphasia
% 221.79/221.96  |- skos__historyNote mesh__D001039 Aphasia %28%1966-1979%29%
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Nonfluent Aphasia
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Frontocortical Aphasias
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Syndrome, Verbal Aphasia
% 221.79/221.96  |- skos__altLabel mesh__D001039 Aphasia, Nonfluent
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Broca Dysphasia
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Ataxic Aphasia
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Aphasias, Anterior
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D001039 2000
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Anterior Aphasias
% 221.79/221.96  |- skos__altLabel mesh__D001039 Dysphasia, Broca%27%s
% 221.79/221.96  |- skos__annotation mesh__D001039
% 221.79/221.96       subject understands language but cannot express it; do not confuse with APHASIA, WERNICKE where subject does not understand language%A%  
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D001039 2005
% 221.79/221.96  |- skos__prefLabel mesh__D001039 Aphasia, Broca
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Broca Aphasias
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D001039 2001
% 221.79/221.96  |- mesh__dateCreated mesh__D001039 1978-12-14
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Frontocortical Aphasia
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Syndromes, Verbal Aphasia
% 221.79/221.96  |- skos__hiddenLabel mesh__D001039 Aphasia Syndrome, Verbal
% 221.79/221.96  |- skos__hiddenLabel mesh__D006522 Canine Hepatitides, Infectious
% 221.79/221.96  |- skos__altLabel mesh__D006522 Hepatitis, Canine Infectious
% 221.79/221.96  |- mesh__dateCreated mesh__D006522 1999-01-01
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D006522 2006
% 221.79/221.96  |- skos__broader mesh__D006522smesh__D006524
% 221.79/221.96  |- skos__hiddenLabel mesh__D006522 Canine Hepatitis, Infectious
% 221.79/221.96  |- skos__hiddenLabel mesh__D006522 Infectious Hepatitis, Canine
% 221.79/221.96  |- skos__historyNote mesh__D006522 Hepatitis, Animal %28%1966-1970%29%
% 221.79/221.96  |- skos__hiddenLabel mesh__D006522 Hepatitides, Infectious Canine
% 221.79/221.96  |- mesh__dateRevised mesh__D006522 2004-07-07
% 221.79/221.96  |- skos__hiddenLabel mesh__D006522 Infectious Hepatitides, Canine
% 221.79/221.96  |- mesh__dateEstablished mesh__D006522 1971-01-01
% 221.79/221.96  |- skos__hiddenLabel mesh__D006522 Canine Infectious Hepatitides
% 221.79/221.96  |- mesh__onlineNote mesh__D006522
% 221.79/221.96       use HEPATITIS, INFECTIOUS CANINE to search HEPATITIS, CANINE INFECTIOUS 1971-81%A%  
% 221.79/221.96  |- skos__altLabel mesh__D006522 Infectious Canine Hepatitis
% 221.79/221.96  |- mesh__historyNote mesh__D006522
% 221.79/221.96       82; was HEPATITIS, CANINE INFECTIOUS 1971-81   
% 221.79/221.96  |- skos__altLabel mesh__D006522 Canine Infectious Hepatitis
% 221.79/221.96  |- skos__prefLabel mesh__D006522 Hepatitis, Infectious Canine
% 221.79/221.96  |- skos__broader mesh__D006522smesh__D004283
% 221.79/221.96  |- mesh__recordOriginator mesh__D006522 NLM
% 221.79/221.96  |- skos__hiddenLabel mesh__D006522 Hepatitides, Canine Infectious
% 221.79/221.96  |- rdf__type mesh__D006522sskos__Concept
% 221.79/221.96  |- skos__scopeNote mesh__D006522
% 221.79/221.96       A contagious disease caused by canine adenovirus %28%ADENOVIRUSES, CANINE%29% infecting the LIVER, the EYE, the KIDNEY, and other organs in dogs, other canids, and bears. Symptoms include FEVER; EDEMA; VOMITING; and DIARRHEA.%A%    
% 221.79/221.96  |- mesh__publicMeSHNote mesh__D006522
% 221.79/221.96       82; was HEPATITIS, CANINE INFECTIOUS 1971-81   
% 221.79/221.96  |- mesh__recordAuthorizer mesh__D006522 sjn
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D006522 2005
% 221.79/221.96  |- mesh__recordMaintainer mesh__D006522 lkt
% 221.79/221.96  |- skos__broader mesh__D006522smesh__D000257
% 221.79/221.96  |- skos__annotation mesh__D006522
% 221.79/221.96       check the tags DOGS and ANIMALS or index other animal term if appropriate%A%  
% 221.79/221.96  |- skos__hiddenLabel mesh__D006522 Infectious Canine Hepatitides
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D011467 2002
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D011467 2005
% 221.79/221.96  |- rdf__type mesh__D011467sskos__Concept
% 221.79/221.96  |- skos__broader mesh__D011467smesh__D005088
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D011467 2001
% 221.79/221.96  |- mesh__dateCreated mesh__D011467 1999-01-01
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D011467 2004
% 221.79/221.96  |- mesh__recordOriginator mesh__D011467 NLM
% 221.79/221.96  |- skos__scopeNote mesh__D011467
% 221.79/221.96       A gland in males that surrounds the neck of the BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM.%A%    
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D011467 2000
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D011467 2003
% 221.79/221.96  |- skos__broader mesh__D011467smesh__D005837
% 221.79/221.96  |- mesh__recordMaintainer mesh__D011467 jls
% 221.79/221.96  |- skos__prefLabel mesh__D011467 Prostate
% 221.79/221.96  |- mesh__recordAuthorizer mesh__D011467 jls
% 221.79/221.96  |- skos__annotation mesh__D011467
% 221.79/221.96       adenoma, hyperplasia %26% hypertrophy = PROSTATIC HYPERPLASIA; /surg: probably PROSTATECTOMY; inflammation = PROSTATITIS; PROSTATE-SPECIFIC ANTIGEN %28%a serine proteinase%29% is available: do not confuse with prostate-specific acid phosphatase %28% = PROSTATE + ACID PHOSPHATASE%29%%A%  
% 221.79/221.96  |- skos__related mesh__D011467smesh__D011468
% 221.79/221.96  |- mesh__dateRevised mesh__D011467 2004-07-30
% 221.79/221.96  |- skos__hiddenLabel mesh__D011467 Prostates
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D011467 2006
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D011467 2005A
% 221.79/221.96  |- mesh__activeMeSHYear mesh__D016950 2006
% 221.79/221.96  |- mesh__recordMaintainer mesh__D016950 SYSTEM
% 221.79/221.96  |- mesh__recordAuthorizer mesh__D016950 sjn
% 221.79/221.96  |- mesh__dateEstablished mesh__D016950 1992-01-01
% 221.79/221.99  |- skos__broader mesh__D016950smesh__D001884
% 221.79/221.99  |- mesh__dateRevised mesh__D016950 2005-06-30
% 221.79/221.99  |- skos__historyNote mesh__D016950 Bordetella %28%1966-1991%29%
% 221.79/221.99  |- skos__annotation mesh__D016950
% 221.79/221.99       infection: coord IM with BORDETELLA INFECTIONS %28%IM%29%   
% 221.79/221.99  |- mesh__historyNote mesh__D016950 92   
% 221.79/221.99  |- skos__scopeNote mesh__D016950
% 221.79/221.99       A species of BORDETELLA that is parasitic and pathogenic. It is found in the respiratory tract of domestic and wild mammalian animals and can be transmitted from animals to man. It is a common cause of bronchopneumonia in lower animals.%A%    
% 221.79/221.99  |- mesh__publicMeSHNote mesh__D016950 92   
% 221.79/221.99  |- rdf__type mesh__D016950sskos__Concept
% 221.79/221.99  |- skos__prefLabel mesh__D016950 Bordetella bronchiseptica
% 221.79/221.99  |- mesh__dateCreated mesh__D016950 1991-05-30
% 221.79/221.99  |- mesh__recordOriginator mesh__D016950 PXP
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002930 2004
% 221.79/221.99  |- mesh__dateCreated mesh__D002930 1976-05-19
% 221.79/221.99  |- skos__hiddenLabel mesh__D002930 Alkaloids, Cinchona
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002930 1996
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002930 2002
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002930 1993
% 221.79/221.99  |- skos__historyNote mesh__D002930 Cinchona %28%1966-1976%29%
% 221.79/221.99  |- rdf__type mesh__D002930sskos__Concept
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002930 1997
% 221.79/221.99  |- mesh__historyNote mesh__D002930 77   
% 221.79/221.99  |- mesh__recordOriginator mesh__D002930 RLS
% 221.79/221.99  |- skos__scopeNote mesh__D002930
% 221.79/221.99       Alkaloids extracted from various species of Cinchona.     
% 221.79/221.99  |- skos__broader mesh__D002930smesh__D000470
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002930 2005
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002930 2000
% 221.79/221.99  |- mesh__recordMaintainer mesh__D002930 TAP
% 221.79/221.99  |- mesh__dateEstablished mesh__D002930 1977-01-01
% 221.79/221.99  |- mesh__publicMeSHNote mesh__D002930 77   
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002930 1994
% 221.79/221.99  |- skos__prefLabel mesh__D002930 Cinchona Alkaloids
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002930 2006
% 221.79/221.99  |- mesh__recordAuthorizer mesh__D002930 PLS
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002930 2001
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002930 1998
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002930 2003
% 221.79/221.99  |- skos__annotation mesh__D002930
% 221.79/221.99       GEN or unspecified: prefer specific indentions   
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002930 1995
% 221.79/221.99  |- mesh__dateRevised mesh__D002930 1992-05-11
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002930 1999
% 221.79/221.99  |- rdf__type mesh__D002132sskos__Concept
% 221.79/221.99  |- skos__hiddenLabel mesh__D002132 Radioisotopes, Calcium
% 221.79/221.99  |- mesh__historyNote mesh__D002132 74   
% 221.79/221.99  |- skos__annotation mesh__D002132
% 221.79/221.99       Ca-37-39, 41, 45, 47, 49, 50; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002132 2002
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002132 1997
% 221.79/221.99  |- skos__scopeNote mesh__D002132
% 221.79/221.99       Unstable isotopes of calcium that decay or disintegrate emitting radiation. Ca atoms with atomic weights 39, 41, 45, 47, 49, and 50 are radioactive calcium isotopes.%A%    
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002132 1999
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002132 2004
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002132 2001
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002132 1996
% 221.79/221.99  |- mesh__dateCreated mesh__D002132 1999-01-01
% 221.79/221.99  |- skos__broader mesh__D002132smesh__D011868
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002132 2006
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002132 1995
% 221.79/221.99  |- mesh__recordAuthorizer mesh__D002132 PLS
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002132 1998
% 221.79/221.99  |- mesh__dateEstablished mesh__D002132 1974-01-01
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002132 2003
% 221.79/221.99  |- mesh__recordMaintainer mesh__D002132 TPW
% 221.79/221.99  |- mesh__onlineNote mesh__D002132 search CALCIUM ISOTOPES 1966-73   
% 221.79/221.99  |- skos__broader mesh__D002132smesh__D002127
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002132 1994
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002132 2005
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002132 2000
% 221.79/221.99  |- mesh__recordOriginator mesh__D002132 NLM
% 221.79/221.99  |- mesh__publicMeSHNote mesh__D002132 74   
% 221.79/221.99  |- skos__prefLabel mesh__D002132 Calcium Radioisotopes
% 221.79/221.99  |- mesh__dateRevised mesh__D002132 1993-06-04
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D015858 2004
% 221.79/221.99  |- mesh__historyNote mesh__D015858 90; was see REFRACTIVE ERRORS 1984-89   
% 221.79/221.99  |- mesh__dateCreated mesh__D015858 1989-05-25
% 221.79/221.99  |- skos__scopeNote mesh__D015858
% 221.79/221.99       A condition of an inequality of refractive power of the two eyes.%A%    
% 221.79/221.99  |- mesh__recordOriginator mesh__D015858 EGC
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D015858 2003
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D015858 2002
% 221.79/221.99  |- mesh__onlineNote mesh__D015858
% 221.79/221.99       use REFRACTIVE ERRORS to search ANISOMETROPIA 1984-89   
% 221.79/221.99  |- skos__broader mesh__D015858smesh__D012030
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D015858 2001
% 221.79/221.99  |- mesh__recordMaintainer mesh__D015858 KEV
% 221.79/221.99  |- skos__historyNote mesh__D015858 Refractive Errors %28%1966-1989%29%
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D015858 2006
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D015858 2000
% 221.79/221.99  |- mesh__dateRevised mesh__D015858 1999-11-03
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D015858 2005
% 221.79/221.99  |- skos__prefLabel mesh__D015858 Anisometropia
% 221.79/221.99  |- mesh__recordAuthorizer mesh__D015858 sjn
% 221.79/221.99  |- rdf__type mesh__D015858sskos__Concept
% 221.79/221.99  |- mesh__dateEstablished mesh__D015858 1990-01-01
% 221.79/221.99  |- mesh__publicMeSHNote mesh__D015858
% 221.79/221.99       90; was see REFRACTIVE ERRORS 1984-89   
% 221.79/221.99  |- skos__broader mesh__D008099Q000637smesh__D008099
% 221.79/221.99  |- mesh__preferredCombination mesh__D008099Q000637smesh__D016031
% 221.79/221.99  |- rdf__type mesh__D008099Q000637smesh__CompoundConcept
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D001838 1989
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D001838 1992
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D001838 1995
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D001838 2004
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D001838 1996
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D001838 1999
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D001838 1993
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D001838 2000
% 221.79/221.99  |- mesh__recordAuthorizer mesh__D001838 PLS
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D001838 1997
% 221.79/221.99  |- mesh__dateCreated mesh__D001838 1999-01-01
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D001838 2001
% 221.79/221.99  |- skos__broader mesh__D001838smesh__D013020
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D001838 1990
% 221.79/221.99  |- mesh__recordMaintainer mesh__D001838 PLS
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D001838 2002
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D001838 1991
% 221.79/221.99  |- rdf__type mesh__D001838sskos__Concept
% 221.79/221.99  |- mesh__recordOriginator mesh__D001838 NLM
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D001838 2005
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D001838 1994
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D001838 2006
% 221.79/221.99  |- skos__prefLabel mesh__D001838 Bolivia
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D001838 2003
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D001838 1998
% 221.79/221.99  |- mesh__dateRevised mesh__D001838 1991-11-02
% 221.79/221.99  |- skos__hiddenLabel mesh__D012560 Catatonic Schizophrenias
% 221.79/221.99  |- mesh__recordMaintainer mesh__D012560 JLS
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D012560 2005
% 221.79/221.99  |- skos__broader mesh__D012560smesh__D012559
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D012560 1999
% 221.79/221.99  |- rdf__type mesh__D012560sskos__Concept
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D012560 2002
% 221.79/221.99  |- skos__historyNote mesh__D012560 Schizophrenia %28%1966-1974%29%
% 221.79/221.99  |- skos__historyNote mesh__D012560 Catatonia %28%1966-1974%29%
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D012560 1998
% 221.79/221.99  |- skos__scopeNote mesh__D012560
% 221.79/221.99       A type of schizophrenia characterized by abnormality of motor behavior which may involve particular forms of stupor, rigidity, excitement or inappropriate posture.%A%    
% 221.79/221.99  |- mesh__recordAuthorizer mesh__D012560 SJN
% 221.79/221.99  |- skos__annotation mesh__D012560
% 221.79/221.99       /psychol permitted but consider SCHIZOPHRENIC PSYCHOLOGY %28%IM%29% if catatonic aspect is less relevant %28%NIM%29%%A%  
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D012560 2004
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D012560 2001
% 221.79/221.99  |- skos__prefLabel mesh__D012560 Schizophrenia, Catatonic
% 221.79/221.99  |- mesh__recordOriginator mesh__D012560 NLM
% 221.79/221.99  |- mesh__dateCreated mesh__D012560 1974-11-11
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D012560 2003
% 221.79/221.99  |- skos__hiddenLabel mesh__D012560 Schizophrenias, Catatonic
% 221.79/221.99  |- mesh__historyNote mesh__D012560 75   
% 221.79/221.99  |- mesh__dateEstablished mesh__D012560 1975-09-01
% 221.79/221.99  |- mesh__dateRevised mesh__D012560 1997-06-20
% 221.79/221.99  |- skos__altLabel mesh__D012560 Catatonic Schizophrenia
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D012560 2000
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D012560 2006
% 221.79/221.99  |- mesh__publicMeSHNote mesh__D012560 75   
% 221.79/221.99  |- mesh__recordAuthorizer mesh__D006523 sjn
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D006523 2006
% 221.79/221.99  |- skos__broader mesh__D006523smesh__D011041
% 221.79/221.99  |- skos__prefLabel mesh__D006523 Hepatitis, Toxic
% 221.79/221.99  |- skos__broader mesh__D006523smesh__D006505
% 221.79/221.99  |- skos__scopeNote mesh__D006523
% 221.79/221.99       INFLAMMATION of the LIVER due to hepatocellular toxicity, caused by drug metabolites and chemicals from the environment.%A%    
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D006523 2005
% 221.79/221.99  |- mesh__recordMaintainer mesh__D006523 lkt
% 221.79/221.99  |- skos__annotation mesh__D006523
% 221.79/221.99       coord IM with specific toxic agent /adv eff-pois-tox %28%IM%29%; chronic = HEPATITIS, CHRONIC, DRUG-INDUCED; HEPATITIS, ALCOHOLIC is also available%A%  
% 221.79/221.99  |- mesh__dateRevised mesh__D006523 2004-07-07
% 221.79/221.99  |- skos__altLabel mesh__D006523 Toxic Hepatitis
% 221.79/221.99  |- mesh__dateCreated mesh__D006523 1999-01-01
% 221.79/221.99  |- rdf__type mesh__D006523sskos__Concept
% 221.79/221.99  |- mesh__recordOriginator mesh__D006523 NLM
% 221.79/221.99  |- skos__hiddenLabel mesh__D011468 Retropubic Prostatectomies
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D011468 2003
% 221.79/221.99  |- skos__broader mesh__D011468smesh__D013521
% 221.79/221.99  |- mesh__dateRevised mesh__D011468 1999-11-08
% 221.79/221.99  |- skos__hiddenLabel mesh__D011468 Suprapubic Prostatectomies
% 221.79/221.99  |- skos__hiddenLabel mesh__D011468 Retropubic Prostatectomy
% 221.79/221.99  |- skos__hiddenLabel mesh__D011468 Prostatectomies, Suprapubic
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D011468 2002
% 221.79/221.99  |- mesh__recordMaintainer mesh__D011468 adp
% 221.79/221.99  |- skos__hiddenLabel mesh__D011468 Suprapubic Prostatectomy
% 221.79/221.99  |- skos__prefLabel mesh__D011468 Prostatectomy
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D011468 2006
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D011468 2001
% 221.79/221.99  |- mesh__recordOriginator mesh__D011468 NLM
% 221.79/221.99  |- mesh__recordAuthorizer mesh__D011468 sjn
% 221.79/221.99  |- rdf__type mesh__D011468sskos__Concept
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D011468 2005
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D011468 2000
% 221.79/221.99  |- mesh__dateCreated mesh__D011468 1999-01-01
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D011468 2004
% 221.79/221.99  |- skos__scopeNote mesh__D011468
% 221.79/221.99       Complete or partial surgical removal of the prostate. Three primary approaches are commonly employed: suprapubic - removal through an incision above the pubis and through the urinary bladder; retropubic - as for suprapubic but without entering the urinary bladder; and transurethral %28%TRANSURETHRAL RESECTION OF PROSTATE%29%.%A%    
% 221.79/221.99  |- skos__hiddenLabel mesh__D011468 Prostatectomies
% 221.79/221.99  |- skos__hiddenLabel mesh__D011468 Prostatectomies, Retropubic
% 221.79/221.99  |- skos__broader mesh__D016951smesh__D020563
% 221.79/221.99  |- skos__broader mesh__D016951smesh__D016946
% 221.79/221.99  |- mesh__recordAuthorizer mesh__D016951 sjn
% 221.79/221.99  |- skos__prefLabel mesh__D016951 Legionellaceae
% 221.79/221.99  |- mesh__historyNote mesh__D016951 92   
% 221.79/221.99  |- rdf__type mesh__D016951sskos__Concept
% 221.79/221.99  |- mesh__dateEstablished mesh__D016951 1992-01-01
% 221.79/221.99  |- mesh__dateCreated mesh__D016951 1991-05-30
% 221.79/221.99  |- mesh__dateRevised mesh__D016951 2005-06-30
% 221.79/221.99  |- mesh__recordOriginator mesh__D016951 PXP
% 221.79/221.99  |- skos__scopeNote mesh__D016951
% 221.79/221.99       A family of gram-negative, aerobic bacteria that do not form endospores or microcysts.%A%    
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D016951 2006
% 221.79/221.99  |- mesh__publicMeSHNote mesh__D016951 92   
% 221.79/221.99  |- mesh__recordMaintainer mesh__D016951 SYSTEM
% 221.79/221.99  |- skos__hiddenLabel mesh__D016153 Ochre Suppressor Gene
% 221.79/221.99  |- mesh__publicMeSHNote mesh__D016153
% 221.79/221.99       91; was see SUPPRESSION, GENETIC 1980-90; was heading 1970-79%A%  
% 221.79/221.99  |- skos__altLabel mesh__D016153 Ochre Suppressor Genes
% 221.79/221.99  |- skos__hiddenLabel mesh__D016153 Gene, Amber Suppressor
% 221.79/221.99  |- mesh__recordAuthorizer mesh__D016153 sjn
% 221.79/221.99  |- mesh__historyNote mesh__D016153
% 221.79/221.99       91; was see SUPPRESSION, GENETIC 1980-90; was heading 1968-79 %28%Prov 1968-69%29%%A%  
% 221.79/221.99  |- mesh__onlineNote mesh__D016153
% 221.79/221.99       use SUPPRESSION, GENETIC to search GENES, SUPPRESSOR 1968-90 %28%Prov 1968-69%29%%A%  
% 221.79/221.99  |- skos__hiddenLabel mesh__D016153 Suppressor Gene, Frameshift
% 221.79/221.99  |- rdf__type mesh__D016153sskos__Concept
% 221.79/221.99  |- skos__hiddenLabel mesh__D016153 Suppressor Gene, Second-Site
% 221.79/221.99  |- skos__hiddenLabel mesh__D016153 Amber Suppressor Gene
% 221.79/221.99  |- skos__hiddenLabel mesh__D016153 Suppressor Genes, Amber
% 221.79/221.99  |- mesh__recordOriginator mesh__D016153 AGS
% 221.79/221.99  |- mesh__dateEstablished mesh__D016153 1991-01-01
% 221.79/221.99  |- skos__hiddenLabel mesh__D016153 Suppressor Genes, Frameshift
% 221.79/221.99  |- skos__hiddenLabel mesh__D016153 Gene, Suppressor
% 221.79/221.99  |- skos__hiddenLabel mesh__D016153 Second-Site Suppressor Gene
% 221.79/221.99  |- skos__hiddenLabel mesh__D016153 Suppressor Gene, Amber
% 221.79/221.99  |- skos__historyNote mesh__D016153 Genes, Suppressor %28%1968-1979%29%
% 221.79/221.99  |- skos__hiddenLabel mesh__D016153 Frameshift Suppressor Gene
% 221.79/221.99  |- skos__hiddenLabel mesh__D016153 Gene, Ochre Suppressor
% 221.79/221.99  |- skos__altLabel mesh__D016153 Nonsense Mutation Suppressor Genes
% 221.79/221.99  |- skos__prefLabel mesh__D016153 Genes, Suppressor
% 221.79/221.99  |- skos__annotation mesh__D016153
% 221.79/221.99       GENES, TUMOR SUPPRESSOR is also available; see MeSH definition; for genes involved in suppression of a physiologic process, index the physiologic process /genet + specific gene if pertinent %28%genes involved in memory suppression = MEMORY /genet + specific gene term if pertinent but not GENES, SUPPRESSOR%29%%A%  
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D016153 2006
% 221.79/221.99  |- skos__historyNote mesh__D016153 Suppression, Genetic %28%1980-1990%29%
% 221.79/221.99  |- mesh__recordMaintainer mesh__D016153 nns
% 221.79/221.99  |- skos__altLabel mesh__D016153 Suppressor Genes
% 221.79/221.99  |- skos__hiddenLabel mesh__D016153 Suppressor Gene, Ochre
% 221.79/221.99  |- skos__altLabel mesh__D016153 Frameshift Suppressor Genes
% 221.79/221.99  |- skos__hiddenLabel mesh__D016153 Suppressor Gene
% 221.79/221.99  |- skos__scopeNote mesh__D016153
% 221.79/221.99       Genes that have a suppressor allele or suppressor mutation %28%SUPPRESSION, GENETIC%29% which cancels the effect of a previous mutation, enabling the wild-type phenotype to be maintained or partially restored.%A%    
% 221.79/221.99  |- skos__hiddenLabel mesh__D016153 Genes, Second Site Suppressor
% 221.79/221.99  |- skos__broader mesh__D016153smesh__D005796
% 221.79/221.99  |- skos__hiddenLabel mesh__D016153 Gene, Frameshift Suppressor
% 221.79/221.99  |- skos__altLabel mesh__D016153 Genes, Second-Site Suppressor
% 221.79/221.99  |- mesh__dateCreated mesh__D016153 1990-06-06
% 221.79/221.99  |- skos__hiddenLabel mesh__D016153 Suppressor Genes, Second-Site
% 221.79/221.99  |- skos__altLabel mesh__D016153 Second-Site Suppressor Genes
% 221.79/221.99  |- skos__related mesh__D016153smesh__D013489
% 221.79/221.99  |- skos__hiddenLabel mesh__D016153 Suppressor Genes, Ochre
% 221.79/221.99  |- skos__hiddenLabel mesh__D016153 Second Site Suppressor Genes
% 221.79/221.99  |- skos__altLabel mesh__D016153 Amber Suppressor Genes
% 221.79/221.99  |- mesh__dateRevised mesh__D016153 2005-06-30
% 221.79/221.99  |- skos__hiddenLabel mesh__D016153 Gene, Second-Site Suppressor
% 221.79/221.99  |- skos__broader mesh__D004622Q000254smesh__D004622
% 221.79/221.99  |- mesh__preferredCombination mesh__D004622Q000254smesh__D047108
% 221.79/221.99  |- rdf__type mesh__D004622Q000254smesh__CompoundConcept
% 221.79/221.99  |- mesh__recordAuthorizer mesh__D002133 sjn
% 221.79/221.99  |- mesh__dateCreated mesh__D002133 1999-01-01
% 221.79/221.99  |- mesh__onlineNote mesh__D002133
% 221.79/221.99       use CALCIUM SULFATE to search PLASTER OF PARIS 1966-79   
% 221.79/221.99  |- skos__altLabel mesh__D002133 Artificial Dental Stone
% 221.79/221.99  |- skos__broader mesh__D002133smesh__D008903
% 221.79/221.99  |- skos__altLabel mesh__D002133 Stone, Artificial Dental
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002133 2006
% 221.79/221.99  |- mesh__publicMeSHNote mesh__D002133
% 221.79/221.99       80; PLASTER OF PARIS was heading 1963-79   
% 221.79/221.99  |- skos__scopeNote mesh__D002133
% 221.79/221.99       A calcium salt that is used for a variety of purposes including: building materials, as a desiccant, in dentistry as an impression material, cast, or die, and in medicine for immobilizing casts and as a tablet excipient. It exists in various forms and states of hydration. Plaster of Paris is a mixture of powdered and heat-treated gypsum.%A%    
% 221.79/221.99  |- skos__prefLabel mesh__D002133 Calcium Sulfate
% 221.79/221.99  |- skos__hiddenLabel mesh__D002133 Sulfate, Calcium
% 221.79/221.99  |- mesh__recordOriginator mesh__D002133 NLM
% 221.79/221.99  |- skos__altLabel mesh__D002133 Gypsum, Dental
% 221.79/221.99  |- skos__hiddenLabel mesh__D002133 Sulphate, Calcium
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D002133 2005
% 221.79/221.99  |- skos__hiddenLabel mesh__D002133 Lime Anhydrous Sulfate
% 221.79/221.99  |- skos__altLabel mesh__D002133 Anhydrous Sulfate of Lime
% 221.79/221.99  |- skos__altLabel mesh__D002133 Dental Stone, Artificial
% 221.79/221.99  |- mesh__dateRevised mesh__D002133 2004-07-19
% 221.79/221.99  |- skos__altLabel mesh__D002133 Calcium Sulphate
% 221.79/221.99  |- skos__broader mesh__D002133smesh__D017610
% 221.79/221.99  |- rdf__type mesh__D002133sskos__Concept
% 221.79/221.99  |- skos__altLabel mesh__D002133 Calcium Sulfate, Dihydrate
% 221.79/221.99  |- skos__hiddenLabel mesh__D002133 Paris Plaster
% 221.79/221.99  |- mesh__historyNote mesh__D002133
% 221.79/221.99       80; PLASTER OF PARIS was heading 1963-79   
% 221.79/221.99  |- skos__hiddenLabel mesh__D002133 Anhydrous Calcium Sulfate
% 221.79/221.99  |- skos__broader mesh__D002133smesh__D013431
% 221.79/221.99  |- skos__hiddenLabel mesh__D002133 Dihydrate Calcium Sulfate
% 221.79/221.99  |- skos__hiddenLabel mesh__D002133 Hemihydrate Calcium Sulfate
% 221.79/221.99  |- mesh__recordMaintainer mesh__D002133 jls
% 221.79/221.99  |- skos__prefLabel mesh__D026581 Isoaspartic Acid
% 221.79/221.99  |- mesh__dateCreated mesh__D026581 2001-07-25
% 221.79/221.99  |- skos__scopeNote mesh__D026581
% 221.79/221.99       An ASPARTIC ACID residue in polypeptide chains that is linked at the beta-carboxyl group instead of at the normal, alpha-carboxyl group, polypeptide linkage. It is a result of the spontaneous decomposition of aspartic acid or ASPARAGINE residues.%A%    
% 221.79/221.99  |- skos__altLabel mesh__D026581 beta-Aspartic Acid
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D026581 2005
% 221.79/221.99  |- skos__hiddenLabel mesh__D026581 beta Aspartate
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D026581 2003
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D026581 2006
% 221.79/221.99  |- mesh__historyNote mesh__D026581 2002; use ASPARTIC ACID 1993-2001   
% 221.79/221.99  |- skos__historyNote mesh__D026581 Aspartic Acid %28%1984-2001%29%
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D026581 2004
% 221.79/221.99  |- skos__hiddenLabel mesh__D026581 beta Aspartic Acid
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D026581 2002
% 221.79/221.99  |- mesh__dateEstablished mesh__D026581 2002-01-01
% 221.79/221.99  |- rdf__type mesh__D026581sskos__Concept
% 221.79/221.99  |- mesh__publicMeSHNote mesh__D026581 2002; see ASPARTIC ACID 1993-2001   
% 221.79/221.99  |- skos__broader mesh__D026581smesh__D001224
% 221.79/221.99  |- skos__altLabel mesh__D026581 beta-Aspartate
% 221.79/221.99  |- rdf__type mesh__D001839sskos__Concept
% 221.79/221.99  |- skos__prefLabel mesh__D001839 Bombesin
% 221.79/221.99  |- mesh__recordOriginator mesh__D001839 NLM
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D001839 2006
% 221.79/221.99  |- mesh__publicMeSHNote mesh__D001839 86; was see under PEPTIDES 1975-85   
% 221.79/221.99  |- skos__broader mesh__D001839smesh__D009479
% 221.79/221.99  |- skos__historyNote mesh__D001839 Anura %28%1966-1974%29%
% 221.79/221.99  |- mesh__recordAuthorizer mesh__D001839 sjn
% 221.79/221.99  |- mesh__historyNote mesh__D001839
% 221.79/221.99       86%28%75%29%; was see under PEPTIDES 1975-85   
% 221.79/221.99  |- mesh__dateCreated mesh__D001839 1974-11-11
% 221.79/221.99  |- mesh__dateEstablished mesh__D001839 1986-01-01
% 221.79/221.99  |- skos__altLabel mesh__D001839 Bombesin 14
% 221.79/221.99  |- skos__hiddenLabel mesh__D001839 Dihydrochloride, Bombesin
% 221.79/221.99  |- skos__scopeNote mesh__D001839
% 221.79/221.99       A tetradecapeptide originally obtained from the skins of toads Bombina bombina and B. variegata. It is also an endogenous neurotransmitter in many animals including mammals. Bombesin affects vascular and other smooth muscle, gastric secretion, and renal circulation and function.%A%    
% 221.79/221.99  |- skos__related mesh__D001839smesh__D018004
% 221.79/221.99  |- skos__historyNote mesh__D001839 Peptides %28%1966-1974%29%
% 221.79/221.99  |- skos__broader mesh__D001839smesh__D036361
% 221.79/221.99  |- skos__broader mesh__D001839smesh__D000664
% 221.79/221.99  |- mesh__recordMaintainer mesh__D001839 ssb
% 221.79/221.99  |- mesh__dateRevised mesh__D001839 2005-06-30
% 221.79/221.99  |- rdf__type mesh__D012561sskos__Concept
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D012561 2000
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D012561 1998
% 221.79/221.99  |- skos__prefLabel mesh__D012561 Schizophrenia, Childhood
% 221.79/221.99  |- mesh__recordMaintainer mesh__D012561 JLS
% 221.79/221.99  |- skos__hiddenLabel mesh__D012561 Schizophrenias, Childhood
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D012561 2004
% 221.79/221.99  |- mesh__dateCreated mesh__D012561 1999-01-01
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D012561 2002
% 221.79/221.99  |- skos__annotation mesh__D012561
% 221.79/221.99       obsolete concept, historical; do not use for schizophrenia in a child; /psychol permitted but consider SCHIZOPHRENIC PSYCHOLOGY %28%IM%29% if juvenile aspect is less relevant %28%NIM%29%%A%  
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D012561 2003
% 221.79/221.99  |- mesh__recordAuthorizer mesh__D012561 SJN
% 221.79/221.99  |- skos__altLabel mesh__D012561 Childhood Schizophrenia
% 221.79/221.99  |- skos__hiddenLabel mesh__D012561 Childhood Schizophrenias
% 221.79/221.99  |- mesh__dateRevised mesh__D012561 1997-07-03
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D012561 2006
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D012561 2001
% 221.79/221.99  |- skos__broader mesh__D012561smesh__D002659
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D012561 2005
% 221.79/221.99  |- mesh__recordOriginator mesh__D012561 NLM
% 221.79/221.99  |- skos__scopeNote mesh__D012561
% 221.79/221.99       An obsolete concept, historically used for childhood mental disorders thought to be a form of schizophrenia.%A%    
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D012561 1999
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D006524 2006
% 221.79/221.99  |- mesh__activeMeSHYear mesh__D006524 2005
% 221.79/221.99  |- mesh__recordAuthorizer mesh__D006524 sjn
% 221.79/221.99  |- mesh__recordOriginator mesh__D006524 FPG
% 221.79/221.99  |- mesh__historyNote mesh__D006524 77   
% 221.79/221.99  |- mesh__dateRevised mesh__D006524 2004-07-07
% 221.79/221.99  |- mesh__dateCreated mesh__D006524 1976-04-27
% 221.79/222.00  |- skos__broader mesh__D006524smesh__D006520
% 221.79/222.00  |- mesh__recordMaintainer mesh__D006524 lkt
% 221.79/222.00  |- rdf__type mesh__D006524sskos__Concept
% 221.79/222.00  |- skos__historyNote mesh__D006524 Hepatitis, Animal %28%1966-1976%29%
% 221.79/222.00  |- mesh__dateEstablished mesh__D006524 1977-01-01
% 221.79/222.00  |- skos__prefLabel mesh__D006524 Hepatitis, Viral, Animal
% 221.79/222.00  |- skos__annotation mesh__D006524
% 221.79/222.00       not restricted to hepatitis caused by hepatitis viruses: use also for hepatitis caused by other viruses; exper or vet but do not use /vet; don%27%t forget to check tag ANIMALS%A%  
% 221.79/222.00  |- skos__broader mesh__D006524smesh__D014777
% 221.79/222.00  |- skos__scopeNote mesh__D006524
% 221.79/222.00       INFLAMMATION of the LIVER in animals due to viral infection.%A%    
% 221.79/222.00  |- mesh__publicMeSHNote mesh__D006524 77   
% 221.79/222.00  |- skos__broader mesh__D050680smesh__D014157
% 221.79/222.00  |- mesh__dateCreated mesh__D050680 2005-06-30
% 221.79/222.00  |- skos__annotation mesh__D050680 see SCR for organism-specific terms   
% 221.79/222.00  |- skos__hiddenLabel mesh__D050680 Transcription Factor, DRTF1a
% 221.79/222.00  |- skos__altLabel mesh__D050680 E2F Dimerization Partner 1
% 221.79/222.00  |- skos__hiddenLabel mesh__D050680 Transcription Factor, DRTF1c
% 221.79/222.00  |- skos__hiddenLabel mesh__D050680 DRTF1, Transcription Factor
% 221.79/222.00  |- skos__historyNote mesh__D050680 Cell Cycle Proteins %28%1993-2005%29%
% 221.79/222.00  |- mesh__recordOriginator mesh__D050680 DRC
% 221.79/222.00  |- skos__hiddenLabel mesh__D050680 Transcription Factor, DRTF1
% 221.79/222.00  |- skos__hiddenLabel mesh__D050680 Transcription Factor DP 1
% 221.79/222.00  |- skos__historyNote mesh__D050680 Transcription Factors %28%1993-2005%29%
% 221.79/222.00  |- skos__hiddenLabel mesh__D050680 Transcription Factor, DRTF1b
% 221.79/222.00  |- skos__hiddenLabel mesh__D050680 Transcription Factor, DP-1
% 221.79/222.00  |- skos__hiddenLabel mesh__D050680 Factor DP-1, Transcription
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D050680 2006
% 221.79/222.00  |- mesh__recordMaintainer mesh__D050680 DRC
% 221.79/222.00  |- mesh__historyNote mesh__D050680 2006%28%1997%29%   
% 221.79/222.00  |- skos__prefLabel mesh__D050680 Transcription Factor DP1
% 221.79/222.00  |- skos__altLabel mesh__D050680 DP1 Protein
% 221.79/222.00  |- skos__scopeNote mesh__D050680
% 221.79/222.00       A transcription factor that possesses DNA-binding and E2F-binding domains but lacks a transcriptional activation domain. It is a binding partner for E2F TRANSCRIPTION FACTORS and enhances the DNA binding and transactivation function of the DP-E2F complex.%A%    
% 221.79/222.00  |- mesh__recordAuthorizer mesh__D050680 sjn
% 221.79/222.00  |- mesh__publicMeSHNote mesh__D050680
% 221.79/222.00       2006; TRANSCRIPTION FACTOR DP1 was indexed under CELL CYCLE PROTEINS %26% TRANSCRIPTION FACTORS 1997-2005%A%  
% 221.79/222.00  |- skos__altLabel mesh__D050680 Transcription Factor DP-1
% 221.79/222.00  |- skos__altLabel mesh__D050680 DP-1 Transcription Factor
% 221.79/222.00  |- rdf__type mesh__D050680sskos__Concept
% 221.79/222.00  |- skos__hiddenLabel mesh__D050680 DP1, Transcription Factor
% 221.79/222.00  |- skos__altLabel mesh__D050680 DRTF1 Transcription Factor
% 221.79/222.00  |- mesh__dateEstablished mesh__D050680 2006-01-01
% 221.79/222.00  |- skos__altLabel mesh__D050680 TFDP1 Protein
% 221.79/222.00  |- skos__altLabel mesh__D050680 Transcription Factor DRTF1
% 221.79/222.00  |- skos__altLabel mesh__D050680 Dimerization Partner 1 Protein
% 221.79/222.00  |- skos__historyNote mesh__D044643 beta-Glucosidase %28%1981-2003%29%
% 221.79/222.00  |- mesh__dateEstablished mesh__D044643 2004-01-01
% 221.79/222.00  |- mesh__dateCreated mesh__D044643 2003-07-09
% 221.79/222.00  |- skos__altLabel mesh__D044643 Exo-1,4-beta-Glucosidase
% 221.79/222.00  |- skos__hiddenLabel mesh__D044643 1,4-beta-Glucosidase, Glucan
% 221.79/222.00  |- mesh__publicMeSHNote mesh__D044643
% 221.79/222.00       2004; EXO-1,4-BETA-GLUCOSIDASE was indexed under BETA-GLUCOSIDASE 1981-2003%A%  
% 221.79/222.00  |- skos__prefLabel mesh__D044643 Glucan 1,4-beta-Glucosidase
% 221.79/222.00  |- skos__altLabel mesh__D044643 Exo-beta-1,4-Glucanase
% 221.79/222.00  |- skos__hiddenLabel mesh__D044643 Glucohydrolase, 1,4-beta-D-Glucan
% 221.79/222.00  |- skos__hiddenLabel mesh__D044643 Glucan 1,4 beta Glucosidase
% 221.79/222.00  |- skos__hiddenLabel mesh__D044643 1,4 beta D Glucan Glucohydrolase
% 221.79/222.00  |- skos__altLabel mesh__D044643 1,4-beta-D-Glucan Glucohydrolase
% 221.79/222.00  |- skos__hiddenLabel mesh__D044643 Exo beta 1,4 Glucanase
% 221.79/222.00  |- rdf__type mesh__D044643sskos__Concept
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D044643 2006
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D044643 2004
% 221.79/222.00  |- skos__broader mesh__D044643smesh__D044602
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D044643 2005
% 221.79/222.00  |- skos__hiddenLabel mesh__D044643 Exo 1,4 beta Glucosidase
% 221.79/222.00  |- mesh__historyNote mesh__D044643
% 221.79/222.00       2004; use EXO-1,4-BETA-GLUCOSIDASE %28%NM%29% 1981-2003   
% 221.79/222.00  |- skos__scopeNote mesh__D044643
% 221.79/222.00       An exocellulase with specificity for the hydrolysis of 1,4-beta-glucosidic linkages of 1,4-beta-D-glucans resulting in successive removal of GLUCOSE units.%A%    
% 221.79/222.00  |- skos__altLabel mesh__D044643 beta-%28%1-4%29%-Glucanase
% 221.79/222.00  |- mesh__recordAuthorizer mesh__D011469 SJN
% 221.79/222.00  |- mesh__dateEstablished mesh__D011469 1966-01-01
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D011469 2006
% 221.79/222.00  |- skos__hiddenLabel mesh__D011469 Diseases, Prostatic
% 221.79/222.00  |- mesh__dateRevised mesh__D011469 1997-06-20
% 221.79/222.00  |- rdf__type mesh__D011469sskos__Concept
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D011469 2005
% 221.79/222.00  |- skos__prefLabel mesh__D011469 Prostatic Diseases
% 221.79/222.00  |- mesh__dateCreated mesh__D011469 1999-01-01
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D011469 2002
% 221.79/222.00  |- skos__broader mesh__D011469smesh__D005832
% 221.79/222.00  |- skos__annotation mesh__D011469 inflamm dis = PROSTATITIS   
% 221.79/222.00  |- skos__hiddenLabel mesh__D011469 Disease, Prostatic
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D011469 2004
% 221.79/222.00  |- mesh__recordMaintainer mesh__D011469 TGC
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D011469 1999
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D011469 2001
% 221.79/222.00  |- mesh__publicMeSHNote mesh__D011469 66   
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D011469 2003
% 221.79/222.00  |- mesh__historyNote mesh__D011469 66   
% 221.79/222.00  |- mesh__recordOriginator mesh__D011469 NLM
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D011469 1998
% 221.79/222.00  |- skos__hiddenLabel mesh__D011469 Prostatic Disease
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D011469 2000
% 221.79/222.00  |- mesh__historyNote mesh__D016952 92   
% 221.79/222.00  |- mesh__dateRevised mesh__D016952 2005-06-30
% 221.79/222.00  |- rdf__type mesh__D016952sskos__Concept
% 221.79/222.00  |- skos__annotation mesh__D016952 infection = LEGIONNAIRES%27% DISEASE   
% 221.79/222.00  |- mesh__publicMeSHNote mesh__D016952 92   
% 221.79/222.00  |- skos__prefLabel mesh__D016952 Legionella pneumophila
% 221.79/222.00  |- mesh__dateCreated mesh__D016952 1991-05-30
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D016952 2006
% 221.79/222.00  |- mesh__recordOriginator mesh__D016952 PXP
% 221.79/222.00  |- skos__historyNote mesh__D016952 Bacteria %28%1978-1980%29%
% 221.79/222.00  |- skos__scopeNote mesh__D016952
% 221.79/222.00       A species of gram-negative, aerobic bacteria that is the causative agent of LEGIONNAIRES%27% DISEASE. It has been isolated from numerous environmental sites as well as from human lung tissue, respiratory secretions, and blood.%A%    
% 221.79/222.00  |- mesh__recordAuthorizer mesh__D016952 sjn
% 221.79/222.00  |- skos__broader mesh__D016952smesh__D007875
% 221.79/222.00  |- mesh__dateEstablished mesh__D016952 1992-01-01
% 221.79/222.00  |- mesh__recordMaintainer mesh__D016952 SYSTEM
% 221.79/222.00  |- skos__historyNote mesh__D016952 Legionella %28%1981-1991%29%
% 221.79/222.00  |- skos__broader mesh__D016154smesh__D004066
% 221.79/222.00  |- skos__scopeNote mesh__D016154
% 221.79/222.00       An abnormal passage communicating between any components of the digestive system, or between any part of the digestive system and surrounding organ%28%s%29%.%A%    
% 221.79/222.00  |- mesh__dateRevised mesh__D016154 2003-07-09
% 221.79/222.00  |- skos__hiddenLabel mesh__D016154 Fistulas, Digestive System
% 221.79/222.00  |- skos__historyNote mesh__D016154 specific fistula %28%1966-1997%29%
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D016154 2005
% 221.79/222.00  |- mesh__dateEstablished mesh__D016154 1998-01-01
% 221.79/222.00  |- skos__hiddenLabel mesh__D016154 Fistula, Digestive System
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D016154 2006
% 221.79/222.00  |- skos__prefLabel mesh__D016154 Digestive System Fistula
% 221.79/222.00  |- mesh__publicMeSHNote mesh__D016154 98   
% 221.79/222.00  |- mesh__recordOriginator mesh__D016154 TGC
% 221.79/222.00  |- skos__hiddenLabel mesh__D016154 Digestive System Fistulas
% 221.79/222.00  |- rdf__type mesh__D016154sskos__Concept
% 221.79/222.00  |- mesh__recordMaintainer mesh__D016154 lkt
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D016154 2004
% 221.79/222.00  |- skos__broader mesh__D016154smesh__D005402
% 221.79/222.00  |- skos__annotation mesh__D016154
% 221.79/222.00       GEN or unspecified; prefer specifics; fistula policy: Manual 23.19+%A%  
% 221.79/222.00  |- skos__historyNote mesh__D016154 Fistula %28%1966-1997%29%
% 221.79/222.00  |- mesh__recordAuthorizer mesh__D016154 sjn
% 221.79/222.00  |- mesh__historyNote mesh__D016154 98; use explode 1991-97   
% 221.79/222.00  |- mesh__dateCreated mesh__D016154 1990-04-24
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D002932 1999
% 221.79/222.00  |- mesh__recordAuthorizer mesh__D002932 SJN
% 221.79/222.00  |- mesh__publicMeSHNote mesh__D002932 66   
% 221.79/222.00  |- mesh__recordOriginator mesh__D002932 NLM
% 221.79/222.00  |- skos__prefLabel mesh__D002932 Cineangiography
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D002932 2002
% 221.79/222.00  |- skos__broader mesh__D002932smesh__D002933
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D002932 1998
% 221.79/222.00  |- mesh__historyNote mesh__D002932 66%28%64%29%   
% 221.79/222.00  |- mesh__dateRevised mesh__D002932 1997-06-20
% 221.79/222.00  |- rdf__type mesh__D002932sskos__Concept
% 221.79/222.00  |- skos__scopeNote mesh__D002932
% 221.79/222.00       Motion pictures of the passage of contrast medium through blood vessels.%A%    
% 221.79/222.00  |- skos__hiddenLabel mesh__D002932 Cineangiographies
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D002932 2001
% 221.79/222.00  |- mesh__recordMaintainer mesh__D002932 PXP
% 221.79/222.00  |- mesh__dateEstablished mesh__D002932 1966-01-01
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D002932 2006
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D002932 2000
% 221.79/222.00  |- skos__broader mesh__D002932smesh__D000792
% 221.79/222.00  |- skos__annotation mesh__D002932
% 221.79/222.00       /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: CINEANGIOGR%A%  
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D002932 2004
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D002932 2005
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D002932 2003
% 221.79/222.00  |- mesh__dateCreated mesh__D002932 1999-01-01
% 221.79/222.00  |- skos__broader mesh__D001769Q000166smesh__D001769
% 221.79/222.00  |- mesh__preferredCombination mesh__D001769Q000166smesh__D001773
% 221.79/222.00  |- rdf__type mesh__D001769Q000166smesh__CompoundConcept
% 221.79/222.00  |- skos__scopeNote mesh__D002134
% 221.79/222.00       A protein that plays a fundamental role in the Vitamin D mediated transport of calcium in reptiles, amphibians, birds and mammals. It is found in the intestine, kidneys, egg shell gland, brain, and possibly other organs. Its molecular weight is species dependent.%A%    
% 221.79/222.00  |- mesh__dateRevised mesh__D002134 2005-06-30
% 221.79/222.00  |- skos__altLabel mesh__D002134 IMCal
% 221.79/222.00  |- skos__prefLabel mesh__D002134
% 221.79/222.00       Calcium-Binding Protein, Vitamin D-Dependent
% 221.79/222.00  |- skos__annotation mesh__D002134 /biosyn /physiol permitted; DF: CABP   
% 221.79/222.00  |- skos__altLabel mesh__D002134
% 221.79/222.00       Calcium Binding Protein, Vitamin D Dependent
% 221.79/222.00  |- mesh__recordAuthorizer mesh__D002134 sjn
% 221.79/222.00  |- mesh__recordMaintainer mesh__D002134 SYSTEM
% 221.79/222.00  |- skos__hiddenLabel mesh__D002134
% 221.79/222.00       Intestinal Membrane Calcium Binding Protein
% 221.79/222.00  |- mesh__historyNote mesh__D002134
% 221.79/222.00       87%28%79%29%; was see under CALCIUM-BINDING PROTEINS 1980-86, was see under CARRIER PROTEINS 1979%A%  
% 221.79/222.00  |- rdf__type mesh__D002134sskos__Concept
% 221.79/222.00  |- mesh__dateCreated mesh__D002134 1978-03-08
% 221.79/222.00  |- skos__historyNote mesh__D002134 Vitamin D %28%1966-1978%29%
% 221.79/222.00  |- skos__altLabel mesh__D002134 Vitamin D-Dependent Calcium-Binding Protein
% 221.79/222.00  |- skos__hiddenLabel mesh__D002134
% 221.79/222.00       Vitamin D Dependent Calcium Binding Protein
% 221.79/222.00  |- mesh__recordOriginator mesh__D002134 RLS
% 221.79/222.00  |- skos__historyNote mesh__D002134 Carrier Proteins %28%1971-1978%29%
% 221.79/222.00  |- skos__altLabel mesh__D002134 Cholecalcin
% 221.79/222.00  |- skos__broader mesh__D002134smesh__D002135
% 221.79/222.00  |- mesh__publicMeSHNote mesh__D002134
% 221.79/222.00       87; was see under CALCIUM-BINDING PROTEINS 1980-86, was see under CARRIER PROTEINS 1979%A%  
% 221.79/222.00  |- skos__historyNote mesh__D002134 Calcium %28%1966-1978%29%
% 221.79/222.00  |- mesh__dateEstablished mesh__D002134 1987-01-01
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D002134 2006
% 221.79/222.00  |- skos__historyNote mesh__D002134 Protein Binding %28%1966-1978%29%
% 221.79/222.00  |- mesh__dateCreated mesh__D012562 1999-01-01
% 221.79/222.00  |- mesh__dateRevised mesh__D012562 1997-06-20
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D012562 2000
% 221.79/222.00  |- skos__hiddenLabel mesh__D012562 Schizophrenias, Hebephrenic
% 221.79/222.00  |- mesh__onlineNote mesh__D012562
% 221.79/222.00       use SCHIZOPHRENIA, DISORGANIZED to search SCHIZOPHRENIA, HEBEPHRENIC 1972-80 %28%as Prov 1972%29%%A%  
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D012562 2003
% 221.79/222.00  |- mesh__historyNote mesh__D012562
% 221.79/222.00       81; was SCHIZOPHRENIA, HEBEPHRENIC 1972-80 %28%Prov 1972%29%   
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D012562 2001
% 221.79/222.00  |- mesh__dateEstablished mesh__D012562 1973-01-01
% 221.79/222.00  |- skos__hiddenLabel mesh__D012562 Disorganized Schizophrenia
% 221.79/222.00  |- skos__hiddenLabel mesh__D012562 Hebephrenic Schizophrenias
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D012562 2004
% 221.79/222.00  |- mesh__recordOriginator mesh__D012562 NLM
% 221.79/222.00  |- skos__annotation mesh__D012562
% 221.79/222.00       /psychol permitted but consider SCHIZOPHRENIC PSYCHOLOGY %28%IM%29% if hebephrenic aspect is less relevant %28%NIM%29%%A%  
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D012562 2002
% 221.79/222.00  |- skos__prefLabel mesh__D012562 Schizophrenia, Disorganized
% 221.79/222.00  |- skos__historyNote mesh__D012562 Schizophrenia %28%1966-1971%29%
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D012562 2005
% 221.79/222.00  |- mesh__recordAuthorizer mesh__D012562 SJN
% 221.79/222.00  |- skos__hiddenLabel mesh__D012562 Disorganized Schizophrenias
% 221.79/222.00  |- skos__broader mesh__D012562smesh__D012559
% 221.79/222.00  |- skos__altLabel mesh__D012562 Hebephrenic Schizophrenia
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D012562 2006
% 221.79/222.00  |- skos__altLabel mesh__D012562 Schizophrenia, Hebephrenic
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D012562 1998
% 221.79/222.00  |- skos__scopeNote mesh__D012562
% 221.79/222.00       A type of schizophrenia characterized by frequent incoherence; marked loosening of associations, or grossly disorganized behavior and flat or grossly inappropriate affect that does not meet the criteria for the catatonic type; associated features include extreme social withdrawal, grimacing, mannerisms, mirror gazing, inappropriate giggling, and other odd behavior. %28%Dorland, 27th ed%29%%A%    
% 221.79/222.00  |- mesh__publicMeSHNote mesh__D012562
% 221.79/222.00       81; was SCHIZOPHRENIA, HEBEPHRENIC 1973-80   
% 221.79/222.00  |- mesh__recordMaintainer mesh__D012562 JLS
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D012562 1999
% 221.79/222.00  |- rdf__type mesh__D012562sskos__Concept
% 221.79/222.00  |- skos__hiddenLabel mesh__D012562 Schizophrenias, Disorganized
% 221.79/222.00  |- skos__historyNote mesh__D006525 Hepatitis A %28%1966-1976%29%
% 221.79/222.00  |- mesh__dateCreated mesh__D006525 1976-04-27
% 221.79/222.00  |- mesh__publicMeSHNote mesh__D006525
% 221.79/222.00       77; HEPATITIS, VIRAL, NON-A, NON-B was heading 1980-91 %28%see under HEPATITIS, VIRAL, HUMAN 1980-90%29%, was see HEPATITIS C 1992-93%A%  
% 221.79/222.00  |- skos__scopeNote mesh__D006525
% 221.79/222.00       INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission %28%HEPATITIS A; HEPATITIS E%29% or blood transfusion %28%HEPATITIS B; HEPATITIS C; and HEPATITIS D%29%.%A%    
% 221.79/222.00  |- skos__broader mesh__D006525smesh__D014777
% 221.79/222.00  |- rdf__type mesh__D006525sskos__Concept
% 221.79/222.00  |- mesh__recordOriginator mesh__D006525 FPG
% 221.79/222.00  |- mesh__recordMaintainer mesh__D006525 sjn
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D006525 2006
% 221.79/222.00  |- mesh__recordAuthorizer mesh__D006525 sjn
% 221.79/222.00  |- mesh__dateRevised mesh__D006525 2004-07-13
% 221.79/222.00  |- mesh__historyNote mesh__D006525
% 221.79/222.00       77; HEPATITIS, VIRAL, NON-A, NON-B was heading 1980-91 %28%see under HEPATITIS, VIRAL, HUMAN 1980-90%29%, was see HEPATITIS C 1992-93%A%  
% 221.79/222.00  |- skos__annotation mesh__D006525
% 221.79/222.00       coordinate IM with pre-coordinated virus disease term %28%IM%29% but note specific viral hepatitis terms%A%  
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D006525 2005
% 221.79/222.00  |- skos__prefLabel mesh__D006525 Hepatitis, Viral, Human
% 221.79/222.00  |- mesh__onlineNote mesh__D006525
% 221.79/222.00       use HEPATITIS C to search HEPATITIS, VIRAL, NON-A, NON-B 1980-93%A%  
% 221.79/222.00  |- skos__broader mesh__D006525smesh__D006505
% 221.79/222.00  |- mesh__dateEstablished mesh__D006525 1977-01-01
% 221.79/222.00  |- skos__hiddenLabel mesh__D050681 Bottle Nosed Dolphins
% 221.79/222.00  |- skos__hiddenLabel mesh__D050681 Bottle-Nose Dolphin
% 221.79/222.00  |- skos__hiddenLabel mesh__D050681 Dolphin, Bottle-Nosed
% 221.79/222.00  |- skos__hiddenLabel mesh__D050681 Bottle Nose Dolphins
% 221.79/222.00  |- mesh__dateCreated mesh__D050681 2005-06-30
% 221.79/222.00  |- skos__hiddenLabel mesh__D050681 Dolphin, Bottlenose
% 221.79/222.00  |- skos__hiddenLabel mesh__D050681 Dolphins, Bottlenosed
% 221.79/222.00  |- skos__hiddenLabel mesh__D050681 Dolphins, Bottle-Nose
% 221.79/222.00  |- skos__altLabel mesh__D050681 Bottle-Nose Dolphins
% 221.79/222.00  |- skos__hiddenLabel mesh__D050681 Dolphin, Bottle-Nose
% 221.79/222.00  |- skos__hiddenLabel mesh__D050681 Bottlenose Dolphin
% 221.79/222.00  |- skos__altLabel mesh__D050681 Tursiops truncatus
% 221.79/222.00  |- mesh__historyNote mesh__D050681 2006; use DOLPHINS 1998-2005   
% 221.79/222.00  |- skos__hiddenLabel mesh__D050681 Bottle Nosed Dolphin
% 221.79/222.00  |- mesh__recordAuthorizer mesh__D050681 sjn
% 221.79/222.00  |- mesh__recordMaintainer mesh__D050681 ags
% 221.79/222.00  |- skos__broader mesh__D050681smesh__D004289
% 221.79/222.00  |- mesh__recordOriginator mesh__D050681 ags
% 221.79/222.00  |- skos__hiddenLabel mesh__D050681 Bottlenosed Dolphins
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D050681 2006
% 221.79/222.00  |- rdf__type mesh__D050681sskos__Concept
% 221.79/222.00  |- skos__altLabel mesh__D050681 Bottlenosed Dolphin
% 221.79/222.00  |- mesh__publicMeSHNote mesh__D050681 2006; see DOLPHINS 1998-2005   
% 221.79/222.00  |- skos__hiddenLabel mesh__D050681 Dolphins, Bottlenose
% 221.79/222.00  |- skos__hiddenLabel mesh__D050681 Dolphins, Bottle-Nosed
% 221.79/222.00  |- skos__prefLabel mesh__D050681 Bottle-Nosed Dolphin
% 221.79/222.00  |- skos__hiddenLabel mesh__D050681 Dolphin, Bottlenosed
% 221.79/222.00  |- skos__altLabel mesh__D050681 Bottlenose Dolphins
% 221.79/222.00  |- skos__historyNote mesh__D050681 Dolphins %28%1966-2005%29%
% 221.79/222.00  |- mesh__dateEstablished mesh__D050681 2006-01-01
% 221.79/222.00  |- skos__scopeNote mesh__D050681
% 221.79/222.00       The species Tursiops truncatus, in the family Delphinidae, characterized by a bottle-shaped beak and slightly hooked broad dorsal fin.%A%    
% 221.79/222.00  |- skos__altLabel mesh__D050681 Bottle-Nosed Dolphins
% 221.79/222.00  |- mesh__historyNote mesh__D044644 2004   
% 221.79/222.00  |- skos__scopeNote mesh__D044644
% 221.79/222.00       An endocellulase with specificity for the hydrolysis of 1,3- or 1,4-linkages in beta-D-glucans. This enzyme specifically acts on sites where reducing glucose residues are substituted at the 3 position.%A%    
% 221.79/222.00  |- mesh__dateEstablished mesh__D044644 2004-01-01
% 221.79/222.00  |- mesh__recordOriginator mesh__D044644 jmp
% 221.79/222.00  |- mesh__recordAuthorizer mesh__D044644 sjn
% 221.79/222.00  |- skos__altLabel mesh__D044644 endo-1,3%28%4%29%-beta-D-glucanase
% 221.79/222.00  |- rdf__type mesh__D044644sskos__Concept
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D044644 2006
% 221.79/222.00  |- mesh__publicMeSHNote mesh__D044644
% 221.79/222.00       2004; ENDO-1,3%28%4%29%-BETA-D-GLUCANASE was indexed under GLYCOSIDE HYDROLASES 1993-2003%A%  
% 221.79/222.00  |- mesh__recordMaintainer mesh__D044644 jmp
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D044644 2005
% 221.79/222.00  |- skos__altLabel mesh__D044644 Endo-1,3%28%4%29%-B-Glucanase
% 221.79/222.00  |- skos__prefLabel mesh__D044644 Endo-1,3%28%4%29%-beta-Glucanase
% 221.79/222.00  |- skos__altLabel mesh__D044644 beta-%28%1-3,1-4%29%glucanase
% 221.79/222.00  |- mesh__dateRevised mesh__D044644 2004-07-07
% 221.79/222.00  |- mesh__dateCreated mesh__D044644 2003-07-09
% 221.79/222.00  |- skos__broader mesh__D044644smesh__D044602
% 221.79/222.00  |- mesh__dateEstablished mesh__D016953 1992-01-01
% 221.79/222.00  |- skos__annotation mesh__D016953 a family of gram-neg aerobic bacteria   
% 221.79/222.00  |- mesh__dateCreated mesh__D016953 1991-05-30
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D016953 2006
% 221.79/222.00  |- mesh__recordOriginator mesh__D016953 PXP
% 221.79/222.00  |- mesh__dateRevised mesh__D016953 2005-06-30
% 221.79/222.00  |- skos__scopeNote mesh__D016953
% 221.79/222.00       A family of bacteria consisting of flexible helical cells exhibiting a right-handed conformation. It consists of a single genus, LEPTOSPIRA.%A%    
% 221.79/222.00  |- mesh__recordMaintainer mesh__D016953 SYSTEM
% 221.79/222.00  |- mesh__publicMeSHNote mesh__D016953 92   
% 221.79/222.00  |- skos__prefLabel mesh__D016953 Leptospiraceae
% 221.79/222.00  |- skos__broader mesh__D016953smesh__D016946
% 221.79/222.00  |- skos__broader mesh__D016953smesh__D013144
% 221.79/222.00  |- mesh__historyNote mesh__D016953 92   
% 221.79/222.00  |- rdf__type mesh__D016953sskos__Concept
% 221.79/222.00  |- mesh__recordAuthorizer mesh__D016953 sjn
% 221.79/222.00  |- skos__broader mesh__D016155smesh__D009059
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D016155 2005
% 221.79/222.00  |- skos__scopeNote mesh__D016155
% 221.79/222.00       An abnormal passage within the mouth communicating between two or more anatomical structures.%A%    
% 221.79/222.00  |- mesh__dateCreated mesh__D016155 1990-04-24
% 221.79/222.00  |- skos__historyNote mesh__D016155 Oroantral Fistula %28%1966-1997%29%
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D016155 2002
% 221.79/222.00  |- skos__prefLabel mesh__D016155 Oral Fistula
% 221.79/222.00  |- mesh__recordAuthorizer mesh__D016155 sjn
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D016155 2006
% 221.79/222.00  |- mesh__recordMaintainer mesh__D016155 KEV
% 221.79/222.00  |- skos__hiddenLabel mesh__D016155 Fistula, Oral
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D016155 2003
% 221.79/222.00  |- mesh__dateEstablished mesh__D016155 1998-01-01
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D016155 2000
% 221.79/222.00  |- skos__broader mesh__D016155smesh__D005402
% 221.79/222.00  |- rdf__type mesh__D016155sskos__Concept
% 221.79/222.00  |- skos__annotation mesh__D016155
% 221.79/222.00       GEN or unspecified; prefer specifics; fistula policy: Manual 23.19+%A%  
% 221.79/222.00  |- mesh__dateRevised mesh__D016155 1999-11-08
% 221.79/222.00  |- skos__hiddenLabel mesh__D016155 Fistulas, Oral
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D016155 2004
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D016155 2001
% 221.79/222.00  |- mesh__historyNote mesh__D016155 98; use explode 1991-97   
% 221.79/222.00  |- skos__hiddenLabel mesh__D016155 Oral Fistulas
% 221.79/222.00  |- mesh__publicMeSHNote mesh__D016155 98   
% 221.79/222.00  |- mesh__recordOriginator mesh__D016155 TGC
% 221.79/222.00  |- skos__historyNote mesh__D016155 specific fistula %28%1966-1997%29%
% 221.79/222.00  |- mesh__onlineNote mesh__D002933
% 221.79/222.00       use CINERADIOGRAPHY to search CINEFLUOROGRAPHY 1966-72   
% 221.79/222.00  |- rdf__type mesh__D002933sskos__Concept
% 221.79/222.00  |- mesh__publicMeSHNote mesh__D002933 73; was CINEFLUOROGRAPHY 1963-72   
% 221.79/222.00  |- skos__altLabel mesh__D002933 Cinefluorography
% 221.79/222.00  |- mesh__dateEstablished mesh__D002933 1973-01-01
% 221.79/222.00  |- skos__altLabel mesh__D002933 Radiocinematography
% 221.79/222.00  |- mesh__recordAuthorizer mesh__D002933 SJN
% 221.79/222.00  |- skos__annotation mesh__D002933
% 221.79/222.00       do not use /util except by MeSH definition; DF: CINERADIOGR%A%  
% 221.79/222.00  |- mesh__recordOriginator mesh__D002933 NLM
% 221.79/222.00  |- skos__prefLabel mesh__D002933 Cineradiography
% 221.79/222.00  |- skos__hiddenLabel mesh__D002933 Cineradiographies
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D002933 2002
% 221.79/222.00  |- skos__scopeNote mesh__D002933
% 221.79/222.00       Motion picture study of successive images appearing on a fluoroscopic screen.%A%    
% 221.79/222.00  |- mesh__dateRevised mesh__D002933 1997-06-20
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D002933 2006
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D002933 2004
% 221.79/222.00  |- skos__hiddenLabel mesh__D002933 Cinefluorographies
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D002933 2005
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D002933 2003
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D002933 2001
% 221.79/222.00  |- mesh__recordMaintainer mesh__D002933 PXP
% 221.79/222.00  |- mesh__dateCreated mesh__D002933 1999-01-01
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D002933 1999
% 221.79/222.00  |- mesh__historyNote mesh__D002933 73; was CINEFLUOROGRAPHY 1963-72   
% 221.79/222.00  |- skos__broader mesh__D002933smesh__D011859
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D002933 2000
% 221.79/222.00  |- skos__hiddenLabel mesh__D002933 Radiocinematographies
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D002933 1998
% 221.79/222.00  |- skos__historyNote mesh__D002135 Proteins %28%1966-1970%29%
% 221.79/222.00  |- skos__scopeNote mesh__D002135
% 221.79/222.00       Proteins to which calcium ions are bound. They can act as transport proteins, regulator proteins, or activator proteins. They typically contain EF HAND MOTIFS.%A%    
% 221.79/222.00  |- mesh__dateCreated mesh__D002135 1979-05-23
% 221.79/222.00  |- mesh__dateEstablished mesh__D002135 1980-01-01
% 221.79/222.00  |- mesh__recordOriginator mesh__D002135 RLS
% 221.79/222.00  |- mesh__historyNote mesh__D002135 80   
% 221.79/222.00  |- skos__historyNote mesh__D002135 Calcium %28%1966-1979%29%
% 221.79/222.00  |- skos__prefLabel mesh__D002135 Calcium-Binding Proteins
% 221.79/222.00  |- rdf__type mesh__D002135sskos__Concept
% 221.79/222.00  |- mesh__dateRevised mesh__D002135 2005-06-30
% 221.79/222.00  |- skos__annotation mesh__D002135
% 221.79/222.00       RECEPTORS, CALCIUM-SENSING is also available   
% 221.79/222.00  |- mesh__recordAuthorizer mesh__D002135 sjn
% 221.79/222.00  |- mesh__recordMaintainer mesh__D002135 SYSTEM
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D002135 2006
% 221.79/222.00  |- skos__hiddenLabel mesh__D002135 Binding Proteins, Calcium
% 221.79/222.00  |- skos__altLabel mesh__D002135 Calcium Binding Proteins
% 221.79/222.00  |- skos__broader mesh__D002135smesh__D002352
% 221.79/222.00  |- mesh__publicMeSHNote mesh__D002135
% 221.79/222.00       80; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT %26% CALCIUM-DEPENDENT REGULATOR were see under CARRIER PROTEINS 1979%A%  
% 221.79/222.00  |- skos__historyNote mesh__D002135 Carrier Proteins %28%1971-1979%29%
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D012563 2003
% 221.79/222.00  |- skos__hiddenLabel mesh__D012563 Schizophrenias, Paranoid
% 221.79/222.00  |- skos__hiddenLabel mesh__D012563 Delusional Disorders
% 221.79/222.00  |- mesh__recordMaintainer mesh__D012563 JLS
% 221.79/222.00  |- skos__hiddenLabel mesh__D012563 Disorders, Delusional
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D012563 2004
% 221.79/222.00  |- mesh__dateRevised mesh__D012563 1997-06-20
% 221.79/222.00  |- skos__altLabel mesh__D012563 Delusional Disorder
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D012563 2000
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D012563 2005
% 221.79/222.00  |- mesh__historyNote mesh__D012563 73   
% 221.79/222.00  |- skos__scopeNote mesh__D012563
% 221.79/222.00       A chronic form of schizophrenia characterized primarily by the presence of persecutory or grandiose delusions, often associated with hallucination.%A%    
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D012563 2001
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D012563 2006
% 221.79/222.00  |- mesh__dateEstablished mesh__D012563 1973-01-01
% 221.79/222.00  |- skos__annotation mesh__D012563
% 221.79/222.00       /psychol permitted but consider SCHIZOPHRENIC PSYCHOLOGY %28%IM%29% if paranoid aspect is less relevant %28%NIM%29%%A%  
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D012563 1998
% 221.79/222.00  |- mesh__recordOriginator mesh__D012563 NLM
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D012563 2002
% 221.79/222.00  |- skos__hiddenLabel mesh__D012563 Disorder, Delusional
% 221.79/222.00  |- mesh__publicMeSHNote mesh__D012563 73   
% 221.79/222.00  |- skos__historyNote mesh__D012563 Paranoid Disorders %28%1966-1972%29%
% 221.79/222.00  |- mesh__activeMeSHYear mesh__D012563 1999
% 221.79/222.00  |- rdf__type mesh__D012563sskos__Concept
% 221.79/222.00  |- mesh__recordAuthorizer mesh__D012563 SJN
% 221.79/222.00  |- mesh__dateCreated mesh__D012563 1999-01-01
% 221.79/222.00  |- skos__prefLabel mesh__D012563 Schizophrenia, Paranoid
% 221.79/222.00  |- skos__broader mesh__D012563smesh__D012559
% 221.79/222.00  |- skos__altLabel mesh__D012563 Paranoid Schizophrenia
% 221.79/222.00  |- skos__historyNote mesh__D012563 Schizophrenia %28%1966-1972%29%
% 221.79/222.00  |- skos__hiddenLabel mesh__D012563 Paranoid Schizophrenias
% 221.79/222.00  |- skos__hiddenLabel mesh__D006526
% 221.79/222.00       Parenterally Transmitted Non A, Non B Hepatitis
% 221.79/222.00  |- mesh__recordMaintainer mesh__D006526 lkt
% 221.79/222.00  |- mesh__recordOriginator mesh__D006526 AEP
% 221.79/222.00  |- skos__annotation mesh__D006526 chronic = HEPATITIS C, CHRONIC   
% 221.79/222.00  |- rdf__type mesh__D006526sskos__Concept
% 221.79/222.01  |- skos__scopeNote mesh__D006526
% 221.79/222.01       INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.%A%    
% 221.79/222.01  |- mesh__dateCreated mesh__D006526 1979-05-23
% 221.79/222.01  |- mesh__publicMeSHNote mesh__D006526
% 221.79/222.01       92; was HEPATITIS, VIRAL, NON-A, NON-B 1980-91 %28%see under HEPATITIS, VIRAL, HUMAN 1980-90%29%; HEPATITIS C was see HEPATITIS, VIRAL, NON-A, NON-B 1985-91%A%  
% 221.79/222.01  |- skos__altLabel mesh__D006526
% 221.79/222.01       Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
% 221.79/222.01  |- skos__altLabel mesh__D006526 PT-NANBH
% 221.79/222.01  |- skos__broader mesh__D006526smesh__D018178
% 221.79/222.01  |- skos__broader mesh__D006526smesh__D006525
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D006526 2006
% 221.79/222.01  |- skos__historyNote mesh__D006526
% 221.79/222.01       Hepatitis, Viral, Human %28%1977-1979%29%
% 221.79/222.01  |- skos__historyNote mesh__D006526 Hepatitis %28%1972-1979%29%
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D006526 2005
% 221.79/222.01  |- skos__altLabel mesh__D006526
% 221.79/222.01       Parenterally-Transmitted Non-A, Non-B Hepatitis
% 221.79/222.01  |- mesh__onlineNote mesh__D006526
% 221.79/222.01       use HEPATITIS C to search HEPATITIS, VIRAL, NON-A, NON-B 1980-91%A%  
% 221.79/222.01  |- mesh__dateRevised mesh__D006526 2004-07-07
% 221.79/222.01  |- skos__prefLabel mesh__D006526 Hepatitis C
% 221.79/222.01  |- mesh__dateEstablished mesh__D006526 1991-01-01
% 221.79/222.01  |- mesh__recordAuthorizer mesh__D006526 sjn
% 221.79/222.01  |- mesh__historyNote mesh__D006526
% 221.79/222.01       92; was HEPATITIS, VIRAL, NON-A, NON-B 1980-91 %28%see under HEPATITIS, VIRAL, HUMAN 1980-90%29%; HEPATITIS C was see HEPATITIS, VIRAL, NON-A, NON-B 1985-91%A%  
% 221.79/222.01  |- skos__prefLabel mesh__D050682 Q-SNARE Proteins
% 221.79/222.01  |- mesh__dateEstablished mesh__D050682 2006-01-01
% 221.79/222.01  |- skos__hiddenLabel mesh__D050682
% 221.79/222.01       Q N ethylmaleimide Sensitive Factor Attachment Protein Receptors
% 221.79/222.01  |- skos__altLabel mesh__D050682
% 221.79/222.01       Q-N-ethylmaleimide-Sensitive-Factor Attachment Protein Receptors
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D050682 2006
% 221.79/222.01  |- rdf__type mesh__D050682sskos__Concept
% 221.79/222.01  |- mesh__recordOriginator mesh__D050682 nns
% 221.79/222.01  |- skos__scopeNote mesh__D050682
% 221.79/222.01       SNARE proteins in which the central amino acid residue of the SNARE motif is a GLUTAMINE. They are classified separately from the R-SNARE PROTEINS where the central amino acid residue of the SNARE motif is an ARGININE.  Subfamilies, the QA-SNARES; QB-SNARES; and QC-SNARES are grouped by the position of their SNARE motif-containing-domains in the SNARE complex and by their sequence similarities.%A%    
% 221.79/222.01  |- skos__altLabel mesh__D050682 Q-SNAREs
% 221.79/222.01  |- skos__hiddenLabel mesh__D050682 Q SNARE Proteins
% 221.79/222.01  |- skos__hiddenLabel mesh__D050682 Q SNAREs
% 221.79/222.01  |- mesh__dateCreated mesh__D050682 2005-06-30
% 221.79/222.01  |- mesh__historyNote mesh__D050682 2006   
% 221.79/222.01  |- mesh__publicMeSHNote mesh__D050682 2006   
% 221.79/222.01  |- mesh__recordAuthorizer mesh__D050682 sjn
% 221.79/222.01  |- skos__broader mesh__D050682smesh__D050600
% 221.79/222.01  |- mesh__recordMaintainer mesh__D050682 nns
% 221.79/222.01  |- mesh__recordOriginator mesh__D044645 ags
% 221.79/222.01  |- mesh__publicMeSHNote mesh__D044645 2004   
% 221.79/222.01  |- skos__historyNote mesh__D044645 Algae %28%1965-2003%29%
% 221.79/222.01  |- skos__prefLabel mesh__D044645 Fucus
% 221.79/222.01  |- rdf__type mesh__D044645sskos__Concept
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D044645 2006
% 221.79/222.01  |- mesh__historyNote mesh__D044645 2004   
% 221.79/222.01  |- skos__scopeNote mesh__D044645
% 221.79/222.01       A genus of BROWN ALGAE in the family Fucaceae. It is found in temperate, marine intertidal areas along rocky coasts and is a source of ALGINATES. Some species of Fucus are referred to as KELP.%A%    
% 221.79/222.01  |- mesh__recordAuthorizer mesh__D044645 sjn
% 221.79/222.01  |- mesh__dateEstablished mesh__D044645 2004-01-01
% 221.79/222.01  |- skos__broader mesh__D044645smesh__D000459
% 221.79/222.01  |- mesh__dateCreated mesh__D044645 2003-07-09
% 221.79/222.01  |- mesh__dateRevised mesh__D044645 2005-06-30
% 221.79/222.01  |- mesh__recordMaintainer mesh__D044645 SYSTEM
% 221.79/222.01  |- skos__annotation mesh__D016954
% 221.79/222.01       in soil %26% water; nosocomial; infection: coord IM with ACINETOBACTER INFECTIONS %28%IM%29%%A%  
% 221.79/222.01  |- mesh__dateEstablished mesh__D016954 1992-01-01
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D016954 2006
% 221.79/222.01  |- mesh__recordAuthorizer mesh__D016954 sjn
% 221.79/222.01  |- skos__scopeNote mesh__D016954
% 221.79/222.01       A species of gram-negative, aerobic bacteria found in soil and water. Although considered to be normally nonpathogenic, this bacterium is a causative agent of nosocomial infections, particularly in debilitated individuals.%A%    
% 221.79/222.01  |- skos__historyNote mesh__D016954 Acinetobacter %28%1975-1991%29%
% 221.79/222.01  |- mesh__dateCreated mesh__D016954 1991-05-30
% 221.79/222.01  |- mesh__dateRevised mesh__D016954 2005-06-30
% 221.79/222.01  |- mesh__recordOriginator mesh__D016954 PXP
% 221.79/222.01  |- skos__historyNote mesh__D016954 Alcaligenes %28%1971-1974%29%
% 221.79/222.01  |- mesh__historyNote mesh__D016954 92   
% 221.79/222.01  |- skos__broader mesh__D016954smesh__D000150
% 221.79/222.01  |- rdf__type mesh__D016954sskos__Concept
% 221.79/222.01  |- mesh__publicMeSHNote mesh__D016954 92   
% 221.79/222.01  |- skos__prefLabel mesh__D016954 Acinetobacter calcoaceticus
% 221.79/222.01  |- mesh__recordMaintainer mesh__D016954 SYSTEM
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D016156 2003
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D016156 2001
% 221.79/222.01  |- mesh__publicMeSHNote mesh__D016156 98   
% 221.79/222.01  |- rdf__type mesh__D016156sskos__Concept
% 221.79/222.01  |- skos__broader mesh__D016156smesh__D005402
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D016156 2004
% 221.79/222.01  |- skos__historyNote mesh__D016156 Fistula %28%1966-1997%29%
% 221.79/222.01  |- mesh__recordOriginator mesh__D016156 TGC
% 221.79/222.01  |- skos__annotation mesh__D016156
% 221.79/222.01       GEN or unspecified; prefer specifics; fistula policy: Manual 23.19+%A%  
% 221.79/222.01  |- skos__hiddenLabel mesh__D016156 Respiratory Tract Fistulas
% 221.79/222.01  |- mesh__dateCreated mesh__D016156 1990-04-24
% 221.79/222.01  |- mesh__historyNote mesh__D016156 98; use explode 1991-97   
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D016156 2002
% 221.79/222.01  |- mesh__recordAuthorizer mesh__D016156 sjn
% 221.79/222.01  |- skos__prefLabel mesh__D016156 Respiratory Tract Fistula
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D016156 2005
% 221.79/222.01  |- skos__scopeNote mesh__D016156
% 221.79/222.01       An abnormal passage communicating between any component of the respiratory tract or between any part of the respiratory system and surrounding organs.%A%    
% 221.79/222.01  |- skos__hiddenLabel mesh__D016156 Fistula, Respiratory Tract
% 221.79/222.01  |- mesh__dateEstablished mesh__D016156 1998-01-01
% 221.79/222.01  |- skos__historyNote mesh__D016156 specific fistula %28%1966-1997%29%
% 221.79/222.01  |- mesh__dateRevised mesh__D016156 1999-11-08
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D016156 2006
% 221.79/222.01  |- mesh__recordMaintainer mesh__D016156 KEV
% 221.79/222.01  |- skos__hiddenLabel mesh__D016156 Fistulas, Respiratory Tract
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D016156 2000
% 221.79/222.01  |- skos__broader mesh__D016156smesh__D012140
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D002934 2006
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D002934 2001
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D002934 2004
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D002934 1995
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D002934 2000
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D002934 2005
% 221.79/222.01  |- mesh__recordMaintainer mesh__D002934 TGC
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D002934 1993
% 221.79/222.01  |- mesh__dateCreated mesh__D002934 1999-01-01
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D002934 2003
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D002934 1999
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D002934 1994
% 221.79/222.01  |- mesh__recordAuthorizer mesh__D002934 PLS
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D002934 1997
% 221.79/222.01  |- skos__prefLabel mesh__D002934 Cinnamates
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D002934 1998
% 221.79/222.01  |- rdf__type mesh__D002934sskos__Concept
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D002934 2002
% 221.79/222.01  |- mesh__activeMeSHYear mesh__D002934 1996
% 221.79/222.01  |- mesh__dateRevised mesh__D002934 1992-05-11
% 221.79/222.01  |- mesh__recordOriginator mesh__D002934 NLM
% 221.86/222.01  |- skos__broader mesh__D002934smesh__D000146
% 221.86/222.01  |- mesh__recordOriginator mesh__D002136 NLM
% 221.86/222.01  |- skos__annotation mesh__D002136
% 221.86/222.01       /adv eff: coordinate with disease /etiol, not /chem ind; /ther use: coord with disease /diet ther%A%  
% 221.86/222.01  |- rdf__type mesh__D002136sskos__Concept
% 221.86/222.01  |- mesh__dateCreated mesh__D002136 1999-01-01
% 221.86/222.01  |- mesh__recordMaintainer mesh__D002136 ssb
% 221.86/222.01  |- skos__altLabel mesh__D002136 Dietary Calcium
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D002136 2006
% 221.86/222.01  |- mesh__dateRevised mesh__D002136 2005-06-30
% 221.86/222.01  |- skos__scopeNote mesh__D002136
% 221.86/222.01       Calcium compounds used as food supplements or in food to supply the body with calcium. Dietary calcium is needed during growth for bone development and for maintenance of skeletal integrity later in life to prevent osteoporosis.%A%    
% 221.86/222.01  |- mesh__recordAuthorizer mesh__D002136 sjn
% 221.86/222.01  |- skos__broader mesh__D002136smesh__D017610
% 221.86/222.01  |- skos__prefLabel mesh__D002136 Calcium, Dietary
% 221.86/222.01  |- skos__broader mesh__D012564smesh__D001526
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D012564 2006
% 221.86/222.01  |- skos__scopeNote mesh__D012564
% 221.86/222.01       The artificial language of schizophrenic patients - neologisms %28%words of the patient%27%s own making with new meanings%29%.%A%    
% 221.86/222.01  |- mesh__dateRevised mesh__D012564 2002-07-03
% 221.86/222.01  |- mesh__recordMaintainer mesh__D012564 JLS
% 221.86/222.01  |- rdf__type mesh__D012564sskos__Concept
% 221.86/222.01  |- mesh__dateCreated mesh__D012564 1999-01-01
% 221.86/222.01  |- skos__prefLabel mesh__D012564 Schizophrenic Language
% 221.86/222.01  |- mesh__recordAuthorizer mesh__D012564 sjn
% 221.86/222.01  |- skos__annotation mesh__D012564
% 221.86/222.01       no qualif; any language concept in schizophrenia; coord IM with specific language term %28%IM%29% + specific type of schizophrenia if relevant %28%IM or NIM%29%%A%  
% 221.86/222.01  |- skos__hiddenLabel mesh__D012564 Language, Schizophrenic
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D012564 2003
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D012564 2004
% 221.86/222.01  |- mesh__recordOriginator mesh__D012564 NLM
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D012564 2005
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Degeneration, Hepatolenticular
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Lenticular Degeneration, Progressive
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Degenerations, Neurohepatic
% 221.86/222.01  |- mesh__dateRevised mesh__D006527 2004-07-07
% 221.86/222.01  |- skos__altLabel mesh__D006527 Wilson Disease
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Wilson Diseases, Hepato-Neurologic
% 221.86/222.01  |- skos__scopeNote mesh__D006527
% 221.86/222.01       A rare autosomal recessive disease characterized by the deposition of copper in the BRAIN; LIVER; CORNEA; and other organs. It is caused by defects in the ATP7B gene encoding copper-transporting ATPase 2 %28%EC 3.6.3.4%29%, also known as the Wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as LIVER CIRRHOSIS; TREMOR; ATAXIA and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years.%A%    
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Wilson Disease, Hepato-Neurologic
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Neurohepatic Degenerations
% 221.86/222.01  |- skos__altLabel mesh__D006527 Progressive Lenticular Degeneration
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Kinnier-Wilson Diseases
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Degeneration, Hepatocerebral
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Westphal-Strumpell Syndromes
% 221.86/222.01  |- skos__altLabel mesh__D006527 Pseudosclerosis
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Westphal Strumpell Syndrome
% 221.86/222.01  |- skos__altLabel mesh__D006527 Hepatocerebral Degeneration
% 221.86/222.01  |- skos__broader mesh__D006527smesh__D020271
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Diseases, Hepato-Neurologic Wilson
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Diseases, Kinnier-Wilson
% 221.86/222.01  |- rdf__type mesh__D006527sskos__Concept
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Degenerations, Hepatocerebral
% 221.86/222.01  |- skos__broader mesh__D006527smesh__D008664
% 221.86/222.01  |- mesh__historyNote mesh__D006527 1964%28%1963%29%   
% 221.86/222.01  |- mesh__recordAuthorizer mesh__D006527 sjn
% 221.86/222.01  |- skos__altLabel mesh__D006527 Neurohepatic Degeneration
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Hepato Neurologic Wilson Disease
% 221.86/222.01  |- mesh__publicMeSHNote mesh__D006527
% 221.86/222.01       1964; see HEPATO-LENTICULAR DEGENERATION 1963   
% 221.86/222.01  |- skos__annotation mesh__D006527
% 221.86/222.01       lenticular refers to the lenticular nucleus in the brain   
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Hepato-Neurologic Wilson Diseases
% 221.86/222.01  |- mesh__recordOriginator mesh__D006527 NLM
% 221.86/222.01  |- skos__altLabel mesh__D006527 Wilson%27%s Disease
% 221.86/222.01  |- skos__altLabel mesh__D006527 Hepato-Neurologic Wilson Disease
% 221.86/222.01  |- skos__prefLabel mesh__D006527 Hepatolenticular Degeneration
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Pseudosclerosis, Cerebral
% 221.86/222.01  |- skos__altLabel mesh__D006527 Kinnier-Wilson Disease
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D006527 2005
% 221.86/222.01  |- skos__altLabel mesh__D006527 Westphal-Strumpell Syndrome
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Degeneration, Neurohepatic
% 221.86/222.01  |- skos__broader mesh__D006527smesh__D001480
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Cerebral Pseudoscleroses
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Hepatocerebral Degenerations
% 221.86/222.01  |- skos__broader mesh__D006527smesh__D008107
% 221.86/222.01  |- skos__altLabel mesh__D006527 Wilson Disease, Hepatic Form
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Kinnier Wilson Disease
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D006527 2006
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Degeneration, Progressive Lenticular
% 221.86/222.01  |- mesh__dateCreated mesh__D006527 1999-01-01
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Wilsons Disease
% 221.86/222.01  |- mesh__recordMaintainer mesh__D006527 lkt
% 221.86/222.01  |- skos__broader mesh__D006527smesh__D020739
% 221.86/222.01  |- skos__broader mesh__D006527smesh__D009069
% 221.86/222.01  |- skos__altLabel mesh__D006527 Cerebral Pseudosclerosis
% 221.86/222.01  |- skos__hiddenLabel mesh__D006527 Pseudoscleroses, Cerebral
% 221.86/222.01  |- mesh__recordAuthorizer mesh__D050683 sjn
% 221.86/222.01  |- rdf__type mesh__D050683sskos__Concept
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D050683 2006
% 221.86/222.01  |- skos__broader mesh__D050683smesh__D050600
% 221.86/222.01  |- mesh__recordMaintainer mesh__D050683 nns
% 221.86/222.01  |- skos__hiddenLabel mesh__D050683 Vesicle Associated Membrane Proteins
% 221.86/222.01  |- skos__hiddenLabel mesh__D050683 Vesicle Associated Membrane Protein
% 221.86/222.01  |- skos__altLabel mesh__D050683 Synaptobrevins
% 221.86/222.01  |- mesh__recordOriginator mesh__D050683 nns
% 221.86/222.01  |- mesh__dateEstablished mesh__D050683 2006-01-01
% 221.86/222.01  |- skos__scopeNote mesh__D050683
% 221.86/222.01       SNARE proteins where the central amino acid residue of the SNARE motif is an ARGININE. They are classified separately from the Q-SNARE PROTEINS where the central amino acid residue of the SNARE motif is a GLUTAMINE. This subfamily contains the vesicle associated membrane proteins %28%VAMPs%29% based on similarity to the prototype for the R-SNAREs, VAMP2 %28%synaptobrevin 2%29%.%A%    
% 221.86/222.01  |- skos__hiddenLabel mesh__D050683 Membrane Protein, Vesicle-Associated
% 221.86/222.01  |- skos__hiddenLabel mesh__D050683 R SNARE Proteins
% 221.86/222.01  |- mesh__publicMeSHNote mesh__D050683
% 221.86/222.01       2006; VESICLE-ASSOCIATED MEMBRANE PROTEIN %28%now R-SNARE PROTEINS%29% was indexed under MEMBRANE PROTEINS 1996-2005 and NERVE TISSUE PROTEINS 1988-1995%A%  
% 221.86/222.01  |- skos__hiddenLabel mesh__D050683 Membrane Proteins, Vesicle-Associated
% 221.86/222.01  |- skos__hiddenLabel mesh__D050683 Proteins, R-SNARE
% 221.86/222.01  |- skos__prefLabel mesh__D050683 R-SNARE Proteins
% 221.86/222.01  |- skos__hiddenLabel mesh__D050683 R SNARES
% 221.86/222.01  |- skos__altLabel mesh__D050683 Vesicle-Associated Membrane Protein
% 221.86/222.01  |- skos__altLabel mesh__D050683 Synaptobrevin
% 221.86/222.01  |- mesh__historyNote mesh__D050683 2006 %28%1988%29%   
% 221.86/222.01  |- mesh__dateCreated mesh__D050683 2005-06-30
% 221.86/222.01  |- skos__altLabel mesh__D050683 R-SNARES
% 221.86/222.01  |- skos__broader mesh__D044646smesh__D000459
% 221.86/222.01  |- mesh__dateRevised mesh__D044646 2005-06-30
% 221.86/222.01  |- rdf__type mesh__D044646sskos__Concept
% 221.86/222.01  |- skos__prefLabel mesh__D044646 Ascophyllum
% 221.86/222.01  |- mesh__recordOriginator mesh__D044646 ags
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D044646 2006
% 221.86/222.01  |- mesh__dateCreated mesh__D044646 2003-07-09
% 221.86/222.01  |- mesh__historyNote mesh__D044646 2004   
% 221.86/222.01  |- mesh__recordMaintainer mesh__D044646 SYSTEM
% 221.86/222.01  |- skos__historyNote mesh__D044646 Algae %28%1969-2003%29%
% 221.86/222.01  |- skos__scopeNote mesh__D044646
% 221.86/222.01       A BROWN ALGAE closely related to FUCUS. It is found attached to rocks and boulders on the middle shore, primarily in the North Atlantic basin.%A%    
% 221.86/222.01  |- mesh__publicMeSHNote mesh__D044646 2004   
% 221.86/222.01  |- mesh__recordAuthorizer mesh__D044646 sjn
% 221.86/222.01  |- mesh__dateEstablished mesh__D044646 2004-01-01
% 221.86/222.01  |- mesh__historyNote mesh__D016955 92   
% 221.86/222.01  |- skos__scopeNote mesh__D016955
% 221.86/222.01       A species of gram-negative, aerobic bacteria that is most frequently isolated from bovine eyes in cases of infectious keratoconjunctivitis %28%KERATOCONJUNCTIVITIS, INFECTIOUS%29%, but also occurs in unaffected eyes and the nasal cavity of cattle.%A%    
% 221.86/222.01  |- mesh__publicMeSHNote mesh__D016955 92   
% 221.86/222.01  |- mesh__recordMaintainer mesh__D016955 SYSTEM
% 221.86/222.01  |- skos__altLabel mesh__D016955 Moraxella bovis
% 221.86/222.01  |- mesh__recordAuthorizer mesh__D016955 sjn
% 221.86/222.01  |- mesh__dateEstablished mesh__D016955 1992-01-01
% 221.86/222.01  |- skos__annotation mesh__D016955
% 221.86/222.01       infection: coord IM with MORAXELLACEAE INFECTIONS %28%IM%29%   
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D016955 2006
% 221.86/222.01  |- mesh__dateCreated mesh__D016955 1991-05-30
% 221.86/222.01  |- mesh__recordOriginator mesh__D016955 PXP
% 221.86/222.01  |- skos__broader mesh__D016955smesh__D009016
% 221.86/222.01  |- mesh__dateRevised mesh__D016955 2005-06-30
% 221.86/222.01  |- rdf__type mesh__D016955sskos__Concept
% 221.86/222.01  |- skos__historyNote mesh__D016955 Moraxella %28%1966-1991%29%
% 221.86/222.01  |- skos__prefLabel mesh__D016955 Moraxella %28%Moraxella%29% bovis
% 221.86/222.01  |- rdf__type mesh__D016157sskos__Concept
% 221.86/222.01  |- skos__broader mesh__D016157smesh__D005402
% 221.86/222.01  |- mesh__dateRevised mesh__D016157 1999-11-08
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D016157 2004
% 221.86/222.01  |- skos__historyNote mesh__D016157 Fistula %28%1966-1997%29%
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D016157 2000
% 221.86/222.01  |- skos__hiddenLabel mesh__D016157 Fistula, Vascular
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D016157 2001
% 221.86/222.01  |- skos__annotation mesh__D016157
% 221.86/222.01       GEN or unspecified; prefer ARTERIO-ARTERIAL FISTULA or ARTERIOVENOUS FISTULA; fistula policy: Manual 23.19+%A%  
% 221.86/222.01  |- mesh__historyNote mesh__D016157 98; use explode 1991-97   
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D016157 2005
% 221.86/222.01  |- mesh__publicMeSHNote mesh__D016157 98   
% 221.86/222.01  |- skos__scopeNote mesh__D016157
% 221.86/222.01       An abnormal passage between two or more arteries, or between an artery and a vein.%A%    
% 221.86/222.01  |- mesh__recordOriginator mesh__D016157 TGC
% 221.86/222.01  |- skos__historyNote mesh__D016157 specific fistula %28%1966-1997%29%
% 221.86/222.01  |- skos__prefLabel mesh__D016157 Vascular Fistula
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D016157 2006
% 221.86/222.01  |- mesh__recordMaintainer mesh__D016157 KEV
% 221.86/222.01  |- skos__broader mesh__D016157smesh__D014652
% 221.86/222.01  |- mesh__dateCreated mesh__D016157 1990-04-24
% 221.86/222.01  |- skos__hiddenLabel mesh__D016157 Vascular Fistulas
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D016157 2002
% 221.86/222.01  |- mesh__recordAuthorizer mesh__D016157 sjn
% 221.86/222.01  |- skos__hiddenLabel mesh__D016157 Fistulas, Vascular
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D016157 2003
% 221.86/222.01  |- mesh__dateEstablished mesh__D016157 1998-01-01
% 221.86/222.01  |- skos__prefLabel mesh__D002935 Cinnamomum zeylanicum
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D002935 2005
% 221.86/222.01  |- mesh__dateCreated mesh__D002935 1999-01-01
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D002935 2003
% 221.86/222.01  |- skos__scopeNote mesh__D002935
% 221.86/222.01       The tree which is known for its bark which is sold as cinnamon. The oil contains about 65-80%25% cinnamaldehyde and 10%25% EUGENOL and many TERPENES.%A%    
% 221.86/222.01  |- mesh__publicMeSHNote mesh__D002935
% 221.86/222.01       2002; see CINNAMON 1991-2001, see CONDIMENTS 1975-1990;   
% 221.86/222.01  |- rdf__type mesh__D002935sskos__Concept
% 221.86/222.01  |- mesh__historyNote mesh__D002935 2002%28%1975%29%   
% 221.86/222.01  |- mesh__dateEstablished mesh__D002935 1991-01-01
% 221.86/222.01  |- skos__broader mesh__D002935smesh__D027424
% 221.86/222.01  |- skos__annotation mesh__D002935
% 221.86/222.01       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.86/222.01  |- mesh__recordAuthorizer mesh__D002935 sjn
% 221.86/222.01  |- mesh__recordMaintainer mesh__D002935 ssb
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D002935 2006
% 221.86/222.01  |- mesh__recordOriginator mesh__D002935 NLM
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D002935 2004
% 221.86/222.01  |- mesh__dateRevised mesh__D002935 2002-07-03
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D002137 2003
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D002137 2001
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D002137 2005
% 221.86/222.01  |- mesh__dateRevised mesh__D002137 1999-11-08
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D002137 2004
% 221.86/222.01  |- skos__broader mesh__D002137smesh__D020763
% 221.86/222.01  |- mesh__recordAuthorizer mesh__D002137 sjn
% 221.86/222.01  |- skos__prefLabel mesh__D002137 Calculi
% 221.86/222.01  |- skos__scopeNote mesh__D002137
% 221.86/222.01       An abnormal concretion occurring mostly in the urinary and biliary tracts, usually composed of mineral salts. Also called stones.%A%    
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D002137 2006
% 221.86/222.01  |- mesh__recordMaintainer mesh__D002137 KEV
% 221.86/222.01  |- skos__related mesh__D002137smesh__D008096
% 221.86/222.01  |- mesh__recordOriginator mesh__D002137 NLM
% 221.86/222.01  |- skos__hiddenLabel mesh__D002137 Calculus
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D002137 2002
% 221.86/222.01  |- skos__annotation mesh__D002137
% 221.86/222.01       GEN or unspecified: prefer specifics; coord IM with organ/diseases term %28%IM%29%; chem composition of calculi: use /chem; /ultrastruct permitted; chemolysis of calculi: coord dis with /ther, not /drug ther%A%  
% 221.86/222.01  |- skos__altLabel mesh__D002137 Biliary or Urinary Stones
% 221.86/222.01  |- mesh__onlineNote mesh__D002137
% 221.86/222.01       to search for chem composition of calculi, use CALCULI/anal 1987-1990 %26% CALCULI/metab 1966-86%A%  
% 221.86/222.01  |- rdf__type mesh__D002137sskos__Concept
% 221.86/222.01  |- mesh__dateCreated mesh__D002137 1999-01-01
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D002137 2000
% 221.86/222.01  |- skos__related mesh__D002137smesh__D020347
% 221.86/222.01  |- mesh__dateEstablished mesh__D007620 1967-01-01
% 221.86/222.01  |- mesh__recordAuthorizer mesh__D007620 sjn
% 221.86/222.01  |- rdf__type mesh__D007620sskos__Concept
% 221.86/222.01  |- mesh__dateCreated mesh__D007620 1999-01-01
% 221.86/222.01  |- mesh__recordOriginator mesh__D007620 NLM
% 221.86/222.01  |- skos__hiddenLabel mesh__D007620 Karyometries
% 221.86/222.01  |- mesh__historyNote mesh__D007620 67%28%64%29%   
% 221.86/222.01  |- mesh__dateRevised mesh__D007620 2000-06-22
% 221.86/222.01  |- skos__broader mesh__D007620smesh__D003584
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D007620 2005
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D007620 2003
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D007620 2006
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D007620 2001
% 221.86/222.01  |- skos__prefLabel mesh__D007620 Karyometry
% 221.86/222.01  |- mesh__recordMaintainer mesh__D007620 TPW
% 221.86/222.01  |- mesh__publicMeSHNote mesh__D007620 67   
% 221.86/222.01  |- skos__annotation mesh__D007620 NIM   
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D007620 2004
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D007620 2002
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D012565 2001
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D012565 1994
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D012565 1999
% 221.86/222.01  |- mesh__recordOriginator mesh__D012565 NLM
% 221.86/222.01  |- skos__prefLabel mesh__D012565 Schizophrenic Psychology
% 221.86/222.01  |- rdf__type mesh__D012565sskos__Concept
% 221.86/222.01  |- mesh__recordAuthorizer mesh__D012565 PLS
% 221.86/222.01  |- mesh__dateCreated mesh__D012565 1999-01-01
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D012565 2002
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D012565 1995
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D012565 2003
% 221.86/222.01  |- mesh__recordMaintainer mesh__D012565 JLS
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D012565 2004
% 221.86/222.01  |- skos__altLabel mesh__D012565 Psychology, Schizophrenic
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D012565 1996
% 221.86/222.01  |- skos__annotation mesh__D012565
% 221.86/222.01       no qualif; any mental process in schizophrenia; coord IM with specific psychol term %28%IM%29% + specific type of schizophrenia if relevant %28%IM or NIM%29%; DF: SCHIZOPHRENIC PSYCHOL%A%  
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D012565 2005
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D012565 1997
% 221.86/222.01  |- skos__broader mesh__D012565smesh__D004191
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D012565 2006
% 221.86/222.01  |- mesh__dateRevised mesh__D012565 1993-06-04
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D012565 2000
% 221.86/222.01  |- skos__scopeNote mesh__D012565
% 221.86/222.01       Study of mental processes and behavior of schizophrenics.%A%    
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D012565 1998
% 221.86/222.01  |- mesh__dateCreated mesh__D039702 2002-07-03
% 221.86/222.01  |- mesh__publicMeSHNote mesh__D039702 2003   
% 221.86/222.01  |- skos__scopeNote mesh__D039702
% 221.86/222.01       Descriptive terms and identifying codes for reporting medical services and procedures performed by PHYSICIANS. It is produced by the AMERICAN MEDICAL ASSOCIATION and used in insurance claim reporting for MEDICARE; MEDICAID; and private health insurance programs %28%From CPT 2002%29%.%A%    
% 221.86/222.01  |- skos__hiddenLabel mesh__D039702 CPT Code
% 221.86/222.01  |- skos__hiddenLabel mesh__D039702 Codes, CPT
% 221.86/222.01  |- mesh__historyNote mesh__D039702 2003   
% 221.86/222.01  |- mesh__recordOriginator mesh__D039702 ags
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D039702 2003
% 221.86/222.01  |- skos__hiddenLabel mesh__D039702 Code, CPT
% 221.86/222.01  |- mesh__dateEstablished mesh__D039702 2003-01-01
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D039702 2004
% 221.86/222.01  |- mesh__dateRevised mesh__D039702 2005-07-19
% 221.86/222.01  |- rdf__type mesh__D039702sskos__Concept
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D039702 2005
% 221.86/222.01  |- skos__altLabel mesh__D039702 Current Procedural Terminology Codes
% 221.86/222.01  |- skos__annotation mesh__D039702 CATALOG:  use NAF entry   
% 221.86/222.01  |- mesh__recordAuthorizer mesh__D039702 ags
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D039702 2006A
% 221.86/222.01  |- skos__historyNote mesh__D039702 Terminology %28%1970-2002%29%
% 221.86/222.01  |- mesh__activeMeSHYear mesh__D039702 2006
% 221.86/222.01  |- skos__prefLabel mesh__D039702 Current Procedural Terminology
% 221.86/222.01  |- skos__broader mesh__D039702smesh__D018875
% 221.86/222.01  |- mesh__recordMaintainer mesh__D039702 ags
% 221.86/222.01  |- mesh__dateRevised mesh__D006528 2003-07-09
% 221.86/222.01  |- mesh__recordAuthorizer mesh__D006528 sjn
% 221.86/222.01  |- skos__scopeNote mesh__D006528
% 221.86/222.01       A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.%A%    
% 221.86/222.01  |- skos__broader mesh__D006528smesh__D008113
% 221.86/222.02  |- skos__broader mesh__D006528smesh__D000230
% 221.86/222.02  |- skos__annotation mesh__D006528
% 221.86/222.02       human %26% vet only: note X ref HEPATOMA: also available is HEPATOMA, EXPERIMENTAL see LIVER NEOPLASMS, EXPERIMENTAL for exper anim; coord IM with LIVER NEOPLASMS %28%IM%29%%A%  
% 221.86/222.02  |- skos__hiddenLabel mesh__D006528 Hepatomas
% 221.86/222.02  |- skos__hiddenLabel mesh__D006528 Hepatocellular Carcinomas
% 221.86/222.02  |- skos__hiddenLabel mesh__D006528 Carcinomas, Hepatocellular
% 221.86/222.02  |- skos__altLabel mesh__D006528 Hepatoma
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D006528 2005
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D006528 2004
% 221.86/222.02  |- mesh__publicMeSHNote mesh__D006528
% 221.86/222.02       94; was HEPATOMA 1963-93; CARCINOMA, HEPATOCELLULAR was see HEPATOMA 1991-93%A%  
% 221.86/222.02  |- mesh__historyNote mesh__D006528
% 221.86/222.02       94; was HEPATOMA 1963-93; CARCINOMA, HEPATOCELLULAR was see HEPATOMA 1991-93%A%  
% 221.86/222.02  |- mesh__onlineNote mesh__D006528
% 221.86/222.02       use CARCINOMA, HEPATOCELLULAR to search HEPATOMA 1966-93   
% 221.86/222.02  |- mesh__dateCreated mesh__D006528 1999-01-01
% 221.86/222.02  |- skos__altLabel mesh__D006528 Hepatocellular Carcinoma
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D006528 2006
% 221.86/222.02  |- mesh__recordMaintainer mesh__D006528 lkt
% 221.86/222.02  |- skos__prefLabel mesh__D006528 Carcinoma, Hepatocellular
% 221.86/222.02  |- rdf__type mesh__D006528sskos__Concept
% 221.86/222.02  |- mesh__recordOriginator mesh__D006528 NLM
% 221.86/222.02  |- mesh__publicMeSHNote mesh__D017250
% 221.86/222.02       94; was CALICIVIRUS INFECTIONS 1993   
% 221.86/222.02  |- skos__hiddenLabel mesh__D017250 Infection, Calicivirus
% 221.86/222.02  |- mesh__recordMaintainer mesh__D017250 mdb
% 221.86/222.02  |- skos__hiddenLabel mesh__D017250 Calicivirus Infection
% 221.86/222.02  |- skos__broader mesh__D017250smesh__D012327
% 221.86/222.02  |- skos__hiddenLabel mesh__D017250 Infection, Caliciviridae
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D017250 2005
% 221.86/222.02  |- skos__hiddenLabel mesh__D017250 Caliciviridae Infection
% 221.86/222.02  |- skos__historyNote mesh__D017250
% 221.86/222.02       Picornavirus Infections %28%1980-1992%29%
% 221.86/222.02  |- skos__altLabel mesh__D017250 Infections, Caliciviridae
% 221.86/222.02  |- mesh__dateRevised mesh__D017250 2001-07-25
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D017250 2006
% 221.86/222.02  |- skos__altLabel mesh__D017250 Calicivirus Infections
% 221.86/222.02  |- mesh__onlineNote mesh__D017250
% 221.86/222.02       use CALICIVIRIDAE INFECTIONS to search CALICIVIRUS INFECTIONS 1993%A%  
% 221.86/222.02  |- mesh__dateEstablished mesh__D017250 1993-01-01
% 221.86/222.02  |- mesh__historyNote mesh__D017250 94; was CALICIVIRUS INFECTIONS 1993   
% 221.86/222.02  |- skos__scopeNote mesh__D017250
% 221.86/222.02       Virus diseases caused by CALICIVIRIDAE. They include HEPATITIS E; VESICULAR EXANTHEMA OF SWINE; acute respiratory infections in felines, rabbit hemorrhagic disease, and some cases of gastroenteritis in humans.%A%    
% 221.86/222.02  |- mesh__recordAuthorizer mesh__D017250 sjn
% 221.86/222.02  |- rdf__type mesh__D017250sskos__Concept
% 221.86/222.02  |- skos__historyNote mesh__D017250 Virus Diseases %28%1975-1979%29%
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D017250 2002
% 221.86/222.02  |- mesh__recordOriginator mesh__D017250 AGS
% 221.86/222.02  |- skos__annotation mesh__D017250 GEN or unspecified; prefer specifics   
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D017250 2003
% 221.86/222.02  |- mesh__dateCreated mesh__D017250 1992-05-07
% 221.86/222.02  |- skos__prefLabel mesh__D017250 Caliciviridae Infections
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D017250 2004
% 221.86/222.02  |- skos__hiddenLabel mesh__D050684 E2F, Transcription Factor
% 221.86/222.02  |- skos__altLabel mesh__D050684 E2F Proteins
% 221.86/222.02  |- mesh__recordMaintainer mesh__D050684 DRC
% 221.86/222.02  |- skos__broader mesh__D050684smesh__D014157
% 221.86/222.02  |- mesh__dateCreated mesh__D050684 2005-06-30
% 221.86/222.02  |- rdf__type mesh__D050684sskos__Concept
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D050684 2006
% 221.86/222.02  |- skos__historyNote mesh__D050684 DNA-Binding Proteins %28%1991-2005%29%
% 221.86/222.02  |- skos__hiddenLabel mesh__D050684 Transcription Factors, E2F
% 221.86/222.02  |- mesh__recordAuthorizer mesh__D050684 sjn
% 221.86/222.02  |- skos__prefLabel mesh__D050684 E2F Transcription Factors
% 221.86/222.02  |- mesh__publicMeSHNote mesh__D050684
% 221.86/222.02       2006; E2F TRANSCRIPTION FACTORS was indexed under CELL CYCLE PROTEINS, DNA-BINDING PROTEINS, %26% TRANSCRIPTION FACTORS 1991-2005%A%  
% 221.86/222.02  |- skos__altLabel mesh__D050684 Transcription Factor E2F
% 221.86/222.02  |- mesh__dateEstablished mesh__D050684 2006-01-01
% 221.86/222.02  |- skos__historyNote mesh__D050684 Transcription Factors %28%1991-2005%29%
% 221.86/222.02  |- skos__historyNote mesh__D050684 Cell Cycle Proteins %28%1991-2005%29%
% 221.86/222.02  |- mesh__historyNote mesh__D050684 2006%28%1991%29%   
% 221.86/222.02  |- skos__scopeNote mesh__D050684
% 221.86/222.02       A family of basic helix-loop-helix transcription factors that control expression of a variety of GENES involved in CELL CYCLE regulation.  E2F transcription factors typically form heterodimeric complexes with TRANSCRIPTION FACTOR DP1 or transcription factor DP2, and they have N-terminal DNA binding and dimerization domains. E2F transcription factors can act as mediators of transcriptional repression or transcriptional activation.%A%    
% 221.86/222.02  |- mesh__recordOriginator mesh__D050684 DRC
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003230 2004
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003230 2001
% 221.86/222.02  |- mesh__dateCreated mesh__D003230 1980-04-04
% 221.86/222.02  |- rdf__type mesh__D003230sskos__Concept
% 221.86/222.02  |- skos__prefLabel mesh__D003230 Conjunctival Neoplasms
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003230 2002
% 221.86/222.02  |- skos__broader mesh__D003230smesh__D003229
% 221.86/222.02  |- mesh__recordMaintainer mesh__D003230 nns
% 221.86/222.02  |- mesh__dateEstablished mesh__D003230 1981-01-01
% 221.86/222.02  |- mesh__publicMeSHNote mesh__D003230 81   
% 221.86/222.02  |- skos__hiddenLabel mesh__D003230 Neoplasms, Conjunctival
% 221.86/222.02  |- skos__historyNote mesh__D003230 Eye Neoplasms %28%1966-1980%29%
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003230 2005
% 221.86/222.02  |- skos__hiddenLabel mesh__D003230 Neoplasm, Conjunctival
% 221.86/222.02  |- skos__broader mesh__D003230smesh__D005134
% 221.86/222.02  |- skos__annotation mesh__D003230
% 221.86/222.02       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A%  
% 221.86/222.02  |- skos__historyNote mesh__D003230 Conjunctiva %28%1966-1980%29%
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003230 2003
% 221.86/222.02  |- mesh__recordAuthorizer mesh__D003230 sjn
% 221.86/222.02  |- skos__scopeNote mesh__D003230 Tumors or cancer of the CONJUNCTIVA.     
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003230 2006
% 221.86/222.02  |- mesh__recordOriginator mesh__D003230 RC
% 221.86/222.02  |- mesh__historyNote mesh__D003230 81   
% 221.86/222.02  |- mesh__dateRevised mesh__D003230 2000-06-22
% 221.86/222.02  |- skos__hiddenLabel mesh__D003230 Conjunctival Neoplasm
% 221.86/222.02  |- mesh__historyNote mesh__D044647 2004   
% 221.86/222.02  |- skos__historyNote mesh__D044647 Algae, Brown %28%1974-2003%29%
% 221.86/222.02  |- mesh__dateEstablished mesh__D044647 2004-01-01
% 221.86/222.02  |- skos__prefLabel mesh__D044647 Sargassum
% 221.86/222.02  |- skos__historyNote mesh__D044647 Seaweed %28%1974-2003%29%
% 221.86/222.02  |- mesh__dateCreated mesh__D044647 2003-07-09
% 221.86/222.02  |- mesh__recordAuthorizer mesh__D044647 sjn
% 221.86/222.02  |- skos__broader mesh__D044647smesh__D000459
% 221.86/222.02  |- mesh__dateRevised mesh__D044647 2005-06-30
% 221.86/222.02  |- mesh__publicMeSHNote mesh__D044647 2004   
% 221.86/222.02  |- mesh__recordMaintainer mesh__D044647 SYSTEM
% 221.86/222.02  |- mesh__recordOriginator mesh__D044647 ags
% 221.86/222.02  |- skos__scopeNote mesh__D044647
% 221.86/222.02       One of the largest genera of BROWN ALGAE, comprised of more than 150 species found in tropical, subtropical, and temperate zones of both hemispheres. Some species are attached %28%benthic%29% but most float in the open sea %28%pelagic%29%. Sargassum provides a critical habitat for hundreds of species of FISHES; TURTLES; and INVERTEBRATES.%A%    
% 221.86/222.02  |- rdf__type mesh__D044647sskos__Concept
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D044647 2006
% 221.86/222.02  |- skos__prefLabel mesh__D016956 Burkholderia cepacia
% 221.86/222.02  |- skos__broader mesh__D016956smesh__D042602
% 221.86/222.02  |- mesh__publicMeSHNote mesh__D016956
% 221.86/222.02       96; was PSEUDOMONAS CEPACIA 1992-95   
% 221.86/222.02  |- skos__scopeNote mesh__D016956
% 221.86/222.02       A species of BURKHOLDERIA considered to be an opportunistic human pathogen. It has been associated with various types of infections of nosocomial origin.%A%    
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D016956 2006
% 221.86/222.02  |- mesh__dateCreated mesh__D016956 1991-05-30
% 221.86/222.02  |- mesh__recordOriginator mesh__D016956 PXP
% 221.86/222.02  |- mesh__recordAuthorizer mesh__D016956 sjn
% 221.86/222.02  |- skos__annotation mesh__D016956
% 221.86/222.02       nosocomial %26% opportunistic; infection: coord IM with BURKHOLDERIA INFECTIONS %28%IM%29%%A%  
% 221.86/222.02  |- mesh__dateEstablished mesh__D016956 1992-01-01
% 221.86/222.02  |- skos__historyNote mesh__D016956 Pseudomonas %28%1971-1991%29%
% 221.86/222.02  |- rdf__type mesh__D016956sskos__Concept
% 221.86/222.02  |- skos__altLabel mesh__D016956 Pseudomonas cepacia
% 221.86/222.02  |- mesh__historyNote mesh__D016956 96; was PSEUDOMONAS CEPACIA 1992-95   
% 221.86/222.02  |- mesh__recordMaintainer mesh__D016956 SYSTEM
% 221.86/222.02  |- mesh__dateRevised mesh__D016956 2005-06-30
% 221.86/222.02  |- skos__altLabel mesh__D016158 TP53 Genes
% 221.86/222.02  |- skos__altLabel mesh__D016158 p53 Genes
% 221.86/222.02  |- mesh__recordAuthorizer mesh__D016158 sjn
% 221.86/222.02  |- skos__hiddenLabel mesh__D016158 p53 Gene
% 221.86/222.02  |- mesh__publicMeSHNote mesh__D016158 91   
% 221.86/222.02  |- mesh__dateRevised mesh__D016158 2005-06-30
% 221.86/222.02  |- rdf__type mesh__D016158sskos__Concept
% 221.86/222.02  |- skos__hiddenLabel mesh__D016158 TP53 Gene
% 221.86/222.02  |- skos__hiddenLabel mesh__D016158 Gene, TP53
% 221.86/222.02  |- skos__hiddenLabel mesh__D016158 Gene, p53
% 221.86/222.02  |- skos__historyNote mesh__D016158 Genes, Structural %28%1986-1990%29%
% 221.86/222.02  |- skos__scopeNote mesh__D016158
% 221.86/222.02       Tumor suppressor genes located on the short arm of human chromosome 17 and coding for the phosphoprotein p53.%A%    
% 221.86/222.02  |- mesh__recordMaintainer mesh__D016158 nns
% 221.86/222.02  |- mesh__historyNote mesh__D016158 91   
% 221.86/222.02  |- skos__prefLabel mesh__D016158 Genes, p53
% 221.86/222.02  |- mesh__dateCreated mesh__D016158 1990-06-06
% 221.86/222.02  |- skos__related mesh__D016158smesh__D016159
% 221.86/222.02  |- mesh__dateEstablished mesh__D016158 1991-01-01
% 221.86/222.02  |- skos__altLabel mesh__D016158 Genes, TP53
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D016158 2006
% 221.86/222.02  |- mesh__recordOriginator mesh__D016158 AGS
% 221.86/222.02  |- skos__broader mesh__D016158smesh__D016147
% 221.86/222.02  |- mesh__historyNote mesh__D002936 86%28%75%29%   
% 221.86/222.02  |- skos__hiddenLabel mesh__D002936 Cinnarizine L Tartrate
% 221.86/222.02  |- skos__altLabel mesh__D002936 Cinnarizin-ratiopharm
% 221.86/222.02  |- skos__broader mesh__D002936smesh__D010879
% 221.86/222.02  |- mesh__recordAuthorizer mesh__D002936 sjn
% 221.86/222.02  |- skos__altLabel mesh__D002936 Ashbourne Brand of Cinnarizine
% 221.86/222.02  |- skos__altLabel mesh__D002936 Janssen Brand of Cinnarizine
% 221.86/222.02  |- skos__altLabel mesh__D002936 Stugeron Forte
% 221.86/222.02  |- mesh__dateRevised mesh__D002936 2005-06-30
% 221.86/222.02  |- skos__altLabel mesh__D002936 cinnarizin von ct
% 221.86/222.02  |- skos__altLabel mesh__D002936 Artu Brand of Cinnarizine
% 221.86/222.02  |- mesh__recordOriginator mesh__D002936 NLM
% 221.86/222.02  |- skos__altLabel mesh__D002936 Kendrick Brand of Cinnarizine
% 221.86/222.02  |- rdf__type mesh__D002936sskos__Concept
% 221.86/222.02  |- mesh__dateEstablished mesh__D002936 1986-01-01
% 221.86/222.02  |- skos__historyNote mesh__D002936 Cinnamates %28%1971-1974%29%
% 221.86/222.02  |- skos__altLabel mesh__D002936 ratiopharm Brand of Cinnarizine
% 221.86/222.02  |- skos__altLabel mesh__D002936 Cinarizine
% 221.86/222.02  |- mesh__dateCreated mesh__D002936 1974-11-19
% 221.86/222.02  |- skos__historyNote mesh__D002936 Piperazines %28%1968-1974%29%
% 221.86/222.02  |- skos__altLabel mesh__D002936 Aliud Brand of Cinnarizine
% 221.86/222.02  |- skos__hiddenLabel mesh__D002936 R 516
% 221.86/222.02  |- skos__altLabel mesh__D002936
% 221.86/222.02       1-%28%Diphenylmethyl%29%-4-%28%3-phenyl-2-propenyl%29%piperazine
% 221.86/222.02  |- skos__prefLabel mesh__D002936 Cinnarizine
% 221.86/222.02  |- skos__altLabel mesh__D002936 Alpharma Brand of Cinnarizine
% 221.86/222.02  |- skos__hiddenLabel mesh__D002936 L-Tartrate, Cinnarizine
% 221.86/222.02  |- skos__altLabel mesh__D002936 Esteve Brand of Cinnarizine
% 221.86/222.02  |- skos__hiddenLabel mesh__D002936 Dihydrochloride Cinnarizine
% 221.86/222.02  |- mesh__recordMaintainer mesh__D002936 lkw
% 221.86/222.02  |- mesh__publicMeSHNote mesh__D002936 86; see PIPERAZINES 1975-85   
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D002936 2006
% 221.86/222.02  |- skos__scopeNote mesh__D002936
% 221.86/222.02       A piperazine derivative with histamine H1-receptor and calcium-channel blocking activity and considerable antiemetic properties.%A%    
% 221.86/222.02  |- skos__altLabel mesh__D002936 ct-Arzneimittel Brand of Cinnarizine
% 221.86/222.02  |- skos__altLabel mesh__D002936 Inkeysa Brand of Cinnarizine
% 221.86/222.02  |- skos__hiddenLabel mesh__D002936 R516
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D002138 2003
% 221.86/222.02  |- mesh__recordMaintainer mesh__D002138 TAP
% 221.86/222.02  |- mesh__publicMeSHNote mesh__D002138
% 221.86/222.02       91; was see under WEIGHTS AND MEASURES 1978-90   
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D002138 1999
% 221.86/222.02  |- skos__prefLabel mesh__D002138 Calibration
% 221.86/222.02  |- skos__broader mesh__D002138smesh__D008919
% 221.86/222.02  |- mesh__dateRevised mesh__D002138 1992-05-07
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D002138 1994
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D002138 2005
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D002138 2004
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D002138 1993
% 221.86/222.02  |- skos__scopeNote mesh__D002138
% 221.86/222.02       Determination, by measurement or comparison with a standard, of the correct value of each scale reading on a meter or other measuring instrument; or determination of the settings of a control device that correspond to particular values of voltage, current, frequency or other output.%A%    
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D002138 2002
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D002138 1995
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D002138 2006
% 221.86/222.02  |- skos__annotation mesh__D002138
% 221.86/222.02       NIM; coord with specific scale %28%IM%29% if relevant   
% 221.86/222.02  |- mesh__recordAuthorizer mesh__D002138 PLS
% 221.86/222.02  |- mesh__dateEstablished mesh__D002138 1991-01-01
% 221.86/222.02  |- skos__hiddenLabel mesh__D002138 Calibrations
% 221.86/222.02  |- mesh__historyNote mesh__D002138
% 221.86/222.02       91%28%78%29%; was see under WEIGHTS AND MEASURES 1978-90   
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D002138 1996
% 221.86/222.02  |- rdf__type mesh__D002138sskos__Concept
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D002138 2000
% 221.86/222.02  |- mesh__recordOriginator mesh__D002138 VDK
% 221.86/222.02  |- mesh__dateCreated mesh__D002138 1977-04-27
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D002138 1998
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D002138 1997
% 221.86/222.02  |- skos__broader mesh__D002138smesh__D014894
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D002138 2001
% 221.86/222.02  |- mesh__dateCreated mesh__D007621 1999-01-01
% 221.86/222.02  |- skos__annotation mesh__D007621 NIM   
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D007621 2002
% 221.86/222.02  |- mesh__recordMaintainer mesh__D007621 KEV
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D007621 2005
% 221.86/222.02  |- mesh__recordAuthorizer mesh__D007621 sjn
% 221.86/222.02  |- skos__broader mesh__D007621smesh__D020732
% 221.86/222.02  |- mesh__recordOriginator mesh__D007621 NLM
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D007621 2003
% 221.86/222.02  |- mesh__historyNote mesh__D007621 67%28%65%29%   
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D007621 2006
% 221.86/222.02  |- mesh__dateRevised mesh__D007621 1999-11-03
% 221.86/222.02  |- mesh__publicMeSHNote mesh__D007621 67   
% 221.86/222.02  |- skos__hiddenLabel mesh__D007621 Karyotypings
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D007621 2004
% 221.86/222.02  |- skos__scopeNote mesh__D007621
% 221.86/222.02       Mapping of the full chromosome set of the nucleus of a cell. The chromosome characteristics of an individual or a cell line are usually presented as a systematized array of metaphase chromosomes from a photomicrograph of a single cell nucleus arranged in pairs in descending order of size and according to the position of the centromere. %28%From Stedman, 25th ed%29%%A%    
% 221.86/222.02  |- mesh__dateEstablished mesh__D007621 1967-01-01
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D007621 2000
% 221.86/222.02  |- skos__prefLabel mesh__D007621 Karyotyping
% 221.86/222.02  |- rdf__type mesh__D007621sskos__Concept
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D007621 2001
% 221.86/222.02  |- skos__altLabel mesh__D012566 Sizofilan
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D012566 2006
% 221.86/222.02  |- rdf__type mesh__D012566sskos__Concept
% 221.86/222.02  |- mesh__dateRevised mesh__D012566 2004-07-07
% 221.86/222.02  |- mesh__dateCreated mesh__D012566 1975-07-25
% 221.86/222.02  |- skos__scopeNote mesh__D012566
% 221.86/222.02       A beta-D-glucan obtained from the Aphyllophoral fungus Schizophyllum commune. It is used as an immunoadjuvant in the treatment of neoplasms, especially tumors found in the stomach.%A%    
% 221.86/222.02  |- mesh__onlineNote mesh__D012566
% 221.86/222.02       use SIZOFIRAN to search SCHIZOPHYLLAN 1976-91   
% 221.86/222.02  |- mesh__dateEstablished mesh__D012566 1991-01-01
% 221.86/222.02  |- mesh__recordOriginator mesh__D012566 SH
% 221.86/222.02  |- skos__historyNote mesh__D012566 Mucopolysaccharides %28%1973-1975%29%
% 221.86/222.02  |- skos__altLabel mesh__D012566 Sonifilan
% 221.86/222.02  |- mesh__historyNote mesh__D012566
% 221.86/222.02       92; was SCHIZOPHYLLAN 1976-91 %28%see under MUCOPOLYSACCHARIDES 1976-90%29%%A%  
% 221.86/222.02  |- skos__prefLabel mesh__D012566 Sizofiran
% 221.86/222.02  |- skos__altLabel mesh__D012566 Schizophyllan
% 221.86/222.02  |- mesh__recordAuthorizer mesh__D012566 sjn
% 221.86/222.02  |- skos__annotation mesh__D012566 /biosyn permitted if by living matter   
% 221.86/222.02  |- mesh__recordMaintainer mesh__D012566 jmp
% 221.86/222.02  |- mesh__publicMeSHNote mesh__D012566
% 221.86/222.02       92; was SCHIZOPHYLLAN 1976-91 %28%see under MUCOPOLYSACCHARIDES 1976-90%29%%A%  
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D012566 2005
% 221.86/222.02  |- skos__broader mesh__D012566smesh__D047071
% 221.86/222.02  |- mesh__dateCreated mesh__D039703 2002-07-03
% 221.86/222.02  |- mesh__publicMeSHNote mesh__D039703 2003   
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D039703 2003
% 221.86/222.02  |- skos__historyNote mesh__D039703 Vocabulary, Controlled %28%1996-2002%29%
% 221.86/222.02  |- mesh__historyNote mesh__D039703 2003   
% 221.86/222.02  |- rdf__type mesh__D039703sskos__Concept
% 221.86/222.02  |- skos__altLabel mesh__D039703 LOINC
% 221.86/222.02  |- skos__annotation mesh__D039703 CATALOG: use NAF entry   
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D039703 2004
% 221.86/222.02  |- mesh__dateEstablished mesh__D039703 2003-01-01
% 221.86/222.02  |- skos__scopeNote mesh__D039703
% 221.86/222.02       A vocabulary database of universal identifiers for laboratory and clinical test results. Its purpose is to facilitate the exchange and pooling of results for clinical care, outcomes management, and research. It is produced by the Regenstrief Institute. %28%LOINC and RELMA %5B%Internet%5D%. Indianapolis: The Regenstrief Institute; c1995-2001 %5B%cited 2002 Apr 2%5D%. Available from http://www.regenstrief.org/loinc%29%%A%    
% 221.86/222.02  |- skos__broader mesh__D039703smesh__D018875
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D039703 2005
% 221.86/222.02  |- skos__prefLabel mesh__D039703
% 221.86/222.02       Logical Observation Identifiers Names and Codes
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D039703 2006
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D006529 2003
% 221.86/222.02  |- mesh__publicMeSHNote mesh__D006529 66   
% 221.86/222.02  |- skos__scopeNote mesh__D006529 Enlargement of the liver.     
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D006529 2001
% 221.86/222.02  |- mesh__recordOriginator mesh__D006529 NLM
% 221.86/222.02  |- skos__prefLabel mesh__D006529 Hepatomegaly
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D006529 2005
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D006529 2004
% 221.86/222.02  |- skos__hiddenLabel mesh__D006529 Liver, Enlarged
% 221.86/222.02  |- mesh__historyNote mesh__D006529 66%28%63%29%   
% 221.86/222.02  |- mesh__recordMaintainer mesh__D006529 KEV
% 221.86/222.02  |- mesh__recordAuthorizer mesh__D006529 sjn
% 221.86/222.02  |- mesh__dateCreated mesh__D006529 1999-01-01
% 221.86/222.02  |- skos__broader mesh__D006529smesh__D006984
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D006529 2006
% 221.86/222.02  |- skos__altLabel mesh__D006529 Enlarged Liver
% 221.86/222.02  |- skos__annotation mesh__D006529 NIM when symptom   
% 221.86/222.02  |- mesh__dateEstablished mesh__D006529 1966-01-01
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D006529 2002
% 221.86/222.02  |- rdf__type mesh__D006529sskos__Concept
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D006529 2000
% 221.86/222.02  |- mesh__dateRevised mesh__D006529 1999-11-03
% 221.86/222.02  |- mesh__recordMaintainer mesh__D050685 ags
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D050685 2006
% 221.86/222.02  |- rdf__type mesh__D050685sskos__Concept
% 221.86/222.02  |- skos__altLabel mesh__D050685 Killer Whale
% 221.86/222.02  |- skos__prefLabel mesh__D050685 Whale, Killer
% 221.86/222.02  |- skos__broader mesh__D050685smesh__D004289
% 221.86/222.02  |- skos__scopeNote mesh__D050685
% 221.86/222.02       The species Orcinus orca, in the family Delphinidae, characterized by its black and white coloration, and huge triangular dorsal fin. It is the largest member of the DOLPHINS and derives its name from the fact that it is a fearsome predator.%A%    
% 221.86/222.02  |- mesh__dateCreated mesh__D050685 2005-06-30
% 221.86/222.02  |- mesh__publicMeSHNote mesh__D050685 2006; see DOLPHINS 1998-2005   
% 221.86/222.02  |- mesh__recordAuthorizer mesh__D050685 sjn
% 221.86/222.02  |- skos__hiddenLabel mesh__D050685 Killer Whales
% 221.86/222.02  |- skos__historyNote mesh__D050685 Dolphins %28%1968-2005%29%
% 221.86/222.02  |- mesh__historyNote mesh__D050685 2006; use DOLPHINS 1998-2005   
% 221.86/222.02  |- mesh__recordOriginator mesh__D050685 ags
% 221.86/222.02  |- skos__altLabel mesh__D050685 Orcinus orca
% 221.86/222.02  |- skos__hiddenLabel mesh__D050685 Whales, Killer
% 221.86/222.02  |- mesh__dateEstablished mesh__D050685 2006-01-01
% 221.86/222.02  |- rdf__type mesh__D003231sskos__Concept
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003231 1995
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003231 1998
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003231 2000
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003231 1993
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003231 2001
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003231 1996
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003231 1999
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003231 2005
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003231 2002
% 221.86/222.02  |- skos__broader mesh__D003231smesh__D003229
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003231 1997
% 221.86/222.02  |- skos__hiddenLabel mesh__D003231 Conjunctivitides
% 221.86/222.02  |- mesh__recordOriginator mesh__D003231 NLM
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003231 2003
% 221.86/222.02  |- mesh__dateCreated mesh__D003231 1999-01-01
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003231 2006
% 221.86/222.02  |- skos__prefLabel mesh__D003231 Conjunctivitis
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003231 1994
% 221.86/222.02  |- mesh__recordMaintainer mesh__D003231 PLS
% 221.86/222.02  |- mesh__dateRevised mesh__D003231 1990-05-29
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003231 2004
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003231 1991
% 221.86/222.02  |- mesh__recordAuthorizer mesh__D003231 NLM
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D003231 1992
% 221.86/222.02  |- skos__historyNote mesh__D044648 Seaweed %28%1970-2003%29%
% 221.86/222.02  |- mesh__dateCreated mesh__D044648 2003-07-09
% 221.86/222.02  |- mesh__historyNote mesh__D044648 2004   
% 221.86/222.02  |- mesh__publicMeSHNote mesh__D044648 2004   
% 221.86/222.02  |- mesh__recordMaintainer mesh__D044648 SYSTEM
% 221.86/222.02  |- mesh__dateEstablished mesh__D044648 2004-01-01
% 221.86/222.02  |- skos__historyNote mesh__D044648 Algae, Brown %28%1993-2003%29%
% 221.86/222.02  |- mesh__recordAuthorizer mesh__D044648 sjn
% 221.86/222.02  |- skos__scopeNote mesh__D044648
% 221.86/222.02       A genus of BROWN ALGAE, in the family Alariaceae, native to Japan, Korea, and China. The edible SEAWEED Undaria pinnatifida is also called wakame.%A%    
% 221.86/222.02  |- skos__broader mesh__D044648smesh__D000459
% 221.86/222.02  |- rdf__type mesh__D044648sskos__Concept
% 221.86/222.02  |- mesh__dateRevised mesh__D044648 2005-06-30
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D044648 2006
% 221.86/222.02  |- skos__altLabel mesh__D044648 Undaria pinnatifida
% 221.86/222.02  |- skos__prefLabel mesh__D044648 Undaria
% 221.86/222.02  |- mesh__recordOriginator mesh__D044648 ags
% 221.86/222.02  |- skos__altLabel mesh__D016957 Pseudomonas pseudomallei
% 221.86/222.02  |- mesh__dateCreated mesh__D016957 1991-05-30
% 221.86/222.02  |- skos__prefLabel mesh__D016957 Burkholderia pseudomallei
% 221.86/222.02  |- mesh__recordOriginator mesh__D016957 PXP
% 221.86/222.02  |- rdf__type mesh__D016957sskos__Concept
% 221.86/222.02  |- skos__annotation mesh__D016957 infection = MELIOIDOSIS   
% 221.86/222.02  |- mesh__dateRevised mesh__D016957 2005-06-30
% 221.86/222.02  |- skos__scopeNote mesh__D016957
% 221.86/222.02       A species of gram-negative, aerobic bacteria that causes MELIOIDOSIS. It has been isolated from soil and water in tropical regions, particularly Southeast Asia.%A%    
% 221.86/222.02  |- skos__historyNote mesh__D016957 Pseudomonas %28%1967-1991%29%
% 221.86/222.02  |- skos__broader mesh__D016957smesh__D019117
% 221.86/222.02  |- mesh__historyNote mesh__D016957
% 221.86/222.02       96; was PSEUDOMONAS PSEUDOMALLEI 1992-95   
% 221.86/222.02  |- mesh__recordMaintainer mesh__D016957 SYSTEM
% 221.86/222.02  |- mesh__dateEstablished mesh__D016957 1992-01-01
% 221.86/222.02  |- mesh__publicMeSHNote mesh__D016957
% 221.86/222.02       96; was PSEUDOMONAS PSEUDOMALLEI 1992-95   
% 221.86/222.02  |- mesh__recordAuthorizer mesh__D016957 sjn
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D016957 2006
% 221.86/222.02  |- skos__broader mesh__D016159smesh__D010750
% 221.86/222.02  |- rdf__type mesh__D016159sskos__Concept
% 221.86/222.02  |- skos__prefLabel mesh__D016159 Tumor Suppressor Protein p53
% 221.86/222.02  |- mesh__recordOriginator mesh__D016159 AGS
% 221.86/222.02  |- skos__broader mesh__D016159smesh__D025521
% 221.86/222.02  |- skos__hiddenLabel mesh__D016159 Phosphoprotein, pp53
% 221.86/222.02  |- skos__altLabel mesh__D016159 pp53 Phosphoprotein
% 221.86/222.02  |- mesh__dateCreated mesh__D016159 1990-06-19
% 221.86/222.02  |- mesh__recordAuthorizer mesh__D016159 sjn
% 221.86/222.02  |- skos__altLabel mesh__D016159 p53 Tumor Suppressor Protein
% 221.86/222.02  |- mesh__dateRevised mesh__D016159 2005-06-30
% 221.86/222.02  |- mesh__publicMeSHNote mesh__D016159
% 221.86/222.02       2005; see TP53 PROTEIN 1991-2005; TP53 PROTEIN was indexed under NERVE TISSUE PROTEINS %26% NEOPLASM PROTEINS 1992-1993%A%  
% 221.86/222.02  |- skos__historyNote mesh__D016159 Oncogene Products %28%1990%29%
% 221.86/222.02  |- skos__altLabel mesh__D016159 Cellular Tumor Antigen p53
% 221.86/222.02  |- skos__historyNote mesh__D016159 Phosphoproteins %28%1981-1990%29%
% 221.86/222.02  |- skos__altLabel mesh__D016159 p53 Antigen
% 221.86/222.02  |- skos__altLabel mesh__D016159 TRP53 Protein
% 221.86/222.02  |- mesh__dateEstablished mesh__D016159 1991-01-01
% 221.86/222.02  |- mesh__recordMaintainer mesh__D016159 DRC
% 221.86/222.02  |- skos__altLabel mesh__D016159 TP53 Protein
% 221.86/222.02  |- mesh__activeMeSHYear mesh__D016159 2006
% 221.86/222.02  |- skos__broader mesh__D016159smesh__D009687
% 221.86/222.02  |- skos__altLabel mesh__D016159 Oncoprotein p53
% 221.86/222.02  |- mesh__historyNote mesh__D016159 2005%28%1991%29%;   
% 221.86/222.02  |- skos__scopeNote mesh__D016159
% 221.86/222.02       Nuclear phosphoprotein encoded by the p53 gene %28%GENES, P53%29% whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER.%A%    
% 221.86/222.02  |- skos__historyNote mesh__D016159 Neoplasm Proteins %28%1981-1989%29%
% 221.86/222.02  |- skos__broader mesh__D016159smesh__D004268
% 221.86/222.02  |- skos__broader mesh__D002937smesh__D006575
% 221.86/222.02  |- mesh__recordMaintainer mesh__D002937 ssb
% 221.86/222.02  |- skos__prefLabel mesh__D002937 Cinoxacin
% 221.86/222.02  |- rdf__type mesh__D002937sskos__Concept
% 221.86/222.02  |- skos__scopeNote mesh__D002937
% 221.86/222.02       Synthetic antimicrobial related to OXOLINIC ACID and NALIDIXIC ACID and used in URINARY TRACT INFECTIONS.%A%    
% 221.86/222.02  |- skos__altLabel mesh__D002937 Azolinic Acid
% 221.86/222.02  |- mesh__recordAuthorizer mesh__D002937 sjn
% 221.86/222.03  |- mesh__publicMeSHNote mesh__D002937
% 221.86/222.03       91; was see under PYRIDAZINES 1980-90   
% 221.86/222.03  |- skos__hiddenLabel mesh__D002937 64716, Compound
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D002937 2005
% 221.86/222.03  |- skos__hiddenLabel mesh__D002937 Acid, Azolinic
% 221.86/222.03  |- skos__broader mesh__D002937smesh__D000147
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D002937 2006
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D002937 2004
% 221.86/222.03  |- mesh__recordOriginator mesh__D002937 SH
% 221.86/222.03  |- skos__historyNote mesh__D002937 Pyridazines %28%1966-1979%29%
% 221.86/222.03  |- mesh__dateRevised mesh__D002937 2003-07-09
% 221.86/222.03  |- mesh__dateEstablished mesh__D002937 1991-01-01
% 221.86/222.03  |- mesh__dateCreated mesh__D002937 1979-03-01
% 221.86/222.03  |- mesh__historyNote mesh__D002937
% 221.86/222.03       91%28%80%29%; was see under PYRIDAZINES 1980-90   
% 221.86/222.03  |- skos__altLabel mesh__D002937 Clinoxacin
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D002139 2005
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D002139 2004
% 221.86/222.03  |- skos__historyNote mesh__D002139 Picornaviridae %28%1966-1978%29%
% 221.86/222.03  |- skos__scopeNote mesh__D002139
% 221.86/222.03       A family of RNA viruses infecting a broad range of animals. Most individual species are restricted to their natural hosts. They possess a characteristic six-pointed starlike shape whose surfaces have cup-shaped %28%chalice%29% indentions. Transmission is by contaminated food, water, fomites, and occasionally aerosolization of secretions. Genera include LAGOVIRUS; NORWALK-LIKE VIRUSES; SAPPORO-LIKE VIRUSES; and VESIVIRUS.%A%    
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D002139 2006
% 221.86/222.03  |- mesh__onlineNote mesh__D002139
% 221.86/222.03       use CALICIVIRIDAE to search CALICIVIRUSES 1979-81 %26% 1993   
% 221.86/222.03  |- mesh__recordAuthorizer mesh__D002139 sjn
% 221.86/222.03  |- mesh__dateCreated mesh__D002139 1977-12-02
% 221.86/222.03  |- mesh__dateEstablished mesh__D002139 1979-01-01
% 221.86/222.03  |- mesh__recordMaintainer mesh__D002139 ags
% 221.86/222.03  |- skos__prefLabel mesh__D002139 Caliciviridae
% 221.86/222.03  |- mesh__historyNote mesh__D002139
% 221.86/222.03       82; was CALICIVIRUSES 1979-81; CALICIVIRUSES was see CALICVIRIDAE 1993%A%  
% 221.86/222.03  |- rdf__type mesh__D002139sskos__Concept
% 221.86/222.03  |- mesh__recordOriginator mesh__D002139 AEP
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D002139 2002
% 221.86/222.03  |- mesh__dateRevised mesh__D002139 2001-07-25
% 221.86/222.03  |- skos__broader mesh__D002139smesh__D012328
% 221.86/222.03  |- skos__annotation mesh__D002139 infection = CALICIVIRIDAE INFECTIONS   
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D002139 2003
% 221.86/222.03  |- mesh__publicMeSHNote mesh__D002139
% 221.86/222.03       82; was CALICIVIRUSES 1979-81; CALICIVIRUSES was see CALICIVIRIDAE 1993%A%  
% 221.86/222.03  |- skos__annotation mesh__D012567
% 221.86/222.03       infection: coord IM with MYCOSES %28%IM%29% or specific mycosis %28%IM%29%%A%  
% 221.86/222.03  |- mesh__dateRevised mesh__D012567 2005-06-30
% 221.86/222.03  |- mesh__recordMaintainer mesh__D012567 ags
% 221.86/222.03  |- skos__prefLabel mesh__D012567 Schizophyllum
% 221.86/222.03  |- skos__scopeNote mesh__D012567
% 221.86/222.03       A genus of fleshy shelf basidiomycetous fungi, family Schizophyllaceae, order POLYPORALES, growing on woody substrata. It is pathogenic in humans.%A%    
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D012567 2006
% 221.86/222.03  |- rdf__type mesh__D012567sskos__Concept
% 221.86/222.03  |- skos__broader mesh__D012567smesh__D000363
% 221.86/222.03  |- mesh__recordOriginator mesh__D012567 NLM
% 221.86/222.03  |- mesh__dateEstablished mesh__D012567 1991-01-01
% 221.86/222.03  |- mesh__dateCreated mesh__D012567 1974-12-12
% 221.86/222.03  |- mesh__publicMeSHNote mesh__D012567
% 221.86/222.03       91; see BASIDIOMYCETES 1986-90, see AGARICACEAE 1975-85   
% 221.86/222.03  |- mesh__historyNote mesh__D012567 91%28%75%29%   
% 221.86/222.03  |- mesh__recordAuthorizer mesh__D012567 sjn
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D031721 2005
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D031721 2006
% 221.86/222.03  |- skos__annotation mesh__D031721
% 221.86/222.03       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.86/222.03  |- mesh__historyNote mesh__D031721 2003   
% 221.86/222.03  |- mesh__dateEstablished mesh__D031721 2003-01-01
% 221.86/222.03  |- mesh__publicMeSHNote mesh__D031721 2003   
% 221.86/222.03  |- rdf__type mesh__D031721sskos__Concept
% 221.86/222.03  |- skos__broader mesh__D031721smesh__D031701
% 221.86/222.03  |- mesh__dateCreated mesh__D031721 2002-07-03
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D031721 2003
% 221.86/222.03  |- skos__prefLabel mesh__D031721 Piper betle
% 221.86/222.03  |- skos__scopeNote mesh__D031721
% 221.86/222.03       A plant genus of the family PIPERACEAE that is indigenous in the Indian Malay region and cultivated in Madagascar, and the West Indies. It contains chavibetol, chavicol and cadinene. The leaf is chewed as a stimulant, antiseptic and sialogogue. The common name of betel is also used for ARECA.%A%    
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D031721 2004
% 221.86/222.03  |- mesh__dateEstablished mesh__D017252 1993-01-01
% 221.86/222.03  |- skos__altLabel mesh__D017252 T3 Antigens
% 221.86/222.03  |- skos__annotation mesh__D017252 T-lymphocyte differentiation antigens   
% 221.86/222.03  |- skos__altLabel mesh__D017252 CD3 Antigen
% 221.86/222.03  |- mesh__historyNote mesh__D017252
% 221.86/222.03       93; was T3 ANTIGEN COMPLEX %28%NM%29% 1983-92; T3 ANTIGENS was see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-92%A%  
% 221.86/222.03  |- skos__hiddenLabel mesh__D017252 Antigen, T3
% 221.86/222.03  |- skos__hiddenLabel mesh__D017252 Antigen, CD3
% 221.86/222.03  |- skos__altLabel mesh__D017252 T3 Complex
% 221.86/222.03  |- mesh__recordMaintainer mesh__D017252 ssb
% 221.86/222.03  |- skos__altLabel mesh__D017252 CD3 Complex
% 221.86/222.03  |- mesh__onlineNote mesh__D017252
% 221.86/222.03       use ANTIGENS, CD3 %28%NM%29% to search T3 ANTIGEN COMPLEX 1983-92; use ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE to search T3 ANTIGENS 1988-92%A%  
% 221.86/222.03  |- mesh__recordAuthorizer mesh__D017252 sjn
% 221.86/222.03  |- skos__altLabel mesh__D017252 T3 Antigen
% 221.86/222.03  |- skos__historyNote mesh__D017252 Antigens, Surface %28%1983-1987%29%
% 221.86/222.03  |- skos__hiddenLabel mesh__D017252 Antigens, T3
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D017252 2006
% 221.86/222.03  |- mesh__publicMeSHNote mesh__D017252
% 221.86/222.03       93; T3 ANTIGEN COMPLEX was indexed under RECEPTORS, ANTIGEN, T-CELL 1990-92 %26% ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-92 %26% ANTIGENS, SURFACE 1983-87 %26% ANTIGENS 1983-84; T3 ANTIGENS was see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-92%A%  
% 221.86/222.03  |- skos__historyNote mesh__D017252
% 221.86/222.03       Antigens, Differentiation, T-Lymphocyte %28%1988-1992%29%
% 221.86/222.03  |- skos__prefLabel mesh__D017252 Antigens, CD3
% 221.86/222.03  |- skos__altLabel mesh__D017252 CD3 Antigens
% 221.86/222.03  |- skos__broader mesh__D017252smesh__D015703
% 221.86/222.03  |- skos__historyNote mesh__D017252
% 221.86/222.03       Receptors, Antigen, T-Cell %28%1990-1992%29%
% 221.86/222.03  |- mesh__dateRevised mesh__D017252 2005-06-30
% 221.86/222.03  |- skos__historyNote mesh__D017252 Antigens %28%1983-1984%29%
% 221.86/222.03  |- rdf__type mesh__D017252sskos__Concept
% 221.86/222.03  |- mesh__recordOriginator mesh__D017252 AGS
% 221.86/222.03  |- skos__related mesh__D017252smesh__D011948
% 221.86/222.03  |- mesh__dateCreated mesh__D017252 1992-05-07
% 221.86/222.03  |- skos__scopeNote mesh__D017252
% 221.86/222.03       Complex of at least five membrane-bound polypeptides in mature T-lymphocytes that are non-covalently associated with one another and with the T-cell receptor %28%RECEPTORS, ANTIGEN, T-CELL%29%. The CD3 complex includes the gamma, delta, epsilon, zeta, and eta chains %28%subunits%29%. When antigen binds to the T-cell receptor, the CD3 complex transduces the activating signals to the cytoplasm of the T-cell. The CD3 gamma and delta chains %28%subunits%29% are separate from and not related to the gamma/delta chains of the T-cell receptor %28%RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA%29%.%A%    
% 221.86/222.03  |- skos__broader mesh__D017252smesh__D000945
% 221.86/222.03  |- skos__hiddenLabel mesh__D050686 Whale, Pilot
% 221.86/222.03  |- skos__hiddenLabel mesh__D050686 Pilot Whale
% 221.86/222.03  |- skos__prefLabel mesh__D050686 Whales, Pilot
% 221.86/222.03  |- mesh__historyNote mesh__D050686 2006; use DOLPHINS 1998-2005   
% 221.86/222.03  |- mesh__recordOriginator mesh__D050686 ags
% 221.86/222.03  |- mesh__dateEstablished mesh__D050686 2006-01-01
% 221.86/222.03  |- mesh__publicMeSHNote mesh__D050686 2006; use DOLPHINS 1998-2005   
% 221.86/222.03  |- skos__altLabel mesh__D050686 Globicephala
% 221.86/222.03  |- skos__historyNote mesh__D050686 Dolphins %28%1990-2005%29%
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D050686 2006
% 221.86/222.03  |- rdf__type mesh__D050686sskos__Concept
% 221.86/222.03  |- skos__scopeNote mesh__D050686
% 221.86/222.03       The genus Globicephala, in the family Delphinidae, consisting of two species of DOLPHINS. They are mostly black with a stocky shape and bulbous foreheads.%A%    
% 221.86/222.03  |- skos__altLabel mesh__D050686 Globicephala melaena
% 221.86/222.03  |- mesh__dateCreated mesh__D050686 2005-06-30
% 221.86/222.03  |- mesh__recordMaintainer mesh__D050686 ags
% 221.86/222.03  |- skos__broader mesh__D050686smesh__D004289
% 221.86/222.03  |- mesh__recordAuthorizer mesh__D050686 sjn
% 221.86/222.03  |- skos__altLabel mesh__D050686 Pilot Whales
% 221.86/222.03  |- mesh__recordMaintainer mesh__D003232 TGC
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003232 2005
% 221.86/222.03  |- skos__hiddenLabel mesh__D003232 Hemorrhagic Conjunctivitis, Acute
% 221.86/222.03  |- mesh__dateCreated mesh__D003232 1985-06-05
% 221.86/222.03  |- skos__broader mesh__D003232smesh__D004769
% 221.86/222.03  |- skos__broader mesh__D003232smesh__D003384
% 221.86/222.03  |- mesh__recordAuthorizer mesh__D003232 PLS
% 221.86/222.03  |- mesh__dateEstablished mesh__D003232 1986-01-01
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003232 2002
% 221.86/222.03  |- mesh__dateRevised mesh__D003232 1991-04-29
% 221.86/222.03  |- rdf__type mesh__D003232sskos__Concept
% 221.86/222.03  |- skos__historyNote mesh__D003232 Hemorrhage %28%1966-1985%29%
% 221.86/222.03  |- skos__annotation mesh__D003232
% 221.86/222.03       coord IM with precoord virus infect %28%IM%29% + specific virus %28%IM%29%%A%  
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003232 2001
% 221.86/222.03  |- skos__hiddenLabel mesh__D003232 Conjunctivitides, Acute Hemorrhagic
% 221.86/222.03  |- skos__historyNote mesh__D003232 Conjunctivitis %28%1966-1985%29%
% 221.86/222.03  |- mesh__publicMeSHNote mesh__D003232 86   
% 221.86/222.03  |- skos__historyNote mesh__D003232 Enterovirus Infections %28%1966-1985%29%
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003232 1997
% 221.86/222.03  |- skos__hiddenLabel mesh__D003232 Hemorrhagic Conjunctivitides, Acute
% 221.86/222.03  |- skos__hiddenLabel mesh__D003232 Acute Hemorrhagic Conjunctivitides
% 221.86/222.03  |- skos__broader mesh__D003232smesh__D003236
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003232 2000
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003232 1999
% 221.86/222.03  |- skos__historyNote mesh__D003232 Disease Outbreaks %28%1966-1985%29%
% 221.86/222.03  |- mesh__recordOriginator mesh__D003232 RC
% 221.86/222.03  |- skos__hiddenLabel mesh__D003232 Acute Hemorrhagic Conjunctivitis
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003232 1993
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003232 1996
% 221.86/222.03  |- skos__scopeNote mesh__D003232
% 221.86/222.03       A highly contagious disease characterized by subconjunctival hemorrhage, sudden swelling of the eyelids and congestion, redness, and pain in the eye. Epidemic conjunctivitis caused by Enterovirus 70 %28%EV-70%29% was first described in Africa in 1969. It is caused also by Coxsackievirus A24 variant %28%CA24v%29%. Epidemics by this organism have appeared most frequently in Asia.%A%    
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003232 2004
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003232 1995
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003232 1998
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003232 2006
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003232 1992
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003232 2003
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003232 1994
% 221.86/222.03  |- mesh__historyNote mesh__D003232 86   
% 221.86/222.03  |- skos__prefLabel mesh__D003232 Conjunctivitis, Acute Hemorrhagic
% 221.86/222.03  |- skos__annotation mesh__D016958
% 221.86/222.03       infection: coord IM with PSEUDOMONAS INFECTIONS %28%IM%29%   
% 221.86/222.03  |- rdf__type mesh__D016958sskos__Concept
% 221.86/222.03  |- mesh__recordAuthorizer mesh__D016958 sjn
% 221.86/222.03  |- skos__scopeNote mesh__D016958
% 221.86/222.03       A species of gram-negative, aerobic bacteria isolated from soil and water as well as clinical specimens. Occasionally it is an opportunistic pathogen.%A%    
% 221.86/222.03  |- mesh__historyNote mesh__D016958 92   
% 221.86/222.03  |- skos__broader mesh__D016958smesh__D011549
% 221.86/222.03  |- mesh__recordMaintainer mesh__D016958 SYSTEM
% 221.86/222.03  |- mesh__dateRevised mesh__D016958 2005-06-30
% 221.86/222.03  |- skos__prefLabel mesh__D016958 Pseudomonas putida
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D016958 2006
% 221.86/222.03  |- skos__historyNote mesh__D016958 Pseudomonas %28%1966-1991%29%
% 221.86/222.03  |- mesh__dateCreated mesh__D016958 1991-05-30
% 221.86/222.03  |- mesh__publicMeSHNote mesh__D016958 92   
% 221.86/222.03  |- mesh__dateEstablished mesh__D016958 1992-01-01
% 221.86/222.03  |- mesh__recordOriginator mesh__D016958 PXP
% 221.86/222.03  |- mesh__publicMeSHNote mesh__D002938
% 221.86/222.03       91; was see under UROCHORDATA 1975-90   
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D002938 2005
% 221.86/222.03  |- mesh__recordMaintainer mesh__D002938 ags
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D002938 2006
% 221.86/222.03  |- mesh__dateRevised mesh__D002938 2003-07-09
% 221.86/222.03  |- mesh__dateCreated mesh__D002938 1974-12-12
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D002938 2004
% 221.86/222.03  |- skos__prefLabel mesh__D002938 Ciona intestinalis
% 221.86/222.03  |- skos__broader mesh__D002938smesh__D014561
% 221.86/222.03  |- mesh__dateEstablished mesh__D002938 1991-01-01
% 221.86/222.03  |- mesh__recordAuthorizer mesh__D002938 sjn
% 221.86/222.03  |- skos__scopeNote mesh__D002938
% 221.86/222.03       The only species of a cosmopolitan ascidian. It is useful as a research animal.%A%    
% 221.86/222.03  |- rdf__type mesh__D002938sskos__Concept
% 221.86/222.03  |- mesh__historyNote mesh__D002938
% 221.86/222.03       91%28%75%29%; was see under UROCHORDATA 1975-90   
% 221.86/222.03  |- mesh__recordOriginator mesh__D002938 NLM
% 221.86/222.03  |- skos__annotation mesh__D002938
% 221.86/222.03       a tunicate used in research; /microbiol /parasitol /virol permitted%A%  
% 221.86/222.03  |- skos__scopeNote mesh__D013660
% 221.86/222.03       Governmental levies on property, inheritance, gifts, etc.%A%    
% 221.86/222.03  |- rdf__type mesh__D013660sskos__Concept
% 221.86/222.03  |- skos__annotation mesh__D013660
% 221.86/222.03       coord IM with subject of tax %28%IM%29%; specify geog; INCOME TAX is also available%A%  
% 221.86/222.03  |- mesh__publicMeSHNote mesh__D013660 78   
% 221.86/222.03  |- mesh__onlineNote mesh__D013660
% 221.86/222.03       use TAXES to search INSTITUTIONAL TAXES 1978-82   
% 221.86/222.03  |- mesh__historyNote mesh__D013660
% 221.86/222.03       INSTITUTIONAL TAX was see under TAXES 1978-82   
% 221.86/222.03  |- mesh__recordAuthorizer mesh__D013660 sjn
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D013660 2002
% 221.86/222.03  |- skos__hiddenLabel mesh__D013660 Taxes, Institutional
% 221.86/222.03  |- mesh__recordOriginator mesh__D013660 EC
% 221.86/222.03  |- mesh__dateEstablished mesh__D013660 1978-01-01
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D013660 2004
% 221.86/222.03  |- skos__prefLabel mesh__D013660 Taxes
% 221.86/222.03  |- mesh__dateRevised mesh__D013660 1999-11-03
% 221.86/222.03  |- skos__altLabel mesh__D013660 Institutional Taxes
% 221.86/222.03  |- mesh__recordMaintainer mesh__D013660 kle
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D013660 2003
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D013660 2001
% 221.86/222.03  |- mesh__dateCreated mesh__D013660 1977-05-11
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D013660 2006
% 221.86/222.03  |- skos__broader mesh__D013660smesh__D004467
% 221.86/222.03  |- skos__hiddenLabel mesh__D013660 Tax, Institutional
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D013660 2005
% 221.86/222.03  |- skos__altLabel mesh__D013660 Tax
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D013660 2000
% 221.86/222.03  |- skos__annotation mesh__D007623 use this spelling in translations   
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D007623 2004
% 221.86/222.03  |- mesh__recordOriginator mesh__D007623 NLM
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D007623 1995
% 221.86/222.03  |- skos__broader mesh__D007623smesh__D017517
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D007623 1998
% 221.86/222.03  |- mesh__recordAuthorizer mesh__D007623 PLS
% 221.86/222.03  |- rdf__type mesh__D007623sskos__Concept
% 221.86/222.03  |- mesh__dateCreated mesh__D007623 1999-01-01
% 221.86/222.03  |- mesh__recordMaintainer mesh__D007623 PLS
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D007623 2000
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D007623 1999
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D007623 1996
% 221.86/222.03  |- mesh__onlineNote mesh__D007623
% 221.86/222.03       use KAZAKHSTAN to search KAZAKH S.S.R. 1982-92   
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D007623 2001
% 221.86/222.03  |- skos__broader mesh__D007623smesh__D001209
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D007623 1997
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D007623 2005
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D007623 2002
% 221.86/222.03  |- skos__altLabel mesh__D007623 Kazakh SSR
% 221.86/222.03  |- skos__prefLabel mesh__D007623 Kazakhstan
% 221.86/222.03  |- mesh__dateRevised mesh__D007623 1994-03-17
% 221.86/222.03  |- skos__altLabel mesh__D007623 Kazakh S.S.R.
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D007623 2006
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D007623 2003
% 221.86/222.03  |- skos__broader mesh__D007623smesh__D014586
% 221.86/222.03  |- mesh__historyNote mesh__D007623
% 221.86/222.03       93; was KAZAKH S.S.R. 1982-92; was heading 1963-81   
% 221.86/222.03  |- skos__broader mesh__D012568smesh__D001203
% 221.86/222.03  |- rdf__type mesh__D012568sskos__Concept
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D012568 2006
% 221.86/222.03  |- mesh__publicMeSHNote mesh__D012568
% 221.86/222.03       91; see ENDOMYCETALES 1986-90, see ASCOMYCETES 1975-85   
% 221.86/222.03  |- mesh__recordMaintainer mesh__D012568 SYSTEM
% 221.86/222.03  |- mesh__recordAuthorizer mesh__D012568 sjn
% 221.86/222.03  |- mesh__dateRevised mesh__D012568 2005-06-30
% 221.86/222.03  |- skos__altLabel mesh__D012568 Fission Yeast
% 221.86/222.03  |- skos__altLabel mesh__D012568 Yeast, Fission
% 221.86/222.03  |- mesh__dateCreated mesh__D012568 1974-12-12
% 221.86/222.03  |- mesh__dateEstablished mesh__D012568 1991-01-01
% 221.86/222.03  |- skos__altLabel mesh__D012568 S pombe
% 221.86/222.03  |- mesh__recordOriginator mesh__D012568 NLM
% 221.86/222.03  |- mesh__historyNote mesh__D012568 91%28%75%29%   
% 221.86/222.03  |- skos__scopeNote mesh__D012568
% 221.86/222.03       A genus of ascomycetous fungi of the family Schizosaccharomycetaceae, order Schizosaccharomycetales.%A%    
% 221.86/222.03  |- skos__related mesh__D012568smesh__D029702
% 221.86/222.03  |- skos__broader mesh__D012568smesh__D015003
% 221.86/222.03  |- skos__prefLabel mesh__D012568 Schizosaccharomyces
% 221.86/222.03  |- skos__scopeNote mesh__D031722
% 221.86/222.03       A plant genus of the family POACEAE. The common name of bluestem is also used for other plants in this family. Andropogon nardus has been reclassified as CYMBOPOGON nardus and Andropogon zizanioides to VETIVERIA zizanioides.%A%    
% 221.86/222.03  |- mesh__dateCreated mesh__D031722 2002-07-02
% 221.86/222.03  |- mesh__publicMeSHNote mesh__D031722 2003   
% 221.86/222.03  |- skos__broader mesh__D031722smesh__D006109
% 221.86/222.03  |- rdf__type mesh__D031722sskos__Concept
% 221.86/222.03  |- mesh__historyNote mesh__D031722 2003   
% 221.86/222.03  |- mesh__recordAuthorizer mesh__D031722 sjn
% 221.86/222.03  |- mesh__dateEstablished mesh__D031722 2003-01-01
% 221.86/222.03  |- skos__annotation mesh__D031722
% 221.86/222.03       ANDROPOGON NARDUS see CYMBOPOGON and ANDROPOGON ZIZANOIDES see VETIVERIA are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.86/222.03  |- mesh__recordOriginator mesh__D031722 ssb
% 221.86/222.03  |- mesh__dateRevised mesh__D031722 2005-06-30
% 221.86/222.03  |- skos__prefLabel mesh__D031722 Andropogon
% 221.86/222.03  |- mesh__recordMaintainer mesh__D031722 ssb
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D031722 2006
% 221.86/222.03  |- skos__broader mesh__D017253smesh__D020271
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D017253 2006
% 221.86/222.03  |- skos__altLabel mesh__D017253 Neurofibromatosis
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D017253 2002
% 221.86/222.03  |- mesh__recordOriginator mesh__D017253 AGS
% 221.86/222.03  |- skos__hiddenLabel mesh__D017253 Neurofibromatosis 3s
% 221.86/222.03  |- skos__altLabel mesh__D017253 Neurofibromatosis Syndrome
% 221.86/222.03  |- mesh__dateEstablished mesh__D017253 1993-01-01
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D017253 2005
% 221.86/222.03  |- skos__hiddenLabel mesh__D017253 Neurofibromatosis Syndromes
% 221.86/222.03  |- rdf__type mesh__D017253sskos__Concept
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D017253 2004
% 221.86/222.03  |- mesh__historyNote mesh__D017253 2000%28%1993%29%   
% 221.86/222.03  |- skos__hiddenLabel mesh__D017253 Syndromes, Neurofibromatosis
% 221.86/222.03  |- skos__broader mesh__D017253smesh__D009455
% 221.86/222.03  |- skos__broader mesh__D017253smesh__D020752
% 221.86/222.03  |- mesh__dateCreated mesh__D017253 1992-05-22
% 221.86/222.03  |- mesh__dateRevised mesh__D017253 2001-07-25
% 221.86/222.03  |- skos__hiddenLabel mesh__D017253 Neurofibroma, Multiple
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D017253 2003
% 221.86/222.03  |- mesh__recordAuthorizer mesh__D017253 sjn
% 221.86/222.03  |- skos__scopeNote mesh__D017253
% 221.86/222.03       A group of disorders characterized by an autosomal dominant pattern of inheritance with high rates of spontaneous mutation and multiple neurofibromas or neurilemmomas. NEUROFIBROMATOSIS 1 %28%generalized neurofibromatosis%29% accounts for approximately 95%25% of cases, although multiple additional subtypes %28%e.g., NEUROFIBROMATOSIS 2, neurofibromatosis 3, etc.%29% have been described. %28%From Neurochirurgie 1998 Nov;44%28%4%29%:267-72%29%%A%    
% 221.86/222.03  |- mesh__publicMeSHNote mesh__D017253
% 221.86/222.03       2000; see NEUROFIBROMATOSIS 1993-1999   
% 221.86/222.03  |- skos__altLabel mesh__D017253 Multiple Neurofibromas
% 221.86/222.03  |- skos__hiddenLabel mesh__D017253 Syndrome, Neurofibromatosis
% 221.86/222.03  |- mesh__recordMaintainer mesh__D017253 nns
% 221.86/222.03  |- skos__hiddenLabel mesh__D017253 Neurofibromas, Multiple
% 221.86/222.03  |- skos__broader mesh__D017253smesh__D009386
% 221.86/222.03  |- skos__annotation mesh__D017253
% 221.86/222.03       multiple neurofibromas; specifics are available   
% 221.86/222.03  |- skos__hiddenLabel mesh__D017253 Multiple Neurofibroma
% 221.86/222.03  |- skos__prefLabel mesh__D017253 Neurofibromatoses
% 221.86/222.03  |- skos__historyNote mesh__D050687 Cell Cycle Proteins %28%1991-2005%29%
% 221.86/222.03  |- skos__hiddenLabel mesh__D050687 Retinoblastoma Associated Protein 1
% 221.86/222.03  |- mesh__recordOriginator mesh__D050687 DRC
% 221.86/222.03  |- skos__hiddenLabel mesh__D050687 Transcription Factor, E2F1
% 221.86/222.03  |- rdf__type mesh__D050687sskos__Concept
% 221.86/222.03  |- skos__hiddenLabel mesh__D050687 Transcription Factor, E2F-1
% 221.86/222.03  |- skos__altLabel mesh__D050687 E2F-1 Transcription Factor
% 221.86/222.03  |- mesh__dateEstablished mesh__D050687 2006-01-01
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D050687 2006
% 221.86/222.03  |- mesh__dateRevised mesh__D050687 2005-07-13
% 221.86/222.03  |- skos__altLabel mesh__D050687 Transcription Factor E2F-1
% 221.86/222.03  |- skos__altLabel mesh__D050687 E2F-1 Protein
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D050687 2006A
% 221.86/222.03  |- mesh__recordMaintainer mesh__D050687 ags
% 221.86/222.03  |- skos__annotation mesh__D050687 see SCR for organism-specific terms   
% 221.86/222.03  |- skos__hiddenLabel mesh__D050687 Transcription Factor E2F 1
% 221.86/222.03  |- skos__historyNote mesh__D050687 Transcription Factors %28%1991-2005%29%
% 221.86/222.03  |- skos__altLabel mesh__D050687 Retinoblastoma Binding Protein 3
% 221.86/222.03  |- skos__prefLabel mesh__D050687 E2F1 Transcription Factor
% 221.86/222.03  |- skos__altLabel mesh__D050687 Retinoblastoma-Associated Protein 1
% 221.86/222.03  |- mesh__historyNote mesh__D050687 2006%28%1991%29%   
% 221.86/222.03  |- skos__broader mesh__D050687smesh__D050684
% 221.86/222.03  |- skos__altLabel mesh__D050687 Transcription Factor E2F1
% 221.86/222.03  |- skos__altLabel mesh__D050687 E2F Transcription Factor 1 Protein
% 221.86/222.03  |- mesh__recordAuthorizer mesh__D050687 ags
% 221.86/222.03  |- mesh__publicMeSHNote mesh__D050687
% 221.86/222.03       2006; E2F TRANSCRIPTION FACTORS was indexed under CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; %26% TRANSCRIPTION FACTORS 1991-2005%A%  
% 221.86/222.03  |- skos__scopeNote mesh__D050687
% 221.86/222.03       An E2F transcription factor that interacts directly with RETINOBLASTOMA PROTEIN and CYCLIN A and activates GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis.  E2F1 is involved in DNA REPAIR and APOPTOSIS.%A%    
% 221.86/222.03  |- skos__historyNote mesh__D050687 DNA-Binding Proteins %28%1991-2005%29%
% 221.86/222.03  |- mesh__dateCreated mesh__D050687 2005-06-30
% 221.86/222.03  |- mesh__recordAuthorizer mesh__D003233 NLM
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003233 2006
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003233 2001
% 221.86/222.03  |- skos__hiddenLabel mesh__D003233 Vernal Keratoconjunctivitides
% 221.86/222.03  |- skos__hiddenLabel mesh__D003233 Conjunctivitides, Giant Papillary
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003233 2003
% 221.86/222.03  |- skos__hiddenLabel mesh__D003233 Vernal Conjunctivitides
% 221.86/222.03  |- skos__hiddenLabel mesh__D003233 Giant Papillary Conjunctivitis
% 221.86/222.03  |- mesh__historyNote mesh__D003233 86   
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003233 1994
% 221.86/222.03  |- skos__hiddenLabel mesh__D003233 Keratoconjunctivitides, Vernal
% 221.86/222.03  |- skos__annotation mesh__D003233
% 221.86/222.03       coord IM with etiol of the allergy %28%IM%29% if specified   
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003233 2002
% 221.86/222.03  |- mesh__dateCreated mesh__D003233 1985-06-06
% 221.86/222.03  |- skos__hiddenLabel mesh__D003233 Papillary Conjunctivitis, Giant
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003233 2004
% 221.86/222.03  |- skos__hiddenLabel mesh__D003233 Papillary Conjunctivitides, Giant
% 221.86/222.03  |- skos__scopeNote mesh__D003233
% 221.86/222.03       Conjunctivitis due to hypersensitivity to various allergens.%A%    
% 221.86/222.03  |- mesh__publicMeSHNote mesh__D003233 86   
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003233 1998
% 221.86/222.03  |- skos__broader mesh__D003233smesh__D006969
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003233 1995
% 221.86/222.03  |- skos__hiddenLabel mesh__D003233 Allergic Conjunctivitides
% 221.86/222.03  |- skos__hiddenLabel mesh__D003233 Vernal Keratoconjunctivitis
% 221.86/222.03  |- mesh__recordMaintainer mesh__D003233 PLS
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003233 1992
% 221.86/222.03  |- skos__prefLabel mesh__D003233 Conjunctivitis, Allergic
% 221.86/222.03  |- skos__historyNote mesh__D003233 Hypersensitivity %28%1966-1985%29%
% 221.86/222.03  |- skos__hiddenLabel mesh__D003233 Vernal Conjunctivitis
% 221.86/222.03  |- skos__hiddenLabel mesh__D003233 Atopic Conjunctivitides
% 221.86/222.03  |- skos__altLabel mesh__D003233 Conjunctivitis, Atopic
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003233 1999
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003233 1991
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003233 1996
% 221.86/222.03  |- skos__hiddenLabel mesh__D003233 Conjunctivitides, Atopic
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003233 1993
% 221.86/222.03  |- skos__altLabel mesh__D003233 Allergic Conjunctivitis
% 221.86/222.03  |- mesh__recordOriginator mesh__D003233 RC
% 221.86/222.03  |- rdf__type mesh__D003233sskos__Concept
% 221.86/222.03  |- mesh__dateEstablished mesh__D003233 1986-01-01
% 221.86/222.03  |- mesh__dateRevised mesh__D003233 1990-05-29
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003233 2005
% 221.86/222.03  |- skos__hiddenLabel mesh__D003233 Conjunctivitides, Vernal
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003233 2000
% 221.86/222.03  |- skos__historyNote mesh__D003233 Conjunctivitis %28%1966-1985%29%
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D003233 1997
% 221.86/222.03  |- skos__hiddenLabel mesh__D003233 Conjunctivitides, Allergic
% 221.86/222.03  |- skos__hiddenLabel mesh__D003233 Giant Papillary Conjunctivitides
% 221.86/222.03  |- skos__hiddenLabel mesh__D003233 Atopic Conjunctivitis
% 221.86/222.03  |- skos__broader mesh__D003233smesh__D003231
% 221.86/222.03  |- skos__prefLabel mesh__D016959 Xanthomonas campestris
% 221.86/222.03  |- mesh__recordOriginator mesh__D016959 PXP
% 221.86/222.03  |- skos__broader mesh__D016959smesh__D014974
% 221.86/222.03  |- rdf__type mesh__D016959sskos__Concept
% 221.86/222.03  |- mesh__recordAuthorizer mesh__D016959 sjn
% 221.86/222.03  |- mesh__historyNote mesh__D016959 92   
% 221.86/222.03  |- mesh__recordMaintainer mesh__D016959 SYSTEM
% 221.86/222.03  |- skos__historyNote mesh__D016959 Xanthomonas %28%1966-1991%29%
% 221.86/222.03  |- mesh__publicMeSHNote mesh__D016959 92   
% 221.86/222.03  |- mesh__dateCreated mesh__D016959 1991-05-30
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D016959 2006
% 221.86/222.03  |- skos__scopeNote mesh__D016959
% 221.86/222.03       A species of gram-negative, aerobic bacteria that is pathogenic for plants.%A%    
% 221.86/222.03  |- mesh__dateEstablished mesh__D016959 1992-01-01
% 221.86/222.03  |- mesh__dateRevised mesh__D016959 2005-06-30
% 221.86/222.03  |- mesh__dateEstablished mesh__D027681 2002-01-01
% 221.86/222.03  |- skos__broader mesh__D027681smesh__D008517
% 221.86/222.03  |- mesh__historyNote mesh__D027681 2002   
% 221.86/222.03  |- skos__prefLabel mesh__D027681 Eclecticism, Historical
% 221.86/222.03  |- mesh__publicMeSHNote mesh__D027681 2002   
% 221.86/222.03  |- skos__hiddenLabel mesh__D027681 Historical Eclecticism
% 221.86/222.03  |- mesh__dateCreated mesh__D027681 2001-07-25
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D027681 2006
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D027681 2004
% 221.86/222.03  |- rdf__type mesh__D027681sskos__Concept
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D027681 2005
% 221.86/222.03  |- mesh__activeMeSHYear mesh__D027681 2002
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D027681 2003
% 221.86/222.04  |- skos__scopeNote mesh__D027681
% 221.86/222.04       A system of medicine, most popular in the 19th century, that advocates the use of indigenous plants in the treatment of specific signs and symptoms.%A%    
% 221.86/222.04  |- mesh__recordAuthorizer mesh__D002939 sjn
% 221.86/222.04  |- skos__hiddenLabel mesh__D002939 Hydrochloride, Ciprofloxacin
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D002939 2006
% 221.86/222.04  |- mesh__historyNote mesh__D002939 87   
% 221.86/222.04  |- mesh__dateRevised mesh__D002939 2003-07-09
% 221.86/222.04  |- mesh__recordOriginator mesh__D002939 RLS
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D002939 2004
% 221.86/222.04  |- skos__historyNote mesh__D002939 Quinolines %28%1966-1986%29%
% 221.86/222.04  |- skos__hiddenLabel mesh__D002939 Bay 09867
% 221.86/222.04  |- mesh__publicMeSHNote mesh__D002939 87   
% 221.86/222.04  |- rdf__type mesh__D002939sskos__Concept
% 221.86/222.04  |- mesh__recordMaintainer mesh__D002939 ssb
% 221.86/222.04  |- skos__prefLabel mesh__D002939 Ciprofloxacin
% 221.86/222.04  |- skos__scopeNote mesh__D002939
% 221.86/222.04       A broad-spectrum antimicrobial carboxyfluoroquinoline.     
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D002939 2005
% 221.86/222.04  |- mesh__dateEstablished mesh__D002939 1987-01-01
% 221.86/222.04  |- mesh__dateCreated mesh__D002939 1986-06-16
% 221.86/222.04  |- skos__hiddenLabel mesh__D002939 Bay09867
% 221.86/222.04  |- skos__broader mesh__D002939smesh__D024841
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D013661 2004
% 221.86/222.04  |- skos__historyNote mesh__D013661 Lipoidosis %28%1966-1978%29%
% 221.86/222.04  |- mesh__publicMeSHNote mesh__D013661
% 221.86/222.04       1979; see AMAUROTIC FAMILIAL IDIOCY 1963-1978   
% 221.86/222.04  |- skos__altLabel mesh__D013661 G%28%M2%29% Gangliosidosis, Type I
% 221.86/222.04  |- skos__altLabel mesh__D013661 Gangliosidosis G%28%M2%29%, Type I
% 221.86/222.04  |- skos__broader mesh__D013661smesh__D020143
% 221.86/222.04  |- skos__altLabel mesh__D013661 GM2 Gangliosidosis, Type I
% 221.86/222.04  |- mesh__recordMaintainer mesh__D013661 jmp
% 221.86/222.04  |- skos__scopeNote mesh__D013661
% 221.86/222.04       An autosomal recessive inherited gangliosidosis characterized by the onset in the first 6 months of life of an exaggerated startle response, delay in psychomotor development, hypotonia %28%followed by spasticity%29%, visual loss, and a macular cherry red spot. Hexosaminidase A %28%see BETA-N-ACETYLHEXOSAMINIDASE%29% is deficient, leading to the accumulation of GM2 ganglioside in neurons of the central nervous system and retina. This condition is strongly associated with Askenazic Jewish ancestory. %28%Menkes, Textbook of Pediatric Neurology, 5th ed pp89-96%29%%A%    
% 221.86/222.04  |- skos__altLabel mesh__D013661 Gangliosidosis GM2, Type I
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D013661 2006
% 221.86/222.04  |- mesh__historyNote mesh__D013661
% 221.86/222.04       1979; use AMAUROTIC FAMILIAL IDIOCY 1963-1978   
% 221.86/222.04  |- skos__altLabel mesh__D013661 Hexosaminidase A Deficiency Disease
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D013661 2005
% 221.86/222.04  |- mesh__dateCreated mesh__D013661 1978-05-22
% 221.86/222.04  |- skos__hiddenLabel mesh__D013661 Tay Sachs Disease
% 221.86/222.04  |- mesh__dateRevised mesh__D013661 2003-07-09
% 221.86/222.04  |- skos__related mesh__D013661smesh__D001619
% 221.86/222.04  |- mesh__recordAuthorizer mesh__D013661 sjn
% 221.86/222.04  |- rdf__type mesh__D013661sskos__Concept
% 221.86/222.04  |- mesh__recordOriginator mesh__D013661 RC
% 221.86/222.04  |- skos__prefLabel mesh__D013661 Tay-Sachs Disease
% 221.86/222.04  |- skos__altLabel mesh__D013661 Deficiency Disease Hexosaminidase A
% 221.86/222.04  |- mesh__dateEstablished mesh__D013661 1979-01-01
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D007624 2006
% 221.86/222.04  |- mesh__recordAuthorizer mesh__D007624 sjn
% 221.86/222.04  |- mesh__dateCreated mesh__D007624 1984-04-05
% 221.86/222.04  |- mesh__recordOriginator mesh__D007624 AEP
% 221.86/222.04  |- skos__scopeNote mesh__D007624
% 221.86/222.04       This line KB is now known to be a subline of the ubiquitous KERATIN-forming tumor cell line HeLa. It was originally thought to be derived from an epidermal carcinoma of the mouth, but was subsequently found, based on isoenzyme analysis, HeLa marker chromosomes, and DNA fingerprinting, to have been established via contamination by HELA CELLS. The cells are positive for keratin by immunoperoxidase staining. KB cells have been reported to contain human papillomavirus18 %28%HPV-18%29% sequences.%A%    
% 221.86/222.04  |- skos__hiddenLabel mesh__D007624 Cells, HeLa-KB
% 221.86/222.04  |- skos__prefLabel mesh__D007624 KB Cells
% 221.86/222.04  |- skos__annotation mesh__D007624
% 221.86/222.04       almost always NIM with no subheadings; check HUMAN; do not routinely add neoplasm term%A%  
% 221.86/222.04  |- mesh__recordMaintainer mesh__D007624 ags
% 221.86/222.04  |- mesh__dateEstablished mesh__D007624 1985-01-01
% 221.86/222.04  |- rdf__type mesh__D007624sskos__Concept
% 221.86/222.04  |- skos__hiddenLabel mesh__D007624 Cell, KB
% 221.86/222.04  |- skos__hiddenLabel mesh__D007624 KB Cell
% 221.86/222.04  |- skos__hiddenLabel mesh__D007624 HeLa-KB Cell
% 221.86/222.04  |- skos__hiddenLabel mesh__D007624 Cell, HeLa-KB
% 221.86/222.04  |- skos__hiddenLabel mesh__D007624 HeLa KB Cells
% 221.86/222.04  |- skos__altLabel mesh__D007624 HeLa-KB Cells
% 221.86/222.04  |- skos__historyNote mesh__D007624 Cell Line %28%1969-1984%29%
% 221.86/222.04  |- skos__broader mesh__D007624smesh__D006367
% 221.86/222.04  |- mesh__publicMeSHNote mesh__D007624 85   
% 221.86/222.04  |- skos__hiddenLabel mesh__D007624 Cells, KB
% 221.86/222.04  |- mesh__dateRevised mesh__D007624 2005-06-30
% 221.86/222.04  |- skos__historyNote mesh__D007624 Tissue Culture %28%1966-1971%29%
% 221.86/222.04  |- mesh__historyNote mesh__D007624 85   
% 221.86/222.04  |- skos__altLabel mesh__D051780 SRE-1 Binding Protein
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D051780 2006
% 221.86/222.04  |- mesh__dateCreated mesh__D051780 2005-06-30
% 221.86/222.04  |- skos__altLabel mesh__D051780 Transcription Factor ADD1
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D051780 2006B
% 221.86/222.04  |- mesh__publicMeSHNote mesh__D051780
% 221.86/222.04       2006; STEROL REGULATORY ELEMENT BINDING PROTEIN 1 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1993-2005, %26% under CCAAT-ENHANCER-BINDING PROTEINS 2001-2005, %26% under NUCLEAR PROTEINS 1999-2000%A%  
% 221.86/222.04  |- skos__hiddenLabel mesh__D051780 ADD1, Transcription Factor
% 221.86/222.04  |- mesh__recordMaintainer mesh__D051780 ags
% 221.86/222.04  |- skos__broader mesh__D051780smesh__D051779
% 221.86/222.04  |- skos__hiddenLabel mesh__D051780 SREBP 1c
% 221.86/222.04  |- skos__altLabel mesh__D051780 Sterol Regulatory Element-Binding Protein 1
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D051780 2006C
% 221.86/222.04  |- mesh__recordAuthorizer mesh__D051780 ags
% 221.86/222.04  |- mesh__dateRevised mesh__D051780 2005-08-03
% 221.86/222.04  |- rdf__type mesh__D051780sskos__Concept
% 221.86/222.04  |- skos__altLabel mesh__D051780 SREBP-1a
% 221.86/222.04  |- mesh__recordOriginator mesh__D051780 DRC
% 221.86/222.04  |- mesh__historyNote mesh__D051780 2006%28%1993%29%   
% 221.86/222.04  |- skos__hiddenLabel mesh__D051780 SRE 1 Binding Protein
% 221.86/222.04  |- skos__altLabel mesh__D051780
% 221.86/222.04       Adipocyte Determination And Differentiation Factor 1
% 221.86/222.04  |- skos__hiddenLabel mesh__D051780 SREBP 1a
% 221.86/222.04  |- skos__altLabel mesh__D051780 SREBP-1c
% 221.86/222.04  |- skos__prefLabel mesh__D051780
% 221.86/222.04       Sterol Regulatory Element Binding Protein 1
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D051780 2006A
% 221.86/222.04  |- skos__altLabel mesh__D051780 SREBP1 Protein
% 221.86/222.04  |- mesh__dateEstablished mesh__D051780 2006-01-01
% 221.86/222.04  |- skos__scopeNote mesh__D051780
% 221.86/222.04       A sterol regulatory element binding protein that regulates expression of GENES involved in FATTY ACIDS metabolism and LIPOGENESIS. Two major isoforms of the protein exist due to ALTERNATIVE SPLICING.%A%    
% 221.86/222.04  |- skos__altLabel mesh__D045743 Diffuse Scleroderma
% 221.86/222.04  |- mesh__historyNote mesh__D045743
% 221.86/222.04       2004; use SCLERODERMA, SYSTEMIC 1975-2003   
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D045743 2006
% 221.86/222.04  |- skos__altLabel mesh__D045743 Sclerosis, Progressive Systemic
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D045743 2004
% 221.86/222.04  |- skos__hiddenLabel mesh__D045743 Progressive Systemic Sclerosis
% 221.86/222.04  |- skos__hiddenLabel mesh__D045743 Progressive Scleroderma
% 221.86/222.04  |- skos__altLabel mesh__D045743 Scleroderma, Progressive
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D045743 2005
% 221.86/222.04  |- mesh__dateCreated mesh__D045743 2003-07-09
% 221.86/222.04  |- mesh__dateEstablished mesh__D045743 2004-01-01
% 221.86/222.04  |- skos__prefLabel mesh__D045743 Scleroderma, Diffuse
% 221.86/222.04  |- skos__broader mesh__D045743smesh__D012595
% 221.86/222.04  |- skos__historyNote mesh__D045743 Scleroderma, Systemic %28%1975-2003%29%
% 221.86/222.04  |- skos__scopeNote mesh__D045743
% 221.86/222.04       A rapid onset form of SYSTEMIC SCLERODERMA with progressive widespread SKIN thickening over the arms, the legs and the trunk, resulting in stiffness and disability.%A%    
% 221.86/222.04  |- skos__hiddenLabel mesh__D045743 Systemic Sclerosis, Progressive
% 221.86/222.04  |- rdf__type mesh__D045743sskos__Concept
% 221.86/222.04  |- mesh__publicMeSHNote mesh__D045743
% 221.86/222.04       2004; see SCLERODERMA, SYSTEMIC 1975-2003   
% 221.86/222.04  |- skos__altLabel mesh__D012569 Personality Disorder, Schizotypal
% 221.86/222.04  |- skos__hiddenLabel mesh__D012569 Schizophrenias, Latent
% 221.86/222.04  |- skos__historyNote mesh__D012569 Schizophrenia %28%1966-1971%29%
% 221.86/222.04  |- skos__hiddenLabel mesh__D012569 Schizophrenia, Incipient
% 221.86/222.04  |- skos__scopeNote mesh__D012569
% 221.86/222.04       A personality disorder in which there are oddities of thought %28%magical thinking, paranoid ideation, suspiciousness%29%, perception %28%illusions, depersonalization%29%, speech %28%digressive, vague, overelaborate%29%, and behavior %28%inappropriate affect in social interactions, frequently social isolation%29% that are not severe enough to characterize schizophrenia.%A%    
% 221.86/222.04  |- skos__broader mesh__D012569smesh__D010554
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D012569 2002
% 221.86/222.04  |- mesh__dateCreated mesh__D012569 1999-01-01
% 221.86/222.04  |- skos__hiddenLabel mesh__D012569 Disorder, Schizotypal Personality
% 221.86/222.04  |- rdf__type mesh__D012569sskos__Concept
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D012569 2003
% 221.86/222.04  |- skos__hiddenLabel mesh__D012569 Schizophrenia, Pseudopsychopathic
% 221.86/222.04  |- skos__hiddenLabel mesh__D012569 Schizotypal Personality Disorders
% 221.86/222.04  |- mesh__recordMaintainer mesh__D012569 JLS
% 221.86/222.04  |- skos__hiddenLabel mesh__D012569 Latent Schizophrenias
% 221.86/222.04  |- skos__hiddenLabel mesh__D012569 Incipient Schizophrenias
% 221.86/222.04  |- mesh__recordOriginator mesh__D012569 NLM
% 221.86/222.04  |- mesh__historyNote mesh__D012569
% 221.86/222.04       81; was SCHIZOPHRENIA, LATENT 1972-80 %28%Prov 1972%29%   
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D012569 2004
% 221.86/222.04  |- skos__hiddenLabel mesh__D012569 Schizophrenias, Incipient
% 221.86/222.04  |- skos__altLabel mesh__D012569 Latent Schizophrenia
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D012569 1998
% 221.86/222.04  |- mesh__onlineNote mesh__D012569
% 221.86/222.04       use SCHIZOTYPAL PERSONALITY DISORDER to search SCHIZOPHRENIA, LATENT 1972-80 %28%as Prov 1972%29%%A%  
% 221.86/222.04  |- mesh__recordAuthorizer mesh__D012569 SJN
% 221.86/222.04  |- skos__hiddenLabel mesh__D012569 Pseudopsychopathic Schizophrenias
% 221.86/222.04  |- skos__altLabel mesh__D012569 Pseudoneurotic Schizophrenia
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D012569 2000
% 221.86/222.04  |- skos__hiddenLabel mesh__D012569 Borderline Schizophrenias
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D012569 2005
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D012569 1999
% 221.86/222.04  |- skos__prefLabel mesh__D012569 Schizotypal Personality Disorder
% 221.86/222.04  |- skos__hiddenLabel mesh__D012569 Disorders, Schizotypal Personality
% 221.86/222.04  |- mesh__publicMeSHNote mesh__D012569
% 221.86/222.04       81; was SCHIZOPHRENIA, LATENT 1973-80   
% 221.86/222.04  |- skos__hiddenLabel mesh__D012569 Personality Disorders, Schizotypal
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D012569 2001
% 221.86/222.04  |- skos__hiddenLabel mesh__D012569 Pseudoneurotic Schizophrenias
% 221.86/222.04  |- mesh__dateRevised mesh__D012569 1997-06-20
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D012569 2006
% 221.86/222.04  |- skos__hiddenLabel mesh__D012569 Schizophrenias, Pseudopsychopathic
% 221.86/222.04  |- skos__hiddenLabel mesh__D012569 Schizophrenias, Pseudoneurotic
% 221.86/222.04  |- mesh__dateEstablished mesh__D012569 1973-01-01
% 221.86/222.04  |- skos__hiddenLabel mesh__D012569 Schizophrenias, Borderline
% 221.86/222.04  |- skos__hiddenLabel mesh__D012569 Borderline Schizophrenia
% 221.86/222.04  |- skos__broader mesh__D031723smesh__D006109
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D031723 2006
% 221.86/222.04  |- mesh__dateCreated mesh__D031723 2002-07-02
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D031723 2005
% 221.86/222.04  |- mesh__publicMeSHNote mesh__D031723 2003   
% 221.86/222.04  |- skos__scopeNote mesh__D031723
% 221.86/222.04       A plant genus of the family POACEAE. Young shoots are eaten in Asian foods while the stiff mature stems are used for construction of many things.  The common name of bamboo is also used for other genera of Poaceae including Phyllostachys, SASA, and Dendrocalamus.%A%    
% 221.86/222.04  |- mesh__dateEstablished mesh__D031723 2003-01-01
% 221.86/222.04  |- rdf__type mesh__D031723sskos__Concept
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D031723 2004
% 221.86/222.04  |- skos__prefLabel mesh__D031723 Bambusa
% 221.86/222.04  |- mesh__historyNote mesh__D031723 2003   
% 221.86/222.04  |- skos__annotation mesh__D031723
% 221.86/222.04       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D031723 2003
% 221.86/222.04  |- skos__hiddenLabel mesh__D017254 Leukemic Infiltrations
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D017254 2005
% 221.86/222.04  |- rdf__type mesh__D017254sskos__Concept
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D017254 2004
% 221.86/222.04  |- mesh__recordOriginator mesh__D017254 TGC
% 221.86/222.04  |- skos__broader mesh__D017254smesh__D009361
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D017254 2002
% 221.86/222.04  |- skos__hiddenLabel mesh__D017254 Infiltrations, Leukemic
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D017254 2003
% 221.86/222.04  |- mesh__dateRevised mesh__D017254 2000-06-22
% 221.86/222.04  |- mesh__dateEstablished mesh__D017254 1993-01-01
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D017254 2001
% 221.86/222.04  |- mesh__historyNote mesh__D017254 93   
% 221.86/222.04  |- skos__scopeNote mesh__D017254
% 221.86/222.04       A pathologic change in leukemia in which leukemic cells permeate various organs at any stage of the disease. All types of leukemia show various degrees of infiltration, depending upon the type of leukemia. The degree of infiltration may vary from site to site. The liver and spleen are common sites of infiltration, the greatest appearing in myelocytic leukemia, but infiltration is seen also in the granulocytic and lymphocytic types. The kidney is also a common site and of the gastrointestinal system, the stomach and ileum are commonly involved. In lymphocytic leukemia the skin is often infiltrated. The central nervous system too is a common site.%A%    
% 221.86/222.04  |- mesh__dateCreated mesh__D017254 1992-05-22
% 221.86/222.04  |- skos__hiddenLabel mesh__D017254 Infiltration, Leukemic
% 221.86/222.04  |- mesh__recordMaintainer mesh__D017254 KEV
% 221.86/222.04  |- mesh__publicMeSHNote mesh__D017254 93   
% 221.86/222.04  |- skos__historyNote mesh__D017254 specific neoplasm %28%1966-1992%29%
% 221.86/222.04  |- skos__annotation mesh__D017254
% 221.86/222.04       IM; coord with organ /pathol %28%IM%29% %28%not the precoord organ/neopl term%29% + the specific type of leukemia /pathol %28%IM%29%, as %22%leukemic infiltration of the skin in lymphocytic leukemia%22% = LEUKEMIC INFILTRATION %28%IM%29% + SKIN /pathol %28%IM%29% %28%not SKIN NEOPLASMS%29% + LEUKEMIA, LYMPHOCYTIC /pathol %28%IM%29%; Manual 24.4.1.2%A%  
% 221.86/222.04  |- mesh__recordAuthorizer mesh__D017254 sjn
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D017254 2006
% 221.86/222.04  |- skos__prefLabel mesh__D017254 Leukemic Infiltration
% 221.86/222.04  |- skos__historyNote mesh__D017254 specific leukemia %28%1966-1992%29%
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003234 1997
% 221.86/222.04  |- skos__hiddenLabel mesh__D003234 Mucopurulent Conjunctivitides
% 221.86/222.04  |- skos__scopeNote mesh__D003234
% 221.86/222.04       Purulent infections of the conjunctiva by several species of gram-negative, gram-positive, or acid-fast organisms. Some of the more commonly found genera causing conjunctival infections are Haemophilus, Streptococcus, Neisseria, and Chlamydia.%A%    
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003234 2002
% 221.86/222.04  |- skos__hiddenLabel mesh__D003234 Conjunctivitides, Purulent
% 221.86/222.04  |- skos__broader mesh__D003234smesh__D003231
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003234 2006
% 221.86/222.04  |- mesh__publicMeSHNote mesh__D003234 86   
% 221.86/222.04  |- skos__broader mesh__D003234smesh__D015818
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003234 2003
% 221.86/222.04  |- skos__altLabel mesh__D003234 Conjunctivitides, Bacterial
% 221.86/222.04  |- mesh__dateRevised mesh__D003234 1991-06-26
% 221.86/222.04  |- mesh__historyNote mesh__D003234 86   
% 221.86/222.04  |- skos__altLabel mesh__D003234 Bacterial Conjunctivitis
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003234 1994
% 221.86/222.04  |- skos__hiddenLabel mesh__D003234 Purulent Conjunctivitides
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003234 2004
% 221.86/222.04  |- skos__prefLabel mesh__D003234 Conjunctivitis, Bacterial
% 221.86/222.04  |- skos__hiddenLabel mesh__D003234 Purulent Conjunctivitis
% 221.86/222.04  |- mesh__recordAuthorizer mesh__D003234 PLS
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003234 1998
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003234 1995
% 221.86/222.04  |- skos__altLabel mesh__D003234 Conjunctivitis, Mucopurulent
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003234 1992
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003234 2000
% 221.86/222.04  |- skos__altLabel mesh__D003234 Bacterial Conjunctivitides
% 221.86/222.04  |- mesh__recordMaintainer mesh__D003234 TGC
% 221.86/222.04  |- skos__historyNote mesh__D003234
% 221.86/222.04       Bacterial Infections or specifics %28%1966-1985%29%
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003234 1999
% 221.86/222.04  |- skos__altLabel mesh__D003234 Conjunctivitis, Purulent
% 221.86/222.04  |- mesh__dateCreated mesh__D003234 1985-06-05
% 221.86/222.04  |- skos__historyNote mesh__D003234 Conjunctivitis %28%1966-1985%29%
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003234 1996
% 221.86/222.04  |- mesh__dateEstablished mesh__D003234 1986-01-01
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003234 1993
% 221.86/222.04  |- skos__hiddenLabel mesh__D003234 Conjunctivitides, Mucopurulent
% 221.86/222.04  |- skos__hiddenLabel mesh__D003234 Mucopurulent Conjunctivitis
% 221.86/222.04  |- skos__annotation mesh__D003234
% 221.86/222.04       coord IM with specific bact/infect heading %28%IM%29%; DF: CONJUNCTIVITIS BACT%A%  
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003234 2001
% 221.86/222.04  |- rdf__type mesh__D003234sskos__Concept
% 221.86/222.04  |- mesh__recordOriginator mesh__D003234 RC
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003234 2005
% 221.86/222.04  |- skos__hiddenLabel mesh__D027682 Pumps, Cation
% 221.86/222.04  |- skos__hiddenLabel mesh__D027682 Pump, Cation
% 221.86/222.04  |- mesh__dateRevised mesh__D027682 2005-06-30
% 221.86/222.04  |- skos__prefLabel mesh__D027682 Cation Transport Proteins
% 221.86/222.04  |- mesh__recordAuthorizer mesh__D027682 sjn
% 221.86/222.04  |- mesh__publicMeSHNote mesh__D027682
% 221.86/222.04       2002; for CATION PUMPS %26% CATION PUMP see ION PUMPS 1992-2001%A%  
% 221.86/222.04  |- mesh__dateEstablished mesh__D027682 2002-01-01
% 221.86/222.04  |- skos__altLabel mesh__D027682 Cation Pumps
% 221.86/222.04  |- mesh__recordMaintainer mesh__D027682 SYSTEM
% 221.86/222.04  |- mesh__dateCreated mesh__D027682 2001-07-25
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D027682 2006
% 221.86/222.04  |- skos__historyNote mesh__D027682 Ion Pumps %28%1992-2001%29%
% 221.86/222.04  |- mesh__historyNote mesh__D027682
% 221.86/222.04       2002; for CATION PUMPS %26% CATION PUMP use ION PUMPS 1992-2001%A%  
% 221.86/222.04  |- skos__broader mesh__D027682smesh__D016623
% 221.86/222.04  |- rdf__type mesh__D027682sskos__Concept
% 221.86/222.04  |- skos__scopeNote mesh__D027682
% 221.86/222.04       Membrane proteins whose primary function is to facilitate the transport of positively charged molecules %28%cations%29% across a biological membrane.%A%    
% 221.86/222.04  |- mesh__recordOriginator mesh__D027682 jmp
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D013662 2003
% 221.86/222.04  |- mesh__historyNote mesh__D013662 66   
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D013662 2006
% 221.86/222.04  |- skos__annotation mesh__D013662
% 221.86/222.04       restrict to drink prepared from tea plant, CAMELLIA SINENSIS %28%formerly Thea sinensis%29%; %22%teas%22% from other plants go under plant term %28%IM%29% + BEVERAGES %28%IM%29%%A%  
% 221.86/222.04  |- skos__broader mesh__D013662smesh__D001628
% 221.86/222.04  |- skos__related mesh__D013662smesh__D028241
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D013662 2005
% 221.86/222.04  |- skos__prefLabel mesh__D013662 Tea
% 221.86/222.04  |- rdf__type mesh__D013662sskos__Concept
% 221.86/222.04  |- mesh__dateCreated mesh__D013662 1999-01-01
% 221.86/222.04  |- mesh__recordMaintainer mesh__D013662 ssb
% 221.86/222.04  |- mesh__recordOriginator mesh__D013662 NLM
% 221.86/222.04  |- mesh__dateRevised mesh__D013662 2001-07-25
% 221.86/222.04  |- skos__scopeNote mesh__D013662
% 221.86/222.04       The infusion of leaves of CAMELLIA SINENSIS %28%formerly Thea sinensis%29% as a beverage, the familiar Oriental tea, which contains CATECHIN %28%especially epigallocatechin gallate%29% and CAFFEINE.%A%    
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D013662 2004
% 221.86/222.04  |- mesh__recordAuthorizer mesh__D013662 sjn
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D013662 2002
% 221.86/222.04  |- skos__related mesh__D013662smesh__D013806
% 221.86/222.04  |- mesh__historyNote mesh__D007625 2005 %28%1983%29%   
% 221.86/222.04  |- skos__broader mesh__D007625smesh__D012174
% 221.86/222.04  |- skos__hiddenLabel mesh__D007625 Kearns Sayer Syndrome
% 221.86/222.04  |- skos__hiddenLabel mesh__D007625 Mitochondrial Cytopathy, Kearn-Sayre
% 221.86/222.04  |- mesh__recordMaintainer mesh__D007625 lkt
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D007625 2005
% 221.86/222.04  |- skos__hiddenLabel mesh__D007625 Syndrome, Kearns-Sayer
% 221.86/222.04  |- mesh__dateCreated mesh__D007625 1982-04-26
% 221.86/222.04  |- mesh__recordOriginator mesh__D007625 RC
% 221.86/222.04  |- skos__hiddenLabel mesh__D007625 Syndrome, Kearns-Sayre-Shy-Daroff
% 221.86/222.04  |- skos__hiddenLabel mesh__D007625 Kearns Sayre Shy Daroff Syndrome
% 221.86/222.04  |- skos__altLabel mesh__D007625 Kearns Syndrome
% 221.86/222.04  |- rdf__type mesh__D007625sskos__Concept
% 221.86/222.04  |- skos__altLabel mesh__D007625 Kearns-Sayre-Shy-Daroff Syndrome
% 221.86/222.04  |- mesh__recordAuthorizer mesh__D007625 sjn
% 221.86/222.04  |- skos__historyNote mesh__D007625 Ophthalmoplegia %28%1966-1982%29%
% 221.86/222.04  |- skos__broader mesh__D007625smesh__D009202
% 221.86/222.04  |- skos__hiddenLabel mesh__D007625 Syndrome, Kearns%27%
% 221.86/222.04  |- mesh__publicMeSHNote mesh__D007625
% 221.86/222.04       2005; see KEARNS SYNDROME 1991-2004, see OPHTHALMOPLEGIA 1983-1990%A%  
% 221.86/222.04  |- skos__hiddenLabel mesh__D007625 Syndrome, Kearns
% 221.86/222.04  |- skos__prefLabel mesh__D007625 Kearns-Sayer Syndrome
% 221.86/222.04  |- skos__broader mesh__D007625smesh__D017246
% 221.86/222.04  |- mesh__dateEstablished mesh__D007625 1991-01-01
% 221.86/222.04  |- skos__scopeNote mesh__D007625
% 221.86/222.04       A mitochondrial disorder featuring the triad of chronic progressive EXTERNAL OPHTHALMOPLEGIA, cardiomyopathy %28%CARDIOMYOPATHIES%29% with conduction block %28%HEART BLOCK%29%, and RETINITIS PIGMENTOSA. Disease onset is in the first or second decade. Elevated CSF protein, sensorineural deafness, seizures, and pyramidal signs may also be present. Ragged-red fibers are found on muscle biopsy. %28%Adams et al., Principles of Neurology, 6th ed, p984%29%%A%    
% 221.86/222.04  |- mesh__dateRevised mesh__D007625 2004-07-07
% 221.86/222.04  |- skos__altLabel mesh__D007625 Kearns%27% Syndrome
% 221.86/222.04  |- skos__historyNote mesh__D007625 Heart Block %28%1966-1982%29%
% 221.86/222.04  |- skos__hiddenLabel mesh__D007625 Cytopathy, Kearn-Sayre Mitochondrial
% 221.86/222.04  |- skos__historyNote mesh__D007625 Retinitis Pigmentosa %28%1966-1982%29%
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D007625 2006
% 221.86/222.04  |- skos__hiddenLabel mesh__D007625 Kearn Syndrome
% 221.86/222.04  |- skos__hiddenLabel mesh__D007625 Kearn Sayre Mitochondrial Cytopathy
% 221.86/222.04  |- skos__altLabel mesh__D007625 Kearn-Sayre Mitochondrial Cytopathy
% 221.86/222.04  |- skos__annotation mesh__D045744
% 221.86/222.04       almost always NIM with no subheadings; check ANIMALS or HUMAN; do not routinely add neoplasm term; policy Manual 21.57, 22.26.1, 24.4.5%A%  
% 221.86/222.04  |- mesh__recordAuthorizer mesh__D045744 sjn
% 221.86/222.04  |- skos__broader mesh__D045744smesh__D002460
% 221.86/222.04  |- mesh__publicMeSHNote mesh__D045744 2004   
% 221.86/222.04  |- skos__scopeNote mesh__D045744
% 221.86/222.04       A cell line derived from cultured tumor cells.     
% 221.86/222.04  |- skos__hiddenLabel mesh__D045744 Cell Lines, Tumor
% 221.86/222.04  |- skos__historyNote mesh__D045744 Cell Line %28%1969-1989%29%
% 221.86/222.04  |- mesh__recordMaintainer mesh__D045744 nns
% 221.86/222.04  |- skos__hiddenLabel mesh__D045744 Line, Tumor Cell
% 221.86/222.04  |- rdf__type mesh__D045744sskos__Concept
% 221.86/222.04  |- skos__prefLabel mesh__D045744 Cell Line, Tumor
% 221.86/222.04  |- mesh__recordOriginator mesh__D045744 nns
% 221.86/222.04  |- mesh__historyNote mesh__D045744 2004   
% 221.86/222.04  |- skos__altLabel mesh__D045744 Tumor Cell Line
% 221.86/222.04  |- skos__historyNote mesh__D045744 Tumor Cells, Cultured %28%1988-2003%29%
% 221.86/222.04  |- mesh__dateEstablished mesh__D045744 2004-01-01
% 221.86/222.04  |- mesh__dateCreated mesh__D045744 2003-07-30
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D045744 2006
% 221.86/222.04  |- skos__hiddenLabel mesh__D045744 Lines, Tumor Cell
% 221.86/222.04  |- skos__broader mesh__D045744smesh__D014407
% 221.86/222.04  |- skos__hiddenLabel mesh__D045744 Tumor Cell Lines
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D045744 2004
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D045744 2005
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D031724 2006
% 221.86/222.04  |- skos__prefLabel mesh__D031724 Bromus
% 221.86/222.04  |- skos__altLabel mesh__D031724 Brome
% 221.86/222.04  |- mesh__historyNote mesh__D031724 2003   
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D031724 2005
% 221.86/222.04  |- skos__broader mesh__D031724smesh__D006109
% 221.86/222.04  |- mesh__publicMeSHNote mesh__D031724 2003   
% 221.86/222.04  |- mesh__dateCreated mesh__D031724 2002-07-02
% 221.86/222.04  |- rdf__type mesh__D031724sskos__Concept
% 221.86/222.04  |- skos__annotation mesh__D031724
% 221.86/222.04       do not confuse with Broom terms in MeSH; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D031724 2004
% 221.86/222.04  |- skos__altLabel mesh__D031724 Bromegrass
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D031724 2003
% 221.86/222.04  |- mesh__dateEstablished mesh__D031724 2003-01-01
% 221.86/222.04  |- skos__scopeNote mesh__D031724
% 221.86/222.04       A plant genus of the family POACEAE. The name is similar to Broom or Scotch Broom %28%CYTISUS%29% or Butcher%27%s Broom %28%RUSCUS%29% or Desert Broom %28%BACCHARIS%29% or Spanish Broom %28%SPARTIUM%29%.%A%    
% 221.86/222.04  |- skos__altLabel mesh__D017255 Roche Brand of Acitretin
% 221.86/222.04  |- skos__hiddenLabel mesh__D017255 Acitretin Andreu Brand
% 221.86/222.04  |- skos__hiddenLabel mesh__D017255 Ro101670
% 221.86/222.04  |- rdf__type mesh__D017255sskos__Concept
% 221.86/222.04  |- skos__historyNote mesh__D017255
% 221.86/222.04       Tretinoin/analogs %26% derivatives %28%1977-1992%29%
% 221.86/222.04  |- skos__hiddenLabel mesh__D017255 Ro 101670
% 221.86/222.04  |- mesh__recordAuthorizer mesh__D017255 sjn
% 221.86/222.04  |- skos__altLabel mesh__D017255 Hoffmann-La Roche Brand of Acitretin
% 221.86/222.04  |- mesh__dateCreated mesh__D017255 1992-05-07
% 221.86/222.04  |- skos__broader mesh__D017255smesh__D012176
% 221.86/222.04  |- mesh__historyNote mesh__D017255 93; was ACITRETIN %28%NM%29% 1977-91   
% 221.86/222.04  |- skos__scopeNote mesh__D017255
% 221.86/222.04       An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of ETRETINATE with the advantage of a much shorter half-life when compared with etretinate.%A%    
% 221.86/222.04  |- skos__hiddenLabel mesh__D017255 Ro 137652
% 221.86/222.04  |- skos__altLabel mesh__D017255 Andreu Brand of Acitretin
% 221.86/222.04  |- mesh__publicMeSHNote mesh__D017255
% 221.86/222.04       93; ACITRETIN was indexed under TRETINOIN/analogs %26% derivatives 1977-92%A%  
% 221.86/222.04  |- skos__hiddenLabel mesh__D017255 Ro137652
% 221.86/222.04  |- skos__altLabel mesh__D017255 Ro 13-7652
% 221.86/222.04  |- skos__prefLabel mesh__D017255 Acitretin
% 221.86/222.04  |- mesh__dateRevised mesh__D017255 2005-06-30
% 221.86/222.04  |- skos__altLabel mesh__D017255 Etretin
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D017255 2006
% 221.86/222.04  |- mesh__onlineNote mesh__D017255
% 221.86/222.04       use ACITRETIN %28%NM%29% to search ACITRETIN 1980-92   
% 221.86/222.04  |- mesh__recordOriginator mesh__D017255 TPW
% 221.86/222.04  |- skos__altLabel mesh__D017255 Soriatane
% 221.86/222.04  |- mesh__recordMaintainer mesh__D017255 ssb
% 221.86/222.04  |- mesh__dateEstablished mesh__D017255 1993-01-01
% 221.86/222.04  |- skos__hiddenLabel mesh__D017255 Acitretin Roche Brand
% 221.86/222.04  |- skos__altLabel mesh__D017255 Ro-10-1670
% 221.86/222.04  |- skos__broader mesh__D006296Q000458smesh__D006296
% 221.86/222.04  |- mesh__preferredCombination mesh__D006296Q000458smesh__D006298
% 221.86/222.04  |- rdf__type mesh__D006296Q000458smesh__CompoundConcept
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003235 2002
% 221.86/222.04  |- skos__prefLabel mesh__D003235 Conjunctivitis, Inclusion
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003235 2006
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003235 1998
% 221.86/222.04  |- skos__hiddenLabel mesh__D003235 Conjunctivitides, Inclusion
% 221.86/222.04  |- skos__hiddenLabel mesh__D003235 Inclusion Blennorrheas
% 221.86/222.04  |- mesh__recordMaintainer mesh__D003235 PXP
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003235 2003
% 221.86/222.04  |- mesh__publicMeSHNote mesh__D003235 67   
% 221.86/222.04  |- skos__broader mesh__D003235smesh__D002690
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003235 2001
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003235 2005
% 221.86/222.04  |- skos__altLabel mesh__D003235 Blennorrhea, Inclusion
% 221.86/222.04  |- skos__hiddenLabel mesh__D003235 Inclusion Conjunctivitis
% 221.86/222.04  |- mesh__dateRevised mesh__D003235 1997-06-20
% 221.86/222.04  |- rdf__type mesh__D003235sskos__Concept
% 221.86/222.04  |- mesh__activeMeSHYear mesh__D003235 2000
% 221.86/222.04  |- skos__hiddenLabel mesh__D003235 Inclusion Conjunctivitides
% 221.86/222.04  |- skos__hiddenLabel mesh__D003235 Blennorrheas, Inclusion
% 221.86/222.04  |- mesh__historyNote mesh__D003235 67%28%65%29%   
% 221.86/222.04  |- mesh__dateCreated mesh__D003235 1999-01-01
% 221.86/222.04  |- mesh__dateEstablished mesh__D003235 1967-01-01
% 221.86/222.04  |- skos__annotation mesh__D003235 caused by Chlamydia trachomatis   
% 221.86/222.04  |- skos__hiddenLabel mesh__D003235 Inclusion Blennorrhea
% 221.86/222.04  |- mesh__recordOriginator mesh__D003235 NLM
% 221.86/222.04  |- skos__scopeNote mesh__D003235
% 221.86/222.04       An infection of the eyes characterized by the presence in conjunctival epithelial cells of inclusion bodies indistinguishable from those of trachoma. It is acquired by infants during birth and by adults from swimming pools. The etiological agent is CHLAMYDIA TRACHOMATIS whose natural habitat appears to be the genito-urinary tract. Inclusion conjunctivitis is a less severe disease than trachoma and usually clears up spontaneously.%A%    
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003235 1999
% 221.86/222.05  |- mesh__recordAuthorizer mesh__D003235 SJN
% 221.86/222.05  |- skos__broader mesh__D003235smesh__D003234
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003235 2004
% 221.86/222.05  |- skos__altLabel mesh__D013663 Educational Technics
% 221.86/222.05  |- skos__hiddenLabel mesh__D013663 Techniques, Training
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D013663 1998
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D013663 2001
% 221.86/222.05  |- skos__hiddenLabel mesh__D013663 Method, Teaching
% 221.86/222.05  |- skos__hiddenLabel mesh__D013663 Educational Technic
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D013663 2006
% 221.86/222.05  |- mesh__recordOriginator mesh__D013663 NLM
% 221.86/222.05  |- skos__hiddenLabel mesh__D013663 Technique, Educational
% 221.86/222.05  |- skos__altLabel mesh__D013663 Educational Personnel
% 221.86/222.05  |- skos__broader mesh__D013663smesh__D004493
% 221.86/222.05  |- skos__hiddenLabel mesh__D013663 Technic, Educational
% 221.86/222.05  |- skos__hiddenLabel mesh__D013663 Training Technique
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D013663 1997
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D013663 2000
% 221.86/222.05  |- skos__hiddenLabel mesh__D013663 Trainers Training
% 221.86/222.05  |- mesh__recordAuthorizer mesh__D013663 PLS
% 221.86/222.05  |- mesh__dateCreated mesh__D013663 1999-01-01
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D013663 2005
% 221.86/222.05  |- skos__hiddenLabel mesh__D013663 Educational Technique
% 221.86/222.05  |- skos__scopeNote mesh__D013663
% 221.86/222.05       The educational process of instructing.     
% 221.86/222.05  |- mesh__dateRevised mesh__D013663 1995-06-08
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D013663 1996
% 221.86/222.05  |- skos__hiddenLabel mesh__D013663 Technic, Training
% 221.86/222.05  |- rdf__type mesh__D013663sskos__Concept
% 221.86/222.05  |- skos__altLabel mesh__D013663 Technics, Educational
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D013663 2004
% 221.86/222.05  |- skos__hiddenLabel mesh__D013663 Training, Academic
% 221.86/222.05  |- skos__hiddenLabel mesh__D013663 Activities, Training
% 221.86/222.05  |- skos__hiddenLabel mesh__D013663 Training Activity
% 221.86/222.05  |- skos__altLabel mesh__D013663 Educational Techniques
% 221.86/222.05  |- skos__hiddenLabel mesh__D013663 Training Technic
% 221.86/222.05  |- skos__hiddenLabel mesh__D013663 Methods, Teaching
% 221.86/222.05  |- skos__hiddenLabel mesh__D013663 Technique, Training
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D013663 2003
% 221.86/222.05  |- mesh__recordMaintainer mesh__D013663 RAZ
% 221.86/222.05  |- skos__hiddenLabel mesh__D013663 Technics, Training
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D013663 1999
% 221.86/222.05  |- skos__altLabel mesh__D013663 Training Technics
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D013663 2002
% 221.86/222.05  |- skos__hiddenLabel mesh__D013663 Teaching Method
% 221.86/222.05  |- skos__related mesh__D013663smesh__D005178
% 221.86/222.05  |- skos__prefLabel mesh__D013663 Teaching
% 221.86/222.05  |- skos__annotation mesh__D013663
% 221.86/222.05       teacher as the imparter of knowledge goes here, not under FACULTY which is differentiated from student or administrator: Manual 30.25%A%  
% 221.86/222.05  |- rdf__type mesh__D007626sskos__Concept
% 221.86/222.05  |- skos__broader mesh__D007626smesh__D001789
% 221.86/222.05  |- skos__scopeNote mesh__D007626
% 221.86/222.05       Multiple erythrocytic antigens that comprise at least three pairs of alternates and amorphs, determined by one complex gene or possibly several genes at closely linked loci. The system is important in transfusion reactions. Its expression involves the X-chromosome.%A%    
% 221.86/222.05  |- skos__hiddenLabel mesh__D007626 Kell Blood Group System
% 221.86/222.05  |- mesh__publicMeSHNote mesh__D007626
% 221.86/222.05       91; was see under BLOOD GROUPS 1976-90   
% 221.86/222.05  |- mesh__dateEstablished mesh__D007626 1991-01-01
% 221.86/222.05  |- mesh__dateRevised mesh__D007626 2005-06-30
% 221.86/222.05  |- skos__hiddenLabel mesh__D007626 Blood-Group System, Kell
% 221.86/222.05  |- mesh__dateCreated mesh__D007626 1975-07-25
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D007626 2006
% 221.86/222.05  |- skos__annotation mesh__D007626
% 221.86/222.05       IM; coord with disease /blood %28%IM%29%, not /immunol nor /genet; TN 230%A%  
% 221.86/222.05  |- mesh__recordOriginator mesh__D007626 SH
% 221.86/222.05  |- mesh__recordMaintainer mesh__D007626 ssb
% 221.86/222.05  |- skos__hiddenLabel mesh__D007626 System, Kell Blood-Group
% 221.86/222.05  |- skos__prefLabel mesh__D007626 Kell Blood-Group System
% 221.86/222.05  |- mesh__historyNote mesh__D007626
% 221.86/222.05       91%28%76%29%; was see under BLOOD GROUPS 1976-90   
% 221.86/222.05  |- mesh__recordAuthorizer mesh__D007626 sjn
% 221.86/222.05  |- skos__historyNote mesh__D007626 Blood Groups %28%1966-1975%29%
% 221.86/222.05  |- skos__hiddenLabel mesh__D051782 SRE 2 Binding Protein
% 221.86/222.05  |- skos__broader mesh__D051782smesh__D051779
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D051782 2006
% 221.86/222.05  |- mesh__publicMeSHNote mesh__D051782
% 221.86/222.05       2006; STEROL REGULATORY ELEMENT BINDING PROTEIN 2 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1994-2005%A%  
% 221.86/222.05  |- rdf__type mesh__D051782sskos__Concept
% 221.86/222.05  |- mesh__dateEstablished mesh__D051782 2006-01-01
% 221.86/222.05  |- mesh__recordOriginator mesh__D051782 DRC
% 221.86/222.05  |- skos__scopeNote mesh__D051782
% 221.86/222.05       A sterol regulatory element binding protein that regulates GENES involved in CHOLESTEROL synthesis and uptake.%A%    
% 221.86/222.05  |- skos__prefLabel mesh__D051782
% 221.86/222.05       Sterol Regulatory Element Binding Protein 2
% 221.86/222.05  |- mesh__recordAuthorizer mesh__D051782 sjn
% 221.86/222.05  |- mesh__dateCreated mesh__D051782 2005-06-30
% 221.86/222.05  |- skos__altLabel mesh__D051782 SREBP2 Protein
% 221.86/222.05  |- mesh__historyNote mesh__D051782 2006%28%1994%29%   
% 221.86/222.05  |- skos__altLabel mesh__D051782 Sterol-Regulatory Element-Binding Protein 2
% 221.86/222.05  |- skos__altLabel mesh__D051782 SRE-2 Binding Protein
% 221.86/222.05  |- mesh__recordMaintainer mesh__D051782 DRC
% 221.86/222.05  |- mesh__publicMeSHNote mesh__D045745 2004   
% 221.86/222.05  |- skos__historyNote mesh__D045745
% 221.86/222.05       Scleroderma, Circumscribed %28%1986-2003%29%
% 221.86/222.05  |- rdf__type mesh__D045745sskos__Concept
% 221.86/222.05  |- skos__scopeNote mesh__D045745
% 221.86/222.05       The least progressive form of SYSTEMIC SCLERODERMA with skin thickening restricted to the FACE; NECK; and areas distal to the elbows and/or knees, sparing the trunk. The CREST SYNDROME is a form of limited scleroderma.%A%    
% 221.86/222.05  |- skos__annotation mesh__D045745
% 221.86/222.05       do not confuse with SCLERODERMA, LOCALIZED   
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D045745 2006
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D045745 2004
% 221.86/222.05  |- skos__prefLabel mesh__D045745 Scleroderma, Limited
% 221.86/222.05  |- skos__altLabel mesh__D045745 Limited Scleroderma
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D045745 2005
% 221.86/222.05  |- mesh__historyNote mesh__D045745 2004   
% 221.86/222.05  |- mesh__dateCreated mesh__D045745 2003-07-09
% 221.86/222.05  |- mesh__dateEstablished mesh__D045745 2004-01-01
% 221.86/222.05  |- skos__broader mesh__D045745smesh__D012595
% 221.86/222.05  |- skos__historyNote mesh__D045745 Scleroderma, Systemic %28%1990-2003%29%
% 221.86/222.05  |- skos__altLabel mesh__D017256 Technetium-99m-Hexamibi
% 221.86/222.05  |- mesh__dateEstablished mesh__D017256 1993-01-01
% 221.86/222.05  |- skos__broader mesh__D017256smesh__D015609
% 221.86/222.05  |- skos__altLabel mesh__D017256 99mTc-Hexamibi
% 221.86/222.05  |- mesh__historyNote mesh__D017256
% 221.86/222.05       93; was TECHNETIUM TC 99M HEXAKIS%28%2-METHOXY-2-METHYLPROPYLISONITRILE%29% 1987-92; for TECHNETIUM TC 99M 2-METHOXY-2-METHYLPROPYLISONITRILE use TECHNETIUM TC 99M SESTAMIBI %28%NM%29% 1987-98%A%  
% 221.86/222.05  |- mesh__onlineNote mesh__D017256
% 221.86/222.05       use TECHNETIUM TC 99M SESTAMIBI %28%NM%29% to search TECHNETIUM TC 99M HEXAKIS%28%2-METHOXY-2-METHYLPROPYLISONITRILE%29% 1987-92%A%  
% 221.86/222.05  |- skos__broader mesh__D017256smesh__D009570
% 221.86/222.05  |- skos__hiddenLabel mesh__D017256 Technetium 99m Sestamibi
% 221.86/222.05  |- skos__hiddenLabel mesh__D017256 99mTc Hexamibi
% 221.86/222.05  |- mesh__recordAuthorizer mesh__D017256 sjn
% 221.86/222.05  |- skos__altLabel mesh__D017256 Tc MIBI
% 221.86/222.05  |- skos__historyNote mesh__D017256
% 221.86/222.05       Organotechnetium Compounds %28%1989-1992%29%
% 221.86/222.05  |- skos__historyNote mesh__D017256
% 221.86/222.05       Organometallic Compounds %28%1987-1989%29%
% 221.86/222.05  |- mesh__dateCreated mesh__D017256 1992-06-29
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D017256 2006
% 221.86/222.05  |- mesh__recordMaintainer mesh__D017256 CCR
% 221.86/222.05  |- skos__altLabel mesh__D017256 Tc-99m-Methoxy-2-isobutylisonitrile
% 221.86/222.05  |- skos__altLabel mesh__D017256 99mTc-Sestamibi
% 221.86/222.05  |- skos__hiddenLabel mesh__D017256 Technetium 99m Hexamibi
% 221.86/222.05  |- skos__prefLabel mesh__D017256 Technetium Tc 99m Sestamibi
% 221.86/222.05  |- skos__scopeNote mesh__D017256
% 221.86/222.05       A technetium imaging agent used to reveal blood-starved cardiac tissue during a heart attack.%A%    
% 221.86/222.05  |- skos__hiddenLabel mesh__D017256 99mTc Sestamibi
% 221.86/222.05  |- skos__historyNote mesh__D017256 Technetium %28%1987-1989%29%
% 221.86/222.05  |- skos__annotation mesh__D017256 as label, use /diag use   
% 221.86/222.05  |- skos__altLabel mesh__D017256
% 221.86/222.05       Technetium Tc 99m 2-Methoxy-2-methylpropylisonitrile
% 221.86/222.05  |- rdf__type mesh__D017256sskos__Concept
% 221.86/222.05  |- mesh__publicMeSHNote mesh__D017256
% 221.86/222.05       93; TECHNETIUM TC 99M HEXAKIS%28%2-METHOXY-2-METHYLPROPYLISONITRILE%29% was indexed under ORGANOTECHNETIUM COMPOUNDS 1989-92 and ORGANOMETALLIC COMPOUNDS %26% TECHNETIUM 1987-92; TECHNETIUM TC 99M 2-METHOXY-2-METHYLPROPYLISONITRILE was indexed under NITRILES %28%1987-93%29%, ORGANOMETALLIC COMPOUNDS %28%1987-89%29%, ORGANOTECHNETIUM COMPOUNDS %28%1990-93%29%, %26% TECHNETIUM TC 99M SESTAMIMBI %28%1994-98%29%%A%  
% 221.86/222.05  |- mesh__dateRevised mesh__D017256 2005-06-30
% 221.86/222.05  |- skos__hiddenLabel mesh__D017256
% 221.86/222.05       Technetium Tc 99m 2 Methoxy 2 methylpropylisonitrile
% 221.86/222.05  |- skos__hiddenLabel mesh__D017256 Tc 99m Methoxy 2 isobutylisonitrile
% 221.86/222.05  |- skos__altLabel mesh__D017256 Technetium-99m-Sestamibi
% 221.86/222.05  |- skos__altLabel mesh__D017256
% 221.86/222.05       Du Pont Brand of Technetium Tc 99m Sestamibi
% 221.86/222.05  |- mesh__recordOriginator mesh__D017256 TPW
% 221.86/222.05  |- mesh__dateEstablished mesh__D003236 1986-01-01
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003236 2002
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003236 2006
% 221.86/222.05  |- mesh__recordMaintainer mesh__D003236 EGC
% 221.86/222.05  |- skos__scopeNote mesh__D003236
% 221.86/222.05       Inflammation, often mild, of the conjunctiva caused by a variety of viral agents. Conjunctival involvement may be part of a systemic infection.%A%    
% 221.86/222.05  |- skos__historyNote mesh__D003236 Virus Diseases %28%1966-1985%29%
% 221.86/222.05  |- skos__historyNote mesh__D003236 Conjunctivitis %28%1966-1985%29%
% 221.86/222.05  |- skos__altLabel mesh__D003236 Viral Conjunctivitis
% 221.86/222.05  |- skos__historyNote mesh__D003236 Adenovirus Infections %28%1966-1985%29%
% 221.86/222.05  |- mesh__publicMeSHNote mesh__D003236 86   
% 221.86/222.05  |- skos__prefLabel mesh__D003236 Conjunctivitis, Viral
% 221.86/222.05  |- rdf__type mesh__D003236sskos__Concept
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003236 2000
% 221.86/222.05  |- mesh__recordOriginator mesh__D003236 RC
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003236 1990
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003236 1996
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003236 2001
% 221.86/222.05  |- skos__hiddenLabel mesh__D003236 Viral Conjunctivitides
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003236 1998
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003236 1992
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003236 1997
% 221.86/222.05  |- mesh__historyNote mesh__D003236 86   
% 221.86/222.05  |- skos__broader mesh__D003236smesh__D003231
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003236 2003
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003236 1994
% 221.86/222.05  |- skos__broader mesh__D003236smesh__D015828
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003236 1999
% 221.86/222.05  |- skos__hiddenLabel mesh__D003236 Conjunctivitides, Viral
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003236 2005
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003236 1993
% 221.86/222.05  |- mesh__dateCreated mesh__D003236 1985-06-05
% 221.86/222.05  |- mesh__dateRevised mesh__D003236 1989-05-25
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003236 1991
% 221.86/222.05  |- mesh__recordAuthorizer mesh__D003236 PLS
% 221.86/222.05  |- skos__annotation mesh__D003236
% 221.86/222.05       coord IM with specific virus/infect heading %28%IM%29%   
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003236 2004
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003236 1995
% 221.86/222.05  |- skos__hiddenLabel mesh__D013664 Teaching Material
% 221.86/222.05  |- mesh__publicMeSHNote mesh__D013664 74   
% 221.86/222.05  |- mesh__dateEstablished mesh__D013664 1974-01-01
% 221.86/222.05  |- rdf__type mesh__D013664sskos__Concept
% 221.86/222.05  |- mesh__recordOriginator mesh__D013664 NLM
% 221.86/222.05  |- mesh__recordAuthorizer mesh__D013664 sjn
% 221.86/222.05  |- mesh__dateRevised mesh__D013664 2004-07-07
% 221.86/222.05  |- skos__scopeNote mesh__D013664
% 221.86/222.05       Instructional materials used in teaching.     
% 221.86/222.05  |- mesh__recordMaintainer mesh__D013664 ags
% 221.86/222.05  |- skos__hiddenLabel mesh__D013664 Materials, Teaching
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D013664 2005
% 221.86/222.05  |- skos__prefLabel mesh__D013664 Teaching Materials
% 221.86/222.05  |- skos__broader mesh__D013664smesh__D003146
% 221.86/222.05  |- skos__related mesh__D013664smesh__D001296
% 221.86/222.05  |- mesh__historyNote mesh__D013664 74   
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D013664 2006
% 221.86/222.05  |- skos__hiddenLabel mesh__D013664 Material, Teaching
% 221.86/222.05  |- mesh__dateCreated mesh__D013664 1999-01-01
% 221.86/222.05  |- skos__broader mesh__D007627smesh__D002921
% 221.86/222.05  |- mesh__recordAuthorizer mesh__D007627 SJN
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D007627 2002
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D007627 1999
% 221.86/222.05  |- skos__broader mesh__D007627smesh__D003095
% 221.86/222.05  |- skos__hiddenLabel mesh__D007627 Keloids
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D007627 2001
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D007627 1998
% 221.86/222.05  |- skos__related mesh__D007627smesh__D017439
% 221.86/222.05  |- skos__prefLabel mesh__D007627 Keloid
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D007627 2000
% 221.86/222.05  |- skos__scopeNote mesh__D007627
% 221.86/222.05       A sharply elevated, irregularly shaped, progressively enlarging scar resulting from formation of excessive amounts of collagen in the dermis during connective tissue repair. It is differentiated from a hypertrophic scar %28%CICATRIX, HYPERTROPHIC%29% in that the former does not spread to surrounding tissues.%A%    
% 221.86/222.05  |- mesh__dateRevised mesh__D007627 1997-06-20
% 221.86/222.05  |- mesh__dateCreated mesh__D007627 1999-01-01
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D007627 2004
% 221.86/222.05  |- mesh__recordMaintainer mesh__D007627 TPW
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D007627 2003
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D007627 2006
% 221.86/222.05  |- skos__annotation mesh__D007627
% 221.86/222.05       spreads to surrounding tissue: do not confuse with CICATRIX, HYPERTROPHIC which does not; follow text of author; ACNE KELOID is also available%A%  
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D007627 2005
% 221.86/222.05  |- rdf__type mesh__D007627sskos__Concept
% 221.86/222.05  |- mesh__recordOriginator mesh__D007627 NLM
% 221.86/222.05  |- mesh__publicMeSHNote mesh__D051783
% 221.86/222.05       2006; METHYL-CPG-BINDING PROTEIN 2 was indexed under CHROMOSOMAL PROTEINS, NON-HISTONE %26% DNA-BINDING PROTEINS %26% REPRESSOR PROTEINS 2005, %26% under TRANSCRIPTION FACTORS 1992-2004%A%  
% 221.86/222.05  |- skos__altLabel mesh__D051783 MeCP2 Protein
% 221.86/222.05  |- skos__scopeNote mesh__D051783
% 221.86/222.05       A DNA-binding protein that interacts with methylated CPG ISLANDS. It plays a role in repressing GENETIC TRANSCRIPTION and is frequently mutated in RETT SYNDROME.%A%    
% 221.86/222.05  |- skos__broader mesh__D051783smesh__D004268
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D051783 2006A
% 221.86/222.05  |- skos__hiddenLabel mesh__D051783 Methyl CpG Binding Protein 2
% 221.86/222.05  |- mesh__dateEstablished mesh__D051783 2006-01-01
% 221.86/222.05  |- skos__broader mesh__D051783smesh__D002868
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D051783 2006
% 221.86/222.05  |- skos__related mesh__D051783smesh__D015518
% 221.86/222.05  |- mesh__historyNote mesh__D051783 2006%28%1992%29%   
% 221.86/222.05  |- skos__prefLabel mesh__D051783 Methyl-CpG-Binding Protein 2
% 221.86/222.05  |- rdf__type mesh__D051783sskos__Concept
% 221.86/222.05  |- mesh__recordAuthorizer mesh__D051783 ags
% 221.86/222.05  |- mesh__recordOriginator mesh__D051783 DRC
% 221.86/222.05  |- mesh__recordMaintainer mesh__D051783 ags
% 221.86/222.05  |- mesh__dateRevised mesh__D051783 2005-08-03
% 221.86/222.05  |- mesh__dateCreated mesh__D051783 2005-06-30
% 221.86/222.05  |- skos__altLabel mesh__D017257 Aventis Pharma Brand of Ramipril
% 221.86/222.05  |- mesh__recordMaintainer mesh__D017257 lkw
% 221.86/222.05  |- skos__altLabel mesh__D017257 Tritace
% 221.86/222.05  |- skos__scopeNote mesh__D017257
% 221.86/222.05       A long-acting angiotensin-converting enzyme inhibitor. It is a prodrug that is transformed in the liver to its active metabolite ramiprilat.%A%    
% 221.86/222.05  |- skos__altLabel mesh__D017257 Aventis Brand of Ramipril
% 221.86/222.05  |- mesh__recordOriginator mesh__D017257 TPW
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D017257 2006
% 221.86/222.05  |- skos__altLabel mesh__D017257 Ramace
% 221.86/222.05  |- skos__altLabel mesh__D017257 Astra Brand of Ramipril
% 221.86/222.05  |- skos__altLabel mesh__D017257 Zabien
% 221.86/222.05  |- mesh__onlineNote mesh__D017257
% 221.86/222.05       use RAMIPRIL %28%NM%29% to search RAMIPRIL 1984-92   
% 221.86/222.05  |- mesh__dateRevised mesh__D017257 2005-06-30
% 221.86/222.05  |- skos__altLabel mesh__D017257 Delix
% 221.86/222.05  |- skos__altLabel mesh__D017257 Acovil
% 221.86/222.05  |- mesh__dateEstablished mesh__D017257 1993-01-01
% 221.86/222.05  |- skos__altLabel mesh__D017257 AstraZeneca Brand of Ramipril
% 221.86/222.05  |- skos__altLabel mesh__D017257 Altace
% 221.86/222.05  |- mesh__publicMeSHNote mesh__D017257
% 221.86/222.05       93; RAMIPRIL was indexed under BICYCLO COMPOUNDS 1984-92   
% 221.86/222.05  |- skos__altLabel mesh__D017257 Promed Brand of Ramipril
% 221.86/222.05  |- skos__altLabel mesh__D017257 Monarch Brand of Ramipril
% 221.86/222.05  |- mesh__dateCreated mesh__D017257 1992-05-20
% 221.86/222.05  |- rdf__type mesh__D017257sskos__Concept
% 221.86/222.05  |- skos__prefLabel mesh__D017257 Ramipril
% 221.86/222.05  |- skos__altLabel mesh__D017257 Almirall Brand of Ramipril
% 221.86/222.05  |- skos__historyNote mesh__D017257 Bicyclo Compounds %28%1984-1992%29%
% 221.86/222.05  |- mesh__historyNote mesh__D017257 93; was RAMIPRIL %28%NM%29% 1984-92   
% 221.86/222.05  |- skos__altLabel mesh__D017257 Hoechst Brand of Ramipril
% 221.86/222.05  |- skos__broader mesh__D017257smesh__D019086
% 221.86/222.05  |- mesh__recordAuthorizer mesh__D017257 sjn
% 221.86/222.05  |- skos__hiddenLabel mesh__D017257 HOE498
% 221.86/222.05  |- skos__hiddenLabel mesh__D017257 HOE 498
% 221.86/222.05  |- skos__broader mesh__D003237smesh__D009511
% 221.86/222.05  |- mesh__dateCreated mesh__D003237 1999-01-01
% 221.86/222.05  |- mesh__recordAuthorizer mesh__D003237 SJN
% 221.86/222.05  |- rdf__type mesh__D003237sskos__Concept
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003237 2002
% 221.86/222.05  |- mesh__recordOriginator mesh__D003237 NLM
% 221.86/222.05  |- mesh__recordMaintainer mesh__D003237 PXP
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003237 1998
% 221.86/222.05  |- skos__prefLabel mesh__D003237 Connecticut
% 221.86/222.05  |- mesh__dateRevised mesh__D003237 1997-06-20
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003237 2003
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003237 1999
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003237 2000
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003237 2005
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003237 2004
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003237 2001
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D003237 2006
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D008720 2005
% 221.86/222.05  |- mesh__publicMeSHNote mesh__D008720
% 221.86/222.05       91; was see under THIOSEMICARBAZONES 1975-90   
% 221.86/222.05  |- mesh__recordOriginator mesh__D008720 NLM
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D008720 2004
% 221.86/222.05  |- mesh__dateEstablished mesh__D008720 1991-01-01
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D008720 2002
% 221.86/222.05  |- skos__broader mesh__D008720smesh__D007211
% 221.86/222.05  |- mesh__dateCreated mesh__D008720 1974-11-19
% 221.86/222.05  |- mesh__historyNote mesh__D008720
% 221.86/222.05       91%28%75%29%; was see under THIOSEMICARBAZONES 1975-90   
% 221.86/222.05  |- mesh__recordAuthorizer mesh__D008720 sjn
% 221.86/222.05  |- mesh__dateRevised mesh__D008720 2000-06-22
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D008720 2003
% 221.86/222.05  |- skos__scopeNote mesh__D008720
% 221.86/222.05       An antiviral agent effective against pox viruses.     
% 221.86/222.05  |- rdf__type mesh__D008720sskos__Concept
% 221.86/222.05  |- mesh__recordMaintainer mesh__D008720 CCR
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D008720 2001
% 221.86/222.05  |- skos__prefLabel mesh__D008720 Methisazone
% 221.86/222.05  |- skos__historyNote mesh__D008720 Indoles %28%1969-1974%29%
% 221.86/222.05  |- skos__historyNote mesh__D008720 Thiosemicarbazones %28%1971-1974%29%
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D008720 2006
% 221.86/222.05  |- skos__altLabel mesh__D008720 Metisazone
% 221.86/222.05  |- skos__broader mesh__D008720smesh__D013882
% 221.86/222.05  |- mesh__publicMeSHNote mesh__D013665 73   
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D013665 2004
% 221.86/222.05  |- mesh__recordMaintainer mesh__D013665 ssb
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D013665 2005
% 221.86/222.05  |- skos__altLabel mesh__D013665 Tear Gas
% 221.86/222.05  |- skos__broader mesh__D013665smesh__D007509
% 221.86/222.05  |- skos__hiddenLabel mesh__D013665 Gases, Tear
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D013665 2006
% 221.86/222.05  |- skos__prefLabel mesh__D013665 Tear Gases
% 221.86/222.05  |- mesh__dateEstablished mesh__D013665 1973-01-01
% 221.86/222.05  |- mesh__dateCreated mesh__D013665 1999-01-01
% 221.86/222.05  |- mesh__recordOriginator mesh__D013665 NLM
% 221.86/222.05  |- skos__hiddenLabel mesh__D013665 Gas, Tear
% 221.86/222.05  |- mesh__dateRevised mesh__D013665 2003-07-09
% 221.86/222.05  |- mesh__recordAuthorizer mesh__D013665 sjn
% 221.86/222.05  |- skos__scopeNote mesh__D013665
% 221.86/222.05       Gases that irritate the eyes, throat, or skin. Severe lacrimation develops upon irritation of the eyes.%A%    
% 221.86/222.05  |- rdf__type mesh__D013665sskos__Concept
% 221.86/222.05  |- mesh__historyNote mesh__D013665 73%28%68%29%   
% 221.86/222.05  |- mesh__recordAuthorizer mesh__D018350 sjn
% 221.86/222.05  |- mesh__onlineNote mesh__D018350
% 221.86/222.05       use ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID %28%NM%29% to search ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID 1980-93%A%  
% 221.86/222.05  |- skos__historyNote mesh__D018350
% 221.86/222.05       Ibotenic Acid/analogs %26% derivatives %28%1980-1993%29%
% 221.86/222.05  |- mesh__publicMeSHNote mesh__D018350
% 221.86/222.05       94; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID was indexed under IBOTENIC ACID/analogs %26% derivatives 1980-93%A%  
% 221.86/222.05  |- mesh__dateEstablished mesh__D018350 1994-01-01
% 221.86/222.05  |- skos__scopeNote mesh__D018350
% 221.86/222.05       An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors %28%RECEPTORS, AMPA%29%. It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.%A%    
% 221.86/222.05  |- mesh__dateRevised mesh__D018350 2005-06-30
% 221.86/222.05  |- skos__broader mesh__D018350smesh__D007555
% 221.86/222.05  |- mesh__dateCreated mesh__D018350 1993-06-18
% 221.86/222.05  |- mesh__historyNote mesh__D018350
% 221.86/222.05       94; was ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID %28%NM%29% 1980-93%A%  
% 221.86/222.05  |- mesh__recordMaintainer mesh__D018350 ssb
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D018350 2006
% 221.86/222.05  |- skos__related mesh__D018350smesh__D018091
% 221.86/222.05  |- mesh__recordOriginator mesh__D018350 TPW
% 221.86/222.05  |- rdf__type mesh__D018350sskos__Concept
% 221.86/222.05  |- skos__hiddenLabel mesh__D018350
% 221.86/222.05       alpha Amino 3 hydroxy 5 methyl 4 isoxazolepropionic Acid
% 221.86/222.05  |- skos__annotation mesh__D018350 DF:  note short X ref   
% 221.86/222.05  |- skos__prefLabel mesh__D018350
% 221.86/222.05       alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
% 221.86/222.05  |- skos__altLabel mesh__D018350 AMPA
% 221.86/222.05  |- mesh__publicMeSHNote mesh__D051784
% 221.86/222.05       2006; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS %26% RECEPTORS, ARYL HYDROCARBON 1995-2005, %26% under PROTEINS 1991-1994%A%  
% 221.86/222.05  |- mesh__recordAuthorizer mesh__D051784 sjn
% 221.86/222.05  |- mesh__dateCreated mesh__D051784 2005-06-30
% 221.86/222.05  |- skos__altLabel mesh__D051784 AhR Nuclear Translocator
% 221.86/222.05  |- mesh__recordMaintainer mesh__D051784 DRC
% 221.86/222.05  |- skos__altLabel mesh__D051784 Aryl Hydrocarbon Nuclear Translocator
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D051784 2006
% 221.86/222.05  |- skos__altLabel mesh__D051784 Ah Receptor Nuclear Translocator Protein
% 221.86/222.05  |- skos__hiddenLabel mesh__D051784 Hypoxia Inducible Factor 1, beta Subunit
% 221.86/222.05  |- skos__altLabel mesh__D051784 Hypoxia-Inducible Factor 1, beta Subunit
% 221.86/222.05  |- rdf__type mesh__D051784sskos__Concept
% 221.86/222.05  |- mesh__dateEstablished mesh__D051784 2006-01-01
% 221.86/222.05  |- mesh__recordOriginator mesh__D051784 DRC
% 221.86/222.05  |- skos__broader mesh__D051784smesh__D029543
% 221.86/222.05  |- skos__broader mesh__D051784smesh__D051793
% 221.86/222.05  |- skos__hiddenLabel mesh__D051784 Nuclear Translocator, AhR
% 221.86/222.05  |- skos__prefLabel mesh__D051784
% 221.86/222.05       Aryl Hydrocarbon Receptor Nuclear Translocator
% 221.86/222.05  |- skos__scopeNote mesh__D051784
% 221.86/222.05       Aryl hydrocarbon receptor nuclear translocator is a basic HELIX-LOOP-HELIX MOTIF containing protein that forms a complex with DIOXIN RECEPTOR. The complex binds xenobiotic regulatory elements and activates transcription of a variety of genes including UDP GLUCURONOSYLTRANSFERASE. AhR nuclear translocator is also a subunit of HYPOXIA-INDUCIBLE FACTOR 1.%A%    
% 221.86/222.05  |- skos__altLabel mesh__D051784 Dioxin Receptor, Nuclear Translocator
% 221.86/222.05  |- mesh__historyNote mesh__D051784 2006%28%1991%29%   
% 221.86/222.05  |- rdf__type mesh__D004330sskos__Concept
% 221.86/222.05  |- mesh__recordAuthorizer mesh__D004330 sjn
% 221.86/222.05  |- skos__related mesh__D004330smesh__D029721
% 221.86/222.05  |- skos__scopeNote mesh__D004330
% 221.86/222.05       A genus of small, two-winged flies containing approximately 900 described species. These organisms are the most extensively studied of all genera from the standpoint of genetics and cytology.%A%    
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D004330 2005
% 221.86/222.05  |- mesh__recordOriginator mesh__D004330 NLM
% 221.86/222.05  |- skos__altLabel mesh__D004330 Fruit Fly, Drosophila
% 221.86/222.05  |- skos__prefLabel mesh__D004330 Drosophila
% 221.86/222.05  |- mesh__dateCreated mesh__D004330 1999-01-01
% 221.86/222.05  |- mesh__dateRevised mesh__D004330 2003-07-09
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D004330 2006
% 221.86/222.05  |- skos__broader mesh__D004330smesh__D018428
% 221.86/222.05  |- mesh__recordMaintainer mesh__D004330 ags
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D004330 2004
% 221.86/222.05  |- skos__historyNote mesh__D017258 Hydroxyprogesterones %28%1976-1978%29%
% 221.86/222.05  |- skos__scopeNote mesh__D017258
% 221.86/222.05       A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms.%A%    
% 221.86/222.05  |- skos__historyNote mesh__D017258
% 221.86/222.05       Medroxyprogesterone/analogs %26% derivatives %28%1978-1992%29%
% 221.86/222.05  |- mesh__recordAuthorizer mesh__D017258 sjn
% 221.86/222.05  |- skos__historyNote mesh__D017258 Medroxyprogesterone %28%1973-1975%29%
% 221.86/222.05  |- skos__hiddenLabel mesh__D017258 Depo Medroxyprogesterone Acetate
% 221.86/222.05  |- skos__hiddenLabel mesh__D017258 Depo Provera
% 221.86/222.05  |- skos__prefLabel mesh__D017258 Medroxyprogesterone 17-Acetate
% 221.86/222.05  |- skos__hiddenLabel mesh__D017258 Medroxyprogesterone 17 Acetate
% 221.86/222.05  |- mesh__dateRevised mesh__D017258 2003-07-09
% 221.86/222.05  |- mesh__recordMaintainer mesh__D017258 lkt
% 221.86/222.05  |- rdf__type mesh__D017258sskos__Concept
% 221.86/222.05  |- skos__altLabel mesh__D017258
% 221.86/222.05       6-alpha-Methyl-17alpha-hydroxyprogesterone Acetate
% 221.86/222.05  |- mesh__recordOriginator mesh__D017258 TPW
% 221.86/222.05  |- mesh__dateCreated mesh__D017258 1992-05-18
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D017258 2004
% 221.86/222.05  |- mesh__dateEstablished mesh__D017258 1993-01-01
% 221.86/222.05  |- skos__hiddenLabel mesh__D017258 17-Acetate, Medroxyprogesterone
% 221.86/222.05  |- skos__broader mesh__D017258smesh__D008525
% 221.86/222.05  |- mesh__publicMeSHNote mesh__D017258
% 221.86/222.05       93; MEDROXYPROGESTERONE 17-ACETATE was indexed under MEDROXYPROGESTERONE/analogs %26% derivatives 1978-1992, HYDROXYPROGESTERONES 1976-78, %26% MEDROXYPROGESTERONE 1973-75%A%  
% 221.86/222.05  |- skos__hiddenLabel mesh__D017258 DepoProvera
% 221.86/222.05  |- skos__hiddenLabel mesh__D017258
% 221.86/222.05       6 alpha Methyl 17alpha hydroxyprogesterone Acetate
% 221.86/222.05  |- mesh__activeMeSHYear mesh__D017258 2005
% 221.86/222.05  |- skos__hiddenLabel mesh__D017258 Acetate, Medroxyprogesterone
% 221.86/222.05  |- skos__altLabel mesh__D017258 Depo-Medroxyprogesterone Acetate
% 221.86/222.05  |- mesh__onlineNote mesh__D017258
% 221.86/222.05       use MEDROXYPROGESTERONE 17-ACETATE %28%NM%29% to search MEDROXYPROGESTERONE 17-ACETATE 1979-92%A%  
% 221.86/222.05  |- skos__hiddenLabel mesh__D017258 Acetate, Depo-Medroxyprogesterone
% 221.86/222.05  |- skos__hiddenLabel mesh__D017258
% 221.86/222.05       Acetate, 6-alpha-Methyl-17alpha-hydroxyprogesterone
% 221.86/222.05  |- mesh__historyNote mesh__D017258
% 221.86/222.05       93: was MEDROXYPROGESTERONE 17-ACETATE %28%NM%29% 1973-92   
% 221.86/222.06  |- skos__altLabel mesh__D017258 Medroxyprogesterone Acetate
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D017258 2006
% 221.86/222.06  |- skos__altLabel mesh__D017258
% 221.86/222.06       %28%6 alpha%29%-17-%28%Acetoxy%29%-6-methylpregn-4-ene-3,20-dione
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D003238 2006
% 221.86/222.06  |- skos__related mesh__D003238smesh__D002481
% 221.86/222.06  |- rdf__type mesh__D003238sskos__Concept
% 221.86/222.06  |- skos__related mesh__D003238smesh__D003094
% 221.86/222.06  |- mesh__recordOriginator mesh__D003238 NLM
% 221.86/222.06  |- skos__hiddenLabel mesh__D003238 Adventitious Tissues
% 221.86/222.06  |- skos__hiddenLabel mesh__D003238 Tissues, Adventitious
% 221.86/222.06  |- mesh__recordMaintainer mesh__D003238 nns
% 221.86/222.06  |- skos__hiddenLabel mesh__D003238 Connective Tissues
% 221.86/222.06  |- skos__hiddenLabel mesh__D003238 Tissue, Adventitious
% 221.86/222.06  |- skos__scopeNote mesh__D003238
% 221.86/222.06       Tissue that supports and binds other tissues. It consists of CONNECTIVE TISSUE CELLS embedded in a large amount of EXTRACELLULAR MATRIX.%A%    
% 221.86/222.06  |- skos__hiddenLabel mesh__D003238 Tissue, Adventitial
% 221.86/222.06  |- skos__altLabel mesh__D003238 Adventitious Tissue
% 221.86/222.06  |- skos__hiddenLabel mesh__D003238 Tissue, Connective
% 221.86/222.06  |- skos__hiddenLabel mesh__D003238 Tissues, Adventitial
% 221.86/222.06  |- mesh__recordAuthorizer mesh__D003238 sjn
% 221.86/222.06  |- skos__hiddenLabel mesh__D003238 Adventitial Tissues
% 221.86/222.06  |- skos__annotation mesh__D003238 inflammation: consider CELLULITIS   
% 221.86/222.06  |- mesh__dateRevised mesh__D003238 2004-07-07
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D003238 2005
% 221.86/222.06  |- skos__prefLabel mesh__D003238 Connective Tissue
% 221.86/222.06  |- skos__hiddenLabel mesh__D003238 Tissues, Connective
% 221.86/222.06  |- skos__broader mesh__D003238smesh__D014024
% 221.86/222.06  |- mesh__dateCreated mesh__D003238 1999-01-01
% 221.86/222.06  |- skos__altLabel mesh__D008721 Shire Brand of Methocarbamol
% 221.86/222.06  |- skos__altLabel mesh__D008721 Guaiphenesin Carbamate
% 221.86/222.06  |- mesh__recordMaintainer mesh__D008721 CCR
% 221.86/222.06  |- skos__broader mesh__D008721smesh__D006140
% 221.86/222.06  |- skos__altLabel mesh__D008721 Whitehall-Robins Brand of Methocarbamol
% 221.86/222.06  |- skos__scopeNote mesh__D008721
% 221.86/222.06       A centrally acting muscle relaxant whose mode of action has not been established. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1206%29%%A%    
% 221.86/222.06  |- skos__altLabel mesh__D008721 Ipsen Brand of Methocarbamol
% 221.86/222.06  |- skos__altLabel mesh__D008721 Alpharma Brand of Methocarbamol
% 221.86/222.06  |- skos__broader mesh__D008721smesh__D002219
% 221.86/222.06  |- skos__hiddenLabel mesh__D008721 Carbamate, Guaiphenesin
% 221.86/222.06  |- skos__altLabel mesh__D008721 Schwarz Brand of Methocarbamol
% 221.86/222.06  |- skos__altLabel mesh__D008721 Bastian Brand of Methocarbamol
% 221.86/222.06  |- rdf__type mesh__D008721sskos__Concept
% 221.86/222.06  |- mesh__recordOriginator mesh__D008721 NLM
% 221.86/222.06  |- skos__altLabel mesh__D008721 Parmed Brand of Methocarbamol
% 221.86/222.06  |- mesh__dateRevised mesh__D008721 2005-06-30
% 221.86/222.06  |- skos__broader mesh__D008721smesh__D048448
% 221.86/222.06  |- mesh__recordAuthorizer mesh__D008721 sjn
% 221.86/222.06  |- skos__prefLabel mesh__D008721 Methocarbamol
% 221.86/222.06  |- skos__hiddenLabel mesh__D008721 Whitehall Robins Brand of Methocarbamol
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D008721 2006
% 221.86/222.06  |- mesh__dateCreated mesh__D008721 1999-01-01
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D013666 2003
% 221.86/222.06  |- mesh__dateRevised mesh__D013666 2001-08-03
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D013666 2004
% 221.86/222.06  |- mesh__considerAlso mesh__D013666
% 221.86/222.06       consider also terms at DACRYO- and LACRIMAL   
% 221.86/222.06  |- skos__annotation mesh__D013666
% 221.86/222.06       lacrimation = TEARS /secret unless LACRIMAL APPARATUS /secret or LACRIMAL APPARATUS /physiol is particularly discussed; epiphora: index under LACRIMAL APPARATUS DISEASES; IMMUNOGLOBULIN A in tears: index TEARS %28%IM%29% + IMMUNOGLOBULIN A, SECRETORY %28%IM%29%%A%  
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D013666 2002
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D013666 2005
% 221.86/222.06  |- mesh__dateCreated mesh__D013666 1999-01-01
% 221.86/222.06  |- skos__prefLabel mesh__D013666 Tears
% 221.86/222.06  |- skos__hiddenLabel mesh__D013666 Tear
% 221.86/222.06  |- mesh__recordOriginator mesh__D013666 NLM
% 221.86/222.06  |- mesh__recordAuthorizer mesh__D013666 sjn
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D013666 2006
% 221.86/222.06  |- rdf__type mesh__D013666sskos__Concept
% 221.86/222.06  |- skos__scopeNote mesh__D013666
% 221.86/222.06       The fluid secreted by the lacrimal glands. This fluid moistens the CONJUNCTIVA and CORNEA.%A%    
% 221.86/222.06  |- mesh__recordMaintainer mesh__D013666 sjn
% 221.86/222.06  |- skos__broader mesh__D013666smesh__D012634
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D007629 2003
% 221.86/222.06  |- mesh__recordAuthorizer mesh__D007629 SJN
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D007629 2002
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D007629 2005
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D007629 2004
% 221.86/222.06  |- skos__broader mesh__D007629smesh__D015146
% 221.86/222.06  |- mesh__recordMaintainer mesh__D007629 PXP
% 221.86/222.06  |- mesh__recordOriginator mesh__D007629 NLM
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D007629 2006
% 221.86/222.06  |- skos__broader mesh__D007629smesh__D001061
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D007629 2000
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D007629 1998
% 221.86/222.06  |- rdf__type mesh__D007629sskos__Concept
% 221.86/222.06  |- mesh__dateRevised mesh__D007629 1997-06-20
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D007629 2001
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D007629 1999
% 221.86/222.06  |- mesh__dateCreated mesh__D007629 1999-01-01
% 221.86/222.06  |- skos__prefLabel mesh__D007629 Kentucky
% 221.86/222.06  |- skos__prefLabel mesh__D032022 Delegation, Professional
% 221.86/222.06  |- skos__scopeNote mesh__D032022
% 221.86/222.06       The process of assigning duties to a subordinate with lesser qualifications.%A%    
% 221.86/222.06  |- mesh__publicMeSHNote mesh__D032022 2003   
% 221.86/222.06  |- skos__broader mesh__D032022smesh__D003695
% 221.86/222.06  |- rdf__type mesh__D032022sskos__Concept
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D032022 2003
% 221.86/222.06  |- mesh__dateCreated mesh__D032022 2002-07-03
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D032022 2004
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D032022 2005
% 221.86/222.06  |- skos__altLabel mesh__D032022 Professional Delegation
% 221.86/222.06  |- mesh__dateEstablished mesh__D032022 2003-01-01
% 221.86/222.06  |- mesh__historyNote mesh__D032022 2003   
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D032022 2006
% 221.86/222.06  |- skos__altLabel mesh__D051785 Sma- and Mad-Related Proteins
% 221.86/222.06  |- skos__broader mesh__D051785smesh__D048868
% 221.86/222.06  |- mesh__recordOriginator mesh__D051785 DRC
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D051785 2006A
% 221.86/222.06  |- mesh__publicMeSHNote mesh__D051785
% 221.86/222.06       2006; SMAD PROTEINS was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1996-2005%A%  
% 221.86/222.06  |- skos__prefLabel mesh__D051785 Smad Proteins
% 221.86/222.06  |- skos__annotation mesh__D051785 general; prefer specifics   
% 221.86/222.06  |- mesh__dateEstablished mesh__D051785 2006-01-01
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D051785 2006D
% 221.86/222.06  |- mesh__historyNote mesh__D051785 2006%28%1996%29%   
% 221.86/222.06  |- mesh__recordAuthorizer mesh__D051785 ags
% 221.86/222.06  |- skos__broader mesh__D051785smesh__D014157
% 221.86/222.06  |- skos__scopeNote mesh__D051785
% 221.86/222.06       A family of proteins that are involved in the translocation of signals from TGF-BETA RECEPTORS; BONE MORPHOGENETIC PROTEIN RECEPTORS; and other surface receptors to the CELL NUCLEUS. They were originally identified as a class of proteins that are related to the mothers against decapentaplegic protein, Drosophila and sma proteins from CAENORHABDITIS ELEGANS.%A%    
% 221.86/222.06  |- mesh__dateRevised mesh__D051785 2005-07-21
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D051785 2006C
% 221.86/222.06  |- mesh__dateCreated mesh__D051785 2005-06-30
% 221.86/222.06  |- skos__hiddenLabel mesh__D051785 Sma  and Mad Related Proteins
% 221.86/222.06  |- skos__altLabel mesh__D051785 Mothers Against Decapentaplegic Homolog
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D051785 2006B
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D051785 2006
% 221.86/222.06  |- mesh__recordMaintainer mesh__D051785 ags
% 221.86/222.06  |- rdf__type mesh__D051785sskos__Concept
% 221.86/222.06  |- skos__broader mesh__D051785smesh__D004268
% 221.86/222.06  |- mesh__recordOriginator mesh__D004331 NLM
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D004331 2005
% 221.86/222.06  |- skos__historyNote mesh__D004331 Drosophila %28%1966-1971%29%
% 221.86/222.06  |- mesh__publicMeSHNote mesh__D004331 72   
% 221.86/222.06  |- mesh__dateCreated mesh__D004331 1999-01-01
% 221.86/222.06  |- mesh__dateRevised mesh__D004331 2003-07-09
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D004331 2006
% 221.86/222.06  |- mesh__recordAuthorizer mesh__D004331 sjn
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D004331 2004
% 221.86/222.06  |- skos__scopeNote mesh__D004331
% 221.86/222.06       A species of fruit fly much used in genetics because of the large size of its chromosomes.%A%    
% 221.86/222.06  |- mesh__historyNote mesh__D004331 72   
% 221.86/222.06  |- mesh__dateEstablished mesh__D004331 1972-01-01
% 221.86/222.06  |- rdf__type mesh__D004331sskos__Concept
% 221.86/222.06  |- skos__annotation mesh__D004331
% 221.86/222.06       /microbiol /parasitol /virol permitted; NIM when merely research organism in genetic studies; DF: D MELANOGASTER%A%  
% 221.86/222.06  |- mesh__recordMaintainer mesh__D004331 ags
% 221.86/222.06  |- skos__broader mesh__D004331smesh__D004330
% 221.86/222.06  |- skos__related mesh__D004331smesh__D029721
% 221.86/222.06  |- skos__prefLabel mesh__D004331 Drosophila melanogaster
% 221.86/222.06  |- mesh__recordOriginator mesh__D017259 TPW
% 221.86/222.06  |- skos__annotation mesh__D017259
% 221.86/222.06       dimaprit stands for DI-Methyl-Amino-Propyl-Iso-Thiourea   
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D017259 2006
% 221.86/222.06  |- skos__prefLabel mesh__D017259 Dimaprit
% 221.86/222.06  |- mesh__dateCreated mesh__D017259 1992-05-13
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D017259 2001
% 221.86/222.06  |- skos__historyNote mesh__D017259
% 221.86/222.06       APT/analogs %26% derivatives %28%1979-1980%29%
% 221.86/222.06  |- skos__scopeNote mesh__D017259
% 221.86/222.06       A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.%A%    
% 221.86/222.06  |- mesh__dateRevised mesh__D017259 2000-06-22
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D017259 2004
% 221.86/222.06  |- mesh__historyNote mesh__D017259 93; was DIMAPRIT %28%NM%29% 1977-92   
% 221.86/222.06  |- mesh__dateEstablished mesh__D017259 1993-01-01
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D017259 2005
% 221.86/222.06  |- skos__hiddenLabel mesh__D017259 Dihydrochloride, Dimaprit
% 221.86/222.06  |- mesh__recordAuthorizer mesh__D017259 sjn
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D017259 2003
% 221.86/222.06  |- mesh__recordMaintainer mesh__D017259 CCR
% 221.86/222.06  |- rdf__type mesh__D017259sskos__Concept
% 221.86/222.06  |- mesh__onlineNote mesh__D017259
% 221.86/222.06       use DIMAPRIT %28%NM%29% to search DIMAPRIT 1980-92   
% 221.86/222.06  |- skos__historyNote mesh__D017259
% 221.86/222.06       Thiourea/analogs %26% derivatives %28%1977-1979%29%
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D017259 2002
% 221.86/222.06  |- skos__historyNote mesh__D017259 APT %28%1980-1992%29%
% 221.86/222.06  |- skos__broader mesh__D017259smesh__D013890
% 221.86/222.06  |- mesh__publicMeSHNote mesh__D017259
% 221.86/222.06       93; DIMAPRIT was indexed under APT 1980-92, APT/analogs %26% derivatives 1979-80 %26% THIOUREA/analogs %26% derivatives 1977-79%A%  
% 221.86/222.06  |- mesh__recordAuthorizer mesh__D003239 sjn
% 221.86/222.06  |- skos__broader mesh__D003239smesh__D002477
% 221.86/222.06  |- skos__hiddenLabel mesh__D003239 Cell, Connective Tissue
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D003239 2001
% 221.86/222.06  |- skos__historyNote mesh__D003239
% 221.86/222.06       Connective Tissue/cytology %28%1978-1997%29%
% 221.86/222.06  |- skos__historyNote mesh__D003239
% 221.86/222.06       Connective Tissue Cells %28%1966-1977%29%
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D003239 2003
% 221.86/222.06  |- skos__hiddenLabel mesh__D003239 Cells, Connective Tissue
% 221.86/222.06  |- skos__prefLabel mesh__D003239 Connective Tissue Cells
% 221.86/222.06  |- mesh__historyNote mesh__D003239 98, 65-77; use explode 1978-97   
% 221.86/222.06  |- skos__scopeNote mesh__D003239
% 221.86/222.06       A group of cells that includes FIBROBLASTS, cartilage cells, ADIPOCYTES, smooth muscle cells, and bone cells.%A%    
% 221.86/222.06  |- mesh__dateEstablished mesh__D003239 1998-01-01
% 221.86/222.06  |- mesh__recordMaintainer mesh__D003239 KEV
% 221.86/222.06  |- mesh__publicMeSHNote mesh__D003239 98, 65-77   
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D003239 2005
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D003239 2004
% 221.86/222.06  |- skos__hiddenLabel mesh__D003239 Connective Tissue Cell
% 221.86/222.06  |- mesh__recordOriginator mesh__D003239 NLM
% 221.86/222.06  |- mesh__dateCreated mesh__D003239 1999-01-01
% 221.86/222.06  |- mesh__dateRevised mesh__D003239 1999-11-03
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D003239 2002
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D003239 2006
% 221.86/222.06  |- rdf__type mesh__D003239sskos__Concept
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D003239 2000
% 221.86/222.06  |- skos__broader mesh__D008722smesh__D008919
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D008722 2000
% 221.86/222.06  |- mesh__recordAuthorizer mesh__D008722 PLS
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D008722 2001
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D008722 1997
% 221.86/222.06  |- skos__annotation mesh__D008722
% 221.86/222.06       no qualif; prefer /methods %28%Manual 19.7+%29%, with correct category but do not index /methods routinely: the method should be discussed substantively; never IM; policy: Manual 19.8.45, 26.3.7+%A%  
% 221.86/222.06  |- mesh__historyNote mesh__D008722
% 221.86/222.06       91%28%67%29%; was see under SCIENCE 1967-90   
% 221.86/222.06  |- mesh__onlineNote mesh__D008722 use SCIENCE to search METHODS 1969-74   
% 221.86/222.06  |- rdf__type mesh__D008722sskos__Concept
% 221.86/222.06  |- skos__altLabel mesh__D008722 Methodological Study
% 221.86/222.06  |- mesh__dateEstablished mesh__D008722 1991-01-01
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D008722 2002
% 221.86/222.06  |- mesh__recordMaintainer mesh__D008722 PLS
% 221.86/222.06  |- skos__prefLabel mesh__D008722 Methods
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D008722 2005
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D008722 1995
% 221.86/222.06  |- skos__altLabel mesh__D008722 Studies, Methodological
% 221.86/222.06  |- mesh__publicMeSHNote mesh__D008722 91; was see under SCIENCE 1967-90   
% 221.86/222.06  |- mesh__recordOriginator mesh__D008722 NLM
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D008722 2003
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D008722 2006
% 221.86/222.06  |- mesh__dateCreated mesh__D008722 1999-01-01
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D008722 1998
% 221.86/222.06  |- skos__broader mesh__D008722smesh__D012586
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D008722 2004
% 221.86/222.06  |- skos__hiddenLabel mesh__D008722 Procedure
% 221.86/222.06  |- mesh__dateRevised mesh__D008722 1994-05-23
% 221.86/222.06  |- skos__altLabel mesh__D008722 Methodological Studies
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D008722 1996
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D008722 1999
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D013667 2004
% 221.86/222.06  |- skos__related mesh__D013667smesh__D015609
% 221.86/222.06  |- mesh__dateCreated mesh__D013667 1999-01-01
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D013667 2005
% 221.86/222.06  |- skos__annotation mesh__D013667
% 221.86/222.06       note X ref: many specific Technetium Tc 99m terms are available%A%  
% 221.86/222.06  |- skos__broader mesh__D013667smesh__D019216
% 221.86/222.06  |- mesh__recordMaintainer mesh__D013667 nns
% 221.86/222.06  |- skos__scopeNote mesh__D013667
% 221.86/222.06       The first artificially produced element and a radioactive fission product of URANIUM. Technetium has the atomic symbol Tc, atomic number 43, and atomic weight 98.91. All technetium isotopes are radioactive. Technetium 99m %28%m=metastable%29% which is the decay product of Molybdenum 99, has a half-life of about 6 hours and is used diagnostically as a radioactive imaging agent. Technetium 99 which is a decay product of technetium 99m, has a half-life of 210,000 years.%A%    
% 221.86/222.06  |- skos__hiddenLabel mesh__D013667 99m, Technetium
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D013667 2006
% 221.86/222.06  |- mesh__dateRevised mesh__D013667 2002-07-03
% 221.86/222.06  |- rdf__type mesh__D013667sskos__Concept
% 221.86/222.06  |- skos__prefLabel mesh__D013667 Technetium
% 221.86/222.06  |- skos__broader mesh__D013667smesh__D004603
% 221.86/222.06  |- mesh__recordOriginator mesh__D013667 NLM
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D013667 2003
% 221.86/222.06  |- mesh__recordAuthorizer mesh__D013667 sjn
% 221.86/222.06  |- skos__broader mesh__D013667smesh__D028561
% 221.86/222.06  |- mesh__dateCreated mesh__D032821 2002-07-03
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D032821 2003
% 221.86/222.06  |- skos__scopeNote mesh__D032821
% 221.86/222.06       The social process by which something or someone comes to be regarded and treated as an article of trade or commerce.%A%    
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D032821 2004
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D032821 2005
% 221.86/222.06  |- skos__broader mesh__D032821smesh__D032981
% 221.86/222.06  |- mesh__dateEstablished mesh__D032821 2003-01-01
% 221.86/222.06  |- skos__historyNote mesh__D032821 Economics %28%1986-2002%29%
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D032821 2006
% 221.86/222.06  |- rdf__type mesh__D032821sskos__Concept
% 221.86/222.06  |- mesh__publicMeSHNote mesh__D032821 2003; see ECONOMICS 2001-2002   
% 221.86/222.06  |- skos__prefLabel mesh__D032821 Commodification
% 221.86/222.06  |- skos__historyNote mesh__D032821 Commerce %28%1991-2002%29%
% 221.86/222.06  |- mesh__historyNote mesh__D032821 2003; use ECONOMICS 2001-2002   
% 221.86/222.06  |- skos__broader mesh__D032821smesh__D003132
% 221.86/222.06  |- skos__scopeNote mesh__D018352
% 221.86/222.06       Virus diseases caused by the CORONAVIRUS genus. Some specifics include transmissible enteritis of turkeys %28%ENTERITIS, TRANSMISSIBLE, OF TURKEYS%29%; FELINE INFECTIOUS PERITONITIS; and transmissible gastroenteritis of swine %28%GASTROENTERITIS, TRANSMISSIBLE, OF SWINE%29%.%A%    
% 221.86/222.06  |- mesh__onlineNote mesh__D018352
% 221.86/222.06       use CORONAVIRIDAE INFECTIONS to search CORONAVIRUS INFECTIONS 1977-93%A%  
% 221.86/222.06  |- skos__prefLabel mesh__D018352 Coronavirus Infections
% 221.86/222.06  |- mesh__dateEstablished mesh__D018352 1994-01-01
% 221.86/222.06  |- mesh__recordOriginator mesh__D018352 AGS
% 221.86/222.06  |- mesh__recordMaintainer mesh__D018352 ags
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D018352 2002
% 221.86/222.06  |- mesh__publicMeSHNote mesh__D018352 94; was heading 1977-93   
% 221.86/222.06  |- mesh__dateCreated mesh__D018352 1993-06-04
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D018352 2006
% 221.86/222.06  |- mesh__dateRevised mesh__D018352 2001-07-25
% 221.86/222.06  |- rdf__type mesh__D018352sskos__Concept
% 221.86/222.06  |- mesh__historyNote mesh__D018352 94; was heading 1977-93   
% 221.86/222.06  |- skos__hiddenLabel mesh__D018352 Coronavirus Infection
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D018352 2005
% 221.86/222.06  |- skos__annotation mesh__D018352
% 221.86/222.06       caused by members of the Coronavirus genus: do not confuse with CORONAVIRIDAE INFECTIONS caused by members of the Coronaviridae family; GEN or unspecified; prefer specifics%A%  
% 221.86/222.06  |- skos__broader mesh__D018352smesh__D003333
% 221.86/222.06  |- mesh__recordAuthorizer mesh__D018352 sjn
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D018352 2004
% 221.86/222.06  |- skos__hiddenLabel mesh__D018352 Infection, Coronavirus
% 221.86/222.06  |- skos__altLabel mesh__D018352 Infections, Coronavirus
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D018352 2003
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D032023 2006
% 221.86/222.06  |- mesh__dateEstablished mesh__D032023 2003-01-01
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D032023 2005
% 221.86/222.06  |- mesh__publicMeSHNote mesh__D032023 2003   
% 221.86/222.06  |- mesh__dateCreated mesh__D032023 2002-07-03
% 221.86/222.06  |- skos__prefLabel mesh__D032023 Integrons
% 221.86/222.06  |- skos__annotation mesh__D032023
% 221.86/222.06       do not confuse with INTEGRINS %28%membrane glycoproteins%29%   
% 221.86/222.06  |- skos__hiddenLabel mesh__D032023 Integron
% 221.86/222.06  |- rdf__type mesh__D032023sskos__Concept
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D032023 2004
% 221.86/222.06  |- skos__scopeNote mesh__D032023
% 221.86/222.06       DNA elements that include the component genes and insertion site for a site-specific recombination system that enables them to capture mobile gene cassettes.%A%    
% 221.86/222.06  |- mesh__historyNote mesh__D032023 2003   
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D032023 2003
% 221.86/222.06  |- skos__broader mesh__D032023smesh__D004251
% 221.86/222.06  |- skos__hiddenLabel mesh__D051786 cAMP Responsive Element Modulator
% 221.86/222.06  |- skos__prefLabel mesh__D051786 Cyclic AMP Response Element Modulator
% 221.86/222.06  |- skos__altLabel mesh__D051786 Inducible cAMP Early Regulator
% 221.86/222.06  |- skos__broader mesh__D051786smesh__D050976
% 221.86/222.06  |- mesh__dateEstablished mesh__D051786 2006-01-01
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D051786 2006
% 221.86/222.06  |- skos__altLabel mesh__D051786 cAMP-Responsive Element Modulator
% 221.86/222.06  |- mesh__publicMeSHNote mesh__D051786
% 221.86/222.06       2006; CYCLIC AMP RESPONSE ELEMENT MODULATOR was indexed under DNA-BINDING PROTEINS %26% REPRESSOR PROTEINS %26% TRANSCRIPTION FACTORS 1991-2005%A%  
% 221.86/222.06  |- rdf__type mesh__D051786sskos__Concept
% 221.86/222.06  |- skos__scopeNote mesh__D051786
% 221.86/222.06       Cyclic AMP response element modulator is a basic leucine zipper transcription factor that is regulated by CYCLIC AMP. It plays an important role in SPERMATID development in the mammalian TESTIS.%A%    
% 221.86/222.06  |- mesh__recordAuthorizer mesh__D051786 sjn
% 221.86/222.06  |- mesh__dateCreated mesh__D051786 2005-06-30
% 221.86/222.06  |- mesh__recordMaintainer mesh__D051786 DRC
% 221.86/222.06  |- mesh__historyNote mesh__D051786 2006%28%1991%29%   
% 221.86/222.06  |- mesh__recordOriginator mesh__D051786 DRC
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D004332 2005
% 221.86/222.06  |- mesh__recordMaintainer mesh__D004332 KEV
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D004332 2002
% 221.86/222.06  |- skos__prefLabel mesh__D004332 Drowning
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D004332 2003
% 221.86/222.06  |- mesh__dateCreated mesh__D004332 1999-01-01
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D004332 2006
% 221.86/222.06  |- mesh__recordOriginator mesh__D004332 NLM
% 221.86/222.06  |- mesh__dateRevised mesh__D004332 1999-11-03
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D004332 2004
% 221.86/222.06  |- skos__broader mesh__D004332smesh__D000059
% 221.86/222.06  |- rdf__type mesh__D004332sskos__Concept
% 221.86/222.06  |- skos__related mesh__D004332smesh__D015701
% 221.86/222.06  |- skos__hiddenLabel mesh__D004332 Drownings
% 221.86/222.06  |- skos__scopeNote mesh__D004332
% 221.86/222.06       Death that occurs as a result of anoxia or heart arrest, associated with immersion in liquid.%A%    
% 221.86/222.06  |- skos__related mesh__D004332smesh__D012151
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D004332 2000
% 221.86/222.06  |- mesh__recordAuthorizer mesh__D004332 sjn
% 221.86/222.06  |- skos__broader mesh__D004332smesh__D014947
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D004332 2001
% 221.86/222.06  |- skos__broader mesh__D004332smesh__D003643
% 221.86/222.06  |- skos__hiddenLabel mesh__D014760 Fusion Protein, Paramyxovirus
% 221.86/222.06  |- skos__hiddenLabel mesh__D014760 Fusion Protein, Measles
% 221.86/222.06  |- mesh__dateEstablished mesh__D014760 1987-01-01
% 221.86/222.06  |- skos__annotation mesh__D014760
% 221.86/222.06       coord with specific virus; do not confuse with RECOMBINANT FUSION PROTEINS%A%  
% 221.86/222.06  |- skos__altLabel mesh__D014760 Glycoprotein, Viral Fusion
% 221.86/222.06  |- mesh__historyNote mesh__D014760 87   
% 221.86/222.06  |- skos__altLabel mesh__D014760 F Protein %28%Sendai Virus%29%
% 221.86/222.06  |- mesh__recordAuthorizer mesh__D014760 sjn
% 221.86/222.06  |- skos__prefLabel mesh__D014760 Viral Fusion Proteins
% 221.86/222.06  |- skos__broader mesh__D014760smesh__D050576
% 221.86/222.06  |- skos__hiddenLabel mesh__D014760 Fusion-GP, Viral
% 221.86/222.06  |- skos__altLabel mesh__D014760 Viral Fusion-GP
% 221.86/222.06  |- skos__hiddenLabel mesh__D014760 Viral Fusion Glycoprotein
% 221.86/222.06  |- skos__altLabel mesh__D014760 F-Glycoprotein SV
% 221.86/222.06  |- skos__altLabel mesh__D014760 F Protein Measles Virus
% 221.86/222.06  |- skos__hiddenLabel mesh__D014760 Fusion Glycoproteins, Viral
% 221.86/222.06  |- skos__broader mesh__D014760smesh__D014759
% 221.86/222.06  |- rdf__type mesh__D014760sskos__Concept
% 221.86/222.06  |- mesh__recordOriginator mesh__D014760 RLS
% 221.86/222.06  |- skos__scopeNote mesh__D014760
% 221.86/222.06       Proteins, usually glycoproteins, found in the viral envelopes of a variety of viruses. They promote cell membrane fusion and thereby may function in the uptake of the virus by cells.%A%    
% 221.86/222.06  |- skos__hiddenLabel mesh__D014760 Viral Fusion GP
% 221.86/222.06  |- skos__altLabel mesh__D014760 Fusion Proteins, Viral
% 221.86/222.06  |- mesh__recordMaintainer mesh__D014760 nns
% 221.86/222.06  |- mesh__publicMeSHNote mesh__D014760 87   
% 221.86/222.06  |- skos__hiddenLabel mesh__D014760 VP1 Protein, Fusion
% 221.86/222.06  |- skos__historyNote mesh__D014760
% 221.86/222.06       Viral Envelope Proteins %28%1984-1986%29%
% 221.86/222.06  |- skos__altLabel mesh__D014760 F Protein SV
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D014760 2006
% 221.86/222.06  |- skos__hiddenLabel mesh__D014760 Glycoproteins, Viral Fusion
% 221.86/222.06  |- mesh__dateRevised mesh__D014760 2005-06-30
% 221.86/222.06  |- skos__historyNote mesh__D014760 Viral Proteins %28%1966-1983%29%
% 221.86/222.06  |- skos__altLabel mesh__D014760 Fusion Glycoprotein, Viral
% 221.86/222.06  |- mesh__dateCreated mesh__D014760 1986-06-16
% 221.86/222.06  |- mesh__dateRevised mesh__D008723 2005-06-30
% 221.86/222.06  |- mesh__recordOriginator mesh__D008723 NLM
% 221.86/222.06  |- skos__altLabel mesh__D008723 Jones Brand of Methohexital Sodium
% 221.86/222.06  |- mesh__recordAuthorizer mesh__D008723 sjn
% 221.86/222.06  |- skos__hiddenLabel mesh__D008723 Sodium, Methohexital
% 221.86/222.06  |- skos__hiddenLabel mesh__D008723 Monosodium Salt Methohexital
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D008723 2006
% 221.86/222.06  |- mesh__dateCreated mesh__D008723 1999-01-01
% 221.86/222.06  |- skos__hiddenLabel mesh__D008723 Brietal Sodium
% 221.86/222.06  |- skos__altLabel mesh__D008723 Methohexitone
% 221.86/222.06  |- skos__altLabel mesh__D008723 Brietal-Sodium
% 221.86/222.06  |- mesh__recordMaintainer mesh__D008723 CCR
% 221.86/222.06  |- skos__prefLabel mesh__D008723 Methohexital
% 221.86/222.06  |- skos__altLabel mesh__D008723 Methohexital, Monosodium Salt
% 221.86/222.06  |- mesh__onlineNote mesh__D008723
% 221.86/222.06       use METHOHEXITAL to search ENALLYNYMALUM 1977-94   
% 221.86/222.06  |- skos__hiddenLabel mesh__D008723 Natrium, Brevimytal
% 221.86/222.06  |- rdf__type mesh__D008723sskos__Concept
% 221.86/222.06  |- skos__scopeNote mesh__D008723
% 221.86/222.06       An intravenous anesthetic with a short duration of action that may be used for induction of anesthesia.%A%    
% 221.86/222.06  |- mesh__historyNote mesh__D008723
% 221.86/222.06       ENALLYNYMALUM was see METHOHEXITAL 1977-94   
% 221.86/222.06  |- skos__broader mesh__D008723smesh__D001463
% 221.86/222.06  |- skos__altLabel mesh__D008723 Lilly Brand of Methohexital Sodium
% 221.86/222.06  |- mesh__publicMeSHNote mesh__D008723
% 221.86/222.06       ENALLYNYMALUM was see METHOHEXITAL 1977-94   
% 221.86/222.06  |- skos__annotation mesh__D000740 GEN or unspecified; prefer specifics   
% 221.86/222.06  |- mesh__dateCreated mesh__D000740 1999-01-01
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D000740 2002
% 221.86/222.06  |- mesh__recordAuthorizer mesh__D000740 PLS
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D000740 2003
% 221.86/222.06  |- mesh__recordOriginator mesh__D000740 NLM
% 221.86/222.06  |- mesh__dateRevised mesh__D000740 1996-06-10
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D000740 2004
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D000740 1997
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D000740 2000
% 221.86/222.06  |- skos__hiddenLabel mesh__D000740 Anemias
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D000740 2001
% 221.86/222.06  |- mesh__recordMaintainer mesh__D000740 TGC
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D000740 2005
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D000740 1998
% 221.86/222.06  |- skos__broader mesh__D000740smesh__D006402
% 221.86/222.06  |- skos__prefLabel mesh__D000740 Anemia
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D000740 2006
% 221.86/222.06  |- mesh__activeMeSHYear mesh__D000740 1999
% 221.86/222.06  |- rdf__type mesh__D000740sskos__Concept
% 221.86/222.07  |- skos__scopeNote mesh__D000740
% 221.86/222.07       A reduction in the number of circulating erythrocytes or in the quantity of hemoglobin.%A%    
% 221.86/222.07  |- skos__hiddenLabel mesh__D013668 Technetium 99m Albumin Colloid
% 221.86/222.07  |- mesh__dateCreated mesh__D013668 1984-06-11
% 221.86/222.07  |- skos__hiddenLabel mesh__D013668 99mTc Human Serum Albumin
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D013668 2001
% 221.86/222.07  |- skos__annotation mesh__D013668 as label, use /diag use; DF: TC HSA   
% 221.86/222.07  |- mesh__publicMeSHNote mesh__D013668 85   
% 221.86/222.07  |- mesh__recordOriginator mesh__D013668 RLS
% 221.86/222.07  |- skos__hiddenLabel mesh__D013668 99mTcAlbures
% 221.86/222.07  |- skos__scopeNote mesh__D013668
% 221.86/222.07       A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in cardiovascular and cerebral circulation.%A%    
% 221.86/222.07  |- skos__hiddenLabel mesh__D013668 Colloid, Tc 99m-Albumin
% 221.86/222.07  |- skos__hiddenLabel mesh__D013668 Tc 99m Albumin Colloid
% 221.86/222.07  |- skos__hiddenLabel mesh__D013668 Tc 99m Albumin
% 221.86/222.07  |- rdf__type mesh__D013668sskos__Concept
% 221.86/222.07  |- skos__hiddenLabel mesh__D013668 Tc99m Albumin
% 221.86/222.07  |- skos__hiddenLabel mesh__D013668 Colloid, Technetium-99m Albumin
% 221.86/222.07  |- mesh__recordAuthorizer mesh__D013668 sjn
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D013668 2003
% 221.86/222.07  |- skos__broader mesh__D013668smesh__D015609
% 221.86/222.07  |- skos__prefLabel mesh__D013668 Technetium Tc 99m Aggregated Albumin
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D013668 2002
% 221.86/222.07  |- mesh__dateEstablished mesh__D013668 1985-01-01
% 221.86/222.07  |- skos__hiddenLabel mesh__D013668 Albumin Colloid, Technetium-99m
% 221.86/222.07  |- skos__hiddenLabel mesh__D013668 99mTc Albures
% 221.86/222.07  |- skos__broader mesh__D013668smesh__D000418
% 221.86/222.07  |- skos__hiddenLabel mesh__D013668 Albumin, 99mTc-Human Serum
% 221.86/222.07  |- skos__altLabel mesh__D013668 Technetium-99m Albumin Colloid
% 221.86/222.07  |- skos__hiddenLabel mesh__D013668 Tc 99m HAM
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D013668 2004
% 221.86/222.07  |- mesh__recordMaintainer mesh__D013668 CCR
% 221.86/222.07  |- skos__altLabel mesh__D013668 Tc 99m-Albumin Colloid
% 221.86/222.07  |- mesh__dateRevised mesh__D013668 2000-06-21
% 221.86/222.07  |- skos__hiddenLabel mesh__D013668 Serum Albumin, 99mTc-Human
% 221.86/222.07  |- skos__altLabel mesh__D013668 Tc99m-Albumin
% 221.86/222.07  |- skos__historyNote mesh__D013668 Technetium %28%1966-1984%29%
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D013668 2005
% 221.86/222.07  |- skos__altLabel mesh__D013668 99m-Tc-HSA
% 221.86/222.07  |- skos__hiddenLabel mesh__D013668 Tc 99m Microalbumin
% 221.86/222.07  |- skos__altLabel mesh__D013668 Tc-99m-MAA
% 221.86/222.07  |- skos__altLabel mesh__D013668 Tc-HAMM
% 221.86/222.07  |- skos__altLabel mesh__D013668 99mTc-HSA
% 221.86/222.07  |- skos__altLabel mesh__D013668 Tc-99m-Microalbumin
% 221.86/222.07  |- skos__hiddenLabel mesh__D013668 Tc HAMM
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D013668 2006
% 221.86/222.07  |- mesh__historyNote mesh__D013668 85   
% 221.86/222.07  |- skos__historyNote mesh__D013668 Serum Albumin %28%1966-1984%29%
% 221.86/222.07  |- skos__hiddenLabel mesh__D013668 Tc 99m MAA
% 221.86/222.07  |- skos__altLabel mesh__D013668 Tc-99m-HAM
% 221.86/222.07  |- skos__historyNote mesh__D013668 Albumins %28%1966-1984%29%
% 221.86/222.07  |- skos__hiddenLabel mesh__D018353 Rhabdoviridae Infection
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D018353 2006
% 221.86/222.07  |- rdf__type mesh__D018353sskos__Concept
% 221.86/222.07  |- skos__broader mesh__D018353smesh__D018701
% 221.86/222.07  |- mesh__recordOriginator mesh__D018353 AGS
% 221.86/222.07  |- mesh__dateEstablished mesh__D018353 1994-01-01
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D018353 2005
% 221.86/222.07  |- mesh__publicMeSHNote mesh__D018353 94   
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D018353 2002
% 221.86/222.07  |- skos__hiddenLabel mesh__D018353 Infection, Rhabdoviridae
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D018353 2004
% 221.86/222.07  |- mesh__dateCreated mesh__D018353 1993-06-04
% 221.86/222.07  |- skos__annotation mesh__D018353 GEN or unspecified; prefer specifics   
% 221.86/222.07  |- mesh__dateRevised mesh__D018353 2001-07-25
% 221.86/222.07  |- mesh__historyNote mesh__D018353 94   
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D018353 2003
% 221.86/222.07  |- skos__scopeNote mesh__D018353
% 221.86/222.07       Virus diseases caused by RHABDOVIRIDAE. Important infections include RABIES; EPHEMERAL FEVER; and vesicular stomatitis.%A%    
% 221.86/222.07  |- skos__altLabel mesh__D018353 Infections, Rhabdoviridae
% 221.86/222.07  |- mesh__recordAuthorizer mesh__D018353 sjn
% 221.86/222.07  |- mesh__recordMaintainer mesh__D018353 mdb
% 221.86/222.07  |- skos__prefLabel mesh__D018353 Rhabdoviridae Infections
% 221.86/222.07  |- skos__scopeNote mesh__D010370
% 221.86/222.07       Persons academically trained to provide medical care, under the supervision of a physician, to infants and children.%A%    
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010370 2004
% 221.86/222.07  |- rdf__type mesh__D010370sskos__Concept
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010370 2001
% 221.86/222.07  |- skos__annotation mesh__D010370 check also tag CHILD or specific   
% 221.86/222.07  |- skos__hiddenLabel mesh__D010370 Pediatric Assistant
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010370 2003
% 221.86/222.07  |- mesh__historyNote mesh__D010370
% 221.86/222.07       91%28%75%29%; was see under PHYSICIANS%27% ASSISTANTS 1975-90   
% 221.86/222.07  |- mesh__dateEstablished mesh__D010370 1991-01-01
% 221.86/222.07  |- skos__hiddenLabel mesh__D010370 Assistant, Pediatric
% 221.86/222.07  |- mesh__dateRevised mesh__D010370 1992-05-15
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010370 1997
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010370 2000
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010370 2006
% 221.86/222.07  |- skos__hiddenLabel mesh__D010370 Assistants, Pediatric
% 221.86/222.07  |- mesh__recordOriginator mesh__D010370 NLM
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010370 1996
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010370 1993
% 221.86/222.07  |- skos__prefLabel mesh__D010370 Pediatric Assistants
% 221.86/222.07  |- mesh__publicMeSHNote mesh__D010370
% 221.86/222.07       91; was see under PHYSICIANS%27% ASSISTANTS 1975-90   
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010370 2005
% 221.86/222.07  |- mesh__recordAuthorizer mesh__D010370 PLS
% 221.86/222.07  |- skos__broader mesh__D010370smesh__D010823
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010370 1999
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010370 2002
% 221.86/222.07  |- mesh__recordMaintainer mesh__D010370 TAP
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010370 1995
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010370 1998
% 221.86/222.07  |- mesh__onlineNote mesh__D010370
% 221.86/222.07       search PHYSICIANS%27% ASSISTANTS 1971-74   
% 221.86/222.07  |- mesh__dateCreated mesh__D010370 1999-01-01
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010370 1994
% 221.86/222.07  |- skos__scopeNote mesh__D032024
% 221.86/222.07       To entrust to the care or management of another, to transfer or to assign tasks within an organizational or administrative unit or structure%A%    
% 221.86/222.07  |- skos__prefLabel mesh__D032024 Personnel Delegation
% 221.86/222.07  |- mesh__recordMaintainer mesh__D032024 jls
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D032024 2005
% 221.86/222.07  |- mesh__publicMeSHNote mesh__D032024 2003   
% 221.86/222.07  |- skos__broader mesh__D032024smesh__D010559
% 221.86/222.07  |- rdf__type mesh__D032024sskos__Concept
% 221.86/222.07  |- mesh__recordAuthorizer mesh__D032024 jls
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D032024 2004
% 221.86/222.07  |- mesh__dateEstablished mesh__D032024 2003-01-01
% 221.86/222.07  |- mesh__dateRevised mesh__D032024 2004-07-30
% 221.86/222.07  |- skos__altLabel mesh__D032024 Delegation, Personnel
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D032024 2003
% 221.86/222.07  |- mesh__dateCreated mesh__D032024 2002-07-03
% 221.86/222.07  |- mesh__recordOriginator mesh__D032024 jls
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D032024 2005A
% 221.86/222.07  |- mesh__historyNote mesh__D032024 2003   
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D032024 2006
% 221.86/222.07  |- mesh__publicMeSHNote mesh__D051787
% 221.86/222.07       2006; MYOGENIC REGULATORY FACTOR 5 was indexed under DNA-BINDING PROTEINS %26% MUSCLE PROTEINS 1989-2005, TRANS-ACTIVATORS 2005, %26% under TRANSCRIPTION FACTORS 1989-2004%A%  
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D051787 2006
% 221.86/222.07  |- mesh__recordAuthorizer mesh__D051787 sjn
% 221.86/222.07  |- mesh__dateCreated mesh__D051787 2005-06-30
% 221.86/222.07  |- rdf__type mesh__D051787sskos__Concept
% 221.86/222.07  |- skos__broader mesh__D051787smesh__D018006
% 221.86/222.07  |- skos__prefLabel mesh__D051787 Myogenic Regulatory Factor 5
% 221.86/222.07  |- skos__altLabel mesh__D051787 Myogenic Factor 5
% 221.86/222.07  |- skos__altLabel mesh__D051787 Myf5 Transcription Factor
% 221.86/222.07  |- mesh__recordOriginator mesh__D051787 DRC
% 221.86/222.07  |- mesh__dateEstablished mesh__D051787 2006-01-01
% 221.86/222.07  |- skos__hiddenLabel mesh__D051787 Transcription Factor, Myf5
% 221.86/222.07  |- skos__scopeNote mesh__D051787
% 221.86/222.07       A SKELETAL MUSCLE-specific transcription factor that contains a basic HELIX-LOOP-HELIX MOTIF. It plays an essential role in MUSCLE DEVELOPMENT.%A%    
% 221.86/222.07  |- mesh__historyNote mesh__D051787 2006%28%1989%29%   
% 221.86/222.07  |- mesh__recordMaintainer mesh__D051787 DRC
% 221.86/222.07  |- skos__prefLabel mesh__D004333 Drug Administration Routes
% 221.86/222.07  |- mesh__dateEstablished mesh__D004333 1987-01-01
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D004333 1998
% 221.86/222.07  |- mesh__recordMaintainer mesh__D004333 ADP
% 221.86/222.07  |- mesh__dateCreated mesh__D004333 1999-01-01
% 221.86/222.07  |- skos__hiddenLabel mesh__D004333 Drug Administration Route
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D004333 2000
% 221.86/222.07  |- skos__altLabel mesh__D004333 Administration Routes, Drug
% 221.86/222.07  |- mesh__recordAuthorizer mesh__D004333 SJN
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D004333 2004
% 221.86/222.07  |- skos__broader mesh__D004333smesh__D008919
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D004333 2006
% 221.86/222.07  |- skos__scopeNote mesh__D004333
% 221.86/222.07       The various ways of administering a drug or other chemical to a site in a patient or animal from where the chemical is absorbed into the blood and delivered to the target tissue.%A%    
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D004333 2003
% 221.86/222.07  |- mesh__historyNote mesh__D004333
% 221.86/222.07       87; was DRUG ADMINISTRATION %28%NON MESH%29% before 1987   
% 221.86/222.07  |- skos__hiddenLabel mesh__D004333 Administration Route, Drug
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D004333 2005
% 221.86/222.07  |- mesh__publicMeSHNote mesh__D004333 87   
% 221.86/222.07  |- mesh__recordOriginator mesh__D004333 NLM
% 221.86/222.07  |- skos__hiddenLabel mesh__D004333 Routes, Drug Administration
% 221.86/222.07  |- rdf__type mesh__D004333sskos__Concept
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D004333 2002
% 221.86/222.07  |- skos__hiddenLabel mesh__D004333 Route, Drug Administration
% 221.86/222.07  |- skos__annotation mesh__D004333
% 221.86/222.07       GEN %26% unspecified: prefer specific; NIM   
% 221.86/222.07  |- skos__related mesh__D004333smesh__D004304
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D004333 1999
% 221.86/222.07  |- mesh__dateRevised mesh__D004333 1997-06-20
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D004333 2001
% 221.86/222.07  |- skos__hiddenLabel mesh__D028781 Relativism, Ethical
% 221.86/222.07  |- skos__prefLabel mesh__D028781 Ethical Relativism
% 221.86/222.07  |- mesh__dateRevised mesh__D028781 2002-07-03
% 221.86/222.07  |- mesh__publicMeSHNote mesh__D028781 2002   
% 221.86/222.07  |- skos__historyNote mesh__D028781 Ethics %28%1979-2001%29%
% 221.86/222.07  |- mesh__recordOriginator mesh__D028781 jrf
% 221.86/222.07  |- skos__related mesh__D028781smesh__D018864
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D028781 2006
% 221.86/222.07  |- mesh__dateCreated mesh__D028781 2001-07-25
% 221.86/222.07  |- skos__related mesh__D028781smesh__D035481
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D028781 2004
% 221.86/222.07  |- rdf__type mesh__D028781sskos__Concept
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D028781 2005
% 221.86/222.07  |- mesh__recordMaintainer mesh__D028781 hjn
% 221.86/222.07  |- skos__broader mesh__D028781smesh__D004989
% 221.86/222.07  |- mesh__historyNote mesh__D028781 2002   
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D028781 2003
% 221.86/222.07  |- mesh__dateEstablished mesh__D028781 2002-01-01
% 221.86/222.07  |- skos__scopeNote mesh__D028781
% 221.86/222.07       The philosophical view that conceptions of truth and moral values are not absolute but are relative to the persons or groups holding them. %28%from American Heritage Dictionary of the English Language, 4th ed%29%%A%    
% 221.86/222.07  |- mesh__recordAuthorizer mesh__D028781 sjn
% 221.86/222.07  |- skos__scopeNote mesh__D014761
% 221.86/222.07       Any vaccine raised against any virus or viral derivative that causes hepatitis.%A%    
% 221.86/222.07  |- mesh__dateRevised mesh__D014761 2005-06-30
% 221.86/222.07  |- skos__hiddenLabel mesh__D014761 Vaccines, Viral Hepatitis
% 221.86/222.07  |- skos__prefLabel mesh__D014761 Viral Hepatitis Vaccines
% 221.86/222.07  |- skos__altLabel mesh__D014761 Hepatitis, Viral, Vaccines
% 221.86/222.07  |- mesh__recordMaintainer mesh__D014761 ssb
% 221.86/222.07  |- skos__broader mesh__D014761smesh__D014765
% 221.86/222.07  |- skos__historyNote mesh__D014761 Viral Vaccines %28%1966-1984%29%
% 221.86/222.07  |- mesh__publicMeSHNote mesh__D014761 85   
% 221.86/222.07  |- rdf__type mesh__D014761sskos__Concept
% 221.86/222.07  |- skos__hiddenLabel mesh__D014761 Hepatitis Vaccines, Viral
% 221.86/222.07  |- mesh__recordAuthorizer mesh__D014761 sjn
% 221.86/222.07  |- mesh__recordOriginator mesh__D014761 SH
% 221.86/222.07  |- mesh__dateCreated mesh__D014761 1984-05-02
% 221.86/222.07  |- skos__historyNote mesh__D014761
% 221.86/222.07       Hepatitis, Viral, Animal %28%1977-1984%29%
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D014761 2006
% 221.86/222.07  |- mesh__dateEstablished mesh__D014761 1985-01-01
% 221.86/222.07  |- skos__annotation mesh__D014761
% 221.86/222.07       coord IM with specific hepatitis virus or viral hepatitis %28%IM or NIM%29% if pertinent%A%  
% 221.86/222.07  |- skos__historyNote mesh__D014761
% 221.86/222.07       Hepatitis, Viral, Human %28%1977-1984%29%
% 221.86/222.07  |- mesh__historyNote mesh__D014761 85   
% 221.86/222.07  |- mesh__dateCreated mesh__D008724 1974-11-19
% 221.86/222.07  |- skos__broader mesh__D008724smesh__D013859
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D008724 2006
% 221.86/222.07  |- skos__historyNote mesh__D008724 Imines %28%1971-1974%29%
% 221.86/222.07  |- skos__broader mesh__D008724smesh__D002219
% 221.86/222.07  |- skos__scopeNote mesh__D008724
% 221.86/222.07       A carbamate insecticide with anticholinesterase activity.%A%    
% 221.86/222.07  |- mesh__dateRevised mesh__D008724 2005-06-30
% 221.86/222.07  |- mesh__recordOriginator mesh__D008724 NLM
% 221.86/222.07  |- skos__historyNote mesh__D008724 Sulfides %28%1971-1974%29%
% 221.86/222.07  |- mesh__recordAuthorizer mesh__D008724 sjn
% 221.86/222.07  |- skos__annotation mesh__D008724
% 221.86/222.07       for effect on insects, see note at INSECTICIDES   
% 221.86/222.07  |- mesh__recordMaintainer mesh__D008724 ssb
% 221.86/222.07  |- skos__historyNote mesh__D008724 Carbamates %28%1971-1974%29%
% 221.86/222.07  |- skos__prefLabel mesh__D008724 Methomyl
% 221.86/222.07  |- rdf__type mesh__D008724sskos__Concept
% 221.86/222.07  |- mesh__historyNote mesh__D008724
% 221.86/222.07       91%28%75%29%; was see under INSECTICIDES, CARBAMATE 1975-90   
% 221.86/222.07  |- skos__hiddenLabel mesh__D008724 20, Lannate
% 221.86/222.07  |- mesh__publicMeSHNote mesh__D008724
% 221.86/222.07       91; was see under INSECTICIDES, CARBAMATE 1975-90   
% 221.86/222.07  |- mesh__dateEstablished mesh__D008724 1991-01-01
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D000741 2002
% 221.86/222.07  |- mesh__recordAuthorizer mesh__D000741 PLS
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D000741 1996
% 221.86/222.07  |- skos__hiddenLabel mesh__D000741 Hypoplastic Anemia
% 221.86/222.07  |- skos__broader mesh__D000741smesh__D000740
% 221.86/222.07  |- skos__broader mesh__D000741smesh__D001855
% 221.86/222.07  |- skos__hiddenLabel mesh__D000741 Anemias, Aplastic
% 221.86/222.07  |- mesh__recordOriginator mesh__D000741 NLM
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D000741 2006
% 221.86/222.07  |- mesh__dateRevised mesh__D000741 1995-06-08
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D000741 2003
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D000741 1997
% 221.86/222.07  |- skos__hiddenLabel mesh__D000741 Anemias, Hypoplastic
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D000741 2000
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D000741 2004
% 221.86/222.07  |- skos__hiddenLabel mesh__D000741 Hypoplastic Anemias
% 221.86/222.07  |- skos__annotation mesh__D000741 a bone marrow dis   
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D000741 2001
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D000741 1998
% 221.86/222.07  |- skos__hiddenLabel mesh__D000741 Aplastic Anemias
% 221.86/222.07  |- rdf__type mesh__D000741sskos__Concept
% 221.86/222.07  |- skos__hiddenLabel mesh__D000741 Aplastic Anemia
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D000741 2005
% 221.86/222.07  |- mesh__dateCreated mesh__D000741 1999-01-01
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D000741 1999
% 221.86/222.07  |- skos__prefLabel mesh__D000741 Anemia, Aplastic
% 221.86/222.07  |- mesh__recordMaintainer mesh__D000741 RAZ
% 221.86/222.07  |- skos__scopeNote mesh__D000741
% 221.86/222.07       A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.%A%    
% 221.86/222.07  |- skos__hiddenLabel mesh__D013669 Medronate, Tc-99
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D013669 2001
% 221.86/222.07  |- rdf__type mesh__D013669sskos__Concept
% 221.86/222.07  |- mesh__recordOriginator mesh__D013669 RLS
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D013669 2003
% 221.86/222.07  |- skos__historyNote mesh__D013669 Diphosphonates %28%1977-1985%29%
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D013669 1998
% 221.86/222.07  |- skos__annotation mesh__D013669
% 221.86/222.07       as label, use /diag use; DF: TC MEDRONATE   
% 221.86/222.07  |- mesh__dateEstablished mesh__D013669 1986-01-01
% 221.86/222.07  |- skos__altLabel mesh__D013669 99mTc-MDP
% 221.86/222.07  |- skos__broader mesh__D013669smesh__D015609
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D013669 2002
% 221.86/222.07  |- mesh__historyNote mesh__D013669 86   
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D013669 2004
% 221.86/222.07  |- skos__hiddenLabel mesh__D013669 Tc 99m Methylene Diphosphonate
% 221.86/222.07  |- skos__hiddenLabel mesh__D013669 Diphosphonate, Technetium Methylene
% 221.86/222.07  |- skos__hiddenLabel mesh__D013669 Diphosphonate, 99mTc-Methylene
% 221.86/222.07  |- mesh__dateCreated mesh__D013669 1985-03-08
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D013669 1999
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D013669 2005
% 221.86/222.07  |- skos__historyNote mesh__D013669 Technetium %28%1966-1985%29%
% 221.86/222.07  |- skos__hiddenLabel mesh__D013669 Tc 99 Medronate
% 221.86/222.07  |- mesh__recordAuthorizer mesh__D013669 PLS
% 221.86/222.07  |- skos__hiddenLabel mesh__D013669 Methylene Diphosphonate, Technetium
% 221.86/222.07  |- skos__altLabel mesh__D013669 Tc-99 Medronate
% 221.86/222.07  |- mesh__publicMeSHNote mesh__D013669 86   
% 221.86/222.07  |- skos__hiddenLabel mesh__D013669 99mTc Methylene Diphosphonate
% 221.86/222.07  |- mesh__recordMaintainer mesh__D013669 TPW
% 221.86/222.07  |- mesh__dateRevised mesh__D013669 1996-06-10
% 221.86/222.07  |- skos__altLabel mesh__D013669 Tc-99m MDP
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D013669 2006
% 221.86/222.07  |- skos__altLabel mesh__D013669 Tc-99m Methylene Diphosphonate
% 221.86/222.07  |- skos__hiddenLabel mesh__D013669 Diphosphonate, Tc-99m Methylene
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D013669 2000
% 221.86/222.07  |- skos__altLabel mesh__D013669 99mTc-Methylene Diphosphonate
% 221.86/222.07  |- skos__broader mesh__D013669smesh__D004164
% 221.86/222.07  |- skos__prefLabel mesh__D013669 Technetium Tc 99m Medronate
% 221.86/222.07  |- skos__hiddenLabel mesh__D013669 Methylene Diphosphonate, Tc-99m
% 221.86/222.07  |- skos__altLabel mesh__D013669 Technetium Tc 99m Methylenediphosphonate
% 221.86/222.07  |- skos__scopeNote mesh__D013669
% 221.86/222.07       A gamma-emitting radionuclide imaging agent used primarily in skeletal scintigraphy. Because of its absorption by a variety of tumors, it is useful for the detection of neoplasms.%A%    
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D013669 1997
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D018354 2005
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D018354 1995
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D018354 2001
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D018354 2004
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D018354 2000
% 221.86/222.07  |- skos__altLabel mesh__D018354 Infections, Alphavirus
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D018354 1994
% 221.86/222.07  |- skos__hiddenLabel mesh__D018354 Alphavirus Infection
% 221.86/222.07  |- skos__scopeNote mesh__D018354
% 221.86/222.07       Virus diseases caused by members of the ALPHAVIRUS genus of the family TOGAVIRIDAE.%A%    
% 221.86/222.07  |- mesh__historyNote mesh__D018354 94   
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D018354 2003
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D018354 1999
% 221.86/222.07  |- skos__hiddenLabel mesh__D018354 Infection, Alphavirus
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D018354 1998
% 221.86/222.07  |- mesh__dateEstablished mesh__D018354 1994-01-01
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D018354 1997
% 221.86/222.07  |- skos__broader mesh__D018354smesh__D014036
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D018354 2006
% 221.86/222.07  |- skos__prefLabel mesh__D018354 Alphavirus Infections
% 221.86/222.07  |- mesh__publicMeSHNote mesh__D018354 94   
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D018354 2002
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D018354 1996
% 221.86/222.07  |- rdf__type mesh__D018354sskos__Concept
% 221.86/222.07  |- skos__annotation mesh__D018354
% 221.86/222.07       caused by a togavirus; GEN or unspecified; prefer specifics%A%  
% 221.86/222.07  |- mesh__dateCreated mesh__D018354 1993-06-04
% 221.86/222.07  |- skos__broader mesh__D010371smesh__D013041
% 221.86/222.07  |- skos__scopeNote mesh__D010371
% 221.86/222.07       The nursing care of children from birth to adolescence. It includes the clinical and psychological aspects of nursing care.%A%    
% 221.86/222.07  |- skos__historyNote mesh__D010371 Nursing %28%1966%29%
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010371 1997
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010371 2006
% 221.86/222.07  |- skos__annotation mesh__D010371
% 221.86/222.07       SPEC; SPEC qualif; check also tag CHILD or specific   
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010371 2001
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010371 1996
% 221.86/222.07  |- skos__prefLabel mesh__D010371 Pediatric Nursing
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010371 1993
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010371 2005
% 221.86/222.07  |- mesh__dateRevised mesh__D010371 1992-05-22
% 221.86/222.07  |- skos__broader mesh__D010371smesh__D009732
% 221.86/222.07  |- mesh__publicMeSHNote mesh__D010371 67   
% 221.86/222.07  |- mesh__dateEstablished mesh__D010371 1967-01-01
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010371 1999
% 221.86/222.07  |- mesh__historyNote mesh__D010371 67   
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010371 2000
% 221.86/222.07  |- skos__historyNote mesh__D010371 Nursing Care %28%1966%29%
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010371 1995
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010371 1998
% 221.86/222.07  |- mesh__recordOriginator mesh__D010371 NLM
% 221.86/222.07  |- skos__hiddenLabel mesh__D010371 Pediatric Nursings
% 221.86/222.07  |- mesh__dateCreated mesh__D010371 1999-01-01
% 221.86/222.07  |- skos__altLabel mesh__D010371 Nursing, Pediatric
% 221.86/222.07  |- skos__hiddenLabel mesh__D010371 Nursings, Pediatric
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010371 1994
% 221.86/222.07  |- mesh__recordAuthorizer mesh__D010371 PLS
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010371 2004
% 221.86/222.07  |- rdf__type mesh__D010371sskos__Concept
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010371 2002
% 221.86/222.07  |- mesh__recordMaintainer mesh__D010371 TGC
% 221.86/222.07  |- skos__historyNote mesh__D010371 Pediatrics %28%1966%29%
% 221.86/222.07  |- skos__related mesh__D010371smesh__D016389
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D010371 2003
% 221.86/222.07  |- rdf__type mesh__D051788sskos__Concept
% 221.86/222.07  |- skos__hiddenLabel mesh__D051788
% 221.86/222.07       Myeloid/Lymphoid Or Mixed Lineage Leukemia Protein
% 221.86/222.07  |- skos__altLabel mesh__D051788 MLL Proto-Oncogene Protein
% 221.86/222.07  |- skos__scopeNote mesh__D051788
% 221.86/222.07       Myeloid-lymphoid leukemia protein is a transcription factor that maintains high levels of HOMEOTIC GENE expression during development. The GENE for myeloid-lymphoid leukemia protein is commonly disrupted in LEUKEMIA and combines with over 40 partner genes to form FUSION ONCOGENE PROTEINS.%A%    
% 221.86/222.07  |- skos__broader mesh__D051788smesh__D004268
% 221.86/222.07  |- mesh__recordMaintainer mesh__D051788 ags
% 221.86/222.07  |- skos__altLabel mesh__D051788 Proto-Oncogene Proteins MLL
% 221.86/222.07  |- mesh__recordOriginator mesh__D051788 DRC
% 221.86/222.07  |- skos__hiddenLabel mesh__D051788 MLL Proto Oncogene Protein
% 221.86/222.07  |- mesh__dateCreated mesh__D051788 2005-06-30
% 221.86/222.07  |- skos__hiddenLabel mesh__D051788 MLL, Proto-Oncogene Proteins
% 221.86/222.07  |- skos__altLabel mesh__D051788 Zinc Finger Protein HRX
% 221.86/222.07  |- skos__altLabel mesh__D051788 Mixed-Lineage Leukemia Protein
% 221.86/222.07  |- skos__hiddenLabel mesh__D051788 Proto Oncogene Proteins MLL
% 221.86/222.07  |- skos__broader mesh__D051788smesh__D014157
% 221.86/222.07  |- mesh__recordAuthorizer mesh__D051788 ags
% 221.86/222.07  |- skos__hiddenLabel mesh__D051788 Mixed Lineage Leukemia Protein
% 221.86/222.07  |- mesh__historyNote mesh__D051788 2006%28%1992%29%   
% 221.86/222.07  |- skos__broader mesh__D051788smesh__D011518
% 221.86/222.07  |- skos__altLabel mesh__D051788
% 221.86/222.07       Myeloid/Lymphoid Or Mixed-Lineage Leukemia Protein
% 221.86/222.07  |- skos__hiddenLabel mesh__D051788 Proto-Oncogene Protein, MLL
% 221.86/222.07  |- mesh__dateRevised mesh__D051788 2005-07-13
% 221.86/222.07  |- skos__prefLabel mesh__D051788 Myeloid-Lymphoid Leukemia Protein
% 221.86/222.07  |- skos__hiddenLabel mesh__D051788 Myeloid Lymphoid Leukemia Protein
% 221.86/222.07  |- skos__altLabel mesh__D051788 Acute Lymphoblastic Leukemia Protein 1
% 221.86/222.07  |- mesh__dateEstablished mesh__D051788 2006-01-01
% 221.86/222.07  |- mesh__publicMeSHNote mesh__D051788
% 221.86/222.07       2006; MYELOID-LYMPHOID LEUKEMIA PROTEIN was indexed under DNA-BINDING PROTEINS %26% PROTO-ONCOGENE PROTEINS %26% TRANSCRIPTION FACTORS 1992-2005%A%  
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D051788 2006
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D051788 2006A
% 221.86/222.07  |- skos__hiddenLabel mesh__D004334 Administration Schedules, Drug
% 221.86/222.07  |- skos__historyNote mesh__D004334
% 221.86/222.07       specific drug/administration %26% dosage %28%1966-1974%29%
% 221.86/222.07  |- skos__altLabel mesh__D004334 Administration Schedule, Drug
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D004334 2004
% 221.86/222.07  |- mesh__dateCreated mesh__D004334 1974-11-19
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D004334 2001
% 221.86/222.07  |- mesh__recordMaintainer mesh__D004334 TGC
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D004334 2006
% 221.86/222.07  |- skos__prefLabel mesh__D004334 Drug Administration Schedule
% 221.86/222.07  |- mesh__dateRevised mesh__D004334 1996-06-13
% 221.86/222.07  |- mesh__dateEstablished mesh__D004334 1975-09-01
% 221.86/222.07  |- mesh__historyNote mesh__D004334 75   
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D004334 2003
% 221.86/222.07  |- skos__scopeNote mesh__D004334
% 221.86/222.07       Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience.%A%    
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D004334 2000
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D004334 2005
% 221.86/222.07  |- mesh__publicMeSHNote mesh__D004334 75   
% 221.86/222.07  |- skos__hiddenLabel mesh__D004334 Schedules, Drug Administration
% 221.86/222.07  |- skos__hiddenLabel mesh__D004334 Schedule, Drug Administration
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D004334 1997
% 221.86/222.07  |- rdf__type mesh__D004334sskos__Concept
% 221.86/222.07  |- skos__annotation mesh__D004334
% 221.86/222.07       NIM only; coord NIM with drug term /admin %28%IM%29%; drug admin based on circadian rhythm = CHRONOTHERAPY: do not coord with DRUG ADMINISTRATION SCHEDULE or CIRCADIAN RHYTHM; DF: DRUG ADMIN SCHEDULE%A%  
% 221.86/222.07  |- mesh__activeMeSHYear mesh__D004334 1999
% 221.86/222.07  |- skos__broader mesh__D004334smesh__D008919
% 221.86/222.08  |- mesh__recordAuthorizer mesh__D004334 PLS
% 221.86/222.08  |- skos__related mesh__D004334smesh__D019454
% 221.86/222.08  |- skos__hiddenLabel mesh__D004334 Drug Administration Schedules
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D004334 1998
% 221.86/222.08  |- mesh__recordOriginator mesh__D004334 NLM
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D004334 2002
% 221.86/222.08  |- rdf__type mesh__D014762sskos__Concept
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D014762 2003
% 221.86/222.08  |- mesh__recordAuthorizer mesh__D014762 SJN
% 221.86/222.08  |- skos__prefLabel mesh__D014762 Viral Interference
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D014762 2000
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D014762 2006
% 221.86/222.08  |- skos__broader mesh__D014762smesh__D018406
% 221.86/222.08  |- mesh__dateEstablished mesh__D014762 1966-01-01
% 221.86/222.08  |- skos__related mesh__D014762smesh__D007372
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D014762 1999
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D014762 2005
% 221.86/222.08  |- skos__hiddenLabel mesh__D014762 Interferences, Viral
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D014762 2002
% 221.86/222.08  |- mesh__recordOriginator mesh__D014762 NLM
% 221.86/222.08  |- skos__hiddenLabel mesh__D014762 Viral Interferences
% 221.86/222.08  |- mesh__historyNote mesh__D014762 66%28%65%29%   
% 221.86/222.08  |- mesh__dateRevised mesh__D014762 1998-06-11
% 221.86/222.08  |- mesh__publicMeSHNote mesh__D014762 66   
% 221.86/222.08  |- mesh__recordMaintainer mesh__D014762 PXP
% 221.86/222.08  |- skos__hiddenLabel mesh__D014762 Interference, Viral
% 221.86/222.08  |- skos__related mesh__D014762smesh__D015163
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D014762 2004
% 221.86/222.08  |- skos__scopeNote mesh__D014762
% 221.86/222.08       A phenomenon in which infection by a first virus results in resistance of cells or tissues to infection by a second, unrelated virus.%A%    
% 221.86/222.08  |- mesh__dateCreated mesh__D014762 1999-01-01
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D014762 2001
% 221.86/222.08  |- skos__annotation mesh__D008725 DF: METHONIUM CPDS   
% 221.86/222.08  |- mesh__dateCreated mesh__D008725 1999-01-01
% 221.86/222.08  |- skos__hiddenLabel mesh__D008725 Bis Trimethyl Ammonium Compounds
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D008725 2006
% 221.86/222.08  |- skos__scopeNote mesh__D008725
% 221.86/222.08       Compounds containing polymethylene bis-trimethylammonium cations. Members of this group frequently act as ganglionic blockers and neuromuscular depolarizing agents.%A%    
% 221.86/222.08  |- mesh__publicMeSHNote mesh__D008725
% 221.86/222.08       2006; see METHONIUM COMPOUNDS 1963-2005   
% 221.86/222.08  |- mesh__recordMaintainer mesh__D008725 ssb
% 221.86/222.08  |- skos__broader mesh__D008725smesh__D000644
% 221.86/222.08  |- mesh__historyNote mesh__D008725 2006%28%1963%29%   
% 221.86/222.08  |- mesh__dateRevised mesh__D008725 2005-06-30
% 221.86/222.08  |- skos__altLabel mesh__D008725 Bis-Trimethyl-Ammonium Compounds
% 221.86/222.08  |- rdf__type mesh__D008725sskos__Concept
% 221.86/222.08  |- mesh__recordAuthorizer mesh__D008725 sjn
% 221.86/222.08  |- mesh__recordOriginator mesh__D008725 NLM
% 221.86/222.08  |- skos__hiddenLabel mesh__D008725 Bis Trimethylammonium Compounds
% 221.86/222.08  |- skos__prefLabel mesh__D008725 Bis-Trimethylammonium Compounds
% 221.86/222.08  |- mesh__recordAuthorizer mesh__D000742 sjn
% 221.86/222.08  |- rdf__type mesh__D000742sskos__Concept
% 221.86/222.08  |- skos__altLabel mesh__D000742
% 221.86/222.08       Hereditary Erythroblast Multinuclearity with Positive Acidified Serum
% 221.86/222.08  |- skos__altLabel mesh__D000742 HEMPAS
% 221.86/222.08  |- skos__altLabel mesh__D000742 Anemia, Congenital Dyserythropoietic
% 221.86/222.08  |- skos__hiddenLabel mesh__D000742 Dyserythropoietic Anemias, Congenital
% 221.86/222.08  |- skos__hiddenLabel mesh__D000742 Congenital Dyserythropoietic Anemias
% 221.86/222.08  |- skos__altLabel mesh__D000742 Congenital Dyserythropoietic Anemia, Type I
% 221.86/222.08  |- skos__scopeNote mesh__D000742
% 221.86/222.08       A familial disorder characterized by ANEMIA with multinuclear ERYTHROBLASTS, karyorrhexis, asynchrony of nuclear and cytoplasmic maturation, and various nuclear abnormalities of bone marrow erythrocyte precursors %28%ERYTHROID PROGENITOR CELLS%29%. Type II is the most common of the 3 types; it is often referred to as HEMPAS, based on the Hereditary Erythroblast Multinuclearity with Positive Acidified Serum test.%A%    
% 221.86/222.08  |- skos__altLabel mesh__D000742
% 221.86/222.08       Anemia, Congenital Dyserythropoietic, Type II
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D000742 2006
% 221.86/222.08  |- mesh__recordOriginator mesh__D000742 VDK
% 221.86/222.08  |- skos__altLabel mesh__D000742 Congenital Dyserythropoietic Anemia Type II
% 221.86/222.08  |- mesh__dateCreated mesh__D000742 1979-04-23
% 221.86/222.08  |- mesh__historyNote mesh__D000742
% 221.86/222.08       91%28%80%29%; was see under ANEMIA, HEMOLYTIC, CONGENITAL 1980-90%A%  
% 221.86/222.08  |- skos__altLabel mesh__D000742
% 221.86/222.08       Congenital Dyserythropoietic Anemia, Type III
% 221.86/222.08  |- skos__altLabel mesh__D000742 Congenital Dyserythropoietic Anemia
% 221.86/222.08  |- mesh__dateEstablished mesh__D000742 1991-01-01
% 221.86/222.08  |- skos__prefLabel mesh__D000742 Anemia, Dyserythropoietic, Congenital
% 221.86/222.08  |- skos__hiddenLabel mesh__D000742 Anemias, Congenital Dyserythropoietic
% 221.86/222.08  |- mesh__publicMeSHNote mesh__D000742
% 221.86/222.08       91; was see under ANEMIA, HEMOLYTIC, CONGENITAL 1980-90   
% 221.86/222.08  |- mesh__recordMaintainer mesh__D000742 nns
% 221.86/222.08  |- skos__altLabel mesh__D000742 Dyserythropoietic Anemia, Congenital
% 221.86/222.08  |- mesh__dateRevised mesh__D000742 2005-06-30
% 221.86/222.08  |- skos__broader mesh__D000742smesh__D000745
% 221.86/222.08  |- skos__historyNote mesh__D000742 Erythropoiesis %28%1966-1979%29%
% 221.86/222.08  |- skos__historyNote mesh__D000742 Anemia %28%1966-1979%29%
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D018355 2002
% 221.86/222.08  |- mesh__publicMeSHNote mesh__D018355 94   
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D018355 1999
% 221.86/222.08  |- mesh__historyNote mesh__D018355 94   
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D018355 2003
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D018355 2001
% 221.86/222.08  |- skos__altLabel mesh__D018355 Infections, Rubivirus
% 221.86/222.08  |- mesh__dateCreated mesh__D018355 1993-06-04
% 221.86/222.08  |- skos__annotation mesh__D018355
% 221.86/222.08       caused by a togavirus; GEN or unspecified; prefer specifics%A%  
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D018355 1998
% 221.86/222.08  |- skos__hiddenLabel mesh__D018355 Rubivirus Infection
% 221.86/222.08  |- skos__prefLabel mesh__D018355 Rubivirus Infections
% 221.86/222.08  |- skos__hiddenLabel mesh__D018355 Infection, Rubivirus
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D018355 2000
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D018355 1997
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D018355 2006
% 221.86/222.08  |- skos__broader mesh__D018355smesh__D014036
% 221.86/222.08  |- skos__scopeNote mesh__D018355
% 221.86/222.08       Virus diseases caused by the RUBIVIRUS genus, of the family TOGAVIRIDAE.%A%    
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D018355 1996
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D018355 2005
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D018355 1995
% 221.86/222.08  |- mesh__dateEstablished mesh__D018355 1994-01-01
% 221.86/222.08  |- rdf__type mesh__D018355sskos__Concept
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D018355 1994
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D018355 2004
% 221.86/222.08  |- mesh__recordOriginator mesh__D010372 NLM
% 221.86/222.08  |- skos__prefLabel mesh__D010372 Pediatrics
% 221.86/222.08  |- skos__annotation mesh__D010372
% 221.86/222.08       SPEC: SPEC qualif; when permitted for %22%pediatric dis%22%: Manual 28.10.1%A%  
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D010372 2006
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D010372 1998
% 221.86/222.08  |- mesh__dateCreated mesh__D010372 1999-01-01
% 221.86/222.08  |- mesh__recordAuthorizer mesh__D010372 SJN
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D010372 1999
% 221.86/222.08  |- skos__scopeNote mesh__D010372
% 221.86/222.08       A medical specialty concerned with maintaining health and providing medical care to children from birth to adolescence.%A%    
% 221.86/222.08  |- mesh__dateRevised mesh__D010372 1997-06-20
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D010372 2000
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D010372 2003
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D010372 2001
% 221.86/222.08  |- skos__broader mesh__D010372smesh__D013040
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D010372 2004
% 221.86/222.08  |- rdf__type mesh__D010372sskos__Concept
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D010372 2002
% 221.86/222.08  |- mesh__recordMaintainer mesh__D010372 PXP
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D010372 2005
% 221.86/222.08  |- skos__prefLabel mesh__D051789 Proto-Oncogene Protein c-fli-1
% 221.86/222.08  |- mesh__historyNote mesh__D051789 2006%28%1993%29%   
% 221.86/222.08  |- mesh__publicMeSHNote mesh__D051789
% 221.86/222.08       2006; PROTO-ONCOGENE PROTEIN C-FLI-1 was indexed under DNA-BINDING PROTEINS %26% PROTO-ONCOGENE PROTEINS %26% TRANS-ACTIVATORS 1993-2005%A%  
% 221.86/222.08  |- rdf__type mesh__D051789sskos__Concept
% 221.86/222.08  |- skos__altLabel mesh__D051789 Retroviral Integration Site Protein Fli-1
% 221.86/222.08  |- skos__hiddenLabel mesh__D051789 Proto Oncogene Proteins c fli 1
% 221.86/222.08  |- skos__hiddenLabel mesh__D051789
% 221.86/222.08       Retroviral Integration Site Protein Fli 1
% 221.86/222.08  |- skos__altLabel mesh__D051789
% 221.86/222.08       Friend Leukemia Integration 1 Transcription Factor
% 221.86/222.08  |- mesh__recordMaintainer mesh__D051789 DRC
% 221.86/222.08  |- skos__hiddenLabel mesh__D051789 Proto Oncogene Protein c fli 1
% 221.86/222.08  |- mesh__dateEstablished mesh__D051789 2006-01-01
% 221.86/222.08  |- skos__scopeNote mesh__D051789
% 221.86/222.08       A member of the c-ets family of transcription factors that is preferentially expressed in cells of hematopoietic lineages and vascular endothelial cells. It was originally identified as a protein that provides a retroviral integration site for integration of FRIEND MURINE LEUKEMIA VIRUS.%A%    
% 221.86/222.08  |- mesh__dateCreated mesh__D051789 2005-06-30
% 221.86/222.08  |- skos__broader mesh__D051789smesh__D050783
% 221.86/222.08  |- skos__hiddenLabel mesh__D051789 c-fli-1, Proto-Oncogene Protein
% 221.86/222.08  |- mesh__recordAuthorizer mesh__D051789 sjn
% 221.86/222.08  |- mesh__recordOriginator mesh__D051789 DRC
% 221.86/222.08  |- skos__altLabel mesh__D051789 fli-1 Transcription Factor
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D051789 2006
% 221.86/222.08  |- skos__hiddenLabel mesh__D051789 fli 1 Transcription Factor
% 221.86/222.08  |- skos__hiddenLabel mesh__D051789 Transcription Factor, fli-1
% 221.86/222.08  |- skos__altLabel mesh__D051789 Proto-Oncogene Proteins c-fli-1
% 221.86/222.08  |- skos__hiddenLabel mesh__D004335 Regulations, Drug
% 221.86/222.08  |- skos__broader mesh__D004335smesh__D007880
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D004335 2005
% 221.86/222.08  |- skos__hiddenLabel mesh__D004335 Recall, Drug
% 221.86/222.08  |- mesh__dateRevised mesh__D004335 2001-07-25
% 221.86/222.08  |- skos__altLabel mesh__D004335 Narcotic and Drug Control
% 221.86/222.08  |- rdf__type mesh__D004335sskos__Concept
% 221.86/222.08  |- mesh__dateEstablished mesh__D004335 1968-01-01
% 221.86/222.08  |- skos__hiddenLabel mesh__D004335 Recalls, Drug
% 221.86/222.08  |- mesh__onlineNote mesh__D004335
% 221.86/222.08       use LEGISLATION, DRUG to search DRUG REGULATIONS 1990-92 %26% DRUG RECALL 1985-92; use DRUG AND NARCOTIC CONTROL to search NARCOTIC TRADE 1966-67%A%  
% 221.86/222.08  |- mesh__recordOriginator mesh__D004335 NLM
% 221.86/222.08  |- mesh__historyNote mesh__D004335
% 221.86/222.08       68; DRUG REGULATIONS was see LEGISLATION, DRUG 1990-92; DRUG RECALL was see LEGISLATION, DRUG 1985-92; NARCOTIC TRADE was heading 1963-67%A%  
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D004335 2002
% 221.86/222.08  |- skos__prefLabel mesh__D004335 Drug and Narcotic Control
% 221.86/222.08  |- mesh__dateCreated mesh__D004335 1999-01-01
% 221.86/222.08  |- skos__hiddenLabel mesh__D004335 Pharmaceutical Policies
% 221.86/222.08  |- skos__hiddenLabel mesh__D004335 Drug Regulation
% 221.86/222.08  |- skos__scopeNote mesh__D004335
% 221.86/222.08       Control of drug and narcotic use by international agreement, or by institutional systems for handling prescribed drugs. This includes regulations concerned with the manufacturing, dispensing, approval %28%DRUG APPROVAL%29%, and marketing of drugs.%A%    
% 221.86/222.08  |- skos__hiddenLabel mesh__D004335 Regulation, Drug
% 221.86/222.08  |- skos__hiddenLabel mesh__D004335 Drug Controls
% 221.86/222.08  |- skos__hiddenLabel mesh__D004335 Narcotic Controls
% 221.86/222.08  |- mesh__publicMeSHNote mesh__D004335
% 221.86/222.08       68; DRUG REGULATIONS was see LEGISLATION, DRUG 1990-92; DRUG RECALL was see LEGISLATION, DRUG 1985-92; NARCOTIC TRADE was heading 1963-67%A%  
% 221.86/222.08  |- skos__annotation mesh__D004335
% 221.86/222.08       Public Law 91-513; includes internat agreement; specify country or state; DF: DRUG CONTROL%A%  
% 221.86/222.08  |- skos__hiddenLabel mesh__D004335 Control, Narcotic
% 221.86/222.08  |- mesh__recordAuthorizer mesh__D004335 sjn
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D004335 2004
% 221.86/222.08  |- skos__broader mesh__D004335smesh__D010605
% 221.86/222.08  |- skos__hiddenLabel mesh__D004335 Policy, Pharmaceutical
% 221.86/222.08  |- skos__hiddenLabel mesh__D004335 Control, Drug
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D004335 2006
% 221.86/222.08  |- mesh__recordMaintainer mesh__D004335 jls
% 221.86/222.08  |- skos__hiddenLabel mesh__D004335 Policies, Pharmaceutical
% 221.86/222.08  |- skos__hiddenLabel mesh__D004335 Controls, Narcotic
% 221.86/222.08  |- skos__hiddenLabel mesh__D004335 Controls, Drug
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D004335 2003
% 221.86/222.08  |- skos__altLabel mesh__D004335 Pharmaceutic Policy
% 221.86/222.08  |- skos__hiddenLabel mesh__D004335 Drug Recalls
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D009020 2005
% 221.86/222.08  |- skos__hiddenLabel mesh__D009020 Contin, MS
% 221.86/222.08  |- mesh__publicMeSHNote mesh__D009020
% 221.86/222.08       MORPHINE SULFATE was indexed under MORPHINE 1980-96   
% 221.86/222.08  |- skos__altLabel mesh__D009020 SDZ202-250
% 221.86/222.08  |- skos__related mesh__D009020smesh__D011957
% 221.86/222.08  |- skos__hiddenLabel mesh__D009020 SDZ 202 250
% 221.86/222.08  |- mesh__recordMaintainer mesh__D009020 CCR
% 221.86/222.08  |- skos__hiddenLabel mesh__D009020 Sulfate, Morphine
% 221.86/222.08  |- mesh__recordOriginator mesh__D009020 NLM
% 221.86/222.08  |- skos__hiddenLabel mesh__D009020 SDZ202 250
% 221.86/222.08  |- skos__scopeNote mesh__D009020
% 221.86/222.08       The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle.%A%    
% 221.86/222.08  |- mesh__dateCreated mesh__D009020 1999-01-01
% 221.86/222.08  |- skos__hiddenLabel mesh__D009020 SDZ 202250
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D009020 2002
% 221.86/222.08  |- rdf__type mesh__D009020sskos__Concept
% 221.86/222.08  |- mesh__recordAuthorizer mesh__D009020 sjn
% 221.86/222.08  |- skos__prefLabel mesh__D009020 Morphine
% 221.86/222.08  |- skos__hiddenLabel mesh__D009020 Chloride, Morphine
% 221.86/222.08  |- mesh__dateRevised mesh__D009020 2001-07-25
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D009020 2004
% 221.86/222.08  |- skos__hiddenLabel mesh__D009020 SDZ202250
% 221.86/222.08  |- mesh__historyNote mesh__D009020
% 221.86/222.08       MORPHINE SULFATE was %28%NM%29% 1980-96   
% 221.86/222.08  |- skos__annotation mesh__D009020 /analogs = MORPHINE DERIVATIVES   
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D009020 2003
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D009020 2006
% 221.86/222.08  |- skos__altLabel mesh__D009020 Morphia
% 221.86/222.08  |- skos__broader mesh__D009020smesh__D009019
% 221.86/222.08  |- mesh__recordAuthorizer mesh__D014763 sjn
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D014763 2006
% 221.86/222.08  |- skos__hiddenLabel mesh__D014763 Protein, Viral M
% 221.86/222.08  |- mesh__recordMaintainer mesh__D014763 SYSTEM
% 221.86/222.08  |- skos__altLabel mesh__D014763 Viral Membrane Proteins
% 221.86/222.08  |- skos__hiddenLabel mesh__D014763 M Proteins, Viral
% 221.86/222.08  |- skos__hiddenLabel mesh__D014763 Proteins, Viral M
% 221.86/222.08  |- skos__hiddenLabel mesh__D014763 M Protein, Viral
% 221.86/222.08  |- skos__hiddenLabel mesh__D014763 Proteins, Viral Membrane
% 221.86/222.08  |- mesh__recordOriginator mesh__D014763 RLS
% 221.86/222.08  |- skos__hiddenLabel mesh__D014763 Proteins, Viral Matrix
% 221.86/222.08  |- skos__broader mesh__D014763smesh__D014759
% 221.86/222.08  |- skos__annotation mesh__D014763
% 221.86/222.08       IM; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 221.86/222.08  |- mesh__historyNote mesh__D014763 88   
% 221.86/222.08  |- skos__altLabel mesh__D014763 Membrane Proteins, Viral
% 221.86/222.08  |- skos__hiddenLabel mesh__D014763 Matrix Proteins, Viral
% 221.86/222.08  |- mesh__dateCreated mesh__D014763 1987-05-05
% 221.86/222.08  |- skos__hiddenLabel mesh__D014763 Matrix Proteins, Granulin
% 221.86/222.08  |- mesh__dateEstablished mesh__D014763 1988-01-01
% 221.86/222.08  |- mesh__dateRevised mesh__D014763 2005-06-30
% 221.86/222.08  |- skos__scopeNote mesh__D014763
% 221.86/222.08       Proteins associated with the inner surface of the lipid bilayer of the viral envelope. These proteins have been implicated in control of viral transcription and may possibly serve as the %22%glue%22% that binds the nucleocapsid to the appropriate membrane site during viral budding from the host cell.%A%    
% 221.86/222.08  |- skos__historyNote mesh__D014763 Viral Proteins %28%1966-1987%29%
% 221.86/222.08  |- skos__prefLabel mesh__D014763 Viral Matrix Proteins
% 221.86/222.08  |- skos__hiddenLabel mesh__D014763 Proteins, Granulin Matrix
% 221.86/222.08  |- skos__altLabel mesh__D014763 Viral M Proteins
% 221.86/222.08  |- rdf__type mesh__D014763sskos__Concept
% 221.86/222.08  |- mesh__publicMeSHNote mesh__D014763 88   
% 221.86/222.08  |- skos__hiddenLabel mesh__D008726 ZR515
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D008726 2004
% 221.86/222.08  |- skos__historyNote mesh__D008726 Juvenile Hormones %28%1973-1975%29%
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D008726 2006
% 221.86/222.08  |- mesh__dateRevised mesh__D008726 2002-07-03
% 221.86/222.08  |- skos__hiddenLabel mesh__D008726 Altosid PS10
% 221.86/222.08  |- skos__hiddenLabel mesh__D008726 ZR 515
% 221.86/222.08  |- mesh__dateEstablished mesh__D008726 1991-01-01
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D008726 2003
% 221.86/222.08  |- mesh__historyNote mesh__D008726
% 221.86/222.08       91%28%75%29%; was see under JUVENILE HORMONES 1975-90   
% 221.86/222.08  |- skos__scopeNote mesh__D008726
% 221.86/222.08       Juvenile hormone analog and insect growth regulator used to control insects by disrupting metamorphosis. Has been effective in controlling mosquito larvae.%A%    
% 221.86/222.08  |- mesh__activeMeSHYear mesh__D008726 2005
% 221.86/222.08  |- skos__historyNote mesh__D008726
% 221.86/222.08       Fatty Acids, Unsaturated %28%1973-1974%29%
% 221.95/222.10  |- rdf__type mesh__D008726sskos__Concept
% 221.95/222.10  |- mesh__publicMeSHNote mesh__D008726
% 221.95/222.10       91; was see under JUVENILE HORMONES 1975-90   
% 221.95/222.10  |- skos__hiddenLabel mesh__D008726 Altosid PS 10
% 221.95/222.10  |- skos__historyNote mesh__D008726 Methyl Ethers %28%1974%29%
% 221.95/222.10  |- skos__broader mesh__D008726smesh__D007605
% 221.95/222.10  |- mesh__dateCreated mesh__D008726 1974-11-19
% 221.95/222.10  |- mesh__recordMaintainer mesh__D008726 CCR
% 221.95/222.10  |- mesh__recordAuthorizer mesh__D008726 sjn
% 221.95/222.10  |- mesh__recordOriginator mesh__D008726 NLM
% 221.95/222.10  |- skos__prefLabel mesh__D008726 Methoprene
% 221.95/222.10  |- mesh__activeMeSHYear mesh__D000743 2002
% 221.95/222.10  |- mesh__dateCreated mesh__D000743 1999-01-01
% 221.95/222.10  |- mesh__historyNote mesh__D000743
% 221.95/222.10       ANEMIA, HEMOLYTIC, ACQUIRED was heading 1968-81, was ANEMIA, ACQUIRED HEMOLYTIC 1965-67; ANEMIA, CHEMICAL INDUCED HEMOLYTIC %26% ANEMIA, SECONDARY ACQUIRED HEMOLYTIC were headings 1965-67%A%  
% 221.95/222.11  |- skos__hiddenLabel mesh__D000743 Hemolytic Anemia
% 221.95/222.11  |- skos__hiddenLabel mesh__D000743 Acquired Hemolytic Anemias
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D000743 1998
% 221.95/222.11  |- skos__annotation mesh__D000743 GEN or unspecified: prefer specifics   
% 221.95/222.11  |- skos__hiddenLabel mesh__D000743 Hemolytic Anemias
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D000743 2006
% 221.95/222.11  |- mesh__onlineNote mesh__D000743
% 221.95/222.11       use ANEMIA, HEMOLYTIC to search ANEMIA, ACQUIRED HEMOLYTIC; ANEMIA, CHEMICAL INDUCED HEMOLYTIC; %26% ANEMIA, SECONDARY ACQUIRED HEMOLYTIC 1966-67; %26% ANEMIA, HEMOLYTIC, ACQUIRED 1968-81%A%  
% 221.95/222.11  |- skos__hiddenLabel mesh__D000743 Anemias, Acquired Hemolytic
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D000743 2004
% 221.95/222.11  |- skos__hiddenLabel mesh__D000743 Hemolytic Anemias, Acquired
% 221.95/222.11  |- skos__hiddenLabel mesh__D000743 Jaundices, Hemolytic
% 221.95/222.11  |- skos__hiddenLabel mesh__D000743 Anemia, Acquired Hemolytic
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D000743 2005
% 221.95/222.11  |- mesh__dateRevised mesh__D000743 1997-06-20
% 221.95/222.11  |- skos__hiddenLabel mesh__D000743 Acquired Hemolytic Anemia
% 221.95/222.11  |- skos__hiddenLabel mesh__D000743 Hemolytic Jaundice
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D000743 2001
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D000743 2003
% 221.95/222.11  |- skos__broader mesh__D000743smesh__D000740
% 221.95/222.11  |- mesh__recordMaintainer mesh__D000743 TGC
% 221.95/222.11  |- skos__hiddenLabel mesh__D000743 Hemolytic Jaundices
% 221.95/222.11  |- skos__hiddenLabel mesh__D000743 Anemias, Hemolytic
% 221.95/222.11  |- skos__altLabel mesh__D000743 Hemolytic Anemia, Acquired
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D000743 2000
% 221.95/222.11  |- skos__hiddenLabel mesh__D000743 Microangiopathic Anemias
% 221.95/222.11  |- mesh__publicMeSHNote mesh__D000743
% 221.95/222.11       ANEMIA, HEMOLYTIC, ACQUIRED was heading 1968-81, was ANEMIA, ACQUIRED HEMOLYTIC 1965-67; ANEMIA, CHEMICAL INDUCED HEMOLYTIC %26% ANEMIA, SECONDARY ACQUIRED HEMOLYTIC were headings 1965-67%A%  
% 221.95/222.11  |- mesh__recordOriginator mesh__D000743 NLM
% 221.95/222.11  |- skos__prefLabel mesh__D000743 Anemia, Hemolytic
% 221.95/222.11  |- skos__scopeNote mesh__D000743
% 221.95/222.11       Anemia due to decreased life span of erythrocytes.     
% 221.95/222.11  |- skos__hiddenLabel mesh__D000743 Anemias, Microangiopathic
% 221.95/222.11  |- mesh__recordAuthorizer mesh__D000743 SJN
% 221.95/222.11  |- rdf__type mesh__D000743sskos__Concept
% 221.95/222.11  |- skos__hiddenLabel mesh__D000743 Microangiopathic Anemia
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D000743 1999
% 221.95/222.11  |- mesh__dateCreated mesh__D010373 1999-01-01
% 221.95/222.11  |- mesh__dateRevised mesh__D010373 2005-06-30
% 221.95/222.11  |- skos__broader mesh__D010373smesh__D004478
% 221.95/222.11  |- skos__hiddenLabel mesh__D010373 Infestations, Lice
% 221.95/222.11  |- mesh__recordOriginator mesh__D010373 NLM
% 221.95/222.11  |- skos__hiddenLabel mesh__D010373 Infestation, Lice
% 221.95/222.11  |- mesh__historyNote mesh__D010373 1999%28%1966%29%   
% 221.95/222.11  |- skos__prefLabel mesh__D010373 Lice Infestations
% 221.95/222.11  |- rdf__type mesh__D010373sskos__Concept
% 221.95/222.11  |- mesh__recordMaintainer mesh__D010373 ags
% 221.95/222.11  |- skos__hiddenLabel mesh__D010373 Lice Infestation
% 221.95/222.11  |- skos__annotation mesh__D010373
% 221.95/222.11       coord IM with specific louse %28%IM%29%; head lice: coord IM with SCALP DERMATOSES %28%IM%29% and PEDICULUS %28%IM%29%%A%  
% 221.95/222.11  |- skos__hiddenLabel mesh__D010373 Pediculoses
% 221.95/222.11  |- mesh__publicMeSHNote mesh__D010373
% 221.95/222.11       1999; see PEDICULOSIS 1966-1998; for LICE INFESTATIONS see PEDICULOSIS 1998%A%  
% 221.95/222.11  |- skos__altLabel mesh__D010373 Pediculosis
% 221.95/222.11  |- skos__broader mesh__D010373smesh__D012876
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D010373 2006
% 221.95/222.11  |- mesh__recordAuthorizer mesh__D010373 sjn
% 221.95/222.11  |- skos__scopeNote mesh__D010373
% 221.95/222.11       Parasitic attack or subsistence on the skin by members of the order Phthiraptera, especially on humans by Pediculus humanus of the family Pediculidae. The hair of the head, eyelashes, and pubis is a frequent site of infestation. %28%From Dorland, 28th ed; Stedman, 26th ed%29%%A%    
% 221.95/222.11  |- mesh__historyNote mesh__D004336 68%28%66%29%   
% 221.95/222.11  |- mesh__publicMeSHNote mesh__D004336 68   
% 221.95/222.11  |- skos__hiddenLabel mesh__D004336 Antagonisms, Drug
% 221.95/222.11  |- mesh__dateCreated mesh__D004336 1999-01-01
% 221.95/222.11  |- skos__prefLabel mesh__D004336 Drug Antagonism
% 221.95/222.11  |- mesh__recordOriginator mesh__D004336 NLM
% 221.95/222.11  |- skos__hiddenLabel mesh__D004336 Drug Antagonisms
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D004336 2004
% 221.95/222.11  |- skos__broader mesh__D004336smesh__D004347
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D004336 2006
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D004336 2005
% 221.95/222.11  |- skos__annotation mesh__D004336
% 221.95/222.11       GEN %26% IM only as pharmacol principle irrespective of specific drugs; prefer specific drug with /antag; no qualif; DF: DRUG ANTAG%A%  
% 221.95/222.11  |- mesh__recordMaintainer mesh__D004336 ssb
% 221.95/222.11  |- mesh__recordAuthorizer mesh__D004336 sjn
% 221.95/222.11  |- mesh__dateRevised mesh__D004336 2003-07-09
% 221.95/222.11  |- skos__hiddenLabel mesh__D004336 Antagonism, Drug
% 221.95/222.11  |- rdf__type mesh__D004336sskos__Concept
% 221.95/222.11  |- skos__related mesh__D004336smesh__D009292
% 221.95/222.11  |- mesh__dateEstablished mesh__D004336 1968-01-01
% 221.95/222.11  |- mesh__recordMaintainer mesh__D009021 adp
% 221.95/222.11  |- skos__broader mesh__D009021smesh__D009293
% 221.95/222.11  |- mesh__dateCreated mesh__D009021 1999-01-01
% 221.95/222.11  |- rdf__type mesh__D009021sskos__Concept
% 221.95/222.11  |- skos__hiddenLabel mesh__D009021 Users, Morphine
% 221.95/222.11  |- skos__hiddenLabel mesh__D009021 User, Morphine
% 221.95/222.11  |- skos__hiddenLabel mesh__D009021 Morphine User
% 221.95/222.11  |- skos__prefLabel mesh__D009021 Morphine Dependence
% 221.95/222.11  |- skos__hiddenLabel mesh__D009021 Abuse, Morphine
% 221.95/222.11  |- skos__annotation mesh__D009021 HEROIN DEPENDENCE is also available   
% 221.95/222.11  |- skos__scopeNote mesh__D009021
% 221.95/222.11       Strong dependence, both physiological and emotional, upon morphine.%A%    
% 221.95/222.11  |- mesh__publicMeSHNote mesh__D009021 81; was MORPHINE ADDICTION 1963-80   
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009021 2004
% 221.95/222.11  |- mesh__recordOriginator mesh__D009021 NLM
% 221.95/222.11  |- skos__hiddenLabel mesh__D009021 Dependence, Morphine
% 221.95/222.11  |- mesh__historyNote mesh__D009021 81; was MORPHINE ADDICTION 1963-80   
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009021 2002
% 221.95/222.11  |- skos__altLabel mesh__D009021 Morphine Addiction
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009021 2003
% 221.95/222.11  |- mesh__recordAuthorizer mesh__D009021 sjn
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009021 2006
% 221.95/222.11  |- mesh__onlineNote mesh__D009021
% 221.95/222.11       use MORPHINE DEPENDENCE to search MORPHINE ADDICTION 1966-80%A%  
% 221.95/222.11  |- skos__hiddenLabel mesh__D009021 Addiction, Morphine
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009021 2001
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009021 2005
% 221.95/222.11  |- mesh__dateRevised mesh__D009021 1999-11-03
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009021 2000
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D014764 2006
% 221.95/222.11  |- mesh__dateRevised mesh__D014764 2005-06-30
% 221.95/222.11  |- skos__broader mesh__D014764smesh__D011506
% 221.95/222.11  |- mesh__recordOriginator mesh__D014764 NLM
% 221.95/222.11  |- skos__altLabel mesh__D014764 Viral Gene Products
% 221.95/222.11  |- skos__scopeNote mesh__D014764
% 221.95/222.11       Proteins found in any species of virus.     
% 221.95/222.11  |- mesh__dateCreated mesh__D014764 1999-01-01
% 221.95/222.11  |- mesh__recordAuthorizer mesh__D014764 sjn
% 221.95/222.11  |- skos__altLabel mesh__D014764 Viral Gene Proteins
% 221.95/222.11  |- mesh__recordMaintainer mesh__D014764 SYSTEM
% 221.95/222.11  |- skos__annotation mesh__D014764
% 221.95/222.11       /drug eff /ultrastruct permitted; /physiol permitted for function with the virus; IM; coord with specific protein %28%IM%29% + specific virus %28%IM%29%%A%  
% 221.95/222.11  |- skos__altLabel mesh__D014764 Gene Products, Viral
% 221.95/222.11  |- rdf__type mesh__D014764sskos__Concept
% 221.95/222.11  |- skos__hiddenLabel mesh__D014764 Proteins, Viral
% 221.95/222.11  |- skos__prefLabel mesh__D014764 Viral Proteins
% 221.95/222.11  |- skos__hiddenLabel mesh__D008727 Hydrate, Methotrexate
% 221.95/222.11  |- skos__hiddenLabel mesh__D008727 Sodium Salt Methotrexate
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D008727 2004
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D008727 2003
% 221.95/222.11  |- skos__altLabel mesh__D008727 Amethopterin
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D008727 2006
% 221.95/222.11  |- skos__hiddenLabel mesh__D008727 Dicesium Salt Methotrexate
% 221.95/222.11  |- rdf__type mesh__D008727sskos__Concept
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D008727 2005
% 221.95/222.11  |- mesh__dateRevised mesh__D008727 2001-07-25
% 221.95/222.11  |- mesh__dateCreated mesh__D008727 1999-01-01
% 221.95/222.11  |- mesh__recordOriginator mesh__D008727 NLM
% 221.95/222.11  |- skos__broader mesh__D008727smesh__D000630
% 221.95/222.11  |- mesh__recordAuthorizer mesh__D008727 sjn
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D008727 2002
% 221.95/222.11  |- skos__hiddenLabel mesh__D008727 Disodium Salt Methotrexate
% 221.95/222.11  |- skos__prefLabel mesh__D008727 Methotrexate
% 221.95/222.11  |- skos__scopeNote mesh__D008727
% 221.95/222.11       An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.%A%    
% 221.95/222.11  |- mesh__recordMaintainer mesh__D008727 jmp
% 221.95/222.11  |- skos__hiddenLabel mesh__D000744 Anemia, Autoimmune Hemolytic
% 221.95/222.11  |- mesh__recordOriginator mesh__D000744 NLM
% 221.95/222.11  |- skos__broader mesh__D000744smesh__D001327
% 221.95/222.11  |- skos__hiddenLabel mesh__D000744 Agglutinin Diseases, Cold
% 221.95/222.11  |- mesh__publicMeSHNote mesh__D000744
% 221.95/222.11       68; was ANEMIA, IDIOPATHIC ACQUIRED HEMOLYTIC 1965-67   
% 221.95/222.11  |- skos__altLabel mesh__D000744 Hemolytic Anemia, Autoimmune
% 221.95/222.11  |- skos__hiddenLabel mesh__D000744 Diseases, Cold Agglutinin
% 221.95/222.11  |- skos__altLabel mesh__D000744 Autoimmune Hemolytic Anemia
% 221.95/222.11  |- mesh__dateRevised mesh__D000744 2005-06-30
% 221.95/222.11  |- skos__hiddenLabel mesh__D000744 Disease, Cold Agglutinin
% 221.95/222.11  |- mesh__dateEstablished mesh__D000744 1968-01-01
% 221.95/222.11  |- rdf__type mesh__D000744sskos__Concept
% 221.95/222.11  |- skos__broader mesh__D000744smesh__D000743
% 221.95/222.11  |- skos__hiddenLabel mesh__D000744 Autoimmune Hemolytic Anemias
% 221.95/222.11  |- skos__hiddenLabel mesh__D000744 Hemolytic Anemias, Autoimmune
% 221.95/222.11  |- mesh__historyNote mesh__D000744
% 221.95/222.11       68; was ANEMIA, IDIOPATHIC ACQUIRED HEMOLYTIC 1965-67   
% 221.95/222.11  |- mesh__recordAuthorizer mesh__D000744 sjn
% 221.95/222.11  |- mesh__dateCreated mesh__D000744 1999-01-01
% 221.95/222.11  |- skos__prefLabel mesh__D000744 Anemia, Hemolytic, Autoimmune
% 221.95/222.11  |- skos__hiddenLabel mesh__D000744 Cold Agglutinin Diseases
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D000744 2006
% 221.95/222.11  |- skos__hiddenLabel mesh__D000744 Agglutinin Disease, Cold
% 221.95/222.11  |- mesh__onlineNote mesh__D000744
% 221.95/222.11       use ANEMIA, HEMOLYTIC, AUTOIMMUNE to search ANEMIA, IDIOPATHIC ACQUIRED HEMOLYTIC 1966-67%A%  
% 221.95/222.11  |- skos__scopeNote mesh__D000744
% 221.95/222.11       Acquired hemolytic anemia due to the presence of AUTOANTIBODIES which agglutinate or lyse the patient%27%s own RED BLOOD CELLS.%A%    
% 221.95/222.11  |- skos__hiddenLabel mesh__D000744 Anemias, Autoimmune Hemolytic
% 221.95/222.11  |- mesh__recordMaintainer mesh__D000744 nns
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D046048 2006
% 221.95/222.11  |- mesh__dateEstablished mesh__D046048 2005-01-01
% 221.95/222.11  |- skos__altLabel mesh__D046048 Pagophilus groenlandicus
% 221.95/222.11  |- skos__hiddenLabel mesh__D046048 Seals, Elephant
% 221.95/222.11  |- skos__altLabel mesh__D046048 Seals, True
% 221.95/222.11  |- skos__broader mesh__D046048smesh__D010872
% 221.95/222.11  |- skos__altLabel mesh__D046048 Halichoerus grypus
% 221.95/222.11  |- skos__hiddenLabel mesh__D046048 Harp Seal
% 221.95/222.11  |- skos__hiddenLabel mesh__D046048 True Seals
% 221.95/222.11  |- skos__hiddenLabel mesh__D046048 Elephant Seals
% 221.95/222.11  |- skos__altLabel mesh__D046048 Phocidae
% 221.95/222.11  |- skos__hiddenLabel mesh__D046048 Earless Seals
% 221.95/222.11  |- mesh__recordOriginator mesh__D046048 ags
% 221.95/222.11  |- mesh__recordMaintainer mesh__D046048 ags
% 221.95/222.11  |- mesh__recordAuthorizer mesh__D046048 sjn
% 221.95/222.11  |- skos__hiddenLabel mesh__D046048 Gray Seal
% 221.95/222.11  |- mesh__historyNote mesh__D046048 2005   
% 221.95/222.11  |- skos__hiddenLabel mesh__D046048 Seals, Harp
% 221.95/222.11  |- mesh__dateCreated mesh__D046048 2004-07-07
% 221.95/222.11  |- skos__hiddenLabel mesh__D046048 Harp Seals
% 221.95/222.11  |- skos__hiddenLabel mesh__D046048 Seal, True
% 221.95/222.11  |- rdf__type mesh__D046048sskos__Concept
% 221.95/222.11  |- skos__hiddenLabel mesh__D046048 Seals, Gray
% 221.95/222.11  |- skos__hiddenLabel mesh__D046048 Gray Seals
% 221.95/222.11  |- skos__scopeNote mesh__D046048
% 221.95/222.11       The family Phocidae, suborder PINNIPEDIA, order CARNIVORA, comprising the true seals. They lack external ears and are unable to use their hind flippers to walk. It includes over 18 species including the harp seal, probably the best known seal species in the world.%A%    
% 221.95/222.11  |- skos__altLabel mesh__D046048 Mirounga
% 221.95/222.11  |- skos__hiddenLabel mesh__D046048 Seal, Earless
% 221.95/222.11  |- skos__hiddenLabel mesh__D046048 True Seal
% 221.95/222.11  |- skos__altLabel mesh__D046048 Phoca groenlandica
% 221.95/222.11  |- skos__prefLabel mesh__D046048 Seals, Earless
% 221.95/222.11  |- skos__hiddenLabel mesh__D046048 Earless Seal
% 221.95/222.11  |- skos__hiddenLabel mesh__D046048 Elephant Seal
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D046048 2005
% 221.95/222.11  |- mesh__publicMeSHNote mesh__D046048 2005; see SEALS 1975-2004   
% 221.95/222.11  |- skos__annotation mesh__D046048
% 221.95/222.11       seals unspecified goes here; FUR SEALS is also available   
% 221.95/222.11  |- mesh__recordOriginator mesh__D018357 AGS
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D018357 2005
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D018357 1996
% 221.95/222.11  |- skos__altLabel mesh__D018357 Infections, Respiratory Syncytial Virus
% 221.95/222.11  |- mesh__dateEstablished mesh__D018357 1994-01-01
% 221.95/222.11  |- skos__broader mesh__D018357smesh__D018186
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D018357 2002
% 221.95/222.11  |- mesh__dateRevised mesh__D018357 1994-05-12
% 221.95/222.11  |- skos__historyNote mesh__D018357
% 221.95/222.11       Respiratory Tract Infections %28%1966-1993%29%
% 221.95/222.11  |- skos__prefLabel mesh__D018357 Respiratory Syncytial Virus Infections
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D018357 1997
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D018357 2006
% 221.95/222.11  |- mesh__dateCreated mesh__D018357 1993-06-04
% 221.95/222.11  |- rdf__type mesh__D018357sskos__Concept
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D018357 2003
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D018357 1995
% 221.95/222.11  |- mesh__publicMeSHNote mesh__D018357 94   
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D018357 2000
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D018357 1998
% 221.95/222.11  |- skos__scopeNote mesh__D018357
% 221.95/222.11       Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.%A%    
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D018357 2004
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D018357 2001
% 221.95/222.11  |- mesh__recordMaintainer mesh__D018357 AGS
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D018357 1999
% 221.95/222.11  |- mesh__recordAuthorizer mesh__D018357 PLS
% 221.95/222.11  |- mesh__historyNote mesh__D018357 94   
% 221.95/222.11  |- skos__annotation mesh__D018357 caused by a pneumovirus   
% 221.95/222.11  |- skos__historyNote mesh__D018357
% 221.95/222.11       Paramyxoviridae Infections %28%1977-1993%29%
% 221.95/222.11  |- mesh__recordMaintainer mesh__D010374 sjn
% 221.95/222.11  |- skos__historyNote mesh__D010374 Lice %28%1966-1974%29%
% 221.95/222.11  |- skos__scopeNote mesh__D010374
% 221.95/222.11       Lice of the genus Pediculus, family Pediculidae. Pediculus humanus corporus is the human body louse and Pediculus humanus capitis is the human head louse.%A%    
% 221.95/222.11  |- skos__prefLabel mesh__D010374 Pediculus
% 221.95/222.11  |- rdf__type mesh__D010374sskos__Concept
% 221.95/222.11  |- skos__altLabel mesh__D010374 Head Lice
% 221.95/222.11  |- mesh__recordAuthorizer mesh__D010374 sjn
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D010374 2005
% 221.95/222.11  |- mesh__publicMeSHNote mesh__D010374 75; was see under LICE 1963-74   
% 221.95/222.11  |- skos__altLabel mesh__D010374 Pediculi
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D010374 2006
% 221.95/222.11  |- skos__broader mesh__D010374smesh__D000854
% 221.95/222.11  |- mesh__onlineNote mesh__D010374 search LICE 1966-74   
% 221.95/222.11  |- mesh__dateCreated mesh__D010374 1999-01-01
% 221.95/222.11  |- mesh__recordOriginator mesh__D010374 NLM
% 221.95/222.11  |- skos__altLabel mesh__D010374 Body Lice
% 221.95/222.11  |- mesh__historyNote mesh__D010374 75; was see under LICE 1963-74   
% 221.95/222.11  |- mesh__dateEstablished mesh__D010374 1975-01-01
% 221.95/222.11  |- skos__annotation mesh__D010374
% 221.95/222.11       infestation: coord IM with PEDICULOSIS see LICE INFESTATIONS %28%IM%29%; do not use /drug eff for insecticides: TN 111%A%  
% 221.95/222.11  |- mesh__dateRevised mesh__D010374 2004-07-13
% 221.95/222.11  |- skos__historyNote mesh__D004337
% 221.95/222.11       Delayed-Action Preparations %28%1966-1987%29%
% 221.95/222.11  |- mesh__recordOriginator mesh__D004337 RLS
% 221.95/222.11  |- skos__annotation mesh__D004337 coord with specific drug   
% 221.95/222.11  |- mesh__dateEstablished mesh__D004337 1988-01-01
% 221.95/222.11  |- mesh__dateRevised mesh__D004337 2004-07-07
% 221.95/222.11  |- mesh__dateCreated mesh__D004337 1987-05-04
% 221.95/222.11  |- mesh__recordAuthorizer mesh__D004337 sjn
% 221.95/222.11  |- mesh__publicMeSHNote mesh__D004337 88   
% 221.95/222.11  |- skos__historyNote mesh__D004337 Drugs %28%1966-1987%29%
% 221.95/222.11  |- skos__broader mesh__D004337smesh__D004304
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D004337 2005
% 221.95/222.11  |- skos__scopeNote mesh__D004337
% 221.95/222.11       Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs.  Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and  reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers.%A%    
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D004337 2006
% 221.95/222.11  |- mesh__historyNote mesh__D004337 88   
% 221.95/222.11  |- skos__hiddenLabel mesh__D004337 Drug Carrier
% 221.95/222.11  |- skos__broader mesh__D004337smesh__D016503
% 221.95/222.11  |- skos__prefLabel mesh__D004337 Drug Carriers
% 221.95/222.11  |- mesh__recordMaintainer mesh__D004337 ssb
% 221.95/222.11  |- rdf__type mesh__D004337sskos__Concept
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009820 2006
% 221.95/222.11  |- mesh__recordOriginator mesh__D009820 NLM
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009820 2005
% 221.95/222.11  |- mesh__recordAuthorizer mesh__D009820 SJN
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009820 2004
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009820 2001
% 221.95/222.11  |- mesh__recordMaintainer mesh__D009820 PXP
% 221.95/222.11  |- mesh__dateCreated mesh__D009820 1999-01-01
% 221.95/222.11  |- skos__broader mesh__D009820smesh__D006114
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009820 2003
% 221.95/222.11  |- rdf__type mesh__D009820sskos__Concept
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009820 1999
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009820 2000
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009820 1998
% 221.95/222.11  |- skos__prefLabel mesh__D009820 Ohio
% 221.95/222.11  |- skos__broader mesh__D009820smesh__D001061
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009820 2002
% 221.95/222.11  |- mesh__dateRevised mesh__D009820 1997-06-20
% 221.95/222.11  |- skos__broader mesh__D009820smesh__D015146
% 221.95/222.11  |- skos__prefLabel mesh__D009022 Morphine Derivatives
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009022 1995
% 221.95/222.11  |- skos__broader mesh__D009022smesh__D009020
% 221.95/222.11  |- mesh__recordAuthorizer mesh__D009022 PLS
% 221.95/222.11  |- mesh__recordMaintainer mesh__D009022 TAP
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009022 2001
% 221.95/222.11  |- rdf__type mesh__D009022sskos__Concept
% 221.95/222.11  |- mesh__publicMeSHNote mesh__D009022
% 221.95/222.11       78; was see under MORPHINE 1975-77, was see under MORPHINANS 1969-74%A%  
% 221.95/222.11  |- skos__historyNote mesh__D009022 Morphinans %28%1969-1974%29%
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009022 2003
% 221.95/222.11  |- skos__scopeNote mesh__D009022 Analogs or derivatives of morphine.     
% 221.95/222.11  |- mesh__dateRevised mesh__D009022 1992-05-18
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009022 2005
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009022 2004
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009022 1996
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009022 2002
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009022 2006
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009022 1998
% 221.95/222.11  |- mesh__onlineNote mesh__D009022 search MORPHINANS 1969-74   
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009022 1997
% 221.95/222.11  |- mesh__historyNote mesh__D009022
% 221.95/222.11       78%28%75%29%; was see under MORPHINE 1975-77, was see under MORPHINANS 1969-74%A%  
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009022 1994
% 221.95/222.11  |- skos__hiddenLabel mesh__D009022 Derivatives, Morphine
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009022 1993
% 221.95/222.11  |- skos__historyNote mesh__D009022 Morphine %28%1966-1974%29%
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009022 1999
% 221.95/222.11  |- mesh__dateCreated mesh__D009022 1977-05-04
% 221.95/222.11  |- mesh__dateEstablished mesh__D009022 1978-01-01
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D009022 2000
% 221.95/222.11  |- mesh__recordOriginator mesh__D009022 GHR
% 221.95/222.11  |- mesh__dateEstablished mesh__D014765 1965-01-01
% 221.95/222.11  |- mesh__dateCreated mesh__D014765 1999-01-01
% 221.95/222.11  |- mesh__dateRevised mesh__D014765 2005-06-30
% 221.95/222.11  |- mesh__publicMeSHNote mesh__D014765 65   
% 221.95/222.11  |- mesh__recordOriginator mesh__D014765 NLM
% 221.95/222.11  |- mesh__historyNote mesh__D014765 65   
% 221.95/222.11  |- rdf__type mesh__D014765sskos__Concept
% 221.95/222.11  |- mesh__recordAuthorizer mesh__D014765 sjn
% 221.95/222.11  |- skos__hiddenLabel mesh__D014765 Vaccines, Viral
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D014765 2006
% 221.95/222.11  |- skos__scopeNote mesh__D014765
% 221.95/222.11       Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease.%A%    
% 221.95/222.11  |- skos__broader mesh__D014765smesh__D014612
% 221.95/222.11  |- skos__annotation mesh__D014765
% 221.95/222.11       for specifics not indented here coord IM with specific virus /immunol %28%IM%29%%A%  
% 221.95/222.11  |- mesh__recordMaintainer mesh__D014765 ssb
% 221.95/222.11  |- skos__prefLabel mesh__D014765 Viral Vaccines
% 221.95/222.11  |- skos__altLabel mesh__D008728 Tizercine
% 221.95/222.11  |- skos__broader mesh__D008728smesh__D010640
% 221.95/222.11  |- rdf__type mesh__D008728sskos__Concept
% 221.95/222.11  |- mesh__recordOriginator mesh__D008728 NLM
% 221.95/222.11  |- mesh__dateRevised mesh__D008728 2005-06-30
% 221.95/222.11  |- mesh__recordAuthorizer mesh__D008728 sjn
% 221.95/222.11  |- skos__altLabel mesh__D008728 Levomeprazin
% 221.95/222.11  |- mesh__dateEstablished mesh__D008728 1968-01-01
% 221.95/222.11  |- skos__altLabel mesh__D008728 Levopromazine
% 221.95/222.11  |- mesh__dateCreated mesh__D008728 1999-01-01
% 221.95/222.11  |- skos__prefLabel mesh__D008728 Methotrimeprazine
% 221.95/222.11  |- mesh__publicMeSHNote mesh__D008728 68; was LEVOMEPROMAZINE 1963-67   
% 221.95/222.11  |- skos__scopeNote mesh__D008728
% 221.95/222.11       A phenothiazine with pharmacological activity similar to that of both CHLORPROMAZINE and PROMETHAZINE. It has the histamine-antagonist properties of the antihistamines together with CENTRAL NERVOUS SYSTEM effects resembling those of chlorpromazine. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p604%29%%A%    
% 221.95/222.11  |- skos__altLabel mesh__D008728 Levomepromazine
% 221.95/222.11  |- mesh__historyNote mesh__D008728 68; was LEVOMEPROMAZINE 1963-67   
% 221.95/222.11  |- skos__altLabel mesh__D008728 Tizertsin
% 221.95/222.11  |- mesh__recordMaintainer mesh__D008728 ssb
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D008728 2006
% 221.95/222.11  |- mesh__onlineNote mesh__D008728
% 221.95/222.11       use METHOTRIMEPRAZINE to search LEVOMEPROMAZINE 1966-67   
% 221.95/222.11  |- mesh__publicMeSHNote mesh__D000745
% 221.95/222.11       68; was ANEMIA, CONGENITAL HEMOLYTIC 1965-67, was ANEMIA, CONGENITAL HEMOLYTIC see SPHEROCYTOSIS, HEREDITARY 1963-64; ANEMIA, HEMOLYTIC, CONGENITAL NONSPHEROCYTIC was heading 1968-81, was ANEMIA, CONGENITAL NON-SPHEROCYTIC HEMOLYTIC 1965-67%A%  
% 221.95/222.11  |- skos__altLabel mesh__D000745 Hemolytic Anemia, Congenital
% 221.95/222.11  |- skos__hiddenLabel mesh__D000745 Anemias, Congenital Hemolytic
% 221.95/222.11  |- skos__hiddenLabel mesh__D000745 Hemolytic Anemias, Congenital
% 221.95/222.11  |- mesh__dateEstablished mesh__D000745 1968-01-01
% 221.95/222.11  |- skos__broader mesh__D000745smesh__D030342
% 221.95/222.11  |- mesh__recordMaintainer mesh__D000745 nns
% 221.95/222.11  |- rdf__type mesh__D000745sskos__Concept
% 221.95/222.11  |- skos__hiddenLabel mesh__D000745 Congenital Hemolytic Anemias
% 221.95/222.11  |- mesh__recordOriginator mesh__D000745 NLM
% 221.95/222.11  |- mesh__onlineNote mesh__D000745
% 221.95/222.11       use ANEMIA, HEMOLYTIC, CONGENITAL to search ANEMIA, CONGENITAL HEMOLYTIC 1966-67%A%  
% 221.95/222.11  |- skos__altLabel mesh__D000745 Congenital Hemolytic Anemia
% 221.95/222.11  |- mesh__dateCreated mesh__D000745 1999-01-01
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D000745 2006
% 221.95/222.11  |- skos__altLabel mesh__D000745 Hemolytic Anemia, Hereditary
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D000745 2002
% 221.95/222.11  |- skos__prefLabel mesh__D000745 Anemia, Hemolytic, Congenital
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D000745 2004
% 221.95/222.11  |- skos__hiddenLabel mesh__D000745 Hereditary Hemolytic Anemias
% 221.95/222.11  |- skos__broader mesh__D000745smesh__D000743
% 221.95/222.11  |- mesh__dateRevised mesh__D000745 2001-07-25
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D000745 2005
% 221.95/222.11  |- mesh__historyNote mesh__D000745
% 221.95/222.11       68; was ANEMIA, CONGENITAL HEMOLYTIC 1965-67, was ANEMIA, CONGENITAL HEMOLYTIC see SPHEROCYTOSIS, HEREDITARY 1963-64%A%  
% 221.95/222.11  |- skos__hiddenLabel mesh__D000745 Hemolytic Anemias, Hereditary
% 221.95/222.11  |- skos__hiddenLabel mesh__D000745 Anemia, Hereditary Hemolytic
% 221.95/222.11  |- skos__altLabel mesh__D000745 Hereditary Hemolytic Anemia
% 221.95/222.11  |- mesh__recordAuthorizer mesh__D000745 sjn
% 221.95/222.11  |- mesh__activeMeSHYear mesh__D000745 2003
% 221.95/222.11  |- skos__altLabel mesh__D000745 Anemia, Hemolytic, Hereditary
% 221.95/222.11  |- skos__scopeNote mesh__D000745
% 221.95/222.11       Hemolytic anemia due to various intrinsic defects of the erythrocyte.%A%    
% 221.95/222.11  |- skos__hiddenLabel mesh__D000745 Anemias, Hereditary Hemolytic
% 221.95/222.11  |- skos__hiddenLabel mesh__D000745 Anemia, Congenital Hemolytic
% 221.95/222.11  |- skos__broader mesh__D019450smesh__D005810
% 221.95/222.11  |- skos__historyNote mesh__D019450 Multigene Family %28%1989-1996%29%
% 221.95/222.11  |- skos__related mesh__D019450smesh__D018432
% 221.95/222.11  |- skos__hiddenLabel mesh__D019450 Multidrug Resistance Genes
% 221.95/222.11  |- mesh__recordOriginator mesh__D019450 ADP
% 221.95/222.11  |- skos__altLabel mesh__D019450 Multidrug Resistance Gene
% 221.95/222.11  |- skos__broader mesh__D019450smesh__D005796
% 221.95/222.11  |- skos__hiddenLabel mesh__D019450 Gene-1s, Multidrug Resistance
% 221.95/222.11  |- skos__altLabel mesh__D019450 MDR Genes
% 221.95/222.11  |- skos__scopeNote mesh__D019450
% 221.95/222.11       Genes responsible for multidrug resistance resulting from their overexpression in mammalian cells. Mammalian P-glycoproteins are encoded by small MDR gene families. The human multidrug resistance 1 %28%MDR1%29% gene responds to environmental stress including various anticancer agents. It is a major determinant in the development of resistance to a large number of cancer chemotherapeutic agents. %28%Biochem Biophys Res Commun 1994;199%28%3%29%:1428-35; Cancer Res 1994:54%28%6%29%:1536-41%29%%A%    
% 221.95/222.12  |- skos__hiddenLabel mesh__D019450 Gene-1, Multidrug Resistance
% 221.95/222.12  |- mesh__dateEstablished mesh__D019450 1997-01-01
% 221.95/222.12  |- skos__hiddenLabel mesh__D019450 Resistance Gene-1s, Multidrug
% 221.95/222.12  |- mesh__publicMeSHNote mesh__D019450 97   
% 221.95/222.12  |- skos__hiddenLabel mesh__D019450 Resistance Gene, Multidrug
% 221.95/222.12  |- mesh__historyNote mesh__D019450 97   
% 221.95/222.12  |- skos__hiddenLabel mesh__D019450 Genes, MDR1
% 221.95/222.12  |- mesh__recordAuthorizer mesh__D019450 sjn
% 221.95/222.12  |- skos__hiddenLabel mesh__D019450 Gene, MDR
% 221.95/222.12  |- skos__altLabel mesh__D019450 MDR1 Gene
% 221.95/222.12  |- skos__hiddenLabel mesh__D019450 MDR1 Genes
% 221.95/222.12  |- skos__historyNote mesh__D019450 Drug Resistance %28%1986-1994%29%
% 221.95/222.12  |- skos__related mesh__D019450smesh__D018435
% 221.95/222.12  |- skos__hiddenLabel mesh__D019450 Resistance Gene-1, Multidrug
% 221.95/222.12  |- skos__hiddenLabel mesh__D019450 Multidrug Resistance Gene 1
% 221.95/222.12  |- mesh__dateCreated mesh__D019450 1996-06-13
% 221.95/222.12  |- mesh__dateRevised mesh__D019450 2005-06-30
% 221.95/222.12  |- skos__related mesh__D019450smesh__D020168
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D019450 2006
% 221.95/222.12  |- skos__hiddenLabel mesh__D019450 Multidrug Resistance Gene-1s
% 221.95/222.12  |- skos__hiddenLabel mesh__D019450 Gene, Multidrug Resistance
% 221.95/222.12  |- skos__hiddenLabel mesh__D019450 MDR Gene
% 221.95/222.12  |- skos__historyNote mesh__D019450
% 221.95/222.12       Drug Resistance, Multiple %28%1995-1996%29%
% 221.95/222.12  |- skos__hiddenLabel mesh__D019450 Gene, MDR1
% 221.95/222.12  |- mesh__recordMaintainer mesh__D019450 nns
% 221.95/222.12  |- skos__prefLabel mesh__D019450 Genes, MDR
% 221.95/222.12  |- rdf__type mesh__D019450sskos__Concept
% 221.95/222.12  |- skos__hiddenLabel mesh__D019450 Genes, Multidrug Resistance
% 221.95/222.12  |- skos__hiddenLabel mesh__D019450 Resistance Genes, Multidrug
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005430 1993
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005430 2004
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005430 2002
% 221.95/222.12  |- mesh__recordMaintainer mesh__D005430 TGC
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005430 1996
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005430 1999
% 221.95/222.12  |- skos__hiddenLabel mesh__D005430 Carpet
% 221.95/222.12  |- skos__hiddenLabel mesh__D005430 Floorcoverings and Floors
% 221.95/222.12  |- mesh__dateEstablished mesh__D005430 1991-01-01
% 221.95/222.12  |- mesh__historyNote mesh__D005430
% 221.95/222.12       91%28%Aug 77%29%; was see under FACILITY DESIGN AND CONSTRUCTION 1977-90%A%  
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005430 1997
% 221.95/222.12  |- skos__hiddenLabel mesh__D005430 Floorcovering
% 221.95/222.12  |- skos__annotation mesh__D005430
% 221.95/222.12       for houses, commerc estab, hosp, institutions, etc.; DF: FLOORS%A%  
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005430 1994
% 221.95/222.12  |- skos__prefLabel mesh__D005430 Floors and Floorcoverings
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005430 2005
% 221.95/222.12  |- mesh__recordAuthorizer mesh__D005430 PLS
% 221.95/222.12  |- rdf__type mesh__D005430sskos__Concept
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005430 2000
% 221.95/222.12  |- skos__scopeNote mesh__D005430
% 221.95/222.12       The surface of a structure upon which one stands or walks.%A%    
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005430 1995
% 221.95/222.12  |- skos__hiddenLabel mesh__D005430 Floor
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005430 2003
% 221.95/222.12  |- skos__broader mesh__D005430smesh__D005160
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005430 2006
% 221.95/222.12  |- mesh__publicMeSHNote mesh__D005430
% 221.95/222.12       91; was see under FACILITY DESIGN AND CONSTRUCTION Aug 1977-90%A%  
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005430 2001
% 221.95/222.12  |- mesh__recordOriginator mesh__D005430 EC
% 221.95/222.12  |- mesh__dateRevised mesh__D005430 1992-05-15
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005430 1998
% 221.95/222.12  |- mesh__dateCreated mesh__D005430 1977-05-05
% 221.95/222.12  |- mesh__dateRevised mesh__D046049 2005-07-27
% 221.95/222.12  |- skos__hiddenLabel mesh__D046049 Harbor Seals
% 221.95/222.12  |- skos__hiddenLabel mesh__D046049 Harbor Seal
% 221.95/222.12  |- skos__broader mesh__D046049smesh__D046048
% 221.95/222.12  |- mesh__recordMaintainer mesh__D046049 ags
% 221.95/222.12  |- skos__historyNote mesh__D046049 Pinnipedia %28%1966-1974%29%
% 221.95/222.12  |- skos__hiddenLabel mesh__D046049 Seals, Harbor
% 221.95/222.12  |- mesh__dateCreated mesh__D046049 2004-07-07
% 221.95/222.12  |- mesh__dateEstablished mesh__D046049 2005-01-01
% 221.95/222.12  |- mesh__recordAuthorizer mesh__D046049 ags
% 221.95/222.12  |- rdf__type mesh__D046049sskos__Concept
% 221.95/222.12  |- skos__scopeNote mesh__D046049
% 221.95/222.12       A genus in the family of EARLESS SEALS %28%Phocidae%29% and collectively the most abundant PINNIPEDS in the Northern Hemisphere.%A%    
% 221.95/222.12  |- skos__historyNote mesh__D046049 Seals, Earless %28%1975-2004%29%
% 221.95/222.12  |- mesh__recordOriginator mesh__D046049 ags
% 221.95/222.12  |- skos__altLabel mesh__D046049 Phoca vitulina
% 221.95/222.12  |- mesh__publicMeSHNote mesh__D046049 2005   
% 221.95/222.12  |- mesh__historyNote mesh__D046049 2005   
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D046049 2006A
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D046049 2005
% 221.95/222.12  |- skos__prefLabel mesh__D046049 Phoca
% 221.95/222.12  |- skos__hiddenLabel mesh__D046049 Phocas
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D046049 2006
% 221.95/222.12  |- mesh__publicMeSHNote mesh__D018358 94   
% 221.95/222.12  |- mesh__recordMaintainer mesh__D018358 ags
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D018358 2000
% 221.95/222.12  |- rdf__type mesh__D018358sskos__Concept
% 221.95/222.12  |- skos__hiddenLabel mesh__D018358 Tumors, Neuroendocrine
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D018358 2003
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D018358 2001
% 221.95/222.12  |- skos__broader mesh__D018358smesh__D017599
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D018358 1998
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D018358 2004
% 221.95/222.12  |- mesh__dateEstablished mesh__D018358 1994-01-01
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D018358 2005A
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D018358 1999
% 221.95/222.12  |- mesh__historyNote mesh__D018358 94   
% 221.95/222.12  |- skos__prefLabel mesh__D018358 Neuroendocrine Tumors
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D018358 2002
% 221.95/222.12  |- mesh__dateRevised mesh__D018358 2005-07-08
% 221.95/222.12  |- skos__hiddenLabel mesh__D018358 Tumor, Neuroendocrine
% 221.95/222.12  |- skos__hiddenLabel mesh__D018358 Neuroendocrine Tumor
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D018358 2005
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D018358 1996
% 221.95/222.12  |- mesh__recordAuthorizer mesh__D018358 ags
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D018358 2006A
% 221.95/222.12  |- mesh__recordOriginator mesh__D018358 PLS
% 221.95/222.12  |- skos__annotation mesh__D018358
% 221.95/222.12       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 221.95/222.12  |- skos__scopeNote mesh__D018358
% 221.95/222.12       Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production %28%often via APUD CELLS%29%, the presence of tumor-associated antigens, and isozyme composition.%A%    
% 221.95/222.12  |- mesh__dateCreated mesh__D018358 1993-06-25
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D018358 1997
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D018358 2006
% 221.95/222.12  |- rdf__type mesh__D010375sskos__Concept
% 221.95/222.12  |- skos__hiddenLabel mesh__D010375 Genetic Identities
% 221.95/222.12  |- mesh__dateRevised mesh__D010375 2003-07-25
% 221.95/222.12  |- skos__hiddenLabel mesh__D010375 Genealogical Trees
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D010375 2005
% 221.95/222.12  |- skos__historyNote mesh__D010375 Genetics, Medical %28%1966-1967%29%
% 221.95/222.12  |- mesh__recordMaintainer mesh__D010375 sjn
% 221.95/222.12  |- skos__hiddenLabel mesh__D010375 Tree, Genealogic
% 221.95/222.12  |- skos__hiddenLabel mesh__D010375 Trees, Genealogic
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D010375 2006
% 221.95/222.12  |- skos__annotation mesh__D010375 human %26% animal   
% 221.95/222.12  |- mesh__historyNote mesh__D010375 68   
% 221.95/222.12  |- skos__scopeNote mesh__D010375
% 221.95/222.12       The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition.%A%    
% 221.95/222.12  |- skos__historyNote mesh__D010375 Genetics %28%1966-1967%29%
% 221.95/222.12  |- mesh__dateCreated mesh__D010375 1999-01-01
% 221.95/222.12  |- skos__hiddenLabel mesh__D010375 Family Trees
% 221.95/222.12  |- mesh__recordAuthorizer mesh__D010375 sjn
% 221.95/222.12  |- skos__hiddenLabel mesh__D010375 Genealogic Trees
% 221.95/222.12  |- skos__broader mesh__D010375smesh__D005821
% 221.95/222.12  |- skos__prefLabel mesh__D010375 Pedigree
% 221.95/222.12  |- skos__hiddenLabel mesh__D010375 Tree, Family
% 221.95/222.12  |- skos__hiddenLabel mesh__D010375 Trees, Family
% 221.95/222.12  |- skos__hiddenLabel mesh__D010375 Trees, Genealogical
% 221.95/222.12  |- skos__hiddenLabel mesh__D010375 Identities, Genetic
% 221.95/222.12  |- mesh__publicMeSHNote mesh__D010375 68   
% 221.95/222.12  |- mesh__dateEstablished mesh__D010375 1968-01-01
% 221.95/222.12  |- skos__hiddenLabel mesh__D010375 Tree, Genealogical
% 221.95/222.12  |- skos__altLabel mesh__D010375 Genealogical Tree
% 221.95/222.12  |- mesh__recordOriginator mesh__D010375 NLM
% 221.95/222.12  |- skos__altLabel mesh__D010375 Genealogic Tree
% 221.95/222.12  |- skos__related mesh__D010375smesh__D030661
% 221.95/222.12  |- skos__altLabel mesh__D010375 Genetic Identity
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D010375 2004
% 221.95/222.12  |- skos__broader mesh__D008055Q000378smesh__D008055
% 221.95/222.12  |- mesh__preferredCombination mesh__D008055Q000378smesh__D050356
% 221.95/222.12  |- rdf__type mesh__D008055Q000378smesh__CompoundConcept
% 221.95/222.12  |- skos__related mesh__D004338smesh__D004357
% 221.95/222.12  |- mesh__recordAuthorizer mesh__D004338 sjn
% 221.95/222.12  |- skos__annotation mesh__D004338
% 221.95/222.12       IM for general only; NIM with specific drugs; differentiate from DRUG THERAPY, COMBINATION: drug combinations = 2 or more drugs in a single dosage form; combination ther = 2 or more drugs separately for a combined eff;%A%  
% 221.95/222.12  |- mesh__publicMeSHNote mesh__D004338 73   
% 221.95/222.12  |- skos__hiddenLabel mesh__D004338 Combinations, Drug
% 221.95/222.12  |- skos__prefLabel mesh__D004338 Drug Combinations
% 221.95/222.12  |- skos__related mesh__D004338smesh__D004359
% 221.95/222.12  |- mesh__dateRevised mesh__D004338 2005-06-30
% 221.95/222.12  |- mesh__dateCreated mesh__D004338 1999-01-01
% 221.95/222.12  |- mesh__recordOriginator mesh__D004338 NLM
% 221.95/222.12  |- skos__historyNote mesh__D004338 Dosage Forms %28%1966-1970%29%
% 221.95/222.12  |- mesh__recordMaintainer mesh__D004338 ssb
% 221.95/222.12  |- mesh__dateEstablished mesh__D004338 1973-01-01
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D004338 2006
% 221.95/222.12  |- rdf__type mesh__D004338sskos__Concept
% 221.95/222.12  |- skos__broader mesh__D004338smesh__D004364
% 221.95/222.12  |- skos__scopeNote mesh__D004338
% 221.95/222.12       Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture.%A%    
% 221.95/222.12  |- mesh__historyNote mesh__D004338 73%28%71%29%   
% 221.95/222.12  |- skos__altLabel mesh__D015060 Dipalmitoylglycerophosphocholine
% 221.95/222.12  |- skos__altLabel mesh__D015060 1,2-Dihexadecyl-sn-Glycerophosphocholine
% 221.95/222.12  |- mesh__dateCreated mesh__D015060 1986-06-12
% 221.95/222.12  |- skos__annotation mesh__D015060
% 221.95/222.12       %22%a major constituent of pulmonary surfactants%22%; /biosyn /physiol permitted; DF: DPPC%A%  
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D015060 2005
% 221.95/222.12  |- skos__broader mesh__D015060smesh__D010713
% 221.95/222.12  |- mesh__recordOriginator mesh__D015060 RLS
% 221.95/222.12  |- skos__historyNote mesh__D015060 Surface-Active Agents %28%1966-1970%29%
% 221.95/222.12  |- skos__hiddenLabel mesh__D015060 1,2 Dipalmitoylphosphatidylcholine
% 221.95/222.12  |- mesh__recordAuthorizer mesh__D015060 sjn
% 221.95/222.12  |- skos__scopeNote mesh__D015060
% 221.95/222.12       Synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. It is also a major constituent of PULMONARY SURFACTANTS.%A%    
% 221.95/222.12  |- skos__hiddenLabel mesh__D015060 1,2 Dihexadecyl sn Glycerophosphocholine
% 221.95/222.12  |- mesh__dateEstablished mesh__D015060 1987-01-01
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D015060 2006
% 221.95/222.12  |- mesh__recordMaintainer mesh__D015060 ssb
% 221.95/222.12  |- mesh__historyNote mesh__D015060 87   
% 221.95/222.12  |- mesh__dateRevised mesh__D015060 2003-07-09
% 221.95/222.12  |- rdf__type mesh__D015060sskos__Concept
% 221.95/222.12  |- skos__altLabel mesh__D015060 Dipalmitoyllecithin
% 221.95/222.12  |- skos__historyNote mesh__D015060 Pulmonary Surfactant %28%1971-1986%29%
% 221.95/222.12  |- skos__altLabel mesh__D015060 1,2-Dipalmitoyl-Glycerophosphocholine
% 221.95/222.12  |- mesh__publicMeSHNote mesh__D015060
% 221.95/222.12       87; was DIPALMITOYL PHOSPHATIDYLCHOLINE see PULMONARY SURFACTANT 1977-86%A%  
% 221.95/222.12  |- skos__prefLabel mesh__D015060 1,2-Dipalmitoylphosphatidylcholine
% 221.95/222.12  |- skos__altLabel mesh__D015060 Dipalmitoylphosphatidylcholine
% 221.95/222.12  |- skos__hiddenLabel mesh__D015060 Phosphatidylcholine, Dipalmitoyl
% 221.95/222.12  |- skos__altLabel mesh__D015060 Dipalmitoyl Phosphatidylcholine
% 221.95/222.12  |- skos__hiddenLabel mesh__D015060 1,2 Dipalmitoyl Glycerophosphocholine
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D015060 2004
% 221.95/222.12  |- mesh__onlineNote mesh__D015060 search PULMONARY SURFACTANTS 1977-86   
% 221.95/222.12  |- mesh__dateCreated mesh__D009821 1977-05-09
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D009821 2005
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D009821 2004
% 221.95/222.12  |- skos__broader mesh__D009821smesh__D008055
% 221.95/222.12  |- mesh__dateRevised mesh__D009821 2003-07-09
% 221.95/222.12  |- rdf__type mesh__D009821sskos__Concept
% 221.95/222.12  |- mesh__recordAuthorizer mesh__D009821 sjn
% 221.95/222.12  |- mesh__recordMaintainer mesh__D009821 ssb
% 221.95/222.12  |- mesh__recordOriginator mesh__D009821 VDK
% 221.95/222.12  |- skos__annotation mesh__D009821
% 221.95/222.12       GEN or unspecified: prefer specific oil groups %26% specific oils; D25-26 qualif; coord IM with source of oil %28%IM or NIM%29%%A%  
% 221.95/222.12  |- skos__scopeNote mesh__D009821
% 221.95/222.12       Unctuous combustible substances that are liquid or easily liquefiable on warming, and are soluble in ether but insoluble in water. Such substances, depending on their origin, are classified as animal, mineral, or vegetable oils. Depending on their behavior on heating, they are volatile or fixed. %28%Dorland, 28th ed%29%%A%    
% 221.95/222.12  |- skos__prefLabel mesh__D009821 Oils
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D009821 2006
% 221.95/222.12  |- skos__historyNote mesh__D014766 specific virus %28%1966%29%
% 221.95/222.12  |- skos__broader mesh__D014766smesh__D014777
% 221.95/222.12  |- mesh__publicMeSHNote mesh__D014766 80   
% 221.95/222.12  |- mesh__dateCreated mesh__D014766 1979-02-23
% 221.95/222.12  |- skos__historyNote mesh__D014766
% 221.95/222.12       specific virus disease/blood %28%1967-1979%29%
% 221.95/222.12  |- mesh__dateRevised mesh__D014766 1998-06-11
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D014766 2003
% 221.95/222.12  |- skos__prefLabel mesh__D014766 Viremia
% 221.95/222.12  |- mesh__recordMaintainer mesh__D014766 PXP
% 221.95/222.12  |- mesh__recordAuthorizer mesh__D014766 SJN
% 221.95/222.12  |- rdf__type mesh__D014766sskos__Concept
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D014766 2000
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D014766 2004
% 221.95/222.12  |- skos__broader mesh__D014766smesh__D012687
% 221.95/222.12  |- mesh__recordOriginator mesh__D014766 AEP
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D014766 2001
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D014766 2005
% 221.95/222.12  |- skos__scopeNote mesh__D014766 The presence of viruses in the blood.     
% 221.95/222.12  |- skos__annotation mesh__D014766
% 221.95/222.12       coord with specific virus disease or specific virus if specific virus dis is not in MeSH %28%do not use /blood to indicate -emia%29%%A%  
% 221.95/222.12  |- mesh__dateEstablished mesh__D014766 1980-01-01
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D014766 2002
% 221.95/222.12  |- mesh__historyNote mesh__D014766 80   
% 221.95/222.12  |- skos__hiddenLabel mesh__D014766 Viremias
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D014766 2006
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D014766 1999
% 221.95/222.12  |- skos__altLabel mesh__D008729 Vasoxine
% 221.95/222.12  |- skos__broader mesh__D008729smesh__D011412
% 221.95/222.12  |- skos__broader mesh__D008729smesh__D010627
% 221.95/222.12  |- mesh__recordMaintainer mesh__D008729 CCR
% 221.95/222.12  |- mesh__dateCreated mesh__D008729 1999-01-01
% 221.95/222.12  |- skos__altLabel mesh__D008729 Wellcome Brand of Methoxamine Hydrochloride
% 221.95/222.12  |- skos__hiddenLabel mesh__D008729 Wellcome, Metoxamine
% 221.95/222.12  |- skos__altLabel mesh__D008729
% 221.95/222.12       Glaxo Wellcome Brand 1 of Methoxamine Hydrochloride
% 221.95/222.12  |- skos__annotation mesh__D008729 do not confuse with methoxyamine   
% 221.95/222.12  |- mesh__recordOriginator mesh__D008729 NLM
% 221.95/222.12  |- mesh__dateRevised mesh__D008729 2005-06-30
% 221.95/222.12  |- mesh__recordAuthorizer mesh__D008729 sjn
% 221.95/222.12  |- skos__scopeNote mesh__D008729
% 221.95/222.12       An alpha-adrenergic agonist that causes prolonged peripheral vasoconstriction. It has little if any direct effect on the central nervous system.%A%    
% 221.95/222.12  |- skos__altLabel mesh__D008729 Vasoxin
% 221.95/222.12  |- skos__altLabel mesh__D008729
% 221.95/222.12       Glaxo Wellcome Brand 2 of Methoxamine Hydrochloride
% 221.95/222.12  |- skos__altLabel mesh__D008729 Methoxamedrin
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D008729 2006
% 221.95/222.12  |- rdf__type mesh__D008729sskos__Concept
% 221.95/222.12  |- skos__hiddenLabel mesh__D008729 Hydrochloride, Methoxamine
% 221.95/222.12  |- skos__prefLabel mesh__D008729 Methoxamine
% 221.95/222.12  |- skos__altLabel mesh__D000746
% 221.95/222.12       Anemia, Hemolytic Congenital, Nonspherocytic
% 221.95/222.12  |- mesh__historyNote mesh__D000746
% 221.95/222.12       91%28%82%29%68; was see under ANEMIA, HEMOLYTIC, CONGENITAL 1982-90; was heading 1968-81; was ANEMIA, CONGENITAL NONSPHEROCYTIC HEMOLYTIC 1965-67%A%  
% 221.95/222.12  |- skos__altLabel mesh__D000746 Congenital Nonspherocytic Hemolytic Anemia
% 221.95/222.12  |- mesh__dateCreated mesh__D000746 1999-01-01
% 221.95/222.12  |- skos__altLabel mesh__D000746 Anemia, Congenital Nonspherocytic Hemolytic
% 221.95/222.12  |- mesh__recordAuthorizer mesh__D000746 sjn
% 221.95/222.12  |- skos__scopeNote mesh__D000746
% 221.95/222.12       Any one of a group of congenital hemolytic anemias in which there is no abnormal hemoglobin or spherocytosis and in which there is a defect of glycolysis in the erythrocyte. In some cases, pyruvate kinase deficiency has been demonstrated; in other cases, glucose-6-phosphate dehydrogenase deficiency has been demonstrated.%A%    
% 221.95/222.12  |- rdf__type mesh__D000746sskos__Concept
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D000746 2005
% 221.95/222.12  |- mesh__recordMaintainer mesh__D000746 nns
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D000746 2003
% 221.95/222.12  |- skos__broader mesh__D000746smesh__D000745
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D000746 2006
% 221.95/222.12  |- skos__prefLabel mesh__D000746
% 221.95/222.12       Anemia, Hemolytic, Congenital Nonspherocytic
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D000746 2002
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D000746 2004
% 221.95/222.12  |- skos__altLabel mesh__D000746 Hemolytic Anemia, Congenital Nonspherocytic
% 221.95/222.12  |- mesh__recordOriginator mesh__D000746 NLM
% 221.95/222.12  |- mesh__publicMeSHNote mesh__D000746
% 221.95/222.12       91,68; was see under ANEMIA, HEMOLYTIC, CONGENITAL 1982-90; was heading 1968-81; was ANEMIA, CONGENITAL NONSPHEROCYTIC HEMOLYTIC 1965-67%A%  
% 221.95/222.12  |- mesh__dateRevised mesh__D000746 2001-07-25
% 221.95/222.12  |- skos__annotation mesh__D000746
% 221.95/222.12       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: ANEMIA HEMOL CONGEN NONSPHER%A%  
% 221.95/222.12  |- mesh__dateEstablished mesh__D000746 1968-01-01
% 221.95/222.12  |- mesh__onlineNote mesh__D000746
% 221.95/222.12       use ANEMIA, HEMOLYTIC, CONGENITAL NONSPHEROCYTIC to search ANEMIA, CONGENITAL NON-SPHEROCYTIC HEMOLYTIC 1966-67%A%  
% 221.95/222.12  |- skos__annotation mesh__D019451
% 221.95/222.12       management of acquis, organiz, storage %26% retrieval of information; SPEC qualif%A%  
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D019451 2001
% 221.95/222.12  |- mesh__recordAuthorizer mesh__D019451 SJN
% 221.95/222.12  |- skos__hiddenLabel mesh__D019451 Management, Information
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D019451 2005
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D019451 2002
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D019451 2006
% 221.95/222.12  |- mesh__dateCreated mesh__D019451 1996-06-10
% 221.95/222.12  |- mesh__dateRevised mesh__D019451 1997-06-20
% 221.95/222.12  |- skos__prefLabel mesh__D019451 Information Management
% 221.95/222.12  |- mesh__dateEstablished mesh__D019451 1997-01-01
% 221.95/222.12  |- rdf__type mesh__D019451sskos__Concept
% 221.95/222.12  |- mesh__recordOriginator mesh__D019451 JLS
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D019451 1998
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D019451 2003
% 221.95/222.12  |- mesh__publicMeSHNote mesh__D019451 97   
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D019451 2000
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D019451 1999
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D019451 2004
% 221.95/222.12  |- skos__scopeNote mesh__D019451
% 221.95/222.12       Management of the acquisition, organization, storage, retrieval, and dissemination of information. %28%From Thesaurus of ERIC Descriptors, 1994%29%%A%    
% 221.95/222.12  |- skos__broader mesh__D019451smesh__D007254
% 221.95/222.12  |- mesh__recordMaintainer mesh__D019451 JLS
% 221.95/222.12  |- mesh__historyNote mesh__D019451 97   
% 221.95/222.12  |- skos__broader mesh__D004364Q000633smesh__D004364
% 221.95/222.12  |- mesh__preferredCombination mesh__D004364Q000633smesh__D004362
% 221.95/222.12  |- rdf__type mesh__D004364Q000633smesh__CompoundConcept
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005431 2000
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005431 2001
% 221.95/222.12  |- skos__broader mesh__D005431smesh__D015144
% 221.95/222.12  |- mesh__dateRevised mesh__D005431 1997-06-20
% 221.95/222.12  |- skos__prefLabel mesh__D005431 Florida
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005431 2002
% 221.95/222.12  |- mesh__recordMaintainer mesh__D005431 PXP
% 221.95/222.12  |- mesh__recordAuthorizer mesh__D005431 SJN
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005431 2005
% 221.95/222.12  |- rdf__type mesh__D005431sskos__Concept
% 221.95/222.12  |- mesh__recordOriginator mesh__D005431 NLM
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005431 2003
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005431 2006
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005431 1998
% 221.95/222.12  |- mesh__dateCreated mesh__D005431 1999-01-01
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005431 2004
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D005431 1999
% 221.95/222.12  |- mesh__historyNote mesh__D046848 2005   
% 221.95/222.12  |- mesh__dateCreated mesh__D046848 2004-07-07
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D046848 2005
% 221.95/222.12  |- mesh__recordAuthorizer mesh__D046848 sjn
% 221.95/222.12  |- rdf__type mesh__D046848sskos__Concept
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D046848 2006
% 221.95/222.12  |- mesh__dateEstablished mesh__D046848 2005-01-01
% 221.95/222.12  |- mesh__recordOriginator mesh__D046848 ags
% 221.95/222.12  |- skos__broader mesh__D046848smesh__D046849
% 221.95/222.12  |- skos__historyNote mesh__D046848 DNA Viruses %28%1997-2004%29%
% 221.95/222.12  |- mesh__recordMaintainer mesh__D046848 ags
% 221.95/222.12  |- skos__scopeNote mesh__D046848
% 221.95/222.12       A species of DNA virus, in the genus WHISPOVIRUS, infecting PENAEID SHRIMP.%A%    
% 221.95/222.12  |- skos__altLabel mesh__D046848 White Spot Syndrome Virus
% 221.95/222.12  |- mesh__publicMeSHNote mesh__D046848 2005   
% 221.95/222.12  |- skos__prefLabel mesh__D046848 White spot syndrome virus 1
% 221.95/222.12  |- mesh__dateRevised mesh__D010376 2005-06-30
% 221.95/222.12  |- rdf__type mesh__D010376sskos__Concept
% 221.95/222.12  |- mesh__recordOriginator mesh__D010376 NLM
% 221.95/222.12  |- mesh__dateCreated mesh__D010376 1999-01-01
% 221.95/222.12  |- skos__broader mesh__D010376smesh__D013289
% 221.95/222.12  |- mesh__recordMaintainer mesh__D010376 SYSTEM
% 221.95/222.12  |- skos__prefLabel mesh__D010376 Pediococcus
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D010376 2006
% 221.95/222.12  |- skos__scopeNote mesh__D010376
% 221.95/222.12       A genus of gram-positive, facultatively anaerobic bacteria whose growth is dependent on the presence of a fermentable carbohydrate. No endospores are produced. Its organisms are found in fermenting plant products and are nonpathogenic to plants and animals, including humans.%A%    
% 221.95/222.12  |- mesh__recordAuthorizer mesh__D010376 sjn
% 221.95/222.12  |- skos__scopeNote mesh__D029081
% 221.95/222.12       Eukaryotic enzymes of the DNA TOPOISOMERASES, TYPE II class that  catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex. Isozymes of the eukaryotic DNA topoisomerase II consist of homodimers of alpha or beta subunits.%A%    
% 221.95/222.12  |- skos__broader mesh__D029081smesh__D004250
% 221.95/222.12  |- mesh__dateEstablished mesh__D029081 2002-01-01
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D029081 2004
% 221.95/222.12  |- skos__hiddenLabel mesh__D029081 Eukaryotic Topoisomerases II
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D029081 2006
% 221.95/222.12  |- mesh__historyNote mesh__D029081 2002   
% 221.95/222.12  |- skos__altLabel mesh__D029081 Topoisomerases II, Eukaryotic
% 221.95/222.12  |- rdf__type mesh__D029081sskos__Concept
% 221.95/222.12  |- skos__altLabel mesh__D029081 DNA Topoisomerases II, Eukaryotic
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D029081 2005
% 221.95/222.12  |- mesh__publicMeSHNote mesh__D029081 2002   
% 221.95/222.12  |- skos__historyNote mesh__D029081
% 221.95/222.12       DNA Topoisomerase %28%ATP-Hydrolysing%29% %28%1980-2001%29%
% 221.95/222.12  |- mesh__dateCreated mesh__D029081 2001-07-25
% 221.95/222.12  |- skos__prefLabel mesh__D029081 DNA Topoisomerases, Type II, Eukaryotic
% 221.95/222.12  |- mesh__dateRevised mesh__D029081 2003-07-09
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D004339 2000
% 221.95/222.12  |- skos__annotation mesh__D004339
% 221.95/222.12       IM when general; do not confuse with PRESCRIPTIONS, DRUG %28%prescribing is by the MD, cpding by the pharmacist or drug co.%29% or with DRUG FORMULATION see CHEMISTRY, PHARMACEUTICAL%A%  
% 221.95/222.12  |- mesh__recordAuthorizer mesh__D004339 SJN
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D004339 2003
% 221.95/222.12  |- skos__hiddenLabel mesh__D004339 Preparations, Drug
% 221.95/222.12  |- mesh__recordMaintainer mesh__D004339 MSR
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D004339 2001
% 221.95/222.12  |- skos__hiddenLabel mesh__D004339 Drug Preparations
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D004339 2005
% 221.95/222.12  |- skos__prefLabel mesh__D004339 Drug Compounding
% 221.95/222.12  |- skos__altLabel mesh__D004339 Drug Preparation
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D004339 2004
% 221.95/222.12  |- skos__broader mesh__D004339smesh__D013678
% 221.95/222.12  |- mesh__dateCreated mesh__D004339 1999-01-01
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D004339 2006
% 221.95/222.12  |- rdf__type mesh__D004339sskos__Concept
% 221.95/222.12  |- mesh__dateRevised mesh__D004339 1998-06-10
% 221.95/222.12  |- skos__hiddenLabel mesh__D004339 Preparation, Drug
% 221.95/222.12  |- skos__hiddenLabel mesh__D004339 Microencapsulations
% 221.95/222.12  |- skos__hiddenLabel mesh__D004339 Compounding, Drug
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D004339 2002
% 221.95/222.12  |- skos__scopeNote mesh__D004339
% 221.95/222.12       The preparation, mixing, and assembling of a drug. %28%From Remington, The Science and Practice of Pharmacy, 19th ed, p1814%29%%A%    
% 221.95/222.12  |- mesh__activeMeSHYear mesh__D004339 1999
% 221.95/222.12  |- mesh__recordOriginator mesh__D004339 NLM
% 221.95/222.12  |- skos__hiddenLabel mesh__D015061 Branching Enzyme, 1,4-alpha-Glucan
% 221.95/222.12  |- mesh__dateRevised mesh__D015061 2003-07-09
% 221.95/222.12  |- mesh__publicMeSHNote mesh__D015061
% 221.95/222.12       91; was see under GLUCOSYLTRANSFERASES 1976-90   
% 221.95/222.12  |- skos__prefLabel mesh__D015061 1,4-alpha-Glucan Branching Enzyme
% 221.95/222.12  |- skos__historyNote mesh__D015061 Polysaccharides %28%1973-1975%29%
% 221.95/222.12  |- skos__historyNote mesh__D015061
% 221.95/222.12       specific polysaccharide %28%1973-1975%29%
% 221.95/222.12  |- skos__hiddenLabel mesh__D015061 Branching Enzyme, Starch
% 221.95/222.12  |- mesh__dateEstablished mesh__D015061 1991-01-01
% 221.95/222.12  |- skos__hiddenLabel mesh__D015061 Glycosyltransferase, Branching
% 221.95/222.12  |- skos__hiddenLabel mesh__D015061 Enzyme, Glycogen Branching
% 221.95/222.12  |- skos__altLabel mesh__D015061 Branching Glycosyltransferase
% 221.95/222.12  |- skos__hiddenLabel mesh__D015061 Enzyme, Amylopectin Branching
% 221.95/222.12  |- skos__hiddenLabel mesh__D015061 Branching Enzyme, Amylopectin
% 221.95/222.12  |- skos__hiddenLabel mesh__D015061 Q Enzyme
% 221.95/222.12  |- skos__hiddenLabel mesh__D015061 Branching Enzyme, Glycogen
% 221.95/222.12  |- skos__hiddenLabel mesh__D015061 Enzyme, Starch Branching
% 221.95/222.12  |- mesh__dateCreated mesh__D015061 1975-07-23
% 221.95/222.12  |- mesh__recordMaintainer mesh__D015061 ssb
% 221.95/222.12  |- mesh__historyNote mesh__D015061
% 221.95/222.12       91%28%76%29%; was see under GLUCOSYLTRANSFERASES 1976-90   
% 221.95/222.13  |- skos__historyNote mesh__D015061 Glucosyltransferases %28%1973-1975%29%
% 221.95/222.13  |- mesh__recordOriginator mesh__D015061 RLS
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D015061 2006
% 221.95/222.13  |- skos__hiddenLabel mesh__D015061 1,4 alpha Glucan Branching Enzyme
% 221.95/222.13  |- skos__altLabel mesh__D015061 Q-Enzyme
% 221.95/222.13  |- skos__altLabel mesh__D015061 Starch Branching Enzyme
% 221.95/222.13  |- mesh__recordAuthorizer mesh__D015061 sjn
% 221.95/222.13  |- skos__annotation mesh__D015061 DF: GLUCAN BRANCHING ENZYME   
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D015061 2005
% 221.95/222.13  |- rdf__type mesh__D015061sskos__Concept
% 221.95/222.13  |- skos__hiddenLabel mesh__D015061 Enzyme, Branching
% 221.95/222.13  |- skos__scopeNote mesh__D015061
% 221.95/222.13       In glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. EC 2.4.1.18.%A%    
% 221.95/222.13  |- skos__altLabel mesh__D015061 Glycogen Branching Enzyme
% 221.95/222.13  |- skos__broader mesh__D015061smesh__D005964
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D015061 2004
% 221.95/222.13  |- skos__hiddenLabel mesh__D015061 Enzyme, 1,4-alpha-Glucan Branching
% 221.95/222.13  |- skos__altLabel mesh__D015061 Branching Enzyme
% 221.95/222.13  |- skos__hiddenLabel mesh__D009822 Essential Oils
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D009822 2004
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D009822 2005A
% 221.95/222.13  |- skos__hiddenLabel mesh__D009822 Volatile Oils
% 221.95/222.13  |- rdf__type mesh__D009822sskos__Concept
% 221.95/222.13  |- skos__annotation mesh__D009822
% 221.95/222.13       D25-26 qualif; coord IM with source of oil %28%IM or NIM%29%; AROMATHERAPY %28%use of essential oils to treat dis in alternative med%29% is also available%A%  
% 221.95/222.13  |- mesh__dateRevised mesh__D009822 2004-07-29
% 221.95/222.13  |- skos__scopeNote mesh__D009822
% 221.95/222.13       Oils which evaporate readily. The volatile oils occur in aromatic plants, to which they give odor and other characteristics. Most volatile oils consist of a mixture of two or more TERPENES or of a mixture of an eleoptene %28%the more volatile constituent of a volatile oil%29% with a stearopten %28%the more solid constituent%29%. The synonym essential oils refers to the essence of a plant, as its perfume or scent, and not to its indispensability.%A%    
% 221.95/222.13  |- skos__broader mesh__D009822smesh__D009821
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D009822 2005
% 221.95/222.13  |- mesh__recordMaintainer mesh__D009822 jls
% 221.95/222.13  |- mesh__recordOriginator mesh__D009822 NLM
% 221.95/222.13  |- skos__prefLabel mesh__D009822 Oils, Volatile
% 221.95/222.13  |- mesh__dateCreated mesh__D009822 1999-01-01
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D009822 2006
% 221.95/222.13  |- mesh__recordAuthorizer mesh__D009822 jls
% 221.95/222.13  |- skos__altLabel mesh__D009822 Oils, Essential
% 221.95/222.13  |- skos__related mesh__D009822smesh__D019341
% 221.95/222.13  |- skos__broader mesh__D016226Q000172smesh__D016226
% 221.95/222.13  |- mesh__preferredCombination mesh__D016226Q000172smesh__D010758Q000172
% 221.95/222.13  |- rdf__type mesh__D016226Q000172smesh__CompoundConcept
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D009024 2006
% 221.95/222.13  |- skos__broader mesh__D009024smesh__D048788
% 221.95/222.13  |- skos__annotation mesh__D009024
% 221.95/222.13       coordinate with specific organ or organism / embryol or /growth%A%  
% 221.95/222.13  |- mesh__publicMeSHNote mesh__D009024 72   
% 221.95/222.13  |- mesh__dateRevised mesh__D009024 2004-07-07
% 221.95/222.13  |- mesh__dateCreated mesh__D009024 1999-01-01
% 221.95/222.13  |- skos__prefLabel mesh__D009024 Morphogenesis
% 221.95/222.13  |- skos__scopeNote mesh__D009024
% 221.95/222.13       The development of anatomical structures to create the form of a single- or multi-cell organism. Morphogenesis provides form changes of a part, parts, or the whole organism.%A%    
% 221.95/222.13  |- mesh__historyNote mesh__D009024 72%28%68%29%   
% 221.95/222.13  |- mesh__recordMaintainer mesh__D009024 lkt
% 221.95/222.13  |- mesh__recordOriginator mesh__D009024 NLM
% 221.95/222.13  |- rdf__type mesh__D009024sskos__Concept
% 221.95/222.13  |- mesh__recordAuthorizer mesh__D009024 sjn
% 221.95/222.13  |- mesh__dateEstablished mesh__D009024 1972-01-01
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D009024 2005
% 221.95/222.13  |- skos__historyNote mesh__D009024 Growth %28%1966-1967%29%
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Jargon Aphasia
% 221.95/222.13  |- mesh__dateEstablished mesh__D001041 1991-01-01
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Psychosensory Aphasias
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Posterior Aphasia
% 221.95/222.13  |- skos__altLabel mesh__D001041 Dysphasia, Wernicke%27%s
% 221.95/222.13  |- mesh__dateCreated mesh__D001041 1978-12-14
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001041 2000
% 221.95/222.13  |- mesh__recordMaintainer mesh__D001041 KEV
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Posterior Aphasias
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Receptive Dysphasia
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Psychosensory Aphasia
% 221.95/222.13  |- skos__altLabel mesh__D001041 Fluent Aphasia, Wernicke%27%s
% 221.95/222.13  |- skos__altLabel mesh__D001041 Aphasia, Psychosensory
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Sensory Dysphasia
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Fluent Aphasia
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Aphasias, Wernicke
% 221.95/222.13  |- mesh__recordAuthorizer mesh__D001041 sjn
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Dysphasias, Fluent
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Fluent Dysphasia
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Aphasias, Posterior
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Jargon Aphasias
% 221.95/222.13  |- skos__altLabel mesh__D001041 Dysphasia, Wernicke
% 221.95/222.13  |- mesh__dateRevised mesh__D001041 1999-11-03
% 221.95/222.13  |- skos__altLabel mesh__D001041 Aphasia, Fluent
% 221.95/222.13  |- skos__prefLabel mesh__D001041 Aphasia, Wernicke
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Wernicke Aphasias
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Dysphasia, Wernickes
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001041 2004
% 221.95/222.13  |- skos__altLabel mesh__D001041 Dysphasia, Fluent
% 221.95/222.13  |- mesh__recordOriginator mesh__D001041 RC
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Fluent Dysphasias
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Wernicke Dysphasia
% 221.95/222.13  |- skos__scopeNote mesh__D001041
% 221.95/222.13       Impairment in the comprehension of speech and meaning of words, both spoken and written, and of the meanings conveyed by their grammatical relationships in sentences. It is caused by lesions that primarily affect Wernicke%27%s area, which lies in the posterior perisylvian region of the temporal lobe of the dominant hemisphere. %28%From Brain %26% Bannister, Clinical Neurology, 7th ed, p141; Kandel et al., Principles of Neural Science, 3d ed, p846%29%%A%    
% 221.95/222.13  |- skos__altLabel mesh__D001041 Dysphasia, Sensory
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Dysphasias, Receptive
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Sensory Dysphasias
% 221.95/222.13  |- skos__altLabel mesh__D001041 Sensory Aphasia
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Aphasias, Jargon
% 221.95/222.13  |- skos__annotation mesh__D001041
% 221.95/222.13       do not confuse with APHASIA, BROCA where subject understands language but cannot express it%A%  
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Receptive Dysphasias
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001041 2002
% 221.95/222.13  |- skos__altLabel mesh__D001041 Wernicke Aphasia
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001041 2003
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001041 2006
% 221.95/222.13  |- skos__historyNote mesh__D001041 Aphasia %28%1966-1979%29%
% 221.95/222.13  |- skos__altLabel mesh__D001041 Dysphasia, Receptive
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Fluent Aphasia, Wernicke
% 221.95/222.13  |- skos__broader mesh__D001041smesh__D001037
% 221.95/222.13  |- mesh__publicMeSHNote mesh__D001041 1991; see APHASIA 1980-1990   
% 221.95/222.13  |- mesh__historyNote mesh__D001041 1991%28%1980%29%   
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Aphasia, Wernicke%27%s Fluent
% 221.95/222.13  |- rdf__type mesh__D001041sskos__Concept
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Wernicke%27%s Dysphasia
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001041 2001
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Aphasias, Psychosensory
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Aphasia, Sensory
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Dysphasias, Sensory
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001041 2005
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Aphasia, Receptive
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Wernicke%27%s Fluent Aphasia
% 221.95/222.13  |- skos__hiddenLabel mesh__D001041 Fluent Aphasia, Wernickes
% 221.95/222.13  |- skos__broader mesh__D014767smesh__D014900
% 221.95/222.13  |- mesh__dateRevised mesh__D014767 1995-02-21
% 221.95/222.13  |- rdf__type mesh__D014767sskos__Concept
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D014767 2001
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D014767 2004
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D014767 1997
% 221.95/222.13  |- mesh__recordOriginator mesh__D014767 SMH
% 221.95/222.13  |- skos__altLabel mesh__D014767 United States Virgin Islands
% 221.95/222.13  |- mesh__recordMaintainer mesh__D014767 TGC
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D014767 2002
% 221.95/222.13  |- skos__scopeNote mesh__D014767
% 221.95/222.13       A group of islands in the Lesser Antilles in the West Indies, the three main islands being St. Croix, St. Thomas, and St. John. The capital is Charlotte Amalie. The Virgin Islands were discovered by Columbus in 1493. Before 1917 the U.S. Virgin Islands were held by the Danish and called the Danish West Indies but the name was changed when the United States acquired them by purchase. Virgin refers to the fact that Columbus made his discovery on St. Ursula%27%s day - virgins being her legendary companions - or to the resemblance of the chain of islands to a procession of nuns or virgins. %28%From Webster%27%s New Geographical Dictionary, 1988, p1305 %26% Room, Brewer%27%s Dictionary of Names, 1992, p577%29%%A%    
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D014767 2005
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D014767 1998
% 221.95/222.13  |- mesh__dateCreated mesh__D014767 1981-05-15
% 221.95/222.13  |- mesh__recordAuthorizer mesh__D014767 PLS
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D014767 2006
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D014767 1999
% 221.95/222.13  |- skos__prefLabel mesh__D014767 Virgin Islands of the United States
% 221.95/222.13  |- skos__annotation mesh__D014767
% 221.95/222.13       a group of islands in the Lesser Antilles in the West Indies; do not confuse with the British Virgin Islands to their north %28% = VIRGIN ISLANDS, BRITISH see WEST INDIES%29%; DF: VIRGIN ISLANDS%A%  
% 221.95/222.13  |- mesh__dateEstablished mesh__D014767 1982-01-01
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D014767 2000
% 221.95/222.13  |- skos__historyNote mesh__D014767 West Indies %28%1966-1981%29%
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D014767 2003
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D014767 1996
% 221.95/222.13  |- mesh__historyNote mesh__D014767 82   
% 221.95/222.13  |- skos__scopeNote mesh__D033921
% 221.95/222.13       A broad category of proteins involved in the formation, transport and dissolution of TRANSPORT VESICLES. They play a role in the intracellular transport of molecules contained within membrane vesicles. Vesicular transport proteins are distinguished from MEMBRANE TRANSPORT PROTEINS, which move molecules across membranes, by the mode in which the molecules are transported.%A%    
% 221.95/222.13  |- mesh__publicMeSHNote mesh__D033921 2003   
% 221.95/222.13  |- mesh__dateCreated mesh__D033921 2002-07-03
% 221.95/222.13  |- mesh__dateEstablished mesh__D033921 2003-01-01
% 221.95/222.13  |- mesh__dateRevised mesh__D033921 2005-06-30
% 221.95/222.13  |- skos__hiddenLabel mesh__D033921 Transport Proteins, Vesicular
% 221.95/222.13  |- skos__related mesh__D033921smesh__D022161
% 221.95/222.13  |- mesh__historyNote mesh__D033921 2003   
% 221.95/222.13  |- skos__related mesh__D033921smesh__D021381
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D033921 2006
% 221.95/222.13  |- skos__broader mesh__D033921smesh__D008565
% 221.95/222.13  |- mesh__recordOriginator mesh__D033921 jmp
% 221.95/222.13  |- mesh__recordAuthorizer mesh__D033921 sjn
% 221.95/222.13  |- skos__prefLabel mesh__D033921 Vesicular Transport Proteins
% 221.95/222.13  |- mesh__recordMaintainer mesh__D033921 SYSTEM
% 221.95/222.13  |- rdf__type mesh__D033921sskos__Concept
% 221.95/222.13  |- skos__related mesh__D033921smesh__D007425
% 221.95/222.13  |- skos__broader mesh__D000010Q000293smesh__D000010
% 221.95/222.13  |- mesh__preferredCombination mesh__D000010Q000293smesh__D020222
% 221.95/222.13  |- rdf__type mesh__D000010Q000293smesh__CompoundConcept
% 221.95/222.13  |- rdf__type mesh__D000747sskos__Concept
% 221.95/222.13  |- mesh__recordAuthorizer mesh__D000747 PLS
% 221.95/222.13  |- skos__prefLabel mesh__D000747 Anemia, Hypochromic
% 221.95/222.13  |- skos__hiddenLabel mesh__D000747 Hypochromic Anemias
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D000747 1999
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D000747 2005
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D000747 1997
% 221.95/222.13  |- mesh__dateRevised mesh__D000747 1996-06-10
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D000747 2003
% 221.95/222.13  |- skos__hiddenLabel mesh__D000747 Chloroses
% 221.95/222.13  |- skos__broader mesh__D000747smesh__D000740
% 221.95/222.13  |- skos__hiddenLabel mesh__D000747 Hypochromic Anemia
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D000747 2006
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D000747 2000
% 221.95/222.13  |- skos__annotation mesh__D000747
% 221.95/222.13       note X ref; ANEMIA, IRON-DEFICIENCY is also available   
% 221.95/222.13  |- skos__scopeNote mesh__D000747
% 221.95/222.13       Anemia characterized by a decrease in the ratio of the weight of hemoglobin to the volume of the erythrocyte, i.e., the mean corpuscular hemoglobin concentration is less than normal. The individual cells contain less hemoglobin than they could have under optimal conditions. Hypochromic anemia may be caused by iron deficiency from a low iron intake, diminished iron absorption, or excessive iron loss. It can also be caused by infections or other diseases, therapeutic drugs, lead poisoning, and other conditions. %28%Stedman, 25th ed; from Miale, Laboratory Medicine: Hematology, 6th ed, p393%29%%A%    
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D000747 2004
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D000747 2001
% 221.95/222.13  |- mesh__recordMaintainer mesh__D000747 TGC
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D000747 2002
% 221.95/222.13  |- mesh__dateCreated mesh__D000747 1999-01-01
% 221.95/222.13  |- mesh__recordOriginator mesh__D000747 NLM
% 221.95/222.13  |- skos__hiddenLabel mesh__D000747 Anemias, Hypochromic
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D000747 1998
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D019452 2000
% 221.95/222.13  |- skos__broader mesh__D019452smesh__D009272
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D019452 2006
% 221.95/222.13  |- skos__prefLabel mesh__D019452 Terminally Ill
% 221.95/222.13  |- skos__scopeNote mesh__D019452
% 221.95/222.13       Persons with an incurable or irreversible illness at the end stage that will result in death within a short time. %28%From O%27%Leary et al., Lexikon: Dictionary of Health Care Terms, Organizations, and Acronyms for the Era of Reform, 1994, p780%29%%A%    
% 221.95/222.13  |- mesh__recordMaintainer mesh__D019452 JLS
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D019452 2001
% 221.95/222.13  |- mesh__recordAuthorizer mesh__D019452 SJN
% 221.95/222.13  |- mesh__dateRevised mesh__D019452 1998-06-11
% 221.95/222.13  |- rdf__type mesh__D019452sskos__Concept
% 221.95/222.13  |- skos__hiddenLabel mesh__D019452 Ill, Terminally
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D019452 2002
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D019452 2003
% 221.95/222.13  |- mesh__dateCreated mesh__D019452 1996-06-10
% 221.95/222.13  |- skos__historyNote mesh__D019452 Terminal Care %28%1966-1996%29%
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D019452 1999
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D019452 2004
% 221.95/222.13  |- mesh__dateEstablished mesh__D019452 1997-01-01
% 221.95/222.13  |- mesh__historyNote mesh__D019452 97   
% 221.95/222.13  |- mesh__publicMeSHNote mesh__D019452 97   
% 221.95/222.13  |- skos__annotation mesh__D019452
% 221.95/222.13       the terminal patient himself; care of the terminal patient = TERMINAL CARE%A%  
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D019452 2005
% 221.95/222.13  |- mesh__recordOriginator mesh__D019452 TGC
% 221.95/222.13  |- skos__prefLabel mesh__D005432 Flounder
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D005432 2005
% 221.95/222.13  |- mesh__dateCreated mesh__D005432 1986-04-15
% 221.95/222.13  |- skos__broader mesh__D005432smesh__D005412
% 221.95/222.13  |- rdf__type mesh__D005432sskos__Concept
% 221.95/222.13  |- skos__altLabel mesh__D005432 Pleuronectes platessa
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D005432 2006
% 221.95/222.13  |- mesh__recordOriginator mesh__D005432 EC
% 221.95/222.13  |- skos__annotation mesh__D005432
% 221.95/222.13       sole may be FLOUNDER %28%Pleuronectidae%29% or SOLEA see FLATFISHES%A%  
% 221.95/222.13  |- mesh__publicMeSHNote mesh__D005432
% 221.95/222.13       91; was see under FLATFISHES 1987-90   
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D005432 2004
% 221.95/222.13  |- mesh__historyNote mesh__D005432
% 221.95/222.13       91%28%87%29%; was see under FLATFISHES 1987-90   
% 221.95/222.13  |- mesh__dateRevised mesh__D005432 2003-07-09
% 221.95/222.13  |- skos__hiddenLabel mesh__D005432 Flounders
% 221.95/222.13  |- mesh__recordMaintainer mesh__D005432 ags
% 221.95/222.13  |- mesh__recordAuthorizer mesh__D005432 sjn
% 221.95/222.13  |- skos__scopeNote mesh__D005432
% 221.95/222.13       Common name for two families of FLATFISHES belonging to the order Pleuronectiformes: left-eye flounders %28%Bothidae%29% and right-eye flounders %28%Pleuronectidae%29%. The latter is more commonly used in research.%A%    
% 221.95/222.13  |- mesh__dateEstablished mesh__D005432 1991-01-01
% 221.95/222.13  |- skos__historyNote mesh__D005432 Fishes %28%1966-1986%29%
% 221.95/222.13  |- skos__broader mesh__D046849smesh__D004267
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D046849 2006
% 221.95/222.13  |- skos__scopeNote mesh__D046849
% 221.95/222.13       A family of DNA invertebrate viruses with one genus: Whispovirus.%A%    
% 221.95/222.13  |- mesh__publicMeSHNote mesh__D046849 2005   
% 221.95/222.13  |- mesh__recordMaintainer mesh__D046849 ags
% 221.95/222.13  |- mesh__historyNote mesh__D046849 2005   
% 221.95/222.13  |- skos__prefLabel mesh__D046849 Nimaviridae
% 221.95/222.13  |- mesh__dateEstablished mesh__D046849 2005-01-01
% 221.95/222.13  |- mesh__recordAuthorizer mesh__D046849 sjn
% 221.95/222.13  |- skos__hiddenLabel mesh__D046849 Whispoviruses
% 221.95/222.13  |- mesh__dateCreated mesh__D046849 2004-07-07
% 221.95/222.13  |- mesh__recordOriginator mesh__D046849 ags
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D046849 2005
% 221.95/222.13  |- rdf__type mesh__D046849sskos__Concept
% 221.95/222.13  |- mesh__dateEstablished mesh__D010377 1965-01-01
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D010377 2004
% 221.95/222.13  |- skos__altLabel mesh__D010377 Pedodontics
% 221.95/222.13  |- mesh__recordMaintainer mesh__D010377 TGC
% 221.95/222.13  |- mesh__recordOriginator mesh__D010377 NLM
% 221.95/222.13  |- skos__related mesh__D010377smesh__D019140
% 221.95/222.13  |- rdf__type mesh__D010377sskos__Concept
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D010377 1997
% 221.95/222.13  |- mesh__historyNote mesh__D010377
% 221.95/222.13       93; was PEDODONTICS 1965-92; was PEDODONTIA 1963-64   
% 221.95/222.13  |- mesh__dateCreated mesh__D010377 1999-01-01
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D010377 2003
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D010377 1996
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D010377 2002
% 221.95/222.13  |- mesh__dateRevised mesh__D010377 1995-06-08
% 221.95/222.13  |- mesh__recordAuthorizer mesh__D010377 PLS
% 221.95/222.13  |- skos__broader mesh__D010377smesh__D003813
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D010377 2001
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D010377 2006
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D010377 2000
% 221.95/222.13  |- skos__prefLabel mesh__D010377 Pediatric Dentistry
% 221.95/222.13  |- skos__altLabel mesh__D010377 Dentistry, Pediatric
% 221.95/222.13  |- skos__annotation mesh__D010377 SPEC: SPEC qualif; DF: PEDIATRIC DENT   
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D010377 1999
% 221.95/222.13  |- mesh__publicMeSHNote mesh__D010377
% 221.95/222.13       93; was PEDODONTICS 1965-92; was PEDODONTIA 1963-64   
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D010377 2005
% 221.95/222.13  |- mesh__onlineNote mesh__D010377
% 221.95/222.13       use PEDIATRIC DENTISTRY to search PEDODONTICS 1966-92   
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D010377 1998
% 221.95/222.13  |- skos__scopeNote mesh__D010377
% 221.95/222.13       The practice of dentistry concerned with the dental problems of children, proper maintenance, and treatment. The dental care may include the services provided by dental specialists.%A%    
% 221.95/222.13  |- skos__broader mesh__D010377smesh__D013039
% 221.95/222.13  |- mesh__recordOriginator mesh__D029082 ags
% 221.95/222.13  |- mesh__dateCreated mesh__D029082 2001-07-25
% 221.95/222.13  |- skos__altLabel mesh__D029082 Hemagglutinating Virus of Japan
% 221.95/222.13  |- rdf__type mesh__D029082sskos__Concept
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D029082 2005
% 221.95/222.13  |- skos__scopeNote mesh__D029082
% 221.95/222.13       The type species of RESPIROVIRUS in the subfamily PARAMYXOVIRINAE. It is the murine version of HUMAN PARAINFLUENZA VIRUS 1, distinguished by host range.%A%    
% 221.95/222.13  |- skos__historyNote mesh__D029082 Respirovirus %28%1965-2001%29%
% 221.95/222.13  |- skos__hiddenLabel mesh__D029082 Influenza D Viruses
% 221.95/222.13  |- skos__hiddenLabel mesh__D029082 Japan Hemagglutinating Virus
% 221.95/222.13  |- mesh__recordAuthorizer mesh__D029082 sjn
% 221.95/222.13  |- skos__annotation mesh__D029082
% 221.95/222.13       infection: coord IM with RESPIROVIRUS INFECTIONS %28%IM%29%   
% 221.95/222.13  |- skos__broader mesh__D029082smesh__D018108
% 221.95/222.13  |- mesh__historyNote mesh__D029082
% 221.95/222.13       2002; use RESPIROVIRUS 1997-2001, use PARAINFLUENZA VIRUS TYPE 1 1977-1996, use SENDAI VIRUS 1964-1976; for SHIPPING FEVER VIRUS use RESPIROVIRUS 1997-2001, use PARAINFLUENZA VIRUS TYPE 3 1976-1996; for INFLUENZA D VIRUS use RESPIROVIRUS 1997-2001, use PARAINFLUENZA VIRUS I, HUMAN 1976-1996%A%  
% 221.95/222.13  |- mesh__publicMeSHNote mesh__D029082
% 221.95/222.13       2002; see PARAMYXOVIRUS 1997-2001, see PARAINFLUENZA VIRUS TYPE 1 1977-1996, see SENDAI VIRUS 1964-1976; for SHIPPING FEVER VIRUS see PARAMYXOVIRUS 1997-2001, see PARAINFLUENZA VIRUS TYPE 3 1976-1996; for INFLUENZA D VIRUS see PARAMYXOVIRUS 1997-2001, use PARAINFLUENZA VIRUS I, HUMAN 1976-1996%A%  
% 221.95/222.13  |- skos__altLabel mesh__D029082 Influenza D Virus
% 221.95/222.13  |- mesh__dateRevised mesh__D029082 2004-07-13
% 221.95/222.13  |- mesh__recordMaintainer mesh__D029082 sjn
% 221.95/222.13  |- skos__prefLabel mesh__D029082 Sendai virus
% 221.95/222.13  |- skos__historyNote mesh__D029082
% 221.95/222.13       Parainfluenza Virus 1, Human %28%1965-2001%29%
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D029082 2006
% 221.95/222.13  |- mesh__dateEstablished mesh__D029082 2002-01-01
% 221.95/222.13  |- skos__hiddenLabel mesh__D015062 11 Hydroxycorticosteroids
% 221.95/222.13  |- skos__scopeNote mesh__D015062
% 221.95/222.13       A group of corticosteroids bearing a hydroxy group at the 11-position.%A%    
% 221.95/222.13  |- mesh__dateRevised mesh__D015062 2005-07-11
% 221.95/222.13  |- mesh__recordOriginator mesh__D015062 NLM
% 221.95/222.13  |- mesh__historyNote mesh__D015062 73%28%72%29%   
% 221.95/222.13  |- mesh__dateCreated mesh__D015062 1999-01-01
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D015062 2006
% 221.95/222.13  |- mesh__dateEstablished mesh__D015062 1973-01-01
% 221.95/222.13  |- skos__historyNote mesh__D015062 Glucocorticoids %28%1967-1971%29%
% 221.95/222.13  |- rdf__type mesh__D015062sskos__Concept
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D015062 2005
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D015062 2004
% 221.95/222.13  |- mesh__publicMeSHNote mesh__D015062 73   
% 221.95/222.13  |- mesh__recordMaintainer mesh__D015062 ags
% 221.95/222.13  |- mesh__recordAuthorizer mesh__D015062 ags
% 221.95/222.13  |- skos__broader mesh__D015062smesh__D006889
% 221.95/222.13  |- skos__prefLabel mesh__D015062 11-Hydroxycorticosteroids
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D015062 2006A
% 221.95/222.13  |- mesh__recordOriginator mesh__D009823 NLM
% 221.95/222.13  |- rdf__type mesh__D009823sskos__Concept
% 221.95/222.13  |- skos__prefLabel mesh__D009823 Ointment Bases
% 221.95/222.13  |- mesh__onlineNote mesh__D009823 search PHARMACEUTIC AIDS 1968-74   
% 221.95/222.13  |- skos__related mesh__D009823smesh__D009824
% 221.95/222.13  |- mesh__dateEstablished mesh__D009823 1991-01-01
% 221.95/222.13  |- skos__annotation mesh__D009823
% 221.95/222.13       IM for general only; NIM when specific drug is IM; when IM, D25-26 qualif; when NIM, no qualif%A%  
% 221.95/222.13  |- skos__broader mesh__D009823smesh__D010592
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D009823 2005
% 221.95/222.13  |- skos__hiddenLabel mesh__D009823 Bases, Ointment
% 221.95/222.13  |- mesh__dateCreated mesh__D009823 1999-01-01
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D009823 2006
% 221.95/222.13  |- mesh__recordMaintainer mesh__D009823 ssb
% 221.95/222.13  |- mesh__publicMeSHNote mesh__D009823
% 221.95/222.13       91; was see under PHARMACEUTIC AIDS 1975-90   
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D009823 2004
% 221.95/222.13  |- mesh__recordAuthorizer mesh__D009823 sjn
% 221.95/222.13  |- mesh__historyNote mesh__D009823
% 221.95/222.13       91%28%75%29%; was see under PHARMACEUTIC AIDS 1975-90   
% 221.95/222.13  |- skos__scopeNote mesh__D009823
% 221.95/222.13       Various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons; vehicles for medicinal substances intended for external application; there are four classes: hydrocarbon base, absorption base, water-removable base and water-soluble base; several are also emollients.%A%    
% 221.95/222.13  |- mesh__dateRevised mesh__D009823 2003-07-09
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001840 1995
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001840 2000
% 221.95/222.13  |- mesh__recordAuthorizer mesh__D001840 PLS
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001840 1998
% 221.95/222.13  |- skos__altLabel mesh__D001840 Bonding, Dental
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001840 2003
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001840 2001
% 221.95/222.13  |- skos__broader mesh__D001840smesh__D003813
% 221.95/222.13  |- skos__historyNote mesh__D001840 Surface Properties %28%1966-1970%29%
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001840 1999
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001840 2004
% 221.95/222.13  |- mesh__onlineNote mesh__D001840
% 221.95/222.13       use DENTAL BONDING to search BONDING, DENTAL 1971-90 %28%as Prov 1971%29%%A%  
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001840 1993
% 221.95/222.13  |- mesh__historyNote mesh__D001840
% 221.95/222.13       91%28%71%29%; was BONDING, DENTAL 1971-90 %28%Prov 1971%29%   
% 221.95/222.13  |- mesh__publicMeSHNote mesh__D001840 91; was BONDING, DENTAL 1972-90   
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001840 2002
% 221.95/222.13  |- mesh__dateRevised mesh__D001840 1992-05-14
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001840 1996
% 221.95/222.13  |- mesh__recordMaintainer mesh__D001840 TAP
% 221.95/222.13  |- mesh__dateEstablished mesh__D001840 1972-01-01
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001840 2005
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001840 1997
% 221.95/222.13  |- mesh__dateCreated mesh__D001840 1999-01-01
% 221.95/222.13  |- mesh__recordOriginator mesh__D001840 NLM
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001840 1994
% 221.95/222.13  |- skos__prefLabel mesh__D001840 Dental Bonding
% 221.95/222.13  |- skos__annotation mesh__D001840 DF: DENT BONDING   
% 221.95/222.13  |- rdf__type mesh__D001840sskos__Concept
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001840 2006
% 221.95/222.13  |- mesh__recordMaintainer mesh__D009025 ags
% 221.95/222.13  |- skos__prefLabel mesh__D009025 Morpholines
% 221.95/222.13  |- rdf__type mesh__D009025sskos__Concept
% 221.95/222.13  |- skos__altLabel mesh__D009025 Tetrahydro-1,4-Oxazines
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D009025 2005
% 221.95/222.13  |- mesh__recordOriginator mesh__D009025 NLM
% 221.95/222.13  |- skos__broader mesh__D009025smesh__D010078
% 221.95/222.13  |- skos__hiddenLabel mesh__D009025 Tetrahydro 1,4 Oxazines
% 221.95/222.13  |- mesh__recordAuthorizer mesh__D009025 sjn
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D009025 2006
% 221.95/222.13  |- mesh__dateRevised mesh__D009025 2004-07-07
% 221.95/222.13  |- mesh__dateCreated mesh__D009025 1999-01-01
% 221.95/222.13  |- mesh__dateCreated mesh__D001042 1999-01-01
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001042 2004
% 221.95/222.13  |- mesh__historyNote mesh__D001042 72   
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001042 2006
% 221.95/222.13  |- mesh__recordOriginator mesh__D001042 NLM
% 221.95/222.13  |- mesh__recordMaintainer mesh__D001042 ags
% 221.95/222.13  |- skos__altLabel mesh__D001042 Aphididae
% 221.95/222.13  |- skos__altLabel mesh__D001042 Lice, Plant
% 221.95/222.13  |- mesh__publicMeSHNote mesh__D001042 72   
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D001042 2005
% 221.95/222.13  |- skos__annotation mesh__D001042
% 221.95/222.13       do not use /drug eff for insecticides: TN 111   
% 221.95/222.13  |- rdf__type mesh__D001042sskos__Concept
% 221.95/222.13  |- mesh__recordAuthorizer mesh__D001042 sjn
% 221.95/222.13  |- mesh__dateEstablished mesh__D001042 1972-01-01
% 221.95/222.13  |- mesh__dateRevised mesh__D001042 2003-07-09
% 221.95/222.13  |- skos__broader mesh__D001042smesh__D006430
% 221.95/222.13  |- skos__altLabel mesh__D001042 Plant Louse
% 221.95/222.13  |- skos__altLabel mesh__D001042 Louse, Plant
% 221.95/222.13  |- skos__scopeNote mesh__D001042
% 221.95/222.13       A family %28%Aphididae%29% of small insects, in the suborder Sternorrhyncha, that suck the juices of plants. Important genera include Schizaphis and Myzus. The latter is known to carry more than 100 virus diseases between plants.%A%    
% 221.95/222.13  |- skos__historyNote mesh__D001042 Insects %28%1966-1971%29%
% 221.95/222.13  |- skos__altLabel mesh__D001042 Plant Lice
% 221.95/222.13  |- skos__prefLabel mesh__D001042 Aphids
% 221.95/222.13  |- mesh__recordAuthorizer mesh__D014768 SJN
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D014768 2000
% 221.95/222.13  |- skos__broader mesh__D014768smesh__D001061
% 221.95/222.13  |- skos__prefLabel mesh__D014768 Virginia
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D014768 2005
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D014768 1998
% 221.95/222.13  |- mesh__dateRevised mesh__D014768 1997-06-20
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D014768 2001
% 221.95/222.13  |- skos__broader mesh__D014768smesh__D015144
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D014768 2006
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D014768 1999
% 221.95/222.13  |- mesh__dateCreated mesh__D014768 1999-01-01
% 221.95/222.13  |- mesh__activeMeSHYear mesh__D014768 2002
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D014768 2003
% 221.95/222.14  |- mesh__recordOriginator mesh__D014768 NLM
% 221.95/222.14  |- rdf__type mesh__D014768sskos__Concept
% 221.95/222.14  |- mesh__recordMaintainer mesh__D014768 PXP
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D014768 2004
% 221.95/222.14  |- skos__historyNote mesh__D033922 Clathrin %28%1996-2002%29%
% 221.95/222.14  |- skos__broader mesh__D033922smesh__D002966
% 221.95/222.14  |- mesh__publicMeSHNote mesh__D033922
% 221.95/222.14       2003; CLATHERIN HEAVY CHAIN was indexed under CLATHRIN 1996-2002%A%  
% 221.95/222.14  |- skos__scopeNote mesh__D033922 The heavy chain subunits of clathrin.     
% 221.95/222.14  |- skos__prefLabel mesh__D033922 Clathrin Heavy Chains
% 221.95/222.14  |- skos__hiddenLabel mesh__D033922 Heavy Chain, Clathrin
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D033922 2006
% 221.95/222.14  |- mesh__dateCreated mesh__D033922 2002-07-03
% 221.95/222.14  |- mesh__recordMaintainer mesh__D033922 SYSTEM
% 221.95/222.14  |- mesh__dateEstablished mesh__D033922 2003-01-01
% 221.95/222.14  |- mesh__dateRevised mesh__D033922 2005-06-30
% 221.95/222.14  |- rdf__type mesh__D033922sskos__Concept
% 221.95/222.14  |- skos__altLabel mesh__D033922 Clathrin Heavy Chain
% 221.95/222.14  |- skos__hiddenLabel mesh__D033922 Heavy Chains, Clathrin
% 221.95/222.14  |- mesh__historyNote mesh__D033922
% 221.95/222.14       2003; use CLATHRIN HEAVY CHAINS %28%NM%29% 1996-2002   
% 221.95/222.14  |- mesh__recordOriginator mesh__D033922 jmp
% 221.95/222.14  |- mesh__recordAuthorizer mesh__D033922 sjn
% 221.95/222.14  |- skos__historyNote mesh__D019453 Escherichia coli %28%1977-1996%29%
% 221.95/222.14  |- skos__prefLabel mesh__D019453 Escherichia coli O157
% 221.95/222.14  |- skos__altLabel mesh__D019453 E coli O157-H7
% 221.95/222.14  |- skos__scopeNote mesh__D019453
% 221.95/222.14       A verocytotoxin-producing serogroup belonging to the O subfamily of Escherichia coli which has been shown to cause severe food-borne disease. Recently, a strain from this serogroup, serotype H7 which produces Shiga-like toxins, has been linked to human disease outbreaks resulting from contamination of foods from bovine origin. This serogroup causes hemorrhagic and HEMOLYTIC-UREMIC SYNDROME and predominantly hemorrhagic diarrhea and GASTROENTERITIS in children.%A%    
% 221.95/222.14  |- mesh__publicMeSHNote mesh__D019453 97   
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D019453 2006
% 221.95/222.14  |- skos__altLabel mesh__D019453 E coli O157
% 221.95/222.14  |- skos__broader mesh__D019453smesh__D004926
% 221.95/222.14  |- mesh__recordAuthorizer mesh__D019453 sjn
% 221.95/222.14  |- mesh__dateEstablished mesh__D019453 1997-01-01
% 221.95/222.14  |- mesh__historyNote mesh__D019453 97   
% 221.95/222.14  |- rdf__type mesh__D019453sskos__Concept
% 221.95/222.14  |- skos__annotation mesh__D019453
% 221.95/222.14       infection: coord IM with ESCHERICHIA COLI INFECTIONS %28%IM%29%; consider also HEMOLYTIC-UREMIC SYNDROME; in titles %26% translations use O157 %28%the letter O%29%, not 0157 %28%the number zero%29%%A%  
% 221.95/222.14  |- mesh__recordMaintainer mesh__D019453 SYSTEM
% 221.95/222.14  |- mesh__dateRevised mesh__D019453 2005-06-30
% 221.95/222.14  |- mesh__recordOriginator mesh__D019453 ADP
% 221.95/222.14  |- mesh__dateCreated mesh__D019453 1996-06-14
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D000748 2001
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D000748 2004
% 221.95/222.14  |- mesh__recordMaintainer mesh__D000748 PLS
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D000748 2002
% 221.95/222.14  |- skos__hiddenLabel mesh__D000748 Macrocytic Anemias
% 221.95/222.14  |- mesh__recordOriginator mesh__D000748 NLM
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D000748 1994
% 221.95/222.14  |- skos__scopeNote mesh__D000748
% 221.95/222.14       Anemia characterized by larger than normal erythrocytes, increased mean corpuscular volume %28%MCV%29% and increased mean corpuscular hemoglobin %28%MCH%29%.%A%    
% 221.95/222.14  |- mesh__dateCreated mesh__D000748 1999-01-01
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D000748 1992
% 221.95/222.14  |- skos__hiddenLabel mesh__D000748 Anemias, Macrocytic
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D000748 1998
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D000748 1995
% 221.95/222.14  |- rdf__type mesh__D000748sskos__Concept
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D000748 1993
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D000748 1996
% 221.95/222.14  |- skos__hiddenLabel mesh__D000748 Macrocytic Anemia
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D000748 2000
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D000748 1999
% 221.95/222.14  |- mesh__recordAuthorizer mesh__D000748 NLM
% 221.95/222.14  |- mesh__dateRevised mesh__D000748 1990-05-29
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D000748 2005
% 221.95/222.14  |- skos__prefLabel mesh__D000748 Anemia, Macrocytic
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D000748 1991
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D000748 1997
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D000748 2003
% 221.95/222.14  |- skos__broader mesh__D000748smesh__D000740
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D000748 2006
% 221.95/222.14  |- skos__related mesh__D000748smesh__D005365
% 221.95/222.14  |- skos__altLabel mesh__D011470 Prostatic Adenoma
% 221.95/222.14  |- rdf__type mesh__D011470sskos__Concept
% 221.95/222.14  |- skos__hiddenLabel mesh__D011470 Hyperplasia, Benign Prostatic
% 221.95/222.14  |- skos__altLabel mesh__D011470 Prostatic Hyperplasia, Benign
% 221.95/222.14  |- skos__hiddenLabel mesh__D011470 Benign Prostatic Hyperplasias
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D011470 2004
% 221.95/222.14  |- skos__hiddenLabel mesh__D011470 Hyperplasias, Benign Prostatic
% 221.95/222.14  |- skos__hiddenLabel mesh__D011470 Hyperplasia, Prostatic
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D011470 2003
% 221.95/222.14  |- skos__prefLabel mesh__D011470 Prostatic Hyperplasia
% 221.95/222.14  |- mesh__recordOriginator mesh__D011470 NLM
% 221.95/222.14  |- mesh__recordAuthorizer mesh__D011470 sjn
% 221.95/222.14  |- mesh__historyNote mesh__D011470
% 221.95/222.14       96; was PROSTATIC HYPERTROPHY 1963-95; PROSTATIC HYPERPLASIA was see PROSTATIC HYPERTROPHY 1992-95%A%  
% 221.95/222.14  |- skos__hiddenLabel mesh__D011470 Hypertrophy, Benign Prostatic
% 221.95/222.14  |- skos__scopeNote mesh__D011470
% 221.95/222.14       Enlargement or overgrowth of the PROSTATE gland as a result of an increase in the number of its constituent cells.%A%    
% 221.95/222.14  |- skos__related mesh__D011470smesh__D011471
% 221.95/222.14  |- skos__hiddenLabel mesh__D011470 Prostatic Hyperplasias, Benign
% 221.95/222.14  |- skos__altLabel mesh__D011470 Prostatic Hypertrophy
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D011470 2006
% 221.95/222.14  |- skos__hiddenLabel mesh__D011470 Adenomas, Prostatic
% 221.95/222.14  |- skos__annotation mesh__D011470
% 221.95/222.14       note category: non-neoplastic despite X refs ADENOMA, PROSTATIC %26% PROSTATIC ADENOMA%A%  
% 221.95/222.14  |- skos__hiddenLabel mesh__D011470 Hypertrophy, Prostatic
% 221.95/222.14  |- mesh__recordMaintainer mesh__D011470 ags
% 221.95/222.14  |- skos__broader mesh__D011470smesh__D011469
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D011470 2005
% 221.95/222.14  |- mesh__publicMeSHNote mesh__D011470
% 221.95/222.14       96; was PROSTATIC HYPERTROPHY 1963-95; PROSTATIC HYPERPLASIA was see PROSTATIC HYPERTROPHY 1992-95%A%  
% 221.95/222.14  |- skos__hiddenLabel mesh__D011470 Benign Prostatic Hypertrophy
% 221.95/222.14  |- skos__hiddenLabel mesh__D011470 Prostatic Adenomas
% 221.95/222.14  |- mesh__dateRevised mesh__D011470 2002-07-02
% 221.95/222.14  |- mesh__dateCreated mesh__D011470 1999-01-01
% 221.95/222.14  |- skos__altLabel mesh__D011470 Benign Prostatic Hyperplasia
% 221.95/222.14  |- mesh__recordAuthorizer mesh__D005433 SJN
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D005433 2003
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D005433 2006
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D005433 1998
% 221.95/222.14  |- mesh__dateCreated mesh__D005433 1999-01-01
% 221.95/222.14  |- mesh__recordOriginator mesh__D005433 NLM
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D005433 2004
% 221.95/222.14  |- skos__prefLabel mesh__D005433 Flour
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D005433 1999
% 221.95/222.14  |- skos__broader mesh__D005433smesh__D005502
% 221.95/222.14  |- skos__annotation mesh__D005433
% 221.95/222.14       restrict to wheat or other grains; FISH FLOUR is available%A%  
% 221.95/222.14  |- mesh__recordMaintainer mesh__D005433 JLS
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D005433 2000
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D005433 2001
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D005433 2005
% 221.95/222.14  |- mesh__dateRevised mesh__D005433 1997-06-20
% 221.95/222.14  |- rdf__type mesh__D005433sskos__Concept
% 221.95/222.14  |- skos__hiddenLabel mesh__D005433 Flours
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D005433 2002
% 221.95/222.14  |- skos__scopeNote mesh__D029881
% 221.95/222.14       A plant genus of the family FABACEAE that contains galegine %28%GUANIDINES%29%. Most of the other species have been reclassified to TEPHROSIA; a few to ASTRAGALUS PLANT; and INDIGOFERA.%A%    
% 221.95/222.14  |- skos__altLabel mesh__D029881 Goat Rue
% 221.95/222.14  |- rdf__type mesh__D029881sskos__Concept
% 221.95/222.14  |- skos__altLabel mesh__D029881 Goats Rue
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D029881 2006
% 221.95/222.14  |- mesh__publicMeSHNote mesh__D029881 2002   
% 221.95/222.14  |- skos__annotation mesh__D029881
% 221.95/222.14       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.95/222.14  |- mesh__dateRevised mesh__D029881 2005-07-08
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D029881 2004
% 221.95/222.14  |- skos__prefLabel mesh__D029881 Galega
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D029881 2005
% 221.95/222.14  |- mesh__historyNote mesh__D029881 2002   
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D029881 2003
% 221.95/222.14  |- mesh__dateEstablished mesh__D029881 2002-01-01
% 221.95/222.14  |- mesh__recordAuthorizer mesh__D029881 ags
% 221.95/222.14  |- mesh__recordOriginator mesh__D029881 ssb
% 221.95/222.14  |- skos__broader mesh__D029881smesh__D007887
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D029881 2006A
% 221.95/222.14  |- skos__altLabel mesh__D029881 Rue, Goat%27%s
% 221.95/222.14  |- mesh__dateCreated mesh__D029881 2001-07-25
% 221.95/222.14  |- mesh__recordMaintainer mesh__D029881 ags
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D010378 2003
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D010378 2005A
% 221.95/222.14  |- mesh__recordAuthorizer mesh__D010378 jls
% 221.95/222.14  |- skos__prefLabel mesh__D010378 Pedophilia
% 221.95/222.14  |- mesh__recordOriginator mesh__D010378 NLM
% 221.95/222.14  |- skos__broader mesh__D010378smesh__D010262
% 221.95/222.14  |- mesh__historyNote mesh__D010378
% 221.95/222.14       91%28%75%29%; was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1969-80%A%  
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D010378 2006
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D010378 2002
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D010378 1999
% 221.95/222.14  |- skos__scopeNote mesh__D010378
% 221.95/222.14       A sexual disorder occurring in a person 16 years or older and that is recurrent with intense sexually arousing fantasies, sexual urges, or behaviors involving sexual activity with a prepubescent child %28%generally age 13 or younger%29%. %28%from APA, DSM-IV, 1994%29%.%A%    
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D010378 2005
% 221.95/222.14  |- mesh__dateRevised mesh__D010378 2004-07-30
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D010378 2001
% 221.95/222.14  |- mesh__onlineNote mesh__D010378 search PARAPHILIAS 1969-74   
% 221.95/222.14  |- mesh__publicMeSHNote mesh__D010378
% 221.95/222.14       91; was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1969-80%A%  
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D010378 2004
% 221.95/222.14  |- mesh__recordMaintainer mesh__D010378 jls
% 221.95/222.14  |- rdf__type mesh__D010378sskos__Concept
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D010378 2000
% 221.95/222.14  |- mesh__dateEstablished mesh__D010378 1991-01-01
% 221.95/222.14  |- skos__hiddenLabel mesh__D010378 Pedophilias
% 221.95/222.14  |- mesh__dateCreated mesh__D010378 1999-01-01
% 221.95/222.14  |- rdf__type mesh__D015861sskos__Concept
% 221.95/222.14  |- mesh__dateEstablished mesh__D015861 1990-01-01
% 221.95/222.14  |- skos__historyNote mesh__D015861 Retinal Diseases %28%1974-1989%29%
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D015861 2004
% 221.95/222.14  |- mesh__recordAuthorizer mesh__D015861 sjn
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D015861 2000
% 221.95/222.14  |- mesh__recordMaintainer mesh__D015861 KEV
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D015861 2003
% 221.95/222.14  |- skos__broader mesh__D015861smesh__D009389
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D015861 2006
% 221.95/222.14  |- skos__historyNote mesh__D015861 Retinal Vessels %28%1969-1989%29%
% 221.95/222.14  |- skos__scopeNote mesh__D015861
% 221.95/222.14       Formation of new blood vessels originating from the retinal veins and extending along the inner %28%vitreal%29% surface of the retina.%A%    
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D015861 2002
% 221.95/222.14  |- skos__altLabel mesh__D015861 Neovascularization, Retinal
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D015861 2005
% 221.95/222.14  |- mesh__dateCreated mesh__D015861 1989-05-26
% 221.95/222.14  |- mesh__recordOriginator mesh__D015861 EGC
% 221.95/222.14  |- mesh__historyNote mesh__D015861 90   
% 221.95/222.14  |- mesh__dateRevised mesh__D015861 1999-11-03
% 221.95/222.14  |- mesh__publicMeSHNote mesh__D015861 90   
% 221.95/222.14  |- skos__historyNote mesh__D015861 Neovascularization %28%1966-1989%29%
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D015861 2001
% 221.95/222.14  |- skos__prefLabel mesh__D015861 Retinal Neovascularization
% 221.95/222.14  |- skos__broader mesh__D015861smesh__D012164
% 221.95/222.14  |- mesh__recordMaintainer mesh__D009824 ssb
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D009824 2005
% 221.95/222.14  |- mesh__dateCreated mesh__D009824 1999-01-01
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D009824 2006
% 221.95/222.14  |- mesh__recordAuthorizer mesh__D009824 sjn
% 221.95/222.14  |- skos__broader mesh__D009824smesh__D004304
% 221.95/222.14  |- mesh__recordOriginator mesh__D009824 NLM
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D009824 2004
% 221.95/222.14  |- mesh__dateRevised mesh__D009824 2003-07-09
% 221.95/222.14  |- rdf__type mesh__D009824sskos__Concept
% 221.95/222.14  |- skos__prefLabel mesh__D009824 Ointments
% 221.95/222.14  |- skos__scopeNote mesh__D009824
% 221.95/222.14       Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons.%A%    
% 221.95/222.14  |- skos__altLabel mesh__D009824 Unguents
% 221.95/222.14  |- skos__altLabel mesh__D009824 Salves
% 221.95/222.14  |- skos__related mesh__D009824smesh__D009823
% 221.95/222.14  |- skos__annotation mesh__D009824
% 221.95/222.14       IM for general only, qualif permitted; NIM %28%no qualif%29% with specific drug IM %28%with qualif%29%%A%  
% 221.95/222.14  |- skos__hiddenLabel mesh__D001841 Bonding, Pet-Human
% 221.95/222.14  |- skos__hiddenLabel mesh__D001841 Bondings, Human-Pet
% 221.95/222.14  |- skos__annotation mesh__D001841
% 221.95/222.14       no qualif; coord with specific animal pet %28%IM or NIM%29%; check tags ANIMALS %26% HUMAN%A%  
% 221.95/222.14  |- skos__hiddenLabel mesh__D001841 Bonding, Animal-Human
% 221.95/222.14  |- skos__hiddenLabel mesh__D001841 Pet-Human Bondings
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D001841 2006
% 221.95/222.14  |- skos__hiddenLabel mesh__D001841 Bonding, Human Pet
% 221.95/222.14  |- skos__hiddenLabel mesh__D001841 Bondings, Animal-Human
% 221.95/222.14  |- skos__broader mesh__D001841smesh__D009769
% 221.95/222.14  |- skos__hiddenLabel mesh__D001841 Human-Pet Bondings
% 221.95/222.14  |- skos__altLabel mesh__D001841 Pet-Human Bonding
% 221.95/222.14  |- mesh__dateRevised mesh__D001841 2003-07-30
% 221.95/222.14  |- mesh__publicMeSHNote mesh__D001841
% 221.95/222.14       91; was see under OBJECT ATTACHMENT 1983-90   
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D001841 2004
% 221.95/222.14  |- mesh__recordMaintainer mesh__D001841 ags
% 221.95/222.14  |- mesh__dateEstablished mesh__D001841 1991-01-01
% 221.95/222.14  |- skos__hiddenLabel mesh__D001841 Animal-Human Bondings
% 221.95/222.14  |- skos__hiddenLabel mesh__D001841 Pet Human Bonding
% 221.95/222.14  |- mesh__historyNote mesh__D001841
% 221.95/222.14       91%28%83%29%; was see under OBJECT ATTACHMENT 1983-90   
% 221.95/222.14  |- skos__scopeNote mesh__D001841
% 221.95/222.14       The emotional attachment of individuals to pets.     
% 221.95/222.14  |- skos__hiddenLabel mesh__D001841 Human Pet Bonding
% 221.95/222.14  |- skos__altLabel mesh__D001841 Human-Pet Bonding
% 221.95/222.14  |- skos__prefLabel mesh__D001841 Bonding, Human-Pet
% 221.95/222.14  |- mesh__recordOriginator mesh__D001841 EC
% 221.95/222.14  |- rdf__type mesh__D001841sskos__Concept
% 221.95/222.14  |- skos__hiddenLabel mesh__D001841 Bondings, Pet-Human
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D001841 2005
% 221.95/222.14  |- skos__hiddenLabel mesh__D001841 Animal Human Bonding
% 221.95/222.14  |- mesh__dateCreated mesh__D001841 1982-04-28
% 221.95/222.14  |- mesh__recordAuthorizer mesh__D001841 sjn
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Death Rates, Age-Specific
% 221.95/222.14  |- skos__altLabel mesh__D009026 Differential Mortality
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Excess Mortalities
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Declines, Mortality
% 221.95/222.14  |- rdf__type mesh__D009026sskos__Concept
% 221.95/222.14  |- mesh__dateRevised mesh__D009026 2004-07-13
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Mortalities
% 221.95/222.14  |- skos__altLabel mesh__D009026 Excess Mortality
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Mortality Declines
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Mortality Determinant
% 221.95/222.14  |- mesh__recordMaintainer mesh__D009026 sjn
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Death Rates
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D009026 2005
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Mortalities, Premature
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Rates, Age-Specific Death
% 221.95/222.14  |- skos__scopeNote mesh__D009026
% 221.95/222.14       All deaths reported in a given population.     
% 221.95/222.14  |- skos__broader mesh__D009026smesh__D014798
% 221.95/222.14  |- mesh__publicMeSHNote mesh__D009026
% 221.95/222.14       1963; for MORTALITY, PREMATURE see INFANT MORTALITY 1995-2004%A%  
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Case Fatality Rates
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Rates, Case Fatality
% 221.95/222.14  |- skos__altLabel mesh__D009026 Mortality Decline
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D009026 2006
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Determinant, Mortality
% 221.95/222.14  |- skos__altLabel mesh__D009026 Determinants, Mortality
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Mortalities, Excess
% 221.95/222.14  |- skos__altLabel mesh__D009026 Premature Mortality
% 221.95/222.14  |- skos__altLabel mesh__D009026 Age Specific Death Rate
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Age-Specific Death Rates
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Death Rate, Age-Specific
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Mortalities, Differential
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Rates, Death
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Rate, Case Fatality
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Rate, Death
% 221.95/222.14  |- skos__related mesh__D009026smesh__D017809
% 221.95/222.14  |- mesh__historyNote mesh__D009026
% 221.95/222.14       1963; for MORTALITY, PREMATURE use INFANT MORTALITY 1995-2004%A%  
% 221.95/222.14  |- mesh__dateCreated mesh__D009026 1999-01-01
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Rate, Age-Specific Death
% 221.95/222.14  |- mesh__recordAuthorizer mesh__D009026 sjn
% 221.95/222.14  |- mesh__recordOriginator mesh__D009026 NLM
% 221.95/222.14  |- skos__annotation mesh__D009026
% 221.95/222.14       a statistical concept, not for individual deaths in case reports %28% = FATAL OUTCOME%29%; do not confuse with DEATH, the physiol dying or death; IM GEN only; prefer /mortal with diseases: Manual 19.7+, 19.8.47; specify geog; for human %26% animal; DF: MORTAL%A%  
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Differential Mortalities
% 221.95/222.14  |- skos__prefLabel mesh__D009026 Mortality
% 221.95/222.14  |- skos__hiddenLabel mesh__D009026 Premature Mortalities
% 221.95/222.14  |- skos__broader mesh__D013906Q000295smesh__D013906
% 221.95/222.14  |- mesh__preferredCombination mesh__D013906Q000295smesh__D020708
% 221.95/222.14  |- rdf__type mesh__D013906Q000295smesh__CompoundConcept
% 221.95/222.14  |- skos__scopeNote mesh__D014769
% 221.95/222.14       A cyclic polypeptide antibiotic complex from Streptomyces virginiae, S. loidensis, S. mitakaensis, S. pristina-spiralis, S. ostreogriseus, and others. It consists of 2 major components, VIRGINIAMYCIN FACTOR M1 and virginiamycin Factor S1. It is used to treat infections with gram-positive organisms and as a growth promoter in cattle, swine, and poultry.%A%    
% 221.95/222.14  |- rdf__type mesh__D014769sskos__Concept
% 221.95/222.14  |- mesh__recordOriginator mesh__D014769 NLM
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D014769 2006A
% 221.95/222.14  |- mesh__dateCreated mesh__D014769 1999-01-01
% 221.95/222.14  |- skos__broader mesh__D014769smesh__D025361
% 221.95/222.14  |- mesh__recordMaintainer mesh__D014769 ags
% 221.95/222.14  |- skos__prefLabel mesh__D014769 Virginiamycin
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D014769 2006
% 221.95/222.14  |- mesh__recordAuthorizer mesh__D014769 ags
% 221.95/222.14  |- mesh__publicMeSHNote mesh__D014769 1991; see VIRGINIAMYCINS 1974-1990   
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D014769 2005
% 221.95/222.14  |- mesh__historyNote mesh__D014769 1991%28%1974%29%;   
% 221.95/222.14  |- mesh__dateRevised mesh__D014769 2005-07-19
% 221.95/222.14  |- skos__altLabel mesh__D014769 Virgimycine
% 221.95/222.14  |- mesh__recordMaintainer mesh__D019454 lkt
% 221.95/222.14  |- skos__annotation mesh__D019454
% 221.95/222.14       not restricted to drug therapy; coordinate IM with type of therapy %28%IM%29% or specific drug with probably /admin %28%IM%29% but do not coordinate with DRUG ADMINISTRATION SCHEDULE or CIRCADIAN RHYTHM; DF: CHRONOTHER%A%  
% 221.95/222.14  |- skos__hiddenLabel mesh__D019454 Chronotherapies
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D019454 2006
% 221.95/222.14  |- mesh__recordOriginator mesh__D019454 TGC
% 221.95/222.14  |- mesh__historyNote mesh__D019454 97   
% 221.95/222.14  |- rdf__type mesh__D019454sskos__Concept
% 221.95/222.14  |- mesh__dateCreated mesh__D019454 1996-06-10
% 221.95/222.14  |- mesh__publicMeSHNote mesh__D019454 97   
% 221.95/222.14  |- mesh__recordAuthorizer mesh__D019454 sjn
% 221.95/222.14  |- skos__prefLabel mesh__D019454 Chronotherapy
% 221.95/222.14  |- mesh__dateEstablished mesh__D019454 1997-01-01
% 221.95/222.14  |- skos__broader mesh__D019454smesh__D004358
% 221.95/222.14  |- skos__scopeNote mesh__D019454
% 221.95/222.14       The adaptation of drug administration to the known variations in biological RHYTHMICITY, such as CIRCADIAN RHYTHMS. The treatment is aimed at supporting normal rhythms, or modifying the timing of therapy to achieve maximal efficacy and minimal adverse effect.%A%    
% 221.95/222.14  |- mesh__dateRevised mesh__D019454 2005-06-30
% 221.95/222.14  |- skos__historyNote mesh__D019454 Circadian Rhythm %28%1972-1996%29%
% 221.95/222.14  |- mesh__publicMeSHNote mesh__D000749
% 221.95/222.14       91; was see under ANEMIA, MACROCYTIC 1975-90   
% 221.95/222.14  |- mesh__recordAuthorizer mesh__D000749 sjn
% 221.95/222.14  |- skos__broader mesh__D000749smesh__D000748
% 221.95/222.14  |- skos__hiddenLabel mesh__D000749 Megaloblastic Anemia
% 221.95/222.14  |- skos__hiddenLabel mesh__D000749 Anemias, Megaloblastic
% 221.95/222.14  |- mesh__dateCreated mesh__D000749 1999-01-01
% 221.95/222.14  |- skos__hiddenLabel mesh__D000749 Megaloblastic Anemias
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D000749 2005
% 221.95/222.14  |- skos__prefLabel mesh__D000749 Anemia, Megaloblastic
% 221.95/222.14  |- rdf__type mesh__D000749sskos__Concept
% 221.95/222.14  |- mesh__recordOriginator mesh__D000749 NLM
% 221.95/222.14  |- skos__related mesh__D000749smesh__D008534
% 221.95/222.14  |- mesh__onlineNote mesh__D000749 search ANEMIA, MACROCYTIC 1966-74   
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D000749 2006
% 221.95/222.14  |- mesh__dateRevised mesh__D000749 2003-07-09
% 221.95/222.14  |- skos__scopeNote mesh__D000749
% 221.95/222.14       A disorder characterized by the presence of ANEMIA, abnormally large red blood cells %28%megalocytes or macrocytes%29%, and MEGALOBLASTS.%A%    
% 221.95/222.14  |- mesh__dateEstablished mesh__D000749 1991-01-01
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D000749 2004
% 221.95/222.14  |- mesh__historyNote mesh__D000749
% 221.95/222.14       91%28%75%29%; was see under ANEMIA, MACROCYTIC 1975-90   
% 221.95/222.14  |- mesh__recordMaintainer mesh__D000749 nns
% 221.95/222.14  |- skos__hiddenLabel mesh__D011471 Neoplasm, Prostatic
% 221.95/222.14  |- skos__altLabel mesh__D011471 Prostate Neoplasms
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D011471 2003
% 221.95/222.14  |- skos__prefLabel mesh__D011471 Prostatic Neoplasms
% 221.95/222.14  |- skos__altLabel mesh__D011471 Neoplasms, Prostate
% 221.95/222.14  |- skos__hiddenLabel mesh__D011471 Prostate Cancers
% 221.95/222.14  |- skos__broader mesh__D011471smesh__D011469
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D011471 2006
% 221.95/222.14  |- skos__altLabel mesh__D011471 Neoplasms, Prostatic
% 221.95/222.14  |- skos__related mesh__D011471smesh__D017430
% 221.95/222.14  |- skos__hiddenLabel mesh__D011471 Cancer, Prostate
% 221.95/222.14  |- skos__broader mesh__D011471smesh__D005834
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D011471 2005
% 221.95/222.14  |- mesh__dateRevised mesh__D011471 2002-07-03
% 221.95/222.14  |- mesh__recordMaintainer mesh__D011471 ags
% 221.95/222.14  |- skos__scopeNote mesh__D011471 Tumors or cancer of the prostate.     
% 221.95/222.14  |- mesh__dateCreated mesh__D011471 1999-01-01
% 221.95/222.14  |- skos__hiddenLabel mesh__D011471 Prostate Neoplasm
% 221.95/222.14  |- skos__altLabel mesh__D011471 Cancer of the Prostate
% 221.95/222.14  |- skos__altLabel mesh__D011471 Prostatic Cancer
% 221.95/222.14  |- skos__annotation mesh__D011471
% 221.95/222.14       coord IM with histol type of neopl %28%IM%29%; note PROSTATIC ADENOMA see PROSTATIC HYPERPLASIA is also available%A%  
% 221.95/222.14  |- skos__hiddenLabel mesh__D011471 Cancers, Prostatic
% 221.95/222.14  |- skos__hiddenLabel mesh__D011471 Cancers, Prostate
% 221.95/222.14  |- rdf__type mesh__D011471sskos__Concept
% 221.95/222.14  |- skos__hiddenLabel mesh__D011471 Cancer, Prostatic
% 221.95/222.14  |- skos__hiddenLabel mesh__D011471 Neoplasm, Prostate
% 221.95/222.14  |- skos__altLabel mesh__D011471 Cancer of Prostate
% 221.95/222.14  |- skos__hiddenLabel mesh__D011471 Prostatic Neoplasm
% 221.95/222.14  |- skos__related mesh__D011471smesh__D011470
% 221.95/222.14  |- mesh__recordOriginator mesh__D011471 NLM
% 221.95/222.14  |- mesh__recordAuthorizer mesh__D011471 sjn
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D011471 2004
% 221.95/222.14  |- skos__hiddenLabel mesh__D011471 Prostatic Cancers
% 221.95/222.14  |- skos__hiddenLabel mesh__D005434 Flow Cytometries
% 221.95/222.14  |- rdf__type mesh__D005434sskos__Concept
% 221.95/222.14  |- skos__broader mesh__D005434smesh__D003592
% 221.95/222.14  |- skos__hiddenLabel mesh__D005434 Cytometries, Flow
% 221.95/222.14  |- mesh__dateCreated mesh__D005434 1981-02-24
% 221.95/222.14  |- mesh__recordMaintainer mesh__D005434 ssb
% 221.95/222.14  |- mesh__recordAuthorizer mesh__D005434 sjn
% 221.95/222.14  |- skos__hiddenLabel mesh__D005434 Flow Microfluorometry
% 221.95/222.14  |- skos__altLabel mesh__D005434 Flow Microfluorimetry
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D005434 2006
% 221.95/222.14  |- mesh__historyNote mesh__D005434
% 221.95/222.14       82; FLOW MICROFLUORIMETRY was see FLUOROIMMUNOASSAY 1989-90%A%  
% 221.95/222.14  |- skos__hiddenLabel mesh__D005434 Fluorescence Activated Cell Sorting
% 221.95/222.14  |- mesh__dateRevised mesh__D005434 2004-07-07
% 221.95/222.14  |- skos__hiddenLabel mesh__D005434 Flow Cytofluorometry
% 221.95/222.14  |- skos__scopeNote mesh__D005434
% 221.95/222.14       Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam %28%laser or mercury arc lamp%29%. Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake.%A%    
% 221.95/222.14  |- skos__altLabel mesh__D005434 Cytofluorometry, Flow
% 221.95/222.14  |- skos__prefLabel mesh__D005434 Flow Cytometry
% 221.95/222.14  |- mesh__publicMeSHNote mesh__D005434
% 221.95/222.14       82; FLOW MICROFLUORIMETRY was see FLUOROIMMUNOASSAY 1989-90%A%  
% 221.95/222.14  |- skos__hiddenLabel mesh__D005434 Cell Sorting, Fluorescence-Activated
% 221.95/222.14  |- skos__hiddenLabel mesh__D005434 Flow Cytofluorometries
% 221.95/222.14  |- skos__hiddenLabel mesh__D005434 Flow Microfluorometries
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D005434 2005
% 221.95/222.14  |- skos__altLabel mesh__D005434 Cytometry, Flow
% 221.95/222.14  |- skos__hiddenLabel mesh__D005434 Fluorescence-Activated Cell Sortings
% 221.95/222.14  |- skos__hiddenLabel mesh__D005434 Sortings, Fluorescence-Activated Cell
% 221.95/222.14  |- skos__hiddenLabel mesh__D005434 Microfluorimetry, Flow
% 221.95/222.14  |- skos__hiddenLabel mesh__D005434 Sorting, Fluorescence-Activated Cell
% 221.95/222.14  |- skos__altLabel mesh__D005434 Microfluorometry, Flow
% 221.95/222.14  |- mesh__dateEstablished mesh__D005434 1982-01-01
% 221.95/222.14  |- skos__annotation mesh__D005434
% 221.95/222.14       flow cell sorting %26% FLUORESCENCE-ACTIVATED CELL SORTING: coord with CELL SEPARATION%A%  
% 221.95/222.14  |- skos__hiddenLabel mesh__D005434 Cell Sortings, Fluorescence-Activated
% 221.95/222.14  |- mesh__recordOriginator mesh__D005434 SMH
% 221.95/222.14  |- skos__hiddenLabel mesh__D005434 Cytofluorometries, Flow
% 221.95/222.14  |- mesh__onlineNote mesh__D005434
% 221.95/222.14       use FLUOROIMMUNOASSAY to search FLOW MICROFLUORIMETRY 1989-90%A%  
% 221.95/222.14  |- skos__hiddenLabel mesh__D005434 Microfluorometries, Flow
% 221.95/222.14  |- mesh__activeMeSHYear mesh__D029882 2003
% 221.95/222.14  |- mesh__dateEstablished mesh__D029882 2002-01-01
% 221.95/222.14  |- skos__altLabel mesh__D029882 Gan zao
% 221.95/222.14  |- skos__altLabel mesh__D029882 Chinese Licorice
% 221.95/222.15  |- mesh__dateCreated mesh__D029882 2001-07-25
% 221.95/222.15  |- skos__scopeNote mesh__D029882
% 221.95/222.15       A plant species of the family FABACEAE.     
% 221.95/222.15  |- skos__broader mesh__D029882smesh__D006035
% 221.95/222.15  |- skos__prefLabel mesh__D029882 Glycyrrhiza uralensis
% 221.95/222.15  |- skos__altLabel mesh__D029882 Gan cao
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D029882 2002
% 221.95/222.15  |- rdf__type mesh__D029882sskos__Concept
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D029882 2006
% 221.95/222.15  |- mesh__publicMeSHNote mesh__D029882 2002   
% 221.95/222.15  |- mesh__historyNote mesh__D029882 2002   
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D029882 2004
% 221.95/222.15  |- skos__annotation mesh__D029882
% 221.95/222.15       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D029882 2005
% 221.95/222.15  |- mesh__recordMaintainer mesh__D010379 PLS
% 221.95/222.15  |- skos__historyNote mesh__D010379 Group Processes %28%1966-1967%29%
% 221.95/222.15  |- mesh__recordAuthorizer mesh__D010379 PLS
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D010379 1995
% 221.95/222.15  |- skos__prefLabel mesh__D010379 Peer Group
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D010379 2006
% 221.95/222.15  |- skos__scopeNote mesh__D010379
% 221.95/222.15       Group composed of associates of same species, approximately the same age, and usually of similar rank or social status.%A%    
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D010379 2001
% 221.95/222.15  |- mesh__dateRevised mesh__D010379 1993-06-03
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D010379 1999
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D010379 1994
% 221.95/222.15  |- skos__hiddenLabel mesh__D010379 Peer Groups
% 221.95/222.15  |- skos__hiddenLabel mesh__D010379 Groups, Peer
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D010379 2005
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D010379 2000
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D010379 1998
% 221.95/222.15  |- mesh__historyNote mesh__D010379 68   
% 221.95/222.15  |- skos__annotation mesh__D010379 no qualif   
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D010379 2004
% 221.95/222.15  |- rdf__type mesh__D010379sskos__Concept
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D010379 1997
% 221.95/222.15  |- mesh__dateCreated mesh__D010379 1999-01-01
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D010379 2003
% 221.95/222.15  |- mesh__recordOriginator mesh__D010379 NLM
% 221.95/222.15  |- skos__broader mesh__D010379smesh__D006126
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D010379 1996
% 221.95/222.15  |- skos__hiddenLabel mesh__D010379 Group, Peer
% 221.95/222.15  |- mesh__dateEstablished mesh__D010379 1968-01-01
% 221.95/222.15  |- mesh__publicMeSHNote mesh__D010379 68   
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D010379 2002
% 221.95/222.15  |- skos__broader mesh__D015862smesh__D014603
% 221.95/222.15  |- skos__hiddenLabel mesh__D015862 Diseases, Choroidal
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015862 2003
% 221.95/222.15  |- skos__hiddenLabel mesh__D015862 Disease, Choroidal
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015862 1995
% 221.95/222.15  |- skos__hiddenLabel mesh__D015862 Choroid Disease
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015862 2001
% 221.95/222.15  |- mesh__dateRevised mesh__D015862 1993-05-26
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015862 1998
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015862 2006
% 221.95/222.15  |- mesh__recordMaintainer mesh__D015862 TGC
% 221.95/222.15  |- skos__altLabel mesh__D015862 Choroidal Diseases
% 221.95/222.15  |- skos__hiddenLabel mesh__D015862 Diseases, Choroid
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015862 1994
% 221.95/222.15  |- skos__prefLabel mesh__D015862 Choroid Diseases
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015862 2000
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015862 2005
% 221.95/222.15  |- skos__scopeNote mesh__D015862
% 221.95/222.15       Disorders of the choroid including hereditary choroidal diseases, neoplasms, and other abnormalities of the vascular layer of the uvea.%A%    
% 221.95/222.15  |- mesh__recordOriginator mesh__D015862 EGC
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015862 1997
% 221.95/222.15  |- mesh__publicMeSHNote mesh__D015862 90   
% 221.95/222.15  |- skos__hiddenLabel mesh__D015862 Disease, Choroid
% 221.95/222.15  |- mesh__recordAuthorizer mesh__D015862 PLS
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015862 2002
% 221.95/222.15  |- mesh__dateCreated mesh__D015862 1989-05-25
% 221.95/222.15  |- rdf__type mesh__D015862sskos__Concept
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015862 1996
% 221.95/222.15  |- mesh__dateEstablished mesh__D015862 1990-01-01
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015862 2004
% 221.95/222.15  |- skos__annotation mesh__D015862 of the eye, not of the choroid plexus   
% 221.95/222.15  |- mesh__historyNote mesh__D015862 90   
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015862 1999
% 221.95/222.15  |- skos__hiddenLabel mesh__D015862 Choroidal Disease
% 221.95/222.15  |- skos__broader mesh__D015064smesh__D011459
% 221.95/222.15  |- mesh__onlineNote mesh__D015064
% 221.95/222.15       use 16,16-DIMETHYLPROSTAGLANDIN E2 to search DIMETHYLDINOPROSTONE %26% 16,16-DIMETHYLPROSTAGLANDIN E2 METHYL ESTER 1980-93%A%  
% 221.95/222.15  |- mesh__dateCreated mesh__D015064 1979-05-23
% 221.95/222.15  |- skos__prefLabel mesh__D015064 16,16-Dimethylprostaglandin E2
% 221.95/222.15  |- skos__scopeNote mesh__D015064
% 221.95/222.15       A synthetic prostaglandin E analog that protects the gastric mucosa, prevents ulceration, and promotes the healing of peptic ulcers. The protective effect is independent of acid inhibition. It is also a potent inhibitor of pancreatic function and growth of experimental tumors.%A%    
% 221.95/222.15  |- mesh__recordOriginator mesh__D015064 RLS
% 221.95/222.15  |- skos__hiddenLabel mesh__D015064 16,16 Dimethylprostaglandin E2
% 221.95/222.15  |- mesh__recordMaintainer mesh__D015064 ssb
% 221.95/222.15  |- mesh__dateRevised mesh__D015064 2005-06-30
% 221.95/222.15  |- skos__historyNote mesh__D015064
% 221.95/222.15       Prostaglandins E, Synthetic %28%1978-1979%29%
% 221.95/222.15  |- skos__historyNote mesh__D015064 Prostaglandins, Synthetic %28%1977%29%
% 221.95/222.15  |- skos__annotation mesh__D015064 DF: DIMETHYLPGE2   
% 221.95/222.15  |- mesh__recordAuthorizer mesh__D015064 sjn
% 221.95/222.15  |- mesh__dateEstablished mesh__D015064 1991-01-01
% 221.95/222.15  |- skos__hiddenLabel mesh__D015064 E2, 16,16-Dimethylprostaglandin
% 221.95/222.15  |- skos__hiddenLabel mesh__D015064 16,16 Dimethyl PGE2
% 221.95/222.15  |- skos__historyNote mesh__D015064 Prostaglandins E %28%1975-1977%29%
% 221.95/222.15  |- skos__historyNote mesh__D015064 Prostaglandins %28%1966-1974%29%
% 221.95/222.15  |- mesh__historyNote mesh__D015064
% 221.95/222.15       91%28%80%29%; was see under PROSTAGLANDINS E, SYNTHETIC 1980-90; DIMETHYLDINOPROSTONE %26% 16,16-DIMETHYLPROSTAGLANDIN E2 METHYL ESTER were see 16,16-DIMETHYLPROSTAGLANDIN E2 1980-93%A%  
% 221.95/222.15  |- skos__altLabel mesh__D015064 16,16-Dimethyl-PGE2
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015064 2006
% 221.95/222.15  |- mesh__publicMeSHNote mesh__D015064
% 221.95/222.15       91; was see under PROSTAGLANDINS E, SYNTHETIC 1980-90; DIMETHYLDINOPROSTONE %26% 16,16-DIMETHYLPROSTAGLANDIN E2 METHYL ESTER were see 16,16-DIMETHYLPROSTAGLANDIN E2 1980-93%A%  
% 221.95/222.15  |- rdf__type mesh__D015064sskos__Concept
% 221.95/222.15  |- skos__prefLabel mesh__D009825 Oklahoma
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009825 2006
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009825 2003
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009825 2004
% 221.95/222.15  |- mesh__recordAuthorizer mesh__D009825 SJN
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009825 1998
% 221.95/222.15  |- mesh__recordMaintainer mesh__D009825 PXP
% 221.95/222.15  |- rdf__type mesh__D009825sskos__Concept
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009825 1999
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009825 2000
% 221.95/222.15  |- mesh__recordOriginator mesh__D009825 NLM
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009825 2001
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009825 2005
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009825 2002
% 221.95/222.15  |- mesh__dateCreated mesh__D009825 1999-01-01
% 221.95/222.15  |- mesh__dateRevised mesh__D009825 1997-06-20
% 221.95/222.15  |- skos__broader mesh__D009825smesh__D015146
% 221.95/222.15  |- skos__broader mesh__D001842smesh__D003238
% 221.95/222.15  |- skos__altLabel mesh__D001842 Bones and Bone Tissue
% 221.95/222.15  |- skos__hiddenLabel mesh__D001842 Tissues, Bone
% 221.95/222.15  |- mesh__considerAlso mesh__D001842
% 221.95/222.15       consider also terms at OSSI- and OSTE-   
% 221.95/222.15  |- skos__hiddenLabel mesh__D001842 Bone Tissues
% 221.95/222.15  |- skos__altLabel mesh__D001842 Bones and Bone
% 221.95/222.15  |- skos__related mesh__D001842smesh__D010027
% 221.95/222.15  |- skos__annotation mesh__D001842
% 221.95/222.15       /cytol: consider also OSTEOBLASTS; OSTEOCLASTS; OSTEOCYTES; /embryol: consider also OSTEOGENESIS; /surg: consider also OSTEOTOMY or ARTHRODESIS or FRACTURE FIXATION %26% its specifics; osteosynthesis not one of the preceding terms goes under BONE AND BONES /surg; differentiate from SKELETON which is almost never used: restrict SKELETON to bone arrangement as a whole %26% not for %22%skeletal%22% which usually means %22%bone%22% %28% = BONE AND BONES%29%; %22%disappearing bone%22% = OSTEOLYSIS, ESSENTIAL; inflammation = OSTEITIS; necrosis = OSTEONECROSIS; %22%bone minerals%22% = BONE AND BONES %28%IM%29% + MINERALS %28%IM%29% or specific mineral %28%IM%29%%A%  
% 221.95/222.15  |- skos__related mesh__D001842smesh__D001174
% 221.95/222.15  |- skos__prefLabel mesh__D001842 Bone and Bones
% 221.95/222.15  |- mesh__dateCreated mesh__D001842 1999-01-01
% 221.95/222.15  |- skos__altLabel mesh__D001842 Bone
% 221.95/222.15  |- skos__broader mesh__D001842smesh__D012863
% 221.95/222.15  |- mesh__historyNote mesh__D001842
% 221.95/222.15       /transplantation was BONE TRANSPLANTATION 1963-65; was BONE AND BONES/transplantation 1966-89%A%  
% 221.95/222.15  |- skos__hiddenLabel mesh__D001842 Tissue, Bone
% 221.95/222.15  |- mesh__dateRevised mesh__D001842 2005-07-30
% 221.95/222.15  |- rdf__type mesh__D001842sskos__Concept
% 221.95/222.15  |- mesh__recordMaintainer mesh__D001842 jls
% 221.95/222.15  |- mesh__publicMeSHNote mesh__D001842
% 221.95/222.15       /transplantation was BONE TRANSPLANTATION 1963-65; was BONE AND BONES/transplantation 1966-89%A%  
% 221.95/222.15  |- mesh__recordAuthorizer mesh__D001842 jls
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D001842 2005
% 221.95/222.15  |- skos__related mesh__D001842smesh__D002113
% 221.95/222.15  |- skos__scopeNote mesh__D001842
% 221.95/222.15       A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principle cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX.%A%    
% 221.95/222.15  |- mesh__onlineNote mesh__D001842
% 221.95/222.15       use BONE TRANSPLANTATION to search BONE AND BONES/transplantation 1966-89%A%  
% 221.95/222.15  |- mesh__recordOriginator mesh__D001842 NLM
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D001842 2006A
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D001842 2006
% 221.95/222.15  |- skos__related mesh__D001842smesh__D010012
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009027 2005
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009027 2000
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009027 1992
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009027 1999
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009027 1995
% 221.95/222.15  |- mesh__recordAuthorizer mesh__D009027 PLS
% 221.95/222.15  |- mesh__dateCreated mesh__D009027 1999-01-01
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009027 1998
% 221.95/222.15  |- skos__hiddenLabel mesh__D009027 Practice, Mortuary
% 221.95/222.15  |- skos__broader mesh__D009027smesh__D006281
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009027 2002
% 221.95/222.15  |- mesh__recordOriginator mesh__D009027 NLM
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009027 1994
% 221.95/222.15  |- skos__hiddenLabel mesh__D009027 Undertakings
% 221.95/222.15  |- mesh__onlineNote mesh__D009027
% 221.95/222.15       use MORTUARY PRACTICE to search CEMETERIES %26% CREMATION 1966-77%A%  
% 221.95/222.15  |- rdf__type mesh__D009027sskos__Concept
% 221.95/222.15  |- skos__hiddenLabel mesh__D009027 Cremations
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009027 2004
% 221.95/222.15  |- skos__hiddenLabel mesh__D009027 Mortuary Practices
% 221.95/222.15  |- skos__prefLabel mesh__D009027 Mortuary Practice
% 221.95/222.15  |- mesh__historyNote mesh__D009027
% 221.95/222.15       CEMETERIES %26% CREMATION were see under MORTUARY PRACTICE 1963-78%A%  
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009027 2003
% 221.95/222.15  |- skos__annotation mesh__D009027 SPEC: SPEC qualif   
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009027 1997
% 221.95/222.15  |- skos__scopeNote mesh__D009027
% 221.95/222.15       Activities associated with the physical burial of the dead. It excludes cultural practices such as funeral rites.%A%    
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009027 2001
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009027 2006
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009027 1993
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009027 1996
% 221.95/222.15  |- mesh__dateRevised mesh__D009027 1991-05-28
% 221.95/222.15  |- mesh__recordMaintainer mesh__D009027 PLS
% 221.95/222.15  |- skos__hiddenLabel mesh__D009027 Practices, Mortuary
% 221.95/222.15  |- skos__hiddenLabel mesh__D009027 Cemetery
% 221.95/222.15  |- skos__altLabel mesh__D001044 Absence of Voice
% 221.95/222.15  |- skos__hiddenLabel mesh__D001044 Aphonia, Functional
% 221.95/222.15  |- skos__hiddenLabel mesh__D001044 Aphonia, Nonorganic
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D001044 2002
% 221.95/222.15  |- skos__hiddenLabel mesh__D001044 Voice Absences
% 221.95/222.15  |- skos__hiddenLabel mesh__D001044 Aphonias, Spastic
% 221.95/222.15  |- skos__altLabel mesh__D001044 Nonorganic Aphonia
% 221.95/222.15  |- mesh__historyNote mesh__D001044 1972%28%1963%29%   
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D001044 2001
% 221.95/222.15  |- skos__hiddenLabel mesh__D001044 Voice Absence
% 221.95/222.15  |- skos__historyNote mesh__D001044 Voice %28%1966-1968%29%
% 221.95/222.15  |- skos__broader mesh__D001044smesh__D014832
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D001044 2000A
% 221.95/222.15  |- mesh__dateCreated mesh__D001044 1999-01-01
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D001044 2004
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D001044 2000
% 221.95/222.15  |- skos__prefLabel mesh__D001044 Aphonia
% 221.95/222.15  |- skos__hiddenLabel mesh__D001044 Aphonia, Spastic
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D001044 2006
% 221.95/222.15  |- skos__hiddenLabel mesh__D001044 Paralytica, Aphonia
% 221.95/222.15  |- skos__scopeNote mesh__D001044
% 221.95/222.15       Complete loss of phonation due to organic disease of the larynx or to nonorganic %28%i.e., psychogenic%29% causes.%A%    
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D001044 2003
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D001044 2005
% 221.95/222.15  |- mesh__recordOriginator mesh__D001044 NLM
% 221.95/222.15  |- mesh__recordAuthorizer mesh__D001044 ags
% 221.95/222.15  |- mesh__publicMeSHNote mesh__D001044 1972; see VOICE 1963-1971   
% 221.95/222.15  |- mesh__recordMaintainer mesh__D001044 ags
% 221.95/222.15  |- rdf__type mesh__D001044sskos__Concept
% 221.95/222.15  |- skos__hiddenLabel mesh__D001044 Spastic Aphonias
% 221.95/222.15  |- skos__hiddenLabel mesh__D001044 Aphonias, Nonorganic
% 221.95/222.15  |- mesh__dateRevised mesh__D001044 1999-11-23
% 221.95/222.15  |- skos__hiddenLabel mesh__D001044 Nonorganic Aphonias
% 221.95/222.15  |- mesh__dateEstablished mesh__D001044 1972-01-01
% 221.95/222.15  |- skos__hiddenLabel mesh__D001044 Functional Aphonias
% 221.95/222.15  |- skos__hiddenLabel mesh__D001044 Aphonias, Functional
% 221.95/222.15  |- mesh__historyNote mesh__D019455 97   
% 221.95/222.15  |- rdf__type mesh__D019455sskos__Concept
% 221.95/222.15  |- skos__historyNote mesh__D019455 Psychoanalytic Theory %28%1966-1996%29%
% 221.95/222.15  |- skos__altLabel mesh__D019455 Psychology, Self
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D019455 2004
% 221.95/222.15  |- mesh__recordMaintainer mesh__D019455 JLS
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D019455 2000
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D019455 1999
% 221.95/222.15  |- skos__related mesh__D019455smesh__D009289
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D019455 2003
% 221.95/222.15  |- mesh__dateRevised mesh__D019455 1997-06-20
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D019455 1998
% 221.95/222.15  |- mesh__recordOriginator mesh__D019455 JLS
% 221.95/222.15  |- skos__broader mesh__D019455smesh__D011574
% 221.95/222.15  |- skos__annotation mesh__D019455
% 221.95/222.15       psychoanal theory; normal or pathol; do not confuse with SELF CONCEPT; no qualif; DF: SELF PSYCHOL%A%  
% 221.95/222.15  |- skos__scopeNote mesh__D019455
% 221.95/222.15       Psychoanalytic theory focusing on interpretation of behavior in reference to self. %28%From APA, Thesaurus of Psychological Terms, 1994%29% This elaboration of the psychoanalytic concepts of narcissism and the self, was developed by Heinz Kohut, and stresses the importance of the self-awareness of excessive needs for approval and self-gratification.%A%    
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D019455 2006
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D019455 2002
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D019455 2005
% 221.95/222.15  |- skos__prefLabel mesh__D019455 Self Psychology
% 221.95/222.15  |- mesh__dateEstablished mesh__D019455 1997-01-01
% 221.95/222.15  |- mesh__dateCreated mesh__D019455 1996-06-13
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D019455 2001
% 221.95/222.15  |- mesh__recordAuthorizer mesh__D019455 SJN
% 221.95/222.15  |- mesh__publicMeSHNote mesh__D019455 97   
% 221.95/222.15  |- mesh__recordMaintainer mesh__D011472 TAP
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D011472 1994
% 221.95/222.15  |- skos__prefLabel mesh__D011472 Prostatitis
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D011472 2006
% 221.95/222.15  |- mesh__recordOriginator mesh__D011472 NLM
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D011472 2001
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D011472 2005
% 221.95/222.15  |- mesh__recordAuthorizer mesh__D011472 PLS
% 221.95/222.15  |- mesh__dateCreated mesh__D011472 1999-01-01
% 221.95/222.15  |- skos__broader mesh__D011472smesh__D011469
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D011472 1997
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D011472 2000
% 221.95/222.15  |- rdf__type mesh__D011472sskos__Concept
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D011472 1996
% 221.95/222.15  |- mesh__dateRevised mesh__D011472 1993-06-02
% 221.95/222.15  |- skos__scopeNote mesh__D011472
% 221.95/222.15       Inflammation of the prostate. %28%Dorland, 27th ed%29%     
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D011472 2004
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D011472 1999
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D011472 2002
% 221.95/222.15  |- skos__annotation mesh__D011472 inflamm of prostate   
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D011472 1995
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D011472 2003
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D011472 1998
% 221.95/222.15  |- skos__hiddenLabel mesh__D011472 Prostatitides
% 221.95/222.15  |- skos__annotation mesh__D029883
% 221.95/222.15       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.95/222.15  |- mesh__recordOriginator mesh__D029883 ssb
% 221.95/222.15  |- mesh__dateEstablished mesh__D029883 2002-01-01
% 221.95/222.15  |- mesh__recordAuthorizer mesh__D029883 sjn
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D029883 2006
% 221.95/222.15  |- mesh__publicMeSHNote mesh__D029883 2002   
% 221.95/222.15  |- skos__scopeNote mesh__D029883
% 221.95/222.15       A plant genus of the family FABACEAE. The common name of indigo also refers to Baptisia or Amorpha genera %28%FABACEAE%29%.%A%    
% 221.95/222.15  |- mesh__dateCreated mesh__D029883 2001-07-25
% 221.95/222.15  |- rdf__type mesh__D029883sskos__Concept
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D029883 2005
% 221.95/222.15  |- mesh__dateRevised mesh__D029883 2002-07-03
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D029883 2004
% 221.95/222.15  |- mesh__recordMaintainer mesh__D029883 ssb
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D029883 2003
% 221.95/222.15  |- skos__prefLabel mesh__D029883 Indigofera
% 221.95/222.15  |- skos__broader mesh__D029883smesh__D007887
% 221.95/222.15  |- mesh__historyNote mesh__D029883 2002   
% 221.95/222.15  |- skos__hiddenLabel mesh__D015863 Cyclitides, Heterochromic
% 221.95/222.15  |- mesh__dateCreated mesh__D015863 1989-05-26
% 221.95/222.15  |- mesh__recordAuthorizer mesh__D015863 PLS
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015863 2002
% 221.95/222.15  |- mesh__recordMaintainer mesh__D015863 PLS
% 221.95/222.15  |- mesh__dateRevised mesh__D015863 1993-06-03
% 221.95/222.15  |- skos__altLabel mesh__D015863 Heterochromic Cyclitis
% 221.95/222.15  |- skos__annotation mesh__D015863 a type of anterior uveitis   
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015863 1997
% 221.95/222.15  |- mesh__publicMeSHNote mesh__D015863
% 221.95/222.15       90; was see UVEITIS, ANTERIOR 1985-89; was heading 1963-85%A%  
% 221.95/222.15  |- skos__altLabel mesh__D015863 Cyclitis, Heterochromic
% 221.95/222.15  |- mesh__recordOriginator mesh__D015863 EGC
% 221.95/222.15  |- skos__hiddenLabel mesh__D015863 Iridocyclitides
% 221.95/222.15  |- skos__historyNote mesh__D015863 Uveitis, Anterior %28%1966-1989%29%
% 221.95/222.15  |- skos__broader mesh__D015863smesh__D014606
% 221.95/222.15  |- rdf__type mesh__D015863sskos__Concept
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015863 1996
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015863 2004
% 221.95/222.15  |- mesh__historyNote mesh__D015863
% 221.95/222.15       90; was see UVEITIS, ANTERIOR 1985-89; was heading 1963-85%A%  
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015863 2001
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015863 1999
% 221.95/222.15  |- mesh__dateEstablished mesh__D015863 1990-01-01
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015863 2003
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015863 1995
% 221.95/222.15  |- skos__hiddenLabel mesh__D015863 Heterochromic Cyclitides
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015863 2000
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015863 1998
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015863 2006
% 221.95/222.15  |- skos__broader mesh__D015863smesh__D007499
% 221.95/222.15  |- skos__prefLabel mesh__D015863 Iridocyclitis
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015863 1994
% 221.95/222.15  |- mesh__onlineNote mesh__D015863
% 221.95/222.15       use UVEITIS, ANTERIOR to search IRIDOCYCLITIS 1966-89   
% 221.95/222.15  |- skos__scopeNote mesh__D015863
% 221.95/222.15       Acute or chronic inflammation of the iris and ciliary body characterized by exudates into the anterior chamber, discoloration of the iris, and constricted, sluggish pupil. Symptoms include radiating pain, photophobia, lacrimation, and interference with vision.%A%    
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015863 2005
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015065 2004
% 221.95/222.15  |- mesh__recordMaintainer mesh__D015065 ags
% 221.95/222.15  |- mesh__recordOriginator mesh__D015065 NLM
% 221.95/222.15  |- skos__scopeNote mesh__D015065
% 221.95/222.15       A group of hydroxycorticosteroids bearing a hydroxy group at the 17-position. Urinary excretion of these compounds is used as an index of adrenal function. They are used systemically in the free alcohol form, but with esterification of the hydroxy groups, topical effectiveness is increased.%A%    
% 221.95/222.15  |- mesh__dateCreated mesh__D015065 1999-01-01
% 221.95/222.15  |- mesh__dateEstablished mesh__D015065 1965-01-01
% 221.95/222.15  |- mesh__publicMeSHNote mesh__D015065 65   
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015065 2005
% 221.95/222.15  |- mesh__historyNote mesh__D015065 65   
% 221.95/222.15  |- skos__prefLabel mesh__D015065 17-Hydroxycorticosteroids
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015065 2006
% 221.95/222.15  |- mesh__dateRevised mesh__D015065 2005-07-11
% 221.95/222.15  |- mesh__recordAuthorizer mesh__D015065 ags
% 221.95/222.15  |- skos__broader mesh__D015065smesh__D006889
% 221.95/222.15  |- rdf__type mesh__D015065sskos__Concept
% 221.95/222.15  |- skos__hiddenLabel mesh__D015065 17 Hydroxycorticosteroids
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D015065 2006A
% 221.95/222.15  |- mesh__recordMaintainer mesh__D009826 kle
% 221.95/222.15  |- skos__hiddenLabel mesh__D009826 Assistance, Old Age
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009826 2000
% 221.95/222.15  |- skos__prefLabel mesh__D009826 Old Age Assistance
% 221.95/222.15  |- skos__broader mesh__D009826smesh__D011632
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009826 2004
% 221.95/222.15  |- mesh__dateEstablished mesh__D009826 1991-01-01
% 221.95/222.15  |- skos__altLabel mesh__D009826 Old Age Security
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009826 2006
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009826 2003
% 221.95/222.15  |- skos__hiddenLabel mesh__D009826 Assistances, Old Age
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009826 2005
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009826 2002
% 221.95/222.15  |- rdf__type mesh__D009826sskos__Concept
% 221.95/222.15  |- mesh__onlineNote mesh__D009826 search PUBLIC ASSISTANCE 1968-74   
% 221.95/222.15  |- mesh__publicMeSHNote mesh__D009826
% 221.95/222.15       91; was see under PUBLIC ASSISTANCE 1975-90   
% 221.95/222.15  |- skos__scopeNote mesh__D009826
% 221.95/222.15       Financial assistance for the impoverished elderly through public funding of programs, services, and individual income supplements.%A%    
% 221.95/222.15  |- mesh__dateCreated mesh__D009826 1999-01-01
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009826 2001
% 221.95/222.15  |- mesh__historyNote mesh__D009826
% 221.95/222.15       91%28%75%29%; was see under PUBLIC ASSISTANCE 1975-90   
% 221.95/222.15  |- mesh__recordAuthorizer mesh__D009826 sjn
% 221.95/222.15  |- skos__annotation mesh__D009826 specify geog   
% 221.95/222.15  |- skos__hiddenLabel mesh__D009826 Security, Old Age
% 221.95/222.15  |- mesh__dateRevised mesh__D009826 1999-11-03
% 221.95/222.15  |- mesh__recordOriginator mesh__D009826 NLM
% 221.95/222.15  |- skos__scopeNote mesh__D001843
% 221.95/222.15       Adhesives used to fix prosthetic devices to bones and to cement bone to bone in difficult fractures. Synthetic resins are commonly used as cements. A mixture of monocalcium phosphate, monohydrate, alpha-tricalcium phosphate, and calcium carbonate with a sodium phosphate solution is also a useful bone paste.%A%    
% 221.95/222.15  |- skos__altLabel mesh__D001843 Bone Paste
% 221.95/222.15  |- skos__altLabel mesh__D001843 Bone Pastes
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D001843 2006
% 221.95/222.15  |- mesh__recordOriginator mesh__D001843 NLM
% 221.95/222.15  |- skos__prefLabel mesh__D001843 Bone Cements
% 221.95/222.15  |- mesh__dateRevised mesh__D001843 2004-07-07
% 221.95/222.15  |- skos__historyNote mesh__D001843 Tissue Adhesives %28%1966-1971%29%
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D001843 2005
% 221.95/222.15  |- skos__hiddenLabel mesh__D001843 Glues, Bone
% 221.95/222.15  |- skos__broader mesh__D001843smesh__D012117
% 221.95/222.15  |- skos__hiddenLabel mesh__D001843 Pastes, Bone
% 221.95/222.15  |- skos__altLabel mesh__D001843 Bone Glue
% 221.95/222.15  |- mesh__historyNote mesh__D001843 72   
% 221.95/222.15  |- skos__hiddenLabel mesh__D001843 Glue, Bone
% 221.95/222.15  |- mesh__recordMaintainer mesh__D001843 jmp
% 221.95/222.15  |- mesh__recordAuthorizer mesh__D001843 sjn
% 221.95/222.15  |- skos__hiddenLabel mesh__D001843 Paste, Bone
% 221.95/222.15  |- skos__annotation mesh__D001843
% 221.95/222.15       IM; coord with specific material if relevant %28%IM%29%; D25-26 qualif%A%  
% 221.95/222.15  |- rdf__type mesh__D001843sskos__Concept
% 221.95/222.15  |- mesh__publicMeSHNote mesh__D001843 72   
% 221.95/222.15  |- mesh__dateCreated mesh__D001843 1999-01-01
% 221.95/222.15  |- mesh__dateEstablished mesh__D001843 1972-01-01
% 221.95/222.15  |- skos__altLabel mesh__D001843 Bone Glues
% 221.95/222.15  |- skos__broader mesh__D001843smesh__D001697
% 221.95/222.15  |- skos__hiddenLabel mesh__D001843 Cements, Bone
% 221.95/222.15  |- skos__broader mesh__D009028smesh__D002970
% 221.95/222.15  |- rdf__type mesh__D009028sskos__Concept
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009028 2004
% 221.95/222.15  |- skos__prefLabel mesh__D009028 Morula
% 221.95/222.15  |- mesh__dateCreated mesh__D009028 1979-04-17
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009028 2003
% 221.95/222.15  |- skos__hiddenLabel mesh__D009028 Morulas
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009028 2006
% 221.95/222.15  |- mesh__activeMeSHYear mesh__D009028 2005
% 221.95/222.15  |- mesh__recordMaintainer mesh__D009028 lkt
% 221.95/222.15  |- mesh__recordOriginator mesh__D009028 AEP
% 221.95/222.15  |- mesh__dateRevised mesh__D009028 2002-07-03
% 221.95/222.15  |- mesh__dateEstablished mesh__D009028 1991-01-01
% 221.95/222.15  |- skos__scopeNote mesh__D009028
% 221.95/222.15       The early embryo at the developmental stage in which the BLASTOMERES, resulting from repeated mitotic divisions of the fertilized ovum %28%ZYGOTE%29%, form a compact cell mass.%A%    
% 221.95/222.15  |- mesh__recordAuthorizer mesh__D009028 sjn
% 221.95/222.15  |- mesh__publicMeSHNote mesh__D009028
% 221.95/222.15       91; was see under CLEAVAGE STAGE, OVUM 1980-90   
% 221.95/222.15  |- mesh__historyNote mesh__D009028
% 221.95/222.15       91%28%80%29%; was see under CLEAVAGE STAGE, OVUM 1980-90   
% 221.95/222.15  |- mesh__recordOriginator mesh__D001045 NLM
% 221.95/222.15  |- skos__hiddenLabel mesh__D001045 Aphorism
% 221.95/222.15  |- mesh__dateCreated mesh__D001045 1999-01-01
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D001045 2004
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D001045 2002
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D001045 2006
% 221.95/222.16  |- skos__annotation mesh__D001045
% 221.95/222.16       no qualif; includes fables %26% maxims; DF: APHORISMS   
% 221.95/222.16  |- skos__prefLabel mesh__D001045 Aphorisms and Proverbs
% 221.95/222.16  |- skos__altLabel mesh__D001045 Proverbs and Aphorisms
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D001045 1997
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D001045 2003
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D001045 2001
% 221.95/222.16  |- skos__scopeNote mesh__D001045
% 221.95/222.16       Short popular sayings effectively expressing or astutely professing general truths or useful thoughts. %28%From Random House Unabridged Dictionary, 2d ed, p97, p1556%29%%A%    
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D001045 1999
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D001045 2005
% 221.95/222.16  |- rdf__type mesh__D001045sskos__Concept
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D001045 1996
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D001045 2000
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D001045 1998
% 221.95/222.16  |- skos__hiddenLabel mesh__D001045 Proverb
% 221.95/222.16  |- skos__broader mesh__D001045smesh__D008091
% 221.95/222.16  |- mesh__recordAuthorizer mesh__D001045 PLS
% 221.95/222.16  |- mesh__recordMaintainer mesh__D001045 TGC
% 221.95/222.16  |- skos__altLabel mesh__D001045 Aphorisms
% 221.95/222.16  |- mesh__dateRevised mesh__D001045 1995-05-18
% 221.95/222.16  |- skos__hiddenLabel mesh__D001045 Maxim
% 221.95/222.16  |- mesh__dateCreated mesh__D019456 1996-06-10
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D019456 1999
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D019456 2003
% 221.95/222.16  |- mesh__dateEstablished mesh__D019456 1997-01-01
% 221.95/222.16  |- skos__broader mesh__D019456smesh__D011634
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D019456 2001
% 221.95/222.16  |- mesh__publicMeSHNote mesh__D019456 97   
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D019456 1998
% 221.95/222.16  |- skos__annotation mesh__D019456
% 221.95/222.16       demogr %26% epidemiol changes in health picture in a population%A%  
% 221.95/222.16  |- skos__broader mesh__D019456smesh__D011157
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D019456 2000
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D019456 1997
% 221.95/222.16  |- skos__hiddenLabel mesh__D019456 Health Transitions
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D019456 2006
% 221.95/222.16  |- skos__scopeNote mesh__D019456
% 221.95/222.16       Demographic and epidemiologic changes that have occurred in the last five decades in many developing countries and that are characterized by major growth in the number and proportion of middle-aged and elderly persons and in the frequency of the diseases that occur in these age groups. The health transition is the result of efforts to improve maternal and child health via primary care and outreach services and such efforts have been responsible for a decrease in the birth rate; reduced maternal mortality; improved preventive services; reduced infant mortality, and the increased life expectancy that defines the transition. %28%From Ann Intern Med 1992 Mar 15;116%28%6%29%:499-504%29%%A%    
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D019456 2005
% 221.95/222.16  |- skos__hiddenLabel mesh__D019456 Transitions, Health
% 221.95/222.16  |- skos__prefLabel mesh__D019456 Health Transition
% 221.95/222.16  |- skos__hiddenLabel mesh__D019456 Transition, Health
% 221.95/222.16  |- mesh__historyNote mesh__D019456 97   
% 221.95/222.16  |- rdf__type mesh__D019456sskos__Concept
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D019456 2004
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D019456 2002
% 221.95/222.16  |- skos__broader mesh__D006761Q000458smesh__D006761
% 221.95/222.16  |- mesh__preferredCombination mesh__D006761Q000458smesh__D006739
% 221.95/222.16  |- rdf__type mesh__D006761Q000458smesh__CompoundConcept
% 221.95/222.16  |- skos__scopeNote mesh__D005436 Antibiotic analog of CLOXACILLIN.     
% 221.95/222.16  |- skos__altLabel mesh__D005436 Fluorochloroxacillin
% 221.95/222.16  |- mesh__publicMeSHNote mesh__D005436
% 221.95/222.16       91; was see under CLOXACILLIN 1975-90   
% 221.95/222.16  |- mesh__recordOriginator mesh__D005436 NLM
% 221.95/222.16  |- skos__prefLabel mesh__D005436 Floxacillin
% 221.95/222.16  |- rdf__type mesh__D005436sskos__Concept
% 221.95/222.16  |- mesh__historyNote mesh__D005436
% 221.95/222.16       91%28%75%29%; was see under CLOXACILLIN 1975-90   
% 221.95/222.16  |- skos__altLabel mesh__D005436 Flucloxacillin
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D005436 2006
% 221.95/222.16  |- mesh__recordMaintainer mesh__D005436 exl
% 221.95/222.16  |- mesh__dateCreated mesh__D005436 1974-11-19
% 221.95/222.16  |- skos__historyNote mesh__D005436 Cloxacillin %28%1974%29%
% 221.95/222.16  |- mesh__dateEstablished mesh__D005436 1991-01-01
% 221.95/222.16  |- mesh__recordAuthorizer mesh__D005436 sjn
% 221.95/222.16  |- mesh__dateRevised mesh__D005436 2005-06-30
% 221.95/222.16  |- skos__broader mesh__D005436smesh__D003023
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D029884 2005
% 221.95/222.16  |- mesh__historyNote mesh__D029884 2002   
% 221.95/222.16  |- mesh__recordMaintainer mesh__D029884 ags
% 221.95/222.16  |- mesh__dateRevised mesh__D029884 2005-07-19
% 221.95/222.16  |- mesh__recordAuthorizer mesh__D029884 ags
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D029884 2003
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D029884 2006
% 221.95/222.16  |- mesh__publicMeSHNote mesh__D029884 2002   
% 221.95/222.16  |- mesh__recordOriginator mesh__D029884 ssb
% 221.95/222.16  |- skos__prefLabel mesh__D029884 Lespedeza
% 221.95/222.16  |- mesh__dateEstablished mesh__D029884 2002-01-01
% 221.95/222.16  |- skos__broader mesh__D029884smesh__D007887
% 221.95/222.16  |- rdf__type mesh__D029884sskos__Concept
% 221.95/222.16  |- mesh__dateCreated mesh__D029884 2001-07-25
% 221.95/222.16  |- skos__altLabel mesh__D029884 Bush Clover
% 221.95/222.16  |- skos__scopeNote mesh__D029884 A plant genus of the family FABACEAE.     
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D029884 2004
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D029884 2006A
% 221.95/222.16  |- skos__annotation mesh__D029884
% 221.95/222.16       note X ref BUSH CLOVER: SWEET CLOVER see MELILOTUS; CLOVER see MEDICAGO; and RED CLOVER see TRIFOLIUM are also available;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D029884 2002
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D015864 1997
% 221.95/222.16  |- skos__annotation mesh__D015864
% 221.95/222.16       inflamm of anterior %26% posterior uvea   
% 221.95/222.16  |- mesh__dateRevised mesh__D015864 1994-06-28
% 221.95/222.16  |- mesh__recordOriginator mesh__D015864 EGC
% 221.95/222.16  |- skos__broader mesh__D015864smesh__D014605
% 221.95/222.16  |- mesh__dateCreated mesh__D015864 1989-05-25
% 221.95/222.16  |- rdf__type mesh__D015864sskos__Concept
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D015864 1996
% 221.95/222.16  |- mesh__publicMeSHNote mesh__D015864 90   
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D015864 2004
% 221.95/222.16  |- mesh__recordMaintainer mesh__D015864 PLS
% 221.95/222.16  |- mesh__recordAuthorizer mesh__D015864 PLS
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D015864 2002
% 221.95/222.16  |- mesh__historyNote mesh__D015864 90   
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D015864 1999
% 221.95/222.16  |- mesh__dateEstablished mesh__D015864 1990-01-01
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D015864 2003
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D015864 1995
% 221.95/222.16  |- skos__prefLabel mesh__D015864 Panuveitis
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D015864 1998
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D015864 2006
% 221.95/222.16  |- skos__historyNote mesh__D015864 Uveitis %28%1977-1989%29%
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D015864 2001
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D015864 2005
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D015864 2000
% 221.95/222.16  |- skos__scopeNote mesh__D015864
% 221.95/222.16       Inflammation in which both the anterior and posterior segments of the uvea are involved and a specific focus is not apparent. It is often severe and extensive and a serious threat to vision. Causes include systemic diseases such as tuberculosis, sarcoidosis, and syphilis, as well as malignancies. The intermediate segment of the eye is not involved.%A%    
% 221.95/222.16  |- mesh__recordMaintainer mesh__D009827 ssb
% 221.95/222.16  |- skos__scopeNote mesh__D009827
% 221.95/222.16       Antibiotic macrolide produced by Streptomyces antibioticus.%A%    
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D009827 2006
% 221.95/222.16  |- skos__broader mesh__D009827smesh__D018942
% 221.95/222.16  |- rdf__type mesh__D009827sskos__Concept
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D009827 2005
% 221.95/222.16  |- skos__prefLabel mesh__D009827 Oleandomycin
% 221.95/222.16  |- mesh__dateRevised mesh__D009827 2004-07-07
% 221.95/222.16  |- mesh__dateCreated mesh__D009827 1999-01-01
% 221.95/222.16  |- mesh__recordAuthorizer mesh__D009827 sjn
% 221.95/222.16  |- mesh__recordOriginator mesh__D009827 NLM
% 221.95/222.16  |- skos__hiddenLabel mesh__D009827 Phosphate, Oleandomycin
% 221.95/222.16  |- mesh__publicMeSHNote mesh__D001844 67   
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D001844 2004
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D001844 2005
% 221.95/222.16  |- skos__prefLabel mesh__D001844 Bone Conduction
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D001844 2001
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D001844 2003
% 221.95/222.16  |- mesh__dateEstablished mesh__D001844 1967-01-01
% 221.95/222.16  |- mesh__recordOriginator mesh__D001844 NLM
% 221.95/222.16  |- rdf__type mesh__D001844sskos__Concept
% 221.95/222.16  |- mesh__dateCreated mesh__D001844 1999-01-01
% 221.95/222.16  |- mesh__historyNote mesh__D001844 67%28%64%29%   
% 221.95/222.16  |- mesh__dateRevised mesh__D001844 2000-06-22
% 221.95/222.16  |- skos__broader mesh__D001844smesh__D006309
% 221.95/222.16  |- skos__scopeNote mesh__D001844
% 221.95/222.16       Sound transmission through the bones of the skull to the inner ear.%A%    
% 221.95/222.16  |- mesh__recordAuthorizer mesh__D001844 sjn
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D001844 2002
% 221.95/222.16  |- skos__hiddenLabel mesh__D001844 Bone Conductions
% 221.95/222.16  |- mesh__recordMaintainer mesh__D001844 adp
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D001844 2006
% 221.95/222.16  |- skos__hiddenLabel mesh__D001844 Conduction, Bone
% 221.95/222.16  |- skos__historyNote mesh__D009029 Plant Viruses %28%1966-1972%29%
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D009029 2003
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D009029 1997
% 221.95/222.16  |- skos__annotation mesh__D009029
% 221.95/222.16       a group of RNA plant viruses; GEN or unspecified; prefer specifics; coord IM with specific plant /virol %28%IM or NIM%29%%A%  
% 221.95/222.16  |- skos__scopeNote mesh__D009029
% 221.95/222.16       Viruses which produce a mottled appearance of the leaves of plants.%A%    
% 221.95/222.16  |- mesh__dateRevised mesh__D009029 1995-03-13
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D009029 2006
% 221.95/222.16  |- mesh__historyNote mesh__D009029
% 221.95/222.16       79%28%73%29%; was see under PLANT VIRUSES 1975-78   
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D009029 1996
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D009029 2001
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D009029 2005
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D009029 1999
% 221.95/222.16  |- skos__broader mesh__D009029smesh__D012328
% 221.95/222.16  |- mesh__publicMeSHNote mesh__D009029
% 221.95/222.16       79; was see under PLANT VIRUSES 1975-78   
% 221.95/222.16  |- mesh__dateEstablished mesh__D009029 1979-01-01
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D009029 2000
% 221.95/222.16  |- mesh__dateCreated mesh__D009029 1999-01-01
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D009029 1998
% 221.95/222.16  |- skos__broader mesh__D009029smesh__D010942
% 221.95/222.16  |- skos__hiddenLabel mesh__D009029 Virus, Mosaic
% 221.95/222.16  |- mesh__recordMaintainer mesh__D009029 TGC
% 221.95/222.16  |- mesh__recordAuthorizer mesh__D009029 PLS
% 221.95/222.16  |- skos__hiddenLabel mesh__D009029 Viruses, Mosaic
% 221.95/222.16  |- skos__prefLabel mesh__D009029 Mosaic Viruses
% 221.95/222.16  |- rdf__type mesh__D009029sskos__Concept
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D009029 2004
% 221.95/222.16  |- mesh__recordOriginator mesh__D009029 NLM
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D009029 2002
% 221.95/222.16  |- skos__hiddenLabel mesh__D009029 Mosaic Virus
% 221.95/222.16  |- mesh__dateRevised mesh__D001046 2005-06-30
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D001046 2006
% 221.95/222.16  |- skos__prefLabel mesh__D001046 Aphrodisiacs
% 221.95/222.16  |- mesh__recordOriginator mesh__D001046 NLM
% 221.95/222.16  |- rdf__type mesh__D001046sskos__Concept
% 221.95/222.16  |- mesh__recordAuthorizer mesh__D001046 sjn
% 221.95/222.16  |- skos__scopeNote mesh__D001046
% 221.95/222.16       Chemical agents or odors that stimulate sexual desires. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 221.95/222.16  |- mesh__dateCreated mesh__D001046 1999-01-01
% 221.95/222.16  |- mesh__recordMaintainer mesh__D001046 ssb
% 221.95/222.16  |- skos__broader mesh__D001046smesh__D000697
% 221.95/222.16  |- skos__broader mesh__D014357Q000037smesh__D014357
% 221.95/222.16  |- mesh__preferredCombination mesh__D014357Q000037smesh__D014361
% 221.95/222.16  |- rdf__type mesh__D014357Q000037smesh__CompoundConcept
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D020200 2006
% 221.95/222.16  |- skos__hiddenLabel mesh__D020200 Hematoma, Chronic Subdural
% 221.95/222.16  |- skos__hiddenLabel mesh__D020200 Hematomas, Chronic Subdural
% 221.95/222.16  |- skos__scopeNote mesh__D020200
% 221.95/222.16       Chronic accumulation of blood in the subdural space, most frequently occurring over the lateral and superior aspects of a cerebral hemisphere. Clinical manifestations may be delayed for days to weeks, when affected individuals may present with confusion, drowsiness, hemiparesis, ATAXIA; APHASIA; and other signs of neurologic dysfunction. The condition tends to occur after the age of 50 years. It may be spontaneous, follow CRANIOCEREBRAL TRAUMA, or occur in association with bleeding disorders, the use of anticoagulant medication, locally invasive tumors, and other disorders. %28%From Adams et al., Principles of Neurology, 6th ed, p887%29%%A%    
% 221.95/222.16  |- skos__altLabel mesh__D020200 Subdural Hematoma, Chronic
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D020200 2005
% 221.95/222.16  |- skos__prefLabel mesh__D020200 Hematoma, Subdural, Chronic
% 221.95/222.16  |- mesh__historyNote mesh__D020200 2000   
% 221.95/222.16  |- mesh__dateCreated mesh__D020200 1999-11-03
% 221.95/222.16  |- skos__broader mesh__D020200smesh__D006408
% 221.95/222.16  |- mesh__dateRevised mesh__D020200 2005-07-08
% 221.95/222.16  |- skos__hiddenLabel mesh__D020200 Chronic Subdural Hematomas
% 221.95/222.16  |- skos__hiddenLabel mesh__D020200 Subdural Hematomas, Chronic
% 221.95/222.16  |- rdf__type mesh__D020200sskos__Concept
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D020200 2006A
% 221.95/222.16  |- skos__historyNote mesh__D020200 Hematoma, Subdural %28%1966-1999%29%
% 221.95/222.16  |- mesh__recordAuthorizer mesh__D020200 ags
% 221.95/222.16  |- skos__hiddenLabel mesh__D020200 Chronic Subdural Hematoma
% 221.95/222.16  |- mesh__recordOriginator mesh__D020200 KEV
% 221.95/222.16  |- mesh__recordMaintainer mesh__D020200 ags
% 221.95/222.16  |- mesh__dateEstablished mesh__D020200 2000-01-01
% 221.95/222.16  |- mesh__publicMeSHNote mesh__D020200 2000   
% 221.95/222.16  |- skos__altLabel mesh__D020200 Hemorrhage, Subdural, Chronic
% 221.95/222.16  |- skos__broader mesh__D006321Q000166smesh__D006321
% 221.95/222.16  |- mesh__preferredCombination mesh__D006321Q000166smesh__D009206Q000166
% 221.95/222.16  |- rdf__type mesh__D006321Q000166smesh__CompoundConcept
% 221.95/222.16  |- skos__hiddenLabel mesh__D019457 Chromosome Break
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D019457 2006A
% 221.95/222.16  |- skos__historyNote mesh__D019457 Chromosome Aberrations %28%1967-1996%29%
% 221.95/222.16  |- skos__hiddenLabel mesh__D019457 Breaks, Chromosome
% 221.95/222.16  |- skos__broader mesh__D019457smesh__D002869
% 221.95/222.16  |- skos__hiddenLabel mesh__D019457 Breakages, Chromosomal
% 221.95/222.16  |- skos__hiddenLabel mesh__D019457 Chromosomal Break
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D019457 2005
% 221.95/222.16  |- skos__hiddenLabel mesh__D019457 Break, Chromosome
% 221.95/222.16  |- skos__altLabel mesh__D019457 Chromosomal Breakage
% 221.95/222.16  |- mesh__recordAuthorizer mesh__D019457 ags
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D019457 2006B
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D019457 2006
% 221.95/222.16  |- mesh__recordMaintainer mesh__D019457 ags
% 221.95/222.16  |- mesh__publicMeSHNote mesh__D019457 97   
% 221.95/222.16  |- skos__hiddenLabel mesh__D019457 Breakage, Chromosomal
% 221.95/222.16  |- skos__hiddenLabel mesh__D019457 Breakage, Chromosome
% 221.95/222.16  |- skos__broader mesh__D019457smesh__D004249
% 221.95/222.16  |- skos__scopeNote mesh__D019457
% 221.95/222.16       A type of chromosomal aberration which may result from spontaneous or induced breakage. ALKYLATING AGENTS and other chemical MUTAGENS, and various types of RADIATION have been found to cause chromosomal breakage. Breakage can result in translocation; CHROMOSOME INVERSION; or SEQUENCE DELETION.%A%    
% 221.95/222.16  |- skos__hiddenLabel mesh__D019457 Chromosomal Breakages
% 221.95/222.16  |- mesh__dateEstablished mesh__D019457 1997-01-01
% 221.95/222.16  |- mesh__dateCreated mesh__D019457 1996-06-13
% 221.95/222.16  |- skos__hiddenLabel mesh__D019457 Chromosome Breakages
% 221.95/222.16  |- mesh__historyNote mesh__D019457 97   
% 221.95/222.16  |- skos__historyNote mesh__D019457
% 221.95/222.16       Chromosome Abnormalities %28%1966-1996%29%
% 221.95/222.16  |- rdf__type mesh__D019457sskos__Concept
% 221.95/222.16  |- mesh__recordOriginator mesh__D019457 ADP
% 221.95/222.16  |- skos__hiddenLabel mesh__D019457 Breakages, Chromosome
% 221.95/222.16  |- skos__hiddenLabel mesh__D019457 Breaks, Chromosomal
% 221.95/222.16  |- mesh__dateRevised mesh__D019457 2005-08-02
% 221.95/222.16  |- skos__altLabel mesh__D019457 Chromosomal Breaks
% 221.95/222.16  |- skos__prefLabel mesh__D019457 Chromosome Breakage
% 221.95/222.16  |- skos__hiddenLabel mesh__D019457 Break, Chromosomal
% 221.95/222.16  |- skos__prefLabel mesh__D011474 Prosthesis Design
% 221.95/222.16  |- skos__scopeNote mesh__D011474
% 221.95/222.16       The plan and delineation of prostheses in general or a specific prosthesis.%A%    
% 221.95/222.16  |- skos__hiddenLabel mesh__D011474 Designs, Prosthesis
% 221.95/222.16  |- skos__historyNote mesh__D011474 specific prosthesis %28%1966-1970%29%
% 221.95/222.16  |- mesh__dateEstablished mesh__D011474 1974-01-01
% 221.95/222.16  |- skos__hiddenLabel mesh__D011474 Design, Prosthesis
% 221.95/222.16  |- skos__hiddenLabel mesh__D011474 Prosthesis Designs
% 221.95/222.16  |- skos__related mesh__D011474smesh__D003779
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D011474 2003
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D011474 1998
% 221.95/222.16  |- rdf__type mesh__D011474sskos__Concept
% 221.95/222.16  |- mesh__recordAuthorizer mesh__D011474 SJN
% 221.95/222.16  |- skos__annotation mesh__D011474
% 221.95/222.16       NIM; coord with specific prosth %28%IM%29% or specific techn /instrum %28%IM%29%%A%  
% 221.95/222.16  |- mesh__recordMaintainer mesh__D011474 PXP
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D011474 2004
% 221.95/222.16  |- mesh__historyNote mesh__D011474 74%28%71%29%   
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D011474 1999
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D011474 2000
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D011474 2005
% 221.95/222.16  |- mesh__dateRevised mesh__D011474 1997-06-20
% 221.95/222.16  |- mesh__recordOriginator mesh__D011474 NLM
% 221.95/222.16  |- mesh__dateCreated mesh__D011474 1999-01-01
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D011474 2001
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D011474 2006
% 221.95/222.16  |- mesh__publicMeSHNote mesh__D011474 74   
% 221.95/222.16  |- skos__broader mesh__D011474smesh__D004867
% 221.95/222.16  |- skos__historyNote mesh__D011474 Prosthesis %28%1966-1970%29%
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D011474 2002
% 221.95/222.16  |- skos__altLabel mesh__D005437 CSP Brand of Flucytosine
% 221.95/222.16  |- mesh__recordAuthorizer mesh__D005437 sjn
% 221.95/222.16  |- mesh__dateRevised mesh__D005437 2005-06-30
% 221.95/222.16  |- skos__altLabel mesh__D005437 Dermatech Brand of Flucytosine
% 221.95/222.16  |- rdf__type mesh__D005437sskos__Concept
% 221.95/222.16  |- skos__altLabel mesh__D005437 Alcobon
% 221.95/222.16  |- skos__historyNote mesh__D005437 Cytosine %28%1966-1971%29%
% 221.95/222.16  |- skos__scopeNote mesh__D005437
% 221.95/222.16       A fluorinated cytosine analog that is used as an antifungal agent.%A%    
% 221.95/222.16  |- mesh__dateCreated mesh__D005437 1999-01-01
% 221.95/222.16  |- mesh__historyNote mesh__D005437
% 221.95/222.16       87%28%72%29%; was see under CYTOSINE 1972-86   
% 221.95/222.16  |- mesh__publicMeSHNote mesh__D005437 87; was see under CYTOSINE 1972-86   
% 221.95/222.16  |- skos__altLabel mesh__D005437 5-Fluorocytosine
% 221.95/222.16  |- mesh__recordMaintainer mesh__D005437 CCR
% 221.95/222.16  |- skos__altLabel mesh__D005437 Ancotil
% 221.95/222.16  |- skos__historyNote mesh__D005437 Antifungal Agents %28%1966-1971%29%
% 221.95/222.16  |- mesh__recordOriginator mesh__D005437 NLM
% 221.95/222.16  |- skos__altLabel mesh__D005437 ICN Pharmaceuticals Brand of Flucytosine
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D005437 2006
% 221.95/222.16  |- skos__altLabel mesh__D005437 Allphar Brand of Flucytosine
% 221.95/222.16  |- skos__prefLabel mesh__D005437 Flucytosine
% 221.95/222.16  |- skos__altLabel mesh__D005437 Roche Brand of Flucytosine
% 221.95/222.16  |- mesh__dateEstablished mesh__D005437 1987-01-01
% 221.95/222.16  |- skos__broader mesh__D005437smesh__D003596
% 221.95/222.16  |- mesh__recordAuthorizer mesh__D029885 sjn
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D029885 2005
% 221.95/222.16  |- skos__prefLabel mesh__D029885 Lotus
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D029885 2006
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D029885 2003
% 221.95/222.16  |- mesh__dateRevised mesh__D029885 2002-07-03
% 221.95/222.16  |- mesh__recordOriginator mesh__D029885 ssb
% 221.95/222.16  |- mesh__publicMeSHNote mesh__D029885 2002   
% 221.95/222.16  |- skos__broader mesh__D029885smesh__D007887
% 221.95/222.16  |- mesh__dateEstablished mesh__D029885 2002-01-01
% 221.95/222.16  |- rdf__type mesh__D029885sskos__Concept
% 221.95/222.16  |- skos__altLabel mesh__D029885 Tetragonolobus
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D029885 2004
% 221.95/222.16  |- skos__scopeNote mesh__D029885
% 221.95/222.16       A plant genus of the family FABACEAE. This genus was formerly known as Tetragonolobus. The common name of lotus is also used for NYMPHAEA and NELUMBO.%A%    
% 221.95/222.16  |- mesh__historyNote mesh__D029885 2002   
% 221.95/222.16  |- skos__annotation mesh__D029885
% 221.95/222.16       NYMPHAEA LOTUS is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 221.95/222.16  |- mesh__dateCreated mesh__D029885 2001-07-25
% 221.95/222.16  |- mesh__recordMaintainer mesh__D029885 ssb
% 221.95/222.16  |- mesh__publicMeSHNote mesh__D015865 90   
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D015865 2003
% 221.95/222.16  |- skos__altLabel mesh__D015865 Racketball
% 221.95/222.16  |- skos__annotation mesh__D015865
% 221.95/222.16       /inj: coord IM with specific injury %28%IM%29%; Manual 30.15.1; do not confuse X ref SQUASH %28%SPORT%29% with SQUASH PLANT see CUCURBITA%A%  
% 221.95/222.16  |- rdf__type mesh__D015865sskos__Concept
% 221.95/222.16  |- mesh__dateEstablished mesh__D015865 1990-01-01
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D015865 2004
% 221.95/222.16  |- skos__hiddenLabel mesh__D015865 Sports, Racquet
% 221.95/222.16  |- skos__hiddenLabel mesh__D015865 Racquet Sport
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D015865 2002
% 221.95/222.16  |- skos__hiddenLabel mesh__D015865 Sports, Racket
% 221.95/222.16  |- mesh__dateRevised mesh__D015865 2001-07-25
% 221.95/222.16  |- mesh__recordAuthorizer mesh__D015865 sjn
% 221.95/222.16  |- skos__hiddenLabel mesh__D015865 Racket Sport
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D015865 2005
% 221.95/222.16  |- skos__prefLabel mesh__D015865 Racquet Sports
% 221.95/222.16  |- mesh__recordMaintainer mesh__D015865 ssb
% 221.95/222.16  |- skos__historyNote mesh__D015865 Tennis %28%1978-1989%29%
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D015865 2006
% 221.95/222.16  |- skos__hiddenLabel mesh__D015865 Sport, Racquet
% 221.95/222.16  |- skos__hiddenLabel mesh__D015865 Sport, Racket
% 221.95/222.16  |- skos__altLabel mesh__D015865 Racket Sports
% 221.95/222.16  |- skos__scopeNote mesh__D015865
% 221.95/222.16       Games in which players use a racquet to hit a ball or similar type object.%A%    
% 221.95/222.16  |- skos__hiddenLabel mesh__D015865 Ball, Racket
% 221.95/222.16  |- skos__broader mesh__D015865smesh__D013177
% 221.95/222.16  |- mesh__recordOriginator mesh__D015865 PXP
% 221.95/222.16  |- mesh__dateCreated mesh__D015865 1989-05-25
% 221.95/222.16  |- skos__historyNote mesh__D015865 Sports %28%1977-1989%29%
% 221.95/222.16  |- skos__altLabel mesh__D015865 Racket Ball
% 221.95/222.16  |- mesh__historyNote mesh__D015865 90   
% 221.95/222.16  |- skos__broader mesh__D015067smesh__D006913
% 221.95/222.16  |- mesh__publicMeSHNote mesh__D015067
% 221.95/222.16       78; TESTOSTERONE DEHYDROGENASES was heading 1978-93 %28%see under 17-HYDROXYSTEROID DEHYDROGENASES 1978-90%29%%A%  
% 221.95/222.16  |- mesh__recordOriginator mesh__D015067 RLS
% 221.95/222.16  |- skos__hiddenLabel mesh__D015067 Reductases, 17-Ketosteroid
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D015067 2006
% 221.95/222.16  |- skos__hiddenLabel mesh__D015067 Dehydrogenases, 17 beta-Hydroxysteroid
% 221.95/222.16  |- skos__altLabel mesh__D015067 17-Ketosteroid Reductases
% 221.95/222.16  |- skos__hiddenLabel mesh__D015067 17 Ketosteroid Reductases
% 221.95/222.16  |- mesh__dateEstablished mesh__D015067 1978-01-01
% 221.95/222.16  |- skos__historyNote mesh__D015067
% 221.95/222.16       Hydroxysteroid Dehydrogenases %28%1966-1977%29%
% 221.95/222.16  |- mesh__historyNote mesh__D015067
% 221.95/222.16       78; TESTOSTERONE DEHYDROGENASES was heading 1978-93 %28%see under 17-HYDROXYSTEROID DEHYDROGENASES 1978-90%29%%A%  
% 221.95/222.16  |- skos__hiddenLabel mesh__D015067 Dehydrogenases, 17-Hydroxysteroid
% 221.95/222.16  |- rdf__type mesh__D015067sskos__Concept
% 221.95/222.16  |- skos__hiddenLabel mesh__D015067 17 beta Hydroxysteroid Dehydrogenases
% 221.95/222.16  |- mesh__recordAuthorizer mesh__D015067 sjn
% 221.95/222.16  |- mesh__dateRevised mesh__D015067 2003-07-09
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D015067 2004
% 221.95/222.16  |- skos__hiddenLabel mesh__D015067 Dehydrogenases, Testosterone
% 221.95/222.16  |- mesh__onlineNote mesh__D015067
% 221.95/222.16       use 17-HYDROXYSTEROID DEHYDROGENASES to search TESTOSTERONE DEHYDROGENASES 1978-93%A%  
% 221.95/222.16  |- skos__scopeNote mesh__D015067
% 221.95/222.16       A class of enzymes that catalyzes the oxidation of 17-hydroxysteroids to 17-ketosteroids. EC 1.1.-.%A%    
% 221.95/222.16  |- skos__hiddenLabel mesh__D015067 17 Hydroxysteroid Dehydrogenases
% 221.95/222.16  |- skos__prefLabel mesh__D015067 17-Hydroxysteroid Dehydrogenases
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D015067 2005
% 221.95/222.16  |- mesh__recordMaintainer mesh__D015067 ssb
% 221.95/222.16  |- mesh__dateCreated mesh__D015067 1977-04-15
% 221.95/222.16  |- mesh__recordOriginator mesh__D009828 NLM
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D009828 2004
% 221.95/222.16  |- mesh__dateRevised mesh__D009828 2000-06-21
% 221.95/222.16  |- skos__historyNote mesh__D009828 Carboxylic Acids %28%1974%29%
% 221.95/222.16  |- mesh__historyNote mesh__D009828
% 221.95/222.16       91%28%75%29%; was see under SAPOGENINS 1979-90; was see under TRITERPENES 1975-78%A%  
% 221.95/222.16  |- skos__broader mesh__D009828smesh__D012502
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D009828 2003
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D009828 2006
% 221.95/222.16  |- skos__prefLabel mesh__D009828 Oleanolic Acid
% 221.95/222.16  |- rdf__type mesh__D009828sskos__Concept
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D009828 2005
% 221.95/222.16  |- skos__scopeNote mesh__D009828
% 221.95/222.16       Occurs in leaves of Olea europaea, Viscum album L., and other higher plants. It is also the aglycone component of many saponins.%A%    
% 221.95/222.16  |- mesh__dateCreated mesh__D009828 1974-11-19
% 221.95/222.16  |- mesh__recordMaintainer mesh__D009828 CCR
% 221.95/222.16  |- skos__historyNote mesh__D009828 Triterpenes %28%1974%29%
% 221.95/222.16  |- mesh__publicMeSHNote mesh__D009828
% 221.95/222.16       91; was see under SAPOGENINS 1979-90; was see under TRITERPENES 1975-78%A%  
% 221.95/222.16  |- skos__altLabel mesh__D009828 Oleanol
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D009828 2002
% 221.95/222.16  |- mesh__dateEstablished mesh__D009828 1991-01-01
% 221.95/222.16  |- skos__hiddenLabel mesh__D009828 Acid, Oleanolic
% 221.95/222.16  |- mesh__activeMeSHYear mesh__D009828 2001
% 221.95/222.16  |- mesh__recordAuthorizer mesh__D009828 sjn
% 221.95/222.16  |- mesh__dateRevised mesh__D001845 1999-11-08
% 221.95/222.16  |- skos__altLabel mesh__D001845 Solitary Cysts
% 221.95/222.16  |- skos__hiddenLabel mesh__D001845 Subchondral Cyst
% 221.95/222.16  |- skos__hiddenLabel mesh__D001845 Cyst, Solitary
% 221.95/222.16  |- skos__altLabel mesh__D001845 Ganglia, Intra-Osseous
% 221.95/222.16  |- skos__hiddenLabel mesh__D001845 Ganglion, Intra Osseous
% 221.95/222.16  |- skos__annotation mesh__D001845 coord IM with specific bone %28%IM%29%   
% 221.95/222.16  |- skos__broader mesh__D001845smesh__D001847
% 221.95/222.16  |- skos__hiddenLabel mesh__D001845 Intraosseous Ganglia
% 221.95/222.16  |- skos__hiddenLabel mesh__D001845 Intra-Osseous Ganglias
% 221.95/222.17  |- skos__altLabel mesh__D001845 Intra-Osseous Ganglia
% 221.95/222.17  |- skos__hiddenLabel mesh__D001845 Cyst, Subchondral
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D001845 2002
% 221.95/222.17  |- mesh__recordMaintainer mesh__D001845 KEV
% 221.95/222.17  |- mesh__publicMeSHNote mesh__D001845 80; was BONE CYST 1963-79   
% 221.95/222.17  |- skos__altLabel mesh__D001845 Intra-Osseous Ganglion
% 221.95/222.17  |- skos__hiddenLabel mesh__D001845 Solitary Cyst
% 221.95/222.17  |- skos__hiddenLabel mesh__D001845 Intra Osseous Ganglia
% 221.95/222.17  |- mesh__onlineNote mesh__D001845
% 221.95/222.17       use BONE CYSTS to search BONE CYST 1966-79   
% 221.95/222.17  |- skos__hiddenLabel mesh__D001845 Cysts, Bone
% 221.95/222.17  |- skos__altLabel mesh__D001845 Ganglion, Intra-Osseous
% 221.95/222.17  |- skos__prefLabel mesh__D001845 Bone Cysts
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D001845 2003
% 221.95/222.17  |- skos__hiddenLabel mesh__D001845 Cysts, Solitary
% 221.95/222.17  |- skos__hiddenLabel mesh__D001845 Ganglions, Intra-Osseous
% 221.95/222.17  |- skos__hiddenLabel mesh__D001845 Bone Cyst
% 221.95/222.17  |- skos__hiddenLabel mesh__D001845 Cyst, Bone
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D001845 2004
% 221.95/222.17  |- skos__scopeNote mesh__D001845
% 221.95/222.17       Benign unilocular lytic areas in the proximal end of a long bone with well defined and narrow endosteal margins. The cysts contain fluid and the cyst walls may contain some giant cells. Bone cysts usually occur in males between the ages 3-15 years.%A%    
% 221.95/222.17  |- skos__hiddenLabel mesh__D001845 Intra Osseous Ganglion
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D001845 2000
% 221.95/222.17  |- skos__hiddenLabel mesh__D001845 Cysts, Subchondral
% 221.95/222.17  |- rdf__type mesh__D001845sskos__Concept
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D001845 2005
% 221.95/222.17  |- mesh__historyNote mesh__D001845 80; was BONE CYST 1963-79   
% 221.95/222.17  |- skos__hiddenLabel mesh__D001845 Ganglia, Intra Osseous
% 221.95/222.17  |- skos__hiddenLabel mesh__D001845 Intraosseous Ganglias
% 221.95/222.17  |- mesh__recordAuthorizer mesh__D001845 sjn
% 221.95/222.17  |- mesh__recordOriginator mesh__D001845 NLM
% 221.95/222.17  |- skos__altLabel mesh__D001845 Ganglia, Intraosseous
% 221.95/222.17  |- skos__broader mesh__D001845smesh__D003560
% 221.95/222.17  |- skos__hiddenLabel mesh__D001845 Ganglias, Intra-Osseous
% 221.95/222.17  |- skos__hiddenLabel mesh__D001845 Intraosseous Ganglions
% 221.95/222.17  |- skos__hiddenLabel mesh__D001845 Intra-Osseous Ganglions
% 221.95/222.17  |- mesh__dateCreated mesh__D001845 1999-01-01
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D001845 2001
% 221.95/222.17  |- skos__hiddenLabel mesh__D001845 Ganglias, Intraosseous
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D001845 2006
% 221.95/222.17  |- skos__hiddenLabel mesh__D001845 Ganglion, Intraosseous
% 221.95/222.17  |- skos__altLabel mesh__D034221 Vibrio marinus
% 221.95/222.17  |- skos__scopeNote mesh__D034221
% 221.95/222.17       A genus of gram-negative, curved or straight rod-shaped bacteria, in the family ALTEROMONADACEAE. They are chemo-organotrophic, halophilic, and associated with cold marine habitats.%A%    
% 221.95/222.17  |- skos__prefLabel mesh__D034221 Moritella
% 221.95/222.17  |- skos__broader mesh__D034221smesh__D006092
% 221.95/222.17  |- skos__broader mesh__D034221smesh__D034241
% 221.95/222.17  |- rdf__type mesh__D034221sskos__Concept
% 221.95/222.17  |- mesh__recordOriginator mesh__D034221 ags
% 221.95/222.17  |- mesh__dateCreated mesh__D034221 2002-07-03
% 221.95/222.17  |- mesh__historyNote mesh__D034221 2003   
% 221.95/222.17  |- mesh__recordMaintainer mesh__D034221 SYSTEM
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D034221 2006
% 221.95/222.17  |- mesh__dateRevised mesh__D034221 2005-06-30
% 221.95/222.17  |- skos__altLabel mesh__D034221 Vibrio viscosus
% 221.95/222.17  |- mesh__dateEstablished mesh__D034221 2003-01-01
% 221.95/222.17  |- mesh__recordAuthorizer mesh__D034221 sjn
% 221.95/222.17  |- mesh__publicMeSHNote mesh__D034221 2003   
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D001047 2004
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D001047 2001
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D001047 2006
% 221.95/222.17  |- mesh__dateEstablished mesh__D001047 1965-01-01
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D001047 1998
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D001047 1999
% 221.95/222.17  |- skos__annotation mesh__D001047
% 221.95/222.17       do not use /util except by MeSH definition   
% 221.95/222.17  |- rdf__type mesh__D001047sskos__Concept
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D001047 2002
% 221.95/222.17  |- skos__broader mesh__D001047smesh__D019647
% 221.95/222.17  |- skos__scopeNote mesh__D001047
% 221.95/222.17       Excision of the apical portion of a tooth through an opening made in the overlying labial, buccal, or palatal alveolar bone. %28%Dorland, 28th ed%29%%A%    
% 221.95/222.17  |- mesh__recordOriginator mesh__D001047 NLM
% 221.95/222.17  |- mesh__dateCreated mesh__D001047 1999-01-01
% 221.95/222.17  |- skos__hiddenLabel mesh__D001047 Apicoectomies
% 221.95/222.17  |- mesh__historyNote mesh__D001047 65   
% 221.95/222.17  |- skos__prefLabel mesh__D001047 Apicoectomy
% 221.95/222.17  |- mesh__dateRevised mesh__D001047 1997-06-20
% 221.95/222.17  |- mesh__publicMeSHNote mesh__D001047 65   
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D001047 2003
% 221.95/222.17  |- mesh__recordMaintainer mesh__D001047 PXP
% 221.95/222.17  |- mesh__recordAuthorizer mesh__D001047 SJN
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D001047 2000
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D001047 2005
% 221.95/222.17  |- skos__broader mesh__D001047smesh__D004708
% 221.95/222.17  |- mesh__recordAuthorizer mesh__D006530 sjn
% 221.95/222.17  |- mesh__publicMeSHNote mesh__D006530
% 221.95/222.17       91; was see under KIDNEY DISEASES 1987-90   
% 221.95/222.17  |- skos__historyNote mesh__D006530 Kidney Diseases %28%1966-1986%29%
% 221.95/222.17  |- mesh__recordMaintainer mesh__D006530 lkt
% 221.95/222.17  |- skos__hiddenLabel mesh__D006530 Syndrome, Hepatorenal
% 221.95/222.17  |- skos__prefLabel mesh__D006530 Hepatorenal Syndrome
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D006530 2006
% 221.95/222.17  |- skos__historyNote mesh__D006530 Liver Cirrhosis %28%1966-1986%29%
% 221.95/222.17  |- skos__historyNote mesh__D006530 Syndrome %28%1972-1986%29%
% 221.95/222.17  |- skos__broader mesh__D006530smesh__D008107
% 221.95/222.17  |- mesh__dateCreated mesh__D006530 1986-04-04
% 221.95/222.17  |- skos__scopeNote mesh__D006530
% 221.95/222.17       Functional KIDNEY FAILURE in patients with liver disease, usually LIVER CIRRHOSIS or portal hypertension %28%HYPERTENSION, PORTAL%29%, and in the absence of intrinsic renal disease or kidney abnormality. It is characterized by intense renal vasculature constriction, reduced renal blood flow, OLIGURIA, and sodium retention.%A%    
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D006530 2005
% 221.95/222.17  |- skos__historyNote mesh__D006530
% 221.95/222.17       Kidney Failure, Chronic %28%1966-1986%29%
% 221.95/222.17  |- mesh__dateEstablished mesh__D006530 1991-01-01
% 221.95/222.17  |- skos__broader mesh__D006530smesh__D007674
% 221.95/222.17  |- skos__historyNote mesh__D006530 Kidney Failure, Acute %28%1967-1986%29%
% 221.95/222.17  |- mesh__historyNote mesh__D006530
% 221.95/222.17       91%28%87%29%; was see under KIDNEY DISEASES 1987-90   
% 221.95/222.17  |- mesh__recordOriginator mesh__D006530 RC
% 221.95/222.17  |- mesh__dateRevised mesh__D006530 2004-07-07
% 221.95/222.17  |- skos__historyNote mesh__D006530 Liver Diseases %28%1966-1986%29%
% 221.95/222.17  |- rdf__type mesh__D006530sskos__Concept
% 221.95/222.17  |- skos__scopeNote mesh__D020201
% 221.95/222.17       Bleeding within the brain as a result of penetrating and nonpenetrating CRANIOCEREBRAL TRAUMA. Traumatically induced hemorrhages may occur in any area of the brain, including the cerebral hemispheres, diencephalon, brain stem %28%see BRAIN STEM HEMORRHAGE, TRAUMATIC%29%, and cerebellum.%A%    
% 221.95/222.17  |- skos__hiddenLabel mesh__D020201 Traumatic Cerebellar Hemorrhages
% 221.95/222.17  |- skos__hiddenLabel mesh__D020201 Traumatic Cerebellar Hemorrhage
% 221.95/222.17  |- skos__hiddenLabel mesh__D020201 Hemorrhage, Traumatic Cerebellar
% 221.95/222.17  |- skos__broader mesh__D020201smesh__D001930
% 221.95/222.17  |- skos__hiddenLabel mesh__D020201 Hemorrhages, Traumatic Cerebellar
% 221.95/222.17  |- skos__altLabel mesh__D020201 Traumatic Brain Hemorrhage
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D020201 2002
% 221.95/222.17  |- skos__annotation mesh__D020201
% 221.95/222.17       note specifics; coord with organ/dis term or site   
% 221.95/222.17  |- rdf__type mesh__D020201sskos__Concept
% 221.95/222.17  |- mesh__publicMeSHNote mesh__D020201 2000   
% 221.95/222.17  |- skos__hiddenLabel mesh__D020201 Cerebellar Hemorrhages, Traumatic
% 221.95/222.17  |- mesh__dateCreated mesh__D020201 1999-11-03
% 221.95/222.17  |- skos__hiddenLabel mesh__D020201 Brain Hemorrhages, Traumatic
% 221.95/222.17  |- skos__hiddenLabel mesh__D020201 Hemorrhage, Traumatic Brain
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D020201 2006
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D020201 2001
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D020201 2004
% 221.95/222.17  |- mesh__dateEstablished mesh__D020201 2000-01-01
% 221.95/222.17  |- skos__broader mesh__D020201smesh__D020198
% 221.95/222.17  |- skos__hiddenLabel mesh__D020201 Traumatic Brain Hemorrhages
% 221.95/222.17  |- skos__historyNote mesh__D020201 Cerebral Hemorrhage %28%1964-1999%29%
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D020201 2005
% 221.95/222.17  |- skos__prefLabel mesh__D020201 Brain Hemorrhage, Traumatic
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D020201 2000
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D020201 2003
% 221.95/222.17  |- mesh__historyNote mesh__D020201 2000   
% 221.95/222.17  |- skos__hiddenLabel mesh__D019458 Coverage, Insurance
% 221.95/222.17  |- mesh__recordMaintainer mesh__D019458 kle
% 221.95/222.17  |- skos__prefLabel mesh__D019458 Insurance Coverage
% 221.95/222.17  |- mesh__recordOriginator mesh__D019458 JLS
% 221.95/222.17  |- skos__broader mesh__D019458smesh__D007341
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D019458 2005
% 221.95/222.17  |- skos__historyNote mesh__D019458 Insurance, Health %28%1966-1996%29%
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D019458 2002
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D019458 2006
% 221.95/222.17  |- mesh__dateRevised mesh__D019458 1999-11-03
% 221.95/222.17  |- skos__altLabel mesh__D019458 Insurance Status
% 221.95/222.17  |- skos__hiddenLabel mesh__D019458 Status, Insurance
% 221.95/222.17  |- skos__historyNote mesh__D019458 Insurance Benefits %28%1966-1996%29%
% 221.95/222.17  |- mesh__dateCreated mesh__D019458 1996-06-13
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D019458 2003
% 221.95/222.17  |- mesh__historyNote mesh__D019458 97   
% 221.95/222.17  |- rdf__type mesh__D019458sskos__Concept
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D019458 2000
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D019458 2004
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D019458 2001
% 221.95/222.17  |- mesh__publicMeSHNote mesh__D019458 97   
% 221.95/222.17  |- skos__annotation mesh__D019458
% 221.95/222.17       coord IM with specific type of insurance %28%IM%29%; not restricted to health insurance; specify geog if pertinent; UNIVERSAL COVERAGE %28%restricted to health insurance%29% is also available%A%  
% 221.95/222.17  |- mesh__recordAuthorizer mesh__D019458 sjn
% 221.95/222.17  |- mesh__dateEstablished mesh__D019458 1997-01-01
% 221.95/222.17  |- skos__scopeNote mesh__D019458
% 221.95/222.17       Generally refers to the amount of protection available and the kind of loss which would be paid for under an insurance contract with an insurer. %28%Slee %26% Slee, Health Care Terms, 2d ed%29%%A%    
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D011475 2000
% 221.95/222.17  |- skos__historyNote mesh__D011475
% 221.95/222.17       Postoperative Complications %28%1966-1985%29%
% 221.95/222.17  |- skos__related mesh__D011475smesh__D019232
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D011475 2004
% 221.95/222.17  |- mesh__recordAuthorizer mesh__D011475 sjn
% 221.95/222.17  |- skos__broader mesh__D011475smesh__D004868
% 221.95/222.17  |- skos__scopeNote mesh__D011475
% 221.95/222.17       Malfunction of implantation shunts, valves, etc., and prosthesis loosening, migration, and breaking.%A%    
% 221.95/222.17  |- mesh__publicMeSHNote mesh__D011475
% 221.95/222.17       91; was see under EQUIPMENT FAILURE 1986-90   
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D011475 2001
% 221.95/222.17  |- skos__prefLabel mesh__D011475 Prosthesis Failure
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D011475 2005
% 221.95/222.17  |- skos__historyNote mesh__D011475 Prosthesis Design %28%1971-1985%29%
% 221.95/222.17  |- mesh__dateEstablished mesh__D011475 1991-01-01
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D011475 2002
% 221.95/222.17  |- skos__annotation mesh__D011475
% 221.95/222.17       restrict to non-dent prostheses: dent prostheses of all types = DENTAL RESTORATION FAILURE %28%see MeSH definition there%29%; coord IM or NIM with specific prosthesis with no qualif %28%IM%29%%A%  
% 221.95/222.17  |- mesh__recordOriginator mesh__D011475 SH
% 221.95/222.17  |- mesh__historyNote mesh__D011475
% 221.95/222.17       91%28%86%29%; was see under EQUIPMENT FAILURE 1986-90   
% 221.95/222.17  |- skos__hiddenLabel mesh__D011475 Failures, Prosthesis
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D011475 2006
% 221.95/222.17  |- skos__hiddenLabel mesh__D011475 Prosthesis Loosenings
% 221.95/222.17  |- mesh__recordMaintainer mesh__D011475 KEV
% 221.95/222.17  |- skos__hiddenLabel mesh__D011475 Prosthesis Failures
% 221.95/222.17  |- skos__hiddenLabel mesh__D011475 Failure, Prosthesis
% 221.95/222.17  |- skos__broader mesh__D011475smesh__D011183
% 221.95/222.17  |- mesh__dateCreated mesh__D011475 1985-06-17
% 221.95/222.17  |- skos__hiddenLabel mesh__D011475 Loosening, Prosthesis
% 221.95/222.17  |- rdf__type mesh__D011475sskos__Concept
% 221.95/222.17  |- skos__hiddenLabel mesh__D011475 Loosenings, Prosthesis
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D011475 2003
% 221.95/222.17  |- mesh__dateRevised mesh__D011475 1999-11-03
% 221.95/222.17  |- skos__broader mesh__D002922Q000506smesh__D002922
% 221.95/222.17  |- mesh__preferredCombination mesh__D002922Q000506smesh__D036841
% 221.95/222.17  |- rdf__type mesh__D002922Q000506smesh__CompoundConcept
% 221.95/222.17  |- rdf__type mesh__D005438sskos__Concept
% 221.95/222.17  |- mesh__dateRevised mesh__D005438 2005-06-30
% 221.95/222.17  |- skos__broader mesh__D005438smesh__D006854
% 221.95/222.17  |- mesh__dateCreated mesh__D005438 1999-01-01
% 221.95/222.17  |- skos__hiddenLabel mesh__D005438 9 alpha Fluorohydrocortisone
% 221.95/222.17  |- skos__scopeNote mesh__D005438
% 221.95/222.17       A synthetic mineralocorticoid with anti-inflammatory activity.%A%    
% 221.95/222.17  |- skos__hiddenLabel mesh__D005438 9 Fluorocortisol
% 221.95/222.17  |- skos__hiddenLabel mesh__D005438 Astonin H
% 221.95/222.17  |- mesh__recordMaintainer mesh__D005438 CCR
% 221.95/222.17  |- mesh__recordOriginator mesh__D005438 NLM
% 221.95/222.17  |- skos__altLabel mesh__D005438 9 alpha-Fluorohydrocortisone
% 221.95/222.17  |- skos__altLabel mesh__D005438 Astonin Merck
% 221.95/222.17  |- skos__altLabel mesh__D005438 9-Fluorohydrocortisone
% 221.95/222.17  |- skos__hiddenLabel mesh__D005438 9 alpha Fluoro 17 Hydroxycorticosterone
% 221.95/222.17  |- skos__altLabel mesh__D005438 9-Fluorocortisol
% 221.95/222.17  |- skos__altLabel mesh__D005438 Astonin-H
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D005438 2006
% 221.95/222.17  |- skos__altLabel mesh__D005438 9-Fluoro-17-Hydroxycortisone
% 221.95/222.17  |- skos__altLabel mesh__D005438 9 alpha-Fluoro-17-Hydroxycorticosterone
% 221.95/222.17  |- skos__hiddenLabel mesh__D005438 9 Fluoro 17 Hydroxycortisone
% 221.95/222.17  |- skos__hiddenLabel mesh__D005438 Merck, Astonin
% 221.95/222.17  |- skos__hiddenLabel mesh__D005438 9 Fluorohydrocortisone
% 221.95/222.17  |- skos__altLabel mesh__D005438 9 alpha Fludrohydrocortisone
% 221.95/222.17  |- skos__altLabel mesh__D005438 Merck Brand of Fludrocortisone
% 221.95/222.17  |- skos__prefLabel mesh__D005438 Fludrocortisone
% 221.95/222.17  |- mesh__recordAuthorizer mesh__D005438 sjn
% 221.95/222.17  |- skos__prefLabel mesh__D016160 Retinoblastoma Protein
% 221.95/222.17  |- rdf__type mesh__D016160sskos__Concept
% 221.95/222.17  |- mesh__recordOriginator mesh__D016160 AGS
% 221.95/222.17  |- skos__annotation mesh__D016160
% 221.95/222.17       /biosyn /drug eff /physiol /ultrastruct permitted   
% 221.95/222.17  |- skos__altLabel mesh__D016160 Rb1 Gene Product
% 221.95/222.17  |- skos__altLabel mesh__D016160 Rb Gene Product
% 221.95/222.17  |- mesh__dateEstablished mesh__D016160 1991-01-01
% 221.95/222.17  |- skos__hiddenLabel mesh__D016160
% 221.95/222.17       Retinoblastoma Nuclear Phosphoprotein p105 Rb
% 221.95/222.17  |- skos__historyNote mesh__D016160 Phosphoproteins %28%1990%29%
% 221.95/222.17  |- skos__broader mesh__D016160smesh__D004268
% 221.95/222.17  |- mesh__recordAuthorizer mesh__D016160 sjn
% 221.95/222.17  |- mesh__dateRevised mesh__D016160 2005-06-30
% 221.95/222.17  |- mesh__recordMaintainer mesh__D016160 DRC
% 221.95/222.17  |- skos__broader mesh__D016160smesh__D025521
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D016160 2006
% 221.95/222.17  |- skos__scopeNote mesh__D016160
% 221.95/222.17       Product of the retinoblastoma tumor suppressor gene. It is a nuclear phosphoprotein hypothesized to normally act as an inhibitor of cell proliferation. Rb protein is absent in retinoblastoma cell lines. It also has been shown to form complexes with the adenovirus E1A protein, the SV40 T antigen, and the human papilloma virus E7 protein.%A%    
% 221.95/222.17  |- mesh__publicMeSHNote mesh__D016160 91   
% 221.95/222.17  |- skos__hiddenLabel mesh__D016160 p105 Rb Protein
% 221.95/222.17  |- skos__altLabel mesh__D016160
% 221.95/222.17       Retinoblastoma Nuclear Phosphoprotein p105-Rb
% 221.95/222.17  |- skos__altLabel mesh__D016160 Rb Protein
% 221.95/222.17  |- mesh__dateCreated mesh__D016160 1990-06-19
% 221.95/222.17  |- skos__broader mesh__D016160smesh__D009687
% 221.95/222.17  |- mesh__historyNote mesh__D016160 91   
% 221.95/222.17  |- skos__broader mesh__D016160smesh__D010750
% 221.95/222.17  |- rdf__type mesh__D002140sskos__Concept
% 221.95/222.17  |- skos__broader mesh__D002140smesh__D015206
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D002140 2001
% 221.95/222.17  |- mesh__recordOriginator mesh__D002140 NLM
% 221.95/222.17  |- mesh__recordAuthorizer mesh__D002140 SJN
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D002140 2002
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D002140 1998
% 221.95/222.17  |- mesh__dateRevised mesh__D002140 1997-06-20
% 221.95/222.17  |- skos__broader mesh__D002140smesh__D019601
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D002140 2005
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D002140 1999
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D002140 2003
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D002140 2006
% 221.95/222.17  |- mesh__recordMaintainer mesh__D002140 PXP
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D002140 2004
% 221.95/222.17  |- mesh__dateCreated mesh__D002140 1999-01-01
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D002140 2000
% 221.95/222.17  |- skos__prefLabel mesh__D002140 California
% 221.95/222.17  |- skos__annotation mesh__D002140 LOS ANGELES is also available   
% 221.95/222.17  |- mesh__recordMaintainer mesh__D015866 PLS
% 221.95/222.17  |- skos__scopeNote mesh__D015866
% 221.95/222.17       Inflammation of the choroid as well as the retina and vitreous body. Some form of visual disturbance is usually present. The most important characteristics of posterior uveitis are vitreous opacities, choroiditis, and chorioretinitis.%A%    
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015866 1992
% 221.95/222.17  |- mesh__dateEstablished mesh__D015866 1990-01-01
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015866 2001
% 221.95/222.17  |- rdf__type mesh__D015866sskos__Concept
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015866 2003
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015866 1998
% 221.95/222.17  |- skos__annotation mesh__D015866
% 221.95/222.17       inflammation of the choroid, retina %26% vitreous body; of choroid alone = CHOROIDITIS; of choroid + retina = CHORIORETINITIS; of vitreous body alone = VITREOUS BODY %28%IM%29% + EYE DISEASES %28%NIM%29%%A%  
% 221.95/222.17  |- mesh__dateRevised mesh__D015866 1990-05-29
% 221.95/222.17  |- skos__historyNote mesh__D015866 Uveitis %28%1966-1989%29%
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015866 1991
% 221.95/222.17  |- skos__hiddenLabel mesh__D015866 Posterior Uveitis
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015866 1993
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015866 2002
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015866 2004
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015866 1999
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015866 1994
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015866 2005
% 221.95/222.17  |- mesh__dateCreated mesh__D015866 1989-05-25
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015866 1995
% 221.95/222.17  |- mesh__recordOriginator mesh__D015866 EGC
% 221.95/222.17  |- mesh__recordAuthorizer mesh__D015866 NLM
% 221.95/222.17  |- skos__prefLabel mesh__D015866 Uveitis, Posterior
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015866 1996
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015866 2006
% 221.95/222.17  |- mesh__historyNote mesh__D015866 90   
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015866 2000
% 221.95/222.17  |- mesh__publicMeSHNote mesh__D015866 90   
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015866 1997
% 221.95/222.17  |- skos__broader mesh__D015866smesh__D015864
% 221.95/222.17  |- mesh__recordOriginator mesh__D015068 NLM
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015068 2002
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015068 1998
% 221.95/222.17  |- skos__scopeNote mesh__D015068
% 221.95/222.17       Steroids that contain a ketone group at position 17.     
% 221.95/222.17  |- mesh__recordMaintainer mesh__D015068 TPW
% 221.95/222.17  |- skos__broader mesh__D015068smesh__D007664
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015068 2003
% 221.95/222.17  |- rdf__type mesh__D015068sskos__Concept
% 221.95/222.17  |- skos__prefLabel mesh__D015068 17-Ketosteroids
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015068 1999
% 221.95/222.17  |- skos__annotation mesh__D015068 adrenal cortex hormones   
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015068 2004
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015068 2000
% 221.95/222.17  |- mesh__recordAuthorizer mesh__D015068 SJN
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015068 2001
% 221.95/222.17  |- mesh__dateCreated mesh__D015068 1999-01-01
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015068 2005
% 221.95/222.17  |- skos__hiddenLabel mesh__D015068 17 Ketosteroids
% 221.95/222.17  |- skos__broader mesh__D015068smesh__D000305
% 221.95/222.17  |- skos__hiddenLabel mesh__D015068 17 Oxosteroids
% 221.95/222.17  |- skos__altLabel mesh__D015068 17-Oxosteroids
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D015068 2006
% 221.95/222.17  |- mesh__dateRevised mesh__D015068 1997-06-20
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D009829 2005
% 221.95/222.17  |- mesh__dateCreated mesh__D009829 1999-01-01
% 221.95/222.17  |- mesh__historyNote mesh__D009829 75; was OLEIC ACID 1963-74   
% 221.95/222.17  |- mesh__recordAuthorizer mesh__D009829 sjn
% 221.95/222.17  |- mesh__onlineNote mesh__D009829
% 221.95/222.17       use OLEIC ACIDS to search OLEIC ACID 1966-74   
% 221.95/222.17  |- mesh__recordOriginator mesh__D009829 NLM
% 221.95/222.17  |- mesh__dateRevised mesh__D009829 2003-07-09
% 221.95/222.17  |- skos__scopeNote mesh__D009829
% 221.95/222.17       A group of fatty acids that contain 18 carbon atoms and a double bond at the omega 9 carbon.%A%    
% 221.95/222.17  |- skos__prefLabel mesh__D009829 Oleic Acids
% 221.95/222.17  |- skos__broader mesh__D009829smesh__D005229
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D009829 2004
% 221.95/222.17  |- skos__hiddenLabel mesh__D009829 Acids, Oleic
% 221.95/222.17  |- mesh__recordMaintainer mesh__D009829 ssb
% 221.95/222.17  |- mesh__publicMeSHNote mesh__D009829
% 221.95/222.17       75; was OLEIC ACID 1963-74; RICINOLEIC ACIDS was see under FATTY ACIDS, UNSATURATED 1975-87, was RICINOLEIC ACID see under FATTY ACIDS 1963-74; SODIUM RICINOLEATE was see under SCLEROSING SOLUTIONS 1963-74%A%  
% 221.95/222.17  |- skos__annotation mesh__D009829
% 221.95/222.17       do not confuse with OLEIC ACID; do not confuse X ref OCTADECENOIC ACIDS with OCTADECANOIC ACIDS see STEARIC ACIDS%A%  
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D009829 2006
% 221.95/222.17  |- rdf__type mesh__D009829sskos__Concept
% 221.95/222.17  |- skos__hiddenLabel mesh__D009829 Acids, Octadecenoic
% 221.95/222.17  |- rdf__type mesh__D001846sskos__Concept
% 221.95/222.17  |- mesh__dateEstablished mesh__D001846 1965-01-01
% 221.95/222.17  |- skos__annotation mesh__D001846 OSTEOGENESIS is also available   
% 221.95/222.17  |- mesh__dateCreated mesh__D001846 1978-06-21
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D001846 2006
% 221.95/222.17  |- mesh__recordAuthorizer mesh__D001846 sjn
% 221.95/222.17  |- skos__scopeNote mesh__D001846
% 221.95/222.17       The growth and development of bones from fetus to adult. It includes two principal mechanisms of bone growth: growth in length of long bones at the epiphyseal cartilages and growth in thickness by depositing new bone %28%OSTEOGENESIS%29% with the actions of OSTEOBLASTS and OSTEOCLASTS.%A%    
% 221.95/222.17  |- mesh__dateRevised mesh__D001846 2004-07-07
% 221.95/222.17  |- mesh__recordMaintainer mesh__D001846 lkt
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D001846 2005
% 221.95/222.17  |- skos__broader mesh__D001846smesh__D041641
% 221.95/222.17  |- mesh__publicMeSHNote mesh__D001846 65   
% 221.95/222.17  |- mesh__recordOriginator mesh__D001846 HMM
% 221.95/222.17  |- skos__prefLabel mesh__D001846 Bone Development
% 221.95/222.17  |- mesh__historyNote mesh__D001846 65   
% 221.95/222.17  |- skos__scopeNote mesh__D001048
% 221.95/222.17       An opisthobranch mollusk of the order Anaspidea. It is used frequently in studies of nervous system development because of its large identifiable neurons. Aplysiatoxin and its derivatives are not biosynthesized by Aplysia, but acquired by ingestion of Lyngbya %28%seaweed%29% species.%A%    
% 221.95/222.17  |- skos__annotation mesh__D001048
% 221.95/222.17       mollusk; /microbiol /parasitol /virol permitted   
% 221.95/222.17  |- skos__broader mesh__D001048smesh__D049851
% 221.95/222.17  |- mesh__recordAuthorizer mesh__D001048 sjn
% 221.95/222.17  |- mesh__publicMeSHNote mesh__D001048 78   
% 221.95/222.17  |- skos__prefLabel mesh__D001048 Aplysia
% 221.95/222.17  |- mesh__dateEstablished mesh__D001048 1978-01-01
% 221.95/222.17  |- mesh__historyNote mesh__D001048 78   
% 221.95/222.17  |- mesh__recordOriginator mesh__D001048 AEP
% 221.95/222.17  |- mesh__dateRevised mesh__D001048 2005-06-30
% 221.95/222.17  |- mesh__dateCreated mesh__D001048 1977-05-13
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D001048 2006
% 221.95/222.17  |- skos__historyNote mesh__D001048 Mollusca %28%1966-1977%29%
% 221.95/222.17  |- rdf__type mesh__D001048sskos__Concept
% 221.95/222.17  |- mesh__recordMaintainer mesh__D001048 ags
% 221.95/222.17  |- skos__prefLabel mesh__D006531 HEPES
% 221.95/222.17  |- skos__broader mesh__D006531smesh__D017738
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D006531 2005
% 221.95/222.17  |- mesh__dateEstablished mesh__D006531 1991-01-01
% 221.95/222.17  |- mesh__publicMeSHNote mesh__D006531
% 221.95/222.17       91; was see under PIPERAZINES 1975-90   
% 221.95/222.17  |- skos__broader mesh__D006531smesh__D010879
% 221.95/222.17  |- mesh__recordMaintainer mesh__D006531 sjn
% 221.95/222.17  |- mesh__dateCreated mesh__D006531 1974-11-19
% 221.95/222.17  |- skos__historyNote mesh__D006531 Piperazines %28%1970-1974%29%
% 221.95/222.17  |- mesh__dateRevised mesh__D006531 2003-07-25
% 221.95/222.17  |- mesh__recordOriginator mesh__D006531 NLM
% 221.95/222.17  |- skos__historyNote mesh__D006531 Alkyl Sulfonates %28%1974%29%
% 221.95/222.17  |- skos__scopeNote mesh__D006531 A dipolar ionic buffer.     
% 221.95/222.17  |- skos__annotation mesh__D006531 D25-26 qualif   
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D006531 2006
% 221.95/222.17  |- skos__hiddenLabel mesh__D006531 Monosodium Salt, HEPES
% 221.95/222.17  |- mesh__historyNote mesh__D006531
% 221.95/222.17       91%28%75%29%; was see under PIPERAZINES 1975-90   
% 221.95/222.17  |- mesh__recordAuthorizer mesh__D006531 sjn
% 221.95/222.17  |- skos__hiddenLabel mesh__D006531 Salt, HEPES Monosodium
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D006531 2004
% 221.95/222.17  |- skos__historyNote mesh__D006531 Alcohol, Ethyl %28%1971-1974%29%
% 221.95/222.17  |- skos__altLabel mesh__D006531
% 221.95/222.17       N-2-Hydroxyethylpiperazine-N%27%-2%27%-ethanesulfonic Acid
% 221.95/222.17  |- skos__hiddenLabel mesh__D006531
% 221.95/222.17       N 2 Hydroxyethylpiperazine N%27% 2%27% ethanesulfonic Acid
% 221.95/222.17  |- rdf__type mesh__D006531sskos__Concept
% 221.95/222.17  |- skos__altLabel mesh__D020202
% 221.95/222.17       Cerebral Intraparenchymal Hematoma, Traumatic
% 221.95/222.17  |- skos__scopeNote mesh__D020202
% 221.95/222.17       Bleeding into the CEREBRAL CORTEX; CORPUS CALLOSUM; BASAL GANGLIA, or subcortical white matter following CRANIOCEREBRAL TRAUMA. DIFFUSE AXONAL INJURY, cerebral edema, and INTRACRANIAL HYPERTENSION are frequently associated conditions. Relatively frequent clinical manifestations include SEIZURES; APHASIA; VISION DISORDERS; MOVEMENT DISORDERS; PARALYSIS, and COMA.%A%    
% 221.95/222.17  |- skos__prefLabel mesh__D020202 Cerebral Hemorrhage, Traumatic
% 221.95/222.17  |- mesh__dateCreated mesh__D020202 1999-11-05
% 221.95/222.17  |- skos__hiddenLabel mesh__D020202 Traumatic Intracerebral Hemorrhage
% 221.95/222.17  |- skos__annotation mesh__D020202 coord with specific site   
% 221.95/222.17  |- skos__broader mesh__D020202smesh__D002543
% 221.95/222.17  |- skos__historyNote mesh__D020202 Cerebral Hemorrhage %28%1966-1999%29%
% 221.95/222.17  |- skos__hiddenLabel mesh__D020202 Traumatic Cerebral Hematoma
% 221.95/222.17  |- skos__hiddenLabel mesh__D020202 Cerebral Hemorrhages, Traumatic
% 221.95/222.17  |- skos__hiddenLabel mesh__D020202 Cerebral Hematomas, Traumatic
% 221.95/222.17  |- skos__altLabel mesh__D020202 Intracerebral Hemorrhage, Traumatic
% 221.95/222.17  |- skos__hiddenLabel mesh__D020202 Intracerebral Hemorrhages, Traumatic
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D020202 2002
% 221.95/222.17  |- skos__hiddenLabel mesh__D020202 Hemorrhage, Traumatic Intracerebral
% 221.95/222.17  |- skos__hiddenLabel mesh__D020202 Hemorrhage, Traumatic Cerebral
% 221.95/222.17  |- mesh__activeMeSHYear mesh__D020202 2003
% 221.95/222.17  |- skos__historyNote mesh__D020202 Brain Concussion %28%1966-1999%29%
% 221.95/222.17  |- skos__hiddenLabel mesh__D020202 Traumatic Cerebral Hematomas
% 221.95/222.17  |- skos__altLabel mesh__D020202
% 221.95/222.17       Cerebral Intraparenchymal Hemorrhage, Traumatic
% 221.95/222.18  |- skos__hiddenLabel mesh__D020202 Hematoma, Traumatic Cerebral
% 221.95/222.18  |- skos__broader mesh__D020202smesh__D020201
% 221.95/222.18  |- skos__hiddenLabel mesh__D020202 Traumatic Cerebral Hemorrhages
% 221.95/222.18  |- skos__historyNote mesh__D020202 Brain Injuries %28%1966-1999%29%
% 221.95/222.18  |- skos__hiddenLabel mesh__D020202 Traumatic Intracerebral Hemorrhages
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D020202 2004
% 221.95/222.18  |- skos__hiddenLabel mesh__D020202 Hemorrhages, Traumatic Cerebral
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D020202 2005
% 221.95/222.18  |- rdf__type mesh__D020202sskos__Concept
% 221.95/222.18  |- skos__hiddenLabel mesh__D020202 Traumatic Cerebral Hemorrhage
% 221.95/222.18  |- mesh__historyNote mesh__D020202 2000   
% 221.95/222.18  |- skos__hiddenLabel mesh__D020202 Hemorrhages, Traumatic Intracerebral
% 221.95/222.18  |- mesh__dateEstablished mesh__D020202 2000-01-01
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D020202 2000
% 221.95/222.18  |- skos__hiddenLabel mesh__D020202 Hematomas, Traumatic Cerebral
% 221.95/222.18  |- mesh__publicMeSHNote mesh__D020202 2000   
% 221.95/222.18  |- skos__altLabel mesh__D020202 Traumatic Cerebral Parenchymal Hemorrhage
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D020202 2006
% 221.95/222.18  |- skos__altLabel mesh__D020202 Brain Hemorrhage, Cerebral, Traumatic
% 221.95/222.18  |- skos__altLabel mesh__D020202
% 221.95/222.18       Traumatic Cerebral Intraparenchymal Hemorrhage
% 221.95/222.18  |- skos__altLabel mesh__D020202
% 221.95/222.18       Traumatic Cerebral Intraparenchymal Hematoma
% 221.95/222.18  |- skos__altLabel mesh__D020202 Cerebral Parenchymal Hemorrhage, Traumatic
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D020202 2001
% 221.95/222.18  |- mesh__dateEstablished mesh__D019459 1997-01-01
% 221.95/222.18  |- skos__prefLabel mesh__D019459 Urothelium
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D019459 2003
% 221.95/222.18  |- mesh__publicMeSHNote mesh__D019459 97   
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D019459 2001
% 221.95/222.18  |- mesh__historyNote mesh__D019459 97   
% 221.95/222.18  |- skos__broader mesh__D019459smesh__D004848
% 221.95/222.18  |- rdf__type mesh__D019459sskos__Concept
% 221.95/222.18  |- mesh__recordAuthorizer mesh__D019459 sjn
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D019459 2004
% 221.95/222.18  |- skos__historyNote mesh__D019459 Epithelium %28%1967-1996%29%
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D019459 2002
% 221.95/222.18  |- mesh__dateRevised mesh__D019459 1999-11-03
% 221.95/222.18  |- skos__annotation mesh__D019459
% 221.95/222.18       IM GEN only; coord NIM with specific urinary organ %28%IM%29% but not URINARY TRACT%A%  
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D019459 2005
% 221.95/222.18  |- skos__scopeNote mesh__D019459
% 221.95/222.18       The epithelial lining of the URINARY TRACT.     
% 221.95/222.18  |- mesh__recordMaintainer mesh__D019459 KEV
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D019459 2006
% 221.95/222.18  |- mesh__recordOriginator mesh__D019459 TGC
% 221.95/222.18  |- mesh__dateCreated mesh__D019459 1996-06-10
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D019459 2000
% 221.95/222.18  |- skos__broader mesh__D011476smesh__D003813
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D011476 2005
% 221.95/222.18  |- mesh__dateEstablished mesh__D011476 1965-01-01
% 221.95/222.18  |- mesh__historyNote mesh__D011476 65   
% 221.95/222.18  |- skos__hiddenLabel mesh__D011476 Prosthodontic
% 221.95/222.18  |- mesh__dateCreated mesh__D011476 1999-01-01
% 221.95/222.18  |- skos__scopeNote mesh__D011476
% 221.95/222.18       A dental specialty concerned with the restoration and maintenance of oral function by the replacement of missing teeth and structures by artificial devices or prostheses.%A%    
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D011476 2006
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D011476 2000
% 221.95/222.18  |- mesh__dateRevised mesh__D011476 1997-06-20
% 221.95/222.18  |- skos__broader mesh__D011476smesh__D013039
% 221.95/222.18  |- mesh__recordOriginator mesh__D011476 NLM
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D011476 2001
% 221.95/222.18  |- skos__related mesh__D011476smesh__D013516
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D011476 2002
% 221.95/222.18  |- rdf__type mesh__D011476sskos__Concept
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D011476 2003
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D011476 1998
% 221.95/222.18  |- skos__prefLabel mesh__D011476 Prosthodontics
% 221.95/222.18  |- skos__annotation mesh__D011476 SPEC: SPEC qualif   
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D011476 2004
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D011476 1999
% 221.95/222.18  |- mesh__publicMeSHNote mesh__D011476 65   
% 221.95/222.18  |- mesh__recordAuthorizer mesh__D011476 SJN
% 221.95/222.18  |- mesh__recordMaintainer mesh__D011476 PXP
% 221.95/222.18  |- rdf__type mesh__D005439sskos__Concept
% 221.95/222.18  |- mesh__recordAuthorizer mesh__D005439 sjn
% 221.95/222.18  |- mesh__publicMeSHNote mesh__D005439 73   
% 221.95/222.18  |- skos__hiddenLabel mesh__D005439 Acid, Flufenamic
% 221.95/222.18  |- skos__altLabel mesh__D005439 Sankyo Brand of Flufenamic Acid
% 221.95/222.18  |- mesh__historyNote mesh__D005439 73%28%65%29%   
% 221.95/222.18  |- skos__broader mesh__D005439smesh__D000879
% 221.95/222.18  |- mesh__dateRevised mesh__D005439 2005-06-30
% 221.95/222.18  |- skos__scopeNote mesh__D005439
% 221.95/222.18       An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p16%29%%A%    
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D005439 2006
% 221.95/222.18  |- mesh__recordOriginator mesh__D005439 NLM
% 221.95/222.18  |- mesh__dateEstablished mesh__D005439 1973-01-01
% 221.95/222.18  |- skos__prefLabel mesh__D005439 Flufenamic Acid
% 221.95/222.18  |- mesh__dateCreated mesh__D005439 1999-01-01
% 221.95/222.18  |- mesh__recordMaintainer mesh__D005439 CCR
% 221.95/222.18  |- skos__hiddenLabel mesh__D016161 Gene, Rb
% 221.95/222.18  |- skos__hiddenLabel mesh__D016161 Retinoblastoma Gene
% 221.95/222.18  |- skos__broader mesh__D016161smesh__D016147
% 221.95/222.18  |- mesh__dateEstablished mesh__D016161 1991-01-01
% 221.95/222.18  |- skos__hiddenLabel mesh__D016161 Rb Gene
% 221.95/222.18  |- skos__hiddenLabel mesh__D016161 Gene, Retinoblastoma
% 221.95/222.18  |- mesh__recordOriginator mesh__D016161 AGS
% 221.95/222.18  |- skos__historyNote mesh__D016161
% 221.95/222.18       Retinoblastoma/genetics %28%1972-1990%29%
% 221.95/222.18  |- skos__altLabel mesh__D016161 Retinoblastoma Genes
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D016161 2006
% 221.95/222.18  |- mesh__dateCreated mesh__D016161 1990-05-07
% 221.95/222.18  |- skos__scopeNote mesh__D016161
% 221.95/222.18       Tumor suppressor genes located on human chromosome 13 in the region 13q14 and coding for a family of phosphoproteins with molecular weights ranging from 104 kDa to 115 kDa. One copy of the wild-type Rb gene is necessary for normal retinal development. Loss or inactivation of both alleles at this locus results in retinoblastoma.%A%    
% 221.95/222.18  |- mesh__recordMaintainer mesh__D016161 nns
% 221.95/222.18  |- mesh__historyNote mesh__D016161 91   
% 221.95/222.18  |- skos__altLabel mesh__D016161 Genes, Rb
% 221.95/222.18  |- mesh__recordAuthorizer mesh__D016161 sjn
% 221.95/222.18  |- skos__prefLabel mesh__D016161 Genes, Retinoblastoma
% 221.95/222.18  |- skos__altLabel mesh__D016161 Rb Genes
% 221.95/222.18  |- rdf__type mesh__D016161sskos__Concept
% 221.95/222.18  |- mesh__dateRevised mesh__D016161 2005-06-30
% 221.95/222.18  |- mesh__publicMeSHNote mesh__D016161 91   
% 221.95/222.18  |- mesh__dateCreated mesh__D002141 1974-11-11
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D002141 2006
% 221.95/222.18  |- mesh__historyNote mesh__D002141 2002 %28%1977%29%   
% 221.95/222.18  |- mesh__publicMeSHNote mesh__D002141
% 221.95/222.18       2002: see CALIFORNIA GROUP VIRUSES 1991-2001, see BUNYAVIRIDAE 1981-1990, see ENCEPHALITIS VIRUSES 1977-1980; for CALIFORNIA VIRUS see ARBOVIRUSES 1975-1976%A%  
% 221.95/222.18  |- mesh__recordAuthorizer mesh__D002141 sjn
% 221.95/222.18  |- mesh__dateRevised mesh__D002141 2004-07-07
% 221.95/222.18  |- skos__altLabel mesh__D002141 California encephalitis virus
% 221.95/222.18  |- mesh__recordOriginator mesh__D002141 NLM
% 221.95/222.18  |- mesh__dateEstablished mesh__D002141 1991-01-01
% 221.95/222.18  |- skos__annotation mesh__D002141 infection = ENCEPHALITIS, CALIFORNIA   
% 221.95/222.18  |- rdf__type mesh__D002141sskos__Concept
% 221.95/222.18  |- skos__scopeNote mesh__D002141
% 221.95/222.18       A species in the ORTHOBUNYAVIRUS genus of the family BUNYAVIRIDAE. Serotypes are found in temperate and arctic regions and each is closely associated with a single species of vector mosquito. The vertebrate hosts are usually small mammals but several serotypes infect humans.%A%    
% 221.95/222.18  |- skos__altLabel mesh__D002141 California Encephalitis Viruses
% 221.95/222.18  |- skos__broader mesh__D002141smesh__D016851
% 221.95/222.18  |- skos__prefLabel mesh__D002141 Encephalitis Virus, California
% 221.95/222.18  |- skos__altLabel mesh__D002141 Encephalitis Viruses, California
% 221.95/222.18  |- skos__broader mesh__D002141smesh__D004668
% 221.95/222.18  |- mesh__recordMaintainer mesh__D002141 ags
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D002141 2005
% 221.95/222.18  |- skos__altLabel mesh__D002141 California Virus
% 221.95/222.18  |- skos__hiddenLabel mesh__D015867 Chronic Cyclitis
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D015867 2000
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D015867 1993
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D015867 2004
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D015867 1999
% 221.95/222.18  |- mesh__recordMaintainer mesh__D015867 PLS
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D015867 1994
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D015867 2001
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D015867 2005
% 221.95/222.18  |- skos__altLabel mesh__D015867 Cyclitis, Chronic
% 221.95/222.18  |- mesh__dateCreated mesh__D015867 1989-05-25
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D015867 1991
% 221.95/222.18  |- mesh__recordOriginator mesh__D015867 EGC
% 221.95/222.18  |- mesh__recordAuthorizer mesh__D015867 NLM
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D015867 1995
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D015867 1996
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D015867 2002
% 221.95/222.18  |- skos__scopeNote mesh__D015867
% 221.95/222.18       Inflammation of the pars plana, ciliary body, and adjacent structures.%A%    
% 221.95/222.18  |- skos__broader mesh__D015867smesh__D014605
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D015867 2006
% 221.95/222.18  |- skos__annotation mesh__D015867
% 221.95/222.18       inflammation of pars plana, ciliary body %26% adjacent structures; of pars plana alone = PARS PLANITIS; of ciliary body alone = CILIARY BODY %28%IM%29% + UVEITIS, ANTERIOR %28%IM%29%%A%  
% 221.95/222.18  |- mesh__publicMeSHNote mesh__D015867 90   
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D015867 1997
% 221.95/222.18  |- skos__hiddenLabel mesh__D015867 Intermediate Uveitis
% 221.95/222.18  |- skos__historyNote mesh__D015867 Uveitis %28%1971-1989%29%
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D015867 1992
% 221.95/222.18  |- mesh__dateEstablished mesh__D015867 1990-01-01
% 221.95/222.18  |- rdf__type mesh__D015867sskos__Concept
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D015867 2003
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D015867 1998
% 221.95/222.18  |- mesh__dateRevised mesh__D015867 1990-05-29
% 221.95/222.18  |- skos__prefLabel mesh__D015867 Uveitis, Intermediate
% 221.95/222.18  |- mesh__historyNote mesh__D015867 90   
% 221.95/222.18  |- skos__prefLabel mesh__D015069 18-Hydroxycorticosterone
% 221.95/222.18  |- mesh__recordMaintainer mesh__D015069 ssb
% 221.95/222.18  |- mesh__recordAuthorizer mesh__D015069 sjn
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D015069 2006
% 221.95/222.18  |- skos__broader mesh__D015069smesh__D003345
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D015069 2005
% 221.95/222.18  |- mesh__dateRevised mesh__D015069 2003-07-09
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D015069 2004
% 221.95/222.18  |- mesh__recordOriginator mesh__D015069 NLM
% 221.95/222.18  |- mesh__historyNote mesh__D015069
% 221.95/222.18       91%28%75%29%; was see under CORTICOSTERONE 1975-90   
% 221.95/222.18  |- mesh__publicMeSHNote mesh__D015069
% 221.95/222.18       91; was see under CORTICOSTERONE 1975-90   
% 221.95/222.18  |- skos__hiddenLabel mesh__D015069 18 Hydrocorticosterone
% 221.95/222.18  |- rdf__type mesh__D015069sskos__Concept
% 221.95/222.18  |- skos__historyNote mesh__D015069 Hydrocortisone %28%1973-1974%29%
% 221.95/222.18  |- skos__hiddenLabel mesh__D015069 Hydroxycorticosterone, 18
% 221.95/222.18  |- skos__altLabel mesh__D015069 18 Hydroxycorticosterone
% 221.95/222.18  |- skos__broader mesh__D015069smesh__D015062
% 221.95/222.18  |- mesh__dateEstablished mesh__D015069 1991-01-01
% 221.95/222.18  |- mesh__dateCreated mesh__D015069 1974-11-19
% 221.95/222.18  |- skos__altLabel mesh__D015069 18-Hydrocorticosterone
% 221.95/222.18  |- skos__scopeNote mesh__D015069
% 221.95/222.18       11 beta,18,21-Trihydroxypregn-4-ene-3,20-dione.     
% 221.95/222.18  |- skos__annotation mesh__D001847 inflammatory disease = OSTEITIS   
% 221.95/222.18  |- skos__hiddenLabel mesh__D001847 Disease, Bone
% 221.95/222.18  |- skos__broader mesh__D001847smesh__D009140
% 221.95/222.18  |- skos__hiddenLabel mesh__D001847 Diseases, Bone
% 221.95/222.18  |- mesh__dateRevised mesh__D001847 2005-06-30
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D001847 2006
% 221.95/222.18  |- skos__scopeNote mesh__D001847 Diseases of BONES.     
% 221.95/222.18  |- mesh__recordOriginator mesh__D001847 NLM
% 221.95/222.18  |- mesh__recordMaintainer mesh__D001847 ssb
% 221.95/222.18  |- skos__related mesh__D001847smesh__D050723
% 221.95/222.18  |- mesh__dateCreated mesh__D001847 1999-01-01
% 221.95/222.18  |- skos__hiddenLabel mesh__D001847 Bone Disease
% 221.95/222.18  |- mesh__recordAuthorizer mesh__D001847 sjn
% 221.95/222.18  |- skos__prefLabel mesh__D001847 Bone Diseases
% 221.95/222.18  |- rdf__type mesh__D001847sskos__Concept
% 221.95/222.18  |- skos__broader mesh__D001049smesh__D012120
% 221.95/222.18  |- mesh__dateCreated mesh__D001049 1999-01-01
% 221.95/222.18  |- mesh__recordAuthorizer mesh__D001049 sjn
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D001049 2000
% 221.95/222.18  |- skos__scopeNote mesh__D001049
% 221.95/222.18       A transient absence of spontaneous respiration.     
% 221.95/222.18  |- skos__hiddenLabel mesh__D001049 Apneas
% 221.95/222.18  |- mesh__recordMaintainer mesh__D001049 KEV
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D001049 2001
% 221.95/222.18  |- mesh__dateRevised mesh__D001049 1999-11-03
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D001049 2003
% 221.95/222.18  |- skos__prefLabel mesh__D001049 Apnea
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D001049 2005
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D001049 2004
% 221.95/222.18  |- skos__annotation mesh__D001049
% 221.95/222.18       do not confuse APNEA with other resp disord: use only when text uses APNEA; apnea neonatorum = APNEA + check tags INFANT, NEWBORN + HUMAN%A%  
% 221.95/222.18  |- mesh__recordOriginator mesh__D001049 NLM
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D001049 2002
% 221.95/222.18  |- rdf__type mesh__D001049sskos__Concept
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D001049 2006
% 221.95/222.18  |- skos__broader mesh__D001049smesh__D012818
% 221.95/222.18  |- skos__altLabel mesh__D020203 Bulbar Hemorrhage, Traumatic
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Medullary Hemorrhages, Traumatic
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Midbrain Hemorrhages, Traumatic
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D020203 2000
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Hematomas, Traumatic Brainstem
% 221.95/222.18  |- skos__altLabel mesh__D020203 Traumatic Brainstem Hemorrhage
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Traumatic Midbrain Hemorrhages
% 221.95/222.18  |- skos__altLabel mesh__D020203 Brainstem Hematoma, Traumatic
% 221.95/222.18  |- mesh__dateEstablished mesh__D020203 2000-01-01
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Traumatic Brainstem Hemorrhages
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Brainstem Hemorrhage, Post-Traumatic
% 221.95/222.18  |- skos__altLabel mesh__D020203 Hemorrhage, Brain Stem , Traumatic
% 221.95/222.18  |- mesh__publicMeSHNote mesh__D020203 2000   
% 221.95/222.18  |- skos__historyNote mesh__D020203 Cerebral Hemorrhage %28%1968-1999%29%
% 221.95/222.18  |- skos__altLabel mesh__D020203 Traumatic Brain Stem Hemorrhage
% 221.95/222.18  |- skos__altLabel mesh__D020203 Brain Stem Hemorrhage, Post-Traumatic
% 221.95/222.18  |- mesh__dateCreated mesh__D020203 1999-11-03
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Traumatic Brainstem Hematomas
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Hemorrhages, Traumatic Midbrain
% 221.95/222.18  |- skos__scopeNote mesh__D020203
% 221.95/222.18       Extravasation of blood into the midbrain, pons, or medulla following CRANIOCEREBRAL TRAUMA. DIFFUSE AXONAL INJURY is commonly associated. Clinical manifestations which may be associated with this condition include OCULAR MOTILITY DISORDERS; ATAXIA; PARALYSIS; PERSISTENT VEGETATIVE STATE; and COMA.%A%    
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Brainstem Hematomas, Traumatic
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Hemorrhage, Traumatic Pontine
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Brainstem Hemorrhages, Post-Traumatic
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Traumatic Pontine Hemorrhage
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Hemorrhages, Traumatic Bulbar
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Traumatic Pontine Hemorrhages
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Hematoma, Traumatic Brainstem
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Traumatic Medullary Hemorrhages
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Post Traumatic Brainstem Hemorrhage
% 221.95/222.18  |- skos__broader mesh__D020203smesh__D020201
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D020203 2004
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Hemorrhages, Traumatic Brainstem
% 221.95/222.18  |- skos__annotation mesh__D020203 coord with site   
% 221.95/222.18  |- rdf__type mesh__D020203sskos__Concept
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Hemorrhage, Traumatic Midbrain
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Hemorrhages, Post-Traumatic Brainstem
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Hemorrhage, Traumatic Medullary
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Traumatic Medullary Hemorrhage
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Brain Stem Hemorrhage, Post Traumatic
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Pontine Hemorrhages, Traumatic
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Bulbar Hemorrhages, Traumatic
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Hemorrhage, Post-Traumatic Brainstem
% 221.95/222.18  |- skos__altLabel mesh__D020203 Post-Traumatic Brainstem Hemorrhage
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D020203 2003
% 221.95/222.18  |- skos__historyNote mesh__D020203 Brain Injuries %28%1968-1999%29%
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Traumatic Midbrain Hemorrhage
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D020203 2002
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Post-Traumatic Brainstem Hemorrhages
% 221.95/222.18  |- mesh__activeMeSHYear mesh__D020203 2006
% 221.95/222.18  |- skos__altLabel mesh__D020203 Traumatic Brain Stem Hematoma
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Brainstem Hemorrhages, Traumatic
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Traumatic Brainstem Hematoma
% 221.95/222.18  |- skos__altLabel mesh__D020203 Brainstem Hemorrhage, Traumatic
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Hemorrhages, Traumatic Medullary
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Traumatic Bulbar Hemorrhage
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Traumatic Bulbar Hemorrhages
% 221.95/222.18  |- skos__hiddenLabel mesh__D020203 Post Traumatic Brain Stem Hemorrhage
% 221.95/222.18  |- skos__altLabel mesh__D020203 Post-Traumatic Brain Stem Hemorrhage
% 221.95/222.18  |- skos__prefLabel mesh__D020203 Brain Stem Hemorrhage, Traumatic
% 222.04/222.18  |- mesh__activeMeSHYear mesh__D020203 2001
% 222.04/222.18  |- mesh__activeMeSHYear mesh__D020203 2005
% 222.04/222.18  |- mesh__historyNote mesh__D020203 2000   
% 222.04/222.18  |- skos__hiddenLabel mesh__D020203 Hemorrhage, Traumatic Brainstem
% 222.04/222.18  |- skos__hiddenLabel mesh__D020203 Hemorrhage, Traumatic Bulbar
% 222.04/222.18  |- skos__historyNote mesh__D020203 Brain Stem %28%1968-1999%29%
% 222.04/222.18  |- skos__hiddenLabel mesh__D020203 Hemorrhages, Traumatic Pontine
% 222.04/222.18  |- mesh__dateCreated mesh__D011477 1999-01-01
% 222.04/222.18  |- mesh__recordMaintainer mesh__D011477 lkt
% 222.04/222.18  |- skos__prefLabel mesh__D011477 Prostitution
% 222.04/222.18  |- skos__scopeNote mesh__D011477
% 222.04/222.18       The practice of indulging in sexual relations for money.%A%    
% 222.04/222.18  |- mesh__recordOriginator mesh__D011477 NLM
% 222.04/222.18  |- mesh__recordAuthorizer mesh__D011477 sjn
% 222.04/222.18  |- mesh__activeMeSHYear mesh__D011477 2005
% 222.04/222.18  |- skos__broader mesh__D011477smesh__D012940
% 222.04/222.18  |- mesh__dateRevised mesh__D011477 2004-07-07
% 222.04/222.18  |- mesh__activeMeSHYear mesh__D011477 2006
% 222.04/222.18  |- rdf__type mesh__D011477sskos__Concept
% 222.04/222.18  |- skos__broader mesh__D011477smesh__D012725
% 222.04/222.18  |- mesh__historyNote mesh__D016960 2004 %28%1992%29%   
% 222.04/222.18  |- mesh__dateCreated mesh__D016960 1991-05-30
% 222.04/222.18  |- mesh__recordAuthorizer mesh__D016960 sjn
% 222.04/222.18  |- rdf__type mesh__D016960sskos__Concept
% 222.04/222.18  |- mesh__publicMeSHNote mesh__D016960
% 222.04/222.18       2004; see AGROBACTERIUM TUMEFACIENS 1992-2003   
% 222.04/222.18  |- skos__historyNote mesh__D016960 Agrobacterium %28%1966-1991%29%
% 222.04/222.18  |- skos__scopeNote mesh__D016960
% 222.04/222.18       A species of gram-negative, aerobic bacteria isolated from soil and the stems and roots of plants. It causes the formation of PLANT TUMORS in a wide variety of higher plants.%A%    
% 222.04/222.18  |- skos__broader mesh__D016960smesh__D012231
% 222.04/222.18  |- mesh__dateRevised mesh__D016960 2005-06-30
% 222.04/222.18  |- mesh__recordOriginator mesh__D016960 PXP
% 222.04/222.18  |- skos__annotation mesh__D016960 DF: RHIZOBIUM RADIOBACT   
% 222.04/222.18  |- mesh__activeMeSHYear mesh__D016960 2006
% 222.04/222.18  |- mesh__recordMaintainer mesh__D016960 SYSTEM
% 222.04/222.18  |- mesh__dateEstablished mesh__D016960 1992-01-01
% 222.04/222.18  |- skos__prefLabel mesh__D016960 Rhizobium radiobacter
% 222.04/222.18  |- skos__altLabel mesh__D016960 Agrobacterium tumefaciens
% 222.04/222.18  |- skos__hiddenLabel mesh__D016162 Tumor Genes, Wilms
% 222.04/222.18  |- skos__hiddenLabel mesh__D016162 Genes, Wilm
% 222.04/222.18  |- mesh__recordOriginator mesh__D016162 AGS
% 222.04/222.18  |- mesh__recordMaintainer mesh__D016162 nns
% 222.04/222.18  |- skos__hiddenLabel mesh__D016162 Wilms Genes
% 222.04/222.18  |- skos__broader mesh__D016162smesh__D016147
% 222.04/222.18  |- skos__related mesh__D016162smesh__D025721
% 222.04/222.18  |- mesh__dateRevised mesh__D016162 2005-07-01
% 222.04/222.18  |- mesh__activeMeSHYear mesh__D016162 2006
% 222.04/222.18  |- skos__altLabel mesh__D016162 Wilms%27% Tumor Genes
% 222.04/222.18  |- skos__altLabel mesh__D016162 WT2 Genes, Human
% 222.04/222.18  |- mesh__dateEstablished mesh__D016162 1991-01-01
% 222.04/222.18  |- skos__altLabel mesh__D016162 Genes, Wilms%27%
% 222.04/222.18  |- skos__scopeNote mesh__D016162
% 222.04/222.18       Genes at loci that are involved in the development of WILMS TUMOR. Included are human WT1 at 11p13 and human WT2 %28%MTACR1%29% at 11p15.%A%    
% 222.04/222.18  |- mesh__historyNote mesh__D016162 91   
% 222.04/222.18  |- skos__related mesh__D016162smesh__D001506
% 222.04/222.18  |- skos__altLabel mesh__D016162 MTACR1 Genes
% 222.04/222.18  |- mesh__publicMeSHNote mesh__D016162 91   
% 222.04/222.18  |- skos__hiddenLabel mesh__D016162 Genes, Human WT2
% 222.04/222.18  |- skos__hiddenLabel mesh__D016162 Genes, MTACR1
% 222.04/222.18  |- skos__related mesh__D016162smesh__D030321
% 222.04/222.18  |- skos__hiddenLabel mesh__D016162 Tumor Genes, Wilms%27%
% 222.04/222.18  |- skos__hiddenLabel mesh__D016162
% 222.04/222.18       Multiple Tumor Associated Chromosome Region 1 Genes
% 222.04/222.18  |- skos__hiddenLabel mesh__D016162 Gene, Human WT2
% 222.04/222.18  |- rdf__type mesh__D016162sskos__Concept
% 222.04/222.18  |- skos__hiddenLabel mesh__D016162 MTACR1 Gene
% 222.04/222.18  |- skos__related mesh__D016162smesh__D017624
% 222.04/222.18  |- mesh__dateCreated mesh__D016162 1990-05-07
% 222.04/222.18  |- skos__hiddenLabel mesh__D016162 Genes, Wilm%27%s
% 222.04/222.18  |- skos__hiddenLabel mesh__D016162 Human WT2 Genes
% 222.04/222.18  |- skos__hiddenLabel mesh__D016162 Wilms%27% Genes
% 222.04/222.18  |- skos__hiddenLabel mesh__D016162 WT2 Gene, Human
% 222.04/222.18  |- skos__hiddenLabel mesh__D016162 Genes, Wilms%27% Tumor
% 222.04/222.18  |- skos__altLabel mesh__D016162 Genes, Wilms
% 222.04/222.18  |- skos__altLabel mesh__D016162 WT1 Genes, Human
% 222.04/222.18  |- skos__prefLabel mesh__D016162 Genes, Wilms Tumor
% 222.04/222.18  |- mesh__recordAuthorizer mesh__D016162 sjn
% 222.04/222.18  |- skos__related mesh__D016162smesh__D009396
% 222.04/222.18  |- skos__altLabel mesh__D016162
% 222.04/222.18       Multiple Tumor-Associated Chromosome Region 1 Genes
% 222.04/222.18  |- skos__hiddenLabel mesh__D016162 Human WT2 Gene
% 222.04/222.18  |- skos__hiddenLabel mesh__D016162 Gene, MTACR1
% 222.04/222.18  |- skos__altLabel mesh__D016162 Wilms Tumor Genes
% 222.04/222.18  |- skos__hiddenLabel mesh__D002940 Rhythms, Diurnal
% 222.04/222.18  |- skos__broader mesh__D002940smesh__D010507
% 222.04/222.18  |- rdf__type mesh__D002940sskos__Concept
% 222.04/222.18  |- skos__altLabel mesh__D002940 Diurnal Rhythm
% 222.04/222.18  |- mesh__recordMaintainer mesh__D002940 nns
% 222.04/222.18  |- mesh__dateRevised mesh__D002940 2000-06-22
% 222.04/222.18  |- skos__hiddenLabel mesh__D002940 Twenty Four Hour Rhythm
% 222.04/222.18  |- mesh__activeMeSHYear mesh__D002940 2005
% 222.04/222.18  |- mesh__activeMeSHYear mesh__D002940 2002
% 222.04/222.18  |- mesh__historyNote mesh__D002940
% 222.04/222.18       66%28%64%29%; DIURNAL RHYTHM was see under CIRCADIAN RHYTHM 1975-85 %28%Prov 1969-74%29%%A%  
% 222.04/222.18  |- skos__altLabel mesh__D002940 Nyctohemeral Rhythm
% 222.04/222.18  |- skos__hiddenLabel mesh__D002940 Rhythm, Circadian
% 222.04/222.18  |- mesh__activeMeSHYear mesh__D002940 2006
% 222.04/222.18  |- skos__altLabel mesh__D002940 Twenty-Four Hour Rhythm
% 222.04/222.18  |- skos__annotation mesh__D002940
% 222.04/222.18       drug admin based on circadian rhythm = CHRONOTHERAPY: do not coord with CIRCADIAN RHYTHM or DRUG ADMINISTRATION SCHEDULE; jet lag: index JET LAG SYNDROME%A%  
% 222.04/222.18  |- skos__hiddenLabel mesh__D002940 Rhythm, Diurnal
% 222.04/222.18  |- skos__hiddenLabel mesh__D002940 Rhythm, Nyctohemeral
% 222.04/222.18  |- skos__scopeNote mesh__D002940
% 222.04/222.18       The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs and stimuli, hormone secretion, sleeping, feeding, etc. This rhythm seems to be set by a %27%biological clock%27% which seems to be set by recurring daylight and darkness.%A%    
% 222.04/222.18  |- mesh__publicMeSHNote mesh__D002940
% 222.04/222.18       66; DIURNAL RHYTHM was see under CIRCADIAN RHYTHM 1975-85%A%  
% 222.04/222.18  |- skos__hiddenLabel mesh__D002940 Rhythm, Twenty-Four Hour
% 222.04/222.18  |- mesh__recordAuthorizer mesh__D002940 sjn
% 222.04/222.18  |- skos__related mesh__D002940smesh__D017440
% 222.04/222.18  |- mesh__activeMeSHYear mesh__D002940 2003
% 222.04/222.18  |- mesh__dateEstablished mesh__D002940 1966-01-01
% 222.04/222.18  |- skos__hiddenLabel mesh__D002940 Diurnal Rhythms
% 222.04/222.18  |- skos__prefLabel mesh__D002940 Circadian Rhythm
% 222.04/222.18  |- skos__related mesh__D002940smesh__D019454
% 222.04/222.18  |- mesh__activeMeSHYear mesh__D002940 2004
% 222.04/222.18  |- skos__hiddenLabel mesh__D002940 Rhythms, Circadian
% 222.04/222.18  |- skos__hiddenLabel mesh__D002940 Twenty-Four Hour Rhythms
% 222.04/222.18  |- mesh__activeMeSHYear mesh__D002940 2001
% 222.04/222.18  |- skos__hiddenLabel mesh__D002940 Nyctohemeral Rhythms
% 222.04/222.18  |- mesh__recordOriginator mesh__D002940 NLM
% 222.04/222.18  |- skos__hiddenLabel mesh__D002940 Rhythms, Twenty-Four Hour
% 222.04/222.18  |- mesh__dateCreated mesh__D002940 1999-01-01
% 222.04/222.18  |- skos__hiddenLabel mesh__D002940 Rhythms, Nyctohemeral
% 222.04/222.18  |- skos__hiddenLabel mesh__D002940 Circadian Rhythms
% 222.04/222.18  |- mesh__recordMaintainer mesh__D002142 jmp
% 222.04/222.18  |- skos__scopeNote mesh__D002142
% 222.04/222.18       Californium. A man-made radioactive actinide with atomic symbol Cf, atomic number 98, and atomic weight 251. Its valence can be +2 or +3. Californium has medical use as a radiation source for radiotherapy.%A%    
% 222.04/222.18  |- mesh__dateCreated mesh__D002142 1999-01-01
% 222.04/222.18  |- skos__broader mesh__D002142smesh__D008671
% 222.04/222.18  |- mesh__dateRevised mesh__D002142 2005-06-30
% 222.04/222.18  |- rdf__type mesh__D002142sskos__Concept
% 222.04/222.19  |- skos__prefLabel mesh__D002142 Californium
% 222.04/222.19  |- mesh__recordAuthorizer mesh__D002142 sjn
% 222.04/222.19  |- skos__annotation mesh__D002142 man-made radioactive element; IM   
% 222.04/222.19  |- mesh__recordOriginator mesh__D002142 NLM
% 222.04/222.19  |- skos__broader mesh__D002142smesh__D019216
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D002142 2006
% 222.04/222.19  |- skos__prefLabel mesh__D015868 Pars Planitis
% 222.04/222.19  |- mesh__recordAuthorizer mesh__D015868 NLM
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D015868 1995
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D015868 1996
% 222.04/222.19  |- mesh__dateCreated mesh__D015868 1989-05-26
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D015868 2006
% 222.04/222.19  |- mesh__historyNote mesh__D015868 90   
% 222.04/222.19  |- skos__historyNote mesh__D015868 Uveitis %28%1971-1989%29%
% 222.04/222.19  |- mesh__recordOriginator mesh__D015868 EGC
% 222.04/222.19  |- skos__hiddenLabel mesh__D015868 Planitis, Pars
% 222.04/222.19  |- skos__broader mesh__D015868smesh__D015867
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D015868 1997
% 222.04/222.19  |- mesh__recordMaintainer mesh__D015868 PLS
% 222.04/222.19  |- rdf__type mesh__D015868sskos__Concept
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D015868 2000
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D015868 1992
% 222.04/222.19  |- skos__annotation mesh__D015868 a type of uveitis   
% 222.04/222.19  |- mesh__publicMeSHNote mesh__D015868 90   
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D015868 2003
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D015868 1998
% 222.04/222.19  |- mesh__dateRevised mesh__D015868 1990-05-29
% 222.04/222.19  |- skos__broader mesh__D015868smesh__D002833
% 222.04/222.19  |- mesh__dateEstablished mesh__D015868 1990-01-01
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D015868 2001
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D015868 1993
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D015868 2004
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D015868 1999
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D015868 1991
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D015868 1994
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D015868 2002
% 222.04/222.19  |- skos__scopeNote mesh__D015868
% 222.04/222.19       Form of granulomatous uveitis occurring in the region of the pars plana. This disorder is a common condition with no detectable focal pathology. It causes fibrovascular proliferation at the inferior ora serrata.%A%    
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D015868 2005
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D040261 2004
% 222.04/222.19  |- rdf__type mesh__D040261sskos__Concept
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D040261 2005
% 222.04/222.19  |- skos__scopeNote mesh__D040261
% 222.04/222.19       The application of methods designed to reduce the risk of harm associated with certain behaviors without reduction in frequency of those behaviors. The risk-associated behaviors include ongoing and active addictive behaviors.%A%    
% 222.04/222.19  |- mesh__dateEstablished mesh__D040261 2003-01-01
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D040261 2003
% 222.04/222.19  |- skos__hiddenLabel mesh__D040261 Minimization, Harm
% 222.04/222.19  |- skos__broader mesh__D040261smesh__D001519
% 222.04/222.19  |- mesh__historyNote mesh__D040261 2003   
% 222.04/222.19  |- mesh__dateCreated mesh__D040261 2002-07-03
% 222.04/222.19  |- mesh__publicMeSHNote mesh__D040261 2003   
% 222.04/222.19  |- mesh__recordOriginator mesh__D040261 jls
% 222.04/222.19  |- skos__prefLabel mesh__D040261 Harm Reduction
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D040261 2006
% 222.04/222.19  |- skos__altLabel mesh__D040261 Harm Minimization
% 222.04/222.19  |- skos__related mesh__D040261smesh__D012306
% 222.04/222.19  |- skos__hiddenLabel mesh__D040261 Reduction, Harm
% 222.04/222.19  |- mesh__recordMaintainer mesh__D040261 jls
% 222.04/222.19  |- mesh__recordAuthorizer mesh__D040261 sjn
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001848 1994
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001848 2003
% 222.04/222.19  |- skos__prefLabel mesh__D001848 Bone Diseases, Developmental
% 222.04/222.19  |- skos__broader mesh__D001848smesh__D001847
% 222.04/222.19  |- skos__hiddenLabel mesh__D001848 Dysplasia, Bone
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001848 2006
% 222.04/222.19  |- skos__historyNote mesh__D001848 Bone Diseases %28%1966-1969%29%
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001848 1992
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001848 2000
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001848 1998
% 222.04/222.19  |- mesh__recordAuthorizer mesh__D001848 PLS
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001848 1995
% 222.04/222.19  |- mesh__dateEstablished mesh__D001848 1970-01-01
% 222.04/222.19  |- mesh__historyNote mesh__D001848 70   
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001848 2004
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001848 1996
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001848 1993
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001848 1999
% 222.04/222.19  |- mesh__publicMeSHNote mesh__D001848
% 222.04/222.19       70; HYPERTELORISM was see under CRANIOFACIAL DYSOSTOSIS 1963-84%A%  
% 222.04/222.19  |- skos__altLabel mesh__D001848 Developmental Bone Disease
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001848 2001
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001848 1997
% 222.04/222.19  |- mesh__dateCreated mesh__D001848 1999-01-01
% 222.04/222.19  |- skos__hiddenLabel mesh__D001848 Dysplasias, Bone
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001848 2002
% 222.04/222.19  |- mesh__recordOriginator mesh__D001848 NLM
% 222.04/222.19  |- skos__altLabel mesh__D001848 Bone Dysplasias
% 222.04/222.19  |- rdf__type mesh__D001848sskos__Concept
% 222.04/222.19  |- skos__hiddenLabel mesh__D001848 Bone Dysplasia
% 222.04/222.19  |- skos__hiddenLabel mesh__D001848 Bone Disease, Developmental
% 222.04/222.19  |- skos__hiddenLabel mesh__D001848 Developmental Bone Diseases
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001848 2005
% 222.04/222.19  |- mesh__dateRevised mesh__D001848 1991-06-13
% 222.04/222.19  |- mesh__recordMaintainer mesh__D001848 TGC
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D012570 2006
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D012570 2003A
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D012570 1996
% 222.04/222.19  |- skos__hiddenLabel mesh__D012570 Criteria, School Admission
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D012570 2002
% 222.04/222.19  |- skos__annotation mesh__D012570 few qualif apply   
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D012570 2005
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D012570 1999
% 222.04/222.19  |- skos__prefLabel mesh__D012570 School Admission Criteria
% 222.04/222.19  |- mesh__recordAuthorizer mesh__D012570 sjn
% 222.04/222.19  |- rdf__type mesh__D012570sskos__Concept
% 222.04/222.19  |- skos__hiddenLabel mesh__D012570 Selection, Student
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D012570 1998
% 222.04/222.19  |- mesh__historyNote mesh__D012570
% 222.04/222.19       91%28%75%29%; was see under EDUCATIONAL MEASUREMENT 1975-90   
% 222.04/222.19  |- skos__broader mesh__D012570smesh__D004521
% 222.04/222.19  |- skos__hiddenLabel mesh__D012570 Admission Criteria, School
% 222.04/222.19  |- skos__hiddenLabel mesh__D012570 Selections, Student
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D012570 2001
% 222.04/222.19  |- mesh__publicMeSHNote mesh__D012570
% 222.04/222.19       91; was see under EDUCATIONAL MEASUREMENT 1975-90   
% 222.04/222.19  |- mesh__dateEstablished mesh__D012570 1991-01-01
% 222.04/222.19  |- skos__hiddenLabel mesh__D012570 Student Selections
% 222.04/222.19  |- mesh__recordOriginator mesh__D012570 NLM
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D012570 2004
% 222.04/222.19  |- mesh__dateRevised mesh__D012570 2002-10-24
% 222.04/222.19  |- mesh__recordMaintainer mesh__D012570 sjn
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D012570 2000
% 222.04/222.19  |- mesh__dateCreated mesh__D012570 1974-11-11
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D012570 2003
% 222.04/222.19  |- skos__scopeNote mesh__D012570
% 222.04/222.19       Requirements for the selection of students for admission to academic institutions.%A%    
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D012570 1997
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D006533 2005A
% 222.04/222.19  |- mesh__recordAuthorizer mesh__D006533 jls
% 222.04/222.19  |- rdf__type mesh__D006533sskos__Concept
% 222.04/222.19  |- skos__broader mesh__D006533smesh__D006843
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D006533 2005
% 222.04/222.19  |- skos__historyNote mesh__D006533 Insecticides %28%1966-1970%29%
% 222.04/222.19  |- skos__annotation mesh__D006533 TN 111 for eff on insects   
% 222.04/222.19  |- mesh__recordMaintainer mesh__D006533 jls
% 222.04/222.19  |- skos__prefLabel mesh__D006533 Heptachlor
% 222.04/222.19  |- mesh__dateEstablished mesh__D006533 1973-01-01
% 222.04/222.19  |- mesh__dateCreated mesh__D006533 1999-01-01
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D006533 2006
% 222.04/222.19  |- skos__scopeNote mesh__D006533
% 222.04/222.19       A man-made compound previously used to control termites and other insects. Even though production of heptachlor was phased out of use in the United States during the late 1980%27%s it remains in soil and hazardous waste sites. It is clearly toxic to animals and humans but, the International Agency for Research on Cancer %28%IARC%29% has determined that heptachlor is not classifiable as to its carcinogenicity to humans. %28%From ATSDR Public Heath Statement, April 1989%29%%A%    
% 222.04/222.19  |- mesh__recordOriginator mesh__D006533 NLM
% 222.04/222.19  |- mesh__dateRevised mesh__D006533 2004-07-28
% 222.04/222.19  |- mesh__publicMeSHNote mesh__D006533 73   
% 222.04/222.19  |- mesh__historyNote mesh__D006533 73%28%71%29%   
% 222.04/222.19  |- mesh__historyNote mesh__D020204 2000   
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D020204 2006
% 222.04/222.19  |- skos__historyNote mesh__D020204 Brain Injuries %28%1965-1999%29%
% 222.04/222.19  |- skos__altLabel mesh__D020204 Skull Fractures, Compound Depressed
% 222.04/222.19  |- skos__scopeNote mesh__D020204
% 222.04/222.19       A skull fracture characterized by inward depression of a fragment or section of cranial bone, often compressing the underlying dura mater and brain. Depressed cranial fractures which feature open skin wounds that communicate with skull fragments are referred to as compound depressed skull fractures.%A%    
% 222.04/222.19  |- skos__broader mesh__D020204smesh__D012887
% 222.04/222.19  |- skos__hiddenLabel mesh__D020204 Depressed Skull Fractures
% 222.04/222.19  |- mesh__dateCreated mesh__D020204 1999-11-03
% 222.04/222.19  |- skos__historyNote mesh__D020204 Skull Fractures %28%1965-1999%29%
% 222.04/222.19  |- skos__altLabel mesh__D020204 Compound Depressed Skull Fractures
% 222.04/222.19  |- skos__hiddenLabel mesh__D020204 Skull Fractures, Depressed
% 222.04/222.19  |- skos__hiddenLabel mesh__D020204 Fracture, Depressed Skull
% 222.04/222.19  |- skos__prefLabel mesh__D020204 Skull Fracture, Depressed
% 222.04/222.19  |- mesh__recordMaintainer mesh__D020204 ssb
% 222.04/222.19  |- skos__altLabel mesh__D020204 Compound Depressed Skull Fracture
% 222.04/222.19  |- mesh__dateEstablished mesh__D020204 2000-01-01
% 222.04/222.19  |- mesh__recordAuthorizer mesh__D020204 sjn
% 222.04/222.19  |- mesh__publicMeSHNote mesh__D020204 2000   
% 222.04/222.19  |- mesh__dateRevised mesh__D020204 2005-06-30
% 222.04/222.19  |- rdf__type mesh__D020204sskos__Concept
% 222.04/222.19  |- skos__annotation mesh__D020204
% 222.04/222.19       coord %28%IM%29% with specific bone in the skull/inj %28%IM%29% if pertinent%A%  
% 222.04/222.19  |- mesh__recordOriginator mesh__D020204 KEV
% 222.04/222.19  |- skos__hiddenLabel mesh__D020204 Depressed Skull Fracture
% 222.04/222.19  |- skos__hiddenLabel mesh__D020204 Fractures, Depressed Skull
% 222.04/222.19  |- skos__annotation mesh__D011478 naturally radioactive; IM   
% 222.04/222.19  |- skos__broader mesh__D011478smesh__D019216
% 222.04/222.19  |- skos__prefLabel mesh__D011478 Protactinium
% 222.04/222.19  |- skos__broader mesh__D011478smesh__D008671
% 222.04/222.19  |- mesh__recordOriginator mesh__D011478 NLM
% 222.04/222.19  |- mesh__recordAuthorizer mesh__D011478 sjn
% 222.04/222.19  |- mesh__recordMaintainer mesh__D011478 jmp
% 222.04/222.19  |- skos__scopeNote mesh__D011478
% 222.04/222.19       Protactinium. A radioactive element of the actinide group of metals. It has the atomic symbol Pa, atomic number 91, and atomic weight 231. It decays by alpha-emission.%A%    
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D011478 2006
% 222.04/222.19  |- mesh__dateRevised mesh__D011478 2005-06-30
% 222.04/222.19  |- rdf__type mesh__D011478sskos__Concept
% 222.04/222.19  |- mesh__dateCreated mesh__D011478 1999-01-01
% 222.04/222.19  |- mesh__dateEstablished mesh__D016961 1992-01-01
% 222.04/222.19  |- mesh__historyNote mesh__D016961 92   
% 222.04/222.19  |- skos__prefLabel mesh__D016961 Rhizobium leguminosarum
% 222.04/222.19  |- skos__historyNote mesh__D016961 Rhizobium %28%1966-1991%29%
% 222.04/222.19  |- mesh__recordOriginator mesh__D016961 PXP
% 222.04/222.19  |- mesh__recordAuthorizer mesh__D016961 sjn
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D016961 2006
% 222.04/222.19  |- mesh__recordMaintainer mesh__D016961 SYSTEM
% 222.04/222.19  |- skos__scopeNote mesh__D016961
% 222.04/222.19       A species of gram-negative, aerobic bacteria that is found in soil and which causes formation of root nodules on some, but not all, types of field pea, lentil, kidney bean, and clover.%A%    
% 222.04/222.19  |- mesh__dateRevised mesh__D016961 2005-06-30
% 222.04/222.19  |- mesh__publicMeSHNote mesh__D016961 92   
% 222.04/222.19  |- mesh__dateCreated mesh__D016961 1991-05-30
% 222.04/222.19  |- rdf__type mesh__D016961sskos__Concept
% 222.04/222.19  |- skos__broader mesh__D016961smesh__D012231
% 222.04/222.19  |- mesh__historyNote mesh__D016163 91   
% 222.04/222.19  |- mesh__recordOriginator mesh__D016163 AGS
% 222.04/222.19  |- mesh__recordAuthorizer mesh__D016163 sjn
% 222.04/222.19  |- mesh__dateEstablished mesh__D016163 1991-01-01
% 222.04/222.19  |- mesh__dateRevised mesh__D016163 2005-06-30
% 222.04/222.19  |- skos__hiddenLabel mesh__D016163 DCC Gene
% 222.04/222.19  |- mesh__publicMeSHNote mesh__D016163 91   
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D016163 2006
% 222.04/222.19  |- skos__hiddenLabel mesh__D016163 Gene, DCC
% 222.04/222.19  |- skos__hiddenLabel mesh__D016163 DCC Genes
% 222.04/222.19  |- skos__scopeNote mesh__D016163
% 222.04/222.19       Tumor suppressor genes located in the 18q21-qter region of human chromosome 18. The absence of these genes is associated with the formation of colorectal cancer %28%DCC stands for deleted in colorectal cancer%29%. The products of these genes show significant homology to neural cell adhesion molecules and other related cell surface glycoproteins.%A%    
% 222.04/222.19  |- mesh__recordMaintainer mesh__D016163 nns
% 222.04/222.19  |- skos__annotation mesh__D016163
% 222.04/222.19       DCC stands for %22%Deleted in Colorectal Cancer%22%   
% 222.04/222.19  |- skos__prefLabel mesh__D016163 Genes, DCC
% 222.04/222.19  |- skos__broader mesh__D016163smesh__D016147
% 222.04/222.19  |- mesh__dateCreated mesh__D016163 1990-05-07
% 222.04/222.19  |- rdf__type mesh__D016163sskos__Concept
% 222.04/222.19  |- skos__related mesh__D016163smesh__D017431
% 222.04/222.19  |- mesh__recordMaintainer mesh__D002941 ags
% 222.04/222.19  |- skos__altLabel mesh__D002941 Cerebral Arterial Circle
% 222.04/222.19  |- mesh__dateRevised mesh__D002941 2005-07-07
% 222.04/222.19  |- mesh__recordAuthorizer mesh__D002941 ags
% 222.04/222.19  |- skos__broader mesh__D002941smesh__D002536
% 222.04/222.19  |- skos__hiddenLabel mesh__D002941 Willis Circle
% 222.04/222.19  |- mesh__dateEstablished mesh__D002941 1965-01-01
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D002941 2002
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D002941 2005
% 222.04/222.19  |- skos__scopeNote mesh__D002941
% 222.04/222.19       A polygonal anastomosis at the base of the brain formed by the internal carotid %28%CAROTID ARTERY, INTERNAL%29%, proximal parts of the anterior, middle, and posterior cerebral arteries %28%ANTERIOR CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY; POSTERIOR CEREBRAL ARTERY%29%, the anterior communicating artery and the posterior communicating arteries.%A%    
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D002941 2006A
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D002941 2006
% 222.04/222.19  |- skos__hiddenLabel mesh__D002941 Arterial Circle, Cerebral
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D002941 2000
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D002941 2003
% 222.04/222.19  |- skos__altLabel mesh__D002941 Willis%27% Circle
% 222.04/222.19  |- mesh__recordOriginator mesh__D002941 NLM
% 222.04/222.19  |- skos__hiddenLabel mesh__D002941 Circle, Willis%27%
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D002941 2001
% 222.04/222.19  |- mesh__dateCreated mesh__D002941 1999-01-01
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D002941 2004
% 222.04/222.19  |- mesh__historyNote mesh__D002941 65   
% 222.04/222.19  |- mesh__publicMeSHNote mesh__D002941 65   
% 222.04/222.19  |- rdf__type mesh__D002941sskos__Concept
% 222.04/222.19  |- skos__prefLabel mesh__D002941 Circle of Willis
% 222.04/222.19  |- skos__altLabel mesh__D002143 Callitrichinae
% 222.04/222.19  |- skos__scopeNote mesh__D002143
% 222.04/222.19       A family of the order PRIMATES that consists of four genera: CALLITHRIX %28%marmosets%29%, CALLIMICO %28%Goeldi%27%s monkey%29%, LEONTOPITHECUS %28%lion tamarins%29%, and SAGUINUS %28%long-tusked tamarins%29%. The members of this family inhabit the tropical forests of South and Central America.%A%    
% 222.04/222.19  |- mesh__dateCreated mesh__D002143 1974-11-19
% 222.04/222.19  |- mesh__recordMaintainer mesh__D002143 ags
% 222.04/222.19  |- skos__altLabel mesh__D002143 Callithricidae
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D002143 2006
% 222.04/222.19  |- mesh__recordOriginator mesh__D002143 NLM
% 222.04/222.19  |- mesh__publicMeSHNote mesh__D002143
% 222.04/222.19       2006; see CALLITRICHINAE 1992-2005, see CALLITHRICIDAE 1981-1991, see MARMOSETS 1975-1980%A%  
% 222.04/222.19  |- mesh__dateEstablished mesh__D002143 1975-09-01
% 222.04/222.19  |- skos__historyNote mesh__D002143 Anthropoidea %28%1966-1974%29%
% 222.04/222.19  |- mesh__historyNote mesh__D002143 2006 %28%1975%29%   
% 222.04/222.19  |- rdf__type mesh__D002143sskos__Concept
% 222.04/222.19  |- mesh__dateRevised mesh__D002143 2005-06-30
% 222.04/222.19  |- skos__broader mesh__D002143smesh__D051078
% 222.04/222.19  |- skos__prefLabel mesh__D002143 Callitrichidae
% 222.04/222.19  |- mesh__recordAuthorizer mesh__D002143 sjn
% 222.04/222.19  |- skos__annotation mesh__D002143
% 222.04/222.19       diseases: coordinate IM with MONKEY DISEASES %28%IM%29%   
% 222.04/222.19  |- mesh__dateCreated mesh__D040262 2002-07-03
% 222.04/222.19  |- skos__prefLabel mesh__D040262
% 222.04/222.19       Receptors, Vascular Endothelial Growth Factor
% 222.04/222.19  |- skos__hiddenLabel mesh__D040262 Receptors, VEGF
% 222.04/222.19  |- mesh__recordOriginator mesh__D040262 MDJ
% 222.04/222.19  |- skos__historyNote mesh__D040262
% 222.04/222.19       Receptors, Growth Factor %28%1993-2002%29%
% 222.04/222.19  |- skos__altLabel mesh__D040262 Vascular Permeability Factor Receptor
% 222.04/222.19  |- skos__altLabel mesh__D040262 Receptor, Vascular Permeability Factor
% 222.04/222.19  |- mesh__dateEstablished mesh__D040262 2003-01-01
% 222.04/222.19  |- mesh__publicMeSHNote mesh__D040262
% 222.04/222.19       2003; VASCULAR ENDOTHELIAL CELL GROWTH FACTOR RECEPTOR %28%now RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR%29% was indexed under RECEPTORS, GROWTH FACTOR 1993-2002, RECEPTORS PROTEIN-TYROSINE KINASES 1994-2002, PROTEIN-TYROSINE KINASE 1993 %26% RECEPTORS, MITOGEN 1991-1992; ENDOTHELIAL GROWTH FACTOR RECEPTOR was indexed under RECEPTORS, MITOGEN %26% RECEPTORS, GROWTH FACTOR 1985-2003%A%  
% 222.04/222.19  |- mesh__historyNote mesh__D040262
% 222.04/222.19       2003; use RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR %28%NM%29% 1991-2002; for ENDOTHELIAL GROWTH FACTOR RECEPTOR use  RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR %28%NM%29% 1985-2003%A%  
% 222.04/222.19  |- mesh__recordAuthorizer mesh__D040262 sjn
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D040262 2006
% 222.04/222.19  |- skos__annotation mesh__D040262 GEN; prefer specifics, DF: VEGF RECEPT   
% 222.04/222.19  |- skos__broader mesh__D040262smesh__D020794
% 222.04/222.19  |- skos__historyNote mesh__D040262 Receptors, Mitogen %28%1991-1992%29%
% 222.04/222.19  |- skos__broader mesh__D040262smesh__D017978
% 222.04/222.19  |- skos__altLabel mesh__D040262 VEGF Receptors
% 222.04/222.19  |- rdf__type mesh__D040262sskos__Concept
% 222.04/222.19  |- skos__altLabel mesh__D040262
% 222.04/222.19       Receptor, Vascular Endothelial Cell Growth Factor
% 222.04/222.19  |- mesh__dateRevised mesh__D040262 2005-06-30
% 222.04/222.19  |- skos__historyNote mesh__D040262 Protein-Tyrosine Kinase %28%1993%29%
% 222.04/222.19  |- skos__altLabel mesh__D040262 VEGF Receptor
% 222.04/222.19  |- skos__historyNote mesh__D040262
% 222.04/222.19       Receptor Protein-Tyrosine Kinases %28%1994-2002%29%
% 222.04/222.19  |- skos__altLabel mesh__D040262 VPF Receptor
% 222.04/222.19  |- skos__altLabel mesh__D040262 Receptor, Endothelial Growth Factors
% 222.04/222.19  |- skos__scopeNote mesh__D040262
% 222.04/222.19       A family of closely related RECEPTOR PROTEIN-TYROSINE KINASES that bind vascular endothelial growth factors. They share a cluster of seven extracellular Ig-like domains which are important for ligand binding. They are highly expressed in vascular endothelial cells and are critical for the physiological and pathological growth, development and maintenance of blood and lymphatic vessels.%A%    
% 222.04/222.19  |- skos__altLabel mesh__D040262
% 222.04/222.19       Vascular Endothelial Cell Growth Factor Receptor
% 222.04/222.19  |- skos__altLabel mesh__D040262 Vascular Endothelial Growth Factor Receptor
% 222.04/222.19  |- mesh__recordMaintainer mesh__D040262 jmp
% 222.04/222.19  |- skos__hiddenLabel mesh__D001849 Endocrine Bone Disease
% 222.04/222.19  |- mesh__dateEstablished mesh__D001849 1998-01-01
% 222.04/222.19  |- mesh__recordOriginator mesh__D001849 NLM
% 222.04/222.19  |- mesh__dateCreated mesh__D001849 1999-01-01
% 222.04/222.19  |- skos__hiddenLabel mesh__D001849 Diseases, Endocrine Bone
% 222.04/222.19  |- skos__hiddenLabel mesh__D001849 Bone Disease, Endocrine
% 222.04/222.19  |- skos__hiddenLabel mesh__D001849 Endocrine Bone Diseases
% 222.04/222.19  |- skos__historyNote mesh__D001849 Bone Diseases %28%1966-1997%29%
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001849 2005
% 222.04/222.19  |- rdf__type mesh__D001849sskos__Concept
% 222.04/222.19  |- mesh__publicMeSHNote mesh__D001849 98   
% 222.04/222.19  |- skos__broader mesh__D001849smesh__D001847
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001849 2000
% 222.04/222.19  |- skos__prefLabel mesh__D001849 Bone Diseases, Endocrine
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001849 2003
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001849 2006
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001849 1998
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001849 2001
% 222.04/222.19  |- skos__hiddenLabel mesh__D001849 Disease, Endocrine Bone
% 222.04/222.19  |- mesh__recordMaintainer mesh__D001849 TGC
% 222.04/222.19  |- skos__scopeNote mesh__D001849
% 222.04/222.19       Diseases of the bones related to hyperfunction or hypofunction of the endocrine glands.%A%    
% 222.04/222.19  |- skos__annotation mesh__D001849
% 222.04/222.19       GEN or unspecified; prefer specifics; coord IM with specific endocr dis %28%IM%29%; DF: BONE DIS ENDOCRINE%A%  
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001849 2004
% 222.04/222.19  |- skos__historyNote mesh__D001849 Endocrine Diseases %28%1966-1997%29%
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001849 1999
% 222.04/222.19  |- mesh__dateRevised mesh__D001849 1997-06-20
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D001849 2002
% 222.04/222.19  |- mesh__recordAuthorizer mesh__D001849 SJN
% 222.04/222.19  |- mesh__historyNote mesh__D001849 98; use explode 1971-97   
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D012571 2000
% 222.04/222.19  |- rdf__type mesh__D012571sskos__Concept
% 222.04/222.19  |- mesh__publicMeSHNote mesh__D012571 74   
% 222.04/222.19  |- skos__hiddenLabel mesh__D012571 Dentistries, School
% 222.04/222.19  |- skos__prefLabel mesh__D012571 School Dentistry
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D012571 2002
% 222.04/222.19  |- mesh__historyNote mesh__D012571 74%28%72%29%   
% 222.04/222.19  |- skos__historyNote mesh__D012571 School Health Services %28%1966-1971%29%
% 222.04/222.19  |- mesh__recordMaintainer mesh__D012571 kle
% 222.04/222.19  |- skos__hiddenLabel mesh__D012571 School Dentistries
% 222.04/222.19  |- mesh__recordAuthorizer mesh__D012571 sjn
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D012571 2004
% 222.04/222.19  |- mesh__dateCreated mesh__D012571 1999-01-01
% 222.04/222.19  |- mesh__dateRevised mesh__D012571 1999-11-03
% 222.04/222.19  |- skos__scopeNote mesh__D012571
% 222.04/222.19       Preventive dental services provided for students in primary and secondary schools.%A%    
% 222.04/222.19  |- skos__hiddenLabel mesh__D012571 Dentistry, School
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D012571 2003
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D012571 2001
% 222.04/222.19  |- mesh__dateEstablished mesh__D012571 1974-01-01
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D012571 2006
% 222.04/222.19  |- skos__broader mesh__D012571smesh__D012572
% 222.04/222.19  |- mesh__recordOriginator mesh__D012571 NLM
% 222.04/222.19  |- skos__annotation mesh__D012571 SPEC; SPEC qualif   
% 222.04/222.19  |- skos__historyNote mesh__D012571 Dentistry %28%1966-1971%29%
% 222.04/222.19  |- skos__broader mesh__D012571smesh__D003813
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D012571 2005
% 222.04/222.19  |- mesh__recordOriginator mesh__D006534 NLM
% 222.04/222.19  |- mesh__historyNote mesh__D006534
% 222.04/222.19       91%28%75%29%; was see under HEPTACHLOR 1975-90   
% 222.04/222.19  |- rdf__type mesh__D006534sskos__Concept
% 222.04/222.19  |- mesh__recordAuthorizer mesh__D006534 sjn
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D006534 2005
% 222.04/222.19  |- skos__prefLabel mesh__D006534 Heptachlor Epoxide
% 222.04/222.19  |- mesh__dateEstablished mesh__D006534 1991-01-01
% 222.04/222.19  |- mesh__dateCreated mesh__D006534 1999-01-01
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D006534 2006
% 222.04/222.19  |- skos__scopeNote mesh__D006534
% 222.04/222.19       An oxidation product of HEPTACHLOR formed by many plants and animals, including humans, after exposure to HEPTACHLOR. It has been shown to remain in soil treated with HEPTACHLOR for over fifteen years and is toxic to animals and humans. %28%From ATSDR Public Heath Statement, April 1989%29%%A%    
% 222.04/222.19  |- mesh__dateRevised mesh__D006534 2004-07-07
% 222.04/222.19  |- mesh__publicMeSHNote mesh__D006534
% 222.04/222.19       91; was see under HEPTACHLOR 1975-90   
% 222.04/222.19  |- skos__broader mesh__D006534smesh__D006533
% 222.04/222.19  |- skos__annotation mesh__D006534 TN 111 for eff on insects   
% 222.04/222.19  |- mesh__recordMaintainer mesh__D006534 ssb
% 222.04/222.19  |- skos__hiddenLabel mesh__D006534 Epoxide, Heptachlor
% 222.04/222.19  |- mesh__onlineNote mesh__D006534 search HEPTACHLOR 1973-74   
% 222.04/222.19  |- skos__hiddenLabel mesh__D020205 Fracture, Frontobasilar Skull
% 222.04/222.19  |- skos__hiddenLabel mesh__D020205 Basilar Skull Fractures
% 222.04/222.19  |- skos__prefLabel mesh__D020205 Skull Fracture, Basilar
% 222.04/222.19  |- mesh__recordMaintainer mesh__D020205 ssb
% 222.04/222.19  |- skos__historyNote mesh__D020205 Skull Fractures %28%1966-1999%29%
% 222.04/222.19  |- skos__hiddenLabel mesh__D020205 Frontobasilar Skull Fractures
% 222.04/222.19  |- mesh__recordAuthorizer mesh__D020205 sjn
% 222.04/222.19  |- mesh__dateCreated mesh__D020205 1999-11-08
% 222.04/222.19  |- mesh__publicMeSHNote mesh__D020205 2000   
% 222.04/222.19  |- mesh__dateRevised mesh__D020205 2005-06-30
% 222.04/222.19  |- mesh__recordOriginator mesh__D020205 KEV
% 222.04/222.19  |- skos__altLabel mesh__D020205 Battle%27%s Sign
% 222.04/222.19  |- skos__hiddenLabel mesh__D020205 Skull Fractures, Frontobasilar
% 222.04/222.19  |- skos__hiddenLabel mesh__D020205 Sign, Battle
% 222.04/222.19  |- skos__hiddenLabel mesh__D020205 Fractures, Frontobasilar Skull
% 222.04/222.19  |- skos__scopeNote mesh__D020205
% 222.04/222.19       Fractures which extend through the base of the SKULL, usually involving the PETROUS BONE. Battle%27%s sign %28%characterized by skin discoloration due to extravasation of blood into the subcutaneous tissue behind the ear and over the mastoid process%29%, CRANIAL NEUROPATHIES, TRAUMATIC; CAROTID-CAVERNOUS SINUS FISTULA; and CEREBROSPINAL FLUID OTORRHEA are relatively frequent sequelae of this condition. %28%Adams et al., Principles of Neurology, 6th ed, p876%29%%A%    
% 222.04/222.19  |- rdf__type mesh__D020205sskos__Concept
% 222.04/222.19  |- skos__hiddenLabel mesh__D020205 Skull Fractures, Basilar
% 222.04/222.19  |- skos__hiddenLabel mesh__D020205 Fractures, Basilar Skull
% 222.04/222.19  |- mesh__dateEstablished mesh__D020205 2000-01-01
% 222.04/222.19  |- skos__annotation mesh__D020205
% 222.04/222.19       coord %28%IM%29% with specific bone in the skull/inj %28%IM%29% if pertinent%A%  
% 222.04/222.19  |- skos__historyNote mesh__D020205 Temporal Bone %28%1966-1999%29%
% 222.04/222.19  |- skos__hiddenLabel mesh__D020205 Battles Sign
% 222.04/222.19  |- mesh__historyNote mesh__D020205 2000   
% 222.04/222.19  |- skos__hiddenLabel mesh__D020205 Sign, Battle%27%s
% 222.04/222.19  |- skos__altLabel mesh__D020205 Basilar Skull Fracture
% 222.04/222.19  |- skos__broader mesh__D020205smesh__D012887
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D020205 2006
% 222.04/222.19  |- skos__hiddenLabel mesh__D020205 Frontobasilar Skull Fracture
% 222.04/222.19  |- skos__hiddenLabel mesh__D020205 Fracture, Basilar Skull
% 222.04/222.19  |- skos__annotation mesh__D011479 heparin antag   
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D011479 1998
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D011479 1997
% 222.04/222.19  |- mesh__recordAuthorizer mesh__D011479 PLS
% 222.04/222.19  |- mesh__recordMaintainer mesh__D011479 JRT
% 222.04/222.19  |- skos__broader mesh__D011479smesh__D009698
% 222.04/222.19  |- skos__scopeNote mesh__D011479
% 222.04/222.19       A group of simple proteins that yield basic amino acids on hydrolysis and that occur combined with nucleic acid in the sperm of fish. Protamines contain very few kinds of amino acids. Protamine sulfate combines with heparin to form a stable inactive complex; it is used to neutralize the anticoagulant action of heparin in the treatment of heparin overdose. %28%From Merck Index, 11th ed; Martindale, The Extra Pharmacopoeia, 30th ed, p692%29%%A%    
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D011479 1996
% 222.04/222.19  |- skos__broader mesh__D011479smesh__D009687
% 222.04/222.19  |- skos__prefLabel mesh__D011479 Protamines
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D011479 2006
% 222.04/222.19  |- mesh__activeMeSHYear mesh__D011479 2002
% 222.04/222.19  |- skos__hiddenLabel mesh__D011479 Sulfate, Protamine
% 222.04/222.19  |- skos__hiddenLabel mesh__D011479 Chloride, Protamine
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D011479 2005
% 222.04/222.20  |- rdf__type mesh__D011479sskos__Concept
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D011479 2001
% 222.04/222.20  |- mesh__dateCreated mesh__D011479 1999-01-01
% 222.04/222.20  |- mesh__recordOriginator mesh__D011479 NLM
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D011479 2004
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D011479 2000
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D011479 1999
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D011479 2003
% 222.04/222.20  |- mesh__dateRevised mesh__D011479 1995-06-08
% 222.04/222.20  |- rdf__type mesh__D016962sskos__Concept
% 222.04/222.20  |- mesh__dateCreated mesh__D016962 1991-05-30
% 222.04/222.20  |- mesh__publicMeSHNote mesh__D016962
% 222.04/222.20       2000; see RHIZOBIUM MELILOTI 1992-1999   
% 222.04/222.20  |- skos__scopeNote mesh__D016962
% 222.04/222.20       A species of gram-negative, aerobic bacteria that causes formation of root nodules on some, but not all, types of sweet clover, MEDICAGO SATIVA, and fenugreek.%A%    
% 222.04/222.20  |- skos__prefLabel mesh__D016962 Sinorhizobium meliloti
% 222.04/222.20  |- mesh__recordOriginator mesh__D016962 PXP
% 222.04/222.20  |- skos__broader mesh__D016962smesh__D020579
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D016962 2006
% 222.04/222.20  |- mesh__recordAuthorizer mesh__D016962 sjn
% 222.04/222.20  |- skos__altLabel mesh__D016962 Rhizobium meliloti
% 222.04/222.20  |- skos__historyNote mesh__D016962 Rhizobium %28%1966-1991%29%
% 222.04/222.20  |- mesh__historyNote mesh__D016962 2000%28%1992%29%   
% 222.04/222.20  |- mesh__recordMaintainer mesh__D016962 SYSTEM
% 222.04/222.20  |- mesh__dateRevised mesh__D016962 2005-06-30
% 222.04/222.20  |- mesh__dateEstablished mesh__D016962 1992-01-01
% 222.04/222.20  |- skos__hiddenLabel mesh__D016164 American Buffaloes
% 222.04/222.20  |- skos__altLabel mesh__D016164 Buffalo, American
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D016164 2006
% 222.04/222.20  |- mesh__dateEstablished mesh__D016164 1991-01-01
% 222.04/222.20  |- skos__hiddenLabel mesh__D016164 American Buffalo
% 222.04/222.20  |- skos__broader mesh__D016164smesh__D012418
% 222.04/222.20  |- skos__hiddenLabel mesh__D016164 Bisons
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D016164 2005
% 222.04/222.20  |- rdf__type mesh__D016164sskos__Concept
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D016164 2004
% 222.04/222.20  |- mesh__recordOriginator mesh__D016164 PXP
% 222.04/222.20  |- skos__historyNote mesh__D016164 Animal %28%1967-1990%29%
% 222.04/222.20  |- skos__annotation mesh__D016164
% 222.04/222.20       do not confuse with BUFFALOES but note X ref; IM; qualif permitted%A%  
% 222.04/222.20  |- skos__scopeNote mesh__D016164
% 222.04/222.20       A genus of the family Bovidae having two species: B. bison and B. bonasus. This concept is differentiated from BUFFALOES, which refers to Bubalus arnee and Syncerus caffer.%A%    
% 222.04/222.20  |- mesh__recordAuthorizer mesh__D016164 sjn
% 222.04/222.20  |- mesh__recordMaintainer mesh__D016164 ags
% 222.04/222.20  |- mesh__historyNote mesh__D016164 91   
% 222.04/222.20  |- mesh__dateCreated mesh__D016164 1990-04-24
% 222.04/222.20  |- mesh__dateRevised mesh__D016164 2003-07-09
% 222.04/222.20  |- skos__historyNote mesh__D016164 Artiodactyla %28%1973-1990%29%
% 222.04/222.20  |- mesh__publicMeSHNote mesh__D016164 91   
% 222.04/222.20  |- skos__prefLabel mesh__D016164 Bison
% 222.04/222.20  |- skos__broader mesh__D002942smesh__D013057
% 222.04/222.20  |- mesh__historyNote mesh__D002942
% 222.04/222.20       91%28%70%29%; was see under SPECTRUM ANALYSIS 1970-90   
% 222.04/222.20  |- skos__scopeNote mesh__D002942
% 222.04/222.20       A change from planar to elliptic polarization when an initially plane-polarized light wave traverses an optically active medium. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 222.04/222.20  |- mesh__recordOriginator mesh__D002942 NLM
% 222.04/222.20  |- mesh__publicMeSHNote mesh__D002942
% 222.04/222.20       91; was see under SPECTRUM ANALYSIS 1970-90   
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D002942 2006
% 222.04/222.20  |- mesh__dateRevised mesh__D002942 2002-07-03
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D002942 2003
% 222.04/222.20  |- mesh__recordMaintainer mesh__D002942 ssb
% 222.04/222.20  |- skos__hiddenLabel mesh__D002942 Dichroism, Circular
% 222.04/222.20  |- skos__prefLabel mesh__D002942 Circular Dichroism
% 222.04/222.20  |- mesh__dateCreated mesh__D002942 1999-01-01
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D002942 2004
% 222.04/222.20  |- mesh__dateEstablished mesh__D002942 1991-01-01
% 222.04/222.20  |- rdf__type mesh__D002942sskos__Concept
% 222.04/222.20  |- skos__historyNote mesh__D002942 Spectrum Analysis %28%1966-1969%29%
% 222.04/222.20  |- mesh__recordAuthorizer mesh__D002942 sjn
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D002942 2005
% 222.04/222.20  |- skos__hiddenLabel mesh__D002942 Vibrational Circular Dichroism
% 222.04/222.20  |- skos__hiddenLabel mesh__D002144 Marmoset
% 222.04/222.20  |- skos__scopeNote mesh__D002144
% 222.04/222.20       A genus of CALLITRICHIDAE occurring in forests of Brazil and Bolivia and containing seventeen species.%A%    
% 222.04/222.20  |- skos__hiddenLabel mesh__D002144 Marmoset, Short Tusked
% 222.04/222.20  |- mesh__recordOriginator mesh__D002144 EC
% 222.04/222.20  |- mesh__publicMeSHNote mesh__D002144
% 222.04/222.20       1992; see CALLITHRICIDAE 1981-1991; for CEBUELLA see CALLITRICHIDAE 1981-2005%A%  
% 222.04/222.20  |- mesh__recordAuthorizer mesh__D002144 sjn
% 222.04/222.20  |- mesh__dateCreated mesh__D002144 1980-05-07
% 222.04/222.20  |- skos__annotation mesh__D002144
% 222.04/222.20       diseases: coordinate IM with MONKEY DISEASES %28%IM%29%   
% 222.04/222.20  |- skos__hiddenLabel mesh__D002144 Short-Tusked Marmosets
% 222.04/222.20  |- skos__hiddenLabel mesh__D002144 Marmosets, Short-Tusked
% 222.04/222.20  |- skos__hiddenLabel mesh__D002144 Common Marmosets
% 222.04/222.20  |- rdf__type mesh__D002144sskos__Concept
% 222.04/222.20  |- skos__altLabel mesh__D002144 Marmoset, Common
% 222.04/222.20  |- skos__historyNote mesh__D002144 Callithricidae %28%1975-1980%29%
% 222.04/222.20  |- skos__hiddenLabel mesh__D002144 Marmosets, Common
% 222.04/222.20  |- skos__broader mesh__D002144smesh__D002143
% 222.04/222.20  |- skos__altLabel mesh__D002144 Hapale
% 222.04/222.20  |- skos__hiddenLabel mesh__D002144 Common Marmoset
% 222.04/222.20  |- mesh__dateEstablished mesh__D002144 1991-01-01
% 222.04/222.20  |- skos__hiddenLabel mesh__D002144 Cebuellas
% 222.04/222.20  |- skos__altLabel mesh__D002144 Marmosets
% 222.04/222.20  |- skos__altLabel mesh__D002144 Marmoset, Short-Tusked
% 222.04/222.20  |- mesh__recordMaintainer mesh__D002144 ags
% 222.04/222.20  |- skos__hiddenLabel mesh__D002144 Short-Tusked Marmoset
% 222.04/222.20  |- mesh__dateRevised mesh__D002144 2005-06-30
% 222.04/222.20  |- skos__prefLabel mesh__D002144 Callithrix
% 222.04/222.20  |- mesh__historyNote mesh__D002144
% 222.04/222.20       1992 %28%1981%29%; for CEBUELLA use CALLITRICHIDAE 1981-2005   
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D002144 2006
% 222.04/222.20  |- skos__hiddenLabel mesh__D012572 Health Service, School
% 222.04/222.20  |- mesh__publicMeSHNote mesh__D012572 79; was SCHOOL HEALTH 1963-78   
% 222.04/222.20  |- skos__broader mesh__D012572smesh__D011314
% 222.04/222.20  |- skos__hiddenLabel mesh__D012572 Services, School-Based
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D012572 2004
% 222.04/222.20  |- skos__hiddenLabel mesh__D012572 Service, School-Based
% 222.04/222.20  |- mesh__dateCreated mesh__D012572 1999-01-01
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D012572 2001
% 222.04/222.20  |- skos__altLabel mesh__D012572 Services, School Health
% 222.04/222.20  |- mesh__recordOriginator mesh__D012572 NLM
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D012572 2003
% 222.04/222.20  |- skos__hiddenLabel mesh__D012572 School Health Service
% 222.04/222.20  |- skos__scopeNote mesh__D012572
% 222.04/222.20       Preventive health services provided for students. It excludes college or university students.%A%    
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D012572 2000
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D012572 2006
% 222.04/222.20  |- skos__hiddenLabel mesh__D012572 School-Based Service
% 222.04/222.20  |- skos__hiddenLabel mesh__D012572 Service, School Health
% 222.04/222.20  |- mesh__onlineNote mesh__D012572
% 222.04/222.20       use SCHOOL HEALTH SERVICES to search SCHOOL HEALTH 1966-78%A%  
% 222.04/222.20  |- skos__annotation mesh__D012572
% 222.04/222.20       for high school %26% under; do not confuse with STUDENT HEALTH SERVICES for univ; specify geog; DF: SCHOOL HEALTH SERV%A%  
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D012572 2005
% 222.04/222.20  |- skos__hiddenLabel mesh__D012572 School Based Services
% 222.04/222.20  |- skos__prefLabel mesh__D012572 School Health Services
% 222.04/222.20  |- skos__altLabel mesh__D012572 School-Based Services
% 222.04/222.20  |- mesh__historyNote mesh__D012572 79; was SCHOOL HEALTH 1963-78   
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D012572 2002
% 222.04/222.20  |- mesh__dateRevised mesh__D012572 1999-11-03
% 222.04/222.20  |- rdf__type mesh__D012572sskos__Concept
% 222.04/222.20  |- mesh__recordMaintainer mesh__D012572 kle
% 222.04/222.20  |- skos__hiddenLabel mesh__D012572 Health, School
% 222.04/222.20  |- mesh__recordAuthorizer mesh__D012572 sjn
% 222.04/222.20  |- skos__altLabel mesh__D012572 Health Services, School
% 222.04/222.20  |- skos__historyNote mesh__D006535 Alcohols, Octyl %28%1973-1975%29%
% 222.04/222.20  |- skos__historyNote mesh__D006535 Amino Alcohols %28%1969-1975%29%
% 222.04/222.20  |- skos__prefLabel mesh__D006535 Heptaminol
% 222.04/222.20  |- mesh__dateRevised mesh__D006535 2003-07-09
% 222.04/222.20  |- mesh__historyNote mesh__D006535
% 222.04/222.20       91%28%76%29%; was see under AMINO ALCOHOLS 1976-90   
% 222.04/222.20  |- mesh__dateCreated mesh__D006535 1975-07-25
% 222.04/222.20  |- rdf__type mesh__D006535sskos__Concept
% 222.04/222.20  |- skos__altLabel mesh__D006535 Novartis Brand of Heptaminol Hydrochloride
% 222.04/222.20  |- skos__broader mesh__D006535smesh__D000605
% 222.04/222.20  |- mesh__recordAuthorizer mesh__D006535 sjn
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D006535 2004
% 222.04/222.20  |- mesh__recordOriginator mesh__D006535 SH
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D006535 2006
% 222.04/222.20  |- skos__scopeNote mesh__D006535
% 222.04/222.20       An amino alcohol that has been used as a myocardial stimulant and vasodilator and to relieve bronchospasm. Its most common therapeutic use is in orthostatic hypotension. The mechanism of heptaminol%27%s therapeutic actions is not well understood although it has been suggested to affect catecholamine release or calcium metabolism.%A%    
% 222.04/222.20  |- mesh__dateEstablished mesh__D006535 1991-01-01
% 222.04/222.20  |- mesh__recordMaintainer mesh__D006535 BYM
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D006535 2005
% 222.04/222.20  |- mesh__publicMeSHNote mesh__D006535
% 222.04/222.20       91; was see under AMINO ALCOHOLS 1976-90   
% 222.04/222.20  |- skos__hiddenLabel mesh__D020206 Subarachnoid Hemorrhages, Traumatic
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D020206 2001
% 222.04/222.20  |- skos__hiddenLabel mesh__D020206 Hemorrhage, Traumatic Subarachnoid
% 222.04/222.20  |- skos__historyNote mesh__D020206 Craniocerebral Trauma %28%1965-1999%29%
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D020206 2002
% 222.04/222.20  |- rdf__type mesh__D020206sskos__Concept
% 222.04/222.20  |- mesh__dateEstablished mesh__D020206 2000-01-01
% 222.04/222.20  |- skos__broader mesh__D020206smesh__D020198
% 222.04/222.20  |- skos__hiddenLabel mesh__D020206 Post-Traumatic Subarachnoid Hemorrhages
% 222.04/222.20  |- mesh__publicMeSHNote mesh__D020206 2000   
% 222.04/222.20  |- skos__hiddenLabel mesh__D020206 Post Traumatic Subarachnoid Hemorrhage
% 222.04/222.20  |- skos__hiddenLabel mesh__D020206 Hemorrhages, Post-Traumatic Subarachnoid
% 222.04/222.20  |- skos__broader mesh__D020206smesh__D013345
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D020206 2005
% 222.04/222.20  |- skos__altLabel mesh__D020206 Traumatic Subarachnoid Hemorrhage
% 222.04/222.20  |- skos__hiddenLabel mesh__D020206 Hemorrhage, Post-Traumatic Subarachnoid
% 222.04/222.20  |- mesh__historyNote mesh__D020206 2000   
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D020206 2003
% 222.04/222.20  |- skos__broader mesh__D020206smesh__D020214
% 222.04/222.20  |- skos__altLabel mesh__D020206 Post-Traumatic Subarachnoid Hemorrhage
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D020206 2006
% 222.04/222.20  |- skos__hiddenLabel mesh__D020206 Subarachnoid Hemorrhage, Post-Traumatic
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D020206 2004
% 222.04/222.20  |- skos__historyNote mesh__D020206
% 222.04/222.20       Subarachnoid Hemorrhage %28%1965-1999%29%
% 222.04/222.20  |- skos__hiddenLabel mesh__D020206 Subarachnoid Hemorrhages, Post-Traumatic
% 222.04/222.20  |- mesh__activeMeSHYear mesh__D020206 2000
% 222.04/222.20  |- skos__scopeNote mesh__D020206
% 222.04/222.20       Bleeding into the subarachnoid space following CRANIOCEREBRAL TRAUMA. Minor hemorrhages may be asymptomatic; moderate to severe hemorrhages may be associated with INTRACRANIAL HYPERTENSION and VASOSPASM, INTRACRANIAL.%A%    
% 222.04/222.20  |- skos__prefLabel mesh__D020206 Subarachnoid Hemorrhage, Traumatic
% 222.04/222.20  |- mesh__dateCreated mesh__D020206 1999-11-03
% 222.04/222.20  |- skos__hiddenLabel mesh__D020206 Traumatic Subarachnoid Hemorrhages
% 222.04/222.20  |- mesh__dateCreated mesh__D016963 1991-05-30
% 222.04/222.20  |- skos__historyNote mesh__D016963 Thermus %28%1978-1991%29%
% 222.04/222.20  |- skos__prefLabel mesh__D016963 Thermus thermophilus
% 222.04/222.20  |- mesh__historyNote mesh__D016963 92   
% 222.04/222.20  |- mesh__dateRevised mesh__D016963 2005-06-30
% 222.07/222.22  |- mesh__dateEstablished mesh__D016963 1992-01-01
% 222.07/222.22  |- skos__broader mesh__D016963smesh__D013824
% 222.07/222.22  |- mesh__recordOriginator mesh__D016963 PXP
% 222.07/222.22  |- skos__annotation mesh__D016963
% 222.07/222.22       found in hot springs %26% hot-water tanks   
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D016963 2006
% 222.07/222.22  |- mesh__publicMeSHNote mesh__D016963 92   
% 222.07/222.22  |- skos__scopeNote mesh__D016963
% 222.07/222.22       A species of gram-negative, aerobic, rod-shaped bacteria found in hot springs of neutral to alkaline pH, as well as in hot-water heaters.%A%    
% 222.07/222.22  |- skos__historyNote mesh__D016963
% 222.07/222.22       Gram-Negative Aerobic Bacteria %28%1976-1977%29%
% 222.07/222.22  |- mesh__recordMaintainer mesh__D016963 SYSTEM
% 222.07/222.22  |- skos__historyNote mesh__D016963 Bacteria %28%1975%29%
% 222.07/222.22  |- mesh__recordAuthorizer mesh__D016963 sjn
% 222.07/222.22  |- rdf__type mesh__D016963sskos__Concept
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D002943 2006A
% 222.07/222.22  |- mesh__runningHead mesh__D002943
% 222.07/222.22       G9 - PHYSIOLOGY-CIRCULATORY AND RESPIRATORY   
% 222.07/222.22  |- mesh__dateCreated mesh__D002943 1999-01-01
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D002943 2004
% 222.07/222.22  |- mesh__recordOriginator mesh__D002943 NLM
% 222.07/222.22  |- mesh__dateRevised mesh__D002943 2005-07-08
% 222.07/222.22  |- skos__prefLabel mesh__D002943 Circulatory and Respiratory Physiology
% 222.07/222.22  |- rdf__type mesh__D002943sskos__Concept
% 222.07/222.22  |- skos__historyNote mesh__D002943 Blood Circulation %28%1966-1997%29%
% 222.07/222.22  |- mesh__recordAuthorizer mesh__D002943 ags
% 222.07/222.22  |- mesh__recordMaintainer mesh__D002943 ags
% 222.07/222.22  |- mesh__publicMeSHNote mesh__D002943 98   
% 222.07/222.22  |- mesh__onlineNote mesh__D002943
% 222.07/222.22       pre-explosion = CIRCULATORY RESPIRATORY PHYSIOLOGY %28%PX%29%   
% 222.07/222.22  |- mesh__dateEstablished mesh__D002943 1998-01-01
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D002943 2005
% 222.07/222.22  |- skos__scopeNote mesh__D002943
% 222.07/222.22       Functional processes and activities, properties, and phenomenon characteristic of the BLOOD; CARDIOVASCULAR SYSTEM; and the RESPIRATORY SYSTEM.%A%    
% 222.07/222.22  |- mesh__historyNote mesh__D002943 98; use pre-explosion   
% 222.07/222.22  |- skos__annotation mesh__D002943
% 222.07/222.22       not used for indexing; DF: CIRC RESPIRATORY PHYSIOL      CATALOG: do not use%A%  
% 222.07/222.22  |- skos__historyNote mesh__D002943 Respiration %28%1966-1997%29%
% 222.07/222.22  |- skos__altLabel mesh__D002943 Physiology, Circulatory and Respiratory
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D002943 2006
% 222.07/222.22  |- rdf__type mesh__D002145sskos__Concept
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D002145 2002
% 222.07/222.22  |- skos__prefLabel mesh__D002145 Callosities
% 222.07/222.22  |- skos__broader mesh__D002145smesh__D007642
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D002145 2001
% 222.07/222.22  |- mesh__recordAuthorizer mesh__D002145 ags
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D002145 2000A
% 222.07/222.22  |- mesh__dateRevised mesh__D002145 1999-11-29
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D002145 2004
% 222.07/222.22  |- skos__scopeNote mesh__D002145
% 222.07/222.22       Localized hyperplasia of the horny layer of the epidermis due to pressure or friction. %28%Dorland, 27th ed%29%%A%    
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D002145 2000
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D002145 2006
% 222.07/222.22  |- mesh__dateCreated mesh__D002145 1999-01-01
% 222.07/222.22  |- skos__annotation mesh__D002145
% 222.07/222.22       callous goes here: do not confuse with BONY CALLUS, post-fract bone formation%A%  
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D002145 2003
% 222.07/222.22  |- mesh__recordMaintainer mesh__D002145 ags
% 222.07/222.22  |- skos__hiddenLabel mesh__D002145 Callosity
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D002145 2005
% 222.07/222.22  |- mesh__recordOriginator mesh__D002145 NLM
% 222.07/222.22  |- mesh__onlineNote mesh__D002145
% 222.07/222.22       use CALLOSITIES to search CORNS 1975-92   
% 222.07/222.22  |- mesh__publicMeSHNote mesh__D002145
% 222.07/222.22       CORNS was heading 1975-92 %28%see under CALLOSITIES 1975-90%29%%A%  
% 222.07/222.22  |- mesh__historyNote mesh__D002145
% 222.07/222.22       CORNS was heading 1975-92 %28%see under CALLOSITIES 1975-90%29%%A%  
% 222.07/222.22  |- mesh__recordAuthorizer mesh__D012573 sjn
% 222.07/222.22  |- skos__broader mesh__D012573smesh__D013041
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D012573 2003
% 222.07/222.22  |- skos__hiddenLabel mesh__D012573 School Nursings
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D012573 2006
% 222.07/222.22  |- skos__broader mesh__D012573smesh__D012572
% 222.07/222.22  |- mesh__dateEstablished mesh__D012573 1967-01-01
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D012573 2001
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D012573 2005
% 222.07/222.22  |- skos__altLabel mesh__D012573 Nursing, School
% 222.07/222.22  |- mesh__historyNote mesh__D012573 67   
% 222.07/222.22  |- skos__hiddenLabel mesh__D012573 Nursings, School
% 222.07/222.22  |- mesh__recordOriginator mesh__D012573 NLM
% 222.07/222.22  |- rdf__type mesh__D012573sskos__Concept
% 222.07/222.22  |- skos__scopeNote mesh__D012573
% 222.07/222.22       Health and nursing care given to primary and secondary school students by a registered nurse.%A%    
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D012573 2000
% 222.07/222.22  |- skos__prefLabel mesh__D012573 School Nursing
% 222.07/222.22  |- skos__annotation mesh__D012573
% 222.07/222.22       do not confuse with SCHOOLS, NURSING; SPEC: SPEC qualif   
% 222.07/222.22  |- mesh__publicMeSHNote mesh__D012573 67   
% 222.07/222.22  |- skos__historyNote mesh__D012573 Public Health Nursing %28%1966%29%
% 222.07/222.22  |- skos__historyNote mesh__D012573 Nursing %28%1966%29%
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D012573 2004
% 222.07/222.22  |- skos__historyNote mesh__D012573 School Health Services %28%1966%29%
% 222.07/222.22  |- mesh__dateCreated mesh__D012573 1999-01-01
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D012573 2002
% 222.07/222.22  |- mesh__dateRevised mesh__D012573 1999-11-03
% 222.07/222.22  |- mesh__recordMaintainer mesh__D012573 kle
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D006536 1999
% 222.07/222.22  |- mesh__historyNote mesh__D006536 78   
% 222.07/222.22  |- rdf__type mesh__D006536sskos__Concept
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D006536 1993
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D006536 1996
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D006536 1995
% 222.07/222.22  |- mesh__recordAuthorizer mesh__D006536 PLS
% 222.07/222.22  |- mesh__dateEstablished mesh__D006536 1978-01-01
% 222.07/222.22  |- skos__historyNote mesh__D006536 Hydrocarbons %28%1966-1977%29%
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D006536 2002
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D006536 1998
% 222.07/222.22  |- mesh__recordOriginator mesh__D006536 RLS
% 222.07/222.22  |- mesh__dateCreated mesh__D006536 1977-05-20
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D006536 1994
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D006536 2004
% 222.07/222.22  |- skos__historyNote mesh__D006536 Alkanes %28%1966-1977%29%
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D006536 2001
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D006536 2006
% 222.07/222.22  |- skos__broader mesh__D006536smesh__D000473
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D006536 2003
% 222.07/222.22  |- skos__annotation mesh__D006536
% 222.07/222.22       does not include heptenes %28% = ALKENES%29%, heptadienes %28% = ALKADIENES%29%, or heptatrienes %28% = POLYENES%29%; CYCLOHEPTANES is also available%A%  
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D006536 2000
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D006536 2005
% 222.07/222.22  |- skos__scopeNote mesh__D006536
% 222.07/222.22       Seven-carbon saturated hydrocarbon group of the methane series. Include isomers and derivatives.%A%    
% 222.07/222.22  |- mesh__publicMeSHNote mesh__D006536 78   
% 222.07/222.22  |- mesh__recordMaintainer mesh__D006536 TGC
% 222.07/222.22  |- mesh__dateRevised mesh__D006536 1992-05-19
% 222.07/222.22  |- skos__prefLabel mesh__D006536 Heptanes
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D006536 1997
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D020207 2005
% 222.07/222.22  |- skos__historyNote mesh__D020207 Coma %28%1965-1999%29%
% 222.07/222.22  |- skos__hiddenLabel mesh__D020207 Coma, Post Concussive
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D020207 2001
% 222.07/222.22  |- skos__broader mesh__D020207smesh__D003128
% 222.07/222.22  |- skos__hiddenLabel mesh__D020207 Coma, Post Head Injury
% 222.07/222.22  |- mesh__dateCreated mesh__D020207 1999-11-08
% 222.07/222.22  |- skos__hiddenLabel mesh__D020207 Post-Trauma Coma
% 222.07/222.22  |- skos__altLabel mesh__D020207 Coma, Traumatic
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D020207 2000
% 222.07/222.22  |- skos__hiddenLabel mesh__D020207 Post-Trauma Comas
% 222.07/222.22  |- skos__hiddenLabel mesh__D020207 Traumatic Coma
% 222.07/222.22  |- mesh__dateEstablished mesh__D020207 2000-01-01
% 222.07/222.22  |- skos__historyNote mesh__D020207 Brain Injuries %28%1965-1999%29%
% 222.07/222.22  |- skos__hiddenLabel mesh__D020207 Comas, Post-Concussive
% 222.07/222.22  |- skos__altLabel mesh__D020207 Coma, Post-Trauma
% 222.07/222.22  |- rdf__type mesh__D020207sskos__Concept
% 222.07/222.22  |- skos__hiddenLabel mesh__D020207 Post-Head Injury Comas
% 222.07/222.22  |- skos__hiddenLabel mesh__D020207 Coma, Post Trauma
% 222.07/222.22  |- skos__broader mesh__D020207smesh__D006259
% 222.07/222.22  |- skos__hiddenLabel mesh__D020207 Post Head Injury Coma
% 222.07/222.22  |- skos__hiddenLabel mesh__D020207 Post-Concussive Comas
% 222.07/222.22  |- skos__prefLabel mesh__D020207 Coma, Post-Head Injury
% 222.07/222.22  |- skos__altLabel mesh__D020207 Coma, Post-Traumatic
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D020207 2004
% 222.07/222.22  |- skos__altLabel mesh__D020207 Coma, Post-Concussive
% 222.07/222.22  |- skos__hiddenLabel mesh__D020207 Comas, Post-Trauma
% 222.07/222.22  |- skos__hiddenLabel mesh__D020207 Post-Traumatic Coma
% 222.07/222.22  |- skos__hiddenLabel mesh__D020207 Coma, Post Traumatic
% 222.07/222.22  |- skos__hiddenLabel mesh__D020207 Post-Concussive Coma
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D020207 2006
% 222.07/222.22  |- skos__scopeNote mesh__D020207
% 222.07/222.22       Prolonged unconsciousness from which the individual cannot be aroused, associated with traumatic injuries to the BRAIN. This may be defined as unconsciousness persisting for 6 hours or longer. Coma results from injury to both cerebral hemispheres or the RETICULAR FORMATION of the BRAIN STEM. Contributing mechanisms include DIFFUSE AXONAL INJURY and BRAIN EDEMA. %28%From J Neurotrauma 1997 Oct;14%28%10%29%:699-713%29%%A%    
% 222.07/222.22  |- mesh__activeMeSHYear mesh__D020207 2003
% 222.07/222.22  |- mesh__publicMeSHNote mesh__D020207 2000   
% 222.07/222.22  |- skos__altLabel mesh__D020207 Post-Head Injury Coma
% 222.07/222.22  |- mesh__historyNote mesh__D020207 2000   
% 222.07/222.22  |- skos__hiddenLabel mesh__D020207 Comas, Post-Head Injury
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D020207 2002
% 222.07/222.23  |- mesh__recordOriginator mesh__D016964 PXP
% 222.07/222.23  |- skos__prefLabel mesh__D016964 Gram-Negative Anaerobic Cocci
% 222.07/222.23  |- skos__broader mesh__D016964smesh__D006089
% 222.07/222.23  |- mesh__recordAuthorizer mesh__D016964 sjn
% 222.07/222.23  |- skos__historyNote mesh__D016964 Bacteria %28%1966-1975%29%
% 222.07/222.23  |- mesh__dateEstablished mesh__D016964 1992-01-01
% 222.07/222.23  |- mesh__recordMaintainer mesh__D016964 SYSTEM
% 222.07/222.23  |- mesh__dateRevised mesh__D016964 2005-06-30
% 222.07/222.23  |- rdf__type mesh__D016964sskos__Concept
% 222.07/222.23  |- skos__scopeNote mesh__D016964
% 222.07/222.23       A group of anaerobic coccoid bacteria that show up as pink %28%negative%29% when treated by the gram-staining method.%A%    
% 222.07/222.23  |- skos__historyNote mesh__D016964
% 222.07/222.23       Gram-Negative Anaerobic Bacteria %28%1976-1991%29%
% 222.07/222.23  |- skos__annotation mesh__D016964
% 222.07/222.23       GEN: avoid; prefer specifics; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%; DF: GRAM NEG ANAEROBIC COCCI%A%  
% 222.07/222.23  |- skos__altLabel mesh__D016964 Gram Negative Anaerobic Cocci
% 222.07/222.23  |- mesh__historyNote mesh__D016964 92   
% 222.07/222.23  |- mesh__publicMeSHNote mesh__D016964 92   
% 222.07/222.23  |- mesh__dateCreated mesh__D016964 1991-05-30
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D016964 2006
% 222.07/222.23  |- skos__scopeNote mesh__D016166
% 222.07/222.23       Substances that influence the course of a chemical reaction by ready combination with free radicals. Among other effects, this combining activity protects pancreatic islets against damage by cytokines and prevents myocardial and pulmonary perfusion injuries.%A%    
% 222.07/222.23  |- skos__hiddenLabel mesh__D016166 Scavengers, Free Radical
% 222.07/222.23  |- rdf__type mesh__D016166sskos__Concept
% 222.07/222.23  |- mesh__dateCreated mesh__D016166 1990-04-24
% 222.07/222.23  |- mesh__recordAuthorizer mesh__D016166 sjn
% 222.07/222.23  |- mesh__dateEstablished mesh__D016166 1991-01-01
% 222.07/222.23  |- mesh__publicMeSHNote mesh__D016166 91   
% 222.07/222.23  |- mesh__dateRevised mesh__D016166 2005-06-30
% 222.07/222.23  |- skos__prefLabel mesh__D016166 Free Radical Scavengers
% 222.07/222.23  |- mesh__historyNote mesh__D016166 91   
% 222.07/222.23  |- mesh__recordOriginator mesh__D016166 RLS
% 222.07/222.23  |- mesh__recordMaintainer mesh__D016166 ssb
% 222.07/222.23  |- skos__historyNote mesh__D016166 Free Radicals %28%1967-1990%29%
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D016166 2006
% 222.07/222.23  |- skos__broader mesh__D016166smesh__D000975
% 222.07/222.23  |- skos__altLabel mesh__D002944 Male Circumcision
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D002944 2006
% 222.07/222.23  |- skos__hiddenLabel mesh__D002944 Circumcisions, Male
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D002944 2005
% 222.07/222.23  |- skos__hiddenLabel mesh__D002944 Circumcisions
% 222.07/222.23  |- mesh__recordAuthorizer mesh__D002944 sjn
% 222.07/222.23  |- skos__broader mesh__D002944smesh__D013521
% 222.07/222.23  |- rdf__type mesh__D002944sskos__Concept
% 222.07/222.23  |- skos__annotation mesh__D002944
% 222.07/222.23        GEN or unspecified but usually male; when male, check tags  HUMANS %26% MALE; when unspecified, check HUMANS but no sex tag; for female, CIRCUMCISION, FEMALE is available%A%  
% 222.07/222.23  |- skos__hiddenLabel mesh__D002944 Male Circumcisions
% 222.07/222.23  |- skos__prefLabel mesh__D002944 Circumcision
% 222.07/222.23  |- mesh__dateCreated mesh__D002944 1999-01-01
% 222.07/222.23  |- mesh__recordMaintainer mesh__D002944 sjn
% 222.07/222.23  |- mesh__recordOriginator mesh__D002944 NLM
% 222.07/222.23  |- skos__broader mesh__D002944smesh__D046289
% 222.07/222.23  |- mesh__dateRevised mesh__D002944 2004-07-13
% 222.07/222.23  |- skos__scopeNote mesh__D002944
% 222.07/222.23       Excision of the prepuce or part of it.     
% 222.07/222.23  |- skos__hiddenLabel mesh__D002944 Circumcision, Male
% 222.07/222.23  |- mesh__recordOriginator mesh__D002146 NLM
% 222.07/222.23  |- skos__hiddenLabel mesh__D002146 Callus, Bony
% 222.07/222.23  |- skos__prefLabel mesh__D002146 Bony Callus
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D002146 2006
% 222.07/222.23  |- skos__broader mesh__D002146smesh__D001842
% 222.07/222.23  |- mesh__dateCreated mesh__D002146 1999-01-01
% 222.07/222.23  |- skos__annotation mesh__D002146
% 222.07/222.23       post-fract bone formation; do not confuse with %22%callous%22% %28% = CALLOSITIES%29%%A%  
% 222.07/222.23  |- mesh__dateRevised mesh__D002146 2005-06-30
% 222.07/222.23  |- mesh__recordMaintainer mesh__D002146 ssb
% 222.07/222.23  |- skos__scopeNote mesh__D002146
% 222.07/222.23       The bony deposit formed between and around the broken ends of BONE FRACTURES during normal healing.%A%    
% 222.07/222.23  |- skos__related mesh__D002146smesh__D050723
% 222.07/222.23  |- mesh__publicMeSHNote mesh__D002146
% 222.07/222.23       2000; see CALLUS 1973-1999, see FRACTURES 1963-1972   
% 222.07/222.23  |- skos__altLabel mesh__D002146 Callus
% 222.07/222.23  |- mesh__historyNote mesh__D002146 2000%28%1973%29%   
% 222.07/222.23  |- skos__historyNote mesh__D002146 Fractures %28%1966-1972%29%
% 222.07/222.23  |- mesh__recordAuthorizer mesh__D002146 sjn
% 222.07/222.23  |- rdf__type mesh__D002146sskos__Concept
% 222.07/222.23  |- mesh__dateEstablished mesh__D002146 1973-01-01
% 222.07/222.23  |- skos__related mesh__D002146smesh__D010012
% 222.07/222.23  |- skos__historyNote mesh__D048248 Acanthamoeba %28%1987-2004%29%
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D048248 2006
% 222.07/222.23  |- rdf__type mesh__D048248sskos__Concept
% 222.07/222.23  |- skos__scopeNote mesh__D048248
% 222.07/222.23       A species of free-living soil amoebae in the family Acanthamoebidae. It can cause ENCEPHALITIS and KERATITIS in humans.%A%    
% 222.07/222.23  |- skos__historyNote mesh__D048248 Sarcodina %28%1968-1974%29%
% 222.07/222.23  |- mesh__recordMaintainer mesh__D048248 ags
% 222.07/222.23  |- skos__prefLabel mesh__D048248 Acanthamoeba castellanii
% 222.07/222.23  |- skos__historyNote mesh__D048248 Amoeba %28%1974-1987%29%
% 222.07/222.23  |- mesh__publicMeSHNote mesh__D048248 2005   
% 222.07/222.23  |- skos__annotation mesh__D048248
% 222.07/222.23       infection: coordinate IM with AMEBIASIS %28%IM%29%; or ACANTHAMOEBA KERATITIS %28%IM%29% if pertinent%A%  
% 222.07/222.23  |- mesh__dateEstablished mesh__D048248 2005-01-01
% 222.07/222.23  |- mesh__recordOriginator mesh__D048248 ags
% 222.07/222.23  |- mesh__dateCreated mesh__D048248 2004-07-07
% 222.07/222.23  |- skos__broader mesh__D048248smesh__D000048
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D048248 2005
% 222.07/222.23  |- mesh__recordAuthorizer mesh__D048248 sjn
% 222.07/222.23  |- mesh__historyNote mesh__D048248 2005   
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D012574 2005
% 222.07/222.23  |- skos__broader mesh__D012574smesh__D004493
% 222.07/222.23  |- skos__annotation mesh__D012574
% 222.07/222.23       policy: Manual 30.7.3, 30.8; specify geog if pertinent   
% 222.07/222.23  |- skos__hiddenLabel mesh__D012574 School
% 222.07/222.23  |- skos__altLabel mesh__D012574 Secondary Schools
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D012574 2006
% 222.07/222.23  |- skos__prefLabel mesh__D012574 Schools
% 222.07/222.23  |- skos__hiddenLabel mesh__D012574 Secondary School
% 222.07/222.23  |- mesh__recordMaintainer mesh__D012574 kle
% 222.07/222.23  |- skos__hiddenLabel mesh__D012574 School, Primary
% 222.07/222.23  |- mesh__recordAuthorizer mesh__D012574 sjn
% 222.07/222.23  |- skos__hiddenLabel mesh__D012574 Schools, Primary
% 222.07/222.23  |- mesh__dateCreated mesh__D012574 1999-01-01
% 222.07/222.23  |- rdf__type mesh__D012574sskos__Concept
% 222.07/222.23  |- mesh__dateRevised mesh__D012574 1999-11-03
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D012574 2000
% 222.07/222.23  |- skos__hiddenLabel mesh__D012574 School, Secondary
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D012574 2003
% 222.07/222.23  |- skos__hiddenLabel mesh__D012574 Primary School
% 222.07/222.23  |- skos__scopeNote mesh__D012574 Educational institutions.     
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D012574 2001
% 222.07/222.23  |- skos__broader mesh__D012574smesh__D004505
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D012574 2004
% 222.07/222.23  |- mesh__recordOriginator mesh__D012574 NLM
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D012574 2002
% 222.07/222.23  |- mesh__historyNote mesh__D006537
% 222.07/222.23       91%28%75%29%; was see under HEPTANOIC ACIDS 1975-90   
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D006537 2004
% 222.07/222.23  |- mesh__recordOriginator mesh__D006537 NLM
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D006537 2006
% 222.07/222.23  |- mesh__recordAuthorizer mesh__D006537 sjn
% 222.07/222.23  |- mesh__publicMeSHNote mesh__D006537
% 222.07/222.23       91; was see under HEPTANOIC ACIDS 1975-90   
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D006537 2005
% 222.07/222.23  |- mesh__dateCreated mesh__D006537 1974-11-14
% 222.07/222.23  |- mesh__dateEstablished mesh__D006537 1991-01-01
% 222.07/222.23  |- mesh__recordMaintainer mesh__D006537 ssb
% 222.07/222.23  |- skos__scopeNote mesh__D006537
% 222.07/222.23       Salts and esters of the 7-carbon saturated monocarboxylic acid heptanoic acid.%A%    
% 222.07/222.23  |- skos__broader mesh__D006537smesh__D006538
% 222.07/222.23  |- skos__altLabel mesh__D006537 Enanthates
% 222.07/222.23  |- mesh__dateRevised mesh__D006537 2003-07-09
% 222.07/222.23  |- skos__prefLabel mesh__D006537 Heptanoates
% 222.07/222.23  |- skos__historyNote mesh__D006537 Fatty Acids %28%1969-1974%29%
% 222.07/222.23  |- rdf__type mesh__D006537sskos__Concept
% 222.07/222.23  |- skos__historyNote mesh__D020208 Brain Damage, Chronic %28%1965-1999%29%
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208 Post-Concussive Chronic Encephalopathy
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208
% 222.07/222.23       Encephalopathies, Chronic Post-Concussive
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208 Encephalopathies, Chronic Post-Traumatic
% 222.07/222.23  |- mesh__publicMeSHNote mesh__D020208 2000   
% 222.07/222.23  |- mesh__dateEstablished mesh__D020208 2000-01-01
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208
% 222.07/222.23       Encephalopathies, Post-Concussive Chronic
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208
% 222.07/222.23       Post-Concussive Encephalopathies, Chronic
% 222.07/222.23  |- skos__scopeNote mesh__D020208
% 222.07/222.23       Conditions characterized by persistent brain damage or dysfunction as sequelae of cranial trauma. This disorder may result from DIFFUSE AXONAL INJURY; INTRACRANIAL HEMORRHAGES; BRAIN EDEMA; and other conditions. Clinical features may include DEMENTIA; focal neurologic deficits; PERSISTENT VEGETATIVE STATE; AKINETIC MUTISM; or COMA.%A%    
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208
% 222.07/222.23       Chronic Encephalopathies, Post-Concussive
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208 Post-Concussive Chronic Encephalopathies
% 222.07/222.23  |- skos__broader mesh__D020208smesh__D001925
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D020208 2006
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208 Chronic Post Concussive Encephalopathy
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208 Post-Traumatic Encephalopathy, Chronic
% 222.07/222.23  |- skos__altLabel mesh__D020208 Encephalopathy, Post-Traumatic, Chronic
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D020208 2003
% 222.07/222.23  |- mesh__recordAuthorizer mesh__D020208 sjn
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208 Brain Injuries, Chronic
% 222.07/222.23  |- mesh__recordMaintainer mesh__D020208 lkt
% 222.07/222.23  |- skos__altLabel mesh__D020208 Chronic Post-Traumatic Encephalopathy
% 222.07/222.23  |- skos__altLabel mesh__D020208 Chronic Brain Injury
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208 Chronic Post Traumatic Encephalopathy
% 222.07/222.23  |- skos__altLabel mesh__D020208 Chronic Post-Concussive Encephalopathy
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208 Chronic Encephalopathy, Post Concussive
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208 Encephalopathy, Post-Concussive Chronic
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208 Traumatic Encephalopathies, Chronic
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D020208 2004
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208 Encephalopathy, Chronic Traumatic
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208 Chronic Post-Traumatic Encephalopathies
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208 Chronic Brain Injuries
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208 Chronic Post-Concussive Encephalopathies
% 222.07/222.23  |- skos__broader mesh__D020208smesh__D001930
% 222.07/222.23  |- skos__altLabel mesh__D020208 Traumatic Encephalopathy, Chronic
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208 Chronic Traumatic Encephalopathy
% 222.07/222.23  |- mesh__dateCreated mesh__D020208 1999-11-08
% 222.07/222.23  |- rdf__type mesh__D020208sskos__Concept
% 222.07/222.23  |- skos__altLabel mesh__D020208 Injury, Brain, Chronic
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208 Encephalopathy, Chronic Post-Concussive
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208 Post-Traumatic Encephalopathies, Chronic
% 222.07/222.23  |- mesh__dateRevised mesh__D020208 2002-07-02
% 222.07/222.23  |- skos__prefLabel mesh__D020208 Brain Injury, Chronic
% 222.07/222.23  |- mesh__historyNote mesh__D020208 2000   
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208 Encephalopathy, Chronic Post-Traumatic
% 222.07/222.23  |- skos__hiddenLabel mesh__D020208 Post-Concussive Encephalopathy, Chronic
% 222.07/222.23  |- mesh__recordOriginator mesh__D020208 KEV
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D020208 2005
% 222.07/222.23  |- skos__prefLabel mesh__D016965
% 222.07/222.23       Gram-Negative Anaerobic Straight, Curved, and Helical Rods
% 222.07/222.23  |- skos__scopeNote mesh__D016965
% 222.07/222.23       A group of anaerobic, rod-shaped bacteria that show up as pink %28%negative%29% when treated by the Gram-staining method.%A%    
% 222.07/222.23  |- mesh__dateCreated mesh__D016965 1991-08-23
% 222.07/222.23  |- mesh__recordMaintainer mesh__D016965 SYSTEM
% 222.07/222.23  |- skos__historyNote mesh__D016965
% 222.07/222.23       Gram-Negative Anaerobic Bacteria %28%1992-1997%29%
% 222.07/222.23  |- skos__broader mesh__D016965smesh__D006089
% 222.07/222.23  |- rdf__type mesh__D016965sskos__Concept
% 222.07/222.23  |- skos__annotation mesh__D016965
% 222.07/222.23       avoid: too general; prefer specific families %26% genera; coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%; DF: GRAM NEG ANAEROBIC RODS%A%  
% 222.07/222.23  |- mesh__recordAuthorizer mesh__D016965 sjn
% 222.07/222.23  |- mesh__dateRevised mesh__D016965 2005-06-30
% 222.07/222.23  |- mesh__publicMeSHNote mesh__D016965 98   
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D016965 2006
% 222.07/222.23  |- mesh__dateEstablished mesh__D016965 1998-01-01
% 222.07/222.23  |- mesh__recordOriginator mesh__D016965 PXP
% 222.07/222.23  |- mesh__historyNote mesh__D016965 98; use explode 1992-97   
% 222.07/222.23  |- skos__altLabel mesh__D016965
% 222.07/222.23       Gram Negative Anaerobic Straight, Curved, and Helical Rods
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D016167 2006A
% 222.07/222.23  |- skos__altLabel mesh__D016167 Complement Receptor Type 4
% 222.07/222.23  |- rdf__type mesh__D016167sskos__Concept
% 222.07/222.23  |- skos__altLabel mesh__D016167 Neutrophil Glycoprotein Gp150
% 222.07/222.23  |- skos__hiddenLabel mesh__D016167 Integrin, alphaXbeta2
% 222.07/222.23  |- skos__broader mesh__D016167smesh__D016028
% 222.07/222.23  |- mesh__dateEstablished mesh__D016167 1991-01-01
% 222.07/222.23  |- mesh__recordMaintainer mesh__D016167 ags
% 222.07/222.23  |- skos__altLabel mesh__D016167 Receptor, CR4
% 222.07/222.23  |- skos__hiddenLabel mesh__D016167 Gp150, Neutrophil Glycoprotein
% 222.07/222.23  |- skos__annotation mesh__D016167 DF: CR4 RECEPT   
% 222.07/222.23  |- skos__historyNote mesh__D016167
% 222.07/222.23       Antigens, Differentiation %28%1988-1990%29%
% 222.07/222.23  |- skos__historyNote mesh__D016167
% 222.07/222.23       Receptors, Leukocyte-Adhesion %28%1989-1990%29%
% 222.07/222.23  |- skos__altLabel mesh__D016167 Antigen p150,95
% 222.07/222.23  |- skos__altLabel mesh__D016167 alphaXbeta2 Integrin
% 222.07/222.23  |- skos__hiddenLabel mesh__D016167 alphaXbeta2, Integrin
% 222.07/222.23  |- skos__altLabel mesh__D016167 p150,95 Glycoprotein
% 222.07/222.23  |- skos__hiddenLabel mesh__D016167 GP150, Neutrophil
% 222.07/222.23  |- mesh__dateCreated mesh__D016167 1990-04-24
% 222.07/222.23  |- skos__broader mesh__D016167smesh__D015815
% 222.07/222.23  |- skos__altLabel mesh__D016167 CR4 Receptor
% 222.07/222.23  |- skos__altLabel mesh__D016167 p150,95 Antigen
% 222.07/222.23  |- skos__altLabel mesh__D016167 Neutrophil GP150
% 222.07/222.23  |- mesh__historyNote mesh__D016167
% 222.07/222.23       2003 %28%1991%29%; use INTEGRIN ALPHAXBETA2 %28%NM%29% 1985-2002   
% 222.07/222.23  |- mesh__dateRevised mesh__D016167 2005-07-20
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D016167 2006
% 222.07/222.23  |- skos__broader mesh__D016167smesh__D011951
% 222.07/222.23  |- mesh__recordAuthorizer mesh__D016167 ags
% 222.07/222.23  |- skos__prefLabel mesh__D016167 Integrin alphaXbeta2
% 222.07/222.23  |- skos__altLabel mesh__D016167 Leukocyte Adhesion Protein p150,95
% 222.07/222.23  |- skos__altLabel mesh__D016167 Complement Receptor 4
% 222.07/222.23  |- mesh__publicMeSHNote mesh__D016167
% 222.07/222.23       2003; see COMPLEMENT 4-BINDING PROTEIN 2002, see ANTIGEN P150,95 1991-2001; INTEGRIN APHAXBETA2 was indexed under MEMBRANE GLYCOPROTEINS 1988-2002 %26% GLYCOPROTEINS 1985-1987%A%  
% 222.07/222.23  |- skos__hiddenLabel mesh__D016167 Glycoprotein, p150,95
% 222.07/222.23  |- mesh__recordOriginator mesh__D016167 RLS
% 222.07/222.23  |- skos__scopeNote mesh__D016167
% 222.07/222.23       A major adhesion-associated heterodimer molecule expressed by MONOCYTES; GRANULOCYTES; NK CELLS; and some LYMPHOCYTES. The alpha subunit is the CD11c ANTIGEN %28%also called Leu-M5%29%, a surface antigen expressed on some myeloid cells. The beta subunit is the CD18 antigen %28%ANTIGENS, CD18%29%.%A%    
% 222.07/222.23  |- skos__hiddenLabel mesh__D016167 Glycoprotein Gp150, Neutrophil
% 222.07/222.23  |- skos__hiddenLabel mesh__D016167 Antigen, p150,95
% 222.07/222.23  |- skos__hiddenLabel mesh__D002945 Diamminodichloride, Platinum
% 222.07/222.23  |- skos__broader mesh__D002945smesh__D017606
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D002945 2004
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D002945 2005
% 222.07/222.23  |- skos__historyNote mesh__D002945 Platinum %28%1966-1973%29%
% 222.07/222.23  |- skos__altLabel mesh__D002945 cis-Diamminedichloroplatinum
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D002945 2003
% 222.07/222.23  |- skos__historyNote mesh__D002945 Ammonium Compounds %28%1966-1973%29%
% 222.07/222.23  |- skos__altLabel mesh__D002945 Platinum Diamminodichloride
% 222.07/222.23  |- skos__hiddenLabel mesh__D002945 cis Platinum
% 222.07/222.23  |- skos__altLabel mesh__D002945 Dichlorodiammineplatinum
% 222.07/222.23  |- mesh__dateEstablished mesh__D002945 1984-01-01
% 222.07/222.23  |- mesh__dateCreated mesh__D002945 1999-01-01
% 222.07/222.23  |- rdf__type mesh__D002945sskos__Concept
% 222.07/222.23  |- skos__altLabel mesh__D002945 cis-Diamminedichloroplatinum%28%II%29%
% 222.07/222.23  |- mesh__onlineNote mesh__D002945
% 222.07/222.23       use CISPLATIN to search PLATINUM DIAMMINODICHLORIDE 1974-80 %26% DIAMMONIUM CHLOROPLATINUM COMPOUNDS 1974-83%A%  
% 222.07/222.23  |- skos__altLabel mesh__D002945 cis-Platinum
% 222.07/222.23  |- mesh__historyNote mesh__D002945
% 222.07/222.23       84%28%81%29%; was see under DIAMMONIUM CHLOROPLATINUM COMPOUNDS 1981-83; was PLATINUM DIAMMINODICHLORIDE see under DIAMMONIUM CHLOROPLATINUM COMPOUNDS 1974-80; DIAMMONIUM CHLOROPLATINUM COMPOUNDS was heading 1974-83%A%  
% 222.07/222.23  |- skos__historyNote mesh__D002945 Amines %28%1966-1973%29%
% 222.07/222.23  |- skos__historyNote mesh__D002945 Chlorides %28%1966-1973%29%
% 222.07/222.23  |- skos__prefLabel mesh__D002945 Cisplatin
% 222.07/222.23  |- mesh__recordAuthorizer mesh__D002945 sjn
% 222.07/222.23  |- skos__scopeNote mesh__D002945
% 222.07/222.23       An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle.%A%    
% 222.07/222.23  |- mesh__dateRevised mesh__D002945 2001-07-25
% 222.07/222.23  |- skos__altLabel mesh__D002945 cis-Dichlorodiammineplatinum%28%II%29%
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D002945 2002
% 222.07/222.23  |- skos__broader mesh__D002945smesh__D017671
% 222.07/222.23  |- skos__hiddenLabel mesh__D002945 cis Diamminedichloroplatinum
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D002945 2006
% 222.07/222.23  |- mesh__recordOriginator mesh__D002945 NLM
% 222.07/222.23  |- mesh__recordMaintainer mesh__D002945 jmp
% 222.07/222.23  |- skos__broader mesh__D002945smesh__D017672
% 222.07/222.23  |- mesh__publicMeSHNote mesh__D002945
% 222.07/222.23       84; was see under DIAMMONIUM CHLOROPLATINUM COMPOUNDS 1981-83; was PLATINUM DIAMMINODICHLORIDE see under DIAMMONIUM CHLOROPLATINUM COMPOUNDS 1974-80; DIAMMONIUM CHLOROPLATINUM COMPOUNDS was heading 1974-83%A%  
% 222.07/222.23  |- mesh__dateRevised mesh__D035321 2005-08-02
% 222.07/222.23  |- mesh__dateCreated mesh__D035321 2002-07-03
% 222.07/222.23  |- skos__scopeNote mesh__D035321
% 222.07/222.23       A ubiquitously expressed telomere-binding protein that is present at TELOMERES throughout the CELL CYCLE. It is a suppressor of telomere elongation and may be involved in stabilization of telomere length. It is structurally different from TELOMERIC REPEAT BINDING PROTEIN 2 in that it contains acidic N-terminal amino acid residues.%A%    
% 222.07/222.23  |- skos__historyNote mesh__D035321 DNA-Binding Proteins %28%1997-2002%29%
% 222.07/222.23  |- mesh__recordMaintainer mesh__D035321 ags
% 222.07/222.23  |- mesh__recordAuthorizer mesh__D035321 ags
% 222.07/222.23  |- skos__altLabel mesh__D035321 TRF1 Protein
% 222.07/222.23  |- skos__prefLabel mesh__D035321 Telomeric Repeat Binding Protein 1
% 222.07/222.23  |- skos__broader mesh__D035321smesh__D034501
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D035321 2006A
% 222.07/222.23  |- rdf__type mesh__D035321sskos__Concept
% 222.07/222.23  |- skos__altLabel mesh__D035321 TERF1 Protein
% 222.07/222.23  |- mesh__historyNote mesh__D035321
% 222.07/222.23       2003; for TRF1 PROTEIN use TELOMERE-BINDING PROTEINS %28%NM%29% 1997-2002;%A%  
% 222.07/222.23  |- skos__altLabel mesh__D035321 TTAGGG Repeat Binding Factor 1
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D035321 2006
% 222.07/222.23  |- mesh__dateEstablished mesh__D035321 2003-01-01
% 222.07/222.23  |- mesh__recordOriginator mesh__D035321 jmp
% 222.07/222.23  |- mesh__publicMeSHNote mesh__D035321
% 222.07/222.23       2003; TRF1 PROTEIN was indexed under DNA-BINDING PROTEINS 1997-2002%A%  
% 222.07/222.23  |- skos__hiddenLabel mesh__D002147 Protein, Bovine Activator
% 222.07/222.23  |- skos__hiddenLabel mesh__D002147 Factor, Phosphodiesterase Activating
% 222.07/222.23  |- skos__altLabel mesh__D002147 Phosphodiesterase Activator Protein
% 222.07/222.23  |- skos__historyNote mesh__D002147 Calcium %28%1966-1978%29%
% 222.07/222.23  |- skos__hiddenLabel mesh__D002147 Activator Protein, Bovine
% 222.07/222.23  |- skos__altLabel mesh__D002147 Phosphodiesterase Protein Activator
% 222.07/222.23  |- skos__altLabel mesh__D002147 Calcium-Dependent Regulator
% 222.07/222.23  |- mesh__recordAuthorizer mesh__D002147 sjn
% 222.07/222.23  |- mesh__recordMaintainer mesh__D002147 jmp
% 222.07/222.23  |- skos__hiddenLabel mesh__D002147 Calcium Dependent Activator Protein
% 222.07/222.23  |- skos__hiddenLabel mesh__D002147 Activator Protein, Calcium-Dependent
% 222.07/222.23  |- skos__hiddenLabel mesh__D002147 Activating Factor, Phosphodiesterase
% 222.07/222.23  |- skos__historyNote mesh__D002147 Carrier Proteins %28%1971-1978%29%
% 222.07/222.23  |- mesh__historyNote mesh__D002147
% 222.07/222.23       84; was CALCIUM-DEPENDENT REGULATOR see under CALCIUM-BINDING PROTEINS 1980-83; was CALCIUM-DEPENDENT REGULATOR see under CARRIER PROTEINS 1979%A%  
% 222.07/222.23  |- skos__annotation mesh__D002147
% 222.07/222.23       a calcium-binding protein; /biosyn /physiol permitted   
% 222.07/222.23  |- skos__hiddenLabel mesh__D002147 Activator Protein, Phosphodiesterase
% 222.07/222.23  |- skos__hiddenLabel mesh__D002147 Protein Activator, Phosphodiesterase
% 222.07/222.23  |- mesh__publicMeSHNote mesh__D002147
% 222.07/222.23       84; was CALCIUM-DEPENDENT REGULATOR see under CALCIUM-BINDING PROTEINS 1980-83; was CALCIUM-DEPENDENT REGULATOR see under CARRIER PROTEINS 1979%A%  
% 222.07/222.23  |- mesh__dateEstablished mesh__D002147 1984-01-01
% 222.07/222.23  |- skos__hiddenLabel mesh__D002147 Protein, Phosphodiesterase Activator
% 222.07/222.23  |- skos__hiddenLabel mesh__D002147 Calcium Dependent Regulator
% 222.07/222.23  |- skos__historyNote mesh__D002147 Enzyme Activation %28%1969-1978%29%
% 222.07/222.23  |- skos__scopeNote mesh__D002147
% 222.07/222.23       A heat-stable, low-molecular-weight activator protein found mainly in the brain and heart. The binding of calcium ions to this protein allows this protein to bind to cyclic nucleotide phosphodiesterases and to adenyl cyclase with subsequent activation. Thereby this protein modulates cyclic AMP and cyclic GMP levels.%A%    
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D002147 2006
% 222.07/222.23  |- skos__hiddenLabel mesh__D002147 Protein, Calcium-Dependent Activator
% 222.07/222.23  |- mesh__dateRevised mesh__D002147 2005-06-30
% 222.07/222.23  |- skos__hiddenLabel mesh__D002147 AMP-Phosphodiesterase Activator, Cyclic
% 222.07/222.23  |- skos__hiddenLabel mesh__D002147 Cyclic AMP Phosphodiesterase Activator
% 222.07/222.23  |- mesh__recordOriginator mesh__D002147 RLS
% 222.07/222.23  |- skos__hiddenLabel mesh__D002147 Activator, Phosphodiesterase Protein
% 222.07/222.23  |- mesh__onlineNote mesh__D002147
% 222.07/222.23       use CALMODULIN to search CALCIUM-DEPENDENT REGULATOR 1979-83%A%  
% 222.07/222.23  |- skos__altLabel mesh__D002147 Regulator, Calcium-Dependent
% 222.07/222.23  |- skos__altLabel mesh__D002147 Calcium-Dependent Activator Protein
% 222.07/222.23  |- skos__hiddenLabel mesh__D002147 Activator, Cyclic AMP-Phosphodiesterase
% 222.07/222.23  |- skos__prefLabel mesh__D002147 Calmodulin
% 222.07/222.23  |- skos__altLabel mesh__D002147 Phosphodiesterase Activating Factor
% 222.07/222.23  |- skos__broader mesh__D002147smesh__D052139
% 222.07/222.23  |- rdf__type mesh__D002147sskos__Concept
% 222.07/222.23  |- skos__hiddenLabel mesh__D002147 Regulator, Calcium Dependent
% 222.07/222.23  |- mesh__dateCreated mesh__D002147 1978-03-08
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D007630 1998
% 222.07/222.23  |- mesh__recordMaintainer mesh__D007630 TGC
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D007630 1997
% 222.07/222.23  |- mesh__recordOriginator mesh__D007630 NLM
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D007630 2002
% 222.07/222.23  |- mesh__dateCreated mesh__D007630 1999-01-01
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D007630 1996
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D007630 2006
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D007630 2005
% 222.07/222.23  |- skos__annotation mesh__D007630 a republic in eastern Africa   
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D007630 2004
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D007630 2001
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D007630 2003
% 222.07/222.23  |- skos__prefLabel mesh__D007630 Kenya
% 222.07/222.23  |- mesh__recordAuthorizer mesh__D007630 PLS
% 222.07/222.23  |- mesh__dateRevised mesh__D007630 1995-02-21
% 222.07/222.23  |- skos__broader mesh__D007630smesh__D000351
% 222.07/222.23  |- rdf__type mesh__D007630sskos__Concept
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D007630 2000
% 222.07/222.23  |- skos__scopeNote mesh__D007630
% 222.07/222.23       A republic in eastern Africa, south of ETHIOPIA and east of SOMALIA. Its capital is Nairobi. The region was organized as the British East Africa Protectorate in 1895, became a British colony in 1920, became independent in 1963, and became a republic in 1964. It took its name from Mount Kenya which probably meant simply mountain. %28%From Webster%27%s New Geographical Dictionary, 1988, p601 %26% Room, Brewer%27%s Dictionary of Names, 1992, p282%29%%A%    
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D007630 1999
% 222.07/222.23  |- mesh__historyNote mesh__D021301
% 222.07/222.23       2001; use ANTIFREEZE PROTEINS %28%NM%29% 1980-2000   
% 222.07/222.23  |- mesh__recordMaintainer mesh__D021301 SYSTEM
% 222.07/222.23  |- skos__hiddenLabel mesh__D021301 Proteins, Antifreeze
% 222.07/222.23  |- skos__prefLabel mesh__D021301 Antifreeze Proteins
% 222.07/222.23  |- skos__hiddenLabel mesh__D021301 Glycoproteins, Antifreeze
% 222.07/222.23  |- mesh__recordOriginator mesh__D021301 NLM
% 222.07/222.23  |- skos__scopeNote mesh__D021301
% 222.07/222.23       Proteins that bind to ice and modify the growth of ice crystals. They perform a cryoprotective role in a variety of organisms.%A%    
% 222.07/222.23  |- mesh__dateCreated mesh__D021301 2000-06-21
% 222.07/222.23  |- skos__annotation mesh__D021301
% 222.07/222.23       GEN or unspecified; prefer specific types   
% 222.07/222.23  |- skos__altLabel mesh__D021301 Thermal Hysteresis Proteins
% 222.07/222.23  |- skos__hiddenLabel mesh__D021301 Hysteresis Proteins, Thermal
% 222.07/222.23  |- skos__altLabel mesh__D021301 AFGP
% 222.07/222.23  |- skos__altLabel mesh__D021301 Antifreeze Peptides
% 222.07/222.23  |- skos__hiddenLabel mesh__D021301 Proteins, Thermal Hysteresis
% 222.07/222.23  |- skos__hiddenLabel mesh__D021301 Peptides, Antifreeze
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D021301 2006
% 222.07/222.23  |- rdf__type mesh__D021301sskos__Concept
% 222.07/222.23  |- skos__hiddenLabel mesh__D021301 Glycopeptides, Antifreeze
% 222.07/222.23  |- mesh__publicMeSHNote mesh__D021301
% 222.07/222.23       2001; ANTIFREEZE GLYCOPROTEINS %28%now ANTIFREEZE PROTEINS%29% was indexed under GLYCOPROTEINS 1983-2000 %26% PEPTIDES 1980-1982%A%  
% 222.07/222.23  |- mesh__dateRevised mesh__D021301 2005-06-30
% 222.07/222.23  |- skos__broader mesh__D021301smesh__D011506
% 222.07/222.23  |- skos__historyNote mesh__D021301 Glycoproteins %28%1983-2000%29%
% 222.07/222.23  |- skos__altLabel mesh__D021301 Antifreeze Glycopeptides
% 222.07/222.23  |- skos__historyNote mesh__D021301 Peptides %28%1980-1982%29%
% 222.07/222.23  |- mesh__dateEstablished mesh__D021301 2001-01-01
% 222.07/222.23  |- mesh__recordAuthorizer mesh__D021301 sjn
% 222.07/222.23  |- mesh__recordOriginator mesh__D048249 ags
% 222.07/222.23  |- rdf__type mesh__D048249sskos__Concept
% 222.07/222.23  |- mesh__recordAuthorizer mesh__D048249 sjn
% 222.07/222.23  |- mesh__historyNote mesh__D048249 2005   
% 222.07/222.23  |- mesh__publicMeSHNote mesh__D048249 2005   
% 222.07/222.23  |- skos__broader mesh__D048249smesh__D013291
% 222.07/222.23  |- mesh__dateRevised mesh__D048249 2005-06-30
% 222.07/222.23  |- skos__prefLabel mesh__D048249 Streptococcus thermophilus
% 222.07/222.23  |- mesh__recordMaintainer mesh__D048249 SYSTEM
% 222.07/222.23  |- mesh__dateCreated mesh__D048249 2004-07-07
% 222.07/222.23  |- skos__scopeNote mesh__D048249
% 222.07/222.23       A species of thermophilic, gram-positive bacteria found in MILK and milk products.%A%    
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D048249 2006
% 222.07/222.23  |- mesh__dateEstablished mesh__D048249 2005-01-01
% 222.07/222.23  |- skos__historyNote mesh__D048249 Streptococcus %28%1968-2004%29%
% 222.07/222.23  |- mesh__recordOriginator mesh__D012575 NLM
% 222.07/222.23  |- mesh__activeMeSHYear mesh__D012575 2002
% 222.07/222.23  |- skos__broader mesh__D012575smesh__D012576
% 222.07/222.23  |- mesh__dateCreated mesh__D012575 1999-01-01
% 222.07/222.24  |- rdf__type mesh__D012575sskos__Concept
% 222.07/222.24  |- skos__annotation mesh__D012575
% 222.07/222.24       Manual 30.7.3, 30.8; specify geog if pertinent; DF: SCHOOLS DENT%A%  
% 222.07/222.24  |- skos__scopeNote mesh__D012575
% 222.07/222.24       Educational institutions for individuals specializing in the field of dentistry.%A%    
% 222.07/222.24  |- skos__prefLabel mesh__D012575 Schools, Dental
% 222.07/222.24  |- skos__altLabel mesh__D012575 School, Dental
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D012575 2003
% 222.07/222.24  |- skos__altLabel mesh__D012575 Dental School
% 222.07/222.24  |- mesh__recordMaintainer mesh__D012575 kle
% 222.07/222.24  |- mesh__recordAuthorizer mesh__D012575 sjn
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D012575 2004
% 222.07/222.24  |- mesh__dateRevised mesh__D012575 1999-11-03
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D012575 2000
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D012575 2005
% 222.07/222.24  |- skos__altLabel mesh__D012575 Dental Schools
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D012575 2001
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D012575 2006
% 222.07/222.24  |- rdf__type mesh__D020209sskos__Concept
% 222.07/222.24  |- skos__altLabel mesh__D020209 Cranial Neuropathies, Traumatic
% 222.07/222.24  |- skos__related mesh__D020209smesh__D020435
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D020209 2004
% 222.07/222.24  |- skos__hiddenLabel mesh__D020209 Injury, Cranial Nerve
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D020209 2006
% 222.07/222.24  |- skos__related mesh__D020209smesh__D020436
% 222.07/222.24  |- skos__hiddenLabel mesh__D020209 Traumatic Cranial Neuropathy
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D020209 2003
% 222.07/222.24  |- skos__scopeNote mesh__D020209
% 222.07/222.24       Dysfunction of one or more cranial nerves causally related to a traumatic injury. Penetrating and nonpenetrating CRANIOCEREBRAL TRAUMA; NECK INJURIES; and trauma to the facial region are conditions associated with cranial nerve injuries.%A%    
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D020209 2005
% 222.07/222.24  |- mesh__historyNote mesh__D020209 2000   
% 222.07/222.24  |- skos__broader mesh__D020209smesh__D003389
% 222.07/222.24  |- skos__annotation mesh__D020209
% 222.07/222.24       coordinate with specific cranial nerve; gen prefer specifics%A%  
% 222.07/222.24  |- mesh__publicMeSHNote mesh__D020209 2000   
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D020209 2002
% 222.07/222.24  |- skos__related mesh__D020209smesh__D000160
% 222.07/222.24  |- skos__related mesh__D020209smesh__D020421
% 222.07/222.24  |- skos__hiddenLabel mesh__D020209 Traumatic Cranial Neuropathies
% 222.07/222.24  |- skos__related mesh__D020209smesh__D015840
% 222.07/222.24  |- skos__hiddenLabel mesh__D020209 Injuries, Cranial Nerve
% 222.07/222.24  |- skos__hiddenLabel mesh__D020209 Cranial Nerve Injury
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D020209 2001
% 222.07/222.24  |- skos__hiddenLabel mesh__D020209 Neuropathy, Traumatic Cranial
% 222.07/222.24  |- skos__hiddenLabel mesh__D020209 Cranial Neuropathy, Traumatic
% 222.07/222.24  |- skos__related mesh__D020209smesh__D020433
% 222.07/222.24  |- skos__prefLabel mesh__D020209 Cranial Nerve Injuries
% 222.07/222.24  |- skos__hiddenLabel mesh__D020209 Nerve Injury, Cranial
% 222.07/222.24  |- skos__hiddenLabel mesh__D020209 Nerve Injuries, Cranial
% 222.07/222.24  |- mesh__dateCreated mesh__D020209 1999-11-05
% 222.07/222.24  |- skos__hiddenLabel mesh__D020209 Neuropathies, Traumatic Cranial
% 222.07/222.24  |- skos__related mesh__D020209smesh__D020437
% 222.07/222.24  |- skos__broader mesh__D020209smesh__D006259
% 222.07/222.24  |- skos__related mesh__D020209smesh__D020431
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D020209 2000
% 222.07/222.24  |- mesh__dateEstablished mesh__D020209 2000-01-01
% 222.07/222.24  |- mesh__recordAuthorizer mesh__D006538 sjn
% 222.07/222.24  |- skos__hiddenLabel mesh__D006538 Acids, Heptanoic
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D006538 2004
% 222.07/222.24  |- skos__broader mesh__D006538smesh__D005227
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D006538 2006
% 222.07/222.24  |- mesh__dateCreated mesh__D006538 1974-11-11
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D006538 2005
% 222.07/222.24  |- mesh__recordMaintainer mesh__D006538 ssb
% 222.07/222.24  |- skos__scopeNote mesh__D006538
% 222.07/222.24       7-carbon saturated monocarboxylic acids.     
% 222.07/222.24  |- skos__prefLabel mesh__D006538 Heptanoic Acids
% 222.07/222.24  |- skos__historyNote mesh__D006538 Fatty Acids %28%1966-1974%29%
% 222.07/222.24  |- rdf__type mesh__D006538sskos__Concept
% 222.07/222.24  |- mesh__dateRevised mesh__D006538 2003-07-09
% 222.07/222.24  |- mesh__publicMeSHNote mesh__D006538 75   
% 222.07/222.24  |- mesh__recordOriginator mesh__D006538 NLM
% 222.07/222.24  |- mesh__dateEstablished mesh__D006538 1975-09-01
% 222.07/222.24  |- mesh__historyNote mesh__D006538 75   
% 222.07/222.24  |- skos__historyNote mesh__D017260 Antigens, CD %28%1990-1992%29%
% 222.07/222.24  |- mesh__dateRevised mesh__D017260 2005-06-30
% 222.07/222.24  |- skos__historyNote mesh__D017260
% 222.07/222.24       Receptors, Antigen, T-Cell, alpha-beta %28%1992%29%
% 222.07/222.24  |- skos__altLabel mesh__D017260 TCR-CD3 Complex
% 222.07/222.24  |- skos__hiddenLabel mesh__D017260 TCR CD3 Complex
% 222.07/222.24  |- mesh__dateCreated mesh__D017260 1992-05-22
% 222.07/222.24  |- skos__historyNote mesh__D017260
% 222.07/222.24       Antigens, Differentiation, T-Lymphocyte %28%1987-1992%29%
% 222.07/222.24  |- skos__scopeNote mesh__D017260
% 222.07/222.24       Molecule composed of the non-covalent association of the T-cell antigen receptor %28%RECEPTORS, ANTIGEN, T-CELL%29% with the CD3 complex %28%ANTIGENS, CD3%29%. This association is required for the surface expression and function of both components. The molecule consists of up to seven chains: either the alpha/beta or gamma/delta chains of the T-cell receptor, and four or five chains in the CD3 complex.%A%    
% 222.07/222.24  |- skos__hiddenLabel mesh__D017260 T Cell Antigen Receptor CD3 Complex
% 222.07/222.24  |- mesh__publicMeSHNote mesh__D017260 93   
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D017260 2006
% 222.07/222.24  |- mesh__recordAuthorizer mesh__D017260 sjn
% 222.07/222.24  |- mesh__dateEstablished mesh__D017260 1993-01-01
% 222.07/222.24  |- mesh__recordOriginator mesh__D017260 AGS
% 222.07/222.24  |- skos__historyNote mesh__D017260
% 222.07/222.24       Receptors, Antigen, T-Cell %28%1987-1992%29%
% 222.07/222.24  |- skos__altLabel mesh__D017260 T-Cell Antigen Receptor-CD3 Complex
% 222.07/222.24  |- skos__annotation mesh__D017260 DF: note short X ref   
% 222.07/222.24  |- skos__broader mesh__D017260smesh__D011948
% 222.07/222.24  |- mesh__recordMaintainer mesh__D017260 ssb
% 222.07/222.24  |- mesh__historyNote mesh__D017260 93   
% 222.07/222.24  |- rdf__type mesh__D017260sskos__Concept
% 222.07/222.24  |- skos__hiddenLabel mesh__D017260 Complex, TCR-CD3
% 222.07/222.24  |- skos__related mesh__D017260smesh__D015398
% 222.07/222.24  |- skos__prefLabel mesh__D017260 Receptor-CD3 Complex, Antigen, T-Cell
% 222.07/222.24  |- skos__historyNote mesh__D017260
% 222.07/222.24       Receptors, Antigen, T-Cell, gamma-delta %28%1992%29%
% 222.07/222.24  |- skos__broader mesh__D017260smesh__D017252
% 222.07/222.24  |- skos__annotation mesh__D003240
% 222.07/222.24       GEN or unspecified: prefer specifics; note %26% do not confuse with MIXED CONNECTIVE TISSUE DISEASE, a specific connective tissue dis entity%A%  
% 222.07/222.24  |- skos__historyNote mesh__D003240 Connective Tissue %28%1966-1979%29%
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D003240 2004
% 222.07/222.24  |- mesh__publicMeSHNote mesh__D003240 80   
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D003240 2001
% 222.07/222.24  |- skos__hiddenLabel mesh__D003240 Connective Tissue Disease
% 222.07/222.24  |- mesh__dateCreated mesh__D003240 1978-12-21
% 222.07/222.24  |- skos__scopeNote mesh__D003240
% 222.07/222.24       A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides.%A%    
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D003240 2002
% 222.07/222.24  |- rdf__type mesh__D003240sskos__Concept
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D003240 1994
% 222.07/222.24  |- skos__prefLabel mesh__D003240 Connective Tissue Diseases
% 222.07/222.24  |- mesh__recordOriginator mesh__D003240 AEP
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D003240 1995
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D003240 1993
% 222.07/222.24  |- skos__historyNote mesh__D003240 Collagen Diseases %28%1966-1979%29%
% 222.07/222.24  |- skos__broader mesh__D003240smesh__D017437
% 222.07/222.24  |- skos__related mesh__D003240smesh__D003095
% 222.07/222.24  |- mesh__historyNote mesh__D003240 80   
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D003240 1998
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D003240 1996
% 222.07/222.24  |- mesh__dateRevised mesh__D003240 1992-05-20
% 222.07/222.24  |- skos__hiddenLabel mesh__D003240 Diseases, Connective Tissue
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D003240 1999
% 222.07/222.24  |- mesh__recordAuthorizer mesh__D003240 PLS
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D003240 2000
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D003240 2005
% 222.07/222.24  |- mesh__recordMaintainer mesh__D003240 PLS
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D003240 1997
% 222.07/222.24  |- skos__related mesh__D003240smesh__D001848
% 222.07/222.24  |- mesh__dateEstablished mesh__D003240 1980-01-01
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D003240 2003
% 222.07/222.24  |- skos__hiddenLabel mesh__D003240 Disease, Connective Tissue
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D003240 2006
% 222.07/222.24  |- mesh__publicMeSHNote mesh__D016966
% 222.07/222.24       94; was BACTEROIDES GINGIVALIS 1992-93   
% 222.07/222.24  |- skos__historyNote mesh__D016966 Bacteroides %28%1981-1991%29%
% 222.07/222.24  |- skos__scopeNote mesh__D016966
% 222.07/222.24       A species of gram-negative, anaerobic, rod-shaped bacteria originally classified within the BACTEROIDES genus. This bacterium produces a cell-bound, oxygen-sensitive collagenase and is isolated from the human mouth.%A%    
% 222.07/222.24  |- rdf__type mesh__D016966sskos__Concept
% 222.07/222.24  |- mesh__recordAuthorizer mesh__D016966 sjn
% 222.07/222.24  |- skos__broader mesh__D016966smesh__D017861
% 222.07/222.24  |- skos__altLabel mesh__D016966 Bacteroides gingivalis
% 222.07/222.24  |- mesh__recordMaintainer mesh__D016966 SYSTEM
% 222.07/222.24  |- mesh__onlineNote mesh__D016966
% 222.07/222.24       use PORPHYROMONAS GINGIVALIS to search BACTEROIDES GINGIVALIS 1992-93%A%  
% 222.07/222.24  |- mesh__historyNote mesh__D016966
% 222.07/222.24       94; was BACTEROIDES GINGIVALIS 1992-93   
% 222.07/222.24  |- mesh__dateCreated mesh__D016966 1991-05-30
% 222.07/222.24  |- skos__annotation mesh__D016966
% 222.07/222.24       isolated from human mouth; infection: coord IM with BACTEROIDACEAE INFECTIONS %28%IM%29%%A%  
% 222.07/222.24  |- mesh__dateEstablished mesh__D016966 1992-01-01
% 222.07/222.24  |- mesh__recordOriginator mesh__D016966 PXP
% 222.07/222.24  |- mesh__dateRevised mesh__D016966 2005-06-30
% 222.07/222.24  |- skos__prefLabel mesh__D016966 Porphyromonas gingivalis
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D016966 2006
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D002946 1994
% 222.07/222.24  |- mesh__dateRevised mesh__D002946 1992-05-07
% 222.07/222.24  |- skos__prefLabel mesh__D002946 Cisterna Magna
% 222.07/222.24  |- skos__broader mesh__D002946smesh__D013346
% 222.07/222.24  |- mesh__recordAuthorizer mesh__D002946 PLS
% 222.07/222.24  |- skos__annotation mesh__D002946
% 222.07/222.24       /surg: VENTRICULOCISTERNOSTOMY see VENTRICULOSTOMY is also available%A%  
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D002946 1998
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D002946 2002
% 222.07/222.24  |- mesh__recordMaintainer mesh__D002946 TAP
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D002946 1996
% 222.07/222.24  |- skos__hiddenLabel mesh__D002946 Magna, Cisterna
% 222.07/222.24  |- skos__hiddenLabel mesh__D002946 Cisterna Magnas
% 222.07/222.24  |- mesh__recordOriginator mesh__D002946 NLM
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D002946 2006
% 222.07/222.24  |- skos__related mesh__D002946smesh__D014696
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D002946 2001
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D002946 2004
% 222.07/222.24  |- skos__hiddenLabel mesh__D002946 Magnas, Cisterna
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D002946 2000
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D002946 2005
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D002946 1995
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D002946 1993
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D002946 2003
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D002946 1999
% 222.07/222.24  |- rdf__type mesh__D002946sskos__Concept
% 222.07/222.24  |- mesh__dateCreated mesh__D002946 1999-01-01
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D002946 1997
% 222.07/222.24  |- skos__annotation mesh__D035322
% 222.07/222.24       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.07/222.24  |- mesh__dateEstablished mesh__D035322 2003-01-01
% 222.07/222.24  |- skos__scopeNote mesh__D035322
% 222.07/222.24       A plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida composed of tropical plants with parallel-nerved leaves.%A%    
% 222.07/222.24  |- skos__prefLabel mesh__D035322 Melastomataceae
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D035322 2003
% 222.07/222.24  |- rdf__type mesh__D035322sskos__Concept
% 222.07/222.24  |- mesh__dateCreated mesh__D035322 2002-07-03
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D035322 2004
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D035322 2005
% 222.07/222.24  |- mesh__publicMeSHNote mesh__D035322 2003   
% 222.07/222.24  |- skos__broader mesh__D035322smesh__D019684
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D035322 2006
% 222.07/222.24  |- mesh__historyNote mesh__D035322 2003   
% 222.07/222.24  |- skos__broader mesh__D014867Q000506smesh__D014867
% 222.07/222.24  |- mesh__preferredCombination mesh__D014867Q000506smesh__D014869
% 222.07/222.24  |- rdf__type mesh__D014867Q000506smesh__CompoundConcept
% 222.07/222.24  |- skos__hiddenLabel mesh__D002148 Proteins, Calmodulin-Binding
% 222.07/222.24  |- mesh__dateCreated mesh__D002148 1985-04-25
% 222.07/222.24  |- mesh__recordMaintainer mesh__D002148 SYSTEM
% 222.07/222.24  |- mesh__dateRevised mesh__D002148 2005-06-30
% 222.07/222.24  |- skos__annotation mesh__D002148 /biosyn /drug eff /physiol permitted   
% 222.07/222.24  |- skos__prefLabel mesh__D002148 Calmodulin-Binding Proteins
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D002148 2006
% 222.07/222.24  |- mesh__historyNote mesh__D002148 86   
% 222.07/222.24  |- skos__broader mesh__D002148smesh__D002352
% 222.07/222.24  |- mesh__recordAuthorizer mesh__D002148 sjn
% 222.07/222.24  |- skos__historyNote mesh__D002148
% 222.07/222.24       Calcium-Binding Proteins %28%1980-1985%29%
% 222.07/222.24  |- skos__historyNote mesh__D002148
% 222.07/222.24       Phosphoprotein Phosphatases %28%1982-1985%29%
% 222.07/222.24  |- skos__hiddenLabel mesh__D002148 Calmodulin Binding Proteins
% 222.07/222.24  |- skos__historyNote mesh__D002148 Carrier Proteins %28%1966-1979%29%
% 222.07/222.24  |- rdf__type mesh__D002148sskos__Concept
% 222.07/222.24  |- skos__scopeNote mesh__D002148
% 222.07/222.24       Proteins which bind calmodulin. They are found in many tissues and have a variety of functions including F-actin cross-linking properties, inhibition of cyclic nucleotide phosphodiesterase and calcium and magnesium ATPases.%A%    
% 222.07/222.24  |- mesh__recordOriginator mesh__D002148 RLS
% 222.07/222.24  |- mesh__dateEstablished mesh__D002148 1986-01-01
% 222.07/222.24  |- mesh__publicMeSHNote mesh__D002148 86   
% 222.07/222.24  |- skos__scopeNote mesh__D007631
% 222.07/222.24       A highly chlorinated polycyclic hydrocarbon insecticide whose large number of chlorine atoms makes it resistant to degradation. It has been shown to be toxic to mammals and causes abnormal cellular changes in laboratory animals.%A%    
% 222.07/222.24  |- skos__broader mesh__D007631smesh__D006843
% 222.07/222.24  |- mesh__dateEstablished mesh__D007631 1991-01-01
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D007631 2006
% 222.07/222.24  |- mesh__recordAuthorizer mesh__D007631 sjn
% 222.07/222.24  |- mesh__dateRevised mesh__D007631 2004-07-07
% 222.07/222.24  |- skos__prefLabel mesh__D007631 Chlordecone
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D007631 2005
% 222.07/222.24  |- skos__historyNote mesh__D007631
% 222.07/222.24       Insecticides, Organochlorine %28%1973-1976%29%
% 222.07/222.24  |- skos__historyNote mesh__D007631 Bridged Compounds %28%1969-1976%29%
% 222.07/222.24  |- mesh__historyNote mesh__D007631
% 222.07/222.24       96; was KEPONE 1977-95 %28%see under INSECTICIDES, ORGANOCHLORINE 1977-90%29%; CHLORDECONE was see KEPONE 1977-95%A%  
% 222.07/222.24  |- mesh__recordOriginator mesh__D007631 RLS
% 222.07/222.24  |- mesh__publicMeSHNote mesh__D007631
% 222.07/222.24       96; was KEPONE 1977-95 %28%see under INSECTICIDES, ORGANOCHLORINE 1977-90%29%; CHLORDECONE was see KEPONE 1977-95%A%  
% 222.07/222.24  |- rdf__type mesh__D007631sskos__Concept
% 222.07/222.24  |- mesh__recordMaintainer mesh__D007631 ssb
% 222.07/222.24  |- mesh__dateCreated mesh__D007631 1976-04-16
% 222.07/222.24  |- skos__annotation mesh__D007631 TN 111 for eff on insects   
% 222.07/222.24  |- mesh__recordMaintainer mesh__D021302 SYSTEM
% 222.07/222.24  |- skos__prefLabel mesh__D021302 Antifreeze Proteins, Type IV
% 222.07/222.24  |- skos__historyNote mesh__D021302 Peptides %28%1980-1982%29%
% 222.07/222.24  |- mesh__dateRevised mesh__D021302 2005-06-30
% 222.07/222.24  |- mesh__recordOriginator mesh__D021302 jmp
% 222.07/222.24  |- mesh__dateCreated mesh__D021302 2000-06-21
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D021302 2006
% 222.07/222.24  |- skos__altLabel mesh__D021302 Fish Type IV AFP
% 222.07/222.24  |- rdf__type mesh__D021302sskos__Concept
% 222.07/222.24  |- mesh__publicMeSHNote mesh__D021302
% 222.07/222.24       2001; ANTIFREEZE GLYCOPROTEINS, TYPE IV was indexed under GLYCOPROTEINS 1997-2000%A%  
% 222.07/222.24  |- mesh__recordAuthorizer mesh__D021302 sjn
% 222.07/222.24  |- mesh__historyNote mesh__D021302
% 222.07/222.24       2001; use ANTIFREEZE PROTEINS %28%NM%29% 1997-2000   
% 222.07/222.24  |- skos__broader mesh__D021302smesh__D021301
% 222.07/222.24  |- skos__altLabel mesh__D021302 Type IV Antifreeze Proteins
% 222.07/222.24  |- skos__altLabel mesh__D021302 Fish Antifreeze Proteins, Type IV
% 222.07/222.24  |- skos__historyNote mesh__D021302 Glycoproteins %28%1983-2000%29%
% 222.07/222.24  |- mesh__dateEstablished mesh__D021302 2001-01-01
% 222.07/222.24  |- skos__scopeNote mesh__D021302
% 222.07/222.24       A subclass of ANTIFREEZE PROTEINS that contain four amphipathic alpha-helices folded into an antiparallel helix bundle.%A%    
% 222.07/222.24  |- mesh__recordAuthorizer mesh__D012576 sjn
% 222.07/222.24  |- skos__prefLabel mesh__D012576 Schools, Health Occupations
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D012576 2003
% 222.07/222.24  |- skos__hiddenLabel mesh__D012576 Occupations School, Health
% 222.07/222.24  |- skos__broader mesh__D012576smesh__D012574
% 222.07/222.24  |- skos__historyNote mesh__D012576 Health Occupations %28%1966-1967%29%
% 222.07/222.24  |- mesh__historyNote mesh__D012576 68   
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D012576 2000
% 222.07/222.24  |- skos__hiddenLabel mesh__D012576 School, Health Occupations
% 222.07/222.24  |- mesh__publicMeSHNote mesh__D012576 68   
% 222.07/222.24  |- skos__hiddenLabel mesh__D012576 Occupations Schools, Health
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D012576 2004
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D012576 2001
% 222.07/222.24  |- skos__historyNote mesh__D012576 Universities %28%1966-1967%29%
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D012576 2005
% 222.07/222.24  |- mesh__recordOriginator mesh__D012576 NLM
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D012576 2002
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D012576 2006
% 222.07/222.24  |- mesh__dateEstablished mesh__D012576 1968-01-01
% 222.07/222.24  |- skos__hiddenLabel mesh__D012576 Health Occupations School
% 222.07/222.24  |- skos__annotation mesh__D012576
% 222.07/222.24       Manual 30.7.3, 30.8; specify geog if pertinent; DF: SCHOOLS HEALTH OCCUP%A%  
% 222.07/222.24  |- skos__scopeNote mesh__D012576
% 222.07/222.24       Schools which offer training in the area of health.     
% 222.07/222.24  |- skos__altLabel mesh__D012576 Health Occupations Schools
% 222.07/222.24  |- mesh__dateCreated mesh__D012576 1999-01-01
% 222.07/222.24  |- rdf__type mesh__D012576sskos__Concept
% 222.07/222.24  |- mesh__dateRevised mesh__D012576 1999-11-03
% 222.07/222.24  |- mesh__recordMaintainer mesh__D012576 kle
% 222.07/222.24  |- skos__prefLabel mesh__D006539 Heptoses
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D006539 2006
% 222.07/222.24  |- mesh__recordOriginator mesh__D006539 NLM
% 222.07/222.24  |- mesh__recordAuthorizer mesh__D006539 sjn
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D006539 2005
% 222.07/222.24  |- mesh__dateRevised mesh__D006539 2004-07-07
% 222.07/222.24  |- mesh__dateCreated mesh__D006539 1999-01-01
% 222.07/222.24  |- rdf__type mesh__D006539sskos__Concept
% 222.07/222.24  |- mesh__recordMaintainer mesh__D006539 ssb
% 222.07/222.24  |- skos__annotation mesh__D006539
% 222.07/222.24       monosaccharides; GEN only; prefer specifics   
% 222.07/222.24  |- skos__broader mesh__D006539smesh__D009005
% 222.07/222.24  |- skos__altLabel mesh__D017261 GPI Membrane Anchors
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D017261 2006
% 222.07/222.24  |- skos__hiddenLabel mesh__D017261 Glycan, Phosphatidylinositol
% 222.07/222.24  |- skos__altLabel mesh__D017261 Glycoinositol Phospholipid Membrane Anchor
% 222.07/222.24  |- mesh__recordMaintainer mesh__D017261 ssb
% 222.07/222.24  |- skos__hiddenLabel mesh__D017261 PI Glycan
% 222.07/222.24  |- skos__altLabel mesh__D017261 Glycosylated Phosphatidylinositols
% 222.07/222.24  |- skos__hiddenLabel mesh__D017261 Anchors, Glycosylphosphatidylinositol
% 222.07/222.24  |- skos__hiddenLabel mesh__D017261 Anchors, GPI Membrane
% 222.07/222.24  |- skos__hiddenLabel mesh__D017261 Membrane Anchors, GPI
% 222.07/222.24  |- skos__altLabel mesh__D017261
% 222.07/222.24       Glycosyl-Phosphatidylinositol Membrane Protein Anchors
% 222.07/222.24  |- mesh__historyNote mesh__D017261
% 222.07/222.24       93; was GLYCOSYL-PHOSPHATIDYLINOSITOL %28%NM%29% 1988-92   
% 222.07/222.24  |- skos__altLabel mesh__D017261 Glycosylphosphatidylinositol
% 222.07/222.24  |- rdf__type mesh__D017261sskos__Concept
% 222.07/222.24  |- mesh__onlineNote mesh__D017261
% 222.07/222.24       use GLYCOSYLPHOSPHATIDYLINOSITOLS %28%NM%29% to search GLYCOSYL-PHOSPHATIDYLINOSITOL %28%NM%29% 1988-92%A%  
% 222.07/222.24  |- skos__hiddenLabel mesh__D017261 Glycosyl Phosphatidylinositol
% 222.07/222.24  |- mesh__dateRevised mesh__D017261 2004-07-07
% 222.07/222.24  |- skos__altLabel mesh__D017261 PI-Glycan
% 222.07/222.24  |- skos__altLabel mesh__D017261 Glycosyl-Phosphatidylinositol
% 222.07/222.24  |- skos__broader mesh__D017261smesh__D006017
% 222.07/222.24  |- skos__prefLabel mesh__D017261 Glycosylphosphatidylinositols
% 222.07/222.24  |- mesh__publicMeSHNote mesh__D017261
% 222.07/222.24       93; GLYCOSYL-PHOSPHATIDYLINOSITOL was indexed under GLYCOLIPIDS %26% PHOSPHATIDYLINOSITOLS 1988-92%A%  
% 222.07/222.24  |- skos__altLabel mesh__D017261 Gly-PtdIns
% 222.07/222.24  |- skos__hiddenLabel mesh__D017261
% 222.07/222.24       Glycosyl Phosphatidylinositol Membrane Protein Anchors
% 222.07/222.24  |- mesh__dateCreated mesh__D017261 1992-05-20
% 222.07/222.24  |- mesh__recordOriginator mesh__D017261 TPW
% 222.07/222.24  |- skos__hiddenLabel mesh__D017261 Phosphatidylinositols, Glycosylated
% 222.07/222.24  |- mesh__dateEstablished mesh__D017261 1993-01-01
% 222.07/222.24  |- skos__annotation mesh__D017261 DF: GPTI   
% 222.07/222.24  |- skos__broader mesh__D017261smesh__D010716
% 222.07/222.24  |- skos__scopeNote mesh__D017261
% 222.07/222.24       Compounds containing carbohydrate or glycosyl groups linked to phosphatidylinositols. They act to anchor proteins or polysaccharides to cell membranes.%A%    
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D017261 2005
% 222.07/222.24  |- skos__historyNote mesh__D017261 Phosphatidylinositols %28%1988-1992%29%
% 222.07/222.24  |- skos__hiddenLabel mesh__D017261 Linkage, Glycosylphosphatidylinositol
% 222.07/222.24  |- mesh__recordAuthorizer mesh__D017261 sjn
% 222.07/222.24  |- skos__historyNote mesh__D017261 Glycolipids %28%1988-1992%29%
% 222.07/222.24  |- skos__altLabel mesh__D003241 Inbreeding, Human
% 222.07/222.24  |- skos__hiddenLabel mesh__D003241 Consanguinities
% 222.07/222.24  |- rdf__type mesh__D003241sskos__Concept
% 222.07/222.24  |- mesh__recordMaintainer mesh__D003241 TGC
% 222.07/222.24  |- skos__hiddenLabel mesh__D003241 Consanguinous Matings
% 222.07/222.24  |- skos__hiddenLabel mesh__D003241 Human Inbreeding
% 222.07/222.24  |- mesh__recordOriginator mesh__D003241 NLM
% 222.07/222.24  |- skos__hiddenLabel mesh__D003241 Matings, Consanguinous
% 222.07/222.24  |- skos__scopeNote mesh__D003241
% 222.07/222.24       The magnitude of INBREEDING in humans.     
% 222.07/222.24  |- skos__prefLabel mesh__D003241 Consanguinity
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D003241 2005
% 222.07/222.24  |- mesh__dateRevised mesh__D003241 2002-07-03
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D003241 2003
% 222.07/222.24  |- mesh__dateCreated mesh__D003241 1999-01-01
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D003241 2006
% 222.07/222.24  |- skos__hiddenLabel mesh__D003241 Mating, Consanguinous
% 222.07/222.24  |- skos__annotation mesh__D003241 human only: for animals use INBREEDING   
% 222.07/222.24  |- skos__hiddenLabel mesh__D003241 Inbreedings, Human
% 222.07/222.24  |- skos__hiddenLabel mesh__D003241 Human Inbreedings
% 222.07/222.24  |- skos__broader mesh__D003241smesh__D007178
% 222.07/222.24  |- skos__broader mesh__D003241smesh__D040341
% 222.07/222.24  |- mesh__recordAuthorizer mesh__D003241 sjn
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D003241 2004
% 222.07/222.24  |- mesh__recordOriginator mesh__D016967 PXP
% 222.07/222.24  |- mesh__dateRevised mesh__D016967 2005-06-30
% 222.07/222.24  |- rdf__type mesh__D016967sskos__Concept
% 222.07/222.24  |- skos__annotation mesh__D016967
% 222.07/222.24       isolated from mouth %26% resp tract; infection: coord IM with FUSOBACTERIUM INFECTIONS %28%IM%29%; DF: FUSOBACT NUCLEATUM%A%  
% 222.07/222.24  |- mesh__publicMeSHNote mesh__D016967 92   
% 222.07/222.24  |- skos__prefLabel mesh__D016967 Fusobacterium nucleatum
% 222.07/222.24  |- mesh__historyNote mesh__D016967 92   
% 222.07/222.24  |- mesh__recordAuthorizer mesh__D016967 sjn
% 222.07/222.24  |- mesh__recordMaintainer mesh__D016967 SYSTEM
% 222.07/222.24  |- skos__broader mesh__D016967smesh__D005673
% 222.07/222.24  |- skos__historyNote mesh__D016967 Fusobacterium %28%1977-1991%29%
% 222.07/222.24  |- mesh__dateCreated mesh__D016967 1991-05-30
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D016967 2006
% 222.07/222.24  |- mesh__dateEstablished mesh__D016967 1992-01-01
% 222.07/222.24  |- skos__scopeNote mesh__D016967
% 222.07/222.24       A species of gram-negative, anaerobic, rod-shaped bacteria isolated from the gingival margin and sulcus and from infections of the upper respiratory tract and pleural cavity.%A%    
% 222.07/222.24  |- skos__prefLabel mesh__D016169 Lymphocyte Function-Associated Antigen-1
% 222.07/222.24  |- skos__scopeNote mesh__D016169
% 222.07/222.24       An integrin heterodimer widely expressed on cells of hematopoietic origin. CD11A ANTIGEN comprises the alpha chain and the CD18 antigen %28%ANTIGENS, CD18%29% the beta chain. Lymphocyte function-associated antigen-1 is a major receptor of T-CELLS; B-CELLS; and GRANULOCYTES. It mediates the leukocyte adhesion reactions underlying cytolytic conjugate formation, helper T-cell interactions, and antibody-dependent killing by NATURAL KILLER CELLS and granulocytes. Intracellular adhesion molecule-1 has been defined as a ligand for lymphocyte function-associated antigen-1.%A%    
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D016169 2006B
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D016169 2006
% 222.07/222.24  |- mesh__dateRevised mesh__D016169 2005-08-01
% 222.07/222.24  |- mesh__recordAuthorizer mesh__D016169 ags
% 222.07/222.24  |- skos__altLabel mesh__D016169 LFA-1
% 222.07/222.24  |- mesh__dateCreated mesh__D016169 1990-04-24
% 222.07/222.24  |- mesh__recordOriginator mesh__D016169 RLS
% 222.07/222.24  |- skos__annotation mesh__D016169 DF: LFA1 or LFA 1   
% 222.07/222.24  |- skos__altLabel mesh__D016169 Integrin alphaLbeta2
% 222.07/222.24  |- skos__broader mesh__D016169smesh__D016201
% 222.07/222.24  |- mesh__publicMeSHNote mesh__D016169 91   
% 222.07/222.24  |- rdf__type mesh__D016169sskos__Concept
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D016169 2006A
% 222.07/222.24  |- skos__broader mesh__D016169smesh__D016028
% 222.07/222.24  |- skos__hiddenLabel mesh__D016169
% 222.07/222.24       Antigen-1, Lymphocyte Function-Associated
% 222.07/222.24  |- skos__broader mesh__D016169smesh__D018845
% 222.07/222.24  |- skos__hiddenLabel mesh__D016169 alphaLbeta2, Integrin
% 222.07/222.24  |- mesh__historyNote mesh__D016169 91   
% 222.07/222.24  |- mesh__recordMaintainer mesh__D016169 ags
% 222.07/222.24  |- mesh__dateEstablished mesh__D016169 1991-01-01
% 222.07/222.24  |- skos__historyNote mesh__D016169
% 222.07/222.24       Antigens, Differentiation %28%1988-1990%29%
% 222.07/222.24  |- skos__historyNote mesh__D016169
% 222.07/222.24       Receptors, Leukocyte-Adhesion %28%1989-1990%29%
% 222.07/222.24  |- skos__altLabel mesh__D016169 Leukocyte Function Associated Antigen-1
% 222.07/222.24  |- mesh__recordAuthorizer mesh__D002947 sjn
% 222.07/222.24  |- skos__related mesh__D002947smesh__D014507
% 222.07/222.24  |- skos__related mesh__D002947smesh__D014505
% 222.07/222.24  |- skos__broader mesh__D002947smesh__D005842
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D002947 2006
% 222.07/222.24  |- skos__broader mesh__D002947smesh__D004777
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D002947 2002
% 222.07/222.24  |- mesh__activeMeSHYear mesh__D002947 2004
% 222.07/222.24  |- mesh__dateRevised mesh__D002947 1999-11-03
% 222.07/222.24  |- skos__historyNote mesh__D002947 specific city %28%1966-1997%29%
% 222.07/222.24  |- skos__annotation mesh__D002947
% 222.07/222.24       IM for cities as sociol or population entities; specific indentions are available %28%NIM only%29% for epidemiol or ethnol studies; URBANIZATION is available for the develop from rural to urban society; URBAN POPULATION and URBAN HEALTH are also available%A%  
% 222.07/222.24  |- mesh__recordOriginator mesh__D002947 NLM
% 222.07/222.25  |- mesh__dateEstablished mesh__D002947 1998-01-01
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002947 2005
% 222.07/222.25  |- skos__scopeNote mesh__D002947
% 222.07/222.25       A large or important municipality of a country, usually a major metropolitan center.%A%    
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002947 2003
% 222.07/222.25  |- rdf__type mesh__D002947sskos__Concept
% 222.07/222.25  |- mesh__dateCreated mesh__D002947 1999-01-01
% 222.07/222.25  |- skos__prefLabel mesh__D002947 Cities
% 222.07/222.25  |- mesh__recordMaintainer mesh__D002947 kle
% 222.07/222.25  |- skos__related mesh__D002947smesh__D014504
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002947 2001
% 222.07/222.25  |- mesh__historyNote mesh__D002947 98; use explode 1967-97   
% 222.07/222.25  |- mesh__publicMeSHNote mesh__D002947 98   
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002947 2000
% 222.07/222.25  |- mesh__dateCreated mesh__D002149 1976-04-16
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002149 2001
% 222.07/222.25  |- mesh__dateEstablished mesh__D002149 1984-01-01
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002149 1999
% 222.07/222.25  |- skos__broader mesh__D002149smesh__D004032
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002149 2005
% 222.07/222.25  |- mesh__recordOriginator mesh__D002149 VDK
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002149 2004
% 222.07/222.25  |- mesh__recordMaintainer mesh__D002149 AGS
% 222.07/222.25  |- skos__scopeNote mesh__D002149
% 222.07/222.25       Total number of calories taken in daily whether ingested or by parenteral routes.%A%    
% 222.07/222.25  |- skos__historyNote mesh__D002149 Diet %28%1966-1976%29%
% 222.07/222.25  |- skos__annotation mesh__D002149
% 222.07/222.25       %22%total no. of calories taken in daily%22%   
% 222.07/222.25  |- mesh__dateRevised mesh__D002149 1996-02-12
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002149 2006
% 222.07/222.25  |- skos__historyNote mesh__D002149 Nutrition %28%1966-1976%29%
% 222.07/222.25  |- rdf__type mesh__D002149sskos__Concept
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002149 2002
% 222.07/222.25  |- skos__altLabel mesh__D002149 Caloric Intake
% 222.07/222.25  |- skos__prefLabel mesh__D002149 Energy Intake
% 222.07/222.25  |- mesh__publicMeSHNote mesh__D002149
% 222.07/222.25       97: was CALORIC INTAKE 1977-96 %28%see under DIET 1977-83%29%   
% 222.07/222.25  |- mesh__historyNote mesh__D002149
% 222.07/222.25       97: was CALORIC INTAKE 1977-96 %28%see under DIET 1977-83%29%   
% 222.07/222.25  |- mesh__recordAuthorizer mesh__D002149 PLS
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002149 2000
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002149 1998
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002149 1997
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002149 2003
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D007632 2005
% 222.07/222.25  |- skos__scopeNote mesh__D007632
% 222.07/222.25       A sulfated mucopolysaccharide initially isolated from bovine cornea. At least two types are known. Type I, found mostly in the cornea, contains D-galactose and D-glucosamine-6-O-sulfate as the repeating unit; type II, found in skeletal tissues, contains D-galactose and D-galactosamine-6-O-sulfate as the repeating unit.%A%    
% 222.07/222.25  |- mesh__publicMeSHNote mesh__D007632
% 222.07/222.25       91; was see under MUCOPOLYSACCHARIDES 1975-90   
% 222.07/222.25  |- skos__prefLabel mesh__D007632 Keratan Sulfate
% 222.07/222.25  |- mesh__dateCreated mesh__D007632 1974-11-19
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D007632 2006
% 222.07/222.25  |- skos__historyNote mesh__D007632 Galactosamine %28%1972-1974%29%
% 222.07/222.25  |- skos__annotation mesh__D007632 /biosyn /physiol permitted   
% 222.07/222.25  |- mesh__historyNote mesh__D007632
% 222.07/222.25       91%28%75%29%; was see under MUCOPOLYSACCHARIDES 1975-90   
% 222.07/222.25  |- skos__hiddenLabel mesh__D007632 Sulfate, Keratan
% 222.07/222.25  |- skos__historyNote mesh__D007632 Mucopolysaccharides %28%1970-1974%29%
% 222.07/222.25  |- mesh__dateEstablished mesh__D007632 1991-01-01
% 222.07/222.25  |- mesh__recordAuthorizer mesh__D007632 sjn
% 222.07/222.25  |- skos__altLabel mesh__D007632 Keratosulfate
% 222.07/222.25  |- rdf__type mesh__D007632sskos__Concept
% 222.07/222.25  |- mesh__recordMaintainer mesh__D007632 ssb
% 222.07/222.25  |- mesh__recordOriginator mesh__D007632 NLM
% 222.07/222.25  |- mesh__dateRevised mesh__D007632 2004-07-07
% 222.07/222.25  |- skos__broader mesh__D007632smesh__D006025
% 222.07/222.25  |- skos__annotation mesh__D012577
% 222.07/222.25       includes Facult%C3%%A9% de M%C3%%A9%decine, Facultad de Medicina; %22%College of Physicians%22% = SOCIETIES, MEDICAL; Uniformed Services University of the Health Sciences %28%USUHS%29%, under US Dept of Defense, goes here + UNITED STATES; Manual 30.7.3, 30.8; specify geog if pertinent; DF: SCHOOLS MED%A%  
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D012577 2003
% 222.07/222.25  |- skos__broader mesh__D012577smesh__D000046
% 222.07/222.25  |- mesh__recordOriginator mesh__D012577 NLM
% 222.07/222.25  |- skos__prefLabel mesh__D012577 Schools, Medical
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D012577 2004
% 222.07/222.25  |- skos__scopeNote mesh__D012577
% 222.07/222.25       Educational institutions for individuals specializing in the field of medicine.%A%    
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D012577 2002
% 222.07/222.25  |- mesh__dateRevised mesh__D012577 2001-08-13
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D012577 2005
% 222.07/222.25  |- skos__altLabel mesh__D012577 School, Medical
% 222.07/222.25  |- mesh__recordMaintainer mesh__D012577 jls
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D012577 2006
% 222.07/222.25  |- mesh__dateCreated mesh__D012577 1999-01-01
% 222.07/222.25  |- skos__altLabel mesh__D012577 Medical School
% 222.07/222.25  |- rdf__type mesh__D012577sskos__Concept
% 222.07/222.25  |- skos__broader mesh__D012577smesh__D012576
% 222.07/222.25  |- skos__altLabel mesh__D012577 Medical Schools
% 222.07/222.25  |- mesh__recordAuthorizer mesh__D012577 sjn
% 222.07/222.25  |- skos__historyNote mesh__D017262 Hydroxamic Acids %28%1972-1981%29%
% 222.07/222.25  |- mesh__recordAuthorizer mesh__D017262 sjn
% 222.07/222.25  |- mesh__publicMeSHNote mesh__D017262
% 222.07/222.25       93; SIDEROCHROMES was indexed under IRON CHELATES 1981-92,  HYDROXAMIC ACIDS 1972-81, PEPTIDES 1972-78 %26% CATECHOLS  1972-75%A%  
% 222.07/222.25  |- skos__scopeNote mesh__D017262
% 222.07/222.25       Low-molecular-weight compounds produced by microorganisms that aid in the transport and sequestration of ferric iron. %28%The Encyclopedia of Molecular Biology, 1994%29%%A%    
% 222.07/222.25  |- skos__historyNote mesh__D017262 Iron Chelates %28%1981-1992%29%
% 222.07/222.25  |- rdf__type mesh__D017262sskos__Concept
% 222.07/222.25  |- mesh__historyNote mesh__D017262
% 222.07/222.25       93; was SIDEROCHROMES %28%NM%29% 1972-92   
% 222.07/222.25  |- skos__altLabel mesh__D017262 Siderochromes
% 222.07/222.25  |- mesh__recordMaintainer mesh__D017262 ssb
% 222.07/222.25  |- skos__prefLabel mesh__D017262 Siderophores
% 222.07/222.25  |- skos__historyNote mesh__D017262 Peptides %28%1972-1978%29%
% 222.07/222.25  |- mesh__dateRevised mesh__D017262 2005-06-30
% 222.07/222.25  |- mesh__onlineNote mesh__D017262
% 222.07/222.25       use SIDEROPHORES %28%NM%29% to search SIDEROCHROMES 1980-92   
% 222.07/222.25  |- mesh__dateCreated mesh__D017262 1992-05-22
% 222.07/222.25  |- skos__historyNote mesh__D017262 Catechols %28%1972-1975%29%
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D017262 2006
% 222.07/222.25  |- skos__broader mesh__D017262smesh__D007502
% 222.07/222.25  |- mesh__dateEstablished mesh__D017262 1993-01-01
% 222.07/222.25  |- mesh__recordOriginator mesh__D017262 TPW
% 222.07/222.25  |- skos__historyNote mesh__D050696 Dolphins %28%1966-2005%29%
% 222.07/222.25  |- skos__hiddenLabel mesh__D050696 Common Dolphin, Short-Beaked
% 222.07/222.25  |- skos__hiddenLabel mesh__D050696 Short-Beaked Common Dolphins
% 222.07/222.25  |- mesh__recordOriginator mesh__D050696 ags
% 222.07/222.25  |- mesh__historyNote mesh__D050696 2006; use DOLPHINS 1998-2005   
% 222.07/222.25  |- skos__hiddenLabel mesh__D050696 Dolphins, Saddleback
% 222.07/222.25  |- skos__altLabel mesh__D050696 Delphinus
% 222.07/222.25  |- skos__hiddenLabel mesh__D050696 Saddleback Dolphin
% 222.07/222.25  |- mesh__publicMeSHNote mesh__D050696 2006; see DOLPHINS 1998-2005   
% 222.07/222.25  |- mesh__dateEstablished mesh__D050696 2006-01-01
% 222.07/222.25  |- skos__hiddenLabel mesh__D050696 Common Dolphin, Long-Beaked
% 222.07/222.25  |- skos__altLabel mesh__D050696 Delphinus capensis
% 222.07/222.25  |- skos__altLabel mesh__D050696 Saddleback Dolphins
% 222.07/222.25  |- skos__hiddenLabel mesh__D050696 Long Beaked Common Dolphin
% 222.07/222.25  |- skos__hiddenLabel mesh__D050696 Dolphin, Saddleback
% 222.07/222.25  |- skos__hiddenLabel mesh__D050696 Long-Beaked Common Dolphins
% 222.07/222.25  |- skos__hiddenLabel mesh__D050696 Dolphins, Common
% 222.07/222.25  |- skos__hiddenLabel mesh__D050696 Short Beaked Common Dolphin
% 222.07/222.25  |- skos__prefLabel mesh__D050696 Common Dolphins
% 222.07/222.25  |- skos__hiddenLabel mesh__D050696 Common Dolphins, Long-Beaked
% 222.07/222.25  |- mesh__dateCreated mesh__D050696 2005-06-30
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D050696 2006
% 222.07/222.25  |- mesh__recordMaintainer mesh__D050696 ags
% 222.07/222.25  |- rdf__type mesh__D050696sskos__Concept
% 222.07/222.25  |- skos__hiddenLabel mesh__D050696 Common Dolphins, Short-Beaked
% 222.07/222.25  |- skos__altLabel mesh__D050696 Delphinus delphis
% 222.07/222.25  |- mesh__recordAuthorizer mesh__D050696 sjn
% 222.07/222.25  |- skos__scopeNote mesh__D050696
% 222.07/222.25       The genus Delphinus, in the family Delphinidae, consisting of two species of DOLPHINS. They are multicolored, with a characteristic yellow-tan criss-cross hourglass pattern behind the eyes.%A%    
% 222.07/222.25  |- skos__hiddenLabel mesh__D050696 Dolphin, Common
% 222.07/222.25  |- skos__broader mesh__D050696smesh__D004289
% 222.07/222.25  |- skos__hiddenLabel mesh__D050696 Common Dolphin
% 222.07/222.25  |- skos__scopeNote mesh__D003242
% 222.07/222.25       The cognitive and affective processes which constitute an internalized moral governor over an individual%27%s moral conduct.%A%    
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003242 1996
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003242 2005
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003242 1999
% 222.07/222.25  |- mesh__historyNote mesh__D003242
% 222.07/222.25       91%28%75%29%; was see under MORALS 1975-90   
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003242 1991
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003242 2003
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003242 1997
% 222.07/222.25  |- mesh__dateCreated mesh__D003242 1999-01-01
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003242 2006
% 222.07/222.25  |- mesh__dateRevised mesh__D003242 1990-08-14
% 222.07/222.25  |- mesh__recordAuthorizer mesh__D003242 PLS
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003242 2000
% 222.07/222.25  |- mesh__onlineNote mesh__D003242 search MORALS 1966-74   
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003242 2004
% 222.07/222.25  |- skos__broader mesh__D003242smesh__D009014
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003242 2001
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003242 1994
% 222.07/222.25  |- mesh__publicMeSHNote mesh__D003242 91; was see under MORALS 1975-90   
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003242 1992
% 222.07/222.25  |- mesh__dateEstablished mesh__D003242 1991-01-01
% 222.07/222.25  |- skos__prefLabel mesh__D003242 Conscience
% 222.07/222.25  |- rdf__type mesh__D003242sskos__Concept
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003242 2002
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003242 1995
% 222.07/222.25  |- mesh__recordOriginator mesh__D003242 NLM
% 222.07/222.25  |- skos__hiddenLabel mesh__D003242 Consciences
% 222.07/222.25  |- skos__annotation mesh__D003242 no qualif   
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003242 1998
% 222.07/222.25  |- mesh__recordMaintainer mesh__D003242 NLM
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003242 1993
% 222.07/222.25  |- skos__prefLabel mesh__D016968 Wolinella
% 222.07/222.25  |- mesh__dateEstablished mesh__D016968 1992-01-01
% 222.07/222.25  |- skos__scopeNote mesh__D016968
% 222.07/222.25       A genus of gram-negative, anaerobic, rod-shaped bacteria isolated from the bovine RUMEN, the human gingival sulcus, and dental PULPITIS infections.%A%    
% 222.07/222.25  |- mesh__dateRevised mesh__D016968 2005-06-30
% 222.07/222.25  |- mesh__historyNote mesh__D016968 92   
% 222.07/222.25  |- skos__annotation mesh__D016968
% 222.07/222.25       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 222.07/222.25  |- mesh__recordMaintainer mesh__D016968 SYSTEM
% 222.07/222.25  |- mesh__publicMeSHNote mesh__D016968 92   
% 222.07/222.25  |- mesh__dateCreated mesh__D016968 1991-05-30
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D016968 2006
% 222.07/222.25  |- skos__historyNote mesh__D016968 Bacteroidaceae %28%1986-1991%29%
% 222.07/222.25  |- skos__broader mesh__D016968smesh__D020565
% 222.07/222.25  |- skos__broader mesh__D016968smesh__D016965
% 222.07/222.25  |- mesh__recordAuthorizer mesh__D016968 sjn
% 222.07/222.25  |- mesh__recordOriginator mesh__D016968 PXP
% 222.07/222.25  |- rdf__type mesh__D016968sskos__Concept
% 222.07/222.25  |- skos__hiddenLabel mesh__D041361 Pacifier
% 222.07/222.25  |- skos__historyNote mesh__D041361 Infant Care %28%1972-2002%29%
% 222.07/222.25  |- skos__broader mesh__D041361smesh__D015370
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D041361 2006
% 222.07/222.25  |- rdf__type mesh__D041361sskos__Concept
% 222.07/222.25  |- skos__scopeNote mesh__D041361
% 222.07/222.25       Devices that babies can suck on when they are not feeding. The extra sucking can be comforting to the babies and pacify them. Pacifiers usually are used as a substitute for the thumb in babies who suck on their thumb or fingers almost constantly.%A%    
% 222.07/222.25  |- skos__prefLabel mesh__D041361 Pacifiers
% 222.07/222.25  |- mesh__publicMeSHNote mesh__D041361 2003; see INFANT CARE 1989-2002   
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D041361 2004
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D041361 2005
% 222.07/222.25  |- mesh__dateEstablished mesh__D041361 2003-01-01
% 222.07/222.25  |- mesh__dateCreated mesh__D041361 2002-07-03
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D041361 2003
% 222.07/222.25  |- mesh__historyNote mesh__D041361 2003; use INFANT CARE 1989-2002   
% 222.07/222.25  |- mesh__dateCreated mesh__D013670 1984-06-11
% 222.07/222.25  |- skos__altLabel mesh__D013670 99mTcO4
% 222.07/222.25  |- skos__altLabel mesh__D013670 Technetium-99mTc-pertechnetate
% 222.07/222.25  |- skos__hiddenLabel mesh__D013670 99Tc Pertechnetate
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D013670 2004
% 222.07/222.25  |- mesh__recordAuthorizer mesh__D013670 sjn
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D013670 2006
% 222.07/222.25  |- skos__hiddenLabel mesh__D013670 Sodium, Pertechnetate
% 222.07/222.25  |- mesh__recordMaintainer mesh__D013670 nns
% 222.07/222.25  |- skos__broader mesh__D013670smesh__D017556
% 222.07/222.25  |- skos__altLabel mesh__D013670 Tc 99m-Pertechnetate
% 222.07/222.25  |- mesh__recordOriginator mesh__D013670 RLS
% 222.07/222.25  |- rdf__type mesh__D013670sskos__Concept
% 222.07/222.25  |- skos__hiddenLabel mesh__D013670 Tc 99m Pertechnetate
% 222.07/222.25  |- skos__altLabel mesh__D013670 Technetium Tc 99m O%28%4%29%
% 222.07/222.25  |- skos__altLabel mesh__D013670 Technetium Pertechnetate
% 222.07/222.25  |- mesh__dateRevised mesh__D013670 2002-07-03
% 222.07/222.25  |- mesh__dateEstablished mesh__D013670 1985-01-01
% 222.07/222.25  |- skos__altLabel mesh__D013670 99TcmO4
% 222.07/222.25  |- mesh__publicMeSHNote mesh__D013670
% 222.07/222.25       1994; see TECHNETIUM TC 99M PERTECHNETATE 1985-1993; TECHNETIUM TC 99M O%28%4%29% was indexed under TECHNETIUM COMPOUNDS 2001-2002%A%  
% 222.07/222.25  |- skos__hiddenLabel mesh__D013670 99m-Pertechnetate, Tc
% 222.07/222.25  |- skos__scopeNote mesh__D013670
% 222.07/222.25       A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, cardiovascular and cerebral circulation, brain, thyroid, and joints.%A%    
% 222.07/222.25  |- skos__historyNote mesh__D013670 Technetium %28%1966-1984%29%
% 222.07/222.25  |- mesh__historyNote mesh__D013670
% 222.07/222.25       1994; use TECHNETIUM TC 99M PERTECHNETATE 1985-1993; for TECHNETIUM TC 99M O%28%4%29% use TECHNETIUM TC 99M O%28%4%29% %28%NM%29% 2001-2002%A%  
% 222.07/222.25  |- skos__hiddenLabel mesh__D013670 Technetium 99mTc pertechnetate
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D013670 2003
% 222.07/222.25  |- skos__annotation mesh__D013670
% 222.07/222.25       as label in diagnosis; use /diag use; no qualif for other use as label; DF: TC PERTECHNETATE%A%  
% 222.07/222.25  |- skos__hiddenLabel mesh__D013670 Pertechnetate, Technetium
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D013670 2005
% 222.07/222.25  |- skos__prefLabel mesh__D013670 Sodium Pertechnetate Tc 99m
% 222.07/222.25  |- skos__hiddenLabel mesh__D007633 Endo A Cytokeratin
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D007633 2006
% 222.07/222.25  |- skos__related mesh__D007633smesh__D015603
% 222.07/222.25  |- skos__annotation mesh__D007633 /biosyn /physiol permitted   
% 222.07/222.25  |- mesh__recordMaintainer mesh__D007633 jmp
% 222.07/222.25  |- skos__broader mesh__D007633smesh__D012596
% 222.07/222.25  |- skos__hiddenLabel mesh__D007633 Endo B Protein
% 222.07/222.25  |- skos__hiddenLabel mesh__D007633 Cytokeratin, Endo-A
% 222.07/222.25  |- skos__altLabel mesh__D007633 Cytokeratin 19
% 222.07/222.25  |- skos__hiddenLabel mesh__D007633 beta Keratin
% 222.07/222.25  |- rdf__type mesh__D007633sskos__Concept
% 222.07/222.25  |- mesh__dateCreated mesh__D007633 1999-01-01
% 222.07/222.25  |- skos__hiddenLabel mesh__D007633 Protein, Endo-B
% 222.07/222.25  |- skos__prefLabel mesh__D007633 Keratin
% 222.07/222.25  |- skos__altLabel mesh__D007633 Endo-A Cytokeratin
% 222.07/222.25  |- skos__broader mesh__D007633smesh__D007381
% 222.07/222.25  |- mesh__dateRevised mesh__D007633 2004-07-07
% 222.07/222.25  |- skos__hiddenLabel mesh__D007633 Endo A Protein
% 222.07/222.25  |- skos__hiddenLabel mesh__D007633 Cytokeratin, Endo-C
% 222.07/222.25  |- skos__hiddenLabel mesh__D007633 Cytokeratin, Endo-B
% 222.07/222.25  |- skos__hiddenLabel mesh__D007633 Keratin 19
% 222.07/222.25  |- skos__hiddenLabel mesh__D007633 Protein, Endo-A
% 222.07/222.25  |- skos__hiddenLabel mesh__D007633 Endo C Cytokeratin
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D007633 2005
% 222.07/222.25  |- mesh__recordAuthorizer mesh__D007633 sjn
% 222.07/222.25  |- skos__hiddenLabel mesh__D007633 Endo B Cytokeratin
% 222.07/222.25  |- skos__altLabel mesh__D007633 Endo-B Cytokeratin
% 222.07/222.25  |- skos__scopeNote mesh__D007633
% 222.07/222.25       A class of fibrous proteins or scleroproteins important both as structural proteins and as keys to the study of protein conformation. The family represents the principal constituent of epidermis, hair, nails, horny tissues, and the organic matrix of tooth enamel. Two major conformational groups have been characterized, alpha-keratin, whose peptide backbone forms an alpha-helix, and beta-keratin, whose backbone forms a zigzag or pleated sheet structure.%A%    
% 222.07/222.25  |- mesh__recordOriginator mesh__D007633 NLM
% 222.07/222.25  |- skos__broader mesh__D012578smesh__D012574
% 222.07/222.25  |- mesh__recordAuthorizer mesh__D012578 sjn
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D012578 2004
% 222.07/222.25  |- mesh__recordMaintainer mesh__D012578 kle
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D012578 2000
% 222.07/222.25  |- mesh__dateRevised mesh__D012578 1999-11-03
% 222.07/222.25  |- skos__hiddenLabel mesh__D012578 Nursery School
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D012578 2005
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D012578 2001
% 222.07/222.25  |- mesh__recordOriginator mesh__D012578 NLM
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D012578 2006
% 222.07/222.25  |- mesh__dateCreated mesh__D012578 1999-01-01
% 222.07/222.25  |- rdf__type mesh__D012578sskos__Concept
% 222.07/222.25  |- skos__scopeNote mesh__D012578
% 222.07/222.25       Schools for children usually under five years of age.     
% 222.07/222.25  |- skos__related mesh__D012578smesh__D002656
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D012578 2002
% 222.07/222.25  |- skos__altLabel mesh__D012578 Nursery Schools
% 222.07/222.25  |- skos__hiddenLabel mesh__D012578 School, Nursery
% 222.07/222.25  |- skos__prefLabel mesh__D012578 Schools, Nursery
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D012578 2003
% 222.07/222.25  |- skos__annotation mesh__D012578 IM   
% 222.07/222.25  |- mesh__recordMaintainer mesh__D017263 ags
% 222.07/222.25  |- skos__hiddenLabel mesh__D017263 Technetium 99m Mercaptoacetyltriglycine
% 222.07/222.25  |- mesh__dateCreated mesh__D017263 1992-05-22
% 222.07/222.25  |- skos__altLabel mesh__D017263
% 222.07/222.25       Technetium-99m-Mercaptoacetylglycylglycylglycine
% 222.07/222.25  |- skos__altLabel mesh__D017263
% 222.07/222.25       Technetium 99m Mercaptoacetylglycyl-glycyl-glycine
% 222.07/222.25  |- skos__altLabel mesh__D017263 99mTc-MAG3
% 222.07/222.25  |- skos__hiddenLabel mesh__D017263
% 222.07/222.25       Mercaptoacetylglycyl-glycyl-glycine, Technetium 99m
% 222.07/222.25  |- skos__broader mesh__D017263smesh__D015609
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D017263 2005
% 222.07/222.25  |- mesh__recordAuthorizer mesh__D017263 sjn
% 222.07/222.25  |- skos__altLabel mesh__D017263 Technetium-99m-MAG3
% 222.07/222.25  |- skos__historyNote mesh__D017263
% 222.07/222.25       Organometallic Compounds %28%1986-1989%29%
% 222.07/222.25  |- skos__hiddenLabel mesh__D017263 Technetium 99m MAG3
% 222.07/222.25  |- skos__annotation mesh__D017263
% 222.07/222.25       as label, use /diag use; DF: TC MERTIATIDE   
% 222.07/222.25  |- skos__hiddenLabel mesh__D017263
% 222.07/222.25       99m Mercaptoacetylglycyl-glycyl-glycine, Technetium
% 222.07/222.25  |- skos__hiddenLabel mesh__D017263
% 222.07/222.25       Technetium 99m Mercaptoacetylglycylglycylglycine
% 222.07/222.25  |- skos__historyNote mesh__D017263
% 222.07/222.25       Organotechnetium Compounds %28%1990-1992%29%
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D017263 2006
% 222.07/222.25  |- skos__altLabel mesh__D017263 Technetium-99m-Mercaptoacetyltriglycine
% 222.07/222.25  |- skos__prefLabel mesh__D017263 Technetium Tc 99m Mertiatide
% 222.07/222.25  |- mesh__historyNote mesh__D017263
% 222.07/222.25       93; was TECHNETIUM TC 99M MERCAPTOACETYLGLYCYL-GLYCYL-GLYCINE %28%NM%29% 1986-92%A%  
% 222.07/222.25  |- mesh__publicMeSHNote mesh__D017263
% 222.07/222.25       93; TECHNETIUM TC 99M MERTIATIDE was indexed under ORGANOTECHNETIUM COMPOUNDS 1990-92, OLIGOPEPTIDES %26% TECHNETIUM 1986-92, %26% ORGANOMETALLIC COMPOUNDS 1986-89%A%  
% 222.07/222.25  |- skos__hiddenLabel mesh__D017263 99m Mertiatide, Tc
% 222.07/222.25  |- skos__hiddenLabel mesh__D017263 99mTc MAG3
% 222.07/222.25  |- mesh__dateEstablished mesh__D017263 1993-01-01
% 222.07/222.25  |- skos__hiddenLabel mesh__D017263 Mertiatide, Tc 99m
% 222.07/222.25  |- skos__broader mesh__D017263smesh__D009842
% 222.07/222.25  |- skos__hiddenLabel mesh__D017263
% 222.07/222.25       Technetium 99m Mercaptoacetylglycyl glycyl glycine
% 222.07/222.25  |- rdf__type mesh__D017263sskos__Concept
% 222.07/222.25  |- skos__hiddenLabel mesh__D017263 99mTc Mercaptoacetyltriglycine
% 222.07/222.25  |- skos__hiddenLabel mesh__D017263 MAG3, TechneScan
% 222.07/222.25  |- skos__historyNote mesh__D017263 Technetium %28%1986-1989%29%
% 222.07/222.25  |- skos__scopeNote mesh__D017263
% 222.07/222.25       A technetium diagnostic aid used in renal function determination.%A%    
% 222.07/222.25  |- mesh__dateRevised mesh__D017263 2003-07-09
% 222.07/222.25  |- mesh__onlineNote mesh__D017263
% 222.07/222.25       use TECHNETIUM TC 99M MERTIATIDE %28%NM%29% to search TECHNETIUM TC 99M MERCAPTOACETYLGLYCYL-GLYCYL-GLYCINE %28%NM%29% 1986-92%A%  
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D017263 2004
% 222.07/222.25  |- skos__historyNote mesh__D017263 Oligopeptides %28%1986-1992%29%
% 222.07/222.25  |- mesh__recordOriginator mesh__D017263 TPW
% 222.07/222.25  |- skos__altLabel mesh__D017263 99mTc-Mercaptoacetyltriglycine
% 222.07/222.25  |- skos__altLabel mesh__D017263 Tc 99m Mertiatide
% 222.07/222.25  |- skos__hiddenLabel mesh__D050697 Retinal Dehydrogenase, Cytosolic
% 222.07/222.25  |- skos__broader mesh__D050697smesh__D000445
% 222.07/222.25  |- mesh__recordOriginator mesh__D050697 AKE
% 222.07/222.25  |- skos__hiddenLabel mesh__D050697 Dehydrogenase, Cytosolic Retinal
% 222.07/222.25  |- mesh__dateRevised mesh__D050697 2005-07-13
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D050697 2006A
% 222.07/222.25  |- mesh__dateEstablished mesh__D050697 2006-01-01
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D050697 2006
% 222.07/222.25  |- mesh__recordMaintainer mesh__D050697 ags
% 222.07/222.25  |- mesh__publicMeSHNote mesh__D050697
% 222.07/222.25       2006; RETINAL DEHYDROGENASE was indexed under ALDEHYDE OXIDOREDUCTASES 1977-2005%A%  
% 222.07/222.25  |- rdf__type mesh__D050697sskos__Concept
% 222.07/222.25  |- skos__broader mesh__D050697smesh__D019159
% 222.07/222.25  |- skos__hiddenLabel mesh__D050697 Dehydrogenase, Retinal
% 222.07/222.25  |- mesh__historyNote mesh__D050697 2006%28%1977%29%   
% 222.07/222.25  |- skos__broader mesh__D050697smesh__D005420
% 222.07/222.25  |- skos__scopeNote mesh__D050697
% 222.07/222.25       A metalloflavoprotein enzyme involved the metabolism of VITAMIN A, this enzyme catalyzes the oxidation of RETINAL to RETINOIC ACID, using both NAD+ and FAD coenzymes. It also acts on both the 11-trans- and 13-cis-forms of RETINAL.%A%    
% 222.07/222.25  |- skos__prefLabel mesh__D050697 Retinal Dehydrogenase
% 222.07/222.25  |- mesh__dateCreated mesh__D050697 2005-06-30
% 222.07/222.25  |- skos__altLabel mesh__D050697 Cytosolic Retinal Dehydrogenase
% 222.07/222.25  |- mesh__recordAuthorizer mesh__D050697 ags
% 222.07/222.25  |- mesh__recordOriginator mesh__D003243 NLM
% 222.07/222.25  |- skos__broader mesh__D003243smesh__D011603
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003243 2003
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003243 1997
% 222.07/222.25  |- mesh__dateCreated mesh__D003243 1999-01-01
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003243 2006
% 222.07/222.25  |- mesh__dateRevised mesh__D003243 1995-06-08
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003243 2004
% 222.07/222.25  |- skos__scopeNote mesh__D003243
% 222.07/222.25       Sense of awareness of self and of the environment.     
% 222.07/222.25  |- rdf__type mesh__D003243sskos__Concept
% 222.07/222.25  |- skos__hiddenLabel mesh__D003243 Consciousnesses
% 222.07/222.25  |- mesh__recordAuthorizer mesh__D003243 PLS
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003243 2000
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003243 1998
% 222.07/222.25  |- mesh__recordMaintainer mesh__D003243 TGC
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003243 2001
% 222.07/222.25  |- skos__broader mesh__D003243smesh__D003071
% 222.07/222.25  |- skos__related mesh__D003243smesh__D014474
% 222.07/222.25  |- skos__prefLabel mesh__D003243 Consciousness
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003243 1996
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003243 2005
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003243 1999
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D003243 2002
% 222.07/222.25  |- mesh__historyNote mesh__D016969 92   
% 222.07/222.25  |- mesh__publicMeSHNote mesh__D016969 92   
% 222.07/222.25  |- skos__broader mesh__D016969smesh__D003901
% 222.07/222.25  |- mesh__recordAuthorizer mesh__D016969 sjn
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D016969 2006
% 222.07/222.25  |- mesh__dateEstablished mesh__D016969 1992-01-01
% 222.07/222.25  |- mesh__recordMaintainer mesh__D016969 SYSTEM
% 222.07/222.25  |- skos__scopeNote mesh__D016969
% 222.07/222.25       A species of gram-negative, anaerobic, rod-shaped bacteria isolated from soil, animal intestines and feces, and fresh and salt water.%A%    
% 222.07/222.25  |- mesh__dateCreated mesh__D016969 1991-05-30
% 222.07/222.25  |- skos__annotation mesh__D016969
% 222.07/222.25       infection: coord IM with DESULFOVIBRIONACEAE INFECTIONS %28%IM%29%%A%  
% 222.07/222.25  |- skos__prefLabel mesh__D016969 Desulfovibrio vulgaris
% 222.07/222.25  |- rdf__type mesh__D016969sskos__Concept
% 222.07/222.25  |- skos__historyNote mesh__D016969 Desulfovibrio %28%1968-1991%29%
% 222.07/222.25  |- mesh__recordOriginator mesh__D016969 PXP
% 222.07/222.25  |- mesh__dateRevised mesh__D016969 2005-06-30
% 222.07/222.25  |- skos__broader mesh__D002949smesh__D000812
% 222.07/222.25  |- mesh__recordMaintainer mesh__D002949 TGC
% 222.07/222.25  |- mesh__onlineNote mesh__D002949
% 222.07/222.25       use CITRACONIC ANHYDRIDES to search CITRACONIC ANHYDRIDE 1975-78%A%  
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002949 2003
% 222.07/222.25  |- skos__historyNote mesh__D002949 Anhydrides %28%1969-1974%29%
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002949 2006
% 222.07/222.25  |- mesh__dateCreated mesh__D002949 1974-11-19
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002949 1994
% 222.07/222.25  |- mesh__recordOriginator mesh__D002949 NLM
% 222.07/222.25  |- skos__broader mesh__D002949smesh__D005663
% 222.07/222.25  |- skos__historyNote mesh__D002949 Maleates %28%1972-1974%29%
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002949 2000
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002949 1998
% 222.07/222.25  |- mesh__publicMeSHNote mesh__D002949
% 222.07/222.25       91; was see under FURANS 1979-90; was CITRACONIC ANHYDRIDE see under FURANS 1977-78 %26% see under MALEATES 1975-76%A%  
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002949 2004
% 222.07/222.25  |- mesh__historyNote mesh__D002949
% 222.07/222.25       91%28%79%29%; was see under FURANS 1979-90; was CITRACONIC ANHYDRIDE see under FURANS 1977-78 %26% see under MALEATES 1975-76%A%  
% 222.07/222.25  |- skos__altLabel mesh__D002949 Methylmaleic Anhydrides
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002949 2001
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002949 1995
% 222.07/222.25  |- mesh__dateEstablished mesh__D002949 1991-01-01
% 222.07/222.25  |- skos__hiddenLabel mesh__D002949 Anhydrides, Methylmaleic
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002949 1996
% 222.07/222.25  |- mesh__activeMeSHYear mesh__D002949 1999
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D002949 1993
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D002949 2002
% 222.07/222.26  |- mesh__dateRevised mesh__D002949 1992-05-11
% 222.07/222.26  |- mesh__recordAuthorizer mesh__D002949 PLS
% 222.07/222.26  |- rdf__type mesh__D002949sskos__Concept
% 222.07/222.26  |- skos__hiddenLabel mesh__D002949 Anhydrides, Citraconic
% 222.07/222.26  |- skos__scopeNote mesh__D002949 Methylmaleic anhydrides.     
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D002949 1997
% 222.07/222.26  |- skos__prefLabel mesh__D002949 Citraconic Anhydrides
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D002949 2005
% 222.07/222.26  |- skos__altLabel mesh__D013671 Tc 99m Sulfur Colloid
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013671 2004
% 222.07/222.26  |- skos__broader mesh__D013671smesh__D013457
% 222.07/222.26  |- mesh__dateEstablished mesh__D013671 1985-01-01
% 222.07/222.26  |- skos__altLabel mesh__D013671 Technetium Sulfur Colloid
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013671 2003
% 222.07/222.26  |- mesh__recordOriginator mesh__D013671 RLS
% 222.07/222.26  |- skos__hiddenLabel mesh__D013671 Colloid, Tc-99m Sulfur
% 222.07/222.26  |- skos__hiddenLabel mesh__D013671 Colloid, Technetium Sulfur
% 222.07/222.26  |- mesh__recordMaintainer mesh__D013671 ssb
% 222.07/222.26  |- mesh__dateRevised mesh__D013671 2001-07-25
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013671 2006
% 222.07/222.26  |- skos__scopeNote mesh__D013671
% 222.07/222.26       A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, liver, and spleen.%A%    
% 222.07/222.26  |- skos__broader mesh__D013671smesh__D017556
% 222.07/222.26  |- mesh__recordAuthorizer mesh__D013671 sjn
% 222.07/222.26  |- skos__prefLabel mesh__D013671 Technetium Tc 99m Sulfur Colloid
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013671 2002
% 222.07/222.26  |- skos__historyNote mesh__D013671 Sulfur %28%1966-1984%29%
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013671 2005
% 222.07/222.26  |- rdf__type mesh__D013671sskos__Concept
% 222.07/222.26  |- skos__altLabel mesh__D013671 Tc-99m Sulfur Colloid
% 222.07/222.26  |- mesh__dateCreated mesh__D013671 1984-06-11
% 222.07/222.26  |- mesh__publicMeSHNote mesh__D013671 85   
% 222.07/222.26  |- mesh__historyNote mesh__D013671 85   
% 222.07/222.26  |- skos__annotation mesh__D013671
% 222.07/222.26       as label, use /diag use; DF: TC SULFUR COLLOID   
% 222.07/222.26  |- skos__historyNote mesh__D013671 Technetium %28%1966-1984%29%
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007634 2002
% 222.07/222.26  |- skos__scopeNote mesh__D007634 Inflammation of the cornea.     
% 222.07/222.26  |- mesh__dateCreated mesh__D007634 1999-01-01
% 222.07/222.26  |- rdf__type mesh__D007634sskos__Concept
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007634 1999
% 222.07/222.26  |- skos__annotation mesh__D007634
% 222.07/222.26       inflamm of cornea; GEN or unspecified; prefer specifics   
% 222.07/222.26  |- mesh__dateRevised mesh__D007634 1997-06-20
% 222.07/222.26  |- mesh__recordMaintainer mesh__D007634 TGC
% 222.07/222.26  |- skos__prefLabel mesh__D007634 Keratitis
% 222.07/222.26  |- mesh__recordOriginator mesh__D007634 NLM
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007634 2005
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007634 2006
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007634 2003
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007634 2000
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007634 2004
% 222.07/222.26  |- mesh__recordAuthorizer mesh__D007634 SJN
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007634 2001
% 222.07/222.26  |- skos__hiddenLabel mesh__D007634 Keratitides
% 222.07/222.26  |- skos__broader mesh__D007634smesh__D003316
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007634 1998
% 222.07/222.26  |- rdf__type mesh__D051790sskos__Concept
% 222.07/222.26  |- skos__hiddenLabel mesh__D051790 Transcription Factors, GBF
% 222.07/222.26  |- skos__broader mesh__D051790smesh__D004268
% 222.07/222.26  |- skos__hiddenLabel mesh__D051790 G Box Binding Factors
% 222.07/222.26  |- skos__broader mesh__D051790smesh__D014157
% 222.07/222.26  |- mesh__recordAuthorizer mesh__D051790 sjn
% 222.07/222.26  |- skos__scopeNote mesh__D051790
% 222.07/222.26       A family of transcription factors found primarily in PLANTS that bind to the G-box DNA sequence CACGTG or to a consensus sequence CANNTG.%A%    
% 222.07/222.26  |- mesh__recordOriginator mesh__D051790 DRC
% 222.07/222.26  |- mesh__recordMaintainer mesh__D051790 DRC
% 222.07/222.26  |- mesh__publicMeSHNote mesh__D051790
% 222.07/222.26       2006; G-BOX BINDING FACTORS was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1992-2005, %26% under REPRESSOR PROTEINS 1992-2004, %26% under PLANT PROTEINS 1992-1993%A%  
% 222.07/222.26  |- skos__altLabel mesh__D051790 GBF Transcription Factors
% 222.07/222.26  |- skos__prefLabel mesh__D051790 G-Box Binding Factors
% 222.07/222.26  |- mesh__dateEstablished mesh__D051790 2006-01-01
% 222.07/222.26  |- skos__broader mesh__D051790smesh__D010940
% 222.07/222.26  |- mesh__historyNote mesh__D051790 2006%28%1992%29%   
% 222.07/222.26  |- mesh__dateCreated mesh__D051790 2005-06-30
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D051790 2006
% 222.07/222.26  |- mesh__recordMaintainer mesh__D012579 kle
% 222.07/222.26  |- skos__altLabel mesh__D012579 Schools, Nurse Training
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D012579 2004
% 222.07/222.26  |- skos__hiddenLabel mesh__D012579 School, Nurse Training
% 222.07/222.26  |- skos__hiddenLabel mesh__D012579 Nurse Training School
% 222.07/222.26  |- skos__prefLabel mesh__D012579 Schools, Nursing
% 222.07/222.26  |- skos__hiddenLabel mesh__D012579 Nursing School
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D012579 2003
% 222.07/222.26  |- skos__broader mesh__D012579smesh__D012576
% 222.07/222.26  |- skos__altLabel mesh__D012579 Nursing Schools
% 222.07/222.26  |- mesh__dateCreated mesh__D012579 1999-01-01
% 222.07/222.26  |- skos__hiddenLabel mesh__D012579 School, Nursing
% 222.07/222.26  |- skos__altLabel mesh__D012579 Nurse Training Schools
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D012579 2002
% 222.07/222.26  |- mesh__recordAuthorizer mesh__D012579 sjn
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D012579 2001
% 222.07/222.26  |- skos__annotation mesh__D012579
% 222.07/222.26       do not confuse with SCHOOL NURSING; Manual 30.7.3, 30.8; specify geog if pertinent; DF: SCHOOLS NURS%A%  
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D012579 2006
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D012579 2000
% 222.07/222.26  |- rdf__type mesh__D012579sskos__Concept
% 222.07/222.26  |- skos__hiddenLabel mesh__D012579 Training Schools, Nurse
% 222.07/222.26  |- mesh__dateRevised mesh__D012579 1999-11-03
% 222.07/222.26  |- mesh__recordOriginator mesh__D012579 NLM
% 222.07/222.26  |- skos__hiddenLabel mesh__D012579 Training School, Nurse
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D012579 2005
% 222.07/222.26  |- skos__scopeNote mesh__D012579
% 222.07/222.26       Educational institutions for individuals specializing in the field of nursing.%A%    
% 222.07/222.26  |- skos__broader mesh__D011950Q000037smesh__D011950
% 222.07/222.26  |- mesh__preferredCombination mesh__D011950Q000037smesh__D018680
% 222.07/222.26  |- rdf__type mesh__D011950Q000037smesh__CompoundConcept
% 222.07/222.26  |- skos__hiddenLabel mesh__D050698 Gamma Glutamylphosphate Reductase
% 222.07/222.26  |- skos__historyNote mesh__D050698
% 222.07/222.26       Aldehyde Oxidoreductases %28%1978-2005%29%
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D050698 2006
% 222.07/222.26  |- rdf__type mesh__D050698sskos__Concept
% 222.07/222.26  |- skos__hiddenLabel mesh__D050698 Glutamate 5 Semialdehyde Dehydrogenase
% 222.07/222.26  |- mesh__dateCreated mesh__D050698 2005-06-30
% 222.07/222.26  |- mesh__recordOriginator mesh__D050698 AKE
% 222.07/222.26  |- skos__hiddenLabel mesh__D050698 Dehydrogenase, Glutamate-Semialdehyde
% 222.07/222.26  |- skos__hiddenLabel mesh__D050698 Dehydrogenase, Glutamate 5-Semialdehyde
% 222.07/222.26  |- mesh__recordMaintainer mesh__D050698 AKE
% 222.07/222.26  |- mesh__recordAuthorizer mesh__D050698 sjn
% 222.07/222.26  |- skos__altLabel mesh__D050698 Glutamate-Semialdehyde Dehydrogenase
% 222.07/222.26  |- skos__broader mesh__D050698smesh__D000445
% 222.07/222.26  |- mesh__publicMeSHNote mesh__D050698
% 222.07/222.26       2006; GLUTAMATE-5-SEMIALDEHYDE DEHYDROGENASE was indexed under ALDEHYDE OXIDOREDUCTASES 1978-2005%A%  
% 222.07/222.26  |- skos__hiddenLabel mesh__D050698 Dehydrogenase, Glutamate-5-Semialdehyde
% 222.07/222.26  |- skos__altLabel mesh__D050698 Gamma-Glutamylphosphate Reductase
% 222.07/222.26  |- skos__hiddenLabel mesh__D050698 5-Semialdehyde Dehydrogenase, Glutamate
% 222.07/222.26  |- mesh__historyNote mesh__D050698 2006%28%1978%29%   
% 222.07/222.26  |- skos__altLabel mesh__D050698 Glutamate 5-Semialdehyde Dehydrogenase
% 222.07/222.26  |- mesh__dateEstablished mesh__D050698 2006-01-01
% 222.07/222.26  |- skos__prefLabel mesh__D050698 Glutamate-5-Semialdehyde Dehydrogenase
% 222.07/222.26  |- skos__hiddenLabel mesh__D050698 Reductase, Gamma-Glutamylphosphate
% 222.07/222.26  |- skos__altLabel mesh__D050698 Beta-Glutamylphosphate Reductase
% 222.07/222.26  |- skos__hiddenLabel mesh__D050698 Beta Glutamylphosphate Reductase
% 222.07/222.26  |- skos__hiddenLabel mesh__D050698 Glutamate Semialdehyde Dehydrogenase
% 222.07/222.26  |- skos__hiddenLabel mesh__D050698 Reductase, Beta-Glutamylphosphate
% 222.07/222.26  |- skos__scopeNote mesh__D050698
% 222.07/222.26       An NADP+ dependent enzyme that catalyzes the oxidation of L-glutamate 5-semialdehyde to L-glutamyl 5-phosphate. It plays a role in the urea cycle and metabolism of amino groups.%A%    
% 222.07/222.26  |- skos__scopeNote mesh__D003244
% 222.07/222.26       Organic mental disorders in which there is impairment of the ability to maintain awareness of self and environment and to respond to environmental stimuli. Dysfunction of the cerebral hemispheres or brain stem RETICULAR FORMATION may result in this condition.%A%    
% 222.07/222.26  |- mesh__publicMeSHNote mesh__D003244
% 222.07/222.26       91; was see under COGNITION DISORDERS 1975-90   
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D003244 2000
% 222.07/222.26  |- skos__broader mesh__D003244smesh__D019954
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D003244 2004
% 222.07/222.26  |- skos__prefLabel mesh__D003244 Consciousness Disorders
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D003244 2006
% 222.07/222.26  |- mesh__recordOriginator mesh__D003244 NLM
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D003244 2003
% 222.07/222.26  |- skos__broader mesh__D003244smesh__D019965
% 222.07/222.26  |- skos__altLabel mesh__D003244 Depressed Level of Consciousness
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D003244 2005
% 222.07/222.26  |- skos__hiddenLabel mesh__D003244 Consciousness Disorder
% 222.07/222.26  |- skos__altLabel mesh__D003244 Altered Level of Consciousness
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D003244 2002
% 222.07/222.26  |- rdf__type mesh__D003244sskos__Concept
% 222.07/222.26  |- mesh__historyNote mesh__D003244
% 222.07/222.26       91%28%75%29%; was see under COGNITION DISORDERS 1975-90   
% 222.07/222.26  |- skos__annotation mesh__D003244 prefer specifics   
% 222.07/222.26  |- mesh__recordAuthorizer mesh__D003244 sjn
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D003244 2001
% 222.07/222.26  |- mesh__onlineNote mesh__D003244 search COGNITION DISORDERS 1969-74   
% 222.07/222.26  |- mesh__recordMaintainer mesh__D003244 jls
% 222.07/222.26  |- mesh__dateEstablished mesh__D003244 1991-01-01
% 222.07/222.26  |- mesh__dateCreated mesh__D003244 1999-01-01
% 222.07/222.26  |- mesh__dateRevised mesh__D003244 1999-11-09
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013672 2003
% 222.07/222.26  |- skos__prefLabel mesh__D013672 Technology
% 222.07/222.26  |- skos__scopeNote mesh__D013672
% 222.07/222.26       The application of scientific knowledge to practical purposes in any field. It includes methods, techniques, and instrumentation.%A%    
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013672 2001
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013672 2006
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013672 1997
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013672 2005
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013672 1996
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013672 2000
% 222.07/222.26  |- skos__broader mesh__D013672smesh__D013676
% 222.07/222.26  |- rdf__type mesh__D013672sskos__Concept
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013672 1999
% 222.07/222.26  |- skos__annotation mesh__D013672 SPEC: SPEC qualif; DF: TECHNOL   
% 222.07/222.26  |- mesh__dateRevised mesh__D013672 1995-05-22
% 222.07/222.26  |- skos__altLabel mesh__D013672 Arts, Industrial
% 222.07/222.26  |- mesh__recordOriginator mesh__D013672 NLM
% 222.07/222.26  |- mesh__publicMeSHNote mesh__D013672
% 222.07/222.26       INDUSTRIAL ARTS was see under TECHNOLOGY 1967-78; was see under OCCUPATIONS AND PROFESSIONS 1963-66%A%  
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013672 1998
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013672 2002
% 222.07/222.26  |- mesh__historyNote mesh__D013672
% 222.07/222.26       INDUSTRIAL ARTS was see under TECHNOLOGY 1967-78; was see under OCCUPATIONS AND PROFESSIONS 1963-66%A%  
% 222.07/222.26  |- mesh__dateCreated mesh__D013672 1999-01-01
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013672 2004
% 222.07/222.26  |- mesh__onlineNote mesh__D013672
% 222.07/222.26       search INDUSTRIAL ARTS under TECHNOLOGY 1967-present %26% under OCCUPATIONS 1966%A%  
% 222.07/222.26  |- mesh__recordMaintainer mesh__D013672 KEV
% 222.07/222.26  |- mesh__recordAuthorizer mesh__D013672 PLS
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007635 2001
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007635 1997
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007635 2005
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007635 2002
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007635 2006
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007635 2003
% 222.07/222.26  |- mesh__dateRevised mesh__D007635 1995-06-08
% 222.07/222.26  |- skos__prefLabel mesh__D007635 Keratitis, Dendritic
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007635 2004
% 222.07/222.26  |- skos__hiddenLabel mesh__D007635 Dendritic Keratitis
% 222.07/222.26  |- mesh__recordOriginator mesh__D007635 NLM
% 222.07/222.26  |- skos__scopeNote mesh__D007635
% 222.07/222.26       A form of herpetic keratitis characterized by the formation of small vesicles which break down and coalesce to form recurring dendritic ulcers, characteristically irregular, linear, branching, and ending in knoblike extremities. %28%Dictionary of Visual Science, 3d ed%29%%A%    
% 222.07/222.26  |- skos__hiddenLabel mesh__D007635 Furrow Keratitides
% 222.07/222.26  |- skos__annotation mesh__D007635
% 222.07/222.26       a form of herpetic keratitis with dendritic %28%branching%29% ulcers%A%  
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007635 1998
% 222.07/222.26  |- skos__altLabel mesh__D007635 Keratitis, Furrow
% 222.07/222.26  |- skos__altLabel mesh__D007635 Furrow Keratitis
% 222.07/222.26  |- mesh__recordAuthorizer mesh__D007635 PLS
% 222.07/222.26  |- mesh__recordMaintainer mesh__D007635 TAP
% 222.07/222.26  |- rdf__type mesh__D007635sskos__Concept
% 222.07/222.26  |- mesh__dateCreated mesh__D007635 1999-01-01
% 222.07/222.26  |- skos__hiddenLabel mesh__D007635 Keratitides, Dendritic
% 222.07/222.26  |- skos__hiddenLabel mesh__D007635 Keratitides, Furrow
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007635 2000
% 222.07/222.26  |- skos__hiddenLabel mesh__D007635 Dendritic Keratitides
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007635 1999
% 222.07/222.26  |- skos__broader mesh__D007635smesh__D016849
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007635 1996
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D017265 2003
% 222.07/222.26  |- mesh__recordAuthorizer mesh__D017265 sjn
% 222.07/222.26  |- skos__historyNote mesh__D017265 Amino Alcohols %28%1978-1980%29%
% 222.07/222.26  |- mesh__dateRevised mesh__D017265 2000-06-22
% 222.07/222.26  |- skos__prefLabel mesh__D017265 Procaterol
% 222.07/222.26  |- skos__historyNote mesh__D017265 Ethanolamines %28%1981-1992%29%
% 222.07/222.26  |- skos__altLabel mesh__D017265
% 222.07/222.26       %28%R*,S*%29%-%28%+-%29%-8-Hydroxy-5-%28%1-hydroxy-2-%28%%28%1-methylethyl%29%amino%29%butyl%29%-2%28%1H%29%-quinolinone
% 222.07/222.26  |- skos__historyNote mesh__D017265 Hydroxyquinolines %28%1978-1980%29%
% 222.07/222.26  |- skos__scopeNote mesh__D017265
% 222.07/222.26       A long-acting beta-2-adrenergic receptor agonist. It is a potent bronchodilator that may be administered orally or by aerosol inhalation.%A%    
% 222.07/222.26  |- mesh__onlineNote mesh__D017265
% 222.07/222.26       use PROCATEROL %28%NM%29% to search PROCATEROL 1979-92   
% 222.07/222.26  |- mesh__recordOriginator mesh__D017265 TPW
% 222.07/222.26  |- skos__broader mesh__D017265smesh__D004983
% 222.07/222.26  |- skos__hiddenLabel mesh__D017265 CI 888
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D017265 2006
% 222.07/222.26  |- skos__hiddenLabel mesh__D017265 Pro Air
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D017265 2002
% 222.07/222.26  |- skos__hiddenLabel mesh__D017265 CI888
% 222.07/222.26  |- skos__hiddenLabel mesh__D017265 OPC2009
% 222.07/222.26  |- skos__hiddenLabel mesh__D017265 ProAir
% 222.07/222.26  |- skos__hiddenLabel mesh__D017265 OPC 2009
% 222.07/222.26  |- skos__hiddenLabel mesh__D017265 Hydrochloride, Procaterol
% 222.07/222.26  |- mesh__dateEstablished mesh__D017265 1993-01-01
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D017265 2005
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D017265 2001
% 222.07/222.26  |- skos__broader mesh__D017265smesh__D006912
% 222.07/222.26  |- rdf__type mesh__D017265sskos__Concept
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D017265 2004
% 222.07/222.26  |- mesh__publicMeSHNote mesh__D017265
% 222.07/222.26       93; PROCATEROL was indexed under ETHANOLAMINES 1981-92 %26% AMINO ALCOHOLS %26% HYDROXYQUINOLINES 1978-80%A%  
% 222.07/222.26  |- mesh__dateCreated mesh__D017265 1992-05-20
% 222.07/222.26  |- skos__hiddenLabel mesh__D017265 Monohydrochloride, Procaterol
% 222.07/222.26  |- skos__altLabel mesh__D017265 Procaterol Monohydrochloride
% 222.07/222.26  |- mesh__historyNote mesh__D017265 93; was PROCATEROL %28%NM%29% 1978-92   
% 222.07/222.26  |- mesh__recordMaintainer mesh__D017265 CCR
% 222.07/222.26  |- mesh__historyNote mesh__D050699 2006%28%2004%29%   
% 222.07/222.26  |- mesh__dateRevised mesh__D050699 2005-07-13
% 222.07/222.26  |- skos__scopeNote mesh__D050699
% 222.07/222.26       An E2F transcription factor that interacts directly with RETINOBLASTOMA PROTEIN and CYCLIN A.  E2F3 regulates GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis.%A%    
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D050699 2006A
% 222.07/222.26  |- skos__hiddenLabel mesh__D050699 E2F-3, Transcription Factor
% 222.07/222.26  |- mesh__publicMeSHNote mesh__D050699
% 222.07/222.26       2006; E2F3 transcription factor, E2F Transcription Factor 3 Protein, %26% Transcription Factor E2F-3 were indexed under CELL CYCLE PROTEINS, DNA-BINDING PROTEINS, %26% TRANSCRIPTION FACTORS 2004-2005%A%  
% 222.07/222.26  |- mesh__recordMaintainer mesh__D050699 ags
% 222.07/222.26  |- skos__annotation mesh__D050699 see SCR for organism-specific terms   
% 222.07/222.26  |- skos__historyNote mesh__D050699 Transcription Factors %28%1991-2005%29%
% 222.07/222.26  |- skos__hiddenLabel mesh__D050699 Transcription Factor, E2F3b
% 222.07/222.26  |- skos__altLabel mesh__D050699 E2F Transcription Factor 3 Protein
% 222.07/222.26  |- skos__broader mesh__D050699smesh__D050684
% 222.07/222.26  |- mesh__recordAuthorizer mesh__D050699 ags
% 222.07/222.26  |- skos__historyNote mesh__D050699 DNA-Binding Proteins %28%1991-2005%29%
% 222.07/222.26  |- skos__hiddenLabel mesh__D050699 Transcription Factor, E2F3
% 222.07/222.26  |- mesh__dateCreated mesh__D050699 2005-06-30
% 222.07/222.26  |- skos__hiddenLabel mesh__D050699 Transcription Factor E2F 3
% 222.07/222.26  |- skos__historyNote mesh__D050699 Cell Cycle Proteins %28%1991-2005%29%
% 222.07/222.26  |- skos__prefLabel mesh__D050699 E2F3 Transcription Factor
% 222.07/222.26  |- skos__altLabel mesh__D050699 Transcription Factor E2F-3
% 222.07/222.26  |- mesh__recordOriginator mesh__D050699 DRC
% 222.07/222.26  |- mesh__dateEstablished mesh__D050699 2006-01-01
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D050699 2006
% 222.07/222.26  |- rdf__type mesh__D050699sskos__Concept
% 222.07/222.26  |- skos__hiddenLabel mesh__D050699 Transcription Factor, E2F3a
% 222.07/222.26  |- skos__altLabel mesh__D003245 Workshops, Consensus
% 222.07/222.26  |- mesh__recordOriginator mesh__D003245 EC
% 222.07/222.26  |- mesh__recordAuthorizer mesh__D003245 sjn
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D003245 2004
% 222.07/222.26  |- skos__altLabel mesh__D003245 Conferences, Consensus Development
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D003245 2006
% 222.07/222.26  |- skos__altLabel mesh__D003245 Workshop, Consensus
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D003245 2003
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D003245 2005
% 222.07/222.26  |- skos__annotation mesh__D003245
% 222.07/222.26       no qualif; do not confuse with Publication Type CONSENSUS DEVELOPMENT CONFERENCE; IM for consensus confs as a means of scientific interchange; Manual section 12 %26% TN L; include name of conf as part of title when it appears in author position, in footnote or at end of article; CONSENSUS DEVELOPMENT CONFERENCES, NIH is also available; specify geog only if pertinent; DF: CONSENS DEV CONF%A%  
% 222.07/222.26  |- skos__altLabel mesh__D003245 Consensus Workshop
% 222.07/222.26  |- skos__prefLabel mesh__D003245 Consensus Development Conferences
% 222.07/222.26  |- mesh__dateCreated mesh__D003245 1987-05-12
% 222.07/222.26  |- rdf__type mesh__D003245sskos__Concept
% 222.07/222.26  |- mesh__publicMeSHNote mesh__D003245 88   
% 222.07/222.26  |- skos__broader mesh__D003245smesh__D003226
% 222.07/222.26  |- skos__related mesh__D003245smesh__D032921
% 222.07/222.26  |- skos__broader mesh__D003245smesh__D012196
% 222.07/222.26  |- mesh__dateRevised mesh__D003245 2002-07-03
% 222.07/222.26  |- mesh__recordMaintainer mesh__D003245 jrf
% 222.07/222.26  |- mesh__dateEstablished mesh__D003245 1988-01-01
% 222.07/222.26  |- mesh__historyNote mesh__D003245
% 222.07/222.26       88; for both the publication type %26% the main heading 1988-90; main heading only 1991 forward%A%  
% 222.07/222.26  |- skos__scopeNote mesh__D003245
% 222.07/222.26       Presentations of summary statements representing the majority agreement of physicians, scientists, and other professionals convening for the purpose of reaching a consensus--often with findings and recommendations--on a subject of interest. The Conference, consisting of participants representing the scientific and lay viewpoints, is a significant means of evaluating current medical thought and reflects the latest advances in research for the respective field being addressed.%A%    
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013673 2005
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013673 1996
% 222.07/222.26  |- mesh__dateEstablished mesh__D013673 1980-01-01
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013673 2002
% 222.07/222.26  |- mesh__recordOriginator mesh__D013673 EC
% 222.07/222.26  |- rdf__type mesh__D013673sskos__Concept
% 222.07/222.26  |- skos__broader mesh__D013673smesh__D017531
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013673 1999
% 222.07/222.26  |- skos__hiddenLabel mesh__D013673 Biomedical Technology Assessments
% 222.07/222.26  |- skos__hiddenLabel mesh__D013673 Technology Assessments
% 222.07/222.26  |- skos__altLabel mesh__D013673 Assessment, Biomedical Technology
% 222.07/222.26  |- mesh__recordMaintainer mesh__D013673 PLS
% 222.07/222.26  |- skos__scopeNote mesh__D013673
% 222.07/222.26       Evaluation of biomedical technology in relation to cost, efficacy, utilization, etc., and its future impact on social, ethical, and legal systems.%A%    
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013673 1995
% 222.07/222.26  |- mesh__recordAuthorizer mesh__D013673 PLS
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013673 1998
% 222.07/222.26  |- mesh__dateCreated mesh__D013673 1979-06-01
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013673 2004
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013673 2001
% 222.07/222.26  |- mesh__dateRevised mesh__D013673 1994-02-08
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013673 2003
% 222.07/222.26  |- mesh__publicMeSHNote mesh__D013673 80   
% 222.07/222.26  |- skos__annotation mesh__D013673
% 222.07/222.26       restrict to MeSH definition: do not use as routine coord for %22%evaluation%22% of a specific technique or %22%technol%22%; DF: TECHNOL ASSESS BIOMED%A%  
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013673 2000
% 222.07/222.26  |- skos__hiddenLabel mesh__D013673 Technology Assessments, Biomedical
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013673 2006
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D013673 1997
% 222.07/222.26  |- skos__hiddenLabel mesh__D013673 Assessments, Technology
% 222.07/222.26  |- skos__altLabel mesh__D013673 Assessment, Technology
% 222.07/222.26  |- skos__broader mesh__D013673smesh__D004472
% 222.07/222.26  |- skos__altLabel mesh__D013673 Biomedical Technology Assessment
% 222.07/222.26  |- skos__prefLabel mesh__D013673 Technology Assessment, Biomedical
% 222.07/222.26  |- mesh__historyNote mesh__D013673 80   
% 222.07/222.26  |- skos__hiddenLabel mesh__D013673 Assessments, Biomedical Technology
% 222.07/222.26  |- skos__hiddenLabel mesh__D007636 Keratoacanthomas
% 222.07/222.26  |- rdf__type mesh__D007636sskos__Concept
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007636 1997
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007636 2001
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007636 1999
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007636 1993
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007636 1996
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007636 1995
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007636 2000
% 222.07/222.26  |- skos__broader mesh__D007636smesh__D012871
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007636 1998
% 222.07/222.26  |- mesh__dateRevised mesh__D007636 1992-05-20
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007636 2004
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007636 1994
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007636 2006
% 222.07/222.26  |- mesh__dateCreated mesh__D007636 1999-01-01
% 222.07/222.26  |- skos__scopeNote mesh__D007636
% 222.07/222.26       A benign, non-neoplastic, usually self-limiting epithelial lesion closely resembling squamous cell carcinoma clinically and histopathologically. It occurs in solitary, multiple, and eruptive forms. The solitary and multiple forms occur on sunlight exposed areas and are identical histologically; they affect primarily white males. The eruptive form usually involves both sexes and appears as a generalized papular eruption.%A%    
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007636 2003
% 222.07/222.26  |- mesh__recordMaintainer mesh__D007636 PLS
% 222.07/222.26  |- skos__annotation mesh__D007636
% 222.07/222.26       note category: non-neoplastic; coord IM with precoord organ/dis term %28%IM%29%; do not confuse with ACANTHAMOEBA KERATITIS%A%  
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007636 2005
% 222.07/222.26  |- mesh__recordAuthorizer mesh__D007636 PLS
% 222.07/222.26  |- mesh__recordOriginator mesh__D007636 NLM
% 222.07/222.26  |- skos__prefLabel mesh__D007636 Keratoacanthoma
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D007636 2002
% 222.07/222.26  |- skos__scopeNote mesh__D051792
% 222.07/222.26       A family of DNA-binding transcription factors that contain a basic HELIX-LOOP-HELIX MOTIF.%A%    
% 222.07/222.26  |- skos__related mesh__D051792smesh__D018257
% 222.07/222.26  |- mesh__dateCreated mesh__D051792 2005-06-30
% 222.07/222.26  |- mesh__recordOriginator mesh__D051792 DRC
% 222.07/222.26  |- skos__broader mesh__D051792smesh__D004268
% 222.07/222.26  |- skos__prefLabel mesh__D051792
% 222.07/222.26       Basic Helix-Loop-Helix Transcription Factors
% 222.07/222.26  |- skos__broader mesh__D051792smesh__D014157
% 222.07/222.26  |- skos__altLabel mesh__D051792 bHLH Transcription Factors
% 222.07/222.26  |- mesh__recordAuthorizer mesh__D051792 sjn
% 222.07/222.26  |- skos__altLabel mesh__D051792 bHLH Proteins
% 222.07/222.26  |- skos__hiddenLabel mesh__D051792
% 222.07/222.26       Basic Helix Loop Helix Transcription Factors
% 222.07/222.26  |- skos__hiddenLabel mesh__D051792 Transcription Factors, bHLH
% 222.07/222.26  |- rdf__type mesh__D051792sskos__Concept
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D051792 2006
% 222.07/222.26  |- mesh__recordMaintainer mesh__D051792 DRC
% 222.07/222.26  |- mesh__publicMeSHNote mesh__D051792 2006   
% 222.07/222.26  |- mesh__historyNote mesh__D051792 2006   
% 222.07/222.26  |- mesh__dateEstablished mesh__D051792 2006-01-01
% 222.07/222.26  |- skos__historyNote mesh__D017266 Dentures %28%1991-1992%29%
% 222.07/222.26  |- mesh__onlineNote mesh__D017266
% 222.07/222.26       use DENTURES to search DENTAL PROSTHESIS 1966-92   
% 222.07/222.26  |- skos__broader mesh__D017266smesh__D011476
% 222.07/222.26  |- mesh__dateCreated mesh__D017266 1992-05-20
% 222.07/222.26  |- skos__altLabel mesh__D017266 Dental Prostheses
% 222.07/222.26  |- skos__altLabel mesh__D017266 Prosthesis, Dental
% 222.07/222.26  |- mesh__historyNote mesh__D017266
% 222.07/222.26       93; was heading 1963-90; was see DENTURES 1991-92   
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D017266 2000
% 222.07/222.26  |- mesh__publicMeSHNote mesh__D017266
% 222.07/222.26       93; was heading 1963-90; was see DENTURES 1991-92   
% 222.07/222.26  |- skos__related mesh__D017266smesh__D019232
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D017266 2006
% 222.07/222.26  |- skos__scopeNote mesh__D017266
% 222.07/222.26       An artificial replacement for one or more natural teeth or part of a tooth, or associated structures, ranging from a portion of a tooth to a complete denture. The dental prosthesis is used for cosmetic or functional reasons, or both. DENTURES and specific types of dentures are also available. %28%From Boucher%27%s Clinical Dental Terminology, 4th ed, p244 %26% Jablonski, Dictionary of Dentistry, 1992, p643%29%%A%    
% 222.07/222.26  |- mesh__recordAuthorizer mesh__D017266 sjn
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D017266 2005
% 222.07/222.26  |- mesh__recordMaintainer mesh__D017266 jls
% 222.07/222.26  |- skos__broader mesh__D017266smesh__D019736
% 222.07/222.26  |- skos__related mesh__D017266smesh__D003778
% 222.07/222.26  |- skos__related mesh__D017266smesh__D003793
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D017266 2004
% 222.07/222.26  |- rdf__type mesh__D017266sskos__Concept
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D017266 2002
% 222.07/222.26  |- mesh__recordOriginator mesh__D017266 TGC
% 222.07/222.26  |- skos__related mesh__D017266smesh__D003794
% 222.07/222.26  |- mesh__dateRevised mesh__D017266 1999-11-03
% 222.07/222.26  |- mesh__activeMeSHYear mesh__D017266 2003
% 222.07/222.27  |- mesh__dateEstablished mesh__D017266 1993-01-01
% 222.07/222.27  |- skos__prefLabel mesh__D017266 Dental Prosthesis
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D017266 2001
% 222.07/222.27  |- skos__altLabel mesh__D017266 Prostheses, Dental
% 222.07/222.27  |- skos__annotation mesh__D017266
% 222.07/222.27       GEN or unspecified; prefer specifics; specialty is PROSTHODONTICS; DF: DENT PROSTHESIS%A%  
% 222.07/222.27  |- mesh__historyNote mesh__D003246
% 222.07/222.27       91%28%80%29%; was see under CONSERVATION OF NATURAL RESOURCES 1980-90%A%  
% 222.07/222.27  |- rdf__type mesh__D003246sskos__Concept
% 222.07/222.27  |- skos__hiddenLabel mesh__D003246 Conservation, Energy Resources
% 222.07/222.27  |- mesh__publicMeSHNote mesh__D003246
% 222.07/222.27       91; was see under CONSERVATION OF NATURAL RESOURCES 1980-90%A%  
% 222.07/222.27  |- mesh__recordAuthorizer mesh__D003246 PLS
% 222.07/222.27  |- mesh__dateCreated mesh__D003246 1979-04-11
% 222.07/222.27  |- mesh__recordOriginator mesh__D003246 EC
% 222.07/222.27  |- skos__scopeNote mesh__D003246
% 222.07/222.27       Planned management, use, and preservation of energy resources.%A%    
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003246 2002
% 222.07/222.27  |- skos__prefLabel mesh__D003246 Conservation of Energy Resources
% 222.07/222.27  |- mesh__dateRevised mesh__D003246 1992-05-07
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003246 1997
% 222.07/222.27  |- mesh__dateEstablished mesh__D003246 1991-01-01
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003246 2001
% 222.07/222.27  |- skos__altLabel mesh__D003246 Energy Resources Conservation
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003246 1999
% 222.07/222.27  |- skos__hiddenLabel mesh__D003246 Resources Conservation, Energy
% 222.07/222.27  |- mesh__recordMaintainer mesh__D003246 TAP
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003246 1993
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003246 2004
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003246 1996
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003246 1995
% 222.07/222.27  |- skos__hiddenLabel mesh__D003246 Conservations, Energy Resources
% 222.07/222.27  |- skos__hiddenLabel mesh__D003246 Resources Conservations, Energy
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003246 2006
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003246 2000
% 222.07/222.27  |- skos__historyNote mesh__D003246
% 222.07/222.27       Conservation of Natural Resources %28%1977-1979%29%
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003246 1998
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003246 2003
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003246 1994
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003246 2005
% 222.07/222.27  |- skos__broader mesh__D003246smesh__D003247
% 222.07/222.27  |- skos__hiddenLabel mesh__D003246 Energy Resources Conservations
% 222.07/222.27  |- skos__broader mesh__D013674smesh__D003813
% 222.07/222.27  |- skos__scopeNote mesh__D013674
% 222.07/222.27       The field of dentistry involved in procedures for designing and constructing dental appliances. It includes also the application of any technology to the field of dentistry.%A%    
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013674 1995
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013674 1998
% 222.07/222.27  |- mesh__dateCreated mesh__D013674 1999-01-01
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013674 2004
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013674 2002
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013674 1994
% 222.07/222.27  |- skos__altLabel mesh__D013674 Dental Technology
% 222.07/222.27  |- mesh__recordOriginator mesh__D013674 NLM
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013674 2003
% 222.07/222.27  |- skos__prefLabel mesh__D013674 Technology, Dental
% 222.07/222.27  |- mesh__recordAuthorizer mesh__D013674 PLS
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013674 2006
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013674 1997
% 222.07/222.27  |- skos__annotation mesh__D013674 SPEC: SPEC qualif; DF: TECHNOL DENT   
% 222.07/222.27  |- mesh__dateRevised mesh__D013674 1993-06-04
% 222.07/222.27  |- skos__broader mesh__D013674smesh__D016390
% 222.07/222.27  |- mesh__recordMaintainer mesh__D013674 JLS
% 222.07/222.27  |- skos__broader mesh__D013674smesh__D013672
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013674 2001
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013674 2005
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013674 1996
% 222.07/222.27  |- rdf__type mesh__D013674sskos__Concept
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013674 1999
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013674 2000
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007637 1999
% 222.07/222.27  |- mesh__recordAuthorizer mesh__D007637 PLS
% 222.07/222.27  |- mesh__recordOriginator mesh__D007637 NLM
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007637 2002
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007637 1996
% 222.07/222.27  |- skos__annotation mesh__D007637 inflamm of cornea %26% conjunctiva   
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007637 1995
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007637 1998
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007637 2004
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007637 2001
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007637 1994
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007637 2006
% 222.07/222.27  |- mesh__dateCreated mesh__D007637 1999-01-01
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007637 2003
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007637 2000
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007637 2005
% 222.07/222.27  |- mesh__recordMaintainer mesh__D007637 TGC
% 222.07/222.27  |- skos__prefLabel mesh__D007637 Keratoconjunctivitis
% 222.07/222.27  |- skos__broader mesh__D007637smesh__D007634
% 222.07/222.27  |- skos__scopeNote mesh__D007637
% 222.07/222.27       Simultaneous inflammation of the cornea and conjunctiva.%A%    
% 222.07/222.27  |- skos__broader mesh__D007637smesh__D003231
% 222.07/222.27  |- skos__hiddenLabel mesh__D007637 Keratoconjunctivitides
% 222.07/222.27  |- rdf__type mesh__D007637sskos__Concept
% 222.07/222.27  |- mesh__dateRevised mesh__D007637 1993-06-02
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007637 1997
% 222.07/222.27  |- mesh__recordMaintainer mesh__D051793 DRC
% 222.07/222.27  |- mesh__historyNote mesh__D051793 2006%28%1993%29%   
% 222.07/222.27  |- skos__prefLabel mesh__D051793 Hypoxia-Inducible Factor 1
% 222.07/222.27  |- skos__scopeNote mesh__D051793
% 222.07/222.27       A basic helix-loop-helix transcription factor that plays a role in APOPTOSIS. It is composed of two subunits: ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR and HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT.%A%    
% 222.07/222.27  |- skos__hiddenLabel mesh__D051793 Hypoxia Inducible Factor 1
% 222.07/222.27  |- mesh__dateEstablished mesh__D051793 2006-01-01
% 222.07/222.27  |- mesh__dateCreated mesh__D051793 2005-06-30
% 222.07/222.27  |- skos__broader mesh__D051793smesh__D051792
% 222.07/222.27  |- mesh__publicMeSHNote mesh__D051793
% 222.07/222.27       2006; HYPOXIA-INDUCIBLE FACTOR 1 was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1993-2005%A%  
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D051793 2006
% 222.07/222.27  |- rdf__type mesh__D051793sskos__Concept
% 222.07/222.27  |- mesh__recordAuthorizer mesh__D051793 sjn
% 222.07/222.27  |- mesh__recordOriginator mesh__D051793 DRC
% 222.07/222.27  |- mesh__recordMaintainer mesh__D017267 sjn
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D017267 2005
% 222.07/222.27  |- skos__broader mesh__D017267smesh__D017266
% 222.07/222.27  |- mesh__historyNote mesh__D017267
% 222.07/222.27       93; was heading 1970-90, was see DENTURE DESIGN 1991-92; PROSTHESIS DESIGN, DENTAL was see DENTURE DESIGN 1992%A%  
% 222.07/222.27  |- mesh__recordOriginator mesh__D017267 TGC
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D017267 2006
% 222.07/222.27  |- skos__altLabel mesh__D017267 Prosthesis Designs, Dental
% 222.07/222.27  |- skos__altLabel mesh__D017267 Prosthesis Design, Dental
% 222.07/222.27  |- skos__altLabel mesh__D017267 Dental Prosthesis Designs
% 222.07/222.27  |- skos__altLabel mesh__D017267 Designs, Dental Prosthesis
% 222.07/222.27  |- mesh__onlineNote mesh__D017267
% 222.07/222.27       use DENTURE DESIGN to search DENTAL PROSTHESIS DESIGN 1970-92 %26% PROSTHESIS DESIGN, DENTAL 1992%A%  
% 222.07/222.27  |- mesh__dateEstablished mesh__D017267 1993-01-01
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D017267 2003
% 222.07/222.27  |- mesh__dateCreated mesh__D017267 1992-05-20
% 222.07/222.27  |- skos__historyNote mesh__D017267 Denture Design %28%1970-1992%29%
% 222.07/222.27  |- skos__broader mesh__D017267smesh__D013674
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D017267 2004
% 222.07/222.27  |- rdf__type mesh__D017267sskos__Concept
% 222.07/222.27  |- mesh__recordAuthorizer mesh__D017267 sjn
% 222.07/222.27  |- skos__scopeNote mesh__D017267
% 222.07/222.27       The plan and delineation of dental prostheses in general or a specific dental prosthesis. It does not include DENTURE DESIGN. The framework usually consists of metal.%A%    
% 222.07/222.27  |- mesh__publicMeSHNote mesh__D017267
% 222.07/222.27       93; was heading 1970-90, was see DENTURE DESIGN 1991-92; PROSTHESIS DESIGN, DENTAL was see DENTURE DESIGN 1992%A%  
% 222.07/222.27  |- skos__annotation mesh__D017267
% 222.07/222.27       coord IM with specific dent prosth %28%IM%29%; specify material of framework %28%IM or NIM%29% if pertinent; DENTURE DESIGN is also available; DF: DENT PROSTHESIS DESIGN%A%  
% 222.07/222.27  |- skos__prefLabel mesh__D017267 Dental Prosthesis Design
% 222.07/222.27  |- mesh__dateRevised mesh__D017267 2002-07-18
% 222.07/222.27  |- skos__altLabel mesh__D017267 Design, Dental Prosthesis
% 222.07/222.27  |- mesh__recordAuthorizer mesh__D036421 sjn
% 222.07/222.27  |- skos__scopeNote mesh__D036421
% 222.07/222.27       A class of nerve fibers as defined by their structure, specifically the nerve sheath arrangement. The AXONS of the unmyelinated nerve fibers are small. The axons to SCHWANN CELLS ratio is greater in the unmyelinated nerve fibers than that in the myelinated fiber %28%NERVE FIBERS, MYELINATED%29% which is 1:1. Usually several axons are surrounded by a single Schwann cell in the unmyelinated nerve fibers. Therefore, each unmyelinated fiber is not completely covered by the MYELIN SHEATH formed by the Schwann cell. Unmyelinated nerve fibers conduct impulses at low velocities. They represent the majority of peripheral sensory and autonomic fibers. They are also found in the spinal cord and brain.%A%    
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D036421 2005
% 222.07/222.27  |- skos__prefLabel mesh__D036421 Nerve Fibers, Unmyelinated
% 222.07/222.27  |- mesh__dateCreated mesh__D036421 2002-07-03
% 222.07/222.27  |- skos__historyNote mesh__D036421 Nerve Fibers %28%1976-2002%29%
% 222.07/222.27  |- skos__broader mesh__D036421smesh__D009412
% 222.07/222.27  |- skos__hiddenLabel mesh__D036421 Unmyelinated Nerve Fiber
% 222.07/222.27  |- mesh__historyNote mesh__D036421
% 222.07/222.27       2003; for C FIBERS use NERVE FIBERS 1977-2002   
% 222.07/222.27  |- skos__hiddenLabel mesh__D036421 Nerve Fiber, Unmyelinated
% 222.07/222.27  |- skos__hiddenLabel mesh__D036421 Unmyelinated Nerve Fibers
% 222.07/222.27  |- rdf__type mesh__D036421sskos__Concept
% 222.07/222.27  |- mesh__recordMaintainer mesh__D036421 lkt
% 222.07/222.27  |- skos__hiddenLabel mesh__D036421 C Fiber
% 222.07/222.27  |- mesh__publicMeSHNote mesh__D036421
% 222.07/222.27       2003; for C FIBERS see NERVE FIBERS 1977-2002   
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D036421 2004
% 222.07/222.27  |- mesh__recordOriginator mesh__D036421 lkt
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D036421 2003
% 222.07/222.27  |- mesh__dateEstablished mesh__D036421 2003-01-01
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D036421 2006
% 222.07/222.27  |- skos__broader mesh__D003247smesh__D004777
% 222.07/222.27  |- skos__related mesh__D003247smesh__D004463
% 222.07/222.27  |- skos__prefLabel mesh__D003247 Conservation of Natural Resources
% 222.07/222.27  |- skos__hiddenLabel mesh__D003247 Development, Sustainable
% 222.07/222.27  |- skos__hiddenLabel mesh__D003247 Resources Conservation, Natural
% 222.07/222.27  |- skos__altLabel mesh__D003247 Environmental Protection
% 222.07/222.27  |- skos__hiddenLabel mesh__D003247 Carrying Capacities
% 222.07/222.27  |- mesh__recordMaintainer mesh__D003247 JLS
% 222.07/222.27  |- mesh__historyNote mesh__D003247 77   
% 222.07/222.27  |- skos__altLabel mesh__D003247 Natural Resources Conservation
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003247 1997
% 222.07/222.27  |- mesh__dateEstablished mesh__D003247 1977-01-01
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003247 1999
% 222.07/222.27  |- skos__scopeNote mesh__D003247
% 222.07/222.27       The protection, preservation, restoration, and rational use of all resources in the total environment.%A%    
% 222.07/222.27  |- skos__hiddenLabel mesh__D003247 Resources, Natural
% 222.07/222.27  |- skos__hiddenLabel mesh__D003247 Conservation, Natural Resources
% 222.07/222.27  |- mesh__recordOriginator mesh__D003247 EC
% 222.07/222.27  |- mesh__recordAuthorizer mesh__D003247 PLS
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003247 2004
% 222.07/222.27  |- mesh__publicMeSHNote mesh__D003247 77   
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003247 1996
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003247 2002
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003247 2006
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003247 1998
% 222.07/222.27  |- mesh__dateRevised mesh__D003247 1995-05-25
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003247 2003
% 222.07/222.27  |- mesh__dateCreated mesh__D003247 1976-05-19
% 222.07/222.27  |- skos__hiddenLabel mesh__D003247 Capacity, Carrying
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003247 2001
% 222.07/222.27  |- skos__hiddenLabel mesh__D003247 Resource, Natural
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003247 2005
% 222.07/222.27  |- skos__hiddenLabel mesh__D003247 Capacities, Carrying
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D003247 2000
% 222.07/222.27  |- skos__hiddenLabel mesh__D003247 Natural Resource
% 222.07/222.27  |- rdf__type mesh__D003247sskos__Concept
% 222.07/222.27  |- skos__altLabel mesh__D008730 Chinoin Brand of Methoxsalen
% 222.07/222.27  |- skos__altLabel mesh__D008730 8-Methoxypsoralen
% 222.07/222.27  |- skos__altLabel mesh__D008730 Meladinine
% 222.07/222.27  |- skos__hiddenLabel mesh__D008730 Methoxsalen Canderm Brand
% 222.07/222.27  |- skos__altLabel mesh__D008730 DB Brand of Methoxsalen
% 222.07/222.27  |- skos__altLabel mesh__D008730 Sanofi-Synthelabo Brand of Methoxsalen
% 222.07/222.27  |- skos__altLabel mesh__D008730 Ammoidin
% 222.07/222.27  |- skos__altLabel mesh__D008730 Xanthotoxin
% 222.07/222.27  |- skos__altLabel mesh__D008730 Delta Brand of Methoxsalen
% 222.07/222.27  |- skos__hiddenLabel mesh__D008730 8 MOP
% 222.07/222.27  |- skos__altLabel mesh__D008730 Canderm Brand of Methoxsalen
% 222.07/222.27  |- mesh__dateCreated mesh__D008730 1999-01-01
% 222.07/222.27  |- skos__altLabel mesh__D008730 ICN Brand 2 of Methoxsalen
% 222.07/222.27  |- rdf__type mesh__D008730sskos__Concept
% 222.07/222.27  |- skos__altLabel mesh__D008730 ICN Brand 3 of Methoxsalen
% 222.07/222.27  |- skos__altLabel mesh__D008730 ICN Brand 1 of Methoxsalen
% 222.07/222.27  |- skos__hiddenLabel mesh__D008730 8MOP
% 222.07/222.27  |- skos__scopeNote mesh__D008730
% 222.07/222.27       A naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia. It is a photoactive substance that forms DNA ADDUCTS in the presence of ultraviolet A irradiation.%A%    
% 222.07/222.27  |- skos__hiddenLabel mesh__D008730 Methoxa Dome
% 222.07/222.27  |- skos__hiddenLabel mesh__D008730 Methoxsalen Dermatech Brand
% 222.07/222.27  |- skos__broader mesh__D008730smesh__D011564
% 222.07/222.27  |- skos__altLabel mesh__D008730 Boehringer Ingelheim Brand of Methoxsalen
% 222.07/222.27  |- skos__altLabel mesh__D008730 M%C3%%A9%ladinine
% 222.07/222.27  |- skos__prefLabel mesh__D008730 Methoxsalen
% 222.07/222.27  |- mesh__recordAuthorizer mesh__D008730 sjn
% 222.07/222.27  |- skos__hiddenLabel mesh__D008730 8 Methoxypsoralen
% 222.07/222.27  |- skos__hiddenLabel mesh__D008730 Methoxsalen Chinoin Brand
% 222.07/222.27  |- skos__annotation mesh__D008730
% 222.07/222.27       do not index here for use in PUVA THERAPY unless particularly discussed%A%  
% 222.07/222.27  |- mesh__recordMaintainer mesh__D008730 ssb
% 222.07/222.27  |- skos__altLabel mesh__D008730 Dermatech Brand of Methoxsalen
% 222.07/222.27  |- skos__altLabel mesh__D008730 Galderma Brand of Methoxsalen
% 222.07/222.27  |- skos__hiddenLabel mesh__D008730 Oxsoralen Ultra
% 222.07/222.27  |- skos__hiddenLabel mesh__D008730 Methoxsalen Sanofi-Synthelabo Brand
% 222.07/222.27  |- skos__altLabel mesh__D008730 Mex-America Brand of Methoxsalen
% 222.07/222.27  |- skos__hiddenLabel mesh__D008730 Methoxsalen Delta Brand
% 222.07/222.27  |- mesh__dateRevised mesh__D008730 2005-06-30
% 222.07/222.27  |- mesh__recordOriginator mesh__D008730 NLM
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D008730 2006
% 222.07/222.27  |- skos__hiddenLabel mesh__D008730 Methoxsalen Mex-America Brand
% 222.07/222.27  |- skos__hiddenLabel mesh__D008730 Sanofi Synthelabo Brand of Methoxsalen
% 222.07/222.27  |- skos__hiddenLabel mesh__D008730 Mex America Brand of Methoxsalen
% 222.07/222.27  |- mesh__dateEstablished mesh__D022401 2001-01-01
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D022401 2006
% 222.07/222.27  |- mesh__recordMaintainer mesh__D022401 ssb
% 222.07/222.27  |- rdf__type mesh__D022401sskos__Concept
% 222.07/222.27  |- mesh__recordAuthorizer mesh__D022401 sjn
% 222.07/222.27  |- skos__historyNote mesh__D022401 Bacterial Vaccines %28%1965-2000%29%
% 222.07/222.27  |- mesh__recordOriginator mesh__D022401 ags
% 222.07/222.27  |- skos__scopeNote mesh__D022401
% 222.07/222.27       Vaccines or candidate vaccines used to prevent infection with NEISSERIA MENINGITIDIS.%A%    
% 222.07/222.27  |- skos__hiddenLabel mesh__D022401 Polysaccharide Vaccine, Meningococcal
% 222.07/222.27  |- mesh__dateCreated mesh__D022401 2000-06-22
% 222.07/222.27  |- mesh__historyNote mesh__D022401
% 222.07/222.27       2001; use MENINGOCOCCAL VACCINES %28%NM%29% to search MENINGOCOCCAL VACCINE 1983-2000%A%  
% 222.07/222.27  |- skos__hiddenLabel mesh__D022401 Meningococcal Vaccine, Bivalent
% 222.07/222.27  |- skos__hiddenLabel mesh__D022401 Meningococcal Vaccine, Tetravalent
% 222.07/222.27  |- mesh__dateRevised mesh__D022401 2005-06-30
% 222.07/222.27  |- skos__hiddenLabel mesh__D022401 Vaccine, Meningococcal Polysaccharide
% 222.07/222.27  |- mesh__publicMeSHNote mesh__D022401
% 222.07/222.27       2001; MENINGOCOCCAL VACCINE was indexed under BACTERIAL VACCINES 1983-2000%A%  
% 222.07/222.27  |- skos__altLabel mesh__D022401 Meningococcal Vaccine
% 222.07/222.27  |- skos__hiddenLabel mesh__D022401 Vaccine, Meningococcal
% 222.07/222.27  |- skos__hiddenLabel mesh__D022401 Vaccines, Meningococcal
% 222.07/222.27  |- skos__broader mesh__D022401smesh__D001428
% 222.07/222.27  |- skos__prefLabel mesh__D022401 Meningococcal Vaccines
% 222.07/222.27  |- skos__altLabel mesh__D049349 Edg Receptors
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D049349 2006
% 222.07/222.27  |- mesh__dateEstablished mesh__D049349 2005-01-01
% 222.07/222.27  |- skos__altLabel mesh__D049349 Edg-5 Receptor
% 222.07/222.27  |- skos__altLabel mesh__D049349 Receptor, Sphingosine-1-Phosphate
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 Edg 5 Receptor
% 222.07/222.27  |- skos__historyNote mesh__D049349
% 222.07/222.27       Receptors, G-Protein-Coupled %28%2004%29%
% 222.07/222.27  |- skos__broader mesh__D049349smesh__D049312
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 Receptor, edg-6
% 222.07/222.27  |- skos__altLabel mesh__D049349 Lysosphingolipid Receptor
% 222.07/222.27  |- rdf__type mesh__D049349sskos__Concept
% 222.07/222.27  |- skos__altLabel mesh__D049349 Sphingosine 1-Phosphate Receptor
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 Receptor, S1P3
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 Phosphorylcholine Receptors, Sphingosine
% 222.07/222.27  |- mesh__historyNote mesh__D049349 2005%28%1996%29%   
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D049349 2005
% 222.07/222.27  |- skos__altLabel mesh__D049349 edg-6 Receptor
% 222.07/222.27  |- mesh__recordOriginator mesh__D049349 jmp
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 edg 8 Protein
% 222.07/222.27  |- skos__scopeNote mesh__D049349
% 222.07/222.27       A subfamily of lysophospholipid receptors with specificity for LYSOSPHINGOLIPIDS such as sphingosine-1-phosphate and sphingosine phosphorylcholine.%A%    
% 222.07/222.27  |- skos__altLabel mesh__D049349 edg-3 Protein
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 Receptors, Sphingosine-1-Phosphate
% 222.07/222.27  |- skos__altLabel mesh__D049349 S1P Receptor
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 Receptors, Edg
% 222.07/222.27  |- skos__altLabel mesh__D049349 G-Protein Coupled Receptor H218
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 Receptor, edg-1
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 Receptor, Sphingosine 1 Phosphate
% 222.07/222.27  |- skos__altLabel mesh__D049349 Receptor, Lysosphingolipid
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 1-Phosphate Receptor, Sphingosine
% 222.07/222.27  |- skos__historyNote mesh__D049349
% 222.07/222.27       Receptors, Cell Surface %28%1996-2003%29%
% 222.07/222.27  |- skos__altLabel mesh__D049349 Lysosphingolipid Receptors
% 222.07/222.27  |- skos__altLabel mesh__D049349 edg-1 Protein
% 222.07/222.27  |- skos__altLabel mesh__D049349 H218 Protein
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 Nrg 1 Receptor
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 Receptor, S1P4
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 edg 1 Receptor
% 222.07/222.27  |- skos__altLabel mesh__D049349 EDG5 Protein
% 222.07/222.27  |- mesh__recordAuthorizer mesh__D049349 sjn
% 222.07/222.27  |- mesh__publicMeSHNote mesh__D049349
% 222.07/222.27       2005; RECEPTORS, LYSOSPHINGOLIPID was indexed under RECEPTORS, CELL SURFACE 1996-2003 %26% under RECEPTORS, G-PROTEIN-COUPLED 2004%A%  
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 edg 3 Protein
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 G Protein Coupled Receptor H218
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 Receptor, S1P5
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 Sphingosine 1 Phosphate Receptor
% 222.07/222.27  |- skos__prefLabel mesh__D049349 Receptors, Lysosphingolipid
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 edg 6 Receptor
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 Sphingosine 1 Phosphate Receptors
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 edg 1 Protein
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 Protein, edg-3
% 222.07/222.27  |- mesh__recordMaintainer mesh__D049349 jmp
% 222.07/222.27  |- skos__altLabel mesh__D049349 edg-1 Receptor
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 Receptors, Sphingosine Phosphorylcholine
% 222.07/222.27  |- skos__altLabel mesh__D049349 edg-8 Protein
% 222.07/222.27  |- skos__altLabel mesh__D049349 AGR16 Protein
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 Receptor, Edg-5
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 Receptor, Nrg-1
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 Protein, edg-8
% 222.07/222.27  |- mesh__dateCreated mesh__D049349 2004-07-07
% 222.07/222.27  |- skos__altLabel mesh__D049349 Sphingosine-1-Phosphate Receptor
% 222.07/222.27  |- skos__altLabel mesh__D049349 Nrg-1 Receptor
% 222.07/222.27  |- skos__hiddenLabel mesh__D049349 Receptor, S1P2
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013675 2000
% 222.07/222.27  |- mesh__recordMaintainer mesh__D013675 PLS
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013675 1995
% 222.07/222.27  |- mesh__recordAuthorizer mesh__D013675 NLM
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013675 2003
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013675 2001
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013675 2004
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013675 2002
% 222.07/222.27  |- mesh__historyNote mesh__D013675 80   
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013675 2005
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013675 1996
% 222.07/222.27  |- skos__prefLabel mesh__D013675 Technology, High-Cost
% 222.07/222.27  |- mesh__recordOriginator mesh__D013675 EC
% 222.07/222.27  |- skos__annotation mesh__D013675
% 222.07/222.27       costly advanced technol; DF: TECHNOL HIGH COST   
% 222.07/222.27  |- skos__hiddenLabel mesh__D013675 Technology, High Cost
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013675 2006
% 222.07/222.27  |- skos__altLabel mesh__D013675 High-Cost Technology
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013675 1997
% 222.07/222.27  |- mesh__dateEstablished mesh__D013675 1980-01-01
% 222.07/222.27  |- skos__hiddenLabel mesh__D013675 High Cost Technology
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013675 1998
% 222.07/222.27  |- skos__scopeNote mesh__D013675
% 222.07/222.27       Advanced technology that is costly, requires highly skilled personnel, and is unique in its particular application. Includes innovative, specialized medical/surgical procedures as well as advanced diagnostic and therapeutic equipment.%A%    
% 222.07/222.27  |- mesh__dateCreated mesh__D013675 1979-06-01
% 222.07/222.27  |- rdf__type mesh__D013675sskos__Concept
% 222.07/222.27  |- mesh__dateRevised mesh__D013675 1993-09-16
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D013675 1999
% 222.07/222.27  |- mesh__publicMeSHNote mesh__D013675 80   
% 222.07/222.27  |- skos__broader mesh__D013675smesh__D013673
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007638 1999
% 222.07/222.27  |- mesh__dateEstablished mesh__D007638 1991-01-01
% 222.07/222.27  |- mesh__historyNote mesh__D007638
% 222.07/222.27       91%28%86%29%; was see under KERATOCONJUNCTIVITIS 1986-90   
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007638 2002
% 222.07/222.27  |- mesh__dateCreated mesh__D007638 1985-06-05
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007638 1993
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007638 1998
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007638 2001
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007638 1992
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007638 1995
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007638 2004
% 222.07/222.27  |- mesh__recordMaintainer mesh__D007638 AGS
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007638 2000
% 222.07/222.27  |- skos__annotation mesh__D007638
% 222.07/222.27       if with xerostomia or xerostomia %26% connective tissue dis, index as SJOGREN%27%S SYNDROME%A%  
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007638 1994
% 222.07/222.27  |- mesh__publicMeSHNote mesh__D007638
% 222.07/222.27       91; was see under KERATOCONJUNCTIVITIS 1986-90   
% 222.07/222.27  |- mesh__dateRevised mesh__D007638 1990-02-12
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007638 2003
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007638 2006
% 222.07/222.27  |- skos__scopeNote mesh__D007638
% 222.07/222.27       Drying and inflammation of the conjunctiva as a result of insufficient lacrimal secretion. When found in association with XEROSTOMIA and polyarthritis, it is called SJOGREN%27%S SYNDROME.%A%    
% 222.07/222.27  |- skos__broader mesh__D007638smesh__D015352
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007638 2005
% 222.07/222.27  |- skos__historyNote mesh__D007638 Keratoconjunctivitis %28%1966-1985%29%
% 222.07/222.27  |- rdf__type mesh__D007638sskos__Concept
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007638 1997
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007638 1991
% 222.07/222.27  |- mesh__recordOriginator mesh__D007638 RC
% 222.07/222.27  |- skos__hiddenLabel mesh__D007638 Sicca, Keratoconjunctivitis
% 222.07/222.27  |- mesh__recordAuthorizer mesh__D007638 PLS
% 222.07/222.27  |- skos__broader mesh__D007638smesh__D007637
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D007638 1996
% 222.07/222.27  |- skos__prefLabel mesh__D007638 Keratoconjunctivitis Sicca
% 222.07/222.27  |- mesh__publicMeSHNote mesh__D018360 94   
% 222.07/222.27  |- mesh__recordOriginator mesh__D018360 PLS
% 222.07/222.27  |- mesh__recordAuthorizer mesh__D018360 sjn
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D018360 2004
% 222.07/222.27  |- skos__scopeNote mesh__D018360
% 222.07/222.27       The study of crystal structure using X-RAY DIFFRACTION techniques. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 222.07/222.27  |- skos__altLabel mesh__D018360 Crystallography, X Ray
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D018360 2005
% 222.07/222.27  |- mesh__dateCreated mesh__D018360 1993-06-03
% 222.07/222.27  |- mesh__dateEstablished mesh__D018360 1994-01-01
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D018360 2006
% 222.07/222.27  |- skos__hiddenLabel mesh__D018360 Crystallographies, X Ray
% 222.07/222.27  |- rdf__type mesh__D018360sskos__Concept
% 222.07/222.27  |- skos__annotation mesh__D018360
% 222.07/222.27       study of crystal struct using x-ray diffraction; NIM; DF: CRYSTALLOGR XRAY%A%  
% 222.07/222.27  |- skos__altLabel mesh__D018360 X Ray Crystallography
% 222.07/222.27  |- skos__broader mesh__D018360smesh__D014961
% 222.07/222.27  |- mesh__activeMeSHYear mesh__D018360 2003
% 222.07/222.27  |- skos__hiddenLabel mesh__D018360 X Ray Crystallographies
% 222.07/222.27  |- mesh__dateRevised mesh__D018360 2002-07-03
% 222.07/222.27  |- mesh__recordMaintainer mesh__D018360 lkt
% 222.07/222.27  |- skos__altLabel mesh__D018360 X-Ray Crystallography
% 222.07/222.27  |- skos__prefLabel mesh__D018360 Crystallography, X-Ray
% 222.07/222.27  |- mesh__historyNote mesh__D018360 94   
% 222.07/222.27  |- skos__altLabel mesh__D018360 Xray Crystallography
% 222.07/222.27  |- skos__altLabel mesh__D018360 Crystallography, Xray
% 222.07/222.27  |- mesh__historyNote mesh__D051794 2006%28%1995%29%   
% 222.07/222.27  |- mesh__recordAuthorizer mesh__D051794 sjn
% 222.07/222.27  |- mesh__recordMaintainer mesh__D051794 DRC
% 222.07/222.27  |- skos__prefLabel mesh__D051794 Von Hippel-Lindau Tumor Suppressor Protein
% 222.07/222.27  |- mesh__publicMeSHNote mesh__D051794
% 222.07/222.27       2006; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN was indexed under TUMOR SUPPRESSOR PROTEINS 2002-2005, under UBIQUITIN-PROTEIN LIGASES 2004-2005, under LIGASES 2002-3003, under PROTEINS 1995-2001, %26% under NUCLEAR PROTEINS 1995%A%  
% 222.07/222.27  |- skos__hiddenLabel mesh__D051794
% 222.07/222.27       Von Hippel Lindau Tumor Suppressor Protein
% 222.07/222.27  |- skos__altLabel mesh__D051794 VHL Tumor Suppressor Protein
% 222.07/222.27  |- rdf__type mesh__D051794sskos__Concept
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D051794 2006
% 222.07/222.28  |- mesh__recordOriginator mesh__D051794 DRC
% 222.07/222.28  |- skos__scopeNote mesh__D051794
% 222.07/222.28       A ubiquitin-protein ligase that mediates OXYGEN-dependent polyubiquitination of HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT. It is inactivated in VON HIPPEL-LINDAU SYNDROME.%A%    
% 222.07/222.28  |- mesh__dateEstablished mesh__D051794 2006-01-01
% 222.07/222.28  |- skos__broader mesh__D051794smesh__D044767
% 222.07/222.28  |- mesh__dateCreated mesh__D051794 2005-06-30
% 222.07/222.28  |- skos__broader mesh__D051794smesh__D025521
% 222.07/222.28  |- skos__scopeNote mesh__D004340
% 222.07/222.28       The presence of organisms, or any foreign material that makes a drug preparation impure.%A%    
% 222.07/222.28  |- skos__hiddenLabel mesh__D004340 Drug Adulterations
% 222.07/222.28  |- mesh__dateRevised mesh__D004340 2002-07-02
% 222.07/222.28  |- skos__hiddenLabel mesh__D004340 Drug Contaminations
% 222.07/222.28  |- mesh__publicMeSHNote mesh__D004340
% 222.07/222.28       74; DRUG ADULTERATION was heading 1963-76   
% 222.07/222.28  |- mesh__dateEstablished mesh__D004340 1974-01-01
% 222.07/222.28  |- mesh__historyNote mesh__D004340
% 222.07/222.28       74; DRUG ADULTERATION was heading 1963-76   
% 222.07/222.28  |- skos__prefLabel mesh__D004340 Drug Contamination
% 222.07/222.28  |- skos__hiddenLabel mesh__D004340 Adulterations, Drug
% 222.07/222.28  |- skos__hiddenLabel mesh__D004340 Adulteration, Drug
% 222.07/222.28  |- mesh__onlineNote mesh__D004340
% 222.07/222.28       use DRUG CONTAMINATION to search DRUG ADULTERATION 1966-76%A%  
% 222.07/222.28  |- skos__annotation mesh__D004340
% 222.07/222.28       can be used for contamination of any Category D term   
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D004340 2006
% 222.07/222.28  |- skos__hiddenLabel mesh__D004340 Contamination, Drug
% 222.07/222.28  |- mesh__recordOriginator mesh__D004340 NLM
% 222.07/222.28  |- mesh__recordMaintainer mesh__D004340 lkt
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D004340 2004
% 222.07/222.28  |- skos__broader mesh__D004340smesh__D011634
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D004340 2005
% 222.07/222.28  |- rdf__type mesh__D004340sskos__Concept
% 222.07/222.28  |- mesh__dateCreated mesh__D004340 1999-01-01
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D004340 2003
% 222.07/222.28  |- skos__hiddenLabel mesh__D004340 Contaminations, Drug
% 222.07/222.28  |- mesh__recordAuthorizer mesh__D004340 sjn
% 222.07/222.28  |- skos__annotation mesh__D017268
% 222.07/222.28       coord IM with specific dent prosth %28%IM or NIM%29%; DF: DENT PROSTHESIS RETENTION%A%  
% 222.07/222.28  |- skos__altLabel mesh__D017268 Retention, Dental Prosthesis
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017268 2006
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017268 1998
% 222.07/222.28  |- mesh__historyNote mesh__D017268
% 222.07/222.28       93; was heading 1966-90; was see DENTURE RETENTION 1991-92%A%  
% 222.07/222.28  |- skos__prefLabel mesh__D017268 Dental Prosthesis Retention
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017268 2003
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017268 1999
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017268 1993
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017268 2000
% 222.07/222.28  |- mesh__onlineNote mesh__D017268
% 222.07/222.28       use DENTURE RETENTION to search DENTAL PROSTHESIS RETENTION 1966-92%A%  
% 222.07/222.28  |- rdf__type mesh__D017268sskos__Concept
% 222.07/222.28  |- skos__scopeNote mesh__D017268
% 222.07/222.28       The retention of a dental prosthesis in place by design, device, or adhesion.%A%    
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017268 2004
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017268 1996
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017268 2001
% 222.07/222.28  |- mesh__dateEstablished mesh__D017268 1993-01-01
% 222.07/222.28  |- skos__altLabel mesh__D017268 Prosthesis Retention, Dental
% 222.07/222.28  |- mesh__dateCreated mesh__D017268 1992-05-20
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017268 1997
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017268 1994
% 222.07/222.28  |- skos__historyNote mesh__D017268 Denture Retention %28%1990-1992%29%
% 222.07/222.28  |- skos__historyNote mesh__D017268
% 222.07/222.28       Dental Prosthesis Retention %28%1966-1989%29%
% 222.07/222.28  |- skos__broader mesh__D017268smesh__D017266
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017268 2005
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017268 1995
% 222.07/222.28  |- mesh__publicMeSHNote mesh__D017268
% 222.07/222.28       93; was heading 1966-90; was see DENTURE RETENTION 1991-92%A%  
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017268 2002
% 222.07/222.28  |- mesh__recordAuthorizer mesh__D003248 sjn
% 222.07/222.28  |- skos__prefLabel mesh__D003248 Constipation
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D003248 2005
% 222.07/222.28  |- skos__scopeNote mesh__D003248
% 222.07/222.28       Infrequent or difficult evacuation of FECES. These symptoms are associated with a variety of causes, including low DIETARY FIBER intake, emotional or nervous disturbances, systemic and structural disorders, drug-induced aggravation, and infections.%A%    
% 222.07/222.28  |- mesh__recordMaintainer mesh__D003248 lkt
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D003248 2004
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D003248 2006
% 222.07/222.28  |- mesh__recordOriginator mesh__D003248 NLM
% 222.07/222.28  |- skos__broader mesh__D003248smesh__D012817
% 222.07/222.28  |- mesh__dateCreated mesh__D003248 1999-01-01
% 222.07/222.28  |- mesh__dateRevised mesh__D003248 2003-07-09
% 222.07/222.28  |- rdf__type mesh__D003248sskos__Concept
% 222.07/222.28  |- mesh__dateRevised mesh__D008731 2004-07-07
% 222.07/222.28  |- rdf__type mesh__D008731sskos__Concept
% 222.07/222.28  |- mesh__dateEstablished mesh__D008731 1974-01-01
% 222.07/222.28  |- skos__hiddenLabel mesh__D008731 Trichloroethane, Dianisyl
% 222.07/222.28  |- skos__historyNote mesh__D008731 Insecticides %28%1966-1972%29%
% 222.07/222.28  |- skos__annotation mesh__D008731 TN 111 for eff on insects   
% 222.07/222.28  |- mesh__dateCreated mesh__D008731 1999-01-01
% 222.07/222.28  |- skos__altLabel mesh__D008731 Dianisyl Trichloroethane
% 222.07/222.28  |- skos__scopeNote mesh__D008731
% 222.07/222.28       An insecticide. Methoxychlor has estrogenic effects in mammals, among other effects.%A%    
% 222.07/222.28  |- mesh__recordOriginator mesh__D008731 NLM
% 222.07/222.28  |- mesh__recordAuthorizer mesh__D008731 sjn
% 222.07/222.28  |- mesh__publicMeSHNote mesh__D008731 74   
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D008731 2006
% 222.07/222.28  |- skos__prefLabel mesh__D008731 Methoxychlor
% 222.07/222.28  |- skos__broader mesh__D008731smesh__D006843
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D008731 2005
% 222.07/222.28  |- skos__altLabel mesh__D008731 DMDT
% 222.07/222.28  |- mesh__recordMaintainer mesh__D008731 ssb
% 222.07/222.28  |- mesh__historyNote mesh__D008731 74%28%72%29%   
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D013676 2004
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D013676 2000
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D013676 2005
% 222.07/222.28  |- mesh__recordAuthorizer mesh__D013676 SJN
% 222.07/222.28  |- skos__prefLabel mesh__D013676 Technology, Industry, and Agriculture
% 222.07/222.28  |- skos__annotation mesh__D013676
% 222.07/222.28       not used for indexing      CATALOG: do not use   
% 222.07/222.28  |- mesh__runningHead mesh__D013676
% 222.07/222.28       J1 - TECHNOLOGY, INDUSTRY, AND AGRICULTURE   
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D013676 2001
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D013676 2006
% 222.07/222.28  |- mesh__historyNote mesh__D013676 98; use explode   
% 222.07/222.28  |- mesh__dateEstablished mesh__D013676 1998-01-01
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D013676 2002
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D013676 1998
% 222.07/222.28  |- mesh__dateCreated mesh__D013676 1999-01-01
% 222.07/222.28  |- rdf__type mesh__D013676sskos__Concept
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D013676 1999
% 222.07/222.28  |- mesh__dateRevised mesh__D013676 1997-06-26
% 222.07/222.28  |- mesh__recordMaintainer mesh__D013676 TGC
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D013676 2003
% 222.07/222.28  |- mesh__recordOriginator mesh__D013676 NLM
% 222.07/222.28  |- mesh__publicMeSHNote mesh__D013676 98   
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D007639 2004
% 222.07/222.28  |- skos__broader mesh__D007639smesh__D000820
% 222.07/222.28  |- skos__broader mesh__D007639smesh__D015818
% 222.07/222.28  |- skos__hiddenLabel mesh__D007639 Infectious Keratoconjunctivitides
% 222.07/222.28  |- skos__historyNote mesh__D007639 Cattle Diseases %28%1966-1985%29%
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D007639 2006
% 222.07/222.28  |- mesh__recordAuthorizer mesh__D007639 sjn
% 222.07/222.28  |- skos__altLabel mesh__D007639 Infectious Keratoconjunctivitis
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D007639 2005
% 222.07/222.28  |- skos__scopeNote mesh__D007639
% 222.07/222.28       Infectious diseases of cattle, sheep, and goats, characterized by blepharospasm, lacrimation, conjunctivitis, and varying degrees of corneal opacity and ulceration. In cattle the causative agent is MORAXELLA %28%MORAXELLA%29% BOVIS; in sheep, MYCOPLASMA; RICKETTSIA; CHLAMYDIA; or ACHOLEPLASMA; in goats, RICKETTSIA.%A%    
% 222.07/222.28  |- rdf__type mesh__D007639sskos__Concept
% 222.07/222.28  |- mesh__historyNote mesh__D007639 86   
% 222.07/222.28  |- mesh__recordOriginator mesh__D007639 RC
% 222.07/222.28  |- skos__broader mesh__D007639smesh__D007637
% 222.07/222.28  |- mesh__dateEstablished mesh__D007639 1986-01-01
% 222.07/222.28  |- skos__historyNote mesh__D007639 Keratoconjunctivitis %28%1966-1985%29%
% 222.07/222.28  |- mesh__recordMaintainer mesh__D007639 ags
% 222.07/222.28  |- mesh__dateCreated mesh__D007639 1985-06-05
% 222.07/222.28  |- skos__annotation mesh__D007639
% 222.07/222.28       animal only; check tag ANIMALS; coord IM with organism/infect heading /vet %28%IM%29%; DF: KERATOCONJUNCTIVITIS INFECT%A%  
% 222.07/222.28  |- skos__historyNote mesh__D007639 Bacterial Infections %28%1972-1985%29%
% 222.07/222.28  |- mesh__dateRevised mesh__D007639 2003-07-30
% 222.07/222.28  |- skos__prefLabel mesh__D007639 Keratoconjunctivitis, Infectious
% 222.07/222.28  |- skos__hiddenLabel mesh__D007639 Keratoconjunctivitides, Infectious
% 222.07/222.28  |- skos__historyNote mesh__D007639 Moraxella %28%1966-1985%29%
% 222.07/222.28  |- mesh__publicMeSHNote mesh__D007639 86   
% 222.07/222.28  |- rdf__type mesh__D051795sskos__Concept
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D051795 2006
% 222.07/222.28  |- mesh__dateCreated mesh__D051795 2005-06-30
% 222.07/222.28  |- skos__scopeNote mesh__D051795
% 222.07/222.28       Hypoxia-inducible factor 1, alpha subunit is a basic helix-loop-helix transcription factor that is regulated by OXYGEN availability and is targeted for degradation by VHL TUMOR SUPPRESSOR PROTEIN.%A%    
% 222.07/222.28  |- skos__broader mesh__D051795smesh__D051793
% 222.07/222.28  |- mesh__recordOriginator mesh__D051795 DRC
% 222.07/222.28  |- skos__prefLabel mesh__D051795 Hypoxia-Inducible Factor 1, alpha Subunit
% 222.07/222.28  |- mesh__historyNote mesh__D051795 2006%28%2001%29%   
% 222.07/222.28  |- mesh__recordMaintainer mesh__D051795 DRC
% 222.07/222.28  |- mesh__recordAuthorizer mesh__D051795 sjn
% 222.07/222.28  |- mesh__publicMeSHNote mesh__D051795
% 222.07/222.28       2006; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT was indexed under TRANSCRIPTION FACTORS 2001-2005%A%  
% 222.07/222.28  |- skos__hiddenLabel mesh__D051795
% 222.07/222.28       Hypoxia Inducible Factor 1, alpha Subunit
% 222.07/222.28  |- mesh__dateEstablished mesh__D051795 2006-01-01
% 222.07/222.28  |- mesh__recordOriginator mesh__D004341 NLM
% 222.07/222.28  |- skos__related mesh__D004341smesh__D002986
% 222.07/222.28  |- mesh__recordMaintainer mesh__D004341 TPW
% 222.07/222.28  |- skos__broader mesh__D004341smesh__D005069
% 222.07/222.28  |- skos__hiddenLabel mesh__D004341 Studies, Drug Evaluation
% 222.07/222.28  |- skos__prefLabel mesh__D004341 Drug Evaluation
% 222.07/222.28  |- skos__altLabel mesh__D004341 Drug Evaluation Studies
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D004341 2005
% 222.07/222.28  |- skos__hiddenLabel mesh__D004341 Drug Evaluation Study
% 222.07/222.28  |- skos__annotation mesh__D004341
% 222.07/222.28       GEN: more likely CLINICAL TRIAL %28%PT%29% %26% its indentations or CLINICAL TRIALS %26% its indentations; differentiate from DRUG EVALUATION, PRECLINICAL which is used for studies in exper animals or in vitro%A%  
% 222.07/222.28  |- skos__hiddenLabel mesh__D004341 Study, Drug Evaluation
% 222.07/222.28  |- mesh__historyNote mesh__D004341 74; was in Cat E %26% G 1974-79   
% 222.07/222.28  |- skos__hiddenLabel mesh__D004341 Evaluations, Drug
% 222.07/222.28  |- skos__altLabel mesh__D004341 Evaluation Studies, Drug
% 222.07/222.28  |- mesh__dateRevised mesh__D004341 2000-06-22
% 222.07/222.28  |- mesh__dateEstablished mesh__D004341 1974-01-01
% 222.07/222.28  |- mesh__recordAuthorizer mesh__D004341 sjn
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D004341 2003
% 222.07/222.28  |- mesh__dateCreated mesh__D004341 1999-01-01
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D004341 2006
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D004341 2001
% 222.07/222.28  |- skos__scopeNote mesh__D004341
% 222.07/222.28       Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals.%A%    
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D004341 2004
% 222.07/222.28  |- skos__hiddenLabel mesh__D004341 Evaluation, Drug
% 222.07/222.28  |- skos__hiddenLabel mesh__D004341 Evaluation Study, Drug
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D004341 2002
% 222.07/222.28  |- mesh__publicMeSHNote mesh__D004341 74   
% 222.07/222.28  |- rdf__type mesh__D004341sskos__Concept
% 222.07/222.28  |- skos__hiddenLabel mesh__D004341 Drug Evaluations
% 222.07/222.28  |- skos__annotation mesh__D017269
% 222.07/222.28       coord IM with specific prosth %28%IM or NIM%29%; DF: DENT PROSTHESIS REPAIR%A%  
% 222.07/222.28  |- skos__broader mesh__D017269smesh__D013674
% 222.07/222.28  |- rdf__type mesh__D017269sskos__Concept
% 222.07/222.28  |- mesh__dateCreated mesh__D017269 1992-05-20
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017269 2004
% 222.07/222.28  |- skos__altLabel mesh__D017269 Repair, Dental Prosthesis
% 222.07/222.28  |- skos__altLabel mesh__D017269 Repairs, Dental Prosthesis
% 222.07/222.28  |- skos__prefLabel mesh__D017269 Dental Prosthesis Repair
% 222.07/222.28  |- skos__historyNote mesh__D017269 Denture Repair %28%1972-1992%29%
% 222.07/222.28  |- skos__altLabel mesh__D017269 Dental Prosthesis Repairs
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017269 1997
% 222.07/222.28  |- skos__scopeNote mesh__D017269
% 222.07/222.28       The process of reuniting or replacing a broken or worn dental prosthesis or its part.%A%    
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017269 2002
% 222.07/222.28  |- mesh__dateRevised mesh__D017269 1996-06-10
% 222.07/222.28  |- skos__altLabel mesh__D017269 Prosthesis Repairs, Dental
% 222.07/222.28  |- mesh__onlineNote mesh__D017269
% 222.07/222.28       use DENTURE REPAIR to search DENTAL PROSTHESIS REPAIR 1972-92 %28%as Prov 1972-73%29%%A%  
% 222.07/222.28  |- skos__broader mesh__D017269smesh__D017266
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017269 2005
% 222.07/222.28  |- mesh__publicMeSHNote mesh__D017269
% 222.07/222.28       93; was heading 1974-90; was see DENTURE REPAIR 1991-92   
% 222.07/222.28  |- mesh__historyNote mesh__D017269
% 222.07/222.28       93; was heading 1972-90 %28%Prov 1972-73%29%; was see DENTURE REPAIR 1991-92%A%  
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017269 2006
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017269 1998
% 222.07/222.28  |- mesh__recordOriginator mesh__D017269 TGC
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017269 2000
% 222.07/222.28  |- mesh__recordAuthorizer mesh__D017269 PLS
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017269 2003
% 222.07/222.28  |- mesh__dateEstablished mesh__D017269 1993-01-01
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017269 1999
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D017269 2001
% 222.07/222.28  |- mesh__recordMaintainer mesh__D017269 JLS
% 222.07/222.28  |- skos__altLabel mesh__D017269 Prosthesis Repair, Dental
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D003249 2001
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D003249 1998
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D003249 1997
% 222.07/222.28  |- skos__hiddenLabel mesh__D003249 Bylaw
% 222.07/222.28  |- mesh__publicMeSHNote mesh__D003249
% 222.07/222.28       91; was see under ORGANIZATION AND ADMINISTRATION Aug 1977-90%A%  
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D003249 2003
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D003249 1999
% 222.07/222.28  |- mesh__recordAuthorizer mesh__D003249 PLS
% 222.07/222.28  |- skos__annotation mesh__D003249
% 222.07/222.28       NIM; no qualif; coord with specific organiz or society %28%IM%29% + geog; DF: CONSTITUTION%A%  
% 222.07/222.28  |- mesh__historyNote mesh__D003249
% 222.07/222.28       91%28%Aug 77%29%; was see under ORGANIZATION AND ADMINISTRATION 1977-90%A%  
% 222.07/222.28  |- skos__hiddenLabel mesh__D003249 Bylaws and Constitution
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D003249 2002
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D003249 2005
% 222.07/222.28  |- mesh__dateRevised mesh__D003249 1994-03-17
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D003249 2004
% 222.07/222.28  |- mesh__recordMaintainer mesh__D003249 PLS
% 222.07/222.28  |- skos__broader mesh__D003249smesh__D009934
% 222.07/222.28  |- mesh__dateEstablished mesh__D003249 1991-01-01
% 222.07/222.28  |- mesh__recordOriginator mesh__D003249 EC
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D003249 1995
% 222.07/222.28  |- skos__altLabel mesh__D003249 Constitution
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D003249 2006
% 222.07/222.28  |- skos__scopeNote mesh__D003249
% 222.07/222.28       The fundamental principles and laws adopted by an organization for the regulation and governing of its affairs.%A%    
% 222.07/222.28  |- mesh__dateCreated mesh__D003249 1977-05-05
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D003249 2000
% 222.07/222.28  |- rdf__type mesh__D003249sskos__Concept
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D003249 1996
% 222.07/222.28  |- skos__prefLabel mesh__D003249 Constitution and Bylaws
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D008732 2001
% 222.07/222.28  |- mesh__publicMeSHNote mesh__D008732
% 222.07/222.28       91; was see under TRYPTAMINES 1989-90; was see under SEROTONIN 1984-88; was METHOXYDIMETHYLTRYPTAMINE see under SEROTONIN 1980-83%A%  
% 222.07/222.28  |- skos__hiddenLabel mesh__D008732 5 Methoxy N,N Dimethyltryptamine
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D008732 1996
% 222.07/222.28  |- skos__annotation mesh__D008732 /biosyn /physiol permitted   
% 222.07/222.28  |- skos__historyNote mesh__D008732
% 222.07/222.28       Serotonin %28%1966-1974%29% /analogs %26% derivatives %28%1975-1979%29%
% 222.07/222.28  |- skos__hiddenLabel mesh__D008732 N,N Dimethyl 5 Methoxytryptamine
% 222.07/222.28  |- skos__broader mesh__D008732smesh__D004130
% 222.07/222.28  |- skos__altLabel mesh__D008732 N,N-Dimethyl-5-Methoxytryptamine
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D008732 2000
% 222.07/222.28  |- skos__broader mesh__D008732smesh__D002027
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D008732 2006
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D008732 1995
% 222.07/222.28  |- skos__historyNote mesh__D008732
% 222.07/222.28       Bufotenin %28%1966-1974%29% /analogs %26% derivatives %28%1975-1979%29%
% 222.07/222.28  |- mesh__recordAuthorizer mesh__D008732 PLS
% 222.07/222.28  |- skos__scopeNote mesh__D008732
% 222.07/222.28       Compounds that contain the biogenic monoamine tryptamine and are substituted with one methoxy group and two methyl groups. Members of this group include several potent serotonergic hallucinogens found in several unrelated plants, skins of certain toads, and in mammalian brains. They are possibly involved in the etiology of schizophrenia.%A%    
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D008732 2005
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D008732 2004
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D008732 2002
% 222.07/222.28  |- skos__historyNote mesh__D008732 Tryptamines %28%1966-1973%29%
% 222.07/222.28  |- skos__altLabel mesh__D008732 5-Methoxy-N,N-Dimethyltryptamine
% 222.07/222.28  |- mesh__dateEstablished mesh__D008732 1991-01-01
% 222.07/222.28  |- mesh__onlineNote mesh__D008732
% 222.07/222.28       use METHOXYDIMETHYLTRYPTAMINES to search METHOXYDIMETHYLTRYPTAMINE 1980-83%A%  
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D008732 1999
% 222.07/222.28  |- skos__prefLabel mesh__D008732 Methoxydimethyltryptamines
% 222.07/222.28  |- mesh__dateRevised mesh__D008732 1994-05-24
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D008732 2003
% 222.07/222.28  |- skos__historyNote mesh__D008732 Dimethyltryptamine %28%1973-1979%29%
% 222.07/222.28  |- mesh__historyNote mesh__D008732
% 222.07/222.28       91%28%84%29%; was see under TRYPTAMINES 1989-90; was see under SEROTONIN 1984-88; was METHOXYDIMETHYLTRYPTAMINE see under SEROTONIN 1980-83%A%  
% 222.07/222.28  |- rdf__type mesh__D008732sskos__Concept
% 222.07/222.28  |- mesh__recordOriginator mesh__D008732 SH
% 222.07/222.28  |- mesh__dateCreated mesh__D008732 1979-03-02
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D008732 1998
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D008732 1997
% 222.07/222.28  |- mesh__recordMaintainer mesh__D008732 RAZ
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D013677 2004
% 222.07/222.28  |- skos__hiddenLabel mesh__D013677 Technologies, Medical Laboratory
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D013677 2001
% 222.07/222.28  |- skos__related mesh__D013677smesh__D003942
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D013677 2005
% 222.07/222.28  |- skos__altLabel mesh__D013677 Medical Laboratory Technology
% 222.07/222.28  |- skos__broader mesh__D013677smesh__D016390
% 222.07/222.28  |- mesh__dateCreated mesh__D013677 1999-01-01
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D013677 2002
% 222.07/222.28  |- rdf__type mesh__D013677sskos__Concept
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D013677 2006
% 222.07/222.28  |- skos__altLabel mesh__D013677 Medical Technology
% 222.07/222.28  |- skos__prefLabel mesh__D013677 Technology, Medical
% 222.07/222.28  |- mesh__dateRevised mesh__D013677 2000-06-22
% 222.07/222.28  |- mesh__recordAuthorizer mesh__D013677 sjn
% 222.07/222.28  |- mesh__recordOriginator mesh__D013677 NLM
% 222.07/222.28  |- skos__related mesh__D013677smesh__D019411
% 222.07/222.28  |- skos__hiddenLabel mesh__D013677 Laboratory Technology, Medical
% 222.07/222.28  |- skos__hiddenLabel mesh__D013677 Laboratory Technologies, Medical
% 222.07/222.28  |- skos__scopeNote mesh__D013677
% 222.07/222.28       The specialty related to the performance of techniques in clinical pathology such as those in hematology, microbiology, and other general clinical laboratory applications.%A%    
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D013677 2003
% 222.07/222.28  |- skos__hiddenLabel mesh__D013677 Medical Laboratory Technologies
% 222.07/222.28  |- mesh__recordMaintainer mesh__D013677 jls
% 222.07/222.28  |- skos__broader mesh__D013677smesh__D013672
% 222.07/222.28  |- skos__annotation mesh__D013677 SPEC: SPEC qualif; DF: TECHNOL MED   
% 222.07/222.28  |- skos__scopeNote mesh__D051796
% 222.07/222.28       Inhibitor of differentiation proteins are negative regulators of BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS. They inhibit CELL DIFFERENTIATION and induce CELL PROLIFERATION by modulating different CELL CYCLE regulators.%A%    
% 222.07/222.28  |- skos__prefLabel mesh__D051796 Inhibitor of Differentiation Proteins
% 222.07/222.28  |- mesh__publicMeSHNote mesh__D051796 2006   
% 222.07/222.28  |- mesh__dateEstablished mesh__D051796 2006-01-01
% 222.07/222.28  |- mesh__historyNote mesh__D051796 2006   
% 222.07/222.28  |- mesh__recordOriginator mesh__D051796 DRC
% 222.07/222.28  |- skos__broader mesh__D051796smesh__D014157
% 222.07/222.28  |- skos__altLabel mesh__D051796 ID DNA Binding Protein Inhibitor
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D051796 2006A
% 222.07/222.28  |- mesh__recordAuthorizer mesh__D051796 ags
% 222.07/222.28  |- mesh__dateCreated mesh__D051796 2005-06-30
% 222.07/222.28  |- mesh__recordMaintainer mesh__D051796 ags
% 222.07/222.28  |- mesh__dateRevised mesh__D051796 2005-07-12
% 222.07/222.28  |- skos__hiddenLabel mesh__D051796 Differentiation Proteins Inhibitor
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D051796 2006
% 222.07/222.28  |- rdf__type mesh__D051796sskos__Concept
% 222.07/222.28  |- skos__altLabel mesh__D004342 Hypersensitivity, Drug
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D004342 2005
% 222.07/222.28  |- skos__prefLabel mesh__D004342 Drug Hypersensitivity
% 222.07/222.28  |- skos__hiddenLabel mesh__D004342 Drug Hypersensitivities
% 222.07/222.28  |- mesh__recordOriginator mesh__D004342 NLM
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D004342 2003
% 222.07/222.28  |- mesh__dateCreated mesh__D004342 1999-01-01
% 222.07/222.28  |- mesh__recordMaintainer mesh__D004342 tpw
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D004342 2006
% 222.07/222.28  |- skos__hiddenLabel mesh__D004342 Allergies, Drug
% 222.07/222.28  |- skos__scopeNote mesh__D004342
% 222.07/222.28       Immunologically mediated adverse reactions to medicinal substances used legally or illegally.%A%    
% 222.07/222.28  |- mesh__historyNote mesh__D004342 66; was DRUG ALLERGY 1963-65   
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D004342 2004
% 222.07/222.28  |- skos__annotation mesh__D004342
% 222.07/222.28       use in conventional sense and not for allergy to every category D term; allergy to non-drug chemical substance=substance /ad eff + HYPERSENSITIVITY or its specifics /etiol; manual 23.24+%A%  
% 222.07/222.28  |- skos__broader mesh__D004342smesh__D006967
% 222.07/222.28  |- rdf__type mesh__D004342sskos__Concept
% 222.07/222.28  |- skos__hiddenLabel mesh__D004342 Hypersensitivities, Drug
% 222.07/222.28  |- skos__hiddenLabel mesh__D004342 Drug Allergies
% 222.07/222.28  |- mesh__recordAuthorizer mesh__D004342 sjn
% 222.07/222.28  |- skos__altLabel mesh__D004342 Drug Allergy
% 222.07/222.28  |- skos__altLabel mesh__D004342 Allergy, Drug
% 222.07/222.28  |- mesh__dateEstablished mesh__D004342 1966-01-01
% 222.07/222.28  |- mesh__publicMeSHNote mesh__D004342 66; was DRUG ALLERGY 1963-65   
% 222.07/222.28  |- mesh__dateRevised mesh__D004342 2001-07-25
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D004342 2002
% 222.07/222.28  |- mesh__dateRevised mesh__D042461 2005-06-30
% 222.07/222.28  |- skos__altLabel mesh__D042461 Vascular Endothelial Growth Factor-A
% 222.07/222.28  |- skos__historyNote mesh__D042461
% 222.07/222.28       Endothelial Growth Factors %28%2000-2003%29%
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D042461 2006
% 222.07/222.28  |- skos__altLabel mesh__D042461 Vasculotropin
% 222.07/222.28  |- skos__annotation mesh__D042461 see SCR for organism-specific terms   
% 222.07/222.28  |- skos__altLabel mesh__D042461 Vascular Permeability Factor
% 222.07/222.28  |- skos__altLabel mesh__D042461 Vascular Endothelial Growth Factor
% 222.07/222.28  |- skos__hiddenLabel mesh__D042461 Permeability Factor, Vascular
% 222.07/222.28  |- skos__prefLabel mesh__D042461 Vascular Endothelial Growth Factor A
% 222.07/222.28  |- skos__altLabel mesh__D042461 GD-VEGF
% 222.07/222.28  |- rdf__type mesh__D042461sskos__Concept
% 222.07/222.28  |- skos__altLabel mesh__D042461 VEGF-A
% 222.07/222.28  |- mesh__recordMaintainer mesh__D042461 ssb
% 222.07/222.28  |- mesh__publicMeSHNote mesh__D042461
% 222.07/222.28       2004; VASCULAR ENDOTHELIAL GROWTH FACTOR was indexed under ENDOTHELIAL GROWTH FACTORS 2000-2002%A%  
% 222.07/222.28  |- mesh__recordOriginator mesh__D042461 jmp
% 222.07/222.28  |- mesh__historyNote mesh__D042461
% 222.07/222.28       2004;  use VASCULAR ENDOTHELIAL GROWTH FACTOR A %28%NM%29% 2000-2002%A%  
% 222.07/222.28  |- mesh__dateEstablished mesh__D042461 2004-01-01
% 222.07/222.28  |- skos__hiddenLabel mesh__D042461
% 222.07/222.28       Glioma Derived Vascular Endothelial Cell Growth Factor
% 222.07/222.28  |- mesh__recordAuthorizer mesh__D042461 sjn
% 222.07/222.28  |- mesh__dateCreated mesh__D042461 2003-07-09
% 222.07/222.28  |- skos__scopeNote mesh__D042461
% 222.07/222.28       The original member of the family of endothelial cell growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as %22%tumor angiogenesis factor%22% and %22%vascular permeability factor%22%. Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for vascular endothelial growth factor A results in several isoforms of the protein being produced.%A%    
% 222.07/222.28  |- skos__broader mesh__D042461smesh__D042442
% 222.07/222.28  |- skos__altLabel mesh__D042461 VEGF
% 222.07/222.28  |- skos__prefLabel mesh__D014770 Virilism
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D014770 2005
% 222.07/222.28  |- mesh__recordAuthorizer mesh__D014770 sjn
% 222.07/222.28  |- rdf__type mesh__D014770sskos__Concept
% 222.07/222.28  |- mesh__dateRevised mesh__D014770 2004-07-07
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D014770 2006
% 222.07/222.28  |- skos__broader mesh__D014770smesh__D012816
% 222.07/222.28  |- mesh__recordMaintainer mesh__D014770 lkt
% 222.07/222.28  |- skos__annotation mesh__D014770 check the tag FEMALE   
% 222.07/222.28  |- skos__scopeNote mesh__D014770
% 222.07/222.28       Development of male secondary SEX CHARACTERISTICS in the FEMALE. It is due to the effects of androgenic metabolites of precursors from endogenous or exogenous sources, such as ADRENAL GLANDS or therapeutic drugs.%A%    
% 222.07/222.28  |- mesh__dateCreated mesh__D014770 1999-01-01
% 222.07/222.28  |- mesh__recordOriginator mesh__D014770 NLM
% 222.07/222.28  |- skos__altLabel mesh__D014770 Virilization
% 222.07/222.28  |- skos__broader mesh__D008733smesh__D008738
% 222.07/222.28  |- mesh__recordOriginator mesh__D008733 NLM
% 222.07/222.28  |- mesh__historyNote mesh__D008733 65%28%63%29%   
% 222.07/222.28  |- mesh__recordAuthorizer mesh__D008733 sjn
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D008733 2005
% 222.07/222.28  |- mesh__publicMeSHNote mesh__D008733 65   
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D008733 2003
% 222.07/222.28  |- skos__prefLabel mesh__D008733 Methoxyflurane
% 222.07/222.28  |- mesh__dateRevised mesh__D008733 2000-06-21
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D008733 2006
% 222.07/222.28  |- mesh__activeMeSHYear mesh__D008733 2001
% 222.07/222.28  |- mesh__recordMaintainer mesh__D008733 CCR
% 222.07/222.29  |- mesh__dateCreated mesh__D008733 1999-01-01
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D008733 2004
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D008733 2002
% 222.07/222.29  |- skos__altLabel mesh__D008733 Methofluranum
% 222.07/222.29  |- skos__broader mesh__D008733smesh__D005019
% 222.07/222.29  |- skos__scopeNote mesh__D008733
% 222.07/222.29       An inhalation anesthetic. Currently, methoxyflurane is rarely used for surgical, obstetric, or dental anesthesia. If so employed, it should be administered with NITROUS OXIDE to achieve a relatively light level of anesthesia, and a neuromuscular blocking agent given concurrently to obtain the desired degree of muscular relaxation. %28%From AMA Drug Evaluations Annual, 1994, p180%29%%A%    
% 222.07/222.29  |- mesh__dateEstablished mesh__D008733 1965-01-01
% 222.07/222.29  |- rdf__type mesh__D008733sskos__Concept
% 222.07/222.29  |- skos__altLabel mesh__D008733 Pentrane
% 222.07/222.29  |- skos__hiddenLabel mesh__D000750 Myelophthisic Anemias
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000750 2006
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000750 1999
% 222.07/222.29  |- mesh__recordAuthorizer mesh__D000750 PLS
% 222.07/222.29  |- rdf__type mesh__D000750sskos__Concept
% 222.07/222.29  |- skos__broader mesh__D000750smesh__D000740
% 222.07/222.29  |- mesh__dateCreated mesh__D000750 1999-01-01
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000750 1993
% 222.07/222.29  |- skos__hiddenLabel mesh__D000750 Anemias, Leukoerythroblastic
% 222.07/222.29  |- skos__scopeNote mesh__D000750
% 222.07/222.29       Anemia characterized by appearance of immature myeloid and nucleated erythrocytes in the peripheral blood, resulting from infiltration of the bone marrow by foreign or abnormal tissue.%A%    
% 222.07/222.29  |- mesh__recordOriginator mesh__D000750 NLM
% 222.07/222.29  |- skos__hiddenLabel mesh__D000750 Leukoerythroblastic Anemia
% 222.07/222.29  |- skos__altLabel mesh__D000750 Anemia, Leukoerythroblastic
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000750 2003
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000750 1996
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000750 2000
% 222.07/222.29  |- skos__hiddenLabel mesh__D000750 Anemias, Myelophthisic
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000750 2004
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000750 1997
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000750 2001
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000750 1994
% 222.07/222.29  |- mesh__recordMaintainer mesh__D000750 TGC
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000750 1995
% 222.07/222.29  |- skos__hiddenLabel mesh__D000750 Leukoerythroblastic Anemias
% 222.07/222.29  |- mesh__dateRevised mesh__D000750 1991-06-13
% 222.07/222.29  |- skos__hiddenLabel mesh__D000750 Myelophthisic Anemia
% 222.07/222.29  |- skos__broader mesh__D000750smesh__D009196
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000750 2005
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000750 1998
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000750 2002
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000750 1992
% 222.07/222.29  |- skos__prefLabel mesh__D000750 Anemia, Myelophthisic
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013678 1998
% 222.07/222.29  |- mesh__dateCreated mesh__D013678 1999-01-01
% 222.07/222.29  |- skos__altLabel mesh__D013678 Pharmacy Technology
% 222.07/222.29  |- mesh__recordOriginator mesh__D013678 NLM
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013678 2006
% 222.07/222.29  |- rdf__type mesh__D013678sskos__Concept
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013678 1999
% 222.07/222.29  |- skos__broader mesh__D013678smesh__D008919
% 222.07/222.29  |- skos__historyNote mesh__D013678 Pharmacy %28%1966-1967%29%
% 222.07/222.29  |- mesh__dateEstablished mesh__D013678 1968-01-01
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013678 2000
% 222.07/222.29  |- mesh__recordAuthorizer mesh__D013678 SJN
% 222.07/222.29  |- mesh__dateRevised mesh__D013678 1997-06-20
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013678 2003
% 222.07/222.29  |- skos__historyNote mesh__D013678
% 222.07/222.29       Chemistry, Pharmaceutical %28%1966-1967%29%
% 222.07/222.29  |- skos__broader mesh__D013678smesh__D013672
% 222.07/222.29  |- skos__annotation mesh__D013678 SPEC: SPEC qualif; DF: TECHNOL PHARM   
% 222.07/222.29  |- mesh__historyNote mesh__D013678 68   
% 222.07/222.29  |- skos__altLabel mesh__D013678 Technology, Pharmacy
% 222.07/222.29  |- skos__altLabel mesh__D013678 Pharmaceutic Technology
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013678 2001
% 222.07/222.29  |- skos__scopeNote mesh__D013678
% 222.07/222.29       The application of scientific knowledge or technology to pharmacy, pharmacology, and the pharmaceutical industry. It includes methods, techniques, and instrumentation in the manufacture, preparation, compounding, dispensing, packaging, and storing of drugs and other preparations used in diagnostic and determinative procedures and in the treatment of patients.%A%    
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013678 2004
% 222.07/222.29  |- skos__altLabel mesh__D013678 Pharmaceutical Technology
% 222.07/222.29  |- skos__broader mesh__D013678smesh__D006281
% 222.07/222.29  |- skos__altLabel mesh__D013678 Technology, Pharmaceutic
% 222.07/222.29  |- mesh__recordMaintainer mesh__D013678 TGC
% 222.07/222.29  |- skos__prefLabel mesh__D013678 Technology, Pharmaceutical
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013678 2002
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013678 2005
% 222.07/222.29  |- mesh__publicMeSHNote mesh__D013678 68   
% 222.07/222.29  |- rdf__type mesh__D010380sskos__Concept
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D010380 2004
% 222.07/222.29  |- mesh__recordAuthorizer mesh__D010380 jls
% 222.07/222.29  |- mesh__dateCreated mesh__D010380 1999-01-01
% 222.07/222.29  |- mesh__recordMaintainer mesh__D010380 jls
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D010380 2003
% 222.07/222.29  |- skos__scopeNote mesh__D010380
% 222.07/222.29       An organized procedure carried out by a select committee of professionals in evaluating the performance of other professionals in meeting the standards of their specialty. Review by peers is used by editors in the evaluation of articles and other papers submitted for publication. Peer review is used also in the evaluation of grant applications. It is applied also in evaluating the quality of health care provided to patients.%A%    
% 222.07/222.29  |- skos__historyNote mesh__D010380 Medical Assistance %28%1968-1970%29%
% 222.07/222.29  |- mesh__dateEstablished mesh__D010380 1971-01-01
% 222.07/222.29  |- mesh__historyNote mesh__D010380 71   
% 222.07/222.29  |- skos__hiddenLabel mesh__D010380 Reviews, Peer
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D010380 2006
% 222.07/222.29  |- skos__prefLabel mesh__D010380 Peer Review
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D010380 2003A
% 222.07/222.29  |- skos__altLabel mesh__D010380 Review, Peer
% 222.07/222.29  |- mesh__recordOriginator mesh__D010380 NLM
% 222.07/222.29  |- mesh__dateRevised mesh__D010380 2002-10-31
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D010380 2002
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D010380 2005
% 222.07/222.29  |- skos__historyNote mesh__D010380 Quality of Health Care %28%1968-1970%29%
% 222.07/222.29  |- skos__annotation mesh__D010380 professionals evaluating professionals   
% 222.07/222.29  |- skos__related mesh__D010380smesh__D026724
% 222.07/222.29  |- skos__broader mesh__D010380smesh__D012926
% 222.07/222.29  |- mesh__publicMeSHNote mesh__D010380 71   
% 222.07/222.29  |- skos__broader mesh__D010380smesh__D006126
% 222.07/222.29  |- skos__hiddenLabel mesh__D010380 Peer Reviews
% 222.07/222.29  |- mesh__recordAuthorizer mesh__D051797 sjn
% 222.07/222.29  |- skos__altLabel mesh__D051797 Inhibitor of DNA Binding 2 Protein
% 222.07/222.29  |- rdf__type mesh__D051797sskos__Concept
% 222.07/222.29  |- mesh__publicMeSHNote mesh__D051797
% 222.07/222.29       2006; INHIBITOR OF DIFFERENTIATION PROTEIN 2 was indexed under DNA-BINDING PROTEINS %26% REPRESSOR PROTEINS %26% TRANSCRIPTION FACTORS 1992-2005%A%  
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D051797 2006
% 222.07/222.29  |- skos__prefLabel mesh__D051797 Inhibitor of Differentiation Protein 2
% 222.07/222.29  |- skos__altLabel mesh__D051797 DNA-Binding Protein Inhibitor ID-2
% 222.07/222.29  |- skos__hiddenLabel mesh__D051797 DNA Binding Protein Inhibitor ID 2
% 222.07/222.29  |- mesh__historyNote mesh__D051797 2006%28%1992%29%   
% 222.07/222.29  |- mesh__recordOriginator mesh__D051797 DRC
% 222.07/222.29  |- skos__altLabel mesh__D051797 Inhibitor of Differentiation 2 Protein
% 222.07/222.29  |- mesh__dateEstablished mesh__D051797 2006-01-01
% 222.07/222.29  |- skos__scopeNote mesh__D051797
% 222.07/222.29       A negative regulator of BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS. It plays a role in regulating IMMUNOGLOBULIN E expression.%A%    
% 222.07/222.29  |- skos__broader mesh__D051797smesh__D051796
% 222.07/222.29  |- mesh__dateCreated mesh__D051797 2005-06-30
% 222.07/222.29  |- mesh__recordMaintainer mesh__D051797 DRC
% 222.07/222.29  |- skos__scopeNote mesh__D004343
% 222.07/222.29       Small containers or pellets of a solid drug implanted in the body to achieve sustained release of the drug.%A%    
% 222.07/222.29  |- mesh__recordAuthorizer mesh__D004343 sjn
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D004343 2004
% 222.07/222.29  |- skos__broader mesh__D004343smesh__D003692
% 222.07/222.29  |- rdf__type mesh__D004343sskos__Concept
% 222.07/222.29  |- mesh__historyNote mesh__D004343 75   
% 222.07/222.29  |- mesh__dateEstablished mesh__D004343 1975-09-01
% 222.07/222.29  |- skos__historyNote mesh__D004343
% 222.07/222.29       Delayed-Action Preparations %28%1966-1974%29%
% 222.07/222.29  |- mesh__recordMaintainer mesh__D004343 ssb
% 222.07/222.29  |- mesh__dateCreated mesh__D004343 1974-11-11
% 222.07/222.29  |- mesh__publicMeSHNote mesh__D004343 75   
% 222.07/222.29  |- skos__related mesh__D004343smesh__D015918
% 222.07/222.29  |- skos__hiddenLabel mesh__D004343 Implants, Drug
% 222.07/222.29  |- mesh__recordOriginator mesh__D004343 NLM
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D004343 2005
% 222.07/222.29  |- skos__hiddenLabel mesh__D004343 Drug Pellets
% 222.07/222.29  |- mesh__dateRevised mesh__D004343 2003-07-09
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D004343 2006
% 222.07/222.29  |- skos__annotation mesh__D004343
% 222.07/222.29       not for radioisotope implants %28% = RADIOISOTOPES or specific /admin or BRACHYTHERAPY %28%see X refs there%29% %29% or prosthetic injections %28% = PROSTHESES AND IMPLANTS + substance implanted%29%; IM for general only, D25-26 qualif; NIM when specific chemical is IM, no qualif%A%  
% 222.07/222.29  |- skos__prefLabel mesh__D004343 Drug Implants
% 222.07/222.29  |- skos__scopeNote mesh__D042462
% 222.07/222.29       QUINOLONES containing a 4-oxo %28%a carbonyl in the para position to the nitrogen%29%.  They inhibit the A subunit of DNA GYRASE and are used as antimicrobials. Second generation 4-quinoloines are also substituted with a 1-piperazinyl group at the 7-position and a fluorine at the 6-position.%A%    
% 222.07/222.29  |- skos__hiddenLabel mesh__D042462 4 Quinolones
% 222.07/222.29  |- mesh__historyNote mesh__D042462 2004   
% 222.07/222.29  |- skos__prefLabel mesh__D042462 4-Quinolones
% 222.07/222.29  |- skos__broader mesh__D042462smesh__D015363
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D042462 2006
% 222.07/222.29  |- mesh__publicMeSHNote mesh__D042462 2004   
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D042462 2004
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D042462 2005
% 222.07/222.29  |- mesh__dateEstablished mesh__D042462 2004-01-01
% 222.07/222.29  |- rdf__type mesh__D042462sskos__Concept
% 222.07/222.29  |- mesh__dateCreated mesh__D042462 2003-07-09
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014771 1996
% 222.07/222.29  |- mesh__recordMaintainer mesh__D014771 TGC
% 222.07/222.29  |- mesh__recordOriginator mesh__D014771 AEP
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014771 2006
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014771 1998
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014771 2000
% 222.07/222.29  |- skos__broader mesh__D014771smesh__D014780
% 222.07/222.29  |- skos__historyNote mesh__D014771 specific virus
% 222.07/222.29  |- skos__prefLabel mesh__D014771 Virion
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014771 2001
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014771 1997
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014771 1994
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014771 1999
% 222.07/222.29  |- mesh__dateCreated mesh__D014771 1977-05-04
% 222.07/222.29  |- skos__scopeNote mesh__D014771
% 222.07/222.29       The infective system of a virus, composed of the viral genome, a protein core, and a protein coat called a capsid, which may be naked or enclosed in a lipoprotein envelope called the peplos.%A%    
% 222.07/222.29  |- skos__hiddenLabel mesh__D014771 Particle, Virus
% 222.07/222.29  |- skos__annotation mesh__D014771
% 222.07/222.29       %22%the infective system of a virus%22%; read MeSH definition for component parts%A%  
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014771 1993
% 222.07/222.29  |- skos__hiddenLabel mesh__D014771 Virus Particles
% 222.07/222.29  |- skos__hiddenLabel mesh__D014771 Virions
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014771 1995
% 222.07/222.29  |- skos__historyNote mesh__D014771 Viral Proteins %28%1966-1977%29%
% 222.07/222.29  |- skos__hiddenLabel mesh__D014771 Particles, Virus
% 222.07/222.29  |- skos__altLabel mesh__D014771 Virus Particle
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014771 2002
% 222.07/222.29  |- mesh__recordAuthorizer mesh__D014771 PLS
% 222.07/222.29  |- mesh__publicMeSHNote mesh__D014771 78   
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014771 2003
% 222.07/222.29  |- mesh__dateEstablished mesh__D014771 1978-01-01
% 222.07/222.29  |- mesh__dateRevised mesh__D014771 1992-05-18
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014771 2005
% 222.07/222.29  |- mesh__historyNote mesh__D014771 78   
% 222.07/222.29  |- rdf__type mesh__D014771sskos__Concept
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014771 2004
% 222.07/222.29  |- skos__altLabel mesh__D008734 4-Hydroxy-3-methoxyphenylethylene Glycol
% 222.07/222.29  |- skos__prefLabel mesh__D008734 Methoxyhydroxyphenylglycol
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D008734 2006
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D008734 2003
% 222.07/222.29  |- mesh__recordAuthorizer mesh__D008734 sjn
% 222.07/222.29  |- mesh__recordMaintainer mesh__D008734 ssb
% 222.07/222.29  |- mesh__historyNote mesh__D008734
% 222.07/222.29       91%28%77%29%; was see under GLYCOLS 1977-90; was METHOXYHYDROXYPHENYL GLYCOL see under GLYCOLS 1975-76; was METHOXYHYDROXYPHENYL GLYCOL 1973-74 %28%Prov%29%%A%  
% 222.07/222.29  |- mesh__recordOriginator mesh__D008734 NLM
% 222.07/222.29  |- mesh__dateCreated mesh__D008734 1999-01-01
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D008734 2004
% 222.07/222.29  |- mesh__onlineNote mesh__D008734
% 222.07/222.29       use METHOXYHYDROXYPHENYLGLYCOL to search METHOXYHYDROXYPHENYL GLYCOL 1973-76 %28%as Prov 1973-74%29%%A%  
% 222.07/222.29  |- skos__hiddenLabel mesh__D008734 4 Hydroxy 3 methoxyphenylethyleneglycol
% 222.07/222.29  |- mesh__publicMeSHNote mesh__D008734
% 222.07/222.29       91; was see under GLYCOLS 1977-90; was METHOXYHYDROXYPHENYL GLYCOL see under GLYCOLS 1975-76%A%  
% 222.07/222.29  |- skos__historyNote mesh__D008734 Glycols %28%1966-1974%29%
% 222.07/222.29  |- skos__hiddenLabel mesh__D008734 4 Hydroxy 3 methoxyphenylglycol
% 222.07/222.29  |- rdf__type mesh__D008734sskos__Concept
% 222.07/222.29  |- skos__altLabel mesh__D008734 Vanylglycol
% 222.07/222.29  |- skos__hiddenLabel mesh__D008734 4 Hydroxy 3 methoxyphenylethylene Glycol
% 222.07/222.29  |- mesh__dateRevised mesh__D008734 2001-07-25
% 222.07/222.29  |- skos__altLabel mesh__D008734 4-Hydroxy-3-methoxyphenylglycol
% 222.07/222.29  |- skos__altLabel mesh__D008734 4-Hydroxy-3-methoxyphenylethyleneglycol
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D008734 2002
% 222.07/222.29  |- skos__scopeNote mesh__D008734
% 222.07/222.29       Synthesized from endogenous epinephrine and norepinephrine in vivo. It is found in brain, blood, CSF, and urine, where its concentrations are used to measure catecholamine turnover.%A%    
% 222.07/222.29  |- skos__altLabel mesh__D008734 MHPG
% 222.07/222.29  |- mesh__dateEstablished mesh__D008734 1991-01-01
% 222.07/222.29  |- skos__altLabel mesh__D008734 MOPEG
% 222.07/222.29  |- skos__broader mesh__D008734smesh__D005026
% 222.07/222.29  |- skos__altLabel mesh__D008734 Hydroxymethoxyphenylglycol
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D008734 2005
% 222.07/222.29  |- skos__hiddenLabel mesh__D000751 Anemias, Neonatal
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000751 2004
% 222.07/222.29  |- mesh__recordAuthorizer mesh__D000751 sjn
% 222.07/222.29  |- mesh__historyNote mesh__D000751 68   
% 222.07/222.29  |- skos__scopeNote mesh__D000751
% 222.07/222.29       The mildest form of erythroblastosis fetalis in which anemia is the chief manifestation.%A%    
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000751 2002
% 222.07/222.29  |- skos__annotation mesh__D000751
% 222.07/222.29       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; check the tag INFANT, NEWBORN%A%  
% 222.07/222.29  |- skos__broader mesh__D000751smesh__D007232
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000751 2005
% 222.07/222.29  |- mesh__recordOriginator mesh__D000751 NLM
% 222.07/222.29  |- skos__historyNote mesh__D000751
% 222.07/222.29       Infant, Newborn, Diseases %28%1966-1967%29%
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000751 2006
% 222.07/222.29  |- skos__altLabel mesh__D000751 Anemia Neonatorum
% 222.07/222.29  |- mesh__publicMeSHNote mesh__D000751 68   
% 222.07/222.29  |- skos__historyNote mesh__D000751 Anemia %28%1966-1967%29%
% 222.07/222.29  |- rdf__type mesh__D000751sskos__Concept
% 222.07/222.29  |- mesh__dateCreated mesh__D000751 1999-01-01
% 222.07/222.29  |- skos__broader mesh__D000751smesh__D000740
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000751 2000
% 222.07/222.29  |- mesh__dateRevised mesh__D000751 1999-11-03
% 222.07/222.29  |- mesh__recordMaintainer mesh__D000751 kle
% 222.07/222.29  |- skos__hiddenLabel mesh__D000751 Neonatal Anemias
% 222.07/222.29  |- skos__prefLabel mesh__D000751 Anemia, Neonatal
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000751 2003
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000751 2001
% 222.07/222.29  |- mesh__dateEstablished mesh__D000751 1968-01-01
% 222.07/222.29  |- skos__hiddenLabel mesh__D000751 Neonatal Anemia
% 222.07/222.29  |- skos__altLabel mesh__D013679 Technology, Radiological
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013679 2002
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013679 1999
% 222.07/222.29  |- skos__annotation mesh__D013679
% 222.07/222.29       SPEC: SPEC qualif; do not confuse with RADIOGRAPHY %28% = x-ray diag%29%; TECHNOLOGY, RADIOLOGIC is not restricted to radiography %26% the emphasis is on the technol; IM general only, NIM as the technol coord for a specific radiologic technol; DF: TECHNOL RADIOL%A%  
% 222.07/222.29  |- mesh__recordAuthorizer mesh__D013679 PLS
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013679 1994
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013679 2003
% 222.07/222.29  |- mesh__recordOriginator mesh__D013679 NLM
% 222.07/222.29  |- skos__broader mesh__D013679smesh__D013672
% 222.07/222.29  |- skos__hiddenLabel mesh__D013679 Radiological Technology
% 222.07/222.29  |- mesh__dateRevised mesh__D013679 1993-06-04
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013679 1995
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013679 1996
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013679 2004
% 222.07/222.29  |- skos__broader mesh__D013679smesh__D008919
% 222.07/222.29  |- skos__prefLabel mesh__D013679 Technology, Radiologic
% 222.07/222.29  |- skos__scopeNote mesh__D013679
% 222.07/222.29       The application of scientific knowledge or technology to the field of radiology. The applications center mostly around x-ray or radioisotopes for diagnostic and therapeutic purposes but the technological applications of any radiation or radiologic procedure is within the scope of radiologic technology.%A%    
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013679 2000
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013679 1997
% 222.07/222.29  |- mesh__recordMaintainer mesh__D013679 JLS
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013679 2005
% 222.07/222.29  |- skos__altLabel mesh__D013679 Radiologic Technology
% 222.07/222.29  |- skos__broader mesh__D013679smesh__D016390
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013679 2001
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013679 1998
% 222.07/222.29  |- mesh__dateCreated mesh__D013679 1999-01-01
% 222.07/222.29  |- rdf__type mesh__D013679sskos__Concept
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D013679 2006
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D010381 2003
% 222.07/222.29  |- skos__scopeNote mesh__D010381
% 222.07/222.29       An inherited defect interfering with normal nuclear lobulation of neutrophils and eosinophils. The nuclei appear rodlike, spherical, or dumbbell-shaped and their structure is coarse and lumpy. %28%From Dorland, 27th ed%29%%A%    
% 222.07/222.29  |- skos__broader mesh__D010381smesh__D007960
% 222.07/222.29  |- skos__annotation mesh__D010381
% 222.07/222.29       a neutrophil abnorm; in titles %26% translations, use diacrit: H%C3%%BC%et%A%  
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D010381 2006
% 222.07/222.29  |- mesh__recordAuthorizer mesh__D010381 sjn
% 222.07/222.29  |- skos__hiddenLabel mesh__D010381 Anomaly, Pelger-Huet
% 222.07/222.29  |- mesh__recordMaintainer mesh__D010381 jls
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D010381 2005
% 222.07/222.29  |- mesh__dateRevised mesh__D010381 2001-08-13
% 222.07/222.29  |- mesh__recordOriginator mesh__D010381 NLM
% 222.07/222.29  |- skos__prefLabel mesh__D010381 Pelger-Huet Anomaly
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D010381 2002
% 222.07/222.29  |- rdf__type mesh__D010381sskos__Concept
% 222.07/222.29  |- skos__hiddenLabel mesh__D010381 Pelger Huet Anomaly
% 222.07/222.29  |- mesh__dateCreated mesh__D010381 1999-01-01
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D010381 2004
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D051798 2006
% 222.07/222.29  |- mesh__recordMaintainer mesh__D051798 DRC
% 222.07/222.29  |- mesh__recordAuthorizer mesh__D051798 sjn
% 222.07/222.29  |- mesh__recordOriginator mesh__D051798 DRC
% 222.07/222.29  |- mesh__publicMeSHNote mesh__D051798
% 222.07/222.29       2006; INHIBITOR OF DIFFERENTIATION PROTEIN 1 was indexed under REPRESSOR PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005, %26% under DNA-BINDING PROTEINS 1990-1996%A%  
% 222.07/222.29  |- skos__hiddenLabel mesh__D051798 DNA Binding Protein Inhibitor ID1
% 222.07/222.29  |- skos__prefLabel mesh__D051798 Inhibitor of Differentiation Protein 1
% 222.07/222.29  |- mesh__historyNote mesh__D051798 2006%28%1990%29%   
% 222.07/222.29  |- skos__altLabel mesh__D051798 Inhibitor of DNA Binding Protein 1
% 222.07/222.29  |- mesh__dateEstablished mesh__D051798 2006-01-01
% 222.07/222.29  |- skos__altLabel mesh__D051798 DNA-Binding Protein Inhibitor ID1
% 222.07/222.29  |- skos__scopeNote mesh__D051798
% 222.07/222.29       A negative regulator of BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS that blocks activation of CYCLIN-DEPENDENT KINASE INHIBITOR P16 and is de-regulated in a variety of NEOPLASMS.%A%    
% 222.07/222.29  |- skos__broader mesh__D051798smesh__D051796
% 222.07/222.29  |- mesh__dateCreated mesh__D051798 2005-06-30
% 222.07/222.29  |- rdf__type mesh__D051798sskos__Concept
% 222.07/222.29  |- mesh__historyNote mesh__D004344 73%28%65%29%   
% 222.07/222.29  |- rdf__type mesh__D004344sskos__Concept
% 222.07/222.29  |- skos__hiddenLabel mesh__D004344 Incompatibility, Drug
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D004344 1996
% 222.07/222.29  |- mesh__recordMaintainer mesh__D004344 TGC
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D004344 1999
% 222.07/222.29  |- skos__hiddenLabel mesh__D004344 Incompatibilities, Drug
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D004344 2000
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D004344 1997
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D004344 2001
% 222.07/222.29  |- skos__broader mesh__D004344smesh__D013678
% 222.07/222.29  |- skos__hiddenLabel mesh__D004344 Drug Incompatibilities
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D004344 2005
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D004344 2002
% 222.07/222.29  |- mesh__dateRevised mesh__D004344 1992-05-08
% 222.07/222.29  |- mesh__publicMeSHNote mesh__D004344 73   
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D004344 1994
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D004344 2003
% 222.07/222.29  |- skos__prefLabel mesh__D004344 Drug Incompatibility
% 222.07/222.29  |- mesh__dateCreated mesh__D004344 1999-01-01
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D004344 2006
% 222.07/222.29  |- mesh__dateEstablished mesh__D004344 1973-01-01
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D004344 1995
% 222.07/222.29  |- mesh__recordOriginator mesh__D004344 NLM
% 222.07/222.29  |- skos__scopeNote mesh__D004344
% 222.07/222.29       The quality of not being miscible with another given substance without a chemical change. One drug is not of suitable composition to be combined or mixed with another agent or substance. The incompatibility usually results in an undesirable reaction, including chemical alteration or destruction. %28%Dorland, 27th ed; Stedman, 25th ed%29%%A%    
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D004344 2004
% 222.07/222.29  |- skos__annotation mesh__D004344
% 222.07/222.29       %22%one drug is not of suitable composition to be combined or mixed with another%22%: do not confuse with DRUG INTERACTIONS, %22%the action of one drug on the metab, effect or tox of another%22%; IM when general; NIM when with specific drug; no qualif%A%  
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D004344 1998
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D004344 1993
% 222.07/222.29  |- mesh__recordAuthorizer mesh__D004344 PLS
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014772 2004
% 222.07/222.29  |- skos__broader mesh__D014772smesh__D014780
% 222.07/222.29  |- skos__hiddenLabel mesh__D014772 Viroid
% 222.07/222.29  |- mesh__publicMeSHNote mesh__D014772 81   
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014772 2000
% 222.07/222.29  |- mesh__historyNote mesh__D014772 81   
% 222.07/222.29  |- skos__prefLabel mesh__D014772 Viroids
% 222.07/222.29  |- rdf__type mesh__D014772sskos__Concept
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014772 2003
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014772 1997
% 222.07/222.29  |- mesh__dateRevised mesh__D014772 1992-05-18
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014772 2006
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014772 1996
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014772 1993
% 222.07/222.29  |- skos__annotation mesh__D014772
% 222.07/222.29       %22%smallest known agents of infect dis%22%; read MeSH definition%A%  
% 222.07/222.29  |- skos__historyNote mesh__D014772 Plant Viruses %28%1971-1980%29%
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014772 2002
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014772 2005
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014772 1999
% 222.07/222.29  |- skos__historyNote mesh__D014772 RNA, Viral %28%1971-1980%29%
% 222.07/222.29  |- mesh__recordOriginator mesh__D014772 AEP
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014772 1995
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014772 1998
% 222.07/222.29  |- mesh__recordAuthorizer mesh__D014772 PLS
% 222.07/222.29  |- mesh__dateCreated mesh__D014772 1980-04-02
% 222.07/222.29  |- mesh__recordMaintainer mesh__D014772 TGC
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014772 1994
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D014772 2001
% 222.07/222.29  |- mesh__dateEstablished mesh__D014772 1981-01-01
% 222.07/222.29  |- skos__scopeNote mesh__D014772
% 222.07/222.29       A group of pathogens comprising the smallest known agents of infectious disease. They are unencapsulated and are capable of replicating autonomously in susceptible cells. Positively identified viroids composed of single-stranded RNA have been isolated from higher plants, but the existence of DNA viroids pathogenic to animals is suspected.%A%    
% 222.07/222.29  |- skos__altLabel mesh__D008735 Meksamine
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D008735 2001
% 222.07/222.29  |- mesh__onlineNote mesh__D008735
% 222.07/222.29       use 5-METHOXYTRYPTAMINE to search METHOXYTRYPTAMINE 1975-88; use TRYPTAMINES 1966-74%A%  
% 222.07/222.29  |- skos__altLabel mesh__D008735 Mexamine
% 222.07/222.29  |- skos__scopeNote mesh__D008735
% 222.07/222.29       Serotonin derivative proposed as potentiator for hypnotics and sedatives.%A%    
% 222.07/222.29  |- skos__broader mesh__D008735smesh__D012701
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D008735 2002
% 222.07/222.29  |- rdf__type mesh__D008735sskos__Concept
% 222.07/222.29  |- skos__hiddenLabel mesh__D008735 5 Methoxytryptamine
% 222.07/222.29  |- skos__prefLabel mesh__D008735 5-Methoxytryptamine
% 222.07/222.29  |- mesh__historyNote mesh__D008735
% 222.07/222.29       91%28%89%29%; was see under SEROTONIN 1989-90; was METHOXYTRYPTAMINE see under TRYPTAMINES 1966-88%A%  
% 222.07/222.29  |- mesh__publicMeSHNote mesh__D008735
% 222.07/222.29       91; was see under SEROTONIN 1989-90; was METHOXYTRYPTAMINE see under TRYPTAMINES 1966-88%A%  
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D008735 2005
% 222.07/222.29  |- mesh__dateEstablished mesh__D008735 1991-01-01
% 222.07/222.29  |- mesh__recordAuthorizer mesh__D008735 sjn
% 222.07/222.29  |- mesh__recordOriginator mesh__D008735 NLM
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D008735 2006
% 222.07/222.29  |- mesh__dateRevised mesh__D008735 2000-06-22
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D008735 2003
% 222.07/222.29  |- mesh__recordMaintainer mesh__D008735 CCR
% 222.07/222.29  |- mesh__dateCreated mesh__D008735 1999-01-01
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D008735 2004
% 222.07/222.29  |- skos__related mesh__D000752smesh__D012546
% 222.07/222.29  |- skos__hiddenLabel mesh__D000752 Anemia, Addisons
% 222.07/222.29  |- mesh__dateRevised mesh__D000752 2003-07-09
% 222.07/222.29  |- skos__prefLabel mesh__D000752 Anemia, Pernicious
% 222.07/222.29  |- mesh__activeMeSHYear mesh__D000752 2004
% 222.07/222.29  |- skos__scopeNote mesh__D000752
% 222.07/222.29       A megaloblastic anemia occurring in children but more commonly in later life, characterized by histamine-fast achlorhydria, in which the laboratory and clinical manifestations are based on malabsorption of vitamin B 12 due to a failure of the gastric mucosa to secrete adequate and potent intrinsic factor. %28%Dorland, 27th ed%29%%A%    
% 222.07/222.29  |- skos__broader mesh__D000752smesh__D014806
% 222.07/222.29  |- skos__annotation mesh__D000752 a type of megaloblastic anemia   
% 222.07/222.29  |- mesh__recordOriginator mesh__D000752 NLM
% 222.07/222.29  |- rdf__type mesh__D000752sskos__Concept
% 222.07/222.29  |- mesh__dateCreated mesh__D000752 1999-01-01
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000752 2005
% 222.07/222.30  |- mesh__recordMaintainer mesh__D000752 lkt
% 222.07/222.30  |- skos__hiddenLabel mesh__D000752 Anemia, Addison
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000752 2006
% 222.07/222.30  |- skos__broader mesh__D000752smesh__D000749
% 222.07/222.30  |- skos__hiddenLabel mesh__D000752 Addison Anemia
% 222.07/222.30  |- skos__hiddenLabel mesh__D000752 Addisons Anemia
% 222.07/222.30  |- skos__altLabel mesh__D000752 Anemia, Addison%27%s
% 222.07/222.30  |- mesh__recordAuthorizer mesh__D000752 sjn
% 222.07/222.30  |- skos__hiddenLabel mesh__D000752 Pernicious Anemia
% 222.07/222.30  |- skos__altLabel mesh__D000752 Addison%27%s Anemia
% 222.07/222.30  |- skos__hiddenLabel mesh__D018365 Minimal Residual Diseases
% 222.07/222.30  |- skos__altLabel mesh__D018365 Residual Neoplasm
% 222.07/222.30  |- skos__hiddenLabel mesh__D018365 Disease, Residual Minimal
% 222.07/222.30  |- skos__hiddenLabel mesh__D018365 Tumor, Residual
% 222.07/222.30  |- skos__scopeNote mesh__D018365
% 222.07/222.30       Remnant of a tumor or cancer after primary, potentially curative therapy. %28%Dr. Daniel Masys, written communication%29%%A%    
% 222.07/222.30  |- skos__hiddenLabel mesh__D018365 Neoplasms, Residual
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D018365 2001
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D018365 2003
% 222.07/222.30  |- skos__altLabel mesh__D018365 Minimal Disease, Residual
% 222.07/222.30  |- skos__hiddenLabel mesh__D018365 Residual Cancers
% 222.07/222.30  |- mesh__historyNote mesh__D018365 95   
% 222.07/222.30  |- skos__hiddenLabel mesh__D018365 Residual Minimal Diseases
% 222.07/222.30  |- mesh__dateEstablished mesh__D018365 1995-01-01
% 222.07/222.30  |- skos__altLabel mesh__D018365 Minimal Residual Disease
% 222.07/222.30  |- skos__hiddenLabel mesh__D018365 Diseases, Residual Minimal
% 222.07/222.30  |- mesh__recordAuthorizer mesh__D018365 sjn
% 222.07/222.30  |- skos__hiddenLabel mesh__D018365 Disease, Minimal Residual
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D018365 2002
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D018365 2004
% 222.07/222.30  |- skos__altLabel mesh__D018365 Residual Disease, Minimal
% 222.07/222.30  |- skos__hiddenLabel mesh__D018365 Cancers, Residual
% 222.07/222.30  |- skos__hiddenLabel mesh__D018365 Residual Tumors
% 222.07/222.30  |- skos__hiddenLabel mesh__D018365 Diseases, Minimal Residual
% 222.07/222.30  |- skos__hiddenLabel mesh__D018365 Cancer, Residual
% 222.07/222.30  |- rdf__type mesh__D018365sskos__Concept
% 222.07/222.30  |- skos__historyNote mesh__D018365
% 222.07/222.30       Neoplasm Recurrence, Local %28%1968-1994%29%
% 222.07/222.30  |- skos__prefLabel mesh__D018365 Neoplasm, Residual
% 222.07/222.30  |- skos__hiddenLabel mesh__D018365 Minimal Diseases, Residual
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D018365 2005
% 222.07/222.30  |- mesh__dateRevised mesh__D018365 2000-06-22
% 222.07/222.30  |- skos__annotation mesh__D018365
% 222.07/222.30       IM for GEN only; when IM for GEN only, qualif permitted; as NIM coord, no qualif; DF: NEOPL RESIDUAL%A%  
% 222.07/222.30  |- skos__hiddenLabel mesh__D018365 Residual Neoplasms
% 222.07/222.30  |- skos__hiddenLabel mesh__D018365 Residual Diseases, Minimal
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D018365 2006
% 222.07/222.30  |- mesh__publicMeSHNote mesh__D018365 95   
% 222.07/222.30  |- mesh__recordOriginator mesh__D018365 TGC
% 222.07/222.30  |- skos__hiddenLabel mesh__D018365 Tumors, Residual
% 222.07/222.30  |- mesh__dateCreated mesh__D018365 1994-05-23
% 222.07/222.30  |- skos__broader mesh__D018365smesh__D009385
% 222.07/222.30  |- skos__hiddenLabel mesh__D018365 Residual Minimal Disease
% 222.07/222.30  |- mesh__recordMaintainer mesh__D018365 KEV
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D010382 2005
% 222.07/222.30  |- skos__broader mesh__D010382smesh__D008107
% 222.07/222.30  |- skos__historyNote mesh__D010382 Liver Diseases %28%1966-1980%29%
% 222.07/222.30  |- skos__hiddenLabel mesh__D010382 Hepatis, Peliosis
% 222.07/222.30  |- skos__prefLabel mesh__D010382 Peliosis Hepatis
% 222.07/222.30  |- mesh__recordOriginator mesh__D010382 RC
% 222.07/222.30  |- mesh__publicMeSHNote mesh__D010382
% 222.07/222.30       91; was see under LIVER DISEASES 1981-90   
% 222.07/222.30  |- skos__scopeNote mesh__D010382
% 222.07/222.30       A vascular disease of the LIVER characterized by the occurrence of multiple blood-filled CYSTS or cavities. The cysts are lined with ENDOTHELIAL CELLS; the cavities lined with hepatic parenchymal cells %28%HEPATOCYTES%29%. Peliosis hepatis has been associated with use of anabolic steroids %28%ANABOLIC AGENTS%29% and certain drugs.%A%    
% 222.07/222.30  |- rdf__type mesh__D010382sskos__Concept
% 222.07/222.30  |- mesh__dateCreated mesh__D010382 1980-04-09
% 222.07/222.30  |- mesh__historyNote mesh__D010382
% 222.07/222.30       91%28%81%29%; was see under LIVER DISEASES 1981-90   
% 222.07/222.30  |- mesh__recordMaintainer mesh__D010382 lkt
% 222.07/222.30  |- mesh__dateRevised mesh__D010382 2004-07-07
% 222.07/222.30  |- mesh__recordAuthorizer mesh__D010382 sjn
% 222.07/222.30  |- mesh__dateEstablished mesh__D010382 1991-01-01
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D010382 2006
% 222.07/222.30  |- mesh__recordMaintainer mesh__D051799 ags
% 222.07/222.30  |- mesh__dateEstablished mesh__D051799 2006-01-01
% 222.07/222.30  |- mesh__historyNote mesh__D051799 2006   
% 222.07/222.30  |- skos__related mesh__D051799smesh__D006084
% 222.07/222.30  |- skos__hiddenLabel mesh__D051799 Graft Function, Delayed
% 222.07/222.30  |- skos__prefLabel mesh__D051799 Delayed Graft Function
% 222.07/222.30  |- skos__related mesh__D051799smesh__D006085
% 222.07/222.30  |- mesh__dateCreated mesh__D051799 2005-06-30
% 222.07/222.30  |- skos__historyNote mesh__D051799 Graft Survival %28%1984-2005%29%
% 222.07/222.30  |- skos__historyNote mesh__D051799 Graft Rejection %28%1983-2005%29%
% 222.07/222.30  |- skos__broader mesh__D051799smesh__D010335
% 222.07/222.30  |- rdf__type mesh__D051799sskos__Concept
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D051799 2006
% 222.07/222.30  |- mesh__recordAuthorizer mesh__D051799 sjn
% 222.07/222.30  |- mesh__publicMeSHNote mesh__D051799 2006   
% 222.07/222.30  |- mesh__recordOriginator mesh__D051799 ags
% 222.07/222.30  |- skos__scopeNote mesh__D051799
% 222.07/222.30       General dysfunction of an organ occurring immediately following its transplantation. The term most frequently refers to renal dysfunction following KIDNEY TRANSPLANTATION.%A%    
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D004345 2003
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D004345 2005
% 222.07/222.30  |- mesh__recordOriginator mesh__D004345 NLM
% 222.07/222.30  |- mesh__recordMaintainer mesh__D004345 kle
% 222.07/222.30  |- skos__hiddenLabel mesh__D004345 Industries, Pharmaceutical
% 222.07/222.30  |- skos__broader mesh__D004345smesh__D007221
% 222.07/222.30  |- skos__annotation mesh__D004345
% 222.07/222.30       SPEC: SPEC qualif; /instrum /methods: consider probably better TECHNOLOGY, PHARMACEUTICAL; DF: DRUG INDUST%A%  
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D004345 2002
% 222.07/222.30  |- rdf__type mesh__D004345sskos__Concept
% 222.07/222.30  |- skos__prefLabel mesh__D004345 Drug Industry
% 222.07/222.30  |- mesh__dateRevised mesh__D004345 1999-11-03
% 222.07/222.30  |- skos__hiddenLabel mesh__D004345 Pharmaceutical Industries
% 222.07/222.30  |- skos__altLabel mesh__D004345 Industry, Pharmaceutical
% 222.07/222.30  |- skos__scopeNote mesh__D004345
% 222.07/222.30       That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function.%A%    
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D004345 2001
% 222.07/222.30  |- mesh__dateCreated mesh__D004345 1999-01-01
% 222.07/222.30  |- mesh__recordAuthorizer mesh__D004345 sjn
% 222.07/222.30  |- skos__hiddenLabel mesh__D004345 Pharmaceutic Industry
% 222.07/222.30  |- skos__related mesh__D004345smesh__D013678
% 222.07/222.30  |- skos__hiddenLabel mesh__D004345 Pharmaceutic Industries
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D004345 2000
% 222.07/222.30  |- skos__hiddenLabel mesh__D004345 Industries, Drug
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D004345 2004
% 222.07/222.30  |- skos__altLabel mesh__D004345 Industry, Drug
% 222.07/222.30  |- skos__altLabel mesh__D004345 Industries, Pharmaceutic
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D004345 2006
% 222.07/222.30  |- skos__hiddenLabel mesh__D004345 Drug Industries
% 222.07/222.30  |- skos__altLabel mesh__D004345 Industry, Pharmaceutic
% 222.07/222.30  |- skos__altLabel mesh__D004345 Pharmaceutical Industry
% 222.07/222.30  |- skos__related mesh__D009030smesh__D046528
% 222.07/222.30  |- mesh__recordMaintainer mesh__D009030 ags
% 222.07/222.30  |- skos__scopeNote mesh__D009030
% 222.07/222.30       The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from a single ZYGOTE, as opposed to CHIMERISM in which the different cell populations are derived from more than one zygote.%A%    
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D009030 2005
% 222.07/222.30  |- mesh__publicMeSHNote mesh__D009030 67   
% 222.07/222.30  |- mesh__recordOriginator mesh__D009030 NLM
% 222.07/222.30  |- mesh__recordAuthorizer mesh__D009030 sjn
% 222.07/222.30  |- mesh__historyNote mesh__D009030 67%28%64%29%   
% 222.07/222.30  |- mesh__dateRevised mesh__D009030 2004-07-07
% 222.07/222.30  |- mesh__dateCreated mesh__D009030 1999-01-01
% 222.07/222.30  |- skos__related mesh__D009030smesh__D008822
% 222.07/222.30  |- rdf__type mesh__D009030sskos__Concept
% 222.07/222.30  |- skos__broader mesh__D009030smesh__D002869
% 222.07/222.30  |- mesh__dateEstablished mesh__D009030 1967-01-01
% 222.07/222.30  |- skos__prefLabel mesh__D009030 Mosaicism
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D009030 2006
% 222.07/222.30  |- skos__historyNote mesh__D014773 Viruses %28%1966%29%
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D014773 2006
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D014773 2005
% 222.07/222.30  |- skos__historyNote mesh__D014773 Virus Diseases %28%1966%29%
% 222.07/222.30  |- mesh__dateRevised mesh__D014773 2001-07-25
% 222.07/222.30  |- mesh__historyNote mesh__D014773 67   
% 222.07/222.30  |- skos__broader mesh__D014773smesh__D008829
% 222.07/222.30  |- mesh__publicMeSHNote mesh__D014773 67   
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D014773 2002
% 222.07/222.30  |- skos__prefLabel mesh__D014773 Virology
% 222.07/222.30  |- mesh__recordOriginator mesh__D014773 NLM
% 222.07/222.30  |- skos__annotation mesh__D014773
% 222.07/222.30       SPEC: SPEC qualif; prefer /virol with specific organ, higher animal %26% disease: Manual 19.8.82; DF: VIROL%A%  
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D014773 2004
% 222.07/222.30  |- mesh__dateCreated mesh__D014773 1999-01-01
% 222.07/222.30  |- mesh__dateEstablished mesh__D014773 1967-01-01
% 222.07/222.30  |- mesh__recordAuthorizer mesh__D014773 sjn
% 222.07/222.30  |- mesh__recordMaintainer mesh__D014773 jls
% 222.07/222.30  |- rdf__type mesh__D014773sskos__Concept
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D014773 2003
% 222.07/222.30  |- rdf__type mesh__D008736sskos__Concept
% 222.07/222.30  |- mesh__publicMeSHNote mesh__D008736 65   
% 222.07/222.30  |- skos__scopeNote mesh__D008736
% 222.07/222.30       A thiazide diuretic with properties similar to those of HYDROCHLOROTHIAZIDE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p825%29%%A%    
% 222.07/222.30  |- mesh__dateEstablished mesh__D008736 1965-01-01
% 222.07/222.30  |- skos__prefLabel mesh__D008736 Methyclothiazide
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D008736 2006
% 222.07/222.30  |- mesh__dateRevised mesh__D008736 2005-06-30
% 222.07/222.30  |- mesh__dateCreated mesh__D008736 1999-01-01
% 222.07/222.30  |- skos__broader mesh__D008736smesh__D001581
% 222.07/222.30  |- mesh__recordMaintainer mesh__D008736 ssb
% 222.07/222.30  |- mesh__recordOriginator mesh__D008736 NLM
% 222.07/222.30  |- mesh__recordAuthorizer mesh__D008736 sjn
% 222.07/222.30  |- mesh__historyNote mesh__D008736 65%28%63%29%   
% 222.07/222.30  |- skos__hiddenLabel mesh__D000753 Anemias, Refractory
% 222.07/222.30  |- mesh__recordOriginator mesh__D000753 VDK
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000753 2001
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000753 1994
% 222.07/222.30  |- skos__historyNote mesh__D000753 Anemia, Aplastic %28%1966-1985%29%
% 222.07/222.30  |- skos__altLabel mesh__D000753 Refractory Anemia
% 222.07/222.30  |- mesh__historyNote mesh__D000753 86; was see ANEMIA, APLASTIC 1975-85   
% 222.07/222.30  |- mesh__publicMeSHNote mesh__D000753
% 222.07/222.30       86; was see ANEMIA, APLASTIC 1975-85   
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000753 1998
% 222.07/222.30  |- mesh__dateEstablished mesh__D000753 1986-01-01
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000753 1995
% 222.07/222.30  |- skos__broader mesh__D000753smesh__D009190
% 222.07/222.30  |- rdf__type mesh__D000753sskos__Concept
% 222.07/222.30  |- skos__scopeNote mesh__D000753
% 222.07/222.30       A severe sometimes chronic anemia, usually macrocytic in type, that does not respond to ordinary antianemic therapy.%A%    
% 222.07/222.30  |- skos__hiddenLabel mesh__D000753 Refractory Anemias
% 222.07/222.30  |- mesh__recordMaintainer mesh__D000753 TGC
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000753 1992
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000753 2005
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000753 1999
% 222.07/222.30  |- mesh__onlineNote mesh__D000753 search ANEMIA, APLASTIC 1975-85   
% 222.07/222.30  |- mesh__dateRevised mesh__D000753 1991-06-24
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000753 2002
% 222.07/222.30  |- mesh__recordAuthorizer mesh__D000753 PLS
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000753 1996
% 222.07/222.30  |- skos__prefLabel mesh__D000753 Anemia, Refractory
% 222.07/222.30  |- skos__broader mesh__D000753smesh__D000740
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000753 1993
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000753 2006
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000753 2003
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000753 1997
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000753 2000
% 222.07/222.30  |- mesh__dateCreated mesh__D000753 1985-06-06
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000753 2004
% 222.07/222.30  |- skos__hiddenLabel mesh__D018366 Angiitides, Leukocytoclastic
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D018366 1997
% 222.07/222.30  |- skos__prefLabel mesh__D018366 Vasculitis, Hypersensitivity
% 222.07/222.30  |- skos__hiddenLabel mesh__D018366 Vasculitides, Hypersensitivity
% 222.07/222.30  |- skos__hiddenLabel mesh__D018366 Angiitides, Hypersensitivity
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D018366 2002
% 222.07/222.30  |- skos__scopeNote mesh__D018366
% 222.07/222.30       Heterogeneous group of disorders characterized by a vasculitic syndrome presumed to be associated with a hypersensitivity reaction following exposure to an antigen such as an infectious agent, a drug, or other foreign or endogenous substance %28%Wilson et al, Harrison%27%s Principles of Internal Medicine, 12th ed, p1459%29%.%A%    
% 222.07/222.30  |- skos__hiddenLabel mesh__D018366 Hypersensitivity Vasculitides
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D018366 1998
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D018366 2003
% 222.07/222.30  |- mesh__dateEstablished mesh__D018366 1995-01-01
% 222.07/222.30  |- mesh__historyNote mesh__D018366 95   
% 222.07/222.30  |- mesh__recordOriginator mesh__D018366 AGS
% 222.07/222.30  |- skos__altLabel mesh__D018366 Angiitis, Hypersensitivity
% 222.07/222.30  |- skos__hiddenLabel mesh__D018366 Hypersensitivity Angiitides
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D018366 1999
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D018366 2004
% 222.07/222.30  |- mesh__recordAuthorizer mesh__D018366 PLS
% 222.07/222.30  |- mesh__recordMaintainer mesh__D018366 TAP
% 222.07/222.30  |- skos__historyNote mesh__D018366
% 222.07/222.30       Vasculitis, Allergic Cutaneous %28%1978-1994%29%
% 222.07/222.30  |- skos__altLabel mesh__D018366 Vasculitis, Leukocytoclastic
% 222.07/222.30  |- mesh__publicMeSHNote mesh__D018366 95   
% 222.07/222.30  |- skos__altLabel mesh__D018366 Angiitis, Leukocytoclastic
% 222.07/222.30  |- skos__hiddenLabel mesh__D018366 Leukocytoclastic Vasculitides
% 222.07/222.30  |- rdf__type mesh__D018366sskos__Concept
% 222.07/222.30  |- skos__hiddenLabel mesh__D018366 Leukocytoclastic Angiitides
% 222.07/222.30  |- skos__hiddenLabel mesh__D018366 Leukocytoclastic Angiitis
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D018366 2005
% 222.07/222.30  |- mesh__dateRevised mesh__D018366 1995-06-09
% 222.07/222.30  |- skos__broader mesh__D018366smesh__D007105
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D018366 2000
% 222.07/222.30  |- skos__hiddenLabel mesh__D018366 Leukocytoclastic Vasculitis
% 222.07/222.30  |- skos__broader mesh__D018366smesh__D014657
% 222.07/222.30  |- mesh__dateCreated mesh__D018366 1994-01-25
% 222.07/222.30  |- skos__altLabel mesh__D018366 Hypersensitivity Vasculitis
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D018366 1996
% 222.07/222.30  |- skos__hiddenLabel mesh__D018366 Vasculitides, Leukocytoclastic
% 222.07/222.30  |- skos__altLabel mesh__D018366 Hypersensitivity Angiitis
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D018366 2006
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D018366 2001
% 222.07/222.30  |- rdf__type mesh__D010383sskos__Concept
% 222.07/222.30  |- mesh__recordOriginator mesh__D010383 NLM
% 222.07/222.30  |- mesh__dateCreated mesh__D010383 1999-01-01
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D010383 2004
% 222.07/222.30  |- skos__broader mesh__D010383smesh__D014804
% 222.07/222.30  |- skos__prefLabel mesh__D010383 Pellagra
% 222.07/222.30  |- skos__annotation mesh__D010383 consider also VITAMIN B DEFICIENCY   
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D010383 2006
% 222.07/222.30  |- mesh__recordMaintainer mesh__D010383 lkt
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D010383 2005
% 222.07/222.30  |- skos__hiddenLabel mesh__D010383 Pellagras
% 222.07/222.30  |- mesh__recordAuthorizer mesh__D010383 sjn
% 222.07/222.30  |- mesh__dateRevised mesh__D010383 2003-07-09
% 222.07/222.30  |- rdf__type mesh__D004346sskos__Concept
% 222.07/222.30  |- skos__annotation mesh__D004346 IM; DF: DRUG INFORMATION SERV   
% 222.07/222.30  |- skos__altLabel mesh__D004346 Information Services, Drug
% 222.07/222.30  |- mesh__historyNote mesh__D004346
% 222.07/222.30       81%28%77%29%; was see under INFORMATION SERVICES 1977-80   
% 222.07/222.30  |- skos__scopeNote mesh__D004346
% 222.07/222.30       Services providing pharmaceutic and therapeutic drug information and consultation.%A%    
% 222.07/222.30  |- skos__historyNote mesh__D004346 Drugs %28%1966-1976%29%
% 222.07/222.30  |- mesh__recordMaintainer mesh__D004346 kle
% 222.07/222.30  |- skos__hiddenLabel mesh__D004346 Information Service, Drug
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D004346 2002
% 222.07/222.30  |- mesh__dateRevised mesh__D004346 1999-11-03
% 222.07/222.30  |- skos__altLabel mesh__D004346 Services, Drug Information
% 222.07/222.30  |- skos__hiddenLabel mesh__D004346 Drug Information Service
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D004346 2004
% 222.07/222.30  |- mesh__publicMeSHNote mesh__D004346
% 222.07/222.30       81; was see under INFORMATION SERVICES 1977-80   
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D004346 2001
% 222.07/222.30  |- skos__broader mesh__D004346smesh__D007255
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D004346 2006
% 222.07/222.30  |- mesh__dateEstablished mesh__D004346 1981-01-01
% 222.07/222.30  |- mesh__recordAuthorizer mesh__D004346 sjn
% 222.07/222.30  |- skos__hiddenLabel mesh__D004346 Service, Drug Information
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D004346 2003
% 222.07/222.30  |- skos__prefLabel mesh__D004346 Drug Information Services
% 222.07/222.30  |- skos__historyNote mesh__D004346 Information Services %28%1966-1976%29%
% 222.07/222.30  |- skos__historyNote mesh__D004346 Drug Therapy %28%1966-1976%29%
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D004346 2000
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D004346 2005
% 222.07/222.30  |- mesh__recordOriginator mesh__D004346 SMH
% 222.07/222.30  |- mesh__dateCreated mesh__D004346 1976-05-19
% 222.07/222.30  |- skos__broader mesh__D004346smesh__D010593
% 222.07/222.30  |- mesh__recordAuthorizer mesh__D009031 PLS
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D009031 1995
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D009031 1998
% 222.07/222.30  |- skos__prefLabel mesh__D009031 Moscow
% 222.07/222.30  |- mesh__dateCreated mesh__D009031 1999-01-01
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D009031 1994
% 222.07/222.30  |- rdf__type mesh__D009031sskos__Concept
% 222.07/222.30  |- skos__broader mesh__D009031smesh__D002947
% 222.07/222.30  |- mesh__recordOriginator mesh__D009031 NLM
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D009031 2002
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D009031 2004
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D009031 2001
% 222.07/222.30  |- skos__broader mesh__D009031smesh__D012426
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D009031 2003
% 222.07/222.30  |- skos__annotation mesh__D009031
% 222.07/222.30       for pre- %26% post-1917 Moscow; Manual 36.12   
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D009031 2006
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D009031 1997
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D009031 2000
% 222.07/222.30  |- mesh__recordMaintainer mesh__D009031 PLS
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D009031 2005
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D009031 1999
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D009031 1996
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D009031 1993
% 222.07/222.30  |- mesh__historyNote mesh__D009031 66   
% 222.07/222.30  |- mesh__dateRevised mesh__D009031 1992-05-22
% 222.07/222.30  |- mesh__recordOriginator mesh__D014774 NLM
% 222.07/222.30  |- skos__annotation mesh__D014774
% 222.07/222.30       coord NIM with micro-organism or parasite /pathogen %28%IM%29%   
% 222.07/222.30  |- mesh__historyNote mesh__D014774 66%28%65%29%   
% 222.07/222.30  |- skos__scopeNote mesh__D014774
% 222.07/222.30       The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS.%A%    
% 222.07/222.30  |- skos__related mesh__D014774smesh__D037521
% 222.07/222.30  |- mesh__publicMeSHNote mesh__D014774 66   
% 222.07/222.30  |- skos__broader mesh__D014774smesh__D008827
% 222.07/222.30  |- mesh__recordAuthorizer mesh__D014774 sjn
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D014774 2004
% 222.07/222.30  |- mesh__dateCreated mesh__D014774 1999-01-01
% 222.07/222.30  |- mesh__dateRevised mesh__D014774 2002-07-03
% 222.07/222.30  |- rdf__type mesh__D014774sskos__Concept
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D014774 2003
% 222.07/222.30  |- skos__prefLabel mesh__D014774 Virulence
% 222.07/222.30  |- mesh__recordMaintainer mesh__D014774 nns
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D014774 2006
% 222.07/222.30  |- mesh__dateEstablished mesh__D014774 1966-01-01
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D014774 2005
% 222.07/222.30  |- skos__altLabel mesh__D047150 Serum Eosinophil Cationic Protein
% 222.07/222.30  |- skos__altLabel mesh__D047150 RNase 3
% 222.07/222.30  |- mesh__recordOriginator mesh__D047150 jmp
% 222.07/222.30  |- skos__scopeNote mesh__D047150
% 222.07/222.30       One of several basic proteins released from EOSINOPHIL cytoplasmic granules. Eosinophil cationic protein is a 21-kDa cytotoxic peptide with a pI of 10.9. Although eosinophil cationic protein is considered a member of the RNAse A superfamily of proteins, it has only limited RNAse activity.%A%    
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D047150 2006
% 222.07/222.30  |- skos__hiddenLabel mesh__D047150 Ribonuclease, Eosinophil-Associated
% 222.07/222.30  |- skos__broader mesh__D047150smesh__D047091
% 222.07/222.30  |- mesh__dateEstablished mesh__D047150 2005-01-01
% 222.07/222.30  |- mesh__publicMeSHNote mesh__D047150
% 222.07/222.30       2005; EOSINOPHIL CATIONIC PROTEIN was indexed under BLOOD PROTEINS %26% RIBONUCLEASES 1979-2004%A%  
% 222.07/222.30  |- mesh__dateRevised mesh__D047150 2005-06-30
% 222.07/222.30  |- rdf__type mesh__D047150sskos__Concept
% 222.07/222.30  |- skos__hiddenLabel mesh__D047150 Eosinophil Associated Ribonuclease
% 222.07/222.30  |- mesh__recordAuthorizer mesh__D047150 sjn
% 222.07/222.30  |- skos__broader mesh__D047150smesh__D004722
% 222.07/222.30  |- skos__hiddenLabel mesh__D047150 Cationic Protein, Eosinophil
% 222.07/222.30  |- skos__altLabel mesh__D047150 Eosinophil-Associated Ribonuclease
% 222.07/222.30  |- skos__altLabel mesh__D047150 RNS3 Protein
% 222.07/222.30  |- skos__historyNote mesh__D047150 Blood Proteins %28%1979-2004%29%
% 222.07/222.30  |- mesh__recordMaintainer mesh__D047150 ssb
% 222.07/222.30  |- mesh__historyNote mesh__D047150 2005%28%1979%29%   
% 222.07/222.30  |- mesh__dateCreated mesh__D047150 2004-07-07
% 222.07/222.30  |- skos__historyNote mesh__D047150 Ribonucleases %28%1979-2004%29%
% 222.07/222.30  |- skos__prefLabel mesh__D047150 Eosinophil Cationic Protein
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D008737 2005
% 222.07/222.30  |- skos__annotation mesh__D008737 do not confuse with METHYLENE CHLORIDE   
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D008737 2002
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D008737 1999
% 222.07/222.30  |- skos__hiddenLabel mesh__D008737 Chloride, Methyl
% 222.07/222.30  |- rdf__type mesh__D008737sskos__Concept
% 222.07/222.30  |- mesh__recordOriginator mesh__D008737 NLM
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D008737 1998
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D008737 2001
% 222.07/222.30  |- skos__altLabel mesh__D008737 Chloromethane
% 222.07/222.30  |- mesh__dateRevised mesh__D008737 1997-06-20
% 222.07/222.30  |- skos__scopeNote mesh__D008737
% 222.07/222.30       A hydrocarbon used as an industrial solvent. It has been used as an aerosal propellent, as a refrigerant and as a local anesthetic. %28%From Martindale, The Extra Pharmacopoeia, 31st ed, p1403%29%%A%    
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D008737 2000
% 222.07/222.30  |- mesh__dateCreated mesh__D008737 1999-01-01
% 222.07/222.30  |- skos__prefLabel mesh__D008737 Methyl Chloride
% 222.07/222.30  |- skos__broader mesh__D008737smesh__D006843
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D008737 2004
% 222.07/222.30  |- mesh__recordAuthorizer mesh__D008737 SJN
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D008737 2006
% 222.07/222.30  |- mesh__recordMaintainer mesh__D008737 KEV
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D008737 2003
% 222.07/222.30  |- skos__scopeNote mesh__D000754
% 222.07/222.30       Chronic refractory anemia with granulocytopenia, and/or thrombocytopenia. Myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells.%A%    
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000754 2006
% 222.07/222.30  |- skos__altLabel mesh__D000754 Leukemia, Smouldering
% 222.07/222.30  |- mesh__dateCreated mesh__D000754 1985-06-06
% 222.07/222.30  |- rdf__type mesh__D000754sskos__Concept
% 222.07/222.30  |- mesh__publicMeSHNote mesh__D000754 86   
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000754 1996
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000754 2001
% 222.07/222.30  |- mesh__historyNote mesh__D000754 86   
% 222.07/222.30  |- skos__altLabel mesh__D000754 Refractory Anemia with Excess of Blasts
% 222.07/222.30  |- skos__prefLabel mesh__D000754 Anemia, Refractory, with Excess of Blasts
% 222.07/222.30  |- skos__broader mesh__D000754smesh__D000753
% 222.07/222.30  |- skos__hiddenLabel mesh__D000754 Leukemias, Smoldering
% 222.07/222.30  |- mesh__dateRevised mesh__D000754 2005-07-29
% 222.07/222.30  |- mesh__recordOriginator mesh__D000754 VDK
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000754 2006A
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000754 1992
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000754 1997
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000754 1991
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000754 1998
% 222.07/222.30  |- mesh__recordMaintainer mesh__D000754 jls
% 222.07/222.30  |- mesh__recordAuthorizer mesh__D000754 jls
% 222.07/222.30  |- skos__altLabel mesh__D000754 RAEB
% 222.07/222.30  |- skos__hiddenLabel mesh__D000754 Smoldering Leukemia
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000754 2003
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000754 1993
% 222.07/222.30  |- skos__altLabel mesh__D000754 Leukemia, Smoldering
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000754 2002
% 222.07/222.30  |- mesh__activeMeSHYear mesh__D000754 1994
% 222.07/222.30  |- mesh__dateEstablished mesh__D000754 1986-01-01
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D000754 1999
% 222.07/222.31  |- skos__hiddenLabel mesh__D000754 Smoldering Leukemias
% 222.07/222.31  |- skos__altLabel mesh__D000754 RAEM
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D000754 2006B
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D000754 2004
% 222.07/222.31  |- skos__historyNote mesh__D000754 Anemia, Aplastic %28%1966-1985%29%
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D000754 2005
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D000754 1995
% 222.07/222.31  |- skos__hiddenLabel mesh__D000754 Smouldering Leukemia
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D000754 2000
% 222.07/222.31  |- skos__hiddenLabel mesh__D010384 Bones, Pelvic
% 222.07/222.31  |- rdf__type mesh__D010384sskos__Concept
% 222.07/222.31  |- mesh__recordAuthorizer mesh__D010384 sjn
% 222.07/222.31  |- skos__prefLabel mesh__D010384 Pelvic Bones
% 222.07/222.31  |- mesh__dateRevised mesh__D010384 2005-06-30
% 222.07/222.31  |- mesh__recordMaintainer mesh__D010384 ags
% 222.07/222.31  |- skos__hiddenLabel mesh__D010384 Bone, Pelvic
% 222.07/222.31  |- skos__broader mesh__D010384smesh__D050281
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D010384 2006
% 222.07/222.31  |- mesh__recordOriginator mesh__D010384 NLM
% 222.07/222.31  |- skos__annotation mesh__D010384
% 222.07/222.31       /anat: CEPHALOPELVIC PROPORTION see PELVIMETRY is also available%A%  
% 222.07/222.31  |- mesh__dateCreated mesh__D010384 1999-01-01
% 222.07/222.31  |- skos__hiddenLabel mesh__D010384 Pelvic Bone
% 222.07/222.31  |- skos__related mesh__D037521smesh__D014774
% 222.07/222.31  |- skos__altLabel mesh__D037521 Pathogenicity Factors
% 222.07/222.31  |- skos__prefLabel mesh__D037521 Virulence Factors
% 222.07/222.31  |- skos__hiddenLabel mesh__D037521 Factors, Pathogenicity
% 222.07/222.31  |- skos__historyNote mesh__D037521 Virulence %28%1967-2002%29%
% 222.07/222.31  |- mesh__recordMaintainer mesh__D037521 sjn
% 222.07/222.31  |- skos__broader mesh__D037521smesh__D014118
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D037521 2006
% 222.07/222.31  |- mesh__historyNote mesh__D037521 2003   
% 222.07/222.31  |- skos__hiddenLabel mesh__D037521 Factors, Virulence
% 222.07/222.31  |- mesh__dateEstablished mesh__D037521 2003-01-01
% 222.07/222.31  |- skos__scopeNote mesh__D037521
% 222.07/222.31       Those components of an organism that determine its capacity to cause disease but are not required for its viability per se. Two classes have been characterized: TOXINS, BIOLOGICAL and surface adhesion molecules that effect the ability of the microorganism to invade and colonize a host. %28%From Davis et al., Microbiology, 4th ed. p486%29%%A%    
% 222.07/222.31  |- mesh__dateCreated mesh__D037521 2002-07-03
% 222.07/222.31  |- mesh__dateRevised mesh__D037521 2005-07-01
% 222.07/222.31  |- rdf__type mesh__D037521sskos__Concept
% 222.07/222.31  |- mesh__publicMeSHNote mesh__D037521 2003   
% 222.07/222.31  |- skos__annotation mesh__D037521
% 222.07/222.31       coord with specific factors if pertinent   
% 222.07/222.31  |- mesh__recordAuthorizer mesh__D037521 sjn
% 222.07/222.31  |- mesh__recordOriginator mesh__D037521 nns
% 222.07/222.31  |- skos__hiddenLabel mesh__D004347 Interaction, Drug
% 222.07/222.31  |- mesh__recordMaintainer mesh__D004347 ssb
% 222.07/222.31  |- mesh__recordAuthorizer mesh__D004347 sjn
% 222.07/222.31  |- mesh__publicMeSHNote mesh__D004347 72   
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D004347 2006
% 222.07/222.31  |- skos__annotation mesh__D004347
% 222.07/222.31       do not confuse with DRUG INCOMPATIBILITY; IM when general;  NIM with specific drugs %28%IM%29%%A%  
% 222.07/222.31  |- skos__historyNote mesh__D004347 Drug Synergism %28%1966-1971%29%
% 222.07/222.31  |- skos__related mesh__D004347smesh__D004362
% 222.07/222.31  |- mesh__dateRevised mesh__D004347 2005-06-30
% 222.07/222.31  |- skos__historyNote mesh__D004347 Drug Antagonism %28%1966-1971%29%
% 222.07/222.31  |- rdf__type mesh__D004347sskos__Concept
% 222.07/222.31  |- skos__broader mesh__D004347smesh__D002620
% 222.07/222.31  |- mesh__recordOriginator mesh__D004347 NLM
% 222.07/222.31  |- skos__prefLabel mesh__D004347 Drug Interactions
% 222.07/222.31  |- skos__scopeNote mesh__D004347
% 222.07/222.31       The action of a drug that may affect the activity, metabolism, or toxicity of another drug.%A%    
% 222.07/222.31  |- mesh__dateEstablished mesh__D004347 1972-01-01
% 222.07/222.31  |- skos__hiddenLabel mesh__D004347 Interactions, Drug
% 222.07/222.31  |- skos__hiddenLabel mesh__D004347 Drug Interaction
% 222.07/222.31  |- mesh__historyNote mesh__D004347 72   
% 222.07/222.31  |- mesh__dateCreated mesh__D004347 1999-01-01
% 222.07/222.31  |- skos__prefLabel mesh__D009830 Olfactory Bulb
% 222.07/222.31  |- mesh__recordAuthorizer mesh__D009830 sjn
% 222.07/222.31  |- mesh__dateRevised mesh__D009830 1999-11-03
% 222.07/222.31  |- skos__hiddenLabel mesh__D009830 Accessory Olfactory Bulbs
% 222.07/222.31  |- mesh__recordOriginator mesh__D009830 NLM
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D009830 2006
% 222.07/222.31  |- mesh__recordMaintainer mesh__D009830 ags
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D009830 2001
% 222.07/222.31  |- skos__historyNote mesh__D009830 Limbic System %28%1966-1971%29%
% 222.07/222.31  |- skos__hiddenLabel mesh__D009830 Bulbs, Olfactory
% 222.07/222.31  |- mesh__publicMeSHNote mesh__D009830
% 222.07/222.31       74; was see under LIMBIC SYSTEM 1963-73   
% 222.07/222.31  |- skos__broader mesh__D009830smesh__D009833
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D009830 2005
% 222.07/222.31  |- skos__hiddenLabel mesh__D009830 Olfactory Bulb, Accessory
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D009830 2004
% 222.07/222.31  |- skos__hiddenLabel mesh__D009830 Olfactory Bulbs, Accessory
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D009830 2000
% 222.07/222.31  |- mesh__dateCreated mesh__D009830 1999-01-01
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D009830 2003
% 222.07/222.31  |- rdf__type mesh__D009830sskos__Concept
% 222.07/222.31  |- skos__scopeNote mesh__D009830
% 222.07/222.31       Ovoid body resting on the cribriform plate of the ethmoid bone where the olfactory nerve terminates. The olfactory bulb contains several types of nerve cells including the mitral cells, on whose dendrites the olfactory nerve synapses, forming the olfactory glomeruli. The accessory olfactory bulb, which receives the projection from the VOMERONASAL ORGAN via the vomeronasal nerve, is also included here.%A%    
% 222.07/222.31  |- mesh__onlineNote mesh__D009830 search LIMBIC SYSTEM 1966-71   
% 222.07/222.31  |- skos__hiddenLabel mesh__D009830 Olfactory Bulbs
% 222.07/222.31  |- skos__hiddenLabel mesh__D009830 Bulb, Olfactory
% 222.07/222.31  |- mesh__dateEstablished mesh__D009830 1974-01-01
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D009830 2002
% 222.07/222.31  |- mesh__historyNote mesh__D009830
% 222.07/222.31       74%28%72%29%; was see under LIMBIC SYSTEM 1963-73   
% 222.07/222.31  |- skos__hiddenLabel mesh__D009830 Bulb, Accessory Olfactory
% 222.07/222.31  |- skos__annotation mesh__D009830
% 222.07/222.31       neopl: coord IM with BRAIN NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 222.07/222.31  |- skos__hiddenLabel mesh__D009830 Bulbs, Accessory Olfactory
% 222.07/222.31  |- mesh__publicMeSHNote mesh__D023501 2001   
% 222.07/222.31  |- skos__prefLabel mesh__D023501 Chlamydophila
% 222.07/222.31  |- skos__annotation mesh__D023501 infection = CHLAMYDOPHILA INFECTIONS   
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D023501 2006A
% 222.07/222.31  |- mesh__recordAuthorizer mesh__D023501 ags
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D023501 2006
% 222.07/222.31  |- rdf__type mesh__D023501sskos__Concept
% 222.07/222.31  |- skos__scopeNote mesh__D023501
% 222.07/222.31       A genus of the family CHLAMYDIACEAE comprising gram-negative non CHLAMYDIA TRACHOMATIS-like species infecting vertebrates. Chlamydophila do not produce detectable quantities of glycogen. The type species is CHLAMYDOPHILA PSITTACI.%A%    
% 222.07/222.31  |- mesh__historyNote mesh__D023501 2001   
% 222.07/222.31  |- mesh__dateEstablished mesh__D023501 2001-01-01
% 222.07/222.31  |- mesh__dateRevised mesh__D023501 2005-07-12
% 222.07/222.31  |- skos__broader mesh__D023501smesh__D002693
% 222.07/222.31  |- mesh__recordMaintainer mesh__D023501 ags
% 222.07/222.31  |- mesh__recordOriginator mesh__D023501 ags
% 222.07/222.31  |- mesh__dateCreated mesh__D023501 2000-06-23
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D009032 2001
% 222.07/222.31  |- mesh__recordMaintainer mesh__D009032 TAP
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D009032 2004
% 222.07/222.31  |- skos__annotation mesh__D009032
% 222.07/222.31       coord IM with specific mosquito %28%IM%29% if pertinent   
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D009032 2000
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D009032 2003
% 222.07/222.31  |- mesh__dateRevised mesh__D009032 1992-05-15
% 222.07/222.31  |- skos__related mesh__D009032smesh__D010572
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D009032 2006
% 222.07/222.31  |- skos__related mesh__D009032smesh__D007305
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D009032 1997
% 222.07/222.31  |- mesh__recordAuthorizer mesh__D009032 PLS
% 222.07/222.31  |- skos__related mesh__D009032smesh__D002629
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D009032 2005
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D009032 1996
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D009032 1993
% 222.07/222.31  |- skos__hiddenLabel mesh__D009032 Control, Mosquito
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D009032 1999
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D009032 1995
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D009032 1998
% 222.07/222.31  |- skos__prefLabel mesh__D009032 Mosquito Control
% 222.07/222.31  |- skos__scopeNote mesh__D009032
% 222.07/222.31       The reduction or regulation of the population of mosquitoes through chemical, biological, or other means.%A%    
% 222.07/222.31  |- mesh__recordOriginator mesh__D009032 NLM
% 222.07/222.31  |- mesh__dateCreated mesh__D009032 1999-01-01
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D009032 1994
% 222.07/222.31  |- skos__broader mesh__D009032smesh__D007300
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D009032 2002
% 222.07/222.31  |- rdf__type mesh__D009032sskos__Concept
% 222.07/222.31  |- skos__related mesh__D014775smesh__D008242
% 222.07/222.31  |- skos__altLabel mesh__D014775 Virus Induction
% 222.07/222.31  |- skos__annotation mesh__D014775
% 222.07/222.31       coord with specific virus /physiol %28%IM or NIM%29%   
% 222.07/222.31  |- skos__hiddenLabel mesh__D014775 Induction, Virus
% 222.07/222.31  |- skos__hiddenLabel mesh__D014775 Prophage Inductions
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D014775 2004
% 222.07/222.31  |- mesh__recordMaintainer mesh__D014775 ags
% 222.07/222.31  |- skos__hiddenLabel mesh__D014775 Virus Activations
% 222.07/222.31  |- mesh__publicMeSHNote mesh__D014775 80   
% 222.07/222.31  |- skos__historyNote mesh__D014775 specific virus %28%1966-1967%29%
% 222.07/222.31  |- skos__historyNote mesh__D014775 Virus Replication %28%1968-1979%29%
% 222.07/222.31  |- skos__hiddenLabel mesh__D014775 Virus Inductions
% 222.07/222.31  |- skos__hiddenLabel mesh__D014775 Activations, Virus
% 222.07/222.31  |- rdf__type mesh__D014775sskos__Concept
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D014775 2003
% 222.07/222.31  |- mesh__recordOriginator mesh__D014775 AEP
% 222.07/222.31  |- skos__hiddenLabel mesh__D014775 Excision, Prophage
% 222.07/222.31  |- mesh__recordAuthorizer mesh__D014775 sjn
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D014775 2006
% 222.07/222.31  |- mesh__dateRevised mesh__D014775 2002-07-02
% 222.07/222.31  |- skos__broader mesh__D014775smesh__D014779
% 222.07/222.31  |- skos__hiddenLabel mesh__D014775 Prophage Excisions
% 222.07/222.31  |- skos__hiddenLabel mesh__D014775 Activation, Virus
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D014775 2005
% 222.07/222.31  |- skos__historyNote mesh__D014775 Lysogeny %28%1968-1979%29%
% 222.07/222.31  |- skos__hiddenLabel mesh__D014775 Inductions, Virus
% 222.07/222.31  |- skos__hiddenLabel mesh__D014775 Excisions, Prophage
% 222.07/222.31  |- skos__prefLabel mesh__D014775 Virus Activation
% 222.07/222.31  |- skos__hiddenLabel mesh__D014775 Inductions, Prophage
% 222.07/222.31  |- mesh__historyNote mesh__D014775 80   
% 222.07/222.31  |- mesh__dateEstablished mesh__D014775 1980-01-01
% 222.07/222.31  |- skos__hiddenLabel mesh__D014775 Induction, Prophage
% 222.07/222.31  |- mesh__dateCreated mesh__D014775 1978-12-21
% 222.07/222.31  |- skos__scopeNote mesh__D014775
% 222.07/222.31       The mechanism by which latent viruses, such as genetically transmitted tumor viruses %28%PROVIRUSES%29% or PROPHAGES of lysogenic bacteria, are induced to replicate and then released as infectious viruses. It may be effected by various endogenous and exogenous stimuli, including B-cell LIPOPOLYSACCHARIDES, glucocorticoid hormones, halogenated pyrimidines, IONIZING RADIATION, ultraviolet light, and superinfecting viruses.%A%    
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D047151 2006
% 222.07/222.31  |- skos__hiddenLabel mesh__D047151 Alkaloids, Amaryllidaceae
% 222.07/222.31  |- rdf__type mesh__D047151sskos__Concept
% 222.07/222.31  |- mesh__dateCreated mesh__D047151 2004-07-07
% 222.07/222.31  |- mesh__historyNote mesh__D047151 2005   
% 222.07/222.31  |- mesh__recordAuthorizer mesh__D047151 ags
% 222.07/222.31  |- mesh__recordMaintainer mesh__D047151 ags
% 222.07/222.31  |- mesh__activeMeSHYear mesh__D047151 2006A
% 222.07/222.31  |- skos__historyNote mesh__D047151 Alkaloids %28%1965-2004%29%
% 222.17/222.31  |- mesh__dateEstablished mesh__D047151 2005-01-01
% 222.17/222.31  |- skos__broader mesh__D047151smesh__D000470
% 222.17/222.31  |- skos__scopeNote mesh__D047151
% 222.17/222.31       Alkaloids derived from TYRAMINE combined with 3,4-dihydroxybenzaldehyde via a norbelladine pathway, including GALANTAMINE, lycorine and crinine. They are found in the Amaryllidaceae %28%LILIACEAE%29% plant family.%A%    
% 222.17/222.31  |- mesh__recordOriginator mesh__D047151 ssb
% 222.17/222.31  |- skos__prefLabel mesh__D047151 Amaryllidaceae Alkaloids
% 222.17/222.31  |- mesh__dateRevised mesh__D047151 2005-07-19
% 222.17/222.31  |- mesh__publicMeSHNote mesh__D047151 2005   
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D047151 2005
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D008738 2005
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D008738 1996
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D008738 2002
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D008738 1999
% 222.17/222.31  |- mesh__recordOriginator mesh__D008738 NLM
% 222.17/222.31  |- mesh__recordAuthorizer mesh__D008738 PLS
% 222.17/222.31  |- rdf__type mesh__D008738sskos__Concept
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D008738 1998
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D008738 2001
% 222.17/222.31  |- skos__hiddenLabel mesh__D008738 Ethers, Methyl
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D008738 2000
% 222.17/222.31  |- mesh__dateCreated mesh__D008738 1999-01-01
% 222.17/222.31  |- mesh__historyNote mesh__D008738
% 222.17/222.31       74; was METHYL ETHER 1972-73 %28%Prov%29%   
% 222.17/222.31  |- mesh__publicMeSHNote mesh__D008738 74   
% 222.17/222.31  |- skos__historyNote mesh__D008738 Ethers %28%1966-1971%29%
% 222.17/222.31  |- skos__scopeNote mesh__D008738
% 222.17/222.31       A group of compounds that contain the general formula R-OCH3.%A%    
% 222.17/222.31  |- mesh__onlineNote mesh__D008738
% 222.17/222.31       use METHYL ETHERS to search METHYL ETHER 1972-73 %28%as Prov%29%%A%  
% 222.17/222.31  |- mesh__dateEstablished mesh__D008738 1974-01-01
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D008738 2004
% 222.17/222.31  |- mesh__recordMaintainer mesh__D008738 KEV
% 222.17/222.31  |- mesh__dateRevised mesh__D008738 1995-05-18
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D008738 1997
% 222.17/222.31  |- skos__broader mesh__D008738smesh__D004987
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D008738 2003
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D008738 2006
% 222.17/222.31  |- skos__prefLabel mesh__D008738 Methyl Ethers
% 222.17/222.31  |- skos__altLabel mesh__D000755 Sickle Cell Anemia
% 222.17/222.31  |- mesh__recordOriginator mesh__D000755 NLM
% 222.17/222.31  |- mesh__recordMaintainer mesh__D000755 nns
% 222.17/222.31  |- skos__hiddenLabel mesh__D000755 Diseases, Hemoglobin S
% 222.17/222.31  |- skos__broader mesh__D000755smesh__D000745
% 222.17/222.31  |- rdf__type mesh__D000755sskos__Concept
% 222.17/222.31  |- skos__hiddenLabel mesh__D000755 Anemias, Sickle Cell
% 222.17/222.31  |- skos__prefLabel mesh__D000755 Anemia, Sickle Cell
% 222.17/222.31  |- skos__broader mesh__D000755smesh__D006453
% 222.17/222.31  |- skos__scopeNote mesh__D000755
% 222.17/222.31       A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.%A%    
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D000755 2002
% 222.17/222.31  |- skos__related mesh__D000755smesh__D000986
% 222.17/222.31  |- mesh__dateCreated mesh__D000755 1999-01-01
% 222.17/222.31  |- mesh__dateRevised mesh__D000755 2001-07-25
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D000755 2006
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D000755 2004
% 222.17/222.31  |- mesh__recordAuthorizer mesh__D000755 sjn
% 222.17/222.31  |- skos__hiddenLabel mesh__D000755 Hemoglobin S Diseases
% 222.17/222.31  |- skos__hiddenLabel mesh__D000755 Sickle Cell Anemias
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D000755 2005
% 222.17/222.31  |- skos__annotation mesh__D000755
% 222.17/222.31       PL 92-294: Natl Sickle Cell Anemia Control Act; sickle cell dis goes here unless specifically HEMOGLOBIN SC DISEASE or HEMOGLOBIN C DISEASE or SICKLE CELL TRAIT or THALASSEMIA; /drug ther: consider also ANTISICKLING AGENTS%A%  
% 222.17/222.31  |- skos__hiddenLabel mesh__D000755 Disease, Hemoglobin S
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D000755 2003
% 222.17/222.31  |- skos__altLabel mesh__D000755 Hemoglobin S Disease
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D019460 2004
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D019460 1999
% 222.17/222.31  |- skos__broader mesh__D019460smesh__D007221
% 222.17/222.31  |- skos__annotation mesh__D019460 SPEC; SPEC qualif; DF: TOBACCO INDUST   
% 222.17/222.31  |- mesh__historyNote mesh__D019460 97   
% 222.17/222.31  |- skos__hiddenLabel mesh__D019460 Tobacco Industries
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D019460 2002
% 222.17/222.31  |- mesh__dateEstablished mesh__D019460 1997-01-01
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D019460 2003
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D019460 1998
% 222.17/222.31  |- mesh__publicMeSHNote mesh__D019460 97   
% 222.17/222.31  |- skos__scopeNote mesh__D019460
% 222.17/222.31       The aggregate business enterprise of agriculture, manufacture, and distribution related to tobacco and tobacco-derived products.%A%    
% 222.17/222.31  |- skos__altLabel mesh__D019460 Industry, Tobacco
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D019460 2006
% 222.17/222.31  |- skos__hiddenLabel mesh__D019460 Industries, Tobacco
% 222.17/222.31  |- rdf__type mesh__D019460sskos__Concept
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D019460 2001
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D019460 1997
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D019460 2005
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D019460 2000
% 222.17/222.31  |- mesh__dateCreated mesh__D019460 1996-06-10
% 222.17/222.31  |- skos__historyNote mesh__D019460 Tobacco %28%1966-1996%29%
% 222.17/222.31  |- skos__prefLabel mesh__D019460 Tobacco Industry
% 222.17/222.31  |- skos__historyNote mesh__D019460 Industry %28%1966-1996%29%
% 222.17/222.31  |- rdf__type mesh__D005440sskos__Concept
% 222.17/222.31  |- mesh__historyNote mesh__D005440 79   
% 222.17/222.31  |- skos__hiddenLabel mesh__D005440 Rehydration Therapies, Oral
% 222.17/222.31  |- skos__scopeNote mesh__D005440
% 222.17/222.31       Therapy whose basic objective is to restore the volume and composition of the body fluids to normal with respect to water-electrolyte balance. Fluids may be administered intravenously, orally, by intermittent gavage, or by hypodermoclysis.%A%    
% 222.17/222.31  |- skos__hiddenLabel mesh__D005440 Fluid Therapies
% 222.17/222.31  |- skos__hiddenLabel mesh__D005440 Oral Rehydrations
% 222.17/222.31  |- skos__altLabel mesh__D005440 Rehydration Therapy, Oral
% 222.17/222.31  |- skos__annotation mesh__D005440
% 222.17/222.31       %22%to restore volume %26% composition of body fluids...with respect to water-electrolyte balance%22%; for other nourishment use PARENTERAL FEEDING or specifics; do not use /util except by MeSH definition; coord IM with dis /ther %28%IM%29%, not dis /diet ther; do not specify route of admin unless particularly significant %28%%26% then only NIM%29%%A%  
% 222.17/222.31  |- skos__prefLabel mesh__D005440 Fluid Therapy
% 222.17/222.31  |- skos__hiddenLabel mesh__D005440 Rehydrations, Oral
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D005440 2002
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D005440 1996
% 222.17/222.31  |- skos__altLabel mesh__D005440 Therapy, Fluid
% 222.17/222.31  |- skos__hiddenLabel mesh__D005440 Rehydrations
% 222.17/222.31  |- skos__altLabel mesh__D005440 Rehydration, Oral
% 222.17/222.31  |- mesh__dateRevised mesh__D005440 1992-05-20
% 222.17/222.31  |- mesh__recordOriginator mesh__D005440 SMH
% 222.17/222.31  |- skos__historyNote mesh__D005440 Electrolytes %28%1966-1978%29%
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D005440 2003
% 222.17/222.31  |- mesh__dateCreated mesh__D005440 1977-11-28
% 222.17/222.31  |- skos__hiddenLabel mesh__D005440 Therapies, Fluid
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D005440 1997
% 222.17/222.31  |- skos__historyNote mesh__D005440 Infusions, Parenteral %28%1966-1978%29%
% 222.17/222.31  |- skos__related mesh__D005440smesh__D015532
% 222.17/222.31  |- mesh__recordAuthorizer mesh__D005440 PLS
% 222.17/222.31  |- skos__hiddenLabel mesh__D005440 Therapies, Oral Rehydration
% 222.17/222.31  |- skos__broader mesh__D005440smesh__D004358
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D005440 1998
% 222.17/222.31  |- mesh__publicMeSHNote mesh__D005440 79   
% 222.17/222.31  |- skos__hiddenLabel mesh__D005440 Oral Rehydration Therapies
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D005440 2004
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D005440 2005
% 222.17/222.31  |- skos__historyNote mesh__D005440
% 222.17/222.31       Water-Electrolyte Balance %28%1966-1978%29%
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D005440 2000
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D005440 1994
% 222.17/222.31  |- mesh__dateEstablished mesh__D005440 1979-01-01
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D005440 1999
% 222.17/222.31  |- skos__altLabel mesh__D005440 Therapy, Oral Rehydration
% 222.17/222.31  |- mesh__recordMaintainer mesh__D005440 PXP
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D005440 2006
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D005440 1995
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D005440 2001
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D005440 1993
% 222.17/222.31  |- rdf__type mesh__D052096sskos__Concept
% 222.17/222.31  |- skos__hiddenLabel mesh__D052096 Time, Warm Ischemia
% 222.17/222.31  |- skos__hiddenLabel mesh__D052096 Times, Warm Ischemia
% 222.17/222.31  |- mesh__historyNote mesh__D052096 2006   
% 222.17/222.31  |- mesh__recordMaintainer mesh__D052096 nns
% 222.17/222.31  |- skos__hiddenLabel mesh__D052096 Warm Ischemias
% 222.17/222.31  |- skos__hiddenLabel mesh__D052096 Ischemia, Warm
% 222.17/222.31  |- skos__hiddenLabel mesh__D052096 Warm Ischemic Times
% 222.17/222.31  |- skos__prefLabel mesh__D052096 Warm Ischemia
% 222.17/222.31  |- mesh__recordAuthorizer mesh__D052096 sjn
% 222.17/222.31  |- skos__hiddenLabel mesh__D052096 Ischemic Times, Warm
% 222.17/222.31  |- skos__hiddenLabel mesh__D052096 Ischemic Time, Warm
% 222.17/222.31  |- skos__hiddenLabel mesh__D052096 Ischemias, Warm
% 222.17/222.31  |- mesh__dateEstablished mesh__D052096 2006-01-01
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D052096 2006
% 222.17/222.31  |- skos__hiddenLabel mesh__D052096 Times, Warm Ischemic
% 222.17/222.31  |- mesh__recordOriginator mesh__D052096 nns
% 222.17/222.31  |- skos__hiddenLabel mesh__D052096 Ischemia Times, Warm
% 222.17/222.31  |- skos__hiddenLabel mesh__D052096 Time, Warm Ischemic
% 222.17/222.31  |- skos__historyNote mesh__D052096 Ischemia %28%1968-2005%29%
% 222.17/222.31  |- skos__related mesh__D052096smesh__D007511
% 222.17/222.31  |- skos__related mesh__D052096smesh__D050377
% 222.17/222.31  |- mesh__dateCreated mesh__D052096 2005-06-30
% 222.17/222.31  |- skos__hiddenLabel mesh__D052096 Ischemia Time, Warm
% 222.17/222.31  |- skos__hiddenLabel mesh__D052096 Warm Ischemia Times
% 222.17/222.31  |- skos__broader mesh__D052096smesh__D014180
% 222.17/222.31  |- skos__scopeNote mesh__D052096
% 222.17/222.31       A tissue or organ remaining at physiological temperature during decreased BLOOD perfusion or in the absence of blood supply. During ORGAN TRANSPLANTATION it begins when the organ reaches physiological temperature before the completion of SURGICAL ANASTOMOSIS and ends with reestablishment of the BLOOD CIRCULATION through the tissue.%A%    
% 222.17/222.31  |- skos__altLabel mesh__D052096 Warm Ischemic Time
% 222.17/222.31  |- mesh__publicMeSHNote mesh__D052096 2006   
% 222.17/222.31  |- skos__hiddenLabel mesh__D010385 Exenteration, Pelvic
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D010385 2004
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D010385 2000
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D010385 2005
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D010385 1996
% 222.17/222.31  |- mesh__dateRevised mesh__D010385 1995-03-13
% 222.17/222.31  |- skos__hiddenLabel mesh__D010385 Pelvic Exenterations
% 222.17/222.31  |- skos__scopeNote mesh__D010385
% 222.17/222.31       Removal of all of the organs and adjacent structures of the pelvis. It is usually performed to surgically remove cancer involving the bladder, uterine cervix, or rectum. %28%Stedman, 25th ed%29%%A%    
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D010385 2001
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D010385 2006
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D010385 1997
% 222.17/222.31  |- skos__prefLabel mesh__D010385 Pelvic Exenteration
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D010385 2002
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D010385 1998
% 222.17/222.31  |- mesh__recordAuthorizer mesh__D010385 PLS
% 222.17/222.31  |- mesh__dateCreated mesh__D010385 1999-01-01
% 222.17/222.31  |- skos__hiddenLabel mesh__D010385 Exenterations, Pelvic
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D010385 1999
% 222.17/222.31  |- mesh__recordOriginator mesh__D010385 NLM
% 222.17/222.31  |- skos__broader mesh__D010385smesh__D013514
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D010385 2003
% 222.17/222.31  |- mesh__recordMaintainer mesh__D010385 TGC
% 222.17/222.31  |- skos__annotation mesh__D010385
% 222.17/222.31       surg removal of pelvic organs; do not use /util except by MeSH definition%A%  
% 222.17/222.31  |- rdf__type mesh__D010385sskos__Concept
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D004348 2004
% 222.17/222.31  |- skos__altLabel mesh__D004348 Drug Labelling
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D004348 2002
% 222.17/222.31  |- skos__historyNote mesh__D004348 Drug Therapy %28%1966-1967%29%
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D004348 2006
% 222.17/222.31  |- skos__broader mesh__D004348smesh__D004349
% 222.17/222.31  |- mesh__dateRevised mesh__D004348 1997-06-20
% 222.17/222.31  |- skos__historyNote mesh__D004348 Drug Industry %28%1966-1967%29%
% 222.17/222.31  |- skos__altLabel mesh__D004348 Labeling, Drug
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D004348 2003
% 222.17/222.31  |- skos__prefLabel mesh__D004348 Drug Labeling
% 222.17/222.31  |- skos__historyNote mesh__D004348 Medication Errors %28%1966-1967%29%
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D004348 2001
% 222.17/222.31  |- skos__hiddenLabel mesh__D004348 Drug Package Insert
% 222.17/222.31  |- skos__altLabel mesh__D004348 Package Inserts, Drug
% 222.17/222.31  |- mesh__activeMeSHYear mesh__D004348 2005
% 222.17/222.31  |- skos__altLabel mesh__D004348 Product Labeling, Drug
% 222.17/222.31  |- mesh__recordMaintainer mesh__D004348 JLS
% 222.17/222.31  |- mesh__dateEstablished mesh__D004348 1968-01-01
% 222.17/222.31  |- skos__broader mesh__D004348smesh__D013678
% 222.17/222.31  |- rdf__type mesh__D004348sskos__Concept
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D004348 2000
% 222.17/222.32  |- mesh__historyNote mesh__D004348 68   
% 222.17/222.32  |- skos__hiddenLabel mesh__D004348 Labeling, Drug Product
% 222.17/222.32  |- skos__scopeNote mesh__D004348
% 222.17/222.32       Use of written, printed, or graphic materials upon or accompanying a drug container or wrapper. It includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information.%A%    
% 222.17/222.32  |- mesh__recordAuthorizer mesh__D004348 SJN
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D004348 1999
% 222.17/222.32  |- mesh__publicMeSHNote mesh__D004348 68   
% 222.17/222.32  |- skos__hiddenLabel mesh__D004348 Inserts, Drug Package
% 222.17/222.32  |- skos__hiddenLabel mesh__D004348 Drug Package Inserts
% 222.17/222.32  |- mesh__dateCreated mesh__D004348 1999-01-01
% 222.17/222.32  |- skos__hiddenLabel mesh__D004348 Labelling, Drug
% 222.17/222.32  |- skos__hiddenLabel mesh__D004348 Insert, Drug Package
% 222.17/222.32  |- skos__hiddenLabel mesh__D004348 Package Insert, Drug
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D004348 1998
% 222.17/222.32  |- skos__hiddenLabel mesh__D004348 Drug Product Labeling
% 222.17/222.32  |- mesh__recordOriginator mesh__D004348 NLM
% 222.17/222.32  |- skos__historyNote mesh__D015070 Desoxycorticosterone %28%1973-1974%29%
% 222.17/222.32  |- skos__altLabel mesh__D015070 18 Hydroxydesoxycorticosterone
% 222.17/222.32  |- skos__altLabel mesh__D015070 18-Hydroxy-11-Desoxycorticosterone
% 222.17/222.32  |- mesh__dateCreated mesh__D015070 1974-11-19
% 222.17/222.32  |- mesh__recordAuthorizer mesh__D015070 sjn
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D015070 2005
% 222.17/222.32  |- skos__scopeNote mesh__D015070
% 222.17/222.32       An analog of desoxycorticosterone which is substituted by a hydroxyl group at the C-18 position.%A%    
% 222.17/222.32  |- skos__prefLabel mesh__D015070 18-Hydroxydesoxycorticosterone
% 222.17/222.32  |- skos__broader mesh__D015070smesh__D003900
% 222.17/222.32  |- skos__altLabel mesh__D015070 18-Hydroxy-11-Deoxycorticosterone
% 222.17/222.32  |- mesh__recordMaintainer mesh__D015070 ssb
% 222.17/222.32  |- mesh__historyNote mesh__D015070
% 222.17/222.32       1991%28%1975%29%; for 18-HYDROXY-11-DEOXYCORTICOSTERONE use 18-HYDROXYDESOXYCORTICOSTERONE %28%NM%29% 2003-2004%A%  
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D015070 2006
% 222.17/222.32  |- mesh__recordOriginator mesh__D015070 NLM
% 222.17/222.32  |- skos__hiddenLabel mesh__D015070 Hydroxydesoxycorticosterone, 18
% 222.17/222.32  |- mesh__dateRevised mesh__D015070 2004-07-07
% 222.17/222.32  |- skos__hiddenLabel mesh__D015070 18 Hydroxy 11 Deoxycorticosterone
% 222.17/222.32  |- mesh__dateEstablished mesh__D015070 1991-01-01
% 222.17/222.32  |- rdf__type mesh__D015070sskos__Concept
% 222.17/222.32  |- mesh__publicMeSHNote mesh__D015070
% 222.17/222.32       1991; see DESOXYCORTICOSTERONE 1975-1990; 18-HYDROXY-11-DEOXYCORTICOSTERONE was indexed under 18-HYDROXYCORTICOSTERONE 2003-2004%A%  
% 222.17/222.32  |- skos__hiddenLabel mesh__D015070 18 Hydroxy 11 Desoxycorticosterone
% 222.17/222.32  |- mesh__dateEstablished mesh__D009831 1972-01-01
% 222.17/222.32  |- skos__scopeNote mesh__D009831
% 222.17/222.32       That portion of the nasal mucosa containing the sensory nerve endings for SMELL, located at the dome of each NASAL CAVITY. The yellow-brownish olfactory epithelium consists of OLFACTORY RECEPTOR NEURONS; brush cells; STEM CELLS; and the associated olfactory glands.%A%    
% 222.17/222.32  |- mesh__dateCreated mesh__D009831 1999-01-01
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D009831 2006A
% 222.17/222.32  |- mesh__recordOriginator mesh__D009831 NLM
% 222.17/222.32  |- mesh__dateRevised mesh__D009831 2005-08-01
% 222.17/222.32  |- skos__historyNote mesh__D009831 Nasal Mucosa %28%1966-1971%29%
% 222.17/222.32  |- skos__hiddenLabel mesh__D009831 Mucosa, Olfactory
% 222.17/222.32  |- skos__broader mesh__D009831smesh__D009666
% 222.17/222.32  |- rdf__type mesh__D009831sskos__Concept
% 222.17/222.32  |- mesh__publicMeSHNote mesh__D009831 72   
% 222.17/222.32  |- skos__broader mesh__D009831smesh__D009297
% 222.17/222.32  |- skos__prefLabel mesh__D009831 Olfactory Mucosa
% 222.17/222.32  |- skos__related mesh__D009831smesh__D019147
% 222.17/222.32  |- skos__hiddenLabel mesh__D009831 Epithelium, Olfactory
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D009831 2006
% 222.17/222.32  |- mesh__historyNote mesh__D009831 72   
% 222.17/222.32  |- mesh__recordMaintainer mesh__D009831 ags
% 222.17/222.32  |- mesh__recordAuthorizer mesh__D009831 ags
% 222.17/222.32  |- mesh__recordMaintainer mesh__D023502 SYSTEM
% 222.17/222.32  |- mesh__publicMeSHNote mesh__D023502 2001   
% 222.17/222.32  |- mesh__recordOriginator mesh__D023502 ags
% 222.17/222.32  |- skos__prefLabel mesh__D023502 Chlamydia muridarum
% 222.17/222.32  |- skos__historyNote mesh__D023502 Chlamydia trachomatis %28%1980-2000%29%
% 222.17/222.32  |- skos__annotation mesh__D023502
% 222.17/222.32       infection: coord IM with CHLAMYDIA INFECTIONS %28%IM%29%; index also PNEUMONIA, BACTERIAL if pertinent%A%  
% 222.17/222.32  |- mesh__dateEstablished mesh__D023502 2001-01-01
% 222.17/222.32  |- skos__scopeNote mesh__D023502
% 222.17/222.32       Species of CHLAMYDIA causing pneumonitis in mice and hamsters. These isolates formerly belonged to CHLAMYDIA TRACHOMATIS.%A%    
% 222.17/222.32  |- skos__broader mesh__D023502smesh__D002689
% 222.17/222.32  |- mesh__dateCreated mesh__D023502 2000-06-23
% 222.17/222.32  |- rdf__type mesh__D023502sskos__Concept
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D023502 2006
% 222.17/222.32  |- mesh__dateRevised mesh__D023502 2005-06-30
% 222.17/222.32  |- mesh__historyNote mesh__D023502 2001   
% 222.17/222.32  |- mesh__recordAuthorizer mesh__D023502 sjn
% 222.17/222.32  |- mesh__recordOriginator mesh__D009033 NLM
% 222.17/222.32  |- mesh__publicMeSHNote mesh__D009033 95; was MOSQUITOES 1963-94   
% 222.17/222.32  |- skos__prefLabel mesh__D009033 Culicidae
% 222.17/222.32  |- mesh__recordAuthorizer mesh__D009033 sjn
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D009033 2006
% 222.17/222.32  |- skos__scopeNote mesh__D009033
% 222.17/222.32       A family of the order DIPTERA that comprises the mosquitoes. The larval stages are aquatic, and the adults can be recognized by the characteristic wing venation, the scales along the wing veins, and the long proboscis. Many species are of particular medical importance.%A%    
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D009033 2005
% 222.17/222.32  |- skos__annotation mesh__D009033
% 222.17/222.32       mosquitoes, a family of Diptera; do not confuse with CULICOIDES %28%see CERATOPOGONIDAE%29%, a gnat; GEN: prefer specifics; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111; mosquito bites = CULICIDAE or specific genus %28%IM%29% + INSECT BITES AND STINGS %28%IM%29%%A%  
% 222.17/222.32  |- mesh__recordMaintainer mesh__D009033 ags
% 222.17/222.32  |- mesh__dateCreated mesh__D009033 1999-01-01
% 222.17/222.32  |- skos__broader mesh__D009033smesh__D004175
% 222.17/222.32  |- rdf__type mesh__D009033sskos__Concept
% 222.17/222.32  |- skos__altLabel mesh__D009033 Mosquitoes
% 222.17/222.32  |- mesh__historyNote mesh__D009033 95; was MOSQUITOES 1963-94   
% 222.17/222.32  |- mesh__onlineNote mesh__D009033
% 222.17/222.32       use CULICIDAE to search MOSQUITOES 1966-94   
% 222.17/222.32  |- mesh__dateRevised mesh__D009033 2003-07-09
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D009033 2004
% 222.17/222.32  |- skos__related mesh__D001050smesh__D013546
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D001050 2005
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D001050 2003
% 222.17/222.32  |- mesh__dateRevised mesh__D001050 2002-07-02
% 222.17/222.32  |- skos__hiddenLabel mesh__D001050 Glands, Apocrine
% 222.17/222.32  |- skos__prefLabel mesh__D001050 Apocrine Glands
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D001050 2006
% 222.17/222.32  |- mesh__recordMaintainer mesh__D001050 NNS
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D001050 2004
% 222.17/222.32  |- skos__scopeNote mesh__D001050
% 222.17/222.32       Large, branched, specialized sweat glands that empty into the upper portion of a HAIR FOLLICLE instead of directly onto the SKIN.%A%    
% 222.17/222.32  |- rdf__type mesh__D001050sskos__Concept
% 222.17/222.32  |- skos__annotation mesh__D001050
% 222.17/222.32       /secret: consider also SWEAT or SWEATING   
% 222.17/222.32  |- mesh__dateCreated mesh__D001050 1999-01-01
% 222.17/222.32  |- mesh__recordOriginator mesh__D001050 NLM
% 222.17/222.32  |- skos__broader mesh__D001050smesh__D013545
% 222.17/222.32  |- skos__hiddenLabel mesh__D001050 Gland, Apocrine
% 222.17/222.32  |- mesh__publicMeSHNote mesh__D001050
% 222.17/222.32       91; was see under SWEAT GLANDS 1975-90   
% 222.17/222.32  |- mesh__recordAuthorizer mesh__D001050 sjn
% 222.17/222.32  |- mesh__onlineNote mesh__D001050 search SWEAT GLANDS 1971-74   
% 222.17/222.32  |- mesh__historyNote mesh__D001050
% 222.17/222.32       91%28%75%29%; was see under SWEAT GLANDS 1975-90   
% 222.17/222.32  |- skos__hiddenLabel mesh__D001050 Apocrine Gland
% 222.17/222.32  |- mesh__dateEstablished mesh__D001050 1991-01-01
% 222.17/222.32  |- mesh__recordMaintainer mesh__D014776 ags
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D014776 2001
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D014776 2004
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D014776 2002
% 222.17/222.32  |- skos__hiddenLabel mesh__D014776 Virus Cultivations
% 222.17/222.32  |- rdf__type mesh__D014776sskos__Concept
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D014776 2005
% 222.17/222.32  |- mesh__dateRevised mesh__D014776 2005-08-02
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D014776 2006A
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D014776 2006
% 222.17/222.32  |- skos__prefLabel mesh__D014776 Virus Cultivation
% 222.17/222.32  |- skos__hiddenLabel mesh__D014776 Cultivation, Virus
% 222.17/222.32  |- mesh__recordOriginator mesh__D014776 NLM
% 222.17/222.32  |- skos__broader mesh__D014776smesh__D008828
% 222.17/222.32  |- skos__annotation mesh__D014776
% 222.17/222.32       NIM; relation to TISSUE CULTURE TECHNIQUES: Manual 26.23.3%A%  
% 222.17/222.32  |- skos__hiddenLabel mesh__D014776 Cultivations, Virus
% 222.17/222.32  |- mesh__dateCreated mesh__D014776 1999-01-01
% 222.17/222.32  |- mesh__recordAuthorizer mesh__D014776 ags
% 222.17/222.32  |- mesh__activeMeSHYear mesh__D014776 2003
% 222.17/222.32  |- skos__historyNote mesh__D008739 Rosaniline Dyes %28%1972-1974%29%
% 222.17/222.32  |- mesh__publicMeSHNote mesh__D008739
% 222.17/222.32       91; was see under ROSANILINE DYES 1975-90   
% 222.17/222.32  |- skos__scopeNote mesh__D008739
% 222.17/222.32       A tri-benzene-ammonium usually compounded with zinc chloride. It is used as a biological stain and for the dyeing and printing of textiles.%A%    
% 222.17/222.32  |- skos__altLabel mesh__D008739 Light Green
% 222.17/222.32  |- mesh__recordOriginator mesh__D008739 NLM
% 222.17/222.32  |- skos__hiddenLabel mesh__D008739 Green, Light
% 222.17/222.32  |- mesh__recordAuthorizer mesh__D008739 NLM
% 222.17/222.32  |- mesh__dateEstablished mesh__D008739 1991-01-01
% 222.17/222.32  |- skos__prefLabel mesh__D008739 Methyl Green
% 222.17/222.34  |- mesh__recordMaintainer mesh__D008739 NLM
% 222.17/222.34  |- mesh__dateRevised mesh__D008739 2005-07-06
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D008739 2006
% 222.17/222.34  |- skos__hiddenLabel mesh__D008739 Green, Methyl
% 222.17/222.34  |- skos__broader mesh__D008739smesh__D000814
% 222.17/222.34  |- mesh__historyNote mesh__D008739
% 222.17/222.34       91%28%75%29%; was see under ROSANILINE DYES 1975-90   
% 222.17/222.34  |- mesh__dateCreated mesh__D008739 1974-11-27
% 222.17/222.34  |- rdf__type mesh__D008739sskos__Concept
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D000756 1999
% 222.17/222.34  |- mesh__recordMaintainer mesh__D000756 TAP
% 222.17/222.34  |- mesh__recordAuthorizer mesh__D000756 PLS
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D000756 1994
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D000756 1997
% 222.17/222.34  |- mesh__dateCreated mesh__D000756 1999-01-01
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D000756 1992
% 222.17/222.34  |- mesh__dateRevised mesh__D000756 1990-03-29
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D000756 2006
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D000756 1998
% 222.17/222.34  |- mesh__onlineNote mesh__D000756
% 222.17/222.34       use ANEMIA, SIDEROBLASTIC to search ANEMIA, SIDEROBLASTIC REFRACTORY 1966 %28%as Prov 1966%29%%A%  
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D000756 2001
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D000756 2004
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D000756 1996
% 222.17/222.34  |- skos__hiddenLabel mesh__D000756 Sideroblastic Anemias
% 222.17/222.34  |- skos__hiddenLabel mesh__D000756 Anemias, Sideroblastic
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D000756 2000
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D000756 2005
% 222.17/222.34  |- mesh__historyNote mesh__D000756
% 222.17/222.34       67; was ANEMIA, SIDEROBLASTIC REFRACTORY 1963-66 %28%Prov 1966%29%%A%  
% 222.17/222.34  |- skos__broader mesh__D000756smesh__D009190
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D000756 1991
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D000756 2003
% 222.17/222.34  |- skos__broader mesh__D000756smesh__D000740
% 222.17/222.34  |- skos__prefLabel mesh__D000756 Anemia, Sideroblastic
% 222.17/222.34  |- mesh__recordOriginator mesh__D000756 NLM
% 222.17/222.34  |- mesh__publicMeSHNote mesh__D000756 67   
% 222.17/222.34  |- skos__hiddenLabel mesh__D000756 Sideroblastic Anemia
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D000756 2002
% 222.17/222.34  |- skos__scopeNote mesh__D000756
% 222.17/222.34       Anemia characterized by the presence of erythroblasts containing excessive deposits of iron in the marrow.%A%    
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D000756 1995
% 222.17/222.34  |- mesh__dateEstablished mesh__D000756 1967-01-01
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D000756 1993
% 222.17/222.34  |- rdf__type mesh__D000756sskos__Concept
% 222.17/222.34  |- skos__scopeNote mesh__D019461
% 222.17/222.34       A 1974 Federal act which preempts states%27% rights with regard to workers%27% pension benefits and employee benefits. It does not affect the benefits and rights of employees whose employer is self-insured. %28%From Slee %26% Slee, Health Care Reform Terms, 1993%29%%A%    
% 222.17/222.34  |- mesh__historyNote mesh__D019461 97   
% 222.17/222.34  |- skos__broader mesh__D019461smesh__D006264
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D019461 2002
% 222.17/222.34  |- skos__altLabel mesh__D019461 ERISA
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D019461 2005
% 222.17/222.34  |- mesh__recordMaintainer mesh__D019461 jls
% 222.17/222.34  |- skos__altLabel mesh__D019461
% 222.17/222.34       United States Employee Retirement Income Security Act
% 222.17/222.34  |- skos__historyNote mesh__D019461 Insurance, Health %28%1975-1990%29%
% 222.17/222.34  |- mesh__dateCreated mesh__D019461 1996-06-13
% 222.17/222.34  |- skos__altLabel mesh__D019461 PL93-406
% 222.17/222.34  |- mesh__dateRevised mesh__D019461 2001-07-25
% 222.17/222.34  |- skos__historyNote mesh__D019461
% 222.17/222.34       Health Benefit Plans, Employee %28%1991-1996%29%
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D019461 2006
% 222.17/222.34  |- rdf__type mesh__D019461sskos__Concept
% 222.17/222.34  |- skos__altLabel mesh__D019461 PL 93-406
% 222.17/222.34  |- skos__prefLabel mesh__D019461 Employee Retirement Income Security Act
% 222.17/222.34  |- skos__hiddenLabel mesh__D019461 Public Law 93 406
% 222.17/222.34  |- mesh__publicMeSHNote mesh__D019461 97   
% 222.17/222.34  |- mesh__dateEstablished mesh__D019461 1997-01-01
% 222.17/222.34  |- skos__altLabel mesh__D019461 Public Law 93-406
% 222.17/222.34  |- mesh__recordAuthorizer mesh__D019461 sjn
% 222.17/222.34  |- skos__broader mesh__D019461smesh__D010415
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D019461 2003
% 222.17/222.34  |- mesh__recordOriginator mesh__D019461 JLS
% 222.17/222.34  |- skos__annotation mesh__D019461 add UNITED STATES %28%NIM%29%   
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D019461 2004
% 222.17/222.34  |- mesh__dateCreated mesh__D005441 1999-01-01
% 222.17/222.34  |- skos__annotation mesh__D005441
% 222.17/222.34       not used for indexing       CATALOG: do not use   
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D005441 2001
% 222.17/222.34  |- mesh__publicMeSHNote mesh__D005441 98   
% 222.17/222.34  |- mesh__dateEstablished mesh__D005441 1998-01-01
% 222.17/222.34  |- mesh__historyNote mesh__D005441 98; use explode   
% 222.17/222.34  |- skos__prefLabel mesh__D005441 Fluids and Secretions
% 222.17/222.34  |- rdf__type mesh__D005441sskos__Concept
% 222.17/222.34  |- skos__historyNote mesh__D005441 specific body fluids %28%1966-1997%29%
% 222.17/222.34  |- mesh__dateRevised mesh__D005441 1997-06-26
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D005441 2000
% 222.17/222.34  |- skos__historyNote mesh__D005441 specific secretion %28%1966-1997%29%
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D005441 2006
% 222.17/222.34  |- skos__scopeNote mesh__D005441
% 222.17/222.34       Liquid substances produced by living organisms to fulfill specific functions or excreted as waste. Secretions do not include hormones or enzymes.%A%    
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D005441 2005
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D005441 2004
% 222.17/222.34  |- skos__hiddenLabel mesh__D005441 Secretions and Fluids
% 222.17/222.34  |- mesh__runningHead mesh__D005441 A12 - ANATOMY-FLUIDS AND SECRETIONS   
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D005441 2002
% 222.17/222.34  |- mesh__recordOriginator mesh__D005441 NLM
% 222.17/222.34  |- mesh__recordAuthorizer mesh__D005441 SJN
% 222.17/222.34  |- skos__historyNote mesh__D005441 Body Fluids %28%1966-1997%29%
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D005441 2003
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D005441 1999
% 222.17/222.34  |- mesh__recordMaintainer mesh__D005441 TGC
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D005441 1998
% 222.17/222.34  |- skos__historyNote mesh__D005441
% 222.17/222.34       specific organ/secretion %28%1966-1997%29%
% 222.17/222.34  |- mesh__dateEstablished mesh__D052097 2006-01-01
% 222.17/222.34  |- rdf__type mesh__D052097sskos__Concept
% 222.17/222.34  |- skos__historyNote mesh__D052097 Muscles %28%1963-1994%29%
% 222.17/222.34  |- skos__historyNote mesh__D052097 Muscle, Skeletal %28%1995-2005%29%
% 222.17/222.34  |- skos__hiddenLabel mesh__D052097 Muscle, Quadriceps
% 222.17/222.34  |- skos__scopeNote mesh__D052097
% 222.17/222.34       The quadriceps femoris. A collective name of the four-headed skeletal muscle of the thigh, comprised of the rectus femoris, vastus intermedius, vastus lateralis, and vastus medialis.%A%    
% 222.17/222.34  |- mesh__historyNote mesh__D052097 2006   
% 222.17/222.34  |- skos__broader mesh__D052097smesh__D018482
% 222.17/222.34  |- mesh__dateCreated mesh__D052097 2005-06-30
% 222.17/222.34  |- skos__hiddenLabel mesh__D052097 Muscles, Quadriceps
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D052097 2006
% 222.17/222.34  |- mesh__publicMeSHNote mesh__D052097 2006   
% 222.17/222.34  |- mesh__recordAuthorizer mesh__D052097 sjn
% 222.17/222.34  |- skos__prefLabel mesh__D052097 Quadriceps Muscle
% 222.17/222.34  |- mesh__recordMaintainer mesh__D052097 ags
% 222.17/222.34  |- skos__hiddenLabel mesh__D052097 Quadriceps Muscles
% 222.17/222.34  |- skos__altLabel mesh__D052097 Quadriceps Femoris
% 222.17/222.34  |- mesh__recordOriginator mesh__D052097 ags
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D010386 2006
% 222.17/222.34  |- skos__hiddenLabel mesh__D010386 Pelvis Neoplasm
% 222.17/222.34  |- skos__hiddenLabel mesh__D010386 Neoplasm, Pelvis
% 222.17/222.34  |- skos__hiddenLabel mesh__D010386 Cancer, Pelvis
% 222.17/222.34  |- mesh__recordMaintainer mesh__D010386 nns
% 222.17/222.34  |- skos__hiddenLabel mesh__D010386 Pelvic Neoplasm
% 222.17/222.34  |- skos__hiddenLabel mesh__D010386 Neoplasms, Pelvis
% 222.17/222.34  |- mesh__recordOriginator mesh__D010386 NLM
% 222.17/222.34  |- mesh__dateCreated mesh__D010386 1999-01-01
% 222.17/222.34  |- skos__altLabel mesh__D010386 Pelvic Cancer
% 222.17/222.34  |- skos__altLabel mesh__D010386 Neoplasms of Pelvis
% 222.17/222.34  |- skos__hiddenLabel mesh__D010386 Cancers, Pelvis
% 222.17/222.34  |- mesh__dateRevised mesh__D010386 1999-11-05
% 222.17/222.34  |- skos__annotation mesh__D010386
% 222.17/222.34       internal pelvic organs %26% region, not bones; if referring to pelvic region as an external site %28%as in skin lesions%29% ignore; GEN: prefer specific precoord; coord IM with histol type of neopl if possible %28%IM%29%%A%  
% 222.17/222.34  |- skos__hiddenLabel mesh__D010386 Cancer, Pelvic
% 222.17/222.34  |- skos__altLabel mesh__D010386 Pelvis Cancer
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D010386 2003
% 222.17/222.34  |- skos__scopeNote mesh__D010386
% 222.17/222.34       Tumors or cancer of the pelvic region.     
% 222.17/222.34  |- skos__prefLabel mesh__D010386 Pelvic Neoplasms
% 222.17/222.34  |- skos__hiddenLabel mesh__D010386 Neoplasm, Pelvic
% 222.17/222.34  |- rdf__type mesh__D010386sskos__Concept
% 222.17/222.34  |- skos__broader mesh__D010386smesh__D009371
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D010386 2000
% 222.17/222.34  |- skos__hiddenLabel mesh__D010386 Neoplasms, Pelvic
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D010386 2004
% 222.17/222.34  |- skos__altLabel mesh__D010386 Pelvis Neoplasms
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D010386 2001
% 222.17/222.34  |- skos__hiddenLabel mesh__D010386 Pelvis Cancers
% 222.17/222.34  |- mesh__recordAuthorizer mesh__D010386 sjn
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D010386 2005
% 222.17/222.34  |- skos__hiddenLabel mesh__D010386 Cancers, Pelvic
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D010386 2002
% 222.17/222.34  |- skos__altLabel mesh__D010386 Cancer of the Pelvis
% 222.17/222.34  |- skos__hiddenLabel mesh__D010386 Pelvic Cancers
% 222.17/222.34  |- skos__scopeNote mesh__D004349
% 222.17/222.34       Containers, packaging, and packaging materials for drugs and biological products. These include those in ampule, capsule, tablet, solution or other forms. Packaging includes immediate-containers, secondary-containers, and cartons. In the United States, such packaging is controlled under the Federal Food, Drug, and Cosmetic Act which also stipulates requirements for tamper-resistance and child-resistance. Similar laws govern use elsewhere. %28%From Code of Federal Regulations, 21 CFR 1 Section 210, 1993%29% DRUG LABELING is also available.%A%    
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D004349 2002
% 222.17/222.34  |- skos__altLabel mesh__D004349 Drug Containers
% 222.17/222.34  |- mesh__onlineNote mesh__D004349
% 222.17/222.34       use DRUG PACKAGING to search DRUG CONTAINERS AND CLOSURES 1968-77%A%  
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D004349 2004
% 222.17/222.34  |- skos__historyNote mesh__D004349 Pharmacy %28%1966-1967%29%
% 222.17/222.34  |- skos__hiddenLabel mesh__D004349 Drug Packagings
% 222.17/222.34  |- skos__hiddenLabel mesh__D004349 Container, Drug
% 222.17/222.34  |- skos__prefLabel mesh__D004349 Drug Packaging
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D004349 2001
% 222.17/222.34  |- mesh__recordMaintainer mesh__D004349 JLS
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D004349 2003
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D004349 2006
% 222.17/222.34  |- skos__annotation mesh__D004349
% 222.17/222.34       includes containers, packaging methods, packaging materials; IM; DRUG LABELING is also available%A%  
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D004349 2000
% 222.17/222.34  |- rdf__type mesh__D004349sskos__Concept
% 222.17/222.34  |- skos__historyNote mesh__D004349 Drug Industry %28%1966-1967%29%
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D004349 1997
% 222.17/222.34  |- skos__broader mesh__D004349smesh__D013678
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D004349 2005
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D004349 1996
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D004349 1999
% 222.17/222.34  |- mesh__dateCreated mesh__D004349 1999-01-01
% 222.17/222.34  |- mesh__dateEstablished mesh__D004349 1968-01-01
% 222.17/222.34  |- mesh__recordAuthorizer mesh__D004349 PLS
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D004349 1998
% 222.17/222.34  |- mesh__dateRevised mesh__D004349 1995-06-05
% 222.17/222.34  |- mesh__recordOriginator mesh__D004349 NLM
% 222.17/222.34  |- skos__hiddenLabel mesh__D004349 Containers, Drug
% 222.17/222.34  |- skos__altLabel mesh__D004349 Packaging, Drug
% 222.17/222.34  |- skos__broader mesh__D004349smesh__D019064
% 222.17/222.34  |- skos__broader mesh__D004349smesh__D004345
% 222.17/222.34  |- mesh__publicMeSHNote mesh__D004349
% 222.17/222.34       78; was DRUG CONTAINERS AND CLOSURES 1968-77   
% 222.17/222.34  |- skos__hiddenLabel mesh__D004349 Packagings, Drug
% 222.17/222.34  |- skos__hiddenLabel mesh__D004349 Drug Container
% 222.17/222.34  |- mesh__historyNote mesh__D004349
% 222.17/222.34       78; was DRUG CONTAINERS AND CLOSURES 1968-77   
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D015071 2000A
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D015071 2006
% 222.17/222.34  |- mesh__dateRevised mesh__D015071 1999-12-16
% 222.17/222.34  |- mesh__recordMaintainer mesh__D015071 ags
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D015071 1993
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D015071 1998
% 222.17/222.34  |- skos__scopeNote mesh__D015071
% 222.17/222.34       19-Iodocholest-5-en-3 beta-ol. A cholesterol derivative usually substituted with radioactive iodine in the 19 position. The compound is an adrenal cortex scanning agent used in the assessment of patients suspected of having Cushing%27%s syndrome, hyperaldosteronism, pheochromocytoma and adrenal remnants following total adrenalectomy.%A%    
% 222.17/222.34  |- mesh__publicMeSHNote mesh__D015071
% 222.17/222.34       91; was see under CHOLESTEROL 1979-90   
% 222.17/222.34  |- skos__historyNote mesh__D015071 Iodine Radioisotopes %28%1966-1978%29%
% 222.17/222.34  |- skos__historyNote mesh__D015071
% 222.17/222.34       Cholesterol %28%1968-1974%29% /AA %28%1975-1978%29%
% 222.17/222.34  |- rdf__type mesh__D015071sskos__Concept
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D015071 1994
% 222.17/222.34  |- skos__broader mesh__D015071smesh__D002784
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D015071 1999
% 222.17/222.34  |- mesh__dateEstablished mesh__D015071 1991-01-01
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D015071 2003
% 222.17/222.34  |- skos__altLabel mesh__D015071 19 Iodocholesterol
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D015071 1995
% 222.17/222.34  |- mesh__recordOriginator mesh__D015071 RLS
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D015071 2000
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D015071 2004
% 222.17/222.34  |- mesh__recordAuthorizer mesh__D015071 ags
% 222.17/222.34  |- skos__hiddenLabel mesh__D015071 Iodocholesterol, 19
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D015071 1996
% 222.17/222.34  |- mesh__activeMeSHYear mesh__D015071 2001
% 222.17/222.35  |- skos__prefLabel mesh__D015071 19-Iodocholesterol
% 222.17/222.35  |- mesh__dateCreated mesh__D015071 1978-05-16
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D015071 2005
% 222.17/222.35  |- mesh__historyNote mesh__D015071
% 222.17/222.35       91%28%79%29%; was see under CHOLESTEROL 1979-90   
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D015071 1997
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D015071 2002
% 222.17/222.35  |- skos__hiddenLabel mesh__D009832 Olfactory Nerves
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009832 2000
% 222.17/222.35  |- skos__hiddenLabel mesh__D009832 Nerves, First Cranial
% 222.17/222.35  |- skos__hiddenLabel mesh__D009832 Is, Cranial Nerve
% 222.17/222.35  |- skos__scopeNote mesh__D009832
% 222.17/222.35       The 1st cranial nerve. The olfactory nerve conveys the sense of smell. It is formed by the axons of OLFACTORY RECEPTOR NEURONS which project from the olfactory epithelium %28%in the nasal epithelium%29% to the OLFACTORY BULB.%A%    
% 222.17/222.35  |- skos__broader mesh__D009832smesh__D003391
% 222.17/222.35  |- skos__hiddenLabel mesh__D009832 Cranial Nerve, First
% 222.17/222.35  |- skos__hiddenLabel mesh__D009832 Cranial Nerves, First
% 222.17/222.35  |- skos__hiddenLabel mesh__D009832 First Cranial Nerves
% 222.17/222.35  |- skos__hiddenLabel mesh__D009832 Cranial Nerve Is
% 222.17/222.35  |- skos__annotation mesh__D009832
% 222.17/222.35       neopl = OLFACTORY NERVE DISEASES %28%IM%29% + CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009832 2002
% 222.17/222.35  |- skos__hiddenLabel mesh__D009832 Nerves, Olfactory
% 222.17/222.35  |- mesh__dateRevised mesh__D009832 1999-11-03
% 222.17/222.35  |- skos__hiddenLabel mesh__D009832 Nerve, First Cranial
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009832 2006
% 222.17/222.35  |- skos__prefLabel mesh__D009832 Olfactory Nerve
% 222.17/222.35  |- skos__hiddenLabel mesh__D009832 Nerve I, Cranial
% 222.17/222.35  |- skos__altLabel mesh__D009832 Cranial Nerve I
% 222.17/222.35  |- skos__altLabel mesh__D009832 First Cranial Nerve
% 222.17/222.35  |- mesh__recordAuthorizer mesh__D009832 sjn
% 222.17/222.35  |- mesh__recordOriginator mesh__D009832 NLM
% 222.17/222.35  |- skos__hiddenLabel mesh__D009832 Nerve, Olfactory
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009832 2005
% 222.17/222.35  |- mesh__recordMaintainer mesh__D009832 ags
% 222.17/222.35  |- skos__hiddenLabel mesh__D009832 Nerve Is, Cranial
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009832 2004
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009832 2001
% 222.17/222.35  |- mesh__dateCreated mesh__D009832 1999-01-01
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009832 2003
% 222.17/222.35  |- rdf__type mesh__D009832sskos__Concept
% 222.17/222.35  |- skos__hiddenLabel mesh__D009832 I, Cranial Nerve
% 222.17/222.35  |- skos__hiddenLabel mesh__D009034 Mother-Child Relation
% 222.17/222.35  |- skos__hiddenLabel mesh__D009034 Relations, Mother-Child
% 222.17/222.35  |- skos__hiddenLabel mesh__D009034 Mother Child Relations
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009034 2002
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009034 2006
% 222.17/222.35  |- skos__historyNote mesh__D009034 Parent-Child Relations %28%1966-1967%29%
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009034 1997
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009034 1998
% 222.17/222.35  |- mesh__dateCreated mesh__D009034 1999-01-01
% 222.17/222.35  |- skos__scopeNote mesh__D009034
% 222.17/222.35       Interaction between the mother and the child.     
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009034 1999
% 222.17/222.35  |- mesh__historyNote mesh__D009034 68   
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009034 2000
% 222.17/222.35  |- mesh__recordMaintainer mesh__D009034 KEV
% 222.17/222.35  |- mesh__recordOriginator mesh__D009034 NLM
% 222.17/222.35  |- skos__hiddenLabel mesh__D009034 Relationship, Mother-Child
% 222.17/222.35  |- skos__hiddenLabel mesh__D009034 Relationships, Mother-Child
% 222.17/222.35  |- mesh__dateEstablished mesh__D009034 1968-01-01
% 222.17/222.35  |- skos__annotation mesh__D009034 human only; DF: MOTHER CHILD RELAT   
% 222.17/222.35  |- mesh__recordAuthorizer mesh__D009034 PLS
% 222.17/222.35  |- skos__hiddenLabel mesh__D009034 Mother Child Relationship
% 222.17/222.35  |- skos__hiddenLabel mesh__D009034 Relation, Mother-Child
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009034 2001
% 222.17/222.35  |- mesh__publicMeSHNote mesh__D009034 68   
% 222.17/222.35  |- skos__broader mesh__D009034smesh__D010287
% 222.17/222.35  |- skos__prefLabel mesh__D009034 Mother-Child Relations
% 222.17/222.35  |- rdf__type mesh__D009034sskos__Concept
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009034 2003
% 222.17/222.35  |- skos__hiddenLabel mesh__D009034 Mother-Child Relationships
% 222.17/222.35  |- skos__altLabel mesh__D009034 Mother-Child Relationship
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009034 2004
% 222.17/222.35  |- mesh__dateRevised mesh__D009034 1995-05-23
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009034 2005
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009034 1996
% 222.17/222.35  |- mesh__recordMaintainer mesh__D001051 SYSTEM
% 222.17/222.35  |- skos__broader mesh__D001051smesh__D001059
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D001051 2006
% 222.17/222.35  |- mesh__onlineNote mesh__D001051 search APOPROTEINS 1974   
% 222.17/222.35  |- rdf__type mesh__D001051sskos__Concept
% 222.17/222.35  |- mesh__dateCreated mesh__D001051 1999-01-01
% 222.17/222.35  |- mesh__historyNote mesh__D001051
% 222.17/222.35       91%28%75%29%; was see under APOPROTEINS 1975-90   
% 222.17/222.35  |- mesh__publicMeSHNote mesh__D001051
% 222.17/222.35       91; was see under APOPROTEINS 1975-90   
% 222.17/222.35  |- mesh__dateRevised mesh__D001051 2005-06-30
% 222.17/222.35  |- skos__prefLabel mesh__D001051 Apoenzymes
% 222.17/222.35  |- mesh__recordOriginator mesh__D001051 NLM
% 222.17/222.35  |- mesh__dateEstablished mesh__D001051 1991-01-01
% 222.17/222.35  |- skos__scopeNote mesh__D001051
% 222.17/222.35       The protein components of the enzyme minus any cofactors or prosthetic groups that might be required for the enzyme to be functional %28%HOLOENZYMES%29%.%A%    
% 222.17/222.35  |- skos__annotation mesh__D001051
% 222.17/222.35       IM GEN only; coord NIM with specific enzyme %28%IM%29%   
% 222.17/222.35  |- mesh__recordAuthorizer mesh__D001051 sjn
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D014777 2003
% 222.17/222.35  |- mesh__recordMaintainer mesh__D014777 kle
% 222.17/222.35  |- skos__prefLabel mesh__D014777 Virus Diseases
% 222.17/222.35  |- skos__hiddenLabel mesh__D014777 Viral Disease
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D014777 2002
% 222.17/222.35  |- rdf__type mesh__D014777sskos__Concept
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D014777 2004
% 222.17/222.35  |- skos__hiddenLabel mesh__D014777 Diseases, Viral
% 222.17/222.35  |- mesh__onlineNote mesh__D014777
% 222.17/222.35       pre-explosion = VIRUS DISEASES %28%PX%29%   
% 222.17/222.35  |- mesh__runningHead mesh__D014777 C2 - DISEASES-VIRAL   
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D014777 2005
% 222.17/222.35  |- mesh__recordOriginator mesh__D014777 NLM
% 222.17/222.35  |- skos__scopeNote mesh__D014777
% 222.17/222.35       A general term for diseases produced by viruses.     
% 222.17/222.35  |- skos__hiddenLabel mesh__D014777 Virus Disease
% 222.17/222.35  |- skos__annotation mesh__D014777
% 222.17/222.35       GEN: prefer specifics; /drug ther: consider also ANTIVIRAL AGENTS%A%  
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D014777 2006
% 222.17/222.35  |- mesh__dateCreated mesh__D014777 1999-01-01
% 222.17/222.35  |- skos__hiddenLabel mesh__D014777 Disease, Virus
% 222.17/222.35  |- skos__related mesh__D014777smesh__D000998
% 222.17/222.35  |- mesh__dateRevised mesh__D014777 1999-11-03
% 222.17/222.35  |- mesh__recordAuthorizer mesh__D014777 sjn
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D014777 2000
% 222.17/222.35  |- skos__altLabel mesh__D014777 Viral Diseases
% 222.17/222.35  |- skos__hiddenLabel mesh__D014777 Diseases, Virus
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D014777 2001
% 222.17/222.35  |- skos__hiddenLabel mesh__D014777 Disease, Viral
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D000757 2006
% 222.17/222.35  |- mesh__dateEstablished mesh__D000757 1966-01-01
% 222.17/222.35  |- mesh__publicMeSHNote mesh__D000757 79; was ANENCEPHALUS 1966-78   
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D000757 2002
% 222.17/222.35  |- skos__altLabel mesh__D000757 Congenital Absence of Brain
% 222.17/222.35  |- skos__altLabel mesh__D000757 Anencephalus
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D000757 2004
% 222.17/222.35  |- mesh__historyNote mesh__D000757
% 222.17/222.35       79; was ANENCEPHALUS 1964-78 %28%Prov 1964-65%29%   
% 222.17/222.35  |- mesh__dateRevised mesh__D000757 2001-07-25
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D000757 2005
% 222.17/222.35  |- skos__altLabel mesh__D000757 Hemicranial Anencephaly
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D000757 2003
% 222.17/222.35  |- skos__prefLabel mesh__D000757 Anencephaly
% 222.17/222.35  |- mesh__recordAuthorizer mesh__D000757 sjn
% 222.17/222.35  |- mesh__onlineNote mesh__D000757
% 222.17/222.35       use ANENCEPHALY to search ANENCEPHALUS 1966-78   
% 222.17/222.35  |- skos__hiddenLabel mesh__D000757 Anencephaly, Hemicranial
% 222.17/222.35  |- skos__altLabel mesh__D000757 Absence of Brain, Congenital
% 222.17/222.35  |- skos__hiddenLabel mesh__D000757 Anencephaly, Incomplete
% 222.17/222.35  |- skos__altLabel mesh__D000757 Partial Anencephaly
% 222.17/222.35  |- skos__altLabel mesh__D000757 Anencephalia
% 222.17/222.35  |- skos__hiddenLabel mesh__D000757 Brain Congenital Absence
% 222.17/222.35  |- skos__broader mesh__D000757smesh__D009008
% 222.17/222.35  |- skos__hiddenLabel mesh__D000757 Anencephalias
% 222.17/222.35  |- skos__hiddenLabel mesh__D000757 Aprosencephalies
% 222.17/222.35  |- skos__related mesh__D000757smesh__D000509
% 222.17/222.35  |- rdf__type mesh__D000757sskos__Concept
% 222.17/222.35  |- mesh__recordMaintainer mesh__D000757 ags
% 222.17/222.35  |- mesh__recordOriginator mesh__D000757 NLM
% 222.17/222.35  |- skos__broader mesh__D000757smesh__D009436
% 222.17/222.35  |- skos__hiddenLabel mesh__D000757 Partial Anencephalies
% 222.17/222.35  |- mesh__dateCreated mesh__D000757 1999-01-01
% 222.17/222.35  |- skos__hiddenLabel mesh__D000757 Anencephaly, Partial
% 222.17/222.35  |- skos__scopeNote mesh__D000757
% 222.17/222.35       A malformation of the nervous system caused by failure of the anterior neuropore to close. Infants are born with intact spinal cords, cerebellums, and brainstems, but lack formation of neural structures above this level. The skull is only partially formed but the eyes are usually normal. This condition may be associated with folate deficiency. Affected infants are only capable of primitive %28%brain stem%29% reflexes and usually do not survive for more than two weeks. %28%From Menkes, Textbook of Child Neurology, 5th ed, p247%29%%A%    
% 222.17/222.35  |- skos__hiddenLabel mesh__D000757 Anencephalies, Partial
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Syncopes, Supine
% 222.17/222.35  |- rdf__type mesh__D019462sskos__Concept
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Vasovagal Syncopes
% 222.17/222.35  |- skos__altLabel mesh__D019462 Syncope, Vasodepressor
% 222.17/222.35  |- skos__altLabel mesh__D019462 Syncope, Vasovagal, Neurally-Mediated
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Neurocardiogenic Syncopes, Malignant
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Supine Syncopes
% 222.17/222.35  |- mesh__publicMeSHNote mesh__D019462 1997   
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Syncopes, Neurogenic
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Vasovagal Syncope
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D019462 2000
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D019462 2005
% 222.17/222.35  |- skos__altLabel mesh__D019462 Syncope, Neurocardiogenic
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Syncopes, Cerebral
% 222.17/222.35  |- mesh__dateRevised mesh__D019462 1999-11-03
% 222.17/222.35  |- skos__historyNote mesh__D019462 Syncope %28%1968-1996%29%
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Neurocardiogenic Syncope, Malignant
% 222.17/222.35  |- mesh__dateCreated mesh__D019462 1996-06-10
% 222.17/222.35  |- skos__prefLabel mesh__D019462 Syncope, Vasovagal
% 222.17/222.35  |- mesh__recordOriginator mesh__D019462 TGC
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D019462 2004
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Faints, Neurally Mediated
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Neurogenic Syncope
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Neurogenic Syncopes
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Malignant Neurocardiogenic Syncope
% 222.17/222.35  |- mesh__recordAuthorizer mesh__D019462 sjn
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Vasodepressor Syncopes
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Faint, Neurally Mediated
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Syncopes, Vasovagal
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D019462 2003
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Neurocardiogenic Syncope
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Malignant Neurocardiogenic Syncopes
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Neurocardiogenic Syncopes
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Syncopes, Malignant Neurocardiogenic
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Syncopes, Vasodepressor
% 222.17/222.35  |- skos__broader mesh__D019462smesh__D013575
% 222.17/222.35  |- mesh__recordMaintainer mesh__D019462 KEV
% 222.17/222.35  |- mesh__historyNote mesh__D019462 1997   
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Neurally Mediated Faints
% 222.17/222.35  |- mesh__dateEstablished mesh__D019462 1997-01-01
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Cerebral Syncope
% 222.17/222.35  |- skos__scopeNote mesh__D019462
% 222.17/222.35       Loss of consciousness due to a reduction in blood pressure that is associated with an increase in vagal tone and peripheral vasodilation.%A%    
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D019462 2002
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Syncopes, Neurocardiogenic
% 222.17/222.35  |- skos__altLabel mesh__D019462 Syncope, Neurogenic
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Vasodepressor Syncope
% 222.17/222.35  |- skos__altLabel mesh__D019462 Neurally Mediated Faint
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Cerebral Syncopes
% 222.17/222.35  |- skos__hiddenLabel mesh__D019462 Supine Syncope
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D019462 2006
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D019462 2001
% 222.17/222.35  |- skos__prefLabel mesh__D005442 Flumazenil
% 222.17/222.35  |- rdf__type mesh__D005442sskos__Concept
% 222.17/222.35  |- skos__hiddenLabel mesh__D005442 Hoffman La Roche Brand of Flumazenil
% 222.17/222.35  |- skos__hiddenLabel mesh__D005442 Ro 151788
% 222.17/222.35  |- mesh__recordOriginator mesh__D005442 RLS
% 222.17/222.35  |- mesh__publicMeSHNote mesh__D005442 91; was FLUMAZEPIL 1987-90   
% 222.17/222.35  |- skos__altLabel mesh__D005442 Hoffman-La Roche Brand of Flumazenil
% 222.17/222.35  |- mesh__dateEstablished mesh__D005442 1987-01-01
% 222.17/222.35  |- mesh__historyNote mesh__D005442 91; was FLUMAZEPIL 1987-90   
% 222.17/222.35  |- skos__historyNote mesh__D005442 Azepines %28%1966-1973%29%
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D005442 2006
% 222.17/222.35  |- skos__altLabel mesh__D005442 Lanexat
% 222.17/222.35  |- skos__altLabel mesh__D005442 Anexate
% 222.17/222.35  |- skos__broader mesh__D005442smesh__D001570
% 222.17/222.35  |- mesh__recordAuthorizer mesh__D005442 sjn
% 222.17/222.35  |- mesh__dateRevised mesh__D005442 2005-06-30
% 222.17/222.35  |- mesh__onlineNote mesh__D005442
% 222.17/222.35       use FLUMAZENIL to search FLUMAZEPIL 1987-90   
% 222.17/222.35  |- skos__altLabel mesh__D005442 Roche Brand of Flumazenil
% 222.17/222.35  |- skos__historyNote mesh__D005442 Benzodiazepinones %28%1974-1986%29%
% 222.17/222.35  |- mesh__recordMaintainer mesh__D005442 ssb
% 222.17/222.35  |- skos__hiddenLabel mesh__D005442 Ro 15 1788
% 222.17/222.35  |- skos__altLabel mesh__D005442 Flumazepil
% 222.17/222.35  |- skos__scopeNote mesh__D005442
% 222.17/222.35       A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.%A%    
% 222.17/222.35  |- mesh__dateCreated mesh__D005442 1986-04-09
% 222.17/222.35  |- mesh__recordAuthorizer mesh__D010387 sjn
% 222.17/222.35  |- mesh__dateCreated mesh__D010387 1999-01-01
% 222.17/222.35  |- mesh__dateRevised mesh__D010387 2004-07-07
% 222.17/222.35  |- skos__broader mesh__D010387smesh__D000886
% 222.17/222.35  |- skos__hiddenLabel mesh__D010387 Cephalopelvic Proportions
% 222.17/222.35  |- skos__hiddenLabel mesh__D010387 Cephalopelvimetries
% 222.17/222.35  |- mesh__recordMaintainer mesh__D010387 nns
% 222.17/222.35  |- rdf__type mesh__D010387sskos__Concept
% 222.17/222.35  |- skos__annotation mesh__D010387 NIM   
% 222.17/222.35  |- skos__hiddenLabel mesh__D010387 Proportion, Cephalopelvic
% 222.17/222.35  |- mesh__recordOriginator mesh__D010387 NLM
% 222.17/222.35  |- skos__hiddenLabel mesh__D010387 Proportions, Cephalopelvic
% 222.17/222.35  |- skos__prefLabel mesh__D010387 Pelvimetry
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D010387 2005
% 222.17/222.35  |- skos__hiddenLabel mesh__D010387 Pelvimetries
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D010387 2006
% 222.17/222.35  |- skos__related mesh__D010387smesh__D010388
% 222.17/222.35  |- skos__broader mesh__D010387smesh__D003944
% 222.17/222.35  |- skos__scopeNote mesh__D010387
% 222.17/222.35       Measurement of the dimensions and capacity of the pelvis. It includes cephalopelvimetry %28%measurement of fetal head size in relation to maternal pelvic capacity%29%, a prognostic guide to the management of LABOR, OBSTETRIC associated with disproportion.%A%    
% 222.17/222.35  |- skos__historyNote mesh__D015870 Phenotype %28%1969-1989%29%
% 222.17/222.35  |- skos__hiddenLabel mesh__D015870 Gene Expressions
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D015870 2005
% 222.17/222.35  |- skos__hiddenLabel mesh__D015870 Expressions, Gene
% 222.17/222.35  |- skos__prefLabel mesh__D015870 Gene Expression
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D015870 2004
% 222.17/222.35  |- skos__related mesh__D015870smesh__D010641
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D015870 2006
% 222.17/222.35  |- mesh__recordMaintainer mesh__D015870 nns
% 222.17/222.35  |- skos__historyNote mesh__D015870 Genes %28%1966-1980%29%
% 222.17/222.35  |- mesh__onlineNote mesh__D015870
% 222.17/222.35       use GENE EXPRESSION to search MYELOID ANTIGEN EXPRESSION 1994%A%  
% 222.17/222.35  |- skos__hiddenLabel mesh__D015870 Expression, Gene
% 222.17/222.35  |- mesh__publicMeSHNote mesh__D015870
% 222.17/222.35       90; MYELOID ANTIGEN EXPRESSION was heading 1994   
% 222.17/222.35  |- skos__related mesh__D015870smesh__D020869
% 222.17/222.35  |- mesh__dateCreated mesh__D015870 1989-10-16
% 222.17/222.35  |- mesh__historyNote mesh__D015870
% 222.17/222.35       90; MYELOID ANTIGEN EXPRESSION was heading 1994   
% 222.17/222.35  |- mesh__recordAuthorizer mesh__D015870 sjn
% 222.17/222.35  |- mesh__dateRevised mesh__D015870 2003-07-09
% 222.17/222.35  |- mesh__recordOriginator mesh__D015870 PXP
% 222.17/222.35  |- skos__scopeNote mesh__D015870
% 222.17/222.35       The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION.%A%    
% 222.17/222.35  |- skos__broader mesh__D015870smesh__D039361
% 222.17/222.35  |- skos__historyNote mesh__D015870
% 222.17/222.35       Gene Expression Regulation %28%1981-1989%29%
% 222.17/222.35  |- mesh__dateEstablished mesh__D015870 1990-01-01
% 222.17/222.35  |- rdf__type mesh__D015870sskos__Concept
% 222.17/222.35  |- mesh__dateRevised mesh__D015072 2003-07-09
% 222.17/222.35  |- skos__broader mesh__D015072smesh__D019751
% 222.17/222.35  |- rdf__type mesh__D015072sskos__Concept
% 222.17/222.35  |- mesh__recordOriginator mesh__D015072 NLM
% 222.17/222.35  |- skos__hiddenLabel mesh__D015072 Mutase, 2-Acetolactate
% 222.17/222.35  |- mesh__dateEstablished mesh__D015072 1991-01-01
% 222.17/222.35  |- skos__hiddenLabel mesh__D015072 Acid Reductoisomerase, Acetohydroxy
% 222.17/222.35  |- skos__historyNote mesh__D015072 Hydroxybutyrates %28%1973-1974%29%
% 222.17/222.35  |- skos__prefLabel mesh__D015072 2-Acetolactate Mutase
% 222.17/222.35  |- skos__scopeNote mesh__D015072
% 222.17/222.35       An enzyme involved in the biosynthesis of isoleucine and valine. It converts 2-acetolactate into 3-hydroxy-2-oxo-isovalerate. Also acts on 2-hydroxy-2-acetobutyrate to form 2-hydroxy-2-oxo-3-methylvalerate. EC 5.4.99.3.%A%    
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D015072 2004
% 222.17/222.35  |- mesh__historyNote mesh__D015072
% 222.17/222.35       91%28%75%29%; was see under ISOMERASES 1975-90   
% 222.17/222.35  |- skos__hiddenLabel mesh__D015072 Reductoisomerase, Acetohydroxy Acid
% 222.17/222.35  |- skos__hiddenLabel mesh__D015072 2 Acetolactate Mutase
% 222.17/222.35  |- skos__historyNote mesh__D015072 Lactates %28%1973-1974%29%
% 222.17/222.35  |- mesh__dateCreated mesh__D015072 1974-11-19
% 222.17/222.35  |- skos__hiddenLabel mesh__D015072
% 222.17/222.35       2 Acetohydroxy 3 Ketoacid Isomeroreductase
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D015072 2005
% 222.17/222.35  |- skos__historyNote mesh__D015072 Isomerases %28%1973-1974%29%
% 222.17/222.35  |- skos__altLabel mesh__D015072 Acetohydroxy Acid Reductoisomerase
% 222.17/222.35  |- mesh__recordAuthorizer mesh__D015072 sjn
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D015072 2006
% 222.17/222.35  |- mesh__publicMeSHNote mesh__D015072
% 222.17/222.35       91; was see under ISOMERASES 1975-90   
% 222.17/222.35  |- skos__altLabel mesh__D015072 2-Acetohydroxy-3-Ketoacid Isomeroreductase
% 222.17/222.35  |- skos__hiddenLabel mesh__D015072
% 222.17/222.35       Isomeroreductase, 2-Acetohydroxy-3-Ketoacid
% 222.17/222.35  |- mesh__recordMaintainer mesh__D015072 ssb
% 222.17/222.35  |- skos__hiddenLabel mesh__D009833 Cortex, Olfactory
% 222.17/222.35  |- mesh__publicMeSHNote mesh__D009833
% 222.17/222.35       1991; see CENTRAL NERVOUS SYSTEM 1972-90; for RHINENCEPHALON see LIMBIC SYSTEM 1963-1999%A%  
% 222.17/222.35  |- skos__hiddenLabel mesh__D009833 Substances, Anterior Perforated
% 222.17/222.35  |- skos__hiddenLabel mesh__D009833 Perforated Substances, Anterior
% 222.17/222.35  |- skos__hiddenLabel mesh__D009833 Perforated Substance, Anterior
% 222.17/222.35  |- skos__hiddenLabel mesh__D009833 Pathway, Olfactory
% 222.17/222.35  |- skos__hiddenLabel mesh__D009833 Tract, Olfactory
% 222.17/222.35  |- skos__hiddenLabel mesh__D009833 Tubercle, Olfactory
% 222.17/222.35  |- skos__hiddenLabel mesh__D009833 Rhinencephalons
% 222.17/222.35  |- skos__broader mesh__D009833smesh__D008032
% 222.17/222.35  |- skos__hiddenLabel mesh__D009833 Tracts, Olfactory
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009833 2006
% 222.17/222.35  |- skos__hiddenLabel mesh__D009833 Anterior Perforated Substances
% 222.17/222.35  |- skos__broader mesh__D009833smesh__D000344
% 222.17/222.35  |- skos__hiddenLabel mesh__D009833 Olfactory Tubercles
% 222.17/222.35  |- skos__hiddenLabel mesh__D009833 Olfactory Pathway
% 222.17/222.35  |- mesh__dateEstablished mesh__D009833 1991-01-01
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009833 2005
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009833 2004
% 222.17/222.35  |- skos__historyNote mesh__D009833 Central Nervous System %28%1966-1971%29%
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009833 2002
% 222.17/222.35  |- mesh__dateCreated mesh__D009833 1999-01-01
% 222.17/222.35  |- skos__hiddenLabel mesh__D009833 Substance, Anterior Perforated
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009833 2003
% 222.17/222.35  |- skos__historyNote mesh__D009833 Smell %28%1966-1971%29%
% 222.17/222.35  |- skos__scopeNote mesh__D009833
% 222.17/222.35       Set of nerve fibers conducting impulses from olfactory receptors to the cerebral cortex. It includes the OLFACTORY NERVE; OLFACTORY BULB; olfactory tract, olfactory tubercle, anterior perforated substance, and olfactory cortex. The term rhinencephalon is restricted to structures in the CNS receiving fibers from the olfactory bulb.%A%    
% 222.17/222.35  |- rdf__type mesh__D009833sskos__Concept
% 222.17/222.35  |- mesh__dateRevised mesh__D009833 2001-07-25
% 222.17/222.35  |- skos__hiddenLabel mesh__D009833 Olfactory Tracts
% 222.17/222.35  |- skos__hiddenLabel mesh__D009833 Tubercles, Olfactory
% 222.17/222.35  |- mesh__recordMaintainer mesh__D009833 mdb
% 222.17/222.35  |- skos__prefLabel mesh__D009833 Olfactory Pathways
% 222.17/222.35  |- skos__broader mesh__D009833smesh__D013687
% 222.17/222.35  |- mesh__recordAuthorizer mesh__D009833 sjn
% 222.17/222.35  |- mesh__recordOriginator mesh__D009833 NLM
% 222.17/222.35  |- mesh__historyNote mesh__D009833
% 222.17/222.35       1991%28%1972%29%; for RHINENCEPHALON use LIMBIC SYSTEM 1963-1999%A%  
% 222.17/222.35  |- skos__historyNote mesh__D009833 specific brain site %28%1966-1971%29%
% 222.17/222.35  |- skos__hiddenLabel mesh__D009833 Pathways, Olfactory
% 222.17/222.35  |- skos__historyNote mesh__D001850 Orthopedics %28%1966-1997%29%
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D001850 2006
% 222.17/222.35  |- rdf__type mesh__D001850sskos__Concept
% 222.17/222.35  |- skos__historyNote mesh__D001850 Infection %28%1966-1997%29%
% 222.17/222.35  |- skos__hiddenLabel mesh__D001850 Infectious Bone Diseases
% 222.17/222.35  |- mesh__recordMaintainer mesh__D001850 TGC
% 222.17/222.35  |- skos__scopeNote mesh__D001850
% 222.17/222.35       Bone diseases caused by pathogenic microorganisms.     
% 222.17/222.35  |- mesh__publicMeSHNote mesh__D001850 98   
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D001850 2003
% 222.17/222.35  |- skos__hiddenLabel mesh__D001850 Infectious Bone Disease
% 222.17/222.35  |- skos__broader mesh__D001850smesh__D007239
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D001850 2004
% 222.17/222.35  |- skos__hiddenLabel mesh__D001850 Disease, Infectious Bone
% 222.17/222.35  |- skos__hiddenLabel mesh__D001850 Bone Disease, Infectious
% 222.17/222.35  |- skos__annotation mesh__D001850
% 222.17/222.35       GEN or unspecified; prefer specifics; coord IM with specific infection %28%IM%29%; DF: BONE DIS INFECT%A%  
% 222.17/222.35  |- skos__historyNote mesh__D001850 Bone Diseases %28%1966-1997%29%
% 222.17/222.35  |- skos__hiddenLabel mesh__D001850 Diseases, Infectious Bone
% 222.17/222.35  |- mesh__dateEstablished mesh__D001850 1998-01-01
% 222.17/222.35  |- mesh__historyNote mesh__D001850 98; use explode 1971-97   
% 222.17/222.35  |- mesh__recordOriginator mesh__D001850 NLM
% 222.17/222.35  |- skos__prefLabel mesh__D001850 Bone Diseases, Infectious
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D001850 2005
% 222.17/222.35  |- mesh__dateCreated mesh__D001850 1999-01-01
% 222.17/222.35  |- skos__broader mesh__D001850smesh__D001847
% 222.17/222.35  |- mesh__dateRevised mesh__D001850 2002-07-02
% 222.17/222.35  |- mesh__recordAuthorizer mesh__D001850 sjn
% 222.17/222.35  |- skos__hiddenLabel mesh__D009035 Mothers%27% Club
% 222.17/222.35  |- skos__hiddenLabel mesh__D009035 Clubs, Mothers%27%
% 222.17/222.35  |- mesh__dateEstablished mesh__D009035 1978-01-01
% 222.17/222.35  |- skos__broader mesh__D009035smesh__D010290
% 222.17/222.35  |- skos__annotation mesh__D009035
% 222.17/222.35       human %26% animal; /psychol: consider also MOTHER-CHILD RELATIONS; permitted for legal aspects of establishing maternity %28%as counterpart of PATERNITY%29%; note category: do not confuse with PREGNANCY, a physiol state%A%  
% 222.17/222.35  |- mesh__dateRevised mesh__D009035 2004-07-13
% 222.17/222.35  |- mesh__publicMeSHNote mesh__D009035 78   
% 222.17/222.35  |- skos__historyNote mesh__D009035 Maternal Behavior %28%1968-1977%29%
% 222.17/222.35  |- mesh__historyNote mesh__D009035 78   
% 222.17/222.35  |- rdf__type mesh__D009035sskos__Concept
% 222.17/222.35  |- skos__historyNote mesh__D009035 Mother-Child Relations %28%1968-1977%29%
% 222.17/222.35  |- skos__historyNote mesh__D009035 Female %28%1966-1977%29%
% 222.17/222.35  |- mesh__recordMaintainer mesh__D009035 sjn
% 222.17/222.35  |- skos__hiddenLabel mesh__D009035 Club, Mothers%27%
% 222.17/222.35  |- skos__hiddenLabel mesh__D009035 Mother%27%s Clubs
% 222.17/222.35  |- mesh__dateCreated mesh__D009035 1977-04-22
% 222.17/222.35  |- skos__scopeNote mesh__D009035 Female parents, human or animal.     
% 222.17/222.35  |- mesh__recordAuthorizer mesh__D009035 sjn
% 222.17/222.35  |- mesh__recordOriginator mesh__D009035 EC
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009035 2005
% 222.17/222.35  |- skos__hiddenLabel mesh__D009035 Mother
% 222.17/222.35  |- skos__related mesh__D009035smesh__D008425
% 222.17/222.35  |- skos__prefLabel mesh__D009035 Mothers
% 222.17/222.35  |- skos__hiddenLabel mesh__D009035 Mother Clubs
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D009035 2006
% 222.17/222.35  |- skos__hiddenLabel mesh__D009035 Mothers Clubs
% 222.17/222.35  |- skos__broader mesh__D001052smesh__D005293
% 222.17/222.35  |- mesh__recordOriginator mesh__D001052 NLM
% 222.17/222.35  |- mesh__onlineNote mesh__D001052 search FERRITIN 1966-74   
% 222.17/222.35  |- mesh__recordMaintainer mesh__D001052 TAP
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D001052 2005
% 222.17/222.35  |- mesh__recordAuthorizer mesh__D001052 sjn
% 222.17/222.35  |- skos__prefLabel mesh__D001052 Apoferritin
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D001052 2003
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D001052 2006
% 222.17/222.35  |- mesh__dateEstablished mesh__D001052 1991-01-01
% 222.17/222.35  |- mesh__historyNote mesh__D001052
% 222.17/222.35       91%28%75%29%; was see under FERRITIN 1975-90   
% 222.17/222.35  |- mesh__dateRevised mesh__D001052 2002-07-02
% 222.17/222.35  |- mesh__activeMeSHYear mesh__D001052 2004
% 222.17/222.35  |- rdf__type mesh__D001052sskos__Concept
% 222.17/222.35  |- mesh__dateCreated mesh__D001052 1999-01-01
% 222.17/222.36  |- mesh__publicMeSHNote mesh__D001052 91; was see under FERRITIN 1975-90   
% 222.17/222.36  |- skos__hiddenLabel mesh__D019463 lpr Mice, MRL
% 222.17/222.36  |- mesh__recordOriginator mesh__D019463 ADP
% 222.17/222.36  |- skos__hiddenLabel mesh__D019463 lpr Mouse, MRL
% 222.17/222.36  |- mesh__dateEstablished mesh__D019463 1997-01-01
% 222.17/222.36  |- skos__prefLabel mesh__D019463 Mice, Inbred MRL lpr
% 222.17/222.36  |- skos__hiddenLabel mesh__D019463 MRL lpr Mouse
% 222.17/222.36  |- skos__hiddenLabel mesh__D019463 MRL lpr Mice
% 222.17/222.36  |- skos__altLabel mesh__D019463 Mouse, Inbred MRL lpr
% 222.17/222.36  |- mesh__publicMeSHNote mesh__D019463 97   
% 222.17/222.36  |- skos__altLabel mesh__D019463 Mouse, MRL lpr
% 222.17/222.36  |- mesh__recordAuthorizer mesh__D019463 sjn
% 222.17/222.36  |- mesh__recordMaintainer mesh__D019463 ags
% 222.17/222.36  |- mesh__dateRevised mesh__D019463 2005-06-30
% 222.17/222.36  |- mesh__historyNote mesh__D019463 97   
% 222.17/222.36  |- skos__annotation mesh__D019463
% 222.17/222.36       a strain predisposed to develop of systemic lupus erythematosus; MRL stands for %22%Murphy-Roths Lymphoma%22%, lpr stands for %22%LymphoPRoliferative%22%; NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check MICE; in titles %26% translations use lpr %28%the letter l%29%, not 1pr %28%the figure one%29%%A%  
% 222.17/222.36  |- skos__altLabel mesh__D019463 Mice, MRL lpr
% 222.17/222.36  |- skos__broader mesh__D019463smesh__D008815
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D019463 2006
% 222.17/222.36  |- skos__scopeNote mesh__D019463
% 222.17/222.36       A mouse substrain that is genetically predisposed to the development of systemic lupus erythematosus-like syndrome, which has been found to be clinically similar to the human disease. It has been determined that this mouse strain carries a mutation in the fas gene. Also, the MRL/lpr is a useful model to study behavioral and cognitive deficits found in autoimmune diseases and the efficacy of immunosuppressive agents.%A%    
% 222.17/222.36  |- mesh__dateCreated mesh__D019463 1996-06-19
% 222.17/222.36  |- rdf__type mesh__D019463sskos__Concept
% 222.17/222.36  |- skos__historyNote mesh__D019463 Mice %28%1981-1996%29%
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D000758 2006
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D000758 2002
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D000758 2004
% 222.17/222.36  |- skos__broader mesh__D000758smesh__D000760
% 222.17/222.36  |- skos__scopeNote mesh__D000758
% 222.17/222.36       A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures.%A%    
% 222.17/222.36  |- skos__prefLabel mesh__D000758 Anesthesia
% 222.17/222.36  |- mesh__recordOriginator mesh__D000758 NLM
% 222.17/222.36  |- skos__annotation mesh__D000758 Manual 26.21+   
% 222.17/222.36  |- mesh__recordMaintainer mesh__D000758 kle
% 222.17/222.36  |- mesh__dateCreated mesh__D000758 1999-01-01
% 222.17/222.36  |- mesh__onlineNote mesh__D000758 pre-explosion = ANESTHESIA %28%PX%29%   
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D000758 2000
% 222.17/222.36  |- mesh__recordAuthorizer mesh__D000758 sjn
% 222.17/222.36  |- rdf__type mesh__D000758sskos__Concept
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D000758 2005
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D000758 2001
% 222.17/222.36  |- mesh__dateRevised mesh__D000758 1999-11-03
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D000758 2003
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D011480 2004
% 222.17/222.36  |- skos__altLabel mesh__D011480 Peptide Hydrolase Inhibitors
% 222.17/222.36  |- skos__hiddenLabel mesh__D011480 Inhibitors, Protease
% 222.17/222.36  |- skos__altLabel mesh__D011480 Peptide Peptidohydrolase Inhibitors
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D011480 2006
% 222.17/222.36  |- skos__altLabel mesh__D011480 Endopeptidase Inhibitors
% 222.17/222.36  |- mesh__recordMaintainer mesh__D011480 ssb
% 222.17/222.36  |- skos__broader mesh__D011480smesh__D004791
% 222.17/222.36  |- skos__hiddenLabel mesh__D011480 Inhibitors, Endopeptidase
% 222.17/222.36  |- skos__hiddenLabel mesh__D011480 Hydrolase Inhibitors, Peptide
% 222.17/222.36  |- skos__historyNote mesh__D011480
% 222.17/222.36       Peptide Peptidohydrolases/antagonists %26% inhibitors %28%1968-1978%29%
% 222.17/222.36  |- skos__hiddenLabel mesh__D011480 Antagonists, Protease
% 222.17/222.36  |- skos__hiddenLabel mesh__D011480 Inhibitors, Proteinase
% 222.17/222.36  |- skos__altLabel mesh__D011480 Proteinase Inhibitors
% 222.17/222.36  |- mesh__publicMeSHNote mesh__D011480 79   
% 222.17/222.36  |- skos__scopeNote mesh__D011480
% 222.17/222.36       Compounds which inhibit or antagonize biosynthesis or actions of proteases %28%ENDOPEPTIDASES%29%.%A%    
% 222.17/222.36  |- skos__altLabel mesh__D011480 Peptidase Inhibitors
% 222.17/222.36  |- skos__hiddenLabel mesh__D011480 Inhibitor, Protease
% 222.17/222.36  |- mesh__recordAuthorizer mesh__D011480 sjn
% 222.17/222.36  |- skos__prefLabel mesh__D011480 Protease Inhibitors
% 222.17/222.36  |- skos__altLabel mesh__D011480 Protease Antagonists
% 222.17/222.36  |- skos__altLabel mesh__D011480 Antiproteases
% 222.17/222.36  |- skos__hiddenLabel mesh__D011480 Inhibitors, Peptide Peptidohydrolase
% 222.17/222.36  |- mesh__recordOriginator mesh__D011480 RLS
% 222.17/222.36  |- skos__hiddenLabel mesh__D011480 Inhibitors, Peptidase
% 222.17/222.36  |- rdf__type mesh__D011480sskos__Concept
% 222.17/222.36  |- skos__hiddenLabel mesh__D011480 Peptidohydrolase Inhibitors, Peptide
% 222.17/222.36  |- skos__altLabel mesh__D011480 Protease Inhibitor
% 222.17/222.36  |- skos__hiddenLabel mesh__D011480 Inhibitors, Peptide Hydrolase
% 222.17/222.36  |- mesh__dateEstablished mesh__D011480 1979-01-01
% 222.17/222.36  |- mesh__dateRevised mesh__D011480 2003-07-09
% 222.17/222.36  |- skos__annotation mesh__D011480 DF: PROTEASE INHIB   
% 222.17/222.36  |- mesh__dateCreated mesh__D011480 1978-05-19
% 222.17/222.36  |- mesh__historyNote mesh__D011480 79   
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D011480 2005
% 222.17/222.36  |- skos__historyNote mesh__D011480
% 222.17/222.36       Peptide Hydrolases/antagonists %26% inhibitors %28%1968-1978%29%
% 222.17/222.36  |- mesh__recordMaintainer mesh__D005443 ssb
% 222.17/222.36  |- mesh__historyNote mesh__D005443 72%28%66%29%   
% 222.17/222.36  |- skos__scopeNote mesh__D005443
% 222.17/222.36       An anti-inflammatory glucocorticoid used in veterinary practice.%A%    
% 222.17/222.36  |- mesh__publicMeSHNote mesh__D005443 72   
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D005443 2006
% 222.17/222.36  |- mesh__recordOriginator mesh__D005443 NLM
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D005443 2004
% 222.17/222.36  |- mesh__dateCreated mesh__D005443 1999-01-01
% 222.17/222.36  |- mesh__dateRevised mesh__D005443 2003-07-09
% 222.17/222.36  |- skos__altLabel mesh__D005443 Fluorodexamethasone
% 222.17/222.36  |- skos__broader mesh__D005443smesh__D011246
% 222.17/222.36  |- skos__prefLabel mesh__D005443 Flumethasone
% 222.17/222.36  |- mesh__recordAuthorizer mesh__D005443 sjn
% 222.17/222.36  |- rdf__type mesh__D005443sskos__Concept
% 222.17/222.36  |- mesh__dateEstablished mesh__D005443 1972-01-01
% 222.17/222.36  |- skos__broader mesh__D005443smesh__D013259
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D005443 2005
% 222.17/222.36  |- rdf__type mesh__D043562sskos__Concept
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D043562 2004
% 222.17/222.36  |- skos__annotation mesh__D043562 GEN or unspecified; prefer specifics   
% 222.17/222.36  |- skos__prefLabel mesh__D043562 Receptors, G-Protein-Coupled
% 222.17/222.36  |- skos__hiddenLabel mesh__D043562 G Protein Coupled Receptors
% 222.17/222.36  |- mesh__dateCreated mesh__D043562 2003-07-09
% 222.17/222.36  |- mesh__publicMeSHNote mesh__D043562 2004   
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D043562 2005
% 222.17/222.36  |- mesh__dateEstablished mesh__D043562 2004-01-01
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D043562 2006
% 222.17/222.36  |- skos__hiddenLabel mesh__D043562 Receptors, G Protein Coupled
% 222.17/222.36  |- skos__broader mesh__D043562smesh__D011956
% 222.17/222.36  |- mesh__historyNote mesh__D043562 2004   
% 222.17/222.36  |- skos__scopeNote mesh__D043562
% 222.17/222.36       The largest family of cell surface receptors involved in SIGNAL TRANSDUCTION. They share a common structure and signal through HETEROTRIMERIC G-PROTEINS.%A%    
% 222.17/222.36  |- skos__historyNote mesh__D043562
% 222.17/222.36       Receptors, Cell Surface %28%1968-2003%29%
% 222.17/222.36  |- skos__altLabel mesh__D043562 G-Protein-Coupled Receptors
% 222.17/222.36  |- skos__hiddenLabel mesh__D010388 Region, Pelvic
% 222.17/222.36  |- skos__related mesh__D010388smesh__D010387
% 222.17/222.36  |- skos__related mesh__D010388smesh__D000292
% 222.17/222.36  |- skos__prefLabel mesh__D010388 Pelvis
% 222.17/222.36  |- skos__related mesh__D010388smesh__D034161
% 222.17/222.36  |- rdf__type mesh__D010388sskos__Concept
% 222.17/222.36  |- mesh__recordOriginator mesh__D010388 NLM
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D010388 2003
% 222.17/222.36  |- skos__related mesh__D010388smesh__D010385
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D010388 2004
% 222.17/222.36  |- skos__annotation mesh__D010388
% 222.17/222.36       internal pelvic region, not PELVIC BONES; /surg: consider also PELVIC EXENTERATION; pelvic disease is prob PELVIC INFLAMMATORY DISEASE%A%  
% 222.17/222.36  |- skos__scopeNote mesh__D010388
% 222.17/222.36       The basin-like area outlined by the hip bones and the vertebral column %28%SPINE%29%.%A%    
% 222.17/222.36  |- mesh__dateRevised mesh__D010388 2002-07-03
% 222.17/222.36  |- skos__altLabel mesh__D010388 Pelvic Region
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D010388 2005
% 222.17/222.36  |- mesh__recordAuthorizer mesh__D010388 sjn
% 222.17/222.36  |- mesh__recordMaintainer mesh__D010388 lkt
% 222.17/222.36  |- mesh__dateCreated mesh__D010388 1999-01-01
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D010388 2006
% 222.17/222.36  |- skos__broader mesh__D010388smesh__D001829
% 222.17/222.36  |- skos__hiddenLabel mesh__D015871 Scientific Fraud
% 222.17/222.36  |- skos__hiddenLabel mesh__D015871 Misconduct, Research
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D015871 2002
% 222.17/222.36  |- mesh__recordAuthorizer mesh__D015871 sjn
% 222.17/222.36  |- skos__hiddenLabel mesh__D015871 Misconduct, Scientific
% 222.17/222.36  |- skos__altLabel mesh__D015871 Fraud, Scientific
% 222.17/222.36  |- skos__scopeNote mesh__D015871
% 222.17/222.36       Intentional falsification of scientific data by presentation of fraudulent or incomplete or uncorroborated findings as scientific fact.%A%    
% 222.17/222.36  |- mesh__historyNote mesh__D015871 90   
% 222.17/222.36  |- skos__hiddenLabel mesh__D015871 Scientific Frauds
% 222.17/222.36  |- skos__hiddenLabel mesh__D015871 Publishing, Ethics in
% 222.17/222.36  |- skos__prefLabel mesh__D015871 Scientific Misconduct
% 222.17/222.36  |- skos__historyNote mesh__D015871 Ethics %28%1977-1989%29%
% 222.17/222.36  |- rdf__type mesh__D015871sskos__Concept
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D015871 2003
% 222.17/222.36  |- mesh__recordMaintainer mesh__D015871 tjk
% 222.17/222.36  |- mesh__dateCreated mesh__D015871 1989-05-16
% 222.17/222.36  |- skos__related mesh__D015871smesh__D015714
% 222.17/222.36  |- skos__hiddenLabel mesh__D015871 Frauds, Scientific
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D015871 2005
% 222.17/222.36  |- mesh__recordOriginator mesh__D015871 TGC
% 222.17/222.36  |- skos__hiddenLabel mesh__D015871 Data, Fraudulent
% 222.17/222.36  |- mesh__dateEstablished mesh__D015871 1990-01-01
% 222.17/222.36  |- mesh__dateRevised mesh__D015871 2001-07-25
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D015871 2004
% 222.17/222.36  |- mesh__publicMeSHNote mesh__D015871 90   
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D015871 2006
% 222.17/222.36  |- skos__related mesh__D015871smesh__D015713
% 222.17/222.36  |- skos__historyNote mesh__D015871 Fraud %28%1974-1989%29%
% 222.17/222.36  |- skos__broader mesh__D015871smesh__D028743
% 222.17/222.36  |- skos__annotation mesh__D015871
% 222.17/222.36       PROFESSIONAL MISCONDUCT  is also available   
% 222.17/222.36  |- skos__related mesh__D015871smesh__D012180
% 222.17/222.36  |- skos__related mesh__D015871smesh__D018172
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D015073 2006
% 222.17/222.36  |- mesh__onlineNote mesh__D015073
% 222.17/222.36       use 2-ACETYLAMINOFLUORENE to search ACETYLAMINOFLUORENE 1975-82%A%  
% 222.17/222.36  |- skos__historyNote mesh__D015073 Acetamides %28%1971-1974%29%
% 222.17/222.36  |- skos__hiddenLabel mesh__D015073 Fluoren 2 ylacetamide
% 222.17/222.36  |- skos__altLabel mesh__D015073 Fluoren-2-ylacetamide
% 222.17/222.36  |- mesh__recordAuthorizer mesh__D015073 sjn
% 222.17/222.36  |- skos__altLabel mesh__D015073 2-AAF
% 222.17/222.36  |- mesh__historyNote mesh__D015073
% 222.17/222.36       83; was ACETYLAMINOFLUORENE 1980-82; was ACETYLAMINOFLUORENE see under FLUORENES 1975-79%A%  
% 222.17/222.36  |- skos__hiddenLabel mesh__D015073 2 Acetamidofluorene
% 222.17/222.36  |- skos__prefLabel mesh__D015073 2-Acetylaminofluorene
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D015073 2005
% 222.17/222.36  |- rdf__type mesh__D015073sskos__Concept
% 222.17/222.36  |- mesh__dateRevised mesh__D015073 2004-07-19
% 222.17/222.36  |- skos__hiddenLabel mesh__D015073 2 Fluorenylacetamide
% 222.17/222.36  |- skos__broader mesh__D015073smesh__D000081
% 222.17/222.36  |- skos__broader mesh__D015073smesh__D005449
% 222.17/222.36  |- mesh__recordMaintainer mesh__D015073 jls
% 222.17/222.36  |- skos__annotation mesh__D015073 D25-26 qualif   
% 222.17/222.36  |- skos__hiddenLabel mesh__D015073 N 2 Fluorenylacetamide
% 222.17/222.36  |- skos__hiddenLabel mesh__D015073 2 Acetylaminofluorene
% 222.17/222.36  |- skos__historyNote mesh__D015073 Fluorenes %28%1966-1974%29%
% 222.17/222.36  |- mesh__recordOriginator mesh__D015073 NLM
% 222.17/222.36  |- mesh__dateEstablished mesh__D015073 1980-01-01
% 222.17/222.36  |- mesh__publicMeSHNote mesh__D015073
% 222.17/222.36       83; was ACETYLAMINOFLUORENE 1980-82; was ACETYLAMINOFLUORENE see under FLUORENES 1975-79%A%  
% 222.17/222.36  |- skos__altLabel mesh__D015073 2-Acetamidofluorene
% 222.17/222.36  |- mesh__dateCreated mesh__D015073 1974-11-11
% 222.17/222.36  |- skos__scopeNote mesh__D015073
% 222.17/222.36       A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.%A%    
% 222.17/222.36  |- skos__altLabel mesh__D015073 2-Fluorenylacetamide
% 222.17/222.36  |- skos__altLabel mesh__D015073 N-2-Fluorenylacetamide
% 222.17/222.36  |- skos__historyNote mesh__D009834 Glycoside Hydrolases %28%1966-1977%29%
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D009834 2005
% 222.17/222.36  |- mesh__recordAuthorizer mesh__D009834 sjn
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D009834 2006
% 222.17/222.36  |- mesh__historyNote mesh__D009834
% 222.17/222.36       91%28%78%29%; was see under GLYCOSIDE HYDROLASES 1978-90   
% 222.17/222.36  |- skos__annotation mesh__D009834
% 222.17/222.36       consider also SUCRASE-ISOMALTASE COMPLEX; /defic: consider also SUCROSE /metab %28%IM%29% + CARBOHYDRATE METABOLISM, INBORN ERRORS %28%IM%29%%A%  
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D009834 2004
% 222.17/222.36  |- skos__altLabel mesh__D009834 Isomaltase
% 222.17/222.36  |- mesh__publicMeSHNote mesh__D009834
% 222.17/222.36       91; was see under GLYCOSIDE HYDROLASES 1978-90   
% 222.17/222.36  |- skos__broader mesh__D009834smesh__D006026
% 222.17/222.36  |- skos__scopeNote mesh__D009834
% 222.17/222.36       An enzyme that catalyzes the endohydrolysis of 1,6-alpha-glucosidic linkages in isomaltose and dextrins produced from starch and glycogen by alpha-amylase. EC 3.2.1.10.%A%    
% 222.17/222.36  |- skos__hiddenLabel mesh__D009834 Oligo 1,6 Glucosidase
% 222.17/222.36  |- mesh__dateRevised mesh__D009834 2003-07-09
% 222.17/222.36  |- mesh__dateCreated mesh__D009834 1977-04-15
% 222.17/222.36  |- skos__hiddenLabel mesh__D009834 Exo Oligo 1,6 Glucosidase
% 222.17/222.36  |- rdf__type mesh__D009834sskos__Concept
% 222.17/222.36  |- skos__prefLabel mesh__D009834 Oligo-1,6-Glucosidase
% 222.17/222.36  |- mesh__dateEstablished mesh__D009834 1991-01-01
% 222.17/222.36  |- mesh__recordMaintainer mesh__D009834 ssb
% 222.17/222.36  |- mesh__recordOriginator mesh__D009834 RLS
% 222.17/222.36  |- skos__prefLabel mesh__D001851 Bone Diseases, Metabolic
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D001851 2003
% 222.17/222.36  |- skos__broader mesh__D001851smesh__D001847
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D001851 2000
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D001851 1998
% 222.17/222.36  |- mesh__recordAuthorizer mesh__D001851 PLS
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D001851 1992
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D001851 2004
% 222.17/222.36  |- mesh__dateRevised mesh__D001851 1990-08-16
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D001851 2001
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D001851 1999
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D001851 1993
% 222.17/222.36  |- mesh__historyNote mesh__D001851 80; was NON MESH before 1980   
% 222.17/222.36  |- skos__historyNote mesh__D001851 Bone Diseases %28%1966-1979%29%
% 222.17/222.36  |- mesh__dateEstablished mesh__D001851 1980-01-01
% 222.17/222.36  |- mesh__publicMeSHNote mesh__D001851 80   
% 222.17/222.36  |- skos__hiddenLabel mesh__D001851 Metabolic Bone Disease
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D001851 1996
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D001851 2005
% 222.17/222.36  |- mesh__dateCreated mesh__D001851 1999-01-01
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D001851 2002
% 222.17/222.36  |- skos__altLabel mesh__D001851 Metabolic Bone Diseases
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D001851 1997
% 222.17/222.36  |- rdf__type mesh__D001851sskos__Concept
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D001851 1994
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D001851 2006
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D001851 1991
% 222.17/222.36  |- skos__hiddenLabel mesh__D001851 Disease, Metabolic Bone
% 222.17/222.36  |- mesh__recordMaintainer mesh__D001851 NLM
% 222.17/222.36  |- mesh__recordOriginator mesh__D001851 NLM
% 222.17/222.36  |- skos__hiddenLabel mesh__D001851 Diseases, Metabolic Bone
% 222.17/222.36  |- skos__hiddenLabel mesh__D001851 Bone Disease, Metabolic
% 222.17/222.36  |- skos__hiddenLabel mesh__D001851 Osteopenias
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D001851 1995
% 222.17/222.36  |- skos__broader mesh__D004724Q000295smesh__D004724
% 222.17/222.36  |- mesh__preferredCombination mesh__D004724Q000295smesh__D019723
% 222.17/222.36  |- rdf__type mesh__D004724Q000295smesh__CompoundConcept
% 222.17/222.36  |- skos__scopeNote mesh__D009036
% 222.17/222.36       Insects of the suborder Heterocera of the order LEPIDOPTERA.%A%    
% 222.17/222.36  |- mesh__recordOriginator mesh__D009036 NLM
% 222.17/222.36  |- skos__altLabel mesh__D009036 Giant Silkworms
% 222.17/222.36  |- rdf__type mesh__D009036sskos__Concept
% 222.17/222.36  |- mesh__recordAuthorizer mesh__D009036 sjn
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D009036 2005
% 222.17/222.36  |- mesh__dateEstablished mesh__D009036 1991-01-01
% 222.17/222.36  |- skos__prefLabel mesh__D009036 Moths
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D009036 2006
% 222.17/222.36  |- skos__altLabel mesh__D009036 Silkmoths, Giant
% 222.17/222.36  |- mesh__dateRevised mesh__D009036 2004-07-13
% 222.17/222.36  |- mesh__publicMeSHNote mesh__D009036
% 222.17/222.36       91; was see under LEPIDOPTERA 1975-90   
% 222.17/222.36  |- mesh__historyNote mesh__D009036
% 222.17/222.36       91%28%75%29%; was see under LEPIDOPTERA 1975-90   
% 222.17/222.36  |- mesh__recordMaintainer mesh__D009036 sjn
% 222.17/222.36  |- skos__annotation mesh__D009036
% 222.17/222.36        /microbiol /parasitol /virol permitted; don%27%t forget  BOMBYX exists; TN 111 for eff of insecticides%A%  
% 222.17/222.36  |- skos__broader mesh__D009036smesh__D007915
% 222.17/222.36  |- mesh__dateCreated mesh__D009036 1974-12-12
% 222.17/222.36  |- skos__scopeNote mesh__D001053
% 222.17/222.36       The protein components of lipoproteins which remain after the lipids to which the proteins are bound have been removed. They play an important role in lipid transport and metabolism.%A%    
% 222.17/222.36  |- mesh__publicMeSHNote mesh__D001053 77   
% 222.17/222.36  |- skos__prefLabel mesh__D001053 Apolipoproteins
% 222.17/222.36  |- mesh__recordOriginator mesh__D001053 RLS
% 222.17/222.36  |- mesh__dateCreated mesh__D001053 1976-04-16
% 222.17/222.36  |- skos__altLabel mesh__D001053 Apolipoprotein
% 222.17/222.36  |- skos__historyNote mesh__D001053 specific lipoprotein %28%1972-1976%29%
% 222.17/222.36  |- skos__historyNote mesh__D001053 Apoproteins %28%1972-1976%29%
% 222.17/222.36  |- skos__annotation mesh__D001053
% 222.17/222.36       /biosyn /drug eff /physiol /ultrastruct permitted   
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D001053 2006
% 222.17/222.36  |- skos__broader mesh__D001053smesh__D001059
% 222.17/222.36  |- mesh__recordMaintainer mesh__D001053 SYSTEM
% 222.17/222.36  |- mesh__dateEstablished mesh__D001053 1977-01-01
% 222.17/222.36  |- mesh__recordAuthorizer mesh__D001053 sjn
% 222.17/222.36  |- rdf__type mesh__D001053sskos__Concept
% 222.17/222.36  |- mesh__historyNote mesh__D001053 77   
% 222.17/222.36  |- skos__historyNote mesh__D001053 Lipoproteins %28%1966-1976%29%
% 222.17/222.36  |- mesh__dateRevised mesh__D001053 2005-06-30
% 222.17/222.36  |- mesh__recordOriginator mesh__D014779 NLM
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D014779 2006
% 222.17/222.36  |- mesh__dateCreated mesh__D014779 1999-01-01
% 222.17/222.36  |- skos__historyNote mesh__D014779 Viruses %28%1966-1967%29%
% 222.17/222.36  |- skos__prefLabel mesh__D014779 Virus Replication
% 222.17/222.36  |- skos__hiddenLabel mesh__D014779 Virus Replications
% 222.17/222.36  |- mesh__recordAuthorizer mesh__D014779 sjn
% 222.17/222.36  |- skos__historyNote mesh__D014779 specific virus %28%1966-1967%29%
% 222.17/222.36  |- skos__scopeNote mesh__D014779
% 222.17/222.36       The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle.%A%    
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D014779 2003
% 222.17/222.36  |- mesh__historyNote mesh__D014779 68   
% 222.17/222.36  |- mesh__dateEstablished mesh__D014779 1968-01-01
% 222.17/222.36  |- rdf__type mesh__D014779sskos__Concept
% 222.17/222.36  |- mesh__recordMaintainer mesh__D014779 ags
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D014779 2004
% 222.17/222.36  |- skos__broader mesh__D014779smesh__D018406
% 222.17/222.36  |- skos__hiddenLabel mesh__D014779 Replication, Virus
% 222.17/222.36  |- skos__annotation mesh__D014779 coord with specific virus /physiol   
% 222.17/222.36  |- skos__related mesh__D014779smesh__D004261
% 222.17/222.36  |- skos__hiddenLabel mesh__D014779 Replications, Virus
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D014779 2005
% 222.17/222.36  |- mesh__publicMeSHNote mesh__D014779 68   
% 222.17/222.36  |- mesh__dateRevised mesh__D014779 2002-07-03
% 222.17/222.36  |- skos__broader mesh__D014779smesh__D001669
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D019464 2003
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D019464 1998
% 222.17/222.36  |- skos__scopeNote mesh__D019464
% 222.17/222.36       Status not subject to taxation; as the income of a philanthropic organization. Tax-exempt organizations may also qualify to receive tax-deductible donations if they are considered to be nonprofit corporations under Section 501%28%c%29%3 of the United States Internal Revenue Code.%A%    
% 222.17/222.36  |- skos__hiddenLabel mesh__D019464 Tax Exemptions
% 222.17/222.36  |- skos__hiddenLabel mesh__D019464 Exemption, Tax
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D019464 2004
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D019464 1999
% 222.17/222.36  |- skos__prefLabel mesh__D019464 Tax Exemption
% 222.17/222.36  |- mesh__historyNote mesh__D019464 97   
% 222.17/222.36  |- mesh__dateEstablished mesh__D019464 1997-01-01
% 222.17/222.36  |- skos__hiddenLabel mesh__D019464 Exemptions, Tax
% 222.17/222.36  |- skos__historyNote mesh__D019464 Taxes %28%1986-1996%29%
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D019464 2005
% 222.17/222.36  |- mesh__publicMeSHNote mesh__D019464 97   
% 222.17/222.36  |- mesh__dateCreated mesh__D019464 1996-06-13
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D019464 2000
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D019464 2006
% 222.17/222.36  |- rdf__type mesh__D019464sskos__Concept
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D019464 1997
% 222.17/222.36  |- skos__annotation mesh__D019464
% 222.17/222.36       coord IM with subject of tax %28%IM%29%; specify geog   
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D019464 2001
% 222.17/222.36  |- skos__broader mesh__D019464smesh__D013660
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D019464 2002
% 222.17/222.36  |- skos__annotation mesh__D000759
% 222.17/222.36       IM; coord with specific adjuvant %28%IM%29% %26% specific type of anesthesia %28%IM%29%%A%  
% 222.17/222.36  |- mesh__recordMaintainer mesh__D000759 ssb
% 222.17/222.36  |- skos__hiddenLabel mesh__D000759 Adjuvants, Anesthetic
% 222.17/222.36  |- skos__prefLabel mesh__D000759 Adjuvants, Anesthesia
% 222.17/222.36  |- mesh__dateCreated mesh__D000759 1999-01-01
% 222.17/222.36  |- mesh__historyNote mesh__D000759 99%28%63%29%   
% 222.17/222.36  |- skos__altLabel mesh__D000759 Anesthesia Adjuvants
% 222.17/222.36  |- mesh__recordOriginator mesh__D000759 NLM
% 222.17/222.36  |- skos__scopeNote mesh__D000759
% 222.17/222.36       Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage.%A%    
% 222.17/222.36  |- mesh__publicMeSHNote mesh__D000759
% 222.17/222.36       99; see ANESTHESIA ADJUVANTS 1963-98   
% 222.17/222.36  |- rdf__type mesh__D000759sskos__Concept
% 222.17/222.36  |- mesh__dateRevised mesh__D000759 2005-06-30
% 222.17/222.36  |- skos__altLabel mesh__D000759 Anesthetic Adjuvants
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D000759 2006
% 222.17/222.36  |- skos__broader mesh__D000759smesh__D002491
% 222.17/222.36  |- mesh__recordAuthorizer mesh__D000759 sjn
% 222.17/222.36  |- skos__historyNote mesh__D011481 Clothing %28%1966-1969%29%
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D011481 2000
% 222.17/222.36  |- mesh__historyNote mesh__D011481 70   
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D011481 2003
% 222.17/222.36  |- mesh__recordMaintainer mesh__D011481 jls
% 222.17/222.36  |- skos__scopeNote mesh__D011481
% 222.17/222.36       Clothing designed to protect the individual against possible exposure to known hazards.%A%    
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D011481 2006
% 222.17/222.36  |- skos__broader mesh__D011481smesh__D003020
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D011481 2002
% 222.17/222.36  |- mesh__publicMeSHNote mesh__D011481 70   
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D011481 2005
% 222.17/222.36  |- skos__altLabel mesh__D011481 Clothing, Protective
% 222.17/222.36  |- mesh__dateCreated mesh__D011481 1999-01-01
% 222.17/222.36  |- mesh__recordAuthorizer mesh__D011481 sjn
% 222.17/222.36  |- mesh__dateEstablished mesh__D011481 1970-01-01
% 222.17/222.36  |- mesh__recordOriginator mesh__D011481 NLM
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D011481 2001
% 222.17/222.36  |- mesh__dateRevised mesh__D011481 1999-11-03
% 222.17/222.36  |- rdf__type mesh__D011481sskos__Concept
% 222.17/222.36  |- skos__prefLabel mesh__D011481 Protective Clothing
% 222.17/222.36  |- skos__broader mesh__D011481smesh__D011482
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D011481 2004
% 222.17/222.36  |- skos__hiddenLabel mesh__D005444 Dihydrochloride, Flunarizine
% 222.17/222.36  |- skos__altLabel mesh__D005444 Flunarizine Dihydrochloride
% 222.17/222.36  |- skos__historyNote mesh__D005444
% 222.17/222.36       Cinnarizine/analogs %26% derivatives %28%1975-1986%29%
% 222.17/222.36  |- skos__altLabel mesh__D005444 Flunarizin
% 222.17/222.36  |- mesh__recordAuthorizer mesh__D005444 sjn
% 222.17/222.36  |- skos__prefLabel mesh__D005444 Flunarizine
% 222.17/222.36  |- mesh__dateRevised mesh__D005444 2005-06-30
% 222.17/222.36  |- skos__hiddenLabel mesh__D005444 R14950
% 222.17/222.36  |- mesh__historyNote mesh__D005444 87   
% 222.17/222.36  |- rdf__type mesh__D005444sskos__Concept
% 222.17/222.36  |- mesh__publicMeSHNote mesh__D005444 87   
% 222.17/222.36  |- skos__historyNote mesh__D005444 Piperazines %28%1966-1974%29%
% 222.17/222.36  |- mesh__recordOriginator mesh__D005444 RLS
% 222.17/222.36  |- skos__hiddenLabel mesh__D005444 Hydrochloride, Flunarizine
% 222.17/222.36  |- mesh__dateCreated mesh__D005444 1986-06-16
% 222.17/222.36  |- mesh__dateEstablished mesh__D005444 1987-01-01
% 222.17/222.36  |- skos__scopeNote mesh__D005444
% 222.17/222.36       Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy.%A%    
% 222.17/222.36  |- skos__broader mesh__D005444smesh__D010879
% 222.17/222.36  |- mesh__recordMaintainer mesh__D005444 exl
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D005444 2006
% 222.17/222.36  |- skos__hiddenLabel mesh__D005444 R 14950
% 222.17/222.36  |- skos__scopeNote mesh__D043563
% 222.17/222.36       Cell surface receptors that respond to PHEROMONES.     
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D043563 2004
% 222.17/222.36  |- mesh__activeMeSHYear mesh__D043563 2005
% 222.17/222.36  |- mesh__publicMeSHNote mesh__D043563 2004; see CHEMORECEPTORS 1991-2003   
% 222.17/222.36  |- rdf__type mesh__D043563sskos__Concept
% 222.17/222.36  |- mesh__dateCreated mesh__D043563 2003-07-09
% 222.17/222.37  |- mesh__dateEstablished mesh__D043563 2004-01-01
% 222.17/222.37  |- skos__broader mesh__D043563smesh__D011956
% 222.17/222.37  |- mesh__historyNote mesh__D043563 2004; use CHEMORECEPTORS 1991-2003   
% 222.17/222.37  |- skos__historyNote mesh__D043563 Chemoreceptors %28%1991-2003%29%
% 222.17/222.37  |- skos__broader mesh__D043563smesh__D043562
% 222.17/222.37  |- skos__altLabel mesh__D043563 Pheromone Receptors
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D043563 2006
% 222.17/222.37  |- skos__prefLabel mesh__D043563 Receptors, Pheromone
% 222.17/222.37  |- mesh__dateEstablished mesh__D010389 1970-01-01
% 222.17/222.37  |- mesh__onlineNote mesh__D010389
% 222.17/222.37       use PEMOLINE to search PEMOLINE COMPOUNDS 1966-78 %28%as Prov 1966-69%29%%A%  
% 222.17/222.37  |- skos__hiddenLabel mesh__D010389 Compounds, Pemoline
% 222.17/222.37  |- mesh__historyNote mesh__D010389
% 222.17/222.37       79; was PEMOLINE COMPOUNDS 1966-78 %28%Prov 1966-69%29%   
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D010389 2006
% 222.17/222.37  |- mesh__recordAuthorizer mesh__D010389 sjn
% 222.17/222.37  |- skos__hiddenLabel mesh__D010389 Magnesium, Pemoline
% 222.17/222.37  |- mesh__publicMeSHNote mesh__D010389 79; was PEMOLINE COMPOUNDS 1970-78   
% 222.17/222.37  |- rdf__type mesh__D010389sskos__Concept
% 222.17/222.37  |- mesh__dateRevised mesh__D010389 2005-06-30
% 222.17/222.37  |- mesh__recordMaintainer mesh__D010389 lkw
% 222.17/222.37  |- skos__broader mesh__D010389smesh__D010080
% 222.17/222.37  |- skos__scopeNote mesh__D010389
% 222.17/222.37       A central nervous system stimulant used in fatigue and depressive states and to treat hyperkinetic disorders in children.%A%    
% 222.17/222.37  |- mesh__recordOriginator mesh__D010389 NLM
% 222.17/222.37  |- skos__altLabel mesh__D010389 Phenoxazole
% 222.17/222.37  |- skos__altLabel mesh__D010389 Mallinckrodt Brand of Pemoline
% 222.17/222.37  |- skos__altLabel mesh__D010389 Phenylisohydantoin
% 222.17/222.37  |- mesh__dateCreated mesh__D010389 1999-01-01
% 222.17/222.37  |- skos__prefLabel mesh__D010389 Pemoline
% 222.17/222.37  |- skos__altLabel mesh__D010389 Abbott Brand of Pemoline
% 222.17/222.37  |- skos__altLabel mesh__D010389 Lilly Brand of Pemoline
% 222.17/222.37  |- skos__hiddenLabel mesh__D015074 Acid, 2 Aminoadipic
% 222.17/222.37  |- mesh__recordMaintainer mesh__D015074 mdb
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D015074 2005
% 222.17/222.37  |- skos__altLabel mesh__D015074 2-Aminohexanedioic Acid
% 222.17/222.37  |- skos__broader mesh__D015074smesh__D000272
% 222.17/222.37  |- rdf__type mesh__D015074sskos__Concept
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D015074 2002
% 222.17/222.37  |- skos__broader mesh__D015074smesh__D000600
% 222.17/222.37  |- skos__historyNote mesh__D015074
% 222.17/222.37       Amino Acids, Dicarboxylic %28%1974-1975%29%
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D015074 2004
% 222.17/222.37  |- skos__hiddenLabel mesh__D015074 Aminoadipic Acid, 2
% 222.17/222.37  |- mesh__publicMeSHNote mesh__D015074
% 222.17/222.37       91; was see under AMINO ACIDS, DICARBOXYLIC 1976-90   
% 222.17/222.37  |- skos__hiddenLabel mesh__D015074 Acid, 2-Aminoadipic
% 222.17/222.37  |- mesh__historyNote mesh__D015074
% 222.17/222.37       91%28%76%29%; was see under AMINO ACIDS, DICARBOXYLIC 1976-90   
% 222.17/222.37  |- mesh__recordOriginator mesh__D015074 RLS
% 222.17/222.37  |- skos__scopeNote mesh__D015074
% 222.17/222.37       A metabolite in the principal biochemical pathway of lysine. It antagonizes neuroexcitatory activity modulated by the glutamate receptor, N-METHYL-D-ASPARTATE; %28%NMDA%29%.%A%    
% 222.17/222.37  |- skos__hiddenLabel mesh__D015074 Acid, alpha-Aminoadipic
% 222.17/222.37  |- mesh__recordAuthorizer mesh__D015074 sjn
% 222.17/222.37  |- mesh__dateEstablished mesh__D015074 1991-01-01
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D015074 2003
% 222.17/222.37  |- skos__hiddenLabel mesh__D015074 2 Aminohexanedioic Acid
% 222.17/222.37  |- skos__prefLabel mesh__D015074 2-Aminoadipic Acid
% 222.17/222.37  |- skos__historyNote mesh__D015074 Adipic Acids %28%1969-1975%29%
% 222.17/222.37  |- skos__altLabel mesh__D015074 2 Aminoadipic Acid
% 222.17/222.37  |- skos__hiddenLabel mesh__D015074 Acid, 2-Aminohexanedioic
% 222.17/222.37  |- mesh__dateCreated mesh__D015074 1975-07-21
% 222.17/222.37  |- mesh__dateRevised mesh__D015074 2001-07-25
% 222.17/222.37  |- skos__hiddenLabel mesh__D015074 alpha Aminoadipic Acid
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D015074 2006
% 222.17/222.37  |- skos__altLabel mesh__D015074 alpha-Aminoadipic Acid
% 222.17/222.37  |- mesh__dateCreated mesh__D009835 1999-01-01
% 222.17/222.37  |- mesh__dateEstablished mesh__D009835 1979-01-01
% 222.17/222.37  |- skos__prefLabel mesh__D009835 Oligochaeta
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009835 2006
% 222.17/222.37  |- skos__broader mesh__D009835smesh__D000845
% 222.17/222.37  |- mesh__recordMaintainer mesh__D009835 ags
% 222.17/222.37  |- mesh__historyNote mesh__D009835
% 222.17/222.37       79%28%75%29%; was see under ANNELIDA 1969-78; EARTHWORMS was heading 1972-78%A%  
% 222.17/222.37  |- mesh__publicMeSHNote mesh__D009835
% 222.17/222.37       79; was see under ANNELIDA 1969-78; EARTHWORMS was heading 1972-78%A%  
% 222.17/222.37  |- skos__altLabel mesh__D009835 Eisenia fetida
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009835 2004
% 222.17/222.37  |- mesh__recordAuthorizer mesh__D009835 sjn
% 222.17/222.37  |- mesh__dateRevised mesh__D009835 2003-07-09
% 222.17/222.37  |- mesh__recordOriginator mesh__D009835 NLM
% 222.17/222.37  |- rdf__type mesh__D009835sskos__Concept
% 222.17/222.37  |- skos__historyNote mesh__D009835 Annelida %28%1966-1974%29%
% 222.17/222.37  |- skos__scopeNote mesh__D009835
% 222.17/222.37       A class of annelid worms with few setae per segment. It includes the earthworms such as Lumbricus and Eisenia.%A%    
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009835 2005
% 222.17/222.37  |- mesh__onlineNote mesh__D009835
% 222.17/222.37       search ANNELIDA 1969-74; use OLIGOCHAETA to search EARTHWORMS 1972-78%A%  
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D001852 2000
% 222.17/222.37  |- mesh__dateEstablished mesh__D001852 1972-01-01
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D001852 1998
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D001852 2003
% 222.17/222.37  |- mesh__historyNote mesh__D001852
% 222.17/222.37       72; LEG LENGTHENING was heading 1964-71 %28%Prov 1964-66%29%   
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D001852 2001
% 222.17/222.37  |- mesh__publicMeSHNote mesh__D001852
% 222.17/222.37       72; LEG LENGTHENING was heading 1967-71   
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D001852 1999
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D001852 2004
% 222.17/222.37  |- skos__historyNote mesh__D001852 Leg Length Inequality %28%1966-1971%29%
% 222.17/222.37  |- mesh__dateRevised mesh__D001852 1997-06-20
% 222.17/222.37  |- mesh__recordAuthorizer mesh__D001852 SJN
% 222.17/222.37  |- skos__hiddenLabel mesh__D001852 Lengthening, Bone
% 222.17/222.37  |- mesh__dateCreated mesh__D001852 1999-01-01
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D001852 2002
% 222.17/222.37  |- skos__broader mesh__D001852smesh__D019637
% 222.17/222.37  |- mesh__recordOriginator mesh__D001852 NLM
% 222.17/222.37  |- rdf__type mesh__D001852sskos__Concept
% 222.17/222.37  |- mesh__onlineNote mesh__D001852
% 222.17/222.37       search LEG LENGTHENING under LEG LENGTH INEQUALITY 1966-71 %28%as Prov 1966%29%%A%  
% 222.17/222.37  |- mesh__recordMaintainer mesh__D001852 PXP
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D001852 2005
% 222.17/222.37  |- skos__annotation mesh__D001852
% 222.17/222.37       not restricted to long bones; coord IM with specific bone /surg %28%IM%29% or specific disease /surg %28%IM%29%%A%  
% 222.17/222.37  |- skos__historyNote mesh__D001852 Osteotomy %28%1966-1971%29%
% 222.17/222.37  |- skos__prefLabel mesh__D001852 Bone Lengthening
% 222.17/222.37  |- skos__historyNote mesh__D001852 specific bone/surgery %28%1966-1971%29%
% 222.17/222.37  |- skos__scopeNote mesh__D001852
% 222.17/222.37       Increase in the longest dimension of a bone to correct anatomical deficiencies, congenital, traumatic, or as a result of disease. The lengthening is not restricted to long bones. The usual surgical methods are internal fixation and distraction.%A%    
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D001852 2006
% 222.17/222.37  |- skos__broader mesh__D009037smesh__D036361
% 222.17/222.37  |- skos__broader mesh__D009037smesh__D005768
% 222.17/222.37  |- skos__scopeNote mesh__D009037
% 222.17/222.37       A peptide of about 22-amino acids isolated from the DUODENUM. At low pH it inhibits gastric motor activity, whereas at high pH it has a stimulating effect.%A%    
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009037 2006
% 222.17/222.37  |- mesh__recordAuthorizer mesh__D009037 sjn
% 222.17/222.37  |- mesh__dateEstablished mesh__D009037 1986-01-01
% 222.17/222.37  |- mesh__recordOriginator mesh__D009037 RLS
% 222.17/222.37  |- skos__historyNote mesh__D009037 Peptides %28%1972-1976%29%
% 222.17/222.37  |- mesh__historyNote mesh__D009037
% 222.17/222.37       86%28%77%29%; was see under GASTROINTESTINAL HORMONES 1977-85   
% 222.17/222.37  |- mesh__dateRevised mesh__D009037 2005-06-30
% 222.17/222.37  |- skos__broader mesh__D009037smesh__D009479
% 222.17/222.37  |- mesh__dateCreated mesh__D009037 1976-04-13
% 222.17/222.37  |- skos__prefLabel mesh__D009037 Motilin
% 222.17/222.37  |- rdf__type mesh__D009037sskos__Concept
% 222.17/222.37  |- mesh__publicMeSHNote mesh__D009037
% 222.17/222.37       86; was see under GASTROINTESTINAL HORMONES 1977-85   
% 222.17/222.37  |- mesh__recordMaintainer mesh__D009037 ssb
% 222.17/222.37  |- skos__historyNote mesh__D009037
% 222.17/222.37       Gastrointestinal Hormones %28%1972-1976%29%
% 222.17/222.37  |- mesh__dateEstablished mesh__D001054 1985-01-01
% 222.17/222.37  |- skos__altLabel mesh__D001054 Apo A
% 222.17/222.37  |- skos__prefLabel mesh__D001054 Apolipoproteins A
% 222.17/222.37  |- mesh__dateRevised mesh__D001054 2005-06-30
% 222.17/222.37  |- mesh__recordMaintainer mesh__D001054 SYSTEM
% 222.17/222.37  |- mesh__dateCreated mesh__D001054 1984-05-25
% 222.17/222.37  |- mesh__recordOriginator mesh__D001054 RLS
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D001054 2006
% 222.17/222.37  |- mesh__historyNote mesh__D001054 85   
% 222.17/222.37  |- skos__altLabel mesh__D001054 Apoproteins A
% 222.17/222.37  |- skos__historyNote mesh__D001054 Apolipoproteins %28%1977-1984%29%
% 222.17/222.37  |- skos__broader mesh__D001054smesh__D001053
% 222.17/222.37  |- mesh__publicMeSHNote mesh__D001054 85   
% 222.17/222.37  |- skos__annotation mesh__D001054
% 222.17/222.37       /biosyn /drug eff /physiol /ultrastruct permitted   
% 222.17/222.37  |- skos__scopeNote mesh__D001054
% 222.17/222.37       Lipoproteins found in human blood serum in the high-density and very-high-density lipoprotein fraction %28%HDL; VHDL%29%. They consist of several different polypeptides, the most important of which are apolipoprotein A-I and A-II. They maintain the structural integrity of the HDL particles and are activators of lecithin cholesterol acyltransferase %28%LCAT%29%. Atherosclerotic patients show low apolipoprotein A levels and these apolipoproteins are either absent or present in extremely low plasma concentration in TANGIER DISEASE.%A%    
% 222.17/222.37  |- rdf__type mesh__D001054sskos__Concept
% 222.17/222.37  |- skos__altLabel mesh__D001054 Apo-A
% 222.17/222.37  |- skos__altLabel mesh__D001054 ApoA
% 222.17/222.37  |- mesh__recordAuthorizer mesh__D001054 sjn
% 222.17/222.37  |- skos__hiddenLabel mesh__D019465 Abnormalities, Craniofacial
% 222.17/222.37  |- mesh__historyNote mesh__D019465 97   
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D019465 2000
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D019465 2005
% 222.17/222.37  |- skos__historyNote mesh__D019465 Skull/abnormalities %28%1966-1996%29%
% 222.17/222.37  |- mesh__dateEstablished mesh__D019465 1997-01-01
% 222.17/222.37  |- skos__hiddenLabel mesh__D019465 Craniofacial Abnormality
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D019465 2004
% 222.17/222.37  |- skos__broader mesh__D019465smesh__D009139
% 222.17/222.37  |- mesh__recordMaintainer mesh__D019465 kle
% 222.17/222.37  |- skos__scopeNote mesh__D019465
% 222.17/222.37       Congenital structural deformities, malformations, or other abnormalities of the cranium and facial bones.%A%    
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D019465 2003
% 222.17/222.37  |- skos__annotation mesh__D019465
% 222.17/222.37       GEN or unspecified; prefer specifics; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: CRANIOFACIAL ABNORM%A%  
% 222.17/222.37  |- mesh__dateRevised mesh__D019465 1999-11-03
% 222.17/222.37  |- mesh__recordOriginator mesh__D019465 TGC
% 222.17/222.37  |- mesh__dateCreated mesh__D019465 1996-06-10
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D019465 2002
% 222.17/222.37  |- skos__hiddenLabel mesh__D019465 Abnormality, Craniofacial
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D019465 2006
% 222.17/222.37  |- skos__prefLabel mesh__D019465 Craniofacial Abnormalities
% 222.17/222.37  |- mesh__publicMeSHNote mesh__D019465 97   
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D019465 2001
% 222.17/222.37  |- mesh__recordAuthorizer mesh__D019465 sjn
% 222.17/222.37  |- rdf__type mesh__D019465sskos__Concept
% 222.17/222.37  |- skos__historyNote mesh__D019465 Facial Bones %28%1966-1996%29%
% 222.17/222.37  |- mesh__recordOriginator mesh__D011482 NLM
% 222.17/222.37  |- skos__hiddenLabel mesh__D011482 Protective Device
% 222.17/222.37  |- mesh__dateEstablished mesh__D011482 1970-01-01
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D011482 2001
% 222.17/222.37  |- mesh__recordMaintainer mesh__D011482 PXP
% 222.17/222.37  |- skos__altLabel mesh__D011482 Safety Devices
% 222.17/222.37  |- mesh__recordAuthorizer mesh__D011482 SJN
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D011482 2006
% 222.17/222.37  |- skos__hiddenLabel mesh__D011482 Devices, Protective
% 222.17/222.37  |- skos__historyNote mesh__D011482 Occupational Medicine %28%1966-1969%29%
% 222.17/222.37  |- skos__hiddenLabel mesh__D011482 Device, Safety
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D011482 2005
% 222.17/222.37  |- skos__historyNote mesh__D011482 Athletic Injuries %28%1968-1969%29%
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D011482 2000
% 222.17/222.37  |- skos__scopeNote mesh__D011482
% 222.17/222.37       Devices designed to provide personal protection against injury to individuals exposed to hazards in industry, sports, aviation, or daily activities.%A%    
% 222.17/222.37  |- skos__hiddenLabel mesh__D011482 Devices, Safety
% 222.17/222.37  |- mesh__dateRevised mesh__D011482 1997-06-20
% 222.17/222.37  |- mesh__dateCreated mesh__D011482 1999-01-01
% 222.17/222.37  |- skos__broader mesh__D011482smesh__D008420
% 222.17/222.37  |- skos__historyNote mesh__D011482 Aerospace Medicine %28%1966-1969%29%
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D011482 2002
% 222.17/222.37  |- mesh__publicMeSHNote mesh__D011482 70   
% 222.17/222.37  |- rdf__type mesh__D011482sskos__Concept
% 222.17/222.37  |- skos__historyNote mesh__D011482 Accident Prevention %28%1966-1969%29%
% 222.17/222.37  |- skos__prefLabel mesh__D011482 Protective Devices
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D011482 2004
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D011482 1999
% 222.17/222.37  |- skos__historyNote mesh__D011482 Clothing %28%1966-1969%29%
% 222.17/222.37  |- skos__broader mesh__D011482smesh__D004864
% 222.17/222.37  |- skos__hiddenLabel mesh__D011482 Safety Device
% 222.17/222.37  |- skos__hiddenLabel mesh__D011482 Device, Protective
% 222.17/222.37  |- skos__annotation mesh__D011482 for personal protection   
% 222.17/222.37  |- mesh__historyNote mesh__D011482 70   
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D011482 2003
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D011482 1998
% 222.17/222.37  |- skos__hiddenLabel mesh__D005445 Flunitrazepam Teva
% 222.17/222.37  |- skos__historyNote mesh__D005445 Nitro Compounds %28%1974%29%
% 222.17/222.37  |- skos__altLabel mesh__D005445 Teva Brand of Flunitrazepam
% 222.17/222.37  |- skos__hiddenLabel mesh__D005445 Flunitrazepam neuraxpharm
% 222.17/222.37  |- mesh__recordMaintainer mesh__D005445 CCR
% 222.17/222.37  |- rdf__type mesh__D005445sskos__Concept
% 222.17/222.37  |- skos__annotation mesh__D005445
% 222.17/222.37       colloquially called %22%rophies%22% %26% %22%roofies%22% from X ref ROHYPNOL%A%  
% 222.17/222.37  |- skos__historyNote mesh__D005445 Benzodiazepinones %28%1974%29%
% 222.17/222.37  |- skos__hiddenLabel mesh__D005445 ct Arzneimittel Brand of Flunitrazepam
% 222.17/222.37  |- mesh__dateCreated mesh__D005445 1974-11-19
% 222.17/222.37  |- mesh__recordAuthorizer mesh__D005445 sjn
% 222.17/222.37  |- skos__altLabel mesh__D005445 1A Brand of Flunitrazepam
% 222.17/222.37  |- mesh__dateRevised mesh__D005445 2005-06-30
% 222.17/222.37  |- skos__altLabel mesh__D005445 betapharm Brand of Flunitrazepam
% 222.17/222.37  |- skos__altLabel mesh__D005445 ct-Arzneimittel Brand of Flunitrazepam
% 222.17/222.37  |- mesh__publicMeSHNote mesh__D005445
% 222.17/222.37       84; was see under BENZODIAZEPINE TRANQUILIZERS 1975-83   
% 222.17/222.37  |- skos__prefLabel mesh__D005445 Flunitrazepam
% 222.17/222.37  |- skos__scopeNote mesh__D005445
% 222.17/222.37       A benzodiazepine with pharmacologic actions similar to those of DIAZEPAM that can cause ANTEROGRADE AMNESIA. Some reports indicate that it is used as a date rape drug and suggest that it may precipitate violent behavior. The United States Government has banned the importation of this drug.%A%    
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D005445 2006
% 222.17/222.37  |- skos__altLabel mesh__D005445 Roche Brand of Flunitrazepam
% 222.17/222.37  |- skos__altLabel mesh__D005445 neuraxpharm Brand of Flunitrazepam
% 222.17/222.37  |- skos__altLabel mesh__D005445 Fluridrazepam
% 222.17/222.37  |- mesh__historyNote mesh__D005445
% 222.17/222.37       84%28%75%29%; was see under BENZODIAZEPINE TRANQUILIZERS 1975-83%A%  
% 222.17/222.37  |- skos__hiddenLabel mesh__D005445 Flunitrazepam ratiopharm
% 222.17/222.37  |- mesh__dateEstablished mesh__D005445 1984-01-01
% 222.17/222.37  |- skos__historyNote mesh__D005445 Fluorobenzenes %28%1974%29%
% 222.17/222.37  |- skos__broader mesh__D005445smesh__D001570
% 222.17/222.37  |- skos__altLabel mesh__D005445 Narcozep
% 222.17/222.37  |- skos__altLabel mesh__D005445 Rohipnol
% 222.17/222.37  |- mesh__recordOriginator mesh__D005445 NLM
% 222.17/222.37  |- skos__altLabel mesh__D005445 Hexal Brand of Flunitrazepam
% 222.17/222.37  |- skos__altLabel mesh__D005445 Merck dura Brand of Flunitrazepam
% 222.17/222.37  |- skos__hiddenLabel mesh__D005445 RO54200
% 222.17/222.37  |- skos__altLabel mesh__D005445 ratiopharm Brand of Flunitrazepam
% 222.17/222.37  |- mesh__publicMeSHNote mesh__D043564
% 222.17/222.37       2004; INORGANIC PYROPHOSPHATASE was indexed under PYROPHOSPHATASES 1980-2003%A%  
% 222.17/222.37  |- skos__historyNote mesh__D043564 Pyrophosphatases %28%1980-2003%29%
% 222.17/222.37  |- skos__altLabel mesh__D043564 Pyrophosphatase, Inorganic
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D043564 2006
% 222.17/222.37  |- skos__hiddenLabel mesh__D043564 H+ Pyrophosphatase
% 222.17/222.37  |- rdf__type mesh__D043564sskos__Concept
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D043564 2004
% 222.17/222.37  |- skos__hiddenLabel mesh__D043564
% 222.17/222.37       Pyrophosphatase, Proton-Pumping Inorganic
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D043564 2005
% 222.17/222.37  |- skos__broader mesh__D043564smesh__D011755
% 222.17/222.37  |- skos__altLabel mesh__D043564 H+-Pyrophosphatase
% 222.17/222.37  |- skos__hiddenLabel mesh__D043564
% 222.17/222.37       Inorganic Pyrophosphatase, Proton-Pumping
% 222.17/222.37  |- mesh__dateCreated mesh__D043564 2003-07-09
% 222.17/222.37  |- skos__hiddenLabel mesh__D043564 Proton Pumping Inorganic Pyrophosphatase
% 222.17/222.37  |- skos__hiddenLabel mesh__D043564 Proton Translocating Pyrophosphatase
% 222.17/222.37  |- skos__altLabel mesh__D043564
% 222.17/222.37       Pyrophosphate-Energized Inorganic Pyrophosphatase
% 222.17/222.37  |- skos__hiddenLabel mesh__D043564
% 222.17/222.37       Pyrophosphatase, Pyrophosphate-Energized Inorganic
% 222.17/222.37  |- mesh__dateEstablished mesh__D043564 2004-01-01
% 222.17/222.37  |- skos__altLabel mesh__D043564 H%28%+%29%-PPase
% 222.17/222.37  |- skos__altLabel mesh__D043564 Proton-Translocating Pyrophosphatase
% 222.17/222.37  |- skos__hiddenLabel mesh__D043564
% 222.17/222.37       Inorganic Pyrophosphatase, Pyrophosphate-Energized
% 222.17/222.37  |- skos__altLabel mesh__D043564 Proton-Pumping Inorganic Pyrophosphatase
% 222.17/222.37  |- skos__prefLabel mesh__D043564 Inorganic Pyrophosphatase
% 222.17/222.37  |- skos__broader mesh__D043564smesh__D017494
% 222.17/222.37  |- skos__hiddenLabel mesh__D043564
% 222.17/222.37       Pyrophosphate Energized Inorganic Pyrophosphatase
% 222.17/222.37  |- skos__hiddenLabel mesh__D043564 Pyrophosphatase, Proton-Translocating
% 222.17/222.37  |- mesh__historyNote mesh__D043564
% 222.17/222.37       2004; use INORGANIC PYROPHOSPHATASE %28%NM%29% 1980-2003   
% 222.17/222.37  |- skos__scopeNote mesh__D043564
% 222.17/222.37       An enzyme which catalyzes the hydrolysis of diphosphate %28%DIPHOSPHATES%29% into inorganic phosphate. The hydrolysis of  pyrophosphate is coupled to the transport of HYDROGEN IONS across a membrane.%A%    
% 222.17/222.37  |- skos__historyNote mesh__D015873 Canada %28%1966-1989%29%
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D015873 2005
% 222.17/222.37  |- mesh__dateRevised mesh__D015873 1999-11-08
% 222.17/222.37  |- mesh__historyNote mesh__D015873 90   
% 222.17/222.37  |- mesh__dateCreated mesh__D015873 1989-10-13
% 222.17/222.37  |- skos__prefLabel mesh__D015873 Northwest Territories
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D015873 2001
% 222.17/222.37  |- mesh__recordOriginator mesh__D015873 TGC
% 222.17/222.37  |- rdf__type mesh__D015873sskos__Concept
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D015873 2004
% 222.17/222.37  |- mesh__dateEstablished mesh__D015873 1990-01-01
% 222.17/222.37  |- skos__scopeNote mesh__D015873
% 222.17/222.37       A federally administered division of Canada. Its capital is Yellowknife. The former northern and eastern-most parts of the Territory comprise the new territory of Nunavut, effective April 1, 1999.%A%    
% 222.17/222.37  |- mesh__recordAuthorizer mesh__D015873 sjn
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D015873 2000
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D015873 2003
% 222.17/222.37  |- mesh__recordMaintainer mesh__D015873 jls
% 222.17/222.37  |- skos__broader mesh__D015873smesh__D002170
% 222.17/222.37  |- skos__altLabel mesh__D015873 Northwest Territory
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D015873 2006
% 222.17/222.37  |- skos__annotation mesh__D015873
% 222.17/222.37       a division of northwestern Canada; do not confuse with NORTHERN TERRITORY in Australia%A%  
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D015873 2002
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D015075 2003
% 222.17/222.37  |- mesh__recordOriginator mesh__D015075 NLM
% 222.17/222.37  |- mesh__dateEstablished mesh__D015075 1991-01-01
% 222.17/222.37  |- mesh__dateCreated mesh__D015075 1974-11-19
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D015075 2006
% 222.17/222.37  |- skos__historyNote mesh__D015075 Amines %28%1972-1974%29%
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D015075 2002
% 222.17/222.37  |- skos__hiddenLabel mesh__D015075 2 Aminopurine
% 222.17/222.37  |- mesh__dateRevised mesh__D015075 2000-06-21
% 222.17/222.37  |- skos__prefLabel mesh__D015075 2-Aminopurine
% 222.17/222.37  |- skos__scopeNote mesh__D015075
% 222.17/222.37       A purine that is an isomer of ADENINE %28%6-aminopurine%29%.     
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D015075 2005
% 222.17/222.37  |- rdf__type mesh__D015075sskos__Concept
% 222.17/222.37  |- skos__broader mesh__D015075smesh__D000225
% 222.17/222.37  |- skos__historyNote mesh__D015075 Purines %28%1972-1974%29%
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D015075 2001
% 222.17/222.37  |- mesh__recordAuthorizer mesh__D015075 sjn
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D015075 2004
% 222.17/222.37  |- mesh__historyNote mesh__D015075
% 222.17/222.37       91%28%75%29%; was see under ADENINE 1975-90   
% 222.17/222.37  |- mesh__recordMaintainer mesh__D015075 TWD
% 222.17/222.37  |- mesh__publicMeSHNote mesh__D015075 91; was see under ADENINE 1975-90   
% 222.17/222.37  |- skos__hiddenLabel mesh__D009836 Oligodendrocyte
% 222.17/222.37  |- skos__broader mesh__D009836smesh__D009457
% 222.17/222.37  |- skos__hiddenLabel mesh__D009836 Oligodendrocyte, Perineuronal Satellite
% 222.17/222.37  |- rdf__type mesh__D009836sskos__Concept
% 222.17/222.37  |- skos__altLabel mesh__D009836 Oligodendrocytes
% 222.17/222.37  |- mesh__onlineNote mesh__D009836 search NEUROGLIA 1966-74   
% 222.17/222.37  |- skos__scopeNote mesh__D009836
% 222.17/222.37       A class of large neuroglial %28%macroglial%29% cells in the central nervous system. Oligodendroglia may be called interfascicular, perivascular, or perineuronal %28%not the same as SATELLITE CELLS, PERINEURONAL of GANGLIA%29% according to their location. They form the insulating MYELIN SHEATH of axons in the central nervous system.%A%    
% 222.17/222.37  |- skos__hiddenLabel mesh__D009836 Interfascicular Oligodendroglias
% 222.17/222.37  |- mesh__historyNote mesh__D009836
% 222.17/222.37       90%28%75%29%; was see under NEUROGLIA 1966-89   
% 222.17/222.37  |- mesh__publicMeSHNote mesh__D009836
% 222.17/222.37       90; was see under NEUROGLIA 1966-89   
% 222.17/222.37  |- skos__hiddenLabel mesh__D009836 Perineuronal Satellite Oligodendrocyte
% 222.17/222.37  |- skos__hiddenLabel mesh__D009836 Oligodendrocytes, Perineuronal Satellite
% 222.17/222.37  |- skos__hiddenLabel mesh__D009836 Oligodendroglia, Perineuronal
% 222.17/222.37  |- skos__hiddenLabel mesh__D009836 Satellite Oligodendrocyte, Perineuronal
% 222.17/222.37  |- skos__hiddenLabel mesh__D009836 Satellite Oligodendrocytes, Perineuronal
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009836 2005
% 222.17/222.37  |- mesh__dateCreated mesh__D009836 1999-01-01
% 222.17/222.37  |- skos__hiddenLabel mesh__D009836 Oligodendroglia, Interfascicular
% 222.17/222.37  |- skos__prefLabel mesh__D009836 Oligodendroglia
% 222.17/222.37  |- mesh__recordMaintainer mesh__D009836 sjn
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009836 2006
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009836 2003
% 222.17/222.37  |- mesh__dateEstablished mesh__D009836 1990-01-01
% 222.17/222.37  |- mesh__recordAuthorizer mesh__D009836 sjn
% 222.17/222.37  |- mesh__dateRevised mesh__D009836 2002-07-03
% 222.17/222.37  |- skos__hiddenLabel mesh__D009836 Oligodendroglia, Perivascular
% 222.17/222.37  |- skos__altLabel mesh__D009836 Perineuronal Satellite Oligodendrocytes
% 222.17/222.37  |- mesh__recordOriginator mesh__D009836 NLM
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009836 2004
% 222.17/222.37  |- skos__altLabel mesh__D009836
% 222.17/222.37       Satellite Cells, Perineuronal, Oligodendroglia
% 222.17/222.37  |- skos__altLabel mesh__D009836
% 222.17/222.37       Perineuronal Satellite Oligodendroglia Cells
% 222.17/222.37  |- mesh__recordMaintainer mesh__D001853 TGC
% 222.17/222.37  |- mesh__historyNote mesh__D001853
% 222.17/222.37       65; BONE MARROW CELLS was heading 1965-77; /transplantation was BONE MARROW TRANSPLANTATION 1964-65, was BONE MARROW/transplantation 1966-89%A%  
% 222.17/222.37  |- skos__hiddenLabel mesh__D001853 Marrow, Red
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D001853 2002
% 222.17/222.37  |- mesh__recordOriginator mesh__D001853 NLM
% 222.17/222.37  |- mesh__dateCreated mesh__D001853 1999-01-01
% 222.17/222.37  |- mesh__considerAlso mesh__D001853 consider also terms at MYEL-   
% 222.17/222.37  |- rdf__type mesh__D001853sskos__Concept
% 222.17/222.37  |- mesh__publicMeSHNote mesh__D001853
% 222.17/222.37       65; BONE MARROW CELLS was heading 1965-77; /transplantation was BONE MARROW TRANSPLANTATION 1964-65, was BONE MARROW/transplantation 1966-89%A%  
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D001853 2005
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D001853 2000
% 222.17/222.37  |- skos__prefLabel mesh__D001853 Bone Marrow
% 222.17/222.37  |- skos__broader mesh__D001853smesh__D007107
% 222.17/222.37  |- skos__scopeNote mesh__D001853
% 222.17/222.37       The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells.%A%    
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D001853 2006
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D001853 2001
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D001853 1998
% 222.17/222.37  |- mesh__onlineNote mesh__D001853
% 222.17/222.37       use BONE MARROW /CY + BONE MARROW /qualif to search BONE MARROW CELLS /same qualif 1966-77, e.g., search BONE MARROW CELLS /DE under BONE MARROW /CY + BONE MARROW /DE%A%  
% 222.17/222.37  |- skos__hiddenLabel mesh__D001853 Marrow, Yellow
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D001853 2003
% 222.17/222.37  |- skos__annotation mesh__D001853
% 222.17/222.37       /cytol = BONE MARROW CELLS; /transpl = BONE MARROW TRANSPLANTATION: do not coord with TRANSPLANTATION, HOMOLOGOUS; inflammation = OSTEOMYELITIS; fibrosis = MYELOFIBROSIS; do not confuse words containing %22%myel-%22% for spinal cord with %22%myel-%22% for bone marrow%A%  
% 222.17/222.37  |- mesh__dateRevised mesh__D001853 1997-06-20
% 222.17/222.37  |- mesh__recordAuthorizer mesh__D001853 SJN
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D001853 1999
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D001853 2004
% 222.17/222.37  |- skos__hiddenLabel mesh__D001853 Marrow, Bone
% 222.17/222.37  |- skos__broader mesh__D009038smesh__D010825
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009038 2001
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009038 1991
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009038 1994
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009038 2004
% 222.17/222.37  |- rdf__type mesh__D009038sskos__Concept
% 222.17/222.37  |- skos__scopeNote mesh__D009038
% 222.17/222.37       Physical motion, i.e., a change in position of a body or subject as a result of an external force. It is distinguished from MOVEMENT, a process resulting from biological activity.%A%    
% 222.17/222.37  |- mesh__recordMaintainer mesh__D009038 PLS
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009038 2000
% 222.17/222.37  |- mesh__dateEstablished mesh__D009038 1968-01-01
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009038 2003
% 222.17/222.37  |- skos__historyNote mesh__D009038 Kinetics %28%1966-1967%29%
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009038 1997
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009038 1990
% 222.17/222.37  |- skos__prefLabel mesh__D009038 Motion
% 222.17/222.37  |- mesh__recordAuthorizer mesh__D009038 PLS
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009038 2006
% 222.17/222.37  |- skos__annotation mesh__D009038
% 222.17/222.37       no qualif; a concept in physics: a bullet shot from a gun is MOTION: differentiate from MOVEMENT, a concept in physiol; see note there%A%  
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009038 1996
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009038 1993
% 222.17/222.37  |- mesh__onlineNote mesh__D009038 search MOVEMENT 1966-67   
% 222.17/222.37  |- skos__historyNote mesh__D009038 Acceleration %28%1966-1967%29%
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009038 2002
% 222.17/222.37  |- skos__related mesh__D009038smesh__D009068
% 222.17/222.37  |- mesh__recordOriginator mesh__D009038 NLM
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009038 2005
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009038 1999
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009038 1992
% 222.17/222.37  |- skos__hiddenLabel mesh__D009038 Motions
% 222.17/222.37  |- mesh__historyNote mesh__D009038 68; was see under MOVEMENT 1963-67   
% 222.17/222.37  |- skos__historyNote mesh__D009038 Movement %28%1966-1967%29%
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009038 1995
% 222.17/222.37  |- mesh__dateCreated mesh__D009038 1999-01-01
% 222.17/222.37  |- mesh__activeMeSHYear mesh__D009038 1998
% 222.17/222.37  |- mesh__dateRevised mesh__D009038 1989-10-17
% 222.17/222.37  |- mesh__publicMeSHNote mesh__D009038 68; was see under MOVEMENT 1963-67   
% 222.17/222.38  |- skos__altLabel mesh__D001055 Apoprotein %28%B%29%
% 222.17/222.38  |- mesh__recordAuthorizer mesh__D001055 sjn
% 222.17/222.38  |- mesh__recordMaintainer mesh__D001055 SYSTEM
% 222.17/222.38  |- mesh__dateCreated mesh__D001055 1984-05-25
% 222.17/222.38  |- mesh__onlineNote mesh__D001055
% 222.17/222.38       use APOLIPOPROTEINS B to search APOLIPOPROTEIN B 1985-93   
% 222.17/222.38  |- skos__prefLabel mesh__D001055 Apolipoproteins B
% 222.17/222.38  |- mesh__dateEstablished mesh__D001055 1985-01-01
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D001055 2006
% 222.17/222.38  |- skos__related mesh__D001055smesh__D000012
% 222.17/222.38  |- mesh__publicMeSHNote mesh__D001055
% 222.17/222.38       85; APOLIPOPROTEIN B was see APOLIPOPROTEINS B 1985-93   
% 222.17/222.38  |- mesh__dateRevised mesh__D001055 2005-06-30
% 222.17/222.38  |- skos__broader mesh__D001055smesh__D001053
% 222.17/222.38  |- mesh__historyNote mesh__D001055
% 222.17/222.38       85; APOLIPOPROTEIN B was see APOLIPOPROTEINS B 1985-93   
% 222.17/222.38  |- rdf__type mesh__D001055sskos__Concept
% 222.17/222.38  |- skos__scopeNote mesh__D001055
% 222.17/222.38       Structural proteins of chylomicrons, VLDL; and LDL. They are important in the secretion and transport of these LIPOPROTEINS and function as recognition signals for binding and internalization of LDL particles by the LDL receptor %28%RECEPTORS, LDL%29%. Atherosclerotic patients show high levels of Apo-B in the blood while in the case of ABETALIPOPROTEINEMIA they are not detectable in serum.%A%    
% 222.17/222.38  |- skos__annotation mesh__D001055
% 222.17/222.38       /biosyn /drug eff /physiol /ultrastruct permitted; /defic: consider also ABETALIPOPROTEINEMIA%A%  
% 222.17/222.38  |- mesh__recordOriginator mesh__D001055 RLS
% 222.17/222.38  |- skos__altLabel mesh__D001055 Apo-B
% 222.17/222.38  |- skos__altLabel mesh__D001055 Apo B
% 222.17/222.38  |- skos__historyNote mesh__D001055 Apolipoproteins %28%1977-1984%29%
% 222.17/222.38  |- skos__altLabel mesh__D001055 ApoB
% 222.17/222.38  |- skos__broader mesh__D000906Q000172smesh__D000906
% 222.17/222.38  |- mesh__preferredCombination mesh__D000906Q000172smesh__D007153
% 222.17/222.38  |- rdf__type mesh__D000906Q000172smesh__CompoundConcept
% 222.17/222.38  |- skos__scopeNote mesh__D019466
% 222.17/222.38       Relatively bright light, or the dazzling sensation of relatively bright light, which produces unpleasantness or discomfort, or which interferes with optimal VISION. %28%Cline et al., Dictionary of Visual Science, 4th ed%29%%A%    
% 222.17/222.38  |- skos__prefLabel mesh__D019466 Glare
% 222.17/222.38  |- mesh__publicMeSHNote mesh__D019466 97   
% 222.17/222.38  |- mesh__recordAuthorizer mesh__D019466 sjn
% 222.17/222.38  |- mesh__recordOriginator mesh__D019466 ADP
% 222.17/222.38  |- mesh__dateEstablished mesh__D019466 1997-01-01
% 222.17/222.38  |- skos__broader mesh__D019466smesh__D043722
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D019466 2006
% 222.17/222.38  |- mesh__dateRevised mesh__D019466 2004-07-07
% 222.17/222.38  |- mesh__dateCreated mesh__D019466 1996-06-13
% 222.17/222.38  |- mesh__recordMaintainer mesh__D019466 ssb
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D019466 2005
% 222.17/222.38  |- rdf__type mesh__D019466sskos__Concept
% 222.17/222.38  |- skos__broader mesh__D019466smesh__D008027
% 222.17/222.38  |- mesh__historyNote mesh__D019466 97   
% 222.17/222.38  |- skos__historyNote mesh__D019466 Light %28%1966-1996%29%
% 222.17/222.38  |- skos__prefLabel mesh__D011483 Proteidae
% 222.17/222.38  |- mesh__recordMaintainer mesh__D011483 ags
% 222.17/222.38  |- mesh__publicMeSHNote mesh__D011483 81   
% 222.17/222.38  |- mesh__dateRevised mesh__D011483 2003-07-09
% 222.17/222.38  |- skos__broader mesh__D011483smesh__D014562
% 222.17/222.38  |- rdf__type mesh__D011483sskos__Concept
% 222.17/222.38  |- skos__scopeNote mesh__D011483
% 222.17/222.38       The Proteidae family of permanently larval aquatic salamanders. It consists of two living genera - Necturus %28%mudpuppy%29% of the eastern United States and Proteus %28%the European olm%29%.%A%    
% 222.17/222.38  |- mesh__dateEstablished mesh__D011483 1981-01-01
% 222.17/222.38  |- mesh__recordAuthorizer mesh__D011483 sjn
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D011483 2004
% 222.17/222.38  |- mesh__recordOriginator mesh__D011483 EC
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D011483 2006
% 222.17/222.38  |- mesh__historyNote mesh__D011483 81   
% 222.17/222.38  |- skos__annotation mesh__D011483
% 222.17/222.38       note category: a family of aquatic salamanders; NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D011483 2005
% 222.17/222.38  |- mesh__dateCreated mesh__D011483 1980-05-12
% 222.17/222.38  |- mesh__dateEstablished mesh__D005446 1965-01-01
% 222.17/222.38  |- mesh__recordOriginator mesh__D005446 NLM
% 222.17/222.38  |- rdf__type mesh__D005446sskos__Concept
% 222.17/222.38  |- skos__altLabel mesh__D005446 Hill Brand 2 of Fluocinolone Acetonide
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D005446 2006
% 222.17/222.38  |- skos__broader mesh__D005446smesh__D013259
% 222.17/222.38  |- mesh__recordAuthorizer mesh__D005446 sjn
% 222.17/222.38  |- mesh__recordMaintainer mesh__D005446 CCR
% 222.17/222.38  |- skos__hiddenLabel mesh__D005446 Co Fluocin
% 222.17/222.38  |- skos__altLabel mesh__D005446 Savage Brand of Fluocinolone Acetonide
% 222.17/222.38  |- skos__prefLabel mesh__D005446 Fluocinolone Acetonide
% 222.17/222.38  |- skos__altLabel mesh__D005446 Fluortriamcinolone Acetonide
% 222.17/222.38  |- skos__altLabel mesh__D005446 Synalar-HP
% 222.17/222.38  |- skos__altLabel mesh__D005446 Yamanouchi Brand of Fluocinolone Acetonide
% 222.17/222.38  |- skos__altLabel mesh__D005446 Synamol
% 222.17/222.38  |- skos__altLabel mesh__D005446
% 222.17/222.38       Gr%C3%%BC%nenthal Brand of Fluocinolone Acetonide
% 222.17/222.38  |- skos__altLabel mesh__D005446 Galderma Brand of Fluocinolone Acetonide
% 222.17/222.38  |- skos__altLabel mesh__D005446 Rugby Brand of Fluocinolone Acetonide
% 222.17/222.38  |- skos__altLabel mesh__D005446 Inkeysa Brand of Fluocinolone Acetonide
% 222.17/222.38  |- skos__hiddenLabel mesh__D005446 Acetonide, Fluocinolone
% 222.17/222.38  |- skos__altLabel mesh__D005446 medphano Brand of Fluocinolone Acetonide
% 222.17/222.38  |- mesh__publicMeSHNote mesh__D005446 65   
% 222.17/222.38  |- mesh__dateRevised mesh__D005446 2005-06-30
% 222.17/222.38  |- skos__altLabel mesh__D005446 Inexfa Brand of Fluocinolone Acetonide
% 222.17/222.38  |- skos__broader mesh__D005446smesh__D011245
% 222.17/222.38  |- skos__altLabel mesh__D005446 Medicis Brand 1 of Fluocinolone Acetonide
% 222.17/222.38  |- skos__altLabel mesh__D005446 Geni Brand of Fluocinolone Acetonide
% 222.17/222.38  |- skos__altLabel mesh__D005446 Allergan Brand of Fluocinolone Acetonide
% 222.17/222.38  |- skos__altLabel mesh__D005446 Bioglan Brand of Fluocinolone Acetonide
% 222.17/222.38  |- skos__altLabel mesh__D005446 Smaller Brand of Fluocinolone Acetonide
% 222.17/222.38  |- skos__scopeNote mesh__D005446
% 222.17/222.38       A glucocorticoid derivative used topically in the treatment of various skin disorders. It is usually employed as a cream, gel, lotion, or ointment. It has also been used topically in the treatment of inflammatory eye, ear, and nose disorders. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p732%29%%A%    
% 222.17/222.38  |- skos__altLabel mesh__D005446 Hill Brand 1 of Fluocinolone Acetonide
% 222.17/222.38  |- skos__altLabel mesh__D005446 Septa Brand of Fluocinolone Acetonide
% 222.17/222.38  |- mesh__dateCreated mesh__D005446 1999-01-01
% 222.17/222.38  |- skos__hiddenLabel mesh__D005446 Acetonide, Fluortriamcinolone
% 222.17/222.38  |- mesh__historyNote mesh__D005446 65%28%63%29%   
% 222.17/222.38  |- skos__altLabel mesh__D005446 Syntex Brand of Fluocinolone Acetonide
% 222.17/222.38  |- skos__altLabel mesh__D005446 Centrum Brand of Fluocinolone Acetonide
% 222.17/222.38  |- skos__hiddenLabel mesh__D005446 Derma Smooth/FS
% 222.17/222.38  |- skos__hiddenLabel mesh__D005446 Synalar HP
% 222.17/222.38  |- skos__altLabel mesh__D005446 Medicis Brand 2 of Fluocinolone Acetonide
% 222.17/222.38  |- skos__altLabel mesh__D005446 Jellisoft
% 222.17/222.38  |- skos__broader mesh__D015874smesh__D002170
% 222.17/222.38  |- mesh__dateRevised mesh__D015874 1995-02-21
% 222.17/222.38  |- skos__scopeNote mesh__D015874
% 222.17/222.38       A territory of northwest Canada, bounded on the north by the Arctic Ocean, on the south by British Columbia, and on the west by Alaska. Its capital is Whitehorse. It takes its name from the Yukon River, the Indian yu-kun-ah, meaning big river. %28%From Webster%27%s New Geographical Dictionary, 1988, p1367 %26% Room, Brewer%27%s Dictionary of Names, 1992, p608%29%%A%    
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D015874 2002
% 222.17/222.38  |- mesh__recordAuthorizer mesh__D015874 PLS
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D015874 1997
% 222.17/222.38  |- skos__historyNote mesh__D015874 Canada %28%1966-1989%29%
% 222.17/222.38  |- rdf__type mesh__D015874sskos__Concept
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D015874 2004
% 222.17/222.38  |- mesh__dateEstablished mesh__D015874 1990-01-01
% 222.17/222.38  |- skos__altLabel mesh__D015874 Yukon
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D015874 1996
% 222.17/222.38  |- mesh__historyNote mesh__D015874 90   
% 222.17/222.38  |- mesh__dateCreated mesh__D015874 1989-10-13
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D015874 1999
% 222.17/222.38  |- skos__prefLabel mesh__D015874 Yukon Territory
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D015874 2003
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D015874 2001
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D015874 2006
% 222.17/222.38  |- mesh__recordOriginator mesh__D015874 TGC
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D015874 1998
% 222.17/222.38  |- mesh__recordMaintainer mesh__D015874 TGC
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D015874 2000
% 222.17/222.38  |- skos__annotation mesh__D015874 a division of northwest Canada   
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D015874 2005
% 222.17/222.38  |- mesh__recordMaintainer mesh__D048250 ags
% 222.17/222.38  |- mesh__dateEstablished mesh__D048250 2005-01-01
% 222.17/222.38  |- mesh__dateCreated mesh__D048250 2004-07-07
% 222.17/222.38  |- mesh__historyNote mesh__D048250 2005; use DOGFISH 1994-2004   
% 222.17/222.38  |- mesh__publicMeSHNote mesh__D048250 2005; see DOGFISH 1994-2004   
% 222.17/222.38  |- skos__historyNote mesh__D048250 Sharks %28%1965-1991%29%
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D048250 2006
% 222.17/222.38  |- rdf__type mesh__D048250sskos__Concept
% 222.17/222.38  |- mesh__recordOriginator mesh__D048250 ags
% 222.17/222.38  |- mesh__recordAuthorizer mesh__D048250 sjn
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D048250 2005
% 222.17/222.38  |- skos__prefLabel mesh__D048250 Squalus
% 222.17/222.38  |- skos__broader mesh__D048250smesh__D004284
% 222.17/222.38  |- skos__scopeNote mesh__D048250
% 222.17/222.38       A genus of SHARKS in the family SQUALIDAE, comprised of many different species. They travel in large groups and are bottom dwellers that feed mostly on bony fishes.%A%    
% 222.17/222.38  |- skos__historyNote mesh__D048250 Dogfish %28%1992-2004%29%
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Oligodendrogliomas
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Oligodendroglioma-Astrocytomas, Mixed
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Mixed Oligodendroglioma Ependymoma
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Mixed Oligodendroglioma-Astrocytomas
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Oligodendroglioma-Ependymomas, Mixed
% 222.17/222.38  |- mesh__recordOriginator mesh__D009837 NLM
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Oligodendroglioma, Anaplastic
% 222.17/222.38  |- skos__annotation mesh__D009837
% 222.17/222.38       coord IM with precoord brain/neopl term %28%IM%29% + site %28%IM%29%; for MIXED OLIGODENDROGLIOMA-ASTROCYTOMA or MIXED OLIGODENDROGLIOMA-EPENDYMOMA index here only, do not coord with ASTROCYTOMA or EPENDYMOMA%A%  
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Adult Oligodendroglioma
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Mixed Oligodendroglioma Astrocytoma
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D009837 2004
% 222.17/222.38  |- skos__altLabel mesh__D009837 Well-Differentiated Oligodendroglioma
% 222.17/222.38  |- mesh__onlineNote mesh__D009837
% 222.17/222.38       use OLIGODENDROGLIOMA to search OLIGODENDROMA 1966-93   
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Oligodendroglioma-Astrocytoma, Mixed
% 222.17/222.38  |- mesh__dateRevised mesh__D009837 2001-07-25
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Anaplastic Oligodendrogliomas
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Oligodendrogliomas, Anaplastic
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Childhood Oligodendrogliomas
% 222.17/222.38  |- mesh__publicMeSHNote mesh__D009837
% 222.17/222.38       68; was OLIGODENDROMA 1963-67; OLIGODENDROMA was see OLIGODENDROGLIOMA 1968-93%A%  
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D009837 2002
% 222.17/222.38  |- skos__scopeNote mesh__D009837
% 222.17/222.38       A relatively slow-growing glioma that is derived from oligodendrocytes and tends to occur in the cerebral hemispheres, thalamus, or lateral ventricle. They may present at any age, but are most frequent in the third to fifth decades, with an earlier incidence peak in the first decade. Histologically, these tumors are encapsulated, relatively avascular, and tend to form cysts and microcalcifications. Neoplastic cells tend to have small round nuclei surrounded by unstained nuclei. The tumors may vary from well-differentiated to highly anaplastic forms. %28%From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2052; Adams et al., Principles of Neurology, 6th ed, p655%29%%A%    
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D009837 2003
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D009837 2006
% 222.17/222.38  |- mesh__recordMaintainer mesh__D009837 nns
% 222.17/222.38  |- mesh__dateCreated mesh__D009837 1999-01-01
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Oligodendrogliomas, Well-Differentiated
% 222.17/222.38  |- skos__broader mesh__D009837smesh__D005910
% 222.17/222.38  |- skos__prefLabel mesh__D009837 Oligodendroglioma
% 222.17/222.38  |- mesh__recordAuthorizer mesh__D009837 sjn
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Childhood Oligodendroglioma
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Oligodendrogliomas, Adult
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D009837 2005
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Oligodendroglioma, Well Differentiated
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Adult Oligodendrogliomas
% 222.17/222.38  |- mesh__historyNote mesh__D009837
% 222.17/222.38       68; was OLIGODENDROMA 1963-67; OLIGODENDROMA was see OLIGODENDROGLIOMA 1968-93%A%  
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Oligodendroblastomas
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Oligodendrogliomas, Childhood
% 222.17/222.38  |- rdf__type mesh__D009837sskos__Concept
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Oligodendroglioma-Ependymoma, Mixed
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Mixed Oligodendroglioma-Ependymomas
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Well Differentiated Oligodendroglioma
% 222.17/222.38  |- mesh__dateEstablished mesh__D009837 1968-01-01
% 222.17/222.38  |- skos__hiddenLabel mesh__D009837 Well-Differentiated Oligodendrogliomas
% 222.17/222.38  |- skos__hiddenLabel mesh__D001854 Marrow Cell, Bone
% 222.17/222.38  |- skos__hiddenLabel mesh__D001854 Cells, Bone Marrow
% 222.17/222.38  |- mesh__dateEstablished mesh__D001854 1998-01-01
% 222.17/222.38  |- rdf__type mesh__D001854sskos__Concept
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D001854 2005
% 222.17/222.38  |- skos__broader mesh__D001854smesh__D002477
% 222.17/222.38  |- mesh__recordMaintainer mesh__D001854 nns
% 222.17/222.38  |- mesh__recordOriginator mesh__D001854 NLM
% 222.17/222.38  |- skos__related mesh__D001854smesh__D001856
% 222.17/222.38  |- skos__historyNote mesh__D001854 Bone Marrow/cytology %28%1978-1997%29%
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D001854 2006
% 222.17/222.38  |- mesh__historyNote mesh__D001854 98; 65-77, use explode 1978-97   
% 222.17/222.38  |- mesh__dateRevised mesh__D001854 2003-07-09
% 222.17/222.38  |- mesh__publicMeSHNote mesh__D001854 98, 65-77   
% 222.17/222.38  |- skos__prefLabel mesh__D001854 Bone Marrow Cells
% 222.17/222.38  |- mesh__recordAuthorizer mesh__D001854 sjn
% 222.17/222.38  |- skos__historyNote mesh__D001854 Bone Marrow Cells %28%1966-1977%29%
% 222.17/222.38  |- skos__hiddenLabel mesh__D001854 Marrow Cells, Bone
% 222.17/222.38  |- skos__hiddenLabel mesh__D001854 Cell, Bone Marrow
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D001854 2004
% 222.17/222.38  |- skos__broader mesh__D001854smesh__D006413
% 222.17/222.38  |- skos__hiddenLabel mesh__D001854 Bone Marrow Cell
% 222.17/222.38  |- mesh__dateCreated mesh__D001854 1999-01-01
% 222.17/222.38  |- skos__scopeNote mesh__D001854
% 222.17/222.38       Cells contained in the bone marrow including fat cells %28%see ADIPOCYTES%29%, STROMAL CELLS, MEGAKARYOCYTES, and the immediate precursors of most blood cells.%A%    
% 222.17/222.38  |- rdf__type mesh__D009039sskos__Concept
% 222.17/222.38  |- skos__broader mesh__D009039smesh__D014796
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D009039 2006
% 222.17/222.38  |- skos__hiddenLabel mesh__D009039 Perception, Motion
% 222.17/222.38  |- skos__annotation mesh__D009039 TN 129: relation to KINESTHESIS   
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D009039 2005
% 222.17/222.38  |- skos__prefLabel mesh__D009039 Motion Perception
% 222.17/222.38  |- skos__scopeNote mesh__D009039
% 222.17/222.38       The real or apparent movement of objects through the visual field.%A%    
% 222.17/222.38  |- mesh__dateCreated mesh__D009039 1999-01-01
% 222.17/222.38  |- mesh__recordMaintainer mesh__D009039 nns
% 222.17/222.38  |- mesh__dateRevised mesh__D009039 2003-07-09
% 222.17/222.38  |- mesh__recordOriginator mesh__D009039 NLM
% 222.17/222.38  |- mesh__recordAuthorizer mesh__D009039 sjn
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D009039 2004
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D001056 2006
% 222.17/222.38  |- mesh__recordOriginator mesh__D001056 RLS
% 222.17/222.38  |- mesh__recordMaintainer mesh__D001056 SYSTEM
% 222.17/222.38  |- skos__altLabel mesh__D001056 Apo C
% 222.17/222.38  |- skos__prefLabel mesh__D001056 Apolipoproteins C
% 222.17/222.38  |- skos__scopeNote mesh__D001056
% 222.17/222.38       Lipoproteins located on the surface of VLDL. They are transferred to HDL throughout the catabolism of VLDL and affect lipoprotein lipase activity. A genetic lack of Apo C-II results in hyperglyceridemia and low levels of HDL. Another form of hyperglyceridemia with normal Apo C-II levels is caused by a high concentration of Apo C-III in VLDL.%A%    
% 222.17/222.38  |- mesh__onlineNote mesh__D001056
% 222.17/222.38       use APOLIPOPROTEINS C to search APOLIPOPROTEIN C 1985-93   
% 222.17/222.38  |- skos__broader mesh__D001056smesh__D001053
% 222.17/222.38  |- rdf__type mesh__D001056sskos__Concept
% 222.17/222.38  |- skos__historyNote mesh__D001056 Apolipoproteins %28%1977-1984%29%
% 222.17/222.38  |- skos__annotation mesh__D001056
% 222.17/222.38       /biosyn /drug eff /physiol /ultrastruct permitted   
% 222.17/222.38  |- mesh__dateCreated mesh__D001056 1984-05-30
% 222.17/222.38  |- mesh__recordAuthorizer mesh__D001056 sjn
% 222.17/222.38  |- mesh__dateEstablished mesh__D001056 1985-01-01
% 222.17/222.38  |- skos__altLabel mesh__D001056 Apo-C
% 222.17/222.38  |- mesh__publicMeSHNote mesh__D001056
% 222.17/222.38       85; APOLIPOPROTEIN C was see APOLIPOPROTEINS C 1985-93   
% 222.17/222.38  |- mesh__historyNote mesh__D001056
% 222.17/222.38       85; APOLIPOPROTEIN C was see APOLIPOPROTEINS C 1985-93   
% 222.17/222.38  |- skos__altLabel mesh__D001056 ApoC
% 222.17/222.38  |- skos__altLabel mesh__D001056 Apoprotein %28%C%29%
% 222.17/222.38  |- mesh__dateRevised mesh__D001056 2005-06-30
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D020210 2002
% 222.17/222.38  |- mesh__historyNote mesh__D020210 2000   
% 222.17/222.38  |- skos__historyNote mesh__D020210 Spinal Cord %28%1971-1999%29%
% 222.17/222.38  |- skos__altLabel mesh__D020210 Central Cord Injury Syndrome
% 222.17/222.38  |- skos__broader mesh__D020210smesh__D013119
% 222.17/222.38  |- skos__historyNote mesh__D020210 Spinal Diseases %28%1971-1999%29%
% 222.17/222.38  |- mesh__publicMeSHNote mesh__D020210 2000   
% 222.17/222.38  |- skos__prefLabel mesh__D020210 Central Cord Syndrome
% 222.17/222.38  |- skos__related mesh__D020210smesh__D020760
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D020210 2006
% 222.17/222.38  |- mesh__dateCreated mesh__D020210 1999-11-03
% 222.17/222.38  |- rdf__type mesh__D020210sskos__Concept
% 222.17/222.38  |- skos__scopeNote mesh__D020210
% 222.17/222.38       A syndrome associated with traumatic injury to the cervical or upper thoracic regions of the spinal cord characterized by weakness in the arms with relative sparing of the legs and variable sensory loss. This condition is associated with ischemia, hemorrhage, or necrosis involving the central portions of the spinal cord. Corticospinal fibers destined for the legs are spared due to their more external location in the spinal cord. This clinical pattern may emerge during recovery from spinal shock. Deficits may be transient or permanent.%A%    
% 222.17/222.38  |- mesh__dateEstablished mesh__D020210 2000-01-01
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D020210 2001
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D020210 2004
% 222.17/222.38  |- skos__annotation mesh__D020210
% 222.17/222.38       coord IM with specific vertebrae %28%NIM%29% to locate site on spinal cord%A%  
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D020210 2005
% 222.17/222.38  |- skos__altLabel mesh__D020210 Central Spinal Cord Syndrome
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D020210 2000
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D020210 2003
% 222.17/222.38  |- skos__scopeNote mesh__D019467
% 222.17/222.38       Medical and skilled nursing services provided to patients who are not in an acute phase of an illness but who require a level of care higher than that provided in a long-term care setting. %28%JCAHO, Lexikon, 1994%29%%A%    
% 222.17/222.38  |- skos__annotation mesh__D019467
% 222.17/222.38       med %26% nurs care for patient out of acute phase of dis   
% 222.17/222.38  |- mesh__recordOriginator mesh__D019467 JLS
% 222.17/222.38  |- skos__hiddenLabel mesh__D019467 Care, Subacute
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D019467 2006
% 222.17/222.38  |- skos__historyNote mesh__D019467 Long-Term Care %28%1993-1996%29%
% 222.17/222.38  |- skos__hiddenLabel mesh__D019467 Sub Acute Care
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D019467 2002
% 222.17/222.38  |- mesh__dateCreated mesh__D019467 1996-06-13
% 222.17/222.38  |- skos__hiddenLabel mesh__D019467 Care, Sub-Acute
% 222.17/222.38  |- skos__hiddenLabel mesh__D019467 Cares, Sub-Acute
% 222.17/222.38  |- skos__prefLabel mesh__D019467 Subacute Care
% 222.17/222.38  |- skos__hiddenLabel mesh__D019467 Sub-Acute Cares
% 222.17/222.38  |- mesh__recordAuthorizer mesh__D019467 SJN
% 222.17/222.38  |- mesh__recordMaintainer mesh__D019467 PXP
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D019467 2005
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D019467 2001
% 222.17/222.38  |- rdf__type mesh__D019467sskos__Concept
% 222.17/222.38  |- mesh__historyNote mesh__D019467 97   
% 222.17/222.38  |- mesh__dateEstablished mesh__D019467 1997-01-01
% 222.17/222.38  |- mesh__publicMeSHNote mesh__D019467 97   
% 222.17/222.38  |- skos__broader mesh__D019467smesh__D005791
% 222.17/222.38  |- skos__altLabel mesh__D019467 Sub-Acute Care
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D019467 2004
% 222.17/222.38  |- skos__historyNote mesh__D019467
% 222.17/222.38       Progressive Patient Care %28%1993-1996%29%
% 222.17/222.38  |- skos__hiddenLabel mesh__D019467 Subacute Cares
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D019467 2000
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D019467 1999
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D019467 2003
% 222.17/222.38  |- skos__hiddenLabel mesh__D019467 Cares, Subacute
% 222.17/222.38  |- mesh__dateRevised mesh__D019467 1997-06-20
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D019467 1998
% 222.17/222.38  |- skos__hiddenLabel mesh__D011484 N-Methyltransferase, Protein-Arginine
% 222.17/222.38  |- mesh__recordOriginator mesh__D011484 RLS
% 222.17/222.38  |- mesh__historyNote mesh__D011484 98%28%77%29%   
% 222.17/222.38  |- rdf__type mesh__D011484sskos__Concept
% 222.17/222.38  |- skos__altLabel mesh__D011484
% 222.17/222.38       Myelin Basic Protein %28%Arginine%29% Methyltransferase
% 222.17/222.38  |- skos__hiddenLabel mesh__D011484 Protein Arginine N Methyltransferase
% 222.17/222.38  |- mesh__dateCreated mesh__D011484 1976-05-21
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D011484 2004
% 222.17/222.38  |- mesh__publicMeSHNote mesh__D011484
% 222.17/222.38       98; see PROTEIN-ARGININE METHYLTRANSFERASE 1991-97; see PROTEIN METHYLTRANSFERASES 1977-90%A%  
% 222.17/222.38  |- skos__historyNote mesh__D011484 Proteins %28%1966-1976%29%
% 222.17/222.38  |- skos__scopeNote mesh__D011484
% 222.17/222.38       An enzyme that catalyzes the methylation of arginine residues of proteins to yield N-mono- and N,N-dimethylarginine. This enzyme is found in many organs, primarily brain and spleen. EC 2.1.1.23.%A%    
% 222.17/222.38  |- skos__hiddenLabel mesh__D011484 Methyltransferase I, Protein
% 222.17/222.38  |- skos__altLabel mesh__D011484 Protein Methyltransferase I
% 222.17/222.38  |- skos__altLabel mesh__D011484 Arginine Methylase
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D011484 2006
% 222.17/222.38  |- skos__historyNote mesh__D011484 specific protein%28%1966-1976%29%
% 222.17/222.38  |- mesh__recordAuthorizer mesh__D011484 sjn
% 222.17/222.38  |- skos__historyNote mesh__D011484 Methyltransferases %28%1971-1976%29%
% 222.17/222.38  |- skos__historyNote mesh__D011484 Arginine %28%1966-1976%29%
% 222.17/222.38  |- skos__hiddenLabel mesh__D011484 Arginine Methyltransferase, Protein
% 222.17/222.38  |- skos__hiddenLabel mesh__D011484 Methylase I, Protein
% 222.17/222.38  |- skos__altLabel mesh__D011484 Protein Methylase I
% 222.17/222.38  |- skos__altLabel mesh__D011484 Histone %28%Arginine%29% Methyltransferase
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D011484 2005
% 222.17/222.38  |- skos__broader mesh__D011484smesh__D011496
% 222.17/222.38  |- skos__altLabel mesh__D011484 Protein Arginine Methyltransferase
% 222.17/222.38  |- mesh__dateEstablished mesh__D011484 1991-01-01
% 222.17/222.38  |- skos__hiddenLabel mesh__D011484 Methylase, Arginine
% 222.17/222.38  |- skos__prefLabel mesh__D011484 Protein-Arginine N-Methyltransferase
% 222.17/222.38  |- mesh__recordMaintainer mesh__D011484 ssb
% 222.17/222.38  |- skos__hiddenLabel mesh__D011484 Methyltransferase, Protein Arginine
% 222.17/222.38  |- mesh__dateRevised mesh__D011484 2003-07-09
% 222.17/222.38  |- skos__broader mesh__D038621smesh__D012045
% 222.17/222.38  |- mesh__dateEstablished mesh__D038621 2003-01-01
% 222.17/222.38  |- mesh__historyNote mesh__D038621 2003   
% 222.17/222.38  |- skos__scopeNote mesh__D038621
% 222.17/222.38       Sequences within RNA that regulate the processing, stability %28%RNA STABILITY%29% or translation %28%TRANSLATION, GENETIC%29% of RNA.%A%    
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D038621 2003
% 222.17/222.38  |- skos__broader mesh__D038621smesh__D022661
% 222.17/222.38  |- skos__altLabel mesh__D038621 Regulatory RNA Region
% 222.17/222.38  |- skos__hiddenLabel mesh__D038621 Sequences, RNA Regulatory
% 222.17/222.38  |- mesh__dateCreated mesh__D038621 2002-07-03
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D038621 2006
% 222.17/222.38  |- skos__hiddenLabel mesh__D038621 RNA Regions, Regulatory
% 222.17/222.38  |- skos__altLabel mesh__D038621 Regulatory Sequences, RNA
% 222.17/222.38  |- skos__altLabel mesh__D038621 Regulatory Ribonucleic Acid Region
% 222.17/222.38  |- skos__altLabel mesh__D038621 Ribonucleic Acid Regulatory Sequences
% 222.17/222.38  |- skos__prefLabel mesh__D038621 Regulatory Sequences, Ribonucleic Acid
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D038621 2005
% 222.17/222.38  |- skos__altLabel mesh__D038621 RNA Regulatory Sequences
% 222.17/222.38  |- skos__hiddenLabel mesh__D038621 Regulatory RNA Regions
% 222.17/222.38  |- mesh__publicMeSHNote mesh__D038621 2003   
% 222.17/222.38  |- skos__hiddenLabel mesh__D038621 Regulatory Sequence, RNA
% 222.17/222.38  |- rdf__type mesh__D038621sskos__Concept
% 222.17/222.38  |- skos__hiddenLabel mesh__D038621 RNA Regulatory Sequence
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D038621 2004
% 222.17/222.38  |- skos__hiddenLabel mesh__D038621 RNA Region, Regulatory
% 222.17/222.38  |- skos__altLabel mesh__D005447 Gr%C3%%BC%nenthal Brand of Fluocinonide
% 222.17/222.38  |- mesh__dateRevised mesh__D005447 2005-06-30
% 222.17/222.38  |- skos__altLabel mesh__D005447 Lidemol
% 222.17/222.38  |- skos__scopeNote mesh__D005447
% 222.17/222.38       A topical glucocorticoid used in the treatment of ECZEMA.%A%    
% 222.17/222.38  |- skos__historyNote mesh__D005447 Acetic Acids %28%1972-1974%29%
% 222.17/222.38  |- skos__hiddenLabel mesh__D005447 Fluocinolone Acetonide 21 Acetate
% 222.17/222.38  |- skos__altLabel mesh__D005447 Medicis Brand of Fluocinonide
% 222.17/222.38  |- skos__altLabel mesh__D005447 Fluocinolone Acetonide 21-Acetate
% 222.17/222.38  |- skos__prefLabel mesh__D005447 Fluocinonide
% 222.17/222.38  |- skos__broader mesh__D005447smesh__D005446
% 222.17/222.38  |- skos__altLabel mesh__D005447 Bioglan Brand of Fluocinonide
% 222.17/222.38  |- skos__altLabel mesh__D005447 Yamanouchi Brand of Fluocinonide
% 222.17/222.38  |- rdf__type mesh__D005447sskos__Concept
% 222.17/222.38  |- mesh__dateCreated mesh__D005447 1974-11-11
% 222.17/222.38  |- skos__hiddenLabel mesh__D005447 FAPG, Fluocinonide
% 222.17/222.38  |- skos__altLabel mesh__D005447 Tiamol
% 222.17/222.38  |- mesh__recordOriginator mesh__D005447 NLM
% 222.17/222.38  |- mesh__dateEstablished mesh__D005447 1991-01-01
% 222.17/222.38  |- skos__historyNote mesh__D005447 Fluocinolone Acetonide %28%1972-1974%29%
% 222.17/222.38  |- skos__altLabel mesh__D005447 Fluocinonide FAPG
% 222.17/222.38  |- mesh__recordMaintainer mesh__D005447 CCR
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D005447 2006
% 222.17/222.38  |- skos__altLabel mesh__D005447 Teofarma Brand of Fluocinonide
% 222.17/222.38  |- mesh__publicMeSHNote mesh__D005447
% 222.17/222.38       91; was see under FLUOCINOLONE ACETONIDE 1975-90   
% 222.17/222.38  |- skos__altLabel mesh__D005447 Syntex Brand of Fluocinonide
% 222.17/222.38  |- skos__altLabel mesh__D005447 Clariana Brand of Fluocinonide
% 222.17/222.38  |- mesh__historyNote mesh__D005447
% 222.17/222.38       91%28%75%29%; was see under FLUOCINOLONE ACETONIDE 1975-90   
% 222.17/222.38  |- skos__hiddenLabel mesh__D005447 Acetonide 21-Acetate, Fluocinolone
% 222.17/222.38  |- skos__altLabel mesh__D005447 Fluocinolide
% 222.17/222.38  |- mesh__recordAuthorizer mesh__D005447 sjn
% 222.17/222.38  |- skos__altLabel mesh__D005447 Optimapharma Brand of Fluocinonide
% 222.17/222.38  |- mesh__dateCreated mesh__D024601 2001-07-25
% 222.17/222.38  |- mesh__activeMeSHYear mesh__D024601 2006
% 222.17/222.38  |- skos__historyNote mesh__D024601
% 222.17/222.38       Glyceraldehyde-3-Phosphate Dehydrogenases %28%1965-2001%29%
% 222.17/222.38  |- mesh__recordAuthorizer mesh__D024601 sjn
% 222.17/222.38  |- skos__altLabel mesh__D024601
% 222.17/222.38       Glyceraldehyde 3-Phosphate-Dehydrogenase, NADP-Dependent
% 222.17/222.38  |- mesh__dateRevised mesh__D024601 2005-06-30
% 222.17/222.38  |- mesh__dateEstablished mesh__D024601 2002-01-01
% 222.17/222.38  |- mesh__publicMeSHNote mesh__D024601
% 222.17/222.38       2002; see GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES 1999-2001%A%  
% 222.17/222.38  |- skos__scopeNote mesh__D024601
% 222.17/222.38       An NADP-dependent, non-phosphorylating aldehyde dehydrogenase that catalyzes the irreversible oxidation of GLYCERALDEHYDE 3-PHOSPHATE to 3-phosphoglycerate. It is found in the cytosol of a wide variety of organisms.%A%    
% 222.17/222.38  |- skos__hiddenLabel mesh__D024601
% 222.17/222.38       NADP-Dependent Glyceraldehyde 3-Phosphate-Dehydrogenase
% 222.17/222.38  |- skos__altLabel mesh__D024601 GAPD%28%NADP+%29%
% 222.17/222.38  |- skos__prefLabel mesh__D024601
% 222.17/222.38       Glyceraldehyde 3-Phosphate Dehydrogenase %28%NADP+%29%
% 222.17/222.38  |- mesh__recordOriginator mesh__D024601 jmp
% 222.17/222.38  |- mesh__recordMaintainer mesh__D024601 jmp
% 222.17/222.38  |- skos__altLabel mesh__D024601
% 222.17/222.38       Glyceraldehyde 3-Phosphate Dehydrogenase, NADP
% 222.17/222.39  |- rdf__type mesh__D024601sskos__Concept
% 222.17/222.39  |- skos__annotation mesh__D024601
% 222.17/222.39       do not confuse with Glyceraldehyde 3 Phosphate-Dehydrogenase %28%NADP+%29%%28%Phosphorylating%29%%A%  
% 222.17/222.39  |- skos__broader mesh__D024601smesh__D005987
% 222.17/222.39  |- mesh__historyNote mesh__D024601
% 222.17/222.39       2002; use GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES 1999-2001%A%  
% 222.17/222.39  |- mesh__publicMeSHNote mesh__D015875 90   
% 222.17/222.39  |- skos__scopeNote mesh__D015875
% 222.17/222.39       Unequal pupil size, which may represent a benign physiologic variant or a manifestation of disease. Pathologic anisocoria reflects an abnormality in the musculature of the iris %28%IRIS DISEASES%29% or in the parasympathetic or sympathetic pathways that innervate the pupil. Physiologic anisocoria refers to an asymmetry of pupil diameter, usually less than 2mm, that is not associated with disease.%A%    
% 222.17/222.39  |- skos__historyNote mesh__D015875 Pupil %28%1966-1989%29%
% 222.17/222.39  |- mesh__dateRevised mesh__D015875 2004-07-19
% 222.17/222.39  |- skos__broader mesh__D015875smesh__D011681
% 222.17/222.39  |- mesh__recordMaintainer mesh__D015875 jls
% 222.17/222.39  |- mesh__dateEstablished mesh__D015875 1990-01-01
% 222.17/222.39  |- skos__historyNote mesh__D015875 Iris Diseases %28%1983-1989%29%
% 222.17/222.39  |- skos__hiddenLabel mesh__D015875 Inequality, Pupillary Size
% 222.17/222.39  |- mesh__dateCreated mesh__D015875 1989-09-06
% 222.17/222.39  |- mesh__recordAuthorizer mesh__D015875 sjn
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D015875 2006
% 222.17/222.39  |- skos__altLabel mesh__D015875 Pupillary Size Inequality
% 222.17/222.39  |- skos__prefLabel mesh__D015875 Anisocoria
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D015875 2005
% 222.17/222.39  |- skos__annotation mesh__D015875
% 222.17/222.39       consider also PUPIL DISORDERS or MIOSIS   
% 222.17/222.39  |- mesh__historyNote mesh__D015875 90   
% 222.17/222.39  |- skos__altLabel mesh__D015875 Pupil Diameter Unequal
% 222.17/222.39  |- mesh__recordOriginator mesh__D015875 EGC
% 222.17/222.39  |- skos__hiddenLabel mesh__D015875 Physiologic Anisocoria
% 222.17/222.39  |- rdf__type mesh__D015875sskos__Concept
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D048251 2006
% 222.17/222.39  |- skos__hiddenLabel mesh__D048251 Spiny Dogfish
% 222.17/222.39  |- rdf__type mesh__D048251sskos__Concept
% 222.17/222.39  |- skos__historyNote mesh__D048251 Sharks %28%1965-2004%29%
% 222.17/222.39  |- skos__prefLabel mesh__D048251 Squalus acanthias
% 222.17/222.39  |- mesh__historyNote mesh__D048251 2005   
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D048251 2005
% 222.17/222.39  |- mesh__publicMeSHNote mesh__D048251 2005   
% 222.17/222.39  |- mesh__dateEstablished mesh__D048251 2005-01-01
% 222.17/222.39  |- skos__broader mesh__D048251smesh__D048250
% 222.17/222.39  |- skos__altLabel mesh__D048251 Dogfish, Spiny
% 222.17/222.39  |- mesh__recordOriginator mesh__D048251 ags
% 222.17/222.39  |- mesh__recordAuthorizer mesh__D048251 sjn
% 222.17/222.39  |- skos__scopeNote mesh__D048251
% 222.17/222.39       A species of shark in the family SQUALIDAE, used for its oil %28%SQUALENE%29% and as fish meal. It also figures heavily in biological research, especially with reference to its RECTAL GLAND in studies of WATER-ELECTROLYTE BALANCE.%A%    
% 222.17/222.39  |- mesh__recordMaintainer mesh__D048251 ags
% 222.17/222.39  |- mesh__dateCreated mesh__D048251 2004-07-07
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D015077 2005
% 222.17/222.39  |- skos__historyNote mesh__D015077 Nitrophenols %28%1973-1974%29%
% 222.17/222.39  |- skos__hiddenLabel mesh__D015077 2 Hydroxy 5 nitrobenzyl Bromide
% 222.17/222.39  |- skos__annotation mesh__D015077 D25-26 qualif   
% 222.17/222.39  |- skos__prefLabel mesh__D015077 2-Hydroxy-5-nitrobenzyl Bromide
% 222.17/222.39  |- mesh__publicMeSHNote mesh__D015077
% 222.17/222.39       91; was see under NITROPHENOLS 1975-90   
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D015077 2006
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D015077 2001
% 222.17/222.39  |- skos__hiddenLabel mesh__D015077 Reagent, Koshland
% 222.17/222.39  |- mesh__historyNote mesh__D015077
% 222.17/222.39       91%28%75%29%; was see under NITROPHENOLS 1975-90   
% 222.17/222.39  |- skos__scopeNote mesh__D015077
% 222.17/222.39       A chemical reagent that reacts with and modifies chemically the tryptophan portion of protein molecules. Used for %27%active site%27% enzyme studies and other protein studies. Sometimes referred to as Koshland%27%s reagent.%A%    
% 222.17/222.39  |- skos__altLabel mesh__D015077 Koshlands Reagent
% 222.17/222.39  |- mesh__recordAuthorizer mesh__D015077 sjn
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D015077 2003
% 222.17/222.39  |- skos__hiddenLabel mesh__D015077 Reagent I, Koshland%27%s
% 222.17/222.39  |- mesh__dateEstablished mesh__D015077 1991-01-01
% 222.17/222.39  |- skos__altLabel mesh__D015077 Koshland%27%s Reagent I
% 222.17/222.39  |- skos__historyNote mesh__D015077 Benzyl Compounds %28%1973-1974%29%
% 222.17/222.39  |- rdf__type mesh__D015077sskos__Concept
% 222.17/222.39  |- skos__altLabel mesh__D015077 Koshland Reagent
% 222.17/222.39  |- skos__hiddenLabel mesh__D015077 Koshland Reagent I
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D015077 2004
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D015077 2002
% 222.17/222.39  |- mesh__recordOriginator mesh__D015077 NLM
% 222.17/222.39  |- skos__broader mesh__D015077smesh__D001593
% 222.17/222.39  |- skos__hiddenLabel mesh__D015077 Koshlands Reagent I
% 222.17/222.39  |- mesh__dateCreated mesh__D015077 1974-11-19
% 222.17/222.39  |- skos__hiddenLabel mesh__D015077 Reagent, Koshlands
% 222.17/222.39  |- mesh__dateRevised mesh__D015077 2000-06-22
% 222.17/222.39  |- mesh__recordMaintainer mesh__D015077 CCR
% 222.17/222.39  |- skos__broader mesh__D015077smesh__D009596
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D009838 1997
% 222.17/222.39  |- mesh__recordAuthorizer mesh__D009838 PLS
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D009838 2001
% 222.17/222.39  |- mesh__dateRevised mesh__D009838 1992-05-19
% 222.17/222.39  |- mesh__recordOriginator mesh__D009838 SH
% 222.17/222.39  |- skos__broader mesh__D009838smesh__D009841
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D009838 2002
% 222.17/222.39  |- skos__scopeNote mesh__D009838
% 222.17/222.39       A group of deoxyribonucleotides %28%up to 12%29% in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties.%A%    
% 222.17/222.39  |- skos__annotation mesh__D009838 2-12 nucleotides   
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D009838 2005
% 222.17/222.39  |- mesh__publicMeSHNote mesh__D009838
% 222.17/222.39       86; was see under OLIGONUCLEOTIDES 1976-85   
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D009838 2003
% 222.17/222.39  |- mesh__historyNote mesh__D009838
% 222.17/222.39       86%28%76%29%; was see under OLIGONUCLEOTIDES 1976-85   
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D009838 1994
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D009838 2006
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D009838 1998
% 222.17/222.39  |- skos__prefLabel mesh__D009838 Oligodeoxyribonucleotides
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D009838 2004
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D009838 1995
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D009838 1996
% 222.17/222.39  |- rdf__type mesh__D009838sskos__Concept
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D009838 1993
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D009838 2000
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D009838 1999
% 222.17/222.39  |- mesh__dateCreated mesh__D009838 1975-07-25
% 222.17/222.39  |- skos__historyNote mesh__D009838 Oligonucleotides %28%1974-1975%29%
% 222.17/222.39  |- mesh__dateEstablished mesh__D009838 1986-01-01
% 222.17/222.39  |- mesh__recordMaintainer mesh__D009838 TGC
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D001855 1992
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D001855 1997
% 222.17/222.39  |- skos__hiddenLabel mesh__D001855 Marrow Diseases, Bone
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D001855 2002
% 222.17/222.39  |- skos__annotation mesh__D001855 inflamm dis = OSTEOMYELITIS   
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D001855 1998
% 222.17/222.39  |- mesh__dateRevised mesh__D001855 1990-05-29
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D001855 1996
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D001855 1991
% 222.17/222.39  |- skos__hiddenLabel mesh__D001855 Disease, Bone Marrow
% 222.17/222.39  |- mesh__dateCreated mesh__D001855 1999-01-01
% 222.17/222.39  |- rdf__type mesh__D001855sskos__Concept
% 222.17/222.39  |- skos__broader mesh__D001855smesh__D006402
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D001855 2001
% 222.17/222.39  |- skos__prefLabel mesh__D001855 Bone Marrow Diseases
% 222.17/222.39  |- mesh__recordAuthorizer mesh__D001855 NLM
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D001855 2006
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D001855 2000
% 222.17/222.39  |- mesh__recordOriginator mesh__D001855 NLM
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D001855 2004
% 222.17/222.39  |- skos__hiddenLabel mesh__D001855 Bone Marrow Disease
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D001855 1995
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D001855 2005
% 222.17/222.39  |- mesh__recordMaintainer mesh__D001855 PLS
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D001855 1993
% 222.17/222.39  |- skos__hiddenLabel mesh__D001855 Marrow Disease, Bone
% 222.17/222.39  |- skos__hiddenLabel mesh__D001855 Diseases, Bone Marrow
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D001855 2003
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D001855 1999
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D001855 1994
% 222.17/222.39  |- skos__broader mesh__D001057smesh__D001053
% 222.17/222.39  |- mesh__onlineNote mesh__D001057
% 222.17/222.39       use APOLIPOPROTEINS E to search APOLIPOPROTEIN E 1985-93   
% 222.17/222.39  |- rdf__type mesh__D001057sskos__Concept
% 222.17/222.39  |- mesh__dateRevised mesh__D001057 2005-06-30
% 222.17/222.39  |- skos__altLabel mesh__D001057 Apo-E
% 222.17/222.39  |- skos__prefLabel mesh__D001057 Apolipoproteins E
% 222.17/222.39  |- skos__annotation mesh__D001057
% 222.17/222.39       /biosyn /drug eff /physiol /ultrastruct permitted   
% 222.17/222.39  |- mesh__recordOriginator mesh__D001057 RLS
% 222.17/222.39  |- skos__scopeNote mesh__D001057
% 222.17/222.39       Prominent protein constituents of plasma VLDL, chylomicrons, and a subfraction of HDL as well as of remnant lipoproteins which are derived from the lipoprotein lipase-mediated intravascular catabolism of triglyceride-rich lipoproteins. Apolipoproteins E are recognized by the LDL receptor and Apo E receptor. Any defect in the Apo E metabolism leads to increased plasma Apo E levels. A strong association has been found between high levels of Apo E and type III hyperlipoproteinemia.%A%    
% 222.17/222.39  |- skos__altLabel mesh__D001057 ApoE
% 222.17/222.39  |- mesh__historyNote mesh__D001057
% 222.17/222.39       85; APOLIPOPROTEIN E was see APOLIPOPROTEINS E 1985-93   
% 222.17/222.39  |- skos__historyNote mesh__D001057 Apolipoproteins %28%1977-1984%29%
% 222.17/222.39  |- mesh__dateCreated mesh__D001057 1984-05-25
% 222.17/222.39  |- skos__altLabel mesh__D001057 Apo E
% 222.17/222.39  |- mesh__publicMeSHNote mesh__D001057
% 222.17/222.39       85; APOLIPOPROTEIN E was see APOLIPOPROTEINS E 1985-93   
% 222.17/222.39  |- mesh__recordAuthorizer mesh__D001057 sjn
% 222.17/222.39  |- mesh__dateEstablished mesh__D001057 1985-01-01
% 222.17/222.39  |- skos__altLabel mesh__D001057 Apoprotein %28%E%29%
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D001057 2006
% 222.17/222.39  |- mesh__recordMaintainer mesh__D001057 SYSTEM
% 222.17/222.39  |- rdf__type mesh__D006540sskos__Concept
% 222.17/222.39  |- skos__annotation mesh__D006540
% 222.17/222.39       GEN or unspecified; prefer specific herbicide groups or specific herbicide%A%  
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D006540 2006
% 222.17/222.39  |- skos__scopeNote mesh__D006540
% 222.17/222.39       Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses %28%POACEAE%29%, and woody plants.%A%    
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D006540 2004
% 222.17/222.39  |- skos__prefLabel mesh__D006540 Herbicides
% 222.17/222.39  |- skos__broader mesh__D006540smesh__D010575
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D006540 2005
% 222.17/222.39  |- mesh__dateCreated mesh__D006540 1999-01-01
% 222.17/222.39  |- mesh__dateRevised mesh__D006540 2003-07-09
% 222.17/222.39  |- mesh__recordOriginator mesh__D006540 NLM
% 222.17/222.39  |- mesh__recordAuthorizer mesh__D006540 sjn
% 222.17/222.39  |- mesh__recordMaintainer mesh__D006540 ssb
% 222.17/222.39  |- skos__hiddenLabel mesh__D020211 Autonomic Hyperreflexias
% 222.17/222.39  |- mesh__historyNote mesh__D020211 2000   
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D020211 2002
% 222.17/222.39  |- skos__broader mesh__D020211smesh__D013119
% 222.17/222.39  |- skos__hiddenLabel mesh__D020211 Dysreflexias, Autonomic
% 222.17/222.39  |- skos__hiddenLabel mesh__D020211 Dysreflexias, Spinal Autonomic
% 222.17/222.39  |- skos__altLabel mesh__D020211 Autonomic Hyperreflexia
% 222.17/222.39  |- mesh__publicMeSHNote mesh__D020211 2000   
% 222.17/222.39  |- skos__altLabel mesh__D020211 Hyperreflexia, Autonomic
% 222.17/222.39  |- skos__broader mesh__D020211smesh__D001342
% 222.17/222.39  |- rdf__type mesh__D020211sskos__Concept
% 222.17/222.39  |- skos__historyNote mesh__D020211 Spinal Cord Injuries %28%1973-1999%29%
% 222.17/222.39  |- skos__historyNote mesh__D020211 Quadriplegia %28%1968-1999%29%
% 222.17/222.39  |- skos__hiddenLabel mesh__D020211 Hyperreflexias, Autonomic
% 222.17/222.39  |- skos__altLabel mesh__D020211 Spinal Autonomic Dysreflexia
% 222.17/222.39  |- skos__hiddenLabel mesh__D020211 Autonomic Dysreflexias, Spinal
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D020211 2001
% 222.17/222.39  |- mesh__dateCreated mesh__D020211 1999-11-03
% 222.17/222.39  |- mesh__dateEstablished mesh__D020211 2000-01-01
% 222.17/222.39  |- skos__hiddenLabel mesh__D020211 Spinal Autonomic Dysreflexias
% 222.17/222.39  |- skos__related mesh__D020211smesh__D012021
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D020211 2006
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D020211 2000
% 222.17/222.39  |- skos__historyNote mesh__D020211
% 222.17/222.39       Autonomic Nervous System %28%1968-1980%29%
% 222.17/222.39  |- skos__hiddenLabel mesh__D020211 Autonomic Dysreflexias
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D020211 2004
% 222.17/222.39  |- skos__hiddenLabel mesh__D020211 Autonomic Dysreflexia, Spinal
% 222.17/222.39  |- skos__hiddenLabel mesh__D020211 Dysreflexia, Spinal Autonomic
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D020211 2005
% 222.17/222.39  |- skos__scopeNote mesh__D020211
% 222.17/222.39       A syndrome associated with damage to the spinal cord above the mid thoracic level %28%see SPINAL CORD INJURIES%29% characterized by a marked increase in the sympathetic response to minor stimuli such as bladder or rectal distention. Manifestations include HYPERTENSION; TACHYCARDIA %28%or reflex bradycardia%29%; FEVER; FLUSHING; and HYPERHIDROSIS. Extreme hypertension may be associated with a CEREBROVASCULAR ACCIDENT. %28%From Adams et al., Principles of Neurology, 6th ed, pp538 and 1232; J Spinal Cord Med 1997;20%28%3%29%:355-60%29%%A%    
% 222.17/222.39  |- skos__altLabel mesh__D020211 Dysreflexia, Autonomic
% 222.17/222.39  |- skos__prefLabel mesh__D020211 Autonomic Dysreflexia
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D020211 2003
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D019468 2006
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D019468 1997
% 222.17/222.39  |- skos__annotation mesh__D019468
% 222.17/222.39       selection of appropriate dis ther processes in relation to cost %26% clin outcome; DF: DIS MANAGEMENT%A%  
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D019468 2005
% 222.17/222.39  |- rdf__type mesh__D019468sskos__Concept
% 222.17/222.39  |- skos__historyNote mesh__D019468 Patient Care Planning %28%1992-1996%29%
% 222.17/222.39  |- skos__hiddenLabel mesh__D019468 Management, Disease
% 222.17/222.39  |- skos__hiddenLabel mesh__D019468 Disease Managements
% 222.17/222.39  |- mesh__historyNote mesh__D019468 97   
% 222.17/222.39  |- skos__prefLabel mesh__D019468 Disease Management
% 222.17/222.39  |- mesh__dateCreated mesh__D019468 1996-06-10
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D019468 2004
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D019468 2002
% 222.17/222.39  |- skos__scopeNote mesh__D019468
% 222.17/222.39       A broad approach to appropriate coordination of the entire disease treatment process that often involves shifting away from more expensive inpatient and acute care to areas such as preventive medicine, patient counseling and education, and outpatient care. This concept includes implications of appropriate versus inappropriate therapy on the overall cost and clinical outcome of a particular disease. %28%From Hosp Pharm 1995 Jul;30%28%7%29%:596%29%%A%    
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D019468 1999
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D019468 2003
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D019468 2001
% 222.17/222.39  |- skos__hiddenLabel mesh__D019468 Managements, Disease
% 222.17/222.39  |- mesh__dateEstablished mesh__D019468 1997-01-01
% 222.17/222.39  |- mesh__publicMeSHNote mesh__D019468 97   
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D019468 1998
% 222.17/222.39  |- skos__historyNote mesh__D019468 Managed Care Programs %28%1992-1996%29%
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D019468 2000
% 222.17/222.39  |- skos__broader mesh__D019468smesh__D010346
% 222.17/222.39  |- rdf__type mesh__D011485sskos__Concept
% 222.17/222.39  |- mesh__recordOriginator mesh__D011485 NLM
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D011485 2001
% 222.17/222.39  |- skos__scopeNote mesh__D011485
% 222.17/222.39       The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments.%A%    
% 222.17/222.39  |- skos__related mesh__D011485smesh__D001665
% 222.17/222.39  |- skos__related mesh__D011485smesh__D013975
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D011485 2004
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D011485 1999
% 222.17/222.39  |- mesh__dateRevised mesh__D011485 2005-07-28
% 222.17/222.39  |- skos__hiddenLabel mesh__D011485 Binding, Protein
% 222.17/222.39  |- skos__broader mesh__D011485smesh__D008660
% 222.17/222.39  |- skos__prefLabel mesh__D011485 Protein Binding
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D011485 2002
% 222.17/222.39  |- skos__related mesh__D011485smesh__D008667
% 222.17/222.39  |- mesh__activeMeSHYear mesh__D011485 2005
% 222.17/222.39  |- mesh__recordAuthorizer mesh__D011485 ags
% 222.25/222.39  |- mesh__dateCreated mesh__D011485 1999-01-01
% 222.25/222.39  |- skos__broader mesh__D011485smesh__D001669
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D011485 2006
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D011485 2006A
% 222.25/222.39  |- skos__annotation mesh__D011485
% 222.25/222.39       NIM; restrict to the chem or metab binding mechanism; coord NIM with substance being bound /metab %28%IM%29% + specific protein /metab %28%IM%29%; do not use with receptors terms unless the substance bound to the receptor is a protein %26% the binding mechanism is discussed; do not confuse with BINDING PROTEINS see CARRIER PROTEINS%A%  
% 222.25/222.39  |- mesh__publicMeSHNote mesh__D011485 70   
% 222.25/222.39  |- mesh__dateEstablished mesh__D011485 1970-01-01
% 222.25/222.39  |- mesh__recordMaintainer mesh__D011485 ags
% 222.25/222.39  |- skos__related mesh__D011485smesh__D002352
% 222.25/222.39  |- skos__related mesh__D011485smesh__D011869
% 222.25/222.39  |- mesh__historyNote mesh__D011485 70%28%66%29%   
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D011485 2000
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D011485 2003
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D011485 1998
% 222.25/222.39  |- skos__hiddenLabel mesh__D038622 Aspects, International
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D038622 2006
% 222.25/222.39  |- skos__hiddenLabel mesh__D038622 Perspectives, International
% 222.25/222.39  |- skos__broader mesh__D038622smesh__D012942
% 222.25/222.39  |- skos__altLabel mesh__D038622 Multinational Aspects
% 222.25/222.39  |- skos__hiddenLabel mesh__D038622 International Perspective
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D038622 2005
% 222.25/222.39  |- mesh__dateEstablished mesh__D038622 2003-01-01
% 222.25/222.39  |- mesh__historyNote mesh__D038622 2003   
% 222.25/222.39  |- mesh__dateCreated mesh__D038622 2002-07-02
% 222.25/222.39  |- skos__prefLabel mesh__D038622 Internationality
% 222.25/222.39  |- skos__hiddenLabel mesh__D038622 Relations, International
% 222.25/222.39  |- skos__hiddenLabel mesh__D038622 Multinational Perspective
% 222.25/222.39  |- mesh__publicMeSHNote mesh__D038622 2003   
% 222.25/222.39  |- mesh__recordMaintainer mesh__D038622 sjn
% 222.25/222.39  |- mesh__recordOriginator mesh__D038622 hjn
% 222.25/222.39  |- rdf__type mesh__D038622sskos__Concept
% 222.25/222.39  |- skos__hiddenLabel mesh__D038622 Aspects, Multinational
% 222.25/222.39  |- skos__hiddenLabel mesh__D038622 Aspect, International
% 222.25/222.39  |- skos__scopeNote mesh__D038622
% 222.25/222.39       The quality or state of relating to or affecting two or more nations. %28%After Merriam-Webster Collegiate Dictionary, 10th ed%29%%A%    
% 222.25/222.39  |- mesh__recordAuthorizer mesh__D038622 sjn
% 222.25/222.39  |- skos__hiddenLabel mesh__D038622 Multinational Aspect
% 222.25/222.39  |- skos__hiddenLabel mesh__D038622 Perspective, Multinational
% 222.25/222.39  |- skos__hiddenLabel mesh__D038622 Aspect, Multinational
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D038622 2004
% 222.25/222.39  |- mesh__dateRevised mesh__D038622 2003-07-25
% 222.25/222.39  |- skos__hiddenLabel mesh__D038622 Perspectives, Multinational
% 222.25/222.39  |- skos__altLabel mesh__D038622 Multinational Perspectives
% 222.25/222.39  |- skos__hiddenLabel mesh__D038622 Perspective, International
% 222.25/222.39  |- skos__hiddenLabel mesh__D038622 International Aspect
% 222.25/222.39  |- skos__annotation mesh__D038622 specify geog if pertinent   
% 222.25/222.39  |- skos__prefLabel mesh__D005448 Fluocortolone
% 222.25/222.39  |- mesh__publicMeSHNote mesh__D005448
% 222.25/222.39       80; was see under PREGNADIENEDIOLS 1975-79; FLUORMETHYLDEHYDROCORTICOSTERONE was see FLUOCORTOLONE 1975-94%A%  
% 222.25/222.39  |- skos__scopeNote mesh__D005448
% 222.25/222.39       A glucocorticoid with anti-inflammatory activity used topically for various skin disorders.%A%    
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D005448 2006
% 222.25/222.39  |- mesh__recordMaintainer mesh__D005448 exl
% 222.25/222.39  |- mesh__historyNote mesh__D005448
% 222.25/222.39       80%28%75%29%; was see under PREGNADIENEDIOLS 1975-79; FLUORMETHYLDEHYDROCORTICOSTERONE was see FLUOCORTOLONE 1975-94%A%  
% 222.25/222.39  |- skos__historyNote mesh__D005448 Steroids, Fluorinated %28%1974%29%
% 222.25/222.39  |- skos__broader mesh__D005448smesh__D011244
% 222.25/222.39  |- skos__hiddenLabel mesh__D005448 Pivalate, Fluocortolone
% 222.25/222.39  |- mesh__recordAuthorizer mesh__D005448 sjn
% 222.25/222.39  |- mesh__dateRevised mesh__D005448 2005-06-30
% 222.25/222.39  |- skos__historyNote mesh__D005448 Pregnadienediols %28%1974%29%
% 222.25/222.39  |- skos__hiddenLabel mesh__D005448 Caproate, Fluocortolone
% 222.25/222.39  |- skos__broader mesh__D005448smesh__D013259
% 222.25/222.39  |- mesh__onlineNote mesh__D005448
% 222.25/222.39       use FLUOCORTOLONE to search FLUORMETHYLDEHYDROCORTICOSTERONE 1975-94%A%  
% 222.25/222.39  |- skos__historyNote mesh__D005448 Ketosteroids %28%1974%29%
% 222.25/222.39  |- mesh__recordOriginator mesh__D005448 NLM
% 222.25/222.39  |- mesh__dateEstablished mesh__D005448 1980-01-01
% 222.25/222.39  |- rdf__type mesh__D005448sskos__Concept
% 222.25/222.39  |- mesh__dateCreated mesh__D005448 1974-11-11
% 222.25/222.39  |- skos__hiddenLabel mesh__D016170 Rhythm, Accelerated Idioventricular
% 222.25/222.39  |- rdf__type mesh__D016170sskos__Concept
% 222.25/222.39  |- skos__historyNote mesh__D016170 Arrhythmia %28%1975-1990%29%
% 222.25/222.39  |- skos__broader mesh__D016170smesh__D013617
% 222.25/222.39  |- mesh__historyNote mesh__D016170 91   
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D016170 2000
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D016170 2003
% 222.25/222.39  |- mesh__dateCreated mesh__D016170 1990-04-24
% 222.25/222.39  |- skos__scopeNote mesh__D016170
% 222.25/222.39       A transient and intermittent type of arrhythmia with episodes lasting from a few seconds to a minute which usually occurs in patients with acute myocardial infarction or with digitalis toxicity. Suppressive therapy is rarely necessary because the ventricular rate is generally less than 100 beats per minute.%A%    
% 222.25/222.39  |- mesh__recordMaintainer mesh__D016170 TAP
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D016170 2001
% 222.25/222.39  |- mesh__dateEstablished mesh__D016170 1991-01-01
% 222.25/222.39  |- skos__annotation mesh__D016170
% 222.25/222.39       a supraventric tachycardia; DF: note short X ref   
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D016170 2004
% 222.25/222.39  |- mesh__recordAuthorizer mesh__D016170 sjn
% 222.25/222.39  |- skos__historyNote mesh__D016170 Tachycardia %28%1975-1990%29%
% 222.25/222.39  |- mesh__publicMeSHNote mesh__D016170 91   
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D016170 2002
% 222.25/222.39  |- skos__hiddenLabel mesh__D016170 Rhythms, Accelerated Idioventricular
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D016170 2005
% 222.25/222.39  |- skos__hiddenLabel mesh__D016170 Idioventricular Rhythms, Accelerated
% 222.25/222.39  |- skos__hiddenLabel mesh__D016170 Idioventricular Rhythm, Accelerated
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D016170 2006
% 222.25/222.39  |- skos__prefLabel mesh__D016170 Accelerated Idioventricular Rhythm
% 222.25/222.39  |- mesh__dateRevised mesh__D016170 1999-11-03
% 222.25/222.39  |- mesh__recordOriginator mesh__D016170 PXP
% 222.25/222.39  |- skos__altLabel mesh__D016170 AIVR
% 222.25/222.39  |- skos__hiddenLabel mesh__D016170 Accelerated Idioventricular Rhythms
% 222.25/222.39  |- mesh__publicMeSHNote mesh__D024602
% 222.25/222.39       2002; see GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES 1999-2001; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE %28%NADP+%29% %28%PHOSPHORYLATING%29% was indexed under GLYCERALDEHYDEPHOSPHATE DEHYDROGENASE 1991-1998 %26% ALDEHYDE OXIDOREDUCTASES 1991-1994%A%  
% 222.25/222.39  |- mesh__dateEstablished mesh__D024602 2002-01-01
% 222.25/222.39  |- skos__scopeNote mesh__D024602
% 222.25/222.39       A phosphorylating glyceraldehyde-3-phosphate dehydrogenase found in the CHLOROPLASTS of higher plants. This enzyme exists as an A2B2 heterotetramer and transfers hydrogen to NADP. It plays an important role in catalyzing the reductive step of the Calvin cycle.%A%    
% 222.25/222.39  |- skos__prefLabel mesh__D024602
% 222.25/222.39       Glyceraldehyde-3-Phosphate Dehydrogenase %28%NADP+%29%%28%Phosphorylating%29%
% 222.25/222.39  |- mesh__dateCreated mesh__D024602 2001-07-25
% 222.25/222.39  |- mesh__recordAuthorizer mesh__D024602 sjn
% 222.25/222.39  |- skos__altLabel mesh__D024602 GAPD%28%NADP+%29%%28%Phosphorylating%29%
% 222.25/222.39  |- mesh__historyNote mesh__D024602
% 222.25/222.39       2002; use GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES 1999-2001; use GLYCERALDEHYDEPHOSPHATE DEHYDROGENASES %28%NM%29% 1991-1998%A%  
% 222.25/222.39  |- mesh__recordMaintainer mesh__D024602 jmp
% 222.25/222.39  |- mesh__dateRevised mesh__D024602 2005-06-30
% 222.25/222.39  |- skos__altLabel mesh__D024602
% 222.25/222.39       Glyceraldehyde-3-Phosphate Dehydrogenase, NADP-Dependent, Phosphorylating
% 222.25/222.39  |- skos__historyNote mesh__D024602
% 222.25/222.39       Glyceraldehyde-3-Phosphate Dehydrogenases %28%1972-2001%29%
% 222.25/222.39  |- rdf__type mesh__D024602sskos__Concept
% 222.25/222.39  |- skos__broader mesh__D024602smesh__D005987
% 222.25/222.39  |- mesh__recordOriginator mesh__D024602 jmp
% 222.25/222.39  |- skos__altLabel mesh__D024602
% 222.25/222.39       Glyceraldehyde-3-Phosphate Dehydrogenase, NADP, Phosphorylating
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D024602 2006
% 222.25/222.39  |- skos__annotation mesh__D024602
% 222.25/222.39       do not confuse with Glyceraldehyde 3 Phosphate Dehydrogenase %28%NADP+%29% or Glyceraldehyde-3-Phosphate-Dehydrogenase %28%Phosphorylating%29%%A%  
% 222.25/222.39  |- mesh__publicMeSHNote mesh__D002150
% 222.25/222.39       91; see VESTIBULAR FUNCTION TESTS 1975-90; BARANY TEST was BARANY%27%S TEST 1993-97%A%  
% 222.25/222.39  |- mesh__dateEstablished mesh__D002150 1991-01-01
% 222.25/222.39  |- mesh__recordOriginator mesh__D002150 NLM
% 222.25/222.39  |- skos__hiddenLabel mesh__D002150 Test, Barany%27%s
% 222.25/222.39  |- skos__altLabel mesh__D002150 Barany Test
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D002150 2006
% 222.25/222.39  |- mesh__historyNote mesh__D002150
% 222.25/222.39       91%28%75%29%; BARANY TEST was BARANY%27%S TEST 1993-97   
% 222.25/222.39  |- mesh__dateCreated mesh__D002150 1974-12-12
% 222.25/222.39  |- skos__annotation mesh__D002150
% 222.25/222.39       vestib funct test using heat or cold; note X ref: spell in titles %26% transl with accents: B%C3%%A1%r%C3%%A1%ny%A%  
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D002150 2004
% 222.25/222.39  |- skos__hiddenLabel mesh__D002150 Tests, Caloric
% 222.25/222.39  |- skos__broader mesh__D002150smesh__D014724
% 222.25/222.39  |- skos__hiddenLabel mesh__D002150 Baranys Test
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D002150 2005
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D002150 2002
% 222.25/222.39  |- skos__hiddenLabel mesh__D002150 Test, Barany
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D002150 2003
% 222.25/222.39  |- rdf__type mesh__D002150sskos__Concept
% 222.25/222.39  |- mesh__dateRevised mesh__D002150 2001-08-13
% 222.25/222.39  |- mesh__recordAuthorizer mesh__D002150 sjn
% 222.25/222.39  |- skos__hiddenLabel mesh__D002150 Caloric Test
% 222.25/222.39  |- skos__scopeNote mesh__D002150
% 222.25/222.39       Elicitation of a rotatory nystagmus by stimulating the semicircular canals with water or air which is above or below body temperature. In warm caloric stimulation a rotatory nystagmus is developed toward the side of the stimulated ear; in cold, away from the stimulated side. Absence of nystagmus indicates the labyrinth is not functioning.%A%    
% 222.25/222.39  |- skos__hiddenLabel mesh__D002150 Test, Caloric
% 222.25/222.39  |- skos__prefLabel mesh__D002150 Caloric Tests
% 222.25/222.39  |- mesh__recordMaintainer mesh__D002150 jls
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D015876 2006
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D015876 1998
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D015876 2001
% 222.25/222.39  |- mesh__recordOriginator mesh__D015876 TGC
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D015876 2005
% 222.25/222.39  |- skos__scopeNote mesh__D015876
% 222.25/222.39       A territory in north central Australia, east of the state of Queensland. Its capital is Darwin. Originally a part of New South Wales, it was annexed to South Australia in 1863, entered the Commonwealth as part of it in 190l, transferred to the Commonwealth in 1911, divided in 1927, but was reestablished in 1931. It was granted self government within the Commonwealth of Australia in 1978. %28%From Webster%27%s New Geographical Dictionary, 1988, p864%29%%A%    
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D015876 2000
% 222.25/222.39  |- mesh__dateRevised mesh__D015876 1995-02-21
% 222.25/222.39  |- skos__prefLabel mesh__D015876 Northern Territory
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D015876 1997
% 222.25/222.39  |- rdf__type mesh__D015876sskos__Concept
% 222.25/222.39  |- skos__historyNote mesh__D015876 Australia %28%1969-1989%29%
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D015876 2004
% 222.25/222.39  |- mesh__recordAuthorizer mesh__D015876 PLS
% 222.25/222.39  |- mesh__activeMeSHYear mesh__D015876 2002
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D015876 1996
% 222.25/222.40  |- mesh__historyNote mesh__D015876 90   
% 222.25/222.40  |- mesh__recordMaintainer mesh__D015876 PLS
% 222.25/222.40  |- mesh__dateCreated mesh__D015876 1989-10-13
% 222.25/222.40  |- skos__broader mesh__D015876smesh__D001315
% 222.25/222.40  |- skos__annotation mesh__D015876
% 222.25/222.40       a territory of Australia; do not confuse with NORTHWEST TERRITORIES, a division of Canada%A%  
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D015876 1999
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D015876 2003
% 222.25/222.40  |- mesh__dateEstablished mesh__D015876 1990-01-01
% 222.25/222.40  |- skos__prefLabel mesh__D015078 2-Hydroxyphenethylamine
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D015078 2006
% 222.25/222.40  |- skos__hiddenLabel mesh__D015078 beta Phenylethanolamine
% 222.25/222.40  |- skos__hiddenLabel mesh__D015078 beta Hydroxyphenethylamine
% 222.25/222.40  |- mesh__recordMaintainer mesh__D015078 CCR
% 222.25/222.40  |- skos__scopeNote mesh__D015078
% 222.25/222.40       Simple amine found in the brain. It may be modulator of sympathetic functions. Its derivatives are adrenergic agonists and antagonists. It is also used in chemical industry.%A%    
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D015078 2003
% 222.25/222.40  |- mesh__dateCreated mesh__D015078 1977-04-22
% 222.25/222.40  |- mesh__historyNote mesh__D015078
% 222.25/222.40       91%28%78%29%; was see under PHENETHYLAMINES 1978-90   
% 222.25/222.40  |- mesh__dateEstablished mesh__D015078 1991-01-01
% 222.25/222.40  |- skos__altLabel mesh__D015078 Bisnorephedrine
% 222.25/222.40  |- rdf__type mesh__D015078sskos__Concept
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D015078 2004
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D015078 2001
% 222.25/222.40  |- skos__broader mesh__D015078smesh__D015306
% 222.25/222.40  |- skos__broader mesh__D015078smesh__D010627
% 222.25/222.40  |- skos__broader mesh__D015078smesh__D004983
% 222.25/222.40  |- skos__hiddenLabel mesh__D015078 2 Phenylethanolamine
% 222.25/222.40  |- mesh__recordAuthorizer mesh__D015078 sjn
% 222.25/222.40  |- skos__altLabel mesh__D015078 beta-Phenylethanolamine
% 222.25/222.40  |- skos__altLabel mesh__D015078 2-Phenylethanolamine
% 222.25/222.40  |- mesh__recordOriginator mesh__D015078 SH
% 222.25/222.40  |- mesh__dateRevised mesh__D015078 2000-06-22
% 222.25/222.40  |- skos__historyNote mesh__D015078 Phenethylamines %28%1966-1973%29%
% 222.25/222.40  |- skos__altLabel mesh__D015078 beta-Hydroxyphenethylamine
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D015078 2005
% 222.25/222.40  |- skos__hiddenLabel mesh__D015078 2 Hydroxyphenethylamine
% 222.25/222.40  |- mesh__publicMeSHNote mesh__D015078
% 222.25/222.40       91; was see under PHENETHYLAMINES 1978-90   
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D015078 2002
% 222.25/222.40  |- skos__historyNote mesh__D015078 Ethanolamines %28%1973-1977%29%
% 222.25/222.40  |- skos__historyNote mesh__D015078 Amino Alcohols %28%1966-1972%29%
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D009839 2000
% 222.25/222.40  |- mesh__recordOriginator mesh__D009839 NLM
% 222.25/222.40  |- mesh__recordAuthorizer mesh__D009839 sjn
% 222.25/222.40  |- mesh__dateCreated mesh__D009839 1974-11-11
% 222.25/222.40  |- skos__annotation mesh__D009839
% 222.25/222.40       differentiate from scanty or shortlasting menstruation %28% = HYPOMENORRHEA see MENSTRUATION DISORDERS%29%%A%  
% 222.25/222.40  |- mesh__historyNote mesh__D009839
% 222.25/222.40       91%28%75%29%; was see under MENSTRUATION DISORDERS 1975-90   
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D009839 2004
% 222.25/222.40  |- mesh__dateRevised mesh__D009839 1999-11-03
% 222.25/222.40  |- mesh__recordMaintainer mesh__D009839 KEV
% 222.25/222.40  |- skos__scopeNote mesh__D009839 Abnormally infrequent menstruation.     
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D009839 2003
% 222.25/222.40  |- rdf__type mesh__D009839sskos__Concept
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D009839 2006
% 222.25/222.40  |- skos__prefLabel mesh__D009839 Oligomenorrhea
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D009839 2002
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D009839 2005
% 222.25/222.40  |- skos__hiddenLabel mesh__D009839 Oligomenorrheas
% 222.25/222.40  |- mesh__publicMeSHNote mesh__D009839
% 222.25/222.40       91; was see under MENSTRUATION DISORDERS 1975-90   
% 222.25/222.40  |- mesh__dateEstablished mesh__D009839 1991-01-01
% 222.25/222.40  |- skos__broader mesh__D009839smesh__D008599
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D009839 2001
% 222.25/222.40  |- skos__related mesh__D009839smesh__D000568
% 222.25/222.40  |- mesh__dateCreated mesh__D001856 1999-01-01
% 222.25/222.40  |- rdf__type mesh__D001856sskos__Concept
% 222.25/222.40  |- mesh__dateRevised mesh__D001856 1997-06-20
% 222.25/222.40  |- mesh__recordAuthorizer mesh__D001856 SJN
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001856 2002
% 222.25/222.40  |- skos__scopeNote mesh__D001856
% 222.25/222.40       Removal of bone marrow and evaluation of its histologic picture.%A%    
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001856 2006
% 222.25/222.40  |- skos__broader mesh__D001856smesh__D006403
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001856 2004
% 222.25/222.40  |- skos__hiddenLabel mesh__D001856 Bone Marrow Examinations
% 222.25/222.40  |- skos__prefLabel mesh__D001856 Bone Marrow Examination
% 222.25/222.40  |- mesh__recordMaintainer mesh__D001856 PXP
% 222.25/222.40  |- skos__annotation mesh__D001856 NIM; DF: BONE MARROW EXAM   
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001856 2005
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001856 2001
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001856 1999
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001856 2003
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001856 2000
% 222.25/222.40  |- skos__altLabel mesh__D001856 Examination, Bone Marrow
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001856 1998
% 222.25/222.40  |- mesh__recordOriginator mesh__D001856 NLM
% 222.25/222.40  |- skos__hiddenLabel mesh__D001856 Examinations, Bone Marrow
% 222.25/222.40  |- skos__hiddenLabel mesh__D001058 ApomorphinTeclapharm
% 222.25/222.40  |- skos__altLabel mesh__D001058
% 222.25/222.40       Aguettant Brand of Apomorphine Hydrochloride
% 222.25/222.40  |- rdf__type mesh__D001058sskos__Concept
% 222.25/222.40  |- skos__broader mesh__D001058smesh__D001060
% 222.25/222.40  |- skos__altLabel mesh__D001058
% 222.25/222.40       Britannia Brand of Apomorphine Hydrochloride
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001058 2006A
% 222.25/222.40  |- mesh__recordMaintainer mesh__D001058 jls
% 222.25/222.40  |- mesh__dateCreated mesh__D001058 1999-01-01
% 222.25/222.40  |- skos__altLabel mesh__D001058
% 222.25/222.40       Teclapharm Brand of Apomorphine Hydrochloride
% 222.25/222.40  |- skos__annotation mesh__D001058
% 222.25/222.40       apomorphine derivatives = APOMORPHINE/analogs   
% 222.25/222.40  |- skos__hiddenLabel mesh__D001058 Hydrochloride, Anhydrous Apomorphine
% 222.25/222.40  |- mesh__onlineNote mesh__D001058
% 222.25/222.40       use APOMORPHINE/analogs %26% derivatives to search APOMORPHINE DERIVATIVES 1975-77; use APOMORPHINE 1969-74%A%  
% 222.25/222.40  |- skos__scopeNote mesh__D001058
% 222.25/222.40       A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use.%A%    
% 222.25/222.40  |- mesh__recordAuthorizer mesh__D001058 jls
% 222.25/222.40  |- mesh__historyNote mesh__D001058
% 222.25/222.40       APOMORPHINE DERIVATIVES was see under APOMORPHINE 1969-77%A%  
% 222.25/222.40  |- skos__hiddenLabel mesh__D001058 Hemihydrate Apomorphine Hydrochloride
% 222.25/222.40  |- skos__hiddenLabel mesh__D001058 Apomorphin Teclapharm
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001058 2005
% 222.25/222.40  |- skos__hiddenLabel mesh__D001058 Hydrochloride, Hemihydrate Apomorphine
% 222.25/222.40  |- skos__hiddenLabel mesh__D001058 Chloride, Apomorphine
% 222.25/222.40  |- skos__prefLabel mesh__D001058 Apomorphine
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001058 2006
% 222.25/222.40  |- mesh__dateRevised mesh__D001058 2005-07-29
% 222.25/222.40  |- skos__hiddenLabel mesh__D001058 Anhydrous Apomorphine Hydrochloride
% 222.25/222.40  |- mesh__recordOriginator mesh__D001058 NLM
% 222.25/222.40  |- mesh__publicMeSHNote mesh__D001058
% 222.25/222.40       APOMORPHINE DERIVATIVES was see under APOMORPHINE 1969-77%A%  
% 222.25/222.40  |- skos__scopeNote mesh__D020212
% 222.25/222.40       Blunt and penetrating traumatic injuries of the common, internal, or external carotid arteries which may result from CRANIOCEREBRAL TRAUMA; THORACIC INJURIES; and NECK INJURIES. Damage to the artery may lead to CAROTID ARTERY THROMBOSIS; CAROTID-CAVERNOUS SINUS FISTULA; pseudoaneurysm formation; and internal carotid artery dissection %28%CAROTID ARTERY, INTERNAL, DISSECTION%29%. Clinical manifestations %28%e.g., stroke, HORNER SYNDROME%29% may be immediate or delayed. %28%From Am J Forensic Med Pathol 1997 Sep;18%28%3%29%:251-7; J Trauma 1994 Sep;37%28%3%29%:473-9%29%%A%    
% 222.25/222.40  |- skos__hiddenLabel mesh__D020212 Carotid Artery Trauma
% 222.25/222.40  |- skos__hiddenLabel mesh__D020212 Arteriopathy, Traumatic Carotid
% 222.25/222.40  |- skos__hiddenLabel mesh__D020212 Traumatic Carotid Arteriopathy
% 222.25/222.40  |- skos__hiddenLabel mesh__D020212 Arteriopathies, Traumatic Carotid
% 222.25/222.40  |- rdf__type mesh__D020212sskos__Concept
% 222.25/222.40  |- skos__altLabel mesh__D020212 Carotid Arteriopathies, Traumatic
% 222.25/222.40  |- skos__hiddenLabel mesh__D020212 Carotid Artery Traumas
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D020212 2002
% 222.25/222.40  |- skos__hiddenLabel mesh__D020212 Carotid Arteriopathy, Traumatic
% 222.25/222.40  |- mesh__dateEstablished mesh__D020212 2000-01-01
% 222.25/222.40  |- skos__prefLabel mesh__D020212 Carotid Artery Injuries
% 222.25/222.40  |- skos__hiddenLabel mesh__D020212 Traumatic Carotid Arteriopathies
% 222.25/222.40  |- skos__hiddenLabel mesh__D020212 Artery Traumas, Carotid
% 222.25/222.40  |- skos__hiddenLabel mesh__D020212 Artery Trauma, Carotid
% 222.25/222.40  |- mesh__publicMeSHNote mesh__D020212 2000   
% 222.25/222.40  |- skos__hiddenLabel mesh__D020212 Carotid Artery Injury
% 222.25/222.40  |- skos__broader mesh__D020212smesh__D002340
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D020212 2006
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D020212 2004
% 222.25/222.40  |- skos__broader mesh__D020212smesh__D020214
% 222.25/222.40  |- skos__hiddenLabel mesh__D020212 Artery Injuries, Carotid
% 222.25/222.40  |- skos__altLabel mesh__D020212 Injuries, Carotid Artery
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D020212 2005
% 222.25/222.40  |- skos__historyNote mesh__D020212
% 222.25/222.40       Carotid Artery Diseases %28%1965-1999%29%
% 222.25/222.40  |- skos__altLabel mesh__D020212 Trauma, Carotid Artery
% 222.25/222.40  |- mesh__dateCreated mesh__D020212 1999-11-03
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D020212 2001
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D020212 2003
% 222.25/222.40  |- skos__annotation mesh__D020212
% 222.25/222.40       GEN or unspecified; coord %28%IM%29% with specific carotid artery/inj %28%IM%29%%A%  
% 222.25/222.40  |- skos__hiddenLabel mesh__D020212 Injury, Carotid Artery
% 222.25/222.40  |- mesh__historyNote mesh__D020212 2000   
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D020212 2000
% 222.25/222.40  |- skos__hiddenLabel mesh__D020212 Artery Injury, Carotid
% 222.25/222.40  |- skos__hiddenLabel mesh__D020212 Traumas, Carotid Artery
% 222.25/222.40  |- skos__scopeNote mesh__D019469
% 222.25/222.40       A potent and specific HIV protease inhibitor that appears to have good oral bioavailability.%A%    
% 222.25/222.40  |- skos__hiddenLabel mesh__D019469 Sulfate, Indinavir
% 222.25/222.40  |- skos__hiddenLabel mesh__D019469 L 735,524
% 222.25/222.40  |- rdf__type mesh__D019469sskos__Concept
% 222.25/222.40  |- mesh__recordAuthorizer mesh__D019469 sjn
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D019469 2003
% 222.25/222.40  |- skos__historyNote mesh__D019469 Pyridines %28%1994-1996%29%
% 222.25/222.40  |- skos__hiddenLabel mesh__D019469 L 735 524
% 222.25/222.40  |- mesh__dateEstablished mesh__D019469 1997-01-01
% 222.25/222.40  |- mesh__dateRevised mesh__D019469 2001-07-25
% 222.25/222.40  |- mesh__recordMaintainer mesh__D019469 jmp
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D019469 2004
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D019469 2002
% 222.25/222.40  |- skos__altLabel mesh__D019469 Indinavir, Sulfate %28%1:1%29%
% 222.25/222.40  |- mesh__historyNote mesh__D019469 97; was INDINAVIR %28%NM%29% 1994-96   
% 222.25/222.40  |- mesh__publicMeSHNote mesh__D019469
% 222.25/222.40       97; INDINAVIR was indexed under PYRIDINES 1994-96   
% 222.25/222.40  |- skos__hiddenLabel mesh__D019469 L735,524
% 222.25/222.40  |- mesh__recordOriginator mesh__D019469 AGS
% 222.25/222.40  |- skos__prefLabel mesh__D019469 Indinavir
% 222.25/222.40  |- mesh__onlineNote mesh__D019469
% 222.25/222.40       use INDINAVIR %28%NM%29% to search INDINAVIR 1994-96   
% 222.25/222.40  |- skos__hiddenLabel mesh__D019469 L735 524
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D019469 2005
% 222.25/222.40  |- mesh__dateCreated mesh__D019469 1996-06-10
% 222.25/222.40  |- skos__altLabel mesh__D019469 L-735,524
% 222.25/222.40  |- skos__hiddenLabel mesh__D019469 MK 639
% 222.25/222.40  |- skos__hiddenLabel mesh__D019469 MK639
% 222.25/222.40  |- skos__broader mesh__D019469smesh__D011725
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D019469 2006
% 222.25/222.40  |- mesh__dateEstablished mesh__D011486 1987-01-01
% 222.25/222.40  |- skos__broader mesh__D011486smesh__D004792
% 222.25/222.40  |- mesh__dateRevised mesh__D011486 2005-06-30
% 222.25/222.40  |- mesh__recordMaintainer mesh__D011486 ssb
% 222.25/222.40  |- skos__broader mesh__D011486smesh__D019774
% 222.25/222.40  |- mesh__historyNote mesh__D011486 87   
% 222.25/222.40  |- mesh__recordAuthorizer mesh__D011486 sjn
% 222.25/222.40  |- mesh__dateCreated mesh__D011486 1986-06-02
% 222.25/222.40  |- skos__historyNote mesh__D011486 Glycoproteins %28%1966-1986%29%
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D011486 2006
% 222.25/222.40  |- skos__prefLabel mesh__D011486 Protein C
% 222.25/222.40  |- mesh__publicMeSHNote mesh__D011486 87   
% 222.25/222.40  |- mesh__recordOriginator mesh__D011486 RLS
% 222.25/222.40  |- rdf__type mesh__D011486sskos__Concept
% 222.25/222.40  |- skos__broader mesh__D011486smesh__D006023
% 222.25/222.40  |- skos__broader mesh__D011486smesh__D001798
% 222.25/222.40  |- skos__historyNote mesh__D011486 Blood Proteins %28%1966-1986%29%
% 222.25/222.40  |- skos__scopeNote mesh__D011486
% 222.25/222.40       A vitamin-K dependent zymogen present in the blood, which, upon activation by thrombin and thrombomodulin exerts anticoagulant properties by inactivating factors Va and VIIIa at the rate-limiting steps of thrombin formation.%A%    
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D005449 2000
% 222.25/222.40  |- mesh__recordMaintainer mesh__D005449 adp
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D005449 2004
% 222.25/222.40  |- mesh__recordAuthorizer mesh__D005449 sjn
% 222.25/222.40  |- skos__broader mesh__D005449smesh__D011084
% 222.25/222.40  |- skos__annotation mesh__D005449
% 222.25/222.40       carcinogenic aromatic hydrocarbons; do not confuse with FLUORINE; D25-26 qualif%A%  
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D005449 2003
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D005449 2006
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D005449 2005
% 222.25/222.40  |- skos__prefLabel mesh__D005449 Fluorenes
% 222.25/222.40  |- mesh__dateRevised mesh__D005449 1999-11-03
% 222.25/222.40  |- skos__scopeNote mesh__D005449
% 222.25/222.40       A family of diphenylenemethane derivatives.     
% 222.25/222.40  |- mesh__recordOriginator mesh__D005449 NLM
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D005449 2002
% 222.25/222.40  |- rdf__type mesh__D005449sskos__Concept
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D005449 2001
% 222.25/222.40  |- mesh__dateCreated mesh__D005449 1999-01-01
% 222.25/222.40  |- skos__hiddenLabel mesh__D016171 Pointes, Torsades de
% 222.25/222.40  |- mesh__recordMaintainer mesh__D016171 mdb
% 222.25/222.40  |- skos__hiddenLabel mesh__D016171 de Pointes, Torsades
% 222.25/222.40  |- mesh__dateEstablished mesh__D016171 1991-01-01
% 222.25/222.40  |- skos__broader mesh__D016171smesh__D017180
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D016171 2004
% 222.25/222.40  |- skos__prefLabel mesh__D016171 Torsades de Pointes
% 222.25/222.40  |- skos__historyNote mesh__D016171 Tachycardia %28%1974-1990%29%
% 222.25/222.40  |- skos__hiddenLabel mesh__D016171 Pointes, Torsade de
% 222.25/222.40  |- mesh__onlineNote mesh__D016171
% 222.25/222.40       use TACHYCARDIA to search TORSADES DE POINTES 1983-90   
% 222.25/222.40  |- mesh__dateRevised mesh__D016171 2002-07-03
% 222.25/222.40  |- skos__annotation mesh__D016171
% 222.25/222.40       a ventric tachycardia; in transl %22%torsade%22% or %22%torsades%22% is acceptable: use word of author%A%  
% 222.25/222.40  |- skos__scopeNote mesh__D016171
% 222.25/222.40       A ventricular tachycardia characterized by periodic twisting of the points of the QRS complexes and rates between 200 and 250 beats per minute. It may be self-limited or may progress to ventricular fibrillation.%A%    
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D016171 2005
% 222.25/222.40  |- mesh__dateCreated mesh__D016171 1990-04-24
% 222.25/222.40  |- skos__hiddenLabel mesh__D016171 de Pointes, Torsade
% 222.25/222.40  |- skos__altLabel mesh__D016171 Torsade de Pointes
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D016171 2006
% 222.25/222.40  |- skos__historyNote mesh__D016171 Arrhythmia %28%1974-1982%29%
% 222.25/222.40  |- mesh__recordOriginator mesh__D016171 PXP
% 222.25/222.40  |- mesh__recordAuthorizer mesh__D016171 sjn
% 222.25/222.40  |- rdf__type mesh__D016171sskos__Concept
% 222.25/222.40  |- mesh__publicMeSHNote mesh__D016171 91; was see TACHYCARDIA 1983-90   
% 222.25/222.40  |- mesh__historyNote mesh__D016171 91; was see TACHYCARDIA 1983-90   
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D016171 2003
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D002151 2005
% 222.25/222.40  |- mesh__dateEstablished mesh__D002151 1967-01-01
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D002151 2003
% 222.25/222.40  |- mesh__recordAuthorizer mesh__D002151 sjn
% 222.25/222.40  |- skos__scopeNote mesh__D002151
% 222.25/222.40       The measurement of the quantity of heat involved in various processes, such as chemical reactions, changes of state, and formations of solutions, or in the determination of the heat capacities of substances. The fundamental unit of measurement is the joule or the calorie %28%4.184 joules%29%. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D002151 2006
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D002151 2004
% 222.25/222.40  |- skos__annotation mesh__D002151 an anal chem technique; NIM   
% 222.25/222.40  |- mesh__recordMaintainer mesh__D002151 lkt
% 222.25/222.40  |- mesh__recordOriginator mesh__D002151 NLM
% 222.25/222.40  |- skos__broader mesh__D002151smesh__D002623
% 222.25/222.40  |- skos__prefLabel mesh__D002151 Calorimetry
% 222.25/222.40  |- mesh__publicMeSHNote mesh__D002151 67   
% 222.25/222.40  |- rdf__type mesh__D002151sskos__Concept
% 222.25/222.40  |- mesh__historyNote mesh__D002151 67%28%65%29%   
% 222.25/222.40  |- mesh__dateCreated mesh__D002151 1999-01-01
% 222.25/222.40  |- skos__broader mesh__D002151smesh__D008919
% 222.25/222.40  |- mesh__dateRevised mesh__D002151 2002-07-03
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D015877 2000A
% 222.25/222.40  |- rdf__type mesh__D015877sskos__Concept
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D015877 2000
% 222.25/222.40  |- skos__prefLabel mesh__D015877 Miosis
% 222.25/222.40  |- skos__hiddenLabel mesh__D015877 Pupil, Constricted
% 222.25/222.40  |- mesh__recordOriginator mesh__D015877 EGC
% 222.25/222.40  |- skos__hiddenLabel mesh__D015877 Constricted Pupils
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D015877 2001
% 222.25/222.40  |- skos__hiddenLabel mesh__D015877 Pupils, Small
% 222.25/222.40  |- skos__related mesh__D015877smesh__D008916
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D015877 2005
% 222.25/222.40  |- skos__hiddenLabel mesh__D015877 Mioses, Persistent
% 222.25/222.40  |- skos__hiddenLabel mesh__D015877 Mioses, Pupillary
% 222.25/222.40  |- mesh__historyNote mesh__D015877 1990   
% 222.25/222.40  |- skos__hiddenLabel mesh__D015877 Mioses
% 222.25/222.40  |- skos__hiddenLabel mesh__D015877 Pupils, Constricted
% 222.25/222.40  |- skos__hiddenLabel mesh__D015877 Pupillary Mioses
% 222.25/222.40  |- skos__historyNote mesh__D015877 Pupils %28%1966-1989%29%
% 222.25/222.40  |- skos__altLabel mesh__D015877 Small Pupil
% 222.25/222.40  |- skos__altLabel mesh__D015877 Miosis, Persistent
% 222.25/222.40  |- skos__hiddenLabel mesh__D015877 Persistent Mioses
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D015877 2006
% 222.25/222.40  |- mesh__publicMeSHNote mesh__D015877 1990   
% 222.25/222.40  |- skos__annotation mesh__D015877
% 222.25/222.40       do not confuse with MEIOSIS nor with MITOSIS, both cell division concepts%A%  
% 222.25/222.40  |- mesh__dateRevised mesh__D015877 1999-12-08
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D015877 2002
% 222.25/222.40  |- skos__hiddenLabel mesh__D015877 Miosis, Pupillary
% 222.25/222.40  |- skos__altLabel mesh__D015877 Constricted Pupil
% 222.25/222.40  |- mesh__recordMaintainer mesh__D015877 ags
% 222.25/222.40  |- mesh__dateCreated mesh__D015877 1989-05-25
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D015877 2003
% 222.25/222.40  |- mesh__recordAuthorizer mesh__D015877 ags
% 222.25/222.40  |- skos__hiddenLabel mesh__D015877 Pupil, Small
% 222.25/222.40  |- skos__scopeNote mesh__D015877
% 222.25/222.40       Pupillary constriction. This may result from congenital absence of the dilatator pupillary muscle, defective sympathetic innervation, or irritation of the CONJUNCTIVA or CORNEA.%A%    
% 222.25/222.40  |- skos__hiddenLabel mesh__D015877 Persistent Miosis
% 222.25/222.40  |- skos__hiddenLabel mesh__D015877 Small Pupils
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D015877 2004
% 222.25/222.40  |- mesh__dateEstablished mesh__D015877 1990-01-01
% 222.25/222.40  |- skos__altLabel mesh__D015877 Pupillary Miosis
% 222.25/222.40  |- skos__broader mesh__D015877smesh__D011681
% 222.25/222.40  |- mesh__recordAuthorizer mesh__D015079 sjn
% 222.25/222.40  |- skos__historyNote mesh__D015079 Ketoacid-Lyases %28%1973-1974%29%
% 222.25/222.40  |- mesh__dateEstablished mesh__D015079 1991-01-01
% 222.25/222.40  |- skos__hiddenLabel mesh__D015079 2 Isopropylmalate Synthase
% 222.25/222.40  |- mesh__dateCreated mesh__D015079 1974-11-19
% 222.25/222.40  |- skos__scopeNote mesh__D015079
% 222.25/222.40       An enzyme that catalyzes the first step in the biosynthetic pathway to LEUCINE, forming isopropyl malate from acetyl-CoA and alpha-ketoisovaleric acid. This enzyme was formerly listed as EC 4.1.3.12.%A%    
% 222.25/222.40  |- mesh__recordOriginator mesh__D015079 NLM
% 222.25/222.40  |- skos__historyNote mesh__D015079 Ketoacids %28%1973-1974%29%
% 222.25/222.40  |- skos__altLabel mesh__D015079 alpha-Isopropylmalate Synthase
% 222.25/222.40  |- skos__prefLabel mesh__D015079 2-Isopropylmalate Synthase
% 222.25/222.40  |- mesh__publicMeSHNote mesh__D015079
% 222.25/222.40       91; was see under KETOACID-LYASES 1975-90   
% 222.25/222.40  |- skos__hiddenLabel mesh__D015079 alpha Isopropylmalate Synthase
% 222.25/222.40  |- skos__historyNote mesh__D015079 Malates %28%1973-1974%29%
% 222.25/222.40  |- skos__broader mesh__D015079smesh__D000217
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D015079 2006
% 222.25/222.40  |- mesh__recordMaintainer mesh__D015079 jmp
% 222.25/222.40  |- mesh__historyNote mesh__D015079
% 222.25/222.40       91%28%75%29%; was see under KETOACID-LYASES 1975-90   
% 222.25/222.40  |- skos__hiddenLabel mesh__D015079 Synthase, alpha-Isopropylmalate
% 222.25/222.40  |- mesh__dateRevised mesh__D015079 2005-06-30
% 222.25/222.40  |- skos__hiddenLabel mesh__D015079 Synthase, 2-Isopropylmalate
% 222.25/222.40  |- rdf__type mesh__D015079sskos__Concept
% 222.25/222.40  |- skos__broader mesh__D011634Q000458smesh__D011634
% 222.25/222.40  |- mesh__preferredCombination mesh__D011634Q000458smesh__D011635
% 222.25/222.40  |- rdf__type mesh__D011634Q000458smesh__CompoundConcept
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001857 2006
% 222.25/222.40  |- skos__broader mesh__D001857smesh__D001842
% 222.25/222.40  |- skos__historyNote mesh__D001857 Bone and Bones %28%1966-1971%29%
% 222.25/222.40  |- skos__hiddenLabel mesh__D001857 Matrix, Bone
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001857 2001
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001857 2004
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001857 2000
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001857 1995
% 222.25/222.40  |- mesh__recordMaintainer mesh__D001857 TGC
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001857 1993
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001857 1990
% 222.25/222.40  |- mesh__recordAuthorizer mesh__D001857 PLS
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001857 2005
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001857 1999
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001857 2003
% 222.25/222.40  |- mesh__recordOriginator mesh__D001857 NLM
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001857 1994
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001857 1997
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001857 1992
% 222.25/222.40  |- skos__prefLabel mesh__D001857 Bone Matrix
% 222.25/222.40  |- mesh__historyNote mesh__D001857 72   
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001857 1998
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001857 1996
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001857 2002
% 222.25/222.40  |- mesh__dateCreated mesh__D001857 1999-01-01
% 222.25/222.40  |- rdf__type mesh__D001857sskos__Concept
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001857 1991
% 222.25/222.40  |- mesh__dateEstablished mesh__D001857 1972-01-01
% 222.25/222.40  |- skos__hiddenLabel mesh__D001857 Matrices, Bone
% 222.25/222.40  |- mesh__dateRevised mesh__D001857 1989-04-17
% 222.25/222.40  |- mesh__publicMeSHNote mesh__D001857 72   
% 222.25/222.40  |- skos__hiddenLabel mesh__D001857 Bone Matrices
% 222.25/222.40  |- skos__historyNote mesh__D001059 Proteins %28%1966-1971%29%
% 222.25/222.40  |- mesh__recordOriginator mesh__D001059 NLM
% 222.25/222.40  |- skos__historyNote mesh__D001059 Enzymes %28%1966-1971%29%
% 222.25/222.40  |- mesh__dateCreated mesh__D001059 1999-01-01
% 222.25/222.40  |- skos__prefLabel mesh__D001059 Apoproteins
% 222.25/222.40  |- mesh__historyNote mesh__D001059 74%28%72%29%   
% 222.25/222.40  |- skos__historyNote mesh__D001059
% 222.25/222.40       specific enzyme or protein %28%1966-1971%29%
% 222.25/222.40  |- mesh__recordAuthorizer mesh__D001059 sjn
% 222.25/222.40  |- skos__broader mesh__D001059smesh__D011506
% 222.25/222.40  |- skos__annotation mesh__D001059
% 222.25/222.40       /biosyn /drug eff /physiol /ultrastruct permitted   
% 222.25/222.40  |- mesh__publicMeSHNote mesh__D001059 74   
% 222.25/222.40  |- mesh__recordMaintainer mesh__D001059 DRC
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D001059 2006
% 222.25/222.40  |- mesh__dateRevised mesh__D001059 2005-06-30
% 222.25/222.40  |- rdf__type mesh__D001059sskos__Concept
% 222.25/222.40  |- mesh__dateEstablished mesh__D001059 1974-01-01
% 222.25/222.40  |- mesh__dateRevised mesh__D011487 2004-07-07
% 222.25/222.40  |- skos__hiddenLabel mesh__D011487 Conformation, Protein
% 222.25/222.40  |- skos__broader mesh__D011487smesh__D008968
% 222.25/222.40  |- skos__hiddenLabel mesh__D011487 Conformations, Protein
% 222.25/222.40  |- mesh__historyNote mesh__D011487 72   
% 222.25/222.40  |- rdf__type mesh__D011487sskos__Concept
% 222.25/222.40  |- skos__prefLabel mesh__D011487 Protein Conformation
% 222.25/222.40  |- skos__scopeNote mesh__D011487
% 222.25/222.40       The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary %28%motifs%29%, tertiary %28%domains%29% and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins %28%aggregates of more than one polypeptide chain%29%.%A%    
% 222.25/222.40  |- skos__annotation mesh__D011487
% 222.25/222.40       IM general; coord NIM with specific protein; peptide conformation = PEPTIDES or specific peptide %28%IM%29% + PROTEIN CONFORMATION %28%NIM%29%; index protein architecture here or under its specifics%A%  
% 222.25/222.40  |- mesh__recordAuthorizer mesh__D011487 sjn
% 222.25/222.40  |- mesh__recordOriginator mesh__D011487 NLM
% 222.25/222.40  |- skos__hiddenLabel mesh__D011487 Protein Conformations
% 222.25/222.40  |- skos__historyNote mesh__D011487 Proteins %28%1966-1971%29%
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D011487 2005
% 222.25/222.40  |- mesh__dateEstablished mesh__D011487 1972-01-01
% 222.25/222.40  |- mesh__dateCreated mesh__D011487 1999-01-01
% 222.25/222.40  |- mesh__activeMeSHYear mesh__D011487 2006
% 222.25/222.40  |- mesh__publicMeSHNote mesh__D011487 72   
% 222.25/222.40  |- mesh__recordMaintainer mesh__D011487 nns
% 222.25/222.40  |- skos__annotation mesh__D016970
% 222.25/222.40       in mouth %26% intestine; opportunistic; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 222.25/222.40  |- mesh__dateRevised mesh__D016970 2005-06-30
% 222.25/222.40  |- rdf__type mesh__D016970sskos__Concept
% 222.25/222.40  |- skos__historyNote mesh__D016970 Eikenella corrodens %28%1976-1991%29%
% 222.25/222.40  |- mesh__historyNote mesh__D016970 92   
% 222.25/222.40  |- mesh__recordOriginator mesh__D016970 PXP
% 222.25/222.40  |- skos__prefLabel mesh__D016970 Eikenella
% 222.25/222.41  |- mesh__publicMeSHNote mesh__D016970 92   
% 222.25/222.41  |- mesh__recordMaintainer mesh__D016970 SYSTEM
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D016970 2006
% 222.25/222.41  |- skos__broader mesh__D016970smesh__D009346
% 222.25/222.41  |- skos__historyNote mesh__D016970 Bacteroides %28%1973-1975%29%
% 222.25/222.41  |- skos__broader mesh__D016970smesh__D006092
% 222.25/222.41  |- mesh__dateCreated mesh__D016970 1991-05-30
% 222.25/222.41  |- mesh__dateEstablished mesh__D016970 1992-01-01
% 222.25/222.41  |- skos__scopeNote mesh__D016970
% 222.25/222.41       A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the human mouth and intestine. Organisms of this genus can be opportunistic pathogens.%A%    
% 222.25/222.41  |- mesh__recordAuthorizer mesh__D016970 sjn
% 222.25/222.41  |- mesh__historyNote mesh__D016172 91   
% 222.25/222.41  |- skos__annotation mesh__D016172
% 222.25/222.41       DNA FOOTPRINTING is available; do not confuse X ref DNA PROFILING with GENE EXPRESSION PROFILING%A%  
% 222.25/222.41  |- mesh__publicMeSHNote mesh__D016172 91   
% 222.25/222.41  |- skos__hiddenLabel mesh__D016172 Fingerprintings, Genetic
% 222.25/222.41  |- skos__hiddenLabel mesh__D016172 Fingerprinting, DNA
% 222.25/222.41  |- skos__hiddenLabel mesh__D016172 Fingerprintings, DNA
% 222.25/222.41  |- skos__broader mesh__D016172smesh__D005821
% 222.25/222.41  |- skos__prefLabel mesh__D016172 DNA Fingerprinting
% 222.25/222.41  |- skos__hiddenLabel mesh__D016172 Profiling, DNA
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D016172 2006
% 222.25/222.41  |- mesh__recordMaintainer mesh__D016172 nns
% 222.25/222.41  |- skos__altLabel mesh__D016172 DNA Typing
% 222.25/222.41  |- skos__hiddenLabel mesh__D016172 DNA Profilings
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D016172 2005
% 222.25/222.41  |- skos__historyNote mesh__D016172 Forensic Medicine %28%1986-1990%29%
% 222.25/222.41  |- skos__related mesh__D016172smesh__D018598
% 222.25/222.41  |- skos__historyNote mesh__D016172 Nucleotide Mapping %28%1986-1990%29%
% 222.25/222.41  |- skos__hiddenLabel mesh__D016172 Typing, DNA
% 222.25/222.41  |- skos__hiddenLabel mesh__D016172 Genetic Fingerprintings
% 222.25/222.41  |- skos__hiddenLabel mesh__D016172 DNA Typings
% 222.25/222.41  |- skos__altLabel mesh__D016172 DNA Profiling
% 222.25/222.41  |- mesh__recordOriginator mesh__D016172 PXP
% 222.25/222.41  |- skos__hiddenLabel mesh__D016172 Fingerprints, DNA
% 222.25/222.41  |- skos__related mesh__D016172smesh__D012150
% 222.25/222.41  |- rdf__type mesh__D016172sskos__Concept
% 222.25/222.41  |- mesh__recordAuthorizer mesh__D016172 sjn
% 222.25/222.41  |- skos__hiddenLabel mesh__D016172 Fingerprinting, Genetic
% 222.25/222.41  |- skos__related mesh__D016172smesh__D030561
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D016172 2004
% 222.25/222.41  |- skos__historyNote mesh__D016172 DNA %28%1986-1990%29%
% 222.25/222.41  |- skos__hiddenLabel mesh__D016172 Fingerprint, DNA
% 222.25/222.41  |- skos__related mesh__D016172smesh__D030661
% 222.25/222.41  |- mesh__dateCreated mesh__D016172 1990-05-07
% 222.25/222.41  |- mesh__dateEstablished mesh__D016172 1991-01-01
% 222.25/222.41  |- skos__broader mesh__D016172smesh__D005554
% 222.25/222.41  |- mesh__dateRevised mesh__D016172 2003-07-09
% 222.25/222.41  |- skos__hiddenLabel mesh__D016172 DNA Fingerprint
% 222.25/222.41  |- skos__hiddenLabel mesh__D016172 Typings, DNA
% 222.25/222.41  |- skos__hiddenLabel mesh__D016172 DNA Fingerprintings
% 222.25/222.41  |- skos__scopeNote mesh__D016172
% 222.25/222.41       A technique for identifying individuals of a species that is based on the uniqueness of their DNA sequence. Uniqueness is determined by identifying which combination of allelic variations occur in the individual at a statistically relevant number of different loci. In forensic studies, RESTRICTION FRAGMENT LENGTH POLYMORPHISM of multiple, highly polymorphic VNTR LOCI or MICROSATELLITE REPEAT loci are analyzed. The number of loci used for the profile depends on the ALLELE FREQUENCY in the population.%A%    
% 222.25/222.41  |- mesh__dateCreated mesh__D002950 1999-01-01
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002950 2006
% 222.25/222.41  |- mesh__dateEstablished mesh__D002950 1991-01-01
% 222.25/222.41  |- skos__broader mesh__D002950smesh__D000217
% 222.25/222.41  |- skos__altLabel mesh__D002950 Citrate Synthase
% 222.25/222.41  |- skos__prefLabel mesh__D002950 Citrate %28%si%29%-Synthase
% 222.25/222.41  |- mesh__dateRevised mesh__D002950 2005-06-30
% 222.25/222.41  |- mesh__publicMeSHNote mesh__D002950
% 222.25/222.41       98; see CITRATE SYNTHASE 1991-97, see KETOACID-LYASES 1973-90%A%  
% 222.25/222.41  |- mesh__recordMaintainer mesh__D002950 jmp
% 222.25/222.41  |- mesh__recordAuthorizer mesh__D002950 sjn
% 222.25/222.41  |- skos__hiddenLabel mesh__D002950 Synthase, Citrate
% 222.25/222.41  |- mesh__historyNote mesh__D002950 98%28%73%29%   
% 222.25/222.41  |- rdf__type mesh__D002950sskos__Concept
% 222.25/222.41  |- mesh__recordOriginator mesh__D002950 NLM
% 222.25/222.41  |- skos__scopeNote mesh__D002950
% 222.25/222.41       Enzyme that catalyzes the first step of the tricarboxylic acid cycle %28%CITRIC ACID CYCLE%29%. It catalyzes the reaction of oxaloacetate and acetyl CoA to form citrate and coenzyme A. This enzyme was formerly listed as EC 4.1.3.7.%A%    
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002152 2003
% 222.25/222.41  |- skos__prefLabel mesh__D002152 Calorimetry, Differential Scanning
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002152 2006
% 222.25/222.41  |- mesh__dateRevised mesh__D002152 2002-07-03
% 222.25/222.41  |- skos__altLabel mesh__D002152 Differential Scanning Calorimetry
% 222.25/222.41  |- mesh__historyNote mesh__D002152
% 222.25/222.41       91%28%77%29%; was see under CALORIMETRY 1977-90   
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002152 2004
% 222.25/222.41  |- skos__hiddenLabel mesh__D002152 Scanning Calorimetry, Differential
% 222.25/222.41  |- mesh__dateCreated mesh__D002152 1976-04-13
% 222.25/222.41  |- skos__broader mesh__D002152smesh__D004055
% 222.25/222.41  |- mesh__dateEstablished mesh__D002152 1991-01-01
% 222.25/222.41  |- mesh__publicMeSHNote mesh__D002152
% 222.25/222.41       91; was see under CALORIMETRY 1977-90   
% 222.25/222.41  |- skos__scopeNote mesh__D002152
% 222.25/222.41       Differential thermal analysis in which the sample compartment of the apparatus is a differential calorimeter, allowing an exact measure of the heat of transition independent of the specific heat, thermal conductivity, and other variables of the sample.%A%    
% 222.25/222.41  |- mesh__recordAuthorizer mesh__D002152 sjn
% 222.25/222.41  |- rdf__type mesh__D002152sskos__Concept
% 222.25/222.41  |- skos__annotation mesh__D002152
% 222.25/222.41       an anal chem technique; NIM; DF: CALORIMETRY DIFFER SCAN   
% 222.25/222.41  |- skos__historyNote mesh__D002152 Calorimetry %28%1966-1976%29%
% 222.25/222.41  |- mesh__recordMaintainer mesh__D002152 lkt
% 222.25/222.41  |- skos__broader mesh__D002152smesh__D002151
% 222.25/222.41  |- skos__altLabel mesh__D002152 Differential Thermal Analysis, Calorimetric
% 222.25/222.41  |- mesh__recordOriginator mesh__D002152 SMH
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002152 2005
% 222.25/222.41  |- skos__altLabel mesh__D002152 Calorimetric Differential Thermal Analysis
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D015878 2005
% 222.25/222.41  |- skos__prefLabel mesh__D015878 Mydriasis
% 222.25/222.41  |- mesh__dateRevised mesh__D015878 1999-11-09
% 222.25/222.41  |- mesh__recordOriginator mesh__D015878 EGC
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D015878 2006
% 222.25/222.41  |- mesh__historyNote mesh__D015878 90   
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D015878 2000
% 222.25/222.41  |- mesh__publicMeSHNote mesh__D015878 90   
% 222.25/222.41  |- skos__scopeNote mesh__D015878
% 222.25/222.41       Dilation of pupils to greater than 6 mm combined with failure of the pupils to constrict when stimulated with light. This condition may occur due to injury of the pupillary fibers in the oculomotor nerve, in acute angle-closure glaucoma, and in ADIE SYNDROME.%A%    
% 222.25/222.41  |- skos__related mesh__D015878smesh__D009184
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D015878 2001
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D015878 2003
% 222.25/222.41  |- mesh__dateEstablished mesh__D015878 1990-01-01
% 222.25/222.41  |- skos__historyNote mesh__D015878 Pupil %28%1967-1989%29%
% 222.25/222.41  |- rdf__type mesh__D015878sskos__Concept
% 222.25/222.41  |- mesh__recordAuthorizer mesh__D015878 sjn
% 222.25/222.41  |- skos__broader mesh__D015878smesh__D011681
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D015878 2002
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D015878 2004
% 222.25/222.41  |- skos__annotation mesh__D015878
% 222.25/222.41       pathol dilation of the pupils; do not use for state after admin of mydriatics %28% = PUPIL /drug eff%29% but MYDRIATICS is available%A%  
% 222.25/222.41  |- mesh__recordMaintainer mesh__D015878 KEV
% 222.25/222.41  |- mesh__dateCreated mesh__D015878 1989-09-06
% 222.25/222.41  |- skos__broader mesh__D001858smesh__D009984
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D001858 2005
% 222.25/222.41  |- skos__broader mesh__D001858smesh__D019736
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D001858 1999
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D001858 2003
% 222.25/222.41  |- mesh__recordMaintainer mesh__D001858 PXP
% 222.25/222.41  |- skos__related mesh__D001858smesh__D001863
% 222.25/222.41  |- mesh__dateEstablished mesh__D001858 1974-01-01
% 222.25/222.41  |- skos__annotation mesh__D001858 note X ref BONE PINS   
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D001858 2001
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D001858 1998
% 222.25/222.41  |- skos__scopeNote mesh__D001858
% 222.25/222.41       Rods of bone, metal, or other material used for fixation of the fragments or ends of fractured bones.%A%    
% 222.25/222.41  |- skos__hiddenLabel mesh__D001858 Pin, Bone
% 222.25/222.41  |- skos__prefLabel mesh__D001858 Bone Nails
% 222.25/222.41  |- skos__related mesh__D001858smesh__D001864
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D001858 2000
% 222.25/222.41  |- skos__hiddenLabel mesh__D001858 Pins, Bone
% 222.25/222.41  |- mesh__publicMeSHNote mesh__D001858 74   
% 222.25/222.41  |- mesh__dateCreated mesh__D001858 1999-01-01
% 222.25/222.41  |- mesh__recordOriginator mesh__D001858 NLM
% 222.25/222.41  |- rdf__type mesh__D001858sskos__Concept
% 222.25/222.41  |- skos__hiddenLabel mesh__D001858 Bone Pin
% 222.25/222.41  |- mesh__historyNote mesh__D001858 74%28%71%29%   
% 222.25/222.41  |- mesh__dateRevised mesh__D001858 1997-06-20
% 222.25/222.41  |- skos__altLabel mesh__D001858 Bone Pins
% 222.25/222.41  |- skos__hiddenLabel mesh__D001858 Bone Nail
% 222.25/222.41  |- mesh__recordAuthorizer mesh__D001858 SJN
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D001858 2006
% 222.25/222.41  |- skos__hiddenLabel mesh__D001858 Nails, Bone
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D001858 2002
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D001858 2004
% 222.25/222.41  |- skos__hiddenLabel mesh__D001858 Nail, Bone
% 222.25/222.41  |- mesh__dateCreated mesh__D012580 1999-01-01
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D012580 2000
% 222.25/222.41  |- mesh__publicMeSHNote mesh__D012580 68   
% 222.25/222.41  |- skos__altLabel mesh__D012580 Pharmacy Schools
% 222.25/222.41  |- mesh__recordAuthorizer mesh__D012580 sjn
% 222.25/222.41  |- skos__annotation mesh__D012580
% 222.25/222.41       Manual 30.7.3, 30.8; specify geog if pertinent; DF: SCHOOLS PHARM%A%  
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D012580 2003
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D012580 2001
% 222.25/222.41  |- mesh__recordMaintainer mesh__D012580 kle
% 222.25/222.41  |- skos__prefLabel mesh__D012580 Schools, Pharmacy
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D012580 2005
% 222.25/222.41  |- mesh__historyNote mesh__D012580 68   
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D012580 2004
% 222.25/222.41  |- skos__altLabel mesh__D012580 School, Pharmacy
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D012580 2006
% 222.25/222.41  |- mesh__dateEstablished mesh__D012580 1968-01-01
% 222.25/222.41  |- mesh__recordOriginator mesh__D012580 NLM
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D012580 2002
% 222.25/222.41  |- skos__scopeNote mesh__D012580
% 222.25/222.41       Educational institutions for individuals specializing in the field of pharmacy.%A%    
% 222.25/222.41  |- skos__broader mesh__D012580smesh__D012576
% 222.25/222.41  |- skos__historyNote mesh__D012580 Education, Pharmacy %28%1966-1967%29%
% 222.25/222.41  |- skos__altLabel mesh__D012580 Pharmacy School
% 222.25/222.41  |- rdf__type mesh__D012580sskos__Concept
% 222.25/222.41  |- mesh__dateRevised mesh__D012580 1999-11-03
% 222.25/222.41  |- skos__broader mesh__D020214smesh__D020196
% 222.25/222.41  |- skos__hiddenLabel mesh__D020214 Injury, Vascular Brain
% 222.25/222.41  |- skos__altLabel mesh__D020214 Injury, Vascular, Brain
% 222.25/222.41  |- skos__annotation mesh__D020214
% 222.25/222.41       GEN or unspecified only: prefer specific vessel/inj   
% 222.25/222.41  |- mesh__publicMeSHNote mesh__D020214 2000   
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D020214 2005
% 222.25/222.41  |- skos__historyNote mesh__D020214
% 222.25/222.41       Cerebrovascular Disorders %28%1964-1999%29%
% 222.25/222.41  |- skos__hiddenLabel mesh__D020214 Trauma, Cerebrovascular
% 222.25/222.41  |- skos__hiddenLabel mesh__D020214 Brain Vascular Trauma
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D020214 2003
% 222.25/222.41  |- mesh__historyNote mesh__D020214 2000   
% 222.25/222.41  |- skos__hiddenLabel mesh__D020214 Trauma, Brain Vascular
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D020214 2001
% 222.25/222.41  |- skos__hiddenLabel mesh__D020214 Vascular Brain Injury
% 222.25/222.41  |- mesh__dateCreated mesh__D020214 1999-11-04
% 222.25/222.41  |- skos__altLabel mesh__D020214 Vascular Injury, Brain
% 222.25/222.41  |- skos__altLabel mesh__D020214 Brain Injury, Vascular
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D020214 2000
% 222.25/222.41  |- skos__scopeNote mesh__D020214
% 222.25/222.41       Penetrating and nonpenetrating traumatic injuries to an extracranial or intracranial blood vessel that supplies the brain. This includes the CAROTID ARTERIES, vertebral arteries %28%VERTEBRAL ARTERY%29%, and intracranial arteries, veins, and venous sinuses.%A%    
% 222.25/222.41  |- skos__hiddenLabel mesh__D020214 Injury, Brain Vascular
% 222.25/222.41  |- skos__hiddenLabel mesh__D020214 Vascular Brain Injuries
% 222.25/222.41  |- rdf__type mesh__D020214sskos__Concept
% 222.25/222.41  |- skos__prefLabel mesh__D020214 Cerebrovascular Trauma
% 222.25/222.41  |- skos__hiddenLabel mesh__D020214 Brain Vascular Injury
% 222.25/222.41  |- skos__broader mesh__D020214smesh__D002561
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D020214 2006
% 222.25/222.41  |- skos__altLabel mesh__D020214 Vascular Trauma, Brain
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D020214 2002
% 222.25/222.41  |- skos__historyNote mesh__D020214
% 222.25/222.41       Carotid Artery Diseases %28%1964-1999%29%
% 222.25/222.41  |- skos__hiddenLabel mesh__D020214 Vascular Traumas, Brain
% 222.25/222.41  |- mesh__dateEstablished mesh__D020214 2000-01-01
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D020214 2004
% 222.25/222.41  |- skos__scopeNote mesh__D044662
% 222.25/222.41       A genus of BROWN ALGAE in the family Lessoniaceae, and one of the major forms of KELP. The species Macrocystis pyrifera, also known as giant kelp, is the largest of the marine algae.%A%    
% 222.25/222.41  |- mesh__dateRevised mesh__D044662 2005-06-30
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D044662 2006
% 222.25/222.41  |- mesh__recordAuthorizer mesh__D044662 sjn
% 222.25/222.41  |- skos__prefLabel mesh__D044662 Macrocystis
% 222.25/222.41  |- mesh__recordOriginator mesh__D044662 ags
% 222.25/222.41  |- skos__altLabel mesh__D044662 Macrocystis pyrifera
% 222.25/222.41  |- rdf__type mesh__D044662sskos__Concept
% 222.25/222.41  |- mesh__dateEstablished mesh__D044662 2004-01-01
% 222.25/222.41  |- mesh__historyNote mesh__D044662 2004   
% 222.25/222.41  |- mesh__recordMaintainer mesh__D044662 SYSTEM
% 222.25/222.41  |- skos__broader mesh__D044662smesh__D000459
% 222.25/222.41  |- mesh__publicMeSHNote mesh__D044662 2004   
% 222.25/222.41  |- mesh__dateCreated mesh__D044662 2003-07-09
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D011488 2006
% 222.25/222.41  |- skos__prefLabel mesh__D011488 Protein Deficiency
% 222.25/222.41  |- mesh__recordMaintainer mesh__D011488 lkt
% 222.25/222.41  |- rdf__type mesh__D011488sskos__Concept
% 222.25/222.41  |- skos__scopeNote mesh__D011488
% 222.25/222.41       A nutritional condition produced by a deficiency of proteins in the diet, characterized by adaptive enzyme changes in the liver, increase in amino acid synthetases, and diminution of urea formation, thus conserving nitrogen and reducing its loss in the urine. Growth, immune response, repair, and production of enzymes and hormones are all impaired in severe protein deficiency. Protein deficiency may also arise in the face of adequate protein intake if the protein is of poor quality %28%i.e., the content of one or more amino acids is inadequate and thus becomes the limiting factor in protein utilization%29%. %28%From Merck Manual, 16th ed; Harrison%27%s Principles of Internal Medicine, 12th ed, p406%29%%A%    
% 222.25/222.41  |- skos__hiddenLabel mesh__D011488 Deficiencies, Protein
% 222.25/222.41  |- mesh__recordAuthorizer mesh__D011488 sjn
% 222.25/222.41  |- mesh__recordOriginator mesh__D011488 NLM
% 222.25/222.41  |- skos__altLabel mesh__D011488 Deficiency, Protein
% 222.25/222.41  |- mesh__dateRevised mesh__D011488 2003-07-09
% 222.25/222.41  |- skos__hiddenLabel mesh__D011488 Protein Deficiencies
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D011488 2004
% 222.25/222.41  |- mesh__dateCreated mesh__D011488 1999-01-01
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D011488 2005
% 222.25/222.41  |- skos__broader mesh__D011488smesh__D003677
% 222.25/222.41  |- skos__annotation mesh__D011488
% 222.25/222.41       deficiency of dietary protein, not genetic defic of specific proteins; consider also PROTEIN-CALORIE MALNUTRITION; DF: PROTEIN DEFIC%A%  
% 222.25/222.41  |- rdf__type mesh__D016971sskos__Concept
% 222.25/222.41  |- mesh__dateEstablished mesh__D016971 1992-01-01
% 222.25/222.41  |- mesh__historyNote mesh__D016971 92   
% 222.25/222.41  |- mesh__recordAuthorizer mesh__D016971 sjn
% 222.25/222.41  |- skos__broader mesh__D016971smesh__D002954
% 222.25/222.41  |- mesh__recordOriginator mesh__D016971 PXP
% 222.25/222.41  |- skos__annotation mesh__D016971
% 222.25/222.41       infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 222.25/222.41  |- mesh__recordMaintainer mesh__D016971 SYSTEM
% 222.25/222.41  |- skos__scopeNote mesh__D016971
% 222.25/222.41       A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in humans and other animals including MAMMALS; BIRDS; REPTILES; and AMPHIBIANS. It has also been isolated from SOIL and WATER as well as from clinical specimens such as URINE; THROAT; SPUTUM; BLOOD; and wound swabs as an opportunistic pathogen.%A%    
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D016971 2006
% 222.25/222.41  |- mesh__dateRevised mesh__D016971 2005-06-30
% 222.25/222.41  |- skos__historyNote mesh__D016971 Citrobacter %28%1975-1991%29%
% 222.25/222.41  |- skos__historyNote mesh__D016971 Enterobacteriaceae %28%1966-1974%29%
% 222.25/222.41  |- skos__historyNote mesh__D016971 Escherichia %28%1966-1974%29%
% 222.25/222.41  |- mesh__publicMeSHNote mesh__D016971 92   
% 222.25/222.41  |- mesh__dateCreated mesh__D016971 1991-05-30
% 222.25/222.41  |- skos__prefLabel mesh__D016971 Citrobacter freundii
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D016173 2006
% 222.25/222.41  |- skos__altLabel mesh__D016173 Colony-Stimulating Factor, Macrophage
% 222.25/222.41  |- skos__altLabel mesh__D016173 Colony-Stimulating Factor 1
% 222.25/222.41  |- rdf__type mesh__D016173sskos__Concept
% 222.25/222.41  |- mesh__dateCreated mesh__D016173 1990-06-19
% 222.25/222.41  |- skos__scopeNote mesh__D016173
% 222.25/222.41       A mononuclear phagocyte colony-stimulating factor %28%M-CSF%29% synthesized by mesenchymal cells. The compound stimulates the survival, proliferation, and differentiation of hematopoietic cells of the monocyte-macrophage series. M-CSF is a disulfide-bonded glycoprotein dimer with a MW of 70 kDa. It binds to a specific high affinity receptor %28%RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR%29%.%A%    
% 222.25/222.41  |- mesh__recordAuthorizer mesh__D016173 sjn
% 222.25/222.41  |- mesh__dateRevised mesh__D016173 2005-06-30
% 222.25/222.41  |- skos__altLabel mesh__D016173 CSF-M
% 222.25/222.41  |- skos__altLabel mesh__D016173 CSF-1
% 222.25/222.41  |- mesh__historyNote mesh__D016173 91   
% 222.25/222.41  |- mesh__recordMaintainer mesh__D016173 ssb
% 222.25/222.41  |- mesh__publicMeSHNote mesh__D016173 91   
% 222.25/222.41  |- mesh__recordOriginator mesh__D016173 RLS
% 222.25/222.41  |- skos__altLabel mesh__D016173 M-CSF
% 222.25/222.41  |- skos__broader mesh__D016173smesh__D003115
% 222.25/222.41  |- skos__annotation mesh__D016173 DF: MCSF   
% 222.25/222.41  |- skos__hiddenLabel mesh__D016173 Colony Stimulating Factor 1
% 222.25/222.41  |- mesh__dateEstablished mesh__D016173 1991-01-01
% 222.25/222.41  |- skos__hiddenLabel mesh__D016173 Colony Stimulating Factor, Macrophage
% 222.25/222.41  |- skos__prefLabel mesh__D016173 Macrophage Colony-Stimulating Factor
% 222.25/222.41  |- skos__historyNote mesh__D016173
% 222.25/222.41       Colony-Stimulating Factors %28%1976-1990%29%
% 222.25/222.41  |- skos__related mesh__D016173smesh__D016186
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002951 2006
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002951 1997
% 222.25/222.41  |- mesh__dateRevised mesh__D002951 1992-05-11
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002951 1994
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002951 2001
% 222.25/222.41  |- mesh__publicMeSHNote mesh__D002951
% 222.25/222.41       RENACIDIN was see under PHARMACEUTIC AIDS 1964-80   
% 222.25/222.41  |- mesh__recordOriginator mesh__D002951 NLM
% 222.25/222.41  |- mesh__recordMaintainer mesh__D002951 TGC
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002951 1995
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002951 2003
% 222.25/222.41  |- mesh__recordAuthorizer mesh__D002951 PLS
% 222.25/222.41  |- mesh__historyNote mesh__D002951
% 222.25/222.41       RENACIDIN was see under PHARMACEUTIC AIDS 1964-80 %28%Prov 1964-74%29%%A%  
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002951 1998
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002951 2004
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002951 2002
% 222.25/222.41  |- skos__annotation mesh__D002951
% 222.25/222.41       /metab: consider also CITRIC ACID CYCLE   
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002951 1999
% 222.25/222.41  |- mesh__dateCreated mesh__D002951 1999-01-01
% 222.25/222.41  |- skos__broader mesh__D002951smesh__D014233
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002951 1993
% 222.25/222.41  |- skos__prefLabel mesh__D002951 Citrates
% 222.25/222.41  |- rdf__type mesh__D002951sskos__Concept
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002951 2005
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002951 1996
% 222.25/222.41  |- skos__related mesh__D002951smesh__D002952
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002951 2000
% 222.25/222.41  |- mesh__dateRevised mesh__D002153 1994-05-12
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002153 2002
% 222.25/222.41  |- rdf__type mesh__D002153sskos__Concept
% 222.25/222.41  |- mesh__dateEstablished mesh__D002153 1991-01-01
% 222.25/222.41  |- mesh__recordOriginator mesh__D002153 NLM
% 222.25/222.41  |- skos__hiddenLabel mesh__D002153 Respiration Calorimetry
% 222.25/222.41  |- mesh__recordAuthorizer mesh__D002153 PLS
% 222.25/222.41  |- skos__prefLabel mesh__D002153 Calorimetry, Indirect
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002153 1995
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002153 1998
% 222.25/222.41  |- skos__hiddenLabel mesh__D002153 Calorimetries, Respiration
% 222.25/222.41  |- skos__altLabel mesh__D002153 Calorimetry, Respiration
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002153 2005
% 222.25/222.41  |- skos__hiddenLabel mesh__D002153 Calorimetries, Indirect
% 222.25/222.41  |- mesh__publicMeSHNote mesh__D002153
% 222.25/222.41       91; was see under CALORIMETRY 1975-90   
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002153 1996
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002153 1999
% 222.25/222.41  |- mesh__recordMaintainer mesh__D002153 TGC
% 222.25/222.41  |- skos__hiddenLabel mesh__D002153 Respiration Calorimetries
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002153 2006
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002153 2003
% 222.25/222.41  |- mesh__dateCreated mesh__D002153 1974-12-12
% 222.25/222.41  |- mesh__historyNote mesh__D002153
% 222.25/222.41       91%28%75%29%; was see under CALORIMETRY 1975-90   
% 222.25/222.41  |- skos__scopeNote mesh__D002153
% 222.25/222.41       Calculation of the energy expenditure in the form of heat production of the whole body or individual organs based on respiratory gas exchange.%A%    
% 222.25/222.41  |- skos__hiddenLabel mesh__D002153 Indirect Calorimetries
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002153 2000
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002153 1997
% 222.25/222.41  |- skos__annotation mesh__D002153 an anal chem technique; NIM   
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002153 2004
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D002153 2001
% 222.25/222.41  |- skos__hiddenLabel mesh__D002153 Indirect Calorimetry
% 222.25/222.41  |- skos__broader mesh__D002153smesh__D002151
% 222.25/222.41  |- skos__hiddenLabel mesh__D015879 Subfragment-1, Heavy Meromyosin
% 222.25/222.41  |- skos__hiddenLabel mesh__D015879 Subfragment-2, Heavy Meromyosin
% 222.25/222.41  |- mesh__dateRevised mesh__D015879 2005-07-22
% 222.25/222.41  |- skos__hiddenLabel mesh__D015879 Subfragments, Myosin
% 222.25/222.41  |- mesh__recordOriginator mesh__D015879 AGS
% 222.25/222.41  |- skos__hiddenLabel mesh__D015879 Subfragments, Meromyosin
% 222.25/222.41  |- skos__hiddenLabel mesh__D015879 Meromyosin Subfragment-2, Heavy
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D015879 2006
% 222.25/222.41  |- skos__hiddenLabel mesh__D015879 Actin-S1 ATPase
% 222.25/222.41  |- mesh__historyNote mesh__D015879
% 222.25/222.41       90; MEROMYOSINS was heading 1971-90 %28%Prov 1971-73%29%   
% 222.25/222.41  |- skos__hiddenLabel mesh__D015879 Subfragment-2, Myosin
% 222.25/222.41  |- skos__hiddenLabel mesh__D015879 Subfragment-1, Myosin
% 222.25/222.41  |- skos__historyNote mesh__D015879 Muscle Proteins %28%1966-1970%29%
% 222.25/222.41  |- skos__hiddenLabel mesh__D015879 Meromyosin, Heavy
% 222.25/222.41  |- skos__altLabel mesh__D015879 Myosin S-2
% 222.25/222.41  |- skos__hiddenLabel mesh__D015879 Heavy Meromyosin Subfragment 1
% 222.25/222.41  |- skos__altLabel mesh__D015879 H-Meromyosin
% 222.25/222.41  |- skos__altLabel mesh__D015879 Myosin Subfragment-2
% 222.25/222.41  |- skos__broader mesh__D015879smesh__D009218
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D015879 2006A
% 222.25/222.41  |- skos__hiddenLabel mesh__D015879 Subfragments, Actomyosin
% 222.25/222.41  |- skos__hiddenLabel mesh__D015879 Myosin Subfragment 1
% 222.25/222.41  |- skos__hiddenLabel mesh__D015879 Meromyosin Subfragment-1, Heavy
% 222.25/222.41  |- skos__scopeNote mesh__D015879
% 222.25/222.41       Parts of the myosin molecule resulting from cleavage by proteolytic enzymes %28%PAPAIN; TRYPSIN; or CHYMOTRYPSIN%29% at well-localized regions. Study of these isolated fragments helps to delineate the functional roles of different parts of myosin. Two of the most common subfragments are myosin S-1 and myosin S-2. S-1 contains the heads of the heavy chains plus the light chains and S-2 contains part of the double-stranded, alpha-helical, heavy chain tail %28%myosin rod%29%.%A%    
% 222.25/222.41  |- mesh__recordMaintainer mesh__D015879 ags
% 222.25/222.41  |- skos__historyNote mesh__D015879 Peptide Fragments %28%1974-1989%29%
% 222.25/222.41  |- skos__hiddenLabel mesh__D015879 Heavy Meromyosin Subfragment 2
% 222.25/222.41  |- skos__altLabel mesh__D015879 ATPase, Actin-S1
% 222.25/222.41  |- skos__historyNote mesh__D015879 Myosin %28%1966-1989%29%
% 222.25/222.41  |- skos__altLabel mesh__D015879 Myosin Rod
% 222.25/222.41  |- skos__hiddenLabel mesh__D015879 Meromyosin, Actoheavy
% 222.25/222.41  |- skos__altLabel mesh__D015879 Myosin S-1
% 222.25/222.41  |- skos__altLabel mesh__D015879 Myosin Subfragment-1
% 222.25/222.41  |- skos__prefLabel mesh__D015879 Myosin Subfragments
% 222.25/222.41  |- skos__hiddenLabel mesh__D015879 Myosin S 1
% 222.25/222.41  |- rdf__type mesh__D015879sskos__Concept
% 222.25/222.41  |- skos__altLabel mesh__D015879 Actomyosin Subfragment 1 ATPase
% 222.25/222.41  |- skos__hiddenLabel mesh__D015879 Myosin Subfragment 2
% 222.25/222.41  |- skos__hiddenLabel mesh__D015879 H Meromyosin
% 222.25/222.41  |- mesh__dateCreated mesh__D015879 1989-05-25
% 222.25/222.41  |- skos__hiddenLabel mesh__D015879 Meromyosin, Light
% 222.25/222.41  |- mesh__dateEstablished mesh__D015879 1990-01-01
% 222.25/222.41  |- mesh__onlineNote mesh__D015879
% 222.25/222.41       use MYOSIN SUBFRAGMENTS to search MEROMYOSINS 1971-90 %28%as Prov 1971-73%29%%A%  
% 222.25/222.41  |- mesh__recordAuthorizer mesh__D015879 ags
% 222.25/222.41  |- mesh__publicMeSHNote mesh__D015879
% 222.25/222.41       90; MEROMYOSINS was heading 1974-90   
% 222.25/222.41  |- skos__hiddenLabel mesh__D015879 Myosin S 2
% 222.25/222.41  |- skos__hiddenLabel mesh__D015879 ATPase, Actin S1
% 222.25/222.41  |- skos__altLabel mesh__D015879 Actin S1 ATPase
% 222.25/222.41  |- mesh__recordMaintainer mesh__D001859 ags
% 222.25/222.41  |- mesh__dateCreated mesh__D001859 1999-01-01
% 222.25/222.41  |- skos__scopeNote mesh__D001859
% 222.25/222.41       Tumors or cancer located in bone tissue or specific BONES.%A%    
% 222.25/222.41  |- skos__altLabel mesh__D001859 Cancer of Bone
% 222.25/222.41  |- mesh__recordAuthorizer mesh__D001859 sjn
% 222.25/222.41  |- skos__altLabel mesh__D001859 Cancer of the Bone
% 222.25/222.41  |- skos__annotation mesh__D001859
% 222.25/222.41       GEN: prefer specific precoord; do not confuse with NEOPLASMS, BONE TISSUE %28%neopl composed of bone tissue%29%; coord IM with specific bone %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 222.25/222.41  |- skos__broader mesh__D001859smesh__D001847
% 222.25/222.41  |- rdf__type mesh__D001859sskos__Concept
% 222.25/222.41  |- skos__prefLabel mesh__D001859 Bone Neoplasms
% 222.25/222.41  |- skos__hiddenLabel mesh__D001859 Neoplasm, Bone
% 222.25/222.41  |- mesh__dateRevised mesh__D001859 2005-06-30
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D001859 2006
% 222.25/222.41  |- skos__altLabel mesh__D001859 Neoplasms, Bone
% 222.25/222.41  |- mesh__recordOriginator mesh__D001859 NLM
% 222.25/222.41  |- skos__hiddenLabel mesh__D001859 Bone Neoplasm
% 222.25/222.41  |- skos__broader mesh__D001859smesh__D009371
% 222.25/222.41  |- skos__hiddenLabel mesh__D012581 Health School, Public
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D012581 2005
% 222.25/222.41  |- skos__hiddenLabel mesh__D012581 School, Public Health
% 222.25/222.41  |- skos__hiddenLabel mesh__D012581 Public Health School
% 222.25/222.41  |- skos__hiddenLabel mesh__D012581 Health Schools, Public
% 222.25/222.41  |- mesh__activeMeSHYear mesh__D012581 2004
% 222.25/222.42  |- mesh__dateRevised mesh__D012581 1999-11-03
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012581 2006
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012581 2000
% 222.25/222.42  |- mesh__recordAuthorizer mesh__D012581 sjn
% 222.25/222.42  |- skos__altLabel mesh__D012581 Public Health Schools
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012581 2001
% 222.25/222.42  |- mesh__recordMaintainer mesh__D012581 kle
% 222.25/222.42  |- skos__broader mesh__D012581smesh__D012576
% 222.25/222.42  |- skos__prefLabel mesh__D012581 Schools, Public Health
% 222.25/222.42  |- rdf__type mesh__D012581sskos__Concept
% 222.25/222.42  |- mesh__recordOriginator mesh__D012581 NLM
% 222.25/222.42  |- skos__annotation mesh__D012581
% 222.25/222.42       Manual 30.7.3, 30.8; specify geog if pertinent   
% 222.25/222.42  |- mesh__dateCreated mesh__D012581 1999-01-01
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012581 2002
% 222.25/222.42  |- skos__scopeNote mesh__D012581
% 222.25/222.42       Educational institutions for individuals specializing in the field of public health.%A%    
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012581 2003
% 222.25/222.42  |- mesh__publicMeSHNote mesh__D020215 2000   
% 222.25/222.42  |- skos__altLabel mesh__D020215 Carotid Artery Dissection, Internal
% 222.25/222.42  |- skos__broader mesh__D020215smesh__D000784
% 222.25/222.42  |- mesh__dateEstablished mesh__D020215 2000-01-01
% 222.25/222.42  |- skos__scopeNote mesh__D020215
% 222.25/222.42       A hemorrhage into the wall of the carotid artery, separating the intima from the media and leading to aneurysm formation. This process may occlude the carotid artery and result in thromboembolic complications, including CEREBRAL INFARCTION. Dissections may occur spontaneously or follow CRANIOCEREBRAL TRAUMA; NECK INJURIES; and rarely severe bouts of coughing. %28%Adams et al., Principles of Neurology, 6th ed, p830%29%%A%    
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D020215 2000
% 222.25/222.42  |- skos__broader mesh__D020215smesh__D002340
% 222.25/222.42  |- skos__altLabel mesh__D020215 Internal Carotid Artery Dissection
% 222.25/222.42  |- rdf__type mesh__D020215sskos__Concept
% 222.25/222.42  |- skos__broader mesh__D020215smesh__D020212
% 222.25/222.42  |- skos__prefLabel mesh__D020215 Carotid Artery, Internal, Dissection
% 222.25/222.42  |- skos__historyNote mesh__D020215
% 222.25/222.42       Carotid Artery Diseases %28%1969-1999%29%
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D020215 2005
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D020215 2001
% 222.25/222.42  |- mesh__dateCreated mesh__D020215 1999-11-03
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D020215 2003
% 222.25/222.42  |- mesh__historyNote mesh__D020215 2000   
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D020215 2006
% 222.25/222.42  |- skos__altLabel mesh__D020215 Dissection, Internal Carotid Artery
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D020215 2002
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D020215 2004
% 222.25/222.42  |- skos__broader mesh__D044663smesh__D044523
% 222.25/222.42  |- skos__historyNote mesh__D044663 Algae %28%1966-2003%29%
% 222.25/222.42  |- rdf__type mesh__D044663sskos__Concept
% 222.25/222.42  |- skos__prefLabel mesh__D044663 Ochromonas
% 222.25/222.42  |- mesh__dateRevised mesh__D044663 2005-06-30
% 222.25/222.42  |- mesh__recordAuthorizer mesh__D044663 sjn
% 222.25/222.42  |- skos__historyNote mesh__D044663 Mastigophora %28%1965-1985%29%
% 222.25/222.42  |- mesh__recordMaintainer mesh__D044663 SYSTEM
% 222.25/222.42  |- mesh__recordOriginator mesh__D044663 ags
% 222.25/222.42  |- mesh__publicMeSHNote mesh__D044663 2004   
% 222.25/222.42  |- mesh__dateEstablished mesh__D044663 2004-01-01
% 222.25/222.42  |- mesh__dateCreated mesh__D044663 2003-07-09
% 222.25/222.42  |- skos__scopeNote mesh__D044663
% 222.25/222.42       A genus of GOLDEN-BROWN ALGAE in the family Ochromonadaceae, found mostly in freshwater. They bear two unequal FLAGELLA and are heterotrophic.%A%    
% 222.25/222.42  |- mesh__historyNote mesh__D044663 2004   
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D044663 2006
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D011489 1998
% 222.25/222.42  |- rdf__type mesh__D011489sskos__Concept
% 222.25/222.42  |- mesh__dateEstablished mesh__D011489 1966-01-01
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D011489 2003
% 222.25/222.42  |- mesh__dateRevised mesh__D011489 1992-05-18
% 222.25/222.42  |- skos__hiddenLabel mesh__D011489 Denaturation, Protein
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D011489 1993
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D011489 1999
% 222.25/222.42  |- mesh__historyNote mesh__D011489 66%28%64%29%   
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D011489 2004
% 222.25/222.42  |- skos__broader mesh__D011489smesh__D001669
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D011489 1994
% 222.25/222.42  |- mesh__recordAuthorizer mesh__D011489 PLS
% 222.25/222.42  |- mesh__dateCreated mesh__D011489 1999-01-01
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D011489 2000
% 222.25/222.42  |- mesh__recordMaintainer mesh__D011489 TGC
% 222.25/222.42  |- skos__annotation mesh__D011489
% 222.25/222.42       IM general only; coord NIM with specific protein %28%IM%29%   
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D011489 2005
% 222.25/222.42  |- mesh__recordOriginator mesh__D011489 NLM
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D011489 1995
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D011489 1996
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D011489 2001
% 222.25/222.42  |- skos__prefLabel mesh__D011489 Protein Denaturation
% 222.25/222.42  |- skos__hiddenLabel mesh__D011489 Protein Denaturations
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D011489 2006
% 222.25/222.42  |- mesh__publicMeSHNote mesh__D011489 66   
% 222.25/222.42  |- skos__hiddenLabel mesh__D011489 Denaturations, Protein
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D011489 1997
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D011489 2002
% 222.25/222.42  |- mesh__recordOriginator mesh__D016972 PXP
% 222.25/222.42  |- skos__annotation mesh__D016972
% 222.25/222.42       nosocomial; infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 222.25/222.42  |- mesh__publicMeSHNote mesh__D016972 92   
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D016972 2006
% 222.25/222.42  |- mesh__recordMaintainer mesh__D016972 SYSTEM
% 222.25/222.42  |- mesh__dateEstablished mesh__D016972 1992-01-01
% 222.25/222.42  |- skos__historyNote mesh__D016972 Enterobacter %28%1966-1991%29%
% 222.25/222.42  |- mesh__dateCreated mesh__D016972 1991-05-30
% 222.25/222.42  |- mesh__recordAuthorizer mesh__D016972 sjn
% 222.25/222.42  |- skos__prefLabel mesh__D016972 Enterobacter cloacae
% 222.25/222.42  |- rdf__type mesh__D016972sskos__Concept
% 222.25/222.42  |- mesh__historyNote mesh__D016972 92   
% 222.25/222.42  |- mesh__dateRevised mesh__D016972 2005-06-30
% 222.25/222.42  |- skos__broader mesh__D016972smesh__D004754
% 222.25/222.42  |- skos__scopeNote mesh__D016972
% 222.25/222.42       A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in water, sewage, soil, meat, hospital environments, and on the skin and in the intestinal tract of man and animals as a commensal.%A%    
% 222.25/222.42  |- skos__hiddenLabel mesh__D016174 Hepatitis C Viruses
% 222.25/222.42  |- mesh__dateEstablished mesh__D016174 1991-01-01
% 222.25/222.42  |- mesh__historyNote mesh__D016174 2002 %28%1991%29%   
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D016174 2006
% 222.25/222.42  |- skos__scopeNote mesh__D016174
% 222.25/222.42       A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the only member and type species.%A%    
% 222.25/222.42  |- skos__altLabel mesh__D016174 Hepatitis C-Like Viruses
% 222.25/222.42  |- skos__historyNote mesh__D016174 Hepatitis Viruses %28%1988-1990%29%
% 222.25/222.42  |- rdf__type mesh__D016174sskos__Concept
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D016174 2005
% 222.25/222.42  |- skos__hiddenLabel mesh__D016174 Hepatitis C Like Viruses
% 222.25/222.42  |- skos__annotation mesh__D016174
% 222.25/222.42       infection = HEPATITIS C or HEPATITIS C, CHRONIC   
% 222.25/222.42  |- mesh__recordAuthorizer mesh__D016174 sjn
% 222.25/222.42  |- mesh__dateCreated mesh__D016174 1990-04-24
% 222.25/222.42  |- mesh__recordOriginator mesh__D016174 AGS
% 222.25/222.42  |- mesh__recordMaintainer mesh__D016174 lkt
% 222.25/222.42  |- mesh__publicMeSHNote mesh__D016174
% 222.25/222.42       2002; see HEPATITIS C-LIKE VIRUSES 1997-2001, see HEPATITIS C VIRUSES 1994-1996, see HEPATITIS C VIRUS 1991-1993%A%  
% 222.25/222.42  |- skos__broader mesh__D016174smesh__D006518
% 222.25/222.42  |- skos__hiddenLabel mesh__D016174 Hepatitis C-Like Virus
% 222.25/222.42  |- skos__prefLabel mesh__D016174 Hepacivirus
% 222.25/222.42  |- mesh__dateRevised mesh__D016174 2004-07-07
% 222.25/222.42  |- skos__hiddenLabel mesh__D016174 Hepaciviruses
% 222.25/222.42  |- skos__broader mesh__D016174smesh__D018067
% 222.25/222.42  |- skos__scopeNote mesh__D002952
% 222.25/222.42       A series of oxidative reactions in the breakdown of acetyl units derived from GLUCOSE; FATTY ACIDS; or AMINO ACIDS by means of tricarboxylic acid intermediates. The end products are CARBON DIOXIDE, water, and energy in the form of phosphate bonds.%A%    
% 222.25/222.42  |- mesh__recordOriginator mesh__D002952 NLM
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D002952 2006
% 222.25/222.42  |- mesh__recordMaintainer mesh__D002952 lkt
% 222.25/222.42  |- skos__broader mesh__D002952smesh__D004734
% 222.25/222.42  |- mesh__historyNote mesh__D002952 85; was KREBS CYCLE 1963-84   
% 222.25/222.42  |- mesh__dateCreated mesh__D002952 1999-01-01
% 222.25/222.42  |- skos__hiddenLabel mesh__D002952 Cycles, Citric Acid
% 222.25/222.42  |- skos__hiddenLabel mesh__D002952 Cycle, Tricarboxylic Acid
% 222.25/222.42  |- skos__hiddenLabel mesh__D002952 Cycle, Citric Acid
% 222.25/222.42  |- skos__prefLabel mesh__D002952 Citric Acid Cycle
% 222.25/222.42  |- rdf__type mesh__D002952sskos__Concept
% 222.25/222.42  |- skos__altLabel mesh__D002952 Tricarboxylic Acid Cycle
% 222.25/222.42  |- skos__hiddenLabel mesh__D002952 Tricarboxylic Acid Cycles
% 222.25/222.42  |- mesh__recordAuthorizer mesh__D002952 sjn
% 222.25/222.42  |- skos__hiddenLabel mesh__D002952 Cycles, Tricarboxylic Acid
% 222.25/222.42  |- skos__altLabel mesh__D002952 Krebs Cycle
% 222.25/222.42  |- mesh__publicMeSHNote mesh__D002952 85; was KREBS CYCLE 1963-84   
% 222.25/222.42  |- mesh__dateRevised mesh__D002952 2005-06-30
% 222.25/222.42  |- skos__hiddenLabel mesh__D002952 Citric Acid Cycles
% 222.25/222.42  |- mesh__onlineNote mesh__D002952
% 222.25/222.42       use CITRIC ACID CYCLE to search KREBS CYCLE 1966-84   
% 222.25/222.42  |- skos__hiddenLabel mesh__D002952 Cycle, Krebs
% 222.25/222.42  |- skos__hiddenLabel mesh__D002154 Protease, Calcium-Activated Neutral
% 222.25/222.42  |- skos__hiddenLabel mesh__D002154 Calcium Activated Protease
% 222.25/222.42  |- skos__hiddenLabel mesh__D002154 Calcium Activated Neutral Protease
% 222.25/222.42  |- skos__hiddenLabel mesh__D002154 II, Calpain
% 222.25/222.42  |- mesh__recordAuthorizer mesh__D002154 sjn
% 222.25/222.42  |- skos__altLabel mesh__D002154 Calcium-Activated Neutral Proteinase
% 222.25/222.42  |- skos__hiddenLabel mesh__D002154 Proteinase, Calcium-Dependent Neutral
% 222.25/222.42  |- skos__scopeNote mesh__D002154
% 222.25/222.42       Cysteine proteinase found in many tissues. Hydrolyzes a variety of endogenous proteins including neuropeptides, cytoskeletal proteins, proteins from smooth muscle, cardiac muscle, liver, platelets and erythrocytes. Two subclasses having high and low calcium sensitivity are known. Removes Z-discs and M-lines from myofibrils. Activates phosphorylase kinase and cyclic nucleotide-independent protein kinase. This enzyme was formerly listed as EC 3.4.22.4.%A%    
% 222.25/222.42  |- rdf__type mesh__D002154sskos__Concept
% 222.25/222.42  |- skos__hiddenLabel mesh__D002154 Calcium Activated Neutral Proteinase
% 222.25/222.42  |- skos__hiddenLabel mesh__D002154 Protease, Ca2+-Activated
% 222.25/222.42  |- skos__prefLabel mesh__D002154 Calpain
% 222.25/222.42  |- mesh__dateRevised mesh__D002154 2005-06-30
% 222.25/222.42  |- skos__hiddenLabel mesh__D002154 Protease, Calcium-Activated
% 222.25/222.42  |- skos__hiddenLabel mesh__D002154 Neutral Proteinase, Calcium-Activated
% 222.25/222.42  |- mesh__recordMaintainer mesh__D002154 jmp
% 222.25/222.42  |- skos__hiddenLabel mesh__D002154 I, Calpain
% 222.25/222.42  |- skos__annotation mesh__D002154 /biosyn /physiol permitted   
% 222.25/222.42  |- mesh__recordOriginator mesh__D002154 RLS
% 222.25/222.42  |- skos__altLabel mesh__D002154 Calcium-Activated Protease
% 222.25/222.42  |- skos__altLabel mesh__D002154 Ca2+-Activated Protease
% 222.25/222.42  |- skos__altLabel mesh__D002154 Calcium-Dependent Neutral Proteinase
% 222.25/222.42  |- skos__historyNote mesh__D002154
% 222.25/222.42       Peptide Peptidohydrolases %28%1966-1985%29%
% 222.25/222.42  |- skos__hiddenLabel mesh__D002154 Proteinase, Calcium-Activated Neutral
% 222.25/222.42  |- skos__hiddenLabel mesh__D002154 Neutral Proteinase, Calcium-Dependent
% 222.25/222.42  |- skos__broader mesh__D002154smesh__D003546
% 222.25/222.42  |- mesh__historyNote mesh__D002154 86   
% 222.25/222.42  |- mesh__publicMeSHNote mesh__D002154 86   
% 222.25/222.42  |- mesh__dateEstablished mesh__D002154 1986-01-01
% 222.25/222.42  |- skos__hiddenLabel mesh__D002154 Calcium Dependent Neutral Proteinase
% 222.25/222.42  |- skos__hiddenLabel mesh__D002154 Calcium Dependent Neutral Protease
% 222.25/222.42  |- mesh__dateCreated mesh__D002154 1985-04-25
% 222.25/222.42  |- skos__hiddenLabel mesh__D002154 Ca2+ Activated Protease
% 222.25/222.42  |- skos__altLabel mesh__D002154 Calcium-Activated Neutral Protease
% 222.25/222.42  |- skos__hiddenLabel mesh__D002154 Protease, Calcium-Dependent Neutral
% 222.25/222.42  |- skos__altLabel mesh__D002154 Calcium-Dependent Neutral Protease
% 222.25/222.42  |- skos__hiddenLabel mesh__D002154 Neutral Protease, Calcium-Dependent
% 222.25/222.42  |- skos__altLabel mesh__D002154 Desminase
% 222.25/222.42  |- skos__hiddenLabel mesh__D002154 Neutral Protease, Calcium-Activated
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D002154 2006
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012582 2001
% 222.25/222.42  |- mesh__recordOriginator mesh__D012582 NLM
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012582 2004
% 222.25/222.42  |- skos__scopeNote mesh__D012582
% 222.25/222.42       Educational institutions for individuals specializing in the field of veterinary medicine.%A%    
% 222.25/222.42  |- mesh__dateCreated mesh__D012582 1999-01-01
% 222.25/222.42  |- skos__prefLabel mesh__D012582 Schools, Veterinary
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012582 2000
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012582 2003
% 222.25/222.42  |- skos__altLabel mesh__D012582 Veterinary School
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012582 2006
% 222.25/222.42  |- skos__altLabel mesh__D012582 School, Veterinary
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012582 2002
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012582 2005
% 222.25/222.42  |- skos__broader mesh__D012582smesh__D012576
% 222.25/222.42  |- skos__altLabel mesh__D012582 Veterinary Schools
% 222.25/222.42  |- mesh__recordAuthorizer mesh__D012582 sjn
% 222.25/222.42  |- mesh__recordMaintainer mesh__D012582 kle
% 222.25/222.42  |- mesh__dateRevised mesh__D012582 1999-11-03
% 222.25/222.42  |- rdf__type mesh__D012582sskos__Concept
% 222.25/222.42  |- skos__annotation mesh__D012582
% 222.25/222.42       Manual 30.7.3, 30.8; specify geog if pertinent; DF: SCHOOLS VET%A%  
% 222.25/222.42  |- mesh__recordMaintainer mesh__D020216 jls
% 222.25/222.42  |- skos__hiddenLabel mesh__D020216 Fistula, Carotid Artery Cavernous Sinus
% 222.25/222.42  |- skos__hiddenLabel mesh__D020216 Fistula, C-C
% 222.25/222.42  |- skos__hiddenLabel mesh__D020216 Fistulas, C-C
% 222.25/222.42  |- mesh__dateEstablished mesh__D020216 2000-01-01
% 222.25/222.42  |- mesh__recordAuthorizer mesh__D020216 sjn
% 222.25/222.42  |- skos__hiddenLabel mesh__D020216 Fistula, Carotid-Cavernous Sinus
% 222.25/222.42  |- mesh__publicMeSHNote mesh__D020216 2000   
% 222.25/222.42  |- skos__historyNote mesh__D020216 Arteriovenous Fistula %28%1964-1999%29%
% 222.25/222.42  |- skos__hiddenLabel mesh__D020216 Pseudoaneurysm, Carotid
% 222.25/222.42  |- skos__broader mesh__D020216smesh__D002340
% 222.25/222.42  |- rdf__type mesh__D020216sskos__Concept
% 222.25/222.42  |- skos__historyNote mesh__D020216
% 222.25/222.42       Carotid Artery Diseases %28%1964-1999%29%
% 222.25/222.42  |- skos__hiddenLabel mesh__D020216 C-C Fistulas
% 222.25/222.42  |- skos__prefLabel mesh__D020216 Carotid-Cavernous Sinus Fistula
% 222.25/222.42  |- skos__hiddenLabel mesh__D020216 Fistulas, Carotid-Cavernous Sinus
% 222.25/222.42  |- skos__altLabel mesh__D020216 Fistula, Carotid Artery-Cavernous Sinus
% 222.25/222.42  |- mesh__recordOriginator mesh__D020216 KEV
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D020216 2005
% 222.25/222.42  |- skos__altLabel mesh__D020216 Carotid Artery-Cavernous Sinus Fistula
% 222.25/222.42  |- mesh__dateRevised mesh__D020216 2004-07-19
% 222.25/222.42  |- skos__historyNote mesh__D020216 Cavernous Sinus %28%1964-1999%29%
% 222.25/222.42  |- skos__hiddenLabel mesh__D020216 Carotid Cavernous Sinus Fistula
% 222.25/222.42  |- mesh__historyNote mesh__D020216 2000   
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D020216 2006
% 222.25/222.42  |- skos__scopeNote mesh__D020216
% 222.25/222.42       Laceration of the intracavernous portion of the carotid artery or one of its intracavernous branches resulting in a direct communication between the internal carotid artery and the cavernous sinus. Clinically, this produces a pulsatile exophthalmus and a marked limitation of extraocular motion in the affected eye. CRANIOCEREBRAL TRAUMA, especially basilar skull fractures %28%SKULL FRACTURE, BASILAR%29% is the most common cause of this condition, but it may also occur spontaneously or in association with diseases featuring defective connective tissue, such as EHLERS-DANLOS SYNDROME. %28%Adams et al., Principles of Neurology, 6th ed, p877%29%%A%    
% 222.25/222.42  |- skos__hiddenLabel mesh__D020216 Carotid Artery Cavernous Sinus Fistula
% 222.25/222.42  |- skos__broader mesh__D020216smesh__D020212
% 222.25/222.42  |- skos__hiddenLabel mesh__D020216 Carotid-Cavernous Sinus Fistulas
% 222.25/222.42  |- skos__hiddenLabel mesh__D020216
% 222.25/222.42       Traumatic Carotid Cavernous Sinus Fistula
% 222.25/222.42  |- skos__altLabel mesh__D020216 C-C Fistula
% 222.25/222.42  |- mesh__dateCreated mesh__D020216 1999-11-03
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D044664 2006
% 222.25/222.42  |- rdf__type mesh__D044664sskos__Concept
% 222.25/222.42  |- skos__broader mesh__D044664smesh__D000461
% 222.25/222.42  |- mesh__recordAuthorizer mesh__D044664 sjn
% 222.25/222.42  |- skos__prefLabel mesh__D044664 Porphyra
% 222.25/222.42  |- skos__scopeNote mesh__D044664
% 222.25/222.42       A genus of RED ALGAE in the family Bangiaceae.  It is the most widely consumed SEAWEED in the world and especially in Asia.%A%    
% 222.25/222.42  |- mesh__dateRevised mesh__D044664 2005-06-30
% 222.25/222.42  |- skos__historyNote mesh__D044664 Algae, Red %28%1976-2003%29%
% 222.25/222.42  |- mesh__recordOriginator mesh__D044664 ags
% 222.25/222.42  |- mesh__recordMaintainer mesh__D044664 SYSTEM
% 222.25/222.42  |- mesh__dateCreated mesh__D044664 2003-07-09
% 222.25/222.42  |- mesh__publicMeSHNote mesh__D044664 2004   
% 222.25/222.42  |- mesh__dateEstablished mesh__D044664 2004-01-01
% 222.25/222.42  |- mesh__historyNote mesh__D044664 2004   
% 222.25/222.42  |- skos__broader mesh__D016973smesh__D044043
% 222.25/222.42  |- mesh__dateRevised mesh__D016973 2005-06-30
% 222.25/222.42  |- skos__altLabel mesh__D016973 Erwinia carotovora
% 222.25/222.42  |- mesh__historyNote mesh__D016973 2004 %28%1992%29%   
% 222.25/222.42  |- mesh__dateCreated mesh__D016973 1991-05-30
% 222.25/222.42  |- skos__scopeNote mesh__D016973
% 222.25/222.42       A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that causes rotting, particularly of storage tissues, of a wide variety of plants and causes a vascular disease in CARROTS; and POTATO plants.%A%    
% 222.25/222.42  |- rdf__type mesh__D016973sskos__Concept
% 222.25/222.42  |- mesh__publicMeSHNote mesh__D016973
% 222.25/222.42       2004; see ERWINIA CAROTOVORA 1992-2003   
% 222.25/222.42  |- mesh__dateEstablished mesh__D016973 1992-01-01
% 222.25/222.42  |- skos__prefLabel mesh__D016973 Pectobacterium carotovorum
% 222.25/222.42  |- mesh__recordAuthorizer mesh__D016973 sjn
% 222.25/222.42  |- mesh__recordOriginator mesh__D016973 PXP
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D016973 2006
% 222.25/222.42  |- mesh__recordMaintainer mesh__D016973 SYSTEM
% 222.25/222.42  |- skos__historyNote mesh__D016973 Erwinia %28%1967-1991%29%
% 222.25/222.42  |- mesh__dateCreated mesh__D016175 1990-03-23
% 222.25/222.42  |- skos__hiddenLabel mesh__D016175 B Lymphocyte Subsets
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D016175 2006
% 222.25/222.42  |- skos__hiddenLabel mesh__D016175 B-Cell Subset
% 222.25/222.42  |- skos__annotation mesh__D016175 A 11 qualif   
% 222.25/222.42  |- skos__hiddenLabel mesh__D016175 Subsets, B-Lymphocyte
% 222.25/222.42  |- rdf__type mesh__D016175sskos__Concept
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D016175 2005
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D016175 2004
% 222.25/222.42  |- skos__hiddenLabel mesh__D016175 B-Lymphocyte Subset
% 222.25/222.42  |- skos__hiddenLabel mesh__D016175 Subset, B-Cell
% 222.25/222.42  |- mesh__recordMaintainer mesh__D016175 jmp
% 222.25/222.42  |- skos__broader mesh__D016175smesh__D001402
% 222.25/222.42  |- skos__historyNote mesh__D016175
% 222.25/222.42       B-Lymphocytes/classification %28%1980-1990%29%
% 222.25/222.42  |- skos__prefLabel mesh__D016175 B-Lymphocyte Subsets
% 222.25/222.42  |- skos__hiddenLabel mesh__D016175 Subset, B-Lymphocyte
% 222.25/222.42  |- skos__broader mesh__D016175smesh__D016131
% 222.25/222.42  |- skos__hiddenLabel mesh__D016175 Subsets, B-Cell
% 222.25/222.42  |- mesh__recordOriginator mesh__D016175 AGS
% 222.25/222.42  |- mesh__historyNote mesh__D016175 91   
% 222.25/222.42  |- mesh__recordAuthorizer mesh__D016175 sjn
% 222.25/222.42  |- mesh__dateRevised mesh__D016175 2003-07-09
% 222.25/222.42  |- skos__hiddenLabel mesh__D016175 B Cell Subsets
% 222.25/222.42  |- mesh__publicMeSHNote mesh__D016175 91   
% 222.25/222.42  |- mesh__dateEstablished mesh__D016175 1991-01-01
% 222.25/222.42  |- skos__scopeNote mesh__D016175
% 222.25/222.42       A classification of B-lymphocytes based on structurally or functionally different populations of cells.%A%    
% 222.25/222.42  |- skos__altLabel mesh__D016175 B-Cell Subsets
% 222.25/222.42  |- skos__historyNote mesh__D002953 Benzopyrans %28%1969-1974%29%
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D002953 2006
% 222.25/222.42  |- skos__scopeNote mesh__D002953
% 222.25/222.42       Antibiotic and mycotoxin from Aspergillus niveus and Penicillium citrinum.%A%    
% 222.25/222.42  |- mesh__dateEstablished mesh__D002953 1991-01-01
% 222.25/222.42  |- mesh__recordOriginator mesh__D002953 NLM
% 222.25/222.42  |- mesh__dateCreated mesh__D002953 1974-11-19
% 222.25/222.42  |- mesh__historyNote mesh__D002953
% 222.25/222.42       91%28%75%29%; was see under BENZOPYRANS 1975-90   
% 222.25/222.42  |- mesh__recordMaintainer mesh__D002953 ssb
% 222.25/222.42  |- rdf__type mesh__D002953sskos__Concept
% 222.25/222.42  |- skos__broader mesh__D002953smesh__D009183
% 222.25/222.42  |- skos__prefLabel mesh__D002953 Citrinin
% 222.25/222.42  |- mesh__publicMeSHNote mesh__D002953
% 222.25/222.42       91; was see under BENZOPYRANS 1975-90   
% 222.25/222.42  |- skos__broader mesh__D002953smesh__D001578
% 222.25/222.42  |- mesh__recordAuthorizer mesh__D002953 sjn
% 222.25/222.42  |- mesh__dateRevised mesh__D002953 2005-06-30
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D002155 2002
% 222.25/222.42  |- skos__broader mesh__D002155smesh__D009124
% 222.25/222.42  |- skos__historyNote mesh__D002155 Muscle Proteins %28%1974-1975%29%
% 222.25/222.42  |- rdf__type mesh__D002155sskos__Concept
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D002155 2001
% 222.25/222.42  |- mesh__dateCreated mesh__D002155 1975-07-23
% 222.25/222.42  |- mesh__dateEstablished mesh__D002155 1991-01-01
% 222.25/222.42  |- mesh__recordMaintainer mesh__D002155 adp
% 222.25/222.42  |- mesh__recordAuthorizer mesh__D002155 sjn
% 222.25/222.42  |- skos__scopeNote mesh__D002155
% 222.25/222.42       Acidic protein found in SARCOPLASMIC RETICULUM that binds calcium to the extent of 700-900 nmoles/mg. It plays the role of sequestering calcium transported to the interior of the intracellular vesicle.%A%    
% 222.25/222.42  |- skos__broader mesh__D002155smesh__D002135
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D002155 2004
% 222.25/222.42  |- mesh__publicMeSHNote mesh__D002155
% 222.25/222.42       91; was see under MUSCLE PROTEINS 1976-90   
% 222.25/222.42  |- mesh__dateRevised mesh__D002155 2000-06-22
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D002155 2006
% 222.25/222.42  |- skos__historyNote mesh__D002155 Calcium %28%1974-1975%29%
% 222.25/222.42  |- mesh__historyNote mesh__D002155
% 222.25/222.42       91%28%76%29%; was see under MUSCLE PROTEINS 1976-90   
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D002155 2003
% 222.25/222.42  |- mesh__recordOriginator mesh__D002155 RLS
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D002155 2005
% 222.25/222.42  |- skos__prefLabel mesh__D002155 Calsequestrin
% 222.25/222.42  |- mesh__dateCreated mesh__D012583 1999-01-01
% 222.25/222.42  |- mesh__recordMaintainer mesh__D012583 RAZ
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012583 2003
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012583 2001
% 222.25/222.42  |- skos__broader mesh__D012583smesh__D009457
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012583 1997
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012583 2006
% 222.25/222.42  |- mesh__recordOriginator mesh__D012583 NLM
% 222.25/222.42  |- skos__annotation mesh__D012583
% 222.25/222.42       cells of peripheral nerves; A 11 qualif   
% 222.25/222.42  |- skos__broader mesh__D012583smesh__D010525
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012583 1996
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012583 2005
% 222.25/222.42  |- mesh__historyNote mesh__D012583 68%28%63%29%   
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012583 2000
% 222.25/222.42  |- skos__hiddenLabel mesh__D012583 Cells, Schwann
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012583 1999
% 222.25/222.42  |- rdf__type mesh__D012583sskos__Concept
% 222.25/222.42  |- mesh__dateEstablished mesh__D012583 1968-01-01
% 222.25/222.42  |- skos__scopeNote mesh__D012583
% 222.25/222.42       Neuroglial cells of the peripheral nervous system which form the insulating myelin sheaths of peripheral axons.%A%    
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012583 1995
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012583 1998
% 222.25/222.42  |- mesh__recordAuthorizer mesh__D012583 PLS
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012583 2002
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012583 1994
% 222.25/222.42  |- mesh__dateRevised mesh__D012583 1993-06-21
% 222.25/222.42  |- mesh__publicMeSHNote mesh__D012583 68   
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D012583 2004
% 222.25/222.42  |- skos__prefLabel mesh__D012583 Schwann Cells
% 222.25/222.42  |- skos__altLabel mesh__D006546 Intersexuality
% 222.25/222.42  |- skos__annotation mesh__D006546
% 222.25/222.42       permissible NIM for biological hermaphroditism in lower animals despite category; use check tags for genetic sex for higher animals but do not check sex tags for lower animals; do not confuse with BISEXUALITY, a behavioral term; HERMAPHRODITISM, TRUE is also available%A%  
% 222.25/222.42  |- mesh__recordOriginator mesh__D006546 NLM
% 222.25/222.42  |- skos__broader mesh__D006546smesh__D012734
% 222.25/222.42  |- mesh__recordAuthorizer mesh__D006546 sjn
% 222.25/222.42  |- rdf__type mesh__D006546sskos__Concept
% 222.25/222.42  |- mesh__onlineNote mesh__D006546
% 222.25/222.42       use HERMAPHRODITISM to search INTERSEXUALITY 1966-74 %28%as Prov 1966%29%%A%  
% 222.25/222.42  |- mesh__dateRevised mesh__D006546 2005-06-30
% 222.25/222.42  |- mesh__historyNote mesh__D006546 INTERSEXUALITY was Prov 1964-66   
% 222.25/222.42  |- skos__scopeNote mesh__D006546
% 222.25/222.42       A state of intersex or sexual ambiguity, involving the GENOTYPE, the GONADS, the reproductive tract, and/or the external GENITALIA or PHENOTYPE. This concept covers TRUE HERMAPHRODITISM and PSEUDOHERMAPHRODITISM. True hermaphrodites are rare and they possess gonadal tissues of both SEXES, tissues from the OVARY and the TESTIS. Pseudohermaphrodites possess gonadal tissue of one sex but exhibit external phenotype of the opposite sex.%A%    
% 222.25/222.42  |- skos__prefLabel mesh__D006546 Hermaphroditism
% 222.25/222.42  |- mesh__recordMaintainer mesh__D006546 lkt
% 222.25/222.42  |- mesh__dateCreated mesh__D006546 1999-01-01
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D006546 2006
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D020217 2005
% 222.25/222.42  |- skos__altLabel mesh__D020217 Dissecting Vertebral Artery Aneurysm
% 222.25/222.42  |- skos__altLabel mesh__D020217 Vertebral Artery Dissection, Spontaneous
% 222.25/222.42  |- mesh__dateCreated mesh__D020217 1999-11-03
% 222.25/222.42  |- skos__hiddenLabel mesh__D020217 Dissections, Vertebral Artery
% 222.25/222.42  |- skos__broader mesh__D020217smesh__D002561
% 222.25/222.42  |- mesh__historyNote mesh__D020217 2000   
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D020217 2006
% 222.25/222.42  |- skos__scopeNote mesh__D020217
% 222.25/222.42       Dissection of the wall of the vertebral artery, leading to the formation of an aneurysm that may occlude the vessel. Thrombus formation may occur and give rise to emboli. Cervical fractures or related NECK INJURIES and CRANIOCEREBRAL TRAUMA are commonly associated conditions, although this process may occur spontaneously. Ischemia, infarction, and hemorrhage in the vascular distribution of the affected vertebral artery may complicate this condition.%A%    
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D020217 2004
% 222.25/222.42  |- skos__prefLabel mesh__D020217 Vertebral Artery Dissection
% 222.25/222.42  |- skos__hiddenLabel mesh__D020217 Dissection, Vertebral Artery
% 222.25/222.42  |- mesh__dateRevised mesh__D020217 2003-07-22
% 222.25/222.42  |- mesh__recordAuthorizer mesh__D020217 sjn
% 222.25/222.42  |- skos__hiddenLabel mesh__D020217 Artery Dissections, Vertebral
% 222.25/222.42  |- mesh__publicMeSHNote mesh__D020217 2000   
% 222.25/222.42  |- mesh__recordOriginator mesh__D020217 KEV
% 222.25/222.42  |- skos__historyNote mesh__D020217
% 222.25/222.42       Cerebrovascular Disorders %28%1975-1999%29%
% 222.25/222.42  |- skos__broader mesh__D020217smesh__D000784
% 222.25/222.42  |- skos__broader mesh__D020217smesh__D020214
% 222.25/222.42  |- skos__hiddenLabel mesh__D020217 Vertebral Artery Dissections
% 222.25/222.42  |- skos__altLabel mesh__D020217 Vertebral Artery Dissection, Traumatic
% 222.25/222.42  |- skos__hiddenLabel mesh__D020217 Artery Dissection, Vertebral
% 222.25/222.42  |- mesh__recordMaintainer mesh__D020217 sjn
% 222.25/222.42  |- mesh__dateEstablished mesh__D020217 2000-01-01
% 222.25/222.42  |- skos__historyNote mesh__D020217 Vertebral Artery %28%1975-1999%29%
% 222.25/222.42  |- rdf__type mesh__D020217sskos__Concept
% 222.25/222.42  |- mesh__recordMaintainer mesh__D044665 SYSTEM
% 222.25/222.42  |- mesh__activeMeSHYear mesh__D044665 2006
% 222.25/222.42  |- mesh__historyNote mesh__D044665 2004   
% 222.25/222.43  |- rdf__type mesh__D044665sskos__Concept
% 222.25/222.43  |- skos__prefLabel mesh__D044665 Porphyridium
% 222.25/222.43  |- mesh__recordAuthorizer mesh__D044665 sjn
% 222.25/222.43  |- skos__historyNote mesh__D044665 Algae, Red %28%1971-2003%29%
% 222.25/222.43  |- mesh__dateEstablished mesh__D044665 2004-01-01
% 222.25/222.43  |- mesh__dateCreated mesh__D044665 2003-07-09
% 222.25/222.43  |- mesh__dateRevised mesh__D044665 2005-06-30
% 222.25/222.43  |- skos__broader mesh__D044665smesh__D000461
% 222.25/222.43  |- mesh__recordOriginator mesh__D044665 ags
% 222.25/222.43  |- mesh__publicMeSHNote mesh__D044665 2004   
% 222.25/222.43  |- skos__scopeNote mesh__D044665
% 222.25/222.43       A genus of RED ALGAE in the family Porphyridiaceae. A single stellate CHLOROPLAST is present in each cell which has no CELL WALL.%A%    
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D016974 2006
% 222.25/222.43  |- mesh__publicMeSHNote mesh__D016974
% 222.25/222.43       2004; see ERWINIA CHRYSANTHEMI 1992-2003   
% 222.25/222.43  |- mesh__recordAuthorizer mesh__D016974 sjn
% 222.25/222.43  |- skos__altLabel mesh__D016974 Erwinia chrysanthemi
% 222.25/222.43  |- mesh__recordMaintainer mesh__D016974 SYSTEM
% 222.25/222.43  |- skos__broader mesh__D016974smesh__D044043
% 222.25/222.43  |- mesh__dateRevised mesh__D016974 2005-06-30
% 222.25/222.43  |- skos__scopeNote mesh__D016974
% 222.25/222.43       A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that causes vascular wilts on a wide range of plant species. It was formerly named Erwinia chrysanthemi.%A%    
% 222.25/222.43  |- mesh__dateEstablished mesh__D016974 1992-01-01
% 222.25/222.43  |- rdf__type mesh__D016974sskos__Concept
% 222.25/222.43  |- mesh__dateCreated mesh__D016974 1991-05-30
% 222.25/222.43  |- mesh__historyNote mesh__D016974 2004 %28%1992%29%   
% 222.25/222.43  |- skos__historyNote mesh__D016974 Erwinia %28%1980-1991%29%
% 222.25/222.43  |- mesh__recordOriginator mesh__D016974 PXP
% 222.25/222.43  |- skos__prefLabel mesh__D016974 Pectobacterium chrysanthemi
% 222.25/222.43  |- skos__hiddenLabel mesh__D016176 Subsets, T-Lymphocyte
% 222.25/222.43  |- skos__hiddenLabel mesh__D016176 T Lymphocyte Subsets
% 222.25/222.43  |- skos__hiddenLabel mesh__D016176 Subsets, T-Cell
% 222.25/222.43  |- skos__prefLabel mesh__D016176 T-Lymphocyte Subsets
% 222.25/222.43  |- skos__hiddenLabel mesh__D016176 T-Lymphocyte Subset
% 222.25/222.43  |- skos__annotation mesh__D016176
% 222.25/222.43       A 11 qualif; coord IM with specific T-lymphocyte %28%IM%29%   
% 222.25/222.43  |- mesh__recordAuthorizer mesh__D016176 sjn
% 222.25/222.43  |- mesh__recordMaintainer mesh__D016176 jmp
% 222.25/222.43  |- mesh__recordOriginator mesh__D016176 AGS
% 222.25/222.43  |- skos__broader mesh__D016176smesh__D013601
% 222.25/222.43  |- mesh__publicMeSHNote mesh__D016176 91   
% 222.25/222.43  |- skos__hiddenLabel mesh__D016176 T Cell Subsets
% 222.25/222.43  |- skos__historyNote mesh__D016176
% 222.25/222.43       T-Lymphocytes/classification %28%1977-1990%29%
% 222.25/222.43  |- mesh__dateCreated mesh__D016176 1990-03-23
% 222.25/222.43  |- mesh__historyNote mesh__D016176 91   
% 222.25/222.43  |- mesh__dateRevised mesh__D016176 2003-07-09
% 222.25/222.43  |- skos__altLabel mesh__D016176 T-Cell Subsets
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D016176 2006
% 222.25/222.43  |- skos__hiddenLabel mesh__D016176 Subset, T-Cell
% 222.25/222.43  |- skos__hiddenLabel mesh__D016176 T-Cell Subset
% 222.25/222.43  |- mesh__dateEstablished mesh__D016176 1991-01-01
% 222.25/222.43  |- rdf__type mesh__D016176sskos__Concept
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D016176 2005
% 222.25/222.43  |- skos__scopeNote mesh__D016176
% 222.25/222.43       A classification of T-lymphocytes, especially into helper/inducer, suppressor/effector, and cytotoxic subsets, based on structurally or functionally different populations of cells.%A%    
% 222.25/222.43  |- skos__hiddenLabel mesh__D016176 Subset, T-Lymphocyte
% 222.25/222.43  |- skos__broader mesh__D016176smesh__D016131
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D016176 2004
% 222.25/222.43  |- skos__related mesh__D016176smesh__D016516
% 222.25/222.43  |- mesh__publicMeSHNote mesh__D002954
% 222.25/222.43       79; was see under ENTEROBACTERIACEAE 1976-78; was see under ESCHERICHIA 1974-75%A%  
% 222.25/222.43  |- skos__historyNote mesh__D002954 Escherichia %28%1966-1974%29%
% 222.25/222.43  |- rdf__type mesh__D002954sskos__Concept
% 222.25/222.43  |- skos__broader mesh__D002954smesh__D004755
% 222.25/222.43  |- mesh__recordAuthorizer mesh__D002954 sjn
% 222.25/222.43  |- skos__scopeNote mesh__D002954
% 222.25/222.43       A genus of gram-negative, rod-shaped enterobacteria that can use citrate as the sole source of carbon.%A%    
% 222.25/222.43  |- mesh__dateRevised mesh__D002954 2005-06-30
% 222.25/222.43  |- skos__prefLabel mesh__D002954 Citrobacter
% 222.25/222.43  |- mesh__recordOriginator mesh__D002954 NLM
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D002954 2006
% 222.25/222.43  |- skos__annotation mesh__D002954
% 222.25/222.43       in soil, water %26% sometimes intestine; infection: coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 222.25/222.43  |- mesh__dateEstablished mesh__D002954 1979-01-01
% 222.25/222.43  |- mesh__historyNote mesh__D002954
% 222.25/222.43       79%28%75%29%; was see under ENTEROBACTERIACEAE 1976-78; was see under ESCHERICHIA 1974-75%A%  
% 222.25/222.43  |- mesh__dateCreated mesh__D002954 1999-01-01
% 222.25/222.43  |- mesh__recordMaintainer mesh__D002954 SYSTEM
% 222.25/222.43  |- skos__historyNote mesh__D002954 Enterobacteriaceae %28%1966-1974%29%
% 222.25/222.43  |- mesh__onlineNote mesh__D002954 search ESCHERICHIA 1974   
% 222.25/222.43  |- skos__related mesh__D012584smesh__D012585
% 222.25/222.43  |- skos__prefLabel mesh__D012584 Sciatic Nerve
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D012584 2005
% 222.25/222.43  |- skos__hiddenLabel mesh__D012584 Nerve, Sciatic
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D012584 2002
% 222.25/222.43  |- mesh__dateRevised mesh__D012584 1999-11-03
% 222.25/222.43  |- rdf__type mesh__D012584sskos__Concept
% 222.25/222.43  |- mesh__recordAuthorizer mesh__D012584 sjn
% 222.25/222.43  |- skos__scopeNote mesh__D012584
% 222.25/222.43       A nerve which originates in the lumbar and sacral spinal cord %28%L4 to S3%29% and supplies motor and sensory innervation to the lower extremity. The sciatic nerve, which is the main continuation of the sacral plexus, is the largest nerve in the body. It has two major branches, the TIBIAL NERVE and the PERONEAL NERVE.%A%    
% 222.25/222.43  |- skos__broader mesh__D012584smesh__D008160
% 222.25/222.43  |- skos__annotation mesh__D012584
% 222.25/222.43       dis = SCIATIC NEUROPATHY %28%IM%29%; neopl = SCIATIC NEUROPATHY %28%IM%29% + PERIPHERAL NERVOUS SYSTEM NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D012584 2004
% 222.25/222.43  |- mesh__recordMaintainer mesh__D012584 ags
% 222.25/222.43  |- mesh__dateCreated mesh__D012584 1999-01-01
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D012584 2001
% 222.25/222.43  |- mesh__recordOriginator mesh__D012584 NLM
% 222.25/222.43  |- skos__hiddenLabel mesh__D012584 Sciatic Nerves
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D012584 2003
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D012584 2000
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D012584 2006
% 222.25/222.43  |- skos__hiddenLabel mesh__D012584 Nerves, Sciatic
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D039721 2005
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D039721 2004
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D039721 2006
% 222.25/222.43  |- skos__prefLabel mesh__D039721
% 222.25/222.43       Diagnostic and Statistical Manual of Mental Disorders
% 222.25/222.43  |- skos__historyNote mesh__D039721
% 222.25/222.43       specific mental disorder/diagnosis %28%1969-2002%29%
% 222.25/222.43  |- mesh__dateCreated mesh__D039721 2002-07-03
% 222.25/222.43  |- skos__historyNote mesh__D039721
% 222.25/222.43       specific mental disorder/classification %28%1969-2002%29%
% 222.25/222.43  |- mesh__dateEstablished mesh__D039721 2003-01-01
% 222.25/222.43  |- skos__scopeNote mesh__D039721
% 222.25/222.43       Categorical classification of MENTAL DISORDERS based on criteria sets with defining features. It is produced by the American Psychiatric Association. %28%DSM-IV, page xxii%29%%A%    
% 222.25/222.43  |- mesh__historyNote mesh__D039721 2003   
% 222.25/222.43  |- skos__broader mesh__D039721smesh__D018875
% 222.25/222.43  |- mesh__publicMeSHNote mesh__D039721 2003   
% 222.25/222.43  |- rdf__type mesh__D039721sskos__Concept
% 222.25/222.43  |- skos__historyNote mesh__D039721
% 222.25/222.43       Psychiatric Status Rating Scales %28%1980-2002%29%
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D039721 2003
% 222.25/222.43  |- mesh__recordAuthorizer mesh__D006547 sjn
% 222.25/222.43  |- mesh__recordOriginator mesh__D006547 NLM
% 222.25/222.43  |- skos__prefLabel mesh__D006547 Hernia
% 222.25/222.43  |- skos__broader mesh__D006547smesh__D005767
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D006547 2006
% 222.25/222.43  |- mesh__recordMaintainer mesh__D006547 lkt
% 222.25/222.43  |- skos__hiddenLabel mesh__D006547 Hernias
% 222.25/222.43  |- skos__scopeNote mesh__D006547
% 222.25/222.43       Protrusion of  tissue, structure, or part of an organ through the muscular tissue or the membrane by which it is normally contained. Hernia may involve tissues such as the ABDOMINAL WALL or the respiratory DIAPHRAGM. Hernias may be internal, external, congenital, or acquired.%A%    
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D006547 2005
% 222.25/222.43  |- skos__related mesh__D006547smesh__D014340
% 222.25/222.43  |- skos__annotation mesh__D006547
% 222.25/222.43       General or unspecified; prefer specifics; coordinate with specific organ/disease%A%  
% 222.25/222.43  |- mesh__dateCreated mesh__D006547 1999-01-01
% 222.25/222.43  |- skos__broader mesh__D006547smesh__D020763
% 222.25/222.43  |- rdf__type mesh__D006547sskos__Concept
% 222.25/222.43  |- mesh__dateRevised mesh__D006547 2004-07-07
% 222.25/222.43  |- mesh__dateEstablished mesh__D020218 1999-01-01
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D020218 2006
% 222.25/222.43  |- mesh__dateCreated mesh__D020218 1998-06-11
% 222.25/222.43  |- skos__broader mesh__D020218smesh__D004742
% 222.25/222.43  |- mesh__publicMeSHNote mesh__D020218 99   
% 222.25/222.43  |- mesh__historyNote mesh__D020218 99   
% 222.25/222.43  |- skos__hiddenLabel mesh__D020218 Elements, Response
% 222.25/222.43  |- skos__prefLabel mesh__D020218 Response Elements
% 222.25/222.43  |- skos__hiddenLabel mesh__D020218 Element, Response
% 222.25/222.43  |- mesh__recordOriginator mesh__D020218 NDW
% 222.25/222.43  |- skos__historyNote mesh__D020218
% 222.25/222.43       Regulatory Sequences, Nucleic Acid %28%1988-1998%29%
% 222.25/222.43  |- rdf__type mesh__D020218sskos__Concept
% 222.25/222.43  |- mesh__recordAuthorizer mesh__D020218 sjn
% 222.25/222.43  |- mesh__recordMaintainer mesh__D020218 nns
% 222.25/222.43  |- skos__scopeNote mesh__D020218
% 222.25/222.43       Nucleotide sequences, usually upstream, which are recognized by specific regulatory transcription factors, thereby causing gene response to various regulatory agents. These elements may be found in both promoter and enhancer regions.%A%    
% 222.25/222.43  |- mesh__dateRevised mesh__D020218 2005-06-30
% 222.25/222.43  |- skos__hiddenLabel mesh__D020218 Response Element
% 222.25/222.43  |- skos__broader mesh__D020218smesh__D011401
% 222.25/222.43  |- mesh__historyNote mesh__D025701 2002   
% 222.25/222.43  |- skos__prefLabel mesh__D025701 Asfarviridae
% 222.25/222.43  |- skos__altLabel mesh__D025701 African Swine Fever-Like Viruses
% 222.25/222.43  |- rdf__type mesh__D025701sskos__Concept
% 222.25/222.43  |- skos__scopeNote mesh__D025701
% 222.25/222.43       A family of double-stranded DNA viruses containing one genus Asfivirus. It is the source of AFRICAN SWINE FEVER.%A%    
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D025701 2002
% 222.25/222.43  |- skos__hiddenLabel mesh__D025701 Asfiviruses
% 222.25/222.43  |- skos__annotation mesh__D025701
% 222.25/222.43       infection: coord IM with DNA VIRUS INFECTIONS %28%IM%29%   
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D025701 2005
% 222.25/222.43  |- mesh__dateEstablished mesh__D025701 2002-01-01
% 222.25/222.43  |- skos__broader mesh__D025701smesh__D004267
% 222.25/222.43  |- mesh__dateCreated mesh__D025701 2001-07-25
% 222.25/222.43  |- mesh__recordAuthorizer mesh__D025701 sjn
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D025701 2006
% 222.25/222.43  |- mesh__recordOriginator mesh__D025701 ags
% 222.25/222.43  |- mesh__publicMeSHNote mesh__D025701
% 222.25/222.43       2002; for AFRICAN SWINE FEVER-LIKE VIRUSES see AFRICAN SWINE FEVER-LIKE VIRUSES 1997-2001%A%  
% 222.25/222.43  |- skos__hiddenLabel mesh__D025701 African Swine Fever Like Viruses
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D025701 2003
% 222.25/222.43  |- mesh__recordMaintainer mesh__D025701 ags
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D025701 2004
% 222.25/222.43  |- mesh__recordMaintainer mesh__D016975 SYSTEM
% 222.25/222.43  |- mesh__recordAuthorizer mesh__D016975 sjn
% 222.25/222.43  |- rdf__type mesh__D016975sskos__Concept
% 222.25/222.43  |- mesh__dateCreated mesh__D016975 1991-05-30
% 222.25/222.43  |- mesh__historyNote mesh__D016975 92   
% 222.25/222.43  |- mesh__dateRevised mesh__D016975 2005-06-30
% 222.25/222.43  |- mesh__dateEstablished mesh__D016975 1992-01-01
% 222.25/222.43  |- mesh__recordOriginator mesh__D016975 PXP
% 222.25/222.43  |- skos__prefLabel mesh__D016975 Gardnerella
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D016975 2006
% 222.25/222.43  |- skos__historyNote mesh__D016975 Gardnerella vaginalis %28%1975-1991%29%
% 222.25/222.43  |- mesh__publicMeSHNote mesh__D016975 92   
% 222.25/222.43  |- skos__scopeNote mesh__D016975
% 222.25/222.43       A genus of bacteria found in the human genital and urinary tract. It is considered to be a major cause of bacterial vaginosis %28%VAGINOSIS, BACTERIAL%29%.%A%    
% 222.25/222.43  |- skos__annotation mesh__D016975
% 222.25/222.43       infection: coord IM with BACTERIAL INFECTIONS %28%IM%29% but see note at GARDNERELLA VAGINALIS%A%  
% 222.25/222.43  |- skos__broader mesh__D016975smesh__D039903
% 222.25/222.43  |- skos__broader mesh__D016975smesh__D006092
% 222.25/222.43  |- mesh__dateEstablished mesh__D016177 1991-01-01
% 222.25/222.43  |- skos__hiddenLabel mesh__D016177 Antigen Receptor, Mo1
% 222.25/222.43  |- skos__hiddenLabel mesh__D016177 Macrophage 1 Antigen
% 222.25/222.43  |- skos__hiddenLabel mesh__D016177 Antigen, Macrophage-1
% 222.25/222.43  |- skos__altLabel mesh__D016177 Integrin alphaMbeta2
% 222.25/222.43  |- skos__altLabel mesh__D016177 Complement 3 Receptor
% 222.25/222.43  |- skos__altLabel mesh__D016177 Receptor, Complement 3
% 222.25/222.43  |- mesh__historyNote mesh__D016177
% 222.25/222.43       91; INTEGRIN ALPHA%28%M%29%BETA%28%2%29% was NM 1994-95   
% 222.25/222.43  |- rdf__type mesh__D016177sskos__Concept
% 222.25/222.43  |- skos__hiddenLabel mesh__D016177 Mac 1 Adhesive Receptor
% 222.25/222.43  |- skos__broader mesh__D016177smesh__D039341
% 222.25/222.43  |- skos__broader mesh__D016177smesh__D011951
% 222.25/222.43  |- skos__scopeNote mesh__D016177
% 222.25/222.43       An adhesion-promoting leukocyte surface membrane heterodimer. The alpha subunit consists of the CD11b ANTIGEN and the beta subunit the CD18 ANTIGEN. The antigen, which is an integrin, functions both as a receptor for complement 3 and in cell-cell and cell-substrate adhesive interactions.%A%    
% 222.25/222.43  |- mesh__recordOriginator mesh__D016177 RLS
% 222.25/222.43  |- skos__altLabel mesh__D016177 Adhesive Receptor Mac-1
% 222.25/222.43  |- mesh__dateRevised mesh__D016177 2003-07-09
% 222.25/222.43  |- skos__altLabel mesh__D016177 Receptor, Mo1 Glycoprotein
% 222.25/222.43  |- skos__historyNote mesh__D016177
% 222.25/222.43       Antigens, Differentiation %28%1988-1990%29%
% 222.25/222.43  |- skos__prefLabel mesh__D016177 Macrophage-1 Antigen
% 222.25/222.43  |- skos__hiddenLabel mesh__D016177 alpha-M beta-2, Integrin
% 222.25/222.43  |- skos__hiddenLabel mesh__D016177 Glycoprotein Receptor, Mo1
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D016177 2004
% 222.25/222.43  |- skos__altLabel mesh__D016177 Mac-1 Receptor
% 222.25/222.43  |- mesh__recordAuthorizer mesh__D016177 sjn
% 222.25/222.43  |- skos__hiddenLabel mesh__D016177 Adhesive Receptor, Mac-1
% 222.25/222.43  |- skos__altLabel mesh__D016177 Mo1 Antigen Receptor
% 222.25/222.43  |- mesh__recordMaintainer mesh__D016177 jmp
% 222.25/222.43  |- skos__broader mesh__D016177smesh__D016028
% 222.25/222.43  |- skos__altLabel mesh__D016177 Receptor, CR3
% 222.25/222.43  |- skos__altLabel mesh__D016177 Integrin alpha%28%M%29%beta%28%2%29%
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D016177 2005
% 222.25/222.43  |- skos__altLabel mesh__D016177 Mac-1 Adhesive Receptor
% 222.25/222.43  |- skos__altLabel mesh__D016177 CR3 Receptor
% 222.25/222.43  |- skos__altLabel mesh__D016177 Integrin alpha-M beta-2
% 222.25/222.43  |- skos__historyNote mesh__D016177
% 222.25/222.43       Receptors, Leukocyte-Adhesion %28%1989-1990%29%
% 222.25/222.43  |- skos__altLabel mesh__D016177 Mac-1 Antigen
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D016177 2006
% 222.25/222.43  |- skos__hiddenLabel mesh__D016177 alphaMbeta2, Integrin
% 222.25/222.43  |- mesh__onlineNote mesh__D016177
% 222.25/222.43       use MACROPHAGE-1 ANTIGEN %28%NM%29% to search INTEGRIN ALPHA%28%M%29%BETA%28%2%29% 1994-95%A%  
% 222.25/222.43  |- skos__altLabel mesh__D016177 Receptor, Mo1 Antigen
% 222.25/222.43  |- skos__altLabel mesh__D016177 Mo1 Glycoprotein Receptor
% 222.25/222.43  |- skos__hiddenLabel mesh__D016177 Mac 1 Receptor
% 222.25/222.43  |- skos__hiddenLabel mesh__D016177 Receptor, Mac-1 Adhesive
% 222.25/222.43  |- skos__hiddenLabel mesh__D016177 Integrin alpha M beta 2
% 222.25/222.43  |- mesh__dateCreated mesh__D016177 1990-04-24
% 222.25/222.43  |- mesh__publicMeSHNote mesh__D016177
% 222.25/222.43       91; INTEGRIN ALPHA%28%M%29%BETA%28%2%29% was indexed under INTEGRINS 1994-95%A%  
% 222.25/222.43  |- skos__hiddenLabel mesh__D016177 Mac 1 Antigen
% 222.25/222.43  |- skos__altLabel mesh__D002955 Levoleucovorin
% 222.25/222.43  |- skos__altLabel mesh__D002955 Folinic Acid-SF
% 222.25/222.43  |- skos__annotation mesh__D002955
% 222.25/222.43       deficiency: coordinate LEUCOVORIN /defic %28%IM%29% with FOLIC ACID DEFICIENCY %28%IM%29%%A%  
% 222.25/222.43  |- skos__broader mesh__D002955smesh__D005575
% 222.25/222.43  |- mesh__onlineNote mesh__D002955
% 222.25/222.43       use LEUCOVORIN to search CITROVORUM FACTOR 1966-89   
% 222.25/222.43  |- skos__scopeNote mesh__D002955
% 222.25/222.43       The active metabolite of FOLIC ACID. Leucovorin is used principally as its calcium salt as an antidote to folic acid antagonists which block the conversion of folic acid to folinic acid.%A%    
% 222.25/222.43  |- skos__hiddenLabel mesh__D002955 Folinate, Calcium
% 222.25/222.43  |- skos__altLabel mesh__D002955 Calcium Folinate
% 222.25/222.43  |- skos__hiddenLabel mesh__D002955 Leucovorin, Calcium
% 222.25/222.43  |- skos__altLabel mesh__D002955 Leukovorin
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D002955 2006
% 222.25/222.43  |- skos__hiddenLabel mesh__D002955 Monosodium Salt Leucovorin
% 222.25/222.43  |- skos__prefLabel mesh__D002955 Leucovorin
% 222.25/222.43  |- skos__hiddenLabel mesh__D002955 Factor, Citrovorum
% 222.25/222.43  |- mesh__recordAuthorizer mesh__D002955 sjn
% 222.25/222.43  |- skos__hiddenLabel mesh__D002955 Folinic Acid SF
% 222.25/222.43  |- skos__altLabel mesh__D002955 Leukovorum
% 222.25/222.43  |- mesh__dateRevised mesh__D002955 2005-06-30
% 222.25/222.43  |- mesh__publicMeSHNote mesh__D002955 90; was CITROVORUM FACTOR 1964-89   
% 222.25/222.43  |- skos__hiddenLabel mesh__D002955 Acid, Folinic
% 222.25/222.43  |- skos__altLabel mesh__D002955 Calcium Leucovorin
% 222.25/222.43  |- mesh__dateCreated mesh__D002955 1999-01-01
% 222.25/222.43  |- skos__hiddenLabel mesh__D002955 5 Formyltetrahydropteroylglutamate
% 222.25/222.43  |- skos__hiddenLabel mesh__D002955 5 Formyltetrahydrofolate
% 222.25/222.43  |- skos__altLabel mesh__D002955 Folinic Acid
% 222.25/222.43  |- mesh__recordOriginator mesh__D002955 NLM
% 222.25/222.43  |- skos__altLabel mesh__D002955 5-Formyltetrahydrofolate
% 222.25/222.43  |- rdf__type mesh__D002955sskos__Concept
% 222.25/222.43  |- mesh__historyNote mesh__D002955 90; was CITROVORUM FACTOR 1964-89   
% 222.25/222.43  |- mesh__recordMaintainer mesh__D002955 ssb
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D002157 2006
% 222.25/222.43  |- skos__annotation mesh__D002157
% 222.25/222.43       infection: probably GRANULOMA INGUINALE, otherwise coord IM with ENTEROBACTERIACEAE INFECTIONS %28%IM%29% + GRANULOMA or specific granuloma if pertinent%A%  
% 222.25/222.43  |- skos__broader mesh__D002157smesh__D004755
% 222.25/222.43  |- mesh__recordOriginator mesh__D002157 FPG
% 222.25/222.43  |- skos__historyNote mesh__D002157 Bacteria %28%1966-1976%29%
% 222.25/222.43  |- skos__historyNote mesh__D002157 Granuloma Inguinale %28%1966-1976%29%
% 222.25/222.43  |- mesh__dateCreated mesh__D002157 1976-04-16
% 222.25/222.43  |- skos__altLabel mesh__D002157 Donovania
% 222.25/222.43  |- mesh__dateEstablished mesh__D002157 1977-01-01
% 222.25/222.43  |- mesh__publicMeSHNote mesh__D002157 77,63-65   
% 222.25/222.43  |- rdf__type mesh__D002157sskos__Concept
% 222.25/222.43  |- mesh__recordMaintainer mesh__D002157 SYSTEM
% 222.25/222.43  |- mesh__historyNote mesh__D002157 77,63-65   
% 222.25/222.43  |- skos__scopeNote mesh__D002157
% 222.25/222.43       A genus of bacteria causing GRANULOMA INGUINALE and other granulomatous lesions.%A%    
% 222.25/222.43  |- mesh__dateRevised mesh__D002157 2005-06-30
% 222.25/222.43  |- skos__prefLabel mesh__D002157 Calymmatobacterium
% 222.25/222.43  |- mesh__recordAuthorizer mesh__D002157 sjn
% 222.25/222.43  |- mesh__recordOriginator mesh__D007640 NLM
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D007640 1994
% 222.25/222.43  |- mesh__recordMaintainer mesh__D007640 TGC
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D007640 1999
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D007640 2002
% 222.25/222.43  |- skos__scopeNote mesh__D007640
% 222.25/222.43       A noninflammatory, usually bilateral protrusion of the cornea, the apex being displaced downward and nasally. It occurs most commonly in females at about puberty. The cause is unknown but hereditary factors may play a role. The -conus refers to the cone shape of the corneal protrusion. %28%From Dorland, 27th ed%29%%A%    
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D007640 1997
% 222.25/222.43  |- mesh__dateCreated mesh__D007640 1999-01-01
% 222.25/222.43  |- mesh__dateRevised mesh__D007640 1993-06-02
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D007640 1998
% 222.25/222.43  |- skos__annotation mesh__D007640 cone-shaped protrusion of cornea   
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D007640 1996
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D007640 2006
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D007640 2004
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D007640 2001
% 222.25/222.43  |- mesh__recordAuthorizer mesh__D007640 PLS
% 222.25/222.43  |- skos__broader mesh__D007640smesh__D003316
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D007640 2000
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D007640 2005
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D007640 1995
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D007640 2003
% 222.25/222.43  |- rdf__type mesh__D007640sskos__Concept
% 222.25/222.43  |- skos__prefLabel mesh__D007640 Keratoconus
% 222.25/222.43  |- skos__hiddenLabel mesh__D012585 Sciatic Neuralgias
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D012585 2000
% 222.25/222.43  |- rdf__type mesh__D012585sskos__Concept
% 222.25/222.43  |- skos__hiddenLabel mesh__D012585 Neuralgias, Sciatic
% 222.25/222.43  |- skos__hiddenLabel mesh__D012585 Bilateral Sciaticas
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D012585 2004
% 222.25/222.43  |- mesh__recordMaintainer mesh__D012585 ags
% 222.25/222.43  |- mesh__dateCreated mesh__D012585 1999-01-01
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D012585 2002
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D012585 2006A
% 222.25/222.43  |- skos__broader mesh__D012585smesh__D020426
% 222.25/222.43  |- skos__broader mesh__D012585smesh__D009437
% 222.25/222.43  |- skos__prefLabel mesh__D012585 Sciatica
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D012585 2003
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D012585 2006
% 222.25/222.43  |- skos__related mesh__D012585smesh__D017116
% 222.25/222.43  |- skos__scopeNote mesh__D012585
% 222.25/222.43       A condition characterized by pain radiating from the back into the buttock and posterior/lateral aspects of the leg. Sciatica may be a manifestation of SCIATIC NEUROPATHY; RADICULOPATHY %28%involving the SPINAL NERVE ROOTS; L4, L5, S1, or S2, often associated with INTERVERTEBRAL DISK DISPLACEMENT%29%; or lesions of the CAUDA EQUINA.%A%    
% 222.25/222.43  |- skos__altLabel mesh__D012585 Sciatic Neuralgia
% 222.25/222.43  |- skos__annotation mesh__D012585
% 222.25/222.43       do not confuse with BACK PAIN or LUMBAGO see LOW BACK PAIN: use term of text; %22%lombo-sciatique%22% in French texts is indexed here %28%IM%29% + LOW BACK PAIN %28%IM%29%%A%  
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D012585 2001
% 222.25/222.43  |- mesh__dateRevised mesh__D012585 2005-07-29
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D012585 2005
% 222.25/222.43  |- skos__altLabel mesh__D012585 Neuralgia, Sciatic
% 222.25/222.43  |- mesh__recordOriginator mesh__D012585 NLM
% 222.25/222.43  |- skos__hiddenLabel mesh__D012585 Bilateral Sciatica
% 222.25/222.43  |- mesh__recordAuthorizer mesh__D012585 ags
% 222.25/222.43  |- rdf__type mesh__D020219sskos__Concept
% 222.25/222.43  |- mesh__recordAuthorizer mesh__D020219 sjn
% 222.25/222.43  |- mesh__dateCreated mesh__D020219 1998-06-10
% 222.25/222.43  |- mesh__dateRevised mesh__D020219 2004-07-07
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D020219 2006
% 222.25/222.43  |- skos__broader mesh__D020219smesh__D041641
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D020219 2005
% 222.25/222.43  |- mesh__recordMaintainer mesh__D020219 lkt
% 222.25/222.43  |- skos__scopeNote mesh__D020219
% 222.25/222.43       The formation of cartilage. This process is directed by CHONDROCYTES which continually divide and lay down matrix during development. It is sometimes a precursor to OSTEOGENESIS.%A%    
% 222.25/222.43  |- mesh__historyNote mesh__D020219 99   
% 222.25/222.43  |- mesh__dateEstablished mesh__D020219 1999-01-01
% 222.25/222.43  |- skos__prefLabel mesh__D020219 Chondrogenesis
% 222.25/222.43  |- mesh__recordOriginator mesh__D020219 AGS
% 222.25/222.43  |- skos__historyNote mesh__D020219 Cartilage/embryology %28%1966-1998%29%
% 222.25/222.43  |- mesh__publicMeSHNote mesh__D020219 99   
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D006548 2006
% 222.25/222.43  |- mesh__historyNote mesh__D006548 80; was DIAPHRAGMATIC HERNIA 1963-79   
% 222.25/222.43  |- skos__annotation mesh__D006548
% 222.25/222.43       HERNIA, DIAPHRAGMATIC, TRAUMATIC is also available   
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D006548 2005
% 222.25/222.43  |- mesh__recordAuthorizer mesh__D006548 sjn
% 222.25/222.43  |- mesh__publicMeSHNote mesh__D006548
% 222.25/222.43       80; was DIAPHRAGMATIC HERNIA 1963-79   
% 222.25/222.43  |- mesh__recordOriginator mesh__D006548 NLM
% 222.25/222.43  |- skos__scopeNote mesh__D006548
% 222.25/222.43       Protrusion of abdominal structures into the THORAX as a result of congenital or traumatic defects in the respiratory DIAPHRAGM.%A%    
% 222.25/222.43  |- skos__altLabel mesh__D006548 Diaphragmatic Hernia
% 222.25/222.43  |- mesh__dateCreated mesh__D006548 1999-01-01
% 222.25/222.43  |- mesh__recordMaintainer mesh__D006548 lkt
% 222.25/222.43  |- skos__hiddenLabel mesh__D006548 Diaphragmatic Hernias
% 222.25/222.43  |- rdf__type mesh__D006548sskos__Concept
% 222.25/222.43  |- mesh__dateRevised mesh__D006548 2004-07-07
% 222.25/222.43  |- skos__prefLabel mesh__D006548 Hernia, Diaphragmatic
% 222.25/222.43  |- mesh__onlineNote mesh__D006548
% 222.25/222.43       use HERNIA, DIAPHRAGMATIC to search DIAPHRAGMATIC HERNIA 1966-79%A%  
% 222.25/222.43  |- skos__hiddenLabel mesh__D006548 Hernias, Diaphragmatic
% 222.25/222.43  |- skos__broader mesh__D006548smesh__D006547
% 222.25/222.43  |- mesh__dateCreated mesh__D017270 1992-05-22
% 222.25/222.43  |- skos__broader mesh__D017270smesh__D008074
% 222.25/222.43  |- skos__altLabel mesh__D017270 Lipoprotein Lp%28%a%29%
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D017270 2006
% 222.25/222.43  |- mesh__dateEstablished mesh__D017270 1993-01-01
% 222.25/222.43  |- skos__historyNote mesh__D017270 Lipoproteins %28%1977-1992%29%
% 222.25/222.43  |- mesh__dateRevised mesh__D017270 2003-07-09
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D017270 2005
% 222.25/222.43  |- rdf__type mesh__D017270sskos__Concept
% 222.25/222.43  |- mesh__publicMeSHNote mesh__D017270
% 222.25/222.43       93; LIPOPROTEIN LP%28%A%29% was indexed under LIPOPROTEINS 1977-92%A%  
% 222.25/222.43  |- skos__annotation mesh__D017270 DF: note short X ref   
% 222.25/222.43  |- skos__altLabel mesh__D017270 Lp%28%a%29%
% 222.25/222.43  |- skos__altLabel mesh__D017270 Lipoprotein A
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D017270 2004
% 222.25/222.43  |- skos__scopeNote mesh__D017270
% 222.25/222.43       A family of lipoprotein particles varying in density and size depending on the protein-lipid ratio and the protein composition. These particles consist of apolipoprotein B-100 covalently linked to apolipoprotein-a by one or two disulfide bonds. There is a correlation between high plasma levels of this lipoprotein and increased risk for atherosclerotic cardiovascular disease.%A%    
% 222.25/222.43  |- mesh__onlineNote mesh__D017270
% 222.25/222.43       use LIPOPROTEIN%28%A%29% %28%NM%29% to search LIPOPROTEIN LP%28%A%29% 1980-92%A%  
% 222.25/222.43  |- skos__altLabel mesh__D017270 Lipoprotein %28%a%29%
% 222.25/222.43  |- skos__prefLabel mesh__D017270 Lipoprotein%28%a%29%
% 222.25/222.43  |- mesh__historyNote mesh__D017270
% 222.25/222.43       93; was LIPOPROTEIN LP%28%A%29% %28%NM%29% 1977-92   
% 222.25/222.43  |- mesh__recordAuthorizer mesh__D003250 SJN
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D003250 2000
% 222.25/222.43  |- mesh__publicMeSHNote mesh__D003250 76; was see under PHYSIOLOGY 1975   
% 222.25/222.43  |- mesh__recordOriginator mesh__D003250 NLM
% 222.25/222.43  |- skos__hiddenLabel mesh__D003250 Constrictions
% 222.25/222.43  |- skos__hiddenLabel mesh__D003250 Clampings
% 222.25/222.43  |- mesh__recordMaintainer mesh__D003250 TGC
% 222.25/222.43  |- skos__scopeNote mesh__D003250 The act of constricting.     
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D003250 1999
% 222.25/222.43  |- mesh__dateRevised mesh__D003250 1997-06-20
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D003250 2002
% 222.25/222.43  |- mesh__dateEstablished mesh__D003250 1976-01-01
% 222.25/222.43  |- skos__prefLabel mesh__D003250 Constriction
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D003250 2006
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D003250 1998
% 222.25/222.43  |- skos__broader mesh__D003250smesh__D008919
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D003250 2004
% 222.25/222.43  |- skos__annotation mesh__D003250 never IM; no qualif   
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D003250 2005
% 222.25/222.43  |- mesh__dateCreated mesh__D003250 1999-01-01
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D003250 2001
% 222.25/222.43  |- rdf__type mesh__D003250sskos__Concept
% 222.25/222.43  |- mesh__activeMeSHYear mesh__D003250 2003
% 222.25/222.43  |- mesh__historyNote mesh__D003250
% 222.25/222.43       76%28%68%29%; was in Cat C %26% E 1968-75 %28%Prov 1968-74%29%, was see under PHYSIOLOGY 1975%A%  
% 222.25/222.43  |- mesh__dateRevised mesh__D016976 2005-06-30
% 222.25/222.43  |- rdf__type mesh__D016976sskos__Concept
% 222.25/222.43  |- skos__scopeNote mesh__D016976
% 222.25/222.43       A species of gram-negative, facultatively anaerobic spherical or rod-shaped bacteria that associates with species of ACTINOMYCES in actinomycotic lesions.%A%    
% 222.25/222.43  |- mesh__historyNote mesh__D016976 92   
% 222.25/222.43  |- mesh__publicMeSHNote mesh__D016976 92   
% 222.25/222.44  |- mesh__dateCreated mesh__D016976 1991-05-30
% 222.25/222.44  |- mesh__activeMeSHYear mesh__D016976 2006
% 222.25/222.44  |- mesh__recordOriginator mesh__D016976 PXP
% 222.25/222.44  |- mesh__recordAuthorizer mesh__D016976 sjn
% 222.25/222.44  |- skos__historyNote mesh__D016976 Actinobacillus %28%1966-1991%29%
% 222.25/222.44  |- skos__broader mesh__D016976smesh__D000188
% 222.25/222.44  |- skos__prefLabel mesh__D016976 Actinobacillus actinomycetemcomitans
% 222.25/222.44  |- skos__annotation mesh__D016976
% 222.25/222.44       for name, see MeSH definition; infection: coord IM with ACTINOBACILLUS INFECTIONS %28%IM%29%; DF: ACTINOBACILLUS ACT%A%  
% 222.25/222.44  |- mesh__recordMaintainer mesh__D016976 SYSTEM
% 222.25/222.44  |- mesh__dateEstablished mesh__D016976 1992-01-01
% 222.25/222.44  |- mesh__dateEstablished mesh__D016178 1991-01-01
% 222.25/222.44  |- mesh__recordOriginator mesh__D016178 RLS
% 222.25/222.44  |- skos__historyNote mesh__D016178 Interleukin-3 %28%1981-1987%29%
% 222.25/222.44  |- skos__altLabel mesh__D016178 GM-CSF
% 222.25/222.44  |- skos__scopeNote mesh__D016178
% 222.25/222.44       An acidic glycoprotein of MW 23 kDa with internal disulfide bonds. The protein is produced in response to a number of inflammatory mediators by mesenchymal cells present in the hemopoietic environment and at peripheral sites of inflammation. GM-CSF is able to stimulate the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells and can stimulate the formation of eosinophil colonies from fetal liver progenitor cells. GM-CSF can also stimulate some functional activities in mature granulocytes and macrophages.%A%    
% 222.25/222.44  |- skos__historyNote mesh__D016178
% 222.25/222.44       Colony-Stimulating Factors %28%1976-1990%29%
% 222.25/222.44  |- skos__hiddenLabel mesh__D016178
% 222.25/222.44       Histamine Producing Cell Stimulating Factor
% 222.25/222.44  |- skos__altLabel mesh__D016178 Histamine-Producing Cell-Stimulating Factor
% 222.25/222.44  |- skos__prefLabel mesh__D016178
% 222.25/222.44       Granulocyte-Macrophage Colony-Stimulating Factor
% 222.25/222.44  |- mesh__recordMaintainer mesh__D016178 ssb
% 222.25/222.44  |- skos__annotation mesh__D016178 /drug eff permitted; DF: GMCSF   
% 222.25/222.44  |- skos__altLabel mesh__D016178
% 222.25/222.44       Tumor-Cell Human GM Colony-Stimulating Factor
% 222.25/222.44  |- mesh__dateCreated mesh__D016178 1990-06-19
% 222.25/222.44  |- mesh__activeMeSHYear mesh__D016178 2006
% 222.25/222.44  |- skos__altLabel mesh__D016178 CSF-2
% 222.25/222.44  |- skos__hiddenLabel mesh__D016178
% 222.25/222.44       Granulocyte Macrophage Colony Stimulating Factor
% 222.25/222.44  |- mesh__historyNote mesh__D016178
% 222.25/222.44       91; HISTAMINE-PRODUCING CELL-STIMULATING FACTOR was HISTAMINE-PRODUCING CELL STIMULATING FACTOR see INTERLEUKIN-3 1987-91%A%  
% 222.25/222.44  |- skos__altLabel mesh__D016178 TC-GM-CSF
% 222.25/222.44  |- skos__altLabel mesh__D016178
% 222.25/222.44       Colony-Stimulating Factor, Granulocyte-Macrophage
% 222.25/222.44  |- skos__hiddenLabel mesh__D016178
% 222.25/222.44       Cell-Stimulating Factor, Histamine-Producing
% 222.25/222.44  |- mesh__onlineNote mesh__D016178
% 222.25/222.44       use INTERLEUKIN-3 to search HISTAMINE-PRODUCING CELL-STIMULATING FACTOR 1987-91%A%  
% 222.25/222.44  |- skos__hiddenLabel mesh__D016178
% 222.25/222.44       Tumor Cell Human GM Colony Stimulating Factor
% 222.25/222.44  |- rdf__type mesh__D016178sskos__Concept
% 222.25/222.44  |- mesh__publicMeSHNote mesh__D016178
% 222.25/222.44       91; HISTAMINE-PRODUCING CELL-STIMULATING FACTOR was HISTAMINE-PRODUCING CELL STIMULATING FACTOR see INTERLEUKIN-3 1987-91%A%  
% 222.25/222.44  |- skos__historyNote mesh__D016178 Growth Substances %28%1966-1990%29%
% 222.25/222.44  |- skos__broader mesh__D016178smesh__D003115
% 222.25/222.44  |- mesh__dateRevised mesh__D016178 2005-06-30
% 222.25/222.44  |- mesh__recordAuthorizer mesh__D016178 sjn
% 222.25/222.44  |- skos__altLabel mesh__D016178 CSF-GM
% 222.25/222.44  |- skos__related mesh__D016178smesh__D016187
% 222.25/222.44  |- skos__hiddenLabel mesh__D016178
% 222.25/222.44       Colony Stimulating Factor, Granulocyte Macrophage
% 222.25/222.44  |- mesh__activeMeSHYear mesh__D002956 1999
% 222.25/222.44  |- mesh__activeMeSHYear mesh__D002956 2002
% 222.25/222.44  |- mesh__dateCreated mesh__D002956 1999-01-01
% 222.25/222.44  |- mesh__dateRevised mesh__D002956 1992-05-11
% 222.25/222.44  |- rdf__type mesh__D002956sskos__Concept
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D002956 1994
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D002956 1997
% 222.25/222.46  |- mesh__recordMaintainer mesh__D002956 TAP
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D002956 1998
% 222.25/222.46  |- mesh__recordOriginator mesh__D002956 NLM
% 222.25/222.46  |- skos__broader mesh__D002956smesh__D000599
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D002956 1996
% 222.25/222.46  |- skos__prefLabel mesh__D002956 Citrulline
% 222.25/222.46  |- skos__annotation mesh__D002956 an amino acid   
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D002956 2001
% 222.25/222.46  |- mesh__historyNote mesh__D002956
% 222.25/222.46       65%28%64%29%; was see under AMINO ACIDS 1963-64   
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D002956 2006
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D002956 2000
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D002956 2004
% 222.25/222.46  |- mesh__dateEstablished mesh__D002956 1965-01-01
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D002956 2005
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D002956 1995
% 222.25/222.46  |- mesh__publicMeSHNote mesh__D002956
% 222.25/222.46       65; was see under AMINO ACIDS 1963-64   
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D002956 2003
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D002956 1993
% 222.25/222.46  |- mesh__recordAuthorizer mesh__D002956 PLS
% 222.25/222.46  |- skos__prefLabel mesh__D007641 Keratolytic Agents
% 222.25/222.46  |- mesh__dateEstablished mesh__D007641 1991-01-01
% 222.25/222.46  |- mesh__recordAuthorizer mesh__D007641 sjn
% 222.25/222.46  |- mesh__dateCreated mesh__D007641 1999-01-01
% 222.25/222.46  |- mesh__onlineNote mesh__D007641 search DERMATOLOGIC AGENTS 1967-74   
% 222.25/222.46  |- mesh__recordOriginator mesh__D007641 NLM
% 222.25/222.46  |- mesh__historyNote mesh__D007641
% 222.25/222.46       91%28%75%29%; was see under DERMATOLOGIC AGENTS 1975-90   
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D007641 2006
% 222.25/222.46  |- skos__altLabel mesh__D007641 Desquamating Agents
% 222.25/222.46  |- skos__hiddenLabel mesh__D007641 Agents, Desquamating
% 222.25/222.46  |- skos__historyNote mesh__D007641 Dermatologic Agents %28%1967-1974%29%
% 222.25/222.46  |- skos__broader mesh__D007641smesh__D003879
% 222.25/222.46  |- mesh__recordMaintainer mesh__D007641 ssb
% 222.25/222.46  |- skos__annotation mesh__D007641 GEN or unspecified; prefer specifics   
% 222.25/222.46  |- skos__hiddenLabel mesh__D007641 Agents, Keratolytic
% 222.25/222.46  |- skos__scopeNote mesh__D007641
% 222.25/222.46       Agents that soften, separate, and cause desquamation of the cornified epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases.%A%    
% 222.25/222.46  |- skos__hiddenLabel mesh__D007641 Agents, Skin-Peeling
% 222.25/222.46  |- mesh__dateRevised mesh__D007641 2005-06-30
% 222.25/222.46  |- skos__historyNote mesh__D007641 Skin Diseases %28%1966%29%
% 222.25/222.46  |- skos__hiddenLabel mesh__D007641 Skin Peeling Agents
% 222.25/222.46  |- skos__altLabel mesh__D007641 Skin-Peeling Agents
% 222.25/222.46  |- rdf__type mesh__D007641sskos__Concept
% 222.25/222.46  |- mesh__publicMeSHNote mesh__D007641
% 222.25/222.46       91; was see under DERMATOLOGIC AGENTS 1975-90   
% 222.25/222.46  |- rdf__type mesh__D012586sskos__Concept
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D012586 2000
% 222.25/222.46  |- skos__related mesh__D012586smesh__D012070
% 222.25/222.46  |- mesh__recordAuthorizer mesh__D012586 jls
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D012586 2003
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D012586 2001
% 222.25/222.46  |- mesh__recordOriginator mesh__D012586 NLM
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D012586 2004
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D012586 2002
% 222.25/222.46  |- skos__prefLabel mesh__D012586 Science
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D012586 1996
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D012586 2005
% 222.25/222.46  |- skos__annotation mesh__D012586 SPEC: SPEC qualif   
% 222.25/222.46  |- skos__broader mesh__D012586smesh__D010811
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D012586 1997
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D012586 2006
% 222.25/222.46  |- skos__hiddenLabel mesh__D012586 Sciences
% 222.25/222.46  |- skos__scopeNote mesh__D012586
% 222.25/222.46       The systematic observation of natural phenomena for the purpose of discovering laws governing those phenomena. The body of knowledge accumulated by such means. %28%From Dorland, 28th ed%29%%A%    
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D012586 1998
% 222.25/222.46  |- mesh__dateRevised mesh__D012586 2004-08-02
% 222.25/222.46  |- mesh__recordMaintainer mesh__D012586 jls
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D012586 2005A
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D012586 1999
% 222.25/222.46  |- mesh__dateCreated mesh__D012586 1999-01-01
% 222.25/222.46  |- skos__hiddenLabel mesh__D006549 Hernia, Traumatic Diaphragmatic
% 222.25/222.46  |- skos__hiddenLabel mesh__D006549 Traumatic Diaphragmatic Hernias
% 222.25/222.46  |- mesh__recordAuthorizer mesh__D006549 sjn
% 222.25/222.46  |- mesh__recordOriginator mesh__D006549 NLM
% 222.25/222.46  |- mesh__onlineNote mesh__D006549
% 222.25/222.46       use HERNIA, DIAPHRAGMATIC, TRAUMATIC to search DIAPHRAGMATIC HERNIA, TRAUMATIC 1966-79%A%  
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D006549 2006
% 222.25/222.46  |- skos__broader mesh__D006549smesh__D006548
% 222.25/222.46  |- mesh__historyNote mesh__D006549
% 222.25/222.46       80; was DIAPHRAGMATIC HERNIA, TRAUMATIC 1963-79   
% 222.25/222.46  |- mesh__dateCreated mesh__D006549 1999-01-01
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D006549 2005
% 222.25/222.46  |- skos__hiddenLabel mesh__D006549 Traumatic Diaphragmatic Hernia
% 222.25/222.46  |- skos__altLabel mesh__D006549 Diaphragmatic Hernia, Traumatic
% 222.25/222.46  |- rdf__type mesh__D006549sskos__Concept
% 222.25/222.46  |- skos__prefLabel mesh__D006549 Hernia, Diaphragmatic, Traumatic
% 222.25/222.46  |- mesh__recordMaintainer mesh__D006549 lkt
% 222.25/222.46  |- mesh__dateRevised mesh__D006549 2004-07-07
% 222.25/222.46  |- skos__broader mesh__D006549smesh__D000007
% 222.25/222.46  |- skos__hiddenLabel mesh__D006549 Hernias, Traumatic Diaphragmatic
% 222.25/222.46  |- skos__scopeNote mesh__D006549
% 222.25/222.46       The type of DIAPHRAGMATIC HERNIA caused by TRAUMA or injury, usually to the ABDOMEN.%A%    
% 222.25/222.46  |- mesh__publicMeSHNote mesh__D006549
% 222.25/222.46       80; was DIAPHRAGMATIC HERNIA, TRAUMATIC 1963-79   
% 222.25/222.46  |- skos__hiddenLabel mesh__D006549 Diaphragmatic Hernias, Traumatic
% 222.25/222.46  |- mesh__recordAuthorizer mesh__D017271 PLS
% 222.25/222.46  |- skos__historyNote mesh__D017271
% 222.25/222.46       Temporomandibular Joint Diseases %28%1982-1992%29%
% 222.25/222.46  |- mesh__dateRevised mesh__D017271 1996-06-10
% 222.25/222.46  |- skos__altLabel mesh__D017271 Craniomandibular Diseases
% 222.25/222.46  |- skos__hiddenLabel mesh__D017271 Craniomandibular Disorder
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D017271 2006
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D017271 1998
% 222.25/222.46  |- skos__annotation mesh__D017271
% 222.25/222.46       GEN or unspecified; prefer specifics; usually called this or CMD by authors; DF: CMD%A%  
% 222.25/222.46  |- skos__prefLabel mesh__D017271 Craniomandibular Disorders
% 222.25/222.46  |- mesh__historyNote mesh__D017271
% 222.25/222.46       93; was see TEMPOROMANDIBULAR JOINT SYNDROME 1991-92   
% 222.25/222.46  |- skos__broader mesh__D017271smesh__D009135
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D017271 1999
% 222.25/222.46  |- mesh__recordMaintainer mesh__D017271 TGC
% 222.25/222.46  |- mesh__recordOriginator mesh__D017271 TGC
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D017271 2000
% 222.25/222.46  |- skos__hiddenLabel mesh__D017271 Disease, Craniomandibular
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D017271 2003
% 222.25/222.46  |- rdf__type mesh__D017271sskos__Concept
% 222.25/222.46  |- skos__hiddenLabel mesh__D017271 Craniomandibular Disease
% 222.25/222.46  |- mesh__dateCreated mesh__D017271 1992-05-20
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D017271 2001
% 222.25/222.46  |- skos__broader mesh__D017271smesh__D008336
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D017271 2004
% 222.25/222.46  |- skos__hiddenLabel mesh__D017271 Diseases, Craniomandibular
% 222.25/222.46  |- skos__scopeNote mesh__D017271
% 222.25/222.46       Diseases or disorders of the muscles of the head and neck, with special reference to the masticatory muscles. The most notable examples are TEMPOROMANDIBULAR JOINT DISORDERS and TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME.%A%    
% 222.25/222.46  |- skos__hiddenLabel mesh__D017271 Disorders, Craniomandibular
% 222.25/222.46  |- mesh__dateEstablished mesh__D017271 1993-01-01
% 222.25/222.46  |- mesh__publicMeSHNote mesh__D017271
% 222.25/222.46       93; was see TEMPOROMANDIBULAR JOINT SYNDROME 1991-92   
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D017271 2002
% 222.25/222.46  |- mesh__onlineNote mesh__D017271
% 222.25/222.46       use TEMPOROMANDIBULAR JOINT SYNDROME to search CRANIOMANDIBULAR DISORDERS 1991-92%A%  
% 222.25/222.46  |- skos__historyNote mesh__D017271
% 222.25/222.46       Temporomandibular Joint Syndrome %28%1979-1992%29%
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D017271 2005
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D017271 1997
% 222.25/222.46  |- skos__hiddenLabel mesh__D017271 Disorder, Craniomandibular
% 222.25/222.46  |- skos__hiddenLabel mesh__D003251 Constrictions, Pathologic
% 222.25/222.46  |- skos__annotation mesh__D003251
% 222.25/222.46       never IM; when NIM use any Cat C qualif pertinent; includes %22%stenosis%22%; DF: CONSTRICTION PATHOL%A%  
% 222.25/222.46  |- skos__hiddenLabel mesh__D003251 Stenoses
% 222.25/222.46  |- skos__broader mesh__D003251smesh__D020763
% 222.25/222.46  |- mesh__recordOriginator mesh__D003251 SMH
% 222.25/222.46  |- mesh__publicMeSHNote mesh__D003251
% 222.25/222.46       76; was included in CONSTRICTION see under PHYSIOLOGY 1975%A%  
% 222.25/222.46  |- skos__altLabel mesh__D003251 Constriction, Pathological
% 222.25/222.46  |- skos__related mesh__D003251smesh__D023921
% 222.25/222.46  |- skos__hiddenLabel mesh__D003251 Pathologic Constrictions
% 222.25/222.46  |- skos__prefLabel mesh__D003251 Constriction, Pathologic
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D003251 2006
% 222.25/222.46  |- skos__scopeNote mesh__D003251
% 222.25/222.46       The condition of an anatomical structure%27%s being constricted beyond normal dimensions.%A%    
% 222.25/222.46  |- skos__altLabel mesh__D003251 Pathologic Constriction
% 222.25/222.46  |- skos__altLabel mesh__D003251 Stenosis
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D003251 2004
% 222.25/222.46  |- mesh__onlineNote mesh__D003251
% 222.25/222.46       search CONSTRICTION 1968-75 %28%as Prov 1968-74, as Cat C %26% E heading 1968-75%29%%A%  
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D003251 2005
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D003251 2002
% 222.25/222.46  |- mesh__dateEstablished mesh__D003251 1976-01-01
% 222.25/222.46  |- mesh__recordAuthorizer mesh__D003251 sjn
% 222.25/222.46  |- rdf__type mesh__D003251sskos__Concept
% 222.25/222.46  |- mesh__dateRevised mesh__D003251 2001-07-25
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D003251 2003
% 222.25/222.46  |- mesh__recordMaintainer mesh__D003251 nns
% 222.25/222.46  |- mesh__dateCreated mesh__D003251 1975-07-25
% 222.25/222.46  |- mesh__historyNote mesh__D003251
% 222.25/222.46       76; was included in CONSTRICTION 1968-75 %28%Prov 1968-74, Cat C %26% E heading 1968-75%29%%A%  
% 222.25/222.46  |- skos__hiddenLabel mesh__D003251 Pathological Constriction
% 222.25/222.46  |- skos__historyNote mesh__D003251 Constriction %28%1968-1975%29%
% 222.25/222.46  |- mesh__dateEstablished mesh__D016977 1992-01-01
% 222.25/222.46  |- mesh__recordMaintainer mesh__D016977 SYSTEM
% 222.25/222.46  |- mesh__dateRevised mesh__D016977 2005-06-30
% 222.25/222.46  |- mesh__dateCreated mesh__D016977 1991-05-30
% 222.25/222.46  |- skos__historyNote mesh__D016977 Haemophilus %28%1980-1985%29%
% 222.25/222.46  |- mesh__historyNote mesh__D016977 92   
% 222.25/222.46  |- mesh__publicMeSHNote mesh__D016977 92   
% 222.25/222.46  |- skos__annotation mesh__D016977
% 222.25/222.46       infection: coord IM with ACTINOBACILLUS INFECTIONS %28%IM%29%   
% 222.25/222.46  |- mesh__recordOriginator mesh__D016977 PXP
% 222.25/222.46  |- skos__historyNote mesh__D016977 Actinobacillus %28%1985-1991%29%
% 222.25/222.46  |- mesh__recordAuthorizer mesh__D016977 sjn
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D016977 2006
% 222.25/222.46  |- skos__scopeNote mesh__D016977
% 222.25/222.46       A species of gram-negative, facultatively anaerobic coccobacillus-shaped bacteria that has been isolated from pneumonic lesions and blood. It produces pneumonia with accompanying fibrinous pleuritis in swine.%A%    
% 222.25/222.46  |- skos__altLabel mesh__D016977 Hemophilus pleuropneumoniae
% 222.25/222.46  |- skos__broader mesh__D016977smesh__D000188
% 222.25/222.46  |- skos__prefLabel mesh__D016977 Actinobacillus pleuropneumoniae
% 222.25/222.46  |- rdf__type mesh__D016977sskos__Concept
% 222.25/222.46  |- skos__altLabel mesh__D016977 Haemophilus pleuropneumoniae
% 222.25/222.46  |- mesh__historyNote mesh__D016179 91   
% 222.25/222.46  |- mesh__publicMeSHNote mesh__D016179 91   
% 222.25/222.46  |- mesh__dateRevised mesh__D016179 2005-06-30
% 222.25/222.46  |- mesh__dateCreated mesh__D016179 1990-06-19
% 222.25/222.46  |- mesh__recordAuthorizer mesh__D016179 sjn
% 222.25/222.46  |- mesh__recordOriginator mesh__D016179 RLS
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D016179 2006
% 222.25/222.46  |- mesh__recordMaintainer mesh__D016179 ssb
% 222.25/222.46  |- rdf__type mesh__D016179sskos__Concept
% 222.25/222.46  |- skos__related mesh__D016179smesh__D016188
% 222.25/222.46  |- skos__prefLabel mesh__D016179 Granulocyte Colony-Stimulating Factor
% 222.25/222.46  |- skos__broader mesh__D016179smesh__D003115
% 222.25/222.46  |- skos__scopeNote mesh__D016179
% 222.25/222.46       A glycoprotein of MW 25 kDa containing internal disulfide bonds. It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukemic myeloid cell lines.%A%    
% 222.25/222.46  |- skos__altLabel mesh__D016179 G-CSF
% 222.25/222.46  |- mesh__dateEstablished mesh__D016179 1991-01-01
% 222.25/222.46  |- skos__historyNote mesh__D016179
% 222.25/222.46       Colony-Stimulating Factors %28%1976-1990%29%
% 222.25/222.46  |- skos__annotation mesh__D016179 /drug eff permitted; DF: GCSF   
% 222.25/222.46  |- mesh__recordMaintainer mesh__D002957 ags
% 222.25/222.46  |- skos__altLabel mesh__D002957 Orange Tree, Sour
% 222.25/222.46  |- skos__altLabel mesh__D002957 Citrus Fruit
% 222.25/222.46  |- skos__altLabel mesh__D002957 Citron Tree
% 222.25/222.46  |- skos__prefLabel mesh__D002957 Citrus
% 222.25/222.46  |- skos__altLabel mesh__D002957 Orange Tree, Mandarin
% 222.25/222.46  |- skos__altLabel mesh__D002957 Orange Tree, Seville
% 222.25/222.46  |- skos__altLabel mesh__D002957 Pomelo Tree
% 222.25/222.46  |- mesh__recordAuthorizer mesh__D002957 ags
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D002957 2006
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D002957 2006A
% 222.25/222.46  |- mesh__dateRevised mesh__D002957 2005-07-12
% 222.25/222.46  |- mesh__recordOriginator mesh__D002957 NLM
% 222.25/222.46  |- mesh__historyNote mesh__D002957 was Citrus Fruits 1966-1997   
% 222.25/222.46  |- skos__annotation mesh__D002957
% 222.25/222.46       X ref CITRUS BERGAMIA: The common name of Bergamot is also used for MONARDA, check ref; prefer specifics; as plant %26% fruit; juices: coord IM with BEVERAGES %28%IM%29%; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.25/222.46  |- skos__altLabel mesh__D002957 Tangerine Tree
% 222.25/222.46  |- skos__altLabel mesh__D002957 Citrus grandis
% 222.25/222.46  |- mesh__publicMeSHNote mesh__D002957 was Citrus Fruits 1966-1997   
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D002957 2005
% 222.25/222.46  |- skos__broader mesh__D002957smesh__D027821
% 222.25/222.46  |- skos__altLabel mesh__D002957 Pummelo Tree
% 222.25/222.46  |- skos__altLabel mesh__D002957 Lemon Tree
% 222.25/222.46  |- skos__altLabel mesh__D002957 Orange Tree, Bitter
% 222.25/222.46  |- skos__altLabel mesh__D002957 Kaffir Lime
% 222.25/222.46  |- skos__scopeNote mesh__D002957
% 222.25/222.46       A plant genus of the family RUTACEAE.  They bear the familiar citrus fruits including oranges, grapefruit, lemons, and limes.  There are many hybrids which makes the nomenclature confusing.%A%    
% 222.25/222.46  |- mesh__dateCreated mesh__D002957 1999-01-01
% 222.25/222.46  |- rdf__type mesh__D002957sskos__Concept
% 222.25/222.46  |- mesh__recordMaintainer mesh__D002159 ssb
% 222.25/222.46  |- mesh__dateCreated mesh__D002159 1974-11-11
% 222.25/222.46  |- mesh__dateEstablished mesh__D002159 1991-01-01
% 222.25/222.46  |- mesh__historyNote mesh__D002159
% 222.25/222.46       91%28%75%29%; was see under BENZIMIDAZOLES 1975-90   
% 222.25/222.46  |- skos__broader mesh__D002159smesh__D001562
% 222.25/222.46  |- rdf__type mesh__D002159sskos__Concept
% 222.25/222.46  |- skos__scopeNote mesh__D002159
% 222.25/222.46       A nematocide effective against a variety of gastrointestinal parasites in cattle, sheep, and horses.%A%    
% 222.25/222.46  |- skos__altLabel mesh__D002159
% 222.25/222.46       5-Isopropoxycarbonylamino-2-%28%4-thiazoyl%29%benzimidazole
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D002159 2003
% 222.25/222.46  |- mesh__recordAuthorizer mesh__D002159 sjn
% 222.25/222.46  |- mesh__publicMeSHNote mesh__D002159
% 222.25/222.46       91; was see under BENZIMIDAZOLES 1975-90   
% 222.25/222.46  |- skos__historyNote mesh__D002159 Carbamates %28%1972-1974%29%
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D002159 2005
% 222.25/222.46  |- skos__historyNote mesh__D002159 Benzimidazoles %28%1971-1974%29%
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D002159 2004
% 222.25/222.46  |- mesh__dateRevised mesh__D002159 2001-07-25
% 222.25/222.46  |- skos__prefLabel mesh__D002159 Cambendazole
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D002159 2002
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D002159 2006
% 222.25/222.46  |- mesh__recordOriginator mesh__D002159 NLM
% 222.25/222.46  |- skos__historyNote mesh__D002159 Thiazoles %28%1971-1974%29%
% 222.25/222.46  |- mesh__dateRevised mesh__D007642 1997-06-20
% 222.25/222.46  |- skos__hiddenLabel mesh__D007642 Blennorrhagicum, Keratoderma
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D007642 2005
% 222.25/222.46  |- skos__hiddenLabel mesh__D007642 Keratomas
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D007642 2004
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D007642 2001
% 222.25/222.46  |- skos__hiddenLabel mesh__D007642 Keratosis Blennorrhagicas
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D007642 2003
% 222.25/222.46  |- skos__hiddenLabel mesh__D007642 Keratoses
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D007642 2000
% 222.25/222.46  |- rdf__type mesh__D007642sskos__Concept
% 222.25/222.46  |- skos__annotation mesh__D007642 a horny skin dis   
% 222.25/222.46  |- skos__altLabel mesh__D007642 Keratoderma Blennorrhagicum
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D007642 1999
% 222.25/222.46  |- skos__scopeNote mesh__D007642
% 222.25/222.46       Any horny growth such as a wart or callus.     
% 222.25/222.46  |- mesh__recordAuthorizer mesh__D007642 SJN
% 222.25/222.46  |- skos__hiddenLabel mesh__D007642 Blennorrhagicums, Keratoderma
% 222.25/222.46  |- mesh__onlineNote mesh__D007642
% 222.25/222.46       use GONORRHEA to search KERATODERMA BLENNORRHAGICUM 1966-74%A%  
% 222.25/222.46  |- mesh__recordOriginator mesh__D007642 NLM
% 222.25/222.46  |- skos__broader mesh__D007642smesh__D012871
% 222.25/222.46  |- skos__prefLabel mesh__D007642 Keratosis
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D007642 1998
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D007642 2002
% 222.25/222.46  |- mesh__dateCreated mesh__D007642 1999-01-01
% 222.25/222.46  |- skos__hiddenLabel mesh__D007642 Keratoderma Blennorrhagicums
% 222.25/222.46  |- mesh__historyNote mesh__D007642
% 222.25/222.46       KERATODERMA BLENNORRHAGICUM was heading 1975-96 %28%was KERATOSIS BLENNORRHAGICA 1963-92 %28%see under KERATOSIS 1979-90, see under GONORRHEA 1975-78%29%%29%, was see under GONORRHEA 1963-74; KERATOSIS BLENNORRHAGICA was see KERATODERMA BLENNORRHAGICUM 1993-96%A%  
% 222.25/222.46  |- skos__hiddenLabel mesh__D007642 Blennorrhagica, Keratosis
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D007642 2006
% 222.25/222.46  |- mesh__publicMeSHNote mesh__D007642
% 222.25/222.46       KERATODERMA BLENNORRHAGICUM was heading 1975-96 %28%was KERATOSIS BLENNORRHAGICA 1963-92 %28%see under KERATOSIS 1979-90, see under GONORRHEA 1975-78%29%%29%, was see under GONORRHEA 1963-74; KERATOSIS BLENNORRHAGICA was see KERATODERMA BLENNORRHAGICUM 1993-96%A%  
% 222.25/222.46  |- skos__hiddenLabel mesh__D007642 Blennorrhagicas, Keratosis
% 222.25/222.46  |- mesh__recordMaintainer mesh__D007642 TPW
% 222.25/222.46  |- skos__historyNote mesh__D012587
% 222.25/222.46       Pulmonary Artery/abnormalities %28%1966-1984%29%
% 222.25/222.46  |- skos__broader mesh__D012587smesh__D018376
% 222.25/222.46  |- skos__broader mesh__D012587smesh__D002318
% 222.25/222.46  |- skos__hiddenLabel mesh__D012587 Syndrome, Scimitar
% 222.25/222.46  |- mesh__recordAuthorizer mesh__D012587 sjn
% 222.25/222.46  |- mesh__recordMaintainer mesh__D012587 kle
% 222.25/222.46  |- mesh__dateEstablished mesh__D012587 1985-01-01
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D012587 2004
% 222.25/222.46  |- skos__broader mesh__D012587smesh__D014652
% 222.25/222.46  |- mesh__dateRevised mesh__D012587 1999-11-03
% 222.25/222.46  |- skos__broader mesh__D012587smesh__D015619
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D012587 2000
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D012587 2005
% 222.25/222.46  |- mesh__recordOriginator mesh__D012587 VDK
% 222.25/222.46  |- mesh__dateCreated mesh__D012587 1984-05-29
% 222.25/222.46  |- skos__hiddenLabel mesh__D012587 Syndromes, Scimitar
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D012587 2001
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D012587 2006
% 222.25/222.46  |- skos__hiddenLabel mesh__D012587 Scimitar Syndromes
% 222.25/222.46  |- mesh__historyNote mesh__D012587 85   
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D012587 2002
% 222.25/222.46  |- skos__broader mesh__D012587smesh__D008171
% 222.25/222.46  |- skos__scopeNote mesh__D012587
% 222.25/222.46       Anomalous venous drainage of the right lung into the inferior vena cava, with hypoplasia of the right lung. The scimitar-shaped radiographic shadow of the anomalous vein gives the syndrome its name.%A%    
% 222.25/222.46  |- skos__annotation mesh__D012587
% 222.25/222.46       lung abnorm named from shape of x-ray shadow; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 222.25/222.46  |- skos__historyNote mesh__D012587 Lung/abnormalities %28%1966-1984%29%
% 222.25/222.46  |- skos__prefLabel mesh__D012587 Scimitar Syndrome
% 222.25/222.46  |- rdf__type mesh__D012587sskos__Concept
% 222.25/222.46  |- mesh__publicMeSHNote mesh__D012587 85   
% 222.25/222.46  |- skos__historyNote mesh__D012587
% 222.25/222.46       Pulmonary Veins/abnormalities %28%1966-1984%29%
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D012587 2003
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D031741 2005
% 222.25/222.46  |- mesh__historyNote mesh__D031741 2003   
% 222.25/222.46  |- mesh__publicMeSHNote mesh__D031741 2003   
% 222.25/222.46  |- skos__broader mesh__D031741smesh__D006109
% 222.25/222.46  |- skos__scopeNote mesh__D031741
% 222.25/222.46       A plant genus of the family POACEAE. The common name of buffelgrass is also used for PENNISETUM.%A%    
% 222.25/222.46  |- rdf__type mesh__D031741sskos__Concept
% 222.25/222.46  |- mesh__dateCreated mesh__D031741 2002-07-03
% 222.25/222.46  |- skos__prefLabel mesh__D031741 Cenchrus
% 222.25/222.46  |- mesh__dateEstablished mesh__D031741 2003-01-01
% 222.25/222.46  |- skos__altLabel mesh__D031741 Sandbur
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D031741 2004
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D031741 2003
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D031741 2006
% 222.25/222.46  |- skos__annotation mesh__D031741
% 222.25/222.46       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.25/222.46  |- mesh__recordAuthorizer mesh__D017272 sjn
% 222.25/222.46  |- mesh__recordOriginator mesh__D017272 TPW
% 222.25/222.46  |- skos__broader mesh__D017272smesh__D011412
% 222.25/222.46  |- mesh__dateEstablished mesh__D017272 1993-01-01
% 222.25/222.46  |- skos__altLabel mesh__D017272
% 222.25/222.46       N%27%-%28%3-Acetyl-4-%28%3-%28%%28%1,1-dimethylethyl%29%amino%29%-2-hydroxypropoxy%29%phenyl%29%-N,N-diethylurea
% 222.25/222.46  |- mesh__onlineNote mesh__D017272
% 222.25/222.46       use CELIPROLOL %28%NM%29% to search CELIPROLOL 1982-92   
% 222.25/222.46  |- skos__hiddenLabel mesh__D017272 REV 5320A
% 222.25/222.46  |- skos__hiddenLabel mesh__D017272 ST 1396
% 222.25/222.46  |- skos__hiddenLabel mesh__D017272 Hydrochloride, Celiprolol
% 222.25/222.46  |- mesh__recordMaintainer mesh__D017272 ssb
% 222.25/222.46  |- rdf__type mesh__D017272sskos__Concept
% 222.25/222.46  |- skos__hiddenLabel mesh__D017272 REV5320A
% 222.25/222.46  |- mesh__dateCreated mesh__D017272 1992-05-07
% 222.25/222.46  |- mesh__historyNote mesh__D017272 93; was CELIPROLOL %28%NM%29% 1978-92   
% 222.25/222.46  |- skos__broader mesh__D017272smesh__D050198
% 222.25/222.46  |- skos__altLabel mesh__D017272 Celiprolol Hydrochloride
% 222.25/222.46  |- mesh__dateRevised mesh__D017272 2005-06-30
% 222.25/222.46  |- skos__broader mesh__D017272smesh__D010671
% 222.25/222.46  |- mesh__publicMeSHNote mesh__D017272
% 222.25/222.46       93; CELIPROLOL was indexed under PROPANOLAMINES 1982-92 %26% under UREA/analogs %26% derivatives 1978-82%A%  
% 222.25/222.46  |- skos__historyNote mesh__D017272 Propanolamines %28%1982-1992%29%
% 222.25/222.46  |- skos__scopeNote mesh__D017272
% 222.25/222.46       A cardioselective beta-1-adrenergic antagonist that may act as a partial agonist at some adrenergic sites.%A%    
% 222.25/222.46  |- skos__hiddenLabel mesh__D017272 ST1396
% 222.25/222.46  |- skos__historyNote mesh__D017272
% 222.25/222.46       Urea/analogs %26% derivatives %28%1978-1982%29%
% 222.25/222.46  |- skos__hiddenLabel mesh__D017272 Monohydrochloride, Celiprolol
% 222.25/222.46  |- skos__prefLabel mesh__D017272 Celiprolol
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D017272 2006
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D003252 1993
% 222.25/222.46  |- mesh__dateEstablished mesh__D003252 1974-01-01
% 222.25/222.46  |- skos__broader mesh__D003252smesh__D008420
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D003252 1996
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D003252 2005
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D003252 1999
% 222.25/222.46  |- mesh__recordAuthorizer mesh__D003252 PLS
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D003252 2000
% 222.25/222.46  |- skos__hiddenLabel mesh__D003252 Materials, Construction
% 222.25/222.46  |- mesh__publicMeSHNote mesh__D003252 74   
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D003252 2003
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D003252 1997
% 222.25/222.46  |- mesh__dateCreated mesh__D003252 1999-01-01
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D003252 2006
% 222.25/222.46  |- mesh__activeMeSHYear mesh__D003252 2001
% 222.25/222.46  |- mesh__dateRevised mesh__D003252 1992-05-07
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003252 2004
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003252 1994
% 222.25/222.47  |- skos__hiddenLabel mesh__D003252 Construction Material
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003252 2002
% 222.25/222.47  |- mesh__historyNote mesh__D003252 74%28%72%29%   
% 222.25/222.47  |- mesh__recordOriginator mesh__D003252 NLM
% 222.25/222.47  |- rdf__type mesh__D003252sskos__Concept
% 222.25/222.47  |- skos__prefLabel mesh__D003252 Construction Materials
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003252 1995
% 222.25/222.47  |- mesh__recordMaintainer mesh__D003252 TGC
% 222.25/222.47  |- skos__hiddenLabel mesh__D003252 Material, Construction
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003252 1998
% 222.25/222.47  |- skos__altLabel mesh__D016978 Pasteurella hemolytica
% 222.25/222.47  |- mesh__recordAuthorizer mesh__D016978 ags
% 222.25/222.47  |- mesh__dateEstablished mesh__D016978 1992-01-01
% 222.25/222.47  |- mesh__recordOriginator mesh__D016978 PXP
% 222.25/222.47  |- skos__altLabel mesh__D016978 Pasteurella haemolytica
% 222.25/222.47  |- mesh__historyNote mesh__D016978 2003 %28%1992%29%   
% 222.25/222.47  |- skos__broader mesh__D016978smesh__D031121
% 222.25/222.47  |- mesh__publicMeSHNote mesh__D016978
% 222.25/222.47       2003; see PASTEURELLA HAEMOLYTICA 1992-2002   
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D016978 2006A
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D016978 2006
% 222.25/222.47  |- skos__prefLabel mesh__D016978 Mannheimia haemolytica
% 222.25/222.47  |- skos__historyNote mesh__D016978 Pasteurella %28%1966-1991%29%
% 222.25/222.47  |- mesh__recordMaintainer mesh__D016978 ags
% 222.25/222.47  |- skos__annotation mesh__D016978
% 222.25/222.47       infection: coordinate IM with PASTEURELLACEAE INFECTIONS %28%IM%29% or PASTEURELLOSIS, PNEUMONIC %28%IM%29% or PNEUMONIA OF CALVES, ENZOOTIC %28%IM%29% if pertinent%A%  
% 222.25/222.47  |- rdf__type mesh__D016978sskos__Concept
% 222.25/222.47  |- mesh__dateRevised mesh__D016978 2005-07-27
% 222.25/222.47  |- skos__scopeNote mesh__D016978
% 222.25/222.47       A species of gram-negative, facultatively anaerobic, rod-shaped bacteria normally commensal in the flora of CATTLE and SHEEP. But under conditions of physical or physiological STRESS, it can cause MASTITIS in sheep and SHIPPING FEVER or ENZOOTIC CALF PNEUMONIA in cattle. Its former name was Pasteurella haemolytica.%A%    
% 222.25/222.47  |- mesh__dateCreated mesh__D016978 1991-05-30
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D002958 2006
% 222.25/222.47  |- skos__hiddenLabel mesh__D002958 Planning, Urban
% 222.25/222.47  |- mesh__recordMaintainer mesh__D002958 kle
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D002958 2001
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D002958 2004
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D002958 2000
% 222.25/222.47  |- skos__hiddenLabel mesh__D002958 Plannings, Urban
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D002958 2005
% 222.25/222.47  |- skos__hiddenLabel mesh__D002958 Plannings, Town
% 222.25/222.47  |- skos__hiddenLabel mesh__D002958 Town Plannings
% 222.25/222.47  |- skos__hiddenLabel mesh__D002958 Urban Plannings
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D002958 2003
% 222.25/222.47  |- mesh__dateCreated mesh__D002958 1999-01-01
% 222.25/222.47  |- rdf__type mesh__D002958sskos__Concept
% 222.25/222.47  |- skos__scopeNote mesh__D002958
% 222.25/222.47       Comprehensive planning for the physical development of the city.%A%    
% 222.25/222.47  |- mesh__recordAuthorizer mesh__D002958 sjn
% 222.25/222.47  |- skos__hiddenLabel mesh__D002958 Planning, Town
% 222.25/222.47  |- skos__hiddenLabel mesh__D002958 Plannings, City
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D002958 2002
% 222.25/222.47  |- skos__annotation mesh__D002958 IM   
% 222.25/222.47  |- skos__broader mesh__D002958smesh__D012939
% 222.25/222.47  |- skos__prefLabel mesh__D002958 City Planning
% 222.25/222.47  |- skos__hiddenLabel mesh__D002958 Planning, City
% 222.25/222.47  |- mesh__dateRevised mesh__D002958 1999-11-03
% 222.25/222.47  |- mesh__recordOriginator mesh__D002958 NLM
% 222.25/222.47  |- skos__hiddenLabel mesh__D002958 City Plannings
% 222.25/222.47  |- mesh__recordAuthorizer mesh__D013680 sjn
% 222.25/222.47  |- skos__hiddenLabel mesh__D013680 Membranes, Tectorial
% 222.25/222.47  |- mesh__publicMeSHNote mesh__D013680 91; was see under COCHLEA 1979-90   
% 222.25/222.47  |- skos__prefLabel mesh__D013680 Tectorial Membrane
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D013680 2006
% 222.25/222.47  |- skos__hiddenLabel mesh__D013680 Membrane, Tectorial
% 222.25/222.47  |- mesh__recordOriginator mesh__D013680 RC
% 222.25/222.47  |- skos__scopeNote mesh__D013680
% 222.25/222.47       A membrane, attached to the bony SPIRAL LAMINA, overlying and coupling with the HAIR CELLS of the ORGAN OF CORTI in the inner ear. It is a glycoprotein-rich keratin-like layer containing fibrils embedded in a dense amorphous substance.%A%    
% 222.25/222.47  |- mesh__recordMaintainer mesh__D013680 lkt
% 222.25/222.47  |- mesh__dateCreated mesh__D013680 1978-05-19
% 222.25/222.47  |- rdf__type mesh__D013680sskos__Concept
% 222.25/222.47  |- skos__hiddenLabel mesh__D013680 Tectorial Membranes
% 222.25/222.47  |- mesh__dateRevised mesh__D013680 2005-06-30
% 222.25/222.47  |- skos__historyNote mesh__D013680 Cochlea %28%1966-1978%29%
% 222.25/222.47  |- skos__broader mesh__D013680smesh__D003053
% 222.25/222.47  |- mesh__dateEstablished mesh__D013680 1991-01-01
% 222.25/222.47  |- mesh__historyNote mesh__D013680
% 222.25/222.47       91%28%79%29%; was see under COCHLEA 1979-90   
% 222.25/222.47  |- skos__scopeNote mesh__D045762
% 222.25/222.47       Biological catalysts and their cofactors.     
% 222.25/222.47  |- mesh__publicMeSHNote mesh__D045762 2004   
% 222.25/222.47  |- skos__prefLabel mesh__D045762 Enzymes and Coenzymes
% 222.25/222.47  |- skos__annotation mesh__D045762
% 222.25/222.47       not used for indexing; CATALOG: do not use   
% 222.25/222.47  |- mesh__dateCreated mesh__D045762 2003-07-09
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D045762 2005
% 222.25/222.47  |- skos__hiddenLabel mesh__D045762 Coenzymes and Enzymes
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D045762 2006
% 222.25/222.47  |- rdf__type mesh__D045762sskos__Concept
% 222.25/222.47  |- mesh__historyNote mesh__D045762 2004   
% 222.25/222.47  |- mesh__dateEstablished mesh__D045762 2004-01-01
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D045762 2004
% 222.25/222.47  |- mesh__runningHead mesh__D045762 D8 - ENZYMES AND COENZYMES   
% 222.25/222.47  |- skos__hiddenLabel mesh__D012588 Scintillation Counter
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D012588 1995
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D012588 1996
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D012588 2000
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D012588 2004
% 222.25/222.47  |- skos__hiddenLabel mesh__D012588 Counting, Scintillation
% 222.25/222.47  |- skos__historyNote mesh__D012588 Radiometry %28%1966-1972%29%
% 222.25/222.47  |- mesh__recordMaintainer mesh__D012588 TAP
% 222.25/222.47  |- skos__broader mesh__D012588smesh__D011874
% 222.25/222.47  |- skos__scopeNote mesh__D012588
% 222.25/222.47       Detection and counting of scintillations produced in a fluorescent material by ionizing radiation.%A%    
% 222.25/222.47  |- mesh__publicMeSHNote mesh__D012588
% 222.25/222.47       79; was SCINTILLATION COUNTERS 1973-78; was SCINTILLATION COUNTER see under RADIOMETRY 1963-72%A%  
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D012588 1997
% 222.25/222.47  |- skos__related mesh__D012588smesh__D015902
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D012588 2001
% 222.25/222.47  |- skos__prefLabel mesh__D012588 Scintillation Counting
% 222.25/222.47  |- mesh__recordOriginator mesh__D012588 NLM
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D012588 2005
% 222.25/222.47  |- mesh__recordAuthorizer mesh__D012588 PLS
% 222.25/222.47  |- mesh__historyNote mesh__D012588
% 222.25/222.47       79; was SCINTILLATION COUNTERS 1973-78; was SCINTILLATION COUNTER see under RADIOMETRY 1963-72%A%  
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D012588 1998
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D012588 2002
% 222.25/222.47  |- mesh__dateEstablished mesh__D012588 1973-01-01
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D012588 2006
% 222.25/222.47  |- mesh__dateCreated mesh__D012588 1999-01-01
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D012588 1993
% 222.25/222.47  |- mesh__dateRevised mesh__D012588 1992-05-18
% 222.25/222.47  |- rdf__type mesh__D012588sskos__Concept
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D012588 1999
% 222.25/222.47  |- skos__hiddenLabel mesh__D012588 Counter, Scintillation
% 222.25/222.47  |- mesh__onlineNote mesh__D012588
% 222.25/222.47       use SCINTILLATION COUNTING to search SCINTILLATION COUNTERS 1973-78; use RADIOMETRY to search SCINITLLATION COUNTER 1966-72%A%  
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D012588 1994
% 222.25/222.47  |- skos__hiddenLabel mesh__D012588 Counters, Scintillation
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D012588 2003
% 222.25/222.47  |- mesh__publicMeSHNote mesh__D031742 2003   
% 222.25/222.47  |- skos__prefLabel mesh__D031742 Coix
% 222.25/222.47  |- rdf__type mesh__D031742sskos__Concept
% 222.25/222.47  |- mesh__dateCreated mesh__D031742 2002-07-02
% 222.25/222.47  |- skos__altLabel mesh__D031742 Adlay Seed Plant
% 222.25/222.47  |- mesh__historyNote mesh__D031742 2003   
% 222.25/222.47  |- skos__broader mesh__D031742smesh__D006109
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D031742 2004
% 222.25/222.47  |- skos__scopeNote mesh__D031742
% 222.25/222.47       A plant genus of the family POACEAE. The seed is used in folk medicine %28%DRUGS, CHINESE HERBAL%29%.%A%    
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D031742 2003
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D031742 2006
% 222.25/222.47  |- skos__annotation mesh__D031742
% 222.25/222.47       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.25/222.47  |- skos__altLabel mesh__D031742 Job%27%s Tears
% 222.25/222.47  |- mesh__dateEstablished mesh__D031742 2003-01-01
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D031742 2005
% 222.25/222.47  |- skos__broader mesh__D019038Q000172smesh__D019038
% 222.25/222.47  |- mesh__preferredCombination mesh__D019038Q000172smesh__D001606
% 222.25/222.47  |- rdf__type mesh__D019038Q000172smesh__CompoundConcept
% 222.25/222.47  |- mesh__onlineNote mesh__D017273
% 222.25/222.47       use GOSERELIN %28%NM%29% to search ICI 118630 1980-92   
% 222.25/222.47  |- skos__prefLabel mesh__D017273 Goserelin
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D017273 2004
% 222.25/222.47  |- mesh__dateRevised mesh__D017273 2001-07-25
% 222.25/222.47  |- mesh__dateCreated mesh__D017273 1992-05-19
% 222.25/222.47  |- mesh__dateEstablished mesh__D017273 1993-01-01
% 222.25/222.47  |- mesh__recordOriginator mesh__D017273 TPW
% 222.25/222.47  |- mesh__recordAuthorizer mesh__D017273 sjn
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D017273 2005
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D017273 2002
% 222.25/222.47  |- skos__scopeNote mesh__D017273
% 222.25/222.47       This long-acting GONADORELIN analog and agonist is used in the treatment of malignant NEOPLASMS of the prostate, uterine fibromas, and metastatic breast cancer.%A%    
% 222.25/222.47  |- mesh__publicMeSHNote mesh__D017273
% 222.25/222.47       93; ICI 118630 was indexed under BUSERELIN/analogs %26% derivatives 1984-92 %26% GONADORELIN/analogs %26% derivatives 1979-84%A%  
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D017273 2006
% 222.25/222.47  |- skos__historyNote mesh__D017273
% 222.25/222.47       Buserelin/analogs %26% derivatives %28%1984-1992%29%
% 222.25/222.47  |- mesh__recordMaintainer mesh__D017273 ssb
% 222.25/222.47  |- skos__broader mesh__D017273smesh__D007987
% 222.25/222.47  |- skos__historyNote mesh__D017273
% 222.25/222.47       Gonadorelin/analogs %26% derivatives %28%1979-1984%29%
% 222.25/222.47  |- rdf__type mesh__D017273sskos__Concept
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D017273 2003
% 222.25/222.47  |- mesh__historyNote mesh__D017273 93; was ICI 118630 %28%NM%29% 1979-92   
% 222.25/222.47  |- skos__broader mesh__D000418Q000097smesh__D000418
% 222.25/222.47  |- mesh__preferredCombination mesh__D000418Q000097smesh__D012709
% 222.25/222.47  |- rdf__type mesh__D000418Q000097smesh__CompoundConcept
% 222.25/222.47  |- skos__annotation mesh__D003253 few qualif apply   
% 222.25/222.47  |- skos__historyNote mesh__D003253
% 222.25/222.47       Referral and Consultation %28%1968-1977%29%
% 222.25/222.47  |- mesh__dateEstablished mesh__D003253 1978-01-01
% 222.25/222.47  |- skos__hiddenLabel mesh__D003253 Service, Advisory
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003253 2003
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003253 1997
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003253 2006
% 222.25/222.47  |- skos__prefLabel mesh__D003253 Consultants
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003253 2004
% 222.25/222.47  |- mesh__publicMeSHNote mesh__D003253 78   
% 222.25/222.47  |- mesh__recordOriginator mesh__D003253 EC
% 222.25/222.47  |- mesh__recordAuthorizer mesh__D003253 PLS
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003253 2000
% 222.25/222.47  |- skos__broader mesh__D003253smesh__D009272
% 222.25/222.47  |- mesh__dateCreated mesh__D003253 1977-05-05
% 222.25/222.47  |- rdf__type mesh__D003253sskos__Concept
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003253 2001
% 222.25/222.47  |- skos__hiddenLabel mesh__D003253 Consultant
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003253 1998
% 222.25/222.47  |- skos__altLabel mesh__D003253 Advisory Services
% 222.25/222.47  |- mesh__historyNote mesh__D003253 78   
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003253 2002
% 222.25/222.47  |- skos__scopeNote mesh__D003253
% 222.25/222.47       Individuals referred to for expert or professional advice or services.%A%    
% 222.25/222.47  |- skos__hiddenLabel mesh__D003253 Advisory Service
% 222.25/222.47  |- mesh__recordMaintainer mesh__D003253 KEV
% 222.25/222.47  |- mesh__dateRevised mesh__D003253 1995-05-22
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003253 1996
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003253 2005
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003253 1999
% 222.25/222.47  |- mesh__historyNote mesh__D016979 92   
% 222.25/222.47  |- mesh__recordAuthorizer mesh__D016979 sjn
% 222.25/222.47  |- skos__prefLabel mesh__D016979 Pasteurella multocida
% 222.25/222.47  |- mesh__recordMaintainer mesh__D016979 SYSTEM
% 222.25/222.47  |- mesh__dateCreated mesh__D016979 1991-05-30
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D016979 2006
% 222.25/222.47  |- skos__scopeNote mesh__D016979
% 222.25/222.47       A species of gram-negative, facultatively anaerobic, rod-shaped bacteria normally found in the flora of the mouth and respiratory tract of animals and birds. It causes shipping fever %28%see PASTEURELLOSIS, PNEUMONIC%29%; HEMORRHAGIC BACTEREMIA; and intestinal disease in animals. In humans, disease usually arises from a wound infection following a bite or scratch from domesticated animals.%A%    
% 222.25/222.47  |- mesh__dateEstablished mesh__D016979 1992-01-01
% 222.25/222.47  |- skos__broader mesh__D016979smesh__D010325
% 222.25/222.47  |- skos__historyNote mesh__D016979 Pasteurella %28%1966-1991%29%
% 222.25/222.47  |- mesh__recordOriginator mesh__D016979 PXP
% 222.25/222.47  |- mesh__dateRevised mesh__D016979 2005-06-30
% 222.25/222.47  |- rdf__type mesh__D016979sskos__Concept
% 222.25/222.47  |- skos__annotation mesh__D016979
% 222.25/222.47       infection: coord IM with PASTEURELLA INFECTIONS %28%IM%29% or specific indentions %28%IM%29% if pertinent%A%  
% 222.25/222.47  |- mesh__publicMeSHNote mesh__D016979 92   
% 222.25/222.47  |- mesh__dateRevised mesh__D002959 1999-11-03
% 222.25/222.47  |- mesh__recordOriginator mesh__D002959 NLM
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D002959 2005
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D002959 2003
% 222.25/222.47  |- mesh__dateCreated mesh__D002959 1999-01-01
% 222.25/222.47  |- rdf__type mesh__D002959sskos__Concept
% 222.25/222.47  |- skos__hiddenLabel mesh__D002959 Defense, Civil
% 222.25/222.47  |- mesh__recordMaintainer mesh__D002959 kle
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D002959 2001
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D002959 2000
% 222.25/222.47  |- skos__hiddenLabel mesh__D002959 Civil Defenses
% 222.25/222.47  |- skos__annotation mesh__D002959 SPEC: SPEC qualif   
% 222.25/222.47  |- mesh__recordAuthorizer mesh__D002959 sjn
% 222.25/222.47  |- skos__scopeNote mesh__D002959
% 222.25/222.47       Preventive emergency measures and programs designed to protect the individual or community in times of hostile attack.%A%    
% 222.25/222.47  |- skos__broader mesh__D002959smesh__D006078
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D002959 2006
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D002959 2002
% 222.25/222.47  |- skos__prefLabel mesh__D002959 Civil Defense
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D002959 2004
% 222.25/222.47  |- skos__hiddenLabel mesh__D002959 Defenses, Civil
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D013681 1998
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D013681 2002
% 222.25/222.47  |- mesh__recordAuthorizer mesh__D013681 PLS
% 222.25/222.47  |- skos__broader mesh__D013681smesh__D008636
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D013681 1997
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D013681 1994
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D013681 1999
% 222.25/222.47  |- rdf__type mesh__D013681sskos__Concept
% 222.25/222.47  |- skos__hiddenLabel mesh__D013681 Tegmentum Mesencephalus
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D013681 1995
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D013681 1993
% 222.25/222.47  |- mesh__historyNote mesh__D013681 74%28%71%29%   
% 222.25/222.47  |- mesh__dateCreated mesh__D013681 1999-01-01
% 222.25/222.47  |- skos__annotation mesh__D013681
% 222.25/222.47       do not confuse with TECTUM MESENCEPHALI   
% 222.25/222.47  |- skos__historyNote mesh__D013681 Mesencephalon %28%1966-1970%29%
% 222.25/222.47  |- skos__prefLabel mesh__D013681 Tegmentum Mesencephali
% 222.25/222.47  |- mesh__recordOriginator mesh__D013681 NLM
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D013681 2000
% 222.25/222.47  |- skos__hiddenLabel mesh__D013681 Mesencephalus, Tegmentum
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D013681 2003
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D013681 2001
% 222.25/222.47  |- mesh__dateEstablished mesh__D013681 1974-01-01
% 222.25/222.47  |- mesh__recordMaintainer mesh__D013681 TAP
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D013681 2005
% 222.25/222.47  |- mesh__dateRevised mesh__D013681 1992-05-18
% 222.25/222.47  |- mesh__publicMeSHNote mesh__D013681 74   
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D013681 2004
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D013681 2006
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D013681 1996
% 222.25/222.47  |- skos__hiddenLabel mesh__D013681 Mesencephali, Tegmentum
% 222.25/222.47  |- mesh__recordAuthorizer mesh__D007644 sjn
% 222.25/222.47  |- skos__scopeNote mesh__D007644
% 222.25/222.47       A slowly progressive autosomal dominant disorder of keratinization characterized by pinkish-to-tan papules that coalesce to form plaques. These lesions become darker over time and commonly fuse, forming papillomatous and warty malodorous growths.%A%    
% 222.25/222.47  |- mesh__dateCreated mesh__D007644 1999-01-01
% 222.25/222.47  |- rdf__type mesh__D007644sskos__Concept
% 222.25/222.47  |- skos__hiddenLabel mesh__D007644 Disease, Darier
% 222.25/222.47  |- mesh__recordOriginator mesh__D007644 NLM
% 222.25/222.47  |- skos__altLabel mesh__D007644 Darier%27%s Disease
% 222.25/222.47  |- skos__hiddenLabel mesh__D007644 Dariers Disease
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D007644 2005
% 222.25/222.47  |- mesh__dateRevised mesh__D007644 2001-07-25
% 222.25/222.47  |- skos__prefLabel mesh__D007644 Keratosis Follicularis
% 222.25/222.47  |- skos__hiddenLabel mesh__D007644 Disease, Darier%27%s
% 222.25/222.47  |- skos__broader mesh__D007644smesh__D012873
% 222.25/222.47  |- skos__altLabel mesh__D007644 Darier Disease
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D007644 2003
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D007644 2006
% 222.25/222.47  |- mesh__recordMaintainer mesh__D007644 nns
% 222.25/222.47  |- skos__broader mesh__D007644smesh__D007642
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D007644 2004
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D007644 2002
% 222.25/222.47  |- skos__historyNote mesh__D012589 Rodentia %28%1966-1967%29%
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D012589 2005
% 222.25/222.47  |- mesh__historyNote mesh__D012589
% 222.25/222.47       82; was SQUIRRELS 1968-81; CHIPMUNKS was see under RODENTS 1975-81; GROUND SQUIRRELS was see SQUIRRELS 1981, was see under CHIPMUNKS 1975-80%A%  
% 222.25/222.47  |- skos__altLabel mesh__D012589 Spermophilus
% 222.25/222.47  |- mesh__dateEstablished mesh__D012589 1968-01-01
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D012589 2006
% 222.25/222.47  |- mesh__dateCreated mesh__D012589 1999-01-01
% 222.25/222.47  |- skos__annotation mesh__D012589
% 222.25/222.47       in addition to X refs, includes WOODCHUCKS see MARMOTA; IM; qualif permitted%A%  
% 222.25/222.47  |- skos__hiddenLabel mesh__D012589 Squirrel
% 222.25/222.47  |- rdf__type mesh__D012589sskos__Concept
% 222.25/222.47  |- skos__hiddenLabel mesh__D012589 Dogs, Prairie
% 222.25/222.47  |- mesh__recordAuthorizer mesh__D012589 sjn
% 222.25/222.47  |- skos__broader mesh__D012589smesh__D012377
% 222.25/222.47  |- mesh__dateRevised mesh__D012589 2004-07-07
% 222.25/222.47  |- skos__prefLabel mesh__D012589 Sciuridae
% 222.25/222.47  |- mesh__onlineNote mesh__D012589
% 222.25/222.47       use SCIURIDAE to search SQUIRRELS 1968-81 %26% CHIPMUNKS %26% GROUND SQUIRRELS 1975-81%A%  
% 222.25/222.47  |- skos__scopeNote mesh__D012589
% 222.25/222.47       A family of the order Rodentia which contains 49 genera. Some of the more common genera are MARMOTA, which includes the marmot and woodchuck; Sciurus, the gray squirrel, S. carolinensis, and the fox squirrel, S. niger; Tamias, the eastern and western chipmunk; and Tamiasciurus, the red squirrel. The flying squirrels, except the scaly-tailed Anomaluridae, also belong to this family.%A%    
% 222.25/222.47  |- skos__hiddenLabel mesh__D012589 Prairie Dog
% 222.25/222.47  |- skos__hiddenLabel mesh__D012589 Dog, Prairie
% 222.25/222.47  |- mesh__recordOriginator mesh__D012589 NLM
% 222.25/222.47  |- skos__hiddenLabel mesh__D012589 Suslik
% 222.25/222.47  |- mesh__recordMaintainer mesh__D012589 ags
% 222.25/222.47  |- skos__hiddenLabel mesh__D012589 Chipmunk
% 222.25/222.47  |- skos__altLabel mesh__D012589 Citellus
% 222.25/222.47  |- skos__altLabel mesh__D012589 Tamias
% 222.25/222.47  |- mesh__publicMeSHNote mesh__D012589
% 222.25/222.47       82; was SQUIRRELS 1968-81; CHIPMUNKS was see under RODENTS 1975-81; GROUND SQUIRRELS was see SQUIRRELS 1981, was indexed under RODENTS or SQUIRRELS 1975-80; MARMOTA was MARMOTS see under RODENTS 1975-81%A%  
% 222.25/222.47  |- mesh__dateEstablished mesh__D031743 2003-01-01
% 222.25/222.47  |- mesh__publicMeSHNote mesh__D031743 2003   
% 222.25/222.47  |- skos__altLabel mesh__D031743 Citronella
% 222.25/222.47  |- skos__altLabel mesh__D031743 Lemongrass
% 222.25/222.47  |- rdf__type mesh__D031743sskos__Concept
% 222.25/222.47  |- skos__altLabel mesh__D031743 Andropogon nardus
% 222.25/222.47  |- mesh__dateCreated mesh__D031743 2002-07-02
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D031743 2003
% 222.25/222.47  |- skos__broader mesh__D031743smesh__D006109
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D031743 2004
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D031743 2005
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D031743 2006
% 222.25/222.47  |- skos__annotation mesh__D031743
% 222.25/222.47       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.25/222.47  |- mesh__historyNote mesh__D031743 2003   
% 222.25/222.47  |- skos__scopeNote mesh__D031743
% 222.25/222.47       A plant genus of the family POACEAE which is a source of citronella oil and lemongrass oil.%A%    
% 222.25/222.47  |- skos__prefLabel mesh__D031743 Cymbopogon
% 222.25/222.47  |- skos__altLabel mesh__D031743 Lemon Grass
% 222.25/222.47  |- skos__historyNote mesh__D017274
% 222.25/222.47       Gonadorelin/analogs %26% derivatives %28%1981-1992%29%
% 222.25/222.47  |- skos__altLabel mesh__D017274 Nafarelin Acetate, Hydrate
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D017274 2005
% 222.25/222.47  |- mesh__historyNote mesh__D017274 93; was NAFARELIN %28%NM%29% 1981-92   
% 222.25/222.47  |- mesh__dateCreated mesh__D017274 1992-05-22
% 222.25/222.47  |- skos__scopeNote mesh__D017274
% 222.25/222.47       This GONADORELIN analog has been used in the treatment of central precocious puberty and endometriosis.%A%    
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D017274 2006
% 222.25/222.47  |- mesh__publicMeSHNote mesh__D017274
% 222.25/222.47       93; NAFARELIN was indexed under GONADORELIN/analogs %26% derivatives 1981-92%A%  
% 222.25/222.47  |- mesh__dateEstablished mesh__D017274 1993-01-01
% 222.25/222.47  |- mesh__recordOriginator mesh__D017274 TPW
% 222.25/222.47  |- mesh__dateRevised mesh__D017274 2003-07-09
% 222.25/222.47  |- mesh__onlineNote mesh__D017274
% 222.25/222.47       use NAFARELIN %28%NM%29% to search NAFARELIN 1981-92   
% 222.25/222.47  |- mesh__recordAuthorizer mesh__D017274 sjn
% 222.25/222.47  |- skos__broader mesh__D017274smesh__D007987
% 222.25/222.47  |- skos__hiddenLabel mesh__D017274 RS94991298
% 222.25/222.47  |- rdf__type mesh__D017274sskos__Concept
% 222.25/222.47  |- skos__hiddenLabel mesh__D017274 RS 94991 298
% 222.25/222.47  |- mesh__recordMaintainer mesh__D017274 ssb
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D017274 2004
% 222.25/222.47  |- skos__prefLabel mesh__D017274 Nafarelin
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003254 2004
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003254 2001
% 222.25/222.47  |- mesh__dateCreated mesh__D003254 1981-05-19
% 222.25/222.47  |- rdf__type mesh__D003254sskos__Concept
% 222.25/222.47  |- skos__hiddenLabel mesh__D003254 Advocacies, Consumer
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003254 2002
% 222.25/222.47  |- skos__prefLabel mesh__D003254 Consumer Advocacy
% 222.25/222.47  |- skos__hiddenLabel mesh__D003254 Consumer Advocacies
% 222.25/222.47  |- skos__hiddenLabel mesh__D003254 Advocacy, Public
% 222.25/222.47  |- skos__historyNote mesh__D003254 Consumer Satisfaction %28%1968-1981%29%
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003254 1998
% 222.25/222.47  |- skos__scopeNote mesh__D003254
% 222.25/222.47       The promotion and support of consumers%27% rights and interests.%A%    
% 222.25/222.47  |- skos__hiddenLabel mesh__D003254 Public Advocacies
% 222.25/222.47  |- skos__hiddenLabel mesh__D003254 Advocacy, Consumer
% 222.25/222.47  |- skos__historyNote mesh__D003254 Consumer Organizations %28%1968-1981%29%
% 222.25/222.47  |- mesh__recordMaintainer mesh__D003254 KEV
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003254 1996
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003254 2005
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003254 1999
% 222.25/222.47  |- skos__historyNote mesh__D003254 Consumer Participation %28%1974-1981%29%
% 222.25/222.47  |- mesh__recordOriginator mesh__D003254 EC
% 222.25/222.47  |- mesh__publicMeSHNote mesh__D003254 82   
% 222.25/222.47  |- mesh__historyNote mesh__D003254 82   
% 222.25/222.47  |- skos__hiddenLabel mesh__D003254 Advocacies, Public
% 222.25/222.47  |- skos__broader mesh__D003254smesh__D006806
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003254 2003
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003254 1997
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003254 2006
% 222.25/222.47  |- mesh__recordAuthorizer mesh__D003254 PLS
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D003254 2000
% 222.25/222.47  |- mesh__dateRevised mesh__D003254 1995-05-23
% 222.25/222.47  |- mesh__dateEstablished mesh__D003254 1982-01-01
% 222.25/222.47  |- rdf__type mesh__D013682sskos__Concept
% 222.25/222.47  |- skos__historyNote mesh__D013682 Phosphoric Acids %28%1966-1970%29%
% 222.25/222.47  |- skos__broader mesh__D013682smesh__D006027
% 222.25/222.47  |- mesh__dateCreated mesh__D013682 1999-01-01
% 222.25/222.47  |- skos__hiddenLabel mesh__D013682 Acid, Glycerol Teichoic
% 222.25/222.47  |- mesh__dateRevised mesh__D013682 2005-06-30
% 222.25/222.47  |- skos__broader mesh__D013682smesh__D011135
% 222.25/222.47  |- mesh__historyNote mesh__D013682 74%28%71%29%   
% 222.25/222.47  |- skos__prefLabel mesh__D013682 Teichoic Acids
% 222.25/222.47  |- mesh__recordAuthorizer mesh__D013682 sjn
% 222.25/222.47  |- mesh__recordOriginator mesh__D013682 NLM
% 222.25/222.47  |- skos__scopeNote mesh__D013682
% 222.25/222.47       Bacterial polysaccharides that are rich in phosphodiester linkages. They are the major components of the cell walls and membranes of many bacteria.%A%    
% 222.25/222.47  |- skos__hiddenLabel mesh__D013682 Acids, Teichoic
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D013682 2006
% 222.25/222.47  |- mesh__dateEstablished mesh__D013682 1974-01-01
% 222.25/222.47  |- skos__hiddenLabel mesh__D013682 Acids, Glycerol Teichoic
% 222.25/222.47  |- skos__altLabel mesh__D013682 Glycerol Teichoic Acid
% 222.25/222.47  |- mesh__recordMaintainer mesh__D013682 ssb
% 222.25/222.47  |- skos__historyNote mesh__D013682 Glycosides %28%1966-1970%29%
% 222.25/222.47  |- skos__broader mesh__D013682smesh__D013403
% 222.25/222.47  |- mesh__publicMeSHNote mesh__D013682 74   
% 222.25/222.47  |- skos__hiddenLabel mesh__D007645 Keratodermas, Palmoplantar
% 222.25/222.47  |- skos__scopeNote mesh__D007645
% 222.25/222.47       Group of mostly hereditary disorders characterized by thickening of the palms and soles as a result of excessive keratin formation leading to hypertrophy of the stratum corneum %28%hyperkeratosis%29%.%A%    
% 222.25/222.47  |- skos__altLabel mesh__D007645 Palmoplantar Keratoderma
% 222.25/222.47  |- mesh__recordMaintainer mesh__D007645 nns
% 222.25/222.47  |- mesh__activeMeSHYear mesh__D007645 2002
% 222.25/222.47  |- skos__hiddenLabel mesh__D007645 Disease, Meleda
% 222.25/222.48  |- mesh__publicMeSHNote mesh__D007645
% 222.25/222.48       93; was KERATOSIS PALMARIS ET PLANTARIS 1974-92; KERATODERMA, PALMOPLANTAR was see KERATOSIS PALMARIS ET PLANTARIS 1990-92%A%  
% 222.25/222.48  |- skos__hiddenLabel mesh__D007645 Palmoplantar Keratosis
% 222.25/222.48  |- mesh__recordAuthorizer mesh__D007645 sjn
% 222.25/222.48  |- skos__annotation mesh__D007645
% 222.25/222.48       do not confuse with KERATODERMA, PALMOPLANTAR, DIFFUSE or with POROKERATOSIS PALMARIS ET PLANTARIS see POROKERATOSIS; note X-ref HYPERKERATOSIS PALMARIS ET PLANTARIS%A%  
% 222.25/222.48  |- mesh__activeMeSHYear mesh__D007645 2005
% 222.25/222.48  |- skos__altLabel mesh__D007645 Keratosis Palmaris et Plantaris
% 222.25/222.48  |- mesh__activeMeSHYear mesh__D007645 2006
% 222.25/222.48  |- mesh__recordOriginator mesh__D007645 NLM
% 222.25/222.48  |- skos__broader mesh__D007645smesh__D012873
% 222.25/222.48  |- mesh__activeMeSHYear mesh__D007645 2003
% 222.25/222.48  |- skos__prefLabel mesh__D007645 Keratoderma, Palmoplantar
% 222.25/222.48  |- skos__altLabel mesh__D007645 Keratosis, Palmoplantar
% 222.25/222.48  |- skos__altLabel mesh__D007645 Hyperkeratosis Palmaris et Plantaris
% 222.25/222.48  |- mesh__activeMeSHYear mesh__D007645 2004
% 222.25/222.48  |- mesh__dateEstablished mesh__D007645 1974-01-01
% 222.25/222.48  |- skos__broader mesh__D007645smesh__D007642
% 222.25/222.48  |- mesh__dateRevised mesh__D007645 2001-07-25
% 222.25/222.48  |- mesh__onlineNote mesh__D007645
% 222.25/222.48       use KERATODERMA, PALMOPLANTAR to search KERATOSIS PALMARIS ET PLANTARIS 1974-92%A%  
% 222.25/222.48  |- skos__hiddenLabel mesh__D007645 Palmoplantar Keratodermas
% 222.25/222.48  |- skos__hiddenLabel mesh__D007645 Palmoplantar Keratoses
% 222.25/222.48  |- skos__hiddenLabel mesh__D007645 Keratoses, Palmoplantar
% 222.25/222.48  |- mesh__historyNote mesh__D007645
% 222.25/222.48       93; was KERATOSIS PALMARIS ET PLANTARIS 1974-92; KERATODERMA, PALMOPLANTAR was see KERATOSIS PALMARIS ET PLANTARIS 1990-92%A%  
% 222.25/222.48  |- mesh__dateCreated mesh__D007645 1999-01-01
% 222.25/222.48  |- rdf__type mesh__D007645sskos__Concept
% 222.25/222.48  |- skos__broader mesh__D009206Q000002smesh__D009206
% 222.25/222.48  |- mesh__preferredCombination mesh__D009206Q000002smesh__D006330
% 222.25/222.48  |- rdf__type mesh__D009206Q000002smesh__CompoundConcept
% 222.25/222.48  |- rdf__type mesh__D031744sskos__Concept
% 222.25/222.48  |- skos__scopeNote mesh__D031744
% 222.25/222.48       A plant genus of the family POACEAE that is considered a lawngrass by some and a weed by others.  It contains allergen Cyn d 7.%A%    
% 222.25/222.48  |- mesh__activeMeSHYear mesh__D031744 2003
% 222.25/222.48  |- skos__altLabel mesh__D031744 Grass, Bermuda
% 222.25/222.48  |- mesh__dateEstablished mesh__D031744 2003-01-01
% 222.25/222.48  |- mesh__activeMeSHYear mesh__D031744 2004
% 222.25/222.48  |- mesh__activeMeSHYear mesh__D031744 2005
% 222.25/222.48  |- mesh__activeMeSHYear mesh__D031744 2006
% 222.25/222.48  |- mesh__dateCreated mesh__D031744 2002-07-02
% 222.25/222.48  |- skos__annotation mesh__D031744
% 222.25/222.48       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.25/222.48  |- skos__altLabel mesh__D031744 Bermudagrass
% 222.25/222.48  |- skos__prefLabel mesh__D031744 Cynodon
% 222.25/222.48  |- skos__broader mesh__D031744smesh__D006109
% 222.25/222.48  |- mesh__publicMeSHNote mesh__D031744 2003   
% 222.25/222.48  |- mesh__historyNote mesh__D031744 2003   
% 222.25/222.48  |- skos__hiddenLabel mesh__D017275 PN 205033
% 222.25/222.48  |- mesh__publicMeSHNote mesh__D017275
% 222.25/222.48       93; ISRADIPINE was indexed under DIHYDROPYRIDINES 1991-92, PYRIDINES 1987-91, %26% OXADIAZOLES 1983-91%A%  
% 222.25/222.48  |- mesh__activeMeSHYear mesh__D017275 2003
% 222.25/222.48  |- skos__scopeNote mesh__D017275
% 222.25/222.48       A potent antagonist of CALCIUM CHANNELS that is highly selective for vascular smooth muscle. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.%A%    
% 222.25/222.48  |- skos__hiddenLabel mesh__D017275 PN 205034
% 222.25/222.48  |- skos__altLabel mesh__D017275 PN 205-033
% 222.25/222.48  |- mesh__onlineNote mesh__D017275
% 222.25/222.48       use ISRADIPINE %28%NM%29% to search ISRADIPINE 1983-92   
% 222.25/222.48  |- skos__prefLabel mesh__D017275 Isradipine
% 222.25/222.48  |- mesh__historyNote mesh__D017275 93; was ISRADIPINE %28%NM%29% 1983-92   
% 222.25/222.48  |- mesh__activeMeSHYear mesh__D017275 2002
% 222.25/222.48  |- mesh__recordOriginator mesh__D017275 TPW
% 222.25/222.48  |- mesh__activeMeSHYear mesh__D017275 2006
% 222.25/222.48  |- skos__hiddenLabel mesh__D017275 PN205033
% 222.25/222.48  |- skos__altLabel mesh__D017275 PN-205-034
% 222.25/222.48  |- skos__historyNote mesh__D017275 Pyridines %28%1987-1991%29%
% 222.25/222.48  |- skos__hiddenLabel mesh__D017275 PN 205 033
% 222.25/222.48  |- mesh__dateEstablished mesh__D017275 1993-01-01
% 222.25/222.48  |- mesh__activeMeSHYear mesh__D017275 2005
% 222.25/222.48  |- skos__historyNote mesh__D017275 Oxadiazoles %28%1983-1991%29%
% 222.25/222.48  |- skos__hiddenLabel mesh__D017275 PN205034
% 222.25/222.48  |- mesh__dateCreated mesh__D017275 1992-05-20
% 222.25/222.48  |- skos__historyNote mesh__D017275 Dihydropyridines %28%1991-1992%29%
% 222.25/222.48  |- mesh__dateRevised mesh__D017275 2001-07-25
% 222.25/222.48  |- mesh__recordMaintainer mesh__D017275 ssb
% 222.25/222.48  |- skos__altLabel mesh__D017275 PN-200-110
% 222.25/222.48  |- mesh__activeMeSHYear mesh__D017275 2004
% 222.25/222.48  |- rdf__type mesh__D017275sskos__Concept
% 222.25/222.48  |- skos__hiddenLabel mesh__D017275 PN 205 034
% 222.25/222.48  |- skos__broader mesh__D017275smesh__D004095
% 222.25/222.48  |- mesh__recordAuthorizer mesh__D017275 sjn
% 222.25/222.48  |- rdf__type mesh__D003255sskos__Concept
% 222.25/222.48  |- mesh__historyNote mesh__D003255 68   
% 222.25/222.48  |- skos__scopeNote mesh__D003255
% 222.25/222.48       Organized groups of users of goods and services.     
% 222.33/222.48  |- skos__altLabel mesh__D003255 Organizations, Consumer
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D003255 2000
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D003255 2001
% 222.33/222.48  |- mesh__dateRevised mesh__D003255 1999-11-03
% 222.33/222.48  |- skos__hiddenLabel mesh__D003255 Organization, Consumer
% 222.33/222.48  |- mesh__recordMaintainer mesh__D003255 kle
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D003255 2005
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D003255 2002
% 222.33/222.48  |- skos__prefLabel mesh__D003255 Consumer Organizations
% 222.33/222.48  |- mesh__recordOriginator mesh__D003255 NLM
% 222.33/222.48  |- skos__annotation mesh__D003255
% 222.33/222.48       IM; specify services, area of interest or geog if pertinent%A%  
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D003255 2003
% 222.33/222.48  |- mesh__dateCreated mesh__D003255 1999-01-01
% 222.33/222.48  |- mesh__publicMeSHNote mesh__D003255 68   
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D003255 2006
% 222.33/222.48  |- mesh__dateEstablished mesh__D003255 1968-01-01
% 222.33/222.48  |- skos__hiddenLabel mesh__D003255 Consumer Organization
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D003255 2004
% 222.33/222.48  |- skos__broader mesh__D003255smesh__D009938
% 222.33/222.48  |- mesh__recordAuthorizer mesh__D003255 sjn
% 222.33/222.48  |- mesh__recordOriginator mesh__D013683 NLM
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D013683 2002
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D013683 2005
% 222.33/222.48  |- skos__broader mesh__D013683smesh__D020141
% 222.33/222.48  |- skos__hiddenLabel mesh__D013683 Hemorrhagic Telangiectasia, Hereditary
% 222.33/222.48  |- rdf__type mesh__D013683sskos__Concept
% 222.33/222.48  |- mesh__historyNote mesh__D013683
% 222.33/222.48       68%28%66%29%; OSLER-RENDU DISEASE was see under ANGIOMATOSIS 1963-67%A%  
% 222.33/222.48  |- skos__hiddenLabel mesh__D013683 Hereditary Hemorrhagic Telangiectasia
% 222.33/222.48  |- mesh__recordMaintainer mesh__D013683 NNS
% 222.33/222.48  |- mesh__publicMeSHNote mesh__D013683
% 222.33/222.48       68; OSLER-RENDU DISEASE was see under ANGIOMATOSIS 1963-67%A%  
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D013683 1999
% 222.33/222.48  |- skos__scopeNote mesh__D013683
% 222.33/222.48       An autosomal dominant vascular anomaly characterized by the presence of multiple small telangiectases of the skin, mucous membranes, gastrointestinal tract, and other organs, associated with recurrent episodes of bleeding from affected sites and gross or occult melena. %28%Dorland, 27th ed%29%%A%    
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D013683 2001
% 222.33/222.48  |- skos__prefLabel mesh__D013683 Telangiectasia, Hereditary Hemorrhagic
% 222.33/222.48  |- mesh__dateCreated mesh__D013683 1999-01-01
% 222.33/222.48  |- skos__hiddenLabel mesh__D013683 Telangiectasias, Hereditary Hemorrhagic
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D013683 2004
% 222.33/222.48  |- skos__hiddenLabel mesh__D013683 Disease, Osler-Rendu
% 222.33/222.48  |- mesh__dateEstablished mesh__D013683 1968-01-01
% 222.33/222.48  |- skos__annotation mesh__D013683
% 222.33/222.48       multiple telangiectases; note short X ref   
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D013683 2000
% 222.33/222.48  |- skos__hiddenLabel mesh__D013683 Osler Rendu Disease
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D013683 2003
% 222.33/222.48  |- mesh__recordAuthorizer mesh__D013683 SJN
% 222.33/222.48  |- mesh__onlineNote mesh__D013683
% 222.33/222.48       use TELANGIECTASIA, HEREDITARY HEMORRHAGIC %26% ANGIOMATOSIS to search OSLER-RENDU DISEASE 1966-67%A%  
% 222.33/222.48  |- skos__altLabel mesh__D013683 Osler-Rendu Disease
% 222.33/222.48  |- mesh__dateRevised mesh__D013683 1998-06-11
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D013683 2006
% 222.33/222.48  |- skos__broader mesh__D013683smesh__D013684
% 222.33/222.48  |- skos__hiddenLabel mesh__D013683 Hemorrhagic Telangiectasias, Hereditary
% 222.33/222.48  |- skos__hiddenLabel mesh__D013683 Hereditary Hemorrhagic Telangiectasias
% 222.33/222.48  |- skos__broader mesh__D007646smesh__D013508
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D007646 2006
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D007646 2003
% 222.33/222.48  |- skos__historyNote mesh__D007646 Cornea %28%1966-1986%29%
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D007646 2000
% 222.33/222.48  |- skos__hiddenLabel mesh__D007646 Radial Keratotomies
% 222.33/222.48  |- mesh__recordOriginator mesh__D007646 SH
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D007646 2004
% 222.33/222.48  |- mesh__dateCreated mesh__D007646 1986-06-20
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D007646 2001
% 222.33/222.48  |- mesh__recordAuthorizer mesh__D007646 SJN
% 222.33/222.48  |- skos__altLabel mesh__D007646 Radial Keratotomy
% 222.33/222.48  |- skos__historyNote mesh__D007646 Myopia %28%1966-1986%29%
% 222.33/222.48  |- skos__annotation mesh__D007646
% 222.33/222.48       do not use /util except by MeSH definition   
% 222.33/222.48  |- skos__hiddenLabel mesh__D007646 Keratotomies, Radial
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D007646 2002
% 222.33/222.48  |- mesh__publicMeSHNote mesh__D007646 87   
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D007646 1998
% 222.33/222.48  |- mesh__dateEstablished mesh__D007646 1987-01-01
% 222.33/222.48  |- rdf__type mesh__D007646sskos__Concept
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D007646 1999
% 222.33/222.48  |- skos__scopeNote mesh__D007646
% 222.33/222.48       A procedure to treat myopia by cutting radial slits into the cornea to flatten it and thereby change its refractive properties.%A%    
% 222.33/222.48  |- mesh__recordMaintainer mesh__D007646 PXP
% 222.33/222.48  |- mesh__historyNote mesh__D007646 87   
% 222.33/222.48  |- mesh__dateRevised mesh__D007646 1997-06-20
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D007646 2005
% 222.33/222.48  |- skos__prefLabel mesh__D007646 Keratotomy, Radial
% 222.33/222.48  |- skos__prefLabel mesh__D026002 Herpesvirus 1, Meleagrid
% 222.33/222.48  |- skos__annotation mesh__D026002 infection = MAREK DISEASE   
% 222.33/222.48  |- skos__altLabel mesh__D026002 Marek%27%s Disease Virus Serotype 3
% 222.33/222.48  |- mesh__dateCreated mesh__D026002 2001-07-25
% 222.33/222.48  |- skos__altLabel mesh__D026002 Turkey herpesvirus
% 222.33/222.48  |- skos__historyNote mesh__D026002 Herpesviridae %28%1971-2001%29%
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D026002 2003
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D026002 2006
% 222.33/222.48  |- skos__broader mesh__D026002smesh__D025922
% 222.33/222.48  |- skos__hiddenLabel mesh__D026002 herpesvirus, Turkey
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D026002 2004
% 222.33/222.48  |- mesh__publicMeSHNote mesh__D026002 2002   
% 222.33/222.48  |- rdf__type mesh__D026002sskos__Concept
% 222.33/222.48  |- mesh__historyNote mesh__D026002 2002   
% 222.33/222.48  |- skos__scopeNote mesh__D026002
% 222.33/222.48       A species in the genus MAREK%27%S DISEASE-LIKE VIRUSES, in the family HERPESVIRIDAE, infecting turkeys.%A%    
% 222.33/222.48  |- mesh__dateEstablished mesh__D026002 2002-01-01
% 222.33/222.48  |- skos__hiddenLabel mesh__D026002 Turkey herpesviruses
% 222.33/222.48  |- skos__altLabel mesh__D026002 Meleagrid herpesvirus 1
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D026002 2002
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D026002 2005
% 222.33/222.48  |- skos__hiddenLabel mesh__D026002 herpesviruses, Turkey
% 222.33/222.48  |- skos__broader mesh__D031745smesh__D006109
% 222.33/222.48  |- skos__altLabel mesh__D031745 Grass, Orchard
% 222.33/222.48  |- skos__prefLabel mesh__D031745 Dactylis
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D031745 2006
% 222.33/222.48  |- skos__annotation mesh__D031745
% 222.33/222.48       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.33/222.48  |- mesh__historyNote mesh__D031745 2003   
% 222.33/222.48  |- mesh__dateEstablished mesh__D031745 2003-01-01
% 222.33/222.48  |- mesh__publicMeSHNote mesh__D031745 2003   
% 222.33/222.48  |- rdf__type mesh__D031745sskos__Concept
% 222.33/222.48  |- mesh__dateCreated mesh__D031745 2002-07-03
% 222.33/222.48  |- skos__altLabel mesh__D031745 Orchardgrass
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D031745 2003
% 222.33/222.48  |- skos__scopeNote mesh__D031745
% 222.33/222.48       A plant genus of the family POACEAE that contains allergen Dac g I.%A%    
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D031745 2004
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D031745 2005
% 222.33/222.48  |- mesh__dateCreated mesh__D017276 1992-05-20
% 222.33/222.48  |- skos__broader mesh__D017276smesh__D001696
% 222.33/222.48  |- mesh__publicMeSHNote mesh__D017276 93   
% 222.33/222.48  |- mesh__recordAuthorizer mesh__D017276 sjn
% 222.33/222.48  |- mesh__historyNote mesh__D017276 93   
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D017276 2006
% 222.33/222.48  |- skos__scopeNote mesh__D017276
% 222.33/222.48       Surface resistance to the relative motion of one body against the rubbing, sliding, rolling, or flowing of another with which it is in contact.%A%    
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D017276 2005
% 222.33/222.48  |- mesh__recordMaintainer mesh__D017276 nns
% 222.33/222.48  |- skos__annotation mesh__D017276 NIM; biol %26% non-biol application   
% 222.33/222.48  |- skos__prefLabel mesh__D017276 Friction
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D017276 2004
% 222.33/222.48  |- mesh__recordOriginator mesh__D017276 TPW
% 222.33/222.48  |- rdf__type mesh__D017276sskos__Concept
% 222.33/222.48  |- mesh__dateRevised mesh__D017276 2003-07-09
% 222.33/222.48  |- skos__broader mesh__D017276smesh__D019563
% 222.33/222.48  |- mesh__dateEstablished mesh__D017276 1993-01-01
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D003256 1993
% 222.33/222.48  |- skos__scopeNote mesh__D003256
% 222.33/222.48       Community or individual involvement in the decision-making process.%A%    
% 222.33/222.48  |- mesh__recordMaintainer mesh__D003256 PLS
% 222.33/222.48  |- skos__hiddenLabel mesh__D003256 Community Actions
% 222.33/222.48  |- skos__hiddenLabel mesh__D003256 Actions, Community
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D003256 1996
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D003256 1995
% 222.33/222.48  |- mesh__historyNote mesh__D003256 74   
% 222.33/222.48  |- skos__hiddenLabel mesh__D003256 Involvement, Consumer
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D003256 1998
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D003256 2000
% 222.33/222.48  |- skos__prefLabel mesh__D003256 Consumer Participation
% 222.33/222.48  |- mesh__dateCreated mesh__D003256 1999-01-01
% 222.33/222.48  |- skos__broader mesh__D003256smesh__D003255
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D003256 2004
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D003256 1994
% 222.33/222.48  |- skos__hiddenLabel mesh__D003256 Participation, Public
% 222.33/222.48  |- skos__broader mesh__D003256smesh__D003153
% 222.33/222.48  |- skos__hiddenLabel mesh__D003256 Participation, Consumer
% 222.33/222.48  |- skos__hiddenLabel mesh__D003256 Participation, Community
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D003256 2006
% 222.33/222.48  |- mesh__recordOriginator mesh__D003256 NLM
% 222.33/222.48  |- skos__altLabel mesh__D003256 Consumer Involvement
% 222.33/222.48  |- mesh__publicMeSHNote mesh__D003256 74   
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D003256 2003
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D003256 2005
% 222.33/222.48  |- skos__hiddenLabel mesh__D003256 Consumer Involvements
% 222.33/222.48  |- rdf__type mesh__D003256sskos__Concept
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D003256 2002
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D003256 1997
% 222.33/222.48  |- mesh__dateRevised mesh__D003256 1993-11-29
% 222.33/222.48  |- mesh__recordAuthorizer mesh__D003256 PLS
% 222.33/222.48  |- skos__hiddenLabel mesh__D003256 Action, Community
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D003256 1999
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D003256 2001
% 222.33/222.48  |- rdf__type mesh__D013684sskos__Concept
% 222.33/222.48  |- skos__hiddenLabel mesh__D013684 Vein, Spider
% 222.33/222.48  |- mesh__recordAuthorizer mesh__D013684 ags
% 222.33/222.48  |- mesh__recordMaintainer mesh__D013684 ags
% 222.33/222.48  |- skos__broader mesh__D013684smesh__D014652
% 222.33/222.48  |- mesh__dateRevised mesh__D013684 2005-07-11
% 222.33/222.48  |- mesh__activeMeSHYear mesh__D013684 2006A
% 222.33/222.48  |- skos__hiddenLabel mesh__D013684 Telangiectases
% 222.33/222.48  |- mesh__recordOriginator mesh__D013684 NLM
% 222.34/222.48  |- mesh__dateCreated mesh__D013684 1999-01-01
% 222.34/222.48  |- skos__scopeNote mesh__D013684
% 222.34/222.48       Permanent dilation of preexisting blood vessels %28%capillaries, arterioles, venules%29% creating small focal red lesions, most commonly in the skin or mucous membranes.%A%    
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D013684 2004
% 222.34/222.48  |- skos__hiddenLabel mesh__D013684 Veins, Spider
% 222.34/222.48  |- skos__hiddenLabel mesh__D013684 Spider Vein
% 222.34/222.48  |- skos__prefLabel mesh__D013684 Telangiectasis
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D013684 2003
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D013684 2006
% 222.34/222.48  |- skos__altLabel mesh__D013684 Telangiectasia
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D013684 2005
% 222.34/222.48  |- skos__hiddenLabel mesh__D013684 Telangiectasias
% 222.34/222.48  |- skos__annotation mesh__D013684
% 222.34/222.48       note specifics; CAPILLARY TELANGIECTASIA, BRAIN and PONTINE CAPILLARY TELANGIECTASIAS see CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS are also available%A%  
% 222.34/222.48  |- mesh__recordOriginator mesh__D007647 NLM
% 222.34/222.48  |- skos__altLabel mesh__D007647 Bilirubin Encephalopathy
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D007647 2004
% 222.34/222.48  |- skos__altLabel mesh__D007647 Encephalopathy, Bilirubin
% 222.34/222.48  |- skos__hiddenLabel mesh__D007647 Bilirubin Encephalopathies
% 222.34/222.48  |- skos__hiddenLabel mesh__D007647 Encephalopathies, Hyperbilirubinemic
% 222.34/222.48  |- skos__broader mesh__D007647smesh__D004899
% 222.34/222.48  |- skos__hiddenLabel mesh__D007647 Encephalopathies, Bilirubin
% 222.34/222.48  |- mesh__dateRevised mesh__D007647 2001-07-25
% 222.34/222.48  |- mesh__dateCreated mesh__D007647 1999-01-01
% 222.34/222.48  |- rdf__type mesh__D007647sskos__Concept
% 222.34/222.48  |- skos__altLabel mesh__D007647 Hyperbilirubinemic Encephalopathy
% 222.34/222.48  |- skos__altLabel mesh__D007647 Encephalopathy, Hyperbilirubinemic
% 222.34/222.48  |- mesh__recordMaintainer mesh__D007647 nns
% 222.34/222.48  |- skos__broader mesh__D007647smesh__D001928
% 222.34/222.48  |- skos__broader mesh__D007647smesh__D006932
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D007647 2005
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D007647 2002
% 222.34/222.48  |- skos__hiddenLabel mesh__D007647 Hyperbilirubinemic Encephalopathies
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D007647 2006
% 222.34/222.48  |- mesh__recordAuthorizer mesh__D007647 sjn
% 222.34/222.48  |- skos__prefLabel mesh__D007647 Kernicterus
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D007647 2003
% 222.34/222.48  |- skos__scopeNote mesh__D007647
% 222.34/222.48       A term used pathologically to describe BILIRUBIN staining of the BASAL GANGLIA; BRAIN STEM; and CEREBELLUM and clinically to describe a syndrome associated with HYPERBILIRUBINEMIA. Clinical features include athetosis, MUSCLE SPASTICITY or hypotonia, impaired vertical gaze, and DEAFNESS. Nonconjugated bilirubin enters the brain and acts as a neurotoxin, often in association with conditions that impair the BLOOD-BRAIN BARRIER %28%e.g., SEPSIS%29%. This condition occurs primarily in neonates %28%INFANT, NEWBORN%29%,  but may rarely occur in adults. %28%Menkes, Textbook of Child Neurology, 5th ed, p613%29%%A%    
% 222.34/222.48  |- skos__altLabel mesh__D026801 Syntenic Conservation
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D026801 2004
% 222.34/222.48  |- skos__hiddenLabel mesh__D026801 Conservations, Syntenic
% 222.34/222.48  |- skos__broader mesh__D026801smesh__D012689
% 222.34/222.48  |- skos__related mesh__D026801smesh__D002874
% 222.34/222.48  |- skos__hiddenLabel mesh__D026801 Conservation, Syntenic
% 222.34/222.48  |- skos__historyNote mesh__D026801 Chromosome Mapping %28%1971-2001%29%
% 222.34/222.48  |- skos__historyNote mesh__D026801
% 222.34/222.48       specific Chromosome Mapping %28%1971-2001%29%
% 222.34/222.48  |- skos__hiddenLabel mesh__D026801 Conserved Syntenies
% 222.34/222.48  |- skos__scopeNote mesh__D026801
% 222.34/222.48       The presence of two or more genetic loci on the same chromosome. Extensions of this original definition refer to the similarity in content and organization  between chromosomes, of different species for example.%A%    
% 222.34/222.48  |- skos__hiddenLabel mesh__D026801 Syntenic Homologies
% 222.34/222.48  |- skos__related mesh__D026801smesh__D008040
% 222.34/222.48  |- skos__hiddenLabel mesh__D026801 Syntenies, Conserved
% 222.34/222.48  |- skos__hiddenLabel mesh__D026801 Syntenic Conservations
% 222.34/222.48  |- mesh__publicMeSHNote mesh__D026801
% 222.34/222.48       2002; see LINKAGE%28%GENETICS%29% 2001   
% 222.34/222.48  |- mesh__recordOriginator mesh__D026801 nns
% 222.34/222.48  |- rdf__type mesh__D026801sskos__Concept
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D026801 2005
% 222.34/222.48  |- mesh__recordAuthorizer mesh__D026801 jls
% 222.34/222.48  |- mesh__historyNote mesh__D026801
% 222.34/222.48       2002; use LINKAGE%28%GENETICS%29% 2001   
% 222.34/222.48  |- skos__hiddenLabel mesh__D026801 Chromosomal Colinearities
% 222.34/222.48  |- skos__historyNote mesh__D026801 Comparative Study %28%1976-2001%29%
% 222.34/222.48  |- skos__altLabel mesh__D026801 Chromosomal Colinearity
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D026801 2006
% 222.34/222.48  |- mesh__recordMaintainer mesh__D026801 jls
% 222.34/222.48  |- skos__hiddenLabel mesh__D026801 Homology, Syntenic
% 222.34/222.48  |- skos__hiddenLabel mesh__D026801 Synteny, Conserved
% 222.34/222.48  |- skos__hiddenLabel mesh__D026801 Homologies, Syntenic
% 222.34/222.48  |- skos__prefLabel mesh__D026801 Synteny
% 222.34/222.48  |- skos__hiddenLabel mesh__D026801 Syntenies
% 222.34/222.48  |- skos__hiddenLabel mesh__D026801 Colinearities, Chromosomal
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D026801 2005A
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D026801 2003
% 222.34/222.48  |- skos__altLabel mesh__D026801 Syntenic Homology
% 222.34/222.48  |- skos__related mesh__D026801smesh__D023061
% 222.34/222.48  |- mesh__dateRevised mesh__D026801 2004-08-02
% 222.34/222.48  |- mesh__dateEstablished mesh__D026801 2002-01-01
% 222.34/222.48  |- mesh__dateCreated mesh__D026801 2001-07-25
% 222.34/222.48  |- skos__broader mesh__D001999Q000295smesh__D001999
% 222.34/222.48  |- mesh__preferredCombination mesh__D001999Q000295smesh__D020680
% 222.34/222.48  |- rdf__type mesh__D001999Q000295smesh__CompoundConcept
% 222.34/222.48  |- skos__broader mesh__D010302Q000139smesh__D010302
% 222.34/222.48  |- rdf__type mesh__D010302Q000139smesh__CompoundConcept
% 222.34/222.48  |- skos__altLabel mesh__D031746 Crabgrass
% 222.34/222.48  |- skos__broader mesh__D031746smesh__D006109
% 222.34/222.48  |- mesh__publicMeSHNote mesh__D031746 2003   
% 222.34/222.48  |- skos__scopeNote mesh__D031746
% 222.34/222.48       A plant genus of the family POACEAE that many people consider to be a weed.%A%    
% 222.34/222.48  |- rdf__type mesh__D031746sskos__Concept
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D031746 2003
% 222.34/222.48  |- mesh__historyNote mesh__D031746 2003   
% 222.34/222.48  |- mesh__dateEstablished mesh__D031746 2003-01-01
% 222.34/222.48  |- skos__prefLabel mesh__D031746 Digitaria
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D031746 2004
% 222.34/222.48  |- skos__altLabel mesh__D031746 Grass, Crab
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D031746 2005
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D031746 2006
% 222.34/222.48  |- mesh__dateCreated mesh__D031746 2002-07-03
% 222.34/222.48  |- skos__annotation mesh__D031746
% 222.34/222.48       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D017277 2002
% 222.34/222.48  |- skos__hiddenLabel mesh__D017277 Processes, Drug Approval
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D017277 2005
% 222.34/222.48  |- mesh__dateEstablished mesh__D017277 1993-01-01
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D017277 1999
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D017277 2001
% 222.34/222.48  |- skos__broader mesh__D017277smesh__D005069
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D017277 1993
% 222.34/222.48  |- skos__altLabel mesh__D017277 Food and Drug Administration Drug Approval
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D017277 1998
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D017277 2004
% 222.34/222.48  |- skos__related mesh__D017277smesh__D015507
% 222.34/222.48  |- mesh__dateCreated mesh__D017277 1992-05-20
% 222.34/222.48  |- rdf__type mesh__D017277sskos__Concept
% 222.34/222.48  |- skos__hiddenLabel mesh__D017277 Drug Approvals
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D017277 2000
% 222.34/222.48  |- skos__hiddenLabel mesh__D017277 New Drug Approvals
% 222.34/222.48  |- skos__scopeNote mesh__D017277
% 222.34/222.48       Process that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug.%A%    
% 222.34/222.48  |- skos__annotation mesh__D017277
% 222.34/222.48       by govt regulatory agency, U.S. %28%not restricted to FDA%29% or foreign%A%  
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D017277 2003
% 222.34/222.48  |- skos__hiddenLabel mesh__D017277 Drug Approval Processes
% 222.34/222.48  |- mesh__publicMeSHNote mesh__D017277 93   
% 222.34/222.48  |- skos__hiddenLabel mesh__D017277 Approvals, New Drug
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D017277 1997
% 222.34/222.48  |- skos__broader mesh__D017277smesh__D004335
% 222.34/222.48  |- skos__hiddenLabel mesh__D017277 Approval, New Drug
% 222.34/222.48  |- skos__prefLabel mesh__D017277 Drug Approval
% 222.34/222.48  |- skos__hiddenLabel mesh__D017277 Approval Processes, Drug
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D017277 1996
% 222.34/222.48  |- skos__hiddenLabel mesh__D017277 Approval, Drug
% 222.34/222.48  |- skos__hiddenLabel mesh__D017277 Approval Process, Drug
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D017277 1995
% 222.34/222.48  |- skos__hiddenLabel mesh__D017277 Drug Approvals, New
% 222.34/222.48  |- mesh__historyNote mesh__D017277 93   
% 222.34/222.48  |- skos__hiddenLabel mesh__D017277 Process, Drug Approval
% 222.34/222.48  |- skos__hiddenLabel mesh__D017277 Drug Approval, New
% 222.34/222.48  |- mesh__activeMeSHYear mesh__D017277 2006
% 222.34/222.49  |- skos__hiddenLabel mesh__D017277 Approvals, Drug
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D017277 1994
% 222.34/222.49  |- mesh__historyNote mesh__D050900 2006   
% 222.34/222.49  |- mesh__recordMaintainer mesh__D050900 ags
% 222.34/222.49  |- mesh__recordOriginator mesh__D050900 AKE
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D050900 2006A
% 222.34/222.49  |- mesh__publicMeSHNote mesh__D050900
% 222.34/222.49       2006; FERREDOXIN-NITRITE REDUCTASE was indexed under NITRITE REDUCTASES 1980-2004%A%  
% 222.34/222.49  |- skos__scopeNote mesh__D050900
% 222.34/222.49       An IRON-containing protein that uses siroheme and 4Fe-4S iron-sulfur centers as prosthetic groups. It catalyzes the six-electron oxidation of AMMONIA to nitrite.%A%    
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D050900 2006
% 222.34/222.49  |- skos__broader mesh__D050900smesh__D009572
% 222.34/222.49  |- mesh__dateEstablished mesh__D050900 2006-01-01
% 222.34/222.49  |- skos__hiddenLabel mesh__D050900 Ferredoxin Nitrite Reductase
% 222.34/222.49  |- mesh__dateCreated mesh__D050900 2005-06-30
% 222.34/222.49  |- skos__hiddenLabel mesh__D050900 Reductase, Ferredoxin-Nitrite
% 222.34/222.49  |- mesh__recordAuthorizer mesh__D050900 ags
% 222.34/222.49  |- rdf__type mesh__D050900sskos__Concept
% 222.34/222.49  |- skos__broader mesh__D050900smesh__D007506
% 222.34/222.49  |- mesh__dateRevised mesh__D050900 2005-07-21
% 222.34/222.49  |- skos__prefLabel mesh__D050900 Ferredoxin-Nitrite Reductase
% 222.34/222.49  |- mesh__dateCreated mesh__D003257 1981-05-19
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003257 2004
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003257 1994
% 222.34/222.49  |- mesh__dateEstablished mesh__D003257 1982-01-01
% 222.34/222.49  |- mesh__recordAuthorizer mesh__D003257 PLS
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003257 2001
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003257 2006
% 222.34/222.49  |- skos__hiddenLabel mesh__D003257 Approval, Product
% 222.34/222.49  |- skos__altLabel mesh__D003257 Safety, Consumer Product
% 222.34/222.49  |- mesh__recordMaintainer mesh__D003257 PLS
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003257 2003
% 222.34/222.49  |- skos__hiddenLabel mesh__D003257 Product Approvals
% 222.34/222.49  |- skos__hiddenLabel mesh__D003257 Approvals, Product
% 222.34/222.49  |- skos__historyNote mesh__D003257 Accident Prevention %28%1966-1981%29%
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003257 2000
% 222.34/222.49  |- mesh__publicMeSHNote mesh__D003257 82   
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003257 2005
% 222.34/222.49  |- mesh__dateRevised mesh__D003257 1993-11-23
% 222.34/222.49  |- mesh__historyNote mesh__D003257 82   
% 222.34/222.49  |- rdf__type mesh__D003257sskos__Concept
% 222.34/222.49  |- mesh__recordOriginator mesh__D003257 EC
% 222.34/222.49  |- skos__hiddenLabel mesh__D003257 Product Safety, Consumer
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003257 1997
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003257 1999
% 222.34/222.49  |- skos__prefLabel mesh__D003257 Consumer Product Safety
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003257 1993
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003257 1996
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003257 1995
% 222.34/222.49  |- skos__broader mesh__D003257smesh__D011634
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003257 2002
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003257 1998
% 222.34/222.49  |- skos__prefLabel mesh__D013685 Telecommunications
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D013685 2001
% 222.34/222.49  |- skos__hiddenLabel mesh__D013685 Teleconferences
% 222.34/222.49  |- skos__historyNote mesh__D013685 Television %28%1966-1975%29%
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D013685 2003
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D013685 2000
% 222.34/222.49  |- skos__historyNote mesh__D013685 Telephone %28%1971-1975%29%
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D013685 2006
% 222.34/222.49  |- skos__hiddenLabel mesh__D013685 Telegraphies
% 222.34/222.49  |- mesh__historyNote mesh__D013685 76; was NON MESH before 1976   
% 222.34/222.49  |- mesh__recordMaintainer mesh__D013685 jmp
% 222.34/222.49  |- mesh__dateEstablished mesh__D013685 1976-01-01
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D013685 2005
% 222.34/222.49  |- skos__historyNote mesh__D013685 Communication %28%1966-1975%29%
% 222.34/222.49  |- mesh__recordAuthorizer mesh__D013685 sjn
% 222.34/222.49  |- skos__scopeNote mesh__D013685
% 222.34/222.49       Transmission of information over distances via electronic means.%A%    
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D013685 2002
% 222.34/222.49  |- skos__related mesh__D013685smesh__D003195
% 222.34/222.49  |- rdf__type mesh__D013685sskos__Concept
% 222.34/222.49  |- mesh__dateRevised mesh__D013685 1999-11-03
% 222.34/222.49  |- mesh__recordOriginator mesh__D013685 NLM
% 222.34/222.49  |- skos__historyNote mesh__D013685 Radio %28%1966-1975%29%
% 222.34/222.49  |- mesh__publicMeSHNote mesh__D013685 76   
% 222.34/222.49  |- skos__broader mesh__D013685smesh__D003146
% 222.34/222.49  |- mesh__dateCreated mesh__D013685 1975-07-23
% 222.34/222.49  |- skos__hiddenLabel mesh__D013685 Telecommunication
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D013685 2004
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D007648 2004
% 222.34/222.49  |- mesh__onlineNote mesh__D007648
% 222.34/222.49       use KEROSINE to search KEROSENE 1966-81 %28%as Prov 1966-74, as Cat D %26% H heading 1968-74, as Cat D heading 1966-67%29%%A%  
% 222.34/222.49  |- mesh__dateRevised mesh__D007648 1997-06-20
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D007648 2006
% 222.34/222.49  |- skos__broader mesh__D007648smesh__D010578
% 222.34/222.49  |- mesh__dateCreated mesh__D007648 1999-01-01
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D007648 2003
% 222.34/222.49  |- mesh__recordMaintainer mesh__D007648 TPW
% 222.34/222.49  |- skos__altLabel mesh__D007648 Kerosine
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D007648 2005
% 222.34/222.49  |- mesh__historyNote mesh__D007648
% 222.34/222.49       98; was KEROSINE 1982-97 %28%see under PETROLEUM 1982-90%29%; was KEROSENE see under PETROLEUM 1963-81 %28%Prov 1963-74%29%; was Cat J heading only 1975-81, Cat D %26% H heading 1968-74, Cat D heading only 1963-67%A%  
% 222.34/222.49  |- mesh__recordOriginator mesh__D007648 NLM
% 222.34/222.49  |- mesh__publicMeSHNote mesh__D007648
% 222.34/222.49       98; was KEROSINE 1982-97 %28%see under PETROLEUM 1982-90%29%; was KEROSENE see under PETROLEUM 1975-81; was Cat J heading only 1975-81%A%  
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D007648 2002
% 222.34/222.49  |- skos__prefLabel mesh__D007648 Kerosene
% 222.34/222.49  |- mesh__recordAuthorizer mesh__D007648 SJN
% 222.34/222.49  |- rdf__type mesh__D007648sskos__Concept
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D007648 2001
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D007648 1999
% 222.34/222.49  |- skos__scopeNote mesh__D007648
% 222.34/222.49       A refined petroleum fraction used as a fuel as well as a solvent.%A%    
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D007648 2000
% 222.34/222.49  |- mesh__dateEstablished mesh__D007648 1991-01-01
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D007648 1998
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D018370 2000
% 222.34/222.49  |- mesh__recordMaintainer mesh__D018370 TGC
% 222.34/222.49  |- skos__hiddenLabel mesh__D018370 Deficiency Syndromes, Leukocyte-Adhesion
% 222.34/222.49  |- mesh__historyNote mesh__D018370 95   
% 222.34/222.49  |- mesh__dateRevised mesh__D018370 1996-06-13
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D018370 2006
% 222.34/222.49  |- mesh__publicMeSHNote mesh__D018370 95   
% 222.34/222.49  |- skos__broader mesh__D018370smesh__D007153
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D018370 2005
% 222.34/222.49  |- skos__scopeNote mesh__D018370
% 222.34/222.49       Rare, autosomal recessive disorder caused by deficiency of the beta 2 integrin receptors %28%RECEPTORS, LEUKOCYTE-ADHESION%29% comprising the CD11/CD18 family of glycoproteins. The syndrome is characterized by abnormal adhesion-dependent functions, especially defective tissue emigration of neutrophils, leading to recurrent infection.%A%    
% 222.34/222.49  |- skos__prefLabel mesh__D018370 Leukocyte-Adhesion Deficiency Syndrome
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D018370 1997
% 222.34/222.49  |- rdf__type mesh__D018370sskos__Concept
% 222.34/222.49  |- skos__hiddenLabel mesh__D018370 Leukocyte-Adhesion Deficiency Syndromes
% 222.34/222.49  |- mesh__recordOriginator mesh__D018370 AGS
% 222.34/222.49  |- skos__historyNote mesh__D018370
% 222.34/222.49       Receptors, Leukocyte-Adhesion/deficiency %28%1988-1990%29%
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D018370 2002
% 222.34/222.49  |- mesh__dateEstablished mesh__D018370 1995-01-01
% 222.34/222.49  |- skos__hiddenLabel mesh__D018370 Deficiency Syndrome, Leukocyte Adhesion
% 222.34/222.49  |- skos__annotation mesh__D018370
% 222.34/222.49       an immunol defic syndrome; DF: LEUKOCYTE ADHESION DEFIC SYNDROME%A%  
% 222.34/222.49  |- skos__historyNote mesh__D018370
% 222.34/222.49       Immunologic Deficiency Syndromes %28%1988-1994%29%
% 222.34/222.49  |- skos__hiddenLabel mesh__D018370 Syndrome, Leukocyte-Adhesion Deficiency
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D018370 2004
% 222.34/222.49  |- mesh__recordAuthorizer mesh__D018370 PLS
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D018370 1999
% 222.34/222.49  |- skos__altLabel mesh__D018370 Deficiency Syndrome, Leukocyte-Adhesion
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D018370 2001
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D018370 2003
% 222.34/222.49  |- mesh__dateCreated mesh__D018370 1994-01-25
% 222.34/222.49  |- skos__hiddenLabel mesh__D018370 Syndromes, Leukocyte-Adhesion Deficiency
% 222.34/222.49  |- skos__hiddenLabel mesh__D018370 Leukocyte Adhesion Deficiency Syndrome
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D018370 1998
% 222.34/222.49  |- mesh__historyNote mesh__D032041 2003   
% 222.34/222.49  |- mesh__dateRevised mesh__D032041 2005-07-21
% 222.34/222.49  |- mesh__dateCreated mesh__D032041 2002-07-03
% 222.34/222.49  |- skos__altLabel mesh__D032041 Genes, Nested
% 222.34/222.49  |- skos__hiddenLabel mesh__D032041 Gene, Nested
% 222.34/222.49  |- skos__hiddenLabel mesh__D032041 Nested Gene
% 222.34/222.49  |- mesh__recordAuthorizer mesh__D032041 ags
% 222.34/222.49  |- mesh__recordMaintainer mesh__D032041 ags
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D032041 2006
% 222.34/222.49  |- skos__prefLabel mesh__D032041 Nested Genes
% 222.34/222.49  |- skos__broader mesh__D032041smesh__D005807
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D032041 2006A
% 222.34/222.49  |- skos__annotation mesh__D032041
% 222.34/222.49       for nested primers use NESTED PCR; %28%POLYMERASE CHAIN REACTION%29%%A%  
% 222.34/222.49  |- rdf__type mesh__D032041sskos__Concept
% 222.34/222.49  |- mesh__recordOriginator mesh__D032041 nns
% 222.34/222.49  |- skos__scopeNote mesh__D032041
% 222.34/222.49       Genes whose entire sequences are contained within other genes.%A%    
% 222.34/222.49  |- mesh__publicMeSHNote mesh__D032041 2003   
% 222.34/222.49  |- mesh__dateEstablished mesh__D032041 2003-01-01
% 222.34/222.49  |- skos__related mesh__D004350smesh__D010573
% 222.34/222.49  |- mesh__dateRevised mesh__D004350 2005-06-30
% 222.34/222.49  |- skos__hiddenLabel mesh__D004350 Residues, Drug
% 222.34/222.49  |- mesh__dateCreated mesh__D004350 1987-05-04
% 222.34/222.49  |- skos__prefLabel mesh__D004350 Drug Residues
% 222.34/222.49  |- skos__scopeNote mesh__D004350
% 222.34/222.49       Drugs and their metabolites which are found in the edible tissues and milk of animals after their medication with specific drugs. This term can also apply to drugs found in adipose tissue of humans after drug treatment.%A%    
% 222.34/222.49  |- skos__historyNote mesh__D004350 Drugs %28%1966-1987%29%
% 222.34/222.49  |- mesh__historyNote mesh__D004350 88   
% 222.34/222.49  |- mesh__recordMaintainer mesh__D004350 ssb
% 222.34/222.49  |- mesh__publicMeSHNote mesh__D004350 88   
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D004350 2006
% 222.34/222.49  |- skos__hiddenLabel mesh__D004350 Residue, Drug
% 222.34/222.49  |- skos__hiddenLabel mesh__D004350 Drug Residue
% 222.34/222.49  |- mesh__recordAuthorizer mesh__D004350 sjn
% 222.34/222.49  |- rdf__type mesh__D004350sskos__Concept
% 222.34/222.49  |- mesh__dateEstablished mesh__D004350 1988-01-01
% 222.34/222.49  |- mesh__recordOriginator mesh__D004350 RLS
% 222.34/222.49  |- skos__broader mesh__D004350smesh__D001822
% 222.34/222.49  |- skos__broader mesh__D031747smesh__D006109
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D031747 2006
% 222.34/222.49  |- skos__scopeNote mesh__D031747
% 222.34/222.49       A plant genus of the family POACEAE that is grown mainly as a hay crop.%A%    
% 222.34/222.49  |- skos__prefLabel mesh__D031747 Echinochloa
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D031747 2005
% 222.34/222.49  |- mesh__dateCreated mesh__D031747 2002-07-03
% 222.34/222.49  |- mesh__publicMeSHNote mesh__D031747 2003   
% 222.34/222.49  |- skos__altLabel mesh__D031747 Millet, Japanese
% 222.34/222.49  |- skos__altLabel mesh__D031747 Millet, Barnyard
% 222.34/222.49  |- mesh__dateEstablished mesh__D031747 2003-01-01
% 222.34/222.49  |- skos__altLabel mesh__D031747 Grass, Cockspur
% 222.34/222.49  |- rdf__type mesh__D031747sskos__Concept
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D031747 2004
% 222.34/222.49  |- mesh__historyNote mesh__D031747 2003   
% 222.34/222.49  |- skos__annotation mesh__D031747
% 222.34/222.49       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.34/222.49  |- skos__altLabel mesh__D031747 Grass, Barnyard
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D031747 2003
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D017278 1998
% 222.34/222.49  |- mesh__dateRevised mesh__D017278 1997-06-20
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D017278 2004
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D017278 2002
% 222.34/222.49  |- skos__prefLabel mesh__D017278 Air Bags
% 222.34/222.49  |- rdf__type mesh__D017278sskos__Concept
% 222.34/222.49  |- mesh__dateCreated mesh__D017278 1992-05-07
% 222.34/222.49  |- skos__historyNote mesh__D017278 Protective Devices %28%1980-1992%29%
% 222.34/222.49  |- skos__hiddenLabel mesh__D017278 Airbag
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D017278 2003
% 222.34/222.49  |- mesh__dateEstablished mesh__D017278 1993-01-01
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D017278 2001
% 222.34/222.49  |- skos__hiddenLabel mesh__D017278 Bags, Air
% 222.34/222.49  |- mesh__recordAuthorizer mesh__D017278 SJN
% 222.34/222.49  |- skos__hiddenLabel mesh__D017278 Air Bag
% 222.34/222.49  |- mesh__recordMaintainer mesh__D017278 PXP
% 222.34/222.49  |- skos__scopeNote mesh__D017278
% 222.34/222.49       Automotive safety devices consisting of a bag designed to inflate upon collision and prevent passengers from pitching forward. %28%American Heritage Dictionary, 1982%29%%A%    
% 222.34/222.49  |- skos__broader mesh__D017278smesh__D011482
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D017278 2000
% 222.34/222.49  |- mesh__historyNote mesh__D017278 93   
% 222.34/222.49  |- skos__hiddenLabel mesh__D017278 Bag, Air
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D017278 2006
% 222.34/222.49  |- mesh__recordOriginator mesh__D017278 JLS
% 222.34/222.49  |- mesh__publicMeSHNote mesh__D017278 93   
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D017278 2005
% 222.34/222.49  |- skos__altLabel mesh__D017278 Airbags
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D017278 1999
% 222.34/222.49  |- skos__related mesh__D017278smesh__D012622
% 222.34/222.49  |- mesh__historyNote mesh__D050901 2006%28%1985%29%   
% 222.34/222.49  |- skos__altLabel mesh__D050901 Quinol-Nitrate Oxidoreductase
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D050901 2006
% 222.34/222.49  |- skos__broader mesh__D050901smesh__D009565
% 222.34/222.49  |- skos__annotation mesh__D050901
% 222.34/222.49       note other specific nitrate reductases are available   
% 222.34/222.49  |- skos__hiddenLabel mesh__D050901 Oxidoreductase, Quinol-Nitrate
% 222.34/222.49  |- skos__hiddenLabel mesh__D050901 Reductase, Respiratory Nitrate
% 222.34/222.49  |- mesh__publicMeSHNote mesh__D050901
% 222.34/222.49       2006; NITRATE REDUCTASE was indexed under NITRATE REDUCTASES 1985-2004%A%  
% 222.34/222.49  |- mesh__recordAuthorizer mesh__D050901 ags
% 222.34/222.49  |- mesh__dateRevised mesh__D050901 2005-07-21
% 222.34/222.49  |- skos__hiddenLabel mesh__D050901 Reductase, Nitrate
% 222.34/222.49  |- skos__altLabel mesh__D050901 Respiratory Nitrate Reductase
% 222.34/222.49  |- mesh__recordOriginator mesh__D050901 AKE
% 222.34/222.49  |- rdf__type mesh__D050901sskos__Concept
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D050901 2006A
% 222.34/222.49  |- skos__hiddenLabel mesh__D050901 Nitrate Reductase, Respiratory
% 222.34/222.49  |- mesh__dateEstablished mesh__D050901 2006-01-01
% 222.34/222.49  |- skos__hiddenLabel mesh__D050901 Quinol Nitrate Oxidoreductase
% 222.34/222.49  |- skos__prefLabel mesh__D050901 Nitrate Reductase
% 222.34/222.49  |- skos__scopeNote mesh__D050901
% 222.34/222.49       An enzyme that catalyzes the oxidation of nitrite to nitrate. It is a cytochrome protein that contains IRON and MOLYBDENUM.%A%    
% 222.34/222.49  |- mesh__recordMaintainer mesh__D050901 ags
% 222.34/222.49  |- mesh__dateCreated mesh__D050901 2005-06-30
% 222.34/222.49  |- mesh__recordOriginator mesh__D003258 NLM
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003258 2005
% 222.34/222.49  |- mesh__dateEstablished mesh__D003258 1968-01-01
% 222.34/222.49  |- mesh__recordMaintainer mesh__D003258 TAP
% 222.34/222.49  |- rdf__type mesh__D003258sskos__Concept
% 222.34/222.49  |- skos__hiddenLabel mesh__D003258 Satisfaction, Consumer
% 222.34/222.49  |- skos__hiddenLabel mesh__D003258 Preference, Consumer
% 222.34/222.49  |- mesh__publicMeSHNote mesh__D003258 68   
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003258 1997
% 222.34/222.49  |- skos__prefLabel mesh__D003258 Consumer Satisfaction
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003258 2002
% 222.34/222.49  |- mesh__dateRevised mesh__D003258 1992-05-07
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003258 1999
% 222.34/222.49  |- skos__historyNote mesh__D003258 Attitude %28%1966-1967%29%
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003258 1993
% 222.34/222.49  |- skos__broader mesh__D003258smesh__D011641
% 222.34/222.49  |- skos__hiddenLabel mesh__D003258 Preferences, Consumer
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003258 1996
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003258 1995
% 222.34/222.49  |- mesh__recordAuthorizer mesh__D003258 PLS
% 222.34/222.49  |- skos__hiddenLabel mesh__D003258 Consumer Preferences
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003258 2001
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003258 1998
% 222.34/222.49  |- skos__scopeNote mesh__D003258
% 222.34/222.49       Customer satisfaction or dissatisfaction with a benefit or service received.%A%    
% 222.34/222.49  |- mesh__dateCreated mesh__D003258 1999-01-01
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003258 2004
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003258 1994
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003258 2000
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003258 2006
% 222.34/222.49  |- mesh__historyNote mesh__D003258 68   
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D003258 2003
% 222.34/222.49  |- skos__altLabel mesh__D008741 Methyl Methylenesulfonate
% 222.34/222.49  |- skos__historyNote mesh__D008741 Methane %28%1966-1973%29%
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D008741 2003
% 222.34/222.49  |- skos__historyNote mesh__D008741 Sulfonic Acids %28%1966-1973%29%
% 222.34/222.49  |- skos__altLabel mesh__D008741 Methylmesilate
% 222.34/222.49  |- mesh__dateRevised mesh__D008741 2001-07-25
% 222.34/222.49  |- rdf__type mesh__D008741sskos__Concept
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D008741 2002
% 222.34/222.49  |- skos__historyNote mesh__D008741 Methanesulfonates %28%1974%29%
% 222.34/222.49  |- mesh__recordAuthorizer mesh__D008741 sjn
% 222.34/222.49  |- mesh__recordOriginator mesh__D008741 NLM
% 222.34/222.49  |- skos__scopeNote mesh__D008741
% 222.34/222.49       An alkylating agent in cancer therapy that may also act as a mutagen by interfering with and causing damage to DNA.%A%    
% 222.34/222.49  |- skos__hiddenLabel mesh__D008741 Mesylate, Methyl
% 222.34/222.49  |- skos__altLabel mesh__D008741 Methylmethane Sulfonate
% 222.34/222.49  |- mesh__dateEstablished mesh__D008741 1980-01-01
% 222.34/222.49  |- skos__altLabel mesh__D008741 Methyl Mesylate
% 222.34/222.49  |- skos__altLabel mesh__D008741 Mesilate, Methyl
% 222.34/222.49  |- mesh__dateCreated mesh__D008741 1974-11-19
% 222.34/222.49  |- skos__hiddenLabel mesh__D008741 Methyl Mesilate
% 222.34/222.49  |- mesh__historyNote mesh__D008741
% 222.34/222.49       80%28%75%29%; was see under METHANESULFONATES 1975-79; MESILATE, METHYL %26% METHYLMESYLATE were see METHYL METHANESULFONATE 1981-93; METHYL MESILATE was see METHYL METHANESULFONATE 1980-93%A%  
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D008741 2006
% 222.34/222.49  |- skos__prefLabel mesh__D008741 Methyl Methanesulfonate
% 222.34/222.49  |- skos__historyNote mesh__D008741 Alkanes %28%1966-1973%29%
% 222.34/222.49  |- mesh__onlineNote mesh__D008741
% 222.34/222.49       use METHYL METHANESULFONATE to search MESILATE, METHYL %26% METHYLMESYLATE 1981-93 and METHYL MESILATE 1980-93%A%  
% 222.34/222.49  |- mesh__recordMaintainer mesh__D008741 lkt
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D008741 2005
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D008741 2004
% 222.34/222.49  |- skos__hiddenLabel mesh__D008741 Methanesulfonate, Methyl
% 222.34/222.49  |- skos__broader mesh__D008741smesh__D008698
% 222.34/222.49  |- mesh__publicMeSHNote mesh__D008741
% 222.34/222.49       80; was see under METHANESULFONATES 1975-79; MESILATE, METHYL %26% METHYLMESYLATE were see METHYL METHANESULFONATE 1981-93; METHYL MESILATE was see METHYL METHANESULFONATE 1980-93%A%  
% 222.34/222.49  |- skos__broader mesh__D013686smesh__D008991
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D013686 2006
% 222.34/222.49  |- skos__annotation mesh__D013686
% 222.34/222.49       coord IM or NIM with specific procedure if relevant %28%IM or NIM%29%; do not use /util except by MeSH definition%A%  
% 222.34/222.49  |- skos__scopeNote mesh__D013686
% 222.34/222.49       Transmission of the readings of instruments to a remote location by means of wires, radio waves, or other means. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D013686 2001
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D013686 2005
% 222.34/222.49  |- rdf__type mesh__D013686sskos__Concept
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D013686 1999
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D013686 2000
% 222.34/222.49  |- mesh__recordAuthorizer mesh__D013686 SJN
% 222.34/222.49  |- mesh__dateRevised mesh__D013686 1997-06-20
% 222.34/222.49  |- skos__hiddenLabel mesh__D013686 Telemetries
% 222.34/222.49  |- skos__prefLabel mesh__D013686 Telemetry
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D013686 1998
% 222.34/222.49  |- skos__related mesh__D013686smesh__D017216
% 222.34/222.49  |- mesh__dateCreated mesh__D013686 1999-01-01
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D013686 2004
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D013686 2002
% 222.34/222.49  |- mesh__recordOriginator mesh__D013686 NLM
% 222.34/222.49  |- mesh__recordMaintainer mesh__D013686 PXP
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D013686 2003
% 222.34/222.49  |- mesh__dateEstablished mesh__D007649 1973-01-01
% 222.34/222.49  |- mesh__historyNote mesh__D007649 73; was CI-581 1969-72 %28%Prov%29%   
% 222.34/222.49  |- skos__historyNote mesh__D007649 Cyclohexanes %28%1968-1972%29%
% 222.34/222.49  |- mesh__dateCreated mesh__D007649 1999-01-01
% 222.34/222.49  |- skos__altLabel mesh__D007649
% 222.34/222.49       2-%28%2-Chlorophenyl%29%-2-%28%methylamino%29%cyclohexanone
% 222.34/222.49  |- mesh__recordAuthorizer mesh__D007649 sjn
% 222.34/222.49  |- skos__prefLabel mesh__D007649 Ketamine
% 222.34/222.49  |- skos__hiddenLabel mesh__D007649 CI581
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D007649 2006
% 222.34/222.49  |- mesh__recordOriginator mesh__D007649 NLM
% 222.34/222.49  |- skos__historyNote mesh__D007649 Analgesics %28%1966-1971%29%
% 222.34/222.49  |- mesh__publicMeSHNote mesh__D007649 73   
% 222.34/222.49  |- skos__historyNote mesh__D007649 Anesthetics %28%1972%29%
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D007649 2005
% 222.34/222.49  |- rdf__type mesh__D007649sskos__Concept
% 222.34/222.49  |- skos__altLabel mesh__D007649 Kalipsol
% 222.34/222.49  |- skos__hiddenLabel mesh__D007649 CI 581
% 222.34/222.49  |- skos__altLabel mesh__D007649 Calypsol
% 222.34/222.49  |- skos__broader mesh__D007649smesh__D003510
% 222.34/222.49  |- mesh__recordMaintainer mesh__D007649 ssb
% 222.34/222.49  |- mesh__onlineNote mesh__D007649
% 222.34/222.49       use KETAMINE to search CI-581 1969-72 %28%as Prov%29%   
% 222.34/222.49  |- skos__scopeNote mesh__D007649
% 222.34/222.49       A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors %28%RECEPTORS, N-METHYL-D-ASPARTATE%29% and may interact with sigma receptors.%A%    
% 222.34/222.49  |- mesh__dateRevised mesh__D007649 2004-07-07
% 222.34/222.49  |- skos__prefLabel mesh__D004351 Drug Resistance
% 222.34/222.49  |- skos__hiddenLabel mesh__D004351 Resistance, Drug
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D004351 2006
% 222.34/222.49  |- mesh__recordAuthorizer mesh__D004351 sjn
% 222.34/222.49  |- skos__broader mesh__D004351smesh__D002620
% 222.34/222.49  |- skos__annotation mesh__D004351
% 222.34/222.49       GEN or unspecified; prefer specifics; differentiate from DRUG TOLERANCE; resistance of parasites including protozoa goes here%A%  
% 222.34/222.49  |- mesh__historyNote mesh__D004351 1972   
% 222.34/222.49  |- mesh__dateRevised mesh__D004351 2004-07-13
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D004351 2005
% 222.34/222.49  |- rdf__type mesh__D004351sskos__Concept
% 222.34/222.49  |- skos__scopeNote mesh__D004351
% 222.34/222.49       Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration.%A%    
% 222.34/222.49  |- skos__hiddenLabel mesh__D004351 Resistance, Antibiotic
% 222.34/222.49  |- mesh__dateCreated mesh__D004351 1999-01-01
% 222.34/222.49  |- mesh__recordMaintainer mesh__D004351 sjn
% 222.34/222.49  |- mesh__recordOriginator mesh__D004351 NLM
% 222.34/222.49  |- mesh__dateEstablished mesh__D004351 1972-01-01
% 222.34/222.49  |- mesh__publicMeSHNote mesh__D004351 1972   
% 222.34/222.49  |- skos__related mesh__D004351smesh__D010597
% 222.34/222.49  |- skos__scopeNote mesh__D031748
% 222.34/222.49       A plant genus of the family POACEAE. Finger millet or raggee %28%E. coracana%29% is an important food grain in southern Asia and parts of Africa.%A%    
% 222.34/222.49  |- skos__altLabel mesh__D031748 Grass, Goose
% 222.34/222.49  |- mesh__historyNote mesh__D031748 2003   
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D031748 2005
% 222.34/222.49  |- skos__altLabel mesh__D031748 Indian Finger Millet
% 222.34/222.49  |- mesh__publicMeSHNote mesh__D031748 2003   
% 222.34/222.49  |- skos__broader mesh__D031748smesh__D006109
% 222.34/222.49  |- skos__altLabel mesh__D031748 Millet, Indian Finger
% 222.34/222.49  |- rdf__type mesh__D031748sskos__Concept
% 222.34/222.49  |- mesh__dateCreated mesh__D031748 2002-07-03
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D031748 2004
% 222.34/222.49  |- skos__prefLabel mesh__D031748 Eleusine
% 222.34/222.49  |- skos__annotation mesh__D031748
% 222.34/222.49       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.34/222.49  |- mesh__dateEstablished mesh__D031748 2003-01-01
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D031748 2003
% 222.34/222.49  |- skos__altLabel mesh__D031748 Millet, Koracan
% 222.34/222.49  |- skos__altLabel mesh__D031748 Goosegrass
% 222.34/222.49  |- mesh__activeMeSHYear mesh__D031748 2006
% 222.34/222.49  |- skos__altLabel mesh__D031748 Millet, Finger
% 222.34/222.49  |- mesh__dateCreated mesh__D017279 1992-05-22
% 222.34/222.49  |- skos__hiddenLabel mesh__D017279 3 Selenylalanine
% 222.34/222.49  |- rdf__type mesh__D017279sskos__Concept
% 222.34/222.49  |- skos__scopeNote mesh__D017279
% 222.34/222.49       A naturally occurring amino acid in both eukaryotic and prokaryotic organisms. It is found in tRNAs and in the catalytic site of some enzymes. The genes for glutathione peroxidase and formate dehydrogenase contain the TGA codon, which codes for this amino acid.%A%    
% 222.34/222.49  |- skos__historyNote mesh__D017279
% 222.34/222.49       Cysteine/analogs %26% derivatives %28%1977-1992%29%
% 222.34/222.49  |- mesh__recordAuthorizer mesh__D017279 sjn
% 222.34/222.49  |- mesh__publicMeSHNote mesh__D017279
% 222.34/222.49       93; SELENOCYSTEINE was indexed under CYSTEINE/analogs %26% derivatives 1977-92, ORGANOSELENIUM COMPOUNDS 1991-92, %26% SELENIUM 1977-91%A%  
% 222.34/222.49  |- skos__prefLabel mesh__D017279 Selenocysteine
% 222.34/222.49  |- skos__hiddenLabel mesh__D017279 Selenocysteine, DL Isomer
% 222.34/222.50  |- skos__historyNote mesh__D017279
% 222.34/222.50       Organoselenium Compounds %28%1991-1992%29%
% 222.34/222.50  |- skos__broader mesh__D017279smesh__D003545
% 222.34/222.50  |- skos__altLabel mesh__D017279 3-Selenylalanine
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D017279 2006
% 222.34/222.50  |- mesh__recordOriginator mesh__D017279 TPW
% 222.34/222.50  |- mesh__recordMaintainer mesh__D017279 ssb
% 222.34/222.50  |- mesh__dateRevised mesh__D017279 2005-06-30
% 222.34/222.50  |- skos__historyNote mesh__D017279 Selenium %28%1977-1991%29%
% 222.34/222.50  |- mesh__historyNote mesh__D017279
% 222.34/222.50       93; was SELENOCYSTEINE %28%NM%29% 1977-92   
% 222.34/222.50  |- mesh__dateEstablished mesh__D017279 1993-01-01
% 222.34/222.50  |- mesh__onlineNote mesh__D017279
% 222.34/222.50       use SELENOCYSTEINE %28%NM%29% to search SELENOCYSTEINE 1980-92   
% 222.34/222.50  |- skos__broader mesh__D017279smesh__D016566
% 222.34/222.50  |- mesh__recordMaintainer mesh__D050902 AKE
% 222.34/222.50  |- mesh__recordAuthorizer mesh__D050902 sjn
% 222.34/222.50  |- mesh__dateCreated mesh__D050902 2005-06-30
% 222.34/222.50  |- rdf__type mesh__D050902sskos__Concept
% 222.34/222.50  |- skos__broader mesh__D050902smesh__D050862
% 222.34/222.50  |- skos__hiddenLabel mesh__D050902 Dehydrogenase, Sulphite
% 222.34/222.50  |- mesh__publicMeSHNote mesh__D050902
% 222.34/222.50       2006; SULFITE DEHYDROGENASE was indexed as CYTOCHROME REDUCTASES 1981-2004%A%  
% 222.34/222.50  |- skos__prefLabel mesh__D050902 Sulfite Dehydrogenase
% 222.34/222.50  |- skos__altLabel mesh__D050902 Sulfite Cytochrome C Reductase
% 222.34/222.50  |- skos__altLabel mesh__D050902 Sulphite Dehydrogenase
% 222.34/222.50  |- skos__hiddenLabel mesh__D050902 Dehydrogenase, Sulfite
% 222.34/222.50  |- mesh__recordOriginator mesh__D050902 AKE
% 222.34/222.50  |- mesh__historyNote mesh__D050902 2006   
% 222.34/222.50  |- skos__scopeNote mesh__D050902
% 222.34/222.50       An enzyme that catalyzes oxidation of sulfite to sulfate along with the reduction of FERROCYTOCHROME C to FERRICYTOCHROME C.%A%    
% 222.34/222.50  |- skos__altLabel mesh__D050902 Sulphite Cytochrome C Reductase
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D050902 2006
% 222.34/222.50  |- mesh__dateEstablished mesh__D050902 2006-01-01
% 222.34/222.50  |- skos__annotation mesh__D003259
% 222.34/222.50       mainly animal; conclusion of a series of responses: nothing to do with %22%consumption%22% of food or other substances %28% = EATING BEHAVIOR see FEEDING BEHAVIOR%29%%A%  
% 222.34/222.50  |- mesh__publicMeSHNote mesh__D003259 68   
% 222.34/222.50  |- skos__prefLabel mesh__D003259 Consummatory Behavior
% 222.34/222.50  |- mesh__historyNote mesh__D003259 68   
% 222.34/222.50  |- mesh__recordAuthorizer mesh__D003259 sjn
% 222.34/222.50  |- skos__historyNote mesh__D003259 Behavior, Animal %28%1966-1967%29%
% 222.34/222.50  |- skos__scopeNote mesh__D003259
% 222.34/222.50       An act which constitutes the termination of a given instinctive behavior pattern or sequence.%A%    
% 222.34/222.50  |- skos__hiddenLabel mesh__D003259 Behaviors, Consummatory
% 222.34/222.50  |- mesh__recordOriginator mesh__D003259 NLM
% 222.34/222.50  |- skos__hiddenLabel mesh__D003259 Behavior, Consummatory
% 222.34/222.50  |- skos__hiddenLabel mesh__D003259 Consummatory Behaviors
% 222.34/222.50  |- mesh__dateCreated mesh__D003259 1999-01-01
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D003259 2004
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D003259 2006
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D003259 2003
% 222.34/222.50  |- skos__broader mesh__D003259smesh__D001522
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D003259 2005
% 222.34/222.50  |- mesh__dateEstablished mesh__D003259 1968-01-01
% 222.34/222.50  |- mesh__dateRevised mesh__D003259 2002-07-02
% 222.34/222.50  |- mesh__recordMaintainer mesh__D003259 TGC
% 222.34/222.50  |- rdf__type mesh__D003259sskos__Concept
% 222.34/222.50  |- mesh__recordMaintainer mesh__D008742 ssb
% 222.34/222.50  |- skos__historyNote mesh__D008742 Hexanones %28%1975-1976%29%
% 222.34/222.50  |- skos__prefLabel mesh__D008742 Methyl n-Butyl Ketone
% 222.34/222.50  |- skos__historyNote mesh__D008742 Ketones %28%1966-1976%29%
% 222.34/222.50  |- mesh__publicMeSHNote mesh__D008742
% 222.34/222.50       1991; see KETONES 1977-90; HEXAN-2-ONE was indexed under HEXANONES 2002-2003%A%  
% 222.34/222.50  |- mesh__historyNote mesh__D008742
% 222.34/222.50       1991%28%1977%29%; use KETONES 1977-1990; for HEXAN-2-ONE use HEXANONES 2002-2003%A%  
% 222.34/222.50  |- skos__hiddenLabel mesh__D008742 Ketone, Butylmethyl
% 222.34/222.50  |- skos__hiddenLabel mesh__D008742 Hexan 2 one
% 222.34/222.50  |- skos__broader mesh__D008742smesh__D006588
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D008742 2006
% 222.34/222.50  |- mesh__recordOriginator mesh__D008742 RLS
% 222.34/222.50  |- mesh__dateEstablished mesh__D008742 1991-01-01
% 222.34/222.50  |- skos__hiddenLabel mesh__D008742 Methyl n Butyl Ketone
% 222.34/222.50  |- skos__hiddenLabel mesh__D008742 2 Hexanone
% 222.34/222.50  |- mesh__recordAuthorizer mesh__D008742 sjn
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D008742 2005
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D008742 2004
% 222.34/222.50  |- skos__scopeNote mesh__D008742
% 222.34/222.50       An industrial solvent which causes nervous system degeneration. MBK is an acronym often used to refer to it.%A%    
% 222.34/222.50  |- mesh__dateCreated mesh__D008742 1976-05-19
% 222.34/222.50  |- skos__hiddenLabel mesh__D008742 Ketone, Methyl n-Butyl
% 222.34/222.50  |- skos__altLabel mesh__D008742 Hexan-2-one
% 222.34/222.50  |- skos__altLabel mesh__D008742 2-Hexanone
% 222.34/222.50  |- mesh__dateRevised mesh__D008742 2003-07-09
% 222.34/222.50  |- skos__altLabel mesh__D008742 Butylmethyl Ketone
% 222.34/222.50  |- skos__hiddenLabel mesh__D008742 n-Butyl Ketone, Methyl
% 222.34/222.50  |- rdf__type mesh__D008742sskos__Concept
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D013687 2006
% 222.34/222.50  |- mesh__dateRevised mesh__D013687 2004-08-02
% 222.34/222.50  |- skos__scopeNote mesh__D013687
% 222.34/222.50       Paired anteriolateral evaginations of the prosencephalon plus the lamina terminalis. The cerebral hemispheres are derived from it. Many authors consider cerebrum a synonymous term to telencephalon, though a minority include diencephalon as part of the cerebrum %28%Anthoney, 1994%29%.%A%    
% 222.34/222.50  |- mesh__publicMeSHNote mesh__D013687
% 222.34/222.50       1963; for CEREBRUM see BRAIN 1975-2000   
% 222.34/222.50  |- mesh__recordOriginator mesh__D013687 NLM
% 222.34/222.50  |- mesh__dateCreated mesh__D013687 1999-01-01
% 222.34/222.50  |- skos__broader mesh__D013687smesh__D016548
% 222.34/222.50  |- rdf__type mesh__D013687sskos__Concept
% 222.34/222.50  |- mesh__recordMaintainer mesh__D013687 jls
% 222.34/222.50  |- mesh__recordAuthorizer mesh__D013687 jls
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D013687 2005A
% 222.34/222.50  |- mesh__historyNote mesh__D013687
% 222.34/222.50       1963; for CEREBRUM use BRAIN 1975-2000   
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D013687 2003
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D013687 2001
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D013687 2004
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D013687 2002
% 222.34/222.50  |- skos__prefLabel mesh__D013687 Telencephalon
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D013687 2005
% 222.34/222.50  |- skos__scopeNote mesh__D032841
% 222.34/222.50       A plant genus of the family MENISPERMACEAE. Members contain sinomenine, caffeine, 1,7-dimethylxanthine, and other ALKALOIDS.%A%    
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D032841 2004
% 222.34/222.50  |- skos__prefLabel mesh__D032841 Sinomenium
% 222.34/222.50  |- mesh__publicMeSHNote mesh__D032841 2003   
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D032841 2003
% 222.34/222.50  |- skos__altLabel mesh__D032841 Qing Feng Teng
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D032841 2006
% 222.34/222.50  |- mesh__historyNote mesh__D032841 2003   
% 222.34/222.50  |- skos__broader mesh__D032841smesh__D029583
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D032841 2005
% 222.34/222.50  |- skos__annotation mesh__D032841
% 222.34/222.50       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.34/222.50  |- mesh__dateEstablished mesh__D032841 2003-01-01
% 222.34/222.50  |- rdf__type mesh__D032841sskos__Concept
% 222.34/222.50  |- mesh__dateCreated mesh__D032841 2002-07-03
% 222.34/222.50  |- skos__related mesh__D004352smesh__D015163
% 222.34/222.50  |- mesh__recordOriginator mesh__D004352 NLM
% 222.34/222.50  |- skos__altLabel mesh__D004352 Antimicrobial Drug Resistance
% 222.34/222.50  |- mesh__dateRevised mesh__D004352 2001-07-25
% 222.34/222.50  |- mesh__recordMaintainer mesh__D004352 lkt
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D004352 2005
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D004352 2004
% 222.34/222.50  |- skos__scopeNote mesh__D004352
% 222.34/222.50       The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids %28%R FACTORS%29%.%A%    
% 222.34/222.50  |- skos__prefLabel mesh__D004352 Drug Resistance, Microbial
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D004352 2002
% 222.34/222.50  |- skos__annotation mesh__D004352
% 222.34/222.50       GEN or unspecified; prefer specifics; not for protozoa: index DRUG RESISTANCE%A%  
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D004352 2003
% 222.34/222.50  |- mesh__dateCreated mesh__D004352 1999-01-01
% 222.34/222.50  |- rdf__type mesh__D004352sskos__Concept
% 222.34/222.50  |- mesh__recordAuthorizer mesh__D004352 sjn
% 222.34/222.50  |- skos__hiddenLabel mesh__D004352 Antimicrobial Drug Resistances
% 222.34/222.50  |- skos__broader mesh__D004352smesh__D004351
% 222.34/222.50  |- skos__related mesh__D004352smesh__D018088
% 222.34/222.50  |- skos__related mesh__D004352smesh__D008826
% 222.34/222.50  |- skos__related mesh__D004352smesh__D011815
% 222.34/222.50  |- skos__broader mesh__D004352smesh__D008827
% 222.34/222.50  |- skos__hiddenLabel mesh__D004352 Drug Resistances, Microbial
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D004352 2006
% 222.34/222.50  |- mesh__dateCreated mesh__D031749 2002-07-03
% 222.34/222.50  |- rdf__type mesh__D031749sskos__Concept
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D031749 2004
% 222.34/222.50  |- skos__annotation mesh__D031749
% 222.34/222.50       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D031749 2003
% 222.34/222.50  |- mesh__historyNote mesh__D031749 2003   
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D031749 2006
% 222.34/222.50  |- skos__broader mesh__D031749smesh__D006109
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D031749 2005
% 222.34/222.50  |- skos__scopeNote mesh__D031749
% 222.34/222.50       A plant genus of the family POACEAE. The common name of wildrye is used with some other grasses.%A%    
% 222.34/222.50  |- mesh__publicMeSHNote mesh__D031749 2003   
% 222.34/222.50  |- mesh__dateEstablished mesh__D031749 2003-01-01
% 222.34/222.50  |- skos__prefLabel mesh__D031749 Elymus
% 222.34/222.50  |- skos__altLabel mesh__D050903
% 222.34/222.50       Nicotinamide-S-Adenosylmethionine Methyltransferase
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D050903 2006
% 222.34/222.50  |- mesh__dateCreated mesh__D050903 2005-06-30
% 222.34/222.50  |- skos__hiddenLabel mesh__D050903
% 222.34/222.50       Nicotinamide S Adenosylmethionine Methyltransferase
% 222.34/222.50  |- skos__hiddenLabel mesh__D050903
% 222.34/222.50       Methyltransferase, Nicotinamide-S-Adenosylmethionine
% 222.34/222.50  |- skos__hiddenLabel mesh__D050903 Methylase, Nicotinamide
% 222.34/222.50  |- rdf__type mesh__D050903sskos__Concept
% 222.34/222.50  |- skos__altLabel mesh__D050903 Nicotinamide Methylase
% 222.34/222.50  |- skos__hiddenLabel mesh__D050903 Nicotinamide N Methyltransferase
% 222.34/222.50  |- mesh__recordMaintainer mesh__D050903 AKE
% 222.34/222.50  |- mesh__dateEstablished mesh__D050903 2006-01-01
% 222.34/222.50  |- mesh__recordAuthorizer mesh__D050903 sjn
% 222.34/222.50  |- mesh__historyNote mesh__D050903 2006%28%1983%29%   
% 222.34/222.50  |- mesh__recordOriginator mesh__D050903 AKE
% 222.34/222.50  |- skos__altLabel mesh__D050903 Nicotinamide Methyltransferase
% 222.34/222.50  |- mesh__publicMeSHNote mesh__D050903
% 222.34/222.50       2006; NICOTINAMIDE N-METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1983-2004%A%  
% 222.34/222.50  |- skos__scopeNote mesh__D050903
% 222.34/222.50       An enzyme found primarily in the LIVER that catalyzes the N-methylation of NICOTINAMIDE and other structurally related compounds.%A%    
% 222.34/222.50  |- skos__prefLabel mesh__D050903 Nicotinamide N-Methyltransferase
% 222.34/222.50  |- skos__hiddenLabel mesh__D050903 Methyltransferase, Nicotinamide
% 222.34/222.50  |- skos__hiddenLabel mesh__D050903 N-Methyltransferase, Nicotinamide
% 222.34/222.50  |- skos__broader mesh__D050903smesh__D008780
% 222.34/222.50  |- skos__related mesh__D014780smesh__D005822
% 222.34/222.50  |- mesh__recordMaintainer mesh__D014780 ags
% 222.34/222.50  |- skos__scopeNote mesh__D014780
% 222.34/222.50       Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells.%A%    
% 222.34/222.50  |- mesh__runningHead mesh__D014780 B4 - ORGANISMS-VIRUSES   
% 222.34/222.50  |- mesh__dateRevised mesh__D014780 2005-06-30
% 222.34/222.50  |- skos__hiddenLabel mesh__D014780 Viruses, Animal
% 222.34/222.50  |- skos__annotation mesh__D014780
% 222.34/222.50       general or unspecified; prefer specific taxonomic group or genus; do not confuse %22%slow viruses%22% with VIRUS LATENCY: slow cause disease with very long preclinical course %26% very slow progression, VIRUS LATENCY is the ability of a virus to lie dormant in a cell; presence of viruses in blood = VIREMIA; many pre-coordinated viral terms are available such as VIRAL PROTEINS; RNA, VIRAL, etc.; policy: Manual 22.18, 22.24+%A%  
% 222.34/222.50  |- skos__related mesh__D014780smesh__D011991
% 222.34/222.50  |- mesh__recordOriginator mesh__D014780 NLM
% 222.34/222.50  |- skos__prefLabel mesh__D014780 Viruses
% 222.34/222.50  |- skos__hiddenLabel mesh__D014780 Virus, Animal
% 222.34/222.50  |- mesh__historyNote mesh__D014780
% 222.34/222.50       1963; for ANIMAL VIRUSES %26% ZOOPHAGINAE use VERTEBRATE VIRUSES 1975-1991%A%  
% 222.34/222.50  |- skos__hiddenLabel mesh__D014780 Virus
% 222.34/222.50  |- rdf__type mesh__D014780sskos__Concept
% 222.34/222.50  |- mesh__publicMeSHNote mesh__D014780
% 222.34/222.50       1963; for ZOOPHAGINAE see VERTEBRATE VIRUSES 1975-1991;  for ANIMAL VIRUSES see ANIMAL VIRUSES 1963-1965, see VERTEBRATE VIRUSES 1975-1991%A%  
% 222.34/222.50  |- mesh__dateCreated mesh__D014780 1999-01-01
% 222.34/222.50  |- mesh__recordAuthorizer mesh__D014780 sjn
% 222.34/222.50  |- skos__related mesh__D014780smesh__D000998
% 222.34/222.50  |- skos__related mesh__D014780smesh__D007181
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D014780 2006
% 222.34/222.50  |- skos__hiddenLabel mesh__D014780 Animal Virus
% 222.34/222.50  |- mesh__recordAuthorizer mesh__D008743 sjn
% 222.34/222.50  |- mesh__historyNote mesh__D008743
% 222.34/222.50       91%28%75%29%; was see under PARATHION 1975-90   
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D008743 2006
% 222.34/222.50  |- skos__broader mesh__D008743smesh__D010278
% 222.34/222.50  |- skos__altLabel mesh__D008743 Methylparathion
% 222.34/222.50  |- skos__historyNote mesh__D008743 Parathion %28%1973-1974%29%
% 222.34/222.50  |- mesh__dateEstablished mesh__D008743 1991-01-01
% 222.34/222.50  |- mesh__recordMaintainer mesh__D008743 ssb
% 222.34/222.50  |- skos__scopeNote mesh__D008743
% 222.34/222.50       The methyl homolog of parathion. An effective, but highly toxic, organothiophosphate insecticide and cholinesterase inhibitor.%A%    
% 222.34/222.50  |- skos__altLabel mesh__D008743 Parathion Methyl
% 222.34/222.50  |- skos__altLabel mesh__D008743 Metaphos
% 222.34/222.50  |- skos__prefLabel mesh__D008743 Methyl Parathion
% 222.34/222.50  |- rdf__type mesh__D008743sskos__Concept
% 222.34/222.50  |- skos__annotation mesh__D008743 TN 111 for eff on insects   
% 222.34/222.50  |- mesh__dateCreated mesh__D008743 1974-11-11
% 222.34/222.50  |- mesh__dateRevised mesh__D008743 2005-06-30
% 222.34/222.50  |- mesh__publicMeSHNote mesh__D008743
% 222.34/222.50       91; was see under PARATHION 1975-90   
% 222.34/222.50  |- mesh__recordOriginator mesh__D008743 NLM
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D000760 2001
% 222.34/222.50  |- mesh__recordAuthorizer mesh__D000760 SJN
% 222.34/222.50  |- mesh__dateCreated mesh__D000760 1999-01-01
% 222.34/222.50  |- mesh__activeMeSHYear mesh__D000760 1999
% 222.34/222.50  |- mesh__dateEstablished mesh__D000760 1998-01-01
% 222.36/222.50  |- skos__hiddenLabel mesh__D000760 Analgesia and Anesthesia
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D000760 2000
% 222.36/222.50  |- rdf__type mesh__D000760sskos__Concept
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D000760 2006
% 222.36/222.50  |- skos__prefLabel mesh__D000760 Anesthesia and Analgesia
% 222.36/222.50  |- skos__annotation mesh__D000760
% 222.36/222.50       not used for indexing      CATALOG: do not use   
% 222.36/222.50  |- mesh__dateRevised mesh__D000760 1998-06-10
% 222.36/222.50  |- mesh__runningHead mesh__D000760
% 222.36/222.50       E3 - PROCEDURES AND TECHNIQUES-ANESTHETIC AND ANALGESIC   
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D000760 2005
% 222.36/222.50  |- mesh__recordOriginator mesh__D000760 NLM
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D000760 2004
% 222.36/222.50  |- mesh__historyNote mesh__D000760 98; use explode 1971-97   
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D000760 2002
% 222.36/222.50  |- mesh__recordMaintainer mesh__D000760 MSR
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D000760 2003
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D013688 2005
% 222.36/222.50  |- mesh__recordOriginator mesh__D013688 NLM
% 222.36/222.50  |- mesh__dateRevised mesh__D013688 1993-06-04
% 222.36/222.50  |- skos__broader mesh__D013688smesh__D010268
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D013688 1998
% 222.36/222.50  |- mesh__dateCreated mesh__D013688 1999-01-01
% 222.36/222.50  |- skos__prefLabel mesh__D013688 Telepathy
% 222.36/222.50  |- skos__scopeNote mesh__D013688
% 222.36/222.50       The knowledge or communication by one person with the mental processes of another through channels other than known physical or perceptual processes.%A%    
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D013688 2006
% 222.36/222.50  |- rdf__type mesh__D013688sskos__Concept
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D013688 2000
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D013688 1999
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D013688 1994
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D013688 2001
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D013688 2003
% 222.36/222.50  |- mesh__recordMaintainer mesh__D013688 JLS
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D013688 1995
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D013688 1996
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D013688 2002
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D013688 2004
% 222.36/222.50  |- mesh__recordAuthorizer mesh__D013688 PLS
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D013688 1997
% 222.36/222.50  |- mesh__recordMaintainer mesh__D032842 SYSTEM
% 222.36/222.50  |- rdf__type mesh__D032842sskos__Concept
% 222.36/222.50  |- mesh__recordAuthorizer mesh__D032842 sjn
% 222.36/222.50  |- mesh__dateCreated mesh__D032842 2002-07-03
% 222.36/222.50  |- mesh__dateRevised mesh__D032842 2005-06-30
% 222.36/222.50  |- skos__broader mesh__D032842smesh__D032641
% 222.36/222.50  |- skos__historyNote mesh__D032842 Ascomycota %28%1974-2002%29%
% 222.36/222.50  |- skos__scopeNote mesh__D032842
% 222.36/222.50       A genus in the family Trichocomaceae, order EUROTIALES. The anamorph is ASPERGILLUS.%A%    
% 222.36/222.50  |- mesh__historyNote mesh__D032842 2003   
% 222.36/222.50  |- mesh__recordOriginator mesh__D032842 ags
% 222.36/222.50  |- skos__prefLabel mesh__D032842 Emericella
% 222.36/222.50  |- mesh__publicMeSHNote mesh__D032842 2003   
% 222.36/222.50  |- mesh__dateEstablished mesh__D032842 2003-01-01
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D032842 2006
% 222.36/222.50  |- skos__scopeNote mesh__D018373
% 222.36/222.50       Drugs that act principally at one or more sites within the peripheral neuroeffector systems, the autonomic system, and motor nerve-skeletal system. %28%From Smith and Reynard, Textbook of Pharmacology, 1991, p75%29%%A%    
% 222.36/222.50  |- mesh__recordOriginator mesh__D018373 TPW
% 222.36/222.50  |- skos__altLabel mesh__D018373 Peripheral Nervous System Drugs
% 222.36/222.50  |- mesh__historyNote mesh__D018373 98; use explode 1995-97   
% 222.36/222.50  |- mesh__dateCreated mesh__D018373 1994-06-09
% 222.36/222.50  |- mesh__dateEstablished mesh__D018373 1998-01-01
% 222.36/222.50  |- mesh__publicMeSHNote mesh__D018373 98   
% 222.36/222.50  |- mesh__dateRevised mesh__D018373 2005-08-15
% 222.36/222.50  |- skos__prefLabel mesh__D018373 Peripheral Nervous System Agents
% 222.36/222.50  |- skos__annotation mesh__D018373
% 222.36/222.50       GEN or unspecified; prefer specific groups or specific drugs; consider also PERIPHERAL NERVOUS SYSTEM /drug eff %26% PERIPHERAL NERVES /drug eff; DF: PNS AGENTS%A%  
% 222.36/222.50  |- mesh__recordAuthorizer mesh__D018373 sjn
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D018373 2006
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D018373 2006A
% 222.36/222.50  |- mesh__recordMaintainer mesh__D018373 sjn
% 222.36/222.50  |- skos__broader mesh__D018373smesh__D045505
% 222.36/222.50  |- rdf__type mesh__D018373sskos__Concept
% 222.36/222.50  |- skos__altLabel mesh__D010390 Pemphigoid, Cicatricial
% 222.36/222.50  |- skos__scopeNote mesh__D010390
% 222.36/222.50       A chronic blistering disease with predilection for mucous membranes and less frequently the skin, and with a tendency to scarring. It is sometimes called ocular pemphigoid because of conjunctival mucous membrane involvement.%A%    
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D010390 2002
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D010390 1998
% 222.36/222.50  |- mesh__recordAuthorizer mesh__D010390 SJN
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D010390 1999
% 222.36/222.50  |- skos__historyNote mesh__D010390 Skin Diseases, Bullous %28%1976-1980%29%
% 222.36/222.50  |- skos__altLabel mesh__D010390 Benign Mucous Membrane Pemphigoid
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D010390 2000
% 222.36/222.50  |- mesh__dateEstablished mesh__D010390 1991-01-01
% 222.36/222.50  |- rdf__type mesh__D010390sskos__Concept
% 222.36/222.50  |- skos__altLabel mesh__D010390 Mucous Membrane Pemphigoid, Benign
% 222.36/222.50  |- mesh__dateRevised mesh__D010390 1997-06-20
% 222.36/222.50  |- mesh__recordOriginator mesh__D010390 SMH
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D010390 2003
% 222.36/222.50  |- skos__broader mesh__D010390smesh__D012872
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D010390 2001
% 222.36/222.50  |- mesh__publicMeSHNote mesh__D010390
% 222.36/222.50       91; was see under SKIN DISEASES, VESICULOBULLOUS 1981-90   
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D010390 2004
% 222.36/222.50  |- mesh__dateCreated mesh__D010390 1980-05-13
% 222.36/222.50  |- skos__hiddenLabel mesh__D010390 Cicatricial Pemphigoid
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D010390 2005
% 222.36/222.50  |- mesh__recordMaintainer mesh__D010390 TGC
% 222.36/222.50  |- skos__historyNote mesh__D010390 Skin Diseases %28%1966-1975%29%
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D010390 2006
% 222.36/222.50  |- mesh__historyNote mesh__D010390
% 222.36/222.50       91%28%81%29%; was see under SKIN DISEASES, VESICULOBULLOUS 1981-90%A%  
% 222.36/222.50  |- skos__prefLabel mesh__D010390 Pemphigoid, Benign Mucous Membrane
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D004353 2001
% 222.36/222.50  |- skos__related mesh__D004353smesh__D018675
% 222.36/222.50  |- skos__hiddenLabel mesh__D004353 Drug Screenings
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D004353 2004
% 222.36/222.50  |- skos__altLabel mesh__D004353 Evaluation, Preclinical Drug
% 222.36/222.50  |- mesh__publicMeSHNote mesh__D004353 74   
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D004353 2002
% 222.36/222.50  |- skos__hiddenLabel mesh__D004353 Screening, Drug
% 222.36/222.50  |- skos__altLabel mesh__D004353 Evaluations, Preclinical Drug
% 222.36/222.50  |- skos__altLabel mesh__D004353 Evaluation Studies, Drug, Pre-Clinical
% 222.36/222.50  |- rdf__type mesh__D004353sskos__Concept
% 222.36/222.50  |- skos__annotation mesh__D004353
% 222.36/222.50       IM when general; NIM with specific drug; used for studies in exper animals or in vitro; DRUG EVALUATION is available for clin testing; see annotation there; do not confuse X ref DRUG SCREENING for screening for substance abuse %28%=SUBSTANCE ABUSE DETECTION%29%%A%  
% 222.36/222.50  |- skos__hiddenLabel mesh__D004353 Screenings, Drug
% 222.36/222.50  |- skos__altLabel mesh__D004353 Drug Screening
% 222.36/222.50  |- mesh__recordOriginator mesh__D004353 NLM
% 222.36/222.50  |- skos__hiddenLabel mesh__D004353 Prospecting, Drug
% 222.36/222.50  |- mesh__recordMaintainer mesh__D004353 AGS
% 222.36/222.50  |- skos__broader mesh__D004353smesh__D005069
% 222.36/222.50  |- skos__altLabel mesh__D004353 Drug Evaluation Studies, Preclinical
% 222.36/222.50  |- skos__altLabel mesh__D004353 Evaluation Studies, Drug, Preclinical
% 222.36/222.50  |- skos__altLabel mesh__D004353 Preclinical Drug Evaluations
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D004353 2005
% 222.36/222.50  |- skos__prefLabel mesh__D004353 Drug Evaluation, Preclinical
% 222.36/222.50  |- skos__scopeNote mesh__D004353
% 222.36/222.50       Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications.%A%    
% 222.36/222.50  |- mesh__dateEstablished mesh__D004353 1974-01-01
% 222.36/222.50  |- skos__altLabel mesh__D004353 Drug Evaluations, Preclinical
% 222.36/222.50  |- skos__altLabel mesh__D004353 Preclinical Drug Evaluation
% 222.36/222.50  |- mesh__recordAuthorizer mesh__D004353 sjn
% 222.36/222.50  |- mesh__historyNote mesh__D004353 74; was in Cat E %26% G 1974-79   
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D004353 2003
% 222.36/222.50  |- mesh__dateRevised mesh__D004353 2000-06-22
% 222.36/222.50  |- mesh__dateCreated mesh__D004353 1999-01-01
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D004353 2006
% 222.36/222.50  |- skos__hiddenLabel mesh__D050904 Transmethylase, Homocysteine
% 222.36/222.50  |- skos__altLabel mesh__D050904 Homocysteine Transmethylase
% 222.36/222.50  |- rdf__type mesh__D050904sskos__Concept
% 222.36/222.50  |- skos__altLabel mesh__D050904
% 222.36/222.50       S-Methylmethionine Homocysteine Methyltransferase
% 222.36/222.50  |- skos__broader mesh__D050904smesh__D008780
% 222.36/222.50  |- mesh__recordMaintainer mesh__D050904 AKE
% 222.36/222.50  |- skos__hiddenLabel mesh__D050904
% 222.36/222.50       Homocysteine Methyltransferase, S-Adenosylmethionine
% 222.36/222.50  |- mesh__dateCreated mesh__D050904 2005-06-30
% 222.36/222.50  |- skos__hiddenLabel mesh__D050904
% 222.36/222.50       S Methylmethionine Homocysteine Methyltransferase
% 222.36/222.50  |- skos__hiddenLabel mesh__D050904
% 222.36/222.50       S Adenosylmethionine Homocysteine Methyltransferase
% 222.36/222.50  |- skos__scopeNote mesh__D050904
% 222.36/222.50       An enzyme that catalyzes the demethylation of L-homocysteine to L-METHIONINE.%A%    
% 222.36/222.50  |- skos__altLabel mesh__D050904 Homocysteine Methyltransferase
% 222.36/222.50  |- skos__hiddenLabel mesh__D050904 Methyltransferase, Homocysteine
% 222.36/222.50  |- mesh__publicMeSHNote mesh__D050904
% 222.36/222.50       2006; HOMOCYSTEINE S-METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1983-2004 %26% HOMOCYSTEINE 1974-1982%A%  
% 222.36/222.50  |- skos__hiddenLabel mesh__D050904
% 222.36/222.50       Methyltransferase, S-Methylmethionine Homocysteine
% 222.36/222.50  |- skos__hiddenLabel mesh__D050904
% 222.36/222.50       Homocysteine Methyltransferase, S-Methylmethionine
% 222.36/222.50  |- mesh__dateEstablished mesh__D050904 2006-01-01
% 222.36/222.50  |- skos__hiddenLabel mesh__D050904 Homocysteine S Methyltransferase
% 222.36/222.50  |- mesh__recordAuthorizer mesh__D050904 sjn
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D050904 2006
% 222.36/222.50  |- mesh__recordOriginator mesh__D050904 AKE
% 222.36/222.50  |- skos__altLabel mesh__D050904
% 222.36/222.50       S-Adenosylmethionine Homocysteine Methyltransferase
% 222.36/222.50  |- skos__hiddenLabel mesh__D050904 S-Methyltransferase, Homocysteine
% 222.36/222.50  |- skos__hiddenLabel mesh__D050904
% 222.36/222.50       Methyltransferase, S-Adenosylmethionine Homocysteine
% 222.36/222.50  |- mesh__historyNote mesh__D050904
% 222.36/222.50       2006%28%1980%29%; use HOMOCYSTEINE 1974-1980   
% 222.36/222.50  |- skos__prefLabel mesh__D050904 Homocysteine S-Methyltransferase
% 222.36/222.50  |- skos__prefLabel mesh__D014781 Viscera
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D014781 1991
% 222.36/222.50  |- mesh__considerAlso mesh__D014781 consider also terms at SPLANCHN-   
% 222.36/222.50  |- mesh__recordMaintainer mesh__D014781 sjn
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D014781 2002
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D014781 1996
% 222.36/222.50  |- skos__annotation mesh__D014781
% 222.36/222.50       GEN %26% unspecified only: prefer specific organ term   
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D014781 1998
% 222.36/222.50  |- mesh__dateRevised mesh__D014781 2002-10-24
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D014781 1992
% 222.36/222.50  |- mesh__dateEstablished mesh__D014781 1987-01-01
% 222.36/222.50  |- mesh__recordOriginator mesh__D014781 VDK
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D014781 1997
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D014781 1994
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D014781 2003
% 222.36/222.50  |- skos__broader mesh__D014781smesh__D001829
% 222.36/222.50  |- rdf__type mesh__D014781sskos__Concept
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D014781 2005
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D014781 1999
% 222.36/222.50  |- mesh__publicMeSHNote mesh__D014781 87   
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D014781 2003A
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D014781 2000
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D014781 1993
% 222.36/222.50  |- mesh__historyNote mesh__D014781 87   
% 222.36/222.50  |- mesh__activeMeSHYear mesh__D014781 1995
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D014781 2004
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D014781 2001
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D014781 2006
% 222.36/222.51  |- skos__scopeNote mesh__D014781
% 222.36/222.51       Any of the large interior organs in any one of the three great cavities of the body, especially in the abdomen.%A%    
% 222.36/222.51  |- mesh__dateCreated mesh__D014781 1986-04-18
% 222.36/222.51  |- mesh__recordAuthorizer mesh__D014781 sjn
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008744 2005
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008744 1994
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008744 2004
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008744 1993
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008744 2002
% 222.36/222.51  |- mesh__publicMeSHNote mesh__D008744 73   
% 222.36/222.51  |- mesh__recordOriginator mesh__D008744 NLM
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008744 1999
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008744 2003
% 222.36/222.51  |- mesh__historyNote mesh__D008744 73%28%71%29%   
% 222.36/222.51  |- rdf__type mesh__D008744sskos__Concept
% 222.36/222.51  |- skos__broader mesh__D008744smesh__D000588
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008744 1998
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008744 1997
% 222.36/222.51  |- mesh__recordMaintainer mesh__D008744 TAP
% 222.36/222.51  |- mesh__dateCreated mesh__D008744 1999-01-01
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008744 2001
% 222.36/222.51  |- mesh__dateRevised mesh__D008744 1992-05-18
% 222.36/222.51  |- skos__prefLabel mesh__D008744 Methylamines
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008744 1996
% 222.36/222.51  |- skos__historyNote mesh__D008744 Amines %28%1966-1970%29%
% 222.36/222.51  |- mesh__dateEstablished mesh__D008744 1973-01-01
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008744 2000
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008744 2006
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008744 1995
% 222.36/222.51  |- mesh__recordAuthorizer mesh__D008744 PLS
% 222.36/222.51  |- skos__broader mesh__D000761smesh__D006748
% 222.36/222.51  |- skos__hiddenLabel mesh__D000761
% 222.36/222.51       Anesthesia Resuscitation Department, Hospital
% 222.36/222.51  |- skos__hiddenLabel mesh__D000761
% 222.36/222.51       Department, Hospital Anesthesia-Resuscitation
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000761 2000
% 222.36/222.51  |- skos__altLabel mesh__D000761
% 222.36/222.51       Hospital Anesthesia-Resuscitation Department
% 222.36/222.51  |- skos__historyNote mesh__D000761 Anesthesiology %28%1966-Jul 1977%29%
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000761 2004
% 222.36/222.51  |- skos__altLabel mesh__D000761 Hospital Anesthesia Department
% 222.36/222.51  |- mesh__recordOriginator mesh__D000761 EC
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000761 1999
% 222.36/222.51  |- skos__hiddenLabel mesh__D000761 Departments, Anesthesia
% 222.36/222.51  |- mesh__recordMaintainer mesh__D000761 TGC
% 222.36/222.51  |- skos__hiddenLabel mesh__D000761
% 222.36/222.51       Anesthesia-Resuscitation Departments, Hospital
% 222.36/222.51  |- skos__hiddenLabel mesh__D000761 Department, Hospital Anesthesia
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000761 2003
% 222.36/222.51  |- mesh__publicMeSHNote mesh__D000761
% 222.36/222.51       91; was see under HOSPITAL DEPARTMENTS 1977-90   
% 222.36/222.51  |- skos__hiddenLabel mesh__D000761
% 222.36/222.51       Hospital Anesthesia Resuscitation Department
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000761 2002
% 222.36/222.51  |- skos__hiddenLabel mesh__D000761 Anesthesia Departments
% 222.36/222.51  |- mesh__dateEstablished mesh__D000761 1991-01-01
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000761 1998
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000761 2006
% 222.36/222.51  |- skos__historyNote mesh__D000761
% 222.36/222.51       Hospital Departments %28%1968-Jul 1977%29%
% 222.36/222.51  |- skos__hiddenLabel mesh__D000761
% 222.36/222.51       Hospital Anesthesia-Resuscitation Departments
% 222.36/222.51  |- mesh__recordAuthorizer mesh__D000761 PLS
% 222.36/222.51  |- skos__hiddenLabel mesh__D000761 Anesthesia Departments, Hospital
% 222.36/222.51  |- skos__hiddenLabel mesh__D000761 Hospital Anesthesia Departments
% 222.36/222.51  |- mesh__dateRevised mesh__D000761 1996-06-10
% 222.36/222.51  |- skos__altLabel mesh__D000761 Anesthesia Department
% 222.36/222.51  |- skos__annotation mesh__D000761 DF: ANESTH DEP   
% 222.36/222.51  |- mesh__historyNote mesh__D000761
% 222.36/222.51       91%28%Aug 77%29%; was see under HOSPITAL DEPARTMENTS 1977-90   
% 222.36/222.51  |- skos__scopeNote mesh__D000761
% 222.36/222.51       Hospital department responsible for the administration of functions and activities pertaining to the delivery of anesthetics.%A%    
% 222.36/222.51  |- skos__hiddenLabel mesh__D000761 Department, Anesthesia
% 222.36/222.51  |- rdf__type mesh__D000761sskos__Concept
% 222.36/222.51  |- skos__prefLabel mesh__D000761 Anesthesia Department, Hospital
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000761 2005
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000761 2001
% 222.36/222.51  |- mesh__dateCreated mesh__D000761 1977-05-19
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000761 1997
% 222.36/222.51  |- skos__hiddenLabel mesh__D000761 Departments, Hospital Anesthesia
% 222.36/222.51  |- skos__hiddenLabel mesh__D000761
% 222.36/222.51       Departments, Hospital Anesthesia-Resuscitation
% 222.36/222.51  |- skos__historyNote mesh__D013689 Communication %28%1966-1970%29%
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D013689 2006
% 222.36/222.51  |- rdf__type mesh__D013689sskos__Concept
% 222.36/222.51  |- mesh__recordAuthorizer mesh__D013689 PLS
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D013689 1999
% 222.36/222.51  |- skos__prefLabel mesh__D013689 Telephone
% 222.36/222.51  |- skos__altLabel mesh__D013689 Service, Switchboard
% 222.36/222.51  |- mesh__historyNote mesh__D013689 74%28%71%29%   
% 222.36/222.51  |- mesh__recordOriginator mesh__D013689 NLM
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D013689 2003
% 222.36/222.51  |- skos__broader mesh__D013689smesh__D013685
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D013689 2000
% 222.36/222.51  |- mesh__recordMaintainer mesh__D013689 TGC
% 222.36/222.51  |- mesh__dateRevised mesh__D013689 1996-06-10
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D013689 2004
% 222.36/222.51  |- skos__annotation mesh__D013689 modem: index under TELECOMMUNICATIONS   
% 222.36/222.51  |- skos__hiddenLabel mesh__D013689 Telephones
% 222.36/222.51  |- skos__hiddenLabel mesh__D013689 Switchboard Services
% 222.36/222.51  |- skos__hiddenLabel mesh__D013689 Services, Switchboard
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D013689 1997
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D013689 2001
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D013689 2005
% 222.36/222.51  |- skos__scopeNote mesh__D013689
% 222.36/222.51       An instrument for reproducing sounds especially articulate speech at a distance. %28%Webster, 3rd ed%29%%A%    
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D013689 1998
% 222.36/222.51  |- mesh__publicMeSHNote mesh__D013689 74   
% 222.36/222.51  |- mesh__dateEstablished mesh__D013689 1974-01-01
% 222.36/222.51  |- mesh__dateCreated mesh__D013689 1999-01-01
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D013689 2002
% 222.36/222.51  |- skos__historyNote mesh__D018374 Cell Line %28%1979-1994%29%
% 222.36/222.51  |- mesh__dateRevised mesh__D018374 2003-07-30
% 222.36/222.51  |- mesh__recordAuthorizer mesh__D018374 sjn
% 222.36/222.51  |- mesh__dateCreated mesh__D018374 1994-01-25
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D018374 2005
% 222.36/222.51  |- mesh__recordOriginator mesh__D018374 AGS
% 222.36/222.51  |- skos__historyNote mesh__D018374 Cells, Cultured %28%1980-1993%29%
% 222.36/222.51  |- mesh__historyNote mesh__D018374 95   
% 222.36/222.51  |- skos__scopeNote mesh__D018374
% 222.36/222.51       Epithelial cell line originally derived from porcine kidneys. It is used for pharmacologic and metabolic studies.%A%    
% 222.36/222.51  |- skos__hiddenLabel mesh__D018374 Cell, LLC-PK1
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D018374 2006
% 222.36/222.51  |- skos__annotation mesh__D018374
% 222.36/222.51       LLC stands for Lilly Laboratories Cell %26% PK for Porcine Kidney; almost always NIM with no subheadings; check ANIMALS %26% add SWINE %28%NIM%29%; do not routinely add KIDNEY%A%  
% 222.36/222.51  |- skos__hiddenLabel mesh__D018374 Cells, LLC-PK1
% 222.36/222.51  |- mesh__publicMeSHNote mesh__D018374 95   
% 222.36/222.51  |- skos__hiddenLabel mesh__D018374 LLC-PK1 Cell
% 222.36/222.51  |- rdf__type mesh__D018374sskos__Concept
% 222.36/222.51  |- skos__broader mesh__D018374smesh__D004847
% 222.36/222.51  |- mesh__dateEstablished mesh__D018374 1995-01-01
% 222.36/222.51  |- mesh__recordMaintainer mesh__D018374 nns
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D018374 2004
% 222.36/222.51  |- skos__prefLabel mesh__D018374 LLC-PK1 Cells
% 222.36/222.51  |- skos__broader mesh__D018374smesh__D002460
% 222.36/222.51  |- skos__hiddenLabel mesh__D018374 LLC PK1 Cells
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D010391 1999
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D010391 2002
% 222.36/222.51  |- mesh__dateEstablished mesh__D010391 1991-01-01
% 222.36/222.51  |- skos__altLabel mesh__D010391 Pemphigoid
% 222.36/222.51  |- rdf__type mesh__D010391sskos__Concept
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D010391 2003
% 222.36/222.51  |- mesh__recordAuthorizer mesh__D010391 SJN
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D010391 2005
% 222.36/222.51  |- skos__broader mesh__D010391smesh__D001327
% 222.36/222.51  |- skos__broader mesh__D010391smesh__D012872
% 222.36/222.51  |- skos__hiddenLabel mesh__D010391 Pemphigoids
% 222.36/222.51  |- skos__historyNote mesh__D010391 Skin Diseases, Bullous %28%1976-1980%29%
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D010391 2004
% 222.36/222.51  |- mesh__recordMaintainer mesh__D010391 TGC
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D010391 2006
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D010391 2000
% 222.36/222.51  |- skos__historyNote mesh__D010391 Skin Diseases %28%1966-1975%29%
% 222.36/222.51  |- mesh__recordOriginator mesh__D010391 SMH
% 222.36/222.51  |- skos__scopeNote mesh__D010391
% 222.36/222.51       A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis.%A%    
% 222.36/222.51  |- mesh__historyNote mesh__D010391
% 222.36/222.51       91%28%81%29%; was see under SKIN DISEASES, VESICULOBULLOUS 1981-90%A%  
% 222.36/222.51  |- mesh__dateRevised mesh__D010391 1997-06-20
% 222.36/222.51  |- skos__hiddenLabel mesh__D010391 Bullous Pemphigoid
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D010391 2001
% 222.36/222.51  |- skos__prefLabel mesh__D010391 Pemphigoid, Bullous
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D010391 1998
% 222.36/222.51  |- mesh__dateCreated mesh__D010391 1980-05-13
% 222.36/222.51  |- mesh__publicMeSHNote mesh__D010391
% 222.36/222.51       91; was see under SKIN DISEASES, VESICULOBULLOUS 1981-90   
% 222.36/222.51  |- skos__broader mesh__D004354smesh__D003584
% 222.36/222.51  |- skos__altLabel mesh__D004354 Antitumor Drug Screening Assays
% 222.36/222.51  |- skos__historyNote mesh__D004354
% 222.36/222.51       Neoplasms, Experimental or specific %28%1966-1987%29%
% 222.36/222.51  |- mesh__recordMaintainer mesh__D004354 nns
% 222.36/222.51  |- skos__broader mesh__D004354smesh__D004353
% 222.36/222.51  |- skos__hiddenLabel mesh__D004354 Anti Cancer Drug Screens
% 222.36/222.51  |- skos__annotation mesh__D004354
% 222.36/222.51       IM when general; NIM when with specific antineoplastic agent %28%IM%29%%A%  
% 222.36/222.51  |- skos__hiddenLabel mesh__D004354 Screens, Anti-Cancer Drug
% 222.36/222.51  |- skos__altLabel mesh__D004354 Drug Screening Tests, Tumor-Specific
% 222.36/222.51  |- skos__hiddenLabel mesh__D004354 Anti-Cancer Drug Screen
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D004354 2003
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D004354 2006
% 222.36/222.51  |- skos__hiddenLabel mesh__D004354 Drug Screens, Antitumor
% 222.36/222.51  |- skos__historyNote mesh__D004354 Tumor Stem Cell Assay %28%1984-1987%29%
% 222.36/222.51  |- skos__hiddenLabel mesh__D004354 Antitumor Drug Screen
% 222.36/222.51  |- skos__hiddenLabel mesh__D004354 Tumor Specific Drug Screening Tests
% 222.36/222.51  |- skos__hiddenLabel mesh__D004354 Drug Screens, Anti-Cancer
% 222.36/222.51  |- skos__hiddenLabel mesh__D004354 Tests, Cancer Drug
% 222.36/222.51  |- mesh__publicMeSHNote mesh__D004354 88   
% 222.36/222.51  |- skos__altLabel mesh__D004354 Cancer Drug Tests
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D004354 2002
% 222.36/222.51  |- skos__altLabel mesh__D004354 Anticancer Drug Sensitivity Tests
% 222.36/222.51  |- skos__hiddenLabel mesh__D004354 Drug Screen, Antitumor
% 222.36/222.51  |- skos__hiddenLabel mesh__D004354 Drug Screen, Anti-Cancer
% 222.36/222.51  |- mesh__historyNote mesh__D004354 88   
% 222.36/222.51  |- skos__historyNote mesh__D004354 Drug Screening %28%1974-1987%29%
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D004354 2005
% 222.36/222.51  |- mesh__dateEstablished mesh__D004354 1988-01-01
% 222.36/222.51  |- skos__hiddenLabel mesh__D004354 Test, Cancer Drug
% 222.36/222.51  |- mesh__dateRevised mesh__D004354 2000-06-21
% 222.36/222.51  |- skos__altLabel mesh__D004354 Anti-Cancer Drug Screens
% 222.36/222.51  |- mesh__dateCreated mesh__D004354 1987-05-08
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D004354 2001
% 222.36/222.51  |- skos__hiddenLabel mesh__D004354 Drug Screening Tests, Tumor Specific
% 222.36/222.51  |- mesh__recordOriginator mesh__D004354 SCD
% 222.36/222.51  |- mesh__recordAuthorizer mesh__D004354 sjn
% 222.36/222.51  |- skos__hiddenLabel mesh__D004354 Drug Tests, Cancer
% 222.36/222.51  |- skos__hiddenLabel mesh__D004354 Cancer Drug Test
% 222.36/222.51  |- skos__prefLabel mesh__D004354 Drug Screening Assays, Antitumor
% 222.36/222.51  |- skos__hiddenLabel mesh__D004354 Screen, Antitumor Drug
% 222.36/222.51  |- skos__hiddenLabel mesh__D004354 Screens, Antitumor Drug
% 222.36/222.51  |- skos__historyNote mesh__D004354
% 222.36/222.51       Antineoplastic Agents or specific %28%1966-1987%29%
% 222.36/222.51  |- skos__scopeNote mesh__D004354
% 222.36/222.51       Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals.%A%    
% 222.36/222.51  |- skos__hiddenLabel mesh__D004354 Drug Test, Cancer
% 222.36/222.51  |- rdf__type mesh__D004354sskos__Concept
% 222.36/222.51  |- skos__historyNote mesh__D004354 Cell Line %28%1971-1987%29%
% 222.36/222.51  |- skos__altLabel mesh__D004354 Tumor-Specific Drug Screening Tests
% 222.36/222.51  |- skos__hiddenLabel mesh__D004354 Screen, Anti-Cancer Drug
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D004354 2004
% 222.36/222.51  |- skos__altLabel mesh__D004354 Antitumor Drug Screens
% 222.36/222.51  |- skos__historyNote mesh__D004354
% 222.36/222.51       Colony-Forming Units Assay %28%1979-1987%29%
% 222.36/222.51  |- skos__prefLabel mesh__D014782 Visceral Prolapse
% 222.36/222.51  |- mesh__recordOriginator mesh__D014782 NLM
% 222.36/222.51  |- skos__altLabel mesh__D014782 Visceroptosis
% 222.36/222.51  |- rdf__type mesh__D014782sskos__Concept
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D014782 2005
% 222.36/222.51  |- mesh__dateCreated mesh__D014782 1999-01-01
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D014782 2004
% 222.36/222.51  |- skos__broader mesh__D014782smesh__D005767
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D014782 2006
% 222.36/222.51  |- mesh__recordAuthorizer mesh__D014782 sjn
% 222.36/222.51  |- skos__altLabel mesh__D014782 Splanchnoptosis
% 222.36/222.51  |- skos__hiddenLabel mesh__D014782 Prolapse, Visceral
% 222.36/222.51  |- mesh__historyNote mesh__D014782 2004 %28%1966%29%   
% 222.36/222.51  |- skos__scopeNote mesh__D014782
% 222.36/222.51       The prolapse or downward displacement of the VISCERA.     
% 222.36/222.51  |- mesh__publicMeSHNote mesh__D014782 2004; see VISCEROPTOSIS 1966-2003   
% 222.36/222.51  |- mesh__dateRevised mesh__D014782 2003-07-09
% 222.36/222.51  |- mesh__recordMaintainer mesh__D014782 lkt
% 222.36/222.51  |- mesh__dateCreated mesh__D008745 1999-01-01
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008745 1998
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008745 2004
% 222.36/222.51  |- skos__annotation mesh__D008745
% 222.36/222.51       almost never IM; enzymatic methylation: coord NIM with METHYLTRANSFERASES %28%IM%29% + substrate %28%NIM%29% or specific methyltransferase %28%IM%29%; DNA METHYLATION is also available%A%  
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008745 2002
% 222.36/222.51  |- mesh__dateRevised mesh__D008745 1997-06-20
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008745 1999
% 222.36/222.51  |- mesh__recordMaintainer mesh__D008745 PXP
% 222.36/222.51  |- rdf__type mesh__D008745sskos__Concept
% 222.36/222.51  |- mesh__publicMeSHNote mesh__D008745 68   
% 222.36/222.51  |- mesh__recordAuthorizer mesh__D008745 SJN
% 222.36/222.51  |- skos__hiddenLabel mesh__D008745 Methylations
% 222.36/222.51  |- skos__prefLabel mesh__D008745 Methylation
% 222.36/222.51  |- mesh__recordOriginator mesh__D008745 NLM
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008745 2005
% 222.36/222.51  |- skos__scopeNote mesh__D008745
% 222.36/222.51       Addition of methyl groups. In histo-chemistry methylation is used to esterify carboxyl groups and remove sulfate groups by treating tissue sections with hot methanol in the presence of hydrochloric acid. %28%From Stedman, 25th ed%29%%A%    
% 222.36/222.51  |- mesh__historyNote mesh__D008745 68   
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008745 2000
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008745 2006
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008745 2003
% 222.36/222.51  |- mesh__dateEstablished mesh__D008745 1968-01-01
% 222.36/222.51  |- skos__broader mesh__D008745smesh__D000478
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D008745 2001
% 222.36/222.51  |- skos__broader mesh__D000762smesh__D011184
% 222.36/222.51  |- skos__hiddenLabel mesh__D000762 Anesthesia Recovery Periods
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000762 2002
% 222.36/222.51  |- rdf__type mesh__D000762sskos__Concept
% 222.36/222.51  |- skos__annotation mesh__D000762 no qualif   
% 222.36/222.51  |- skos__hiddenLabel mesh__D000762 Periods, Anesthesia Recovery
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000762 2006
% 222.36/222.51  |- skos__altLabel mesh__D000762 Recovery Period, Anesthesia
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000762 1996
% 222.36/222.51  |- skos__prefLabel mesh__D000762 Anesthesia Recovery Period
% 222.36/222.51  |- mesh__recordOriginator mesh__D000762 SH
% 222.36/222.51  |- skos__broader mesh__D000762smesh__D000760
% 222.36/222.51  |- skos__historyNote mesh__D000762 Postoperative Care %28%1966-1985%29%
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000762 1997
% 222.36/222.51  |- skos__historyNote mesh__D000762 Anesthesia or specific %28%1966-1985%29%
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000762 2003
% 222.36/222.51  |- mesh__recordAuthorizer mesh__D000762 PLS
% 222.36/222.51  |- mesh__dateEstablished mesh__D000762 1991-01-01
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000762 1994
% 222.36/222.51  |- mesh__dateCreated mesh__D000762 1985-02-28
% 222.36/222.51  |- skos__hiddenLabel mesh__D000762 Period, Anesthesia Recovery
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000762 2000
% 222.36/222.51  |- skos__related mesh__D000762smesh__D016528
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000762 2004
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000762 1995
% 222.36/222.51  |- skos__hiddenLabel mesh__D000762 Recovery Periods, Anesthesia
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000762 2001
% 222.36/222.51  |- mesh__historyNote mesh__D000762
% 222.36/222.51       91%28%86%29%; was see under POSTOPERATIVE PERIOD 1986-90   
% 222.36/222.51  |- skos__scopeNote mesh__D000762
% 222.36/222.51       The period of emergence from general anesthesia, where different elements of consciousness return at different rates.%A%    
% 222.36/222.51  |- mesh__recordMaintainer mesh__D000762 AGS
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000762 1998
% 222.36/222.51  |- mesh__dateRevised mesh__D000762 1992-05-07
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000762 1999
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000762 1993
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D000762 2005
% 222.36/222.51  |- mesh__publicMeSHNote mesh__D000762
% 222.36/222.51       91; was see under POSTOPERATIVE PERIOD 1986-90   
% 222.36/222.51  |- mesh__dateEstablished mesh__D027101 2002-01-01
% 222.36/222.51  |- skos__altLabel mesh__D027101 parE Gene Product
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D027101 2005
% 222.36/222.51  |- skos__altLabel mesh__D027101 Topoisomerase IV
% 222.36/222.51  |- mesh__dateRevised mesh__D027101 2003-07-09
% 222.36/222.51  |- skos__altLabel mesh__D027101 Topo IV
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D027101 2006
% 222.36/222.51  |- mesh__publicMeSHNote mesh__D027101
% 222.36/222.51       2002; DNA TOPOISOMERASE IV was indexed under TYPE II DNA TOPOISOMERASE 1991-2001%A%  
% 222.36/222.51  |- skos__prefLabel mesh__D027101 DNA Topoisomerase IV
% 222.36/222.51  |- skos__broader mesh__D027101smesh__D027061
% 222.36/222.51  |- rdf__type mesh__D027101sskos__Concept
% 222.36/222.51  |- skos__altLabel mesh__D027101 Topoisomerase IV Subunit A
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D027101 2004
% 222.36/222.51  |- mesh__recordMaintainer mesh__D027101 ssb
% 222.36/222.51  |- skos__historyNote mesh__D027101
% 222.36/222.51       DNA Topoisomerase %28%ATP-Hydrolysing%29% %28%1991-2001%29%
% 222.36/222.51  |- mesh__recordOriginator mesh__D027101 lkt
% 222.36/222.51  |- skos__altLabel mesh__D027101 Topoisomerase IV Subunit B
% 222.36/222.51  |- skos__altLabel mesh__D027101 parE Gene Product, Topo IV
% 222.36/222.51  |- skos__altLabel mesh__D027101 parC Gene Product, Topo IV
% 222.36/222.51  |- mesh__dateCreated mesh__D027101 2001-07-25
% 222.36/222.51  |- mesh__historyNote mesh__D027101
% 222.36/222.51       2002; use DNA TOPOISOMERASE IV %28%NM%29% 1991-2001   
% 222.36/222.51  |- skos__altLabel mesh__D027101 parC Gene Product
% 222.36/222.51  |- mesh__recordAuthorizer mesh__D027101 sjn
% 222.36/222.51  |- skos__historyNote mesh__D027101 DNA Topoisomerase %28%1990-1995%29%
% 222.36/222.51  |- skos__scopeNote mesh__D027101
% 222.36/222.51       A bacterial DNA topoisomerase II that catalyzes ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. Topoisomerase IV binds to DNA as a heterotetramer consisting 2 parC and 2 parE subunits. Topoisomerase IV  is a decatenating enzyme that resolves interlinked daughter chromosomes following DNA replication.%A%    
% 222.36/222.51  |- skos__hiddenLabel mesh__D027101 Topoisomerase IV, DNA
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D018375 2000
% 222.36/222.51  |- mesh__historyNote mesh__D018375 95   
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D018375 2006
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D018375 1996
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D018375 2001
% 222.36/222.51  |- rdf__type mesh__D018375sskos__Concept
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D018375 1997
% 222.36/222.51  |- skos__broader mesh__D018375smesh__D007109
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D018375 2002
% 222.36/222.51  |- skos__hiddenLabel mesh__D018375 Neutrophil Activations
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D018375 2003
% 222.36/222.51  |- skos__historyNote mesh__D018375 Neutrophils %28%1978-1994%29%
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D018375 1998
% 222.36/222.51  |- mesh__publicMeSHNote mesh__D018375 95   
% 222.36/222.51  |- skos__hiddenLabel mesh__D018375 Activations, Neutrophil
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D018375 2004
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D018375 1999
% 222.36/222.51  |- mesh__dateEstablished mesh__D018375 1995-01-01
% 222.36/222.51  |- skos__hiddenLabel mesh__D018375 Activation, Neutrophil
% 222.36/222.51  |- mesh__dateCreated mesh__D018375 1994-01-25
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D018375 1995
% 222.36/222.51  |- skos__prefLabel mesh__D018375 Neutrophil Activation
% 222.36/222.51  |- skos__scopeNote mesh__D018375
% 222.36/222.51       The process in which the neutrophil is stimulated by diverse substances, resulting in degranulation and/or generation of reactive oxygen products, and culminating in the destruction of invading pathogens. The stimulatory substances, including opsonized particles, immune complexes, and chemotactic factors, bind to specific cell-surface receptors on the neutrophil.%A%    
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D018375 2005
% 222.36/222.51  |- skos__annotation mesh__D010392
% 222.36/222.51       do not confuse with PEMPHIGOID;  /genet: consider also PEMPHIGUS, BENIGN FAMILIAL%A%  
% 222.36/222.51  |- skos__prefLabel mesh__D010392 Pemphigus
% 222.36/222.51  |- skos__scopeNote mesh__D010392
% 222.36/222.51       Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS.%A%    
% 222.36/222.51  |- skos__broader mesh__D010392smesh__D012872
% 222.36/222.51  |- skos__hiddenLabel mesh__D010392 Foliaceus, Pemphigus
% 222.36/222.51  |- skos__broader mesh__D010392smesh__D001327
% 222.36/222.51  |- rdf__type mesh__D010392sskos__Concept
% 222.36/222.51  |- mesh__recordMaintainer mesh__D010392 ags
% 222.36/222.51  |- mesh__dateRevised mesh__D010392 2005-07-25
% 222.36/222.51  |- mesh__dateCreated mesh__D010392 1999-01-01
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D010392 2006A
% 222.36/222.51  |- mesh__recordAuthorizer mesh__D010392 ags
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D010392 2006
% 222.36/222.51  |- mesh__recordOriginator mesh__D010392 NLM
% 222.36/222.51  |- mesh__recordAuthorizer mesh__D051200 ags
% 222.36/222.51  |- skos__scopeNote mesh__D051200
% 222.36/222.51       A pattern recognition receptor that recognizes GUANOSINE and URIDINE-rich single-stranded RNA.%A%    
% 222.36/222.51  |- skos__hiddenLabel mesh__D051200 Receptor, TLR8
% 222.36/222.51  |- mesh__dateCreated mesh__D051200 2005-06-30
% 222.36/222.51  |- skos__broader mesh__D051200smesh__D051193
% 222.36/222.51  |- mesh__recordOriginator mesh__D051200 DRC
% 222.36/222.51  |- mesh__publicMeSHNote mesh__D051200
% 222.36/222.51       2006; TOLL-LIKE RECEPTOR 8 was indexed under MEMBRANE GLYCOPROTEINS %26% RECEPTORS, CELL SURFACE 2005%A%  
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D051200 2006
% 222.36/222.51  |- mesh__activeMeSHYear mesh__D051200 2006A
% 222.36/222.51  |- mesh__historyNote mesh__D051200 2006%28%2005%29%   
% 222.36/222.51  |- mesh__dateRevised mesh__D051200 2005-07-29
% 222.36/222.51  |- mesh__recordMaintainer mesh__D051200 ags
% 222.36/222.51  |- mesh__dateEstablished mesh__D051200 2006-01-01
% 222.36/222.51  |- rdf__type mesh__D051200sskos__Concept
% 222.36/222.51  |- skos__hiddenLabel mesh__D051200 Toll Like Receptor 8
% 222.37/222.51  |- skos__prefLabel mesh__D051200 Toll-Like Receptor 8
% 222.37/222.51  |- skos__altLabel mesh__D051200 TLR8 Receptor
% 222.37/222.51  |- mesh__recordOriginator mesh__D004355 NLM
% 222.37/222.51  |- mesh__activeMeSHYear mesh__D004355 1997
% 222.37/222.51  |- mesh__activeMeSHYear mesh__D004355 2005
% 222.37/222.51  |- skos__prefLabel mesh__D004355 Drug Stability
% 222.37/222.51  |- mesh__recordAuthorizer mesh__D004355 PLS
% 222.37/222.51  |- skos__hiddenLabel mesh__D004355 Stabilities, Drug
% 222.37/222.51  |- mesh__activeMeSHYear mesh__D004355 1994
% 222.37/222.51  |- mesh__dateEstablished mesh__D004355 1968-01-01
% 222.37/222.51  |- mesh__activeMeSHYear mesh__D004355 2003
% 222.37/222.51  |- mesh__dateCreated mesh__D004355 1999-01-01
% 222.37/222.51  |- mesh__activeMeSHYear mesh__D004355 2006
% 222.37/222.51  |- skos__annotation mesh__D004355
% 222.37/222.51       IM when general; NIM when with specific drug %28%IM%29%; no qualif; for stability of enzymes use ENZYME STABILITY%A%  
% 222.37/222.51  |- mesh__dateRevised mesh__D004355 1991-06-13
% 222.37/222.51  |- mesh__publicMeSHNote mesh__D004355 68   
% 222.37/222.51  |- mesh__activeMeSHYear mesh__D004355 1992
% 222.37/222.51  |- mesh__activeMeSHYear mesh__D004355 2000
% 222.37/222.51  |- mesh__activeMeSHYear mesh__D004355 1995
% 222.37/222.51  |- mesh__activeMeSHYear mesh__D004355 2004
% 222.37/222.51  |- mesh__historyNote mesh__D004355 68%28%65%29%   
% 222.37/222.51  |- mesh__activeMeSHYear mesh__D004355 2001
% 222.37/222.51  |- mesh__activeMeSHYear mesh__D004355 1998
% 222.37/222.51  |- mesh__activeMeSHYear mesh__D004355 1993
% 222.37/222.51  |- rdf__type mesh__D004355sskos__Concept
% 222.37/222.51  |- skos__broader mesh__D004355smesh__D013678
% 222.37/222.51  |- mesh__activeMeSHYear mesh__D004355 2002
% 222.37/222.51  |- skos__hiddenLabel mesh__D004355 Stability, Drug
% 222.37/222.51  |- mesh__activeMeSHYear mesh__D004355 1996
% 222.37/222.51  |- mesh__recordMaintainer mesh__D004355 TGC
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D004355 1999
% 222.37/222.52  |- skos__hiddenLabel mesh__D004355 Drug Stabilities
% 222.37/222.52  |- skos__related mesh__D009040smesh__D002933
% 222.37/222.52  |- skos__hiddenLabel mesh__D009040 Pictures, Motion
% 222.37/222.52  |- mesh__recordOriginator mesh__D009040 NLM
% 222.37/222.52  |- mesh__recordAuthorizer mesh__D009040 sjn
% 222.37/222.52  |- skos__related mesh__D009040smesh__D002932
% 222.37/222.52  |- mesh__dateCreated mesh__D009040 1999-01-01
% 222.37/222.52  |- skos__hiddenLabel mesh__D009040 Picture, Motion
% 222.37/222.52  |- skos__broader mesh__D009040smesh__D001296
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D009040 2005
% 222.37/222.52  |- skos__scopeNote mesh__D009040
% 222.37/222.52       The art, technique, or business of producing motion pictures for entertainment, propaganda, or instruction.%A%    
% 222.37/222.52  |- mesh__recordMaintainer mesh__D009040 ags
% 222.37/222.52  |- skos__broader mesh__D009040smesh__D008402
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D009040 2006
% 222.37/222.52  |- skos__hiddenLabel mesh__D009040 Motion Picture
% 222.37/222.52  |- skos__prefLabel mesh__D009040 Motion Pictures
% 222.37/222.52  |- rdf__type mesh__D009040sskos__Concept
% 222.37/222.52  |- skos__annotation mesh__D009040
% 222.37/222.52       IM; docudrama if a motion picture goes here   
% 222.37/222.52  |- mesh__dateRevised mesh__D009040 2004-07-07
% 222.37/222.52  |- skos__hiddenLabel mesh__D009040 Film
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D014783 1993
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D014783 2004
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D014783 1995
% 222.37/222.52  |- skos__prefLabel mesh__D014783 Viscosity
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D014783 2006
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D014783 2000
% 222.37/222.52  |- mesh__recordOriginator mesh__D014783 NLM
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D014783 2001
% 222.37/222.52  |- mesh__dateRevised mesh__D014783 1992-05-18
% 222.37/222.52  |- mesh__recordAuthorizer mesh__D014783 PLS
% 222.37/222.52  |- skos__related mesh__D014783smesh__D001809
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D014783 1996
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D014783 1998
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D014783 2002
% 222.37/222.52  |- mesh__recordMaintainer mesh__D014783 TGC
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D014783 1997
% 222.37/222.52  |- skos__hiddenLabel mesh__D014783 Viscosities
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D014783 1994
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D014783 2003
% 222.37/222.52  |- rdf__type mesh__D014783sskos__Concept
% 222.37/222.52  |- skos__broader mesh__D014783smesh__D002627
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D014783 1999
% 222.37/222.52  |- skos__annotation mesh__D014783 NIM   
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D014783 2005
% 222.37/222.52  |- mesh__dateCreated mesh__D014783 1999-01-01
% 222.37/222.52  |- skos__prefLabel mesh__D008746 Methylazoxymethanol Acetate
% 222.37/222.52  |- skos__broader mesh__D008746smesh__D001397
% 222.37/222.52  |- rdf__type mesh__D008746sskos__Concept
% 222.37/222.52  |- mesh__publicMeSHNote mesh__D008746
% 222.37/222.52       91; was see under AZO COMPOUNDS 1975-90   
% 222.37/222.52  |- mesh__dateEstablished mesh__D008746 1991-01-01
% 222.37/222.52  |- skos__altLabel mesh__D008746 %28%Methyl-ONN-azoxy%29%methanol Acetate
% 222.37/222.52  |- mesh__dateRevised mesh__D008746 2005-06-30
% 222.37/222.52  |- skos__historyNote mesh__D008746 Azo Compounds %28%1973-1974%29%
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D008746 2006
% 222.37/222.52  |- mesh__recordAuthorizer mesh__D008746 sjn
% 222.37/222.52  |- mesh__historyNote mesh__D008746
% 222.37/222.52       91%28%75%29%; was see under AZO COMPOUNDS 1975-90   
% 222.37/222.52  |- mesh__recordMaintainer mesh__D008746 ssb
% 222.37/222.52  |- mesh__recordOriginator mesh__D008746 NLM
% 222.37/222.52  |- skos__historyNote mesh__D008746 Alcohol, Methyl %28%1973-1974%29%
% 222.37/222.52  |- skos__hiddenLabel mesh__D008746 Acetate, Methylazoxymethanol
% 222.37/222.52  |- skos__scopeNote mesh__D008746
% 222.37/222.52       The aglycone of CYCASIN. It acts as a potent carcinogen and neurotoxin and inhibits hepatic DNA, RNA, and protein synthesis.%A%    
% 222.37/222.52  |- mesh__dateCreated mesh__D008746 1974-11-11
% 222.37/222.52  |- mesh__recordOriginator mesh__D000763 NLM
% 222.37/222.52  |- skos__hiddenLabel mesh__D000763 Sacral Epidural Anesthesia
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000763 2005
% 222.37/222.52  |- mesh__publicMeSHNote mesh__D000763
% 222.37/222.52       91; was see under ANESTHESIA, EPIDURAL 1975-90   
% 222.37/222.52  |- skos__hiddenLabel mesh__D000763 Caudal Anesthesia
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000763 1997
% 222.37/222.52  |- skos__broader mesh__D000763smesh__D000767
% 222.37/222.52  |- mesh__dateEstablished mesh__D000763 1991-01-01
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000763 2006
% 222.37/222.52  |- skos__scopeNote mesh__D000763
% 222.37/222.52       Epidural anesthesia administered via the sacral canal.     
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000763 2000
% 222.37/222.52  |- skos__hiddenLabel mesh__D000763 Epidural Anesthesia, Sacral
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000763 2003
% 222.37/222.52  |- skos__prefLabel mesh__D000763 Anesthesia, Caudal
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000763 1994
% 222.37/222.52  |- mesh__dateRevised mesh__D000763 1993-02-20
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000763 2001
% 222.37/222.52  |- skos__altLabel mesh__D000763 Anesthesia, Sacral Epidural
% 222.37/222.52  |- skos__annotation mesh__D000763
% 222.37/222.52       /educ: coord IM %28%no qualif%29% with ANESTHESIOLOGY /educ %28%NIM%29%%A%  
% 222.37/222.52  |- mesh__recordMaintainer mesh__D000763 PLS
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000763 2004
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000763 1998
% 222.37/222.52  |- mesh__recordAuthorizer mesh__D000763 NLM
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000763 1995
% 222.37/222.52  |- mesh__historyNote mesh__D000763
% 222.37/222.52       91%28%75%29%; was see under ANESTHESIA, EPIDURAL 1975-90   
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000763 1999
% 222.37/222.52  |- mesh__dateCreated mesh__D000763 1974-12-12
% 222.37/222.52  |- rdf__type mesh__D000763sskos__Concept
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000763 1996
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000763 2002
% 222.37/222.52  |- mesh__dateEstablished mesh__D018376 1998-01-01
% 222.37/222.52  |- skos__hiddenLabel mesh__D018376 Abnormality, Cardiovascular
% 222.37/222.52  |- mesh__recordOriginator mesh__D018376 PXP
% 222.37/222.52  |- skos__scopeNote mesh__D018376
% 222.37/222.52       Congenital structural abnormalities of the cardiovascular system.%A%    
% 222.37/222.52  |- skos__annotation mesh__D018376
% 222.37/222.52       for congen struct abnorm only; GEN or unspecified; prefer specifics or specific organ /abnorm but article is more likely to be on HEART DEFECTS, CONGENITAL: check text; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: CARDIOVASC ABNORM%A%  
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D018376 2002
% 222.37/222.52  |- mesh__dateCreated mesh__D018376 1994-06-03
% 222.37/222.52  |- skos__hiddenLabel mesh__D018376 Cardiovascular Abnormality
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D018376 2006
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D018376 2001
% 222.37/222.52  |- skos__broader mesh__D018376smesh__D000013
% 222.37/222.52  |- skos__broader mesh__D018376smesh__D002318
% 222.37/222.52  |- rdf__type mesh__D018376sskos__Concept
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D018376 2005
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D018376 2000
% 222.37/222.52  |- skos__historyNote mesh__D018376
% 222.37/222.52       Heart Defects, Congenital %28%1966-1997%29%
% 222.37/222.52  |- mesh__dateRevised mesh__D018376 1999-11-03
% 222.37/222.52  |- skos__altLabel mesh__D018376 Abnormalities, Cardiovascular
% 222.37/222.52  |- mesh__recordMaintainer mesh__D018376 kle
% 222.37/222.52  |- mesh__recordAuthorizer mesh__D018376 sjn
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D018376 2004
% 222.37/222.52  |- skos__related mesh__D018376smesh__D006330
% 222.37/222.52  |- mesh__historyNote mesh__D018376 98; use explode 1995-97   
% 222.37/222.52  |- skos__prefLabel mesh__D018376 Cardiovascular Abnormalities
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D018376 2003
% 222.37/222.52  |- mesh__publicMeSHNote mesh__D018376 98   
% 222.37/222.52  |- mesh__dateRevised mesh__D010393 1995-06-08
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D010393 1999
% 222.37/222.52  |- skos__scopeNote mesh__D010393
% 222.37/222.52       A nicotinic antagonist most commonly used as an experimental tool. It has been used as a ganglionic blocker in the treatment of hypertension but has largely been supplanted for that purpose by more specific drugs.%A%    
% 222.37/222.52  |- mesh__recordMaintainer mesh__D010393 JRT
% 222.37/222.52  |- mesh__recordOriginator mesh__D010393 NLM
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D010393 2002
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D010393 1998
% 222.37/222.52  |- rdf__type mesh__D010393sskos__Concept
% 222.37/222.52  |- mesh__recordAuthorizer mesh__D010393 PLS
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D010393 2004
% 222.37/222.52  |- mesh__dateCreated mesh__D010393 1999-01-01
% 222.37/222.52  |- skos__broader mesh__D010393smesh__D010880
% 222.37/222.52  |- skos__annotation mesh__D010393
% 222.37/222.52       a nicotinic antag %26% ganglionic blocker   
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D010393 2003
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D010393 2001
% 222.37/222.52  |- skos__prefLabel mesh__D010393 Pempidine
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D010393 2006
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D010393 1997
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D010393 2005
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D010393 2000
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D010393 1996
% 222.37/222.52  |- skos__hiddenLabel mesh__D051201 Toll Like Receptor 10
% 222.37/222.52  |- skos__broader mesh__D051201smesh__D051193
% 222.37/222.52  |- mesh__recordOriginator mesh__D051201 DRC
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D051201 2006
% 222.37/222.52  |- skos__prefLabel mesh__D051201 Toll-Like Receptor 10
% 222.37/222.52  |- mesh__recordMaintainer mesh__D051201 DRC
% 222.37/222.52  |- mesh__publicMeSHNote mesh__D051201
% 222.37/222.52       2006; TOLL-LIKE RECEPTOR 10 was indexed under MEMBRANE GLYCOPROTEINS %26% RECEPTORS, CELL SURFACE 2005%A%  
% 222.37/222.52  |- mesh__dateCreated mesh__D051201 2005-06-30
% 222.37/222.52  |- mesh__recordAuthorizer mesh__D051201 sjn
% 222.37/222.52  |- rdf__type mesh__D051201sskos__Concept
% 222.37/222.52  |- skos__hiddenLabel mesh__D051201 Receptor, TLR10
% 222.37/222.52  |- mesh__historyNote mesh__D051201 2006%28%2005%29%   
% 222.37/222.52  |- skos__scopeNote mesh__D051201
% 222.37/222.52       A pattern recognition receptor that is expressed in LUNG and in B-LYMPHOCYTES.%A%    
% 222.37/222.52  |- skos__altLabel mesh__D051201 TLR10 Receptor
% 222.37/222.52  |- mesh__dateEstablished mesh__D051201 2006-01-01
% 222.37/222.52  |- skos__hiddenLabel mesh__D004356 Drug Storages
% 222.37/222.52  |- skos__historyNote mesh__D004356 Drugs %28%1966-1967%29%
% 222.37/222.52  |- skos__broader mesh__D004356smesh__D013678
% 222.37/222.52  |- mesh__dateRevised mesh__D004356 1992-05-14
% 222.37/222.52  |- mesh__dateEstablished mesh__D004356 1968-01-01
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D004356 2006
% 222.37/222.52  |- mesh__dateCreated mesh__D004356 1999-01-01
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D004356 1994
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D004356 2003
% 222.37/222.52  |- mesh__publicMeSHNote mesh__D004356 68   
% 222.37/222.52  |- mesh__recordOriginator mesh__D004356 NLM
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D004356 1995
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D004356 2004
% 222.37/222.52  |- mesh__recordMaintainer mesh__D004356 TAP
% 222.37/222.52  |- mesh__recordAuthorizer mesh__D004356 PLS
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D004356 1993
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D004356 1998
% 222.37/222.52  |- rdf__type mesh__D004356sskos__Concept
% 222.37/222.52  |- skos__prefLabel mesh__D004356 Drug Storage
% 222.37/222.52  |- skos__hiddenLabel mesh__D004356 Storage, Drug
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D004356 2000
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D004356 1999
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D004356 1996
% 222.37/222.52  |- skos__annotation mesh__D004356
% 222.37/222.52       IM when general; NIM when with specific drug %28%IM%29%   
% 222.37/222.52  |- skos__hiddenLabel mesh__D004356 Storages, Drug
% 222.37/222.52  |- mesh__historyNote mesh__D004356 68   
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D004356 2001
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D004356 1997
% 222.37/222.52  |- skos__historyNote mesh__D004356
% 222.37/222.52       Pharmacy Service, Hospital %28%1966-1967%29%
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D004356 2005
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D004356 2002
% 222.37/222.52  |- skos__altLabel mesh__D009041 Sea Sickness
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D009041 2003
% 222.37/222.52  |- mesh__dateCreated mesh__D009041 1999-01-01
% 222.37/222.52  |- skos__hiddenLabel mesh__D009041 Sickness, Car
% 222.37/222.52  |- mesh__onlineNote mesh__D009041
% 222.37/222.52       use MOTION SICKNESS to search AIRSICKNESS, CARSICKNESS %26% SEASICKNESS 1966-78%A%  
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D009041 2006
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D009041 2004
% 222.37/222.52  |- mesh__recordMaintainer mesh__D009041 TGC
% 222.37/222.52  |- mesh__recordOriginator mesh__D009041 NLM
% 222.37/222.52  |- skos__scopeNote mesh__D009041
% 222.37/222.52       Disorder caused by motion, as sea sickness, train sickness, car sickness, air sickness, or SPACE MOTION SICKNESS. It may include nausea, vomiting and dizziness.%A%    
% 222.37/222.52  |- skos__altLabel mesh__D009041 Car Sickness
% 222.37/222.52  |- mesh__recordAuthorizer mesh__D009041 sjn
% 222.37/222.52  |- mesh__historyNote mesh__D009041
% 222.37/222.52       AIRSICKNESS, CARSICKNESS %26% SEASICKNESS were see under MOTION SICKNESS 1963-78%A%  
% 222.37/222.52  |- skos__hiddenLabel mesh__D009041 Sickness, Motion
% 222.37/222.52  |- skos__altLabel mesh__D009041 Air Sickness
% 222.37/222.52  |- skos__broader mesh__D009041smesh__D007280
% 222.37/222.52  |- rdf__type mesh__D009041sskos__Concept
% 222.37/222.52  |- skos__hiddenLabel mesh__D009041 Sickness, Sea
% 222.37/222.52  |- skos__hiddenLabel mesh__D009041 Sickness, Air
% 222.37/222.52  |- mesh__dateRevised mesh__D009041 2002-07-02
% 222.37/222.52  |- skos__annotation mesh__D009041
% 222.37/222.52       on sea or air or in cars or trains but SPACE MOTION SICKNESS is available%A%  
% 222.37/222.52  |- skos__prefLabel mesh__D009041 Motion Sickness
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D009041 2005
% 222.37/222.52  |- skos__scopeNote mesh__D014784
% 222.37/222.52       Parasitic plants that form a bushy growth on branches of host trees which are in the order Santalales.  It includes the Christmas mistletoe family %28%VISCACEAE%29%, the showy mistletoe family %28%LORANTHACEAE%29% and the catkin mistletoe family %28%Eremolepidaceae%29%. The composition of toxins, lectins, tyramine, phenethylamines, and other compounds may be affected by the host.%A%    
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D014784 2004
% 222.37/222.52  |- skos__broader mesh__D014784smesh__D019684
% 222.37/222.52  |- rdf__type mesh__D014784sskos__Concept
% 222.37/222.52  |- mesh__dateRevised mesh__D014784 2001-07-25
% 222.37/222.52  |- skos__prefLabel mesh__D014784 Mistletoe
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D014784 2003
% 222.37/222.52  |- mesh__dateCreated mesh__D014784 1999-01-01
% 222.37/222.52  |- skos__annotation mesh__D014784
% 222.37/222.52       traditional mistletoe = VISCUM ALBUM; prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D014784 2006
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D014784 2002
% 222.37/222.52  |- mesh__historyNote mesh__D014784 2002%28%1963%29%   
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D014784 2005
% 222.37/222.52  |- mesh__recordOriginator mesh__D014784 NLM
% 222.37/222.52  |- mesh__recordMaintainer mesh__D014784 ssb
% 222.37/222.52  |- mesh__recordAuthorizer mesh__D014784 sjn
% 222.37/222.52  |- mesh__publicMeSHNote mesh__D014784 2002%28%1963%29%   
% 222.37/222.52  |- skos__altLabel mesh__D008747 Martin Brand of Methylcellulose
% 222.37/222.52  |- skos__altLabel mesh__D008747 Lilly Brand of Methylcellulose
% 222.37/222.52  |- skos__altLabel mesh__D008747 Alphapharm Brand of Methylcellulose
% 222.37/222.52  |- skos__hiddenLabel mesh__D008747 Cellulose, Methyl
% 222.37/222.52  |- skos__hiddenLabel mesh__D008747 Methylcellulose Shire Brand
% 222.37/222.52  |- skos__hiddenLabel mesh__D008747 Methylcellulose Edigen Brand
% 222.37/222.52  |- mesh__recordAuthorizer mesh__D008747 sjn
% 222.37/222.52  |- skos__broader mesh__D008747smesh__D002482
% 222.37/222.52  |- skos__altLabel mesh__D008747 SmithKline Beecham Brand of Methylcellulose
% 222.37/222.52  |- mesh__recordOriginator mesh__D008747 NLM
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D008747 2006
% 222.37/222.52  |- skos__hiddenLabel mesh__D008747 Methylcellulose Alphapharm Brand
% 222.37/222.52  |- skos__prefLabel mesh__D008747 Methylcellulose
% 222.37/222.52  |- skos__altLabel mesh__D008747 Edigen Brand of Methylcellulose
% 222.37/222.52  |- skos__altLabel mesh__D008747 Warner Chilcott Brand 2 of Methylcellulose
% 222.37/222.52  |- skos__altLabel mesh__D008747 Methyl Cellulose
% 222.37/222.52  |- mesh__recordMaintainer mesh__D008747 CCR
% 222.37/222.52  |- mesh__dateCreated mesh__D008747 1999-01-01
% 222.37/222.52  |- skos__hiddenLabel mesh__D008747 Methylcellulose Lilly Brand
% 222.37/222.52  |- skos__altLabel mesh__D008747 Warner Chilcott Brand 1 of Methylcellulose
% 222.37/222.52  |- skos__hiddenLabel mesh__D008747 Methylcellulose Martin Brand
% 222.37/222.52  |- rdf__type mesh__D008747sskos__Concept
% 222.37/222.52  |- skos__annotation mesh__D008747
% 222.37/222.52       used in pharm %26% cosmetic indust; also a cathartic   
% 222.37/222.52  |- skos__scopeNote mesh__D008747
% 222.37/222.52       Methylester of cellulose. Methylcellulose is used as an emulsifying and suspending agent in cosmetics, pharmaceutics and the chemical industry. It is used therapeutically as a bulk laxative.%A%    
% 222.37/222.52  |- skos__altLabel mesh__D008747 Shire Brand of Methylcellulose
% 222.37/222.52  |- mesh__dateRevised mesh__D008747 2005-06-30
% 222.37/222.52  |- skos__hiddenLabel mesh__D000764 Anesthesias, Rebreathing
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000764 2003
% 222.37/222.52  |- mesh__dateRevised mesh__D000764 1992-03-25
% 222.37/222.52  |- mesh__dateEstablished mesh__D000764 1991-01-01
% 222.37/222.52  |- skos__historyNote mesh__D000764 Anesthesia, Inhalation %28%1966-1986%29%
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000764 1994
% 222.37/222.52  |- mesh__publicMeSHNote mesh__D000764
% 222.37/222.52       91; was see under ANESTHESIA, INHALATION 1987-90   
% 222.37/222.52  |- skos__hiddenLabel mesh__D000764 Rebreathing Anesthesia
% 222.37/222.52  |- mesh__dateCreated mesh__D000764 1986-06-20
% 222.37/222.52  |- skos__annotation mesh__D000764
% 222.37/222.52       /educ: coord IM %28%no qualif%29% with ANESTHESIOLOGY /educ %28%NIM%29%%A%  
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000764 2004
% 222.37/222.52  |- skos__altLabel mesh__D000764 Closed-Circuit Anesthesia
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000764 1998
% 222.37/222.52  |- skos__hiddenLabel mesh__D000764 Anesthesia, Closed Circuit
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000764 1995
% 222.37/222.52  |- mesh__recordMaintainer mesh__D000764 TAP
% 222.37/222.52  |- skos__hiddenLabel mesh__D000764 Rebreathing Anesthesias
% 222.37/222.52  |- skos__hiddenLabel mesh__D000764 Closed Circuit Anesthesia
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000764 2002
% 222.37/222.52  |- skos__scopeNote mesh__D000764
% 222.37/222.52       Inhalation anesthesia where the gases exhaled by the patient are rebreathed as some carbon dioxide is simultaneously removed and anesthetic gas and oxygen are added so that no anesthetic escapes into the room. Closed-circuit anesthesia is used especially with explosive anesthetics to prevent fires where electrical sparking from instruments is possible.%A%    
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000764 1999
% 222.37/222.52  |- skos__hiddenLabel mesh__D000764 Anesthesias, Closed-Circuit
% 222.37/222.52  |- rdf__type mesh__D000764sskos__Concept
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000764 1996
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000764 1993
% 222.37/222.52  |- mesh__recordAuthorizer mesh__D000764 PLS
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000764 2005
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000764 2000
% 222.37/222.52  |- mesh__historyNote mesh__D000764
% 222.37/222.52       91%28%87%29%; was see under ANESTHESIA, INHALATION 1987-90   
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000764 1997
% 222.37/222.52  |- mesh__recordOriginator mesh__D000764 SH
% 222.37/222.52  |- skos__hiddenLabel mesh__D000764 Closed-Circuit Anesthesias
% 222.37/222.52  |- skos__altLabel mesh__D000764 Anesthesia, Rebreathing
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000764 2006
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D000764 2001
% 222.37/222.52  |- skos__broader mesh__D000764smesh__D000769
% 222.37/222.52  |- skos__prefLabel mesh__D000764 Anesthesia, Closed-Circuit
% 222.37/222.52  |- mesh__publicMeSHNote mesh__D027901 2002   
% 222.37/222.52  |- skos__prefLabel mesh__D027901 Acanthaceae
% 222.37/222.52  |- mesh__dateRevised mesh__D027901 2003-07-09
% 222.37/222.52  |- mesh__dateEstablished mesh__D027901 2002-01-01
% 222.37/222.52  |- skos__broader mesh__D027901smesh__D019684
% 222.37/222.52  |- skos__altLabel mesh__D027901 Indian Paintbrush
% 222.37/222.52  |- skos__scopeNote mesh__D027901
% 222.37/222.52       A plant family of the order Scrophulariales, subclass Asteridae, class Magnoliopsida.  It is characterized by simple leaves in opposite pairs, cystoliths %28%enlarged cells containing crystals of calcium carbonate%29%, and bilaterally symmetrical and bisexual flowers that are usually crowded together. The common name for Ruellia of wild petunia is easily confused with PETUNIA.%A%    
% 222.37/222.52  |- mesh__recordMaintainer mesh__D027901 ssb
% 222.37/222.52  |- skos__related mesh__D027901smesh__D032306
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D027901 2006
% 222.37/222.52  |- skos__annotation mesh__D027901
% 222.37/222.52       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.37/222.52  |- skos__altLabel mesh__D027901 Paintbrush, Indian
% 222.37/222.52  |- mesh__recordOriginator mesh__D027901 ssb
% 222.37/222.52  |- rdf__type mesh__D027901sskos__Concept
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D027901 2005
% 222.37/222.52  |- mesh__dateCreated mesh__D027901 2001-08-03
% 222.37/222.52  |- mesh__recordAuthorizer mesh__D027901 sjn
% 222.37/222.52  |- mesh__historyNote mesh__D027901 2002   
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D027901 2004
% 222.37/222.52  |- mesh__recordOriginator mesh__D046068 ags
% 222.37/222.52  |- skos__prefLabel mesh__D046068 Caulerpa
% 222.37/222.52  |- mesh__dateEstablished mesh__D046068 2005-01-01
% 222.37/222.52  |- skos__scopeNote mesh__D046068
% 222.37/222.52       A genus of toxic marine GREEN ALGAE found throughout tropical and subtropical seas. One species, Caulerpa taxifolia, is highly invasive and produces the poison caulerpenyne, deadly to marine organisms though not humans.%A%    
% 222.37/222.52  |- mesh__dateRevised mesh__D046068 2005-06-30
% 222.37/222.52  |- mesh__recordMaintainer mesh__D046068 SYSTEM
% 222.37/222.52  |- mesh__historyNote mesh__D046068 2005   
% 222.37/222.52  |- skos__broader mesh__D046068smesh__D000460
% 222.37/222.52  |- mesh__recordAuthorizer mesh__D046068 sjn
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D046068 2006
% 222.37/222.52  |- mesh__dateCreated mesh__D046068 2004-07-19
% 222.37/222.52  |- rdf__type mesh__D046068sskos__Concept
% 222.37/222.52  |- mesh__publicMeSHNote mesh__D046068 2005   
% 222.37/222.52  |- skos__historyNote mesh__D046068 Algae, Green %28%1971-2004%29%
% 222.37/222.52  |- skos__altLabel mesh__D018377 Nerve Transmitter Substances
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D018377 2006
% 222.37/222.52  |- skos__broader mesh__D018377smesh__D045504
% 222.37/222.52  |- mesh__dateRevised mesh__D018377 2005-06-30
% 222.37/222.52  |- skos__scopeNote mesh__D018377
% 222.37/222.52       Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function.%A%    
% 222.37/222.52  |- skos__hiddenLabel mesh__D018377 Agents, Neurotransmitter
% 222.37/222.52  |- skos__broader mesh__D018377smesh__D045505
% 222.37/222.52  |- mesh__dateEstablished mesh__D018377 1998-01-01
% 222.37/222.52  |- skos__prefLabel mesh__D018377 Neurotransmitter Agents
% 222.37/222.52  |- skos__altLabel mesh__D018377 Substances, Nerve Transmitter
% 222.37/222.52  |- rdf__type mesh__D018377sskos__Concept
% 222.37/222.52  |- skos__altLabel mesh__D018377 Neuromodulator
% 222.37/222.52  |- mesh__historyNote mesh__D018377 1998; use explode 1995-1997   
% 222.37/222.52  |- skos__altLabel mesh__D018377 Neurotransmitter
% 222.37/222.52  |- skos__annotation mesh__D018377 general; prefer specifics   
% 222.37/222.52  |- skos__altLabel mesh__D018377 Transmitter Substances, Nerve
% 222.37/222.52  |- mesh__recordOriginator mesh__D018377 RAZ
% 222.37/222.52  |- mesh__publicMeSHNote mesh__D018377
% 222.37/222.52       1998; for NEUROTRANSMITTERS see NEUROTRANSMITTERS 1968-2005; NEUROTRANSMITTERS was NEUROREGULATORS 1980-94, was NEUROHUMORS 1968-79, NEUROREGULATORS 1977-94%A%  
% 222.37/222.52  |- mesh__recordMaintainer mesh__D018377 ssb
% 222.37/222.52  |- skos__altLabel mesh__D018377 Neuroregulator
% 222.37/222.52  |- mesh__dateCreated mesh__D018377 1994-06-01
% 222.37/222.52  |- mesh__recordAuthorizer mesh__D018377 sjn
% 222.37/222.52  |- skos__prefLabel mesh__D010394 Penbutolol
% 222.37/222.52  |- mesh__recordAuthorizer mesh__D010394 sjn
% 222.37/222.52  |- mesh__dateRevised mesh__D010394 2005-06-30
% 222.37/222.52  |- skos__hiddenLabel mesh__D010394 Hoe 893d
% 222.37/222.52  |- mesh__recordMaintainer mesh__D010394 ssb
% 222.37/222.52  |- skos__hiddenLabel mesh__D010394 Hoe893d
% 222.37/222.52  |- mesh__recordOriginator mesh__D010394 SH
% 222.37/222.52  |- mesh__dateEstablished mesh__D010394 1991-01-01
% 222.37/222.52  |- mesh__historyNote mesh__D010394
% 222.37/222.52       91%28%79%29%; was see under PROPANOLAMINES 1979-90   
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D010394 2006
% 222.37/222.52  |- skos__historyNote mesh__D010394 Propanolamines %28%1974-1978%29%
% 222.37/222.52  |- mesh__dateCreated mesh__D010394 1978-03-20
% 222.37/222.52  |- skos__altLabel mesh__D010394 Penbutolol Sulfate %28%2:1%29%
% 222.37/222.52  |- skos__historyNote mesh__D010394 Amino Alcohols %28%1966-1973%29%
% 222.37/222.52  |- skos__broader mesh__D010394smesh__D011412
% 222.37/222.52  |- skos__scopeNote mesh__D010394
% 222.37/222.52       A nonselective beta-blocker used as an antihypertensive and an antianginal agent.%A%    
% 222.37/222.52  |- skos__broader mesh__D010394smesh__D050198
% 222.37/222.52  |- mesh__publicMeSHNote mesh__D010394
% 222.37/222.52       91; was see under PROPANOLAMINES 1979-90   
% 222.37/222.52  |- rdf__type mesh__D010394sskos__Concept
% 222.37/222.52  |- skos__hiddenLabel mesh__D010394 Sulfate, Penbutolol
% 222.37/222.52  |- skos__hiddenLabel mesh__D004357 Potentiation, Drug
% 222.37/222.52  |- mesh__recordAuthorizer mesh__D004357 sjn
% 222.37/222.52  |- mesh__recordMaintainer mesh__D004357 ssb
% 222.37/222.52  |- skos__hiddenLabel mesh__D004357 Potentiations, Drug
% 222.37/222.52  |- mesh__dateEstablished mesh__D004357 1966-01-01
% 222.37/222.52  |- skos__hiddenLabel mesh__D004357 Synergisms, Drug
% 222.37/222.52  |- skos__hiddenLabel mesh__D004357 Drug Potentiations
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D004357 2004
% 222.37/222.52  |- mesh__publicMeSHNote mesh__D004357 66   
% 222.37/222.52  |- skos__prefLabel mesh__D004357 Drug Synergism
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D004357 2006
% 222.37/222.52  |- skos__broader mesh__D004357smesh__D004347
% 222.37/222.52  |- skos__related mesh__D004357smesh__D003043
% 222.37/222.52  |- skos__related mesh__D004357smesh__D010574
% 222.37/222.52  |- mesh__activeMeSHYear mesh__D004357 2005
% 222.37/222.52  |- skos__annotation mesh__D004357
% 222.37/222.52       IM when general; NIM when with specific drugs %28%IM%29%; no qualif%A%  
% 222.37/222.52  |- skos__hiddenLabel mesh__D004357 Drug Synergisms
% 222.37/222.52  |- mesh__recordOriginator mesh__D004357 NLM
% 222.37/222.52  |- mesh__dateRevised mesh__D004357 2003-07-09
% 222.37/222.52  |- skos__hiddenLabel mesh__D004357 Synergism, Drug
% 222.37/222.52  |- rdf__type mesh__D004357sskos__Concept
% 222.37/222.52  |- mesh__historyNote mesh__D004357 66%28%65%29%   
% 222.37/222.52  |- mesh__dateCreated mesh__D004357 1999-01-01
% 222.37/222.52  |- mesh__onlineNote mesh__D009840
% 222.37/222.52       use OLIGOMYCINS to search OLIGOMYCIN 1966-81   
% 222.37/222.52  |- skos__prefLabel mesh__D009840 Oligomycins
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D009840 2005
% 222.37/222.53  |- mesh__recordMaintainer mesh__D009840 ssb
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D009840 2006
% 222.37/222.53  |- mesh__dateEstablished mesh__D009840 1966-01-01
% 222.37/222.53  |- mesh__dateRevised mesh__D009840 2004-07-07
% 222.37/222.53  |- rdf__type mesh__D009840sskos__Concept
% 222.37/222.53  |- mesh__dateCreated mesh__D009840 1999-01-01
% 222.37/222.53  |- mesh__publicMeSHNote mesh__D009840
% 222.37/222.53       82; was OLIGOMYCIN 1966-81; RUTAMYCIN was see under ANTIBIOTICS, ANTIFUNGAL 1975-81%A%  
% 222.37/222.53  |- skos__altLabel mesh__D009840 Oligomycin
% 222.37/222.53  |- mesh__recordAuthorizer mesh__D009840 sjn
% 222.37/222.53  |- mesh__recordOriginator mesh__D009840 NLM
% 222.37/222.53  |- mesh__historyNote mesh__D009840
% 222.37/222.53       82; was OLIGOMYCIN 1963-81 %28%Prov 1963-65%29%   
% 222.37/222.53  |- skos__scopeNote mesh__D009840
% 222.37/222.53       A closely related group of toxic substances elaborated by various strains of Streptomyces. They are 26-membered macrolides with lactone moieties and double bonds and inhibit various ATPases, causing uncoupling of phosphorylation from mitochondrial respiration. Used as tools in cytochemistry. Some specific oligomycins are RUTAMYCIN, peliomycin, and botrycidin %28%formerly venturicidin X%29%.%A%    
% 222.37/222.53  |- skos__broader mesh__D009840smesh__D018942
% 222.37/222.53  |- skos__scopeNote mesh__D009042
% 222.37/222.53       Those factors which cause an organism to behave or act in either a goal-seeking or satisfying manner. They may be influenced by physiological drives or by external stimuli.%A%    
% 222.37/222.53  |- skos__related mesh__D009042smesh__D007989
% 222.37/222.53  |- mesh__recordMaintainer mesh__D009042 jrf
% 222.37/222.53  |- skos__hiddenLabel mesh__D009042 Incentive
% 222.37/222.53  |- skos__hiddenLabel mesh__D009042 Disincentive
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D009042 2004
% 222.37/222.53  |- skos__related mesh__D009042smesh__D033182
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D009042 2003
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D009042 2006
% 222.37/222.53  |- skos__broader mesh__D009042smesh__D001520
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D009042 2005
% 222.37/222.53  |- mesh__dateCreated mesh__D009042 1999-01-01
% 222.37/222.53  |- mesh__recordOriginator mesh__D009042 NLM
% 222.37/222.53  |- mesh__recordAuthorizer mesh__D009042 sjn
% 222.37/222.53  |- skos__related mesh__D009042smesh__D003073
% 222.37/222.53  |- rdf__type mesh__D009042sskos__Concept
% 222.37/222.53  |- skos__annotation mesh__D009042 human %26% animal   
% 222.37/222.53  |- mesh__dateRevised mesh__D009042 2002-07-03
% 222.37/222.53  |- skos__prefLabel mesh__D009042 Motivation
% 222.37/222.53  |- mesh__dateCreated mesh__D014785 1999-01-01
% 222.37/222.53  |- skos__broader mesh__D014785smesh__D043722
% 222.37/222.53  |- mesh__recordAuthorizer mesh__D014785 sjn
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D014785 2006
% 222.37/222.53  |- mesh__recordMaintainer mesh__D014785 nns
% 222.37/222.53  |- skos__related mesh__D014785smesh__D014796
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D014785 2005
% 222.37/222.53  |- skos__broader mesh__D014785smesh__D012677
% 222.37/222.53  |- mesh__dateRevised mesh__D014785 2003-07-09
% 222.37/222.53  |- skos__hiddenLabel mesh__D014785 Visions
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D014785 2004
% 222.37/222.53  |- mesh__recordOriginator mesh__D014785 NLM
% 222.37/222.53  |- rdf__type mesh__D014785sskos__Concept
% 222.37/222.53  |- skos__annotation mesh__D014785
% 222.37/222.53       differentiate from VISUAL PERCEPTION: vis percept takes place in the brain, vision takes place in the eye; visual stimulation: probably PHOTIC STIMULATION but check text for possible non-light %28%non-photic%29% stimul%A%  
% 222.37/222.53  |- skos__scopeNote mesh__D014785 The sensation of sight.     
% 222.37/222.53  |- skos__prefLabel mesh__D014785 Vision
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D008748 2006
% 222.37/222.53  |- mesh__dateRevised mesh__D008748 2004-07-07
% 222.37/222.53  |- mesh__dateCreated mesh__D008748 1999-01-01
% 222.37/222.53  |- skos__altLabel mesh__D008748 3-Methylcholanthrene
% 222.37/222.53  |- mesh__recordAuthorizer mesh__D008748 sjn
% 222.37/222.53  |- mesh__recordMaintainer mesh__D008748 ssb
% 222.37/222.53  |- mesh__recordOriginator mesh__D008748 NLM
% 222.37/222.53  |- skos__hiddenLabel mesh__D008748 3 Methylcholanthrene
% 222.37/222.53  |- rdf__type mesh__D008748sskos__Concept
% 222.37/222.53  |- skos__prefLabel mesh__D008748 Methylcholanthrene
% 222.37/222.53  |- skos__scopeNote mesh__D008748
% 222.37/222.53       A carcinogen that is often used in experimental cancer studies.%A%    
% 222.37/222.53  |- skos__annotation mesh__D008748
% 222.37/222.53       a carcinogen; NIM; D25-26 qualif; in exper cancer studies usually no qualif%A%  
% 222.37/222.53  |- skos__broader mesh__D008748smesh__D001551
% 222.37/222.53  |- skos__hiddenLabel mesh__D008748 20 Methylcholanthrene
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D008748 2005
% 222.37/222.53  |- mesh__recordMaintainer mesh__D000765 PLS
% 222.37/222.53  |- skos__hiddenLabel mesh__D000765 Conduction Anesthesia
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D000765 2004
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D000765 1998
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D000765 2001
% 222.37/222.53  |- mesh__recordAuthorizer mesh__D000765 NLM
% 222.37/222.53  |- mesh__dateRevised mesh__D000765 1993-02-20
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D000765 1995
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D000765 1999
% 222.37/222.53  |- rdf__type mesh__D000765sskos__Concept
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D000765 1996
% 222.37/222.53  |- skos__hiddenLabel mesh__D000765 Regional Anesthesia
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D000765 2005
% 222.37/222.53  |- skos__prefLabel mesh__D000765 Anesthesia, Conduction
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D000765 2002
% 222.37/222.53  |- mesh__recordOriginator mesh__D000765 NLM
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D000765 1997
% 222.37/222.53  |- skos__broader mesh__D000765smesh__D000758
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D000765 2006
% 222.37/222.53  |- mesh__dateCreated mesh__D000765 1999-01-01
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D000765 2003
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D000765 2000
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D000765 1994
% 222.37/222.53  |- skos__altLabel mesh__D000765 Anesthesia, Regional
% 222.37/222.53  |- skos__annotation mesh__D000765
% 222.37/222.53       /educ: coord IM %28%no qualif%29% with ANESTHESIOLOGY /educ %28%NIM%29%%A%  
% 222.37/222.53  |- skos__hiddenLabel mesh__D019470 Biolistic
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D019470 2002
% 222.37/222.53  |- skos__annotation mesh__D019470
% 222.37/222.53       DNA delivery directly into organelles at high speed: from %22%biological ballistic%22%%A%  
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D019470 2004
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D019470 1999
% 222.37/222.53  |- mesh__historyNote mesh__D019470 97   
% 222.37/222.53  |- mesh__publicMeSHNote mesh__D019470 97   
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D019470 2003
% 222.37/222.53  |- mesh__dateEstablished mesh__D019470 1997-01-01
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D019470 1998
% 222.37/222.53  |- skos__hiddenLabel mesh__D019470 Gene-Gun Techniques
% 222.37/222.53  |- skos__hiddenLabel mesh__D019470 Gene Gun Technique
% 222.37/222.53  |- skos__historyNote mesh__D019470 Gene Transfer %28%1993-1996%29%
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D019470 2001
% 222.37/222.53  |- skos__scopeNote mesh__D019470
% 222.37/222.53       Techniques where DNA is delivered directly into organelles at high speed using projectiles coated with nucleic acid, shot from a helium-powered gun %28%gene gun%29%. One of these techniques involves immunization by DNA VACCINES, which delivers DNA-coated gold beads to the epidermis.%A%    
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D019470 2006
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D019470 2000
% 222.37/222.53  |- skos__historyNote mesh__D019470 Genetic Techniques %28%1990-1995%29%
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D019470 1997
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D019470 2005
% 222.37/222.53  |- rdf__type mesh__D019470sskos__Concept
% 222.37/222.53  |- mesh__dateCreated mesh__D019470 1996-06-10
% 222.37/222.53  |- skos__altLabel mesh__D019470 Gene-Gun Technique
% 222.37/222.53  |- skos__broader mesh__D019470smesh__D018014
% 222.37/222.53  |- skos__broader mesh__D019470smesh__D007277
% 222.37/222.53  |- skos__prefLabel mesh__D019470 Biolistics
% 222.37/222.53  |- mesh__dateCreated mesh__D033141 2002-07-03
% 222.37/222.53  |- mesh__dateRevised mesh__D033141 2004-07-13
% 222.37/222.53  |- skos__broader mesh__D033141smesh__D005824
% 222.37/222.53  |- skos__hiddenLabel mesh__D033141 Determinism, Genetic
% 222.37/222.53  |- rdf__type mesh__D033141sskos__Concept
% 222.37/222.53  |- mesh__publicMeSHNote mesh__D033141
% 222.37/222.53       2003; see GENETICS, BEHAVIORAL 2002   
% 222.37/222.53  |- mesh__recordAuthorizer mesh__D033141 sjn
% 222.37/222.53  |- mesh__recordMaintainer mesh__D033141 sjn
% 222.37/222.53  |- mesh__dateEstablished mesh__D033141 2003-01-01
% 222.37/222.53  |- mesh__recordOriginator mesh__D033141 jrf
% 222.37/222.53  |- mesh__historyNote mesh__D033141 2003; use GENETICS, BEHAVIORAL 2002   
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D033141 2006
% 222.37/222.53  |- skos__prefLabel mesh__D033141 Genetic Determinism
% 222.37/222.53  |- skos__scopeNote mesh__D033141
% 222.37/222.53       The theory that human CHARACTER and BEHAVIOR are shaped by the GENES that comprise the individual%27%s GENOTYPE rather than by CULTURE; ENVIRONMENT; and individual choice.%A%    
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D033141 2005
% 222.37/222.53  |- skos__altLabel mesh__D027902 Justicia adhatoda
% 222.37/222.53  |- skos__scopeNote mesh__D027902
% 222.37/222.53       A plant genus in the family ACANTHACEAE.  Adhatoda vasica Nees is a source of vasicine.%A%    
% 222.37/222.53  |- mesh__publicMeSHNote mesh__D027902 2002   
% 222.37/222.53  |- mesh__historyNote mesh__D027902 2002   
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D027902 2005
% 222.37/222.53  |- skos__prefLabel mesh__D027902 Adhatoda
% 222.37/222.53  |- mesh__dateCreated mesh__D027902 2001-07-25
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D027902 2006
% 222.37/222.53  |- mesh__dateEstablished mesh__D027902 2002-01-01
% 222.37/222.53  |- skos__broader mesh__D027902smesh__D027901
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D027902 2003
% 222.37/222.53  |- rdf__type mesh__D027902sskos__Concept
% 222.37/222.53  |- skos__altLabel mesh__D027902 Malabar-nut
% 222.37/222.53  |- skos__annotation mesh__D027902
% 222.37/222.53       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.37/222.53  |- mesh__dateRevised mesh__D027902 2002-07-02
% 222.37/222.53  |- skos__historyNote mesh__D027902 Plants, Medicinal %28%1968-2001%29%
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D027902 2004
% 222.37/222.53  |- skos__broader mesh__D010146Q000187smesh__D010146
% 222.37/222.53  |- mesh__preferredCombination mesh__D010146Q000187smesh__D010146
% 222.37/222.53  |- rdf__type mesh__D010146Q000187smesh__CompoundConcept
% 222.37/222.53  |- skos__historyNote mesh__D005450 Benzofurans %28%1974%29%
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D005450 2003
% 222.37/222.53  |- mesh__publicMeSHNote mesh__D005450
% 222.37/222.53       91; was see under SPIRO COMPOUNDS 1975-90   
% 222.37/222.53  |- mesh__recordMaintainer mesh__D005450 TWD
% 222.37/222.53  |- skos__scopeNote mesh__D005450
% 222.37/222.53       A nonfluorescent reagent for the detection of primary amines, peptides and proteins. The reaction products are highly fluorescent.%A%    
% 222.37/222.53  |- skos__prefLabel mesh__D005450 Fluorescamine
% 222.37/222.53  |- mesh__recordOriginator mesh__D005450 NLM
% 222.37/222.53  |- mesh__historyNote mesh__D005450
% 222.37/222.53       91%28%75%29%; was see under SPIRO COMPOUNDS 1975-90   
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D005450 2002
% 222.37/222.53  |- rdf__type mesh__D005450sskos__Concept
% 222.37/222.53  |- mesh__dateRevised mesh__D005450 2000-06-22
% 222.37/222.53  |- skos__broader mesh__D005450smesh__D013141
% 222.37/222.53  |- mesh__dateEstablished mesh__D005450 1991-01-01
% 222.37/222.53  |- mesh__dateCreated mesh__D005450 1974-11-19
% 222.37/222.53  |- skos__historyNote mesh__D005450 Spiro Compounds %28%1973-1974%29%
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D005450 2006
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D005450 2004
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D005450 2001
% 222.37/222.53  |- mesh__recordAuthorizer mesh__D005450 sjn
% 222.37/222.53  |- skos__annotation mesh__D005450 D25-26 qualif   
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D005450 2005
% 222.37/222.53  |- skos__hiddenLabel mesh__D046069 Eared Seals
% 222.37/222.53  |- skos__prefLabel mesh__D046069 Fur Seals
% 222.37/222.53  |- mesh__dateRevised mesh__D046069 2005-03-04
% 222.37/222.53  |- skos__hiddenLabel mesh__D046069 Eared Seal
% 222.37/222.53  |- mesh__recordMaintainer mesh__D046069 ags
% 222.37/222.53  |- mesh__dateCreated mesh__D046069 2004-07-07
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D046069 2006
% 222.37/222.53  |- skos__annotation mesh__D046069
% 222.37/222.53       SEALS, EARLESS and SEA LIONS are also available   
% 222.37/222.53  |- mesh__recordOriginator mesh__D046069 ags
% 222.37/222.53  |- mesh__recordAuthorizer mesh__D046069 ags
% 222.37/222.53  |- mesh__dateEstablished mesh__D046069 2005-01-01
% 222.37/222.53  |- skos__altLabel mesh__D046069 Seals, Eared
% 222.37/222.53  |- skos__scopeNote mesh__D046069
% 222.37/222.53       A group comprised of several species of eared seals found in two genera, in the family Otariidae. In comparison to SEA LIONS, they have an especially dense wooly undercoat.%A%    
% 222.37/222.53  |- skos__broader mesh__D046069smesh__D010872
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D046069 2005
% 222.37/222.53  |- mesh__historyNote mesh__D046069 2005; use SEALS, EARLESS 1990-2004   
% 222.37/222.53  |- rdf__type mesh__D046069sskos__Concept
% 222.37/222.53  |- skos__hiddenLabel mesh__D046069 Seal, Fur
% 222.37/222.53  |- mesh__publicMeSHNote mesh__D046069 2005; see SEALS 1990-2004   
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D046069 2005A
% 222.37/222.53  |- skos__hiddenLabel mesh__D046069 Seal, Eared
% 222.37/222.53  |- skos__hiddenLabel mesh__D046069 Seals, Fur
% 222.37/222.53  |- skos__hiddenLabel mesh__D046069 Fur Seal
% 222.37/222.53  |- mesh__dateEstablished mesh__D010395 1991-01-01
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D010395 2006
% 222.37/222.53  |- mesh__dateCreated mesh__D010395 1974-11-19
% 222.37/222.53  |- mesh__recordAuthorizer mesh__D010395 sjn
% 222.37/222.53  |- skos__hiddenLabel mesh__D010395 R16341
% 222.37/222.53  |- mesh__dateRevised mesh__D010395 2005-06-30
% 222.37/222.53  |- skos__hiddenLabel mesh__D010395 R 16341
% 222.37/222.53  |- mesh__publicMeSHNote mesh__D010395
% 222.37/222.53       91; was see under PIPERIDINES 1975-90   
% 222.37/222.53  |- skos__historyNote mesh__D010395 Toluene %28%1973-1974%29%
% 222.37/222.53  |- mesh__historyNote mesh__D010395
% 222.37/222.53       91%28%75%29%; was see under PIPERIDINES 1975-90   
% 222.37/222.53  |- skos__historyNote mesh__D010395 Piperidines %28%1971-1974%29%
% 222.37/222.53  |- rdf__type mesh__D010395sskos__Concept
% 222.37/222.53  |- mesh__recordOriginator mesh__D010395 NLM
% 222.37/222.53  |- skos__historyNote mesh__D010395
% 222.37/222.53       Hydrocarbons, Halogenated %28%1971-1974%29%
% 222.37/222.53  |- skos__prefLabel mesh__D010395 Penfluridol
% 222.37/222.53  |- skos__broader mesh__D010395smesh__D010880
% 222.37/222.53  |- skos__scopeNote mesh__D010395
% 222.37/222.53       One of the long-acting ANTIPSYCHOTIC AGENTS used for maintenance or long-term therapy of SCHIZOPHRENIA and other PSYCHOTIC DISORDERS.%A%    
% 222.37/222.53  |- mesh__recordMaintainer mesh__D010395 lkw
% 222.37/222.53  |- skos__altLabel mesh__D010395 Janssen Brand of Penfluridol
% 222.37/222.53  |- skos__related mesh__D004358smesh__D008508
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D004358 2004
% 222.37/222.53  |- skos__hiddenLabel mesh__D004358 Pharmacotherapies
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D004358 2006
% 222.37/222.53  |- skos__altLabel mesh__D004358 Therapy, Drug
% 222.37/222.53  |- skos__hiddenLabel mesh__D004358 Chemotherapies
% 222.37/222.53  |- mesh__dateRevised mesh__D004358 2003-07-30
% 222.37/222.53  |- skos__broader mesh__D004358smesh__D013812
% 222.37/222.53  |- skos__related mesh__D004358smesh__D020228
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D004358 2005
% 222.37/222.53  |- skos__prefLabel mesh__D004358 Drug Therapy
% 222.37/222.53  |- skos__annotation mesh__D004358
% 222.37/222.53       GEN only: prefer /drug ther with disease term: Manual 19.7+, 19.8.26; note X ref CHEMOTHERAPY: prefer specific chem or chem group, e.g., chemotherapy of lymphoma = LYMPHOMA /drug ther + ANTINEOPLASTIC AGENTS /ther use, not DRUG THERAPY; DF: DRUG THER%A%  
% 222.37/222.53  |- rdf__type mesh__D004358sskos__Concept
% 222.37/222.53  |- skos__hiddenLabel mesh__D004358 Therapies, Drug
% 222.37/222.53  |- skos__altLabel mesh__D004358 Pharmacotherapy
% 222.37/222.53  |- mesh__recordMaintainer mesh__D004358 SYSTEM
% 222.37/222.53  |- mesh__recordAuthorizer mesh__D004358 NLM
% 222.37/222.53  |- skos__hiddenLabel mesh__D004358 Drug Therapies
% 222.37/222.53  |- mesh__dateCreated mesh__D004358 1999-01-01
% 222.37/222.53  |- skos__altLabel mesh__D004358 Chemotherapy
% 222.37/222.53  |- mesh__recordOriginator mesh__D004358 NLM
% 222.37/222.53  |- skos__broader mesh__D015080smesh__D000476
% 222.37/222.53  |- skos__altLabel mesh__D015080 Bristol-Myers Squibb Brand of Mesna
% 222.37/222.53  |- mesh__recordAuthorizer mesh__D015080 sjn
% 222.37/222.53  |- skos__historyNote mesh__D015080 Mercaptoethanol %28%1974-1976%29%
% 222.37/222.53  |- mesh__onlineNote mesh__D015080
% 222.37/222.53       use MESNA to search 2-MERCAPTOETHANESULFONATE 1977-91   
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D015080 2006
% 222.37/222.53  |- skos__hiddenLabel mesh__D015080 ASTA D 7093
% 222.37/222.53  |- skos__altLabel mesh__D015080 cell pharm Brand of Mesna
% 222.37/222.53  |- skos__altLabel mesh__D015080 UCB Brand of Mesna
% 222.37/222.53  |- skos__altLabel mesh__D015080 Sodium 2-Mercaptoethanesulphonate
% 222.37/222.53  |- mesh__publicMeSHNote mesh__D015080
% 222.37/222.53       92; was 2-MERCAPTOETHANESULFONATE 1977-91 %28%see under MERCAPTOETHANOL 1977-90%29%; MESNA was see 2-MERCAPTOETHANESULFONATE 1978-91%A%  
% 222.37/222.53  |- skos__altLabel mesh__D015080 Mucofluid
% 222.37/222.53  |- skos__altLabel mesh__D015080 Mistabronco
% 222.37/222.53  |- skos__hiddenLabel mesh__D015080 MESNA cell
% 222.37/222.53  |- skos__hiddenLabel mesh__D015080 UCB3983
% 222.37/222.53  |- rdf__type mesh__D015080sskos__Concept
% 222.37/222.53  |- skos__hiddenLabel mesh__D015080 2 Mercaptoethanesulfonate
% 222.37/222.53  |- skos__altLabel mesh__D015080 ASTA Medica Brand of Mesna
% 222.37/222.53  |- skos__hiddenLabel mesh__D015080 UCB 3983
% 222.37/222.53  |- skos__hiddenLabel mesh__D015080 ASTAD 7093
% 222.37/222.53  |- skos__broader mesh__D015080smesh__D013438
% 222.37/222.53  |- skos__hiddenLabel mesh__D015080 Bristol Myers Squibb Brand of Mesna
% 222.37/222.53  |- mesh__historyNote mesh__D015080
% 222.37/222.53       92; was 2-MERCAPTOETHANESULFONATE 1977-91 %28%see under MERCAPTOETHANOL 1977-90%29%; MESNA was see 2-MERCAPTOETHANESULFONATE 1978-91%A%  
% 222.37/222.53  |- skos__altLabel mesh__D015080 Kendrick Brand of Mesna
% 222.37/222.53  |- skos__scopeNote mesh__D015080
% 222.37/222.53       A sulfhydryl compound used to prevent urothelial toxicity by inactivating metabolites from ANTINEOPLASTIC AGENTS, such as IFOSFAMIDE or CYCLOPHOSPHAMIDE.%A%    
% 222.37/222.53  |- skos__hiddenLabel mesh__D015080 Mesna Kendrick Brand
% 222.37/222.53  |- skos__hiddenLabel mesh__D015080 Mesna Sanfer Brand
% 222.37/222.53  |- skos__altLabel mesh__D015080 Sanfer Brand of Mesna
% 222.37/222.53  |- mesh__recordOriginator mesh__D015080 SH
% 222.37/222.53  |- skos__hiddenLabel mesh__D015080 2-Mercaptoethanesulphonate, Sodium
% 222.37/222.53  |- mesh__dateCreated mesh__D015080 1976-04-16
% 222.37/222.53  |- mesh__recordMaintainer mesh__D015080 CCR
% 222.37/222.53  |- mesh__dateEstablished mesh__D015080 1991-01-01
% 222.37/222.53  |- mesh__dateRevised mesh__D015080 2005-06-30
% 222.37/222.53  |- skos__prefLabel mesh__D015080 Mesna
% 222.37/222.53  |- skos__historyNote mesh__D015080 Alkyl Sulfonates %28%1974-1975%29%
% 222.37/222.53  |- skos__prefLabel mesh__D009841 Oligonucleotides
% 222.37/222.53  |- skos__annotation mesh__D009841 2-12 nucleotides   
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D009841 2002
% 222.37/222.53  |- skos__scopeNote mesh__D009841
% 222.37/222.53       Polymers made up of a few %28%2-20%29% nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe %28%OLIGONUCLEOTIDE PROBES%29%. %28%Dorland, 28th ed%29%%A%    
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D009841 1996
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D009841 2003
% 222.37/222.53  |- mesh__recordMaintainer mesh__D009841 TGC
% 222.37/222.53  |- rdf__type mesh__D009841sskos__Concept
% 222.37/222.53  |- mesh__recordAuthorizer mesh__D009841 PLS
% 222.37/222.53  |- mesh__dateCreated mesh__D009841 1999-01-01
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D009841 1997
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D009841 2004
% 222.37/222.53  |- mesh__dateRevised mesh__D009841 1995-03-17
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D009841 2000
% 222.37/222.53  |- mesh__historyNote mesh__D009841 74%28%72%29%   
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D009841 2001
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D009841 1998
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D009841 2005
% 222.37/222.53  |- mesh__dateEstablished mesh__D009841 1974-01-01
% 222.37/222.53  |- mesh__publicMeSHNote mesh__D009841 74   
% 222.37/222.53  |- mesh__recordOriginator mesh__D009841 NLM
% 222.37/222.53  |- skos__broader mesh__D009841smesh__D011119
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D009841 2006
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D009841 1999
% 222.37/222.53  |- mesh__recordOriginator mesh__D009043 NLM
% 222.37/222.53  |- mesh__recordAuthorizer mesh__D009043 sjn
% 222.37/222.53  |- skos__hiddenLabel mesh__D009043 Physical Activities
% 222.37/222.53  |- skos__altLabel mesh__D009043 Physical Activity
% 222.37/222.53  |- skos__scopeNote mesh__D009043
% 222.37/222.53       The physical activity of a human or an animal as a behavioral phenomenon.%A%    
% 222.37/222.53  |- mesh__recordMaintainer mesh__D009043 sjn
% 222.37/222.53  |- skos__broader mesh__D009043smesh__D009068
% 222.37/222.53  |- skos__hiddenLabel mesh__D009043 Activities, Motor
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D009043 2006
% 222.37/222.53  |- skos__hiddenLabel mesh__D009043 Activity, Locomotor
% 222.37/222.53  |- skos__broader mesh__D009043smesh__D001519
% 222.37/222.53  |- skos__related mesh__D009043smesh__D006948
% 222.37/222.53  |- skos__hiddenLabel mesh__D009043 Locomotor Activities
% 222.37/222.53  |- skos__prefLabel mesh__D009043 Motor Activity
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D009043 2005
% 222.37/222.53  |- skos__historyNote mesh__D009043 Behavior %28%1966-1967%29%
% 222.37/222.53  |- skos__hiddenLabel mesh__D009043 Activity, Physical
% 222.37/222.53  |- mesh__dateCreated mesh__D009043 1999-01-01
% 222.37/222.53  |- mesh__dateRevised mesh__D009043 2004-07-13
% 222.37/222.53  |- skos__annotation mesh__D009043
% 222.37/222.53       = movement as associated with behavior: differentiate from MOVEMENT, a physiol process; animal running in exercise wheel goes here %28%unless better under EXERTION%29%%A%  
% 222.37/222.53  |- skos__historyNote mesh__D009043 Behavior, Animal %28%1966-1967%29%
% 222.37/222.53  |- rdf__type mesh__D009043sskos__Concept
% 222.37/222.53  |- skos__hiddenLabel mesh__D009043 Activity, Motor
% 222.37/222.53  |- skos__related mesh__D009043smesh__D011597
% 222.37/222.53  |- skos__hiddenLabel mesh__D009043 Activities, Physical
% 222.37/222.53  |- skos__altLabel mesh__D009043 Locomotor Activity
% 222.37/222.53  |- mesh__historyNote mesh__D009043 68   
% 222.37/222.53  |- mesh__dateEstablished mesh__D009043 1968-01-01
% 222.37/222.53  |- skos__hiddenLabel mesh__D009043 Motor Activities
% 222.37/222.53  |- skos__hiddenLabel mesh__D009043 Activities, Locomotor
% 222.37/222.53  |- mesh__publicMeSHNote mesh__D009043 68   
% 222.37/222.53  |- skos__prefLabel mesh__D001060 Aporphines
% 222.37/222.53  |- rdf__type mesh__D001060sskos__Concept
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D001060 2005
% 222.37/222.53  |- mesh__dateRevised mesh__D001060 2003-07-09
% 222.37/222.53  |- mesh__publicMeSHNote mesh__D001060 69   
% 222.37/222.53  |- skos__historyNote mesh__D001060 Apomorphine %28%1966-1968%29%
% 222.37/222.53  |- skos__scopeNote mesh__D001060
% 222.37/222.53       Dibenzoquinolines derived in plants from %28%S%29%-reticuline %28%BENZYLISOQUINOLINES%29%.%A%    
% 222.37/222.53  |- mesh__recordOriginator mesh__D001060 NLM
% 222.37/222.53  |- mesh__historyNote mesh__D001060 69   
% 222.37/222.53  |- mesh__dateCreated mesh__D001060 1999-01-01
% 222.37/222.53  |- skos__broader mesh__D001060smesh__D000470
% 222.37/222.53  |- mesh__recordAuthorizer mesh__D001060 sjn
% 222.37/222.53  |- mesh__dateEstablished mesh__D001060 1969-01-01
% 222.37/222.53  |- skos__broader mesh__D001060smesh__D006576
% 222.37/222.53  |- mesh__recordMaintainer mesh__D001060 ssb
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D001060 2006
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D001060 2004
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D014786 2005
% 222.37/222.53  |- skos__hiddenLabel mesh__D014786 Metamorphopsias
% 222.37/222.53  |- skos__hiddenLabel mesh__D014786 Hemeralopias
% 222.37/222.53  |- mesh__recordMaintainer mesh__D014786 ags
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D014786 2002
% 222.37/222.53  |- skos__broader mesh__D014786smesh__D005128
% 222.37/222.53  |- skos__scopeNote mesh__D014786
% 222.37/222.53       Visual impairments limiting one or more of the basic functions of the eye: visual acuity, dark adaptation, color vision, or peripheral vision. These may result from EYE DISEASES; OPTIC NERVE DISEASES; VISUAL PATHWAY diseases; OCCIPITAL LOBE diseases; OCULAR MOTILITY DISORDERS; and other conditions. Visual disability refers to inability of the individual to perform specific visual tasks, such as reading, writing, orientation, or traveling unaided. %28%From Newell, Ophthalmology: Principles and Concepts, 7th ed, p132%29%%A%    
% 222.37/222.53  |- mesh__recordOriginator mesh__D014786 NLM
% 222.37/222.53  |- skos__broader mesh__D014786smesh__D012678
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D014786 2004
% 222.37/222.53  |- mesh__dateRevised mesh__D014786 1999-12-08
% 222.37/222.53  |- skos__prefLabel mesh__D014786 Vision Disorders
% 222.37/222.53  |- rdf__type mesh__D014786sskos__Concept
% 222.37/222.53  |- skos__annotation mesh__D014786
% 222.37/222.53       disord of vision, not dis of the eye %28% = EYE DISEASES%29%; GEN or unspecified: prefer specifics; /diag: consider also DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL%A%  
% 222.37/222.53  |- mesh__publicMeSHNote mesh__D014786
% 222.37/222.53       1967; for HEMERALOPIA see HEMERALOPIA 1963-1989   
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D014786 2001
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D014786 2000A
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D014786 2003
% 222.37/222.53  |- skos__hiddenLabel mesh__D014786 Macropsias
% 222.37/222.53  |- mesh__historyNote mesh__D014786 1967   
% 222.37/222.53  |- mesh__dateCreated mesh__D014786 1999-01-01
% 222.37/222.53  |- skos__hiddenLabel mesh__D014786 Blindness, Day
% 222.37/222.53  |- mesh__dateEstablished mesh__D014786 1967-01-01
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D014786 2000
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D014786 2006
% 222.37/222.53  |- mesh__recordAuthorizer mesh__D014786 ags
% 222.37/222.53  |- skos__hiddenLabel mesh__D014786 Micropsias
% 222.37/222.53  |- skos__historyNote mesh__D014786 Vision %28%1966%29%
% 222.37/222.53  |- skos__altLabel mesh__D014786 Day Blindness
% 222.37/222.53  |- skos__hiddenLabel mesh__D014786 Vision Disorder
% 222.37/222.53  |- skos__related mesh__D014786smesh__D019987
% 222.37/222.53  |- skos__prefLabel mesh__D008749 Methyldimethylaminoazobenzene
% 222.37/222.53  |- skos__historyNote mesh__D008749 Methane %28%1973-1974%29%
% 222.37/222.53  |- mesh__dateRevised mesh__D008749 2000-06-22
% 222.37/222.53  |- skos__hiddenLabel mesh__D008749 3%27% Methyl 4 dimethylaminoazobenzene
% 222.37/222.53  |- mesh__publicMeSHNote mesh__D008749
% 222.37/222.53       91; was see under DIMETHYLAMINOAZOBENZENE 1975-90   
% 222.37/222.53  |- skos__annotation mesh__D008749 D25-26 qualif; DF: note short X ref   
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D008749 2003
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D008749 2006
% 222.37/222.53  |- mesh__recordAuthorizer mesh__D008749 sjn
% 222.37/222.53  |- mesh__recordOriginator mesh__D008749 NLM
% 222.37/222.53  |- skos__historyNote mesh__D008749
% 222.37/222.53       Dimethylaminoazobenzene %28%1972-1974%29%
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D008749 2004
% 222.37/222.53  |- skos__altLabel mesh__D008749 MeDAB
% 222.37/222.53  |- rdf__type mesh__D008749sskos__Concept
% 222.37/222.53  |- skos__broader mesh__D008749smesh__D004124
% 222.37/222.53  |- skos__altLabel mesh__D008749 3%27%-Methyl-4-dimethylaminoazobenzene
% 222.37/222.53  |- mesh__recordMaintainer mesh__D008749 CCR
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D008749 2001
% 222.37/222.53  |- skos__scopeNote mesh__D008749 A very potent liver carcinogen.     
% 222.37/222.53  |- skos__altLabel mesh__D008749 Dimethyl-p-%28%m-tolylazo%29%aniline
% 222.37/222.53  |- mesh__historyNote mesh__D008749
% 222.37/222.53       91%28%75%29%; was see under DIMETHYLAMINOAZOBENZENE 1975-90   
% 222.37/222.53  |- mesh__dateEstablished mesh__D008749 1991-01-01
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D008749 2002
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D008749 2005
% 222.37/222.53  |- mesh__dateCreated mesh__D008749 1974-11-19
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D000766 2004
% 222.37/222.53  |- skos__broader mesh__D000766smesh__D000758
% 222.37/222.53  |- mesh__onlineNote mesh__D000766
% 222.37/222.53       use ANESTHESIA, DENTAL to search ANESTHESIA, INTRALIGAMENTAL, DENTAL 1984-92%A%  
% 222.37/222.53  |- mesh__dateCreated mesh__D000766 1999-01-01
% 222.37/222.53  |- mesh__activeMeSHYear mesh__D000766 2005
% 222.37/222.53  |- mesh__publicMeSHNote mesh__D000766
% 222.37/222.53       ANESTHESIA, INTRALIGAMENTAL, DENTAL was see ANESTHESIA, DENTAL 1984-92%A%  
% 222.37/222.53  |- mesh__dateRevised mesh__D000766 1993-02-20
% 222.37/222.54  |- skos__broader mesh__D000766smesh__D003813
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000766 2003
% 222.37/222.54  |- skos__prefLabel mesh__D000766 Anesthesia, Dental
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000766 2002
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000766 1995
% 222.37/222.54  |- mesh__historyNote mesh__D000766
% 222.37/222.54       ANESTHESIA, INTRALIGAMENTAL, DENTAL was see ANESTHESIA, DENTAL 1984-92%A%  
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000766 1999
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000766 1994
% 222.37/222.54  |- rdf__type mesh__D000766sskos__Concept
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000766 1997
% 222.37/222.54  |- skos__altLabel mesh__D000766 Dental Anesthesia
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000766 1998
% 222.37/222.54  |- mesh__recordAuthorizer mesh__D000766 NLM
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000766 1996
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000766 2001
% 222.37/222.54  |- mesh__recordMaintainer mesh__D000766 PLS
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000766 2006
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000766 2000
% 222.37/222.54  |- skos__annotation mesh__D000766
% 222.37/222.54       /educ: coord IM %28%no qualif%29% with ANESTHESIOLOGY /educ %28%NIM%29%%A%  
% 222.37/222.54  |- mesh__recordOriginator mesh__D000766 NLM
% 222.37/222.54  |- mesh__dateRevised mesh__D019471 1999-11-03
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D019471 2006
% 222.37/222.54  |- mesh__dateCreated mesh__D019471 1996-06-10
% 222.37/222.54  |- skos__hiddenLabel mesh__D019471 Elementary Particle Interaction
% 222.37/222.54  |- skos__altLabel mesh__D019471 Particle Interactions, Elementary
% 222.37/222.54  |- rdf__type mesh__D019471sskos__Concept
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D019471 2005
% 222.37/222.54  |- mesh__recordMaintainer mesh__D019471 nns
% 222.37/222.54  |- skos__hiddenLabel mesh__D019471 Particle Interaction, Elementary
% 222.37/222.54  |- skos__scopeNote mesh__D019471
% 222.37/222.54       The interactions of particles responsible for their scattering and transformations %28%decays and reactions%29%. Because of interactions, an isolated particle may decay into other particles. Two particles passing near each other may transform, perhaps into the same particles but with changed momenta %28%elastic scattering%29% or into other particles %28%inelastic scattering%29%. Interactions fall into three groups: strong, electromagnetic, and weak. %28%From McGraw-Hill Encyclopedia of Science %26% Technology, 7th ed%29%%A%    
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D019471 2002
% 222.37/222.54  |- skos__hiddenLabel mesh__D019471 Interaction, Elementary Particle
% 222.37/222.54  |- mesh__dateEstablished mesh__D019471 1997-01-01
% 222.37/222.54  |- mesh__recordOriginator mesh__D019471 JLS
% 222.37/222.54  |- mesh__publicMeSHNote mesh__D019471 97   
% 222.37/222.54  |- mesh__recordAuthorizer mesh__D019471 sjn
% 222.37/222.54  |- skos__prefLabel mesh__D019471 Elementary Particle Interactions
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D019471 2004
% 222.37/222.54  |- skos__hiddenLabel mesh__D019471 Interactions, Elementary Particle
% 222.37/222.54  |- skos__annotation mesh__D019471
% 222.37/222.54       a concept in nuclear physics; sub-atomic particles only   
% 222.37/222.54  |- mesh__historyNote mesh__D019471 97   
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D019471 2001
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D019471 2003
% 222.37/222.54  |- skos__broader mesh__D019471smesh__D009686
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D019471 2000
% 222.37/222.54  |- skos__prefLabel mesh__D033142 Genetic Services
% 222.37/222.54  |- skos__related mesh__D033142smesh__D011296
% 222.37/222.54  |- skos__broader mesh__D033142smesh__D006296
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D033142 2004
% 222.37/222.54  |- mesh__historyNote mesh__D033142
% 222.37/222.54       2003; use GENETIC COUNSELING 2002, use REPRODUCTION TECHNIQUES 1999-2001%A%  
% 222.37/222.54  |- rdf__type mesh__D033142sskos__Concept
% 222.37/222.54  |- mesh__publicMeSHNote mesh__D033142
% 222.37/222.54       2003; see GENETIC COUNSELING 2002, see REPRODUCTION TECHNIQUES 1999-2001%A%  
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D033142 2003
% 222.37/222.54  |- mesh__dateCreated mesh__D033142 2002-07-03
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D033142 2006
% 222.37/222.54  |- skos__broader mesh__D033142smesh__D005826
% 222.37/222.54  |- skos__hiddenLabel mesh__D033142 Service, Genetic
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D033142 2005
% 222.37/222.54  |- skos__scopeNote mesh__D033142
% 222.37/222.54       Organized services to provide diagnosis, treatment, and prevention of genetic disorders.%A%    
% 222.37/222.54  |- skos__hiddenLabel mesh__D033142 Genetic Service
% 222.37/222.54  |- skos__related mesh__D033142smesh__D015316
% 222.37/222.54  |- skos__historyNote mesh__D033142 Genetics, Medical %28%1978-2002%29%
% 222.37/222.54  |- skos__historyNote mesh__D033142 Genetics %28%1978-2002%29%
% 222.37/222.54  |- skos__altLabel mesh__D033142 Services, Genetic
% 222.37/222.54  |- mesh__dateEstablished mesh__D033142 2003-01-01
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D005451 2001
% 222.37/222.54  |- mesh__dateCreated mesh__D005451 1999-01-01
% 222.37/222.54  |- skos__altLabel mesh__D005451 Photography, Fundus Fluorescence
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D005451 1998
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D005451 2000
% 222.37/222.54  |- rdf__type mesh__D005451sskos__Concept
% 222.37/222.54  |- skos__scopeNote mesh__D005451
% 222.37/222.54       Visualization of a vascular system after intravenous injection of a fluorescein solution. The images may be photographed or televised. It is used especially in studying the retinal and uveal vasculature.%A%    
% 222.37/222.54  |- skos__historyNote mesh__D005451 Fluoresceins %28%1966-1972%29%
% 222.37/222.54  |- skos__prefLabel mesh__D005451 Fluorescein Angiography
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D005451 2006
% 222.37/222.54  |- mesh__dateRevised mesh__D005451 1997-06-20
% 222.37/222.54  |- mesh__recordMaintainer mesh__D005451 PXP
% 222.37/222.54  |- mesh__recordAuthorizer mesh__D005451 SJN
% 222.37/222.54  |- mesh__dateEstablished mesh__D005451 1973-01-01
% 222.37/222.54  |- mesh__recordOriginator mesh__D005451 NLM
% 222.37/222.54  |- mesh__historyNote mesh__D005451
% 222.37/222.54       79; was FLUORESCENCE ANGIOGRAPHY 1973-78; FUNDUS FLUORESCENCE PHOTOGRAPHY was see under FLUORESCENCE ANGIOGRAPHY 1973-78%A%  
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D005451 2002
% 222.37/222.54  |- skos__annotation mesh__D005451
% 222.37/222.54       /drug eff /rad eff permitted; coord disease with /diag, not /radiogr since this is not a radiogr technique; DF: FLUORESCEIN ANGIOGR%A%  
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D005451 2004
% 222.37/222.54  |- skos__altLabel mesh__D005451 Angiography, Fluorescein
% 222.37/222.54  |- skos__altLabel mesh__D005451 Angiography, Fluorescence
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D005451 2005
% 222.37/222.54  |- mesh__publicMeSHNote mesh__D005451
% 222.37/222.54       79; was FLUORESCENCE ANGIOGRAPHY 1973-78   
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D005451 2003
% 222.37/222.54  |- skos__altLabel mesh__D005451 Fundus Fluorescence Photography
% 222.37/222.54  |- skos__historyNote mesh__D005451 Photography %28%1966-1972%29%
% 222.37/222.54  |- skos__broader mesh__D005451smesh__D000792
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D005451 1999
% 222.37/222.54  |- skos__broader mesh__D005451smesh__D003941
% 222.37/222.54  |- mesh__onlineNote mesh__D005451
% 222.37/222.54       use FLUORESCEIN ANGIOGRAPHY to search FLUORESCENCE ANGIOGRAPHY %26% FUNDUS FLUORESCENCE ANGIOGRAPHY 1973-78%A%  
% 222.37/222.54  |- mesh__historyNote mesh__D046868 2005   
% 222.37/222.54  |- rdf__type mesh__D046868sskos__Concept
% 222.37/222.54  |- mesh__recordAuthorizer mesh__D046868 sjn
% 222.37/222.54  |- skos__prefLabel mesh__D046868 Anabaena cylindrica
% 222.37/222.54  |- mesh__dateCreated mesh__D046868 2004-07-07
% 222.37/222.54  |- skos__scopeNote mesh__D046868
% 222.37/222.54       A species in the genus ANABAENA whose trichomes are composed of cylindrical cells.%A%    
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D046868 2006
% 222.37/222.54  |- mesh__recordOriginator mesh__D046868 ags
% 222.37/222.54  |- mesh__publicMeSHNote mesh__D046868 2005   
% 222.37/222.54  |- skos__broader mesh__D046868smesh__D017033
% 222.37/222.54  |- mesh__dateRevised mesh__D046868 2005-06-30
% 222.37/222.54  |- mesh__dateEstablished mesh__D046868 2005-01-01
% 222.37/222.54  |- skos__historyNote mesh__D046868 Anabaena %28%1992-2004%29%
% 222.37/222.54  |- mesh__recordMaintainer mesh__D046868 SYSTEM
% 222.37/222.54  |- skos__scopeNote mesh__D010396
% 222.37/222.54       3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson%27%s disease.%A%    
% 222.37/222.54  |- mesh__historyNote mesh__D010396 64%28%63%29%   
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D010396 2006
% 222.37/222.54  |- mesh__publicMeSHNote mesh__D010396 64   
% 222.37/222.54  |- skos__altLabel mesh__D010396 D-Penicillamine
% 222.37/222.54  |- skos__hiddenLabel mesh__D010396 D 3 Mercaptovaline
% 222.37/222.54  |- mesh__recordOriginator mesh__D010396 NLM
% 222.37/222.54  |- skos__altLabel mesh__D010396 Mercaptovaline
% 222.37/222.54  |- skos__altLabel mesh__D010396 Dimethylcysteine
% 222.37/222.54  |- skos__altLabel mesh__D010396 D-3-Mercaptovaline
% 222.37/222.54  |- mesh__dateCreated mesh__D010396 1999-01-01
% 222.37/222.54  |- skos__hiddenLabel mesh__D010396 beta,beta Dimethylcysteine
% 222.37/222.54  |- mesh__recordMaintainer mesh__D010396 ssb
% 222.37/222.54  |- skos__prefLabel mesh__D010396 Penicillamine
% 222.37/222.54  |- skos__hiddenLabel mesh__D010396 Penicillaminate, Copper
% 222.37/222.54  |- skos__annotation mesh__D010396
% 222.37/222.54       degradation product of the penicillin antibiotics   
% 222.37/222.54  |- mesh__dateEstablished mesh__D010396 1964-01-01
% 222.37/222.54  |- mesh__recordAuthorizer mesh__D010396 sjn
% 222.37/222.54  |- rdf__type mesh__D010396sskos__Concept
% 222.37/222.54  |- skos__altLabel mesh__D010396 beta,beta-Dimethylcysteine
% 222.37/222.54  |- mesh__dateRevised mesh__D010396 2005-06-30
% 222.37/222.54  |- skos__hiddenLabel mesh__D010396 D Penicillamine
% 222.37/222.54  |- skos__broader mesh__D010396smesh__D000603
% 222.37/222.54  |- skos__altLabel mesh__D004359 Combination Drug Therapy
% 222.37/222.54  |- rdf__type mesh__D004359sskos__Concept
% 222.37/222.54  |- mesh__recordOriginator mesh__D004359 NLM
% 222.37/222.54  |- skos__prefLabel mesh__D004359 Drug Therapy, Combination
% 222.37/222.54  |- skos__hiddenLabel mesh__D004359 Polychemotherapies
% 222.37/222.54  |- mesh__publicMeSHNote mesh__D004359 74   
% 222.37/222.54  |- skos__annotation mesh__D004359
% 222.37/222.54       IM when general; NIM when with specific drugs; differentiate from DRUG COMBINATIONS which is single preparation of multiple drugs; note X ref POLYCHEMOTHERAPY: do not confuse with POLYPHARMACY which is available for the use of multiple drugs administered to the same patient%A%  
% 222.37/222.54  |- skos__hiddenLabel mesh__D004359 Therapies, Combination Drug
% 222.37/222.54  |- skos__altLabel mesh__D004359 Chemotherapy, Combination
% 222.37/222.54  |- mesh__historyNote mesh__D004359 74   
% 222.37/222.54  |- skos__hiddenLabel mesh__D004359 Chemotherapies, Combination
% 222.37/222.54  |- mesh__dateCreated mesh__D004359 1999-01-01
% 222.37/222.54  |- skos__related mesh__D004359smesh__D004357
% 222.37/222.54  |- skos__broader mesh__D004359smesh__D004358
% 222.37/222.54  |- skos__hiddenLabel mesh__D004359 Combination Chemotherapies
% 222.37/222.54  |- skos__hiddenLabel mesh__D004359 Drug Therapies, Combination
% 222.37/222.54  |- skos__hiddenLabel mesh__D004359 Combination Drug Therapies
% 222.37/222.54  |- skos__altLabel mesh__D004359 Therapy, Combination Drug
% 222.37/222.54  |- mesh__recordMaintainer mesh__D004359 ssb
% 222.37/222.54  |- mesh__dateEstablished mesh__D004359 1974-01-01
% 222.37/222.54  |- mesh__recordAuthorizer mesh__D004359 sjn
% 222.37/222.54  |- skos__altLabel mesh__D004359 Combination Chemotherapy
% 222.37/222.54  |- skos__related mesh__D004359smesh__D000971
% 222.37/222.54  |- skos__scopeNote mesh__D004359
% 222.37/222.54       Therapy with two or more separate preparations given for a combined effect.%A%    
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D004359 2006
% 222.37/222.54  |- skos__altLabel mesh__D004359 Polychemotherapy
% 222.37/222.54  |- skos__related mesh__D004359smesh__D004338
% 222.37/222.54  |- mesh__dateRevised mesh__D004359 2005-06-30
% 222.37/222.54  |- skos__scopeNote mesh__D015081
% 222.37/222.54       A naphthalene derivative with carcinogenic action.     
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D015081 2006
% 222.37/222.54  |- mesh__dateRevised mesh__D015081 2000-06-22
% 222.37/222.54  |- skos__hiddenLabel mesh__D015081 2 Aminonaphthalene
% 222.37/222.54  |- skos__altLabel mesh__D015081 beta-Naphthylamine
% 222.37/222.54  |- mesh__dateCreated mesh__D015081 1974-11-11
% 222.37/222.54  |- skos__broader mesh__D015081smesh__D009281
% 222.37/222.54  |- mesh__dateEstablished mesh__D015081 1991-01-01
% 222.37/222.54  |- rdf__type mesh__D015081sskos__Concept
% 222.37/222.54  |- skos__historyNote mesh__D015081 Amines %28%1971-1974%29%
% 222.37/222.54  |- skos__hiddenLabel mesh__D015081 beta Naphthylamine
% 222.37/222.54  |- skos__prefLabel mesh__D015081 2-Naphthylamine
% 222.37/222.54  |- mesh__recordAuthorizer mesh__D015081 sjn
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D015081 2003
% 222.37/222.54  |- mesh__recordMaintainer mesh__D015081 CCR
% 222.37/222.54  |- skos__hiddenLabel mesh__D015081 2 Naphthylamine
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D015081 2001
% 222.37/222.54  |- skos__historyNote mesh__D015081 Naphthalenes %28%1971-1974%29%
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D015081 2004
% 222.37/222.54  |- skos__broader mesh__D015081smesh__D000588
% 222.37/222.54  |- mesh__recordOriginator mesh__D015081 NLM
% 222.37/222.54  |- mesh__publicMeSHNote mesh__D015081
% 222.37/222.54       91; was see under NAPHTHALENES 1975-90   
% 222.37/222.54  |- mesh__historyNote mesh__D015081
% 222.37/222.54       91%28%75%29%; was see under NAPHTHALENES 1975-90   
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D015081 2002
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D015081 2005
% 222.37/222.54  |- skos__annotation mesh__D015081 D25-26 qualif   
% 222.37/222.54  |- skos__altLabel mesh__D015081 2-Aminonaphthalene
% 222.37/222.54  |- mesh__publicMeSHNote mesh__D009842 73   
% 222.37/222.54  |- mesh__recordMaintainer mesh__D009842 TGC
% 222.37/222.54  |- skos__prefLabel mesh__D009842 Oligopeptides
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D009842 1999
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D009842 2006
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D009842 2001
% 222.37/222.54  |- mesh__recordOriginator mesh__D009842 NLM
% 222.37/222.54  |- mesh__recordAuthorizer mesh__D009842 PLS
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D009842 1998
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D009842 2005
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D009842 1997
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D009842 2004
% 222.37/222.54  |- mesh__historyNote mesh__D009842 73   
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D009842 2000
% 222.37/222.54  |- rdf__type mesh__D009842sskos__Concept
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D009842 1996
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D009842 2003
% 222.37/222.54  |- skos__historyNote mesh__D009842 Peptides %28%1966-1972%29%
% 222.37/222.54  |- skos__broader mesh__D009842smesh__D010455
% 222.37/222.54  |- skos__scopeNote mesh__D009842
% 222.37/222.54       Peptides composed of between two and twelve amino acids.%A%    
% 222.37/222.54  |- mesh__dateRevised mesh__D009842 1995-06-08
% 222.37/222.54  |- mesh__dateCreated mesh__D009842 1999-01-01
% 222.37/222.54  |- skos__annotation mesh__D009842
% 222.37/222.54       2-12 amino acids %28%includes DIPEPTIDES, tripeptides, tetrapeptides, pentapeptides, etc.%29%; GEN; prefer specifics; conformation: coord OLIGOPEPTIDES or specific peptide %28%IM%29% + PROTEIN CONFORMATION %28%NIM%29%%A%  
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D009842 2002
% 222.37/222.54  |- mesh__dateEstablished mesh__D009842 1973-01-01
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D009044 2005
% 222.37/222.54  |- mesh__recordMaintainer mesh__D009044 MSR
% 222.37/222.54  |- mesh__dateCreated mesh__D009044 1999-01-01
% 222.37/222.54  |- rdf__type mesh__D009044sskos__Concept
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D009044 2002
% 222.37/222.54  |- mesh__recordOriginator mesh__D009044 NLM
% 222.37/222.54  |- mesh__publicMeSHNote mesh__D009044 71   
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D009044 2001
% 222.37/222.54  |- skos__hiddenLabel mesh__D009044 Cortex, Motor
% 222.37/222.54  |- mesh__recordAuthorizer mesh__D009044 SJN
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D009044 2004
% 222.37/222.54  |- mesh__dateEstablished mesh__D009044 1971-01-01
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D009044 2000
% 222.37/222.54  |- mesh__dateRevised mesh__D009044 1998-06-10
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D009044 2003
% 222.37/222.54  |- mesh__historyNote mesh__D009044 71   
% 222.37/222.54  |- skos__prefLabel mesh__D009044 Motor Cortex
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D009044 1999
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D009044 2006
% 222.37/222.54  |- skos__broader mesh__D009044smesh__D005625
% 222.37/222.54  |- skos__historyNote mesh__D009044 Cerebral Cortex %28%1966-1970%29%
% 222.37/222.54  |- skos__scopeNote mesh__D009044
% 222.37/222.54       Area of the frontal lobe concerned with primary motor control. It lies anterior to the central sulcus.%A%    
% 222.37/222.54  |- mesh__recordAuthorizer mesh__D001061 SJN
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D001061 2003
% 222.37/222.54  |- skos__altLabel mesh__D001061 Appalachia
% 222.37/222.54  |- mesh__dateEstablished mesh__D001061 1975-01-01
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D001061 1998
% 222.37/222.54  |- mesh__dateCreated mesh__D001061 1999-01-01
% 222.37/222.54  |- mesh__historyNote mesh__D001061 75   
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D001061 2001
% 222.37/222.54  |- skos__broader mesh__D001061smesh__D014481
% 222.37/222.54  |- skos__scopeNote mesh__D001061
% 222.37/222.54       A geographical area of the United States with no definite boundaries but comprising northeastern Alabama, northwestern Georgia, northwestern South Carolina, western North Carolina, eastern Kentucky, eastern Tennessee, western Virginia, West Virginia, western Maryland, southwestern Pennsylvania, southern Ohio, and southern New York.%A%    
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D001061 2000
% 222.37/222.54  |- mesh__recordOriginator mesh__D001061 NLM
% 222.37/222.54  |- mesh__recordMaintainer mesh__D001061 PXP
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D001061 2006
% 222.37/222.54  |- skos__annotation mesh__D001061
% 222.37/222.54       includes northeast Ala, northwest Ga, northwest S Carolina, western N Carolina, eastern Ky, eastern Tenn, western Va, West Virginia, western Md, southwest Pa, south Ohio, south NY; specify as needed but use APPALACHIAN REGION when text uses the term %26% when the region is the intent of the author      CATALOG: use for 4 or more states%A%  
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D001061 2004
% 222.37/222.54  |- skos__prefLabel mesh__D001061 Appalachian Region
% 222.37/222.54  |- mesh__dateRevised mesh__D001061 1997-06-20
% 222.37/222.54  |- rdf__type mesh__D001061sskos__Concept
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D001061 2005
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D001061 2002
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D001061 1999
% 222.37/222.54  |- mesh__dateRevised mesh__D014787 1997-06-20
% 222.37/222.54  |- mesh__recordMaintainer mesh__D014787 PXP
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D014787 2004
% 222.37/222.54  |- rdf__type mesh__D014787sskos__Concept
% 222.37/222.54  |- mesh__recordAuthorizer mesh__D014787 SJN
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D014787 2002
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D014787 1999
% 222.37/222.54  |- skos__annotation mesh__D014787
% 222.37/222.54       for an individual: differentiate from VISION SCREENING on a given population%A%  
% 222.37/222.54  |- mesh__recordOriginator mesh__D014787 NLM
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D014787 2003
% 222.37/222.54  |- mesh__dateCreated mesh__D014787 1999-01-01
% 222.37/222.54  |- skos__hiddenLabel mesh__D014787 Tests, Vision
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D014787 1998
% 222.37/222.54  |- skos__hiddenLabel mesh__D014787 Vision Test
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D014787 2006
% 222.37/222.54  |- skos__prefLabel mesh__D014787 Vision Tests
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D014787 2001
% 222.37/222.54  |- skos__broader mesh__D014787smesh__D003941
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D014787 2005
% 222.37/222.54  |- skos__hiddenLabel mesh__D014787 Test, Vision
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D014787 2000
% 222.37/222.54  |- mesh__publicMeSHNote mesh__D033941 2003   
% 222.37/222.54  |- mesh__recordMaintainer mesh__D033941 SYSTEM
% 222.37/222.54  |- mesh__dateCreated mesh__D033941 2002-07-03
% 222.37/222.54  |- mesh__dateRevised mesh__D033941 2005-06-30
% 222.37/222.54  |- mesh__historyNote mesh__D033941 2003   
% 222.37/222.54  |- skos__hiddenLabel mesh__D033941 Light Chains, Clathrin
% 222.37/222.54  |- skos__altLabel mesh__D033941 Clathrin Light Chain
% 222.37/222.54  |- mesh__recordOriginator mesh__D033941 jmp
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D033941 2006
% 222.37/222.54  |- skos__historyNote mesh__D033941 Clathrin %28%1986-2002%29%
% 222.37/222.54  |- mesh__dateEstablished mesh__D033941 2003-01-01
% 222.37/222.54  |- skos__scopeNote mesh__D033941 The light chain subunits of clathrin.     
% 222.37/222.54  |- mesh__recordAuthorizer mesh__D033941 sjn
% 222.37/222.54  |- rdf__type mesh__D033941sskos__Concept
% 222.37/222.54  |- skos__broader mesh__D033941smesh__D002966
% 222.37/222.54  |- skos__prefLabel mesh__D033941 Clathrin Light Chains
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000767 2003
% 222.37/222.54  |- skos__historyNote mesh__D000767
% 222.37/222.54       Anesthesia, Obstetrical %28%1966-1970%29%
% 222.37/222.54  |- skos__hiddenLabel mesh__D000767 Peridural Anesthesia
% 222.37/222.54  |- mesh__recordMaintainer mesh__D000767 PLS
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000767 2000
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000767 1995
% 222.37/222.54  |- skos__hiddenLabel mesh__D000767 Extradural Anesthesia
% 222.37/222.54  |- skos__prefLabel mesh__D000767 Anesthesia, Epidural
% 222.37/222.54  |- mesh__dateEstablished mesh__D000767 1972-01-01
% 222.37/222.54  |- mesh__recordOriginator mesh__D000767 NLM
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000767 1999
% 222.37/222.54  |- mesh__dateRevised mesh__D000767 1993-02-20
% 222.37/222.54  |- mesh__publicMeSHNote mesh__D000767 72   
% 222.37/222.54  |- rdf__type mesh__D000767sskos__Concept
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000767 1994
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000767 1997
% 222.37/222.54  |- mesh__historyNote mesh__D000767 72%28%71%29%   
% 222.37/222.54  |- skos__altLabel mesh__D000767 Anesthesia, Peridural
% 222.37/222.54  |- skos__broader mesh__D000767smesh__D000765
% 222.37/222.54  |- skos__altLabel mesh__D000767 Anesthesia, Extradural
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000767 1998
% 222.37/222.54  |- mesh__recordAuthorizer mesh__D000767 NLM
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000767 2002
% 222.37/222.54  |- skos__altLabel mesh__D000767 Epidural Anesthesia
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000767 1996
% 222.37/222.54  |- skos__historyNote mesh__D000767 Anesthesia, Conduction %28%1966-1970%29%
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000767 2006
% 222.37/222.54  |- skos__annotation mesh__D000767
% 222.37/222.54       /educ: coord IM %28%no qualif%29% with ANESTHESIOLOGY /educ %28%NIM%29%%A%  
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000767 2004
% 222.37/222.54  |- mesh__dateCreated mesh__D000767 1999-01-01
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000767 2005
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D000767 2001
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D019472 2001
% 222.37/222.54  |- rdf__type mesh__D019472sskos__Concept
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D019472 1997
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D019472 2005
% 222.37/222.54  |- skos__broader mesh__D019472smesh__D019458
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D019472 2000
% 222.37/222.54  |- mesh__dateCreated mesh__D019472 1996-06-10
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D019472 2004
% 222.37/222.54  |- skos__hiddenLabel mesh__D019472 Coverage, Universal
% 222.37/222.54  |- skos__prefLabel mesh__D019472 Universal Coverage
% 222.37/222.54  |- skos__annotation mesh__D019472
% 222.37/222.54       restrict to health insurance; specify geog if pertinent   
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D019472 1999
% 222.37/222.54  |- mesh__historyNote mesh__D019472 97   
% 222.37/222.54  |- skos__scopeNote mesh__D019472
% 222.37/222.54       Health insurance coverage for all persons in a state or country, rather than for some subset of the population. It may extend to the unemployed as well as to the employed; to aliens as well as to citizens; for pre-existing conditions as well as for current illnesses; for mental as well as for physical conditions.%A%    
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D019472 2002
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D019472 2003
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D019472 1998
% 222.37/222.54  |- mesh__dateEstablished mesh__D019472 1997-01-01
% 222.37/222.54  |- mesh__publicMeSHNote mesh__D019472 97   
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D019472 2006
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D005452 2006
% 222.37/222.54  |- mesh__recordMaintainer mesh__D005452 ssb
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D005452 2005
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D005452 2004
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D005452 2003
% 222.37/222.54  |- skos__scopeNote mesh__D005452
% 222.37/222.54       A family of spiro%28%isobenzofuran-1%28%3H%29%,9%27%-%28%9H%29%xanthen%29%-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.%A%    
% 222.37/222.54  |- mesh__recordAuthorizer mesh__D005452 sjn
% 222.37/222.54  |- skos__prefLabel mesh__D005452 Fluoresceins
% 222.37/222.54  |- skos__broader mesh__D005452smesh__D014966
% 222.37/222.54  |- mesh__dateCreated mesh__D005452 1999-01-01
% 222.37/222.54  |- mesh__dateRevised mesh__D005452 2002-07-03
% 222.37/222.54  |- rdf__type mesh__D005452sskos__Concept
% 222.37/222.54  |- skos__broader mesh__D005452smesh__D013141
% 222.37/222.54  |- mesh__recordOriginator mesh__D005452 NLM
% 222.37/222.54  |- skos__historyNote mesh__D046869 Cyanobacteria %28%1969-1991%29%
% 222.37/222.54  |- mesh__dateRevised mesh__D046869 2005-06-30
% 222.37/222.54  |- mesh__publicMeSHNote mesh__D046869 2005   
% 222.37/222.54  |- mesh__historyNote mesh__D046869 2005   
% 222.37/222.54  |- mesh__recordAuthorizer mesh__D046869 sjn
% 222.37/222.54  |- skos__prefLabel mesh__D046869 Anabaena flos-aquae
% 222.37/222.54  |- rdf__type mesh__D046869sskos__Concept
% 222.37/222.54  |- skos__historyNote mesh__D046869 Anabaena %28%1991-2004%29%
% 222.37/222.54  |- skos__historyNote mesh__D046869 Algae %28%1965-1968%29%
% 222.37/222.54  |- mesh__recordOriginator mesh__D046869 ags
% 222.37/222.54  |- mesh__dateCreated mesh__D046869 2004-07-07
% 222.37/222.54  |- mesh__recordMaintainer mesh__D046869 SYSTEM
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D046869 2006
% 222.37/222.54  |- skos__broader mesh__D046869smesh__D017033
% 222.37/222.54  |- skos__scopeNote mesh__D046869
% 222.37/222.54       A species in the genus ANABAENA containing gas vacuoles that gives buoyancy to the organism. It can form extensive blooms in FRESH WATER and is responsible for acute poisonings of various animals.%A%    
% 222.37/222.54  |- mesh__dateEstablished mesh__D046869 2005-01-01
% 222.37/222.54  |- skos__scopeNote mesh__D010397
% 222.37/222.54       A building block of penicillin, devoid of significant antibacterial activity. %28%From Merck Index, 11th ed%29%%A%    
% 222.37/222.54  |- skos__historyNote mesh__D010397 Thiazoles %28%1966-1970%29%
% 222.37/222.54  |- skos__broader mesh__D010397smesh__D010406
% 222.37/222.54  |- mesh__dateCreated mesh__D010397 1999-01-01
% 222.37/222.54  |- mesh__onlineNote mesh__D010397
% 222.37/222.54       use PENICILLANIC ACID to search PENICILLANIC ACIDS 1975-93%A%  
% 222.37/222.54  |- mesh__dateRevised mesh__D010397 2004-07-07
% 222.37/222.54  |- mesh__recordOriginator mesh__D010397 NLM
% 222.37/222.54  |- skos__prefLabel mesh__D010397 Penicillanic Acid
% 222.37/222.54  |- rdf__type mesh__D010397sskos__Concept
% 222.37/222.54  |- skos__historyNote mesh__D010397 Penicillins %28%1966-1970%29%
% 222.37/222.54  |- mesh__dateEstablished mesh__D010397 1973-01-01
% 222.37/222.54  |- mesh__publicMeSHNote mesh__D010397
% 222.37/222.54       94,73-74; was PENICILLANIC ACIDS 1975-93   
% 222.37/222.54  |- mesh__historyNote mesh__D010397
% 222.37/222.54       94,73-74%28%71-72%29%; was PENICILLANIC ACIDS 1975-93   
% 222.37/222.54  |- mesh__recordMaintainer mesh__D010397 ssb
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D010397 2005
% 222.37/222.54  |- skos__annotation mesh__D010397 do not confuse with PENICILLIC ACID   
% 222.37/222.54  |- skos__hiddenLabel mesh__D010397 Acid, Penicillanic
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D010397 2006
% 222.37/222.54  |- mesh__recordAuthorizer mesh__D010397 sjn
% 222.37/222.54  |- skos__scopeNote mesh__D015082
% 222.37/222.54       A reagent used for the determination of iron.     
% 222.37/222.54  |- skos__altLabel mesh__D015082 alpha,alpha-Dipyridyl
% 222.37/222.54  |- mesh__dateEstablished mesh__D015082 1991-01-01
% 222.37/222.54  |- rdf__type mesh__D015082sskos__Concept
% 222.37/222.54  |- skos__altLabel mesh__D015082 2,2-Bipyridine
% 222.37/222.54  |- skos__hiddenLabel mesh__D015082 alpha,alpha Dipyridyl
% 222.37/222.54  |- mesh__dateRevised mesh__D015082 2002-07-02
% 222.37/222.54  |- skos__hiddenLabel mesh__D015082 Dipyridyl, 2,2%27%
% 222.37/222.54  |- mesh__activeMeSHYear mesh__D015082 2003
% 222.37/222.54  |- skos__broader mesh__D015082smesh__D011725
% 222.37/222.54  |- skos__hiddenLabel mesh__D015082 2,2%27% Bipyridine
% 222.37/222.54  |- skos__annotation mesh__D015082 DF: DIPYRIDYL   
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D015082 2004
% 222.37/222.55  |- skos__altLabel mesh__D015082 2,2-Bipyridyl
% 222.37/222.55  |- skos__hiddenLabel mesh__D015082 2,2 Bipyridine
% 222.37/222.55  |- skos__hiddenLabel mesh__D015082 Dipyridyl, 2,2
% 222.37/222.55  |- skos__historyNote mesh__D015082 Pyridines %28%1969-1974%29%
% 222.37/222.55  |- skos__prefLabel mesh__D015082 2,2%27%-Dipyridyl
% 222.37/222.55  |- skos__altLabel mesh__D015082 2,2%27%-Bipyridine
% 222.37/222.55  |- mesh__recordAuthorizer mesh__D015082 sjn
% 222.37/222.55  |- mesh__dateCreated mesh__D015082 1974-11-19
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D015082 2005
% 222.37/222.55  |- mesh__onlineNote mesh__D015082
% 222.37/222.55       use 2,2%27%-DIPYRIDYL to search ALPHA,ALPHA-DIPYRIDYL 1975-76%A%  
% 222.37/222.55  |- skos__altLabel mesh__D015082 2,2%27% Dipyridyl
% 222.37/222.55  |- mesh__recordMaintainer mesh__D015082 ssb
% 222.37/222.55  |- skos__altLabel mesh__D015082 2,2-Dipyridyl
% 222.37/222.55  |- skos__altLabel mesh__D015082 2,2 Dipyridyl
% 222.37/222.55  |- mesh__publicMeSHNote mesh__D015082
% 222.37/222.55       91; was see under PYRIDINES 1977-90; was ALPHA,ALPHA-DIPYRIDYL see under PYRIDINES 1975-76%A%  
% 222.37/222.55  |- mesh__historyNote mesh__D015082
% 222.37/222.55       91%28%77%29%; was see under PYRIDINES 1977-90; was ALPHA,ALPHA-DIPYRIDYL see under PYRIDINES 1975-76%A%  
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D015082 2006
% 222.37/222.55  |- mesh__recordOriginator mesh__D015082 NLM
% 222.37/222.55  |- skos__hiddenLabel mesh__D015082 2,2 Bipyridyl
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009843 1999
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009843 2006
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009843 2002
% 222.37/222.55  |- skos__scopeNote mesh__D009843
% 222.37/222.55       A group of ribonucleotides %28%up to 12%29% in which the phosphate residues of each ribonucleotide act as bridges in forming diester linkages between the ribose moieties.%A%    
% 222.37/222.55  |- mesh__historyNote mesh__D009843
% 222.37/222.55       86%28%76%29%; was see under OLIGONUCLEOTIDES 1976-85   
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009843 1998
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009843 2005
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009843 1997
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009843 2004
% 222.37/222.55  |- skos__prefLabel mesh__D009843 Oligoribonucleotides
% 222.37/222.55  |- rdf__type mesh__D009843sskos__Concept
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009843 2003
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009843 1996
% 222.37/222.55  |- mesh__recordOriginator mesh__D009843 RLS
% 222.37/222.55  |- skos__annotation mesh__D009843 2-12 nucleotides   
% 222.37/222.55  |- skos__broader mesh__D009843smesh__D009841
% 222.37/222.55  |- skos__historyNote mesh__D009843 Oligonucleotides %28%1974-1975%29%
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009843 2001
% 222.37/222.55  |- mesh__recordAuthorizer mesh__D009843 PLS
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009843 1995
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009843 2000
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009843 1994
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009843 1993
% 222.37/222.55  |- mesh__recordMaintainer mesh__D009843 TGC
% 222.37/222.55  |- mesh__publicMeSHNote mesh__D009843
% 222.37/222.55       86; was see under OLIGONUCLEOTIDES 1976-85   
% 222.37/222.55  |- mesh__dateEstablished mesh__D009843 1986-01-01
% 222.37/222.55  |- mesh__dateRevised mesh__D009843 1992-05-19
% 222.37/222.55  |- mesh__dateCreated mesh__D009843 1975-07-25
% 222.37/222.55  |- skos__hiddenLabel mesh__D001860 Plates, Bone
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D001860 2004
% 222.37/222.55  |- skos__scopeNote mesh__D001860
% 222.37/222.55       Implantable fracture fixation devices attached to bone fragments with screws to bridge the fracture gap and shield the fracture site from stress as bone heals. %28%UMDNS, 1999%29%%A%    
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D001860 2000
% 222.37/222.55  |- mesh__publicMeSHNote mesh__D001860 74   
% 222.37/222.55  |- mesh__recordMaintainer mesh__D001860 adp
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D001860 2003
% 222.37/222.55  |- skos__broader mesh__D001860smesh__D019736
% 222.37/222.55  |- skos__broader mesh__D001860smesh__D009984
% 222.37/222.55  |- skos__hiddenLabel mesh__D001860 Plate, Bone
% 222.37/222.55  |- skos__hiddenLabel mesh__D001860 Bone Plate
% 222.37/222.55  |- mesh__dateRevised mesh__D001860 1999-11-08
% 222.37/222.55  |- mesh__historyNote mesh__D001860 74%28%71%29%   
% 222.37/222.55  |- mesh__recordOriginator mesh__D001860 NLM
% 222.37/222.55  |- skos__prefLabel mesh__D001860 Bone Plates
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D001860 2006
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D001860 2002
% 222.37/222.55  |- rdf__type mesh__D001860sskos__Concept
% 222.37/222.55  |- mesh__recordAuthorizer mesh__D001860 sjn
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D001860 2005
% 222.37/222.55  |- mesh__dateCreated mesh__D001860 1999-01-01
% 222.37/222.55  |- mesh__dateEstablished mesh__D001860 1974-01-01
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D001860 2001
% 222.37/222.55  |- skos__hiddenLabel mesh__D009045 Motor End-Plates
% 222.37/222.55  |- skos__hiddenLabel mesh__D009045 Motor Endplates
% 222.37/222.55  |- mesh__dateRevised mesh__D009045 2000-06-22
% 222.37/222.55  |- mesh__historyNote mesh__D009045
% 222.37/222.55       91%28%75%29%; was see under NEUROMUSCULAR JUNCTION 1975-90   
% 222.37/222.55  |- rdf__type mesh__D009045sskos__Concept
% 222.37/222.55  |- skos__hiddenLabel mesh__D009045 Motor End Plate
% 222.37/222.55  |- skos__hiddenLabel mesh__D009045 Endplates, Motor
% 222.37/222.55  |- mesh__onlineNote mesh__D009045 search NEUROMUSCULAR JUNCTION 1968-74   
% 222.37/222.55  |- skos__prefLabel mesh__D009045 Motor Endplate
% 222.37/222.55  |- skos__hiddenLabel mesh__D009045 Endplate, Motor
% 222.37/222.55  |- mesh__recordMaintainer mesh__D009045 TGC
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009045 2004
% 222.37/222.55  |- skos__altLabel mesh__D009045 Motor End-Plate
% 222.37/222.55  |- mesh__publicMeSHNote mesh__D009045
% 222.37/222.55       91; was see under NEUROMUSCULAR JUNCTION 1975-90   
% 222.37/222.55  |- skos__scopeNote mesh__D009045
% 222.37/222.55       The specialized postsynaptic region of a muscle cell. The motor endplate is immediately across the synaptic cleft from the presynaptic axon terminal. Among its anatomical specializations are junctional folds which harbor a high density of cholinergic receptors.%A%    
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009045 2002
% 222.37/222.55  |- mesh__recordAuthorizer mesh__D009045 sjn
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009045 2006
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009045 2003
% 222.37/222.55  |- mesh__dateEstablished mesh__D009045 1991-01-01
% 222.37/222.55  |- mesh__recordOriginator mesh__D009045 NLM
% 222.37/222.55  |- skos__broader mesh__D009045smesh__D009469
% 222.37/222.55  |- skos__hiddenLabel mesh__D009045 End-Plates, Motor
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009045 2001
% 222.37/222.55  |- skos__annotation mesh__D009045 do not confuse with NERVE ENDINGS   
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009045 2005
% 222.37/222.55  |- mesh__dateCreated mesh__D009045 1999-01-01
% 222.37/222.55  |- skos__hiddenLabel mesh__D009045 End-Plate, Motor
% 222.37/222.55  |- mesh__recordAuthorizer mesh__D001062 SJN
% 222.37/222.55  |- skos__prefLabel mesh__D001062 Appendectomy
% 222.37/222.55  |- skos__scopeNote mesh__D001062
% 222.37/222.55       Surgical removal of the vermiform appendix. %28%Dorland, 28th ed%29%%A%    
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D001062 2000
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D001062 2005
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D001062 2003
% 222.37/222.55  |- mesh__recordMaintainer mesh__D001062 PXP
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D001062 2006
% 222.37/222.55  |- skos__hiddenLabel mesh__D001062 Appendectomies
% 222.37/222.55  |- skos__broader mesh__D001062smesh__D013505
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D001062 2004
% 222.37/222.55  |- skos__annotation mesh__D001062
% 222.37/222.55       do not use /util except by MeSH definition   
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D001062 2001
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D001062 1998
% 222.37/222.55  |- mesh__dateRevised mesh__D001062 1997-06-20
% 222.37/222.55  |- mesh__dateCreated mesh__D001062 1999-01-01
% 222.37/222.55  |- rdf__type mesh__D001062sskos__Concept
% 222.37/222.55  |- mesh__recordOriginator mesh__D001062 NLM
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D001062 2002
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D001062 1999
% 222.37/222.55  |- mesh__dateRevised mesh__D014788 2003-07-09
% 222.37/222.55  |- skos__broader mesh__D014788smesh__D014785
% 222.37/222.55  |- mesh__dateCreated mesh__D014788 1974-11-19
% 222.37/222.55  |- mesh__dateEstablished mesh__D014788 1991-01-01
% 222.37/222.55  |- rdf__type mesh__D014788sskos__Concept
% 222.37/222.55  |- mesh__recordOriginator mesh__D014788 NLM
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D014788 2004
% 222.37/222.55  |- skos__hiddenLabel mesh__D014788 Enoptic Visions
% 222.37/222.55  |- skos__hiddenLabel mesh__D014788 Entoptic Visions
% 222.37/222.55  |- mesh__historyNote mesh__D014788
% 222.37/222.55       91%28%75%29%; was see under VISION 1975-90   
% 222.37/222.55  |- skos__prefLabel mesh__D014788 Vision, Entoptic
% 222.37/222.55  |- skos__hiddenLabel mesh__D014788 Visions, Enoptic
% 222.37/222.55  |- mesh__recordMaintainer mesh__D014788 nns
% 222.37/222.55  |- mesh__recordAuthorizer mesh__D014788 sjn
% 222.37/222.55  |- skos__hiddenLabel mesh__D014788 Visions, Entoptic
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D014788 2006
% 222.37/222.55  |- skos__altLabel mesh__D014788 Entoptic Vision
% 222.37/222.55  |- mesh__publicMeSHNote mesh__D014788 91; was see under VISION 1975-90   
% 222.37/222.55  |- skos__altLabel mesh__D014788 Enoptic Vision
% 222.37/222.55  |- skos__scopeNote mesh__D014788
% 222.37/222.55       Visual sensation due to shadows or optical effects of structures within the eye or to excitation of the receptor system by stimuli other than light.%A%    
% 222.37/222.55  |- skos__hiddenLabel mesh__D014788 Vision, Enoptic
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D014788 2005
% 222.37/222.55  |- skos__hiddenLabel mesh__D033942 Adaptors, Clathrin
% 222.37/222.55  |- mesh__publicMeSHNote mesh__D033942
% 222.37/222.55       2005; see ADAPTOR PROTEINS 2002-2004; CLATHRIN ASSEMBLY PROTEINS was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 2001-2002, and under NERVE TISSUE PROTEINS %26% PHOSPHOPROTEINS 1987-2001%A%  
% 222.37/222.55  |- skos__hiddenLabel mesh__D033942 Clathrin Associated Adaptors
% 222.37/222.55  |- skos__broader mesh__D033942smesh__D033921
% 222.37/222.55  |- skos__altLabel mesh__D033942
% 222.37/222.55       Vesicular Transport Adaptor Protein Complexes
% 222.37/222.55  |- skos__hiddenLabel mesh__D033942 Adaptors, Clathrin-Associated
% 222.37/222.55  |- skos__altLabel mesh__D033942 Clathrin Adaptor Protein Complexes
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D033942 2006
% 222.37/222.55  |- skos__altLabel mesh__D033942 Clathrin Assembly Proteins
% 222.37/222.55  |- skos__scopeNote mesh__D033942
% 222.37/222.55       A class of proteins involved in the transport of molecules via TRANSPORT VESICLES. They perform functions such as binding to the cell membrane, capturing cargo molecules and promoting the assembly of CLATHRIN. The majority of adaptor proteins exist as multi-subunit complexes, however monomeric varieties have also been found.%A%    
% 222.37/222.55  |- mesh__historyNote mesh__D033942 2005%28%1987%29%   
% 222.37/222.55  |- mesh__dateRevised mesh__D033942 2005-06-30
% 222.37/222.55  |- rdf__type mesh__D033942sskos__Concept
% 222.37/222.55  |- skos__prefLabel mesh__D033942 Adaptor Proteins, Vesicular Transport
% 222.37/222.55  |- skos__historyNote mesh__D033942 Carrier Proteins %28%2001-2002%29%
% 222.37/222.55  |- skos__historyNote mesh__D033942 Nerve Tissue Proteins %28%1987-2001%29%
% 222.37/222.55  |- skos__altLabel mesh__D033942 Vesicular Transport Adaptor Proteins
% 222.37/222.55  |- skos__altLabel mesh__D033942 Clathrin-Associated Adaptors
% 222.37/222.55  |- skos__hiddenLabel mesh__D033942 Clathrin Associated Proteins
% 222.37/222.55  |- mesh__recordOriginator mesh__D033942 jmp
% 222.37/222.55  |- mesh__dateEstablished mesh__D033942 2003-01-01
% 222.37/222.55  |- skos__historyNote mesh__D033942 Membrane Proteins %28%2001-2002%29%
% 222.37/222.55  |- mesh__recordAuthorizer mesh__D033942 sjn
% 222.37/222.55  |- skos__hiddenLabel mesh__D033942 Assembly Proteins, Clathrin
% 222.37/222.55  |- skos__altLabel mesh__D033942 Clathrin-Associated Proteins
% 222.37/222.55  |- skos__historyNote mesh__D033942 Phosphoproteins %28%1987-2001%29%
% 222.37/222.55  |- mesh__recordMaintainer mesh__D033942 SYSTEM
% 222.37/222.55  |- mesh__dateCreated mesh__D033942 2002-07-02
% 222.37/222.55  |- rdf__type mesh__D019473sskos__Concept
% 222.37/222.55  |- skos__broader mesh__D019473smesh__D035165
% 222.37/222.55  |- mesh__publicMeSHNote mesh__D019473 97   
% 222.37/222.55  |- mesh__recordAuthorizer mesh__D019473 sjn
% 222.37/222.55  |- mesh__dateEstablished mesh__D019473 1997-01-01
% 222.37/222.55  |- mesh__recordMaintainer mesh__D019473 ags
% 222.37/222.55  |- skos__altLabel mesh__D019473 TFII Transcription Factors
% 222.37/222.55  |- mesh__dateRevised mesh__D019473 2005-06-30
% 222.37/222.55  |- skos__prefLabel mesh__D019473 Transcription Factors, TFII
% 222.37/222.55  |- mesh__historyNote mesh__D019473 97   
% 222.37/222.55  |- skos__historyNote mesh__D019473 Transcription Factors %28%1979-1996%29%
% 222.37/222.55  |- mesh__dateCreated mesh__D019473 1996-06-10
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D019473 2006
% 222.37/222.55  |- mesh__recordOriginator mesh__D019473 AGS
% 222.37/222.55  |- skos__scopeNote mesh__D019473
% 222.37/222.55       The so-called general transcription factors that bind to RNA POLYMERASE II and that are required to initiate transcription. They include TFIIA; TFIIB; TFIID; TFIIE; TFIIF; TFIIH; TFII-I; and TFIIJ. In vivo they apparently bind in an ordered multi-step process and/or may form a large preinitiation complex called RNA polymerase II holoenzyme.%A%    
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D000768 1998
% 222.37/222.55  |- mesh__recordAuthorizer mesh__D000768 NLM
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D000768 1996
% 222.37/222.55  |- mesh__recordMaintainer mesh__D000768 PLS
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D000768 2006
% 222.37/222.55  |- skos__annotation mesh__D000768
% 222.37/222.55       /educ: coord IM %28%no qualif%29% with ANESTHESIOLOGY /educ %28%NIM%29%%A%  
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D000768 2001
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D000768 2004
% 222.37/222.55  |- mesh__dateCreated mesh__D000768 1999-01-01
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D000768 2000
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D000768 2005
% 222.37/222.55  |- skos__hiddenLabel mesh__D000768 General Anesthesia
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D000768 2003
% 222.37/222.55  |- mesh__recordOriginator mesh__D000768 NLM
% 222.37/222.55  |- skos__prefLabel mesh__D000768 Anesthesia, General
% 222.37/222.55  |- skos__broader mesh__D000768smesh__D000758
% 222.37/222.55  |- mesh__dateRevised mesh__D000768 1993-02-20
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D000768 1995
% 222.37/222.55  |- skos__hiddenLabel mesh__D000768 Anesthesias, General
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D000768 1999
% 222.37/222.55  |- skos__hiddenLabel mesh__D000768 General Anesthesias
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D000768 2002
% 222.37/222.55  |- rdf__type mesh__D000768sskos__Concept
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D000768 1994
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D000768 1997
% 222.37/222.55  |- mesh__recordMaintainer mesh__D011490 jmp
% 222.37/222.55  |- skos__scopeNote mesh__D011490
% 222.37/222.55       An enzyme that catalyzes the reduction of a protein-disulfide in the presence of glutathione, forming a protein-dithiol. Insulin is one of its substrates. EC 1.8.4.2.%A%    
% 222.37/222.55  |- skos__hiddenLabel mesh__D011490 Disulfide Oxidoreductase, Thiol-Protein
% 222.37/222.55  |- skos__hiddenLabel mesh__D011490 Oxidoreductase, Thiol-Protein Disulfide
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D011490 2006
% 222.37/222.55  |- mesh__recordAuthorizer mesh__D011490 sjn
% 222.37/222.55  |- skos__broader mesh__D011490smesh__D050862
% 222.37/222.55  |- skos__historyNote mesh__D011490 Glutathione %28%1972-1974%29%
% 222.37/222.55  |- mesh__dateRevised mesh__D011490 2005-06-30
% 222.37/222.55  |- skos__hiddenLabel mesh__D011490 Insulin Transhydrogenase, Glutathione
% 222.37/222.55  |- mesh__historyNote mesh__D011490
% 222.37/222.55       91%28%75%29%; was see under OXIDOREDUCTASES 1975-90   
% 222.37/222.55  |- mesh__recordOriginator mesh__D011490 NLM
% 222.37/222.55  |- skos__historyNote mesh__D011490 Insulin %28%1972-1974%29%
% 222.37/222.55  |- skos__hiddenLabel mesh__D011490 Oxidoreductase, Thiol-Disulfide
% 222.37/222.55  |- rdf__type mesh__D011490sskos__Concept
% 222.37/222.55  |- skos__hiddenLabel mesh__D011490 Thiol Protein Disulfide Oxidoreductase
% 222.37/222.55  |- mesh__dateEstablished mesh__D011490 1991-01-01
% 222.37/222.55  |- skos__altLabel mesh__D011490
% 222.37/222.55       Glutathione Protein Disulfide Oxidoreductase
% 222.37/222.55  |- skos__historyNote mesh__D011490 Oxidoreductases %28%1972-1974%29%
% 222.37/222.55  |- skos__prefLabel mesh__D011490
% 222.37/222.55       Protein Disulfide Reductase %28%Glutathione%29%
% 222.37/222.55  |- skos__hiddenLabel mesh__D011490 Thiol Disulfide Oxidoreductase
% 222.37/222.55  |- mesh__dateCreated mesh__D011490 1974-11-19
% 222.37/222.55  |- skos__hiddenLabel mesh__D011490 Transhydrogenase, Glutathione Insulin
% 222.37/222.55  |- skos__altLabel mesh__D011490 Thiol-Protein Disulfide Oxidoreductase
% 222.37/222.55  |- skos__altLabel mesh__D011490 Glutathione Insulin Transhydrogenase
% 222.37/222.55  |- skos__historyNote mesh__D011490 Glutathione Reductase %28%1974%29%
% 222.37/222.55  |- mesh__publicMeSHNote mesh__D011490
% 222.37/222.55       91; was see under OXIDOREDUCTASES 1975-90   
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D005453 2005
% 222.37/222.55  |- mesh__recordOriginator mesh__D005453 NLM
% 222.37/222.55  |- mesh__dateRevised mesh__D005453 2004-07-07
% 222.37/222.55  |- mesh__recordMaintainer mesh__D005453 ssb
% 222.37/222.55  |- mesh__dateCreated mesh__D005453 1999-01-01
% 222.37/222.55  |- skos__broader mesh__D005453smesh__D049449
% 222.37/222.55  |- rdf__type mesh__D005453sskos__Concept
% 222.37/222.55  |- mesh__recordAuthorizer mesh__D005453 sjn
% 222.37/222.55  |- skos__annotation mesh__D005453
% 222.37/222.55       no qualif; IM for principle of physics but be careful of use of word describing many %22%fluorescence%22% techniques as main headings; fluorescence-activated cell sorting: index under CELL SEPARATION + FLOW CYTOMETRY%A%  
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D005453 2006
% 222.37/222.55  |- skos__scopeNote mesh__D005453
% 222.37/222.55       The property of emitting radiation while being irradiated. The radiation emitted is usually of longer wavelength than that incident or absorbed, e.g., a substance can be irradiated with invisible radiation and emit visible light. X-ray fluorescence is used in diagnosis.%A%    
% 222.37/222.55  |- skos__prefLabel mesh__D005453 Fluorescence
% 222.37/222.55  |- mesh__publicMeSHNote mesh__D010398
% 222.37/222.55       91; was see under CAPROATES 1975-90   
% 222.37/222.55  |- mesh__recordMaintainer mesh__D010398 ssb
% 222.37/222.55  |- mesh__dateEstablished mesh__D010398 1991-01-01
% 222.37/222.55  |- rdf__type mesh__D010398sskos__Concept
% 222.37/222.55  |- skos__scopeNote mesh__D010398
% 222.37/222.55       A mycotoxin with antibiotic and carcinogenic activity produced by various strains of PENICILLIUM and ASPERGILLUS. It has been found in tobacco, sausages, and corn.%A%    
% 222.37/222.55  |- skos__annotation mesh__D010398 do not confuse with PENICILLANIC ACID   
% 222.37/222.55  |- skos__broader mesh__D010398smesh__D006587
% 222.37/222.55  |- skos__historyNote mesh__D010398 Lactones %28%1973-1974%29%
% 222.37/222.55  |- mesh__recordAuthorizer mesh__D010398 sjn
% 222.37/222.55  |- mesh__dateRevised mesh__D010398 2005-06-30
% 222.37/222.55  |- mesh__dateCreated mesh__D010398 1974-11-11
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D010398 2006
% 222.37/222.55  |- skos__historyNote mesh__D010398 Keto Acids %28%1972-1974%29%
% 222.37/222.55  |- skos__historyNote mesh__D010398 Caproates %28%1969-1974%29%
% 222.37/222.55  |- skos__prefLabel mesh__D010398 Penicillic Acid
% 222.37/222.55  |- mesh__recordOriginator mesh__D010398 NLM
% 222.37/222.55  |- skos__hiddenLabel mesh__D010398 Acid, Penicillic
% 222.37/222.55  |- skos__broader mesh__D010398smesh__D009183
% 222.37/222.55  |- mesh__historyNote mesh__D010398
% 222.37/222.55       91%28%75%29%; was see under CAPROATES 1975-90   
% 222.37/222.55  |- skos__broader mesh__D015083smesh__D013400
% 222.37/222.55  |- mesh__recordAuthorizer mesh__D015083 sjn
% 222.37/222.55  |- skos__historyNote mesh__D015083 Sugar Acids %28%1973-1974%29%
% 222.37/222.55  |- mesh__recordMaintainer mesh__D015083 ssb
% 222.37/222.55  |- mesh__publicMeSHNote mesh__D015083
% 222.37/222.55       91; was see under SUGAR ACIDS 1975-90   
% 222.37/222.55  |- skos__prefLabel mesh__D015083 2,3-Diketogulonic Acid
% 222.37/222.55  |- mesh__recordOriginator mesh__D015083 NLM
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D015083 2005
% 222.37/222.55  |- skos__hiddenLabel mesh__D015083 Acid, 2,3-Diketogulonic
% 222.37/222.55  |- mesh__historyNote mesh__D015083
% 222.37/222.55       91%28%75%29%; was see under SUGAR ACIDS 1975-90   
% 222.37/222.55  |- skos__hiddenLabel mesh__D015083 2,3 Diketogulonic Acid
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D015083 2006
% 222.37/222.55  |- skos__historyNote mesh__D015083 Ketoses %28%1974%29%
% 222.37/222.55  |- mesh__dateCreated mesh__D015083 1974-11-27
% 222.37/222.55  |- mesh__dateRevised mesh__D015083 2004-07-07
% 222.37/222.55  |- skos__scopeNote mesh__D015083
% 222.37/222.55       Metabolite of ASCORBIC ACID and the oxidized form of the lactone DEHYDROASCORBIC ACID.%A%    
% 222.37/222.55  |- rdf__type mesh__D015083sskos__Concept
% 222.37/222.55  |- mesh__dateEstablished mesh__D015083 1991-01-01
% 222.37/222.55  |- mesh__recordMaintainer mesh__D009844 ssb
% 222.37/222.55  |- mesh__dateRevised mesh__D009844 2004-07-07
% 222.37/222.55  |- mesh__dateCreated mesh__D009844 1999-01-01
% 222.37/222.55  |- skos__broader mesh__D009844smesh__D011134
% 222.37/222.55  |- skos__prefLabel mesh__D009844 Oligosaccharides
% 222.37/222.55  |- skos__annotation mesh__D009844 GEN; prefer specifics   
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009844 2006
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009844 2005
% 222.37/222.55  |- mesh__recordOriginator mesh__D009844 NLM
% 222.37/222.55  |- rdf__type mesh__D009844sskos__Concept
% 222.37/222.55  |- mesh__recordAuthorizer mesh__D009844 sjn
% 222.37/222.55  |- skos__scopeNote mesh__D009844
% 222.37/222.55       Carbohydrates consisting of between two %28%DISACCHARIDES%29% and ten MONOSACCHARIDES connected by either an alpha- or beta-glycosidic link. They are found throughout nature in both the free and bound form.%A%    
% 222.37/222.55  |- skos__hiddenLabel mesh__D001861 Bone Regenerations
% 222.37/222.55  |- mesh__recordAuthorizer mesh__D001861 sjn
% 222.37/222.55  |- mesh__publicMeSHNote mesh__D001861 65   
% 222.37/222.55  |- skos__related mesh__D001861smesh__D002146
% 222.37/222.55  |- skos__annotation mesh__D001861
% 222.37/222.55       not for callus formation %28%= BONY CALLUS with required qualifiers%29%; not for fracture healing %28%= FRACTURE HEALING%29%%A%  
% 222.37/222.55  |- mesh__dateRevised mesh__D001861 2005-06-30
% 222.37/222.55  |- skos__broader mesh__D001861smesh__D016723
% 222.37/222.55  |- skos__related mesh__D001861smesh__D017102
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D001861 2006
% 222.37/222.55  |- skos__hiddenLabel mesh__D001861 Regenerations, Bone
% 222.37/222.55  |- rdf__type mesh__D001861sskos__Concept
% 222.37/222.55  |- skos__hiddenLabel mesh__D001861 Regeneration, Bone
% 222.37/222.55  |- skos__prefLabel mesh__D001861 Bone Regeneration
% 222.37/222.55  |- mesh__historyNote mesh__D001861 65   
% 222.37/222.55  |- mesh__dateCreated mesh__D001861 1999-01-01
% 222.37/222.55  |- mesh__recordOriginator mesh__D001861 NLM
% 222.37/222.55  |- skos__scopeNote mesh__D001861
% 222.37/222.55       Renewal or repair of lost bone tissue. It excludes BONY CALLUS formed after BONE FRACTURES but not yet replaced by hard bone.%A%    
% 222.37/222.55  |- skos__related mesh__D001861smesh__D050071
% 222.37/222.55  |- mesh__dateEstablished mesh__D001861 1965-01-01
% 222.37/222.55  |- mesh__recordMaintainer mesh__D001861 ssb
% 222.37/222.55  |- mesh__recordOriginator mesh__D009046 NLM
% 222.37/222.55  |- rdf__type mesh__D009046sskos__Concept
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009046 2001
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009046 2003
% 222.37/222.55  |- skos__prefLabel mesh__D009046 Motor Neurons
% 222.37/222.55  |- mesh__publicMeSHNote mesh__D009046 66   
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009046 2004
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009046 2005
% 222.37/222.55  |- skos__related mesh__D009046smesh__D009469
% 222.37/222.55  |- skos__hiddenLabel mesh__D009046 Neuron, Motor
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009046 2002
% 222.37/222.55  |- mesh__dateCreated mesh__D009046 1999-01-01
% 222.37/222.55  |- mesh__activeMeSHYear mesh__D009046 2006
% 222.37/222.55  |- mesh__recordMaintainer mesh__D009046 jls
% 222.37/222.55  |- mesh__dateEstablished mesh__D009046 1966-01-01
% 222.37/222.55  |- mesh__dateRevised mesh__D009046 1999-11-09
% 222.37/222.55  |- skos__broader mesh__D009046smesh__D009476
% 222.37/222.57  |- skos__scopeNote mesh__D009046 Neurons which activate muscle cells.     
% 222.37/222.57  |- skos__annotation mesh__D009046
% 222.37/222.57       efferent neurons activating muscle cells; A 11 qualif   
% 222.37/222.57  |- skos__related mesh__D009046smesh__D016472
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D009046 2000
% 222.37/222.57  |- mesh__historyNote mesh__D009046 66%28%64%29%   
% 222.37/222.57  |- skos__altLabel mesh__D009046 Neurons, Motor
% 222.37/222.57  |- skos__hiddenLabel mesh__D009046 Motor Neuron
% 222.37/222.57  |- mesh__recordAuthorizer mesh__D009046 sjn
% 222.37/222.57  |- skos__related mesh__D001063smesh__D011553
% 222.37/222.57  |- skos__annotation mesh__D001063
% 222.37/222.57       coord IM with histol type of neopl %28%IM%29%   
% 222.37/222.57  |- skos__hiddenLabel mesh__D001063 Neoplasm, Appendiceal
% 222.37/222.57  |- skos__altLabel mesh__D001063 Neoplasms, Appendiceal
% 222.37/222.57  |- skos__hiddenLabel mesh__D001063 Cancer, Appendix
% 222.37/222.57  |- skos__altLabel mesh__D001063 Cancer of Appendix
% 222.37/222.57  |- mesh__recordOriginator mesh__D001063 NLM
% 222.37/222.57  |- skos__altLabel mesh__D001063 Cancer, Appendiceal
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D001063 2005
% 222.37/222.57  |- skos__broader mesh__D001063smesh__D002430
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D001063 2006
% 222.37/222.57  |- mesh__recordAuthorizer mesh__D001063 sjn
% 222.37/222.57  |- mesh__recordMaintainer mesh__D001063 lkt
% 222.37/222.57  |- mesh__dateRevised mesh__D001063 2003-07-09
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D001063 2004
% 222.37/222.57  |- skos__prefLabel mesh__D001063 Appendiceal Neoplasms
% 222.37/222.57  |- mesh__dateCreated mesh__D001063 1999-01-01
% 222.37/222.57  |- rdf__type mesh__D001063sskos__Concept
% 222.37/222.57  |- skos__altLabel mesh__D001063 Cancer of the Appendix
% 222.37/222.57  |- skos__hiddenLabel mesh__D001063 Appendiceal Neoplasm
% 222.37/222.57  |- skos__scopeNote mesh__D001063 Tumors or cancer of the APPENDIX.     
% 222.37/222.57  |- skos__altLabel mesh__D001063 Appendix Cancer
% 222.37/222.57  |- skos__hiddenLabel mesh__D014789 Visitor, Patients%27%
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D014789 2001
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D014789 1998
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D014789 2003
% 222.37/222.57  |- rdf__type mesh__D014789sskos__Concept
% 222.37/222.57  |- mesh__recordAuthorizer mesh__D014789 PLS
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D014789 1993
% 222.37/222.57  |- mesh__dateCreated mesh__D014789 1977-05-12
% 222.37/222.57  |- mesh__historyNote mesh__D014789 78   
% 222.37/222.57  |- skos__hiddenLabel mesh__D014789 Patients Visitors
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D014789 2004
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D014789 2002
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D014789 1999
% 222.37/222.57  |- skos__scopeNote mesh__D014789
% 222.37/222.57       Patients%27% guests and rules for visiting.     
% 222.37/222.57  |- mesh__publicMeSHNote mesh__D014789 78   
% 222.37/222.57  |- mesh__recordOriginator mesh__D014789 EC
% 222.37/222.57  |- skos__hiddenLabel mesh__D014789 Visitors to Patient
% 222.37/222.57  |- skos__hiddenLabel mesh__D014789 Patient%27%s Visitors
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D014789 1994
% 222.37/222.57  |- skos__hiddenLabel mesh__D014789 Visitors, Patients%27%
% 222.37/222.57  |- mesh__recordMaintainer mesh__D014789 TAP
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D014789 2005
% 222.37/222.57  |- skos__altLabel mesh__D014789 Patients%27% Visitors
% 222.37/222.57  |- skos__hiddenLabel mesh__D014789 Patients%27% Visitor
% 222.37/222.57  |- skos__hiddenLabel mesh__D014789 Patient Visitors
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D014789 1995
% 222.37/222.57  |- mesh__dateRevised mesh__D014789 1992-05-18
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D014789 1996
% 222.37/222.57  |- mesh__dateEstablished mesh__D014789 1978-01-01
% 222.37/222.57  |- skos__prefLabel mesh__D014789 Visitors to Patients
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D014789 2006
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D014789 2000
% 222.37/222.57  |- skos__broader mesh__D014789smesh__D009272
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D014789 1997
% 222.37/222.57  |- skos__historyNote mesh__D019474 Transcription Factors %28%1983-1996%29%
% 222.37/222.57  |- mesh__recordMaintainer mesh__D019474 ags
% 222.37/222.57  |- mesh__recordOriginator mesh__D019474 AGS
% 222.37/222.57  |- skos__altLabel mesh__D019474 TFIII Transcription Factors
% 222.37/222.57  |- mesh__historyNote mesh__D019474 97   
% 222.37/222.57  |- mesh__publicMeSHNote mesh__D019474 97   
% 222.37/222.57  |- mesh__recordAuthorizer mesh__D019474 sjn
% 222.37/222.57  |- mesh__dateEstablished mesh__D019474 1997-01-01
% 222.37/222.57  |- skos__hiddenLabel mesh__D019474 Factors, TFIII Transcription
% 222.37/222.57  |- skos__scopeNote mesh__D019474
% 222.37/222.57       Factors that bind to RNA POLYMERASE III and aid in transcription. They include the assembly factors TFIIIA and TFIIIC and the initiation factor TFIIIB. All combine to form a preinitiation complex at the promotor that directs the binding of RNA POLYMERASE III.%A%    
% 222.37/222.57  |- mesh__dateRevised mesh__D019474 2005-06-30
% 222.37/222.57  |- skos__prefLabel mesh__D019474 Transcription Factors, TFIII
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D019474 2006
% 222.37/222.57  |- rdf__type mesh__D019474sskos__Concept
% 222.37/222.57  |- skos__broader mesh__D019474smesh__D035165
% 222.37/222.57  |- mesh__dateCreated mesh__D019474 1996-06-10
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D000769 2006
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D000769 2002
% 222.37/222.57  |- skos__annotation mesh__D000769
% 222.37/222.57       /educ: coord IM %28%no qualif%29% with ANESTHESIOLOGY /educ %28%NIM%29%%A%  
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D000769 2004
% 222.37/222.57  |- skos__hiddenLabel mesh__D000769 Inhalation Anesthesia
% 222.37/222.57  |- skos__hiddenLabel mesh__D000769 Anesthesia, Insufflation
% 222.37/222.57  |- mesh__dateCreated mesh__D000769 1999-01-01
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D000769 2005
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D000769 2003
% 222.37/222.57  |- mesh__recordMaintainer mesh__D000769 PLS
% 222.37/222.57  |- skos__prefLabel mesh__D000769 Anesthesia, Inhalation
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D000769 1995
% 222.37/222.57  |- skos__scopeNote mesh__D000769
% 222.37/222.57       Anesthesia caused by the breathing of anesthetic gases or vapors or by insufflating anesthetic gases or vapors into the respiratory tract.%A%    
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D000769 2001
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D000769 1999
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D000769 2000
% 222.37/222.57  |- rdf__type mesh__D000769sskos__Concept
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D000769 1994
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D000769 1997
% 222.37/222.57  |- skos__broader mesh__D000769smesh__D000768
% 222.37/222.57  |- mesh__recordOriginator mesh__D000769 NLM
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D000769 1998
% 222.37/222.57  |- mesh__dateRevised mesh__D000769 1993-02-20
% 222.37/222.57  |- mesh__recordAuthorizer mesh__D000769 NLM
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D000769 1996
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D011491 1998
% 222.37/222.57  |- skos__hiddenLabel mesh__D011491 Hybridization, Protein
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D011491 1997
% 222.37/222.57  |- skos__annotation mesh__D011491
% 222.37/222.57       IM general only; coord NIM with specific protein %28%IM%29%   
% 222.37/222.57  |- mesh__dateEstablished mesh__D011491 1978-01-01
% 222.37/222.57  |- mesh__activeMeSHYear mesh__D011491 1994
% 222.37/222.58  |- mesh__publicMeSHNote mesh__D011491 78   
% 222.37/222.58  |- mesh__recordAuthorizer mesh__D011491 PLS
% 222.37/222.58  |- mesh__historyNote mesh__D011491 78   
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D011491 1999
% 222.37/222.58  |- rdf__type mesh__D011491sskos__Concept
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D011491 1993
% 222.37/222.58  |- skos__broader mesh__D011491smesh__D001669
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D011491 2000
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D011491 1995
% 222.37/222.58  |- mesh__dateRevised mesh__D011491 1992-05-18
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D011491 2003
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D011491 2001
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D011491 2005
% 222.37/222.58  |- skos__prefLabel mesh__D011491 Protein Hybridization
% 222.37/222.58  |- mesh__recordOriginator mesh__D011491 VDK
% 222.37/222.58  |- mesh__recordMaintainer mesh__D011491 TGC
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D011491 2004
% 222.37/222.58  |- skos__hiddenLabel mesh__D011491 Protein Hybridizations
% 222.37/222.58  |- skos__scopeNote mesh__D011491
% 222.37/222.58       The formation of a protein consisting of two or more polypeptide chains from separate and different polypeptide chains.%A%    
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D011491 2006
% 222.37/222.58  |- mesh__dateCreated mesh__D011491 1977-04-27
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D011491 1996
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D011491 2002
% 222.37/222.58  |- skos__hiddenLabel mesh__D011491 Hybridizations, Protein
% 222.37/222.58  |- skos__hiddenLabel mesh__D005454 Polarizations, Fluorescence
% 222.37/222.58  |- skos__hiddenLabel mesh__D005454 Anisotropies, Fluorescence
% 222.37/222.58  |- mesh__recordAuthorizer mesh__D005454 sjn
% 222.37/222.58  |- skos__historyNote mesh__D005454 Fluorometry %28%1966-1978%29%
% 222.37/222.58  |- skos__altLabel mesh__D005454 Fluorescence Anisotropy
% 222.37/222.58  |- mesh__dateCreated mesh__D005454 1978-04-28
% 222.37/222.58  |- skos__prefLabel mesh__D005454 Fluorescence Polarization
% 222.37/222.58  |- mesh__recordMaintainer mesh__D005454 ssb
% 222.37/222.58  |- mesh__historyNote mesh__D005454 79   
% 222.37/222.58  |- skos__annotation mesh__D005454
% 222.37/222.58       determ of polarization of fluorescent light: do not confuse with FLUORESCENCE POLARIZATION IMMUNOASSAY, its application to hapten-antibody reaction; NIM%A%  
% 222.37/222.58  |- mesh__publicMeSHNote mesh__D005454 79   
% 222.37/222.58  |- skos__hiddenLabel mesh__D005454 Fluorescence Polarizations
% 222.37/222.58  |- rdf__type mesh__D005454sskos__Concept
% 222.37/222.58  |- skos__scopeNote mesh__D005454
% 222.37/222.58       Measurement of the polarization of fluorescent light from solutions or microscopic specimens. It is used to provide information concerning molecular size, shape, and conformation, molecular anisotropy, electronic energy transfer, molecular interaction, including dye and coenzyme binding, and the antigen-antibody reaction.%A%    
% 222.37/222.58  |- mesh__recordOriginator mesh__D005454 SMH
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D005454 2005
% 222.37/222.58  |- mesh__dateEstablished mesh__D005454 1979-01-01
% 222.37/222.58  |- skos__historyNote mesh__D005454
% 222.37/222.58       Spectrometry, Fluorescence %28%1972-1978%29%
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D005454 2006
% 222.37/222.58  |- mesh__dateRevised mesh__D005454 2004-07-07
% 222.37/222.58  |- skos__hiddenLabel mesh__D005454 Fluorescence Anisotropies
% 222.37/222.58  |- skos__altLabel mesh__D005454 Polarization, Fluorescence
% 222.37/222.58  |- skos__broader mesh__D005454smesh__D005470
% 222.37/222.58  |- skos__hiddenLabel mesh__D010399 Acylase, Penicillin G
% 222.37/222.58  |- mesh__recordAuthorizer mesh__D010399 sjn
% 222.37/222.58  |- skos__altLabel mesh__D010399 Penicillin Amidohydrolase
% 222.37/222.58  |- skos__historyNote mesh__D010399 Penicillins %28%1970-1974%29%
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D010399 2004
% 222.37/222.58  |- skos__hiddenLabel mesh__D010399 Acylase, Benzylpenicillin
% 222.37/222.58  |- skos__broader mesh__D010399smesh__D000581
% 222.37/222.58  |- skos__historyNote mesh__D010399 Amidohydrolases %28%1970-1974%29%
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D010399 2005
% 222.37/222.58  |- skos__altLabel mesh__D010399 Penicillin Acylase
% 222.37/222.58  |- skos__hiddenLabel mesh__D010399 Acylase, Cephalosporin
% 222.37/222.58  |- skos__scopeNote mesh__D010399
% 222.37/222.58       An enzyme catalyzing the hydrolysis of penicillin to penicin and a carboxylic acid anion. EC 3.5.1.11.%A%    
% 222.37/222.58  |- mesh__historyNote mesh__D010399
% 222.37/222.58       91%28%75%29%; was see under AMIDOHYDROLASES 1975-90   
% 222.37/222.58  |- mesh__recordOriginator mesh__D010399 NLM
% 222.37/222.58  |- mesh__dateCreated mesh__D010399 1974-11-19
% 222.37/222.58  |- skos__hiddenLabel mesh__D010399 Amidohydrolase, Penicillin
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D010399 2006
% 222.37/222.58  |- skos__hiddenLabel mesh__D010399 Acylase, Penicillin
% 222.37/222.58  |- skos__prefLabel mesh__D010399 Penicillin Amidase
% 222.37/222.58  |- skos__hiddenLabel mesh__D010399 Amidase, Penicillin
% 222.37/222.58  |- mesh__publicMeSHNote mesh__D010399
% 222.37/222.58       91; was see under AMIDOHYDROLASES 1975-90   
% 222.37/222.58  |- skos__hiddenLabel mesh__D010399 Acylase, Penicillin V
% 222.37/222.58  |- mesh__recordMaintainer mesh__D010399 ssb
% 222.37/222.58  |- mesh__dateEstablished mesh__D010399 1991-01-01
% 222.37/222.58  |- mesh__dateRevised mesh__D010399 2003-07-09
% 222.37/222.58  |- rdf__type mesh__D010399sskos__Concept
% 222.37/222.58  |- skos__historyNote mesh__D015882 Necrosis %28%1966-1989%29%
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015882 2002
% 222.37/222.58  |- skos__annotation mesh__D015882 a form of retinitis; DF: ARN SYNDROME   
% 222.37/222.58  |- skos__historyNote mesh__D015882 Retinitis %28%1975-1989%29%
% 222.37/222.58  |- skos__hiddenLabel mesh__D015882 Necroses, Acute Retinal
% 222.37/222.58  |- mesh__dateCreated mesh__D015882 1989-05-25
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015882 1996
% 222.37/222.58  |- skos__hiddenLabel mesh__D015882 Retinal Necrosis, Acute
% 222.37/222.58  |- skos__hiddenLabel mesh__D015882 Acute Retinal Necroses
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015882 1998
% 222.37/222.58  |- skos__altLabel mesh__D015882 Acute Retinal Necrosis
% 222.37/222.58  |- rdf__type mesh__D015882sskos__Concept
% 222.37/222.58  |- skos__historyNote mesh__D015882 Retinal Detachment %28%1970-1989%29%
% 222.37/222.58  |- mesh__dateEstablished mesh__D015882 1990-01-01
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015882 2003
% 222.37/222.58  |- mesh__historyNote mesh__D015882 90   
% 222.37/222.58  |- mesh__recordMaintainer mesh__D015882 PLS
% 222.37/222.58  |- mesh__publicMeSHNote mesh__D015882 90   
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015882 1997
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015882 1994
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015882 2005
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015882 2000
% 222.37/222.58  |- skos__prefLabel mesh__D015882 Retinal Necrosis Syndrome, Acute
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015882 1999
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015882 2004
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015882 2001
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015882 1995
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015882 2006
% 222.37/222.58  |- mesh__dateRevised mesh__D015882 1993-05-24
% 222.37/222.58  |- skos__hiddenLabel mesh__D015882 Retinal Necroses, Acute
% 222.37/222.58  |- skos__broader mesh__D015882smesh__D012173
% 222.37/222.58  |- mesh__recordAuthorizer mesh__D015882 PLS
% 222.37/222.58  |- mesh__recordOriginator mesh__D015882 EGC
% 222.37/222.58  |- skos__historyNote mesh__D015882 Retinal Diseases %28%1975-1989%29%
% 222.37/222.58  |- skos__hiddenLabel mesh__D015882 Necrosis, Acute Retinal
% 222.37/222.58  |- skos__scopeNote mesh__D015882
% 222.37/222.58       Mild to fulminant necrotizing vaso-occlusive retinitis associated with a high incidence of retinal detachment and poor vision outcome.%A%    
% 222.37/222.58  |- mesh__recordMaintainer mesh__D015084 CCR
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015084 2005
% 222.37/222.58  |- skos__annotation mesh__D015084 DF: note short X ref   
% 222.37/222.58  |- skos__historyNote mesh__D015084 Herbicides %28%1966-1970%29%
% 222.37/222.58  |- mesh__recordAuthorizer mesh__D015084 sjn
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015084 2006
% 222.37/222.58  |- mesh__publicMeSHNote mesh__D015084 73   
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015084 2001
% 222.37/222.58  |- skos__broader mesh__D015084smesh__D006016
% 222.37/222.58  |- skos__historyNote mesh__D015084 Phenols %28%1966-1970%29%
% 222.37/222.58  |- skos__historyNote mesh__D015084 Acetic Acids %28%1966-1970%29%
% 222.37/222.58  |- skos__prefLabel mesh__D015084 2,4-Dichlorophenoxyacetic Acid
% 222.37/222.58  |- mesh__recordOriginator mesh__D015084 NLM
% 222.37/222.58  |- skos__scopeNote mesh__D015084
% 222.37/222.58       An herbicide with irritant effects on the eye and the gastrointestinal system.%A%    
% 222.37/222.58  |- rdf__type mesh__D015084sskos__Concept
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015084 2002
% 222.37/222.58  |- mesh__historyNote mesh__D015084 73%28%71%29%   
% 222.37/222.58  |- mesh__dateCreated mesh__D015084 1999-01-01
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015084 2003
% 222.37/222.58  |- skos__hiddenLabel mesh__D015084 2,4 Dichlorophenoxyacetic Acid
% 222.37/222.58  |- mesh__dateRevised mesh__D015084 2000-06-21
% 222.37/222.58  |- skos__altLabel mesh__D015084 2,4-D
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015084 2004
% 222.37/222.58  |- mesh__dateEstablished mesh__D015084 1973-01-01
% 222.37/222.58  |- skos__historyNote mesh__D009845 Spermatozoa %28%1966-1974%29%
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009845 1995
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009845 2001
% 222.37/222.58  |- mesh__recordAuthorizer mesh__D009845 PLS
% 222.37/222.58  |- mesh__recordOriginator mesh__D009845 NLM
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009845 1994
% 222.37/222.58  |- skos__hiddenLabel mesh__D009845 Oligospermias
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009845 2000
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009845 1999
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009845 2006
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009845 2004
% 222.37/222.58  |- skos__annotation mesh__D009845 defic of no. of sperm in semen   
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009845 1997
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009845 1998
% 222.37/222.58  |- mesh__recordMaintainer mesh__D009845 TAP
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009845 2005
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009845 2002
% 222.37/222.58  |- skos__scopeNote mesh__D009845
% 222.37/222.58       Deficiency in the number of spermatozoa in semen. %28%Dorland, 27th ed%29%%A%    
% 222.37/222.58  |- rdf__type mesh__D009845sskos__Concept
% 222.37/222.58  |- skos__hiddenLabel mesh__D009845 Azoospermias
% 222.37/222.58  |- mesh__dateEstablished mesh__D009845 1975-09-01
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009845 2003
% 222.37/222.58  |- mesh__dateRevised mesh__D009845 1993-06-02
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009845 1996
% 222.37/222.58  |- mesh__historyNote mesh__D009845 75   
% 222.37/222.58  |- skos__prefLabel mesh__D009845 Oligospermia
% 222.37/222.58  |- mesh__publicMeSHNote mesh__D009845 75   
% 222.37/222.58  |- skos__broader mesh__D009845smesh__D007248
% 222.37/222.58  |- mesh__dateCreated mesh__D009845 1974-11-11
% 222.37/222.58  |- skos__hiddenLabel mesh__D001862 Resorptions, Bone
% 222.37/222.58  |- mesh__historyNote mesh__D001862 65%28%64%29%   
% 222.37/222.58  |- skos__broader mesh__D001862smesh__D016723
% 222.37/222.58  |- mesh__recordMaintainer mesh__D001862 nns
% 222.37/222.58  |- mesh__recordOriginator mesh__D001862 NLM
% 222.37/222.58  |- mesh__publicMeSHNote mesh__D001862 65   
% 222.37/222.58  |- skos__annotation mesh__D001862 use Cat C qualif   
% 222.37/222.58  |- skos__hiddenLabel mesh__D001862 Resorption, Bone
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D001862 2005
% 222.37/222.58  |- mesh__dateCreated mesh__D001862 1999-01-01
% 222.37/222.58  |- skos__broader mesh__D001862smesh__D001847
% 222.37/222.58  |- mesh__recordAuthorizer mesh__D001862 sjn
% 222.37/222.58  |- skos__related mesh__D001862smesh__D010010
% 222.37/222.58  |- skos__altLabel mesh__D001862 Bone Loss, Osteoclastic
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D001862 2006
% 222.37/222.58  |- mesh__dateEstablished mesh__D001862 1965-01-01
% 222.37/222.58  |- rdf__type mesh__D001862sskos__Concept
% 222.37/222.58  |- mesh__dateRevised mesh__D001862 2003-07-09
% 222.37/222.58  |- skos__scopeNote mesh__D001862
% 222.37/222.58       Bone loss due to osteoclastic activity.     
% 222.37/222.58  |- skos__prefLabel mesh__D001862 Bone Resorption
% 222.37/222.58  |- skos__altLabel mesh__D001862 Osteoclastic Bone Loss
% 222.37/222.58  |- skos__hiddenLabel mesh__D001862 Osteoclastic Bone Losses
% 222.37/222.58  |- skos__hiddenLabel mesh__D001862 Bone Losses, Osteoclastic
% 222.37/222.58  |- skos__hiddenLabel mesh__D001862 Losses, Osteoclastic Bone
% 222.37/222.58  |- skos__hiddenLabel mesh__D001862 Bone Resorptions
% 222.37/222.58  |- skos__hiddenLabel mesh__D001862 Loss, Osteoclastic Bone
% 222.37/222.58  |- skos__related mesh__D001862smesh__D016301
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D001862 2004
% 222.37/222.58  |- skos__hiddenLabel mesh__D009047 Fusimotor Neuron
% 222.37/222.58  |- skos__hiddenLabel mesh__D009047 Neuron, Gamma Motor
% 222.37/222.58  |- mesh__recordAuthorizer mesh__D009047 SJN
% 222.37/222.58  |- skos__hiddenLabel mesh__D009047 Gamma-Efferent Motor Neurons
% 222.37/222.58  |- mesh__recordOriginator mesh__D009047 NLM
% 222.37/222.58  |- skos__scopeNote mesh__D009047
% 222.37/222.58       Motor neurons which activate the contractile regions of intrafusal muscle fibers, thus adjusting the sensitivity of the muscle spindles to stretch. Gamma motor neurons may be %22%static%22% or %22%dynamic%22% according to which aspect of responsiveness %28%or which fiber types%29% they regulate. The alpha and gamma motor neurons are often activated together %28%alpha gamma coactivation%29% which allows the spindles to contribute to the control of movement trajectories despite changes in muscle length.%A%    
% 222.37/222.58  |- skos__hiddenLabel mesh__D009047 Neuron, Fusimotor
% 222.37/222.58  |- skos__hiddenLabel mesh__D009047 Gamma Motor Neuron
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009047 1999
% 222.37/222.58  |- skos__broader mesh__D009047smesh__D009046
% 222.37/222.58  |- skos__hiddenLabel mesh__D009047 Fusimotor Neurons
% 222.37/222.58  |- mesh__historyNote mesh__D009047
% 222.37/222.58       91%28%79%29%; was see under MOTOR NEURONS 1979-90; was MOTOR NEURONS, GAMMA EFFERENT see under MOTOR NEURONS 1975-78%A%  
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009047 2006
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009047 2001
% 222.37/222.58  |- skos__hiddenLabel mesh__D009047 Motor Neuron, Gamma-Efferent
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009047 1998
% 222.37/222.58  |- mesh__dateCreated mesh__D009047 1974-11-11
% 222.37/222.58  |- skos__altLabel mesh__D009047 Neurons, Fusimotor
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009047 2000
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009047 2005
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009047 2004
% 222.37/222.58  |- rdf__type mesh__D009047sskos__Concept
% 222.37/222.58  |- skos__hiddenLabel mesh__D009047 Motor Neurons, Gamma Efferent
% 222.37/222.58  |- skos__hiddenLabel mesh__D009047 Gamma Motor Neurons
% 222.37/222.58  |- mesh__recordMaintainer mesh__D009047 AGS
% 222.37/222.58  |- skos__related mesh__D009047smesh__D009470
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009047 2003
% 222.37/222.58  |- mesh__onlineNote mesh__D009047
% 222.37/222.58       use MOTOR NEURONS, GAMMA to search MOTOR NEURONS, GAMMA EFFERENT 1975-78%A%  
% 222.37/222.58  |- skos__hiddenLabel mesh__D009047 Neurons, Gamma-Efferent Motor
% 222.37/222.58  |- skos__annotation mesh__D009047 A 11 qualif   
% 222.37/222.58  |- mesh__dateRevised mesh__D009047 1997-06-20
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009047 2002
% 222.37/222.58  |- skos__altLabel mesh__D009047 Motor Neurons, Gamma-Efferent
% 222.37/222.58  |- mesh__dateEstablished mesh__D009047 1991-01-01
% 222.37/222.58  |- skos__prefLabel mesh__D009047 Motor Neurons, Gamma
% 222.37/222.58  |- skos__hiddenLabel mesh__D009047 Motor Neuron, Gamma
% 222.37/222.58  |- skos__altLabel mesh__D009047 Neurons, Gamma Motor
% 222.37/222.58  |- mesh__publicMeSHNote mesh__D009047
% 222.37/222.58       91; was see under MOTOR NEURONS 1979-90; was MOTOR NEURONS, GAMMA EFFERENT see under MOTOR NEURONS 1975-78%A%  
% 222.37/222.58  |- skos__hiddenLabel mesh__D009047 Neuron, Gamma-Efferent Motor
% 222.37/222.58  |- skos__hiddenLabel mesh__D009047 Gamma-Efferent Motor Neuron
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D001064 2006
% 222.37/222.58  |- skos__prefLabel mesh__D001064 Appendicitis
% 222.37/222.58  |- mesh__dateRevised mesh__D001064 2003-07-09
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D001064 2004
% 222.37/222.58  |- mesh__dateCreated mesh__D001064 1999-01-01
% 222.37/222.58  |- skos__altLabel mesh__D001064 Perforated Appendicitis
% 222.37/222.58  |- skos__broader mesh__D001064smesh__D002429
% 222.37/222.58  |- rdf__type mesh__D001064sskos__Concept
% 222.37/222.58  |- skos__hiddenLabel mesh__D001064 Appendicitis, Ruptured
% 222.37/222.58  |- skos__broader mesh__D001064smesh__D005759
% 222.37/222.58  |- mesh__recordOriginator mesh__D001064 NLM
% 222.37/222.58  |- mesh__recordMaintainer mesh__D001064 lkt
% 222.37/222.58  |- skos__scopeNote mesh__D001064
% 222.37/222.58       Acute inflammation of the APPENDIX. Acute appendicitis is classified as simple, gangrenous, or perforated.%A%    
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D001064 2005
% 222.37/222.58  |- mesh__recordAuthorizer mesh__D001064 sjn
% 222.37/222.58  |- skos__hiddenLabel mesh__D001064 Appendicitis, Perforated
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D028201 2003
% 222.37/222.58  |- skos__scopeNote mesh__D028201
% 222.37/222.58       A plant family of the order Pinales, class Pinopsida, division Coniferophyta, known for the various conifers.%A%    
% 222.37/222.58  |- mesh__historyNote mesh__D028201 2002   
% 222.37/222.58  |- skos__historyNote mesh__D028201 Plants %28%1965-2001%29%
% 222.37/222.58  |- mesh__publicMeSHNote mesh__D028201 2002   
% 222.37/222.58  |- mesh__dateCreated mesh__D028201 2001-07-25
% 222.37/222.58  |- skos__prefLabel mesh__D028201 Pinaceae
% 222.37/222.58  |- mesh__dateEstablished mesh__D028201 2002-01-01
% 222.37/222.58  |- mesh__dateRevised mesh__D028201 2002-07-03
% 222.37/222.58  |- rdf__type mesh__D028201sskos__Concept
% 222.37/222.58  |- skos__historyNote mesh__D028201 Trees %28%1965-2001%29%
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D028201 2006
% 222.37/222.58  |- skos__annotation mesh__D028201
% 222.37/222.58       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.37/222.58  |- skos__broader mesh__D028201smesh__D032482
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D028201 2005
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D028201 2004
% 222.37/222.58  |- skos__altLabel mesh__D019475 Camphor-5-Monooxygenase
% 222.37/222.58  |- skos__altLabel mesh__D019475 Cytochrome P450%28%cam%29%
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D019475 2005
% 222.37/222.58  |- mesh__dateRevised mesh__D019475 2004-07-07
% 222.37/222.58  |- skos__hiddenLabel mesh__D019475 Cytochrome P 450 101
% 222.37/222.58  |- mesh__onlineNote mesh__D019475
% 222.37/222.58       use CAMPHOR 5-MONOOXYGENASE %28%NM%29% to search CAMPHOR-5-MONOOXYGENASE 1980-96%A%  
% 222.37/222.58  |- skos__historyNote mesh__D019475 Hydroxylases %28%1973-1996%29%
% 222.37/222.58  |- skos__historyNote mesh__D019475 Cytochrome P-450 %28%1973-1996%29%
% 222.37/222.58  |- skos__hiddenLabel mesh__D019475 Camphor 5 Monooxygenase
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D019475 2006
% 222.37/222.58  |- mesh__historyNote mesh__D019475
% 222.37/222.58       97; was CAMPHOR-5-MONOOXYGENASE %28%NM%29% 1973-96   
% 222.37/222.58  |- rdf__type mesh__D019475sskos__Concept
% 222.37/222.58  |- skos__broader mesh__D019475smesh__D003577
% 222.37/222.58  |- skos__altLabel mesh__D019475 Cytochrome P-450 101
% 222.37/222.58  |- skos__hiddenLabel mesh__D019475 Cytochrome P 450 cam
% 222.37/222.58  |- mesh__recordOriginator mesh__D019475 ADP
% 222.37/222.58  |- mesh__dateCreated mesh__D019475 1996-06-24
% 222.37/222.58  |- skos__prefLabel mesh__D019475 Camphor 5-Monooxygenase
% 222.37/222.58  |- mesh__dateEstablished mesh__D019475 1997-01-01
% 222.37/222.58  |- skos__scopeNote mesh__D019475
% 222.37/222.58       A soluble cytochrome P-450 enzyme that catalyzes camphor monooxygenation in the presence of putidaredoxin, putidaredoxin reductase, and molecular oxygen. This enzyme, encoded by the CAMC gene also known as CYP101, has been crystallized from bacteria and the structure is well defined. Under anaerobic conditions, this enzyme reduces the polyhalogenated compounds bound at the camphor-binding site.%A%    
% 222.37/222.58  |- mesh__recordMaintainer mesh__D019475 ssb
% 222.37/222.58  |- skos__altLabel mesh__D019475 Cytochrome P-450%28%cam%29%
% 222.37/222.58  |- skos__altLabel mesh__D019475 CYP101
% 222.37/222.58  |- mesh__recordAuthorizer mesh__D019475 sjn
% 222.37/222.58  |- skos__altLabel mesh__D019475 Cytochrome P-450-cam
% 222.37/222.58  |- mesh__publicMeSHNote mesh__D019475
% 222.37/222.58       97; CAMPHOR-5-MONOOXYGENASE was indexed under CYTOCHROME P-450 %26% HYDROXYLASES 1973-96, %26% CAMPHOR 1973-82%A%  
% 222.37/222.58  |- skos__altLabel mesh__D019475 P450cam
% 222.37/222.58  |- skos__historyNote mesh__D019475 Camphor %28%1973-1982%29%
% 222.37/222.58  |- rdf__type mesh__D011492sskos__Concept
% 222.37/222.58  |- mesh__recordOriginator mesh__D011492 NLM
% 222.37/222.58  |- mesh__recordMaintainer mesh__D011492 SYSTEM
% 222.37/222.58  |- skos__annotation mesh__D011492
% 222.37/222.58       a ther agent %26% nutrient: do not confuse with the hydrolysis of proteins %28% = PROTEINS + HYDROLYSIS %28%NIM%29%%29%%A%  
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D011492 2006
% 222.37/222.58  |- skos__hiddenLabel mesh__D011492 Hydrolysates, Protein
% 222.37/222.58  |- mesh__dateCreated mesh__D011492 1999-01-01
% 222.37/222.58  |- skos__broader mesh__D011492smesh__D011506
% 222.37/222.58  |- skos__prefLabel mesh__D011492 Protein Hydrolysates
% 222.37/222.58  |- mesh__recordAuthorizer mesh__D011492 sjn
% 222.37/222.58  |- mesh__dateRevised mesh__D011492 2005-06-30
% 222.37/222.58  |- skos__broader mesh__D005455smesh__D007159
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Antibody Technics, Fluorescent
% 222.37/222.58  |- rdf__type mesh__D005455sskos__Concept
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Technique, Coon%27%s
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Antibody Techniques, Fluorescent
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Coon Technic
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D005455 2003
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Fluorescent Protein Tracings
% 222.37/222.58  |- skos__altLabel mesh__D005455 Coon%27%s Technique
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D005455 2006
% 222.37/222.58  |- skos__broader mesh__D005455smesh__D007150
% 222.37/222.58  |- mesh__recordMaintainer mesh__D005455 kle
% 222.37/222.58  |- mesh__publicMeSHNote mesh__D005455
% 222.37/222.58       91; was FLUORESCENT ANTIBODY TECHNIC 1963-90   
% 222.37/222.58  |- skos__prefLabel mesh__D005455 Fluorescent Antibody Technique
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Techniques, Fluorescent Antibody
% 222.37/222.58  |- skos__scopeNote mesh__D005455
% 222.37/222.58       Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye %28%FLUORESCENT ANTIBODY TECHNIQUE, DIRECT%29% or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody %28%FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT%29%. The tissue is then examined by fluorescence microscopy.%A%    
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D005455 2002
% 222.37/222.58  |- mesh__dateRevised mesh__D005455 2000-06-21
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Antibody Technique, Fluorescent
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D005455 2005
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Immunofluorescence Techniques
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Coons Technique
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Technique, Immunofluorescence
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Coons Technic
% 222.37/222.58  |- skos__altLabel mesh__D005455 Immunofluorescence Technique
% 222.37/222.58  |- skos__altLabel mesh__D005455 Fluorescent Antinuclear Antibody Test
% 222.37/222.58  |- mesh__dateCreated mesh__D005455 1999-01-01
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D005455 2001
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Technique, Fluorescent Antibody
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Protein Tracing, Fluorescent
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Techniques, Immunofluorescence
% 222.37/222.58  |- skos__altLabel mesh__D005455 Immunofluorescence Technic
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Fluorescent Antibody Technics
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Antibody Technic, Fluorescent
% 222.37/222.58  |- mesh__recordOriginator mesh__D005455 NLM
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Tracings, Fluorescent Protein
% 222.37/222.58  |- mesh__onlineNote mesh__D005455
% 222.37/222.58       use FLUORESCENT ANTIBODY TECHNIQUE to search FLUORESCENT ANTIBODY TECHNIC 1966-90%A%  
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Technics, Fluorescent Antibody
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Immunofluorescence Technics
% 222.37/222.58  |- skos__annotation mesh__D005455
% 222.37/222.58       NIM; GEN or unspecified; prefer specifics; DF: FANA TEST   
% 222.37/222.58  |- skos__altLabel mesh__D005455 Coon%27%s Technic
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Technics, Immunofluorescence
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Technic, Fluorescent Antibody
% 222.37/222.58  |- mesh__recordAuthorizer mesh__D005455 sjn
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Technic, Immunofluorescence
% 222.37/222.58  |- skos__altLabel mesh__D005455 Antinuclear Antibody Test, Fluorescent
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Protein Tracings, Fluorescent
% 222.37/222.58  |- mesh__historyNote mesh__D005455
% 222.37/222.58       91; was FLUORESCENT ANTIBODY TECHNIC 1963-90   
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Fluorescent Antibody Techniques
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D005455 2004
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Technic, Coon%27%s
% 222.37/222.58  |- skos__altLabel mesh__D005455 Fluorescent Antibody Technic
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Coon Technique
% 222.37/222.58  |- skos__hiddenLabel mesh__D005455 Tracing, Fluorescent Protein
% 222.37/222.58  |- mesh__publicMeSHNote mesh__D015085 74   
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015085 2003
% 222.37/222.58  |- mesh__historyNote mesh__D015085 74%28%71%29%   
% 222.37/222.58  |- mesh__recordMaintainer mesh__D015085 CCR
% 222.37/222.58  |- skos__broader mesh__D015085smesh__D006016
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015085 2002
% 222.37/222.58  |- mesh__dateCreated mesh__D015085 1999-01-01
% 222.37/222.58  |- mesh__dateRevised mesh__D015085 2000-06-21
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015085 2006
% 222.37/222.58  |- skos__scopeNote mesh__D015085
% 222.37/222.58       An herbicide with strong irritant properties. Use of this compound on rice fields, orchards, sugarcane, rangeland, and other noncrop sites was terminated by the EPA in 1985. %28%From Merck Index, 11th ed%29%%A%    
% 222.37/222.58  |- skos__prefLabel mesh__D015085 2,4,5-Trichlorophenoxyacetic Acid
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015085 2001
% 222.37/222.58  |- mesh__recordAuthorizer mesh__D015085 sjn
% 222.37/222.58  |- mesh__dateEstablished mesh__D015085 1974-01-01
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015085 2005
% 222.37/222.58  |- skos__historyNote mesh__D015085 Acetic Acids %28%1966-1970%29%
% 222.37/222.58  |- rdf__type mesh__D015085sskos__Concept
% 222.37/222.58  |- skos__historyNote mesh__D015085 Herbicides %28%1966-1970%29%
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D015085 2004
% 222.37/222.58  |- skos__historyNote mesh__D015085 Phenols %28%1966-1970%29%
% 222.37/222.58  |- skos__altLabel mesh__D015085 2,4,5-T
% 222.37/222.58  |- mesh__recordOriginator mesh__D015085 NLM
% 222.37/222.58  |- mesh__publicMeSHNote mesh__D009846 91; was see under ANURIA 1975-90   
% 222.37/222.58  |- skos__scopeNote mesh__D009846
% 222.37/222.58       Clinical manifestation of the urinary system consisting of a decrease in the amount of urine secreted.%A%    
% 222.37/222.58  |- skos__broader mesh__D009846smesh__D020924
% 222.37/222.58  |- skos__annotation mesh__D009846 do not confuse with ANURIA   
% 222.37/222.58  |- mesh__historyNote mesh__D009846
% 222.37/222.58       91%28%75%29%; was see under ANURIA 1975-90   
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009846 2005
% 222.37/222.58  |- mesh__dateRevised mesh__D009846 1999-11-09
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009846 2000
% 222.37/222.58  |- skos__broader mesh__D009846smesh__D014555
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009846 2006
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009846 2003
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009846 2001
% 222.37/222.58  |- mesh__recordAuthorizer mesh__D009846 sjn
% 222.37/222.58  |- mesh__onlineNote mesh__D009846 search ANURIA 1966-74   
% 222.37/222.58  |- mesh__recordOriginator mesh__D009846 NLM
% 222.37/222.58  |- mesh__dateEstablished mesh__D009846 1991-01-01
% 222.37/222.58  |- mesh__dateCreated mesh__D009846 1999-01-01
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009846 2004
% 222.37/222.58  |- mesh__activeMeSHYear mesh__D009846 2002
% 222.37/222.58  |- mesh__recordMaintainer mesh__D009846 jls
% 222.37/222.58  |- rdf__type mesh__D009846sskos__Concept
% 222.37/222.59  |- skos__hiddenLabel mesh__D009846 Oligurias
% 222.37/222.59  |- skos__prefLabel mesh__D009846 Oliguria
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001863 2004
% 222.37/222.59  |- mesh__recordOriginator mesh__D001863 NLM
% 222.37/222.59  |- mesh__recordMaintainer mesh__D001863 PXP
% 222.37/222.59  |- mesh__historyNote mesh__D001863 74%28%71%29%   
% 222.37/222.59  |- mesh__dateCreated mesh__D001863 1999-01-01
% 222.37/222.59  |- skos__broader mesh__D001863smesh__D019736
% 222.37/222.59  |- mesh__dateEstablished mesh__D001863 1974-01-01
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001863 2000
% 222.37/222.59  |- skos__historyNote mesh__D001863
% 222.37/222.59       Fracture Fixation, Intramedullary %28%1970%29%
% 222.37/222.59  |- skos__historyNote mesh__D001863 Fracture Fixation %28%1966-1970%29%
% 222.37/222.59  |- rdf__type mesh__D001863sskos__Concept
% 222.37/222.59  |- skos__related mesh__D001863smesh__D001864
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001863 2005
% 222.37/222.59  |- skos__related mesh__D001863smesh__D001858
% 222.37/222.59  |- skos__hiddenLabel mesh__D001863 Screws, Bone
% 222.37/222.59  |- skos__prefLabel mesh__D001863 Bone Screws
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001863 2001
% 222.37/222.59  |- skos__annotation mesh__D001863
% 222.37/222.59       do not confuse with BONE PINS see BONE NAILS   
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001863 2006
% 222.37/222.59  |- mesh__dateRevised mesh__D001863 1997-06-20
% 222.37/222.59  |- mesh__recordAuthorizer mesh__D001863 SJN
% 222.37/222.59  |- mesh__publicMeSHNote mesh__D001863 74   
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001863 1998
% 222.37/222.59  |- skos__broader mesh__D001863smesh__D009984
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001863 2003
% 222.37/222.59  |- skos__historyNote mesh__D001863 Fracture Fixation, Internal %28%1970%29%
% 222.37/222.59  |- skos__hiddenLabel mesh__D001863 Screw, Bone
% 222.37/222.59  |- skos__hiddenLabel mesh__D001863 Bone Screw
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001863 2002
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001863 1999
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009048 1999
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009048 2006
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009048 1995
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009048 2002
% 222.37/222.59  |- skos__hiddenLabel mesh__D009048 Motor Skill
% 222.37/222.59  |- skos__broader mesh__D009048smesh__D011597
% 222.37/222.59  |- rdf__type mesh__D009048sskos__Concept
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009048 2000
% 222.37/222.59  |- mesh__recordAuthorizer mesh__D009048 PLS
% 222.37/222.59  |- skos__hiddenLabel mesh__D009048 Skills, Motor
% 222.37/222.59  |- skos__prefLabel mesh__D009048 Motor Skills
% 222.37/222.59  |- mesh__dateRevised mesh__D009048 1992-05-15
% 222.37/222.59  |- mesh__recordOriginator mesh__D009048 NLM
% 222.37/222.59  |- skos__hiddenLabel mesh__D009048 Skill, Motor
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009048 1996
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009048 2003
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009048 2001
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009048 2004
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009048 1997
% 222.37/222.59  |- mesh__recordMaintainer mesh__D009048 TAP
% 222.37/222.59  |- skos__scopeNote mesh__D009048 Performance of complex motor acts.     
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009048 1998
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009048 2005
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009048 1993
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009048 1994
% 222.37/222.59  |- mesh__dateCreated mesh__D009048 1999-01-01
% 222.37/222.59  |- mesh__dateRevised mesh__D001065 2003-07-09
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001065 2004
% 222.37/222.59  |- mesh__recordAuthorizer mesh__D001065 sjn
% 222.37/222.59  |- mesh__dateCreated mesh__D001065 1999-01-01
% 222.37/222.59  |- rdf__type mesh__D001065sskos__Concept
% 222.37/222.59  |- skos__hiddenLabel mesh__D001065 Appendix, Vermiform
% 222.37/222.59  |- skos__broader mesh__D001065smesh__D002432
% 222.37/222.59  |- skos__related mesh__D001065smesh__D001062
% 222.37/222.59  |- skos__scopeNote mesh__D001065
% 222.37/222.59       A worm-like blind tube extension from the CECUM.     
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001065 2005
% 222.37/222.59  |- mesh__recordOriginator mesh__D001065 NLM
% 222.37/222.59  |- skos__annotation mesh__D001065
% 222.37/222.59       /surg: probably APPENDECTOMY; diseases: coord IM with CECAL DISEASES %28%IM%29%; inflammation = APPENDICITIS; %22%ruptured%22% or %22%perforated%22% appendix: see note under APPENDICITIS%A%  
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001065 2006
% 222.37/222.59  |- mesh__recordMaintainer mesh__D001065 lkt
% 222.37/222.59  |- skos__altLabel mesh__D001065 Vermiform Appendix
% 222.37/222.59  |- skos__prefLabel mesh__D001065 Appendix
% 222.37/222.59  |- skos__annotation mesh__D028202
% 222.37/222.59       DOUGLAS FIR see PSEUDOTSUGA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.37/222.59  |- mesh__dateRevised mesh__D028202 2003-07-09
% 222.37/222.59  |- mesh__publicMeSHNote mesh__D028202 2002   
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D028202 2005
% 222.37/222.59  |- mesh__dateCreated mesh__D028202 2001-07-25
% 222.37/222.59  |- skos__historyNote mesh__D028202 Trees %28%1966-2001%29%
% 222.37/222.59  |- rdf__type mesh__D028202sskos__Concept
% 222.37/222.59  |- skos__broader mesh__D028202smesh__D028201
% 222.37/222.59  |- mesh__historyNote mesh__D028202 2002   
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D028202 2006
% 222.37/222.59  |- skos__scopeNote mesh__D028202
% 222.37/222.59       A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta. Balm of Gilead is a common name more often referring to POPULUS and sometimes to COMMIPHORA.%A%    
% 222.37/222.59  |- skos__altLabel mesh__D028202 Fir, Balsam
% 222.37/222.59  |- skos__altLabel mesh__D028202 Balsam Fir
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D028202 2004
% 222.37/222.59  |- skos__prefLabel mesh__D028202 Abies
% 222.37/222.59  |- skos__altLabel mesh__D028202 Fir Tree
% 222.37/222.59  |- mesh__dateEstablished mesh__D028202 2002-01-01
% 222.37/222.59  |- mesh__recordAuthorizer mesh__D019476 sjn
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D019476 2006
% 222.37/222.59  |- mesh__dateRevised mesh__D019476 2005-06-30
% 222.37/222.59  |- rdf__type mesh__D019476sskos__Concept
% 222.37/222.59  |- skos__historyNote mesh__D019476 specific insect %28%1966-1996%29%
% 222.37/222.59  |- skos__historyNote mesh__D019476 Proteins %28%1966-1996%29%
% 222.37/222.59  |- mesh__dateCreated mesh__D019476 1996-06-10
% 222.37/222.59  |- mesh__recordOriginator mesh__D019476 PXP
% 222.37/222.59  |- skos__annotation mesh__D019476
% 222.37/222.59       /drug eff /ultrastruct permitted; /physiol permitted for function within the insect; coord IM with specific protein %28%IM%29% + specific insect %28%IM%29%%A%  
% 222.37/222.59  |- skos__prefLabel mesh__D019476 Insect Proteins
% 222.37/222.59  |- skos__broader mesh__D019476smesh__D011506
% 222.37/222.59  |- skos__scopeNote mesh__D019476
% 222.37/222.59       Proteins found in any species of insect.     
% 222.37/222.59  |- mesh__historyNote mesh__D019476 97   
% 222.37/222.59  |- mesh__recordMaintainer mesh__D019476 SYSTEM
% 222.37/222.59  |- mesh__dateEstablished mesh__D019476 1997-01-01
% 222.37/222.59  |- skos__hiddenLabel mesh__D019476 Proteins, Insect
% 222.37/222.59  |- mesh__publicMeSHNote mesh__D019476 97   
% 222.37/222.59  |- mesh__recordOriginator mesh__D011493 RLS
% 222.37/222.59  |- skos__broader mesh__D011493smesh__D017346
% 222.37/222.59  |- skos__hiddenLabel mesh__D011493
% 222.37/222.59       Calcium Phospholipid Dependent Protein Kinase
% 222.37/222.59  |- skos__hiddenLabel mesh__D011493
% 222.37/222.59       Calcium Activated Phospholipid Dependent Kinase
% 222.37/222.59  |- skos__scopeNote mesh__D011493
% 222.37/222.59       An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters.%A%    
% 222.37/222.59  |- rdf__type mesh__D011493sskos__Concept
% 222.37/222.59  |- mesh__publicMeSHNote mesh__D011493
% 222.37/222.59       86; CALCIUM PHOSPHOLIPID-DEPENDENT PROTEIN KINASE was CALCIUM-PHOSPHOLIPID DEPENDENT PROTEIN KINASE 1986-93%A%  
% 222.37/222.59  |- skos__altLabel mesh__D011493 PKC Serine-Threonine Kinase
% 222.37/222.59  |- mesh__recordAuthorizer mesh__D011493 sjn
% 222.37/222.59  |- skos__hiddenLabel mesh__D011493 Serine-Threonine Kinase, PKC
% 222.37/222.59  |- skos__hiddenLabel mesh__D011493 PKC Serine Threonine Kinase
% 222.37/222.59  |- mesh__dateRevised mesh__D011493 2005-06-30
% 222.37/222.59  |- skos__hiddenLabel mesh__D011493
% 222.37/222.59       Phospholipid Sensitive Calcium Dependent Protein Kinase
% 222.37/222.59  |- skos__prefLabel mesh__D011493 Protein Kinase C
% 222.37/222.59  |- mesh__dateCreated mesh__D011493 1985-05-17
% 222.37/222.59  |- mesh__historyNote mesh__D011493
% 222.37/222.59       86; CALCIUM PHOSPHOLIPID-DEPENDENT PROTEIN KINASE was CALCIUM-PHOSPHOLIPID DEPENDENT PROTEIN KINASE 1986-93%A%  
% 222.37/222.59  |- skos__altLabel mesh__D011493
% 222.37/222.59       Calcium-Activated Phospholipid-Dependent Kinase
% 222.37/222.59  |- skos__altLabel mesh__D011493
% 222.37/222.59       Phospholipid-Sensitive Calcium-Dependent Protein Kinase
% 222.37/222.59  |- mesh__recordMaintainer mesh__D011493 jmp
% 222.37/222.59  |- skos__historyNote mesh__D011493 Protein Kinases %28%1973-1985%29%
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D011493 2006
% 222.37/222.59  |- mesh__dateEstablished mesh__D011493 1986-01-01
% 222.37/222.59  |- skos__hiddenLabel mesh__D011493
% 222.37/222.59       Phospholipid-Dependent Kinase, Calcium-Activated
% 222.37/222.59  |- skos__altLabel mesh__D011493
% 222.37/222.59       Calcium Phospholipid-Dependent Protein Kinase
% 222.37/222.59  |- rdf__type mesh__D005456sskos__Concept
% 222.37/222.59  |- skos__prefLabel mesh__D005456 Fluorescent Dyes
% 222.37/222.59  |- mesh__recordOriginator mesh__D005456 NLM
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D005456 2006
% 222.37/222.59  |- skos__annotation mesh__D005456 D25-26 qualif   
% 222.37/222.59  |- skos__altLabel mesh__D005456 Fluorescence Agents
% 222.37/222.59  |- mesh__dateCreated mesh__D005456 1999-01-01
% 222.37/222.59  |- skos__hiddenLabel mesh__D005456 Agents, Fluorescence
% 222.37/222.59  |- skos__hiddenLabel mesh__D005456 Agents, Fluorescent
% 222.37/222.59  |- skos__scopeNote mesh__D005456
% 222.37/222.59       Agents that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags.%A%    
% 222.37/222.59  |- skos__broader mesh__D005456smesh__D004396
% 222.37/222.59  |- skos__hiddenLabel mesh__D005456 Substrate, Fluorogenic
% 222.37/222.59  |- mesh__recordAuthorizer mesh__D005456 sjn
% 222.37/222.59  |- mesh__dateRevised mesh__D005456 2005-06-30
% 222.37/222.59  |- skos__hiddenLabel mesh__D005456 Probes, Fluorescent
% 222.37/222.59  |- skos__broader mesh__D005456smesh__D049408
% 222.37/222.59  |- skos__altLabel mesh__D005456 Fluorescent Agents
% 222.37/222.59  |- mesh__recordMaintainer mesh__D005456 ssb
% 222.37/222.59  |- skos__hiddenLabel mesh__D005456 Dyes, Fluorescent
% 222.37/222.59  |- skos__hiddenLabel mesh__D015086 Sodium 2,6 Dichloroindophenol
% 222.37/222.59  |- skos__altLabel mesh__D015086 Dichlorophenolindophenol
% 222.37/222.59  |- skos__annotation mesh__D015086 D25-26 qualif   
% 222.37/222.59  |- mesh__recordOriginator mesh__D015086 NLM
% 222.37/222.59  |- skos__hiddenLabel mesh__D015086 Dye, 2,6-Dichlorobenzenoneindophenol
% 222.37/222.59  |- skos__hiddenLabel mesh__D015086 2,6-Dichloroindophenol, Sodium
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D015086 2006
% 222.37/222.59  |- mesh__recordMaintainer mesh__D015086 CCR
% 222.37/222.59  |- skos__historyNote mesh__D015086 Indophenol %28%1972-1974%29%
% 222.37/222.59  |- skos__hiddenLabel mesh__D015086 Indophenol, Dichlorophenol
% 222.37/222.59  |- mesh__dateRevised mesh__D015086 2000-06-22
% 222.37/222.59  |- mesh__historyNote mesh__D015086
% 222.37/222.59       91%28%75%29%; was see under INDOPHENOL 1975-90   
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D015086 2005
% 222.37/222.59  |- rdf__type mesh__D015086sskos__Concept
% 222.37/222.59  |- skos__hiddenLabel mesh__D015086 Tillman Reagent
% 222.37/222.59  |- skos__altLabel mesh__D015086 Dichlorophenol Indophenol
% 222.37/222.59  |- skos__hiddenLabel mesh__D015086 Reagent, Tillmans
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D015086 2002
% 222.37/222.59  |- skos__hiddenLabel mesh__D015086 2,6 Dichlorobenzenoneindophenol Dye
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D015086 2004
% 222.37/222.59  |- mesh__publicMeSHNote mesh__D015086
% 222.37/222.59       91; was see under INDOPHENOL 1975-90   
% 222.37/222.59  |- skos__prefLabel mesh__D015086 2,6-Dichloroindophenol
% 222.37/222.59  |- skos__historyNote mesh__D015086 Chlorine %28%1972-1974%29%
% 222.37/222.59  |- mesh__dateCreated mesh__D015086 1974-11-19
% 222.37/222.59  |- skos__hiddenLabel mesh__D015086 Tillman%27%s Reagent
% 222.37/222.59  |- skos__hiddenLabel mesh__D015086 Dichloroindophenol, 2,6
% 222.37/222.59  |- skos__altLabel mesh__D015086 2,6 Dichloroindophenol
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D015086 2001
% 222.37/222.59  |- mesh__recordAuthorizer mesh__D015086 sjn
% 222.37/222.59  |- skos__hiddenLabel mesh__D015086 Reagent, Tillmans%27%
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D015086 2003
% 222.37/222.59  |- skos__broader mesh__D015086smesh__D007215
% 222.37/222.59  |- skos__scopeNote mesh__D015086
% 222.37/222.59       A dye used as a reagent in the determination of vitamin C.%A%    
% 222.37/222.59  |- skos__hiddenLabel mesh__D015086 2,6 Dichlorophenolindophenol
% 222.37/222.59  |- skos__altLabel mesh__D015086 Tillmans Reagent
% 222.37/222.59  |- mesh__dateEstablished mesh__D015086 1991-01-01
% 222.37/222.59  |- skos__altLabel mesh__D015086 2,6-Dichlorobenzenoneindophenol Dye
% 222.37/222.59  |- skos__altLabel mesh__D015086 2,6-Dichlorophenolindophenol
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009847 1993
% 222.37/222.59  |- skos__hiddenLabel mesh__D009847 Olivary Basal Nucleus
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009847 1998
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009847 2005
% 222.37/222.59  |- skos__altLabel mesh__D009847 Nucleus Basalis, Olivary
% 222.37/222.59  |- skos__prefLabel mesh__D009847 Olivary Nucleus
% 222.37/222.59  |- skos__hiddenLabel mesh__D009847 Basalis, Olivary Nucleus
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009847 1999
% 222.37/222.59  |- mesh__recordMaintainer mesh__D009847 TAP
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009847 2006
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009847 1996
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009847 2003
% 222.37/222.59  |- skos__altLabel mesh__D009847 Basal Nucleus, Olivary
% 222.37/222.59  |- mesh__dateRevised mesh__D009847 1992-05-15
% 222.37/222.59  |- mesh__recordAuthorizer mesh__D009847 PLS
% 222.37/222.59  |- mesh__dateCreated mesh__D009847 1999-01-01
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009847 1997
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009847 2004
% 222.37/222.59  |- rdf__type mesh__D009847sskos__Concept
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009847 2000
% 222.37/222.59  |- skos__broader mesh__D009847smesh__D008526
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009847 1994
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009847 2001
% 222.37/222.59  |- mesh__recordOriginator mesh__D009847 NLM
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009847 1995
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009847 2002
% 222.37/222.59  |- skos__hiddenLabel mesh__D009847 Nucleus, Olivary Basal
% 222.37/222.59  |- skos__hiddenLabel mesh__D009847 Nucleus, Olivary
% 222.37/222.59  |- skos__hiddenLabel mesh__D001864 Wires, Bone
% 222.37/222.59  |- skos__prefLabel mesh__D001864 Bone Wires
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001864 2002
% 222.37/222.59  |- rdf__type mesh__D001864sskos__Concept
% 222.37/222.59  |- mesh__recordMaintainer mesh__D001864 PXP
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001864 2005
% 222.37/222.59  |- skos__annotation mesh__D001864
% 222.37/222.59       do not confuse with BONE PINS see BONE NAILS   
% 222.37/222.59  |- skos__scopeNote mesh__D001864
% 222.37/222.59       Steel wires, often threaded through the skin, soft tissues, and bone, used to fix broken bones. Kirschner wires or apparatus also includes the application of traction to the healing bones through the wires.%A%    
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001864 2006
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001864 2000
% 222.37/222.59  |- skos__broader mesh__D001864smesh__D009984
% 222.37/222.59  |- mesh__dateCreated mesh__D001864 1985-06-07
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001864 1998
% 222.37/222.59  |- mesh__publicMeSHNote mesh__D001864
% 222.37/222.59       91; was see under ORTHOPEDIC FIXATION DEVICES 1986-90   
% 222.37/222.59  |- skos__hiddenLabel mesh__D001864 Wire, Bone
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001864 2003
% 222.37/222.59  |- skos__historyNote mesh__D001864
% 222.37/222.59       Fracture Fixation, Internal %28%1970-1985%29%
% 222.37/222.59  |- skos__related mesh__D001864smesh__D001858
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001864 2001
% 222.37/222.59  |- mesh__dateEstablished mesh__D001864 1991-01-01
% 222.37/222.59  |- skos__hiddenLabel mesh__D001864 Bone Wire
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001864 1999
% 222.37/222.59  |- mesh__recordOriginator mesh__D001864 SH
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001864 2004
% 222.37/222.59  |- skos__related mesh__D001864smesh__D001863
% 222.37/222.59  |- skos__hiddenLabel mesh__D001864 Wires, Kirschner
% 222.37/222.59  |- mesh__dateRevised mesh__D001864 1997-06-20
% 222.37/222.59  |- mesh__recordAuthorizer mesh__D001864 SJN
% 222.37/222.59  |- mesh__historyNote mesh__D001864
% 222.37/222.59       91%28%86%29%; was see under ORTHOPEDIC FIXATION DEVICES 1986-90%A%  
% 222.37/222.59  |- skos__broader mesh__D051760Q000172smesh__D051760
% 222.37/222.59  |- mesh__preferredCombination mesh__D051760Q000172smesh__D014983
% 222.37/222.59  |- rdf__type mesh__D051760Q000172smesh__CompoundConcept
% 222.37/222.59  |- mesh__dateCreated mesh__D009049 1986-04-18
% 222.37/222.59  |- mesh__dateEstablished mesh__D009049 1987-01-01
% 222.37/222.59  |- mesh__publicMeSHNote mesh__D009049 87   
% 222.37/222.59  |- mesh__recordMaintainer mesh__D009049 JLS
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009049 2002
% 222.37/222.59  |- rdf__type mesh__D009049sskos__Concept
% 222.37/222.59  |- mesh__historyNote mesh__D009049 87   
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009049 2003
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009049 1996
% 222.37/222.59  |- mesh__dateRevised mesh__D009049 1995-05-31
% 222.37/222.59  |- mesh__recordOriginator mesh__D009049 VDK
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009049 1998
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009049 2005
% 222.37/222.59  |- skos__annotation mesh__D009049
% 222.37/222.59       MOTORCYCLES are public-road vehicles: OFF-ROAD MOTOR VEHICLES is also available%A%  
% 222.37/222.59  |- skos__hiddenLabel mesh__D009049 Moped
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009049 1997
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009049 2004
% 222.37/222.59  |- skos__hiddenLabel mesh__D009049 Motorcycle
% 222.37/222.59  |- skos__prefLabel mesh__D009049 Motorcycles
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009049 2006
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009049 1999
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009049 2000
% 222.37/222.59  |- mesh__recordAuthorizer mesh__D009049 PLS
% 222.37/222.59  |- skos__broader mesh__D009049smesh__D018986
% 222.37/222.59  |- skos__related mesh__D009049smesh__D015541
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D009049 2001
% 222.37/222.59  |- skos__scopeNote mesh__D009049 Two-wheeled, engine-driven vehicles.     
% 222.37/222.59  |- skos__historyNote mesh__D009049 Transportation %28%1976-1986%29%
% 222.37/222.59  |- mesh__dateCreated mesh__D001066 1999-01-01
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001066 2004
% 222.37/222.59  |- mesh__recordMaintainer mesh__D001066 PLS
% 222.37/222.59  |- mesh__recordAuthorizer mesh__D001066 PLS
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001066 2006
% 222.37/222.59  |- mesh__recordOriginator mesh__D001066 NLM
% 222.37/222.59  |- skos__hiddenLabel mesh__D001066 Alterations, Appetite
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001066 2003
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001066 2005
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001066 1997
% 222.37/222.59  |- skos__prefLabel mesh__D001066 Appetite
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001066 1999
% 222.37/222.59  |- rdf__type mesh__D001066sskos__Concept
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001066 2002
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001066 1996
% 222.37/222.59  |- skos__annotation mesh__D001066
% 222.37/222.59       /drug eff: consider also APPETITE DEPRESSANTS   
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001066 1998
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001066 2001
% 222.37/222.59  |- skos__hiddenLabel mesh__D001066 Alteration, Appetite
% 222.37/222.59  |- skos__related mesh__D001066smesh__D001067
% 222.37/222.59  |- skos__scopeNote mesh__D001066 Natural recurring desire for food.     
% 222.37/222.59  |- skos__hiddenLabel mesh__D001066 Appetite Alteration
% 222.37/222.59  |- skos__broader mesh__D001066smesh__D004068
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D001066 2000
% 222.37/222.59  |- skos__broader mesh__D001066smesh__D011603
% 222.37/222.59  |- mesh__dateRevised mesh__D001066 1995-05-25
% 222.37/222.59  |- skos__hiddenLabel mesh__D001066 Appetites
% 222.37/222.59  |- skos__scopeNote mesh__D028203
% 222.37/222.59       A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta.  It is the source of cedarwood oil.  Cedar ordinarily refers to this but also forms part of the name of plants in other genera.%A%    
% 222.37/222.59  |- skos__annotation mesh__D028203
% 222.37/222.59       X ref CEDAR TREE:  check text; restrict to genus CEDRUS; do not use for other genera referred to as cedar in the literature; check MeSH for other cedar terms; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.37/222.59  |- mesh__publicMeSHNote mesh__D028203 2002   
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D028203 2005
% 222.37/222.59  |- rdf__type mesh__D028203sskos__Concept
% 222.37/222.59  |- skos__broader mesh__D028203smesh__D028201
% 222.37/222.59  |- skos__altLabel mesh__D028203 Cedar Tree
% 222.37/222.59  |- skos__historyNote mesh__D028203 Trees %28%1965-2001%29%
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D028203 2006
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D028203 2004
% 222.37/222.59  |- mesh__dateCreated mesh__D028203 2001-07-25
% 222.37/222.59  |- mesh__dateEstablished mesh__D028203 2002-01-01
% 222.37/222.59  |- skos__prefLabel mesh__D028203 Cedrus
% 222.37/222.59  |- mesh__historyNote mesh__D028203 2002   
% 222.37/222.59  |- mesh__dateRevised mesh__D028203 2003-07-09
% 222.37/222.59  |- mesh__publicMeSHNote mesh__D020220 2000   
% 222.37/222.59  |- skos__hiddenLabel mesh__D020220 Trauma, Facial Nerve
% 222.37/222.59  |- mesh__dateCreated mesh__D020220 1999-11-03
% 222.37/222.59  |- skos__historyNote mesh__D020220 Facial Nerve %28%1966-1980%29%
% 222.37/222.59  |- mesh__historyNote mesh__D020220 2000   
% 222.37/222.59  |- skos__hiddenLabel mesh__D020220 Nerve Avulsions, Facial
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D020220 2004
% 222.37/222.59  |- skos__historyNote mesh__D020220 Facial Nerve Diseases %28%1981-1999%29%
% 222.37/222.59  |- skos__altLabel mesh__D020220 Facial Neuropathy, Traumatic
% 222.37/222.59  |- skos__hiddenLabel mesh__D020220 Injuries, Facial Nerve
% 222.37/222.59  |- skos__hiddenLabel mesh__D020220 Nerve Injuries, Facial
% 222.37/222.59  |- skos__historyNote mesh__D020220 Facial Paralysis %28%1965-1999%29%
% 222.37/222.59  |- skos__hiddenLabel mesh__D020220 Facial Neuropathies, Traumatic
% 222.37/222.59  |- mesh__recordMaintainer mesh__D020220 sjn
% 222.37/222.59  |- skos__hiddenLabel mesh__D020220 Facial Nerve Injury
% 222.37/222.59  |- skos__hiddenLabel mesh__D020220 Traumas, Facial Nerve
% 222.37/222.59  |- skos__hiddenLabel mesh__D020220 Nerve Traumas, Facial
% 222.37/222.59  |- skos__broader mesh__D020220smesh__D020209
% 222.37/222.59  |- skos__hiddenLabel mesh__D020220 Nerve Trauma, Facial
% 222.37/222.59  |- skos__altLabel mesh__D020220 Cranial Nerve VII Injuries
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D020220 2006
% 222.37/222.59  |- skos__hiddenLabel mesh__D020220 Avulsions, Facial Nerve
% 222.37/222.59  |- skos__hiddenLabel mesh__D020220 Traumatic Facial Neuropathies
% 222.37/222.59  |- skos__altLabel mesh__D020220 Facial Nerve Trauma
% 222.37/222.59  |- skos__hiddenLabel mesh__D020220 Facial Nerve Avulsions
% 222.37/222.59  |- skos__scopeNote mesh__D020220
% 222.37/222.59       Traumatic injuries to the facial nerve. This may result in FACIAL PARALYSIS, decreased lacrimation and salivation, and loss of taste sensation in the anterior tongue. The nerve may regenerate and reform its original pattern of innervation, or regenerate aberrantly, resulting in inappropriate lacrimation in response to gustatory stimuli %28%e.g., %22%crocodile tears%22%%29% and other syndromes.%A%    
% 222.37/222.59  |- skos__broader mesh__D020220smesh__D005155
% 222.37/222.59  |- skos__hiddenLabel mesh__D020220 Neuropathy, Traumatic Facial
% 222.37/222.59  |- mesh__recordAuthorizer mesh__D020220 sjn
% 222.37/222.59  |- skos__altLabel mesh__D020220 Injuries, Cranial Nerve VII
% 222.37/222.59  |- mesh__dateEstablished mesh__D020220 2000-01-01
% 222.37/222.59  |- mesh__dateRevised mesh__D020220 2003-07-22
% 222.37/222.59  |- skos__altLabel mesh__D020220 Nerve Injury, Facial
% 222.37/222.59  |- rdf__type mesh__D020220sskos__Concept
% 222.37/222.59  |- skos__hiddenLabel mesh__D020220 Traumatic Facial Neuropathy
% 222.37/222.59  |- skos__prefLabel mesh__D020220 Facial Nerve Injuries
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D020220 2005
% 222.37/222.59  |- skos__altLabel mesh__D020220 Injuries, Seventh Cranial Nerve
% 222.37/222.59  |- skos__hiddenLabel mesh__D020220 Avulsion, Facial Nerve
% 222.37/222.59  |- skos__hiddenLabel mesh__D020220 Nerve Avulsion, Facial
% 222.37/222.59  |- skos__hiddenLabel mesh__D020220 Neuropathies, Traumatic Facial
% 222.37/222.59  |- skos__hiddenLabel mesh__D020220 Facial Nerve Traumas
% 222.37/222.59  |- skos__altLabel mesh__D020220 Injury, Facial Nerve
% 222.37/222.59  |- skos__altLabel mesh__D020220 Seventh Cranial Nerve Injuries
% 222.37/222.59  |- mesh__recordOriginator mesh__D020220 KEV
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D047168 2005
% 222.37/222.59  |- rdf__type mesh__D047168sskos__Concept
% 222.37/222.59  |- mesh__recordOriginator mesh__D047168 ssb
% 222.37/222.59  |- mesh__recordMaintainer mesh__D047168 ssb
% 222.37/222.59  |- skos__hiddenLabel mesh__D047168 Knot Motifs, Cystine
% 222.37/222.59  |- mesh__dateEstablished mesh__D047168 2005-01-01
% 222.37/222.59  |- skos__hiddenLabel mesh__D047168 Cystine Knot Motif
% 222.37/222.59  |- skos__scopeNote mesh__D047168
% 222.37/222.59       Amino acid sequence in which two disulfide bonds %28%DISULFIDES%29% and their connecting backbone form a ring that is penetrated by a third disulfide bond. Members include CYCLOTIDES and agouti-related protein.%A%    
% 222.37/222.59  |- skos__prefLabel mesh__D047168 Cystine Knot Motifs
% 222.37/222.59  |- skos__hiddenLabel mesh__D047168 Knot Motif, Cystine
% 222.37/222.59  |- skos__broader mesh__D047168smesh__D020816
% 222.37/222.59  |- mesh__publicMeSHNote mesh__D047168 2005   
% 222.37/222.59  |- mesh__dateCreated mesh__D047168 2004-07-07
% 222.37/222.59  |- mesh__recordAuthorizer mesh__D047168 sjn
% 222.37/222.59  |- skos__hiddenLabel mesh__D047168 Motifs, Cystine Knot
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D047168 2006
% 222.37/222.59  |- mesh__historyNote mesh__D047168 2005   
% 222.37/222.59  |- skos__hiddenLabel mesh__D047168 Motif, Cystine Knot
% 222.37/222.59  |- mesh__dateCreated mesh__D019477 1996-06-21
% 222.37/222.59  |- mesh__historyNote mesh__D019477 1997   
% 222.37/222.59  |- mesh__recordMaintainer mesh__D019477 jls
% 222.37/222.59  |- skos__annotation mesh__D019477
% 222.37/222.59       publication type only; for single individuals %26% for group portraits; for portraits as a subject, index under main heading PORTRAITS%A%  
% 222.37/222.59  |- mesh__recordOriginator mesh__D019477 TGC
% 222.37/222.59  |- skos__scopeNote mesh__D019477
% 222.37/222.59       Works consisting of graphic representations, especially of the face, of real persons, usually posed, living or dead. They are pictures whose purpose is the portrayal of an individual or group of individuals, not pictures which merely include people as part of an event or scene. %28%From Thesaurus for Graphic Materials II, p540, 1995%29%%A%    
% 222.37/222.59  |- mesh__activeMeSHYear mesh__D019477 2006
% 222.37/222.59  |- skos__altLabel mesh__D019477 Portraits %28%PT%29%
% 222.37/222.59  |- mesh__recordAuthorizer mesh__D019477 sjn
% 222.37/222.59  |- rdf__type mesh__D019477sskos__Concept
% 222.37/222.59  |- mesh__dateEstablished mesh__D019477 1997-01-01
% 222.37/222.59  |- mesh__dateRevised mesh__D019477 2005-06-30
% 222.37/222.60  |- skos__prefLabel mesh__D019477 Portraits %5B%Publication Type%5D%
% 222.37/222.60  |- skos__broader mesh__D019477smesh__D020495
% 222.37/222.60  |- rdf__type mesh__D011494sskos__Concept
% 222.37/222.60  |- mesh__publicMeSHNote mesh__D011494 80; was PROTEIN KINASE 1974-79   
% 222.37/222.60  |- mesh__onlineNote mesh__D011494
% 222.37/222.60       use PROTEIN KINASES to search PROTEIN KINASE 1973-79 %28%as Prov 1973%29%%A%  
% 222.37/222.60  |- mesh__dateRevised mesh__D011494 2004-07-07
% 222.37/222.60  |- mesh__recordAuthorizer mesh__D011494 sjn
% 222.37/222.60  |- skos__altLabel mesh__D011494 Protein Kinase
% 222.37/222.60  |- skos__broader mesh__D011494smesh__D017853
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D011494 2006
% 222.37/222.60  |- mesh__recordOriginator mesh__D011494 NLM
% 222.37/222.60  |- mesh__dateEstablished mesh__D011494 1974-01-01
% 222.37/222.60  |- skos__hiddenLabel mesh__D011494 Kinases, Protein
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D011494 2005
% 222.37/222.60  |- mesh__recordMaintainer mesh__D011494 ssb
% 222.37/222.60  |- mesh__dateCreated mesh__D011494 1999-01-01
% 222.37/222.60  |- skos__prefLabel mesh__D011494 Protein Kinases
% 222.37/222.60  |- mesh__historyNote mesh__D011494
% 222.37/222.60       80; was PROTEIN KINASE 1973-79 %28%Prov 1973%29%   
% 222.37/222.60  |- skos__scopeNote mesh__D011494
% 222.37/222.60       A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein. EC 2.7.1.37.%A%    
% 222.37/222.60  |- skos__hiddenLabel mesh__D011494 Kinase, Protein
% 222.37/222.60  |- skos__broader mesh__D013252Q000172smesh__D013252
% 222.37/222.60  |- mesh__preferredCombination mesh__D013252Q000172smesh__D000312
% 222.37/222.60  |- rdf__type mesh__D013252Q000172smesh__CompoundConcept
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005457 2006
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005457 2003
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005457 1995
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005457 2004
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005457 1998
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005457 1993
% 222.37/222.60  |- mesh__dateCreated mesh__D005457 1999-01-01
% 222.37/222.60  |- skos__broader mesh__D005457smesh__D011636
% 222.37/222.60  |- mesh__dateRevised mesh__D005457 1994-07-20
% 222.37/222.60  |- mesh__recordOriginator mesh__D005457 NLM
% 222.37/222.60  |- skos__prefLabel mesh__D005457 Fluoridation
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005457 1999
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005457 1996
% 222.37/222.60  |- mesh__recordMaintainer mesh__D005457 PLS
% 222.37/222.60  |- mesh__publicMeSHNote mesh__D005457 65   
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005457 2000
% 222.37/222.60  |- mesh__recordAuthorizer mesh__D005457 PLS
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005457 1997
% 222.37/222.60  |- skos__annotation mesh__D005457
% 222.37/222.60       /adv eff permitted but more likely is FLUORIDES /adv eff or specific fluoride terms /adv eff; = %22%fluoridation of water supply%22% so do not also coord with WATER SUPPLY%A%  
% 222.37/222.60  |- mesh__historyNote mesh__D005457 65   
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005457 2001
% 222.37/222.60  |- skos__broader mesh__D005457smesh__D014881
% 222.37/222.60  |- rdf__type mesh__D005457sskos__Concept
% 222.37/222.60  |- skos__broader mesh__D005457smesh__D011313
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005457 2005
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005457 2002
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005457 1994
% 222.37/222.60  |- skos__prefLabel mesh__D015087
% 222.37/222.60       2%27%,3%27%-Cyclic-Nucleotide Phosphodiesterases
% 222.37/222.60  |- skos__historyNote mesh__D015087
% 222.37/222.60       Adenosine Cyclic Monophosphate %28%1973-1974%29%
% 222.37/222.60  |- skos__hiddenLabel mesh__D015087
% 222.37/222.60       2%27%,3%27% Cyclic Nucleotide Phosphodiesterases
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D015087 2005
% 222.37/222.60  |- skos__altLabel mesh__D015087 2,3-Cyclic Nucleotide Phosphodiesterase
% 222.37/222.60  |- rdf__type mesh__D015087sskos__Concept
% 222.37/222.60  |- mesh__dateCreated mesh__D015087 1974-11-27
% 222.37/222.60  |- skos__hiddenLabel mesh__D015087
% 222.37/222.60       Phosphodiesterases, 2%27%,3%27%-Cyclic-Nucleotide
% 222.37/222.60  |- skos__altLabel mesh__D015087 CNPase
% 222.37/222.60  |- mesh__recordAuthorizer mesh__D015087 sjn
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D015087 2004
% 222.37/222.60  |- skos__hiddenLabel mesh__D015087 2,3 Cyclic Nucleotide Phosphodiesterases
% 222.37/222.60  |- skos__altLabel mesh__D015087
% 222.37/222.60       2%27%,3%27%-Cyclic Nucleotide Phosphodiesterases
% 222.37/222.60  |- skos__scopeNote mesh__D015087
% 222.37/222.60       Nucleoside-2%27%,3%27%-cyclic phosphate nucleotidohydrolase. Enzymes that catalyze the hydrolysis of the 2%27%- or 3%27%- phosphate bonds of 2%27%,3%27%-cyclic nucleotides. Also hydrolyzes nucleoside monophosphates. Includes EC 3.1.4.16 and EC 3.1.4.37. EC 3.1.4.-.%A%    
% 222.37/222.60  |- skos__annotation mesh__D015087 DF: 2 3 CYCL NPD   
% 222.37/222.60  |- skos__altLabel mesh__D015087
% 222.37/222.60       2%27%,3%27%-Cyclic Nucleotide Phosphodiesterase
% 222.37/222.60  |- skos__hiddenLabel mesh__D015087 Nucleotide Phosphodiesterase, 2,3-Cyclic
% 222.37/222.60  |- mesh__dateEstablished mesh__D015087 1985-01-01
% 222.37/222.60  |- skos__historyNote mesh__D015087 Phosphodiesterases %28%1973-1974%29%
% 222.37/222.60  |- mesh__dateRevised mesh__D015087 2003-07-09
% 222.37/222.60  |- skos__hiddenLabel mesh__D015087 Phosphodiesterase, 2,3-Cyclic Nucleotide
% 222.37/222.60  |- skos__hiddenLabel mesh__D015087
% 222.37/222.60       2%27%,3%27% Cyclic Nucleotide Phosphodiesterase
% 222.37/222.60  |- mesh__recordOriginator mesh__D015087 NLM
% 222.37/222.60  |- skos__hiddenLabel mesh__D015087 2,3 Cyclic Nucleotide Phosphodiesterase
% 222.37/222.60  |- skos__hiddenLabel mesh__D015087
% 222.37/222.60       Nucleotide Phosphodiesterase, 2%27%,3%27%-Cyclic
% 222.37/222.60  |- skos__altLabel mesh__D015087 2,3-Cyclic Nucleotide Phosphodiesterases
% 222.37/222.60  |- mesh__onlineNote mesh__D015087
% 222.37/222.60       use 2%27%,3%27%-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES to search 2%27%,3%27%-CYCLIC NUCLEOTIDE PHOSPHODIESTERASES 1985-93 %26% 2%27%,3%27%-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE 1975-84%A%  
% 222.37/222.60  |- mesh__publicMeSHNote mesh__D015087
% 222.37/222.60       94; was 2%27%,3%27%-CYCLIC NUCLEOTIDE PHOSPHODIESTERASES 1985-93; was 2%27%,3%27%-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE see under PHOSPHODIESTERASES 1975-84%A%  
% 222.37/222.60  |- skos__hiddenLabel mesh__D015087
% 222.37/222.60       Phosphodiesterases, 2,3-Cyclic Nucleotide
% 222.37/222.60  |- mesh__historyNote mesh__D015087
% 222.37/222.60       94; was 2%27%,3%27%-CYCLIC NUCLEOTIDE PHOSPHODIESTERASES 1985-93; was 2%27%,3%27%-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE see under PHOSPHODIESTERASES 1975-84%A%  
% 222.37/222.60  |- skos__hiddenLabel mesh__D015087
% 222.37/222.60       Nucleotide Phosphodiesterases, 2%27%,3%27%-Cyclic
% 222.37/222.60  |- skos__hiddenLabel mesh__D015087
% 222.37/222.60       Phosphodiesterase, 2%27%,3%27%-Cyclic Nucleotide
% 222.37/222.60  |- skos__broader mesh__D015087smesh__D010727
% 222.37/222.60  |- skos__hiddenLabel mesh__D015087
% 222.37/222.60       Phosphodiesterases, 2%27%,3%27%-Cyclic Nucleotide
% 222.37/222.60  |- skos__hiddenLabel mesh__D015087
% 222.37/222.60       Nucleotide Phosphodiesterases, 2,3-Cyclic
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D015087 2006
% 222.37/222.60  |- mesh__recordMaintainer mesh__D015087 ssb
% 222.37/222.60  |- rdf__type mesh__D009848sskos__Concept
% 222.37/222.60  |- skos__altLabel mesh__D009848 Olivomycin
% 222.37/222.60  |- mesh__recordOriginator mesh__D009848 NLM
% 222.37/222.60  |- mesh__recordAuthorizer mesh__D009848 sjn
% 222.37/222.60  |- mesh__onlineNote mesh__D009848
% 222.37/222.60       use OLIVOMYCINS to search OLIVOMYCIN 1965-80 %28%as Prov 1966-71%29%%A%  
% 222.37/222.60  |- mesh__publicMeSHNote mesh__D009848 81; was OLIVOMYCIN 1972-80   
% 222.37/222.60  |- mesh__historyNote mesh__D009848
% 222.37/222.60       81; was OLIVOMYCIN 1965-80 %28%Prov 1965-71%29%   
% 222.37/222.60  |- skos__broader mesh__D009848smesh__D006027
% 222.37/222.60  |- skos__scopeNote mesh__D009848
% 222.37/222.60       A mixture of several closely related glycosidic antibiotics obtained from Actinomyces %28%or Streptomyces%29% olivoreticuli. They are used as fluorescent dyes that bind to DNA and prevent both RNA and protein synthesis and are also used as antineoplastic agents.%A%    
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D009848 2005
% 222.37/222.60  |- mesh__dateEstablished mesh__D009848 1972-01-01
% 222.37/222.60  |- mesh__recordMaintainer mesh__D009848 ssb
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D009848 2006
% 222.37/222.60  |- mesh__dateRevised mesh__D009848 2004-07-07
% 222.37/222.60  |- skos__prefLabel mesh__D009848 Olivomycins
% 222.37/222.60  |- mesh__dateCreated mesh__D009848 1999-01-01
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D001865 2006
% 222.37/222.60  |- mesh__publicMeSHNote mesh__D001865
% 222.37/222.60       91; was see under ANTIBIOTICS 1975-90   
% 222.37/222.60  |- skos__scopeNote mesh__D001865
% 222.37/222.60       An antibiotic produced by Pseudomonas cocovenenans. It is an inhibitor of MITOCHONDRIAL ADP, ATP TRANSLOCASES. Specifically, it blocks adenine nucleotide efflux from mitochondria by enhancing membrane binding.%A%    
% 222.37/222.60  |- mesh__dateRevised mesh__D001865 2003-07-30
% 222.37/222.60  |- mesh__dateCreated mesh__D001865 1974-11-19
% 222.37/222.60  |- skos__historyNote mesh__D001865 Pseudomonas %28%1968-1974%29%
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D001865 2004
% 222.37/222.60  |- skos__historyNote mesh__D001865 Antibiotics %28%1973-1974%29%
% 222.37/222.60  |- skos__broader mesh__D001865smesh__D003998
% 222.37/222.60  |- skos__historyNote mesh__D001865 Carboxylic Acids %28%1973-1974%29%
% 222.37/222.60  |- mesh__recordMaintainer mesh__D001865 SYSTEM
% 222.37/222.60  |- mesh__dateEstablished mesh__D001865 1991-01-01
% 222.37/222.60  |- mesh__recordOriginator mesh__D001865 NLM
% 222.37/222.60  |- skos__altLabel mesh__D001865 Flavotoxin A
% 222.37/222.60  |- mesh__recordAuthorizer mesh__D001865 NLM
% 222.37/222.60  |- skos__prefLabel mesh__D001865 Bongkrekic Acid
% 222.37/222.60  |- rdf__type mesh__D001865sskos__Concept
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D001865 2005
% 222.37/222.60  |- mesh__historyNote mesh__D001865
% 222.37/222.60       91%28%75%29%; was see under ANTIBIOTICS 1975-90   
% 222.37/222.60  |- mesh__dateCreated mesh__D034241 2002-07-02
% 222.37/222.60  |- mesh__dateEstablished mesh__D034241 2003-01-01
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D034241 2006A
% 222.37/222.60  |- mesh__recordOriginator mesh__D034241 ags
% 222.37/222.60  |- rdf__type mesh__D034241sskos__Concept
% 222.37/222.60  |- mesh__recordMaintainer mesh__D034241 ags
% 222.37/222.60  |- mesh__historyNote mesh__D034241 2003   
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D034241 2006
% 222.37/222.60  |- skos__prefLabel mesh__D034241 Alteromonadaceae
% 222.37/222.60  |- mesh__dateRevised mesh__D034241 2005-07-20
% 222.37/222.60  |- mesh__publicMeSHNote mesh__D034241 2003   
% 222.37/222.60  |- mesh__recordAuthorizer mesh__D034241 ags
% 222.37/222.60  |- skos__broader mesh__D034241smesh__D020563
% 222.37/222.60  |- skos__historyNote mesh__D034241 Proteobacteria %28%2001-2002%29%
% 222.37/222.60  |- skos__scopeNote mesh__D034241
% 222.37/222.60       A family of marine, gram-negative PROTEOBACTERIA including the genera ALTEROMONAS; Colwellia; Idiomarina; Marinobacter; MORITELLA; PSEUDOALTEROMONAS; and SHEWANELLA.%A%    
% 222.37/222.60  |- mesh__dateRevised mesh__D001067 2005-06-30
% 222.37/222.60  |- skos__hiddenLabel mesh__D001067 Appetite Suppressant Drugs
% 222.37/222.60  |- skos__hiddenLabel mesh__D001067 Depressants, Appetite
% 222.37/222.60  |- skos__broader mesh__D001067smesh__D019440
% 222.37/222.60  |- rdf__type mesh__D001067sskos__Concept
% 222.37/222.60  |- mesh__recordMaintainer mesh__D001067 ssb
% 222.37/222.60  |- skos__altLabel mesh__D001067 Anorexigenic Drugs
% 222.37/222.60  |- skos__altLabel mesh__D001067 Anorectics
% 222.37/222.60  |- skos__prefLabel mesh__D001067 Appetite Depressants
% 222.37/222.60  |- skos__hiddenLabel mesh__D001067 Drugs, Appetite-Depressing
% 222.37/222.60  |- mesh__recordOriginator mesh__D001067 NLM
% 222.37/222.60  |- skos__altLabel mesh__D001067 Appetite-Depressing Drugs
% 222.37/222.60  |- skos__hiddenLabel mesh__D001067 Drugs, Anorexigenic
% 222.37/222.60  |- skos__altLabel mesh__D001067 Anorexic Drugs
% 222.37/222.60  |- skos__hiddenLabel mesh__D001067 Drugs, Appetite-Suppressant
% 222.37/222.60  |- mesh__recordAuthorizer mesh__D001067 sjn
% 222.37/222.60  |- skos__hiddenLabel mesh__D001067 Suppressants, Appetite
% 222.37/222.60  |- skos__scopeNote mesh__D001067
% 222.37/222.60       Agents that are used to decrease appetite.     
% 222.37/222.60  |- mesh__dateCreated mesh__D001067 1999-01-01
% 222.37/222.60  |- skos__altLabel mesh__D001067 Appetite-Suppressant Drugs
% 222.37/222.60  |- skos__hiddenLabel mesh__D001067 Appetite Depressing Drugs
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D001067 2006
% 222.37/222.60  |- skos__hiddenLabel mesh__D001067 Drugs, Anorexic
% 222.37/222.60  |- skos__annotation mesh__D001067
% 222.37/222.60       GEN or unspecified; prefer specifics; consider also APPETITE /drug eff %26% OBESITY /drug ther%A%  
% 222.37/222.60  |- skos__altLabel mesh__D001067 Appetite Suppressants
% 222.37/222.60  |- skos__hiddenLabel mesh__D006550 Femoral Hernias
% 222.37/222.60  |- mesh__recordMaintainer mesh__D006550 jls
% 222.37/222.60  |- mesh__onlineNote mesh__D006550
% 222.37/222.60       use HERNIA, FEMORAL to search FEMORAL HERNIA 1966-79   
% 222.37/222.60  |- skos__hiddenLabel mesh__D006550 Hernias, Femoral
% 222.37/222.60  |- skos__broader mesh__D006550smesh__D046449
% 222.37/222.60  |- skos__scopeNote mesh__D006550
% 222.37/222.60       A groin hernia occurring inferior to the inguinal ligament and medial to the FEMORAL VEIN and FEMORAL ARTERY. The femoral hernia sac has a small neck but may enlarge considerably when it enters the subcutaneous tissue of the thigh. It is caused by defects in the ABDOMINAL WALL.%A%    
% 222.37/222.60  |- rdf__type mesh__D006550sskos__Concept
% 222.37/222.60  |- mesh__publicMeSHNote mesh__D006550 80; was FEMORAL HERNIA 1963-79   
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D006550 2005
% 222.37/222.60  |- mesh__recordOriginator mesh__D006550 NLM
% 222.37/222.60  |- skos__prefLabel mesh__D006550 Hernia, Femoral
% 222.37/222.60  |- skos__altLabel mesh__D006550 Femoral Hernia
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D006550 2005A
% 222.37/222.60  |- mesh__historyNote mesh__D006550 80; was FEMORAL HERNIA 1963-79   
% 222.37/222.60  |- mesh__recordAuthorizer mesh__D006550 jls
% 222.37/222.60  |- mesh__dateCreated mesh__D006550 1999-01-01
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D006550 2006
% 222.37/222.60  |- mesh__dateRevised mesh__D006550 2004-07-28
% 222.37/222.60  |- mesh__recordOriginator mesh__D020221 KEV
% 222.37/222.60  |- mesh__historyNote mesh__D020221 2000   
% 222.37/222.60  |- mesh__publicMeSHNote mesh__D020221 2000   
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Nerve Contusion, Optic
% 222.37/222.60  |- skos__altLabel mesh__D020221 Optic Nerve Trauma
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Traumas, Optic Nerve
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Optic Neuropathies, Traumatic
% 222.37/222.60  |- skos__altLabel mesh__D020221 Optic Neuropathy, Traumatic
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D020221 2004
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Nerve Avulsion, Optic
% 222.37/222.60  |- skos__scopeNote mesh__D020221
% 222.37/222.60       Injuries to the optic nerve induced by a trauma to the face or head. These may occur with closed or penetrating injuries. Relatively minor compression of the superior aspect of orbit may also result in trauma to the optic nerve. Clinical manifestations may include visual loss, PAPILLEDEMA, and an afferent pupillary defect.%A%    
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Nerve Trauma, Optic
% 222.37/222.60  |- mesh__recordAuthorizer mesh__D020221 ags
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Nerve Contusions, Optic
% 222.37/222.60  |- skos__related mesh__D020221smesh__D006259
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Optic Nerve Contusions
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D020221 2002
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Nerve Transections, Optic
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D020221 2003
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Optic Nerve Injury
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Contusions, Optic Nerve
% 222.37/222.60  |- mesh__recordMaintainer mesh__D020221 ags
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Optic Nerve Traumas
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Nerve Injuries, Optic
% 222.37/222.60  |- mesh__dateRevised mesh__D020221 1999-12-16
% 222.37/222.60  |- mesh__dateCreated mesh__D020221 1999-11-08
% 222.37/222.60  |- skos__broader mesh__D020221smesh__D020209
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Optic Nerve Transections
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D020221 2006
% 222.37/222.60  |- skos__altLabel mesh__D020221 Trauma, Second Cranial Nerve
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Transection, Optic Nerve
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Traumatic Optic Neuropathy
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Optic Nerve Avulsions
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Injury, Optic Nerve
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Avulsions, Optic Nerve
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Avulsion, Optic Nerve
% 222.37/222.60  |- skos__altLabel mesh__D020221 Second Cranial Nerve Injuries
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D020221 2001
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Trauma, Optic Nerve
% 222.37/222.60  |- mesh__dateEstablished mesh__D020221 2000-01-01
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Neuropathies, Traumatic Optic
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Nerve Traumas, Optic
% 222.37/222.60  |- rdf__type mesh__D020221sskos__Concept
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Injuries, Optic Nerve
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D020221 2005
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Transections, Optic Nerve
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Neuropathy, Traumatic Optic
% 222.37/222.60  |- skos__altLabel mesh__D020221 Second Cranial Nerve Trauma
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Traumatic Optic Neuropathies
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Nerve Injury, Optic
% 222.37/222.60  |- skos__altLabel mesh__D020221 Cranial Nerve II Injuries
% 222.37/222.60  |- skos__broader mesh__D020221smesh__D009901
% 222.37/222.60  |- skos__historyNote mesh__D020221 Optic Nerve Diseases %28%1976-1999%29%
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D020221 2000A
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D020221 2000
% 222.37/222.60  |- skos__prefLabel mesh__D020221 Optic Nerve Injuries
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Contusion, Optic Nerve
% 222.37/222.60  |- skos__historyNote mesh__D020221 Optic Nerve %28%1969-1975%29%
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Nerve Avulsions, Optic
% 222.37/222.60  |- skos__hiddenLabel mesh__D020221 Nerve Transection, Optic
% 222.37/222.60  |- skos__broader mesh__D006321Q000187smesh__D006321
% 222.37/222.60  |- rdf__type mesh__D006321Q000187smesh__CompoundConcept
% 222.37/222.60  |- skos__historyNote mesh__D047169 Peptides, Cyclic %28%2000-2004%29%
% 222.37/222.60  |- mesh__recordAuthorizer mesh__D047169 sjn
% 222.37/222.60  |- mesh__publicMeSHNote mesh__D047169 2005   
% 222.37/222.60  |- mesh__dateCreated mesh__D047169 2004-07-07
% 222.37/222.60  |- mesh__historyNote mesh__D047169 2005   
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D047169 2006
% 222.37/222.60  |- skos__broader mesh__D047169smesh__D010456
% 222.37/222.60  |- mesh__dateEstablished mesh__D047169 2005-01-01
% 222.37/222.60  |- skos__prefLabel mesh__D047169 Cyclotides
% 222.37/222.60  |- mesh__recordMaintainer mesh__D047169 ssb
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D047169 2005
% 222.37/222.60  |- rdf__type mesh__D047169sskos__Concept
% 222.37/222.60  |- skos__scopeNote mesh__D047169
% 222.37/222.60       A continuous circle of peptide bonds, typically of 2-3 dozen AMINO ACIDS, so there is no free N- or C-terminus. They are further characterized by six conserved CYSTEINE residues that form CYSTINE KNOT MOTIFS.%A%    
% 222.37/222.60  |- mesh__recordOriginator mesh__D047169 ssb
% 222.37/222.60  |- mesh__dateCreated mesh__D019478 1996-06-20
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D019478 2006
% 222.37/222.60  |- skos__scopeNote mesh__D019478
% 222.37/222.60       Works consisting of formal presentations made usually to fulfill requirements for an academic degree.%A%    
% 222.37/222.60  |- skos__altLabel mesh__D019478 Academic Dissertations %28%PT%29%
% 222.37/222.60  |- skos__altLabel mesh__D019478 Theses %28%PT%29%
% 222.37/222.60  |- mesh__historyNote mesh__D019478 1997   
% 222.37/222.60  |- skos__prefLabel mesh__D019478
% 222.37/222.60       Academic Dissertations %5B%Publication Type%5D%
% 222.37/222.60  |- mesh__recordMaintainer mesh__D019478 jls
% 222.37/222.60  |- rdf__type mesh__D019478sskos__Concept
% 222.37/222.60  |- mesh__recordOriginator mesh__D019478 TGC
% 222.37/222.60  |- mesh__recordAuthorizer mesh__D019478 sjn
% 222.37/222.60  |- skos__broader mesh__D019478smesh__D052180
% 222.37/222.60  |- mesh__dateEstablished mesh__D019478 1997-01-01
% 222.37/222.60  |- mesh__dateRevised mesh__D019478 2005-06-30
% 222.37/222.60  |- skos__annotation mesh__D019478
% 222.37/222.60       publication type only; academic dissertations as a subject are indexed under the main heading DISSERTATIONS, ACADEMIC; used by History of Medicine Division and collaborating  partners only; CATALOG: Do not use for current materials.%A%  
% 222.37/222.60  |- skos__historyNote mesh__D011495 Lysine %28%1966-1976%29%
% 222.37/222.60  |- skos__scopeNote mesh__D011495
% 222.37/222.60       An enzyme that catalyzes the methylation of the epsilon-amino group of lysine residues in proteins to yield epsilon mono-, di-, and trimethyllysine. EC 2.1.1.43.%A%    
% 222.37/222.60  |- skos__historyNote mesh__D011495 specific protein %28%1966-1976%29%
% 222.37/222.60  |- skos__historyNote mesh__D011495 Methyltransferases %28%1971-1976%29%
% 222.37/222.60  |- skos__hiddenLabel mesh__D011495 Methyltransferase, Histone-Lysine
% 222.37/222.60  |- mesh__recordMaintainer mesh__D011495 ssb
% 222.37/222.60  |- mesh__historyNote mesh__D011495 98%28%77%29%   
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D011495 2006
% 222.37/222.60  |- mesh__dateEstablished mesh__D011495 1991-01-01
% 222.37/222.60  |- skos__hiddenLabel mesh__D011495 N-Methyltransferase, Histone-Lysine
% 222.37/222.60  |- skos__hiddenLabel mesh__D011495 Histone Lysine N Methyltransferase
% 222.37/222.60  |- skos__altLabel mesh__D011495 Protein Methyltransferase III
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D011495 2005
% 222.37/222.60  |- skos__hiddenLabel mesh__D011495 Methyltransferase, Protein Lysine
% 222.37/222.60  |- mesh__publicMeSHNote mesh__D011495
% 222.37/222.60       98; see HISTONE-LYSINE METHYLTRANSFERASE 1991-97; see METHYLTRANSFERASES 1977-90%A%  
% 222.37/222.60  |- skos__historyNote mesh__D011495 Proteins %28%1966-1976%29%
% 222.37/222.60  |- mesh__recordOriginator mesh__D011495 RLS
% 222.37/222.60  |- skos__prefLabel mesh__D011495 Histone-Lysine N-Methyltransferase
% 222.37/222.60  |- rdf__type mesh__D011495sskos__Concept
% 222.37/222.60  |- mesh__dateCreated mesh__D011495 1976-05-21
% 222.37/222.60  |- skos__broader mesh__D011495smesh__D011496
% 222.37/222.60  |- skos__altLabel mesh__D011495 Histone-Lysine Methyltransferase
% 222.37/222.60  |- mesh__dateRevised mesh__D011495 2003-07-09
% 222.37/222.60  |- skos__altLabel mesh__D011495 Protein Methylase III
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D011495 2004
% 222.37/222.60  |- mesh__recordAuthorizer mesh__D011495 sjn
% 222.37/222.60  |- skos__altLabel mesh__D011495 Protein Lysine Methyltransferase
% 222.37/222.60  |- skos__hiddenLabel mesh__D011495 Histone Lysine Methyltransferase
% 222.37/222.60  |- rdf__type mesh__D005458sskos__Concept
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005458 2000
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005458 1994
% 222.37/222.60  |- mesh__dateCreated mesh__D005458 1999-01-01
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005458 2004
% 222.37/222.60  |- mesh__recordMaintainer mesh__D005458 TGC
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005458 2006
% 222.37/222.60  |- skos__prefLabel mesh__D005458 Fluoride Poisoning
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005458 2003
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005458 2005
% 222.37/222.60  |- mesh__recordAuthorizer mesh__D005458 PLS
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005458 2002
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005458 1997
% 222.37/222.60  |- skos__scopeNote mesh__D005458
% 222.37/222.60       GEN or unspecified fluoride; prefer /pois with specific fluoride term%A%    
% 222.37/222.60  |- mesh__recordOriginator mesh__D005458 NLM
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005458 1999
% 222.37/222.60  |- mesh__dateRevised mesh__D005458 1992-05-15
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005458 1993
% 222.37/222.60  |- skos__altLabel mesh__D005458 Poisoning, Fluoride
% 222.37/222.60  |- skos__hiddenLabel mesh__D005458 Fluoride Poisonings
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005458 2001
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005458 1996
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005458 1995
% 222.37/222.60  |- skos__broader mesh__D005458smesh__D011041
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D005458 1998
% 222.37/222.60  |- skos__hiddenLabel mesh__D005458 Poisonings, Fluoride
% 222.37/222.60  |- mesh__dateCreated mesh__D016180 1990-03-23
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D016180 2004
% 222.37/222.60  |- skos__hiddenLabel mesh__D016180 Lentivirus Infection
% 222.37/222.60  |- skos__annotation mesh__D016180
% 222.37/222.60       caused by a retrovirus; GEN or unspecified: prefer specifics%A%  
% 222.37/222.60  |- skos__broader mesh__D016180smesh__D012192
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D016180 1997
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D016180 2001
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D016180 2003
% 222.37/222.60  |- skos__prefLabel mesh__D016180 Lentivirus Infections
% 222.37/222.60  |- mesh__recordOriginator mesh__D016180 AGS
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D016180 2000
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D016180 1996
% 222.37/222.60  |- skos__altLabel mesh__D016180 Infections, Lentivirus
% 222.37/222.60  |- mesh__recordMaintainer mesh__D016180 AGS
% 222.37/222.60  |- mesh__publicMeSHNote mesh__D016180 91   
% 222.37/222.60  |- skos__hiddenLabel mesh__D016180 Infection, Lentivirus
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D016180 2006
% 222.37/222.60  |- mesh__dateEstablished mesh__D016180 1991-01-01
% 222.37/222.60  |- mesh__recordAuthorizer mesh__D016180 PLS
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D016180 1999
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D016180 2005
% 222.37/222.60  |- rdf__type mesh__D016180sskos__Concept
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D016180 1995
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D016180 1998
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D016180 2002
% 222.37/222.60  |- mesh__dateRevised mesh__D016180 1993-06-04
% 222.37/222.60  |- mesh__historyNote mesh__D016180 91   
% 222.37/222.60  |- skos__historyNote mesh__D016180 Retrovirus Infections %28%1981-1990%29%
% 222.37/222.60  |- skos__scopeNote mesh__D016180
% 222.37/222.60       Virus diseases caused by the Lentivirus genus. They are multi-organ diseases characterized by long incubation periods and persistent infection.%A%    
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D016180 1994
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D002160 1993
% 222.37/222.60  |- mesh__recordOriginator mesh__D002160 NLM
% 222.37/222.60  |- mesh__dateCreated mesh__D002160 1999-01-01
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D002160 1994
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D002160 1992
% 222.37/222.60  |- skos__altLabel mesh__D002160 Kampuchea
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D002160 1999
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D002160 2006
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D002160 1997
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D002160 2002
% 222.37/222.60  |- mesh__recordAuthorizer mesh__D002160 PLS
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D002160 2004
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D002160 1998
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D002160 2005
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D002160 1996
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D002160 2003
% 222.37/222.60  |- rdf__type mesh__D002160sskos__Concept
% 222.37/222.60  |- skos__prefLabel mesh__D002160 Cambodia
% 222.37/222.60  |- mesh__recordMaintainer mesh__D002160 PLS
% 222.37/222.60  |- skos__altLabel mesh__D002160 Khmer Republic
% 222.37/222.60  |- skos__broader mesh__D002160smesh__D001210
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D002160 2001
% 222.37/222.60  |- mesh__dateRevised mesh__D002160 1991-11-04
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D002160 1995
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D002160 2000
% 222.37/222.60  |- skos__hiddenLabel mesh__D015088 Polymerase, 2%27%,5%27%-Oligoadenylate
% 222.37/222.60  |- skos__altLabel mesh__D015088 2,5 Oligoadenylate Polymerase
% 222.37/222.60  |- skos__hiddenLabel mesh__D015088 Synthetase, 2,5 Oligoadenylate
% 222.37/222.60  |- rdf__type mesh__D015088sskos__Concept
% 222.37/222.60  |- skos__broader mesh__D015088smesh__D009713
% 222.37/222.60  |- skos__altLabel mesh__D015088 2%27%,5%27%-Oligoadenylate Polymerase
% 222.37/222.60  |- mesh__activeMeSHYear mesh__D015088 2004
% 222.37/222.60  |- skos__altLabel mesh__D015088 2,5 Oligoadenylate Synthetase
% 222.37/222.60  |- mesh__recordOriginator mesh__D015088 RLS
% 222.37/222.60  |- skos__altLabel mesh__D015088
% 222.37/222.60       ATP-%28%2%27%-5%27%%29%oligo%28%A%29%adenylyltransferase
% 222.37/222.60  |- mesh__dateRevised mesh__D015088 2003-07-09
% 222.37/222.60  |- skos__hiddenLabel mesh__D015088 2 5A Synthetase
% 222.37/222.61  |- skos__altLabel mesh__D015088 2%27%,5%27%-Oligo%28%A%29% Synthetase
% 222.37/222.61  |- mesh__recordMaintainer mesh__D015088 ssb
% 222.37/222.61  |- mesh__dateEstablished mesh__D015088 1983-01-01
% 222.37/222.61  |- skos__hiddenLabel mesh__D015088 2%27%,5%27% Oligoadenylate Polymerase
% 222.37/222.61  |- mesh__dateCreated mesh__D015088 1982-05-04
% 222.37/222.61  |- skos__hiddenLabel mesh__D015088 Oligoadenylate Synthetase, 2,5
% 222.37/222.61  |- mesh__recordAuthorizer mesh__D015088 sjn
% 222.37/222.61  |- skos__historyNote mesh__D015088
% 222.37/222.61       Nucleotidyltransferases %28%1966-1982%29%
% 222.37/222.61  |- skos__altLabel mesh__D015088 %28%2%27%-5%27%%29%An Polymerase
% 222.37/222.61  |- skos__altLabel mesh__D015088 2%27%,5%27%-Oligo%28%A%29% Polymerase
% 222.37/222.61  |- mesh__publicMeSHNote mesh__D015088 83   
% 222.37/222.61  |- mesh__historyNote mesh__D015088 83   
% 222.37/222.61  |- skos__scopeNote mesh__D015088
% 222.37/222.61       An enzyme that catalyzes the conversion of ATP into a series of %28%2%27%-5%27%%29% linked oligoadenylates and pyrophosphate in the presence of double-stranded RNA. These oligonucleotides activate an endoribonuclease %28%RNase L%29% which cleaves single-stranded RNA. Interferons can act as inducers of these reactions. EC 2.7.7.-.%A%    
% 222.37/222.61  |- mesh__activeMeSHYear mesh__D015088 2006
% 222.37/222.61  |- skos__altLabel mesh__D015088 2-5A Synthetase
% 222.37/222.61  |- skos__hiddenLabel mesh__D015088 Oligoadenylate Polymerase, 2,5
% 222.37/222.61  |- skos__prefLabel mesh__D015088 2%27%,5%27%-Oligoadenylate Synthetase
% 222.37/222.61  |- skos__hiddenLabel mesh__D015088 Synthetase, 2%27%,5%27%-Oligoadenylate
% 222.37/222.61  |- mesh__activeMeSHYear mesh__D015088 2005
% 222.37/222.61  |- skos__hiddenLabel mesh__D015088 Polymerase, 2,5 Oligoadenylate
% 222.37/222.61  |- skos__hiddenLabel mesh__D015088 2%27%,5%27% Oligoadenylate Synthetase
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Atrophy, Familial Olivopontocerebellar
% 222.37/222.61  |- mesh__publicMeSHNote mesh__D009849
% 222.37/222.61       2000; see OLIVOPONTOCEREBELLAR ATROPHY 1991-1999, see SPINOCEREBELLAR DEGENERATION 1987-1990%A%  
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Atrophy, Olivo-Ponto-Cerebellar
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849
% 222.37/222.61       Olivopontocerebellar Atrophy, Nonfamilial
% 222.37/222.61  |- skos__altLabel mesh__D009849 Olivopontocerebellar Atrophy
% 222.37/222.61  |- mesh__activeMeSHYear mesh__D009849 2006A
% 222.37/222.61  |- skos__altLabel mesh__D009849 Dejerine-Thomas Syndrome
% 222.37/222.61  |- mesh__recordMaintainer mesh__D009849 ags
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Degeneration, Olivopontocerebellar
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Olivo Ponto Cerebellar Atrophy
% 222.37/222.61  |- mesh__activeMeSHYear mesh__D009849 2005
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Syndrome, Dejerine-Thomas
% 222.37/222.61  |- skos__historyNote mesh__D009849 Cerebellar Ataxia %28%1968-1986%29%
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849
% 222.37/222.61       Olivopontocerebellar Atrophies, Nonfamilial
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Degenerations, Olivo-Ponto-Cerebellar
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Pontoolivocerebellar Atrophies
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849
% 222.37/222.61       Atrophy, Nonfamilial Olivopontocerebellar
% 222.37/222.61  |- skos__altLabel mesh__D009849 Olivo-Ponto-Cerebellar Atrophy
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849
% 222.37/222.61       Olivopontocerebellar Atrophies, Inherited
% 222.37/222.61  |- rdf__type mesh__D009849sskos__Concept
% 222.37/222.61  |- skos__altLabel mesh__D009849 Presenile Ataxia
% 222.37/222.61  |- mesh__dateRevised mesh__D009849 2005-07-21
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Olivopontocerebellar Atrophy, Familial
% 222.37/222.61  |- skos__prefLabel mesh__D009849 Olivopontocerebellar Atrophies
% 222.37/222.61  |- skos__broader mesh__D009849smesh__D019578
% 222.37/222.61  |- mesh__recordOriginator mesh__D009849 RC
% 222.37/222.61  |- skos__altLabel mesh__D009849 Pontoolivocerebellar Atrophy
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Olivopontocerebellar Atrophy, Inherited
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849
% 222.37/222.61       Idiopathic Olivopontocerebellar Atrophies
% 222.37/222.61  |- skos__historyNote mesh__D009849 Atrophy %28%1966-1986%29%
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Degenerations, Olivopontocerebellar
% 222.37/222.61  |- skos__altLabel mesh__D009849 Olivo-Ponto-Cerebellar Degeneration
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Dejerine Thomas Syndrome
% 222.37/222.61  |- mesh__historyNote mesh__D009849 2000%28%1987%29%   
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Atrophy, Olivopontocerebellar
% 222.37/222.61  |- skos__historyNote mesh__D009849 Olivary Nucleus %28%1966-1986%29%
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Olivopontocerebellar Degenerations
% 222.37/222.61  |- skos__related mesh__D009849smesh__D019578
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Idiopathic Olivopontocerebellar Atrophy
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Olivo-Ponto-Cerebellar Degenerations
% 222.37/222.61  |- mesh__dateCreated mesh__D009849 1986-03-31
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Olivo Ponto Cerebellar Degeneration
% 222.37/222.61  |- skos__historyNote mesh__D009849 Cerebellar Diseases %28%1966-1986%29%
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Degeneration, Olivo-Ponto-Cerebellar
% 222.37/222.61  |- mesh__recordAuthorizer mesh__D009849 ags
% 222.37/222.61  |- skos__broader mesh__D009849smesh__D013132
% 222.37/222.61  |- skos__altLabel mesh__D009849 Olivopontocerebellar Degeneration
% 222.37/222.61  |- skos__scopeNote mesh__D009849
% 222.37/222.61       A group of inherited and sporadic disorders which share progressive ataxia in combination with atrophy of the CEREBELLUM; PONS; and inferior olivary nuclei. Additional clinical features may include MUSCLE RIGIDITY; NYSTAGMUS, PATHOLOGIC; RETINAL DEGENERATION; MUSCLE SPASTICITY; DEMENTIA; URINARY INCONTINENCE; and OPHTHALMOPLEGIA. The familial form has an earlier onset %28%second decade%29% and may feature spinal cord atrophy. The sporadic form tends to present in the fifth or sixth decade, and is considered a clinical subtype of MULTIPLE SYSTEM ATROPHY. %28%From Adams et al., Principles of Neurology, 6th ed, p1085%29%%A%    
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Ataxia, Presenile
% 222.37/222.61  |- mesh__activeMeSHYear mesh__D009849 2004
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Ataxias, Presenile
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Presenile Ataxias
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Olivopontocerebellar Atrophies, Familial
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Atrophy, Idiopathic Olivopontocerebellar
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Atrophy, Inherited Olivopontocerebellar
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Familial Olivopontocerebellar Atrophies
% 222.37/222.61  |- skos__historyNote mesh__D009849 Brain Diseases %28%1966-1986%29%
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Inherited Olivopontocerebellar Atrophies
% 222.37/222.61  |- skos__annotation mesh__D009849 DF: OPCA   
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849
% 222.37/222.61       Nonfamilial Olivopontocerebellar Atrophies
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849
% 222.37/222.61       Olivopontocerebellar Atrophies, Idiopathic
% 222.37/222.61  |- skos__historyNote mesh__D009849 Pons %28%1966-1986%29%
% 222.37/222.61  |- mesh__activeMeSHYear mesh__D009849 2006
% 222.37/222.61  |- skos__hiddenLabel mesh__D009849 Atrophy, Pontoolivocerebellar
% 222.37/222.61  |- skos__broader mesh__D009849smesh__D019636
% 222.37/222.61  |- skos__altLabel mesh__D009849 Inherited Olivopontocerebellar Atrophy
% 222.37/222.61  |- mesh__dateEstablished mesh__D009849 1991-01-01
% 222.37/222.61  |- rdf__type mesh__D034242sskos__Concept
% 222.37/222.61  |- mesh__recordMaintainer mesh__D034242 ssb
% 222.37/222.61  |- mesh__activeMeSHYear mesh__D034242 2006
% 222.37/222.61  |- mesh__dateCreated mesh__D034242 2002-07-02
% 222.37/222.61  |- mesh__dateEstablished mesh__D034242 2003-01-01
% 222.37/222.61  |- skos__broader mesh__D034242smesh__D003516
% 222.37/222.61  |- mesh__activeMeSHYear mesh__D034242 2005
% 222.37/222.61  |- skos__scopeNote mesh__D034242
% 222.37/222.61       A group of compounds with an 8-carbon ring. They may be saturated or unsaturated.%A%    
% 222.37/222.61  |- mesh__publicMeSHNote mesh__D034242 2003   
% 222.37/222.61  |- mesh__historyNote mesh__D034242 2003   
% 222.37/222.61  |- skos__prefLabel mesh__D034242 Cyclooctanes
% 222.37/222.61  |- mesh__recordOriginator mesh__D034242 ssb
% 222.37/222.61  |- mesh__recordAuthorizer mesh__D034242 sjn
% 222.37/222.61  |- skos__historyNote mesh__D034242 Cycloparaffins %28%1963-2002%29%
% 222.37/222.61  |- mesh__dateRevised mesh__D034242 2004-07-07
% 222.37/222.61  |- mesh__activeMeSHYear mesh__D001068 2002
% 222.37/222.61  |- skos__annotation mesh__D001068
% 222.37/222.61       in children, use FEEDING AND EATING DISORDERS OF CHILDHOOD if related to mental disorder%A%  
% 222.37/222.61  |- mesh__onlineNote mesh__D001068
% 222.37/222.61       use EATING DISORDERS to search APPETITE DISORDERS 1966-88%A%  
% 222.37/222.61  |- mesh__activeMeSHYear mesh__D001068 2001
% 222.37/222.61  |- skos__related mesh__D001068smesh__D009765
% 222.37/222.61  |- skos__prefLabel mesh__D001068 Eating Disorders
% 222.37/222.61  |- mesh__recordMaintainer mesh__D001068 JLS
% 222.37/222.61  |- mesh__dateRevised mesh__D001068 1997-06-20
% 222.37/222.61  |- mesh__dateCreated mesh__D001068 1999-01-01
% 222.37/222.61  |- mesh__activeMeSHYear mesh__D001068 2004
% 222.37/222.61  |- skos__broader mesh__D001068smesh__D001523
% 222.37/222.61  |- mesh__activeMeSHYear mesh__D001068 2000
% 222.37/222.61  |- mesh__activeMeSHYear mesh__D001068 2006
% 222.37/222.61  |- mesh__historyNote mesh__D001068 89; was APPETITE DISORDERS 1963-88   
% 222.37/222.61  |- mesh__recordAuthorizer mesh__D001068 SJN
% 222.37/222.61  |- skos__related mesh__D001068smesh__D013851
% 222.37/222.61  |- mesh__activeMeSHYear mesh__D001068 2003
% 222.37/222.61  |- skos__scopeNote mesh__D001068
% 222.37/222.61       A group of disorders characterized by physiological and psychological disturbances in appetite or food intake.%A%    
% 222.37/222.61  |- mesh__activeMeSHYear mesh__D001068 2005
% 222.37/222.61  |- mesh__recordOriginator mesh__D001068 NLM
% 222.37/222.61  |- mesh__activeMeSHYear mesh__D001068 1999
% 222.37/222.61  |- mesh__publicMeSHNote mesh__D001068 89; was APPETITE DISORDERS 1963-88   
% 222.37/222.61  |- rdf__type mesh__D001068sskos__Concept
% 222.37/222.61  |- skos__hiddenLabel mesh__D001068 Eating Disorder
% 222.37/222.61  |- mesh__activeMeSHYear mesh__D001068 1998
% 222.37/222.61  |- skos__hiddenLabel mesh__D001068 Appetite Disorder
% 222.37/222.61  |- skos__altLabel mesh__D006551 Hernia, Paraesophageal
% 222.37/222.61  |- skos__scopeNote mesh__D006551
% 222.37/222.61       STOMACH herniation located at or near the diaphragmatic opening for the ESOPHAGUS, esophageal hiatus. When the ESOPHAGOGASTRIC JUNCTION is above the DIAPHRAGM, it is called a SLIDING HIATAL HERNIA. When the ESOPHAGOGASTRIC JUNCTION is below the DIAPHRAGM, it is called a PARAESOPHAGEAL HIATAL HERNIA.%A%    
% 222.37/222.61  |- mesh__dateRevised mesh__D006551 2004-07-07
% 222.37/222.61  |- skos__broader mesh__D006551smesh__D006548
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Esophageal Hernias, Sliding
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Hernias, Sliding Hiatal
% 222.37/222.61  |- mesh__onlineNote mesh__D006551
% 222.37/222.61       use HERNIA, HIATAL to search HIATAL HERNIA 1975-79; use HERNIA, DIAPHRAGMATIC 1966-74%A%  
% 222.37/222.61  |- skos__altLabel mesh__D006551 Esophageal Hernia
% 222.37/222.61  |- mesh__recordMaintainer mesh__D006551 lkt
% 222.37/222.61  |- mesh__activeMeSHYear mesh__D006551 2005
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Hernia, Paraesophageal Hiatal
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Hiatal Hernias, Sliding
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Hernias, Sliding Esophageal
% 222.37/222.61  |- mesh__recordOriginator mesh__D006551 NLM
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Hernias, Paraesophageal
% 222.37/222.61  |- mesh__activeMeSHYear mesh__D006551 2006
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Hiatal Hernia, Sliding
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Esophageal Hernia, Sliding
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Esophageal Hernias
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Hiatal Hernia, Paraesophageal
% 222.37/222.61  |- skos__prefLabel mesh__D006551 Hernia, Hiatal
% 222.37/222.61  |- skos__altLabel mesh__D006551 Sliding Esophageal Hernia
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Hernias, Hiatal
% 222.37/222.61  |- rdf__type mesh__D006551sskos__Concept
% 222.37/222.61  |- mesh__dateEstablished mesh__D006551 1991-01-01
% 222.37/222.61  |- mesh__recordAuthorizer mesh__D006551 sjn
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Paraesophageal Hiatal Hernias
% 222.37/222.61  |- skos__altLabel mesh__D006551 Hiatal Hernia
% 222.37/222.61  |- mesh__historyNote mesh__D006551
% 222.37/222.61       91%28%80%29%; was see under HERNIA, DIAPHRAGMATIC 1980-90; was HIATAL HERNIA see under DIAPHRAGMATIC HERNIA 1963-79%A%  
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Hernia, Sliding Hiatal
% 222.37/222.61  |- skos__altLabel mesh__D006551 Hernia, Esophageal
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Hernias, Paraesophageal Hiatal
% 222.37/222.61  |- mesh__publicMeSHNote mesh__D006551
% 222.37/222.61       91; was see under HERNIA, DIAPHRAGMATIC 1980-90; was HIATAL HERNIA see under DIAPHRAGMATIC HERNIA 1963-79%A%  
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Hiatal Hernias, Paraesophageal
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Paraesophageal Hernia
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Sliding Esophageal Hernias
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Sliding Hiatal Hernias
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Hernia, Sliding Esophageal
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Hiatal Hernias
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Paraesophageal Hernias
% 222.37/222.61  |- skos__hiddenLabel mesh__D006551 Hernias, Esophageal
% 222.37/222.61  |- mesh__dateCreated mesh__D006551 1999-01-01
% 222.37/222.61  |- mesh__historyNote mesh__D020222 2000   
% 222.37/222.61  |- skos__hiddenLabel mesh__D020222 Sixth Nerve Palsy, Traumatic
% 222.37/222.61  |- mesh__publicMeSHNote mesh__D020222 2000   
% 222.37/222.61  |- skos__hiddenLabel mesh__D020222 Nerve Traumas, Abducens
% 222.37/222.61  |- skos__altLabel mesh__D020222 Traumatic Sixth-Nerve Palsy
% 222.46/222.61  |- mesh__recordOriginator mesh__D020222 KEV
% 222.46/222.61  |- skos__altLabel mesh__D020222 Sixth-Nerve Trauma
% 222.46/222.61  |- skos__historyNote mesh__D020222 Abducens Nerve %28%1967-1999%29%
% 222.46/222.61  |- mesh__dateCreated mesh__D020222 1999-11-03
% 222.46/222.61  |- skos__hiddenLabel mesh__D020222 Traumatic Abducens Neuropathy
% 222.46/222.61  |- skos__prefLabel mesh__D020222 Abducens Nerve Injury
% 222.46/222.61  |- skos__hiddenLabel mesh__D020222 Traumatic Abducens Neuropathies
% 222.46/222.61  |- skos__hiddenLabel mesh__D020222 Nerve Trauma, Abducens
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D020222 2004
% 222.46/222.61  |- skos__hiddenLabel mesh__D020222 Abducens Neuropathies, Traumatic
% 222.46/222.61  |- skos__hiddenLabel mesh__D020222 Abducens Nerve Injuries
% 222.46/222.61  |- skos__hiddenLabel mesh__D020222 Sixth Nerve Trauma
% 222.46/222.61  |- skos__altLabel mesh__D020222 Cranial Nerve VI Injury
% 222.46/222.61  |- skos__altLabel mesh__D020222 Injury, Cranial Nerve VI
% 222.46/222.61  |- skos__hiddenLabel mesh__D020222 Traumatic Sixth-Nerve Palsies
% 222.46/222.61  |- skos__altLabel mesh__D020222 Sixth-Nerve Palsy, Traumatic
% 222.46/222.61  |- skos__hiddenLabel mesh__D020222 Traumas, Sixth-Nerve
% 222.46/222.61  |- skos__hiddenLabel mesh__D020222 Injury, Abducens Nerve
% 222.46/222.61  |- skos__hiddenLabel mesh__D020222 Traumatic Sixth Nerve Palsy
% 222.46/222.61  |- skos__altLabel mesh__D020222 Abducens Neuropathy, Traumatic
% 222.46/222.61  |- skos__hiddenLabel mesh__D020222 Injuries, Abducens Nerve
% 222.46/222.61  |- skos__hiddenLabel mesh__D020222 Traumas, Abducens Nerve
% 222.46/222.61  |- skos__broader mesh__D020222smesh__D020209
% 222.46/222.61  |- skos__hiddenLabel mesh__D020222 Nerve Injury, Abducens
% 222.46/222.61  |- skos__hiddenLabel mesh__D020222 Nerve Injuries, Abducens
% 222.46/222.61  |- skos__altLabel mesh__D020222 Sixth Cranial Nerve Injury
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D020222 2006
% 222.46/222.61  |- skos__broader mesh__D020222smesh__D020434
% 222.46/222.61  |- mesh__recordMaintainer mesh__D020222 sjn
% 222.46/222.61  |- mesh__dateEstablished mesh__D020222 2000-01-01
% 222.46/222.61  |- skos__hiddenLabel mesh__D020222 Sixth-Nerve Traumas
% 222.46/222.61  |- skos__hiddenLabel mesh__D020222 Abducens Nerve Traumas
% 222.46/222.61  |- rdf__type mesh__D020222sskos__Concept
% 222.46/222.61  |- skos__hiddenLabel mesh__D020222 Trauma, Sixth-Nerve
% 222.46/222.61  |- mesh__recordAuthorizer mesh__D020222 sjn
% 222.46/222.61  |- skos__hiddenLabel mesh__D020222 Trauma, Abducens Nerve
% 222.46/222.61  |- skos__hiddenLabel mesh__D020222 Sixth-Nerve Palsies, Traumatic
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D020222 2005
% 222.46/222.61  |- skos__altLabel mesh__D020222 Injury, Sixth Cranial Nerve
% 222.46/222.61  |- mesh__dateRevised mesh__D020222 2003-07-22
% 222.46/222.61  |- skos__historyNote mesh__D020222 Ophthalmoplegia %28%1966-1999%29%
% 222.46/222.61  |- skos__altLabel mesh__D020222 Abducens Nerve Trauma
% 222.46/222.61  |- skos__scopeNote mesh__D020222
% 222.46/222.61       Traumatic injury to the abducens, or sixth, cranial nerve. Injury to this nerve results in lateral rectus muscle weakness or paralysis. The nerve may be damaged by closed or penetrating CRANIOCEREBRAL TRAUMA or by facial trauma involving the orbit.%A%    
% 222.46/222.61  |- skos__scopeNote mesh__D047968
% 222.46/222.61       Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type C which is neurotoxic to ANIMALS, especially CATTLE, but not humans. It causes dissociation of ACTIN FILAMENTS.%A%    
% 222.46/222.61  |- rdf__type mesh__D047968sskos__Concept
% 222.46/222.61  |- mesh__recordOriginator mesh__D047968 ags
% 222.46/222.61  |- mesh__recordAuthorizer mesh__D047968 sjn
% 222.46/222.61  |- mesh__dateRevised mesh__D047968 2005-06-30
% 222.46/222.61  |- mesh__historyNote mesh__D047968 2005   
% 222.46/222.61  |- mesh__dateCreated mesh__D047968 2004-07-07
% 222.46/222.61  |- skos__historyNote mesh__D047968 Clostridium botulinum %28%1965-2004%29%
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D047968 2006
% 222.46/222.61  |- mesh__dateEstablished mesh__D047968 2005-01-01
% 222.46/222.61  |- mesh__publicMeSHNote mesh__D047968 2005   
% 222.46/222.61  |- skos__broader mesh__D047968smesh__D003014
% 222.46/222.61  |- skos__prefLabel mesh__D047968 Clostridium botulinum type C
% 222.46/222.61  |- skos__altLabel mesh__D047968 Clostridium botulinum C
% 222.46/222.61  |- skos__annotation mesh__D047968
% 222.46/222.61       infection: coordinate IM with BOTULISM %28%IM%29%   
% 222.46/222.61  |- mesh__recordMaintainer mesh__D047968 SYSTEM
% 222.46/222.61  |- mesh__dateEstablished mesh__D019479 1997-01-01
% 222.46/222.61  |- skos__altLabel mesh__D019479 Account Books %28%PT%29%
% 222.46/222.61  |- mesh__recordAuthorizer mesh__D019479 sjn
% 222.46/222.61  |- mesh__dateRevised mesh__D019479 2005-06-30
% 222.46/222.61  |- skos__broader mesh__D019479smesh__D052180
% 222.46/222.61  |- skos__altLabel mesh__D019479 Account Books
% 222.46/222.61  |- skos__annotation mesh__D019479
% 222.46/222.61       publication type only; for account books as a subject, index under main heading ACCOUNTING%A%  
% 222.46/222.61  |- mesh__recordMaintainer mesh__D019479 jls
% 222.46/222.61  |- skos__prefLabel mesh__D019479 Account Books %5B%Publication Type%5D%
% 222.46/222.61  |- skos__scopeNote mesh__D019479
% 222.46/222.61       Books in which personal or commercial accounts of financial transactions are recorded. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 222.46/222.61  |- mesh__dateCreated mesh__D019479 1996-06-21
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D019479 2006
% 222.46/222.61  |- mesh__historyNote mesh__D019479 1997   
% 222.46/222.61  |- mesh__recordOriginator mesh__D019479 TGC
% 222.46/222.61  |- rdf__type mesh__D019479sskos__Concept
% 222.46/222.61  |- skos__altLabel mesh__D011496 Protein Methylases
% 222.46/222.61  |- mesh__recordAuthorizer mesh__D011496 sjn
% 222.46/222.61  |- skos__hiddenLabel mesh__D011496 Methyltransferases, Protein
% 222.46/222.61  |- skos__historyNote mesh__D011496 S-Adenosylmethionine %28%1971-1976%29%
% 222.46/222.61  |- mesh__dateEstablished mesh__D011496 1977-01-01
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D011496 2005
% 222.46/222.61  |- skos__annotation mesh__D011496
% 222.46/222.61       do not confuse with PROTEIN O-METHYLTRANSFERASE; DF: note short X ref%A%  
% 222.46/222.61  |- mesh__publicMeSHNote mesh__D011496 77   
% 222.46/222.61  |- skos__broader mesh__D011496smesh__D008780
% 222.46/222.61  |- mesh__recordMaintainer mesh__D011496 ssb
% 222.46/222.61  |- skos__prefLabel mesh__D011496 Protein Methyltransferases
% 222.46/222.61  |- skos__historyNote mesh__D011496 specific protein
% 222.46/222.61  |- rdf__type mesh__D011496sskos__Concept
% 222.46/222.61  |- mesh__dateRevised mesh__D011496 2003-07-09
% 222.46/222.61  |- skos__scopeNote mesh__D011496
% 222.46/222.61       Enzymes that catalyze the methylation of amino acids after their incorporation into a polypeptide chain. S-Adenosyl-L-methionine acts as the methylating agent. EC 2.1.1.%A%    
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D011496 2004
% 222.46/222.61  |- skos__historyNote mesh__D011496 Proteins %28%1966-1976%29%
% 222.46/222.61  |- mesh__recordOriginator mesh__D011496 RLS
% 222.46/222.61  |- skos__hiddenLabel mesh__D011496 Methylases, Protein
% 222.46/222.61  |- skos__historyNote mesh__D011496 Methyltransferases %28%1971-1976%29%
% 222.46/222.61  |- mesh__dateCreated mesh__D011496 1976-05-19
% 222.46/222.61  |- mesh__historyNote mesh__D011496 77   
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D011496 2006
% 222.46/222.61  |- skos__broader mesh__D005459smesh__D006858
% 222.46/222.61  |- skos__prefLabel mesh__D005459 Fluorides
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D005459 2001
% 222.46/222.61  |- mesh__recordMaintainer mesh__D005459 JAG
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D005459 2006
% 222.46/222.61  |- mesh__recordAuthorizer mesh__D005459 SJN
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D005459 2003
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D005459 2000
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D005459 2005
% 222.46/222.61  |- skos__scopeNote mesh__D005459
% 222.46/222.61       Inorganic salts of hydrofluoric acid, HF, in which the fluorine atom is in the -1 oxidation state. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29% Sodium and stannous salts are commonly used in dentifrices.%A%    
% 222.46/222.61  |- skos__related mesh__D005459smesh__D005460
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D005459 1999
% 222.46/222.61  |- skos__related mesh__D005459smesh__D009050
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D005459 2002
% 222.46/222.61  |- rdf__type mesh__D005459sskos__Concept
% 222.46/222.61  |- mesh__recordOriginator mesh__D005459 NLM
% 222.46/222.61  |- skos__altLabel mesh__D005459 Fluoride
% 222.46/222.61  |- skos__annotation mesh__D005459
% 222.46/222.61       only for inorganic cpds or fluoride ion; /admin: consider also FLUORIDES, TOPICAL%A%  
% 222.46/222.61  |- skos__broader mesh__D005459smesh__D000838
% 222.46/222.61  |- mesh__dateCreated mesh__D005459 1999-01-01
% 222.46/222.61  |- mesh__dateRevised mesh__D005459 1998-06-10
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D005459 2004
% 222.46/222.61  |- skos__broader mesh__D016181smesh__D012897
% 222.46/222.61  |- skos__historyNote mesh__D016181 Cat Diseases %28%1986-1990%29%
% 222.46/222.61  |- skos__altLabel mesh__D016181 Feline AIDS
% 222.46/222.61  |- mesh__dateCreated mesh__D016181 1990-03-23
% 222.46/222.61  |- skos__altLabel mesh__D016181 AIDS, Feline
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D016181 2006
% 222.46/222.61  |- mesh__recordMaintainer mesh__D016181 ags
% 222.46/222.61  |- skos__altLabel mesh__D016181 Feline Acquired Immuno-Deficiency Syndrome
% 222.46/222.61  |- mesh__dateEstablished mesh__D016181 1991-01-01
% 222.46/222.61  |- skos__broader mesh__D016181smesh__D016180
% 222.46/222.61  |- skos__altLabel mesh__D016181 Feline Acquired Immune Deficiency Syndrome
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D016181 2005
% 222.46/222.61  |- mesh__recordOriginator mesh__D016181 AGS
% 222.46/222.61  |- rdf__type mesh__D016181sskos__Concept
% 222.46/222.61  |- mesh__recordAuthorizer mesh__D016181 sjn
% 222.46/222.61  |- skos__historyNote mesh__D016181
% 222.46/222.61       Immunologic Deficiency Syndromes %28%1988-1990%29%
% 222.46/222.61  |- skos__scopeNote mesh__D016181
% 222.46/222.61       Acquired defect of cellular immunity that occurs in cats infected with feline immunodeficiency virus %28%FIV%29% and in some cats infected with feline leukemia virus %28%FeLV%29%.%A%    
% 222.46/222.61  |- skos__altLabel mesh__D016181 FAIDS
% 222.46/222.61  |- mesh__historyNote mesh__D016181 91   
% 222.46/222.61  |- skos__annotation mesh__D016181
% 222.46/222.61       caused by a lentivirus; coord IM with FELINE IMMUNODEFICIENCY VIRUS %28%IM%29% or LEUKEMIA VIRUS, FELINE %28%IM%29% if pertinent; don%27%t forget also CATS %28%NIM%29% %26% check tag ANIMALS; DF: note short X ref%A%  
% 222.46/222.61  |- mesh__publicMeSHNote mesh__D016181 91   
% 222.46/222.61  |- skos__broader mesh__D016181smesh__D002371
% 222.46/222.61  |- skos__hiddenLabel mesh__D016181
% 222.46/222.61       Feline Acquired Immuno Deficiency Syndrome
% 222.46/222.61  |- mesh__dateRevised mesh__D016181 2003-07-30
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D016181 2004
% 222.46/222.61  |- skos__prefLabel mesh__D016181 Feline Acquired Immunodeficiency Syndrome
% 222.46/222.61  |- mesh__dateCreated mesh__D002161 1974-12-12
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D002161 2004
% 222.46/222.61  |- mesh__publicMeSHNote mesh__D002161
% 222.46/222.61       91; was see under ARTIODACTYLA 1975-90   
% 222.46/222.61  |- mesh__recordAuthorizer mesh__D002161 sjn
% 222.46/222.61  |- skos__hiddenLabel mesh__D002161 Guanaco
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D002161 2005
% 222.46/222.61  |- skos__prefLabel mesh__D002161 Camelids, New World
% 222.46/222.61  |- rdf__type mesh__D002161sskos__Concept
% 222.46/222.61  |- mesh__dateRevised mesh__D002161 2003-07-09
% 222.46/222.61  |- skos__scopeNote mesh__D002161
% 222.46/222.61       Ruminant mammals of South America. They are related to camels.%A%    
% 222.46/222.61  |- mesh__recordOriginator mesh__D002161 NLM
% 222.46/222.61  |- skos__hiddenLabel mesh__D002161 Llama
% 222.46/222.61  |- mesh__recordMaintainer mesh__D002161 ags
% 222.46/222.61  |- skos__hiddenLabel mesh__D002161 Camelid, New World
% 222.46/222.61  |- skos__hiddenLabel mesh__D002161 New World Camelid
% 222.46/222.61  |- skos__hiddenLabel mesh__D002161 Alpaca
% 222.46/222.61  |- mesh__historyNote mesh__D002161
% 222.46/222.61       91%28%75%29%; was see under ARTIODACTYLA 1975-90   
% 222.46/222.61  |- mesh__dateEstablished mesh__D002161 1991-01-01
% 222.46/222.61  |- skos__annotation mesh__D002161 note X refs; IM; qualif permitted   
% 222.46/222.61  |- skos__hiddenLabel mesh__D002161 New World Camelids
% 222.46/222.61  |- skos__broader mesh__D002161smesh__D012418
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D002161 2006
% 222.46/222.61  |- skos__hiddenLabel mesh__D015089 Dehydrogenases, 20 Hydroxysteroid
% 222.46/222.61  |- rdf__type mesh__D015089sskos__Concept
% 222.46/222.61  |- skos__hiddenLabel mesh__D015089 Hydroxysteroid Dehydrogenases, 20
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D015089 2004
% 222.46/222.61  |- mesh__dateRevised mesh__D015089 2003-07-09
% 222.46/222.61  |- mesh__recordMaintainer mesh__D015089 lkt
% 222.46/222.61  |- skos__hiddenLabel mesh__D015089 Dehydrogenases, 20-Hydroxysteroid
% 222.46/222.61  |- skos__broader mesh__D015089smesh__D006913
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D015089 2005
% 222.46/222.61  |- skos__altLabel mesh__D015089 20 Hydroxysteroid Dehydrogenases
% 222.46/222.61  |- mesh__dateCreated mesh__D015089 1977-04-15
% 222.46/222.61  |- skos__annotation mesh__D015089
% 222.46/222.61       do not confuse with 20-BETA-HYDROXYSTEROID DEHYDROGENASE %28%see CORTISONE REDUCTASE%29%%A%  
% 222.46/222.61  |- skos__scopeNote mesh__D015089
% 222.46/222.61       A group of enzymes that catalyze the reversible reduction-oxidation reaction of 20-hydroxysteroids, such as from a 20-ketosteroid to a 20-alpha-hydroxysteroid %28%EC 1.1.1.149%29% or to a 20-beta-hydroxysteroid %28%EC 1.1.1.53%29%.%A%    
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D015089 2006
% 222.46/222.61  |- skos__prefLabel mesh__D015089 20-Hydroxysteroid Dehydrogenases
% 222.46/222.61  |- mesh__recordOriginator mesh__D015089 RLS
% 222.46/222.61  |- skos__historyNote mesh__D015089
% 222.46/222.61       Hydroxysteroid Dehydrogenases %28%1966-1977%29%
% 222.46/222.61  |- mesh__historyNote mesh__D015089 78   
% 222.46/222.61  |- mesh__publicMeSHNote mesh__D015089 78   
% 222.46/222.61  |- mesh__recordAuthorizer mesh__D015089 sjn
% 222.46/222.61  |- mesh__dateEstablished mesh__D015089 1978-01-01
% 222.46/222.61  |- skos__hiddenLabel mesh__D001867 Book Classifications
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D001867 2006
% 222.46/222.61  |- skos__broader mesh__D001867smesh__D002376
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D001867 2004
% 222.46/222.61  |- skos__prefLabel mesh__D001867 Book Classification
% 222.46/222.61  |- mesh__recordOriginator mesh__D001867 NLM
% 222.46/222.61  |- mesh__recordMaintainer mesh__D001867 TAP
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D001867 2005
% 222.46/222.61  |- mesh__activeMeSHYear mesh__D001867 2003
% 222.46/222.61  |- mesh__dateRevised mesh__D001867 2002-07-02
% 222.46/222.61  |- mesh__recordAuthorizer mesh__D001867 sjn
% 222.46/222.61  |- skos__altLabel mesh__D001867 Classification, Book
% 222.46/222.61  |- mesh__dateCreated mesh__D001867 1999-01-01
% 222.46/222.61  |- rdf__type mesh__D001867sskos__Concept
% 222.46/222.61  |- skos__scopeNote mesh__D001867
% 222.46/222.61       A general term covering bibliographical and bibliothecal classifications. It mostly refers to library CLASSIFICATION for arrangement of books and documents on the shelves. %28%Harrod%27%s Librarians%27% Glossary, 7th ed, p85%29%%A%    
% 222.46/222.61  |- skos__hiddenLabel mesh__D001867 Classifications, Book
% 222.46/222.61  |- skos__altLabel mesh__D001069 Regulation, Food Intake
% 222.46/222.61  |- skos__altLabel mesh__D001069 Regulation, Appetite
% 222.46/222.62  |- mesh__publicMeSHNote mesh__D001069 72   
% 222.46/222.62  |- mesh__dateEstablished mesh__D001069 1972-01-01
% 222.46/222.62  |- skos__broader mesh__D001069smesh__D001066
% 222.46/222.62  |- mesh__dateCreated mesh__D001069 1999-01-01
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001069 2004
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001069 2002
% 222.46/222.62  |- mesh__recordMaintainer mesh__D001069 TAP
% 222.46/222.62  |- skos__hiddenLabel mesh__D001069 Intake Regulations, Food
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001069 2006
% 222.46/222.62  |- skos__hiddenLabel mesh__D001069 Appetite Regulations
% 222.46/222.62  |- skos__hiddenLabel mesh__D001069 Food Intake Regulations
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001069 2003
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001069 2001
% 222.46/222.62  |- skos__hiddenLabel mesh__D001069 Regulations, Food Intake
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001069 1997
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001069 2005
% 222.46/222.62  |- skos__hiddenLabel mesh__D001069 Regulations, Appetite
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001069 1999
% 222.46/222.62  |- mesh__historyNote mesh__D001069 72%28%66%29%   
% 222.46/222.62  |- rdf__type mesh__D001069sskos__Concept
% 222.46/222.62  |- skos__scopeNote mesh__D001069
% 222.46/222.62       Physiologic mechanisms which regulate or control the appetite and food intake.%A%    
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001069 1993
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001069 2000
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001069 1996
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001069 1995
% 222.46/222.62  |- skos__altLabel mesh__D001069 Food Intake Regulation
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001069 1998
% 222.46/222.62  |- mesh__dateRevised mesh__D001069 1992-03-25
% 222.46/222.62  |- skos__prefLabel mesh__D001069 Appetite Regulation
% 222.46/222.62  |- skos__annotation mesh__D001069 DF: APPETITE REG   
% 222.46/222.62  |- mesh__recordAuthorizer mesh__D001069 PLS
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001069 1994
% 222.46/222.62  |- mesh__recordOriginator mesh__D001069 NLM
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D006552 2005
% 222.46/222.62  |- skos__broader mesh__D006552smesh__D046449
% 222.46/222.62  |- skos__hiddenLabel mesh__D006552 Indirect Inguinal Hernia
% 222.46/222.62  |- mesh__dateCreated mesh__D006552 1999-01-01
% 222.46/222.62  |- skos__hiddenLabel mesh__D006552 Hernias, Indirect Inguinal
% 222.46/222.62  |- skos__hiddenLabel mesh__D006552 Inguinal Hernias, Direct
% 222.46/222.62  |- skos__hiddenLabel mesh__D006552 Hernias, Direct Inguinal
% 222.46/222.62  |- mesh__publicMeSHNote mesh__D006552 80; was INGUINAL HERNIA 1963-79   
% 222.46/222.62  |- skos__scopeNote mesh__D006552
% 222.46/222.62       An abdominal hernia with an external bulge in the GROIN region. It can be classified by the location of herniation. Indirect inguinal hernias occur through the internal inguinal ring. Direct inguinal hernias occur through defects in the ABDOMINAL WALL %28%transversalis fascia%29% in Hesselbach%27%s triangle. The former type is commonly seen in children and young adults; the latter in adults.%A%    
% 222.46/222.62  |- skos__hiddenLabel mesh__D006552 Hernias, Inguinal
% 222.46/222.62  |- skos__hiddenLabel mesh__D006552 Direct Inguinal Hernia
% 222.46/222.62  |- mesh__recordOriginator mesh__D006552 NLM
% 222.46/222.62  |- mesh__recordAuthorizer mesh__D006552 sjn
% 222.46/222.62  |- skos__hiddenLabel mesh__D006552 Inguinal Hernias
% 222.46/222.62  |- rdf__type mesh__D006552sskos__Concept
% 222.46/222.62  |- skos__hiddenLabel mesh__D006552 Inguinal Hernias, Indirect
% 222.46/222.62  |- skos__hiddenLabel mesh__D006552 Direct Inguinal Hernias
% 222.46/222.62  |- mesh__recordMaintainer mesh__D006552 lkt
% 222.46/222.62  |- skos__hiddenLabel mesh__D006552 Hernia, Indirect Inguinal
% 222.46/222.62  |- mesh__historyNote mesh__D006552 80; was INGUINAL HERNIA 1963-79   
% 222.46/222.62  |- mesh__dateRevised mesh__D006552 2004-07-07
% 222.46/222.62  |- skos__altLabel mesh__D006552 Inguinal Hernia
% 222.46/222.62  |- skos__prefLabel mesh__D006552 Hernia, Inguinal
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D006552 2006
% 222.46/222.62  |- skos__hiddenLabel mesh__D006552 Indirect Inguinal Hernias
% 222.46/222.62  |- skos__hiddenLabel mesh__D006552 Hernia, Direct Inguinal
% 222.46/222.62  |- mesh__onlineNote mesh__D006552
% 222.46/222.62       use HERNIA, INGUINAL to search INGUINAL HERNIA 1966-79   
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D020223 2001
% 222.46/222.62  |- skos__scopeNote mesh__D020223
% 222.46/222.62       A technique for visualizing CHROMOSOME ABERRATIONS using fluorescently labeled DNA probes which are hybridized to chromosomal DNA. Multiple fluorochromes may be attached to the probes. Upon hybridization, this produces a multicolored, or painted, effect with a unique color at each site of hybridization. This technique may also be used to identify cross-species homology by labeling probes from one species for hybridization with chromosomes from another species.%A%    
% 222.46/222.62  |- mesh__recordMaintainer mesh__D020223 ags
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D020223 2006
% 222.46/222.62  |- skos__hiddenLabel mesh__D020223 Chromosome Paintings
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D020223 2004
% 222.46/222.62  |- mesh__historyNote mesh__D020223 99   
% 222.46/222.62  |- mesh__recordAuthorizer mesh__D020223 sjn
% 222.46/222.62  |- skos__hiddenLabel mesh__D020223 Painting, Chromosome
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D020223 2005
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D020223 2003
% 222.46/222.62  |- mesh__dateCreated mesh__D020223 1998-06-18
% 222.46/222.62  |- mesh__dateRevised mesh__D020223 2000-06-22
% 222.46/222.62  |- skos__prefLabel mesh__D020223 Chromosome Painting
% 222.46/222.62  |- skos__broader mesh__D020223smesh__D017404
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D020223 2002
% 222.46/222.62  |- skos__historyNote mesh__D020223
% 222.46/222.62       In Situ Hybridization, Fluorescence %28%1993-1998%29%
% 222.46/222.62  |- mesh__dateEstablished mesh__D020223 1999-01-01
% 222.46/222.62  |- skos__hiddenLabel mesh__D020223 Paintings, Chromosome
% 222.46/222.62  |- mesh__publicMeSHNote mesh__D020223 99   
% 222.46/222.62  |- rdf__type mesh__D020223sskos__Concept
% 222.46/222.62  |- mesh__recordOriginator mesh__D020223 NDW
% 222.46/222.62  |- skos__prefLabel mesh__D047969 Clostridium botulinum type D
% 222.46/222.62  |- mesh__dateCreated mesh__D047969 2004-07-07
% 222.46/222.62  |- skos__scopeNote mesh__D047969
% 222.46/222.62       Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type D which is neurotoxic to ANIMALS, especially CATTLE, but not humans.%A%    
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D047969 2006
% 222.46/222.62  |- skos__altLabel mesh__D047969 Clostridium botulinum D
% 222.46/222.62  |- mesh__recordOriginator mesh__D047969 ags
% 222.46/222.62  |- mesh__recordAuthorizer mesh__D047969 sjn
% 222.46/222.62  |- mesh__dateRevised mesh__D047969 2005-06-30
% 222.46/222.62  |- mesh__historyNote mesh__D047969 2005   
% 222.46/222.62  |- mesh__publicMeSHNote mesh__D047969 2005   
% 222.46/222.62  |- skos__broader mesh__D047969smesh__D003014
% 222.46/222.62  |- mesh__dateEstablished mesh__D047969 2005-01-01
% 222.46/222.62  |- skos__annotation mesh__D047969
% 222.46/222.62       infection: coordinate IM with BOTULISM %28%IM%29%   
% 222.46/222.62  |- mesh__recordMaintainer mesh__D047969 SYSTEM
% 222.46/222.62  |- skos__historyNote mesh__D047969 Clostridium botulinum %28%1968-2004%29%
% 222.46/222.62  |- rdf__type mesh__D047969sskos__Concept
% 222.46/222.62  |- skos__altLabel mesh__D011497 Protein Carboxylmethyltransferase
% 222.46/222.62  |- skos__hiddenLabel mesh__D011497
% 222.46/222.62       Protein Carboxymethyltransferase, S-Adenosylmethionine
% 222.46/222.62  |- skos__hiddenLabel mesh__D011497
% 222.46/222.62       Protein O-Methyltransferase, S-Adenosylmethionine
% 222.46/222.62  |- skos__altLabel mesh__D011497 Protein Carboxyl-Methylase
% 222.46/222.62  |- skos__hiddenLabel mesh__D011497 Protein O Carboxymethyltransferase
% 222.46/222.62  |- skos__hiddenLabel mesh__D011497
% 222.46/222.62       Carboxymethyltransferase, S-Adenosylmethionine Protein
% 222.46/222.62  |- skos__altLabel mesh__D011497
% 222.46/222.62       S-Adenosylmethionine Protein O-Methyltransferase
% 222.46/222.62  |- mesh__dateRevised mesh__D011497 2003-07-09
% 222.46/222.62  |- mesh__historyNote mesh__D011497
% 222.46/222.62       91%28%77%29%; was see under PROTEIN METHYLTRANSFERASES 1977-90   
% 222.46/222.62  |- skos__prefLabel mesh__D011497 Protein O-Methyltransferase
% 222.46/222.62  |- skos__hiddenLabel mesh__D011497 Methylase II, Protein
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D011497 2006
% 222.46/222.62  |- mesh__recordAuthorizer mesh__D011497 sjn
% 222.46/222.62  |- skos__altLabel mesh__D011497
% 222.46/222.62       Protein-Glutamic%28%Aspartic%29%-Methyltransferase
% 222.46/222.62  |- skos__hiddenLabel mesh__D011497 Carboxyl-Methylase, Protein
% 222.46/222.62  |- skos__historyNote mesh__D011497 Proteins %28%1966-1976%29%
% 222.46/222.62  |- skos__hiddenLabel mesh__D011497 O-Methyltransferase, Protein
% 222.46/222.62  |- skos__hiddenLabel mesh__D011497
% 222.46/222.62       Transferase, S-Adenosylmethionine-Protein Carboxymethyl
% 222.46/222.62  |- mesh__dateEstablished mesh__D011497 1991-01-01
% 222.46/222.62  |- skos__scopeNote mesh__D011497
% 222.46/222.62       An enzyme that catalyzes the transfer of methyl groups from S-adenosylmethionine to free carboxyl groups of a protein molecule forming methyl esters. EC 2.1.1.-.%A%    
% 222.46/222.62  |- skos__broader mesh__D011497smesh__D011496
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D011497 2005
% 222.46/222.62  |- skos__hiddenLabel mesh__D011497
% 222.46/222.62       S Adenosylmethionine Protein O Methyltransferase
% 222.46/222.62  |- skos__hiddenLabel mesh__D011497 Methyltransferase II, Protein
% 222.46/222.62  |- mesh__publicMeSHNote mesh__D011497
% 222.46/222.62       91; was see under PROTEIN METHYLTRANSFERASES 1977-90   
% 222.46/222.62  |- skos__altLabel mesh__D011497 Protein O-Carboxymethyltransferase
% 222.46/222.62  |- skos__hiddenLabel mesh__D011497 Protein O Methyltransferase
% 222.46/222.62  |- rdf__type mesh__D011497sskos__Concept
% 222.46/222.62  |- skos__altLabel mesh__D011497 Protein Carboxymethylase
% 222.46/222.62  |- skos__altLabel mesh__D011497
% 222.46/222.62       S-Adenosylmethionine Protein Carboxymethyltransferase
% 222.46/222.62  |- skos__hiddenLabel mesh__D011497
% 222.46/222.62       S Adenosylmethionine Protein Carboxymethyl Transferase
% 222.46/222.62  |- skos__altLabel mesh__D011497 Protein Methylase II
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D011497 2004
% 222.46/222.62  |- skos__historyNote mesh__D011497 S-Adenosylmethionine %28%1971-1976%29%
% 222.46/222.62  |- skos__hiddenLabel mesh__D011497 O-Carboxymethyltransferase, Protein
% 222.46/222.62  |- mesh__recordMaintainer mesh__D011497 ssb
% 222.46/222.62  |- skos__hiddenLabel mesh__D011497 Carboxylmethyltransferase, Protein
% 222.46/222.62  |- skos__annotation mesh__D011497
% 222.46/222.62       do not confuse with PROTEIN METHYLTRANSFERASES; DF: note short X ref%A%  
% 222.46/222.62  |- skos__altLabel mesh__D011497
% 222.46/222.62       S-Adenosylmethionine-Protein Carboxymethyl Transferase
% 222.46/222.62  |- skos__hiddenLabel mesh__D011497 Carboxymethylase, Protein
% 222.46/222.62  |- skos__hiddenLabel mesh__D011497 Protein Carboxyl Methylase
% 222.46/222.62  |- mesh__dateCreated mesh__D011497 1976-05-21
% 222.46/222.62  |- skos__historyNote mesh__D011497 Methyltransferases %28%1971-1976%29%
% 222.46/222.62  |- skos__hiddenLabel mesh__D011497
% 222.46/222.62       Carboxymethyl Transferase, S-Adenosylmethionine-Protein
% 222.46/222.62  |- skos__hiddenLabel mesh__D011497
% 222.46/222.62       O-Methyltransferase, S-Adenosylmethionine Protein
% 222.46/222.62  |- skos__altLabel mesh__D011497 Protein Methyltransferase II
% 222.46/222.62  |- mesh__recordOriginator mesh__D011497 RLS
% 222.46/222.62  |- skos__hiddenLabel mesh__D011497
% 222.46/222.62       S Adenosylmethionine Protein Carboxymethyltransferase
% 222.46/222.62  |- mesh__historyNote mesh__D016980 92   
% 222.46/222.62  |- mesh__dateRevised mesh__D016980 2005-06-30
% 222.46/222.62  |- skos__broader mesh__D016980smesh__D000333
% 222.46/222.62  |- mesh__dateCreated mesh__D016980 1991-05-30
% 222.46/222.62  |- skos__annotation mesh__D016980
% 222.46/222.62       pathogenic for frog, fish, humans %26% other mammals; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 222.46/222.62  |- skos__prefLabel mesh__D016980 Aeromonas hydrophila
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D016980 2006
% 222.46/222.62  |- mesh__publicMeSHNote mesh__D016980 92   
% 222.46/222.62  |- mesh__recordOriginator mesh__D016980 PXP
% 222.46/222.62  |- mesh__recordMaintainer mesh__D016980 SYSTEM
% 222.46/222.62  |- mesh__recordAuthorizer mesh__D016980 sjn
% 222.46/222.62  |- skos__scopeNote mesh__D016980
% 222.46/222.62       A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that may be pathogenic for frogs, fish, and mammals, including man. In humans, cellulitis and diarrhea can result from infection with this organism.%A%    
% 222.46/222.62  |- skos__historyNote mesh__D016980 Aeromonas %28%1967-1991%29%
% 222.46/222.62  |- mesh__dateEstablished mesh__D016980 1992-01-01
% 222.46/222.62  |- rdf__type mesh__D016980sskos__Concept
% 222.46/222.62  |- skos__broader mesh__D016182smesh__D016180
% 222.46/222.62  |- skos__broader mesh__D016182smesh__D012897
% 222.46/222.62  |- mesh__publicMeSHNote mesh__D016182 91   
% 222.46/222.62  |- skos__hiddenLabel mesh__D016182 Visnas
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D016182 2005
% 222.46/222.62  |- skos__hiddenLabel mesh__D016182 Ovine Encephalomyelitides
% 222.46/222.62  |- mesh__recordMaintainer mesh__D016182 jls
% 222.46/222.62  |- skos__altLabel mesh__D016182 Encephalomyelitis, Ovine
% 222.46/222.62  |- skos__scopeNote mesh__D016182
% 222.46/222.62       Demyelinating leukoencephalomyelitis of sheep caused by the VISNA-MAEDI VIRUS. It is similar to but not the same as SCRAPIE.%A%    
% 222.46/222.62  |- mesh__dateCreated mesh__D016182 1990-03-23
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D016182 2006
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D016182 2005A
% 222.46/222.62  |- mesh__recordAuthorizer mesh__D016182 jls
% 222.46/222.62  |- rdf__type mesh__D016182sskos__Concept
% 222.46/222.62  |- mesh__recordOriginator mesh__D016182 AGS
% 222.46/222.62  |- mesh__historyNote mesh__D016182 91   
% 222.46/222.62  |- skos__broader mesh__D016182smesh__D012757
% 222.46/222.62  |- mesh__dateRevised mesh__D016182 2004-08-03
% 222.46/222.62  |- skos__prefLabel mesh__D016182 Visna
% 222.46/222.62  |- skos__annotation mesh__D016182
% 222.46/222.62       caused by a lentivirus; don%27%t forget also SHEEP %28%NIM%29% %26% check tag ANIMALS%A%  
% 222.46/222.62  |- mesh__dateEstablished mesh__D016182 1991-01-01
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D016182 2004
% 222.46/222.62  |- skos__hiddenLabel mesh__D016182 Encephalomyelitides, Ovine
% 222.46/222.62  |- skos__altLabel mesh__D016182 Ovine Encephalomyelitis
% 222.46/222.62  |- skos__hiddenLabel mesh__D002960 Civil Disorder
% 222.46/222.62  |- mesh__dateCreated mesh__D002960 1999-01-01
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D002960 2006
% 222.46/222.62  |- skos__historyNote mesh__D002960 Disasters %28%1966-1968%29%
% 222.46/222.62  |- mesh__recordMaintainer mesh__D002960 hjn
% 222.46/222.62  |- skos__hiddenLabel mesh__D002960 Disorder, Civil
% 222.46/222.62  |- skos__broader mesh__D002960smesh__D012940
% 222.46/222.62  |- skos__historyNote mesh__D002960
% 222.46/222.62       Emergency Service, Hospital %28%1966-1968%29%
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D002960 2005
% 222.46/222.62  |- mesh__recordAuthorizer mesh__D002960 sjn
% 222.46/222.62  |- mesh__historyNote mesh__D002960 70%28%69%29%   
% 222.46/222.62  |- mesh__publicMeSHNote mesh__D002960 70   
% 222.46/222.62  |- mesh__dateRevised mesh__D002960 2002-07-03
% 222.46/222.62  |- skos__prefLabel mesh__D002960 Civil Disorders
% 222.46/222.62  |- skos__related mesh__D002960smesh__D034462
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D002960 2004
% 222.46/222.62  |- skos__annotation mesh__D002960 specify geog if pertinent   
% 222.46/222.62  |- mesh__dateEstablished mesh__D002960 1970-01-01
% 222.46/222.62  |- mesh__recordOriginator mesh__D002960 NLM
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D002960 2003
% 222.46/222.62  |- skos__hiddenLabel mesh__D002960 Disorders, Civil
% 222.46/222.62  |- skos__scopeNote mesh__D002960
% 222.46/222.62       Deliberate and planned acts of unlawful behavior engaged in by aggrieved segments of the population in seeking social change.%A%    
% 222.46/222.62  |- rdf__type mesh__D002960sskos__Concept
% 222.46/222.62  |- skos__broader mesh__D002162smesh__D012418
% 222.46/222.62  |- rdf__type mesh__D002162sskos__Concept
% 222.46/222.62  |- mesh__dateRevised mesh__D002162 2003-07-09
% 222.46/222.62  |- mesh__dateEstablished mesh__D002162 1968-01-01
% 222.46/222.62  |- mesh__recordAuthorizer mesh__D002162 sjn
% 222.46/222.62  |- mesh__historyNote mesh__D002162 68   
% 222.46/222.62  |- mesh__recordMaintainer mesh__D002162 ags
% 222.46/222.62  |- skos__historyNote mesh__D002162 Artiodactyla %28%1966-1967%29%
% 222.46/222.62  |- mesh__dateCreated mesh__D002162 1999-01-01
% 222.46/222.62  |- mesh__recordOriginator mesh__D002162 NLM
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D002162 2006
% 222.46/222.62  |- skos__hiddenLabel mesh__D002162 Dromedaries
% 222.46/222.62  |- skos__annotation mesh__D002162 IM; qualif permitted   
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D002162 2004
% 222.46/222.62  |- skos__hiddenLabel mesh__D002162 Camel
% 222.46/222.62  |- mesh__publicMeSHNote mesh__D002162 68   
% 222.46/222.62  |- skos__prefLabel mesh__D002162 Camels
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D002162 2005
% 222.46/222.62  |- skos__hiddenLabel mesh__D040281 FLT VEGF Receptor
% 222.46/222.62  |- skos__altLabel mesh__D040281 fms-Like Tyrosine Kinase
% 222.46/222.62  |- skos__altLabel mesh__D040281 Proto-Oncogene Protein flt
% 222.46/222.62  |- skos__historyNote mesh__D040281
% 222.46/222.62       Receptor Protein-Tyrosine Kinases %28%1991-2002%29%
% 222.46/222.62  |- skos__scopeNote mesh__D040281
% 222.46/222.62       A 180-kDa VEGF receptor found primarily in endothelial cells that is essential for vasculogenesis and vascular maintenance.  It is also known as Flt-1 %28%fms-like tyrosine kinase receptor-1%29%.  A soluble, alternatively spliced isoform of the receptor may serve as a binding protein that regulates the availability of various ligands for VEGF receptor binding and signal transduction.%A%    
% 222.46/222.62  |- skos__altLabel mesh__D040281 FLT1 Receptor Tyrosine Kinase
% 222.46/222.62  |- skos__altLabel mesh__D040281 FLT1 RTK
% 222.46/222.62  |- skos__altLabel mesh__D040281 VEGF Receptor flt-1 Protein
% 222.46/222.62  |- mesh__recordOriginator mesh__D040281 MDJ
% 222.46/222.62  |- skos__prefLabel mesh__D040281
% 222.46/222.62       Vascular Endothelial Growth Factor Receptor-1
% 222.46/222.62  |- skos__hiddenLabel mesh__D040281 Tyrosine Kinase, fms-Like
% 222.46/222.62  |- mesh__dateRevised mesh__D040281 2005-06-30
% 222.46/222.62  |- skos__hiddenLabel mesh__D040281 Proto Oncogene Protein flt
% 222.46/222.62  |- skos__altLabel mesh__D040281 VEGF Receptor, FLT
% 222.46/222.62  |- skos__broader mesh__D040281smesh__D040262
% 222.46/222.62  |- skos__altLabel mesh__D040281 VEGFR-1
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D040281 2006
% 222.46/222.62  |- mesh__dateCreated mesh__D040281 2002-07-03
% 222.46/222.62  |- rdf__type mesh__D040281sskos__Concept
% 222.46/222.62  |- skos__historyNote mesh__D040281
% 222.46/222.62       Proto-Oncogene Proteins %28%1991-2002%29%
% 222.46/222.62  |- mesh__recordMaintainer mesh__D040281 jmp
% 222.46/222.62  |- mesh__publicMeSHNote mesh__D040281
% 222.46/222.62       2003; PROTO-ONCOGENE PROTEIN FLT %28%now VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1%29% was indexed under PROTO-ONCOGENE PROTEINS %26% RECEPTOR PROTEIN-TYROSINE KINASE 1991-2002%A%  
% 222.46/222.62  |- skos__hiddenLabel mesh__D040281
% 222.46/222.62       Vascular Endothelial Growth Factor Receptor 1
% 222.46/222.62  |- skos__historyNote mesh__D040281
% 222.46/222.62       Receptors, Growth Factor %28%1993-2002%29%
% 222.46/222.62  |- skos__hiddenLabel mesh__D040281 Receptor, FLT VEGF
% 222.46/222.62  |- mesh__dateEstablished mesh__D040281 2003-01-01
% 222.46/222.62  |- skos__hiddenLabel mesh__D040281 VEGF Receptor flt 1 Protein
% 222.46/222.62  |- mesh__recordAuthorizer mesh__D040281 sjn
% 222.46/222.62  |- mesh__historyNote mesh__D040281
% 222.46/222.62       2003; use VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1 %28%NM%29% 1990-2002; for FLK-1 RECEPTOR TYROSINE KINASE use RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR %28%NM%29% 1993-2002%A%  
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001868 1995
% 222.46/222.62  |- skos__hiddenLabel mesh__D001868 Collectings, Book
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001868 2005
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001868 1993
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001868 2001
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001868 1999
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001868 2003
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001868 2000
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001868 1994
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001868 1997
% 222.46/222.62  |- skos__prefLabel mesh__D001868 Book Collecting
% 222.46/222.62  |- mesh__dateRevised mesh__D001868 1992-03-25
% 222.46/222.62  |- mesh__recordAuthorizer mesh__D001868 PLS
% 222.46/222.62  |- skos__broader mesh__D001868smesh__D007254
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001868 1998
% 222.46/222.62  |- mesh__recordOriginator mesh__D001868 NLM
% 222.46/222.62  |- mesh__recordMaintainer mesh__D001868 TAP
% 222.46/222.62  |- skos__hiddenLabel mesh__D001868 Book Collectings
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001868 1996
% 222.46/222.62  |- mesh__dateCreated mesh__D001868 1999-01-01
% 222.46/222.62  |- rdf__type mesh__D001868sskos__Concept
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001868 2002
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001868 2006
% 222.46/222.62  |- skos__hiddenLabel mesh__D001868 Collecting, Book
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D001868 2004
% 222.46/222.62  |- mesh__dateCreated mesh__D012590 1999-01-01
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D012590 2001
% 222.46/222.62  |- mesh__recordAuthorizer mesh__D012590 PLS
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D012590 2003
% 222.46/222.62  |- skos__prefLabel mesh__D012590 Sclera
% 222.46/222.62  |- skos__broader mesh__D012590smesh__D005123
% 222.46/222.62  |- skos__scopeNote mesh__D012590
% 222.46/222.62       The white, opaque, fibrous, outer tunic of the eyeball, covering it entirely excepting the segment covered anteriorly by the cornea. It is essentially avascular but contains apertures for vessels, lymphatics, and nerves. It receives the tendons of insertion of the extraocular muscles and at the corneoscleral junction contains the canal of Schlemm. %28%From Cline et al., Dictionary of Visual Science, 4th ed%29%%A%    
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D012590 2004
% 222.46/222.62  |- mesh__recordOriginator mesh__D012590 NLM
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D012590 2005
% 222.46/222.62  |- skos__related mesh__D012590smesh__D012599
% 222.46/222.62  |- skos__related mesh__D012590smesh__D016850
% 222.46/222.62  |- skos__related mesh__D012590smesh__D012591
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D012590 1996
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D012590 2002
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D012590 2006
% 222.46/222.62  |- skos__annotation mesh__D012590
% 222.46/222.62       the outer coat of the eyeball; inflammation = SCLERITIS; neopl = SCLERAL DISEASES %28%IM%29% + EYE NEOPLASMS %28%IM%29%; blue sclera = SCLERA /abnorm%A%  
% 222.46/222.62  |- skos__related mesh__D012590smesh__D016639
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D012590 1997
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D012590 1998
% 222.46/222.62  |- rdf__type mesh__D012590sskos__Concept
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D012590 2000
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D012590 1999
% 222.46/222.62  |- skos__hiddenLabel mesh__D012590 Scleras
% 222.46/222.62  |- mesh__dateRevised mesh__D012590 1995-05-18
% 222.46/222.62  |- mesh__recordMaintainer mesh__D012590 TGC
% 222.46/222.62  |- rdf__type mesh__D006553sskos__Concept
% 222.46/222.62  |- skos__broader mesh__D006553smesh__D006547
% 222.46/222.62  |- mesh__onlineNote mesh__D006553
% 222.46/222.62       use HERNIA, OBTURATOR to search OBTURATOR HERNIA 1975-79   
% 222.46/222.62  |- mesh__publicMeSHNote mesh__D006553
% 222.46/222.62       91; was see under HERNIA 1980-90; was OBTURATOR HERNIA see under HERNIA 1975-79%A%  
% 222.46/222.62  |- mesh__dateRevised mesh__D006553 2004-07-07
% 222.46/222.62  |- skos__hiddenLabel mesh__D006553 Hernias, Obturator
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D006553 2006
% 222.46/222.62  |- skos__hiddenLabel mesh__D006553 Obturator Hernias
% 222.46/222.62  |- mesh__dateCreated mesh__D006553 1974-11-19
% 222.46/222.62  |- mesh__dateEstablished mesh__D006553 1991-01-01
% 222.46/222.62  |- skos__prefLabel mesh__D006553 Hernia, Obturator
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D006553 2005
% 222.46/222.62  |- mesh__historyNote mesh__D006553
% 222.46/222.62       91%28%80%29%; was see under HERNIA 1980-90; was OBTURATOR HERNIA see under HERNIA 1975-79%A%  
% 222.46/222.62  |- skos__scopeNote mesh__D006553
% 222.46/222.62       A pelvic hernia through the obturator foramen, a large aperture in the hip bone normally covered by a membrane. Obturator hernia can lead to intestinal incarceration and INTESTINAL OBSTRUCTION.%A%    
% 222.46/222.62  |- mesh__recordAuthorizer mesh__D006553 sjn
% 222.46/222.62  |- mesh__recordOriginator mesh__D006553 NLM
% 222.46/222.62  |- mesh__recordMaintainer mesh__D006553 lkt
% 222.46/222.62  |- skos__altLabel mesh__D006553 Obturator Hernia
% 222.46/222.62  |- skos__hiddenLabel mesh__D020224 Sequence Tags, Expressed
% 222.46/222.62  |- skos__related mesh__D020224smesh__D015723
% 222.46/222.62  |- mesh__recordMaintainer mesh__D020224 nns
% 222.46/222.62  |- skos__historyNote mesh__D020224 DNA, Complementary %28%1994-1998%29%
% 222.46/222.62  |- skos__annotation mesh__D020224
% 222.46/222.62       do not confuse with SEQUENCE TAGGED SITES   
% 222.46/222.62  |- skos__hiddenLabel mesh__D020224 Expressed Sequence Tag
% 222.46/222.62  |- skos__hiddenLabel mesh__D020224 Tag, Expressed Sequence
% 222.46/222.62  |- skos__historyNote mesh__D020224 Gene Expression %28%1991-1998%29%
% 222.46/222.62  |- skos__related mesh__D020224smesh__D016324
% 222.46/222.62  |- mesh__historyNote mesh__D020224 99   
% 222.46/222.62  |- mesh__dateCreated mesh__D020224 1998-06-10
% 222.46/222.62  |- mesh__recordAuthorizer mesh__D020224 sjn
% 222.46/222.62  |- skos__scopeNote mesh__D020224
% 222.46/222.62       Partial cDNA %28%DNA, COMPLEMENTARY%29% sequences that are unique to the cDNAs from which they were derived.%A%    
% 222.46/222.62  |- skos__hiddenLabel mesh__D020224 Tags, Expressed Sequence
% 222.46/222.62  |- mesh__publicMeSHNote mesh__D020224 99   
% 222.46/222.62  |- mesh__dateRevised mesh__D020224 2005-06-30
% 222.46/222.62  |- skos__hiddenLabel mesh__D020224 Sequence Tag, Expressed
% 222.46/222.62  |- rdf__type mesh__D020224sskos__Concept
% 222.46/222.62  |- mesh__recordOriginator mesh__D020224 NDW
% 222.46/222.62  |- skos__broader mesh__D020224smesh__D040461
% 222.46/222.62  |- skos__prefLabel mesh__D020224 Expressed Sequence Tags
% 222.46/222.62  |- skos__altLabel mesh__D020224 ESTs
% 222.46/222.62  |- mesh__dateEstablished mesh__D020224 1999-01-01
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D020224 2006
% 222.46/222.62  |- mesh__publicMeSHNote mesh__D011498 73   
% 222.46/222.62  |- skos__historyNote mesh__D011498 specific protein %28%1966-1970%29%
% 222.46/222.62  |- skos__annotation mesh__D011498
% 222.46/222.62       IM; coord with specific protein %28%IM%29%   
% 222.46/222.62  |- rdf__type mesh__D011498sskos__Concept
% 222.46/222.62  |- mesh__dateEstablished mesh__D011498 1973-01-01
% 222.46/222.62  |- mesh__recordMaintainer mesh__D011498 SYSTEM
% 222.46/222.62  |- skos__prefLabel mesh__D011498 Protein Precursors
% 222.46/222.62  |- skos__related mesh__D011498smesh__D004792
% 222.46/222.62  |- skos__historyNote mesh__D011498 Proteins %28%1966-1970%29%
% 222.46/222.62  |- mesh__dateCreated mesh__D011498 1999-01-01
% 222.46/222.62  |- skos__hiddenLabel mesh__D011498 Precursors, Protein
% 222.46/222.62  |- mesh__recordAuthorizer mesh__D011498 sjn
% 222.46/222.62  |- skos__broader mesh__D011498smesh__D011506
% 222.46/222.62  |- mesh__dateRevised mesh__D011498 2005-06-30
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D011498 2006
% 222.46/222.62  |- mesh__recordOriginator mesh__D011498 NLM
% 222.46/222.62  |- mesh__historyNote mesh__D011498 73   
% 222.46/222.62  |- mesh__dateCreated mesh__D016981 1991-05-30
% 222.46/222.62  |- mesh__recordAuthorizer mesh__D016981 sjn
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D016981 2006
% 222.46/222.62  |- skos__scopeNote mesh__D016981
% 222.46/222.62       A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in fish and other aquatic animals and in a variety of mammals, including man. Its organisms probably do not belong to the normal intestinal flora of man and can cause diarrhea.%A%    
% 222.46/222.62  |- mesh__dateEstablished mesh__D016981 1992-01-01
% 222.46/222.62  |- mesh__dateRevised mesh__D016981 2005-06-30
% 222.46/222.62  |- mesh__recordOriginator mesh__D016981 PXP
% 222.46/222.62  |- mesh__recordMaintainer mesh__D016981 SYSTEM
% 222.46/222.62  |- skos__annotation mesh__D016981
% 222.46/222.62       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 222.46/222.62  |- mesh__publicMeSHNote mesh__D016981 92   
% 222.46/222.62  |- skos__historyNote mesh__D016981 Vibrionaceae %28%1978-1991%29%
% 222.46/222.62  |- skos__prefLabel mesh__D016981 Plesiomonas
% 222.46/222.62  |- skos__broader mesh__D016981smesh__D004755
% 222.46/222.62  |- rdf__type mesh__D016981sskos__Concept
% 222.46/222.62  |- mesh__historyNote mesh__D016981 92   
% 222.46/222.62  |- skos__altLabel mesh__D016183 AIDS, Murine
% 222.46/222.62  |- skos__historyNote mesh__D016183 Retrovirus Infections %28%1987-1990%29%
% 222.46/222.62  |- skos__prefLabel mesh__D016183 Murine Acquired Immunodeficiency Syndrome
% 222.46/222.62  |- skos__broader mesh__D016183smesh__D012192
% 222.46/222.62  |- skos__hiddenLabel mesh__D016183 Murine AIDSs
% 222.46/222.62  |- mesh__activeMeSHYear mesh__D016183 2006
% 222.46/222.62  |- skos__broader mesh__D016183smesh__D014412
% 222.46/222.62  |- skos__altLabel mesh__D016183 Murine Acquired Immune Deficiency Syndrome
% 222.46/222.62  |- mesh__recordAuthorizer mesh__D016183 sjn
% 222.46/222.62  |- skos__altLabel mesh__D016183 Murine AIDS
% 222.46/222.62  |- skos__hiddenLabel mesh__D016183 AIDSs, Murine
% 222.46/222.63  |- mesh__publicMeSHNote mesh__D016183 91   
% 222.46/222.63  |- rdf__type mesh__D016183sskos__Concept
% 222.46/222.63  |- mesh__recordMaintainer mesh__D016183 sjn
% 222.46/222.63  |- skos__scopeNote mesh__D016183
% 222.46/222.63       Acquired defect of cellular immunity that occurs in mice infected with mouse leukemia viruses %28%MuLV%29%. The syndrome shows striking similarities with human AIDS and is characterized by lymphadenopathy, profound immunosuppression, enhanced susceptibility to opportunistic infections, and B-cell lymphomas.%A%    
% 222.46/222.63  |- mesh__historyNote mesh__D016183 91   
% 222.46/222.63  |- mesh__dateCreated mesh__D016183 1990-03-23
% 222.46/222.63  |- mesh__dateEstablished mesh__D016183 1991-01-01
% 222.46/222.63  |- skos__annotation mesh__D016183
% 222.46/222.63       caused by a retrovirus; don%27%t forget also MICE %28%NIM%29% %26% check tag ANIMALS; DF: note short X ref%A%  
% 222.46/222.63  |- skos__broader mesh__D016183smesh__D012376
% 222.46/222.63  |- mesh__recordOriginator mesh__D016183 AGS
% 222.46/222.63  |- skos__altLabel mesh__D016183 MAIDS
% 222.46/222.63  |- mesh__dateRevised mesh__D016183 2004-07-13
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D016183 2005
% 222.46/222.63  |- skos__altLabel mesh__D016183 Murine Acquired Immuno-Deficiency Syndrome
% 222.46/222.63  |- skos__hiddenLabel mesh__D016183
% 222.46/222.63       Murine Acquired Immuno Deficiency Syndrome
% 222.46/222.63  |- skos__hiddenLabel mesh__D002961 Right, Legal
% 222.46/222.63  |- mesh__recordOriginator mesh__D002961 NLM
% 222.46/222.63  |- skos__broader mesh__D002961smesh__D006806
% 222.46/222.63  |- mesh__dateRevised mesh__D002961 2004-07-13
% 222.46/222.63  |- mesh__historyNote mesh__D002961 68   
% 222.46/222.63  |- skos__hiddenLabel mesh__D002961 Legal Right
% 222.46/222.63  |- skos__scopeNote mesh__D002961
% 222.46/222.63       Legal guarantee protecting the individual from attack on personal liberties, right to fair trial, right to vote, and freedom from discrimination on the basis of race, color, religion, sex, age, disability, or national origin. %28%from http://www.usccr.gov/ accessed 1/31/2003%29%%A%    
% 222.46/222.63  |- skos__historyNote mesh__D002961 Legislation %28%1966-1967%29%
% 222.46/222.63  |- skos__hiddenLabel mesh__D002961 Right, Civil
% 222.46/222.63  |- mesh__dateEstablished mesh__D002961 1968-01-01
% 222.46/222.63  |- rdf__type mesh__D002961sskos__Concept
% 222.46/222.63  |- mesh__recordMaintainer mesh__D002961 sjn
% 222.46/222.63  |- skos__annotation mesh__D002961
% 222.46/222.63       Specify geog; consider also HUMAN RIGHTS %26% SOCIAL JUSTICE; PRIVACY ACT see PRIVACY is also available%A%  
% 222.46/222.63  |- skos__hiddenLabel mesh__D002961 Voting Right
% 222.46/222.63  |- skos__hiddenLabel mesh__D002961 Rights, Legal
% 222.46/222.63  |- skos__hiddenLabel mesh__D002961 Rights, Civil
% 222.46/222.63  |- skos__prefLabel mesh__D002961 Civil Rights
% 222.46/222.63  |- skos__historyNote mesh__D002961
% 222.46/222.63       Interpersonal Relations %28%1966-1967%29%
% 222.46/222.63  |- mesh__publicMeSHNote mesh__D002961
% 222.46/222.63       68; DUE PROCESS see JURISPRUDENCE 1977-97   
% 222.46/222.63  |- mesh__dateCreated mesh__D002961 1999-01-01
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D002961 2006
% 222.46/222.63  |- mesh__recordAuthorizer mesh__D002961 sjn
% 222.46/222.63  |- skos__hiddenLabel mesh__D002961 Right, Voting
% 222.46/222.63  |- skos__hiddenLabel mesh__D002961 Protection, Equal
% 222.46/222.63  |- skos__hiddenLabel mesh__D002961 Rights, Voting
% 222.46/222.63  |- skos__hiddenLabel mesh__D002961 Civil Right
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D002961 2005
% 222.46/222.63  |- mesh__recordOriginator mesh__D002163 NLM
% 222.46/222.63  |- mesh__recordAuthorizer mesh__D002163 PLS
% 222.46/222.63  |- mesh__dateCreated mesh__D002163 1999-01-01
% 222.46/222.63  |- rdf__type mesh__D002163sskos__Concept
% 222.46/222.63  |- skos__altLabel mesh__D002163 United Republic of Cameroon
% 222.46/222.63  |- mesh__dateRevised mesh__D002163 1995-02-17
% 222.46/222.63  |- skos__prefLabel mesh__D002163 Cameroon
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D002163 1998
% 222.46/222.63  |- mesh__recordMaintainer mesh__D002163 TGC
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D002163 2005
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D002163 1996
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D002163 2000
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D002163 1999
% 222.46/222.63  |- skos__annotation mesh__D002163 a republic in central Africa   
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D002163 2003
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D002163 2006
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D002163 2001
% 222.46/222.63  |- skos__altLabel mesh__D002163 Cameroons
% 222.46/222.63  |- skos__scopeNote mesh__D002163
% 222.46/222.63       A republic in central Africa lying east of CHAD and the CENTRAL AFRICAN REPUBLIC. Its capital is Yaounde. As the Cameroons, it existed from 1884 under German, British, French, and UN mandates until it achieved independence in 1960. It united with the former British trust territory of Southern Cameroons in 1961. Its name is from the river that runs through it, Rio dos Camaroes, river of prawns, so called by 16th century Portuguese explorers impressed by the abundance of prawns in its waters. %28%From Webster%27%s New Geographical Dictionary, 1988, p208 %26% Room, Brewer%27%s Dictionary of Names, 1992, p93%29%%A%    
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D002163 1997
% 222.46/222.63  |- skos__broader mesh__D002163smesh__D000350
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D002163 2004
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D002163 2002
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D001869 1998
% 222.46/222.63  |- skos__hiddenLabel mesh__D001869 Imprint, Book
% 222.46/222.63  |- skos__prefLabel mesh__D001869 Book Imprints
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D001869 1996
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D001869 2002
% 222.46/222.63  |- mesh__dateCreated mesh__D001869 1999-01-01
% 222.46/222.63  |- rdf__type mesh__D001869sskos__Concept
% 222.46/222.63  |- skos__hiddenLabel mesh__D001869 Book Imprint
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D001869 2006
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D001869 2001
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D001869 2004
% 222.46/222.63  |- skos__hiddenLabel mesh__D001869 Imprints, Book
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D001869 1995
% 222.46/222.63  |- skos__broader mesh__D001869smesh__D001877
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D001869 2000
% 222.46/222.63  |- mesh__recordAuthorizer mesh__D001869 PLS
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D001869 2005
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D001869 1993
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D001869 1999
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D001869 2003
% 222.46/222.63  |- mesh__recordOriginator mesh__D001869 NLM
% 222.46/222.63  |- mesh__recordMaintainer mesh__D001869 TAP
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D001869 1994
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D001869 1997
% 222.46/222.63  |- mesh__dateRevised mesh__D001869 1992-03-25
% 222.46/222.63  |- skos__broader mesh__D012591smesh__D013508
% 222.46/222.63  |- skos__scopeNote mesh__D012591
% 222.46/222.63       An operation for retinal detachment which reduces the size of the globe by indenting the sclera so that it approximates the retina.%A%    
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012591 2003
% 222.46/222.63  |- skos__historyNote mesh__D012591 Sclera %28%1966-1974%29%
% 222.46/222.63  |- mesh__dateCreated mesh__D012591 1974-11-11
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012591 2005
% 222.46/222.63  |- skos__annotation mesh__D012591
% 222.46/222.63       do not use /util except by MeSH definition   
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012591 2000
% 222.46/222.63  |- skos__historyNote mesh__D012591
% 222.46/222.63       Retinal Detachment/surgery %28%1966-1974%29%
% 222.46/222.63  |- mesh__dateRevised mesh__D012591 1997-06-20
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012591 2004
% 222.46/222.63  |- skos__prefLabel mesh__D012591 Scleral Buckling
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012591 2001
% 222.46/222.63  |- skos__hiddenLabel mesh__D012591 Bucklings, Scleral
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012591 2006
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012591 1998
% 222.46/222.63  |- mesh__historyNote mesh__D012591 75   
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012591 1999
% 222.46/222.63  |- mesh__recordOriginator mesh__D012591 NLM
% 222.46/222.63  |- mesh__publicMeSHNote mesh__D012591 75   
% 222.46/222.63  |- mesh__dateEstablished mesh__D012591 1975-09-01
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012591 2002
% 222.46/222.63  |- rdf__type mesh__D012591sskos__Concept
% 222.46/222.63  |- mesh__recordAuthorizer mesh__D012591 SJN
% 222.46/222.63  |- skos__hiddenLabel mesh__D012591 Scleral Bucklings
% 222.46/222.63  |- mesh__recordMaintainer mesh__D012591 PXP
% 222.46/222.63  |- skos__hiddenLabel mesh__D012591 Buckling, Scleral
% 222.46/222.63  |- mesh__historyNote mesh__D006554 80; was UMBILICAL HERNIA 1963-79   
% 222.46/222.63  |- skos__prefLabel mesh__D006554 Hernia, Umbilical
% 222.46/222.63  |- mesh__dateRevised mesh__D006554 2004-07-07
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D006554 2006
% 222.46/222.63  |- skos__broader mesh__D006554smesh__D006555
% 222.46/222.63  |- skos__altLabel mesh__D006554 Exomphalos
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D006554 2005
% 222.46/222.63  |- mesh__publicMeSHNote mesh__D006554 80; was UMBILICAL HERNIA 1963-79   
% 222.46/222.63  |- mesh__dateCreated mesh__D006554 1999-01-01
% 222.46/222.63  |- skos__hiddenLabel mesh__D006554 Umbilical Hernias
% 222.46/222.63  |- mesh__onlineNote mesh__D006554
% 222.46/222.63       use HERNIA, UMBILICAL to search UMBILICAL HERNIA 1966-79   
% 222.46/222.63  |- skos__broader mesh__D006554smesh__D007232
% 222.46/222.63  |- rdf__type mesh__D006554sskos__Concept
% 222.46/222.63  |- skos__scopeNote mesh__D006554
% 222.46/222.63       A HERNIA due to an imperfect closure or weakness of the umbilical ring. It appears as a skin-covered protrusion at the UMBILICUS during crying, coughing, or straining. The hernia generally consists of OMENTUM or SMALL INTESTINE. The vast majority of umbilical hernias are congenital but can be acquired due to severe abdominal distention.%A%    
% 222.46/222.63  |- skos__related mesh__D006554smesh__D001506
% 222.46/222.63  |- skos__hiddenLabel mesh__D006554 Omphaloceles
% 222.46/222.63  |- skos__altLabel mesh__D006554 Umbilical Hernia
% 222.46/222.63  |- skos__hiddenLabel mesh__D006554 Hernias, Umbilical
% 222.46/222.63  |- mesh__recordOriginator mesh__D006554 NLM
% 222.46/222.63  |- mesh__recordMaintainer mesh__D006554 lkt
% 222.46/222.63  |- mesh__recordAuthorizer mesh__D006554 sjn
% 222.46/222.63  |- skos__hiddenLabel mesh__D020225 Sinus Thrombophlebitis, Sagittal
% 222.46/222.63  |- skos__altLabel mesh__D020225 Phlebitis, Sagittal Sinus, Septic
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D020225 2002
% 222.46/222.63  |- skos__historyNote mesh__D020225
% 222.46/222.63       Sinus Thrombosis, Intracranial %28%1968-1999%29%
% 222.46/222.63  |- rdf__type mesh__D020225sskos__Concept
% 222.46/222.63  |- mesh__publicMeSHNote mesh__D020225 2000   
% 222.46/222.63  |- skos__prefLabel mesh__D020225 Sagittal Sinus Thrombosis
% 222.46/222.63  |- mesh__dateCreated mesh__D020225 1999-11-03
% 222.46/222.63  |- skos__hiddenLabel mesh__D020225 Thromboses, Sagittal Sinus
% 222.46/222.63  |- skos__altLabel mesh__D020225 Sagittal Sinus Septic Phlebitis
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D020225 2006
% 222.46/222.63  |- skos__broader mesh__D020225smesh__D012851
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D020225 2001
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D020225 2004
% 222.46/222.63  |- mesh__dateEstablished mesh__D020225 2000-01-01
% 222.46/222.63  |- skos__hiddenLabel mesh__D020225 Sagittal Sinus Thromboses
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D020225 2005
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D020225 2000
% 222.46/222.63  |- skos__altLabel mesh__D020225 Thrombosis, Sagittal Sinus
% 222.46/222.63  |- skos__hiddenLabel mesh__D020225 Sinus Thrombosis, Sagittal
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D020225 2003
% 222.46/222.63  |- skos__scopeNote mesh__D020225
% 222.46/222.63       Infectious or noninfectious venous thrombosis of the sagittal sinus. Spontaneous and secondary forms occur. Associated conditions include DEHYDRATION; SEPSIS; THROMBOPHILIA; CRANIOCEREBRAL TRAUMA; and NEUROSURGICAL PROCEDURES. Affected individuals may present with or develop HEADACHE; neck pain; PAPILLEDEMA; SEIZURES; INTRACRANIAL HYPERTENSION; venous CEREBRAL INFARCTION; INTRACRANIAL HEMORRHAGES; hemiparesis; and other focal neurologic deficits. %28%From Adams et al., Principles of Neurology, 6th ed, p612%29%%A%    
% 222.46/222.63  |- skos__hiddenLabel mesh__D020225 Thrombophlebitis, Sagittal Sinus
% 222.46/222.63  |- skos__hiddenLabel mesh__D020225 Sinus Thromboses, Sagittal
% 222.46/222.63  |- mesh__historyNote mesh__D020225 2000   
% 222.46/222.63  |- skos__altLabel mesh__D011499 Protein Modification, Post-Translational
% 222.46/222.63  |- skos__altLabel mesh__D011499 Protein Processing, Posttranslational
% 222.46/222.63  |- skos__altLabel mesh__D011499 Post-Translational Protein Modification
% 222.46/222.63  |- skos__hiddenLabel mesh__D011499
% 222.46/222.63       Modifications, Post-Translational Protein
% 222.46/222.63  |- mesh__recordOriginator mesh__D011499 AEP
% 222.46/222.63  |- skos__hiddenLabel mesh__D011499 Modification, Posttranslational
% 222.46/222.63  |- skos__altLabel mesh__D011499 Posttranslational Protein Processing
% 222.46/222.63  |- mesh__dateCreated mesh__D011499 1982-04-26
% 222.46/222.63  |- skos__hiddenLabel mesh__D011499
% 222.46/222.63       Post Translational Amino Acid Modification
% 222.46/222.63  |- skos__hiddenLabel mesh__D011499 Post Translational Protein Processing
% 222.46/222.63  |- skos__altLabel mesh__D011499 Post-Translational Modifications
% 222.46/222.63  |- skos__hiddenLabel mesh__D011499
% 222.46/222.63       Protein Modifications, Post-Translational
% 222.46/222.63  |- skos__hiddenLabel mesh__D011499 Protein Modification, Post Translational
% 222.46/222.63  |- mesh__dateRevised mesh__D011499 2005-07-07
% 222.46/222.63  |- skos__altLabel mesh__D011499 Posttranslational Amino Acid Modification
% 222.46/222.63  |- skos__hiddenLabel mesh__D011499 Processing, Posttranslational Protein
% 222.46/222.63  |- skos__altLabel mesh__D011499 Protein Processing, Post Translational
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D011499 2006
% 222.46/222.63  |- skos__altLabel mesh__D011499 Amino Acid Modification, Posttranslational
% 222.46/222.63  |- skos__hiddenLabel mesh__D011499 Post Translational Protein Modification
% 222.46/222.63  |- skos__hiddenLabel mesh__D011499 Post-Translational Modification
% 222.46/222.63  |- skos__historyNote mesh__D011499 Translation, Genetic %28%1973-1982%29%
% 222.46/222.63  |- skos__altLabel mesh__D011499 Post-Translational Amino Acid Modification
% 222.46/222.63  |- skos__annotation mesh__D011499
% 222.46/222.63       coord IM with specific protein /metab %28%IM%29% and with specific modification, for example, ACYLATION; AMINATION; DEAMINATION; PROTEIN ISOPRENYLATION; etc.; do not confuse with PROTEIN MODIFICATION, TRANSLATIONAL; DF: PROTEIN PROC POST%A%  
% 222.46/222.63  |- skos__broader mesh__D011499smesh__D046188
% 222.46/222.63  |- skos__hiddenLabel mesh__D011499 Modifications, Post-Translational
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D011499 2005
% 222.46/222.63  |- rdf__type mesh__D011499sskos__Concept
% 222.46/222.63  |- skos__related mesh__D011499smesh__D042421
% 222.46/222.63  |- skos__hiddenLabel mesh__D011499 Modifications, Posttranslational
% 222.46/222.63  |- skos__hiddenLabel mesh__D011499 Post Translational Modifications
% 222.46/222.63  |- mesh__recordMaintainer mesh__D011499 ags
% 222.46/222.63  |- mesh__publicMeSHNote mesh__D011499 83   
% 222.46/222.63  |- skos__hiddenLabel mesh__D011499 Posttranslational Modification
% 222.46/222.63  |- skos__hiddenLabel mesh__D011499 Processing, Post-Translational Protein
% 222.46/222.63  |- skos__altLabel mesh__D011499 Post-Translational Protein Processing
% 222.46/222.63  |- skos__hiddenLabel mesh__D011499 Modification, Post-Translational Protein
% 222.46/222.63  |- skos__altLabel mesh__D011499 Posttranslational Modifications
% 222.46/222.63  |- mesh__recordAuthorizer mesh__D011499 ags
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D011499 2006A
% 222.46/222.63  |- mesh__dateEstablished mesh__D011499 1983-01-01
% 222.46/222.63  |- skos__hiddenLabel mesh__D011499
% 222.46/222.63       Amino Acid Modification, Post Translational
% 222.46/222.63  |- mesh__historyNote mesh__D011499 83   
% 222.46/222.63  |- skos__scopeNote mesh__D011499
% 222.46/222.63       Any of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility.%A%    
% 222.46/222.63  |- skos__prefLabel mesh__D011499 Protein Processing, Post-Translational
% 222.46/222.63  |- skos__hiddenLabel mesh__D011499 Modification, Post-Translational
% 222.46/222.63  |- skos__hiddenLabel mesh__D011499 Post-Translational Protein Modifications
% 222.46/222.63  |- skos__annotation mesh__D016982 found on mammalian skin   
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D016982 2006
% 222.46/222.63  |- skos__scopeNote mesh__D016982
% 222.46/222.63       A species of gram-positive, spherical bacteria whose organisms occur in tetrads and in irregular clusters of tetrads. The primary habitat is mammalian skin.%A%    
% 222.46/222.63  |- mesh__dateEstablished mesh__D016982 1992-01-01
% 222.46/222.63  |- mesh__recordAuthorizer mesh__D016982 sjn
% 222.46/222.63  |- mesh__dateCreated mesh__D016982 1991-05-30
% 222.46/222.63  |- skos__broader mesh__D016982smesh__D008837
% 222.46/222.63  |- skos__historyNote mesh__D016982 Micrococcus %28%1968-1991%29%
% 222.46/222.63  |- rdf__type mesh__D016982sskos__Concept
% 222.46/222.63  |- mesh__dateRevised mesh__D016982 2005-06-30
% 222.46/222.63  |- mesh__historyNote mesh__D016982 92   
% 222.46/222.63  |- skos__prefLabel mesh__D016982 Micrococcus luteus
% 222.46/222.63  |- mesh__recordOriginator mesh__D016982 PXP
% 222.46/222.63  |- mesh__recordMaintainer mesh__D016982 SYSTEM
% 222.46/222.63  |- mesh__publicMeSHNote mesh__D016982 92   
% 222.46/222.63  |- mesh__historyNote mesh__D016184 91   
% 222.46/222.63  |- skos__hiddenLabel mesh__D016184 Colony Stimulating Factor Receptors
% 222.46/222.63  |- skos__altLabel mesh__D016184 Colony-Stimulating Factor Receptor
% 222.46/222.63  |- skos__altLabel mesh__D016184 Colony-Stimulating Factor Receptors
% 222.46/222.63  |- skos__scopeNote mesh__D016184
% 222.46/222.63       Cell surface receptors for colony stimulating factors, local mediators, and hormones that regulate the survival, proliferation, and differentiation of hemopoietic cells.%A%    
% 222.46/222.63  |- skos__hiddenLabel mesh__D016184 Colony Stimulating Factor Receptor
% 222.46/222.63  |- skos__altLabel mesh__D016184 Receptors, Hematopoietic Growth Factors
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D016184 2004
% 222.46/222.63  |- mesh__dateRevised mesh__D016184 2003-07-09
% 222.46/222.63  |- mesh__recordMaintainer mesh__D016184 jmp
% 222.46/222.63  |- mesh__dateCreated mesh__D016184 1990-04-24
% 222.46/222.63  |- mesh__dateEstablished mesh__D016184 1991-01-01
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D016184 2005
% 222.46/222.63  |- mesh__recordAuthorizer mesh__D016184 sjn
% 222.46/222.63  |- skos__broader mesh__D016184smesh__D018121
% 222.46/222.63  |- skos__hiddenLabel mesh__D016184 Receptor, Colony-Stimulating Factor
% 222.46/222.63  |- mesh__publicMeSHNote mesh__D016184 91   
% 222.46/222.63  |- skos__altLabel mesh__D016184 Hematopoietic Growth Factors Receptors
% 222.46/222.63  |- skos__annotation mesh__D016184 DF: RECEPT CSF   
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D016184 2006
% 222.46/222.63  |- skos__broader mesh__D016184smesh__D017978
% 222.46/222.63  |- skos__hiddenLabel mesh__D016184 Receptors, CSF
% 222.46/222.63  |- mesh__recordOriginator mesh__D016184 RLS
% 222.46/222.63  |- skos__altLabel mesh__D016184 Hematopoietic Growth Factor Receptor
% 222.46/222.63  |- skos__prefLabel mesh__D016184 Receptors, Colony-Stimulating Factor
% 222.46/222.63  |- skos__historyNote mesh__D016184
% 222.46/222.63       Receptors, Endogenous Substances %28%1973-1990%29%
% 222.46/222.63  |- rdf__type mesh__D016184sskos__Concept
% 222.46/222.63  |- skos__hiddenLabel mesh__D016184 Receptors, Colony Stimulating Factor
% 222.46/222.63  |- skos__altLabel mesh__D016184 CSF Receptors
% 222.46/222.63  |- skos__annotation mesh__D002962 specify geog if pertinent   
% 222.46/222.63  |- mesh__recordOriginator mesh__D002962 NLM
% 222.46/222.63  |- skos__hiddenLabel mesh__D002962 Civilizations
% 222.46/222.63  |- rdf__type mesh__D002962sskos__Concept
% 222.46/222.63  |- mesh__dateCreated mesh__D002962 1999-01-01
% 222.46/222.63  |- mesh__dateRevised mesh__D002962 2004-07-13
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D002962 2006
% 222.46/222.63  |- skos__broader mesh__D002962smesh__D003469
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D002962 2005
% 222.46/222.63  |- mesh__recordMaintainer mesh__D002962 sjn
% 222.46/222.63  |- skos__scopeNote mesh__D002962
% 222.46/222.63       The distinctly human attributes and attainments of a particular society.%A%    
% 222.46/222.63  |- skos__prefLabel mesh__D002962 Civilization
% 222.46/222.63  |- mesh__recordAuthorizer mesh__D002962 sjn
% 222.46/222.63  |- rdf__type mesh__D002164sskos__Concept
% 222.46/222.63  |- mesh__recordMaintainer mesh__D002164 ssb
% 222.46/222.63  |- mesh__recordOriginator mesh__D002164 NLM
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D002164 2005
% 222.46/222.63  |- skos__scopeNote mesh__D002164
% 222.46/222.63       A bicyclic monoterpene ketone found widely in plant %28%primarily the camphor tree, Cinnamomum camphora%29%.  Natural camphor is used topically as a skin antipruritic and as an anti-infective agent.%A%    
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D002164 2006
% 222.46/222.63  |- skos__prefLabel mesh__D002164 Camphor
% 222.46/222.63  |- skos__broader mesh__D002164smesh__D007659
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D002164 2004
% 222.46/222.63  |- mesh__dateRevised mesh__D002164 2003-07-09
% 222.46/222.63  |- skos__broader mesh__D002164smesh__D001892
% 222.46/222.63  |- mesh__recordAuthorizer mesh__D002164 sjn
% 222.46/222.63  |- mesh__dateCreated mesh__D002164 1999-01-01
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D029301 2006
% 222.46/222.63  |- rdf__type mesh__D029301sskos__Concept
% 222.46/222.63  |- mesh__dateEstablished mesh__D029301 2002-01-01
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D029301 2005
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D029301 2004
% 222.46/222.63  |- mesh__publicMeSHNote mesh__D029301 2002   
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D029301 2003
% 222.46/222.63  |- mesh__historyNote mesh__D029301 2002   
% 222.46/222.63  |- skos__annotation mesh__D029301
% 222.46/222.63       do not confuse with SANDFLY FEVER SICILIAN VIRUS see PHLEBOVIRUS; infection: coord IM with PHLEBOTOMUS FEVER %28%IM%29% or if not so specified coord with BUNYAVIRIDAE INFECTIONS %28%IM%29%%A%  
% 222.46/222.63  |- skos__broader mesh__D029301smesh__D016856
% 222.46/222.63  |- skos__historyNote mesh__D029301 Phlebovirus %28%1977-2001%29%
% 222.46/222.63  |- skos__prefLabel mesh__D029301 Sandfly fever Naples virus
% 222.46/222.63  |- skos__scopeNote mesh__D029301
% 222.46/222.63       A species in the genus PHLEBOVIRUS causing PHLEBOTOMUS FEVER, an influenza-like illness. Related serotypes include Toscana virus and Tehran virus.%A%    
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D029301 2002
% 222.46/222.63  |- mesh__dateCreated mesh__D029301 2001-07-25
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012592 1998
% 222.46/222.63  |- mesh__recordOriginator mesh__D012592 NLM
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012592 2002
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012592 1997
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012592 1994
% 222.46/222.63  |- skos__broader mesh__D012592smesh__D012871
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012592 1999
% 222.46/222.63  |- skos__broader mesh__D012592smesh__D017520
% 222.46/222.63  |- skos__prefLabel mesh__D012592 Scleredema Adultorum
% 222.46/222.63  |- rdf__type mesh__D012592sskos__Concept
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012592 1995
% 222.46/222.63  |- mesh__dateCreated mesh__D012592 1999-01-01
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012592 2000
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012592 2003
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012592 2001
% 222.46/222.63  |- skos__scopeNote mesh__D012592
% 222.46/222.63       A diffuse, non-pitting induration of the skin of unknown etiology that occurs most commonly in association with diabetes mellitus, predominantly in females. It typically begins on the face or head and spreads to other areas of the body, sometimes involving noncutaneous tissues. Often it is preceded by any of various infections, notably staphylococcal infections. The condition resolves spontaneously, usually within two years of onset. %28%From Dorland, 27th ed%29%%A%    
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012592 2005
% 222.46/222.63  |- mesh__dateRevised mesh__D012592 1993-06-03
% 222.46/222.63  |- skos__annotation mesh__D012592 induration of skin in diabetes   
% 222.46/222.63  |- mesh__recordMaintainer mesh__D012592 TAP
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012592 2004
% 222.46/222.63  |- mesh__recordAuthorizer mesh__D012592 PLS
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012592 2006
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D012592 1996
% 222.46/222.63  |- skos__broader mesh__D006555smesh__D046449
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D006555 2005
% 222.46/222.63  |- mesh__dateCreated mesh__D006555 1999-01-01
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D006555 2006
% 222.46/222.63  |- mesh__publicMeSHNote mesh__D006555 80; was VENTRAL HERNIA 1963-79   
% 222.46/222.63  |- skos__scopeNote mesh__D006555
% 222.46/222.63       A hernia caused by weakness of the anterior ABDOMINAL WALL due to midline defects, previous incisions, or increased intra-abdominal pressure. Ventral hernias include UMBILICAL HERNIA, incisional, epigastric, and spigelian hernias.%A%    
% 222.46/222.63  |- mesh__recordOriginator mesh__D006555 NLM
% 222.46/222.63  |- mesh__recordAuthorizer mesh__D006555 sjn
% 222.46/222.63  |- mesh__onlineNote mesh__D006555
% 222.46/222.63       use HERNIA, VENTRAL to search VENTRAL HERNIA 1966-79   
% 222.46/222.63  |- mesh__recordMaintainer mesh__D006555 lkt
% 222.46/222.63  |- skos__hiddenLabel mesh__D006555 Hernias, Ventral
% 222.46/222.63  |- skos__altLabel mesh__D006555 Ventral Hernia
% 222.46/222.63  |- skos__hiddenLabel mesh__D006555 Ventral Hernias
% 222.46/222.63  |- mesh__dateRevised mesh__D006555 2004-07-07
% 222.46/222.63  |- skos__prefLabel mesh__D006555 Hernia, Ventral
% 222.46/222.63  |- rdf__type mesh__D006555sskos__Concept
% 222.46/222.63  |- mesh__historyNote mesh__D006555 80; was VENTRAL HERNIA 1963-79   
% 222.46/222.63  |- skos__hiddenLabel mesh__D020226 Thrombophlebitides, Cavernous Sinus
% 222.46/222.63  |- mesh__recordAuthorizer mesh__D020226 sjn
% 222.46/222.63  |- rdf__type mesh__D020226sskos__Concept
% 222.46/222.63  |- skos__hiddenLabel mesh__D020226 Sinus Thromboses, Cavernous
% 222.46/222.63  |- skos__hiddenLabel mesh__D020226 Thrombophlebitis, Cavernous Sinus
% 222.46/222.63  |- skos__hiddenLabel mesh__D020226 Sinus Thrombosis, Cavernous
% 222.46/222.63  |- mesh__recordOriginator mesh__D020226 KEV
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D020226 2006
% 222.46/222.63  |- skos__broader mesh__D020226smesh__D012851
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D020226 2004
% 222.46/222.63  |- mesh__dateEstablished mesh__D020226 2000-01-01
% 222.46/222.63  |- mesh__publicMeSHNote mesh__D020226 2000   
% 222.46/222.63  |- skos__altLabel mesh__D020226 Phlebitis, Cavernous Sinus, Septic
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D020226 2005
% 222.46/222.63  |- skos__scopeNote mesh__D020226
% 222.46/222.63       Formation of a blood clot composed of platelets and fibrin in the CAVERNOUS SINUS of the brain. Infections of the paranasal sinuses and adjacent structures, CRANIOCEREBRAL TRAUMA, and THROMBOPHILIA are associated conditions. Clinical manifestations include dysfunction of cranial nerves III, IV, V, and VI, marked periorbital swelling, chemosis, fever, and visual loss. %28%From Adams et al., Principles of Neurology, 6th ed, p711%29%%A%    
% 222.46/222.63  |- skos__hiddenLabel mesh__D020226 Sinus Thrombophlebitis, Cavernous
% 222.46/222.63  |- mesh__dateRevised mesh__D020226 2003-07-25
% 222.46/222.63  |- skos__altLabel mesh__D020226 Thrombosis, Cavernous Sinus
% 222.46/222.63  |- skos__altLabel mesh__D020226 Cavernous Sinus, Phlebitis, Septic
% 222.46/222.63  |- skos__hiddenLabel mesh__D020226 Cavernous Sinus Thromboses
% 222.46/222.63  |- mesh__historyNote mesh__D020226 2000   
% 222.46/222.63  |- skos__historyNote mesh__D020226
% 222.46/222.63       Sinus Thrombosis, Intracranial %28%1966-1999%29%
% 222.46/222.63  |- skos__hiddenLabel mesh__D020226 Thromboses, Cavernous Sinus
% 222.46/222.63  |- skos__prefLabel mesh__D020226 Cavernous Sinus Thrombosis
% 222.46/222.63  |- mesh__recordMaintainer mesh__D020226 sjn
% 222.46/222.63  |- skos__altLabel mesh__D020226 Caverous Sinus Septic Phlebitis
% 222.46/222.63  |- mesh__dateCreated mesh__D020226 1999-11-04
% 222.46/222.63  |- skos__hiddenLabel mesh__D020226 Sinus Thrombophlebitides, Cavernous
% 222.46/222.63  |- skos__hiddenLabel mesh__D020226 Cavernous Sinus Thrombophlebitides
% 222.46/222.63  |- skos__historyNote mesh__D016983 Streptococcus %28%1966-1991%29%
% 222.46/222.63  |- mesh__publicMeSHNote mesh__D016983 92   
% 222.46/222.63  |- mesh__dateCreated mesh__D016983 1991-05-30
% 222.46/222.63  |- skos__scopeNote mesh__D016983
% 222.46/222.63       A genus of gram-positive, coccoid bacteria consisting of organisms causing variable hemolysis that are normal flora of the intestinal tract. Previously thought to be a member of the genus STREPTOCOCCUS, it is now recognized as a separate genus.%A%    
% 222.46/222.63  |- skos__annotation mesh__D016983
% 222.46/222.63       %22%normal flora of the intestinal tract%22%; usually non-pathogenic%A%  
% 222.46/222.63  |- rdf__type mesh__D016983sskos__Concept
% 222.46/222.63  |- mesh__dateEstablished mesh__D016983 1992-01-01
% 222.46/222.63  |- mesh__historyNote mesh__D016983 92   
% 222.46/222.63  |- mesh__recordAuthorizer mesh__D016983 sjn
% 222.46/222.63  |- skos__prefLabel mesh__D016983 Enterococcus
% 222.46/222.63  |- mesh__recordOriginator mesh__D016983 PXP
% 222.46/222.63  |- mesh__recordMaintainer mesh__D016983 SYSTEM
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D016983 2006
% 222.46/222.63  |- skos__broader mesh__D016983smesh__D013289
% 222.46/222.63  |- mesh__dateRevised mesh__D016983 2005-06-30
% 222.46/222.63  |- skos__altLabel mesh__D016185 IL3 Receptors
% 222.46/222.63  |- skos__hiddenLabel mesh__D016185 Receptor, Interleukin-3
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D016185 2004
% 222.46/222.63  |- skos__annotation mesh__D016185 DF: RECEPT IL 3 or RECEPT IL3   
% 222.46/222.63  |- mesh__dateRevised mesh__D016185 2003-07-09
% 222.46/222.63  |- mesh__recordOriginator mesh__D016185 RLS
% 222.46/222.63  |- skos__hiddenLabel mesh__D016185 Interleukin 3 Receptor
% 222.46/222.63  |- skos__altLabel mesh__D016185 Interleukin-3 Receptors
% 222.46/222.63  |- skos__hiddenLabel mesh__D016185 Receptors, Interleukin 3
% 222.46/222.63  |- skos__hiddenLabel mesh__D016185 Interleukin 3 Receptors
% 222.46/222.63  |- mesh__recordMaintainer mesh__D016185 jmp
% 222.46/222.63  |- skos__altLabel mesh__D016185 Receptors, IL-3
% 222.46/222.63  |- mesh__dateEstablished mesh__D016185 1991-01-01
% 222.46/222.63  |- skos__hiddenLabel mesh__D016185 Receptors, IL 3
% 222.46/222.63  |- skos__hiddenLabel mesh__D016185 Receptor, IL3
% 222.46/222.63  |- skos__hiddenLabel mesh__D016185 IL 3 Receptor
% 222.46/222.63  |- skos__altLabel mesh__D016185 Interleukin-3 Receptor
% 222.46/222.63  |- mesh__activeMeSHYear mesh__D016185 2005
% 222.46/222.64  |- skos__broader mesh__D016185smesh__D018123
% 222.46/222.64  |- skos__hiddenLabel mesh__D016185 IL 3 Receptors
% 222.46/222.64  |- skos__altLabel mesh__D016185 IL-3 Receptor
% 222.46/222.64  |- skos__hiddenLabel mesh__D016185 Receptors, IL3
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D016185 2006
% 222.46/222.64  |- mesh__dateCreated mesh__D016185 1990-04-24
% 222.46/222.64  |- skos__hiddenLabel mesh__D016185 Receptor, IL-3
% 222.46/222.64  |- skos__altLabel mesh__D016185 IL-3 Receptors
% 222.46/222.64  |- skos__broader mesh__D016185smesh__D016184
% 222.46/222.64  |- rdf__type mesh__D016185sskos__Concept
% 222.46/222.64  |- mesh__recordAuthorizer mesh__D016185 sjn
% 222.46/222.64  |- skos__prefLabel mesh__D016185 Receptors, Interleukin-3
% 222.46/222.64  |- skos__altLabel mesh__D016185 IL3 Receptor
% 222.46/222.64  |- mesh__historyNote mesh__D016185 91   
% 222.46/222.64  |- mesh__publicMeSHNote mesh__D016185 91   
% 222.46/222.64  |- skos__scopeNote mesh__D016185
% 222.46/222.64       Phosphotyrosine-containing proteins, MW 140 kD. They form a stable complex with INTERLEUKIN-3 with an apparent mass of 170 kD. They are found on a variety of cells and activate INTERLEUKIN-3.%A%    
% 222.46/222.64  |- skos__historyNote mesh__D016185 Receptors, Immunologic %28%1980-1990%29%
% 222.46/222.64  |- mesh__dateCreated mesh__D002963 1974-12-12
% 222.46/222.64  |- mesh__recordOriginator mesh__D002963 NLM
% 222.46/222.64  |- rdf__type mesh__D002963sskos__Concept
% 222.46/222.64  |- skos__prefLabel mesh__D002963 Cladosporium
% 222.46/222.64  |- skos__scopeNote mesh__D002963
% 222.46/222.64       A mitosporic Loculoascomycetes fungal genus including some economically important plant parasites. Teleomorphs include Mycosphaerella and Venturia.%A%    
% 222.46/222.64  |- mesh__recordMaintainer mesh__D002963 SYSTEM
% 222.46/222.64  |- skos__annotation mesh__D002963
% 222.46/222.64       infection: coord IM with probably MYCOSES or TINEA %28%IM%29%   
% 222.46/222.64  |- mesh__dateEstablished mesh__D002963 1991-01-01
% 222.46/222.64  |- mesh__historyNote mesh__D002963
% 222.46/222.64       91%28%75%29%; was see under HYPHOMYCETES 1986-90; was see under MONILIALES 1975-85%A%  
% 222.46/222.64  |- skos__broader mesh__D002963smesh__D003904
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002963 2006
% 222.46/222.64  |- mesh__recordAuthorizer mesh__D002963 sjn
% 222.46/222.64  |- mesh__dateRevised mesh__D002963 2005-06-30
% 222.46/222.64  |- mesh__publicMeSHNote mesh__D002963
% 222.46/222.64       91; was see under HYPHOMYCETES 1986-90; was see under MONILIALES 1975-85%A%  
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002165 1996
% 222.46/222.64  |- mesh__recordMaintainer mesh__D002165 TGC
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002165 1999
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002165 2003
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002165 2006
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002165 2000
% 222.46/222.64  |- skos__prefLabel mesh__D002165 Camping
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002165 1997
% 222.46/222.64  |- skos__scopeNote mesh__D002165
% 222.46/222.64       Living outdoors as a recreational activity.     
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002165 2004
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002165 2001
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002165 1994
% 222.46/222.64  |- mesh__dateRevised mesh__D002165 1992-05-07
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002165 2002
% 222.46/222.64  |- mesh__dateCreated mesh__D002165 1999-01-01
% 222.46/222.64  |- rdf__type mesh__D002165sskos__Concept
% 222.46/222.64  |- mesh__recordOriginator mesh__D002165 NLM
% 222.46/222.64  |- mesh__recordAuthorizer mesh__D002165 PLS
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002165 1995
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002165 1998
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002165 1993
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002165 2005
% 222.46/222.64  |- skos__broader mesh__D002165smesh__D011998
% 222.46/222.64  |- skos__broader mesh__D012593smesh__D007232
% 222.46/222.64  |- rdf__type mesh__D012593sskos__Concept
% 222.46/222.64  |- mesh__recordOriginator mesh__D012593 NLM
% 222.46/222.64  |- skos__prefLabel mesh__D012593 Sclerema Neonatorum
% 222.46/222.64  |- mesh__dateCreated mesh__D012593 1999-01-01
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D012593 2002
% 222.46/222.64  |- mesh__recordMaintainer mesh__D012593 nns
% 222.46/222.64  |- skos__scopeNote mesh__D012593
% 222.46/222.64       A severe, sometimes fatal, disorder of adipose tissue occurring chiefly in preterm or debilitated infants suffering from an underlying illness and manifested by a diffuse, nonpitting induration of the affected tissue. The skin becomes cold, yellowish, mottled, and inflexible.%A%    
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D012593 2003
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D012593 2005
% 222.46/222.64  |- mesh__dateRevised mesh__D012593 2001-07-25
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D012593 2004
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D012593 2006
% 222.46/222.64  |- mesh__recordAuthorizer mesh__D012593 sjn
% 222.46/222.64  |- skos__broader mesh__D012593smesh__D012868
% 222.46/222.64  |- skos__annotation mesh__D012593
% 222.46/222.64       a skin abnorm; adipose tissue dis in preterm or debilitated inf; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 222.46/222.64  |- skos__historyNote mesh__D006556 Diacetylmorphine %28%1966-1972%29%
% 222.46/222.64  |- mesh__publicMeSHNote mesh__D006556 81; was HEROIN ADDICTION 1974-80   
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006556 2006
% 222.46/222.64  |- skos__hiddenLabel mesh__D006556 Abuse, Heroin
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006556 2003
% 222.46/222.64  |- skos__hiddenLabel mesh__D006556 Dependence, Heroin
% 222.46/222.64  |- skos__scopeNote mesh__D006556
% 222.46/222.64       Strong dependence, both physiological and emotional, upon heroin.%A%    
% 222.46/222.64  |- skos__hiddenLabel mesh__D006556 Users, Heroin
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006556 2004
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006556 2000
% 222.46/222.64  |- skos__hiddenLabel mesh__D006556 Heroin User
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006556 2001
% 222.46/222.64  |- mesh__dateEstablished mesh__D006556 1974-01-01
% 222.46/222.64  |- mesh__historyNote mesh__D006556
% 222.46/222.64       81; was HEROIN ADDICTION 1973-80 %28%Prov 1973%29%   
% 222.46/222.64  |- mesh__recordAuthorizer mesh__D006556 sjn
% 222.46/222.64  |- mesh__onlineNote mesh__D006556
% 222.46/222.64       use HEROIN DEPENDENCE to search HEROIN ADDICTION 1973-80 %28%as Prov 1973%29%%A%  
% 222.46/222.64  |- mesh__recordOriginator mesh__D006556 NLM
% 222.46/222.64  |- rdf__type mesh__D006556sskos__Concept
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006556 2002
% 222.46/222.64  |- skos__broader mesh__D006556smesh__D009293
% 222.46/222.64  |- skos__historyNote mesh__D006556 Morphine Dependence %28%1966-1972%29%
% 222.46/222.64  |- skos__historyNote mesh__D006556 Substance Dependence %28%1966-1972%29%
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006556 2005
% 222.46/222.64  |- mesh__dateCreated mesh__D006556 1999-01-01
% 222.46/222.64  |- skos__hiddenLabel mesh__D006556 User, Heroin
% 222.46/222.64  |- skos__hiddenLabel mesh__D006556 Addiction, Heroin
% 222.46/222.64  |- skos__prefLabel mesh__D006556 Heroin Dependence
% 222.46/222.64  |- mesh__dateRevised mesh__D006556 1999-11-05
% 222.46/222.64  |- mesh__recordMaintainer mesh__D006556 adp
% 222.46/222.64  |- skos__altLabel mesh__D006556 Heroin Addiction
% 222.46/222.64  |- skos__prefLabel mesh__D020227 Lateral Sinus Thrombosis
% 222.46/222.64  |- rdf__type mesh__D020227sskos__Concept
% 222.46/222.64  |- skos__scopeNote mesh__D020227
% 222.46/222.64       Infectious or noninfectious thrombosis of the lateral sinus of the brain. Septic thrombosis may be associated with OTITIS MEDIA or MASTOIDITIS. CRANIOCEREBRAL TRAUMA; BRAIN NEOPLASMS; NEUROSURGICAL PROCEDURES; THROMBOPHILIA; and other conditions may result in non-septic thrombosis. Clinical manifestations include headache, vertigo, and increased intracranial pressure. Extension of the thrombus into adjacent venous structures may result in INTRACRANIAL HEMORRHAGES or SEIZURES. %28%From Joynt, Clinical Neurology, 1997, Ch23, pp60-8%29%%A%    
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D020227 2005
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D020227 2001
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D020227 2003
% 222.46/222.64  |- mesh__dateCreated mesh__D020227 1999-11-03
% 222.46/222.64  |- mesh__historyNote mesh__D020227 2000   
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D020227 2006
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D020227 2002
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D020227 2004
% 222.46/222.64  |- skos__broader mesh__D020227smesh__D012851
% 222.46/222.64  |- skos__historyNote mesh__D020227
% 222.46/222.64       Sinus Thrombosis, Intracranial %28%1968-1999%29%
% 222.46/222.64  |- mesh__publicMeSHNote mesh__D020227 2000   
% 222.46/222.64  |- skos__altLabel mesh__D020227 Phlebitis, Lateral Sinus, Septic
% 222.46/222.64  |- skos__hiddenLabel mesh__D020227 Lateral Sinus Thromboses
% 222.46/222.64  |- skos__altLabel mesh__D020227 Thrombosis, Lateral Sinus
% 222.46/222.64  |- skos__hiddenLabel mesh__D020227 Thrombophlebitis, Lateral Sinus
% 222.46/222.64  |- skos__hiddenLabel mesh__D020227 Sinus Thrombophlebitis, Lateral
% 222.46/222.64  |- skos__hiddenLabel mesh__D020227 Thromboses, Lateral Sinus
% 222.46/222.64  |- mesh__dateEstablished mesh__D020227 2000-01-01
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D020227 2000
% 222.46/222.64  |- mesh__recordAuthorizer mesh__D016984 sjn
% 222.46/222.64  |- mesh__dateCreated mesh__D016984 1991-05-30
% 222.46/222.64  |- skos__prefLabel mesh__D016984 Enterococcus faecium
% 222.46/222.64  |- skos__annotation mesh__D016984
% 222.46/222.64       normal intestinal flora; do not confuse with ENTEROCOCCUS FAECALIS; infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 222.46/222.64  |- rdf__type mesh__D016984sskos__Concept
% 222.46/222.64  |- mesh__historyNote mesh__D016984 92   
% 222.46/222.64  |- skos__scopeNote mesh__D016984
% 222.46/222.64       A species of gram-positive, coccoid bacteria whose organisms are normal flora of the intestinal tract. Unlike ENTEROCOCCUS FAECALIS, this species may produce an alpha-hemolytic reaction on blood agar and is unable to utilize pyruvic acid as an energy source.%A%    
% 222.46/222.64  |- mesh__dateRevised mesh__D016984 2005-06-30
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D016984 2006
% 222.46/222.64  |- skos__broader mesh__D016984smesh__D016983
% 222.46/222.64  |- mesh__recordOriginator mesh__D016984 PXP
% 222.46/222.64  |- mesh__recordMaintainer mesh__D016984 SYSTEM
% 222.46/222.64  |- mesh__publicMeSHNote mesh__D016984 92   
% 222.46/222.64  |- skos__altLabel mesh__D016984 Streptococcus faecium
% 222.46/222.64  |- skos__historyNote mesh__D016984 Streptococcus %28%1966-1991%29%
% 222.46/222.64  |- mesh__dateEstablished mesh__D016984 1992-01-01
% 222.46/222.64  |- mesh__recordMaintainer mesh__D016186 jmp
% 222.46/222.64  |- skos__altLabel mesh__D016186 M-CSF Receptors
% 222.46/222.64  |- skos__hiddenLabel mesh__D016186 fms Proto Oncogene Protein
% 222.46/222.64  |- skos__hiddenLabel mesh__D016186 c fms Protein
% 222.46/222.64  |- skos__altLabel mesh__D016186 CD115 Antigen
% 222.46/222.64  |- skos__altLabel mesh__D016186 CSF-1 Receptor
% 222.46/222.64  |- skos__altLabel mesh__D016186 Receptors, CSF-1
% 222.46/222.64  |- skos__hiddenLabel mesh__D016186 Antigen, CD115
% 222.46/222.64  |- mesh__recordAuthorizer mesh__D016186 sjn
% 222.46/222.64  |- skos__hiddenLabel mesh__D016186 CSF-1 Receptors
% 222.46/222.64  |- mesh__dateRevised mesh__D016186 2005-06-30
% 222.46/222.64  |- skos__prefLabel mesh__D016186
% 222.46/222.64       Receptor, Macrophage Colony-Stimulating Factor
% 222.46/222.64  |- mesh__dateCreated mesh__D016186 1990-06-19
% 222.46/222.64  |- skos__altLabel mesh__D016186
% 222.46/222.64       Macrophage Colony-Stimulating Factor Receptors
% 222.46/222.64  |- mesh__publicMeSHNote mesh__D016186
% 222.46/222.64       2000; was RECEPTORS, MACROPHAGE COLONY-STIMULATING FACTOR 1993-1999; was RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR 1991-1992%A%  
% 222.46/222.64  |- skos__historyNote mesh__D016186
% 222.46/222.64       Receptors, Endogenous Substances %28%1973-1990%29%
% 222.46/222.64  |- skos__broader mesh__D016186smesh__D011518
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D016186 2006
% 222.46/222.64  |- rdf__type mesh__D016186sskos__Concept
% 222.46/222.64  |- mesh__recordOriginator mesh__D016186 RLS
% 222.46/222.64  |- skos__altLabel mesh__D016186 fms Proto-Oncogene Protein
% 222.46/222.64  |- mesh__historyNote mesh__D016186 2000%28%1991%29%   
% 222.46/222.64  |- skos__annotation mesh__D016186 DF: RECEPT MCSF   
% 222.46/222.64  |- skos__broader mesh__D016186smesh__D020794
% 222.46/222.64  |- skos__scopeNote mesh__D016186
% 222.46/222.64       A receptor for MACROPHAGE COLONY-STIMULATING FACTOR encoded by the c-fms proto-oncogene %28%GENES, FMS%29%. It contains an intrinsic protein-tyrosine kinase activity. When activated the receptor undergoes autophosphorylation, phosphorylation of down-stream signaling molecules and rapid down-regulation.%A%    
% 222.46/222.64  |- skos__hiddenLabel mesh__D016186 Receptors, CSF 1
% 222.46/222.64  |- skos__hiddenLabel mesh__D016186 Proto-Oncogene Protein, fms
% 222.46/222.64  |- skos__broader mesh__D016186smesh__D016184
% 222.46/222.64  |- skos__hiddenLabel mesh__D016186 Receptors, M CSF
% 222.46/222.64  |- skos__altLabel mesh__D016186 Proto-Oncogene Protein fms
% 222.46/222.64  |- skos__hiddenLabel mesh__D016186
% 222.46/222.64       Macrophage Colony Stimulating Factor Receptors
% 222.46/222.64  |- skos__hiddenLabel mesh__D016186
% 222.46/222.64       Receptors, Macrophage Colony Stimulating Factor
% 222.46/222.64  |- skos__altLabel mesh__D016186 Antigens, CD115
% 222.46/222.64  |- mesh__onlineNote mesh__D016186
% 222.46/222.64       use RECEPTORS, MACROPHAGE COLONY-STIMULATING FACTOR to MACROPHAGE-COLONY-STIMULATING FACTOR RECEPTORS 1993-96; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; CSF-1 RECEPTOR %26% MACROPHAGE-COLONY-STIMULATING FACTOR RECEPTOR 1991-92%A%  
% 222.46/222.64  |- skos__altLabel mesh__D016186 CD115 Antigens
% 222.46/222.64  |- skos__hiddenLabel mesh__D016186
% 222.46/222.64       Receptor, Macrophage Colony Stimulating Factor
% 222.46/222.64  |- skos__altLabel mesh__D016186 Receptor, CSF-1
% 222.46/222.64  |- mesh__dateEstablished mesh__D016186 1991-01-01
% 222.46/222.64  |- skos__altLabel mesh__D016186 Receptors, M-CSF
% 222.46/222.64  |- skos__related mesh__D016186smesh__D016236
% 222.46/222.64  |- skos__altLabel mesh__D016186 c-fms Protein
% 222.46/222.64  |- skos__altLabel mesh__D016186
% 222.46/222.64       Receptors, Macrophage Colony-Stimulating Factor
% 222.46/222.64  |- skos__broader mesh__D016186smesh__D015703
% 222.46/222.64  |- skos__historyNote mesh__D016186
% 222.46/222.64       Proto-Oncogene Proteins %28%1986-1990%29%
% 222.46/222.64  |- skos__hiddenLabel mesh__D016186 Receptor, CSF 1
% 222.46/222.64  |- mesh__historyNote mesh__D002166 73   
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002166 2004
% 222.46/222.64  |- mesh__dateRevised mesh__D002166 2001-08-03
% 222.46/222.64  |- skos__altLabel mesh__D002166 Camptothecine
% 222.46/222.64  |- mesh__dateCreated mesh__D002166 1999-01-01
% 222.46/222.64  |- rdf__type mesh__D002166sskos__Concept
% 222.46/222.64  |- mesh__recordMaintainer mesh__D002166 sjn
% 222.46/222.64  |- mesh__recordAuthorizer mesh__D002166 sjn
% 222.46/222.64  |- skos__historyNote mesh__D002166 Alkaloids %28%1966-1972%29%
% 222.46/222.64  |- skos__broader mesh__D002166smesh__D000470
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002166 2005
% 222.46/222.64  |- skos__scopeNote mesh__D002166
% 222.46/222.64       An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity.%A%    
% 222.46/222.64  |- skos__historyNote mesh__D002166 Antineoplastic Agents %28%1966-1972%29%
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002166 2002
% 222.46/222.64  |- mesh__publicMeSHNote mesh__D002166 73   
% 222.46/222.64  |- mesh__recordOriginator mesh__D002166 NLM
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002166 2003
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002166 2006
% 222.46/222.64  |- skos__prefLabel mesh__D002166 Camptothecin
% 222.46/222.64  |- mesh__dateEstablished mesh__D002166 1973-01-01
% 222.46/222.64  |- skos__broader mesh__D007830Q000294smesh__D007830
% 222.46/222.64  |- mesh__preferredCombination mesh__D007830Q000294smesh__D007823
% 222.46/222.64  |- rdf__type mesh__D007830Q000294smesh__CompoundConcept
% 222.46/222.64  |- skos__scopeNote mesh__D012594
% 222.46/222.64       A term used to describe a variety of localized asymmetrical SKIN thickening that is similar to those of  SYSTEMIC SCLERODERMA but without the disease features in the multiple internal organs and BLOOD VESSELS. Lesions may be characterized as patches or plaques %28%morphea%29%, bands %28%linear%29%, or nodules.%A%    
% 222.46/222.64  |- mesh__recordMaintainer mesh__D012594 lkt
% 222.46/222.64  |- skos__annotation mesh__D012594
% 222.46/222.64       do not confuse with SCLERODERMA, LIMITED   
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D012594 2005
% 222.46/222.64  |- mesh__dateEstablished mesh__D012594 1971-01-01
% 222.46/222.64  |- skos__altLabel mesh__D012594 Scleroderma, Circumscribed
% 222.46/222.64  |- mesh__recordAuthorizer mesh__D012594 sjn
% 222.46/222.64  |- mesh__dateRevised mesh__D012594 2003-07-09
% 222.46/222.64  |- skos__broader mesh__D012594smesh__D012871
% 222.46/222.64  |- rdf__type mesh__D012594sskos__Concept
% 222.46/222.64  |- skos__prefLabel mesh__D012594 Scleroderma, Localized
% 222.46/222.64  |- skos__hiddenLabel mesh__D012594 Circumscribed Scleroderma
% 222.46/222.64  |- mesh__publicMeSHNote mesh__D012594
% 222.46/222.64       2004; see SCLERODERMA, CIRCUMSCRIBED 1971-2003   
% 222.46/222.64  |- skos__historyNote mesh__D012594 Scleroderma, Systemic %28%1966-1970%29%
% 222.46/222.64  |- mesh__recordOriginator mesh__D012594 NLM
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D012594 2004
% 222.46/222.64  |- mesh__dateCreated mesh__D012594 1999-01-01
% 222.46/222.64  |- mesh__historyNote mesh__D012594 2004 %28%1971%29%   
% 222.46/222.64  |- skos__broader mesh__D012594smesh__D003240
% 222.46/222.64  |- skos__hiddenLabel mesh__D012594 Localized Scleroderma
% 222.46/222.64  |- skos__hiddenLabel mesh__D012594 Sclerodermas, Localized
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D012594 2006
% 222.46/222.64  |- skos__prefLabel mesh__D006557 Herpangina
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006557 1991
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006557 2002
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006557 1997
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006557 1989
% 222.46/222.64  |- rdf__type mesh__D006557sskos__Concept
% 222.46/222.64  |- skos__broader mesh__D006557smesh__D003384
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006557 2005
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006557 1994
% 222.46/222.64  |- skos__hiddenLabel mesh__D006557 Herpanginas
% 222.46/222.64  |- mesh__dateCreated mesh__D006557 1999-01-01
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006557 1992
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006557 1995
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006557 2006
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006557 2003
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006557 2000
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006557 1993
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006557 1998
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006557 2004
% 222.46/222.64  |- mesh__dateRevised mesh__D006557 1978-02-03
% 222.46/222.64  |- mesh__recordMaintainer mesh__D006557 JWH
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006557 1990
% 222.46/222.64  |- mesh__recordAuthorizer mesh__D006557 MED
% 222.46/222.64  |- skos__annotation mesh__D006557 caused by Coxsackie A virus   
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006557 2001
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006557 1999
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D006557 1996
% 222.46/222.64  |- mesh__recordOriginator mesh__D006557 NLM
% 222.46/222.64  |- mesh__dateRevised mesh__D020228 2003-07-09
% 222.46/222.64  |- mesh__historyNote mesh__D020228 2004%28%1999%29%   
% 222.46/222.64  |- mesh__dateEstablished mesh__D020228 1999-01-01
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D020228 2006
% 222.46/222.64  |- skos__hiddenLabel mesh__D020228 Actions, Chemical
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D020228 2004
% 222.46/222.64  |- skos__prefLabel mesh__D020228 Pharmacologic Actions
% 222.46/222.64  |- skos__broader mesh__D020228smesh__D020164
% 222.46/222.64  |- skos__hiddenLabel mesh__D020228 Actions, Pharmacologic
% 222.46/222.64  |- mesh__recordOriginator mesh__D020228 ADP
% 222.46/222.64  |- mesh__publicMeSHNote mesh__D020228
% 222.46/222.64       2004; see CHEMICAL ACTIONS 1999-2003   
% 222.46/222.64  |- mesh__recordMaintainer mesh__D020228 ssb
% 222.46/222.64  |- skos__annotation mesh__D020228
% 222.46/222.64       not used for indexing      CATALOG: do not use   
% 222.46/222.64  |- mesh__recordAuthorizer mesh__D020228 sjn
% 222.46/222.64  |- mesh__dateCreated mesh__D020228 1998-06-10
% 222.46/222.64  |- skos__related mesh__D020228smesh__D004358
% 222.46/222.64  |- rdf__type mesh__D020228sskos__Concept
% 222.46/222.64  |- skos__scopeNote mesh__D020228
% 222.46/222.64       A broad category of chemical actions and uses that result in the prevention, treatment, cure or diagnosis of disease. Included here are drugs and chemicals that act by altering normal body functions, such as the REPRODUCTIVE CONTROL AGENTS and ANESTHETICS. Effects of chemicals on the environment are also included.%A%    
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D020228 2005
% 222.46/222.64  |- mesh__historyNote mesh__D016985 92   
% 222.46/222.64  |- mesh__recordAuthorizer mesh__D016985 sjn
% 222.46/222.64  |- skos__prefLabel mesh__D016985 Streptococcus bovis
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D016985 2006
% 222.46/222.64  |- mesh__recordOriginator mesh__D016985 PXP
% 222.46/222.64  |- mesh__recordMaintainer mesh__D016985 SYSTEM
% 222.46/222.64  |- skos__historyNote mesh__D016985 Streptococcus %28%1966-1991%29%
% 222.46/222.64  |- mesh__dateRevised mesh__D016985 2005-06-30
% 222.46/222.64  |- skos__annotation mesh__D016985
% 222.46/222.64       rumen bacterium; sometimes in human endocarditis; infection: coord IM with STREPTOCOCCAL INFECTIONS %28%IM%29%; DF: STREP BOVIS%A%  
% 222.46/222.64  |- skos__broader mesh__D016985smesh__D013291
% 222.46/222.64  |- mesh__publicMeSHNote mesh__D016985 92   
% 222.46/222.64  |- mesh__dateCreated mesh__D016985 1991-05-30
% 222.46/222.64  |- rdf__type mesh__D016985sskos__Concept
% 222.46/222.64  |- skos__scopeNote mesh__D016985
% 222.46/222.64       A species of gram-positive, coccoid bacteria commonly found in the alimentary tract of cows, sheep, and other ruminants. It occasionally is encountered in cases of human endocarditis. This species is nonhemolytic.%A%    
% 222.46/222.64  |- mesh__dateEstablished mesh__D016985 1992-01-01
% 222.46/222.64  |- mesh__recordMaintainer mesh__D016187 sjn
% 222.46/222.64  |- mesh__publicMeSHNote mesh__D016187
% 222.46/222.64       93; was RECEPTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR 1991-92; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTORS was GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR see RECEPTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR 1991-92; GM-CSF RECEPTORS was GM-CSF RECEPTOR see RECEPTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR 1991-92%A%  
% 222.46/222.64  |- skos__hiddenLabel mesh__D016187 GM CSF Receptor
% 222.46/222.64  |- skos__annotation mesh__D016187 DF: RECEPT GMCSF   
% 222.46/222.64  |- skos__historyNote mesh__D016187
% 222.46/222.64       Receptors, Endogenous Substances %28%1973-1990%29%
% 222.46/222.64  |- skos__altLabel mesh__D016187 CD116 Antigens
% 222.46/222.64  |- skos__altLabel mesh__D016187 GM-CSF Receptors
% 222.46/222.64  |- skos__prefLabel mesh__D016187
% 222.46/222.64       Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
% 222.46/222.64  |- skos__broader mesh__D016187smesh__D016184
% 222.46/222.64  |- skos__altLabel mesh__D016187 GM-CSF Receptor
% 222.46/222.64  |- mesh__recordAuthorizer mesh__D016187 sjn
% 222.46/222.64  |- mesh__historyNote mesh__D016187
% 222.46/222.64       93; was RECEPTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR 1991-92; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTORS was GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR see RECEPTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR 1991-92; GM-CSF RECEPTORS was GM-CSF RECEPTOR see RECEPTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR 1991-92%A%  
% 222.46/222.64  |- mesh__dateEstablished mesh__D016187 1991-01-01
% 222.46/222.64  |- skos__scopeNote mesh__D016187
% 222.46/222.64       Receptors that bind and internalize the granulocyte-macrophage stimulating factor. Their MW is believed to be 84 kD. The most mature myelomonocytic cells, specifically human neutrophils, macrophages, and eosinophils, express the highest number of affinity receptors for this growth factor.%A%    
% 222.46/222.64  |- skos__altLabel mesh__D016187
% 222.46/222.64       Receptor, Granulocyte-Macrophage Colony-Stimulating Factor
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D016187 2006
% 222.46/222.64  |- mesh__dateRevised mesh__D016187 2004-07-13
% 222.46/222.64  |- mesh__dateCreated mesh__D016187 1990-07-05
% 222.46/222.64  |- skos__altLabel mesh__D016187 Antigens, CD116
% 222.46/222.64  |- mesh__recordOriginator mesh__D016187 RLS
% 222.46/222.64  |- skos__hiddenLabel mesh__D016187 Antigen, CD116
% 222.46/222.64  |- rdf__type mesh__D016187sskos__Concept
% 222.46/222.64  |- skos__altLabel mesh__D016187 CD116 Antigen
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D016187 2005
% 222.46/222.64  |- skos__hiddenLabel mesh__D016187 GM CSF Receptors
% 222.46/222.64  |- skos__hiddenLabel mesh__D016187 Receptors, GM CSF
% 222.46/222.64  |- skos__hiddenLabel mesh__D016187
% 222.46/222.64       Receptor, Granulocyte Macrophage Colony Stimulating Factor
% 222.46/222.64  |- skos__hiddenLabel mesh__D016187
% 222.46/222.64       Receptors, Granulocyte Macrophage Colony Stimulating Factor
% 222.46/222.64  |- skos__hiddenLabel mesh__D016187 Receptor, GM-CSF
% 222.46/222.64  |- skos__altLabel mesh__D016187 Receptors, GM-CSF
% 222.46/222.64  |- mesh__onlineNote mesh__D016187
% 222.46/222.64       use RECEPTORS, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR to search RECEPTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR %26% GM-CSF RECEPTOR 1991-92%A%  
% 222.46/222.64  |- rdf__type mesh__D002965sskos__Concept
% 222.46/222.64  |- skos__hiddenLabel mesh__D002965 Taxonomies
% 222.46/222.64  |- skos__scopeNote mesh__D002965
% 222.46/222.64       The systematic arrangement of entities in any field into categories classes based on common characteristics such as properties, morphology, subject matter, etc.%A%    
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002965 2005
% 222.46/222.64  |- skos__prefLabel mesh__D002965 Classification
% 222.46/222.64  |- mesh__recordAuthorizer mesh__D002965 sjn
% 222.46/222.64  |- skos__broader mesh__D002965smesh__D007254
% 222.46/222.64  |- skos__hiddenLabel mesh__D002965 Classifications
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002965 2006
% 222.46/222.64  |- mesh__recordMaintainer mesh__D002965 MSR
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002965 2003
% 222.46/222.64  |- mesh__recordOriginator mesh__D002965 NLM
% 222.46/222.64  |- skos__altLabel mesh__D002965 Systematics
% 222.46/222.64  |- skos__annotation mesh__D002965
% 222.46/222.64       GEN only; prefer /class: Manual 19.7+, 19.8.6; DF; CLASS   
% 222.46/222.64  |- mesh__dateRevised mesh__D002965 2002-07-03
% 222.46/222.64  |- mesh__dateCreated mesh__D002965 1999-01-01
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002965 2004
% 222.46/222.64  |- skos__related mesh__D002965smesh__D010802
% 222.46/222.64  |- skos__broader mesh__D002965smesh__D004282
% 222.46/222.64  |- skos__broader mesh__D035341smesh__D034501
% 222.46/222.64  |- rdf__type mesh__D035341sskos__Concept
% 222.46/222.64  |- skos__altLabel mesh__D035341 TRBF2 Protein
% 222.46/222.64  |- mesh__dateRevised mesh__D035341 2005-06-30
% 222.46/222.64  |- skos__scopeNote mesh__D035341
% 222.46/222.64       A ubiquitously expressed telomere-binding protein that is present at TELOMERES throughout the cell cycle. It is a suppressor of telomere elongation and may be involved in stabilization of telomere length. It is structurally different from TELOMERIC REPEAT BINDING PROTEIN 1 in that it contains basic N-terminal amino acid residues.%A%    
% 222.46/222.64  |- mesh__recordAuthorizer mesh__D035341 sjn
% 222.46/222.64  |- mesh__dateEstablished mesh__D035341 2003-01-01
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D035341 2006
% 222.46/222.64  |- mesh__publicMeSHNote mesh__D035341
% 222.46/222.64       2003; TRF2 PROTEIN %28%now TELOMERIC REPEAT BINDING PROTEIN 2%29% was indexed under DNA-BINDING PROTEINS 1998-2002%A%  
% 222.46/222.64  |- skos__altLabel mesh__D035341 TRF2 Protein
% 222.46/222.64  |- skos__altLabel mesh__D035341 TERF2 Protein
% 222.46/222.64  |- mesh__recordOriginator mesh__D035341 jmp
% 222.46/222.64  |- mesh__recordMaintainer mesh__D035341 ags
% 222.46/222.64  |- skos__historyNote mesh__D035341 DNA-Binding Proteins %28%1998-2002%29%
% 222.46/222.64  |- skos__prefLabel mesh__D035341 Telomeric Repeat Binding Protein 2
% 222.46/222.64  |- mesh__dateCreated mesh__D035341 2002-07-03
% 222.46/222.64  |- skos__altLabel mesh__D035341 Trf2 Gene Product
% 222.46/222.64  |- mesh__historyNote mesh__D035341
% 222.46/222.64       2003; use TELOMERIC REPEAT BINDING PROTEIN 2 %28%NM%29% 1998-2002%A%  
% 222.46/222.64  |- skos__broader mesh__D002167smesh__D020565
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D002167 2006
% 222.46/222.64  |- skos__annotation mesh__D002167
% 222.46/222.64       infection = CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER PYLORI see HELICOBACTER PYLORI is also available%A%  
% 222.46/222.64  |- skos__prefLabel mesh__D002167 Campylobacter
% 222.46/222.64  |- skos__historyNote mesh__D002167 Vibrio %28%1968-1975%29%
% 222.46/222.64  |- mesh__recordMaintainer mesh__D002167 SYSTEM
% 222.46/222.64  |- mesh__recordOriginator mesh__D002167 JW
% 222.46/222.64  |- mesh__dateEstablished mesh__D002167 1976-01-01
% 222.46/222.64  |- mesh__dateCreated mesh__D002167 1975-07-25
% 222.46/222.64  |- skos__scopeNote mesh__D002167
% 222.46/222.64       A genus of bacteria found in the reproductive organs, intestinal tract, and oral cavity of animals and man. Some species are pathogenic.%A%    
% 222.46/222.64  |- rdf__type mesh__D002167sskos__Concept
% 222.46/222.64  |- mesh__publicMeSHNote mesh__D002167 76   
% 222.46/222.64  |- mesh__dateRevised mesh__D002167 2005-06-30
% 222.46/222.64  |- mesh__recordAuthorizer mesh__D002167 sjn
% 222.46/222.64  |- skos__broader mesh__D002167smesh__D006090
% 222.46/222.64  |- mesh__historyNote mesh__D002167 76   
% 222.46/222.64  |- mesh__recordMaintainer mesh__D007650 TWD
% 222.46/222.64  |- skos__hiddenLabel mesh__D007650 R 41468
% 222.46/222.64  |- mesh__recordOriginator mesh__D007650 RLS
% 222.46/222.64  |- skos__hiddenLabel mesh__D007650 R41468
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D007650 2003
% 222.46/222.64  |- skos__altLabel mesh__D007650
% 222.46/222.64       3-%28%2-%28%4-%28%4-Fluorobenzoyl%29%piperidinol%29%ethyl%29%-2,4%28%1H,3H%29%-quinazolinedione
% 222.46/222.64  |- mesh__dateRevised mesh__D007650 2000-06-22
% 222.46/222.64  |- skos__scopeNote mesh__D007650
% 222.46/222.64       A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.%A%    
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D007650 2001
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D007650 2004
% 222.46/222.64  |- mesh__dateCreated mesh__D007650 1986-04-09
% 222.46/222.64  |- mesh__dateEstablished mesh__D007650 1987-01-01
% 222.46/222.64  |- rdf__type mesh__D007650sskos__Concept
% 222.46/222.64  |- skos__hiddenLabel mesh__D007650 R 41,468
% 222.46/222.64  |- skos__prefLabel mesh__D007650 Ketanserin
% 222.46/222.64  |- mesh__publicMeSHNote mesh__D007650 87   
% 222.46/222.64  |- mesh__historyNote mesh__D007650 87   
% 222.46/222.64  |- skos__hiddenLabel mesh__D007650 R41,468
% 222.46/222.64  |- skos__altLabel mesh__D007650 R-41468
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D007650 2002
% 222.46/222.64  |- mesh__recordAuthorizer mesh__D007650 sjn
% 222.46/222.64  |- skos__broader mesh__D007650smesh__D010880
% 222.46/222.64  |- mesh__activeMeSHYear mesh__D007650 2005
% 222.46/222.64  |- skos__historyNote mesh__D007650 Piperidines %28%1966-1986%29%
% 222.46/222.65  |- skos__broader mesh__D007650smesh__D011799
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D007650 2006
% 222.46/222.65  |- skos__broader mesh__D012595smesh__D003240
% 222.46/222.65  |- mesh__dateRevised mesh__D012595 2003-07-09
% 222.46/222.65  |- skos__broader mesh__D012595smesh__D012871
% 222.46/222.65  |- skos__annotation mesh__D012595
% 222.46/222.65       note specific indentations and SCLERODERMA, LOCALIZED   
% 222.46/222.65  |- rdf__type mesh__D012595sskos__Concept
% 222.46/222.65  |- skos__scopeNote mesh__D012595
% 222.46/222.65       A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature %28%hard skin%29%, and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.%A%    
% 222.46/222.65  |- skos__altLabel mesh__D012595 Systemic Sclerosis
% 222.46/222.65  |- mesh__historyNote mesh__D012595 1971   
% 222.46/222.65  |- mesh__recordMaintainer mesh__D012595 lkt
% 222.46/222.65  |- mesh__dateEstablished mesh__D012595 1971-01-01
% 222.46/222.65  |- mesh__recordAuthorizer mesh__D012595 sjn
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D012595 2004
% 222.46/222.65  |- skos__prefLabel mesh__D012595 Scleroderma, Systemic
% 222.46/222.65  |- mesh__dateCreated mesh__D012595 1999-01-01
% 222.46/222.65  |- skos__altLabel mesh__D012595 Sclerosis, Systemic
% 222.46/222.65  |- skos__altLabel mesh__D012595 Systemic Scleroderma
% 222.46/222.65  |- mesh__publicMeSHNote mesh__D012595
% 222.46/222.65       1971; SCLERODERMA was heading 1963-70   
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D012595 2006
% 222.46/222.65  |- mesh__recordOriginator mesh__D012595 NLM
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D012595 2005
% 222.46/222.65  |- rdf__type mesh__D006558sskos__Concept
% 222.46/222.65  |- skos__historyNote mesh__D006558
% 222.46/222.65       Genital Diseases, Female %28%1966-1981%29%
% 222.46/222.65  |- skos__hiddenLabel mesh__D006558 Herpes, Genital
% 222.46/222.65  |- skos__broader mesh__D006558smesh__D005832
% 222.46/222.65  |- mesh__recordAuthorizer mesh__D006558 sjn
% 222.46/222.65  |- mesh__recordMaintainer mesh__D006558 lkt
% 222.46/222.65  |- skos__broader mesh__D006558smesh__D005831
% 222.46/222.65  |- mesh__publicMeSHNote mesh__D006558 82   
% 222.46/222.65  |- skos__hiddenLabel mesh__D006558 Genital Herpes Simplex
% 222.46/222.65  |- skos__broader mesh__D006558smesh__D015229
% 222.46/222.65  |- skos__historyNote mesh__D006558 Genital Diseases, Male %28%1966-1981%29%
% 222.46/222.65  |- mesh__dateRevised mesh__D006558 2005-06-30
% 222.46/222.65  |- skos__altLabel mesh__D006558 Genital Herpes
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D006558 2006
% 222.46/222.65  |- mesh__dateCreated mesh__D006558 1981-03-02
% 222.46/222.65  |- mesh__historyNote mesh__D006558 82   
% 222.46/222.65  |- skos__prefLabel mesh__D006558 Herpes Genitalis
% 222.46/222.65  |- skos__altLabel mesh__D006558 Herpes Simplex, Genital
% 222.46/222.65  |- skos__broader mesh__D006558smesh__D006561
% 222.46/222.65  |- mesh__dateEstablished mesh__D006558 1982-01-01
% 222.46/222.65  |- mesh__recordOriginator mesh__D006558 RC
% 222.46/222.65  |- skos__historyNote mesh__D006558 Herpes Simplex %28%1966-1981%29%
% 222.46/222.65  |- skos__scopeNote mesh__D006558 Herpes simplex of the genitals.     
% 222.46/222.65  |- skos__broader mesh__D017280smesh__D003275
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D017280 2005
% 222.46/222.65  |- mesh__dateCreated mesh__D017280 1992-05-13
% 222.46/222.65  |- mesh__recordAuthorizer mesh__D017280 sjn
% 222.46/222.65  |- rdf__type mesh__D017280sskos__Concept
% 222.46/222.65  |- skos__hiddenLabel mesh__D017280 Manufacture, Condom
% 222.46/222.65  |- mesh__historyNote mesh__D017280
% 222.46/222.65       93; was see CONTRACEPTIVE DEVICES, MALE 1988-92   
% 222.46/222.65  |- mesh__dateEstablished mesh__D017280 1993-01-01
% 222.46/222.65  |- mesh__publicMeSHNote mesh__D017280
% 222.46/222.65       93; was see CONTRACEPTIVE DEVICES, MALE 1988-92   
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D017280 2002
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D017280 2004
% 222.46/222.65  |- skos__altLabel mesh__D017280 Condom
% 222.46/222.65  |- mesh__recordOriginator mesh__D017280 JLS
% 222.46/222.65  |- skos__annotation mesh__D017280
% 222.46/222.65       GEN or unspecified but probably for males; CONDOMS, FEMALE is also available%A%  
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D017280 2003
% 222.46/222.65  |- mesh__onlineNote mesh__D017280
% 222.46/222.65       use CONTRACEPTIVE DEVICES, MALE to search CONDOMS 1988-92%A%  
% 222.46/222.65  |- skos__historyNote mesh__D017280
% 222.46/222.65       Contraceptive Devices, Male %28%1975-1992%29%
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D017280 2001
% 222.46/222.65  |- mesh__recordMaintainer mesh__D017280 jls
% 222.46/222.65  |- skos__scopeNote mesh__D017280
% 222.46/222.65       A sheath that is worn over the penis during sexual behavior in order to prevent pregnancy or spread of sexually transmitted disease.%A%    
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D017280 2006
% 222.46/222.65  |- skos__historyNote mesh__D017280 Contraceptive Devices %28%1966-1974%29%
% 222.46/222.65  |- skos__prefLabel mesh__D017280 Condoms
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D017280 2000
% 222.46/222.65  |- mesh__dateRevised mesh__D017280 1999-11-08
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D003260 1998
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D003260 1996
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D003260 2006
% 222.46/222.65  |- mesh__dateRevised mesh__D003260 1992-05-07
% 222.46/222.65  |- mesh__historyNote mesh__D003260 70%28%68%29%   
% 222.46/222.65  |- skos__historyNote mesh__D003260 Cytology %28%1966-1967%29%
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D003260 2004
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D003260 2001
% 222.46/222.65  |- rdf__type mesh__D003260sskos__Concept
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D003260 2005
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D003260 2000
% 222.46/222.65  |- mesh__recordOriginator mesh__D003260 NLM
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D003260 1995
% 222.46/222.65  |- skos__hiddenLabel mesh__D003260 Contact Inhibitions
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D003260 1993
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D003260 2003
% 222.46/222.65  |- mesh__recordMaintainer mesh__D003260 TAP
% 222.46/222.65  |- skos__prefLabel mesh__D003260 Contact Inhibition
% 222.46/222.65  |- mesh__recordAuthorizer mesh__D003260 PLS
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D003260 1994
% 222.46/222.65  |- skos__altLabel mesh__D003260 Inhibition, Contact
% 222.46/222.65  |- mesh__dateEstablished mesh__D003260 1970-01-01
% 222.46/222.65  |- skos__hiddenLabel mesh__D003260 Inhibitions, Contact
% 222.46/222.65  |- mesh__dateCreated mesh__D003260 1999-01-01
% 222.46/222.65  |- skos__broader mesh__D003260smesh__D002468
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D003260 1999
% 222.46/222.65  |- skos__scopeNote mesh__D003260
% 222.46/222.65       Arrest of cell locomotion or cell division when two cells come into contact.%A%    
% 222.46/222.65  |- mesh__publicMeSHNote mesh__D003260 70   
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D003260 2002
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D003260 1997
% 222.46/222.65  |- skos__broader mesh__D016986smesh__D034363
% 222.46/222.65  |- skos__historyNote mesh__D016986 Streptococcus %28%1986-1991%29%
% 222.46/222.65  |- rdf__type mesh__D016986sskos__Concept
% 222.46/222.65  |- mesh__publicMeSHNote mesh__D016986 92   
% 222.46/222.65  |- mesh__historyNote mesh__D016986 92   
% 222.46/222.65  |- mesh__dateCreated mesh__D016986 1991-05-30
% 222.46/222.65  |- skos__prefLabel mesh__D016986 Streptococcus sobrinus
% 222.46/222.65  |- skos__annotation mesh__D016986
% 222.46/222.65       a cariogenic bacterium on human teeth; infection: coord IM with STREPTOCOCCAL INFECTIONS %28%IM%29%; DF: STREP SOBRINUS%A%  
% 222.46/222.65  |- mesh__recordOriginator mesh__D016986 PXP
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D016986 2006
% 222.46/222.65  |- mesh__recordAuthorizer mesh__D016986 sjn
% 222.46/222.65  |- skos__scopeNote mesh__D016986
% 222.46/222.65       A species of gram-positive, coccoid bacteria isolated from the human tooth surface. Strains have been shown to be cariogenic in experimental animals and may be associated with human dental caries.%A%    
% 222.46/222.65  |- mesh__recordMaintainer mesh__D016986 SYSTEM
% 222.46/222.65  |- mesh__dateRevised mesh__D016986 2005-06-30
% 222.46/222.65  |- mesh__dateEstablished mesh__D016986 1992-01-01
% 222.46/222.65  |- skos__altLabel mesh__D016188 Receptors, G-CSF
% 222.46/222.65  |- mesh__dateCreated mesh__D016188 1990-06-19
% 222.46/222.65  |- mesh__onlineNote mesh__D016188
% 222.46/222.65       use RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR to search GRANULOCYTE-COLONY-STIMULATING FACTOR RECEPTORS 1993-96, RECEPTOR, GRANULOCYTE COLONY-STIMULATING FACTOR; G-CSF RECEPTOR %26% GRANULOCYTE-COLONY-STIMULATING RECEPTOR 1991-92%A%  
% 222.46/222.65  |- skos__altLabel mesh__D016188
% 222.46/222.65       Receptor, Granulocyte Colony-Stimulating Factor
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D016188 2006
% 222.46/222.65  |- skos__hiddenLabel mesh__D016188 G CSF Receptors
% 222.46/222.65  |- skos__annotation mesh__D016188 DF: RECEPT GCSF   
% 222.46/222.65  |- skos__hiddenLabel mesh__D016188 Receptor, G-CSF
% 222.46/222.65  |- mesh__dateEstablished mesh__D016188 1991-01-01
% 222.46/222.65  |- skos__hiddenLabel mesh__D016188
% 222.46/222.65       Receptor, Granulocyte Colony Stimulating Factor
% 222.46/222.65  |- skos__prefLabel mesh__D016188
% 222.46/222.65       Receptors, Granulocyte Colony-Stimulating Factor
% 222.46/222.65  |- rdf__type mesh__D016188sskos__Concept
% 222.46/222.65  |- skos__hiddenLabel mesh__D016188
% 222.46/222.65       Granulocyte Colony Stimulating Factor Receptors
% 222.46/222.65  |- skos__scopeNote mesh__D016188
% 222.46/222.65       Receptors that bind and internalize GRANULOCYTE COLONY-STIMULATING FACTOR. Their MW is believed to be 150 kD. These receptors are found mainly on a subset of myelomonocytic cells.%A%    
% 222.46/222.65  |- skos__broader mesh__D016188smesh__D016184
% 222.46/222.65  |- skos__hiddenLabel mesh__D016188 Receptors, G CSF
% 222.46/222.65  |- mesh__historyNote mesh__D016188
% 222.46/222.65       93; was RECEPTOR, GRANULOCYTE COLONY-STIMULATING FACTOR 1991-92; G-CSF RECEPTORS was G-CSF RECEPTOR see RECEPTOR, GRANULOCYTE COLONY-STIMULATING FACTOR 1991-92; GRANULOCYTE-COLONY-STIMULATING FACTOR RECEPTORS was see RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR 1993-96, was GRANULOCYTE-COLONY-STIMULATING FACTOR RECEPTOR see RECEPTOR, GRANULOCYTE COLONY-STIMULATING FACTOR 1991-92%A%  
% 222.46/222.65  |- mesh__publicMeSHNote mesh__D016188
% 222.46/222.65       93; was RECEPTOR, GRANULOCYTE COLONY-STIMULATING FACTOR 1991-92; G-CSF RECEPTORS was G-CSF RECEPTOR see RECEPTOR, GRANULOCYTE COLONY-STIMULATING FACTOR 1991-92; GRANULOCYTE-COLONY-STIMULATING FACTOR RECEPTORS was see RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR 1993-96, was GRANULOCYTE-COLONY-STIMULATING FACTOR RECEPTOR see RECEPTOR, GRANULOCYTE COLONY-STIMULATING FACTOR 1991-92%A%  
% 222.46/222.65  |- skos__altLabel mesh__D016188 G-CSF Receptors
% 222.46/222.65  |- mesh__recordOriginator mesh__D016188 RLS
% 222.46/222.65  |- skos__historyNote mesh__D016188
% 222.46/222.65       Receptors, Endogenous Substances %28%1973-1990%29%
% 222.46/222.65  |- skos__altLabel mesh__D016188
% 222.46/222.65       Granulocyte Colony-Stimulating Factor Receptors
% 222.46/222.65  |- skos__altLabel mesh__D016188 G-CSF Receptor
% 222.46/222.65  |- mesh__recordAuthorizer mesh__D016188 sjn
% 222.46/222.65  |- mesh__recordMaintainer mesh__D016188 jmp
% 222.46/222.65  |- skos__hiddenLabel mesh__D016188
% 222.46/222.65       Receptors, Granulocyte Colony Stimulating Factor
% 222.46/222.65  |- mesh__dateRevised mesh__D016188 2005-06-30
% 222.46/222.65  |- skos__hiddenLabel mesh__D016188 G CSF Receptor
% 222.46/222.65  |- skos__historyNote mesh__D002966 Membrane Proteins %28%1977-1983%29%
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D002966 2006
% 222.46/222.65  |- skos__annotation mesh__D002966
% 222.46/222.65        CLATHRIN ASSEMBLY PROTEINS see  ADAPTOR PROTEINS, VESICULAR TRANSPORT is available%A%  
% 222.46/222.65  |- skos__scopeNote mesh__D002966
% 222.46/222.65       The main structural coat protein of COATED VESICLES which play a key role in the intracellular transport between membranous organelles. Each molecule of clathrin consists of three light chains %28%CLATHRIN LIGHT CHAINS%29% and three heavy chains %28%CLATHRIN HEAVY CHAINS%29% that form a structure called a triskelion. Clathrin also interacts with cytoskeletal proteins.%A%    
% 222.46/222.65  |- mesh__dateRevised mesh__D002966 2004-07-13
% 222.46/222.65  |- mesh__historyNote mesh__D002966 84   
% 222.46/222.65  |- mesh__recordMaintainer mesh__D002966 sjn
% 222.46/222.65  |- mesh__publicMeSHNote mesh__D002966 84   
% 222.46/222.65  |- rdf__type mesh__D002966sskos__Concept
% 222.46/222.65  |- mesh__dateCreated mesh__D002966 1983-05-31
% 222.46/222.65  |- mesh__recordOriginator mesh__D002966 RLS
% 222.46/222.65  |- skos__historyNote mesh__D002966 Proteins %28%1966-1976%29%
% 222.46/222.65  |- mesh__recordAuthorizer mesh__D002966 sjn
% 222.46/222.65  |- mesh__dateEstablished mesh__D002966 1984-01-01
% 222.46/222.65  |- skos__prefLabel mesh__D002966 Clathrin
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D002966 2005
% 222.46/222.65  |- skos__broader mesh__D002966smesh__D033921
% 222.46/222.65  |- mesh__recordAuthorizer mesh__D002168 sjn
% 222.46/222.65  |- skos__altLabel mesh__D002168 Vibrio fetus
% 222.46/222.65  |- mesh__dateEstablished mesh__D002168 1984-01-01
% 222.46/222.65  |- mesh__recordMaintainer mesh__D002168 SYSTEM
% 222.46/222.65  |- skos__broader mesh__D002168smesh__D002167
% 222.46/222.65  |- mesh__historyNote mesh__D002168
% 222.46/222.65       84%28%76%29%; was see under CAMPYLOBACTER 1976-83; was VIBRIO FETUS 1972-75 %28%Prov 1972-73%29%%A%  
% 222.46/222.65  |- skos__prefLabel mesh__D002168 Campylobacter fetus
% 222.46/222.65  |- skos__annotation mesh__D002168
% 222.46/222.65       causes abortion in cattle %26% sheep; infection: coord IM with CAMPYLOBACTER INFECTIONS %28%IM%29%%A%  
% 222.46/222.65  |- mesh__dateCreated mesh__D002168 1975-08-01
% 222.46/222.65  |- rdf__type mesh__D002168sskos__Concept
% 222.46/222.65  |- mesh__recordOriginator mesh__D002168 JW
% 222.46/222.65  |- skos__historyNote mesh__D002168 Vibrio %28%1966-1971%29%
% 222.46/222.65  |- mesh__onlineNote mesh__D002168
% 222.46/222.65       use CAMPYLOBACTER FETUS to search VIBRIO FETUS 1972-83 %28%as Prov 1972-73%29%%A%  
% 222.46/222.65  |- mesh__publicMeSHNote mesh__D002168
% 222.46/222.65       84; was see under CAMPYLOBACTER 1976-83; was VIBRIO FETUS 1974-75%A%  
% 222.46/222.65  |- skos__scopeNote mesh__D002168
% 222.46/222.65       A species of bacteria present in man and many kinds of animals and birds, often causing infertility and/or abortion.%A%    
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D002168 2006
% 222.46/222.65  |- mesh__dateRevised mesh__D002168 2005-06-30
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D007651 1995
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D007651 2004
% 222.46/222.65  |- mesh__recordAuthorizer mesh__D007651 PLS
% 222.46/222.65  |- mesh__recordOriginator mesh__D007651 NLM
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D007651 2000
% 222.46/222.65  |- rdf__type mesh__D007651sskos__Concept
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D007651 1998
% 222.46/222.65  |- skos__hiddenLabel mesh__D007651 Acids, Keto
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D007651 1999
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D007651 1993
% 222.46/222.65  |- mesh__dateCreated mesh__D007651 1999-01-01
% 222.46/222.65  |- skos__prefLabel mesh__D007651 Keto Acids
% 222.46/222.65  |- skos__broader mesh__D007651smesh__D002264
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D007651 2001
% 222.46/222.65  |- mesh__recordMaintainer mesh__D007651 TAP
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D007651 1996
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D007651 2005
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D007651 1997
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D007651 2006
% 222.46/222.65  |- mesh__dateRevised mesh__D007651 1992-05-18
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D007651 2002
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D007651 1994
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D007651 2003
% 222.46/222.65  |- skos__broader mesh__D021322smesh__D021301
% 222.46/222.65  |- mesh__recordOriginator mesh__D021322 jmp
% 222.46/222.65  |- mesh__dateRevised mesh__D021322 2005-06-30
% 222.46/222.65  |- skos__scopeNote mesh__D021322
% 222.46/222.65       A subclass of ANTIFREEZE PROTEINS that are 3-5 kDa in size and contain a single alanine-rich amphipathic alpha-helix.%A%    
% 222.46/222.65  |- mesh__dateCreated mesh__D021322 2000-06-21
% 222.46/222.65  |- mesh__recordAuthorizer mesh__D021322 sjn
% 222.46/222.65  |- mesh__recordMaintainer mesh__D021322 SYSTEM
% 222.46/222.65  |- skos__altLabel mesh__D021322 Type I Antifreeze Proteins
% 222.46/222.65  |- mesh__dateEstablished mesh__D021322 2001-01-01
% 222.46/222.65  |- mesh__publicMeSHNote mesh__D021322 2001   
% 222.46/222.65  |- skos__altLabel mesh__D021322 Type I Fish Antifreeze Proteins
% 222.46/222.65  |- skos__altLabel mesh__D021322 Fish Type I APF
% 222.46/222.65  |- skos__prefLabel mesh__D021322 Antifreeze Proteins, Type I
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D021322 2006
% 222.46/222.65  |- mesh__historyNote mesh__D021322 2001   
% 222.46/222.65  |- rdf__type mesh__D021322sskos__Concept
% 222.46/222.65  |- mesh__recordMaintainer mesh__D012596 ADP
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D012596 2004
% 222.46/222.65  |- skos__prefLabel mesh__D012596 Scleroproteins
% 222.46/222.65  |- mesh__dateCreated mesh__D012596 1999-01-01
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D012596 2001
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D012596 2003
% 222.46/222.65  |- mesh__recordOriginator mesh__D012596 NLM
% 222.46/222.65  |- skos__broader mesh__D012596smesh__D011506
% 222.46/222.65  |- skos__scopeNote mesh__D012596
% 222.46/222.65       Simple proteins characterized by their insolubility and fibrous structure. Within the body, they perform a supportive or protective function.%A%    
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D012596 2000
% 222.46/222.65  |- mesh__publicMeSHNote mesh__D012596 98   
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D012596 2006
% 222.46/222.65  |- mesh__dateRevised mesh__D012596 1997-06-20
% 222.46/222.65  |- mesh__dateEstablished mesh__D012596 1998-01-01
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D012596 2005
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D012596 2002
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D012596 1999
% 222.46/222.65  |- mesh__historyNote mesh__D012596 98; use explode 1967-97   
% 222.46/222.65  |- rdf__type mesh__D012596sskos__Concept
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D012596 1998
% 222.46/222.65  |- mesh__recordAuthorizer mesh__D012596 SJN
% 222.46/222.65  |- skos__annotation mesh__D012596
% 222.46/222.65       GEN; prefer specifics; used for mapping supplementary chemicals%A%  
% 222.46/222.65  |- skos__scopeNote mesh__D031750 A plant genus of the family POACEAE.     
% 222.46/222.65  |- mesh__publicMeSHNote mesh__D031750 2003   
% 222.46/222.65  |- skos__prefLabel mesh__D031750 Eragrostis
% 222.46/222.65  |- mesh__historyNote mesh__D031750 2003   
% 222.46/222.65  |- mesh__dateEstablished mesh__D031750 2003-01-01
% 222.46/222.65  |- rdf__type mesh__D031750sskos__Concept
% 222.46/222.65  |- skos__broader mesh__D031750smesh__D006109
% 222.46/222.65  |- mesh__dateCreated mesh__D031750 2002-07-03
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D031750 2005
% 222.46/222.65  |- skos__annotation mesh__D031750
% 222.46/222.65       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D031750 2003
% 222.46/222.65  |- skos__altLabel mesh__D031750 Teff
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D031750 2006
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D031750 2004
% 222.46/222.65  |- skos__hiddenLabel mesh__D006559 Gestationis, Pemphigoid
% 222.46/222.65  |- skos__broader mesh__D006559smesh__D012872
% 222.46/222.65  |- skos__hiddenLabel mesh__D006559 Gestationi, Pemphigoid
% 222.46/222.65  |- skos__annotation mesh__D006559
% 222.46/222.65       check the tags FEMALE and probably PREGNANCY   
% 222.46/222.65  |- mesh__recordOriginator mesh__D006559 SMH
% 222.46/222.65  |- rdf__type mesh__D006559sskos__Concept
% 222.46/222.65  |- skos__hiddenLabel mesh__D006559 Pemphigoid Gestationi
% 222.46/222.65  |- mesh__recordAuthorizer mesh__D006559 sjn
% 222.46/222.65  |- skos__prefLabel mesh__D006559 Pemphigoid Gestationis
% 222.46/222.65  |- mesh__dateEstablished mesh__D006559 1991-01-01
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D006559 2006
% 222.46/222.65  |- mesh__publicMeSHNote mesh__D006559
% 222.46/222.65       2006; see HERPES GESTATIONIS 1991-2005, see SKIN DISEASES, VESICULOBULLOUS 1976-1990%A%  
% 222.46/222.65  |- mesh__recordMaintainer mesh__D006559 lkt
% 222.46/222.65  |- mesh__dateCreated mesh__D006559 1975-07-30
% 222.46/222.65  |- mesh__dateRevised mesh__D006559 2005-06-30
% 222.46/222.65  |- skos__broader mesh__D006559smesh__D011248
% 222.46/222.65  |- skos__historyNote mesh__D006559
% 222.46/222.65       Dermatitis Herpetiformis %28%1966-1975%29%
% 222.46/222.65  |- skos__altLabel mesh__D006559 Herpes Gestationis
% 222.46/222.65  |- mesh__historyNote mesh__D006559 2006 %28%1976%29%   
% 222.46/222.65  |- skos__scopeNote mesh__D006559
% 222.46/222.65       An itching, autoimmune, bullous SKIN disease that occurs during the last two trimesters of PREGNANCY and PUERPERIUM. It also affects non-pregnant females with tissue of PLACENTA origin, such as CHORIOCARCINOMA; or HYDATIDIFORM MOLE. It exhibits antigenic and clinical similarity to bullous pemphigoid %28%PEMPHIGOID, BULLOUS%29%. This disease does not involve herpes viruses %28%old name, herpes gestationis%29%.%A%    
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D017281 2006
% 222.46/222.65  |- mesh__dateRevised mesh__D017281 1999-11-03
% 222.46/222.65  |- rdf__type mesh__D017281sskos__Concept
% 222.46/222.65  |- skos__broader mesh__D017281smesh__D003365
% 222.46/222.65  |- skos__hiddenLabel mesh__D017281 Illness Burdens
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D017281 2002
% 222.46/222.65  |- skos__hiddenLabel mesh__D017281 Illness Burden
% 222.46/222.65  |- skos__altLabel mesh__D017281 Costs of Disease
% 222.46/222.65  |- skos__historyNote mesh__D017281
% 222.46/222.65       Costs and Cost Analysis %28%1966-1992%29%
% 222.46/222.65  |- skos__hiddenLabel mesh__D017281 Cost, Sickness
% 222.46/222.65  |- skos__prefLabel mesh__D017281 Cost of Illness
% 222.46/222.65  |- skos__altLabel mesh__D017281 Burden of Illness
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D017281 2003
% 222.46/222.65  |- skos__altLabel mesh__D017281 Cost of Disease
% 222.46/222.65  |- skos__hiddenLabel mesh__D017281 Costs, Sickness
% 222.46/222.65  |- skos__hiddenLabel mesh__D017281 Illness Cost
% 222.46/222.65  |- mesh__dateEstablished mesh__D017281 1993-01-01
% 222.46/222.65  |- skos__altLabel mesh__D017281 Disease Costs
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D017281 2004
% 222.46/222.65  |- skos__hiddenLabel mesh__D017281 Cost, Disease
% 222.46/222.65  |- skos__historyNote mesh__D017281 specific disease %28%1966-1992%29%
% 222.46/222.65  |- skos__related mesh__D017281smesh__D011788
% 222.46/222.65  |- skos__altLabel mesh__D017281 Sickness Cost
% 222.46/222.65  |- skos__broader mesh__D017281smesh__D012942
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D017281 2000
% 222.46/222.65  |- skos__scopeNote mesh__D017281
% 222.46/222.65       The personal cost of acute or chronic disease. The cost to the patient may be an economic, social, or psychological cost or personal loss to self, family, or immediate community. The cost of illness may be reflected in absenteeism, productivity, response to treatment, peace of mind, QUALITY OF LIFE, etc. It differs from HEALTH CARE COSTS, meaning the societal cost of providing services related to the delivery of health care, rather than personal impact on individuals.%A%    
% 222.46/222.65  |- mesh__recordAuthorizer mesh__D017281 sjn
% 222.46/222.65  |- skos__altLabel mesh__D017281 Disease Cost
% 222.46/222.65  |- skos__annotation mesh__D017281
% 222.46/222.65       no qualif; IM; coord IM with specific disease with pertinent qualif; if monetary cost in disease, coord IM with specific disease /econ; COST OF ILLNESS is personal cost to the patient including economic and psychosocial costs; it is not HEALTH CARE COSTS, the cost of providing serv in delivery of health care%A%  
% 222.46/222.65  |- mesh__historyNote mesh__D017281 93   
% 222.46/222.65  |- mesh__recordOriginator mesh__D017281 TGC
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D017281 2001
% 222.46/222.65  |- mesh__recordMaintainer mesh__D017281 jls
% 222.46/222.65  |- skos__hiddenLabel mesh__D017281 Sickness Costs
% 222.46/222.65  |- skos__hiddenLabel mesh__D017281 Costs, Disease
% 222.46/222.65  |- mesh__publicMeSHNote mesh__D017281 93   
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D017281 2005
% 222.46/222.65  |- mesh__dateCreated mesh__D017281 1992-05-07
% 222.46/222.65  |- skos__altLabel mesh__D017281 Cost of Sickness
% 222.46/222.65  |- skos__hiddenLabel mesh__D017281 Illness Costs
% 222.46/222.65  |- mesh__recordMaintainer mesh__D003261 mdb
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D003261 2006
% 222.46/222.65  |- skos__altLabel mesh__D003261 Lenses, Contact
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D003261 2004
% 222.46/222.65  |- rdf__type mesh__D003261sskos__Concept
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D003261 2005
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D003261 2003
% 222.46/222.65  |- skos__scopeNote mesh__D003261
% 222.46/222.65       Lenses designed to be worn on the front surface of the eyeball. %28%UMDNS, 1999%29%%A%    
% 222.46/222.65  |- mesh__recordAuthorizer mesh__D003261 sjn
% 222.46/222.65  |- mesh__dateCreated mesh__D003261 1999-01-01
% 222.46/222.65  |- mesh__recordOriginator mesh__D003261 NLM
% 222.46/222.65  |- skos__broader mesh__D003261smesh__D007909
% 222.46/222.65  |- mesh__dateRevised mesh__D003261 2002-07-03
% 222.46/222.65  |- skos__prefLabel mesh__D003261 Contact Lenses
% 222.46/222.65  |- mesh__historyNote mesh__D016987 92   
% 222.46/222.65  |- mesh__dateCreated mesh__D016987 1991-05-30
% 222.46/222.65  |- mesh__dateRevised mesh__D016987 2005-06-30
% 222.46/222.65  |- mesh__dateEstablished mesh__D016987 1992-01-01
% 222.46/222.65  |- mesh__recordOriginator mesh__D016987 PXP
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D016987 2006
% 222.46/222.65  |- skos__prefLabel mesh__D016987 Gram-Positive Rods
% 222.46/222.65  |- mesh__publicMeSHNote mesh__D016987 92   
% 222.46/222.65  |- skos__scopeNote mesh__D016987
% 222.46/222.65       A large group of rod-shaped bacteria that retains the crystal violet stain when treated by Gram%27%s method.%A%    
% 222.46/222.65  |- skos__annotation mesh__D016987
% 222.46/222.65       GEN: avoid; prefer specifics; infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS %28%IM%29%; DF: GRAM POS RODS%A%  
% 222.46/222.65  |- mesh__recordMaintainer mesh__D016987 SYSTEM
% 222.46/222.65  |- mesh__recordAuthorizer mesh__D016987 sjn
% 222.46/222.65  |- skos__altLabel mesh__D016987 Gram Positive Rods
% 222.46/222.65  |- rdf__type mesh__D016987sskos__Concept
% 222.46/222.65  |- skos__broader mesh__D016987smesh__D006094
% 222.46/222.65  |- mesh__recordAuthorizer mesh__D016189 sjn
% 222.46/222.65  |- mesh__recordMaintainer mesh__D016189 KEV
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D016189 2005
% 222.46/222.65  |- mesh__dateEstablished mesh__D016189 1991-01-01
% 222.46/222.65  |- skos__broader mesh__D016189smesh__D003598
% 222.46/222.65  |- mesh__dateRevised mesh__D016189 1999-11-03
% 222.46/222.65  |- rdf__type mesh__D016189sskos__Concept
% 222.46/222.65  |- skos__scopeNote mesh__D016189
% 222.46/222.65       A muscle protein localized in surface membranes which is the product of the Duchenne/Becker muscular dystrophy gene. Individuals with Duchenne muscular dystrophy usually lack dystrophin completely while those with Becker muscular dystrophy have dystrophin of an altered size. It shares features with other cytoskeletal proteins such as SPECTRIN and alpha-actinin but the precise function of dystrophin is not clear. One possible role might be to preserve the integrity and alignment of the plasma membrane to the myofibrils during muscle contraction and relaxation. MW 400 kDa.%A%    
% 222.46/222.65  |- skos__prefLabel mesh__D016189 Dystrophin
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D016189 2004
% 222.46/222.65  |- mesh__dateCreated mesh__D016189 1990-06-17
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D016189 2002
% 222.46/222.65  |- skos__historyNote mesh__D016189 Muscle Proteins %28%1988-1990%29%
% 222.46/222.65  |- skos__broader mesh__D016189smesh__D008565
% 222.46/222.65  |- mesh__recordOriginator mesh__D016189 PXP
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D016189 2003
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D016189 2001
% 222.46/222.65  |- skos__related mesh__D016189smesh__D020388
% 222.46/222.65  |- skos__broader mesh__D016189smesh__D009124
% 222.46/222.65  |- mesh__historyNote mesh__D016189 91   
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D016189 2000
% 222.46/222.65  |- skos__related mesh__D016189smesh__D018101
% 222.46/222.65  |- skos__annotation mesh__D016189
% 222.46/222.65       a muscle protein: see MeSH definition for relation to musc dystrophy; /biosyn /drug eff /physiol /ultrastruct permitted%A%  
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D016189 2006
% 222.46/222.65  |- mesh__publicMeSHNote mesh__D016189 91   
% 222.46/222.65  |- mesh__dateRevised mesh__D002967 2005-06-30
% 222.46/222.65  |- skos__broader mesh__D002967smesh__D006999
% 222.46/222.65  |- mesh__dateCreated mesh__D002967 1999-01-01
% 222.46/222.65  |- mesh__recordMaintainer mesh__D002967 SYSTEM
% 222.46/222.65  |- mesh__dateEstablished mesh__D002967 1974-01-01
% 222.46/222.65  |- mesh__recordOriginator mesh__D002967 NLM
% 222.46/222.65  |- rdf__type mesh__D002967sskos__Concept
% 222.46/222.65  |- mesh__publicMeSHNote mesh__D002967 74; see ASCOMYCETES 1963-73   
% 222.46/222.65  |- skos__prefLabel mesh__D002967 Claviceps
% 222.46/222.65  |- skos__scopeNote mesh__D002967
% 222.46/222.65       A genus of ascomycetous fungi, family Clavicipitaceae, order Hypocreales, parasitic on various grasses %28%POACEAE%29%. The sclerotia contain several toxic alkaloids. Claviceps purpurea on rye causes ergotism.%A%    
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D002967 2006
% 222.46/222.65  |- mesh__historyNote mesh__D002967 74%28%63%29%   
% 222.46/222.65  |- mesh__recordAuthorizer mesh__D002967 sjn
% 222.46/222.65  |- rdf__type mesh__D002169sskos__Concept
% 222.46/222.65  |- skos__historyNote mesh__D002169 Vibrio Infections %28%1968-1976%29%
% 222.46/222.65  |- mesh__activeMeSHYear mesh__D002169 2002
% 222.46/222.65  |- skos__scopeNote mesh__D002169
% 222.46/222.65       Infections with bacteria of the genus CAMPYLOBACTER.     
% 222.46/222.65  |- mesh__historyNote mesh__D002169 77   
% 222.46/222.66  |- skos__historyNote mesh__D002169 Vibrio %28%1966-1967%29%
% 222.46/222.66  |- skos__broader mesh__D002169smesh__D016905
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002169 2001
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002169 2004
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002169 1997
% 222.46/222.66  |- skos__prefLabel mesh__D002169 Campylobacter Infections
% 222.46/222.66  |- mesh__recordAuthorizer mesh__D002169 PLS
% 222.46/222.66  |- mesh__recordMaintainer mesh__D002169 TAP
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002169 2000
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002169 2006
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002169 1999
% 222.46/222.66  |- skos__annotation mesh__D002169 gram-neg bact infect   
% 222.46/222.66  |- skos__hiddenLabel mesh__D002169 Infection, Campylobacter
% 222.46/222.66  |- skos__hiddenLabel mesh__D002169 Campylobacter Infection
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002169 2003
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002169 1996
% 222.46/222.66  |- mesh__publicMeSHNote mesh__D002169 77   
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002169 1995
% 222.46/222.66  |- mesh__dateRevised mesh__D002169 1993-06-02
% 222.46/222.66  |- mesh__recordOriginator mesh__D002169 FPG
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002169 2005
% 222.46/222.66  |- skos__altLabel mesh__D002169 Infections, Campylobacter
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002169 1998
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002169 1994
% 222.46/222.66  |- mesh__dateCreated mesh__D002169 1976-04-16
% 222.46/222.66  |- mesh__dateEstablished mesh__D002169 1977-01-01
% 222.46/222.66  |- skos__broader mesh__D007652smesh__D019755
% 222.46/222.66  |- skos__historyNote mesh__D007652 Lyases %28%1966-1972%29%
% 222.46/222.66  |- mesh__dateRevised mesh__D007652 2003-07-09
% 222.46/222.66  |- mesh__publicMeSHNote mesh__D007652 98; see KETOACID-LYASES 1973-97   
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D007652 2005
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D007652 2004
% 222.46/222.66  |- mesh__dateEstablished mesh__D007652 1973-01-01
% 222.46/222.66  |- skos__scopeNote mesh__D007652
% 222.46/222.66       Enzymes that catalyze the cleavage of a carbon-carbon bond of a 3-hydroxy acid. %28%Dorland, 28th ed%29% EC 4.1.3.%A%    
% 222.46/222.66  |- mesh__recordAuthorizer mesh__D007652 sjn
% 222.46/222.66  |- skos__hiddenLabel mesh__D007652 Ketoacid Lyases
% 222.46/222.66  |- skos__prefLabel mesh__D007652 Oxo-Acid-Lyases
% 222.46/222.66  |- skos__altLabel mesh__D007652 Ketoacid-Lyases
% 222.46/222.66  |- mesh__historyNote mesh__D007652 98%28%73%29%   
% 222.46/222.66  |- rdf__type mesh__D007652sskos__Concept
% 222.46/222.66  |- mesh__recordOriginator mesh__D007652 NLM
% 222.46/222.66  |- mesh__dateCreated mesh__D007652 1999-01-01
% 222.46/222.66  |- skos__hiddenLabel mesh__D007652 Oxo Acid Lyases
% 222.46/222.66  |- mesh__recordMaintainer mesh__D007652 ssb
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D007652 2006
% 222.46/222.66  |- skos__broader mesh__D012597smesh__D019999
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D012597 2006
% 222.46/222.66  |- mesh__recordMaintainer mesh__D012597 ssb
% 222.46/222.66  |- skos__hiddenLabel mesh__D012597 Drugs, Sclerosing
% 222.46/222.66  |- skos__annotation mesh__D012597
% 222.46/222.66       D25-26 qualif; coord /ther use with dis /ther, not dis /drug ther; DF: SCLEROSING SOL%A%  
% 222.46/222.66  |- skos__prefLabel mesh__D012597 Sclerosing Solutions
% 222.46/222.66  |- mesh__recordOriginator mesh__D012597 NLM
% 222.46/222.66  |- skos__hiddenLabel mesh__D012597 Solutions, Sclerosing
% 222.46/222.66  |- skos__altLabel mesh__D012597 Injections, Sclerosing
% 222.46/222.66  |- rdf__type mesh__D012597sskos__Concept
% 222.46/222.66  |- skos__broader mesh__D012597smesh__D002317
% 222.46/222.66  |- skos__scopeNote mesh__D012597
% 222.46/222.66       Chemical agents injected into veins to cause localized thrombosis and eventual fibrosis and obliteration of the vessels. They are used in the treatment of varicose veins, hemorrhoids, gastric and esophageal varices, and peptic ulcer hemorrhage.%A%    
% 222.46/222.66  |- mesh__dateCreated mesh__D012597 1999-01-01
% 222.46/222.66  |- skos__hiddenLabel mesh__D012597 Agents, Sclerosing
% 222.46/222.66  |- mesh__dateRevised mesh__D012597 2005-06-30
% 222.46/222.66  |- mesh__recordAuthorizer mesh__D012597 sjn
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D031751 2003
% 222.46/222.66  |- skos__broader mesh__D031751smesh__D006109
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D031751 2006
% 222.46/222.66  |- mesh__publicMeSHNote mesh__D031751 2003   
% 222.46/222.66  |- skos__scopeNote mesh__D031751
% 222.46/222.66       A plant genus of the family POACEAE. The common name of fescue is also used with some other grasses.%A%    
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D031751 2005
% 222.46/222.66  |- mesh__historyNote mesh__D031751 2003   
% 222.46/222.66  |- skos__annotation mesh__D031751
% 222.46/222.66       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.46/222.66  |- mesh__dateCreated mesh__D031751 2002-07-03
% 222.46/222.66  |- rdf__type mesh__D031751sskos__Concept
% 222.46/222.66  |- skos__prefLabel mesh__D031751 Festuca
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D031751 2004
% 222.46/222.66  |- mesh__dateEstablished mesh__D031751 2003-01-01
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017282 2003
% 222.46/222.66  |- mesh__dateCreated mesh__D017282 1992-05-22
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017282 1999
% 222.46/222.66  |- skos__hiddenLabel mesh__D017282 Diseases, Tick-Borne
% 222.46/222.66  |- skos__hiddenLabel mesh__D017282 Tick-Borne Infection
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017282 1995
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017282 1998
% 222.46/222.66  |- mesh__historyNote mesh__D017282 93   
% 222.46/222.66  |- skos__prefLabel mesh__D017282 Tick-Borne Diseases
% 222.46/222.66  |- mesh__publicMeSHNote mesh__D017282 93   
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017282 2006
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017282 1994
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017282 2001
% 222.46/222.66  |- skos__broader mesh__D017282smesh__D016905
% 222.46/222.66  |- skos__hiddenLabel mesh__D017282 Tick-Borne Disease
% 222.46/222.66  |- skos__broader mesh__D017282smesh__D011528
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017282 2005
% 222.46/222.66  |- rdf__type mesh__D017282sskos__Concept
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017282 2000
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017282 1997
% 222.46/222.66  |- skos__hiddenLabel mesh__D017282 Infection, Tick-Borne
% 222.46/222.66  |- skos__annotation mesh__D017282
% 222.46/222.66       can be bacterial, viral or protozoan; GEN or unspecified; prefer specifics; for GEN articles specifying type, coord IM with GEN organism/infect term %28%IM%29%, as %22%tick-borne arbovirus diseases%22% = TICK-BORNE DISEASES %28%IM%29% + ARBOVIRUS INFECTIONS %28%IM%29%%A%  
% 222.46/222.66  |- mesh__dateEstablished mesh__D017282 1993-01-01
% 222.46/222.66  |- skos__hiddenLabel mesh__D017282 Disease, Tick-Borne
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017282 1993
% 222.46/222.66  |- skos__hiddenLabel mesh__D017282 Infections, Tick Borne
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017282 1996
% 222.46/222.66  |- skos__hiddenLabel mesh__D017282 Tick Borne Diseases
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017282 2004
% 222.46/222.66  |- skos__altLabel mesh__D017282 Infections, Tick-Borne
% 222.46/222.66  |- skos__scopeNote mesh__D017282
% 222.46/222.66       Bacterial, viral, or parasitic diseases transmitted to humans and animals by the bite of infected ticks. The families Ixodidae and Argasidae contain many bloodsucking species that are important pests of man and domestic birds and mammals and probably exceed all other arthropods in the number and variety of disease agents they transmit. Many of the tick-borne diseases are zoonotic.%A%    
% 222.46/222.66  |- skos__broader mesh__D017282smesh__D001102
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017282 2002
% 222.46/222.66  |- skos__hiddenLabel mesh__D017282 Tick Borne Infections
% 222.46/222.66  |- skos__hiddenLabel mesh__D003262 Lens, Extended-Wear Contact
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003262 1993
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003262 2001
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003262 2003
% 222.46/222.66  |- mesh__recordOriginator mesh__D003262 RC
% 222.46/222.66  |- skos__prefLabel mesh__D003262 Contact Lenses, Extended-Wear
% 222.46/222.66  |- mesh__dateCreated mesh__D003262 1983-02-09
% 222.46/222.66  |- skos__hiddenLabel mesh__D003262 Contact Lens, Extended Wear
% 222.46/222.66  |- skos__historyNote mesh__D003262 Contact Lenses %28%1966-1969%29%
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003262 2000
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003262 1994
% 222.46/222.66  |- skos__broader mesh__D003262smesh__D003263
% 222.46/222.66  |- skos__hiddenLabel mesh__D003262 Contact Lenses, Extended Wear
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003262 1999
% 222.46/222.66  |- mesh__recordAuthorizer mesh__D003262 PLS
% 222.46/222.66  |- mesh__recordMaintainer mesh__D003262 PLS
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003262 1997
% 222.46/222.66  |- skos__hiddenLabel mesh__D003262 Lenses, Extended-Wear Contact
% 222.46/222.66  |- skos__scopeNote mesh__D003262
% 222.46/222.66       Hydrophilic contact lenses worn for an extended period or permanently.%A%    
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003262 1998
% 222.46/222.66  |- mesh__historyNote mesh__D003262
% 222.46/222.66       89%28%84%29%; was see under CONTACT LENSES, HYDROPHILIC 1984-88%A%  
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003262 2002
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003262 1996
% 222.46/222.66  |- skos__altLabel mesh__D003262 Contact Lens, Extended-Wear
% 222.46/222.66  |- mesh__publicMeSHNote mesh__D003262
% 222.46/222.66       89; was see under CONTACT LENSES, HYDROPHILIC 1984-88   
% 222.46/222.66  |- skos__hiddenLabel mesh__D003262 Extended-Wear Contact Lenses
% 222.46/222.66  |- skos__historyNote mesh__D003262
% 222.46/222.66       Contact Lenses, Hydrophilic %28%1971-1983%29%
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003262 2006
% 222.46/222.66  |- mesh__dateEstablished mesh__D003262 1989-01-01
% 222.46/222.66  |- mesh__dateRevised mesh__D003262 1992-05-07
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003262 2004
% 222.46/222.66  |- skos__hiddenLabel mesh__D003262 Extended-Wear Contact Lens
% 222.46/222.66  |- rdf__type mesh__D003262sskos__Concept
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003262 2005
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003262 1995
% 222.46/222.66  |- skos__annotation mesh__D016988
% 222.46/222.66       do not confuse with GRAM-POSITIVE ASPOROGENOUS RODS, REGULAR; avoid: too general; prefer specific families %26% genera; infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS %28%IM%29%; DF: GRAM POS ASPOROGENOUS RODS IRREGULAR%A%  
% 222.46/222.66  |- mesh__historyNote mesh__D016988 98; use explode 1992-97   
% 222.46/222.66  |- mesh__recordOriginator mesh__D016988 PXP
% 222.46/222.66  |- mesh__dateEstablished mesh__D016988 1998-01-01
% 222.46/222.66  |- mesh__dateRevised mesh__D016988 2005-06-30
% 222.46/222.66  |- skos__altLabel mesh__D016988 Gram Positive Asporogenous Rods, Irregular
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D016988 2006
% 222.46/222.66  |- skos__broader mesh__D016988smesh__D006093
% 222.46/222.66  |- mesh__dateCreated mesh__D016988 1991-08-23
% 222.46/222.66  |- skos__historyNote mesh__D016988
% 222.46/222.66       Gram-Positive Asporogenous Rods %28%1992-1997%29%
% 222.46/222.66  |- mesh__recordAuthorizer mesh__D016988 sjn
% 222.46/222.66  |- mesh__recordMaintainer mesh__D016988 SYSTEM
% 222.46/222.66  |- skos__scopeNote mesh__D016988
% 222.46/222.66       A group of irregular rod-shaped bacteria that stain gram-positive and do not produce endospores.%A%    
% 222.46/222.66  |- rdf__type mesh__D016988sskos__Concept
% 222.46/222.66  |- skos__prefLabel mesh__D016988 Gram-Positive Asporogenous Rods, Irregular
% 222.46/222.66  |- mesh__publicMeSHNote mesh__D016988 98   
% 222.46/222.66  |- skos__hiddenLabel mesh__D041381 Infant Diaper
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D041381 2006
% 222.46/222.66  |- mesh__publicMeSHNote mesh__D041381 2003; see INFANT CARE 1989-2002   
% 222.46/222.66  |- skos__hiddenLabel mesh__D041381 Infant Diapers
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D041381 2003
% 222.46/222.66  |- skos__hiddenLabel mesh__D041381 Pin, Diaper
% 222.46/222.66  |- mesh__recordOriginator mesh__D041381 lkt
% 222.46/222.66  |- skos__hiddenLabel mesh__D041381 Diaper Pin
% 222.46/222.66  |- mesh__historyNote mesh__D041381 2003; use INFANT CARE 1989-2002   
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D041381 2004
% 222.46/222.66  |- mesh__recordMaintainer mesh__D041381 lkt
% 222.46/222.66  |- mesh__dateCreated mesh__D041381 2002-07-03
% 222.46/222.66  |- skos__broader mesh__D041381smesh__D041342
% 222.46/222.66  |- skos__hiddenLabel mesh__D041381 Pins, Diaper
% 222.46/222.66  |- skos__scopeNote mesh__D041381
% 222.46/222.66       Absorbent pads designed to be worn by infants and very young children.%A%    
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D041381 2005
% 222.46/222.66  |- mesh__recordAuthorizer mesh__D041381 sjn
% 222.46/222.66  |- skos__hiddenLabel mesh__D041381 Diaper, Infant
% 222.46/222.66  |- skos__historyNote mesh__D041381 Infant Care %28%1989-2002%29%
% 222.46/222.66  |- rdf__type mesh__D041381sskos__Concept
% 222.46/222.66  |- mesh__dateEstablished mesh__D041381 2003-01-01
% 222.46/222.66  |- skos__prefLabel mesh__D041381 Diapers, Infant
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002968 2001
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002968 2006
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002968 2000
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002968 2004
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002968 1990
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002968 2005
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002968 2003
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002968 1995
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002968 1993
% 222.46/222.66  |- mesh__dateCreated mesh__D002968 1999-01-01
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002968 2002
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002968 1999
% 222.46/222.66  |- rdf__type mesh__D002968sskos__Concept
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002968 1994
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002968 1997
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002968 1992
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002968 1989
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002968 1998
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002968 1991
% 222.46/222.66  |- skos__prefLabel mesh__D002968 Clavicle
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002968 1996
% 222.46/222.66  |- skos__hiddenLabel mesh__D002968 Clavicles
% 222.46/222.66  |- skos__broader mesh__D002968smesh__D001133
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D013690 2006
% 222.46/222.66  |- skos__scopeNote mesh__D013690
% 222.46/222.66       The transmission and reproduction of transient images of fixed or moving objects. An electronic system of transmitting such images together with sound over a wire or through space by apparatus that converts light and sound into electrical waves and reconverts them into visible light rays and audible sound. %28%From Webster, 3rd ed%29%%A%    
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D013690 2005
% 222.46/222.66  |- skos__annotation mesh__D013690
% 222.46/222.66       for color TV do not coord with COLOR unless specifically emphasized %26% then NIM only%A%  
% 222.46/222.66  |- skos__broader mesh__D013690smesh__D008402
% 222.46/222.66  |- rdf__type mesh__D013690sskos__Concept
% 222.46/222.66  |- skos__broader mesh__D013690smesh__D001296
% 222.46/222.66  |- skos__prefLabel mesh__D013690 Television
% 222.46/222.66  |- skos__hiddenLabel mesh__D013690 Televisions
% 222.46/222.66  |- skos__broader mesh__D013690smesh__D013685
% 222.46/222.66  |- mesh__recordMaintainer mesh__D013690 ags
% 222.46/222.66  |- mesh__dateCreated mesh__D013690 1999-01-01
% 222.46/222.66  |- mesh__recordAuthorizer mesh__D013690 sjn
% 222.46/222.66  |- mesh__recordOriginator mesh__D013690 NLM
% 222.46/222.66  |- mesh__dateRevised mesh__D013690 2004-07-07
% 222.46/222.66  |- mesh__recordMaintainer mesh__D007653 ssb
% 222.46/222.66  |- skos__broader mesh__D007653smesh__D002783
% 222.46/222.66  |- mesh__recordOriginator mesh__D007653 RLS
% 222.46/222.66  |- skos__broader mesh__D007653smesh__D002784
% 222.46/222.66  |- rdf__type mesh__D007653sskos__Concept
% 222.46/222.66  |- skos__historyNote mesh__D007653
% 222.46/222.66       Cholesterol %28%1966-1974%29% /analogs %26% derivatives %28%1975-1979%29%
% 222.46/222.66  |- skos__altLabel mesh__D007653 Oxocholesterols
% 222.46/222.66  |- mesh__historyNote mesh__D007653
% 222.46/222.66       91%28%80%29%; was see under CHOLESTEROL 1980-90   
% 222.46/222.66  |- skos__scopeNote mesh__D007653
% 222.46/222.66       Cholesterol substituted in any position by a keto moiety. The 7-keto isomer inhibits 3-hydroxy-3-methylglutaryl-CoA reductase activity and inhibits cholesterol uptake in the coronary arteries and aorta in vitro.%A%    
% 222.46/222.66  |- mesh__dateEstablished mesh__D007653 1991-01-01
% 222.46/222.66  |- mesh__recordAuthorizer mesh__D007653 sjn
% 222.46/222.66  |- mesh__publicMeSHNote mesh__D007653
% 222.46/222.66       91; was see under CHOLESTEROL 1980-90   
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D007653 2006
% 222.46/222.66  |- mesh__dateRevised mesh__D007653 2003-07-09
% 222.46/222.66  |- skos__prefLabel mesh__D007653 Ketocholesterols
% 222.46/222.66  |- skos__annotation mesh__D007653 /biosyn /physiol permitted   
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D007653 2005
% 222.46/222.66  |- mesh__dateCreated mesh__D007653 1979-02-21
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D007653 2004
% 222.46/222.66  |- skos__prefLabel mesh__D012598 Sclerosis
% 222.46/222.66  |- skos__scopeNote mesh__D012598
% 222.46/222.66       A pathological process consisting of hardening or fibrosis of an anatomical structure, often a vessel or a nerve.%A%    
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D012598 2006
% 222.46/222.66  |- skos__hiddenLabel mesh__D012598 Scleroses
% 222.46/222.66  |- mesh__recordAuthorizer mesh__D012598 sjn
% 222.46/222.66  |- mesh__dateCreated mesh__D012598 1999-01-01
% 222.46/222.66  |- skos__broader mesh__D012598smesh__D010335
% 222.46/222.66  |- mesh__dateRevised mesh__D012598 1999-11-03
% 222.46/222.66  |- rdf__type mesh__D012598sskos__Concept
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D012598 2000
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D012598 2003
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D012598 2001
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D012598 2004
% 222.46/222.66  |- mesh__recordOriginator mesh__D012598 NLM
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D012598 2002
% 222.46/222.66  |- mesh__recordMaintainer mesh__D012598 KEV
% 222.46/222.66  |- skos__annotation mesh__D012598
% 222.46/222.66       NIM as pathol process with no qualif: coord with Cat A term /pathol %28%IM%29%%A%  
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D012598 2005
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D031752 2005
% 222.46/222.66  |- mesh__dateEstablished mesh__D031752 2003-01-01
% 222.46/222.66  |- skos__annotation mesh__D031752
% 222.46/222.66       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.46/222.66  |- skos__altLabel mesh__D031752 Velvetgrass
% 222.46/222.66  |- skos__broader mesh__D031752smesh__D006109
% 222.46/222.66  |- rdf__type mesh__D031752sskos__Concept
% 222.46/222.66  |- skos__scopeNote mesh__D031752
% 222.46/222.66       A plant genus of the family POACEAE that contains Hol l 1 and Hol l 5 allergens.%A%    
% 222.46/222.66  |- mesh__historyNote mesh__D031752 2003   
% 222.46/222.66  |- mesh__dateCreated mesh__D031752 2002-07-03
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D031752 2004
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D031752 2003
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D031752 2006
% 222.46/222.66  |- skos__prefLabel mesh__D031752 Holcus
% 222.46/222.66  |- mesh__publicMeSHNote mesh__D031752 2003   
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017283 1999
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017283 2005
% 222.46/222.66  |- skos__altLabel mesh__D017283 Nursing, Neonatal
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017283 1995
% 222.46/222.66  |- mesh__onlineNote mesh__D017283
% 222.46/222.66       use MATERNAL-CHILD NURSING to search NEONATAL NURSING %26% PERINATAL NURSING 1991-92%A%  
% 222.46/222.66  |- skos__scopeNote mesh__D017283
% 222.46/222.66       The nursing specialty that deals with the care of newborn infants during the first four weeks after birth.%A%    
% 222.46/222.66  |- mesh__historyNote mesh__D017283
% 222.46/222.66       93; NEONATAL NURSING %26% PERINATAL NURSING were see MATERNAL-CHILD NURSING 1991-92%A%  
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017283 2006
% 222.46/222.66  |- mesh__dateEstablished mesh__D017283 1993-01-01
% 222.46/222.66  |- skos__historyNote mesh__D017283 Maternal-Child Nursing %28%1991-1992%29%
% 222.46/222.66  |- skos__annotation mesh__D017283
% 222.46/222.66       SPEC; SPEC qualif; check also tag INFANT, NEWBORN   
% 222.46/222.66  |- mesh__publicMeSHNote mesh__D017283
% 222.46/222.66       93; NEONATAL NURSING %26% PERINATAL NURSING were see MATERNAL-CHILD NURSING 1991-92%A%  
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017283 1996
% 222.46/222.66  |- mesh__dateCreated mesh__D017283 1992-05-22
% 222.46/222.66  |- rdf__type mesh__D017283sskos__Concept
% 222.46/222.66  |- skos__prefLabel mesh__D017283 Neonatal Nursing
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017283 2000
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017283 1997
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017283 2003
% 222.46/222.66  |- skos__broader mesh__D017283smesh__D010371
% 222.46/222.66  |- skos__broader mesh__D017283smesh__D016389
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017283 1993
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017283 2001
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017283 1998
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017283 2004
% 222.46/222.66  |- skos__altLabel mesh__D017283 Perinatal Nursing
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017283 1994
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D017283 2002
% 222.46/222.66  |- skos__historyNote mesh__D003263 Contact Lenses %28%1966-1970%29%
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003263 1999
% 222.46/222.66  |- mesh__publicMeSHNote mesh__D003263 74   
% 222.46/222.66  |- mesh__dateCreated mesh__D003263 1999-01-01
% 222.46/222.66  |- skos__hiddenLabel mesh__D003263 Hydrophilic Contact Lenses
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003263 2001
% 222.46/222.66  |- skos__hiddenLabel mesh__D003263 Lens, Hydrophilic Contact
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003263 1998
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003263 1997
% 222.46/222.66  |- skos__prefLabel mesh__D003263 Contact Lenses, Hydrophilic
% 222.46/222.66  |- skos__hiddenLabel mesh__D003263 Contact Lenses, Soft
% 222.46/222.66  |- skos__hiddenLabel mesh__D003263 Lenses, Hydrophilic Contact
% 222.46/222.66  |- mesh__recordOriginator mesh__D003263 NLM
% 222.46/222.66  |- skos__hiddenLabel mesh__D003263 Contact Lens, Soft
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003263 2000
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003263 1996
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003263 2006
% 222.46/222.66  |- mesh__dateRevised mesh__D003263 1992-05-07
% 222.46/222.66  |- mesh__recordMaintainer mesh__D003263 PLS
% 222.46/222.66  |- skos__scopeNote mesh__D003263
% 222.46/222.66       Soft, supple contact lenses made of plastic polymers which interact readily with water molecules. Many types are available, including continuous and extended-wear versions, which are gas-permeable and easily sterilized.%A%    
% 222.46/222.66  |- skos__broader mesh__D003263smesh__D003261
% 222.46/222.66  |- skos__hiddenLabel mesh__D003263 Contact Lens, Hydrophilic
% 222.46/222.66  |- skos__hiddenLabel mesh__D003263 Lenses, Soft Contact
% 222.46/222.66  |- mesh__recordAuthorizer mesh__D003263 PLS
% 222.46/222.66  |- mesh__dateEstablished mesh__D003263 1974-01-01
% 222.46/222.66  |- skos__altLabel mesh__D003263 Lenses, Contact, Hydrophilic
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003263 2005
% 222.46/222.66  |- skos__altLabel mesh__D003263 Soft Contact Lens
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003263 2004
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003263 1995
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003263 2002
% 222.46/222.66  |- skos__altLabel mesh__D003263 Soft Contact Lenses
% 222.46/222.66  |- mesh__historyNote mesh__D003263 74%28%71%29%   
% 222.46/222.66  |- rdf__type mesh__D003263sskos__Concept
% 222.46/222.66  |- skos__hiddenLabel mesh__D003263 Lens, Soft Contact
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003263 2003
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003263 1993
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D003263 1994
% 222.46/222.66  |- skos__altLabel mesh__D003263 Hydrophilic Contact Lens
% 222.46/222.66  |- mesh__recordAuthorizer mesh__D016989 sjn
% 222.46/222.66  |- skos__scopeNote mesh__D016989
% 222.46/222.66       A group of regular rod-shaped bacteria that stain gram-positive and do not produce endospores.%A%    
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D016989 2006
% 222.46/222.66  |- skos__historyNote mesh__D016989
% 222.46/222.66       Gram-Positive Asporogenous Rods %28%1992-1997%29%
% 222.46/222.66  |- skos__annotation mesh__D016989
% 222.46/222.66       do not confuse with GRAM-POSITIVE ASPOROGENOUS RODS, IRREGULAR; avoid: too general; prefer specific families %26% genera; infection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS %28%IM%29%; DF: GRAM POS ASPOROGENOUS RODS REGULAR%A%  
% 222.46/222.66  |- mesh__publicMeSHNote mesh__D016989 98   
% 222.46/222.66  |- mesh__dateEstablished mesh__D016989 1998-01-01
% 222.46/222.66  |- rdf__type mesh__D016989sskos__Concept
% 222.46/222.66  |- mesh__recordMaintainer mesh__D016989 SYSTEM
% 222.46/222.66  |- mesh__dateRevised mesh__D016989 2005-06-30
% 222.46/222.66  |- skos__broader mesh__D016989smesh__D006093
% 222.46/222.66  |- mesh__historyNote mesh__D016989 98; use explode 1992-97   
% 222.46/222.66  |- mesh__recordOriginator mesh__D016989 PXP
% 222.46/222.66  |- skos__prefLabel mesh__D016989 Gram-Positive Asporogenous Rods, Regular
% 222.46/222.66  |- skos__altLabel mesh__D016989 Gram Positive Asporogenous Rods, Regular
% 222.46/222.66  |- mesh__dateCreated mesh__D016989 1991-08-23
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D041382 2003
% 222.46/222.66  |- mesh__publicMeSHNote mesh__D041382
% 222.46/222.66       2003; see INCONTINENCE PADS 1992-2002   
% 222.46/222.66  |- mesh__dateEstablished mesh__D041382 2003-01-01
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D041382 2004
% 222.46/222.66  |- skos__hiddenLabel mesh__D041382 Adult Diapers
% 222.46/222.66  |- skos__scopeNote mesh__D041382
% 222.46/222.66       Absorbent pads designed to be worn as underpants or pants liners by adults.%A%    
% 222.46/222.66  |- skos__historyNote mesh__D041382 Incontinence Pads %28%1992-2002%29%
% 222.46/222.66  |- skos__hiddenLabel mesh__D041382 Diaper, Adult
% 222.46/222.66  |- mesh__historyNote mesh__D041382 2003; use INCONTINENCE PADS 1992-2002   
% 222.46/222.66  |- skos__hiddenLabel mesh__D041382 Adult Diaper
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D041382 2005
% 222.46/222.66  |- rdf__type mesh__D041382sskos__Concept
% 222.46/222.66  |- skos__prefLabel mesh__D041382 Diapers, Adult
% 222.46/222.66  |- skos__broader mesh__D041382smesh__D041342
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D041382 2006
% 222.46/222.66  |- skos__historyNote mesh__D041382 Clothing %28%1990-1991%29%
% 222.46/222.66  |- mesh__dateCreated mesh__D041382 2002-07-02
% 222.46/222.66  |- skos__historyNote mesh__D002969 Penicillinase %28%1966-1978%29%
% 222.46/222.66  |- mesh__dateRevised mesh__D002969 2004-07-07
% 222.46/222.66  |- skos__annotation mesh__D002969 /biosyn permitted if by living matter   
% 222.46/222.66  |- skos__historyNote mesh__D002969 Amidohydrolases %28%1966-1978%29%
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002969 2005
% 222.46/222.66  |- mesh__recordOriginator mesh__D002969 SH
% 222.46/222.66  |- skos__historyNote mesh__D002969 beta-Lactamases %28%1979-1982%29%
% 222.46/222.66  |- skos__broader mesh__D002969smesh__D047090
% 222.46/222.66  |- rdf__type mesh__D002969sskos__Concept
% 222.46/222.66  |- mesh__historyNote mesh__D002969 83   
% 222.46/222.66  |- mesh__publicMeSHNote mesh__D002969 83   
% 222.46/222.66  |- mesh__dateCreated mesh__D002969 1982-05-05
% 222.46/222.66  |- mesh__recordAuthorizer mesh__D002969 sjn
% 222.46/222.66  |- mesh__recordMaintainer mesh__D002969 ssb
% 222.46/222.66  |- skos__hiddenLabel mesh__D002969 Acids, Clavulanic
% 222.46/222.66  |- mesh__dateEstablished mesh__D002969 1983-01-01
% 222.46/222.66  |- skos__scopeNote mesh__D002969
% 222.46/222.66       Acids, salts, and derivatives of clavulanic acid %28%C8H9O5N%29%. They consist of those beta-lactam compounds that differ from penicillin in having the sulfur of the thiazolidine ring replaced by an oxygen. They have limited antibacterial action, but block bacterial beta-lactamase irreversibly, so that similar antibiotics are not broken down by the bacterial enzymes and therefore can exert their antibacterial effects.%A%    
% 222.46/222.66  |- skos__historyNote mesh__D002969 Lactams %28%1974-1982%29%
% 222.46/222.66  |- skos__prefLabel mesh__D002969 Clavulanic Acids
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D002969 2006
% 222.46/222.66  |- skos__historyNote mesh__D002969 Amides %28%1966-1973%29%
% 222.46/222.66  |- skos__broader mesh__D013691smesh__D018011
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D013691 1996
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D013691 1998
% 222.46/222.66  |- skos__prefLabel mesh__D013691 Tellurium
% 222.46/222.66  |- mesh__recordOriginator mesh__D013691 NLM
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D013691 1997
% 222.46/222.66  |- mesh__activeMeSHYear mesh__D013691 1994
% 222.46/222.67  |- rdf__type mesh__D013691sskos__Concept
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D013691 2000
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D013691 1999
% 222.46/222.67  |- mesh__dateCreated mesh__D013691 1999-01-01
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D013691 2001
% 222.46/222.67  |- mesh__recordMaintainer mesh__D013691 TPW
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D013691 1995
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D013691 2003
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D013691 2005
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D013691 2004
% 222.46/222.67  |- skos__annotation mesh__D013691
% 222.46/222.67       Te-130; Te-120, 122-126, 128 = TELLURIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Te-115-119, 121, 127, 129, 131-135 = TELLURIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 222.46/222.67  |- skos__scopeNote mesh__D013691
% 222.46/222.67       Tellurium. An element that is a member of the chalcogen family. It has the atomic symbol Te, atomic number 52, and atomic weight 127.60. It has been used as a coloring agent and in the manufacture of electrical equipment. Exposure may cause nausea, vomiting, and CNS depression.%A%    
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D013691 2002
% 222.46/222.67  |- mesh__recordAuthorizer mesh__D013691 PLS
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D013691 2006
% 222.46/222.67  |- mesh__dateRevised mesh__D013691 1993-06-04
% 222.46/222.67  |- mesh__dateEstablished mesh__D007654 1984-01-01
% 222.46/222.67  |- mesh__dateCreated mesh__D007654 1983-03-11
% 222.46/222.67  |- skos__historyNote mesh__D007654 Imidazoles %28%1966-1983%29%
% 222.46/222.67  |- skos__hiddenLabel mesh__D007654 R 41400
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D007654 2002
% 222.46/222.67  |- skos__scopeNote mesh__D007654
% 222.46/222.67       Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients.%A%    
% 222.46/222.67  |- mesh__publicMeSHNote mesh__D007654 84   
% 222.46/222.67  |- skos__prefLabel mesh__D007654 Ketoconazole
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D007654 2006
% 222.46/222.67  |- mesh__historyNote mesh__D007654 84   
% 222.46/222.67  |- mesh__recordOriginator mesh__D007654 SH
% 222.46/222.67  |- skos__historyNote mesh__D007654 Piperazines %28%1966-1983%29%
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D007654 2005
% 222.46/222.67  |- skos__broader mesh__D007654smesh__D010879
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D007654 2004
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D007654 2001
% 222.46/222.67  |- mesh__recordMaintainer mesh__D007654 TWD
% 222.46/222.67  |- skos__altLabel mesh__D007654 R41,400
% 222.46/222.67  |- mesh__dateRevised mesh__D007654 2000-06-22
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D007654 2003
% 222.46/222.67  |- skos__altLabel mesh__D007654 R41400
% 222.46/222.67  |- rdf__type mesh__D007654sskos__Concept
% 222.46/222.67  |- mesh__recordAuthorizer mesh__D007654 sjn
% 222.46/222.67  |- mesh__recordAuthorizer mesh__D012599 SJN
% 222.46/222.67  |- skos__broader mesh__D012599smesh__D010030
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D012599 2005
% 222.46/222.67  |- skos__prefLabel mesh__D012599 Sclerostomy
% 222.46/222.67  |- mesh__historyNote mesh__D012599 88   
% 222.46/222.67  |- mesh__dateEstablished mesh__D012599 1988-01-01
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D012599 1998
% 222.46/222.67  |- mesh__publicMeSHNote mesh__D012599 88   
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D012599 2006
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D012599 2000
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D012599 1999
% 222.46/222.67  |- rdf__type mesh__D012599sskos__Concept
% 222.46/222.67  |- mesh__dateRevised mesh__D012599 1997-06-20
% 222.46/222.67  |- skos__scopeNote mesh__D012599
% 222.46/222.67       Surgical formation of an external opening in the sclera, primarily in the treatment of glaucoma.%A%    
% 222.46/222.67  |- mesh__recordMaintainer mesh__D012599 PXP
% 222.46/222.67  |- mesh__dateCreated mesh__D012599 1987-03-23
% 222.46/222.67  |- skos__broader mesh__D012599smesh__D018463
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D012599 2001
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D012599 2003
% 222.46/222.67  |- skos__annotation mesh__D012599
% 222.46/222.67       do not use /util except by MeSH definition   
% 222.46/222.67  |- skos__hiddenLabel mesh__D012599 Sclerostomies
% 222.46/222.67  |- skos__historyNote mesh__D012599 Glaucoma/surgery %28%1971-1987%29%
% 222.46/222.67  |- skos__historyNote mesh__D012599 Sclera/surgery %28%1971-1987%29%
% 222.46/222.67  |- mesh__recordOriginator mesh__D012599 SCD
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D012599 2002
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D012599 2004
% 222.46/222.67  |- skos__scopeNote mesh__D003264
% 222.46/222.67       Provision of physical and biological barriers to the dissemination of potentially hazardous biologically active agents %28%bacteria, viruses, recombinant DNA, etc.%29%. Physical containment involves the use of special equipment, facilities, and procedures to prevent the escape of the agent. Biological containment includes use of immune personnel and the selection of agents and hosts that will minimize the risk should the agent escape the containment facility.%A%    
% 222.46/222.67  |- mesh__historyNote mesh__D003264 80   
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D003264 1996
% 222.46/222.67  |- mesh__dateCreated mesh__D003264 1979-03-09
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D003264 1999
% 222.46/222.67  |- mesh__recordMaintainer mesh__D003264 PLS
% 222.46/222.67  |- skos__hiddenLabel mesh__D003264 Containment, Biological
% 222.46/222.67  |- skos__hiddenLabel mesh__D003264 Containment, Biohazard
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D003264 1997
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D003264 2005
% 222.46/222.67  |- mesh__dateRevised mesh__D003264 1992-12-18
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D003264 2000
% 222.46/222.67  |- skos__broader mesh__D003264smesh__D008919
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D003264 2003
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D003264 2006
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D003264 1994
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D003264 2001
% 222.46/222.67  |- skos__hiddenLabel mesh__D003264 Biologic Containment
% 222.46/222.67  |- mesh__recordOriginator mesh__D003264 SMH
% 222.46/222.67  |- mesh__recordAuthorizer mesh__D003264 PLS
% 222.46/222.67  |- skos__hiddenLabel mesh__D003264 Containment, Physical
% 222.46/222.67  |- skos__prefLabel mesh__D003264 Containment of Biohazards
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D003264 2004
% 222.46/222.67  |- skos__altLabel mesh__D003264 Biohazards Containment
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D003264 1995
% 222.46/222.67  |- skos__altLabel mesh__D003264 Biohazard Containment
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D003264 2002
% 222.46/222.67  |- rdf__type mesh__D003264sskos__Concept
% 222.46/222.67  |- mesh__dateEstablished mesh__D003264 1980-01-01
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D003264 1998
% 222.46/222.67  |- skos__annotation mesh__D003264
% 222.46/222.67       for procedures, facilities, programs %26% equipment for containing hazardous biologic agents; do not use for radiation %28% = RADIATION PROTECTION%29%; for recombinant DNA research: use only by MeSH definition: not for ethical, moral or religious aspects%A%  
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D003264 1993
% 222.46/222.67  |- mesh__publicMeSHNote mesh__D003264 80   
% 222.46/222.67  |- skos__hiddenLabel mesh__D003264 Containment, Biohazards
% 222.46/222.67  |- skos__altLabel mesh__D003264 Biological Containment
% 222.46/222.67  |- skos__annotation mesh__D041383
% 222.46/222.67       do not confuse with the seroGROUP icterohaemorrhagiae, sometimes termed Leptospira icterohaemorrhagiae %28%index LEPTOSPIRA INTERROGANS%29%; infection: probably WEIL DISEASE or if not coord IM with LEPTOSPIROSIS %28%IM%29%%A%  
% 222.46/222.67  |- mesh__dateCreated mesh__D041383 2002-07-03
% 222.46/222.67  |- skos__historyNote mesh__D041383 Leptospira interrogans %28%1980-2002%29%
% 222.46/222.67  |- rdf__type mesh__D041383sskos__Concept
% 222.46/222.67  |- mesh__dateEstablished mesh__D041383 2003-01-01
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D041383 2006
% 222.46/222.67  |- mesh__recordAuthorizer mesh__D041383 sjn
% 222.46/222.67  |- skos__scopeNote mesh__D041383
% 222.46/222.67       A serovar of the bacterial species LEPTOSPIRA INTERROGANS, whose primary host is RATS.%A%    
% 222.46/222.67  |- mesh__historyNote mesh__D041383 2003   
% 222.46/222.67  |- skos__broader mesh__D041383smesh__D007921
% 222.46/222.67  |- mesh__dateRevised mesh__D041383 2005-06-30
% 222.46/222.67  |- mesh__recordOriginator mesh__D041383 ags
% 222.46/222.67  |- skos__prefLabel mesh__D041383
% 222.46/222.67       Leptospira interrogans serovar icterohaemorrhagiae
% 222.46/222.67  |- mesh__recordMaintainer mesh__D041383 SYSTEM
% 222.46/222.67  |- mesh__publicMeSHNote mesh__D041383 2003   
% 222.46/222.67  |- skos__annotation mesh__D013692
% 222.46/222.67       coordinate with specific cell /cytol; permitted with microorganisms%A%  
% 222.46/222.67  |- rdf__type mesh__D013692sskos__Concept
% 222.46/222.67  |- skos__broader mesh__D013692smesh__D008938
% 222.46/222.67  |- mesh__historyNote mesh__D013692
% 222.46/222.67       81%28%78%29%; was see under CELL CYCLE 1978-80   
% 222.46/222.67  |- mesh__dateRevised mesh__D013692 2005-06-30
% 222.46/222.67  |- skos__historyNote mesh__D013692 Mitosis %28%1968-1977%29%
% 222.46/222.67  |- mesh__recordAuthorizer mesh__D013692 sjn
% 222.46/222.67  |- mesh__recordOriginator mesh__D013692 AEP
% 222.46/222.67  |- skos__historyNote mesh__D013692 Cell Division %28%1966-1977%29%
% 222.46/222.67  |- skos__prefLabel mesh__D013692 Telophase
% 222.46/222.67  |- skos__scopeNote mesh__D013692
% 222.46/222.67       The final phase of cell nucleus division following ANAPHASE, in which two daughter nuclei are formed, the CYTOPLASM completes division, and the CHROMOSOMES lose their distinctness and are transformed into CHROMATIN threads.%A%    
% 222.46/222.67  |- skos__broader mesh__D013692smesh__D048750
% 222.46/222.67  |- mesh__dateCreated mesh__D013692 1977-05-10
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D013692 2006
% 222.46/222.67  |- skos__hiddenLabel mesh__D013692 Telophases
% 222.46/222.67  |- mesh__publicMeSHNote mesh__D013692
% 222.46/222.67       81; was see under CELL CYCLE 1978-80   
% 222.46/222.67  |- mesh__dateEstablished mesh__D013692 1981-01-01
% 222.46/222.67  |- mesh__recordMaintainer mesh__D013692 nns
% 222.46/222.67  |- skos__historyNote mesh__D013692 Meiosis %28%1968-1977%29%
% 222.46/222.67  |- skos__broader mesh__D006257Q000293smesh__D006257
% 222.46/222.67  |- mesh__preferredCombination mesh__D006257Q000293smesh__D006259
% 222.46/222.67  |- rdf__type mesh__D006257Q000293smesh__CompoundConcept
% 222.46/222.67  |- skos__hiddenLabel mesh__D007655 2 Keto 4 Hydroxyglutarate Dehydrogenase
% 222.46/222.67  |- skos__broader mesh__D007655smesh__D007658
% 222.46/222.67  |- mesh__dateCreated mesh__D007655 1999-01-01
% 222.46/222.67  |- skos__broader mesh__D007655smesh__D009097
% 222.46/222.67  |- skos__hiddenLabel mesh__D007655
% 222.46/222.67       alpha Ketoglutarate Dehydrogenase Complex
% 222.46/222.67  |- skos__hiddenLabel mesh__D007655
% 222.46/222.67       Dehydrogenase Complex, alpha-Ketoglutarate
% 222.46/222.67  |- skos__hiddenLabel mesh__D007655 2 Oxoglutarate Dehydrogenase Complex
% 222.46/222.67  |- mesh__recordAuthorizer mesh__D007655 sjn
% 222.46/222.67  |- mesh__dateEstablished mesh__D007655 1991-01-01
% 222.46/222.67  |- skos__prefLabel mesh__D007655 Ketoglutarate Dehydrogenase Complex
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D007655 2006
% 222.46/222.67  |- skos__altLabel mesh__D007655 2-Oxoglutarate Dehydrogenase Complex
% 222.46/222.67  |- skos__altLabel mesh__D007655 2-Keto-4-Hydroxyglutarate Dehydrogenase
% 222.46/222.67  |- mesh__publicMeSHNote mesh__D007655
% 222.46/222.67       91; was see under KETONE OXIDOREDUCTASES 1973-90   
% 222.46/222.67  |- skos__hiddenLabel mesh__D007655 Dehydrogenase, 2-Oxoglutarate
% 222.46/222.67  |- skos__hiddenLabel mesh__D007655 Dehydrogenase Complex, 2-Oxoglutarate
% 222.46/222.67  |- skos__hiddenLabel mesh__D007655 Complex, Ketoglutarate Dehydrogenase
% 222.46/222.67  |- skos__hiddenLabel mesh__D007655 2 Oxoglutarate Dehydrogenase
% 222.46/222.67  |- mesh__recordOriginator mesh__D007655 NLM
% 222.46/222.67  |- skos__altLabel mesh__D007655 2-Oxoglutarate Dehydrogenase
% 222.46/222.67  |- mesh__recordMaintainer mesh__D007655 jmp
% 222.46/222.67  |- skos__hiddenLabel mesh__D007655 Dehydrogenase, alpha-Ketoglutarate
% 222.46/222.67  |- skos__hiddenLabel mesh__D007655 alpha Ketoglutarate Dehydrogenase
% 222.46/222.67  |- skos__hiddenLabel mesh__D007655 Dehydrogenase, 2-Keto-4-Hydroxyglutarate
% 222.46/222.67  |- skos__hiddenLabel mesh__D007655 Complex, 2-Oxoglutarate Dehydrogenase
% 222.46/222.67  |- skos__hiddenLabel mesh__D007655 Dehydrogenase, Oxoglutarate
% 222.46/222.67  |- skos__hiddenLabel mesh__D007655 Dehydrogenase Complex, Ketoglutarate
% 222.46/222.67  |- mesh__historyNote mesh__D007655
% 222.46/222.67       91%28%73%29%; was see under KETONE OXIDOREDUCTASES 1973-90   
% 222.46/222.67  |- rdf__type mesh__D007655sskos__Concept
% 222.46/222.67  |- skos__hiddenLabel mesh__D007655
% 222.46/222.67       Complex, alpha-Ketoglutarate Dehydrogenase
% 222.46/222.67  |- skos__altLabel mesh__D007655 alpha-Ketoglutarate Dehydrogenase Complex
% 222.46/222.67  |- mesh__dateRevised mesh__D007655 2005-06-30
% 222.46/222.67  |- skos__altLabel mesh__D007655 alpha-Ketoglutarate Dehydrogenase
% 222.46/222.67  |- skos__altLabel mesh__D007655 Oxoglutarate Dehydrogenase
% 222.46/222.67  |- skos__broader mesh__D006597Q000172smesh__D006597
% 222.46/222.67  |- mesh__preferredCombination mesh__D006597Q000172smesh__D015319
% 222.46/222.67  |- rdf__type mesh__D006597Q000172smesh__CompoundConcept
% 222.46/222.67  |- skos__prefLabel mesh__D017285 Polymyositis
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D017285 2003
% 222.46/222.67  |- skos__hiddenLabel mesh__D017285 Polymyositides
% 222.46/222.67  |- skos__hiddenLabel mesh__D017285 Myositides, Multiple
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D017285 2000
% 222.46/222.67  |- mesh__recordAuthorizer mesh__D017285 ags
% 222.46/222.67  |- mesh__recordMaintainer mesh__D017285 ags
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D017285 2004
% 222.46/222.67  |- mesh__publicMeSHNote mesh__D017285 93   
% 222.46/222.67  |- mesh__recordOriginator mesh__D017285 JLS
% 222.46/222.67  |- skos__hiddenLabel mesh__D017285 Idiopathic Polymyositides
% 222.46/222.67  |- skos__scopeNote mesh__D017285
% 222.46/222.67       Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity %28%DRUG TOXICITY%29%; CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of  muscle fibers and an inflammatory cellular response. %28%Adams et al., Principles of Neurology, 6th ed, pp1404-9%29%%A%    
% 222.46/222.67  |- skos__historyNote mesh__D017285 Myositis %28%1966-1992%29%
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D017285 2001
% 222.46/222.67  |- skos__broader mesh__D017285smesh__D009220
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D017285 2005
% 222.46/222.67  |- skos__hiddenLabel mesh__D017285 Multiple Myositis
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D017285 2002
% 222.46/222.67  |- mesh__historyNote mesh__D017285 93   
% 222.46/222.67  |- mesh__dateEstablished mesh__D017285 1993-01-01
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D017285 2006
% 222.46/222.67  |- mesh__activeMeSHYear mesh__D017285 2006A
% 222.46/222.69  |- skos__hiddenLabel mesh__D017285 Polymyositides, Idiopathic
% 222.46/222.69  |- skos__hiddenLabel mesh__D017285 Ossificans, Polymyositis
% 222.46/222.69  |- rdf__type mesh__D017285sskos__Concept
% 222.46/222.69  |- skos__hiddenLabel mesh__D017285 Idiopathic Polymyositis
% 222.46/222.69  |- mesh__dateRevised mesh__D017285 2005-07-13
% 222.46/222.69  |- mesh__dateCreated mesh__D017285 1992-05-22
% 222.46/222.69  |- skos__altLabel mesh__D017285 Myositis, Multiple
% 222.46/222.69  |- skos__hiddenLabel mesh__D050110 Surgeries, Bariatric
% 222.46/222.69  |- skos__scopeNote mesh__D050110
% 222.46/222.69       Surgical procedures aimed at producing major WEIGHT REDUCTION in patients with MORBID OBESITY.%A%    
% 222.46/222.69  |- skos__related mesh__D050110smesh__D049088
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D050110 2006
% 222.46/222.69  |- mesh__dateCreated mesh__D050110 2005-06-30
% 222.46/222.69  |- mesh__historyNote mesh__D050110 2006   
% 222.46/222.69  |- skos__historyNote mesh__D050110 Obesity %28%1981-2005%29%
% 222.46/222.69  |- skos__altLabel mesh__D050110 Bariatric Surgeries
% 222.46/222.69  |- skos__hiddenLabel mesh__D050110 Surgery, Bariatric
% 222.46/222.69  |- skos__historyNote mesh__D050110 Gastroenterostomy %28%1984-2005%29%
% 222.46/222.69  |- mesh__publicMeSHNote mesh__D050110 2006   
% 222.46/222.69  |- mesh__dateEstablished mesh__D050110 2006-01-01
% 222.46/222.69  |- skos__prefLabel mesh__D050110 Bariatric Surgery
% 222.46/222.69  |- mesh__recordAuthorizer mesh__D050110 sjn
% 222.46/222.69  |- rdf__type mesh__D050110sskos__Concept
% 222.46/222.69  |- mesh__recordOriginator mesh__D050110 lkt
% 222.46/222.69  |- skos__broader mesh__D050110smesh__D013514
% 222.46/222.69  |- mesh__recordMaintainer mesh__D050110 lkt
% 222.46/222.69  |- skos__annotation mesh__D003265
% 222.46/222.69       refers to cortical electrical potentials   
% 222.46/222.69  |- mesh__historyNote mesh__D003265
% 222.46/222.69       91%28%71%29%; was see under ELECTROPHYSIOLOGY 1971-90   
% 222.46/222.69  |- skos__hiddenLabel mesh__D003265 Potentials, Readiness
% 222.46/222.69  |- skos__hiddenLabel mesh__D003265 Negative Variation, Contingent
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D003265 2005
% 222.46/222.69  |- mesh__recordAuthorizer mesh__D003265 SJN
% 222.46/222.69  |- skos__scopeNote mesh__D003265
% 222.46/222.69       An increasing negative shift of the cortical electrical potentials associated with an anticipated response to an expected stimulus. It is an electrical event indicative of a state of readiness or expectancy.%A%    
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D003265 2003
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D003265 2006
% 222.46/222.69  |- mesh__publicMeSHNote mesh__D003265
% 222.46/222.69       91; was see under ELECTROPHYSIOLOGY 1971-90   
% 222.46/222.69  |- skos__prefLabel mesh__D003265 Contingent Negative Variation
% 222.46/222.69  |- skos__hiddenLabel mesh__D003265 Bereitschaftspotentials
% 222.46/222.69  |- skos__hiddenLabel mesh__D003265 Potential, Readiness
% 222.46/222.69  |- skos__altLabel mesh__D003265 Readiness Potential
% 222.46/222.69  |- skos__hiddenLabel mesh__D003265 Contingent Negative Variations
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D003265 2004
% 222.46/222.69  |- mesh__dateCreated mesh__D003265 1999-01-01
% 222.46/222.69  |- rdf__type mesh__D003265sskos__Concept
% 222.46/222.69  |- skos__historyNote mesh__D003265 Electroencephalography %28%1966-1970%29%
% 222.46/222.69  |- skos__hiddenLabel mesh__D003265 Negative Variations, Contingent
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D003265 2000
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D003265 1998
% 222.46/222.69  |- mesh__dateEstablished mesh__D003265 1991-01-01
% 222.46/222.69  |- mesh__recordMaintainer mesh__D003265 TGC
% 222.46/222.69  |- skos__hiddenLabel mesh__D003265 Readiness Potentials
% 222.46/222.69  |- skos__broader mesh__D003265smesh__D005071
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D003265 2001
% 222.46/222.69  |- skos__hiddenLabel mesh__D003265 Variations, Contingent Negative
% 222.46/222.69  |- skos__historyNote mesh__D003265 Electrophysiology %28%1966-1970%29%
% 222.46/222.69  |- skos__hiddenLabel mesh__D003265 Variation, Contingent Negative
% 222.46/222.69  |- skos__altLabel mesh__D003265 Bereitschaftspotential
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D003265 1999
% 222.46/222.69  |- mesh__dateRevised mesh__D003265 1997-06-20
% 222.46/222.69  |- mesh__recordOriginator mesh__D003265 NLM
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D003265 2002
% 222.46/222.69  |- skos__broader mesh__D013752Q000031smesh__D013752
% 222.46/222.69  |- mesh__preferredCombination mesh__D013752Q000031smesh__D013754
% 222.46/222.69  |- rdf__type mesh__D013752Q000031smesh__CompoundConcept
% 222.46/222.69  |- skos__altLabel mesh__D013693 Katwijk Brand of Temazepam
% 222.46/222.69  |- skos__historyNote mesh__D013693
% 222.46/222.69       Benzodiazepine Tranquilizers %28%1975-1978%29%
% 222.46/222.69  |- skos__altLabel mesh__D013693 Pharmacia Brand of Temazepam
% 222.46/222.69  |- skos__historyNote mesh__D013693 Benzazepines %28%1968-1973%29%
% 222.46/222.69  |- skos__historyNote mesh__D013693 Benzodiazepinones %28%1974-1978%29%
% 222.46/222.69  |- skos__hiddenLabel mesh__D013693 Novo Temazepam
% 222.46/222.69  |- skos__scopeNote mesh__D013693
% 222.46/222.69       A benzodiazepine that acts as a GAMMA-AMINOBUTYRIC ACID modulator and anti-anxiety agent.%A%    
% 222.46/222.69  |- skos__altLabel mesh__D013693 Orion Brand of Temazepam
% 222.46/222.69  |- skos__altLabel mesh__D013693 Hydroxydiazepam
% 222.46/222.69  |- skos__altLabel mesh__D013693 Novartis Brand of Temazepam
% 222.46/222.69  |- skos__broader mesh__D013693smesh__D001570
% 222.46/222.69  |- skos__hiddenLabel mesh__D013693 PMS Temazepam
% 222.46/222.69  |- skos__hiddenLabel mesh__D013693 Ro 5 5345
% 222.46/222.69  |- skos__hiddenLabel mesh__D013693 Apo Temazepam
% 222.46/222.69  |- skos__altLabel mesh__D013693 Sigma Brand of Temazepam
% 222.46/222.69  |- skos__altLabel mesh__D013693 Knoll Brand of Temazepam
% 222.46/222.69  |- mesh__historyNote mesh__D013693
% 222.46/222.69       91%28%79%29%; was see under BENZODIAZEPINE TRANQUILIZERS 1979-90%A%  
% 222.46/222.69  |- skos__altLabel mesh__D013693 Norton Brand of Temazepam
% 222.46/222.69  |- skos__hiddenLabel mesh__D013693 ct Arzneimittel Brand of Temazepam
% 222.46/222.69  |- skos__hiddenLabel mesh__D013693 Nu Pharm Brand of Temazepam
% 222.46/222.69  |- skos__altLabel mesh__D013693 Nu-Pharm Brand of Temazepam
% 222.46/222.69  |- skos__altLabel mesh__D013693 Scheffler Brand of Temazepam
% 222.46/222.69  |- mesh__dateCreated mesh__D013693 1978-03-20
% 222.46/222.69  |- skos__altLabel mesh__D013693 Planum
% 222.46/222.69  |- skos__altLabel mesh__D013693 Oxydiazepam
% 222.46/222.69  |- skos__altLabel mesh__D013693 Desitin Brand of Temazepam
% 222.46/222.69  |- mesh__dateRevised mesh__D013693 2005-06-30
% 222.46/222.69  |- mesh__recordOriginator mesh__D013693 SH
% 222.46/222.69  |- skos__altLabel mesh__D013693 Novopharm Brand of Temazepam
% 222.46/222.69  |- skos__altLabel mesh__D013693 Pharmascience Brand of Temazepam
% 222.46/222.69  |- skos__altLabel mesh__D013693 Wyeth Brand of Temazepam
% 222.46/222.69  |- skos__hiddenLabel mesh__D013693 WY3917
% 222.46/222.69  |- skos__altLabel mesh__D013693 Apotex Brand of Temazepam
% 222.46/222.69  |- skos__altLabel mesh__D013693 ICN Brand of Temazepam
% 222.46/222.69  |- skos__altLabel mesh__D013693 Genopharm Brand of Temazepam
% 222.46/222.69  |- skos__altLabel mesh__D013693 AHP Brand of Temazepam
% 222.46/222.69  |- mesh__publicMeSHNote mesh__D013693
% 222.46/222.69       91; was see under BENZODIAZEPINE TRANQUILIZERS 1979-90   
% 222.46/222.69  |- rdf__type mesh__D013693sskos__Concept
% 222.46/222.69  |- skos__altLabel mesh__D013693 Alphapharm Brand of Temazepam
% 222.46/222.69  |- skos__hiddenLabel mesh__D013693 Ro55345
% 222.46/222.69  |- skos__altLabel mesh__D013693 Temtabs
% 222.46/222.69  |- skos__hiddenLabel mesh__D013693 Gen Temazepam
% 222.46/222.69  |- skos__hiddenLabel mesh__D013693 3 Hydroxydiazepam
% 222.46/222.69  |- skos__hiddenLabel mesh__D013693 SaH 47 603
% 222.46/222.69  |- mesh__recordAuthorizer mesh__D013693 sjn
% 222.46/222.69  |- skos__hiddenLabel mesh__D013693 Nu Temazepam
% 222.46/222.69  |- skos__altLabel mesh__D013693 Genpharm Brand of Temazepam
% 222.46/222.69  |- mesh__dateEstablished mesh__D013693 1991-01-01
% 222.46/222.69  |- mesh__recordMaintainer mesh__D013693 CCR
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D013693 2006
% 222.46/222.69  |- skos__altLabel mesh__D013693 3-Hydroxydiazepam
% 222.46/222.69  |- skos__altLabel mesh__D013693 ct-Arzneimittel Brand of Temazepam
% 222.46/222.69  |- skos__altLabel mesh__D013693 Methyloxazepam
% 222.46/222.69  |- skos__hiddenLabel mesh__D013693 SaH 47603
% 222.46/222.69  |- skos__altLabel mesh__D013693 Nocturne
% 222.46/222.69  |- skos__hiddenLabel mesh__D013693 WY 3917
% 222.46/222.69  |- skos__hiddenLabel mesh__D013693 Tema, Norkotral
% 222.46/222.69  |- skos__altLabel mesh__D013693 Mallinckrodt Brand of Temazepam
% 222.46/222.69  |- skos__prefLabel mesh__D013693 Temazepam
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D007656 2000
% 222.46/222.69  |- skos__hiddenLabel mesh__D007656 Acid, Ketoglutaric
% 222.46/222.69  |- skos__broader mesh__D007656smesh__D007651
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D007656 2006
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D007656 2003
% 222.46/222.69  |- mesh__historyNote mesh__D007656 75; was KETOGLUTARIC ACID 1963-74   
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D007656 2001
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D007656 2004
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D007656 2002
% 222.46/222.69  |- mesh__dateRevised mesh__D007656 1995-05-18
% 222.46/222.69  |- skos__broader mesh__D007656smesh__D005977
% 222.46/222.69  |- skos__altLabel mesh__D007656 Oxoglutarates
% 222.46/222.69  |- mesh__publicMeSHNote mesh__D007656 75; was KETOGLUTARIC ACID 1963-74   
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D007656 1998
% 222.46/222.69  |- mesh__dateCreated mesh__D007656 1999-01-01
% 222.46/222.69  |- rdf__type mesh__D007656sskos__Concept
% 222.46/222.69  |- skos__hiddenLabel mesh__D007656 Acids, Ketoglutaric
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D007656 1999
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D007656 1996
% 222.46/222.69  |- mesh__recordOriginator mesh__D007656 NLM
% 222.46/222.69  |- skos__prefLabel mesh__D007656 Ketoglutaric Acids
% 222.46/222.69  |- skos__scopeNote mesh__D007656
% 222.46/222.69       A family of compounds containing an oxo group with the general structure of 1,5-pentanedioic acid. %28%From Lehninger, Principles of Biochemistry, 1982, p442%29%%A%    
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D007656 2005
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D007656 1997
% 222.46/222.69  |- mesh__recordAuthorizer mesh__D007656 PLS
% 222.46/222.69  |- mesh__recordMaintainer mesh__D007656 KEV
% 222.46/222.69  |- mesh__onlineNote mesh__D007656
% 222.46/222.69       use KETOGLUTARIC ACIDS to search KETOGLUTARIC ACID 1966-74%A%  
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D017286 2004
% 222.46/222.69  |- skos__altLabel mesh__D017286 Monitoring, Sleep
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D017286 1998
% 222.46/222.69  |- mesh__recordOriginator mesh__D017286 JLS
% 222.46/222.69  |- skos__historyNote mesh__D017286 Sleep %28%1972-1992%29%
% 222.46/222.69  |- skos__hiddenLabel mesh__D017286 Sleep Monitoring
% 222.46/222.69  |- mesh__dateCreated mesh__D017286 1992-05-22
% 222.46/222.69  |- mesh__dateRevised mesh__D017286 1997-06-20
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D017286 1999
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D017286 2005
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D017286 2000
% 222.46/222.69  |- mesh__historyNote mesh__D017286 93   
% 222.46/222.69  |- skos__historyNote mesh__D017286
% 222.46/222.69       Monitoring, Physiologic %28%1978-1992%29%
% 222.46/222.69  |- mesh__publicMeSHNote mesh__D017286 93   
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D017286 2006
% 222.46/222.69  |- skos__scopeNote mesh__D017286
% 222.46/222.69       Simultaneous and continuous monitoring of relevant normal and abnormal physiological activity during sleep. %28%Stedman, 25th ed%29%%A%    
% 222.46/222.69  |- skos__annotation mesh__D017286
% 222.46/222.69       recording physiol activity during sleep; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: POLYSOMNOGR%A%  
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D017286 2001
% 222.46/222.69  |- skos__broader mesh__D017286smesh__D008991
% 222.46/222.69  |- rdf__type mesh__D017286sskos__Concept
% 222.46/222.69  |- skos__prefLabel mesh__D017286 Polysomnography
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D017286 2002
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D017286 2003
% 222.46/222.69  |- mesh__dateEstablished mesh__D017286 1993-01-01
% 222.46/222.69  |- mesh__recordMaintainer mesh__D017286 PXP
% 222.46/222.69  |- skos__altLabel mesh__D017286 Somnography
% 222.46/222.69  |- skos__hiddenLabel mesh__D017286 Polysomnographies
% 222.46/222.69  |- mesh__recordAuthorizer mesh__D017286 SJN
% 222.46/222.69  |- skos__hiddenLabel mesh__D017286 Somnographies
% 222.46/222.69  |- mesh__recordAuthorizer mesh__D050111 sjn
% 222.46/222.69  |- mesh__dateEstablished mesh__D050111 2006-01-01
% 222.46/222.69  |- skos__broader mesh__D050111smesh__D007097
% 222.46/222.69  |- skos__scopeNote mesh__D050111
% 222.46/222.69       Sugars in which the OXYGEN is replaced by a NITROGEN atom. This substitution prevents normal METABOLISM resulting in inhibition of GLYCOSIDASES and GLYCOSYLTRANSFERASES.%A%    
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D050111 2006
% 222.46/222.69  |- mesh__recordOriginator mesh__D050111 ssb
% 222.46/222.69  |- skos__prefLabel mesh__D050111 Imino Sugars
% 222.46/222.69  |- mesh__publicMeSHNote mesh__D050111 2006   
% 222.46/222.69  |- skos__broader mesh__D050111smesh__D002241
% 222.46/222.69  |- skos__hiddenLabel mesh__D050111 Sugars, Imino
% 222.46/222.69  |- mesh__recordMaintainer mesh__D050111 ssb
% 222.46/222.69  |- rdf__type mesh__D050111sskos__Concept
% 222.46/222.69  |- mesh__dateCreated mesh__D050111 2005-06-30
% 222.46/222.69  |- mesh__historyNote mesh__D050111 2006   
% 222.46/222.69  |- mesh__publicMeSHNote mesh__D003266
% 222.46/222.69       91; was see under PRIMARY HEALTH CARE 1979-90; was see under COMPREHENSIVE HEALTH CARE 1968-78%A%  
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D003266 2000
% 222.46/222.69  |- skos__broader mesh__D003266smesh__D011320
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D003266 2004
% 222.46/222.69  |- mesh__dateRevised mesh__D003266 1999-11-03
% 222.46/222.69  |- skos__prefLabel mesh__D003266 Continuity of Patient Care
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D003266 2001
% 222.46/222.69  |- mesh__dateCreated mesh__D003266 1999-01-01
% 222.46/222.69  |- rdf__type mesh__D003266sskos__Concept
% 222.46/222.69  |- mesh__recordAuthorizer mesh__D003266 sjn
% 222.46/222.69  |- skos__scopeNote mesh__D003266
% 222.46/222.69       Health care provided on a continuing basis from the initial contact, following the patient through all phases of medical care.%A%    
% 222.46/222.69  |- skos__hiddenLabel mesh__D003266 Care Continuum
% 222.46/222.69  |- mesh__recordOriginator mesh__D003266 NLM
% 222.46/222.69  |- mesh__onlineNote mesh__D003266
% 222.46/222.69       search COMPREHENSIVE HEALTH CARE 1968-74   
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D003266 2002
% 222.46/222.69  |- skos__hiddenLabel mesh__D003266 Patient Care Continuity
% 222.46/222.69  |- mesh__dateEstablished mesh__D003266 1991-01-01
% 222.46/222.69  |- skos__altLabel mesh__D003266 Continuum of Care
% 222.46/222.69  |- mesh__historyNote mesh__D003266
% 222.46/222.69       91%28%75%29%; was see under PRIMARY HEALTH CARE 1979-90; was see under COMPREHENSIVE HEALTH CARE 1968-78%A%  
% 222.46/222.69  |- skos__altLabel mesh__D003266 Continuity of Care
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D003266 2005
% 222.46/222.69  |- skos__hiddenLabel mesh__D003266 Care Continuity, Patient
% 222.46/222.69  |- skos__hiddenLabel mesh__D003266 Care Continuity
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D003266 2003
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D003266 2006
% 222.46/222.69  |- mesh__recordMaintainer mesh__D003266 jls
% 222.46/222.69  |- skos__scopeNote mesh__D049368
% 222.46/222.69       A subfamily of lysophospholipid receptors with specificity for LYSOPHOSPHATIDIC ACIDS.%A%    
% 222.46/222.69  |- mesh__recordAuthorizer mesh__D049368 sjn
% 222.46/222.69  |- skos__hiddenLabel mesh__D049368 vzg 1 Receptor
% 222.46/222.69  |- skos__altLabel mesh__D049368 Edg2 Protein
% 222.46/222.69  |- skos__hiddenLabel mesh__D049368 Acid Receptors, Lysophosphatidic
% 222.46/222.69  |- skos__hiddenLabel mesh__D049368 Receptor, LPA1
% 222.46/222.69  |- mesh__historyNote mesh__D049368 2005%28%1992%29%   
% 222.46/222.69  |- mesh__activeMeSHYear mesh__D049368 2005
% 222.46/222.69  |- skos__hiddenLabel mesh__D049368 Edg 7 Receptor
% 222.46/222.69  |- mesh__recordMaintainer mesh__D049368 jmp
% 222.46/222.69  |- skos__hiddenLabel mesh__D049368 Edg 4 Receptor
% 222.46/222.69  |- skos__historyNote mesh__D049368
% 222.46/222.69       Receptors, Cell Surface %28%1992-2003%29%
% 222.46/222.69  |- mesh__recordOriginator mesh__D049368 jmp
% 222.46/222.69  |- skos__hiddenLabel mesh__D049368 edg 2 Receptor
% 222.46/222.69  |- skos__hiddenLabel mesh__D049368 Receptor, LPA2
% 222.46/222.69  |- skos__hiddenLabel mesh__D049368 LPA 1 Receptor
% 222.46/222.69  |- skos__hiddenLabel mesh__D049368 Receptor, Edg-7
% 222.46/222.69  |- skos__hiddenLabel mesh__D049368 Receptor, vzg-1
% 222.46/222.69  |- skos__hiddenLabel mesh__D049368 Receptor, LPA3
% 222.46/222.69  |- skos__hiddenLabel mesh__D049368 Receptor, edg-2
% 222.46/222.69  |- skos__altLabel mesh__D049368 EDG7 Protein
% 222.46/222.69  |- skos__prefLabel mesh__D049368 Receptors, Lysophosphatidic Acid
% 222.46/222.69  |- skos__altLabel mesh__D049368 Lysophosphatidic Acid Receptors
% 222.46/222.69  |- skos__altLabel mesh__D049368 LPA Receptors
% 222.46/222.69  |- skos__hiddenLabel mesh__D049368 Acid Receptor, Lysophosphatidic
% 222.46/222.69  |- mesh__dateCreated mesh__D049368 2004-07-07
% 222.46/222.69  |- skos__broader mesh__D049368smesh__D049312
% 222.46/222.69  |- skos__altLabel mesh__D049368 Receptor, Lysophosphatidic Acid
% 222.46/222.69  |- mesh__dateEstablished mesh__D049368 2005-01-01
% 222.46/222.69  |- mesh__publicMeSHNote mesh__D049368
% 222.46/222.69       2005; RECEPTORS, LYSOPHOSPHATIDIC ACID  was indexed under RECEPTORS, CELL SURFACE 1992-2003 %26% under RECEPTORS, G-PROTEIN-COUPLED 2004%A%  
% 222.46/222.70  |- rdf__type mesh__D049368sskos__Concept
% 222.46/222.70  |- skos__historyNote mesh__D049368
% 222.46/222.70       Receptors, G-Protein-Coupled %28%2004%29%
% 222.46/222.70  |- skos__altLabel mesh__D049368 edg-2 Receptor
% 222.46/222.70  |- skos__hiddenLabel mesh__D049368 Receptors, LPA
% 222.46/222.70  |- skos__altLabel mesh__D049368 Edg-7 Receptor
% 222.46/222.70  |- skos__altLabel mesh__D049368 Lysophosphatidic Acid Receptor
% 222.46/222.70  |- skos__altLabel mesh__D049368 LPA-1 Receptor
% 222.46/222.70  |- skos__altLabel mesh__D049368 Edg4 Protein
% 222.46/222.70  |- skos__hiddenLabel mesh__D049368 Receptor, Edg-4
% 222.46/222.70  |- skos__altLabel mesh__D049368 Edg-4 Receptor
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D049368 2006
% 222.46/222.70  |- skos__altLabel mesh__D049368 vzg-1 Receptor
% 222.46/222.70  |- mesh__dateEstablished mesh__D013694 1991-01-01
% 222.46/222.70  |- mesh__recordOriginator mesh__D013694 NLM
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D013694 2004
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D013694 2006
% 222.46/222.70  |- mesh__historyNote mesh__D013694
% 222.46/222.70       91%28%75%29%; was see under PERSONALITY 1975-90   
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D013694 2000
% 222.46/222.70  |- skos__hiddenLabel mesh__D013694 Temperaments
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D013694 2001
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D013694 1996
% 222.46/222.70  |- mesh__recordMaintainer mesh__D013694 TAP
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D013694 1998
% 222.46/222.70  |- mesh__publicMeSHNote mesh__D013694
% 222.46/222.70       91; was see under PERSONALITY 1975-90   
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D013694 1997
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D013694 1994
% 222.46/222.70  |- rdf__type mesh__D013694sskos__Concept
% 222.46/222.70  |- skos__prefLabel mesh__D013694 Temperament
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D013694 1999
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D013694 1993
% 222.46/222.70  |- mesh__dateCreated mesh__D013694 1999-01-01
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D013694 2002
% 222.46/222.70  |- mesh__onlineNote mesh__D013694 search PERSONALITY 1968-74   
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D013694 1995
% 222.46/222.70  |- mesh__recordAuthorizer mesh__D013694 PLS
% 222.46/222.70  |- skos__scopeNote mesh__D013694
% 222.46/222.70       Predisposition to react to one%27%s environment in a certain way; usually refers to mood changes.%A%    
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D013694 2003
% 222.46/222.70  |- skos__broader mesh__D013694smesh__D010551
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D013694 2005
% 222.46/222.70  |- mesh__dateRevised mesh__D013694 1992-05-18
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D046070 2006
% 222.46/222.70  |- mesh__historyNote mesh__D046070
% 222.46/222.70       2005; use SEALS, EARLESS 1980-2004, use PINNIPEDIA 1968-1979%A%  
% 222.46/222.70  |- mesh__recordMaintainer mesh__D046070 ags
% 222.46/222.70  |- rdf__type mesh__D046070sskos__Concept
% 222.46/222.70  |- skos__scopeNote mesh__D046070
% 222.46/222.70       A group comprised of several species of aquatic carnivores in different genera, in the family Otariidae. In comparison to FUR SEALS, they have shorter, less dense hair.%A%    
% 222.46/222.70  |- skos__altLabel mesh__D046070 Zalophus califorianus
% 222.46/222.70  |- skos__hiddenLabel mesh__D046070 Sea Lion
% 222.46/222.70  |- skos__broader mesh__D046070smesh__D010872
% 222.46/222.70  |- mesh__dateEstablished mesh__D046070 2005-01-01
% 222.46/222.70  |- skos__hiddenLabel mesh__D046070 Sealion
% 222.46/222.70  |- mesh__recordOriginator mesh__D046070 ags
% 222.46/222.70  |- mesh__dateCreated mesh__D046070 2004-07-07
% 222.46/222.70  |- skos__hiddenLabel mesh__D046070 Lion, Sea
% 222.46/222.70  |- skos__hiddenLabel mesh__D046070 Lions, Sea
% 222.46/222.70  |- skos__altLabel mesh__D046070 Sea Lion, California
% 222.46/222.70  |- mesh__dateRevised mesh__D046070 2005-06-30
% 222.46/222.70  |- mesh__publicMeSHNote mesh__D046070
% 222.46/222.70       2005; see SEALS 1978-2004, see PINNIPEDIA 1968-1979   
% 222.46/222.70  |- skos__prefLabel mesh__D046070 Sea Lions
% 222.46/222.70  |- skos__altLabel mesh__D046070 Sealions
% 222.46/222.70  |- mesh__recordAuthorizer mesh__D046070 sjn
% 222.46/222.70  |- mesh__dateRevised mesh__D007657 1995-03-17
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D007657 2004
% 222.46/222.70  |- skos__scopeNote mesh__D007657
% 222.46/222.70       The substances beta-hydroxybutyric acid, acetoacetic acid, and acetone, which are produced by fatty acid and carbohydrate metabolism in the liver in approximately a 78:20:2 ratio. Acetoacetate is produced from acetyl-CoA. Most is enzymatically converted to beta-ketobutyrate, but a small amount is spontaneously decarboxylated to acetone. The ketone bodies can be used as fuels by muscle and brain tissue. In starvation and uncontrolled diabetes mellitus, large quantities are produced, causing metabolic acidosis and elevated blood and urine levels of all three ketone bodies. %28%Dorland, 28th ed%29%%A%    
% 222.46/222.70  |- mesh__recordAuthorizer mesh__D007657 PLS
% 222.46/222.70  |- skos__hiddenLabel mesh__D007657 Bodies, Ketone
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D007657 2000
% 222.46/222.70  |- skos__prefLabel mesh__D007657 Ketone Bodies
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D007657 1998
% 222.46/222.70  |- mesh__dateCreated mesh__D007657 1999-01-01
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D007657 2001
% 222.46/222.70  |- rdf__type mesh__D007657sskos__Concept
% 222.46/222.70  |- skos__annotation mesh__D007657
% 222.46/222.70       acetonemia, acetonuria, ketonemia %26% ketonuria go here; ketogenesis is probably KETONE BODIES /biosyn%A%  
% 222.46/222.70  |- mesh__recordMaintainer mesh__D007657 TGC
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D007657 1999
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D007657 1996
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D007657 2002
% 222.46/222.70  |- skos__broader mesh__D007657smesh__D007659
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D007657 1997
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D007657 2005
% 222.46/222.70  |- skos__hiddenLabel mesh__D007657 Bodies, Acetone
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D007657 2006
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D007657 2003
% 222.46/222.70  |- mesh__recordOriginator mesh__D007657 NLM
% 222.46/222.70  |- mesh__historyNote mesh__D017287 93   
% 222.46/222.70  |- mesh__dateEstablished mesh__D017287 1993-01-01
% 222.46/222.70  |- skos__hiddenLabel mesh__D017287 Ventriculo-peritoneal Shunts
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017287 2003
% 222.46/222.70  |- mesh__dateRevised mesh__D017287 1997-06-20
% 222.46/222.70  |- skos__prefLabel mesh__D017287 Ventriculoperitoneal Shunt
% 222.46/222.70  |- skos__hiddenLabel mesh__D017287 Ventriculo peritoneal Shunt
% 222.46/222.70  |- mesh__recordMaintainer mesh__D017287 PXP
% 222.46/222.70  |- skos__broader mesh__D017287smesh__D002557
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017287 1999
% 222.46/222.70  |- skos__annotation mesh__D017287
% 222.46/222.70       ventriculo- refers to cerebral ventricles; a type of csf shunt%A%  
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017287 2002
% 222.46/222.70  |- skos__scopeNote mesh__D017287
% 222.46/222.70       Surgical creation of a communication between a cerebral ventricle and the peritoneum by means of a plastic tube to permit drainage of cerebrospinal fluid for relief of hydrocephalus. %28%From Dorland, 28th ed%29%%A%    
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017287 1998
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017287 2006
% 222.46/222.70  |- skos__altLabel mesh__D017287 Ventriculo-peritoneal Shunt
% 222.46/222.70  |- skos__hiddenLabel mesh__D017287 Shunt, Ventriculoperitoneal
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017287 2001
% 222.46/222.70  |- skos__hiddenLabel mesh__D017287 Shunts, Ventriculoperitoneal
% 222.46/222.70  |- mesh__publicMeSHNote mesh__D017287 93   
% 222.46/222.70  |- mesh__recordOriginator mesh__D017287 JLS
% 222.46/222.70  |- mesh__dateCreated mesh__D017287 1992-05-22
% 222.46/222.70  |- skos__hiddenLabel mesh__D017287 Shunt, Ventriculo-peritoneal
% 222.46/222.70  |- skos__hiddenLabel mesh__D017287 Shunts, Ventriculo-peritoneal
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017287 2000
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017287 2005
% 222.46/222.70  |- skos__hiddenLabel mesh__D017287 Ventriculoperitoneal Shunts
% 222.46/222.70  |- rdf__type mesh__D017287sskos__Concept
% 222.46/222.70  |- skos__historyNote mesh__D017287
% 222.46/222.70       Cerebrospinal Fluid Shunts %28%1969-1992%29%
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017287 2004
% 222.46/222.70  |- mesh__recordAuthorizer mesh__D017287 SJN
% 222.46/222.70  |- skos__hiddenLabel mesh__D050112 1 N Imino Sugars
% 222.46/222.70  |- mesh__dateCreated mesh__D050112 2005-06-30
% 222.46/222.70  |- mesh__historyNote mesh__D050112 2006   
% 222.46/222.70  |- skos__prefLabel mesh__D050112 Imino Pyranoses
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D050112 2006
% 222.46/222.70  |- mesh__recordOriginator mesh__D050112 ssb
% 222.46/222.70  |- skos__altLabel mesh__D050112 1-N-Imino Sugars
% 222.46/222.70  |- skos__broader mesh__D050112smesh__D010880
% 222.46/222.70  |- mesh__recordAuthorizer mesh__D050112 sjn
% 222.46/222.70  |- skos__hiddenLabel mesh__D050112 1,5 Imino Sugars
% 222.46/222.70  |- mesh__publicMeSHNote mesh__D050112 2006   
% 222.46/222.70  |- mesh__dateEstablished mesh__D050112 2006-01-01
% 222.46/222.70  |- skos__scopeNote mesh__D050112
% 222.46/222.70       Six-carbon pyranose sugars in which the OXYGEN is replaced by a NITROGEN atom.%A%    
% 222.46/222.70  |- skos__altLabel mesh__D050112 5-Imino-Pyranoses
% 222.46/222.70  |- skos__hiddenLabel mesh__D050112 5 Imino Pyranoses
% 222.46/222.70  |- skos__hiddenLabel mesh__D050112 Pyranoses, Imino
% 222.46/222.70  |- skos__broader mesh__D050112smesh__D050111
% 222.46/222.70  |- skos__hiddenLabel mesh__D050112 Sugars, 1-N-Imino
% 222.46/222.70  |- skos__hiddenLabel mesh__D050112 Sugars, 1,5-Imino
% 222.46/222.70  |- rdf__type mesh__D050112sskos__Concept
% 222.46/222.70  |- skos__altLabel mesh__D050112 1,5-Imino Sugars
% 222.46/222.70  |- mesh__recordMaintainer mesh__D050112 ssb
% 222.46/222.70  |- mesh__publicMeSHNote mesh__D036441 2003   
% 222.46/222.70  |- mesh__dateEstablished mesh__D036441 2003-01-01
% 222.46/222.70  |- mesh__historyNote mesh__D036441 2003   
% 222.46/222.70  |- mesh__dateCreated mesh__D036441 2002-07-02
% 222.46/222.70  |- skos__hiddenLabel mesh__D036441 Smelt
% 222.46/222.70  |- skos__altLabel mesh__D036441 Galaxiids
% 222.46/222.70  |- mesh__dateRevised mesh__D036441 2003-07-09
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D036441 2005
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D036441 2004
% 222.46/222.70  |- skos__altLabel mesh__D036441 Ayu
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D036441 2006
% 222.46/222.70  |- skos__altLabel mesh__D036441 Smelts
% 222.46/222.70  |- skos__hiddenLabel mesh__D036441 Galaxiid
% 222.46/222.70  |- skos__scopeNote mesh__D036441
% 222.46/222.70       An order of fish including smelts, galaxiids, and salamanderfish.%A%    
% 222.46/222.70  |- skos__prefLabel mesh__D036441 Osmeriformes
% 222.46/222.70  |- rdf__type mesh__D036441sskos__Concept
% 222.46/222.70  |- skos__historyNote mesh__D036441 Fishes %28%2001-2002%29%
% 222.46/222.70  |- skos__broader mesh__D036441smesh__D005399
% 222.46/222.70  |- skos__broader mesh__D003267smesh__D012099
% 222.46/222.70  |- skos__altLabel mesh__D003267 Birth Control
% 222.46/222.70  |- skos__hiddenLabel mesh__D003267 Fertilization Inhibition
% 222.46/222.70  |- mesh__recordMaintainer mesh__D003267 ags
% 222.46/222.70  |- mesh__publicMeSHNote mesh__D003267
% 222.46/222.70       1963; for BIRTH CONTROL see FAMILY PLANNING 1968-1974, see BIRTH CONTROL 1963-1967%A%  
% 222.46/222.70  |- mesh__historyNote mesh__D003267
% 222.46/222.70       1963; for BIRTH CONTROL use FAMILY PLANNING 1968-1974, use BIRTH CONTROL 1963-1967%A%  
% 222.46/222.70  |- skos__related mesh__D003267smesh__D005193
% 222.46/222.70  |- skos__hiddenLabel mesh__D003267 Female Contraceptions
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D003267 2006A
% 222.46/222.70  |- skos__prefLabel mesh__D003267 Contraception
% 222.46/222.70  |- skos__hiddenLabel mesh__D003267 Contraception, Female
% 222.46/222.70  |- skos__altLabel mesh__D003267 Inhibition of Fertilization
% 222.46/222.70  |- mesh__recordAuthorizer mesh__D003267 ags
% 222.46/222.70  |- skos__scopeNote mesh__D003267
% 222.46/222.70       Prevention of CONCEPTION by blocking fertility temporarily, or permanently %28%STERILIZATION, REPRODUCTIVE%29%. Common means of reversible contraception include NATURAL FAMILY PLANNING METHODS; CONTRACEPTIVE AGENTS; or CONTRACEPTIVE DEVICES.%A%    
% 222.46/222.70  |- skos__hiddenLabel mesh__D003267 Contraceptive Method
% 222.46/222.70  |- skos__related mesh__D003267smesh__D011155
% 222.46/222.70  |- mesh__recordOriginator mesh__D003267 NLM
% 222.46/222.70  |- mesh__dateRevised mesh__D003267 2005-07-21
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D003267 2006
% 222.46/222.70  |- skos__hiddenLabel mesh__D003267 Contraceptions, Male
% 222.46/222.70  |- skos__hiddenLabel mesh__D003267 Contraception, Male
% 222.46/222.70  |- skos__hiddenLabel mesh__D003267 Contraceptions, Female
% 222.46/222.70  |- skos__altLabel mesh__D003267 Fertility Control
% 222.46/222.70  |- skos__altLabel mesh__D003267 Contraceptive Methods
% 222.46/222.70  |- mesh__dateCreated mesh__D003267 1999-01-01
% 222.46/222.70  |- skos__hiddenLabel mesh__D003267 Male Contraceptions
% 222.46/222.70  |- rdf__type mesh__D003267sskos__Concept
% 222.46/222.70  |- skos__altLabel mesh__D008750 Merck Sharp %26% Dohme Brand of Methyldopa
% 222.46/222.70  |- skos__hiddenLabel mesh__D008750 Methyldopa Alphapharm Brand
% 222.46/222.70  |- skos__hiddenLabel mesh__D008750 Nu Pharm Brand of Methyldopa
% 222.46/222.70  |- skos__broader mesh__D008750smesh__D004295
% 222.46/222.70  |- mesh__recordAuthorizer mesh__D008750 sjn
% 222.46/222.70  |- skos__hiddenLabel mesh__D008750 alpha Methyldopa
% 222.46/222.70  |- skos__hiddenLabel mesh__D008750 Methyldopa Biopat Brand
% 222.46/222.70  |- mesh__dateCreated mesh__D008750 1999-01-01
% 222.46/222.70  |- skos__hiddenLabel mesh__D008750 Nu Medopa
% 222.46/222.70  |- skos__altLabel mesh__D008750
% 222.46/222.70       Rh%C3%%B4%ne-Poulenc Rorer Brand of Methyldopa
% 222.46/222.70  |- skos__prefLabel mesh__D008750 Methyldopa
% 222.46/222.70  |- skos__altLabel mesh__D008750 Cahill May Roberts Brand of Methyldopa
% 222.46/222.70  |- skos__altLabel mesh__D008750 alpha-Methyldopa
% 222.46/222.70  |- skos__hiddenLabel mesh__D008750 Methyldopa Clonmel Brand
% 222.46/222.70  |- skos__hiddenLabel mesh__D008750 Methyldopa Merck Brand
% 222.46/222.70  |- skos__altLabel mesh__D008750 Dopegit
% 222.46/222.70  |- rdf__type mesh__D008750sskos__Concept
% 222.46/222.70  |- skos__hiddenLabel mesh__D008750
% 222.46/222.70       Rh%C3%%B4%ne Poulenc Rorer Brand of Methyldopa
% 222.46/222.70  |- skos__scopeNote mesh__D008750
% 222.46/222.70       An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent.%A%    
% 222.46/222.70  |- skos__hiddenLabel mesh__D008750 Methyldopa Apotex Brand
% 222.46/222.70  |- skos__hiddenLabel mesh__D008750 Methyldopa Nu-Pharm Brand
% 222.46/222.70  |- mesh__recordOriginator mesh__D008750 NLM
% 222.46/222.70  |- skos__hiddenLabel mesh__D008750 Apo Methyldopa
% 222.46/222.70  |- skos__altLabel mesh__D008750 Biopat Brand of Methyldopa
% 222.46/222.70  |- skos__altLabel mesh__D008750 Orion Brand of Methyldopa
% 222.46/222.70  |- skos__hiddenLabel mesh__D008750 Methyldopa Orion Brand
% 222.46/222.70  |- skos__altLabel mesh__D008750 Alphapharm Brand of Methyldopa
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D008750 2006
% 222.46/222.70  |- skos__altLabel mesh__D008750 Nu-Pharm Brand of Methyldopa
% 222.46/222.70  |- skos__altLabel mesh__D008750 Apotex Brand of Methyldopa
% 222.46/222.70  |- skos__altLabel mesh__D008750 Dopergit
% 222.46/222.70  |- skos__altLabel mesh__D008750 Alphamethyldopa
% 222.46/222.70  |- mesh__dateRevised mesh__D008750 2005-06-30
% 222.46/222.70  |- skos__altLabel mesh__D008750 alpha-Methyl-L-Dopa
% 222.46/222.70  |- mesh__recordMaintainer mesh__D008750 ssb
% 222.46/222.70  |- mesh__publicMeSHNote mesh__D008750
% 222.46/222.70       65; ALPHAMETHYLDOPA was see METHYLDOPA 1977-94   
% 222.46/222.70  |- mesh__dateEstablished mesh__D008750 1965-01-01
% 222.46/222.70  |- mesh__onlineNote mesh__D008750
% 222.46/222.70       use METHYLDOPA to search ALPHAMETHYLDOPA 1977-94   
% 222.46/222.70  |- skos__altLabel mesh__D008750 Clonmel Brand of Methyldopa
% 222.46/222.70  |- mesh__historyNote mesh__D008750
% 222.46/222.70       65%28%63%29%; ALPHAMETHYLDOPA was see METHYLDOPA 1977-94   
% 222.46/222.70  |- skos__altLabel mesh__D008750 Merck Brand of Methyldopa
% 222.46/222.70  |- skos__hiddenLabel mesh__D008750 alpha Methyl L Dopa
% 222.46/222.70  |- skos__scopeNote mesh__D022421
% 222.46/222.70       Vaccines or candidate vaccines used to prevent PSEUDORABIES %28%Aujeszky%27%s disease%29%, a herpesvirus of swine and other animals.%A%    
% 222.46/222.70  |- skos__prefLabel mesh__D022421 Pseudorabies Vaccines
% 222.46/222.70  |- skos__hiddenLabel mesh__D022421 Vaccines, Pseudorabies
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D022421 2006
% 222.46/222.70  |- mesh__dateRevised mesh__D022421 2005-06-30
% 222.46/222.70  |- mesh__recordAuthorizer mesh__D022421 sjn
% 222.46/222.70  |- skos__broader mesh__D022421smesh__D014765
% 222.46/222.70  |- mesh__recordOriginator mesh__D022421 ags
% 222.46/222.70  |- skos__historyNote mesh__D022421 Vaccines, Attenuated %28%1978-1993%29%
% 222.46/222.70  |- skos__altLabel mesh__D022421 Pseudorabies Vaccine
% 222.46/222.70  |- skos__hiddenLabel mesh__D022421 Vaccine, Pseudorabies
% 222.46/222.70  |- mesh__dateEstablished mesh__D022421 2001-01-01
% 222.46/222.70  |- mesh__historyNote mesh__D022421
% 222.46/222.70       2001; use PSEUDORABIES VACCINES %28%NM%29% to search PSEUDORABIES VACCINE 1992-2000%A%  
% 222.46/222.70  |- rdf__type mesh__D022421sskos__Concept
% 222.46/222.70  |- mesh__recordMaintainer mesh__D022421 ssb
% 222.46/222.70  |- mesh__dateCreated mesh__D022421 2000-06-22
% 222.46/222.70  |- mesh__publicMeSHNote mesh__D022421
% 222.46/222.70       2001; PSUEDORABIES VACCINE was indexed under VIRAL VACCINES 1992-2000 %26% VACCINES, ATTENUATED 1992-1993%A%  
% 222.46/222.70  |- skos__historyNote mesh__D022421 Viral Vaccines %28%1971-2000%29%
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D013695 2004
% 222.46/222.70  |- skos__hiddenLabel mesh__D013695 Temperances
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D013695 2000
% 222.46/222.70  |- mesh__recordMaintainer mesh__D013695 KEV
% 222.46/222.70  |- skos__broader mesh__D013695smesh__D006802
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D013695 2003
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D013695 2006
% 222.46/222.70  |- mesh__recordAuthorizer mesh__D013695 sjn
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D013695 2002
% 222.46/222.70  |- mesh__recordOriginator mesh__D013695 NLM
% 222.46/222.70  |- skos__prefLabel mesh__D013695 Temperance
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D013695 2005
% 222.46/222.70  |- skos__scopeNote mesh__D013695 Abstinence from alcohol.     
% 222.46/222.70  |- rdf__type mesh__D013695sskos__Concept
% 222.46/222.70  |- mesh__dateRevised mesh__D013695 1999-11-04
% 222.46/222.70  |- skos__annotation mesh__D013695 %22%abstinence from alcohol%22%   
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D013695 2001
% 222.46/222.70  |- mesh__dateCreated mesh__D013695 1999-01-01
% 222.46/222.70  |- mesh__dateCreated mesh__D007658 1999-01-01
% 222.46/222.70  |- skos__scopeNote mesh__D007658
% 222.46/222.70       Oxidoreductases that are specific for KETONES.     
% 222.46/222.70  |- rdf__type mesh__D007658sskos__Concept
% 222.46/222.70  |- mesh__recordAuthorizer mesh__D007658 sjn
% 222.46/222.70  |- skos__broader mesh__D007658smesh__D050837
% 222.46/222.70  |- skos__historyNote mesh__D007658 Oxidoreductases %28%1966-1972%29%
% 222.46/222.70  |- mesh__recordOriginator mesh__D007658 NLM
% 222.46/222.70  |- skos__hiddenLabel mesh__D007658 Oxidoreductases, Ketone
% 222.46/222.70  |- mesh__publicMeSHNote mesh__D007658 73   
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D007658 2006
% 222.46/222.70  |- mesh__historyNote mesh__D007658 73   
% 222.46/222.70  |- mesh__dateRevised mesh__D007658 2005-06-30
% 222.46/222.70  |- mesh__recordMaintainer mesh__D007658 jmp
% 222.46/222.70  |- skos__prefLabel mesh__D007658 Ketone Oxidoreductases
% 222.46/222.70  |- mesh__dateEstablished mesh__D007658 1973-01-01
% 222.46/222.70  |- skos__broader mesh__D018380smesh__D033581
% 222.46/222.70  |- skos__altLabel mesh__D018380 Stem Cell Transplantation, Hematopoietic
% 222.46/222.70  |- skos__related mesh__D018380smesh__D016465
% 222.46/222.70  |- mesh__publicMeSHNote mesh__D018380
% 222.46/222.70       95; was HEMATOPOIETIC STEM CELLS/transplantation 1972-94   
% 222.46/222.70  |- skos__annotation mesh__D018380
% 222.46/222.70       conditioning before transpl of hematopoietic stem cells: coord IM with TRANSPLANTATION CONDITIONING %28%IM%29%%A%  
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D018380 2006
% 222.46/222.70  |- skos__scopeNote mesh__D018380
% 222.46/222.70       Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species %28%TRANSPLANTATION, HOMOLOGOUS%29% or transfer within the same individual %28%TRANSPLANTATION, AUTOLOGOUS%29%. Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms.%A%    
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D018380 2005A
% 222.46/222.70  |- mesh__recordOriginator mesh__D018380 AGS
% 222.46/222.70  |- skos__related mesh__D018380smesh__D019650
% 222.46/222.70  |- skos__historyNote mesh__D018380
% 222.46/222.70       Bone Marrow/transplantation %28%1966-1970%29%
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D018380 2005
% 222.46/222.70  |- mesh__recordMaintainer mesh__D018380 jls
% 222.46/222.70  |- rdf__type mesh__D018380sskos__Concept
% 222.46/222.70  |- mesh__recordAuthorizer mesh__D018380 jls
% 222.46/222.70  |- mesh__dateEstablished mesh__D018380 1995-01-01
% 222.46/222.70  |- mesh__historyNote mesh__D018380
% 222.46/222.70       95; was HEMATOPOIETIC STEM CELLS/transplantation 1971-94   
% 222.46/222.70  |- skos__prefLabel mesh__D018380 Hematopoietic Stem Cell Transplantation
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D018380 2004
% 222.46/222.70  |- mesh__dateRevised mesh__D018380 2004-07-27
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D018380 2005B
% 222.46/222.70  |- skos__altLabel mesh__D018380 Transplantation, Hematopoietic Stem Cell
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D018380 2003
% 222.46/222.70  |- mesh__dateCreated mesh__D018380 1994-01-25
% 222.46/222.70  |- skos__historyNote mesh__D018380
% 222.46/222.70       Hematopoietic Stem Cells/transplantation %28%1971-1994%29%
% 222.46/222.70  |- mesh__publicMeSHNote mesh__D004360
% 222.46/222.70       91; was see under THERAPY, COMPUTER-ASSISTED 1987-90   
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D004360 2006
% 222.46/222.70  |- skos__broader mesh__D004360smesh__D013813
% 222.46/222.70  |- mesh__dateRevised mesh__D004360 2005-06-30
% 222.46/222.70  |- skos__related mesh__D004360smesh__D050316
% 222.46/222.70  |- skos__hiddenLabel mesh__D004360 Protocol Drug Therapy, Computer Assisted
% 222.46/222.70  |- mesh__historyNote mesh__D004360
% 222.46/222.70       91%28%87%29%; was see under THERAPY, COMPUTER-ASSISTED 1987-90   
% 222.46/222.70  |- rdf__type mesh__D004360sskos__Concept
% 222.46/222.70  |- skos__broader mesh__D004360smesh__D004358
% 222.46/222.70  |- mesh__recordMaintainer mesh__D004360 ags
% 222.46/222.70  |- mesh__recordOriginator mesh__D004360 EC
% 222.46/222.70  |- skos__hiddenLabel mesh__D004360 Computer Assisted Drug Therapy
% 222.46/222.70  |- skos__hiddenLabel mesh__D004360 Drug Therapy, Computer Assisted
% 222.46/222.70  |- skos__hiddenLabel mesh__D004360 Drug Therapies, Computer-Assisted
% 222.46/222.70  |- skos__hiddenLabel mesh__D004360 Therapies, Computer-Assisted Drug
% 222.46/222.70  |- skos__hiddenLabel mesh__D004360 Computer-Assisted Drug Therapies
% 222.46/222.70  |- skos__altLabel mesh__D004360 Therapy, Computer-Assisted Drug
% 222.46/222.70  |- skos__hiddenLabel mesh__D004360 Therapy, Computer Assisted Drug
% 222.46/222.70  |- mesh__recordAuthorizer mesh__D004360 sjn
% 222.46/222.70  |- skos__prefLabel mesh__D004360 Drug Therapy, Computer-Assisted
% 222.46/222.70  |- mesh__dateEstablished mesh__D004360 1991-01-01
% 222.46/222.70  |- skos__scopeNote mesh__D004360
% 222.46/222.70       Adjunctive computer programs in providing drug treatment to patients.%A%    
% 222.46/222.70  |- mesh__dateCreated mesh__D004360 1986-06-17
% 222.46/222.70  |- skos__altLabel mesh__D004360 Computer-Assisted Drug Therapy
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017288 2003
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017288 1994
% 222.46/222.70  |- mesh__dateCreated mesh__D017288 1992-05-22
% 222.46/222.70  |- mesh__publicMeSHNote mesh__D017288 93   
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017288 2000
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017288 1999
% 222.46/222.70  |- skos__historyNote mesh__D017288 Sensory Thresholds %28%1979-1992%29%
% 222.46/222.70  |- skos__prefLabel mesh__D017288 Pain Threshold
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017288 1993
% 222.46/222.70  |- skos__historyNote mesh__D017288 Pain %28%1966-1992%29%
% 222.46/222.70  |- mesh__dateEstablished mesh__D017288 1993-01-01
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017288 1998
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017288 2006
% 222.46/222.70  |- skos__hiddenLabel mesh__D017288 Thresholds, Pain
% 222.46/222.70  |- skos__scopeNote mesh__D017288
% 222.46/222.70       Amount of stimulation required before the sensation of pain is experienced.%A%    
% 222.46/222.70  |- skos__hiddenLabel mesh__D017288 Pain Thresholds
% 222.46/222.70  |- skos__broader mesh__D017288smesh__D010146
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017288 2005
% 222.46/222.70  |- skos__broader mesh__D017288smesh__D012684
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017288 1997
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017288 2002
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017288 1996
% 222.46/222.70  |- rdf__type mesh__D017288sskos__Concept
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017288 2004
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017288 1995
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D017288 2001
% 222.46/222.70  |- skos__hiddenLabel mesh__D017288 Threshold, Pain
% 222.46/222.70  |- mesh__historyNote mesh__D017288 93   
% 222.46/222.70  |- rdf__type mesh__D050113sskos__Concept
% 222.46/222.70  |- mesh__recordMaintainer mesh__D050113 ssb
% 222.46/222.70  |- skos__scopeNote mesh__D050113
% 222.46/222.70       Five-carbon furanose sugars in which the OXYGEN is replaced by a NITROGEN atom.%A%    
% 222.46/222.70  |- skos__hiddenLabel mesh__D050113 1,4 Imino Sugars
% 222.46/222.70  |- mesh__dateCreated mesh__D050113 2005-06-30
% 222.46/222.70  |- mesh__historyNote mesh__D050113 2006   
% 222.46/222.70  |- skos__altLabel mesh__D050113 Hydroxymethylpyrrolidines
% 222.46/222.70  |- skos__hiddenLabel mesh__D050113 Sugars, 1,4-Imino
% 222.46/222.70  |- mesh__dateEstablished mesh__D050113 2006-01-01
% 222.46/222.70  |- skos__hiddenLabel mesh__D050113 Furanoses, Imino
% 222.46/222.70  |- skos__altLabel mesh__D050113 Hydroxy-Methyl-Pyrrolidines
% 222.46/222.70  |- mesh__recordAuthorizer mesh__D050113 sjn
% 222.46/222.70  |- mesh__activeMeSHYear mesh__D050113 2006
% 222.46/222.70  |- skos__hiddenLabel mesh__D050113 Hydroxy Methyl Pyrrolidines
% 222.46/222.70  |- skos__broader mesh__D050113smesh__D011759
% 222.46/222.70  |- skos__broader mesh__D050113smesh__D050111
% 222.46/222.70  |- skos__prefLabel mesh__D050113 Imino Furanoses
% 222.46/222.70  |- mesh__recordOriginator mesh__D050113 ssb
% 222.46/222.71  |- mesh__publicMeSHNote mesh__D050113 2006   
% 222.46/222.71  |- skos__altLabel mesh__D050113 1,4-Imino Sugars
% 222.46/222.71  |- mesh__recordMaintainer mesh__D003268 lkt
% 222.46/222.71  |- skos__hiddenLabel mesh__D003268 Contraception Behaviors
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D003268 2005
% 222.46/222.71  |- skos__scopeNote mesh__D003268
% 222.46/222.71       Behavior patterns of those practicing CONTRACEPTION.     
% 222.46/222.71  |- rdf__type mesh__D003268sskos__Concept
% 222.46/222.71  |- mesh__publicMeSHNote mesh__D003268 75   
% 222.46/222.71  |- skos__prefLabel mesh__D003268 Contraception Behavior
% 222.46/222.71  |- mesh__historyNote mesh__D003268 75   
% 222.46/222.71  |- skos__historyNote mesh__D003268 Contraception %28%1966-1967%29%
% 222.46/222.71  |- skos__hiddenLabel mesh__D003268 Contraceptive Behaviors
% 222.46/222.71  |- mesh__dateCreated mesh__D003268 1974-11-11
% 222.46/222.71  |- mesh__dateEstablished mesh__D003268 1975-09-01
% 222.46/222.71  |- mesh__dateRevised mesh__D003268 2003-07-09
% 222.46/222.71  |- mesh__recordAuthorizer mesh__D003268 sjn
% 222.46/222.71  |- skos__historyNote mesh__D003268 Sex Behavior %28%1966-1974%29%
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D003268 2004
% 222.46/222.71  |- skos__broader mesh__D003268smesh__D043762
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D003268 2006
% 222.46/222.71  |- skos__altLabel mesh__D003268 Contraceptive Behavior
% 222.46/222.71  |- mesh__recordOriginator mesh__D003268 NLM
% 222.46/222.71  |- skos__hiddenLabel mesh__D008751 N, Methylene Blue
% 222.46/222.71  |- skos__hiddenLabel mesh__D008751 Blue, Swiss
% 222.46/222.71  |- mesh__dateRevised mesh__D008751 2005-06-30
% 222.46/222.71  |- skos__hiddenLabel mesh__D008751 Blue N, Methylene
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D008751 2006
% 222.46/222.71  |- mesh__recordAuthorizer mesh__D008751 sjn
% 222.46/222.71  |- mesh__recordOriginator mesh__D008751 NLM
% 222.46/222.71  |- skos__hiddenLabel mesh__D008751 Blue, Methylene
% 222.46/222.71  |- skos__altLabel mesh__D008751 Methylthionine Chloride
% 222.46/222.71  |- skos__altLabel mesh__D008751 Methylene Blue N
% 222.46/222.71  |- skos__altLabel mesh__D008751 Methylthioninium Chloride
% 222.46/222.71  |- mesh__dateCreated mesh__D008751 1999-01-01
% 222.46/222.71  |- rdf__type mesh__D008751sskos__Concept
% 222.46/222.71  |- skos__scopeNote mesh__D008751
% 222.46/222.71       A compound consisting of dark green crystals or crystalline powder, having a bronze-like luster. Solutions in water or alcohol have a deep blue color. Methylene blue is used as a bacteriologic stain and as an indicator. It inhibits GUANYLATE CYCLASE, and has been used to treat cyanide poisoning and to lower levels of METHEMOGLOBIN.%A%    
% 222.46/222.71  |- skos__altLabel mesh__D008751 Swiss Blue
% 222.46/222.71  |- skos__prefLabel mesh__D008751 Methylene Blue
% 222.46/222.71  |- mesh__recordMaintainer mesh__D008751 ssb
% 222.46/222.71  |- skos__broader mesh__D008751smesh__D010640
% 222.46/222.71  |- skos__hiddenLabel mesh__D022422 Vaccine, Diphtheria-Tetanus
% 222.46/222.71  |- skos__hiddenLabel mesh__D022422 Vaccine, DT
% 222.46/222.71  |- skos__prefLabel mesh__D022422 Diphtheria-Tetanus Vaccine
% 222.46/222.71  |- skos__hiddenLabel mesh__D022422 Diphtheria Tetanus Vaccine
% 222.46/222.71  |- skos__historyNote mesh__D022422 Tetanus Toxoid %28%1983-2000%29%
% 222.46/222.71  |- mesh__publicMeSHNote mesh__D022422
% 222.46/222.71       2001; DT VACCINE %28%now DIPHTHERIA-TETANUS VACCINE%29% was indexed under DIPHTHERIA TOXOID %26% TETANUS TOXOID 1983-2000;  VACCINES, COMBINED 1994-2000; and DRUG COMBINATIONS 1983-1995%A%  
% 222.46/222.71  |- skos__historyNote mesh__D022422 Drug Combinations %28%1983-1995%29%
% 222.46/222.71  |- mesh__recordAuthorizer mesh__D022422 sjn
% 222.46/222.71  |- mesh__dateEstablished mesh__D022422 2001-01-01
% 222.46/222.71  |- skos__historyNote mesh__D022422 Vaccines, Combined %28%1994-2000%29%
% 222.46/222.71  |- mesh__dateRevised mesh__D022422 2005-06-30
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D022422 2006
% 222.46/222.71  |- mesh__recordOriginator mesh__D022422 ags
% 222.46/222.71  |- skos__broader mesh__D022422smesh__D001428
% 222.46/222.71  |- rdf__type mesh__D022422sskos__Concept
% 222.46/222.71  |- skos__annotation mesh__D022422
% 222.46/222.71       DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES and DIPHTHERIA-TETANUS-PERTUSSIS VACCINE are also available%A%  
% 222.46/222.71  |- mesh__dateCreated mesh__D022422 2000-06-22
% 222.46/222.71  |- mesh__recordMaintainer mesh__D022422 ssb
% 222.46/222.71  |- skos__broader mesh__D022422smesh__D013745
% 222.46/222.71  |- skos__broader mesh__D022422smesh__D004168
% 222.46/222.71  |- mesh__historyNote mesh__D022422
% 222.46/222.71       2001; use DIPHTHERIA-TETANUS VACCINE %28%NM%29% to search DT VACCINE 1983-2000%A%  
% 222.46/222.71  |- skos__scopeNote mesh__D022422
% 222.46/222.71       A combined vaccine used to prevent infection with diphtheria and tetanus toxoid. This is used in place of DTP vaccine %28%DIPHTHERIA-TETANUS-PERTUSSIS VACCINE%29% when PERTUSSIS VACCINE is contraindicated.%A%    
% 222.46/222.71  |- skos__historyNote mesh__D022422 Diphtheria Toxoid %28%1983-2000%29%
% 222.46/222.71  |- skos__altLabel mesh__D022422 DT Vaccine
% 222.46/222.71  |- skos__broader mesh__D022422smesh__D017778
% 222.46/222.71  |- skos__historyNote mesh__D046870 Cyanobacteria %28%1969-1992%29%
% 222.46/222.71  |- mesh__recordAuthorizer mesh__D046870 sjn
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D046870 2006
% 222.46/222.71  |- rdf__type mesh__D046870sskos__Concept
% 222.46/222.71  |- mesh__dateEstablished mesh__D046870 2005-01-01
% 222.46/222.71  |- mesh__recordOriginator mesh__D046870 ags
% 222.46/222.71  |- skos__prefLabel mesh__D046870 Anabaena variabilis
% 222.46/222.71  |- mesh__dateCreated mesh__D046870 2004-07-07
% 222.46/222.71  |- skos__historyNote mesh__D046870 Algae %28%1965-1970%29%
% 222.46/222.71  |- skos__broader mesh__D046870smesh__D017033
% 222.46/222.71  |- mesh__dateRevised mesh__D046870 2005-06-30
% 222.46/222.71  |- mesh__publicMeSHNote mesh__D046870 2005   
% 222.46/222.71  |- mesh__recordMaintainer mesh__D046870 SYSTEM
% 222.46/222.71  |- mesh__historyNote mesh__D046870 2005   
% 222.46/222.71  |- skos__historyNote mesh__D046870 Anabaena %28%1992-2004%29%
% 222.46/222.71  |- skos__scopeNote mesh__D046870
% 222.46/222.71       A species of ANABAENA that can form SPORES called akinetes.%A%    
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D013696 2003
% 222.46/222.71  |- mesh__recordMaintainer mesh__D013696 PLS
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D013696 2001
% 222.46/222.71  |- skos__hiddenLabel mesh__D013696 Temperatures
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D013696 2006
% 222.46/222.71  |- skos__related mesh__D013696smesh__D013821
% 222.46/222.71  |- skos__annotation mesh__D013696
% 222.46/222.71       no qualif; prefer to specify HEAT or COLD   
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D013696 1991
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D013696 1997
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D013696 2000
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D013696 2005
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D013696 1993
% 222.46/222.71  |- skos__broader mesh__D013696smesh__D014887
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D013696 1996
% 222.46/222.71  |- mesh__dateRevised mesh__D013696 1989-07-14
% 222.46/222.71  |- rdf__type mesh__D013696sskos__Concept
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D013696 1999
% 222.46/222.71  |- skos__broader mesh__D013696smesh__D004780
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D013696 1992
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D013696 2002
% 222.46/222.71  |- mesh__recordOriginator mesh__D013696 NLM
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D013696 1990
% 222.46/222.71  |- skos__prefLabel mesh__D013696 Temperature
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D013696 1995
% 222.46/222.71  |- mesh__dateCreated mesh__D013696 1999-01-01
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D013696 1998
% 222.46/222.71  |- skos__broader mesh__D013696smesh__D010825
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D013696 2004
% 222.46/222.71  |- skos__related mesh__D013696smesh__D001831
% 222.46/222.71  |- mesh__recordAuthorizer mesh__D013696 PLS
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D013696 1994
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D007659 1996
% 222.46/222.71  |- skos__annotation mesh__D007659
% 222.46/222.71       KETO ACIDS %26% KETOSES are also available; ketonemia %26% ketonuria go under KETONE BODIES; ketogenesis is probably KETONE BODIES /biosyn%A%  
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D007659 2001
% 222.46/222.71  |- skos__prefLabel mesh__D007659 Ketones
% 222.46/222.71  |- mesh__dateRevised mesh__D007659 1992-05-18
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D007659 1997
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D007659 2005
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D007659 2002
% 222.46/222.71  |- skos__broader mesh__D007659smesh__D009930
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D007659 2006
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D007659 2003
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D007659 1994
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D007659 2004
% 222.46/222.71  |- mesh__recordOriginator mesh__D007659 NLM
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D007659 1995
% 222.46/222.71  |- mesh__recordAuthorizer mesh__D007659 PLS
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D007659 1998
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D007659 1993
% 222.46/222.71  |- mesh__dateCreated mesh__D007659 1999-01-01
% 222.46/222.71  |- mesh__recordMaintainer mesh__D007659 TAP
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D007659 2000
% 222.46/222.71  |- rdf__type mesh__D007659sskos__Concept
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D007659 1999
% 222.46/222.71  |- mesh__recordAuthorizer mesh__D004361 sjn
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D004361 2006
% 222.46/222.71  |- mesh__dateRevised mesh__D004361 2004-07-13
% 222.46/222.71  |- skos__annotation mesh__D004361
% 222.46/222.71       differentiate from DRUG RESISTANCE; not for tolerability %28% = drug /adv eff%29%: Manual 28.19%A%  
% 222.46/222.71  |- skos__broader mesh__D004361smesh__D002620
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D004361 2005
% 222.46/222.71  |- mesh__dateCreated mesh__D004361 1999-01-01
% 222.46/222.71  |- rdf__type mesh__D004361sskos__Concept
% 222.46/222.71  |- mesh__recordMaintainer mesh__D004361 sjn
% 222.46/222.71  |- skos__scopeNote mesh__D004361
% 222.46/222.71       Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL.%A%    
% 222.46/222.71  |- skos__hiddenLabel mesh__D004361 Drug Tolerances
% 222.46/222.71  |- mesh__recordOriginator mesh__D004361 NLM
% 222.46/222.71  |- skos__prefLabel mesh__D004361 Drug Tolerance
% 222.46/222.71  |- skos__hiddenLabel mesh__D004361 Tolerances, Drug
% 222.46/222.71  |- skos__hiddenLabel mesh__D004361 Tolerance, Drug
% 222.46/222.71  |- skos__prefLabel mesh__D017289 Orthodontic Appliances, Functional
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D017289 2006
% 222.46/222.71  |- mesh__publicMeSHNote mesh__D017289
% 222.46/222.71       93; was FUNCTIONAL ORTHODONIC APPLIANCES see ACTIVATOR APPLIANCES 1975-92%A%  
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D017289 2002
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D017289 2005
% 222.46/222.71  |- skos__hiddenLabel mesh__D017289 Function Regulator, Frankel
% 222.46/222.71  |- skos__historyNote mesh__D017289 Activator Appliances %28%1975-1992%29%
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D017289 1997
% 222.46/222.71  |- mesh__activeMeSHYear mesh__D017289 2001
% 222.56/222.71  |- skos__hiddenLabel mesh__D017289 Orthodontic Appliance, Functional
% 222.56/222.71  |- skos__hiddenLabel mesh__D017289 Appliances, Functional Orthodontic
% 222.56/222.71  |- skos__broader mesh__D017289smesh__D009967
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D017289 1996
% 222.56/222.71  |- rdf__type mesh__D017289sskos__Concept
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D017289 2004
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D017289 1995
% 222.56/222.71  |- mesh__dateCreated mesh__D017289 1992-05-22
% 222.56/222.71  |- skos__hiddenLabel mesh__D017289 Functional Orthodontic Appliance
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D017289 2000
% 222.56/222.71  |- mesh__dateEstablished mesh__D017289 1993-01-01
% 222.56/222.71  |- mesh__historyNote mesh__D017289
% 222.56/222.71       93; was FUNCTIONAL ORTHODONTIC APPLIANCES see ACTIVATOR APPLIANCES 1975-92%A%  
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D017289 2003
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D017289 1994
% 222.56/222.71  |- skos__hiddenLabel mesh__D017289 Appliance, Bimler
% 222.56/222.71  |- skos__hiddenLabel mesh__D017289 Appliance, Herbst
% 222.56/222.71  |- mesh__onlineNote mesh__D017289
% 222.56/222.71       use ACTIVATOR APPLIANCES to search FUNCTIONAL ORTHODONTIC APPLIANCES 1975-92%A%  
% 222.56/222.71  |- skos__scopeNote mesh__D017289
% 222.56/222.71       Loose, usually removable intra-oral devices which alter the muscle forces against the teeth and craniofacial skeleton. These are dynamic appliances which depend on altered neuromuscular action to effect bony growth and occlusal development. They are usually used in mixed dentition to treat pediatric malocclusions. %28%ADA, 1992%29%%A%    
% 222.56/222.71  |- skos__hiddenLabel mesh__D017289 Regulator, Frankel Function
% 222.56/222.71  |- skos__hiddenLabel mesh__D017289 Appliance, Functional Orthodontic
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D017289 1999
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D017289 1993
% 222.56/222.71  |- skos__hiddenLabel mesh__D017289 Kinetors
% 222.56/222.71  |- skos__hiddenLabel mesh__D017289 Functional Orthodontic Appliances
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D017289 1998
% 222.56/222.71  |- mesh__recordAuthorizer mesh__D003269 sjn
% 222.56/222.71  |- rdf__type mesh__D003269sskos__Concept
% 222.56/222.71  |- skos__hiddenLabel mesh__D003269 Immunological Contraceptive Technic
% 222.56/222.71  |- mesh__recordOriginator mesh__D003269 NLM
% 222.56/222.71  |- mesh__dateCreated mesh__D003269 1974-11-19
% 222.56/222.71  |- mesh__recordMaintainer mesh__D003269 lkt
% 222.56/222.71  |- mesh__dateRevised mesh__D003269 2005-06-30
% 222.56/222.71  |- skos__altLabel mesh__D003269 Immunological Contraceptive Technics
% 222.56/222.71  |- skos__altLabel mesh__D003269 Immunocontraception
% 222.56/222.71  |- skos__broader mesh__D003269smesh__D003267
% 222.56/222.71  |- skos__hiddenLabel mesh__D003269 Immunological Contraception
% 222.56/222.71  |- skos__altLabel mesh__D003269 Immunological Contraceptive Techniques
% 222.56/222.71  |- mesh__dateEstablished mesh__D003269 1991-01-01
% 222.56/222.71  |- skos__prefLabel mesh__D003269 Contraception, Immunologic
% 222.56/222.71  |- skos__hiddenLabel mesh__D003269 Contraceptive Techniques, Immunological
% 222.56/222.71  |- skos__related mesh__D003269smesh__D022642
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D003269 2006
% 222.56/222.71  |- skos__altLabel mesh__D003269 Immunologic Contraception
% 222.56/222.71  |- skos__scopeNote mesh__D003269
% 222.56/222.71       Contraceptive methods based on immunological processes and techniques, such as the use of CONTRACEPTIVE VACCINES.%A%    
% 222.56/222.71  |- skos__hiddenLabel mesh__D003269 Contraceptive Technique, Immunological
% 222.56/222.71  |- mesh__publicMeSHNote mesh__D003269
% 222.56/222.71       91; was see under CONTRACEPTION 1975-90   
% 222.56/222.71  |- skos__annotation mesh__D003269 DF: CONTRACEPTION IMMUNOL   
% 222.56/222.71  |- skos__altLabel mesh__D003269 Fertility Control, Immunological
% 222.56/222.71  |- skos__hiddenLabel mesh__D003269 Immunocontraceptive Technique
% 222.56/222.71  |- skos__hiddenLabel mesh__D003269 Contraceptive Technics, Immunological
% 222.56/222.71  |- mesh__historyNote mesh__D003269
% 222.56/222.71       91%28%75%29%; was see under CONTRACEPTION 1975-90   
% 222.56/222.71  |- skos__altLabel mesh__D003269 Contraception, Immunological
% 222.56/222.71  |- skos__hiddenLabel mesh__D003269 Contraceptive Technic, Immunological
% 222.56/222.71  |- skos__hiddenLabel mesh__D003269 Immunological Contraceptive Technique
% 222.56/222.71  |- skos__altLabel mesh__D008752 Dichloromethane
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D008752 2002
% 222.56/222.71  |- skos__hiddenLabel mesh__D008752 Chloride, Methylene
% 222.56/222.71  |- skos__hiddenLabel mesh__D008752 Dichloride, Methylene
% 222.56/222.71  |- skos__hiddenLabel mesh__D008752 Bichloride, Methylene
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D008752 2003
% 222.56/222.71  |- mesh__dateCreated mesh__D008752 1974-11-19
% 222.56/222.71  |- skos__annotation mesh__D008752 do not confuse with METHYL CHLORIDE   
% 222.56/222.71  |- mesh__dateRevised mesh__D008752 2000-06-22
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D008752 2004
% 222.56/222.71  |- rdf__type mesh__D008752sskos__Concept
% 222.56/222.71  |- mesh__recordOriginator mesh__D008752 NLM
% 222.56/222.71  |- mesh__recordAuthorizer mesh__D008752 sjn
% 222.56/222.71  |- skos__scopeNote mesh__D008752
% 222.56/222.71       A chlorinated hydrocarbon that has been used as an inhalation anesthetic and acts as a narcotic in high concentrations. Its primary use is as a solvent in manufacturing and food technology.%A%    
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D008752 2001
% 222.56/222.71  |- skos__historyNote mesh__D008752 Methane %28%1974%29%
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D008752 2005
% 222.56/222.71  |- mesh__recordMaintainer mesh__D008752 CCR
% 222.56/222.71  |- skos__altLabel mesh__D008752 Methylene Bichloride
% 222.56/222.71  |- mesh__historyNote mesh__D008752
% 222.56/222.71       91%28%75%29%; was see under HYDROCARBONS, CHLORINATED 1975-90   
% 222.56/222.71  |- skos__altLabel mesh__D008752 Methylene Dichloride
% 222.56/222.71  |- skos__historyNote mesh__D008752 Hydrocarbons, Chlorinated %28%1974%29%
% 222.56/222.71  |- mesh__dateEstablished mesh__D008752 1991-01-01
% 222.56/222.71  |- mesh__publicMeSHNote mesh__D008752
% 222.56/222.71       91; was see under HYDROCARBONS, CHLORINATED 1975-90   
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D008752 2006
% 222.56/222.71  |- skos__broader mesh__D008752smesh__D006843
% 222.56/222.71  |- skos__prefLabel mesh__D008752 Methylene Chloride
% 222.56/222.71  |- mesh__publicMeSHNote mesh__D022423 2001   
% 222.56/222.71  |- rdf__type mesh__D022423sskos__Concept
% 222.56/222.71  |- skos__hiddenLabel mesh__D022423 Myeloid Cell
% 222.56/222.71  |- mesh__dateEstablished mesh__D022423 2001-01-01
% 222.56/222.71  |- skos__scopeNote mesh__D022423
% 222.56/222.71       The classes of BONE MARROW-derived blood cells in the monocytic series %28%MONOCYTES and their precursors%29% and granulocytic series %28%GRANULOCYTES and their precursors%29%.%A%    
% 222.56/222.71  |- mesh__historyNote mesh__D022423 2001   
% 222.56/222.71  |- mesh__recordOriginator mesh__D022423 nns
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D022423 2004
% 222.56/222.71  |- skos__broader mesh__D022423smesh__D002477
% 222.56/222.71  |- skos__prefLabel mesh__D022423 Myeloid Cells
% 222.56/222.71  |- mesh__recordAuthorizer mesh__D022423 sjn
% 222.56/222.71  |- mesh__dateCreated mesh__D022423 2000-07-06
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D022423 2005
% 222.56/222.71  |- skos__hiddenLabel mesh__D022423 Cells, Myeloid
% 222.56/222.71  |- mesh__recordMaintainer mesh__D022423 nns
% 222.56/222.71  |- mesh__dateRevised mesh__D022423 2003-07-09
% 222.56/222.71  |- skos__hiddenLabel mesh__D022423 Cell, Myeloid
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D022423 2006
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D013697 1993
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D013697 2002
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D013697 1996
% 222.56/222.71  |- mesh__recordOriginator mesh__D013697 NLM
% 222.56/222.71  |- skos__hiddenLabel mesh__D013697 Temperature Senses
% 222.56/222.71  |- rdf__type mesh__D013697sskos__Concept
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D013697 1999
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D013697 1995
% 222.56/222.71  |- mesh__recordAuthorizer mesh__D013697 PLS
% 222.56/222.71  |- mesh__recordMaintainer mesh__D013697 TAP
% 222.56/222.71  |- mesh__dateCreated mesh__D013697 1999-01-01
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D013697 1998
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D013697 2004
% 222.56/222.71  |- skos__prefLabel mesh__D013697 Temperature Sense
% 222.56/222.71  |- skos__hiddenLabel mesh__D013697 Sense, Temperature
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D013697 2001
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D013697 1994
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D013697 2003
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D013697 2000
% 222.56/222.71  |- mesh__dateRevised mesh__D013697 1992-05-18
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D013697 2006
% 222.56/222.71  |- skos__scopeNote mesh__D013697
% 222.56/222.71       The sensation of cold, heat, coolness, and warmth.     
% 222.56/222.71  |- skos__hiddenLabel mesh__D013697 Senses, Temperature
% 222.56/222.71  |- skos__broader mesh__D013697smesh__D012677
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D013697 1997
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D013697 2005
% 222.56/222.71  |- mesh__dateEstablished mesh__D018382 1995-01-01
% 222.56/222.71  |- mesh__recordMaintainer mesh__D018382 lkt
% 222.56/222.71  |- skos__hiddenLabel mesh__D018382 Hormone Resistance, Thyroid
% 222.56/222.71  |- skos__broader mesh__D018382smesh__D006981
% 222.56/222.71  |- skos__hiddenLabel mesh__D018382 Syndrome, Refetoff-DeWind-DeGroot
% 222.56/222.71  |- skos__related mesh__D018382smesh__D005067
% 222.56/222.71  |- skos__altLabel mesh__D018382 Refetoff Syndrome
% 222.56/222.71  |- skos__hiddenLabel mesh__D018382 Syndrome, Refetoff
% 222.56/222.71  |- skos__altLabel mesh__D018382 Generalized Thyroid Hormone Resistance
% 222.56/222.71  |- mesh__recordAuthorizer mesh__D018382 sjn
% 222.56/222.71  |- mesh__recordOriginator mesh__D018382 TGC
% 222.56/222.71  |- skos__altLabel mesh__D018382 Thyroid Hormone Resistance
% 222.56/222.71  |- skos__altLabel mesh__D018382 Refetoff-DeWind-DeGroot Syndrome
% 222.56/222.71  |- skos__prefLabel mesh__D018382 Thyroid Hormone Resistance Syndrome
% 222.56/222.71  |- mesh__dateRevised mesh__D018382 2005-06-30
% 222.56/222.71  |- mesh__historyNote mesh__D018382 95   
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D018382 2006
% 222.56/222.71  |- skos__annotation mesh__D018382
% 222.56/222.71       differentiate from EUTHYROID SICK SYNDROME where a non-thyroid disease is also present%A%  
% 222.56/222.71  |- skos__hiddenLabel mesh__D018382 Resistance, Thyroid Hormone
% 222.56/222.71  |- mesh__publicMeSHNote mesh__D018382 95   
% 222.56/222.71  |- mesh__dateCreated mesh__D018382 1994-02-28
% 222.56/222.71  |- rdf__type mesh__D018382sskos__Concept
% 222.56/222.71  |- skos__hiddenLabel mesh__D018382 Refetoff DeWind DeGroot Syndrome
% 222.56/222.71  |- skos__scopeNote mesh__D018382
% 222.56/222.71       An inherited autosomal recessive trait, characterized by peripheral resistance to THYROID HORMONES and the resulting elevation in serum levels of THYROXINE and TRIIODOTHYRONINE. This syndrome is caused by mutations of gene THRB encoding the THYROID HORMONE RECEPTORS BETA in target cells. HYPOTHYROIDISM in these patients is partly overcome by the increased thyroid hormone levels.%A%    
% 222.56/222.71  |- mesh__historyNote mesh__D004362 98; use explode 1970-97   
% 222.56/222.71  |- mesh__recordMaintainer mesh__D004362 ssb
% 222.56/222.71  |- skos__related mesh__D004362smesh__D004347
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D004362 2006
% 222.56/222.71  |- skos__scopeNote mesh__D004362
% 222.56/222.71       Manifestations of the adverse effects of drugs administered therapeutically or in the course of diagnostic techniques. It does not include accidental or intentional poisoning for which specific headings are available.%A%    
% 222.56/222.71  |- skos__related mesh__D004362smesh__D017327
% 222.56/222.71  |- skos__hiddenLabel mesh__D004362 Toxicities, Drug
% 222.56/222.71  |- mesh__recordAuthorizer mesh__D004362 sjn
% 222.56/222.71  |- skos__prefLabel mesh__D004362 Drug Toxicity
% 222.56/222.71  |- mesh__dateCreated mesh__D004362 1999-01-01
% 222.56/222.71  |- rdf__type mesh__D004362sskos__Concept
% 222.56/222.71  |- mesh__publicMeSHNote mesh__D004362 98   
% 222.56/222.71  |- skos__annotation mesh__D004362
% 222.56/222.71       note category: do not confuse with TOXICOLOGY, the specialty; general or unspecified; prefer specifics or specific drug with /adv eff /pois or /tox; DF: DRUG TOX%A%  
% 222.56/222.71  |- skos__hiddenLabel mesh__D004362 Safety, Drug
% 222.56/222.71  |- mesh__dateRevised mesh__D004362 2005-06-30
% 222.56/222.71  |- mesh__dateEstablished mesh__D004362 1998-01-01
% 222.56/222.71  |- skos__historyNote mesh__D004362
% 222.56/222.71       Pharmaceutical Preparations/toxicity %28%1966-1997%29%
% 222.56/222.71  |- skos__hiddenLabel mesh__D004362 Drug Toxicities
% 222.56/222.71  |- skos__altLabel mesh__D004362 Toxicity, Drug
% 222.56/222.71  |- skos__broader mesh__D004362smesh__D011041
% 222.56/222.71  |- mesh__recordOriginator mesh__D004362 NLM
% 222.56/222.71  |- mesh__publicMeSHNote mesh__D042481 2004   
% 222.56/222.71  |- skos__historyNote mesh__D042481 Alcaligenes %28%1965-2003%29%
% 222.56/222.71  |- skos__scopeNote mesh__D042481
% 222.56/222.71       The type species of gram negative bacteria in the genus ALCALIGENES, found in soil. It is non-pathogenic, non-pigmented, and used for the production of amino acids.%A%    
% 222.56/222.71  |- rdf__type mesh__D042481sskos__Concept
% 222.56/222.71  |- skos__broader mesh__D042481smesh__D000421
% 222.56/222.71  |- mesh__historyNote mesh__D042481 2004   
% 222.56/222.71  |- mesh__recordAuthorizer mesh__D042481 sjn
% 222.56/222.71  |- mesh__recordMaintainer mesh__D042481 SYSTEM
% 222.56/222.71  |- mesh__dateCreated mesh__D042481 2003-07-09
% 222.56/222.71  |- mesh__dateEstablished mesh__D042481 2004-01-01
% 222.56/222.71  |- mesh__recordOriginator mesh__D042481 ags
% 222.56/222.71  |- skos__prefLabel mesh__D042481 Alcaligenes faecalis
% 222.56/222.71  |- mesh__dateRevised mesh__D042481 2005-06-30
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D042481 2006
% 222.56/222.71  |- skos__altLabel mesh__D014790 Maedi-Visna Virus
% 222.56/222.71  |- skos__scopeNote mesh__D014790
% 222.56/222.71       A species of LENTIVIRUS, subgenus ovine-caprine lentiviruses %28%LENTIVIRUSES, OVINE-CAPRINE%29%, that can cause chronic pneumonia %28%maedi%29%, mastitis, arthritis, and encephalomyelitis %28%visna%29% in sheep. Maedi is a progressive pneumonia of sheep which is similar to but not the same as jaagsiekte %28%PULMONARY ADENOMATOSIS, OVINE%29%. Visna is a demyelinating leukoencephalomyelitis of sheep which is similar to but not the same as SCRAPIE.%A%    
% 222.56/222.71  |- mesh__dateEstablished mesh__D014790 1978-01-01
% 222.56/222.71  |- skos__prefLabel mesh__D014790 Visna-maedi virus
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D014790 2002
% 222.56/222.71  |- skos__historyNote mesh__D014790
% 222.56/222.71       Pulmonary Adenomatosis, Ovine %28%1968-1972%29%
% 222.56/222.71  |- mesh__recordOriginator mesh__D014790 NLM
% 222.56/222.71  |- rdf__type mesh__D014790sskos__Concept
% 222.56/222.71  |- skos__historyNote mesh__D014790 Scrapie %28%1968-1972%29%
% 222.56/222.71  |- skos__altLabel mesh__D014790 Visna Virus
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D014790 2004
% 222.56/222.71  |- skos__hiddenLabel mesh__D014790 Visna Maedi Virus
% 222.56/222.71  |- mesh__onlineNote mesh__D014790
% 222.56/222.71       use VISNA-MAEDI VIRUS to search VISNA VIRUS 1991-93 %26% VISNA-MAEDI VIRUSES 1978-90%A%  
% 222.56/222.71  |- mesh__recordAuthorizer mesh__D014790 sjn
% 222.56/222.71  |- skos__broader mesh__D014790smesh__D017972
% 222.56/222.71  |- mesh__dateRevised mesh__D014790 2001-07-25
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D014790 2006
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D014790 2003
% 222.56/222.71  |- skos__annotation mesh__D014790
% 222.56/222.71       infection = VISNA or MAEDI see PNEUMONIA, PROGRESSIVE INTERSTITIAL, OF SHEEP%A%  
% 222.56/222.71  |- skos__hiddenLabel mesh__D014790 Maedi Visna Virus
% 222.56/222.71  |- mesh__dateCreated mesh__D014790 1999-01-01
% 222.56/222.71  |- mesh__historyNote mesh__D014790
% 222.56/222.71       94; was VISNA VIRUS 1991-93; was VISNA-MAEDI VIRUSES 1975-90 %28%see under RNA VIRUSES 1975-77%29%; VISNA-MAEDI VIRUS was see VISNA VIRUS 1991-93%A%  
% 222.56/222.71  |- mesh__publicMeSHNote mesh__D014790
% 222.56/222.71       94; was VISNA VIRUS 1991-93; was VISNA-MAEDI VIRUSES 1975-90 %28%see under RNA VIRUSES 1975-77%29%; VISNA-MAEDI VIRUS was see VISNA VIRUS 1991-93%A%  
% 222.56/222.71  |- skos__hiddenLabel mesh__D014790 Maedi Viruses
% 222.56/222.71  |- skos__altLabel mesh__D014790 Maedi Virus
% 222.56/222.71  |- mesh__activeMeSHYear mesh__D014790 2005
% 222.56/222.71  |- mesh__recordMaintainer mesh__D014790 ags
% 222.56/222.71  |- skos__broader mesh__D008753smesh__D000814
% 222.56/222.71  |- skos__scopeNote mesh__D008753
% 222.56/222.71       Aromatic diamine used in the plastics industry as curing agent for epoxy resins and urethane rubbers. It causes bladder, liver, lung, and other neoplasms.%A%    
% 222.56/222.72  |- skos__historyNote mesh__D008753 Hydrocarbons, Chlorinated %28%1974%29%
% 222.56/222.72  |- skos__altLabel mesh__D008753
% 222.56/222.72       3,3%27%-Dichloro-4,4%27%-Diaminodiphenylmethane
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D008753 2006
% 222.56/222.72  |- mesh__historyNote mesh__D008753
% 222.56/222.72       91%28%77%29%; was see under BENZHYDRYL COMPOUNDS 1977-90   
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D008753 2001
% 222.56/222.72  |- mesh__recordMaintainer mesh__D008753 CCR
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D008753 2005
% 222.56/222.72  |- mesh__dateEstablished mesh__D008753 1991-01-01
% 222.56/222.72  |- skos__prefLabel mesh__D008753 Methylenebis%28%chloroaniline%29%
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D008753 2004
% 222.56/222.72  |- mesh__dateRevised mesh__D008753 2000-06-22
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D008753 2003
% 222.56/222.72  |- skos__altLabel mesh__D008753 Methylene Bis%28%chloroaniline%29%
% 222.56/222.72  |- skos__altLabel mesh__D008753 MOCA
% 222.56/222.72  |- skos__broader mesh__D008753smesh__D001559
% 222.56/222.72  |- rdf__type mesh__D008753sskos__Concept
% 222.56/222.72  |- skos__historyNote mesh__D008753 Benzhydryl Compounds %28%1975-1976%29%
% 222.56/222.72  |- skos__annotation mesh__D008753 D25-26 qualif   
% 222.56/222.72  |- mesh__recordOriginator mesh__D008753 SH
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D008753 2002
% 222.56/222.72  |- mesh__publicMeSHNote mesh__D008753
% 222.56/222.72       91; was see under BENZHYDRYL COMPOUNDS 1977-90   
% 222.56/222.72  |- skos__altLabel mesh__D008753 4,4%27%-Methylenebis%28%2-chloroaniline%29%
% 222.56/222.72  |- mesh__recordAuthorizer mesh__D008753 sjn
% 222.56/222.72  |- skos__historyNote mesh__D008753 Aniline Compounds %28%1974-1976%29%
% 222.56/222.72  |- mesh__dateCreated mesh__D008753 1976-04-16
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000770 2003
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000770 1994
% 222.56/222.72  |- mesh__dateCreated mesh__D000770 1999-01-01
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000770 2000
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000770 1999
% 222.56/222.72  |- mesh__dateRevised mesh__D000770 1993-02-20
% 222.56/222.72  |- skos__broader mesh__D000770smesh__D000758
% 222.56/222.72  |- rdf__type mesh__D000770sskos__Concept
% 222.56/222.72  |- skos__hiddenLabel mesh__D000770 Intratracheal Anesthesias
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000770 1998
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000770 2006
% 222.56/222.72  |- mesh__recordAuthorizer mesh__D000770 NLM
% 222.56/222.72  |- mesh__recordOriginator mesh__D000770 NLM
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000770 1997
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000770 2005
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000770 2002
% 222.56/222.72  |- mesh__recordMaintainer mesh__D000770 PLS
% 222.56/222.72  |- skos__hiddenLabel mesh__D000770 Anesthesias, Intratracheal
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000770 2004
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000770 1996
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000770 1995
% 222.56/222.72  |- skos__hiddenLabel mesh__D000770 Intratracheal Anesthesia
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000770 2001
% 222.56/222.72  |- skos__annotation mesh__D000770
% 222.56/222.72       /educ: coord IM %28%no qualif%29% with ANESTHESIOLOGY /educ %28%NIM%29%%A%  
% 222.56/222.72  |- skos__prefLabel mesh__D000770 Anesthesia, Intratracheal
% 222.56/222.72  |- skos__historyNote mesh__D013698 DNA %28%1966-1967%29%
% 222.56/222.72  |- skos__broader mesh__D013698smesh__D040342
% 222.56/222.72  |- mesh__dateCreated mesh__D013698 1999-01-01
% 222.56/222.72  |- mesh__recordMaintainer mesh__D013698 ags
% 222.56/222.72  |- mesh__dateEstablished mesh__D013698 1968-01-01
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D013698 2004
% 222.56/222.72  |- mesh__recordOriginator mesh__D013698 NLM
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D013698 2006A
% 222.56/222.72  |- skos__hiddenLabel mesh__D013698 Genetic Template
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D013698 2003
% 222.56/222.72  |- skos__annotation mesh__D013698
% 222.56/222.72       biol context only: not for metal templates or patterns or gauges; NIM%A%  
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D013698 2006
% 222.56/222.72  |- mesh__historyNote mesh__D013698 2003   
% 222.56/222.72  |- skos__historyNote mesh__D013698 RNA %28%1966-1967%29%
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D013698 2006C
% 222.56/222.72  |- skos__hiddenLabel mesh__D013698 Template, Genetic
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D013698 2005
% 222.56/222.72  |- skos__historyNote mesh__D013698 Genetics %28%1966-1967%29%
% 222.56/222.72  |- skos__hiddenLabel mesh__D013698 Genetic Templates
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D013698 2006B
% 222.56/222.72  |- mesh__dateRevised mesh__D013698 2005-08-03
% 222.56/222.72  |- mesh__publicMeSHNote mesh__D013698
% 222.56/222.72       2003; TEMPLATES was heading 1968-2002   
% 222.56/222.72  |- rdf__type mesh__D013698sskos__Concept
% 222.56/222.72  |- skos__scopeNote mesh__D013698
% 222.56/222.72       Macromolecular molds for the synthesis of complementary macromolecules, as in DNA REPLICATION; GENETIC TRANSCRIPTION of DNA to RNA, and GENETIC TRANSLATION of RNA into POLYPEPTIDES.%A%    
% 222.56/222.72  |- mesh__recordAuthorizer mesh__D013698 ags
% 222.56/222.72  |- skos__prefLabel mesh__D013698 Templates, Genetic
% 222.56/222.72  |- mesh__publicMeSHNote mesh__D018383 95   
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018383 2004
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018383 1999
% 222.56/222.72  |- skos__hiddenLabel mesh__D018383 Regions, Bay %28%Chemistry%29%
% 222.56/222.72  |- skos__hiddenLabel mesh__D018383 Bay Regions %28%Chemistry%29%
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018383 2002
% 222.56/222.72  |- mesh__dateCreated mesh__D018383 1994-05-27
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018383 2003
% 222.56/222.72  |- mesh__dateEstablished mesh__D018383 1995-01-01
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018383 1998
% 222.56/222.72  |- skos__altLabel mesh__D018383 Bay Region
% 222.56/222.72  |- skos__scopeNote mesh__D018383
% 222.56/222.72       An indentation of three fused benzene rings. A common bay region is the site on BENZO%28%A%29%PYRENE, an indirect carcinogen that is metabolically activated by the P-450 system at the 7,8-double bond, leading to a 7,8-oxide, which is rapidly converted to a 7,8-dihydrodiol and later epoxidated near the bay region at the 9,10-double bond. The resulting product, a diol-epoxide is a poor substrate for epoxide hydratase and is released from the mitochondria into the cell as a highly reactive electrophil, becoming an %27%ultimate%27% carcinogen, as it reacts with negative charges in DNA. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 222.56/222.72  |- skos__prefLabel mesh__D018383 Bay Region %28%Chemistry%29%
% 222.56/222.72  |- mesh__historyNote mesh__D018383 95   
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018383 2006
% 222.56/222.72  |- skos__hiddenLabel mesh__D018383 Region, Bay
% 222.56/222.72  |- mesh__recordAuthorizer mesh__D018383 PLS
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018383 2001
% 222.56/222.72  |- skos__hiddenLabel mesh__D018383 Bay Regions
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018383 2005
% 222.56/222.72  |- skos__hiddenLabel mesh__D018383 Region, Bay %28%Chemistry%29%
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018383 1997
% 222.56/222.72  |- rdf__type mesh__D018383sskos__Concept
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018383 2000
% 222.56/222.72  |- mesh__recordOriginator mesh__D018383 PXP
% 222.56/222.72  |- mesh__recordMaintainer mesh__D018383 KEV
% 222.56/222.72  |- skos__broader mesh__D018383smesh__D001665
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018383 1996
% 222.56/222.72  |- skos__annotation mesh__D018383
% 222.56/222.72       note category: a binding site; bay refers to an open graphic representation of a chem structure resembling a bay%A%  
% 222.56/222.72  |- mesh__dateRevised mesh__D018383 1995-06-08
% 222.56/222.72  |- skos__hiddenLabel mesh__D018383 Regions, Bay
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D004363 2003
% 222.56/222.72  |- mesh__dateCreated mesh__D004363 1999-01-01
% 222.56/222.72  |- skos__historyNote mesh__D004363 specific drug %28%1966-1972%29%
% 222.56/222.72  |- rdf__type mesh__D004363sskos__Concept
% 222.56/222.72  |- mesh__publicMeSHNote mesh__D004363 73   
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D004363 2000
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D004363 1999
% 222.56/222.72  |- mesh__recordMaintainer mesh__D004363 TGC
% 222.56/222.72  |- skos__hiddenLabel mesh__D004363 Utilizations, Drug
% 222.56/222.72  |- skos__hiddenLabel mesh__D004363 Drug Utilizations
% 222.56/222.72  |- skos__scopeNote mesh__D004363
% 222.56/222.72       The utilization of drugs as reported in individual hospital studies, FDA studies, marketing, or consumption, etc. This includes drug stockpiling, and patient drug profiles.%A%    
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D004363 1998
% 222.56/222.72  |- mesh__dateEstablished mesh__D004363 1973-01-01
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D004363 1997
% 222.56/222.72  |- mesh__recordOriginator mesh__D004363 NLM
% 222.56/222.72  |- mesh__dateRevised mesh__D004363 1994-05-05
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D004363 2002
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D004363 1996
% 222.56/222.72  |- skos__prefLabel mesh__D004363 Drug Utilization
% 222.56/222.72  |- skos__annotation mesh__D004363
% 222.56/222.72       NIM; not for %22%use%22% in ther from patient%27%s viewpoint %28% = drug /ther use%29%: for use by MDs, hosp, clinics, pharmacies, localities, etc.; includes over-use or over-prescription of a drug or drugs by a physician%A%  
% 222.56/222.72  |- skos__historyNote mesh__D004363 specific drug class %28%1966-1972%29%
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D004363 2006
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D004363 2005
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D004363 1995
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D004363 2004
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D004363 2001
% 222.56/222.72  |- mesh__historyNote mesh__D004363 73%28%68%29%   
% 222.56/222.72  |- skos__altLabel mesh__D004363 Utilization, Drug
% 222.56/222.72  |- mesh__recordAuthorizer mesh__D004363 PLS
% 222.56/222.72  |- skos__broader mesh__D004363smesh__D010605
% 222.56/222.72  |- mesh__recordAuthorizer mesh__D042482 sjn
% 222.56/222.72  |- skos__broader mesh__D042482smesh__D001884
% 222.56/222.72  |- mesh__recordMaintainer mesh__D042482 SYSTEM
% 222.56/222.72  |- skos__annotation mesh__D042482
% 222.56/222.72       infection: coord IM with BORDETELLA INFECTIONS %28%IM%29%   
% 222.56/222.72  |- mesh__recordOriginator mesh__D042482 ags
% 222.56/222.72  |- mesh__dateEstablished mesh__D042482 2004-01-01
% 222.56/222.72  |- mesh__dateRevised mesh__D042482 2005-06-30
% 222.56/222.72  |- rdf__type mesh__D042482sskos__Concept
% 222.56/222.72  |- skos__historyNote mesh__D042482 Bordetella %28%1984-2003%29%
% 222.56/222.72  |- skos__prefLabel mesh__D042482 Bordetella avium
% 222.56/222.72  |- mesh__dateCreated mesh__D042482 2003-07-09
% 222.56/222.72  |- skos__scopeNote mesh__D042482
% 222.56/222.72       A species of BORDETELLA isolated from the respiratory tracts of TURKEYS and other BIRDS. It causes a highly contagious bordetellosis.%A%    
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D042482 2006
% 222.56/222.72  |- mesh__historyNote mesh__D042482 2004   
% 222.56/222.72  |- mesh__publicMeSHNote mesh__D042482 2004   
% 222.56/222.72  |- mesh__recordAuthorizer mesh__D008754 ags
% 222.56/222.72  |- mesh__recordOriginator mesh__D008754 NLM
% 222.56/222.72  |- skos__historyNote mesh__D008754 Oxidoreductases %28%1973-1974%29%
% 222.56/222.72  |- mesh__dateEstablished mesh__D008754 1991-01-01
% 222.56/222.72  |- skos__hiddenLabel mesh__D008754 Dehydrogenase, Methylenetetrahydrofolate
% 222.56/222.72  |- mesh__publicMeSHNote mesh__D008754
% 222.56/222.72       2004; see METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1991-2003; see OXIDOREDUCTASES 1975-1990%A%  
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D008754 2006A
% 222.56/222.72  |- mesh__dateCreated mesh__D008754 1974-11-19
% 222.56/222.72  |- skos__broader mesh__D008754smesh__D000587
% 222.56/222.72  |- skos__annotation mesh__D008754
% 222.56/222.72       do not confuse with METHYLENETRAHYDROFOLATE DEHYDROGENASE %28%NAD+%29%%A%  
% 222.56/222.72  |- rdf__type mesh__D008754sskos__Concept
% 222.56/222.72  |- skos__prefLabel mesh__D008754
% 222.56/222.72       Methylenetetrahydrofolate Dehydrogenase %28%NADP%29%
% 222.56/222.72  |- skos__scopeNote mesh__D008754
% 222.56/222.72       An NADP-dependent oxidoreductase that catalyses the conversion of 5,10-methyleneterahydrofolate to 5,10-methenyl-tetrahydrofolate. In higher eukaryotes a trifunctional enzyme exists with additional METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE and FORMATE-TETRAHYDROFOLATE LIGASE activity. The enzyme plays an important role in the synthesis of 5-methyltetrahydrofolate, the methyl donor for the VITAMIN B12-dependent remethylation of HOMOCYSTEINE to METHIONINE via METHIONINE SYNTHETASE.%A%    
% 222.56/222.72  |- mesh__dateRevised mesh__D008754 2005-07-20
% 222.56/222.72  |- skos__related mesh__D008754smesh__D045064
% 222.56/222.72  |- skos__related mesh__D008754smesh__D005574
% 222.56/222.72  |- skos__altLabel mesh__D008754 Methylenetetrahydrofolate Dehydrogenase
% 222.56/222.72  |- skos__historyNote mesh__D008754 Tetrahydrofolates %28%1973-1974%29%
% 222.56/222.72  |- mesh__historyNote mesh__D008754 2004%28%1975%29%;   
% 222.56/222.72  |- mesh__recordMaintainer mesh__D008754 ags
% 222.56/222.72  |- skos__altLabel mesh__D008754
% 222.56/222.72       Methylenetetrahydrofolate Dehydrogenase %28%NADP+%29%
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D008754 2006
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000771 1998
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000771 2006
% 222.56/222.72  |- skos__hiddenLabel mesh__D000771 Intravenous Anesthesias
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000771 2002
% 222.56/222.72  |- skos__hiddenLabel mesh__D000771 Anesthesias, Intravenous
% 222.56/222.72  |- mesh__recordAuthorizer mesh__D000771 NLM
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000771 1997
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000771 2005
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000771 2001
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000771 2004
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000771 1996
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000771 1995
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000771 2000
% 222.56/222.72  |- skos__annotation mesh__D000771
% 222.56/222.72       /educ: coord IM %28%no qualif%29% with ANESTHESIOLOGY /educ %28%NIM%29%%A%  
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000771 2003
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000771 1994
% 222.56/222.72  |- skos__prefLabel mesh__D000771 Anesthesia, Intravenous
% 222.56/222.72  |- mesh__dateRevised mesh__D000771 1993-02-20
% 222.56/222.72  |- mesh__dateCreated mesh__D000771 1999-01-01
% 222.56/222.72  |- skos__broader mesh__D000771smesh__D000758
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000771 1999
% 222.56/222.72  |- mesh__recordOriginator mesh__D000771 NLM
% 222.56/222.72  |- rdf__type mesh__D000771sskos__Concept
% 222.56/222.72  |- mesh__recordMaintainer mesh__D000771 PLS
% 222.56/222.72  |- skos__hiddenLabel mesh__D000771 Intravenous Anesthesia
% 222.56/222.72  |- mesh__dateCreated mesh__D013699 1999-01-01
% 222.56/222.72  |- skos__hiddenLabel mesh__D013699 Arteries, Temporal
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D013699 1998
% 222.56/222.72  |- mesh__recordOriginator mesh__D013699 NLM
% 222.56/222.72  |- skos__broader mesh__D013699smesh__D002536
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D013699 2002
% 222.56/222.72  |- skos__hiddenLabel mesh__D013699 Temporal Artery
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D013699 2004
% 222.56/222.72  |- mesh__dateRevised mesh__D013699 1995-05-31
% 222.56/222.72  |- mesh__recordAuthorizer mesh__D013699 PLS
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D013699 2003
% 222.56/222.72  |- skos__hiddenLabel mesh__D013699 Artery, Temporal
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D013699 1997
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D013699 2001
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D013699 1996
% 222.56/222.72  |- mesh__recordMaintainer mesh__D013699 PXP
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D013699 2006
% 222.56/222.72  |- rdf__type mesh__D013699sskos__Concept
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D013699 2000
% 222.56/222.72  |- skos__prefLabel mesh__D013699 Temporal Arteries
% 222.56/222.72  |- skos__scopeNote mesh__D013699
% 222.56/222.72       Arteries arising from the external carotid or the maxillary artery and distributing to the temporal region.%A%    
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D013699 2005
% 222.56/222.72  |- skos__annotation mesh__D013699 inflammation = TEMPORAL ARTERITIS   
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D013699 1999
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018384 1999
% 222.56/222.72  |- skos__broader mesh__D018384smesh__D008660
% 222.56/222.72  |- mesh__recordOriginator mesh__D018384 AGS
% 222.56/222.72  |- skos__prefLabel mesh__D018384 Oxidative Stress
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018384 2002
% 222.56/222.72  |- mesh__recordMaintainer mesh__D018384 TAP
% 222.56/222.72  |- mesh__dateCreated mesh__D018384 1994-01-25
% 222.56/222.72  |- skos__hiddenLabel mesh__D018384 Stresses, Oxidative
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018384 2005
% 222.56/222.72  |- skos__annotation mesh__D018384
% 222.56/222.72       %22%disturbance in the prooxidant-antioxidant balance in favor of the former%22%%A%  
% 222.56/222.72  |- skos__hiddenLabel mesh__D018384 Oxidative Stresses
% 222.56/222.72  |- mesh__publicMeSHNote mesh__D018384 95   
% 222.56/222.72  |- mesh__historyNote mesh__D018384 95   
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018384 2006
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018384 1996
% 222.56/222.72  |- mesh__recordAuthorizer mesh__D018384 PLS
% 222.56/222.72  |- skos__scopeNote mesh__D018384
% 222.56/222.72       A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products %28%Sies, Oxidative Stress, 1991, pxv-xvi%29%.%A%    
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018384 1997
% 222.56/222.72  |- rdf__type mesh__D018384sskos__Concept
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018384 2000
% 222.56/222.72  |- skos__altLabel mesh__D018384 Stress, Oxidative
% 222.56/222.72  |- mesh__dateEstablished mesh__D018384 1995-01-01
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018384 2003
% 222.56/222.72  |- mesh__dateRevised mesh__D018384 1995-06-08
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018384 1998
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018384 2004
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018384 2001
% 222.56/222.72  |- mesh__dateRevised mesh__D004364 2004-07-13
% 222.56/222.72  |- skos__altLabel mesh__D004364 Pharmaceutic Preparations
% 222.56/222.72  |- skos__prefLabel mesh__D004364 Pharmaceutical Preparations
% 222.56/222.72  |- skos__related mesh__D004364smesh__D011955
% 222.56/222.72  |- mesh__recordMaintainer mesh__D004364 sjn
% 222.56/222.72  |- mesh__publicMeSHNote mesh__D004364 98; see DRUGS 1963-97   
% 222.56/222.72  |- skos__altLabel mesh__D004364 Preparations, Pharmaceutical
% 222.56/222.72  |- skos__hiddenLabel mesh__D004364 Preparations, Pharmaceutic
% 222.56/222.72  |- skos__altLabel mesh__D004364 Drugs
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D004364 2006
% 222.56/222.72  |- mesh__historyNote mesh__D004364 98%28%63%29%   
% 222.56/222.72  |- skos__related mesh__D004364smesh__D010946
% 222.56/222.72  |- skos__related mesh__D004364smesh__D010600
% 222.56/222.72  |- mesh__recordOriginator mesh__D004364 NLM
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D004364 2005
% 222.56/222.72  |- mesh__dateCreated mesh__D004364 1999-01-01
% 222.56/222.72  |- skos__annotation mesh__D004364
% 222.56/222.72       GEN %26% unspecified only; /adv eff permitted but consider DRUG THERAPY /adv eff; drug names: use NOMENCLATURE; policy: Manual section 25; metab detoxication of drugs = METABOLIC DETOXICATION, DRUG;%A%  
% 222.56/222.72  |- rdf__type mesh__D004364sskos__Concept
% 222.56/222.72  |- skos__scopeNote mesh__D004364
% 222.56/222.72       Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.%A%    
% 222.56/222.72  |- mesh__runningHead mesh__D004364 D26 - PHARMACEUTICAL PREPARATIONS   
% 222.56/222.72  |- mesh__recordAuthorizer mesh__D004364 sjn
% 222.56/222.72  |- mesh__historyNote mesh__D042483 2004   
% 222.56/222.72  |- skos__prefLabel mesh__D042483 Bordetella parapertussis
% 222.56/222.72  |- rdf__type mesh__D042483sskos__Concept
% 222.56/222.72  |- skos__historyNote mesh__D042483 Bordetella %28%1964-2003%29%
% 222.56/222.72  |- mesh__recordAuthorizer mesh__D042483 sjn
% 222.56/222.72  |- mesh__recordOriginator mesh__D042483 ags
% 222.56/222.72  |- mesh__dateEstablished mesh__D042483 2004-01-01
% 222.56/222.72  |- mesh__dateRevised mesh__D042483 2005-06-30
% 222.56/222.72  |- mesh__dateCreated mesh__D042483 2003-07-09
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D042483 2006
% 222.56/222.72  |- skos__scopeNote mesh__D042483
% 222.56/222.72       A species of BORDETELLA with similar morphology to BORDETELLA PERTUSSIS, but growth is more rapid. It is found only in the RESPIRATORY TRACT of humans.%A%    
% 222.56/222.72  |- mesh__publicMeSHNote mesh__D042483 2004   
% 222.56/222.72  |- skos__broader mesh__D042483smesh__D001884
% 222.56/222.72  |- mesh__recordMaintainer mesh__D042483 SYSTEM
% 222.56/222.72  |- skos__annotation mesh__D042483
% 222.56/222.72       infection: coord IM with BORDETELLA INFECTIONS %28%IM%29%   
% 222.56/222.72  |- skos__hiddenLabel mesh__D014792 Acuity, Visual
% 222.56/222.72  |- mesh__publicMeSHNote mesh__D014792 70   
% 222.56/222.72  |- skos__scopeNote mesh__D014792
% 222.56/222.72       Acuteness or clearness of vision, especially of form vision, which is dependent mainly on the sharpness of the retinal focus.%A%    
% 222.56/222.72  |- rdf__type mesh__D014792sskos__Concept
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D014792 2005
% 222.56/222.72  |- mesh__dateCreated mesh__D014792 1999-01-01
% 222.56/222.72  |- mesh__recordAuthorizer mesh__D014792 sjn
% 222.56/222.72  |- skos__prefLabel mesh__D014792 Visual Acuity
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D014792 2004
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D014792 2006
% 222.56/222.72  |- skos__related mesh__D014792smesh__D012029
% 222.56/222.72  |- skos__related mesh__D014792smesh__D005556
% 222.56/222.72  |- skos__hiddenLabel mesh__D014792 Acuities, Visual
% 222.56/222.72  |- mesh__historyNote mesh__D014792 70%28%68%29%   
% 222.56/222.72  |- skos__broader mesh__D014792smesh__D014785
% 222.56/222.72  |- mesh__recordMaintainer mesh__D014792 nns
% 222.56/222.72  |- mesh__dateEstablished mesh__D014792 1970-01-01
% 222.56/222.72  |- skos__hiddenLabel mesh__D014792 Visual Acuities
% 222.56/222.72  |- skos__historyNote mesh__D014792 Vision %28%1966-1967%29%
% 222.56/222.72  |- skos__related mesh__D014792smesh__D012030
% 222.56/222.72  |- mesh__dateRevised mesh__D014792 2003-07-09
% 222.56/222.72  |- mesh__recordOriginator mesh__D014792 NLM
% 222.56/222.72  |- skos__altLabel mesh__D008755 Methergin
% 222.56/222.72  |- rdf__type mesh__D008755sskos__Concept
% 222.56/222.72  |- mesh__dateCreated mesh__D008755 1999-01-01
% 222.56/222.72  |- skos__altLabel mesh__D008755 Novartis Brand of Methylergonovine Maleate
% 222.56/222.72  |- skos__altLabel mesh__D008755 Methylergobasin
% 222.56/222.72  |- mesh__dateRevised mesh__D008755 2005-06-30
% 222.56/222.72  |- skos__prefLabel mesh__D008755 Methylergonovine
% 222.56/222.72  |- mesh__recordOriginator mesh__D008755 NLM
% 222.56/222.72  |- mesh__recordAuthorizer mesh__D008755 sjn
% 222.56/222.72  |- skos__scopeNote mesh__D008755
% 222.56/222.72       A homolog of ERGONOVINE containing one more CH2 group. %28%Merck Index, 11th ed%29%%A%    
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D008755 2006
% 222.56/222.72  |- skos__altLabel mesh__D008755 M%C3%%A9%thergin
% 222.56/222.72  |- mesh__publicMeSHNote mesh__D008755
% 222.56/222.72       1966; for METHLERGOMETRINE MALEATE was indexed under METHYLERGONOVINE %28%NM%29% 1966-2001%A%  
% 222.56/222.72  |- mesh__recordMaintainer mesh__D008755 CCR
% 222.56/222.72  |- skos__broader mesh__D008755smesh__D004874
% 222.56/222.72  |- skos__altLabel mesh__D008755 Methylergometrine Maleate
% 222.56/222.72  |- mesh__historyNote mesh__D008755
% 222.56/222.72       1966; for METHLERGOMETRINE MALEATE use METHYLERGONOVINE %28%NM%29% 1966-2001%A%  
% 222.56/222.72  |- skos__altLabel mesh__D008755 Methylergometrine
% 222.56/222.72  |- skos__altLabel mesh__D008755 Methylergometrin
% 222.56/222.72  |- mesh__recordMaintainer mesh__D000772 ssb
% 222.56/222.72  |- mesh__recordAuthorizer mesh__D000772 sjn
% 222.56/222.72  |- skos__scopeNote mesh__D000772
% 222.56/222.72       A blocking of nerve conduction to a specific area by an injection of an anesthetic agent.%A%    
% 222.56/222.72  |- mesh__recordOriginator mesh__D000772 NLM
% 222.56/222.72  |- skos__broader mesh__D000772smesh__D000765
% 222.56/222.72  |- mesh__dateRevised mesh__D000772 2005-06-30
% 222.56/222.72  |- skos__prefLabel mesh__D000772 Anesthesia, Local
% 222.56/222.72  |- mesh__dateCreated mesh__D000772 1999-01-01
% 222.56/222.72  |- skos__related mesh__D000772smesh__D000779
% 222.56/222.72  |- skos__hiddenLabel mesh__D000772 Huneke Neural Therapy
% 222.56/222.72  |- skos__hiddenLabel mesh__D000772 Infiltration Anesthesia
% 222.56/222.72  |- skos__altLabel mesh__D000772 Local Anesthesia
% 222.56/222.72  |- rdf__type mesh__D000772sskos__Concept
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D000772 2006
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018385 2005
% 222.56/222.72  |- skos__broader mesh__D018385smesh__D022101
% 222.56/222.72  |- mesh__recordMaintainer mesh__D018385 nns
% 222.56/222.72  |- mesh__recordAuthorizer mesh__D018385 sjn
% 222.56/222.72  |- mesh__historyNote mesh__D018385 95   
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018385 2006
% 222.56/222.72  |- skos__prefLabel mesh__D018385 Centrosome
% 222.56/222.72  |- mesh__recordOriginator mesh__D018385 AGS
% 222.56/222.72  |- skos__scopeNote mesh__D018385
% 222.56/222.72       The cell center, consisting of a pair of CENTRIOLES surrounded by a cloud of amorphous material called the pericentriolar region. During interphase, the centrosome nucleates microtubule outgrowth. The centrosome duplicates and, during mitosis, separates to form the two poles of the mitotic spindle %28%MITOTIC SPINDLE APPARATUS%29%.%A%    
% 222.56/222.72  |- rdf__type mesh__D018385sskos__Concept
% 222.56/222.72  |- mesh__publicMeSHNote mesh__D018385 95   
% 222.56/222.72  |- skos__hiddenLabel mesh__D018385 Region, Pericentriolar
% 222.56/222.72  |- skos__hiddenLabel mesh__D018385 Regions, Pericentriolar
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D018385 2004
% 222.56/222.72  |- mesh__dateRevised mesh__D018385 2003-07-09
% 222.56/222.72  |- skos__hiddenLabel mesh__D018385 Pericentriolar Regions
% 222.56/222.72  |- skos__historyNote mesh__D018385 Centrioles %28%1982-1994%29%
% 222.56/222.72  |- mesh__dateEstablished mesh__D018385 1995-01-01
% 222.56/222.72  |- skos__hiddenLabel mesh__D018385 Centrosomes
% 222.56/222.72  |- mesh__dateCreated mesh__D018385 1994-01-25
% 222.56/222.72  |- mesh__historyNote mesh__D004365 88   
% 222.56/222.72  |- skos__annotation mesh__D004365
% 222.56/222.72       drugs used in MEDICINE, CHINESE TRADITIONAL or MEDICINE, KAMPO not synthetic drugs manufactured in China; D25-26 qualif; Chinese names of these drugs not capitalized in titles or translations; TN J: indexing instructions%A%  
% 222.56/222.72  |- mesh__dateEstablished mesh__D004365 1988-01-01
% 222.56/222.72  |- skos__historyNote mesh__D004365 Plant Extracts %28%1967-1987%29%
% 222.56/222.72  |- skos__hiddenLabel mesh__D004365 Extracts, Chinese Plant
% 222.56/222.72  |- skos__hiddenLabel mesh__D004365 Herbal Drugs, Chinese
% 222.56/222.72  |- mesh__recordAuthorizer mesh__D004365 sjn
% 222.56/222.72  |- mesh__recordOriginator mesh__D004365 RLS
% 222.56/222.72  |- mesh__dateCreated mesh__D004365 1987-03-25
% 222.56/222.72  |- skos__scopeNote mesh__D004365
% 222.56/222.72       Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China.%A%    
% 222.56/222.72  |- mesh__activeMeSHYear mesh__D004365 2006
% 222.56/222.72  |- skos__historyNote mesh__D004365
% 222.56/222.72       Medicine, Oriental Traditional %28%1967-1974%29%
% 222.56/222.72  |- mesh__publicMeSHNote mesh__D004365 88   
% 222.56/222.72  |- skos__altLabel mesh__D004365 Chinese Drugs, Plant
% 222.56/222.72  |- skos__hiddenLabel mesh__D004365 Chinese Plant Extracts
% 222.56/222.72  |- skos__historyNote mesh__D004365
% 222.56/222.72       Medicine, Chinese Traditional %28%1975-1987%29%
% 222.56/222.72  |- skos__broader mesh__D004365smesh__D004364
% 222.56/222.72  |- mesh__recordMaintainer mesh__D004365 ssb
% 222.56/222.72  |- mesh__dateRevised mesh__D004365 2005-06-30
% 222.56/222.72  |- skos__historyNote mesh__D004365 Plants, Medicinal %28%1966-1987%29%
% 222.56/222.72  |- rdf__type mesh__D004365sskos__Concept
% 222.56/222.72  |- skos__prefLabel mesh__D004365 Drugs, Chinese Herbal
% 222.56/222.72  |- skos__altLabel mesh__D004365 Chinese Herbal Drugs
% 222.56/222.73  |- skos__broader mesh__D004365smesh__D010936
% 222.56/222.73  |- skos__annotation mesh__D009050
% 222.56/222.73       do not confuse with TOOTH DISCOLORATION; DF: FLUOROSIS DENT%A%  
% 222.56/222.73  |- mesh__recordOriginator mesh__D009050 NLM
% 222.56/222.73  |- mesh__historyNote mesh__D009050
% 222.56/222.73       97; was MOTTLED ENAMEL 1965-96; FLUOROSIS, DENTAL was see MOTTLED ENAMEL 1987-96%A%  
% 222.56/222.73  |- mesh__dateCreated mesh__D009050 1999-01-01
% 222.56/222.73  |- mesh__publicMeSHNote mesh__D009050
% 222.56/222.73       97; was MOTTLED ENAMEL 1965-96; FLUOROSIS, DENTAL was see MOTTLED ENAMEL 1987-96%A%  
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009050 2000
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009050 1999
% 222.56/222.73  |- skos__prefLabel mesh__D009050 Fluorosis, Dental
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009050 2005
% 222.56/222.73  |- skos__hiddenLabel mesh__D009050 Enamel, Mottled
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009050 2001
% 222.56/222.73  |- skos__broader mesh__D009050smesh__D014076
% 222.56/222.73  |- skos__scopeNote mesh__D009050
% 222.56/222.73       A chronic endemic form of hypoplasia of the dental enamel caused by drinking water with a high fluorine content during the time of tooth formation, and characterized by defective calcification that gives a white chalky appearance to the enamel, which gradually undergoes brown discoloration. %28%Jablonski%27%s Dictionary of Dentistry, 1992, p286%29%%A%    
% 222.56/222.73  |- skos__hiddenLabel mesh__D009050 Enamels, Mottled
% 222.56/222.73  |- skos__altLabel mesh__D009050 Mottled Enamel
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009050 2006
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009050 2003
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009050 2002
% 222.56/222.73  |- skos__altLabel mesh__D009050 Fluoroses, Dental
% 222.56/222.73  |- mesh__recordAuthorizer mesh__D009050 SJN
% 222.56/222.73  |- skos__altLabel mesh__D009050 Dental Fluoroses
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009050 2004
% 222.56/222.73  |- skos__altLabel mesh__D009050 Dental Fluorosis
% 222.56/222.73  |- mesh__dateRevised mesh__D009050 1998-06-10
% 222.56/222.73  |- mesh__recordMaintainer mesh__D009050 AGS
% 222.56/222.73  |- rdf__type mesh__D009050sskos__Concept
% 222.56/222.73  |- mesh__dateEstablished mesh__D009050 1965-01-01
% 222.56/222.73  |- skos__hiddenLabel mesh__D009050 Mottled Enamels
% 222.56/222.73  |- mesh__recordMaintainer mesh__D050916 ssb
% 222.56/222.73  |- skos__altLabel mesh__D050916 Capsaicin Receptors
% 222.56/222.73  |- skos__hiddenLabel mesh__D050916 Channels, TRPV Cation
% 222.56/222.73  |- mesh__dateEstablished mesh__D050916 2006-01-01
% 222.56/222.73  |- skos__altLabel mesh__D050916 Vanilloid Receptors
% 222.56/222.73  |- mesh__recordAuthorizer mesh__D050916 sjn
% 222.56/222.73  |- mesh__publicMeSHNote mesh__D050916
% 222.56/222.73       2006; CAPSAICIN RECEPTORS was indexed under RECEPTRS, DRUG 1991-2005%A%  
% 222.56/222.73  |- skos__scopeNote mesh__D050916
% 222.56/222.73       A subgroup of TRP cation channels named after vanilloid receptor. They are very sensitive to TEMPERATURE and hot spicy food and CAPSAICIN. They have the TRP domain and ANKYRIN repeats. Selectivity for CALCIUM over SODIUM ranges from 3 to 100 fold.%A%    
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D050916 2006
% 222.56/222.73  |- skos__broader mesh__D050916smesh__D050051
% 222.56/222.73  |- skos__prefLabel mesh__D050916 TRPV Cation Channels
% 222.56/222.73  |- rdf__type mesh__D050916sskos__Concept
% 222.56/222.73  |- skos__hiddenLabel mesh__D050916 Cation Channels, TRPV
% 222.56/222.73  |- mesh__historyNote mesh__D050916 2006%28%1991%29%   
% 222.56/222.73  |- skos__hiddenLabel mesh__D050916 Receptors, Vanilloid
% 222.56/222.73  |- mesh__recordOriginator mesh__D050916 ssb
% 222.56/222.73  |- skos__hiddenLabel mesh__D050916 Receptors, Capsaicin
% 222.56/222.73  |- mesh__dateCreated mesh__D050916 2005-06-30
% 222.56/222.73  |- skos__broader mesh__D005784Q000379smesh__D005784
% 222.56/222.73  |- mesh__preferredCombination mesh__D005784Q000379smesh__D021141
% 222.56/222.73  |- rdf__type mesh__D005784Q000379smesh__CompoundConcept
% 222.56/222.73  |- rdf__type mesh__D014793sskos__Concept
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D014793 1999
% 222.56/222.73  |- mesh__dateEstablished mesh__D014793 1970-01-01
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D014793 2005
% 222.56/222.73  |- mesh__dateCreated mesh__D014793 1999-01-01
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D014793 2000
% 222.56/222.73  |- mesh__recordOriginator mesh__D014793 NLM
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D014793 2004
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D014793 2001
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D014793 2006
% 222.56/222.73  |- mesh__dateRevised mesh__D014793 1998-06-11
% 222.56/222.73  |- mesh__publicMeSHNote mesh__D014793 70   
% 222.56/222.73  |- skos__historyNote mesh__D014793 Cerebral Cortex %28%1966-1967%29%
% 222.56/222.73  |- mesh__recordMaintainer mesh__D014793 MSR
% 222.56/222.73  |- skos__annotation mesh__D014793
% 222.56/222.73       do not confuse STRIATE CORTEX with CORPUS STRIATUM %28%basal ganglia%29%%A%  
% 222.56/222.73  |- mesh__recordAuthorizer mesh__D014793 SJN
% 222.56/222.73  |- mesh__historyNote mesh__D014793 70%28%68%29%   
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D014793 2002
% 222.56/222.73  |- skos__historyNote mesh__D014793 Vision %28%1966-1967%29%
% 222.56/222.73  |- skos__hiddenLabel mesh__D014793 Cortex, Visual
% 222.56/222.73  |- skos__hiddenLabel mesh__D014793 Cortex, Striate
% 222.56/222.73  |- skos__broader mesh__D014793smesh__D009778
% 222.56/222.73  |- skos__prefLabel mesh__D014793 Visual Cortex
% 222.56/222.73  |- skos__scopeNote mesh__D014793
% 222.56/222.73       Area of the occipital lobe concerned with vision.     
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D014793 2003
% 222.56/222.73  |- mesh__recordMaintainer mesh__D008756 ssb
% 222.56/222.73  |- skos__broader mesh__D008756smesh__D005697
% 222.56/222.73  |- mesh__historyNote mesh__D008756
% 222.56/222.73       91%28%75%29%; was see under METHYLGLYCOSIDES 1975-90   
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D008756 2006
% 222.56/222.73  |- mesh__publicMeSHNote mesh__D008756
% 222.56/222.73       91; was see under METHYLGLYCOSIDES 1975-90   
% 222.56/222.73  |- skos__broader mesh__D008756smesh__D008759
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D008756 2005
% 222.56/222.73  |- mesh__onlineNote mesh__D008756 search METHYLGLYCOSIDES 1974   
% 222.56/222.73  |- mesh__recordAuthorizer mesh__D008756 sjn
% 222.56/222.73  |- mesh__recordOriginator mesh__D008756 NLM
% 222.56/222.73  |- mesh__dateEstablished mesh__D008756 1991-01-01
% 222.56/222.73  |- skos__prefLabel mesh__D008756 Methylgalactosides
% 222.56/222.73  |- mesh__dateRevised mesh__D008756 2004-07-07
% 222.56/222.73  |- skos__altLabel mesh__D008756 Methylgalactopyranosides
% 222.56/222.73  |- rdf__type mesh__D008756sskos__Concept
% 222.56/222.73  |- mesh__dateCreated mesh__D008756 1999-01-01
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000773 1997
% 222.56/222.73  |- skos__hiddenLabel mesh__D000773 Anesthesia, Gynecologic
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000773 2003
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000773 1994
% 222.56/222.73  |- mesh__dateCreated mesh__D000773 1999-01-01
% 222.56/222.73  |- skos__hiddenLabel mesh__D000773 Obstetric Anesthesia
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000773 2004
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000773 1995
% 222.56/222.73  |- skos__broader mesh__D000773smesh__D000758
% 222.56/222.73  |- skos__altLabel mesh__D000773 Anesthesia, Obstetric
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000773 2002
% 222.56/222.73  |- skos__annotation mesh__D000773
% 222.56/222.73       /educ: coord IM %28%no qualif%29% with ANESTHESIOLOGY /educ %28%NIM%29%%A%  
% 222.56/222.73  |- skos__prefLabel mesh__D000773 Anesthesia, Obstetrical
% 222.56/222.73  |- skos__hiddenLabel mesh__D000773 Gynecological Anesthesia
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000773 1998
% 222.56/222.73  |- mesh__recordOriginator mesh__D000773 NLM
% 222.56/222.73  |- mesh__recordAuthorizer mesh__D000773 NLM
% 222.56/222.73  |- skos__hiddenLabel mesh__D000773 Paracervical Blocks
% 222.56/222.73  |- skos__altLabel mesh__D000773 Anesthesia, Gynecological
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000773 1999
% 222.56/222.73  |- skos__hiddenLabel mesh__D000773 Blocks, Paracervical
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000773 2005
% 222.56/222.73  |- skos__hiddenLabel mesh__D000773 Block, Paracervical
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000773 2000
% 222.56/222.73  |- mesh__recordMaintainer mesh__D000773 PLS
% 222.56/222.73  |- rdf__type mesh__D000773sskos__Concept
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000773 2006
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000773 1996
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000773 2001
% 222.56/222.73  |- skos__hiddenLabel mesh__D000773 Obstetrical Anesthesia
% 222.56/222.73  |- mesh__dateRevised mesh__D000773 1993-02-20
% 222.56/222.73  |- rdf__type mesh__D018386sskos__Concept
% 222.56/222.73  |- skos__historyNote mesh__D018386 Chromosomes %28%1966-1994%29%
% 222.56/222.73  |- skos__scopeNote mesh__D018386
% 222.56/222.73       Large multiprotein complexes that bind the centromeres of the chromosomes to the microtubules of the mitotic spindle during metaphase in the cell cycle.%A%    
% 222.56/222.73  |- mesh__dateEstablished mesh__D018386 1995-01-01
% 222.56/222.73  |- skos__annotation mesh__D018386 A 11 qualif except /cytol   
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D018386 2004
% 222.56/222.73  |- mesh__dateRevised mesh__D018386 2003-07-09
% 222.56/222.73  |- skos__hiddenLabel mesh__D018386 Kinetochore
% 222.56/222.73  |- mesh__dateCreated mesh__D018386 1994-01-25
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D018386 2005
% 222.56/222.73  |- skos__prefLabel mesh__D018386 Kinetochores
% 222.56/222.73  |- mesh__historyNote mesh__D018386 95   
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D018386 2006
% 222.56/222.73  |- skos__broader mesh__D018386smesh__D002503
% 222.56/222.73  |- mesh__publicMeSHNote mesh__D018386 95   
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D004366 2005
% 222.56/222.73  |- skos__hiddenLabel mesh__D004366 Drugs, Over-the-Counter
% 222.56/222.73  |- skos__hiddenLabel mesh__D004366 Nonprescription Drugs
% 222.56/222.73  |- mesh__recordOriginator mesh__D004366 NLM
% 222.56/222.73  |- skos__altLabel mesh__D004366 Over-the-Counter Drugs
% 222.56/222.73  |- mesh__dateCreated mesh__D004366 1999-01-01
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D004366 2006
% 222.56/222.73  |- skos__altLabel mesh__D004366 Drugs, Nonprescription
% 222.56/222.73  |- mesh__dateRevised mesh__D004366 2003-07-09
% 222.56/222.73  |- skos__altLabel mesh__D004366 Medicines, Patent
% 222.56/222.73  |- mesh__historyNote mesh__D004366 74%28%73%29%   
% 222.56/222.73  |- skos__altLabel mesh__D004366 Patent Medicines
% 222.56/222.73  |- skos__annotation mesh__D004366 D25-26 qualif; DF: note short X ref   
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D004366 2004
% 222.56/222.73  |- skos__hiddenLabel mesh__D004366 Over the Counter Drugs
% 222.56/222.73  |- skos__scopeNote mesh__D004366
% 222.56/222.73       Drugs that can be sold legally without a prescription.     
% 222.56/222.73  |- skos__broader mesh__D004366smesh__D004364
% 222.56/222.73  |- skos__hiddenLabel mesh__D004366 Drugs, OTC
% 222.56/222.73  |- mesh__dateEstablished mesh__D004366 1974-01-01
% 222.56/222.73  |- mesh__recordAuthorizer mesh__D004366 sjn
% 222.56/222.73  |- rdf__type mesh__D004366sskos__Concept
% 222.56/222.73  |- skos__hiddenLabel mesh__D004366 Non-Prescription Drugs
% 222.56/222.73  |- skos__prefLabel mesh__D004366 Drugs, Non-Prescription
% 222.56/222.73  |- skos__hiddenLabel mesh__D004366 Drugs, Non Prescription
% 222.56/222.73  |- skos__altLabel mesh__D004366 OTC Drugs
% 222.56/222.73  |- mesh__publicMeSHNote mesh__D004366 74   
% 222.56/222.73  |- mesh__recordMaintainer mesh__D004366 ssb
% 222.56/222.73  |- skos__historyNote mesh__D004366 Drugs %28%1966-1972%29%
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009051 1999
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009051 2005
% 222.56/222.73  |- mesh__dateRevised mesh__D009051 1996-06-10
% 222.56/222.73  |- skos__broader mesh__D009051smesh__D013177
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009051 1997
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009051 2006
% 222.56/222.73  |- mesh__recordOriginator mesh__D009051 NLM
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009051 2003
% 222.56/222.73  |- skos__prefLabel mesh__D009051 Mountaineering
% 222.56/222.73  |- mesh__recordMaintainer mesh__D009051 TAP
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009051 2000
% 222.56/222.73  |- skos__related mesh__D009051smesh__D000531
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009051 2004
% 222.56/222.73  |- skos__annotation mesh__D009051
% 222.56/222.73       /inj: coord IM with specific inj %28%IM%29%; /physiol permitted; Manual 30.15.1%A%  
% 222.56/222.73  |- skos__scopeNote mesh__D009051
% 222.56/222.73       A sport involving mountain climbing techniques.     
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009051 2001
% 222.56/222.73  |- rdf__type mesh__D009051sskos__Concept
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009051 2002
% 222.56/222.73  |- skos__hiddenLabel mesh__D009051 Mountaineerings
% 222.56/222.73  |- mesh__recordAuthorizer mesh__D009051 PLS
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009051 1998
% 222.56/222.73  |- mesh__dateCreated mesh__D009051 1999-01-01
% 222.56/222.73  |- skos__broader mesh__D014794smesh__D014785
% 222.56/222.73  |- mesh__recordMaintainer mesh__D014794 nns
% 222.56/222.73  |- skos__related mesh__D014794smesh__D010499
% 222.56/222.73  |- mesh__dateRevised mesh__D014794 2003-07-09
% 222.56/222.73  |- skos__prefLabel mesh__D014794 Visual Fields
% 222.56/222.73  |- mesh__recordOriginator mesh__D014794 NLM
% 222.56/222.73  |- rdf__type mesh__D014794sskos__Concept
% 222.56/222.73  |- skos__hiddenLabel mesh__D014794 Visual Field
% 222.56/222.73  |- skos__hiddenLabel mesh__D014794 Fields, Visual
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D014794 2005
% 222.56/222.73  |- mesh__dateCreated mesh__D014794 1999-01-01
% 222.56/222.73  |- skos__hiddenLabel mesh__D014794 Field, Visual
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D014794 2004
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D014794 2006
% 222.56/222.73  |- mesh__recordAuthorizer mesh__D014794 sjn
% 222.56/222.73  |- skos__broader mesh__D008757smesh__D005960
% 222.56/222.73  |- mesh__recordAuthorizer mesh__D008757 sjn
% 222.56/222.73  |- mesh__recordOriginator mesh__D008757 NLM
% 222.56/222.73  |- mesh__recordMaintainer mesh__D008757 ssb
% 222.56/222.73  |- mesh__onlineNote mesh__D008757 search METHYLGLYCOSIDES 1974   
% 222.56/222.73  |- mesh__historyNote mesh__D008757
% 222.56/222.73       91%28%75%29%; was see under METHYLGLYCOSIDES 1975-90   
% 222.56/222.73  |- mesh__dateEstablished mesh__D008757 1991-01-01
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D008757 2005
% 222.56/222.73  |- skos__annotation mesh__D008757 do not confuse with METHYLGLYCOSIDES   
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D008757 2006
% 222.56/222.73  |- mesh__publicMeSHNote mesh__D008757
% 222.56/222.73       91; was see under METHYLGLYCOSIDES 1975-90   
% 222.56/222.73  |- skos__broader mesh__D008757smesh__D008759
% 222.56/222.73  |- mesh__dateRevised mesh__D008757 2004-07-07
% 222.56/222.73  |- mesh__dateCreated mesh__D008757 1999-01-01
% 222.56/222.73  |- skos__altLabel mesh__D008757 Methylglucopyranosides
% 222.56/222.73  |- skos__prefLabel mesh__D008757 Methylglucosides
% 222.56/222.73  |- rdf__type mesh__D008757sskos__Concept
% 222.56/222.73  |- skos__broader mesh__D000774smesh__D000768
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000774 2003
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000774 1994
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000774 2002
% 222.56/222.73  |- skos__annotation mesh__D000774
% 222.56/222.73       /educ: coord IM %28%no qualif%29% with ANESTHESIOLOGY /educ %28%NIM%29%%A%  
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000774 2004
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000774 1998
% 222.56/222.73  |- skos__prefLabel mesh__D000774 Anesthesia, Rectal
% 222.56/222.73  |- mesh__recordOriginator mesh__D000774 NLM
% 222.56/222.73  |- mesh__recordAuthorizer mesh__D000774 NLM
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000774 1995
% 222.56/222.73  |- skos__hiddenLabel mesh__D000774 Rectal Anesthesias
% 222.56/222.73  |- skos__hiddenLabel mesh__D000774 Rectal Anesthesia
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000774 1999
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000774 2000
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000774 1996
% 222.56/222.73  |- rdf__type mesh__D000774sskos__Concept
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000774 2005
% 222.56/222.73  |- mesh__dateRevised mesh__D000774 1993-02-20
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000774 2001
% 222.56/222.73  |- skos__hiddenLabel mesh__D000774 Anesthesias, Rectal
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000774 1997
% 222.56/222.73  |- mesh__recordMaintainer mesh__D000774 PLS
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D000774 2006
% 222.56/222.73  |- mesh__dateCreated mesh__D000774 1999-01-01
% 222.56/222.73  |- mesh__dateRevised mesh__D018387 2005-06-30
% 222.56/222.73  |- mesh__publicMeSHNote mesh__D018387 95   
% 222.56/222.73  |- skos__hiddenLabel mesh__D018387 Codons, Start
% 222.56/222.73  |- skos__prefLabel mesh__D018387 Codon, Initiator
% 222.56/222.73  |- skos__scopeNote mesh__D018387
% 222.56/222.73       A codon that directs initiation of protein translation %28%TRANSLATION, GENETIC%29% by stimulating the binding of initiator tRNA %28%RNA, TRANSFER, MET%29%. In prokaryotes, the codons AUG or GUG can act as initiators while in eukaryotes, AUG is the only initiator codon.%A%    
% 222.56/222.73  |- skos__hiddenLabel mesh__D018387 Initiation Codons
% 222.56/222.73  |- skos__related mesh__D018387smesh__D014176
% 222.56/222.73  |- skos__altLabel mesh__D018387 Codon, Initiation
% 222.56/222.73  |- mesh__dateEstablished mesh__D018387 1995-01-01
% 222.56/222.73  |- skos__altLabel mesh__D018387 Initiator Codon
% 222.56/222.73  |- skos__hiddenLabel mesh__D018387 Initiator Codons
% 222.56/222.73  |- skos__hiddenLabel mesh__D018387 Start Codons
% 222.56/222.73  |- skos__hiddenLabel mesh__D018387 Initiation Codon
% 222.56/222.73  |- mesh__recordOriginator mesh__D018387 PXP
% 222.56/222.73  |- mesh__recordMaintainer mesh__D018387 nns
% 222.56/222.73  |- skos__hiddenLabel mesh__D018387 Codons, Initiator
% 222.56/222.73  |- mesh__historyNote mesh__D018387 95   
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D018387 2006
% 222.56/222.73  |- mesh__recordAuthorizer mesh__D018387 sjn
% 222.56/222.73  |- rdf__type mesh__D018387sskos__Concept
% 222.56/222.73  |- skos__broader mesh__D018387smesh__D003062
% 222.56/222.73  |- skos__altLabel mesh__D018387 Start Codon
% 222.56/222.73  |- skos__hiddenLabel mesh__D018387 Codons, Initiation
% 222.56/222.73  |- skos__related mesh__D018387smesh__D010442
% 222.56/222.73  |- skos__historyNote mesh__D018387 Codon %28%1975-1994%29%
% 222.56/222.73  |- skos__altLabel mesh__D018387 Codon, Start
% 222.56/222.73  |- mesh__dateCreated mesh__D018387 1994-06-03
% 222.56/222.73  |- mesh__publicMeSHNote mesh__D037541
% 222.56/222.73       2003; LACTOSE-BINDING AGGLUTINATION FACTOR was indexed under HEMAGGLUTININS 1984-2002%A%  
% 222.56/222.73  |- mesh__recordMaintainer mesh__D037541 jmp
% 222.56/222.73  |- skos__scopeNote mesh__D037541
% 222.56/222.73       A galectin found in the small and large intestine and the stomach. It occurs as a homodimer with two 36-kDa subunits and is localized to sites of cell adhesion where it may play role in assembly of ADHERENS JUNCTIONS.%A%    
% 222.56/222.73  |- skos__altLabel mesh__D037541 Lactose-Binding Lectin, L-36
% 222.56/222.73  |- skos__hiddenLabel mesh__D037541 L-36 Lactose-Binding Lectin
% 222.56/222.73  |- mesh__dateCreated mesh__D037541 2002-07-03
% 222.56/222.73  |- skos__prefLabel mesh__D037541 Galectin 4
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D037541 2005
% 222.56/222.73  |- mesh__recordAuthorizer mesh__D037541 sjn
% 222.56/222.73  |- skos__hiddenLabel mesh__D037541 L-36 Lactose-Binding Protein
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D037541 2006
% 222.56/222.73  |- skos__altLabel mesh__D037541 Lactose-Binding Protein, L-36
% 222.56/222.73  |- mesh__historyNote mesh__D037541
% 222.56/222.73       2003; use GALECTIN 4 %28%NM%29% 1984-2002   
% 222.56/222.73  |- skos__altLabel mesh__D037541 LGALS4
% 222.56/222.73  |- skos__altLabel mesh__D037541 Galectin-4
% 222.56/222.73  |- skos__broader mesh__D037541smesh__D037161
% 222.56/222.73  |- mesh__recordOriginator mesh__D037541 jmp
% 222.56/222.73  |- skos__historyNote mesh__D037541 Hemagglutinins %28%1984-2002%29%
% 222.56/222.73  |- skos__altLabel mesh__D037541
% 222.56/222.73       Lectin, Galactoside-Binding, Soluble, 4 Protein
% 222.56/222.73  |- mesh__dateEstablished mesh__D037541 2003-01-01
% 222.56/222.73  |- mesh__dateRevised mesh__D037541 2004-07-07
% 222.56/222.73  |- skos__hiddenLabel mesh__D037541 Lactose Binding Protein, L 36
% 222.56/222.73  |- rdf__type mesh__D037541sskos__Concept
% 222.56/222.73  |- skos__hiddenLabel mesh__D037541 Lactose Binding Lectin, L 36
% 222.56/222.73  |- skos__hiddenLabel mesh__D037541 Lectin, L-36 Lactose-Binding
% 222.56/222.73  |- skos__annotation mesh__D004367 note X ref; a refrigerant   
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D004367 2004
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D004367 2001
% 222.56/222.73  |- skos__hiddenLabel mesh__D004367 Dioxide Snow, Carbon
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D004367 1998
% 222.56/222.73  |- rdf__type mesh__D004367sskos__Concept
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D004367 2002
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D004367 1999
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D004367 1996
% 222.56/222.73  |- skos__hiddenLabel mesh__D004367 Snow, Carbon Dioxide
% 222.56/222.73  |- skos__broader mesh__D004367smesh__D002245
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D004367 1997
% 222.56/222.73  |- mesh__recordMaintainer mesh__D004367 TPW
% 222.56/222.73  |- mesh__recordOriginator mesh__D004367 NLM
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D004367 2005
% 222.56/222.73  |- mesh__dateRevised mesh__D004367 1993-06-04
% 222.56/222.73  |- skos__altLabel mesh__D004367 Carbon Dioxide Snow
% 222.56/222.73  |- mesh__recordAuthorizer mesh__D004367 PLS
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D004367 2006
% 222.56/222.73  |- mesh__dateCreated mesh__D004367 1999-01-01
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D004367 1994
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D004367 2003
% 222.56/222.73  |- skos__hiddenLabel mesh__D004367 Ice, Dry
% 222.56/222.73  |- skos__prefLabel mesh__D004367 Dry Ice
% 222.56/222.73  |- skos__scopeNote mesh__D004367
% 222.56/222.73       A solid form of carbon dioxide used as a refrigerant.     
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D004367 2000
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D004367 1995
% 222.56/222.73  |- skos__scopeNote mesh__D009850
% 222.56/222.73       A sultanate on the southeast coast of the Arabian peninsula. Its capital is Masqat. Before the 16th century it was ruled by independent emirs but was captured and controlled by the Portuguese 1508-1648. In 1741 it was recovered by a descendent of Yemen%27%s imam. After its decline in the 19th century, it became virtually a political and economic dependency within the British Government of India, retaining close ties with Great Britain by treaty from 1939 to 1970 when it achieved autonomy. The name was recorded by Pliny in the 1st century A.D. as Omana, said to be derived from the founder of the state, Oman ben Ibrahim al-Khalil. %28%From Webster%27%s New Geographical Dictionary, 1988, p890; Oman Embassy, Washington; Room, Brewer%27%s Dictionary of Names, 1992, p391%29%%A%    
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009850 2000
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009850 1998
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009850 2005
% 222.56/222.73  |- skos__annotation mesh__D009850
% 222.56/222.73       a sultanate on the southeast Arabian peninsula   
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009850 1999
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009850 2006
% 222.56/222.73  |- mesh__recordMaintainer mesh__D009850 TGC
% 222.56/222.73  |- skos__broader mesh__D009850smesh__D008877
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009850 2001
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009850 2003
% 222.56/222.73  |- mesh__dateEstablished mesh__D009850 1975-01-01
% 222.56/222.73  |- rdf__type mesh__D009850sskos__Concept
% 222.56/222.73  |- skos__prefLabel mesh__D009850 Oman
% 222.56/222.73  |- mesh__historyNote mesh__D009850 79; was MUSCAT %26% OMAN 1975-78   
% 222.56/222.73  |- mesh__dateRevised mesh__D009850 1996-06-10
% 222.56/222.73  |- mesh__recordOriginator mesh__D009850 NLM
% 222.56/222.73  |- mesh__onlineNote mesh__D009850
% 222.56/222.73       use OMAN to search MUSCAT %26% OMAN 1975-78   
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009850 1997
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009850 2004
% 222.56/222.73  |- mesh__dateCreated mesh__D009850 1974-11-11
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009850 2002
% 222.56/222.73  |- mesh__recordAuthorizer mesh__D009850 PLS
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D023521 2002
% 222.56/222.73  |- skos__hiddenLabel mesh__D023521 Chlamydophila Infection
% 222.56/222.73  |- mesh__dateCreated mesh__D023521 2000-06-22
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D023521 2005
% 222.56/222.73  |- skos__hiddenLabel mesh__D023521 Infection, Chlamydophila
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D023521 2006
% 222.56/222.73  |- mesh__historyNote mesh__D023521 2001   
% 222.56/222.73  |- skos__prefLabel mesh__D023521 Chlamydophila Infections
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D023521 2001
% 222.56/222.73  |- rdf__type mesh__D023521sskos__Concept
% 222.56/222.73  |- mesh__dateEstablished mesh__D023521 2001-01-01
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D023521 2003
% 222.56/222.73  |- skos__broader mesh__D023521smesh__D002694
% 222.56/222.73  |- skos__scopeNote mesh__D023521
% 222.56/222.73       Infections with bacteria of the genus CHLAMYDOPHILA.     
% 222.56/222.73  |- mesh__publicMeSHNote mesh__D023521 2001   
% 222.56/222.73  |- skos__hiddenLabel mesh__D023521 Infections, Chlamydophila
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D023521 2004
% 222.56/222.73  |- skos__altLabel mesh__D009052 Leukemia Viruses, Murine
% 222.56/222.73  |- skos__altLabel mesh__D009052 Murine Leukemia Viruses
% 222.56/222.73  |- skos__broader mesh__D009052smesh__D017988
% 222.56/222.73  |- mesh__publicMeSHNote mesh__D009052
% 222.56/222.73       2002; see LEUKEMIA VIRUSES, MURINE 1994-2001, see MOUSE LEUKEMIA VIRUSES 1966-1993; for GRAFFI VIRUS see GRAFFI VIRUS 1991, see MOUSE LEUKEMIA VIRUSES 1975-1990; for GRAFFI%27%S CHLOROLEUKEMIC STRAIN see GRAFFI VIRUS 1975-1991%A%  
% 222.56/222.73  |- rdf__type mesh__D009052sskos__Concept
% 222.56/222.73  |- skos__altLabel mesh__D009052 Mouse Leukemia Viruses
% 222.56/222.73  |- skos__hiddenLabel mesh__D009052 Graffi Chloroleukemic Strain
% 222.56/222.73  |- skos__altLabel mesh__D009052 Murine leukemia virus
% 222.56/222.73  |- skos__hiddenLabel mesh__D009052 Graffis Chloroleukemic Strain
% 222.56/222.73  |- skos__annotation mesh__D009052
% 222.56/222.73       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% + LEUKEMIA, EXPERIMENTAL %28%IM%29%%A%  
% 222.56/222.73  |- mesh__dateCreated mesh__D009052 1999-01-01
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009052 2005
% 222.56/222.73  |- skos__scopeNote mesh__D009052
% 222.56/222.73       Species of GAMMARETROVIRUS, containing many well-defined strains, producing leukemia in mice. Disease is commonly induced by injecting filtrates of propagable tumors into newborn mice.%A%    
% 222.56/222.73  |- mesh__recordOriginator mesh__D009052 NLM
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009052 2003
% 222.56/222.73  |- mesh__recordAuthorizer mesh__D009052 sjn
% 222.56/222.73  |- mesh__dateEstablished mesh__D009052 1966-01-01
% 222.56/222.73  |- mesh__historyNote mesh__D009052
% 222.56/222.73       2002 %28%1966%29%; was MOUSE LEUKEMIA VIRUSES 1966-93; for GRAFFI VIRUS use GRAFFI VIRUS 1991, use MOUSE LEUKEMIA VIRUSES 1975-1990; for GRAFFI%27%S CHLOROLEUKEMIC STRAIN use GRAFFI VIRUS 1975-1991%A%  
% 222.56/222.73  |- skos__hiddenLabel mesh__D009052 Leukemia Viruses, Mouse
% 222.56/222.73  |- mesh__recordMaintainer mesh__D009052 ags
% 222.56/222.73  |- mesh__dateRevised mesh__D009052 2002-07-03
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009052 2006
% 222.56/222.73  |- skos__prefLabel mesh__D009052 Leukemia Virus, Murine
% 222.56/222.73  |- mesh__activeMeSHYear mesh__D009052 2004
% 222.56/222.73  |- skos__hiddenLabel mesh__D050918
% 222.56/222.73       N-Methyltransferase-2, Phosphatidylethanolamine
% 222.56/222.73  |- skos__broader mesh__D050918smesh__D008780
% 222.56/222.73  |- skos__hiddenLabel mesh__D050918 Methyltransferase II, Phospholipid
% 222.56/222.73  |- skos__altLabel mesh__D050918
% 222.56/222.73       S-Adenosylmethionine Phosphatidylethanolamine N-Methyltransferase
% 222.56/222.73  |- rdf__type mesh__D050918sskos__Concept
% 222.56/222.73  |- skos__altLabel mesh__D050918 PHET Methyltransferase II
% 222.56/222.73  |- skos__hiddenLabel mesh__D050918
% 222.56/222.73       Phosphatidylethanolamine Methyltransferase II
% 222.56/222.73  |- skos__altLabel mesh__D050918
% 222.56/222.73       Phosphatidylethanolamine-Phosphatidylcholine N-Methyltransferase
% 222.56/222.73  |- mesh__recordMaintainer mesh__D050918 AKE
% 222.56/222.74  |- mesh__historyNote mesh__D050918
% 222.56/222.74       2006%28%1980%29%; use CEPHALINS 1971-1979   
% 222.56/222.74  |- skos__hiddenLabel mesh__D050918 N-Methyltransferase, Cephalin
% 222.56/222.74  |- skos__hiddenLabel mesh__D050918
% 222.56/222.74       Phosphatidylethanolamine N-Methyltransferase, S-Adenosylmethionine
% 222.56/222.74  |- skos__hiddenLabel mesh__D050918
% 222.56/222.74       Phosphatidylethanolamine N Methyltransferase
% 222.56/222.74  |- skos__altLabel mesh__D050918
% 222.56/222.74       Phosphatidylethanolamine-Methyltransferase II
% 222.56/222.74  |- skos__altLabel mesh__D050918 Phosphatidylethanolamine Methyltransferase
% 222.56/222.74  |- mesh__dateCreated mesh__D050918 2005-06-30
% 222.56/222.74  |- mesh__dateEstablished mesh__D050918 2006-01-01
% 222.56/222.74  |- skos__altLabel mesh__D050918 Phospholipid Methyltransferase II
% 222.56/222.74  |- skos__hiddenLabel mesh__D050918
% 222.56/222.74       Phosphatidylethanolamine N Methyltransferase 2
% 222.56/222.74  |- mesh__publicMeSHNote mesh__D050918
% 222.56/222.74       2006; PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1981-2005, %26% under CEPHALINS 1971-1979%A%  
% 222.56/222.74  |- skos__hiddenLabel mesh__D050918
% 222.56/222.74       N-Methyltransferase, S-Adenosylmethionine Phosphatidylethanolamine
% 222.56/222.74  |- mesh__recordOriginator mesh__D050918 AKE
% 222.56/222.74  |- skos__hiddenLabel mesh__D050918
% 222.56/222.74       Phosphatidylethanolamine Phosphatidylcholine N Methyltransferase
% 222.56/222.74  |- skos__hiddenLabel mesh__D050918 Cephalin N Methyltransferase
% 222.56/222.74  |- skos__hiddenLabel mesh__D050918
% 222.56/222.74       Methyltransferase, Phosphatidylethanolamine
% 222.56/222.74  |- skos__hiddenLabel mesh__D050918
% 222.56/222.74       N-Methyltransferase, Phosphatidylethanolamine
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D050918 2006
% 222.56/222.74  |- skos__prefLabel mesh__D050918
% 222.56/222.74       Phosphatidylethanolamine N-Methyltransferase
% 222.56/222.74  |- skos__hiddenLabel mesh__D050918
% 222.56/222.74       N-Methyltransferase, Phosphatidylethanolamine-Phosphatidylcholine
% 222.56/222.74  |- mesh__recordAuthorizer mesh__D050918 sjn
% 222.56/222.74  |- skos__hiddenLabel mesh__D050918
% 222.56/222.74       S Adenosylmethionine Phosphatidylethanolamine N Methyltransferase
% 222.56/222.74  |- skos__scopeNote mesh__D050918
% 222.56/222.74       An enzyme that catalyses three sequential METHYLATION reactions for conversion of PHOSPHATIDYLETHANOLAMINE to PHOSPHATIDYLCHOLINE.%A%    
% 222.56/222.74  |- skos__hiddenLabel mesh__D050918 Methyltransferase II, PHET
% 222.56/222.74  |- skos__hiddenLabel mesh__D014795 Visual Pathway
% 222.56/222.74  |- mesh__dateRevised mesh__D014795 2005-07-28
% 222.56/222.74  |- skos__hiddenLabel mesh__D014795 Pathway, Visual
% 222.56/222.74  |- skos__historyNote mesh__D014795 Vision %28%1966-1970%29%
% 222.56/222.74  |- skos__hiddenLabel mesh__D014795 Tract, Optic
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D014795 2002
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D014795 2006A
% 222.56/222.74  |- mesh__publicMeSHNote mesh__D014795 72   
% 222.56/222.74  |- mesh__recordAuthorizer mesh__D014795 ags
% 222.56/222.74  |- skos__scopeNote mesh__D014795
% 222.56/222.74       Set of cell bodies and nerve fibers conducting impulses from the eyes to the cerebral cortex. It includes the RETINA; OPTIC NERVE; optic tract; and geniculocalcarine tract.%A%    
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D014795 2003
% 222.56/222.74  |- rdf__type mesh__D014795sskos__Concept
% 222.56/222.74  |- mesh__dateCreated mesh__D014795 1999-01-01
% 222.56/222.74  |- skos__hiddenLabel mesh__D014795 Optic Tracts
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D014795 2005
% 222.56/222.74  |- mesh__historyNote mesh__D014795 72%28%71%29%   
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D014795 2004
% 222.56/222.74  |- skos__historyNote mesh__D014795 Central Nervous System %28%1966-1970%29%
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D014795 2006
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D014795 2000
% 222.56/222.74  |- mesh__dateEstablished mesh__D014795 1972-01-01
% 222.56/222.74  |- skos__hiddenLabel mesh__D014795 Pathways, Visual
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D014795 2001
% 222.56/222.74  |- mesh__recordOriginator mesh__D014795 NLM
% 222.56/222.74  |- skos__hiddenLabel mesh__D014795 Tracts, Optic
% 222.56/222.74  |- skos__prefLabel mesh__D014795 Visual Pathways
% 222.56/222.74  |- skos__broader mesh__D014795smesh__D000344
% 222.56/222.74  |- mesh__recordMaintainer mesh__D014795 ags
% 222.56/222.74  |- skos__hiddenLabel mesh__D000775 Spinal Anesthesia
% 222.56/222.74  |- skos__prefLabel mesh__D000775 Anesthesia, Spinal
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D000775 2004
% 222.56/222.74  |- skos__broader mesh__D000775smesh__D000765
% 222.56/222.74  |- skos__hiddenLabel mesh__D000775 Spinal Anesthesias
% 222.56/222.74  |- skos__hiddenLabel mesh__D000775 Anesthesias, Spinal
% 222.56/222.74  |- rdf__type mesh__D000775sskos__Concept
% 222.56/222.74  |- mesh__recordAuthorizer mesh__D000775 sjn
% 222.56/222.74  |- mesh__dateRevised mesh__D000775 2003-07-09
% 222.56/222.74  |- mesh__recordOriginator mesh__D000775 NLM
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D000775 2005
% 222.56/222.74  |- mesh__recordMaintainer mesh__D000775 mdb
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D000775 2006
% 222.56/222.74  |- mesh__dateCreated mesh__D000775 1999-01-01
% 222.56/222.74  |- skos__annotation mesh__D000775
% 222.56/222.74       /educ: coord IM %28%no qualif with ANESTHESIOLOGY /educ %28%NIM%29%%29%%A%  
% 222.56/222.74  |- skos__broader mesh__D019480smesh__D052180
% 222.56/222.74  |- skos__scopeNote mesh__D019480
% 222.56/222.74       Works consisting of publicly distributed notices, usually as paid announcements in mass media such as newspapers,  magazines, or on billboards. They include those in motion picture, television advertising, or electronic media.%A%    
% 222.56/222.74  |- mesh__recordAuthorizer mesh__D019480 sjn
% 222.56/222.74  |- rdf__type mesh__D019480sskos__Concept
% 222.56/222.74  |- mesh__recordMaintainer mesh__D019480 jls
% 222.56/222.74  |- skos__prefLabel mesh__D019480 Advertisements %5B%Publication Type%5D%
% 222.56/222.74  |- mesh__historyNote mesh__D019480 1997   
% 222.56/222.74  |- mesh__dateRevised mesh__D019480 2005-06-30
% 222.56/222.74  |- skos__annotation mesh__D019480
% 222.56/222.74       publication type only; for advertisements in newspapers, magazine, billboards, %26% in electronic media etc.; Publication Types BROADSIDES %26% POSTERS %26% PROSPECTUSES are also available; for advertisements as a subject, index under main heading ADVERTISING%A%  
% 222.56/222.74  |- mesh__dateCreated mesh__D019480 1996-06-21
% 222.56/222.74  |- skos__broader mesh__D019480smesh__D019502
% 222.56/222.74  |- mesh__dateEstablished mesh__D019480 1997-01-01
% 222.56/222.74  |- skos__altLabel mesh__D019480 Advertisements %28%PT%29%
% 222.56/222.74  |- skos__broader mesh__D019480smesh__D052181
% 222.56/222.74  |- mesh__recordOriginator mesh__D019480 TGC
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D019480 2006
% 222.56/222.74  |- skos__hiddenLabel mesh__D005460 Topical Fluorides
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D005460 2006
% 222.56/222.74  |- mesh__recordOriginator mesh__D005460 NLM
% 222.56/222.74  |- mesh__publicMeSHNote mesh__D005460 65   
% 222.56/222.74  |- skos__annotation mesh__D005460
% 222.56/222.74       fluoride-containing toothpastes: index TOOTHPASTE %28%IM%29% + FLUORIDES %28%IM%29%, not here; fluoride-containing mouthwashes: index MOUTHWASHES %28%IM%29% + FLUORIDES %28%IM%29%, not here%A%  
% 222.56/222.74  |- skos__scopeNote mesh__D005460
% 222.56/222.74       Fluorides, usually in pastes or gels, used for topical application to reduce the incidence of DENTAL CARIES.%A%    
% 222.56/222.74  |- skos__hiddenLabel mesh__D005460 Varnishes, Fluoride
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D005460 2004
% 222.56/222.74  |- mesh__dateCreated mesh__D005460 1999-01-01
% 222.56/222.74  |- skos__broader mesh__D005460smesh__D005459
% 222.56/222.74  |- skos__broader mesh__D005460smesh__D002327
% 222.56/222.74  |- mesh__recordMaintainer mesh__D005460 ssb
% 222.56/222.74  |- mesh__recordAuthorizer mesh__D005460 sjn
% 222.56/222.74  |- skos__prefLabel mesh__D005460 Fluorides, Topical
% 222.56/222.74  |- rdf__type mesh__D005460sskos__Concept
% 222.56/222.74  |- mesh__dateRevised mesh__D005460 2003-07-09
% 222.56/222.74  |- mesh__historyNote mesh__D005460 65   
% 222.56/222.74  |- mesh__dateEstablished mesh__D005460 1965-01-01
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D005460 2005
% 222.56/222.74  |- skos__broader mesh__D004040Q000737smesh__D004040
% 222.56/222.74  |- mesh__preferredCombination mesh__D004040Q000737smesh__D002241Q000737
% 222.56/222.74  |- rdf__type mesh__D004040Q000737smesh__CompoundConcept
% 222.56/222.74  |- skos__historyNote mesh__D018388 Codon %28%1975-1994%29%
% 222.56/222.74  |- skos__hiddenLabel mesh__D018388 Stop Codon
% 222.56/222.74  |- skos__historyNote mesh__D018388 Genetic Code %28%1967-1974%29%
% 222.56/222.74  |- rdf__type mesh__D018388sskos__Concept
% 222.56/222.74  |- skos__hiddenLabel mesh__D018388 Codons, Stop
% 222.56/222.74  |- mesh__recordMaintainer mesh__D018388 nns
% 222.56/222.74  |- mesh__recordAuthorizer mesh__D018388 sjn
% 222.56/222.74  |- skos__altLabel mesh__D018388 Terminator Codon
% 222.56/222.74  |- mesh__historyNote mesh__D018388 95   
% 222.56/222.74  |- skos__prefLabel mesh__D018388 Codon, Terminator
% 222.56/222.74  |- skos__broader mesh__D018388smesh__D003062
% 222.56/222.74  |- skos__hiddenLabel mesh__D018388 Terminator Codons
% 222.56/222.74  |- skos__related mesh__D018388smesh__D010443
% 222.56/222.74  |- skos__hiddenLabel mesh__D018388 Termination Codons
% 222.56/222.74  |- mesh__dateRevised mesh__D018388 2005-06-30
% 222.56/222.74  |- mesh__dateEstablished mesh__D018388 1995-01-01
% 222.56/222.74  |- mesh__publicMeSHNote mesh__D018388 95   
% 222.56/222.74  |- skos__related mesh__D018388smesh__D014176
% 222.56/222.74  |- skos__hiddenLabel mesh__D018388 Codons, Termination
% 222.56/222.74  |- skos__hiddenLabel mesh__D018388 Stop Signals, Translation
% 222.56/222.74  |- skos__altLabel mesh__D018388 Stop Signal, Translation
% 222.56/222.74  |- skos__hiddenLabel mesh__D018388 Translation Stop Signals
% 222.56/222.74  |- skos__hiddenLabel mesh__D018388 Translation Stop Signal
% 222.56/222.74  |- skos__hiddenLabel mesh__D018388 Stop Codons
% 222.56/222.74  |- skos__hiddenLabel mesh__D018388 Codons, Terminator
% 222.56/222.74  |- skos__altLabel mesh__D018388 Codon, Termination
% 222.56/222.74  |- mesh__recordOriginator mesh__D018388 PXP
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D018388 2006
% 222.56/222.74  |- mesh__dateCreated mesh__D018388 1994-06-03
% 222.56/222.74  |- skos__altLabel mesh__D018388 Codon, Stop
% 222.56/222.74  |- skos__scopeNote mesh__D018388
% 222.56/222.74       Any codon that signals the termination of genetic translation %28%TRANSLATION, GENETIC%29%.  PEPTIDE TERMINATION FACTORS bind to the stop codon and trigger the hydrolysis of the aminoacyl bond connecting the completed polypeptide to the tRNA. Terminator codons do not specify amino acids.%A%    
% 222.56/222.74  |- skos__hiddenLabel mesh__D018388 Termination Codon
% 222.56/222.74  |- rdf__type mesh__D004368sskos__Concept
% 222.56/222.74  |- skos__altLabel mesh__D004368 Alveolitis Sicca Dolorosa
% 222.56/222.74  |- mesh__dateEstablished mesh__D004368 1965-01-01
% 222.56/222.74  |- skos__annotation mesh__D004368
% 222.56/222.74       note category: after surg or traumatic tooth extraction   
% 222.56/222.74  |- skos__hiddenLabel mesh__D004368 Periostitides, Alveolar
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D004368 2000
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D004368 1999
% 222.56/222.74  |- mesh__recordMaintainer mesh__D004368 TGC
% 222.56/222.74  |- skos__scopeNote mesh__D004368
% 222.56/222.74       A condition sometimes occurring after tooth extraction, particularly after traumatic extraction, resulting in a dry appearance of the exposed bone in the socket, due to disintegration or loss of the blood clot. It is basically a focal osteomyelitis without suppuration and is accompanied by severe pain %28%alveolalgia%29% and foul odor. %28%Dorland, 28th ed%29%%A%    
% 222.56/222.74  |- skos__related mesh__D004368smesh__D014081
% 222.56/222.74  |- skos__hiddenLabel mesh__D004368 Alveolar Osteitides
% 222.56/222.74  |- skos__altLabel mesh__D004368 Osteitis, Alveolar
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D004368 2001
% 222.56/222.74  |- skos__hiddenLabel mesh__D004368 Sockets, Dry
% 222.56/222.74  |- skos__prefLabel mesh__D004368 Dry Socket
% 222.56/222.74  |- skos__hiddenLabel mesh__D004368 Socket, Dry
% 222.56/222.74  |- mesh__dateRevised mesh__D004368 1997-06-20
% 222.56/222.74  |- mesh__historyNote mesh__D004368 65   
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D004368 2005
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D004368 2002
% 222.56/222.74  |- skos__altLabel mesh__D004368 Alveolar Osteitis
% 222.56/222.74  |- skos__altLabel mesh__D004368 Periostitis, Alveolar
% 222.56/222.74  |- skos__hiddenLabel mesh__D004368 Dry Sockets
% 222.56/222.74  |- mesh__dateCreated mesh__D004368 1999-01-01
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D004368 2006
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D004368 2003
% 222.56/222.74  |- mesh__recordAuthorizer mesh__D004368 SJN
% 222.56/222.74  |- mesh__recordOriginator mesh__D004368 NLM
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D004368 2004
% 222.56/222.74  |- skos__altLabel mesh__D004368 Alveolar Periostitis
% 222.56/222.74  |- mesh__publicMeSHNote mesh__D004368 65   
% 222.56/222.74  |- skos__hiddenLabel mesh__D004368 Osteitides, Alveolar
% 222.56/222.74  |- skos__broader mesh__D004368smesh__D009059
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D004368 1998
% 222.56/222.74  |- skos__hiddenLabel mesh__D004368 Alveolar Periostitides
% 222.56/222.74  |- skos__hiddenLabel mesh__D004368 Alveolalgias
% 222.56/222.74  |- mesh__publicMeSHNote mesh__D015090
% 222.56/222.74       2003; see 25-HYDROXYCHOLECALCIFEROL 1-HYDROXYLASE 1991-2002, see STEROID HYDROXYLASES 1975-1990; 25-HYDROXYVITAMIN D2 1-HYDROXYLASE was indexed under STEROID HYDROXYLASES 1976-2002%A%  
% 222.56/222.74  |- skos__scopeNote mesh__D015090
% 222.56/222.74       A mitochondrial cytochrome P450 enzyme that catalyzes the 1-alpha-hydroxylation of 25-hydroxyvitamin D3 %28%also known as 25-hydroxycholecalciferol%29% in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP27B1 gene, converts 25-hydroxyvitamin D3 to 1-alpha,25-dihydroxyvitamin D3 which is the active form of VITAMIN D in regulating bone growth and calcium metabolism. This enzyme is also active on plant 25-hydroxyvitamin D2 %28%ergocalciferol%29%.%A%    
% 222.56/222.74  |- skos__broader mesh__D015090smesh__D013250
% 222.56/222.74  |- skos__altLabel mesh__D015090 Calcidiol 1-Monooxygenase
% 222.56/222.74  |- skos__hiddenLabel mesh__D015090
% 222.56/222.74       1-alpha-Hydroxylase, 25-Hydroxyergocalciferol
% 222.56/222.74  |- skos__altLabel mesh__D015090 25-Hydroxyvitamin D2 1-hydroxylase
% 222.56/222.74  |- mesh__recordOriginator mesh__D015090 NLM
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D015090 2006
% 222.56/222.74  |- mesh__dateCreated mesh__D015090 1974-11-19
% 222.56/222.74  |- skos__hiddenLabel mesh__D015090 Cytochrome P 450 CYP27B1
% 222.56/222.74  |- skos__altLabel mesh__D015090 CYP27B1
% 222.56/222.74  |- rdf__type mesh__D015090sskos__Concept
% 222.56/222.74  |- mesh__historyNote mesh__D015090
% 222.56/222.74       2003 %28%1975%29%; for 25-HYDROXYVITAMIN D2 1-HYDROXYLASE use STEROID HYDROXYLASES %28%NM%29% 1976-2002%A%  
% 222.56/222.74  |- skos__altLabel mesh__D015090
% 222.56/222.74       25-Hydroxyvitamin D%28%3%29% 1 alpha-Hydroxylase
% 222.56/222.74  |- skos__altLabel mesh__D015090 25-Hydroxycholecalciferol 1-Hydroxylase
% 222.56/222.74  |- skos__hiddenLabel mesh__D015090 25 Hydroxyvitamin D 1 alpha Hydroxylase
% 222.56/222.74  |- skos__hiddenLabel mesh__D015090 25 Hydroxycholecalciferol 1 Hydroxylase
% 222.56/222.74  |- skos__altLabel mesh__D015090 25-Hydroxyvitamin D 1-alpha-Hydroxylase
% 222.56/222.74  |- mesh__recordMaintainer mesh__D015090 ssb
% 222.56/222.74  |- skos__hiddenLabel mesh__D015090 1-alpha-Hydroxylase, 25-Hydroxyvitamin D
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D015090 2005
% 222.56/222.74  |- skos__altLabel mesh__D015090 25-Hydroxycholecalciferol-1-Hydroxylase
% 222.56/222.74  |- skos__altLabel mesh__D015090 Cytochrome P-450 CYP27B1
% 222.56/222.74  |- skos__hiddenLabel mesh__D015090 Calcidiol 1 Monooxygenase
% 222.56/222.74  |- skos__hiddenLabel mesh__D015090
% 222.56/222.74       25 Hydroxyergocalciferol 1 alpha Hydroxylase
% 222.56/222.74  |- skos__historyNote mesh__D015090
% 222.56/222.74       Hydroxycholecalciferols %28%1973-1974%29%
% 222.56/222.74  |- mesh__dateEstablished mesh__D015090 1991-01-01
% 222.56/222.74  |- skos__historyNote mesh__D015090 Steroid Hydroxylases %28%1973-1974%29%
% 222.56/222.74  |- skos__altLabel mesh__D015090
% 222.56/222.74       25-Hydroxyergocalciferol 1-alpha-Hydroxylase
% 222.56/222.74  |- skos__hiddenLabel mesh__D015090 25 Hydroxyvitamin D2 1 hydroxylase
% 222.56/222.74  |- mesh__recordAuthorizer mesh__D015090 sjn
% 222.56/222.74  |- mesh__dateRevised mesh__D015090 2004-07-07
% 222.56/222.74  |- skos__hiddenLabel mesh__D015090 25 Hydroxyvitamin D3 1 alpha Hydroxylase
% 222.56/222.74  |- skos__hiddenLabel mesh__D015090 1-hydroxylase, 25-Hydroxyvitamin D2
% 222.56/222.74  |- skos__prefLabel mesh__D015090 25-Hydroxyvitamin D3 1-alpha-Hydroxylase
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D009851 2002
% 222.56/222.74  |- skos__broader mesh__D009851smesh__D013279
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D009851 1999
% 222.56/222.74  |- mesh__dateEstablished mesh__D009851 1968-01-01
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D009851 2006
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D009851 2005A
% 222.56/222.74  |- skos__historyNote mesh__D009851 Stomach %28%1966-1967%29%
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D009851 1996
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D009851 2003
% 222.56/222.74  |- mesh__recordAuthorizer mesh__D009851 jls
% 222.56/222.74  |- rdf__type mesh__D009851sskos__Concept
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D009851 2000
% 222.56/222.74  |- skos__hiddenLabel mesh__D009851 Omasums
% 222.56/222.74  |- skos__annotation mesh__D009851
% 222.56/222.74       a ruminant%27%s 3d stomach; dis: coord IM with STOMACH DISEASES /vet %28%IM%29%; neopl: coord IM with STOMACH NEOPLASMS /vet + histol type /vet %28%IM%29%; ulcer: coord IM with STOMACH ULCER /vet %28%IM%29%%A%  
% 222.56/222.74  |- mesh__dateCreated mesh__D009851 1999-01-01
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D009851 1997
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D009851 2004
% 222.56/222.74  |- skos__scopeNote mesh__D009851
% 222.56/222.74       The third stomach of ruminants, situated on the right side of the abdomen at a higher level than the fourth stomach and between this latter and the second stomach, with both of which it communicates. From its inner surface project large numbers of leaves or folia, each of which possesses roughened surfaces. In the center of each folium is a band of muscle fibers which produces a rasping movement of the leaf when it contracts. One leaf rubs against those on either side of it, and large particles of food material are ground down between the rough surfaces, preparatory to further digestion in the succeeding parts of the alimentary canal. %28%Black%27%s Veterinary Dictionary, 17th ed%29%%A%    
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D009851 2001
% 222.56/222.74  |- mesh__publicMeSHNote mesh__D009851 68   
% 222.56/222.74  |- skos__prefLabel mesh__D009851 Omasum
% 222.56/222.74  |- mesh__recordMaintainer mesh__D009851 jls
% 222.56/222.74  |- mesh__recordOriginator mesh__D009851 NLM
% 222.56/222.74  |- mesh__historyNote mesh__D009851 68   
% 222.56/222.74  |- mesh__dateRevised mesh__D009851 2004-07-29
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D009851 1998
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D009851 2005
% 222.56/222.74  |- skos__broader mesh__D009053smesh__D017988
% 222.56/222.74  |- mesh__dateCreated mesh__D009053 1974-12-12
% 222.56/222.74  |- mesh__dateRevised mesh__D009053 2002-07-03
% 222.56/222.74  |- rdf__type mesh__D009053sskos__Concept
% 222.56/222.74  |- mesh__onlineNote mesh__D009053
% 222.56/222.74       use SARCOMA VIRUSES, MURINE to search MOUSE SARCOMA VIRUSES 1980-93 %26% MOUSE SARCOMA VIRUS 1975-79%A%  
% 222.56/222.74  |- skos__scopeNote mesh__D009053
% 222.56/222.74       A group of replication-defective viruses, in the genus GAMMARETROVIRUS, which are capable of transforming cells, but which replicate and produce tumors only in the presence of Murine leukemia viruses %28%LEUKEMIA VIRUS, MURINE%29%.%A%    
% 222.56/222.74  |- mesh__historyNote mesh__D009053
% 222.56/222.74       94; was MOUSE SARCOMA VIRUSES 1980-93; was MOUSE SARCOMA VIRUS see under MOUSE TUMOR VIRUSES 1975-79%A%  
% 222.56/222.74  |- skos__broader mesh__D009053smesh__D003673
% 222.56/222.74  |- skos__hiddenLabel mesh__D009053 Murine Sarcoma Viruses
% 222.56/222.74  |- skos__hiddenLabel mesh__D009053 Sarcoma Viruses, Mouse
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D009053 2005
% 222.56/222.74  |- skos__prefLabel mesh__D009053 Sarcoma Viruses, Murine
% 222.56/222.74  |- mesh__recordMaintainer mesh__D009053 sjn
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D009053 2003
% 222.56/222.74  |- skos__annotation mesh__D009053
% 222.56/222.74       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% + SARCOMA, EXPERIMENTAL %28%IM%29%%A%  
% 222.56/222.74  |- mesh__dateEstablished mesh__D009053 1980-01-01
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D009053 2006
% 222.56/222.74  |- skos__historyNote mesh__D009053 Mouse Tumor Viruses %28%1966-1974%29%
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D009053 2004
% 222.56/222.74  |- skos__altLabel mesh__D009053 Mouse Sarcoma Viruses
% 222.56/222.74  |- mesh__publicMeSHNote mesh__D009053
% 222.56/222.74       94; was MOUSE SARCOMA VIRUSES 1980-93; was MOUSE SARCOMA VIRUS see under MOUSE TUMOR VIRUSES 1975-79%A%  
% 222.56/222.74  |- mesh__recordOriginator mesh__D009053 NLM
% 222.56/222.74  |- mesh__recordAuthorizer mesh__D009053 sjn
% 222.56/222.74  |- mesh__recordMaintainer mesh__D001070 JLS
% 222.56/222.74  |- skos__prefLabel mesh__D001070 Appetitive Behavior
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D001070 2004
% 222.56/222.74  |- skos__scopeNote mesh__D001070
% 222.56/222.74       Animal searching behavior. The variable introductory phase of an instinctive behavior pattern or sequence, e.g., looking for food, or sequential courtship patterns prior to mating.%A%    
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D001070 2005
% 222.56/222.74  |- rdf__type mesh__D001070sskos__Concept
% 222.56/222.74  |- skos__altLabel mesh__D001070 Searching Behavior
% 222.56/222.74  |- mesh__recordOriginator mesh__D001070 NLM
% 222.56/222.74  |- skos__hiddenLabel mesh__D001070 Behaviors, Searching
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D001070 2003
% 222.56/222.74  |- mesh__dateRevised mesh__D001070 2002-07-02
% 222.56/222.74  |- mesh__historyNote mesh__D001070 68   
% 222.56/222.74  |- mesh__recordAuthorizer mesh__D001070 sjn
% 222.56/222.74  |- skos__broader mesh__D001070smesh__D001522
% 222.56/222.74  |- skos__hiddenLabel mesh__D001070 Behavior, Appetitive
% 222.56/222.74  |- mesh__dateCreated mesh__D001070 1999-01-01
% 222.56/222.74  |- skos__annotation mesh__D001070
% 222.56/222.74       usually animal; introduct phase of instinctive behav; nothing to do with APPETITE, the desire for food%A%  
% 222.56/222.74  |- skos__hiddenLabel mesh__D001070 Searching Behaviors
% 222.56/222.74  |- skos__historyNote mesh__D001070 Behavior %28%1966-1967%29%
% 222.56/222.74  |- skos__hiddenLabel mesh__D001070 Behaviors, Appetitive
% 222.56/222.74  |- skos__hiddenLabel mesh__D001070 Behavior, Searching
% 222.56/222.74  |- mesh__publicMeSHNote mesh__D001070 68   
% 222.56/222.74  |- skos__hiddenLabel mesh__D001070 Appetitive Behaviors
% 222.56/222.74  |- mesh__dateEstablished mesh__D001070 1968-01-01
% 222.56/222.74  |- skos__related mesh__D001070smesh__D002562
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D001070 2006
% 222.56/222.74  |- mesh__dateEstablished mesh__D047970 2005-01-01
% 222.56/222.74  |- skos__altLabel mesh__D047970 Clostridium botulinum E
% 222.56/222.74  |- skos__broader mesh__D047970smesh__D003014
% 222.56/222.74  |- mesh__publicMeSHNote mesh__D047970 2005   
% 222.56/222.74  |- mesh__historyNote mesh__D047970 2005   
% 222.56/222.74  |- mesh__dateCreated mesh__D047970 2004-07-07
% 222.56/222.74  |- skos__prefLabel mesh__D047970 Clostridium botulinum type E
% 222.56/222.74  |- mesh__recordMaintainer mesh__D047970 SYSTEM
% 222.56/222.74  |- skos__scopeNote mesh__D047970
% 222.56/222.74       Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type E which is neurotoxic to humans and animals.%A%    
% 222.56/222.74  |- skos__annotation mesh__D047970
% 222.56/222.74       infection: coordinate IM with BOTULISM %28%IM%29%   
% 222.56/222.74  |- mesh__recordOriginator mesh__D047970 ags
% 222.56/222.74  |- skos__historyNote mesh__D047970 Clostridium botulinum %28%1965-2004%29%
% 222.56/222.74  |- rdf__type mesh__D047970sskos__Concept
% 222.56/222.74  |- mesh__dateRevised mesh__D047970 2005-06-30
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D047970 2006
% 222.56/222.74  |- mesh__recordAuthorizer mesh__D047970 sjn
% 222.56/222.74  |- skos__broader mesh__D014796smesh__D010465
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D014796 2005
% 222.56/222.74  |- mesh__dateRevised mesh__D014796 2003-07-09
% 222.56/222.74  |- mesh__recordOriginator mesh__D014796 NLM
% 222.56/222.74  |- skos__prefLabel mesh__D014796 Visual Perception
% 222.56/222.74  |- skos__hiddenLabel mesh__D014796 Perceptions, Visual
% 222.56/222.74  |- mesh__recordAuthorizer mesh__D014796 sjn
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D014796 2004
% 222.56/222.74  |- mesh__recordMaintainer mesh__D014796 nns
% 222.56/222.74  |- rdf__type mesh__D014796sskos__Concept
% 222.56/222.74  |- skos__broader mesh__D014796smesh__D043723
% 222.56/222.74  |- skos__hiddenLabel mesh__D014796 Perception, Visual
% 222.56/222.74  |- skos__hiddenLabel mesh__D014796 Visual Perceptions
% 222.56/222.74  |- mesh__dateCreated mesh__D014796 1999-01-01
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D014796 2006
% 222.56/222.74  |- skos__scopeNote mesh__D014796
% 222.56/222.74       The selecting and organizing of visual stimuli based on the individual%27%s past experience.%A%    
% 222.56/222.74  |- skos__annotation mesh__D014796
% 222.56/222.74       differentiate from VISION: vis percept takes place in the brain, vision takes place in the eye%A%  
% 222.56/222.74  |- rdf__type mesh__D008759sskos__Concept
% 222.56/222.74  |- skos__annotation mesh__D008759 do not confuse with METHYLGLUCOSIDES   
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D008759 2005
% 222.56/222.74  |- mesh__recordMaintainer mesh__D008759 ssb
% 222.56/222.74  |- mesh__historyNote mesh__D008759 74   
% 222.56/222.74  |- mesh__recordOriginator mesh__D008759 NLM
% 222.56/222.74  |- mesh__recordAuthorizer mesh__D008759 sjn
% 222.56/222.74  |- skos__broader mesh__D008759smesh__D006027
% 222.56/222.74  |- mesh__publicMeSHNote mesh__D008759 74   
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D008759 2006
% 222.56/222.74  |- mesh__dateRevised mesh__D008759 2004-07-07
% 222.56/222.74  |- mesh__dateEstablished mesh__D008759 1974-01-01
% 222.56/222.74  |- mesh__dateCreated mesh__D008759 1999-01-01
% 222.56/222.74  |- skos__prefLabel mesh__D008759 Methylglycosides
% 222.56/222.74  |- mesh__recordAuthorizer mesh__D000776 SJN
% 222.56/222.74  |- rdf__type mesh__D000776sskos__Concept
% 222.56/222.74  |- skos__scopeNote mesh__D000776
% 222.56/222.74       A specialty concerned with the study of anesthetics and anesthesia.%A%    
% 222.56/222.74  |- skos__annotation mesh__D000776 SPEC: SPEC qualif; DF: ANESTHESIOL   
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D000776 2005
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D000776 2000
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D000776 2006
% 222.56/222.74  |- mesh__dateCreated mesh__D000776 1999-01-01
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D000776 2001
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D000776 2003
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D000776 2004
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D000776 1998
% 222.56/222.74  |- mesh__recordMaintainer mesh__D000776 PXP
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D000776 2002
% 222.56/222.74  |- mesh__dateRevised mesh__D000776 1997-06-20
% 222.56/222.74  |- mesh__recordOriginator mesh__D000776 NLM
% 222.56/222.74  |- skos__prefLabel mesh__D000776 Anesthesiology
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D000776 1999
% 222.56/222.74  |- skos__broader mesh__D000776smesh__D013040
% 222.56/222.74  |- skos__broader mesh__D005461smesh__D006219
% 222.56/222.74  |- mesh__dateRevised mesh__D005461 2005-06-30
% 222.56/222.74  |- skos__related mesh__D005461smesh__D005462
% 222.56/222.74  |- skos__annotation mesh__D005461
% 222.56/222.74       F-19; F-17, 18, 20-22 = FLUORINE RADIOISOTOPES %28%IM%29%; if discussed as a trace element, coordinate with TRACE ELEMENTS%A%  
% 222.56/222.74  |- mesh__dateCreated mesh__D005461 1999-01-01
% 222.56/222.74  |- mesh__recordOriginator mesh__D005461 NLM
% 222.56/222.74  |- rdf__type mesh__D005461sskos__Concept
% 222.56/222.74  |- skos__scopeNote mesh__D005461
% 222.56/222.74       A nonmetallic, diatomic gas that is a trace element and member of the halogen family. It is used in dentistry as flouride %28%FLUORIDES%29% to prevent dental caries.%A%    
% 222.56/222.74  |- skos__prefLabel mesh__D005461 Fluorine
% 222.56/222.74  |- mesh__recordMaintainer mesh__D005461 ssb
% 222.56/222.74  |- mesh__recordAuthorizer mesh__D005461 sjn
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D005461 2006
% 222.56/222.74  |- skos__hiddenLabel mesh__D018389 Codons, Premature Termination
% 222.56/222.74  |- mesh__recordOriginator mesh__D018389 PXP
% 222.56/222.74  |- skos__broader mesh__D018389smesh__D009154
% 222.56/222.74  |- skos__hiddenLabel mesh__D018389 Nonsense Mutations
% 222.56/222.74  |- skos__hiddenLabel mesh__D018389 Termination Codons, Premature
% 222.56/222.74  |- skos__prefLabel mesh__D018389 Codon, Nonsense
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D018389 2006
% 222.56/222.74  |- skos__broader mesh__D018389smesh__D018388
% 222.56/222.74  |- skos__hiddenLabel mesh__D018389 Premature Termination Codons
% 222.56/222.74  |- mesh__publicMeSHNote mesh__D018389 95   
% 222.56/222.74  |- mesh__dateRevised mesh__D018389 2002-07-03
% 222.56/222.74  |- skos__hiddenLabel mesh__D018389 Codon, Premature Termination
% 222.56/222.74  |- mesh__dateCreated mesh__D018389 1994-06-03
% 222.56/222.74  |- skos__historyNote mesh__D018389 Genetic Code %28%1966-1974%29%
% 222.56/222.74  |- rdf__type mesh__D018389sskos__Concept
% 222.56/222.74  |- skos__hiddenLabel mesh__D018389 Unassigned Codons
% 222.56/222.74  |- skos__hiddenLabel mesh__D018389 Codon, Premature Stop
% 222.56/222.74  |- skos__hiddenLabel mesh__D018389 Termination Codon, Premature
% 222.56/222.74  |- skos__hiddenLabel mesh__D018389 Stop Codons, Premature
% 222.56/222.74  |- skos__hiddenLabel mesh__D018389 Codons, Nonsense
% 222.56/222.74  |- skos__hiddenLabel mesh__D018389 Codons, Premature Stop
% 222.56/222.74  |- mesh__activeMeSHYear mesh__D018389 2003
% 222.56/222.74  |- skos__hiddenLabel mesh__D018389 Mutations, Nonsense
% 222.56/222.74  |- skos__altLabel mesh__D018389 Premature Termination Codon
% 222.56/222.74  |- skos__hiddenLabel mesh__D018389 Premature Stop Codons
% 222.56/222.74  |- skos__altLabel mesh__D018389 Premature Stop Codon
% 222.56/222.74  |- skos__hiddenLabel mesh__D018389 Nonsense Codons
% 222.56/222.74  |- skos__altLabel mesh__D018389 Nonsense Codon
% 222.56/222.75  |- skos__hiddenLabel mesh__D018389 Codons, Unassigned
% 222.56/222.75  |- mesh__recordAuthorizer mesh__D018389 sjn
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D018389 2004
% 222.56/222.75  |- skos__altLabel mesh__D018389 Codon, Termination, Premature
% 222.56/222.75  |- mesh__recordMaintainer mesh__D018389 nns
% 222.56/222.75  |- skos__altLabel mesh__D018389 Nonsense Mutation
% 222.56/222.75  |- skos__historyNote mesh__D018389 Codon %28%1975-1994%29%
% 222.56/222.75  |- mesh__historyNote mesh__D018389 95   
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D018389 2005
% 222.56/222.75  |- skos__altLabel mesh__D018389 Unassigned Codon
% 222.56/222.75  |- mesh__dateEstablished mesh__D018389 1995-01-01
% 222.56/222.75  |- skos__hiddenLabel mesh__D018389 Stop Codon, Premature
% 222.56/222.75  |- skos__scopeNote mesh__D018389
% 222.56/222.75       A codon that has been converted to the same sequence as a stop codon %28%CODON, TERMINATOR%29% by a nonsense mutation. It is different from a stop codon in that it occurs abnormally and causes premature termination of protein translation resulting in the production of truncated proteins which may be non-functional.%A%    
% 222.56/222.75  |- skos__hiddenLabel mesh__D004369 Zinc DTPA
% 222.56/222.75  |- rdf__type mesh__D004369sskos__Concept
% 222.56/222.75  |- skos__hiddenLabel mesh__D004369 Pentaacetic Acid, Diethylenetriamine
% 222.56/222.75  |- skos__altLabel mesh__D004369 calcium trisodium pentetate
% 222.56/222.75  |- mesh__recordOriginator mesh__D004369 NLM
% 222.56/222.75  |- skos__altLabel mesh__D004369 Pentaind
% 222.56/222.75  |- skos__annotation mesh__D004369 GADOLINIUM DTPA is also available   
% 222.56/222.75  |- mesh__historyNote mesh__D004369 1999%28%1966%29%   
% 222.56/222.75  |- skos__altLabel mesh__D004369 Penthanil
% 222.56/222.75  |- mesh__publicMeSHNote mesh__D004369
% 222.56/222.75       1999; see DTPA 1966-1998; for PENTETIC ACID see DTPA 1966-1998; CALCIUM TRISODIUM PENTETATE was indexed under ORGANOMETALLIC COMPOUNDS and GLYCINE 1998-2005%A%  
% 222.56/222.75  |- skos__prefLabel mesh__D004369 Pentetic Acid
% 222.56/222.75  |- skos__hiddenLabel mesh__D004369 CaNa DTPA
% 222.56/222.75  |- mesh__dateEstablished mesh__D004369 1966-01-01
% 222.56/222.75  |- mesh__recordMaintainer mesh__D004369 ssb
% 222.56/222.75  |- skos__broader mesh__D004369smesh__D000088
% 222.56/222.75  |- skos__altLabel mesh__D004369 CaNa-DTPA
% 222.56/222.75  |- mesh__recordAuthorizer mesh__D004369 sjn
% 222.56/222.75  |- skos__hiddenLabel mesh__D004369 Mn Dtpa
% 222.56/222.75  |- skos__broader mesh__D004369smesh__D011073
% 222.56/222.75  |- mesh__dateCreated mesh__D004369 1999-01-01
% 222.56/222.75  |- skos__altLabel mesh__D004369 DETAPAC
% 222.56/222.75  |- skos__altLabel mesh__D004369 CaDTPA
% 222.56/222.75  |- skos__scopeNote mesh__D004369
% 222.56/222.75       An iron chelating agent with properties like EDETATES. DTPA has also been used as a chelator for other metals, such as plutonium.%A%    
% 222.56/222.75  |- skos__hiddenLabel mesh__D004369 Sn DTPA
% 222.56/222.75  |- skos__hiddenLabel mesh__D004369 Ca DTPA
% 222.56/222.75  |- mesh__dateRevised mesh__D004369 2005-06-30
% 222.56/222.75  |- skos__hiddenLabel mesh__D004369 Acid, Diethylenetriamine Pentaacetic
% 222.56/222.75  |- skos__altLabel mesh__D004369 Diethylenetriamine Pentaacetic Acid
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D004369 2006
% 222.56/222.75  |- skos__altLabel mesh__D004369 Pentacin
% 222.56/222.75  |- skos__altLabel mesh__D004369 DTPA
% 222.56/222.75  |- skos__hiddenLabel mesh__D004369 Indium DTPA
% 222.56/222.75  |- skos__broader mesh__D015091smesh__D000409
% 222.56/222.75  |- mesh__historyNote mesh__D015091
% 222.56/222.75       92; was 3-AMINOPROPIONIC ACID 1979-91 %28%see under ALANINE 1979-90%29%; BETA-ALANINE was see 3-AMINOPROPIONIC ACID 1979-91%A%  
% 222.56/222.75  |- skos__historyNote mesh__D015091 Alanine %28%1966-1978%29%
% 222.56/222.75  |- mesh__dateCreated mesh__D015091 1978-05-16
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D015091 2002
% 222.56/222.75  |- rdf__type mesh__D015091sskos__Concept
% 222.56/222.75  |- skos__hiddenLabel mesh__D015091 beta Alanine, Monopotassium Salt
% 222.56/222.75  |- skos__hiddenLabel mesh__D015091 beta Alanine
% 222.56/222.75  |- skos__altLabel mesh__D015091 3-Aminopropionic Acid
% 222.56/222.75  |- skos__hiddenLabel mesh__D015091 3 Aminopropionic Acid
% 222.56/222.75  |- mesh__recordAuthorizer mesh__D015091 sjn
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D015091 2004
% 222.56/222.75  |- mesh__recordOriginator mesh__D015091 RLS
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D015091 2003
% 222.56/222.75  |- mesh__dateEstablished mesh__D015091 1991-01-01
% 222.56/222.75  |- skos__prefLabel mesh__D015091 beta-Alanine
% 222.56/222.75  |- mesh__onlineNote mesh__D015091
% 222.56/222.75       use BETA-ALANINE to search 3-AMINOPROPIONIC ACID 1979-90   
% 222.56/222.75  |- mesh__publicMeSHNote mesh__D015091
% 222.56/222.75       92; was 3-AMINOPROPIONIC ACID 1979-91 %28%see under ALANINE 1979-90%29%; BETA-ALANINE was see 3-AMINOPROPIONIC ACID 1979-91%A%  
% 222.56/222.75  |- mesh__recordMaintainer mesh__D015091 jmp
% 222.56/222.75  |- mesh__dateRevised mesh__D015091 2001-07-25
% 222.56/222.75  |- skos__historyNote mesh__D015091 Amino Acids %28%1966-1978%29%
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D015091 2006
% 222.56/222.75  |- skos__hiddenLabel mesh__D015091 beta Alanine, Monosodium Salt
% 222.56/222.75  |- skos__hiddenLabel mesh__D015091 Hydrochloride, beta-Alanine
% 222.56/222.75  |- skos__hiddenLabel mesh__D015091 beta Alanine Hydrochloride
% 222.56/222.75  |- skos__scopeNote mesh__D015091
% 222.56/222.75       An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported.%A%    
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D015091 2005
% 222.56/222.75  |- skos__scopeNote mesh__D009852
% 222.56/222.75       A double-layered fold of peritoneum that attaches the STOMACH to other organs in the ABDOMINAL CAVITY.%A%    
% 222.56/222.75  |- rdf__type mesh__D009852sskos__Concept
% 222.56/222.75  |- mesh__dateCreated mesh__D009852 1999-01-01
% 222.56/222.75  |- skos__hiddenLabel mesh__D009852 Omentums
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D009852 2004
% 222.56/222.75  |- mesh__recordAuthorizer mesh__D009852 sjn
% 222.56/222.75  |- mesh__recordOriginator mesh__D009852 NLM
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D009852 2005
% 222.56/222.75  |- mesh__recordMaintainer mesh__D009852 ags
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D009852 2006
% 222.56/222.75  |- skos__annotation mesh__D009852
% 222.56/222.75       dis: coord IM with PERITONEAL DISEASES %28%IM%29%; neopl: coord IM with PERITONEAL NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 222.56/222.75  |- skos__broader mesh__D009852smesh__D010537
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D009852 2003
% 222.56/222.75  |- mesh__dateRevised mesh__D009852 2002-07-03
% 222.56/222.75  |- skos__prefLabel mesh__D009852 Omentum
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001071 2005
% 222.56/222.75  |- skos__hiddenLabel mesh__D001071 Schedules and Appointments
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001071 1992
% 222.56/222.75  |- skos__hiddenLabel mesh__D001071 Patient Appointment
% 222.56/222.75  |- skos__hiddenLabel mesh__D001071 Appointments, Patient
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001071 1999
% 222.56/222.75  |- mesh__recordAuthorizer mesh__D001071 PLS
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001071 2003
% 222.56/222.75  |- skos__historyNote mesh__D001071
% 222.56/222.75       Outpatient Clinics, Hospital %28%1966-1967%29%
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001071 1997
% 222.56/222.75  |- skos__annotation mesh__D001071 no qualif; DF: APPOINTMENTS   
% 222.56/222.75  |- skos__hiddenLabel mesh__D001071 Appointment
% 222.56/222.75  |- mesh__recordMaintainer mesh__D001071 PLS
% 222.56/222.75  |- skos__hiddenLabel mesh__D001071 Appointment, Patient
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001071 2001
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001071 1998
% 222.56/222.75  |- mesh__dateCreated mesh__D001071 1999-01-01
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001071 1996
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001071 2000
% 222.56/222.75  |- mesh__publicMeSHNote mesh__D001071 68   
% 222.56/222.75  |- skos__hiddenLabel mesh__D001071 Schedule, Patient
% 222.56/222.75  |- mesh__recordOriginator mesh__D001071 NLM
% 222.56/222.75  |- mesh__dateEstablished mesh__D001071 1968-01-01
% 222.56/222.75  |- skos__altLabel mesh__D001071 Patient Schedules
% 222.56/222.75  |- skos__prefLabel mesh__D001071 Appointments and Schedules
% 222.56/222.75  |- skos__scopeNote mesh__D001071
% 222.56/222.75       The different methods of scheduling patient visits, appointment systems, individual or group appointments, waiting times, waiting lists for hospitals, walk-in clinics, etc.%A%    
% 222.56/222.75  |- mesh__historyNote mesh__D001071 68   
% 222.56/222.75  |- mesh__dateRevised mesh__D001071 1991-06-10
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001071 1995
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001071 2006
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001071 1993
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001071 2002
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001071 2004
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001071 1994
% 222.56/222.75  |- skos__broader mesh__D001071smesh__D009934
% 222.56/222.75  |- rdf__type mesh__D001071sskos__Concept
% 222.56/222.75  |- skos__hiddenLabel mesh__D001071 Schedule
% 222.56/222.75  |- skos__hiddenLabel mesh__D001071 Patient Schedule
% 222.56/222.75  |- skos__broader mesh__D012964Q000737smesh__D012964
% 222.56/222.75  |- rdf__type mesh__D012964Q000737smesh__CompoundConcept
% 222.56/222.75  |- skos__altLabel mesh__D047971 Clostridium botulinum F
% 222.56/222.75  |- rdf__type mesh__D047971sskos__Concept
% 222.56/222.75  |- skos__annotation mesh__D047971
% 222.56/222.75       infection: coordinate IM with BOTULISM %28%IM%29%   
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D047971 2006
% 222.56/222.75  |- mesh__recordOriginator mesh__D047971 ags
% 222.56/222.75  |- mesh__dateCreated mesh__D047971 2004-07-07
% 222.56/222.75  |- mesh__historyNote mesh__D047971 2005   
% 222.56/222.75  |- mesh__dateEstablished mesh__D047971 2005-01-01
% 222.56/222.75  |- mesh__dateRevised mesh__D047971 2005-06-30
% 222.56/222.75  |- mesh__recordAuthorizer mesh__D047971 sjn
% 222.56/222.75  |- skos__historyNote mesh__D047971 Clostridium botulinum %28%1965-2004%29%
% 222.56/222.75  |- mesh__publicMeSHNote mesh__D047971 2005   
% 222.56/222.75  |- skos__prefLabel mesh__D047971 Clostridium botulinum type F
% 222.56/222.75  |- skos__scopeNote mesh__D047971
% 222.56/222.75       Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type F which is neurotoxic to humans and animals.%A%    
% 222.56/222.75  |- skos__broader mesh__D047971smesh__D003014
% 222.56/222.75  |- mesh__recordMaintainer mesh__D047971 SYSTEM
% 222.56/222.75  |- skos__hiddenLabel mesh__D014797 Vital Capacity, Forced
% 222.56/222.75  |- skos__hiddenLabel mesh__D014797 Capacities, Forced Vital
% 222.56/222.75  |- mesh__publicMeSHNote mesh__D014797 72   
% 222.56/222.75  |- skos__hiddenLabel mesh__D014797 Capacity, Vital
% 222.56/222.75  |- skos__hiddenLabel mesh__D014797 Capacities, Vital
% 222.56/222.75  |- skos__hiddenLabel mesh__D014797 Capacity, Forced Vital
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D014797 2004
% 222.56/222.75  |- mesh__recordOriginator mesh__D014797 NLM
% 222.56/222.75  |- skos__broader mesh__D014797smesh__D014109
% 222.56/222.75  |- rdf__type mesh__D014797sskos__Concept
% 222.56/222.75  |- skos__scopeNote mesh__D014797
% 222.56/222.75       The volume of air that is exhaled by a maximal expiration following a maximal inspiration.%A%    
% 222.56/222.75  |- skos__prefLabel mesh__D014797 Vital Capacity
% 222.56/222.75  |- mesh__dateCreated mesh__D014797 1999-01-01
% 222.56/222.75  |- mesh__historyNote mesh__D014797 72%28%69%29%   
% 222.56/222.75  |- mesh__recordAuthorizer mesh__D014797 sjn
% 222.56/222.75  |- skos__annotation mesh__D014797
% 222.56/222.75       timed vital capacity is FORCED EXPIRATORY VOLUME; DF: VITAL CAPAC%A%  
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D014797 2006
% 222.56/222.75  |- skos__hiddenLabel mesh__D014797 Vital Capacities
% 222.56/222.75  |- skos__historyNote mesh__D014797 Spirometry %28%1966-1968%29%
% 222.56/222.75  |- mesh__recordMaintainer mesh__D014797 nns
% 222.56/222.75  |- skos__altLabel mesh__D014797 Forced Vital Capacity
% 222.56/222.75  |- skos__hiddenLabel mesh__D014797 Vital Capacities, Forced
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D014797 2005
% 222.56/222.75  |- skos__hiddenLabel mesh__D014797 Forced Vital Capacities
% 222.56/222.75  |- mesh__dateEstablished mesh__D014797 1972-01-01
% 222.56/222.75  |- mesh__dateRevised mesh__D014797 2003-07-09
% 222.56/222.75  |- skos__broader mesh__D016390Q000364smesh__D016390
% 222.56/222.75  |- mesh__preferredCombination mesh__D016390Q000364smesh__D000488
% 222.56/222.75  |- rdf__type mesh__D016390Q000364smesh__CompoundConcept
% 222.56/222.75  |- mesh__recordOriginator mesh__D000777 NLM
% 222.56/222.75  |- mesh__recordAuthorizer mesh__D000777 sjn
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D000777 2006
% 222.56/222.75  |- mesh__dateCreated mesh__D000777 1999-01-01
% 222.56/222.75  |- skos__altLabel mesh__D000777 Anesthetic Agents
% 222.56/222.75  |- mesh__dateRevised mesh__D000777 2005-06-30
% 222.56/222.75  |- skos__altLabel mesh__D000777 Anesthetic Drugs
% 222.56/222.75  |- skos__scopeNote mesh__D000777
% 222.56/222.75       Agents that are capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general anesthesia, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site.%A%    
% 222.56/222.75  |- skos__related mesh__D000777smesh__D000759
% 222.56/222.75  |- skos__hiddenLabel mesh__D000777 Drugs, Anesthetic
% 222.56/222.75  |- mesh__recordMaintainer mesh__D000777 ssb
% 222.56/222.75  |- skos__hiddenLabel mesh__D000777 Agents, Anesthetic
% 222.56/222.75  |- rdf__type mesh__D000777sskos__Concept
% 222.56/222.75  |- skos__broader mesh__D000777smesh__D002492
% 222.56/222.75  |- skos__annotation mesh__D000777
% 222.56/222.75       GEN or unspecified; prefer specific groups or specific anesthetics; no qualif for anesthetics when used to produce anesthesia; with type of anesthesia: Manual 26.21+; policy: Manual 25.21+%A%  
% 222.56/222.75  |- skos__prefLabel mesh__D000777 Anesthetics
% 222.56/222.75  |- skos__broader mesh__D019482smesh__D052180
% 222.56/222.75  |- skos__prefLabel mesh__D019482 Almanacs %5B%Publication Type%5D%
% 222.56/222.75  |- rdf__type mesh__D019482sskos__Concept
% 222.56/222.75  |- skos__annotation mesh__D019482
% 222.56/222.75       publication type only; for almanacs as a subject, index under main heading ALMANACS%A%  
% 222.56/222.75  |- mesh__dateCreated mesh__D019482 1996-06-21
% 222.56/222.75  |- mesh__recordMaintainer mesh__D019482 jls
% 222.56/222.75  |- skos__altLabel mesh__D019482 Almanacs %28%PT%29%
% 222.56/222.75  |- mesh__dateEstablished mesh__D019482 1997-01-01
% 222.56/222.75  |- mesh__recordAuthorizer mesh__D019482 sjn
% 222.56/222.75  |- mesh__recordOriginator mesh__D019482 TGC
% 222.56/222.75  |- mesh__historyNote mesh__D019482 1997   
% 222.56/222.75  |- mesh__dateRevised mesh__D019482 2005-06-30
% 222.56/222.75  |- skos__scopeNote mesh__D019482
% 222.56/222.75       Works consisting of  a calendar of days, weeks, and months, together with information such as astronomical data, various statistics, etc. %28%From Genre Terms: A Thesaurus for Use in Rare Book and Special Collections Cataloguing, 2d ed%29%%A%    
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D019482 2006
% 222.56/222.75  |- skos__scopeNote mesh__D005462
% 222.56/222.75       Unstable isotopes of fluorine that decay or disintegrate emitting radiation. F atoms with atomic weights 17, 18, and 20-22 are radioactive fluorine isotopes.%A%    
% 222.56/222.75  |- skos__broader mesh__D005462smesh__D011868
% 222.56/222.75  |- mesh__recordOriginator mesh__D005462 RLS
% 222.56/222.75  |- mesh__recordMaintainer mesh__D005462 TPW
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D005462 2006
% 222.56/222.75  |- mesh__dateRevised mesh__D005462 1993-06-01
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D005462 2004
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D005462 2001
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D005462 1995
% 222.56/222.75  |- skos__annotation mesh__D005462
% 222.56/222.75       F-17, 18, 20-22; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 222.56/222.75  |- skos__historyNote mesh__D005462 Radioisotopes %28%1966-1987%29%
% 222.56/222.75  |- mesh__publicMeSHNote mesh__D005462 88   
% 222.56/222.75  |- mesh__dateCreated mesh__D005462 1987-04-06
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D005462 2005
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D005462 2000
% 222.56/222.75  |- mesh__recordAuthorizer mesh__D005462 PLS
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D005462 2003
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D005462 1994
% 222.56/222.75  |- skos__historyNote mesh__D005462 Fluorine %28%1966-1987%29%
% 222.56/222.75  |- skos__hiddenLabel mesh__D005462 Radioisotopes, Fluorine
% 222.56/222.75  |- skos__prefLabel mesh__D005462 Fluorine Radioisotopes
% 222.56/222.75  |- mesh__historyNote mesh__D005462 88   
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D005462 1999
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D005462 1997
% 222.56/222.75  |- mesh__dateEstablished mesh__D005462 1988-01-01
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D005462 2002
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D005462 1998
% 222.56/222.75  |- rdf__type mesh__D005462sskos__Concept
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D005462 1996
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D015092 1999
% 222.56/222.75  |- skos__broader mesh__D015092smesh__D014529
% 222.56/222.75  |- skos__prefLabel mesh__D015092 3-Deazauridine
% 222.56/222.75  |- skos__historyNote mesh__D015092 Uridine %28%1972-1974%29%
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D015092 2004
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D015092 1998
% 222.56/222.75  |- skos__altLabel mesh__D015092
% 222.56/222.75       4-Hydroxy-1-%28%beta-D-Ribopentofuranosyl%29%-2-Pyridone
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D015092 2002
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D015092 2003
% 222.56/222.75  |- skos__scopeNote mesh__D015092
% 222.56/222.75       4-Hydroxy-1-%28%beta-D-ribofuranosyl%29%-2-pyridinone. Analog of uridine lacking a ring-nitrogen in the 3-position. Functions as an antineoplastic agent.%A%    
% 222.56/222.75  |- mesh__publicMeSHNote mesh__D015092 91; was see under URIDINE 1975-90   
% 222.56/222.75  |- mesh__dateEstablished mesh__D015092 1991-01-01
% 222.56/222.75  |- skos__historyNote mesh__D015092 Pyridones %28%1973-1974%29%
% 222.56/222.75  |- mesh__dateRevised mesh__D015092 1995-06-09
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D015092 2006
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D015092 1997
% 222.56/222.75  |- skos__annotation mesh__D015092 an antineoplastic antimetabolite   
% 222.56/222.75  |- mesh__recordMaintainer mesh__D015092 JRT
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D015092 2001
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D015092 1996
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D015092 2005
% 222.56/222.75  |- mesh__dateCreated mesh__D015092 1974-11-19
% 222.56/222.75  |- skos__hiddenLabel mesh__D015092 3 Deazauridine
% 222.56/222.75  |- mesh__historyNote mesh__D015092
% 222.56/222.75       91%28%75%29%; was see under URIDINE 1975-90   
% 222.56/222.75  |- mesh__recordOriginator mesh__D015092 NLM
% 222.56/222.75  |- mesh__recordAuthorizer mesh__D015092 PLS
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D015092 2000
% 222.56/222.75  |- rdf__type mesh__D015092sskos__Concept
% 222.56/222.75  |- skos__broader mesh__D009853smesh__D011725
% 222.56/222.75  |- skos__hiddenLabel mesh__D009853 H 168 68
% 222.56/222.75  |- mesh__dateEstablished mesh__D009853 1987-01-01
% 222.56/222.75  |- mesh__dateCreated mesh__D009853 1986-06-16
% 222.56/222.75  |- mesh__recordAuthorizer mesh__D009853 sjn
% 222.56/222.75  |- mesh__historyNote mesh__D009853 87   
% 222.56/222.75  |- skos__hiddenLabel mesh__D009853 H 16868
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D009853 2006
% 222.56/222.75  |- mesh__publicMeSHNote mesh__D009853 87   
% 222.56/222.75  |- skos__broader mesh__D009853smesh__D013454
% 222.56/222.75  |- skos__historyNote mesh__D009853 Benzimidazoles %28%1966-1986%29%
% 222.56/222.75  |- skos__prefLabel mesh__D009853 Omeprazole
% 222.56/222.75  |- mesh__dateRevised mesh__D009853 2005-06-30
% 222.56/222.75  |- skos__scopeNote mesh__D009853
% 222.56/222.75       A highly effective inhibitor of gastric acid secretion used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits the H%28%+%29%-K%28%+%29%-ATPase %28%H%28%+%29%-K%28%+%29%-EXCHANGING ATPASE%29% in the proton pump of GASTRIC PARIETAL CELLS.%A%    
% 222.56/222.75  |- rdf__type mesh__D009853sskos__Concept
% 222.56/222.75  |- skos__broader mesh__D009853smesh__D001562
% 222.56/222.75  |- mesh__recordOriginator mesh__D009853 RLS
% 222.56/222.75  |- mesh__recordMaintainer mesh__D009853 ssb
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001870 2005
% 222.56/222.75  |- skos__altLabel mesh__D001870 Industry, Book
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001870 2000
% 222.56/222.75  |- mesh__dateRevised mesh__D001870 1999-11-03
% 222.56/222.75  |- mesh__dateCreated mesh__D001870 1999-01-01
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001870 2004
% 222.56/222.75  |- mesh__recordMaintainer mesh__D001870 kle
% 222.56/222.75  |- skos__broader mesh__D001870smesh__D011643
% 222.56/222.75  |- skos__hiddenLabel mesh__D001870 Industries, Book
% 222.56/222.75  |- skos__broader mesh__D001870smesh__D007221
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001870 2003
% 222.56/222.75  |- skos__annotation mesh__D001870
% 222.56/222.75       specify geog if pertinent; DF: BOOK INDUST   
% 222.56/222.75  |- mesh__recordOriginator mesh__D001870 NLM
% 222.56/222.75  |- skos__prefLabel mesh__D001870 Book Industry
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001870 2002
% 222.56/222.75  |- rdf__type mesh__D001870sskos__Concept
% 222.56/222.75  |- mesh__recordAuthorizer mesh__D001870 sjn
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001870 2006
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001870 2001
% 222.56/222.75  |- skos__related mesh__D001870smesh__D011643
% 222.56/222.75  |- skos__hiddenLabel mesh__D001870 Book Industries
% 222.56/222.75  |- skos__scopeNote mesh__D001870
% 222.56/222.75       The aggregate enterprise of manufacturing and technically producing books. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 222.56/222.75  |- skos__broader mesh__D009055smesh__D005145
% 222.56/222.75  |- skos__scopeNote mesh__D009055
% 222.56/222.75       The oval-shaped oral cavity located at the apex of the digestive tract and consisting of two parts: the vestibule and the oral cavity proper.%A%    
% 222.56/222.75  |- mesh__dateCreated mesh__D009055 1999-01-01
% 222.56/222.75  |- skos__related mesh__D009055smesh__D009912
% 222.56/222.75  |- skos__related mesh__D009055smesh__D013515
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D009055 2005A
% 222.56/222.75  |- skos__altLabel mesh__D009055 Oral Cavity
% 222.56/222.75  |- skos__altLabel mesh__D009055 Mouth Cavity Proper
% 222.56/222.75  |- rdf__type mesh__D009055sskos__Concept
% 222.56/222.75  |- skos__altLabel mesh__D009055 Cavitas oris propria
% 222.56/222.75  |- skos__broader mesh__D009055smesh__D041981
% 222.56/222.75  |- skos__altLabel mesh__D009055 Vestibule Oris
% 222.56/222.75  |- skos__hiddenLabel mesh__D009055 Cavity, Oral
% 222.56/222.75  |- mesh__dateRevised mesh__D009055 2004-07-28
% 222.56/222.75  |- mesh__onlineNote mesh__D009055
% 222.56/222.75       use MOUTH to search MOUTH MICROORGANISMS 1966-67   
% 222.56/222.75  |- mesh__recordMaintainer mesh__D009055 jls
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D009055 2004
% 222.56/222.75  |- mesh__recordOriginator mesh__D009055 NLM
% 222.56/222.75  |- mesh__historyNote mesh__D009055
% 222.56/222.75       /microbiology was MOUTH MICROORGANISMS 1965-67   
% 222.56/222.75  |- skos__prefLabel mesh__D009055 Mouth
% 222.56/222.75  |- mesh__publicMeSHNote mesh__D009055
% 222.56/222.75       /microbiology was MOUTH MICROORGANISMS 1965-67   
% 222.56/222.75  |- mesh__considerAlso mesh__D009055
% 222.56/222.75       consider also terms at ORAL, ORO-, and STOMAT-   
% 222.56/222.75  |- mesh__recordAuthorizer mesh__D009055 jls
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D009055 2006
% 222.56/222.75  |- skos__altLabel mesh__D009055 Cavitas Oris
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D009055 2005
% 222.56/222.75  |- skos__annotation mesh__D009055
% 222.56/222.75       /surg: consider also ORAL SURGICAL PROCEDURES; inflammation = STOMATITIS%A%  
% 222.56/222.75  |- skos__broader mesh__D009055smesh__D013284
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Verbal Dyspraxias
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001072 2001
% 222.56/222.75  |- rdf__type mesh__D001072sskos__Concept
% 222.56/222.75  |- skos__altLabel mesh__D001072 Dyspraxia
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Verbal Apraxias, Developmental
% 222.56/222.75  |- skos__broader mesh__D001072smesh__D019954
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Gestural Apraxias
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Oral Apraxia
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Phonation Apraxia
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Apraxia, Ideational
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Verbal Apraxia
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Phonation Apraxias
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Dressing Apraxias
% 222.56/222.75  |- mesh__dateRevised mesh__D001072 1999-11-03
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Dyspraxias
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Facial-Oral Apraxia
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Developmental Verbal Apraxias
% 222.56/222.75  |- mesh__dateCreated mesh__D001072 1999-01-01
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Dyspraxias, Articulatory
% 222.56/222.75  |- mesh__publicMeSHNote mesh__D001072 2000; see APRAXIA 1966-1999   
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Apraxia, Dressing
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Apraxias, Oral
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Apraxias, Verbal
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Apraxias, Motor
% 222.56/222.75  |- skos__scopeNote mesh__D001072
% 222.56/222.75       A group of cognitive disorders characterized by the inability to perform previously learned skills that cannot be attributed to deficits of motor or sensory function. The two major subtypes of this condition are ideomotor %28%see APRAXIA, IDEOMOTOR%29% and ideational apraxia, which refers to loss of the ability to mentally formulate the processes involved with performing an action. For example, dressing apraxia may result from an inability to mentally formulate the act of placing clothes on the body. Apraxias are generally associated with lesions of the dominant PARIETAL LOBE and supramarginal gyrus. %28%From Adams et al., Principles of Neurology, 6th ed, pp56-7%29%%A%    
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Apraxias, Gestural
% 222.56/222.75  |- mesh__historyNote mesh__D001072 2000%28%1966%29%   
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001072 2002
% 222.56/222.75  |- skos__altLabel mesh__D001072 Dyspraxia, Oral
% 222.56/222.75  |- mesh__recordAuthorizer mesh__D001072 sjn
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Apraxias, Dressing
% 222.56/222.75  |- skos__altLabel mesh__D001072 Dyspraxia, Articulatory
% 222.56/222.75  |- skos__altLabel mesh__D001072 Apraxia
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Verbal Apraxia, Developmental
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Apraxias, Facial-Oral
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Articulatory Apraxias
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Apraxias, Developmental Verbal
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001072 2003
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Apraxia, Facial Oral
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Dyspraxias, Verbal
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Articulatory Dyspraxias
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Apraxias, Articulatory
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Verbal Apraxias
% 222.56/222.75  |- skos__prefLabel mesh__D001072 Apraxias
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001072 2004
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Articulatory Apraxia
% 222.56/222.75  |- mesh__recordMaintainer mesh__D001072 KEV
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Gestural Apraxia
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Dyspraxias, Oral
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001072 2005
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001072 2000
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Oral Dyspraxia
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Verbal Dyspraxia
% 222.56/222.75  |- mesh__recordOriginator mesh__D001072 NLM
% 222.56/222.75  |- skos__altLabel mesh__D001072 Dyspraxia, Verbal
% 222.56/222.75  |- skos__broader mesh__D001072smesh__D011596
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Facial-Oral Apraxias
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Apraxias, Ideational
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Oral Dyspraxias
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Oral Apraxias
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Developmental Verbal Apraxia
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Motor Apraxia
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Motor Apraxias
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Articulatory Dyspraxia
% 222.56/222.75  |- skos__hiddenLabel mesh__D001072 Ideational Apraxias
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D001072 2006
% 222.56/222.75  |- rdf__type mesh__D014798sskos__Concept
% 222.56/222.75  |- skos__altLabel mesh__D014798 Statistics, Vital
% 222.56/222.75  |- mesh__activeMeSHYear mesh__D014798 2001
% 222.56/222.75  |- mesh__recordAuthorizer mesh__D014798 sjn
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D014798 2003
% 222.56/222.76  |- mesh__dateCreated mesh__D014798 1999-01-01
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D014798 2000
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D014798 2006
% 222.56/222.76  |- skos__annotation mesh__D014798
% 222.56/222.76       GEN only: prefer specifics: no qualif; specify geog   
% 222.56/222.76  |- skos__altLabel mesh__D014798 Registration of Vital Statistics
% 222.56/222.76  |- skos__hiddenLabel mesh__D014798 Registrations, Vital Statistics
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D014798 2005
% 222.56/222.76  |- skos__hiddenLabel mesh__D014798 Vital Statistics Registrations
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D014798 2002
% 222.56/222.76  |- mesh__recordMaintainer mesh__D014798 kle
% 222.56/222.76  |- mesh__dateRevised mesh__D014798 1999-11-03
% 222.56/222.76  |- skos__prefLabel mesh__D014798 Vital Statistics
% 222.56/222.76  |- skos__altLabel mesh__D014798 Registration, Vital Statistics
% 222.56/222.76  |- mesh__recordOriginator mesh__D014798 NLM
% 222.56/222.76  |- skos__scopeNote mesh__D014798
% 222.56/222.76       Used for general articles concerning statistics of births, deaths, marriages, etc.%A%    
% 222.56/222.76  |- skos__broader mesh__D014798smesh__D003710
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D014798 2004
% 222.56/222.76  |- skos__broader mesh__D014798smesh__D003625
% 222.56/222.76  |- skos__historyNote mesh__D000778 Anesthetics %28%1966-1970%29%
% 222.56/222.76  |- rdf__type mesh__D000778sskos__Concept
% 222.56/222.76  |- skos__annotation mesh__D000778
% 222.56/222.76       intravenous anesthetics inducing selective loss of some sensations, leaving others intact%A%  
% 222.56/222.76  |- skos__prefLabel mesh__D000778 Anesthetics, Dissociative
% 222.56/222.76  |- mesh__publicMeSHNote mesh__D000778
% 222.56/222.76       91; was see under ANESTHETICS 1971-90   
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D000778 2006
% 222.56/222.76  |- skos__broader mesh__D000778smesh__D018686
% 222.56/222.76  |- mesh__recordAuthorizer mesh__D000778 sjn
% 222.56/222.76  |- mesh__dateCreated mesh__D000778 1999-01-01
% 222.56/222.76  |- mesh__recordOriginator mesh__D000778 NLM
% 222.56/222.76  |- mesh__dateEstablished mesh__D000778 1991-01-01
% 222.56/222.76  |- mesh__recordMaintainer mesh__D000778 ssb
% 222.56/222.76  |- mesh__dateRevised mesh__D000778 2005-06-30
% 222.56/222.76  |- skos__altLabel mesh__D000778 Dissociative Anesthetics
% 222.56/222.76  |- skos__scopeNote mesh__D000778
% 222.56/222.76       Intravenous anesthetics that induce a state of sedation, immobility, amnesia, and marked analgesia. Subjects may experience a strong feeling of dissociation from the environment. The condition produced is similar to NEUROLEPTANALGESIA, but is brought about by the administration of a single drug. %28%From Gilman et al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 8th ed%29%%A%    
% 222.56/222.76  |- mesh__historyNote mesh__D000778
% 222.56/222.76       91%28%71%29%; was see under ANESTHETICS 1971-90   
% 222.56/222.76  |- mesh__historyNote mesh__D019483
% 222.56/222.76       97; was DISINTEGRINS %28%NM%29% 1992-96   
% 222.56/222.76  |- skos__historyNote mesh__D019483 Peptides %28%1992-1996%29%
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D019483 2004
% 222.56/222.76  |- skos__prefLabel mesh__D019483 Disintegrins
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D019483 1999
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D019483 2001
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D019483 2003
% 222.56/222.76  |- mesh__publicMeSHNote mesh__D019483
% 222.56/222.76       97; DISINTEGRINS was indexed under PEPTIDES 1992-96 %26% VENOMS 1992-94%A%  
% 222.56/222.76  |- mesh__onlineNote mesh__D019483
% 222.56/222.76       use DISINTEGRINS %28%NM%29% to search DISINTEGRINS 1992-96   
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D019483 1998
% 222.56/222.76  |- skos__historyNote mesh__D019483 Venoms %28%1992-1994%29%
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D019483 2000
% 222.56/222.76  |- skos__scopeNote mesh__D019483
% 222.56/222.76       A family of polypeptides purified from snake venoms, which contain the arginine-glycine-aspartic acid %28%RGD%29% sequence. The RGD tripeptide binds to integrin receptors and thus competitively inhibits normal integrin-ligand interactions. Disintegrins thus block adhesive functions and act as platelet aggregation inhibitors.%A%    
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D019483 2006
% 222.56/222.76  |- mesh__dateCreated mesh__D019483 1996-06-10
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D019483 2005
% 222.56/222.76  |- rdf__type mesh__D019483sskos__Concept
% 222.56/222.76  |- skos__broader mesh__D019483smesh__D010455
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D019483 1997
% 222.56/222.76  |- skos__annotation mesh__D019483
% 222.56/222.76       polypeptides from snake venom; platelet aggregation inhib%A%  
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D019483 2002
% 222.56/222.76  |- mesh__dateEstablished mesh__D019483 1997-01-01
% 222.56/222.76  |- skos__prefLabel mesh__D005463 Fluoroacetates
% 222.56/222.76  |- mesh__recordAuthorizer mesh__D005463 SJN
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005463 2005
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005463 2004
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005463 2003
% 222.56/222.76  |- skos__broader mesh__D005463smesh__D000085
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005463 2001
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005463 1999
% 222.56/222.76  |- mesh__dateCreated mesh__D005463 1999-01-01
% 222.56/222.76  |- mesh__dateRevised mesh__D005463 1998-06-10
% 222.56/222.76  |- skos__scopeNote mesh__D005463
% 222.56/222.76       Derivatives of acetic acid with one or more fluorines attached. They are almost odorless, difficult to detect chemically, and very stable. The acid itself, as well as the derivatives that are broken down in the body to the acid, are highly toxic substances, behaving as convulsant poisons with a delayed action. %28%From Miall%27%s Dictionary of Chemistry, 5th ed%29%%A%    
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005463 2000
% 222.56/222.76  |- rdf__type mesh__D005463sskos__Concept
% 222.56/222.76  |- mesh__recordMaintainer mesh__D005463 ADP
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005463 2006
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005463 2002
% 222.56/222.76  |- mesh__recordOriginator mesh__D005463 NLM
% 222.56/222.76  |- skos__altLabel mesh__D043582 5 beta-Pregnane-3,20-dione
% 222.56/222.76  |- skos__altLabel mesh__D043582 3,20-Allopregnanedione
% 222.56/222.76  |- skos__hiddenLabel mesh__D043582 5 alpha Pregnane 3,20 dione
% 222.56/222.76  |- skos__hiddenLabel mesh__D043582 5 beta Dihydroprogesterone
% 222.56/222.76  |- skos__historyNote mesh__D043582 Progesterone %28%1974-2003%29%
% 222.56/222.76  |- skos__hiddenLabel mesh__D043582 5alpha DHP
% 222.56/222.76  |- skos__altLabel mesh__D043582
% 222.56/222.76       3,20-Allopregnanedione, %28%5alpha%29%-Isomer
% 222.56/222.76  |- skos__hiddenLabel mesh__D043582 5 beta Pregnane 3,20 dione
% 222.56/222.76  |- skos__altLabel mesh__D043582 5alpha-DHP
% 222.56/222.76  |- skos__broader mesh__D043582smesh__D011374
% 222.56/222.76  |- skos__altLabel mesh__D043582 5 alpha-Dihydroprogesterone
% 222.56/222.76  |- mesh__dateCreated mesh__D043582 2003-07-09
% 222.56/222.76  |- skos__altLabel mesh__D043582 5-alpha-Pregnanedione
% 222.56/222.76  |- mesh__publicMeSHNote mesh__D043582
% 222.56/222.76       2004; 3,20-ALLOPREGNANEDIONE was indexed under PREGNANEDIONES %28%NM%29% 1971-2003%A%  
% 222.56/222.76  |- skos__prefLabel mesh__D043582 5-alpha-Dihydroprogesterone
% 222.56/222.76  |- skos__historyNote mesh__D043582 Dihydroprogesterone %28%1976-2003%29%
% 222.56/222.76  |- skos__altLabel mesh__D043582 5alpha-Pregnane-3,20-dione
% 222.56/222.76  |- skos__hiddenLabel mesh__D043582 5 alpha Dihydroprogesterone
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D043582 2006
% 222.56/222.76  |- skos__hiddenLabel mesh__D043582 5beta DHP
% 222.56/222.76  |- mesh__dateEstablished mesh__D043582 2004-01-01
% 222.56/222.76  |- skos__broader mesh__D043582smesh__D011277
% 222.56/222.76  |- skos__altLabel mesh__D043582 5 alpha-Pregnane-3,20-dione
% 222.56/222.76  |- skos__hiddenLabel mesh__D043582 5 alpha Pregnanedione
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D043582 2005
% 222.56/222.76  |- skos__altLabel mesh__D043582 5-alpha-Pregnane-3,20-dione
% 222.56/222.76  |- skos__hiddenLabel mesh__D043582 3,20 Allopregnanedione
% 222.56/222.76  |- skos__altLabel mesh__D043582 5beta-DHP
% 222.56/222.76  |- skos__hiddenLabel mesh__D043582 5alpha Pregnane 3,20 dione
% 222.56/222.76  |- skos__scopeNote mesh__D043582
% 222.56/222.76       A biologically active 5-alpha-reduced metabolite of plasma PROGESTERONE. It is the immediate precursor of 5-alpha-pregnan-3-alpha-ol-20-one %28%ALLOPREGNANOLONE%29%, a neuroactive steroid that binds with GABA%28%A%29% RECEPTOR.%A%    
% 222.56/222.76  |- mesh__historyNote mesh__D043582
% 222.56/222.76       2004; for 3,20-ALLOPREGNANEDIONE use PREGNANEDIONES %28%NM%29% 1971-2003%A%  
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D043582 2004
% 222.56/222.76  |- rdf__type mesh__D043582sskos__Concept
% 222.56/222.76  |- mesh__historyNote mesh__D015891 90   
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D015891 2002
% 222.56/222.76  |- skos__broader mesh__D015891smesh__D011506
% 222.56/222.76  |- rdf__type mesh__D015891sskos__Concept
% 222.56/222.76  |- mesh__dateRevised mesh__D015891 1995-06-08
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D015891 2001
% 222.56/222.76  |- skos__historyNote mesh__D015891 Protease Inhibitors %28%1979-1989%29%
% 222.56/222.76  |- mesh__dateEstablished mesh__D015891 1990-01-01
% 222.56/222.76  |- mesh__publicMeSHNote mesh__D015891 90   
% 222.56/222.76  |- skos__historyNote mesh__D015891 Enzyme Inhibitors %28%1975-1978%29%
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D015891 2004
% 222.56/222.76  |- mesh__dateCreated mesh__D015891 1989-05-25
% 222.56/222.76  |- skos__annotation mesh__D015891
% 222.56/222.76       a group of endogenous cysteine proteinase inhib   
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D015891 2000
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D015891 2006
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D015891 2003
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D015891 2005
% 222.56/222.76  |- skos__prefLabel mesh__D015891 Cystatins
% 222.56/222.76  |- skos__hiddenLabel mesh__D015891 Superfamily, Cystatin
% 222.56/222.76  |- skos__altLabel mesh__D015891 Cystatin Superfamily
% 222.56/222.76  |- skos__scopeNote mesh__D015891
% 222.56/222.76       A homologous group of endogenous cysteine proteinase inhibitors. Four distinct families are recognized within the cystatin superfamily: cystatin B or stefins; cystatin C or post-gamma-globulin; egg-white or chicken cystatin; and kininogen cystatin. The cystatins inhibit most Cysteine Endopeptidases of the papain type, and other peptidases which have a sulfhydryl group at the active site.%A%    
% 222.56/222.76  |- skos__altLabel mesh__D051216 TLR6 Receptor
% 222.56/222.76  |- skos__hiddenLabel mesh__D051216 Toll Like Receptor 6
% 222.56/222.76  |- skos__prefLabel mesh__D051216 Toll-Like Receptor 6
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D051216 2006
% 222.56/222.76  |- mesh__dateEstablished mesh__D051216 2006-01-01
% 222.56/222.76  |- mesh__historyNote mesh__D051216 2006%28%1999%29%   
% 222.56/222.76  |- mesh__recordMaintainer mesh__D051216 DRC
% 222.56/222.76  |- mesh__recordOriginator mesh__D051216 DRC
% 222.56/222.76  |- rdf__type mesh__D051216sskos__Concept
% 222.56/222.76  |- skos__broader mesh__D051216smesh__D051193
% 222.56/222.76  |- skos__scopeNote mesh__D051216
% 222.56/222.76       A pattern recognition receptor that forms heterodimers with TLR2 RECEPTOR. The complex interacts with a variety of ligands including LIPOPROTEINS from MYCOPLASMA.%A%    
% 222.56/222.76  |- skos__hiddenLabel mesh__D051216 Receptor, TLR6
% 222.56/222.76  |- mesh__recordAuthorizer mesh__D051216 sjn
% 222.56/222.76  |- mesh__dateCreated mesh__D051216 2005-06-30
% 222.56/222.76  |- mesh__publicMeSHNote mesh__D051216
% 222.56/222.76       2006; TOLL-LIKE RECEPTOR 6 was indexed under MEMBRANE GLYCOPROTEINS %26% RECEPTORS, CELL SURFACE 1999-2005%A%  
% 222.56/222.76  |- mesh__recordMaintainer mesh__D015093 CCR
% 222.56/222.76  |- skos__historyNote mesh__D015093
% 222.56/222.76       Anticholesteremic Agents %28%1966-1979%29%
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D015093 2001
% 222.56/222.76  |- skos__altLabel mesh__D015093 3-Hydroxy-3-methylpentanedioic Acid
% 222.56/222.76  |- mesh__recordOriginator mesh__D015093 RLS
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D015093 2004
% 222.56/222.76  |- skos__hiddenLabel mesh__D015093 3 Hydroxy 3 methylpentanedioic Acid
% 222.56/222.76  |- skos__historyNote mesh__D015093 Hydroxy Acids %28%1975-1979%29%
% 222.56/222.76  |- skos__hiddenLabel mesh__D015093 Acid, 3-Hydroxy-3-methylglutaric
% 222.56/222.76  |- skos__historyNote mesh__D015093 Antilipemic Agents %28%1966-1972%29%
% 222.56/222.76  |- skos__hiddenLabel mesh__D015093 beta Hydroxy beta Methylglutarate
% 222.56/222.76  |- skos__prefLabel mesh__D015093 Meglutol
% 222.56/222.76  |- mesh__historyNote mesh__D015093
% 222.56/222.76       96; was 3-HYDROXY-3-METHYLGLUTARIC ACID 1980-95 %28%see under GLUTARATES 1980-90%29%%A%  
% 222.56/222.76  |- mesh__publicMeSHNote mesh__D015093
% 222.56/222.76       96; was 3-HYDROXY-3-METHYLGLUTARIC ACID 1980-95 %28%see under GLUTARATES 1980-90%29%%A%  
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D015093 2002
% 222.56/222.76  |- skos__altLabel mesh__D015093 3-Hydroxy-3-methylglutaric Acid
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D015093 2005
% 222.56/222.76  |- skos__historyNote mesh__D015093 Glutarates %28%1966-1979%29%
% 222.56/222.76  |- skos__altLabel mesh__D015093 beta-Hydroxy-beta-Methylglutarate
% 222.56/222.76  |- skos__hiddenLabel mesh__D015093 3 Hydroxy 3 methylglutaric Acid
% 222.56/222.76  |- mesh__dateCreated mesh__D015093 1979-05-23
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D015093 2006
% 222.56/222.76  |- skos__broader mesh__D015093smesh__D005977
% 222.56/222.76  |- mesh__dateRevised mesh__D015093 2000-06-21
% 222.56/222.76  |- skos__scopeNote mesh__D015093
% 222.56/222.76       An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate limiting enzyme in the biosynthesis of cholesterol.%A%    
% 222.56/222.76  |- mesh__dateEstablished mesh__D015093 1991-01-01
% 222.56/222.76  |- rdf__type mesh__D015093sskos__Concept
% 222.56/222.76  |- skos__hiddenLabel mesh__D015093 Acid, 3-Hydroxy-3-methylpentanedioic
% 222.56/222.76  |- mesh__recordAuthorizer mesh__D015093 sjn
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D015093 2003
% 222.56/222.76  |- skos__broader mesh__D009854smesh__D005370
% 222.56/222.76  |- rdf__type mesh__D009854sskos__Concept
% 222.56/222.76  |- mesh__dateCreated mesh__D009854 1999-01-01
% 222.56/222.76  |- mesh__recordMaintainer mesh__D009854 ags
% 222.56/222.76  |- skos__scopeNote mesh__D009854
% 222.56/222.76       A genus of parasitic nematodes whose organisms live and breed in skin and subcutaneous tissues. Onchocercal microfilariae may also be found in the urine, blood, or sputum.%A%    
% 222.56/222.76  |- skos__prefLabel mesh__D009854 Onchocerca
% 222.56/222.76  |- mesh__dateRevised mesh__D009854 2003-07-09
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D009854 2006
% 222.56/222.76  |- mesh__recordOriginator mesh__D009854 NLM
% 222.56/222.76  |- mesh__recordAuthorizer mesh__D009854 sjn
% 222.56/222.76  |- skos__annotation mesh__D009854
% 222.56/222.76       infection = ONCHOCERCIASIS; coord with specific helminth term %28%ANTIGENS, HELMINTH, etc%29% if pertinent; /drug eff: consider FILARICIDES%A%  
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D009854 2005
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D009854 2004
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D001871 2004
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D001871 1994
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D001871 2001
% 222.56/222.76  |- skos__hiddenLabel mesh__D001871 Ornamentations, Book
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D001871 1999
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D001871 1993
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D001871 2003
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D001871 2000
% 222.56/222.76  |- skos__broader mesh__D001871smesh__D001877
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D001871 1998
% 222.56/222.76  |- skos__hiddenLabel mesh__D001871 Ornamentation, Book
% 222.56/222.76  |- mesh__dateRevised mesh__D001871 1992-03-25
% 222.56/222.76  |- mesh__recordAuthorizer mesh__D001871 PLS
% 222.56/222.76  |- rdf__type mesh__D001871sskos__Concept
% 222.56/222.76  |- skos__prefLabel mesh__D001871 Book Ornamentation
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D001871 2006
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D001871 1997
% 222.56/222.76  |- mesh__recordMaintainer mesh__D001871 TAP
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D001871 2005
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D001871 1995
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D001871 1996
% 222.56/222.76  |- mesh__recordOriginator mesh__D001871 NLM
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D001871 2002
% 222.56/222.76  |- skos__hiddenLabel mesh__D001871 Book Ornamentations
% 222.56/222.76  |- mesh__dateCreated mesh__D001871 1999-01-01
% 222.56/222.76  |- skos__broader mesh__D009056smesh__D018640
% 222.56/222.76  |- skos__broader mesh__D009056smesh__D009059
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D009056 2001
% 222.56/222.76  |- mesh__dateEstablished mesh__D009056 1965-01-01
% 222.56/222.76  |- mesh__recordMaintainer mesh__D009056 kle
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D009056 2004
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D009056 2000
% 222.56/222.76  |- mesh__dateRevised mesh__D009056 1999-11-03
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D009056 2006
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D009056 2003
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D009056 2005
% 222.56/222.76  |- skos__scopeNote mesh__D009056
% 222.56/222.76       Congenital absence of or defects in structures of the mouth.%A%    
% 222.56/222.76  |- mesh__dateCreated mesh__D009056 1999-01-01
% 222.56/222.76  |- skos__annotation mesh__D009056
% 222.56/222.76       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 222.56/222.76  |- skos__hiddenLabel mesh__D009056 Abnormality, Mouth
% 222.56/222.76  |- skos__prefLabel mesh__D009056 Mouth Abnormalities
% 222.56/222.76  |- skos__hiddenLabel mesh__D009056 Mouth Abnormality
% 222.56/222.76  |- rdf__type mesh__D009056sskos__Concept
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D009056 2002
% 222.56/222.76  |- mesh__recordAuthorizer mesh__D009056 sjn
% 222.56/222.76  |- mesh__historyNote mesh__D009056 65   
% 222.56/222.76  |- mesh__publicMeSHNote mesh__D009056 65   
% 222.56/222.76  |- mesh__recordOriginator mesh__D009056 NLM
% 222.56/222.76  |- skos__altLabel mesh__D009056 Abnormalities, Mouth
% 222.56/222.76  |- skos__prefLabel mesh__D001073 Aprindine
% 222.56/222.76  |- mesh__recordOriginator mesh__D001073 NLM
% 222.56/222.76  |- mesh__recordMaintainer mesh__D001073 mdb
% 222.56/222.76  |- mesh__dateCreated mesh__D001073 1974-11-19
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D001073 2006
% 222.56/222.76  |- skos__altLabel mesh__D001073 PCR Brand of Aprindine Hydrochloride
% 222.56/222.76  |- mesh__historyNote mesh__D001073
% 222.56/222.76       91%28%75%29%; was see under INDENES 1975-90   
% 222.56/222.76  |- mesh__recordAuthorizer mesh__D001073 sjn
% 222.56/222.76  |- skos__historyNote mesh__D001073 Diethylamines %28%1974%29%
% 222.56/222.76  |- mesh__dateRevised mesh__D001073 2004-07-07
% 222.56/222.76  |- skos__altLabel mesh__D001073 Nycomed Brand of Aprindine Hydrochloride
% 222.56/222.76  |- skos__scopeNote mesh__D001073
% 222.56/222.76       A cardiac depressant used in arrhythmias.     
% 222.56/222.76  |- skos__historyNote mesh__D001073 Indenes %28%1973-1975%29%
% 222.56/222.76  |- skos__historyNote mesh__D001073 Aniline Compounds %28%1974%29%
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D001073 2005
% 222.56/222.76  |- rdf__type mesh__D001073sskos__Concept
% 222.56/222.76  |- skos__broader mesh__D001073smesh__D007189
% 222.56/222.76  |- mesh__dateEstablished mesh__D001073 1991-01-01
% 222.56/222.76  |- skos__annotation mesh__D001073 an anti-arrhythmic   
% 222.56/222.76  |- mesh__publicMeSHNote mesh__D001073 91; was see under INDENES 1975-90   
% 222.56/222.76  |- skos__altLabel mesh__D001073
% 222.56/222.76       Christiaens Brand of Aprindine Hydrochloride
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D014799 2004
% 222.56/222.76  |- skos__broader mesh__D014799smesh__D010684
% 222.56/222.76  |- mesh__dateCreated mesh__D014799 1999-01-01
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D014799 2000
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D014799 2003
% 222.56/222.76  |- skos__scopeNote mesh__D014799
% 222.56/222.76       The metaphysical doctrine that the functions and processes of life are due to a vital principle distinct from physicochemical forces and that the laws of physics and chemistry alone cannot explain life functions and processes. Vitalism is opposed to mechanistic materialism. The belief was that matter was divided into two classes based on behavior with respect to heat: organic and inorganic. Inorganic material could be melted but could always be recovered by removing the heat source. Organic compounds changed form upon heating and could not be recovered by removing the heat source. The proposed explanation for the difference between organic and inorganic compounds was the Vitalism Theory, which stated that inorganic materials did not contain the %22%vital force%22% of life.%A%    
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D014799 2006
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D014799 2002
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D014799 2005
% 222.56/222.76  |- mesh__recordOriginator mesh__D014799 NLM
% 222.56/222.76  |- skos__hiddenLabel mesh__D014799 Vitalisms
% 222.56/222.76  |- skos__prefLabel mesh__D014799 Vitalism
% 222.56/222.76  |- mesh__dateRevised mesh__D014799 1999-11-03
% 222.56/222.76  |- mesh__recordMaintainer mesh__D014799 KEV
% 222.56/222.76  |- mesh__recordAuthorizer mesh__D014799 sjn
% 222.56/222.76  |- rdf__type mesh__D014799sskos__Concept
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D014799 2001
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D000779 2006
% 222.56/222.76  |- skos__annotation mesh__D000779 see note at ANESTHETICS   
% 222.56/222.76  |- skos__hiddenLabel mesh__D000779 Conduction Blocking Anesthetics
% 222.56/222.76  |- skos__hiddenLabel mesh__D000779 Anesthetics, Conduction Blocking
% 222.56/222.76  |- mesh__dateCreated mesh__D000779 1999-01-01
% 222.56/222.76  |- skos__prefLabel mesh__D000779 Anesthetics, Local
% 222.56/222.76  |- skos__altLabel mesh__D000779 Anesthetics, Conduction-Blocking
% 222.56/222.76  |- skos__altLabel mesh__D000779 Conduction-Blocking Anesthetics
% 222.56/222.76  |- mesh__recordAuthorizer mesh__D000779 sjn
% 222.56/222.76  |- skos__scopeNote mesh__D000779
% 222.56/222.76       Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. %28%From Gilman AG, et. al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 8th ed%29% Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate.%A%    
% 222.56/222.76  |- mesh__recordOriginator mesh__D000779 NLM
% 222.56/222.76  |- skos__hiddenLabel mesh__D000779 Local Anesthetics
% 222.56/222.76  |- skos__broader mesh__D000779smesh__D018689
% 222.56/222.76  |- rdf__type mesh__D000779sskos__Concept
% 222.56/222.76  |- mesh__recordMaintainer mesh__D000779 ssb
% 222.56/222.76  |- skos__broader mesh__D000779smesh__D000777
% 222.56/222.76  |- mesh__dateRevised mesh__D000779 2005-06-30
% 222.56/222.76  |- mesh__recordMaintainer mesh__D019484 jls
% 222.56/222.76  |- mesh__dateEstablished mesh__D019484 1997-01-01
% 222.56/222.76  |- mesh__dateCreated mesh__D019484 1996-06-21
% 222.56/222.76  |- skos__altLabel mesh__D019484 Addresses %28%PT%29%
% 222.56/222.76  |- skos__scopeNote mesh__D019484
% 222.56/222.76       Works consisting of speeches, orations, or written statements, usually formal, directed to a particular group of persons. These are different from LECTURES %5B%PUBLICATION TYPE%5D% that are usually delivered to classes for instructional purposes.%A%    
% 222.56/222.76  |- mesh__recordAuthorizer mesh__D019484 sjn
% 222.56/222.76  |- mesh__recordOriginator mesh__D019484 TGC
% 222.56/222.76  |- skos__prefLabel mesh__D019484 Addresses %5B%Publication Type%5D%
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D019484 2006
% 222.56/222.76  |- mesh__historyNote mesh__D019484 1997   
% 222.56/222.76  |- mesh__dateRevised mesh__D019484 2005-06-30
% 222.56/222.76  |- skos__broader mesh__D019484smesh__D052180
% 222.56/222.76  |- skos__annotation mesh__D019484
% 222.56/222.76       publication type only; do not confuse with Publication Type LECTURES which is usually for classroom instruction. CATALOG: Do not use for current materials.%A%  
% 222.56/222.76  |- rdf__type mesh__D019484sskos__Concept
% 222.56/222.76  |- skos__altLabel mesh__D019484 Addresses
% 222.56/222.76  |- mesh__recordMaintainer mesh__D005464 TGC
% 222.56/222.76  |- skos__broader mesh__D005464smesh__D006845
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005464 2000
% 222.56/222.76  |- mesh__recordAuthorizer mesh__D005464 PLS
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005464 1998
% 222.56/222.76  |- mesh__dateCreated mesh__D005464 1999-01-01
% 222.56/222.76  |- skos__prefLabel mesh__D005464 Fluorobenzenes
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005464 1997
% 222.56/222.76  |- mesh__publicMeSHNote mesh__D005464 74   
% 222.56/222.76  |- rdf__type mesh__D005464sskos__Concept
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005464 1996
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005464 2002
% 222.56/222.76  |- mesh__recordOriginator mesh__D005464 NLM
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005464 2006
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005464 1995
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005464 2005
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005464 2004
% 222.56/222.76  |- mesh__dateRevised mesh__D005464 1992-05-19
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005464 2001
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005464 1993
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005464 1994
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005464 2003
% 222.56/222.76  |- mesh__historyNote mesh__D005464 74   
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D005464 1999
% 222.56/222.76  |- mesh__dateEstablished mesh__D005464 1974-01-01
% 222.56/222.76  |- skos__hiddenLabel mesh__D043583 Triphosphatase, Nucleoside
% 222.56/222.76  |- mesh__recordOriginator mesh__D043583 AKE
% 222.56/222.76  |- mesh__dateEstablished mesh__D043583 2004-01-01
% 222.56/222.76  |- skos__altLabel mesh__D043583 Nucleoside Triphosphatase
% 222.56/222.76  |- mesh__dateCreated mesh__D043583 2003-07-09
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D043583 2005
% 222.56/222.76  |- skos__historyNote mesh__D043583 Nucleotides %28%1973-1993%29%
% 222.56/222.76  |- skos__altLabel mesh__D043583 NTPase
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D043583 2006
% 222.56/222.76  |- skos__hiddenLabel mesh__D043583
% 222.56/222.76       Phosphohydrolase, Nucleoside Triphosphate
% 222.56/222.76  |- mesh__publicMeSHNote mesh__D043583
% 222.56/222.76       2004; NUCLEOSIDE-TRIPHOSPHATASE was indexed under ACID ANHYDRIDE HYDROLASES 1994-2003, PHOSPHATASES 1973-1993, %26% NUCLEOTIDES 1973-1993%A%  
% 222.56/222.76  |- skos__historyNote mesh__D043583 Phosphatases %28%1973-2003%29%
% 222.56/222.76  |- skos__hiddenLabel mesh__D043583
% 222.56/222.76       Triphosphate Phosphohydrolase, Nucleoside
% 222.56/222.76  |- mesh__recordMaintainer mesh__D043583 AKE
% 222.56/222.76  |- skos__altLabel mesh__D043583 Nucleoside Triphosphate Phosphohydrolase
% 222.56/222.76  |- skos__historyNote mesh__D043583
% 222.56/222.76       Acid Anhydride Hydrolases %28%1994-2003%29%
% 222.56/222.76  |- skos__broader mesh__D043583smesh__D017766
% 222.56/222.76  |- skos__altLabel mesh__D043583 Nucleosidetriphosphatase
% 222.56/222.76  |- skos__prefLabel mesh__D043583 Nucleoside-Triphosphatase
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D043583 2004
% 222.56/222.76  |- rdf__type mesh__D043583sskos__Concept
% 222.56/222.76  |- skos__scopeNote mesh__D043583
% 222.56/222.76       An enzyme which catalyzes the hydrolysis of nucleoside triphosphates to nucleoside diphosphates. It  may also catalyze the hydrolysis of nucleotide triphosphates, diphosphates, thiamine diphosphates and FAD. The nucleoside triphosphate phosphohydrolases I and II are subtypes of the enzyme which are found mostly in viruses.%A%    
% 222.56/222.76  |- mesh__historyNote mesh__D043583
% 222.56/222.76       2004; use NUCLEOSIDE-TRIPHOSPHATASE %28%NM%29% 1973-2003   
% 222.56/222.76  |- mesh__recordAuthorizer mesh__D043583 sjn
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D051217 2006
% 222.56/222.76  |- skos__hiddenLabel mesh__D051217 Toll Like Receptor 9
% 222.56/222.76  |- mesh__dateCreated mesh__D051217 2005-06-30
% 222.56/222.76  |- mesh__recordOriginator mesh__D051217 DRC
% 222.56/222.76  |- skos__hiddenLabel mesh__D051217 Receptor, TLR9
% 222.56/222.76  |- mesh__recordAuthorizer mesh__D051217 sjn
% 222.56/222.76  |- skos__altLabel mesh__D051217 TLR9 Receptor
% 222.56/222.76  |- skos__broader mesh__D051217smesh__D051193
% 222.56/222.76  |- mesh__publicMeSHNote mesh__D051217
% 222.56/222.76       2006; TOLL-LIKE RECEPTOR 9 was indexed under RECEPTORS, CELL SURFACE %26% DNA-BINDING PROTEINS 2001-2005%A%  
% 222.56/222.76  |- rdf__type mesh__D051217sskos__Concept
% 222.56/222.76  |- skos__scopeNote mesh__D051217
% 222.56/222.76       A pattern recognition receptor that binds unmethylated CPG CLUSTERS. It mediates cellular responses to bacterial pathogens by distinguishing between self and bacterial DNA.%A%    
% 222.56/222.76  |- mesh__dateEstablished mesh__D051217 2006-01-01
% 222.56/222.76  |- mesh__recordMaintainer mesh__D051217 DRC
% 222.56/222.76  |- skos__altLabel mesh__D051217 TLR9 Protein
% 222.56/222.76  |- skos__prefLabel mesh__D051217 Toll-Like Receptor 9
% 222.56/222.76  |- skos__broader mesh__D051217smesh__D004268
% 222.56/222.76  |- mesh__historyNote mesh__D051217 2006%28%2001%29%   
% 222.56/222.76  |- mesh__dateCreated mesh__D015094 1977-05-23
% 222.56/222.76  |- mesh__recordAuthorizer mesh__D015094 sjn
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D015094 2005
% 222.56/222.76  |- skos__historyNote mesh__D015094 Coenzyme A %28%1966-1977%29%
% 222.56/222.76  |- skos__hiddenLabel mesh__D015094 beta Keto Reductase
% 222.56/222.76  |- skos__hiddenLabel mesh__D015094 beta Hydroxyacyl CoA Dehydrogenase
% 222.56/222.76  |- mesh__recordMaintainer mesh__D015094 ssb
% 222.56/222.76  |- skos__hiddenLabel mesh__D015094 Dehydrogenases, 3-Hydroxyacyl CoA
% 222.56/222.76  |- skos__hiddenLabel mesh__D015094 CoA Dehydrogenases, 3-Hydroxyacyl
% 222.56/222.76  |- mesh__recordOriginator mesh__D015094 RLS
% 222.56/222.76  |- skos__hiddenLabel mesh__D015094 3 Hydroxyacyl CoA Dehydrogenases
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D015094 2006
% 222.56/222.76  |- mesh__publicMeSHNote mesh__D015094 78   
% 222.56/222.76  |- skos__prefLabel mesh__D015094 3-Hydroxyacyl CoA Dehydrogenases
% 222.56/222.76  |- skos__historyNote mesh__D015094
% 222.56/222.76       Alcohol Oxidoreductases %28%1966-1977%29%
% 222.56/222.76  |- skos__broader mesh__D015094smesh__D000429
% 222.56/222.76  |- mesh__dateRevised mesh__D015094 2003-07-09
% 222.56/222.76  |- mesh__dateEstablished mesh__D015094 1978-01-01
% 222.56/222.76  |- rdf__type mesh__D015094sskos__Concept
% 222.56/222.76  |- skos__hiddenLabel mesh__D015094 CoA Dehydrogenase, beta-Hydroxyacyl
% 222.56/222.76  |- skos__scopeNote mesh__D015094
% 222.56/222.76       Enzymes that reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. They are key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis. EC 1.1.1.35.%A%    
% 222.56/222.76  |- skos__altLabel mesh__D015094 beta-Hydroxyacyl Dehydrogenases
% 222.56/222.76  |- skos__hiddenLabel mesh__D015094 Dehydrogenase, beta-Hydroxyacyl CoA
% 222.56/222.76  |- skos__hiddenLabel mesh__D015094 beta Hydroxyacyl Dehydrogenases
% 222.56/222.76  |- mesh__historyNote mesh__D015094 78   
% 222.56/222.76  |- skos__hiddenLabel mesh__D015094 Dehydrogenases, beta-Hydroxyacyl
% 222.56/222.76  |- mesh__activeMeSHYear mesh__D015094 2004
% 222.56/222.76  |- mesh__recordOriginator mesh__D009855 NLM
% 222.56/222.77  |- mesh__recordAuthorizer mesh__D009855 sjn
% 222.56/222.77  |- mesh__dateCreated mesh__D009855 1999-01-01
% 222.56/222.77  |- mesh__recordMaintainer mesh__D009855 ags
% 222.56/222.77  |- skos__prefLabel mesh__D009855 Onchocerciasis
% 222.56/222.77  |- skos__broader mesh__D009855smesh__D012876
% 222.56/222.77  |- mesh__dateRevised mesh__D009855 2005-06-30
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D009855 2006
% 222.56/222.77  |- skos__broader mesh__D009855smesh__D005368
% 222.56/222.77  |- skos__annotation mesh__D009855
% 222.56/222.77       for drug therapy of onchocerciasis, consider FILARICIDES   
% 222.56/222.77  |- skos__hiddenLabel mesh__D009855 Onchocerciases
% 222.56/222.77  |- rdf__type mesh__D009855sskos__Concept
% 222.56/222.77  |- skos__scopeNote mesh__D009855
% 222.56/222.77       Infection with nematodes of the genus ONCHOCERCA. Characteristics include the presence of firm subcutaneous nodules filled with adult worms, PRURITUS, and ocular lesions.%A%    
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001872 1992
% 222.56/222.77  |- rdf__type mesh__D001872sskos__Concept
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001872 2006
% 222.56/222.77  |- mesh__recordOriginator mesh__D001872 NLM
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001872 1997
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001872 2002
% 222.56/222.77  |- skos__hiddenLabel mesh__D001872 Book Price
% 222.56/222.77  |- mesh__dateRevised mesh__D001872 1989-04-27
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001872 2005
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001872 1996
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001872 1995
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001872 1991
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001872 2001
% 222.56/222.77  |- mesh__recordMaintainer mesh__D001872 TGC
% 222.56/222.77  |- mesh__dateCreated mesh__D001872 1999-01-01
% 222.56/222.77  |- skos__hiddenLabel mesh__D001872 Prices, Book
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001872 2004
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001872 1994
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001872 1990
% 222.56/222.77  |- skos__annotation mesh__D001872 no qualif   
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001872 2000
% 222.56/222.77  |- skos__hiddenLabel mesh__D001872 Price, Book
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001872 1999
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001872 1993
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001872 2003
% 222.56/222.77  |- skos__prefLabel mesh__D001872 Book Prices
% 222.56/222.77  |- mesh__recordAuthorizer mesh__D001872 PLS
% 222.56/222.77  |- skos__broader mesh__D001872smesh__D001879
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001872 1998
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D009057 2002
% 222.56/222.77  |- skos__scopeNote mesh__D009057
% 222.56/222.77       General or unspecified diseases of the stomatognathic system, comprising the mouth, teeth, jaws, and pharynx.%A%    
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D009057 1999
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D009057 2006
% 222.56/222.77  |- skos__hiddenLabel mesh__D009057 Disease, Stomatognathic
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D009057 2003
% 222.56/222.77  |- mesh__historyNote mesh__D009057
% 222.56/222.77       89; was MOUTH AND TOOTH DISEASES %28%NON MESH%29% 1975-88   
% 222.56/222.77  |- mesh__recordOriginator mesh__D009057 NLM
% 222.56/222.77  |- skos__hiddenLabel mesh__D009057 Diseases, Stomatognathic
% 222.56/222.77  |- skos__annotation mesh__D009057
% 222.56/222.77       includes dis of mouth, teeth, jaws %26% pharynx; GEN: prefer specifics; index here for %22%stomatol dis%22% of foreign lit%A%  
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D009057 2001
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D009057 2005
% 222.56/222.77  |- mesh__recordAuthorizer mesh__D009057 SJN
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D009057 2000
% 222.56/222.77  |- mesh__dateCreated mesh__D009057 1999-01-01
% 222.56/222.77  |- mesh__dateRevised mesh__D009057 1998-06-11
% 222.56/222.77  |- mesh__recordMaintainer mesh__D009057 JLS
% 222.56/222.77  |- rdf__type mesh__D009057sskos__Concept
% 222.56/222.77  |- skos__hiddenLabel mesh__D009057 Stomatognathic Disease
% 222.56/222.77  |- mesh__onlineNote mesh__D009057
% 222.56/222.77       pre-explosion = STOMATOGNATHIC DISEASES %28%PX%29%   
% 222.56/222.77  |- skos__altLabel mesh__D009057 Mouth and Tooth Diseases
% 222.56/222.77  |- mesh__runningHead mesh__D009057 C7 - DISEASES-STOMATOGNATHIC   
% 222.56/222.77  |- mesh__dateEstablished mesh__D009057 1989-01-01
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D009057 2004
% 222.56/222.77  |- skos__prefLabel mesh__D009057 Stomatognathic Diseases
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001074 2006
% 222.56/222.77  |- mesh__dateRevised mesh__D001074 2005-06-30
% 222.56/222.77  |- mesh__publicMeSHNote mesh__D001074 2001; see APROCARB 1972-2000   
% 222.56/222.77  |- skos__hiddenLabel mesh__D001074 O Isopropoxyphenylmethylcarbamate
% 222.56/222.77  |- skos__broader mesh__D001074smesh__D048448
% 222.56/222.77  |- mesh__dateCreated mesh__D001074 1999-01-01
% 222.56/222.77  |- mesh__recordOriginator mesh__D001074 NLM
% 222.56/222.77  |- rdf__type mesh__D001074sskos__Concept
% 222.56/222.77  |- mesh__historyNote mesh__D001074 2001%28%1972%29%   
% 222.56/222.77  |- mesh__dateEstablished mesh__D001074 1974-01-01
% 222.56/222.77  |- skos__historyNote mesh__D001074 Carbamates %28%1966-1971%29%
% 222.56/222.77  |- skos__scopeNote mesh__D001074 A carbamate insecticide.     
% 222.56/222.77  |- skos__altLabel mesh__D001074 O-Isopropoxyphenylmethylcarbamate
% 222.56/222.77  |- mesh__recordMaintainer mesh__D001074 ssb
% 222.56/222.77  |- skos__prefLabel mesh__D001074 Propoxur
% 222.56/222.77  |- mesh__recordAuthorizer mesh__D001074 sjn
% 222.56/222.77  |- skos__historyNote mesh__D001074 Insecticides %28%1966-1971%29%
% 222.56/222.77  |- mesh__historyNote mesh__D019485
% 222.56/222.77       97; was BONE MORPHOGENETIC PROTEIN %28%NM%29% 1981-96   
% 222.56/222.77  |- mesh__dateCreated mesh__D019485 1996-06-10
% 222.56/222.77  |- skos__historyNote mesh__D019485 Proteins %28%1981-1996%29%
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D019485 2006
% 222.56/222.77  |- skos__scopeNote mesh__D019485
% 222.56/222.77       Bone-growth regulatory factors that are members of the transforming growth factor-beta superfamily of proteins. They are synthesized as large precursor molecules which are cleaved by proteolytic enzymes. The active form can consist of a dimer of two identical proteins or a heterodimer of two related bone morphogenetic proteins.%A%    
% 222.56/222.77  |- mesh__onlineNote mesh__D019485
% 222.56/222.77       use BONE MORPHOGENETIC PROTEINS %28%NM%29% to search BONE MORPHOGENETIC PROTEIN 1981-96%A%  
% 222.56/222.77  |- mesh__recordOriginator mesh__D019485 AGS
% 222.56/222.77  |- skos__altLabel mesh__D019485 Bone Morphogenetic Protein
% 222.56/222.77  |- rdf__type mesh__D019485sskos__Concept
% 222.56/222.77  |- skos__hiddenLabel mesh__D019485 Morphogenetic Protein, Bone
% 222.56/222.77  |- mesh__dateEstablished mesh__D019485 1997-01-01
% 222.56/222.77  |- mesh__recordAuthorizer mesh__D019485 sjn
% 222.56/222.77  |- skos__broader mesh__D019485smesh__D036341
% 222.56/222.77  |- mesh__publicMeSHNote mesh__D019485
% 222.56/222.77       97; BONE MORPHOGENETIC PROTEIN was indexed under PROTEINS 1981-96%A%  
% 222.56/222.77  |- skos__hiddenLabel mesh__D019485 Morphogenetic Proteins, Bone
% 222.56/222.77  |- skos__prefLabel mesh__D019485 Bone Morphogenetic Proteins
% 222.56/222.77  |- mesh__dateRevised mesh__D019485 2005-06-30
% 222.56/222.77  |- mesh__recordMaintainer mesh__D019485 SYSTEM
% 222.56/222.77  |- mesh__historyNote mesh__D005465 66   
% 222.56/222.77  |- skos__hiddenLabel mesh__D005465 Polymers, Fluorocarbon
% 222.56/222.77  |- mesh__dateEstablished mesh__D005465 1966-01-01
% 222.56/222.77  |- rdf__type mesh__D005465sskos__Concept
% 222.56/222.77  |- skos__prefLabel mesh__D005465 Fluorocarbon Polymers
% 222.56/222.77  |- mesh__recordAuthorizer mesh__D005465 sjn
% 222.56/222.77  |- skos__annotation mesh__D005465 D25-26 qualif   
% 222.56/222.77  |- mesh__recordMaintainer mesh__D005465 jmp
% 222.56/222.77  |- skos__hiddenLabel mesh__D005465 Polymers, Fluorinated
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D005465 2006
% 222.56/222.77  |- skos__altLabel mesh__D005465 Fluorinated Polymers
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D005465 2005
% 222.56/222.77  |- mesh__recordOriginator mesh__D005465 NLM
% 222.56/222.77  |- mesh__dateRevised mesh__D005465 2004-07-07
% 222.56/222.77  |- mesh__publicMeSHNote mesh__D005465 66   
% 222.56/222.77  |- skos__broader mesh__D005465smesh__D011108
% 222.56/222.77  |- skos__hiddenLabel mesh__D005465 Resins, Fluorocarbon
% 222.56/222.77  |- mesh__dateCreated mesh__D005465 1999-01-01
% 222.56/222.77  |- rdf__type mesh__D051218sskos__Concept
% 222.56/222.77  |- skos__altLabel mesh__D051218 MD-2 Protein
% 222.56/222.77  |- skos__scopeNote mesh__D051218
% 222.56/222.77       A secreted protein that associates with TOLL-LIKE RECEPTOR 4 and is essential for receptor recognition of LIPOPOLYSACCHARIDES.%A%    
% 222.56/222.77  |- skos__altLabel mesh__D051218 LY96 Protein
% 222.56/222.77  |- mesh__dateCreated mesh__D051218 2005-06-30
% 222.56/222.77  |- skos__broader mesh__D051218smesh__D002352
% 222.56/222.77  |- mesh__publicMeSHNote mesh__D051218
% 222.56/222.77       2006; MD-2 PROTEIN was indexed under CARRIER PROTEINS %26% ANTIGENS, SURFACE 1999-2005%A%  
% 222.56/222.77  |- mesh__recordAuthorizer mesh__D051218 sjn
% 222.56/222.77  |- skos__prefLabel mesh__D051218 Lymphocyte Antigen 96
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D051218 2006
% 222.56/222.77  |- mesh__historyNote mesh__D051218 2006%28%1999%29%   
% 222.56/222.77  |- mesh__recordOriginator mesh__D051218 DRC
% 222.56/222.77  |- skos__broader mesh__D051218smesh__D000954
% 222.56/222.77  |- mesh__dateEstablished mesh__D051218 2006-01-01
% 222.56/222.77  |- mesh__recordMaintainer mesh__D051218 DRC
% 222.56/222.77  |- mesh__dateRevised mesh__D015095 2004-07-19
% 222.56/222.77  |- skos__scopeNote mesh__D015095
% 222.56/222.77       An oxidation product of tryptophan metabolism. It may be a free radical scavenger and a carcinogen.%A%    
% 222.56/222.77  |- rdf__type mesh__D015095sskos__Concept
% 222.56/222.77  |- mesh__recordMaintainer mesh__D015095 jls
% 222.56/222.77  |- mesh__dateEstablished mesh__D015095 1991-01-01
% 222.56/222.77  |- mesh__dateCreated mesh__D015095 1974-11-19
% 222.56/222.77  |- skos__broader mesh__D015095smesh__D000879
% 222.56/222.77  |- mesh__recordAuthorizer mesh__D015095 sjn
% 222.56/222.77  |- skos__historyNote mesh__D015095 Anthranilic Acids %28%1970-1974%29%
% 222.56/222.77  |- mesh__publicMeSHNote mesh__D015095
% 222.56/222.77       91; was see under ANTHRANILIC ACIDS 1975-90   
% 222.56/222.77  |- mesh__historyNote mesh__D015095
% 222.56/222.77       91%28%75%29%; was see under ANTHRANILIC ACIDS 1975-90   
% 222.56/222.77  |- skos__broader mesh__D015095smesh__D006880
% 222.56/222.77  |- skos__historyNote mesh__D015095 Phenols %28%1972-1974%29%
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D015095 2005
% 222.56/222.77  |- skos__hiddenLabel mesh__D015095 Acid, 3-Hydroxyanthranilic
% 222.56/222.77  |- mesh__recordOriginator mesh__D015095 NLM
% 222.56/222.77  |- skos__prefLabel mesh__D015095 3-Hydroxyanthranilic Acid
% 222.56/222.77  |- skos__hiddenLabel mesh__D015095 3 Hydroxyanthranilic Acid
% 222.56/222.77  |- skos__annotation mesh__D015095 D25-26 qualif   
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D015095 2006
% 222.56/222.77  |- mesh__historyNote mesh__D009856 86   
% 222.56/222.77  |- skos__historyNote mesh__D009856 Antigens, Viral, Tumor %28%1984-1985%29%
% 222.56/222.77  |- skos__historyNote mesh__D009856 Viral Proteins %28%1966-1985%29%
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D009856 2006
% 222.56/222.77  |- mesh__recordMaintainer mesh__D009856 DRC
% 222.56/222.77  |- skos__annotation mesh__D009856
% 222.56/222.77       GEN or unspecified; prefer specifics; coord with specific virus %28%IM%29%; /drug eff /ultrastruct permitted%A%  
% 222.56/222.77  |- mesh__recordOriginator mesh__D009856 RLS
% 222.56/222.77  |- skos__scopeNote mesh__D009856
% 222.56/222.77       Products of viral oncogenes, most commonly retroviral oncogenes. They usually have transforming and often protein kinase activities.%A%    
% 222.56/222.77  |- skos__hiddenLabel mesh__D009856 Transforming Proteins, Viral
% 222.56/222.77  |- skos__altLabel mesh__D009856 Viral Transforming Proteins
% 222.56/222.77  |- mesh__recordAuthorizer mesh__D009856 sjn
% 222.56/222.77  |- skos__hiddenLabel mesh__D009856 v onc Proteins
% 222.56/222.77  |- rdf__type mesh__D009856sskos__Concept
% 222.56/222.77  |- mesh__dateEstablished mesh__D009856 1986-01-01
% 222.56/222.77  |- mesh__dateCreated mesh__D009856 1985-04-25
% 222.56/222.77  |- mesh__dateRevised mesh__D009856 2005-06-30
% 222.56/222.77  |- skos__altLabel mesh__D009856 Viral Oncogene Proteins
% 222.56/222.77  |- skos__altLabel mesh__D009856 v-onc Proteins
% 222.56/222.77  |- skos__broader mesh__D009856smesh__D015513
% 222.56/222.77  |- skos__broader mesh__D009856smesh__D014764
% 222.56/222.77  |- skos__prefLabel mesh__D009856 Oncogene Proteins, Viral
% 222.56/222.77  |- mesh__publicMeSHNote mesh__D009856 86   
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001873 2006
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001873 2005
% 222.56/222.77  |- mesh__recordAuthorizer mesh__D001873 SJN
% 222.56/222.77  |- skos__altLabel mesh__D001873 Reviews, Book
% 222.56/222.77  |- mesh__dateRevised mesh__D001873 1998-06-10
% 222.56/222.77  |- mesh__recordMaintainer mesh__D001873 JLS
% 222.56/222.77  |- mesh__dateCreated mesh__D001873 1999-01-01
% 222.56/222.77  |- mesh__recordOriginator mesh__D001873 NLM
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001873 2004
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001873 2002
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001873 1999
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001873 2003
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001873 2001
% 222.56/222.77  |- skos__annotation mesh__D001873
% 222.56/222.77       do not index book reviews; use for articles on book reviews as a subject; no qualif%A%  
% 222.56/222.77  |- skos__prefLabel mesh__D001873 Book Reviews
% 222.56/222.77  |- skos__broader mesh__D001873smesh__D011642
% 222.56/222.77  |- skos__hiddenLabel mesh__D001873 Review, Book
% 222.56/222.77  |- skos__hiddenLabel mesh__D001873 Book Review
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D001873 2000
% 222.56/222.77  |- rdf__type mesh__D001873sskos__Concept
% 222.56/222.77  |- mesh__dateRevised mesh__D009058 1999-11-03
% 222.56/222.77  |- skos__scopeNote mesh__D009058
% 222.56/222.77       Abnormal breathing through the mouth, usually associated with obstructive disorders of the nasal passages.%A%    
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D009058 2002
% 222.56/222.77  |- mesh__dateCreated mesh__D009058 1999-01-01
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D009058 2006
% 222.56/222.77  |- mesh__recordMaintainer mesh__D009058 KEV
% 222.56/222.77  |- mesh__publicMeSHNote mesh__D009058 72   
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D009058 2000
% 222.56/222.77  |- mesh__historyNote mesh__D009058 72%28%68%29%   
% 222.56/222.77  |- skos__hiddenLabel mesh__D009058 Mouth Breathings
% 222.56/222.77  |- mesh__recordAuthorizer mesh__D009058 sjn
% 222.56/222.77  |- skos__historyNote mesh__D009058 Respiration %28%1966-1967%29%
% 222.56/222.77  |- mesh__recordOriginator mesh__D009058 NLM
% 222.56/222.77  |- rdf__type mesh__D009058sskos__Concept
% 222.56/222.77  |- skos__annotation mesh__D009058
% 222.56/222.77       note category: use all pertinent qualif   
% 222.56/222.77  |- mesh__dateEstablished mesh__D009058 1972-01-01
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D009058 2001
% 222.56/222.77  |- skos__hiddenLabel mesh__D009058 Breathing, Mouth
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D009058 2003
% 222.56/222.77  |- skos__broader mesh__D009058smesh__D012818
% 222.56/222.77  |- skos__prefLabel mesh__D009058 Mouth Breathing
% 222.56/222.77  |- skos__broader mesh__D009058smesh__D012120
% 222.56/222.77  |- skos__hiddenLabel mesh__D009058 Breathings, Mouth
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D009058 2004
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D009058 2005
% 222.56/222.77  |- mesh__historyNote mesh__D019486 1997   
% 222.56/222.77  |- mesh__dateRevised mesh__D019486 2005-06-30
% 222.56/222.77  |- skos__broader mesh__D019486smesh__D052181
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D019486 2006
% 222.56/222.77  |- skos__broader mesh__D019486smesh__D052180
% 222.56/222.77  |- mesh__dateCreated mesh__D019486 1996-06-21
% 222.56/222.77  |- rdf__type mesh__D019486sskos__Concept
% 222.56/222.77  |- skos__annotation mesh__D019486
% 222.56/222.77       publication type only; for animation as a subject, index under main heading MOTION PICTURES; used for historical materials only. CATALOG: do not use for current materials.%A%  
% 222.56/222.77  |- mesh__recordMaintainer mesh__D019486 jls
% 222.56/222.77  |- skos__scopeNote mesh__D019486
% 222.56/222.77       A film or video wholly or partially created by photographing drawings, sculptures, or other inanimate things in sequence to create the illusion of motion. Animations are also generated by computers. %28%From Moving Image Materials: Genre Terms, 1988%29%%A%    
% 222.56/222.77  |- skos__altLabel mesh__D019486 Animation %28%PT%29%
% 222.56/222.77  |- skos__prefLabel mesh__D019486 Animation %5B%Publication Type%5D%
% 222.56/222.77  |- skos__altLabel mesh__D019486 Animation
% 222.56/222.77  |- mesh__dateEstablished mesh__D019486 1997-01-01
% 222.56/222.77  |- mesh__recordAuthorizer mesh__D019486 sjn
% 222.56/222.77  |- mesh__recordOriginator mesh__D019486 TGC
% 222.56/222.77  |- skos__annotation mesh__D005466
% 222.56/222.77       do not confuse with HYDROCARBONS, FLUORINATED or CHLOROFLUOROCARBONS%A%  
% 222.56/222.77  |- mesh__historyNote mesh__D005466
% 222.56/222.77       77%28%75%29%; was see under FLUOROCARBON POLYMERS 1975-76   
% 222.56/222.77  |- rdf__type mesh__D005466sskos__Concept
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D005466 2005
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D005466 1994
% 222.56/222.77  |- mesh__recordMaintainer mesh__D005466 TPW
% 222.56/222.77  |- mesh__dateEstablished mesh__D005466 1977-01-01
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D005466 2000
% 222.56/222.77  |- mesh__recordAuthorizer mesh__D005466 PLS
% 222.56/222.77  |- skos__historyNote mesh__D005466 Freons %28%1974-1976%29%
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D005466 2003
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D005466 2006
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D005466 2001
% 222.56/222.77  |- skos__broader mesh__D005466smesh__D006845
% 222.56/222.77  |- skos__historyNote mesh__D005466
% 222.56/222.77       Hydrocarbons, Fluorinated %28%1974-1976%29%
% 222.56/222.77  |- skos__hiddenLabel mesh__D005466 Emulsions, Fluorocarbon
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D005466 1995
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D005466 2004
% 222.56/222.77  |- mesh__dateRevised mesh__D005466 1992-05-19
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D005466 1998
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D005466 2002
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D005466 1993
% 222.56/222.77  |- skos__historyNote mesh__D005466 Fluorocarbon Polymers %28%1974-1976%29%
% 222.56/222.77  |- mesh__publicMeSHNote mesh__D005466
% 222.56/222.77       77; was see under FLUOROCARBON POLYMERS 1975-76; PERFLUOROBUTYL TETRAHYDROFURAN was see under FURANS 1975-77%A%  
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D005466 1996
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D005466 1999
% 222.56/222.77  |- mesh__dateCreated mesh__D005466 1974-11-19
% 222.56/222.77  |- skos__related mesh__D005466smesh__D001802
% 222.56/222.77  |- skos__altLabel mesh__D005466 Perfluorocarbons
% 222.56/222.77  |- skos__prefLabel mesh__D005466 Fluorocarbons
% 222.56/222.77  |- mesh__recordOriginator mesh__D005466 NLM
% 222.56/222.77  |- skos__scopeNote mesh__D005466
% 222.56/222.77       Liquid perfluorinated carbon compounds which may or may not contain a hetero atom such as nitrogen, oxygen or sulfur, but do not contain another halogen or hydrogen atom. This concept includes fluorocarbon emulsions and fluorocarbon blood substitutes.%A%    
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D005466 1997
% 222.56/222.77  |- skos__hiddenLabel mesh__D043585 Muscarinic M2 Receptors
% 222.56/222.77  |- skos__altLabel mesh__D043585 Receptors, Muscarinic M2
% 222.56/222.77  |- skos__altLabel mesh__D043585 Muscarinic Receptors M2
% 222.56/222.77  |- skos__scopeNote mesh__D043585
% 222.56/222.77       A specific subtype of muscarinic receptor found in the lower BRAIN, the HEART and in SMOOTH MUSCLE-containing organs. Although present in smooth muscle the M2 muscarinic receptor appears not to be involved in contractile responses.%A%    
% 222.56/222.77  |- skos__altLabel mesh__D043585 Muscarinic Receptor M2
% 222.56/222.77  |- skos__hiddenLabel mesh__D043585 M2 Receptor, Muscarinic
% 222.56/222.77  |- rdf__type mesh__D043585sskos__Concept
% 222.56/222.77  |- skos__prefLabel mesh__D043585 Receptor, Muscarinic M2
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D043585 2004
% 222.56/222.77  |- mesh__historyNote mesh__D043585
% 222.56/222.77       2004; use RECEPTOR, MUSCARINIC M2 %28%NM%29% 1996-2003   
% 222.56/222.77  |- mesh__dateEstablished mesh__D043585 2004-01-01
% 222.56/222.77  |- mesh__publicMeSHNote mesh__D043585
% 222.56/222.77       2004; MUSCARINIC RECEPTOR M2 was indexed under RECEPTORS, MUSCARINIC 1996-2003%A%  
% 222.56/222.77  |- skos__historyNote mesh__D043585 Muscarinic Receptors %28%1996-2003%29%
% 222.56/222.77  |- skos__hiddenLabel mesh__D043585 M2, Muscarinic Receptor
% 222.56/222.77  |- mesh__dateCreated mesh__D043585 2003-07-09
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D043585 2005
% 222.56/222.77  |- skos__broader mesh__D043585smesh__D011976
% 222.56/222.77  |- skos__hiddenLabel mesh__D043585 Receptor M2, Muscarinic
% 222.56/222.77  |- skos__hiddenLabel mesh__D043585 Muscarinic M2 Receptor
% 222.56/222.77  |- skos__hiddenLabel mesh__D043585 M2 Receptors, Muscarinic
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D043585 2006
% 222.56/222.77  |- skos__hiddenLabel mesh__D043585 M2, Muscarinic Receptors
% 222.56/222.77  |- skos__hiddenLabel mesh__D043585 Receptors M2, Muscarinic
% 222.56/222.77  |- mesh__dateRevised mesh__D010600 2001-07-25
% 222.56/222.77  |- mesh__recordOriginator mesh__D010600 NLM
% 222.56/222.77  |- mesh__dateCreated mesh__D010600 1999-01-01
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D010600 2004
% 222.56/222.77  |- skos__prefLabel mesh__D010600 Pharmacology
% 222.56/222.77  |- skos__scopeNote mesh__D010600
% 222.56/222.77       The study of the origin, nature, properties, and actions of drugs and their effects on living organisms.%A%    
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D010600 2003
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D010600 2006
% 222.56/222.77  |- skos__hiddenLabel mesh__D010600 Pharmacologies
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D010600 2002
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D010600 2005
% 222.56/222.77  |- skos__annotation mesh__D010600
% 222.56/222.77       SPEC: SPEC qualif; the pharmacol of a drug or chem = Cat D term with /pharmacol: Manual 19.8.54; /methods: consider TECHNOLOGY, PHARMACEUTICAL; DF: PHARMACOL%A%  
% 222.56/222.77  |- mesh__recordMaintainer mesh__D010600 jls
% 222.56/222.77  |- skos__related mesh__D010600smesh__D004364
% 222.56/222.77  |- mesh__recordAuthorizer mesh__D010600 sjn
% 222.56/222.77  |- skos__broader mesh__D010600smesh__D006281
% 222.56/222.77  |- rdf__type mesh__D010600sskos__Concept
% 222.56/222.77  |- skos__broader mesh__D010600smesh__D001690
% 222.56/222.77  |- skos__hiddenLabel mesh__D015894 Human Genomes
% 222.56/222.77  |- mesh__historyNote mesh__D015894 90   
% 222.56/222.77  |- skos__historyNote mesh__D015894 DNA %28%1972-1987%29%
% 222.56/222.77  |- skos__hiddenLabel mesh__D015894 Genomes, Human
% 222.56/222.77  |- mesh__recordMaintainer mesh__D015894 nns
% 222.56/222.77  |- skos__historyNote mesh__D015894 Chromosome Mapping %28%1972-1989%29%
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D015894 2006
% 222.56/222.77  |- skos__broader mesh__D015894smesh__D016678
% 222.56/222.77  |- skos__altLabel mesh__D015894 Human Genome
% 222.56/222.77  |- skos__historyNote mesh__D015894 Base Sequence %28%1972-1989%29%
% 222.56/222.77  |- mesh__recordAuthorizer mesh__D015894 sjn
% 222.56/222.77  |- mesh__dateRevised mesh__D015894 2005-06-30
% 222.56/222.77  |- skos__historyNote mesh__D015894 Genes %28%1972-1989%29%
% 222.56/222.77  |- mesh__dateCreated mesh__D015894 1989-05-25
% 222.56/222.77  |- mesh__recordOriginator mesh__D015894 PXP
% 222.56/222.77  |- rdf__type mesh__D015894sskos__Concept
% 222.56/222.77  |- mesh__dateEstablished mesh__D015894 1990-01-01
% 222.56/222.77  |- skos__prefLabel mesh__D015894 Genome, Human
% 222.56/222.77  |- mesh__publicMeSHNote mesh__D015894 90   
% 222.56/222.77  |- skos__scopeNote mesh__D015894
% 222.56/222.77       The complete genetic complement contained in the DNA of a set of CHROMOSOMES in a HUMAN. The length of the human genome is about 3 billion base pairs.%A%    
% 222.56/222.77  |- skos__altLabel mesh__D051219 PACAP27
% 222.56/222.77  |- mesh__recordMaintainer mesh__D051219 DRC
% 222.56/222.77  |- skos__altLabel mesh__D051219 PACAP-27
% 222.56/222.77  |- skos__broader mesh__D051219smesh__D009414
% 222.56/222.77  |- skos__prefLabel mesh__D051219
% 222.56/222.77       Pituitary Adenylate Cyclase-Activating Polypeptide
% 222.56/222.77  |- skos__broader mesh__D051219smesh__D009479
% 222.56/222.77  |- skos__scopeNote mesh__D051219
% 222.56/222.77       A multi-functional neuropeptide that serves as a NEUROTRANSMITTER, and a VASODILATOR. PACAP can stimulate secretion of GROWTH HORMONE; ACTH; CATECHOLAMINES; and INSULIN; and it interacts with PACAP RECEPTORS.%A%    
% 222.56/222.77  |- skos__altLabel mesh__D051219 PACAP-38
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D051219 2006
% 222.56/222.77  |- mesh__publicMeSHNote mesh__D051219
% 222.56/222.77       2006; PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE was indexed under NERVE GROWTH FACTORS %26% NEUROPEPTIDES %26% NEUROTRANSMITTERS 1990-2005%A%  
% 222.56/222.77  |- skos__altLabel mesh__D051219
% 222.56/222.77       Pituitary Adenylate Cyclase Activating Polypeptide
% 222.56/222.77  |- mesh__recordOriginator mesh__D051219 DRC
% 222.56/222.77  |- mesh__dateCreated mesh__D051219 2005-06-30
% 222.56/222.77  |- mesh__historyNote mesh__D051219 2006%28%1990%29%   
% 222.56/222.77  |- skos__altLabel mesh__D051219 PACAP38
% 222.56/222.77  |- skos__altLabel mesh__D051219 PACAP
% 222.56/222.77  |- mesh__recordAuthorizer mesh__D051219 sjn
% 222.56/222.77  |- rdf__type mesh__D051219sskos__Concept
% 222.56/222.77  |- skos__broader mesh__D051219smesh__D007028
% 222.56/222.77  |- mesh__dateEstablished mesh__D051219 2006-01-01
% 222.56/222.77  |- skos__hiddenLabel mesh__D015096 Dehydrogenases, 3 Hydroxysteroid
% 222.56/222.77  |- skos__hiddenLabel mesh__D015096 Dehydrogenase, 3-beta-Hydroxysteroid
% 222.56/222.77  |- mesh__dateRevised mesh__D015096 2003-07-09
% 222.56/222.77  |- rdf__type mesh__D015096sskos__Concept
% 222.56/222.77  |- mesh__dateEstablished mesh__D015096 1978-01-01
% 222.56/222.77  |- mesh__dateCreated mesh__D015096 1977-04-15
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D015096 2004
% 222.56/222.77  |- skos__broader mesh__D015096smesh__D006913
% 222.56/222.77  |- skos__scopeNote mesh__D015096
% 222.56/222.77       Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids.%A%    
% 222.56/222.77  |- mesh__historyNote mesh__D015096 78   
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D015096 2005
% 222.56/222.77  |- skos__altLabel mesh__D015096 3-beta-Hydroxysteroid Dehydrogenase
% 222.56/222.77  |- skos__prefLabel mesh__D015096 3-Hydroxysteroid Dehydrogenases
% 222.56/222.77  |- skos__hiddenLabel mesh__D015096 3 beta Hydroxysteroid Dehydrogenase
% 222.56/222.77  |- mesh__recordAuthorizer mesh__D015096 sjn
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D015096 2006
% 222.56/222.77  |- mesh__recordOriginator mesh__D015096 RLS
% 222.56/222.77  |- mesh__publicMeSHNote mesh__D015096 78   
% 222.56/222.77  |- skos__hiddenLabel mesh__D015096 Hydroxysteroid Dehydrogenases, 3
% 222.56/222.77  |- skos__historyNote mesh__D015096
% 222.56/222.77       Hydroxysteroid Dehydrogenases %28%1966-1977%29%
% 222.56/222.77  |- skos__altLabel mesh__D015096 3 Hydroxysteroid Dehydrogenases
% 222.56/222.77  |- mesh__recordMaintainer mesh__D015096 ssb
% 222.56/222.77  |- skos__hiddenLabel mesh__D015096 Dehydrogenases, 3-Hydroxysteroid
% 222.56/222.77  |- skos__broader mesh__D009857smesh__D052138
% 222.56/222.77  |- rdf__type mesh__D009857sskos__Concept
% 222.56/222.77  |- skos__altLabel mesh__D009857 Transforming Gene
% 222.56/222.77  |- skos__hiddenLabel mesh__D009857 Genes, Transforming
% 222.56/222.77  |- mesh__recordOriginator mesh__D009857 AEP
% 222.56/222.77  |- skos__historyNote mesh__D009857 Genes %28%1966-1977%29%
% 222.56/222.77  |- mesh__recordAuthorizer mesh__D009857 sjn
% 222.56/222.77  |- skos__hiddenLabel mesh__D009857 Gene, Transforming
% 222.56/222.77  |- mesh__dateCreated mesh__D009857 1982-04-22
% 222.56/222.77  |- skos__historyNote mesh__D009857 Genes, Viral %28%1978-1982%29%
% 222.56/222.77  |- mesh__dateEstablished mesh__D009857 1983-01-01
% 222.56/222.77  |- skos__prefLabel mesh__D009857 Oncogenes
% 222.56/222.77  |- skos__scopeNote mesh__D009857
% 222.56/222.77       Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of %22%v-%22% before oncogene symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix %22%c-%22% before the gene symbol of an oncogene indicates it is the cellular homolog %28%PROTO-ONCOGENES%29% of a v-oncogene.%A%    
% 222.56/222.77  |- mesh__recordMaintainer mesh__D009857 nns
% 222.56/222.77  |- mesh__historyNote mesh__D009857 83   
% 222.56/222.77  |- mesh__dateRevised mesh__D009857 2005-06-30
% 222.56/222.77  |- mesh__activeMeSHYear mesh__D009857 2006
% 222.56/222.77  |- skos__altLabel mesh__D009857 Transforming Genes
% 222.56/222.77  |- mesh__publicMeSHNote mesh__D009857 83   
% 222.56/222.78  |- skos__altLabel mesh__D009857 Oncogene
% 222.56/222.78  |- skos__annotation mesh__D009857
% 222.56/222.78       %22%oncogene%22% used by author may refer to ONCOGENES or PROTO-ONCOGENES; do not confuse with ONCOGENES see CARCINOGENS; Manual 24.4.4.3; do not confuse with GENES, NEOPLASM%A%  
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001874 1996
% 222.56/222.78  |- skos__hiddenLabel mesh__D001874 Selections, Book
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001874 2006
% 222.56/222.78  |- mesh__recordOriginator mesh__D001874 NLM
% 222.56/222.78  |- mesh__dateCreated mesh__D001874 1999-01-01
% 222.56/222.78  |- skos__annotation mesh__D001874
% 222.56/222.78       no qualif; lists of books probably go here but consider also BIBLIOGRAPHY%A%  
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001874 2005
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001874 1995
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001874 2002
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001874 2004
% 222.56/222.78  |- mesh__recordMaintainer mesh__D001874 TGC
% 222.56/222.78  |- skos__prefLabel mesh__D001874 Book Selection
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001874 1999
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001874 1994
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001874 2001
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001874 1991
% 222.56/222.78  |- mesh__dateRevised mesh__D001874 1989-04-27
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001874 2003
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001874 1993
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001874 1998
% 222.56/222.78  |- skos__hiddenLabel mesh__D001874 Book Selections
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001874 2000
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001874 1990
% 222.56/222.78  |- rdf__type mesh__D001874sskos__Concept
% 222.56/222.78  |- skos__hiddenLabel mesh__D001874 Selection, Book
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001874 1992
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001874 1997
% 222.56/222.78  |- skos__broader mesh__D001874smesh__D007255
% 222.56/222.78  |- mesh__recordAuthorizer mesh__D001874 PLS
% 222.56/222.78  |- mesh__dateRevised mesh__D009059 1998-06-10
% 222.56/222.78  |- skos__related mesh__D009059smesh__D009909
% 222.56/222.78  |- mesh__dateEstablished mesh__D009059 1965-01-01
% 222.56/222.78  |- skos__related mesh__D009059smesh__D003945
% 222.56/222.78  |- mesh__recordMaintainer mesh__D009059 JLS
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009059 2002
% 222.56/222.78  |- rdf__type mesh__D009059sskos__Concept
% 222.56/222.78  |- skos__hiddenLabel mesh__D009059 Disease, Mouth
% 222.56/222.78  |- skos__annotation mesh__D009059
% 222.56/222.78       GEN only: prefer specifics; inflamm dis = STOMATITIS; mucositis: index under STOMATITIS %28%IM%29% + MOUTH MUCOSA %28%NIM%29%%A%  
% 222.56/222.78  |- skos__hiddenLabel mesh__D009059 Mouth Disease
% 222.56/222.78  |- mesh__onlineNote mesh__D009059
% 222.56/222.78       search MOUTH MICROORGANISMS under MOUTH 1966-67   
% 222.56/222.78  |- mesh__publicMeSHNote mesh__D009059
% 222.56/222.78       65; was STOMATOLOGY 1963-64; MOUTH MICROORGANISMS was heading 1965-67%A%  
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009059 2003
% 222.56/222.78  |- mesh__recordAuthorizer mesh__D009059 SJN
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009059 2000
% 222.56/222.78  |- skos__prefLabel mesh__D009059 Mouth Diseases
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009059 2004
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009059 2005
% 222.56/222.78  |- mesh__recordOriginator mesh__D009059 NLM
% 222.56/222.78  |- mesh__historyNote mesh__D009059
% 222.56/222.78       65; was STOMATOLOGY 1963-64; MOUTH MICROORGANISMS was heading 1965-67%A%  
% 222.56/222.78  |- skos__hiddenLabel mesh__D009059 Diseases, Mouth
% 222.56/222.78  |- skos__broader mesh__D009059smesh__D009057
% 222.56/222.78  |- skos__related mesh__D009059smesh__D009065
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009059 2001
% 222.56/222.78  |- mesh__dateCreated mesh__D009059 1999-01-01
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009059 1999
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009059 2006
% 222.56/222.78  |- skos__related mesh__D009059smesh__D009912
% 222.56/222.78  |- skos__related mesh__D009059smesh__D006209
% 222.56/222.78  |- skos__prefLabel mesh__D001076 Aptitude
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001076 2002
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001076 1997
% 222.56/222.78  |- mesh__recordOriginator mesh__D001076 NLM
% 222.56/222.78  |- skos__hiddenLabel mesh__D001076 Talents
% 222.56/222.78  |- skos__hiddenLabel mesh__D001076 Aptitudes
% 222.56/222.78  |- skos__hiddenLabel mesh__D001076 Abilities
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001076 1994
% 222.56/222.78  |- mesh__onlineNote mesh__D001076 use APTITUDE to search TALENT 1966-78   
% 222.56/222.78  |- mesh__dateRevised mesh__D001076 1992-03-25
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001076 2005
% 222.56/222.78  |- mesh__recordMaintainer mesh__D001076 TAP
% 222.56/222.78  |- mesh__recordAuthorizer mesh__D001076 PLS
% 222.56/222.78  |- mesh__historyNote mesh__D001076 TALENT was see under APTITUDE 1963-78   
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001076 1995
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001076 2003
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001076 2006
% 222.56/222.78  |- skos__broader mesh__D001076smesh__D011588
% 222.56/222.78  |- skos__scopeNote mesh__D001076
% 222.56/222.78       The ability to acquire general or special types of knowledge or skill.%A%    
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001076 1998
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001076 2000
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001076 1993
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001076 2004
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001076 2001
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001076 1996
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001076 1999
% 222.56/222.78  |- mesh__dateCreated mesh__D001076 1999-01-01
% 222.56/222.78  |- rdf__type mesh__D001076sskos__Concept
% 222.56/222.78  |- mesh__historyNote mesh__D020230 99   
% 222.56/222.78  |- skos__historyNote mesh__D020230 Serotonin %28%1980-1992%29%
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D020230 2006
% 222.56/222.78  |- skos__scopeNote mesh__D020230
% 222.56/222.78       An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor.%A%    
% 222.56/222.78  |- skos__prefLabel mesh__D020230 Serotonin Syndrome
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D020230 2001
% 222.56/222.78  |- mesh__dateEstablished mesh__D020230 1999-01-01
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D020230 2003
% 222.56/222.78  |- skos__hiddenLabel mesh__D020230 Serotonin Syndromes
% 222.56/222.78  |- skos__related mesh__D020230smesh__D008996
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D020230 1999
% 222.56/222.78  |- mesh__publicMeSHNote mesh__D020230 99   
% 222.56/222.78  |- skos__hiddenLabel mesh__D020230 Syndromes, Serotonin
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D020230 2004
% 222.56/222.78  |- skos__hiddenLabel mesh__D020230 Syndrome, Serotonin
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D020230 2002
% 222.56/222.78  |- mesh__dateCreated mesh__D020230 1998-06-11
% 222.56/222.78  |- skos__historyNote mesh__D020230
% 222.56/222.78       Serotonin Uptake Inhibitors/adverse effects %28%1993-1998%29%
% 222.56/222.78  |- skos__related mesh__D020230smesh__D017367
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D020230 2005
% 222.56/222.78  |- skos__related mesh__D020230smesh__D012701
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D020230 2000
% 222.56/222.78  |- skos__broader mesh__D020230smesh__D004362
% 222.56/222.78  |- rdf__type mesh__D020230sskos__Concept
% 222.56/222.78  |- skos__broader mesh__D006321Q000196smesh__D006321
% 222.56/222.78  |- rdf__type mesh__D006321Q000196smesh__CompoundConcept
% 222.56/222.78  |- mesh__dateEstablished mesh__D019487 1997-01-01
% 222.56/222.78  |- skos__scopeNote mesh__D019487
% 222.56/222.78       Works consisting of annual statements concerning the administrative and operational functions of an institution or organization.%A%    
% 222.56/222.78  |- mesh__recordAuthorizer mesh__D019487 sjn
% 222.56/222.78  |- mesh__recordOriginator mesh__D019487 TGC
% 222.56/222.78  |- skos__prefLabel mesh__D019487 Annual Reports %5B%Publication Type%5D%
% 222.56/222.78  |- mesh__historyNote mesh__D019487 1997   
% 222.56/222.78  |- mesh__dateRevised mesh__D019487 2005-06-30
% 222.56/222.78  |- skos__altLabel mesh__D019487 Annual Reports %28%PT%29%
% 222.56/222.78  |- mesh__recordMaintainer mesh__D019487 jls
% 222.56/222.78  |- mesh__dateCreated mesh__D019487 1996-06-21
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D019487 2006
% 222.56/222.78  |- skos__broader mesh__D019487smesh__D052180
% 222.56/222.78  |- skos__annotation mesh__D019487
% 222.56/222.78       CATALOG: Do not use for current materials.   
% 222.56/222.78  |- rdf__type mesh__D019487sskos__Concept
% 222.56/222.78  |- skos__hiddenLabel mesh__D038641 Sequence, 5%27% TOP
% 222.56/222.78  |- skos__altLabel mesh__D038641 5%27% TOP Messenger RNA
% 222.56/222.78  |- mesh__dateCreated mesh__D038641 2002-07-03
% 222.56/222.78  |- mesh__recordAuthorizer mesh__D038641 sjn
% 222.56/222.78  |- mesh__publicMeSHNote mesh__D038641 2003   
% 222.56/222.78  |- mesh__dateRevised mesh__D038641 2005-06-30
% 222.56/222.78  |- skos__broader mesh__D038641smesh__D038621
% 222.56/222.78  |- skos__scopeNote mesh__D038641
% 222.56/222.78       A regulatory sequence found in the 5%27% terminal regions of a variety of RNA species. The sequence starts with a CYTIDINE, which is followed by a stretch of 5 to 15 PYRIMIDINE NUCLEOTIDES. Messenger RNA that contains the 5%27% Terminal Oligo Pyrimidine tract is often referred to as 5%27% TOP mRNA.  The sequence acts as a translational regulator and has been found in mRNAs for PEPTIDE ELONGATION FACTORS and RIBOSOMAL PROTEINS.%A%    
% 222.56/222.78  |- rdf__type mesh__D038641sskos__Concept
% 222.56/222.78  |- mesh__recordMaintainer mesh__D038641 nns
% 222.56/222.78  |- skos__hiddenLabel mesh__D038641 5%27% TOP Sequences
% 222.56/222.78  |- mesh__recordOriginator mesh__D038641 jmp
% 222.56/222.78  |- mesh__dateEstablished mesh__D038641 2003-01-01
% 222.56/222.78  |- skos__broader mesh__D038641smesh__D040461
% 222.56/222.78  |- skos__altLabel mesh__D038641
% 222.56/222.78       RNA 5%27% Terminal Oligopyrimidine Regulatory Sequence
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D038641 2006
% 222.56/222.78  |- skos__hiddenLabel mesh__D038641 Sequences, 5%27% TOP
% 222.56/222.78  |- skos__altLabel mesh__D038641 5%27% TOP Sequence
% 222.56/222.78  |- skos__prefLabel mesh__D038641
% 222.56/222.78       RNA 5%27% Terminal Oligopyrimidine Sequence
% 222.56/222.78  |- mesh__historyNote mesh__D038641 2003   
% 222.56/222.78  |- skos__altLabel mesh__D005467 5-Fluorodeoxyuridine
% 222.56/222.78  |- mesh__historyNote mesh__D005467
% 222.56/222.78       93; was FLUORODEOXYURIDINE 1963-92; FLOXURIDINE was see FLUORODEOXYURIDINE 1976-92%A%  
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D005467 2006
% 222.56/222.78  |- skos__altLabel mesh__D005467 Fluorodeoxyuridine
% 222.56/222.78  |- mesh__recordOriginator mesh__D005467 NLM
% 222.56/222.78  |- skos__broader mesh__D005467smesh__D003857
% 222.56/222.78  |- skos__hiddenLabel mesh__D005467 5 Fluorodeoxyuridine
% 222.56/222.78  |- mesh__recordMaintainer mesh__D005467 exl
% 222.56/222.78  |- mesh__dateCreated mesh__D005467 1999-01-01
% 222.56/222.78  |- mesh__publicMeSHNote mesh__D005467
% 222.56/222.78       93; was FLUORODEOXYURIDINE 1963-92; FLOXURIDINE was see FLUORODEOXYURIDINE 1976-92%A%  
% 222.56/222.78  |- skos__prefLabel mesh__D005467 Floxuridine
% 222.56/222.78  |- skos__altLabel mesh__D005467 5-FUdR
% 222.56/222.78  |- mesh__recordAuthorizer mesh__D005467 sjn
% 222.56/222.78  |- skos__annotation mesh__D005467
% 222.56/222.78       an antiviral %26% antineoplastic antimetabolite   
% 222.56/222.78  |- mesh__onlineNote mesh__D005467
% 222.56/222.78       use FLOXURIDINE to search FLUORODEOXYURIDINE 1966-92   
% 222.56/222.78  |- skos__altLabel mesh__D005467 FUdR
% 222.56/222.78  |- mesh__dateRevised mesh__D005467 2005-06-30
% 222.56/222.78  |- skos__scopeNote mesh__D005467
% 222.56/222.78       An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.%A%    
% 222.56/222.78  |- rdf__type mesh__D005467sskos__Concept
% 222.56/222.78  |- skos__hiddenLabel mesh__D043586 Carboxylase, Propionyl-Coenzyme A
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D043586 2006
% 222.56/222.78  |- rdf__type mesh__D043586sskos__Concept
% 222.56/222.78  |- skos__scopeNote mesh__D043586
% 222.56/222.78       A carboxy-lyase that catalyzes the decarboxylation of  %28%S%29%-2-Methyl-3-oxopropanoyl-CoA to propanoyl-CoA. In microorganisms the reaction can be coupled to the vectorial transport of SODIUM ions across the cytoplasmic membrane.%A%    
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D043586 2004
% 222.56/222.78  |- skos__historyNote mesh__D043586 Carboxy-Lyases %28%1983-2003%29%
% 222.56/222.78  |- skos__hiddenLabel mesh__D043586 Propionyl Coenzyme A Carboxylase
% 222.56/222.78  |- skos__historyNote mesh__D043586 Propionates %28%1984-2003%29%
% 222.56/222.78  |- skos__altLabel mesh__D043586 Propionyl-Coenzyme A Carboxylase
% 222.56/222.78  |- skos__prefLabel mesh__D043586 Methylmalonyl-CoA Decarboxylase
% 222.56/222.78  |- mesh__historyNote mesh__D043586
% 222.56/222.78       2004; use METHYLMALONYL-COA DECARBOXYLASE %28%NM%29% 1980-2003   
% 222.56/222.78  |- skos__hiddenLabel mesh__D043586 Decarboxylase, Methylmalonyl-CoA
% 222.56/222.78  |- mesh__dateEstablished mesh__D043586 2004-01-01
% 222.56/222.78  |- mesh__dateCreated mesh__D043586 2003-07-09
% 222.56/222.78  |- skos__hiddenLabel mesh__D043586 Propionyl CoA Carboxylase
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D043586 2005
% 222.56/222.78  |- skos__broader mesh__D043586smesh__D002262
% 222.56/222.78  |- mesh__publicMeSHNote mesh__D043586
% 222.56/222.78       2004; PROPIONYL-COA CARBOXYLASE was indexed under CARBOXY-LYASES 1983-2003 %26% under PROPIONATES 1975-1982%A%  
% 222.56/222.78  |- skos__altLabel mesh__D043586 Propionyl-CoA Carboxylase
% 222.56/222.78  |- skos__hiddenLabel mesh__D043586 Methylmalonyl CoA Decarboxylase
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D010601 2004
% 222.56/222.78  |- skos__annotation mesh__D010601
% 222.56/222.78       SPEC: SPEC qualif; do not use as NIM coord: the pharmacol of a drug or chem in humans = Cat D term with /pharmacol + HUMAN, not PHARMACOLOGY, CLINICAL; DF: PHARMACOL CLIN%A%  
% 222.56/222.78  |- mesh__dateRevised mesh__D010601 2001-07-25
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D010601 2006
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D010601 2003
% 222.56/222.78  |- mesh__dateEstablished mesh__D010601 1980-01-01
% 222.56/222.78  |- mesh__dateCreated mesh__D010601 1979-05-29
% 222.56/222.78  |- mesh__recordOriginator mesh__D010601 EC
% 222.56/222.78  |- mesh__publicMeSHNote mesh__D010601 80   
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D010601 2005
% 222.56/222.78  |- mesh__historyNote mesh__D010601 80   
% 222.56/222.78  |- rdf__type mesh__D010601sskos__Concept
% 222.56/222.78  |- skos__scopeNote mesh__D010601
% 222.56/222.78       The branch of pharmacology that deals directly with the effectiveness and safety of drugs in humans.%A%    
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D010601 2002
% 222.56/222.78  |- skos__broader mesh__D010601smesh__D010600
% 222.56/222.78  |- skos__historyNote mesh__D010601 Pharmacology %28%1966-1979%29%
% 222.56/222.78  |- skos__altLabel mesh__D010601 Clinical Pharmacology
% 222.56/222.78  |- skos__prefLabel mesh__D010601 Pharmacology, Clinical
% 222.56/222.78  |- mesh__recordMaintainer mesh__D010601 jls
% 222.56/222.78  |- mesh__recordAuthorizer mesh__D010601 sjn
% 222.56/222.78  |- skos__altLabel mesh__D015895 Resource-Based Relative Value Scale
% 222.56/222.78  |- skos__historyNote mesh__D015895
% 222.56/222.78       Health Services Research %28%1987-1989%29%
% 222.56/222.78  |- skos__broader mesh__D015895smesh__D005245
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D015895 1996
% 222.56/222.78  |- skos__hiddenLabel mesh__D015895 Scales, Relative Value
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D015895 2000
% 222.56/222.78  |- skos__historyNote mesh__D015895 Fee Schedules %28%1988-1989%29%
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D015895 2006
% 222.56/222.78  |- skos__hiddenLabel mesh__D015895 Schedules, Relative-Value
% 222.56/222.78  |- mesh__recordAuthorizer mesh__D015895 PLS
% 222.56/222.78  |- skos__scopeNote mesh__D015895
% 222.56/222.78       Coded listings of physician or other professional services using units that indicate the relative value of the various services they perform. They take into account time, skill, and overhead cost required for each service, but generally do not consider the relative cost-effectiveness. Appropriate conversion factors can be used to translate the abstract units of the relative value scales into dollar fees for each service based on work expended, practice costs, and training costs.%A%    
% 222.56/222.78  |- mesh__dateCreated mesh__D015895 1989-10-03
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D015895 1995
% 222.56/222.78  |- skos__historyNote mesh__D015895
% 222.56/222.78       Reimbursement Mechanisms %28%1986-1989%29%
% 222.56/222.78  |- mesh__recordOriginator mesh__D015895 EGC
% 222.56/222.78  |- mesh__dateEstablished mesh__D015895 1990-01-01
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D015895 2005
% 222.56/222.78  |- skos__prefLabel mesh__D015895 Relative Value Scales
% 222.56/222.78  |- skos__annotation mesh__D015895
% 222.56/222.78       %22%coded listing of physician or other professional services using units that indicate the relative value of the various services they perform%22%; no qualif; DF: RELAT VALUE SCALES%A%  
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D015895 2004
% 222.56/222.78  |- rdf__type mesh__D015895sskos__Concept
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D015895 2002
% 222.56/222.78  |- skos__hiddenLabel mesh__D015895 Relative-Value Schedule
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D015895 1999
% 222.56/222.78  |- mesh__recordMaintainer mesh__D015895 TGC
% 222.56/222.78  |- skos__hiddenLabel mesh__D015895 Scale, Relative Value
% 222.56/222.78  |- skos__hiddenLabel mesh__D015895 Schedule, Relative-Value
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D015895 1994
% 222.56/222.78  |- skos__altLabel mesh__D015895 Relative-Value Schedules
% 222.56/222.78  |- mesh__historyNote mesh__D015895 90   
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D015895 1993
% 222.56/222.78  |- skos__hiddenLabel mesh__D015895 Relative Value Schedules
% 222.56/222.78  |- skos__historyNote mesh__D015895 Fees, Medical %28%1986-1989%29%
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D015895 2003
% 222.56/222.78  |- mesh__publicMeSHNote mesh__D015895 90   
% 222.56/222.78  |- skos__hiddenLabel mesh__D015895 Relative Value Scale
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D015895 1998
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D015895 1997
% 222.56/222.78  |- skos__broader mesh__D015895smesh__D012051
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D015895 1992
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D015895 2001
% 222.56/222.78  |- mesh__dateRevised mesh__D015895 1991-05-31
% 222.56/222.78  |- skos__broader mesh__D048271smesh__D002686
% 222.56/222.78  |- mesh__publicMeSHNote mesh__D048271
% 222.56/222.78       2005; CHITOSAN was indexed under CHITIN 2001-2004   
% 222.56/222.78  |- mesh__recordMaintainer mesh__D048271 ssb
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D048271 2005
% 222.56/222.78  |- mesh__recordAuthorizer mesh__D048271 sjn
% 222.56/222.78  |- mesh__dateEstablished mesh__D048271 2005-01-01
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D048271 2006
% 222.56/222.78  |- skos__scopeNote mesh__D048271
% 222.56/222.78       Deacetylated CHITIN, a linear polysaccharide of deacetylated beta-1,4-D-glucosamine. It is used in HYDROGEL and to treat WOUNDS.%A%    
% 222.56/222.78  |- skos__historyNote mesh__D048271
% 222.56/222.78       Chitin/analogs %26% derivatives %28%1975-2004%29%
% 222.56/222.78  |- skos__prefLabel mesh__D048271 Chitosan
% 222.56/222.78  |- rdf__type mesh__D048271sskos__Concept
% 222.56/222.78  |- mesh__dateCreated mesh__D048271 2004-07-08
% 222.56/222.78  |- mesh__historyNote mesh__D048271 2005%28%2004%29%   
% 222.56/222.78  |- mesh__recordOriginator mesh__D048271 ssb
% 222.56/222.78  |- skos__altLabel mesh__D048271 Poliglusam
% 222.56/222.78  |- mesh__dateRevised mesh__D015097 2001-08-03
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D015097 2006
% 222.56/222.78  |- skos__hiddenLabel mesh__D015097 Acid, 3-Mercaptopropionic
% 222.56/222.78  |- mesh__recordAuthorizer mesh__D015097 sjn
% 222.56/222.78  |- skos__altLabel mesh__D015097 3-Mercaptopropanoic Acid
% 222.56/222.78  |- skos__hiddenLabel mesh__D015097 3 Mercaptopropionic Acid
% 222.56/222.78  |- skos__hiddenLabel mesh__D015097 3 Mercaptopropanoic Acid
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D015097 2005
% 222.56/222.78  |- skos__broader mesh__D015097smesh__D013438
% 222.56/222.78  |- rdf__type mesh__D015097sskos__Concept
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D015097 2004
% 222.56/222.78  |- skos__prefLabel mesh__D015097 3-Mercaptopropionic Acid
% 222.56/222.78  |- skos__historyNote mesh__D015097 Propionates %28%1966-1977%29%
% 222.56/222.78  |- mesh__historyNote mesh__D015097
% 222.56/222.78       91%28%78%29%; was see under SULFHYDRYL COMPOUNDS 1978-90   
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D015097 2003
% 222.56/222.78  |- mesh__publicMeSHNote mesh__D015097
% 222.56/222.78       91; was see under SULFHYDRYL COMPOUNDS 1978-90   
% 222.56/222.78  |- mesh__dateEstablished mesh__D015097 1991-01-01
% 222.56/222.78  |- skos__hiddenLabel mesh__D015097 beta Mercaptopropionate
% 222.56/222.78  |- mesh__recordMaintainer mesh__D015097 sjn
% 222.56/222.78  |- skos__hiddenLabel mesh__D015097 Acid, 3-Mercaptopropanoic
% 222.56/222.78  |- mesh__recordOriginator mesh__D015097 SH
% 222.56/222.78  |- skos__historyNote mesh__D015097 Sulfhydryl Compounds %28%1966-1977%29%
% 222.56/222.78  |- skos__broader mesh__D015097smesh__D011426
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D015097 2002
% 222.56/222.78  |- skos__scopeNote mesh__D015097
% 222.56/222.78       An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions.%A%    
% 222.56/222.78  |- mesh__dateCreated mesh__D015097 1977-03-01
% 222.56/222.78  |- mesh__recordOriginator mesh__D009858 NLM
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009858 2004
% 222.56/222.78  |- mesh__dateCreated mesh__D009858 1999-01-01
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009858 1997
% 222.56/222.78  |- mesh__publicMeSHNote mesh__D009858 66; was TUMOR VIRUSES 1963-65   
% 222.56/222.78  |- skos__scopeNote mesh__D009858 Viruses that produce tumors.     
% 222.56/222.78  |- skos__broader mesh__D009858smesh__D014712
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009858 2002
% 222.56/222.78  |- skos__hiddenLabel mesh__D009858 Virus, Oncogenic
% 222.56/222.78  |- skos__hiddenLabel mesh__D009858 Viruses, Oncogenic
% 222.56/222.78  |- rdf__type mesh__D009858sskos__Concept
% 222.56/222.78  |- skos__altLabel mesh__D009858 Tumor Viruses
% 222.56/222.78  |- skos__annotation mesh__D009858
% 222.56/222.78       vertebrate viruses producing tumors; infection = TUMOR VIRUS INFECTIONS %28%IM%29% + neopl terms if pertinent%A%  
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009858 1994
% 222.56/222.78  |- skos__related mesh__D009858smesh__D014412
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009858 1995
% 222.56/222.78  |- skos__hiddenLabel mesh__D009858 Virus, Tumor
% 222.56/222.78  |- skos__prefLabel mesh__D009858 Oncogenic Viruses
% 222.56/222.78  |- skos__hiddenLabel mesh__D009858 Viruses, Tumor
% 222.56/222.78  |- mesh__historyNote mesh__D009858 66; was TUMOR VIRUSES 1963-65   
% 222.56/222.78  |- skos__hiddenLabel mesh__D009858 Tumor Virus
% 222.56/222.78  |- mesh__dateRevised mesh__D009858 1992-05-15
% 222.56/222.78  |- mesh__recordAuthorizer mesh__D009858 PLS
% 222.56/222.78  |- skos__hiddenLabel mesh__D009858 Oncogenic Virus
% 222.56/222.78  |- mesh__recordMaintainer mesh__D009858 TGC
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009858 2005
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009858 1998
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009858 1993
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009858 2000
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009858 2006
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009858 1999
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009858 1996
% 222.56/222.78  |- mesh__dateEstablished mesh__D009858 1966-01-01
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009858 2003
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D009858 2001
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001875 2006
% 222.56/222.78  |- skos__prefLabel mesh__D001875 Bookbinding
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001875 2003
% 222.56/222.78  |- mesh__recordMaintainer mesh__D001875 ags
% 222.56/222.78  |- mesh__dateRevised mesh__D001875 1999-11-03
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001875 2002
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001875 2004
% 222.56/222.78  |- mesh__recordOriginator mesh__D001875 NLM
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001875 2000
% 222.56/222.78  |- rdf__type mesh__D001875sskos__Concept
% 222.56/222.78  |- mesh__recordAuthorizer mesh__D001875 sjn
% 222.56/222.78  |- mesh__dateCreated mesh__D001875 1999-01-01
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001875 2005
% 222.56/222.78  |- skos__broader mesh__D001875smesh__D001870
% 222.56/222.78  |- skos__hiddenLabel mesh__D001875 Bookbindings
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001875 2001
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001077 2001
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001077 1994
% 222.56/222.78  |- mesh__dateRevised mesh__D001077 1992-03-25
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001077 2005
% 222.56/222.78  |- skos__hiddenLabel mesh__D001077 Test, Aptitude
% 222.56/222.78  |- skos__broader mesh__D001077smesh__D011581
% 222.56/222.78  |- skos__scopeNote mesh__D001077
% 222.56/222.78       Primarily non-verbal tests designed to predict an individual%27%s future learning ability or performance.%A%    
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001077 2002
% 222.56/222.78  |- mesh__recordOriginator mesh__D001077 NLM
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001077 1995
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001077 2003
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001077 2006
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001077 1998
% 222.56/222.78  |- skos__hiddenLabel mesh__D001077 Tests, Aptitude
% 222.56/222.78  |- skos__prefLabel mesh__D001077 Aptitude Tests
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001077 1993
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001077 2004
% 222.56/222.78  |- mesh__recordMaintainer mesh__D001077 TAP
% 222.56/222.78  |- mesh__recordAuthorizer mesh__D001077 PLS
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001077 1996
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001077 1999
% 222.56/222.78  |- mesh__dateCreated mesh__D001077 1999-01-01
% 222.56/222.78  |- rdf__type mesh__D001077sskos__Concept
% 222.56/222.78  |- skos__hiddenLabel mesh__D001077 Aptitude Test
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001077 1997
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D001077 2000
% 222.56/222.78  |- skos__altLabel mesh__D006560 Cold Sore
% 222.56/222.78  |- skos__hiddenLabel mesh__D006560 Sore, Cold
% 222.56/222.78  |- skos__hiddenLabel mesh__D006560 Blisters, Fever
% 222.56/222.78  |- skos__altLabel mesh__D006560 Fever Blister
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D006560 1998
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D006560 2003
% 222.56/222.78  |- skos__broader mesh__D006560smesh__D006561
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D006560 2000
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D006560 1999
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D006560 2004
% 222.56/222.78  |- skos__altLabel mesh__D006560 Herpes Simplex, Labial
% 222.56/222.78  |- skos__prefLabel mesh__D006560 Herpes Labialis
% 222.56/222.78  |- mesh__recordAuthorizer mesh__D006560 SJN
% 222.56/222.78  |- skos__annotation mesh__D006560
% 222.56/222.78       herpes simplex of the lips %26% nares; STOMATITIS, HERPETIC %28%oral cavity%29% is also available%A%  
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D006560 2001
% 222.56/222.78  |- skos__hiddenLabel mesh__D006560 Sores, Cold
% 222.56/222.78  |- rdf__type mesh__D006560sskos__Concept
% 222.56/222.78  |- skos__broader mesh__D006560smesh__D008047
% 222.56/222.78  |- skos__hiddenLabel mesh__D006560 Labial Herpes Simplex
% 222.56/222.78  |- skos__hiddenLabel mesh__D006560 Cold Sores
% 222.56/222.78  |- mesh__recordOriginator mesh__D006560 NLM
% 222.56/222.78  |- skos__scopeNote mesh__D006560
% 222.56/222.78       Herpes simplex, caused by type 1 virus, primarily spread by oral secretions and usually occurring as a concomitant of fever. It may also develop in the absence of fever or prior illness. It commonly involves the facial region, especially the lips and the nares. %28%Dorland, 27th ed.%29%%A%    
% 222.56/222.78  |- skos__related mesh__D006560smesh__D013283
% 222.56/222.78  |- mesh__activeMeSHYear mesh__D006560 2005
% 222.56/222.78  |- mesh__recordMaintainer mesh__D006560 TGC
% 222.56/222.79  |- mesh__dateRevised mesh__D006560 1997-06-20
% 222.56/222.79  |- skos__hiddenLabel mesh__D006560 Blister, Fever
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D006560 2002
% 222.56/222.79  |- skos__hiddenLabel mesh__D006560 Fever Blisters
% 222.56/222.79  |- mesh__dateCreated mesh__D006560 1999-01-01
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D006560 2006
% 222.56/222.79  |- mesh__dateRevised mesh__D020231 2005-06-30
% 222.56/222.79  |- mesh__recordMaintainer mesh__D020231 SYSTEM
% 222.56/222.79  |- mesh__publicMeSHNote mesh__D020231 99   
% 222.56/222.79  |- mesh__historyNote mesh__D020231 99   
% 222.56/222.79  |- mesh__dateCreated mesh__D020231 1998-06-10
% 222.56/222.79  |- skos__historyNote mesh__D020231 Fungi %28%1965-1972%29%
% 222.56/222.79  |- skos__broader mesh__D020231smesh__D003904
% 222.56/222.79  |- mesh__dateEstablished mesh__D020231 1999-01-01
% 222.56/222.79  |- skos__related mesh__D020231smesh__D020081
% 222.56/222.79  |- skos__historyNote mesh__D020231 Mitosporic Fungi %28%1973-1998%29%
% 222.56/222.79  |- rdf__type mesh__D020231sskos__Concept
% 222.56/222.79  |- skos__scopeNote mesh__D020231
% 222.56/222.79       A genus of mitosporic Phyllachoraceae fungi which contains at least 40 species of plant parasites. They have teleomorphs in the genus Glomerella %28%see PHYLLACHORALES%29%.%A%    
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D020231 2006
% 222.56/222.79  |- skos__prefLabel mesh__D020231 Colletotrichum
% 222.56/222.79  |- mesh__recordOriginator mesh__D020231 AGS
% 222.56/222.79  |- mesh__recordAuthorizer mesh__D020231 sjn
% 222.56/222.79  |- skos__altLabel mesh__D019488 Architectural Drawings
% 222.56/222.79  |- skos__annotation mesh__D019488
% 222.56/222.79       publication type only; for architectural drawings as a subject, index under main heading ARCHITECTURE%A%  
% 222.56/222.79  |- skos__scopeNote mesh__D019488
% 222.56/222.79       Works consisting of drawings of architecture and architectural projects, whether the project was executed or not. %28%Art %26% Architecture Thesaurus, 1990, v.2%29%%A%    
% 222.56/222.79  |- mesh__dateEstablished mesh__D019488 1997-01-01
% 222.56/222.79  |- skos__altLabel mesh__D019488 Architectural Drawings %28%PT%29%
% 222.56/222.79  |- skos__broader mesh__D019488smesh__D052181
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D019488 2006
% 222.56/222.79  |- mesh__recordAuthorizer mesh__D019488 sjn
% 222.56/222.79  |- skos__related mesh__D019488smesh__D020472
% 222.56/222.79  |- mesh__recordOriginator mesh__D019488 TGC
% 222.56/222.79  |- skos__prefLabel mesh__D019488
% 222.56/222.79       Architectural Drawings %5B%Publication Type%5D%
% 222.56/222.79  |- skos__broader mesh__D019488smesh__D052180
% 222.56/222.79  |- mesh__historyNote mesh__D019488 1997   
% 222.56/222.79  |- mesh__dateRevised mesh__D019488 2005-06-30
% 222.56/222.79  |- rdf__type mesh__D019488sskos__Concept
% 222.56/222.79  |- mesh__recordMaintainer mesh__D019488 jls
% 222.56/222.79  |- mesh__dateCreated mesh__D019488 1996-06-21
% 222.56/222.79  |- rdf__type mesh__D038642sskos__Concept
% 222.56/222.79  |- mesh__historyNote mesh__D038642 2003   
% 222.56/222.79  |- skos__prefLabel mesh__D038642 Shaken Baby Syndrome
% 222.56/222.79  |- mesh__dateCreated mesh__D038642 2002-07-03
% 222.56/222.79  |- skos__related mesh__D038642smesh__D002649
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D038642 2003
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D038642 2005
% 222.56/222.79  |- skos__broader mesh__D038642smesh__D001930
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D038642 2004
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D038642 2006
% 222.56/222.79  |- skos__historyNote mesh__D038642 Brain Injuries %28%1984-2002%29%
% 222.56/222.79  |- mesh__dateEstablished mesh__D038642 2003-01-01
% 222.56/222.79  |- skos__historyNote mesh__D038642 Child Abuse %28%1984-2002%29%
% 222.56/222.79  |- mesh__publicMeSHNote mesh__D038642 2003   
% 222.56/222.79  |- skos__scopeNote mesh__D038642
% 222.56/222.79       Brain injuries resulted from vigorous shaking of an infant or young child held by the chest, shoulders, or extremities causing extreme rotational cranial acceleration. It is characterized by the intracranial and intraocular hemorrhages with no evident external trauma. Serious cases may result in death.%A%    
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D005468 1998
% 222.56/222.79  |- skos__scopeNote mesh__D005468
% 222.56/222.79       5-Fluoro-2%27%-deoxyuridylate. An inhibitor of thymidylate synthetase. Formed from 5-fluorouracil or 5-fluorodeoxyuridine.%A%    
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D005468 2002
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D005468 1999
% 222.56/222.79  |- mesh__recordMaintainer mesh__D005468 TGC
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D005468 1996
% 222.56/222.79  |- mesh__dateCreated mesh__D005468 1974-11-19
% 222.56/222.79  |- skos__historyNote mesh__D005468 Fluorine %28%1972-1974%29%
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D005468 1997
% 222.56/222.79  |- skos__prefLabel mesh__D005468 Fluorodeoxyuridylate
% 222.56/222.79  |- mesh__historyNote mesh__D005468
% 222.56/222.79       91%28%75%29%; was see under DEOXYURACIL NUCLEOTIDES 1978-90; was see under URACIL NUCLEOTIDES 1975-77%A%  
% 222.56/222.79  |- mesh__publicMeSHNote mesh__D005468
% 222.56/222.79       91; was see under DEOXYURACIL NUCLEOTIDES 1978-90; was see under URACIL NUCLEOTIDES 1975-77%A%  
% 222.56/222.79  |- mesh__dateEstablished mesh__D005468 1991-01-01
% 222.56/222.79  |- rdf__type mesh__D005468sskos__Concept
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D005468 2005
% 222.56/222.79  |- mesh__recordOriginator mesh__D005468 NLM
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D005468 1994
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D005468 2006
% 222.56/222.79  |- skos__historyNote mesh__D005468 Uracil Nucleotides %28%1972-1974%29%
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D005468 2003
% 222.56/222.79  |- skos__broader mesh__D005468smesh__D003856
% 222.56/222.79  |- skos__altLabel mesh__D005468 FdUMP
% 222.56/222.79  |- skos__altLabel mesh__D005468
% 222.56/222.79       5-Fluoro-2%27%-Deoxyuridine-5%27%-Monophosphate
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D005468 1995
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D005468 2000
% 222.56/222.79  |- mesh__recordAuthorizer mesh__D005468 PLS
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D005468 2004
% 222.56/222.79  |- skos__hiddenLabel mesh__D005468
% 222.56/222.79       5 Fluoro 2%27% Deoxyuridine 5%27% Monophosphate
% 222.56/222.79  |- mesh__dateRevised mesh__D005468 1992-05-19
% 222.56/222.79  |- skos__historyNote mesh__D005468 Deoxyribonucleotides %28%1973-1974%29%
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D005468 1993
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D005468 2001
% 222.56/222.79  |- skos__hiddenLabel mesh__D016190 NSC 241240
% 222.56/222.79  |- skos__altLabel mesh__D016190 Paraplatine
% 222.56/222.79  |- skos__altLabel mesh__D016190 Chiesi Brand of Carboplatin
% 222.56/222.79  |- skos__prefLabel mesh__D016190 Carboplatin
% 222.56/222.79  |- skos__scopeNote mesh__D016190
% 222.56/222.79       An organoplatinum compound that possesses antineoplastic activity.%A%    
% 222.56/222.79  |- skos__historyNote mesh__D016190
% 222.56/222.79       Organoplatinum Compounds %28%1978-1990%29%
% 222.56/222.79  |- skos__historyNote mesh__D016190 Antineoplastic Agents %28%1966-1990%29%
% 222.56/222.79  |- mesh__recordAuthorizer mesh__D016190 sjn
% 222.56/222.79  |- skos__altLabel mesh__D016190 CBDCA
% 222.56/222.79  |- skos__altLabel mesh__D016190 ribosepharm Brand of Carboplatin
% 222.56/222.79  |- skos__altLabel mesh__D016190 Carboplat
% 222.56/222.79  |- skos__altLabel mesh__D016190 Bristol-Myers Squibb Brand of Carboplatin
% 222.56/222.79  |- skos__broader mesh__D016190smesh__D009944
% 222.56/222.79  |- skos__hiddenLabel mesh__D016190 NSC241240
% 222.56/222.79  |- mesh__publicMeSHNote mesh__D016190 91   
% 222.56/222.79  |- skos__altLabel mesh__D016190 Prasfarma Brand of Carboplatin
% 222.56/222.79  |- skos__altLabel mesh__D016190 Almirall Brand of Carboplatin
% 222.56/222.79  |- mesh__dateRevised mesh__D016190 2005-06-30
% 222.56/222.79  |- skos__hiddenLabel mesh__D016190 JM 8
% 222.56/222.79  |- mesh__dateEstablished mesh__D016190 1991-01-01
% 222.56/222.79  |- skos__altLabel mesh__D016190 Neocorp Brand of Carboplatin
% 222.56/222.79  |- mesh__recordMaintainer mesh__D016190 lkw
% 222.56/222.79  |- mesh__activeMeSHYear mesh__D016190 2006
% 222.56/222.79  |- skos__altLabel mesh__D016190
% 222.56/222.79       cis-Diammine%28%cyclobutanedicarboxylato%29%platinum II
% 222.56/222.79  |- skos__altLabel mesh__D016190 Lemery Brand of Carboplatin
% 222.56/222.79  |- rdf__type mesh__D016190sskos__Concept
% 222.56/222.79  |- mesh__recordOriginator mesh__D016190 RLS
% 222.56/222.79  |- skos__altLabel mesh__D016190 Pharmachemie Brand of Carboplatin
% 222.56/222.79  |- skos__altLabel mesh__D016190 Columbia Brand of Carboplatin
% 222.56/222.79  |- mesh__historyNote mesh__D016190 91   
% 222.56/222.79  |- mesh__dateCreated mesh__D016190 1990-04-24
% 222.56/222.79  |- skos__hiddenLabel mesh__D016190 JM8
% 222.56/222.79  |- skos__prefLabel mesh__D002170 Canada
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D002170 2004
% 222.65/222.81  |- mesh__recordMaintainer mesh__D002170 jls
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D002170 2000
% 222.65/222.81  |- rdf__type mesh__D002170sskos__Concept
% 222.65/222.81  |- skos__broader mesh__D002170smesh__D009656
% 222.65/222.81  |- mesh__dateCreated mesh__D002170 1999-01-01
% 222.65/222.81  |- skos__annotation mesh__D002170
% 222.65/222.81       each of the provinces %26% territories is available as a heading%A%  
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D002170 2001
% 222.65/222.81  |- mesh__recordAuthorizer mesh__D002170 sjn
% 222.65/222.81  |- skos__scopeNote mesh__D002170
% 222.65/222.81       The largest country in North America, comprising 10 provinces and three territories. Its capital is Ottawa.%A%    
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D002170 2005
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D002170 2006
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D002170 2002
% 222.65/222.81  |- mesh__recordOriginator mesh__D002170 NLM
% 222.65/222.81  |- mesh__dateRevised mesh__D002170 1999-11-03
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D002170 2003
% 222.65/222.81  |- mesh__publicMeSHNote mesh__D043587
% 222.65/222.81       2004; MUSCARINIC RECEPTOR M3 was indexed under RECEPTORS, MUSCARINIC 1994-2003%A%  
% 222.65/222.81  |- skos__prefLabel mesh__D043587 Receptor, Muscarinic M3
% 222.65/222.81  |- mesh__historyNote mesh__D043587
% 222.65/222.81       2004; use RECEPTOR, MUSCARINIC M3 %28%NM%29% 1994-2003   
% 222.65/222.81  |- skos__hiddenLabel mesh__D043587 Muscarinic M3 Receptors
% 222.65/222.81  |- skos__hiddenLabel mesh__D043587 Muscarinic M3 Receptor
% 222.65/222.81  |- skos__broader mesh__D043587smesh__D011976
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D043587 2004
% 222.65/222.81  |- skos__hiddenLabel mesh__D043587 M3, Muscarinic Receptor
% 222.65/222.81  |- skos__hiddenLabel mesh__D043587 M3 Receptors, Muscarinic
% 222.65/222.81  |- skos__altLabel mesh__D043587 Receptors, Muscarinic M3
% 222.65/222.81  |- skos__altLabel mesh__D043587 Muscarinic Receptor M3
% 222.65/222.81  |- skos__scopeNote mesh__D043587
% 222.65/222.81       A subclass of muscarinic receptor that mediates cholinergic-induced contraction in a variety of SMOOTH MUSCLES.%A%    
% 222.65/222.81  |- skos__hiddenLabel mesh__D043587 Receptors M3, Muscarinic
% 222.65/222.81  |- mesh__dateCreated mesh__D043587 2003-07-09
% 222.65/222.81  |- skos__altLabel mesh__D043587 Muscarinic Receptors M3
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D043587 2005
% 222.65/222.81  |- skos__hiddenLabel mesh__D043587 Receptor M3, Muscarinic
% 222.65/222.81  |- skos__hiddenLabel mesh__D043587 M3, Muscarinic Receptors
% 222.65/222.81  |- skos__historyNote mesh__D043587 Receptors, Muscarinic %28%1994-2003%29%
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D043587 2006
% 222.65/222.81  |- mesh__dateEstablished mesh__D043587 2004-01-01
% 222.65/222.81  |- skos__hiddenLabel mesh__D043587 M3 Receptor, Muscarinic
% 222.65/222.81  |- rdf__type mesh__D043587sskos__Concept
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D010602 2005
% 222.65/222.81  |- mesh__dateRevised mesh__D010602 1999-11-03
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D010602 2002
% 222.65/222.81  |- skos__prefLabel mesh__D010602 Pharmacopoeias
% 222.65/222.81  |- rdf__type mesh__D010602sskos__Concept
% 222.65/222.81  |- mesh__recordAuthorizer mesh__D010602 sjn
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D010602 2001
% 222.65/222.81  |- mesh__dateCreated mesh__D010602 1999-01-01
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D010602 2000
% 222.65/222.81  |- skos__scopeNote mesh__D010602
% 222.65/222.81       Authoritative treatises on drugs and preparations, their description, formulation, analytic composition, physical constants, main chemical properties used in identification, standards for strength, purity, and dosage, chemical tests for determining identity and purity, etc. They are usually published under governmental jurisdiction %28%e.g., USP, the United States Pharmacopoeia; BP, British Pharmacopoeia; P. Helv., the Swiss Pharmacopoeia%29%. They differ from FORMULARIES in that they are far more complete: formularies tend to be mere listings of formulas and prescriptions.%A%    
% 222.65/222.81  |- skos__hiddenLabel mesh__D010602 Formularies, National
% 222.65/222.81  |- skos__broader mesh__D010602smesh__D012013
% 222.65/222.81  |- mesh__recordMaintainer mesh__D010602 kle
% 222.65/222.81  |- skos__altLabel mesh__D010602 Formulary, National
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D010602 2004
% 222.65/222.81  |- mesh__recordOriginator mesh__D010602 NLM
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D010602 2006
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D010602 2003
% 222.65/222.81  |- skos__hiddenLabel mesh__D010602 National Formularies
% 222.65/222.81  |- skos__annotation mesh__D010602
% 222.65/222.81       IM; do not confuse with FORMULARIES which, usually mere lists, are less complete %28%see MeSH definitions%29%; do not confuse with Publication Type PHARMACOPOEIAS; specify country%A%  
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D015098 2005
% 222.65/222.81  |- skos__prefLabel mesh__D015098 3-Methoxy-4-hydroxyphenylethanol
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D015098 2002
% 222.65/222.81  |- rdf__type mesh__D015098sskos__Concept
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D015098 2004
% 222.65/222.81  |- skos__altLabel mesh__D015098 MOPET
% 222.65/222.81  |- skos__altLabel mesh__D015098 MHPE
% 222.65/222.81  |- mesh__dateCreated mesh__D015098 1974-11-19
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D015098 2001
% 222.65/222.81  |- mesh__recordAuthorizer mesh__D015098 sjn
% 222.65/222.81  |- mesh__historyNote mesh__D015098
% 222.65/222.81       91%28%75%29%; was see under CATECHOLS 1975-90   
% 222.65/222.81  |- skos__hiddenLabel mesh__D015098 3 Methoxy 4 hydroxyphenylethanol
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D015098 2003
% 222.65/222.81  |- mesh__publicMeSHNote mesh__D015098
% 222.65/222.81       91; was see under CATECHOLS 1975-90   
% 222.65/222.81  |- mesh__dateEstablished mesh__D015098 1991-01-01
% 222.65/222.81  |- skos__broader mesh__D015098smesh__D002396
% 222.65/222.81  |- skos__altLabel mesh__D015098 Hydroxymethoxyphenethyl Alcohol
% 222.65/222.81  |- skos__scopeNote mesh__D015098
% 222.65/222.81       Metabolite of serotonin and norepinephrine.     
% 222.65/222.81  |- mesh__recordOriginator mesh__D015098 NLM
% 222.65/222.81  |- skos__hiddenLabel mesh__D015098 Alcohol, Hydroxymethoxyphenethyl
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D015098 2006
% 222.65/222.81  |- mesh__dateRevised mesh__D015098 2000-06-21
% 222.65/222.81  |- skos__historyNote mesh__D015098 Alcohol, Ethyl %28%1972-1974%29%
% 222.65/222.81  |- mesh__recordMaintainer mesh__D015098 CCR
% 222.65/222.81  |- skos__altLabel mesh__D015098 Methoxyhydroxyphenylethanol
% 222.65/222.81  |- skos__historyNote mesh__D015098 Catechols %28%1972-1974%29%
% 222.65/222.81  |- mesh__dateEstablished mesh__D009859 1985-01-01
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D009859 2000
% 222.65/222.81  |- skos__altLabel mesh__D009859 Nursing, Oncologic
% 222.65/222.81  |- skos__hiddenLabel mesh__D009859 Nursings, Oncological
% 222.65/222.81  |- skos__hiddenLabel mesh__D009859 Nursing, Oncological
% 222.65/222.81  |- skos__scopeNote mesh__D009859
% 222.65/222.81       Nursing care provided cancer patients. It includes aspects of family functioning through education of both patient and family. The specialty of oncologic nursing focuses on cancer as a major health care problem.%A%    
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D009859 2001
% 222.65/222.81  |- skos__hiddenLabel mesh__D009859 Oncologic Nursings
% 222.65/222.81  |- skos__annotation mesh__D009859
% 222.65/222.81       SPEC: SPEC qualif; ONCOLOGIC NURSING = the nursing specialty, NEOPLASMS /nurs = the patient; DF: ONCOL NURS%A%  
% 222.65/222.81  |- skos__historyNote mesh__D009859 Neoplasms/nursing %28%1975-1984%29%
% 222.65/222.81  |- skos__broader mesh__D009859smesh__D009732
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D009859 1995
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D009859 2002
% 222.65/222.81  |- skos__altLabel mesh__D009859 Oncological Nursing
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D009859 1998
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D009859 2005
% 222.65/222.81  |- mesh__historyNote mesh__D009859 85   
% 222.65/222.81  |- skos__historyNote mesh__D009859 Specialties, Nursing %28%1971-1984%29%
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D009859 1999
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D009859 2006
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D009859 1996
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D009859 2003
% 222.65/222.81  |- skos__broader mesh__D009859smesh__D013041
% 222.65/222.81  |- skos__hiddenLabel mesh__D009859 Oncological Nursings
% 222.65/222.81  |- mesh__recordOriginator mesh__D009859 EC
% 222.65/222.81  |- skos__hiddenLabel mesh__D009859 Nursings, Oncologic
% 222.65/222.81  |- mesh__publicMeSHNote mesh__D009859 85   
% 222.65/222.81  |- mesh__recordAuthorizer mesh__D009859 PLS
% 222.65/222.81  |- mesh__recordMaintainer mesh__D009859 JLS
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D009859 1997
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D009859 2004
% 222.65/222.81  |- skos__prefLabel mesh__D009859 Oncologic Nursing
% 222.65/222.81  |- mesh__dateRevised mesh__D009859 1994-05-27
% 222.65/222.81  |- mesh__dateCreated mesh__D009859 1984-04-11
% 222.65/222.81  |- rdf__type mesh__D009859sskos__Concept
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D001876 2003
% 222.65/222.81  |- mesh__recordMaintainer mesh__D001876 TGC
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D001876 1998
% 222.65/222.81  |- mesh__recordAuthorizer mesh__D001876 PLS
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D001876 2001
% 222.65/222.81  |- skos__annotation mesh__D001876
% 222.65/222.81       designed labels showing ownership of a book; med bookplates: do not coord with MEDICINE; coord IM with subject %28%IM%29% if relevant; bookplates of famous med %26% non-med figures: coord IM with required biog and hist headings %26% check tags; do not confuse with Publication Type BOOKPLATES%A%  
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D001876 2004
% 222.65/222.81  |- skos__broader mesh__D001876smesh__D001877
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D001876 1999
% 222.65/222.81  |- skos__hiddenLabel mesh__D001876 Bookplate
% 222.65/222.81  |- rdf__type mesh__D001876sskos__Concept
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D001876 2002
% 222.65/222.81  |- mesh__dateCreated mesh__D001876 1999-01-01
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D001876 1997
% 222.65/222.81  |- skos__scopeNote mesh__D001876
% 222.65/222.81       Labels pasted in books to mark their ownership and sometimes to indicate their location in a library. Private bookplates are often ornate or artistic: simpler and smaller ones bearing merely the owner%27%s name are called %22%book labels.%22% They are usually pasted on the front endpaper of books. %28%From Harrod, The Librarians%27% Glossary and Reference Book, 4th rev ed %26% Random House Unabridged Dictionary, 2d ed%29%%A%    
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D001876 2005
% 222.65/222.81  |- mesh__dateRevised mesh__D001876 1996-06-10
% 222.65/222.81  |- mesh__recordOriginator mesh__D001876 NLM
% 222.65/222.81  |- skos__prefLabel mesh__D001876 Bookplates
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D001876 2006
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D001876 2000
% 222.65/222.81  |- skos__scopeNote mesh__D001078
% 222.65/222.81       Cells derived from primitive cell types in the neural crest. During ontogeny they migrate to the foregut and specific locations of the neuroendocrine system. Properly located these cells form part of the normal hormone producing tissues of the neuroendocrine system. If misdirected these cells may become hyperplastic, adenomatous, or malignant %28%cf. APUDOMA%29%.%A%    
% 222.65/222.81  |- skos__prefLabel mesh__D001078 APUD Cells
% 222.65/222.81  |- mesh__dateCreated mesh__D001078 1977-04-27
% 222.65/222.81  |- mesh__recordMaintainer mesh__D001078 lkt
% 222.65/222.81  |- skos__hiddenLabel mesh__D001078 Cell, APUD
% 222.65/222.81  |- mesh__dateRevised mesh__D001078 2005-06-30
% 222.65/222.81  |- skos__annotation mesh__D001078
% 222.65/222.81       named APUD from Amine Precursor Uptake %26% Decarboxylation; use term only when used by author; A 11 qualif%A%  
% 222.65/222.81  |- mesh__historyNote mesh__D001078 78   
% 222.65/222.81  |- skos__broader mesh__D001078smesh__D002477
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D001078 2006
% 222.65/222.81  |- mesh__recordOriginator mesh__D001078 VDK
% 222.65/222.81  |- mesh__publicMeSHNote mesh__D001078 78   
% 222.65/222.81  |- skos__related mesh__D001078smesh__D019858
% 222.65/222.81  |- skos__hiddenLabel mesh__D001078 APUD Cell
% 222.65/222.81  |- mesh__dateEstablished mesh__D001078 1978-01-01
% 222.65/222.81  |- skos__hiddenLabel mesh__D001078 Cells, APUD
% 222.65/222.81  |- rdf__type mesh__D001078sskos__Concept
% 222.65/222.81  |- mesh__recordAuthorizer mesh__D001078 sjn
% 222.65/222.81  |- mesh__recordOriginator mesh__D006561 NLM
% 222.65/222.81  |- rdf__type mesh__D006561sskos__Concept
% 222.65/222.81  |- skos__annotation mesh__D006561
% 222.65/222.81       note Cat C; caused by Simplexvirus %28%also called Herpes simplex virus %26% Herpesvirus hominis%29%%A%  
% 222.65/222.81  |- skos__prefLabel mesh__D006561 Herpes Simplex
% 222.65/222.81  |- mesh__dateRevised mesh__D006561 1997-06-20
% 222.65/222.81  |- skos__broader mesh__D006561smesh__D006566
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D006561 2002
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D006561 2005
% 222.65/222.81  |- mesh__dateCreated mesh__D006561 1999-01-01
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D006561 2006
% 222.65/222.81  |- mesh__recordMaintainer mesh__D006561 TGC
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D006561 2000
% 222.65/222.81  |- skos__scopeNote mesh__D006561
% 222.65/222.81       A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. %28%Dorland, 27th ed.%29%%A%    
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D006561 1998
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D006561 2003
% 222.65/222.81  |- mesh__recordAuthorizer mesh__D006561 SJN
% 222.65/222.81  |- skos__broader mesh__D006561smesh__D017193
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D006561 2001
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D006561 1999
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D006561 2004
% 222.65/222.81  |- skos__hiddenLabel mesh__D020232 Syndrome, Kluver-Bucy
% 222.65/222.81  |- skos__hiddenLabel mesh__D020232 Kluver Bucy Syndrome
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D020232 2002
% 222.65/222.81  |- skos__scopeNote mesh__D020232
% 222.65/222.81       A neurobehavioral syndrome associated with bilateral medial temporal lobe dysfunction. Clinical manifestations include oral exploratory behavior; tactile exploratory behavior; hypersexuality; BULIMIA; MEMORY DISORDERS; placidity; and an inability to recognize objects or faces. This disorder may result from a variety of conditions, including CRANIOCEREBRAL TRAUMA; infections; ALZHEIMER DISEASE; PICK DISEASE OF THE BRAIN; and CEREBROVASCULAR DISORDERS.%A%    
% 222.65/222.81  |- mesh__publicMeSHNote mesh__D020232 2000   
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D020232 2005
% 222.65/222.81  |- rdf__type mesh__D020232sskos__Concept
% 222.65/222.81  |- skos__broader mesh__D020232smesh__D003704
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D020232 2006
% 222.65/222.81  |- skos__historyNote mesh__D020232 Dementia %28%1966-1999%29%
% 222.65/222.81  |- skos__prefLabel mesh__D020232 Kluver-Bucy Syndrome
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D020232 2000
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D020232 2001
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D020232 2003
% 222.65/222.81  |- mesh__dateEstablished mesh__D020232 2000-01-01
% 222.65/222.81  |- skos__broader mesh__D020232smesh__D001927
% 222.65/222.81  |- mesh__dateCreated mesh__D020232 1999-11-03
% 222.65/222.81  |- skos__historyNote mesh__D020232 Temporal Lobe %28%1966-1999%29%
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D020232 2004
% 222.65/222.81  |- mesh__historyNote mesh__D020232 2000   
% 222.65/222.81  |- skos__annotation mesh__D019489
% 222.65/222.81       publication type only; for book illustrations as a subject, index under main heading BOOKS, ILLUSTRATED; Manual 17.14%A%  
% 222.65/222.81  |- mesh__dateEstablished mesh__D019489 1997-01-01
% 222.65/222.81  |- rdf__type mesh__D019489sskos__Concept
% 222.65/222.81  |- skos__related mesh__D019489smesh__D020495
% 222.65/222.81  |- mesh__dateRevised mesh__D019489 2005-06-30
% 222.65/222.81  |- skos__prefLabel mesh__D019489
% 222.65/222.81       Book Illustrations %5B%Publication Type%5D%
% 222.65/222.81  |- mesh__recordMaintainer mesh__D019489 jls
% 222.65/222.81  |- skos__broader mesh__D019489smesh__D052181
% 222.65/222.81  |- mesh__historyNote mesh__D019489 1997   
% 222.65/222.81  |- mesh__dateCreated mesh__D019489 1996-06-21
% 222.65/222.81  |- mesh__recordOriginator mesh__D019489 TGC
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D019489 2006
% 222.65/222.81  |- skos__altLabel mesh__D019489 Book Illustrations %28%PT%29%
% 222.65/222.81  |- mesh__recordAuthorizer mesh__D019489 sjn
% 222.65/222.81  |- skos__scopeNote mesh__D019489
% 222.65/222.81       Works consisting of photographs, prints, drawings, portraits, plates, diagrams, facsimiles, maps, tables, or other representations or systematic arrangements of data designed to elucidate or decorate the contents of a publication. %28%From The ALA Glossary of Library and Information Science, 1983, p114%29%%A%    
% 222.65/222.81  |- skos__altLabel mesh__D005469 Novartis Brand of Fluorometholone
% 222.65/222.81  |- skos__hiddenLabel mesh__D005469 Fluor Op
% 222.65/222.81  |- mesh__recordMaintainer mesh__D005469 CCR
% 222.65/222.81  |- skos__hiddenLabel mesh__D005469 Fluoro Ophtal
% 222.65/222.81  |- skos__altLabel mesh__D005469 Ursapharm Brand of Fluorometholone
% 222.65/222.81  |- rdf__type mesh__D005469sskos__Concept
% 222.65/222.81  |- mesh__recordAuthorizer mesh__D005469 sjn
% 222.65/222.81  |- skos__hiddenLabel mesh__D005469 Pharm Allergan Brand of Fluorometholone
% 222.65/222.81  |- skos__altLabel mesh__D005469 Alcon Brand of Fluorometholone
% 222.65/222.81  |- skos__altLabel mesh__D005469 Allergan Brand 2 of Fluorometholone
% 222.65/222.81  |- skos__prefLabel mesh__D005469 Fluorometholone
% 222.65/222.81  |- mesh__dateRevised mesh__D005469 2005-06-30
% 222.65/222.81  |- skos__altLabel mesh__D005469 Isdin Brand of Fluorometholone
% 222.65/222.81  |- skos__altLabel mesh__D005469 Pharmascience Brand of Fluorometholone
% 222.65/222.81  |- skos__altLabel mesh__D005469 Winzer Brand of Fluorometholone
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D005469 2006
% 222.65/222.81  |- skos__hiddenLabel mesh__D005469 Flucon, Isopto
% 222.65/222.81  |- skos__broader mesh__D005469smesh__D013259
% 222.65/222.81  |- skos__broader mesh__D005469smesh__D011244
% 222.65/222.81  |- skos__altLabel mesh__D005469 Allergan Brand 3 of Fluorometholone
% 222.65/222.81  |- skos__scopeNote mesh__D005469
% 222.65/222.81       A glucocorticoid employed, usually as eye drops, in the treatment of allergic and inflammatory conditions of the eye. It has also been used topically in the treatment of various skin disorders. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p732%29%%A%    
% 222.65/222.81  |- skos__altLabel mesh__D005469 Allergan Brand 1 of Fluorometholone
% 222.65/222.81  |- mesh__dateCreated mesh__D005469 1999-01-01
% 222.65/222.81  |- mesh__recordOriginator mesh__D005469 NLM
% 222.65/222.81  |- skos__altLabel mesh__D005469 Pharm-Allergan Brand of Fluorometholone
% 222.65/222.81  |- skos__altLabel mesh__D005469 Isopto Flucon
% 222.65/222.81  |- skos__hiddenLabel mesh__D005469 PMS Fluorometholone
% 222.65/222.81  |- skos__prefLabel mesh__D016191
% 222.65/222.81       %28%R%29%-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol
% 222.65/222.81  |- skos__historyNote mesh__D016191 Benzazepines %28%1968-1990%29%
% 222.65/222.81  |- skos__annotation mesh__D016191
% 222.65/222.81       SCH stands for Schering %28%a pharmaceut co%29%   
% 222.65/222.81  |- skos__hiddenLabel mesh__D016191 Sch 23388
% 222.65/222.81  |- mesh__historyNote mesh__D016191 2005%28%1990%29%   
% 222.65/222.81  |- mesh__dateRevised mesh__D016191 2004-07-07
% 222.65/222.81  |- mesh__dateEstablished mesh__D016191 1991-01-01
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D016191 2006
% 222.65/222.81  |- mesh__recordAuthorizer mesh__D016191 sjn
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D016191 2005
% 222.65/222.81  |- mesh__publicMeSHNote mesh__D016191 2005; see SCH-2330 1990-2004   
% 222.65/222.81  |- mesh__dateCreated mesh__D016191 1990-06-08
% 222.65/222.81  |- skos__historyNote mesh__D016191
% 222.65/222.81       Tranquilizing Agents, Major %28%1975-1990%29%
% 222.65/222.81  |- skos__scopeNote mesh__D016191
% 222.65/222.81       A dopamine D1 receptor antagonist that has no effect or only very limited effect on dopamine D2 receptors. The compound has tranquilizing effects, inhibits conditioned avoidance response, impairs memory acquisition, produces dose-dependent catalepsy, blocks central serotonin receptors, and reduces the lethal effects of cocaine.%A%    
% 222.65/222.81  |- rdf__type mesh__D016191sskos__Concept
% 222.65/222.81  |- skos__broader mesh__D016191smesh__D001552
% 222.65/222.81  |- mesh__recordMaintainer mesh__D016191 jmp
% 222.65/222.81  |- mesh__recordOriginator mesh__D016191 RLS
% 222.65/222.81  |- skos__hiddenLabel mesh__D016191 Sch23388
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D002171 2006
% 222.65/222.81  |- skos__scopeNote mesh__D002171
% 222.65/222.81       Any of several Old World finches of the genus Serinus.     
% 222.65/222.81  |- mesh__historyNote mesh__D002171 68   
% 222.65/222.81  |- skos__hiddenLabel mesh__D002171 Canary
% 222.65/222.81  |- skos__historyNote mesh__D002171 Birds %28%1966-1967%29%
% 222.65/222.81  |- mesh__publicMeSHNote mesh__D002171 68   
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D002171 2005
% 222.65/222.81  |- mesh__recordOriginator mesh__D002171 NLM
% 222.65/222.81  |- rdf__type mesh__D002171sskos__Concept
% 222.65/222.81  |- mesh__recordMaintainer mesh__D002171 ags
% 222.65/222.81  |- mesh__dateEstablished mesh__D002171 1968-01-01
% 222.65/222.81  |- mesh__dateRevised mesh__D002171 2004-07-07
% 222.65/222.81  |- skos__altLabel mesh__D002171 Serinus
% 222.65/222.81  |- skos__broader mesh__D002171smesh__D046369
% 222.65/222.81  |- mesh__dateCreated mesh__D002171 1999-01-01
% 222.65/222.81  |- skos__prefLabel mesh__D002171 Canaries
% 222.65/222.81  |- mesh__recordAuthorizer mesh__D002171 sjn
% 222.65/222.81  |- skos__altLabel mesh__D043588 Receptors, Muscarinic M4
% 222.65/222.81  |- skos__hiddenLabel mesh__D043588 M4, Muscarinic Receptors
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D043588 2006
% 222.65/222.81  |- skos__hiddenLabel mesh__D043588 Receptor M4, Muscarinic
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D043588 2004
% 222.65/222.81  |- rdf__type mesh__D043588sskos__Concept
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D043588 2005
% 222.65/222.81  |- skos__hiddenLabel mesh__D043588 Receptors M4, Muscarinic
% 222.65/222.81  |- skos__hiddenLabel mesh__D043588 Muscarinic M4 Receptors
% 222.65/222.81  |- skos__historyNote mesh__D043588 Receptors, Muscarinic %28%1996-2003%29%
% 222.65/222.81  |- skos__altLabel mesh__D043588 Muscarinic Receptors M4
% 222.65/222.81  |- skos__scopeNote mesh__D043588
% 222.65/222.81       A specific subtype of muscarinic receptor found in the CORPUS STRIATUM and the LUNG. It has similar receptor binding specificities to MUSCARINIC RECEPTOR M1 and MUSCARINIC RECEPTOR M2.%A%    
% 222.65/222.81  |- skos__altLabel mesh__D043588 Muscarinic Receptor M4
% 222.65/222.81  |- mesh__dateCreated mesh__D043588 2003-07-09
% 222.65/222.81  |- mesh__historyNote mesh__D043588
% 222.65/222.81       2004; use RECEPTOR, MUSCARINIC M4 %28%NM%29% 1996-2003   
% 222.65/222.81  |- mesh__publicMeSHNote mesh__D043588
% 222.65/222.81       2004; MUSCARINIC RECEPTOR M4 was indexed under RECEPTORS, MUSCARINIC 1996-2003%A%  
% 222.65/222.81  |- mesh__dateEstablished mesh__D043588 2004-01-01
% 222.65/222.81  |- skos__prefLabel mesh__D043588 Receptor, Muscarinic M4
% 222.65/222.81  |- skos__hiddenLabel mesh__D043588 Muscarinic M4 Receptor
% 222.65/222.81  |- skos__hiddenLabel mesh__D043588 M4 Receptors, Muscarinic
% 222.65/222.81  |- skos__hiddenLabel mesh__D043588 M4 Receptor, Muscarinic
% 222.65/222.81  |- skos__broader mesh__D043588smesh__D011976
% 222.65/222.81  |- skos__hiddenLabel mesh__D043588 M4, Muscarinic Receptor
% 222.65/222.81  |- rdf__type mesh__D010603sskos__Concept
% 222.65/222.81  |- skos__prefLabel mesh__D010603 Pharmacopoeias, Homeopathic
% 222.65/222.81  |- skos__hiddenLabel mesh__D010603 Pharmacopoeia, Homeopathic
% 222.65/222.81  |- mesh__dateCreated mesh__D010603 1999-01-01
% 222.65/222.81  |- skos__hiddenLabel mesh__D010603 Homeopathic Pharmacopoeia
% 222.65/222.81  |- skos__annotation mesh__D010603 IM   
% 222.65/222.81  |- mesh__dateRevised mesh__D010603 1999-11-03
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D010603 2002
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D010603 2004
% 222.65/222.81  |- mesh__recordAuthorizer mesh__D010603 sjn
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D010603 2001
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D010603 2006
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D010603 2003
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D010603 2000
% 222.65/222.81  |- mesh__recordMaintainer mesh__D010603 kle
% 222.65/222.81  |- mesh__recordOriginator mesh__D010603 NLM
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D010603 2005
% 222.65/222.81  |- skos__broader mesh__D010603smesh__D010602
% 222.65/222.81  |- skos__hiddenLabel mesh__D010603 Homeopathic Pharmacopoeias
% 222.65/222.81  |- skos__historyNote mesh__D015897 Length of Stay %28%1986-1989%29%
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D015897 2005
% 222.65/222.81  |- skos__annotation mesh__D015897
% 222.65/222.81       %22%presence of co-existing or additional diseases%22% in epidemiol studies: do not confuse with /compl; IM GEN only; coord NIM with both diseases /epidemiol %28%IM%29%, not /compl; specify geog if pertinent%A%  
% 222.65/222.81  |- mesh__dateRevised mesh__D015897 1999-11-03
% 222.65/222.81  |- mesh__recordMaintainer mesh__D015897 ndw
% 222.65/222.81  |- mesh__recordOriginator mesh__D015897 EGC
% 222.65/222.81  |- mesh__publicMeSHNote mesh__D015897 90   
% 222.65/222.81  |- mesh__historyNote mesh__D015897 90   
% 222.65/222.81  |- rdf__type mesh__D015897sskos__Concept
% 222.65/222.81  |- skos__historyNote mesh__D015897
% 222.65/222.81       specific disease/complications %28%1977-1989%29%
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D015897 2001
% 222.65/222.81  |- mesh__dateEstablished mesh__D015897 1990-01-01
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D015897 2004
% 222.65/222.81  |- skos__historyNote mesh__D015897
% 222.65/222.81       Diagnosis Related Groups %28%1986-1989%29%
% 222.65/222.81  |- mesh__dateCreated mesh__D015897 1989-05-25
% 222.65/222.81  |- skos__scopeNote mesh__D015897
% 222.65/222.81       The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.%A%    
% 222.65/222.81  |- skos__hiddenLabel mesh__D015897 Comorbidities
% 222.65/222.81  |- mesh__recordAuthorizer mesh__D015897 sjn
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D015897 2000
% 222.65/222.81  |- skos__prefLabel mesh__D015897 Comorbidity
% 222.65/222.81  |- skos__broader mesh__D015897smesh__D015981
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D015897 2003
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D015897 2006
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D015897 2002
% 222.65/222.81  |- skos__hiddenLabel mesh__D015099 Acyl Malonyl ACP Condensing Enzyme
% 222.65/222.81  |- skos__hiddenLabel mesh__D015099 3 Oxoacyl Synthetase
% 222.65/222.81  |- mesh__recordOriginator mesh__D015099 NLM
% 222.65/222.81  |- mesh__recordMaintainer mesh__D015099 ags
% 222.65/222.81  |- skos__altLabel mesh__D015099 beta Ketoacyl ACP Synthase
% 222.65/222.81  |- skos__prefLabel mesh__D015099
% 222.65/222.81       3-Oxoacyl-%28%Acyl-Carrier-Protein%29% Synthase
% 222.65/222.81  |- mesh__historyNote mesh__D015099 98%28%75%29%   
% 222.65/222.81  |- skos__hiddenLabel mesh__D015099 Synthase, 3-Keto-ACP
% 222.65/222.81  |- skos__historyNote mesh__D015099 Acyltransferases %28%1970-1974%29%
% 222.65/222.81  |- mesh__dateEstablished mesh__D015099 1991-01-01
% 222.65/222.81  |- skos__broader mesh__D015099smesh__D000217
% 222.65/222.81  |- skos__altLabel mesh__D015099 Acyl-Malonyl-ACP Condensing Enzyme
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D015099 2006
% 222.65/222.81  |- mesh__dateCreated mesh__D015099 1974-11-19
% 222.65/222.81  |- skos__historyNote mesh__D015099 Malonates %28%1970-1974%29%
% 222.65/222.81  |- skos__hiddenLabel mesh__D015099 3 Keto ACP Synthase
% 222.65/222.81  |- skos__hiddenLabel mesh__D015099
% 222.65/222.81       beta Keto Acyl Carrier Protein Synthase I
% 222.65/222.81  |- skos__hiddenLabel mesh__D015099 Condensing Enzyme, Acyl-Malonyl-ACP
% 222.65/222.81  |- skos__hiddenLabel mesh__D015099
% 222.65/222.81       beta Keto Acyl Carrier Protein Synthase II
% 222.65/222.81  |- skos__altLabel mesh__D015099 beta Keto Acyl Synthetase
% 222.65/222.81  |- mesh__dateRevised mesh__D015099 2005-06-30
% 222.65/222.81  |- skos__altLabel mesh__D015099
% 222.65/222.81       beta-Ketoacyl-Coenzyme A %28%CoA%29% Synthase
% 222.65/222.81  |- skos__historyNote mesh__D015099 Carrier Proteins %28%1973-1974%29%
% 222.65/222.81  |- skos__altLabel mesh__D015099 3-Oxoacyl Synthetase
% 222.65/222.81  |- mesh__recordAuthorizer mesh__D015099 sjn
% 222.65/222.81  |- rdf__type mesh__D015099sskos__Concept
% 222.65/222.81  |- skos__altLabel mesh__D015099
% 222.65/222.81       3-Oxoacyl %28%Acyl Carrier Protein%29% Synthase
% 222.65/222.81  |- mesh__publicMeSHNote mesh__D015099
% 222.65/222.81       98; see 3-OXOACYL %28%ACYL CARRIER PROTEIN%29% SYNTHASE 1991-97; see ACYLTRANSFERASES 1975-90%A%  
% 222.65/222.81  |- skos__hiddenLabel mesh__D015099 Synthetase, 3-Oxoacyl
% 222.65/222.81  |- skos__altLabel mesh__D015099
% 222.65/222.81       3 Oxoacyl %28%Acyl Carrier Protein%29% Synthase
% 222.65/222.81  |- skos__annotation mesh__D015099 DF: OXOACYL ACP SYNTHASE   
% 222.65/222.81  |- skos__altLabel mesh__D015099 3-Keto-ACP Synthase
% 222.65/222.81  |- skos__scopeNote mesh__D015099
% 222.65/222.81       An enzyme of long-chain fatty acid synthesis, that adds a two-carbon unit from malonyl-%28%acyl carrier protein%29% to another molecule of fatty acyl-%28%acyl carrier protein%29%, giving a beta-ketoacyl-%28%acyl carrier protein%29% with the release of carbon dioxide. EC 2.3.1.41.%A%    
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D001877 2002
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D001877 1996
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D001877 1993
% 222.65/222.81  |- mesh__dateRevised mesh__D001877 1992-05-26
% 222.65/222.81  |- skos__prefLabel mesh__D001877 Books
% 222.65/222.81  |- mesh__recordMaintainer mesh__D001877 TAP
% 222.65/222.81  |- rdf__type mesh__D001877sskos__Concept
% 222.65/222.81  |- mesh__recordOriginator mesh__D001877 NLM
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D001877 1997
% 222.65/222.81  |- mesh__dateCreated mesh__D001877 1999-01-01
% 222.65/222.81  |- skos__related mesh__D001877smesh__D001638
% 222.65/222.81  |- mesh__historyNote mesh__D001877 64   
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D001877 2005
% 222.65/222.81  |- mesh__activeMeSHYear mesh__D001877 2000
% 222.65/222.82  |- mesh__recordAuthorizer mesh__D001877 PLS
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D001877 2006
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D001877 1994
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D001877 2001
% 222.65/222.82  |- skos__hiddenLabel mesh__D001877 Chapters, Book
% 222.65/222.82  |- mesh__publicMeSHNote mesh__D001877 64   
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D001877 2003
% 222.65/222.82  |- skos__hiddenLabel mesh__D001877 Chapter, Book
% 222.65/222.82  |- skos__annotation mesh__D001877
% 222.65/222.82       NOT for specific books %28% = LITERATURE or its indentions%29%; NOT for lists of books %28% = BIBLIOGRAPHY or its indentions%29%: for books as a means of communication or as a subject %28%%22%books as carriers of germs%22%%29%: Manual 33.11; relation to LITERATURE: Manual 33.11, relation to MANUSCRIPTS: Manual 33.12;TEXTBOOKS %26% REFERENCE BOOKS are also available%A%  
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D001877 1998
% 222.65/222.82  |- skos__broader mesh__D001877smesh__D011642
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D001877 1995
% 222.65/222.82  |- skos__hiddenLabel mesh__D001877 Book Chapters
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D001877 2004
% 222.65/222.82  |- skos__hiddenLabel mesh__D001877 Book
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D001877 1999
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D001079 2002
% 222.65/222.82  |- skos__annotation mesh__D001079
% 222.65/222.82       for derivation of word see note on APUD; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with organ /neopl term %28%IM%29%%A%  
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D001079 2006A
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D001079 2004
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D001079 2001
% 222.65/222.82  |- mesh__dateCreated mesh__D001079 1977-04-27
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D001079 2006
% 222.65/222.82  |- skos__broader mesh__D001079smesh__D000236
% 222.65/222.82  |- mesh__recordMaintainer mesh__D001079 ags
% 222.65/222.82  |- skos__related mesh__D001079smesh__D009377
% 222.65/222.82  |- mesh__publicMeSHNote mesh__D001079 78   
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D001079 2003
% 222.65/222.82  |- mesh__dateRevised mesh__D001079 2005-07-08
% 222.65/222.82  |- mesh__dateEstablished mesh__D001079 1978-01-01
% 222.65/222.82  |- mesh__recordAuthorizer mesh__D001079 ags
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D001079 2000
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D001079 2005
% 222.65/222.82  |- rdf__type mesh__D001079sskos__Concept
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D001079 1997
% 222.65/222.82  |- skos__scopeNote mesh__D001079
% 222.65/222.82       A general term collectively applied to tumors associated with the APUD CELLS series, irrespective of their specific identification.%A%    
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D001079 1999
% 222.65/222.82  |- mesh__historyNote mesh__D001079 78   
% 222.65/222.82  |- skos__broader mesh__D001079smesh__D018358
% 222.65/222.82  |- skos__hiddenLabel mesh__D001079 Apudomas
% 222.65/222.82  |- mesh__recordOriginator mesh__D001079 VDK
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D001079 1998
% 222.65/222.82  |- skos__prefLabel mesh__D001079 Apudoma
% 222.65/222.82  |- skos__broader mesh__D006562smesh__D006566
% 222.65/222.82  |- skos__altLabel mesh__D006562 Shingles
% 222.65/222.82  |- skos__altLabel mesh__D006562 Zoster
% 222.65/222.82  |- skos__related mesh__D006562smesh__D051474
% 222.65/222.82  |- mesh__dateRevised mesh__D006562 2005-07-12
% 222.65/222.82  |- skos__scopeNote mesh__D006562
% 222.65/222.82       An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus %28%HERPESVIRUS 3, HUMAN%29% in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. %28%From Dorland, 27th ed%29%%A%    
% 222.65/222.82  |- skos__prefLabel mesh__D006562 Herpes Zoster
% 222.65/222.82  |- mesh__recordOriginator mesh__D006562 NLM
% 222.65/222.82  |- mesh__dateCreated mesh__D006562 1999-01-01
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D006562 2006
% 222.65/222.82  |- skos__altLabel mesh__D006562 Zona
% 222.65/222.82  |- rdf__type mesh__D006562sskos__Concept
% 222.65/222.82  |- mesh__recordAuthorizer mesh__D006562 ags
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D006562 2006A
% 222.65/222.82  |- mesh__recordMaintainer mesh__D006562 ags
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Unsteady Gait
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Festinating Gait
% 222.65/222.82  |- skos__broader mesh__D020233smesh__D009461
% 222.65/222.82  |- mesh__dateCreated mesh__D020233 1999-11-08
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Charcot Gaits
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Gait, Duck
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Sensorimotor Gait Disorders
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Gait, Charcot%27%s
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Broadened Gait
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D020233 2003
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Scissors Gait
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Rigid Gait
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Spastic Gait
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Stumbling Gait
% 222.65/222.82  |- skos__altLabel mesh__D020233 Ambulation Disorders, Neurologic
% 222.65/222.82  |- mesh__dateRevised mesh__D020233 2001-07-25
% 222.65/222.82  |- mesh__publicMeSHNote mesh__D020233 2000   
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Widebased Gait
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Shuffling Gait
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Neurologic Ambulation Disorder
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Locomotion Disorder, Neurologic
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D020233 2006
% 222.65/222.82  |- skos__altLabel mesh__D020233 Locomotion Disorders, Neurologic
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Athetotic Gait
% 222.65/222.82  |- skos__altLabel mesh__D020233 Sensorimotor Gait Disorder
% 222.65/222.82  |- skos__altLabel mesh__D020233 Charcot%27%s Gait
% 222.65/222.82  |- skos__altLabel mesh__D020233 Neurologic Ambulation Disorders
% 222.65/222.82  |- mesh__recordMaintainer mesh__D020233 nns
% 222.65/222.82  |- mesh__historyNote mesh__D020233 2000   
% 222.65/222.82  |- mesh__recordAuthorizer mesh__D020233 sjn
% 222.65/222.82  |- mesh__dateEstablished mesh__D020233 2000-01-01
% 222.65/222.82  |- rdf__type mesh__D020233sskos__Concept
% 222.65/222.82  |- skos__altLabel mesh__D020233 Gait Dysfunction, Neurologic
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Gait, Charcot
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D020233 2005
% 222.65/222.82  |- skos__annotation mesh__D020233 LAMENESS, ANIMAL is also available   
% 222.65/222.82  |- skos__prefLabel mesh__D020233 Gait Disorders, Neurologic
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Neurologic Gait Disorders
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Neurologic Locomotion Disorder
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Gaits, Charcot
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Hysterical Gait
% 222.65/222.82  |- mesh__recordOriginator mesh__D020233 KEV
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Gait Disorder, Neurologic
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Ambulation Disorder, Neurologic
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Shuffling Gaits
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Foot Gait, Drop
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Reeling Gait
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Neurologic Gait Dysfunctions
% 222.65/222.82  |- skos__altLabel mesh__D020233 Neurologic Locomotion Disorders
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Hemiplegic Gait
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Neurologic Gait Dysfunction
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Drop Foot Gait
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D020233 2004
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Gait Disorders, Sensorimotor
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Frontal Gait
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D020233 2002
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Charcots Gait
% 222.65/222.82  |- skos__historyNote mesh__D020233 Gait %28%1965-1999%29%
% 222.65/222.82  |- skos__scopeNote mesh__D020233
% 222.65/222.82       Gait abnormalities that are a manifestation of nervous system dysfunction. These conditions may be caused by a wide variety of disorders which affect motor control, sensory feedback, and muscle strength including: CENTRAL NERVOUS SYSTEM DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; or MUSCULAR DISEASES.%A%    
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Neurologic Gait Disorder
% 222.65/222.82  |- skos__hiddenLabel mesh__D020233 Gait Dysfunctions, Neurologic
% 222.65/222.82  |- rdf__type mesh__D016990sskos__Concept
% 222.65/222.82  |- mesh__dateRevised mesh__D016990 2005-06-30
% 222.65/222.82  |- skos__prefLabel mesh__D016990 Ureaplasma urealyticum
% 222.65/222.82  |- mesh__dateCreated mesh__D016990 1991-05-30
% 222.65/222.82  |- mesh__dateEstablished mesh__D016990 1992-01-01
% 222.65/222.82  |- skos__scopeNote mesh__D016990
% 222.65/222.82       A species of gram-negative bacteria found in the human genitourinary tract %28%UROGENITAL SYSTEM%29%, oropharynx, and anal canal. Serovars 1, 3, 6, and 14 have been reclassed into a separate species UREAPLASMA parvum.%A%    
% 222.65/222.82  |- mesh__historyNote mesh__D016990 92   
% 222.65/222.82  |- skos__historyNote mesh__D016990 Ureaplasma %28%1976-1991%29%
% 222.65/222.82  |- mesh__publicMeSHNote mesh__D016990 92   
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D016990 2006
% 222.65/222.82  |- skos__altLabel mesh__D016990 Ureaplasma urealyticum biovar 2
% 222.65/222.82  |- mesh__recordOriginator mesh__D016990 PXP
% 222.65/222.82  |- skos__annotation mesh__D016990
% 222.65/222.82       infection: coord IM with UREAPLASMA INFECTIONS %28%IM%29%   
% 222.65/222.82  |- mesh__recordAuthorizer mesh__D016990 sjn
% 222.65/222.82  |- mesh__recordMaintainer mesh__D016990 SYSTEM
% 222.65/222.82  |- skos__broader mesh__D016990smesh__D014509
% 222.65/222.82  |- mesh__recordMaintainer mesh__D030661 jls
% 222.65/222.82  |- mesh__recordAuthorizer mesh__D030661 jls
% 222.65/222.82  |- mesh__dateRevised mesh__D030661 2002-10-31
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D030661 2006
% 222.65/222.82  |- skos__hiddenLabel mesh__D030661 Privacy, Genetic
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D030661 2004
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D030661 2003A
% 222.65/222.82  |- skos__scopeNote mesh__D030661
% 222.65/222.82       The protection of genetic information about an individual, family, or population group, from unauthorized disclosure.%A%    
% 222.65/222.82  |- skos__broader mesh__D030661smesh__D003219
% 222.65/222.82  |- skos__prefLabel mesh__D030661 Genetic Privacy
% 222.65/222.82  |- skos__hiddenLabel mesh__D030661 Information, Personal Genetic
% 222.65/222.82  |- skos__historyNote mesh__D030661 Confidentiality %28%1977-2001%29%
% 222.65/222.82  |- mesh__historyNote mesh__D030661 2002   
% 222.65/222.82  |- skos__historyNote mesh__D030661 Privacy %28%1995-2001%29%
% 222.65/222.82  |- mesh__publicMeSHNote mesh__D030661 2002   
% 222.65/222.82  |- mesh__recordOriginator mesh__D030661 nns
% 222.65/222.82  |- rdf__type mesh__D030661sskos__Concept
% 222.65/222.82  |- skos__related mesh__D030661smesh__D016172
% 222.65/222.82  |- mesh__dateCreated mesh__D030661 2001-07-25
% 222.65/222.82  |- skos__related mesh__D030661smesh__D005820
% 222.65/222.82  |- mesh__dateEstablished mesh__D030661 2002-01-01
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D030661 2005
% 222.65/222.82  |- skos__altLabel mesh__D030661 Personal Genetic Information
% 222.65/222.82  |- skos__related mesh__D030661smesh__D010375
% 222.65/222.82  |- skos__broader mesh__D030661smesh__D018907
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D030661 2003
% 222.65/222.82  |- mesh__historyNote mesh__D016192
% 222.65/222.82       1991; for RESTING PHASE use INTERPHASE %28%1997-2004%29%   
% 222.65/222.82  |- skos__historyNote mesh__D016192 Interphase %28%1978-1990%29%
% 222.65/222.82  |- skos__prefLabel mesh__D016192 G0 Phase
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D016192 2005
% 222.65/222.82  |- mesh__dateEstablished mesh__D016192 1991-01-01
% 222.65/222.82  |- mesh__publicMeSHNote mesh__D016192
% 222.65/222.82       1991; for RESTING PHASE see INTERPHASE %28%1997-2004%29%   
% 222.65/222.82  |- rdf__type mesh__D016192sskos__Concept
% 222.65/222.82  |- skos__hiddenLabel mesh__D016192 Phase, G0
% 222.65/222.82  |- skos__historyNote mesh__D016192 Cell Division %28%1968-1977%29%
% 222.65/222.82  |- skos__scopeNote mesh__D016192
% 222.65/222.82       A quiescent state of cells during G1 PHASE.     
% 222.65/222.82  |- mesh__dateCreated mesh__D016192 1990-04-24
% 222.65/222.82  |- mesh__recordMaintainer mesh__D016192 lkt
% 222.65/222.82  |- skos__hiddenLabel mesh__D016192 Phases, G0
% 222.65/222.82  |- mesh__recordAuthorizer mesh__D016192 sjn
% 222.65/222.82  |- skos__hiddenLabel mesh__D016192 G0 Phases
% 222.65/222.82  |- mesh__recordOriginator mesh__D016192 AGS
% 222.65/222.82  |- skos__broader mesh__D016192smesh__D007399
% 222.65/222.82  |- mesh__dateRevised mesh__D016192 2004-07-07
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D016192 2006
% 222.65/222.82  |- skos__prefLabel mesh__D002970 Cleavage Stage, Ovum
% 222.65/222.82  |- skos__broader mesh__D002970smesh__D004622
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D002970 2003
% 222.65/222.82  |- skos__hiddenLabel mesh__D002970 Ovum Segmentation Stages
% 222.65/222.82  |- mesh__publicMeSHNote mesh__D002970 80   
% 222.65/222.82  |- skos__hiddenLabel mesh__D002970 Ovum Cleavage Stages
% 222.65/222.82  |- skos__annotation mesh__D002970
% 222.65/222.82       note category; %22%the embryo in its earliest stage%22%   
% 222.65/222.82  |- mesh__recordAuthorizer mesh__D002970 sjn
% 222.65/222.82  |- mesh__recordOriginator mesh__D002970 AEP
% 222.65/222.82  |- skos__hiddenLabel mesh__D002970 Ovum Segmentation Stage
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D002970 2004
% 222.65/222.82  |- skos__hiddenLabel mesh__D002970 Ovum Cleavage Stage
% 222.65/222.82  |- mesh__dateRevised mesh__D002970 2002-07-03
% 222.65/222.82  |- skos__historyNote mesh__D002970 Cell Division %28%1966-1979%29%
% 222.65/222.82  |- mesh__dateCreated mesh__D002970 1979-04-17
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D002970 2005
% 222.65/222.82  |- rdf__type mesh__D002970sskos__Concept
% 222.65/222.82  |- mesh__recordMaintainer mesh__D002970 lkt
% 222.65/222.82  |- skos__broader mesh__D002970smesh__D004625
% 222.65/222.82  |- skos__historyNote mesh__D002970 Ovum %28%1966-1979%29%
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D002970 2006
% 222.65/222.82  |- skos__hiddenLabel mesh__D002970 Cleavage Stages, Ovum
% 222.65/222.82  |- mesh__historyNote mesh__D002970 80   
% 222.65/222.82  |- skos__scopeNote mesh__D002970
% 222.65/222.82       The embryo in its earliest stage, lasting from the first mitotic division of the fertilized ovum %28%ZYGOTE%29% into two BLASTOMERES to the formation of the MORULA, a compact mass of blastomeres.%A%    
% 222.65/222.82  |- skos__related mesh__D002970smesh__D002455
% 222.65/222.82  |- skos__historyNote mesh__D002970 Zygote %28%1975-1979%29%
% 222.65/222.82  |- skos__historyNote mesh__D002970 Mitosis %28%1968-1979%29%
% 222.65/222.82  |- mesh__dateEstablished mesh__D002970 1980-01-01
% 222.65/222.82  |- skos__altLabel mesh__D002970 Segmentation Stage, Ovum
% 222.65/222.82  |- skos__hiddenLabel mesh__D002970 Segmentation Stages, Ovum
% 222.65/222.82  |- skos__broader mesh__D004622Q000293smesh__D004622
% 222.65/222.82  |- mesh__preferredCombination mesh__D004622Q000293smesh__D049188
% 222.65/222.82  |- rdf__type mesh__D004622Q000293smesh__CompoundConcept
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D002172 2005
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D002172 1998
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D002172 2003
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D002172 1996
% 222.65/222.82  |- skos__broader mesh__D002172smesh__D000596
% 222.65/222.82  |- rdf__type mesh__D002172sskos__Concept
% 222.65/222.82  |- mesh__recordMaintainer mesh__D002172 TAP
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D002172 2001
% 222.65/222.82  |- mesh__dateRevised mesh__D002172 1992-05-11
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D002172 2000
% 222.65/222.82  |- skos__prefLabel mesh__D002172 Canavanine
% 222.65/222.82  |- mesh__recordOriginator mesh__D002172 NLM
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D002172 1995
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D002172 1993
% 222.65/222.82  |- mesh__dateCreated mesh__D002172 1999-01-01
% 222.65/222.82  |- skos__annotation mesh__D002172 an amino acid   
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D002172 1994
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D002172 2006
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D002172 1999
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D002172 2002
% 222.65/222.82  |- mesh__recordAuthorizer mesh__D002172 PLS
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D002172 2004
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D002172 1997
% 222.65/222.82  |- rdf__type mesh__D010604sskos__Concept
% 222.65/222.82  |- skos__scopeNote mesh__D010604
% 222.65/222.82       The practice of compounding and dispensing medicinal preparations.%A%    
% 222.65/222.82  |- skos__related mesh__D010604smesh__D013678
% 222.65/222.82  |- mesh__recordOriginator mesh__D010604 NLM
% 222.65/222.82  |- skos__related mesh__D010604smesh__D010607
% 222.65/222.82  |- skos__related mesh__D010604smesh__D007885
% 222.65/222.82  |- mesh__dateRevised mesh__D010604 2003-07-14
% 222.65/222.82  |- skos__related mesh__D010604smesh__D003157
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D010604 2004
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D010604 2005
% 222.65/222.82  |- mesh__recordMaintainer mesh__D010604 jls
% 222.65/222.82  |- skos__annotation mesh__D010604
% 222.65/222.82       the field: do not confuse with PHARMACIES; /legislation %26% jurisprudence = LEGISLATION, PHARMACY or PHARMACY %28%IM%29% + JURISPRUDENCE %28%IM%29%; /methods: consider TECHNOLOGY, PHARMACEUTICAL%A%  
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D010604 2006
% 222.65/222.82  |- skos__broader mesh__D010604smesh__D006281
% 222.65/222.82  |- skos__related mesh__D010604smesh__D011307
% 222.65/222.82  |- mesh__dateCreated mesh__D010604 1999-01-01
% 222.65/222.82  |- skos__related mesh__D010604smesh__D004512
% 222.65/222.82  |- mesh__recordAuthorizer mesh__D010604 sjn
% 222.65/222.82  |- skos__prefLabel mesh__D010604 Pharmacy
% 222.65/222.82  |- skos__hiddenLabel mesh__D015898 X-Ray CAT Scanner
% 222.65/222.82  |- skos__altLabel mesh__D015898 X-Ray Computed Tomography Scanner
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D015898 1999
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D015898 2002
% 222.65/222.82  |- mesh__dateEstablished mesh__D015898 1990-01-01
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D015898 2004
% 222.65/222.82  |- skos__altLabel mesh__D015898 Tomography, X-Ray Computed, Scanner
% 222.65/222.82  |- skos__altLabel mesh__D015898 Computed Tomography Scanners, X-Ray
% 222.65/222.82  |- skos__altLabel mesh__D015898 X-Ray Computed Tomography Scanners
% 222.65/222.82  |- mesh__historyNote mesh__D015898 90   
% 222.65/222.82  |- skos__prefLabel mesh__D015898 Tomography Scanners, X-Ray Computed
% 222.65/222.82  |- skos__altLabel mesh__D015898 Computed Tomography Scanner, X-Ray
% 222.65/222.82  |- skos__hiddenLabel mesh__D015898 X-Ray CAT Scanners
% 222.65/222.82  |- skos__hiddenLabel mesh__D015898 Tomography Scanners, X Ray Computed
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D015898 1996
% 222.65/222.82  |- skos__annotation mesh__D015898 DF: CT SCANNERS X RAY   
% 222.65/222.82  |- skos__altLabel mesh__D015898 CAT Scanner, X-Ray
% 222.65/222.82  |- mesh__recordMaintainer mesh__D015898 TGC
% 222.65/222.82  |- skos__altLabel mesh__D015898 Tomography, X-Ray Computed, Scanners
% 222.65/222.82  |- skos__historyNote mesh__D015898
% 222.65/222.82       Tomography, X-Ray Computed/instrumentation %28%1977-1989%29%
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D015898 1997
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D015898 2005
% 222.65/222.82  |- skos__scopeNote mesh__D015898
% 222.65/222.82       X-ray image-detecting devices that make a focused image of body structures lying in a predetermined plane from which more complex images are computed.%A%    
% 222.65/222.82  |- skos__related mesh__D015898smesh__D011856
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D015898 2000
% 222.65/222.82  |- skos__hiddenLabel mesh__D015898 X Ray Computed Tomography Scanners
% 222.65/222.82  |- mesh__recordOriginator mesh__D015898 PLS
% 222.65/222.82  |- skos__hiddenLabel mesh__D015898 Computed Tomography Scanner, X Ray
% 222.65/222.82  |- mesh__publicMeSHNote mesh__D015898 90   
% 222.65/222.82  |- skos__hiddenLabel mesh__D015898 Computed Tomography Scanners, X Ray
% 222.65/222.82  |- mesh__recordAuthorizer mesh__D015898 PLS
% 222.65/222.82  |- skos__hiddenLabel mesh__D015898 Scanners, X-Ray CAT
% 222.65/222.82  |- mesh__dateCreated mesh__D015898 1989-05-16
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D015898 2006
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D015898 2001
% 222.65/222.82  |- skos__altLabel mesh__D015898 CAT Scanners, X-Ray
% 222.65/222.82  |- skos__hiddenLabel mesh__D015898 Scanner, X-Ray CAT
% 222.65/222.82  |- skos__hiddenLabel mesh__D015898 CAT Scanners, X Ray
% 222.65/222.82  |- skos__broader mesh__D015898smesh__D004864
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D015898 1998
% 222.65/222.82  |- skos__historyNote mesh__D015898
% 222.65/222.82       Tomography, X-Ray/instrumentation %28%1974-1976%29%
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D015898 1995
% 222.65/222.82  |- mesh__dateRevised mesh__D015898 1994-05-27
% 222.65/222.82  |- skos__hiddenLabel mesh__D015898 X Ray Computed Tomography Scanner
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D015898 2003
% 222.65/222.82  |- skos__hiddenLabel mesh__D015898 CAT Scanner, X Ray
% 222.65/222.82  |- rdf__type mesh__D015898sskos__Concept
% 222.65/222.82  |- mesh__dateCreated mesh__D001878 1999-01-01
% 222.65/222.82  |- skos__prefLabel mesh__D001878 Books, Illustrated
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D001878 2005
% 222.65/222.82  |- skos__altLabel mesh__D001878 Illustrated Books
% 222.65/222.82  |- skos__broader mesh__D001878smesh__D001296
% 222.65/222.82  |- mesh__dateRevised mesh__D001878 2004-07-07
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D001878 2006
% 222.65/222.82  |- skos__hiddenLabel mesh__D001878 Illustrated Book
% 222.65/222.82  |- mesh__recordOriginator mesh__D001878 NLM
% 222.65/222.82  |- mesh__recordAuthorizer mesh__D001878 sjn
% 222.65/222.82  |- skos__hiddenLabel mesh__D001878 Illustration, Book
% 222.65/222.82  |- mesh__recordMaintainer mesh__D001878 ags
% 222.65/222.82  |- skos__annotation mesh__D001878
% 222.65/222.82       IM; coord with subject %28%IM%29% or type of illus %28%IM%29%; do not confuse X ref BOOK ILLUSTRATION with Publication Type BOOK ILLUSTRATIONS%A%  
% 222.65/222.82  |- skos__hiddenLabel mesh__D001878 Book Illustrations
% 222.65/222.82  |- skos__scopeNote mesh__D001878
% 222.65/222.82       Books containing photographs, prints, drawings, portraits, plates, diagrams, facsimiles, maps, tables, or other representations or systematic arrangement of data designed to elucidate or decorate its contents. %28%From The ALA Glossary of Library and Information Science, 1983, p114%29%%A%    
% 222.65/222.82  |- skos__hiddenLabel mesh__D001878 Illustrations, Book
% 222.65/222.82  |- skos__hiddenLabel mesh__D001878 Book, Illustrated
% 222.65/222.82  |- skos__broader mesh__D001878smesh__D001877
% 222.65/222.82  |- rdf__type mesh__D001878sskos__Concept
% 222.65/222.82  |- skos__broader mesh__D006563smesh__D015828
% 222.65/222.82  |- mesh__dateRevised mesh__D006563 2004-07-13
% 222.65/222.82  |- rdf__type mesh__D006563sskos__Concept
% 222.65/222.82  |- skos__scopeNote mesh__D006563
% 222.65/222.82       Virus infection of the Gasserian ganglion and its nerve branches characterized by pain and vesicular eruptions with much swelling. Ocular involvement is usually heralded by a vesicle on the tip of the nose. This area is innervated by the nasociliary nerve.%A%    
% 222.65/222.82  |- skos__hiddenLabel mesh__D006563 Ocular Herpes Zoster
% 222.65/222.82  |- skos__altLabel mesh__D006563 Herpes Zoster, Ocular
% 222.65/222.82  |- mesh__publicMeSHNote mesh__D006563
% 222.65/222.82       90; was HERPES ZOSTER, OCULAR 1963-89   
% 222.65/222.82  |- skos__annotation mesh__D006563
% 222.65/222.82       caused by human herpesvirus 3 %28%OCULAR HERPES ZOSTER VIRUS see HERPESVIRUS 3, HUMAN%29%%A%  
% 222.65/222.82  |- mesh__historyNote mesh__D006563 90; was HERPES ZOSTER, OCULAR 1963-89   
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D006563 2006
% 222.65/222.82  |- skos__broader mesh__D006563smesh__D006562
% 222.65/222.82  |- mesh__recordAuthorizer mesh__D006563 sjn
% 222.65/222.82  |- mesh__recordOriginator mesh__D006563 NLM
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D006563 2005
% 222.65/222.82  |- mesh__recordMaintainer mesh__D006563 sjn
% 222.65/222.82  |- mesh__onlineNote mesh__D006563
% 222.65/222.82       use HERPES ZOSTER OPHTHALMICUS to search HERPES ZOSTER, OCULAR 1966-89%A%  
% 222.65/222.82  |- mesh__dateCreated mesh__D006563 1999-01-01
% 222.65/222.82  |- skos__prefLabel mesh__D006563 Herpes Zoster Ophthalmicus
% 222.65/222.82  |- skos__scopeNote mesh__D020234
% 222.65/222.82       Impairment of the ability to coordinate the movements required for normal ambulation %28%WALKING%29% which may result from impairments of motor function or sensory feedback. This condition may be associated with BRAIN DISEASES %28%including CEREBELLAR DISEASES and BASAL GANGLIA DISEASES%29%; SPINAL CORD DISEASES; or PERIPHERAL NERVOUS SYSTEM DISEASES.%A%    
% 222.65/222.82  |- skos__altLabel mesh__D020234 Ataxia of Gait
% 222.65/222.82  |- skos__hiddenLabel mesh__D020234 Gait Ataxia, Cerebellar
% 222.65/222.82  |- rdf__type mesh__D020234sskos__Concept
% 222.65/222.82  |- skos__hiddenLabel mesh__D020234 Gait Ataxias, Sensory
% 222.65/222.82  |- skos__hiddenLabel mesh__D020234 Gait Ataxias, Cerebellar
% 222.65/222.82  |- skos__hiddenLabel mesh__D020234 Cerebellar Gaits
% 222.65/222.82  |- mesh__recordOriginator mesh__D020234 KEV
% 222.65/222.82  |- skos__hiddenLabel mesh__D020234 Ataxias, Cerebellar Gait
% 222.65/222.82  |- skos__hiddenLabel mesh__D020234 Ataxia, Gait
% 222.65/222.82  |- skos__hiddenLabel mesh__D020234 Cerebellar Gait Ataxias
% 222.65/222.82  |- skos__altLabel mesh__D020234 Cerebellar Gait
% 222.65/222.82  |- skos__hiddenLabel mesh__D020234 Gaits, Cerebellar
% 222.65/222.82  |- mesh__publicMeSHNote mesh__D020234 2000   
% 222.65/222.82  |- skos__historyNote mesh__D020234 Gait %28%1966-1999%29%
% 222.65/222.82  |- skos__hiddenLabel mesh__D020234 Sensory Gait Ataxias
% 222.65/222.82  |- mesh__recordAuthorizer mesh__D020234 sjn
% 222.65/222.82  |- skos__hiddenLabel mesh__D020234 Ataxias, Gait
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D020234 2006
% 222.65/222.82  |- skos__hiddenLabel mesh__D020234 Sensory Gait Ataxia
% 222.65/222.82  |- mesh__recordMaintainer mesh__D020234 nns
% 222.65/222.82  |- skos__hiddenLabel mesh__D020234 Gait, Cerebellar
% 222.65/222.82  |- mesh__dateEstablished mesh__D020234 2000-01-01
% 222.65/222.82  |- skos__broader mesh__D020234smesh__D001259
% 222.65/222.82  |- skos__hiddenLabel mesh__D020234 Ataxias, Sensory Gait
% 222.65/222.82  |- mesh__historyNote mesh__D020234 2000   
% 222.65/222.82  |- mesh__dateRevised mesh__D020234 2005-06-30
% 222.65/222.82  |- skos__hiddenLabel mesh__D020234 Ataxia, Sensory Gait
% 222.65/222.82  |- skos__prefLabel mesh__D020234 Gait Ataxia
% 222.65/222.82  |- skos__broader mesh__D020234smesh__D020233
% 222.65/222.82  |- skos__hiddenLabel mesh__D020234 Gait Ataxias
% 222.65/222.82  |- mesh__dateCreated mesh__D020234 1999-11-04
% 222.65/222.82  |- skos__hiddenLabel mesh__D020234 Ataxia, Cerebellar Gait
% 222.65/222.82  |- skos__historyNote mesh__D020234 Ataxia %28%1966-1999%29%
% 222.65/222.82  |- skos__historyNote mesh__D044682 Colonic Diseases %28%1965-2003%29%
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D044682 2005
% 222.65/222.82  |- rdf__type mesh__D044682sskos__Concept
% 222.65/222.82  |- skos__broader mesh__D044682smesh__D003106
% 222.65/222.82  |- skos__hiddenLabel mesh__D044682 Colic Flexure, Right
% 222.65/222.82  |- skos__altLabel mesh__D044682 Hepatic Flexture
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D044682 2004
% 222.65/222.82  |- mesh__dateEstablished mesh__D044682 2004-01-01
% 222.65/222.82  |- skos__historyNote mesh__D044682 Colon %28%1965-2003%29%
% 222.65/222.82  |- mesh__publicMeSHNote mesh__D044682 2004   
% 222.65/222.82  |- mesh__historyNote mesh__D044682 2004   
% 222.65/222.82  |- skos__altLabel mesh__D044682 Ascending Colon
% 222.65/222.82  |- mesh__dateCreated mesh__D044682 2003-07-09
% 222.65/222.82  |- skos__scopeNote mesh__D044682
% 222.65/222.82       The segment of LARGE INTESTINE between the CECUM and the TRANSVERSE COLON. It passes cephalad from the cecum to the caudal surface of the right lobe of the LIVER where it bends sharply to the left, forming the right colic flexure.%A%    
% 222.65/222.82  |- skos__hiddenLabel mesh__D044682 Hepatic Flextures
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D044682 2006
% 222.65/222.82  |- skos__prefLabel mesh__D044682 Colon, Ascending
% 222.65/222.82  |- mesh__activeMeSHYear mesh__D016991 2006
% 222.65/222.82  |- skos__broader mesh__D016991smesh__D008973
% 222.65/222.82  |- mesh__dateEstablished mesh__D016991 1992-01-01
% 222.65/222.82  |- mesh__dateRevised mesh__D016991 2005-06-30
% 222.65/222.82  |- mesh__recordMaintainer mesh__D016991 SYSTEM
% 222.65/222.82  |- mesh__recordOriginator mesh__D016991 PXP
% 222.65/222.82  |- mesh__publicMeSHNote mesh__D016991 92   
% 222.65/222.83  |- skos__prefLabel mesh__D016991 Spiroplasmataceae
% 222.65/222.83  |- rdf__type mesh__D016991sskos__Concept
% 222.65/222.83  |- skos__scopeNote mesh__D016991
% 222.65/222.83       A family of gram-negative, helical bacteria in the order Entomoplasmatales, that require STEROLS for growth.%A%    
% 222.65/222.83  |- mesh__dateCreated mesh__D016991 1991-05-30
% 222.65/222.83  |- mesh__historyNote mesh__D016991 92   
% 222.65/222.83  |- mesh__recordAuthorizer mesh__D016991 sjn
% 222.65/222.83  |- skos__hiddenLabel mesh__D016193 Phases, G1b
% 222.65/222.83  |- rdf__type mesh__D016193sskos__Concept
% 222.65/222.83  |- skos__historyNote mesh__D016193 Cell Division %28%1966-1977%29%
% 222.65/222.83  |- skos__hiddenLabel mesh__D016193 1, Gap Phase
% 222.65/222.83  |- skos__prefLabel mesh__D016193 G1 Phase
% 222.65/222.83  |- mesh__recordAuthorizer mesh__D016193 sjn
% 222.65/222.83  |- skos__hiddenLabel mesh__D016193 Phases, First Gap
% 222.65/222.83  |- mesh__recordOriginator mesh__D016193 AGS
% 222.65/222.83  |- mesh__historyNote mesh__D016193 91   
% 222.65/222.83  |- mesh__publicMeSHNote mesh__D016193 91   
% 222.65/222.83  |- skos__hiddenLabel mesh__D016193 Phase 1, Gap
% 222.65/222.83  |- skos__hiddenLabel mesh__D016193 Gap Phases, First
% 222.65/222.83  |- skos__hiddenLabel mesh__D016193 G1 Phases
% 222.65/222.83  |- skos__altLabel mesh__D016193 Gap Phase 1
% 222.65/222.83  |- skos__hiddenLabel mesh__D016193 Phases, G1
% 222.65/222.83  |- skos__hiddenLabel mesh__D016193 Phases, G1a
% 222.65/222.83  |- skos__hiddenLabel mesh__D016193 G1a Phases
% 222.65/222.83  |- skos__hiddenLabel mesh__D016193 First Gap Phases
% 222.65/222.83  |- skos__broader mesh__D016193smesh__D007399
% 222.65/222.83  |- skos__hiddenLabel mesh__D016193 Gap Phase, First
% 222.65/222.83  |- mesh__dateRevised mesh__D016193 2004-07-07
% 222.65/222.83  |- skos__altLabel mesh__D016193 First Gap Phase
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D016193 2006
% 222.65/222.83  |- skos__historyNote mesh__D016193 Interphase %28%1978-1990%29%
% 222.65/222.83  |- skos__hiddenLabel mesh__D016193 Phase, G1b
% 222.65/222.83  |- skos__hiddenLabel mesh__D016193 Phase, G1
% 222.65/222.83  |- mesh__dateCreated mesh__D016193 1990-04-24
% 222.65/222.83  |- mesh__recordMaintainer mesh__D016193 lkt
% 222.65/222.83  |- skos__scopeNote mesh__D016193
% 222.65/222.83       The period of the CELL CYCLE preceding DNA REPLICATION in S PHASE. Subphases of G1 include %22%competence%22% %28%to respond to growth factors%29%,  G1a %28%entry into G1%29%, G1b %28%progression%29%, and G1c %28%assembly%29%. Progression through the G1 subphases is effected by limiting growth factors, nutrients, or inhibitors.%A%    
% 222.65/222.83  |- skos__hiddenLabel mesh__D016193 Phase, G1a
% 222.65/222.83  |- skos__hiddenLabel mesh__D016193 Phase, First Gap
% 222.65/222.83  |- mesh__dateEstablished mesh__D016193 1991-01-01
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D016193 2005
% 222.65/222.83  |- skos__hiddenLabel mesh__D016193 G1b Phases
% 222.65/222.83  |- mesh__recordOriginator mesh__D002971 NLM
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002971 2005
% 222.65/222.83  |- mesh__publicMeSHNote mesh__D002971 65; was HARELIP 1963-64   
% 222.65/222.83  |- skos__broader mesh__D002971smesh__D008047
% 222.65/222.83  |- skos__scopeNote mesh__D002971
% 222.65/222.83       Congenital defect in the upper lip where the maxillary prominence fails to merge with the merged medial nasal prominences. It is thought to be caused by faulty migration of the mesoderm in the head region.%A%    
% 222.65/222.83  |- skos__prefLabel mesh__D002971 Cleft Lip
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002971 2000
% 222.65/222.83  |- skos__hiddenLabel mesh__D002971 Harelips
% 222.65/222.83  |- skos__hiddenLabel mesh__D002971 Lips, Cleft
% 222.65/222.83  |- mesh__recordMaintainer mesh__D002971 kle
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002971 2004
% 222.65/222.83  |- mesh__dateEstablished mesh__D002971 1965-01-01
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002971 2003
% 222.65/222.83  |- mesh__historyNote mesh__D002971 65; was HARELIP 1963-64   
% 222.65/222.83  |- skos__broader mesh__D002971smesh__D009056
% 222.65/222.83  |- mesh__recordAuthorizer mesh__D002971 sjn
% 222.65/222.83  |- rdf__type mesh__D002971sskos__Concept
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002971 2002
% 222.65/222.83  |- skos__hiddenLabel mesh__D002971 Lip, Cleft
% 222.65/222.83  |- mesh__dateCreated mesh__D002971 1999-01-01
% 222.65/222.83  |- skos__altLabel mesh__D002971 Harelip
% 222.65/222.83  |- mesh__dateRevised mesh__D002971 1999-11-03
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002971 2006
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002971 2001
% 222.65/222.83  |- skos__annotation mesh__D002971
% 222.65/222.83       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; when with CLEFT PALATE, do not also use ABNORMALITIES, MULTIPLE%A%  
% 222.65/222.83  |- skos__hiddenLabel mesh__D002971 Cleft Lips
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002173 1995
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002173 1993
% 222.65/222.83  |- skos__hiddenLabel mesh__D002173 Facility, Cancer Care
% 222.65/222.83  |- mesh__dateCreated mesh__D002173 1977-05-19
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002173 2002
% 222.65/222.83  |- mesh__publicMeSHNote mesh__D002173
% 222.65/222.83       91; was see under HOSPITALS, SPECIAL Aug 1977-90   
% 222.65/222.83  |- mesh__recordAuthorizer mesh__D002173 PLS
% 222.65/222.83  |- skos__hiddenLabel mesh__D002173 Cancer Hospitals
% 222.65/222.83  |- mesh__dateEstablished mesh__D002173 1991-01-01
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002173 1994
% 222.65/222.83  |- skos__prefLabel mesh__D002173 Cancer Care Facilities
% 222.65/222.83  |- skos__related mesh__D002173smesh__D016522
% 222.65/222.83  |- skos__scopeNote mesh__D002173
% 222.65/222.83       Institutions specializing in the care of cancer patients.%A%    
% 222.65/222.83  |- mesh__recordMaintainer mesh__D002173 TGC
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002173 2006
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002173 1999
% 222.65/222.83  |- skos__hiddenLabel mesh__D002173 Cancer Hospital
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002173 2004
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002173 1997
% 222.65/222.83  |- skos__hiddenLabel mesh__D002173 Facilities, Cancer Care
% 222.65/222.83  |- skos__hiddenLabel mesh__D002173 Cancer Care Facility
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002173 2005
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002173 1998
% 222.65/222.83  |- skos__broader mesh__D002173smesh__D006782
% 222.65/222.83  |- mesh__historyNote mesh__D002173
% 222.65/222.83       91%28%Aug 77%29%; was see under HOSPITALS, SPECIAL 1977-90   
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002173 2001
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002173 2003
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002173 1996
% 222.65/222.83  |- skos__hiddenLabel mesh__D002173 Hospital, Cancer
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002173 2000
% 222.65/222.83  |- rdf__type mesh__D002173sskos__Concept
% 222.65/222.83  |- mesh__recordOriginator mesh__D002173 EC
% 222.65/222.83  |- mesh__dateRevised mesh__D002173 1992-05-07
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010605 2000
% 222.65/222.83  |- skos__broader mesh__D010605smesh__D009934
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010605 2003
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010605 2001
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010605 1995
% 222.65/222.83  |- skos__altLabel mesh__D010605 Administrations, Pharmacy
% 222.65/222.83  |- skos__historyNote mesh__D010605 Pharmacy %28%1966-1967%29%
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010605 2005
% 222.65/222.83  |- skos__prefLabel mesh__D010605 Pharmacy Administration
% 222.65/222.83  |- skos__altLabel mesh__D010605 Pharmacy Administrations
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010605 2004
% 222.65/222.83  |- skos__related mesh__D010605smesh__D007356
% 222.65/222.83  |- skos__annotation mesh__D010605
% 222.65/222.83       %22%the business %26% managerial aspects of pharmacy in its broadest sense%22%; SPEC; SPEC qualif; DF: PHARM ADMIN%A%  
% 222.65/222.83  |- mesh__historyNote mesh__D010605 68   
% 222.65/222.83  |- mesh__recordAuthorizer mesh__D010605 PLS
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010605 2006
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010605 1996
% 222.65/222.83  |- mesh__recordOriginator mesh__D010605 NLM
% 222.65/222.83  |- skos__historyNote mesh__D010605 Drug Industry %28%1966-1967%29%
% 222.65/222.83  |- mesh__recordMaintainer mesh__D010605 TGC
% 222.65/222.83  |- skos__altLabel mesh__D010605 Administration, Pharmacy
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010605 1998
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010605 2002
% 222.65/222.83  |- skos__related mesh__D010605smesh__D005252
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010605 1997
% 222.65/222.83  |- mesh__dateCreated mesh__D010605 1999-01-01
% 222.65/222.83  |- mesh__publicMeSHNote mesh__D010605 68   
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010605 1999
% 222.65/222.83  |- mesh__dateRevised mesh__D010605 1993-06-02
% 222.65/222.83  |- skos__scopeNote mesh__D010605
% 222.65/222.83       The business and managerial aspects of pharmacy in its broadest sense.%A%    
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010605 1994
% 222.65/222.83  |- rdf__type mesh__D010605sskos__Concept
% 222.65/222.83  |- mesh__dateEstablished mesh__D010605 1968-01-01
% 222.65/222.83  |- skos__historyNote mesh__D015899
% 222.65/222.83       Tomography, Emission-Computed %28%1980-1989%29%
% 222.65/222.83  |- skos__historyNote mesh__D015899
% 222.65/222.83       Tomography, X-Ray Computed %28%1977-1979%29%
% 222.65/222.83  |- mesh__dateEstablished mesh__D015899 1990-01-01
% 222.65/222.83  |- rdf__type mesh__D015899sskos__Concept
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D015899 2002
% 222.65/222.83  |- skos__annotation mesh__D015899
% 222.65/222.83       uses radionuclides %26% computer; do not use /util except by MeSH definition; DF: CT SINGLE PHOTON EMISS but note shorter X ref: SPECT%A%  
% 222.65/222.83  |- skos__altLabel mesh__D015899 Single-Photon Emission-Computed Tomography
% 222.65/222.83  |- skos__hiddenLabel mesh__D015899
% 222.65/222.83       Single Photon Emission Computed Tomography
% 222.65/222.83  |- skos__altLabel mesh__D015899 SPECT
% 222.65/222.83  |- mesh__historyNote mesh__D015899
% 222.65/222.83       90; was SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY %26% SPECT see TOMOGRAPHY, EMISSION-COMPUTED 1989%A%  
% 222.65/222.83  |- mesh__recordMaintainer mesh__D015899 PXP
% 222.65/222.83  |- skos__hiddenLabel mesh__D015899
% 222.65/222.83       Radionuclide Tomography, Single Photon Emission Computed
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D015899 2004
% 222.65/222.83  |- skos__broader mesh__D015899smesh__D014055
% 222.65/222.83  |- skos__altLabel mesh__D015899
% 222.65/222.83       Radionuclide Tomography, Single-Photon Emission-Computed
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D015899 2001
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D015899 1999
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D015899 2003
% 222.65/222.83  |- mesh__recordOriginator mesh__D015899 PLS
% 222.65/222.83  |- mesh__dateCreated mesh__D015899 1989-05-16
% 222.65/222.83  |- skos__scopeNote mesh__D015899
% 222.65/222.83       A method of computed tomography that uses radionuclides which emit a single photon of a given energy. The camera is rotated 180 or 360 degrees around the patient to capture images at multiple positions along the arc. The computer is then used to reconstruct the transaxial, sagittal, and coronal images from the 3-dimensional distribution of radionuclides in the organ. The advantages of SPECT are that it can be used to observe biochemical and physiological processes as well as size and volume of the organ. The disadvantage is that, unlike positron-emission tomography where the positron-electron annihilation results in the emission of 2 photons at 180 degrees from each other, SPECT requires physical collimation to line up the photons, which results in the loss of many available photons and hence degrades the image.%A%    
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D015899 2000
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D015899 1998
% 222.65/222.83  |- skos__hiddenLabel mesh__D015899
% 222.65/222.83       Tomography, Single-Photon Emission-Computed
% 222.65/222.83  |- skos__hiddenLabel mesh__D015899
% 222.65/222.83       Emission-Computed Tomography, Single-Photon
% 222.65/222.83  |- skos__prefLabel mesh__D015899
% 222.65/222.83       Tomography, Emission-Computed, Single-Photon
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D015899 2006
% 222.65/222.83  |- mesh__publicMeSHNote mesh__D015899
% 222.65/222.83       90; was SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY %26% SPECT see TOMOGRAPHY, EMISSION-COMPUTED 1989%A%  
% 222.65/222.83  |- mesh__dateRevised mesh__D015899 1997-06-20
% 222.65/222.83  |- skos__altLabel mesh__D015899
% 222.65/222.83       Tomography, Single-Photon, Emission-Computed
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D015899 2005
% 222.65/222.83  |- mesh__onlineNote mesh__D015899
% 222.65/222.83       use TOMOGRAPHY, EMISSION-COMPUTED to search SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY %26% SPECT 1989%A%  
% 222.65/222.83  |- mesh__recordAuthorizer mesh__D015899 SJN
% 222.65/222.83  |- skos__broader mesh__D001879smesh__D001870
% 222.65/222.83  |- rdf__type mesh__D001879sskos__Concept
% 222.65/222.83  |- skos__annotation mesh__D001879 IM   
% 222.65/222.83  |- mesh__dateCreated mesh__D001879 1999-01-01
% 222.65/222.83  |- skos__prefLabel mesh__D001879 Bookselling
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D001879 2001
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D001879 2006
% 222.65/222.83  |- mesh__recordMaintainer mesh__D001879 kle
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D001879 2000
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D001879 2004
% 222.65/222.83  |- skos__hiddenLabel mesh__D001879 Booksellings
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D001879 2005
% 222.65/222.83  |- mesh__recordOriginator mesh__D001879 NLM
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D001879 2003
% 222.65/222.83  |- mesh__dateRevised mesh__D001879 1999-11-08
% 222.65/222.83  |- mesh__recordAuthorizer mesh__D001879 sjn
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D001879 2002
% 222.65/222.83  |- skos__hiddenLabel mesh__D006564 Thymic Virus, Mouse
% 222.65/222.83  |- skos__hiddenLabel mesh__D006564 herpesvirus 3, Murid
% 222.65/222.83  |- skos__prefLabel mesh__D006564 Herpesviridae
% 222.65/222.83  |- mesh__historyNote mesh__D006564
% 222.65/222.83       81; was HERPESVIRUSES 1975-80, was HERPESVIRUS 1963-74; THYMIC GROUP VIRUSES was see MOUSE LEUKEMIA VIRUSES 1975-91%A%  
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D006564 2006
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D006564 2002
% 222.65/222.83  |- skos__scopeNote mesh__D006564
% 222.65/222.83       A family of enveloped, linear, double-stranded DNA viruses infecting a wide variety of animals. Subfamilies, based on biological characteristics, include: ALPHAHERPESVIRINAE; BETAHERPESVIRINAE; and GAMMAHERPESVIRINAE.%A%    
% 222.65/222.83  |- skos__hiddenLabel mesh__D006564 Thymic Viruses, Mouse
% 222.65/222.83  |- skos__altLabel mesh__D006564 Herpesviruses
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D006564 2005
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D006564 2004
% 222.65/222.83  |- skos__broader mesh__D006564smesh__D004267
% 222.65/222.83  |- mesh__dateCreated mesh__D006564 1999-01-01
% 222.65/222.83  |- skos__annotation mesh__D006564
% 222.65/222.83       GEN: prefer specifics; infection = HERPESVIRIDAE INFECTIONS%A%  
% 222.65/222.83  |- mesh__publicMeSHNote mesh__D006564
% 222.65/222.83       81; was HERPESVIRUSES 1975-80, was HERPESVIRUS 1963-74; THYMIC GROUP VIRUSES was see MOUSE LEUKEMIA VIRUSES 1975-91%A%  
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D006564 2003
% 222.65/222.83  |- skos__hiddenLabel mesh__D006564 Mouse Thymic Viruses
% 222.65/222.83  |- mesh__recordMaintainer mesh__D006564 ags
% 222.65/222.83  |- mesh__recordAuthorizer mesh__D006564 sjn
% 222.65/222.83  |- mesh__recordOriginator mesh__D006564 NLM
% 222.65/222.83  |- skos__altLabel mesh__D006564 Murid herpesvirus 3
% 222.65/222.83  |- mesh__dateRevised mesh__D006564 2001-07-25
% 222.65/222.83  |- mesh__onlineNote mesh__D006564
% 222.65/222.83       use HERPESVIRIDAE to search HERPESVIRUSES 1975-80 %26% HERPESVIRUS 1966-74; use MOUSE LEUKEMIA VIRUSES to search THYMIC GROUP VIRUSES 1975-91%A%  
% 222.65/222.83  |- rdf__type mesh__D006564sskos__Concept
% 222.65/222.83  |- skos__historyNote mesh__D020235 Apraxias %28%1965-1999%29%
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D020235 2002
% 222.65/222.83  |- skos__hiddenLabel mesh__D020235 Apraxia, Gait
% 222.65/222.83  |- skos__altLabel mesh__D020235 Dyspraxia of Gait
% 222.65/222.83  |- skos__hiddenLabel mesh__D020235 Bruns Apraxia, Gait
% 222.65/222.83  |- skos__hiddenLabel mesh__D020235 Gait Apraxia, Bruns%27%
% 222.65/222.83  |- skos__hiddenLabel mesh__D020235 Apraxias, Gait
% 222.65/222.83  |- skos__altLabel mesh__D020235 Bruns%27% Gait Apraxia
% 222.65/222.83  |- rdf__type mesh__D020235sskos__Concept
% 222.65/222.83  |- skos__hiddenLabel mesh__D020235 Bruns Gait Apraxia
% 222.65/222.83  |- skos__hiddenLabel mesh__D020235 Apraxias, Bruns%27% Gait
% 222.65/222.83  |- mesh__publicMeSHNote mesh__D020235 2000   
% 222.65/222.83  |- skos__hiddenLabel mesh__D020235 Frontal Gait Apraxias
% 222.65/222.83  |- skos__broader mesh__D020235smesh__D001072
% 222.65/222.83  |- skos__scopeNote mesh__D020235
% 222.65/222.83       Impaired ambulation not attributed to sensory impairment or motor weakness. FRONTAL LOBE disorders; BASAL GANGLIA DISEASES %28%e.g., PARKINSONIAN DISORDERS%29%; DEMENTIA, MULTI-INFARCT; ALZHEIMER DISEASE; and other conditions may be associated with gait apraxia.%A%    
% 222.65/222.83  |- skos__hiddenLabel mesh__D020235 Gait Apraxias
% 222.65/222.83  |- skos__historyNote mesh__D020235 Gait %28%1965-1999%29%
% 222.65/222.83  |- skos__hiddenLabel mesh__D020235 Bruns%27% Apraxia, Gait
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D020235 2001
% 222.65/222.83  |- skos__broader mesh__D020235smesh__D020233
% 222.65/222.83  |- skos__hiddenLabel mesh__D020235 Gait Apraxia, Frontal
% 222.65/222.83  |- mesh__dateCreated mesh__D020235 1999-11-08
% 222.65/222.83  |- skos__hiddenLabel mesh__D020235 Apraxias, Frontal Gait
% 222.65/222.83  |- skos__hiddenLabel mesh__D020235 Gait Apraxias, Frontal
% 222.65/222.83  |- skos__hiddenLabel mesh__D020235 Gait Apraxias, Bruns%27%
% 222.65/222.83  |- skos__altLabel mesh__D020235 Apraxia of Gait
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D020235 2006
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D020235 2000
% 222.65/222.83  |- skos__hiddenLabel mesh__D020235 Gait Dyspraxias
% 222.65/222.83  |- mesh__dateEstablished mesh__D020235 2000-01-01
% 222.65/222.83  |- skos__hiddenLabel mesh__D020235 Gait Dyspraxia
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D020235 2004
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D020235 2005
% 222.65/222.83  |- skos__hiddenLabel mesh__D020235 Bruns%27% Gait Apraxias
% 222.65/222.83  |- skos__hiddenLabel mesh__D020235 Apraxia, Frontal Gait
% 222.65/222.83  |- skos__prefLabel mesh__D020235 Gait Apraxia
% 222.65/222.83  |- skos__hiddenLabel mesh__D020235 Apraxia, Bruns%27% Gait
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D020235 2003
% 222.65/222.83  |- mesh__historyNote mesh__D020235 2000   
% 222.65/222.83  |- skos__broader mesh__D006373Q000662smesh__D006373
% 222.65/222.83  |- mesh__preferredCombination mesh__D006373Q000662smesh__D006374
% 222.65/222.83  |- rdf__type mesh__D006373Q000662smesh__CompoundConcept
% 222.65/222.83  |- skos__historyNote mesh__D044683 Colonic Diseases %28%1964-2003%29%
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D044683 2004
% 222.65/222.83  |- skos__historyNote mesh__D044683 Colon %28%1967-2003%29%
% 222.65/222.83  |- mesh__publicMeSHNote mesh__D044683 2004   
% 222.65/222.83  |- skos__broader mesh__D044683smesh__D003106
% 222.65/222.83  |- mesh__dateCreated mesh__D044683 2003-07-09
% 222.65/222.83  |- skos__scopeNote mesh__D044683
% 222.65/222.83       The segment of LARGE INTESTINE between TRANSVERSE COLON and the SIGMOID COLON.%A%    
% 222.65/222.83  |- mesh__dateEstablished mesh__D044683 2004-01-01
% 222.65/222.83  |- skos__prefLabel mesh__D044683 Colon, Descending
% 222.65/222.83  |- skos__altLabel mesh__D044683 Descending Colon
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D044683 2006
% 222.65/222.83  |- mesh__historyNote mesh__D044683 2004   
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D044683 2005
% 222.65/222.83  |- rdf__type mesh__D044683sskos__Concept
% 222.65/222.83  |- skos__scopeNote mesh__D016992
% 222.65/222.83       A genus of gram-negative bacteria widely distributed in fresh water as well as marine and hypersaline habitats.%A%    
% 222.65/222.83  |- mesh__recordMaintainer mesh__D016992 SYSTEM
% 222.65/222.83  |- mesh__recordOriginator mesh__D016992 PXP
% 222.65/222.83  |- skos__prefLabel mesh__D016992 Rhodobacter
% 222.65/222.83  |- mesh__recordAuthorizer mesh__D016992 sjn
% 222.65/222.83  |- mesh__dateEstablished mesh__D016992 1992-01-01
% 222.65/222.83  |- rdf__type mesh__D016992sskos__Concept
% 222.65/222.83  |- mesh__historyNote mesh__D016992 92   
% 222.65/222.83  |- skos__historyNote mesh__D016992 Rhodopseudomonas %28%1966-1991%29%
% 222.65/222.83  |- mesh__dateRevised mesh__D016992 2005-06-30
% 222.65/222.83  |- mesh__dateCreated mesh__D016992 1991-05-30
% 222.65/222.83  |- skos__broader mesh__D016992smesh__D006090
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D016992 2006
% 222.65/222.83  |- mesh__publicMeSHNote mesh__D016992 92   
% 222.65/222.83  |- skos__annotation mesh__D016992 in fresh %26% sea water   
% 222.65/222.83  |- skos__broader mesh__D016992smesh__D041902
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D016194 1999
% 222.65/222.83  |- rdf__type mesh__D016194sskos__Concept
% 222.65/222.83  |- skos__historyNote mesh__D016194
% 222.65/222.83       Receptors, Neurotransmitter %28%1985-1990%29%
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D016194 2000
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D016194 2003
% 222.65/222.83  |- skos__altLabel mesh__D016194 Receptors, NMDA
% 222.65/222.83  |- skos__prefLabel mesh__D016194 Receptors, N-Methyl-D-Aspartate
% 222.65/222.83  |- skos__altLabel mesh__D016194 NMDA Receptors
% 222.65/222.83  |- mesh__historyNote mesh__D016194
% 222.65/222.83       93; was RECEPTOR, N-METHYL-D-ASPARTATE 1991-92; N-METHYL-D-ASPARTATE RECEPTORS was N-METHYL-D-ASPARTATE RECEPTOR see RECEPTOR, N-METHYL-D-ASPARTATE 1991-92%A%  
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D016194 2001
% 222.65/222.83  |- skos__hiddenLabel mesh__D016194 NMDA Receptor Ionophore Complex
% 222.65/222.83  |- mesh__recordAuthorizer mesh__D016194 PLS
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D016194 1996
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D016194 2004
% 222.65/222.83  |- mesh__dateEstablished mesh__D016194 1991-01-01
% 222.65/222.83  |- skos__annotation mesh__D016194 DF: RECEPT NMDA   
% 222.65/222.83  |- skos__hiddenLabel mesh__D016194 N Methyl D Aspartate Receptors
% 222.65/222.83  |- skos__altLabel mesh__D016194 NMDA Receptor-Ionophore Complex
% 222.65/222.83  |- skos__altLabel mesh__D016194 N-Methyl-D-Aspartate Receptors
% 222.65/222.83  |- mesh__dateRevised mesh__D016194 1995-06-08
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D016194 2002
% 222.65/222.83  |- skos__altLabel mesh__D016194 Receptors, N-Methylaspartate
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D016194 1997
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D016194 2005
% 222.65/222.83  |- skos__hiddenLabel mesh__D016194 N Methylaspartate Receptors
% 222.65/222.83  |- mesh__onlineNote mesh__D016194
% 222.65/222.83       use RECEPTORS, N-METHYL-D-ASPARTATE to search RECEPTOR, N-METHYL-D-ASPARTATE %26% N-METHYL-D-ASPARTATE RECEPTOR 1991-92%A%  
% 222.65/222.83  |- skos__hiddenLabel mesh__D016194 Receptors, N Methylaspartate
% 222.65/222.83  |- skos__altLabel mesh__D016194 N-Methylaspartate Receptors
% 222.65/222.83  |- skos__hiddenLabel mesh__D016194 Receptors, N Methyl D Aspartate
% 222.65/222.83  |- skos__scopeNote mesh__D016194
% 222.65/222.83       A class of ionotropic glutamate receptors characterized by affinity for N-methyl-D-aspartate. NMDA receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which magnesium ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions %28%as well as to monovalent cations%29% are important in excitotoxicity and neuronal plasticity.%A%    
% 222.65/222.83  |- mesh__recordMaintainer mesh__D016194 KEV
% 222.65/222.83  |- mesh__publicMeSHNote mesh__D016194
% 222.65/222.83       93; was RECEPTOR, N-METHYL-D-ASPARTATE 1991-92; N-METHYL-D-ASPARTATE RECEPTORS was N-METHYL-D-ASPARTATE RECEPTOR see RECEPTOR, N-METHYL-D-ASPARTATE 1991-92%A%  
% 222.65/222.83  |- skos__historyNote mesh__D016194
% 222.65/222.83       Receptors, Cell Surface %28%1973-1984%29%
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D016194 2006
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D016194 1998
% 222.65/222.83  |- mesh__dateCreated mesh__D016194 1990-05-31
% 222.65/222.83  |- skos__broader mesh__D016194smesh__D017470
% 222.65/222.83  |- mesh__recordOriginator mesh__D016194 RLS
% 222.65/222.83  |- skos__hiddenLabel mesh__D002972 Cleft Palates
% 222.65/222.83  |- mesh__dateRevised mesh__D002972 1999-11-03
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002972 2004
% 222.65/222.83  |- skos__hiddenLabel mesh__D002972 Palate, Cleft
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002972 2001
% 222.65/222.83  |- skos__broader mesh__D002972smesh__D007569
% 222.65/222.83  |- skos__prefLabel mesh__D002972 Cleft Palate
% 222.65/222.83  |- mesh__recordOriginator mesh__D002972 NLM
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002972 2003
% 222.65/222.83  |- skos__scopeNote mesh__D002972
% 222.65/222.83       Congenital fissure of the soft and/or hard palate, due to faulty fusion.%A%    
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002972 2000
% 222.65/222.83  |- mesh__recordMaintainer mesh__D002972 kle
% 222.65/222.83  |- rdf__type mesh__D002972sskos__Concept
% 222.65/222.83  |- skos__hiddenLabel mesh__D002972 Palates, Cleft
% 222.65/222.83  |- mesh__dateCreated mesh__D002972 1999-01-01
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002972 2006
% 222.65/222.83  |- skos__broader mesh__D002972smesh__D009056
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002972 2005
% 222.65/222.83  |- mesh__recordAuthorizer mesh__D002972 sjn
% 222.65/222.83  |- skos__annotation mesh__D002972
% 222.65/222.83       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; when with CLEFT LIP, do not also use ABNORMALITIES, MULTIPLE%A%  
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002972 2002
% 222.65/222.83  |- skos__prefLabel mesh__D002174 Candicidin
% 222.65/222.83  |- skos__historyNote mesh__D002174 Polyenes %28%1974%29%
% 222.65/222.83  |- mesh__recordOriginator mesh__D002174 NLM
% 222.65/222.83  |- mesh__dateEstablished mesh__D002174 1991-01-01
% 222.65/222.83  |- mesh__historyNote mesh__D002174
% 222.65/222.83       91%28%75%29%; was see under ANTIBIOTICS, MACROLIDE 1990; was see under ANTIBIOTICS, ANTIFUNGAL 1975-89; LEVORIN was see under ANTIBIOTICS, ANTIFUNGAL 1978-81%A%  
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002174 2006
% 222.65/222.83  |- mesh__publicMeSHNote mesh__D002174
% 222.65/222.83       91; was see under ANTIBIOTICS, MACROLIDE 1990; was see under ANTIBIOTICS, ANTIFUNGAL 1975-89; LEVORIN was see under ANTIBIOTICS, ANTIFUNGAL 1978-81%A%  
% 222.65/222.83  |- skos__broader mesh__D002174smesh__D018942
% 222.65/222.83  |- mesh__dateCreated mesh__D002174 1974-11-19
% 222.65/222.83  |- mesh__recordMaintainer mesh__D002174 ssb
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D002174 2005
% 222.65/222.83  |- mesh__onlineNote mesh__D002174
% 222.65/222.83       use CANDICIDIN to search LEVORIN 1978-89   
% 222.65/222.83  |- skos__historyNote mesh__D002174
% 222.65/222.83       Antibiotics, Antifungal %28%1970-1974%29%
% 222.65/222.83  |- skos__scopeNote mesh__D002174
% 222.65/222.83       Mixture of antifungal heptaene macrolides from Streptomyces griseus or Actinomyces levoris used topically in candidiasis. The antibiotic complex is composed of candicidins A, B, C, and D, of which D is the major component.%A%    
% 222.65/222.83  |- skos__altLabel mesh__D002174 Levorine
% 222.65/222.83  |- rdf__type mesh__D002174sskos__Concept
% 222.65/222.83  |- mesh__recordAuthorizer mesh__D002174 sjn
% 222.65/222.83  |- mesh__dateRevised mesh__D002174 2004-07-07
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010606 1999
% 222.65/222.83  |- mesh__dateCreated mesh__D010606 1999-01-01
% 222.65/222.83  |- skos__historyNote mesh__D010606
% 222.65/222.83       Pharmacy Service, Hospital %28%1966-1967%29%
% 222.65/222.83  |- skos__altLabel mesh__D010606 Committee, Pharmacy
% 222.65/222.83  |- rdf__type mesh__D010606sskos__Concept
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010606 2005
% 222.65/222.83  |- skos__altLabel mesh__D010606 Drug Committee
% 222.65/222.83  |- skos__altLabel mesh__D010606 Committee, Formulary
% 222.65/222.83  |- skos__altLabel mesh__D010606 Committees, Pharmacy
% 222.65/222.83  |- skos__scopeNote mesh__D010606
% 222.65/222.83       An advisory group composed primarily of staff physicians and the pharmacist which serves as the communication link between the medical staff and the pharmacy department.%A%    
% 222.65/222.83  |- skos__altLabel mesh__D010606 Formulary Committees
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010606 2004
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010606 2002
% 222.65/222.83  |- mesh__historyNote mesh__D010606 68   
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010606 1998
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010606 1997
% 222.65/222.83  |- skos__altLabel mesh__D010606 Committee, Therapeutics
% 222.65/222.83  |- skos__altLabel mesh__D010606 Therapeutics Committee
% 222.65/222.83  |- skos__annotation mesh__D010606
% 222.65/222.83       a link between hosp med staff %26% pharm dept; DF: PHARM THER COMM or PHARM COMMITTEE%A%  
% 222.65/222.83  |- mesh__publicMeSHNote mesh__D010606 68   
% 222.65/222.83  |- skos__altLabel mesh__D010606 Therapeutics Committees
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010606 2003
% 222.65/222.83  |- skos__related mesh__D010606smesh__D005572
% 222.65/222.83  |- mesh__dateRevised mesh__D010606 1994-05-05
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010606 1996
% 222.65/222.83  |- skos__altLabel mesh__D010606 Pharmacy Committees
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010606 2001
% 222.65/222.83  |- mesh__dateEstablished mesh__D010606 1968-01-01
% 222.65/222.83  |- skos__broader mesh__D010606smesh__D011367
% 222.65/222.83  |- skos__prefLabel mesh__D010606 Pharmacy and Therapeutics Committee
% 222.65/222.83  |- skos__altLabel mesh__D010606 Committees, Drug
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010606 2000
% 222.65/222.83  |- skos__altLabel mesh__D010606 Pharmacy Committee
% 222.65/222.83  |- skos__altLabel mesh__D010606 Committees, Formulary
% 222.65/222.83  |- skos__altLabel mesh__D010606 Drug Committees
% 222.65/222.83  |- mesh__recordAuthorizer mesh__D010606 PLS
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010606 1995
% 222.65/222.83  |- skos__altLabel mesh__D010606 Formulary Committee
% 222.65/222.83  |- skos__altLabel mesh__D010606 Committees, Therapeutics
% 222.65/222.83  |- mesh__activeMeSHYear mesh__D010606 2006
% 222.65/222.83  |- mesh__recordOriginator mesh__D010606 NLM
% 222.65/222.83  |- mesh__recordMaintainer mesh__D010606 TGC
% 222.65/222.83  |- skos__hiddenLabel mesh__D020236 Global Amnesia, Transient
% 222.65/222.83  |- rdf__type mesh__D020236sskos__Concept
% 222.65/222.83  |- skos__altLabel mesh__D020236 Transient Global Amnesia
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D020236 2002
% 222.65/222.84  |- skos__scopeNote mesh__D020236
% 222.65/222.84       A syndrome characterized by a transient loss of the ability to form new memories. It primarily occurs in middle aged or elderly individuals, and episodes may last from minutes to hours. During the period of amnesia, immediate and recent memory abilities are impaired, but the level of consciousness and ability to perform other intellectual tasks are preserved. The condition is related to bilateral dysfunction of the medial portions of each TEMPORAL LOBE. Complete recovery normally occurs, and recurrences are unusual. %28%From Adams et al., Principles of Neurology, 6th ed, pp429-30%29%%A%    
% 222.65/222.84  |- skos__historyNote mesh__D020236 Amnesia %28%1966-1999%29%
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D020236 2006
% 222.65/222.84  |- mesh__dateEstablished mesh__D020236 2000-01-01
% 222.65/222.84  |- skos__annotation mesh__D020236
% 222.65/222.84       AMNESIA, GLOBAL see AMNESIA is also available   
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D020236 2004
% 222.65/222.84  |- mesh__publicMeSHNote mesh__D020236 2000   
% 222.65/222.84  |- skos__hiddenLabel mesh__D020236 TGAs %28%Transient Global Amnesia%29%
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D020236 2005
% 222.65/222.84  |- skos__prefLabel mesh__D020236 Amnesia, Transient Global
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D020236 2001
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D020236 2003
% 222.65/222.84  |- mesh__historyNote mesh__D020236 2000   
% 222.65/222.84  |- skos__broader mesh__D020236smesh__D000647
% 222.65/222.84  |- skos__altLabel mesh__D020236 TGA %28%Transient Global Amnesia%29%
% 222.65/222.84  |- skos__broader mesh__D020236smesh__D001927
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D020236 2000
% 222.65/222.84  |- mesh__dateCreated mesh__D020236 1999-11-03
% 222.65/222.84  |- skos__historyNote mesh__D020236 Memory %28%1966-1999%29%
% 222.65/222.84  |- mesh__dateEstablished mesh__D044684 2004-01-01
% 222.65/222.84  |- mesh__historyNote mesh__D044684 2004   
% 222.65/222.84  |- skos__prefLabel mesh__D044684 Colon, Transverse
% 222.65/222.84  |- skos__altLabel mesh__D044684 Splenic Flexure
% 222.65/222.84  |- skos__historyNote mesh__D044684 Colon %28%1966-2003%29%
% 222.65/222.84  |- skos__hiddenLabel mesh__D044684 Flexure, Splenic
% 222.65/222.84  |- skos__altLabel mesh__D044684 Transverse Colon
% 222.65/222.84  |- mesh__dateRevised mesh__D044684 2005-06-30
% 222.65/222.84  |- mesh__publicMeSHNote mesh__D044684 2004   
% 222.65/222.84  |- mesh__recordMaintainer mesh__D044684 ags
% 222.65/222.84  |- mesh__dateCreated mesh__D044684 2003-07-09
% 222.65/222.84  |- skos__hiddenLabel mesh__D044684 Colic Flexure, Left
% 222.65/222.84  |- mesh__recordAuthorizer mesh__D044684 sjn
% 222.65/222.84  |- skos__scopeNote mesh__D044684
% 222.65/222.84       The segment of LARGE INTESTINE between ASCENDING COLON and DESCENDING COLON. It passes from the RIGHT COLIC FLEXURE across the ABDOMEN, then turns sharply at the left colonic flexure into the descending colon.%A%    
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D044684 2006
% 222.65/222.84  |- skos__historyNote mesh__D044684 Colonic Diseases %28%1964-2003%29%
% 222.65/222.84  |- skos__broader mesh__D044684smesh__D003106
% 222.65/222.84  |- mesh__recordOriginator mesh__D044684 lkt
% 222.65/222.84  |- rdf__type mesh__D044684sskos__Concept
% 222.65/222.84  |- mesh__recordMaintainer mesh__D016993 SYSTEM
% 222.65/222.84  |- mesh__recordOriginator mesh__D016993 PXP
% 222.65/222.84  |- skos__prefLabel mesh__D016993 Chlamydophila pneumoniae
% 222.65/222.84  |- skos__altLabel mesh__D016993 Chlamydia pneumoniae
% 222.65/222.84  |- skos__broader mesh__D016993smesh__D023501
% 222.65/222.84  |- rdf__type mesh__D016993sskos__Concept
% 222.65/222.84  |- mesh__historyNote mesh__D016993 2001 %28%1992%29%   
% 222.65/222.84  |- mesh__publicMeSHNote mesh__D016993
% 222.65/222.84       2001; use CHLAMYDIA PNEUMONIAE 1992-2000   
% 222.65/222.84  |- skos__historyNote mesh__D016993 Chlamydia %28%1989-1991%29%
% 222.65/222.84  |- skos__annotation mesh__D016993
% 222.65/222.84       infection: coord IM with CHLAMYDOPHILA INFECTIONS %28%IM%29%; index also PNEUMONIA, BACTERIAL if pertinent%A%  
% 222.65/222.84  |- skos__scopeNote mesh__D016993
% 222.65/222.84       A species of CHLAMYDOPHILA that causes acute respiratory infection, especially atypical pneumonia, in humans, horses, and koalas.%A%    
% 222.65/222.84  |- mesh__dateCreated mesh__D016993 1991-05-30
% 222.65/222.84  |- mesh__recordAuthorizer mesh__D016993 sjn
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D016993 2006
% 222.65/222.84  |- mesh__dateEstablished mesh__D016993 1992-01-01
% 222.65/222.84  |- mesh__dateRevised mesh__D016993 2005-06-30
% 222.65/222.84  |- skos__hiddenLabel mesh__D016195 Phase 2, Gap
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D016195 2005A
% 222.65/222.84  |- skos__altLabel mesh__D016195 Gap Phase 2
% 222.65/222.84  |- mesh__dateEstablished mesh__D016195 1991-01-01
% 222.65/222.84  |- mesh__recordAuthorizer mesh__D016195 jls
% 222.65/222.84  |- skos__historyNote mesh__D016195 Interphase %28%1978-1990%29%
% 222.65/222.84  |- skos__hiddenLabel mesh__D016195 Phase, G2
% 222.65/222.84  |- mesh__recordOriginator mesh__D016195 AGS
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D016195 2005
% 222.65/222.84  |- skos__hiddenLabel mesh__D016195 G2 Phases
% 222.65/222.84  |- skos__broader mesh__D016195smesh__D007399
% 222.65/222.84  |- mesh__dateCreated mesh__D016195 1990-04-24
% 222.65/222.84  |- skos__hiddenLabel mesh__D016195 Second Gap Phases
% 222.65/222.84  |- skos__hiddenLabel mesh__D016195 Phases, Second Gap
% 222.65/222.84  |- skos__hiddenLabel mesh__D016195 Phase, Second Gap
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D016195 2006
% 222.65/222.84  |- skos__altLabel mesh__D016195 Second Gap Phase
% 222.65/222.84  |- mesh__dateRevised mesh__D016195 2004-08-06
% 222.65/222.84  |- mesh__publicMeSHNote mesh__D016195 91   
% 222.65/222.84  |- rdf__type mesh__D016195sskos__Concept
% 222.65/222.84  |- skos__scopeNote mesh__D016195
% 222.65/222.84       The period of the CELL CYCLE following DNA synthesis %28%S PHASE%29% and preceding M  PHASE %28%cell division phase%29%. The CHROMOSOMES are tetraploid in this point.%A%    
% 222.65/222.84  |- skos__hiddenLabel mesh__D016195 Gap Phases, Second
% 222.65/222.84  |- skos__historyNote mesh__D016195 Cell Division %28%1966-1977%29%
% 222.65/222.84  |- skos__prefLabel mesh__D016195 G2 Phase
% 222.65/222.84  |- skos__hiddenLabel mesh__D016195 Gap Phase, Second
% 222.65/222.84  |- mesh__historyNote mesh__D016195 91   
% 222.65/222.84  |- mesh__recordMaintainer mesh__D016195 jls
% 222.65/222.84  |- skos__hiddenLabel mesh__D016195 2, Gap Phase
% 222.65/222.84  |- skos__hiddenLabel mesh__D016195 Phases, G2
% 222.65/222.84  |- skos__hiddenLabel mesh__D002973 Cleidocranial Dysplasias
% 222.65/222.84  |- mesh__publicMeSHNote mesh__D002973
% 222.65/222.84       85; was CLEIDOCRANIAL DYSOSTOSIS 1963-84   
% 222.65/222.84  |- rdf__type mesh__D002973sskos__Concept
% 222.65/222.84  |- skos__broader mesh__D002973smesh__D019465
% 222.65/222.84  |- skos__scopeNote mesh__D002973
% 222.65/222.84       A rare autosomal dominant condition in which there is defective ossification of the cranial bones with large fontanels and delayed closing of the sutures, complete or partial absence of the clavicles, wide pubic symphysis, short middle phalanges of the fifth fingers, and dental and vertebral anomalies. %28%From Dorland, 27th ed%29%%A%    
% 222.65/222.84  |- skos__prefLabel mesh__D002973 Cleidocranial Dysplasia
% 222.65/222.84  |- skos__hiddenLabel mesh__D002973 Dysostoses, Cleidocranial
% 222.65/222.84  |- skos__altLabel mesh__D002973 Dysostosis, Cleidocranial
% 222.65/222.84  |- mesh__dateCreated mesh__D002973 1999-01-01
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D002973 2006
% 222.65/222.84  |- mesh__dateRevised mesh__D002973 1999-11-03
% 222.65/222.84  |- mesh__recordAuthorizer mesh__D002973 sjn
% 222.65/222.84  |- skos__annotation mesh__D002973
% 222.65/222.84       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D002973 2002
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D002973 2005
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D002973 2001
% 222.65/222.84  |- mesh__recordOriginator mesh__D002973 NLM
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D002973 2004
% 222.65/222.84  |- mesh__historyNote mesh__D002973
% 222.65/222.84       85; was CLEIDOCRANIAL DYSOSTOSIS 1963-84   
% 222.65/222.84  |- skos__hiddenLabel mesh__D002973 Dysplasia, Cleidocranial
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D002973 2000
% 222.65/222.84  |- skos__altLabel mesh__D002973 Cleidocranial Dysostosis
% 222.65/222.84  |- mesh__recordMaintainer mesh__D002973 kle
% 222.65/222.84  |- skos__hiddenLabel mesh__D002973 Cleidocranial Dysostoses
% 222.65/222.84  |- skos__broader mesh__D002973smesh__D010009
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D002973 2003
% 222.65/222.84  |- skos__hiddenLabel mesh__D002973 Dysplasias, Cleidocranial
% 222.65/222.84  |- mesh__onlineNote mesh__D002973
% 222.65/222.84       use CLEIDOCRANIAL DYSPLASIA to search CLEIDOCRANIAL DYSOSTOSIS l966-84%A%  
% 222.65/222.84  |- mesh__dateRevised mesh__D002175 2005-06-30
% 222.65/222.84  |- mesh__publicMeSHNote mesh__D002175 TORULOPSIS was heading 1974-85   
% 222.65/222.84  |- skos__annotation mesh__D002175
% 222.65/222.84       infection = CANDIDIASIS or its indentions; for specific mycoses in scope note: coord CANDIDIASIS %28%IM%29% or its indentions %28%IM%29% with specific mycosis %28%IM%29%%A%  
% 222.65/222.84  |- skos__prefLabel mesh__D002175 Candida
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D002175 2006
% 222.65/222.84  |- mesh__recordAuthorizer mesh__D002175 sjn
% 222.65/222.84  |- mesh__recordOriginator mesh__D002175 NLM
% 222.65/222.84  |- skos__altLabel mesh__D002175 Monilia
% 222.65/222.84  |- mesh__recordMaintainer mesh__D002175 SYSTEM
% 222.65/222.84  |- skos__broader mesh__D002175smesh__D003904
% 222.65/222.84  |- mesh__dateCreated mesh__D002175 1999-01-01
% 222.65/222.84  |- skos__scopeNote mesh__D002175
% 222.65/222.84       A genus of yeast-like mitosporic Saccharomycetales fungi characterized by producing yeast cells, mycelia, pseudomycelia, and blastophores. It is commonly part of the normal flora of the skin, mouth, intestinal tract, and vagina, but can cause a variety of infections, including CANDIDIASIS; ONYCHOMYCOSIS; vulvovaginal candidiasis %28%CANDIDIASIS, VULVOVAGINAL%29%, and thrush %28%see CANDIDIASIS, ORAL%29%. %28%From Dorland, 28th ed%29%%A%    
% 222.65/222.84  |- rdf__type mesh__D002175sskos__Concept
% 222.65/222.84  |- skos__broader mesh__D002175smesh__D015003
% 222.65/222.84  |- rdf__type mesh__D010607sskos__Concept
% 222.65/222.84  |- mesh__onlineNote mesh__D010607
% 222.65/222.84       use PHARMACY SERVICE, HOSPITAL to search HOSPITAL PHARMACY SERVICE 1966-77%A%  
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010607 2005
% 222.65/222.84  |- skos__altLabel mesh__D010607 Pharmaceutic Service, Hospital
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010607 2004
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010607 1998
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010607 1997
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010607 2002
% 222.65/222.84  |- skos__altLabel mesh__D010607 Hospital Pharmacy Services
% 222.65/222.84  |- skos__altLabel mesh__D010607 Hospital Pharmaceutical Service
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010607 2003
% 222.65/222.84  |- skos__hiddenLabel mesh__D010607 Pharmacy Services, Hospital
% 222.65/222.84  |- skos__altLabel mesh__D010607 Clinical Pharmacy Service
% 222.65/222.84  |- skos__prefLabel mesh__D010607 Pharmacy Service, Hospital
% 222.65/222.84  |- skos__altLabel mesh__D010607 Service, Hospital Pharmaceutic
% 222.65/222.84  |- skos__annotation mesh__D010607 DF: PHARM SERV HOSP   
% 222.65/222.84  |- skos__altLabel mesh__D010607 Service, Hospital Pharmaceutical
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010607 2001
% 222.65/222.84  |- mesh__recordMaintainer mesh__D010607 PXP
% 222.65/222.84  |- skos__altLabel mesh__D010607 Hospital Pharmacy Service
% 222.65/222.84  |- skos__broader mesh__D010607smesh__D006748
% 222.65/222.84  |- skos__hiddenLabel mesh__D010607 Pharmaceutical Services, Hospital
% 222.65/222.84  |- skos__altLabel mesh__D010607 Service, Hospital Pharmacy
% 222.65/222.84  |- skos__hiddenLabel mesh__D010607 Hospital Pharmaceutic Services
% 222.65/222.84  |- skos__hiddenLabel mesh__D010607 Pharmaceutic Services, Hospital
% 222.65/222.84  |- skos__hiddenLabel mesh__D010607 Services, Hospital Pharmaceutical
% 222.65/222.84  |- skos__hiddenLabel mesh__D010607 Clinical Pharmacy Services
% 222.65/222.84  |- mesh__publicMeSHNote mesh__D010607
% 222.65/222.84       78; was HOSPITAL PHARMACY SERVICE 1963-77   
% 222.65/222.84  |- skos__broader mesh__D010607smesh__D010593
% 222.65/222.84  |- mesh__historyNote mesh__D010607
% 222.65/222.84       78; was HOSPITAL PHARMACY SERVICE 1963-77   
% 222.65/222.84  |- skos__altLabel mesh__D010607 Pharmaceutical Service, Hospital
% 222.65/222.84  |- skos__hiddenLabel mesh__D010607 Hospital Pharmaceutical Services
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010607 2000
% 222.65/222.84  |- skos__hiddenLabel mesh__D010607 Services, Clinical Pharmacy
% 222.65/222.84  |- skos__scopeNote mesh__D010607
% 222.65/222.84       Hospital department responsible for the receiving, storing, and distribution of pharmaceutical supplies.%A%    
% 222.65/222.84  |- skos__altLabel mesh__D010607 Service, Clinical Pharmacy
% 222.65/222.84  |- skos__altLabel mesh__D010607 Hospital Pharmaceutic Service
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010607 2006
% 222.65/222.84  |- skos__hiddenLabel mesh__D010607 Services, Hospital Pharmaceutic
% 222.65/222.84  |- mesh__dateRevised mesh__D010607 1996-06-10
% 222.65/222.84  |- mesh__recordAuthorizer mesh__D010607 PLS
% 222.65/222.84  |- skos__hiddenLabel mesh__D010607 Pharmacy Services, Clinical
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010607 1999
% 222.65/222.84  |- skos__hiddenLabel mesh__D010607 Services, Hospital Pharmacy
% 222.65/222.84  |- mesh__dateCreated mesh__D010607 1999-01-01
% 222.65/222.84  |- mesh__recordOriginator mesh__D010607 NLM
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D006566 2002
% 222.65/222.84  |- skos__altLabel mesh__D006566 Herpesvirus Infections
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D006566 1999
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D006566 2003
% 222.65/222.84  |- mesh__onlineNote mesh__D006566
% 222.65/222.84       use HERPESVIRIDAE INFECTIONS to search HERPESVIRUS INFECTIONS 1966-93%A%  
% 222.65/222.84  |- skos__hiddenLabel mesh__D006566 Infection, Herpesviridae
% 222.65/222.84  |- skos__hiddenLabel mesh__D006566 Herpesvirus Infection
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D006566 1998
% 222.65/222.84  |- mesh__dateRevised mesh__D006566 1997-06-20
% 222.65/222.84  |- skos__annotation mesh__D006566 GEN or unspecified; prefer specifics   
% 222.65/222.84  |- rdf__type mesh__D006566sskos__Concept
% 222.65/222.84  |- skos__altLabel mesh__D006566 Infections, Herpesviridae
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D006566 2001
% 222.65/222.84  |- skos__hiddenLabel mesh__D006566 Herpesviridae Infection
% 222.65/222.84  |- skos__altLabel mesh__D006566 Infections, Herpesvirus
% 222.65/222.84  |- mesh__recordOriginator mesh__D006566 NLM
% 222.65/222.84  |- mesh__recordMaintainer mesh__D006566 TGC
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D006566 2000
% 222.65/222.84  |- skos__scopeNote mesh__D006566
% 222.65/222.84       Virus diseases caused by the HERPESVIRIDAE.     
% 222.65/222.84  |- skos__hiddenLabel mesh__D006566 Infection, Herpesvirus
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D006566 2006
% 222.65/222.84  |- skos__broader mesh__D006566smesh__D004266
% 222.65/222.84  |- skos__prefLabel mesh__D006566 Herpesviridae Infections
% 222.65/222.84  |- mesh__publicMeSHNote mesh__D006566
% 222.65/222.84       94; was HERPESVIRUS INFECTIONS 1963-93   
% 222.65/222.84  |- mesh__recordAuthorizer mesh__D006566 SJN
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D006566 2005
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D006566 2004
% 222.65/222.84  |- mesh__historyNote mesh__D006566
% 222.65/222.84       94; was HERPESVIRUS INFECTIONS 1963-93   
% 222.65/222.84  |- mesh__dateCreated mesh__D006566 1999-01-01
% 222.65/222.84  |- skos__broader mesh__D020237smesh__D004411
% 222.65/222.84  |- skos__hiddenLabel mesh__D020237 Blindness, Pure Word
% 222.65/222.84  |- rdf__type mesh__D020237sskos__Concept
% 222.65/222.84  |- skos__hiddenLabel mesh__D020237 Agraphia, Alexia Without
% 222.65/222.84  |- skos__altLabel mesh__D020237 Pure Alexia Without Agraphia
% 222.65/222.84  |- skos__altLabel mesh__D020237 Pure Alexia
% 222.65/222.84  |- skos__prefLabel mesh__D020237 Alexia, Pure
% 222.65/222.84  |- skos__hiddenLabel mesh__D020237 Word Blindness, Pure
% 222.65/222.84  |- skos__hiddenLabel mesh__D020237 Pure Alexias
% 222.65/222.84  |- skos__altLabel mesh__D020237 Alexia Without Agraphia
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D020237 2002
% 222.65/222.84  |- skos__hiddenLabel mesh__D020237 Alexias, Pure
% 222.65/222.84  |- skos__annotation mesh__D020237 ALEXIA see DYSLEXIA is also available   
% 222.65/222.84  |- skos__hiddenLabel mesh__D020237 Visual Verbal Agnosias
% 222.65/222.84  |- mesh__dateCreated mesh__D020237 1999-11-08
% 222.65/222.84  |- skos__hiddenLabel mesh__D020237 Verbal Agnosia, Visual
% 222.65/222.84  |- mesh__publicMeSHNote mesh__D020237 2000   
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D020237 2003
% 222.65/222.84  |- skos__scopeNote mesh__D020237
% 222.65/222.84       Loss of the power to comprehend written materials despite preservation of the ability to write %28%i.e., alexia without agraphia%29%. This condition is generally attributed to lesions that %22%disconnect%22% the visual cortex of the non-dominant hemisphere from language centers in the dominant hemisphere. This may occur when a dominant visual cortex injury is combined with underlying white matter lesions that involve crossing fibers from the occipital lobe of the opposite hemisphere. %28%From Adams et al., Principles of Neurology, 6th ed, p483%29%%A%    
% 222.65/222.84  |- skos__hiddenLabel mesh__D020237 Word Blindnesses, Pure
% 222.65/222.84  |- skos__hiddenLabel mesh__D020237 Verbal Agnosias, Visual
% 222.65/222.84  |- skos__hiddenLabel mesh__D020237 Pure Word Blindnesses
% 222.65/222.84  |- skos__hiddenLabel mesh__D020237 Without Agraphia, Alexia
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D020237 2004
% 222.65/222.84  |- skos__hiddenLabel mesh__D020237 Alexia Without Agraphias
% 222.65/222.84  |- skos__hiddenLabel mesh__D020237 Agnosia, Visual Verbal
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D020237 2000
% 222.65/222.84  |- skos__altLabel mesh__D020237 Alexia Syndrome Without Agraphia
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D020237 2005
% 222.65/222.84  |- mesh__historyNote mesh__D020237 2000   
% 222.65/222.84  |- skos__hiddenLabel mesh__D020237 Blindnesses, Pure Word
% 222.65/222.84  |- skos__hiddenLabel mesh__D020237 Agraphias, Alexia Without
% 222.65/222.84  |- mesh__dateEstablished mesh__D020237 2000-01-01
% 222.65/222.84  |- skos__historyNote mesh__D020237 Dyslexia, Acquired %28%1966-1999%29%
% 222.65/222.84  |- skos__altLabel mesh__D020237 Pure Word Blindness
% 222.65/222.84  |- skos__hiddenLabel mesh__D020237 Without Agraphias, Alexia
% 222.65/222.84  |- skos__altLabel mesh__D020237 Visual Verbal Agnosia
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D020237 2001
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D020237 2006
% 222.65/222.84  |- skos__hiddenLabel mesh__D020237 Agnosias, Visual Verbal
% 222.65/222.84  |- skos__broader mesh__D010564Q000458smesh__D010564
% 222.65/222.84  |- mesh__preferredCombination mesh__D010564Q000458smesh__D010557
% 222.65/222.84  |- rdf__type mesh__D010564Q000458smesh__CompoundConcept
% 222.65/222.84  |- mesh__dateEstablished mesh__D011700 1973-01-01
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D011700 2002
% 222.65/222.84  |- mesh__recordMaintainer mesh__D011700 CCR
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D011700 2005
% 222.65/222.84  |- skos__altLabel mesh__D011700 1,4-Butanediamine
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D011700 2003
% 222.65/222.84  |- skos__historyNote mesh__D011700 Butylamines %28%1970-1971%29%
% 222.65/222.84  |- mesh__recordAuthorizer mesh__D011700 sjn
% 222.65/222.84  |- skos__hiddenLabel mesh__D011700 1,4 Butanediamine
% 222.65/222.84  |- mesh__publicMeSHNote mesh__D011700 73   
% 222.65/222.84  |- skos__scopeNote mesh__D011700
% 222.65/222.84       A toxic diamine formed by putrefaction from the decarboxylation of arginine and ornithine.%A%    
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D011700 2006
% 222.65/222.84  |- skos__hiddenLabel mesh__D011700 1,4 Diaminobutane
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D011700 2004
% 222.65/222.84  |- skos__altLabel mesh__D011700 1,4-Diaminobutane
% 222.65/222.84  |- mesh__historyNote mesh__D011700 73%28%72%29%   
% 222.65/222.84  |- skos__broader mesh__D011700smesh__D015317
% 222.65/222.84  |- rdf__type mesh__D011700sskos__Concept
% 222.65/222.84  |- skos__historyNote mesh__D011700 Polyamines %28%1971%29%
% 222.65/222.84  |- skos__historyNote mesh__D011700 Amines %28%1966-1971%29%
% 222.65/222.84  |- mesh__dateRevised mesh__D011700 2000-06-22
% 222.65/222.84  |- skos__broader mesh__D011700smesh__D003959
% 222.65/222.84  |- mesh__recordOriginator mesh__D011700 NLM
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D011700 2001
% 222.65/222.84  |- mesh__dateCreated mesh__D011700 1999-01-01
% 222.65/222.84  |- skos__altLabel mesh__D011700 Tetramethylenediamine
% 222.65/222.84  |- skos__prefLabel mesh__D011700 Putrescine
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D016196 2005
% 222.65/222.84  |- mesh__recordAuthorizer mesh__D016196 sjn
% 222.65/222.84  |- skos__broader mesh__D016196smesh__D004261
% 222.65/222.84  |- skos__broader mesh__D016196smesh__D007399
% 222.65/222.84  |- mesh__onlineNote mesh__D016196
% 222.65/222.84       use INTERPHASE to search S PERIOD 1981-90   
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D016196 2006
% 222.65/222.84  |- skos__hiddenLabel mesh__D016196 Periods, S
% 222.65/222.84  |- mesh__publicMeSHNote mesh__D016196
% 222.65/222.84       91; was S PERIOD see INTERPHASE 1981-90   
% 222.65/222.84  |- skos__altLabel mesh__D016196 S Period
% 222.65/222.84  |- skos__historyNote mesh__D016196 Cell Division %28%1966-1977%29%
% 222.65/222.84  |- skos__scopeNote mesh__D016196
% 222.65/222.84       Phase of the CELL CYCLE following G1 and preceding G2 when the entire DNA content of the nucleus is replicated. It is achieved by bidirectional replication at multiple sites along each chromosome.%A%    
% 222.65/222.84  |- rdf__type mesh__D016196sskos__Concept
% 222.65/222.84  |- skos__related mesh__D016196smesh__D042522
% 222.65/222.84  |- skos__hiddenLabel mesh__D016196 Phases, S
% 222.65/222.84  |- skos__hiddenLabel mesh__D016196 S Phases
% 222.65/222.84  |- skos__hiddenLabel mesh__D016196 Phase, S
% 222.65/222.84  |- mesh__historyNote mesh__D016196
% 222.65/222.84       91; was S PERIOD see INTERPHASE 1981-90   
% 222.65/222.84  |- skos__hiddenLabel mesh__D016196 S Periods
% 222.65/222.84  |- mesh__recordOriginator mesh__D016196 AGS
% 222.65/222.84  |- mesh__dateRevised mesh__D016196 2004-07-07
% 222.65/222.84  |- skos__historyNote mesh__D016196 Interphase %28%1978-1990%29%
% 222.65/222.84  |- mesh__dateCreated mesh__D016196 1990-04-24
% 222.65/222.84  |- skos__prefLabel mesh__D016196 S Phase
% 222.65/222.84  |- mesh__recordMaintainer mesh__D016196 lkt
% 222.65/222.84  |- skos__related mesh__D016196smesh__D004261
% 222.65/222.84  |- mesh__dateEstablished mesh__D016196 1991-01-01
% 222.65/222.84  |- skos__hiddenLabel mesh__D016196 Period, S
% 222.65/222.84  |- skos__scopeNote mesh__D002974
% 222.65/222.84       A histamine H1 antagonist used as the hydrogen fumarate in hay fever, rhinitis, allergic skin conditions, and pruritus. It causes drowsiness.%A%    
% 222.65/222.84  |- mesh__dateCreated mesh__D002974 1999-01-01
% 222.65/222.84  |- skos__prefLabel mesh__D002974 Clemastine
% 222.65/222.84  |- mesh__publicMeSHNote mesh__D002974
% 222.65/222.84       91; was see under PYRROLIDINES 1979-90; was MECLASTINE see under PYRROLIDINES 1975-78%A%  
% 222.65/222.84  |- mesh__recordAuthorizer mesh__D002974 sjn
% 222.65/222.84  |- mesh__dateEstablished mesh__D002974 1991-01-01
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D002974 2002
% 222.65/222.84  |- skos__broader mesh__D002974smesh__D011759
% 222.65/222.84  |- skos__historyNote mesh__D002974 Pyrrolidines %28%1966-1972%29%
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D002974 2006
% 222.65/222.84  |- mesh__recordOriginator mesh__D002974 NLM
% 222.65/222.84  |- mesh__historyNote mesh__D002974
% 222.65/222.84       91%28%79%29%; was see under PYRROLIDINES 1979-90; was MECLASTINE see under PYRROLIDINES 1973-78 %28%Prov 1973-74%29%%A%  
% 222.65/222.84  |- mesh__onlineNote mesh__D002974
% 222.65/222.84       use CLEMASTINE to search MECLASTINE 1973-78 %28%as Prov 1973-74%29%%A%  
% 222.65/222.84  |- skos__hiddenLabel mesh__D002974 HS 592
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D002974 2005
% 222.65/222.84  |- skos__hiddenLabel mesh__D002974 HS592
% 222.65/222.84  |- skos__historyNote mesh__D002974
% 222.65/222.84       Histamine H1 Receptor Blockaders %28%1966-1972%29%
% 222.65/222.84  |- skos__altLabel mesh__D002974 Mecloprodin
% 222.65/222.84  |- skos__altLabel mesh__D002974 Meclastine
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D002974 2004
% 222.65/222.84  |- mesh__dateRevised mesh__D002974 2001-07-25
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D002974 2003
% 222.65/222.84  |- rdf__type mesh__D002974sskos__Concept
% 222.65/222.84  |- mesh__recordMaintainer mesh__D002974 ssb
% 222.65/222.84  |- skos__altLabel mesh__D002974
% 222.65/222.84       2-%28%2-%28%1-%28%4-Chlorophenyl%29%-1-phenylethoxy%29%ethyl%29%-1-methylpyrrolidine
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D002176 2006
% 222.65/222.84  |- mesh__dateEstablished mesh__D002176 1973-01-01
% 222.65/222.84  |- mesh__dateRevised mesh__D002176 2005-06-30
% 222.65/222.84  |- skos__annotation mesh__D002176
% 222.65/222.84       infection = CANDIDIASIS or its indentions %26% do not coord with CANDIDA ALBICANS unless particularly discussed%A%  
% 222.65/222.84  |- skos__historyNote mesh__D002176 Candida %28%1966-1971%29%
% 222.65/222.84  |- mesh__recordMaintainer mesh__D002176 SYSTEM
% 222.65/222.84  |- skos__broader mesh__D002176smesh__D002175
% 222.65/222.84  |- mesh__recordAuthorizer mesh__D002176 sjn
% 222.65/222.84  |- mesh__dateCreated mesh__D002176 1999-01-01
% 222.65/222.84  |- rdf__type mesh__D002176sskos__Concept
% 222.65/222.84  |- mesh__publicMeSHNote mesh__D002176 73   
% 222.65/222.84  |- mesh__recordOriginator mesh__D002176 NLM
% 222.65/222.84  |- skos__prefLabel mesh__D002176 Candida albicans
% 222.65/222.84  |- mesh__historyNote mesh__D002176 73%28%72%29%   
% 222.65/222.84  |- skos__scopeNote mesh__D002176
% 222.65/222.84       A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS %28%moniliasis%29%.%A%    
% 222.65/222.84  |- skos__hiddenLabel mesh__D010608 Diseases, Pharynx
% 222.65/222.84  |- mesh__recordAuthorizer mesh__D010608 PLS
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010608 2006
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010608 1997
% 222.65/222.84  |- mesh__recordMaintainer mesh__D010608 TAP
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010608 2005
% 222.65/222.84  |- skos__prefLabel mesh__D010608 Pharyngeal Diseases
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010608 1996
% 222.65/222.84  |- skos__hiddenLabel mesh__D010608 Pharynx Disease
% 222.65/222.84  |- skos__hiddenLabel mesh__D010608 Pharyngeal Disease
% 222.65/222.84  |- mesh__dateEstablished mesh__D010608 1966-01-01
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010608 2001
% 222.65/222.84  |- mesh__publicMeSHNote mesh__D010608 66   
% 222.65/222.84  |- skos__broader mesh__D010608smesh__D010038
% 222.65/222.84  |- skos__annotation mesh__D010608 inflamm dis = PHARYNGITIS   
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010608 1999
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010608 1993
% 222.65/222.84  |- mesh__recordOriginator mesh__D010608 NLM
% 222.65/222.84  |- skos__altLabel mesh__D010608 Pharynx Diseases
% 222.65/222.84  |- mesh__dateCreated mesh__D010608 1999-01-01
% 222.65/222.84  |- rdf__type mesh__D010608sskos__Concept
% 222.65/222.84  |- skos__hiddenLabel mesh__D010608 Disease, Pharynx
% 222.65/222.84  |- skos__hiddenLabel mesh__D010608 Disease, Pharyngeal
% 222.65/222.84  |- skos__scopeNote mesh__D010608
% 222.65/222.84       General or unspecified diseases of the pharynx.     
% 222.65/222.84  |- mesh__dateRevised mesh__D010608 1990-03-29
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010608 1998
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010608 1992
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010608 2000
% 222.65/222.84  |- skos__hiddenLabel mesh__D010608 Diseases, Pharyngeal
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010608 1991
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010608 2004
% 222.65/222.84  |- mesh__historyNote mesh__D010608 66   
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010608 1995
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010608 2003
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010608 1994
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D010608 2002
% 222.65/222.84  |- skos__broader mesh__D010608smesh__D009057
% 222.65/222.84  |- mesh__activeMeSHYear mesh__D039741 2006
% 222.65/222.84  |- skos__altLabel mesh__D039741 Antigens, House Dust Mites
% 222.65/222.84  |- mesh__dateRevised mesh__D039741 2005-06-30
% 222.65/222.84  |- skos__historyNote mesh__D039741 Dust %28%1968-2002%29%
% 222.65/222.84  |- mesh__recordAuthorizer mesh__D039741 sjn
% 222.65/222.84  |- skos__prefLabel mesh__D039741 Antigens, Dermatophagoides
% 222.65/222.84  |- skos__annotation mesh__D039741 coordinate with ALLERGENS if pertinent   
% 222.65/222.84  |- mesh__recordOriginator mesh__D039741 lkt
% 222.65/222.84  |- mesh__historyNote mesh__D039741 2003   
% 222.65/222.84  |- skos__hiddenLabel mesh__D039741 Dermatophagoides pteronyssinus Antigens
% 222.65/222.84  |- skos__historyNote mesh__D039741 Allergens %28%1968-2002%29%
% 222.65/222.84  |- skos__scopeNote mesh__D039741
% 222.65/222.84       Antigens from the house dust mites %28%DERMATOPHAGOIDES%29%, mainly D. farinae and D. pteronyssinus. They are proteins, found in mite feces or mite extracts, that can cause ASTHMA and other allergic diseases such as perennial rhinitis %28%RHINITIS, ALLERGIC, PERENNIAL%29% and atopic dermatitis %28%DERMATITIS, ATOPIC%29%. More than 11 groups of Dermatophagoides ALLERGENS have been defined. Group I allergens, such as Der f I and Der p I from the above two species, are among the strongest mite immunogens in humans.%A%    
% 222.65/222.84  |- skos__hiddenLabel mesh__D039741 Dermatophagoides farinae Antigens
% 222.65/222.84  |- mesh__publicMeSHNote mesh__D039741 2003   
% 222.65/222.84  |- mesh__recordMaintainer mesh__D039741 ssb
% 222.65/222.84  |- mesh__dateEstablished mesh__D039741 2003-01-01
% 222.65/222.84  |- skos__broader mesh__D039741smesh__D000941
% 222.65/222.84  |- mesh__dateCreated mesh__D039741 2002-07-02
% 222.65/222.84  |- rdf__type mesh__D039741sskos__Concept
% 222.65/222.84  |- skos__hiddenLabel mesh__D039741
% 222.65/222.84       Allergens, Dermatophagoides pteronyssinus
% 222.65/222.84  |- skos__hiddenLabel mesh__D039741 Allergens, Dermatophagoides
% 222.65/222.84  |- skos__altLabel mesh__D039741 Allergens, House Dust Mites
% 222.65/222.84  |- skos__hiddenLabel mesh__D039741 Allergens, Dermatophagoides farinae
% 222.65/222.84  |- skos__hiddenLabel mesh__D039741 Dermatophagoides Antigens
% 222.65/222.84  |- mesh__historyNote mesh__D006567 2002 %28%1975%29%   
% 222.65/222.84  |- skos__broader mesh__D006567smesh__D018144
% 222.65/222.84  |- skos__prefLabel mesh__D006567 Herpesvirus 2, Saimiriine
% 222.65/222.85  |- mesh__dateCreated mesh__D006567 1974-12-12
% 222.65/222.85  |- mesh__dateEstablished mesh__D006567 1980-01-01
% 222.65/222.85  |- mesh__publicMeSHNote mesh__D006567
% 222.65/222.85       2002; see HERPESVIRUS SAIMIRINE 1994-2001, see HERPESVIRUS SAIMIRI 1980-1993, see HERPESVIRUSES 1975-1979%A%  
% 222.65/222.85  |- mesh__recordMaintainer mesh__D006567 ags
% 222.65/222.85  |- skos__altLabel mesh__D006567 Herpesvirus 2 %28%gamma%29%, Saimirine
% 222.65/222.85  |- rdf__type mesh__D006567sskos__Concept
% 222.65/222.85  |- skos__annotation mesh__D006567
% 222.65/222.85       do not confuse with HERPESVIRUS 1, SAIMIRIINE see SIMPLEXVIRUS; infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%%A%  
% 222.65/222.85  |- skos__hiddenLabel mesh__D006567 saimiri, Herpesvirus
% 222.65/222.85  |- skos__altLabel mesh__D006567 Herpesvirus 2, Saimirine
% 222.65/222.85  |- skos__scopeNote mesh__D006567
% 222.65/222.85       The type species of RHADINOVIRUS, in the subfamily GAMMAHERPESVIRINAE, isolated from squirrel monkeys. It produces malignant lymphomas %28%LYMPHOMA, MALIGNANT%29% in inoculated marmosets or owl monkeys.%A%    
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D006567 2005
% 222.65/222.85  |- mesh__dateRevised mesh__D006567 2001-07-25
% 222.65/222.85  |- skos__altLabel mesh__D006567 Herpesvirus saimiri
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D006567 2006
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D006567 2003
% 222.65/222.85  |- skos__altLabel mesh__D006567 Saimirine Herpesvirus 2
% 222.65/222.85  |- skos__altLabel mesh__D006567 Saimiriine herpesvirus 2
% 222.65/222.85  |- mesh__recordAuthorizer mesh__D006567 sjn
% 222.65/222.85  |- skos__historyNote mesh__D006567 Herpesviridae %28%1966-1974%29%
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D006567 2004
% 222.65/222.85  |- mesh__recordOriginator mesh__D006567 NLM
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D006567 2002
% 222.65/222.85  |- skos__hiddenLabel mesh__D020238 Recognition Agnosia, Facial
% 222.65/222.85  |- skos__hiddenLabel mesh__D020238 Prosopagnosias
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D020238 2005
% 222.65/222.85  |- mesh__dateEstablished mesh__D020238 2000-01-01
% 222.65/222.85  |- skos__hiddenLabel mesh__D020238 Acquired Prosopagnosias
% 222.65/222.85  |- skos__hiddenLabel mesh__D020238 Developmental Prosopagnosias
% 222.65/222.85  |- skos__hiddenLabel mesh__D020238 Agnosia for Face
% 222.65/222.85  |- mesh__historyNote mesh__D020238 2000   
% 222.65/222.85  |- mesh__dateCreated mesh__D020238 1999-11-08
% 222.65/222.85  |- mesh__publicMeSHNote mesh__D020238 2000   
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D020238 2003
% 222.65/222.85  |- skos__historyNote mesh__D020238 Vision Disorders %28%1967-1999%29%
% 222.65/222.85  |- skos__broader mesh__D020238smesh__D000377
% 222.65/222.85  |- skos__altLabel mesh__D020238 Agnosia for Faces
% 222.65/222.85  |- skos__hiddenLabel mesh__D020238 Prosopagnosias, Acquired
% 222.65/222.85  |- skos__altLabel mesh__D020238 Facial Recognition Agnosia
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D020238 2001
% 222.65/222.85  |- skos__historyNote mesh__D020238 Agnosia %28%1967-1999%29%
% 222.65/222.85  |- skos__hiddenLabel mesh__D020238 Recognition Agnosias, Facial
% 222.65/222.85  |- skos__hiddenLabel mesh__D020238 Developmental Prosopagnosia
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D020238 2000
% 222.65/222.85  |- skos__hiddenLabel mesh__D020238 Acquired Prosopagnosia
% 222.65/222.85  |- rdf__type mesh__D020238sskos__Concept
% 222.65/222.85  |- skos__hiddenLabel mesh__D020238 Agnosia, Facial Recognition
% 222.65/222.85  |- skos__scopeNote mesh__D020238
% 222.65/222.85       The inability to recognize a familiar face or to learn to recognize new faces. This visual agnosia is most often associated with lesions involving the junctional regions between the temporal and occipital lobes. The majority of cases are associated with bilateral lesions, however unilateral damage to the right occipito-temporal cortex has also been associated with this condition. %28%From Cortex 1995 Jun;31%28%2%29%:317-29%29%%A%    
% 222.65/222.85  |- skos__hiddenLabel mesh__D020238 Agnosias, Facial Recognition
% 222.65/222.85  |- skos__prefLabel mesh__D020238 Prosopagnosia
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D020238 2006
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D020238 2002
% 222.65/222.85  |- skos__hiddenLabel mesh__D020238 Prosopagnosias, Developmental
% 222.65/222.85  |- skos__hiddenLabel mesh__D020238 Facial Recognition Agnosias
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D020238 2004
% 222.65/222.85  |- mesh__dateCreated mesh__D025721 2001-07-25
% 222.65/222.85  |- skos__altLabel mesh__D025721 WT1 Protein
% 222.65/222.85  |- mesh__historyNote mesh__D025721
% 222.65/222.85       2002; for WT1 PROTEIN use WT1 PROTEINS %28%NM%29% 1991-2001   
% 222.65/222.85  |- skos__historyNote mesh__D025721 DNA-Binding Proteins %28%1991-2001%29%
% 222.65/222.85  |- skos__scopeNote mesh__D025721
% 222.65/222.85       Isoforms encoded by the WT1 Wilms tumor suppressor gene %28%GENES, WILMS TUMOR%29% and produced by alternative splicings. They are zinc finger-containing transcription factors involved in both transactivation and repression, and are critical for normal development and function of the urogenital tract.%A%    
% 222.65/222.85  |- skos__related mesh__D025721smesh__D009396
% 222.65/222.85  |- skos__hiddenLabel mesh__D025721 Gene Product, WT1
% 222.65/222.85  |- mesh__recordOriginator mesh__D025721 nns
% 222.65/222.85  |- skos__prefLabel mesh__D025721 WT1 Proteins
% 222.65/222.85  |- mesh__dateEstablished mesh__D025721 2002-01-01
% 222.65/222.85  |- skos__historyNote mesh__D025721 Transcription Factors %28%1991-2001%29%
% 222.65/222.85  |- skos__broader mesh__D025721smesh__D025521
% 222.65/222.85  |- skos__hiddenLabel mesh__D025721 Proteins, WT1
% 222.65/222.85  |- mesh__recordMaintainer mesh__D025721 SYSTEM
% 222.65/222.85  |- skos__altLabel mesh__D025721 WT1 Gene Product
% 222.65/222.85  |- mesh__dateRevised mesh__D025721 2005-06-30
% 222.65/222.85  |- rdf__type mesh__D025721sskos__Concept
% 222.65/222.85  |- skos__hiddenLabel mesh__D025721 Protein, WT1
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D025721 2006
% 222.65/222.85  |- skos__related mesh__D025721smesh__D016162
% 222.65/222.85  |- mesh__recordAuthorizer mesh__D025721 sjn
% 222.65/222.85  |- mesh__publicMeSHNote mesh__D025721
% 222.65/222.85       2002; WT1 PROTEIN was indexed as DNA-BINDING PROTEINS and TRANSCRIPTION FACTORS 1991-2001%A%  
% 222.65/222.85  |- mesh__dateRevised mesh__D011701 2005-06-30
% 222.65/222.85  |- rdf__type mesh__D011701sskos__Concept
% 222.65/222.85  |- skos__hiddenLabel mesh__D011701 PUVA Therapies
% 222.65/222.85  |- skos__historyNote mesh__D011701 Photochemotherapy %28%1978-Feb 81%29%
% 222.65/222.85  |- skos__historyNote mesh__D011701 Coumarins %28%1966-1974%29%
% 222.65/222.85  |- mesh__historyNote mesh__D011701
% 222.65/222.85       86%28%Mar 81%29%; was see under PHOTOCHEMOTHERAPY 1981-85   
% 222.65/222.85  |- skos__scopeNote mesh__D011701
% 222.65/222.85       Photochemotherapy using a psoralen compound as the photosensitizing agent and ultraviolet light type A %28%UVA%29%.%A%    
% 222.65/222.85  |- skos__historyNote mesh__D011701 Methoxsalen %28%1966-Feb 81%29%
% 222.65/222.85  |- mesh__dateCreated mesh__D011701 1980-12-10
% 222.65/222.85  |- mesh__dateEstablished mesh__D011701 1986-01-01
% 222.65/222.85  |- skos__altLabel mesh__D011701 Psoralen Ultraviolet A Therapy
% 222.65/222.85  |- skos__historyNote mesh__D011701 Ultraviolet Therapy %28%1966-Feb 81%29%
% 222.65/222.85  |- skos__broader mesh__D011701smesh__D014467
% 222.65/222.85  |- skos__historyNote mesh__D011701 Psoralens %28%1979-Feb 81%29%
% 222.65/222.85  |- mesh__publicMeSHNote mesh__D011701
% 222.65/222.85       86; was see under PHOTOCHEMOTHERAPY 1981-85   
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D011701 2006
% 222.65/222.85  |- mesh__recordAuthorizer mesh__D011701 sjn
% 222.65/222.85  |- skos__annotation mesh__D011701
% 222.65/222.85       photochemother with a psoralen cpd %26% ultraviolet light type A %28%UVA%29%; IM; do not use /util except by MeSH definition; coord with disease /drug ther %28%IM%29%; do not index under psoralen cpd or UV angle unless particularly discussed%A%  
% 222.65/222.85  |- skos__altLabel mesh__D011701 Therapy, PUVA
% 222.65/222.85  |- skos__historyNote mesh__D011701 Ficusin %28%1975-Feb 81%29%
% 222.65/222.85  |- mesh__recordOriginator mesh__D011701 SMH
% 222.65/222.85  |- mesh__recordMaintainer mesh__D011701 lkt
% 222.65/222.85  |- skos__historyNote mesh__D011701 Trioxsalen %28%1975-Feb 81%29%
% 222.65/222.85  |- skos__prefLabel mesh__D011701 PUVA Therapy
% 222.65/222.85  |- skos__hiddenLabel mesh__D011701 Therapies, PUVA
% 222.65/222.85  |- rdf__type mesh__D016995sskos__Concept
% 222.65/222.85  |- mesh__recordAuthorizer mesh__D016995 sjn
% 222.65/222.85  |- mesh__dateEstablished mesh__D016995 1992-01-01
% 222.65/222.85  |- skos__scopeNote mesh__D016995
% 222.65/222.85       A species of gram-negative bacteria in the family ANAPLASMATACEAE, that causes HEARTWATER DISEASE in ruminants.%A%    
% 222.65/222.85  |- mesh__recordOriginator mesh__D016995 PXP
% 222.65/222.85  |- mesh__recordMaintainer mesh__D016995 SYSTEM
% 222.65/222.85  |- skos__annotation mesh__D016995 infection = HEARTWATER DISEASE   
% 222.65/222.85  |- skos__broader mesh__D016995smesh__D004536
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D016995 2006
% 222.65/222.85  |- mesh__dateRevised mesh__D016995 2005-06-30
% 222.65/222.85  |- mesh__historyNote mesh__D016995 2003 %28%1992%29%   
% 222.65/222.85  |- skos__prefLabel mesh__D016995 Ehrlichia ruminantium
% 222.65/222.85  |- mesh__dateCreated mesh__D016995 1991-05-30
% 222.65/222.85  |- mesh__publicMeSHNote mesh__D016995 2003; see COWDRIA 1992-2002   
% 222.65/222.85  |- skos__altLabel mesh__D016995 Cowdria ruminantium
% 222.65/222.85  |- skos__historyNote mesh__D016995 Rickettsiaceae %28%1981-1991%29%
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002177 2002
% 222.65/222.85  |- mesh__dateCreated mesh__D002177 1999-01-01
% 222.65/222.85  |- mesh__recordOriginator mesh__D002177 NLM
% 222.65/222.85  |- rdf__type mesh__D002177sskos__Concept
% 222.65/222.85  |- mesh__recordAuthorizer mesh__D002177 PLS
% 222.65/222.85  |- skos__annotation mesh__D002177
% 222.65/222.85       fungus dis; do not bother to coord with CANDIDA or CANDIDA ALBICANS%A%  
% 222.65/222.85  |- skos__hiddenLabel mesh__D002177 Candidiases
% 222.65/222.85  |- skos__scopeNote mesh__D002177
% 222.65/222.85       Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. %28%Dorland, 27th ed%29%%A%    
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002177 2005
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002177 1998
% 222.65/222.85  |- skos__prefLabel mesh__D002177 Candidiasis
% 222.65/222.85  |- mesh__publicMeSHNote mesh__D002177 81; was MONILIASIS 1963-80   
% 222.65/222.85  |- skos__altLabel mesh__D002177 Moniliasis
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002177 2003
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002177 1996
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002177 2006
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002177 1999
% 222.65/222.85  |- skos__broader mesh__D002177smesh__D009181
% 222.65/222.85  |- mesh__onlineNote mesh__D002177
% 222.65/222.85       use CANDIDIASIS to search MONILIASIS 1966-80   
% 222.65/222.85  |- skos__hiddenLabel mesh__D002177 Moniliases
% 222.65/222.85  |- mesh__historyNote mesh__D002177 81; was MONILIASIS 1963-80   
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002177 2000
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002177 2004
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002177 1997
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002177 2001
% 222.65/222.85  |- mesh__recordMaintainer mesh__D002177 RAZ
% 222.65/222.85  |- mesh__dateRevised mesh__D002177 1995-06-08
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D010609 2005
% 222.65/222.85  |- skos__broader mesh__D010609smesh__D010614
% 222.65/222.85  |- skos__historyNote mesh__D010609 Muscles %28%1966-1978%29%
% 222.65/222.85  |- skos__prefLabel mesh__D010609 Pharyngeal Muscles
% 222.65/222.85  |- skos__annotation mesh__D010609
% 222.65/222.85       /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 222.65/222.85  |- mesh__dateEstablished mesh__D010609 1991-01-01
% 222.65/222.85  |- rdf__type mesh__D010609sskos__Concept
% 222.65/222.85  |- mesh__recordOriginator mesh__D010609 RC
% 222.65/222.85  |- mesh__recordAuthorizer mesh__D010609 sjn
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D010609 2004
% 222.65/222.85  |- mesh__recordMaintainer mesh__D010609 lkt
% 222.65/222.85  |- mesh__dateRevised mesh__D010609 2003-07-09
% 222.65/222.85  |- mesh__historyNote mesh__D010609
% 222.65/222.85       91%28%79%29%; was see under MUSCLES 1979-90   
% 222.65/222.85  |- skos__hiddenLabel mesh__D010609 Muscle, Pharyngeal
% 222.65/222.85  |- mesh__publicMeSHNote mesh__D010609 91; was see under MUSCLES 1979-90   
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D010609 2006
% 222.65/222.85  |- mesh__dateCreated mesh__D010609 1978-05-19
% 222.65/222.85  |- skos__broader mesh__D010609smesh__D018482
% 222.65/222.85  |- skos__historyNote mesh__D010609 Pharynx %28%1966-1978%29%
% 222.65/222.85  |- skos__scopeNote mesh__D010609
% 222.65/222.85       The muscles of the pharynx are the inferior, middle and superior constrictors, salpingopharyngeus, and stylopharyngeus.%A%    
% 222.65/222.85  |- skos__hiddenLabel mesh__D010609 Muscles, Pharyngeal
% 222.65/222.85  |- skos__hiddenLabel mesh__D010609 Pharyngeal Muscle
% 222.65/222.85  |- skos__historyNote mesh__D007660 Propionates %28%1966-1967%29%
% 222.65/222.85  |- skos__historyNote mesh__D007660 Benzophenones %28%1968-1974%29%
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D007660 2006
% 222.65/222.85  |- skos__broader mesh__D007660smesh__D010666
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D007660 2001
% 222.65/222.85  |- skos__altLabel mesh__D007660 2-%28%3-Benzoylphenyl%29%propionic Acid
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D007660 2003
% 222.65/222.85  |- mesh__dateEstablished mesh__D007660 1990-01-01
% 222.65/222.85  |- mesh__dateRevised mesh__D007660 2000-06-21
% 222.65/222.85  |- rdf__type mesh__D007660sskos__Concept
% 222.65/222.85  |- skos__scopeNote mesh__D007660
% 222.65/222.85       An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis.%A%    
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D007660 2004
% 222.65/222.85  |- skos__hiddenLabel mesh__D007660 RP19583
% 222.65/222.85  |- skos__hiddenLabel mesh__D007660 RP, 19,583
% 222.65/222.85  |- skos__hiddenLabel mesh__D007660 RP 19583
% 222.65/222.85  |- skos__prefLabel mesh__D007660 Ketoprofen
% 222.65/222.85  |- mesh__dateCreated mesh__D007660 1974-11-19
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D007660 2002
% 222.65/222.85  |- skos__historyNote mesh__D007660 Ketones %28%1966-1967%29%
% 222.65/222.85  |- mesh__recordAuthorizer mesh__D007660 sjn
% 222.65/222.85  |- skos__altLabel mesh__D007660 Benzoylhydratropic Acid
% 222.65/222.85  |- skos__altLabel mesh__D007660 RP-19583
% 222.65/222.85  |- mesh__publicMeSHNote mesh__D007660
% 222.65/222.85       90; was see under PHENYLPROPIONATES 1978-89; was see under BENZOPHENONES 1975-77%A%  
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D007660 2005
% 222.65/222.85  |- mesh__recordMaintainer mesh__D007660 CCR
% 222.65/222.85  |- mesh__recordOriginator mesh__D007660 NLM
% 222.65/222.85  |- mesh__historyNote mesh__D007660
% 222.65/222.85       90%28%75%29%; was see under PHENYLPROPIONATES 1978-89; was see under BENZOPHENONES 1975-77%A%  
% 222.65/222.85  |- skos__prefLabel mesh__D020239 Receptor Cross-Talk
% 222.65/222.85  |- skos__hiddenLabel mesh__D020239 Cross Talk, Receptor
% 222.65/222.85  |- skos__broader mesh__D020239smesh__D002468
% 222.65/222.85  |- skos__related mesh__D020239smesh__D011940
% 222.65/222.85  |- mesh__publicMeSHNote mesh__D020239 99   
% 222.65/222.85  |- mesh__dateCreated mesh__D020239 1998-06-11
% 222.65/222.85  |- mesh__recordMaintainer mesh__D020239 sjn
% 222.65/222.85  |- mesh__dateEstablished mesh__D020239 1999-01-01
% 222.65/222.85  |- rdf__type mesh__D020239sskos__Concept
% 222.65/222.85  |- mesh__dateRevised mesh__D020239 2000-06-22
% 222.65/222.85  |- mesh__recordOriginator mesh__D020239 NDW
% 222.65/222.85  |- mesh__historyNote mesh__D020239 99   
% 222.65/222.85  |- skos__scopeNote mesh__D020239
% 222.65/222.85       The simultaneous or sequential binding of multiple cell surface receptors to different ligands resulting in coordinated stimulation or suppression of signal transduction.%A%    
% 222.65/222.85  |- skos__historyNote mesh__D020239 Signal Transduction %28%1989-1998%29%
% 222.65/222.85  |- skos__related mesh__D020239smesh__D011956
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D020239 2005
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D020239 2001
% 222.65/222.85  |- skos__hiddenLabel mesh__D020239 Cross-Talk, Receptor
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D020239 2003
% 222.65/222.85  |- skos__related mesh__D020239smesh__D015398
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D020239 2006
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D020239 2002
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D020239 2004
% 222.65/222.85  |- skos__altLabel mesh__D020239 Receptor Cross Talk
% 222.65/222.85  |- mesh__recordAuthorizer mesh__D020239 sjn
% 222.65/222.85  |- mesh__recordAuthorizer mesh__D006568 sjn
% 222.65/222.85  |- skos__hiddenLabel mesh__D006568 B Viruses
% 222.65/222.85  |- mesh__recordMaintainer mesh__D006568 ags
% 222.65/222.85  |- skos__altLabel mesh__D006568 Herpesvirus B
% 222.65/222.85  |- mesh__dateEstablished mesh__D006568 1991-01-01
% 222.65/222.85  |- skos__scopeNote mesh__D006568
% 222.65/222.85       A species of SIMPLEXVIRUS that causes vesicular lesions of the mouth in monkeys. When the virus is transmitted to man it causes an acute encephalitis or encephalomyelitis, which is nearly always fatal.%A%    
% 222.65/222.85  |- mesh__recordOriginator mesh__D006568 NLM
% 222.65/222.85  |- rdf__type mesh__D006568sskos__Concept
% 222.65/222.85  |- skos__hiddenLabel mesh__D006568 Herpes B Viruses
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D006568 2002
% 222.65/222.85  |- skos__altLabel mesh__D006568 Herpes B Virus
% 222.65/222.85  |- skos__prefLabel mesh__D006568 Herpesvirus 1, Cercopithecine
% 222.65/222.85  |- skos__altLabel mesh__D006568 Cercopithecine herpesvirus 1
% 222.65/222.85  |- skos__altLabel mesh__D006568 Simian Herpesvirus
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D006568 2005
% 222.65/222.85  |- mesh__dateCreated mesh__D006568 1999-01-01
% 222.65/222.85  |- skos__annotation mesh__D006568
% 222.65/222.85       infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29%   
% 222.65/222.85  |- skos__hiddenLabel mesh__D006568 Simian Herpesviruses
% 222.65/222.85  |- skos__altLabel mesh__D006568 Herpesvirus simiae
% 222.65/222.85  |- skos__altLabel mesh__D006568 Herpes Virus B
% 222.65/222.85  |- skos__hiddenLabel mesh__D006568 Monkey B Viruses
% 222.65/222.85  |- skos__altLabel mesh__D006568 B Virus
% 222.65/222.85  |- skos__hiddenLabel mesh__D006568 Herpesviruses, Simian
% 222.65/222.85  |- skos__altLabel mesh__D006568 Monkey B Virus
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D006568 2006
% 222.65/222.85  |- skos__altLabel mesh__D006568 Herpesvirus 1 %28%alpha%29%, Cercopithecine
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D006568 2003
% 222.65/222.85  |- mesh__historyNote mesh__D006568
% 222.65/222.85       94; was HERPESVIRUS SIMIAE 1991-93; was HERPESVIRUS SIMIAN B see under HERPESVIRIDAE 1981-90 %26% see under HERPESVIRUSES 1971-80 %28%Prov 1971-74%29%; HERPESVIRUS SIMIAN B was see HERPESVIRUS SIMIAE 1991-93%A%  
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D006568 2004
% 222.65/222.85  |- mesh__publicMeSHNote mesh__D006568
% 222.65/222.85       94; was HERPESVIRUS SIMIAE 1991-93; was HERPESVIRUS SIMIAN B see under HERPESVIRIDAE 1981-90 %26% see under HERPESVIRUSES 1975-80; HERPESVIRUS SIMIAN B was see HERPESVIRUS SIMIAE 1991-93%A%  
% 222.65/222.85  |- mesh__dateRevised mesh__D006568 2001-07-25
% 222.65/222.85  |- skos__hiddenLabel mesh__D006568 Herpesvirus, Simian
% 222.65/222.85  |- skos__broader mesh__D006568smesh__D018139
% 222.65/222.85  |- mesh__onlineNote mesh__D006568
% 222.65/222.85       use HERPESVIRUS 1, CERCOPITHECINE to search HERPESVIRUS SIMIAE 1991-93 %26% HERPESVIRUS SIMIAN B 1971-93 %28%as Prov 1971-74%29%%A%  
% 222.65/222.85  |- skos__historyNote mesh__D006568 Herpesviridae %28%1966-1970%29%
% 222.65/222.85  |- mesh__dateCreated mesh__D017290 1992-05-18
% 222.65/222.85  |- mesh__dateRevised mesh__D017290 2004-07-07
% 222.65/222.85  |- skos__broader mesh__D017290smesh__D009621
% 222.65/222.85  |- mesh__publicMeSHNote mesh__D017290
% 222.65/222.85       93; 7-O-METHYLNOGAROL was indexed under NOGALAMYCIN/analogs %26% derivatives 1979-92%A%  
% 222.65/222.85  |- skos__hiddenLabel mesh__D017290 TUT 7
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D017290 2005
% 222.65/222.85  |- skos__scopeNote mesh__D017290
% 222.65/222.85       A semisynthetic anthracycline with the amino sugar on the D ring. It displays broad-spectrum antineoplastic activity against a variety of tumors.%A%    
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D017290 2006
% 222.65/222.85  |- skos__altLabel mesh__D017290 7-O-Methylnogarol
% 222.65/222.85  |- skos__altLabel mesh__D017290 Menogarol
% 222.65/222.85  |- rdf__type mesh__D017290sskos__Concept
% 222.65/222.85  |- mesh__onlineNote mesh__D017290
% 222.65/222.85       use MENOGARIL %28%NM%29% to search 7-O-METHYLNOGAROL 1980-93   
% 222.65/222.85  |- mesh__historyNote mesh__D017290
% 222.65/222.85       93; was 7-O-METHYLNOGAROL %28%NM%29% 1979-92   
% 222.65/222.85  |- mesh__recordOriginator mesh__D017290 TPW
% 222.65/222.85  |- skos__historyNote mesh__D017290
% 222.65/222.85       Nogalamycin/analogs %26% derivatives %28%1979-1992%29%
% 222.65/222.85  |- skos__hiddenLabel mesh__D017290 TUT7
% 222.65/222.85  |- mesh__dateEstablished mesh__D017290 1993-01-01
% 222.65/222.85  |- skos__altLabel mesh__D017290 7-con-O-Methylnogarol
% 222.65/222.85  |- skos__hiddenLabel mesh__D017290 NSC 269148
% 222.65/222.85  |- mesh__recordAuthorizer mesh__D017290 sjn
% 222.65/222.85  |- skos__hiddenLabel mesh__D017290 NSC269148
% 222.65/222.85  |- skos__altLabel mesh__D017290 7-OMEN
% 222.65/222.85  |- mesh__recordMaintainer mesh__D017290 ssb
% 222.65/222.85  |- skos__prefLabel mesh__D017290 Menogaril
% 222.65/222.85  |- skos__historyNote mesh__D025722 Baculoviridae %28%1995-2001%29%
% 222.65/222.85  |- mesh__dateCreated mesh__D025722 2001-07-25
% 222.65/222.85  |- mesh__publicMeSHNote mesh__D025722
% 222.65/222.85       2002; see BACULOVIRIDAE 1997-2001; for GRANULOSIS VIRUSES see BACULOVIRIDAE 1991-2001%A%  
% 222.65/222.85  |- skos__altLabel mesh__D025722 Granulosis Viruses
% 222.65/222.85  |- skos__scopeNote mesh__D025722
% 222.65/222.85       A genus of the family BACULOVIRIDAE, subfamily Eubaculovirinae, characterized by ovicylindrical occlusion bodies. The type species is Cydia pomonella granulovirus.%A%    
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D025722 2005
% 222.65/222.85  |- skos__broader mesh__D025722smesh__D016367
% 222.65/222.85  |- mesh__historyNote mesh__D025722
% 222.65/222.85       2002; use BACULOVIRIDAE 1997-2001; for GRANULOSIS VIRUSES use BACULOVIRIDAE 1991-2001%A%  
% 222.65/222.85  |- skos__hiddenLabel mesh__D025722 Cydia pomonella granuloviruses
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D025722 2004
% 222.65/222.85  |- mesh__dateEstablished mesh__D025722 2002-01-01
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D025722 2003
% 222.65/222.85  |- mesh__recordMaintainer mesh__D025722 ags
% 222.65/222.85  |- rdf__type mesh__D025722sskos__Concept
% 222.65/222.85  |- mesh__recordAuthorizer mesh__D025722 sjn
% 222.65/222.85  |- skos__hiddenLabel mesh__D025722 Granulosis Virus
% 222.65/222.85  |- skos__hiddenLabel mesh__D025722 granulovirus, Cydia pomonella
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D025722 2002
% 222.65/222.85  |- mesh__recordOriginator mesh__D025722 ags
% 222.65/222.85  |- skos__annotation mesh__D025722 coord with specific insect /virol   
% 222.65/222.85  |- skos__prefLabel mesh__D025722 Granulovirus
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D025722 2006
% 222.65/222.85  |- skos__hiddenLabel mesh__D025722 granuloviruses, Cydia pomonella
% 222.65/222.85  |- rdf__type mesh__D003270sskos__Concept
% 222.65/222.85  |- mesh__dateCreated mesh__D003270 1999-01-01
% 222.65/222.85  |- skos__prefLabel mesh__D003270 Contraceptive Agents
% 222.65/222.85  |- mesh__recordAuthorizer mesh__D003270 sjn
% 222.65/222.85  |- skos__scopeNote mesh__D003270
% 222.65/222.85       Chemical substances that prevent or reduce the probability of CONCEPTION.%A%    
% 222.65/222.85  |- mesh__historyNote mesh__D003270 67   
% 222.65/222.85  |- skos__altLabel mesh__D003270 Contraceptives
% 222.65/222.85  |- mesh__recordOriginator mesh__D003270 NLM
% 222.65/222.85  |- skos__historyNote mesh__D003270 Contraceptive Devices %28%1966%29%
% 222.65/222.85  |- mesh__dateRevised mesh__D003270 2005-06-30
% 222.65/222.85  |- mesh__dateEstablished mesh__D003270 1967-01-01
% 222.65/222.85  |- skos__hiddenLabel mesh__D003270 Agents, Contraceptive
% 222.65/222.85  |- skos__annotation mesh__D003270
% 222.65/222.85       chemical, not mechanical %28% = CONTRACEPTIVE DEVICES%29%; pregn despite use = contraceptive term with no qualif, not with /adv eff%A%  
% 222.65/222.85  |- mesh__publicMeSHNote mesh__D003270 67   
% 222.65/222.85  |- mesh__recordMaintainer mesh__D003270 ssb
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D003270 2006
% 222.65/222.85  |- skos__broader mesh__D003270smesh__D012102
% 222.65/222.85  |- mesh__historyNote mesh__D011702
% 222.65/222.85       PYELOCYSTITIS was heading 1963-96; CYSTOPYELITIS was see PYELOCYSTITIS 1963-96%A%  
% 222.65/222.85  |- mesh__recordAuthorizer mesh__D011702 SJN
% 222.65/222.85  |- mesh__dateRevised mesh__D011702 1997-06-20
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D011702 2001
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D011702 2004
% 222.65/222.85  |- mesh__publicMeSHNote mesh__D011702
% 222.65/222.85       PYELOCYSTITIS was heading 1963-96; CYSTOPYELITIS was see PYELOCYSTITIS 1963-96%A%  
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D011702 2000
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D011702 2006
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D011702 2003
% 222.65/222.85  |- mesh__recordOriginator mesh__D011702 NLM
% 222.65/222.85  |- skos__altLabel mesh__D011702 Cystopyelitis
% 222.65/222.85  |- mesh__dateCreated mesh__D011702 1999-01-01
% 222.65/222.85  |- skos__annotation mesh__D011702 = kidney pelvis inflammation   
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D011702 2005
% 222.65/222.85  |- mesh__recordMaintainer mesh__D011702 NDW
% 222.65/222.85  |- skos__prefLabel mesh__D011702 Pyelitis
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D011702 1999
% 222.65/222.85  |- skos__broader mesh__D011702smesh__D007674
% 222.65/222.85  |- rdf__type mesh__D011702sskos__Concept
% 222.65/222.85  |- skos__scopeNote mesh__D011702
% 222.65/222.85       Inflammation of the pelvis of the kidney. %28%Dorland, 28th ed%29%%A%    
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D011702 1998
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D011702 2002
% 222.65/222.85  |- mesh__recordOriginator mesh__D016996 PXP
% 222.65/222.85  |- mesh__recordMaintainer mesh__D016996 SYSTEM
% 222.65/222.85  |- mesh__publicMeSHNote mesh__D016996 92   
% 222.65/222.85  |- mesh__dateEstablished mesh__D016996 1992-01-01
% 222.65/222.85  |- skos__broader mesh__D016996smesh__D012287
% 222.65/222.85  |- skos__prefLabel mesh__D016996 Rickettsieae
% 222.65/222.85  |- mesh__recordAuthorizer mesh__D016996 sjn
% 222.65/222.85  |- mesh__dateCreated mesh__D016996 1991-05-30
% 222.65/222.85  |- skos__annotation mesh__D016996
% 222.65/222.85       a tribe: do not confuse with RICKETTSIACEAE, a family; infection: coord IM with RICKETTSIACEAE INFECTIONS %28%IM%29%%A%  
% 222.65/222.85  |- rdf__type mesh__D016996sskos__Concept
% 222.65/222.85  |- mesh__historyNote mesh__D016996 92   
% 222.65/222.85  |- skos__scopeNote mesh__D016996
% 222.65/222.85       A tribe of gram-negative bacteria of the family RICKETTSIACEAE whose organisms are found in arthropods and are pathogenic for man and certain other vertebrate hosts.%A%    
% 222.65/222.85  |- mesh__dateRevised mesh__D016996 2005-06-30
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D016996 2006
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002976 2001
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002976 2006
% 222.65/222.85  |- skos__prefLabel mesh__D002976 Clenbuterol
% 222.65/222.85  |- skos__hiddenLabel mesh__D002976 NAB365
% 222.65/222.85  |- mesh__historyNote mesh__D002976
% 222.65/222.85       91%28%78%29%; was see under ETHANOLAMINES 1978-90   
% 222.65/222.85  |- skos__broader mesh__D002976smesh__D004983
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002976 2003
% 222.65/222.85  |- mesh__recordOriginator mesh__D002976 SH
% 222.65/222.85  |- skos__hiddenLabel mesh__D002976 NAB 365
% 222.65/222.85  |- mesh__recordMaintainer mesh__D002976 CCR
% 222.65/222.85  |- mesh__dateEstablished mesh__D002976 1991-01-01
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002976 2002
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002976 2004
% 222.65/222.85  |- mesh__publicMeSHNote mesh__D002976
% 222.65/222.85       91; was see under ETHANOLAMINES 1978-90   
% 222.65/222.85  |- skos__scopeNote mesh__D002976
% 222.65/222.85       A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.%A%    
% 222.65/222.85  |- mesh__recordAuthorizer mesh__D002976 sjn
% 222.65/222.85  |- rdf__type mesh__D002976sskos__Concept
% 222.65/222.85  |- mesh__dateCreated mesh__D002976 1977-04-22
% 222.65/222.85  |- skos__historyNote mesh__D002976 Ethanolamines %28%1973-1977%29%
% 222.65/222.85  |- skos__historyNote mesh__D002976 Amino Alcohols %28%1966-1972%29%
% 222.65/222.85  |- mesh__dateRevised mesh__D002976 2000-06-22
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002976 2005
% 222.65/222.85  |- skos__historyNote mesh__D002178 Candidiasis, Cutaneous %28%1966-1980%29%
% 222.65/222.85  |- mesh__recordMaintainer mesh__D002178 TAP
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002178 1995
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002178 2001
% 222.65/222.85  |- skos__hiddenLabel mesh__D002178 Mucocutaneous Candidiasis, Chronic
% 222.65/222.85  |- skos__hiddenLabel mesh__D002178 Mucocutaneous Candidiases, Chronic
% 222.65/222.85  |- skos__scopeNote mesh__D002178
% 222.65/222.85       A clinical syndrome characterized by development, usually in infancy or childhood, of a chronic, often widespread candidiasis of skin, nails, and mucous membranes. It may be secondary to one of the immunodeficiency syndromes, inherited as an autosomal recessive trait, or associated with defects in cell-mediated immunity, endocrine disorders, dental stomatitis, or malignancy.%A%    
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002178 2005
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002178 2002
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002178 1998
% 222.65/222.85  |- mesh__historyNote mesh__D002178
% 222.65/222.85       91%28%81%29%; was see under CANDIDIASIS 1981-90   
% 222.65/222.85  |- skos__annotation mesh__D002178
% 222.65/222.85       fungus dis of skin; do not bother to coord with CANDIDA or CANDIDA ALBICANS%A%  
% 222.65/222.85  |- skos__prefLabel mesh__D002178 Candidiasis, Chronic Mucocutaneous
% 222.65/222.85  |- mesh__dateCreated mesh__D002178 1980-05-12
% 222.65/222.85  |- skos__hiddenLabel mesh__D002178 Chronic Mucocutaneous Candidiasis
% 222.65/222.85  |- mesh__dateRevised mesh__D002178 1993-06-02
% 222.65/222.85  |- skos__hiddenLabel mesh__D002178 Chronic Mucocutaneous Candidiases
% 222.65/222.85  |- skos__historyNote mesh__D002178 Candidiasis %28%1966-1980%29%
% 222.65/222.85  |- mesh__recordAuthorizer mesh__D002178 PLS
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002178 2006
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002178 2003
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002178 1999
% 222.65/222.85  |- mesh__activeMeSHYear mesh__D002178 1996
% 222.65/222.85  |- mesh__recordOriginator mesh__D002178 SMH
% 222.65/222.86  |- skos__broader mesh__D002178smesh__D003881
% 222.65/222.86  |- skos__broader mesh__D002178smesh__D002177
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002178 2004
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002178 1997
% 222.65/222.86  |- mesh__publicMeSHNote mesh__D002178
% 222.65/222.86       91; was see under CANDIDIASIS 1981-90   
% 222.65/222.86  |- skos__hiddenLabel mesh__D002178 Candidiases, Chronic Mucocutaneous
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002178 1994
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002178 2000
% 222.65/222.86  |- rdf__type mesh__D002178sskos__Concept
% 222.65/222.86  |- mesh__dateEstablished mesh__D002178 1991-01-01
% 222.65/222.86  |- mesh__publicMeSHNote mesh__D007661 74   
% 222.65/222.86  |- mesh__dateEstablished mesh__D007661 1974-01-01
% 222.65/222.86  |- skos__annotation mesh__D007661
% 222.65/222.86       monosaccharides; do not confuse with KETOSIS, a disease   
% 222.65/222.86  |- mesh__recordOriginator mesh__D007661 NLM
% 222.65/222.86  |- rdf__type mesh__D007661sskos__Concept
% 222.65/222.86  |- skos__altLabel mesh__D007661 Keto Sugars
% 222.65/222.86  |- mesh__historyNote mesh__D007661 74   
% 222.65/222.86  |- skos__prefLabel mesh__D007661 Ketoses
% 222.65/222.86  |- mesh__dateRevised mesh__D007661 2004-07-07
% 222.65/222.86  |- mesh__dateCreated mesh__D007661 1999-01-01
% 222.65/222.86  |- mesh__recordMaintainer mesh__D007661 ssb
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D007661 2005
% 222.65/222.86  |- mesh__recordAuthorizer mesh__D007661 sjn
% 222.65/222.86  |- skos__broader mesh__D007661smesh__D009005
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D007661 2006
% 222.65/222.86  |- skos__hiddenLabel mesh__D007661 Sugars, Keto
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D006569 2006
% 222.65/222.86  |- mesh__recordMaintainer mesh__D006569 ssb
% 222.65/222.86  |- skos__scopeNote mesh__D006569
% 222.65/222.86       A flavanone glycoside found in CITRUS fruit peels.     
% 222.65/222.86  |- mesh__recordAuthorizer mesh__D006569 sjn
% 222.65/222.86  |- skos__altLabel mesh__D006569 Hesperetin-7-Rutinoside
% 222.65/222.86  |- skos__broader mesh__D006569smesh__D044950
% 222.65/222.86  |- mesh__recordOriginator mesh__D006569 NLM
% 222.65/222.86  |- skos__prefLabel mesh__D006569 Hesperidin
% 222.65/222.86  |- mesh__onlineNote mesh__D006569 search BIOFLAVONOIDS 1966-74   
% 222.65/222.86  |- skos__hiddenLabel mesh__D006569 Hesperetin 7 Rutinoside
% 222.65/222.86  |- mesh__historyNote mesh__D006569
% 222.65/222.86       91%28%75%29%; was see under BIOFLAVONOIDS 1975-90   
% 222.65/222.86  |- mesh__dateRevised mesh__D006569 2005-06-30
% 222.65/222.86  |- rdf__type mesh__D006569sskos__Concept
% 222.65/222.86  |- mesh__dateEstablished mesh__D006569 1991-01-01
% 222.65/222.86  |- mesh__publicMeSHNote mesh__D006569
% 222.65/222.86       91; was see under BIOFLAVONOIDS 1975-90   
% 222.65/222.86  |- mesh__dateCreated mesh__D006569 1999-01-01
% 222.65/222.86  |- mesh__recordOriginator mesh__D017291 TPW
% 222.65/222.86  |- skos__hiddenLabel mesh__D017291 TE 031
% 222.65/222.86  |- mesh__recordMaintainer mesh__D017291 ssb
% 222.65/222.86  |- skos__altLabel mesh__D017291 6-O-Methylerythromycin
% 222.65/222.86  |- mesh__dateCreated mesh__D017291 1992-05-07
% 222.65/222.86  |- skos__broader mesh__D017291smesh__D004917
% 222.65/222.86  |- skos__hiddenLabel mesh__D017291 TE031
% 222.65/222.86  |- skos__hiddenLabel mesh__D017291 A56268
% 222.65/222.86  |- mesh__historyNote mesh__D017291
% 222.65/222.86       93; was CLARITHROMYCIN %28%NM%29% 1987-92   
% 222.65/222.86  |- mesh__dateRevised mesh__D017291 2004-07-07
% 222.65/222.86  |- skos__historyNote mesh__D017291
% 222.65/222.86       Erythromycin/analogs %26% derivatives %28%1987-1992%29%
% 222.65/222.86  |- skos__prefLabel mesh__D017291 Clarithromycin
% 222.65/222.86  |- skos__hiddenLabel mesh__D017291 A 56268
% 222.65/222.86  |- mesh__recordAuthorizer mesh__D017291 sjn
% 222.65/222.86  |- mesh__dateEstablished mesh__D017291 1993-01-01
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D017291 2006
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D017291 2005
% 222.65/222.86  |- skos__scopeNote mesh__D017291
% 222.65/222.86       A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit protein synthesis in bacteria by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation.%A%    
% 222.65/222.86  |- mesh__onlineNote mesh__D017291
% 222.65/222.86       use CLARITHROMYCIN %28%NM%29% to search CLARITHROMYCIN 1987-92   
% 222.65/222.86  |- rdf__type mesh__D017291sskos__Concept
% 222.65/222.86  |- mesh__publicMeSHNote mesh__D017291
% 222.65/222.86       93; CLARITHROMYCIN was indexed under ERYTHROMYCIN/analogs %26% derivatives 1987-92%A%  
% 222.65/222.86  |- skos__altLabel mesh__D003271 Contraceptives, Female
% 222.65/222.86  |- skos__historyNote mesh__D003271 Contraceptive Agents %28%1967-1974%29%
% 222.65/222.86  |- skos__hiddenLabel mesh__D003271 Female Contraceptives
% 222.65/222.86  |- skos__related mesh__D003271smesh__D014622
% 222.65/222.86  |- skos__prefLabel mesh__D003271 Contraceptive Agents, Female
% 222.65/222.86  |- skos__broader mesh__D003271smesh__D003270
% 222.65/222.86  |- skos__scopeNote mesh__D003271
% 222.65/222.86       Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading.%A%    
% 222.65/222.86  |- mesh__dateEstablished mesh__D003271 1975-01-01
% 222.65/222.86  |- mesh__recordAuthorizer mesh__D003271 sjn
% 222.65/222.86  |- skos__hiddenLabel mesh__D003271 Female Contraceptive Agents
% 222.65/222.86  |- mesh__historyNote mesh__D003271 75   
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D003271 2006
% 222.65/222.86  |- mesh__recordOriginator mesh__D003271 NLM
% 222.65/222.86  |- skos__hiddenLabel mesh__D003271 Agents, Female Contraceptive
% 222.65/222.86  |- mesh__dateRevised mesh__D003271 2005-06-30
% 222.65/222.86  |- rdf__type mesh__D003271sskos__Concept
% 222.65/222.86  |- skos__annotation mesh__D003271
% 222.65/222.86       pregn despite use: see note on CONTRACEPTIVE AGENTS   
% 222.65/222.86  |- mesh__recordMaintainer mesh__D003271 ssb
% 222.65/222.86  |- mesh__dateCreated mesh__D003271 1999-01-01
% 222.65/222.86  |- mesh__publicMeSHNote mesh__D003271 75   
% 222.65/222.86  |- mesh__dateRevised mesh__D016997 2005-06-30
% 222.65/222.86  |- skos__broader mesh__D016997smesh__D003381
% 222.65/222.86  |- skos__prefLabel mesh__D016997 Coxiella burnetii
% 222.65/222.86  |- skos__scopeNote mesh__D016997
% 222.65/222.86       A species of gram-negative bacteria that grows preferentially in the vacuoles of the host cell. It is the etiological agent of Q FEVER.%A%    
% 222.65/222.86  |- skos__historyNote mesh__D016997 Coxiella %28%1967-1991%29%
% 222.65/222.86  |- mesh__publicMeSHNote mesh__D016997 92   
% 222.65/222.86  |- mesh__dateCreated mesh__D016997 1991-05-30
% 222.65/222.86  |- rdf__type mesh__D016997sskos__Concept
% 222.65/222.86  |- skos__annotation mesh__D016997 infection = Q FEVER   
% 222.65/222.86  |- mesh__dateEstablished mesh__D016997 1992-01-01
% 222.65/222.86  |- mesh__historyNote mesh__D016997 92   
% 222.65/222.86  |- mesh__recordAuthorizer mesh__D016997 sjn
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D016997 2006
% 222.65/222.86  |- mesh__recordOriginator mesh__D016997 PXP
% 222.65/222.86  |- mesh__recordMaintainer mesh__D016997 SYSTEM
% 222.65/222.86  |- mesh__dateEstablished mesh__D016199 1991-01-01
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D016199 2005
% 222.65/222.86  |- skos__prefLabel mesh__D016199 Herpesvirus 7, Human
% 222.65/222.86  |- skos__historyNote mesh__D016199 Herpesviridae %28%1990%29%
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D016199 2002
% 222.65/222.86  |- skos__altLabel mesh__D016199 HHV-7
% 222.65/222.86  |- skos__broader mesh__D016199smesh__D019211
% 222.65/222.86  |- rdf__type mesh__D016199sskos__Concept
% 222.65/222.86  |- mesh__historyNote mesh__D016199
% 222.65/222.86       94; was HERPESVIRUS-7, HUMAN 1991-93; HUMAN HERPESVIRUS-7 was see HERPESVIRUS-7, HUMAN 1991-93%A%  
% 222.65/222.86  |- skos__scopeNote mesh__D016199
% 222.65/222.86       A species in the genus ROSEOLOVIRUS, of the family HERPESVIRIDAE.  It was isolated from activated, CD4-positive T-lymphocytes taken from the blood of a healthy human.%A%    
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D016199 2004
% 222.65/222.86  |- skos__altLabel mesh__D016199 Human herpesvirus 7
% 222.65/222.86  |- mesh__recordMaintainer mesh__D016199 ags
% 222.65/222.86  |- skos__annotation mesh__D016199
% 222.65/222.86       infection: coord IM with ROSEOLOVIRUS INFECTIONS %28%IM%29%   
% 222.65/222.86  |- mesh__onlineNote mesh__D016199
% 222.65/222.86       use HERPESVIRUS 7, HUMAN to search HERPESVIRUS-7, HUMAN %26% HUMAN HERPESVIRUS-7 1991-93%A%  
% 222.65/222.86  |- mesh__publicMeSHNote mesh__D016199
% 222.65/222.86       94; was HERPESVIRUS-7, HUMAN 1991-93; HUMAN HERPESVIRUS-7 was see HERPESVIRUS-7, HUMAN 1991-93%A%  
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D016199 2003
% 222.65/222.86  |- mesh__dateCreated mesh__D016199 1990-04-24
% 222.65/222.86  |- mesh__recordOriginator mesh__D016199 AGS
% 222.65/222.86  |- mesh__recordAuthorizer mesh__D016199 sjn
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D016199 2006
% 222.65/222.86  |- mesh__dateRevised mesh__D016199 2001-07-25
% 222.65/222.86  |- skos__hiddenLabel mesh__D002977 Clergies
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002977 2000
% 222.65/222.86  |- skos__prefLabel mesh__D002977 Clergy
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002977 1994
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002977 2003
% 222.65/222.86  |- mesh__recordMaintainer mesh__D002977 TAP
% 222.65/222.86  |- mesh__recordOriginator mesh__D002977 NLM
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002977 2001
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002977 1998
% 222.65/222.86  |- mesh__dateCreated mesh__D002977 1999-01-01
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002977 1995
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002977 2004
% 222.65/222.86  |- mesh__recordAuthorizer mesh__D002977 PLS
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002977 1999
% 222.65/222.86  |- mesh__dateRevised mesh__D002977 1992-05-07
% 222.65/222.86  |- rdf__type mesh__D002977sskos__Concept
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002977 1996
% 222.65/222.86  |- mesh__historyNote mesh__D002977 73%28%69%29%   
% 222.65/222.86  |- skos__historyNote mesh__D002977
% 222.65/222.86       appropriate religion heading %28%1966-1968%29%
% 222.65/222.86  |- mesh__dateEstablished mesh__D002977 1973-01-01
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002977 1993
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002977 2002
% 222.65/222.86  |- mesh__publicMeSHNote mesh__D002977 73   
% 222.65/222.86  |- skos__broader mesh__D002977smesh__D009274
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002977 2005
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002977 1997
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002977 2006
% 222.65/222.86  |- mesh__publicMeSHNote mesh__D002179
% 222.65/222.86       81; was MONILIASIS, CUTANEOUS 1963-80   
% 222.65/222.86  |- rdf__type mesh__D002179sskos__Concept
% 222.65/222.86  |- skos__scopeNote mesh__D002179
% 222.65/222.86       Candidiasis of the skin manifested as eczema-like lesions of the interdigital spaces, perleche, or chronic paronychia. %28%Dorland, 27th ed%29%%A%    
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002179 2001
% 222.65/222.86  |- skos__hiddenLabel mesh__D002179 Cutaneous Moniliases
% 222.65/222.86  |- skos__broader mesh__D002179smesh__D002177
% 222.65/222.86  |- skos__hiddenLabel mesh__D002179 Cutaneous Moniliasis
% 222.65/222.86  |- mesh__historyNote mesh__D002179 81; was MONILIASIS, CUTANEOUS 1963-80   
% 222.65/222.86  |- mesh__recordAuthorizer mesh__D002179 PLS
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002179 2000
% 222.65/222.86  |- mesh__recordMaintainer mesh__D002179 TAP
% 222.65/222.86  |- skos__broader mesh__D002179smesh__D003881
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002179 2004
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002179 1997
% 222.65/222.86  |- skos__prefLabel mesh__D002179 Candidiasis, Cutaneous
% 222.65/222.86  |- skos__hiddenLabel mesh__D002179 Cutaneous Candidiases
% 222.65/222.86  |- mesh__dateRevised mesh__D002179 1993-06-02
% 222.65/222.86  |- skos__hiddenLabel mesh__D002179 Cutaneous Candidiasis
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002179 2006
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002179 1999
% 222.65/222.86  |- skos__annotation mesh__D002179
% 222.65/222.86       fungus dis of skin; do not bother to coord with CANDIDA or CANDIDA ALBICANS%A%  
% 222.65/222.86  |- mesh__onlineNote mesh__D002179
% 222.65/222.86       use CANDIDIASIS, CUTANEOUS to search MONILIASIS, CUTANEOUS 1966-80%A%  
% 222.65/222.86  |- skos__hiddenLabel mesh__D002179 Moniliases, Cutaneous
% 222.65/222.86  |- mesh__dateCreated mesh__D002179 1999-01-01
% 222.65/222.86  |- skos__hiddenLabel mesh__D002179 Candidiases, Cutaneous
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002179 2003
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002179 1996
% 222.65/222.86  |- mesh__recordOriginator mesh__D002179 NLM
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002179 1995
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002179 2005
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002179 1998
% 222.65/222.86  |- skos__altLabel mesh__D002179 Moniliasis, Cutaneous
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002179 2002
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D002179 1994
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D007662 1998
% 222.65/222.86  |- mesh__dateEstablished mesh__D007662 1991-01-01
% 222.65/222.86  |- skos__scopeNote mesh__D007662
% 222.65/222.86       A condition characterized by an abnormally elevated concentration of ketone bodies in the body tissues and fluids. It is a complication of diabetes mellitus and starvation. %28%Dorland, 27th ed%29%%A%    
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D007662 2002
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D007662 1999
% 222.65/222.86  |- mesh__dateRevised mesh__D007662 1997-06-20
% 222.65/222.86  |- mesh__dateCreated mesh__D007662 1999-01-01
% 222.65/222.86  |- skos__broader mesh__D007662smesh__D000138
% 222.65/222.86  |- mesh__historyNote mesh__D007662
% 222.65/222.86       91%28%75%29%; was see under ACIDOSIS 1975-90   
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D007662 2005
% 222.65/222.86  |- skos__annotation mesh__D007662
% 222.65/222.86       high levels of ketone bodies; do not confuse with KETOSES %28%monosaccharides%29%%A%  
% 222.65/222.86  |- mesh__recordMaintainer mesh__D007662 TGC
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D007662 2006
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D007662 2000
% 222.65/222.86  |- mesh__recordOriginator mesh__D007662 NLM
% 222.65/222.86  |- mesh__onlineNote mesh__D007662 search ACIDOSIS 1966-74   
% 222.65/222.86  |- mesh__recordAuthorizer mesh__D007662 SJN
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D007662 2003
% 222.65/222.86  |- mesh__publicMeSHNote mesh__D007662 91; was see under ACIDOSIS 1975-90   
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D007662 2001
% 222.65/222.86  |- rdf__type mesh__D007662sskos__Concept
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D007662 2004
% 222.65/222.86  |- skos__prefLabel mesh__D007662 Ketosis
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 AL, Doxazosin
% 222.65/222.86  |- mesh__onlineNote mesh__D017292
% 222.65/222.86       use DOXAZOSIN %28%NM%29% to search UK 33274 1980-92   
% 222.65/222.86  |- skos__altLabel mesh__D017292 Doxazosin beta
% 222.65/222.86  |- mesh__dateRevised mesh__D017292 2005-06-30
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Geminis, Doxazosina
% 222.65/222.86  |- skos__altLabel mesh__D017292 Aliud Brand of Doxazosin Mesylate
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 UK33274
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 ApoDoxazosin
% 222.65/222.86  |- mesh__recordMaintainer mesh__D017292 exl
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 UK 33274
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 MTWDoxazosin
% 222.65/222.86  |- mesh__recordOriginator mesh__D017292 TPW
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 NovoDoxazosin
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Doxazosin ratiopharm
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Heumann, Doxazosin
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 DoxazosinWolff
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 AZU, Doxazosin
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Pharmagenus, Doxazosina
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Novo Doxazosin
% 222.65/222.86  |- skos__altLabel mesh__D017292 Doxazosina Geminis
% 222.65/222.86  |- skos__broader mesh__D017292smesh__D011224
% 222.65/222.86  |- skos__altLabel mesh__D017292 Apotex Brand of Doxazosin Mesylate
% 222.65/222.86  |- rdf__type mesh__D017292sskos__Concept
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 beta, Doxazosin
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Neo, Progandol
% 222.65/222.86  |- skos__altLabel mesh__D017292 Doxazosina Normon
% 222.65/222.86  |- skos__altLabel mesh__D017292 Doxazosina Ur
% 222.65/222.86  |- skos__altLabel mesh__D017292
% 222.65/222.86       1 %28%4-Amino-6,7-dimethoxy-2-quinazolinyl%29%-4-%28%%28%2,3-dihydro-1,4-benzodioxin-2-yl%29%carbonyl%29%piperazine
% 222.65/222.86  |- mesh__dateCreated mesh__D017292 1992-05-13
% 222.65/222.86  |- skos__altLabel mesh__D017292 Doxazosin Klast
% 222.65/222.86  |- skos__altLabel mesh__D017292 Uriduct
% 222.65/222.86  |- skos__altLabel mesh__D017292 Doxazosina Alter
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Neo, Carduran
% 222.65/222.86  |- skos__altLabel mesh__D017292 Doxazosin Apogepha
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Klast, Doxazosin
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Apo Doxazosin
% 222.65/222.86  |- skos__altLabel mesh__D017292 Kade Brand of Doxazosin Mesylate
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Doxazosinratiopharm
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Mesylate, Doxazosin
% 222.65/222.86  |- skos__altLabel mesh__D017292 Doxazosina Combino Pharm
% 222.65/222.86  |- mesh__recordAuthorizer mesh__D017292 sjn
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 ct, doxazosin von
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 GenDoxazosin
% 222.65/222.86  |- skos__altLabel mesh__D017292 Doxazosina Ratiopharm
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Ur, Doxazosina
% 222.65/222.86  |- skos__altLabel mesh__D017292 MTW-Doxazosin
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D017292 2006
% 222.65/222.86  |- skos__prefLabel mesh__D017292 Doxazosin
% 222.65/222.86  |- skos__altLabel mesh__D017292 Solvay Brand of Doxazosin Mesylate
% 222.65/222.86  |- mesh__historyNote mesh__D017292 93; was UK 33274 %28%NM%29% 1980-92   
% 222.65/222.86  |- skos__altLabel mesh__D017292 Novo-Doxazosin
% 222.65/222.86  |- skos__altLabel mesh__D017292 doxazosin von ct
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Gen Doxazosin
% 222.65/222.86  |- skos__altLabel mesh__D017292 ratio-Doxazosin
% 222.65/222.86  |- skos__altLabel mesh__D017292 Hexal Brand of Doxazosin Mesylate
% 222.65/222.86  |- skos__altLabel mesh__D017292 W%C3%%B6%rwag Brand of Doxazosin Mesylate
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Normon, Doxazosina
% 222.65/222.86  |- skos__altLabel mesh__D017292 Zoxan
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Apogepha, Doxazosin
% 222.65/222.86  |- skos__altLabel mesh__D017292 Ciclum Brand of Doxazosin Mesylate
% 222.65/222.86  |- skos__altLabel mesh__D017292 Doxazosin findusFit
% 222.65/222.86  |- skos__altLabel mesh__D017292 Progandol Neo
% 222.65/222.86  |- skos__altLabel mesh__D017292 Diblocin
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 von ct, doxazosin
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 DoxaPuren
% 222.65/222.86  |- skos__altLabel mesh__D017292 Doxazosina Cinfa
% 222.65/222.86  |- skos__altLabel mesh__D017292 Carduran
% 222.65/222.86  |- skos__altLabel mesh__D017292 Cardular
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 MTW Doxazosin
% 222.65/222.86  |- skos__altLabel mesh__D017292 Alpharma Brand of Doxazosin Mesylate
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Cinfa, Doxazosina
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 findusFit, Doxazosin
% 222.65/222.86  |- skos__altLabel mesh__D017292 Doxazosin AZU
% 222.65/222.86  |- skos__altLabel mesh__D017292 Merck dura Brand of Doxazosin Mesylate
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Doxa Puren
% 222.65/222.86  |- skos__altLabel mesh__D017292 Doxazosin-ratiopharm
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Pharm, Doxazosina Combino
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Alter, Doxazosina
% 222.65/222.86  |- skos__altLabel mesh__D017292 Doxazosin Heumann
% 222.65/222.86  |- skos__altLabel mesh__D017292 Jutalar
% 222.65/222.86  |- mesh__dateEstablished mesh__D017292 1993-01-01
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Stada, Doxazosin
% 222.65/222.86  |- skos__altLabel mesh__D017292 DoxaUro
% 222.65/222.86  |- skos__altLabel mesh__D017292 Pfizer Brand of Doxazosin Mesylate
% 222.65/222.86  |- skos__altLabel mesh__D017292 AstraZeneca Brand of Doxazosin Mesylate
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 ratio Doxazosin
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Combino Pharm, Doxazosina
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Monohydrochloride, Doxazosin
% 222.65/222.86  |- skos__altLabel mesh__D017292 esparma Brand of Doxazosin Mesylate
% 222.65/222.86  |- skos__altLabel mesh__D017292 Doxazosin-Wolff
% 222.65/222.86  |- skos__historyNote mesh__D017292
% 222.65/222.86       Prazosin/analogs %26% derivatives %28%1980-1992%29%
% 222.65/222.86  |- skos__scopeNote mesh__D017292
% 222.65/222.86       A selective alpha-1-adrenergic blocker that lowers serum CHOLESTEROL. It is also effective in the treatment of HYPERTENSION.%A%    
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 ratioDoxazosin
% 222.65/222.86  |- skos__altLabel mesh__D017292 Doxazosina Pharmagenus
% 222.65/222.86  |- skos__altLabel mesh__D017292 Doxazosin Stada
% 222.65/222.86  |- skos__altLabel mesh__D017292 Gen-Doxazosin
% 222.65/222.86  |- mesh__publicMeSHNote mesh__D017292
% 222.65/222.86       93; UK 33274 was indexed under PRAZOSIN/analogs %26% derivatives 1980-92%A%  
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Ratiopharm, Doxazosina
% 222.65/222.86  |- skos__hiddenLabel mesh__D017292 Doxazosin Wolff
% 222.65/222.86  |- rdf__type mesh__D003272sskos__Concept
% 222.65/222.86  |- mesh__recordOriginator mesh__D003272 NLM
% 222.65/222.86  |- mesh__dateEstablished mesh__D003272 1975-01-01
% 222.65/222.86  |- skos__broader mesh__D003272smesh__D003270
% 222.65/222.86  |- mesh__dateRevised mesh__D003272 2005-06-30
% 222.65/222.86  |- skos__hiddenLabel mesh__D003272 Male Contraceptives
% 222.65/222.86  |- mesh__dateCreated mesh__D003272 1999-01-01
% 222.65/222.86  |- skos__historyNote mesh__D003272 Contraceptive Agents %28%1967-1974%29%
% 222.65/222.86  |- skos__altLabel mesh__D003272 Contraceptives, Male
% 222.65/222.86  |- mesh__historyNote mesh__D003272 75   
% 222.65/222.86  |- skos__scopeNote mesh__D003272
% 222.65/222.86       Chemical substances or agents with contraceptive activity in males. Use for male contraceptive agents in general or for which there is no specific heading.%A%    
% 222.65/222.86  |- mesh__publicMeSHNote mesh__D003272 75   
% 222.65/222.86  |- skos__hiddenLabel mesh__D003272 Agents, Male Contraceptive
% 222.65/222.86  |- skos__prefLabel mesh__D003272 Contraceptive Agents, Male
% 222.65/222.86  |- skos__hiddenLabel mesh__D003272 Male Contraceptive Agents
% 222.65/222.86  |- skos__annotation mesh__D003272
% 222.65/222.86       pregn despite use: see note on CONTRACEPTIVE AGENTS   
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D003272 2006
% 222.65/222.86  |- mesh__recordAuthorizer mesh__D003272 sjn
% 222.65/222.86  |- mesh__recordMaintainer mesh__D003272 ssb
% 222.65/222.86  |- skos__related mesh__D011704smesh__D007676
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D011704 2005
% 222.65/222.86  |- mesh__recordOriginator mesh__D011704 NLM
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D011704 1999
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D011704 1996
% 222.65/222.86  |- rdf__type mesh__D011704sskos__Concept
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D011704 1993
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D011704 1998
% 222.65/222.86  |- skos__annotation mesh__D011704 = inflammation of kidney + its pelvis   
% 222.65/222.86  |- mesh__dateRevised mesh__D011704 1992-05-18
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D011704 1995
% 222.65/222.86  |- skos__prefLabel mesh__D011704 Pyelonephritis
% 222.65/222.86  |- skos__broader mesh__D011704smesh__D011702
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D011704 2002
% 222.65/222.86  |- skos__hiddenLabel mesh__D011704 Pyelonephritides
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D011704 1994
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D011704 2004
% 222.65/222.86  |- skos__broader mesh__D011704smesh__D009395
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D011704 2001
% 222.65/222.86  |- mesh__recordMaintainer mesh__D011704 TAP
% 222.65/222.86  |- skos__hiddenLabel mesh__D011704 Pyonephroses
% 222.65/222.86  |- mesh__recordAuthorizer mesh__D011704 PLS
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D011704 2006
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D011704 2003
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D011704 1997
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D011704 2000
% 222.65/222.86  |- mesh__dateCreated mesh__D011704 1999-01-01
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D016998 2006
% 222.65/222.86  |- mesh__recordAuthorizer mesh__D016998 sjn
% 222.65/222.86  |- mesh__recordMaintainer mesh__D016998 SYSTEM
% 222.65/222.86  |- skos__scopeNote mesh__D016998
% 222.65/222.86       A genus of gram-negative, spiral-shaped bacteria that is pathogenic and has been isolated from the intestinal tract of mammals, including humans.%A%    
% 222.65/222.86  |- skos__broader mesh__D016998smesh__D020565
% 222.65/222.86  |- skos__annotation mesh__D016998
% 222.65/222.86       infection = HELICOBACTER INFECTIONS %28%IM%29%   
% 222.65/222.86  |- mesh__dateRevised mesh__D016998 2005-06-30
% 222.65/222.86  |- mesh__dateEstablished mesh__D016998 1992-01-01
% 222.65/222.86  |- skos__broader mesh__D016998smesh__D006090
% 222.65/222.86  |- skos__historyNote mesh__D016998 Campylobacter %28%1984-1990%29%
% 222.65/222.86  |- rdf__type mesh__D016998sskos__Concept
% 222.65/222.86  |- mesh__publicMeSHNote mesh__D016998 92   
% 222.65/222.86  |- mesh__dateCreated mesh__D016998 1991-05-30
% 222.65/222.86  |- skos__prefLabel mesh__D016998 Helicobacter
% 222.65/222.86  |- mesh__historyNote mesh__D016998 92   
% 222.65/222.86  |- mesh__recordOriginator mesh__D016998 PXP
% 222.65/222.86  |- mesh__publicMeSHNote mesh__D045782 2004   
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D045782 2006
% 222.65/222.86  |- rdf__type mesh__D045782sskos__Concept
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D045782 2005
% 222.65/222.86  |- mesh__historyNote mesh__D045782 2004   
% 222.65/222.86  |- skos__broader mesh__D045782smesh__D013729
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D045782 2004
% 222.65/222.86  |- mesh__dateEstablished mesh__D045782 2004-01-01
% 222.65/222.86  |- skos__scopeNote mesh__D045782
% 222.65/222.86       The five-carbon building blocks of TERPENES that derive from MEVALONIC ACID or deoxyxylulose phosphate.%A%    
% 222.65/222.86  |- mesh__dateCreated mesh__D045782 2003-07-09
% 222.65/222.86  |- skos__prefLabel mesh__D045782 Hemiterpenes
% 222.65/222.86  |- skos__hiddenLabel mesh__D017293 Vitamin K Dependent Protein S
% 222.65/222.86  |- mesh__historyNote mesh__D017293
% 222.65/222.86       93; was PROTEIN S, VITAMIN K-DEPENDENT %28%NM%29% 1979-92   
% 222.65/222.86  |- mesh__onlineNote mesh__D017293
% 222.65/222.86       use PROTEIN S %28%NM%29% to search PROTEIN S, VITAMIN K-DEPENDENT  1980-92%A%  
% 222.65/222.86  |- skos__historyNote mesh__D017293 Glycoproteins %28%1980-1992%29%
% 222.65/222.86  |- skos__altLabel mesh__D017293 Vitamin K-Dependent Protein S
% 222.65/222.86  |- rdf__type mesh__D017293sskos__Concept
% 222.65/222.86  |- mesh__dateCreated mesh__D017293 1992-05-22
% 222.65/222.86  |- skos__historyNote mesh__D017293 Vitamin K %28%1979-1980%29%
% 222.65/222.86  |- skos__altLabel mesh__D017293 Cofactor Protein S
% 222.65/222.86  |- mesh__dateRevised mesh__D017293 2005-06-30
% 222.65/222.86  |- mesh__recordOriginator mesh__D017293 TPW
% 222.65/222.86  |- skos__broader mesh__D017293smesh__D019774
% 222.65/222.86  |- mesh__publicMeSHNote mesh__D017293
% 222.65/222.86       93; PROTEIN S, VITAMIN K-DEPENDENT was indexed under GLYCOPROTEINS 1980-92, %26% VITAMIN K 1979-80%A%  
% 222.65/222.86  |- skos__hiddenLabel mesh__D017293 Protein S, Vitamin K Dependent
% 222.65/222.86  |- skos__hiddenLabel mesh__D017293 Protein S, Cofactor
% 222.65/222.86  |- mesh__recordMaintainer mesh__D017293 ssb
% 222.65/222.86  |- skos__scopeNote mesh__D017293
% 222.65/222.86       The vitamin K-dependent cofactor of activated PROTEIN C. Together with protein C, it inhibits the action of factors VIIIa and Va. A deficiency in protein S; %28%PROTEIN S DEFICIENCY%29%; can lead to recurrent venous and arterial thrombosis.%A%    
% 222.65/222.86  |- skos__broader mesh__D017293smesh__D001798
% 222.65/222.86  |- skos__altLabel mesh__D017293 Protein S, Vitamin K-Dependent
% 222.65/222.86  |- skos__broader mesh__D017293smesh__D006023
% 222.65/222.86  |- mesh__dateEstablished mesh__D017293 1993-01-01
% 222.65/222.86  |- skos__prefLabel mesh__D017293 Protein S
% 222.65/222.86  |- mesh__activeMeSHYear mesh__D017293 2006
% 222.65/222.87  |- mesh__recordAuthorizer mesh__D017293 sjn
% 222.65/222.87  |- skos__annotation mesh__D017293 a blood protein; an anticoagulant   
% 222.65/222.87  |- skos__hiddenLabel mesh__D003273 Contraceptive Device
% 222.65/222.87  |- skos__hiddenLabel mesh__D003273 Devices, Contraceptive
% 222.65/222.87  |- mesh__recordAuthorizer mesh__D003273 sjn
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D003273 2001
% 222.65/222.87  |- mesh__dateCreated mesh__D003273 1999-01-01
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D003273 2000
% 222.65/222.87  |- mesh__recordOriginator mesh__D003273 NLM
% 222.65/222.87  |- skos__related mesh__D003273smesh__D020878
% 222.65/222.87  |- mesh__dateRevised mesh__D003273 1999-11-03
% 222.65/222.87  |- skos__annotation mesh__D003273
% 222.65/222.87       mechanical devices, not chemicals %28% = CONTRACEPTIVE AGENTS%29%; pregnancy despite use = contraceptive term with no qualif, not /adv eff%A%  
% 222.65/222.87  |- mesh__dateEstablished mesh__D003273 1967-01-01
% 222.65/222.87  |- mesh__recordMaintainer mesh__D003273 jls
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D003273 2006
% 222.65/222.87  |- mesh__publicMeSHNote mesh__D003273 67; was CONTRACEPTIVES 1963-66   
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D003273 2002
% 222.65/222.87  |- skos__hiddenLabel mesh__D003273 Device, Contraceptive
% 222.65/222.87  |- skos__scopeNote mesh__D003273
% 222.65/222.87       Devices that diminish the likelihood of or prevent conception. %28%From Dorland, 28th ed%29%%A%    
% 222.65/222.87  |- skos__broader mesh__D003273smesh__D004864
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D003273 2004
% 222.65/222.87  |- mesh__historyNote mesh__D003273 67; was CONTRACEPTIVES 1963-66   
% 222.65/222.87  |- mesh__onlineNote mesh__D003273
% 222.65/222.87       use CONTRACEPTIVE DEVICES to search CONTRACEPTIVES 1966   
% 222.65/222.87  |- skos__prefLabel mesh__D003273 Contraceptive Devices
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D003273 2005
% 222.65/222.87  |- rdf__type mesh__D003273sskos__Concept
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D003273 2003
% 222.65/222.87  |- skos__historyNote mesh__D011705 Pyelonephritis %28%1966-1985%29%
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D011705 1999
% 222.65/222.87  |- mesh__dateRevised mesh__D011705 1992-05-22
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D011705 2001
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D011705 1994
% 222.65/222.87  |- mesh__dateEstablished mesh__D011705 1986-01-01
% 222.65/222.87  |- rdf__type mesh__D011705sskos__Concept
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D011705 1993
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D011705 1995
% 222.65/222.87  |- skos__altLabel mesh__D011705 Xanthogranulomatous Pyelonephritis
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D011705 2003
% 222.65/222.87  |- skos__prefLabel mesh__D011705 Pyelonephritis, Xanthogranulomatous
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D011705 2002
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D011705 2005
% 222.65/222.87  |- mesh__recordMaintainer mesh__D011705 TGC
% 222.65/222.87  |- mesh__historyNote mesh__D011705 86   
% 222.65/222.87  |- mesh__dateCreated mesh__D011705 1985-02-25
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D011705 2004
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D011705 1996
% 222.65/222.87  |- skos__hiddenLabel mesh__D011705 Xanthogranulomatous Pyelonephritides
% 222.65/222.87  |- skos__scopeNote mesh__D011705
% 222.65/222.87       An inflammatory condition of the kidney most commonly resulting in a grossly enlarged and nonfunctioning kidney associated with stones and infection.%A%    
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D011705 2006
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D011705 1998
% 222.65/222.87  |- skos__broader mesh__D011705smesh__D011704
% 222.65/222.87  |- mesh__publicMeSHNote mesh__D011705 86   
% 222.65/222.87  |- mesh__recordOriginator mesh__D011705 EC
% 222.65/222.87  |- mesh__recordAuthorizer mesh__D011705 PLS
% 222.65/222.87  |- skos__historyNote mesh__D011705 Xanthomatosis %28%1966-1985%29%
% 222.65/222.87  |- skos__hiddenLabel mesh__D011705 Pyelonephritides, Xanthogranulomatous
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D011705 1997
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D011705 2000
% 222.65/222.87  |- skos__scopeNote mesh__D016999
% 222.65/222.87       A group of gram-negative, anaerobic bacteria that is able to oxidize acetate completely to carbon dioxide using elemental sulfur as the electron acceptor.%A%    
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D016999 2006
% 222.65/222.87  |- mesh__recordMaintainer mesh__D016999 SYSTEM
% 222.65/222.87  |- skos__prefLabel mesh__D016999 Sulfur-Reducing Bacteria
% 222.65/222.87  |- mesh__dateRevised mesh__D016999 2005-06-30
% 222.65/222.87  |- rdf__type mesh__D016999sskos__Concept
% 222.65/222.87  |- mesh__dateEstablished mesh__D016999 1992-01-01
% 222.65/222.87  |- mesh__dateCreated mesh__D016999 1991-05-30
% 222.65/222.87  |- skos__altLabel mesh__D016999 Sulfur Reducing Bacteria
% 222.65/222.87  |- skos__annotation mesh__D016999 gram-neg anaerobic bacteria   
% 222.65/222.87  |- mesh__publicMeSHNote mesh__D016999 92   
% 222.65/222.87  |- skos__broader mesh__D016999smesh__D001419
% 222.65/222.87  |- mesh__recordOriginator mesh__D016999 PXP
% 222.65/222.87  |- mesh__historyNote mesh__D016999 92   
% 222.65/222.87  |- mesh__recordAuthorizer mesh__D016999 sjn
% 222.65/222.87  |- skos__hiddenLabel mesh__D002979 Life Change
% 222.65/222.87  |- skos__hiddenLabel mesh__D002979 Climacterics
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D002979 2005
% 222.65/222.87  |- mesh__dateRevised mesh__D002979 2004-07-07
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D002979 2006
% 222.65/222.87  |- skos__scopeNote mesh__D002979
% 222.65/222.87       Physiologic period, characterized by endocrine, somatic, and psychic changes with the termination of ovarian function in the female. It may also accompany the normal diminution of sexual activity in the male.%A%    
% 222.65/222.87  |- mesh__recordAuthorizer mesh__D002979 sjn
% 222.65/222.87  |- skos__annotation mesh__D002979
% 222.65/222.87       female and male; consider also MENOPAUSE or ANDROPAUSE   
% 222.65/222.87  |- skos__altLabel mesh__D002979 Change of Life
% 222.65/222.87  |- skos__broader mesh__D002979smesh__D046468
% 222.65/222.87  |- mesh__dateCreated mesh__D002979 1999-01-01
% 222.65/222.87  |- mesh__publicMeSHNote mesh__D002979 1966   
% 222.65/222.87  |- mesh__recordOriginator mesh__D002979 NLM
% 222.65/222.87  |- mesh__historyNote mesh__D002979 1966   
% 222.65/222.87  |- skos__hiddenLabel mesh__D002979 Life Changes
% 222.65/222.87  |- skos__prefLabel mesh__D002979 Climacteric
% 222.65/222.87  |- mesh__recordMaintainer mesh__D002979 lkt
% 222.65/222.87  |- rdf__type mesh__D002979sskos__Concept
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D007664 2002
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D007664 1999
% 222.65/222.87  |- mesh__recordOriginator mesh__D007664 NLM
% 222.65/222.87  |- skos__altLabel mesh__D007664 Oxosteroids
% 222.65/222.87  |- mesh__publicMeSHNote mesh__D007664 74   
% 222.65/222.87  |- skos__broader mesh__D007664smesh__D013256
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D007664 1998
% 222.65/222.87  |- skos__scopeNote mesh__D007664
% 222.65/222.87       Steroid derivatives formed by oxidation of a methyl group on the side chain or a methylene group in the ring skeleton to form a ketone.%A%    
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D007664 1997
% 222.65/222.87  |- skos__annotation mesh__D007664 /physiol permitted   
% 222.65/222.87  |- mesh__historyNote mesh__D007664 74%28%71%29%   
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D007664 2006
% 222.65/222.87  |- mesh__dateCreated mesh__D007664 1999-01-01
% 222.65/222.87  |- skos__prefLabel mesh__D007664 Ketosteroids
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D007664 2001
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D007664 1996
% 222.65/222.87  |- mesh__dateEstablished mesh__D007664 1974-01-01
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D007664 2005
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D007664 2004
% 222.65/222.87  |- mesh__recordMaintainer mesh__D007664 PLS
% 222.65/222.87  |- skos__historyNote mesh__D007664
% 222.65/222.87       appropriate steroid class %28%1971-1973%29%
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D007664 2000
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D007664 2003
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D007664 1995
% 222.65/222.87  |- mesh__recordAuthorizer mesh__D007664 PLS
% 222.65/222.87  |- rdf__type mesh__D007664sskos__Concept
% 222.65/222.87  |- mesh__dateRevised mesh__D007664 1993-06-03
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D007664 1994
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D045783 2005
% 222.65/222.87  |- mesh__recordOriginator mesh__D045783 ssb
% 222.65/222.87  |- mesh__recordMaintainer mesh__D045783 jls
% 222.65/222.87  |- skos__historyNote mesh__D045783 Eugenol %28%1983-2003%29%
% 222.65/222.87  |- skos__broader mesh__D045783smesh__D010938
% 222.65/222.87  |- skos__scopeNote mesh__D045783
% 222.65/222.87       An oil from flower buds of SYZYGIUM trees which contains large amounts of EUGENOL.%A%    
% 222.65/222.87  |- skos__altLabel mesh__D045783 Oil of Cloves
% 222.65/222.87  |- mesh__dateCreated mesh__D045783 2003-07-09
% 222.65/222.87  |- skos__hiddenLabel mesh__D045783 Oil, Clove
% 222.65/222.87  |- mesh__publicMeSHNote mesh__D045783 2004; see EUGENOL 1983-2003   
% 222.65/222.87  |- mesh__dateRevised mesh__D045783 2004-07-19
% 222.65/222.87  |- skos__prefLabel mesh__D045783 Clove Oil
% 222.65/222.87  |- mesh__recordAuthorizer mesh__D045783 sjn
% 222.65/222.87  |- mesh__historyNote mesh__D045783 2004; use EUGENOL 1983-2003   
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D045783 2006
% 222.65/222.87  |- mesh__dateEstablished mesh__D045783 2004-01-01
% 222.65/222.87  |- rdf__type mesh__D045783sskos__Concept
% 222.65/222.87  |- skos__scopeNote mesh__D012000
% 222.65/222.87       Tests for measuring loudness recruitment.     
% 222.65/222.87  |- mesh__recordOriginator mesh__D012000 RC
% 222.65/222.87  |- mesh__dateCreated mesh__D012000 1978-05-22
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D012000 2001
% 222.65/222.87  |- skos__broader mesh__D012000smesh__D006320
% 222.65/222.87  |- skos__hiddenLabel mesh__D012000 Detection, Recruitment %28%Audiology%29%
% 222.65/222.87  |- skos__prefLabel mesh__D012000 Recruitment Detection %28%Audiology%29%
% 222.65/222.87  |- skos__hiddenLabel mesh__D012000 Recruitment Detections %28%Audiology%29%
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D012000 1999
% 222.65/222.87  |- skos__hiddenLabel mesh__D012000 Loudness Recruitment Detections
% 222.65/222.87  |- mesh__recordMaintainer mesh__D012000 PXP
% 222.65/222.87  |- mesh__publicMeSHNote mesh__D012000 79   
% 222.65/222.87  |- skos__historyNote mesh__D012000 Auditory Threshold %28%1968-1978%29%
% 222.65/222.87  |- mesh__recordAuthorizer mesh__D012000 SJN
% 222.65/222.87  |- mesh__dateEstablished mesh__D012000 1979-01-01
% 222.65/222.87  |- skos__hiddenLabel mesh__D012000 Recruitment Detections, Loudness
% 222.65/222.87  |- skos__hiddenLabel mesh__D012000 Recruitment Detection, Loudness
% 222.65/222.87  |- mesh__dateRevised mesh__D012000 1997-06-20
% 222.65/222.87  |- skos__historyNote mesh__D012000 Audiometry %28%1966-1978%29%
% 222.65/222.87  |- skos__altLabel mesh__D012000 Loudness Recruitment Detection
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D012000 2002
% 222.65/222.87  |- skos__annotation mesh__D012000 DF: RECRUITMENT DETECTION   
% 222.65/222.87  |- mesh__historyNote mesh__D012000 79   
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D012000 2003
% 222.65/222.87  |- skos__hiddenLabel mesh__D012000
% 222.65/222.87       Detections, Recruitment %28%Audiology%29%
% 222.65/222.87  |- skos__hiddenLabel mesh__D012000 Detections, Loudness Recruitment
% 222.65/222.87  |- rdf__type mesh__D012000sskos__Concept
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D012000 2005
% 222.65/222.87  |- skos__hiddenLabel mesh__D012000 Detection, Loudness Recruitment
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D012000 2004
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D012000 2006
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D012000 2000
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D012000 1998
% 222.65/222.87  |- skos__broader mesh__D009055Q000002smesh__D009055
% 222.65/222.87  |- mesh__preferredCombination mesh__D009055Q000002smesh__D009056
% 222.65/222.87  |- rdf__type mesh__D009055Q000002smesh__CompoundConcept
% 222.65/222.87  |- skos__historyNote mesh__D017294 Imidazoles %28%1987-1992%29%
% 222.65/222.87  |- skos__hiddenLabel mesh__D017294 SN307
% 222.65/222.87  |- rdf__type mesh__D017294sskos__Concept
% 222.65/222.87  |- skos__hiddenLabel mesh__D017294 Monohydrochloride, Ondansetron
% 222.65/222.87  |- skos__hiddenLabel mesh__D017294 GR 38032F
% 222.65/222.87  |- mesh__dateEstablished mesh__D017294 1993-01-01
% 222.65/222.87  |- mesh__dateCreated mesh__D017294 1992-05-19
% 222.65/222.87  |- mesh__recordAuthorizer mesh__D017294 sjn
% 222.65/222.87  |- skos__hiddenLabel mesh__D017294 Dihydrate, Ondansetron Monohydrochloride
% 222.65/222.87  |- skos__altLabel mesh__D017294 Ondansetron Hydrochloride
% 222.65/222.87  |- skos__hiddenLabel mesh__D017294 Monohydrochloride Dihydrate, Ondansetron
% 222.65/222.87  |- skos__hiddenLabel mesh__D017294 Hydrochloride, Ondansetron
% 222.65/222.87  |- mesh__historyNote mesh__D017294
% 222.65/222.87       93; was ONDANSETRON %28%NM%29% 1987-92   
% 222.65/222.87  |- skos__hiddenLabel mesh__D017294 SN 307
% 222.65/222.87  |- mesh__dateRevised mesh__D017294 2005-06-30
% 222.65/222.87  |- skos__broader mesh__D017294smesh__D002227
% 222.65/222.87  |- mesh__recordOriginator mesh__D017294 TPW
% 222.65/222.87  |- skos__altLabel mesh__D017294 GR-38032F
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D017294 2006
% 222.65/222.87  |- skos__broader mesh__D017294smesh__D007093
% 222.65/222.87  |- mesh__recordMaintainer mesh__D017294 ssb
% 222.65/222.87  |- skos__scopeNote mesh__D017294
% 222.65/222.87       A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.%A%    
% 222.65/222.87  |- skos__prefLabel mesh__D017294 Ondansetron
% 222.65/222.87  |- mesh__publicMeSHNote mesh__D017294
% 222.65/222.87       93; ONDANSETRON was indexed under IMIDAZOLES 1987-92   
% 222.65/222.87  |- mesh__onlineNote mesh__D017294
% 222.65/222.87       use ONDANSETRON %28%NM%29% to search ONDANSETRON 1987-92   
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Vaginal Diaphragms
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Device, Female Contraceptive
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Rings, Vaginal
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D003274 2006
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Vaginal Ring
% 222.65/222.87  |- rdf__type mesh__D003274sskos__Concept
% 222.65/222.87  |- mesh__dateCreated mesh__D003274 1974-11-19
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Springs, Coiled
% 222.65/222.87  |- skos__scopeNote mesh__D003274
% 222.65/222.87       Contraceptive devices used by females.     
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Diaphragm, Vaginal
% 222.65/222.87  |- skos__historyNote mesh__D003274 Contraceptive Devices %28%1966-1974%29%
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Caps, Cervical
% 222.65/222.87  |- mesh__publicMeSHNote mesh__D003274 75   
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Devices, Female Contraceptive
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Shields, Vaginal
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Spring, Coiled
% 222.65/222.87  |- mesh__historyNote mesh__D003274 75   
% 222.65/222.87  |- mesh__recordOriginator mesh__D003274 NLM
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Ring, Vaginal
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Cap, Cervical
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Cervical Caps
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Diaphragms, Vaginal
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Vaginal Sponges
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Female Contraceptive Devices
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Sponge, Vaginal
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Shield, Vaginal
% 222.65/222.87  |- mesh__dateRevised mesh__D003274 2002-07-03
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D003274 2003
% 222.65/222.87  |- mesh__recordMaintainer mesh__D003274 lkt
% 222.65/222.87  |- skos__prefLabel mesh__D003274 Contraceptive Devices, Female
% 222.65/222.87  |- skos__broader mesh__D003274smesh__D003273
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D003274 2004
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D003274 2005
% 222.65/222.87  |- mesh__dateEstablished mesh__D003274 1975-09-01
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Vaginal Shields
% 222.65/222.87  |- skos__annotation mesh__D003274
% 222.65/222.87       mechanical devices, not chemicals; pregnancy despite use = contraceptive term with no qualif, not /adv eff%A%  
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Female Contraceptive Device
% 222.65/222.87  |- mesh__recordAuthorizer mesh__D003274 sjn
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Contraceptive Device, Female
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Sponges, Vaginal
% 222.65/222.87  |- skos__hiddenLabel mesh__D003274 Coiled Springs
% 222.65/222.87  |- rdf__type mesh__D011706sskos__Concept
% 222.65/222.87  |- mesh__recordAuthorizer mesh__D011706 sjn
% 222.65/222.87  |- skos__prefLabel mesh__D011706 Pyloric Antrum
% 222.65/222.87  |- mesh__recordMaintainer mesh__D011706 lkt
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D011706 2005
% 222.65/222.87  |- mesh__dateCreated mesh__D011706 1999-01-01
% 222.65/222.87  |- skos__scopeNote mesh__D011706
% 222.65/222.87       The region between the sharp indentation at the lower third of the STOMACH %28%incisura angularis%29% and the junction of the PYLORUS with the DUODENUM. Pyloric antral glands contain mucus-secreting cells and gastrin-secreting endocrine cells %28%G CELLS%29%.%A%    
% 222.65/222.87  |- skos__altLabel mesh__D011706 Antrum, Pyloric
% 222.65/222.87  |- skos__hiddenLabel mesh__D011706 Antrums, Pyloric
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D011706 2006
% 222.65/222.87  |- skos__altLabel mesh__D011706 Gastric Antrum
% 222.65/222.87  |- mesh__historyNote mesh__D011706 73   
% 222.65/222.87  |- mesh__recordOriginator mesh__D011706 NLM
% 222.65/222.87  |- mesh__dateEstablished mesh__D011706 1973-01-01
% 222.65/222.87  |- skos__hiddenLabel mesh__D011706 Pyloric Antrums
% 222.65/222.87  |- mesh__dateRevised mesh__D011706 2004-07-07
% 222.65/222.87  |- skos__hiddenLabel mesh__D011706 Antrum, Gastric
% 222.65/222.87  |- mesh__publicMeSHNote mesh__D011706 73   
% 222.65/222.87  |- skos__broader mesh__D011706smesh__D013270
% 222.65/222.87  |- skos__historyNote mesh__D011706 Stomach %28%1966-1972%29%
% 222.65/222.87  |- skos__hiddenLabel mesh__D011706 Gastric Antrums
% 222.65/222.87  |- skos__hiddenLabel mesh__D011706 Antrums, Gastric
% 222.65/222.87  |- skos__historyNote mesh__D011706 Pylorus %28%1966-1972%29%
% 222.65/222.87  |- mesh__dateEstablished mesh__D007665 1982-01-01
% 222.65/222.87  |- mesh__recordAuthorizer mesh__D007665 sjn
% 222.65/222.87  |- mesh__dateCreated mesh__D007665 1981-05-13
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D007665 2006
% 222.65/222.87  |- skos__historyNote mesh__D007665 Piperidines %28%1966-1981%29%
% 222.65/222.87  |- skos__historyNote mesh__D007665 Thiophenes %28%1966-1981%29%
% 222.65/222.87  |- mesh__recordOriginator mesh__D007665 SH
% 222.65/222.87  |- skos__broader mesh__D007665smesh__D010880
% 222.65/222.87  |- skos__altLabel mesh__D007665 Ketotiphen
% 222.65/222.87  |- mesh__recordMaintainer mesh__D007665 ssb
% 222.65/222.87  |- mesh__historyNote mesh__D007665 82   
% 222.65/222.87  |- skos__altLabel mesh__D007665 Ketotifene
% 222.65/222.87  |- mesh__dateRevised mesh__D007665 2005-06-30
% 222.65/222.87  |- skos__altLabel mesh__D007665 Ketotiphene
% 222.65/222.87  |- skos__altLabel mesh__D007665
% 222.65/222.87       4,9-Dihydro-4-%28%1-methyl-4-piperidylidene%29%-10H-benzo%28%4,5%29%-cyclohepta%28%1,2-b%29%thiophen-10-one
% 222.65/222.87  |- rdf__type mesh__D007665sskos__Concept
% 222.65/222.87  |- mesh__publicMeSHNote mesh__D007665 82   
% 222.65/222.87  |- skos__broader mesh__D007665smesh__D013876
% 222.65/222.87  |- skos__scopeNote mesh__D007665
% 222.65/222.87       A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.%A%    
% 222.65/222.87  |- skos__hiddenLabel mesh__D007665 Fumarate, Ketotifen
% 222.65/222.87  |- skos__prefLabel mesh__D007665 Ketotifen
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D026021 2002
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D026021 2004
% 222.65/222.87  |- skos__altLabel mesh__D026021 Bovine herpesvirus 4
% 222.65/222.87  |- rdf__type mesh__D026021sskos__Concept
% 222.65/222.87  |- mesh__publicMeSHNote mesh__D026021 2002   
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D026021 2005
% 222.65/222.87  |- skos__altLabel mesh__D026021 Movar virus
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D026021 2003
% 222.65/222.87  |- skos__broader mesh__D026021smesh__D018144
% 222.65/222.87  |- skos__historyNote mesh__D026021 Herpesviridae %28%1982-1993%29%
% 222.65/222.87  |- mesh__dateEstablished mesh__D026021 2002-01-01
% 222.65/222.87  |- skos__historyNote mesh__D026021 Gammaherpesvirinae %28%1994-2001%29%
% 222.65/222.87  |- mesh__dateCreated mesh__D026021 2001-07-25
% 222.65/222.87  |- skos__scopeNote mesh__D026021
% 222.65/222.87       A species in the genus RHADINOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting cattle.%A%    
% 222.65/222.87  |- skos__prefLabel mesh__D026021 Herpesvirus 4, Bovine
% 222.65/222.87  |- mesh__historyNote mesh__D026021 2002   
% 222.65/222.87  |- skos__annotation mesh__D026021
% 222.65/222.87       infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%%A%  
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D026021 2006
% 222.65/222.87  |- skos__hiddenLabel mesh__D026021 Movar viruses
% 222.65/222.87  |- mesh__historyNote mesh__D045784 2004   
% 222.65/222.87  |- skos__historyNote mesh__D045784 Diterpenes %28%1988-2003%29%
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D045784 2004
% 222.65/222.87  |- mesh__dateEstablished mesh__D045784 2004-01-01
% 222.65/222.87  |- skos__hiddenLabel mesh__D045784 Pimarane Diterpenes
% 222.65/222.87  |- mesh__dateCreated mesh__D045784 2003-07-09
% 222.65/222.87  |- skos__hiddenLabel mesh__D045784 Abietane Diterpenes
% 222.65/222.87  |- skos__scopeNote mesh__D045784
% 222.65/222.87       A group of DITERPENES cyclized into 3-ring PHENANTHRENES.%A%    
% 222.65/222.87  |- mesh__publicMeSHNote mesh__D045784 2004   
% 222.65/222.87  |- skos__broader mesh__D045784smesh__D010616
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D045784 2006
% 222.65/222.87  |- skos__prefLabel mesh__D045784 Diterpenes, Abietane
% 222.65/222.87  |- skos__altLabel mesh__D045784 Pimaranes
% 222.65/222.87  |- skos__altLabel mesh__D045784 Abietanes
% 222.65/222.87  |- rdf__type mesh__D045784sskos__Concept
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D045784 2005
% 222.65/222.87  |- skos__broader mesh__D045784smesh__D004224
% 222.65/222.87  |- skos__hiddenLabel mesh__D012001 Perception Disturbances, Loudness
% 222.65/222.87  |- skos__hiddenLabel mesh__D012001 Hyperesthesias, Auditory
% 222.65/222.87  |- skos__hiddenLabel mesh__D012001 Perception Disturbance, Loudness
% 222.65/222.87  |- skos__hiddenLabel mesh__D012001 Auditory Hyperesthesias
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D012001 2006
% 222.65/222.87  |- skos__altLabel mesh__D012001 Recruitment, Loudness
% 222.65/222.87  |- mesh__recordMaintainer mesh__D012001 lkt
% 222.65/222.87  |- mesh__dateRevised mesh__D012001 2004-07-07
% 222.65/222.87  |- skos__historyNote mesh__D012001 Auditory Threshold %28%1968-1978%29%
% 222.65/222.87  |- skos__hiddenLabel mesh__D012001 Disturbances, Loudness Perception
% 222.65/222.87  |- mesh__historyNote mesh__D012001 2000%28%1979%29%   
% 222.65/222.87  |- skos__hiddenLabel mesh__D012001 Loudness Perception Disturbance
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D012001 2005
% 222.65/222.87  |- mesh__dateEstablished mesh__D012001 1979-01-01
% 222.65/222.87  |- mesh__recordAuthorizer mesh__D012001 sjn
% 222.65/222.87  |- skos__hiddenLabel mesh__D012001 Phonophobias
% 222.65/222.87  |- skos__scopeNote mesh__D012001
% 222.65/222.87       An abnormally disproportionate increase in the sensation of loudness in response to auditory stimuli of normal volume. COCHLEAR DISEASES; VESTIBULOCOCHLEAR NERVE DISEASES; FACIAL NERVE DISEASES; STAPES SURGERY; and other disorders may be associated with this condition.%A%    
% 222.65/222.87  |- skos__hiddenLabel mesh__D012001 Hyperacusias
% 222.65/222.87  |- mesh__dateCreated mesh__D012001 1978-05-22
% 222.65/222.87  |- skos__historyNote mesh__D012001 Auditory Perception %28%1967-1978%29%
% 222.65/222.87  |- skos__hiddenLabel mesh__D012001 Hyperesthesia, Auditory
% 222.65/222.87  |- skos__altLabel mesh__D012001 Hyperacusia
% 222.65/222.87  |- mesh__recordOriginator mesh__D012001 RC
% 222.65/222.87  |- skos__broader mesh__D012001smesh__D006311
% 222.65/222.87  |- skos__prefLabel mesh__D012001 Hyperacusis
% 222.65/222.87  |- skos__hiddenLabel mesh__D012001 Hyperacuses
% 222.65/222.87  |- skos__historyNote mesh__D012001 Audiometry %28%1966-1978%29%
% 222.65/222.87  |- skos__altLabel mesh__D012001 Loudness Perception Disturbances
% 222.65/222.87  |- skos__hiddenLabel mesh__D012001 Loudness Recruitments
% 222.65/222.87  |- skos__historyNote mesh__D012001 Hearing %28%1966-1967%29%
% 222.65/222.87  |- skos__altLabel mesh__D012001 Loudness Recruitment
% 222.65/222.87  |- rdf__type mesh__D012001sskos__Concept
% 222.65/222.87  |- skos__historyNote mesh__D012001 Perception %28%1966-1967%29%
% 222.65/222.87  |- mesh__publicMeSHNote mesh__D012001
% 222.65/222.87       2000; see RECRUITMENT LOUDNESS 1979-1999   
% 222.65/222.87  |- skos__hiddenLabel mesh__D012001 Disturbance, Loudness Perception
% 222.65/222.87  |- skos__hiddenLabel mesh__D003275 Male Contraceptive Device
% 222.65/222.87  |- mesh__dateRevised mesh__D003275 1996-06-10
% 222.65/222.87  |- mesh__recordAuthorizer mesh__D003275 PLS
% 222.65/222.87  |- skos__prefLabel mesh__D003275 Contraceptive Devices, Male
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D003275 2005
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D003275 2004
% 222.65/222.87  |- mesh__dateCreated mesh__D003275 1974-11-19
% 222.65/222.87  |- skos__hiddenLabel mesh__D003275 Contraceptive Device, Male
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D003275 2002
% 222.65/222.87  |- rdf__type mesh__D003275sskos__Concept
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D003275 2003
% 222.65/222.87  |- skos__historyNote mesh__D003275 Contraceptive Devices %28%1966-1974%29%
% 222.65/222.87  |- skos__scopeNote mesh__D003275 Contraceptive devices used by males.     
% 222.65/222.87  |- mesh__publicMeSHNote mesh__D003275 75   
% 222.65/222.87  |- mesh__dateEstablished mesh__D003275 1975-09-01
% 222.65/222.87  |- skos__hiddenLabel mesh__D003275 Devices, Male Contraceptive
% 222.65/222.87  |- skos__annotation mesh__D003275
% 222.65/222.87       mechanical devices, not chemicals; pregnancy despite use = contraceptive term with no qualif, not /adv eff%A%  
% 222.65/222.87  |- skos__hiddenLabel mesh__D003275 Male Contraceptive Devices
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D003275 1999
% 222.65/222.87  |- mesh__recordMaintainer mesh__D003275 TGC
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D003275 2001
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D003275 1998
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D003275 1997
% 222.65/222.87  |- mesh__historyNote mesh__D003275 75   
% 222.65/222.87  |- skos__hiddenLabel mesh__D003275 Device, Male Contraceptive
% 222.65/222.87  |- mesh__recordOriginator mesh__D003275 NLM
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D003275 2000
% 222.65/222.87  |- skos__broader mesh__D003275smesh__D003273
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D003275 2006
% 222.65/222.87  |- mesh__dateCreated mesh__D011707 1999-01-01
% 222.65/222.87  |- mesh__recordOriginator mesh__D011707 NLM
% 222.65/222.87  |- skos__scopeNote mesh__D011707
% 222.65/222.87       Narrowing of the pyloric canal with varied etiology. A common form is due to muscle hypertrophy %28%PYLORIC STENOSIS, HYPERTROPHIC%29% seen in infants.%A%    
% 222.65/222.87  |- skos__altLabel mesh__D011707 Stenosis, Pyloric
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D011707 2006
% 222.65/222.87  |- skos__broader mesh__D011707smesh__D017219
% 222.65/222.87  |- mesh__dateRevised mesh__D011707 2004-07-07
% 222.65/222.87  |- mesh__recordAuthorizer mesh__D011707 sjn
% 222.65/222.87  |- mesh__recordMaintainer mesh__D011707 lkt
% 222.65/222.87  |- rdf__type mesh__D011707sskos__Concept
% 222.65/222.87  |- skos__prefLabel mesh__D011707 Pyloric Stenosis
% 222.65/222.87  |- mesh__activeMeSHYear mesh__D011707 2005
% 222.65/222.87  |- skos__broader mesh__D004384Q000295smesh__D004384
% 222.65/222.87  |- mesh__preferredCombination mesh__D004384Q000295smesh__D020698
% 222.65/222.87  |- rdf__type mesh__D004384Q000295smesh__CompoundConcept
% 222.65/222.87  |- skos__broader mesh__D009206Q000821smesh__D009206
% 222.65/222.87  |- mesh__preferredCombination mesh__D009206Q000821smesh__D006321Q000821
% 222.65/222.87  |- rdf__type mesh__D009206Q000821smesh__CompoundConcept
% 222.65/222.88  |- mesh__dateRevised mesh__D007666 2005-06-30
% 222.65/222.88  |- skos__broader mesh__D007666smesh__D011564
% 222.65/222.88  |- rdf__type mesh__D007666sskos__Concept
% 222.65/222.88  |- skos__altLabel mesh__D007666 Visammin
% 222.65/222.88  |- mesh__recordAuthorizer mesh__D007666 sjn
% 222.65/222.88  |- skos__scopeNote mesh__D007666
% 222.65/222.88       A vasodilator that also has bronchodilatory action. It has been employed in the treatment of angina pectoris, in the treatment of asthma, and in conjunction with ultraviolet light A, has been tried in the treatment of vitiligo. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1024%29%%A%    
% 222.65/222.88  |- skos__prefLabel mesh__D007666 Khellin
% 222.65/222.88  |- mesh__recordOriginator mesh__D007666 NLM
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D007666 2006
% 222.65/222.88  |- mesh__dateCreated mesh__D007666 1999-01-01
% 222.65/222.88  |- mesh__recordMaintainer mesh__D007666 ssb
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D045785 2004
% 222.65/222.88  |- skos__scopeNote mesh__D045785
% 222.65/222.88       A group of DITERPENES cyclized into 2-rings with a side-chain.%A%    
% 222.65/222.88  |- skos__altLabel mesh__D045785 Clerodanes
% 222.65/222.88  |- mesh__dateCreated mesh__D045785 2003-07-09
% 222.65/222.88  |- mesh__historyNote mesh__D045785 2004   
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D045785 2005
% 222.65/222.88  |- mesh__publicMeSHNote mesh__D045785 2004   
% 222.65/222.88  |- skos__hiddenLabel mesh__D045785 Clerodane Diterpenes
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D045785 2006
% 222.65/222.88  |- skos__prefLabel mesh__D045785 Diterpenes, Clerodane
% 222.65/222.88  |- mesh__dateEstablished mesh__D045785 2004-01-01
% 222.65/222.88  |- skos__historyNote mesh__D045785 Diterpenes %28%1977-2003%29%
% 222.65/222.88  |- rdf__type mesh__D045785sskos__Concept
% 222.65/222.88  |- skos__broader mesh__D045785smesh__D004224
% 222.65/222.88  |- mesh__recordAuthorizer mesh__D012800 PLS
% 222.65/222.88  |- mesh__recordOriginator mesh__D012800 NLM
% 222.65/222.88  |- skos__altLabel mesh__D012800 Russian Federation %28%Asia%29%
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012800 2005
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012800 2000
% 222.65/222.88  |- mesh__dateRevised mesh__D012800 1996-06-10
% 222.65/222.88  |- mesh__onlineNote mesh__D012800
% 222.65/222.88       use SIBERIA to search RUSSIAN FEDERATION %28%ASIA%29% 1967-81; use SIBERIA %26% RUSSIAN S.F.S.R. to search RUSSIAN FEDERATION 1966; search RUSSIA under RUSSIA %28%PRE-1917%29% 1966%A%  
% 222.65/222.88  |- skos__altLabel mesh__D012800 Russian S.F.S.R., Asian
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012800 2003
% 222.65/222.88  |- mesh__dateCreated mesh__D012800 1999-01-01
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012800 2006
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012800 2001
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012800 1998
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012800 2004
% 222.65/222.88  |- skos__broader mesh__D012800smesh__D012426
% 222.65/222.88  |- mesh__recordMaintainer mesh__D012800 TGC
% 222.65/222.88  |- rdf__type mesh__D012800sskos__Concept
% 222.65/222.88  |- mesh__historyNote mesh__D012800
% 222.65/222.88       82; was RUSSIAN FEDERATION %28%ASIA%29% 1967-81; RUSSIAN FEDERATION was heading 1966; RUSSIA was heading 1963-66%A%  
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012800 2002
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012800 1999
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012800 1997
% 222.65/222.88  |- skos__prefLabel mesh__D012800 Siberia
% 222.65/222.88  |- skos__hiddenLabel mesh__D012002 Rectal Disease
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012002 2005
% 222.65/222.88  |- skos__broader mesh__D012002smesh__D007410
% 222.65/222.88  |- skos__annotation mesh__D012002 inflamm dis = PROCTITIS   
% 222.65/222.88  |- mesh__dateRevised mesh__D012002 2003-07-09
% 222.65/222.88  |- mesh__recordOriginator mesh__D012002 NLM
% 222.65/222.88  |- mesh__recordMaintainer mesh__D012002 lkt
% 222.65/222.88  |- mesh__historyNote mesh__D012002 66   
% 222.65/222.88  |- mesh__publicMeSHNote mesh__D012002 66   
% 222.65/222.88  |- mesh__recordAuthorizer mesh__D012002 sjn
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012002 2004
% 222.65/222.88  |- skos__hiddenLabel mesh__D012002 Diseases, Rectal
% 222.65/222.88  |- mesh__dateEstablished mesh__D012002 1966-01-01
% 222.65/222.88  |- mesh__dateCreated mesh__D012002 1999-01-01
% 222.65/222.88  |- rdf__type mesh__D012002sskos__Concept
% 222.65/222.88  |- skos__scopeNote mesh__D012002
% 222.65/222.88       Pathological developments in the RECTUM region of the large intestine %28%INTESTINE, LARGE%29%.%A%    
% 222.65/222.88  |- skos__hiddenLabel mesh__D012002 Disease, Rectal
% 222.65/222.88  |- skos__prefLabel mesh__D012002 Rectal Diseases
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012002 2006
% 222.65/222.88  |- skos__broader mesh__D003276smesh__D003271
% 222.65/222.88  |- skos__scopeNote mesh__D003276
% 222.65/222.88       Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both.%A%    
% 222.65/222.88  |- mesh__recordAuthorizer mesh__D003276 sjn
% 222.65/222.88  |- mesh__dateCreated mesh__D003276 1999-01-01
% 222.65/222.88  |- skos__hiddenLabel mesh__D003276 Contraceptives, Low-Dose Oral
% 222.65/222.88  |- mesh__recordOriginator mesh__D003276 NLM
% 222.65/222.88  |- rdf__type mesh__D003276sskos__Concept
% 222.65/222.88  |- skos__hiddenLabel mesh__D003276 Contraceptives, Phasic Oral
% 222.65/222.88  |- skos__prefLabel mesh__D003276 Contraceptives, Oral
% 222.65/222.88  |- skos__hiddenLabel mesh__D003276 Phasic Oral Contraceptives
% 222.65/222.88  |- mesh__dateRevised mesh__D003276 2005-06-30
% 222.65/222.88  |- skos__altLabel mesh__D003276 Oral Contraceptives
% 222.65/222.88  |- skos__annotation mesh__D003276
% 222.65/222.88       pregn despite use: see note on CONTRACEPTIVE AGENTS   
% 222.65/222.88  |- mesh__recordMaintainer mesh__D003276 ssb
% 222.65/222.88  |- skos__hiddenLabel mesh__D003276 Oral Contraceptives, Low Dose
% 222.65/222.88  |- skos__hiddenLabel mesh__D003276 Low-Dose Oral Contraceptives
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D003276 2006
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D011708 2006
% 222.65/222.88  |- skos__prefLabel mesh__D011708 Pylorus
% 222.65/222.88  |- skos__hiddenLabel mesh__D011708 Sphincters, Pyloric
% 222.65/222.88  |- skos__scopeNote mesh__D011708
% 222.65/222.88       The region of the STOMACH at the junction with the DUODENUM. It is marked by the thickening of circular muscle layers forming the pyloric sphincter to control the opening and closure of the lumen.%A%    
% 222.65/222.88  |- mesh__dateRevised mesh__D011708 2004-07-07
% 222.65/222.88  |- mesh__recordOriginator mesh__D011708 NLM
% 222.65/222.88  |- skos__broader mesh__D011708smesh__D013270
% 222.65/222.88  |- rdf__type mesh__D011708sskos__Concept
% 222.65/222.88  |- skos__related mesh__D011708smesh__D005746
% 222.65/222.88  |- skos__hiddenLabel mesh__D011708 Pyloric Sphincters
% 222.65/222.88  |- mesh__recordAuthorizer mesh__D011708 sjn
% 222.65/222.88  |- mesh__recordMaintainer mesh__D011708 lkt
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D011708 2005
% 222.65/222.88  |- mesh__dateCreated mesh__D011708 1999-01-01
% 222.65/222.88  |- skos__hiddenLabel mesh__D011708 Sphincter, Pyloric
% 222.65/222.88  |- mesh__publicMeSHNote mesh__D007667
% 222.65/222.88       91; was see under BLOOD GROUPS 1976-90   
% 222.65/222.88  |- rdf__type mesh__D007667sskos__Concept
% 222.65/222.88  |- mesh__recordMaintainer mesh__D007667 ssb
% 222.65/222.88  |- mesh__dateRevised mesh__D007667 2005-06-30
% 222.65/222.88  |- skos__hiddenLabel mesh__D007667 System, Kidd Blood-Group
% 222.65/222.88  |- skos__historyNote mesh__D007667 Blood Groups %28%1966-1975%29%
% 222.65/222.88  |- skos__hiddenLabel mesh__D007667 Kidd Blood Group System
% 222.65/222.88  |- skos__hiddenLabel mesh__D007667 Blood-Group System, Kidd
% 222.65/222.88  |- mesh__historyNote mesh__D007667
% 222.65/222.88       91%28%76%29%; was see under BLOOD GROUPS 1976-90   
% 222.65/222.88  |- skos__broader mesh__D007667smesh__D001789
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D007667 2006
% 222.65/222.88  |- mesh__recordAuthorizer mesh__D007667 sjn
% 222.65/222.88  |- skos__annotation mesh__D007667
% 222.65/222.88       IM; coord with disease /blood %28%IM%29%, not /immunol nor /genet; TN 230%A%  
% 222.65/222.88  |- mesh__dateEstablished mesh__D007667 1991-01-01
% 222.65/222.88  |- skos__prefLabel mesh__D007667 Kidd Blood-Group System
% 222.65/222.88  |- mesh__recordOriginator mesh__D007667 SH
% 222.65/222.88  |- mesh__dateCreated mesh__D007667 1975-07-25
% 222.65/222.88  |- skos__scopeNote mesh__D007667
% 222.65/222.88       A group of antigens consisting principally of Jk%28%a%29% and Jk%28%b%29%, determined by allelic genes. Amorphs are encountered. Antibodies of these substances are usually weak and quite labile, stimulated by erythrocytes.%A%    
% 222.65/222.88  |- skos__broader mesh__D045786smesh__D004224
% 222.65/222.88  |- skos__altLabel mesh__D045786 Kauranes
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D045786 2004
% 222.65/222.88  |- mesh__dateCreated mesh__D045786 2003-07-09
% 222.65/222.88  |- skos__prefLabel mesh__D045786 Diterpenes, Kaurane
% 222.65/222.88  |- skos__hiddenLabel mesh__D045786 Kaurane Diterpenes
% 222.65/222.88  |- mesh__historyNote mesh__D045786 2004   
% 222.65/222.88  |- mesh__publicMeSHNote mesh__D045786 2004   
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D045786 2005
% 222.65/222.88  |- rdf__type mesh__D045786sskos__Concept
% 222.65/222.88  |- skos__historyNote mesh__D045786 Diterpenes %28%1976-2003%29%
% 222.65/222.88  |- skos__scopeNote mesh__D045786
% 222.65/222.88       A group of DITERPENES cyclized into four rings.     
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D045786 2006
% 222.65/222.88  |- mesh__dateEstablished mesh__D045786 2004-01-01
% 222.65/222.88  |- skos__hiddenLabel mesh__D026023 S 3151
% 222.65/222.88  |- skos__altLabel mesh__D026023 trans-%28%1RS%29%-Permethrin
% 222.65/222.88  |- mesh__recordOriginator mesh__D026023 jmp
% 222.65/222.88  |- skos__hiddenLabel mesh__D026023 NRDC147
% 222.65/222.88  |- skos__altLabel mesh__D026023 cis-%28%1RS%29%-permethrin
% 222.65/222.88  |- skos__altLabel mesh__D026023 Permethrin, trans-%28%1RS%29%-Isomer
% 222.65/222.88  |- skos__prefLabel mesh__D026023 Permethrin
% 222.65/222.88  |- skos__broader mesh__D026023smesh__D011722
% 222.65/222.88  |- skos__hiddenLabel mesh__D026023 trans permethrin
% 222.65/222.88  |- skos__altLabel mesh__D026023 cis-permethrin
% 222.65/222.88  |- mesh__dateEstablished mesh__D026023 2002-01-01
% 222.65/222.88  |- mesh__dateCreated mesh__D026023 2001-07-25
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D026023 2006
% 222.65/222.88  |- skos__altLabel mesh__D026023
% 222.65/222.88       %28%m-Phenoxybenzyl%29%-cis,trans-3-%28%2,2-dichlorovinyl%29%-2,2-dimethylcyclopropanecarboxylate
% 222.65/222.88  |- skos__altLabel mesh__D026023 permethrin, cis-%28%1RS%29%-isomer
% 222.65/222.88  |- skos__hiddenLabel mesh__D026023 NRDC 147
% 222.65/222.88  |- mesh__recordMaintainer mesh__D026023 ssb
% 222.65/222.88  |- skos__hiddenLabel mesh__D026023 S3151
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D026023 2005
% 222.65/222.88  |- skos__hiddenLabel mesh__D026023 NRDC 143
% 222.65/222.88  |- mesh__publicMeSHNote mesh__D026023
% 222.65/222.88       2002; PERMETHRIN was indexed under PYRETHRINS 1978-2001 %26% PYRETHRUM 1975-1977%A%  
% 222.65/222.88  |- mesh__dateRevised mesh__D026023 2004-07-07
% 222.65/222.88  |- skos__hiddenLabel mesh__D026023 cis permethrin
% 222.65/222.88  |- rdf__type mesh__D026023sskos__Concept
% 222.65/222.88  |- skos__scopeNote mesh__D026023
% 222.65/222.88       A pyrethroid insecticide commonly used in the treatment of LICE INFESTATIONS and SCABIES.%A%    
% 222.65/222.88  |- skos__hiddenLabel mesh__D026023 NIA 33297
% 222.65/222.88  |- mesh__recordAuthorizer mesh__D026023 sjn
% 222.65/222.88  |- skos__altLabel mesh__D026023 trans-permethrin
% 222.65/222.88  |- skos__altLabel mesh__D026023
% 222.65/222.88       3-Phenoxybenzyl-%28%+-%29%-cis,trans-2,2-dichlorovinyl-2,2-dimethyl-cyclopropylcarboxylic acid, ester
% 222.65/222.88  |- skos__hiddenLabel mesh__D026023 FMC33297
% 222.65/222.88  |- skos__hiddenLabel mesh__D026023 NRDC143
% 222.65/222.88  |- skos__historyNote mesh__D026023 Pyrethrum %28%1975-1977%29%
% 222.65/222.88  |- mesh__historyNote mesh__D026023
% 222.65/222.88       2002; use PYMETHRIN %28%NM%29% 1975-2001   
% 222.65/222.88  |- skos__hiddenLabel mesh__D026023 PP557
% 222.65/222.88  |- skos__hiddenLabel mesh__D026023 NIA33297
% 222.65/222.88  |- skos__historyNote mesh__D026023 Pyrethrins %28%1978-2001%29%
% 222.65/222.88  |- skos__hiddenLabel mesh__D026023 FMC 33297
% 222.65/222.88  |- skos__altLabel mesh__D026023
% 222.65/222.88       3-Phenoxybenzyl-cis,trans-%28%1RS%29%-3-%28%2,2-dichlorovinyl%29%-2,2-dimethylcyclopropanecarboxylate
% 222.65/222.88  |- skos__hiddenLabel mesh__D026023 PP 557
% 222.65/222.88  |- mesh__publicMeSHNote mesh__D012801 68   
% 222.65/222.88  |- skos__hiddenLabel mesh__D012801 Sibling Relation
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012801 2005
% 222.65/222.88  |- skos__hiddenLabel mesh__D012801 Relation, Sibling
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012801 2003
% 222.65/222.88  |- mesh__dateCreated mesh__D012801 1999-01-01
% 222.65/222.88  |- mesh__recordAuthorizer mesh__D012801 PLS
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012801 2006
% 222.65/222.88  |- mesh__dateEstablished mesh__D012801 1968-01-01
% 222.65/222.88  |- skos__prefLabel mesh__D012801 Sibling Relations
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012801 1998
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012801 2004
% 222.65/222.88  |- mesh__recordOriginator mesh__D012801 NLM
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012801 1996
% 222.65/222.88  |- rdf__type mesh__D012801sskos__Concept
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012801 2000
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012801 1999
% 222.65/222.88  |- skos__hiddenLabel mesh__D012801 Relations, Sibling
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012801 1997
% 222.65/222.88  |- mesh__historyNote mesh__D012801 68   
% 222.65/222.88  |- skos__annotation mesh__D012801 human %26% animal; DF: SIBLING RELAT   
% 222.65/222.88  |- skos__broader mesh__D012801smesh__D005195
% 222.65/222.88  |- skos__historyNote mesh__D012801 Parent-Child Relations %28%1966-1967%29%
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012801 2001
% 222.65/222.88  |- skos__scopeNote mesh__D012801
% 222.65/222.88       Interactions and relationships between sisters and/or brothers. The concept also applies to animal studies.%A%    
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012801 2002
% 222.65/222.88  |- skos__historyNote mesh__D012801 Child Psychology %28%1966-1967%29%
% 222.65/222.88  |- mesh__recordMaintainer mesh__D012801 KEV
% 222.65/222.88  |- mesh__dateRevised mesh__D012801 1995-05-23
% 222.65/222.88  |- skos__scopeNote mesh__D012003
% 222.65/222.88       An abnormal anatomical passage connecting the RECTUM to the outside, with an orifice at the site of drainage.%A%    
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012003 2004
% 222.65/222.88  |- mesh__dateCreated mesh__D012003 1999-01-01
% 222.65/222.88  |- rdf__type mesh__D012003sskos__Concept
% 222.65/222.88  |- skos__hiddenLabel mesh__D012003 Fistula, Rectal
% 222.65/222.88  |- skos__broader mesh__D012003smesh__D012002
% 222.65/222.88  |- skos__broader mesh__D012003smesh__D007412
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012003 2006
% 222.65/222.88  |- mesh__recordMaintainer mesh__D012003 lkt
% 222.65/222.88  |- skos__annotation mesh__D012003
% 222.65/222.88       fistula policy: Manual 23.19+; do not confuse X ref ANAL FISTULA with FISSURE IN ANO; RECTOVAGINAL FISTULA is also available%A%  
% 222.65/222.88  |- mesh__recordOriginator mesh__D012003 NLM
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D012003 2005
% 222.65/222.88  |- mesh__dateRevised mesh__D012003 2003-07-09
% 222.65/222.88  |- skos__prefLabel mesh__D012003 Rectal Fistula
% 222.65/222.88  |- mesh__recordAuthorizer mesh__D012003 sjn
% 222.65/222.88  |- mesh__recordMaintainer mesh__D003277 ssb
% 222.65/222.88  |- mesh__dateCreated mesh__D003277 1975-07-23
% 222.65/222.88  |- skos__hiddenLabel mesh__D003277 Combined Oral Contraceptives
% 222.65/222.88  |- rdf__type mesh__D003277sskos__Concept
% 222.65/222.88  |- mesh__recordOriginator mesh__D003277 RLS
% 222.65/222.88  |- skos__prefLabel mesh__D003277 Contraceptives, Oral, Combined
% 222.65/222.88  |- skos__broader mesh__D003277smesh__D003276
% 222.65/222.88  |- mesh__publicMeSHNote mesh__D003277
% 222.65/222.88       86; was see under CONTRACEPTIVES, ORAL 1976-85   
% 222.65/222.88  |- mesh__recordAuthorizer mesh__D003277 sjn
% 222.65/222.88  |- skos__altLabel mesh__D003277 Oral Contraceptives, Combined
% 222.65/222.88  |- skos__hiddenLabel mesh__D003277 Contraceptives, Combined Oral
% 222.65/222.88  |- skos__scopeNote mesh__D003277
% 222.65/222.88       Fixed drug combinations administered orally for contraceptive purposes.%A%    
% 222.65/222.88  |- mesh__dateRevised mesh__D003277 2005-06-30
% 222.65/222.88  |- skos__historyNote mesh__D003277 Contraceptives, Oral %28%1970-1975%29%
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D003277 2006
% 222.65/222.88  |- skos__altLabel mesh__D003277 Contraceptive Agents, Female, Combined
% 222.65/222.88  |- skos__historyNote mesh__D003277 Drug Combinations %28%1972-1975%29%
% 222.65/222.88  |- mesh__historyNote mesh__D003277
% 222.65/222.88       86%28%76%29%; was see under CONTRACEPTIVES, ORAL 1976-85   
% 222.65/222.88  |- skos__annotation mesh__D003277
% 222.65/222.88       pregn despite use: see note on CONTRACEPTIVE AGENTS   
% 222.65/222.88  |- mesh__dateEstablished mesh__D003277 1986-01-01
% 222.65/222.88  |- skos__prefLabel mesh__D011709 Pyocins
% 222.65/222.88  |- mesh__recordAuthorizer mesh__D011709 sjn
% 222.65/222.88  |- mesh__dateCreated mesh__D011709 1999-01-01
% 222.65/222.88  |- skos__historyNote mesh__D011709 Pyocin %28%1968-1978%29%
% 222.65/222.88  |- skos__historyNote mesh__D011709 Antibiotics %28%1966-1967%29%
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D011709 2006
% 222.65/222.88  |- mesh__historyNote mesh__D011709
% 222.65/222.88       91%28%79%29%; was see under BACTERIOCINS 1979-90; was PYOCIN see under BACTERIOCINS 1968-78, see under ANTIBIOTICS 1966-67%A%  
% 222.65/222.88  |- skos__broader mesh__D011709smesh__D001430
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D011709 2005
% 222.65/222.88  |- skos__altLabel mesh__D011709 Pyocin R 1
% 222.65/222.88  |- mesh__dateEstablished mesh__D011709 1991-01-01
% 222.65/222.88  |- mesh__onlineNote mesh__D011709
% 222.65/222.88       use PYOCINS to search PYOCIN 1975-79; use BACTERIOCINS 1968-74 %26% ANTIBIOTICS 1966-67%A%  
% 222.65/222.88  |- skos__scopeNote mesh__D011709
% 222.65/222.88       Bacteriocins elaborated by mutant strains of Pseudomonas aeruginosa. They are protein or protein-lipopolysaccharide complexes lethal to other strains of the same or related species.%A%    
% 222.65/222.88  |- mesh__dateRevised mesh__D011709 2003-07-09
% 222.65/222.88  |- mesh__recordMaintainer mesh__D011709 jmp
% 222.65/222.88  |- skos__hiddenLabel mesh__D011709 Pyocin 1 4
% 222.65/222.88  |- rdf__type mesh__D011709sskos__Concept
% 222.65/222.88  |- mesh__recordOriginator mesh__D011709 NLM
% 222.65/222.88  |- mesh__publicMeSHNote mesh__D011709
% 222.65/222.88       91; was see under BACTERIOCINS 1979-90; was PYOCIN see under BACTERIOCINS 1968-78, see under ANTIBIOTICS 1966-67%A%  
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D011709 2004
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D008760 2000
% 222.65/222.88  |- skos__scopeNote mesh__D008760 A product of putrefaction. Poisonous.     
% 222.65/222.88  |- mesh__dateRevised mesh__D008760 1992-05-18
% 222.65/222.88  |- mesh__recordMaintainer mesh__D008760 TAP
% 222.65/222.88  |- skos__historyNote mesh__D008760 Guanidines %28%1969-1974%29%
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D008760 1996
% 222.65/222.88  |- mesh__recordAuthorizer mesh__D008760 PLS
% 222.65/222.88  |- mesh__historyNote mesh__D008760
% 222.65/222.88       91%28%75%29%; was see under GUANIDINES 1975-90   
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D008760 2006
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D008760 1995
% 222.65/222.88  |- skos__prefLabel mesh__D008760 Methylguanidine
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D008760 2005
% 222.65/222.88  |- mesh__dateEstablished mesh__D008760 1991-01-01
% 222.65/222.88  |- skos__broader mesh__D008760smesh__D006146
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D008760 1994
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D008760 2004
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D008760 1993
% 222.65/222.88  |- mesh__publicMeSHNote mesh__D008760
% 222.65/222.88       91; was see under GUANIDINES 1975-90   
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D008760 1999
% 222.65/222.88  |- rdf__type mesh__D008760sskos__Concept
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D008760 2002
% 222.65/222.88  |- mesh__recordOriginator mesh__D008760 NLM
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D008760 2003
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D008760 1998
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D008760 2001
% 222.65/222.88  |- mesh__dateCreated mesh__D008760 1974-11-19
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D008760 1997
% 222.65/222.88  |- mesh__recordAuthorizer mesh__D007668 sjn
% 222.65/222.88  |- rdf__type mesh__D007668sskos__Concept
% 222.65/222.88  |- skos__annotation mesh__D007668
% 222.65/222.88       kidney tissue or cells in cultures: Manual 18.6.15, 18.7.2, 26.23+; fetal or embryonic kidney tissue or cells in culture: do not use /embryol with KIDNEY; /blood supply: consider also RENAL CIRCULATION; /radionuclide: consider RADIOISOTOPE RENOGRAPHY, a specific kidney function test %28%see note there%29%; /surg: consider NEPHRECTOMY; cyst = KIDNEY, CYSTIC but KIDNEY, POLYCYSTIC is also available; inflammation = NEPHRITIS; Goldblatt kidney = HYPERTENSION, GOLDBLATT see HYPERTENSION, RENOVASCULAR; nephrostomy: consider NEPHROSTOMY, PERCUTANEOUS%A%  
% 222.65/222.88  |- skos__scopeNote mesh__D007668
% 222.65/222.88       Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.%A%    
% 222.65/222.88  |- mesh__recordMaintainer mesh__D007668 ssb
% 222.65/222.88  |- mesh__dateCreated mesh__D007668 1999-01-01
% 222.65/222.88  |- mesh__recordOriginator mesh__D007668 NLM
% 222.65/222.88  |- skos__related mesh__D007668smesh__D009392
% 222.65/222.88  |- skos__broader mesh__D007668smesh__D014551
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D007668 2005
% 222.65/222.88  |- mesh__considerAlso mesh__D007668
% 222.65/222.88       consider also terms at GLOMERUL-, NEPHR-, PYEL-, and RENAL%A%  
% 222.65/222.88  |- mesh__historyNote mesh__D007668
% 222.65/222.88       /transplantation was KIDNEY TRANSPLANTATION 1963-65; was KIDNEY/transplantation 1966-89%A%  
% 222.65/222.88  |- skos__prefLabel mesh__D007668 Kidney
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D007668 2006
% 222.65/222.88  |- mesh__publicMeSHNote mesh__D007668
% 222.65/222.88       /transplantation was KIDNEY TRANSPLANTATION 1963-65; was KIDNEY/transplantation 1966-89%A%  
% 222.65/222.88  |- skos__related mesh__D007668smesh__D004231
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D007668 2004
% 222.65/222.88  |- mesh__dateRevised mesh__D007668 2003-07-09
% 222.65/222.88  |- skos__related mesh__D007668smesh__D012079
% 222.65/222.88  |- skos__altLabel mesh__D007668 Kidneys
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D018390 1998
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D018390 2000
% 222.65/222.88  |- skos__hiddenLabel mesh__D018390 Targeting, Gene
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D018390 1997
% 222.65/222.88  |- skos__hiddenLabel mesh__D018390 Gene Targetings
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D018390 1999
% 222.65/222.88  |- skos__scopeNote mesh__D018390
% 222.65/222.88       The integration of exogenous DNA into the genome of an organism at sites where its expression can be suitably controlled. This integration occurs as a result of homologous recombination.%A%    
% 222.65/222.88  |- skos__prefLabel mesh__D018390 Gene Targeting
% 222.65/222.88  |- skos__hiddenLabel mesh__D018390 Targetings, Gene
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D018390 2001
% 222.65/222.88  |- skos__broader mesh__D018390smesh__D005821
% 222.65/222.88  |- mesh__dateEstablished mesh__D018390 1995-01-01
% 222.65/222.88  |- mesh__dateCreated mesh__D018390 1994-01-25
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D018390 2003
% 222.65/222.88  |- mesh__historyNote mesh__D018390 95   
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D018390 2005
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D018390 1995
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D018390 2004
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D018390 2002
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D018390 2006
% 222.65/222.88  |- rdf__type mesh__D018390sskos__Concept
% 222.65/222.88  |- mesh__publicMeSHNote mesh__D018390 95   
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D018390 1996
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D032061 2006
% 222.65/222.88  |- mesh__dateCreated mesh__D032061 2002-07-02
% 222.65/222.88  |- skos__altLabel mesh__D032061 Cleavers
% 222.65/222.88  |- skos__broader mesh__D032061smesh__D019666
% 222.65/222.88  |- mesh__dateEstablished mesh__D032061 2003-01-01
% 222.65/222.88  |- rdf__type mesh__D032061sskos__Concept
% 222.65/222.88  |- mesh__publicMeSHNote mesh__D032061 2003   
% 222.65/222.88  |- skos__altLabel mesh__D032061 Bedstraw
% 222.65/222.88  |- skos__prefLabel mesh__D032061 Galium
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D032061 2003
% 222.65/222.88  |- skos__scopeNote mesh__D032061
% 222.65/222.88       A plant genus of the family RUBIACEAE with a name very similar to the element GALLIUM.%A%    
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D032061 2005
% 222.65/222.88  |- mesh__historyNote mesh__D032061 2003   
% 222.65/222.88  |- skos__annotation mesh__D032061
% 222.65/222.88       the element GALLIUM is also available; X ref BEDSTRAW: for %22%smooth bedstraw%22% refering to the Cruciata genus use RUBIACEAE; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D032061 2004
% 222.65/222.88  |- rdf__type mesh__D026822sskos__Concept
% 222.65/222.88  |- skos__hiddenLabel mesh__D026822 Consultants, Ethics
% 222.65/222.88  |- skos__broader mesh__D026822smesh__D009274
% 222.65/222.88  |- mesh__dateCreated mesh__D026822 2001-07-25
% 222.65/222.88  |- skos__hiddenLabel mesh__D026822 Ethics Consultant
% 222.65/222.88  |- skos__historyNote mesh__D026822 Ethics %28%1979-2001%29%
% 222.65/222.88  |- skos__altLabel mesh__D026822 Ethicist, Clinical
% 222.65/222.88  |- skos__hiddenLabel mesh__D026822 Consultants, Bioethics
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D026822 2006
% 222.65/222.88  |- skos__altLabel mesh__D026822 Ethics Consultants
% 222.65/222.88  |- skos__altLabel mesh__D026822 Ethicists, Clinical
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D026822 2002
% 222.65/222.88  |- skos__altLabel mesh__D026822 Bioethics Consultants
% 222.65/222.88  |- skos__altLabel mesh__D026822 Clinical Ethicist
% 222.65/222.88  |- skos__hiddenLabel mesh__D026822 Ethicist
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D026822 2005
% 222.65/222.88  |- skos__scopeNote mesh__D026822
% 222.65/222.88       Persons trained in philosophical or theological ethics who work in clinical, research, public policy, or other settings where they bring their expertise to bear on the analysis of ethical dilemmas in policies or cases. %28%Bioethics Thesaurus%29%%A%    
% 222.65/222.88  |- skos__hiddenLabel mesh__D026822 Bioethics Consultant
% 222.65/222.88  |- mesh__publicMeSHNote mesh__D026822 2002; see ETHICS 1993-2001   
% 222.65/222.88  |- mesh__historyNote mesh__D026822 2002; use ETHICS 1993-2001   
% 222.65/222.88  |- skos__hiddenLabel mesh__D026822 Bioethicist
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D026822 2004
% 222.65/222.88  |- mesh__dateEstablished mesh__D026822 2002-01-01
% 222.65/222.88  |- skos__related mesh__D026822smesh__D001675
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D026822 2003
% 222.65/222.88  |- skos__related mesh__D026822smesh__D026690
% 222.65/222.88  |- skos__broader mesh__D026822smesh__D004989
% 222.65/222.88  |- skos__prefLabel mesh__D026822 Ethicists
% 222.65/222.88  |- skos__hiddenLabel mesh__D004370 Retraction Syndromes, Ocular
% 222.65/222.88  |- skos__altLabel mesh__D004370 Duane%27%s Syndrome
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D004370 2006
% 222.65/222.88  |- mesh__recordMaintainer mesh__D004370 ags
% 222.65/222.88  |- skos__broader mesh__D004370smesh__D015835
% 222.65/222.88  |- skos__hiddenLabel mesh__D004370 Duanes Syndrome
% 222.65/222.88  |- rdf__type mesh__D004370sskos__Concept
% 222.65/222.88  |- mesh__recordOriginator mesh__D004370 NLM
% 222.65/222.88  |- skos__hiddenLabel mesh__D004370 Syndrome, Duane
% 222.65/222.88  |- mesh__historyNote mesh__D004370 2000%28%1966%29%   
% 222.65/222.88  |- mesh__dateCreated mesh__D004370 1999-01-01
% 222.65/222.88  |- mesh__publicMeSHNote mesh__D004370
% 222.65/222.88       2000; see DUANE%27%S SYNDROME 1991-1999, see OPHTHALMOPLEGIA 1979-1990, see OCULOMOTOR PARALYSIS 1966-1978%A%  
% 222.65/222.88  |- skos__altLabel mesh__D004370 Ocular Retraction Syndrome
% 222.65/222.88  |- skos__broader mesh__D004370smesh__D015785
% 222.65/222.88  |- skos__altLabel mesh__D004370 Type 3 Duane Retraction Syndrome
% 222.65/222.88  |- skos__altLabel mesh__D004370 Duane Syndrome
% 222.65/222.88  |- mesh__recordAuthorizer mesh__D004370 sjn
% 222.65/222.88  |- skos__hiddenLabel mesh__D004370 Ocular Retraction Syndromes
% 222.65/222.88  |- skos__scopeNote mesh__D004370
% 222.65/222.88       A syndrome characterized by marked limitation of abduction of the eye, variable limitation of adduction and retraction of the globe, and narrowing of the palpebral fissure on attempted adduction. The condition is caused by aberrant innervation of the lateral rectus by fibers of the oculomotor nerve. There are three subtypes: type 1 %28%associated with loss of abduction%29%, type 2 %28%associated with loss of adduction%29%, and type 3 %28%loss of abduction and adduction%29%. Two loci for Duane retraction syndrome have been located, one at chromosome 8q13 %28%DURS1%29% and another at chromosome 2q31%28%DURS2%29%. It is usually caused by congenital hypoplasia of the abducens nerve or nucleus, but may rarely represent an acquired syndrome. %28%Adams et al., Principles of Neurology, 6th ed, p271; Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p691%29%%A%    
% 222.65/222.88  |- skos__altLabel mesh__D004370 Type 1 Duane Retraction Syndrome
% 222.65/222.88  |- skos__prefLabel mesh__D004370 Duane Retraction Syndrome
% 222.65/222.88  |- skos__hiddenLabel mesh__D004370 Syndrome, Duane%27%s
% 222.65/222.88  |- skos__related mesh__D004370smesh__D009886
% 222.65/222.88  |- mesh__dateEstablished mesh__D004370 1991-01-01
% 222.65/222.88  |- skos__altLabel mesh__D004370 Type 2 Duane Retraction Syndrome
% 222.65/222.88  |- mesh__dateRevised mesh__D004370 2005-06-30
% 222.65/222.88  |- skos__scopeNote mesh__D045787
% 222.65/222.88       SESQUITERPENES cyclized into two adjoining cyclohexane rings but with a different configuration from the ARTEMISININS.%A%    
% 222.65/222.88  |- mesh__dateEstablished mesh__D045787 2004-01-01
% 222.65/222.88  |- mesh__dateCreated mesh__D045787 2003-07-09
% 222.65/222.88  |- mesh__publicMeSHNote mesh__D045787 2004   
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D045787 2005
% 222.65/222.88  |- rdf__type mesh__D045787sskos__Concept
% 222.65/222.88  |- skos__hiddenLabel mesh__D045787 Eudesmane Sesquiterpenes
% 222.65/222.88  |- mesh__activeMeSHYear mesh__D045787 2006
% 222.65/222.88  |- skos__prefLabel mesh__D045787 Sesquiterpenes, Eudesmane
% 222.65/222.88  |- mesh__historyNote mesh__D045787 2004   
% 222.65/222.88  |- skos__broader mesh__D045787smesh__D012717
% 222.65/222.89  |- skos__historyNote mesh__D045787 Diterpenes %28%1977-2003%29%
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D045787 2004
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012802 2000
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012802 1998
% 222.65/222.89  |- mesh__dateRevised mesh__D012802 1995-05-31
% 222.65/222.89  |- mesh__dateCreated mesh__D012802 1999-01-01
% 222.65/222.89  |- mesh__recordAuthorizer mesh__D012802 PLS
% 222.65/222.89  |- mesh__recordMaintainer mesh__D012802 TGC
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012802 2004
% 222.65/222.89  |- skos__prefLabel mesh__D012802 Sicily
% 222.65/222.89  |- skos__broader mesh__D012802smesh__D007558
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012802 2006
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012802 2003
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012802 1997
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012802 2002
% 222.65/222.89  |- skos__broader mesh__D012802smesh__D008521
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012802 2005
% 222.65/222.89  |- mesh__recordOriginator mesh__D012802 NLM
% 222.65/222.89  |- rdf__type mesh__D012802sskos__Concept
% 222.65/222.89  |- mesh__dateEstablished mesh__D012802 1970-01-01
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012802 1999
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012802 1996
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012802 2001
% 222.65/222.89  |- mesh__historyNote mesh__D012802 70   
% 222.65/222.89  |- skos__historyNote mesh__D012802 Italy %28%1966-1969%29%
% 222.65/222.89  |- skos__hiddenLabel mesh__D012004 Neoplasm, Rectal
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012004 2004
% 222.65/222.89  |- skos__prefLabel mesh__D012004 Rectal Neoplasms
% 222.65/222.89  |- mesh__dateCreated mesh__D012004 1999-01-01
% 222.65/222.89  |- rdf__type mesh__D012004sskos__Concept
% 222.65/222.89  |- skos__hiddenLabel mesh__D012004 Cancers, Rectum
% 222.65/222.89  |- mesh__recordAuthorizer mesh__D012004 sjn
% 222.65/222.89  |- skos__hiddenLabel mesh__D012004 Cancer, Rectum
% 222.65/222.89  |- skos__altLabel mesh__D012004 Rectal Cancer
% 222.65/222.89  |- skos__hiddenLabel mesh__D012004 Neoplasms, Rectum
% 222.65/222.89  |- skos__hiddenLabel mesh__D012004 Tumor, Rectal
% 222.65/222.89  |- skos__hiddenLabel mesh__D012004 Cancers, Rectal
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012004 2006
% 222.65/222.89  |- skos__annotation mesh__D012004
% 222.65/222.89       coord IM with histol type of neopl %28%IM%29%; familial: consider also COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS%A%  
% 222.65/222.89  |- skos__altLabel mesh__D012004 Neoplasms, Rectal
% 222.65/222.89  |- skos__altLabel mesh__D012004 Cancer of the Rectum
% 222.65/222.89  |- skos__hiddenLabel mesh__D012004 Rectum Neoplasm
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012004 2005
% 222.65/222.89  |- skos__altLabel mesh__D012004 Rectum Neoplasms
% 222.65/222.89  |- skos__scopeNote mesh__D012004 Tumors or cancer of the RECTUM.     
% 222.65/222.89  |- skos__altLabel mesh__D012004 Rectum Cancer
% 222.65/222.89  |- skos__hiddenLabel mesh__D012004 Tumors, Rectal
% 222.65/222.89  |- mesh__dateRevised mesh__D012004 2003-07-09
% 222.65/222.89  |- skos__hiddenLabel mesh__D012004 Neoplasm, Rectum
% 222.65/222.89  |- skos__hiddenLabel mesh__D012004 Rectal Cancers
% 222.65/222.89  |- skos__hiddenLabel mesh__D012004 Rectal Tumor
% 222.65/222.89  |- mesh__recordMaintainer mesh__D012004 lkt
% 222.65/222.89  |- skos__hiddenLabel mesh__D012004 Cancer, Rectal
% 222.65/222.89  |- skos__hiddenLabel mesh__D012004 Rectum Cancers
% 222.65/222.89  |- mesh__recordOriginator mesh__D012004 NLM
% 222.65/222.89  |- skos__hiddenLabel mesh__D012004 Rectal Neoplasm
% 222.65/222.89  |- skos__broader mesh__D012004smesh__D015179
% 222.65/222.89  |- mesh__onlineNote mesh__D017298
% 222.65/222.89       use BISOPROLOL %28%NM%29% to search BISOPROLOL 1984-92   
% 222.65/222.89  |- skos__broader mesh__D017298smesh__D011412
% 222.65/222.89  |- skos__historyNote mesh__D017298 Propanolamines %28%1984-1992%29%
% 222.65/222.89  |- rdf__type mesh__D017298sskos__Concept
% 222.65/222.89  |- skos__prefLabel mesh__D017298 Bisoprolol
% 222.65/222.89  |- skos__hiddenLabel mesh__D017298 CL 297939
% 222.65/222.89  |- skos__hiddenLabel mesh__D017298 CL297939
% 222.65/222.89  |- mesh__dateEstablished mesh__D017298 1993-01-01
% 222.65/222.89  |- mesh__recordAuthorizer mesh__D017298 sjn
% 222.65/222.89  |- skos__hiddenLabel mesh__D017298 EMD33512
% 222.65/222.89  |- skos__hiddenLabel mesh__D017298 Fumarate, Bisoprolol
% 222.65/222.89  |- mesh__dateCreated mesh__D017298 1992-05-07
% 222.65/222.89  |- skos__scopeNote mesh__D017298
% 222.65/222.89       A cardioselective beta-1-adrenergic blocker. It is effective in the management of hypertension and angina pectoris.%A%    
% 222.65/222.89  |- mesh__recordMaintainer mesh__D017298 ssb
% 222.65/222.89  |- skos__hiddenLabel mesh__D017298 EMD 33512
% 222.65/222.89  |- skos__broader mesh__D017298smesh__D050198
% 222.65/222.89  |- mesh__dateRevised mesh__D017298 2005-06-30
% 222.65/222.89  |- mesh__recordOriginator mesh__D017298 TPW
% 222.65/222.89  |- mesh__publicMeSHNote mesh__D017298
% 222.65/222.89       93; BISOPROLOL was indexed under PROPANOLAMINES 1984-92   
% 222.65/222.89  |- mesh__historyNote mesh__D017298 93; was BISOPROLOL %28%NM%29% 1984-92   
% 222.65/222.89  |- skos__hiddenLabel mesh__D017298 Hydrochloride, Bisoprolol
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D017298 2006
% 222.65/222.89  |- mesh__dateRevised mesh__D003278 2005-06-30
% 222.65/222.89  |- skos__altLabel mesh__D003278 Contraceptive Agents, Estrogen
% 222.65/222.89  |- mesh__publicMeSHNote mesh__D003278
% 222.65/222.89       86; was see under CONTRACEPTIVES, ORAL 1975-85   
% 222.65/222.89  |- skos__annotation mesh__D003278
% 222.65/222.89       pregn despite use: see note on CONTRACEPTIVE AGENTS   
% 222.65/222.89  |- mesh__dateEstablished mesh__D003278 1986-01-01
% 222.65/222.89  |- skos__hiddenLabel mesh__D003278 Hormonal Oral Contraceptives
% 222.65/222.89  |- skos__hiddenLabel mesh__D003278 Contraceptives, Hormonal Oral
% 222.65/222.89  |- skos__altLabel mesh__D003278 Hormonal Oral Contraceptive Agents
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D003278 2006
% 222.65/222.89  |- skos__altLabel mesh__D003278 Contraceptive Agents, Oral, Hormonal
% 222.65/222.89  |- mesh__recordMaintainer mesh__D003278 ssb
% 222.65/222.89  |- skos__hiddenLabel mesh__D003278 Estrogen Contraceptive Agents
% 222.65/222.89  |- skos__hiddenLabel mesh__D003278 Agents, Estrogen Contraceptive
% 222.65/222.89  |- mesh__dateCreated mesh__D003278 1999-01-01
% 222.65/222.89  |- skos__prefLabel mesh__D003278 Contraceptives, Oral, Hormonal
% 222.65/222.89  |- skos__altLabel mesh__D003278 Oral Contraceptive Agents, Hormonal
% 222.65/222.89  |- rdf__type mesh__D003278sskos__Concept
% 222.65/222.89  |- skos__altLabel mesh__D003278 Oral Contraceptives, Hormonal
% 222.65/222.89  |- mesh__recordAuthorizer mesh__D003278 sjn
% 222.65/222.89  |- skos__broader mesh__D003278smesh__D003276
% 222.65/222.89  |- mesh__recordOriginator mesh__D003278 NLM
% 222.65/222.89  |- skos__scopeNote mesh__D003278
% 222.65/222.89       Oral contraceptives which owe their effectiveness to hormonal preparations.%A%    
% 222.65/222.89  |- mesh__historyNote mesh__D003278
% 222.65/222.89       86%28%75%29%; was see under CONTRACEPTIVES, ORAL 1975-85   
% 222.65/222.89  |- mesh__dateRevised mesh__D008761 2005-06-30
% 222.65/222.89  |- mesh__recordAuthorizer mesh__D008761 sjn
% 222.65/222.89  |- skos__historyNote mesh__D008761 Histamine %28%1970-1976%29%
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D008761 2006
% 222.65/222.89  |- skos__prefLabel mesh__D008761 Methylhistamines
% 222.65/222.89  |- mesh__dateEstablished mesh__D008761 1977-01-01
% 222.65/222.89  |- mesh__dateCreated mesh__D008761 1976-04-16
% 222.65/222.89  |- skos__scopeNote mesh__D008761
% 222.65/222.89       Histamine substituted in any position with one or more methyl groups. Many of these are agonists for the H1, H2, or both histamine receptors.%A%    
% 222.65/222.89  |- mesh__historyNote mesh__D008761 77   
% 222.65/222.89  |- rdf__type mesh__D008761sskos__Concept
% 222.65/222.89  |- mesh__publicMeSHNote mesh__D008761 77   
% 222.65/222.89  |- mesh__recordOriginator mesh__D008761 SH
% 222.65/222.89  |- mesh__recordMaintainer mesh__D008761 ssb
% 222.65/222.89  |- skos__broader mesh__D008761smesh__D006632
% 222.65/222.89  |- mesh__dateCreated mesh__D007669 1999-01-01
% 222.65/222.89  |- skos__scopeNote mesh__D007669
% 222.65/222.89       Calculi occurring in the KIDNEY. Calculi too large to pass spontaneously range in size from 1 cm to the staghorn stones that occupy the renal pelvis and calyces.%A%    
% 222.65/222.89  |- skos__hiddenLabel mesh__D007669 Kidney Stone
% 222.65/222.89  |- skos__altLabel mesh__D007669 Renal Calculi
% 222.65/222.89  |- skos__prefLabel mesh__D007669 Kidney Calculi
% 222.65/222.89  |- skos__hiddenLabel mesh__D007669 Calculus, Phosphate
% 222.65/222.89  |- skos__hiddenLabel mesh__D007669 Calculus, Kidney
% 222.65/222.89  |- mesh__recordAuthorizer mesh__D007669 sjn
% 222.65/222.89  |- skos__hiddenLabel mesh__D007669 Renal Calculus
% 222.65/222.89  |- mesh__recordMaintainer mesh__D007669 ags
% 222.65/222.89  |- skos__hiddenLabel mesh__D007669 Stone, Kidney
% 222.65/222.89  |- skos__broader mesh__D007669smesh__D007674
% 222.65/222.89  |- skos__broader mesh__D007669smesh__D014545
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D007669 2006
% 222.65/222.89  |- skos__hiddenLabel mesh__D007669 Stones, Kidney
% 222.65/222.89  |- skos__hiddenLabel mesh__D007669 Kidney Calculus
% 222.65/222.89  |- mesh__onlineNote mesh__D007669
% 222.65/222.89       to search for chem composition of kidney calculi, use KIDNEY CALCULI/anal 1987-90 %26% KIDNEY CALCULI/metab 1966-86%A%  
% 222.65/222.89  |- mesh__recordOriginator mesh__D007669 NLM
% 222.65/222.89  |- skos__hiddenLabel mesh__D007669 Calculi, Phosphate
% 222.65/222.89  |- skos__hiddenLabel mesh__D007669 Calculi, Renal
% 222.65/222.89  |- skos__annotation mesh__D007669
% 222.65/222.89       chemical composition of calculi = KIDNEY CALCULI /chem   
% 222.65/222.89  |- skos__hiddenLabel mesh__D007669 Phosphate Calculus
% 222.65/222.89  |- mesh__dateRevised mesh__D007669 2005-06-30
% 222.65/222.89  |- rdf__type mesh__D007669sskos__Concept
% 222.65/222.89  |- skos__hiddenLabel mesh__D007669 Calculus, Renal
% 222.65/222.89  |- skos__hiddenLabel mesh__D007669 Calculi, Kidney
% 222.65/222.89  |- skos__altLabel mesh__D007669 Kidney Stones
% 222.65/222.89  |- mesh__historyNote mesh__D032062 2003   
% 222.65/222.89  |- skos__prefLabel mesh__D032062 Gardenia
% 222.65/222.89  |- mesh__dateCreated mesh__D032062 2002-07-03
% 222.65/222.89  |- skos__broader mesh__D032062smesh__D019666
% 222.65/222.89  |- skos__annotation mesh__D032062
% 222.65/222.89       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.65/222.89  |- rdf__type mesh__D032062sskos__Concept
% 222.65/222.89  |- mesh__publicMeSHNote mesh__D032062 2003   
% 222.65/222.89  |- skos__scopeNote mesh__D032062
% 222.65/222.89       A plant genus of the family RUBIACEAE. Members contain genepin, from which geniposide is obtained for use as a crosslinking agent in ADHESIVES, and 3-caffeoyl-4-sinapoylquinic acid.%A%    
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D032062 2003
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D032062 2005
% 222.65/222.89  |- mesh__dateEstablished mesh__D032062 2003-01-01
% 222.65/222.89  |- skos__altLabel mesh__D032062 Gardeniae
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D032062 2004
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D032062 2006
% 222.65/222.89  |- mesh__recordAuthorizer mesh__D004371 sjn
% 222.65/222.89  |- mesh__recordMaintainer mesh__D004371 ags
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D004371 2004
% 222.65/222.89  |- skos__scopeNote mesh__D004371
% 222.65/222.89       Unassigned species, in the family PICORNAVIRIDAE, causing high mortality in ducklings 3 days to 3 weeks old.%A%    
% 222.65/222.89  |- skos__broader mesh__D004371smesh__D010849
% 222.65/222.89  |- mesh__dateRevised mesh__D004371 2001-07-25
% 222.65/222.89  |- skos__broader mesh__D004371smesh__D006518
% 222.65/222.89  |- mesh__historyNote mesh__D004371
% 222.65/222.89       91%28%90%29%; was see under ENTEROVIRUSES 1990; was DUCK HEPATITIS VIRUS 1975-89%A%  
% 222.65/222.89  |- skos__annotation mesh__D004371
% 222.65/222.89       infection: coord IM with PICORNAVIRUS INFECTIONS %28%IM%29% + HEPATITIS, VIRAL, ANIMAL %28%IM%29%%A%  
% 222.65/222.89  |- mesh__onlineNote mesh__D004371
% 222.65/222.89       use HEPATITIS VIRUS, DUCK to search DUCK HEPATITIS VIRUS 1975-89%A%  
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D004371 2002
% 222.65/222.89  |- mesh__dateCreated mesh__D004371 1974-12-12
% 222.65/222.89  |- mesh__dateEstablished mesh__D004371 1991-01-01
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D004371 2005
% 222.65/222.89  |- mesh__publicMeSHNote mesh__D004371
% 222.65/222.89       91; was see under ENTEROVIRUSES 1990; was DUCK HEPATITIS VIRUS 1975-89%A%  
% 222.65/222.89  |- skos__hiddenLabel mesh__D004371 Duck Hepatitis Viruses
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D004371 2006
% 222.65/222.89  |- mesh__recordOriginator mesh__D004371 NLM
% 222.65/222.89  |- skos__altLabel mesh__D004371 Duck Hepatitis Virus
% 222.65/222.89  |- skos__prefLabel mesh__D004371 Hepatitis Virus, Duck
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D004371 2003
% 222.65/222.89  |- rdf__type mesh__D004371sskos__Concept
% 222.65/222.89  |- mesh__publicMeSHNote mesh__D045788 2004   
% 222.65/222.89  |- rdf__type mesh__D045788sskos__Concept
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D045788 2005
% 222.65/222.89  |- mesh__historyNote mesh__D045788 2004   
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D045788 2006
% 222.65/222.89  |- mesh__dateEstablished mesh__D045788 2004-01-01
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D045788 2004
% 222.65/222.89  |- skos__broader mesh__D045788smesh__D012717
% 222.65/222.89  |- skos__prefLabel mesh__D045788 Sesquiterpenes, Germacrane
% 222.65/222.89  |- skos__hiddenLabel mesh__D045788 Germacrane Sesquiterpenes
% 222.65/222.89  |- skos__historyNote mesh__D045788 Diterpenes %28%1975-2003%29%
% 222.65/222.89  |- skos__scopeNote mesh__D045788
% 222.65/222.89       SESQUITERPENES cyclized to one 10-carbon ring.     
% 222.65/222.89  |- mesh__dateCreated mesh__D045788 2003-07-09
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012803 1992
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012803 2001
% 222.65/222.89  |- skos__hiddenLabel mesh__D012803 Behavior, Illness
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012803 2004
% 222.65/222.89  |- skos__scopeNote mesh__D012803
% 222.65/222.89       Behavior patterns consistent with those expected of an individual functioning in a state of ill health.%A%    
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012803 1994
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012803 2000
% 222.65/222.89  |- skos__hiddenLabel mesh__D012803 Behaviors, Illness
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012803 2006
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012803 2003
% 222.65/222.89  |- mesh__recordMaintainer mesh__D012803 TAP
% 222.65/222.89  |- skos__hiddenLabel mesh__D012803 Sick Roles
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012803 1997
% 222.65/222.89  |- rdf__type mesh__D012803sskos__Concept
% 222.65/222.89  |- mesh__historyNote mesh__D012803 71   
% 222.65/222.89  |- mesh__recordAuthorizer mesh__D012803 PLS
% 222.65/222.89  |- skos__hiddenLabel mesh__D012803 Roles, Sick
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012803 2005
% 222.65/222.89  |- skos__historyNote mesh__D012803 Role %28%1969-1970%29%
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012803 1991
% 222.65/222.89  |- skos__broader mesh__D012803smesh__D012380
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012803 1999
% 222.65/222.89  |- skos__hiddenLabel mesh__D012803 Illness Behaviors
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012803 1996
% 222.65/222.89  |- skos__annotation mesh__D012803 no qualif   
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012803 1993
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012803 1998
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012803 2002
% 222.65/222.89  |- skos__altLabel mesh__D012803 Illness Behavior
% 222.65/222.89  |- skos__prefLabel mesh__D012803 Sick Role
% 222.65/222.89  |- mesh__recordOriginator mesh__D012803 NLM
% 222.65/222.89  |- mesh__dateCreated mesh__D012803 1999-01-01
% 222.65/222.89  |- mesh__dateEstablished mesh__D012803 1971-01-01
% 222.65/222.89  |- skos__hiddenLabel mesh__D012803 Role, Sick
% 222.65/222.89  |- mesh__dateRevised mesh__D012803 1990-03-22
% 222.65/222.89  |- mesh__publicMeSHNote mesh__D012803 71   
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012803 1995
% 222.65/222.89  |- mesh__recordAuthorizer mesh__D012005 sjn
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012005 2004
% 222.65/222.89  |- skos__scopeNote mesh__D012005
% 222.65/222.89       Protrusion of the rectal mucous membrane through the anus. There are various degrees: incomplete with no displacement of the anal sphincter muscle; complete with displacement of the anal sphincter muscle; complete with no displacement of the anal sphincter muscle but with herniation of the bowel; and internal complete with rectosigmoid or upper rectum intussusception into the lower rectum.%A%    
% 222.65/222.89  |- skos__hiddenLabel mesh__D012005 Anus Prolapses
% 222.65/222.89  |- skos__broader mesh__D012005smesh__D012002
% 222.65/222.89  |- skos__hiddenLabel mesh__D012005 Prolapse, Rectal
% 222.65/222.89  |- skos__hiddenLabel mesh__D012005 Prolapses, Rectal
% 222.65/222.89  |- skos__hiddenLabel mesh__D012005 Prolapse, Anus
% 222.65/222.89  |- skos__hiddenLabel mesh__D012005 Rectal Prolapses
% 222.65/222.89  |- skos__prefLabel mesh__D012005 Rectal Prolapse
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012005 2006
% 222.65/222.89  |- skos__hiddenLabel mesh__D012005 Prolapses, Anus
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012005 2005
% 222.65/222.89  |- mesh__recordOriginator mesh__D012005 NLM
% 222.65/222.89  |- mesh__recordMaintainer mesh__D012005 lkt
% 222.65/222.89  |- mesh__dateRevised mesh__D012005 2003-07-09
% 222.65/222.89  |- mesh__dateCreated mesh__D012005 1999-01-01
% 222.65/222.89  |- rdf__type mesh__D012005sskos__Concept
% 222.65/222.89  |- skos__prefLabel mesh__D017299 Opsin
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D017299 2006
% 222.65/222.89  |- mesh__dateRevised mesh__D017299 2005-06-30
% 222.65/222.89  |- skos__altLabel mesh__D017299 Rod-Opsin
% 222.65/222.89  |- mesh__dateCreated mesh__D017299 1992-05-22
% 222.65/222.89  |- rdf__type mesh__D017299sskos__Concept
% 222.65/222.89  |- mesh__historyNote mesh__D017299 93; was OPSIN %28%NM%29% 1973-92   
% 222.65/222.89  |- skos__scopeNote mesh__D017299
% 222.65/222.89       A visual pigment protein found in the retinal rods. It combines with retinaldehyde to form RHODOPSIN.%A%    
% 222.65/222.89  |- mesh__dateEstablished mesh__D017299 1993-01-01
% 222.65/222.89  |- mesh__recordMaintainer mesh__D017299 ssb
% 222.65/222.89  |- mesh__recordAuthorizer mesh__D017299 sjn
% 222.65/222.89  |- skos__historyNote mesh__D017299 Eye Proteins %28%1973-1992%29%
% 222.65/222.89  |- skos__annotation mesh__D017299
% 222.65/222.89       a retinal pigment; do not confuse X ref ROD-OPSIN with RHODOPSIN%A%  
% 222.65/222.89  |- mesh__onlineNote mesh__D017299
% 222.65/222.89       use OPSIN %28%NM%29% to search OPSIN 1980-92   
% 222.65/222.89  |- mesh__recordOriginator mesh__D017299 TPW
% 222.65/222.89  |- mesh__publicMeSHNote mesh__D017299
% 222.65/222.89       93; OPSIN was indexed under EYE PROTEINS 1973-92   
% 222.65/222.89  |- skos__broader mesh__D017299smesh__D012168
% 222.65/222.89  |- skos__hiddenLabel mesh__D017299 Rod Opsin
% 222.65/222.89  |- skos__broader mesh__D017299smesh__D005136
% 222.65/222.89  |- skos__historyNote mesh__D003279 Contraceptives, Oral %28%1970-1975%29%
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D003279 2006
% 222.65/222.89  |- mesh__dateRevised mesh__D003279 2005-06-30
% 222.65/222.89  |- skos__annotation mesh__D003279
% 222.65/222.89       pregn despite use: see note on CONTRACEPTIVE AGENTS   
% 222.65/222.89  |- skos__altLabel mesh__D003279 Oral Contraceptive Agents, Sequential
% 222.65/222.89  |- skos__scopeNote mesh__D003279
% 222.65/222.89       Drugs administered orally and sequentially for contraceptive purposes.%A%    
% 222.65/222.89  |- mesh__publicMeSHNote mesh__D003279
% 222.65/222.89       91; was see under CONTRACEPTIVES, ORAL 1976-90   
% 222.65/222.89  |- mesh__historyNote mesh__D003279
% 222.65/222.89       91%28%76%29%; was see under CONTRACEPTIVES, ORAL 1976-90   
% 222.65/222.89  |- skos__altLabel mesh__D003279 Contraceptive Agents, Female Sequential
% 222.65/222.89  |- rdf__type mesh__D003279sskos__Concept
% 222.65/222.89  |- skos__hiddenLabel mesh__D003279 Sequential Oral Contraceptives
% 222.65/222.89  |- mesh__recordMaintainer mesh__D003279 ssb
% 222.65/222.89  |- mesh__recordOriginator mesh__D003279 RLS
% 222.65/222.89  |- skos__broader mesh__D003279smesh__D003276
% 222.65/222.89  |- mesh__dateEstablished mesh__D003279 1991-01-01
% 222.65/222.89  |- skos__altLabel mesh__D003279 Contraceptive Agents, Oral, Sequential
% 222.65/222.89  |- skos__prefLabel mesh__D003279 Contraceptives, Oral, Sequential
% 222.65/222.89  |- mesh__dateCreated mesh__D003279 1975-07-18
% 222.65/222.89  |- skos__altLabel mesh__D003279 Sequential Oral Contraceptive Agents
% 222.65/222.89  |- mesh__recordAuthorizer mesh__D003279 sjn
% 222.65/222.89  |- skos__hiddenLabel mesh__D003279 Contraceptives, Sequential Oral
% 222.65/222.89  |- skos__altLabel mesh__D003279 Oral Contraceptives, Sequential
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D008762 2006
% 222.65/222.89  |- skos__scopeNote mesh__D008762
% 222.65/222.89       Histidine substituted in any position with one or more methyl groups.%A%    
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D008762 1995
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D008762 2003
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D008762 2000
% 222.65/222.89  |- skos__prefLabel mesh__D008762 Methylhistidines
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D008762 1998
% 222.65/222.89  |- mesh__publicMeSHNote mesh__D008762
% 222.65/222.89       91; was see under HISTIDINE/analogs %26% derivatives 1981-90; was METHYLHISTIDINE see under HISTIDINE 1975-80%A%  
% 222.65/222.89  |- mesh__recordOriginator mesh__D008762 NLM
% 222.65/222.89  |- mesh__dateCreated mesh__D008762 1999-01-01
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D008762 2004
% 222.65/222.89  |- mesh__recordAuthorizer mesh__D008762 PLS
% 222.65/222.89  |- skos__broader mesh__D008762smesh__D006639
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D008762 1999
% 222.65/222.89  |- rdf__type mesh__D008762sskos__Concept
% 222.65/222.89  |- skos__historyNote mesh__D008762 Histidine %28%1966-1971%29%
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D008762 2001
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D008762 1996
% 222.65/222.89  |- mesh__dateRevised mesh__D008762 1994-06-16
% 222.65/222.89  |- mesh__dateEstablished mesh__D008762 1991-01-01
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D008762 1997
% 222.65/222.89  |- skos__altLabel mesh__D008762 Methylhistidine
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D008762 2005
% 222.65/222.89  |- mesh__onlineNote mesh__D008762
% 222.65/222.89       use METHYLHISTIDINES to search METHYLHISTIDINE 1972-80 %28%as Prov 1972-74%29%%A%  
% 222.65/222.89  |- mesh__historyNote mesh__D008762
% 222.65/222.89       91%28%81%29%; was see under HISTIDINE/analogs %26% derivatives 1981-90; was METHYLHISTIDINE see under HISTIDINE 1972-80 %28%Prov 1972-74%29%%A%  
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D008762 2002
% 222.65/222.89  |- mesh__recordMaintainer mesh__D008762 PLS
% 222.65/222.89  |- rdf__type mesh__D032861sskos__Concept
% 222.65/222.89  |- mesh__dateEstablished mesh__D032861 2003-01-01
% 222.65/222.89  |- skos__prefLabel mesh__D032861 Buddleja
% 222.65/222.89  |- skos__broader mesh__D032861smesh__D028083
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D032861 2005
% 222.65/222.89  |- skos__scopeNote mesh__D032861
% 222.65/222.89       A plant genus of the family SCROPHULARIACEAE. Members contain mimengoside B, verbascoside, and phenylethanoids.%A%    
% 222.65/222.89  |- mesh__historyNote mesh__D032861 2003   
% 222.65/222.89  |- mesh__dateCreated mesh__D032861 2002-07-02
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D032861 2003
% 222.65/222.89  |- mesh__publicMeSHNote mesh__D032861 2003   
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D032861 2006
% 222.65/222.89  |- skos__annotation mesh__D032861
% 222.65/222.89       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D032861 2004
% 222.65/222.89  |- skos__hiddenLabel mesh__D018392 Imprinting, Parental
% 222.65/222.89  |- skos__hiddenLabel mesh__D018392 Imprinting, Genomic
% 222.65/222.89  |- mesh__recordAuthorizer mesh__D018392 sjn
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D018392 2004
% 222.65/222.89  |- skos__altLabel mesh__D018392 Genetic Imprinting
% 222.65/222.89  |- mesh__dateRevised mesh__D018392 2003-07-09
% 222.65/222.89  |- skos__altLabel mesh__D018392 Imprinting, Genetic
% 222.65/222.89  |- mesh__recordMaintainer mesh__D018392 nns
% 222.65/222.89  |- mesh__dateCreated mesh__D018392 1994-01-25
% 222.65/222.89  |- mesh__publicMeSHNote mesh__D018392 95   
% 222.65/222.89  |- skos__related mesh__D018392smesh__D044127
% 222.65/222.89  |- skos__scopeNote mesh__D018392
% 222.65/222.89       The variable phenotypic expression of a GENE depending on whether it is of paternal or maternal origin, which is a function of the DNA METHYLATION pattern. Imprinted regions are observed to be more methylated and less transcriptionally active. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A%    
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D018392 2006
% 222.65/222.89  |- mesh__historyNote mesh__D018392 95   
% 222.65/222.89  |- skos__altLabel mesh__D018392 Parental Imprinting
% 222.65/222.89  |- skos__broader mesh__D018392smesh__D005786
% 222.65/222.89  |- rdf__type mesh__D018392sskos__Concept
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D018392 2005
% 222.65/222.89  |- mesh__recordOriginator mesh__D018392 PXP
% 222.65/222.89  |- skos__prefLabel mesh__D018392 Genomic Imprinting
% 222.65/222.89  |- mesh__dateEstablished mesh__D018392 1995-01-01
% 222.65/222.89  |- skos__scopeNote mesh__D032063
% 222.65/222.89       A plant genus of the family RUBIACEAE that has a name very similar to another plant genus, HAMAMELIS.%A%    
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D032063 2006
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D032063 2005
% 222.65/222.89  |- skos__annotation mesh__D032063
% 222.65/222.89       do not confuse with HAMAMELIS; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.65/222.89  |- mesh__historyNote mesh__D032063 2003   
% 222.65/222.89  |- rdf__type mesh__D032063sskos__Concept
% 222.65/222.89  |- mesh__dateCreated mesh__D032063 2002-07-03
% 222.65/222.89  |- mesh__publicMeSHNote mesh__D032063 2003   
% 222.65/222.89  |- mesh__dateEstablished mesh__D032063 2003-01-01
% 222.65/222.89  |- skos__broader mesh__D032063smesh__D019666
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D032063 2004
% 222.65/222.89  |- skos__prefLabel mesh__D032063 Hamelia
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D032063 2003
% 222.65/222.89  |- mesh__recordAuthorizer mesh__D004372 sjn
% 222.65/222.89  |- mesh__historyNote mesh__D004372 68   
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D004372 2005
% 222.65/222.89  |- skos__annotation mesh__D004372
% 222.65/222.89       domestic or wild; IM; qualif permitted; diseases: coord IM with POULTRY DISEASES %28%IM%29%; diseases of wild ducks: coord IM with BIRD DISEASES %28%IM%29%, not POULTRY DISEASES%A%  
% 222.65/222.89  |- mesh__dateRevised mesh__D004372 2004-07-07
% 222.65/222.89  |- skos__historyNote mesh__D004372 Poultry %28%1966-1967%29%
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D004372 2006
% 222.65/222.89  |- skos__hiddenLabel mesh__D004372 Duck
% 222.65/222.89  |- mesh__publicMeSHNote mesh__D004372 68   
% 222.65/222.89  |- mesh__dateEstablished mesh__D004372 1968-01-01
% 222.65/222.89  |- skos__broader mesh__D004372smesh__D046090
% 222.65/222.89  |- rdf__type mesh__D004372sskos__Concept
% 222.65/222.89  |- mesh__recordMaintainer mesh__D004372 ags
% 222.65/222.89  |- mesh__dateCreated mesh__D004372 1999-01-01
% 222.65/222.89  |- skos__historyNote mesh__D004372 Birds %28%1966-1967%29%
% 222.65/222.89  |- mesh__recordOriginator mesh__D004372 NLM
% 222.65/222.89  |- skos__broader mesh__D004372smesh__D011200
% 222.65/222.89  |- skos__prefLabel mesh__D004372 Ducks
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D045789 2006
% 222.65/222.89  |- skos__hiddenLabel mesh__D045789 Guaiane Sesquiterpenes
% 222.65/222.89  |- mesh__historyNote mesh__D045789 2004   
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D045789 2004
% 222.65/222.89  |- skos__broader mesh__D045789smesh__D012717
% 222.65/222.89  |- mesh__dateEstablished mesh__D045789 2004-01-01
% 222.65/222.89  |- mesh__dateCreated mesh__D045789 2003-07-09
% 222.65/222.89  |- skos__historyNote mesh__D045789 Sesquiterpenes %28%1975-2003%29%
% 222.65/222.89  |- skos__prefLabel mesh__D045789 Sesquiterpenes, Guaiane
% 222.65/222.89  |- skos__scopeNote mesh__D045789
% 222.65/222.89       SESQUITERPENES cyclized into two adjoining rings, one being 7-carbons and the other is 5-carbons.%A%    
% 222.65/222.89  |- mesh__publicMeSHNote mesh__D045789 2004   
% 222.65/222.89  |- rdf__type mesh__D045789sskos__Concept
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D045789 2005
% 222.65/222.89  |- skos__hiddenLabel mesh__D045789 Guaianolide Sesquiterpenes
% 222.65/222.89  |- skos__historyNote mesh__D012804 Arrhythmia, Sinus %28%1966-1979%29%
% 222.65/222.89  |- mesh__publicMeSHNote mesh__D012804 80   
% 222.65/222.89  |- mesh__recordAuthorizer mesh__D012804 sjn
% 222.65/222.89  |- skos__hiddenLabel mesh__D012804 Syndromes, Sick Sinus
% 222.65/222.89  |- rdf__type mesh__D012804sskos__Concept
% 222.65/222.89  |- mesh__activeMeSHYear mesh__D012804 2005
% 222.65/222.90  |- skos__scopeNote mesh__D012804
% 222.65/222.90       Dysfunction of the sinoatrial node manifested by persistent sinus bradycardia, sinus arrest, sinoatrial exit block, chronic atrial fibrillation and inability of the heart to resume sinus rhythm following cardioversion for atrial fibrillation.%A%    
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D012804 2002
% 222.65/222.90  |- skos__hiddenLabel mesh__D012804 Sinus Syndromes, Sick
% 222.65/222.90  |- skos__hiddenLabel mesh__D012804 Syndrome, Sick Sinus
% 222.65/222.90  |- skos__broader mesh__D012804smesh__D001145
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D012804 2001
% 222.65/222.90  |- mesh__recordOriginator mesh__D012804 VDK
% 222.65/222.90  |- mesh__recordMaintainer mesh__D012804 PLS
% 222.65/222.90  |- skos__hiddenLabel mesh__D012804 Sinus Syndrome, Sick
% 222.65/222.90  |- mesh__dateEstablished mesh__D012804 1980-01-01
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D012804 2000
% 222.65/222.90  |- skos__prefLabel mesh__D012804 Sick Sinus Syndrome
% 222.65/222.90  |- mesh__historyNote mesh__D012804 80   
% 222.65/222.90  |- mesh__dateCreated mesh__D012804 1978-12-20
% 222.65/222.90  |- skos__hiddenLabel mesh__D012804 Sick Sinus Syndromes
% 222.65/222.90  |- mesh__dateRevised mesh__D012804 1999-11-03
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D012804 2004
% 222.65/222.90  |- skos__annotation mesh__D012804 sinus refers to sinoatrial node   
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D012804 2006
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D012804 2003
% 222.65/222.90  |- skos__hiddenLabel mesh__D012006 Fistula, Rectovaginal
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D012006 2004
% 222.65/222.90  |- mesh__recordOriginator mesh__D012006 NLM
% 222.65/222.90  |- skos__hiddenLabel mesh__D012006 Fistulas, Rectovaginal
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D012006 2005
% 222.65/222.90  |- skos__hiddenLabel mesh__D012006 Rectovaginal Fistulas
% 222.65/222.90  |- mesh__recordMaintainer mesh__D012006 lkt
% 222.65/222.90  |- mesh__recordAuthorizer mesh__D012006 sjn
% 222.65/222.90  |- skos__scopeNote mesh__D012006
% 222.65/222.90       An abnormal anatomical passage between the RECTUM and the VAGINA.%A%    
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D012006 2006
% 222.65/222.90  |- mesh__dateCreated mesh__D012006 1999-01-01
% 222.65/222.90  |- skos__annotation mesh__D012006 fistula policy: Manual 23.19+   
% 222.65/222.90  |- skos__broader mesh__D012006smesh__D012003
% 222.65/222.90  |- mesh__dateRevised mesh__D012006 2003-07-09
% 222.65/222.90  |- skos__prefLabel mesh__D012006 Rectovaginal Fistula
% 222.65/222.90  |- skos__broader mesh__D012006smesh__D014624
% 222.65/222.90  |- rdf__type mesh__D012006sskos__Concept
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D008763 1999
% 222.65/222.90  |- mesh__dateEstablished mesh__D008763 1978-01-01
% 222.65/222.90  |- mesh__dateCreated mesh__D008763 1977-05-23
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D008763 2004
% 222.65/222.90  |- mesh__recordMaintainer mesh__D008763 TAP
% 222.65/222.90  |- rdf__type mesh__D008763sskos__Concept
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D008763 1996
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D008763 2002
% 222.65/222.90  |- mesh__recordOriginator mesh__D008763 RLS
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D008763 2005
% 222.65/222.90  |- mesh__historyNote mesh__D008763
% 222.65/222.90       78; was METHYLHYDRAZINE see under HYDRAZINES 1967-77   
% 222.65/222.90  |- skos__prefLabel mesh__D008763 Methylhydrazines
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D008763 1997
% 222.65/222.90  |- skos__broader mesh__D008763smesh__D006834
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D008763 2006
% 222.65/222.90  |- skos__historyNote mesh__D008763 Hydrazines %28%1966-1974%29%
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D008763 2000
% 222.65/222.90  |- mesh__onlineNote mesh__D008763
% 222.65/222.90       to search METHYLHYDRAZINE use METHYLHYDRAZINES 1975-77 %26% HYDRAZINES 1967-74%A%  
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D008763 1998
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D008763 2003
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D008763 2001
% 222.65/222.90  |- mesh__recordAuthorizer mesh__D008763 PLS
% 222.65/222.90  |- mesh__dateRevised mesh__D008763 1995-05-18
% 222.65/222.90  |- mesh__publicMeSHNote mesh__D008763
% 222.65/222.90       78; was METHYLHYDRAZINE see under HYDRAZINES 1967-77; DIMETHYLHYDRAZINES was 1,2 DIMETHYLHYDRAZINE see under HYDRAZINES 1975-77; MONOMETHYLHYDRAZINE was METHYLHYDRAZINE see under HYDRAZINES 1966-77%A%  
% 222.65/222.90  |- skos__scopeNote mesh__D008763
% 222.65/222.90       Hydrazines substituted by one or more methyl groups in any position.%A%    
% 222.65/222.90  |- mesh__recordOriginator mesh__D000780 NLM
% 222.65/222.90  |- mesh__recordAuthorizer mesh__D000780 sjn
% 222.65/222.90  |- skos__scopeNote mesh__D000780
% 222.65/222.90       A state of sexual inactivity in female animals exhibiting no ESTROUS CYCLE. Causes of anestrus include pregnancy, presence of offspring, season, stress, and pathology.%A%    
% 222.65/222.90  |- mesh__dateCreated mesh__D000780 1974-11-11
% 222.65/222.90  |- mesh__dateEstablished mesh__D000780 1991-01-01
% 222.65/222.90  |- skos__annotation mesh__D000780 non-primate mammals only   
% 222.65/222.90  |- mesh__historyNote mesh__D000780
% 222.65/222.90       91%28%75%29%; was see under ESTRUS 1975-90   
% 222.65/222.90  |- mesh__recordMaintainer mesh__D000780 lkt
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D000780 2005
% 222.65/222.90  |- skos__broader mesh__D000780smesh__D030762
% 222.65/222.90  |- mesh__publicMeSHNote mesh__D000780 91; was see under ESTRUS 1975-90   
% 222.65/222.90  |- mesh__dateRevised mesh__D000780 2004-07-07
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D000780 2006
% 222.65/222.90  |- skos__prefLabel mesh__D000780 Anestrus
% 222.65/222.90  |- rdf__type mesh__D000780sskos__Concept
% 222.65/222.90  |- mesh__historyNote mesh__D032862 2003   
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D032862 2005
% 222.65/222.90  |- skos__broader mesh__D032862smesh__D019770
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D032862 2003
% 222.65/222.90  |- mesh__publicMeSHNote mesh__D032862 2003   
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D032862 2006
% 222.65/222.90  |- skos__scopeNote mesh__D032862
% 222.65/222.90       A plant genus of the family LAURACEAE. Members contain laurotetanine and other APORPHINES.%A%    
% 222.65/222.90  |- skos__annotation mesh__D032862
% 222.65/222.90       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D032862 2004
% 222.65/222.90  |- mesh__dateCreated mesh__D032862 2002-07-03
% 222.65/222.90  |- mesh__dateEstablished mesh__D032862 2003-01-01
% 222.65/222.90  |- rdf__type mesh__D032862sskos__Concept
% 222.65/222.90  |- skos__prefLabel mesh__D032862 Litsea
% 222.65/222.90  |- skos__prefLabel mesh__D018393 Mycobacterium haemophilum
% 222.65/222.90  |- skos__annotation mesh__D018393
% 222.65/222.90       infection: coord IM with MYCOBACTERIUM INFECTIONS %28%IM%29%; DF: MYCOBACT HAEMOPHILUM%A%  
% 222.65/222.90  |- mesh__dateEstablished mesh__D018393 1995-01-01
% 222.65/222.90  |- mesh__dateCreated mesh__D018393 1994-01-25
% 222.65/222.90  |- skos__broader mesh__D018393smesh__D009161
% 222.65/222.90  |- mesh__recordAuthorizer mesh__D018393 sjn
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D018393 2006
% 222.65/222.90  |- mesh__historyNote mesh__D018393 95   
% 222.65/222.90  |- mesh__dateRevised mesh__D018393 2005-06-30
% 222.65/222.90  |- rdf__type mesh__D018393sskos__Concept
% 222.65/222.90  |- mesh__recordOriginator mesh__D018393 PXP
% 222.65/222.90  |- skos__scopeNote mesh__D018393
% 222.65/222.90       A species of gram-positive, aerobic bacteria that causes granulomatous or ulcerating skin lesions in immunosuppressed persons. This organism owes its name to its requirement for growth of high levels of iron, conveniently supplied as blood, heme, or ferric ammonium citrate.%A%    
% 222.65/222.90  |- skos__altLabel mesh__D018393 Mycobacterium hemophilum
% 222.65/222.90  |- mesh__recordMaintainer mesh__D018393 SYSTEM
% 222.65/222.90  |- skos__historyNote mesh__D018393 Mycobacterium %28%1979-1994%29%
% 222.65/222.90  |- mesh__publicMeSHNote mesh__D018393 95   
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D032064 2005
% 222.65/222.90  |- skos__prefLabel mesh__D032064 Hedyotis
% 222.65/222.90  |- rdf__type mesh__D032064sskos__Concept
% 222.65/222.90  |- mesh__publicMeSHNote mesh__D032064 2003   
% 222.65/222.90  |- skos__broader mesh__D032064smesh__D019666
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D032064 2004
% 222.65/222.90  |- skos__scopeNote mesh__D032064
% 222.65/222.90       A plant genus of the family RUBIACEAE. Members contain anthraquinones and iridoids. H. diffusa is used in DRUGS, CHINESE HERBAL.%A%    
% 222.65/222.90  |- mesh__historyNote mesh__D032064 2003   
% 222.65/222.90  |- mesh__dateCreated mesh__D032064 2002-07-03
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D032064 2003
% 222.65/222.90  |- mesh__dateEstablished mesh__D032064 2003-01-01
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D032064 2006
% 222.65/222.90  |- skos__annotation mesh__D032064
% 222.65/222.90       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D004373 1995
% 222.65/222.90  |- skos__hiddenLabel mesh__D004373 Arteriosus, Ductus
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D004373 1993
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D004373 2003
% 222.65/222.90  |- mesh__dateRevised mesh__D004373 1992-05-14
% 222.65/222.90  |- mesh__dateCreated mesh__D004373 1999-01-01
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D004373 1994
% 222.65/222.90  |- mesh__recordOriginator mesh__D004373 NLM
% 222.65/222.90  |- skos__prefLabel mesh__D004373 Ductus Arteriosus
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D004373 1999
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D004373 2002
% 222.65/222.90  |- skos__broader mesh__D004373smesh__D005318
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D004373 1997
% 222.65/222.90  |- mesh__recordMaintainer mesh__D004373 TAP
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D004373 1998
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D004373 1996
% 222.65/222.90  |- skos__scopeNote mesh__D004373
% 222.65/222.90       A fetal blood vessel connecting the pulmonary artery with the descending aorta.%A%    
% 222.65/222.90  |- skos__annotation mesh__D004373
% 222.65/222.90       normal; abnormal is probably DUCTUS ARTERIOSUS, PATENT   
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D004373 2006
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D004373 2004
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D004373 2001
% 222.65/222.90  |- mesh__recordAuthorizer mesh__D004373 PLS
% 222.65/222.90  |- rdf__type mesh__D004373sskos__Concept
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D004373 2000
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D004373 2005
% 222.65/222.90  |- rdf__type mesh__D012805sskos__Concept
% 222.65/222.90  |- skos__scopeNote mesh__D012805
% 222.65/222.90       The condition of being heterozygous for hemoglobin S.     
% 222.65/222.90  |- mesh__onlineNote mesh__D012805 search ANEMIA, SICKLE CELL 1966-74   
% 222.65/222.90  |- skos__hiddenLabel mesh__D012805 Cell Trait, Sickle
% 222.65/222.90  |- skos__hiddenLabel mesh__D012805 Traits, Sickle Cell
% 222.65/222.90  |- mesh__dateEstablished mesh__D012805 1991-01-01
% 222.65/222.90  |- mesh__recordAuthorizer mesh__D012805 sjn
% 222.65/222.90  |- skos__broader mesh__D012805smesh__D000755
% 222.65/222.90  |- mesh__dateCreated mesh__D012805 1999-01-01
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D012805 2002
% 222.65/222.90  |- mesh__recordMaintainer mesh__D012805 nns
% 222.65/222.90  |- mesh__recordOriginator mesh__D012805 NLM
% 222.65/222.90  |- mesh__historyNote mesh__D012805
% 222.65/222.90       91%28%75%29%; was see under ANEMIA, SICKLE CELL 1975-90   
% 222.65/222.90  |- mesh__dateRevised mesh__D012805 2001-07-25
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D012805 2004
% 222.65/222.90  |- mesh__publicMeSHNote mesh__D012805
% 222.65/222.90       91; was see under ANEMIA, SICKLE CELL 1975-90   
% 222.65/222.90  |- skos__hiddenLabel mesh__D012805 Trait, Sickle Cell
% 222.65/222.90  |- skos__prefLabel mesh__D012805 Sickle Cell Trait
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D012805 2006
% 222.65/222.90  |- skos__hiddenLabel mesh__D012805 Sickle Cell Traits
% 222.65/222.90  |- skos__hiddenLabel mesh__D012805 Cell Traits, Sickle
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D012805 2003
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D012805 2005
% 222.65/222.90  |- mesh__recordMaintainer mesh__D012007 sjn
% 222.65/222.90  |- mesh__dateRevised mesh__D012007 2005-07-01
% 222.65/222.90  |- skos__annotation mesh__D012007
% 222.65/222.90       /surg: do not confuse with the specialty COLORECTAL SURGERY; rectal bleeding: RECTUM %28%NIM%29% + HEMORRHAGE, GASTROINTESTINAL %28%IM%29% for bleeding through the rectum; hemorrhaging rectum is RECTAL DISEASES %28%IM%29% + HEMORRHAGE, GASTROINTESTINAL %28%IM%29%; inflammation = PROCTITIS%A%  
% 222.65/222.90  |- skos__broader mesh__D012007smesh__D007420
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D012007 2006
% 222.65/222.90  |- mesh__dateCreated mesh__D012007 1999-01-01
% 222.65/222.90  |- mesh__recordOriginator mesh__D012007 NLM
% 222.65/222.90  |- skos__scopeNote mesh__D012007
% 222.65/222.90       The distal segment of the LARGE INTESTINE, between the SIGMOID COLON and the ANAL CANAL.%A%    
% 222.65/222.90  |- mesh__recordAuthorizer mesh__D012007 sjn
% 222.65/222.90  |- mesh__considerAlso mesh__D012007 consider also terms at PROCT-   
% 222.65/222.90  |- skos__hiddenLabel mesh__D012007 Rectums
% 222.65/222.90  |- rdf__type mesh__D012007sskos__Concept
% 222.65/222.90  |- skos__prefLabel mesh__D012007 Rectum
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D008764 2001
% 222.65/222.90  |- skos__prefLabel mesh__D008764 Methylmalonic Acid
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D008764 2005
% 222.65/222.90  |- mesh__recordMaintainer mesh__D008764 CCR
% 222.65/222.90  |- skos__annotation mesh__D008764 /biosyn /physiol permitted   
% 222.65/222.90  |- mesh__dateEstablished mesh__D008764 1991-01-01
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D008764 2006
% 222.65/222.90  |- skos__broader mesh__D008764smesh__D008314
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D008764 2002
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D008764 2003
% 222.65/222.90  |- skos__historyNote mesh__D008764 Malonates %28%1974%29%
% 222.65/222.90  |- skos__hiddenLabel mesh__D008764 Acid, Methylmalonic
% 222.65/222.90  |- mesh__publicMeSHNote mesh__D008764
% 222.65/222.90       91; was see under MALONATES 1975-90   
% 222.65/222.90  |- skos__scopeNote mesh__D008764
% 222.65/222.90       A malonic acid derivative which is a vital intermediate in the metabolism of fat and protein. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This metabolic disease is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA.%A%    
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D008764 2004
% 222.65/222.90  |- rdf__type mesh__D008764sskos__Concept
% 222.65/222.90  |- mesh__dateRevised mesh__D008764 2000-06-21
% 222.65/222.90  |- mesh__recordAuthorizer mesh__D008764 sjn
% 222.65/222.90  |- mesh__historyNote mesh__D008764
% 222.65/222.90       91%28%75%29%; was see under MALONATES 1975-90   
% 222.65/222.90  |- mesh__dateCreated mesh__D008764 1974-11-11
% 222.65/222.90  |- mesh__recordOriginator mesh__D008764 NLM
% 222.65/222.90  |- skos__hiddenLabel mesh__D000781 SL 25
% 222.65/222.90  |- skos__historyNote mesh__D000781 Thiones %28%1974-1975%29%
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D000781 2006
% 222.65/222.90  |- rdf__type mesh__D000781sskos__Concept
% 222.65/222.90  |- skos__hiddenLabel mesh__D000781 Dithiolthione, Anethol
% 222.65/222.90  |- mesh__dateRevised mesh__D000781 2004-07-07
% 222.65/222.90  |- skos__altLabel mesh__D000781 Anisyldithiolthionine
% 222.65/222.90  |- skos__altLabel mesh__D000781 Solvay Brand of Anethole Trithione
% 222.65/222.90  |- skos__altLabel mesh__D000781 Kali Brand of Anethole Trithione
% 222.65/222.90  |- mesh__dateCreated mesh__D000781 1976-04-16
% 222.65/222.90  |- mesh__publicMeSHNote mesh__D000781 91; was see under ANISOLES 1977-90   
% 222.65/222.90  |- mesh__activeMeSHYear mesh__D000781 2005
% 222.76/222.90  |- mesh__recordOriginator mesh__D000781 SH
% 222.76/222.90  |- skos__altLabel mesh__D000781 Anetholetrithione
% 222.76/222.90  |- skos__scopeNote mesh__D000781
% 222.76/222.90       Choleretic used to allay dry mouth and constipation due to tranquilizers.%A%    
% 222.76/222.90  |- skos__historyNote mesh__D000781 Anisoles %28%1974-1976%29%
% 222.76/222.90  |- skos__hiddenLabel mesh__D000781 Trithione, Anethole
% 222.76/222.90  |- skos__altLabel mesh__D000781 Trithioparamethoxyphenylpropene
% 222.76/222.90  |- skos__prefLabel mesh__D000781 Anethole Trithione
% 222.76/222.90  |- skos__altLabel mesh__D000781 Sanofi Winthrop Brand of Anethole Trithione
% 222.76/222.90  |- skos__altLabel mesh__D000781 Sonicur
% 222.76/222.90  |- mesh__recordMaintainer mesh__D000781 mdb
% 222.76/222.90  |- skos__historyNote mesh__D000781 Heterocyclic Compounds %28%1974-1976%29%
% 222.76/222.90  |- skos__altLabel mesh__D000781 Sulfralem
% 222.76/222.90  |- skos__altLabel mesh__D000781 Anethol Dithiolthione
% 222.76/222.90  |- mesh__recordAuthorizer mesh__D000781 sjn
% 222.76/222.90  |- skos__altLabel mesh__D000781 Trithioanethol
% 222.76/222.90  |- skos__broader mesh__D000781smesh__D000840
% 222.76/222.90  |- skos__altLabel mesh__D000781 Anetholtrithione
% 222.76/222.90  |- mesh__dateEstablished mesh__D000781 1991-01-01
% 222.76/222.90  |- skos__altLabel mesh__D000781 Anetholtrithion
% 222.76/222.90  |- mesh__historyNote mesh__D000781
% 222.76/222.90       91%28%77%29%; was see under ANISOLES 1977-90   
% 222.76/222.90  |- mesh__activeMeSHYear mesh__D013100 1995
% 222.76/222.90  |- mesh__dateCreated mesh__D013100 1999-01-01
% 222.76/222.90  |- mesh__recordAuthorizer mesh__D013100 MED
% 222.76/222.90  |- mesh__recordMaintainer mesh__D013100 RRC
% 222.76/222.90  |- mesh__activeMeSHYear mesh__D013100 2000
% 222.76/222.90  |- mesh__activeMeSHYear mesh__D013100 1989
% 222.76/222.90  |- mesh__activeMeSHYear mesh__D013100 1991
% 222.76/222.90  |- rdf__type mesh__D013100sskos__Concept
% 222.76/222.90  |- mesh__activeMeSHYear mesh__D013100 2003
% 222.76/222.90  |- mesh__activeMeSHYear mesh__D013100 2001
% 222.76/222.90  |- skos__annotation mesh__D013100
% 222.76/222.90       fractures: coord SPHENOID BONE /inj %28%IM%29% + SKULL FRACTURES %28%IM%29%; neopl: coord IM with SKULL NEOPLASMS %28%IM%29%%A%  
% 222.76/222.90  |- mesh__activeMeSHYear mesh__D013100 2005
% 222.76/222.90  |- mesh__recordOriginator mesh__D013100 NLM
% 222.76/222.90  |- skos__broader mesh__D013100smesh__D012886
% 222.76/222.90  |- skos__hiddenLabel mesh__D013100 Bones, Sphenoid
% 222.76/222.90  |- mesh__activeMeSHYear mesh__D013100 2004
% 222.76/222.90  |- skos__hiddenLabel mesh__D013100 Sphenoid Bones
% 222.76/222.90  |- mesh__activeMeSHYear mesh__D013100 2006
% 222.76/222.90  |- mesh__activeMeSHYear mesh__D013100 1996
% 222.76/222.90  |- mesh__dateRevised mesh__D013100 1982-05-07
% 222.76/222.90  |- mesh__activeMeSHYear mesh__D013100 1998
% 222.76/222.90  |- skos__prefLabel mesh__D013100 Sphenoid Bone
% 222.76/222.90  |- mesh__activeMeSHYear mesh__D013100 2002
% 222.76/222.90  |- mesh__activeMeSHYear mesh__D013100 1992
% 222.76/222.90  |- mesh__activeMeSHYear mesh__D013100 1990
% 222.76/222.90  |- mesh__activeMeSHYear mesh__D013100 1997
% 222.76/222.90  |- mesh__activeMeSHYear mesh__D013100 1994
% 222.76/222.90  |- mesh__activeMeSHYear mesh__D013100 1999
% 222.76/222.90  |- skos__hiddenLabel mesh__D013100 Bone, Sphenoid
% 222.76/222.90  |- mesh__activeMeSHYear mesh__D013100 1993
% 222.76/222.90  |- mesh__dateRevised mesh__D018394 2005-06-30
% 222.76/222.90  |- mesh__publicMeSHNote mesh__D018394
% 222.76/222.90       95; was see ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE 1989-94%A%  
% 222.76/222.90  |- skos__historyNote mesh__D018394
% 222.76/222.90       Antigens, Tumor-Associated, Carbohydrate %28%1988-1994%29%
% 222.76/222.90  |- skos__prefLabel mesh__D018394 CA-125 Antigen
% 222.76/222.90  |- mesh__activeMeSHYear mesh__D018394 2006
% 222.76/222.90  |- skos__annotation mesh__D018394
% 222.76/222.90       a carbohydrate antigen assoc with various tumors but also normal tissue; CA stands for Cancer-Associated%A%  
% 222.76/222.90  |- skos__altLabel mesh__D018394 Antigen CA-125
% 222.76/222.90  |- rdf__type mesh__D018394sskos__Concept
% 222.76/222.90  |- mesh__onlineNote mesh__D018394
% 222.76/222.90       use ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE to search CA-125 ANTIGEN 1989-94%A%  
% 222.76/222.90  |- mesh__dateEstablished mesh__D018394 1995-01-01
% 222.76/222.90  |- skos__hiddenLabel mesh__D018394 Antigen, CA-125
% 222.76/222.90  |- mesh__recordOriginator mesh__D018394 AGS
% 222.76/222.90  |- mesh__dateCreated mesh__D018394 1994-05-23
% 222.76/222.90  |- mesh__recordMaintainer mesh__D018394 ssb
% 222.76/222.90  |- skos__scopeNote mesh__D018394
% 222.76/222.90       Carbohydrate antigen most commonly seen in tumors of the ovary and occasionally seen in breast, kidney, and gastrointestinal tract tumors and normal tissue. CA 125 is clearly tumor-associated but not tumor-specific.%A%    
% 222.76/222.90  |- skos__hiddenLabel mesh__D018394 Antigen, CA 125
% 222.76/222.90  |- mesh__historyNote mesh__D018394
% 222.76/222.90       95; was see ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE 1989-94%A%  
% 222.76/222.90  |- skos__altLabel mesh__D018394 CA 125 Antigen
% 222.76/222.90  |- skos__broader mesh__D018394smesh__D015295
% 222.76/222.90  |- mesh__recordAuthorizer mesh__D018394 sjn
% 222.76/222.90  |- skos__hiddenLabel mesh__D018394 Antigen CA 125
% 222.76/222.90  |- mesh__dateEstablished mesh__D032065 2003-01-01
% 222.76/222.90  |- mesh__dateCreated mesh__D032065 2002-07-03
% 222.76/222.90  |- mesh__historyNote mesh__D032065 2003   
% 222.76/222.90  |- skos__broader mesh__D032065smesh__D019666
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D032065 2004
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D032065 2003
% 222.76/222.92  |- skos__prefLabel mesh__D032065 Mitragyna
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D032065 2006
% 222.76/222.92  |- skos__annotation mesh__D032065
% 222.76/222.92       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D032065 2005
% 222.76/222.92  |- skos__scopeNote mesh__D032065
% 222.76/222.92       A plant genus of the family RUBIACEAE. Members contain antimalarial %28%ANTIMALARIALS%29% and analgesic %28%ANALGESICS%29% indole alkaloids.%A%    
% 222.76/222.92  |- rdf__type mesh__D032065sskos__Concept
% 222.76/222.92  |- mesh__publicMeSHNote mesh__D032065 2003   
% 222.76/222.92  |- mesh__publicMeSHNote mesh__D004374 65   
% 222.76/222.92  |- mesh__recordMaintainer mesh__D004374 kle
% 222.76/222.92  |- mesh__dateCreated mesh__D004374 1999-01-01
% 222.76/222.92  |- mesh__dateEstablished mesh__D004374 1965-01-01
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D004374 2000
% 222.76/222.92  |- skos__scopeNote mesh__D004374
% 222.76/222.92       Abnormal persistence of an open lumen in the ductus arteriosus after birth, the direction of flow being from the aorta to the pulmonary artery, resulting in recirculation of arterial blood through the lungs. %28%Dorland, 27th ed%29%%A%    
% 222.76/222.92  |- skos__annotation mesh__D004374
% 222.76/222.92       abnormal: normal anat structure is DUCTUS ARTERIOSUS; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 222.76/222.92  |- skos__hiddenLabel mesh__D004374 Patent Ductus Arteriosus
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D004374 2006
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D004374 2002
% 222.76/222.92  |- mesh__recordOriginator mesh__D004374 NLM
% 222.76/222.92  |- mesh__dateRevised mesh__D004374 1999-11-03
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D004374 2005
% 222.76/222.92  |- mesh__historyNote mesh__D004374 65%28%64%29%   
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D004374 2004
% 222.76/222.92  |- skos__broader mesh__D004374smesh__D006330
% 222.76/222.92  |- rdf__type mesh__D004374sskos__Concept
% 222.76/222.92  |- skos__hiddenLabel mesh__D004374 Arteriosus, Patent Ductus
% 222.76/222.92  |- mesh__recordAuthorizer mesh__D004374 sjn
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D004374 2003
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D004374 2001
% 222.76/222.92  |- skos__prefLabel mesh__D004374 Ductus Arteriosus, Patent
% 222.76/222.92  |- skos__related mesh__D004374smesh__D010547
% 222.76/222.92  |- mesh__dateCreated mesh__D012806 1999-01-01
% 222.76/222.92  |- rdf__type mesh__D012806sskos__Concept
% 222.76/222.92  |- skos__broader mesh__D012806smesh__D011009
% 222.76/222.92  |- mesh__dateRevised mesh__D012806 2005-07-01
% 222.76/222.92  |- skos__related mesh__D012806smesh__D006486
% 222.76/222.92  |- mesh__recordMaintainer mesh__D012806 sjn
% 222.76/222.92  |- skos__scopeNote mesh__D012806
% 222.76/222.92       The deposition of iron in a tissue. In the eye, the iron may be deposited in the stroma adjacent to the DESCEMET MEMBRANE.%A%    
% 222.76/222.92  |- skos__hiddenLabel mesh__D012806 Sideroses
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D012806 2006
% 222.76/222.92  |- mesh__recordAuthorizer mesh__D012806 sjn
% 222.76/222.92  |- skos__prefLabel mesh__D012806 Siderosis
% 222.76/222.92  |- skos__annotation mesh__D012806
% 222.76/222.92       tissue deposition of iron; do not coord with OCCUPATIONAL DISEASES%A%  
% 222.76/222.92  |- mesh__recordOriginator mesh__D012806 NLM
% 222.76/222.92  |- mesh__recordAuthorizer mesh__D012008 sjn
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D012008 2000
% 222.76/222.92  |- skos__broader mesh__D012008smesh__D020969
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D012008 2003
% 222.76/222.92  |- rdf__type mesh__D012008sskos__Concept
% 222.76/222.92  |- skos__hiddenLabel mesh__D012008 Recrudescences
% 222.76/222.92  |- mesh__publicMeSHNote mesh__D012008 91; was see under DISEASE 1971-90   
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D012008 2001
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D012008 2004
% 222.76/222.92  |- skos__annotation mesh__D012008
% 222.76/222.92       never IM; /prev permitted: coord NIM with disease /prev %28%IM%29%%A%  
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D012008 2002
% 222.76/222.92  |- skos__related mesh__D012008smesh__D009364
% 222.76/222.92  |- mesh__dateEstablished mesh__D012008 1991-01-01
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D012008 2005
% 222.76/222.92  |- mesh__dateRevised mesh__D012008 1999-11-08
% 222.76/222.92  |- mesh__recordOriginator mesh__D012008 NLM
% 222.76/222.92  |- skos__hiddenLabel mesh__D012008 Recurrences
% 222.76/222.92  |- skos__prefLabel mesh__D012008 Recurrence
% 222.76/222.92  |- mesh__historyNote mesh__D012008
% 222.76/222.92       91%28%71%29%; was see under DISEASE 1971-90   
% 222.76/222.92  |- skos__hiddenLabel mesh__D012008 Relapses
% 222.76/222.92  |- mesh__recordMaintainer mesh__D012008 adp
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D012008 2006
% 222.76/222.92  |- mesh__dateCreated mesh__D012008 1999-01-01
% 222.76/222.92  |- skos__scopeNote mesh__D012008
% 222.76/222.92       The return of a sign, symptom, or disease after a remission.%A%    
% 222.76/222.92  |- mesh__dateRevised mesh__D008765 2003-07-09
% 222.76/222.92  |- skos__annotation mesh__D008765
% 222.76/222.92       /defic: consider also METHYLMALONIC ACID /urine %28%IM%29% + AMINO ACID METABOLISM, INBORN ERRORS %28%IM%29%%A%  
% 222.76/222.92  |- skos__hiddenLabel mesh__D008765 Methylmalonyl CoA Mutase
% 222.76/222.92  |- skos__broader mesh__D008765smesh__D019751
% 222.76/222.92  |- skos__hiddenLabel mesh__D008765 Methylmalonyl CoA Isomerase
% 222.76/222.92  |- rdf__type mesh__D008765sskos__Concept
% 222.76/222.92  |- skos__prefLabel mesh__D008765 Methylmalonyl-CoA Mutase
% 222.76/222.92  |- mesh__recordOriginator mesh__D008765 NLM
% 222.76/222.92  |- mesh__dateCreated mesh__D008765 1974-11-11
% 222.76/222.92  |- mesh__recordAuthorizer mesh__D008765 sjn
% 222.76/222.92  |- skos__historyNote mesh__D008765 Isomerases %28%1969-1974%29%
% 222.76/222.92  |- skos__hiddenLabel mesh__D008765 Isomerase, Methylmalonyl-CoA
% 222.76/222.92  |- skos__altLabel mesh__D008765 Methylmalonyl-CoA Isomerase
% 222.76/222.92  |- skos__hiddenLabel mesh__D008765 Mutase, Methylmalonyl-CoA
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D008765 2006
% 222.76/222.92  |- mesh__publicMeSHNote mesh__D008765
% 222.76/222.92       91; was see under ISOMERASES 1975-90   
% 222.76/222.92  |- mesh__historyNote mesh__D008765
% 222.76/222.92       91%28%75%29%; was see under ISOMERASES 1975-90   
% 222.76/222.92  |- skos__scopeNote mesh__D008765
% 222.76/222.92       An enzyme that catalyzes the conversion of methylmalonyl-CoA to succinyl-CoA by transfer of the carbonyl group. It requires a cobamide coenzyme. A block in this enzymatic conversion leads to the metabolic disease, methylmalonic aciduria. EC 5.4.99.2.%A%    
% 222.76/222.92  |- mesh__recordMaintainer mesh__D008765 ssb
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D008765 2005
% 222.76/222.92  |- mesh__dateEstablished mesh__D008765 1991-01-01
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D008765 2004
% 222.76/222.92  |- skos__historyNote mesh__D008765 Malonates %28%1969-1974%29%
% 222.76/222.92  |- mesh__historyNote mesh__D000782 68   
% 222.76/222.92  |- skos__historyNote mesh__D000782
% 222.76/222.92       Chromosome Abnormalities %28%1966-1967%29%
% 222.76/222.92  |- skos__hiddenLabel mesh__D000782 Aneuploid Cells
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D000782 2005
% 222.76/222.92  |- skos__scopeNote mesh__D000782
% 222.76/222.92       The chromosomal constitution of cells which deviate from the normal by the addition or subtraction of CHROMOSOMES, chromosome pairs, or chromosome fragments. In a normally diploid cell %28%DIPLOIDY%29% the loss of a chromosome pair is termed nullisomy %28%symbol: 2N-2%29%, the loss of a single chromosome is MONOSOMY %28%symbol: 2N-1%29%, the addition of a chromosome pair is tetrasomy %28%symbol: 2N+2%29%, the addition of a single chromosome is TRISOMY %28%symbol: 2N+1%29%.%A%    
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D000782 2004
% 222.76/222.92  |- skos__hiddenLabel mesh__D000782 Cell, Aneuploid
% 222.76/222.92  |- mesh__dateEstablished mesh__D000782 1968-01-01
% 222.76/222.92  |- skos__altLabel mesh__D000782 Aneuploid
% 222.76/222.92  |- skos__broader mesh__D000782smesh__D002869
% 222.76/222.92  |- mesh__recordMaintainer mesh__D000782 nns
% 222.76/222.92  |- mesh__dateCreated mesh__D000782 1999-01-01
% 222.76/222.92  |- skos__hiddenLabel mesh__D000782 Cells, Aneuploid
% 222.76/222.92  |- skos__prefLabel mesh__D000782 Aneuploidy
% 222.76/222.92  |- skos__hiddenLabel mesh__D000782 Aneuploidies
% 222.76/222.92  |- skos__hiddenLabel mesh__D000782 Aneuploids
% 222.76/222.92  |- skos__broader mesh__D000782smesh__D011003
% 222.76/222.92  |- mesh__dateRevised mesh__D000782 2003-07-09
% 222.76/222.92  |- mesh__publicMeSHNote mesh__D000782 68   
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D000782 2006
% 222.76/222.92  |- rdf__type mesh__D000782sskos__Concept
% 222.76/222.92  |- mesh__recordAuthorizer mesh__D000782 sjn
% 222.76/222.92  |- mesh__recordOriginator mesh__D000782 NLM
% 222.76/222.92  |- rdf__type mesh__D013101sskos__Concept
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D013101 2003
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D013101 2005
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D013101 2004
% 222.76/222.92  |- skos__hiddenLabel mesh__D013101 Sinus, Sphenoid
% 222.76/222.92  |- skos__broader mesh__D013101smesh__D010256
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D013101 2006
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D013101 2000
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D013101 1996
% 222.76/222.92  |- mesh__recordMaintainer mesh__D013101 PXP
% 222.76/222.92  |- skos__annotation mesh__D013101
% 222.76/222.92       inflammation or sinusitis = SPHENOID SINUSITIS; fractures: coord SPHENOID SINUS /inj %28%IM%29% + SKULL FRACTURES %28%IM%29%; neopl: coord IM with PARANASAL SINUS NEOPLASMS %28%IM%29%%A%  
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D013101 2001
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D013101 1998
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D013101 1997
% 222.76/222.92  |- mesh__recordOriginator mesh__D013101 NLM
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D013101 1999
% 222.76/222.92  |- skos__prefLabel mesh__D013101 Sphenoid Sinus
% 222.76/222.92  |- skos__scopeNote mesh__D013101
% 222.76/222.92       One of the paired paranasal sinuses, located in the body of the sphenoid bone and communicating with the highest meatus of the nasal cavity on the same side.%A%    
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D013101 1995
% 222.76/222.92  |- mesh__dateRevised mesh__D013101 1994-05-12
% 222.76/222.92  |- mesh__dateCreated mesh__D013101 1999-01-01
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D013101 2002
% 222.76/222.92  |- mesh__recordAuthorizer mesh__D013101 PLS
% 222.76/222.92  |- skos__altLabel mesh__D018395 Gastrointestinal Cancer Antigen
% 222.76/222.92  |- rdf__type mesh__D018395sskos__Concept
% 222.76/222.92  |- mesh__recordAuthorizer mesh__D018395 sjn
% 222.76/222.92  |- skos__broader mesh__D018395smesh__D015295
% 222.76/222.92  |- skos__historyNote mesh__D018395
% 222.76/222.92       Antigens, Tumor-Associated, Carbohydrate %28%1989-1994%29%
% 222.76/222.92  |- skos__hiddenLabel mesh__D018395 Antigen, CA 19-9
% 222.76/222.92  |- skos__prefLabel mesh__D018395 CA-19-9 Antigen
% 222.76/222.92  |- skos__scopeNote mesh__D018395
% 222.76/222.92       Sialylated Lewis blood group carbohydrate antigen found in many adenocarcinomas of the digestive tract, especially pancreatic tumors.%A%    
% 222.76/222.92  |- skos__altLabel mesh__D018395 CA 19-9 Antigen
% 222.76/222.92  |- skos__broader mesh__D018395smesh__D007983
% 222.76/222.92  |- mesh__dateRevised mesh__D018395 2005-06-30
% 222.76/222.92  |- skos__annotation mesh__D018395
% 222.76/222.92       a carbohydrate antigen assoc with digestive tract cancer; CA stands for Cancer-Associated%A%  
% 222.76/222.92  |- skos__historyNote mesh__D018395 Antigens, Neoplasm %28%1984-1988%29%
% 222.76/222.92  |- skos__hiddenLabel mesh__D018395 Cancer Antigen, Gastrointestinal
% 222.76/222.92  |- mesh__publicMeSHNote mesh__D018395
% 222.76/222.92       95; was see ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE 1989-94%A%  
% 222.76/222.92  |- skos__altLabel mesh__D018395 Antigen CA-19-9
% 222.76/222.92  |- skos__hiddenLabel mesh__D018395 Antigen CA 19 9
% 222.76/222.92  |- mesh__historyNote mesh__D018395
% 222.76/222.92       95; was see ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE 1989-94%A%  
% 222.76/222.92  |- skos__hiddenLabel mesh__D018395 Antigen, Gastrointestinal Cancer
% 222.76/222.92  |- mesh__dateEstablished mesh__D018395 1995-01-01
% 222.76/222.92  |- mesh__recordMaintainer mesh__D018395 ssb
% 222.76/222.92  |- mesh__recordOriginator mesh__D018395 AGS
% 222.76/222.92  |- skos__hiddenLabel mesh__D018395 CA-19-9, Antigen
% 222.76/222.92  |- mesh__onlineNote mesh__D018395
% 222.76/222.92       use ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE to search CA-19-9 ANTIGEN 1989-94%A%  
% 222.76/222.92  |- skos__altLabel mesh__D018395 CA 19.9 Antigen
% 222.76/222.92  |- skos__hiddenLabel mesh__D018395 Antigen, CA 19.9
% 222.76/222.92  |- skos__hiddenLabel mesh__D018395 CA 19 9 Antigen
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D018395 2006
% 222.76/222.92  |- skos__hiddenLabel mesh__D018395 Antigen, CA-19-9
% 222.76/222.92  |- mesh__dateCreated mesh__D018395 1994-04-16
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D032066 2003
% 222.76/222.92  |- mesh__dateEstablished mesh__D032066 2003-01-01
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D032066 2006
% 222.76/222.92  |- mesh__dateCreated mesh__D032066 2002-07-03
% 222.76/222.92  |- mesh__historyNote mesh__D032066 2003   
% 222.76/222.92  |- skos__annotation mesh__D032066
% 222.76/222.92       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D032066 2005
% 222.76/222.92  |- rdf__type mesh__D032066sskos__Concept
% 222.76/222.92  |- skos__scopeNote mesh__D032066
% 222.76/222.92       A plant genus of the family RUBIACEAE. Members contain iridoid glycosides and ANTHRAQUINONES.%A%    
% 222.76/222.92  |- skos__altLabel mesh__D032066 Noni
% 222.76/222.92  |- mesh__publicMeSHNote mesh__D032066 2003   
% 222.76/222.92  |- skos__broader mesh__D032066smesh__D019666
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D032066 2004
% 222.76/222.92  |- skos__prefLabel mesh__D032066 Morinda
% 222.76/222.92  |- rdf__type mesh__D051220sskos__Concept
% 222.76/222.92  |- skos__hiddenLabel mesh__D051220 Pisiform Bones
% 222.76/222.92  |- mesh__dateEstablished mesh__D051220 2006-01-01
% 222.76/222.92  |- mesh__recordAuthorizer mesh__D051220 sjn
% 222.76/222.92  |- skos__historyNote mesh__D051220 Carpal Bones %28%1971-2005%29%
% 222.76/222.92  |- skos__scopeNote mesh__D051220
% 222.76/222.92       A pea-shaped carpal bone that actually sits in the tendon of the flexor carpi ulnaris muscle.%A%    
% 222.76/222.92  |- skos__hiddenLabel mesh__D051220 Bones, Pisiform
% 222.76/222.92  |- skos__altLabel mesh__D051220 Os Pisiforme
% 222.76/222.92  |- skos__prefLabel mesh__D051220 Pisiform Bone
% 222.76/222.92  |- mesh__historyNote mesh__D051220 2006   
% 222.76/222.92  |- mesh__recordMaintainer mesh__D051220 ags
% 222.76/222.92  |- skos__hiddenLabel mesh__D051220 Bone, Pisiform
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D051220 2006
% 222.76/222.92  |- mesh__dateCreated mesh__D051220 2005-06-30
% 222.76/222.92  |- mesh__recordOriginator mesh__D051220 ags
% 222.76/222.92  |- skos__broader mesh__D051220smesh__D002348
% 222.76/222.92  |- mesh__publicMeSHNote mesh__D051220 2006   
% 222.76/222.92  |- skos__scopeNote mesh__D004375
% 222.76/222.92       A blood group consisting mainly of the antigens Fy%28%a%29% and Fy%28%b%29%, determined by allelic genes, the frequency of which varies profoundly in different human groups; amorphic genes are common.%A%    
% 222.76/222.92  |- skos__hiddenLabel mesh__D004375 Duffy Blood Group System
% 222.76/222.92  |- mesh__activeMeSHYear mesh__D004375 2006
% 222.76/222.92  |- skos__broader mesh__D004375smesh__D001789
% 222.76/222.92  |- mesh__recordAuthorizer mesh__D004375 sjn
% 222.76/222.92  |- mesh__historyNote mesh__D004375
% 222.76/222.92       91%28%76%29%; was see under BLOOD GROUPS 1976-90   
% 222.76/222.92  |- mesh__publicMeSHNote mesh__D004375
% 222.76/222.92       91; was see under BLOOD GROUPS 1976-90   
% 222.76/222.92  |- rdf__type mesh__D004375sskos__Concept
% 222.76/222.92  |- skos__hiddenLabel mesh__D004375 Blood-Group System, Duffy
% 222.76/222.92  |- mesh__dateEstablished mesh__D004375 1991-01-01
% 222.76/222.92  |- mesh__dateCreated mesh__D004375 1975-07-25
% 222.76/222.92  |- skos__annotation mesh__D004375
% 222.76/222.92       IM; coord with disease /blood %28%IM%29%, not /immunol nor /genet; TN 230%A%  
% 222.76/222.92  |- skos__prefLabel mesh__D004375 Duffy Blood-Group System
% 222.76/222.92  |- skos__hiddenLabel mesh__D004375 System, Duffy Blood-Group
% 222.76/222.92  |- mesh__dateRevised mesh__D004375 2005-06-30
% 222.76/222.92  |- mesh__recordOriginator mesh__D004375 SH
% 222.76/222.92  |- skos__historyNote mesh__D004375 Blood Groups %28%1966-1975%29%
% 222.76/222.93  |- mesh__recordMaintainer mesh__D004375 ssb
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D012807 2000
% 222.76/222.93  |- mesh__recordOriginator mesh__D012807 NLM
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D012807 2003
% 222.76/222.93  |- skos__annotation mesh__D012807 a republic in western Africa   
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D012807 2001
% 222.76/222.93  |- mesh__recordMaintainer mesh__D012807 TGC
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D012807 2005
% 222.76/222.93  |- mesh__recordAuthorizer mesh__D012807 PLS
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D012807 2004
% 222.76/222.93  |- skos__scopeNote mesh__D012807
% 222.76/222.93       A republic in western Africa, south of GUINEA and west of LIBERIA. Its capital is Freetown. Its coast was first visited by the Portuguese in 1462, later by English slave traders. In 1787 English philanthropists sponsored settlements on the coast for runaway and freed slaves. After a clash with the French in 1893 the region was acquired by treaty in 1895, proclaimed a protectorate in 1896, and achieved independence in 1961. The name is from the Spanish sierra %28%mountain chain%29% + leone %28%lion%29%, meaning Lion Mountains, which refers not to the roar of lions %28%they are not found in this part of Africa%29% but to the noise from claps of thunder from storm clouds constantly surrounding the mountains. %28%From Webster%27%s New Geographical Dictionary, 1988, p1114 %26% Room, Brewer%27%s Dictionary of Names, 1992, p504%29%%A%    
% 222.76/222.93  |- skos__prefLabel mesh__D012807 Sierra Leone
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D012807 2006
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D012807 1996
% 222.76/222.93  |- skos__broader mesh__D012807smesh__D000354
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D012807 1998
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D012807 2002
% 222.76/222.93  |- mesh__dateRevised mesh__D012807 1995-02-21
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D012807 1997
% 222.76/222.93  |- rdf__type mesh__D012807sskos__Concept
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D012807 1999
% 222.76/222.93  |- mesh__dateCreated mesh__D012807 1999-01-01
% 222.76/222.93  |- skos__hiddenLabel mesh__D012009 Laryngeal Nerves, Inferior
% 222.76/222.93  |- mesh__onlineNote mesh__D012009 search LARYNGEAL NERVES 1966-74   
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D012009 2003
% 222.76/222.93  |- mesh__dateRevised mesh__D012009 1998-06-11
% 222.76/222.93  |- rdf__type mesh__D012009sskos__Concept
% 222.76/222.93  |- skos__hiddenLabel mesh__D012009 Inferior Laryngeal Nerves
% 222.76/222.93  |- skos__broader mesh__D012009smesh__D007823
% 222.76/222.93  |- skos__hiddenLabel mesh__D012009 Nerve, Inferior Laryngeal
% 222.76/222.93  |- skos__hiddenLabel mesh__D012009 Laryngeal Nerve, Recurrent
% 222.76/222.93  |- skos__hiddenLabel mesh__D012009 Inferior Laryngeal Nerve
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D012009 2004
% 222.76/222.93  |- skos__hiddenLabel mesh__D012009 Recurrent Laryngeal Nerves
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D012009 2000
% 222.76/222.93  |- mesh__dateEstablished mesh__D012009 1991-01-01
% 222.76/222.93  |- mesh__historyNote mesh__D012009
% 222.76/222.93       91%28%75%29%; was see under LARYNGEAL NERVES 1975-90   
% 222.76/222.93  |- skos__hiddenLabel mesh__D012009 Nerves, Inferior Laryngeal
% 222.76/222.93  |- skos__prefLabel mesh__D012009 Recurrent Laryngeal Nerve
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D012009 2005
% 222.76/222.93  |- skos__hiddenLabel mesh__D012009 Nerves, Recurrent Laryngeal
% 222.76/222.93  |- skos__annotation mesh__D012009
% 222.76/222.93       dis: coord IM with CRANIAL NERVE DISEASES %28%IM%29%; neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%; paralysis = VOCAL CORD PARALYSIS%A%  
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D012009 2001
% 222.76/222.93  |- skos__hiddenLabel mesh__D012009 Laryngeal Nerves, Recurrent
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D012009 2006
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D012009 1999
% 222.76/222.93  |- mesh__dateCreated mesh__D012009 1999-01-01
% 222.76/222.93  |- mesh__recordAuthorizer mesh__D012009 SJN
% 222.76/222.93  |- mesh__recordMaintainer mesh__D012009 MSR
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D012009 2002
% 222.76/222.93  |- mesh__publicMeSHNote mesh__D012009
% 222.76/222.93       91; was see under LARYNGEAL NERVES 1975-90   
% 222.76/222.93  |- skos__scopeNote mesh__D012009
% 222.76/222.93       Branches of the vagus %28%tenth cranial%29% nerve. The recurrent laryngeal nerves originate more caudally than the superior laryngeal nerves and follow different paths on the right and left sides. They carry efferents to all muscles of the larynx except the cricothyroid and carry sensory and autonomic fibers to the laryngeal, pharyngeal, tracheal, and cardiac regions.%A%    
% 222.76/222.93  |- skos__hiddenLabel mesh__D012009 Nerve, Recurrent Laryngeal
% 222.76/222.93  |- mesh__recordOriginator mesh__D012009 NLM
% 222.76/222.93  |- mesh__recordOriginator mesh__D009060 NLM
% 222.76/222.93  |- skos__altLabel mesh__D009060 Floor of Mouth
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D009060 2006
% 222.76/222.93  |- mesh__dateCreated mesh__D009060 1999-01-01
% 222.76/222.93  |- skos__hiddenLabel mesh__D009060 Mouth Floors
% 222.76/222.93  |- skos__hiddenLabel mesh__D009060 Region, Sublingual
% 222.76/222.93  |- skos__altLabel mesh__D009060 Sublingual Region
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D009060 2004
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D009060 2005
% 222.76/222.93  |- skos__hiddenLabel mesh__D009060 Floor, Mouth
% 222.76/222.93  |- skos__broader mesh__D009060smesh__D009055
% 222.76/222.93  |- skos__prefLabel mesh__D009060 Mouth Floor
% 222.76/222.93  |- mesh__publicMeSHNote mesh__D009060 74   
% 222.76/222.93  |- skos__hiddenLabel mesh__D009060 Regions, Sublingual
% 222.76/222.93  |- rdf__type mesh__D009060sskos__Concept
% 222.76/222.93  |- skos__hiddenLabel mesh__D009060 Floors, Mouth
% 222.76/222.93  |- mesh__historyNote mesh__D009060
% 222.76/222.93       74; was SUBLINGUAL REGION 1972-73 %28%Prov%29%   
% 222.76/222.93  |- mesh__recordMaintainer mesh__D009060 lkt
% 222.76/222.93  |- mesh__dateRevised mesh__D009060 2003-07-09
% 222.76/222.93  |- mesh__onlineNote mesh__D009060
% 222.76/222.93       use MOUTH FLOOR to search SUBLINGUAL REGION 1972-73 %28%as Prov%29%%A%  
% 222.76/222.93  |- skos__annotation mesh__D009060 NIM when merely locational   
% 222.76/222.93  |- skos__hiddenLabel mesh__D009060 Sublingual Regions
% 222.76/222.93  |- mesh__recordAuthorizer mesh__D009060 sjn
% 222.76/222.93  |- skos__prefLabel mesh__D008766 Methylmannosides
% 222.76/222.93  |- mesh__dateCreated mesh__D008766 1974-11-11
% 222.76/222.93  |- skos__historyNote mesh__D008766 Mannose %28%1974%29%
% 222.76/222.93  |- skos__scopeNote mesh__D008766
% 222.76/222.93       Mannosides formed by the reaction of the hydroxyl group on the anomeric carbon atom of mannose with methyl alcohol. They include both alpha- and beta-methylmannosides.%A%    
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D008766 2006
% 222.76/222.93  |- skos__altLabel mesh__D008766 Methylmannopyranosides
% 222.76/222.93  |- skos__broader mesh__D008766smesh__D008759
% 222.76/222.93  |- mesh__publicMeSHNote mesh__D008766
% 222.76/222.93       91; was see under METHYLGLYCOSIDES 1975-90   
% 222.76/222.93  |- mesh__recordOriginator mesh__D008766 NLM
% 222.76/222.93  |- mesh__recordAuthorizer mesh__D008766 sjn
% 222.76/222.93  |- skos__historyNote mesh__D008766 Methylglycosides %28%1974%29%
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D008766 2005
% 222.76/222.93  |- mesh__dateEstablished mesh__D008766 1991-01-01
% 222.76/222.93  |- skos__broader mesh__D008766smesh__D008362
% 222.76/222.93  |- mesh__historyNote mesh__D008766
% 222.76/222.93       91%28%75%29%; was see under METHYLGLYCOSIDES 1975-90   
% 222.76/222.93  |- mesh__recordMaintainer mesh__D008766 ssb
% 222.76/222.93  |- mesh__dateRevised mesh__D008766 2004-07-07
% 222.76/222.93  |- rdf__type mesh__D008766sskos__Concept
% 222.76/222.93  |- skos__annotation mesh__D000783
% 222.76/222.93       IM; coord with specific vessel %28%IM%29% or precoord vasc dis if available %28%IM%29%; also available are AORTIC ANEURYSM; INTRACRANIAL ANEURYSM; CORONARY ANEURYSM; HEART ANEURYSM; ILIAC ANEURYSM; rupture = ANEURYSM, RUPTURED %28%see note there%29%%A%  
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D000783 2003
% 222.76/222.93  |- skos__broader mesh__D000783smesh__D014652
% 222.76/222.93  |- mesh__dateCreated mesh__D000783 1999-01-01
% 222.76/222.93  |- mesh__recordMaintainer mesh__D000783 mdb
% 222.76/222.93  |- skos__prefLabel mesh__D000783 Aneurysm
% 222.76/222.93  |- mesh__recordOriginator mesh__D000783 NLM
% 222.76/222.93  |- mesh__recordAuthorizer mesh__D000783 sjn
% 222.76/222.93  |- mesh__dateRevised mesh__D000783 2001-07-25
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D000783 2006
% 222.76/222.93  |- rdf__type mesh__D000783sskos__Concept
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D000783 2002
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D000783 2005
% 222.76/222.93  |- skos__hiddenLabel mesh__D000783 Aneurysms
% 222.76/222.93  |- skos__scopeNote mesh__D000783
% 222.76/222.93       A sac formed by the dilatation of the wall of an artery, a vein, or the heart.%A%    
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D000783 2004
% 222.76/222.93  |- skos__broader mesh__D005954Q000172smesh__D005954
% 222.76/222.93  |- mesh__preferredCombination mesh__D005954Q000172smesh__D005955
% 222.76/222.93  |- rdf__type mesh__D005954Q000172smesh__CompoundConcept
% 222.76/222.93  |- mesh__onlineNote mesh__D013900
% 222.76/222.93       use THORACIC NERVES to search PECTORAL NERVES 1966-78   
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D013900 2005
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D013900 2003
% 222.76/222.93  |- mesh__recordAuthorizer mesh__D013900 sjn
% 222.76/222.93  |- mesh__dateCreated mesh__D013900 1999-01-01
% 222.76/222.93  |- skos__hiddenLabel mesh__D013900 Nerves, Pectoral
% 222.76/222.93  |- skos__hiddenLabel mesh__D013900 Thoracic Nerve
% 222.76/222.93  |- rdf__type mesh__D013900sskos__Concept
% 222.76/222.93  |- mesh__dateRevised mesh__D013900 1999-11-03
% 222.76/222.93  |- skos__hiddenLabel mesh__D013900 Pectoral Nerve
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D013900 2006
% 222.76/222.93  |- skos__hiddenLabel mesh__D013900 Nerve, Thoracic
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D013900 2000
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D013900 2004
% 222.76/222.93  |- skos__prefLabel mesh__D013900 Thoracic Nerves
% 222.76/222.93  |- skos__scopeNote mesh__D013900
% 222.76/222.93       The twelve spinal nerves on each side of the thorax. They include eleven INTERCOSTAL NERVES and one subcostal nerve. Both sensory and motor, they supply the muscles and skin of the thoracic and abdominal walls.%A%    
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D013900 2001
% 222.76/222.93  |- mesh__recordOriginator mesh__D013900 NLM
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D013900 2002
% 222.76/222.93  |- skos__hiddenLabel mesh__D013900 Nerves, Thoracic
% 222.76/222.93  |- mesh__historyNote mesh__D013900
% 222.76/222.93       PECTORAL NERVES was see under THORACIC NERVES 1963-78   
% 222.76/222.93  |- skos__hiddenLabel mesh__D013900 Nerve, Pectoral
% 222.76/222.93  |- mesh__recordMaintainer mesh__D013900 KEV
% 222.76/222.93  |- skos__broader mesh__D013900smesh__D013127
% 222.76/222.93  |- skos__annotation mesh__D013900
% 222.76/222.93       dis: coord IM with PERIPHERAL NERVOUS SYSTEM DISEASES %28%IM%29%; neopl: coord IM with PERIPHERAL NERVOUS SYSTEM NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 222.76/222.93  |- mesh__dateRevised mesh__D013102 2003-07-09
% 222.76/222.93  |- skos__prefLabel mesh__D013102 Spherocytes
% 222.76/222.93  |- skos__scopeNote mesh__D013102
% 222.76/222.93       Small, abnormal spherical red blood cells with more than the normal amount of hemoglobin.%A%    
% 222.76/222.93  |- mesh__dateEstablished mesh__D013102 1991-01-01
% 222.76/222.93  |- mesh__dateCreated mesh__D013102 1999-01-01
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D013102 2004
% 222.76/222.93  |- rdf__type mesh__D013102sskos__Concept
% 222.76/222.93  |- mesh__historyNote mesh__D013102
% 222.76/222.93       91%28%75%29%%28%63-67%29%; was see under ERYTHROCYTES, ABNORMAL 1963-90 %28%Prov 1963-67%29%%A%  
% 222.76/222.93  |- mesh__recordMaintainer mesh__D013102 nns
% 222.76/222.93  |- skos__hiddenLabel mesh__D013102 Spherocyte
% 222.76/222.93  |- mesh__onlineNote mesh__D013102
% 222.76/222.93       use ERYTHROCYTES, ABNORMAL to search SPHEROCYTES 1966-74 %28%as Prov 1966-67%29%%A%  
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D013102 2006
% 222.76/222.93  |- mesh__recordAuthorizer mesh__D013102 sjn
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D013102 2005
% 222.76/222.93  |- mesh__publicMeSHNote mesh__D013102
% 222.76/222.93       91; was see under ERYTHROCYTES, ABNORMAL 1968-90   
% 222.76/222.93  |- mesh__recordOriginator mesh__D013102 NLM
% 222.76/222.93  |- skos__broader mesh__D013102smesh__D004913
% 222.76/222.93  |- mesh__publicMeSHNote mesh__D018396
% 222.76/222.93       95; was see ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE 1990-94; EPISIALIN was indexed under MEMBRANE GLYCOPROTEINS 1988-96, MUCINS 1981-96, MEMBRANE PROTEINS 1982-87, %26% GLYCOPROTEINS 1981-82%A%  
% 222.76/222.93  |- skos__historyNote mesh__D018396 Antigens, Neoplasm %28%1986-1988%29%
% 222.76/222.93  |- skos__altLabel mesh__D018396 Antigen CA-15-3
% 222.76/222.93  |- skos__hiddenLabel mesh__D018396 Antigen, CA 15.3
% 222.76/222.93  |- skos__hiddenLabel mesh__D018396 Antigen, Epithelial Membrane
% 222.76/222.93  |- skos__hiddenLabel mesh__D018396 Antigen, CA 15-3
% 222.76/222.93  |- mesh__dateEstablished mesh__D018396 1995-01-01
% 222.76/222.93  |- skos__scopeNote mesh__D018396
% 222.76/222.93       Carbohydrate antigen elevated in patients with tumors of the breast, ovary, lung, and prostate as well as other disorders. The mucin is expressed normally by most glandular epithelia but shows particularly increased expression in the breast at lactation and in malignancy. It is thus an established serum marker for breast cancer.%A%    
% 222.76/222.93  |- skos__altLabel mesh__D018396 Epithelial Membrane Antigen
% 222.76/222.93  |- skos__hiddenLabel mesh__D018396 CA-15-3, Antigen
% 222.76/222.93  |- skos__broader mesh__D018396smesh__D009077
% 222.76/222.93  |- mesh__onlineNote mesh__D018396
% 222.76/222.93       use ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE to search CA-15-3 ANTIGEN 1990-94; use CA-15-3 ANTIGEN %28%NM%29% to search EPISIALIN 1981-96%A%  
% 222.76/222.93  |- skos__altLabel mesh__D018396 Polymorphic Epithelial Mucin
% 222.76/222.93  |- skos__altLabel mesh__D018396 Epithelial Mucin, Polymorphic
% 222.76/222.93  |- skos__altLabel mesh__D018396 CA 15.3 Antigen
% 222.76/222.93  |- mesh__recordAuthorizer mesh__D018396 sjn
% 222.76/222.93  |- skos__broader mesh__D018396smesh__D008562
% 222.76/222.93  |- skos__hiddenLabel mesh__D018396 Antigen CA 15 3
% 222.76/222.93  |- mesh__dateCreated mesh__D018396 1994-04-16
% 222.76/222.93  |- mesh__dateRevised mesh__D018396 2005-06-30
% 222.76/222.93  |- skos__broader mesh__D018396smesh__D015295
% 222.76/222.93  |- skos__historyNote mesh__D018396
% 222.76/222.93       Antigens, Tumor-Associated, Carbohydrate %28%1989-1994%29%
% 222.76/222.93  |- skos__hiddenLabel mesh__D018396 CA 15 3 Antigen
% 222.76/222.93  |- skos__prefLabel mesh__D018396 CA-15-3 Antigen
% 222.76/222.93  |- mesh__recordMaintainer mesh__D018396 ssb
% 222.76/222.93  |- skos__altLabel mesh__D018396 CA 15-3 Antigen
% 222.76/222.93  |- skos__altLabel mesh__D018396 Muc1 Mucin
% 222.76/222.93  |- mesh__recordOriginator mesh__D018396 AGS
% 222.76/222.93  |- skos__hiddenLabel mesh__D018396 Mucin, Muc1
% 222.76/222.93  |- skos__annotation mesh__D018396
% 222.76/222.93       a carbohydrate antigen assoc with various tumors %26% other dis; CA stands for Cancer-Associated%A%  
% 222.76/222.93  |- skos__altLabel mesh__D018396 Episialin
% 222.76/222.93  |- skos__hiddenLabel mesh__D018396 Membrane Antigen, Epithelial
% 222.76/222.93  |- skos__hiddenLabel mesh__D018396 Antigen, CA-15-3
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D018396 2006
% 222.76/222.93  |- mesh__historyNote mesh__D018396
% 222.76/222.93       95; was see ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE 1990-94; was also EPISIALIN %28%NM%29% 1981-96%A%  
% 222.76/222.93  |- skos__hiddenLabel mesh__D018396 Mucin, Polymorphic Epithelial
% 222.76/222.93  |- rdf__type mesh__D018396sskos__Concept
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D032067 2005
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D032067 2006
% 222.76/222.93  |- skos__annotation mesh__D032067
% 222.76/222.93       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.76/222.93  |- mesh__dateEstablished mesh__D032067 2003-01-01
% 222.76/222.93  |- skos__broader mesh__D032067smesh__D019666
% 222.76/222.93  |- skos__prefLabel mesh__D032067 Oldenlandia
% 222.76/222.93  |- rdf__type mesh__D032067sskos__Concept
% 222.76/222.93  |- mesh__dateCreated mesh__D032067 2002-07-03
% 222.76/222.93  |- mesh__historyNote mesh__D032067 2003   
% 222.76/222.93  |- skos__scopeNote mesh__D032067
% 222.76/222.93       A plant genus of the family RUBIACEAE. Some species are used as an ingredient in Chinese and African traditional medicines. Members contain kalata B1, a macrocyclic peptide.%A%    
% 222.76/222.93  |- mesh__publicMeSHNote mesh__D032067 2003   
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D032067 2003
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D032067 2004
% 222.76/222.93  |- mesh__recordOriginator mesh__D051221 ags
% 222.76/222.93  |- skos__broader mesh__D051221smesh__D002348
% 222.76/222.93  |- skos__altLabel mesh__D051221 Triquetral Bone
% 222.76/222.93  |- skos__prefLabel mesh__D051221 Triquetrum Bone
% 222.76/222.93  |- mesh__dateEstablished mesh__D051221 2006-01-01
% 222.76/222.93  |- mesh__recordAuthorizer mesh__D051221 sjn
% 222.76/222.93  |- skos__historyNote mesh__D051221 Carpal Bones %28%1972-2005%29%
% 222.76/222.93  |- skos__scopeNote mesh__D051221
% 222.76/222.93       A carpal bone which is located between the LUNATE BONE and HAMATE BONE.%A%    
% 222.76/222.93  |- skos__hiddenLabel mesh__D051221 Bones, Triquetrum
% 222.76/222.93  |- mesh__recordMaintainer mesh__D051221 ags
% 222.76/222.93  |- skos__hiddenLabel mesh__D051221 Triquetrum Bones
% 222.76/222.93  |- skos__hiddenLabel mesh__D051221 Triquetral Bones
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D051221 2006
% 222.76/222.93  |- skos__hiddenLabel mesh__D051221 Bones, Triquetral
% 222.76/222.93  |- skos__hiddenLabel mesh__D051221 Bone, Triquetral
% 222.76/222.93  |- mesh__historyNote mesh__D051221 2006   
% 222.76/222.93  |- mesh__publicMeSHNote mesh__D051221 2006   
% 222.76/222.93  |- rdf__type mesh__D051221sskos__Concept
% 222.76/222.93  |- skos__altLabel mesh__D051221 Os Triquetrum
% 222.76/222.93  |- skos__hiddenLabel mesh__D051221 Bone, Triquetrum
% 222.76/222.93  |- mesh__dateCreated mesh__D051221 2005-06-30
% 222.76/222.93  |- skos__historyNote mesh__D004376 Hexoses %28%1966-1971%29%
% 222.76/222.93  |- skos__historyNote mesh__D004376 Carbohydrates %28%1969-1971%29%
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D004376 2005
% 222.76/222.93  |- mesh__recordOriginator mesh__D004376 NLM
% 222.76/222.93  |- mesh__dateRevised mesh__D004376 2004-07-07
% 222.76/222.93  |- mesh__recordMaintainer mesh__D004376 ssb
% 222.76/222.93  |- mesh__publicMeSHNote mesh__D004376
% 222.76/222.93       98; see DULCITOL 1991-97, see SUGAR ALCOHOLS 1972-90; for GALACTITOL see DULCITOL 1978-97%A%  
% 222.76/222.93  |- mesh__dateEstablished mesh__D004376 1991-01-01
% 222.76/222.93  |- rdf__type mesh__D004376sskos__Concept
% 222.76/222.93  |- skos__historyNote mesh__D004376 Antineoplastic Agents %28%1966-1971%29%
% 222.76/222.93  |- skos__prefLabel mesh__D004376 Galactitol
% 222.76/222.93  |- mesh__historyNote mesh__D004376 98%28%72%29%   
% 222.76/222.93  |- skos__historyNote mesh__D004376 Galactosemia %28%1966-1971%29%
% 222.76/222.93  |- mesh__dateCreated mesh__D004376 1999-01-01
% 222.76/222.93  |- mesh__recordAuthorizer mesh__D004376 sjn
% 222.76/222.93  |- skos__scopeNote mesh__D004376
% 222.76/222.93       A naturally occurring product of plants obtained following reduction of GALACTOSE. It appears as a white crystalline powder with a slight sweet taste. It may form in excess in the lens of the eye in GALACTOSEMIAS, a deficiency of GALACTOKINASE.%A%    
% 222.76/222.93  |- skos__historyNote mesh__D004376 Galactose %28%1966-1971%29%
% 222.76/222.93  |- skos__historyNote mesh__D004376 Alcohols %28%1966-1971%29%
% 222.76/222.93  |- skos__broader mesh__D004376smesh__D013402
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D004376 2006
% 222.76/222.93  |- skos__historyNote mesh__D012808 Proteins %28%1966-1976%29%
% 222.76/222.93  |- skos__hiddenLabel mesh__D012808 Initiation Factor, Sigma
% 222.76/222.93  |- skos__prefLabel mesh__D012808 Sigma Factor
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D012808 2006
% 222.76/222.93  |- skos__broader mesh__D012808smesh__D014157
% 222.76/222.93  |- skos__hiddenLabel mesh__D012808 Sigma Factor, Minor
% 222.76/222.93  |- mesh__dateEstablished mesh__D012808 1991-01-01
% 222.76/222.93  |- mesh__recordAuthorizer mesh__D012808 sjn
% 222.76/222.93  |- skos__historyNote mesh__D012808 Bacterial Proteins %28%1973-1976%29%
% 222.76/222.93  |- rdf__type mesh__D012808sskos__Concept
% 222.76/222.93  |- mesh__recordOriginator mesh__D012808 RLS
% 222.76/222.93  |- mesh__recordMaintainer mesh__D012808 SYSTEM
% 222.76/222.93  |- skos__altLabel mesh__D012808 Sigma Initiation Factor
% 222.76/222.93  |- skos__scopeNote mesh__D012808
% 222.76/222.93       A protein which is a subunit of RNA polymerase. It effects initiation of specific RNA chains from DNA.%A%    
% 222.76/222.93  |- skos__altLabel mesh__D012808 Sigma Subunit
% 222.76/222.93  |- skos__historyNote mesh__D012808 Transcription, Genetic %28%1973-1976%29%
% 222.76/222.93  |- skos__hiddenLabel mesh__D012808 Subunit, Sigma
% 222.76/222.93  |- skos__annotation mesh__D012808
% 222.76/222.93       a transcription factor; /biosyn /physiol permitted   
% 222.76/222.93  |- skos__altLabel mesh__D012808 Sigma Element
% 222.76/222.93  |- mesh__dateRevised mesh__D012808 2005-06-30
% 222.76/222.93  |- mesh__historyNote mesh__D012808
% 222.76/222.93       91%28%77%29%; was see under TRANSCRIPTION FACTORS 1977-90   
% 222.76/222.93  |- skos__hiddenLabel mesh__D012808 Factor, Sigma Initiation
% 222.76/222.93  |- skos__hiddenLabel mesh__D012808 Factor, Sigma
% 222.76/222.93  |- mesh__dateCreated mesh__D012808 1976-04-19
% 222.76/222.93  |- mesh__publicMeSHNote mesh__D012808
% 222.76/222.93       91; was see under TRANSCRIPTION FACTORS 1977-90   
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D009061 2006
% 222.76/222.93  |- mesh__dateCreated mesh__D009061 1999-01-01
% 222.76/222.93  |- mesh__recordAuthorizer mesh__D009061 sjn
% 222.76/222.93  |- skos__hiddenLabel mesh__D009061 Mucosa, Oral
% 222.76/222.93  |- mesh__recordOriginator mesh__D009061 NLM
% 222.76/222.93  |- skos__altLabel mesh__D009061 Oral Mucosa
% 222.76/222.93  |- mesh__historyNote mesh__D009061 65   
% 222.76/222.93  |- skos__annotation mesh__D009061
% 222.76/222.93       /surg: consider also VESTIBULOPLASTY; mucositis: coordinate NIM with STOMATITIS %28%IM%29%%A%  
% 222.76/222.93  |- rdf__type mesh__D009061sskos__Concept
% 222.76/222.93  |- skos__prefLabel mesh__D009061 Mouth Mucosa
% 222.76/222.93  |- skos__scopeNote mesh__D009061
% 222.76/222.93       Lining of the ORAL CAVITY, including mucosa on the GUMS; the PALATE; the LIP; the CHEEK; floor of the mouth; and other structures. The mucosa is generally a nonkeratinized stratified squamous EPITHELIUM covering muscle, bone, or glands but can show varying degree of keratinization at specific locations.%A%    
% 222.76/222.93  |- skos__broader mesh__D009061smesh__D009055
% 222.76/222.93  |- skos__broader mesh__D009061smesh__D009092
% 222.76/222.93  |- skos__hiddenLabel mesh__D009061 Mucosa, Mouth
% 222.76/222.93  |- mesh__dateEstablished mesh__D009061 1965-01-01
% 222.76/222.93  |- mesh__publicMeSHNote mesh__D009061 65   
% 222.76/222.93  |- mesh__dateRevised mesh__D009061 2005-06-30
% 222.76/222.93  |- mesh__recordMaintainer mesh__D009061 lkt
% 222.76/222.93  |- skos__broader mesh__D002875Q000002smesh__D002875
% 222.76/222.93  |- mesh__preferredCombination mesh__D002875Q000002smesh__D002869
% 222.76/222.93  |- rdf__type mesh__D002875Q000002smesh__CompoundConcept
% 222.76/222.93  |- skos__broader mesh__D006617Q000151smesh__D006617
% 222.76/222.93  |- mesh__preferredCombination mesh__D006617Q000151smesh__D006618
% 222.76/222.93  |- rdf__type mesh__D006617Q000151smesh__CompoundConcept
% 222.76/222.93  |- skos__hiddenLabel mesh__D008767 Compounds, Methyl Mercury
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D008767 2006
% 222.76/222.93  |- mesh__recordMaintainer mesh__D008767 JRT
% 222.76/222.93  |- skos__historyNote mesh__D008767 Mercury %28%1966-1971%29%
% 222.76/222.93  |- mesh__dateRevised mesh__D008767 1995-06-08
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D008767 2004
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D008767 2005
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D008767 2001
% 222.76/222.93  |- mesh__publicMeSHNote mesh__D008767
% 222.76/222.93       80; was METHYL MERCURY COMPOUNDS 1974-79   
% 222.76/222.93  |- skos__historyNote mesh__D008767 Mercury Poisoning %28%1966-1971%29%
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D008767 2003
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D008767 1999
% 222.76/222.93  |- skos__scopeNote mesh__D008767
% 222.76/222.93       Organic compounds in which mercury is attached to a methyl group.%A%    
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D008767 2000
% 222.76/222.93  |- mesh__onlineNote mesh__D008767
% 222.76/222.93       use METHYLMERCURY COMPOUNDS to search METHYL MERCURY COMPOUNDS 1972-79 %28%as Prov 1972-73%29%%A%  
% 222.76/222.93  |- mesh__dateEstablished mesh__D008767 1974-01-01
% 222.76/222.93  |- mesh__dateCreated mesh__D008767 1999-01-01
% 222.76/222.93  |- skos__historyNote mesh__D008767 Antifungal Agents %28%1966-1971%29%
% 222.76/222.93  |- rdf__type mesh__D008767sskos__Concept
% 222.76/222.93  |- skos__hiddenLabel mesh__D008767 Compounds, Methylmercury
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D008767 1997
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D008767 1998
% 222.76/222.93  |- skos__broader mesh__D008767smesh__D000479
% 222.76/222.93  |- mesh__recordAuthorizer mesh__D008767 PLS
% 222.76/222.93  |- skos__prefLabel mesh__D008767 Methylmercury Compounds
% 222.76/222.93  |- mesh__historyNote mesh__D008767
% 222.76/222.93       80; was METHYL MERCURY COMPOUNDS 1972-79 %28%Prov 1972-73%29%   
% 222.76/222.93  |- skos__historyNote mesh__D008767
% 222.76/222.93       Organometallic Compounds %28%1968-1971%29%
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D008767 2002
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D008767 1996
% 222.76/222.93  |- skos__hiddenLabel mesh__D008767 Mercury Compounds, Methyl
% 222.76/222.93  |- skos__annotation mesh__D008767 DF: METHYLMERCURY CPDS   
% 222.76/222.93  |- mesh__recordOriginator mesh__D008767 NLM
% 222.76/222.93  |- skos__altLabel mesh__D008767 Methyl Mercury Compounds
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D000784 1994
% 222.76/222.93  |- mesh__recordMaintainer mesh__D000784 TGC
% 222.76/222.93  |- mesh__dateEstablished mesh__D000784 1977-01-01
% 222.76/222.93  |- skos__prefLabel mesh__D000784 Aneurysm, Dissecting
% 222.76/222.93  |- mesh__historyNote mesh__D000784 77   
% 222.76/222.93  |- mesh__recordAuthorizer mesh__D000784 PLS
% 222.76/222.93  |- skos__hiddenLabel mesh__D000784 Dissecting Aneurysms
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D000784 1999
% 222.76/222.93  |- mesh__publicMeSHNote mesh__D000784 77   
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D000784 2000
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D000784 1993
% 222.76/222.93  |- skos__annotation mesh__D000784
% 222.76/222.93       most commonly of aortic aneurysms but when aortic coord IM with AORTIC ANEURYSM %28%IM%29%; for other arteries, coord IM with specific artery or precoord artery/diseases term %28%IM%29%%A%  
% 222.76/222.93  |- skos__altLabel mesh__D000784 Dissecting Aneurysm
% 222.76/222.93  |- rdf__type mesh__D000784sskos__Concept
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D000784 2006
% 222.76/222.93  |- skos__historyNote mesh__D000784 Aneurysm %28%1966-1976%29%
% 222.76/222.93  |- skos__historyNote mesh__D000784 Aortic Aneurysm %28%1966-1976%29%
% 222.76/222.93  |- mesh__dateCreated mesh__D000784 1976-04-27
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D000784 1998
% 222.76/222.93  |- skos__hiddenLabel mesh__D000784 Aneurysms, Dissecting
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D000784 1992
% 222.76/222.93  |- skos__scopeNote mesh__D000784
% 222.76/222.93       Splitting or dissection of an arterial wall by blood entering through an intimal tear or by interstitial hemorrhage. It is most common in the aorta.%A%    
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D000784 2005
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D000784 1997
% 222.76/222.93  |- mesh__dateRevised mesh__D000784 1991-06-13
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D000784 2004
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D000784 2002
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D000784 1996
% 222.76/222.93  |- mesh__recordOriginator mesh__D000784 VDK
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D000784 1995
% 222.76/222.93  |- skos__broader mesh__D000784smesh__D000783
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D000784 2003
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D000784 2001
% 222.76/222.93  |- mesh__dateEstablished mesh__D027921 2002-01-01
% 222.76/222.93  |- skos__broader mesh__D027921smesh__D004250
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D027921 2006
% 222.76/222.93  |- skos__prefLabel mesh__D027921 DNA Topoisomerases, Type II, Archaeal
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D027921 2005
% 222.76/222.93  |- skos__historyNote mesh__D027921
% 222.76/222.93       Type I DNA Topoisomerase %28%1992-2001%29%
% 222.76/222.93  |- skos__altLabel mesh__D027921 Topoisomerases II, Archaeal
% 222.76/222.93  |- rdf__type mesh__D027921sskos__Concept
% 222.76/222.93  |- skos__hiddenLabel mesh__D027921 Archaeal Topoisomerases II
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D027921 2004
% 222.76/222.93  |- skos__scopeNote mesh__D027921
% 222.76/222.93       Archaeal enzymes of the DNA TOPOISOMERASES, TYPE II class that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex.%A%    
% 222.76/222.93  |- skos__historyNote mesh__D027921
% 222.76/222.93       DNA Topoisomerase %28%ATP-Hydrolysing%29% %28%1984-1989%29%
% 222.76/222.93  |- mesh__dateCreated mesh__D027921 2001-07-25
% 222.76/222.93  |- mesh__historyNote mesh__D027921 2002   
% 222.76/222.93  |- mesh__publicMeSHNote mesh__D027921 2002   
% 222.76/222.93  |- mesh__dateRevised mesh__D027921 2003-07-09
% 222.76/222.93  |- skos__hiddenLabel mesh__D013901 Thoracic Outlet Syndromes
% 222.76/222.93  |- mesh__recordOriginator mesh__D013901 NLM
% 222.76/222.93  |- skos__altLabel mesh__D013901 Thoracic Outlet Syndrome, Neurogenic
% 222.76/222.93  |- skos__hiddenLabel mesh__D013901 Syndromes, Costoclavicular
% 222.76/222.93  |- skos__altLabel mesh__D013901 Nerve Compression Syndrome, Thoracic Outlet
% 222.76/222.93  |- mesh__activeMeSHYear mesh__D013901 2002
% 222.76/222.94  |- skos__hiddenLabel mesh__D013901 Syndrome, Scalenus Anticus
% 222.76/222.94  |- skos__altLabel mesh__D013901 Superior Thoracic Aperture Syndrome
% 222.76/222.94  |- skos__hiddenLabel mesh__D013901 Syndromes, Thoracic Outlet
% 222.76/222.94  |- skos__prefLabel mesh__D013901 Thoracic Outlet Syndrome
% 222.76/222.94  |- mesh__dateRevised mesh__D013901 2000-01-03
% 222.76/222.94  |- skos__scopeNote mesh__D013901
% 222.76/222.94       A neurovascular syndrome associated with compression of the BRACHIAL PLEXUS; SUBCLAVIAN ARTERY; and SUBCLAVIAN VEIN at the superior thoracic outlet. This may result from a variety of anomalies such as a cervical rib %28%CERVICAL RIB SYNDROME%29%, anomalous fascial bands, and abnormalities of the origin or insertion of the anterior or medial scalene muscles. Clinical features may include pain in the shoulder and neck region which radiates into the arm, PARESIS or PARALYSIS of brachial plexus innervated muscles, PARESTHESIA, loss of sensation, reduction of arterial pulses in the affected extremity, ISCHEMIA, and EDEMA. %28%Adams et al., Principles of Neurology, 6th ed, pp214-5%29%.%A%    
% 222.76/222.94  |- mesh__historyNote mesh__D013901 1983%28%1963%29%   
% 222.76/222.94  |- skos__broader mesh__D013901smesh__D014652
% 222.76/222.94  |- skos__altLabel mesh__D013901 Thoracic Outlet Neurologic Syndrome
% 222.76/222.94  |- skos__broader mesh__D013901smesh__D009408
% 222.76/222.94  |- mesh__publicMeSHNote mesh__D013901
% 222.76/222.94       1983; see SCALENUS ANTICUS SYNDROME 1963-1982   
% 222.76/222.94  |- skos__hiddenLabel mesh__D013901 Outlet Syndrome, Thoracic
% 222.76/222.94  |- skos__altLabel mesh__D013901 Neurovascular Syndrome, Thoracic Outlet
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013901 2000
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013901 2005
% 222.76/222.94  |- skos__hiddenLabel mesh__D013901 Syndrome, Thoracic Outlet
% 222.76/222.94  |- skos__hiddenLabel mesh__D013901 Costoclavicular Syndromes
% 222.76/222.94  |- mesh__dateCreated mesh__D013901 1999-01-01
% 222.76/222.94  |- skos__altLabel mesh__D013901 Thoracic Outlet Neurovascular Syndrome
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013901 2000A
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013901 2003
% 222.76/222.94  |- skos__hiddenLabel mesh__D013901 Outlet Syndromes, Thoracic
% 222.76/222.94  |- mesh__recordAuthorizer mesh__D013901 ags
% 222.76/222.94  |- skos__hiddenLabel mesh__D013901 Syndrome, Costoclavicular
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013901 2006
% 222.76/222.94  |- rdf__type mesh__D013901sskos__Concept
% 222.76/222.94  |- mesh__recordMaintainer mesh__D013901 ags
% 222.76/222.94  |- skos__altLabel mesh__D013901 Aperture Syndrome, Thoracic Outlet
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013901 2001
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013901 2004
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D046088 2006
% 222.76/222.94  |- skos__broader mesh__D046088smesh__D034381
% 222.76/222.94  |- skos__prefLabel mesh__D046088 Hearing Loss, Unilateral
% 222.76/222.94  |- mesh__recordAuthorizer mesh__D046088 sjn
% 222.76/222.94  |- skos__historyNote mesh__D046088 Hearing Disorders %28%1967-2004%29%
% 222.76/222.94  |- mesh__dateEstablished mesh__D046088 2005-01-01
% 222.76/222.94  |- mesh__recordMaintainer mesh__D046088 lkt
% 222.76/222.94  |- mesh__dateCreated mesh__D046088 2004-07-07
% 222.76/222.94  |- rdf__type mesh__D046088sskos__Concept
% 222.76/222.94  |- skos__altLabel mesh__D046088 Unilateral Hearing Loss
% 222.76/222.94  |- mesh__publicMeSHNote mesh__D046088 2005   
% 222.76/222.94  |- mesh__historyNote mesh__D046088 2005   
% 222.76/222.94  |- skos__scopeNote mesh__D046088
% 222.76/222.94       Partial or complete hearing loss in one ear.     
% 222.76/222.94  |- mesh__recordOriginator mesh__D046088 lkt
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D046088 2005
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013103 2004
% 222.76/222.94  |- skos__scopeNote mesh__D013103
% 222.76/222.94       A familial congenital hemolytic anemia characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. The erythrocytes have increased osmotic fragility and are abnormally permeable to sodium ions.%A%    
% 222.76/222.94  |- skos__hiddenLabel mesh__D013103 Hereditary Spherocytoses
% 222.76/222.94  |- rdf__type mesh__D013103sskos__Concept
% 222.76/222.94  |- skos__broader mesh__D013103smesh__D000745
% 222.76/222.94  |- skos__annotation mesh__D013103
% 222.76/222.94       a congen hemolytic anemia; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 222.76/222.94  |- mesh__dateRevised mesh__D013103 2001-07-25
% 222.76/222.94  |- skos__related mesh__D013103smesh__D000756
% 222.76/222.94  |- mesh__recordOriginator mesh__D013103 NLM
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013103 2003
% 222.76/222.94  |- skos__hiddenLabel mesh__D013103 Spherocytoses, Hereditary
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013103 2006
% 222.76/222.94  |- mesh__recordMaintainer mesh__D013103 nns
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013103 2005
% 222.76/222.94  |- skos__hiddenLabel mesh__D013103 Hereditary Spherocytosis
% 222.76/222.94  |- skos__prefLabel mesh__D013103 Spherocytosis, Hereditary
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013103 2002
% 222.76/222.94  |- mesh__recordAuthorizer mesh__D013103 sjn
% 222.76/222.94  |- mesh__dateCreated mesh__D013103 1999-01-01
% 222.76/222.94  |- mesh__recordMaintainer mesh__D018397 ags
% 222.76/222.94  |- mesh__publicMeSHNote mesh__D018397 95   
% 222.76/222.94  |- skos__prefLabel mesh__D018397 Equidae
% 222.76/222.94  |- skos__altLabel mesh__D018397 Ass
% 222.76/222.94  |- skos__historyNote mesh__D018397 Horses %28%1966-1994%29%
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D018397 2004
% 222.76/222.94  |- skos__hiddenLabel mesh__D018397 Donkey
% 222.76/222.94  |- mesh__dateEstablished mesh__D018397 1995-01-01
% 222.76/222.94  |- mesh__dateRevised mesh__D018397 2003-07-09
% 222.76/222.94  |- mesh__recordOriginator mesh__D018397 PXP
% 222.76/222.94  |- skos__altLabel mesh__D018397 Equus asinus
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D018397 2005
% 222.76/222.94  |- skos__historyNote mesh__D018397 Perissodactyla %28%1966-1994%29%
% 222.76/222.94  |- mesh__dateCreated mesh__D018397 1994-01-25
% 222.76/222.94  |- mesh__recordAuthorizer mesh__D018397 sjn
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D018397 2006
% 222.76/222.94  |- skos__altLabel mesh__D018397 Asses
% 222.76/222.94  |- mesh__historyNote mesh__D018397 95   
% 222.76/222.94  |- skos__scopeNote mesh__D018397
% 222.76/222.94       A family of hoofed MAMMALS consisting of HORSES, donkeys, and zebras. Members of this family are strict herbivores and can be classified as either browsers or grazers depending on how they feed.%A%    
% 222.76/222.94  |- rdf__type mesh__D018397sskos__Concept
% 222.76/222.94  |- skos__hiddenLabel mesh__D018397 Mule
% 222.76/222.94  |- skos__hiddenLabel mesh__D018397 Zebra
% 222.76/222.94  |- skos__broader mesh__D018397smesh__D010527
% 222.76/222.94  |- skos__altLabel mesh__D032068 Pausinystalia yohimbe
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D032068 2006
% 222.76/222.94  |- skos__annotation mesh__D032068
% 222.76/222.94       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.76/222.94  |- skos__broader mesh__D032068smesh__D019666
% 222.76/222.94  |- skos__prefLabel mesh__D032068 Pausinystalia
% 222.76/222.94  |- rdf__type mesh__D032068sskos__Concept
% 222.76/222.94  |- skos__altLabel mesh__D032068 Corynanthe johimbe
% 222.76/222.94  |- skos__scopeNote mesh__D032068
% 222.76/222.94       A plant genus of the family RUBIACEAE. Members produce YOHIMBINE.%A%    
% 222.76/222.94  |- mesh__publicMeSHNote mesh__D032068 2003   
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D032068 2003
% 222.76/222.94  |- mesh__dateEstablished mesh__D032068 2003-01-01
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D032068 2004
% 222.76/222.94  |- skos__altLabel mesh__D032068 Yohimbe
% 222.76/222.94  |- mesh__historyNote mesh__D032068 2003   
% 222.76/222.94  |- mesh__dateCreated mesh__D032068 2002-07-03
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D032068 2005
% 222.76/222.94  |- skos__altLabel mesh__D051222 Os Trapezium
% 222.76/222.94  |- skos__scopeNote mesh__D051222
% 222.76/222.94       A carpal bone adjacent to the TRAPEZOID BONE.     
% 222.76/222.94  |- skos__hiddenLabel mesh__D051222 Bones, Trapezium
% 222.76/222.94  |- mesh__historyNote mesh__D051222 2006   
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D051222 2006
% 222.76/222.94  |- skos__hiddenLabel mesh__D051222 Bone, Trapezium
% 222.76/222.94  |- mesh__recordMaintainer mesh__D051222 ags
% 222.76/222.94  |- mesh__recordOriginator mesh__D051222 ags
% 222.76/222.94  |- mesh__dateCreated mesh__D051222 2005-06-30
% 222.76/222.94  |- mesh__publicMeSHNote mesh__D051222 2006   
% 222.76/222.94  |- rdf__type mesh__D051222sskos__Concept
% 222.76/222.94  |- mesh__dateEstablished mesh__D051222 2006-01-01
% 222.76/222.94  |- skos__broader mesh__D051222smesh__D002348
% 222.76/222.94  |- skos__hiddenLabel mesh__D051222 Trapezium Bones
% 222.76/222.94  |- mesh__recordAuthorizer mesh__D051222 sjn
% 222.76/222.94  |- skos__historyNote mesh__D051222 Carpal Bones %28%1971-2005%29%
% 222.76/222.94  |- skos__prefLabel mesh__D051222 Trapezium Bone
% 222.76/222.94  |- skos__broader mesh__D004377smesh__D011178
% 222.76/222.94  |- mesh__dateCreated mesh__D004377 1999-01-01
% 222.76/222.94  |- mesh__dateRevised mesh__D004377 2003-07-09
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D004377 2004
% 222.76/222.94  |- skos__prefLabel mesh__D004377 Dumping Syndrome
% 222.76/222.94  |- rdf__type mesh__D004377sskos__Concept
% 222.76/222.94  |- skos__hiddenLabel mesh__D004377 Syndrome, Dumping
% 222.76/222.94  |- mesh__recordOriginator mesh__D004377 NLM
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D004377 2005
% 222.76/222.94  |- mesh__recordMaintainer mesh__D004377 lkt
% 222.76/222.94  |- skos__hiddenLabel mesh__D004377 Dumping Syndromes
% 222.76/222.94  |- skos__hiddenLabel mesh__D004377 Syndromes, Dumping
% 222.76/222.94  |- mesh__recordAuthorizer mesh__D004377 sjn
% 222.76/222.94  |- skos__scopeNote mesh__D004377
% 222.76/222.94       Gastrointestinal symptoms resulting from an absent or nonfunctioning pylorus.%A%    
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D004377 2006
% 222.76/222.94  |- skos__related mesh__D012809smesh__D012812
% 222.76/222.94  |- skos__annotation mesh__D012809
% 222.76/222.94       sigmoiditis = SIGMOID DISEASES %28%IM%29% + COLITIS %28%NIM%29% but note PROCTOSIGMOIDITIS see PROCTOCOLITIS %26% RECTOSIGMOIDITIS see PROCTOCOLITIS; diverticulosis %26% diverticulitis: see note on SIGMOID DISEASES%A%  
% 222.76/222.94  |- mesh__dateCreated mesh__D012809 1999-01-01
% 222.76/222.94  |- rdf__type mesh__D012809sskos__Concept
% 222.76/222.94  |- skos__altLabel mesh__D012809 Sigmoid
% 222.76/222.94  |- mesh__recordMaintainer mesh__D012809 lkt
% 222.76/222.94  |- skos__scopeNote mesh__D012809
% 222.76/222.94       A segment of the COLON between the RECTUM and the descending colon.%A%    
% 222.76/222.94  |- mesh__publicMeSHNote mesh__D012809 2004; see SIGMOID 1966-2003   
% 222.76/222.94  |- skos__broader mesh__D012809smesh__D003106
% 222.76/222.94  |- mesh__recordAuthorizer mesh__D012809 sjn
% 222.76/222.94  |- skos__altLabel mesh__D012809 Sigmoid Colon
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D012809 2005
% 222.76/222.94  |- mesh__dateRevised mesh__D012809 2003-07-09
% 222.76/222.94  |- mesh__recordOriginator mesh__D012809 NLM
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D012809 2004
% 222.76/222.94  |- skos__prefLabel mesh__D012809 Colon, Sigmoid
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D012809 2006
% 222.76/222.94  |- mesh__historyNote mesh__D012809 2004 %28%1966%29%   
% 222.76/222.94  |- mesh__dateRevised mesh__D009062 1999-11-05
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D009062 2003
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D009062 2002
% 222.76/222.94  |- skos__hiddenLabel mesh__D009062 Cancer, Oral
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D009062 2004
% 222.76/222.94  |- mesh__recordMaintainer mesh__D009062 nns
% 222.76/222.94  |- skos__hiddenLabel mesh__D009062 Mouth Neoplasm
% 222.76/222.94  |- skos__altLabel mesh__D009062 Oral Cancer
% 222.76/222.94  |- skos__altLabel mesh__D009062 Neoplasms, Mouth
% 222.76/222.94  |- skos__altLabel mesh__D009062 Cancer of the Mouth
% 222.76/222.94  |- rdf__type mesh__D009062sskos__Concept
% 222.76/222.94  |- skos__hiddenLabel mesh__D009062 Cancer, Mouth
% 222.76/222.94  |- skos__hiddenLabel mesh__D009062 Oral Cancers
% 222.76/222.94  |- skos__hiddenLabel mesh__D009062 Mouth Cancers
% 222.76/222.94  |- mesh__recordAuthorizer mesh__D009062 sjn
% 222.76/222.94  |- skos__hiddenLabel mesh__D009062 Oral Neoplasm
% 222.76/222.94  |- mesh__recordOriginator mesh__D009062 NLM
% 222.76/222.94  |- mesh__dateCreated mesh__D009062 1999-01-01
% 222.76/222.94  |- skos__altLabel mesh__D009062 Neoplasms, Oral
% 222.76/222.94  |- skos__altLabel mesh__D009062 Oral Neoplasms
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D009062 2000
% 222.76/222.94  |- skos__broader mesh__D009062smesh__D009059
% 222.76/222.94  |- skos__broader mesh__D009062smesh__D006258
% 222.76/222.94  |- skos__hiddenLabel mesh__D009062 Neoplasm, Mouth
% 222.76/222.94  |- skos__hiddenLabel mesh__D009062 Cancers, Oral
% 222.76/222.94  |- skos__prefLabel mesh__D009062 Mouth Neoplasms
% 222.76/222.94  |- skos__scopeNote mesh__D009062 Tumors or cancer of the MOUTH.     
% 222.76/222.94  |- skos__altLabel mesh__D009062 Mouth Cancer
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D009062 2005
% 222.76/222.94  |- skos__annotation mesh__D009062
% 222.76/222.94       coord IM with histol type of neopl %28%IM%29%   
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D009062 2001
% 222.76/222.94  |- skos__hiddenLabel mesh__D009062 Neoplasm, Oral
% 222.76/222.94  |- skos__hiddenLabel mesh__D009062 Cancers, Mouth
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D009062 2006
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D008768 2005
% 222.76/222.94  |- mesh__recordAuthorizer mesh__D008768 sjn
% 222.76/222.94  |- mesh__recordOriginator mesh__D008768 NLM
% 222.76/222.94  |- skos__broader mesh__D008768smesh__D011109
% 222.76/222.94  |- skos__prefLabel mesh__D008768 Methylmethacrylates
% 222.76/222.94  |- skos__scopeNote mesh__D008768
% 222.76/222.94       The methyl esters of methacrylic acid that polymerize easily and are used as tissue cements, dental materials, and absorbent for biological substances.%A%    
% 222.76/222.94  |- skos__historyNote mesh__D008768 Acrylic Resins %28%1966-1971%29%
% 222.76/222.94  |- mesh__publicMeSHNote mesh__D008768
% 222.76/222.94       83; was METHYLMETHACRYLATE 1973-82, was METHYLMETHACRYLATE see under ACRYLIC RESINS 1963-72%A%  
% 222.76/222.94  |- mesh__dateRevised mesh__D008768 2004-07-07
% 222.76/222.94  |- mesh__dateCreated mesh__D008768 1999-01-01
% 222.76/222.94  |- rdf__type mesh__D008768sskos__Concept
% 222.76/222.94  |- mesh__onlineNote mesh__D008768
% 222.76/222.94       to search METHYLMETHACRYLATE use METHYLMETHACRYLATES 1972-82 %28%as Prov 1972%29% %26% ACRYLIC RESINS 1966-71%A%  
% 222.76/222.94  |- mesh__historyNote mesh__D008768
% 222.76/222.94       83; was METHYLMETHACRYLATE 1972-82 %28%Prov 1972%29%, was METHYLMETHACRYLATE see under ACRYLIC RESINS 1963-72%A%  
% 222.76/222.94  |- mesh__dateEstablished mesh__D008768 1973-01-01
% 222.76/222.94  |- mesh__recordMaintainer mesh__D008768 jmp
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D008768 2006
% 222.76/222.94  |- skos__annotation mesh__D008768 D25-26 qualif   
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D000785 2000
% 222.76/222.94  |- skos__altLabel mesh__D000785 Bacterial Aneurysm
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D000785 1999
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D000785 1994
% 222.76/222.94  |- mesh__historyNote mesh__D000785
% 222.76/222.94       87; was ANEURYSM, MYCOTIC 1964-86 %28%Prov 1964-69%29%   
% 222.76/222.94  |- rdf__type mesh__D000785sskos__Concept
% 222.76/222.94  |- skos__annotation mesh__D000785
% 222.76/222.94       coord IM with specific bact or fungal infect %28%IM%29%; note X refs ANEURYSM, BACTERIAL %26% ANEURYSM, MYCOTIC: do not coord with BACTERIAL INFECTIONS or MYCOSES if the specific bacterium or fungus is not specified%A%  
% 222.76/222.94  |- skos__hiddenLabel mesh__D000785 Infected Aneurysms
% 222.76/222.94  |- skos__broader mesh__D000785smesh__D007239
% 222.76/222.94  |- skos__altLabel mesh__D000785 Bacterial Aneurysms
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D000785 1998
% 222.76/222.94  |- skos__hiddenLabel mesh__D000785 Aneurysms, Infected
% 222.76/222.94  |- mesh__onlineNote mesh__D000785
% 222.76/222.94       use ANEURYSM, INFECTED to search ANEURYSM, MYCOTIC 1966-86 %28%as Prov 1966-69%29%%A%  
% 222.76/222.94  |- skos__hiddenLabel mesh__D000785 Aneurysms, Mycotic
% 222.76/222.94  |- mesh__recordOriginator mesh__D000785 NLM
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D000785 1997
% 222.76/222.94  |- skos__altLabel mesh__D000785 Mycotic Aneurysm
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D000785 2006
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D000785 2005
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D000785 1996
% 222.76/222.94  |- mesh__dateEstablished mesh__D000785 1970-01-01
% 222.76/222.94  |- skos__prefLabel mesh__D000785 Aneurysm, Infected
% 222.76/222.94  |- skos__hiddenLabel mesh__D000785 Aneurysms, Bacterial
% 222.76/222.94  |- skos__scopeNote mesh__D000785
% 222.76/222.94       Aneurysm due to growth of microorganisms in the arterial wall, or infection arising within preexisting arteriosclerotic aneurysms.%A%    
% 222.76/222.94  |- mesh__publicMeSHNote mesh__D000785 87; was ANEURYSM, MYCOTIC 1970-86   
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D000785 2002
% 222.76/222.94  |- mesh__dateRevised mesh__D000785 1993-06-02
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D000785 2004
% 222.76/222.94  |- skos__hiddenLabel mesh__D000785 Mycotic Aneurysms
% 222.76/222.94  |- skos__altLabel mesh__D000785 Infected Aneurysm
% 222.76/222.94  |- mesh__recordMaintainer mesh__D000785 PLS
% 222.76/222.94  |- mesh__dateCreated mesh__D000785 1999-01-01
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D000785 2001
% 222.76/222.94  |- skos__broader mesh__D000785smesh__D000783
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D000785 2003
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D000785 1995
% 222.76/222.94  |- mesh__recordAuthorizer mesh__D000785 PLS
% 222.76/222.94  |- skos__broader mesh__D019490smesh__D052180
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D019490 2006
% 222.76/222.94  |- mesh__historyNote mesh__D019490 1997   
% 222.76/222.94  |- rdf__type mesh__D019490sskos__Concept
% 222.76/222.94  |- skos__annotation mesh__D019490
% 222.76/222.94       publication type only; for broadsides as a subject, index under main heading BROADSIDES; Publication Types ADVERTISEMENTS %26% POSTERS are also available%A%  
% 222.76/222.94  |- mesh__recordMaintainer mesh__D019490 jls
% 222.76/222.94  |- mesh__dateCreated mesh__D019490 1996-06-21
% 222.76/222.94  |- mesh__dateRevised mesh__D019490 2005-06-30
% 222.76/222.94  |- skos__prefLabel mesh__D019490 Broadsides %5B%Publication Type%5D%
% 222.76/222.94  |- mesh__dateEstablished mesh__D019490 1997-01-01
% 222.76/222.94  |- skos__altLabel mesh__D019490 Broadsides %28%PT%29%
% 222.76/222.94  |- mesh__recordOriginator mesh__D019490 TGC
% 222.76/222.94  |- skos__scopeNote mesh__D019490
% 222.76/222.94       Works consisting of published pieces of paper or other material, usually printed on one side and intended to be read unfolded and usually intended to be posted, publicly distributed, or sold, e.g., proclamations, handbills, newssheets, etc. %28%From Genre Terms: A Thesaurus for Use in Rare Book and Special Collections Cataloguing, 2d ed%29%%A%    
% 222.76/222.94  |- mesh__recordAuthorizer mesh__D019490 sjn
% 222.76/222.94  |- mesh__recordOriginator mesh__D033161 jrf
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D033161 2005
% 222.76/222.94  |- mesh__dateEstablished mesh__D033161 2003-01-01
% 222.76/222.94  |- mesh__recordMaintainer mesh__D033161 sjn
% 222.76/222.94  |- rdf__type mesh__D033161sskos__Concept
% 222.76/222.94  |- skos__prefLabel mesh__D033161 Government Regulation
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D033161 2004
% 222.76/222.94  |- mesh__dateRevised mesh__D033161 2003-07-25
% 222.76/222.94  |- skos__historyNote mesh__D033161
% 222.76/222.94       specific heading/legislation %26% jurisprudence %28%1974-2002%29%
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D033161 2006
% 222.76/222.94  |- skos__hiddenLabel mesh__D033161 Regulations, Government
% 222.76/222.94  |- skos__hiddenLabel mesh__D033161 Regulation, Government
% 222.76/222.94  |- mesh__recordAuthorizer mesh__D033161 sjn
% 222.76/222.94  |- mesh__publicMeSHNote mesh__D033161
% 222.76/222.94       2003; see SOCIAL CONTROL, FORMAL 1978-2002   
% 222.76/222.94  |- skos__hiddenLabel mesh__D033161 Government Regulations
% 222.76/222.94  |- skos__scopeNote mesh__D033161
% 222.76/222.94       Exercise of governmental authority to control conduct.     
% 222.76/222.94  |- mesh__historyNote mesh__D033161
% 222.76/222.94       2003; use SOCIAL CONTROL, FORMAL 1978-2002   
% 222.76/222.94  |- skos__annotation mesh__D033161
% 222.76/222.94       coord with subject of regulation /legis if pertinent; for government regulation of health facilities, add FACILITY REGULATION AND CONTROL%A%  
% 222.76/222.94  |- skos__broader mesh__D033161smesh__D012926
% 222.76/222.94  |- skos__historyNote mesh__D033161 Social Control, Formal %28%1974-2002%29%
% 222.76/222.94  |- mesh__dateCreated mesh__D033161 2002-07-03
% 222.76/222.94  |- mesh__historyNote mesh__D027922 2002   
% 222.76/222.94  |- mesh__publicMeSHNote mesh__D027922 2002   
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D027922 2002
% 222.76/222.94  |- skos__annotation mesh__D027922
% 222.76/222.94       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D027922 2006
% 222.76/222.94  |- rdf__type mesh__D027922sskos__Concept
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D027922 2005
% 222.76/222.94  |- skos__broader mesh__D027922smesh__D019684
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D027922 2004
% 222.76/222.94  |- mesh__dateCreated mesh__D027922 2001-07-25
% 222.76/222.94  |- skos__prefLabel mesh__D027922 Caprifoliaceae
% 222.76/222.94  |- mesh__dateEstablished mesh__D027922 2002-01-01
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D027922 2003
% 222.76/222.94  |- skos__scopeNote mesh__D027922
% 222.76/222.94       A plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida.%A%    
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D005470 2005
% 222.76/222.94  |- mesh__recordOriginator mesh__D005470 NLM
% 222.76/222.94  |- skos__altLabel mesh__D005470 Fluorimetry
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D005470 2006
% 222.76/222.94  |- skos__hiddenLabel mesh__D005470 Fluorometries
% 222.76/222.94  |- mesh__dateEstablished mesh__D005470 1966-01-01
% 222.76/222.94  |- mesh__dateRevised mesh__D005470 2004-07-07
% 222.76/222.94  |- skos__broader mesh__D005470smesh__D008163
% 222.76/222.94  |- mesh__dateCreated mesh__D005470 1999-01-01
% 222.76/222.94  |- mesh__recordAuthorizer mesh__D005470 sjn
% 222.76/222.94  |- skos__annotation mesh__D005470 NIM   
% 222.76/222.94  |- mesh__recordMaintainer mesh__D005470 ssb
% 222.76/222.94  |- skos__hiddenLabel mesh__D005470 Fluorimetries
% 222.76/222.94  |- skos__prefLabel mesh__D005470 Fluorometry
% 222.76/222.94  |- mesh__publicMeSHNote mesh__D005470 66   
% 222.76/222.94  |- mesh__historyNote mesh__D005470 66%28%64%29%   
% 222.76/222.94  |- rdf__type mesh__D005470sskos__Concept
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013902 1998
% 222.76/222.94  |- skos__scopeNote mesh__D013902
% 222.76/222.94       X-ray visualization of the chest and organs of the thoracic cavity. It is not restricted to visualization of the lungs.%A%    
% 222.76/222.94  |- mesh__historyNote mesh__D013902 98%28%63%29%   
% 222.76/222.94  |- skos__broader mesh__D013902smesh__D011859
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013902 2001
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013902 1999
% 222.76/222.94  |- skos__hiddenLabel mesh__D013902 Thoracic Radiographies
% 222.76/222.94  |- mesh__recordOriginator mesh__D013902 NLM
% 222.76/222.94  |- mesh__recordMaintainer mesh__D013902 PXP
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013902 2002
% 222.76/222.94  |- mesh__dateRevised mesh__D013902 1997-06-20
% 222.76/222.94  |- mesh__publicMeSHNote mesh__D013902
% 222.76/222.94       98; see THORACIC RADIOGRAPHY 1963-97   
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013902 2005
% 222.76/222.94  |- mesh__dateCreated mesh__D013902 1999-01-01
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013902 2003
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013902 2006
% 222.76/222.94  |- skos__altLabel mesh__D013902 Thoracic Radiography
% 222.76/222.94  |- rdf__type mesh__D013902sskos__Concept
% 222.76/222.94  |- skos__annotation mesh__D013902
% 222.76/222.94       GEN only: not a synonym for LUNG /radiogr; only for %22%thoracic%22% when the enclosed organs are not specified or are irrelevant %26% for THORAX /radiogr; do not use as coord with lung, heart, bronchial, etc. diseases when /radiogr with the specific organ or chest dis is given; /drug eff /rad eff permitted; do not use /util except by MeSH definition; MASS CHEST X-RAY also exists; DF: RADIOGR THORACIC%A%  
% 222.76/222.94  |- mesh__recordAuthorizer mesh__D013902 SJN
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013902 2004
% 222.76/222.94  |- skos__hiddenLabel mesh__D013902 Radiographies, Thoracic
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013902 2000
% 222.76/222.94  |- skos__prefLabel mesh__D013902 Radiography, Thoracic
% 222.76/222.94  |- skos__hiddenLabel mesh__D046089 Hearing Loss, Mixed
% 222.76/222.94  |- mesh__dateCreated mesh__D046089 2004-07-07
% 222.76/222.94  |- skos__broader mesh__D046089smesh__D034381
% 222.76/222.94  |- rdf__type mesh__D046089sskos__Concept
% 222.76/222.94  |- skos__prefLabel mesh__D046089
% 222.76/222.94       Hearing Loss, Mixed Conductive-Sensorineural
% 222.76/222.94  |- skos__historyNote mesh__D046089 Hearing Disorders %28%1985-2004%29%
% 222.76/222.94  |- skos__scopeNote mesh__D046089
% 222.76/222.94       Hearing loss due to damage or impairment of both the conductive elements %28%HEARING LOSS, CONDUCTIVE%29% and the sensorineural elements %28%HEARING LOSS, SENSORINEURAL%29% of the ear.%A%    
% 222.76/222.94  |- skos__hiddenLabel mesh__D046089 Loss, Mixed Hearing
% 222.76/222.94  |- mesh__recordAuthorizer mesh__D046089 sjn
% 222.76/222.94  |- mesh__dateEstablished mesh__D046089 2005-01-01
% 222.76/222.94  |- mesh__recordMaintainer mesh__D046089 lkt
% 222.76/222.94  |- mesh__recordOriginator mesh__D046089 lkt
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D046089 2005
% 222.76/222.94  |- mesh__publicMeSHNote mesh__D046089
% 222.76/222.94       2005; see HEARING DISORDERS 2000-2004   
% 222.76/222.94  |- skos__hiddenLabel mesh__D046089
% 222.76/222.94       Hearing Loss, Mixed Conductive Sensorineural
% 222.76/222.94  |- skos__altLabel mesh__D046089 Mixed Hearing Loss
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D046089 2006
% 222.76/222.94  |- mesh__historyNote mesh__D046089 2005; use HEARING DISORDERS 2000-2004   
% 222.76/222.94  |- skos__hiddenLabel mesh__D046089 Losses, Mixed Hearing
% 222.76/222.94  |- mesh__dateEstablished mesh__D013104 1974-01-01
% 222.76/222.94  |- skos__historyNote mesh__D013104 L Forms %28%1966-1971%29%
% 222.76/222.94  |- skos__broader mesh__D013104smesh__D002477
% 222.76/222.94  |- skos__broader mesh__D013104smesh__D001295
% 222.76/222.94  |- mesh__recordAuthorizer mesh__D013104 sjn
% 222.76/222.94  |- mesh__historyNote mesh__D013104 74%28%72%29%   
% 222.76/222.94  |- skos__prefLabel mesh__D013104 Spheroplasts
% 222.76/222.94  |- skos__scopeNote mesh__D013104
% 222.76/222.94       Cells, usually bacteria or yeast, which have partially lost their cell wall, lost their characteristic shape and become round.%A%    
% 222.76/222.94  |- mesh__publicMeSHNote mesh__D013104 74   
% 222.76/222.94  |- mesh__recordMaintainer mesh__D013104 SYSTEM
% 222.76/222.94  |- mesh__recordOriginator mesh__D013104 NLM
% 222.76/222.94  |- mesh__dateCreated mesh__D013104 1999-01-01
% 222.76/222.94  |- rdf__type mesh__D013104sskos__Concept
% 222.76/222.94  |- mesh__dateRevised mesh__D013104 2005-06-30
% 222.76/222.94  |- skos__hiddenLabel mesh__D013104 Spheroplast
% 222.76/222.94  |- skos__annotation mesh__D013104
% 222.76/222.94       in micro-organisms only; coord IM with specific micro-organism %28%IM%29%%A%  
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D013104 2006
% 222.76/222.94  |- mesh__recordAuthorizer mesh__D018398 sjn
% 222.76/222.94  |- skos__hiddenLabel mesh__D018398 Proteins, Homeodomain
% 222.76/222.94  |- skos__altLabel mesh__D018398 Homeoproteins
% 222.76/222.94  |- skos__hiddenLabel mesh__D018398 Proteins, Homeobox
% 222.76/222.94  |- skos__altLabel mesh__D018398 Homeobox Proteins
% 222.76/222.94  |- mesh__dateRevised mesh__D018398 2005-06-30
% 222.76/222.94  |- skos__altLabel mesh__D018398 Homeotic Proteins
% 222.76/222.94  |- mesh__recordOriginator mesh__D018398 PXP
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D018398 2006
% 222.76/222.94  |- mesh__historyNote mesh__D018398 95   
% 222.76/222.94  |- mesh__recordMaintainer mesh__D018398 SYSTEM
% 222.76/222.94  |- rdf__type mesh__D018398sskos__Concept
% 222.76/222.94  |- mesh__publicMeSHNote mesh__D018398 95   
% 222.76/222.94  |- skos__altLabel mesh__D018398 Homeo Domain Proteins
% 222.76/222.94  |- skos__prefLabel mesh__D018398 Homeodomain Proteins
% 222.76/222.94  |- mesh__dateEstablished mesh__D018398 1995-01-01
% 222.76/222.94  |- skos__annotation mesh__D018398 DNA-binding proteins   
% 222.76/222.94  |- skos__historyNote mesh__D018398 DNA-Binding Proteins %28%1988-1994%29%
% 222.76/222.94  |- skos__scopeNote mesh__D018398
% 222.76/222.94       Proteins encoded by homeobox genes %28%GENES, HOMEOBOX%29% that exhibit structural similarity to certain prokaryotic and eukaryotic DNA-binding proteins. Homeodomain proteins are involved in the control of gene expression during morphogenesis and development %28%GENE EXPRESSION REGULATION, DEVELOPMENTAL%29%.%A%    
% 222.76/222.94  |- skos__hiddenLabel mesh__D018398 Proteins, Homeotic
% 222.76/222.94  |- skos__broader mesh__D018398smesh__D004268
% 222.76/222.94  |- skos__hiddenLabel mesh__D018398 Proteins, Homeo Domain
% 222.76/222.94  |- mesh__dateCreated mesh__D018398 1994-05-31
% 222.76/222.94  |- mesh__historyNote mesh__D032069 2003   
% 222.76/222.94  |- skos__scopeNote mesh__D032069
% 222.76/222.94       A plant genus of the family RUBIACEAE. Members contain psychotridine and brachycerine %28%indole alkaloids%29%.%A%    
% 222.76/222.94  |- skos__broader mesh__D032069smesh__D019666
% 222.76/222.94  |- mesh__activeMeSHYear mesh__D032069 2006
% 222.76/222.95  |- skos__annotation mesh__D032069
% 222.76/222.95       PSYCHOTRIA IPECACUANHA see CEPHAELIS IPECACUANHA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.76/222.95  |- rdf__type mesh__D032069sskos__Concept
% 222.76/222.95  |- skos__prefLabel mesh__D032069 Psychotria
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D032069 2003
% 222.76/222.95  |- mesh__publicMeSHNote mesh__D032069 2003   
% 222.76/222.95  |- mesh__dateEstablished mesh__D032069 2003-01-01
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D032069 2004
% 222.76/222.95  |- mesh__dateCreated mesh__D032069 2002-07-03
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D032069 2005
% 222.76/222.95  |- mesh__recordMaintainer mesh__D051223 ags
% 222.76/222.95  |- skos__hiddenLabel mesh__D051223 Bones, Trapezoid
% 222.76/222.95  |- mesh__publicMeSHNote mesh__D051223 2006   
% 222.76/222.95  |- rdf__type mesh__D051223sskos__Concept
% 222.76/222.95  |- skos__hiddenLabel mesh__D051223 Bone, Trapezoid
% 222.76/222.95  |- mesh__historyNote mesh__D051223 2006   
% 222.76/222.95  |- skos__prefLabel mesh__D051223 Trapezoid Bone
% 222.76/222.95  |- skos__historyNote mesh__D051223 Carpal Bones %28%1978-2005%29%
% 222.76/222.95  |- mesh__recordOriginator mesh__D051223 ags
% 222.76/222.95  |- mesh__dateCreated mesh__D051223 2005-06-30
% 222.76/222.95  |- mesh__dateEstablished mesh__D051223 2006-01-01
% 222.76/222.95  |- skos__altLabel mesh__D051223 Os Trapezoideum
% 222.76/222.95  |- skos__broader mesh__D051223smesh__D002348
% 222.76/222.95  |- skos__scopeNote mesh__D051223
% 222.76/222.95       A carpal bone which is located between the TRAPEZIUM BONE and the CAPITATE BONE.%A%    
% 222.76/222.95  |- mesh__recordAuthorizer mesh__D051223 sjn
% 222.76/222.95  |- skos__hiddenLabel mesh__D051223 Trapezoid Bones
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D051223 2006
% 222.76/222.95  |- rdf__type mesh__D004378sskos__Concept
% 222.76/222.95  |- skos__annotation mesh__D004378
% 222.76/222.95       GEN; prefer specifics; inflamm dis = DUODENITIS; duodenal atresia = DUODENAL OBSTRUCTION /congen %28%IM%29% + INTESTINAL ATRESIA %28%IM%29%%A%  
% 222.76/222.95  |- mesh__recordMaintainer mesh__D004378 lkt
% 222.76/222.95  |- mesh__recordAuthorizer mesh__D004378 sjn
% 222.76/222.95  |- skos__hiddenLabel mesh__D004378 Disease, Duodenal
% 222.76/222.95  |- skos__hiddenLabel mesh__D004378 Duodenal Disease
% 222.76/222.95  |- skos__scopeNote mesh__D004378
% 222.76/222.95       Pathological conditions in the DUODENUM region of the small intestine %28%INTESTINE, SMALL%29%.%A%    
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D004378 2005
% 222.76/222.95  |- skos__prefLabel mesh__D004378 Duodenal Diseases
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D004378 2006
% 222.76/222.95  |- mesh__recordOriginator mesh__D004378 NLM
% 222.76/222.95  |- skos__hiddenLabel mesh__D004378 Diseases, Duodenal
% 222.76/222.95  |- skos__broader mesh__D004378smesh__D007410
% 222.76/222.95  |- mesh__dateCreated mesh__D004378 1999-01-01
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D004378 2004
% 222.76/222.95  |- mesh__dateRevised mesh__D004378 2003-07-09
% 222.76/222.95  |- skos__broader mesh__D009861smesh__D009930
% 222.76/222.95  |- rdf__type mesh__D009861sskos__Concept
% 222.76/222.95  |- mesh__dateEstablished mesh__D009861 1968-01-01
% 222.76/222.95  |- skos__prefLabel mesh__D009861 Onium Compounds
% 222.76/222.95  |- mesh__publicMeSHNote mesh__D009861 68   
% 222.76/222.95  |- mesh__recordMaintainer mesh__D009861 sjn
% 222.76/222.95  |- mesh__dateCreated mesh__D009861 1999-01-01
% 222.76/222.95  |- skos__hiddenLabel mesh__D009861 Compounds, Onium
% 222.76/222.95  |- skos__annotation mesh__D009861 DF: ONIUM CPDS   
% 222.76/222.95  |- mesh__recordAuthorizer mesh__D009861 sjn
% 222.76/222.95  |- mesh__recordOriginator mesh__D009861 NLM
% 222.76/222.95  |- skos__scopeNote mesh__D009861
% 222.76/222.95       Ions with the suffix -onium, indicating cations with coordination number 4 of the type RxA+ which are analogous to QUATERNARY AMMONIUM COMPOUNDS %28%H4N+%29%. Ions include phosphonium R4P+, oxonium R3O+, sulfonium R3S+, chloronium R2Cl+%A%    
% 222.76/222.95  |- mesh__historyNote mesh__D009861 68   
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D009861 2006
% 222.76/222.95  |- mesh__dateRevised mesh__D009861 2005-07-01
% 222.76/222.95  |- skos__broader mesh__D009063smesh__D004069
% 222.76/222.95  |- skos__prefLabel mesh__D009063 Dental Physiology
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D009063 2001
% 222.76/222.95  |- rdf__type mesh__D009063sskos__Concept
% 222.76/222.95  |- mesh__publicMeSHNote mesh__D009063 98   
% 222.76/222.95  |- skos__altLabel mesh__D009063 Physiology, Dental
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D009063 2002
% 222.76/222.95  |- mesh__recordAuthorizer mesh__D009063 SJN
% 222.76/222.95  |- mesh__dateEstablished mesh__D009063 1998-01-01
% 222.76/222.95  |- mesh__dateCreated mesh__D009063 1999-01-01
% 222.76/222.95  |- mesh__historyNote mesh__D009063 98; use explode 1970-97   
% 222.76/222.95  |- mesh__recordMaintainer mesh__D009063 NNS
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D009063 2005
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D009063 2003
% 222.76/222.95  |- mesh__dateRevised mesh__D009063 1998-06-10
% 222.76/222.95  |- skos__annotation mesh__D009063
% 222.76/222.95       GEN or unspecified; prefer specifics; consider also MOUTH /physiol or /physiol with specific parts of the mouth; DF: DENT PHYSIOL%A%  
% 222.76/222.95  |- skos__hiddenLabel mesh__D009063 Physiologies, Dental
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D009063 1999
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D009063 2006
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D009063 2004
% 222.76/222.95  |- skos__historyNote mesh__D009063 Tooth/physiology %28%1966-1997%29%
% 222.76/222.95  |- mesh__recordOriginator mesh__D009063 NLM
% 222.76/222.95  |- skos__hiddenLabel mesh__D009063 Dental Physiologies
% 222.76/222.95  |- skos__scopeNote mesh__D009063
% 222.76/222.95       Functions and activities of dentition as a whole.     
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D009063 2000
% 222.76/222.95  |- skos__broader mesh__D001080smesh__D011742
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D001080 1991
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D001080 2002
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D001080 1997
% 222.76/222.95  |- mesh__dateRevised mesh__D001080 1990-04-13
% 222.76/222.95  |- mesh__recordOriginator mesh__D001080 NLM
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D001080 2005
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D001080 1994
% 222.76/222.95  |- mesh__recordAuthorizer mesh__D001080 PLS
% 222.76/222.95  |- skos__broader mesh__D001080smesh__D011089
% 222.76/222.95  |- mesh__historyNote mesh__D001080
% 222.76/222.95       91%28%75%29%; was see under POLYNUCLEOTIDES 1975-90   
% 222.76/222.95  |- skos__hiddenLabel mesh__D001080 Acid, Apurinic
% 222.76/222.95  |- skos__historyNote mesh__D001080 Polynucleotides %28%1972-1975%29%
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D001080 2006
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D001080 2000
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D001080 1995
% 222.76/222.95  |- mesh__publicMeSHNote mesh__D001080
% 222.76/222.95       91; was see under POLYNUCLEOTIDES 1975-90   
% 222.76/222.95  |- skos__broader mesh__D001080smesh__D011131
% 222.76/222.95  |- rdf__type mesh__D001080sskos__Concept
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D001080 1992
% 222.76/222.95  |- mesh__dateEstablished mesh__D001080 1991-01-01
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D001080 2003
% 222.76/222.95  |- skos__scopeNote mesh__D001080
% 222.76/222.95       Hydrolysate of DNA in which purine bases have been removed.%A%    
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D001080 1998
% 222.76/222.95  |- mesh__recordMaintainer mesh__D001080 NLM
% 222.76/222.95  |- skos__prefLabel mesh__D001080 Apurinic Acid
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D001080 2001
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D001080 1993
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D001080 2004
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D001080 1999
% 222.76/222.95  |- mesh__dateCreated mesh__D001080 1974-11-19
% 222.76/222.95  |- skos__historyNote mesh__D001080 Pyrimidine Nucleotides %28%1974%29%
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D001080 1996
% 222.76/222.95  |- mesh__historyNote mesh__D008769
% 222.76/222.95       77%28%75%29%; was see under NITROSOGUANIDINES 1975-76   
% 222.76/222.95  |- skos__altLabel mesh__D008769 MNNG
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D008769 2002
% 222.76/222.95  |- skos__annotation mesh__D008769 D25-26 qualif; DF: MNNG   
% 222.76/222.95  |- skos__broader mesh__D008769smesh__D009604
% 222.76/222.95  |- mesh__dateEstablished mesh__D008769 1977-01-01
% 222.76/222.95  |- mesh__dateCreated mesh__D008769 1974-11-11
% 222.76/222.95  |- rdf__type mesh__D008769sskos__Concept
% 222.76/222.95  |- skos__historyNote mesh__D008769 Nitrosoguanidines %28%1973-1974%29%
% 222.76/222.95  |- skos__altLabel mesh__D008769 Nitrosomethylnitroguanidine
% 222.76/222.95  |- skos__historyNote mesh__D008769 Nitro Compounds %28%1973-1974%29%
% 222.76/222.95  |- mesh__publicMeSHNote mesh__D008769
% 222.76/222.95       77; was see under NITROSOGUANIDINES 1975-76   
% 222.76/222.95  |- mesh__recordAuthorizer mesh__D008769 sjn
% 222.76/222.95  |- skos__hiddenLabel mesh__D008769 N Methyl N%27% nitro N nitrosoguanidine
% 222.76/222.95  |- skos__altLabel mesh__D008769 N-Methyl-N%27%-nitro-N-nitrosoguanidine
% 222.76/222.95  |- mesh__recordOriginator mesh__D008769 NLM
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D008769 2005
% 222.76/222.95  |- mesh__dateRevised mesh__D008769 2000-06-22
% 222.76/222.95  |- skos__scopeNote mesh__D008769
% 222.76/222.95       A nitrosoguanidine derivative with potent mutagenic and carcinogenic properties.%A%    
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D008769 2006
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D008769 2003
% 222.76/222.95  |- skos__prefLabel mesh__D008769 Methylnitronitrosoguanidine
% 222.76/222.95  |- skos__altLabel mesh__D008769 Nitrosonitromethylguanidine
% 222.76/222.95  |- skos__altLabel mesh__D008769 Methylnitrosonitroguanidine
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D008769 2001
% 222.76/222.95  |- mesh__recordMaintainer mesh__D008769 CCR
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D008769 2004
% 222.76/222.95  |- skos__hiddenLabel mesh__D000786 Angers
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D000786 2000
% 222.76/222.95  |- skos__historyNote mesh__D000786 Hostility %28%1968%29%
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D000786 1999
% 222.76/222.95  |- rdf__type mesh__D000786sskos__Concept
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D000786 1996
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D000786 2005
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D000786 1993
% 222.76/222.95  |- skos__scopeNote mesh__D000786
% 222.76/222.95       A strong emotional feeling of displeasure aroused by being interfered with, injured or threatened.%A%    
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D000786 2001
% 222.76/222.95  |- skos__prefLabel mesh__D000786 Anger
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D000786 1997
% 222.76/222.95  |- mesh__dateEstablished mesh__D000786 1972-01-01
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D000786 2006
% 222.76/222.95  |- mesh__dateCreated mesh__D000786 1999-01-01
% 222.76/222.95  |- skos__annotation mesh__D000786 human %26% animal   
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D000786 2003
% 222.76/222.95  |- mesh__dateRevised mesh__D000786 1992-03-25
% 222.76/222.95  |- mesh__publicMeSHNote mesh__D000786 72   
% 222.76/222.95  |- skos__broader mesh__D000786smesh__D004644
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D000786 2002
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D000786 1994
% 222.76/222.95  |- mesh__recordOriginator mesh__D000786 NLM
% 222.76/222.95  |- mesh__recordMaintainer mesh__D000786 TAP
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D000786 2004
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D000786 1998
% 222.76/222.95  |- mesh__historyNote mesh__D000786 72%28%69%29%   
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D000786 1995
% 222.76/222.95  |- mesh__recordAuthorizer mesh__D000786 PLS
% 222.76/222.95  |- skos__prefLabel mesh__D019491 Bookplates %5B%Publication Type%5D%
% 222.76/222.95  |- skos__annotation mesh__D019491
% 222.76/222.95       publication type only; for bookplates as a subject, index under main heading BOOKPLATES%A%  
% 222.76/222.95  |- mesh__recordOriginator mesh__D019491 TGC
% 222.76/222.95  |- mesh__recordAuthorizer mesh__D019491 sjn
% 222.76/222.95  |- mesh__recordMaintainer mesh__D019491 jls
% 222.76/222.95  |- skos__altLabel mesh__D019491 Book Plates %28%PT%29%
% 222.76/222.95  |- skos__altLabel mesh__D019491 Book Plates %5B%Publication Type%5D%
% 222.76/222.95  |- skos__broader mesh__D019491smesh__D052181
% 222.76/222.95  |- skos__scopeNote mesh__D019491
% 222.76/222.95       Works consisting of book owner%27%s identification labels. They are usually intended for attaching inside a book or similar object. %28%From Thesaurus for Graphic Materials II: Genre and Physical Characteristic Terms, 1995%29%%A%    
% 222.76/222.95  |- mesh__historyNote mesh__D019491 1997   
% 222.76/222.95  |- mesh__dateRevised mesh__D019491 2005-06-30
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D019491 2006
% 222.76/222.95  |- skos__altLabel mesh__D019491 Bookplates %28%PT%29%
% 222.76/222.95  |- mesh__dateCreated mesh__D019491 1996-06-21
% 222.76/222.95  |- rdf__type mesh__D019491sskos__Concept
% 222.76/222.95  |- mesh__dateEstablished mesh__D019491 1997-01-01
% 222.76/222.95  |- skos__prefLabel mesh__D033162 Incidental Findings
% 222.76/222.95  |- skos__hiddenLabel mesh__D033162 Discovery, Incidental
% 222.76/222.95  |- mesh__dateCreated mesh__D033162 2002-07-03
% 222.76/222.95  |- skos__scopeNote mesh__D033162
% 222.76/222.95       Unanticipated information discovered in the course of testing or medical care.  Used in discussions of information that may have social or psychological consequences, such as when it is learned that a child%27%s biological father is someone other than the putative father, or that a person tested for one disease or disorder has, or is at risk for, something else.%A%    
% 222.76/222.95  |- mesh__recordOriginator mesh__D033162 jrf
% 222.76/222.95  |- mesh__dateEstablished mesh__D033162 2003-01-01
% 222.76/222.95  |- mesh__recordMaintainer mesh__D033162 sjn
% 222.76/222.95  |- skos__hiddenLabel mesh__D033162 Incidental Discoveries
% 222.76/222.95  |- skos__hiddenLabel mesh__D033162 Findings, Incidental
% 222.76/222.95  |- skos__hiddenLabel mesh__D033162 Finding, Incidental
% 222.76/222.95  |- skos__annotation mesh__D033162 HUMAN only   
% 222.76/222.95  |- skos__broader mesh__D033162smesh__D003933
% 222.76/222.95  |- mesh__publicMeSHNote mesh__D033162 2003   
% 222.76/222.95  |- mesh__dateRevised mesh__D033162 2003-07-25
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D033162 2005
% 222.76/222.95  |- rdf__type mesh__D033162sskos__Concept
% 222.76/222.95  |- mesh__recordAuthorizer mesh__D033162 sjn
% 222.76/222.95  |- skos__hiddenLabel mesh__D033162 Incidental Finding
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D033162 2004
% 222.76/222.95  |- mesh__historyNote mesh__D033162 2003   
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D033162 2006
% 222.76/222.95  |- skos__hiddenLabel mesh__D033162 Discoveries, Incidental
% 222.76/222.95  |- skos__broader mesh__D027923smesh__D027922
% 222.76/222.95  |- skos__altLabel mesh__D027923 Elder Plant
% 222.76/222.95  |- mesh__dateCreated mesh__D027923 2001-07-25
% 222.76/222.95  |- skos__historyNote mesh__D027923 Plants, Medicinal %28%1968-2001%29%
% 222.76/222.95  |- mesh__historyNote mesh__D027923 2002   
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D027923 2006
% 222.76/222.95  |- mesh__dateRevised mesh__D027923 2005-06-30
% 222.76/222.95  |- mesh__recordOriginator mesh__D027923 ssb
% 222.76/222.95  |- mesh__recordAuthorizer mesh__D027923 sjn
% 222.76/222.95  |- rdf__type mesh__D027923sskos__Concept
% 222.76/222.95  |- skos__prefLabel mesh__D027923 Sambucus
% 222.76/222.95  |- skos__altLabel mesh__D027923 Elderberries
% 222.76/222.95  |- skos__historyNote mesh__D027923 Lectins %28%1969-2001%29%
% 222.76/222.95  |- mesh__dateEstablished mesh__D027923 2002-01-01
% 222.76/222.95  |- skos__annotation mesh__D027923
% 222.76/222.95       coordinate with specific PLANT COMPONENTS term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.76/222.95  |- mesh__publicMeSHNote mesh__D027923 2002   
% 222.76/222.95  |- skos__scopeNote mesh__D027923
% 222.76/222.95       A plant genus in the family CAPRIFOLIACEAE best known for elderberries.%A%    
% 222.76/222.95  |- mesh__recordMaintainer mesh__D027923 ssb
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D005471 2006
% 222.76/222.95  |- skos__prefLabel mesh__D005471 Fluoroscopy
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D005471 2003
% 222.76/222.95  |- skos__hiddenLabel mesh__D005471 Fluoroscopies
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D005471 2000
% 222.76/222.95  |- mesh__recordOriginator mesh__D005471 NLM
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D005471 1998
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D005471 2004
% 222.76/222.95  |- mesh__dateCreated mesh__D005471 1999-01-01
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D005471 1999
% 222.76/222.95  |- skos__broader mesh__D005471smesh__D011859
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D005471 2001
% 222.76/222.95  |- skos__scopeNote mesh__D005471
% 222.76/222.95       Production of an image when x-rays strike a fluorescent screen.%A%    
% 222.76/222.95  |- mesh__dateRevised mesh__D005471 1997-06-20
% 222.76/222.95  |- mesh__recordAuthorizer mesh__D005471 SJN
% 222.76/222.95  |- mesh__recordMaintainer mesh__D005471 PXP
% 222.76/222.95  |- skos__annotation mesh__D005471
% 222.76/222.95       NIM; do not use /util except by MeSH definition   
% 222.76/222.95  |- rdf__type mesh__D005471sskos__Concept
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D005471 2005
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D005471 2002
% 222.76/222.95  |- skos__hiddenLabel mesh__D046888 Tissue Array Analyses
% 222.76/222.95  |- skos__hiddenLabel mesh__D046888 Cell Array Analyses
% 222.76/222.95  |- skos__hiddenLabel mesh__D046888 Analysis, Cell Array
% 222.76/222.95  |- skos__prefLabel mesh__D046888 Tissue Array Analysis
% 222.76/222.95  |- skos__hiddenLabel mesh__D046888 Array Analysis, Cell
% 222.76/222.95  |- mesh__publicMeSHNote mesh__D046888 2005   
% 222.76/222.95  |- skos__hiddenLabel mesh__D046888 Analyses, Tissue Array
% 222.76/222.95  |- skos__hiddenLabel mesh__D046888 Analyses, Cell Array
% 222.76/222.95  |- skos__hiddenLabel mesh__D046888 Array Analyses, Cell
% 222.76/222.95  |- skos__broader mesh__D046888smesh__D046228
% 222.76/222.95  |- mesh__recordMaintainer mesh__D046888 nns
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D046888 2005
% 222.76/222.95  |- skos__hiddenLabel mesh__D046888 Array Analyses, Tissue
% 222.76/222.95  |- mesh__dateCreated mesh__D046888 2004-07-07
% 222.76/222.95  |- rdf__type mesh__D046888sskos__Concept
% 222.76/222.95  |- skos__hiddenLabel mesh__D046888 Array Analysis, Tissue
% 222.76/222.95  |- mesh__recordOriginator mesh__D046888 nns
% 222.76/222.95  |- skos__hiddenLabel mesh__D046888 Analysis, Tissue Array
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D046888 2006
% 222.76/222.95  |- mesh__historyNote mesh__D046888 2005   
% 222.76/222.95  |- mesh__recordAuthorizer mesh__D046888 sjn
% 222.76/222.95  |- mesh__dateEstablished mesh__D046888 2005-01-01
% 222.76/222.95  |- skos__scopeNote mesh__D046888
% 222.76/222.95       The simultaneous analysis of multiple samples of TISSUES or CELLS from BIOPSY or in vitro culture that have been arranged in an array format on slides or microchips.%A%    
% 222.76/222.95  |- skos__related mesh__D013903smesh__D006348
% 222.76/222.95  |- skos__altLabel mesh__D013903 Surgery, Heart
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D013903 2002
% 222.76/222.95  |- skos__altLabel mesh__D013903 Cardiac Surgery
% 222.76/222.95  |- mesh__recordAuthorizer mesh__D013903 sjn
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D013903 2005
% 222.76/222.95  |- mesh__historyNote mesh__D013903
% 222.76/222.95       80; was THORAX /surgery 1966-79 %26% SURGERY, THORACIC %28%NON MESH%29% before 1980%A%  
% 222.76/222.95  |- skos__related mesh__D013903smesh__D019616
% 222.76/222.95  |- skos__related mesh__D013903smesh__D013504
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D013903 2001
% 222.76/222.95  |- mesh__dateEstablished mesh__D013903 1980-01-01
% 222.76/222.95  |- mesh__dateRevised mesh__D013903 1999-11-03
% 222.76/222.95  |- mesh__recordMaintainer mesh__D013903 jls
% 222.76/222.95  |- skos__altLabel mesh__D013903 Surgery, Thoracic
% 222.76/222.95  |- skos__altLabel mesh__D013903 Heart Surgery
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D013903 2000
% 222.76/222.95  |- mesh__dateCreated mesh__D013903 1999-01-01
% 222.76/222.95  |- mesh__publicMeSHNote mesh__D013903 80; was THORAX /surgery 1966-79   
% 222.76/222.95  |- skos__broader mesh__D013903smesh__D013043
% 222.76/222.95  |- skos__annotation mesh__D013903
% 222.76/222.95       a surg specialty: do not confuse with THORACIC SURGICAL PROCEDURES %28%Cat E4%29%; SPEC qualif; do not use for surg of specific thoracic organs %28% = organ /surg%29% or specific thoracic dis %28% = disease /surg%29%; DF: THORACIC SURG%A%  
% 222.76/222.95  |- mesh__recordOriginator mesh__D013903 NLM
% 222.76/222.95  |- skos__scopeNote mesh__D013903
% 222.76/222.95       A surgical specialty concerned with diagnosis and treatment of disorders of the heart, lungs, and esophagus. Two major types of thoracic surgery are classified as pulmonary and cardiovascular.%A%    
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D013903 2004
% 222.76/222.95  |- skos__prefLabel mesh__D013903 Thoracic Surgery
% 222.76/222.95  |- mesh__onlineNote mesh__D013903
% 222.76/222.95       use THORACIC SURGERY to search THORAX /surgery 1966-79 %28%with no qualif 1966-79%29%%A%  
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D013903 2006
% 222.76/222.95  |- rdf__type mesh__D013903sskos__Concept
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D013903 2003
% 222.76/222.95  |- mesh__dateCreated mesh__D013105 1987-03-25
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D013105 2006
% 222.76/222.95  |- mesh__recordAuthorizer mesh__D013105 sjn
% 222.76/222.95  |- skos__hiddenLabel mesh__D013105 Transhepatic Sphincteroplasty
% 222.76/222.95  |- skos__hiddenLabel mesh__D013105 Transduodenal Sphincterotomies
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D013105 2005
% 222.76/222.95  |- skos__broader mesh__D013105smesh__D001662
% 222.76/222.95  |- skos__historyNote mesh__D013105
% 222.76/222.95       Oddi%27%s Sphincter/surgery %28%1975-1987%29%
% 222.76/222.95  |- mesh__historyNote mesh__D013105 88   
% 222.76/222.95  |- skos__hiddenLabel mesh__D013105 Sphincterotomies, Transduodenal
% 222.76/222.95  |- mesh__recordOriginator mesh__D013105 SCD
% 222.76/222.95  |- skos__scopeNote mesh__D013105
% 222.76/222.95       Surgery of the smooth muscle sphincter of the hepatopancreatic ampulla to relieve blocked biliary or pancreatic ducts.%A%    
% 222.76/222.95  |- rdf__type mesh__D013105sskos__Concept
% 222.76/222.95  |- mesh__dateRevised mesh__D013105 2003-07-25
% 222.76/222.95  |- skos__hiddenLabel mesh__D013105 Sphincteroplasties, Transduodenal
% 222.76/222.95  |- skos__hiddenLabel mesh__D013105 Transduodenal Sphincterotomy
% 222.76/222.95  |- mesh__recordMaintainer mesh__D013105 sjn
% 222.76/222.95  |- skos__historyNote mesh__D013105
% 222.76/222.95       Vater%27%s Ampulla/surgery %28%1966-1987%29%
% 222.76/222.95  |- skos__hiddenLabel mesh__D013105 Transhepatic Sphincterotomies
% 222.76/222.95  |- skos__prefLabel mesh__D013105 Sphincterotomy, Transhepatic
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D013105 2004
% 222.76/222.95  |- skos__hiddenLabel mesh__D013105 Transhepatic Sphincteroplasties
% 222.76/222.95  |- skos__hiddenLabel mesh__D013105 Sphincterotomies, Transhepatic
% 222.76/222.95  |- mesh__publicMeSHNote mesh__D013105 88   
% 222.76/222.95  |- skos__hiddenLabel mesh__D013105 Transhepatic Sphincterotomy
% 222.76/222.95  |- skos__altLabel mesh__D013105 Sphincteroplasty, Transhepatic
% 222.76/222.95  |- skos__hiddenLabel mesh__D013105 Transduodenal Sphincteroplasty
% 222.76/222.95  |- skos__altLabel mesh__D013105 Sphincterotomy, Transduodenal
% 222.76/222.95  |- skos__annotation mesh__D013105
% 222.76/222.95       refers to SPHINCTER OF ODDI only; do not use /util except by MeSH definition%A%  
% 222.76/222.95  |- skos__hiddenLabel mesh__D013105 Transduodenal Sphincteroplasties
% 222.76/222.95  |- mesh__dateEstablished mesh__D013105 1988-01-01
% 222.76/222.95  |- skos__hiddenLabel mesh__D013105 Sphincteroplasties, Transhepatic
% 222.76/222.95  |- mesh__recordOriginator mesh__D051224 ags
% 222.76/222.95  |- skos__broader mesh__D051224smesh__D002348
% 222.76/222.95  |- mesh__publicMeSHNote mesh__D051224 2006   
% 222.76/222.95  |- rdf__type mesh__D051224sskos__Concept
% 222.76/222.95  |- mesh__dateEstablished mesh__D051224 2006-01-01
% 222.76/222.95  |- mesh__recordAuthorizer mesh__D051224 sjn
% 222.76/222.95  |- skos__altLabel mesh__D051224 Os Capitatum
% 222.76/222.95  |- skos__scopeNote mesh__D051224
% 222.76/222.95       A carpal bone with a rounded head located between the TRAPEZOID BONE and the HAMATE BONE.%A%    
% 222.76/222.95  |- skos__hiddenLabel mesh__D051224 Bone, Capitate
% 222.76/222.95  |- skos__prefLabel mesh__D051224 Capitate Bone
% 222.76/222.95  |- mesh__historyNote mesh__D051224 2006   
% 222.76/222.95  |- skos__hiddenLabel mesh__D051224 Capitate Bones
% 222.76/222.95  |- mesh__recordMaintainer mesh__D051224 ags
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D051224 2006
% 222.76/222.95  |- skos__historyNote mesh__D051224 Carpal Bones %28%1971-2005%29%
% 222.76/222.95  |- skos__hiddenLabel mesh__D051224 Bones, Capitate
% 222.76/222.95  |- mesh__dateCreated mesh__D051224 2005-06-30
% 222.76/222.95  |- skos__altLabel mesh__D004379 Cancer of the Duodenum
% 222.76/222.95  |- skos__broader mesh__D004379smesh__D007414
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D004379 2005
% 222.76/222.95  |- skos__hiddenLabel mesh__D004379 Duodenum Cancer
% 222.76/222.95  |- mesh__recordOriginator mesh__D004379 NLM
% 222.76/222.95  |- mesh__recordMaintainer mesh__D004379 lkt
% 222.76/222.95  |- skos__hiddenLabel mesh__D004379 Neoplasms, Duodenal
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D004379 2006
% 222.76/222.95  |- skos__hiddenLabel mesh__D004379 Cancer, Duodenal
% 222.76/222.95  |- mesh__recordAuthorizer mesh__D004379 sjn
% 222.76/222.95  |- mesh__dateCreated mesh__D004379 1999-01-01
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D004379 2004
% 222.76/222.95  |- mesh__dateRevised mesh__D004379 2003-07-09
% 222.76/222.95  |- rdf__type mesh__D004379sskos__Concept
% 222.76/222.95  |- skos__annotation mesh__D004379
% 222.76/222.95       coord IM with histol type of neopl %28%IM%29%   
% 222.76/222.95  |- skos__altLabel mesh__D004379 Cancer of Duodenum
% 222.76/222.95  |- skos__hiddenLabel mesh__D004379 Neoplasm, Duodenal
% 222.76/222.95  |- skos__broader mesh__D004379smesh__D004378
% 222.76/222.95  |- skos__prefLabel mesh__D004379 Duodenal Neoplasms
% 222.76/222.95  |- skos__scopeNote mesh__D004379 Tumors or cancer of the DUODENUM.     
% 222.76/222.95  |- skos__hiddenLabel mesh__D004379 Duodenal Neoplasm
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D009862 1996
% 222.76/222.95  |- mesh__recordOriginator mesh__D009862 NLM
% 222.76/222.95  |- rdf__type mesh__D009862sskos__Concept
% 222.76/222.95  |- skos__hiddenLabel mesh__D009862 Systems, Online
% 222.76/222.95  |- skos__hiddenLabel mesh__D009862 Online System
% 222.76/222.95  |- mesh__dateCreated mesh__D009862 1999-01-01
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D009862 2004
% 222.76/222.95  |- skos__annotation mesh__D009862
% 222.76/222.95       IM; coord with discipline, site or application where used %28%IM%29%%A%  
% 222.76/222.95  |- skos__hiddenLabel mesh__D009862 System, Online
% 222.76/222.95  |- skos__historyNote mesh__D009862 Computers %28%1966-1970%29%
% 222.76/222.95  |- skos__hiddenLabel mesh__D009862 On-Line System
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D009862 1997
% 222.76/222.95  |- skos__scopeNote mesh__D009862
% 222.76/222.95       Systems where the input data enter the computer directly from the point of origin %28%usually a terminal or workstation%29% and/or in which output data are transmitted directly to that terminal point of origin. %28%Sippl, Computer Dictionary, 4th ed%29%%A%    
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D009862 2002
% 222.76/222.95  |- mesh__dateEstablished mesh__D009862 1974-01-01
% 222.76/222.95  |- mesh__recordAuthorizer mesh__D009862 PLS
% 222.76/222.95  |- mesh__publicMeSHNote mesh__D009862 79; was ON LINE SYSTEMS 1974-78   
% 222.76/222.95  |- skos__hiddenLabel mesh__D009862 System, On-Line
% 222.76/222.95  |- skos__hiddenLabel mesh__D009862 On Line Systems
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D009862 2000
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D009862 2005
% 222.76/222.95  |- skos__broader mesh__D009862smesh__D007256
% 222.76/222.95  |- mesh__activeMeSHYear mesh__D009862 1998
% 222.76/222.95  |- mesh__onlineNote mesh__D009862
% 222.76/222.95       use ONLINE SYSTEMS to search ON LINE SYSTEMS 1971-78 %28%as Prov 1971-73%29%%A%  
% 222.76/222.96  |- mesh__historyNote mesh__D009862
% 222.76/222.96       79; was ON LINE SYSTEMS 1971-78 %28%Prov 1971-73%29%   
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009862 2006
% 222.76/222.96  |- skos__altLabel mesh__D009862 On-Line Systems
% 222.76/222.96  |- skos__prefLabel mesh__D009862 Online Systems
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009862 1999
% 222.76/222.96  |- mesh__dateRevised mesh__D009862 1995-05-18
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009862 2001
% 222.76/222.96  |- mesh__recordMaintainer mesh__D009862 TGC
% 222.76/222.96  |- skos__hiddenLabel mesh__D009862 Systems, On-Line
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009862 2003
% 222.76/222.96  |- skos__annotation mesh__D009064
% 222.76/222.96       coord IM with specific instrum of relevant subject area %28%IM%29% or procedure %28%IM%29%%A%  
% 222.76/222.96  |- skos__hiddenLabel mesh__D009064 Mouth Piece, Protective
% 222.76/222.96  |- mesh__dateEstablished mesh__D009064 1965-01-01
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009064 2004
% 222.76/222.96  |- mesh__recordOriginator mesh__D009064 NLM
% 222.76/222.96  |- skos__hiddenLabel mesh__D009064 Guards, Mouth
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009064 2002
% 222.76/222.96  |- skos__hiddenLabel mesh__D009064 Protectors, Mouth
% 222.76/222.96  |- rdf__type mesh__D009064sskos__Concept
% 222.76/222.96  |- skos__hiddenLabel mesh__D009064 Protector, Mouth
% 222.76/222.96  |- skos__altLabel mesh__D009064 Mouthpieces, Protective
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009064 2003
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009064 1999
% 222.76/222.96  |- mesh__dateRevised mesh__D009064 1997-06-20
% 222.76/222.96  |- skos__hiddenLabel mesh__D009064 Protective Mouth Piece
% 222.76/222.96  |- mesh__dateCreated mesh__D009064 1999-01-01
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009064 2006
% 222.76/222.96  |- skos__broader mesh__D009064smesh__D011313
% 222.76/222.96  |- skos__hiddenLabel mesh__D009064 Guard, Mouth
% 222.76/222.96  |- skos__altLabel mesh__D009064 Mouth Pieces, Protective
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009064 2001
% 222.76/222.96  |- skos__hiddenLabel mesh__D009064 Mouthpiece, Protective
% 222.76/222.96  |- skos__broader mesh__D009064smesh__D011482
% 222.76/222.96  |- skos__hiddenLabel mesh__D009064 Mouth Guard
% 222.76/222.96  |- skos__prefLabel mesh__D009064 Mouth Protectors
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009064 1998
% 222.76/222.96  |- mesh__recordAuthorizer mesh__D009064 SJN
% 222.76/222.96  |- skos__altLabel mesh__D009064 Mouth Guards
% 222.76/222.96  |- skos__hiddenLabel mesh__D009064 Pieces, Protective Mouth
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009064 2005
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009064 2000
% 222.76/222.96  |- mesh__historyNote mesh__D009064 65   
% 222.76/222.96  |- skos__hiddenLabel mesh__D009064 Mouth Protector
% 222.76/222.96  |- mesh__publicMeSHNote mesh__D009064 65   
% 222.76/222.96  |- skos__scopeNote mesh__D009064
% 222.76/222.96       Devices or pieces of equipment placed in or around the mouth or attached to instruments to protect the external or internal tissues of the mouth and the teeth.%A%    
% 222.76/222.96  |- skos__hiddenLabel mesh__D009064 Protective Mouthpiece
% 222.76/222.96  |- skos__hiddenLabel mesh__D009064 Protective Mouthpieces
% 222.76/222.96  |- skos__hiddenLabel mesh__D009064 Protective Mouth Pieces
% 222.76/222.96  |- skos__hiddenLabel mesh__D009064 Piece, Protective Mouth
% 222.76/222.96  |- mesh__recordMaintainer mesh__D009064 PXP
% 222.76/222.96  |- mesh__publicMeSHNote mesh__D001081
% 222.76/222.96       91; was see under PHOSPHATASES 1976-90; ATP-DIPHOSPHATASE was ATP DIPHOSPHATASE 1976-93%A%  
% 222.76/222.96  |- skos__altLabel mesh__D001081 ADP Phosphohydrolase
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D001081 2005
% 222.76/222.96  |- mesh__recordOriginator mesh__D001081 RLS
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D001081 2006
% 222.76/222.96  |- skos__prefLabel mesh__D001081 Apyrase
% 222.76/222.96  |- mesh__dateCreated mesh__D001081 1975-07-21
% 222.76/222.96  |- mesh__recordMaintainer mesh__D001081 ssb
% 222.76/222.96  |- skos__altLabel mesh__D001081 Adenosine Diphosphatase
% 222.76/222.96  |- skos__hiddenLabel mesh__D001081 Phosphohydrolase, ADP
% 222.76/222.96  |- skos__scopeNote mesh__D001081
% 222.76/222.96       A calcium-activated enzyme that catalyzes the hydrolysis of ATP to yield AMP and orthophosphate. It can also act on ADP and other nucleoside triphosphates and diphosphates. EC 3.6.1.5.%A%    
% 222.76/222.96  |- skos__altLabel mesh__D001081 ADPase
% 222.76/222.96  |- mesh__dateEstablished mesh__D001081 1991-01-01
% 222.76/222.96  |- skos__altLabel mesh__D001081 ATP-Diphosphatase
% 222.76/222.96  |- rdf__type mesh__D001081sskos__Concept
% 222.76/222.96  |- skos__altLabel mesh__D001081 ATP-ADPase
% 222.76/222.96  |- skos__altLabel mesh__D001081 ATP Diphosphohydrolase
% 222.76/222.96  |- skos__historyNote mesh__D001081 Phosphatases %28%1974-1975%29%
% 222.76/222.96  |- skos__hiddenLabel mesh__D001081 Diphosphatase, Adenosine
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D001081 2004
% 222.76/222.96  |- mesh__recordAuthorizer mesh__D001081 sjn
% 222.76/222.96  |- skos__broader mesh__D001081smesh__D017766
% 222.76/222.96  |- mesh__historyNote mesh__D001081
% 222.76/222.96       91%28%76%29%; was see under PHOSPHATASES 1976-90; ATP-DIPHOSPHATASE was ATP DIPHOSPHATASE 1976-93%A%  
% 222.76/222.96  |- skos__historyNote mesh__D001081 Adenosine Triphosphate %28%1974-1975%29%
% 222.76/222.96  |- mesh__dateRevised mesh__D001081 2003-07-09
% 222.76/222.96  |- skos__hiddenLabel mesh__D001081 ATP ADPase
% 222.76/222.96  |- skos__hiddenLabel mesh__D001081 ATP Diphosphatase
% 222.76/222.96  |- skos__hiddenLabel mesh__D001081 Diphosphohydrolase, ATP
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D033961 2004
% 222.76/222.96  |- skos__broader mesh__D033961smesh__D033942
% 222.76/222.96  |- rdf__type mesh__D033961sskos__Concept
% 222.76/222.96  |- skos__altLabel mesh__D033961 Adaptor Protein Complex 1 %28%AP-1%29%
% 222.76/222.96  |- skos__historyNote mesh__D033961 Phosphoproteins %28%1998-2001%29%
% 222.76/222.96  |- mesh__recordAuthorizer mesh__D033961 sjn
% 222.76/222.96  |- mesh__dateEstablished mesh__D033961 2003-01-01
% 222.76/222.96  |- mesh__historyNote mesh__D033961
% 222.76/222.96       2003; for ADAPTOR PROTEIN COMPLEX 1%28%AP-1%29% use CLATHRIN ADAPTOR PROTEINS %28%NM%29% 1998-2002, for GOLGI ADAPTOR PROTEIN 1 use CLATHRIN ADAPTOR PROTEIN ALPHA SUBUNITS 1994-2002%A%  
% 222.76/222.96  |- skos__altLabel mesh__D033961 Clathrin Assembly Protein Complex 1
% 222.76/222.96  |- skos__historyNote mesh__D033961 Membrane Proteins %28%2001-2002%29%
% 222.76/222.96  |- skos__historyNote mesh__D033961 Carrier Proteins %28%2001-2002%29%
% 222.76/222.96  |- mesh__recordMaintainer mesh__D033961 jmp
% 222.76/222.96  |- skos__altLabel mesh__D033961 Clathrin Adaptor Protein Complex 1
% 222.76/222.96  |- skos__historyNote mesh__D033961 Nerve Tissue Proteins %28%1998-2001%29%
% 222.76/222.96  |- mesh__recordOriginator mesh__D033961 jmp
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D033961 2005
% 222.76/222.96  |- skos__altLabel mesh__D033961 Adaptor-Related Protein Complex 1
% 222.76/222.96  |- mesh__dateCreated mesh__D033961 2002-07-02
% 222.76/222.96  |- skos__scopeNote mesh__D033961
% 222.76/222.96       A clathrin adaptor protein complex primarily involved in clathrin-related transport at the TRANS-GOLGI NETWORK.%A%    
% 222.76/222.96  |- skos__hiddenLabel mesh__D033961 Adaptor Related Protein Complex 1
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D033961 2003
% 222.76/222.96  |- skos__altLabel mesh__D033961 Golgi Adaptor Protein 1
% 222.76/222.96  |- mesh__publicMeSHNote mesh__D033961
% 222.76/222.96       2003; ADAPTOR PROTEIN COMPLEX 1%28%AP-1%29% was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 2001-2002, and under NERVE TISSUE PROTEINS %26% PHOSPHOPROTEINS 1998-2001; GOLGI ADAPTOR PROTEIN 1 was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1994-2001%A%  
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D033961 2006
% 222.76/222.96  |- skos__prefLabel mesh__D033961 Adaptor Protein Complex 1
% 222.76/222.96  |- mesh__recordAuthorizer mesh__D000787 sjn
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D000787 2005
% 222.76/222.96  |- skos__scopeNote mesh__D000787
% 222.76/222.96       The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.%A%    
% 222.76/222.96  |- skos__hiddenLabel mesh__D000787 Stenocardias
% 222.76/222.96  |- skos__broader mesh__D000787smesh__D002637
% 222.76/222.96  |- mesh__recordMaintainer mesh__D000787 nns
% 222.76/222.96  |- skos__prefLabel mesh__D000787 Angina Pectoris
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D000787 2006
% 222.76/222.96  |- mesh__dateCreated mesh__D000787 1999-01-01
% 222.76/222.96  |- skos__altLabel mesh__D000787 Angor Pectoris
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D000787 2003
% 222.76/222.96  |- skos__broader mesh__D000787smesh__D003327
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D000787 2004
% 222.76/222.96  |- skos__altLabel mesh__D000787 Stenocardia
% 222.76/222.96  |- mesh__dateRevised mesh__D000787 2001-07-25
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D000787 2002
% 222.76/222.96  |- mesh__recordOriginator mesh__D000787 NLM
% 222.76/222.96  |- rdf__type mesh__D000787sskos__Concept
% 222.76/222.96  |- mesh__dateCreated mesh__D019492 1996-06-21
% 222.76/222.96  |- skos__broader mesh__D019492smesh__D019489
% 222.76/222.96  |- mesh__dateEstablished mesh__D019492 1997-01-01
% 222.76/222.96  |- skos__scopeNote mesh__D019492
% 222.76/222.96       Works portraying in a critical or facetious way a real individual or group, or a figure representing a social, political, ethnic, or racial type. The effect is usually achieved through distortion or exaggeration of characteristics. %28%Genre Terms: A Thesaurus for Use in Rare Book and Special Collection Cataloguing, 2d ed%29%%A%    
% 222.76/222.96  |- skos__annotation mesh__D019492
% 222.76/222.96       publication type only; for caricatures as a subject, index under main heading CARICATURES; Publication Type CARTOONS is also available%A%  
% 222.76/222.96  |- skos__prefLabel mesh__D019492 Caricatures %5B%Publication Type%5D%
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D019492 2006
% 222.76/222.96  |- mesh__recordOriginator mesh__D019492 TGC
% 222.76/222.96  |- skos__broader mesh__D019492smesh__D052180
% 222.76/222.96  |- mesh__recordAuthorizer mesh__D019492 sjn
% 222.76/222.96  |- rdf__type mesh__D019492sskos__Concept
% 222.76/222.96  |- mesh__recordMaintainer mesh__D019492 jls
% 222.76/222.96  |- skos__altLabel mesh__D019492 Caricatures %28%PT%29%
% 222.76/222.96  |- mesh__historyNote mesh__D019492 1997   
% 222.76/222.96  |- mesh__dateRevised mesh__D019492 2005-06-30
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D027924 2005
% 222.76/222.96  |- skos__annotation mesh__D027924
% 222.76/222.96       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.76/222.96  |- mesh__publicMeSHNote mesh__D027924
% 222.76/222.96       2002; SAMBUCUS NIGRA was indexed under SAMBUCUS RIBOSOME-INACTIVATING PROTEIN %28%NM%29% 1999-2001%A%  
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D027924 2004
% 222.76/222.96  |- skos__altLabel mesh__D027924 Elder, European
% 222.76/222.96  |- mesh__historyNote mesh__D027924
% 222.76/222.96       2002; use SAMBUCUS RIBOSOME-INACTIVATING PROTEIN %28%NM%29% 1999-2001%A%  
% 222.76/222.96  |- skos__altLabel mesh__D027924 Elder, Black
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D027924 2003
% 222.76/222.96  |- mesh__dateCreated mesh__D027924 2001-07-25
% 222.76/222.96  |- mesh__dateEstablished mesh__D027924 2002-01-01
% 222.76/222.96  |- skos__broader mesh__D027924smesh__D027923
% 222.76/222.96  |- skos__historyNote mesh__D027924
% 222.76/222.96       Protein Synthesis Inhibitors %28%1999-2001%29%
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D027924 2002
% 222.76/222.96  |- skos__scopeNote mesh__D027924
% 222.76/222.96       A plant species in the genus SAMBUCUS, known for the elderberry fruit.  The plant is also a source of Sambucus nigra lectins and ribosome-inactivating protein.%A%    
% 222.76/222.96  |- skos__altLabel mesh__D027924 Black Elder
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D027924 2006
% 222.76/222.96  |- rdf__type mesh__D027924sskos__Concept
% 222.76/222.96  |- skos__prefLabel mesh__D027924 Sambucus nigra
% 222.76/222.96  |- mesh__dateRevised mesh__D005472 2005-06-30
% 222.76/222.96  |- skos__altLabel mesh__D005472 5-FU
% 222.76/222.96  |- skos__altLabel mesh__D005472 Neocorp Brand of Fluorouracil
% 222.76/222.96  |- skos__altLabel mesh__D005472 Ferrer Brand of Fluorouracil
% 222.76/222.96  |- skos__altLabel mesh__D005472 Fluoruracil
% 222.76/222.96  |- skos__altLabel mesh__D005472 Hexal Brand of Fluorouracil
% 222.76/222.96  |- skos__altLabel mesh__D005472 Gry Brand of Fluorouracil
% 222.76/222.96  |- skos__altLabel mesh__D005472
% 222.76/222.96       Pharmachemie Brand of Fluorouracil Monosodium Salt
% 222.76/222.96  |- skos__altLabel mesh__D005472 Riemser Brand of Fluorouracil
% 222.76/222.96  |- skos__hiddenLabel mesh__D005472 Haemato fu
% 222.76/222.96  |- skos__altLabel mesh__D005472 Haemato Brand of Fluorouracil
% 222.76/222.96  |- skos__hiddenLabel mesh__D005472 Dakota, Fluorouracile
% 222.76/222.96  |- mesh__recordOriginator mesh__D005472 NLM
% 222.76/222.96  |- skos__altLabel mesh__D005472 ribosepharm Brand of Fluorouracil
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D005472 2006
% 222.76/222.96  |- skos__hiddenLabel mesh__D005472 5 Fluorouracil biosyn
% 222.76/222.96  |- skos__altLabel mesh__D005472 5FU
% 222.76/222.96  |- skos__scopeNote mesh__D005472
% 222.76/222.96       A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.%A%    
% 222.76/222.96  |- mesh__recordMaintainer mesh__D005472 CCR
% 222.76/222.96  |- skos__hiddenLabel mesh__D005472 5 FU Lederle
% 222.76/222.96  |- skos__altLabel mesh__D005472 Onkoworks Brand of Fluorouracil
% 222.76/222.96  |- skos__altLabel mesh__D005472 Allergan Brand of Fluorouracil
% 222.76/222.96  |- mesh__recordAuthorizer mesh__D005472 sjn
% 222.76/222.96  |- mesh__dateCreated mesh__D005472 1999-01-01
% 222.76/222.96  |- skos__hiddenLabel mesh__D005472 5 FU medac
% 222.76/222.96  |- skos__hiddenLabel mesh__D005472 5 HU Hexal
% 222.76/222.96  |- skos__altLabel mesh__D005472 medac Brand of Fluorouracil
% 222.76/222.96  |- skos__hiddenLabel mesh__D005472 Fluoro Uracile ICN
% 222.76/222.96  |- rdf__type mesh__D005472sskos__Concept
% 222.76/222.96  |- skos__altLabel mesh__D005472 Dermik Brand of Fluorouracil
% 222.76/222.96  |- skos__prefLabel mesh__D005472 Fluorouracil
% 222.76/222.96  |- skos__altLabel mesh__D005472 Dermatech Brand of Fluorouracil
% 222.76/222.96  |- skos__altLabel mesh__D005472 Roche Brand of Fluorouracil
% 222.76/222.96  |- skos__altLabel mesh__D005472 Dakota Brand of Fluorouracil
% 222.76/222.96  |- skos__altLabel mesh__D005472 CSP Brand of Fluorouracil
% 222.76/222.96  |- skos__altLabel mesh__D005472 ICN Brand of Fluorouracil
% 222.76/222.96  |- skos__altLabel mesh__D005472 Efudex
% 222.76/222.96  |- skos__altLabel mesh__D005472 Fluoro-Uracile ICN
% 222.76/222.96  |- skos__altLabel mesh__D005472 biosyn Brand of Fluorouracil
% 222.76/222.96  |- skos__hiddenLabel mesh__D005472 Fluorouracil GRY
% 222.76/222.96  |- skos__broader mesh__D005472smesh__D014498
% 222.76/222.96  |- skos__altLabel mesh__D005472 5-Fluorouracil
% 222.76/222.96  |- skos__altLabel mesh__D005472 Flurodex
% 222.76/222.96  |- skos__altLabel mesh__D005472 Pharmacia Brand of Fluorouracil
% 222.76/222.96  |- skos__hiddenLabel mesh__D005472 5 Fluorouracil
% 222.76/222.96  |- skos__broader mesh__D046889smesh__D000458
% 222.76/222.96  |- mesh__dateEstablished mesh__D046889 2005-01-01
% 222.76/222.96  |- mesh__historyNote mesh__D046889 2005   
% 222.76/222.96  |- rdf__type mesh__D046889sskos__Concept
% 222.76/222.96  |- skos__scopeNote mesh__D046889
% 222.76/222.96       A form-genus of unicellular coccoid to rod-shaped CYANOBACTERIA, in the order Chroococcales. Three different clusters of strains from diverse habitats are included.%A%    
% 222.76/222.96  |- mesh__dateCreated mesh__D046889 2004-07-07
% 222.76/222.96  |- mesh__recordAuthorizer mesh__D046889 sjn
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D046889 2006
% 222.76/222.96  |- skos__historyNote mesh__D046889 Cyanobacteria %28%1993-2004%29%
% 222.76/222.96  |- skos__prefLabel mesh__D046889 Cyanothece
% 222.76/222.96  |- mesh__recordOriginator mesh__D046889 ags
% 222.76/222.96  |- mesh__publicMeSHNote mesh__D046889 2005   
% 222.76/222.96  |- mesh__recordMaintainer mesh__D046889 SYSTEM
% 222.76/222.96  |- mesh__dateRevised mesh__D046889 2005-06-30
% 222.76/222.96  |- mesh__recordMaintainer mesh__D013904 ags
% 222.76/222.96  |- mesh__dateCreated mesh__D013904 1999-01-01
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D013904 2002
% 222.76/222.96  |- skos__prefLabel mesh__D013904 Thoracic Vertebrae
% 222.76/222.96  |- mesh__recordAuthorizer mesh__D013904 sjn
% 222.76/222.96  |- skos__hiddenLabel mesh__D013904 Vertebrae, Thoracic
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D013904 2001
% 222.76/222.96  |- mesh__dateRevised mesh__D013904 1999-11-03
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D013904 2004
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D013904 2000
% 222.76/222.96  |- skos__broader mesh__D013904smesh__D013131
% 222.76/222.96  |- skos__annotation mesh__D013904
% 222.76/222.96       IM when discussed as bones or as coord with specific  spinal disease %28%IM%29%; NIM when locational; inflammation = THORACIC VERTEBRAE %28%IM%29% + SPONDYLITIS %28%IM%29%%A%  
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D013904 2006
% 222.76/222.96  |- rdf__type mesh__D013904sskos__Concept
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D013904 2003
% 222.76/222.96  |- mesh__recordOriginator mesh__D013904 NLM
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D013904 2005
% 222.76/222.96  |- skos__broader mesh__D013106smesh__D016464
% 222.76/222.96  |- mesh__publicMeSHNote mesh__D013106 1992; see SPHINGOLIPIDOSIS 1974-91   
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D013106 2005
% 222.76/222.96  |- mesh__historyNote mesh__D013106 1992%28%1974%29%   
% 222.76/222.96  |- skos__altLabel mesh__D013106 Sphingolipid Storage Diseases
% 222.76/222.96  |- mesh__dateEstablished mesh__D013106 1974-01-01
% 222.76/222.96  |- skos__altLabel mesh__D013106 Sphingolipidosis
% 222.76/222.96  |- skos__hiddenLabel mesh__D013106 Storage Diseases, Sphingolipid
% 222.76/222.96  |- mesh__dateCreated mesh__D013106 1999-01-01
% 222.76/222.96  |- skos__altLabel mesh__D013106 Deficiency Disease, Multiple Sulphatase
% 222.76/222.96  |- skos__altLabel mesh__D013106 Multiple Sulphatase Deficiency Disease
% 222.76/222.96  |- skos__altLabel mesh__D013106 Multiple Sulfatase Deficiency Disease
% 222.76/222.96  |- skos__altLabel mesh__D013106 Deficiency Disease, Multiple Sulfatase
% 222.76/222.96  |- mesh__recordAuthorizer mesh__D013106 sjn
% 222.76/222.96  |- rdf__type mesh__D013106sskos__Concept
% 222.76/222.96  |- skos__prefLabel mesh__D013106 Sphingolipidoses
% 222.76/222.96  |- skos__broader mesh__D013106smesh__D020140
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D013106 2002
% 222.76/222.96  |- skos__scopeNote mesh__D013106
% 222.76/222.96       A group of inherited metabolic disorders characterized by an excessive intra-lysosomal deposition of glycosphingolipids and phosphosphingolipids in the CENTRAL NERVOUS SYSTEM and, to a variable degree, in visceral structures. Clinical features vary with the specific subtype of the disease, but common features include progressive deterioration in psychomotor and visual function. %28%From Arch Neurol 1998 Aug;55%28%8%29%:1055-6; Menkes, Textbook of Child Neurology, 5th ed, p89%29%%A%    
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D013106 2004
% 222.76/222.96  |- skos__broader mesh__D013106smesh__D020739
% 222.76/222.96  |- mesh__recordOriginator mesh__D013106 NLM
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D013106 2003
% 222.76/222.96  |- skos__hiddenLabel mesh__D013106 Mucosulfatidoses
% 222.76/222.96  |- skos__hiddenLabel mesh__D013106 Sphingolipid Storage Disease
% 222.76/222.96  |- skos__broader mesh__D013106smesh__D008064
% 222.76/222.96  |- mesh__dateRevised mesh__D013106 2001-07-25
% 222.76/222.96  |- skos__hiddenLabel mesh__D013106 Storage Disease, Sphingolipid
% 222.76/222.96  |- mesh__recordMaintainer mesh__D013106 nns
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D013106 2006
% 222.76/222.96  |- skos__altLabel mesh__D051225 Os Hamatum
% 222.76/222.96  |- mesh__dateCreated mesh__D051225 2005-06-30
% 222.76/222.96  |- mesh__recordOriginator mesh__D051225 ags
% 222.76/222.96  |- skos__scopeNote mesh__D051225
% 222.76/222.96       A carpal bone located between the CAPITATE BONE and the TRIQUETRUM BONE. The hamate has a prominent process that projects anteriorly.%A%    
% 222.76/222.96  |- skos__hiddenLabel mesh__D051225 Bone, Hamate
% 222.76/222.96  |- skos__broader mesh__D051225smesh__D002348
% 222.76/222.96  |- skos__prefLabel mesh__D051225 Hamate Bone
% 222.76/222.96  |- mesh__dateEstablished mesh__D051225 2006-01-01
% 222.76/222.96  |- mesh__recordAuthorizer mesh__D051225 sjn
% 222.76/222.96  |- skos__hiddenLabel mesh__D051225 Bones, Hamate
% 222.76/222.96  |- skos__hiddenLabel mesh__D051225 Hamate Bones
% 222.76/222.96  |- mesh__recordMaintainer mesh__D051225 ags
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D051225 2006
% 222.76/222.96  |- skos__historyNote mesh__D051225 Carpal Bones %28%1971-2005%29%
% 222.76/222.96  |- mesh__historyNote mesh__D051225 2006   
% 222.76/222.96  |- mesh__publicMeSHNote mesh__D051225 2006   
% 222.76/222.96  |- rdf__type mesh__D051225sskos__Concept
% 222.76/222.96  |- mesh__dateRevised mesh__D009863 2002-07-03
% 222.76/222.96  |- skos__scopeNote mesh__D009863 Child who has no siblings.     
% 222.76/222.96  |- skos__altLabel mesh__D009863 Only Children
% 222.76/222.96  |- mesh__publicMeSHNote mesh__D009863 68   
% 222.76/222.96  |- skos__broader mesh__D009863smesh__D009679
% 222.76/222.96  |- skos__hiddenLabel mesh__D009863 Child, Only
% 222.76/222.96  |- mesh__recordOriginator mesh__D009863 NLM
% 222.76/222.96  |- mesh__recordMaintainer mesh__D009863 PXP
% 222.76/222.96  |- mesh__recordAuthorizer mesh__D009863 sjn
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009863 2005
% 222.76/222.96  |- mesh__historyNote mesh__D009863 68   
% 222.76/222.96  |- mesh__dateEstablished mesh__D009863 1968-01-01
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009863 2006
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009863 2003
% 222.76/222.96  |- skos__prefLabel mesh__D009863 Only Child
% 222.76/222.96  |- skos__hiddenLabel mesh__D009863 Children, Only
% 222.76/222.96  |- rdf__type mesh__D009863sskos__Concept
% 222.76/222.96  |- mesh__dateCreated mesh__D009863 1999-01-01
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009863 2004
% 222.76/222.96  |- mesh__historyNote mesh__D001880 68   
% 222.76/222.96  |- mesh__dateCreated mesh__D001880 1999-01-01
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D001880 2005
% 222.76/222.96  |- skos__annotation mesh__D001880
% 222.76/222.96       collective name for boron hydrides %28%do not confuse with BOROHYDRIDES%29%; do not confuse with BORATES or BORNANES%A%  
% 222.76/222.96  |- skos__altLabel mesh__D001880 Boron Hydrides
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D001880 2002
% 222.76/222.96  |- rdf__type mesh__D001880sskos__Concept
% 222.76/222.96  |- skos__broader mesh__D001880smesh__D001896
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D001880 2006
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D001880 1996
% 222.76/222.96  |- mesh__dateRevised mesh__D001880 1993-06-04
% 222.76/222.96  |- skos__prefLabel mesh__D001880 Boranes
% 222.76/222.96  |- mesh__dateEstablished mesh__D001880 1968-01-01
% 222.76/222.96  |- mesh__recordOriginator mesh__D001880 NLM
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D001880 1997
% 222.76/222.96  |- skos__hiddenLabel mesh__D001880 Hydrides, Boron
% 222.76/222.96  |- mesh__recordAuthorizer mesh__D001880 PLS
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D001880 1998
% 222.76/222.96  |- mesh__recordMaintainer mesh__D001880 TPW
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D001880 2003
% 222.76/222.96  |- mesh__publicMeSHNote mesh__D001880 68   
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D001880 1994
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D001880 1999
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D001880 2000
% 222.76/222.96  |- skos__scopeNote mesh__D001880
% 222.76/222.96       The collective name for the boron hydrides, which are analogous to the alkanes and silanes. Numerous boranes are known. Some have high calorific values and are used in high-energy fuels. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D001880 2004
% 222.76/222.96  |- skos__historyNote mesh__D001880 Boron %28%1966-1967%29%
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D001880 2001
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D001880 1995
% 222.76/222.96  |- skos__annotation mesh__D009065
% 222.76/222.96       GEN only; to restore mouth to optimal form %26% function %28%filling %26% replacing teeth, ther of mouth %26% tooth dis, etc.%29%: prefer specifics in Cat E6%A%  
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009065 2002
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009065 1996
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009065 2003
% 222.76/222.96  |- mesh__dateEstablished mesh__D009065 1965-01-01
% 222.76/222.96  |- skos__broader mesh__D009065smesh__D003813
% 222.76/222.96  |- mesh__recordAuthorizer mesh__D009065 PLS
% 222.76/222.96  |- mesh__historyNote mesh__D009065 65   
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009065 2006
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009065 1999
% 222.76/222.96  |- skos__prefLabel mesh__D009065 Mouth Rehabilitation
% 222.76/222.96  |- mesh__dateRevised mesh__D009065 1992-05-15
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009065 1997
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009065 2004
% 222.76/222.96  |- skos__hiddenLabel mesh__D009065 Rehabilitation, Mouth
% 222.76/222.96  |- mesh__recordOriginator mesh__D009065 NLM
% 222.76/222.96  |- skos__hiddenLabel mesh__D009065 Mouth Rehabilitations
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009065 2000
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009065 1994
% 222.76/222.96  |- mesh__recordMaintainer mesh__D009065 TAP
% 222.76/222.96  |- rdf__type mesh__D009065sskos__Concept
% 222.76/222.96  |- mesh__publicMeSHNote mesh__D009065 65   
% 222.76/222.96  |- skos__hiddenLabel mesh__D009065 Rehabilitations, Mouth
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009065 2001
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009065 1995
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009065 1993
% 222.76/222.96  |- mesh__dateCreated mesh__D009065 1999-01-01
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009065 1998
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D009065 2005
% 222.76/222.96  |- skos__hiddenLabel mesh__D001082 Intraocular Fluids
% 222.76/222.96  |- skos__hiddenLabel mesh__D001082 Aqueous Humors
% 222.76/222.96  |- skos__broader mesh__D001082smesh__D045604
% 222.76/222.96  |- skos__hiddenLabel mesh__D001082 Fluid, Intraocular
% 222.76/222.96  |- skos__scopeNote mesh__D001082
% 222.76/222.96       The clear, watery fluid which fills the anterior and posterior chambers of the eye. It has a refractive index lower than the crystalline lens, which it surrounds, and is involved in the metabolism of the cornea and the crystalline lens. %28%Cline et al., Dictionary of Visual Science, 4th ed, p319%29%%A%    
% 222.76/222.96  |- mesh__dateCreated mesh__D001082 1999-01-01
% 222.76/222.96  |- skos__hiddenLabel mesh__D001082 Flare, Aqueous
% 222.76/222.96  |- skos__prefLabel mesh__D001082 Aqueous Humor
% 222.76/222.96  |- skos__altLabel mesh__D001082 Intraocular Fluid
% 222.76/222.96  |- skos__annotation mesh__D001082 in the eye   
% 222.76/222.96  |- skos__broader mesh__D001082smesh__D000867
% 222.76/222.96  |- skos__hiddenLabel mesh__D001082 Humor, Aqueous
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D001082 2006
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D001082 2004
% 222.76/222.96  |- rdf__type mesh__D001082sskos__Concept
% 222.76/222.96  |- mesh__activeMeSHYear mesh__D001082 2005
% 222.76/222.96  |- skos__hiddenLabel mesh__D001082 Fluids, Intraocular
% 222.76/222.96  |- skos__hiddenLabel mesh__D001082 Aqueous Flares
% 222.76/222.96  |- mesh__dateRevised mesh__D001082 2003-07-09
% 222.76/222.96  |- skos__hiddenLabel mesh__D001082 Humors, Aqueous
% 222.76/222.96  |- mesh__recordMaintainer mesh__D001082 nns
% 222.76/222.96  |- mesh__recordOriginator mesh__D001082 NLM
% 222.76/222.96  |- mesh__recordAuthorizer mesh__D001082 sjn
% 222.76/222.96  |- skos__altLabel mesh__D033962 Clathrin Adaptor Protein Complex 2
% 222.76/222.96  |- skos__altLabel mesh__D033962 AP-2 Protein Complex
% 222.76/222.96  |- skos__altLabel mesh__D033962 HA-2 Adaptors
% 222.76/222.96  |- skos__historyNote mesh__D033962 Membrane Proteins %28%2001-2002%29%
% 222.76/222.96  |- skos__historyNote mesh__D033962 Carrier Proteins %28%2001-2002%29%
% 222.76/222.96  |- mesh__recordMaintainer mesh__D033962 jmp
% 222.76/222.96  |- skos__altLabel mesh__D033962 Hydroxyapatite 2 Adaptors
% 222.76/222.96  |- skos__altLabel mesh__D033962
% 222.76/222.96       AP-2 Adaptor %28%Clathrin-Coated Vesicles%29%
% 222.76/222.96  |- skos__broader mesh__D033962smesh__D033942
% 222.76/222.96  |- skos__scopeNote mesh__D033962
% 222.76/222.96       An adaptor protein complex primarily involved in the formation of clathrin-related endocytotic vesicles %28%ENDOSOMES%29% at the CELL MEMBRANE.%A%    
% 222.76/222.96  |- skos__altLabel mesh__D033962 Clathrin Assembly Protein Complex 2
% 222.76/222.96  |- skos__altLabel mesh__D033962 Adaptor-Related Protein Complex 2
% 222.76/222.96  |- mesh__recordAuthorizer mesh__D033962 sjn
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D033962 2005
% 222.76/222.97  |- skos__historyNote mesh__D033962 Phosphoproteins %28%1994-2001%29%
% 222.76/222.97  |- mesh__dateRevised mesh__D033962 2004-07-07
% 222.76/222.97  |- mesh__dateEstablished mesh__D033962 2003-01-01
% 222.76/222.97  |- skos__hiddenLabel mesh__D033962 Adaptor Related Protein Complex 2
% 222.76/222.97  |- mesh__historyNote mesh__D033962
% 222.76/222.97       2003; for AP-2 PROTEIN COMPLEX, AP-2 ADAPTOR %28%CLATHRIN-COATED VESICLES%29%, HA-2 ADAPTORS %26% HYDROXYAPATITE 2 ADAPTORS  use CLATHRIN ADAPTOR PROTEINS %28%NM%29% 1994-2002%A%  
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D033962 2006
% 222.76/222.97  |- skos__prefLabel mesh__D033962 Adaptor Protein Complex 2
% 222.76/222.97  |- skos__historyNote mesh__D033962 Nerve Tissue Proteins %28%1994-2001%29%
% 222.76/222.97  |- skos__hiddenLabel mesh__D033962 HA 2 Adaptors
% 222.76/222.97  |- mesh__publicMeSHNote mesh__D033962
% 222.76/222.97       2003; AP-2 PROTEIN COMPLEX, AP-2 ADAPTOR %28%CLATHRIN-COATED VESICLES%29%, HA-2 ADAPTORS, HYDROXYAPATITE 2 ADAPTORS were indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 2001-2002, and under NERVE TISSUE PROTEINS %26% PHOSPHOPROTEINS 1994-2001%A%  
% 222.76/222.97  |- skos__hiddenLabel mesh__D033962 AP 2 Protein Complex
% 222.76/222.97  |- mesh__recordOriginator mesh__D033962 jmp
% 222.76/222.97  |- rdf__type mesh__D033962sskos__Concept
% 222.76/222.97  |- mesh__dateCreated mesh__D033962 2002-07-02
% 222.76/222.97  |- skos__broader mesh__D000788smesh__D003329
% 222.76/222.97  |- skos__hiddenLabel mesh__D000788 Angina, Prinzmetal%27%s
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D000788 2004
% 222.76/222.97  |- skos__hiddenLabel mesh__D000788 Angina, Prinzmetal
% 222.76/222.97  |- skos__hiddenLabel mesh__D000788 Prinzmetals Angina
% 222.76/222.97  |- skos__prefLabel mesh__D000788 Angina Pectoris, Variant
% 222.76/222.97  |- mesh__publicMeSHNote mesh__D000788
% 222.76/222.97       84; was see under CORONARY VASOSPASM 1982-83, was see under ANGINA PECTORIS 1977-81%A%  
% 222.76/222.97  |- mesh__dateRevised mesh__D000788 2001-07-25
% 222.76/222.97  |- skos__broader mesh__D000788smesh__D000789
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D000788 2002
% 222.76/222.97  |- mesh__recordAuthorizer mesh__D000788 sjn
% 222.76/222.97  |- mesh__recordMaintainer mesh__D000788 nns
% 222.76/222.97  |- rdf__type mesh__D000788sskos__Concept
% 222.76/222.97  |- skos__scopeNote mesh__D000788
% 222.76/222.97       A clinical syndrome characterized by the development of CHEST PAIN at rest with concomitant transient ST segment elevation in the electrocardiogram, but with preserved exercise capacity.%A%    
% 222.76/222.97  |- mesh__dateCreated mesh__D000788 1976-04-27
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D000788 2005
% 222.76/222.97  |- mesh__recordOriginator mesh__D000788 VDK
% 222.76/222.97  |- mesh__dateEstablished mesh__D000788 1984-01-01
% 222.76/222.97  |- skos__hiddenLabel mesh__D000788 Variant Angina Pectoris
% 222.76/222.97  |- skos__altLabel mesh__D000788 Prinzmetal Angina
% 222.76/222.97  |- skos__broader mesh__D000788smesh__D000787
% 222.76/222.97  |- skos__historyNote mesh__D000788 Angina Pectoris %28%1966-1976%29%
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D000788 2006
% 222.76/222.97  |- skos__altLabel mesh__D000788 Prinzmetal%27%s Angina
% 222.76/222.97  |- mesh__historyNote mesh__D000788
% 222.76/222.97       84%28%77%29%; was see under CORONARY VASOSPASM 1982-83, was see under ANGINA PECTORIS 1977-81%A%  
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D000788 2003
% 222.76/222.97  |- mesh__recordAuthorizer mesh__D019493 sjn
% 222.76/222.97  |- mesh__dateEstablished mesh__D019493 1997-01-01
% 222.76/222.97  |- mesh__recordOriginator mesh__D019493 TGC
% 222.76/222.97  |- skos__scopeNote mesh__D019493
% 222.76/222.97       Works consisting of humorous, satirical, or ridiculing images executed in a broad or abbreviated manner.%A%    
% 222.76/222.97  |- mesh__historyNote mesh__D019493 1997   
% 222.76/222.97  |- mesh__dateRevised mesh__D019493 2005-06-30
% 222.76/222.97  |- skos__altLabel mesh__D019493 Cartoons %28%PT%29%
% 222.76/222.97  |- skos__prefLabel mesh__D019493 Cartoons %5B%Publication Type%5D%
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D019493 2006
% 222.76/222.97  |- mesh__dateCreated mesh__D019493 1996-06-21
% 222.76/222.97  |- skos__broader mesh__D019493smesh__D052180
% 222.76/222.97  |- skos__annotation mesh__D019493
% 222.76/222.97       publication type only; for cartoons as a subject, index under main heading CARTOONS; Publication Type CARICATURES is also available%A%  
% 222.76/222.97  |- skos__broader mesh__D019493smesh__D020480
% 222.76/222.97  |- mesh__recordMaintainer mesh__D019493 jls
% 222.76/222.97  |- rdf__type mesh__D019493sskos__Concept
% 222.76/222.97  |- skos__scopeNote mesh__D027925
% 222.76/222.97       A plant genus in the family CAPRIFOLIACEAE.  The common name derives from its traditional use for menstrual cramps.  It is a source of viburnine, valerianic acid, vibsanin, and ursolic acid.  Note that true cranberry is VACCINIUM MACROCARPON.%A%    
% 222.76/222.97  |- skos__altLabel mesh__D027925 Cranberry, Highbush
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D027925 2003
% 222.76/222.97  |- mesh__publicMeSHNote mesh__D027925 2002   
% 222.76/222.97  |- mesh__dateEstablished mesh__D027925 2002-01-01
% 222.76/222.97  |- skos__broader mesh__D027925smesh__D027922
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D027925 2006
% 222.76/222.97  |- mesh__dateCreated mesh__D027925 2001-07-25
% 222.76/222.97  |- rdf__type mesh__D027925sskos__Concept
% 222.76/222.97  |- skos__altLabel mesh__D027925 Cramp Bark
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D027925 2005
% 222.76/222.97  |- skos__altLabel mesh__D027925 Highbush Cranberry
% 222.76/222.97  |- mesh__historyNote mesh__D027925 2002   
% 222.76/222.97  |- skos__historyNote mesh__D027925 Plants %28%1966-2001%29%
% 222.76/222.97  |- skos__prefLabel mesh__D027925 Viburnum
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D027925 2002
% 222.76/222.97  |- skos__annotation mesh__D027925
% 222.76/222.97       do not confuse with true cranberry = VACCINIUM MACROCARPON; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D027925 2004
% 222.76/222.97  |- skos__hiddenLabel mesh__D005473 Lilly110140
% 222.76/222.97  |- skos__historyNote mesh__D005473 Phenyl Ethers %28%1974-1978%29%
% 222.76/222.97  |- mesh__recordMaintainer mesh__D005473 lkt
% 222.76/222.97  |- mesh__publicMeSHNote mesh__D005473
% 222.76/222.97       90; was FLUOXETIN see under PROPYLAMINES 1979-88; was FLUOXETIN 1989%A%  
% 222.76/222.97  |- skos__historyNote mesh__D005473 Propylamines %28%1966-1978%29%
% 222.76/222.97  |- rdf__type mesh__D005473sskos__Concept
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D005473 2005
% 222.76/222.97  |- skos__altLabel mesh__D005473 Fluoxetin
% 222.76/222.97  |- skos__altLabel mesh__D005473
% 222.76/222.97       N-Methyl-gamma-%28%4-%28%trifluoromethyl%29%phenoxy%29%benzenepropanamine
% 222.76/222.97  |- mesh__onlineNote mesh__D005473
% 222.76/222.97       use FLUOXETINE to search FLUOXETIN 1979-89   
% 222.76/222.97  |- mesh__recordAuthorizer mesh__D005473 sjn
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D005473 2006
% 222.76/222.97  |- mesh__dateEstablished mesh__D005473 1989-01-01
% 222.76/222.97  |- skos__prefLabel mesh__D005473 Fluoxetine
% 222.76/222.97  |- mesh__recordOriginator mesh__D005473 SH
% 222.76/222.97  |- mesh__dateRevised mesh__D005473 2004-07-07
% 222.76/222.97  |- skos__hiddenLabel mesh__D005473 Hydrochloride, Fluoxetine
% 222.76/222.97  |- skos__hiddenLabel mesh__D005473 Lilly 110140
% 222.76/222.97  |- skos__altLabel mesh__D005473 Sarafem
% 222.76/222.97  |- mesh__dateCreated mesh__D005473 1977-12-09
% 222.76/222.97  |- mesh__historyNote mesh__D005473
% 222.76/222.97       90%28%79%29%; was FLUOXETIN see under PROPYLAMINES 1979-88; was FLUOXETIN 1989%A%  
% 222.76/222.97  |- skos__broader mesh__D005473smesh__D011437
% 222.76/222.97  |- skos__scopeNote mesh__D005473
% 222.76/222.97       The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.%A%    
% 222.76/222.97  |- skos__scopeNote mesh__D013905
% 222.76/222.97       Surgical removal of ribs, allowing the chest wall to move inward and collapse a diseased lung. %28%Dorland, 28th ed%29%%A%    
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D013905 2000
% 222.76/222.97  |- mesh__dateRevised mesh__D013905 1997-06-20
% 222.76/222.97  |- skos__hiddenLabel mesh__D013905 Thoracoplasties
% 222.76/222.97  |- skos__broader mesh__D013905smesh__D019616
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D013905 2004
% 222.76/222.97  |- mesh__recordOriginator mesh__D013905 NLM
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D013905 2006
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D013905 2003
% 222.76/222.97  |- mesh__recordMaintainer mesh__D013905 PXP
% 222.76/222.97  |- rdf__type mesh__D013905sskos__Concept
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D013905 2005
% 222.76/222.97  |- skos__annotation mesh__D013905
% 222.76/222.97       do not use /util except by MeSH definition   
% 222.76/222.97  |- mesh__recordAuthorizer mesh__D013905 SJN
% 222.76/222.97  |- skos__prefLabel mesh__D013905 Thoracoplasty
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D013905 2002
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D013905 1999
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D013905 2001
% 222.76/222.97  |- mesh__dateCreated mesh__D013905 1999-01-01
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D013905 1998
% 222.76/222.97  |- skos__prefLabel mesh__D013107 Sphingolipids
% 222.76/222.97  |- mesh__onlineNote mesh__D013107 search LIPIDS 1966-70   
% 222.76/222.97  |- mesh__recordMaintainer mesh__D013107 jmp
% 222.76/222.97  |- rdf__type mesh__D013107sskos__Concept
% 222.76/222.97  |- skos__scopeNote mesh__D013107
% 222.76/222.97       A class of membrane lipids that have a polar head and two nonpolar tails. They are composed of one molecule of the long-chain amino alcohol sphingosine %28%4-sphingenine%29% or one of its derivatives, one molecule of a long-chain acid, a polar head alcohol and sometimes phosphoric acid in diester linkage at the polar head group. %28%Lehninger et al, Principles of Biochemistry, 2nd ed%29%%A%    
% 222.76/222.97  |- mesh__publicMeSHNote mesh__D013107 72; was see under LIPIDS 1963-71   
% 222.76/222.97  |- skos__related mesh__D013107smesh__D013110
% 222.76/222.97  |- skos__broader mesh__D013107smesh__D008055
% 222.76/222.97  |- mesh__historyNote mesh__D013107
% 222.76/222.97       72%28%71%29%; was see under LIPIDS 1963-71   
% 222.76/222.97  |- mesh__dateRevised mesh__D013107 2004-07-07
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D013107 2005
% 222.76/222.97  |- mesh__recordAuthorizer mesh__D013107 sjn
% 222.76/222.97  |- mesh__dateEstablished mesh__D013107 1972-01-01
% 222.76/222.97  |- skos__historyNote mesh__D013107 Lipids %28%1966-1970%29%
% 222.76/222.97  |- mesh__dateCreated mesh__D013107 1999-01-01
% 222.76/222.97  |- skos__broader mesh__D013107smesh__D008563
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D013107 2006
% 222.76/222.97  |- mesh__recordOriginator mesh__D013107 NLM
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D009864 1998
% 222.76/222.97  |- mesh__recordAuthorizer mesh__D009864 PLS
% 222.76/222.97  |- mesh__dateRevised mesh__D009864 1995-02-21
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D009864 2006
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D009864 1999
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D009864 2000
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D009864 2003
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D009864 2001
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D009864 1996
% 222.76/222.97  |- mesh__recordMaintainer mesh__D009864 TGC
% 222.76/222.97  |- skos__broader mesh__D009864smesh__D002170
% 222.76/222.97  |- skos__scopeNote mesh__D009864
% 222.76/222.97       A province of Canada lying between the provinces of Manitoba and Quebec. Its capital is Toronto. It takes its name from Lake Ontario which is said to represent the Iroquois oniatariio, beautiful lake. %28%From Webster%27%s New Geographical Dictionary, 1988, p892 %26% Room, Brewer%27%s Dictionary of Names, 1992, p391%29%%A%    
% 222.76/222.97  |- rdf__type mesh__D009864sskos__Concept
% 222.76/222.97  |- mesh__dateCreated mesh__D009864 1999-01-01
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D009864 2004
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D009864 1997
% 222.76/222.97  |- mesh__recordOriginator mesh__D009864 NLM
% 222.76/222.97  |- skos__prefLabel mesh__D009864 Ontario
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D009864 2002
% 222.76/222.97  |- skos__annotation mesh__D009864 a province of Canada   
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D009864 2005
% 222.76/222.97  |- skos__broader mesh__D001881smesh__D000838
% 222.76/222.97  |- rdf__type mesh__D001881sskos__Concept
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D001881 2006
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D001881 2000
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D001881 1996
% 222.76/222.97  |- skos__annotation mesh__D001881 do not confuse with BORANES   
% 222.76/222.97  |- mesh__dateRevised mesh__D001881 1993-07-08
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D001881 2001
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D001881 1997
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D001881 2002
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D001881 1998
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D001881 2003
% 222.76/222.97  |- mesh__recordMaintainer mesh__D001881 TPW
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D001881 1994
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D001881 1999
% 222.76/222.97  |- skos__broader mesh__D001881smesh__D001888
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D001881 2004
% 222.76/222.97  |- skos__prefLabel mesh__D001881 Borates
% 222.76/222.97  |- mesh__recordAuthorizer mesh__D001881 PLS
% 222.76/222.97  |- mesh__recordOriginator mesh__D001881 NLM
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D001881 1995
% 222.76/222.97  |- skos__scopeNote mesh__D001881
% 222.76/222.97       Inorganic or organic salts and esters of boric acid.     
% 222.76/222.97  |- mesh__dateCreated mesh__D001881 1999-01-01
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D001881 2005
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D009066 2000
% 222.76/222.97  |- skos__broader mesh__D009066smesh__D009059
% 222.76/222.97  |- mesh__dateEstablished mesh__D009066 1965-01-01
% 222.76/222.97  |- mesh__historyNote mesh__D009066
% 222.76/222.97       65; included total %26% partial edentulous state 1965-79   
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D009066 2004
% 222.76/222.97  |- mesh__dateRevised mesh__D009066 1999-11-03
% 222.76/222.97  |- skos__related mesh__D009066smesh__D003824
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D009066 2003
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D009066 2006
% 222.76/222.97  |- skos__hiddenLabel mesh__D009066 Edentulous Mouths
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D009066 2005
% 222.76/222.97  |- skos__hiddenLabel mesh__D009066 Mouths, Edentulous
% 222.76/222.97  |- skos__prefLabel mesh__D009066 Mouth, Edentulous
% 222.76/222.97  |- skos__annotation mesh__D009066
% 222.76/222.97       total lack of teeth through disease or extraction; do not confuse with ANODONTIA %28%congen absence of one or more teeth%29%; differentiate from JAW, EDENTULOUS %26% JAW, EDENTULOUS, PARTIALLY %28%see definitions under JAW, EDENTULOUS%29%%A%  
% 222.76/222.97  |- skos__related mesh__D009066smesh__D013516
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D009066 2002
% 222.76/222.97  |- mesh__recordMaintainer mesh__D009066 jls
% 222.76/222.97  |- mesh__dateCreated mesh__D009066 1999-01-01
% 222.76/222.97  |- mesh__recordOriginator mesh__D009066 NLM
% 222.76/222.97  |- mesh__recordAuthorizer mesh__D009066 sjn
% 222.76/222.97  |- mesh__publicMeSHNote mesh__D009066
% 222.76/222.97       65; included total %26% partial edentulous state 1965-79   
% 222.76/222.97  |- skos__scopeNote mesh__D009066
% 222.76/222.97       Having teeth in neither the mandible nor the maxilla.     
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D009066 2001
% 222.76/222.97  |- skos__hiddenLabel mesh__D009066 Edentulous Mouth
% 222.76/222.97  |- rdf__type mesh__D009066sskos__Concept
% 222.76/222.97  |- mesh__recordOriginator mesh__D001083 NLM
% 222.76/222.97  |- mesh__recordAuthorizer mesh__D001083 sjn
% 222.76/222.97  |- skos__annotation mesh__D001083
% 222.76/222.97       a hist name; do not confuse with SAUDI ARABIA nor with ARAB WORLD, the culture %26% civilization; Manual 36.13%A%  
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D001083 2006
% 222.76/222.97  |- skos__prefLabel mesh__D001083 Arabia
% 222.76/222.97  |- rdf__type mesh__D001083sskos__Concept
% 222.76/222.97  |- mesh__dateRevised mesh__D001083 2004-07-19
% 222.76/222.97  |- skos__broader mesh__D001083smesh__D018436
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D001083 2005
% 222.76/222.97  |- skos__scopeNote mesh__D001083
% 222.76/222.97       The great peninsula of southwest Asia comprising most of the present countries of the Middle East. It has been known since the first millennium B.C. In early times it was divided into Arabia Petraea, the northwest part, the only part ever conquered, becoming a Roman province; Arabia Deserta, the northern part between Syria and Mesopotamia; and Arabia Felix, the main part of the peninsula but by some geographers restricted to modern Yemen. %28%From Webster%27%s New Geographical Dictionary, 1988, p63%29%%A%    
% 222.76/222.97  |- mesh__recordMaintainer mesh__D001083 jls
% 222.76/222.97  |- mesh__dateCreated mesh__D001083 1999-01-01
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D014200 2004
% 222.76/222.97  |- skos__related mesh__D014200smesh__D000980
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D014200 2006
% 222.76/222.97  |- skos__altLabel mesh__D014200 Flukes
% 222.76/222.97  |- mesh__dateCreated mesh__D014200 1999-01-01
% 222.76/222.97  |- mesh__recordOriginator mesh__D014200 NLM
% 222.76/222.97  |- skos__scopeNote mesh__D014200
% 222.76/222.97       Class of parasitic flukes consisting of three subclasses, Monogenea, Aspidogastrea, and Digenea. The digenetic trematodes are the only ones found in man. They are endoparasites and require two hosts to complete their life cycle.%A%    
% 222.76/222.97  |- mesh__recordMaintainer mesh__D014200 ags
% 222.76/222.97  |- skos__prefLabel mesh__D014200 Trematoda
% 222.76/222.97  |- mesh__dateRevised mesh__D014200 2003-07-09
% 222.76/222.97  |- mesh__recordAuthorizer mesh__D014200 sjn
% 222.76/222.97  |- rdf__type mesh__D014200sskos__Concept
% 222.76/222.97  |- skos__annotation mesh__D014200
% 222.76/222.97       GEN or unspecified; prefer specifics; infection = TREMATODE INFECTIONS; /drug eff: consider also ANTIPLATYHELMINTIC AGENTS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 222.76/222.97  |- skos__broader mesh__D014200smesh__D010986
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D014200 2005
% 222.76/222.97  |- skos__historyNote mesh__D033963 Membrane Proteins %28%2001-2002%29%
% 222.76/222.97  |- skos__altLabel mesh__D033963 Adaptor-Related Protein Complex 3
% 222.76/222.97  |- mesh__recordMaintainer mesh__D033963 jmp
% 222.76/222.97  |- skos__prefLabel mesh__D033963 Adaptor Protein Complex 3
% 222.76/222.97  |- skos__historyNote mesh__D033963 Carrier Proteins %28%2001-2002%29%
% 222.76/222.97  |- skos__historyNote mesh__D033963 Nerve Tissue Proteins %28%1998-2001%29%
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D033963 2005
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D033963 2003
% 222.76/222.97  |- mesh__publicMeSHNote mesh__D033963
% 222.76/222.97       2003; AP3 ADAPTOR COMPLEX was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 2001-2002, and under NERVE TISSUE PROTEINS %26% PHOSPHOPROTEINS 1998-2001%A%  
% 222.76/222.97  |- skos__altLabel mesh__D033963 Clathrin Assembly Protein Complex 3
% 222.76/222.97  |- mesh__recordOriginator mesh__D033963 jmp
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D033963 2006
% 222.76/222.97  |- mesh__dateCreated mesh__D033963 2002-07-02
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D033963 2004
% 222.76/222.97  |- skos__scopeNote mesh__D033963
% 222.76/222.97       An adaptor protein complex found primarily on perinuclear compartments.%A%    
% 222.76/222.97  |- rdf__type mesh__D033963sskos__Concept
% 222.76/222.97  |- skos__hiddenLabel mesh__D033963 Adaptor Complex, AP3
% 222.76/222.97  |- skos__altLabel mesh__D033963 Clathrin Adaptor Protein Complex 3
% 222.76/222.97  |- skos__broader mesh__D033963smesh__D033942
% 222.76/222.97  |- mesh__dateEstablished mesh__D033963 2003-01-01
% 222.76/222.97  |- skos__historyNote mesh__D033963 Phosphoproteins %28%1998-2001%29%
% 222.76/222.97  |- skos__hiddenLabel mesh__D033963 Adaptor Related Protein Complex 3
% 222.76/222.97  |- skos__altLabel mesh__D033963 AP3 Adaptor Complex
% 222.76/222.97  |- mesh__recordAuthorizer mesh__D033963 sjn
% 222.76/222.97  |- mesh__historyNote mesh__D033963
% 222.76/222.97       2003; for AP3 ADAPTOR COMPLEX use CLATHRIN ADAPTOR PROTEINS %28%NM%29% 1998-2002%A%  
% 222.76/222.97  |- skos__broader mesh__D000789smesh__D000787
% 222.76/222.97  |- skos__altLabel mesh__D000789 Unstable Angina
% 222.76/222.97  |- skos__hiddenLabel mesh__D000789 Preinfarction Syndrome, Myocardial
% 222.76/222.97  |- skos__hiddenLabel mesh__D000789 Syndromes, Myocardial Preinfarction
% 222.76/222.97  |- skos__historyNote mesh__D000789 Angina Pectoris %28%1966-1983%29%
% 222.76/222.97  |- skos__prefLabel mesh__D000789 Angina, Unstable
% 222.76/222.97  |- skos__hiddenLabel mesh__D000789 Unstable Anginas
% 222.76/222.97  |- skos__hiddenLabel mesh__D000789 Myocardial Preinfarction Syndromes
% 222.76/222.97  |- skos__historyNote mesh__D000789
% 222.76/222.97       Angina Pectoris, Variant %28%1977-1983%29%
% 222.76/222.97  |- rdf__type mesh__D000789sskos__Concept
% 222.76/222.97  |- skos__historyNote mesh__D000789 Coronary Disease %28%1966-1983%29%
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D000789 2005
% 222.76/222.97  |- skos__hiddenLabel mesh__D000789 Preinfarction Anginas
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D000789 2002
% 222.76/222.97  |- skos__hiddenLabel mesh__D000789 Preinfarction Syndromes, Myocardial
% 222.76/222.97  |- mesh__dateRevised mesh__D000789 2001-07-25
% 222.76/222.97  |- mesh__recordAuthorizer mesh__D000789 sjn
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D000789 2006
% 222.76/222.97  |- mesh__recordMaintainer mesh__D000789 nns
% 222.76/222.97  |- skos__hiddenLabel mesh__D000789 Syndrome, Myocardial Preinfarction
% 222.76/222.97  |- mesh__publicMeSHNote mesh__D000789
% 222.76/222.97       91; was see under ANGINA PECTORIS 1984-90   
% 222.76/222.97  |- skos__hiddenLabel mesh__D000789 Anginas, Preinfarction
% 222.76/222.97  |- mesh__historyNote mesh__D000789
% 222.76/222.97       91%28%84%29%; was see under ANGINA PECTORIS 1984-90   
% 222.76/222.97  |- skos__scopeNote mesh__D000789
% 222.76/222.97       Precordial pain at rest, which may precede a MYOCARDIAL INFARCTION.%A%    
% 222.76/222.97  |- skos__altLabel mesh__D000789 Angina at Rest
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D000789 2003
% 222.76/222.97  |- mesh__dateEstablished mesh__D000789 1991-01-01
% 222.76/222.97  |- skos__hiddenLabel mesh__D000789 Anginas, Unstable
% 222.76/222.97  |- skos__altLabel mesh__D000789 Angina, Preinfarction
% 222.76/222.97  |- skos__hiddenLabel mesh__D000789 Preinfarction Angina
% 222.76/222.97  |- mesh__dateCreated mesh__D000789 1983-05-03
% 222.76/222.97  |- mesh__recordOriginator mesh__D000789 VDK
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D000789 2004
% 222.76/222.97  |- mesh__recordMaintainer mesh__D019494 jls
% 222.76/222.97  |- mesh__recordAuthorizer mesh__D019494 sjn
% 222.76/222.97  |- mesh__dateEstablished mesh__D019494 1997-01-01
% 222.76/222.97  |- mesh__recordOriginator mesh__D019494 TGC
% 222.76/222.97  |- skos__related mesh__D019494smesh__D020507
% 222.76/222.97  |- skos__related mesh__D019494smesh__D020503
% 222.76/222.97  |- mesh__historyNote mesh__D019494 1997   
% 222.76/222.97  |- mesh__dateRevised mesh__D019494 2005-06-30
% 222.76/222.97  |- skos__prefLabel mesh__D019494 Catalogs %5B%Publication Type%5D%
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D019494 2006
% 222.76/222.97  |- skos__altLabel mesh__D019494 Catalogs %28%PT%29%
% 222.76/222.97  |- skos__broader mesh__D019494smesh__D052180
% 222.76/222.97  |- rdf__type mesh__D019494sskos__Concept
% 222.76/222.97  |- skos__scopeNote mesh__D019494
% 222.76/222.97       Works consisting of bibliographic records, created according to specific and uniform principles of construction and under the control of an authority file, which describe the materials contained in a collection, library, or group of libraries. Catalogs include also lists of materials prepared for a particular purpose, such as exhibition catalogs, sales catalogs, garden catalogs, medical supply catalogs. %28%From The ALA Glossary of Library and Information Sciences, 1983%29%%A%    
% 222.76/222.97  |- skos__annotation mesh__D019494
% 222.76/222.97       publication type only; for catalogs as a subject, index under main heading CATALOGS%A%  
% 222.76/222.97  |- mesh__dateCreated mesh__D019494 1996-06-21
% 222.76/222.97  |- mesh__dateRevised mesh__D027926 2002-07-02
% 222.76/222.97  |- skos__annotation mesh__D027926
% 222.76/222.97       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.76/222.97  |- mesh__historyNote mesh__D027926 2002   
% 222.76/222.97  |- mesh__recordAuthorizer mesh__D027926 sjn
% 222.76/222.97  |- mesh__publicMeSHNote mesh__D027926 2002   
% 222.76/222.97  |- mesh__recordOriginator mesh__D027926 ssb
% 222.76/222.97  |- skos__broader mesh__D027926smesh__D019684
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D027926 2005
% 222.76/222.97  |- mesh__recordMaintainer mesh__D027926 ssb
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D027926 2006
% 222.76/222.97  |- skos__scopeNote mesh__D027926
% 222.76/222.97       The sumac plant family in the order Sapindales, subclass Rosidae, class Magnoliopsida.  They are tropical and subtropical trees, shrubs, and woody vines that have resin ducts in the bark. The sap of many of the species is irritating to the skin.%A%    
% 222.76/222.97  |- rdf__type mesh__D027926sskos__Concept
% 222.76/222.97  |- mesh__dateEstablished mesh__D027926 2002-01-01
% 222.76/222.97  |- mesh__dateCreated mesh__D027926 2001-07-25
% 222.76/222.97  |- skos__altLabel mesh__D027926 Peppertree, California
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D027926 2003
% 222.76/222.97  |- skos__altLabel mesh__D027926 Peppertree, Brazilian
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D027926 2004
% 222.76/222.97  |- skos__altLabel mesh__D027926 Marula
% 222.76/222.97  |- skos__prefLabel mesh__D027926 Anacardiaceae
% 222.76/222.97  |- mesh__dateRevised mesh__D005474 2005-06-30
% 222.76/222.97  |- skos__altLabel mesh__D005474 Pharmacia Brand of Fluoxymesterone
% 222.76/222.97  |- mesh__dateCreated mesh__D005474 1999-01-01
% 222.76/222.97  |- skos__altLabel mesh__D005474 Fluoximesteron
% 222.76/222.97  |- mesh__recordOriginator mesh__D005474 NLM
% 222.76/222.97  |- rdf__type mesh__D005474sskos__Concept
% 222.76/222.97  |- skos__prefLabel mesh__D005474 Fluoxymesterone
% 222.76/222.97  |- skos__broader mesh__D005474smesh__D013259
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D005474 2006
% 222.76/222.97  |- skos__scopeNote mesh__D005474
% 222.76/222.97       An anabolic steroid that has been used in the treatment of male hypogonadism, delayed puberty in males, and in the treatment of breast neoplasms in women.%A%    
% 222.76/222.97  |- skos__broader mesh__D005474smesh__D000734
% 222.76/222.97  |- skos__hiddenLabel mesh__D005474 Android F
% 222.76/222.97  |- mesh__recordAuthorizer mesh__D005474 sjn
% 222.76/222.97  |- mesh__recordMaintainer mesh__D005474 CCR
% 222.76/222.97  |- skos__altLabel mesh__D005474 Atlantis Brand of Fluoxymesterone
% 222.76/222.97  |- mesh__recordAuthorizer mesh__D013906 sjn
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D013906 2001
% 222.76/222.97  |- skos__hiddenLabel mesh__D013906 Surgeries, Thoracoscopic
% 222.76/222.97  |- skos__hiddenLabel mesh__D013906 Endoscopies, Pleural
% 222.76/222.97  |- skos__hiddenLabel mesh__D013906 Pleuroscopies
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D013906 2006
% 222.76/222.97  |- skos__altLabel mesh__D013906 Endoscopy, Pleural
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D013906 2003
% 222.76/222.97  |- rdf__type mesh__D013906sskos__Concept
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D013906 2005
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D013906 2000
% 222.76/222.97  |- skos__broader mesh__D013906smesh__D004724
% 222.76/222.97  |- mesh__recordMaintainer mesh__D013906 nns
% 222.76/222.97  |- mesh__recordOriginator mesh__D013906 NLM
% 222.76/222.97  |- skos__altLabel mesh__D013906 Pleural Endoscopy
% 222.76/222.97  |- skos__hiddenLabel mesh__D013906 Thoracoscopies
% 222.76/222.97  |- skos__altLabel mesh__D013906 Surgery, Thoracoscopic
% 222.76/222.97  |- skos__altLabel mesh__D013906 Pleuroscopy
% 222.76/222.97  |- mesh__dateCreated mesh__D013906 1999-01-01
% 222.76/222.97  |- skos__scopeNote mesh__D013906
% 222.76/222.97       Endoscopic examination, therapy or surgery of the pleural cavity.%A%    
% 222.76/222.97  |- skos__hiddenLabel mesh__D013906 Surgical Procedure, Thoracoscopic
% 222.76/222.97  |- mesh__dateRevised mesh__D013906 1999-11-03
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D013906 2002
% 222.76/222.97  |- skos__prefLabel mesh__D013906 Thoracoscopy
% 222.76/222.97  |- skos__broader mesh__D013906smesh__D019616
% 222.76/222.97  |- skos__hiddenLabel mesh__D013906 Thoracoscopic Surgical Procedure
% 222.76/222.97  |- skos__hiddenLabel mesh__D013906 Thoracoscopic Surgeries
% 222.76/222.97  |- skos__hiddenLabel mesh__D013906 Pleural Endoscopies
% 222.76/222.97  |- skos__altLabel mesh__D013906 Thoracoscopic Surgical Procedures
% 222.76/222.97  |- skos__altLabel mesh__D013906 Thoracoscopic Surgery
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D013906 2004
% 222.76/222.97  |- skos__altLabel mesh__D013108 Sphingomyelin Cholinephosphohydrolase
% 222.76/222.97  |- skos__broader mesh__D013108smesh__D010727
% 222.76/222.97  |- rdf__type mesh__D013108sskos__Concept
% 222.76/222.97  |- mesh__dateRevised mesh__D013108 2003-07-09
% 222.76/222.97  |- skos__altLabel mesh__D013108 Sphingomyelinase C
% 222.76/222.97  |- mesh__recordOriginator mesh__D013108 NLM
% 222.76/222.97  |- skos__historyNote mesh__D013108 Sphingomyelins %28%1973-1974%29%
% 222.76/222.97  |- mesh__dateCreated mesh__D013108 1974-11-19
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D013108 2004
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D013108 2005
% 222.76/222.97  |- skos__annotation mesh__D013108
% 222.76/222.97       /defic: consider also NIEMANN-PICK DISEASE   
% 222.76/222.97  |- mesh__publicMeSHNote mesh__D013108
% 222.76/222.97       91; was see under PHOSPHODIESTERASES 1975-90   
% 222.76/222.97  |- skos__altLabel mesh__D013108 Sphingomyelin Cleaving Enzyme
% 222.76/222.97  |- skos__prefLabel mesh__D013108 Sphingomyelin Phosphodiesterase
% 222.76/222.97  |- mesh__dateEstablished mesh__D013108 1991-01-01
% 222.76/222.97  |- skos__historyNote mesh__D013108 Phosphodiesterases %28%1973-1974%29%
% 222.76/222.97  |- mesh__activeMeSHYear mesh__D013108 2006
% 222.76/222.97  |- mesh__recordMaintainer mesh__D013108 ssb
% 222.76/222.97  |- mesh__historyNote mesh__D013108
% 222.76/222.97       91%28%75%29%; was see under PHOSPHODIESTERASES 1975-90   
% 222.76/222.97  |- skos__scopeNote mesh__D013108
% 222.76/222.97       An enzyme that catalyzes the hydrolysis of sphingomyelin to ceramide %28%N-acylsphingosine%29% plus choline phosphate. A defect in this enzyme leads to NIEMANN-PICK DISEASE. EC 3.1.4.12.%A%    
% 222.76/222.97  |- skos__related mesh__D013108smesh__D009542
% 222.76/222.98  |- mesh__recordAuthorizer mesh__D013108 sjn
% 222.76/222.98  |- skos__altLabel mesh__D013108 Sphingomyelinase
% 222.76/222.98  |- skos__hiddenLabel mesh__D009865 Ovocyte
% 222.76/222.98  |- skos__prefLabel mesh__D009865 Oocytes
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D009865 2003
% 222.76/222.98  |- skos__broader mesh__D009865smesh__D010063
% 222.76/222.98  |- skos__altLabel mesh__D009865 Ovocytes
% 222.76/222.98  |- mesh__publicMeSHNote mesh__D009865 84; was see under OVUM 1975-83   
% 222.76/222.98  |- rdf__type mesh__D009865sskos__Concept
% 222.76/222.98  |- skos__scopeNote mesh__D009865
% 222.76/222.98       Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova %28%OVUM%29%.%A%    
% 222.76/222.98  |- skos__annotation mesh__D009865
% 222.76/222.98       do not confuse with OOCYSTS life cycle stage in protozoa   
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D009865 2004
% 222.76/222.98  |- mesh__dateCreated mesh__D009865 1974-11-11
% 222.76/222.98  |- mesh__recordMaintainer mesh__D009865 lkt
% 222.76/222.98  |- skos__hiddenLabel mesh__D009865 Oocyte
% 222.76/222.98  |- mesh__historyNote mesh__D009865
% 222.76/222.98       84%28%75%29%; was see under OVUM 1975-83   
% 222.76/222.98  |- mesh__dateRevised mesh__D009865 2002-07-03
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D009865 2005
% 222.76/222.98  |- mesh__dateEstablished mesh__D009865 1984-01-01
% 222.76/222.98  |- skos__historyNote mesh__D009865 Ovum %28%1966-1974%29%
% 222.76/222.98  |- mesh__recordOriginator mesh__D009865 NLM
% 222.76/222.98  |- mesh__recordAuthorizer mesh__D009865 sjn
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D009865 2006
% 222.76/222.98  |- mesh__publicMeSHNote mesh__D001882
% 222.76/222.98       91; was see under SHEEP DISEASES 1985-90   
% 222.76/222.98  |- skos__broader mesh__D001882smesh__D012757
% 222.76/222.98  |- skos__hiddenLabel mesh__D001882 Border Diseases
% 222.76/222.98  |- skos__broader mesh__D001882smesh__D018182
% 222.76/222.98  |- mesh__recordAuthorizer mesh__D001882 sjn
% 222.76/222.98  |- rdf__type mesh__D001882sskos__Concept
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001882 2006
% 222.76/222.98  |- mesh__dateEstablished mesh__D001882 1991-01-01
% 222.76/222.98  |- skos__annotation mesh__D001882
% 222.76/222.98       caused by a pestivirus; border refers to the English-Welsh border where there is a high mortal among sheep from this dis; usually animal; check tag ANIMALS; don%27%t forget also SHEEP %28%NIM%29% but do not index under SHEEP DISEASES%A%  
% 222.76/222.98  |- skos__historyNote mesh__D001882 Sheep Diseases %28%1966-1984%29%
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001882 2005
% 222.76/222.98  |- skos__prefLabel mesh__D001882 Border Disease
% 222.76/222.98  |- skos__scopeNote mesh__D001882
% 222.76/222.98       Congenital disorder of lambs caused by a virus closely related to or identical with certain strains of bovine viral diarrhea virus.%A%    
% 222.76/222.98  |- mesh__recordMaintainer mesh__D001882 ags
% 222.76/222.98  |- mesh__historyNote mesh__D001882
% 222.76/222.98       91%28%85%29%; was see under SHEEP DISEASES 1985-90   
% 222.76/222.98  |- mesh__recordOriginator mesh__D001882 EC
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001882 2004
% 222.76/222.98  |- mesh__dateRevised mesh__D001882 2003-07-30
% 222.76/222.98  |- mesh__dateCreated mesh__D001882 1984-04-06
% 222.76/222.98  |- skos__historyNote mesh__D001882 Bovine Diarrhea Virus %28%1975-1984%29%
% 222.76/222.98  |- skos__related mesh__D009067smesh__D003802
% 222.76/222.98  |- mesh__recordOriginator mesh__D009067 NLM
% 222.76/222.98  |- mesh__publicMeSHNote mesh__D009067 65   
% 222.76/222.98  |- mesh__dateRevised mesh__D009067 2003-07-09
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D009067 2006
% 222.76/222.98  |- skos__annotation mesh__D009067 D25-26 qualif   
% 222.76/222.98  |- skos__broader mesh__D009067smesh__D003358
% 222.76/222.98  |- mesh__dateEstablished mesh__D009067 1965-01-01
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D009067 2005
% 222.76/222.98  |- skos__prefLabel mesh__D009067 Mouthwashes
% 222.76/222.98  |- mesh__dateCreated mesh__D009067 1999-01-01
% 222.76/222.98  |- skos__scopeNote mesh__D009067
% 222.76/222.98       Solutions for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. %28%From Boucher%27%s Clinical Dental Terminology, 4th ed%29%%A%    
% 222.76/222.98  |- skos__broader mesh__D009067smesh__D001697
% 222.76/222.98  |- rdf__type mesh__D009067sskos__Concept
% 222.76/222.98  |- mesh__historyNote mesh__D009067 65   
% 222.76/222.98  |- mesh__recordMaintainer mesh__D009067 ssb
% 222.76/222.98  |- mesh__recordAuthorizer mesh__D009067 sjn
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D009067 2004
% 222.76/222.98  |- skos__altLabel mesh__D001084 Adenine Arabinoside Monophosphate
% 222.76/222.98  |- skos__hiddenLabel mesh__D001084 Monophosphate, Adenine Arabinoside
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001084 2005
% 222.76/222.98  |- skos__broader mesh__D001084smesh__D001088
% 222.76/222.98  |- skos__historyNote mesh__D001084 Vidarabine %28%1975-1978%29%
% 222.76/222.98  |- skos__scopeNote mesh__D001084
% 222.76/222.98       An adenosine monophosphate analog in which ribose is replaced by an arabinose moiety. It is the monophosphate ester of VIDARABINE with antiviral and possibly antineoplastic properties.%A%    
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001084 2001
% 222.76/222.98  |- mesh__dateCreated mesh__D001084 1978-05-16
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001084 2003
% 222.76/222.98  |- mesh__historyNote mesh__D001084
% 222.76/222.98       96; was ARABINOFURANOSYLADENINE MONOPHOSPHATE 1979-95 %28%see under ARABINONUCLEOTIDES 1979-90%29%%A%  
% 222.76/222.98  |- skos__historyNote mesh__D001084
% 222.76/222.98       Adenosine Monophosphate %28%1971-1978%29%
% 222.76/222.98  |- skos__hiddenLabel mesh__D001084 Monophosphate, Arabinofuranosyladenine
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001084 2000
% 222.76/222.98  |- mesh__recordOriginator mesh__D001084 RLS
% 222.76/222.98  |- mesh__dateEstablished mesh__D001084 1991-01-01
% 222.76/222.98  |- skos__prefLabel mesh__D001084 Vidarabine Phosphate
% 222.76/222.98  |- skos__historyNote mesh__D001084 Adenine Nucleotides %28%1966-1970%29%
% 222.76/222.98  |- skos__hiddenLabel mesh__D001084 Monophosphate, Vidarabine
% 222.76/222.98  |- skos__hiddenLabel mesh__D001084 Ara AMP
% 222.76/222.98  |- mesh__recordAuthorizer mesh__D001084 sjn
% 222.76/222.98  |- skos__altLabel mesh__D001084
% 222.76/222.98       9-%28%5-O-Phosphono-beta-D-arabinofuranosyl%29%-9H-purin-6-amine
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001084 2002
% 222.76/222.98  |- mesh__dateRevised mesh__D001084 1999-11-03
% 222.76/222.98  |- mesh__publicMeSHNote mesh__D001084
% 222.76/222.98       96; was ARABINOFURANOSYLADENINE MONOPHOSPHATE 1979-95 %28%see under ARABINONUCLEOTIDES 1979-90%29%%A%  
% 222.76/222.98  |- skos__hiddenLabel mesh__D001084 Phosphate, Vidarabine
% 222.76/222.98  |- skos__altLabel mesh__D001084 Vidarabine Monophosphate
% 222.76/222.98  |- skos__altLabel mesh__D001084 Arabinofuranosyladenine Monophosphate
% 222.76/222.98  |- skos__annotation mesh__D001084
% 222.76/222.98       a vidarabine ester antimetabolite; DF: note short X ref   
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001084 2006
% 222.76/222.98  |- skos__altLabel mesh__D001084 Ara-AMP
% 222.76/222.98  |- skos__broader mesh__D001084smesh__D000227
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001084 2004
% 222.76/222.98  |- mesh__recordMaintainer mesh__D001084 jmp
% 222.76/222.98  |- rdf__type mesh__D001084sskos__Concept
% 222.76/222.98  |- mesh__dateRevised mesh__D028221 2003-07-09
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D028221 2005
% 222.76/222.98  |- mesh__historyNote mesh__D028221 2002   
% 222.76/222.98  |- rdf__type mesh__D028221sskos__Concept
% 222.76/222.98  |- skos__broader mesh__D028221smesh__D028201
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D028221 2006
% 222.76/222.98  |- skos__historyNote mesh__D028221 Trees %28%1965-2001%29%
% 222.76/222.98  |- skos__prefLabel mesh__D028221 Larix
% 222.76/222.98  |- skos__altLabel mesh__D028221 Tamarack
% 222.76/222.98  |- skos__altLabel mesh__D028221 Larch
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D028221 2004
% 222.76/222.98  |- mesh__dateCreated mesh__D028221 2001-07-25
% 222.76/222.98  |- skos__annotation mesh__D028221
% 222.76/222.98       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.76/222.98  |- mesh__dateEstablished mesh__D028221 2002-01-01
% 222.76/222.98  |- skos__scopeNote mesh__D028221
% 222.76/222.98       A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta.%A%    
% 222.76/222.98  |- mesh__publicMeSHNote mesh__D028221 2002   
% 222.76/222.98  |- mesh__recordMaintainer mesh__D014201 PLS
% 222.76/222.98  |- skos__hiddenLabel mesh__D014201 Infection, Trematode
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D014201 1995
% 222.76/222.98  |- skos__scopeNote mesh__D014201
% 222.76/222.98       Infections caused by infestation with worms of the class Trematoda.%A%    
% 222.76/222.98  |- skos__broader mesh__D014201smesh__D006373
% 222.76/222.98  |- skos__prefLabel mesh__D014201 Trematode Infections
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D014201 2000
% 222.76/222.98  |- rdf__type mesh__D014201sskos__Concept
% 222.76/222.98  |- mesh__dateRevised mesh__D014201 1991-06-19
% 222.76/222.98  |- mesh__onlineNote mesh__D014201
% 222.76/222.98       use TREMATODE INFECTIONS to search FASCIOLOPSIASIS %26% METAGONIMIASIS 1967-81%A%  
% 222.76/222.98  |- mesh__recordAuthorizer mesh__D014201 PLS
% 222.76/222.98  |- mesh__historyNote mesh__D014201
% 222.76/222.98       FASCIOLOPSIASIS %26% METAGONIMIASIS were see under TREMATODE INFECTIONS 1967-81%A%  
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D014201 2003
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D014201 2001
% 222.76/222.98  |- skos__annotation mesh__D014201
% 222.76/222.98       GEN: prefer specific trematode infections in MeSH or coord of specific trematode in MeSH with infection term as directed under name of trematode%A%  
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D014201 2005
% 222.76/222.98  |- skos__hiddenLabel mesh__D014201 Metagonimiases
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D014201 2004
% 222.76/222.98  |- mesh__recordOriginator mesh__D014201 NLM
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D014201 1996
% 222.76/222.98  |- skos__hiddenLabel mesh__D014201 Fasciolopsiases
% 222.76/222.98  |- skos__hiddenLabel mesh__D014201 Trematode Infection
% 222.76/222.98  |- skos__related mesh__D014201smesh__D000980
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D014201 2006
% 222.76/222.98  |- mesh__dateCreated mesh__D014201 1999-01-01
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D014201 1998
% 222.76/222.98  |- skos__altLabel mesh__D014201 Infections, Trematode
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D014201 1997
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D014201 1992
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D014201 2002
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D014201 1994
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D014201 1999
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D014201 1993
% 222.76/222.98  |- mesh__dateEstablished mesh__D033964 2003-01-01
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D033964 2003
% 222.76/222.98  |- skos__scopeNote mesh__D033964
% 222.76/222.98       An adaptor protein complex involved in transport of molecules between the TRANS-GOLGI NETWORK and the endosomal-lysosomal system.%A%    
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D033964 2006
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D033964 2004
% 222.76/222.98  |- skos__altLabel mesh__D033964 AP-4 protein complex
% 222.76/222.98  |- skos__altLabel mesh__D033964 Adaptor-Related Protein Complex 4
% 222.76/222.98  |- rdf__type mesh__D033964sskos__Concept
% 222.76/222.98  |- skos__hiddenLabel mesh__D033964 Adaptor Related Protein Complex 4
% 222.76/222.98  |- mesh__historyNote mesh__D033964
% 222.76/222.98       2003; for AP-4 PROTEIN COMPLEX use ADAPTOR PROTEINS 1999-2002%A%  
% 222.76/222.98  |- mesh__dateCreated mesh__D033964 2002-07-02
% 222.76/222.98  |- mesh__publicMeSHNote mesh__D033964
% 222.76/222.98       2003; AP-4 PROTEIN COMPLEX was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 2001-2002 and under NERVE TISSUE PROTEINS %26% PHOSPHOPROTEINS 1999-2001%A%  
% 222.76/222.98  |- skos__prefLabel mesh__D033964 Adaptor Protein Complex 4
% 222.76/222.98  |- skos__historyNote mesh__D033964 Membrane Proteins %28%2001-2002%29%
% 222.76/222.98  |- skos__historyNote mesh__D033964 Carrier Proteins %28%2001-2002%29%
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D033964 2005
% 222.76/222.98  |- skos__broader mesh__D033964smesh__D033942
% 222.76/222.98  |- mesh__dateRevised mesh__D027927 2002-07-03
% 222.76/222.98  |- mesh__publicMeSHNote mesh__D027927 2002   
% 222.76/222.98  |- mesh__recordOriginator mesh__D027927 ssb
% 222.76/222.98  |- skos__prefLabel mesh__D027927 Pistacia
% 222.76/222.98  |- skos__broader mesh__D027927smesh__D027926
% 222.76/222.98  |- skos__annotation mesh__D027927
% 222.76/222.98       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D027927 2005
% 222.76/222.98  |- skos__altLabel mesh__D027927 Mastictree
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D027927 2006
% 222.76/222.98  |- mesh__historyNote mesh__D027927 2002   
% 222.76/222.98  |- rdf__type mesh__D027927sskos__Concept
% 222.76/222.98  |- mesh__recordAuthorizer mesh__D027927 sjn
% 222.76/222.98  |- mesh__dateEstablished mesh__D027927 2002-01-01
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D027927 2003
% 222.76/222.98  |- skos__altLabel mesh__D027927 Pistachio
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D027927 2004
% 222.76/222.98  |- mesh__recordMaintainer mesh__D027927 ssb
% 222.76/222.98  |- skos__scopeNote mesh__D027927
% 222.76/222.98       A plant genus in the ANACARDIACEAE family known for the Pistachio nuts and for gum Mastic.%A%    
% 222.76/222.98  |- mesh__dateCreated mesh__D027927 2001-07-25
% 222.76/222.98  |- skos__historyNote mesh__D027927 Nuts %28%1972-2001%29%
% 222.76/222.98  |- mesh__recordAuthorizer mesh__D005475 sjn
% 222.76/222.98  |- skos__altLabel mesh__D005475 cis-Flupenthixol
% 222.76/222.98  |- skos__broader mesh__D005475smesh__D010879
% 222.76/222.98  |- mesh__dateRevised mesh__D005475 2005-06-30
% 222.76/222.98  |- skos__scopeNote mesh__D005475
% 222.76/222.98       A thioxanthene neuroleptic that, unlike CHLORPROMAZINE, is claimed to have CNS-activating properties. It is used in the treatment of psychoses although not in excited or manic patients. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p595%29%%A%    
% 222.76/222.98  |- rdf__type mesh__D005475sskos__Concept
% 222.76/222.98  |- mesh__dateEstablished mesh__D005475 1991-01-01
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D005475 2006
% 222.76/222.98  |- skos__historyNote mesh__D005475 Piperazines %28%1970-1974%29%
% 222.76/222.98  |- skos__altLabel mesh__D005475 Flupentixol
% 222.76/222.98  |- skos__prefLabel mesh__D005475 Flupenthixol
% 222.76/222.98  |- mesh__recordOriginator mesh__D005475 NLM
% 222.76/222.98  |- mesh__recordMaintainer mesh__D005475 exl
% 222.76/222.98  |- mesh__publicMeSHNote mesh__D005475
% 222.76/222.98       91; was see under THIOXANTHENES 1975-90   
% 222.76/222.98  |- mesh__dateCreated mesh__D005475 1974-11-19
% 222.76/222.98  |- skos__broader mesh__D005475smesh__D013892
% 222.76/222.98  |- skos__historyNote mesh__D005475 Thioxanthenes %28%1974%29%
% 222.76/222.98  |- skos__historyNote mesh__D005475 Alcohol, Ethyl %28%1970-1974%29%
% 222.76/222.98  |- skos__altLabel mesh__D005475 alpha-Flupenthixol
% 222.76/222.98  |- mesh__historyNote mesh__D005475
% 222.76/222.98       91%28%75%29%; was see under THIOXANTHENES 1975-90   
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D013907 2004
% 222.76/222.98  |- skos__historyNote mesh__D013907 Thoracic Surgery %28%1966-1987%29%
% 222.76/222.98  |- skos__broader mesh__D013907smesh__D010030
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D013907 2006
% 222.76/222.98  |- skos__related mesh__D013907smesh__D015505
% 222.76/222.98  |- skos__annotation mesh__D013907
% 222.76/222.98       do not use /util except by MeSH definition; do not confuse with THORACOTOMY%A%  
% 222.76/222.98  |- rdf__type mesh__D013907sskos__Concept
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D013907 2000
% 222.76/222.98  |- mesh__dateRevised mesh__D013907 1997-06-20
% 222.76/222.98  |- mesh__dateEstablished mesh__D013907 1988-01-01
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D013907 1998
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D013907 2001
% 222.76/222.98  |- skos__scopeNote mesh__D013907
% 222.76/222.98       Surgical creation of an opening %28%stoma%29% into the chest cavity for drainage; used in the treatment of pleural effusion, pneumothorax, hemothorax and empyema.%A%    
% 222.76/222.98  |- skos__broader mesh__D013907smesh__D019616
% 222.76/222.98  |- mesh__recordMaintainer mesh__D013907 PXP
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D013907 1999
% 222.76/222.98  |- skos__prefLabel mesh__D013907 Thoracostomy
% 222.76/222.98  |- mesh__recordAuthorizer mesh__D013907 SJN
% 222.76/222.98  |- mesh__publicMeSHNote mesh__D013907 88   
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D013907 2003
% 222.76/222.98  |- mesh__recordOriginator mesh__D013907 SCD
% 222.76/222.98  |- mesh__dateCreated mesh__D013907 1987-03-25
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D013907 2002
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D013907 2005
% 222.76/222.98  |- mesh__historyNote mesh__D013907 88   
% 222.76/222.98  |- skos__hiddenLabel mesh__D013907 Thoracostomies
% 222.76/222.98  |- mesh__dateRevised mesh__D013109 2004-07-07
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D013109 2005
% 222.76/222.98  |- mesh__recordMaintainer mesh__D013109 ssb
% 222.76/222.98  |- mesh__dateCreated mesh__D013109 1999-01-01
% 222.76/222.98  |- skos__scopeNote mesh__D013109
% 222.76/222.98       A class of sphingolipids found largely in the brain and other nervous tissue. They contain phosphocholine or phosphoethanolamine as their polar head group so therefore are the only sphingolipids classified as PHOSPHOLIPIDS.%A%    
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D013109 2006
% 222.76/222.98  |- mesh__recordAuthorizer mesh__D013109 sjn
% 222.76/222.98  |- mesh__historyNote mesh__D013109
% 222.76/222.98       66%28%63%29%; was see under PHOSPHOLIPIDS 1963-65   
% 222.76/222.98  |- mesh__recordOriginator mesh__D013109 NLM
% 222.76/222.98  |- skos__broader mesh__D013109smesh__D010743
% 222.76/222.98  |- rdf__type mesh__D013109sskos__Concept
% 222.76/222.98  |- skos__broader mesh__D013109smesh__D020383
% 222.76/222.98  |- mesh__dateEstablished mesh__D013109 1966-01-01
% 222.76/222.98  |- skos__prefLabel mesh__D013109 Sphingomyelins
% 222.76/222.98  |- mesh__publicMeSHNote mesh__D013109
% 222.76/222.98       66; was see under PHOSPHOLIPIDS 1963-65   
% 222.76/222.98  |- mesh__recordMaintainer mesh__D051228 AKE
% 222.76/222.98  |- skos__altLabel mesh__D051228 Geranyltransferase
% 222.76/222.98  |- skos__hiddenLabel mesh__D051228 Diphosphate Synthetase, Farnesyl
% 222.76/222.98  |- mesh__dateCreated mesh__D051228 2005-06-30
% 222.76/222.98  |- skos__altLabel mesh__D051228 Farnesyl Diphosphate Synthetase
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D051228 2006
% 222.76/222.98  |- skos__hiddenLabel mesh__D051228 Synthetase, Farnesyl Pyrophosphate
% 222.76/222.98  |- mesh__publicMeSHNote mesh__D051228
% 222.76/222.98       2006; GERANYLGERANYLTRANSFERASE was indexed under ALKYL AND ARYL TRANSFERASES 1997-2005, under PYROPHOSPHORIC ACIDS 1970-1979, under ALLYL CPDS 1975-1979, %26% under TERPENES 1970-1979%A%  
% 222.76/222.98  |- skos__scopeNote mesh__D051228
% 222.76/222.98       An enzyme involved in the MEVALONATE pathway, it catalyses the synthesis of FARNESYL DIPHOSPHATE from ISOPENTENYL DIPHOSPHATE and dimethylallyl diphosphate.%A%    
% 222.76/222.98  |- skos__hiddenLabel mesh__D051228 Pyrophosphate Synthetase, Farnesyl
% 222.76/222.98  |- mesh__dateEstablished mesh__D051228 2006-01-01
% 222.76/222.98  |- mesh__recordAuthorizer mesh__D051228 sjn
% 222.76/222.98  |- skos__altLabel mesh__D051228 FPP Synthetase
% 222.76/222.98  |- mesh__recordOriginator mesh__D051228 AKE
% 222.76/222.98  |- rdf__type mesh__D051228sskos__Concept
% 222.76/222.98  |- skos__prefLabel mesh__D051228 Geranyltranstransferase
% 222.76/222.98  |- skos__altLabel mesh__D051228 Farnesyl Diphosphate Synthase
% 222.76/222.98  |- skos__hiddenLabel mesh__D051228 Synthetase, Farnesyl Diphosphate
% 222.76/222.98  |- mesh__historyNote mesh__D051228
% 222.76/222.98       2006%28%1980%29%; use PYROPHOSPHORIC ACIDS 1970-1979, ALLYL CPDS 1975-1979, %26% TERPENES 1970-1979%A%  
% 222.76/222.98  |- skos__broader mesh__D051228smesh__D019883
% 222.76/222.98  |- skos__altLabel mesh__D051228 Farnesyl Pyrophosphate Synthetase
% 222.76/222.98  |- skos__hiddenLabel mesh__D051228 Synthetase, FPP
% 222.76/222.98  |- skos__hiddenLabel mesh__D051228 Synthase, Farnesyl Diphosphate
% 222.76/222.98  |- skos__hiddenLabel mesh__D051228 Diphosphate Synthase, Farnesyl
% 222.76/222.98  |- mesh__recordMaintainer mesh__D009866 lkt
% 222.76/222.98  |- mesh__publicMeSHNote mesh__D009866 75   
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D009866 2006
% 222.76/222.98  |- skos__scopeNote mesh__D009866
% 222.76/222.98       The process of germ cell development in the female from the primordial germ cells through OOGONIA to the mature haploid ova %28%OVUM%29%.%A%    
% 222.76/222.98  |- skos__prefLabel mesh__D009866 Oogenesis
% 222.76/222.98  |- skos__broader mesh__D009866smesh__D005718
% 222.76/222.98  |- mesh__recordOriginator mesh__D009866 NLM
% 222.76/222.98  |- mesh__recordAuthorizer mesh__D009866 sjn
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D009866 2005
% 222.76/222.98  |- mesh__dateEstablished mesh__D009866 1975-09-01
% 222.76/222.98  |- rdf__type mesh__D009866sskos__Concept
% 222.76/222.98  |- mesh__historyNote mesh__D009866 75   
% 222.76/222.98  |- skos__historyNote mesh__D009866 Ovum %28%1966-1974%29%
% 222.76/222.98  |- mesh__dateRevised mesh__D009866 2004-07-07
% 222.76/222.98  |- mesh__dateCreated mesh__D009866 1974-11-11
% 222.76/222.98  |- skos__hiddenLabel mesh__D009866 Oogeneses
% 222.76/222.98  |- rdf__type mesh__D001883sskos__Concept
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001883 2006
% 222.76/222.98  |- mesh__dateEstablished mesh__D001883 1990-01-01
% 222.76/222.98  |- mesh__recordAuthorizer mesh__D001883 SJN
% 222.76/222.98  |- mesh__historyNote mesh__D001883
% 222.76/222.98       90%28%81%29%; was see under PERSONALITY DISORDERS 1981-89   
% 222.76/222.98  |- mesh__dateRevised mesh__D001883 1997-06-20
% 222.76/222.98  |- mesh__dateCreated mesh__D001883 1980-05-21
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001883 2005
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001883 2002
% 222.76/222.98  |- skos__prefLabel mesh__D001883 Borderline Personality Disorder
% 222.76/222.98  |- mesh__recordMaintainer mesh__D001883 JLS
% 222.76/222.98  |- skos__annotation mesh__D001883
% 222.76/222.98       %22%borderline%22% is a psychiatric diag: follow text   
% 222.76/222.98  |- skos__scopeNote mesh__D001883
% 222.76/222.98       A personality disorder marked by a pattern of instability of interpersonal relationships, self-image, and affects, and marked impulsivity beginning by early adulthood and present in a variety of contexts. %28%DSM-IV%29%%A%    
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001883 2004
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001883 2001
% 222.76/222.98  |- skos__altLabel mesh__D001883 Disorder, Borderline Personality
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001883 1999
% 222.76/222.98  |- skos__broader mesh__D001883smesh__D010554
% 222.76/222.98  |- skos__hiddenLabel mesh__D001883 Borderline Personality Disorders
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001883 2003
% 222.76/222.98  |- mesh__publicMeSHNote mesh__D001883
% 222.76/222.98       90; was see under PERSONALITY DISORDERS 1981-89   
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001883 2000
% 222.76/222.98  |- skos__hiddenLabel mesh__D001883 Disorders, Borderline Personality
% 222.76/222.98  |- mesh__recordOriginator mesh__D001883 EC
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001883 1998
% 222.76/222.98  |- skos__hiddenLabel mesh__D001883 Personality Disorders, Borderline
% 222.76/222.98  |- skos__altLabel mesh__D001883 Personality Disorder, Borderline
% 222.76/222.98  |- mesh__recordMaintainer mesh__D009068 nns
% 222.76/222.98  |- mesh__dateCreated mesh__D009068 1999-01-01
% 222.76/222.98  |- skos__related mesh__D009068smesh__D018953
% 222.76/222.98  |- skos__broader mesh__D009068smesh__D043702
% 222.76/222.98  |- rdf__type mesh__D009068sskos__Concept
% 222.76/222.98  |- mesh__recordAuthorizer mesh__D009068 sjn
% 222.76/222.98  |- skos__annotation mesh__D009068
% 222.76/222.98       the physiol process of an organism in moving one or more parts: do not confuse with LOCOMOTION %28%see note there%29% or MOTION, a concept of physics or MOTOR ACTIVITY, movement associated with behavior; animal running in exercise wheel is probably MOTOR ACTIVITY or EXERTION; NIM for microorganisms; movement of cells = CELL MOVEMENT; probably NIM if specific organism is IM; TN 130: definition %26% examples%A%  
% 222.76/222.98  |- mesh__recordOriginator mesh__D009068 NLM
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D009068 2004
% 222.76/222.98  |- skos__related mesh__D009068smesh__D009038
% 222.76/222.98  |- skos__prefLabel mesh__D009068 Movement
% 222.76/222.98  |- mesh__dateRevised mesh__D009068 2003-07-09
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D009068 2006
% 222.76/222.98  |- skos__scopeNote mesh__D009068
% 222.76/222.98       The act, process, or result of passing from one place or position to another. It differs from LOCOMOTION in that locomotion is restricted to the passing of the whole body from one place to another, while movement encompasses both locomotion but also a change of the position of the whole body or any of its parts. Movement may be used with reference to humans, vertebrate and invertebrate animals, and microorganisms. Differentiate also from MOTOR ACTIVITY, movement associated with behavior.%A%    
% 222.76/222.98  |- skos__related mesh__D009068smesh__D007103
% 222.76/222.98  |- skos__hiddenLabel mesh__D009068 Movements
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D009068 2005
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001085 1999
% 222.76/222.98  |- skos__altLabel mesh__D001085 Cytosine Arabinoside Triphosphate
% 222.76/222.98  |- skos__hiddenLabel mesh__D001085 Triphosphate, Cytarabine
% 222.76/222.98  |- mesh__recordMaintainer mesh__D001085 TPW
% 222.76/222.98  |- skos__annotation mesh__D001085
% 222.76/222.98       a cytarabine analog; DF: note short X ref   
% 222.76/222.98  |- skos__broader mesh__D001085smesh__D003597
% 222.76/222.98  |- skos__hiddenLabel mesh__D001085 Triphosphate, Arabinosylcytosine
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001085 1998
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001085 1997
% 222.76/222.98  |- mesh__publicMeSHNote mesh__D001085
% 222.76/222.98       91; was see under ARABINONUCLEOTIDES 1979-90   
% 222.76/222.98  |- mesh__dateEstablished mesh__D001085 1991-01-01
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001085 2001
% 222.76/222.98  |- mesh__dateRevised mesh__D001085 1996-06-10
% 222.76/222.98  |- mesh__dateCreated mesh__D001085 1978-05-16
% 222.76/222.98  |- skos__hiddenLabel mesh__D001085 Ara CTP
% 222.76/222.98  |- mesh__recordAuthorizer mesh__D001085 PLS
% 222.76/222.98  |- mesh__recordOriginator mesh__D001085 RLS
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001085 2000
% 222.76/222.98  |- skos__altLabel mesh__D001085 Ara-CTP
% 222.76/222.98  |- mesh__historyNote mesh__D001085
% 222.76/222.98       91%28%79%29%; was see under ARABINONUCLEOTIDES 1979-90   
% 222.76/222.98  |- skos__altLabel mesh__D001085 Arabinosylcytosine Triphosphate
% 222.76/222.98  |- skos__scopeNote mesh__D001085
% 222.76/222.98       A triphosphate nucleotide analog which is the biologically active form of CYTARABINE. It inhibits nuclear DNA synthesis.%A%    
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001085 2006
% 222.76/222.98  |- skos__hiddenLabel mesh__D001085 Triphosphate, Arabinofuranosylcytosine
% 222.76/222.98  |- skos__prefLabel mesh__D001085 Arabinofuranosylcytosine Triphosphate
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001085 2005
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001085 2004
% 222.76/222.98  |- skos__historyNote mesh__D001085 Cytarabine %28%1966-1978%29%
% 222.76/222.98  |- skos__altLabel mesh__D001085 Cytarabine Triphosphate
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001085 2002
% 222.76/222.98  |- rdf__type mesh__D001085sskos__Concept
% 222.76/222.98  |- skos__hiddenLabel mesh__D001085 Triphosphate, Cytosine Arabinoside
% 222.76/222.98  |- skos__broader mesh__D001085smesh__D001088
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D001085 2003
% 222.76/222.98  |- skos__scopeNote mesh__D028222
% 222.76/222.98       A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta.  They are evergreen, pyramidal trees with whorled branches and thin, scaly bark. Each of the linear, spirally arranged leaves is jointed near the stem on a separate woody base.%A%    
% 222.76/222.98  |- skos__historyNote mesh__D028222 Trees %28%1965-2001%29%
% 222.76/222.98  |- mesh__publicMeSHNote mesh__D028222 2002   
% 222.76/222.98  |- mesh__dateEstablished mesh__D028222 2002-01-01
% 222.76/222.98  |- skos__altLabel mesh__D028222 Spruce Tree
% 222.76/222.98  |- skos__prefLabel mesh__D028222 Picea
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D028222 2006
% 222.76/222.98  |- rdf__type mesh__D028222sskos__Concept
% 222.76/222.98  |- mesh__historyNote mesh__D028222 2002   
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D028222 2005
% 222.76/222.98  |- mesh__dateCreated mesh__D028222 2001-07-25
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D028222 2004
% 222.76/222.98  |- skos__broader mesh__D028222smesh__D028201
% 222.76/222.98  |- skos__annotation mesh__D028222
% 222.76/222.98       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.76/222.98  |- mesh__dateRevised mesh__D028222 2003-07-09
% 222.76/222.98  |- skos__hiddenLabel mesh__D014202 Tremors, Senile
% 222.76/222.98  |- skos__hiddenLabel mesh__D014202 Tremors, Continuous
% 222.76/222.98  |- skos__hiddenLabel mesh__D014202 Tremors, Nerve
% 222.76/222.98  |- skos__hiddenLabel mesh__D014202 Darkness Tremors
% 222.76/222.98  |- skos__hiddenLabel mesh__D014202 Passive Tremors
% 222.76/222.98  |- skos__hiddenLabel mesh__D014202 Tremor, Saturnine
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D014202 2001
% 222.76/222.98  |- skos__hiddenLabel mesh__D014202 Tremors, Intention
% 222.76/222.98  |- skos__hiddenLabel mesh__D014202 Tremors, Darkness
% 222.76/222.98  |- skos__hiddenLabel mesh__D014202 Semirhythmic Tremors
% 222.76/222.98  |- skos__hiddenLabel mesh__D014202 Tremor, Passive
% 222.76/222.98  |- mesh__recordAuthorizer mesh__D014202 sjn
% 222.76/222.98  |- skos__altLabel mesh__D014202 Intention Tremor
% 222.76/222.98  |- skos__hiddenLabel mesh__D014202 Tremors
% 222.76/222.98  |- skos__hiddenLabel mesh__D014202 Perioral Tremors
% 222.76/222.98  |- mesh__activeMeSHYear mesh__D014202 2006
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Saturnine Tremors
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D014202 2000
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremor, Intermittent
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Muscle Tremor
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremors, Muscle
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremors, Action
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Involuntary Quivers
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Persistent Tremors
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremor, Persistent
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremors, Semirhythmic
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremor, Resting
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremor, Rest
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Intermittent Tremors
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Limb Tremor
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremor, Senile
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Continuous Tremors
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Static Tremors
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D014202 2005
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Limb Tremors
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremors, Passive
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremor, Action
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Massive Tremors
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremors, Resting
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D014202 2004
% 222.76/222.99  |- rdf__type mesh__D014202sskos__Concept
% 222.76/222.99  |- skos__scopeNote mesh__D014202
% 222.76/222.99       Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.%A%    
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Rolling Tremors, Pill
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Quiver, Involuntary
% 222.76/222.99  |- mesh__recordMaintainer mesh__D014202 KEV
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Fine Tremors
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremors, Perioral
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremor, Pill Rolling
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremor, Continuous
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Nerve Tremor
% 222.76/222.99  |- skos__prefLabel mesh__D014202 Tremor
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Neonatal Tremor
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Perioral Tremor
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremors, Neonatal
% 222.76/222.99  |- mesh__dateCreated mesh__D014202 1999-01-01
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Senile Tremors
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Coarse Tremors
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremors, Coarse
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Action Tremors
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D014202 2002
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremor, Fine
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Rest Tremors
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D014202 2003
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremors, Saturnine
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremors, Persistent
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremor, Coarse
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremors, Limb
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Intention Tremors
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremors, Fine
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Quivers, Involuntary
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremors, Rest
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremors, Massive
% 222.76/222.99  |- skos__altLabel mesh__D014202 Rest Tremor
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremors, Intermittent
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Rolling Tremor, Pill
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Resting Tremors
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Nerve Tremors
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremor, Darkness
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Semirhythmic Tremor
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremors, Static
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Muscle Tremors
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Neonatal Tremors
% 222.76/222.99  |- mesh__dateRevised mesh__D014202 1999-11-03
% 222.76/222.99  |- skos__broader mesh__D014202smesh__D020820
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremor, Intention
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Pill Rolling Tremors
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremors, Pill Rolling
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremor, Massive
% 222.76/222.99  |- mesh__recordOriginator mesh__D014202 NLM
% 222.76/222.99  |- skos__hiddenLabel mesh__D014202 Tremor, Static
% 222.76/222.99  |- skos__broader mesh__D033965smesh__D034001
% 222.76/222.99  |- skos__hiddenLabel mesh__D033965 alpha Adaptin
% 222.76/222.99  |- skos__prefLabel mesh__D033965 Adaptor Protein Complex alpha Subunits
% 222.76/222.99  |- mesh__dateRevised mesh__D033965 2004-07-07
% 222.76/222.99  |- mesh__publicMeSHNote mesh__D033965
% 222.76/222.99       2003; ALPHA-ADAPTINS %28%now ADAPTOR PROTEIN COMPLEX ALPHA SUBUNITS%29% was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1989-2002%A%  
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D033965 2006
% 222.76/222.99  |- skos__scopeNote mesh__D033965
% 222.76/222.99       A family of large adaptin protein subunits of approximately 100 kDa in size. They have been primarily found as components of ADAPTOR PROTEIN COMPLEX 2.%A%    
% 222.76/222.99  |- mesh__recordOriginator mesh__D033965 jmp
% 222.76/222.99  |- mesh__recordAuthorizer mesh__D033965 sjn
% 222.76/222.99  |- skos__historyNote mesh__D033965 Carrier Proteins %28%1989-2002%29%
% 222.76/222.99  |- mesh__dateEstablished mesh__D033965 2003-01-01
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D033965 2005
% 222.76/222.99  |- skos__hiddenLabel mesh__D033965 alpha Adaptins
% 222.76/222.99  |- skos__altLabel mesh__D033965 alpha-Adaptins
% 222.76/222.99  |- rdf__type mesh__D033965sskos__Concept
% 222.76/222.99  |- mesh__historyNote mesh__D033965
% 222.76/222.99       2003; use ADAPTOR PROTEIN COMPLEX ALPHA SUBUNITS %28%NM%29% 1989-2002%A%  
% 222.76/222.99  |- mesh__dateCreated mesh__D033965 2002-07-02
% 222.76/222.99  |- skos__altLabel mesh__D033965 Adaptin, alpha
% 222.76/222.99  |- skos__historyNote mesh__D033965 Membrane Proteins %28%1989-2002%29%
% 222.76/222.99  |- skos__altLabel mesh__D033965
% 222.76/222.99       Clathrin Assembly Protein Complex alpha Subunits
% 222.76/222.99  |- mesh__recordMaintainer mesh__D033965 jmp
% 222.76/222.99  |- mesh__recordMaintainer mesh__D019496 ssb
% 222.76/222.99  |- rdf__type mesh__D019496sskos__Concept
% 222.76/222.99  |- skos__broader mesh__D019496smesh__D014612
% 222.76/222.99  |- skos__prefLabel mesh__D019496 Cancer Vaccines
% 222.76/222.99  |- skos__altLabel mesh__D019496 Tumor Vaccines
% 222.76/222.99  |- skos__scopeNote mesh__D019496
% 222.76/222.99       Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient%27%s own whole tumor cells as the source of antigens, or using tumor-specific antigens, often recombinantly produced.%A%    
% 222.76/222.99  |- mesh__historyNote mesh__D019496 97   
% 222.76/222.99  |- skos__altLabel mesh__D019496 Vaccines, Neoplasm
% 222.76/222.99  |- mesh__dateEstablished mesh__D019496 1997-01-01
% 222.76/222.99  |- skos__altLabel mesh__D019496 Neoplasm Vaccines
% 222.76/222.99  |- skos__historyNote mesh__D019496 Vaccines %28%1971-1996%29%
% 222.76/222.99  |- skos__altLabel mesh__D019496 Vaccines, Tumor
% 222.76/222.99  |- skos__annotation mesh__D019496
% 222.76/222.99       coord IM with specific cancer histol type %28%IM%29% + organ/neopl precoord %28%IM%29%%A%  
% 222.76/222.99  |- mesh__recordAuthorizer mesh__D019496 sjn
% 222.76/222.99  |- skos__altLabel mesh__D019496 Vaccines, Cancer
% 222.76/222.99  |- mesh__publicMeSHNote mesh__D019496 97   
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D019496 2006
% 222.76/222.99  |- mesh__dateCreated mesh__D019496 1996-06-13
% 222.76/222.99  |- mesh__recordOriginator mesh__D019496 AGS
% 222.76/222.99  |- mesh__dateRevised mesh__D019496 2005-06-30
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D005476 2006
% 222.76/222.99  |- mesh__recordMaintainer mesh__D005476 ssb
% 222.76/222.99  |- skos__hiddenLabel mesh__D005476 Hydrochloride, Fluphenazine
% 222.76/222.99  |- skos__scopeNote mesh__D005476
% 222.76/222.99       A phenothiazine used in the treatment of PSYCHOSES. Its properties and uses are generally similar to those of CHLORPROMAZINE.%A%    
% 222.76/222.99  |- mesh__recordAuthorizer mesh__D005476 sjn
% 222.76/222.99  |- skos__altLabel mesh__D005476 Flufenazin
% 222.76/222.99  |- mesh__dateRevised mesh__D005476 2005-06-30
% 222.76/222.99  |- mesh__dateCreated mesh__D005476 1999-01-01
% 222.76/222.99  |- skos__prefLabel mesh__D005476 Fluphenazine
% 222.76/222.99  |- skos__broader mesh__D005476smesh__D010640
% 222.76/222.99  |- rdf__type mesh__D005476sskos__Concept
% 222.76/222.99  |- mesh__recordOriginator mesh__D005476 NLM
% 222.76/222.99  |- rdf__type mesh__D013908sskos__Concept
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D013908 2002
% 222.76/222.99  |- skos__historyNote mesh__D013908 Thoracic Surgery %28%1980-1987%29%
% 222.76/222.99  |- mesh__historyNote mesh__D013908 88   
% 222.76/222.99  |- skos__scopeNote mesh__D013908
% 222.76/222.99       Surgical incision into the chest wall.     
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D013908 1998
% 222.76/222.99  |- skos__historyNote mesh__D013908 Thorax/surgery %28%1966-1979%29%
% 222.76/222.99  |- skos__broader mesh__D013908smesh__D019616
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D013908 1999
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D013908 2000
% 222.76/222.99  |- mesh__dateRevised mesh__D013908 1997-06-20
% 222.76/222.99  |- mesh__publicMeSHNote mesh__D013908 88   
% 222.76/222.99  |- mesh__dateEstablished mesh__D013908 1988-01-01
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D013908 2003
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D013908 2001
% 222.76/222.99  |- mesh__recordOriginator mesh__D013908 SCD
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D013908 2005
% 222.76/222.99  |- mesh__recordMaintainer mesh__D013908 PXP
% 222.76/222.99  |- skos__prefLabel mesh__D013908 Thoracotomy
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D013908 2004
% 222.76/222.99  |- skos__annotation mesh__D013908
% 222.76/222.99       do not use /util except by MeSH definition; do not confuse with THORACOSTOMY%A%  
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D013908 2006
% 222.76/222.99  |- mesh__recordAuthorizer mesh__D013908 SJN
% 222.76/222.99  |- skos__hiddenLabel mesh__D013908 Thoracotomies
% 222.76/222.99  |- mesh__dateCreated mesh__D013908 1987-03-23
% 222.76/222.99  |- skos__broader mesh__D013270Q000557smesh__D013270
% 222.76/222.99  |- mesh__preferredCombination mesh__D013270Q000557smesh__D005753Q000557
% 222.76/222.99  |- rdf__type mesh__D013270Q000557smesh__CompoundConcept
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D010610 2004
% 222.76/222.99  |- skos__annotation mesh__D010610
% 222.76/222.99       coord IM with histol type of neopl %28%IM%29%   
% 222.76/222.99  |- skos__hiddenLabel mesh__D010610 Pharyngeal Cancers
% 222.76/222.99  |- skos__broader mesh__D010610smesh__D010039
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D010610 2002
% 222.76/222.99  |- skos__hiddenLabel mesh__D010610 Neoplasm, Pharynx
% 222.76/222.99  |- skos__hiddenLabel mesh__D010610 Pharynx Neoplasm
% 222.76/222.99  |- skos__hiddenLabel mesh__D010610 Neoplasm, Pharyngeal
% 222.76/222.99  |- skos__prefLabel mesh__D010610 Pharyngeal Neoplasms
% 222.76/222.99  |- mesh__recordMaintainer mesh__D010610 nns
% 222.76/222.99  |- skos__altLabel mesh__D010610 Pharynx Neoplasms
% 222.76/222.99  |- skos__scopeNote mesh__D010610 Tumors or cancer of the PHARYNX.     
% 222.76/222.99  |- skos__hiddenLabel mesh__D010610 Pharynx Cancers
% 222.76/222.99  |- rdf__type mesh__D010610sskos__Concept
% 222.76/222.99  |- skos__altLabel mesh__D010610 Pharyngeal Cancer
% 222.76/222.99  |- skos__altLabel mesh__D010610 Neoplasms, Pharyngeal
% 222.76/222.99  |- skos__altLabel mesh__D010610 Pharnyx Cancer
% 222.76/222.99  |- skos__hiddenLabel mesh__D010610 Pharynx Cancer
% 222.76/222.99  |- skos__hiddenLabel mesh__D010610 Pharyngeal Neoplasm
% 222.76/222.99  |- mesh__dateRevised mesh__D010610 1999-11-03
% 222.76/222.99  |- skos__hiddenLabel mesh__D010610 Cancers, Pharnyx
% 222.76/222.99  |- skos__altLabel mesh__D010610 Neoplasms, Pharynx
% 222.76/222.99  |- skos__hiddenLabel mesh__D010610 Cancers, Pharyngeal
% 222.76/222.99  |- skos__altLabel mesh__D010610 Cancer of the Pharynx
% 222.76/222.99  |- mesh__recordAuthorizer mesh__D010610 sjn
% 222.76/222.99  |- skos__broader mesh__D010610smesh__D010608
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D010610 2005
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D010610 2000
% 222.76/222.99  |- skos__hiddenLabel mesh__D010610 Cancer, Pharyngeal
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D010610 2003
% 222.76/222.99  |- skos__hiddenLabel mesh__D010610 Cancer, Pharnyx
% 222.76/222.99  |- mesh__dateCreated mesh__D010610 1999-01-01
% 222.76/222.99  |- skos__hiddenLabel mesh__D010610 Pharnyx Cancers
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D010610 2006
% 222.76/222.99  |- mesh__recordOriginator mesh__D010610 NLM
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D010610 2001
% 222.76/222.99  |- skos__hiddenLabel mesh__D051229
% 222.76/222.99       Acid-3-Phosphate Synthase, 5-Enolpyruvylshikimic
% 222.76/222.99  |- mesh__dateEstablished mesh__D051229 2006-01-01
% 222.76/222.99  |- skos__hiddenLabel mesh__D051229
% 222.76/222.99       3 Enol Pyruvoylshikimate 5 Phosphate Synthase
% 222.76/222.99  |- skos__hiddenLabel mesh__D051229
% 222.76/222.99       5 Enolpyruvyl Shikimic Acid 3 Phosphate Synthetase
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D051229 2006
% 222.76/222.99  |- skos__hiddenLabel mesh__D051229
% 222.76/222.99       5 Enolpyruvylshikimic Acid 3 Phosphate Synthase
% 222.76/222.99  |- skos__altLabel mesh__D051229
% 222.76/222.99       5-Enolpyruvylshikimic Acid-3-Phosphate Synthase
% 222.76/222.99  |- skos__hiddenLabel mesh__D051229
% 222.76/222.99       Synthase, 5-Enolpyruvylshikimate-3-Phosphate
% 222.76/222.99  |- skos__prefLabel mesh__D051229
% 222.76/222.99       3-Phosphoshikimate 1-Carboxyvinyltransferase
% 222.76/222.99  |- skos__hiddenLabel mesh__D051229
% 222.76/222.99       Synthase, 5-Enolpyruvylshikimic Acid-3-Phosphate
% 222.76/222.99  |- skos__hiddenLabel mesh__D051229
% 222.76/222.99       Synthase, 5-Enol-Pyruvyl Shikimate-3-Phosphate
% 222.76/222.99  |- rdf__type mesh__D051229sskos__Concept
% 222.76/222.99  |- skos__hiddenLabel mesh__D051229
% 222.76/222.99       aroA 3 Phosphoshikimate 1 Carboxyvinyltransferase
% 222.76/222.99  |- skos__hiddenLabel mesh__D051229
% 222.76/222.99       5 Enol Pyruvyl Shikimate 3 Phosphate Synthase
% 222.76/222.99  |- skos__altLabel mesh__D051229
% 222.76/222.99       aroA 3-Phosphoshikimate 1-Carboxyvinyltransferase
% 222.76/222.99  |- skos__altLabel mesh__D051229
% 222.76/222.99       5-Enol-Pyruvyl Shikimate-3-Phosphate Synthase
% 222.76/222.99  |- skos__hiddenLabel mesh__D051229
% 222.76/222.99       Synthase, 3-Enol-Pyruvoylshikimate-5-Phosphate
% 222.76/222.99  |- skos__hiddenLabel mesh__D051229
% 222.76/222.99       3 Enolpyruvylshikimate 5 Phosphate Synthase
% 222.76/222.99  |- mesh__recordMaintainer mesh__D051229 AKE
% 222.76/222.99  |- mesh__publicMeSHNote mesh__D051229
% 222.76/222.99       2006; 3-PHOSPHOSHIKIMATE 1-CARBOXYVINYLTRANSFERASE was indexed under ALKYL AND ARYL TRANSFERASES ALKYL 1973-2005, %26% under PHOSPHOENOLPYRUVATE %26% SHIKIMIC ACID 1973-1980%A%  
% 222.76/222.99  |- mesh__recordAuthorizer mesh__D051229 sjn
% 222.76/222.99  |- skos__altLabel mesh__D051229 5-Enolpyruvylshikimate-3-Phosphate Synthase
% 222.76/222.99  |- skos__hiddenLabel mesh__D051229
% 222.76/222.99       1-Carboxyvinyltransferase, 3-Phosphoshikimate
% 222.76/222.99  |- skos__hiddenLabel mesh__D051229
% 222.76/222.99       1-Carboxyvinyltransferase, aroA 3-Phosphoshikimate
% 222.76/222.99  |- skos__altLabel mesh__D051229 EPSP Synthase
% 222.76/222.99  |- skos__hiddenLabel mesh__D051229
% 222.76/222.99       3-Phosphoshikimate 1-Carboxyvinyltransferase, aroA
% 222.76/222.99  |- skos__broader mesh__D051229smesh__D019883
% 222.76/222.99  |- skos__altLabel mesh__D051229
% 222.76/222.99       5-Enolpyruvyl Shikimic Acid 3-Phosphate Synthetase
% 222.76/222.99  |- skos__hiddenLabel mesh__D051229 Synthase, EPSP
% 222.76/222.99  |- skos__hiddenLabel mesh__D051229
% 222.76/222.99       5-Phosphate Synthase, 3-Enolpyruvylshikimate
% 222.76/222.99  |- skos__altLabel mesh__D051229 3-Enolpyruvylshikimate 5-Phosphate Synthase
% 222.76/222.99  |- mesh__historyNote mesh__D051229
% 222.76/222.99       2006%28%1980%29%; use ALKYL AND ARYL TRANSFERASES ALKYL, PHOSPHOENOLPYRUVATE %26% SHIKIMIC ACID 1973-1979%A%  
% 222.76/222.99  |- mesh__dateCreated mesh__D051229 2005-06-30
% 222.76/222.99  |- skos__hiddenLabel mesh__D051229
% 222.76/222.99       5 Enolpyruvylshikimate 3 Phosphate Synthase
% 222.76/222.99  |- skos__altLabel mesh__D051229
% 222.76/222.99       3-Enol-Pyruvoylshikimate-5-Phosphate Synthase
% 222.76/222.99  |- skos__hiddenLabel mesh__D051229
% 222.76/222.99       Synthase, 3-Enolpyruvylshikimate 5-Phosphate
% 222.76/222.99  |- skos__hiddenLabel mesh__D051229
% 222.76/222.99       Shikimate-3-Phosphate Synthase, 5-Enol-Pyruvyl
% 222.76/222.99  |- skos__scopeNote mesh__D051229
% 222.76/222.99       An enzyme of the shikimate pathway of AROMATIC AMINO ACID biosynthesis, it generates 5-enolpyruvylshikimate 3-phosphate and ORTHOPHOSPHATE from PHOSPHOENOLPYRUVATE and SHIKIMATE-3-PHOSPHATE. The shikimate pathway is present in BACTERIA and PLANTS but not in MAMMALS.%A%    
% 222.76/222.99  |- skos__hiddenLabel mesh__D051229
% 222.76/222.99       3 Phosphoshikimate 1 Carboxyvinyltransferase
% 222.76/222.99  |- mesh__recordOriginator mesh__D051229 AKE
% 222.76/222.99  |- mesh__historyNote mesh__D009867
% 222.76/222.99       91%28%75%29%; was see under OVUM 1975-90   
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D009867 2004
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D009867 2005
% 222.76/222.99  |- mesh__dateRevised mesh__D009867 2002-07-03
% 222.76/222.99  |- skos__prefLabel mesh__D009867 Oogonia
% 222.76/222.99  |- skos__broader mesh__D009867smesh__D010063
% 222.76/222.99  |- mesh__recordMaintainer mesh__D009867 lkt
% 222.76/222.99  |- rdf__type mesh__D009867sskos__Concept
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D009867 2003
% 222.76/222.99  |- mesh__recordAuthorizer mesh__D009867 sjn
% 222.76/222.99  |- mesh__recordOriginator mesh__D009867 NLM
% 222.76/222.99  |- mesh__dateEstablished mesh__D009867 1991-01-01
% 222.76/222.99  |- mesh__dateCreated mesh__D009867 1974-11-11
% 222.76/222.99  |- mesh__publicMeSHNote mesh__D009867 91; was see under OVUM 1975-90   
% 222.76/222.99  |- skos__scopeNote mesh__D009867
% 222.76/222.99       Euploid female germ cells of an early stage of OOGENESIS, derived from primordial germ cells during ovarian differentiation. Oogonia undergo MEIOSIS and give rise to haploid OOCYTES%A%    
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D009867 2006
% 222.76/222.99  |- mesh__dateCreated mesh__D001884 1999-01-01
% 222.76/222.99  |- mesh__dateRevised mesh__D001884 2005-06-30
% 222.76/222.99  |- skos__prefLabel mesh__D001884 Bordetella
% 222.76/222.99  |- skos__annotation mesh__D001884 infection = BORDETELLA INFECTIONS   
% 222.76/222.99  |- skos__broader mesh__D001884smesh__D042401
% 222.76/222.99  |- rdf__type mesh__D001884sskos__Concept
% 222.76/222.99  |- mesh__recordMaintainer mesh__D001884 SYSTEM
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D001884 2006
% 222.76/222.99  |- mesh__recordOriginator mesh__D001884 NLM
% 222.76/222.99  |- mesh__recordAuthorizer mesh__D001884 sjn
% 222.76/222.99  |- skos__scopeNote mesh__D001884
% 222.76/222.99       A genus of gram-negative, aerobic bacteria whose cells are minute coccobacilli. It consists of both parasitic and pathogenic species.%A%    
% 222.76/222.99  |- skos__altLabel mesh__D009069 Dyskinesia Syndromes
% 222.76/222.99  |- skos__related mesh__D009069smesh__D011596
% 222.76/222.99  |- rdf__type mesh__D009069sskos__Concept
% 222.76/222.99  |- skos__prefLabel mesh__D009069 Movement Disorders
% 222.76/222.99  |- skos__hiddenLabel mesh__D009069 Movement Disorder
% 222.76/222.99  |- skos__annotation mesh__D009069
% 222.76/222.99       see also DYSKINESIAS for manifestations of disease; use MOVEMENT DISORDERS for diseases%A%  
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D009069 2004
% 222.76/222.99  |- skos__hiddenLabel mesh__D009069 Movement Disorder Syndrome
% 222.76/222.99  |- skos__altLabel mesh__D009069 Movement Disorder Syndromes
% 222.76/222.99  |- skos__scopeNote mesh__D009069
% 222.76/222.99       Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.%A%    
% 222.76/222.99  |- skos__altLabel mesh__D009069 Status Marmoratus
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D009069 2002
% 222.76/222.99  |- skos__broader mesh__D009069smesh__D002493
% 222.76/222.99  |- mesh__recordAuthorizer mesh__D009069 sjn
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D009069 2006
% 222.76/222.99  |- mesh__recordOriginator mesh__D009069 NLM
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D009069 2003
% 222.76/222.99  |- skos__hiddenLabel mesh__D009069 Dyskinesia Syndrome
% 222.76/222.99  |- mesh__recordMaintainer mesh__D009069 KEV
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D009069 2001
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D009069 2005
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D009069 2000
% 222.76/222.99  |- mesh__dateRevised mesh__D009069 1999-11-03
% 222.76/222.99  |- mesh__dateCreated mesh__D009069 1999-01-01
% 222.76/222.99  |- skos__related mesh__D009069smesh__D020820
% 222.76/222.99  |- mesh__recordOriginator mesh__D001086 RLS
% 222.76/222.99  |- skos__hiddenLabel mesh__D001086 Arabinoside, Uracil
% 222.76/222.99  |- mesh__dateRevised mesh__D001086 2001-07-25
% 222.76/222.99  |- mesh__historyNote mesh__D001086
% 222.76/222.99       91%28%76%29%; was see under URIDINE/analogs %26% derivatives 1978-90; was see under PYRIMIDINE NUCLEOSIDES 1976-77%A%  
% 222.76/222.99  |- skos__broader mesh__D001086smesh__D001087
% 222.76/222.99  |- skos__hiddenLabel mesh__D001086 1 beta D Arabinofuranosyl Uracil
% 222.76/222.99  |- mesh__recordAuthorizer mesh__D001086 sjn
% 222.76/222.99  |- skos__hiddenLabel mesh__D001086 Arabinofuranoside, Uracil
% 222.76/222.99  |- skos__altLabel mesh__D001086 Sponguridine
% 222.76/222.99  |- mesh__publicMeSHNote mesh__D001086
% 222.76/222.99       91; was see under URIDINE/analogs %26% derivatives 1978-90; was see under PYRIMIDINE NUCLEOSIDES 1976-77%A%  
% 222.76/222.99  |- skos__altLabel mesh__D001086 Uracil Arabinofuranoside
% 222.76/222.99  |- skos__altLabel mesh__D001086 Arauridine
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D001086 2005
% 222.76/222.99  |- mesh__dateCreated mesh__D001086 1975-07-23
% 222.76/222.99  |- skos__historyNote mesh__D001086 Nucleosides %28%1972-1974%29%
% 222.76/222.99  |- skos__altLabel mesh__D001086 Uracil Arabinoside
% 222.76/222.99  |- skos__scopeNote mesh__D001086
% 222.76/222.99       A pyrimidine nucleoside formed in the body by the deamination of CYTARABINE.%A%    
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D001086 2003
% 222.76/222.99  |- mesh__recordMaintainer mesh__D001086 jmp
% 222.76/222.99  |- skos__hiddenLabel mesh__D001086 Ara U
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D001086 2006
% 222.76/222.99  |- mesh__dateEstablished mesh__D001086 1991-01-01
% 222.76/222.99  |- skos__broader mesh__D001086smesh__D014529
% 222.76/222.99  |- skos__historyNote mesh__D001086
% 222.76/222.99       Uridine/analogs %26% derivatives %28%1975%29%
% 222.76/222.99  |- skos__prefLabel mesh__D001086 Arabinofuranosyluracil
% 222.76/222.99  |- skos__historyNote mesh__D001086 Uracil %28%1972-1974%29%
% 222.76/222.99  |- skos__altLabel mesh__D001086 Ara-U
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D001086 2004
% 222.76/222.99  |- skos__annotation mesh__D001086 /biosyn /physiol permitted   
% 222.76/222.99  |- skos__altLabel mesh__D001086 1-beta-D-Arabinofuranosyl Uracil
% 222.76/222.99  |- rdf__type mesh__D001086sskos__Concept
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D001086 2002
% 222.76/222.99  |- skos__hiddenLabel mesh__D001086 Uracil, 1-beta-D-Arabinofuranosyl
% 222.76/222.99  |- skos__historyNote mesh__D001086
% 222.76/222.99       Arabinose %28%1972-1974%29%/analogs %26% derivatives %28%1975%29%
% 222.76/222.99  |- skos__altLabel mesh__D001086 Arabinosyluracil
% 222.76/222.99  |- mesh__dateEstablished mesh__D028223 2002-01-01
% 222.76/222.99  |- skos__annotation mesh__D028223
% 222.76/222.99       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.76/222.99  |- skos__prefLabel mesh__D028223 Pinus
% 222.76/222.99  |- mesh__recordMaintainer mesh__D028223 ssb
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D028223 2006
% 222.76/222.99  |- rdf__type mesh__D028223sskos__Concept
% 222.76/222.99  |- skos__historyNote mesh__D028223 Trees %28%1965-2001%29%
% 222.76/222.99  |- skos__altLabel mesh__D028223 Pine Tree
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D028223 2005
% 222.76/222.99  |- skos__scopeNote mesh__D028223
% 222.76/222.99       A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta.  They are evergreen trees mainly in temperate climates.%A%    
% 222.76/222.99  |- mesh__recordAuthorizer mesh__D028223 sjn
% 222.76/222.99  |- skos__broader mesh__D028223smesh__D028201
% 222.76/222.99  |- mesh__recordOriginator mesh__D028223 ssb
% 222.76/222.99  |- mesh__historyNote mesh__D028223 2002   
% 222.76/222.99  |- mesh__dateCreated mesh__D028223 2001-07-25
% 222.76/222.99  |- mesh__dateRevised mesh__D028223 2004-07-07
% 222.76/222.99  |- mesh__publicMeSHNote mesh__D028223 2002   
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D020240 2000
% 222.76/222.99  |- skos__hiddenLabel mesh__D020240 Apraxias, Ideokinetic
% 222.76/222.99  |- rdf__type mesh__D020240sskos__Concept
% 222.76/222.99  |- skos__hiddenLabel mesh__D020240 Apraxias, Limb Kinetic
% 222.76/222.99  |- skos__hiddenLabel mesh__D020240 Dyspraxias, Ideomotor
% 222.76/222.99  |- skos__hiddenLabel mesh__D020240 Ideokinetic Apraxia
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D020240 2006
% 222.76/222.99  |- skos__historyNote mesh__D020240 Apraxias %28%1968-1999%29%
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D020240 2001
% 222.76/222.99  |- skos__hiddenLabel mesh__D020240 Limb Kinetic Apraxias
% 222.76/222.99  |- mesh__dateCreated mesh__D020240 1999-11-03
% 222.76/222.99  |- skos__altLabel mesh__D020240 Classic Apraxia
% 222.76/222.99  |- skos__hiddenLabel mesh__D020240 Apraxia, Classic
% 222.76/222.99  |- skos__altLabel mesh__D020240 Ideomotor Apraxia
% 222.76/222.99  |- skos__hiddenLabel mesh__D020240 Transcortical Apraxia
% 222.76/222.99  |- skos__hiddenLabel mesh__D020240 Ideomotor Apraxias
% 222.76/222.99  |- skos__scopeNote mesh__D020240
% 222.76/222.99       A form of APRAXIA characterized by an acquired inability to carry out a complex motor activity despite the ability to mentally formulate the action. This condition has been attributed to a disruption of connections between the dominant parietal cortex and supplementary and premotor cortical regions in both hemispheres. %28%From Adams et al., Principles of Neurology, 6th ed, p57%29%%A%    
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D020240 2002
% 222.76/222.99  |- skos__hiddenLabel mesh__D020240 Limb Kinetic Apraxia
% 222.76/222.99  |- skos__hiddenLabel mesh__D020240 Apraxias, Classic
% 222.76/222.99  |- skos__hiddenLabel mesh__D020240 Ideomotor Dyspraxias
% 222.76/222.99  |- skos__hiddenLabel mesh__D020240 Apraxias, Ideomotor
% 222.76/222.99  |- skos__hiddenLabel mesh__D020240 Kinetic Apraxias, Limb
% 222.76/222.99  |- skos__altLabel mesh__D020240 Apraxia, Transcortical
% 222.76/222.99  |- mesh__dateEstablished mesh__D020240 2000-01-01
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D020240 2003
% 222.76/222.99  |- skos__hiddenLabel mesh__D020240 Kinetic Apraxia, Limb
% 222.76/222.99  |- skos__altLabel mesh__D020240 Apraxia, Limb Kinetic
% 222.76/222.99  |- skos__altLabel mesh__D020240 Apraxia, Ideokinetic
% 222.76/222.99  |- skos__hiddenLabel mesh__D020240 Ideomotor Dyspraxia
% 222.76/222.99  |- skos__hiddenLabel mesh__D020240 Transcortical Apraxias
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D020240 2004
% 222.76/222.99  |- mesh__publicMeSHNote mesh__D020240 2000   
% 222.76/222.99  |- skos__hiddenLabel mesh__D020240 Ideokinetic Apraxias
% 222.76/222.99  |- skos__prefLabel mesh__D020240 Apraxia, Ideomotor
% 222.76/222.99  |- mesh__historyNote mesh__D020240 2000   
% 222.76/222.99  |- skos__altLabel mesh__D020240 Dyspraxia, Ideomotor
% 222.76/222.99  |- skos__broader mesh__D020240smesh__D001072
% 222.76/222.99  |- skos__hiddenLabel mesh__D020240 Apraxias, Transcortical
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D020240 2005
% 222.76/222.99  |- skos__hiddenLabel mesh__D020240 Classic Apraxias
% 222.76/222.99  |- mesh__recordOriginator mesh__D047188 ssb
% 222.76/222.99  |- skos__broader mesh__D047188smesh__D005419
% 222.76/222.99  |- skos__broader mesh__D047188smesh__D011427
% 222.76/222.99  |- mesh__publicMeSHNote mesh__D047188 2005   
% 222.76/222.99  |- skos__altLabel mesh__D047188 1,3-Diphenylpropenones
% 222.76/222.99  |- mesh__historyNote mesh__D047188 2005   
% 222.76/222.99  |- skos__hiddenLabel mesh__D047188 1,3 Diphenylpropenones
% 222.76/222.99  |- skos__historyNote mesh__D047188
% 222.76/222.99       Chalcone/analogs %26% derivatives %28%1991-2004%29%
% 222.76/222.99  |- mesh__activeMeSHYear mesh__D047188 2006
% 222.76/222.99  |- skos__hiddenLabel mesh__D047188 1,3 Diphenylpropanediones
% 222.76/222.99  |- mesh__recordMaintainer mesh__D047188 ssb
% 222.76/222.99  |- mesh__dateEstablished mesh__D047188 2005-01-01
% 222.76/222.99  |- mesh__dateRevised mesh__D047188 2005-06-30
% 222.76/223.00  |- skos__hiddenLabel mesh__D047188 1,3 Diphenyl propanediones
% 222.76/223.00  |- mesh__recordAuthorizer mesh__D047188 sjn
% 222.76/223.00  |- skos__altLabel mesh__D047188 1,3-Diphenyl-propanediones
% 222.76/223.00  |- rdf__type mesh__D047188sskos__Concept
% 222.76/223.00  |- skos__prefLabel mesh__D047188 Chalcones
% 222.76/223.00  |- mesh__dateCreated mesh__D047188 2004-07-07
% 222.76/223.00  |- skos__related mesh__D047188smesh__D001565
% 222.76/223.00  |- skos__scopeNote mesh__D047188
% 222.76/223.00       Compounds based on CHALCONE. They are important intermediates in the formation of FLAVONOIDS.%A%    
% 222.76/223.00  |- skos__altLabel mesh__D047188 1,3-Diphenyl-propenones
% 222.76/223.00  |- skos__hiddenLabel mesh__D047188 1,3 Diphenyl propenones
% 222.76/223.00  |- skos__broader mesh__D014203smesh__D011759
% 222.76/223.00  |- mesh__activeMeSHYear mesh__D014203 1995
% 222.76/223.00  |- skos__prefLabel mesh__D014203 Tremorine
% 222.76/223.00  |- mesh__activeMeSHYear mesh__D014203 1998
% 222.76/223.00  |- mesh__recordOriginator mesh__D014203 NLM
% 222.76/223.00  |- mesh__activeMeSHYear mesh__D014203 2001
% 222.76/223.00  |- mesh__recordMaintainer mesh__D014203 TPW
% 222.76/223.00  |- mesh__activeMeSHYear mesh__D014203 2004
% 222.76/223.00  |- rdf__type mesh__D014203sskos__Concept
% 222.76/223.00  |- mesh__dateRevised mesh__D014203 1994-05-24
% 222.76/223.00  |- mesh__activeMeSHYear mesh__D014203 2000
% 222.76/223.00  |- mesh__activeMeSHYear mesh__D014203 1997
% 222.76/223.00  |- mesh__activeMeSHYear mesh__D014203 2003
% 222.76/223.00  |- mesh__recordAuthorizer mesh__D014203 PLS
% 222.76/223.00  |- mesh__activeMeSHYear mesh__D014203 2006
% 222.76/223.00  |- mesh__dateEstablished mesh__D014203 1966-01-01
% 222.76/223.00  |- mesh__publicMeSHNote mesh__D014203 66   
% 222.76/223.00  |- mesh__activeMeSHYear mesh__D014203 1996
% 222.76/223.00  |- mesh__activeMeSHYear mesh__D014203 2002
% 222.76/223.00  |- mesh__dateCreated mesh__D014203 1999-01-01
% 222.76/223.00  |- mesh__activeMeSHYear mesh__D014203 2005
% 222.76/223.00  |- mesh__activeMeSHYear mesh__D014203 1999
% 222.76/223.00  |- mesh__historyNote mesh__D014203 66   
% 222.76/223.00  |- mesh__dateRevised mesh__D033966 2004-07-07
% 222.76/223.00  |- mesh__activeMeSHYear mesh__D033966 2006
% 222.76/223.00  |- skos__altLabel mesh__D033966 beta-Adaptins
% 222.76/223.00  |- mesh__activeMeSHYear mesh__D033966 2005
% 222.86/223.00  |- rdf__type mesh__D033966sskos__Concept
% 222.86/223.00  |- skos__prefLabel mesh__D033966 Adaptor Protein Complex beta Subunits
% 222.86/223.00  |- mesh__historyNote mesh__D033966
% 222.86/223.00       2003; use ADAPTOR PROTEIN COMPLEX BETA SUBUNITS %28%NM%29% 1990-2002%A%  
% 222.86/223.00  |- mesh__recordOriginator mesh__D033966 jmp
% 222.86/223.00  |- mesh__recordAuthorizer mesh__D033966 sjn
% 222.86/223.00  |- skos__altLabel mesh__D033966 beta-Adaptin
% 222.86/223.00  |- skos__hiddenLabel mesh__D033966 beta Adaptins
% 222.86/223.00  |- mesh__dateEstablished mesh__D033966 2003-01-01
% 222.86/223.00  |- skos__scopeNote mesh__D033966
% 222.86/223.00       A family of large adaptin protein complex subunits of approximately 90-130 kDa in size.%A%    
% 222.86/223.00  |- mesh__publicMeSHNote mesh__D033966
% 222.86/223.00       2003; BETA-ADAPTINS %28%now ADAPTOR PROTEIN COMPLEX BETA SUBUNITS%29% was indexed under MEMBRANE PROTEINS 1995-2002, PROTEINS 1990-1994%A%  
% 222.86/223.00  |- skos__historyNote mesh__D033966 Proteins %28%1990-1994%29%
% 222.86/223.00  |- mesh__recordMaintainer mesh__D033966 jmp
% 222.86/223.00  |- skos__hiddenLabel mesh__D033966 beta Adaptin
% 222.86/223.00  |- mesh__dateCreated mesh__D033966 2002-07-02
% 222.86/223.00  |- skos__broader mesh__D033966smesh__D034001
% 222.86/223.00  |- skos__historyNote mesh__D033966 Membrane Proteins %28%1994-2002%29%
% 222.86/223.00  |- skos__scopeNote mesh__D019497
% 222.86/223.00       Works consisting of  records, usually private, of writers%27% experiences, observations, feelings, attitudes, etc. They may also be works marked in calendar order in which to note appointments and the like. %28%From Random House Unabridged Dictionary, 2d ed%29%%A%    
% 222.86/223.00  |- rdf__type mesh__D019497sskos__Concept
% 222.86/223.00  |- mesh__recordAuthorizer mesh__D019497 sjn
% 222.86/223.00  |- mesh__dateEstablished mesh__D019497 1997-01-01
% 222.86/223.00  |- mesh__recordOriginator mesh__D019497 TGC
% 222.86/223.00  |- skos__annotation mesh__D019497 publication type only   
% 222.86/223.00  |- mesh__historyNote mesh__D019497 1997   
% 222.86/223.00  |- mesh__dateRevised mesh__D019497 2005-06-30
% 222.86/223.00  |- skos__altLabel mesh__D019497 Diaries
% 222.86/223.00  |- mesh__dateCreated mesh__D019497 1996-06-21
% 222.86/223.00  |- mesh__recordMaintainer mesh__D019497 jls
% 222.86/223.00  |- skos__altLabel mesh__D019497 Diaries %28%PT%29%
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D019497 2006
% 222.86/223.00  |- skos__prefLabel mesh__D019497 Diaries %5B%Publication Type%5D%
% 222.86/223.00  |- skos__broader mesh__D019497smesh__D052180
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D005477 2005
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D005477 2004
% 222.86/223.00  |- skos__prefLabel mesh__D005477 Fluprednisolone
% 222.86/223.00  |- mesh__recordOriginator mesh__D005477 NLM
% 222.86/223.00  |- skos__scopeNote mesh__D005477
% 222.86/223.00       A synthetic glucocorticoid with anti-inflammatory properties.%A%    
% 222.86/223.00  |- mesh__dateRevised mesh__D005477 2003-07-09
% 222.86/223.00  |- mesh__recordMaintainer mesh__D005477 ssb
% 222.86/223.00  |- skos__broader mesh__D005477smesh__D013259
% 222.86/223.00  |- skos__broader mesh__D005477smesh__D011239
% 222.86/223.00  |- mesh__dateCreated mesh__D005477 1999-01-01
% 222.86/223.00  |- rdf__type mesh__D005477sskos__Concept
% 222.86/223.00  |- mesh__recordAuthorizer mesh__D005477 sjn
% 222.86/223.00  |- mesh__publicMeSHNote mesh__D005477 65   
% 222.86/223.00  |- mesh__historyNote mesh__D005477 65   
% 222.86/223.00  |- mesh__dateEstablished mesh__D005477 1965-01-01
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D005477 2006
% 222.86/223.00  |- skos__scopeNote mesh__D013909
% 222.86/223.00       The upper part of the trunk between the NECK and the ABDOMEN. It contains the chief organs of the circulatory and respiratory systems. %28%From Stedman, 25th ed%29%%A%    
% 222.86/223.00  |- skos__broader mesh__D013909smesh__D001842
% 222.86/223.00  |- mesh__recordMaintainer mesh__D013909 ags
% 222.86/223.00  |- skos__broader mesh__D013909smesh__D001829
% 222.86/223.00  |- skos__related mesh__D013909smesh__D013903
% 222.86/223.00  |- skos__altLabel mesh__D013909 Chest
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D013909 2003
% 222.86/223.00  |- skos__related mesh__D013909smesh__D013902
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D013909 2005
% 222.86/223.00  |- mesh__publicMeSHNote mesh__D013909
% 222.86/223.00       /surgery %28% = THORACIC SURGERY as of 1980%29% was used for indexing 1966-79%A%  
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D013909 2004
% 222.86/223.00  |- mesh__dateRevised mesh__D013909 2002-07-03
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D013909 2006
% 222.86/223.00  |- mesh__recordOriginator mesh__D013909 NLM
% 222.86/223.00  |- mesh__onlineNote mesh__D013909
% 222.86/223.00       search THORAX/SU under THORACIC SURGERY 1966-79   
% 222.86/223.00  |- skos__related mesh__D013909smesh__D013908
% 222.86/223.00  |- skos__annotation mesh__D013909
% 222.86/223.00       /surg = THORACIC SURGERY, the specialty %28%Cat G2%29% or THORACIC SURGICAL PROCEDURES %28%Cat E4%29%; %22%intrathoracic%22% could be THORAX or HEART or LUNG or RIBS: check text; chest pain = CHEST PAIN%A%  
% 222.86/223.00  |- rdf__type mesh__D013909sskos__Concept
% 222.86/223.00  |- skos__related mesh__D013909smesh__D013907
% 222.86/223.00  |- skos__related mesh__D013909smesh__D008400
% 222.86/223.00  |- skos__prefLabel mesh__D013909 Thorax
% 222.86/223.00  |- mesh__historyNote mesh__D013909
% 222.86/223.00       /surgery was used for indexing 1966-79   
% 222.86/223.00  |- skos__hiddenLabel mesh__D013909 Chests
% 222.86/223.00  |- mesh__dateCreated mesh__D013909 1999-01-01
% 222.86/223.00  |- skos__related mesh__D013909smesh__D013906
% 222.86/223.00  |- skos__hiddenLabel mesh__D013909 Thorace
% 222.86/223.00  |- skos__related mesh__D013909smesh__D013905
% 222.86/223.00  |- skos__altLabel mesh__D013909 Thoraces
% 222.86/223.00  |- mesh__recordAuthorizer mesh__D013909 sjn
% 222.86/223.00  |- skos__broader mesh__D011573Q000266smesh__D011573
% 222.86/223.00  |- mesh__preferredCombination mesh__D011573Q000266smesh__D011572Q000266
% 222.86/223.00  |- rdf__type mesh__D011573Q000266smesh__CompoundConcept
% 222.86/223.00  |- skos__broader mesh__D010611smesh__D013517
% 222.86/223.00  |- skos__scopeNote mesh__D010611
% 222.86/223.00       Surgical removal of a part of the pharynx. %28%Dorland, 28th ed%29%%A%    
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D010611 1999
% 222.86/223.00  |- mesh__dateEstablished mesh__D010611 1974-01-01
% 222.86/223.00  |- mesh__recordMaintainer mesh__D010611 PXP
% 222.86/223.00  |- rdf__type mesh__D010611sskos__Concept
% 222.86/223.00  |- mesh__publicMeSHNote mesh__D010611 74   
% 222.86/223.00  |- mesh__recordOriginator mesh__D010611 NLM
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D010611 2001
% 222.86/223.00  |- mesh__dateRevised mesh__D010611 1997-06-20
% 222.86/223.00  |- skos__hiddenLabel mesh__D010611 Pharyngectomies
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D010611 2002
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D010611 2005
% 222.86/223.00  |- mesh__recordAuthorizer mesh__D010611 SJN
% 222.86/223.00  |- mesh__historyNote mesh__D010611 74%28%64%29%   
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D010611 2003
% 222.86/223.00  |- mesh__dateCreated mesh__D010611 1999-01-01
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D010611 2006
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D010611 2004
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D010611 1998
% 222.86/223.00  |- skos__prefLabel mesh__D010611 Pharyngectomy
% 222.86/223.00  |- skos__annotation mesh__D010611
% 222.86/223.00       do not use /util except by MeSH definition   
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D010611 2000
% 222.86/223.00  |- mesh__dateCreated mesh__D009868 1999-01-01
% 222.86/223.00  |- mesh__dateRevised mesh__D009868 2005-06-30
% 222.86/223.00  |- mesh__publicMeSHNote mesh__D009868
% 222.86/223.00       91; see MASTIGOMYCOTINA 1986-90, see PHYCOMYCETES 1972-85%A%  
% 222.86/223.00  |- skos__altLabel mesh__D009868 Oomycota
% 222.86/223.00  |- skos__prefLabel mesh__D009868 Oomycetes
% 222.86/223.00  |- mesh__dateEstablished mesh__D009868 1991-01-01
% 222.86/223.00  |- skos__broader mesh__D009868smesh__D000456
% 222.86/223.00  |- skos__hiddenLabel mesh__D009868 Oomycete
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D009868 2006
% 222.86/223.00  |- mesh__historyNote mesh__D009868 91%28%75%29%; use FUNGI 1972-74   
% 222.86/223.00  |- skos__hiddenLabel mesh__D009868 Oomycotas
% 222.86/223.00  |- mesh__recordAuthorizer mesh__D009868 sjn
% 222.86/223.00  |- mesh__recordOriginator mesh__D009868 NLM
% 222.86/223.00  |- rdf__type mesh__D009868sskos__Concept
% 222.86/223.00  |- skos__scopeNote mesh__D009868
% 222.86/223.00       A group of ALGAE, formerly considered FUNGI, whose exact taxonomic level is unsettled. Many consider Oomycetes %28%Oomycota%29% a phylum in the kingdom Stramenopila, or alternatively, as Pseudofungi in the phylum Heterokonta of the kingdom Chromista. They are morphologically similar to fungi but have no close phylogenetic relationship to them. Oomycetes are found in both fresh and salt water as well as in terrestrial environments. %28%Alexopoulos et al., Introductory Mycology, 4th ed, pp683-4%29%. They produce flagellated, actively motile spores %28%zoospores%29% that are pathogenic to many crop plants and FISHES.%A%    
% 222.86/223.00  |- skos__annotation mesh__D009868
% 222.86/223.00       GEN or unspecified; prefer specifics; infection: coord IM with INFECTION %28%IM%29%%A%  
% 222.86/223.00  |- mesh__recordMaintainer mesh__D009868 SYSTEM
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001885 2005
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001885 2000
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001885 1995
% 222.86/223.00  |- mesh__recordMaintainer mesh__D001885 PLS
% 222.86/223.00  |- skos__altLabel mesh__D001885 Infections, Bordetella
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001885 2004
% 222.86/223.00  |- mesh__recordAuthorizer mesh__D001885 PLS
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001885 1999
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001885 1994
% 222.86/223.00  |- skos__annotation mesh__D001885 gram-neg bact infect   
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001885 2003
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001885 1998
% 222.86/223.00  |- skos__hiddenLabel mesh__D001885 Bordetella Infection
% 222.86/223.00  |- skos__broader mesh__D001885smesh__D016905
% 222.86/223.00  |- rdf__type mesh__D001885sskos__Concept
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001885 1997
% 222.86/223.00  |- mesh__recordOriginator mesh__D001885 NLM
% 222.86/223.00  |- mesh__historyNote mesh__D001885 72   
% 222.86/223.00  |- skos__prefLabel mesh__D001885 Bordetella Infections
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001885 2002
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001885 1996
% 222.86/223.00  |- mesh__publicMeSHNote mesh__D001885 72   
% 222.86/223.00  |- skos__scopeNote mesh__D001885
% 222.86/223.00       Infections with bacteria of the genus BORDETELLA.     
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001885 2006
% 222.86/223.00  |- skos__historyNote mesh__D001885 Bordetella %28%1966-1971%29%
% 222.86/223.00  |- mesh__dateRevised mesh__D001885 1993-06-02
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001885 2001
% 222.86/223.00  |- skos__hiddenLabel mesh__D001885 Infection, Bordetella
% 222.86/223.00  |- mesh__dateCreated mesh__D001885 1999-01-01
% 222.86/223.00  |- mesh__dateEstablished mesh__D001885 1972-01-01
% 222.86/223.00  |- mesh__dateCreated mesh__D034261 2002-07-03
% 222.86/223.00  |- mesh__publicMeSHNote mesh__D034261 2003   
% 222.86/223.00  |- mesh__recordMaintainer mesh__D034261 ssb
% 222.86/223.00  |- skos__altLabel mesh__D034261 Epothilon
% 222.86/223.00  |- skos__historyNote mesh__D034261 Epoxy Compounds %28%1995-2002%29%
% 222.86/223.00  |- mesh__recordOriginator mesh__D034261 ssb
% 222.86/223.00  |- mesh__historyNote mesh__D034261 2003   
% 222.86/223.00  |- mesh__recordAuthorizer mesh__D034261 sjn
% 222.86/223.00  |- skos__broader mesh__D034261smesh__D018942
% 222.86/223.00  |- mesh__dateEstablished mesh__D034261 2003-01-01
% 222.86/223.00  |- rdf__type mesh__D034261sskos__Concept
% 222.86/223.00  |- skos__historyNote mesh__D034261 Macrolides %28%1998-2002%29%
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D034261 2005
% 222.86/223.00  |- mesh__dateRevised mesh__D034261 2004-07-07
% 222.86/223.00  |- skos__prefLabel mesh__D034261 Epothilones
% 222.86/223.00  |- skos__altLabel mesh__D034261 Epothilone
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D034261 2006
% 222.86/223.00  |- skos__scopeNote mesh__D034261
% 222.86/223.00       A group of 16-member MACROLIDES which stabilize MICROTUBULES in a manner similar to PACLITAXEL. They were originally found in the myxobacterium Sorangium cellulosum, now renamed to Polyangium %28%MYXOCOCCALES%29%.%A%    
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001087 2002
% 222.86/223.00  |- mesh__recordMaintainer mesh__D001087 TGC
% 222.86/223.00  |- skos__historyNote mesh__D001087 specific nucleoside %28%1966-1978%29%
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001087 2005
% 222.86/223.00  |- mesh__recordOriginator mesh__D001087 RLS
% 222.86/223.00  |- mesh__historyNote mesh__D001087 79   
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001087 1994
% 222.86/223.00  |- skos__scopeNote mesh__D001087
% 222.86/223.00       Nucleosides containing arabinose as their sugar moiety.%A%    
% 222.86/223.00  |- skos__prefLabel mesh__D001087 Arabinonucleosides
% 222.86/223.00  |- mesh__dateCreated mesh__D001087 1978-05-17
% 222.86/223.00  |- mesh__publicMeSHNote mesh__D001087 79   
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001087 2003
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001087 2006
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001087 1995
% 222.86/223.00  |- skos__historyNote mesh__D001087 Nucleosides %28%1966-1978%29%
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001087 1998
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001087 1993
% 222.86/223.00  |- mesh__recordAuthorizer mesh__D001087 PLS
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001087 2004
% 222.86/223.00  |- rdf__type mesh__D001087sskos__Concept
% 222.86/223.00  |- mesh__dateRevised mesh__D001087 1992-05-07
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001087 2000
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001087 1996
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001087 1999
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001087 2001
% 222.86/223.00  |- skos__broader mesh__D001087smesh__D009705
% 222.86/223.00  |- mesh__dateEstablished mesh__D001087 1979-01-01
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D001087 1997
% 222.86/223.00  |- skos__altLabel mesh__D001087 Arabinofuranosylnucleosides
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D028224 2005
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D028224 2004
% 222.86/223.00  |- skos__scopeNote mesh__D028224
% 222.86/223.00       A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta.  They are coniferous evergreen trees with long, flat, spirally arranged needles that grow directly from the branch.%A%    
% 222.86/223.00  |- mesh__historyNote mesh__D028224 2002   
% 222.86/223.00  |- skos__broader mesh__D028224smesh__D028201
% 222.86/223.00  |- skos__prefLabel mesh__D028224 Pseudotsuga
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D028224 2003
% 222.86/223.00  |- mesh__dateCreated mesh__D028224 2001-07-25
% 222.86/223.00  |- mesh__dateRevised mesh__D028224 2002-07-03
% 222.86/223.00  |- skos__annotation mesh__D028224
% 222.86/223.00       note X ref: FIR TREE see ABIES is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.86/223.00  |- skos__historyNote mesh__D028224 Trees %28%1965-2001%29%
% 222.86/223.00  |- mesh__publicMeSHNote mesh__D028224 2002   
% 222.86/223.00  |- skos__altLabel mesh__D028224 Douglas Fir
% 222.86/223.00  |- mesh__dateEstablished mesh__D028224 2002-01-01
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D028224 2006
% 222.86/223.00  |- rdf__type mesh__D028224sskos__Concept
% 222.86/223.00  |- mesh__dateCreated mesh__D006570 1999-01-01
% 222.86/223.00  |- mesh__historyNote mesh__D006570 72%28%68%29%   
% 222.86/223.00  |- skos__hiddenLabel mesh__D006570 Heterochromatins
% 222.86/223.00  |- skos__scopeNote mesh__D006570
% 222.86/223.00       The portion of chromosome material that remains condensed and is transcriptionally inactive during INTERPHASE.%A%    
% 222.86/223.00  |- skos__broader mesh__D006570smesh__D002843
% 222.86/223.00  |- rdf__type mesh__D006570sskos__Concept
% 222.86/223.00  |- mesh__dateEstablished mesh__D006570 1972-01-01
% 222.86/223.00  |- mesh__dateRevised mesh__D006570 2003-07-09
% 222.86/223.00  |- mesh__recordAuthorizer mesh__D006570 sjn
% 222.86/223.00  |- mesh__recordOriginator mesh__D006570 NLM
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D006570 2006
% 222.86/223.00  |- mesh__recordMaintainer mesh__D006570 nns
% 222.86/223.00  |- skos__historyNote mesh__D006570 Chromosomes %28%1966-1967%29%
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D006570 2005
% 222.86/223.00  |- skos__prefLabel mesh__D006570 Heterochromatin
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D006570 2004
% 222.86/223.00  |- mesh__publicMeSHNote mesh__D006570 72   
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D020241 2002
% 222.86/223.00  |- skos__hiddenLabel mesh__D020241 Equine Encephalitis, Western
% 222.86/223.00  |- mesh__publicMeSHNote mesh__D020241 2000   
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D020241 2003
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D020241 2001
% 222.86/223.00  |- mesh__dateEstablished mesh__D020241 2000-01-01
% 222.86/223.00  |- mesh__historyNote mesh__D020241 2000   
% 222.86/223.00  |- mesh__dateCreated mesh__D020241 1999-11-03
% 222.86/223.00  |- skos__altLabel mesh__D020241 Western Equine Encephalitis
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D020241 2000
% 222.86/223.00  |- skos__hiddenLabel mesh__D020241 Encephalitis, Western Equine
% 222.86/223.00  |- rdf__type mesh__D020241sskos__Concept
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D020241 2006
% 222.86/223.00  |- skos__scopeNote mesh__D020241
% 222.86/223.00       A form of arboviral encephalitis %28%which primarily affects horses%29% endemic to western and central regions of NORTH AMERICA. The causative organism %28%ENCEPHALOMYELITIS VIRUS, WESTERN EQUINE%29% may be transferred to humans via the bite of mosquitoes %28%CULEX tarsalis and others%29%. Clinical manifestations include headache and influenza-like symptoms followed by alterations in mentation, SEIZURES, and COMA. DEATH occurs in a minority of cases. Survivors may recover fully or be left with residual neurologic dysfunction, including PARKINSONISM, POSTENCEPHALITIC. %28%From Joynt, Clinical Neurology, 1996, Ch26, pp8-9%29%%A%    
% 222.86/223.00  |- skos__broader mesh__D020241smesh__D004683
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D020241 2005
% 222.86/223.00  |- skos__historyNote mesh__D020241 Encephalitis Viruses %28%1966-1999%29%
% 222.86/223.00  |- skos__hiddenLabel mesh__D020241 Western Equine Encephalomyelitis
% 222.86/223.00  |- skos__historyNote mesh__D020241
% 222.86/223.00       Encephalomyelitis, Equine %28%1966-1999%29%
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D020241 2004
% 222.86/223.00  |- skos__prefLabel mesh__D020241 Encephalomyelitis, Western Equine
% 222.86/223.00  |- rdf__type mesh__D014204sskos__Concept
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D014204 2004
% 222.86/223.00  |- skos__scopeNote mesh__D014204
% 222.86/223.00       17-beta-Hydroxyestra-4,9,11-trien-3-one. An anabolic steroid used mainly as a growth substance in animals.%A%    
% 222.86/223.00  |- mesh__recordMaintainer mesh__D014204 lkt
% 222.86/223.00  |- mesh__recordOriginator mesh__D014204 RLS
% 222.86/223.00  |- skos__historyNote mesh__D014204 Estrenes %28%1975-1978%29%
% 222.86/223.00  |- skos__historyNote mesh__D014204 Estranes %28%1968-1974%29%
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D014204 2006
% 222.86/223.00  |- mesh__publicMeSHNote mesh__D014204 91; was see under ESTRENES 1979-90   
% 222.86/223.00  |- mesh__dateCreated mesh__D014204 1977-12-22
% 222.86/223.00  |- skos__historyNote mesh__D014204 Anabolic Steroids %28%1966-1978%29%
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D014204 2005
% 222.86/223.00  |- mesh__dateRevised mesh__D014204 2003-07-09
% 222.86/223.00  |- skos__prefLabel mesh__D014204 Trenbolone
% 222.86/223.00  |- skos__altLabel mesh__D014204 Trienbolone
% 222.86/223.00  |- mesh__historyNote mesh__D014204
% 222.86/223.00       91%28%79%29%; was see under ESTRENES 1979-90   
% 222.86/223.00  |- mesh__recordAuthorizer mesh__D014204 sjn
% 222.86/223.00  |- skos__broader mesh__D014204smesh__D004963
% 222.86/223.00  |- skos__annotation mesh__D014204 an anabolic steroid   
% 222.86/223.00  |- mesh__dateEstablished mesh__D014204 1991-01-01
% 222.86/223.00  |- skos__altLabel mesh__D005478 Flurandrenolide
% 222.86/223.00  |- mesh__dateCreated mesh__D005478 1999-01-01
% 222.86/223.00  |- mesh__recordAuthorizer mesh__D005478 sjn
% 222.86/223.00  |- mesh__recordMaintainer mesh__D005478 CCR
% 222.86/223.00  |- skos__altLabel mesh__D005478 Typharm Brand of Flurandrenolone
% 222.86/223.00  |- mesh__dateRevised mesh__D005478 2005-06-30
% 222.86/223.00  |- skos__scopeNote mesh__D005478
% 222.86/223.00       A corticosteroid used topically in the treatment of various skin disorders. It is usually employed as a cream or an ointment, and is also used as a polyethylene tape with an adhesive. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p733%29%%A%    
% 222.86/223.00  |- mesh__onlineNote mesh__D005478
% 222.86/223.00       use FLURANDRENOLONE to search FLUDROXYCORTID 1977-94   
% 222.86/223.00  |- skos__broader mesh__D005478smesh__D013259
% 222.86/223.00  |- skos__prefLabel mesh__D005478 Flurandrenolone
% 222.86/223.00  |- mesh__dateEstablished mesh__D005478 1965-01-01
% 222.86/223.00  |- mesh__recordOriginator mesh__D005478 NLM
% 222.86/223.00  |- skos__altLabel mesh__D005478 Oclassen Brand of Flurandrenolone
% 222.86/223.00  |- mesh__publicMeSHNote mesh__D005478
% 222.86/223.00       65; FLUDROXYCORTID was see FLURANDRENOLONE 1977-94   
% 222.86/223.00  |- skos__broader mesh__D005478smesh__D011282
% 222.86/223.00  |- mesh__historyNote mesh__D005478
% 222.86/223.00       65%28%63%29%; FLUDROXYCORTID was see FLURANDRENOLONE 1977-94   
% 222.86/223.00  |- rdf__type mesh__D005478sskos__Concept
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D005478 2006
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D002180 2003
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D002180 1996
% 222.86/223.00  |- mesh__historyNote mesh__D002180 81; was MONILIASIS, ORAL 1963-80   
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D002180 2000
% 222.86/223.00  |- skos__scopeNote mesh__D002180
% 222.86/223.00       Infection of the mucous membranes of the mouth by a fungus of the genus CANDIDA. %28%Dorland, 27th ed%29%%A%    
% 222.86/223.00  |- skos__annotation mesh__D002180
% 222.86/223.00       fungus dis of mouth; do not bother to coord with CANDIDA or CANDIDA ALBICANS%A%  
% 222.86/223.00  |- skos__hiddenLabel mesh__D002180 Candidiases, Oral
% 222.86/223.00  |- skos__hiddenLabel mesh__D002180 Oral Moniliases
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D002180 2004
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D002180 1997
% 222.86/223.00  |- skos__altLabel mesh__D002180 Thrush
% 222.86/223.00  |- rdf__type mesh__D002180sskos__Concept
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D002180 2001
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D002180 1994
% 222.86/223.00  |- mesh__dateCreated mesh__D002180 1999-01-01
% 222.86/223.00  |- skos__hiddenLabel mesh__D002180 Oral Candidiases
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D002180 1995
% 222.86/223.00  |- mesh__recordMaintainer mesh__D002180 TAP
% 222.86/223.00  |- mesh__recordAuthorizer mesh__D002180 PLS
% 222.86/223.00  |- skos__prefLabel mesh__D002180 Candidiasis, Oral
% 222.86/223.00  |- mesh__publicMeSHNote mesh__D002180 81; was MONILIASIS, ORAL 1963-80   
% 222.86/223.00  |- skos__hiddenLabel mesh__D002180 Oral Moniliasis
% 222.86/223.00  |- skos__hiddenLabel mesh__D002180 Oral Candidiasis
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D002180 2005
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D002180 1998
% 222.86/223.00  |- skos__altLabel mesh__D002180 Moniliasis, Oral
% 222.86/223.00  |- mesh__dateRevised mesh__D002180 1993-06-02
% 222.86/223.00  |- mesh__recordOriginator mesh__D002180 NLM
% 222.86/223.00  |- skos__hiddenLabel mesh__D002180 Moniliases, Oral
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D002180 2002
% 222.86/223.00  |- skos__broader mesh__D002180smesh__D002177
% 222.86/223.00  |- mesh__onlineNote mesh__D002180
% 222.86/223.00       use CANDIDIASIS, ORAL to search MONILIASIS, ORAL 1966-80   
% 222.86/223.00  |- skos__broader mesh__D002180smesh__D009059
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D002180 2006
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D002180 1999
% 222.86/223.00  |- mesh__recordMaintainer mesh__D010612 TGC
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D010612 2002
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D010612 2005
% 222.86/223.00  |- skos__hiddenLabel mesh__D010612 Throat, Sore
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D010612 2001
% 222.86/223.00  |- mesh__dateRevised mesh__D010612 1997-06-20
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D010612 1999
% 222.86/223.00  |- mesh__onlineNote mesh__D010612
% 222.86/223.00       use PHARYNGITIS to search SORE THROAT 1966-78   
% 222.86/223.00  |- skos__hiddenLabel mesh__D010612 Pharyngitides
% 222.86/223.00  |- rdf__type mesh__D010612sskos__Concept
% 222.86/223.00  |- skos__hiddenLabel mesh__D010612 Sore Throats
% 222.86/223.00  |- mesh__activeMeSHYear mesh__D010612 2000
% 222.86/223.01  |- mesh__dateCreated mesh__D010612 1999-01-01
% 222.86/223.01  |- skos__broader mesh__D010612smesh__D012141
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D010612 1998
% 222.86/223.01  |- mesh__recordAuthorizer mesh__D010612 SJN
% 222.86/223.01  |- mesh__recordOriginator mesh__D010612 NLM
% 222.86/223.01  |- skos__scopeNote mesh__D010612 Inflammation of the throat.     
% 222.86/223.01  |- mesh__historyNote mesh__D010612
% 222.86/223.01       SORE THROAT was see under PHARYNGITIS 1963-78   
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D010612 2004
% 222.86/223.01  |- skos__broader mesh__D010612smesh__D010608
% 222.86/223.01  |- skos__annotation mesh__D010612 inflamm of pharynx: note X ref   
% 222.86/223.01  |- skos__prefLabel mesh__D010612 Pharyngitis
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D010612 2006
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D010612 2003
% 222.86/223.01  |- skos__broader mesh__D009869smesh__D010049
% 222.86/223.01  |- skos__prefLabel mesh__D009869 Oophoritis
% 222.86/223.01  |- mesh__recordOriginator mesh__D009869 NLM
% 222.86/223.01  |- mesh__recordAuthorizer mesh__D009869 sjn
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D009869 2006
% 222.86/223.01  |- skos__hiddenLabel mesh__D009869 Oophoritides
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D009869 2004
% 222.86/223.01  |- skos__broader mesh__D009869smesh__D000292
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D009869 2005
% 222.86/223.01  |- mesh__recordMaintainer mesh__D009869 TAP
% 222.86/223.01  |- rdf__type mesh__D009869sskos__Concept
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D009869 2003
% 222.86/223.01  |- mesh__dateRevised mesh__D009869 2002-07-03
% 222.86/223.01  |- skos__scopeNote mesh__D009869
% 222.86/223.01       Inflammation of the OVARY, generally caused by an ascending infection of organisms from the endocervix.%A%    
% 222.86/223.01  |- mesh__dateCreated mesh__D009869 1999-01-01
% 222.86/223.01  |- skos__annotation mesh__D001886 infection = WHOOPING COUGH   
% 222.86/223.01  |- rdf__type mesh__D001886sskos__Concept
% 222.86/223.01  |- mesh__dateRevised mesh__D001886 2005-06-30
% 222.86/223.01  |- skos__related mesh__D001886smesh__D010566
% 222.86/223.01  |- skos__related mesh__D001886smesh__D010567
% 222.86/223.01  |- mesh__recordMaintainer mesh__D001886 SYSTEM
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001886 2006
% 222.86/223.01  |- skos__altLabel mesh__D001886 Hemophilus pertussis
% 222.86/223.01  |- skos__scopeNote mesh__D001886
% 222.86/223.01       A species of gram-negative, aerobic bacteria that is the causative agent of WHOOPING COUGH. Its cells are minute coccobacilli that are surrounded by a slime sheath.%A%    
% 222.86/223.01  |- mesh__dateCreated mesh__D001886 1999-01-01
% 222.86/223.01  |- mesh__recordOriginator mesh__D001886 NLM
% 222.86/223.01  |- skos__altLabel mesh__D001886 Haemophilus pertussis
% 222.86/223.01  |- skos__broader mesh__D001886smesh__D001884
% 222.86/223.01  |- mesh__recordAuthorizer mesh__D001886 sjn
% 222.86/223.01  |- skos__prefLabel mesh__D001886 Bordetella pertussis
% 222.86/223.01  |- mesh__recordAuthorizer mesh__D001088 PLS
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001088 2003
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001088 2006
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001088 1995
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001088 2000
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001088 1998
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001088 1993
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001088 2004
% 222.86/223.01  |- rdf__type mesh__D001088sskos__Concept
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001088 2001
% 222.86/223.01  |- mesh__dateRevised mesh__D001088 1992-05-07
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001088 1996
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001088 1999
% 222.86/223.01  |- mesh__recordOriginator mesh__D001088 RLS
% 222.86/223.01  |- skos__historyNote mesh__D001088 specific nucleotide %28%1966-1978%29%
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001088 2002
% 222.86/223.01  |- skos__historyNote mesh__D001088 Nucleotides %28%1966-1978%29%
% 222.86/223.01  |- mesh__dateEstablished mesh__D001088 1979-01-01
% 222.86/223.01  |- skos__altLabel mesh__D001088 Arabinofuranosylnucleotides
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001088 1997
% 222.86/223.01  |- mesh__historyNote mesh__D001088 79   
% 222.86/223.01  |- skos__broader mesh__D001088smesh__D009711
% 222.86/223.01  |- skos__scopeNote mesh__D001088
% 222.86/223.01       Nucleotides containing arabinose as their sugar moiety.%A%    
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001088 2005
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001088 1994
% 222.86/223.01  |- mesh__recordMaintainer mesh__D001088 TGC
% 222.86/223.01  |- mesh__dateCreated mesh__D001088 1978-05-16
% 222.86/223.01  |- skos__prefLabel mesh__D001088 Arabinonucleotides
% 222.86/223.01  |- mesh__publicMeSHNote mesh__D001088 79   
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D028225 2003
% 222.86/223.01  |- mesh__historyNote mesh__D028225 2002   
% 222.86/223.01  |- skos__prefLabel mesh__D028225 Tsuga
% 222.86/223.01  |- mesh__publicMeSHNote mesh__D028225 2002   
% 222.86/223.01  |- mesh__dateCreated mesh__D028225 2001-07-25
% 222.86/223.01  |- skos__altLabel mesh__D028225 Hemlock Tree
% 222.86/223.01  |- mesh__dateRevised mesh__D028225 2002-07-03
% 222.86/223.01  |- mesh__dateEstablished mesh__D028225 2002-01-01
% 222.86/223.01  |- skos__annotation mesh__D028225
% 222.86/223.01       distinguish from hemlock plants %28%CICUTA or CONIUM%29%; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D028225 2006
% 222.86/223.01  |- rdf__type mesh__D028225sskos__Concept
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D028225 2005
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D028225 2004
% 222.86/223.01  |- skos__scopeNote mesh__D028225
% 222.86/223.01       A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta.  They are coniferous evergreen trees and should not be confused with hemlock plants %28%CICUTA and CONIUM%29%.%A%    
% 222.86/223.01  |- skos__broader mesh__D028225smesh__D028201
% 222.86/223.01  |- skos__prefLabel mesh__D006571 Heterocyclic Compounds
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D006571 2002
% 222.86/223.01  |- rdf__type mesh__D006571sskos__Concept
% 222.86/223.01  |- mesh__runningHead mesh__D006571 D3 - HETEROCYCLIC COMPOUNDS   
% 222.86/223.01  |- skos__scopeNote mesh__D006571
% 222.86/223.01       Ring compounds having atoms other than carbon in their nuclei. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 222.86/223.01  |- mesh__dateRevised mesh__D006571 2000-06-22
% 222.86/223.01  |- skos__annotation mesh__D006571
% 222.86/223.01       GEN or unspecified; prefer specific groups or specific cpd; DF: HETEROCYCLIC CPDS%A%  
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D006571 2005
% 222.86/223.01  |- mesh__recordMaintainer mesh__D006571 jls
% 222.86/223.01  |- mesh__dateCreated mesh__D006571 1999-01-01
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D006571 2006
% 222.86/223.01  |- skos__hiddenLabel mesh__D006571 Compounds, Heterocyclic
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D006571 2001
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D006571 2003
% 222.86/223.01  |- mesh__recordAuthorizer mesh__D006571 sjn
% 222.86/223.01  |- mesh__recordOriginator mesh__D006571 NLM
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D006571 2004
% 222.86/223.01  |- skos__scopeNote mesh__D020242
% 222.86/223.01       A form of arboviral encephalitis %28%primarily affecting equines%29% endemic to eastern regions of North America. The causative organism %28%ENCEPHALOMYELITIS VIRUS, EASTERN EQUINE%29% may be transmitted to humans via the bite of AEDES mosquitoes. Clinical manifestations include the acute onset of fever, HEADACHE, altered mentation, and SEIZURES followed by coma. The condition is fatal in up to 50%25% of cases. Recovery may be marked by residual neurologic deficits and EPILEPSY. %28%From Joynt, Clinical Neurology, 1996, Ch26, pp9-10%29%%A%    
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D020242 2002
% 222.86/223.01  |- skos__annotation mesh__D020242
% 222.86/223.01       human %26% animal; if in horses, coord /vet %28%IM%29% with HORSE DISEASES %28%IM%29% + HORSES %28%NIM%29%; DF: ENCEPH EASTERN EQUINE%A%  
% 222.86/223.01  |- mesh__publicMeSHNote mesh__D020242 2000   
% 222.86/223.01  |- skos__broader mesh__D020242smesh__D004683
% 222.86/223.01  |- skos__historyNote mesh__D020242
% 222.86/223.01       Encephalomyelitis, Equine %28%1966-1999%29%
% 222.86/223.01  |- skos__historyNote mesh__D020242 Encephalitis Viruses %28%1967-1999%29%
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D020242 2005
% 222.86/223.01  |- skos__hiddenLabel mesh__D020242 Encephalomyelitides, Eastern Equine
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D020242 2000
% 222.86/223.01  |- rdf__type mesh__D020242sskos__Concept
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D020242 2006
% 222.86/223.01  |- skos__hiddenLabel mesh__D020242 Equine Encephalomyelitis, Eastern
% 222.86/223.01  |- skos__hiddenLabel mesh__D020242 Equine Encephalomyelitides, Eastern
% 222.86/223.01  |- skos__altLabel mesh__D020242 Eastern Equine Encephalomyelitis
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D020242 2001
% 222.86/223.01  |- mesh__dateEstablished mesh__D020242 2000-01-01
% 222.86/223.01  |- skos__prefLabel mesh__D020242 Encephalomyelitis, Eastern Equine
% 222.86/223.01  |- skos__hiddenLabel mesh__D020242 Equine Encephalitis, Eastern
% 222.86/223.01  |- skos__altLabel mesh__D020242 Eastern Equine Encephalitis
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D020242 2003
% 222.86/223.01  |- skos__hiddenLabel mesh__D020242 Encephalitides, Eastern Equine
% 222.86/223.01  |- skos__hiddenLabel mesh__D020242 Eastern Equine Encephalitides
% 222.86/223.01  |- skos__hiddenLabel mesh__D020242 Eastern Equine Encephalomyelitides
% 222.86/223.01  |- skos__hiddenLabel mesh__D020242 Equine Encephalitides, Eastern
% 222.86/223.01  |- skos__hiddenLabel mesh__D020242 Encephalitis, Eastern Equine
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D020242 2004
% 222.86/223.01  |- mesh__dateCreated mesh__D020242 1999-11-03
% 222.86/223.01  |- mesh__historyNote mesh__D020242 2000   
% 222.86/223.01  |- mesh__historyNote mesh__D047988 2005%28%1994%29%   
% 222.86/223.01  |- skos__altLabel mesh__D047988 TRIP Protein, TNF
% 222.86/223.01  |- skos__hiddenLabel mesh__D047988 TRAF Interacting Protein
% 222.86/223.01  |- skos__altLabel mesh__D047988 TNF Receptor-Associated Factors
% 222.86/223.01  |- skos__broader mesh__D047988smesh__D048868
% 222.86/223.01  |- skos__hiddenLabel mesh__D047988
% 222.86/223.01       TNF Receptor Associated Death Domain Protein
% 222.86/223.01  |- skos__altLabel mesh__D047988 TRAF and TNF Receptor-Associated Protein
% 222.86/223.01  |- skos__altLabel mesh__D047988 TRAF Proteins
% 222.86/223.01  |- skos__hiddenLabel mesh__D047988 TRAF and TNF Receptor Associated Protein
% 222.86/223.01  |- mesh__publicMeSHNote mesh__D047988
% 222.86/223.01       2005; TRAF-INTERACTING PROTEIN was indexed under RECEPTORS, TUMOR NECROSIS FACTOR; TRADD PROTEIN was indexed under PROTEINS 1994-2004%A%  
% 222.86/223.01  |- skos__hiddenLabel mesh__D047988 TNF Receptor Associated Factors
% 222.86/223.01  |- skos__hiddenLabel mesh__D047988
% 222.86/223.01       Tumor Necrosis Factor Receptor Associated Peptides and Proteins
% 222.86/223.01  |- mesh__recordMaintainer mesh__D047988 jmp
% 222.86/223.01  |- skos__hiddenLabel mesh__D047988 TNF TRIP Protein
% 222.86/223.01  |- mesh__recordOriginator mesh__D047988 jmp
% 222.86/223.01  |- skos__hiddenLabel mesh__D047988 Receptor-Associated Factors, TNF
% 222.86/223.01  |- mesh__dateEstablished mesh__D047988 2005-01-01
% 222.86/223.01  |- rdf__type mesh__D047988sskos__Concept
% 222.86/223.01  |- skos__hiddenLabel mesh__D047988 TRAF Interacting Proteins
% 222.86/223.01  |- skos__altLabel mesh__D047988 TRAF-Interacting Protein
% 222.86/223.01  |- skos__altLabel mesh__D047988 TRADD Protein
% 222.86/223.01  |- mesh__dateCreated mesh__D047988 2004-07-07
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D047988 2005
% 222.86/223.01  |- skos__scopeNote mesh__D047988
% 222.86/223.01       Intracellular signaling peptides and proteins that bind directly or indirectly to the cytoplasmic portion of TUMOR NECROSIS FACTOR RECEPTORS.%A%    
% 222.86/223.01  |- mesh__recordAuthorizer mesh__D047988 sjn
% 222.86/223.01  |- skos__prefLabel mesh__D047988
% 222.86/223.01       Tumor Necrosis Factor Receptor-Associated Peptides and Proteins
% 222.86/223.01  |- skos__hiddenLabel mesh__D047988
% 222.86/223.01       Tumor Necrosis Factor Receptor Associated Factors
% 222.86/223.01  |- skos__altLabel mesh__D047988 TTRAP Proteins
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D047988 2006
% 222.86/223.01  |- skos__hiddenLabel mesh__D047988
% 222.86/223.01       TRAF and TNF Receptor Associated Proteins
% 222.86/223.01  |- skos__scopeNote mesh__D014205
% 222.86/223.01       An intermittent fever characterized by intervals of chills, fever, and splenomegaly each of which may last as long as 40 hours. It is caused by BARTONELLA QUINTANA and transmitted by the human louse.%A%    
% 222.86/223.01  |- skos__annotation mesh__D014205
% 222.86/223.01       caused by Bartonella quintana; do not confuse with TRENCH FOOT%A%  
% 222.86/223.01  |- rdf__type mesh__D014205sskos__Concept
% 222.86/223.01  |- skos__prefLabel mesh__D014205 Trench Fever
% 222.86/223.01  |- mesh__recordOriginator mesh__D014205 NLM
% 222.86/223.01  |- skos__hiddenLabel mesh__D014205 Trench Fevers
% 222.86/223.01  |- mesh__dateRevised mesh__D014205 2004-07-13
% 222.86/223.01  |- mesh__dateCreated mesh__D014205 1999-01-01
% 222.86/223.01  |- skos__broader mesh__D014205smesh__D001474
% 222.86/223.01  |- mesh__recordAuthorizer mesh__D014205 sjn
% 222.86/223.01  |- skos__hiddenLabel mesh__D014205 Fevers, Trench
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D014205 2006
% 222.86/223.01  |- mesh__recordMaintainer mesh__D014205 sjn
% 222.86/223.01  |- skos__hiddenLabel mesh__D014205 Fever, Trench
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D014205 2005
% 222.86/223.01  |- mesh__dateRevised mesh__D019499 2005-06-30
% 222.86/223.01  |- mesh__historyNote mesh__D019499 1997   
% 222.86/223.01  |- mesh__dateCreated mesh__D019499 1996-06-21
% 222.86/223.01  |- mesh__recordMaintainer mesh__D019499 jls
% 222.86/223.01  |- skos__altLabel mesh__D019499 Documentary and Factual Film %28%PT%29%
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D019499 2006
% 222.86/223.01  |- skos__altLabel mesh__D019499 Documentaries and Factual Films %28%PT%29%
% 222.86/223.01  |- skos__broader mesh__D019499smesh__D052180
% 222.86/223.01  |- skos__prefLabel mesh__D019499
% 222.86/223.01       Documentaries and Factual Films %5B%Publication Type%5D%
% 222.86/223.01  |- skos__scopeNote mesh__D019499
% 222.86/223.01       Works consisting of films, videos, and programs which depict actual persons or actual events. They do not include frank historical re-creations and do not attempt to judge the truth of the depiction in a film purporting to be factual or documentary in character. %28%From Moving Image Materials: Genre Terms, 1988%29%%A%    
% 222.86/223.01  |- skos__altLabel mesh__D019499 Documentaries and Factual Films
% 222.86/223.01  |- mesh__dateEstablished mesh__D019499 1997-01-01
% 222.86/223.01  |- rdf__type mesh__D019499sskos__Concept
% 222.86/223.01  |- mesh__onlineNote mesh__D019499
% 222.86/223.01       search policy: Online Manual; use: main heading AND DOCUMENTARIES A%23%D FACTUAL FILMS %28%PT%29%%A%  
% 222.86/223.01  |- mesh__recordAuthorizer mesh__D019499 sjn
% 222.86/223.01  |- mesh__recordOriginator mesh__D019499 TGC
% 222.86/223.01  |- skos__hiddenLabel mesh__D005479 Hydrochloride, Flurazepam
% 222.86/223.01  |- skos__historyNote mesh__D005479
% 222.86/223.01       Hypnotics and Sedatives %28%1967-1974%29%
% 222.86/223.01  |- skos__prefLabel mesh__D005479 Flurazepam
% 222.86/223.01  |- mesh__dateEstablished mesh__D005479 1980-01-01
% 222.86/223.01  |- skos__altLabel mesh__D005479 Dalmadorm
% 222.86/223.01  |- mesh__recordAuthorizer mesh__D005479 sjn
% 222.86/223.01  |- skos__altLabel mesh__D005479 Dormodor
% 222.86/223.01  |- mesh__recordMaintainer mesh__D005479 CCR
% 222.86/223.01  |- skos__altLabel mesh__D005479 Flurazepam Dihydrochloride
% 222.86/223.01  |- mesh__dateRevised mesh__D005479 2005-06-30
% 222.86/223.01  |- rdf__type mesh__D005479sskos__Concept
% 222.86/223.01  |- skos__historyNote mesh__D005479 Benzodiazepinones %28%1974%29%
% 222.86/223.01  |- skos__hiddenLabel mesh__D005479 Mono-Perchlorate, Flurazepam
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D005479 2006
% 222.86/223.01  |- skos__hiddenLabel mesh__D005479 Monohydrochloride, Flurazepam
% 222.86/223.01  |- skos__scopeNote mesh__D005479
% 222.86/223.01       A benzodiazepine derivative used mainly as a hypnotic.     
% 222.86/223.01  |- skos__altLabel mesh__D005479 ICN Brand of Flurazepam Monohydrochloride
% 222.86/223.01  |- mesh__historyNote mesh__D005479
% 222.86/223.01       80%28%75%29%; was see under BENZODIAZEPINE TRANQUILIZERS 1975-79%A%  
% 222.86/223.01  |- skos__altLabel mesh__D005479 Dolorgiet Brand of Flurazepam
% 222.86/223.01  |- skos__hiddenLabel mesh__D005479 Flurazepam Mono Perchlorate
% 222.86/223.01  |- mesh__recordOriginator mesh__D005479 NLM
% 222.86/223.01  |- skos__altLabel mesh__D005479
% 222.86/223.01       Apotex Brand of Flurazepam Monohydrochloride
% 222.86/223.01  |- mesh__dateCreated mesh__D005479 1999-01-01
% 222.86/223.01  |- skos__hiddenLabel mesh__D005479 Dihydrochloride, Flurazepam
% 222.86/223.01  |- skos__historyNote mesh__D005479 Benzazepines %28%1970-1973%29%
% 222.86/223.01  |- skos__broader mesh__D005479smesh__D001570
% 222.86/223.01  |- skos__altLabel mesh__D005479
% 222.86/223.01       Allphar Brand of Flurazepam Monohydrochloride
% 222.86/223.01  |- mesh__publicMeSHNote mesh__D005479
% 222.86/223.01       80; was see under BENZODIAZEPINE TRANQUILIZERS 1975-79   
% 222.86/223.01  |- skos__hiddenLabel mesh__D005479 Apo Flurazepam
% 222.86/223.01  |- mesh__publicMeSHNote mesh__D002181
% 222.86/223.01       81; was MONILIASIS, VULVOVAGINAL 1963-80   
% 222.86/223.01  |- skos__altLabel mesh__D002181 Moniliasis, Vulvovaginal
% 222.86/223.01  |- mesh__dateCreated mesh__D002181 1999-01-01
% 222.86/223.01  |- skos__hiddenLabel mesh__D002181 Monilial Vaginitides
% 222.86/223.01  |- mesh__recordOriginator mesh__D002181 NLM
% 222.86/223.01  |- mesh__historyNote mesh__D002181
% 222.86/223.01       81; was MONILIASIS, VULVOVAGINAL 1963-80   
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D002181 2006
% 222.86/223.01  |- skos__broader mesh__D002181smesh__D002177
% 222.86/223.01  |- skos__hiddenLabel mesh__D002181 Vulvovaginal Candidiases
% 222.86/223.01  |- skos__broader mesh__D002181smesh__D014848
% 222.86/223.01  |- mesh__dateRevised mesh__D002181 2005-06-30
% 222.86/223.01  |- skos__scopeNote mesh__D002181
% 222.86/223.01       Infection of the VULVA and VAGINA with a fungus of the genus CANDIDA.%A%    
% 222.86/223.01  |- skos__hiddenLabel mesh__D002181 Vaginitides, Monilial
% 222.86/223.01  |- skos__hiddenLabel mesh__D002181 Vulvovaginal Moniliasis
% 222.86/223.01  |- skos__hiddenLabel mesh__D002181 Vulvovaginal Candidiasis
% 222.86/223.01  |- skos__prefLabel mesh__D002181 Candidiasis, Vulvovaginal
% 222.86/223.01  |- skos__hiddenLabel mesh__D002181 Monilial Vaginitis
% 222.86/223.01  |- mesh__recordAuthorizer mesh__D002181 sjn
% 222.86/223.01  |- skos__hiddenLabel mesh__D002181 Vulvovaginal Moniliases
% 222.86/223.01  |- mesh__onlineNote mesh__D002181
% 222.86/223.01       use CANDIDIASIS, VULVOVAGINAL to search MONILIASIS, VULVOVAGINAL 1966-80%A%  
% 222.86/223.01  |- mesh__recordMaintainer mesh__D002181 lkt
% 222.86/223.01  |- rdf__type mesh__D002181sskos__Concept
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D010613 1999
% 222.86/223.01  |- mesh__dateCreated mesh__D010613 1987-03-19
% 222.86/223.01  |- rdf__type mesh__D010613sskos__Concept
% 222.86/223.01  |- skos__annotation mesh__D010613
% 222.86/223.01       do not use /util except by MeSH definition   
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D010613 2002
% 222.86/223.01  |- mesh__historyNote mesh__D010613 88   
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D010613 1998
% 222.86/223.01  |- skos__broader mesh__D010613smesh__D013517
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D010613 2001
% 222.86/223.01  |- mesh__dateRevised mesh__D010613 1997-06-20
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D010613 2004
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D010613 2000
% 222.86/223.01  |- skos__hiddenLabel mesh__D010613 Pharyngostomies
% 222.86/223.01  |- skos__historyNote mesh__D010613 Pharynx/surgery %28%1966-1987%29%
% 222.86/223.01  |- skos__broader mesh__D010613smesh__D010030
% 222.86/223.01  |- mesh__dateEstablished mesh__D010613 1988-01-01
% 222.86/223.01  |- skos__scopeNote mesh__D010613
% 222.86/223.01       External surgical fistulization of the pharynx for feeding.%A%    
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D010613 2006
% 222.86/223.01  |- mesh__recordAuthorizer mesh__D010613 SJN
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D010613 2003
% 222.86/223.01  |- mesh__recordMaintainer mesh__D010613 PXP
% 222.86/223.01  |- skos__historyNote mesh__D010613 Enteral Feeding %28%1966-1987%29%
% 222.86/223.01  |- mesh__publicMeSHNote mesh__D010613 88   
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D010613 2005
% 222.86/223.01  |- skos__prefLabel mesh__D010613 Pharyngostomy
% 222.86/223.01  |- mesh__recordOriginator mesh__D010613 SCD
% 222.86/223.01  |- skos__prefLabel mesh__D001887 Boredom
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001887 1999
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001887 1996
% 222.86/223.01  |- mesh__recordOriginator mesh__D001887 NLM
% 222.86/223.01  |- mesh__historyNote mesh__D001887 69   
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001887 1991
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001887 1993
% 222.86/223.01  |- skos__broader mesh__D001887smesh__D004644
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001887 2000
% 222.86/223.01  |- rdf__type mesh__D001887sskos__Concept
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001887 1997
% 222.86/223.01  |- mesh__dateRevised mesh__D001887 1989-04-27
% 222.86/223.01  |- mesh__dateCreated mesh__D001887 1999-01-01
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001887 2005
% 222.86/223.01  |- mesh__recordAuthorizer mesh__D001887 PLS
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001887 2001
% 222.86/223.01  |- skos__historyNote mesh__D001887 Motivation %28%1966-1968%29%
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001887 2006
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001887 1994
% 222.86/223.01  |- mesh__publicMeSHNote mesh__D001887 69   
% 222.86/223.01  |- skos__annotation mesh__D001887 no qualif   
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001887 1990
% 222.86/223.01  |- mesh__dateEstablished mesh__D001887 1969-01-01
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001887 2003
% 222.86/223.01  |- mesh__recordMaintainer mesh__D001887 TGC
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001887 1998
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001887 1995
% 222.86/223.01  |- skos__hiddenLabel mesh__D001887 Boredoms
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001887 2002
% 222.86/223.01  |- skos__scopeNote mesh__D001887
% 222.86/223.01       A psychological state resulting from any activity that lacks motivation, or from enforced continuance in an uninteresting situation.%A%    
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001887 2004
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001887 1992
% 222.86/223.01  |- mesh__recordAuthorizer mesh__D001089 sjn
% 222.86/223.01  |- rdf__type mesh__D001089sskos__Concept
% 222.86/223.01  |- skos__prefLabel mesh__D001089 Arabinose
% 222.86/223.01  |- mesh__dateCreated mesh__D001089 1999-01-01
% 222.86/223.01  |- skos__altLabel mesh__D001089 L-Arabinose
% 222.86/223.01  |- skos__hiddenLabel mesh__D001089 L Arabinose
% 222.86/223.01  |- skos__broader mesh__D001089smesh__D010429
% 222.86/223.01  |- mesh__dateRevised mesh__D001089 2004-07-07
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001089 2005
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D001089 2006
% 222.86/223.01  |- mesh__recordOriginator mesh__D001089 NLM
% 222.86/223.01  |- mesh__recordMaintainer mesh__D001089 ssb
% 222.86/223.01  |- skos__historyNote mesh__D028226 Amyloidosis %28%1966-2001%29%
% 222.86/223.01  |- skos__hiddenLabel mesh__D028226 Familial Amyloidosis
% 222.86/223.01  |- mesh__recordMaintainer mesh__D028226 sjn
% 222.86/223.01  |- mesh__publicMeSHNote mesh__D028226 2002   
% 222.86/223.01  |- skos__scopeNote mesh__D028226
% 222.86/223.01       Diseases in which there is a familial pattern of AMYLOIDOSIS.%A%    
% 222.86/223.01  |- skos__hiddenLabel mesh__D028226 Hereditary Amyloidosis
% 222.86/223.01  |- skos__hiddenLabel mesh__D028226 Amyloidoses, Familial
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D028226 2005
% 222.86/223.01  |- mesh__dateCreated mesh__D028226 2001-07-25
% 222.86/223.01  |- mesh__recordAuthorizer mesh__D028226 sjn
% 222.86/223.01  |- skos__hiddenLabel mesh__D028226 Familial Amyloidoses
% 222.86/223.01  |- mesh__dateRevised mesh__D028226 2003-07-22
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D028226 2006
% 222.86/223.01  |- rdf__type mesh__D028226sskos__Concept
% 222.86/223.01  |- mesh__historyNote mesh__D028226 2002   
% 222.86/223.01  |- skos__hiddenLabel mesh__D028226 Hereditary Amyloidoses
% 222.86/223.01  |- skos__broader mesh__D028226smesh__D000686
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D028226 2004
% 222.86/223.01  |- mesh__recordOriginator mesh__D028226 nns
% 222.86/223.01  |- skos__hiddenLabel mesh__D028226 Amyloidoses, Hereditary
% 222.86/223.01  |- skos__broader mesh__D028226smesh__D008661
% 222.86/223.01  |- skos__prefLabel mesh__D028226 Amyloidosis, Familial
% 222.86/223.01  |- mesh__dateEstablished mesh__D028226 2002-01-01
% 222.86/223.01  |- skos__altLabel mesh__D006572 Bridged-Ring Heterocyclic Compounds
% 222.86/223.01  |- skos__scopeNote mesh__D006572
% 222.86/223.01       A class of organic compounds which contain two rings that share a pair of bridgehead carbon atoms.%A%    
% 222.86/223.01  |- mesh__recordOriginator mesh__D006572 NLM
% 222.86/223.01  |- skos__broader mesh__D006572smesh__D006571
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D006572 2005
% 222.86/223.01  |- mesh__dateRevised mesh__D006572 1997-06-20
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D006572 2002
% 222.86/223.01  |- mesh__publicMeSHNote mesh__D006572 98   
% 222.86/223.01  |- mesh__dateCreated mesh__D006572 1999-01-01
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D006572 2006
% 222.86/223.01  |- mesh__historyNote mesh__D006572 98; use explode 1967-97   
% 222.86/223.01  |- skos__annotation mesh__D006572
% 222.86/223.01       GEN; prefer specifics; used for mapping supplementary chemicals%A%  
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D006572 2003
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D006572 2000
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D006572 1998
% 222.86/223.01  |- skos__hiddenLabel mesh__D006572 Compounds, Bridged-Ring Heterocyclic
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D006572 2004
% 222.86/223.01  |- skos__prefLabel mesh__D006572 Heterocyclic Compounds, Bridged-Ring
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D006572 1999
% 222.86/223.01  |- skos__hiddenLabel mesh__D006572 Heterocyclic Compounds, Bridged Ring
% 222.86/223.01  |- mesh__recordMaintainer mesh__D006572 ADP
% 222.86/223.01  |- mesh__recordAuthorizer mesh__D006572 SJN
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D006572 2001
% 222.86/223.01  |- mesh__dateEstablished mesh__D006572 1998-01-01
% 222.86/223.01  |- rdf__type mesh__D006572sskos__Concept
% 222.86/223.01  |- skos__hiddenLabel mesh__D006572 Bridged Ring Heterocyclic Compounds
% 222.86/223.01  |- skos__hiddenLabel mesh__D020243 Artery Infarction, Heubner%27%s
% 222.86/223.01  |- mesh__recordMaintainer mesh__D020243 ssb
% 222.86/223.01  |- skos__historyNote mesh__D020243
% 222.86/223.01       Cerebral Arterial Diseases %28%1967-1999%29%
% 222.86/223.01  |- mesh__recordOriginator mesh__D020243 KEV
% 222.86/223.01  |- skos__altLabel mesh__D020243 Heubner%27%s Artery Infarction
% 222.86/223.01  |- skos__hiddenLabel mesh__D020243 Infarction, ACA
% 222.86/223.01  |- skos__historyNote mesh__D020243 Cerebral Infarction %28%1979-1999%29%
% 222.86/223.01  |- rdf__type mesh__D020243sskos__Concept
% 222.86/223.01  |- skos__altLabel mesh__D020243 Syndrome, Anterior Cerebral Artery
% 222.86/223.01  |- mesh__activeMeSHYear mesh__D020243 2006
% 222.86/223.01  |- mesh__publicMeSHNote mesh__D020243 2000   
% 222.86/223.01  |- skos__annotation mesh__D020243 DF: ACA INFARCT   
% 222.86/223.01  |- skos__hiddenLabel mesh__D020243 Artery Infarction, Heubner
% 222.86/223.01  |- mesh__recordAuthorizer mesh__D020243 sjn
% 222.86/223.01  |- mesh__dateEstablished mesh__D020243 2000-01-01
% 222.86/223.01  |- skos__altLabel mesh__D020243 ACA Infarction
% 222.86/223.01  |- skos__altLabel mesh__D020243 Infarction, Heubner Artery
% 222.86/223.01  |- skos__hiddenLabel mesh__D020243 ACA Infarctions
% 222.86/223.01  |- skos__broader mesh__D020243smesh__D002544
% 222.86/223.01  |- mesh__dateRevised mesh__D020243 2005-06-30
% 222.86/223.01  |- skos__broader mesh__D020243smesh__D002539
% 222.86/223.01  |- skos__hiddenLabel mesh__D020243 Infarctions, ACA
% 222.86/223.01  |- skos__hiddenLabel mesh__D020243 Infarction, Heubner%27%s Artery
% 222.86/223.01  |- skos__prefLabel mesh__D020243 Infarction, Anterior Cerebral Artery
% 222.86/223.02  |- skos__related mesh__D020243smesh__D007238
% 222.86/223.02  |- skos__hiddenLabel mesh__D020243 Heubners Artery Infarction
% 222.86/223.02  |- skos__altLabel mesh__D020243
% 222.86/223.02       Infarction, Anterior Cerebral Artery Distribution
% 222.86/223.02  |- mesh__historyNote mesh__D020243 2000   
% 222.86/223.02  |- skos__altLabel mesh__D020243 Anterior Cerebral Artery Infarction
% 222.86/223.02  |- skos__altLabel mesh__D020243 Anterior Cerebral Artery Stroke
% 222.86/223.02  |- mesh__dateCreated mesh__D020243 1999-11-08
% 222.86/223.02  |- skos__scopeNote mesh__D020243
% 222.86/223.02       An infarction in the vascular distribution of the anterior cerebral artery which supplies the majority of the medial surface of the cerebral hemispheres, and provides branches %28%including Heubner%27%s artery%29% to the anterior limb of the internal capsule, head of the CAUDATE NUCLEUS, and anterior GLOBUS PALLIDUS. Clinical manifestations may include contralateral lower extremity weakness and sensory loss. Bilateral anterior cerebral artery infarctions are associated with abulia, PARAPLEGIA, and URINARY INCONTINENCE. %28%From Adams et al., Principles of Neurology, 6th ed, pp789-93%29%%A%    
% 222.86/223.02  |- skos__altLabel mesh__D020243
% 222.86/223.02       Infarction, Anterior Cerebral Artery Circulation
% 222.86/223.02  |- skos__historyNote mesh__D020243 Infarction %28%1966-1978%29%
% 222.86/223.02  |- skos__altLabel mesh__D020243 Stroke, Anterior Cerebral Artery
% 222.86/223.02  |- mesh__publicMeSHNote mesh__D047989 2005   
% 222.86/223.02  |- skos__historyNote mesh__D047989 Clostridium %28%1965-2004%29%
% 222.86/223.02  |- mesh__recordAuthorizer mesh__D047989 sjn
% 222.86/223.02  |- mesh__recordOriginator mesh__D047989 ags
% 222.86/223.02  |- skos__altLabel mesh__D047989 Clostridium sordelli
% 222.86/223.02  |- mesh__historyNote mesh__D047989 2005   
% 222.86/223.02  |- mesh__dateRevised mesh__D047989 2005-06-30
% 222.86/223.02  |- rdf__type mesh__D047989sskos__Concept
% 222.86/223.02  |- skos__annotation mesh__D047989
% 222.86/223.02       infection: coordinate IM with CLOSTRIDIUM INFECTIONS %28%IM%29%%A%  
% 222.86/223.02  |- mesh__dateCreated mesh__D047989 2004-07-07
% 222.86/223.02  |- skos__scopeNote mesh__D047989
% 222.86/223.02       A species of gram-positive bacteria in the family Clostridiaceae, found in INTESTINES and SOIL.%A%    
% 222.86/223.02  |- skos__prefLabel mesh__D047989 Clostridium sordellii
% 222.86/223.02  |- skos__broader mesh__D047989smesh__D003013
% 222.86/223.02  |- mesh__dateEstablished mesh__D047989 2005-01-01
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D047989 2006
% 222.86/223.02  |- mesh__recordMaintainer mesh__D047989 SYSTEM
% 222.86/223.02  |- skos__annotation mesh__D002980 GEN; no qualif   
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002980 1994
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002980 1999
% 222.86/223.02  |- mesh__recordMaintainer mesh__D002980 PLS
% 222.86/223.02  |- skos__hiddenLabel mesh__D002980 Climates
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002980 2003
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002980 1990
% 222.86/223.02  |- mesh__recordAuthorizer mesh__D002980 PLS
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002980 1995
% 222.86/223.02  |- mesh__dateRevised mesh__D002980 1991-11-04
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002980 2004
% 222.86/223.02  |- rdf__type mesh__D002980sskos__Concept
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002980 1991
% 222.86/223.02  |- skos__prefLabel mesh__D002980 Climate
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002980 2005
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002980 2000
% 222.86/223.02  |- mesh__recordOriginator mesh__D002980 NLM
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002980 1996
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002980 2001
% 222.86/223.02  |- skos__broader mesh__D002980smesh__D001272
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002980 2006
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002980 1992
% 222.86/223.02  |- skos__related mesh__D002980smesh__D000064
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002980 1997
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002980 2002
% 222.86/223.02  |- mesh__dateCreated mesh__D002980 1999-01-01
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002980 1998
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002980 1993
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002182 2005
% 222.86/223.02  |- mesh__recordAuthorizer mesh__D002182 SJN
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002182 1998
% 222.86/223.02  |- skos__scopeNote mesh__D002182
% 222.86/223.02       Sweet food products combining cane or beet sugars with other carbohydrates and chocolate, milk, eggs, and various flavorings. In the United States, candy refers to both sugar- and cocoa-based confections and is differentiated from sweetened baked goods; elsewhere the terms sugar confectionary, chocolate confectionary, and flour confectionary %28%meaning goods such as cakes and pastries%29% are used.%A%    
% 222.86/223.02  |- skos__hiddenLabel mesh__D002182 Confections
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002182 2006
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002182 1999
% 222.86/223.02  |- mesh__dateRevised mesh__D002182 1997-06-20
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002182 2002
% 222.86/223.02  |- skos__altLabel mesh__D002182 Confection
% 222.86/223.02  |- mesh__recordOriginator mesh__D002182 NLM
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002182 2003
% 222.86/223.02  |- skos__prefLabel mesh__D002182 Candy
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002182 2004
% 222.86/223.02  |- mesh__recordMaintainer mesh__D002182 JLS
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002182 2000
% 222.86/223.02  |- skos__hiddenLabel mesh__D002182 Candies
% 222.86/223.02  |- rdf__type mesh__D002182sskos__Concept
% 222.86/223.02  |- skos__broader mesh__D002182smesh__D005502
% 222.86/223.02  |- mesh__dateCreated mesh__D002182 1999-01-01
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D002182 2001
% 222.86/223.02  |- mesh__recordMaintainer mesh__D010614 ags
% 222.86/223.02  |- skos__broader mesh__D010614smesh__D041981
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D010614 2004
% 222.86/223.02  |- mesh__recordOriginator mesh__D010614 NLM
% 222.86/223.02  |- skos__altLabel mesh__D010614 Throat
% 222.86/223.02  |- skos__hiddenLabel mesh__D010614 Pharynxs
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D010614 2006
% 222.86/223.02  |- skos__broader mesh__D010614smesh__D013284
% 222.86/223.02  |- skos__hiddenLabel mesh__D010614 Throats
% 222.86/223.02  |- mesh__dateRevised mesh__D010614 2005-07-18
% 222.86/223.02  |- skos__broader mesh__D010614smesh__D012137
% 222.86/223.02  |- skos__related mesh__D010614smesh__D010613
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D010614 2005
% 222.86/223.02  |- skos__prefLabel mesh__D010614 Pharynx
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D010614 2005A
% 222.86/223.02  |- skos__annotation mesh__D010614
% 222.86/223.02       inflammation = PHARYNGITIS; /surg: consider also PHARYNGECTOMY %26% PHARYNGOSTOMY; HYPOPHARYNX; NASOPHARYNX; %26% OROPHARYNX are also available%A%  
% 222.86/223.02  |- rdf__type mesh__D010614sskos__Concept
% 222.86/223.02  |- skos__scopeNote mesh__D010614
% 222.86/223.02       A funnel-shaped fibromuscular tube that conducts food to the ESOPHAGUS, and air to the LARYNX and LUNGS. It is located posterior to the NASAL CAVITY; ORAL CAVITY; and LARYNX, and extends from the SKULL BASE to the inferior border of the CRICOID CARTILAGE anteriorly and to the inferior border of the C6 vertebra posteriorly. It is divided into the NASOPHARYNX; OROPHARYNX; and HYPOPHARYNX %28%laryngopharynx%29%.%A%    
% 222.86/223.02  |- mesh__recordAuthorizer mesh__D010614 ags
% 222.86/223.02  |- mesh__dateCreated mesh__D010614 1999-01-01
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D010614 2006A
% 222.86/223.02  |- skos__related mesh__D010614smesh__D010611
% 222.86/223.02  |- skos__broader mesh__D014124Q000151smesh__D014124
% 222.86/223.02  |- rdf__type mesh__D014124Q000151smesh__CompoundConcept
% 222.86/223.02  |- mesh__dateRevised mesh__D001888 1993-06-04
% 222.86/223.02  |- mesh__historyNote mesh__D001888 68   
% 222.86/223.02  |- rdf__type mesh__D001888sskos__Concept
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D001888 2002
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D001888 1997
% 222.86/223.02  |- mesh__dateCreated mesh__D001888 1999-01-01
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D001888 2005
% 222.86/223.02  |- mesh__recordOriginator mesh__D001888 NLM
% 222.86/223.02  |- mesh__publicMeSHNote mesh__D001888 68   
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D001888 2006
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D001888 1994
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D001888 2000
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D001888 2003
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D001888 1998
% 222.86/223.02  |- mesh__recordAuthorizer mesh__D001888 PLS
% 222.86/223.02  |- mesh__dateEstablished mesh__D001888 1968-01-01
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D001888 1995
% 222.86/223.02  |- mesh__recordMaintainer mesh__D001888 TPW
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D001888 2001
% 222.86/223.02  |- skos__scopeNote mesh__D001888
% 222.86/223.02       Inorganic and organic derivatives of boric acid either B%28%OH%29%3 or, preferably H3BO3.%A%    
% 222.86/223.02  |- skos__broader mesh__D001888smesh__D001896
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D001888 2004
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D001888 1999
% 222.86/223.02  |- skos__historyNote mesh__D001888 Borates %28%1966-1967%29%
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D001888 1996
% 222.86/223.02  |- skos__hiddenLabel mesh__D001888 Acids, Boric
% 222.86/223.02  |- skos__broader mesh__D001888smesh__D000148
% 222.86/223.02  |- skos__prefLabel mesh__D001888 Boric Acids
% 222.86/223.02  |- skos__altLabel mesh__D028227 Familial Amyloid Polyneuropathies
% 222.86/223.02  |- mesh__publicMeSHNote mesh__D028227
% 222.86/223.02       2002; see AMYLOID NEUROPATHIES 1994-2001; for FAMILIAL AMYLOID POLYNEUROPATHIES see AMYLOID NEUROPATHIES 1994-2001%A%  
% 222.86/223.02  |- skos__altLabel mesh__D028227 Swiss Type Amyloid Polyneuropathy
% 222.86/223.02  |- skos__altLabel mesh__D028227 Type II Familial Amyloid Polyneuropathy
% 222.86/223.02  |- skos__altLabel mesh__D028227 Jewish Type Familial Amyloid Polyneuropathy
% 222.86/223.02  |- skos__hiddenLabel mesh__D028227 Amyloid Neuropathy, Familial
% 222.86/223.02  |- skos__hiddenLabel mesh__D028227 Polyneuropathy, Familial Amyloid
% 222.86/223.02  |- skos__altLabel mesh__D028227 Familial Amyloid Neuropathy, Andrade Type
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D028227 2003
% 222.86/223.02  |- skos__altLabel mesh__D028227
% 222.86/223.02       Appalachian Type Familial Amyloid Polyneuropathy
% 222.86/223.02  |- skos__broader mesh__D028227smesh__D017772
% 222.86/223.02  |- mesh__recordAuthorizer mesh__D028227 sjn
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D028227 2006
% 222.86/223.02  |- mesh__recordOriginator mesh__D028227 nns
% 222.86/223.02  |- skos__altLabel mesh__D028227 Type III Familial Amyloid Polyneuropathy
% 222.86/223.02  |- skos__historyNote mesh__D028227 Amyloidosis %28%1967-1993%29%
% 222.86/223.02  |- skos__hiddenLabel mesh__D028227 Portuguese Polyneuritic Amyloidoses
% 222.86/223.02  |- skos__altLabel mesh__D028227 Type V Familial Amyloid Polyneuropathy
% 222.86/223.02  |- skos__hiddenLabel mesh__D028227 Polyneuropathies, Familial Amyloid
% 222.86/223.02  |- skos__altLabel mesh__D028227 British Type Amyloid Polyneuropathy
% 222.86/223.02  |- skos__hiddenLabel mesh__D028227 Amyloidoses, Portuguese Polyneuritic
% 222.86/223.02  |- skos__hiddenLabel mesh__D028227 Neuropathy, Familial Amyloid
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D028227 2002
% 222.86/223.02  |- skos__altLabel mesh__D028227 Iowa Type Amyloid Polyneuropathy
% 222.86/223.02  |- skos__scopeNote mesh__D028227
% 222.86/223.02       Inherited disorders of the peripheral nervous system associated with the deposition of AMYLOID in nerve tissue. The different clinical types based on symptoms correspond to the presence of a variety of mutations in several different proteins including transthyretin %28%PREALBUMIN%29%; APOLIPOPROTEIN A-I; and GELSOLIN.%A%    
% 222.86/223.02  |- skos__hiddenLabel mesh__D028227 Amyloidosis, Portuguese Polyneuritic
% 222.86/223.02  |- skos__altLabel mesh__D028227 Amyloid Polyneuropathy, Iowa Type
% 222.86/223.02  |- skos__broader mesh__D028227smesh__D028226
% 222.86/223.02  |- skos__altLabel mesh__D028227 Polyneuritic Amyloidosis, Portuguese
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D028227 2005
% 222.86/223.02  |- skos__hiddenLabel mesh__D028227 Neuropathies, Familial Amyloid
% 222.86/223.02  |- skos__altLabel mesh__D028227 Portuguese Polyneuritic Amyloidosis
% 222.86/223.02  |- skos__altLabel mesh__D028227 Familial Amyloid Polyneuropathy, Type II
% 222.86/223.02  |- mesh__historyNote mesh__D028227
% 222.86/223.02       2002; use AMYLOID NEUROPATHIES 1994-2001; for FAMILIAL AMYLOID POLYNEUROPATHIES use AMYLOID NEUROPATHIES 1994-2001%A%  
% 222.86/223.02  |- skos__altLabel mesh__D028227 Type VI Familial Amyloid Polyneuropathy
% 222.86/223.02  |- skos__hiddenLabel mesh__D028227 Polyneuritic Amyloidoses, Portuguese
% 222.86/223.02  |- skos__hiddenLabel mesh__D028227 Amyloid Polyneuropathies, Familial
% 222.86/223.02  |- skos__broader mesh__D028227smesh__D020271
% 222.86/223.02  |- mesh__dateEstablished mesh__D028227 2002-01-01
% 222.86/223.02  |- skos__hiddenLabel mesh__D028227 Familial Amyloid Polyneuropathy
% 222.86/223.02  |- skos__historyNote mesh__D028227 Amyloid Neuropathies %28%1994-2001%29%
% 222.86/223.02  |- mesh__recordMaintainer mesh__D028227 nns
% 222.86/223.02  |- skos__altLabel mesh__D028227 Portuguese Type Familial Amyloid Neuropathy
% 222.86/223.02  |- mesh__dateCreated mesh__D028227 2001-07-25
% 222.86/223.02  |- rdf__type mesh__D028227sskos__Concept
% 222.86/223.02  |- skos__hiddenLabel mesh__D028227 Familial Amyloid Neuropathies
% 222.86/223.02  |- skos__historyNote mesh__D028227
% 222.86/223.02       Peripheral Nervous System Diseases %28%1967-1993%29%
% 222.86/223.02  |- skos__hiddenLabel mesh__D028227 Familial Amyloid Neuropathy
% 222.86/223.02  |- skos__altLabel mesh__D028227 Familial Amyloid Polyneuropathy, Type I
% 222.86/223.02  |- skos__hiddenLabel mesh__D028227 Amyloid Polyneuropathy, Familial
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D028227 2004
% 222.86/223.02  |- skos__altLabel mesh__D028227 Finnish Type Familial Amyloid Neuropathy
% 222.86/223.02  |- skos__prefLabel mesh__D028227 Amyloid Neuropathies, Familial
% 222.86/223.02  |- skos__altLabel mesh__D028227 Type I Familial Amyloid Polyneuropathy
% 222.86/223.02  |- skos__altLabel mesh__D028227 Type IV Familial Amyloid Polyneuropathy
% 222.86/223.02  |- skos__altLabel mesh__D028227 Familial Amyloid Polyneuropathy, Type III
% 222.86/223.02  |- skos__hiddenLabel mesh__D006573 1-Ring Heterocyclic Cpds
% 222.86/223.02  |- mesh__dateCreated mesh__D006573 1999-01-01
% 222.86/223.02  |- mesh__activeMeSHYear mesh__D006573 2006
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D006573 2000
% 222.86/223.04  |- skos__hiddenLabel mesh__D006573 Heterocyclic Cpds, 1 Ring
% 222.86/223.04  |- mesh__dateEstablished mesh__D006573 1998-01-01
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D006573 2003
% 222.86/223.04  |- skos__hiddenLabel mesh__D006573 Cpds, 1-Ring Heterocyclic
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D006573 1998
% 222.86/223.04  |- skos__altLabel mesh__D006573 Heterocyclic Cpds, 1-Ring
% 222.86/223.04  |- mesh__recordAuthorizer mesh__D006573 SJN
% 222.86/223.04  |- skos__hiddenLabel mesh__D006573 1-Ring Heterocyclic Compounds
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D006573 2001
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D006573 2004
% 222.86/223.04  |- skos__broader mesh__D006573smesh__D006571
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D006573 1999
% 222.86/223.04  |- skos__hiddenLabel mesh__D006573 Heterocyclic Compounds, 1 Ring
% 222.86/223.04  |- mesh__recordOriginator mesh__D006573 NLM
% 222.86/223.04  |- rdf__type mesh__D006573sskos__Concept
% 222.86/223.04  |- skos__prefLabel mesh__D006573 Heterocyclic Compounds, 1-Ring
% 222.86/223.04  |- skos__scopeNote mesh__D006573
% 222.86/223.04       A class of organic compounds containing a ring structure made up of more than one kind of atom, usually carbon plus another atom. The ring structure can be aromatic or nonaromatic.%A%    
% 222.86/223.04  |- mesh__recordMaintainer mesh__D006573 ADP
% 222.86/223.04  |- mesh__dateRevised mesh__D006573 1997-06-20
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D006573 2002
% 222.86/223.04  |- mesh__publicMeSHNote mesh__D006573 98   
% 222.86/223.04  |- mesh__historyNote mesh__D006573 98; use explode 1967-97   
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D006573 2005
% 222.86/223.04  |- skos__annotation mesh__D006573
% 222.86/223.04       GEN; prefer specifics; used for mapping supplementary chemicals%A%  
% 222.86/223.04  |- skos__hiddenLabel mesh__D006573 Compounds, 1-Ring Heterocyclic
% 222.86/223.04  |- skos__altLabel mesh__D020244 Middle Cerebral Artery Stroke
% 222.86/223.04  |- skos__altLabel mesh__D020244 Cerebral Infarction, Middle Cerebral Artery
% 222.86/223.04  |- rdf__type mesh__D020244sskos__Concept
% 222.86/223.04  |- mesh__dateCreated mesh__D020244 1999-11-03
% 222.86/223.04  |- skos__historyNote mesh__D020244 Cerebral Infarction %28%1978-1999%29%
% 222.86/223.04  |- skos__altLabel mesh__D020244 Thrombosis, Middle Cerebral Artery
% 222.86/223.04  |- skos__altLabel mesh__D020244 MCA Infarction
% 222.86/223.04  |- mesh__publicMeSHNote mesh__D020244 2000   
% 222.86/223.04  |- mesh__recordAuthorizer mesh__D020244 sjn
% 222.86/223.04  |- mesh__recordOriginator mesh__D020244 KEV
% 222.86/223.04  |- skos__altLabel mesh__D020244
% 222.86/223.04       Middle Cerebral Artery Circulation Infarction
% 222.86/223.04  |- mesh__dateEstablished mesh__D020244 2000-01-01
% 222.86/223.04  |- skos__altLabel mesh__D020244 Embolus, Middle Cerebral Artery
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D020244 2006
% 222.86/223.04  |- skos__altLabel mesh__D020244 Middle Cerebral Artery Infarction
% 222.86/223.04  |- skos__broader mesh__D020244smesh__D002544
% 222.86/223.04  |- skos__altLabel mesh__D020244
% 222.86/223.04       Middle Cerebral Artery Thrombotic Infarction
% 222.86/223.04  |- mesh__dateRevised mesh__D020244 2005-06-30
% 222.86/223.04  |- mesh__historyNote mesh__D020244 2000   
% 222.86/223.04  |- skos__scopeNote mesh__D020244
% 222.86/223.04       The formation of an area of coagulation necrosis in the vascular distribution of the middle cerebral artery secondary to ISCHEMIA. Clinical features include contralateral weakness and loss of sensation in the arm and face and a contralateral homonymous hemianopsia. Dominant hemisphere lesions may produce APHASIA, alexia, AGRAPHIA, acalculia, finger agnosia, and right-left confusion. Nondominant hemisphere lesions may produce unilateral neglect, dressing APRAXIA, anosognosia, and constructional apraxia. %28%From Adams et al., Principles of Neurology, 6th ed, p786%29%%A%    
% 222.86/223.04  |- skos__related mesh__D020244smesh__D007238
% 222.86/223.04  |- skos__broader mesh__D020244smesh__D002539
% 222.86/223.04  |- skos__historyNote mesh__D020244 Infarction %28%1966-1978%29%
% 222.86/223.04  |- skos__altLabel mesh__D020244 Middle Cerebral Artery Embolic Infarction
% 222.86/223.04  |- skos__prefLabel mesh__D020244 Infarction, Middle Cerebral Artery
% 222.86/223.04  |- skos__altLabel mesh__D020244 Stroke, Middle Cerebral Artery
% 222.86/223.04  |- skos__altLabel mesh__D020244 Occlusion, Middle Cerebral Artery
% 222.86/223.04  |- mesh__recordMaintainer mesh__D020244 ssb
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D014207 2001
% 222.86/223.04  |- skos__annotation mesh__D014207
% 222.86/223.04       in brain surg; restrict to skull: do not use for other tissues; do not use /util except by MeSH definition%A%  
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D014207 2006
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D014207 1999
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D014207 2000
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D014207 2005
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D014207 1998
% 222.86/223.04  |- rdf__type mesh__D014207sskos__Concept
% 222.86/223.04  |- skos__hiddenLabel mesh__D014207 Trephinings
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D014207 2002
% 222.86/223.04  |- mesh__recordMaintainer mesh__D014207 PXP
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D014207 2004
% 222.86/223.04  |- mesh__recordAuthorizer mesh__D014207 SJN
% 222.86/223.04  |- mesh__dateRevised mesh__D014207 1997-06-20
% 222.86/223.04  |- skos__scopeNote mesh__D014207
% 222.86/223.04       The removal of a circular disk of the cranium. It is performed with a trephine, a small circular saw with a center pin mounted on a hollow metal shaft to which is attached a transverse handle. %28%Random House Unabridged Dictionary, 2d ed%29%%A%    
% 222.86/223.04  |- skos__prefLabel mesh__D014207 Trephining
% 222.86/223.04  |- mesh__recordOriginator mesh__D014207 NLM
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D014207 2003
% 222.86/223.04  |- skos__broader mesh__D014207smesh__D019635
% 222.86/223.04  |- mesh__dateCreated mesh__D014207 1999-01-01
% 222.86/223.04  |- mesh__recordOriginator mesh__D002981 NLM
% 222.86/223.04  |- rdf__type mesh__D002981sskos__Concept
% 222.86/223.04  |- skos__broader mesh__D002981smesh__D008034
% 222.86/223.04  |- skos__hiddenLabel mesh__D002981 7 Chloro 7 deoxylincomycin
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002981 2005
% 222.86/223.04  |- skos__prefLabel mesh__D002981 Clindamycin
% 222.86/223.04  |- skos__hiddenLabel mesh__D002981 Monohydrochloride, Clindamycin
% 222.86/223.04  |- skos__hiddenLabel mesh__D002981
% 222.86/223.04       Monohydrate Clindamycin Monohydrochloride
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002981 2006
% 222.86/223.04  |- mesh__dateEstablished mesh__D002981 1974-01-01
% 222.86/223.04  |- mesh__dateCreated mesh__D002981 1999-01-01
% 222.86/223.04  |- skos__altLabel mesh__D002981 Chlolincocin
% 222.86/223.04  |- mesh__recordAuthorizer mesh__D002981 sjn
% 222.86/223.04  |- mesh__publicMeSHNote mesh__D002981 74   
% 222.86/223.04  |- mesh__historyNote mesh__D002981 74%28%72%29%   
% 222.86/223.04  |- skos__scopeNote mesh__D002981
% 222.86/223.04       An antibacterial agent that is a semisynthetic analog of LINCOMYCIN.%A%    
% 222.86/223.04  |- skos__historyNote mesh__D002981 Lincomycin %28%1966-1971%29%
% 222.86/223.04  |- mesh__recordMaintainer mesh__D002981 ssb
% 222.86/223.04  |- skos__hiddenLabel mesh__D002981
% 222.86/223.04       Monohydrochloride, Monohydrate Clindamycin
% 222.86/223.04  |- mesh__dateRevised mesh__D002981 2004-07-07
% 222.86/223.04  |- skos__hiddenLabel mesh__D002981 Hydrochloride, Clindamycin
% 222.86/223.04  |- skos__altLabel mesh__D002981 Chlorlincocin
% 222.86/223.04  |- skos__altLabel mesh__D002981 7-Chloro-7-deoxylincomycin
% 222.86/223.04  |- mesh__dateRevised mesh__D002183 1992-05-07
% 222.86/223.04  |- mesh__publicMeSHNote mesh__D002183
% 222.86/223.04       91; was see under ORTHOPEDIC EQUIPMENT 1975-90   
% 222.86/223.04  |- skos__hiddenLabel mesh__D002183 Sticks, Walking
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002183 2002
% 222.86/223.04  |- mesh__recordAuthorizer mesh__D002183 PLS
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002183 1995
% 222.86/223.04  |- mesh__dateEstablished mesh__D002183 1991-01-01
% 222.86/223.04  |- skos__scopeNote mesh__D002183
% 222.86/223.04       Sticks used as walking aids. The canes may have three or four prongs at the end of the shaft.%A%    
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002183 1993
% 222.86/223.04  |- skos__hiddenLabel mesh__D002183 Stick, Walking
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002183 1994
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002183 2006
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002183 1999
% 222.86/223.04  |- skos__broader mesh__D002183smesh__D009983
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002183 2004
% 222.86/223.04  |- mesh__recordMaintainer mesh__D002183 TAP
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002183 2001
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002183 1997
% 222.86/223.04  |- mesh__dateCreated mesh__D002183 1974-12-12
% 222.86/223.04  |- skos__prefLabel mesh__D002183 Canes
% 222.86/223.04  |- skos__hiddenLabel mesh__D002183 Cane
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002183 2005
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002183 2000
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002183 1998
% 222.86/223.04  |- skos__altLabel mesh__D002183 Walking Sticks
% 222.86/223.04  |- mesh__recordOriginator mesh__D002183 NLM
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002183 2003
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002183 1996
% 222.86/223.04  |- mesh__historyNote mesh__D002183
% 222.86/223.04       91%28%75%29%; was see under ORTHOPEDIC EQUIPMENT 1975-90   
% 222.86/223.04  |- skos__hiddenLabel mesh__D002183 Walking Stick
% 222.86/223.04  |- rdf__type mesh__D002183sskos__Concept
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010615 2001
% 222.86/223.04  |- mesh__publicMeSHNote mesh__D010615 65; see ACETOPHENETIDIN 1963-64   
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010615 2006
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010615 2003
% 222.86/223.04  |- skos__prefLabel mesh__D010615 Phenacetin
% 222.86/223.04  |- mesh__dateEstablished mesh__D010615 1965-01-01
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010615 2000
% 222.86/223.04  |- mesh__recordMaintainer mesh__D010615 KEV
% 222.86/223.04  |- mesh__recordAuthorizer mesh__D010615 SJN
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010615 2005
% 222.86/223.04  |- mesh__recordOriginator mesh__D010615 NLM
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010615 1999
% 222.86/223.04  |- rdf__type mesh__D010615sskos__Concept
% 222.86/223.04  |- mesh__dateRevised mesh__D010615 1998-06-10
% 222.86/223.04  |- mesh__dateCreated mesh__D010615 1999-01-01
% 222.86/223.04  |- skos__scopeNote mesh__D010615
% 222.86/223.04       A non-prostaglandin synthase inhibitor. It was utilized extensively in a wide variety of analgesic mixtures, but its causal role in analgesic-abuse nephropathy led to its withdrawal from the market. %28%From Smith and Reynard, Textbook of Pharmacology,1991, p431%29%%A%    
% 222.86/223.04  |- skos__broader mesh__D010615smesh__D000083
% 222.86/223.04  |- mesh__historyNote mesh__D010615 65%28%63%29%   
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010615 2002
% 222.86/223.04  |- skos__altLabel mesh__D010615 Acetophenetidin
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010615 2004
% 222.86/223.04  |- skos__hiddenLabel mesh__D015300 Weaning, Ventilator
% 222.86/223.04  |- mesh__recordMaintainer mesh__D015300 PLS
% 222.86/223.04  |- skos__broader mesh__D015300smesh__D012121
% 222.86/223.04  |- mesh__onlineNote mesh__D015300
% 222.86/223.04       use VENTILATOR WEANING to search VENTILATORS, MECHANICAL, WEANING %26% VENTILATORS, PULMONARY, WEANING 1989-92%A%  
% 222.86/223.04  |- mesh__historyNote mesh__D015300
% 222.86/223.04       89; VENTILATORS, MECHANICAL, WEANING %26% VENTILATORS, PULMONARY, WEANING were see VENTILATOR WEANING 1989-92%A%  
% 222.86/223.04  |- skos__hiddenLabel mesh__D015300 Ventilator Weaning, Mechanical
% 222.86/223.04  |- mesh__dateRevised mesh__D015300 1993-02-20
% 222.86/223.04  |- skos__altLabel mesh__D015300 Mechanical Ventilator Weaning
% 222.86/223.04  |- mesh__publicMeSHNote mesh__D015300
% 222.86/223.04       89; VENTILATORS, MECHANICAL, WEANING %26% VENTILATORS, PULMONARY, WEANING were see VENTILATOR WEANING 1989-92%A%  
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D015300 1996
% 222.86/223.04  |- skos__historyNote mesh__D015300
% 222.86/223.04       Respiration, Artificial %28%1966-1988%29%
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D015300 2000
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D015300 1998
% 222.86/223.04  |- mesh__dateCreated mesh__D015300 1988-05-26
% 222.86/223.04  |- mesh__recordAuthorizer mesh__D015300 NLM
% 222.86/223.04  |- rdf__type mesh__D015300sskos__Concept
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D015300 2001
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D015300 1997
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D015300 1994
% 222.86/223.04  |- mesh__recordOriginator mesh__D015300 EJB
% 222.86/223.04  |- skos__altLabel mesh__D015300 Respirator Weaning
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D015300 1999
% 222.86/223.04  |- skos__scopeNote mesh__D015300
% 222.86/223.04       Techniques for effecting the transition of the respiratory-failure patient from mechanical ventilation to spontaneous ventilation, while meeting the criteria that tidal volume be above a given threshold %28%greater than 5 ml/kg%29%, respiratory frequency be below a given count %28%less than 30 breaths/min%29%, and oxygen partial pressure be above a given threshold %28%PaO2 greater than 50mm Hg%29%. Weaning studies focus on finding methods to monitor and predict the outcome of mechanical ventilator weaning as well as finding ventilatory support techniques which will facilitate successful weaning. Present methods include intermittent mandatory ventilation, intermittent positive pressure ventilation, and mandatory minute volume ventilation.%A%    
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D015300 2003
% 222.86/223.04  |- skos__historyNote mesh__D015300 Respiration %28%1966-1988%29%
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D015300 1995
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D015300 2005
% 222.86/223.04  |- skos__hiddenLabel mesh__D015300 Weaning, Respirator
% 222.86/223.04  |- mesh__dateEstablished mesh__D015300 1989-01-01
% 222.86/223.04  |- skos__hiddenLabel mesh__D015300 Weaning, Mechanical Ventilator
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D015300 2004
% 222.86/223.04  |- skos__prefLabel mesh__D015300 Ventilator Weaning
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D015300 2002
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D015300 2006
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D001889 2006
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D001889 1994
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D001889 2001
% 222.86/223.04  |- skos__broader mesh__D001889smesh__D001896
% 222.86/223.04  |- skos__historyNote mesh__D001889 Boron %28%1966-1967%29%
% 222.86/223.04  |- skos__scopeNote mesh__D001889
% 222.86/223.04       Inorganic or organic compounds that contain the general structure R2B%28%OH%29%.%A%    
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D001889 2003
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D001889 1998
% 222.86/223.04  |- mesh__dateEstablished mesh__D001889 1968-01-01
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D001889 1995
% 222.86/223.04  |- skos__prefLabel mesh__D001889 Borinic Acids
% 222.86/223.04  |- mesh__recordMaintainer mesh__D001889 TPW
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D001889 2004
% 222.86/223.04  |- mesh__dateRevised mesh__D001889 1993-06-04
% 222.86/223.04  |- skos__broader mesh__D001889smesh__D000148
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D001889 1999
% 222.86/223.04  |- mesh__historyNote mesh__D001889 68   
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D001889 2002
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D001889 1996
% 222.86/223.04  |- rdf__type mesh__D001889sskos__Concept
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D001889 1997
% 222.86/223.04  |- skos__annotation mesh__D001889
% 222.86/223.04       do not confuse with BORONIC ACIDS or BORIC ACIDS   
% 222.86/223.04  |- mesh__dateCreated mesh__D001889 1999-01-01
% 222.86/223.04  |- mesh__recordOriginator mesh__D001889 NLM
% 222.86/223.04  |- skos__hiddenLabel mesh__D001889 Acids, Borinic
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D001889 2000
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D001889 2005
% 222.86/223.04  |- mesh__publicMeSHNote mesh__D001889 68   
% 222.86/223.04  |- mesh__recordAuthorizer mesh__D001889 PLS
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D006574 2003
% 222.86/223.04  |- mesh__historyNote mesh__D006574 98; use explode 1967-97   
% 222.86/223.04  |- skos__annotation mesh__D006574
% 222.86/223.04       GEN; prefer specifics; used for mapping supplementary chemicals%A%  
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D006574 1999
% 222.86/223.04  |- skos__hiddenLabel mesh__D006574 Compounds, 2-Ring Heterocyclic
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D006574 2004
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D006574 2000
% 222.86/223.04  |- skos__hiddenLabel mesh__D006574 2-Ring Heterocyclic Compounds
% 222.86/223.04  |- mesh__dateEstablished mesh__D006574 1998-01-01
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D006574 2001
% 222.86/223.04  |- rdf__type mesh__D006574sskos__Concept
% 222.86/223.04  |- mesh__recordMaintainer mesh__D006574 ADP
% 222.86/223.04  |- skos__broader mesh__D006574smesh__D006571
% 222.86/223.04  |- mesh__recordAuthorizer mesh__D006574 SJN
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D006574 2005
% 222.86/223.04  |- mesh__recordOriginator mesh__D006574 NLM
% 222.86/223.04  |- skos__prefLabel mesh__D006574 Heterocyclic Compounds, 2-Ring
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D006574 2006
% 222.86/223.04  |- skos__scopeNote mesh__D006574
% 222.86/223.04       A class of organic compounds containing two ring structures, one of which is made up of more than one kind of atom, usually carbon plus another atom. The heterocycle may be either aromatic or nonaromatic.%A%    
% 222.86/223.04  |- mesh__dateCreated mesh__D006574 1999-01-01
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D006574 2002
% 222.86/223.04  |- skos__hiddenLabel mesh__D006574 Heterocyclic Compounds, 2 Ring
% 222.86/223.04  |- mesh__publicMeSHNote mesh__D006574 98   
% 222.86/223.04  |- mesh__dateRevised mesh__D006574 1997-06-20
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D006574 1998
% 222.86/223.04  |- skos__hiddenLabel mesh__D020245 4 Chloromercuribenzoic Acid
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D020245 2006
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D020245 2001
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D020245 2003
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D020245 1999
% 222.86/223.04  |- skos__hiddenLabel mesh__D020245 Acid, 4-Chloromercuribenzoic
% 222.86/223.04  |- skos__annotation mesh__D020245
% 222.86/223.04       CHLOROMERCURIBENZOATES is also available   
% 222.86/223.04  |- skos__broader mesh__D020245smesh__D002729
% 222.86/223.04  |- skos__hiddenLabel mesh__D020245 para Chloromercuribenzoate
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D020245 2004
% 222.86/223.04  |- mesh__historyNote mesh__D020245
% 222.86/223.04       99; use P-CHLOROMERCURIBENZOIC ACID %28%NM%29% 1980-98   
% 222.86/223.04  |- skos__historyNote mesh__D020245 Chloromercuribenzoates %28%1980-1998%29%
% 222.86/223.04  |- skos__hiddenLabel mesh__D020245 p Chloromercuribenzoic Acid
% 222.86/223.04  |- skos__prefLabel mesh__D020245 p-Chloromercuribenzoic Acid
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D020245 2002
% 222.86/223.04  |- mesh__publicMeSHNote mesh__D020245
% 222.86/223.04       99; 4-CHLOROMERCURIBENZOIC ACID %28%now P-CHLOROMERCURIBENZOIC ACID%29% was indexed under CHLOROMERCURIBENZOATES 1980-98%A%  
% 222.86/223.04  |- skos__altLabel mesh__D020245 PCMB
% 222.86/223.04  |- skos__hiddenLabel mesh__D020245 Acid, p-Chloromercuribenzoic
% 222.86/223.04  |- skos__scopeNote mesh__D020245
% 222.86/223.04       An organic mercurial used as a sulfhydryl reagent.     
% 222.86/223.04  |- rdf__type mesh__D020245sskos__Concept
% 222.86/223.04  |- skos__altLabel mesh__D020245 4-Chloromercuribenzoic Acid
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D020245 2005
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D020245 2000
% 222.86/223.04  |- mesh__dateCreated mesh__D020245 1998-06-10
% 222.86/223.04  |- mesh__dateEstablished mesh__D020245 1999-01-01
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D014208 2006
% 222.86/223.04  |- skos__broader mesh__D014208smesh__D013143
% 222.86/223.04  |- mesh__recordOriginator mesh__D014208 NLM
% 222.86/223.04  |- mesh__dateRevised mesh__D014208 2005-06-30
% 222.86/223.04  |- skos__scopeNote mesh__D014208
% 222.86/223.04       A genus of microorganisms of the order SPIROCHAETALES, many of which are pathogenic and parasitic for man.%A%    
% 222.86/223.04  |- rdf__type mesh__D014208sskos__Concept
% 222.86/223.04  |- mesh__dateCreated mesh__D014208 1999-01-01
% 222.86/223.04  |- mesh__recordAuthorizer mesh__D014208 sjn
% 222.86/223.04  |- mesh__recordMaintainer mesh__D014208 SYSTEM
% 222.86/223.04  |- skos__prefLabel mesh__D014208 Treponema
% 222.86/223.04  |- skos__annotation mesh__D014208
% 222.86/223.04       infection = TREPONEMAL INFECTIONS or its specifics; Treponema hyodysenteriae = SERPULINA HYODYSENTERIAE, Treponema innocens = SERPULINA%A%  
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002982 1996
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002982 2006
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002982 2000
% 222.86/223.04  |- mesh__recordOriginator mesh__D002982 EC
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002982 1997
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002982 2001
% 222.86/223.04  |- mesh__recordMaintainer mesh__D002982 JLS
% 222.86/223.04  |- skos__historyNote mesh__D002982
% 222.86/223.04       Education, Medical, Undergraduate %28%1971-1982%29%
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002982 1998
% 222.86/223.04  |- skos__altLabel mesh__D002982 Clinical Clerkships
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002982 2002
% 222.86/223.04  |- mesh__dateCreated mesh__D002982 1982-04-28
% 222.86/223.04  |- mesh__publicMeSHNote mesh__D002982
% 222.86/223.04       91; was see under EDUCATION, MEDICAL, UNDERGRADUATE 1983-90%A%  
% 222.86/223.04  |- mesh__historyNote mesh__D002982
% 222.86/223.04       91%28%83%29%; was see under EDUCATION, MEDICAL, UNDERGRADUATE 1983-90%A%  
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002982 1999
% 222.86/223.04  |- mesh__dateRevised mesh__D002982 1994-05-27
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002982 2003
% 222.86/223.04  |- skos__altLabel mesh__D002982 Clerkship, Clinical
% 222.86/223.04  |- mesh__dateEstablished mesh__D002982 1991-01-01
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002982 1995
% 222.86/223.04  |- skos__broader mesh__D002982smesh__D004504
% 222.86/223.04  |- skos__altLabel mesh__D002982 Clerkships, Clinical
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002982 2004
% 222.86/223.04  |- mesh__recordAuthorizer mesh__D002982 PLS
% 222.86/223.04  |- rdf__type mesh__D002982sskos__Concept
% 222.86/223.04  |- skos__scopeNote mesh__D002982
% 222.86/223.04       Undergraduate medical education programs for second- , third- , and fourth-year students in which the students receive clinical training and experience in teaching hospitals or affiliated health centers.%A%    
% 222.86/223.04  |- skos__prefLabel mesh__D002982 Clinical Clerkship
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002982 2005
% 222.86/223.04  |- skos__annotation mesh__D002982
% 222.86/223.04       an undergrad med educ program; DF: CLIN CLERKSHIP   
% 222.86/223.04  |- mesh__recordOriginator mesh__D002184 NLM
% 222.86/223.04  |- mesh__publicMeSHNote mesh__D002184
% 222.86/223.04       94; was CANINE TRACHEOBRONCHITIS VIRUS 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-90%29%; CANINE HERPESVIRUS was see CANINE TRACHEOBRONCHITIS VIRUS 1975-93%A%  
% 222.86/223.04  |- skos__hiddenLabel mesh__D002184 Canine Tracheobronchitis Viruses
% 222.86/223.04  |- skos__scopeNote mesh__D002184
% 222.86/223.04       A species of VARICELLOVIRUS virus that causes a disease in newborn puppies.%A%    
% 222.86/223.04  |- mesh__onlineNote mesh__D002184
% 222.86/223.04       use HERPESVIRUS 1, CANID to search CANINE TRACHEOBRONCHITIS VIRUS %26% CANINE HERPESVIRUS 1975-93%A%  
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002184 2006
% 222.86/223.04  |- skos__altLabel mesh__D002184 Canine Herpesvirus 1
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002184 2002
% 222.86/223.04  |- skos__prefLabel mesh__D002184 Herpesvirus 1, Canid
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002184 2004
% 222.86/223.04  |- mesh__dateCreated mesh__D002184 1974-12-12
% 222.86/223.04  |- skos__hiddenLabel mesh__D002184 Tracheobronchitis Virus, Canine
% 222.86/223.04  |- skos__altLabel mesh__D002184 Canine Tracheobronchitis Virus
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002184 2005
% 222.86/223.04  |- mesh__dateRevised mesh__D002184 2001-07-25
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D002184 2003
% 222.86/223.04  |- skos__broader mesh__D002184smesh__D018140
% 222.86/223.04  |- mesh__recordAuthorizer mesh__D002184 sjn
% 222.86/223.04  |- skos__altLabel mesh__D002184 Canid herpesvirus 1
% 222.86/223.04  |- mesh__historyNote mesh__D002184
% 222.86/223.04       94; was CANINE TRACHEOBRONCHITIS VIRUS 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%; CANINE HERPESVIRUS was see CANINE TRACHEOBRONCHITIS VIRUS 1975-93%A%  
% 222.86/223.04  |- skos__annotation mesh__D002184
% 222.86/223.04       infect: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29%   
% 222.86/223.04  |- rdf__type mesh__D002184sskos__Concept
% 222.86/223.04  |- skos__altLabel mesh__D002184 Herpesvirus 1 %28%alpha%29%, Canine
% 222.86/223.04  |- mesh__recordMaintainer mesh__D002184 ags
% 222.86/223.04  |- skos__hiddenLabel mesh__D002184 Herpesvirus 1, Canine
% 222.86/223.04  |- skos__hiddenLabel mesh__D002184 Tracheobronchitis Viruses, Canine
% 222.86/223.04  |- mesh__dateEstablished mesh__D002184 1991-01-01
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010616 2004
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010616 2006
% 222.86/223.04  |- skos__broader mesh__D010616smesh__D011084
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010616 1996
% 222.86/223.04  |- mesh__recordMaintainer mesh__D010616 TGC
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010616 1998
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010616 2000
% 222.86/223.04  |- skos__annotation mesh__D010616 aromatic hydrocarbons   
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010616 1997
% 222.86/223.04  |- mesh__dateCreated mesh__D010616 1999-01-01
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010616 2001
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010616 1999
% 222.86/223.04  |- mesh__publicMeSHNote mesh__D010616
% 222.86/223.04       GLAUCARUBIN was see under PYRANS 1975-80   
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010616 1994
% 222.86/223.04  |- skos__prefLabel mesh__D010616 Phenanthrenes
% 222.86/223.04  |- rdf__type mesh__D010616sskos__Concept
% 222.86/223.04  |- mesh__recordAuthorizer mesh__D010616 PLS
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010616 1993
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010616 2003
% 222.86/223.04  |- mesh__recordOriginator mesh__D010616 NLM
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010616 1995
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010616 2002
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D010616 2005
% 222.86/223.04  |- mesh__dateRevised mesh__D010616 1992-05-19
% 222.86/223.04  |- mesh__dateEstablished mesh__D029321 2002-01-01
% 222.86/223.04  |- skos__scopeNote mesh__D029321
% 222.86/223.04       A genus of the family CALICIVIRIDAE, associated with infections in rabbits and hares, responsible for epidemics with high mortality. RABBIT HEMORRHAGIC DISEASE VIRUS is the type species.%A%    
% 222.86/223.04  |- mesh__historyNote mesh__D029321 2002   
% 222.86/223.04  |- skos__prefLabel mesh__D029321 Lagovirus
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D029321 2002
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D029321 2005
% 222.86/223.04  |- rdf__type mesh__D029321sskos__Concept
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D029321 2006
% 222.86/223.04  |- skos__annotation mesh__D029321
% 222.86/223.04       infection: coord IM with BUNYAVIRIDAE INFECTIONS %28%IM%29%   
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D029321 2003
% 222.86/223.04  |- skos__broader mesh__D029321smesh__D002139
% 222.86/223.04  |- mesh__dateCreated mesh__D029321 2001-07-25
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D029321 2004
% 222.86/223.04  |- mesh__publicMeSHNote mesh__D029321 2002   
% 222.86/223.04  |- skos__historyNote mesh__D015301 Monkey Diseases %28%1978-1988%29%
% 222.86/223.04  |- skos__hiddenLabel mesh__D015301 Retrovirus, Monkey
% 222.86/223.04  |- mesh__publicMeSHNote mesh__D015301
% 222.86/223.04       94; was SIMIAN RETROVIRUSES 1989-93   
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D015301 1996
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D015301 2002
% 222.86/223.04  |- skos__hiddenLabel mesh__D015301 Chimpanzee Retrovirus
% 222.86/223.04  |- mesh__activeMeSHYear mesh__D015301 1998
% 222.86/223.04  |- skos__hiddenLabel mesh__D015301 Retrovirus, Chimpanzee
% 222.86/223.04  |- rdf__type mesh__D015301sskos__Concept
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D015301 1997
% 222.86/223.05  |- mesh__recordMaintainer mesh__D015301 AGS
% 222.86/223.05  |- mesh__dateCreated mesh__D015301 1988-05-26
% 222.86/223.05  |- skos__scopeNote mesh__D015301
% 222.86/223.05       Classes of retroviruses for which monkeys or apes are hosts. Those isolated from the West African green monkey and the Asian rhesus macaque monkey are of particular interest because of their similarities to viruses causing cancer and acquired immunodeficiency syndrome %28%AIDS%29% in humans.%A%    
% 222.86/223.05  |- skos__hiddenLabel mesh__D015301 Retroviruses, Chimpanzee
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D015301 1994
% 222.86/223.05  |- skos__annotation mesh__D015301
% 222.86/223.05       a group of the family Retroviridae; infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%%A%  
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D015301 1999
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D015301 2003
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D015301 1995
% 222.86/223.05  |- mesh__recordAuthorizer mesh__D015301 PLS
% 222.86/223.05  |- skos__hiddenLabel mesh__D015301 Simian Retrovirus
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D015301 2000
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D015301 2005
% 222.86/223.05  |- skos__hiddenLabel mesh__D015301 Retrovirus, Simian
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D015301 2004
% 222.86/223.05  |- mesh__dateEstablished mesh__D015301 1989-01-01
% 222.86/223.05  |- skos__broader mesh__D015301smesh__D012190
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D015301 2001
% 222.86/223.05  |- mesh__historyNote mesh__D015301 94; was SIMIAN RETROVIRUSES 1989-93   
% 222.86/223.05  |- mesh__dateRevised mesh__D015301 1993-06-04
% 222.86/223.05  |- skos__prefLabel mesh__D015301 Retroviruses, Simian
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D015301 2006
% 222.86/223.05  |- mesh__recordOriginator mesh__D015301 EJB
% 222.86/223.05  |- skos__hiddenLabel mesh__D015301 Retroviruses, Monkey
% 222.86/223.05  |- mesh__onlineNote mesh__D015301
% 222.86/223.05       use RETROVIRUSES, SIMIAN to search SIMIAN RETROVIRUSES 1989-93%A%  
% 222.86/223.05  |- skos__hiddenLabel mesh__D015301 Monkey Retrovirus
% 222.86/223.05  |- skos__altLabel mesh__D015301 Simian Retroviruses
% 222.86/223.05  |- skos__historyNote mesh__D015301 Retroviridae %28%1978-1988%29%
% 222.86/223.05  |- mesh__dateRevised mesh__D006575 1997-06-20
% 222.86/223.05  |- skos__hiddenLabel mesh__D006575 Compounds, 3-Ring Heterocyclic
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D006575 2006
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D006575 2001
% 222.86/223.05  |- mesh__recordOriginator mesh__D006575 NLM
% 222.86/223.05  |- skos__broader mesh__D006575smesh__D006571
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D006575 2005
% 222.86/223.05  |- skos__hiddenLabel mesh__D006575 3-Ring Heterocyclic Compounds
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D006575 2004
% 222.86/223.05  |- mesh__dateCreated mesh__D006575 1999-01-01
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D006575 2000
% 222.86/223.05  |- mesh__publicMeSHNote mesh__D006575 98   
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D006575 2003
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D006575 1999
% 222.86/223.05  |- skos__hiddenLabel mesh__D006575 Heterocyclic Compounds, 3 Ring
% 222.86/223.05  |- skos__scopeNote mesh__D006575
% 222.86/223.05       A class of organic compounds containing three ring structures, one of which is made up of more than one kind of atom, usually carbon plus another atom. The heterocycle may be either aromatic or nonaromatic%A%    
% 222.86/223.05  |- mesh__dateEstablished mesh__D006575 1998-01-01
% 222.86/223.05  |- mesh__recordMaintainer mesh__D006575 ADP
% 222.86/223.05  |- mesh__recordAuthorizer mesh__D006575 SJN
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D006575 1998
% 222.86/223.05  |- skos__altLabel mesh__D006575 Heterocyclic Cpds, 3 Ring
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D006575 2002
% 222.86/223.05  |- rdf__type mesh__D006575sskos__Concept
% 222.86/223.05  |- mesh__historyNote mesh__D006575 98; use explode 1967-97   
% 222.86/223.05  |- skos__prefLabel mesh__D006575 Heterocyclic Compounds, 3-Ring
% 222.86/223.05  |- skos__annotation mesh__D006575
% 222.86/223.05       GEN; prefer specifics; used for mapping supplementary chemicals%A%  
% 222.86/223.05  |- skos__historyNote mesh__D020246 Thrombophlebitis %28%1963-1998%29%
% 222.86/223.05  |- skos__hiddenLabel mesh__D020246 Deep Vein Thromboses
% 222.86/223.05  |- skos__altLabel mesh__D020246 Deep Venous Thrombosis
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D020246 2001
% 222.86/223.05  |- mesh__publicMeSHNote mesh__D020246 99; see THROMBOPHLEBITIS 1963-98   
% 222.86/223.05  |- mesh__dateCreated mesh__D020246 1998-06-11
% 222.86/223.05  |- skos__hiddenLabel mesh__D020246 Vein Thromboses, Deep
% 222.86/223.05  |- skos__altLabel mesh__D020246 Deep-Venous Thrombosis
% 222.86/223.05  |- mesh__recordAuthorizer mesh__D020246 sjn
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D020246 2005
% 222.86/223.05  |- skos__hiddenLabel mesh__D020246 Vein Thrombosis, Deep
% 222.86/223.05  |- skos__annotation mesh__D020246
% 222.86/223.05       GEN: prefer specifics; coord IM with specific vein %28%IM%29% if precoord is not available%A%  
% 222.86/223.05  |- skos__hiddenLabel mesh__D020246 Deep Venous Thromboses
% 222.86/223.05  |- skos__hiddenLabel mesh__D020246 Thrombosis, Deep-Vein
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D020246 2000
% 222.86/223.05  |- mesh__historyNote mesh__D020246 99; use THROMBOPHLEBITIS 1963-98   
% 222.86/223.05  |- skos__hiddenLabel mesh__D020246 Thromboses, Deep Venous
% 222.86/223.05  |- skos__hiddenLabel mesh__D020246 Thromboses, Deep Vein
% 222.86/223.05  |- skos__hiddenLabel mesh__D020246 Thromboses, Deep-Vein
% 222.86/223.05  |- mesh__recordOriginator mesh__D020246 NDW
% 222.86/223.05  |- skos__altLabel mesh__D020246 Deep-Vein Thrombosis
% 222.86/223.05  |- skos__hiddenLabel mesh__D020246 Deep-Venous Thromboses
% 222.86/223.05  |- skos__altLabel mesh__D020246 Thrombosis, Venous
% 222.86/223.05  |- skos__prefLabel mesh__D020246 Venous Thrombosis
% 222.86/223.05  |- skos__hiddenLabel mesh__D020246 Thrombosis, Deep Venous
% 222.86/223.05  |- skos__hiddenLabel mesh__D020246 Venous Thrombosis, Deep
% 222.86/223.05  |- skos__hiddenLabel mesh__D020246 Thrombosis, Deep-Venous
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D020246 2004
% 222.86/223.05  |- skos__hiddenLabel mesh__D020246 Thromboses, Venous
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D020246 2002
% 222.86/223.05  |- skos__hiddenLabel mesh__D020246 Phlebothromboses
% 222.86/223.05  |- skos__altLabel mesh__D020246 Phlebothrombosis
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D020246 2003
% 222.86/223.05  |- rdf__type mesh__D020246sskos__Concept
% 222.86/223.05  |- mesh__recordMaintainer mesh__D020246 ndw
% 222.86/223.05  |- skos__scopeNote mesh__D020246
% 222.86/223.05       The formation or presence of a thrombus within a vein.     
% 222.86/223.05  |- skos__hiddenLabel mesh__D020246 Venous Thromboses, Deep
% 222.86/223.05  |- skos__broader mesh__D020246smesh__D013927
% 222.86/223.05  |- skos__hiddenLabel mesh__D020246 Venous Thromboses
% 222.86/223.05  |- mesh__dateEstablished mesh__D020246 1999-01-01
% 222.86/223.05  |- mesh__dateRevised mesh__D020246 1999-11-03
% 222.86/223.05  |- skos__hiddenLabel mesh__D020246 Thromboses, Deep-Venous
% 222.86/223.05  |- skos__hiddenLabel mesh__D020246 Deep-Vein Thromboses
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D020246 2006
% 222.86/223.05  |- skos__altLabel mesh__D020246 Thrombosis, Deep Vein
% 222.86/223.05  |- skos__hiddenLabel mesh__D014209 Treponema Immobilization Tests
% 222.86/223.05  |- skos__scopeNote mesh__D014209
% 222.86/223.05       Syphilis serodiagnosis employing as the antigen Treponema pallidum obtained from rabbit syphilis orchitis. Treponemes are kept alive for a few hours in a special medium. When syphilitic serum and complement are added and incubated, the treponemes are immobilized, i.e., stop moving.%A%    
% 222.86/223.05  |- skos__hiddenLabel mesh__D014209 Tests, Treponema Immobilization
% 222.86/223.05  |- rdf__type mesh__D014209sskos__Concept
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D014209 2003
% 222.86/223.05  |- mesh__dateCreated mesh__D014209 1999-01-01
% 222.86/223.05  |- skos__prefLabel mesh__D014209 Treponema Immobilization Test
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D014209 2000
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D014209 2004
% 222.86/223.05  |- mesh__recordOriginator mesh__D014209 NLM
% 222.86/223.05  |- skos__hiddenLabel mesh__D014209 Immobilization Test, Treponema
% 222.86/223.05  |- skos__hiddenLabel mesh__D014209 Test, Treponema Immobilization
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D014209 2001
% 222.86/223.05  |- skos__hiddenLabel mesh__D014209 Immobilization Tests, Treponema
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D014209 2005
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D014209 1998
% 222.86/223.05  |- skos__broader mesh__D014209smesh__D013588
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D014209 2002
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D014209 2006
% 222.86/223.05  |- mesh__recordMaintainer mesh__D014209 PXP
% 222.86/223.05  |- mesh__recordAuthorizer mesh__D014209 SJN
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D014209 1999
% 222.86/223.05  |- mesh__dateRevised mesh__D014209 1997-06-20
% 222.86/223.05  |- skos__annotation mesh__D014209
% 222.86/223.05       also called Treponema Pallidum Immobilization %26% TPI   
% 222.86/223.05  |- skos__altLabel mesh__D002983 Skill, Clinical
% 222.86/223.05  |- skos__historyNote mesh__D002983
% 222.86/223.05       Educational Measurement %28%1966-1974%29%
% 222.86/223.05  |- rdf__type mesh__D002983sskos__Concept
% 222.86/223.05  |- skos__annotation mesh__D002983
% 222.86/223.05       competence in professional activities directly related to patient care: differentiate from PROFESSIONAL COMPETENCE which refers to competence not necessarily related to patient care; DF: CLIN COMPETENCE%A%  
% 222.86/223.05  |- skos__prefLabel mesh__D002983 Clinical Competence
% 222.86/223.05  |- skos__broader mesh__D002983smesh__D011361
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002983 1997
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002983 2002
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002983 2006
% 222.86/223.05  |- skos__scopeNote mesh__D002983
% 222.86/223.05       The capability to perform acceptably those duties directly related to patient care.%A%    
% 222.86/223.05  |- skos__altLabel mesh__D002983 Clinical Skills
% 222.86/223.05  |- mesh__dateCreated mesh__D002983 1974-11-11
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002983 2001
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002983 1996
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002983 1995
% 222.86/223.05  |- skos__altLabel mesh__D002983 Skills, Clinical
% 222.86/223.05  |- mesh__dateRevised mesh__D002983 1994-05-27
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002983 2005
% 222.86/223.05  |- mesh__recordOriginator mesh__D002983 NLM
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002983 2000
% 222.86/223.05  |- skos__altLabel mesh__D002983 Competence, Clinical
% 222.86/223.05  |- mesh__historyNote mesh__D002983 75   
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002983 2004
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002983 1999
% 222.86/223.05  |- mesh__publicMeSHNote mesh__D002983 75   
% 222.86/223.05  |- mesh__recordAuthorizer mesh__D002983 PLS
% 222.86/223.05  |- mesh__recordMaintainer mesh__D002983 JLS
% 222.86/223.05  |- mesh__dateEstablished mesh__D002983 1975-09-01
% 222.86/223.05  |- skos__broader mesh__D002983smesh__D011787
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002983 2003
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002983 1998
% 222.86/223.05  |- skos__historyNote mesh__D002185 Cannabis %28%1973-1974%29%
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002185 2005
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002185 2004
% 222.86/223.05  |- mesh__recordAuthorizer mesh__D002185 sjn
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002185 2001
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002185 2003
% 222.86/223.05  |- mesh__publicMeSHNote mesh__D002185
% 222.86/223.05       91; was see under CANNABINOIDS 1977-90; was see under CANNABIS 1975-76%A%  
% 222.86/223.05  |- mesh__dateRevised mesh__D002185 2000-06-22
% 222.86/223.05  |- skos__broader mesh__D002185smesh__D002186
% 222.86/223.05  |- mesh__recordOriginator mesh__D002185 NLM
% 222.86/223.05  |- rdf__type mesh__D002185sskos__Concept
% 222.86/223.05  |- skos__historyNote mesh__D002185 Terpenes %28%1973-1974%29%
% 222.86/223.05  |- skos__historyNote mesh__D002185 Resorcinols %28%1969-1974%29%
% 222.86/223.05  |- mesh__dateCreated mesh__D002185 1974-11-19
% 222.86/223.05  |- skos__scopeNote mesh__D002185
% 222.86/223.05       Compound isolated from Cannabis sativa extract.     
% 222.86/223.05  |- mesh__recordMaintainer mesh__D002185 CCR
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002185 2002
% 222.86/223.05  |- mesh__historyNote mesh__D002185
% 222.86/223.05       91%28%75%29%; was see under CANNABINOIDS 1977-90; was see under CANNABIS 1975-76%A%  
% 222.86/223.05  |- mesh__dateEstablished mesh__D002185 1991-01-01
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002185 2006
% 222.86/223.05  |- skos__prefLabel mesh__D002185 Cannabidiol
% 222.86/223.05  |- mesh__recordOriginator mesh__D010617 NLM
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010617 1998
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010617 2002
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010617 1997
% 222.86/223.05  |- mesh__dateCreated mesh__D010617 1999-01-01
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010617 1999
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010617 1994
% 222.86/223.05  |- mesh__dateEstablished mesh__D010617 1969-01-01
% 222.86/223.05  |- skos__broader mesh__D010617smesh__D006575
% 222.86/223.05  |- rdf__type mesh__D010617sskos__Concept
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010617 2000
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010617 1993
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010617 2003
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010617 2001
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010617 1995
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010617 2005
% 222.86/223.05  |- mesh__recordMaintainer mesh__D010617 TAP
% 222.86/223.05  |- mesh__dateRevised mesh__D010617 1992-05-19
% 222.86/223.05  |- mesh__historyNote mesh__D010617 69   
% 222.86/223.05  |- mesh__publicMeSHNote mesh__D010617 69   
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010617 2004
% 222.86/223.05  |- mesh__recordAuthorizer mesh__D010617 PLS
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010617 2006
% 222.86/223.05  |- skos__prefLabel mesh__D010617 Phenanthridines
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010617 1996
% 222.86/223.05  |- skos__broader mesh__D029322smesh__D002139
% 222.86/223.05  |- skos__scopeNote mesh__D029322
% 222.86/223.05       A genus in the family CALICIVIRIDAE, associated with epidemic GASTROENTERITIS in humans. The type species, NORWALK VIRUS, contains multiple strains.%A%    
% 222.86/223.05  |- mesh__publicMeSHNote mesh__D029322
% 222.86/223.05       2004; see NORWALK-LIKE VIRUSES 2002-2003; for SMALL ROUND-STRUCTURED VIRUSES see NORWALK VIRUS 1992-2001%A%  
% 222.86/223.05  |- mesh__dateCreated mesh__D029322 2001-07-25
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D029322 2005
% 222.86/223.05  |- skos__hiddenLabel mesh__D029322 Small Round Structured Viruses
% 222.86/223.05  |- skos__hiddenLabel mesh__D029322 Round-Structured Viruses, Small
% 222.86/223.05  |- mesh__recordOriginator mesh__D029322 ags
% 222.86/223.05  |- skos__hiddenLabel mesh__D029322 Noroviruses
% 222.86/223.05  |- skos__altLabel mesh__D029322 Norwalk-like Viruses
% 222.86/223.05  |- rdf__type mesh__D029322sskos__Concept
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D029322 2006
% 222.86/223.05  |- mesh__recordAuthorizer mesh__D029322 sjn
% 222.86/223.05  |- mesh__dateRevised mesh__D029322 2003-07-09
% 222.86/223.05  |- skos__hiddenLabel mesh__D029322 Norwalk like Viruses
% 222.86/223.05  |- skos__prefLabel mesh__D029322 Norovirus
% 222.86/223.05  |- skos__annotation mesh__D029322
% 222.86/223.05       infection: coord IM with CALICIVIRIDAE INFECTIONS + probably GASTROENTERITIS %28%IM%29%%A%  
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D029322 2004
% 222.86/223.05  |- mesh__recordMaintainer mesh__D029322 ags
% 222.86/223.05  |- mesh__historyNote mesh__D029322
% 222.86/223.05       2004 %28%2002%29%; for SMALL ROUND-STRUCTURED VIRUSES use NORWALK VIRUS 1992-2001%A%  
% 222.86/223.05  |- mesh__dateEstablished mesh__D029322 2002-01-01
% 222.86/223.05  |- skos__broader mesh__D015302smesh__D015301
% 222.86/223.05  |- mesh__dateRevised mesh__D015302 2005-11-10
% 222.86/223.05  |- skos__hiddenLabel mesh__D015302 Immunodeficiency Virus, Simian
% 222.86/223.05  |- skos__prefLabel mesh__D015302 Simian immunodeficiency virus
% 222.86/223.05  |- skos__altLabel mesh__D015302 Immunodeficiency Viruses, Simian
% 222.86/223.05  |- skos__historyNote mesh__D015302 Retroviridae %28%1978-1988%29%
% 222.86/223.05  |- mesh__dateEstablished mesh__D015302 1989-01-01
% 222.86/223.05  |- skos__altLabel mesh__D015302 SIV %28%Simian immunodeficiency virus%29%
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D015302 2006
% 222.86/223.05  |- skos__altLabel mesh__D015302 Simian Immunodeficiency Viruses
% 222.86/223.05  |- skos__scopeNote mesh__D015302
% 222.86/223.05       Species of the genus LENTIVIRUS, subgenus primate immunodeficiency viruses %28%IMMUNODEFICIENCY VIRUSES, PRIMATE%29%, that induces acquired immunodeficiency syndrome in monkeys and apes %28%SAIDS%29%. The genetic organization of SIV is virtually identical to HIV.%A%    
% 222.86/223.05  |- mesh__recordMaintainer mesh__D015302 ags
% 222.86/223.05  |- skos__historyNote mesh__D015302 Monkey Diseases %28%1978-1988%29%
% 222.86/223.05  |- mesh__publicMeSHNote mesh__D015302 2006; see SIV 1989-2005   
% 222.86/223.05  |- skos__broader mesh__D015302smesh__D017958
% 222.86/223.05  |- skos__annotation mesh__D015302
% 222.86/223.05       do not confuse SIV with swine influenza virus see INFLUENZA A VIRUS; infection = SAIDS often a model for AIDS%A%  
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D015302 2006A
% 222.86/223.05  |- mesh__recordAuthorizer mesh__D015302 ags
% 222.86/223.05  |- rdf__type mesh__D015302sskos__Concept
% 222.86/223.05  |- mesh__dateCreated mesh__D015302 1988-05-31
% 222.86/223.05  |- mesh__historyNote mesh__D015302 2006 %28%1989%29%   
% 222.86/223.05  |- mesh__recordOriginator mesh__D015302 EJB
% 222.86/223.05  |- skos__broader mesh__D002319Q000502smesh__D002319
% 222.86/223.05  |- mesh__preferredCombination mesh__D002319Q000502smesh__D002320
% 222.86/223.05  |- rdf__type mesh__D002319Q000502smesh__CompoundConcept
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D006576 2005
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D006576 2004
% 222.86/223.05  |- skos__scopeNote mesh__D006576
% 222.86/223.05       A class of organic compounds containing four or more ring structures, one of which is made up of more than one kind of atom, usually carbon plus another atom. The heterocycle may be either aromatic or nonaromatic.%A%    
% 222.86/223.05  |- mesh__dateCreated mesh__D006576 1999-01-01
% 222.86/223.05  |- skos__annotation mesh__D006576
% 222.86/223.05       GEN; prefer specifics; used for mapping supplementary chemicals%A%  
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D006576 2003
% 222.86/223.05  |- mesh__dateRevised mesh__D006576 1997-06-20
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D006576 1999
% 222.86/223.05  |- skos__prefLabel mesh__D006576
% 222.86/223.05       Heterocyclic Compounds with 4 or More Rings
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D006576 2001
% 222.86/223.05  |- mesh__recordOriginator mesh__D006576 NLM
% 222.86/223.05  |- skos__broader mesh__D006576smesh__D006571
% 222.86/223.05  |- mesh__recordMaintainer mesh__D006576 ADP
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D006576 1998
% 222.86/223.05  |- rdf__type mesh__D006576sskos__Concept
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D006576 2000
% 222.86/223.05  |- mesh__publicMeSHNote mesh__D006576 98   
% 222.86/223.05  |- skos__altLabel mesh__D006576 Heterocyclic Cpds, 4 or More Rings
% 222.86/223.05  |- mesh__dateEstablished mesh__D006576 1998-01-01
% 222.86/223.05  |- mesh__recordAuthorizer mesh__D006576 SJN
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D006576 2006
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D006576 2002
% 222.86/223.05  |- mesh__historyNote mesh__D006576 98; use explode 1967-97   
% 222.86/223.05  |- skos__scopeNote mesh__D020247
% 222.86/223.05       Training of the orofacial musculature, including modification of habits, in edentulous conditions, malocclusion, or temporomandibular joint disorders. %28%Dorland, 28th ed%29%%A%    
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D020247 2006
% 222.86/223.05  |- mesh__recordOriginator mesh__D020247 NDW
% 222.86/223.05  |- mesh__historyNote mesh__D020247 99   
% 222.86/223.05  |- skos__hiddenLabel mesh__D020247 Orofacial Myotherapies
% 222.86/223.05  |- skos__hiddenLabel mesh__D020247 Myofunctional Therapies
% 222.86/223.05  |- mesh__recordAuthorizer mesh__D020247 sjn
% 222.86/223.05  |- mesh__recordMaintainer mesh__D020247 lkt
% 222.86/223.05  |- skos__hiddenLabel mesh__D020247 Myotherapy, Oral
% 222.86/223.05  |- skos__hiddenLabel mesh__D020247 Myotherapy, Orofacial
% 222.86/223.05  |- skos__prefLabel mesh__D020247 Myofunctional Therapy
% 222.86/223.05  |- skos__hiddenLabel mesh__D020247 Myotherapies, Orofacial
% 222.86/223.05  |- mesh__dateCreated mesh__D020247 1998-06-10
% 222.86/223.05  |- mesh__dateRevised mesh__D020247 2005-06-30
% 222.86/223.05  |- skos__hiddenLabel mesh__D020247 Myotherapies, Oral
% 222.86/223.05  |- skos__hiddenLabel mesh__D020247 Therapy, Myofunctional
% 222.86/223.05  |- skos__hiddenLabel mesh__D020247 Oral Myotherapies
% 222.86/223.05  |- skos__hiddenLabel mesh__D020247 Therapies, Myofunctional
% 222.86/223.05  |- mesh__dateEstablished mesh__D020247 1999-01-01
% 222.86/223.05  |- rdf__type mesh__D020247sskos__Concept
% 222.86/223.05  |- skos__related mesh__D020247smesh__D005152
% 222.86/223.05  |- skos__broader mesh__D020247smesh__D026201
% 222.86/223.05  |- mesh__publicMeSHNote mesh__D020247 99   
% 222.86/223.05  |- skos__scopeNote mesh__D011710
% 222.86/223.05       Antibiotic pigment produced by Pseudomonas aeruginosa.     
% 222.86/223.05  |- mesh__publicMeSHNote mesh__D011710
% 222.86/223.05       91; was see under PHENAZINES 1975-90   
% 222.86/223.05  |- mesh__recordAuthorizer mesh__D011710 sjn
% 222.86/223.05  |- mesh__historyNote mesh__D011710
% 222.86/223.05       91%28%75%29%; was see under PHENAZINES 1975-90   
% 222.86/223.05  |- skos__historyNote mesh__D011710 Phenazines %28%1969-1974%29%
% 222.86/223.05  |- mesh__dateEstablished mesh__D011710 1991-01-01
% 222.86/223.05  |- skos__altLabel mesh__D011710 Pyocyanin
% 222.86/223.05  |- skos__broader mesh__D011710smesh__D010860
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D011710 2006
% 222.86/223.05  |- mesh__dateCreated mesh__D011710 1974-11-19
% 222.86/223.05  |- mesh__dateRevised mesh__D011710 2005-06-30
% 222.86/223.05  |- skos__broader mesh__D011710smesh__D010619
% 222.86/223.05  |- skos__prefLabel mesh__D011710 Pyocyanine
% 222.86/223.05  |- mesh__recordOriginator mesh__D011710 NLM
% 222.86/223.05  |- rdf__type mesh__D011710sskos__Concept
% 222.86/223.05  |- mesh__recordMaintainer mesh__D011710 ssb
% 222.86/223.05  |- mesh__recordAuthorizer mesh__D002984 PLS
% 222.86/223.05  |- mesh__dateCreated mesh__D002984 1986-06-17
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002984 2006
% 222.86/223.05  |- skos__broader mesh__D002984smesh__D008331
% 222.86/223.05  |- skos__hiddenLabel mesh__D002984 Systems, Laboratory Information
% 222.86/223.05  |- skos__broader mesh__D002984smesh__D007256
% 222.86/223.05  |- mesh__historyNote mesh__D002984
% 222.86/223.05       91%28%87%29%; was see under INFORMATION SYSTEMS 1987-90   
% 222.86/223.05  |- skos__altLabel mesh__D002984 Information Systems, Clinical Laboratory
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002984 1996
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002984 1995
% 222.86/223.05  |- skos__annotation mesh__D002984
% 222.86/223.05       DF: CLIN LABORATORY INFORMATION SYSTEMS   
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002984 2005
% 222.86/223.05  |- skos__hiddenLabel mesh__D002984 Information Systems, Laboratory
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002984 2002
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002984 1994
% 222.86/223.05  |- skos__prefLabel mesh__D002984 Clinical Laboratory Information Systems
% 222.86/223.05  |- mesh__publicMeSHNote mesh__D002984
% 222.86/223.05       91; was see under INFORMATION SYSTEMS 1987-90   
% 222.86/223.05  |- skos__altLabel mesh__D002984 Laboratory Information Systems
% 222.86/223.05  |- skos__broader mesh__D002984smesh__D006751
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002984 2004
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002984 1999
% 222.86/223.05  |- mesh__recordMaintainer mesh__D002984 PLS
% 222.86/223.05  |- skos__scopeNote mesh__D002984
% 222.86/223.05       Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative and clinical activities associated with the provision and utilization of clinical laboratory services.%A%    
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002984 2001
% 222.86/223.05  |- skos__hiddenLabel mesh__D002984 System, Laboratory Information
% 222.86/223.05  |- mesh__dateRevised mesh__D002984 1993-05-26
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002984 2003
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002984 1998
% 222.86/223.05  |- mesh__recordOriginator mesh__D002984 EC
% 222.86/223.05  |- rdf__type mesh__D002984sskos__Concept
% 222.86/223.05  |- skos__hiddenLabel mesh__D002984 Information System, Laboratory
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002984 2000
% 222.86/223.05  |- mesh__dateEstablished mesh__D002984 1991-01-01
% 222.86/223.05  |- skos__hiddenLabel mesh__D002984 Laboratory Information System
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002984 1997
% 222.86/223.05  |- skos__scopeNote mesh__D002186
% 222.86/223.05       Compounds having the cannabinoid structure. They were originally extracted from Cannabis sativa L. The most pharmacologically active constituents are TETRAHYDROCANNABINOL; CANNABINOL; and CANNABIDIOL.%A%    
% 222.86/223.05  |- skos__prefLabel mesh__D002186 Cannabinoids
% 222.86/223.05  |- mesh__dateRevised mesh__D002186 2003-07-09
% 222.86/223.05  |- mesh__publicMeSHNote mesh__D002186 77   
% 222.86/223.05  |- mesh__historyNote mesh__D002186 77   
% 222.86/223.05  |- skos__historyNote mesh__D002186 Cannabis %28%1966-1976%29%
% 222.86/223.05  |- rdf__type mesh__D002186sskos__Concept
% 222.86/223.05  |- mesh__recordAuthorizer mesh__D002186 sjn
% 222.86/223.05  |- skos__broader mesh__D002186smesh__D013729
% 222.86/223.05  |- skos__annotation mesh__D002186 endogenous list less /aa/defic   
% 222.86/223.05  |- mesh__dateEstablished mesh__D002186 1977-01-01
% 222.86/223.05  |- skos__related mesh__D002186smesh__D043883
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002186 2006
% 222.86/223.05  |- mesh__dateCreated mesh__D002186 1976-05-19
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002186 2005
% 222.86/223.05  |- mesh__recordOriginator mesh__D002186 RLS
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D002186 2004
% 222.86/223.05  |- skos__related mesh__D002186smesh__D043882
% 222.86/223.05  |- mesh__recordMaintainer mesh__D002186 jmp
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010618 2001
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010618 1994
% 222.86/223.05  |- skos__broader mesh__D010618smesh__D006575
% 222.86/223.05  |- rdf__type mesh__D010618sskos__Concept
% 222.86/223.05  |- mesh__recordMaintainer mesh__D010618 TAP
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010618 1993
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010618 2003
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010618 1995
% 222.86/223.05  |- mesh__recordAuthorizer mesh__D010618 PLS
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010618 2005
% 222.86/223.05  |- mesh__dateRevised mesh__D010618 1992-05-19
% 222.86/223.05  |- mesh__recordOriginator mesh__D010618 NLM
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010618 2004
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010618 2002
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010618 2006
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010618 1996
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010618 1998
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010618 1997
% 222.86/223.05  |- mesh__dateCreated mesh__D010618 1999-01-01
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010618 1999
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D010618 2000
% 222.86/223.05  |- skos__prefLabel mesh__D010618 Phenanthrolines
% 222.86/223.05  |- mesh__dateRevised mesh__D048288 2005-06-30
% 222.86/223.05  |- mesh__recordOriginator mesh__D048288 ssb
% 222.86/223.05  |- mesh__dateEstablished mesh__D048288 2005-01-01
% 222.86/223.05  |- mesh__historyNote mesh__D048288 2005   
% 222.86/223.05  |- skos__historyNote mesh__D048288 Imidazoles %28%1963-2004%29%
% 222.86/223.05  |- skos__broader mesh__D048288smesh__D007093
% 222.86/223.05  |- skos__scopeNote mesh__D048288
% 222.86/223.05       Compounds based on reduced IMIDAZOLES containing a single double bond.%A%    
% 222.86/223.05  |- mesh__activeMeSHYear mesh__D048288 2006
% 222.86/223.06  |- rdf__type mesh__D048288sskos__Concept
% 222.86/223.06  |- mesh__recordAuthorizer mesh__D048288 sjn
% 222.86/223.06  |- mesh__recordMaintainer mesh__D048288 ssb
% 222.86/223.06  |- skos__prefLabel mesh__D048288 Imidazolines
% 222.86/223.06  |- mesh__publicMeSHNote mesh__D048288 2005   
% 222.86/223.06  |- mesh__dateCreated mesh__D048288 2004-07-07
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D015303 2005
% 222.86/223.06  |- skos__scopeNote mesh__D015303
% 222.86/223.06       A strain of PRIMATE T-LYMPHOTROPIC VIRUS 2, closely related to the human HTLV-1 virus. The clinical, hematological, and histopathological characteristics of the disease in STLV-infected monkeys are very similar to those of human adult T-cell leukemia. Subgroups include the African green monkey subtype %28%STLV-I-AGM%29%, for which the nucleotide sequence is 95%25% homologous with that of  HUMAN T-LYMPHOTROPIC VIRUS 1, and the Asian rhesus macaque subtype %28%STLV-I-MM%29%, for which the nucleotide sequence is 90%25% homologous with that of  HUMAN T-LYMPHOTROPIC VIRUS 1.%A%    
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D015303 2006
% 222.86/223.06  |- mesh__recordOriginator mesh__D015303 EJB
% 222.86/223.06  |- skos__annotation mesh__D015303
% 222.86/223.06       infection: coord IM with DELTARETROVIRUS INFECTIONS %28%IM%29%   
% 222.86/223.06  |- mesh__recordAuthorizer mesh__D015303 sjn
% 222.86/223.06  |- skos__altLabel mesh__D015303 T Lymphotropic Virus, Type I, Simian
% 222.86/223.06  |- skos__altLabel mesh__D015303 STLV-I
% 222.86/223.06  |- skos__broader mesh__D015303smesh__D030261
% 222.86/223.06  |- skos__hiddenLabel mesh__D015303 Simian T lymphotropic virus 1
% 222.86/223.06  |- skos__historyNote mesh__D015303 Retroviridae %28%1978-1988%29%
% 222.86/223.06  |- mesh__recordMaintainer mesh__D015303 sjn
% 222.86/223.06  |- skos__historyNote mesh__D015303 Monkey Diseases %28%1978-1988%29%
% 222.86/223.06  |- mesh__dateEstablished mesh__D015303 1991-01-01
% 222.86/223.06  |- mesh__publicMeSHNote mesh__D015303
% 222.86/223.06       2002; see STLV 1994-2001, see STLV-I 1991-1993, see SIMIAN RETROVIRUSES 1989-1990%A%  
% 222.86/223.06  |- rdf__type mesh__D015303sskos__Concept
% 222.86/223.06  |- mesh__historyNote mesh__D015303
% 222.86/223.06       2002 %28%1989%29%; was STLV-I 1989-93 %28%see under SIMIAN RETROVIRUSES 1989-90%29%%A%  
% 222.86/223.06  |- skos__altLabel mesh__D015303 Simian T-Lymphotropic Virus Type I
% 222.86/223.06  |- skos__altLabel mesh__D015303 Simian T Lymphotropic Virus Type I
% 222.86/223.06  |- mesh__dateRevised mesh__D015303 2004-07-13
% 222.86/223.06  |- mesh__dateCreated mesh__D015303 1988-05-31
% 222.86/223.06  |- skos__broader mesh__D015303smesh__D015301
% 222.86/223.06  |- skos__altLabel mesh__D015303 STLV-1
% 222.86/223.06  |- skos__altLabel mesh__D015303 T-Lymphotropic Virus, Type I, Simian
% 222.86/223.06  |- skos__prefLabel mesh__D015303 Simian T-lymphotropic virus 1
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D006577 1998
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D006577 1997
% 222.86/223.06  |- skos__annotation mesh__D006577 GEN or unspecified: prefer specifics   
% 222.86/223.06  |- mesh__dateEstablished mesh__D006577 1975-01-01
% 222.86/223.06  |- rdf__type mesh__D006577sskos__Concept
% 222.86/223.06  |- mesh__dateRevised mesh__D006577 1996-06-10
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D006577 2002
% 222.86/223.06  |- mesh__recordMaintainer mesh__D006577 TGC
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D006577 2006
% 222.86/223.06  |- skos__historyNote mesh__D006577 Heterocyclic Compounds %28%1966-1974%29%
% 222.86/223.06  |- skos__hiddenLabel mesh__D006577 Oxides, Heterocyclic
% 222.86/223.06  |- skos__broader mesh__D006577smesh__D006571
% 222.86/223.06  |- skos__prefLabel mesh__D006577 Heterocyclic Oxides
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D006577 2005
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D006577 2004
% 222.86/223.06  |- skos__historyNote mesh__D006577 Oxides %28%1966-1974%29%
% 222.86/223.06  |- mesh__dateCreated mesh__D006577 1999-01-01
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D006577 2001
% 222.86/223.06  |- mesh__historyNote mesh__D006577 75   
% 222.86/223.06  |- mesh__recordOriginator mesh__D006577 NLM
% 222.86/223.06  |- mesh__recordAuthorizer mesh__D006577 PLS
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D006577 2003
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D006577 1999
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D006577 2000
% 222.86/223.06  |- mesh__publicMeSHNote mesh__D006577 75   
% 222.86/223.06  |- skos__scopeNote mesh__D006577
% 222.86/223.06       Oxides of a ring compound having atoms other than carbon in its ring.%A%    
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D011711 1994
% 222.86/223.06  |- mesh__dateRevised mesh__D011711 1992-05-22
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D011711 2006
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D011711 2001
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D011711 1998
% 222.86/223.06  |- mesh__recordOriginator mesh__D011711 NLM
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D011711 2004
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D011711 1995
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D011711 1996
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D011711 1993
% 222.86/223.06  |- mesh__recordAuthorizer mesh__D011711 PLS
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D011711 2002
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D011711 1999
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D011711 1997
% 222.86/223.06  |- mesh__recordMaintainer mesh__D011711 MXR
% 222.86/223.06  |- rdf__type mesh__D011711sskos__Concept
% 222.86/223.06  |- mesh__dateCreated mesh__D011711 1999-01-01
% 222.86/223.06  |- skos__broader mesh__D011711smesh__D012871
% 222.86/223.06  |- skos__prefLabel mesh__D011711 Pyoderma
% 222.86/223.06  |- skos__scopeNote mesh__D011711
% 222.86/223.06       Any purulent skin disease %28%Dorland, 27th ed%29%.     
% 222.86/223.06  |- skos__hiddenLabel mesh__D011711 Pyodermas
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D011711 2005
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D011711 2000
% 222.86/223.06  |- skos__annotation mesh__D011711
% 222.86/223.06       %22%any purulent skin dis%22% but do not make diagnoses: use term of text%A%  
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D011711 2003
% 222.86/223.06  |- mesh__recordMaintainer mesh__D002985 jmp
% 222.86/223.06  |- mesh__publicMeSHNote mesh__D002985 88   
% 222.86/223.06  |- mesh__historyNote mesh__D002985 88   
% 222.86/223.06  |- skos__altLabel mesh__D002985 Protocol, Clinical Research
% 222.86/223.06  |- skos__prefLabel mesh__D002985 Clinical Protocols
% 222.86/223.06  |- mesh__dateEstablished mesh__D002985 1988-01-01
% 222.86/223.06  |- mesh__recordAuthorizer mesh__D002985 sjn
% 222.86/223.06  |- mesh__dateCreated mesh__D002985 1987-04-30
% 222.86/223.06  |- skos__altLabel mesh__D002985 Protocols, Clinical Research
% 222.86/223.06  |- skos__related mesh__D002985smesh__D018579
% 222.86/223.06  |- skos__related mesh__D002985smesh__D017410
% 222.86/223.06  |- skos__altLabel mesh__D002985 Clinical Protocol
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002985 2006
% 222.86/223.06  |- mesh__dateRevised mesh__D002985 2001-07-25
% 222.86/223.06  |- skos__broader mesh__D002985smesh__D013812
% 222.86/223.06  |- skos__altLabel mesh__D002985 Clinical Research Protocols
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002985 2002
% 222.86/223.06  |- skos__annotation mesh__D002985
% 222.86/223.06       %22%precise %26% detailed plans for the study of a med or biomed problem%22% or %22%plans for a regimen of ther%22%; IM GEN only; do not use for cancer polychemother protocols %28% = ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS%29%; DF: CLIN PROTOCOLS%A%  
% 222.86/223.06  |- skos__related mesh__D002985smesh__D002986
% 222.86/223.06  |- skos__related mesh__D002985smesh__D010347
% 222.86/223.06  |- skos__altLabel mesh__D002985 Research Protocols, Clinical
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002985 2005
% 222.86/223.06  |- skos__broader mesh__D002985smesh__D016020
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002985 2004
% 222.86/223.06  |- skos__hiddenLabel mesh__D002985 Treatment Protocol
% 222.86/223.06  |- skos__related mesh__D002985smesh__D019091
% 222.86/223.06  |- skos__altLabel mesh__D002985 Protocols, Treatment
% 222.86/223.06  |- skos__altLabel mesh__D002985 Protocol, Clinical
% 222.86/223.06  |- rdf__type mesh__D002985sskos__Concept
% 222.86/223.06  |- mesh__recordOriginator mesh__D002985 EC
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002985 2003
% 222.86/223.06  |- skos__scopeNote mesh__D002985
% 222.86/223.06       Precise and detailed plans for the study of a medical or biomedical problem and/or plans for a regimen of therapy.%A%    
% 222.86/223.06  |- skos__altLabel mesh__D002985 Research Protocol, Clinical
% 222.86/223.06  |- skos__altLabel mesh__D002985 Protocols, Clinical
% 222.86/223.06  |- skos__hiddenLabel mesh__D035361 TFIIIB alpha
% 222.86/223.06  |- skos__hiddenLabel mesh__D035361 TFIIIB, Transcription Factor
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D035361 2006
% 222.86/223.06  |- skos__altLabel mesh__D035361 TFIIIB
% 222.86/223.06  |- skos__broader mesh__D035361smesh__D019474
% 222.86/223.06  |- skos__prefLabel mesh__D035361 Transcription Factor TFIIIB
% 222.86/223.06  |- mesh__dateEstablished mesh__D035361 2003-01-01
% 222.86/223.06  |- mesh__recordMaintainer mesh__D035361 ags
% 222.86/223.06  |- mesh__publicMeSHNote mesh__D035361
% 222.86/223.06       2003; TRANSCRIPTION FACTOR TFIIIB was indexed under TRANSCRIPTION FACTORS 1987-2002%A%  
% 222.86/223.06  |- mesh__recordOriginator mesh__D035361 jmp
% 222.86/223.06  |- mesh__recordAuthorizer mesh__D035361 ags
% 222.86/223.06  |- mesh__historyNote mesh__D035361
% 222.86/223.06       2003; use TRANSCRIPTION FACTOR TFIIIB %28%NM%29% 1987-2002   
% 222.86/223.06  |- skos__hiddenLabel mesh__D035361 Factor TFIIIB, Transcription
% 222.86/223.06  |- skos__altLabel mesh__D035361 Transcription Factor IIIB
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D035361 2006A
% 222.86/223.06  |- mesh__dateCreated mesh__D035361 2002-07-03
% 222.86/223.06  |- skos__hiddenLabel mesh__D035361 Factor IIIB, Transcription
% 222.86/223.06  |- rdf__type mesh__D035361sskos__Concept
% 222.86/223.06  |- skos__scopeNote mesh__D035361
% 222.86/223.06       One of several general transcription factors that are specific for RNA POLYMERASE III. TFIIIB recruits and positions pol III over the initiation site and remains stably bound to the DNA through multiple rounds of re-initiation by RNA POLYMERASE III.%A%    
% 222.86/223.06  |- skos__historyNote mesh__D035361 Transcription Factors %28%1987-2002%29%
% 222.86/223.06  |- mesh__dateRevised mesh__D035361 2005-07-28
% 222.86/223.06  |- mesh__recordAuthorizer mesh__D002187 PLS
% 222.86/223.06  |- mesh__dateEstablished mesh__D002187 1991-01-01
% 222.86/223.06  |- rdf__type mesh__D002187sskos__Concept
% 222.86/223.06  |- skos__prefLabel mesh__D002187 Cannabinol
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002187 1995
% 222.86/223.06  |- mesh__recordOriginator mesh__D002187 RLS
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002187 2005
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002187 1998
% 222.86/223.06  |- mesh__publicMeSHNote mesh__D002187
% 222.86/223.06       91; was see under CANNABINOIDS 1977-90   
% 222.86/223.06  |- mesh__dateCreated mesh__D002187 1976-05-21
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002187 2000
% 222.86/223.06  |- mesh__historyNote mesh__D002187
% 222.86/223.06       91%28%77%29%; was see under CANNABINOIDS 1977-90   
% 222.86/223.06  |- skos__scopeNote mesh__D002187
% 222.86/223.06       A physiologically inactive constituent of Cannabis sativa L.%A%    
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002187 2003
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002187 1996
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002187 2006
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002187 1999
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002187 2001
% 222.86/223.06  |- skos__historyNote mesh__D002187 Tetrahydrocannabinol %28%1975-1976%29%
% 222.86/223.06  |- mesh__dateRevised mesh__D002187 1994-05-24
% 222.86/223.06  |- skos__broader mesh__D002187smesh__D002186
% 222.86/223.06  |- skos__historyNote mesh__D002187 Cannabis %28%1966-1976%29%
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002187 2004
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002187 1997
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002187 2002
% 222.86/223.06  |- mesh__recordMaintainer mesh__D002187 TPW
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D010619 2003
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D010619 1995
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D010619 2005
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D010619 2000
% 222.86/223.06  |- mesh__dateRevised mesh__D010619 1992-05-19
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D010619 2004
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D010619 2001
% 222.86/223.06  |- mesh__recordMaintainer mesh__D010619 TAP
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D010619 2006
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D010619 1996
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D010619 1998
% 222.86/223.06  |- mesh__recordAuthorizer mesh__D010619 PLS
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D010619 1997
% 222.86/223.06  |- mesh__recordOriginator mesh__D010619 NLM
% 222.86/223.06  |- mesh__dateCreated mesh__D010619 1999-01-01
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D010619 2002
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D010619 1999
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D010619 1994
% 222.86/223.06  |- skos__broader mesh__D010619smesh__D006575
% 222.86/223.06  |- rdf__type mesh__D010619sskos__Concept
% 222.86/223.06  |- skos__prefLabel mesh__D010619 Phenazines
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D010619 1993
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D007670 2001
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D007670 2004
% 222.86/223.06  |- rdf__type mesh__D007670sskos__Concept
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D007670 2000
% 222.86/223.06  |- mesh__dateRevised mesh__D007670 1995-03-13
% 222.86/223.06  |- skos__scopeNote mesh__D007670
% 222.86/223.06       Recesses of the kidney pelvis which divides into two wide, cup-shaped major renal calices, with each major calix subdivided into 7 to 14 minor calices. Urine empties into a minor calix from collecting tubules, then passes through the major calix, renal pelvis, and ureter to enter the urinary bladder. %28%From Moore, Clinically Oriented Anatomy, 3d ed, p211%29%%A%    
% 222.86/223.06  |- skos__hiddenLabel mesh__D007670 Calices, Kidney
% 222.86/223.06  |- mesh__recordAuthorizer mesh__D007670 PLS
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D007670 2003
% 222.86/223.06  |- skos__hiddenLabel mesh__D007670 Kidney Calice
% 222.86/223.06  |- skos__annotation mesh__D007670 a part of the kidney pelvis   
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D007670 1999
% 222.86/223.06  |- skos__broader mesh__D007670smesh__D007682
% 222.86/223.06  |- mesh__onlineNote mesh__D007670 search KIDNEY PELVIS 1968-74   
% 222.86/223.06  |- skos__hiddenLabel mesh__D007670 Calice, Kidney
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D007670 1998
% 222.86/223.06  |- skos__prefLabel mesh__D007670 Kidney Calices
% 222.86/223.06  |- mesh__recordMaintainer mesh__D007670 TGC
% 222.86/223.06  |- mesh__dateEstablished mesh__D007670 1991-01-01
% 222.86/223.06  |- mesh__historyNote mesh__D007670
% 222.86/223.06       91%28%75%29%; was see under KIDNEY PELVIS 1975-90   
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D007670 2006
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D007670 1997
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D007670 2002
% 222.86/223.06  |- mesh__recordOriginator mesh__D007670 NLM
% 222.86/223.06  |- mesh__dateCreated mesh__D007670 1999-01-01
% 222.86/223.06  |- mesh__publicMeSHNote mesh__D007670
% 222.86/223.06       91; was see under KIDNEY PELVIS 1975-90   
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D007670 2005
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D007670 1996
% 222.86/223.06  |- mesh__recordAuthorizer mesh__D021341 sjn
% 222.86/223.06  |- mesh__historyNote mesh__D021341 2001   
% 222.86/223.06  |- skos__altLabel mesh__D021341 Type II Fish Antifreeze Proteins
% 222.86/223.06  |- skos__broader mesh__D021341smesh__D021301
% 222.86/223.06  |- skos__altLabel mesh__D021341 Fish Type II AFP
% 222.86/223.06  |- mesh__dateEstablished mesh__D021341 2001-01-01
% 222.86/223.06  |- mesh__recordMaintainer mesh__D021341 SYSTEM
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D021341 2006
% 222.86/223.06  |- skos__scopeNote mesh__D021341
% 222.86/223.06       A subclass of ANTIFREEZE PROTEINS that have a cystine-rich globular structure of approximately 14 kD.%A%    
% 222.86/223.06  |- skos__altLabel mesh__D021341 Type II Antifreeze Proteins
% 222.86/223.06  |- mesh__dateRevised mesh__D021341 2005-06-30
% 222.86/223.06  |- rdf__type mesh__D021341sskos__Concept
% 222.86/223.06  |- mesh__publicMeSHNote mesh__D021341 2001   
% 222.86/223.06  |- mesh__recordOriginator mesh__D021341 jmp
% 222.86/223.06  |- skos__prefLabel mesh__D021341 Antifreeze Proteins, Type II
% 222.86/223.06  |- mesh__dateCreated mesh__D021341 2000-06-21
% 222.86/223.06  |- skos__historyNote mesh__D048289 Imidazoles %28%1963-2004%29%
% 222.86/223.06  |- skos__broader mesh__D048289smesh__D007093
% 222.86/223.06  |- mesh__dateRevised mesh__D048289 2005-06-30
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D048289 2006
% 222.86/223.06  |- rdf__type mesh__D048289sskos__Concept
% 222.86/223.06  |- mesh__dateEstablished mesh__D048289 2005-01-01
% 222.86/223.06  |- mesh__historyNote mesh__D048289 2005   
% 222.86/223.06  |- mesh__publicMeSHNote mesh__D048289 2005   
% 222.86/223.06  |- mesh__dateCreated mesh__D048289 2004-07-07
% 222.86/223.06  |- mesh__recordAuthorizer mesh__D048289 sjn
% 222.86/223.06  |- skos__prefLabel mesh__D048289 Imidazolidines
% 222.86/223.06  |- mesh__recordOriginator mesh__D048289 ssb
% 222.86/223.06  |- mesh__recordMaintainer mesh__D048289 ssb
% 222.86/223.06  |- skos__scopeNote mesh__D048289
% 222.86/223.06       Compounds based on reduced IMIDAZOLINES which contain no double bonds in the ring.%A%    
% 222.86/223.06  |- skos__altLabel mesh__D006578 Yokogawa%27%s Fluke
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D006578 2006
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D006578 2004
% 222.86/223.06  |- mesh__historyNote mesh__D006578
% 222.86/223.06       82; HETEROPHYES was see under TREMATODA 1963-81; METAGONIMUS was heading 1963-81%A%  
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D006578 2005
% 222.86/223.06  |- skos__scopeNote mesh__D006578
% 222.86/223.06       A family of intestinal flukes of the class Trematoda which occurs in animals and man. Some of the genera are Heterophyes, Metagonimus, Cryptocotyle, Stellantchasmus, and Euryhelmis.%A%    
% 222.86/223.06  |- mesh__dateCreated mesh__D006578 1981-05-15
% 222.86/223.06  |- mesh__recordOriginator mesh__D006578 EC
% 222.86/223.06  |- skos__broader mesh__D006578smesh__D014200
% 222.86/223.06  |- skos__historyNote mesh__D006578 Trematoda %28%1966-1981%29%
% 222.86/223.06  |- mesh__dateRevised mesh__D006578 2003-07-09
% 222.86/223.06  |- skos__prefLabel mesh__D006578 Heterophyidae
% 222.86/223.06  |- mesh__onlineNote mesh__D006578
% 222.86/223.06       use HETEROPHYIDAE to search HETEROPHYES 1975-81 %26% METAGONIMUS 1966-81; use TREMATODA to search HETEROPHYES 1966-74%A%  
% 222.86/223.06  |- skos__annotation mesh__D006578
% 222.86/223.06       a family of trematodes; infection: coord IM with TREMATODE INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 222.86/223.06  |- rdf__type mesh__D006578sskos__Concept
% 222.86/223.06  |- mesh__dateEstablished mesh__D006578 1982-01-01
% 222.86/223.06  |- mesh__recordAuthorizer mesh__D006578 sjn
% 222.86/223.06  |- mesh__publicMeSHNote mesh__D006578
% 222.86/223.06       82; HETEROPHYES was see under TREMATODA 1963-81; METAGONIMUS was heading 1963-81%A%  
% 222.86/223.06  |- mesh__recordMaintainer mesh__D006578 ags
% 222.86/223.06  |- skos__altLabel mesh__D020249 Replacement Therapy, Hormone
% 222.86/223.06  |- skos__broader mesh__D020249smesh__D004358
% 222.86/223.06  |- skos__hiddenLabel mesh__D020249 Replacement Therapies, Hormone
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D020249 2002
% 222.86/223.06  |- mesh__dateCreated mesh__D020249 1998-06-10
% 222.86/223.06  |- mesh__dateEstablished mesh__D020249 1999-01-01
% 222.86/223.06  |- skos__scopeNote mesh__D020249
% 222.86/223.06       Therapeutic use of hormones to alleviate the effects of hormone deficiency.%A%    
% 222.86/223.06  |- rdf__type mesh__D020249sskos__Concept
% 222.86/223.06  |- mesh__publicMeSHNote mesh__D020249 99   
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D020249 2006
% 222.86/223.06  |- skos__prefLabel mesh__D020249 Hormone Replacement Therapy
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D020249 2001
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D020249 2004
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D020249 1999
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D020249 2000
% 222.86/223.06  |- skos__altLabel mesh__D020249 Therapy, Hormone Replacement
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D020249 2005
% 222.86/223.06  |- skos__hiddenLabel mesh__D020249 Hormone Replacement Therapies
% 222.86/223.06  |- mesh__historyNote mesh__D020249 99   
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D020249 2003
% 222.86/223.06  |- skos__historyNote mesh__D020249
% 222.86/223.06       Estrogen Replacement Therapy %28%1990-1998%29%
% 222.86/223.06  |- skos__annotation mesh__D020249
% 222.86/223.06       coord IM with specific hormone /ther use; ESTROGEN REPLACEMENT THERAPY is also available%A%  
% 222.86/223.06  |- skos__hiddenLabel mesh__D020249 Therapies, Hormone Replacement
% 222.86/223.06  |- rdf__type mesh__D003280sskos__Concept
% 222.86/223.06  |- mesh__recordAuthorizer mesh__D003280 sjn
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D003280 2004
% 222.86/223.06  |- mesh__dateCreated mesh__D003280 1999-01-01
% 222.86/223.06  |- mesh__recordOriginator mesh__D003280 NLM
% 222.86/223.06  |- mesh__recordMaintainer mesh__D003280 lkt
% 222.86/223.06  |- skos__prefLabel mesh__D003280 Contraceptives, Oral, Synthetic
% 222.86/223.06  |- skos__broader mesh__D003280smesh__D003276
% 222.86/223.06  |- mesh__publicMeSHNote mesh__D003280
% 222.86/223.06       86; was see under CONTRACEPTIVES, ORAL 1975-85   
% 222.86/223.06  |- mesh__historyNote mesh__D003280
% 222.86/223.06       86%28%75%29%; was see under CONTRACEPTIVES, ORAL 1975-85   
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D003280 2005
% 222.86/223.06  |- mesh__dateRevised mesh__D003280 2003-07-09
% 222.86/223.06  |- skos__scopeNote mesh__D003280
% 222.86/223.06       Oral contraceptives which owe their effectiveness to synthetic preparations.%A%    
% 222.86/223.06  |- mesh__dateEstablished mesh__D003280 1986-01-01
% 222.86/223.06  |- skos__annotation mesh__D003280
% 222.86/223.06       pregn despite use: see note on CONTRACEPTIVE AGENTS; DF: CONTRACEPTIVES ORAL SYN%A%  
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D003280 2006
% 222.86/223.06  |- skos__hiddenLabel mesh__D011712 Pyramidal Tract
% 222.86/223.06  |- skos__prefLabel mesh__D011712 Pyramidal Tracts
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D011712 2000
% 222.86/223.06  |- skos__broader mesh__D011712smesh__D004525
% 222.86/223.06  |- skos__hiddenLabel mesh__D011712 Corticobulbar Tract
% 222.86/223.06  |- rdf__type mesh__D011712sskos__Concept
% 222.86/223.06  |- mesh__recordMaintainer mesh__D011712 ags
% 222.86/223.06  |- skos__hiddenLabel mesh__D011712 Tract, Corticobulbar
% 222.86/223.06  |- skos__hiddenLabel mesh__D011712 Corticospinal Tract
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D011712 2001
% 222.86/223.06  |- mesh__dateCreated mesh__D011712 1999-01-01
% 222.86/223.06  |- mesh__recordOriginator mesh__D011712 NLM
% 222.86/223.06  |- skos__broader mesh__D011712smesh__D013116
% 222.86/223.06  |- skos__scopeNote mesh__D011712
% 222.86/223.06       Fibers that arise from cells within the cerebral cortex, pass through the medullary pyramid, and descend in the spinal cord. Many authorities say the pyramidal tracts include both the corticospinal and corticobulbar tracts.%A%    
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D011712 2002
% 222.86/223.06  |- skos__hiddenLabel mesh__D011712 Tracts, Corticospinal
% 222.86/223.06  |- skos__hiddenLabel mesh__D011712 Pyramidal Decussation
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D011712 2005
% 222.86/223.06  |- mesh__dateRevised mesh__D011712 1999-11-03
% 222.86/223.06  |- skos__hiddenLabel mesh__D011712 Tracts, Corticobulbar
% 222.86/223.06  |- skos__hiddenLabel mesh__D011712 Tract, Corticospinal
% 222.86/223.06  |- mesh__recordAuthorizer mesh__D011712 sjn
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D011712 2003
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D011712 2006
% 222.86/223.06  |- skos__hiddenLabel mesh__D011712 Tracts, Pyramidal
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D011712 2004
% 222.86/223.06  |- skos__hiddenLabel mesh__D011712 Tract, Pyramidal
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002986 2005
% 222.86/223.06  |- mesh__publicMeSHNote mesh__D002986 80   
% 222.86/223.06  |- mesh__dateRevised mesh__D002986 2002-07-03
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002986 2004
% 222.86/223.06  |- mesh__onlineNote mesh__D002986
% 222.86/223.06       use CLINICAL TRIALS to search CLINICAL RESEARCH 1966-79   
% 222.86/223.06  |- skos__related mesh__D002986smesh__D026661
% 222.86/223.06  |- skos__related mesh__D002986smesh__D035703
% 222.86/223.06  |- skos__hiddenLabel mesh__D002986 Trials, Clinical
% 222.86/223.06  |- rdf__type mesh__D002986sskos__Concept
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002986 2003
% 222.86/223.06  |- mesh__dateCreated mesh__D002986 1979-05-30
% 222.86/223.06  |- skos__prefLabel mesh__D002986 Clinical Trials
% 222.86/223.06  |- skos__related mesh__D002986smesh__D017277
% 222.86/223.06  |- skos__historyNote mesh__D002986 Drug Evaluation %28%1974-1979%29%
% 222.86/223.06  |- skos__related mesh__D002986smesh__D015201
% 222.86/223.06  |- skos__scopeNote mesh__D002986
% 222.86/223.06       Pre-planned studies of the safety, efficacy, or optimum dosage schedule %28%if appropriate%29% of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.%A%    
% 222.86/223.06  |- mesh__recordAuthorizer mesh__D002986 sjn
% 222.86/223.06  |- mesh__recordOriginator mesh__D002986 SMH
% 222.86/223.06  |- skos__broader mesh__D002986smesh__D005069
% 222.86/223.06  |- skos__annotation mesh__D002986
% 222.86/223.06       human %26% vet animals only; GEN or unspecified as to phase: index under specific phase %28%as CLINICAL TRIALS, PHASE I%29% instead if pertinent; IM for articles %26% books about clin trials as a method in med research; do not confuse with Publication Type CLINICAL TRIAL; do not index also under PLACEBOS unless placebos are particularly discussed; Manual 26.26+; CONTROLLED CLINICAL TRIALS %26% RANDOMIZED CONTROLLED TRIALS are also available; DF: CLIN TRIALS%A%  
% 222.86/223.06  |- skos__broader mesh__D002986smesh__D016020
% 222.86/223.06  |- mesh__dateEstablished mesh__D002986 1980-01-01
% 222.86/223.06  |- mesh__recordMaintainer mesh__D002986 hjn
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002986 2006
% 222.86/223.06  |- mesh__historyNote mesh__D002986
% 222.86/223.06       80; for articles that were clinical trials 1980-90; CLINICAL RESEARCH was check tag 1965-79%A%  
% 222.86/223.06  |- mesh__dateCreated mesh__D035362 2002-07-03
% 222.86/223.06  |- skos__scopeNote mesh__D035362
% 222.86/223.06       The major sequence-specific DNA-binding component involved in the activation of transcription of RNA POLYMERASE II. It was originally described as a complex of TATA-BOX BINDING PROTEIN and TATA-BINDING PROTEIN ASSOCIATED FACTORS. It is now know that TATA BOX BINDING PROTEIN-LIKE PROTEINS may take the place of TATA-box binding protein in the complex.%A%    
% 222.86/223.06  |- mesh__historyNote mesh__D035362
% 222.86/223.06       2003; use TRANSCRIPTION FACTOR TFIID %28%NM%29% 1988-2002   
% 222.86/223.06  |- skos__altLabel mesh__D035362 TFIID
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D035362 2006
% 222.86/223.06  |- skos__altLabel mesh__D035362 RNA Polymerase II Transcription Factor D
% 222.86/223.06  |- mesh__recordMaintainer mesh__D035362 ags
% 222.86/223.06  |- skos__prefLabel mesh__D035362 Transcription Factor TFIID
% 222.86/223.06  |- mesh__dateRevised mesh__D035362 2005-06-30
% 222.86/223.06  |- skos__historyNote mesh__D035362
% 222.86/223.06       Transcription Factor TFIID %28%1999-2002%29%
% 222.86/223.06  |- mesh__recordAuthorizer mesh__D035362 sjn
% 222.86/223.06  |- mesh__publicMeSHNote mesh__D035362
% 222.86/223.06       2003; TRANSCRIPTION FACTOR TFIID was indexed under TRANSCRIPTION FACTORS, TFII 1998-2002, TRANSCRIPTION FACTORS 1999-2002%A%  
% 222.86/223.06  |- mesh__dateEstablished mesh__D035362 2003-01-01
% 222.86/223.06  |- skos__broader mesh__D035362smesh__D019473
% 222.86/223.06  |- rdf__type mesh__D035362sskos__Concept
% 222.86/223.06  |- mesh__recordOriginator mesh__D035362 jmp
% 222.86/223.06  |- skos__historyNote mesh__D035362 Transcription Factors %28%1988-1998%29%
% 222.86/223.06  |- skos__altLabel mesh__D035362 Transcription Factor IID
% 222.86/223.06  |- rdf__type mesh__D002188sskos__Concept
% 222.86/223.06  |- skos__altLabel mesh__D002188 Hemp Plant
% 222.86/223.06  |- mesh__recordMaintainer mesh__D002188 ssb
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002188 2002
% 222.86/223.06  |- mesh__recordOriginator mesh__D002188 NLM
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002188 2005
% 222.86/223.06  |- mesh__dateRevised mesh__D002188 2001-07-25
% 222.86/223.06  |- skos__broader mesh__D002188smesh__D027581
% 222.86/223.06  |- skos__annotation mesh__D002188
% 222.86/223.06       plant only; X ref HEMP refers to commercial fiber; note X refs for names of preparations derived from the plant; for chemicals derived from CANNABIS, consider CANNABINOIDS; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.86/223.06  |- skos__related mesh__D002188smesh__D002186
% 222.86/223.06  |- skos__related mesh__D002188smesh__D008385
% 222.86/223.06  |- skos__related mesh__D002188smesh__D002189
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002188 2003
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002188 2006
% 222.86/223.06  |- skos__scopeNote mesh__D002188
% 222.86/223.06       The plant genus in the Cannabaceae plant family, Urticales order, Hamamelidae subclass. The flowering tops are called many slang terms including pot, marijuana, hashish, bhang, and ganja.  The stem is an important source of hemp fiber.%A%    
% 222.86/223.06  |- mesh__historyNote mesh__D002188 was in Cat B %26% D 1963-76   
% 222.86/223.06  |- mesh__activeMeSHYear mesh__D002188 2004
% 222.86/223.06  |- skos__altLabel mesh__D002188 Marijuana
% 222.86/223.06  |- skos__prefLabel mesh__D002188 Cannabis
% 222.86/223.06  |- mesh__recordAuthorizer mesh__D002188 sjn
% 222.86/223.06  |- mesh__dateCreated mesh__D002188 1999-01-01
% 222.86/223.06  |- mesh__recordOriginator mesh__D007671 NLM
% 222.86/223.06  |- skos__hiddenLabel mesh__D007671 Concentrating Abilities, Kidney
% 222.86/223.06  |- skos__broader mesh__D007671smesh__D014553
% 222.86/223.06  |- mesh__publicMeSHNote mesh__D007671 70   
% 222.86/223.07  |- skos__hiddenLabel mesh__D007671 Abilities, Kidney Concentrating
% 222.86/223.07  |- skos__scopeNote mesh__D007671
% 222.86/223.07       The ability of the kidney to excrete in the urine high concentrations of solutes from the blood plasma.%A%    
% 222.86/223.07  |- mesh__recordMaintainer mesh__D007671 lkt
% 222.86/223.07  |- skos__hiddenLabel mesh__D007671 Ability, Kidney Concentrating
% 222.86/223.07  |- mesh__dateEstablished mesh__D007671 1970-01-01
% 222.86/223.07  |- skos__altLabel mesh__D007671 Urine Concentrating Ability
% 222.86/223.07  |- skos__hiddenLabel mesh__D007671 Concentrating Abilities, Urine
% 222.86/223.07  |- skos__hiddenLabel mesh__D007671 Kidney Concentrating Abilities
% 222.86/223.07  |- skos__hiddenLabel mesh__D007671 Concentrating Ability, Kidney
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007671 2006
% 222.86/223.07  |- skos__hiddenLabel mesh__D007671 Urine Concentrating Abilities
% 222.86/223.07  |- skos__hiddenLabel mesh__D007671 Concentrating Ability, Urine
% 222.86/223.07  |- skos__hiddenLabel mesh__D007671 Ability, Urine Concentrating
% 222.86/223.07  |- mesh__historyNote mesh__D007671 70%28%67%29%   
% 222.86/223.07  |- mesh__recordAuthorizer mesh__D007671 sjn
% 222.86/223.07  |- mesh__dateCreated mesh__D007671 1999-01-01
% 222.86/223.07  |- mesh__dateRevised mesh__D007671 2004-07-07
% 222.86/223.07  |- skos__historyNote mesh__D007671 Kidney/physiology %28%1966%29%
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007671 2005
% 222.86/223.07  |- skos__hiddenLabel mesh__D007671 Abilities, Urine Concentrating
% 222.86/223.07  |- skos__prefLabel mesh__D007671 Kidney Concentrating Ability
% 222.86/223.07  |- rdf__type mesh__D007671sskos__Concept
% 222.86/223.07  |- skos__historyNote mesh__D045790 Mycoplasma %28%1966-2003%29%
% 222.86/223.07  |- mesh__dateCreated mesh__D045790 2003-07-09
% 222.86/223.07  |- skos__scopeNote mesh__D045790
% 222.86/223.07       A species of gram-negative bacteria and a common inhabitant of the NASAL CAVITY of both healthy and diseased PIGS. It is a common secondary invader in MYCOPLASMAL PNEUMONIA OF SWINE.%A%    
% 222.86/223.07  |- skos__broader mesh__D045790smesh__D009174
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D045790 2006
% 222.86/223.07  |- rdf__type mesh__D045790sskos__Concept
% 222.86/223.07  |- mesh__recordMaintainer mesh__D045790 SYSTEM
% 222.86/223.07  |- mesh__recordAuthorizer mesh__D045790 sjn
% 222.86/223.07  |- skos__annotation mesh__D045790
% 222.86/223.07       infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29%   
% 222.86/223.07  |- mesh__publicMeSHNote mesh__D045790 2004   
% 222.86/223.07  |- mesh__dateEstablished mesh__D045790 2004-01-01
% 222.86/223.07  |- mesh__historyNote mesh__D045790 2004   
% 222.86/223.07  |- mesh__dateRevised mesh__D045790 2005-06-30
% 222.86/223.07  |- mesh__recordOriginator mesh__D045790 ags
% 222.86/223.07  |- skos__prefLabel mesh__D045790 Mycoplasma hyorhinis
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D006579 2005
% 222.86/223.07  |- mesh__dateCreated mesh__D006579 1999-01-01
% 222.86/223.07  |- skos__hiddenLabel mesh__D006579 Heterozygotes
% 222.86/223.07  |- mesh__historyNote mesh__D006579 68   
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D006579 2006
% 222.86/223.07  |- skos__altLabel mesh__D006579 Carriers, Genetic
% 222.86/223.07  |- skos__prefLabel mesh__D006579 Heterozygote
% 222.86/223.07  |- skos__related mesh__D006579smesh__D006580
% 222.86/223.07  |- mesh__recordAuthorizer mesh__D006579 sjn
% 222.86/223.07  |- mesh__recordOriginator mesh__D006579 NLM
% 222.86/223.07  |- mesh__dateEstablished mesh__D006579 1968-01-01
% 222.86/223.07  |- skos__scopeNote mesh__D006579
% 222.86/223.07       An individual having different alleles at one or more loci regarding a specific character.%A%    
% 222.86/223.07  |- skos__historyNote mesh__D006579 Genetics %28%1966-1967%29%
% 222.86/223.07  |- mesh__publicMeSHNote mesh__D006579 68   
% 222.86/223.07  |- skos__hiddenLabel mesh__D006579 Carrier, Genetic
% 222.86/223.07  |- skos__historyNote mesh__D006579 Genes %28%1966-1967%29%
% 222.86/223.07  |- skos__broader mesh__D006579smesh__D005838
% 222.86/223.07  |- skos__hiddenLabel mesh__D006579 Genetic Carrier
% 222.86/223.07  |- mesh__dateRevised mesh__D006579 2004-07-07
% 222.86/223.07  |- mesh__recordMaintainer mesh__D006579 ags
% 222.86/223.07  |- rdf__type mesh__D006579sskos__Concept
% 222.86/223.07  |- mesh__dateCreated mesh__D003281 1999-01-01
% 222.86/223.07  |- skos__hiddenLabel mesh__D003281 Contraceptive Agents, Post Coital
% 222.86/223.07  |- skos__prefLabel mesh__D003281 Contraceptives, Postcoital
% 222.86/223.07  |- skos__broader mesh__D003281smesh__D003271
% 222.86/223.07  |- skos__historyNote mesh__D003281 Contraceptive Agents %28%1967-1970%29%
% 222.86/223.07  |- mesh__publicMeSHNote mesh__D003281 73   
% 222.86/223.07  |- skos__hiddenLabel mesh__D003281 Post-Coital Contraceptive Agents
% 222.86/223.07  |- skos__historyNote mesh__D003281 Contraceptives, Oral %28%1966-1970%29%
% 222.86/223.07  |- mesh__dateEstablished mesh__D003281 1973-01-01
% 222.86/223.07  |- skos__related mesh__D003281smesh__D044363
% 222.86/223.07  |- skos__hiddenLabel mesh__D003281 Agents, Post-Coital Contraceptive
% 222.86/223.07  |- mesh__recordAuthorizer mesh__D003281 sjn
% 222.86/223.07  |- skos__hiddenLabel mesh__D003281 Contraceptives, Post Coital
% 222.86/223.07  |- skos__altLabel mesh__D003281 Contraceptive Agents, Post-Coital
% 222.86/223.07  |- skos__altLabel mesh__D003281 Contraceptive Agents, Postcoital
% 222.86/223.07  |- skos__altLabel mesh__D003281 Contraceptives, Post-Coital
% 222.86/223.07  |- skos__scopeNote mesh__D003281
% 222.86/223.07       Contraceptive substances to be used after COITUS. These agents include high doses of estrogenic drugs, progesterone-receptor blockers, antimetabolites, ALKALOIDS, and PROSTAGLANDINS.%A%    
% 222.86/223.07  |- skos__hiddenLabel mesh__D003281 Postcoital Contraceptive Agents
% 222.86/223.07  |- mesh__recordOriginator mesh__D003281 NLM
% 222.86/223.07  |- skos__hiddenLabel mesh__D003281 Pill, Morning-After
% 222.86/223.07  |- mesh__historyNote mesh__D003281
% 222.86/223.07       73%28%71%29%; MORNING AFTER PILL was see under CONTRACEPTIVES, POSTCOITAL 1973-83%A%  
% 222.86/223.07  |- skos__annotation mesh__D003281
% 222.86/223.07       pregn despite use = contraceptive term with no qualify, not with /adv eff%A%  
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D003281 2006
% 222.86/223.07  |- skos__hiddenLabel mesh__D003281 Morning After Pill
% 222.86/223.07  |- mesh__dateRevised mesh__D003281 2005-06-30
% 222.86/223.07  |- skos__hiddenLabel mesh__D003281 Agents, Postcoital Contraceptive
% 222.86/223.07  |- mesh__recordMaintainer mesh__D003281 ssb
% 222.86/223.07  |- skos__hiddenLabel mesh__D003281 Post-Coital Contraceptives
% 222.86/223.07  |- rdf__type mesh__D003281sskos__Concept
% 222.86/223.07  |- skos__altLabel mesh__D003281 Postcoital Contraceptives
% 222.86/223.07  |- skos__altLabel mesh__D011713 Divinyl Ether Maleic Anhydride Copolymer
% 222.86/223.07  |- mesh__dateEstablished mesh__D011713 1991-01-01
% 222.86/223.07  |- skos__hiddenLabel mesh__D011713 NSC 46015
% 222.86/223.07  |- skos__altLabel mesh__D011713 Vinyl Ether Maleic Anhydride Polymer
% 222.86/223.07  |- skos__hiddenLabel mesh__D011713 MVE 5
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D011713 2006
% 222.86/223.07  |- mesh__recordAuthorizer mesh__D011713 sjn
% 222.86/223.07  |- mesh__publicMeSHNote mesh__D011713 91; was see under POLYMERS 1975-90   
% 222.86/223.07  |- skos__historyNote mesh__D011713 Furans %28%1974%29%
% 222.86/223.07  |- mesh__dateCreated mesh__D011713 1974-11-19
% 222.86/223.07  |- mesh__historyNote mesh__D011713
% 222.86/223.07       91%28%75%29%; was see under POLYMERS 1975-90   
% 222.86/223.07  |- skos__annotation mesh__D011713 D25-26 qualif   
% 222.86/223.07  |- skos__altLabel mesh__D011713 DIVEMA
% 222.86/223.07  |- rdf__type mesh__D011713sskos__Concept
% 222.86/223.07  |- skos__scopeNote mesh__D011713
% 222.86/223.07       Copolymer of divinyl ether and maleic anhydride that acts as an immunostimulant with antineoplastic and anti-infective properties. It is used in combination with other antineoplastic agents.%A%    
% 222.86/223.07  |- mesh__recordMaintainer mesh__D011713 ssb
% 222.86/223.07  |- skos__broader mesh__D011713smesh__D011108
% 222.86/223.07  |- mesh__dateRevised mesh__D011713 2005-06-30
% 222.86/223.07  |- skos__altLabel mesh__D011713 Maleic Anhydride Vinyl Ether
% 222.86/223.07  |- skos__hiddenLabel mesh__D011713 Copolymer, Pyran
% 222.86/223.07  |- skos__hiddenLabel mesh__D011713 MVE 2
% 222.86/223.07  |- skos__broader mesh__D011713smesh__D011714
% 222.86/223.07  |- skos__prefLabel mesh__D011713 Pyran Copolymer
% 222.86/223.07  |- skos__hiddenLabel mesh__D011713 NSC46015
% 222.86/223.07  |- skos__historyNote mesh__D011713 Polymers %28%1974%29%
% 222.86/223.07  |- mesh__recordOriginator mesh__D011713 NLM
% 222.86/223.07  |- skos__altLabel mesh__D011713 Maleic Anhydride Divinyl Ether
% 222.86/223.07  |- skos__historyNote mesh__D011713 Pyrans %28%1974%29%
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002987 2004
% 222.86/223.07  |- rdf__type mesh__D002987sskos__Concept
% 222.86/223.07  |- mesh__dateCreated mesh__D002987 1999-01-01
% 222.86/223.07  |- mesh__recordMaintainer mesh__D002987 mdb
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002987 2003
% 222.86/223.07  |- mesh__recordOriginator mesh__D002987 NLM
% 222.86/223.07  |- skos__prefLabel mesh__D002987 Clitoris
% 222.86/223.07  |- skos__broader mesh__D002987smesh__D014844
% 222.86/223.07  |- mesh__dateRevised mesh__D002987 2002-07-03
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002987 2006
% 222.86/223.07  |- mesh__recordAuthorizer mesh__D002987 sjn
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002987 2005
% 222.86/223.07  |- skos__hiddenLabel mesh__D002189 Dependence, Cannabis
% 222.86/223.07  |- mesh__recordMaintainer mesh__D002189 adp
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002189 2006
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002189 2003
% 222.86/223.07  |- skos__hiddenLabel mesh__D002189 Cannabis Related Disorder
% 222.86/223.07  |- skos__hiddenLabel mesh__D002189 Dependence, Marijuana
% 222.86/223.07  |- skos__hiddenLabel mesh__D002189 Abuse, Hashish
% 222.86/223.07  |- mesh__dateEstablished mesh__D002189 1981-01-01
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002189 2000
% 222.86/223.07  |- mesh__publicMeSHNote mesh__D002189 90; was CANNABIS ABUSE 1981-89   
% 222.86/223.07  |- mesh__recordOriginator mesh__D002189 EC
% 222.86/223.07  |- skos__prefLabel mesh__D002189 Marijuana Abuse
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002189 2004
% 222.86/223.07  |- mesh__recordAuthorizer mesh__D002189 sjn
% 222.86/223.07  |- skos__historyNote mesh__D002189 Substance Abuse %28%1968-1980%29%
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002189 2001
% 222.86/223.07  |- mesh__dateRevised mesh__D002189 1999-11-04
% 222.86/223.07  |- skos__altLabel mesh__D002189 Marijuana Dependence
% 222.86/223.07  |- skos__hiddenLabel mesh__D002189 Abuse, Marijuana
% 222.86/223.07  |- mesh__historyNote mesh__D002189 90; was CANNABIS ABUSE 1981-89   
% 222.86/223.07  |- skos__scopeNote mesh__D002189
% 222.86/223.07       The excessive use of marijuana with associated psychological symptoms and impairment in social or occupational functioning.%A%    
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002189 2002
% 222.86/223.07  |- mesh__dateCreated mesh__D002189 1980-05-21
% 222.86/223.07  |- skos__hiddenLabel mesh__D002189 Abuse, Cannabis
% 222.86/223.07  |- rdf__type mesh__D002189sskos__Concept
% 222.86/223.07  |- skos__altLabel mesh__D002189 Marihuana Abuse
% 222.86/223.07  |- mesh__onlineNote mesh__D002189
% 222.86/223.07       use MARIJUANA ABUSE to search CANNABIS ABUSE 1981-89   
% 222.86/223.07  |- skos__broader mesh__D002189smesh__D019966
% 222.86/223.07  |- skos__historyNote mesh__D002189 Cannabis %28%1966-1980%29%
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002189 2005
% 222.86/223.07  |- skos__annotation mesh__D002189 see note on CANNABIS   
% 222.86/223.07  |- skos__hiddenLabel mesh__D002189 Disorder, Cannabis-Related
% 222.86/223.07  |- skos__hiddenLabel mesh__D002189 Abuse, Marihuana
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007672 2002
% 222.86/223.07  |- skos__scopeNote mesh__D007672
% 222.86/223.07       The outer zone of the KIDNEY, beneath the capsule, consisting of KIDNEY GLOMERULUS; KIDNEY TUBULES, DISTAL; and KIDNEY TUBULES, PROXIMAL.%A%    
% 222.86/223.07  |- mesh__recordAuthorizer mesh__D007672 sjn
% 222.86/223.07  |- mesh__dateCreated mesh__D007672 1999-01-01
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007672 2005
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007672 2000
% 222.86/223.07  |- mesh__publicMeSHNote mesh__D007672 74   
% 222.86/223.07  |- mesh__dateEstablished mesh__D007672 1974-01-01
% 222.86/223.07  |- mesh__recordOriginator mesh__D007672 NLM
% 222.86/223.07  |- skos__broader mesh__D007672smesh__D007668
% 222.86/223.07  |- skos__prefLabel mesh__D007672 Kidney Cortex
% 222.86/223.07  |- mesh__dateRevised mesh__D007672 1999-11-03
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007672 2006
% 222.86/223.07  |- mesh__historyNote mesh__D007672 74%28%73%29%   
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007672 2001
% 222.86/223.07  |- mesh__recordMaintainer mesh__D007672 KEV
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007672 2003
% 222.86/223.07  |- skos__historyNote mesh__D007672 Kidney %28%1966-1972%29%
% 222.86/223.07  |- skos__hiddenLabel mesh__D007672 Cortex, Kidney
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007672 2004
% 222.86/223.07  |- rdf__type mesh__D007672sskos__Concept
% 222.86/223.07  |- mesh__publicMeSHNote mesh__D021343 2001   
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D021343 2006
% 222.86/223.07  |- skos__altLabel mesh__D021343 Type III Antifreeze Proteins
% 222.86/223.07  |- skos__altLabel mesh__D021343 Type III Fish Antifreeze Proteins
% 222.86/223.07  |- mesh__dateRevised mesh__D021343 2005-06-30
% 222.86/223.07  |- skos__broader mesh__D021343smesh__D021301
% 222.86/223.07  |- mesh__recordOriginator mesh__D021343 jmp
% 222.86/223.07  |- rdf__type mesh__D021343sskos__Concept
% 222.86/223.07  |- mesh__dateCreated mesh__D021343 2000-06-21
% 222.86/223.07  |- mesh__recordMaintainer mesh__D021343 SYSTEM
% 222.86/223.07  |- mesh__historyNote mesh__D021343 2001   
% 222.86/223.07  |- mesh__recordAuthorizer mesh__D021343 sjn
% 222.86/223.07  |- skos__altLabel mesh__D021343 Fish Type III AFP
% 222.86/223.07  |- skos__prefLabel mesh__D021343 Antifreeze Proteins, Type III
% 222.86/223.07  |- mesh__dateEstablished mesh__D021343 2001-01-01
% 222.86/223.07  |- skos__scopeNote mesh__D021343
% 222.86/223.07       A subclass of ANTIFREEZE PROTEINS that are globular, 6.5 kDa in size and contain compact beta-sheet structures.%A%    
% 222.86/223.07  |- mesh__publicMeSHNote mesh__D015306 89   
% 222.86/223.07  |- skos__prefLabel mesh__D015306 Biogenic Monoamines
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D015306 2006
% 222.86/223.07  |- skos__altLabel mesh__D015306 Monoamines, Biogenic
% 222.86/223.07  |- mesh__recordOriginator mesh__D015306 EJB
% 222.86/223.07  |- skos__annotation mesh__D015306 general: prefer specifics   
% 222.86/223.07  |- rdf__type mesh__D015306sskos__Concept
% 222.86/223.07  |- skos__historyNote mesh__D015306 Epinephrine %28%1966-1988%29%
% 222.86/223.07  |- mesh__recordAuthorizer mesh__D015306 sjn
% 222.86/223.07  |- skos__historyNote mesh__D015306 Biogenic Amines %28%1971-1988%29%
% 222.86/223.07  |- mesh__dateCreated mesh__D015306 1988-05-31
% 222.86/223.07  |- skos__broader mesh__D015306smesh__D001679
% 222.86/223.07  |- skos__scopeNote mesh__D015306
% 222.86/223.07       Biogenic amines having only one amine moiety. Included in this group are all natural monoamines formed by the enzymatic decarboxylation of natural amino acids.%A%    
% 222.86/223.07  |- mesh__historyNote mesh__D015306 89   
% 222.86/223.07  |- mesh__recordMaintainer mesh__D015306 ssb
% 222.86/223.07  |- skos__historyNote mesh__D015306 Norepinephrine %28%1966-1988%29%
% 222.86/223.07  |- skos__historyNote mesh__D015306 Dopamine %28%1966-1988%29%
% 222.86/223.07  |- skos__historyNote mesh__D015306 Catecholamines %28%1966-1988%29%
% 222.86/223.07  |- mesh__dateRevised mesh__D015306 2005-06-30
% 222.86/223.07  |- mesh__dateEstablished mesh__D015306 1989-01-01
% 222.86/223.07  |- mesh__dateEstablished mesh__D045791 2004-01-01
% 222.86/223.07  |- rdf__type mesh__D045791sskos__Concept
% 222.86/223.07  |- mesh__recordAuthorizer mesh__D045791 sjn
% 222.86/223.07  |- skos__scopeNote mesh__D045791
% 222.86/223.07       A species of gram-negative bacteria isolated from the SYNOVIAL FLUID; LYMPH NODES; and MUCOUS MEMBRANE secretions in diseased SWINE. It causes nonsuppurative ARTHRITIS.%A%    
% 222.86/223.07  |- mesh__historyNote mesh__D045791 2004   
% 222.86/223.07  |- mesh__dateRevised mesh__D045791 2005-06-30
% 222.86/223.07  |- mesh__recordOriginator mesh__D045791 ags
% 222.86/223.07  |- mesh__recordMaintainer mesh__D045791 SYSTEM
% 222.86/223.07  |- mesh__publicMeSHNote mesh__D045791 2004   
% 222.86/223.07  |- skos__broader mesh__D045791smesh__D009174
% 222.86/223.07  |- skos__prefLabel mesh__D045791 Mycoplasma hyosynoviae
% 222.86/223.07  |- mesh__dateCreated mesh__D045791 2003-07-09
% 222.86/223.07  |- skos__annotation mesh__D045791
% 222.86/223.07       infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29% + probably ARTHRITIS, INFECTIOUS %28%IM%29%%A%  
% 222.86/223.07  |- skos__historyNote mesh__D045791 Mycoplasma %28%1970-2003%29%
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D045791 2006
% 222.86/223.07  |- mesh__dateRevised mesh__D003282 2005-06-30
% 222.86/223.07  |- skos__broader mesh__D003282smesh__D003281
% 222.86/223.07  |- mesh__recordMaintainer mesh__D003282 ssb
% 222.86/223.07  |- skos__annotation mesh__D003282
% 222.86/223.07       pregn despite use: see note on CONTRACEPTIVE AGENTS   
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D003282 2006
% 222.86/223.07  |- rdf__type mesh__D003282sskos__Concept
% 222.86/223.07  |- mesh__dateCreated mesh__D003282 1999-01-01
% 222.86/223.07  |- mesh__publicMeSHNote mesh__D003282
% 222.86/223.07       91; was see under CONTRACEPTIVES, POSTCOITAL 1975-90   
% 222.86/223.07  |- skos__scopeNote mesh__D003282
% 222.86/223.07       Postcoital contraceptives which owe their effectiveness to hormonal preparations.%A%    
% 222.86/223.07  |- mesh__recordAuthorizer mesh__D003282 sjn
% 222.86/223.07  |- mesh__dateEstablished mesh__D003282 1991-01-01
% 222.86/223.07  |- mesh__historyNote mesh__D003282
% 222.86/223.07       91%28%75%29%; was see under CONTRACEPTIVES, POSTCOITAL 1975-90   
% 222.86/223.07  |- skos__prefLabel mesh__D003282 Contraceptives, Postcoital, Hormonal
% 222.86/223.07  |- mesh__recordOriginator mesh__D003282 NLM
% 222.86/223.07  |- skos__broader mesh__D011714smesh__D006571
% 222.86/223.07  |- mesh__recordOriginator mesh__D011714 NLM
% 222.86/223.07  |- rdf__type mesh__D011714sskos__Concept
% 222.86/223.07  |- mesh__recordAuthorizer mesh__D011714 sjn
% 222.86/223.07  |- skos__broader mesh__D011714smesh__D006573
% 222.86/223.07  |- mesh__publicMeSHNote mesh__D011714
% 222.86/223.07       AUROVERTINS was AUROVERTIN see under ANTIBIOTICS 1975-79   
% 222.86/223.07  |- mesh__recordMaintainer mesh__D011714 ssb
% 222.86/223.07  |- skos__prefLabel mesh__D011714 Pyrans
% 222.86/223.07  |- mesh__dateCreated mesh__D011714 1999-01-01
% 222.86/223.07  |- mesh__dateRevised mesh__D011714 2005-06-30
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D011714 2006
% 222.86/223.07  |- skos__annotation mesh__D011714 do not confuse with PYRENES or PYRONES   
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002988 2004
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002988 1996
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002988 1991
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002988 1993
% 222.86/223.07  |- mesh__publicMeSHNote mesh__D002988 68   
% 222.86/223.07  |- rdf__type mesh__D002988sskos__Concept
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002988 1997
% 222.86/223.07  |- skos__annotation mesh__D002988 human %26% animal   
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002988 2000
% 222.86/223.07  |- skos__hiddenLabel mesh__D002988 Cloacas
% 222.86/223.07  |- mesh__recordAuthorizer mesh__D002988 NLM
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002988 1989
% 222.86/223.07  |- mesh__dateRevised mesh__D002988 1982-05-12
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002988 2005
% 222.86/223.07  |- skos__historyNote mesh__D002988 Rectum %28%1966-1967%29%
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002988 2001
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002988 1994
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002988 1990
% 222.86/223.07  |- mesh__recordOriginator mesh__D002988 NLM
% 222.86/223.07  |- mesh__recordMaintainer mesh__D002988 RRC
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002988 2006
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002988 1998
% 222.86/223.07  |- skos__broader mesh__D002988smesh__D004622
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002988 1995
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002988 2003
% 222.86/223.07  |- mesh__dateCreated mesh__D002988 1999-01-01
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002988 1992
% 222.86/223.07  |- skos__scopeNote mesh__D002988
% 222.86/223.07       The common chamber into which the intestinal, urinary and genital tracts discharge in birds, reptiles, amphibians and many fishes; also a phylogenetically related embryonic structure in mammals.%A%    
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002988 1999
% 222.86/223.07  |- skos__prefLabel mesh__D002988 Cloaca
% 222.86/223.07  |- mesh__dateEstablished mesh__D002988 1968-01-01
% 222.86/223.07  |- mesh__historyNote mesh__D002988 68   
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D002988 2002
% 222.86/223.07  |- skos__broader mesh__D002988smesh__D000825
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007673 1993
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007673 1999
% 222.86/223.07  |- skos__scopeNote mesh__D007673
% 222.86/223.07       The death of all the functioning renal cells of the kidney cortex with continued viability of the majority of the medullary units. It is due usually to the arterial distribution peculiar to the kidney which makes the renal cortex more susceptible to diminished blood flow.%A%    
% 222.86/223.07  |- mesh__dateCreated mesh__D007673 1999-01-01
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007673 2005
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007673 1996
% 222.86/223.07  |- skos__hiddenLabel mesh__D007673 Necrosis, Kidney Cortex
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007673 2002
% 222.86/223.07  |- skos__hiddenLabel mesh__D007673 Necroses, Kidney Cortex
% 222.86/223.07  |- skos__hiddenLabel mesh__D007673 Necrosis, Renal Cortical
% 222.86/223.07  |- skos__broader mesh__D007673smesh__D007674
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007673 2006
% 222.86/223.07  |- skos__hiddenLabel mesh__D007673 Renal Cortical Necroses
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007673 1997
% 222.86/223.07  |- skos__hiddenLabel mesh__D007673 Kidney Cortex Necroses
% 222.86/223.07  |- skos__altLabel mesh__D007673 Renal Cortical Necrosis
% 222.86/223.07  |- skos__hiddenLabel mesh__D007673 Necroses, Renal Cortical
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007673 2003
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007673 1994
% 222.86/223.07  |- mesh__historyNote mesh__D007673
% 222.86/223.07       67; was NECROSIS, RENAL CORTICAL 1964-66 %28%Prov%29%   
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007673 2000
% 222.86/223.07  |- mesh__recordAuthorizer mesh__D007673 PLS
% 222.86/223.07  |- mesh__recordOriginator mesh__D007673 NLM
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007673 2004
% 222.86/223.07  |- mesh__publicMeSHNote mesh__D007673 67   
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007673 1995
% 222.86/223.07  |- rdf__type mesh__D007673sskos__Concept
% 222.86/223.07  |- skos__prefLabel mesh__D007673 Kidney Cortex Necrosis
% 222.86/223.07  |- mesh__onlineNote mesh__D007673
% 222.86/223.07       use KIDNEY CORTEX NECROSIS to search NECROSIS, RENAL CORTICAL 1966 %28%as Prov%29%%A%  
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007673 2001
% 222.86/223.07  |- mesh__dateEstablished mesh__D007673 1967-01-01
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007673 1992
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D007673 1998
% 222.86/223.07  |- mesh__dateRevised mesh__D007673 1991-06-18
% 222.86/223.07  |- mesh__recordMaintainer mesh__D007673 PLS
% 222.86/223.07  |- skos__broader mesh__D045792smesh__D002338
% 222.86/223.07  |- mesh__publicMeSHNote mesh__D045792 2004   
% 222.86/223.07  |- mesh__dateEstablished mesh__D045792 2004-01-01
% 222.86/223.07  |- mesh__recordAuthorizer mesh__D045792 sjn
% 222.86/223.07  |- skos__scopeNote mesh__D045792
% 222.86/223.07       Thirteen-carbon butene cyclohexene degradation products formed by the cleavage of CAROTENOIDS. They contribute to the flavor of some FRUIT.%A%    
% 222.86/223.07  |- mesh__recordOriginator mesh__D045792 ssb
% 222.86/223.07  |- mesh__recordMaintainer mesh__D045792 ssb
% 222.86/223.07  |- mesh__historyNote mesh__D045792 2004   
% 222.86/223.07  |- mesh__dateRevised mesh__D045792 2005-06-30
% 222.86/223.07  |- skos__altLabel mesh__D045792 Nor-Isoprenoids
% 222.86/223.07  |- skos__annotation mesh__D045792
% 222.86/223.07       X ref IONONES: do not confuse with IONOL %28%BHT%29%   
% 222.86/223.07  |- skos__broader mesh__D045792smesh__D003510
% 222.86/223.07  |- mesh__dateCreated mesh__D045792 2003-07-09
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D045792 2006
% 222.86/223.07  |- rdf__type mesh__D045792sskos__Concept
% 222.86/223.07  |- skos__hiddenLabel mesh__D045792 Nor Isoprenoids
% 222.86/223.07  |- skos__prefLabel mesh__D045792 Norisoprenoids
% 222.86/223.07  |- skos__broader mesh__D005502Q000469smesh__D005502
% 222.86/223.07  |- mesh__preferredCombination mesh__D005502Q000469smesh__D016266
% 222.86/223.07  |- rdf__type mesh__D005502Q000469smesh__CompoundConcept
% 222.86/223.07  |- skos__prefLabel mesh__D003283 Contraceptives, Postcoital, Synthetic
% 222.86/223.07  |- mesh__historyNote mesh__D003283
% 222.86/223.07       91%28%75%29%; was see under CONTRACEPTIVES, POSTCOITAL 1975-90   
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D003283 2006
% 222.86/223.07  |- mesh__recordOriginator mesh__D003283 NLM
% 222.86/223.07  |- skos__annotation mesh__D003283
% 222.86/223.07       pregn despite use: see note on CONTRACEPTIVE AGENTS; DF: CONTRACEPTIVES POSTCOITAL SYN%A%  
% 222.86/223.07  |- skos__altLabel mesh__D003283 Synthetic Postcoital Contraceptive Agents
% 222.86/223.07  |- skos__altLabel mesh__D003283 Contraceptive Agents, Postcoital, Synthetic
% 222.86/223.07  |- mesh__dateRevised mesh__D003283 2005-06-30
% 222.86/223.07  |- rdf__type mesh__D003283sskos__Concept
% 222.86/223.07  |- skos__broader mesh__D003283smesh__D003281
% 222.86/223.07  |- mesh__recordMaintainer mesh__D003283 ssb
% 222.86/223.07  |- skos__altLabel mesh__D003283 Postcoital Contraceptives, Synthetic
% 222.86/223.07  |- mesh__dateCreated mesh__D003283 1999-01-01
% 222.86/223.07  |- skos__hiddenLabel mesh__D003283 Contraceptives, Synthetic Postcoital
% 222.86/223.07  |- mesh__dateEstablished mesh__D003283 1991-01-01
% 222.86/223.07  |- skos__scopeNote mesh__D003283
% 222.86/223.07       Postcoital contraceptives which owe their effectiveness to synthetic preparations.%A%    
% 222.86/223.07  |- skos__altLabel mesh__D003283 Postcoital Contraceptive Agents, Synthetic
% 222.86/223.07  |- mesh__publicMeSHNote mesh__D003283
% 222.86/223.07       91; was see under CONTRACEPTIVES, POSTCOITAL 1975-90   
% 222.86/223.07  |- mesh__recordAuthorizer mesh__D003283 sjn
% 222.86/223.07  |- skos__altLabel mesh__D003283 Synthetic Postcoital Contraceptives
% 222.86/223.07  |- mesh__recordMaintainer mesh__D011715 ssb
% 222.86/223.07  |- skos__prefLabel mesh__D011715 Pyrantel
% 222.86/223.07  |- mesh__dateRevised mesh__D011715 2005-06-30
% 222.86/223.07  |- skos__scopeNote mesh__D011715
% 222.86/223.07       A depolarizing neuromuscular-blocking agent, that causes persistent nicotinic activation resulting in spastic paralysis of susceptible nematodes. It is a drug of second-choice after benzimidazoles for treatment of ascariasis, hookworm, and pinworm infections, being effective after a single dose. %28%From Smith and Reynard, Textbook of Pharmacology, 1992, p920%29%%A%    
% 222.86/223.07  |- skos__broader mesh__D011715smesh__D013876
% 222.86/223.07  |- mesh__historyNote mesh__D011715 74   
% 222.86/223.07  |- mesh__recordOriginator mesh__D011715 NLM
% 222.86/223.07  |- mesh__dateCreated mesh__D011715 1999-01-01
% 222.86/223.07  |- skos__annotation mesh__D011715 an antinematodal agent   
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D011715 2006
% 222.86/223.07  |- mesh__dateEstablished mesh__D011715 1974-01-01
% 222.86/223.07  |- mesh__recordAuthorizer mesh__D011715 sjn
% 222.86/223.07  |- rdf__type mesh__D011715sskos__Concept
% 222.86/223.07  |- mesh__publicMeSHNote mesh__D011715 74   
% 222.86/223.07  |- skos__broader mesh__D011715smesh__D011743
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D016400 2005
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D016400 2001
% 222.86/223.07  |- skos__hiddenLabel mesh__D016400 Lymphosarcoma, Diffuse Immunoblastic
% 222.86/223.07  |- skos__scopeNote mesh__D016400
% 222.86/223.07       Malignant lymphoma characterized by the presence of immunoblasts with uniformly round-to-oval nuclei, one or more prominent nucleoli, and abundant cytoplasm. This class may be subdivided into plasmacytoid and clear-cell types based on cytoplasmic characteristics. A third category, pleomorphous, may be analogous to some of the peripheral T-cell lymphomas %28%LYMPHOMA, T-CELL, PERIPHERAL%29% recorded in both the United States and Japan.%A%    
% 222.86/223.07  |- skos__hiddenLabel mesh__D016400 Immunoblastic Large-Cell Lymphomas
% 222.86/223.07  |- skos__related mesh__D016400smesh__D016411
% 222.86/223.07  |- skos__hiddenLabel mesh__D016400 Large-Cell Lymphomas, Immunoblastic
% 222.86/223.07  |- skos__hiddenLabel mesh__D016400 Lymphoma, Large-Cell Immunoblastic
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D016400 1998
% 222.86/223.07  |- skos__hiddenLabel mesh__D016400 Immunoblastic Large Cell Lymphoma
% 222.86/223.07  |- skos__hiddenLabel mesh__D016400 Large Cell Immunoblastic Lymphoma
% 222.86/223.07  |- skos__hiddenLabel mesh__D016400 Diffuse Immunoblastic Lymphosarcomas
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D016400 2006
% 222.86/223.07  |- mesh__onlineNote mesh__D016400
% 222.86/223.07       use LYMPHOMA to search IMMUNOBLASTOMA %26% SARCOMA, IMMUNOBLASTIC 1981-90%A%  
% 222.86/223.07  |- mesh__activeMeSHYear mesh__D016400 2002
% 222.86/223.08  |- skos__broader mesh__D016400smesh__D016398
% 222.86/223.08  |- skos__altLabel mesh__D016400 Lymphoma, Immunoblastic, Large Cell
% 222.86/223.08  |- skos__hiddenLabel mesh__D016400 Immunoblastic Lymphomas, Large-Cell
% 222.86/223.08  |- skos__broader mesh__D016400smesh__D016395
% 222.86/223.08  |- rdf__type mesh__D016400sskos__Concept
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D016400 2003
% 222.86/223.08  |- skos__hiddenLabel mesh__D016400 Lymphosarcomas, Diffuse Immunoblastic
% 222.86/223.08  |- skos__altLabel mesh__D016400 Lymphoma, Immunoblastic, Large-Cell
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D016400 1999
% 222.86/223.08  |- skos__hiddenLabel mesh__D016400 Diffuse Immunoblastic Lymphosarcoma
% 222.86/223.08  |- skos__hiddenLabel mesh__D016400 Immunoblastic Lymphoma, Large-Cell
% 222.86/223.08  |- skos__altLabel mesh__D016400 Sarcoma, Immunoblastic
% 222.86/223.08  |- skos__hiddenLabel mesh__D016400 Lymphomas, Large-Cell Immunoblastic
% 222.86/223.08  |- mesh__recordOriginator mesh__D016400 PLS
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D016400 2004
% 222.86/223.08  |- skos__hiddenLabel mesh__D016400 Immunoblastic Lymphosarcomas, Diffuse
% 222.86/223.08  |- skos__altLabel mesh__D016400 Lymphoma, Large Cell, Immunoblastic
% 222.86/223.08  |- skos__annotation mesh__D016400
% 222.86/223.08       a diffuse high-grade non-Hodgkin%27%s lymphoma; DF: LYMPHOMA LARGE IMMUNOBLASTIC%A%  
% 222.86/223.08  |- skos__hiddenLabel mesh__D016400 Immunoblastomas
% 222.86/223.08  |- mesh__recordMaintainer mesh__D016400 PXP
% 222.86/223.08  |- skos__altLabel mesh__D016400 Immunoblastoma
% 222.86/223.08  |- skos__hiddenLabel mesh__D016400 Immunoblastic Sarcomas
% 222.86/223.08  |- skos__prefLabel mesh__D016400 Lymphoma, Large-Cell, Immunoblastic
% 222.86/223.08  |- skos__hiddenLabel mesh__D016400 Sarcomas, Immunoblastic
% 222.86/223.08  |- mesh__historyNote mesh__D016400
% 222.86/223.08       91; IMMUNOBLASTOMA %26% SARCOMA, IMMUNOBLASTIC were see LYMPHOMA 1981-90%A%  
% 222.86/223.08  |- mesh__publicMeSHNote mesh__D016400
% 222.86/223.08       91; IMMUNOBLASTOMA %26% SARCOMA, IMMUNOBLASTIC were see LYMPHOMA 1981-90%A%  
% 222.86/223.08  |- skos__altLabel mesh__D016400 Large-Cell Immunoblastic Lymphoma
% 222.86/223.08  |- mesh__recordAuthorizer mesh__D016400 SJN
% 222.86/223.08  |- skos__hiddenLabel mesh__D016400 Large-Cell Lymphoma, Immunoblastic
% 222.86/223.08  |- skos__altLabel mesh__D016400 Immunoblastic Lymphosarcoma, Diffuse
% 222.86/223.08  |- mesh__dateEstablished mesh__D016400 1991-01-01
% 222.86/223.08  |- skos__hiddenLabel mesh__D016400 Large-Cell Immunoblastic Lymphomas
% 222.86/223.08  |- skos__altLabel mesh__D016400 Immunoblastic Large-Cell Lymphoma
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D016400 2000
% 222.86/223.08  |- skos__hiddenLabel mesh__D016400 Lymphomas, Immunoblastic Large-Cell
% 222.86/223.08  |- skos__broader mesh__D016400smesh__D008225
% 222.86/223.08  |- mesh__dateCreated mesh__D016400 1990-06-01
% 222.86/223.08  |- mesh__dateRevised mesh__D016400 1997-06-20
% 222.86/223.08  |- skos__hiddenLabel mesh__D016400 Immunoblastic Sarcoma
% 222.86/223.08  |- skos__hiddenLabel mesh__D016400 Lymphoma, Immunoblastic Large-Cell
% 222.86/223.08  |- mesh__dateRevised mesh__D002989 2003-07-09
% 222.86/223.08  |- skos__broader mesh__D002989smesh__D001430
% 222.86/223.08  |- mesh__publicMeSHNote mesh__D002989
% 222.86/223.08       91; was see under BACTERIOCINS 1980-90   
% 222.86/223.08  |- skos__historyNote mesh__D002989 Bacteriocins %28%1966-1979%29%
% 222.86/223.08  |- mesh__historyNote mesh__D002989
% 222.86/223.08       91%28%80%29%; was see under BACTERIOCINS 1980-90   
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D002989 2005
% 222.86/223.08  |- mesh__recordMaintainer mesh__D002989 jmp
% 222.86/223.08  |- mesh__recordAuthorizer mesh__D002989 sjn
% 222.86/223.08  |- skos__scopeNote mesh__D002989
% 222.86/223.08       A bacteriocin produced by a plasmid that can occur in several bacterial strains. It is a basic protein of molecular weight 56,000 and exists in a complex with its immunity protein which protects the host bacterium from its effects.%A%    
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D002989 2006
% 222.86/223.08  |- mesh__recordOriginator mesh__D002989 SH
% 222.86/223.08  |- mesh__dateEstablished mesh__D002989 1991-01-01
% 222.86/223.08  |- skos__hiddenLabel mesh__D002989 Complex, Cloacin-Immunity Protein
% 222.86/223.08  |- skos__hiddenLabel mesh__D002989 Complex, Cloacin
% 222.86/223.08  |- skos__hiddenLabel mesh__D002989 Cloacin Immunity Protein Complex
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D002989 2004
% 222.86/223.08  |- mesh__dateCreated mesh__D002989 1979-03-01
% 222.86/223.08  |- rdf__type mesh__D002989sskos__Concept
% 222.86/223.08  |- skos__prefLabel mesh__D002989 Cloacin
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D007674 2000
% 222.86/223.08  |- skos__hiddenLabel mesh__D007674 Diseases, Kidney
% 222.86/223.08  |- mesh__recordOriginator mesh__D007674 NLM
% 222.86/223.08  |- skos__hiddenLabel mesh__D007674 Kidney Disease
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D007674 2003
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D007674 2001
% 222.86/223.08  |- skos__prefLabel mesh__D007674 Kidney Diseases
% 222.86/223.08  |- mesh__recordMaintainer mesh__D007674 kle
% 222.86/223.08  |- skos__hiddenLabel mesh__D007674 Disease, Kidney
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D007674 2004
% 222.86/223.08  |- rdf__type mesh__D007674sskos__Concept
% 222.86/223.08  |- skos__annotation mesh__D007674
% 222.86/223.08       GEN or unspecified: prefer specifics; inflamm dis = NEPHRITIS; consider diseases under NEPHR- %26% RENAL; cyst = KIDNEY, CYSTIC but KIDNEY, POLYCYSTIC is also available; %22%renal failure%22% not specified as %22%acute%22% or %22%chronic%22%: check text for clues in notes under KIDNEY FAILURE, ACUTE %26% KIDNEY FAILURE, CHRONIC %26% if not able to determine, index as KIDNEY DISEASES%A%  
% 222.86/223.08  |- skos__broader mesh__D007674smesh__D014570
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D007674 2002
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D007674 2005
% 222.86/223.08  |- mesh__recordAuthorizer mesh__D007674 sjn
% 222.86/223.08  |- mesh__dateCreated mesh__D007674 1999-01-01
% 222.86/223.08  |- mesh__dateRevised mesh__D007674 1999-11-03
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D007674 2006
% 222.86/223.08  |- mesh__dateCreated mesh__D015308 1988-05-31
% 222.86/223.08  |- mesh__recordMaintainer mesh__D015308 nns
% 222.86/223.08  |- skos__historyNote mesh__D015308 Oxygen Consumption %28%1966-1988%29%
% 222.86/223.08  |- mesh__recordAuthorizer mesh__D015308 sjn
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D015308 2004
% 222.86/223.08  |- mesh__historyNote mesh__D015308 89   
% 222.86/223.08  |- mesh__dateRevised mesh__D015308 2003-07-09
% 222.86/223.08  |- skos__historyNote mesh__D015308 Exertion %28%1966-1988%29%
% 222.86/223.08  |- mesh__dateEstablished mesh__D015308 1989-01-01
% 222.86/223.08  |- mesh__publicMeSHNote mesh__D015308 89   
% 222.86/223.08  |- skos__scopeNote mesh__D015308
% 222.86/223.08       The oxygen consumption level above which aerobic energy production is supplemented by anaerobic mechanisms during exercise, resulting in a sustained increase in lactate concentration and metabolic acidosis. The anaerobic threshold is affected by factors that modify oxygen delivery to the tissues; it is low in patients with heart disease. Methods of measurement include direct measure of lactate concentration, direct measurement of bicarbonate concentration, and gas exchange measurements.%A%    
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D015308 2006
% 222.86/223.08  |- skos__broader mesh__D015308smesh__D010101
% 222.86/223.08  |- skos__hiddenLabel mesh__D015308 Thresholds, Anaerobic
% 222.86/223.08  |- skos__broader mesh__D015308smesh__D010807
% 222.86/223.08  |- mesh__recordOriginator mesh__D015308 EJB
% 222.86/223.08  |- skos__hiddenLabel mesh__D015308 Anaerobic Thresholds
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D015308 2005
% 222.86/223.08  |- skos__prefLabel mesh__D015308 Anaerobic Threshold
% 222.86/223.08  |- skos__hiddenLabel mesh__D015308 Threshold, Anaerobic
% 222.86/223.08  |- rdf__type mesh__D015308sskos__Concept
% 222.86/223.08  |- skos__scopeNote mesh__D045793
% 222.86/223.08       A species of gram-negative bacteria causing lesions to AIR SACS and HOCK joints in TURKEYS.%A%    
% 222.86/223.08  |- mesh__recordMaintainer mesh__D045793 SYSTEM
% 222.86/223.08  |- rdf__type mesh__D045793sskos__Concept
% 222.86/223.08  |- skos__annotation mesh__D045793
% 222.86/223.08       infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29%   
% 222.86/223.08  |- skos__broader mesh__D045793smesh__D009174
% 222.86/223.08  |- skos__historyNote mesh__D045793 Mycoplasma %28%1981-2003%29%
% 222.86/223.08  |- mesh__dateCreated mesh__D045793 2003-07-09
% 222.86/223.08  |- mesh__recordAuthorizer mesh__D045793 sjn
% 222.86/223.08  |- skos__prefLabel mesh__D045793 Mycoplasma iowae
% 222.86/223.08  |- mesh__historyNote mesh__D045793 2004   
% 222.86/223.08  |- mesh__publicMeSHNote mesh__D045793 2004   
% 222.86/223.08  |- mesh__dateRevised mesh__D045793 2005-06-30
% 222.86/223.08  |- mesh__recordOriginator mesh__D045793 ags
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D045793 2006
% 222.86/223.08  |- mesh__dateEstablished mesh__D045793 2004-01-01
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012010 2006
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012010 1996
% 222.86/223.08  |- mesh__dateCreated mesh__D012010 1984-05-29
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012010 1998
% 222.86/223.08  |- mesh__historyNote mesh__D012010
% 222.86/223.08       92; was RED CELL APLASIA, PURE 1985-91   
% 222.86/223.08  |- skos__altLabel mesh__D012010 Erythrocyte Aplasia
% 222.86/223.08  |- mesh__publicMeSHNote mesh__D012010
% 222.86/223.08       92; was RED CELL APLASIA, PURE 1985-91   
% 222.86/223.08  |- mesh__recordAuthorizer mesh__D012010 PLS
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012010 1997
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012010 1994
% 222.86/223.08  |- skos__hiddenLabel mesh__D012010 Aplasia, Pure Red-Cell
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012010 1999
% 222.86/223.08  |- skos__historyNote mesh__D012010 Anemia, Aplastic %28%1966-1984%29%
% 222.86/223.08  |- skos__hiddenLabel mesh__D012010 Erythrocyte Aplasias
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012010 2002
% 222.86/223.08  |- skos__broader mesh__D012010smesh__D000740
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012010 1995
% 222.86/223.08  |- skos__hiddenLabel mesh__D012010 Pure Red-Cell Aplasias
% 222.86/223.08  |- skos__hiddenLabel mesh__D012010 Aplasias, Erythrocyte
% 222.86/223.08  |- skos__scopeNote mesh__D012010
% 222.86/223.08       Suppression of erythropoiesis with little or no abnormality of leukocyte or platelet production.%A%    
% 222.86/223.08  |- skos__prefLabel mesh__D012010 Red-Cell Aplasia, Pure
% 222.86/223.08  |- mesh__recordMaintainer mesh__D012010 TGC
% 222.86/223.08  |- skos__hiddenLabel mesh__D012010 Red Cell Aplasia, Pure
% 222.86/223.08  |- mesh__dateEstablished mesh__D012010 1985-01-01
% 222.86/223.08  |- skos__hiddenLabel mesh__D012010 Aplasias, Pure Red-Cell
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012010 2003
% 222.86/223.08  |- rdf__type mesh__D012010sskos__Concept
% 222.86/223.08  |- skos__hiddenLabel mesh__D012010 Red-Cell Aplasias, Pure
% 222.86/223.08  |- skos__hiddenLabel mesh__D012010 Aplasia, Erythrocyte
% 222.86/223.08  |- mesh__dateRevised mesh__D012010 1993-06-02
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012010 2005
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012010 2000
% 222.86/223.08  |- skos__altLabel mesh__D012010 Pure Red-Cell Aplasia
% 222.86/223.08  |- skos__annotation mesh__D012010 a form of anemia   
% 222.86/223.08  |- mesh__onlineNote mesh__D012010
% 222.86/223.08       use RED-CELL APLASIA, PURE to search RED CELL APLASIA, PURE 1985-91%A%  
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012010 2004
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012010 2001
% 222.86/223.08  |- mesh__recordOriginator mesh__D012010 VDK
% 222.86/223.08  |- skos__hiddenLabel mesh__D012010 Pure Red Cell Aplasia
% 222.86/223.08  |- mesh__dateEstablished mesh__D003284 1991-01-01
% 222.86/223.08  |- mesh__recordOriginator mesh__D003284 EC
% 222.86/223.08  |- skos__altLabel mesh__D003284 Services, Contract
% 222.86/223.08  |- skos__broader mesh__D003284smesh__D005376
% 222.86/223.08  |- skos__hiddenLabel mesh__D003284 Contract Service
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D003284 2006
% 222.86/223.08  |- skos__annotation mesh__D003284
% 222.86/223.08       DF: CONTRACT SERV; CONTRACTS is also available   
% 222.86/223.08  |- mesh__recordAuthorizer mesh__D003284 sjn
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D003284 2004
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D003284 2005
% 222.86/223.08  |- mesh__publicMeSHNote mesh__D003284
% 222.86/223.08       91; was see under FINANCIAL MANAGEMENT 1978-90   
% 222.86/223.08  |- mesh__historyNote mesh__D003284
% 222.86/223.08       91%28%78%29%; was see under FINANCIAL MANAGEMENT 1978-90   
% 222.86/223.08  |- rdf__type mesh__D003284sskos__Concept
% 222.86/223.08  |- skos__prefLabel mesh__D003284 Contract Services
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D003284 2003
% 222.86/223.08  |- skos__related mesh__D003284smesh__D032982
% 222.86/223.08  |- mesh__dateRevised mesh__D003284 2002-07-03
% 222.86/223.08  |- skos__hiddenLabel mesh__D003284 Service, Contract
% 222.86/223.08  |- mesh__dateCreated mesh__D003284 1977-05-05
% 222.86/223.08  |- skos__historyNote mesh__D003284 Economics %28%1966-1977%29%
% 222.86/223.08  |- skos__scopeNote mesh__D003284
% 222.86/223.08       Outside services provided to an institution under a formal financial agreement.%A%    
% 222.86/223.08  |- mesh__recordMaintainer mesh__D003284 tjk
% 222.86/223.08  |- mesh__recordAuthorizer mesh__D011716 sjn
% 222.86/223.08  |- skos__scopeNote mesh__D011716
% 222.86/223.08       Broad spectrum antinematodal anthelmintic used also in veterinary medicine.%A%    
% 222.86/223.08  |- skos__hiddenLabel mesh__D011716 Pamoate, Pyrantel
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D011716 2006
% 222.86/223.08  |- skos__hiddenLabel mesh__D011716 Embonate, Pyrantel
% 222.86/223.08  |- mesh__recordMaintainer mesh__D011716 ssb
% 222.86/223.08  |- mesh__publicMeSHNote mesh__D011716 91; was see under PYRANTEL 1975-90   
% 222.86/223.08  |- skos__historyNote mesh__D011716 Naphthalenes %28%1974%29%
% 222.86/223.08  |- mesh__dateEstablished mesh__D011716 1991-01-01
% 222.86/223.08  |- mesh__historyNote mesh__D011716
% 222.86/223.08       91%28%75%29%; was see under PYRANTEL 1975-90   
% 222.86/223.08  |- skos__altLabel mesh__D011716 Pyrantel Embonate
% 222.86/223.08  |- mesh__dateRevised mesh__D011716 2005-06-30
% 222.86/223.08  |- rdf__type mesh__D011716sskos__Concept
% 222.86/223.08  |- mesh__dateCreated mesh__D011716 1974-11-19
% 222.86/223.08  |- mesh__recordOriginator mesh__D011716 NLM
% 222.86/223.08  |- skos__broader mesh__D011716smesh__D011715
% 222.86/223.08  |- skos__prefLabel mesh__D011716 Pyrantel Pamoate
% 222.86/223.08  |- skos__historyNote mesh__D011716 Pyrantel %28%1974%29%
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Lymphoblastic Large-Cell Lymphomas
% 222.86/223.08  |- mesh__recordAuthorizer mesh__D016401 SJN
% 222.86/223.08  |- skos__broader mesh__D016401smesh__D016398
% 222.86/223.08  |- rdf__type mesh__D016401sskos__Concept
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Lymphoblastic Lymphoma, Large-Cell
% 222.86/223.08  |- skos__related mesh__D016401smesh__D015459
% 222.86/223.08  |- skos__broader mesh__D016401smesh__D008225
% 222.86/223.08  |- skos__historyNote mesh__D016401 Lymphoma %28%1977-1986%29%
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D016401 1999
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D016401 2000
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Large-Cell Lymphoblastic Lymphomas
% 222.86/223.08  |- skos__altLabel mesh__D016401 Lymphoma, Lymphoblastic, Diffuse
% 222.86/223.08  |- mesh__dateEstablished mesh__D016401 1991-01-01
% 222.86/223.08  |- mesh__dateCreated mesh__D016401 1990-06-01
% 222.86/223.08  |- mesh__dateRevised mesh__D016401 1997-06-20
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Lymphoblastic Large Cell Lymphoma
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D016401 2005
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Convoluted T-Cell Lymphomas
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Lymphoma, Lymphoblastic Large-Cell
% 222.86/223.08  |- mesh__recordOriginator mesh__D016401 PLS
% 222.86/223.08  |- skos__prefLabel mesh__D016401 Lymphoma, Lymphoblastic
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Lymphomas, Large-Cell Lymphoblastic
% 222.86/223.08  |- skos__broader mesh__D016401smesh__D016399
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D016401 2004
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Large-Cell Lymphoma, Lymphoblastic
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 T-Cell Lymphoma, Convoluted
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Lymphoblastic Lymphosarcomas, Diffuse
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Convoluted T-Cell Lymphoma
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D016401 1998
% 222.86/223.08  |- skos__broader mesh__D016401smesh__D016395
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Lymphoma, Large-Cell Lymphoblastic
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Lymphosarcoma, Diffuse Lymphoblastic
% 222.86/223.08  |- skos__altLabel mesh__D016401 Lymphoblastic Lymphoma
% 222.86/223.08  |- skos__altLabel mesh__D016401 Large-Cell Lymphoblastic Lymphoma
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D016401 2003
% 222.86/223.08  |- skos__altLabel mesh__D016401 Lymphoblastic Lymphosarcoma, Diffuse
% 222.86/223.08  |- skos__annotation mesh__D016401 a diffuse high-grade T-cell lymphoma   
% 222.86/223.08  |- skos__scopeNote mesh__D016401
% 222.86/223.08       A high-grade malignant lymphoma composed of a diffuse, relatively uniform proliferation of cells with round or convoluted nuclei and scanty cytoplasm. The cells are cytologically similar to the lymphoblasts seen in acute lymphocytic leukemia, and in some cases, the disease may evolve into a leukemic phase morphologically indistinguishable from acute T-lymphocytic leukemia %28%LEUKEMIA, T-CELL, ACUTE%29%. Lymphoblastic lymphoma represents approximately one-third of the cases of non-Hodgkin%27%s lymphomas in children and 5%25% of the cases in adults. It is more prevalent in males.%A%    
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Lymphoblastic Lymphomas
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D016401 2002
% 222.86/223.08  |- mesh__publicMeSHNote mesh__D016401 91   
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Lymphoma, Convoluted T Cell
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Lymphoblastic Lymphomas, Large-Cell
% 222.86/223.08  |- skos__historyNote mesh__D016401
% 222.86/223.08       Lymphoma, Non-Hodgkin%27%s %28%1987-1990%29%
% 222.86/223.08  |- mesh__historyNote mesh__D016401 91   
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Lymphosarcomas, Diffuse Lymphoblastic
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Diffuse Lymphoblastic Lymphosarcoma
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Diffuse Lymphoblastic Lymphosarcomas
% 222.86/223.08  |- skos__altLabel mesh__D016401 Lymphoma, Lymphoblastic, Large-Cell
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 T-Cell Lymphomas, Convoluted
% 222.86/223.08  |- skos__altLabel mesh__D016401 Lymphosarcoma, Lymphoblastic, Diffuse
% 222.86/223.08  |- mesh__recordMaintainer mesh__D016401 PXP
% 222.86/223.08  |- skos__altLabel mesh__D016401 Lymphoblastic Large-Cell Lymphoma
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Large Cell Lymphoblastic Lymphoma
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D016401 2001
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Lymphomas, Lymphoblastic Large-Cell
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Large-Cell Lymphomas, Lymphoblastic
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Lymphomas, Lymphoblastic
% 222.86/223.08  |- skos__hiddenLabel mesh__D016401 Lymphomas, Convoluted T-Cell
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D016401 2006
% 222.86/223.08  |- mesh__onlineNote mesh__D007675
% 222.86/223.08       use KIDNEY FAILURE, ACUTE to search ACUTE RENAL FAILURE 1966%A%  
% 222.86/223.08  |- skos__related mesh__D007675smesh__D001002
% 222.86/223.08  |- mesh__dateEstablished mesh__D007675 1967-01-01
% 222.86/223.08  |- rdf__type mesh__D007675sskos__Concept
% 222.86/223.08  |- skos__annotation mesh__D007675
% 222.86/223.08       RENAL INSUFFICIENCY, ACUTE is also available   
% 222.86/223.08  |- mesh__publicMeSHNote mesh__D007675
% 222.86/223.08       67; was ACUTE RENAL FAILURE 1963-66   
% 222.86/223.08  |- skos__broader mesh__D007675smesh__D017095
% 222.86/223.08  |- mesh__recordOriginator mesh__D007675 NLM
% 222.86/223.08  |- skos__altLabel mesh__D007675 Renal Failure, Acute
% 222.86/223.08  |- skos__scopeNote mesh__D007675
% 222.86/223.08       A severe stage of acute renal insufficiency, characterized by the sudden decrease in GLOMERULAR FILTRATION RATE to less than 15 ml per min, sometime to less than 1 to 2 ml per min. It is usually associated with OLIGURIA; EDEMA; and increase in BLOOD UREA NITROGEN and serum CREATININE concentrations.%A%    
% 222.86/223.08  |- skos__related mesh__D007675smesh__D006435
% 222.86/223.08  |- skos__altLabel mesh__D007675 Acute Renal Failure
% 222.86/223.08  |- skos__altLabel mesh__D007675 Acute Kidney Failure
% 222.86/223.08  |- mesh__recordMaintainer mesh__D007675 lkt
% 222.86/223.08  |- mesh__dateRevised mesh__D007675 2005-06-30
% 222.86/223.08  |- mesh__dateCreated mesh__D007675 1999-01-01
% 222.86/223.08  |- mesh__historyNote mesh__D007675 67; was ACUTE RENAL FAILURE 1963-66   
% 222.86/223.08  |- skos__hiddenLabel mesh__D007675 Kidney Failures, Acute
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D007675 2006
% 222.86/223.08  |- skos__hiddenLabel mesh__D007675 Renal Failures, Acute
% 222.86/223.08  |- skos__prefLabel mesh__D007675 Kidney Failure, Acute
% 222.86/223.08  |- skos__broader mesh__D007675smesh__D051480
% 222.86/223.08  |- skos__hiddenLabel mesh__D007675 Acute Renal Failures
% 222.86/223.08  |- mesh__recordAuthorizer mesh__D007675 sjn
% 222.86/223.08  |- skos__hiddenLabel mesh__D015309 Techniques, Glucose Clamp
% 222.86/223.08  |- skos__hiddenLabel mesh__D015309 Technic, Glucose Clamp
% 222.86/223.08  |- skos__hiddenLabel mesh__D015309 Clamping, Euglycemic
% 222.86/223.08  |- mesh__publicMeSHNote mesh__D015309
% 222.86/223.08       91; was GLUCOSE CLAMP TECHNIC 1989-90   
% 222.86/223.08  |- rdf__type mesh__D015309sskos__Concept
% 222.86/223.08  |- skos__altLabel mesh__D015309 Glucose Clamp Technic
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D015309 2003
% 222.86/223.08  |- skos__altLabel mesh__D015309 Euglycemic Clamping
% 222.86/223.08  |- skos__historyNote mesh__D015309
% 222.86/223.08       Blood Glucose/metabolism %28%1975-1988%29%
% 222.86/223.08  |- skos__hiddenLabel mesh__D015309 Clamp, Glucose
% 222.86/223.08  |- skos__broader mesh__D015309smesh__D001774
% 222.86/223.08  |- mesh__onlineNote mesh__D015309
% 222.86/223.08       use GLUCOSE CLAMP TECHNIQUE to search GLUCOSE CLAMP TECHNIC 1989-90%A%  
% 222.86/223.08  |- skos__broader mesh__D015309smesh__D002623
% 222.86/223.08  |- skos__hiddenLabel mesh__D015309 Euglycaemic Clamps
% 222.86/223.08  |- skos__hiddenLabel mesh__D015309 Glucose Clamps
% 222.86/223.08  |- skos__hiddenLabel mesh__D015309 Technique, Glucose Clamp
% 222.86/223.08  |- mesh__dateCreated mesh__D015309 1988-05-31
% 222.86/223.08  |- skos__hiddenLabel mesh__D015309 Clamps, Euglycaemic
% 222.86/223.08  |- skos__hiddenLabel mesh__D015309 Clamp, Euglycemic
% 222.86/223.08  |- skos__hiddenLabel mesh__D015309 Clamps, Glucose
% 222.86/223.08  |- skos__hiddenLabel mesh__D015309 Clamps, Euglycemic
% 222.86/223.08  |- skos__hiddenLabel mesh__D015309 Euglycemic Clamps
% 222.86/223.08  |- skos__prefLabel mesh__D015309 Glucose Clamp Technique
% 222.86/223.08  |- skos__hiddenLabel mesh__D015309 Glucose Clamp Technics
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D015309 2006
% 222.86/223.08  |- skos__altLabel mesh__D015309 Glucose Clamp
% 222.86/223.08  |- skos__altLabel mesh__D015309 Euglycaemic Clamping
% 222.86/223.08  |- mesh__recordAuthorizer mesh__D015309 sjn
% 222.86/223.08  |- mesh__recordOriginator mesh__D015309 EJB
% 222.86/223.08  |- mesh__dateRevised mesh__D015309 2002-07-03
% 222.86/223.08  |- skos__hiddenLabel mesh__D015309 Clamp, Euglycaemic
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D015309 2005
% 222.86/223.08  |- skos__scopeNote mesh__D015309
% 222.86/223.08       Maintenance of a constant blood glucose level by perfusion or infusion with glucose or insulin. It is used for the study of metabolic rates %28%e.g., in glucose, lipid, amino acid metabolism%29% at constant glucose concentration.%A%    
% 222.86/223.08  |- mesh__dateEstablished mesh__D015309 1989-01-01
% 222.86/223.08  |- mesh__recordMaintainer mesh__D015309 lkt
% 222.86/223.08  |- mesh__historyNote mesh__D015309 91; was GLUCOSE CLAMP TECHNIC 1989-90   
% 222.86/223.08  |- skos__hiddenLabel mesh__D015309 Glucose Clamp Techniques
% 222.86/223.08  |- skos__hiddenLabel mesh__D015309 Clamping, Euglycaemic
% 222.86/223.08  |- skos__altLabel mesh__D015309 Euglycaemic Clamp
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D015309 2004
% 222.86/223.08  |- skos__hiddenLabel mesh__D015309 Technics, Glucose Clamp
% 222.86/223.08  |- skos__hiddenLabel mesh__D015309 Clamping, Glucose
% 222.86/223.08  |- mesh__dateRevised mesh__D045794 2005-06-30
% 222.86/223.08  |- skos__annotation mesh__D045794
% 222.86/223.08       infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29%   
% 222.86/223.08  |- mesh__recordOriginator mesh__D045794 ags
% 222.86/223.08  |- mesh__dateEstablished mesh__D045794 2004-01-01
% 222.86/223.08  |- mesh__dateCreated mesh__D045794 2003-07-09
% 222.86/223.08  |- skos__prefLabel mesh__D045794 Mycoplasma meleagridis
% 222.86/223.08  |- skos__historyNote mesh__D045794 Mycoplasma %28%1966-2003%29%
% 222.86/223.08  |- skos__broader mesh__D045794smesh__D009174
% 222.86/223.08  |- mesh__publicMeSHNote mesh__D045794 2004   
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D045794 2006
% 222.86/223.08  |- mesh__recordAuthorizer mesh__D045794 sjn
% 222.86/223.08  |- mesh__recordMaintainer mesh__D045794 SYSTEM
% 222.86/223.08  |- rdf__type mesh__D045794sskos__Concept
% 222.86/223.08  |- skos__scopeNote mesh__D045794
% 222.86/223.08       A species of gram-negative bacteria producing air sacculitis and skeletal abnormalities in TURKEYS.%A%    
% 222.86/223.08  |- mesh__historyNote mesh__D045794 2004   
% 222.86/223.08  |- skos__hiddenLabel mesh__D012011 Cross, Red
% 222.86/223.08  |- mesh__historyNote mesh__D012011 66   
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012011 1995
% 222.86/223.08  |- skos__broader mesh__D012011smesh__D014837
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012011 2000
% 222.86/223.08  |- mesh__dateCreated mesh__D012011 1999-01-01
% 222.86/223.08  |- mesh__publicMeSHNote mesh__D012011 66   
% 222.86/223.08  |- mesh__recordMaintainer mesh__D012011 TAP
% 222.86/223.08  |- skos__scopeNote mesh__D012011
% 222.86/223.08       An international agency providing various humanitarian services.%A%    
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012011 2003
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012011 2001
% 222.86/223.08  |- rdf__type mesh__D012011sskos__Concept
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012011 2005
% 222.86/223.08  |- skos__prefLabel mesh__D012011 Red Cross
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012011 2004
% 222.86/223.08  |- mesh__recordAuthorizer mesh__D012011 PLS
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012011 2006
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012011 1996
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012011 1998
% 222.86/223.08  |- skos__broader mesh__D012011smesh__D007390
% 222.86/223.08  |- skos__hiddenLabel mesh__D012011 Red Crosses
% 222.86/223.08  |- mesh__dateRevised mesh__D012011 1992-05-18
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012011 2002
% 222.86/223.08  |- skos__hiddenLabel mesh__D012011 Crosses, Red
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012011 1997
% 222.86/223.08  |- skos__annotation mesh__D012011
% 222.86/223.08       specify geog      CATALOG: use NAF entry   
% 222.86/223.08  |- mesh__dateEstablished mesh__D012011 1966-01-01
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012011 1994
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012011 1999
% 222.86/223.08  |- mesh__recordOriginator mesh__D012011 NLM
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D012011 1993
% 222.86/223.08  |- mesh__recordAuthorizer mesh__D050130 sjn
% 222.86/223.08  |- skos__broader mesh__D050130smesh__D001691
% 222.86/223.08  |- skos__hiddenLabel mesh__D050130 Therapies, Oncolytic Virus
% 222.86/223.08  |- skos__hiddenLabel mesh__D050130 Oncolytic Virus Therapies
% 222.86/223.08  |- skos__hiddenLabel mesh__D050130 Virus Therapy, Oncolytic
% 222.86/223.08  |- mesh__recordOriginator mesh__D050130 ssb
% 222.86/223.08  |- skos__prefLabel mesh__D050130 Oncolytic Virotherapy
% 222.86/223.08  |- mesh__publicMeSHNote mesh__D050130 2006   
% 222.86/223.08  |- mesh__dateCreated mesh__D050130 2005-06-30
% 222.86/223.08  |- skos__scopeNote mesh__D050130
% 222.86/223.08       Use of attenuated VIRUSES as ANTINEOPLASTIC AGENTS to selectively kill CANCER cells.%A%    
% 222.86/223.08  |- skos__hiddenLabel mesh__D050130 Virus Therapies, Oncolytic
% 222.86/223.08  |- skos__hiddenLabel mesh__D050130 Oncolytic Virotherapies
% 222.86/223.08  |- skos__altLabel mesh__D050130 Virotherapy, Oncolytic
% 222.86/223.08  |- mesh__historyNote mesh__D050130 2006   
% 222.86/223.08  |- skos__related mesh__D050130smesh__D050504
% 222.86/223.08  |- rdf__type mesh__D050130sskos__Concept
% 222.86/223.08  |- skos__hiddenLabel mesh__D050130 Therapy, Oncolytic Virus
% 222.86/223.08  |- skos__altLabel mesh__D050130 Oncolytic Virus Therapy
% 222.86/223.08  |- skos__hiddenLabel mesh__D050130 Virotherapies, Oncolytic
% 222.86/223.08  |- mesh__dateEstablished mesh__D050130 2006-01-01
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D050130 2006
% 222.86/223.08  |- mesh__recordMaintainer mesh__D050130 ssb
% 222.86/223.08  |- skos__historyNote mesh__D003285 Proteins %28%1966-1976%29%
% 222.86/223.08  |- mesh__activeMeSHYear mesh__D003285 2006
% 222.86/223.08  |- skos__prefLabel mesh__D003285 Contractile Proteins
% 222.86/223.08  |- mesh__publicMeSHNote mesh__D003285 77   
% 222.86/223.08  |- skos__historyNote mesh__D003285 specific protein %28%1966-1976%29%
% 222.86/223.08  |- skos__scopeNote mesh__D003285
% 222.86/223.08       Proteins which participate in contractile processes. They include MUSCLE PROTEINS as well as those found in other cells and tissues. In the latter, these proteins participate in localized contractile events in the cytoplasm, in motile activity, and in cell aggregation phenomena.%A%    
% 222.86/223.08  |- mesh__historyNote mesh__D003285 77   
% 222.86/223.08  |- mesh__recordMaintainer mesh__D003285 SYSTEM
% 222.86/223.08  |- rdf__type mesh__D003285sskos__Concept
% 222.86/223.08  |- mesh__recordOriginator mesh__D003285 RLS
% 222.86/223.09  |- mesh__dateEstablished mesh__D003285 1977-01-01
% 222.86/223.09  |- mesh__recordAuthorizer mesh__D003285 sjn
% 222.86/223.09  |- skos__broader mesh__D003285smesh__D011506
% 222.86/223.09  |- mesh__dateCreated mesh__D003285 1976-04-16
% 222.86/223.09  |- mesh__dateRevised mesh__D003285 2005-06-30
% 222.86/223.09  |- skos__hiddenLabel mesh__D003285 Proteins, Contractile
% 222.86/223.09  |- skos__annotation mesh__D003285
% 222.86/223.09       proteins involved in contractile processes; if in muscle use MUSCLE PROTEINS or specifics but not also here; /biosyn /drug eff /physiol permitted%A%  
% 222.86/223.09  |- skos__historyNote mesh__D011717 Pyrantel %28%1974%29%
% 222.86/223.09  |- mesh__recordOriginator mesh__D011717 NLM
% 222.86/223.09  |- skos__broader mesh__D011717smesh__D011715
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D011717 2006
% 222.86/223.09  |- mesh__historyNote mesh__D011717
% 222.86/223.09       91%28%75%29%; was see under PYRANTEL 1975-90   
% 222.86/223.09  |- skos__hiddenLabel mesh__D011717 Tartrate, Pyrantel
% 222.86/223.09  |- mesh__recordMaintainer mesh__D011717 ssb
% 222.86/223.09  |- mesh__recordAuthorizer mesh__D011717 sjn
% 222.86/223.09  |- skos__prefLabel mesh__D011717 Pyrantel Tartrate
% 222.86/223.09  |- skos__scopeNote mesh__D011717
% 222.86/223.09       Broad spectrum anthelmintic for livestock.     
% 222.86/223.09  |- skos__historyNote mesh__D011717 Tartrates %28%1974%29%
% 222.86/223.09  |- rdf__type mesh__D011717sskos__Concept
% 222.86/223.09  |- mesh__publicMeSHNote mesh__D011717 91; was see under PYRANTEL 1975-90   
% 222.86/223.09  |- mesh__dateCreated mesh__D011717 1974-11-19
% 222.86/223.09  |- mesh__dateEstablished mesh__D011717 1991-01-01
% 222.86/223.09  |- mesh__dateRevised mesh__D011717 2005-06-30
% 222.86/223.09  |- skos__hiddenLabel mesh__D016402 Lymphoma, Small Non Cleaved Cell
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D016402 1999
% 222.86/223.09  |- mesh__recordAuthorizer mesh__D016402 SJN
% 222.86/223.09  |- skos__hiddenLabel mesh__D016402 Non-Cleaved-Cell Lymphoma, Small
% 222.86/223.09  |- mesh__dateEstablished mesh__D016402 1991-01-01
% 222.86/223.09  |- skos__hiddenLabel mesh__D016402 Lymphomas, Diffuse Undifferentiated
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D016402 2005
% 222.86/223.09  |- skos__hiddenLabel mesh__D016402 Small Noncleaved Cell Lymphoma
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D016402 2000
% 222.86/223.09  |- mesh__recordOriginator mesh__D016402 PLS
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D016402 2004
% 222.86/223.09  |- mesh__dateCreated mesh__D016402 1990-06-01
% 222.86/223.09  |- skos__prefLabel mesh__D016402 Lymphoma, Small Noncleaved-Cell
% 222.86/223.09  |- skos__hiddenLabel mesh__D016402 Lymphoma, Small Noncleaved Cell
% 222.86/223.09  |- skos__altLabel mesh__D016402 Small Non-Cleaved-Cell Lymphoma
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D016402 1998
% 222.86/223.09  |- skos__hiddenLabel mesh__D016402 Non-Cleaved-Cell Lymphomas, Small
% 222.86/223.09  |- skos__hiddenLabel mesh__D016402 Small Non Cleaved Cell Lymphoma
% 222.86/223.09  |- skos__broader mesh__D016402smesh__D016395
% 222.86/223.09  |- skos__altLabel mesh__D016402 Lymphoma, Small Non-Cleaved-Cell
% 222.86/223.09  |- skos__broader mesh__D016402smesh__D008226
% 222.86/223.09  |- skos__altLabel mesh__D016402 Lymphoma, Undifferentiated, Diffuse
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D016402 2003
% 222.86/223.09  |- skos__hiddenLabel mesh__D016402 Noncleaved-Cell Lymphomas, Small
% 222.86/223.09  |- skos__scopeNote mesh__D016402
% 222.86/223.09       A high-grade malignant lymphoma that includes both Burkitt tumor %28%BURKITT LYMPHOMA%29% and other lymphomas previously designated undifferentiated non-Burkitt type. Nuclei in Burkitt tumor are round to ovoid and uniform in size. The non-Burkitt type exhibits greater nuclear variation and less evidence of cellular maturation with a correspondingly lesser degree of differentiation.%A%    
% 222.86/223.09  |- skos__hiddenLabel mesh__D016402 Diffuse Undifferentiated Lymphomas
% 222.86/223.09  |- skos__altLabel mesh__D016402 Small Noncleaved-Cell Lymphoma
% 222.86/223.09  |- mesh__historyNote mesh__D016402 91   
% 222.86/223.09  |- skos__hiddenLabel mesh__D016402 Lymphomas, Small Non-Cleaved-Cell
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D016402 2002
% 222.86/223.09  |- mesh__publicMeSHNote mesh__D016402 91   
% 222.86/223.09  |- skos__hiddenLabel mesh__D016402 Lymphomas, Small Noncleaved-Cell
% 222.86/223.09  |- skos__hiddenLabel mesh__D016402 Undifferentiated Lymphomas, Diffuse
% 222.86/223.09  |- mesh__dateRevised mesh__D016402 1997-07-14
% 222.86/223.09  |- skos__altLabel mesh__D016402 Diffuse Undifferentiated Lymphoma
% 222.86/223.09  |- skos__annotation mesh__D016402
% 222.86/223.09       a diffuse high-grade non-Hodgkin%27%s lymphoma; DF: LYMPHOMA SMALL NONCLEAVED%A%  
% 222.86/223.09  |- skos__broader mesh__D016402smesh__D008229
% 222.86/223.09  |- skos__hiddenLabel mesh__D016402 Small Non-Cleaved-Cell Lymphomas
% 222.86/223.09  |- skos__hiddenLabel mesh__D016402 Small Noncleaved-Cell Lymphomas
% 222.86/223.09  |- mesh__recordMaintainer mesh__D016402 PXP
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D016402 2006
% 222.86/223.09  |- skos__hiddenLabel mesh__D016402 Noncleaved-Cell Lymphoma, Small
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D016402 2001
% 222.86/223.09  |- skos__hiddenLabel mesh__D016402 Lymphoma, Diffuse Undifferentiated
% 222.86/223.09  |- skos__hiddenLabel mesh__D016402 Undifferentiated Lymphoma, Diffuse
% 222.86/223.09  |- skos__broader mesh__D016402smesh__D016398
% 222.86/223.09  |- rdf__type mesh__D016402sskos__Concept
% 222.86/223.09  |- skos__altLabel mesh__D007676 Renal Disease, End-Stage
% 222.86/223.09  |- skos__hiddenLabel mesh__D007676 Disease, End-Stage Kidney
% 222.86/223.09  |- skos__hiddenLabel mesh__D007676 Renal Disease, End Stage
% 222.86/223.09  |- skos__broader mesh__D007676smesh__D017095
% 222.86/223.09  |- mesh__recordMaintainer mesh__D007676 lkt
% 222.86/223.09  |- skos__scopeNote mesh__D007676
% 222.86/223.09       The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage %28%as measured by the level of PROTEINURIA%29% and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min %28%Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002%29%. These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.%A%    
% 222.86/223.09  |- skos__broader mesh__D007676smesh__D051436
% 222.86/223.09  |- skos__altLabel mesh__D007676 Chronic Kidney Failure
% 222.86/223.09  |- mesh__publicMeSHNote mesh__D007676 67   
% 222.86/223.09  |- skos__prefLabel mesh__D007676 Kidney Failure, Chronic
% 222.86/223.09  |- skos__annotation mesh__D007676
% 222.86/223.09       RENAL INSUFFICIENCY, CHRONIC is also available   
% 222.86/223.09  |- mesh__recordAuthorizer mesh__D007676 sjn
% 222.86/223.09  |- mesh__dateEstablished mesh__D007676 1967-01-01
% 222.86/223.09  |- rdf__type mesh__D007676sskos__Concept
% 222.86/223.09  |- skos__altLabel mesh__D007676 Renal Failure, End-Stage
% 222.86/223.09  |- skos__hiddenLabel mesh__D007676 Kidney Disease, End-Stage
% 222.86/223.09  |- skos__related mesh__D007676smesh__D014511
% 222.86/223.09  |- skos__hiddenLabel mesh__D007676 End Stage Kidney Disease
% 222.86/223.09  |- skos__altLabel mesh__D007676 End-Stage Kidney Disease
% 222.86/223.09  |- mesh__recordOriginator mesh__D007676 NLM
% 222.86/223.09  |- skos__altLabel mesh__D007676 ESRD
% 222.86/223.09  |- skos__altLabel mesh__D007676 End-Stage Renal Disease
% 222.86/223.09  |- skos__hiddenLabel mesh__D007676 Renal Failure, End Stage
% 222.86/223.09  |- skos__hiddenLabel mesh__D007676 Chronic Renal Failure
% 222.86/223.09  |- skos__altLabel mesh__D007676 Renal Failure, Chronic
% 222.86/223.09  |- skos__hiddenLabel mesh__D007676 Disease, End-Stage Renal
% 222.86/223.09  |- skos__related mesh__D007676smesh__D006435
% 222.86/223.09  |- skos__hiddenLabel mesh__D007676 End-Stage Renal Failure
% 222.86/223.09  |- skos__hiddenLabel mesh__D007676 End Stage Renal Disease
% 222.86/223.09  |- mesh__historyNote mesh__D007676 67%28%66%29%   
% 222.86/223.09  |- mesh__dateCreated mesh__D007676 1999-01-01
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D007676 2006
% 222.86/223.09  |- mesh__dateRevised mesh__D007676 2005-06-30
% 222.86/223.09  |- skos__broader mesh__D009206Q000033smesh__D009206
% 222.86/223.09  |- mesh__preferredCombination mesh__D009206Q000033smesh__D006321Q000033
% 222.86/223.09  |- rdf__type mesh__D009206Q000033smesh__CompoundConcept
% 222.86/223.09  |- skos__altLabel mesh__D040501 Myeloid Calcium-Binding Protein P8
% 222.86/223.09  |- mesh__dateEstablished mesh__D040501 2003-01-01
% 222.86/223.09  |- skos__altLabel mesh__D040501 Leukocyte L1 Protein Light Chain
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D040501 2006A
% 222.86/223.09  |- skos__hiddenLabel mesh__D040501 MRP 8 Protein
% 222.86/223.09  |- skos__altLabel mesh__D040501 Macrophage-Related Protein-8
% 222.86/223.09  |- mesh__historyNote mesh__D040501
% 222.86/223.09       2003; use CALGRANULIN A %28%NM%29% 1998-2002;   
% 222.86/223.09  |- skos__altLabel mesh__D040501 MRP-8 Protein
% 222.86/223.09  |- skos__scopeNote mesh__D040501
% 222.86/223.09       A 10.8-kDa member of the S-100 family of calcium-binding proteins that can form homo- or heterocomplexes with CALGRANULIN B and a variety of other proteins. The calgranulin A/B heterodimer is known as LEUKOCYTE L1 ANTIGEN COMPLEX.  Calgranulin A is found in many cell types including GRANULOCYTES; KERATINOCYTES; and myelomonocytes, and has been shown to act as a chemotactic substance for NEUTROPHILS.  Because it is present in acute inflammation but absent in chronic inflammation, it is a useful biological marker for a number of pathological conditions.%A%    
% 222.86/223.09  |- mesh__dateCreated mesh__D040501 2002-07-02
% 222.86/223.09  |- skos__historyNote mesh__D040501
% 222.86/223.09       Antigens, Differentiation %28%1989-2002%29%
% 222.86/223.09  |- skos__altLabel mesh__D040501 S100 A8 Protein
% 222.86/223.09  |- skos__altLabel mesh__D040501 CABP-P8
% 222.86/223.09  |- skos__hiddenLabel mesh__D040501 A8 Protein, S100
% 222.86/223.09  |- skos__prefLabel mesh__D040501 Calgranulin A
% 222.86/223.09  |- skos__altLabel mesh__D040501 MRP8 Protein
% 222.86/223.09  |- mesh__dateRevised mesh__D040501 2005-07-15
% 222.86/223.09  |- skos__hiddenLabel mesh__D040501 Antigen, 60B8-B
% 222.86/223.09  |- mesh__recordAuthorizer mesh__D040501 ags
% 222.86/223.09  |- mesh__publicMeSHNote mesh__D040501
% 222.86/223.09       2003; CALGRANULIN A was indexed under CALCIUM-BINDING BINDING PROTEINS 1989-2002; MRP-8 PROTEIN %28%now CALGRANULIN A%29% was indexed under ANTIGENS, DIFFERENTIATION %26% CALCIUM-BINDING PROTEINS 1989-2002%A%  
% 222.86/223.09  |- skos__historyNote mesh__D040501
% 222.86/223.09       Calcium-Binding Proteins %28%1989-2002%29%
% 222.86/223.09  |- skos__hiddenLabel mesh__D040501 Myeloid Calcium Binding Protein P8
% 222.86/223.09  |- skos__broader mesh__D040501smesh__D039841
% 222.86/223.09  |- rdf__type mesh__D040501sskos__Concept
% 222.86/223.09  |- skos__hiddenLabel mesh__D040501 Antigen, Cystic Fibrosis
% 222.86/223.09  |- skos__altLabel mesh__D040501 Cystic Fibrosis Antigen
% 222.86/223.09  |- mesh__recordOriginator mesh__D040501 MDJ
% 222.86/223.09  |- mesh__recordMaintainer mesh__D040501 ags
% 222.86/223.09  |- skos__hiddenLabel mesh__D040501 60B8 B Antigen
% 222.86/223.09  |- skos__altLabel mesh__D040501 60B8-B Antigen
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D040501 2006
% 222.86/223.09  |- skos__hiddenLabel mesh__D040501 Macrophage Related Protein 8
% 222.86/223.09  |- skos__altLabel mesh__D040501 S100A8 Protein
% 222.86/223.09  |- mesh__dateCreated mesh__D045795 2003-07-09
% 222.86/223.09  |- mesh__publicMeSHNote mesh__D045795 2004   
% 222.86/223.09  |- mesh__recordAuthorizer mesh__D045795 sjn
% 222.86/223.09  |- skos__prefLabel mesh__D045795 Mycoplasma orale
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D045795 2006
% 222.86/223.09  |- mesh__historyNote mesh__D045795 2004   
% 222.86/223.09  |- mesh__dateEstablished mesh__D045795 2004-01-01
% 222.86/223.09  |- mesh__dateRevised mesh__D045795 2005-06-30
% 222.86/223.09  |- rdf__type mesh__D045795sskos__Concept
% 222.86/223.09  |- mesh__recordOriginator mesh__D045795 ags
% 222.86/223.09  |- skos__scopeNote mesh__D045795
% 222.86/223.09       A species of gram-negative bacteria that is a common inhabitant of the human OROPHARYNX and also cell culture contaminant. It is usually non-pathogenic but it can cause infections in leukemic or immunosuppressed patients.%A%    
% 222.86/223.09  |- skos__annotation mesh__D045795
% 222.86/223.09       infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29%   
% 222.86/223.09  |- mesh__recordMaintainer mesh__D045795 SYSTEM
% 222.86/223.09  |- skos__historyNote mesh__D045795 Mycoplasma %28%1968-2003%29%
% 222.86/223.09  |- skos__broader mesh__D045795smesh__D009174
% 222.86/223.09  |- mesh__dateEstablished mesh__D012810 1980-01-01
% 222.86/223.09  |- skos__hiddenLabel mesh__D012810 Colon Disease, Sigmoid
% 222.86/223.09  |- skos__broader mesh__D012810smesh__D003108
% 222.86/223.09  |- skos__hiddenLabel mesh__D012810 Diseases, Sigmoid
% 222.86/223.09  |- mesh__dateRevised mesh__D012810 2003-07-09
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D012810 2005
% 222.86/223.09  |- mesh__publicMeSHNote mesh__D012810 80   
% 222.86/223.09  |- skos__scopeNote mesh__D012810
% 222.86/223.09       Pathological processes in the SIGMOID COLON region of the large intestine %28%INTESTINE, LARGE%29%.%A%    
% 222.86/223.09  |- skos__hiddenLabel mesh__D012810 Sigmoid Disease
% 222.86/223.09  |- skos__historyNote mesh__D012810 Colonic Diseases %28%1966-1979%29%
% 222.86/223.09  |- mesh__historyNote mesh__D012810 80   
% 222.86/223.09  |- skos__hiddenLabel mesh__D012810 Sigmoid Colon Disease
% 222.86/223.09  |- mesh__dateCreated mesh__D012810 1979-05-29
% 222.86/223.09  |- skos__annotation mesh__D012810
% 222.86/223.09       inflamm dis: coord IM with COLITIS %28%NIM%29% but note PROCTOSIGMOIDITIS see PROCTOCOLITIS %26% RECTOSIGMOIDITIS see PROCTOCOLITIS; diverticula %26% diverticulosis: coord IM with DIVERTICULUM, COLON %28%IM%29%; diverticulitis: coord IM with DIVERTICULITIS, COLONIC %28%IM%29%%A%  
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D012810 2006
% 222.86/223.09  |- skos__hiddenLabel mesh__D012810 Disease, Sigmoid
% 222.86/223.09  |- skos__historyNote mesh__D012810 specific intestinal disease
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D012810 2004
% 222.86/223.09  |- mesh__recordMaintainer mesh__D012810 lkt
% 222.86/223.09  |- skos__historyNote mesh__D012810 specific colonic disease
% 222.86/223.09  |- skos__hiddenLabel mesh__D012810 Diseases, Sigmoid Colon
% 222.86/223.09  |- skos__hiddenLabel mesh__D012810 Colon Diseases, Sigmoid
% 222.86/223.09  |- mesh__recordAuthorizer mesh__D012810 sjn
% 222.86/223.09  |- rdf__type mesh__D012810sskos__Concept
% 222.86/223.09  |- skos__prefLabel mesh__D012810 Sigmoid Diseases
% 222.86/223.09  |- skos__historyNote mesh__D012810 Sigmoid %28%1966-1979%29%
% 222.86/223.09  |- skos__hiddenLabel mesh__D012810 Disease, Sigmoid Colon
% 222.86/223.09  |- mesh__recordOriginator mesh__D012810 SMH
% 222.86/223.09  |- skos__altLabel mesh__D012810 Sigmoid Colon Diseases
% 222.86/223.09  |- skos__hiddenLabel mesh__D012012 Nucleus, Red
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D012012 2003
% 222.86/223.09  |- rdf__type mesh__D012012sskos__Concept
% 222.86/223.09  |- mesh__recordOriginator mesh__D012012 NLM
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D012012 2005
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D012012 2004
% 222.86/223.09  |- skos__altLabel mesh__D012012 Nucleus Ruber
% 222.86/223.09  |- skos__broader mesh__D012012smesh__D013681
% 222.86/223.09  |- mesh__dateRevised mesh__D012012 1999-11-03
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D012012 2006
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D012012 2000
% 222.86/223.09  |- mesh__recordAuthorizer mesh__D012012 sjn
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D012012 2001
% 222.86/223.09  |- mesh__recordMaintainer mesh__D012012 KEV
% 222.86/223.09  |- skos__scopeNote mesh__D012012
% 222.86/223.09       A pinkish-yellow portion of the midbrain situated in the rostral mesencephalic tegmentum. It receives a large projection from the contralateral half of the CEREBELLUM via the superior cerebellar peduncle and a projection from the ipsilateral MOTOR CORTEX.%A%    
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D012012 2002
% 222.86/223.09  |- mesh__dateCreated mesh__D012012 1999-01-01
% 222.86/223.09  |- skos__prefLabel mesh__D012012 Red Nucleus
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D003286 2003
% 222.86/223.09  |- mesh__recordAuthorizer mesh__D003286 sjn
% 222.86/223.09  |- rdf__type mesh__D003286sskos__Concept
% 222.86/223.09  |- skos__broader mesh__D003286smesh__D009135
% 222.86/223.09  |- mesh__recordOriginator mesh__D003286 NLM
% 222.86/223.09  |- skos__hiddenLabel mesh__D003286 Contractures
% 222.86/223.09  |- mesh__dateCreated mesh__D003286 1999-01-01
% 222.86/223.09  |- skos__broader mesh__D003286smesh__D007592
% 222.86/223.09  |- skos__annotation mesh__D003286
% 222.86/223.09       IM; coord with specific muscle or other tissue or site %28%IM%29% but not with MUSCLES; also available are DUPUYTREN%27%S CONTRACTURE; HIP CONTRACTURE %26% VOLKMANN CONTRACTURE see COMPARTMENT SYNDROMES%A%  
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D003286 2002
% 222.86/223.09  |- mesh__dateRevised mesh__D003286 2001-07-25
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D003286 2006
% 222.86/223.09  |- skos__prefLabel mesh__D003286 Contracture
% 222.86/223.09  |- mesh__recordMaintainer mesh__D003286 mdb
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D003286 2005
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D003286 2004
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D011718 2006
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D011718 2002
% 222.86/223.09  |- mesh__recordOriginator mesh__D011718 NLM
% 222.86/223.09  |- skos__broader mesh__D011718smesh__D011719
% 222.86/223.09  |- skos__scopeNote mesh__D011718
% 222.86/223.09       A pyrazine that is used therapeutically as an antitubercular agent.%A%    
% 222.86/223.09  |- rdf__type mesh__D011718sskos__Concept
% 222.86/223.09  |- skos__prefLabel mesh__D011718 Pyrazinamide
% 222.86/223.09  |- mesh__recordMaintainer mesh__D011718 ssb
% 222.86/223.09  |- mesh__recordAuthorizer mesh__D011718 sjn
% 222.86/223.09  |- mesh__dateCreated mesh__D011718 1999-01-01
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D011718 2003
% 222.86/223.09  |- mesh__dateRevised mesh__D011718 2001-07-25
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D011718 2005
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D011718 2004
% 222.86/223.09  |- mesh__dateCreated mesh__D049388 2004-07-07
% 222.86/223.09  |- mesh__publicMeSHNote mesh__D049388 2005   
% 222.86/223.09  |- mesh__recordMaintainer mesh__D049388 ssb
% 222.86/223.09  |- skos__scopeNote mesh__D049388
% 222.86/223.09       Anhydride polymers with a repeating structure of RC%28%=O%29%OC%28%=O%29%R. They readily hydrolyze in water making them useful for DELAYED-ACTION PREPARATIONS.%A%    
% 222.86/223.09  |- mesh__dateEstablished mesh__D049388 2005-01-01
% 222.86/223.09  |- skos__historyNote mesh__D049388 Polymers %28%1983-2004%29%
% 222.86/223.09  |- skos__broader mesh__D049388smesh__D000812
% 222.86/223.09  |- mesh__historyNote mesh__D049388 2005   
% 222.86/223.09  |- skos__prefLabel mesh__D049388 Polyanhydrides
% 222.86/223.09  |- mesh__activeMeSHYear mesh__D049388 2006
% 222.86/223.09  |- mesh__recordAuthorizer mesh__D049388 sjn
% 222.95/223.09  |- skos__broader mesh__D049388smesh__D011108
% 222.95/223.09  |- rdf__type mesh__D049388sskos__Concept
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D049388 2005
% 222.95/223.09  |- skos__historyNote mesh__D049388 Anhydrides %28%1985-2004%29%
% 222.95/223.09  |- mesh__recordOriginator mesh__D049388 ssb
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D016403 2000
% 222.95/223.09  |- skos__hiddenLabel mesh__D016403 Diffuse Large-Cell Lymphomas
% 222.95/223.09  |- mesh__dateEstablished mesh__D016403 1991-01-01
% 222.95/223.09  |- mesh__dateCreated mesh__D016403 1990-06-01
% 222.95/223.09  |- mesh__dateRevised mesh__D016403 1997-06-20
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D016403 2006
% 222.95/223.09  |- skos__broader mesh__D016403smesh__D016398
% 222.95/223.09  |- skos__hiddenLabel mesh__D016403 Lymphomas, Diffuse Large-Cell
% 222.95/223.09  |- rdf__type mesh__D016403sskos__Concept
% 222.95/223.09  |- skos__altLabel mesh__D016403 Lymphoma, Large Lymphoid, Diffuse
% 222.95/223.09  |- skos__scopeNote mesh__D016403
% 222.95/223.09       Malignant lymphoma composed of large cells which may be both cleaved and noncleaved. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.%A%    
% 222.95/223.09  |- skos__altLabel mesh__D016403 Diffuse Large-Cell Lymphoma
% 222.95/223.09  |- skos__broader mesh__D016403smesh__D008225
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D016403 1999
% 222.95/223.09  |- skos__altLabel mesh__D016403 Lymphoma, Histiocytic, Diffuse
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D016403 2005
% 222.95/223.09  |- skos__hiddenLabel mesh__D016403 Diffuse Large Cell Lymphoma
% 222.95/223.09  |- mesh__recordOriginator mesh__D016403 PLS
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D016403 2004
% 222.95/223.09  |- skos__hiddenLabel mesh__D016403
% 222.95/223.09       Diffuse Large Follicular Center Cell Lymphoma
% 222.95/223.09  |- skos__hiddenLabel mesh__D016403 Lymphoma, Diffuse Large Cell
% 222.95/223.09  |- skos__hiddenLabel mesh__D016403 Lymphoma, Diffuse Histiocytic
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D016403 2002
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D016403 1998
% 222.95/223.09  |- mesh__publicMeSHNote mesh__D016403 91   
% 222.95/223.09  |- skos__altLabel mesh__D016403
% 222.95/223.09       Lymphoma, Diffuse, Large Follicular Center Cell
% 222.95/223.09  |- skos__hiddenLabel mesh__D016403 Diffuse Histiocytic Lymphomas
% 222.95/223.09  |- skos__hiddenLabel mesh__D016403 Large-Cell Lymphomas, Diffuse
% 222.95/223.09  |- skos__broader mesh__D016403smesh__D016396
% 222.95/223.09  |- skos__hiddenLabel mesh__D016403 Histiocytic Lymphomas, Diffuse
% 222.95/223.09  |- skos__altLabel mesh__D016403
% 222.95/223.09       Large Follicular Center-Cell Lymphoma, Diffuse
% 222.95/223.09  |- skos__altLabel mesh__D016403
% 222.95/223.09       Lymphoma, Large Cell, Diffuse, Undifferentiated
% 222.95/223.09  |- skos__hiddenLabel mesh__D016403 Large Cell Lymphoma, Diffuse
% 222.95/223.09  |- skos__altLabel mesh__D016403 Large-Cell Lymphoma, Diffuse
% 222.95/223.09  |- skos__prefLabel mesh__D016403 Lymphoma, Large-Cell, Diffuse
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D016403 2003
% 222.95/223.09  |- skos__altLabel mesh__D016403 Large Lymphoid Lymphoma, Diffuse
% 222.95/223.09  |- skos__altLabel mesh__D016403
% 222.95/223.09       Lymphoma, Diffuse, Large Follicular Center-Cell
% 222.95/223.09  |- skos__hiddenLabel mesh__D016403 Diffuse Histiocytic Lymphoma
% 222.95/223.09  |- skos__altLabel mesh__D016403
% 222.95/223.09       Diffuse Large Follicular Center-Cell Lymphoma
% 222.95/223.09  |- skos__altLabel mesh__D016403 Histiocytic Lymphoma, Diffuse
% 222.95/223.09  |- mesh__historyNote mesh__D016403 91   
% 222.95/223.09  |- mesh__recordMaintainer mesh__D016403 PXP
% 222.95/223.09  |- skos__hiddenLabel mesh__D016403 Lymphomas, Diffuse Histiocytic
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D016403 2001
% 222.95/223.09  |- skos__altLabel mesh__D016403
% 222.95/223.09       Lymphoma, Large-Cell, Diffuse, Undifferentiated
% 222.95/223.09  |- skos__hiddenLabel mesh__D016403
% 222.95/223.09       Large Follicular Center Cell Lymphoma, Diffuse
% 222.95/223.09  |- mesh__recordAuthorizer mesh__D016403 SJN
% 222.95/223.09  |- skos__altLabel mesh__D016403 Lymphoma, Diffuse Large-Cell
% 222.95/223.09  |- skos__annotation mesh__D016403
% 222.95/223.09       an intermediate-grade non-Hodgkin%27%s lymphoma; DF: LYMPHOMA LARGE DIFFUSE%A%  
% 222.95/223.09  |- skos__broader mesh__D016403smesh__D008229
% 222.95/223.09  |- skos__altLabel mesh__D016403 Lymphoma, Large Cell, Diffuse
% 222.95/223.09  |- mesh__historyNote mesh__D046090 2005   
% 222.95/223.09  |- skos__historyNote mesh__D046090 Birds %28%1973-2004%29%
% 222.95/223.09  |- mesh__dateCreated mesh__D046090 2004-07-07
% 222.95/223.09  |- skos__broader mesh__D046090smesh__D001717
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D046090 2005
% 222.95/223.09  |- mesh__recordOriginator mesh__D046090 ags
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D046090 2006
% 222.95/223.09  |- skos__scopeNote mesh__D046090
% 222.95/223.09       An order of BIRDS comprising the waterfowl, particularly DUCKS; GEESE; swans; and screamers.%A%    
% 222.95/223.09  |- mesh__recordAuthorizer mesh__D046090 sjn
% 222.95/223.09  |- mesh__dateEstablished mesh__D046090 2005-01-01
% 222.95/223.09  |- mesh__recordMaintainer mesh__D046090 ags
% 222.95/223.09  |- skos__prefLabel mesh__D046090 Anseriformes
% 222.95/223.09  |- rdf__type mesh__D046090sskos__Concept
% 222.95/223.09  |- mesh__publicMeSHNote mesh__D046090 2005   
% 222.95/223.09  |- skos__hiddenLabel mesh__D007677 Kidney Function Test
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D007677 2003
% 222.95/223.09  |- skos__prefLabel mesh__D007677 Kidney Function Tests
% 222.95/223.09  |- mesh__dateRevised mesh__D007677 1997-06-20
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D007677 2001
% 222.95/223.09  |- rdf__type mesh__D007677sskos__Concept
% 222.95/223.09  |- skos__broader mesh__D007677smesh__D003950
% 222.95/223.09  |- skos__hiddenLabel mesh__D007677 Test, Kidney Function
% 222.95/223.09  |- skos__hiddenLabel mesh__D007677 Function Test, Kidney
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D007677 1999
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D007677 2000
% 222.95/223.09  |- mesh__recordAuthorizer mesh__D007677 SJN
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D007677 1998
% 222.95/223.09  |- skos__hiddenLabel mesh__D007677 Tests, Kidney Function
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D007677 2006
% 222.95/223.09  |- mesh__dateCreated mesh__D007677 1999-01-01
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D007677 2002
% 222.95/223.09  |- skos__hiddenLabel mesh__D007677 Function Tests, Kidney
% 222.95/223.09  |- mesh__recordOriginator mesh__D007677 NLM
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D007677 2005
% 222.95/223.09  |- mesh__recordMaintainer mesh__D007677 PXP
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D007677 2004
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D032070 2006
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D032070 2003
% 222.95/223.09  |- mesh__dateEstablished mesh__D032070 2003-01-01
% 222.95/223.09  |- mesh__dateCreated mesh__D032070 2002-07-03
% 222.95/223.09  |- mesh__historyNote mesh__D032070 2003   
% 222.95/223.09  |- rdf__type mesh__D032070sskos__Concept
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D032070 2005
% 222.95/223.09  |- skos__annotation mesh__D032070
% 222.95/223.09       UNCARIA PROCUMBENS see HARPAGOPHYTUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.95/223.09  |- skos__prefLabel mesh__D032070 Uncaria
% 222.95/223.09  |- skos__broader mesh__D032070smesh__D019666
% 222.95/223.09  |- skos__scopeNote mesh__D032070
% 222.95/223.09       A plant genus of the family RUBIACEAE. Members contain uncarine and other cytotoxic and hypotensive oxindole alkaloids.%A%    
% 222.95/223.09  |- mesh__publicMeSHNote mesh__D032070 2003   
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D032070 2004
% 222.95/223.09  |- skos__broader mesh__D003816Q000193smesh__D003816
% 222.95/223.09  |- mesh__preferredCombination mesh__D003816Q000193smesh__D004497
% 222.95/223.09  |- rdf__type mesh__D003816Q000193smesh__CompoundConcept
% 222.95/223.09  |- skos__historyNote mesh__D040502
% 222.95/223.09       Antigens, Differentiation %28%1999-2002%29%
% 222.95/223.09  |- skos__altLabel mesh__D040502 MRP-14 Protein
% 222.95/223.09  |- skos__altLabel mesh__D040502 Antigen 60B8-A
% 222.95/223.09  |- skos__altLabel mesh__D040502 60B8-A Antigen
% 222.95/223.09  |- mesh__publicMeSHNote mesh__D040502
% 222.95/223.09       2003; CALGRANULIN B was indexed under CALCIUM-BINDING PROTEINS 1989-2002; MRP-14 PROTEIN was indexed under ANTIGENS, DIFFERENTIATION %26% NEURONAL PROTEIN S100 1999-2002, CALCIUM-BINDING PROTEINS 1989-1998%A%  
% 222.95/223.09  |- mesh__historyNote mesh__D040502
% 222.95/223.09       2003; use CALGRANULIN B %28%NM%29% 1989-2002   
% 222.95/223.09  |- mesh__dateEstablished mesh__D040502 2003-01-01
% 222.95/223.09  |- mesh__recordMaintainer mesh__D040502 ssb
% 222.95/223.09  |- mesh__recordAuthorizer mesh__D040502 sjn
% 222.95/223.09  |- skos__broader mesh__D040502smesh__D039841
% 222.95/223.09  |- skos__hiddenLabel mesh__D040502 Macrophage Related Protein 14
% 222.95/223.09  |- mesh__dateRevised mesh__D040502 2005-06-30
% 222.95/223.09  |- skos__altLabel mesh__D040502 Myeloid Calcium-Binding Protein p14
% 222.95/223.09  |- rdf__type mesh__D040502sskos__Concept
% 222.95/223.09  |- mesh__recordOriginator mesh__D040502 MDJ
% 222.95/223.09  |- skos__prefLabel mesh__D040502 Calgranulin B
% 222.95/223.09  |- skos__hiddenLabel mesh__D040502 60B8 A Antigen
% 222.95/223.09  |- mesh__activeMeSHYear mesh__D040502 2006
% 222.95/223.09  |- skos__historyNote mesh__D040502
% 222.95/223.09       Calcium-Binding Proteins %28%1989-2002%29%
% 222.95/223.09  |- skos__hiddenLabel mesh__D040502 Myeloid Calcium Binding Protein p14
% 222.95/223.09  |- skos__altLabel mesh__D040502 MRP14 Protein
% 222.95/223.09  |- skos__altLabel mesh__D040502 Macrophage-Related Protein-14
% 222.95/223.09  |- skos__historyNote mesh__D040502
% 222.95/223.09       Calcium-Binding Proteins %28%1989-1998%29%
% 222.95/223.09  |- mesh__dateCreated mesh__D040502 2002-07-02
% 222.95/223.09  |- skos__hiddenLabel mesh__D040502 MRP 14 Protein
% 222.95/223.09  |- skos__altLabel mesh__D040502 S100A9 Protein
% 222.95/223.09  |- skos__scopeNote mesh__D040502
% 222.95/223.09       A 13.2-kDa member of the S-100 family of calcium-binding proteins that can form homo- or heterocomplexes with CALGRANULIN A and a variety of other proteins. The calgranulin A/B heterodimer is known as LEUKOCYTE L1 ANTIGEN COMPLEX. Calgranulin B is expressed at high concentrations in GRANULOCYTES during early monocyte differentiation, and serum calgranulin B levels are elevated in many inflammatory disorders such as CYSTIC FIBROSIS.%A%    
% 222.95/223.09  |- skos__hiddenLabel mesh__D040502 Antigen 60B8 A
% 222.95/223.09  |- skos__altLabel mesh__D040502 CABP-P14
% 222.95/223.09  |- skos__altLabel mesh__D040502 Leukocyte L1 Protein Heavy Chain
% 222.95/223.09  |- skos__historyNote mesh__D040502 S100 Protein Family %28%1999-2002%29%
% 222.95/223.09  |- skos__hiddenLabel mesh__D040502 Antigen, 60B8-A
% 222.95/223.09  |- mesh__dateRevised mesh__D012811 2003-07-09
% 222.95/223.09  |- skos__altLabel mesh__D012811 Sigmoid Colon Neoplasms
% 222.95/223.10  |- skos__altLabel mesh__D012811 Sigmoid Colon Cancer
% 222.95/223.10  |- skos__broader mesh__D012811smesh__D012810
% 222.95/223.10  |- skos__hiddenLabel mesh__D012811 Sigmoid Neoplasm
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012811 2005
% 222.95/223.10  |- skos__hiddenLabel mesh__D012811 Sigmoid Colon Neoplasm
% 222.95/223.10  |- skos__hiddenLabel mesh__D012811 Neoplasms, Sigmoid Colon
% 222.95/223.10  |- mesh__recordOriginator mesh__D012811 NLM
% 222.95/223.10  |- skos__hiddenLabel mesh__D012811 Neoplasm, Sigmoid Colon
% 222.95/223.10  |- skos__altLabel mesh__D012811 Sigmoidal Cancer
% 222.95/223.10  |- skos__altLabel mesh__D012811 Cancer of the Sigmoid
% 222.95/223.10  |- skos__hiddenLabel mesh__D012811 Colon Neoplasms, Sigmoid
% 222.95/223.10  |- skos__hiddenLabel mesh__D012811 Colon Cancer, Sigmoid
% 222.95/223.10  |- skos__altLabel mesh__D012811 Neoplasms, Sigmoid
% 222.95/223.10  |- mesh__dateCreated mesh__D012811 1999-01-01
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012811 2006
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012811 2004
% 222.95/223.10  |- rdf__type mesh__D012811sskos__Concept
% 222.95/223.10  |- skos__hiddenLabel mesh__D012811 Neoplasm, Sigmoid
% 222.95/223.10  |- skos__altLabel mesh__D012811 Cancer of Sigmoid
% 222.95/223.10  |- skos__scopeNote mesh__D012811
% 222.95/223.10       Tumors or cancer of the SIGMOID COLON.     
% 222.95/223.10  |- skos__annotation mesh__D012811
% 222.95/223.10       coord IM with histol type of neopl %28%IM%29%   
% 222.95/223.10  |- mesh__recordMaintainer mesh__D012811 lkt
% 222.95/223.10  |- skos__broader mesh__D012811smesh__D003110
% 222.95/223.10  |- skos__hiddenLabel mesh__D012811 Cancer, Sigmoid
% 222.95/223.10  |- skos__prefLabel mesh__D012811 Sigmoid Neoplasms
% 222.95/223.10  |- skos__hiddenLabel mesh__D012811 Cancer, Sigmoid Colon
% 222.95/223.10  |- mesh__recordAuthorizer mesh__D012811 sjn
% 222.95/223.10  |- skos__hiddenLabel mesh__D012013 Book, Reference
% 222.95/223.10  |- skos__scopeNote mesh__D012013
% 222.95/223.10       Books designed by the arrangement and treatment of their subject matter to be consulted for definite terms of information rather than to be read consecutively. Reference books include DICTIONARIES; ENCYCLOPEDIAS; ATLASES; etc. %28%From the ALA Glossary of Library and Information Science, 1983%29%%A%    
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012013 2004
% 222.95/223.10  |- mesh__dateCreated mesh__D012013 1999-01-01
% 222.95/223.10  |- rdf__type mesh__D012013sskos__Concept
% 222.95/223.10  |- mesh__recordMaintainer mesh__D012013 mdb
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012013 2003
% 222.95/223.10  |- skos__hiddenLabel mesh__D012013 Reference Book
% 222.95/223.10  |- mesh__recordOriginator mesh__D012013 NLM
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012013 2006
% 222.95/223.10  |- mesh__dateRevised mesh__D012013 2001-07-25
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012013 2002
% 222.95/223.10  |- skos__hiddenLabel mesh__D012013 Books, Reference
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012013 2005
% 222.95/223.10  |- skos__broader mesh__D012013smesh__D001877
% 222.95/223.10  |- skos__annotation mesh__D012013 IM   
% 222.95/223.10  |- mesh__recordAuthorizer mesh__D012013 sjn
% 222.95/223.10  |- skos__related mesh__D012013smesh__D013782
% 222.95/223.10  |- skos__prefLabel mesh__D012013 Reference Books
% 222.95/223.10  |- mesh__historyNote mesh__D036461 2003   
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D036461 2004
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D036461 2006
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D036461 2003
% 222.95/223.10  |- mesh__dateEstablished mesh__D036461 2003-01-01
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D036461 2005
% 222.95/223.10  |- skos__broader mesh__D036461smesh__D019665
% 222.95/223.10  |- mesh__dateCreated mesh__D036461 2002-07-03
% 222.95/223.10  |- rdf__type mesh__D036461sskos__Concept
% 222.95/223.10  |- skos__altLabel mesh__D036461 Kamala Tree
% 222.95/223.10  |- mesh__publicMeSHNote mesh__D036461 2003   
% 222.95/223.10  |- skos__prefLabel mesh__D036461 Mallotus Plant
% 222.95/223.10  |- skos__annotation mesh__D036461
% 222.95/223.10       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.95/223.10  |- skos__scopeNote mesh__D036461
% 222.95/223.10       A plant genus of the family EUPHORBIACEAE. Members contain fredelin type TRITERPENES, mallorepine %28%a cyano-pyridone%29%, and hydrolyzable TANNINS.%A%    
% 222.95/223.10  |- mesh__dateCreated mesh__D003287 1999-01-01
% 222.95/223.10  |- mesh__dateRevised mesh__D003287 2003-07-09
% 222.95/223.10  |- mesh__recordAuthorizer mesh__D003287 sjn
% 222.95/223.10  |- mesh__recordMaintainer mesh__D003287 ssb
% 222.95/223.10  |- skos__hiddenLabel mesh__D003287 Media, Radiopaque
% 222.95/223.10  |- skos__broader mesh__D003287smesh__D020313
% 222.95/223.10  |- mesh__recordOriginator mesh__D003287 NLM
% 222.95/223.10  |- skos__prefLabel mesh__D003287 Contrast Media
% 222.95/223.10  |- skos__hiddenLabel mesh__D003287 Media, Contrast
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D003287 2006
% 222.95/223.10  |- skos__altLabel mesh__D003287 Radiopaque Media
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D003287 2005
% 222.95/223.10  |- skos__annotation mesh__D003287
% 222.95/223.10       /adv eff: consider also EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS%A%  
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D003287 2004
% 222.95/223.10  |- skos__scopeNote mesh__D003287
% 222.95/223.10       Substances used in radiography that allow visualization of certain tissues.%A%    
% 222.95/223.10  |- skos__related mesh__D003287smesh__D005119
% 222.95/223.10  |- rdf__type mesh__D003287sskos__Concept
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D011719 1995
% 222.95/223.10  |- rdf__type mesh__D011719sskos__Concept
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D011719 2000
% 222.95/223.10  |- skos__annotation mesh__D011719 do not confuse with PYRIDAZINES   
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D011719 2001
% 222.95/223.10  |- mesh__recordMaintainer mesh__D011719 TAP
% 222.95/223.10  |- mesh__dateCreated mesh__D011719 1999-01-01
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D011719 2003
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D011719 1996
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D011719 2005
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D011719 1998
% 222.95/223.10  |- skos__prefLabel mesh__D011719 Pyrazines
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D011719 2004
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D011719 1997
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D011719 2002
% 222.95/223.10  |- mesh__recordOriginator mesh__D011719 NLM
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D011719 2006
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D011719 1999
% 222.95/223.10  |- skos__broader mesh__D011719smesh__D006573
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D011719 1994
% 222.95/223.10  |- mesh__recordAuthorizer mesh__D011719 PLS
% 222.95/223.10  |- mesh__dateRevised mesh__D011719 1992-05-20
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D011719 1993
% 222.95/223.10  |- skos__annotation mesh__D008770 D25-26 qualif   
% 222.95/223.10  |- skos__hiddenLabel mesh__D008770 NSC23909
% 222.95/223.10  |- skos__hiddenLabel mesh__D008770 NSC 23909
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D008770 2005
% 222.95/223.10  |- skos__broader mesh__D008770smesh__D009607
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D008770 2002
% 222.95/223.10  |- mesh__dateRevised mesh__D008770 2000-06-22
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D008770 2004
% 222.95/223.10  |- rdf__type mesh__D008770sskos__Concept
% 222.95/223.10  |- skos__altLabel mesh__D008770 N-Methyl-N-nitrosourea
% 222.95/223.10  |- mesh__dateCreated mesh__D008770 1974-11-11
% 222.95/223.10  |- mesh__recordOriginator mesh__D008770 NLM
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D008770 2001
% 222.95/223.10  |- skos__historyNote mesh__D008770 Nitrosourea Compounds %28%1973-1974%29%
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D008770 2003
% 222.95/223.10  |- mesh__historyNote mesh__D008770
% 222.95/223.10       86%28%75%29%; was see under NITROSOUREA COMPOUNDS 1975-85   
% 222.95/223.10  |- skos__scopeNote mesh__D008770
% 222.95/223.10       A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties.%A%    
% 222.95/223.10  |- skos__prefLabel mesh__D008770 Methylnitrosourea
% 222.95/223.10  |- skos__hiddenLabel mesh__D008770 N Methyl N nitrosourea
% 222.95/223.10  |- mesh__publicMeSHNote mesh__D008770
% 222.95/223.10       86; was see under NITROSOUREA COMPOUNDS 1975-85   
% 222.95/223.10  |- skos__altLabel mesh__D008770 Nitrosomethylurea
% 222.95/223.10  |- mesh__dateEstablished mesh__D008770 1986-01-01
% 222.95/223.10  |- mesh__recordAuthorizer mesh__D008770 sjn
% 222.95/223.10  |- skos__historyNote mesh__D008770 Methane %28%1973-1974%29%
% 222.95/223.10  |- mesh__recordMaintainer mesh__D008770 CCR
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D008770 2006
% 222.95/223.10  |- mesh__dateEstablished mesh__D016404 1991-01-01
% 222.95/223.10  |- skos__altLabel mesh__D016404 Lymphoma, Large Lymphoid, Nodular
% 222.95/223.10  |- skos__hiddenLabel mesh__D016404 Lymphomas, Nodular Histiocytic
% 222.95/223.10  |- skos__hiddenLabel mesh__D016404 Large-Cell Lymphomas, Follicular
% 222.95/223.10  |- skos__altLabel mesh__D016404
% 222.95/223.10       Nodular Large Follicular Center-Cell Lymphoma
% 222.95/223.10  |- skos__hiddenLabel mesh__D016404
% 222.95/223.10       Nodular Large Follicular Center Cell Lymphoma
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D016404 2006
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D016404 2000
% 222.95/223.10  |- rdf__type mesh__D016404sskos__Concept
% 222.95/223.10  |- skos__hiddenLabel mesh__D016404 Lymphoma, Nodular Histiocytic
% 222.95/223.10  |- mesh__dateCreated mesh__D016404 1990-06-01
% 222.95/223.10  |- skos__altLabel mesh__D016404 Lymphoma, Large Cell, Follicular
% 222.95/223.10  |- skos__broader mesh__D016404smesh__D008225
% 222.95/223.10  |- mesh__dateRevised mesh__D016404 1997-06-20
% 222.95/223.10  |- skos__altLabel mesh__D016404
% 222.95/223.10       Lymphoma, Nodular, Large Follicular Center-Cell
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D016404 1999
% 222.95/223.10  |- skos__hiddenLabel mesh__D016404 Histiocytic Lymphomas, Nodular
% 222.95/223.10  |- skos__prefLabel mesh__D016404 Lymphoma, Large-Cell, Follicular
% 222.95/223.10  |- skos__hiddenLabel mesh__D016404 Follicular Large Cell Lymphoma
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D016404 2005
% 222.95/223.10  |- skos__hiddenLabel mesh__D016404 Large Cell Lymphoma, Follicular
% 222.95/223.10  |- mesh__recordOriginator mesh__D016404 PLS
% 222.95/223.10  |- skos__hiddenLabel mesh__D016404 Nodular Histiocytic Lymphomas
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D016404 2004
% 222.95/223.10  |- skos__scopeNote mesh__D016404
% 222.95/223.10       Malignant lymphoma in which the majority of neoplastic cells within the follicles are large cleaved or noncleaved cells. The degree to which the follicular center cells retain their ability to form follicles varies with the state of B-cell transformation.%A%    
% 222.95/223.10  |- skos__altLabel mesh__D016404 Large Lymphoid Lymphoma, Nodular
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D016404 1998
% 222.95/223.10  |- skos__altLabel mesh__D016404 Large-Cell Lymphoma, Follicular
% 222.95/223.10  |- skos__hiddenLabel mesh__D016404 Follicular Large-Cell Lymphomas
% 222.95/223.10  |- skos__hiddenLabel mesh__D016404 Nodular Histiocytic Lymphoma
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D016404 2002
% 222.95/223.10  |- mesh__publicMeSHNote mesh__D016404 91   
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D016404 2003
% 222.95/223.10  |- skos__altLabel mesh__D016404
% 222.95/223.10       Lymphoma, Nodular, Large Follicular Center Cell
% 222.95/223.10  |- skos__broader mesh__D016404smesh__D016396
% 222.95/223.10  |- skos__hiddenLabel mesh__D016404 Lymphoma, Follicular Large Cell
% 222.95/223.10  |- skos__altLabel mesh__D016404 Histiocytic Lymphoma, Nodular
% 222.95/223.10  |- skos__hiddenLabel mesh__D016404 Lymphomas, Follicular Large-Cell
% 222.95/223.10  |- mesh__historyNote mesh__D016404 91   
% 222.95/223.10  |- skos__annotation mesh__D016404
% 222.95/223.10       an intermediate-grade non-Hodgkin%27%s lymphoma; DF: LYMPHOMA LARGE FOLLIC%A%  
% 222.95/223.10  |- skos__altLabel mesh__D016404 Lymphoma, Follicular Large-Cell
% 222.95/223.10  |- skos__altLabel mesh__D016404 Lymphoma, Histiocytic, Nodular
% 222.95/223.10  |- mesh__recordMaintainer mesh__D016404 PXP
% 222.95/223.10  |- skos__altLabel mesh__D016404 Follicular Large-Cell Lymphoma
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D016404 2001
% 222.95/223.10  |- skos__broader mesh__D016404smesh__D008224
% 222.95/223.10  |- mesh__recordAuthorizer mesh__D016404 SJN
% 222.95/223.10  |- skos__broader mesh__D046091smesh__D001717
% 222.95/223.10  |- mesh__historyNote mesh__D046091 2006 %28%2005%29%   
% 222.95/223.10  |- skos__scopeNote mesh__D046091
% 222.95/223.10       An order of BIRDS including over 300 species that primarily inhabit coastal waters, beaches, and marshes. They are comprised of shorebirds, gulls, and terns.%A%    
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D046091 2006
% 222.95/223.10  |- skos__hiddenLabel mesh__D046091 Gull
% 222.95/223.10  |- skos__hiddenLabel mesh__D046091 Tern
% 222.95/223.10  |- skos__prefLabel mesh__D046091 Charadriiformes
% 222.95/223.10  |- mesh__recordMaintainer mesh__D046091 ags
% 222.95/223.10  |- skos__altLabel mesh__D046091 Laridae
% 222.95/223.10  |- mesh__recordOriginator mesh__D046091 ags
% 222.95/223.10  |- mesh__publicMeSHNote mesh__D046091 2006; see Charadriformes 2005   
% 222.95/223.10  |- rdf__type mesh__D046091sskos__Concept
% 222.95/223.10  |- skos__historyNote mesh__D046091 Birds %28%1967-2004%29%
% 222.95/223.10  |- mesh__dateRevised mesh__D046091 2005-06-30
% 222.95/223.10  |- mesh__recordAuthorizer mesh__D046091 sjn
% 222.95/223.10  |- mesh__dateEstablished mesh__D046091 2005-01-01
% 222.95/223.10  |- mesh__dateCreated mesh__D046091 2004-07-07
% 222.95/223.10  |- skos__related mesh__D007678smesh__D017597
% 222.95/223.10  |- skos__scopeNote mesh__D007678
% 222.95/223.10       A cluster of convoluted capillaries beginning at each nephric tubule in the kidney and held together by connective tissue.%A%    
% 222.95/223.10  |- mesh__recordOriginator mesh__D007678 NLM
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D007678 2006
% 222.95/223.10  |- mesh__dateCreated mesh__D007678 1999-01-01
% 222.95/223.10  |- skos__hiddenLabel mesh__D007678 Glomerulus, Kidney
% 222.95/223.10  |- skos__broader mesh__D007678smesh__D007672
% 222.95/223.10  |- skos__related mesh__D007678smesh__D005919
% 222.95/223.10  |- mesh__dateRevised mesh__D007678 2005-06-30
% 222.95/223.10  |- skos__broader mesh__D007678smesh__D009399
% 222.95/223.10  |- skos__annotation mesh__D007678
% 222.95/223.10       %22%minimal change glomerular disease%22% = NEPHROSIS, LIPOID   
% 222.95/223.10  |- skos__prefLabel mesh__D007678 Kidney Glomerulus
% 222.95/223.10  |- rdf__type mesh__D007678sskos__Concept
% 222.95/223.10  |- skos__related mesh__D007678smesh__D017596
% 222.95/223.10  |- mesh__recordAuthorizer mesh__D007678 sjn
% 222.95/223.10  |- mesh__recordMaintainer mesh__D007678 nns
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D040503 2005
% 222.95/223.10  |- skos__altLabel mesh__D040503 Caffea
% 222.95/223.10  |- skos__related mesh__D040503smesh__D003069
% 222.95/223.10  |- mesh__historyNote mesh__D040503 2003; use COFFEE 1986-2002   
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D040503 2006
% 222.95/223.10  |- skos__annotation mesh__D040503
% 222.95/223.10       for the beverage, use COFFEE; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.95/223.10  |- rdf__type mesh__D040503sskos__Concept
% 222.95/223.10  |- mesh__dateEstablished mesh__D040503 2003-01-01
% 222.95/223.10  |- skos__prefLabel mesh__D040503 Coffea
% 222.95/223.10  |- skos__historyNote mesh__D040503 Coffee %28%1966-2002%29%
% 222.95/223.10  |- mesh__dateCreated mesh__D040503 2002-07-03
% 222.95/223.10  |- skos__broader mesh__D040503smesh__D019666
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D040503 2003
% 222.95/223.10  |- mesh__publicMeSHNote mesh__D040503 2003; see COFFEE 1986-2002   
% 222.95/223.10  |- skos__scopeNote mesh__D040503
% 222.95/223.10       A plant genus of the family RUBIACEAE. It is best known for the COFFEE beverage prepared from the beans %28%SEEDS%29%.%A%    
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D040503 2004
% 222.95/223.10  |- skos__broader mesh__D004380smesh__D007415
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D004380 2005
% 222.95/223.10  |- skos__broader mesh__D004380smesh__D004378
% 222.95/223.10  |- rdf__type mesh__D004380sskos__Concept
% 222.95/223.10  |- skos__scopeNote mesh__D004380
% 222.95/223.10       Hindrance of the passage of luminal contents in the DUODENUM. Duodenal obstruction can be partial or complete, and caused by intrinsic or extrinsic factors. Simple obstruction is associated with diminished or stopped flow of luminal contents. Strangulating obstruction is associated with impaired blood flow to the duodenum in addition to obstructed flow of luminal contents.%A%    
% 222.95/223.10  |- mesh__recordOriginator mesh__D004380 NLM
% 222.95/223.10  |- mesh__dateRevised mesh__D004380 2004-07-19
% 222.95/223.10  |- skos__hiddenLabel mesh__D004380 Obstruction, Duodenal
% 222.95/223.10  |- skos__hiddenLabel mesh__D004380 Duodenal Obstructions
% 222.95/223.10  |- mesh__dateCreated mesh__D004380 1999-01-01
% 222.95/223.10  |- mesh__recordAuthorizer mesh__D004380 sjn
% 222.95/223.10  |- skos__hiddenLabel mesh__D004380 Obstructions, Duodenal
% 222.95/223.10  |- mesh__recordMaintainer mesh__D004380 jls
% 222.95/223.10  |- skos__prefLabel mesh__D004380 Duodenal Obstruction
% 222.95/223.10  |- skos__annotation mesh__D004380
% 222.95/223.10       duodenal compression by superior mesenteric artery = SUPERIOR MESENTERIC ARTERY SYNDROME; duodenal atresia = DUODENAL OBSTRUCTION /congen %28%IM%29% + INTESTINAL ATRESIA %28%IM%29%%A%  
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D004380 2006
% 222.95/223.10  |- skos__hiddenLabel mesh__D012812 Surgeries, Sigmoidoscopic
% 222.95/223.10  |- mesh__dateRevised mesh__D012812 1999-11-03
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012812 2001
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012812 2004
% 222.95/223.10  |- skos__hiddenLabel mesh__D012812 Sigmoidoscopic Surgeries
% 222.95/223.10  |- skos__altLabel mesh__D012812 Sigmoidoscopic Surgery
% 222.95/223.10  |- skos__hiddenLabel mesh__D012812 Proctosigmoidoscopies
% 222.95/223.10  |- skos__hiddenLabel mesh__D012812 Surgical Procedure, Sigmoidoscopic
% 222.95/223.10  |- rdf__type mesh__D012812sskos__Concept
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012812 2002
% 222.95/223.10  |- skos__altLabel mesh__D012812 Proctosigmoidoscopy
% 222.95/223.10  |- mesh__recordAuthorizer mesh__D012812 sjn
% 222.95/223.10  |- skos__hiddenLabel mesh__D012812 Procedures, Sigmoidoscopic Surgical
% 222.95/223.10  |- skos__prefLabel mesh__D012812 Sigmoidoscopy
% 222.95/223.10  |- skos__broader mesh__D012812smesh__D003113
% 222.95/223.10  |- skos__hiddenLabel mesh__D012812 Sigmoidoscopic Surgical Procedure
% 222.95/223.10  |- skos__scopeNote mesh__D012812
% 222.95/223.10       Endoscopic examination, therapy or surgery of the sigmoid flexure.%A%    
% 222.95/223.10  |- mesh__recordMaintainer mesh__D012812 nns
% 222.95/223.10  |- skos__altLabel mesh__D012812 Surgical Procedures, Sigmoidoscopic
% 222.95/223.10  |- mesh__recordOriginator mesh__D012812 NLM
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012812 2000
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012812 2005
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012812 2003
% 222.95/223.10  |- skos__hiddenLabel mesh__D012812 Sigmoidoscopies
% 222.95/223.10  |- skos__altLabel mesh__D012812 Surgery, Sigmoidoscopic
% 222.95/223.10  |- mesh__dateCreated mesh__D012812 1999-01-01
% 222.95/223.10  |- skos__hiddenLabel mesh__D012812 Procedure, Sigmoidoscopic Surgical
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012812 2006
% 222.95/223.10  |- skos__annotation mesh__D012014 no qualif; DF: REFERENCE BOOKS MED   
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012014 1994
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012014 2004
% 222.95/223.10  |- mesh__recordMaintainer mesh__D012014 TAP
% 222.95/223.10  |- mesh__dateCreated mesh__D012014 1999-01-01
% 222.95/223.10  |- rdf__type mesh__D012014sskos__Concept
% 222.95/223.10  |- skos__altLabel mesh__D012014 Books, Medical Reference
% 222.95/223.10  |- skos__altLabel mesh__D012014 Medical Reference Books
% 222.95/223.10  |- skos__broader mesh__D012014smesh__D012013
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012014 2003
% 222.95/223.10  |- skos__prefLabel mesh__D012014 Reference Books, Medical
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012014 2001
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012014 1991
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012014 1997
% 222.95/223.10  |- skos__scopeNote mesh__D012014
% 222.95/223.10       Books in the field of medicine intended primarily for consultation.%A%    
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012014 2006
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012014 1993
% 222.95/223.10  |- mesh__dateEstablished mesh__D012014 1975-01-01
% 222.95/223.10  |- mesh__historyNote mesh__D012014 75   
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012014 2000
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012014 1996
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012014 2005
% 222.95/223.10  |- mesh__publicMeSHNote mesh__D012014 75   
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012014 1999
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012014 1992
% 222.95/223.10  |- mesh__recordOriginator mesh__D012014 NLM
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012014 1995
% 222.95/223.10  |- mesh__dateRevised mesh__D012014 1990-05-17
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012014 2002
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D012014 1998
% 222.95/223.10  |- mesh__recordAuthorizer mesh__D012014 PLS
% 222.95/223.10  |- mesh__recordMaintainer mesh__D003288 KEV
% 222.95/223.10  |- skos__hiddenLabel mesh__D003288 Contusion
% 222.95/223.10  |- skos__scopeNote mesh__D003288
% 222.95/223.10       Injuries resulting in hemorrhage, usually manifested in the skin.%A%    
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D003288 2005
% 222.95/223.10  |- skos__hiddenLabel mesh__D003288 Bruises
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D003288 2000
% 222.95/223.10  |- skos__broader mesh__D003288smesh__D014949
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D003288 2003
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D003288 2006
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D003288 2001
% 222.95/223.10  |- skos__prefLabel mesh__D003288 Contusions
% 222.95/223.10  |- mesh__recordAuthorizer mesh__D003288 sjn
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D003288 2004
% 222.95/223.10  |- mesh__dateRevised mesh__D003288 1999-11-03
% 222.95/223.10  |- skos__altLabel mesh__D003288 Bruise
% 222.95/223.10  |- mesh__recordOriginator mesh__D003288 NLM
% 222.95/223.10  |- mesh__dateCreated mesh__D003288 1999-01-01
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D003288 2002
% 222.95/223.10  |- skos__broader mesh__D003288smesh__D014947
% 222.95/223.10  |- skos__annotation mesh__D003288
% 222.95/223.10       differentiate from ECCHYMOSIS: use term in the text; brain contusion: index under BRAIN INJURIES%A%  
% 222.95/223.10  |- rdf__type mesh__D003288sskos__Concept
% 222.95/223.10  |- skos__hiddenLabel mesh__D008771 3,4 Dihydroxynorephedrine
% 222.95/223.10  |- skos__altLabel mesh__D008771 Norephrine
% 222.95/223.10  |- skos__hiddenLabel mesh__D008771 Neo Cobefrin
% 222.95/223.10  |- mesh__historyNote mesh__D008771
% 222.95/223.10       91%28%75%29%; was METHYLNOREPINEPHRINE see under NOREPINEPHRINE/analogs %26% derivatives 1975-90, see under NORMETANEPHRINE 1971-74, %26% see NORMETANEPHRINE 1966-70%A%  
% 222.95/223.10  |- mesh__publicMeSHNote mesh__D008771
% 222.95/223.10       91; was METHYLNOREPINEPHRINE see under NOREPINEPHRINE/analogs %26% derivatives 1975-90, see under NORMETANEPHRINE 1971-74, %26% see NORMETANEPHRINE 1966-70%A%  
% 222.95/223.10  |- mesh__recordAuthorizer mesh__D008771 sjn
% 222.95/223.10  |- skos__altLabel mesh__D008771
% 222.95/223.10       4-%28%2-Amino-1-hydroxypropyl%29%-1,2-benzenediol Tartrate, %28%R*,R*%29%, %28%R*,R*%29%-Isomer
% 222.95/223.10  |- mesh__onlineNote mesh__D008771
% 222.95/223.10       use NORDEFRIN to search METHYLNOREPINEPHRINE 1975-90; use NORMETANEPHRINE 1966-74%A%  
% 222.95/223.10  |- skos__altLabel mesh__D008771 3,4-Dihydroxynorephedrine
% 222.95/223.10  |- skos__hiddenLabel mesh__D008771 alpha Methylnorepinephrine
% 222.95/223.10  |- skos__altLabel mesh__D008771
% 222.95/223.10       4-%28%2-Amino-1-hydroxypropyl%29%-1,2-benzenediol Tartrate, %28%R*,S*%29%, %28%R*,R*%29%-Isomer
% 222.95/223.10  |- skos__scopeNote mesh__D008771
% 222.95/223.10       A norepinephrine derivative used as a vasoconstrictor agent.%A%    
% 222.95/223.10  |- mesh__dateCreated mesh__D008771 1999-01-01
% 222.95/223.10  |- skos__altLabel mesh__D008771 Levonordefrin
% 222.95/223.10  |- skos__hiddenLabel mesh__D008771 Hydrochloride, Nordefrin
% 222.95/223.10  |- mesh__recordMaintainer mesh__D008771 ssb
% 222.95/223.10  |- mesh__dateRevised mesh__D008771 2003-07-09
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D008771 2006
% 222.95/223.10  |- skos__hiddenLabel mesh__D008771 NeoCobefrin
% 222.95/223.10  |- skos__altLabel mesh__D008771
% 222.95/223.10       4-%28%2-Amino-1-hydroxypropyl%29%-1,2-benzenediol, %28%R*,R*%29%-Isomer
% 222.95/223.10  |- skos__altLabel mesh__D008771
% 222.95/223.10       4-%28%2-Amino-1-hydroxypropyl%29%-1,2-benzenediol, %28%R*,S*%29%-Isomer
% 222.95/223.10  |- skos__altLabel mesh__D008771
% 222.95/223.10       4-%28%2-Amino-1-hydroxypropyl%29%-1,2-benzenediol Hydrochloride, %28%R*,R*%29%-%28%+,-%29%-Isomer
% 222.95/223.10  |- skos__altLabel mesh__D008771 alpha-Methylnorepinephrine
% 222.95/223.10  |- skos__broader mesh__D008771smesh__D009638
% 222.95/223.10  |- skos__altLabel mesh__D008771
% 222.95/223.10       4-%28%2-Amino-1-hydroxypropyl%29%-1,2-benzenediol Hydrochloride, %28%R*,S*%29%-%28%+-%29%-Isomer
% 222.95/223.10  |- skos__hiddenLabel mesh__D008771 alpha Methylnoradrenaline
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D008771 2005
% 222.95/223.10  |- mesh__recordOriginator mesh__D008771 NLM
% 222.95/223.10  |- skos__prefLabel mesh__D008771 Nordefrin
% 222.95/223.10  |- skos__altLabel mesh__D008771 alpha-Methylnoradrenaline
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D008771 2004
% 222.95/223.10  |- rdf__type mesh__D008771sskos__Concept
% 222.95/223.10  |- skos__altLabel mesh__D008771
% 222.95/223.10       4-%28%2-Amino-1-hydroxypropyl%29%-1,2-benzenediol
% 222.95/223.10  |- mesh__dateEstablished mesh__D008771 1991-01-01
% 222.95/223.10  |- mesh__dateRevised mesh__D016405 1997-06-20
% 222.95/223.10  |- skos__altLabel mesh__D016405
% 222.95/223.10       Mixed Small and Large Cell Lymphoma, Diffuse
% 222.95/223.10  |- skos__hiddenLabel mesh__D016405 Mixed-Cell Lymphomas, Diffuse
% 222.95/223.10  |- mesh__dateCreated mesh__D016405 1990-06-01
% 222.95/223.10  |- skos__hiddenLabel mesh__D016405 Diffuse Mixed-Cell Lymphomas
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D016405 2003
% 222.95/223.10  |- mesh__publicMeSHNote mesh__D016405 91   
% 222.95/223.10  |- skos__altLabel mesh__D016405
% 222.95/223.10       Lymphoma, Small and Large Cleaved-Cell, Diffuse
% 222.95/223.10  |- skos__altLabel mesh__D016405
% 222.95/223.10       Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic
% 222.95/223.10  |- skos__hiddenLabel mesh__D016405 Lymphomas, Diffuse Mixed-Cell
% 222.95/223.10  |- skos__prefLabel mesh__D016405 Lymphoma, Mixed-Cell, Diffuse
% 222.95/223.10  |- mesh__historyNote mesh__D016405 91   
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D016405 2000
% 222.95/223.10  |- skos__hiddenLabel mesh__D016405 Lymphoma, Diffuse Mixed-Cell
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D016405 2005
% 222.95/223.10  |- skos__hiddenLabel mesh__D016405 Diffuse Mixed Cell Lymphoma
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D016405 2004
% 222.95/223.10  |- skos__broader mesh__D016405smesh__D008227
% 222.95/223.10  |- skos__altLabel mesh__D016405 Diffuse Mixed-Cell Lymphoma
% 222.95/223.10  |- mesh__recordMaintainer mesh__D016405 PXP
% 222.95/223.10  |- mesh__dateEstablished mesh__D016405 1991-01-01
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D016405 2001
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D016405 2006
% 222.95/223.10  |- rdf__type mesh__D016405sskos__Concept
% 222.95/223.10  |- skos__altLabel mesh__D016405
% 222.95/223.10       Lymphoma, Mixed Small and Large Cell, Diffuse
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D016405 1998
% 222.95/223.10  |- skos__broader mesh__D016405smesh__D016396
% 222.95/223.10  |- skos__hiddenLabel mesh__D016405 Mixed Cell Lymphoma, Diffuse
% 222.95/223.10  |- skos__broader mesh__D016405smesh__D016398
% 222.95/223.10  |- mesh__recordAuthorizer mesh__D016405 SJN
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D016405 1999
% 222.95/223.10  |- mesh__recordOriginator mesh__D016405 PLS
% 222.95/223.10  |- skos__altLabel mesh__D016405 Diffuse Mixed Small and Large Cell Lymphoma
% 222.95/223.10  |- skos__scopeNote mesh__D016405
% 222.95/223.10       A heterogeneous group of intermediate-grade lymphomas of mixed cellular composition. Although they have not been extensively studied, it appears that they are predominantly B-cell diseases.%A%    
% 222.95/223.10  |- skos__altLabel mesh__D016405 Mixed-Cell Lymphoma, Diffuse
% 222.95/223.10  |- mesh__activeMeSHYear mesh__D016405 2002
% 222.95/223.10  |- skos__altLabel mesh__D016405 Lymphoma, Mixed Cell, Diffuse
% 222.95/223.10  |- skos__annotation mesh__D016405
% 222.95/223.10       a diffuse intermediate-grade non-Hodgkin%27%s lymphoma; DF: LYMPHOMA MIXED DIFFUSE%A%  
% 222.95/223.11  |- mesh__publicMeSHNote mesh__D046890 2005   
% 222.95/223.11  |- skos__prefLabel mesh__D046890 Aphanizomenon
% 222.95/223.11  |- mesh__recordOriginator mesh__D046890 ags
% 222.95/223.11  |- mesh__dateRevised mesh__D046890 2005-06-30
% 222.95/223.11  |- mesh__historyNote mesh__D046890 2005   
% 222.95/223.11  |- mesh__dateCreated mesh__D046890 2004-07-07
% 222.95/223.11  |- skos__broader mesh__D046890smesh__D000458
% 222.95/223.11  |- mesh__dateEstablished mesh__D046890 2005-01-01
% 222.95/223.11  |- mesh__recordMaintainer mesh__D046890 SYSTEM
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D046890 2006
% 222.95/223.11  |- rdf__type mesh__D046890sskos__Concept
% 222.95/223.11  |- skos__historyNote mesh__D046890 Cyanobacteria %28%1973-2004%29%
% 222.95/223.11  |- mesh__recordAuthorizer mesh__D046890 sjn
% 222.95/223.11  |- skos__scopeNote mesh__D046890
% 222.95/223.11       A form-genus of planktonic CYANOBACTERIA in the order Nostocales.%A%    
% 222.95/223.11  |- mesh__recordOriginator mesh__D046092 ags
% 222.95/223.11  |- mesh__dateEstablished mesh__D046092 2005-01-01
% 222.95/223.11  |- skos__historyNote mesh__D046092 Birds %28%1966-2004%29%
% 222.95/223.11  |- mesh__recordAuthorizer mesh__D046092 ags
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D046092 2006A
% 222.95/223.11  |- rdf__type mesh__D046092sskos__Concept
% 222.95/223.11  |- mesh__recordMaintainer mesh__D046092 ags
% 222.95/223.11  |- mesh__publicMeSHNote mesh__D046092 2005   
% 222.95/223.11  |- mesh__dateRevised mesh__D046092 2005-07-27
% 222.95/223.11  |- skos__prefLabel mesh__D046092 Columbiformes
% 222.95/223.11  |- mesh__dateCreated mesh__D046092 2004-07-07
% 222.95/223.11  |- mesh__historyNote mesh__D046092 2005   
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D046092 2005
% 222.95/223.11  |- skos__scopeNote mesh__D046092
% 222.95/223.11       An order of BIRDS comprised of PIGEONS; DOVES; and an extinct family that includes dodos.%A%    
% 222.95/223.11  |- skos__broader mesh__D046092smesh__D001717
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D046092 2006
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D007679 1997
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D007679 2000
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D007679 1998
% 222.95/223.11  |- mesh__publicMeSHNote mesh__D007679 79; was see under KIDNEY 1975-78   
% 222.95/223.11  |- skos__prefLabel mesh__D007679 Kidney Medulla
% 222.95/223.11  |- mesh__recordAuthorizer mesh__D007679 PLS
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D007679 2006
% 222.95/223.11  |- mesh__dateCreated mesh__D007679 1999-01-01
% 222.95/223.11  |- skos__hiddenLabel mesh__D007679 Medullas, Kidney
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D007679 1996
% 222.95/223.11  |- mesh__dateEstablished mesh__D007679 1979-01-01
% 222.95/223.11  |- skos__hiddenLabel mesh__D007679 Medulla, Kidney
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D007679 2004
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D007679 2005
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D007679 2002
% 222.95/223.11  |- skos__hiddenLabel mesh__D007679 Kidney Papillas
% 222.95/223.11  |- skos__scopeNote mesh__D007679
% 222.95/223.11       The internal portion of the kidney, consisting of striated conical masses, the renal pyramids, whose bases are adjacent to the cortex and whose apices form prominent papillae projecting into the lumen of the minor calyces.%A%    
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D007679 1995
% 222.95/223.11  |- mesh__recordOriginator mesh__D007679 NLM
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D007679 2003
% 222.95/223.11  |- mesh__historyNote mesh__D007679
% 222.95/223.11       79%28%73%29%; was see under KIDNEY 1975-78   
% 222.95/223.11  |- skos__historyNote mesh__D007679 Kidney %28%1966-1972%29%
% 222.95/223.11  |- mesh__dateRevised mesh__D007679 1991-01-07
% 222.95/223.11  |- rdf__type mesh__D007679sskos__Concept
% 222.95/223.11  |- skos__hiddenLabel mesh__D007679 Kidney Medullas
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D007679 1993
% 222.95/223.11  |- skos__hiddenLabel mesh__D007679 Papilla, Kidney
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D007679 1994
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D007679 2001
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D007679 1999
% 222.95/223.11  |- mesh__recordMaintainer mesh__D007679 TGC
% 222.95/223.11  |- skos__broader mesh__D007679smesh__D007668
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D007679 1992
% 222.95/223.11  |- skos__hiddenLabel mesh__D007679 Papillas, Kidney
% 222.95/223.11  |- skos__broader mesh__D004381smesh__D010437
% 222.95/223.11  |- rdf__type mesh__D004381sskos__Concept
% 222.95/223.11  |- mesh__historyNote mesh__D004381
% 222.95/223.11       CURLING%27%S ULCER was heading 1975-96 %28%see under DUODENAL ULCER 1975-90%29%%A%  
% 222.95/223.11  |- mesh__dateCreated mesh__D004381 1999-01-01
% 222.95/223.11  |- skos__hiddenLabel mesh__D004381 Duodenal Ulcers
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D004381 2004
% 222.95/223.11  |- mesh__dateRevised mesh__D004381 2003-07-09
% 222.95/223.11  |- mesh__publicMeSHNote mesh__D004381
% 222.95/223.11       CURLING%27%S ULCER was heading 1975-96 %28%see under DUODENAL ULCER 1975-90%29%%A%  
% 222.95/223.11  |- skos__annotation mesh__D004381
% 222.95/223.11       perforation = DUODENAL ULCER /compl %28%IM%29% + PEPTIC ULCER PERFORATION %28%IM%29%; hemorrhage = DUODENAL ULCER /compl %28%IM%29% + PEPTIC ULCER HEMORRHAGE %28%IM%29%%A%  
% 222.95/223.11  |- skos__prefLabel mesh__D004381 Duodenal Ulcer
% 222.95/223.11  |- skos__hiddenLabel mesh__D004381 Curlings Ulcer
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D004381 2005
% 222.95/223.11  |- mesh__recordOriginator mesh__D004381 NLM
% 222.95/223.11  |- skos__altLabel mesh__D004381 Curling%27%s Ulcer
% 222.95/223.11  |- skos__hiddenLabel mesh__D004381 Ulcer, Duodenal
% 222.95/223.11  |- skos__scopeNote mesh__D004381
% 222.95/223.11       A PEPTIC ULCER located in the DUODENUM.     
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D004381 2006
% 222.95/223.11  |- skos__hiddenLabel mesh__D004381 Ulcer, Curling
% 222.95/223.11  |- mesh__recordMaintainer mesh__D004381 lkt
% 222.95/223.11  |- mesh__recordAuthorizer mesh__D004381 sjn
% 222.95/223.11  |- skos__hiddenLabel mesh__D004381 Ulcers, Duodenal
% 222.95/223.11  |- rdf__type mesh__D012813sskos__Concept
% 222.95/223.11  |- skos__prefLabel mesh__D012813 Sign Language
% 222.95/223.11  |- skos__hiddenLabel mesh__D012813 Sign Languages
% 222.95/223.11  |- mesh__recordMaintainer mesh__D012813 NLM
% 222.95/223.11  |- skos__broader mesh__D012813smesh__D008369
% 222.95/223.11  |- skos__annotation mesh__D012813 no qualif   
% 222.95/223.11  |- mesh__publicMeSHNote mesh__D012813
% 222.95/223.11       91; was see under MANUAL COMMUNICATION 1974-90; was heading 1963-65%A%  
% 222.95/223.11  |- mesh__historyNote mesh__D012813
% 222.95/223.11       91%28%75%29%63-65; was see under MANUAL COMMUNICATION 1974-90; was heading 1963-65%A%  
% 222.95/223.11  |- mesh__recordAuthorizer mesh__D012813 sjn
% 222.95/223.11  |- skos__hiddenLabel mesh__D012813 Languages, Sign
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012813 2005
% 222.95/223.11  |- mesh__onlineNote mesh__D012813
% 222.95/223.11       use MANUAL COMMUNICATION to search SIGN LANGUAGE 1974   
% 222.95/223.11  |- mesh__dateRevised mesh__D012813 2002-07-03
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012813 2003
% 222.95/223.11  |- skos__hiddenLabel mesh__D012813 Language, Sign
% 222.95/223.11  |- mesh__dateCreated mesh__D012813 1999-01-01
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012813 2006
% 222.95/223.11  |- mesh__dateEstablished mesh__D012813 1991-01-01
% 222.95/223.11  |- skos__scopeNote mesh__D012813
% 222.95/223.11       A system of hand gestures used for communication by the deaf or by people speaking different languages.%A%    
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012813 2004
% 222.95/223.11  |- mesh__recordOriginator mesh__D012813 NLM
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012015 1997
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012015 2006
% 222.95/223.11  |- skos__broader mesh__D012015smesh__D014894
% 222.95/223.11  |- skos__hiddenLabel mesh__D012015 Standard Preparation
% 222.95/223.11  |- mesh__dateCreated mesh__D012015 1978-03-24
% 222.95/223.11  |- mesh__dateEstablished mesh__D012015 1979-01-01
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012015 1996
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012015 2005
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012015 2002
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012015 1999
% 222.95/223.11  |- mesh__recordAuthorizer mesh__D012015 PLS
% 222.95/223.11  |- mesh__recordMaintainer mesh__D012015 PLS
% 222.95/223.11  |- skos__hiddenLabel mesh__D012015 Reference Standard
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012015 1995
% 222.95/223.11  |- mesh__publicMeSHNote mesh__D012015 79   
% 222.95/223.11  |- skos__altLabel mesh__D012015 Preparations, Standard
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012015 1998
% 222.95/223.11  |- mesh__dateRevised mesh__D012015 1993-05-06
% 222.95/223.11  |- mesh__recordOriginator mesh__D012015 VDK
% 222.95/223.11  |- skos__hiddenLabel mesh__D012015 Standard, Reference
% 222.95/223.11  |- skos__altLabel mesh__D012015 Standards, Reference
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012015 2004
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012015 1994
% 222.95/223.11  |- mesh__historyNote mesh__D012015 79   
% 222.95/223.11  |- skos__scopeNote mesh__D012015
% 222.95/223.11       A basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, techniques, and procedures used in diagnosis and therapy.%A%    
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012015 2001
% 222.95/223.11  |- rdf__type mesh__D012015sskos__Concept
% 222.95/223.11  |- skos__hiddenLabel mesh__D012015 Preparation, Standard
% 222.95/223.11  |- skos__annotation mesh__D012015
% 222.95/223.11       NIM with specific subject %28%IM%29% with /stand if permitted by category; no qualif; differentiate from REFERENCE VALUES: REFERENCE STANDARDS = basis of value or standard for a measurement, REFERENCE VALUES = range or frequency distribution of a measurement%A%  
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012015 2003
% 222.95/223.11  |- skos__prefLabel mesh__D012015 Reference Standards
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012015 2000
% 222.95/223.11  |- skos__scopeNote mesh__D003289
% 222.95/223.11       The period of recovery following an illness.     
% 222.95/223.11  |- mesh__dateRevised mesh__D003289 1999-11-08
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D003289 2005
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D003289 2006
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D003289 2003
% 222.95/223.11  |- skos__related mesh__D003289smesh__D020127
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D003289 2004
% 222.95/223.11  |- mesh__dateCreated mesh__D003289 1999-01-01
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D003289 2000
% 222.95/223.11  |- skos__annotation mesh__D003289 coord IM with specific dis %28%IM%29%   
% 222.95/223.11  |- rdf__type mesh__D003289sskos__Concept
% 222.95/223.11  |- skos__hiddenLabel mesh__D003289 Convalescences
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D003289 2001
% 222.95/223.11  |- skos__prefLabel mesh__D003289 Convalescence
% 222.95/223.11  |- mesh__recordAuthorizer mesh__D003289 sjn
% 222.95/223.11  |- mesh__recordMaintainer mesh__D003289 KEV
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D003289 2002
% 222.95/223.11  |- skos__broader mesh__D003289smesh__D020969
% 222.95/223.11  |- mesh__recordOriginator mesh__D003289 NLM
% 222.95/223.11  |- mesh__recordMaintainer mesh__D008772 SYSTEM
% 222.95/223.11  |- mesh__onlineNote mesh__D008772
% 222.95/223.11       use METHYLOCOCCACEAE to search METHYLOMONADACEAE 1976-91 %26% METHANOMONADACEAE 1975%A%  
% 222.95/223.11  |- skos__altLabel mesh__D008772 Methanomonadaceae
% 222.95/223.11  |- mesh__dateEstablished mesh__D008772 1976-01-01
% 222.95/223.11  |- skos__scopeNote mesh__D008772
% 222.95/223.11       A family of gram-negative, aerobic bacteria utilizing only one-carbon organic compounds and isolated from in soil and water.%A%    
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D008772 2006
% 222.95/223.11  |- mesh__recordAuthorizer mesh__D008772 sjn
% 222.95/223.11  |- skos__broader mesh__D008772smesh__D020563
% 222.95/223.11  |- skos__altLabel mesh__D008772 Methylomonadaceae
% 222.95/223.11  |- mesh__dateCreated mesh__D008772 1975-07-23
% 222.95/223.11  |- skos__altLabel mesh__D008772 Methane Oxidizing Bacteria
% 222.95/223.11  |- skos__broader mesh__D008772smesh__D016946
% 222.95/223.11  |- rdf__type mesh__D008772sskos__Concept
% 222.95/223.11  |- mesh__publicMeSHNote mesh__D008772
% 222.95/223.11       92; was METHYLOMONADACEAE 1976-91, was METHANOMONADACEAE 1975%A%  
% 222.95/223.11  |- mesh__historyNote mesh__D008772
% 222.95/223.11       92; was METHYLOMONADACEAE 1976-91, was METHANOMONADACEAE 1975%A%  
% 222.95/223.11  |- mesh__dateRevised mesh__D008772 2005-06-30
% 222.95/223.11  |- skos__prefLabel mesh__D008772 Methylococcaceae
% 222.95/223.11  |- mesh__recordOriginator mesh__D008772 JW
% 222.95/223.11  |- skos__historyNote mesh__D008772 Bacteria %28%1966-1974%29%
% 222.95/223.11  |- skos__altLabel mesh__D008772 Methane-Oxidizing Bacteria
% 222.95/223.11  |- skos__altLabel mesh__D008772 Methylmonadaceae
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D016406 2001
% 222.95/223.11  |- skos__altLabel mesh__D016406 Lymphoma, Small Cleaved Cell, Diffuse
% 222.95/223.11  |- mesh__dateCreated mesh__D016406 1990-06-01
% 222.95/223.11  |- skos__broader mesh__D016406smesh__D016396
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D016406 2000
% 222.95/223.11  |- skos__hiddenLabel mesh__D016406 Small Cleaved Cell Lymphoma, Diffuse
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D016406 2004
% 222.95/223.11  |- mesh__recordAuthorizer mesh__D016406 sjn
% 222.95/223.11  |- mesh__historyNote mesh__D016406 91   
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D016406 2003
% 222.95/223.11  |- mesh__dateRevised mesh__D016406 1999-11-08
% 222.95/223.11  |- mesh__publicMeSHNote mesh__D016406 91   
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D016406 2002
% 222.95/223.11  |- skos__prefLabel mesh__D016406 Lymphoma, Small Cleaved-Cell, Diffuse
% 222.95/223.11  |- skos__scopeNote mesh__D016406
% 222.95/223.11       An intermediate-grade malignant lymphoma in which the neoplastic cells %28%B-lymphocytes%29% exhibit variability in size, configuration, and degree of differentiation. The cells are irregular in shape and have distinct nuclei.%A%    
% 222.95/223.11  |- skos__broader mesh__D016406smesh__D008226
% 222.95/223.11  |- skos__altLabel mesh__D016406 Lymphoma, Atypical Diffuse Small Lymphoid
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D016406 2006
% 222.95/223.11  |- rdf__type mesh__D016406sskos__Concept
% 222.95/223.11  |- skos__hiddenLabel mesh__D016406 Diffuse Small Cleaved Cell Lymphoma
% 222.95/223.11  |- mesh__recordMaintainer mesh__D016406 jls
% 222.95/223.11  |- skos__altLabel mesh__D016406 Diffuse Small Cleaved-Cell Lymphoma
% 222.95/223.11  |- mesh__recordOriginator mesh__D016406 PLS
% 222.95/223.11  |- skos__altLabel mesh__D016406 Small Cleaved-Cell Lymphoma, Diffuse
% 222.95/223.11  |- mesh__dateEstablished mesh__D016406 1991-01-01
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D016406 2005
% 222.95/223.11  |- skos__annotation mesh__D016406 DF: LYMPHOMA SMALL CLEAVED DIFFUSE   
% 222.95/223.11  |- skos__broader mesh__D016406smesh__D016398
% 222.95/223.11  |- skos__prefLabel mesh__D046891 Cylindrospermopsis
% 222.95/223.11  |- skos__scopeNote mesh__D046891
% 222.95/223.11       A form-genus of CYANOBACTERIA in the order Nostocales, characterized by thin trichomes, cylindrical akinetes, and terminal heterocysts.%A%    
% 222.95/223.11  |- mesh__recordAuthorizer mesh__D046891 sjn
% 222.95/223.11  |- mesh__dateCreated mesh__D046891 2004-07-07
% 222.95/223.11  |- skos__historyNote mesh__D046891 Cyanobacteria %28%1985-2004%29%
% 222.95/223.11  |- mesh__recordOriginator mesh__D046891 ags
% 222.95/223.11  |- mesh__recordMaintainer mesh__D046891 SYSTEM
% 222.95/223.11  |- mesh__dateRevised mesh__D046891 2005-06-30
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D046891 2006
% 222.95/223.11  |- mesh__historyNote mesh__D046891 2005   
% 222.95/223.11  |- rdf__type mesh__D046891sskos__Concept
% 222.95/223.11  |- skos__broader mesh__D046891smesh__D000458
% 222.95/223.11  |- mesh__dateEstablished mesh__D046891 2005-01-01
% 222.95/223.11  |- mesh__publicMeSHNote mesh__D046891 2005   
% 222.95/223.11  |- rdf__type mesh__D046093sskos__Concept
% 222.95/223.11  |- mesh__recordMaintainer mesh__D046093 ags
% 222.95/223.11  |- mesh__publicMeSHNote mesh__D046093 2005   
% 222.95/223.11  |- mesh__recordOriginator mesh__D046093 ags
% 222.95/223.11  |- mesh__dateEstablished mesh__D046093 2005-01-01
% 222.95/223.11  |- mesh__dateCreated mesh__D046093 2004-07-07
% 222.95/223.11  |- mesh__recordAuthorizer mesh__D046093 sjn
% 222.95/223.11  |- skos__scopeNote mesh__D046093
% 222.95/223.11       An order of diurnal BIRDS of prey, including EAGLES; HAWKS; buzzards; vultures; and falcons.%A%    
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D046093 2005
% 222.95/223.11  |- skos__historyNote mesh__D046093 Birds %28%1965-2004%29%
% 222.95/223.11  |- skos__prefLabel mesh__D046093 Falconiformes
% 222.95/223.11  |- skos__broader mesh__D046093smesh__D001717
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D046093 2006
% 222.95/223.11  |- skos__broader mesh__D046093smesh__D020304
% 222.95/223.11  |- mesh__historyNote mesh__D046093 2005   
% 222.95/223.11  |- mesh__publicMeSHNote mesh__D004382 80   
% 222.95/223.11  |- mesh__dateRevised mesh__D004382 2003-07-09
% 222.95/223.11  |- mesh__recordMaintainer mesh__D004382 lkt
% 222.95/223.11  |- mesh__recordAuthorizer mesh__D004382 sjn
% 222.95/223.11  |- skos__prefLabel mesh__D004382 Duodenitis
% 222.95/223.11  |- mesh__recordOriginator mesh__D004382 SMH
% 222.95/223.11  |- skos__scopeNote mesh__D004382
% 222.95/223.11       Inflammation of the DUODENUM section of the small intestine %28%INTESTINE, SMALL%29%. Erosive duodenitis may cause bleeding in the UPPER GI TRACT and PEPTIC ULCER.%A%    
% 222.95/223.11  |- skos__broader mesh__D004382smesh__D004378
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D004382 2005
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D004382 2006
% 222.95/223.11  |- skos__hiddenLabel mesh__D004382 Duodenitis, Erosive
% 222.95/223.11  |- skos__broader mesh__D004382smesh__D004751
% 222.95/223.11  |- rdf__type mesh__D004382sskos__Concept
% 222.95/223.11  |- skos__historyNote mesh__D004382 Duodenal Diseases %28%1966-1979%29%
% 222.95/223.11  |- skos__historyNote mesh__D004382 Enteritis %28%1966-1979%29%
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D004382 2004
% 222.95/223.11  |- mesh__dateCreated mesh__D004382 1979-05-29
% 222.95/223.11  |- mesh__dateEstablished mesh__D004382 1980-01-01
% 222.95/223.11  |- mesh__historyNote mesh__D004382 80   
% 222.95/223.11  |- skos__hiddenLabel mesh__D012016 Value, Reference
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012016 1992
% 222.95/223.11  |- mesh__recordAuthorizer mesh__D012016 PLS
% 222.95/223.11  |- mesh__recordOriginator mesh__D012016 VDK
% 222.95/223.11  |- skos__hiddenLabel mesh__D012016 Values, Reference
% 222.95/223.11  |- skos__altLabel mesh__D012016 Normal Values
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012016 1996
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012016 2004
% 222.95/223.11  |- skos__hiddenLabel mesh__D012016 Reference Range
% 222.95/223.11  |- mesh__historyNote mesh__D012016 80; was NORMAL VALUES 1977-79   
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012016 2000
% 222.95/223.11  |- skos__hiddenLabel mesh__D012016 Ranges, Normal
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012016 1993
% 222.95/223.11  |- rdf__type mesh__D012016sskos__Concept
% 222.95/223.11  |- mesh__publicMeSHNote mesh__D012016 80; was NORMAL VALUES 1977-79   
% 222.95/223.11  |- skos__hiddenLabel mesh__D012016 Values, Normal
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012016 1997
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012016 2001
% 222.95/223.11  |- skos__annotation mesh__D012016
% 222.95/223.11       never IM; no qualif; differentiate from REFERENCE STANDARDS: REFERENCE VALUES = range or frequency distribution of a measurement, REFERENCE STANDARDS = basis of value or standard for a measurement%A%  
% 222.95/223.11  |- skos__hiddenLabel mesh__D012016 Range, Normal
% 222.95/223.11  |- skos__broader mesh__D012016smesh__D014894
% 222.95/223.11  |- skos__hiddenLabel mesh__D012016 Range, Reference
% 222.95/223.11  |- mesh__recordMaintainer mesh__D012016 TGC
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012016 2005
% 222.95/223.11  |- mesh__dateRevised mesh__D012016 1991-01-08
% 222.95/223.11  |- skos__hiddenLabel mesh__D012016 Normal Ranges
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012016 1994
% 222.95/223.11  |- skos__altLabel mesh__D012016 Reference Ranges
% 222.95/223.11  |- skos__scopeNote mesh__D012016
% 222.95/223.11       The range or frequency distribution of a measurement in a population %28%of organisms, organs or things%29% that has not been selected for the presence of disease or abnormality.%A%    
% 222.95/223.11  |- mesh__dateEstablished mesh__D012016 1977-01-01
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012016 1998
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012016 2006
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012016 2002
% 222.95/223.11  |- skos__hiddenLabel mesh__D012016 Normal Value
% 222.95/223.11  |- mesh__dateCreated mesh__D012016 1976-04-16
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012016 1995
% 222.95/223.11  |- mesh__onlineNote mesh__D012016
% 222.95/223.11       use REFERENCE VALUES to search NORMAL VALUES 1977-79   
% 222.95/223.11  |- skos__hiddenLabel mesh__D012016 Ranges, Reference
% 222.95/223.11  |- skos__hiddenLabel mesh__D012016 Reference Value
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012016 2003
% 222.95/223.11  |- skos__hiddenLabel mesh__D012016 Value, Normal
% 222.95/223.11  |- skos__prefLabel mesh__D012016 Reference Values
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D012016 1999
% 222.95/223.11  |- skos__broader mesh__D011543Q000037smesh__D011543
% 222.95/223.11  |- mesh__preferredCombination mesh__D011543Q000037smesh__D002800
% 222.95/223.11  |- rdf__type mesh__D011543Q000037smesh__CompoundConcept
% 222.95/223.11  |- skos__altLabel mesh__D008773 5-Methylphenazinium Methyl Sulfate
% 222.95/223.11  |- skos__hiddenLabel mesh__D008773 Sulfate, 5-Methylphenazinium Methyl
% 222.95/223.11  |- skos__hiddenLabel mesh__D008773 5 Methylphenazinium Methyl Sulfate
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D008773 2005
% 222.95/223.11  |- mesh__publicMeSHNote mesh__D008773
% 222.95/223.11       91; was see under PHENAZINES 1975-90   
% 222.95/223.11  |- mesh__dateEstablished mesh__D008773 1991-01-01
% 222.95/223.11  |- mesh__dateRevised mesh__D008773 2000-06-22
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D008773 2006
% 222.95/223.11  |- mesh__recordOriginator mesh__D008773 NLM
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D008773 2001
% 222.95/223.11  |- mesh__historyNote mesh__D008773
% 222.95/223.11       91%28%75%29%; was see under PHENAZINES 1975-90   
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D008773 2003
% 222.95/223.11  |- skos__altLabel mesh__D008773 Phenazine Methosulfate
% 222.95/223.11  |- rdf__type mesh__D008773sskos__Concept
% 222.95/223.11  |- mesh__dateCreated mesh__D008773 1974-11-19
% 222.95/223.11  |- skos__hiddenLabel mesh__D008773 Methosulfate, Methylphenazonium
% 222.95/223.11  |- skos__annotation mesh__D008773 D25-26 qualif   
% 222.95/223.11  |- skos__hiddenLabel mesh__D008773 Methosulfate, Phenazine
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D008773 2004
% 222.95/223.11  |- skos__prefLabel mesh__D008773 Methylphenazonium Methosulfate
% 222.95/223.11  |- mesh__recordAuthorizer mesh__D008773 sjn
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D008773 2002
% 222.95/223.11  |- mesh__recordMaintainer mesh__D008773 TWD
% 222.95/223.11  |- skos__hiddenLabel mesh__D008773 Methyl Sulfate, 5-Methylphenazinium
% 222.95/223.11  |- skos__broader mesh__D008773smesh__D010619
% 222.95/223.11  |- skos__historyNote mesh__D008773 Sulfuric Acids %28%1972-1974%29%
% 222.95/223.11  |- skos__historyNote mesh__D008773 Phenazines %28%1970-1974%29%
% 222.95/223.11  |- skos__scopeNote mesh__D008773
% 222.95/223.11       Used as an electron carrier in place of the flavine enzyme of Warburg in the hexosemonophosphate system and also in the preparation of SUCCINIC DEHYDROGENASE.%A%    
% 222.95/223.11  |- skos__broader mesh__D000790smesh__D000792
% 222.95/223.11  |- rdf__type mesh__D000790sskos__Concept
% 222.95/223.11  |- mesh__dateCreated mesh__D000790 1999-01-01
% 222.95/223.11  |- mesh__dateRevised mesh__D000790 1997-06-20
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D000790 2002
% 222.95/223.11  |- mesh__recordAuthorizer mesh__D000790 SJN
% 222.95/223.11  |- mesh__recordMaintainer mesh__D000790 PXP
% 222.95/223.11  |- mesh__recordOriginator mesh__D000790 NLM
% 222.95/223.11  |- skos__prefLabel mesh__D000790 Angiocardiography
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D000790 2003
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D000790 1998
% 222.95/223.11  |- skos__broader mesh__D000790smesh__D006334
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D000790 2004
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D000790 2005
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D000790 2000
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D000790 1999
% 222.95/223.11  |- skos__hiddenLabel mesh__D000790 Angiocardiographies
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D000790 2001
% 222.95/223.11  |- skos__scopeNote mesh__D000790
% 222.95/223.11       Radiography of the heart and great vessels after injection of a contrast medium.%A%    
% 222.95/223.11  |- skos__annotation mesh__D000790
% 222.95/223.11       NIM; a specific x-ray %28%not radionuclide%29% technique: do not confuse with HEART /radiogr or CORONARY ANGIOGRAPHY; coord with disease /radiogr; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ANGIOCARDIOGR%A%  
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D000790 2006
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D016407 2004
% 222.95/223.11  |- mesh__recordMaintainer mesh__D016407 PXP
% 222.95/223.11  |- mesh__historyNote mesh__D016407 91   
% 222.95/223.11  |- mesh__recordAuthorizer mesh__D016407 SJN
% 222.95/223.11  |- mesh__dateEstablished mesh__D016407 1991-01-01
% 222.95/223.11  |- skos__altLabel mesh__D016407
% 222.95/223.11       Lymphoma, Nodular, Mixed Lymphocytic-Histiocytic
% 222.95/223.11  |- skos__altLabel mesh__D016407 Follicular Mixed-Cell Lymphoma
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D016407 2000
% 222.95/223.11  |- skos__altLabel mesh__D016407
% 222.95/223.11       Lymphoma, Follicular, Small and Large Cleaved Cell
% 222.95/223.11  |- skos__hiddenLabel mesh__D016407 Lymphoma, Follicular Mixed-Cell
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D016407 2005
% 222.95/223.11  |- skos__hiddenLabel mesh__D016407 Lymphomas, Follicular Mixed-Cell
% 222.95/223.11  |- mesh__dateRevised mesh__D016407 1997-06-20
% 222.95/223.11  |- mesh__publicMeSHNote mesh__D016407 91   
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D016407 1998
% 222.95/223.11  |- mesh__dateCreated mesh__D016407 1990-06-01
% 222.95/223.11  |- skos__scopeNote mesh__D016407
% 222.95/223.11       A low-grade malignant lymphoma of follicular pattern in which there is no clear preponderance of one cell type %28%small or large%29% over another. The large cells, cleaved or noncleaved, are often 2-3 times larger in diameter than normal lymphocytes.%A%    
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D016407 2001
% 222.95/223.11  |- skos__hiddenLabel mesh__D016407 Follicular Mixed Cell Lymphoma
% 222.95/223.11  |- rdf__type mesh__D016407sskos__Concept
% 222.95/223.11  |- skos__broader mesh__D016407smesh__D008224
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D016407 2006
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D016407 1999
% 222.95/223.11  |- skos__altLabel mesh__D016407
% 222.95/223.11       Lymphoma, Follicular, Small and Large Cleaved-Cell
% 222.95/223.11  |- skos__altLabel mesh__D016407 Lymphoma, Follicular, Mixed Cell
% 222.95/223.11  |- skos__altLabel mesh__D016407
% 222.95/223.11       Lymphoma, Nodular, Mixed Lymphocytic Histiocytic
% 222.95/223.11  |- skos__altLabel mesh__D016407
% 222.95/223.11       Lymphoma, Nodular, Mixed Small and Large Cell
% 222.95/223.11  |- skos__broader mesh__D016407smesh__D008227
% 222.95/223.11  |- skos__altLabel mesh__D016407
% 222.95/223.11       Lymphoma, Follicular, Mixed Lymphocytic-Histiocytic
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D016407 2003
% 222.95/223.11  |- skos__hiddenLabel mesh__D016407 Follicular Mixed-Cell Lymphomas
% 222.95/223.11  |- skos__altLabel mesh__D016407
% 222.95/223.11       Lymphoma, Follicular, Mixed Small and Large Lymphoid
% 222.95/223.11  |- skos__hiddenLabel mesh__D016407 Mixed Cell Lymphoma, Follicular
% 222.95/223.11  |- skos__hiddenLabel mesh__D016407 Mixed-Cell Lymphomas, Follicular
% 222.95/223.11  |- mesh__recordOriginator mesh__D016407 PLS
% 222.95/223.11  |- skos__prefLabel mesh__D016407 Lymphoma, Mixed-Cell, Follicular
% 222.95/223.11  |- skos__annotation mesh__D016407
% 222.95/223.11       a low-grade non-Hodgkin%27%s lymphoma; DF: LYMPHOMA MIXED FOLLIC%A%  
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D016407 2002
% 222.95/223.11  |- skos__broader mesh__D016407smesh__D016397
% 222.95/223.11  |- skos__altLabel mesh__D016407 Mixed-Cell Lymphoma, Follicular
% 222.95/223.11  |- skos__broader mesh__D046094smesh__D001717
% 222.95/223.11  |- mesh__activeMeSHYear mesh__D046094 2005
% 222.95/223.11  |- mesh__recordMaintainer mesh__D046094 ags
% 222.95/223.11  |- rdf__type mesh__D046094sskos__Concept
% 222.95/223.11  |- mesh__historyNote mesh__D046094 2005   
% 222.95/223.11  |- skos__scopeNote mesh__D046094
% 222.95/223.11       An order of heavy-bodied, largely terrestrial BIRDS including pheasants, TURKEYS, grouse, QUAIL, and CHICKENS.%A%    
% 222.95/223.11  |- mesh__publicMeSHNote mesh__D046094 2005   
% 222.95/223.11  |- skos__historyNote mesh__D046094 Birds %28%1968-2004%29%
% 222.95/223.11  |- mesh__dateEstablished mesh__D046094 2005-01-01
% 222.95/223.11  |- skos__hiddenLabel mesh__D046094 Galliforme
% 222.95/223.12  |- mesh__recordOriginator mesh__D046094 ags
% 222.95/223.12  |- mesh__dateCreated mesh__D046094 2004-07-07
% 222.95/223.12  |- mesh__recordAuthorizer mesh__D046094 sjn
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D046094 2006
% 222.95/223.12  |- skos__prefLabel mesh__D046094 Galliformes
% 222.95/223.12  |- skos__broader mesh__D004383smesh__D004378
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D004383 2005
% 222.95/223.12  |- mesh__dateCreated mesh__D004383 1983-03-11
% 222.95/223.12  |- skos__broader mesh__D004383smesh__D013272
% 222.95/223.12  |- skos__hiddenLabel mesh__D004383 Reflux, Duodenal
% 222.95/223.12  |- skos__historyNote mesh__D004383 Stomach %28%1966-1983%29%
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D004383 2006
% 222.95/223.12  |- mesh__dateRevised mesh__D004383 2004-07-07
% 222.95/223.12  |- skos__hiddenLabel mesh__D004383 Reflux, Duodeno-Gastric
% 222.95/223.12  |- mesh__recordMaintainer mesh__D004383 lkt
% 222.95/223.12  |- skos__historyNote mesh__D004383 Duodenal Diseases %28%1966-1983%29%
% 222.95/223.12  |- skos__hiddenLabel mesh__D004383 Reflux, Duodenogastric
% 222.95/223.12  |- skos__historyNote mesh__D004383 Stomach Diseases%28%1966-1983%29%
% 222.95/223.12  |- mesh__dateEstablished mesh__D004383 1984-01-01
% 222.95/223.12  |- rdf__type mesh__D004383sskos__Concept
% 222.95/223.12  |- skos__scopeNote mesh__D004383
% 222.95/223.12       Retrograde flow of duodenal contents %28%BILE ACIDS; PANCREATIC JUICE%29% into the STOMACH.%A%    
% 222.95/223.12  |- mesh__recordAuthorizer mesh__D004383 sjn
% 222.95/223.12  |- skos__historyNote mesh__D004383 Duodenum %28%1966-1983%29%
% 222.95/223.12  |- skos__prefLabel mesh__D004383 Duodenogastric Reflux
% 222.95/223.12  |- skos__hiddenLabel mesh__D004383 Duodeno Gastric Reflux
% 222.95/223.12  |- mesh__publicMeSHNote mesh__D004383 84   
% 222.95/223.12  |- skos__altLabel mesh__D004383 Duodenal Reflux
% 222.95/223.12  |- skos__hiddenLabel mesh__D004383 Duodenal Refluxs
% 222.95/223.12  |- skos__altLabel mesh__D004383 Duodeno-Gastric Reflux
% 222.95/223.12  |- mesh__historyNote mesh__D004383 84   
% 222.95/223.12  |- mesh__recordOriginator mesh__D004383 RC
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012815 2005
% 222.95/223.12  |- rdf__type mesh__D012815sskos__Concept
% 222.95/223.12  |- skos__hiddenLabel mesh__D012815 Computer-Assisted Signal Interpretation
% 222.95/223.12  |- mesh__recordOriginator mesh__D012815 EC
% 222.95/223.12  |- mesh__recordAuthorizer mesh__D012815 sjn
% 222.95/223.12  |- skos__annotation mesh__D012815 IM   
% 222.95/223.12  |- skos__prefLabel mesh__D012815 Signal Processing, Computer-Assisted
% 222.95/223.12  |- skos__hiddenLabel mesh__D012815 Signal Processing, Computer Assisted
% 222.95/223.12  |- skos__hiddenLabel mesh__D012815 Interpretation, Computer-Assisted Signal
% 222.95/223.12  |- skos__altLabel mesh__D012815 Digital Signal Processing
% 222.95/223.12  |- mesh__dateRevised mesh__D012815 2004-07-07
% 222.95/223.12  |- mesh__recordMaintainer mesh__D012815 jls
% 222.95/223.12  |- skos__hiddenLabel mesh__D012815 Signal Interpretation, Computer Assisted
% 222.95/223.12  |- mesh__publicMeSHNote mesh__D012815
% 222.95/223.12       87; SIGNAL INTERPRETATION, COMPUTER-ASSISTED was see DIAGNOSIS, COMPUTER-ASSISTED 1986-88%A%  
% 222.95/223.12  |- skos__scopeNote mesh__D012815
% 222.95/223.12       Computer-assisted processing of electric, ultrasonic, or electronic signals to interpret function and activity.%A%    
% 222.95/223.12  |- mesh__dateEstablished mesh__D012815 1987-01-01
% 222.95/223.12  |- skos__hiddenLabel mesh__D012815
% 222.95/223.12       Signal Interpretations, Computer-Assisted
% 222.95/223.12  |- skos__hiddenLabel mesh__D012815
% 222.95/223.12       Interpretations, Computer-Assisted Signal
% 222.95/223.12  |- skos__broader mesh__D012815smesh__D003205
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012815 2006
% 222.95/223.12  |- mesh__onlineNote mesh__D012815
% 222.95/223.12       use DIAGNOSIS, COMPUTER-ASSISTED to search SIGNAL INTERPRETATION, COMPUTER-ASSISTED 1986-88%A%  
% 222.95/223.12  |- skos__hiddenLabel mesh__D012815 Computer-Assisted Signal Interpretations
% 222.95/223.12  |- mesh__historyNote mesh__D012815
% 222.95/223.12       87; SIGNAL INTERPRETATION, COMPUTER-ASSISTED was see DIAGNOSIS, COMPUTER-ASSISTED 1986-88%A%  
% 222.95/223.12  |- mesh__dateCreated mesh__D012815 1986-06-18
% 222.95/223.12  |- skos__hiddenLabel mesh__D012815 Computer-Assisted Signal Processing
% 222.95/223.12  |- skos__hiddenLabel mesh__D012017 Opinions, Second
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012017 2000
% 222.95/223.12  |- skos__historyNote mesh__D012017
% 222.95/223.12       Interprofessional Relations %28%1966-1967%29%
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012017 1999
% 222.95/223.12  |- skos__hiddenLabel mesh__D012017 Opinion, Second
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012017 2005
% 222.95/223.12  |- mesh__recordOriginator mesh__D012017 NLM
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012017 1998
% 222.95/223.12  |- skos__hiddenLabel mesh__D012017 Second Opinions
% 222.95/223.12  |- mesh__recordAuthorizer mesh__D012017 PLS
% 222.95/223.12  |- mesh__dateCreated mesh__D012017 1999-01-01
% 222.95/223.12  |- mesh__dateRevised mesh__D012017 1996-06-10
% 222.95/223.12  |- rdf__type mesh__D012017sskos__Concept
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012017 2002
% 222.95/223.12  |- skos__broader mesh__D012017smesh__D011364
% 222.95/223.12  |- skos__scopeNote mesh__D012017
% 222.95/223.12       The practice of sending a patient to another program or practitioner for services or advice which the referring source is not prepared to provide.%A%    
% 222.95/223.12  |- skos__hiddenLabel mesh__D012017 Gatekeeper, Health Service
% 222.95/223.12  |- skos__altLabel mesh__D012017 Consultation and Referral
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012017 2004
% 222.95/223.12  |- skos__altLabel mesh__D012017 Referral, Hospital
% 222.95/223.12  |- skos__hiddenLabel mesh__D012017 Health Service Gatekeeper
% 222.95/223.12  |- skos__hiddenLabel mesh__D012017 Referrals
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012017 1997
% 222.95/223.12  |- mesh__dateEstablished mesh__D012017 1968-01-01
% 222.95/223.12  |- mesh__historyNote mesh__D012017 68   
% 222.95/223.12  |- skos__altLabel mesh__D012017 Hospital Referrals
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012017 2003
% 222.95/223.12  |- mesh__recordMaintainer mesh__D012017 KEV
% 222.95/223.12  |- skos__altLabel mesh__D012017 Health Service Gatekeepers
% 222.95/223.12  |- skos__prefLabel mesh__D012017 Referral and Consultation
% 222.95/223.12  |- skos__hiddenLabel mesh__D012017 Consultations
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012017 2001
% 222.95/223.12  |- skos__altLabel mesh__D012017 Referrals, Hospital
% 222.95/223.12  |- mesh__publicMeSHNote mesh__D012017 68   
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012017 2006
% 222.95/223.12  |- skos__prefLabel mesh__D017500 Adenovirus E1A Proteins
% 222.95/223.12  |- skos__historyNote mesh__D017500 Transcription Factors %28%1985-1992%29%
% 222.95/223.12  |- mesh__recordOriginator mesh__D017500 AGS
% 222.95/223.12  |- skos__historyNote mesh__D017500 Antigens, Viral, Tumor %28%1985%29%
% 222.95/223.12  |- mesh__dateCreated mesh__D017500 1992-05-13
% 222.95/223.12  |- skos__broader mesh__D017500smesh__D017498
% 222.95/223.12  |- mesh__onlineNote mesh__D017500
% 222.95/223.12       use ADENOVIRUS EARLY PROTEINS %28%NM%29% to search ADENOVIRUS E1A PROTEINS 1985-92; use ADENOVIRUS E1A PROTEINS %28%NM%29% to search ADENOVIRUS E1A PROTEIN DOMAIN 3 1988-92%A%  
% 222.95/223.12  |- skos__altLabel mesh__D017500 Adenovirus E1A Protein
% 222.95/223.12  |- mesh__recordAuthorizer mesh__D017500 sjn
% 222.95/223.12  |- rdf__type mesh__D017500sskos__Concept
% 222.95/223.12  |- mesh__historyNote mesh__D017500
% 222.95/223.12       93; ADENOVIRUS E1A PROTEIN was SY to ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS %28%NM%29% 1985-92; ADENOVIRUS E1A PROTEIN DOMAIN 3 was NM 1988-92%A%  
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D017500 2006
% 222.95/223.12  |- skos__broader mesh__D017500smesh__D000957
% 222.95/223.12  |- mesh__dateRevised mesh__D017500 2005-06-30
% 222.95/223.12  |- skos__scopeNote mesh__D017500
% 222.95/223.12       Proteins transcribed from the E1A genome region of ADENOVIRUSES which are involved in positive regulation of transcription of the early genes of host infection.%A%    
% 222.95/223.12  |- skos__hiddenLabel mesh__D017500 E1A Proteins, Adenovirus
% 222.95/223.12  |- skos__broader mesh__D017500smesh__D014157
% 222.95/223.12  |- mesh__dateEstablished mesh__D017500 1993-01-01
% 222.95/223.12  |- skos__hiddenLabel mesh__D017500 E1A Protein, Adenovirus
% 222.95/223.12  |- mesh__publicMeSHNote mesh__D017500
% 222.95/223.12       93; ADENOVIRUS E1A PROTEIN was indexed under ONCOGENE PROTEINS, VIRAL 1985-92 %26% ANTIGENS, VIRAL, TUMOR 1985; ADENOVIRUS E1A PROTEIN DOMAIN 3 was indexed under ONCOGENE PROTEINS, VIRAL %26% TRANSCRIPTION FACTORS 1988-92%A%  
% 222.95/223.12  |- skos__historyNote mesh__D017500
% 222.95/223.12       Oncogene Proteins, Viral %28%1985-1992%29%
% 222.95/223.12  |- mesh__recordMaintainer mesh__D017500 ssb
% 222.95/223.12  |- skos__broader mesh__D019345Q000031smesh__D019345
% 222.95/223.12  |- mesh__preferredCombination mesh__D019345Q000031smesh__D000085
% 222.95/223.12  |- rdf__type mesh__D019345Q000031smesh__CompoundConcept
% 222.95/223.12  |- skos__hiddenLabel mesh__D008774 Hydrochloride, Methylphenidate
% 222.95/223.12  |- mesh__recordAuthorizer mesh__D008774 sjn
% 222.95/223.12  |- mesh__historyNote mesh__D008774
% 222.95/223.12       PHENIDYLATE was see METHYLPHENIDATE 1978-94   
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D008774 2006
% 222.95/223.12  |- mesh__recordMaintainer mesh__D008774 CCR
% 222.95/223.12  |- mesh__dateRevised mesh__D008774 2005-06-30
% 222.95/223.12  |- skos__broader mesh__D008774smesh__D010880
% 222.95/223.12  |- skos__altLabel mesh__D008774
% 222.95/223.12       Novartis Brand 2 of Methylphenidate Hydrochloride
% 222.95/223.12  |- skos__hiddenLabel mesh__D008774 Ritalin SR
% 222.95/223.12  |- rdf__type mesh__D008774sskos__Concept
% 222.95/223.12  |- mesh__recordOriginator mesh__D008774 NLM
% 222.95/223.12  |- skos__altLabel mesh__D008774 Centedrin
% 222.95/223.12  |- skos__broader mesh__D008774smesh__D010648
% 222.95/223.12  |- skos__altLabel mesh__D008774 Equasym
% 222.95/223.12  |- mesh__onlineNote mesh__D008774
% 222.95/223.12       use METHYLPHENIDATE to search PHENIDYLATE 1978-94   
% 222.95/223.12  |- mesh__dateCreated mesh__D008774 1999-01-01
% 222.95/223.12  |- skos__scopeNote mesh__D008774
% 222.95/223.12       A central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE.%A%    
% 222.95/223.12  |- skos__altLabel mesh__D008774
% 222.95/223.12       Celltech Brand of Methylphenidate Hydrochloride
% 222.95/223.12  |- skos__altLabel mesh__D008774 Ritaline
% 222.95/223.12  |- skos__prefLabel mesh__D008774 Methylphenidate
% 222.95/223.12  |- skos__altLabel mesh__D008774
% 222.95/223.12       Novartis Brand 1 of Methylphenidate Hydrochloride
% 222.95/223.12  |- skos__altLabel mesh__D008774
% 222.95/223.12       Mallinckrodt Brand of Methylphenidate Hydrochloride
% 222.95/223.12  |- skos__altLabel mesh__D008774
% 222.95/223.12       Cephalon Brand of Methylphenidate Hydrochloride
% 222.95/223.12  |- mesh__publicMeSHNote mesh__D008774
% 222.95/223.12       PHENIDYLATE was see METHYLPHENIDATE 1978-94   
% 222.95/223.12  |- skos__altLabel mesh__D016408 Lymphoma, Small Follicular Center-Cell
% 222.95/223.12  |- skos__annotation mesh__D016408
% 222.95/223.12       a low-grade non-Hodgkin%27%s lymphoma; DF: LYMPHOMA SMALL CLEAVED FOLLIC%A%  
% 222.95/223.12  |- mesh__publicMeSHNote mesh__D016408 91   
% 222.95/223.12  |- skos__altLabel mesh__D016408
% 222.95/223.12       Lymphoma, Lymphocytic, Nodular, Poorly Differentiated
% 222.95/223.12  |- skos__broader mesh__D016408smesh__D008226
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D016408 2006
% 222.95/223.12  |- rdf__type mesh__D016408sskos__Concept
% 222.95/223.12  |- skos__hiddenLabel mesh__D016408 Small Cleaved Cell Lymphoma, Follicular
% 222.95/223.12  |- mesh__recordOriginator mesh__D016408 PLS
% 222.95/223.12  |- skos__altLabel mesh__D016408 Lymphoma, Small Lymphoid, Follicular
% 222.95/223.12  |- skos__altLabel mesh__D016408 Lymphoma, Small Cleaved Cell, Follicular
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D016408 2002
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D016408 2005
% 222.95/223.12  |- mesh__recordAuthorizer mesh__D016408 SJN
% 222.95/223.12  |- skos__altLabel mesh__D016408
% 222.95/223.12       Lymphocytic Lymphoma, Nodular, Poorly-Differentiated
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D016408 1999
% 222.95/223.12  |- mesh__dateEstablished mesh__D016408 1991-01-01
% 222.95/223.12  |- skos__scopeNote mesh__D016408
% 222.95/223.12       A low-grade malignant lymphoma of predominantly follicular pattern. Follicles are of relatively uniform size and shape and the cells are usually somewhat larger than normal lymphocytes. Nuclei are irregular with prominent indentations and cytoplasm can rarely be identified. Cells exhibiting these characteristics are often called centrocytes.%A%    
% 222.95/223.12  |- skos__altLabel mesh__D016408 Small Cleaved-Cell Lymphoma, Follicular
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D016408 1998
% 222.95/223.12  |- skos__broader mesh__D016408smesh__D008224
% 222.95/223.12  |- skos__altLabel mesh__D016408 Small Follicular Center-Cell Lymphoma
% 222.95/223.12  |- mesh__dateRevised mesh__D016408 1997-06-20
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D016408 2001
% 222.95/223.12  |- mesh__dateCreated mesh__D016408 1990-06-01
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D016408 2004
% 222.95/223.12  |- skos__hiddenLabel mesh__D016408 Lymphoma, Small Follicular Center Cell
% 222.95/223.12  |- skos__altLabel mesh__D016408
% 222.95/223.12       Lymphocytic Lymphoma, Nodular, Poorly Differentiated
% 222.95/223.12  |- skos__altLabel mesh__D016408
% 222.95/223.12       Lymphoma, Lymphocytic, Nodular, Poorly-Differentiated
% 222.95/223.12  |- skos__hiddenLabel mesh__D016408 Small Follicular Center Cell Lymphoma
% 222.95/223.12  |- skos__prefLabel mesh__D016408 Lymphoma, Small Cleaved-Cell, Follicular
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D016408 2000
% 222.95/223.12  |- mesh__historyNote mesh__D016408 91   
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D016408 2003
% 222.95/223.12  |- skos__broader mesh__D016408smesh__D016397
% 222.95/223.12  |- mesh__recordMaintainer mesh__D016408 PXP
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D013110 2000
% 222.95/223.12  |- mesh__dateCreated mesh__D013110 1999-01-01
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D013110 2001
% 222.95/223.12  |- mesh__publicMeSHNote mesh__D013110 72   
% 222.95/223.12  |- skos__related mesh__D013110smesh__D013107
% 222.95/223.12  |- mesh__recordOriginator mesh__D013110 NLM
% 222.95/223.12  |- skos__altLabel mesh__D013110 4-Sphingenine
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D013110 2003
% 222.95/223.12  |- rdf__type mesh__D013110sskos__Concept
% 222.95/223.12  |- skos__hiddenLabel mesh__D013110 4 Sphingenine
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D013110 2005
% 222.95/223.12  |- skos__broader mesh__D013110smesh__D000605
% 222.95/223.12  |- skos__scopeNote mesh__D013110
% 222.95/223.12       An amino alcohol with a long unsaturated hydrocarbon chain. Sphingosine and its derivative sphinganine are the major bases of the sphingolipids in mammals. %28%Dorland, 28th ed%29%%A%    
% 222.95/223.12  |- skos__historyNote mesh__D013110 Glycols %28%1966-1971%29%
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D013110 2004
% 222.95/223.12  |- skos__historyNote mesh__D013110 Amino Alcohols %28%1966-1971%29%
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D013110 2002
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D013110 2006
% 222.95/223.12  |- skos__prefLabel mesh__D013110 Sphingosine
% 222.95/223.12  |- skos__broader mesh__D013110smesh__D006018
% 222.95/223.12  |- mesh__recordMaintainer mesh__D013110 ADP
% 222.95/223.12  |- mesh__dateRevised mesh__D013110 1998-06-11
% 222.95/223.12  |- mesh__historyNote mesh__D013110 72   
% 222.95/223.12  |- mesh__dateEstablished mesh__D013110 1972-01-01
% 222.95/223.12  |- mesh__recordAuthorizer mesh__D013110 SJN
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D013110 1999
% 222.95/223.12  |- skos__historyNote mesh__D004384 Duodenum %28%1966-1980%29%
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D004384 2006
% 222.95/223.12  |- mesh__recordMaintainer mesh__D004384 nns
% 222.95/223.12  |- skos__historyNote mesh__D004384 Endoscopy %28%1966-1980%29%
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D004384 2002
% 222.95/223.12  |- skos__hiddenLabel mesh__D004384 Procedures, Duodenoscopic Surgical
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D004384 2003
% 222.95/223.12  |- skos__altLabel mesh__D004384 Surgical Procedures, Duodenoscopic
% 222.95/223.12  |- rdf__type mesh__D004384sskos__Concept
% 222.95/223.12  |- skos__hiddenLabel mesh__D004384 Duodenoscopies
% 222.95/223.12  |- skos__hiddenLabel mesh__D004384 Duodenoscopic Surgeries
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D004384 2004
% 222.95/223.12  |- skos__prefLabel mesh__D004384 Duodenoscopy
% 222.95/223.12  |- skos__altLabel mesh__D004384 Duodenoscopic Surgery
% 222.95/223.12  |- mesh__dateRevised mesh__D004384 1999-11-03
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D004384 2000
% 222.95/223.12  |- skos__hiddenLabel mesh__D004384 Surgeries, Duodenoscopic
% 222.95/223.12  |- skos__hiddenLabel mesh__D004384 Surgical Procedure, Duodenoscopic
% 222.95/223.12  |- skos__hiddenLabel mesh__D004384 Duodenoscopic Surgical Procedure
% 222.95/223.12  |- mesh__dateCreated mesh__D004384 1980-04-04
% 222.95/223.12  |- mesh__historyNote mesh__D004384 81   
% 222.95/223.12  |- mesh__dateEstablished mesh__D004384 1981-01-01
% 222.95/223.12  |- mesh__publicMeSHNote mesh__D004384 81   
% 222.95/223.12  |- skos__hiddenLabel mesh__D004384 Procedure, Duodenoscopic Surgical
% 222.95/223.12  |- skos__altLabel mesh__D004384 Surgery, Duodenoscopic
% 222.95/223.12  |- skos__broader mesh__D004384smesh__D016099
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D004384 2001
% 222.95/223.12  |- mesh__recordAuthorizer mesh__D004384 sjn
% 222.95/223.12  |- mesh__recordOriginator mesh__D004384 RC
% 222.95/223.12  |- skos__scopeNote mesh__D004384
% 222.95/223.12       Endoscopic examination, therapy or surgery of the luminal surface of the duodenum.%A%    
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D004384 2005
% 222.95/223.12  |- mesh__dateCreated mesh__D012816 1999-01-01
% 222.95/223.12  |- mesh__onlineNote mesh__D012816
% 222.95/223.12       pre-explosion = SIGNS A%23%D SYMPTOMS %28%PX%29%   
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012816 2000
% 222.95/223.12  |- mesh__dateRevised mesh__D012816 1999-11-03
% 222.95/223.12  |- skos__annotation mesh__D012816 not used for indexing   
% 222.95/223.12  |- mesh__dateEstablished mesh__D012816 1998-01-01
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012816 2004
% 222.95/223.12  |- mesh__recordMaintainer mesh__D012816 KEV
% 222.95/223.12  |- mesh__historyNote mesh__D012816 98; use pre-explosion 1970-97   
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012816 2006
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012816 2003
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012816 2005
% 222.95/223.12  |- mesh__publicMeSHNote mesh__D012816 98   
% 222.95/223.12  |- mesh__recordAuthorizer mesh__D012816 sjn
% 222.95/223.12  |- skos__prefLabel mesh__D012816 Signs and Symptoms
% 222.95/223.12  |- skos__broader mesh__D012816smesh__D013568
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012816 2002
% 222.95/223.12  |- rdf__type mesh__D012816sskos__Concept
% 222.95/223.12  |- skos__hiddenLabel mesh__D012816 Symptoms and Signs
% 222.95/223.12  |- skos__scopeNote mesh__D012816
% 222.95/223.12       Clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient.%A%    
% 222.95/223.12  |- mesh__recordOriginator mesh__D012816 NLM
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012816 2001
% 222.95/223.12  |- skos__broader mesh__D012315Q000031smesh__D012315
% 222.95/223.12  |- mesh__preferredCombination mesh__D012315Q000031smesh__D012314
% 222.95/223.12  |- rdf__type mesh__D012315Q000031smesh__CompoundConcept
% 222.95/223.12  |- mesh__dateCreated mesh__D012018 1999-01-01
% 222.95/223.12  |- skos__broader mesh__D012018smesh__D009424
% 222.95/223.12  |- skos__annotation mesh__D012018
% 222.95/223.12       areflexia, hyporeflexia, hyperreflexia, loss of reflex: index under REFLEX, ABNORMAL%A%  
% 222.95/223.12  |- skos__scopeNote mesh__D012018
% 222.95/223.12       An involuntary movement or exercise of function in a part, excited in response to a stimulus applied to the periphery and transmitted to the brain or spinal cord.%A%    
% 222.95/223.12  |- mesh__recordMaintainer mesh__D012018 mdb
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012018 2003
% 222.95/223.12  |- rdf__type mesh__D012018sskos__Concept
% 222.95/223.12  |- mesh__dateRevised mesh__D012018 2002-07-03
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012018 2004
% 222.95/223.12  |- mesh__recordOriginator mesh__D012018 NLM
% 222.95/223.12  |- skos__broader mesh__D012018smesh__D011603
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012018 2005
% 222.95/223.12  |- skos__prefLabel mesh__D012018 Reflex
% 222.95/223.12  |- skos__broader mesh__D012018smesh__D009460
% 222.95/223.12  |- mesh__recordAuthorizer mesh__D012018 sjn
% 222.95/223.12  |- mesh__historyNote mesh__D012018
% 222.95/223.12       REFLEX, BABINSKI was BABINSKI REFLEX see under REFLEX, ABNORMAL 1968-89%A%  
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D012018 2006
% 222.95/223.12  |- mesh__dateEstablished mesh__D017501 1993-01-01
% 222.95/223.12  |- skos__prefLabel mesh__D017501 Adenovirus E1B Proteins
% 222.95/223.12  |- skos__broader mesh__D017501smesh__D017498
% 222.95/223.12  |- mesh__publicMeSHNote mesh__D017501
% 222.95/223.12       93; ADENOVIRUS E1B PROTEIN was indexed under ONCOGENE PROTEINS, VIRAL 1985-92 %26% ANTIGENS, VIRAL, TUMOR 1985%A%  
% 222.95/223.12  |- mesh__historyNote mesh__D017501
% 222.95/223.12       93; ADENOVIRUS E1B PROTEIN was SY to ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS %28%NM%29% 1985-92%A%  
% 222.95/223.12  |- mesh__recordMaintainer mesh__D017501 ssb
% 222.95/223.12  |- skos__historyNote mesh__D017501
% 222.95/223.12       Oncogene Proteins, Viral %28%1986-1992%29%
% 222.95/223.12  |- mesh__onlineNote mesh__D017501
% 222.95/223.12       use ADENOVIRUS EARLY PROTEINS %28%NM%29% to search ADENOVIRUS E1B PROTEINS 1985-92%A%  
% 222.95/223.12  |- rdf__type mesh__D017501sskos__Concept
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D017501 2006
% 222.95/223.12  |- mesh__dateCreated mesh__D017501 1992-05-13
% 222.95/223.12  |- skos__historyNote mesh__D017501 Antigens, Viral, Tumor %28%1985%29%
% 222.95/223.12  |- mesh__recordOriginator mesh__D017501 AGS
% 222.95/223.12  |- mesh__recordAuthorizer mesh__D017501 sjn
% 222.95/223.12  |- skos__hiddenLabel mesh__D017501 E1B Protein, Adenovirus
% 222.95/223.12  |- skos__broader mesh__D017501smesh__D014157
% 222.95/223.12  |- skos__hiddenLabel mesh__D017501 E1B Proteins, Adenovirus
% 222.95/223.12  |- skos__altLabel mesh__D017501 Adenovirus E1B Protein
% 222.95/223.12  |- skos__scopeNote mesh__D017501
% 222.95/223.12       Proteins transcribed from the E1B region of ADENOVIRUSES which are involved in regulation of the levels of early and late viral gene expression.%A%    
% 222.95/223.12  |- mesh__dateRevised mesh__D017501 2005-06-30
% 222.95/223.12  |- skos__broader mesh__D017501smesh__D000957
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D008775 2004
% 222.95/223.12  |- rdf__type mesh__D008775sskos__Concept
% 222.95/223.12  |- skos__altLabel mesh__D008775 6-Methylprednisolone
% 222.95/223.12  |- mesh__publicMeSHNote mesh__D008775
% 222.95/223.12       METIPRED was indexed under GLUCOCORTICOIDS, SYNTHETIC 1989-93%A%  
% 222.95/223.12  |- mesh__dateCreated mesh__D008775 1999-01-01
% 222.95/223.12  |- skos__hiddenLabel mesh__D008775 6 Methylprednisolone
% 222.95/223.12  |- mesh__recordMaintainer mesh__D008775 ssb
% 222.95/223.12  |- mesh__historyNote mesh__D008775 METIPRED was %28%NM%29% 1989-93   
% 222.95/223.12  |- mesh__recordAuthorizer mesh__D008775 sjn
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D008775 2005
% 222.95/223.12  |- skos__altLabel mesh__D008775 Metipred
% 222.95/223.12  |- mesh__onlineNote mesh__D008775
% 222.95/223.12       use METHYLPREDNISOLONE %28%NM%29% to search METIPRED 1989-93   
% 222.95/223.12  |- mesh__dateRevised mesh__D008775 2003-07-09
% 222.95/223.12  |- skos__prefLabel mesh__D008775 Methylprednisolone
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D008775 2006
% 222.95/223.12  |- skos__scopeNote mesh__D008775
% 222.95/223.12       A PREDNISOLONE derivative with similar anti-inflammatory action.%A%    
% 222.95/223.12  |- skos__broader mesh__D008775smesh__D011239
% 222.95/223.12  |- mesh__recordOriginator mesh__D008775 NLM
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D000792 2004
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D000792 1998
% 222.95/223.12  |- skos__broader mesh__D000792smesh__D003935
% 222.95/223.12  |- skos__broader mesh__D000792smesh__D011859
% 222.95/223.12  |- skos__hiddenLabel mesh__D000792 Arteriographies
% 222.95/223.12  |- skos__annotation mesh__D000792
% 222.95/223.12       NIM; GEN or unspecified; prefer /radiogr with specific blood vessels but CORONARY ANGIOGRAPHY is available; /drug eff /rad eff permitted; DF: ANGIOGR%A%  
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D000792 2005
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D000792 1999
% 222.95/223.12  |- skos__prefLabel mesh__D000792 Angiography
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D000792 2006
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D000792 2000
% 222.95/223.12  |- rdf__type mesh__D000792sskos__Concept
% 222.95/223.12  |- mesh__dateCreated mesh__D000792 1999-01-01
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D000792 2001
% 222.95/223.12  |- mesh__dateRevised mesh__D000792 1997-06-20
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D000792 2002
% 222.95/223.12  |- mesh__recordAuthorizer mesh__D000792 SJN
% 222.95/223.12  |- skos__scopeNote mesh__D000792
% 222.95/223.12       Radiography of blood vessels after injection of a contrast medium.%A%    
% 222.95/223.12  |- mesh__recordMaintainer mesh__D000792 PXP
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D000792 2003
% 222.95/223.12  |- mesh__recordOriginator mesh__D000792 NLM
% 222.95/223.12  |- skos__hiddenLabel mesh__D000792 Angiographies
% 222.95/223.12  |- skos__hiddenLabel mesh__D016409 Well-Differentiated Lymphocytic Lymphoma
% 222.95/223.12  |- mesh__recordOriginator mesh__D016409 PLS
% 222.95/223.12  |- mesh__recordMaintainer mesh__D016409 PXP
% 222.95/223.12  |- skos__hiddenLabel mesh__D016409 Lymphomas, CLL Lymphoplasmacytoid
% 222.95/223.12  |- skos__broader mesh__D016409smesh__D016397
% 222.95/223.12  |- skos__broader mesh__D016409smesh__D008226
% 222.95/223.12  |- skos__prefLabel mesh__D016409 Lymphoma, Small Lymphocytic
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D016409 2004
% 222.95/223.12  |- skos__altLabel mesh__D016409 Lymphoma, Small Lymphocytic, Plasmacytoid
% 222.95/223.12  |- skos__hiddenLabel mesh__D016409
% 222.95/223.12       Lymphomas, Well-Differentiated Lymphocytic
% 222.95/223.12  |- skos__altLabel mesh__D016409 Lymphoma, Lymphoplasmacytoid, CLL
% 222.95/223.12  |- skos__altLabel mesh__D016409 Lymphoplasmacytoid Lymphoma, CLL
% 222.95/223.12  |- skos__altLabel mesh__D016409 Lymphocytic Lymphoma, Well Differentiated
% 222.95/223.12  |- mesh__recordAuthorizer mesh__D016409 SJN
% 222.95/223.12  |- skos__hiddenLabel mesh__D016409 Lymphocytic Lymphoma, Small
% 222.95/223.12  |- mesh__dateEstablished mesh__D016409 1991-01-01
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D016409 2000
% 222.95/223.12  |- skos__hiddenLabel mesh__D016409 Small Lymphocytic Lymphoma
% 222.95/223.12  |- mesh__dateRevised mesh__D016409 1997-06-20
% 222.95/223.12  |- skos__hiddenLabel mesh__D016409 Small Lymphocytic Lymphomas
% 222.95/223.12  |- mesh__historyNote mesh__D016409 91   
% 222.95/223.12  |- mesh__publicMeSHNote mesh__D016409 91   
% 222.95/223.12  |- skos__hiddenLabel mesh__D016409 CLL Lymphoplasmacytoid Lymphoma
% 222.95/223.12  |- skos__hiddenLabel mesh__D016409 CLL Lymphoplasmacytoid Lymphomas
% 222.95/223.12  |- mesh__dateCreated mesh__D016409 1990-06-01
% 222.95/223.12  |- skos__hiddenLabel mesh__D016409
% 222.95/223.12       Lymphocytic Lymphomas, Well-Differentiated
% 222.95/223.12  |- skos__altLabel mesh__D016409
% 222.95/223.12       Lymphoma, Lymphocytic, Diffuse, Well Differentiated
% 222.95/223.12  |- skos__altLabel mesh__D016409
% 222.95/223.12       Diffuse Well-Differentiated Lymphocytic Lymphoma
% 222.95/223.12  |- skos__related mesh__D016409smesh__D015462
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D016409 2001
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D016409 2005
% 222.95/223.12  |- skos__altLabel mesh__D016409
% 222.95/223.12       Lymphocytic Lymphoma, Diffuse, Well-Differentiated
% 222.95/223.12  |- skos__scopeNote mesh__D016409
% 222.95/223.12       A low-grade malignant lymphoma that may, in some cases, be considered histologically identical to chronic lymphocytic leukemia %28%CLL; LEUKEMIA, LYMPHOCYTIC, CHRONIC%29%. It is diffuse in pattern, representing the neoplastic proliferation of well-differentiated B-lymphocytes. In patients with immunoglobulin gammopathies, the lymphocytes may exhibit plasmacytoid characteristics.%A%    
% 222.95/223.12  |- skos__annotation mesh__D016409
% 222.95/223.12       a diffuse low-grade non-Hodgkin%27%s lymphoma   
% 222.95/223.12  |- skos__altLabel mesh__D016409 Lymphocytic Lymphoma, Well-Differentiated
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D016409 1998
% 222.95/223.12  |- skos__hiddenLabel mesh__D016409 Lymphocytic Lymphomas, Small
% 222.95/223.12  |- skos__hiddenLabel mesh__D016409 Lymphomas, Small Lymphocytic
% 222.95/223.12  |- rdf__type mesh__D016409sskos__Concept
% 222.95/223.12  |- skos__broader mesh__D016409smesh__D016398
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D016409 2006
% 222.95/223.12  |- skos__hiddenLabel mesh__D016409 Lymphoplasmacytoid Lymphomas, CLL
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D016409 1999
% 222.95/223.12  |- skos__altLabel mesh__D016409
% 222.95/223.12       Lymphocytic Lymphoma, Diffuse, Well Differentiated
% 222.95/223.12  |- skos__altLabel mesh__D016409
% 222.95/223.12       Lymphoma, Lymphocytic, Diffuse, Well-Differentiated
% 222.95/223.12  |- skos__altLabel mesh__D016409 Lymphoma, Lymphocytic, Well-Differentiated
% 222.95/223.12  |- skos__altLabel mesh__D016409 Lymphoma, Lymphocytic, Well Differentiated
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D016409 2002
% 222.95/223.12  |- skos__hiddenLabel mesh__D016409
% 222.95/223.12       Diffuse Well Differentiated Lymphocytic Lymphoma
% 222.95/223.12  |- skos__hiddenLabel mesh__D016409 Lymphoma, CLL Lymphoplasmacytoid
% 222.95/223.12  |- mesh__activeMeSHYear mesh__D016409 2003
% 222.95/223.12  |- skos__hiddenLabel mesh__D016409
% 222.95/223.12       Well-Differentiated Lymphocytic Lymphomas
% 222.95/223.12  |- skos__hiddenLabel mesh__D016409
% 222.95/223.12       Lymphoma, Well-Differentiated Lymphocytic
% 222.95/223.12  |- skos__broader mesh__D013111smesh__D001180
% 222.95/223.12  |- skos__annotation mesh__D013111
% 222.95/223.12       /antag permitted but consider also ANTIVENINS; /enzymol permitted%A%  
% 222.95/223.12  |- skos__altLabel mesh__D013111 Spider Venom
% 222.95/223.12  |- skos__altLabel mesh__D013111 Araneid Venoms
% 222.95/223.12  |- skos__hiddenLabel mesh__D013111 Venoms, Araneid
% 222.95/223.12  |- rdf__type mesh__D013111sskos__Concept
% 222.95/223.12  |- skos__hiddenLabel mesh__D013111 Venoms, Spider
% 222.95/223.13  |- mesh__recordMaintainer mesh__D013111 sjn
% 222.95/223.13  |- mesh__recordAuthorizer mesh__D013111 sjn
% 222.95/223.13  |- skos__hiddenLabel mesh__D013111 Venoms, Tarantula
% 222.95/223.13  |- mesh__recordOriginator mesh__D013111 SH
% 222.95/223.13  |- skos__historyNote mesh__D013111 Venoms %28%1966-1977%29%
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D013111 2006
% 222.95/223.13  |- skos__altLabel mesh__D013111 Arachnid Venom
% 222.95/223.13  |- mesh__publicMeSHNote mesh__D013111
% 222.95/223.13       91; was see under ARTHROPOD VENOMS 1978-90   
% 222.95/223.13  |- skos__hiddenLabel mesh__D013111 Venoms, Arachnid
% 222.95/223.13  |- skos__historyNote mesh__D013111 Spiders %28%1966-1977%29%
% 222.95/223.13  |- skos__prefLabel mesh__D013111 Spider Venoms
% 222.95/223.13  |- mesh__dateEstablished mesh__D013111 1991-01-01
% 222.95/223.13  |- skos__hiddenLabel mesh__D013111 Venom, Araneid
% 222.95/223.13  |- skos__related mesh__D013111smesh__D001098
% 222.95/223.13  |- mesh__historyNote mesh__D013111
% 222.95/223.13       91%28%78%29%; was see under ARTHROPOD VENOMS 1978-90   
% 222.95/223.13  |- skos__hiddenLabel mesh__D013111 Venom, Spider
% 222.95/223.13  |- skos__hiddenLabel mesh__D013111 Venom, Arachnid
% 222.95/223.13  |- skos__scopeNote mesh__D013111
% 222.95/223.13       Venoms of arthropods of the order Araneida of the ARACHNIDA. The venoms usually contain several protein fractions, including ENZYMES, hemolytic, neurolytic, and other TOXINS, BIOLOGICAL.%A%    
% 222.95/223.13  |- skos__altLabel mesh__D013111 Araneid Venom
% 222.95/223.13  |- mesh__dateCreated mesh__D013111 1977-04-27
% 222.95/223.13  |- mesh__dateRevised mesh__D013111 2005-07-01
% 222.95/223.13  |- skos__scopeNote mesh__D004385
% 222.95/223.13       Surgical formation of an opening into the duodenum.     
% 222.95/223.13  |- mesh__historyNote mesh__D004385
% 222.95/223.13       91%28%88%29%; was see under ENTEROSTOMY 1988-90   
% 222.95/223.13  |- mesh__recordAuthorizer mesh__D004385 SJN
% 222.95/223.13  |- skos__historyNote mesh__D004385 Duodenum/surgery %28%1966-1987%29%
% 222.95/223.13  |- skos__prefLabel mesh__D004385 Duodenostomy
% 222.95/223.13  |- mesh__dateCreated mesh__D004385 1987-03-19
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D004385 2006
% 222.95/223.13  |- skos__hiddenLabel mesh__D004385 Duodenostomies
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D004385 2001
% 222.95/223.13  |- mesh__dateEstablished mesh__D004385 1991-01-01
% 222.95/223.13  |- mesh__recordOriginator mesh__D004385 SCD
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D004385 2005
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D004385 2004
% 222.95/223.13  |- skos__annotation mesh__D004385
% 222.95/223.13       do not use /util except by MeSH definition   
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D004385 2000
% 222.95/223.13  |- rdf__type mesh__D004385sskos__Concept
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D004385 2003
% 222.95/223.13  |- mesh__publicMeSHNote mesh__D004385
% 222.95/223.13       91; was see under ENTEROSTOMY 1988-90   
% 222.95/223.13  |- skos__broader mesh__D004385smesh__D004766
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D004385 1999
% 222.95/223.13  |- mesh__recordMaintainer mesh__D004385 PXP
% 222.95/223.13  |- mesh__dateRevised mesh__D004385 1997-06-20
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D004385 2002
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D004385 1998
% 222.95/223.13  |- mesh__dateRevised mesh__D012817 2003-07-09
% 222.95/223.13  |- mesh__recordOriginator mesh__D012817 NLM
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D012817 2004
% 222.95/223.13  |- mesh__onlineNote mesh__D012817
% 222.95/223.13       consider also specific digestive diseases in C6   
% 222.95/223.13  |- skos__scopeNote mesh__D012817
% 222.95/223.13       Digestive system manifestations of diseases of the gastrointestinal system or of other organs.%A%    
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D012817 2006
% 222.95/223.13  |- skos__prefLabel mesh__D012817 Signs and Symptoms, Digestive
% 222.95/223.13  |- mesh__historyNote mesh__D012817 98; use explode 1970-97   
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D012817 2005
% 222.95/223.13  |- skos__broader mesh__D012817smesh__D012816
% 222.95/223.13  |- mesh__dateEstablished mesh__D012817 1998-01-01
% 222.95/223.13  |- skos__annotation mesh__D012817
% 222.95/223.13       not used for indexing; see specific digestive diseases in C6%A%  
% 222.95/223.13  |- skos__historyNote mesh__D012817
% 222.95/223.13       specific sign or symptom %28%1966-1997%29%
% 222.95/223.13  |- rdf__type mesh__D012817sskos__Concept
% 222.95/223.13  |- mesh__publicMeSHNote mesh__D012817 98   
% 222.95/223.13  |- mesh__recordAuthorizer mesh__D012817 sjn
% 222.95/223.13  |- mesh__recordMaintainer mesh__D012817 ags
% 222.95/223.13  |- mesh__dateCreated mesh__D012817 1999-01-01
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D012019 2003
% 222.95/223.13  |- mesh__historyNote mesh__D012019
% 222.95/223.13       1965; HAND-SHOULDER SYNDROME was see REFLEX SYMPATHETIC DYSTROPHY 1992-95; SHOULDER-HAND SYNDROME %26% SUDECK%27%S ATROPHY were headings 1963-95; OSTEOPOROSIS, POST-TRAUMATIC was see SUDECK%27%S ATROPHY 1992-95%A%  
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Shoulder-Hand Syndromes
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Dystrophies, Reflex Sympathetic
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Sympathetic Dystrophy, Cervical
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Atrophy, Sudek%27%s
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D012019 2002
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 CPRS Type Is
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Syndromes, Shoulder-Hand
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Dystrophies, Cervical Sympathetic
% 222.95/223.13  |- skos__altLabel mesh__D012019 Complex Regional Pain Syndrome, Type I
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Dystrophy, Reflex Sympathetic
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Sudek%27%s Atrophies
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Type Is, CPRS
% 222.95/223.13  |- mesh__recordMaintainer mesh__D012019 KEV
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Cervical Sympathetic Dystrophies
% 222.95/223.13  |- skos__altLabel mesh__D012019 Type I Complex Regional Pain Syndrome
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Syndrome, Shoulder-Hand
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Atrophies, Sudek%27%s
% 222.95/223.13  |- skos__altLabel mesh__D012019 Shoulder-Hand Syndrome
% 222.95/223.13  |- mesh__dateEstablished mesh__D012019 1965-01-01
% 222.95/223.13  |- skos__altLabel mesh__D012019 Sympathetic Reflex Dystrophia
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Sympathetic Dystrophy, Reflex
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D012019 2001
% 222.95/223.13  |- skos__altLabel mesh__D012019 Reflex Sympathetic Dystrophy Syndrome
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Reflex Sympathetic Dystrophies
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Shoulder Hand Syndrome
% 222.95/223.13  |- skos__broader mesh__D012019smesh__D020918
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D012019 2006
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 I, CPRS Type
% 222.95/223.13  |- mesh__recordAuthorizer mesh__D012019 sjn
% 222.95/223.13  |- mesh__recordOriginator mesh__D012019 NLM
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Algodystrophies
% 222.95/223.13  |- skos__altLabel mesh__D012019 Sudek%27%s Atrophy
% 222.95/223.13  |- mesh__onlineNote mesh__D012019
% 222.95/223.13       use REFLEX SYMPATHETIC DYSTROPHY to search HAND-SHOULDER SYNDROME 1992-95%A%  
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Syndrome, Algodystrophic
% 222.95/223.13  |- skos__altLabel mesh__D012019 Algodystrophy
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D012019 2000
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Atrophy, Sudek
% 222.95/223.13  |- skos__altLabel mesh__D012019 CPRS Type I
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D012019 2005
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Sudeks Atrophy
% 222.95/223.13  |- mesh__dateCreated mesh__D012019 1999-01-01
% 222.95/223.13  |- skos__altLabel mesh__D012019 Syndrome, Reflex Sympathetic Dystrophy
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Type I, CPRS
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Reflex Dystrophia, Sympathetic
% 222.95/223.13  |- mesh__publicMeSHNote mesh__D012019
% 222.95/223.13       1965; HAND-SHOULDER SYNDROME was see REFLEX SYMPATHETIC DYSTROPHY 1992-95; SHOULDER-HAND SYNDROME %26% SUDECK%27%S ATROPHY were headings 1963-95; OSTEOPOROSIS, POST-TRAUMATIC was see SUDECK%27%S ATROPHY 1992-95%A%  
% 222.95/223.13  |- skos__annotation mesh__D012019 DF: CRPS TYPE I   
% 222.95/223.13  |- skos__altLabel mesh__D012019 Pain Syndrome Type I, Complex Regional
% 222.95/223.13  |- skos__scopeNote mesh__D012019
% 222.95/223.13       A syndrome characterized by severe burning pain in an extremity accompanied by sudomotor, vasomotor, and trophic changes in bone without an associated specific nerve injury. This condition is most often precipitated by trauma to soft tissue or nerve complexes. The skin over the affected region is usually erythematous and demonstrates hypersensitivity to tactile stimuli and erythema. %28%Adams et al., Principles of Neurology, 6th ed, p1360; Pain 1995 Oct;63%28%1%29%:127-33%29%%A%    
% 222.95/223.13  |- skos__prefLabel mesh__D012019 Reflex Sympathetic Dystrophy
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D012019 2004
% 222.95/223.13  |- skos__altLabel mesh__D012019 Pain Syndrome Type I, Regional, Complex
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Dystrophy, Cervical Sympathetic
% 222.95/223.13  |- skos__altLabel mesh__D012019 Sudek Atrophy
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Sympathetic Dystrophies, Cervical
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019
% 222.95/223.13       RSDs %28%Reflex Sympathetic Dystrophy%29%
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Sympathetic Dystrophies, Reflex
% 222.95/223.13  |- rdf__type mesh__D012019sskos__Concept
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Sympathetic Reflex Dystrophias
% 222.95/223.13  |- skos__altLabel mesh__D012019 RSD %28%Reflex Sympathetic Dystrophy%29%
% 222.95/223.13  |- mesh__dateRevised mesh__D012019 1999-11-04
% 222.95/223.13  |- skos__hiddenLabel mesh__D012019 Is, CPRS Type
% 222.95/223.13  |- skos__historyNote mesh__D009070 Cephamycins %28%1975-1977%29%
% 222.95/223.13  |- mesh__dateEstablished mesh__D009070 1984-01-01
% 222.95/223.13  |- skos__hiddenLabel mesh__D009070 Ly 127935
% 222.95/223.13  |- skos__altLabel mesh__D009070 S-6059
% 222.95/223.13  |- skos__altLabel mesh__D009070 Latamoxef
% 222.95/223.13  |- skos__historyNote mesh__D009070 Cephalosporins  %28%1966-1974%29%
% 222.95/223.13  |- skos__hiddenLabel mesh__D009070 1 Oxacephalosporin
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D009070 2006
% 222.95/223.13  |- mesh__historyNote mesh__D009070 84   
% 222.95/223.13  |- mesh__dateCreated mesh__D009070 1983-04-04
% 222.95/223.13  |- skos__hiddenLabel mesh__D009070 Latamoxef, Disodium
% 222.95/223.13  |- mesh__dateRevised mesh__D009070 2004-07-07
% 222.95/223.13  |- skos__hiddenLabel mesh__D009070 Disodium, Moxalactam
% 222.95/223.13  |- skos__altLabel mesh__D009070 Moxalactam Disodium
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D009070 2005
% 222.95/223.13  |- mesh__recordMaintainer mesh__D009070 ssb
% 222.95/223.13  |- skos__hiddenLabel mesh__D009070 S 6059
% 222.95/223.13  |- mesh__recordOriginator mesh__D009070 SH
% 222.95/223.13  |- skos__historyNote mesh__D009070 Lactams %28%1972-1980%29%
% 222.95/223.13  |- skos__prefLabel mesh__D009070 Moxalactam
% 222.95/223.13  |- skos__altLabel mesh__D009070 Lamoxactam
% 222.95/223.13  |- skos__broader mesh__D009070smesh__D047090
% 222.95/223.13  |- rdf__type mesh__D009070sskos__Concept
% 222.95/223.13  |- skos__altLabel mesh__D009070 Disodium Moxalactam
% 222.95/223.13  |- skos__hiddenLabel mesh__D009070 S6059
% 222.95/223.13  |- skos__hiddenLabel mesh__D009070 6059S
% 222.95/223.13  |- skos__altLabel mesh__D009070 Ly127935
% 222.95/223.13  |- mesh__recordAuthorizer mesh__D009070 sjn
% 222.95/223.13  |- skos__broader mesh__D009070smesh__D007769
% 222.95/223.13  |- skos__hiddenLabel mesh__D009070 Moxalactam, Disodium
% 222.95/223.13  |- skos__altLabel mesh__D009070 Ly-127935
% 222.95/223.13  |- skos__historyNote mesh__D009070
% 222.95/223.13       Cefamandole/analogs %26% derivatives %28%1978-1983%29%
% 222.95/223.13  |- skos__historyNote mesh__D009070 Antibiotics %28%1966-1980%29%
% 222.95/223.13  |- skos__hiddenLabel mesh__D009070 6059 S
% 222.95/223.13  |- skos__scopeNote mesh__D009070
% 222.95/223.13       Broad- spectrum beta-lactam antibiotic similar in structure to the CEPHALOSPORINS except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain CEPHALOSPORINS. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections.%A%    
% 222.95/223.13  |- mesh__publicMeSHNote mesh__D009070 84   
% 222.95/223.13  |- skos__broader mesh__D017502smesh__D017456
% 222.95/223.13  |- skos__hiddenLabel mesh__D017502 E2 Proteins, Adenovirus
% 222.95/223.13  |- mesh__recordMaintainer mesh__D017502 ssb
% 222.95/223.13  |- skos__hiddenLabel mesh__D017502 E2F Proteins, Adenovirus
% 222.95/223.13  |- mesh__publicMeSHNote mesh__D017502
% 222.95/223.13       93; ADENOVIRUS E2A PROTEIN %26% ADENOVIRUS E2F PROTEIN were indexed under ONCOGENE PROTEINS, VIRAL 1985-92; ADENOVIRUS 72K PROTEIN %26% ADENOVIRUS DNA-BINDING PROTEIN were indexed under VIRAL PROTEINS %26% DNA-BINDING PROTEINS 1984-92%A%  
% 222.95/223.13  |- mesh__dateRevised mesh__D017502 2005-06-30
% 222.95/223.13  |- rdf__type mesh__D017502sskos__Concept
% 222.95/223.13  |- skos__altLabel mesh__D017502 E2F Protein, Adenovirus
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D017502 2006
% 222.95/223.13  |- skos__altLabel mesh__D017502 E2A Protein, Adenovirus
% 222.95/223.13  |- skos__altLabel mesh__D017502 E2A 72K Protein, Adenovirus
% 222.95/223.13  |- skos__hiddenLabel mesh__D017502 Adenovirus E2F Protein
% 222.95/223.13  |- mesh__dateCreated mesh__D017502 1992-05-13
% 222.95/223.13  |- mesh__recordOriginator mesh__D017502 AGS
% 222.95/223.13  |- skos__altLabel mesh__D017502 E2 Protein, Adenovirus
% 222.95/223.13  |- skos__prefLabel mesh__D017502 Adenovirus E2 Proteins
% 222.95/223.13  |- skos__hiddenLabel mesh__D017502 Adenovirus E2A Protein
% 222.95/223.13  |- mesh__onlineNote mesh__D017502
% 222.95/223.13       use ADENOVIRUS EARLY PROTEINS %28%NM%29% to search ADENOVIRUS E2A PROTEIN %26% ADENOVIRUS E2F PROTEIN 1985-92%A%  
% 222.95/223.13  |- skos__scopeNote mesh__D017502
% 222.95/223.13       Proteins transcribed from the E2 region of ADENOVIRUSES. Several of these are required for viral DNA replication.%A%    
% 222.95/223.13  |- mesh__dateEstablished mesh__D017502 1993-01-01
% 222.95/223.13  |- skos__broader mesh__D017502smesh__D004268
% 222.95/223.13  |- skos__hiddenLabel mesh__D017502 E2A Proteins, Adenovirus
% 222.95/223.13  |- skos__historyNote mesh__D017502 Oncogene Proteins %28%1985-1992%29%
% 222.95/223.13  |- skos__hiddenLabel mesh__D017502 Adenovirus E2 Protein
% 222.95/223.13  |- mesh__recordAuthorizer mesh__D017502 sjn
% 222.95/223.13  |- mesh__historyNote mesh__D017502
% 222.95/223.13       93; ADENOVIRUS E2A PROTEIN %26% ADENOVIRUS E2F PR0TEIN were SY to ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS %28%NM%29% 1985-92; ADENOVIRUS E2A 72K PROTEIN was ADENOVIRUS 72K PROTEIN %28%NM%29% 1984-92; ADENOVIRUS E2A DNA-BINDING PROTEIN was ADENOVIRUS DNA-BINDING PROTEIN %28%SY%29% to ADENOVIRUS 72K PROTEIN %28%NM%29% 1984-92%A%  
% 222.95/223.13  |- mesh__recordAuthorizer mesh__D050936 sjn
% 222.95/223.13  |- mesh__dateCreated mesh__D050936 2005-06-30
% 222.95/223.13  |- rdf__type mesh__D050936sskos__Concept
% 222.95/223.13  |- skos__altLabel mesh__D050936 Basic Reproduction Ratio
% 222.95/223.13  |- skos__annotation mesh__D050936
% 222.95/223.13       not related to REPRODUCTION: see scope note   
% 222.95/223.13  |- mesh__recordOriginator mesh__D050936 ags
% 222.95/223.13  |- skos__altLabel mesh__D050936 Basic Reproductive Rate
% 222.95/223.13  |- mesh__publicMeSHNote mesh__D050936 2006   
% 222.95/223.13  |- skos__hiddenLabel mesh__D050936 Reproductive Rate, Basic
% 222.95/223.13  |- skos__broader mesh__D050936smesh__D009017
% 222.95/223.13  |- mesh__recordMaintainer mesh__D050936 ags
% 222.95/223.13  |- mesh__historyNote mesh__D050936 2006   
% 222.95/223.13  |- skos__prefLabel mesh__D050936 Basic Reproduction Number
% 222.95/223.13  |- skos__scopeNote mesh__D050936
% 222.95/223.13       The expected number of new cases of an infection caused by an infected individual, in a population consisting of susceptible contacts only.%A%    
% 222.95/223.13  |- skos__hiddenLabel mesh__D050936 Number, Basic Reproduction
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D050936 2006
% 222.95/223.13  |- skos__broader mesh__D050936smesh__D018446
% 222.95/223.13  |- mesh__dateEstablished mesh__D050936 2006-01-01
% 222.95/223.13  |- skos__historyNote mesh__D008776 Succinates %28%1966-1979%29%
% 222.95/223.13  |- mesh__onlineNote mesh__D008776
% 222.95/223.13       use METHYLPREDNISOLONE HEMISUCCINATE to search METHYLPREDNISOLONE SUCCINATE 1980-90%A%  
% 222.95/223.13  |- skos__hiddenLabel mesh__D008776 Succinate, Methylprednisolone
% 222.95/223.13  |- skos__hiddenLabel mesh__D008776 Sodium Succinate, Methylprednisolone
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D008776 2005
% 222.95/223.13  |- skos__hiddenLabel mesh__D008776 Sodium Hemisuccinate, Methylprednisolone
% 222.95/223.13  |- skos__hiddenLabel mesh__D008776 UrbasonSoluble
% 222.95/223.13  |- skos__scopeNote mesh__D008776
% 222.95/223.13       A water-soluble ester of METHYLPREDNISOLONE used for cardiac, allergic, and hypoxic emergencies.%A%    
% 222.95/223.13  |- mesh__dateRevised mesh__D008776 2003-07-09
% 222.95/223.13  |- mesh__dateCreated mesh__D008776 1979-05-30
% 222.95/223.13  |- skos__altLabel mesh__D008776 Methylprednisolone Succinate
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D008776 2006
% 222.95/223.13  |- mesh__historyNote mesh__D008776
% 222.95/223.13       91%28%80%29%; was METHYLPREDNISOLONE SUCCINATE see under METHYLPREDNISOLONE/analogs %26% derivatives 1980-90%A%  
% 222.95/223.13  |- skos__altLabel mesh__D008776 Methylprednisolone Sodium Succinate
% 222.95/223.13  |- skos__prefLabel mesh__D008776 Methylprednisolone Hemisuccinate
% 222.95/223.13  |- mesh__recordMaintainer mesh__D008776 ssb
% 222.95/223.13  |- mesh__dateEstablished mesh__D008776 1991-01-01
% 222.95/223.13  |- mesh__publicMeSHNote mesh__D008776
% 222.95/223.13       91; was METHYLPREDNISOLONE SUCCINATE see under METHYLPREDNISOLONE/analogs %26% derivatives 1980-90%A%  
% 222.95/223.13  |- mesh__recordAuthorizer mesh__D008776 sjn
% 222.95/223.13  |- skos__historyNote mesh__D008776
% 222.95/223.13       Methylprednisolone %28%1966-1974%29%/analogs %26% derivatives %28%1975-1979%29%
% 222.95/223.13  |- skos__altLabel mesh__D008776 Solumedrol
% 222.95/223.13  |- mesh__recordOriginator mesh__D008776 SH
% 222.95/223.13  |- skos__broader mesh__D008776smesh__D008775
% 222.95/223.13  |- rdf__type mesh__D008776sskos__Concept
% 222.95/223.13  |- skos__hiddenLabel mesh__D008776 Hemisuccinate, Methylprednisolone
% 222.95/223.13  |- skos__altLabel mesh__D008776 Methylprednisolone Sodium Hemisuccinate
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D008776 2004
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D000793 2004
% 222.95/223.13  |- mesh__recordAuthorizer mesh__D000793 sjn
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D000793 2003
% 222.95/223.13  |- skos__hiddenLabel mesh__D000793 Streak, Angioid
% 222.95/223.13  |- mesh__dateCreated mesh__D000793 1999-01-01
% 222.95/223.13  |- mesh__recordOriginator mesh__D000793 NLM
% 222.95/223.13  |- mesh__recordMaintainer mesh__D000793 KEV
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D000793 2002
% 222.95/223.13  |- skos__hiddenLabel mesh__D000793 Streaks, Angioid
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D000793 2006
% 222.95/223.13  |- rdf__type mesh__D000793sskos__Concept
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D000793 2001
% 222.95/223.13  |- mesh__dateRevised mesh__D000793 1999-11-03
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D000793 2005
% 222.95/223.13  |- skos__hiddenLabel mesh__D000793 Angioid Streak
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D000793 2000
% 222.95/223.13  |- skos__related mesh__D000793smesh__D012160
% 222.95/223.13  |- skos__broader mesh__D000793smesh__D012164
% 222.95/223.13  |- skos__prefLabel mesh__D000793 Angioid Streaks
% 222.95/223.13  |- skos__scopeNote mesh__D000793
% 222.95/223.13       Small breaks in the elastin-filled tissue of the retina.%A%    
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D041601 2006
% 222.95/223.13  |- skos__annotation mesh__D041601
% 222.95/223.13       do not confuse with the protozoa BONAMIA OSTREAE see HAPLOSPORIDA; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.95/223.13  |- mesh__publicMeSHNote mesh__D041601 2004   
% 222.95/223.13  |- skos__prefLabel mesh__D041601 Bonamia Plant
% 222.95/223.13  |- mesh__historyNote mesh__D041601 2004   
% 222.95/223.13  |- skos__broader mesh__D041601smesh__D027722
% 222.95/223.13  |- skos__scopeNote mesh__D041601
% 222.95/223.13       A plant genus of the family CONVOLVULACEAE. Members contain bonaspectins %28%tetrahydrofuran-type sesqui-lignans%29%.%A%    
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D041601 2004
% 222.95/223.13  |- mesh__dateCreated mesh__D041601 2003-07-09
% 222.95/223.13  |- mesh__dateEstablished mesh__D041601 2004-01-01
% 222.95/223.13  |- rdf__type mesh__D041601sskos__Concept
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D041601 2005
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D013910 2006
% 222.95/223.13  |- rdf__type mesh__D013910sskos__Concept
% 222.95/223.13  |- mesh__recordAuthorizer mesh__D013910 sjn
% 222.95/223.13  |- skos__scopeNote mesh__D013910
% 222.95/223.13       Thorium. A radioactive element of the actinide series of metals. It has an atomic symbol Th, atomic number 90, and atomic weight 232.04. It is used as fuel in nuclear reactors to produce fissionable uranium isotopes. Because of its radioopacity, various thorium compounds are used to facilitate visualization in roentgenography.%A%    
% 222.95/223.13  |- mesh__dateCreated mesh__D013910 1999-01-01
% 222.95/223.13  |- mesh__recordOriginator mesh__D013910 NLM
% 222.95/223.13  |- skos__annotation mesh__D013910 naturally radioactive; IM   
% 222.95/223.13  |- skos__prefLabel mesh__D013910 Thorium
% 222.95/223.13  |- skos__broader mesh__D013910smesh__D019216
% 222.95/223.13  |- mesh__dateRevised mesh__D013910 2005-06-30
% 222.95/223.13  |- mesh__recordMaintainer mesh__D013910 jmp
% 222.95/223.13  |- skos__broader mesh__D013910smesh__D008671
% 222.95/223.13  |- skos__scopeNote mesh__D013112
% 222.95/223.13       Arthropods of the class ARACHNIDA, order Araneae. Except for mites and ticks, spiders constitute the largest order of arachnids, with approximately 37,000 species having been described. The majority of spiders are harmless, although some species can be regarded as moderately harmful since their bites can lead to quite severe local symptoms. %28%From Barnes, Invertebrate Zoology, 5th ed, p508; Smith, Insects and Other Arthropods of Medical Importance, 1973, pp424-430%29%%A%    
% 222.95/223.13  |- skos__broader mesh__D013112smesh__D001097
% 222.95/223.13  |- mesh__recordMaintainer mesh__D013112 ags
% 222.95/223.13  |- skos__annotation mesh__D013112
% 222.95/223.13       /microbiol /parasitol /virol permitted; spider bites = ARACHNIDISM; several venomous genera: Latrodectus %28%BLACK WIDOW SPIDER%29%, Loxosceles %28%brown recluse%29%, Tarantula%A%  
% 222.95/223.13  |- mesh__dateCreated mesh__D013112 1999-01-01
% 222.95/223.13  |- mesh__recordAuthorizer mesh__D013112 sjn
% 222.95/223.13  |- skos__prefLabel mesh__D013112 Spiders
% 222.95/223.13  |- mesh__dateRevised mesh__D013112 2003-07-09
% 222.95/223.13  |- rdf__type mesh__D013112sskos__Concept
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D013112 2005
% 222.95/223.13  |- mesh__recordOriginator mesh__D013112 NLM
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D013112 2004
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D013112 2006
% 222.95/223.13  |- skos__altLabel mesh__D051231 GGDP Synthase
% 222.95/223.13  |- skos__hiddenLabel mesh__D051231 Geranylgeranyl Diphosphate Synthase
% 222.95/223.13  |- skos__scopeNote mesh__D051231
% 222.95/223.13       An enzyme that catalyzes the synthesis of geranylgeranyl diphosphate from trans, trans-farnesyl diphosphate and isopentenyl diphosphate.%A%    
% 222.95/223.13  |- skos__historyNote mesh__D051231
% 222.95/223.13       Alkyl and Aryl Transferases %28%1992-2005%29%
% 222.95/223.13  |- skos__hiddenLabel mesh__D051231 Synthase, Geranylgeranyl-Diphosphate
% 222.95/223.13  |- mesh__recordAuthorizer mesh__D051231 sjn
% 222.95/223.13  |- rdf__type mesh__D051231sskos__Concept
% 222.95/223.13  |- skos__hiddenLabel mesh__D051231 Synthase, GGDP
% 222.95/223.13  |- mesh__publicMeSHNote mesh__D051231
% 222.95/223.13       2006; FARNESYLTRANSFERASE was indexed under ALKYL AND ARYL TRANSFERASES 1992-2005%A%  
% 222.95/223.13  |- skos__altLabel mesh__D051231 Geranylgeranyl-Diphosphate Synthase
% 222.95/223.13  |- mesh__dateCreated mesh__D051231 2005-06-30
% 222.95/223.13  |- skos__broader mesh__D051231smesh__D019883
% 222.95/223.13  |- skos__hiddenLabel mesh__D051231 Pyrophosphatase, Geranylgeranyl
% 222.95/223.13  |- skos__altLabel mesh__D051231 Farnesyltransferase
% 222.95/223.13  |- mesh__historyNote mesh__D051231 2006%28%1992%29%   
% 222.95/223.13  |- skos__prefLabel mesh__D051231 Farnesyltranstransferase
% 222.95/223.13  |- skos__hiddenLabel mesh__D051231 Synthase, GGPP
% 222.95/223.13  |- skos__altLabel mesh__D051231 GGPP Synthase
% 222.95/223.13  |- mesh__recordOriginator mesh__D051231 AKE
% 222.95/223.13  |- mesh__recordMaintainer mesh__D051231 AKE
% 222.95/223.13  |- skos__altLabel mesh__D051231 Geranylgeranyl Pyrophosphatase
% 222.95/223.13  |- skos__altLabel mesh__D051231
% 222.95/223.13       Farnesyl Diphosphate-Geranylgeranyl Diphosphate Synthase
% 222.95/223.13  |- skos__hiddenLabel mesh__D051231
% 222.95/223.13       Farnesyl Diphosphate Geranylgeranyl Diphosphate Synthase
% 222.95/223.13  |- mesh__dateEstablished mesh__D051231 2006-01-01
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D051231 2006
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D004386 2006
% 222.95/223.13  |- skos__related mesh__D004386smesh__D004385
% 222.95/223.13  |- mesh__recordOriginator mesh__D004386 NLM
% 222.95/223.13  |- mesh__dateRevised mesh__D004386 2003-07-09
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D004386 2005
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D004386 2004
% 222.95/223.13  |- mesh__recordMaintainer mesh__D004386 lkt
% 222.95/223.13  |- mesh__publicMeSHNote mesh__D004386
% 222.95/223.13       DUODENAL INTUBATION was heading 1963-65   
% 222.95/223.13  |- skos__broader mesh__D004386smesh__D007421
% 222.95/223.13  |- skos__related mesh__D004386smesh__D004384
% 222.95/223.13  |- mesh__recordAuthorizer mesh__D004386 sjn
% 222.95/223.13  |- rdf__type mesh__D004386sskos__Concept
% 222.95/223.13  |- skos__scopeNote mesh__D004386
% 222.95/223.13       The shortest and widest portion of the SMALL INTESTINE adjacent to the PYLORUS of the STOMACH. It is named for having the length equal to about the width of 12 fingers.%A%    
% 222.95/223.13  |- mesh__dateCreated mesh__D004386 1999-01-01
% 222.95/223.13  |- skos__broader mesh__D004386smesh__D041742
% 222.95/223.13  |- skos__annotation mesh__D004386
% 222.95/223.13       inflammation = DUODENITIS; fistula = DUODENAL DISEASES %28%IM%29% + INTESTINAL FISTULA %28%IM%29%; duodenal atresia = DUODENAL OBSTRUCTION /congen %28%IM%29% + INTESTINAL ATRESIA %28%IM%29%; duodenal juice = DUODENUM %28%IM%29% + INTESTINAL SECRETIONS %28%IM%29% %28%not DUODENUM /secret%29%%A%  
% 222.95/223.13  |- skos__prefLabel mesh__D004386 Duodenum
% 222.95/223.13  |- skos__hiddenLabel mesh__D004386 Duodenums
% 222.95/223.13  |- mesh__historyNote mesh__D004386
% 222.95/223.13       DUODENAL INTUBATION was heading 1963-65   
% 222.95/223.13  |- mesh__recordMaintainer mesh__D012818 MSR
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D012818 2004
% 222.95/223.13  |- skos__broader mesh__D012818smesh__D012816
% 222.95/223.13  |- mesh__publicMeSHNote mesh__D012818 98   
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D012818 2006
% 222.95/223.13  |- mesh__recordAuthorizer mesh__D012818 SJN
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D012818 2000
% 222.95/223.13  |- mesh__recordOriginator mesh__D012818 NLM
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D012818 2001
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D012818 1999
% 222.95/223.13  |- mesh__dateCreated mesh__D012818 1999-01-01
% 222.95/223.13  |- rdf__type mesh__D012818sskos__Concept
% 222.95/223.13  |- skos__prefLabel mesh__D012818 Signs and Symptoms, Respiratory
% 222.95/223.13  |- mesh__dateRevised mesh__D012818 1998-06-11
% 222.95/223.13  |- mesh__dateEstablished mesh__D012818 1998-01-01
% 222.95/223.13  |- mesh__historyNote mesh__D012818 98; use explode 1970-97   
% 222.95/223.13  |- skos__historyNote mesh__D012818
% 222.95/223.13       specific sign or symptom %28%1966-1997%29%
% 222.95/223.13  |- skos__scopeNote mesh__D012818
% 222.95/223.13       Respiratory system manifestations of diseases of the respiratory tract or of other organs.%A%    
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D012818 2003
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D012818 2002
% 222.95/223.13  |- skos__annotation mesh__D012818 not used for indexing   
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D012818 2005
% 222.95/223.13  |- mesh__onlineNote mesh__D012818
% 222.95/223.13       consider also RESPIRATORY TRACT DISEASES %26% all specifics in C8%A%  
% 222.95/223.13  |- skos__scopeNote mesh__D009071
% 222.95/223.13       The burning of a small, thimble sized, smoldering plug of dried leaves on the SKIN at an ACUPUNCTURE point. Usually the plugs contain leaves of MUGWORT or moxa.%A%    
% 222.95/223.13  |- mesh__recordAuthorizer mesh__D009071 sjn
% 222.95/223.13  |- mesh__recordMaintainer mesh__D009071 lkt
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D009071 2006
% 222.95/223.13  |- mesh__dateCreated mesh__D009071 1999-01-01
% 222.95/223.13  |- mesh__recordOriginator mesh__D009071 NLM
% 222.95/223.13  |- mesh__publicMeSHNote mesh__D009071 67; was MOXA 1963-66   
% 222.95/223.13  |- rdf__type mesh__D009071sskos__Concept
% 222.95/223.13  |- skos__broader mesh__D009071smesh__D015670
% 222.95/223.13  |- mesh__dateEstablished mesh__D009071 1967-01-01
% 222.95/223.13  |- skos__annotation mesh__D009071
% 222.95/223.13       coordinate with disease /ther, not disease /drug ther   
% 222.95/223.13  |- mesh__onlineNote mesh__D009071 use MOXIBUSTION to search MOXA 1966   
% 222.95/223.13  |- skos__altLabel mesh__D009071 Moxabustion
% 222.95/223.13  |- mesh__historyNote mesh__D009071 67; was MOXA 1963-66   
% 222.95/223.13  |- mesh__dateRevised mesh__D009071 2005-06-30
% 222.95/223.13  |- skos__prefLabel mesh__D009071 Moxibustion
% 222.95/223.13  |- mesh__onlineNote mesh__D017503
% 222.95/223.13       use ADENOVIRUS EARLY PROTEINS %28%NM%29% to search ADENOVIRUS E3 PROTEINS 1985-92 %26% ADENOVIRUS TYPE 2 E3-19K PROTEIN 1987-92%A%  
% 222.95/223.13  |- skos__hiddenLabel mesh__D017503 E3 Proteins, Adenovirus
% 222.95/223.13  |- rdf__type mesh__D017503sskos__Concept
% 222.95/223.13  |- mesh__recordAuthorizer mesh__D017503 sjn
% 222.95/223.13  |- skos__scopeNote mesh__D017503
% 222.95/223.13       Proteins transcribed from the E3 region of ADENOVIRUSES but not essential for viral replication. The E3 19K protein mediates adenovirus persistence by reducing the expression of class I major histocompatibility complex antigens on the surface of infected cells.%A%    
% 222.95/223.13  |- mesh__activeMeSHYear mesh__D017503 2006
% 222.95/223.13  |- skos__altLabel mesh__D017503 Adenovirus Type 2 E3-19K Protein
% 222.95/223.13  |- mesh__recordMaintainer mesh__D017503 ssb
% 222.95/223.13  |- mesh__publicMeSHNote mesh__D017503
% 222.95/223.13       93; ADENOVIRUS E3 PROTEINS was indexed under ONCOGENE PROTEINS, VIRAL 1985-92; ADENOVIRUS E3 19K PROTEIN was indexed under VIRAL PROTEINS 1987-92%A%  
% 222.95/223.13  |- skos__hiddenLabel mesh__D017503 Adenovirus E3 Protein
% 222.95/223.13  |- skos__altLabel mesh__D017503 E3 Protein, Adenovirus
% 222.95/223.15  |- mesh__dateRevised mesh__D017503 2005-06-30
% 222.95/223.15  |- skos__historyNote mesh__D017503
% 222.95/223.15       Oncogene Proteins, Viral %28%1985-1992%29%
% 222.95/223.15  |- mesh__dateCreated mesh__D017503 1992-05-13
% 222.95/223.15  |- mesh__recordOriginator mesh__D017503 AGS
% 222.95/223.15  |- skos__prefLabel mesh__D017503 Adenovirus E3 Proteins
% 222.95/223.15  |- mesh__dateEstablished mesh__D017503 1993-01-01
% 222.95/223.15  |- skos__hiddenLabel mesh__D017503 Adenovirus Type 2 E3 19K Protein
% 222.95/223.15  |- skos__altLabel mesh__D017503 E3 19K Protein, Adenovirus
% 222.95/223.15  |- mesh__historyNote mesh__D017503
% 222.95/223.15       93; was ADENOVIRUS E3 PROTEINS %28%SY%29% to ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS %28%NM%29% 1985-92; ADENOVIRUS E3 19K PROTEIN was ADENOVIRUS TYPE 2 E3-19K PROTEIN %28%NM%29% 1987-92%A%  
% 222.95/223.15  |- skos__broader mesh__D017503smesh__D017456
% 222.95/223.15  |- skos__hiddenLabel mesh__D050937 Methylpherase, Guanidinoacetate
% 222.95/223.15  |- mesh__dateEstablished mesh__D050937 2006-01-01
% 222.95/223.15  |- skos__hiddenLabel mesh__D050937 Transmethylase, Guanidinoacetate
% 222.95/223.15  |- skos__altLabel mesh__D050937 Guanidinoacetate Methyltransferase
% 222.95/223.15  |- skos__hiddenLabel mesh__D050937 Methyltransferase, Guanidinoacetate
% 222.95/223.15  |- mesh__recordAuthorizer mesh__D050937 sjn
% 222.95/223.15  |- skos__hiddenLabel mesh__D050937 N-Methyltransferase, Guanidinoacetate
% 222.95/223.15  |- mesh__publicMeSHNote mesh__D050937
% 222.95/223.15       2006; GUANIDINOACETATE N-METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1978-2005, S-ADENOSYLMETHIONINE 1973-1977, GUANIDINES 1973-1982, %26% ACETIC ACIDS 1973-1977%A%  
% 222.95/223.15  |- skos__scopeNote mesh__D050937
% 222.95/223.15       This enzyme catalyzes the last step of CREATINE biosynthesis by catalyzing the METHYLATION of GUANIDINOACETATE to CREATINE.%A%    
% 222.95/223.15  |- skos__hiddenLabel mesh__D050937
% 222.95/223.15       Transmethylase, Methionine-Guanidinoacetic
% 222.95/223.15  |- skos__altLabel mesh__D050937 Methionine-Guanidinoacetic Transmethylase
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D050937 2006
% 222.95/223.15  |- skos__altLabel mesh__D050937 Guanidoacetate Methyltransferase
% 222.95/223.15  |- skos__altLabel mesh__D050937 GA Methyltransferase
% 222.95/223.15  |- mesh__dateCreated mesh__D050937 2005-06-30
% 222.95/223.15  |- skos__broader mesh__D050937smesh__D008780
% 222.95/223.15  |- skos__altLabel mesh__D050937 Guanidinoacetate Methylpherase
% 222.95/223.15  |- skos__altLabel mesh__D050937 Guanidinoacetate Transmethylase
% 222.95/223.15  |- skos__hiddenLabel mesh__D050937 Methyltransferase, GA
% 222.95/223.15  |- skos__hiddenLabel mesh__D050937 Guanidinoacetate N Methyltransferase
% 222.95/223.15  |- mesh__recordMaintainer mesh__D050937 AKE
% 222.95/223.15  |- rdf__type mesh__D050937sskos__Concept
% 222.95/223.15  |- skos__hiddenLabel mesh__D050937 Methyltransferase, Guanidoacetate
% 222.95/223.15  |- skos__prefLabel mesh__D050937 Guanidinoacetate N-Methyltransferase
% 222.95/223.15  |- mesh__recordOriginator mesh__D050937 AKE
% 222.95/223.15  |- mesh__historyNote mesh__D050937
% 222.95/223.15       2006%28%1980%29%; use METHYLTRANSFERASES 1980-2005, S-ADENOSYLMETHIONINE 1973-1977, GUANIDINES 1973-1980, %26% ACETIC ACIDS 1973-1977%A%  
% 222.95/223.15  |- skos__hiddenLabel mesh__D050937
% 222.95/223.15       Methionine Guanidinoacetic Transmethylase
% 222.95/223.15  |- skos__altLabel mesh__D008777 17-Epimethyltestosterone
% 222.95/223.15  |- skos__hiddenLabel mesh__D008777 Android 5
% 222.95/223.15  |- skos__altLabel mesh__D008777 17alpha-Methyltestosterone
% 222.95/223.15  |- mesh__recordAuthorizer mesh__D008777 sjn
% 222.95/223.15  |- rdf__type mesh__D008777sskos__Concept
% 222.95/223.15  |- skos__scopeNote mesh__D008777
% 222.95/223.15       A synthetic hormone used for androgen replacement therapy and as an hormonal antineoplastic agent %28%ANTINEOPLASTIC AGENTS, HORMONAL%29%.%A%    
% 222.95/223.15  |- mesh__recordMaintainer mesh__D008777 CCR
% 222.95/223.15  |- skos__altLabel mesh__D008777 Schering Brand of Methyltestosterone
% 222.95/223.15  |- mesh__dateRevised mesh__D008777 2005-06-30
% 222.95/223.15  |- skos__altLabel mesh__D008777 Mesterone
% 222.95/223.15  |- mesh__dateCreated mesh__D008777 1999-01-01
% 222.95/223.15  |- skos__hiddenLabel mesh__D008777
% 222.95/223.15       17 beta Hydroxy 17 methyl 4 androsten 3 one
% 222.95/223.15  |- mesh__recordOriginator mesh__D008777 NLM
% 222.95/223.15  |- skos__prefLabel mesh__D008777 Methyltestosterone
% 222.95/223.15  |- skos__hiddenLabel mesh__D008777 17alpha Methyltestosterone
% 222.95/223.15  |- skos__hiddenLabel mesh__D008777 Android 25
% 222.95/223.15  |- skos__altLabel mesh__D008777 17 beta Methyltestosterone
% 222.95/223.15  |- skos__altLabel mesh__D008777 17 beta-Methyltestosterone
% 222.95/223.15  |- skos__altLabel mesh__D008777 ICN Brand 1 of Methyltestosterone
% 222.95/223.15  |- skos__altLabel mesh__D008777 ICN Brand 2 of Methyltestosterone
% 222.95/223.15  |- skos__altLabel mesh__D008777 17beta-Methyltestosterone
% 222.95/223.15  |- skos__altLabel mesh__D008777 17beta-Hydroxy-17-methyl-4-androsten-3-one
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D008777 2006
% 222.95/223.15  |- skos__altLabel mesh__D008777 17alpha-Methyl-Testosterone
% 222.95/223.15  |- skos__altLabel mesh__D008777
% 222.95/223.15       Global Pharmaceutical Brand of Methyltestosterone
% 222.95/223.15  |- skos__broader mesh__D008777smesh__D013739
% 222.95/223.15  |- skos__hiddenLabel mesh__D008777
% 222.95/223.15       17beta Hydroxy 17 methyl 4 androsten 3 one
% 222.95/223.15  |- skos__hiddenLabel mesh__D008777 17alpha Methyl Testosterone
% 222.95/223.15  |- skos__hiddenLabel mesh__D008777 17 alpha Methyltestosterone
% 222.95/223.15  |- skos__altLabel mesh__D008777 Star Brand of Methyltestosterone
% 222.95/223.15  |- skos__hiddenLabel mesh__D008777 Android 10
% 222.95/223.15  |- skos__altLabel mesh__D008777 17 beta-Hydroxy-17-methyl-4-androsten-3-one
% 222.95/223.15  |- skos__hiddenLabel mesh__D008777 17beta Methyltestosterone
% 222.95/223.15  |- skos__hiddenLabel mesh__D008777 17 Epimethyltestosterone
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D000794 2003
% 222.95/223.15  |- mesh__dateCreated mesh__D000794 1999-01-01
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D000794 2000
% 222.95/223.15  |- mesh__recordMaintainer mesh__D000794 KEV
% 222.95/223.15  |- skos__prefLabel mesh__D000794 Angiokeratoma
% 222.95/223.15  |- skos__annotation mesh__D000794
% 222.95/223.15       coord IM with SKIN NEOPLASMS %28%IM%29% + site %28%IM or NIM%29% if relevant%A%  
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D000794 2006
% 222.95/223.15  |- rdf__type mesh__D000794sskos__Concept
% 222.95/223.15  |- mesh__recordAuthorizer mesh__D000794 sjn
% 222.95/223.15  |- mesh__recordOriginator mesh__D000794 NLM
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D000794 2005
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D000794 2002
% 222.95/223.15  |- skos__scopeNote mesh__D000794
% 222.95/223.15       A vascular, horny neoplasm of the skin characterized by TELANGIECTASIS and secondary epithelial changes including acanthosis and hyperkeratosis.%A%    
% 222.95/223.15  |- skos__hiddenLabel mesh__D000794 Angiokeratomas
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D000794 2004
% 222.95/223.15  |- skos__broader mesh__D000794smesh__D009383
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D000794 2001
% 222.95/223.15  |- mesh__dateRevised mesh__D000794 1999-11-03
% 222.95/223.15  |- skos__prefLabel mesh__D041602 Haplosporida
% 222.95/223.15  |- skos__broader mesh__D041602smesh__D011527
% 222.95/223.15  |- mesh__publicMeSHNote mesh__D041602 2004   
% 222.95/223.15  |- skos__annotation mesh__D041602
% 222.95/223.15       X ref BONAMIA OSTREAE: BONAMIA PLANT is also available   
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D041602 2004
% 222.95/223.15  |- mesh__dateCreated mesh__D041602 2003-07-09
% 222.95/223.15  |- skos__scopeNote mesh__D041602
% 222.95/223.15       A phylum of protozoans in the alveloate clade %28%some authorities prefer to call it an order%29%. They are small endoparasites of marine invertebrates. Spores are structurally complex but without polar filaments or tubes.%A%    
% 222.95/223.15  |- skos__altLabel mesh__D041602 Haplosporidia
% 222.95/223.15  |- mesh__historyNote mesh__D041602 2004   
% 222.95/223.15  |- rdf__type mesh__D041602sskos__Concept
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D041602 2005
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D041602 2006
% 222.95/223.15  |- skos__historyNote mesh__D041602 Protozoa %28%1988-2003%29%
% 222.95/223.15  |- mesh__dateEstablished mesh__D041602 2004-01-01
% 222.95/223.15  |- skos__scopeNote mesh__D013911
% 222.95/223.15       Thorium oxide %28%ThO2%29%. A radiographic contrast agent that was used in the early 1930s through about 1954. High rates of mortality have been linked to its use and it has been shown to cause liver cancer.%A%    
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013911 2006
% 222.95/223.15  |- mesh__dateEstablished mesh__D013911 1965-01-01
% 222.95/223.15  |- skos__hiddenLabel mesh__D013911 Oxide, Thorium
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013911 2002
% 222.95/223.15  |- skos__annotation mesh__D013911
% 222.95/223.15       an early %28%1930-50%29% contrast medium; D25-26 qualif   
% 222.95/223.15  |- mesh__recordAuthorizer mesh__D013911 PLS
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013911 2004
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013911 1998
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013911 1996
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013911 1999
% 222.95/223.15  |- mesh__dateRevised mesh__D013911 1995-06-08
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013911 1997
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013911 2000
% 222.95/223.15  |- skos__broader mesh__D013911smesh__D010087
% 222.95/223.15  |- mesh__publicMeSHNote mesh__D013911 65   
% 222.95/223.15  |- skos__broader mesh__D013911smesh__D017970
% 222.95/223.15  |- skos__hiddenLabel mesh__D013911 Dioxide, Thorium
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013911 2005
% 222.95/223.15  |- mesh__historyNote mesh__D013911 65   
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013911 2001
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013911 2003
% 222.95/223.15  |- skos__prefLabel mesh__D013911 Thorium Dioxide
% 222.95/223.15  |- skos__altLabel mesh__D013911 Thorium Oxide
% 222.95/223.15  |- mesh__dateCreated mesh__D013911 1999-01-01
% 222.95/223.15  |- mesh__recordMaintainer mesh__D013911 JRT
% 222.95/223.15  |- mesh__recordOriginator mesh__D013911 NLM
% 222.95/223.15  |- rdf__type mesh__D013911sskos__Concept
% 222.95/223.15  |- skos__related mesh__D013113smesh__D019097
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013113 1997
% 222.95/223.15  |- mesh__recordOriginator mesh__D013113 NLM
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013113 1999
% 222.95/223.15  |- mesh__dateCreated mesh__D013113 1999-01-01
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013113 2002
% 222.95/223.15  |- mesh__recordAuthorizer mesh__D013113 PLS
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013113 2003
% 222.95/223.15  |- rdf__type mesh__D013113sskos__Concept
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013113 2005
% 222.95/223.15  |- skos__annotation mesh__D013113 /chem syn permitted   
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013113 2004
% 222.95/223.15  |- mesh__publicMeSHNote mesh__D013113 74   
% 222.95/223.15  |- skos__scopeNote mesh__D013113
% 222.95/223.15       Molecules which contain an atom or a group of atoms exhibiting an unpaired electron spin that can be detected by electron spin resonance spectroscopy and can be bonded to another molecule. %28%McGraw-Hill Dictionary of Chemical and Technical Terms, 4th ed%29%%A%    
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013113 2006
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013113 2000
% 222.95/223.15  |- skos__hiddenLabel mesh__D013113 Labels, Spin
% 222.95/223.15  |- skos__related mesh__D013113smesh__D004578
% 222.95/223.15  |- skos__prefLabel mesh__D013113 Spin Labels
% 222.95/223.15  |- mesh__recordMaintainer mesh__D013113 TGC
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013113 1996
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013113 2001
% 222.95/223.15  |- mesh__dateEstablished mesh__D013113 1974-01-01
% 222.95/223.15  |- mesh__dateRevised mesh__D013113 1995-03-20
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D013113 1998
% 222.95/223.15  |- mesh__historyNote mesh__D013113 74   
% 222.95/223.15  |- skos__broader mesh__D013113smesh__D005609
% 222.95/223.15  |- mesh__recordMaintainer mesh__D051232 AKE
% 222.95/223.15  |- skos__hiddenLabel mesh__D051232 Synthase, Geranylgeranyl-Pyrophosphate
% 222.95/223.15  |- skos__hiddenLabel mesh__D051232 Synthetase, Phytoene
% 222.95/223.15  |- skos__altLabel mesh__D051232 Phytoene Synthetase
% 222.95/223.15  |- skos__hiddenLabel mesh__D051232
% 222.95/223.15       Geranylgeranyltransferase, Geranylgeranyl-Diphosphate
% 222.95/223.15  |- skos__hiddenLabel mesh__D051232 Synthase, Geranylgeranyl Pyrophosphate
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D051232 2006
% 222.95/223.15  |- skos__altLabel mesh__D051232 Prephytoene-Diphosphate Synthase
% 222.95/223.15  |- mesh__historyNote mesh__D051232 2006%28%1991%29%   
% 222.95/223.15  |- skos__hiddenLabel mesh__D051232 Synthase, Prephytoene-Diphosphate
% 222.95/223.15  |- mesh__dateCreated mesh__D051232 2005-06-30
% 222.95/223.15  |- skos__altLabel mesh__D051232 Geranylgeranyl-Pyrophosphate Synthase
% 222.95/223.15  |- mesh__dateEstablished mesh__D051232 2006-01-01
% 222.95/223.15  |- mesh__recordAuthorizer mesh__D051232 sjn
% 222.95/223.15  |- mesh__publicMeSHNote mesh__D051232
% 222.95/223.15       2006; GERANYLGERANYL-DIPHOSPHATE GERANYLGERANYLTRANSFERASE was indexed under ALKYL AND ARYL TRANSFERASES 1991-2005, %26% under OXIDOREDUCTASES 1991-2002%A%  
% 222.95/223.15  |- rdf__type mesh__D051232sskos__Concept
% 222.95/223.15  |- mesh__recordOriginator mesh__D051232 AKE
% 222.95/223.15  |- skos__broader mesh__D051232smesh__D019883
% 222.95/223.15  |- skos__scopeNote mesh__D051232
% 222.95/223.15       An enzyme that catalyzes the condensation of two molecules of GERANYLGERANYL DIPHOSPHATE to give prephytoene diphosphate. The prephytoene diphosphate molecule is a precursor for CAROTENOIDS and other tetraterpenes.%A%    
% 222.95/223.15  |- skos__altLabel mesh__D051232 Geranylgeranyl Pyrophosphate Synthase
% 222.95/223.15  |- skos__hiddenLabel mesh__D051232
% 222.95/223.15       Geranylgeranyl Diphosphate Geranylgeranyltransferase
% 222.95/223.15  |- skos__prefLabel mesh__D051232
% 222.95/223.15       Geranylgeranyl-Diphosphate Geranylgeranyltransferase
% 222.95/223.15  |- skos__historyNote mesh__D051232
% 222.95/223.15       Alkyl and Aryl Transferases %28%1991-2005%29%
% 222.95/223.15  |- skos__hiddenLabel mesh__D051232 Pyrophosphate Synthase, Geranylgeranyl
% 222.95/223.15  |- skos__hiddenLabel mesh__D051232 Prephytoene Diphosphate Synthase
% 222.95/223.15  |- skos__broader mesh__D037561smesh__D001323
% 222.95/223.15  |- mesh__recordMaintainer mesh__D037561 ssb
% 222.95/223.15  |- skos__altLabel mesh__D037561 Immune Conglutinins
% 222.95/223.15  |- mesh__recordAuthorizer mesh__D037561 sjn
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D037561 2006
% 222.95/223.15  |- skos__historyNote mesh__D037561 Immunoglobulins %28%1981-2002%29%
% 222.95/223.15  |- mesh__dateRevised mesh__D037561 2005-06-30
% 222.95/223.15  |- mesh__recordOriginator mesh__D037561 jmp
% 222.95/223.15  |- skos__hiddenLabel mesh__D037561 Conglutinins, Immune
% 222.95/223.15  |- skos__scopeNote mesh__D037561
% 222.95/223.15       Autoantibodies directed against newly-formed EPITOPES created as the COMPLEMENT cascade is activated and the proteins involved change their conformations.%A%    
% 222.95/223.15  |- mesh__historyNote mesh__D037561
% 222.95/223.15       2003; use IMMUNOCONGLUTININS %28%NM%29% 1981-2002   
% 222.95/223.15  |- rdf__type mesh__D037561sskos__Concept
% 222.95/223.15  |- skos__prefLabel mesh__D037561 Immunoconglutinins
% 222.95/223.15  |- mesh__publicMeSHNote mesh__D037561
% 222.95/223.15       2003; IMMUNOCONGLUTININS was indexed under IMMUNGLOBULINS 1981-2002%A%  
% 222.95/223.15  |- mesh__dateEstablished mesh__D037561 2003-01-01
% 222.95/223.15  |- mesh__dateCreated mesh__D037561 2002-07-03
% 222.95/223.15  |- mesh__recordMaintainer mesh__D004387 TGC
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D004387 1994
% 222.95/223.15  |- mesh__recordAuthorizer mesh__D004387 PLS
% 222.95/223.15  |- skos__broader mesh__D004387smesh__D003240
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D004387 2000
% 222.95/223.15  |- mesh__dateRevised mesh__D004387 1993-05-27
% 222.95/223.15  |- skos__annotation mesh__D004387 contracture of fingers   
% 222.95/223.15  |- mesh__dateCreated mesh__D004387 1999-01-01
% 222.95/223.15  |- skos__prefLabel mesh__D004387 Dupuytren%27%s Contracture
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D004387 1999
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D004387 1998
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D004387 1997
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D004387 2002
% 222.95/223.15  |- mesh__recordOriginator mesh__D004387 NLM
% 222.95/223.15  |- skos__broader mesh__D004387smesh__D003286
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D004387 1996
% 222.95/223.15  |- skos__hiddenLabel mesh__D004387 Dupuytrens Contracture
% 222.95/223.15  |- mesh__activeMeSHYear mesh__D004387 2006
% 222.95/223.16  |- skos__hiddenLabel mesh__D004387 Dupuytren Contracture
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D004387 2005
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D004387 2004
% 222.95/223.16  |- skos__scopeNote mesh__D004387
% 222.95/223.16       A fibromatosis of the palmar fascia characterized by thickening and contracture of the fibrous bands on the palmar surfaces of the hand and fingers. It arises most commonly in men between the ages of 30 and 50.%A%    
% 222.95/223.16  |- skos__hiddenLabel mesh__D004387 Contracture, Dupuytren%27%s
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D004387 2001
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D004387 1995
% 222.95/223.16  |- rdf__type mesh__D004387sskos__Concept
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D004387 2003
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D012819 1998
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D012819 2002
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D012819 1997
% 222.95/223.16  |- mesh__dateCreated mesh__D012819 1974-11-11
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D012819 1999
% 222.95/223.16  |- rdf__type mesh__D012819sskos__Concept
% 222.95/223.16  |- skos__prefLabel mesh__D012819 Sikkim
% 222.95/223.16  |- mesh__dateEstablished mesh__D012819 1975-01-01
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D012819 2000
% 222.95/223.16  |- mesh__recordOriginator mesh__D012819 NLM
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D012819 2003
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D012819 2001
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D012819 2005
% 222.95/223.16  |- mesh__dateRevised mesh__D012819 1995-05-23
% 222.95/223.16  |- mesh__recordAuthorizer mesh__D012819 PLS
% 222.95/223.16  |- mesh__historyNote mesh__D012819 75   
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D012819 2004
% 222.95/223.16  |- skos__broader mesh__D012819smesh__D007194
% 222.95/223.16  |- mesh__recordMaintainer mesh__D012819 KEV
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D012819 2006
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D012819 1996
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009870 2006
% 222.95/223.16  |- mesh__dateRevised mesh__D009870 1994-05-05
% 222.95/223.16  |- mesh__recordAuthorizer mesh__D009870 PLS
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009870 1999
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009870 2001
% 222.95/223.16  |- mesh__recordMaintainer mesh__D009870 TGC
% 222.95/223.16  |- skos__broader mesh__D009870smesh__D006751
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009870 2000
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009870 2005
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009870 1998
% 222.95/223.16  |- rdf__type mesh__D009870sskos__Concept
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009870 2004
% 222.95/223.16  |- mesh__recordOriginator mesh__D009870 EC
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009870 1997
% 222.95/223.16  |- mesh__dateEstablished mesh__D009870 1991-01-01
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009870 2003
% 222.95/223.16  |- mesh__dateCreated mesh__D009870 1986-06-17
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009870 1996
% 222.95/223.16  |- skos__scopeNote mesh__D009870
% 222.95/223.16       Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative activities associated with the provision and utilization of operating room services and facilities.%A%    
% 222.95/223.16  |- mesh__historyNote mesh__D009870
% 222.95/223.16       91%28%87%29%; was see under HOSPITAL INFORMATION SYSTEMS 1987-90%A%  
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009870 1995
% 222.95/223.16  |- mesh__publicMeSHNote mesh__D009870
% 222.95/223.16       91; was see under HOSPITAL INFORMATION SYSTEMS 1987-90   
% 222.95/223.16  |- skos__altLabel mesh__D009870 Information Systems, Operating Room
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009870 2002
% 222.95/223.16  |- skos__prefLabel mesh__D009870 Operating Room Information Systems
% 222.95/223.16  |- mesh__dateRevised mesh__D009072 1999-12-06
% 222.95/223.16  |- skos__hiddenLabel mesh__D009072 Primary Moyamoya Disease
% 222.95/223.16  |- skos__historyNote mesh__D009072
% 222.95/223.16       Carotid Artery Diseases %28%1966-1977%29%
% 222.95/223.16  |- skos__hiddenLabel mesh__D009072 Disease, Primary Moyamoya
% 222.95/223.16  |- skos__hiddenLabel mesh__D009072 Secondary Moyamoya Disease
% 222.95/223.16  |- skos__altLabel mesh__D009072 Cerebrovascular Moyamoya Disease
% 222.95/223.16  |- skos__altLabel mesh__D009072 Moyamoya Syndrome
% 222.95/223.16  |- skos__altLabel mesh__D009072 Moya-Moya Disease
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009072 2003
% 222.95/223.16  |- rdf__type mesh__D009072sskos__Concept
% 222.95/223.16  |- skos__historyNote mesh__D009072
% 222.95/223.16       Cerebrovascular Disorders %28%1966-1977%29%
% 222.95/223.16  |- skos__historyNote mesh__D009072
% 222.95/223.16       Cerebral Artery Diseases %28%1966-1977%29%
% 222.95/223.16  |- skos__broader mesh__D009072smesh__D001157
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009072 2000A
% 222.95/223.16  |- skos__prefLabel mesh__D009072 Moyamoya Disease
% 222.95/223.16  |- mesh__publicMeSHNote mesh__D009072
% 222.95/223.16       1991; see ARTERIAL OCCLUSIVE DISEASES 1978-1990   
% 222.95/223.16  |- skos__altLabel mesh__D009072
% 222.95/223.16       Progressive Intracranial Occlusive Arteropathy %28%Moyamoya%29%
% 222.95/223.16  |- skos__altLabel mesh__D009072 Moyamoya Disease, Primary
% 222.95/223.16  |- skos__hiddenLabel mesh__D009072 Disease, Classic Moyamoya
% 222.95/223.16  |- skos__broader mesh__D009072smesh__D002340
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009072 2002
% 222.95/223.16  |- skos__hiddenLabel mesh__D009072 Moyamoya Diseases, Primary
% 222.95/223.16  |- mesh__historyNote mesh__D009072 1991%28%1978%29%   
% 222.95/223.16  |- skos__hiddenLabel mesh__D009072 Moya Moya Disease
% 222.95/223.16  |- skos__broader mesh__D009072smesh__D002539
% 222.95/223.16  |- skos__hiddenLabel mesh__D009072 Classic Moyamoya Disease
% 222.95/223.16  |- skos__hiddenLabel mesh__D009072 Primary Moyamoya Diseases
% 222.95/223.16  |- skos__hiddenLabel mesh__D009072 Disease, Moya-Moya
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009072 2006
% 222.95/223.16  |- mesh__dateEstablished mesh__D009072 1991-01-01
% 222.95/223.16  |- mesh__dateCreated mesh__D009072 1977-04-27
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009072 2001
% 222.95/223.16  |- mesh__recordAuthorizer mesh__D009072 ags
% 222.95/223.16  |- skos__scopeNote mesh__D009072
% 222.95/223.16       A chronic cerebral vasculopathy primarily occurring in childhood and characterized by slowly progressive carotid artery narrowing and occlusion at the base of the brain. An extensive network of anastomoses forms between branches of the carotid arteries, resulting in a characteristic angiographic appearance. The condition may be idiopathic %28%classic moyamoya disease%29% or occur in association with ANEMIA, SICKLE CELL; DOWN SYNDROME; CRANIOCEREBRAL TRAUMA; RADIOTHERAPY induced arterial injury; NEUROFIBROMATOSIS; and other diseases. Clinical manifestations include hemiparesis, headache, seizures, and delayed mental development. In older individuals, this disease may present as SUBARACHNOID HEMORRHAGE. %28%From Adams et al., Principles of Neurology, 6th ed, p831; Clin Neurol Neurosurg 1997 Oct;99 Suppl 2:S36-8%29%%A%    
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009072 2004
% 222.95/223.16  |- mesh__recordMaintainer mesh__D009072 ags
% 222.95/223.16  |- mesh__recordOriginator mesh__D009072 VDK
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009072 2005
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009072 2000
% 222.95/223.16  |- mesh__dateEstablished mesh__D017504 1993-01-01
% 222.95/223.16  |- mesh__dateCreated mesh__D017504 1992-05-13
% 222.95/223.16  |- mesh__recordOriginator mesh__D017504 AGS
% 222.95/223.16  |- skos__altLabel mesh__D017504 E4 Protein, Adenovirus
% 222.95/223.16  |- skos__historyNote mesh__D017504
% 222.95/223.16       Oncogene Proteins, Viral %28%1985-1992%29%
% 222.95/223.16  |- mesh__publicMeSHNote mesh__D017504
% 222.95/223.16       93; ADENOVIRUS E4 PROTEIN %26% ADENOVIRUS E4F were indexed under ONCOGENIC PROTEINS, VIRAL 1985-92%A%  
% 222.95/223.16  |- skos__altLabel mesh__D017504 E4F Protein, Adenovirus
% 222.95/223.16  |- mesh__historyNote mesh__D017504
% 222.95/223.16       93; ADENOVIRUS E4 PROTEIN was SY to ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS %28%NM%29% 1985-92; ADENOVIRUS E4F PROTEIN was ADENOVIRUS E4F %28%SY%29% to ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS %28%NM%29% 1985-92%A%  
% 222.95/223.16  |- mesh__recordAuthorizer mesh__D017504 sjn
% 222.95/223.16  |- skos__broader mesh__D017504smesh__D017456
% 222.95/223.16  |- mesh__onlineNote mesh__D017504
% 222.95/223.16       use ADENOVIRUS EARLY PROTEINS %28%NM%29% to search ADENOVIRUS E4 PROTEINS %26% ADENOVIRUS E4F 1985-92%A%  
% 222.95/223.16  |- skos__altLabel mesh__D017504 Adenovirus E4 Protein
% 222.95/223.16  |- rdf__type mesh__D017504sskos__Concept
% 222.95/223.16  |- mesh__recordMaintainer mesh__D017504 ssb
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D017504 2006
% 222.95/223.16  |- skos__hiddenLabel mesh__D017504 E4 Proteins, Adenovirus
% 222.95/223.16  |- mesh__dateRevised mesh__D017504 2005-06-30
% 222.95/223.16  |- skos__scopeNote mesh__D017504
% 222.95/223.16       Proteins transcribed from the E4 region of ADENOVIRUSES. The E4 19K protein transactivates transcription of the adenovirus E2F protein and complexes with it.%A%    
% 222.95/223.16  |- skos__prefLabel mesh__D017504 Adenovirus E4 Proteins
% 222.95/223.16  |- skos__hiddenLabel mesh__D050938 N-Methyltransferase, Glycine
% 222.95/223.16  |- mesh__recordOriginator mesh__D050938 AKE
% 222.95/223.16  |- skos__scopeNote mesh__D050938
% 222.95/223.16       An enzyme that catalyzes the METHYLATION of GLYCINE using S-ADENOSYLMETHIONINE to form SARCOSINE with the concomitant production of S-ADENOSYLHOMOCYSTEINE.%A%    
% 222.95/223.16  |- skos__hiddenLabel mesh__D050938 Sarcosine N-Methyltransferase, Glycine
% 222.95/223.16  |- mesh__recordMaintainer mesh__D050938 ags
% 222.95/223.16  |- skos__altLabel mesh__D050938 Glycine Sarcosine N-Methyltransferase
% 222.95/223.16  |- skos__hiddenLabel mesh__D050938 Glycine Sarcosine N Methyltransferase
% 222.95/223.16  |- mesh__historyNote mesh__D050938 2006%28%1980%29%; GLYCINE 1974-1979   
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D050938 2006
% 222.95/223.16  |- mesh__dateEstablished mesh__D050938 2006-01-01
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D050938 2006A
% 222.95/223.16  |- mesh__publicMeSHNote mesh__D050938
% 222.95/223.16       2006; GLYCINE N-METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1983-2005 %26% under GLYCINE 1974-1982%A%  
% 222.95/223.16  |- mesh__recordAuthorizer mesh__D050938 ags
% 222.95/223.16  |- skos__prefLabel mesh__D050938 Glycine N-Methyltransferase
% 222.95/223.16  |- skos__altLabel mesh__D050938 Glycine Methyltransferase
% 222.95/223.16  |- skos__hiddenLabel mesh__D050938 Methyltransferase, Glycine Sarcosine
% 222.95/223.16  |- skos__altLabel mesh__D050938 Glycine Sarcosine Methyltransferase
% 222.95/223.16  |- rdf__type mesh__D050938sskos__Concept
% 222.95/223.16  |- skos__hiddenLabel mesh__D050938 Methyltransferase, Glycine
% 222.95/223.16  |- mesh__dateCreated mesh__D050938 2005-06-30
% 222.95/223.16  |- skos__broader mesh__D050938smesh__D008780
% 222.95/223.16  |- skos__hiddenLabel mesh__D050938 Glycine N Methyltransferase
% 222.95/223.16  |- skos__hiddenLabel mesh__D050938 N-Methyltransferase, Glycine Sarcosine
% 222.95/223.16  |- skos__hiddenLabel mesh__D050938 Sarcosine Methyltransferase, Glycine
% 222.95/223.16  |- mesh__dateRevised mesh__D050938 2005-07-29
% 222.95/223.16  |- skos__historyNote mesh__D008778 Inosine %28%1972-1974%29%
% 222.95/223.16  |- skos__altLabel mesh__D008778 6-Methylmercaptopurine Riboside
% 222.95/223.16  |- mesh__recordAuthorizer mesh__D008778 sjn
% 222.95/223.16  |- skos__hiddenLabel mesh__D008778 Riboside, 6-Methylthiopurine
% 222.95/223.16  |- skos__hiddenLabel mesh__D008778 6 Methylthiopurine Riboside
% 222.95/223.16  |- skos__altLabel mesh__D008778 6-Methylthiopurine Riboside
% 222.95/223.16  |- mesh__dateCreated mesh__D008778 1974-11-19
% 222.95/223.16  |- mesh__historyNote mesh__D008778
% 222.95/223.16       91%28%75%29%; was see under INOSINE 1975-90   
% 222.95/223.16  |- mesh__dateRevised mesh__D008778 2005-06-30
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D008778 2006
% 222.95/223.16  |- skos__historyNote mesh__D008778 Sulfides %28%1972-1974%29%
% 222.95/223.16  |- skos__scopeNote mesh__D008778
% 222.95/223.16       6-%28%Methylthio%29%-9-beta-D-ribofuranosylpurine. An analog of inosine with a methylthio group replacing the hydroxyl group in the 6-position.%A%    
% 222.95/223.16  |- skos__prefLabel mesh__D008778 Methylthioinosine
% 222.95/223.16  |- skos__hiddenLabel mesh__D008778 Riboside, 6-Methylmercaptopurine
% 222.95/223.16  |- mesh__publicMeSHNote mesh__D008778 91; was see under INOSINE 1975-90   
% 222.95/223.16  |- skos__hiddenLabel mesh__D008778 6 Methylmercaptopurine Riboside
% 222.95/223.16  |- mesh__recordMaintainer mesh__D008778 ssb
% 222.95/223.16  |- mesh__recordOriginator mesh__D008778 NLM
% 222.95/223.16  |- mesh__dateEstablished mesh__D008778 1991-01-01
% 222.95/223.16  |- skos__broader mesh__D008778smesh__D013868
% 222.95/223.16  |- rdf__type mesh__D008778sskos__Concept
% 222.95/223.16  |- skos__altLabel mesh__D000795 Angiokeratoma Corporis Diffusum
% 222.95/223.16  |- rdf__type mesh__D000795sskos__Concept
% 222.95/223.16  |- skos__related mesh__D000795smesh__D002518
% 222.95/223.16  |- mesh__recordMaintainer mesh__D000795 nns
% 222.95/223.16  |- skos__hiddenLabel mesh__D000795 Disease, Fabry
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D000795 2005
% 222.95/223.16  |- mesh__historyNote mesh__D000795 99%28%73%29%   
% 222.95/223.16  |- mesh__publicMeSHNote mesh__D000795
% 222.95/223.16       99; see FABRY%27%S DISEASE 1992-98; see ANGIOKERATOMA CORPORIS DIFFUSUM 1973-91; for FABRY%27%S DISEASE see ANGIOKERATOMA CORPORIS DIFFUSUM 1974-91%A%  
% 222.95/223.16  |- skos__hiddenLabel mesh__D000795 Fabrys Disease
% 222.95/223.16  |- skos__scopeNote mesh__D000795
% 222.95/223.16       Lysosomal storage disease caused by a deficiency of alpha-galactosidase A and resulting in an accumulation of globotriaosylceramide in the renal and cardiovascular systems. The disease is X-linked and is characterized by telangiectatic skin lesions, renal failure, and disturbances of the cardiovascular, gastrointestinal, and central nervous systems.%A%    
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D000795 2004
% 222.95/223.16  |- skos__broader mesh__D000795smesh__D040181
% 222.95/223.16  |- skos__altLabel mesh__D000795 Fabry%27%s Disease
% 222.95/223.16  |- skos__hiddenLabel mesh__D000795 Anderson Fabry Disease
% 222.95/223.16  |- skos__altLabel mesh__D000795 Anderson-Fabry Disease
% 222.95/223.16  |- skos__broader mesh__D000795smesh__D013106
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D000795 2003
% 222.95/223.16  |- skos__annotation mesh__D000795
% 222.95/223.16       a lysosomal storage dis; do not coord with INFANT, NEWBORN, DISEASES; do not confuse X ref ANDERSON-FABRY DISEASE with ANDERSEN%27%S DISEASE see GLYCOGEN STORAGE DISEASE TYPE IV%A%  
% 222.95/223.16  |- skos__hiddenLabel mesh__D000795 Disease, Fabry%27%s
% 222.95/223.16  |- mesh__dateCreated mesh__D000795 1999-01-01
% 222.95/223.16  |- skos__hiddenLabel mesh__D000795 Disease, Anderson-Fabry
% 222.95/223.16  |- skos__historyNote mesh__D000795 Angiokeratoma %28%1966-1972%29%
% 222.95/223.16  |- mesh__recordAuthorizer mesh__D000795 sjn
% 222.95/223.16  |- mesh__recordOriginator mesh__D000795 NLM
% 222.95/223.16  |- mesh__dateRevised mesh__D000795 2002-07-02
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D000795 2006
% 222.95/223.16  |- skos__prefLabel mesh__D000795 Fabry Disease
% 222.95/223.16  |- mesh__dateEstablished mesh__D000795 1973-01-01
% 222.95/223.16  |- mesh__dateCreated mesh__D041603 2003-07-09
% 222.95/223.16  |- mesh__historyNote mesh__D041603 2004   
% 222.95/223.16  |- skos__altLabel mesh__D041603 Pine, Loblolly
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D041603 2004
% 222.95/223.16  |- skos__prefLabel mesh__D041603 Pinus taeda
% 222.95/223.16  |- skos__scopeNote mesh__D041603
% 222.95/223.16       A plant species of the genus PINUS which is the subject of genetic study.%A%    
% 222.95/223.16  |- skos__historyNote mesh__D041603 Trees %28%1993-2001%29%
% 222.95/223.16  |- mesh__dateEstablished mesh__D041603 2004-01-01
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D041603 2005
% 222.95/223.16  |- skos__broader mesh__D041603smesh__D028223
% 222.95/223.16  |- rdf__type mesh__D041603sskos__Concept
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D041603 2006
% 222.95/223.16  |- skos__historyNote mesh__D041603 Pinus %28%2002-2003%29%
% 222.95/223.16  |- mesh__publicMeSHNote mesh__D041603 2004   
% 222.95/223.16  |- skos__altLabel mesh__D041603 Loblolly Pine
% 222.95/223.16  |- skos__annotation mesh__D041603
% 222.95/223.16       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.95/223.16  |- skos__altLabel mesh__D005480 Flubiprofen
% 222.95/223.16  |- skos__hiddenLabel mesh__D005480 Apo Flurbiprofen
% 222.95/223.16  |- skos__altLabel mesh__D005480 Knoll Brand of Flurbiprofen
% 222.95/223.16  |- skos__hiddenLabel mesh__D005480 Novo Flurprofen
% 222.95/223.16  |- mesh__recordOriginator mesh__D005480 SH
% 222.95/223.16  |- mesh__historyNote mesh__D005480 90%28%76%29%   
% 222.95/223.16  |- skos__historyNote mesh__D005480 Propionates %28%1973-1975%29%
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D005480 2006
% 222.95/223.16  |- skos__altLabel mesh__D005480 Shire Brand of Flurbiprofen
% 222.95/223.16  |- skos__altLabel mesh__D005480 Pharm-Allergan Brand of Flurbiprofen Sodium
% 222.95/223.16  |- skos__altLabel mesh__D005480 Apotex Brand of Flurbiprofen
% 222.95/223.16  |- skos__hiddenLabel mesh__D005480 ratio Flurbiprofen
% 222.95/223.16  |- mesh__dateRevised mesh__D005480 2005-06-30
% 222.95/223.16  |- skos__altLabel mesh__D005480 Crookes Brand of Flurbiprofen
% 222.95/223.16  |- skos__altLabel mesh__D005480 Nu-Pharm Brand of Flurbiprofen
% 222.95/223.16  |- mesh__recordAuthorizer mesh__D005480 sjn
% 222.95/223.16  |- skos__hiddenLabel mesh__D005480 Nu Flurbiprofen
% 222.95/223.16  |- rdf__type mesh__D005480sskos__Concept
% 222.95/223.16  |- skos__scopeNote mesh__D005480
% 222.95/223.16       An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting carbonic anhydrase.%A%    
% 222.95/223.16  |- skos__altLabel mesh__D005480 Allergan Brand of Flurbiprofen Sodium
% 222.95/223.16  |- mesh__dateCreated mesh__D005480 1975-07-25
% 222.95/223.16  |- skos__hiddenLabel mesh__D005480
% 222.95/223.16       Pharm Allergan Brand of Flurbiprofen Sodium
% 222.95/223.16  |- skos__altLabel mesh__D005480 Froben SR
% 222.95/223.16  |- skos__historyNote mesh__D005480 Fluorine %28%1973-1975%29%
% 222.95/223.16  |- skos__hiddenLabel mesh__D005480 Sodium, Flurbiprofen
% 222.95/223.16  |- skos__altLabel mesh__D005480 Ocuflur
% 222.95/223.16  |- skos__prefLabel mesh__D005480 Flurbiprofen
% 222.95/223.16  |- skos__altLabel mesh__D005480 Recordati Brand of Flurbiprofen
% 222.95/223.16  |- skos__hiddenLabel mesh__D005480 BTS18322
% 222.95/223.16  |- skos__altLabel mesh__D005480 Abbott Brand of Flurbiprofen
% 222.95/223.16  |- skos__altLabel mesh__D005480 Ratiopharm Brand of Flurbiprofen
% 222.95/223.16  |- skos__historyNote mesh__D005480 Biphenyl Compounds %28%1973-1975%29%
% 222.95/223.16  |- skos__hiddenLabel mesh__D005480 Nu Pharm Brand of Flurbiprofen
% 222.95/223.16  |- skos__hiddenLabel mesh__D005480 BTS 18322
% 222.95/223.16  |- mesh__publicMeSHNote mesh__D005480 90; see PROPIONATES 1976-89   
% 222.95/223.16  |- mesh__recordMaintainer mesh__D005480 CCR
% 222.95/223.16  |- mesh__dateEstablished mesh__D005480 1990-01-01
% 222.95/223.16  |- skos__altLabel mesh__D005480 Pharmacia Brand of Flurbiprofen
% 222.95/223.16  |- skos__altLabel mesh__D005480 Cantabria Brand of Flurbiprofen
% 222.95/223.16  |- skos__altLabel mesh__D005480 Novopharm Brand of Flurbiprofen
% 222.95/223.16  |- skos__broader mesh__D005480smesh__D011426
% 222.95/223.16  |- skos__altLabel mesh__D005480 Klosterfrau Brand of Flurbiprofen
% 222.95/223.16  |- skos__altLabel mesh__D005480
% 222.95/223.16       2-Fluoro-alpha-methyl-%28%1,1%27%-biphenyl%29%-4-acetic Acid
% 222.95/223.16  |- skos__altLabel mesh__D005480 Fluriproben
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D013912 2001
% 222.95/223.16  |- mesh__recordOriginator mesh__D013912 NLM
% 222.95/223.16  |- skos__altLabel mesh__D013912 L-Threonine
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D013912 2002
% 222.95/223.16  |- mesh__dateRevised mesh__D013912 2000-06-22
% 222.95/223.16  |- skos__scopeNote mesh__D013912
% 222.95/223.16       An essential amino acid occurring naturally in the L-form, which is the active form. It is found in eggs, milk, gelatin, and other proteins.%A%    
% 222.95/223.16  |- skos__broader mesh__D013912smesh__D000596
% 222.95/223.16  |- skos__hiddenLabel mesh__D013912 L Threonine
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D013912 2005
% 222.95/223.16  |- mesh__recordMaintainer mesh__D013912 adp
% 222.95/223.16  |- mesh__recordAuthorizer mesh__D013912 sjn
% 222.95/223.16  |- mesh__dateCreated mesh__D013912 1999-01-01
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D013912 2003
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D013912 2006
% 222.95/223.16  |- skos__broader mesh__D013912smesh__D000601
% 222.95/223.16  |- rdf__type mesh__D013912sskos__Concept
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D013912 2004
% 222.95/223.16  |- skos__broader mesh__D013912smesh__D021542
% 222.95/223.16  |- skos__annotation mesh__D013912 /biosyn /defic /physiol permitted   
% 222.95/223.16  |- skos__prefLabel mesh__D013912 Threonine
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D004388 1999
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D004388 2001
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D004388 1998
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D004388 1997
% 222.95/223.16  |- skos__broader mesh__D004388smesh__D008578
% 222.95/223.16  |- mesh__recordAuthorizer mesh__D004388 PLS
% 222.95/223.16  |- mesh__dateRevised mesh__D004388 1992-05-14
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D004388 2000
% 222.95/223.16  |- skos__hiddenLabel mesh__D004388 Mater, Dura
% 222.95/223.16  |- skos__hiddenLabel mesh__D004388 Dura Maters
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D004388 1996
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D004388 2006
% 222.95/223.16  |- skos__hiddenLabel mesh__D004388 Maters, Dura
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D004388 2005
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D004388 2004
% 222.95/223.16  |- skos__prefLabel mesh__D004388 Dura Mater
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D004388 2002
% 222.95/223.16  |- mesh__recordOriginator mesh__D004388 NLM
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D004388 1995
% 222.95/223.16  |- mesh__recordMaintainer mesh__D004388 TAP
% 222.95/223.16  |- rdf__type mesh__D004388sskos__Concept
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D004388 2003
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D004388 1994
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D004388 1993
% 222.95/223.16  |- mesh__dateCreated mesh__D004388 1999-01-01
% 222.95/223.16  |- mesh__recordMaintainer mesh__D009871 TGC
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009871 2005
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009871 2002
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009871 1998
% 222.95/223.16  |- rdf__type mesh__D009871sskos__Concept
% 222.95/223.16  |- mesh__historyNote mesh__D009871 74   
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009871 2004
% 222.95/223.16  |- mesh__dateEstablished mesh__D009871 1974-01-01
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009871 1997
% 222.95/223.16  |- skos__prefLabel mesh__D009871 Operating Room Nursing
% 222.95/223.16  |- mesh__recordAuthorizer mesh__D009871 PLS
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009871 2001
% 222.95/223.16  |- skos__annotation mesh__D009871
% 222.95/223.16       a nurs SPEC: a type of PERIOPERATIVE NURSING; DF: OPERATING ROOM NURS%A%  
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009871 2003
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009871 2000
% 222.95/223.16  |- mesh__dateCreated mesh__D009871 1999-01-01
% 222.95/223.16  |- skos__broader mesh__D009871smesh__D013527
% 222.95/223.16  |- mesh__recordOriginator mesh__D009871 NLM
% 222.95/223.16  |- skos__altLabel mesh__D009871 Nursing, Operating Room
% 222.95/223.16  |- mesh__dateRevised mesh__D009871 1996-06-10
% 222.95/223.16  |- mesh__publicMeSHNote mesh__D009871 74   
% 222.95/223.16  |- skos__scopeNote mesh__D009871
% 222.95/223.16       The functions of the professional nurse in the operating room.%A%    
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009871 2006
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009871 1999
% 222.95/223.16  |- skos__altLabel mesh__D009073 Portuguese East Africa
% 222.95/223.16  |- skos__prefLabel mesh__D009073 Mozambique
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009073 2000
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009073 1999
% 222.95/223.16  |- skos__broader mesh__D009073smesh__D000353
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009073 2006
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009073 2002
% 222.95/223.16  |- mesh__dateCreated mesh__D009073 1999-01-01
% 222.95/223.16  |- mesh__dateRevised mesh__D009073 1997-06-20
% 222.95/223.16  |- skos__annotation mesh__D009073
% 222.95/223.16       a country in southern Africa; X ref PORTUGUESE EAST AFRICA was its former name%A%  
% 222.95/223.16  |- mesh__recordMaintainer mesh__D009073 TGC
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009073 1998
% 222.95/223.16  |- skos__scopeNote mesh__D009073
% 222.95/223.16       An independent state in southern Africa, south of TANZANIA and east of ZAMBIA, on the Indian Ocean. Its capital is Maputo. It was formerly called Portuguese East Africa, the town of Mozambique having been a Portuguese trading fort early in the 16th century. Organized as a colony in 1907, it became an overseas province of Portugal in 1951 and became independent in 1975. The name is a Portuguese corruption of the Arabic musa malik: Musa %28%the name of an early African ruler%29% + malik %28%king%29%. %28%From Webster%27%s New Geographical Dictionary, 1992, p798 %26% Room, Brewer%27%s Dictionary of Names, 1992, p365%29%%A%    
% 222.95/223.16  |- mesh__recordAuthorizer mesh__D009073 SJN
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009073 2004
% 222.95/223.16  |- mesh__recordOriginator mesh__D009073 NLM
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009073 2005
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009073 2003
% 222.95/223.16  |- rdf__type mesh__D009073sskos__Concept
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D009073 2001
% 222.95/223.16  |- skos__prefLabel mesh__D050939 Gene Fusion
% 222.95/223.16  |- mesh__recordAuthorizer mesh__D050939 sjn
% 222.95/223.16  |- skos__hiddenLabel mesh__D050939 Gene Fusions
% 222.95/223.16  |- mesh__recordOriginator mesh__D050939 nns
% 222.95/223.16  |- skos__related mesh__D050939smesh__D019677
% 222.95/223.16  |- skos__hiddenLabel mesh__D050939 Fusions, Gene
% 222.95/223.16  |- skos__hiddenLabel mesh__D050939 Fusion, Gene
% 222.95/223.16  |- skos__related mesh__D050939smesh__D050506
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D050939 2006
% 222.95/223.16  |- skos__historyNote mesh__D050939 Artificial Gene Fusion %28%1998-2005%29%
% 222.95/223.16  |- mesh__dateCreated mesh__D050939 2005-06-30
% 222.95/223.16  |- mesh__publicMeSHNote mesh__D050939 2006   
% 222.95/223.16  |- skos__annotation mesh__D050939
% 222.95/223.16       ARTIFICIAL GENE FUSION is also available   
% 222.95/223.16  |- skos__broader mesh__D050939smesh__D011995
% 222.95/223.16  |- mesh__dateEstablished mesh__D050939 2006-01-01
% 222.95/223.16  |- mesh__recordMaintainer mesh__D050939 nns
% 222.95/223.16  |- mesh__historyNote mesh__D050939 2006   
% 222.95/223.16  |- skos__scopeNote mesh__D050939
% 222.95/223.16       The GENETIC RECOMBINATION of the parts of two or more GENES resulting in a gene with different or additional regulatory regions, or a new chimeric gene product. ONCOGENE FUSION includes an ONCOGENE as at least one of the fusion partners and such gene fusions are often detected in neoplastic cells and are transcribed into ONCOGENE FUSION PROTEINS. ARTIFICIAL GENE FUSION is carried out in vitro by RECOMBINANT DNA technology.%A%    
% 222.95/223.16  |- rdf__type mesh__D050939sskos__Concept
% 222.95/223.16  |- skos__altLabel mesh__D047990 TNF Receptor-Associated Protein 1
% 222.95/223.16  |- skos__scopeNote mesh__D047990
% 222.95/223.16       A signal transducing tumor necrosis factor receptor associated factor that is involved in TNF RECEPTOR feedback regulation. It is similar in structure and appears to work in conjunction with TNF RECEPTOR-ASSOCIATED FACTOR 2 to inhibit APOPTOSIS.%A%    
% 222.95/223.16  |- mesh__dateEstablished mesh__D047990 2005-01-01
% 222.95/223.16  |- skos__hiddenLabel mesh__D047990 TNF Receptor Associated Protein 1
% 222.95/223.16  |- mesh__recordMaintainer mesh__D047990 jmp
% 222.95/223.16  |- skos__broader mesh__D047990smesh__D047988
% 222.95/223.16  |- mesh__historyNote mesh__D047990 2005%28%1994%29%   
% 222.95/223.16  |- mesh__dateCreated mesh__D047990 2004-07-07
% 222.95/223.16  |- skos__prefLabel mesh__D047990 TNF Receptor-Associated Factor 1
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D047990 2006
% 222.95/223.16  |- mesh__recordOriginator mesh__D047990 jmp
% 222.95/223.16  |- mesh__recordAuthorizer mesh__D047990 sjn
% 222.95/223.16  |- skos__altLabel mesh__D047990 TRAF1
% 222.95/223.16  |- rdf__type mesh__D047990sskos__Concept
% 222.95/223.16  |- skos__hiddenLabel mesh__D047990 TNF Receptor Associated Factor 1
% 222.95/223.16  |- skos__historyNote mesh__D047990 Proteins %28%1994-2004%29%
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D047990 2005
% 222.95/223.16  |- mesh__publicMeSHNote mesh__D047990
% 222.95/223.16       2005; TNF RECEPTOR-ASSOCIATED FACTOR 1 was indexed under PROTEINS 1994-2004%A%  
% 222.95/223.16  |- skos__broader mesh__D051546Q000037smesh__D051546
% 222.95/223.16  |- mesh__preferredCombination mesh__D051546Q000037smesh__D052246
% 222.95/223.16  |- rdf__type mesh__D051546Q000037smesh__CompoundConcept
% 222.95/223.16  |- skos__broader mesh__D008779smesh__D013889
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D008779 2006
% 222.95/223.16  |- mesh__recordOriginator mesh__D008779 NLM
% 222.95/223.16  |- skos__altLabel mesh__D008779 Alkiron
% 222.95/223.16  |- skos__altLabel mesh__D008779 4-Methyl-2-thiouracil
% 222.95/223.16  |- skos__altLabel mesh__D008779 Physicians Brand of Methylthiouracil
% 222.95/223.16  |- mesh__recordMaintainer mesh__D008779 CCR
% 222.95/223.16  |- rdf__type mesh__D008779sskos__Concept
% 222.95/223.16  |- mesh__recordAuthorizer mesh__D008779 sjn
% 222.95/223.16  |- skos__scopeNote mesh__D008779
% 222.95/223.16       A thiourea antithyroid agent that inhibits the synthesis of thyroid hormone. It is used in the treatment of hyperthyroidism.%A%    
% 222.95/223.16  |- mesh__dateCreated mesh__D008779 1999-01-01
% 222.95/223.16  |- mesh__dateRevised mesh__D008779 2005-06-30
% 222.95/223.16  |- skos__prefLabel mesh__D008779 Methylthiouracil
% 222.95/223.16  |- mesh__activeMeSHYear mesh__D000796 2002
% 222.95/223.16  |- mesh__recordOriginator mesh__D000796 VDK
% 222.95/223.17  |- skos__hiddenLabel mesh__D000796 Pseudopyogenic Granulomas
% 222.95/223.17  |- skos__prefLabel mesh__D000796
% 222.95/223.17       Angiolymphoid Hyperplasia with Eosinophilia
% 222.95/223.17  |- skos__broader mesh__D000796smesh__D004802
% 222.95/223.17  |- skos__altLabel mesh__D000796 Granuloma, Pseudopyogenic
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D000796 2006
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D000796 2001
% 222.95/223.17  |- mesh__publicMeSHNote mesh__D000796 85   
% 222.95/223.17  |- skos__annotation mesh__D000796 DF: ALHE   
% 222.95/223.17  |- mesh__dateRevised mesh__D000796 1999-11-03
% 222.95/223.17  |- skos__hiddenLabel mesh__D000796 Disease, Kimura
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D000796 2005
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D000796 2000
% 222.95/223.17  |- mesh__dateEstablished mesh__D000796 1985-01-01
% 222.95/223.17  |- skos__scopeNote mesh__D000796
% 222.95/223.17       Solitary or multiple benign cutaneous nodules comprised of immature and mature vascular structures intermingled with endothelial cells and a varied infiltrate of eosinophils, histiocytes, lymphocytes, and mast cells.%A%    
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D000796 2004
% 222.95/223.17  |- mesh__historyNote mesh__D000796 85   
% 222.95/223.17  |- skos__broader mesh__D000796smesh__D006099
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D000796 2003
% 222.95/223.17  |- mesh__dateCreated mesh__D000796 1984-05-29
% 222.95/223.17  |- skos__broader mesh__D000796smesh__D012871
% 222.95/223.17  |- mesh__recordAuthorizer mesh__D000796 sjn
% 222.95/223.17  |- mesh__recordMaintainer mesh__D000796 KEV
% 222.95/223.17  |- rdf__type mesh__D000796sskos__Concept
% 222.95/223.17  |- skos__historyNote mesh__D000796 Eosinophilia %28%1966-1984%29%
% 222.95/223.17  |- skos__hiddenLabel mesh__D000796 Granulomas, Pseudopyogenic
% 222.95/223.17  |- skos__broader mesh__D041604smesh__D028223
% 222.95/223.17  |- rdf__type mesh__D041604sskos__Concept
% 222.95/223.17  |- skos__prefLabel mesh__D041604 Pinus ponderosa
% 222.95/223.17  |- skos__altLabel mesh__D041604 Ponderosa Pine
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D041604 2006
% 222.95/223.17  |- skos__historyNote mesh__D041604 Trees %28%1972-2001%29%
% 222.95/223.17  |- mesh__historyNote mesh__D041604 2004   
% 222.95/223.17  |- mesh__dateEstablished mesh__D041604 2004-01-01
% 222.95/223.17  |- mesh__publicMeSHNote mesh__D041604 2004   
% 222.95/223.17  |- skos__annotation mesh__D041604
% 222.95/223.17       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.95/223.17  |- skos__historyNote mesh__D041604 Pinus %28%2002-2003%29%
% 222.95/223.17  |- mesh__dateCreated mesh__D041604 2003-07-09
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D041604 2004
% 222.95/223.17  |- skos__scopeNote mesh__D041604
% 222.95/223.17       A plant species of the genus PINUS that contains isocupressic acid.%A%    
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D041604 2005
% 222.95/223.17  |- mesh__dateEstablished mesh__D005481 1973-01-01
% 222.95/223.17  |- skos__broader mesh__D005481smesh__D005019
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D005481 2004
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D005481 2002
% 222.95/223.17  |- skos__altLabel mesh__D005481 Fluorothyl
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D005481 2003
% 222.95/223.17  |- mesh__recordOriginator mesh__D005481 NLM
% 222.95/223.17  |- mesh__dateCreated mesh__D005481 1999-01-01
% 222.95/223.17  |- rdf__type mesh__D005481sskos__Concept
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D005481 2001
% 222.95/223.17  |- skos__altLabel mesh__D005481 Flurotyl
% 222.95/223.17  |- mesh__historyNote mesh__D005481 73   
% 222.95/223.17  |- skos__scopeNote mesh__D005481
% 222.95/223.17       A convulsant primarily used in experimental animals. It was formerly used to induce convulsions as a alternative to electroshock therapy.%A%    
% 222.95/223.17  |- skos__historyNote mesh__D005481 Ethers %28%1966-1972%29%
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D005481 2006
% 222.95/223.17  |- mesh__recordAuthorizer mesh__D005481 sjn
% 222.95/223.17  |- mesh__publicMeSHNote mesh__D005481 73   
% 222.95/223.17  |- mesh__dateRevised mesh__D005481 2000-06-22
% 222.95/223.17  |- skos__prefLabel mesh__D005481 Flurothyl
% 222.95/223.17  |- skos__historyNote mesh__D005481 Analeptics %28%1966-1972%29%
% 222.95/223.17  |- mesh__recordMaintainer mesh__D005481 CCR
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D005481 2005
% 222.95/223.17  |- mesh__recordAuthorizer mesh__D013913 sjn
% 222.95/223.17  |- mesh__publicMeSHNote mesh__D013913
% 222.95/223.17       78; was see under HYDRO-LYASES 1975-77   
% 222.95/223.17  |- skos__broader mesh__D013913smesh__D000642
% 222.95/223.17  |- skos__hiddenLabel mesh__D013913 Deaminase, Threonine
% 222.95/223.17  |- mesh__dateEstablished mesh__D013913 1978-01-01
% 222.95/223.17  |- mesh__recordMaintainer mesh__D013913 jmp
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D013913 2006
% 222.95/223.17  |- rdf__type mesh__D013913sskos__Concept
% 222.95/223.17  |- mesh__dateCreated mesh__D013913 1974-11-11
% 222.95/223.17  |- skos__prefLabel mesh__D013913 Threonine Dehydratase
% 222.95/223.17  |- skos__scopeNote mesh__D013913
% 222.95/223.17       A pyridoxal-phosphate protein that catalyzes the deamination of THREONINE to 2-ketobutyrate and AMMONIA. The role of this enzyme can be biosynthetic or biodegradative. In the former role it supplies 2-ketobutyrate required for ISOLEUCINE biosynthesis, while in the latter it is only involved in the breakdown of threonine to supply energy. This enzyme was formerly listed as EC 4.2.1.16.%A%    
% 222.95/223.17  |- skos__altLabel mesh__D013913 Threonine Deaminase
% 222.95/223.17  |- skos__hiddenLabel mesh__D013913 Ammonia-Lyase, Threonine
% 222.95/223.17  |- mesh__recordOriginator mesh__D013913 NLM
% 222.95/223.17  |- skos__hiddenLabel mesh__D013913 Dehydratase, Threonine
% 222.95/223.17  |- skos__hiddenLabel mesh__D013913 Threonine Ammonia Lyase
% 222.95/223.17  |- skos__altLabel mesh__D013913 Threonine Dehydrase
% 222.95/223.17  |- skos__hiddenLabel mesh__D013913 Dehydrase, Threonine
% 222.95/223.17  |- skos__historyNote mesh__D013913 Hydro-Lyases %28%1966-1974%29%
% 222.95/223.17  |- skos__altLabel mesh__D013913 Threonine Ammonia-Lyase
% 222.95/223.17  |- mesh__dateRevised mesh__D013913 2005-06-30
% 222.95/223.17  |- skos__historyNote mesh__D013913 Threonine %28%1966-1974%29%
% 222.95/223.17  |- mesh__historyNote mesh__D013913
% 222.95/223.17       78%28%75%29%; was see under HYDRO-LYASES 1975-77   
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D013115 2000
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D013115 2005
% 222.95/223.17  |- skos__broader mesh__D013115smesh__D013131
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D013115 2002
% 222.95/223.17  |- mesh__recordAuthorizer mesh__D013115 sjn
% 222.95/223.17  |- skos__annotation mesh__D013115
% 222.95/223.17       coord IM with specific vertebrae %28%NIM%29% to locate level of spinal canal; %22%narrowing of the spinal canal%22% = SPINAL STENOSIS%A%  
% 222.95/223.17  |- mesh__dateCreated mesh__D013115 1999-01-01
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D013115 2004
% 222.95/223.17  |- rdf__type mesh__D013115sskos__Concept
% 222.95/223.17  |- mesh__dateRevised mesh__D013115 1999-11-03
% 222.95/223.17  |- skos__hiddenLabel mesh__D013115 Canals, Spinal
% 222.95/223.17  |- mesh__recordOriginator mesh__D013115 NLM
% 222.95/223.17  |- skos__hiddenLabel mesh__D013115 Canal, Spinal
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D013115 2003
% 222.95/223.17  |- skos__hiddenLabel mesh__D013115 Spinal Canals
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D013115 2001
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D013115 2006
% 222.95/223.17  |- skos__prefLabel mesh__D013115 Spinal Canal
% 222.95/223.17  |- mesh__recordMaintainer mesh__D013115 ags
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D004389 1997
% 222.95/223.17  |- skos__altLabel mesh__D004389 Equipment, Durable Medical
% 222.95/223.17  |- skos__scopeNote mesh__D004389
% 222.95/223.17       Devices which are very resistant to wear and may be used over a long period of time. They include items such as wheelchairs, hospital beds, artificial limbs, etc.%A%    
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D004389 2005
% 222.95/223.17  |- mesh__recordAuthorizer mesh__D004389 PLS
% 222.95/223.17  |- mesh__recordOriginator mesh__D004389 EC
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D004389 2000
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D004389 2006
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D004389 2003
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D004389 1994
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D004389 2001
% 222.95/223.17  |- mesh__publicMeSHNote mesh__D004389 88   
% 222.95/223.17  |- skos__prefLabel mesh__D004389 Durable Medical Equipment
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D004389 2004
% 222.95/223.17  |- skos__altLabel mesh__D004389 Medical Equipment, Durable
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D004389 1995
% 222.95/223.17  |- mesh__recordMaintainer mesh__D004389 PLS
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D004389 2002
% 222.95/223.17  |- mesh__dateRevised mesh__D004389 1992-05-14
% 222.95/223.17  |- skos__broader mesh__D004389smesh__D004864
% 222.95/223.17  |- rdf__type mesh__D004389sskos__Concept
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D004389 1998
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D004389 1993
% 222.95/223.17  |- skos__altLabel mesh__D004389 Equipment, Medical, Durable
% 222.95/223.17  |- skos__annotation mesh__D004389 DF: DURABLE MED EQUIPMENT   
% 222.95/223.17  |- mesh__dateCreated mesh__D004389 1987-05-02
% 222.95/223.17  |- mesh__historyNote mesh__D004389 88   
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D004389 1999
% 222.95/223.17  |- mesh__dateEstablished mesh__D004389 1988-01-01
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D004389 1996
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009872 2003
% 222.95/223.17  |- mesh__historyNote mesh__D009872 71   
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009872 1996
% 222.95/223.17  |- skos__hiddenLabel mesh__D009872 Technician, Operating Room
% 222.95/223.17  |- skos__hiddenLabel mesh__D009872 Operating Room Technician
% 222.95/223.17  |- mesh__dateEstablished mesh__D009872 1971-01-01
% 222.95/223.17  |- mesh__dateCreated mesh__D009872 1999-01-01
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009872 1995
% 222.95/223.17  |- skos__scopeNote mesh__D009872
% 222.95/223.17       Specially trained personnel to assist in routine technical procedures in the operating room.%A%    
% 222.95/223.17  |- skos__hiddenLabel mesh__D009872 Technicians, Operating Room
% 222.95/223.17  |- skos__historyNote mesh__D009872
% 222.95/223.17       Operating Rooms/manpower %28%1968-1970%29%
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009872 1994
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009872 2006
% 222.95/223.17  |- skos__prefLabel mesh__D009872 Operating Room Technicians
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009872 2002
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009872 1993
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009872 1999
% 222.95/223.17  |- mesh__recordMaintainer mesh__D009872 TAP
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009872 2005
% 222.95/223.17  |- mesh__recordAuthorizer mesh__D009872 PLS
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009872 2001
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009872 1998
% 222.95/223.17  |- rdf__type mesh__D009872sskos__Concept
% 222.95/223.17  |- mesh__dateRevised mesh__D009872 1992-05-15
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009872 2004
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009872 2000
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009872 1997
% 222.95/223.17  |- mesh__publicMeSHNote mesh__D009872 71   
% 222.95/223.17  |- skos__broader mesh__D009872smesh__D000488
% 222.95/223.17  |- mesh__recordOriginator mesh__D009872 NLM
% 222.95/223.17  |- rdf__type mesh__D009074sskos__Concept
% 222.95/223.17  |- skos__broader mesh__D009074smesh__D009479
% 222.95/223.17  |- mesh__recordOriginator mesh__D009074 NLM
% 222.95/223.17  |- mesh__recordAuthorizer mesh__D009074 sjn
% 222.95/223.17  |- mesh__dateCreated mesh__D009074 1999-01-01
% 222.95/223.17  |- skos__altLabel mesh__D009074 Melanophore-Stimulating Hormone
% 222.95/223.17  |- skos__altLabel mesh__D009074 MSH %28%Melanocyte-Stimulating Hormones%29%
% 222.95/223.17  |- skos__hiddenLabel mesh__D009074 Melanophore Stimulating Hormone
% 222.95/223.17  |- mesh__recordMaintainer mesh__D009074 ssb
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009074 2006
% 222.95/223.17  |- mesh__publicMeSHNote mesh__D009074
% 222.95/223.17       2006; see MSH 1968-2005, INTERMEDIN 1963-67   
% 222.95/223.17  |- skos__altLabel mesh__D009074 MSH
% 222.95/223.17  |- skos__prefLabel mesh__D009074 Melanocyte-Stimulating Hormones
% 222.95/223.17  |- skos__broader mesh__D009074smesh__D011333
% 222.95/223.17  |- mesh__dateEstablished mesh__D009074 1968-01-01
% 222.95/223.17  |- skos__hiddenLabel mesh__D009074 Melanocyte Stimulating Hormones
% 222.95/223.17  |- skos__hiddenLabel mesh__D009074 MSH Intermedins
% 222.95/223.17  |- mesh__dateRevised mesh__D009074 2005-06-30
% 222.95/223.17  |- skos__altLabel mesh__D009074 Melanotropin
% 222.95/223.17  |- skos__altLabel mesh__D009074 Intermedins, MSH
% 222.95/223.17  |- mesh__historyNote mesh__D009074 2006%28%1963%29%   
% 222.95/223.17  |- skos__scopeNote mesh__D009074
% 222.95/223.17       Peptide hormones secreted by the intermediate lobe of the pituitary that stimulate melanin release and dispersal. Melanocyte-stimulating hormones are also found in the brain where they are presumed to play a signaling role.%A%    
% 222.95/223.17  |- skos__hiddenLabel mesh__D001091 Lipoxygenases, Arachidonate
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D001091 2005
% 222.95/223.17  |- skos__historyNote mesh__D001091 Lipoxygenases %28%1974-1986%29%
% 222.95/223.17  |- mesh__recordMaintainer mesh__D001091 ssb
% 222.95/223.17  |- mesh__recordOriginator mesh__D001091 RLS
% 222.95/223.17  |- skos__prefLabel mesh__D001091 Arachidonate Lipoxygenases
% 222.95/223.17  |- mesh__dateRevised mesh__D001091 2004-07-07
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D001091 2006
% 222.95/223.17  |- mesh__dateCreated mesh__D001091 1986-06-16
% 222.95/223.17  |- mesh__historyNote mesh__D001091 87   
% 222.95/223.17  |- rdf__type mesh__D001091sskos__Concept
% 222.95/223.17  |- mesh__recordAuthorizer mesh__D001091 sjn
% 222.95/223.17  |- skos__scopeNote mesh__D001091
% 222.95/223.17       Enzymes catalyzing the oxidation of arachidonic acid to hydroperoxyarachidonates %28%HPETES%29%. These products are then rapidly converted by a peroxidase to hydroxyeicosatetraenoic acids %28%HETES%29%. The positional specificity of the enzyme reaction varies from tissue to tissue. The final lipoxygenase pathway leads to the leukotrienes. EC 1.13.11.- .%A%    
% 222.95/223.17  |- skos__altLabel mesh__D001091 Arachidonic Acid Lipoxygenase
% 222.95/223.17  |- skos__historyNote mesh__D001091 Oxygenases %28%1966-1973%29%
% 222.95/223.17  |- mesh__dateEstablished mesh__D001091 1987-01-01
% 222.95/223.17  |- skos__broader mesh__D001091smesh__D008084
% 222.95/223.17  |- mesh__publicMeSHNote mesh__D001091 87   
% 222.95/223.17  |- skos__hiddenLabel mesh__D001091 Lipoxygenase, Arachidonic Acid
% 222.95/223.17  |- skos__broader mesh__D017506smesh__D006180
% 222.95/223.17  |- skos__altLabel mesh__D017506
% 222.95/223.17       Adenosinetriphosphatase, Hydrogen, Potassium
% 222.95/223.17  |- mesh__dateRevised mesh__D017506 2005-06-30
% 222.95/223.17  |- skos__historyNote mesh__D017506
% 222.95/223.17       Adenosinetriphosphatase %28%1980-1992%29%
% 222.95/223.17  |- skos__altLabel mesh__D017506 ATPase, Hydrogen, Potassium
% 222.95/223.17  |- skos__hiddenLabel mesh__D017506 ATPase Hydrogen, Potassium
% 222.95/223.17  |- skos__altLabel mesh__D017506
% 222.95/223.17       Adenosine Triphosphatase, Hydrogen, Potassium
% 222.95/223.17  |- skos__prefLabel mesh__D017506 H%28%+%29%-K%28%+%29%-Exchanging ATPase
% 222.95/223.17  |- skos__altLabel mesh__D017506 Potassium Hydrogen ATPase
% 222.95/223.17  |- skos__scopeNote mesh__D017506
% 222.95/223.17       An enzyme isolated from the gastric mucosa that catalyzes the hydrolysis of ATP coupled with the exchange of hydrogen and potassium ions across the cell wall. This enzyme was formerly listed as EC 3.6.1.36.%A%    
% 222.95/223.17  |- skos__altLabel mesh__D017506
% 222.95/223.17       Hydrogen, Potassium, Adenosinetriphosphatase
% 222.95/223.17  |- skos__altLabel mesh__D017506 Hydrogen, Potassium ATPase
% 222.95/223.17  |- mesh__historyNote mesh__D017506
% 222.95/223.17       94; was H%28%+%29%-K%28%+%29%-TRANSPORTING ATPASE 1993; was POTASSIUM HYDROGEN ATPASE %28%NM%29% 1980-92%A%  
% 222.95/223.17  |- mesh__dateEstablished mesh__D017506 1993-01-01
% 222.95/223.17  |- rdf__type mesh__D017506sskos__Concept
% 222.95/223.17  |- mesh__recordAuthorizer mesh__D017506 sjn
% 222.95/223.17  |- skos__altLabel mesh__D017506
% 222.95/223.17       Hydrogen, Potassium, Adenosine Triphosphatase
% 222.95/223.17  |- skos__altLabel mesh__D017506 H%28%+%29%-K%28%+%29%-Transporting ATPase
% 222.95/223.17  |- skos__hiddenLabel mesh__D017506 ATPase, Potassium Hydrogen
% 222.95/223.17  |- mesh__onlineNote mesh__D017506
% 222.95/223.17       use H%28%+%29%-K%28%+%29%-EXCHANGING ATPASE to search H%28%+%29%-K%28%+%29%-TRANSPORTING ATPASE 1993; use H%28%+%29%-K%28%+%29%-EXCHANGING ATPASE %28%NM%29% to search POTASSIUM HYDROGEN ATPASE 1980-92%A%  
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D017506 2006
% 222.95/223.17  |- mesh__publicMeSHNote mesh__D017506
% 222.95/223.17       94; was H%28%+%29%-K%28%+%29%-TRANSPORTING ATPASE 1993; POTASSIUM HYDROGEN ATPASE was indexed under ADENOSINE TRIPHOSPHATASE 1980-92%A%  
% 222.95/223.17  |- mesh__recordMaintainer mesh__D017506 ssb
% 222.95/223.17  |- mesh__recordOriginator mesh__D017506 TPW
% 222.95/223.17  |- mesh__dateCreated mesh__D017506 1992-05-22
% 222.95/223.17  |- skos__annotation mesh__D017506
% 222.95/223.17       do not confuse X ref H%28%+%29%-K%28%+%29%-TRANSPORTING ATPASE with PROTON-TRANSLOCATING ATPASES; DF: H K ATPASE%A%  
% 222.95/223.17  |- mesh__recordOriginator mesh__D047991 ags
% 222.95/223.17  |- mesh__publicMeSHNote mesh__D047991 2005   
% 222.95/223.17  |- mesh__recordAuthorizer mesh__D047991 sjn
% 222.95/223.17  |- mesh__dateRevised mesh__D047991 2005-06-30
% 222.95/223.17  |- skos__historyNote mesh__D047991 Clostridium %28%1968-2004%29%
% 222.95/223.17  |- mesh__recordMaintainer mesh__D047991 SYSTEM
% 222.95/223.17  |- mesh__dateCreated mesh__D047991 2004-07-07
% 222.95/223.17  |- mesh__dateEstablished mesh__D047991 2005-01-01
% 222.95/223.17  |- skos__broader mesh__D047991smesh__D003013
% 222.95/223.17  |- mesh__historyNote mesh__D047991 2005   
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D047991 2006
% 222.95/223.17  |- rdf__type mesh__D047991sskos__Concept
% 222.95/223.17  |- skos__scopeNote mesh__D047991
% 222.95/223.17       A species of gram-positive, anaerobic bacteria in the family Clostridiaceae frequently used for the study of ENZYMES.%A%    
% 222.95/223.17  |- skos__prefLabel mesh__D047991 Clostridium sticklandii
% 222.95/223.17  |- skos__historyNote mesh__D041605 Pinus %28%2002-2003%29%
% 222.95/223.17  |- skos__scopeNote mesh__D041605
% 222.95/223.17       A plant species of the genus PINUS which is the source of pinosylvin. It is sometimes called Scotch pine or Scots pine, which is also a common name for other species of this genus.%A%    
% 222.95/223.17  |- skos__historyNote mesh__D041605 Trees %28%1975-2001%29%
% 222.95/223.17  |- mesh__dateEstablished mesh__D041605 2004-01-01
% 222.95/223.17  |- skos__annotation mesh__D041605
% 222.95/223.17       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 222.95/223.17  |- mesh__publicMeSHNote mesh__D041605 2004   
% 222.95/223.17  |- rdf__type mesh__D041605sskos__Concept
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D041605 2006
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D041605 2005
% 222.95/223.17  |- mesh__historyNote mesh__D041605 2004   
% 222.95/223.17  |- mesh__dateCreated mesh__D041605 2003-07-09
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D041605 2004
% 222.95/223.17  |- skos__broader mesh__D041605smesh__D028223
% 222.95/223.17  |- skos__prefLabel mesh__D041605 Pinus sylvestris
% 222.95/223.17  |- mesh__publicMeSHNote mesh__D013914
% 222.95/223.17       98; see THREONYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A%  
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D013914 2005
% 222.95/223.17  |- skos__scopeNote mesh__D013914
% 222.95/223.17       An enzyme that activates threonine with its specific transfer RNA. EC 6.1.1.3.%A%    
% 222.95/223.17  |- mesh__dateEstablished mesh__D013914 1991-01-01
% 222.95/223.17  |- skos__hiddenLabel mesh__D013914 Ligase, Thr-tRNA
% 222.95/223.17  |- skos__hiddenLabel mesh__D013914 Thr tRNA Ligase
% 222.95/223.17  |- skos__altLabel mesh__D013914 Threonyl T RNA Synthetase
% 222.95/223.17  |- skos__hiddenLabel mesh__D013914 Ligase, Threonine-tRNA
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D013914 2006
% 222.95/223.17  |- rdf__type mesh__D013914sskos__Concept
% 222.95/223.17  |- skos__historyNote mesh__D013914 Threonine %28%1973-1974%29%
% 222.95/223.17  |- mesh__recordAuthorizer mesh__D013914 sjn
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D013914 2004
% 222.95/223.17  |- mesh__historyNote mesh__D013914 98%28%75%29%   
% 222.95/223.17  |- skos__altLabel mesh__D013914 Threonyl-tRNA Synthetase
% 222.95/223.17  |- mesh__dateRevised mesh__D013914 2003-07-09
% 222.95/223.17  |- skos__hiddenLabel mesh__D013914 Threonyl tRNA Synthetase
% 222.95/223.17  |- skos__prefLabel mesh__D013914 Threonine-tRNA Ligase
% 222.95/223.17  |- skos__hiddenLabel mesh__D013914 Threonine tRNA Ligase
% 222.95/223.17  |- skos__hiddenLabel mesh__D013914 Synthetase, Threonyl-tRNA
% 222.95/223.17  |- skos__altLabel mesh__D013914 Thr-tRNA Ligase
% 222.95/223.17  |- mesh__recordOriginator mesh__D013914 NLM
% 222.95/223.17  |- mesh__recordMaintainer mesh__D013914 ssb
% 222.95/223.17  |- skos__broader mesh__D013914smesh__D000604
% 222.95/223.17  |- skos__historyNote mesh__D013914
% 222.95/223.17       Amino Acyl T RNA Synthetases %28%1973-1974%29%
% 222.95/223.17  |- mesh__dateCreated mesh__D013914 1974-11-19
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D013116 2005
% 222.95/223.17  |- skos__broader mesh__D013116smesh__D002490
% 222.95/223.17  |- mesh__recordAuthorizer mesh__D013116 sjn
% 222.95/223.17  |- skos__related mesh__D013116smesh__D009046
% 222.95/223.17  |- skos__prefLabel mesh__D013116 Spinal Cord
% 222.95/223.17  |- skos__annotation mesh__D013116
% 222.95/223.17       /radiogr permitted but consider MYELOGRAPHY; /surg: probably CORDOTOMY; inflammation = MYELITIS; coord IM with specific vertebrae %28%NIM%29% to locate site on spinal cord; do not confuse words containing %22%myel-%22% for spinal cord with %22%myel-%22% for bone marrow%A%  
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D013116 2002
% 222.95/223.17  |- mesh__dateCreated mesh__D013116 1999-01-01
% 222.95/223.17  |- skos__related mesh__D013116smesh__D009192
% 222.95/223.17  |- rdf__type mesh__D013116sskos__Concept
% 222.95/223.17  |- mesh__recordOriginator mesh__D013116 NLM
% 222.95/223.17  |- skos__hiddenLabel mesh__D013116 Spinal Cords
% 222.95/223.17  |- skos__hiddenLabel mesh__D013116 Cords, Spinal
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D013116 2004
% 222.95/223.17  |- mesh__considerAlso mesh__D013116 consider also terms at MYEL-   
% 222.95/223.17  |- skos__related mesh__D013116smesh__D002818
% 222.95/223.17  |- mesh__recordMaintainer mesh__D013116 KEV
% 222.95/223.17  |- mesh__dateRevised mesh__D013116 1999-11-03
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D013116 2001
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D013116 2003
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D013116 2000
% 222.95/223.17  |- skos__hiddenLabel mesh__D013116 Cord, Spinal
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D013116 2006
% 222.95/223.17  |- mesh__dateRevised mesh__D009873 1992-05-15
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009873 1995
% 222.95/223.17  |- skos__prefLabel mesh__D009873 Operating Rooms
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009873 2000
% 222.95/223.17  |- mesh__recordOriginator mesh__D009873 NLM
% 222.95/223.17  |- skos__hiddenLabel mesh__D009873 Rooms, Operating
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009873 1994
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009873 2006
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009873 1993
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009873 1999
% 222.95/223.17  |- skos__broader mesh__D009873smesh__D006757
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009873 2005
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009873 1998
% 222.95/223.17  |- rdf__type mesh__D009873sskos__Concept
% 222.95/223.17  |- mesh__recordMaintainer mesh__D009873 TGC
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009873 2004
% 222.95/223.17  |- skos__scopeNote mesh__D009873
% 222.95/223.17       Facilities equipped for performing surgery.     
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009873 1997
% 222.95/223.17  |- skos__related mesh__D009873smesh__D015920
% 222.95/223.17  |- skos__hiddenLabel mesh__D009873 Operating Room
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009873 2002
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009873 2003
% 222.95/223.17  |- skos__hiddenLabel mesh__D009873 Room, Operating
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009873 1996
% 222.95/223.17  |- mesh__recordAuthorizer mesh__D009873 PLS
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009873 2001
% 222.95/223.17  |- mesh__dateCreated mesh__D009873 1999-01-01
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D001890 2004
% 222.95/223.17  |- skos__historyNote mesh__D001890 Horse Diseases %28%1966-1969%29%
% 222.95/223.17  |- skos__historyNote mesh__D001890 Cattle Diseases %28%1966-1969%29%
% 222.95/223.17  |- mesh__dateEstablished mesh__D001890 1970-01-01
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D001890 2002
% 222.95/223.17  |- mesh__dateCreated mesh__D001890 1999-01-01
% 222.95/223.17  |- mesh__recordMaintainer mesh__D001890 ags
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D001890 2005
% 222.95/223.17  |- skos__historyNote mesh__D001890 Virus Diseases %28%1966-1969%29%
% 222.95/223.17  |- skos__broader mesh__D001890smesh__D018701
% 222.95/223.17  |- mesh__recordOriginator mesh__D001890 NLM
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D001890 2006
% 222.95/223.17  |- rdf__type mesh__D001890sskos__Concept
% 222.95/223.17  |- mesh__dateRevised mesh__D001890 2001-07-25
% 222.95/223.17  |- mesh__historyNote mesh__D001890 70   
% 222.95/223.17  |- skos__prefLabel mesh__D001890 Borna Disease
% 222.95/223.17  |- mesh__recordAuthorizer mesh__D001890 sjn
% 222.95/223.17  |- skos__scopeNote mesh__D001890
% 222.95/223.17       An encephalomyelitis of horses, sheep and cattle caused by BORNA DISEASE VIRUS.%A%    
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D001890 2003
% 222.95/223.17  |- skos__broader mesh__D001890smesh__D000820
% 222.95/223.17  |- skos__historyNote mesh__D001890 Encephalomyelitis %28%1966-1969%29%
% 222.95/223.17  |- mesh__publicMeSHNote mesh__D001890 70   
% 222.95/223.17  |- skos__historyNote mesh__D009075
% 222.95/223.17       Hypothalamo-Hypophyseal System %28%1966-1974%29%
% 222.95/223.17  |- mesh__dateEstablished mesh__D009075 1975-09-01
% 222.95/223.17  |- skos__historyNote mesh__D009075
% 222.95/223.17       Pituitary Hormone-Releasing Hormones %28%1971-1974%29%
% 222.95/223.17  |- mesh__publicMeSHNote mesh__D009075 75   
% 222.95/223.17  |- mesh__recordMaintainer mesh__D009075 ags
% 222.95/223.17  |- mesh__dateCreated mesh__D009075 1974-11-11
% 222.95/223.17  |- mesh__recordAuthorizer mesh__D009075 ags
% 222.95/223.17  |- skos__altLabel mesh__D009075 H-Pro-Leu-Gly-NH2
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009075 2006
% 222.95/223.17  |- mesh__activeMeSHYear mesh__D009075 2006A
% 222.95/223.17  |- skos__altLabel mesh__D009075 MIF-1
% 222.95/223.17  |- mesh__dateRevised mesh__D009075 2005-07-19
% 222.95/223.17  |- mesh__recordOriginator mesh__D009075 NLM
% 222.95/223.17  |- skos__prefLabel mesh__D009075 MSH Release-Inhibiting Hormone
% 222.95/223.17  |- skos__altLabel mesh__D009075 Oxytocin %28%7-9%29%
% 222.95/223.17  |- skos__altLabel mesh__D009075 Prolylleucylglycinamide
% 222.95/223.17  |- skos__altLabel mesh__D009075 Melanostatin
% 222.95/223.17  |- skos__historyNote mesh__D009075 MSH %28%1966-1974%29%
% 222.95/223.17  |- skos__hiddenLabel mesh__D009075 Prol Leu Gly NH2
% 222.95/223.17  |- skos__historyNote mesh__D009075 Hypothalamus %28%1966-1974%29%
% 222.95/223.17  |- skos__annotation mesh__D009075 DF: MSHRIH   
% 222.95/223.17  |- skos__altLabel mesh__D009075 Prolyl-Leucyl-Glycinamide
% 222.95/223.17  |- skos__altLabel mesh__D009075 Pro-Leu-Gly-NH2
% 222.95/223.17  |- skos__broader mesh__D009075smesh__D036361
% 222.95/223.17  |- skos__altLabel mesh__D009075 Pro-Leu-Glyamide
% 222.95/223.17  |- rdf__type mesh__D009075sskos__Concept
% 222.95/223.17  |- skos__altLabel mesh__D009075 Prol-Leu-Gly-NH2
% 222.95/223.17  |- skos__altLabel mesh__D009075
% 222.95/223.17       Melanocyte-Stimulating Hormone Release-Inhibiting Factor
% 222.95/223.17  |- mesh__historyNote mesh__D009075 75   
% 222.95/223.17  |- skos__broader mesh__D009075smesh__D009479
% 222.95/223.17  |- skos__altLabel mesh__D009075 MIF-I
% 222.95/223.17  |- skos__broader mesh__D009075smesh__D010905
% 222.95/223.17  |- skos__scopeNote mesh__D009075
% 222.95/223.17       A hypothalamic tripeptide, enzymatic degradation product of OXYTOCIN, that inhibits the release of MELANOCYTE-STIMULATING HORMONES.%A%    
% 222.95/223.17  |- skos__hiddenLabel mesh__D009075 Prolyl Leucyl Glycinamide
% 222.95/223.17  |- skos__historyNote mesh__D009075 Peptides %28%1971-1973%29%
% 222.95/223.17  |- skos__historyNote mesh__D009075 Oligopeptides %28%1973-1974%29%
% 222.95/223.17  |- skos__altLabel mesh__D009075
% 222.95/223.17       Melanocyte-Stimulating Hormone Release-Inhibiting Hormone
% 222.95/223.17  |- skos__altLabel mesh__D009075 MSH Release-Inhibiting Factor
% 222.95/223.18  |- mesh__dateEstablished mesh__D001092 1991-01-01
% 222.95/223.18  |- skos__broader mesh__D001092smesh__D001091
% 222.95/223.18  |- skos__hiddenLabel mesh__D001092 12-Lipoxygenase, Arachidonate
% 222.95/223.18  |- mesh__dateCreated mesh__D001092 1986-06-16
% 222.95/223.18  |- rdf__type mesh__D001092sskos__Concept
% 222.95/223.18  |- mesh__publicMeSHNote mesh__D001092
% 222.95/223.18       91; was see under ARACHIDONATE LIPOXYGENASES 1987-90   
% 222.95/223.18  |- skos__hiddenLabel mesh__D001092 Arachidonic Acid 12 Lipoxygenase
% 222.95/223.18  |- skos__hiddenLabel mesh__D001092 12-Lipoxygenase, Arachidonic Acid
% 222.95/223.18  |- skos__prefLabel mesh__D001092 Arachidonate 12-Lipoxygenase
% 222.95/223.18  |- mesh__recordOriginator mesh__D001092 RLS
% 222.95/223.18  |- skos__historyNote mesh__D001092 Lipoxygenases %28%1974-1986%29%
% 222.95/223.18  |- mesh__recordMaintainer mesh__D001092 ssb
% 222.95/223.18  |- skos__altLabel mesh__D001092 12-Lipoxygenase
% 222.95/223.18  |- skos__hiddenLabel mesh__D001092 Arachidonate 12 Lipoxygenase
% 222.95/223.18  |- skos__scopeNote mesh__D001092
% 222.95/223.18       An enzyme that catalyzes the oxidation of arachidonic acid to yield 12-hydroperoxyarachidonate %28%12-HPETE%29% which is itself rapidly converted by a peroxidase to 12-hydroxy-5,8,10,14-eicosatetraenoate %28%12-HETE%29%. The 12-hydroperoxides are preferentially formed in platelets. EC 1.13.11.31.%A%    
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D001092 2005
% 222.95/223.18  |- skos__hiddenLabel mesh__D001092 12 Lipoxygenase
% 222.95/223.18  |- skos__historyNote mesh__D001092 Oxygenases %28%1966-1973%29%
% 222.95/223.18  |- mesh__dateRevised mesh__D001092 2004-07-07
% 222.95/223.18  |- mesh__recordAuthorizer mesh__D001092 sjn
% 222.95/223.18  |- skos__altLabel mesh__D001092 Arachidonic Acid 12-Lipoxygenase
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D001092 2006
% 222.95/223.18  |- mesh__historyNote mesh__D001092
% 222.95/223.18       91%28%87%29%; was see under ARACHIDONATE LIPOXYGENASES 1987-90   
% 222.95/223.18  |- skos__altLabel mesh__D017507 Iles Comores
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D017507 2005
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D017507 1998
% 222.95/223.18  |- mesh__dateEstablished mesh__D017507 1993-01-01
% 222.95/223.18  |- mesh__recordMaintainer mesh__D017507 TGC
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D017507 2001
% 222.95/223.18  |- mesh__onlineNote mesh__D017507
% 222.95/223.18       93; use AFRICA, EASTERN to search COMOROS 1987-92   
% 222.95/223.18  |- skos__prefLabel mesh__D017507 Comoros
% 222.95/223.18  |- mesh__recordOriginator mesh__D017507 TGC
% 222.95/223.18  |- skos__historyNote mesh__D017507 Africa, Eastern %28%1983-1992%29%
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D017507 2000
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D017507 2004
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D017507 1997
% 222.95/223.18  |- rdf__type mesh__D017507sskos__Concept
% 222.95/223.18  |- mesh__historyNote mesh__D017507 93; was see AFRICA, EASTERN 1987-92   
% 222.95/223.18  |- skos__altLabel mesh__D017507 Comoro Islands
% 222.95/223.18  |- mesh__dateCreated mesh__D017507 1992-05-20
% 222.95/223.18  |- mesh__recordAuthorizer mesh__D017507 PLS
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D017507 2003
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D017507 1996
% 222.95/223.18  |- skos__broader mesh__D017507smesh__D007195
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D017507 2002
% 222.95/223.18  |- skos__annotation mesh__D017507
% 222.95/223.18       a group of Indian Ocean Islands between Mozambique %26% Madagascar%A%  
% 222.95/223.18  |- mesh__dateRevised mesh__D017507 1995-02-17
% 222.95/223.18  |- skos__scopeNote mesh__D017507
% 222.95/223.18       A group of Indian Ocean Islands, the islands of Great Comoro, Anjouan, Mayotte, and Moheli, lying between northeast Mozambique and northwest Madagascar. The capital is Moroni. In 1914 they became a colony attached to Madagascar administratively and were made a French overseas territory in 1947. Except for Mayotte which remained French, Comoros became an independent republic in 1975. Comoros represents the Arabic qamar, moon, said by some scholars to be linked with the mystical Mountains of the Moon said to be somewhere in equatorial Africa. %28%From Webster%27%s New Geographical Dictionary, 1988, p283 %26% Room, Brewer%27%s Dictionary of Names, 1992, p122%29%%A%    
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D017507 2006
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D017507 1999
% 222.95/223.18  |- mesh__recordMaintainer mesh__D047992 jmp
% 222.95/223.18  |- skos__scopeNote mesh__D047992
% 222.95/223.18       A signal transducing tumor necrosis factor receptor associated factor that is involved in TNF RECEPTOR feedback regulation. It is similar in structure and appears to work in conjunction with TNF RECEPTOR-ASSOCIATED FACTOR 1 to inhibit APOPTOSIS.%A%    
% 222.95/223.18  |- skos__hiddenLabel mesh__D047992 LMP1 Associated Protein 1
% 222.95/223.18  |- mesh__dateCreated mesh__D047992 2004-07-07
% 222.95/223.18  |- skos__altLabel mesh__D047992 TRAF2
% 222.95/223.18  |- skos__historyNote mesh__D047992 Proteins %28%1994-2004%29%
% 222.95/223.18  |- skos__prefLabel mesh__D047992 TNF Receptor-Associated Factor 2
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D047992 2005
% 222.95/223.18  |- mesh__recordOriginator mesh__D047992 jmp
% 222.95/223.18  |- skos__altLabel mesh__D047992 LMP1-Associated Protein 1
% 222.95/223.18  |- mesh__recordAuthorizer mesh__D047992 sjn
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D047992 2006
% 222.95/223.18  |- rdf__type mesh__D047992sskos__Concept
% 222.95/223.18  |- mesh__dateEstablished mesh__D047992 2005-01-01
% 222.95/223.18  |- mesh__historyNote mesh__D047992 2005%28%1994%29%   
% 222.95/223.18  |- mesh__publicMeSHNote mesh__D047992
% 222.95/223.18       2005; TNF RECEPTOR-ASSOCIATED FACTOR 2 was indexed under PROTEINS 1994-2004%A%  
% 222.95/223.18  |- skos__broader mesh__D047992smesh__D047988
% 222.95/223.18  |- skos__hiddenLabel mesh__D047992 TNF Receptor Associated Factor 2
% 222.95/223.18  |- skos__broader mesh__D001808Q000601smesh__D001808
% 222.95/223.18  |- mesh__preferredCombination mesh__D001808Q000601smesh__D014656
% 222.95/223.18  |- rdf__type mesh__D001808Q000601smesh__CompoundConcept
% 222.95/223.18  |- skos__prefLabel mesh__D000798 Angiomatosis
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000798 2003
% 222.95/223.18  |- skos__related mesh__D000798smesh__D013683
% 222.95/223.18  |- skos__annotation mesh__D000798
% 222.95/223.18       non-neoplastic; coord IM with precoord organ/dis term %28%IM%29%%A%  
% 222.95/223.18  |- mesh__dateRevised mesh__D000798 1993-06-03
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000798 2002
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000798 1994
% 222.95/223.18  |- skos__broader mesh__D000798smesh__D014652
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000798 2004
% 222.95/223.18  |- mesh__recordOriginator mesh__D000798 NLM
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000798 1998
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000798 1995
% 222.95/223.18  |- mesh__recordAuthorizer mesh__D000798 PLS
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000798 2000
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000798 1999
% 222.95/223.18  |- skos__hiddenLabel mesh__D000798 Angiomatoses
% 222.95/223.18  |- rdf__type mesh__D000798sskos__Concept
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000798 1996
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000798 2005
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000798 2001
% 222.95/223.18  |- mesh__recordMaintainer mesh__D000798 PLS
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000798 1997
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000798 2006
% 222.95/223.18  |- mesh__dateCreated mesh__D000798 1999-01-01
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D005483 2001
% 222.95/223.18  |- mesh__recordOriginator mesh__D005483 VDK
% 222.95/223.18  |- rdf__type mesh__D005483sskos__Concept
% 222.95/223.18  |- mesh__historyNote mesh__D005483 84   
% 222.95/223.18  |- mesh__recordAuthorizer mesh__D005483 sjn
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D005483 2005
% 222.95/223.18  |- skos__broader mesh__D005483smesh__D012816
% 222.95/223.18  |- skos__annotation mesh__D005483
% 222.95/223.18       note category: do not confuse with BLUSHING %28%F1 %26% F2%29% nor HOT FLASHES in menopause %28%C23%29%%A%  
% 222.95/223.18  |- skos__hiddenLabel mesh__D005483 Flushings
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D005483 2002
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D005483 2006
% 222.95/223.18  |- mesh__recordMaintainer mesh__D005483 KEV
% 222.95/223.18  |- skos__prefLabel mesh__D005483 Flushing
% 222.95/223.18  |- skos__scopeNote mesh__D005483
% 222.95/223.18       A transient reddening of the face that may be due to fever, certain drugs, exertion, stress, or a disease process.%A%    
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D005483 2003
% 222.95/223.18  |- mesh__dateEstablished mesh__D005483 1984-01-01
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D005483 2000
% 222.95/223.18  |- mesh__dateRevised mesh__D005483 1999-11-08
% 222.95/223.18  |- mesh__publicMeSHNote mesh__D005483 84   
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D005483 2004
% 222.95/223.18  |- mesh__dateCreated mesh__D005483 1983-05-31
% 222.95/223.18  |- skos__related mesh__D005483smesh__D001821
% 222.95/223.18  |- skos__broader mesh__D013915smesh__D006474
% 222.95/223.18  |- skos__scopeNote mesh__D013915
% 222.95/223.18       A congenital bleeding disorder with prolonged bleeding time, absence of aggregation of platelets in response to most agents, especially ADP, and impaired or absent clot retraction. Platelet membranes are deficient in or have a defect in the glycoprotein IIb-IIIa complex %28%PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX%29%.%A%    
% 222.95/223.18  |- mesh__publicMeSHNote mesh__D013915
% 222.95/223.18       91; was see under BLOOD PLATELET DISORDERS 1986-90   
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D013915 2004
% 222.95/223.18  |- skos__hiddenLabel mesh__D013915 Thrombasthenia, Glanzmann
% 222.95/223.18  |- mesh__dateCreated mesh__D013915 1985-03-11
% 222.95/223.18  |- mesh__recordMaintainer mesh__D013915 nns
% 222.95/223.18  |- mesh__historyNote mesh__D013915
% 222.95/223.18       91%28%86%29%; was see under BLOOD PLATELET DISORDERS 1986-90   
% 222.95/223.18  |- skos__broader mesh__D013915smesh__D001791
% 222.95/223.18  |- skos__hiddenLabel mesh__D013915 Thrombasthenias
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D013915 2006
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D013915 2003
% 222.95/223.18  |- mesh__recordOriginator mesh__D013915 VDK
% 222.95/223.18  |- skos__historyNote mesh__D013915
% 222.95/223.18       Blood Platelet Disorders %28%1967-1985%29%
% 222.95/223.18  |- rdf__type mesh__D013915sskos__Concept
% 222.95/223.18  |- skos__altLabel mesh__D013915 Glanzmann Thrombasthenia
% 222.95/223.18  |- skos__related mesh__D013915smesh__D019039
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D013915 2002
% 222.95/223.18  |- mesh__dateEstablished mesh__D013915 1991-01-01
% 222.95/223.18  |- skos__prefLabel mesh__D013915 Thrombasthenia
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D013915 2005
% 222.95/223.18  |- mesh__recordAuthorizer mesh__D013915 sjn
% 222.95/223.18  |- mesh__dateRevised mesh__D013915 2001-07-25
% 222.95/223.18  |- skos__broader mesh__D013915smesh__D025861
% 222.95/223.18  |- skos__hiddenLabel mesh__D013117 Compressive Myelopathy
% 222.95/223.18  |- skos__altLabel mesh__D013117 Extramedullary Spinal Cord Compression
% 222.95/223.18  |- rdf__type mesh__D013117sskos__Concept
% 222.95/223.18  |- skos__broader mesh__D013117smesh__D013118
% 222.95/223.18  |- skos__hiddenLabel mesh__D013117 Syndromes, Conus Medullaris
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D013117 2001
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D013117 2004
% 222.95/223.18  |- skos__hiddenLabel mesh__D013117 Spinal Cord Compressions
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D013117 2000
% 222.95/223.18  |- mesh__recordMaintainer mesh__D013117 KEV
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D013117 2003
% 222.95/223.18  |- skos__broader mesh__D013117smesh__D013119
% 222.95/223.18  |- skos__prefLabel mesh__D013117 Spinal Cord Compression
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D013117 2006
% 222.95/223.18  |- mesh__recordAuthorizer mesh__D013117 sjn
% 222.95/223.18  |- skos__altLabel mesh__D013117 Myelopathy, Compressive
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D013117 2002
% 222.95/223.18  |- skos__hiddenLabel mesh__D013117 Compression, Spinal Cord
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D013117 2005
% 222.95/223.18  |- skos__annotation mesh__D013117
% 222.95/223.18       coord IM with specific vertebrae %28%NIM%29% to locate site on spinal cord; not for %22%cauda equina syndrome%22%: use CAUDA EQUINA %28%IM%29% + NERVE COMPRESSION SYNDROMES %28%IM%29%%A%  
% 222.95/223.18  |- skos__scopeNote mesh__D013117
% 222.95/223.18       Acute and chronic conditions characterized by external mechanical compression of the SPINAL CORD due to extramedullary neoplasm; EPIDURAL ABSCESS; SPINAL FRACTURES; bony deformities of the vertebral bodies; and other conditions. Clinical manifestations vary with the anatomic site of the lesion and may include localized pain, weakness, sensory loss, incontinence, and impotence.%A%    
% 222.95/223.18  |- skos__hiddenLabel mesh__D013117 Syndrome, Conus Medullaris
% 222.95/223.18  |- skos__altLabel mesh__D013117 Spinal Cord Compression, Extramedullary
% 222.95/223.18  |- skos__hiddenLabel mesh__D013117 Compressions, Spinal Cord
% 222.95/223.18  |- mesh__dateRevised mesh__D013117 1999-11-03
% 222.95/223.18  |- mesh__recordOriginator mesh__D013117 NLM
% 222.95/223.18  |- mesh__dateCreated mesh__D013117 1999-01-01
% 222.95/223.18  |- skos__hiddenLabel mesh__D013117 Conus Medullaris Syndromes
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D018600 2005
% 222.95/223.18  |- skos__prefLabel mesh__D018600 Teratology
% 222.95/223.18  |- mesh__recordAuthorizer mesh__D018600 sjn
% 222.95/223.18  |- rdf__type mesh__D018600sskos__Concept
% 222.95/223.18  |- mesh__dateEstablished mesh__D018600 1995-01-01
% 222.95/223.18  |- mesh__recordMaintainer mesh__D018600 jls
% 222.95/223.18  |- skos__annotation mesh__D018600
% 222.95/223.18       SPEC: SPEC qualif; corresponding dis term is ABNORMALITIES; consider also MONSTERS; DF: TERATOL%A%  
% 222.95/223.18  |- mesh__recordOriginator mesh__D018600 TGC
% 222.95/223.18  |- mesh__dateRevised mesh__D018600 2001-07-25
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D018600 2002
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D018600 2004
% 222.95/223.18  |- skos__hiddenLabel mesh__D018600 Teratologies
% 222.95/223.18  |- mesh__historyNote mesh__D018600 95   
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D018600 2006
% 222.95/223.18  |- mesh__dateCreated mesh__D018600 1994-04-19
% 222.95/223.18  |- mesh__publicMeSHNote mesh__D018600 95   
% 222.95/223.18  |- skos__scopeNote mesh__D018600
% 222.95/223.18       That division of embryology which deals with abnormal development and congenital malformations. %28%From Dorland, 27th ed%29%%A%    
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D018600 2003
% 222.95/223.18  |- skos__broader mesh__D018600smesh__D004626
% 222.95/223.18  |- skos__broader mesh__D051236smesh__D043562
% 222.95/223.18  |- skos__hiddenLabel mesh__D051236
% 222.95/223.18       Pituitary Adenylate Cyclase Activating Peptide Receptor
% 222.95/223.18  |- mesh__publicMeSHNote mesh__D051236
% 222.95/223.18       2006; PACAP RECEPTORS was indexed under RECEPTORS, CELL SURFACE 2005, RECEPTORS, PITUITARY HORMONE 1990-2005, %26% under RECEPTORS, ENDOGENOUS SUBSTANCES 1990-1993%A%  
% 222.95/223.18  |- skos__prefLabel mesh__D051236
% 222.95/223.18       Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide
% 222.95/223.18  |- mesh__recordOriginator mesh__D051236 DRC
% 222.95/223.18  |- skos__altLabel mesh__D051236 PACAP Receptors
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D051236 2006
% 222.95/223.18  |- mesh__dateCreated mesh__D051236 2005-06-30
% 222.95/223.18  |- skos__altLabel mesh__D051236 Receptor, PACAP
% 222.95/223.18  |- skos__altLabel mesh__D051236
% 222.95/223.18       Pituitary Adenylate Cyclase-Activating Peptide Receptor
% 222.95/223.18  |- skos__hiddenLabel mesh__D051236
% 222.95/223.18       Pituitary Adenylate Cyclase Activating Peptide Receptors
% 222.95/223.18  |- mesh__historyNote mesh__D051236 2006%28%1990%29%   
% 222.95/223.18  |- skos__scopeNote mesh__D051236
% 222.95/223.18       A family of G-protein-coupled receptors that share significant homology with GLUCAGON RECEPTORS. They bind PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE with high affinity and trigger intracellular changes that influence the behavior of CELLS.%A%    
% 222.95/223.18  |- skos__hiddenLabel mesh__D051236
% 222.95/223.18       Receptors, Pituitary Adenylate Cyclase Activating Polypeptide
% 222.95/223.18  |- skos__altLabel mesh__D051236
% 222.95/223.18       Pituitary Adenylate Cyclase-Activating Peptide Receptors
% 222.95/223.18  |- mesh__dateEstablished mesh__D051236 2006-01-01
% 222.95/223.18  |- mesh__recordAuthorizer mesh__D051236 sjn
% 222.95/223.18  |- rdf__type mesh__D051236sskos__Concept
% 222.95/223.18  |- skos__hiddenLabel mesh__D051236 Receptors, PACAP
% 222.95/223.18  |- mesh__recordMaintainer mesh__D051236 DRC
% 222.95/223.18  |- skos__altLabel mesh__D051236 PACAP Receptor
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D009874 2005
% 222.95/223.18  |- skos__hiddenLabel mesh__D009874 Research, Operations
% 222.95/223.18  |- skos__prefLabel mesh__D009874 Operations Research
% 222.95/223.18  |- skos__related mesh__D009874smesh__D003662
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D009874 2006
% 222.95/223.18  |- mesh__publicMeSHNote mesh__D009874 66   
% 222.95/223.18  |- mesh__recordMaintainer mesh__D009874 lkt
% 222.95/223.18  |- skos__scopeNote mesh__D009874
% 222.95/223.18       A group of techniques developed to apply scientific methods and tools to solve the problems of DECISION MAKING in complex organizations and systems. Operations research searches for optimal solutions in situations of conflicting GOALS and makes use of mathematical models from which solutions for actual problems may be derived. %28%From Psychiatric Dictionary, 6th ed%29%%A%    
% 222.95/223.18  |- skos__annotation mesh__D009874 no qualif   
% 222.95/223.18  |- skos__related mesh__D009874smesh__D007257
% 222.95/223.18  |- mesh__dateRevised mesh__D009874 2003-07-09
% 222.95/223.18  |- mesh__historyNote mesh__D009874 66   
% 222.95/223.18  |- mesh__dateEstablished mesh__D009874 1966-01-01
% 222.95/223.18  |- mesh__recordAuthorizer mesh__D009874 sjn
% 222.95/223.18  |- mesh__recordOriginator mesh__D009874 NLM
% 222.95/223.18  |- mesh__dateCreated mesh__D009874 1999-01-01
% 222.95/223.18  |- rdf__type mesh__D009874sskos__Concept
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D009874 2004
% 222.95/223.18  |- skos__related mesh__D009874smesh__D005716
% 222.95/223.18  |- skos__broader mesh__D009874smesh__D013597
% 222.95/223.18  |- skos__broader mesh__D001891smesh__D028981
% 222.95/223.18  |- skos__prefLabel mesh__D001891 Borna disease virus
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D001891 2006
% 222.95/223.18  |- rdf__type mesh__D001891sskos__Concept
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D001891 2006A
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D001891 2002
% 222.95/223.18  |- skos__altLabel mesh__D001891 Near East Equine Encephalomyelitis Virus
% 222.95/223.18  |- mesh__dateCreated mesh__D001891 1974-12-12
% 222.95/223.18  |- skos__scopeNote mesh__D001891
% 222.95/223.18       A species in the genus Bornavirus, family BORNAVIRIDAE, causing a rare and usually fatal encephalitic disease in horses and other domestic animals and possibly deer. Its name derives from the city in Saxony where the condition was first described in 1894, but the disease occurs in Europe, N. Africa, and the Near East.%A%    
% 222.95/223.18  |- skos__altLabel mesh__D001891 Encephalomyelitis Virus, Enzootic
% 222.95/223.18  |- mesh__recordOriginator mesh__D001891 NLM
% 222.95/223.18  |- mesh__publicMeSHNote mesh__D001891
% 222.95/223.18       91; was see under VERTEBRATE VIRUSES, UNCLASSIFIED 1981-90; was see under ENCEPHALITIS VIRUSES 1977-80; was see under ARBOVIRUSES 1975-76%A%  
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D001891 2003
% 222.95/223.18  |- mesh__historyNote mesh__D001891
% 222.95/223.18       91%28%75%29%; was see under VERTEBRATE VIRUSES, UNCLASSIFIED 1981-90; was see under ENCEPHALITIS VIRUSES 1977-80; was see under ARBOVIRUSES 1975-76%A%  
% 222.95/223.18  |- mesh__recordAuthorizer mesh__D001891 ags
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D001891 2004
% 222.95/223.18  |- mesh__dateEstablished mesh__D001891 1991-01-01
% 222.95/223.18  |- mesh__recordMaintainer mesh__D001891 ags
% 222.95/223.18  |- skos__annotation mesh__D001891
% 222.95/223.18       infection = BORNA DISEASE; DF: BORNA DIS VIRUS   
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D001891 2005
% 222.95/223.18  |- skos__altLabel mesh__D001891 Enzootic Encephalomyelitis Virus
% 222.95/223.18  |- mesh__dateRevised mesh__D001891 2005-07-08
% 222.95/223.18  |- skos__hiddenLabel mesh__D009076
% 222.95/223.18       Melanocyte Stimulating Hormone Releasing Hormone
% 222.95/223.18  |- skos__historyNote mesh__D009076
% 222.95/223.18       Pituitary Hormone Releasing Hormones %28%1968-1974%29%
% 222.95/223.18  |- skos__scopeNote mesh__D009076
% 222.95/223.18       A peptide hormone which originates in the HYPOTHALAMUS and stimulates secretion of MELANOCYTE-STIMULATING HORMONES in the PITUITARY GLAND.%A%    
% 222.95/223.18  |- skos__altLabel mesh__D009076
% 222.95/223.18       Melanocyte-Stimulating Hormone Releasing Hormone
% 222.95/223.18  |- rdf__type mesh__D009076sskos__Concept
% 222.95/223.18  |- skos__broader mesh__D009076smesh__D009479
% 222.95/223.18  |- mesh__historyNote mesh__D009076 92; was MSH RELEASING HORMONE 1975-91   
% 222.95/223.18  |- skos__hiddenLabel mesh__D009076 Hormone, MSH-Releasing
% 222.95/223.18  |- skos__prefLabel mesh__D009076 MSH-Releasing Hormone
% 222.95/223.18  |- skos__broader mesh__D009076smesh__D010906
% 222.95/223.18  |- skos__historyNote mesh__D009076
% 222.95/223.18       MSH/antagonists %26% inhibitors %28%1968-1974%29%
% 222.95/223.18  |- mesh__onlineNote mesh__D009076
% 222.95/223.18       use MSH-RELEASING HORMONE to search MSH RELEASING HORMONE 1975-91%A%  
% 222.95/223.18  |- skos__hiddenLabel mesh__D009076 MSH Releasing Hormone
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D009076 2006A
% 222.95/223.18  |- mesh__recordOriginator mesh__D009076 NLM
% 222.95/223.18  |- mesh__dateCreated mesh__D009076 1974-11-11
% 222.95/223.18  |- mesh__recordAuthorizer mesh__D009076 ags
% 222.95/223.18  |- mesh__publicMeSHNote mesh__D009076
% 222.95/223.18       92; was MSH RELEASING HORMONE 1975-91   
% 222.95/223.18  |- skos__annotation mesh__D009076 DF: MSHRH   
% 222.95/223.18  |- mesh__dateEstablished mesh__D009076 1975-09-01
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D009076 2006
% 222.95/223.18  |- mesh__recordMaintainer mesh__D009076 ags
% 222.95/223.18  |- mesh__dateRevised mesh__D009076 2005-07-19
% 222.95/223.18  |- skos__broader mesh__D009076smesh__D036361
% 222.95/223.18  |- skos__hiddenLabel mesh__D001093 15-Lipoxygenase, Arachidonate
% 222.95/223.18  |- skos__historyNote mesh__D001093 Oxygenases %28%1966-1973%29%
% 222.95/223.18  |- skos__altLabel mesh__D001093 Arachidonic Acid 15-Lipoxygenase
% 222.95/223.18  |- mesh__recordAuthorizer mesh__D001093 sjn
% 222.95/223.18  |- skos__scopeNote mesh__D001093
% 222.95/223.18       An enzyme that catalyzes the oxidation of arachidonic acid to yield 15-hydroperoxyarachidonate %28%15-HPETE%29% which is rapidly converted to 15-hydroxy-5,8,11,13-eicosatetraenoate %28%15-HETE%29%. The 15-hydroperoxides are preferentially formed in neutrophils and lymphocytes. EC 1.13.11.33.%A%    
% 222.95/223.18  |- skos__broader mesh__D001093smesh__D001091
% 222.95/223.18  |- skos__prefLabel mesh__D001093 Arachidonate 15-Lipoxygenase
% 222.95/223.18  |- skos__altLabel mesh__D001093 15-Lipoxygenase
% 222.95/223.18  |- mesh__publicMeSHNote mesh__D001093
% 222.95/223.18       91; was see under ARACHIDONATE LIPOXYGENASES 1987-90   
% 222.95/223.18  |- skos__hiddenLabel mesh__D001093 15 Lipoxygenase
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D001093 2005
% 222.95/223.18  |- skos__hiddenLabel mesh__D001093 Arachidonate 15 Lipoxygenase
% 222.95/223.18  |- skos__hiddenLabel mesh__D001093 Arachidonic Acid 15 Lipoxygenase
% 222.95/223.18  |- mesh__recordOriginator mesh__D001093 RLS
% 222.95/223.18  |- mesh__dateRevised mesh__D001093 2004-07-07
% 222.95/223.18  |- skos__hiddenLabel mesh__D001093 15-Lipoxygenase, Arachidonic Acid
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D001093 2006
% 222.95/223.18  |- skos__historyNote mesh__D001093 Lipoxygenases %28%1974-1986%29%
% 222.95/223.18  |- mesh__recordMaintainer mesh__D001093 ssb
% 222.95/223.18  |- mesh__historyNote mesh__D001093
% 222.95/223.18       91%28%87%29%; was see under ARACHIDONATE LIPOXYGENASES 1987-90   
% 222.95/223.18  |- mesh__dateEstablished mesh__D001093 1991-01-01
% 222.95/223.18  |- mesh__dateCreated mesh__D001093 1986-06-16
% 222.95/223.18  |- rdf__type mesh__D001093sskos__Concept
% 222.95/223.18  |- skos__broader mesh__D017508smesh__D007195
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D017508 2002
% 222.95/223.18  |- skos__scopeNote mesh__D017508
% 222.95/223.18       One of the Indian Ocean Islands, east of Madagascar. Its capital is Saint-Denis. It was discovered in 1507 by the Portuguese and claimed by France in 1638. It was first colonized in 1662 as Isle de Bourbon but renamed Reunion in 1793. In 1946 it was made an overseas department of France. The name commemorates the reunion of the revolutionaries from Marseilles with the National Guard in Paris in 1792. %28%From Webster%27%s New Geographical Dictionary, 1988, p1011; Room, Brewer%27%s Dictionary of Names, 1992, p454; French Embassy%29%%A%    
% 222.95/223.18  |- mesh__recordAuthorizer mesh__D017508 sjn
% 222.95/223.18  |- mesh__onlineNote mesh__D017508
% 222.95/223.18       use INDIAN OCEAN ISLANDS to search REUNION 1987-92   
% 222.95/223.18  |- mesh__recordMaintainer mesh__D017508 jls
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D017508 2004
% 222.95/223.18  |- skos__historyNote mesh__D017508 Indian Ocean Islands %28%1983-1992%29%
% 222.95/223.18  |- rdf__type mesh__D017508sskos__Concept
% 222.95/223.18  |- skos__prefLabel mesh__D017508 Reunion
% 222.95/223.18  |- mesh__dateEstablished mesh__D017508 1993-01-01
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D017508 2003
% 222.95/223.18  |- mesh__dateRevised mesh__D017508 2001-08-13
% 222.95/223.18  |- mesh__historyNote mesh__D017508
% 222.95/223.18       93; was see INDIAN OCEAN ISLANDS 1987-92   
% 222.95/223.18  |- mesh__recordOriginator mesh__D017508 TGC
% 222.95/223.18  |- mesh__dateCreated mesh__D017508 1992-05-22
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D017508 2006
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D017508 2005
% 222.95/223.18  |- skos__annotation mesh__D017508
% 222.95/223.18       one of the Indian Ocean Islands east of Madagascar; in translations use accent: R%C3%%A9%union%A%  
% 222.95/223.18  |- mesh__dateCreated mesh__D014210 1999-01-01
% 222.95/223.18  |- mesh__dateRevised mesh__D014210 2005-06-30
% 222.95/223.18  |- mesh__recordMaintainer mesh__D014210 SYSTEM
% 222.95/223.18  |- mesh__recordOriginator mesh__D014210 NLM
% 222.95/223.18  |- skos__prefLabel mesh__D014210 Treponema pallidum
% 222.95/223.18  |- rdf__type mesh__D014210sskos__Concept
% 222.95/223.18  |- mesh__recordAuthorizer mesh__D014210 sjn
% 222.95/223.18  |- skos__scopeNote mesh__D014210
% 222.95/223.18       The causative agent of venereal and non-venereal syphilis as well as yaws.%A%    
% 222.95/223.18  |- skos__annotation mesh__D014210 infection = SYPHILIS or YAWS   
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D014210 2006
% 222.95/223.18  |- skos__broader mesh__D014210smesh__D014208
% 222.95/223.18  |- skos__broader mesh__D000799smesh__D014652
% 222.95/223.18  |- skos__hiddenLabel mesh__D000799 Edemas, Angioneurotic
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000799 2004
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000799 1998
% 222.95/223.18  |- skos__hiddenLabel mesh__D000799 Angioedemas
% 222.95/223.18  |- skos__hiddenLabel mesh__D000799 Urticarias, Giant
% 222.95/223.18  |- skos__scopeNote mesh__D000799
% 222.95/223.18       Recurring attacks of transient edema suddenly appearing in areas of the skin or mucous membranes and occasionally of the viscera, often associated with dermatographism, urticaria, erythema, and purpura.%A%    
% 222.95/223.18  |- mesh__recordMaintainer mesh__D000799 TPW
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000799 1999
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000799 2002
% 222.95/223.18  |- mesh__recordOriginator mesh__D000799 NLM
% 222.95/223.18  |- rdf__type mesh__D000799sskos__Concept
% 222.95/223.18  |- skos__hiddenLabel mesh__D000799 Giant Urticaria
% 222.95/223.18  |- mesh__dateRevised mesh__D000799 1997-06-20
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000799 2005
% 222.95/223.18  |- skos__altLabel mesh__D000799 Quincke%27%s Edema
% 222.95/223.18  |- skos__hiddenLabel mesh__D000799 Quincke Edema
% 222.95/223.18  |- skos__hiddenLabel mesh__D000799 Quinckes Edema
% 222.95/223.18  |- skos__altLabel mesh__D000799 Urticaria, Giant
% 222.95/223.18  |- skos__annotation mesh__D000799 a vasc dis, a form of urticaria   
% 222.95/223.18  |- mesh__recordAuthorizer mesh__D000799 SJN
% 222.95/223.18  |- skos__hiddenLabel mesh__D000799 Edema, Quincke%27%s
% 222.95/223.18  |- skos__hiddenLabel mesh__D000799 Giant Urticarias
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000799 2006
% 222.95/223.18  |- skos__prefLabel mesh__D000799 Angioneurotic Edema
% 222.95/223.18  |- mesh__dateCreated mesh__D000799 1999-01-01
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000799 2000
% 222.95/223.18  |- skos__hiddenLabel mesh__D000799 Angioneurotic Edemas
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000799 2003
% 222.95/223.18  |- skos__altLabel mesh__D000799 Angioedema
% 222.95/223.18  |- skos__broader mesh__D000799smesh__D014581
% 222.95/223.18  |- skos__hiddenLabel mesh__D000799 Edema, Angioneurotic
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D000799 2001
% 222.95/223.18  |- mesh__dateRevised mesh__D005484 2005-06-30
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D005484 2006
% 222.95/223.18  |- skos__altLabel mesh__D005484 Redeptin
% 222.95/223.18  |- mesh__recordOriginator mesh__D005484 NLM
% 222.95/223.18  |- skos__prefLabel mesh__D005484 Fluspirilene
% 222.95/223.18  |- skos__broader mesh__D005484smesh__D010880
% 222.95/223.18  |- skos__broader mesh__D005484smesh__D013141
% 222.95/223.18  |- mesh__historyNote mesh__D005484
% 222.95/223.18       91%28%75%29%; was see under SPIRO COMPOUNDS 1975-90   
% 222.95/223.18  |- skos__historyNote mesh__D005484 Fluorobenzenes %28%1974%29%
% 222.95/223.18  |- skos__altLabel mesh__D005484 Hormosan Brand of Fluspirilene
% 222.95/223.18  |- skos__altLabel mesh__D005484 Lindopharm Brand of Fluspirilene
% 222.95/223.18  |- mesh__dateEstablished mesh__D005484 1991-01-01
% 222.95/223.18  |- skos__broader mesh__D005484smesh__D007093
% 222.95/223.18  |- skos__historyNote mesh__D005484 Piperidines %28%1972-1974%29%
% 222.95/223.18  |- mesh__dateCreated mesh__D005484 1974-11-19
% 222.95/223.18  |- mesh__recordMaintainer mesh__D005484 ssb
% 222.95/223.18  |- skos__historyNote mesh__D005484 Spiro Compounds %28%1969-1974%29%
% 222.95/223.18  |- mesh__recordAuthorizer mesh__D005484 sjn
% 222.95/223.18  |- rdf__type mesh__D005484sskos__Concept
% 222.95/223.18  |- skos__scopeNote mesh__D005484
% 222.95/223.18       A long-acting injectable antipsychotic agent used for chronic schizophrenia.%A%    
% 222.95/223.18  |- skos__altLabel mesh__D005484 Spirodiflamine
% 222.95/223.18  |- skos__altLabel mesh__D005484 Janssen Brand of Fluspirilene
% 222.95/223.18  |- skos__altLabel mesh__D005484 betapharm Brand of Fluspirilene
% 222.95/223.18  |- mesh__publicMeSHNote mesh__D005484
% 222.95/223.18       91; was see under SPIRO COMPOUNDS 1975-90   
% 222.95/223.18  |- skos__altLabel mesh__D005484 Hexal Brand of Fluspirilene
% 222.95/223.18  |- skos__prefLabel mesh__D013916 Thrombelastography
% 222.95/223.18  |- mesh__activeMeSHYear mesh__D013916 2004
% 222.95/223.19  |- skos__scopeNote mesh__D013916
% 222.95/223.19       Use of a thrombelastograph, which provides a continuous graphic record of the physical shape of a clot during fibrin formation and subsequent lysis.%A%    
% 222.95/223.19  |- skos__annotation mesh__D013916
% 222.95/223.19       records the physical shape of a blood clot; /drug eff /rad eff permitted; do not use /util except by MeSH definition%A%  
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D013916 2000
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D013916 2006
% 222.95/223.19  |- mesh__dateRevised mesh__D013916 1997-06-20
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D013916 2003
% 222.95/223.19  |- skos__hiddenLabel mesh__D013916 Thromboelastographies
% 222.95/223.19  |- skos__altLabel mesh__D013916 Thromboelastography
% 222.95/223.19  |- mesh__recordOriginator mesh__D013916 NLM
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D013916 2005
% 222.95/223.19  |- rdf__type mesh__D013916sskos__Concept
% 222.95/223.19  |- skos__broader mesh__D013916smesh__D001780
% 222.95/223.19  |- mesh__recordMaintainer mesh__D013916 PXP
% 222.95/223.19  |- mesh__recordAuthorizer mesh__D013916 SJN
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D013916 2002
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D013916 1999
% 222.95/223.19  |- skos__hiddenLabel mesh__D013916 Thrombelastographies
% 222.95/223.19  |- mesh__dateCreated mesh__D013916 1999-01-01
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D013916 2001
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D013916 1998
% 222.95/223.19  |- skos__broader mesh__D013118smesh__D002493
% 222.95/223.19  |- mesh__recordOriginator mesh__D013118 NLM
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D013118 2003
% 222.95/223.19  |- mesh__publicMeSHNote mesh__D013118 1966   
% 222.95/223.19  |- skos__altLabel mesh__D013118 Myelopathy
% 222.95/223.19  |- skos__altLabel mesh__D013118 Spinal Cord Disorders
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D013118 2001
% 222.95/223.19  |- mesh__recordAuthorizer mesh__D013118 ags
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D013118 2006
% 222.95/223.19  |- skos__scopeNote mesh__D013118
% 222.95/223.19       Pathologic conditions which feature SPINAL CORD damage or dysfunction, including disorders involving the meninges and perimeningeal spaces surrounding the spinal cord. Traumatic injuries, vascular diseases, infections, and inflammatory/autoimmune processes may affect the spinal cord.%A%    
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D013118 2000
% 222.95/223.19  |- skos__hiddenLabel mesh__D013118 Spinal Cord Disease
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D013118 2005
% 222.95/223.19  |- mesh__recordMaintainer mesh__D013118 ags
% 222.95/223.19  |- mesh__dateCreated mesh__D013118 1999-01-01
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D013118 2000A
% 222.95/223.19  |- mesh__dateRevised mesh__D013118 1999-12-08
% 222.95/223.19  |- mesh__historyNote mesh__D013118 1966   
% 222.95/223.19  |- mesh__dateEstablished mesh__D013118 1966-01-01
% 222.95/223.19  |- rdf__type mesh__D013118sskos__Concept
% 222.95/223.19  |- skos__hiddenLabel mesh__D013118 Spinal Cord Disorder
% 222.95/223.19  |- skos__hiddenLabel mesh__D013118 Myelopathies
% 222.95/223.19  |- skos__annotation mesh__D013118
% 222.95/223.19       coord IM with specific vertebrae %28%NIM%29% to locate site on spinal cord; inflamm dis of spinal cord= MYELITIS%A%  
% 222.95/223.19  |- skos__prefLabel mesh__D013118 Spinal Cord Diseases
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D013118 2002
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D013118 2004
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D018601 2002
% 222.95/223.19  |- skos__historyNote mesh__D018601
% 222.95/223.19       Tuberculosis, Lymph Node %28%1966-1994%29%
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D018601 2001
% 222.95/223.19  |- skos__broader mesh__D018601smesh__D014388
% 222.95/223.19  |- mesh__publicMeSHNote mesh__D018601 95   
% 222.95/223.19  |- skos__prefLabel mesh__D018601 King%27%s Evil
% 222.95/223.19  |- skos__hiddenLabel mesh__D018601 Evil, King%27%s
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D018601 2004
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D018601 2000
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D018601 1997
% 222.95/223.19  |- mesh__historyNote mesh__D018601 95   
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D018601 2006
% 222.95/223.19  |- skos__scopeNote mesh__D018601
% 222.95/223.19       The historic designation for scrofula %28%TUBERCULOSIS, LYMPH NODE%29%. The disease is so called from the belief that it could be healed by the touch of a king. This term is used only for historical articles using the name %22%king%27%s evil%22%, and is to be differentiated from scrofula as lymph node tuberculosis in modern clinical medicine. %28%From Webster, 3d ed%29%%A%    
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D018601 1999
% 222.95/223.19  |- mesh__dateCreated mesh__D018601 1994-04-19
% 222.95/223.19  |- skos__hiddenLabel mesh__D018601 Kings Evil
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D018601 2003
% 222.95/223.19  |- mesh__dateEstablished mesh__D018601 1995-01-01
% 222.95/223.19  |- skos__annotation mesh__D018601
% 222.95/223.19       = scrofula in hist articles only: differentiate from SCROFULA see TUBERCULOSIS, LYMPH NODE which is restricted to scrofula in modern clin med%A%  
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D018601 1996
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D018601 1995
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D018601 2005
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D018601 1998
% 222.95/223.19  |- rdf__type mesh__D018601sskos__Concept
% 222.95/223.19  |- skos__broader mesh__D005123Q000601smesh__D005123
% 222.95/223.19  |- mesh__preferredCombination mesh__D005123Q000601smesh__D013508
% 222.95/223.19  |- rdf__type mesh__D005123Q000601smesh__CompoundConcept
% 222.95/223.19  |- skos__broader mesh__D051237smesh__D051236
% 222.95/223.19  |- mesh__recordMaintainer mesh__D051237 DRC
% 222.95/223.19  |- mesh__recordOriginator mesh__D051237 DRC
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D051237 2006
% 222.95/223.19  |- skos__altLabel mesh__D051237
% 222.95/223.19       Pituitary Adenylate Cyclase-Activating Peptide Receptor Type I
% 222.95/223.19  |- skos__hiddenLabel mesh__D051237
% 222.95/223.19       Pituitary Adenylate Cyclase Activating Peptide Receptor Type I
% 222.95/223.19  |- skos__altLabel mesh__D051237 PACAPR-1 Protein
% 222.95/223.19  |- rdf__type mesh__D051237sskos__Concept
% 222.95/223.19  |- mesh__publicMeSHNote mesh__D051237
% 222.95/223.19       2006 PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE RECEPTOR TYPE I was indexed under RECEPTORS, CELL SURFACE 2005, %26% under RECEPTORS, PITUITARY HORMONE 1999-2005%A%  
% 222.95/223.19  |- skos__hiddenLabel mesh__D051237 PACAPR 1 Protein
% 222.95/223.19  |- skos__altLabel mesh__D051237 PAC1 Receptor
% 222.95/223.19  |- skos__altLabel mesh__D051237 PACAP Receptors, Type I
% 222.95/223.19  |- skos__prefLabel mesh__D051237
% 222.95/223.19       Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
% 222.95/223.19  |- mesh__dateCreated mesh__D051237 2005-06-30
% 222.95/223.19  |- skos__altLabel mesh__D051237 PACAP Type I Receptor
% 222.95/223.19  |- mesh__historyNote mesh__D051237 2006%28%1999%29%   
% 222.95/223.19  |- skos__scopeNote mesh__D051237
% 222.95/223.19       A pituitary adenylate cyclase-activating peptide receptor subtype that is found in the HYPOTHALAMUS; BRAIN STEM; PITUITARY GLAND; ADRENAL GLAND; PANCREAS; and TESTES and has a high affinity only for PACAP.%A%    
% 222.95/223.19  |- mesh__dateEstablished mesh__D051237 2006-01-01
% 222.95/223.19  |- mesh__recordAuthorizer mesh__D051237 sjn
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D009875 2006
% 222.95/223.19  |- skos__hiddenLabel mesh__D009875 Operators %28%Genetics%29%
% 222.95/223.19  |- skos__historyNote mesh__D009875 Operon %28%1969-1985%29%
% 222.95/223.19  |- mesh__historyNote mesh__D009875
% 222.95/223.19       86; OPERATOR %28%GENETICS%29% was see OPERON 1980-85   
% 222.95/223.19  |- skos__hiddenLabel mesh__D009875 Region, Operator %28%Genetics%29%
% 222.95/223.19  |- skos__annotation mesh__D009875 DF: OPERATOR REGIONS   
% 222.95/223.19  |- skos__hiddenLabel mesh__D009875 Region, Operator
% 222.95/223.19  |- skos__altLabel mesh__D009875 Operator Region
% 222.95/223.19  |- skos__hiddenLabel mesh__D009875 Regions, Operator
% 222.95/223.19  |- mesh__dateRevised mesh__D009875 2005-06-30
% 222.95/223.19  |- skos__historyNote mesh__D009875 Genes, Regulator %28%1968-1985%29%
% 222.95/223.19  |- mesh__dateCreated mesh__D009875 1985-02-26
% 222.95/223.19  |- skos__prefLabel mesh__D009875 Operator Regions %28%Genetics%29%
% 222.95/223.19  |- skos__broader mesh__D009875smesh__D009876
% 222.95/223.19  |- mesh__onlineNote mesh__D009875
% 222.95/223.19       use OPERON to search OPERATOR %28%GENETICS%29% 1980-85   
% 222.95/223.19  |- rdf__type mesh__D009875sskos__Concept
% 222.95/223.19  |- mesh__recordOriginator mesh__D009875 AEP
% 222.95/223.19  |- mesh__publicMeSHNote mesh__D009875
% 222.95/223.19       86; OPERATOR %28%GENETICS%29% was see OPERON 1980-85   
% 222.95/223.19  |- mesh__recordMaintainer mesh__D009875 nns
% 222.95/223.19  |- skos__scopeNote mesh__D009875
% 222.95/223.19       The regulatory elements of an OPERON to which activators or repressors bind thereby effecting the transcription of GENES in the operon.%A%    
% 222.95/223.19  |- skos__broader mesh__D009875smesh__D012045
% 222.95/223.19  |- skos__hiddenLabel mesh__D009875 Regions, Operator %28%Genetics%29%
% 222.95/223.19  |- skos__altLabel mesh__D009875 Operator Regions
% 222.95/223.19  |- mesh__dateEstablished mesh__D009875 1986-01-01
% 222.95/223.19  |- mesh__recordAuthorizer mesh__D009875 sjn
% 222.95/223.19  |- skos__hiddenLabel mesh__D009875 Operator Region %28%Genetics%29%
% 222.95/223.19  |- mesh__dateEstablished mesh__D001892 1974-01-01
% 222.95/223.19  |- skos__prefLabel mesh__D001892 Bornanes
% 222.95/223.19  |- mesh__recordAuthorizer mesh__D001892 sjn
% 222.95/223.19  |- mesh__historyNote mesh__D001892 74%28%72%29%   
% 222.95/223.19  |- mesh__publicMeSHNote mesh__D001892 74   
% 222.95/223.19  |- skos__altLabel mesh__D001892 Camphanes
% 222.95/223.19  |- skos__historyNote mesh__D001892 Bridged Compounds %28%1966-1970%29%
% 222.95/223.19  |- skos__broader mesh__D001892smesh__D009636
% 222.95/223.19  |- mesh__recordMaintainer mesh__D001892 ssb
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D001892 2004
% 222.95/223.19  |- skos__annotation mesh__D001892
% 222.95/223.19       do not confuse with BORANES; includes bornenes   
% 222.95/223.19  |- mesh__dateCreated mesh__D001892 1999-01-01
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D001892 2005
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D001892 2006
% 222.95/223.19  |- mesh__dateRevised mesh__D001892 2003-07-09
% 222.95/223.19  |- skos__historyNote mesh__D001892 Terpenes %28%1970-1971%29%
% 222.95/223.19  |- rdf__type mesh__D001892sskos__Concept
% 222.95/223.19  |- skos__historyNote mesh__D001892 Camphor %28%1966-1970%29%
% 222.95/223.19  |- mesh__recordOriginator mesh__D001892 NLM
% 222.95/223.19  |- mesh__recordMaintainer mesh__D009077 jmp
% 222.95/223.19  |- rdf__type mesh__D009077sskos__Concept
% 222.95/223.19  |- mesh__historyNote mesh__D009077 79; was MUCIN 1963-78   
% 222.95/223.19  |- skos__scopeNote mesh__D009077
% 222.95/223.19       High molecular weight mucoproteins that form a protective biofilm on the surface of EPITHELIAL CELLS where they provide a barrier to particulate matter and microorganisms. Membrane-anchored mucins may have additional roles concerned with protein interactions at the cell surface.%A%    
% 222.95/223.19  |- mesh__dateCreated mesh__D009077 1999-01-01
% 222.95/223.19  |- skos__prefLabel mesh__D009077 Mucins
% 222.95/223.19  |- mesh__dateRevised mesh__D009077 2005-06-30
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D009077 2006
% 222.95/223.19  |- mesh__publicMeSHNote mesh__D009077 79; was MUCIN 1963-78   
% 222.95/223.19  |- skos__altLabel mesh__D009077 Mucin
% 222.95/223.19  |- mesh__onlineNote mesh__D009077 use MUCINS to search MUCIN 1966-78   
% 222.95/223.19  |- mesh__recordOriginator mesh__D009077 NLM
% 222.95/223.19  |- skos__broader mesh__D009077smesh__D009088
% 222.95/223.19  |- mesh__recordAuthorizer mesh__D009077 sjn
% 222.95/223.19  |- skos__historyNote mesh__D001094 Oxygenases %28%1966-1973%29%
% 222.95/223.19  |- mesh__dateRevised mesh__D001094 2004-07-07
% 222.95/223.19  |- rdf__type mesh__D001094sskos__Concept
% 222.95/223.19  |- skos__hiddenLabel mesh__D001094 5-Lipoxygenase, Arachidonic Acid
% 222.95/223.19  |- skos__hiddenLabel mesh__D001094 Synthetase, Leukotriene A4
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D001094 2005
% 222.95/223.19  |- skos__prefLabel mesh__D001094 Arachidonate 5-Lipoxygenase
% 222.95/223.19  |- skos__broader mesh__D001094smesh__D001091
% 222.95/223.19  |- skos__hiddenLabel mesh__D001094 Synthase, Leukotriene A
% 222.95/223.19  |- skos__altLabel mesh__D001094 Leukotriene A4 Synthetase
% 222.95/223.19  |- skos__annotation mesh__D001094 /antag permitted   
% 222.95/223.19  |- mesh__dateEstablished mesh__D001094 1991-01-01
% 222.95/223.19  |- skos__hiddenLabel mesh__D001094 5-Lipoxygenase, Arachidonate
% 222.95/223.19  |- mesh__historyNote mesh__D001094
% 222.95/223.19       91%28%87%29%; was see under ARACHIDONATE LIPOXYGENASES 1987-90   
% 222.95/223.19  |- mesh__recordOriginator mesh__D001094 RLS
% 222.95/223.19  |- skos__hiddenLabel mesh__D001094 Synthase, LTA4
% 222.95/223.19  |- skos__altLabel mesh__D001094 Leukotriene A4 Synthase
% 222.95/223.19  |- mesh__recordAuthorizer mesh__D001094 sjn
% 222.95/223.19  |- mesh__dateCreated mesh__D001094 1986-06-16
% 222.95/223.19  |- skos__altLabel mesh__D001094 Leukotriene A Synthase
% 222.95/223.19  |- skos__hiddenLabel mesh__D001094 Arachidonate 5 Lipoxygenase
% 222.95/223.19  |- skos__altLabel mesh__D001094 Arachidonic Acid 5-Lipoxygenase
% 222.95/223.19  |- skos__hiddenLabel mesh__D001094 5 Lipoxygenase
% 222.95/223.19  |- skos__altLabel mesh__D001094 LTA4 Synthase
% 222.95/223.19  |- skos__altLabel mesh__D001094 5-Lipoxygenase
% 222.95/223.19  |- mesh__publicMeSHNote mesh__D001094
% 222.95/223.19       91; was see under ARACHIDONATE LIPOXYGENASES 1987-90   
% 222.95/223.19  |- mesh__recordMaintainer mesh__D001094 ssb
% 222.95/223.19  |- skos__hiddenLabel mesh__D001094 Synthase, Leukotriene A4
% 222.95/223.19  |- skos__historyNote mesh__D001094 Lipoxygenases %28%1974-1986%29%
% 222.95/223.19  |- skos__hiddenLabel mesh__D001094 Arachidonic Acid 5 Lipoxygenase
% 222.95/223.19  |- skos__scopeNote mesh__D001094
% 222.95/223.19       An enzyme that catalyzes the oxidation of arachidonic acid to yield 5-hydroperoxyarachidonate %28%5-HPETE%29% which is rapidly converted by a peroxidase to 5-hydroxy-6,8,11,14-eicosatetraenoate %28%5-HETE%29%. The 5-hydroperoxides are preferentially formed in leukocytes. EC 1.13.11.34.%A%    
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D001094 2006
% 222.95/223.19  |- skos__altLabel mesh__D014211 Infections, Treponemal
% 222.95/223.19  |- skos__annotation mesh__D014211
% 222.95/223.19       gram-neg bact infect; Treponema pallidum infection = SYPHILIS or YAWS%A%  
% 222.95/223.19  |- mesh__recordAuthorizer mesh__D014211 PLS
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D014211 2000
% 222.95/223.19  |- mesh__publicMeSHNote mesh__D014211
% 222.95/223.19       BEJEL was heading 1963-67, 75-96 %28%see under TREPONEMAL INFECTIONS 1975-90%29%; was see under TREPONEMAL INFECTIONS 1968-74%A%  
% 222.95/223.19  |- mesh__recordMaintainer mesh__D014211 PXP
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D014211 2001
% 222.95/223.19  |- skos__hiddenLabel mesh__D014211 Treponemal Infection
% 222.95/223.19  |- rdf__type mesh__D014211sskos__Concept
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D014211 2003
% 222.95/223.19  |- skos__broader mesh__D014211smesh__D016905
% 222.95/223.19  |- mesh__historyNote mesh__D014211
% 222.95/223.19       BEJEL was heading 1963-67, 75-96 %28%see under TREPONEMAL INFECTIONS 1975-90%29%; was see under TREPONEMAL INFECTIONS 1968-74%A%  
% 222.95/223.19  |- skos__scopeNote mesh__D014211
% 222.95/223.19       Infections with bacteria of the genus TREPONEMA.     
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D014211 1998
% 222.95/223.19  |- mesh__recordOriginator mesh__D014211 NLM
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D014211 2005
% 222.95/223.19  |- skos__hiddenLabel mesh__D014211 Infection, Treponemal
% 222.95/223.19  |- skos__hiddenLabel mesh__D014211 Bejels
% 222.95/223.19  |- mesh__dateCreated mesh__D014211 1999-01-01
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D014211 1997
% 222.95/223.19  |- skos__prefLabel mesh__D014211 Treponemal Infections
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D014211 2004
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D014211 2002
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D014211 1999
% 222.95/223.19  |- skos__broader mesh__D014211smesh__D013145
% 222.95/223.19  |- mesh__activeMeSHYear mesh__D014211 2006
% 222.95/223.19  |- mesh__dateRevised mesh__D014211 1996-06-10
% 222.95/223.19  |- mesh__historyNote mesh__D005485
% 222.95/223.19       91%28%75%29%; was see under ANILIDES 1975-90   
% 222.95/223.19  |- mesh__dateEstablished mesh__D005485 1991-01-01
% 222.95/223.19  |- rdf__type mesh__D005485sskos__Concept
% 222.95/223.19  |- mesh__dateRevised mesh__D005485 2005-06-30
% 222.95/223.19  |- skos__prefLabel mesh__D005485 Flutamide
% 222.95/223.19  |- mesh__recordAuthorizer mesh__D005485 sjn
% 222.95/223.19  |- skos__hiddenLabel mesh__D005485 Schering Plough Brand of Flutamide
% 222.95/223.19  |- mesh__publicMeSHNote mesh__D005485 91; was see under ANILIDES 1975-90   
% 222.95/223.19  |- skos__hiddenLabel mesh__D005485 Fluta GRY
% 222.95/223.19  |- skos__altLabel mesh__D005485 cell pharm Brand of Flutamide
% 222.95/223.19  |- skos__broader mesh__D005485smesh__D000813
% 222.95/223.19  |- skos__altLabel mesh__D005485 Alphapharm Brand of Flutamide
% 222.95/223.19  |- skos__hiddenLabel mesh__D005485 PMS Flutamide
% 222.95/223.19  |- skos__altLabel mesh__D005485 Lemery Brand of Flutamide
% 222.95/223.19  |- skos__altLabel mesh__D005485 Tedec Meiji Brand of Flutamide
% 222.95/223.19  |- skos__altLabel mesh__D005485 TAD Brand of Flutamide
% 222.95/223.19  |- skos__historyNote mesh__D005485 Hydrocarbons, Fluorinated %28%1974%29%
% 222.95/223.19  |- skos__hiddenLabel mesh__D005485 Novo Flutamide
% 222.95/223.19  |- skos__altLabel mesh__D005485 Chephasaar Brand of Flutamide
% 222.95/223.19  |- skos__altLabel mesh__D005485 Chiron Brand of Flutamide
% 223.05/223.19  |- skos__altLabel mesh__D005485 Azupharma Brand of Flutamide
% 223.05/223.19  |- skos__hiddenLabel mesh__D005485 FlutaGRY
% 223.05/223.19  |- skos__hiddenLabel mesh__D005485 ApoFlutamide
% 223.05/223.19  |- skos__historyNote mesh__D005485 Anilides %28%1973-1974%29%
% 223.05/223.19  |- skos__altLabel mesh__D005485 Schering Brand of Flutamide
% 223.05/223.19  |- skos__hiddenLabel mesh__D005485 Fluta cell
% 223.05/223.19  |- skos__altLabel mesh__D005485 Eulexine
% 223.05/223.19  |- skos__altLabel mesh__D005485 Drogenil
% 223.05/223.19  |- skos__hiddenLabel mesh__D005485 Flutacell
% 223.05/223.19  |- skos__altLabel mesh__D005485 esparma Brand of Flutamide
% 223.05/223.19  |- skos__hiddenLabel mesh__D005485 Q Pharm Brand of Flutamide
% 223.05/223.19  |- skos__altLabel mesh__D005485 Juta Brand of Flutamide
% 223.05/223.19  |- skos__altLabel mesh__D005485 Kendrick Brand of Flutamide
% 223.05/223.19  |- skos__altLabel mesh__D005485 1A Brand of Flutamide
% 223.05/223.19  |- skos__altLabel mesh__D005485 Prasfarma Brand of Flutamide
% 223.05/223.19  |- skos__historyNote mesh__D005485 Nitro Compounds %28%1973-1974%29%
% 223.05/223.19  |- skos__altLabel mesh__D005485 Apotex Brand of Flutamide
% 223.05/223.19  |- skos__altLabel mesh__D005485 Niftolid
% 223.05/223.19  |- skos__altLabel mesh__D005485 Q-Pharm Brand of Flutamide
% 223.05/223.19  |- skos__altLabel mesh__D005485 Novopharm Brand of Flutamide
% 223.05/223.19  |- mesh__recordMaintainer mesh__D005485 CCR
% 223.05/223.19  |- skos__hiddenLabel mesh__D005485 SCH 13521
% 223.05/223.19  |- skos__scopeNote mesh__D005485
% 223.05/223.19       An antiandrogen with about the same potency as cyproterone in rodent and canine species.%A%    
% 223.05/223.19  |- skos__altLabel mesh__D005485 Gry Brand of Flutamide
% 223.05/223.19  |- skos__altLabel mesh__D005485 Niftolide
% 223.05/223.19  |- skos__altLabel mesh__D005485 Schering-Plough Brand of Flutamide
% 223.05/223.19  |- mesh__activeMeSHYear mesh__D005485 2006
% 223.05/223.19  |- skos__hiddenLabel mesh__D005485 SCH13521
% 223.05/223.19  |- skos__altLabel mesh__D005485 Apogepha Brand of Flutamide
% 223.05/223.19  |- mesh__recordOriginator mesh__D005485 NLM
% 223.05/223.19  |- skos__altLabel mesh__D005485 Ciclum Brand of Flutamide
% 223.05/223.19  |- skos__altLabel mesh__D005485 Inibsa Brand of Flutamide
% 223.05/223.19  |- skos__altLabel mesh__D005485 Pharmascience Brand of Flutamide
% 223.05/223.19  |- skos__altLabel mesh__D005485 Hexal Brand of Flutamide
% 223.05/223.19  |- skos__hiddenLabel mesh__D005485 NovoFlutamide
% 223.05/223.19  |- mesh__dateCreated mesh__D005485 1974-11-19
% 223.05/223.19  |- skos__altLabel mesh__D005485 Essex Brand of Flutamide
% 223.05/223.19  |- skos__hiddenLabel mesh__D005485 Apo Flutamide
% 223.05/223.19  |- skos__altLabel mesh__D005485 Ipsen Brand of Flutamide
% 223.05/223.19  |- skos__altLabel mesh__D005485 Euflex
% 223.05/223.19  |- skos__broader mesh__D013917smesh__D012697
% 223.05/223.19  |- mesh__dateRevised mesh__D013917 2005-06-30
% 223.05/223.19  |- mesh__recordAuthorizer mesh__D013917 sjn
% 223.05/223.19  |- skos__prefLabel mesh__D013917 Thrombin
% 223.05/223.19  |- mesh__dateCreated mesh__D013917 1999-01-01
% 223.05/223.19  |- skos__annotation mesh__D013917
% 223.05/223.19       /antag permitted: not same as ANTITHROMBINS   
% 223.05/223.19  |- skos__scopeNote mesh__D013917
% 223.05/223.19       An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN.%A%    
% 223.05/223.19  |- mesh__recordMaintainer mesh__D013917 ssb
% 223.05/223.19  |- mesh__recordOriginator mesh__D013917 NLM
% 223.05/223.19  |- mesh__activeMeSHYear mesh__D013917 2006
% 223.05/223.19  |- skos__related mesh__D013917smesh__D003029
% 223.05/223.19  |- skos__broader mesh__D013917smesh__D001779
% 223.05/223.19  |- skos__altLabel mesh__D013917 Thrombase
% 223.05/223.19  |- rdf__type mesh__D013917sskos__Concept
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Transection, Spinal Cord
% 223.05/223.19  |- skos__altLabel mesh__D013119 Myelopathy, Traumatic
% 223.05/223.19  |- mesh__activeMeSHYear mesh__D013119 2003
% 223.05/223.19  |- skos__altLabel mesh__D013119 Injuries, Spinal Cord
% 223.05/223.19  |- mesh__recordAuthorizer mesh__D013119 sjn
% 223.05/223.19  |- mesh__activeMeSHYear mesh__D013119 2002
% 223.05/223.19  |- skos__annotation mesh__D013119
% 223.05/223.19       coord IM with specific vertebra %28%NIM%29% to locate site on spinal cord%A%  
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Contusions, Spinal Cord
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Cord Injuries, Spinal
% 223.05/223.19  |- mesh__recordMaintainer mesh__D013119 ags
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Myelopathy, Post-Traumatic
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Contusion, Spinal Cord
% 223.05/223.19  |- rdf__type mesh__D013119sskos__Concept
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Injury, Spinal Cord
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Spinal Cord Transections
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Cord Contusions, Spinal
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Spinal Cord Injury
% 223.05/223.19  |- mesh__recordOriginator mesh__D013119 NLM
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Cord Injury, Spinal
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Cord Transections, Spinal
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Traumas, Spinal Cord
% 223.05/223.19  |- mesh__activeMeSHYear mesh__D013119 2006
% 223.05/223.19  |- skos__broader mesh__D013119smesh__D020196
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Cord Contusion, Spinal
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Lacerations, Spinal Cord
% 223.05/223.19  |- skos__broader mesh__D013119smesh__D013118
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Cord Transection, Spinal
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Cord Trauma, Spinal
% 223.05/223.19  |- mesh__activeMeSHYear mesh__D013119 2005
% 223.05/223.19  |- mesh__dateRevised mesh__D013119 2001-07-25
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Cord Traumas, Spinal
% 223.05/223.19  |- skos__broader mesh__D013119smesh__D014947
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Traumatic Myelopathy
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Trauma, Spinal Cord
% 223.05/223.19  |- mesh__dateCreated mesh__D013119 1999-01-01
% 223.05/223.19  |- skos__altLabel mesh__D013119 Spinal Cord Trauma
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Myelopathies, Traumatic
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Cord Laceration, Spinal
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Myelopathies, Post-Traumatic
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Transections, Spinal Cord
% 223.05/223.19  |- skos__scopeNote mesh__D013119
% 223.05/223.19       Penetrating and non-penetrating injuries to the spinal cord resulting from traumatic external forces %28%e.g., WOUNDS, GUNSHOT; WHIPLASH INJURIES; etc.%29%.%A%    
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Spinal Cord Contusions
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Spinal Cord Lacerations
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Traumatic Myelopathies
% 223.05/223.19  |- mesh__activeMeSHYear mesh__D013119 2004
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Post Traumatic Myelopathy
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Laceration, Spinal Cord
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Cord Lacerations, Spinal
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Spinal Cord Traumas
% 223.05/223.19  |- skos__hiddenLabel mesh__D013119 Post-Traumatic Myelopathies
% 223.05/223.19  |- skos__prefLabel mesh__D013119 Spinal Cord Injuries
% 223.05/223.19  |- mesh__publicMeSHNote mesh__D018602
% 223.05/223.19       95; was see PLANT POISONING 1979-94; was see under PLANT POISONING 1968-78; was heading 1963-67%A%  
% 223.05/223.19  |- skos__prefLabel mesh__D018602 Milk Sickness
% 223.05/223.19  |- mesh__recordOriginator mesh__D018602 TGC
% 223.05/223.19  |- mesh__activeMeSHYear mesh__D018602 2004
% 223.05/223.19  |- mesh__activeMeSHYear mesh__D018602 2002
% 223.05/223.19  |- skos__scopeNote mesh__D018602
% 223.05/223.19       An acute, often fatal disease caused by the ingestion of milk, milk products, or the flesh of cattle or sheep which have a disease known as trembles. It is marked by weakness, anorexia, vomiting, constipation, and sometimes muscular tremors. It is caused by poisoning by white snakeroot %28%Eupatorium rugosum%29% and the rayless goldenrod %28%Haplopappus heterophyllus%29%. %28%From Dorland, 27th ed%29%%A%    
% 223.05/223.19  |- mesh__activeMeSHYear mesh__D018602 1997
% 223.05/223.19  |- mesh__historyNote mesh__D018602
% 223.05/223.19       95; was see PLANT POISONING 1979-94; was see under PLANT POISONING 1968-78; was heading 1963-67%A%  
% 223.05/223.19  |- mesh__activeMeSHYear mesh__D018602 2006
% 223.05/223.19  |- mesh__activeMeSHYear mesh__D018602 1999
% 223.05/223.19  |- mesh__dateCreated mesh__D018602 1994-04-19
% 223.05/223.19  |- mesh__dateRevised mesh__D018602 1996-06-10
% 223.05/223.19  |- mesh__activeMeSHYear mesh__D018602 2003
% 223.05/223.19  |- mesh__onlineNote mesh__D018602
% 223.05/223.19       use PLANT POISONING to search MILK SICKNESS 1966-94   
% 223.05/223.19  |- mesh__activeMeSHYear mesh__D018602 2001
% 223.05/223.19  |- mesh__activeMeSHYear mesh__D018602 2005
% 223.05/223.19  |- skos__broader mesh__D018602smesh__D010939
% 223.05/223.19  |- mesh__activeMeSHYear mesh__D018602 1998
% 223.05/223.19  |- skos__annotation mesh__D018602
% 223.05/223.19       a form of plant pois: see MeSH definition   
% 223.05/223.19  |- mesh__activeMeSHYear mesh__D018602 2000
% 223.05/223.19  |- skos__historyNote mesh__D018602 Plant Poisoning %28%1966-1994%29%
% 223.05/223.19  |- rdf__type mesh__D018602sskos__Concept
% 223.05/223.19  |- mesh__dateEstablished mesh__D018602 1995-01-01
% 223.05/223.19  |- skos__hiddenLabel mesh__D018602 Sickness, Milk
% 223.05/223.19  |- mesh__recordAuthorizer mesh__D018602 PLS
% 223.05/223.19  |- mesh__recordMaintainer mesh__D018602 TGC
% 223.05/223.19  |- skos__hiddenLabel mesh__D051238 Receptors, VIP1
% 223.05/223.19  |- skos__altLabel mesh__D051238 Vasoactive Intestinal Peptide Receptor 1
% 223.05/223.19  |- mesh__dateCreated mesh__D051238 2005-06-30
% 223.05/223.19  |- mesh__dateEstablished mesh__D051238 2006-01-01
% 223.05/223.19  |- rdf__type mesh__D051238sskos__Concept
% 223.05/223.19  |- skos__scopeNote mesh__D051238
% 223.05/223.19       A pituitary adenylate cyclase-activating polypeptide receptor subtype that binds both PACAP and VASOACTIVE INTESTINAL PEPTIDE. It is found predominately in the BRAIN.%A%    
% 223.05/223.19  |- skos__altLabel mesh__D051238 VIP1 Receptor
% 223.05/223.19  |- skos__altLabel mesh__D051238 Vasoactive Intestinal Peptide 1 Receptor
% 223.05/223.19  |- mesh__publicMeSHNote mesh__D051238
% 223.05/223.19       2006; VASOACTIVE INTESTINAL PEPTIDE 1 RECEPTOR was indexed under RECEPTORS, CELL SURFACE 1999-2005%A%  
% 223.05/223.19  |- skos__altLabel mesh__D051238 VIPR1 Protein
% 223.05/223.19  |- mesh__recordAuthorizer mesh__D051238 sjn
% 223.05/223.19  |- mesh__recordMaintainer mesh__D051238 DRC
% 223.05/223.19  |- mesh__historyNote mesh__D051238 2006%28%1999%29%   
% 223.05/223.19  |- skos__broader mesh__D051238smesh__D018005
% 223.05/223.19  |- skos__altLabel mesh__D051238 VPAC1 Receptor
% 223.05/223.19  |- skos__altLabel mesh__D051238 VIP 1 Receptor
% 223.05/223.19  |- skos__altLabel mesh__D051238 PACAP Receptors, Type II
% 223.05/223.19  |- skos__altLabel mesh__D051238 VIP-1 Receptor
% 223.05/223.19  |- skos__hiddenLabel mesh__D051238 Receptor, VPAC1
% 223.05/223.19  |- skos__altLabel mesh__D051238 VIP1 Receptors
% 223.05/223.19  |- skos__broader mesh__D051238smesh__D051236
% 223.05/223.20  |- skos__hiddenLabel mesh__D051238 Receptor, VIP-1
% 223.05/223.20  |- skos__hiddenLabel mesh__D051238
% 223.05/223.20       Pituitary Adenylate Cyclase Activating Peptide Receptor Type II
% 223.05/223.20  |- skos__hiddenLabel mesh__D051238 PACAPR 2 Protein
% 223.05/223.20  |- skos__hiddenLabel mesh__D051238 Receptor, VIP 1
% 223.05/223.20  |- skos__altLabel mesh__D051238 VIP Receptors, Type I
% 223.05/223.20  |- skos__altLabel mesh__D051238 PACAPR-2 Protein
% 223.05/223.20  |- skos__altLabel mesh__D051238
% 223.05/223.20       Vasoactive Intestinal Peptide Receptors, Type I
% 223.05/223.20  |- skos__altLabel mesh__D051238
% 223.05/223.20       Pituitary Adenylate Cyclase-Activating Peptide Receptor Type II
% 223.05/223.20  |- mesh__recordOriginator mesh__D051238 DRC
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D051238 2006
% 223.05/223.20  |- skos__altLabel mesh__D051238
% 223.05/223.20       Receptors, Pituitary Adenylate Cyclase-Activating Peptide, Type II
% 223.05/223.20  |- skos__altLabel mesh__D051238 PACAP Type II Receptor
% 223.05/223.20  |- skos__altLabel mesh__D051238 Receptor, VIP1
% 223.05/223.20  |- skos__prefLabel mesh__D051238
% 223.05/223.20       Receptors, Vasoactive Intestinal Polypeptide, Type I
% 223.05/223.20  |- skos__broader mesh__D009876smesh__D040481
% 223.05/223.20  |- rdf__type mesh__D009876sskos__Concept
% 223.05/223.20  |- mesh__dateCreated mesh__D009876 1999-01-01
% 223.05/223.20  |- skos__annotation mesh__D009876
% 223.05/223.20       LAC OPERON %26% RRNA OPERON are also available   
% 223.05/223.20  |- mesh__historyNote mesh__D009876 72%28%69%29%   
% 223.05/223.20  |- mesh__recordOriginator mesh__D009876 NLM
% 223.05/223.20  |- mesh__recordAuthorizer mesh__D009876 sjn
% 223.05/223.20  |- skos__scopeNote mesh__D009876
% 223.05/223.20       In bacteria, a group of metabolically related genes, with a common PROMOTER, whose transcription into a single polycistronic MESSENGER RNA is under the control of an OPERATOR REGION.%A%    
% 223.05/223.20  |- skos__broader mesh__D009876smesh__D016680
% 223.05/223.20  |- mesh__publicMeSHNote mesh__D009876 72   
% 223.05/223.20  |- skos__prefLabel mesh__D009876 Operon
% 223.05/223.20  |- mesh__dateRevised mesh__D009876 2005-06-30
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D009876 2006
% 223.05/223.20  |- skos__historyNote mesh__D009876 Genetics, Biochemical %28%1968%29%
% 223.05/223.20  |- mesh__recordMaintainer mesh__D009876 nns
% 223.05/223.20  |- mesh__dateEstablished mesh__D009876 1972-01-01
% 223.05/223.20  |- skos__altLabel mesh__D009876 Operons
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D001893 1998
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D001893 2003
% 223.05/223.20  |- skos__annotation mesh__D001893
% 223.05/223.20       an island in the Malay Archipelago; 3d largest island in the world%A%  
% 223.05/223.20  |- skos__prefLabel mesh__D001893 Borneo
% 223.05/223.20  |- mesh__recordMaintainer mesh__D001893 TGC
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D001893 1999
% 223.05/223.20  |- mesh__recordOriginator mesh__D001893 NLM
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D001893 2004
% 223.05/223.20  |- mesh__recordAuthorizer mesh__D001893 PLS
% 223.05/223.20  |- mesh__dateCreated mesh__D001893 1999-01-01
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D001893 2005
% 223.05/223.20  |- mesh__dateRevised mesh__D001893 1995-02-17
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D001893 2006
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D001893 2000
% 223.05/223.20  |- rdf__type mesh__D001893sskos__Concept
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D001893 1996
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D001893 2001
% 223.05/223.20  |- skos__scopeNote mesh__D001893
% 223.05/223.20       An island in the Malay Archipelago, east of Sumatra, north of Java, and west of Celebes. It is the third largest island in the world. Its name is a Portuguese alteration of BRUNEI, located on it. %28%From Webster%27%s New Geographical Dictionary, 1988, p163; Room, Brewer%27%s Dictionary of Names, 1992, p73%29%%A%    
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D001893 1997
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D001893 2002
% 223.05/223.20  |- skos__broader mesh__D001893smesh__D001210
% 223.05/223.20  |- skos__prefLabel mesh__D009078 Mucocele
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D009078 2005
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D009078 1998
% 223.05/223.20  |- mesh__recordMaintainer mesh__D009078 TPW
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D009078 2002
% 223.05/223.20  |- mesh__dateCreated mesh__D009078 1999-01-01
% 223.05/223.20  |- skos__hiddenLabel mesh__D009078 Mucoceles
% 223.05/223.20  |- mesh__recordOriginator mesh__D009078 NLM
% 223.05/223.20  |- mesh__publicMeSHNote mesh__D009078 65   
% 223.05/223.20  |- skos__broader mesh__D009078smesh__D003560
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D009078 2001
% 223.05/223.20  |- mesh__dateRevised mesh__D009078 1997-06-20
% 223.05/223.20  |- rdf__type mesh__D009078sskos__Concept
% 223.05/223.20  |- skos__scopeNote mesh__D009078
% 223.05/223.20       A retention cyst of the salivary gland, lacrimal sac, paranasal sinuses, appendix, or gallbladder. %28%Stedman, 26th ed%29%%A%    
% 223.05/223.20  |- mesh__historyNote mesh__D009078 65   
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D009078 2000
% 223.05/223.20  |- mesh__recordAuthorizer mesh__D009078 SJN
% 223.05/223.20  |- mesh__dateEstablished mesh__D009078 1965-01-01
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D009078 2004
% 223.05/223.20  |- skos__related mesh__D009078smesh__D011900
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D009078 2006
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D009078 2003
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D009078 1999
% 223.05/223.20  |- skos__annotation mesh__D009078 a type of cyst; non-neoplastic   
% 223.05/223.20  |- mesh__dateRevised mesh__D001095 2003-07-09
% 223.05/223.20  |- skos__broader mesh__D001095smesh__D015777
% 223.05/223.20  |- skos__hiddenLabel mesh__D001095 Acids, Arachidonic
% 223.05/223.20  |- mesh__publicMeSHNote mesh__D001095
% 223.05/223.20       75; was ARACHIDONIC ACID 1967-74, was ARACHIDONIC ACID see under FATTY ACIDS, ESSENTIAL 1963-66%A%  
% 223.05/223.20  |- mesh__dateCreated mesh__D001095 1999-01-01
% 223.05/223.20  |- mesh__onlineNote mesh__D001095
% 223.05/223.20       use ARACHIDONIC ACIDS to search ARACHIDONIC ACID 1967-74; use FATTY ACIDS, ESSENTIAL to search ARACHIDONIC ACID 1966%A%  
% 223.05/223.20  |- skos__broader mesh__D001095smesh__D005231
% 223.05/223.20  |- mesh__historyNote mesh__D001095
% 223.05/223.20       75; was ARACHIDONIC ACID 1967-74, was ARACHIDONIC ACID see under FATTY ACIDS, ESSENTIAL 1963-66%A%  
% 223.05/223.20  |- mesh__recordOriginator mesh__D001095 NLM
% 223.05/223.20  |- mesh__recordAuthorizer mesh__D001095 sjn
% 223.05/223.20  |- mesh__dateEstablished mesh__D001095 1967-01-01
% 223.05/223.20  |- skos__broader mesh__D001095smesh__D005228
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D001095 2006
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D001095 2004
% 223.05/223.20  |- skos__prefLabel mesh__D001095 Arachidonic Acids
% 223.05/223.20  |- rdf__type mesh__D001095sskos__Concept
% 223.05/223.20  |- skos__hiddenLabel mesh__D001095 Acids, Eicosatetraenoic
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D001095 2005
% 223.05/223.20  |- mesh__recordMaintainer mesh__D001095 ssb
% 223.05/223.20  |- skos__historyNote mesh__D001095 Fatty Acids, Essential %28%1966%29%
% 223.05/223.20  |- skos__annotation mesh__D001095
% 223.05/223.20       do not confuse with the specific drug ARACHIDONIC ACID   
% 223.05/223.20  |- mesh__publicMeSHNote mesh__D014212
% 223.05/223.20       80; was see under VITAMIN A 1975-79   
% 223.05/223.20  |- skos__related mesh__D014212smesh__D018168
% 223.05/223.20  |- skos__altLabel mesh__D014212 trans-Retinoic Acid
% 223.05/223.20  |- skos__hiddenLabel mesh__D014212 all trans Retinoic Acid
% 223.05/223.20  |- skos__hiddenLabel mesh__D014212 beta all trans Retinoic Acid
% 223.05/223.20  |- skos__altLabel mesh__D014212 Vitamin A Acid
% 223.05/223.20  |- mesh__dateEstablished mesh__D014212 1980-01-01
% 223.05/223.20  |- skos__broader mesh__D014212smesh__D012176
% 223.05/223.20  |- rdf__type mesh__D014212sskos__Concept
% 223.05/223.20  |- skos__hiddenLabel mesh__D014212 Potassium Salt, Tretinoin
% 223.05/223.20  |- skos__hiddenLabel mesh__D014212 Salt, Tretinoin Sodium
% 223.05/223.20  |- skos__hiddenLabel mesh__D014212 Zinc Salt, Tretinoin
% 223.05/223.20  |- mesh__recordAuthorizer mesh__D014212 ags
% 223.05/223.20  |- skos__hiddenLabel mesh__D014212 Sodium Salt, Tretinoin
% 223.05/223.20  |- skos__historyNote mesh__D014212 Vitamin A %28%1966-1974%29%
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D014212 2006A
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D014212 2006
% 223.05/223.20  |- skos__altLabel mesh__D014212 Retinoic Acid
% 223.05/223.20  |- mesh__dateCreated mesh__D014212 1974-11-11
% 223.05/223.20  |- skos__altLabel mesh__D014212 all-trans-Retinoic Acid
% 223.05/223.20  |- skos__hiddenLabel mesh__D014212 trans Retinoic Acid
% 223.05/223.20  |- skos__broader mesh__D014212smesh__D014801
% 223.05/223.20  |- skos__hiddenLabel mesh__D014212 Acid, Retinoic
% 223.05/223.20  |- mesh__historyNote mesh__D014212
% 223.05/223.20       80%28%75%29%; was see under VITAMIN A 1975-79   
% 223.05/223.20  |- mesh__recordOriginator mesh__D014212 NLM
% 223.05/223.20  |- skos__hiddenLabel mesh__D014212 Salt, Tretinoin Zinc
% 223.05/223.20  |- skos__hiddenLabel mesh__D014212 Acid, beta-all-trans-Retinoic
% 223.05/223.20  |- skos__hiddenLabel mesh__D014212 Salt, Tretinoin Potassium
% 223.05/223.20  |- skos__hiddenLabel mesh__D014212 Acid, all-trans-Retinoic
% 223.05/223.20  |- skos__scopeNote mesh__D014212
% 223.05/223.20       An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia %28%LEUKEMIA, PROMYELOCYTIC, ACUTE%29%.%A%    
% 223.05/223.20  |- skos__hiddenLabel mesh__D014212 Acid, trans-Retinoic
% 223.05/223.20  |- skos__hiddenLabel mesh__D014212 Retin A
% 223.05/223.20  |- skos__hiddenLabel mesh__D014212 Acid, Vitamin A
% 223.05/223.20  |- mesh__dateRevised mesh__D014212 2005-07-15
% 223.05/223.20  |- skos__historyNote mesh__D014212 Carotenoids %28%1969-1974%29%
% 223.05/223.20  |- mesh__recordMaintainer mesh__D014212 ags
% 223.05/223.20  |- skos__prefLabel mesh__D014212 Tretinoin
% 223.05/223.20  |- skos__hiddenLabel mesh__D005486 Riboflavin 5%27% Phosphate
% 223.05/223.20  |- skos__altLabel mesh__D005486 Sodium Riboflavin Phosphate
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D005486 2006
% 223.05/223.20  |- skos__hiddenLabel mesh__D005486 Mononucleotide, Riboflavin
% 223.05/223.20  |- skos__hiddenLabel mesh__D005486 Mononucleotide, Flavin
% 223.05/223.20  |- skos__altLabel mesh__D005486 Riboflavin 5%27%-Phosphate
% 223.05/223.20  |- skos__altLabel mesh__D005486 Riboflavin 5%27%-Monophosphate
% 223.05/223.20  |- mesh__historyNote mesh__D005486 1966%28%2003%29%;   
% 223.05/223.20  |- mesh__publicMeSHNote mesh__D005486 1996; see FMN 1966-2002   
% 223.05/223.20  |- skos__broader mesh__D005486smesh__D012265
% 223.05/223.20  |- mesh__recordAuthorizer mesh__D005486 sjn
% 223.05/223.20  |- skos__hiddenLabel mesh__D005486 Phosphate, Sodium Riboflavin
% 223.05/223.20  |- skos__altLabel mesh__D005486 Riboflavin Mononucleotide
% 223.05/223.20  |- skos__prefLabel mesh__D005486 Flavin Mononucleotide
% 223.05/223.20  |- mesh__dateCreated mesh__D005486 1999-01-01
% 223.05/223.20  |- skos__scopeNote mesh__D005486
% 223.05/223.20       A coenzyme for a number of oxidative enzymes including NADH DEHYDROGENASE. It is the principal form in which RIBOFLAVIN is found in cells and tissues.%A%    
% 223.05/223.20  |- mesh__dateRevised mesh__D005486 2005-06-30
% 223.05/223.20  |- skos__altLabel mesh__D005486 FMN
% 223.05/223.20  |- skos__hiddenLabel mesh__D005486 Riboflavin 5%27% Monophosphate
% 223.05/223.20  |- skos__broader mesh__D005486smesh__D012256
% 223.05/223.20  |- skos__hiddenLabel mesh__D005486 5%27%-Monophosphate, Riboflavin
% 223.05/223.20  |- skos__hiddenLabel mesh__D005486 Riboflavin Phosphate, Sodium
% 223.05/223.20  |- rdf__type mesh__D005486sskos__Concept
% 223.05/223.20  |- skos__hiddenLabel mesh__D005486 5%27%-Phosphate, Riboflavin
% 223.05/223.20  |- mesh__recordOriginator mesh__D005486 NLM
% 223.05/223.20  |- mesh__recordMaintainer mesh__D005486 ssb
% 223.05/223.20  |- mesh__dateRevised mesh__D013918 2003-07-09
% 223.05/223.20  |- skos__historyNote mesh__D013918 Thrombin %28%1966-1979%29%
% 223.05/223.20  |- mesh__dateEstablished mesh__D013918 1991-01-01
% 223.05/223.20  |- skos__annotation mesh__D013918 usually NIM   
% 223.05/223.20  |- skos__historyNote mesh__D013918 Fibrinogen %28%1966-1979%29%
% 223.05/223.20  |- mesh__historyNote mesh__D013918
% 223.05/223.20       91%28%80%29%; was see under BLOOD COAGULATION TESTS 1980-90   
% 223.05/223.20  |- skos__hiddenLabel mesh__D013918 Thrombin Times
% 223.05/223.20  |- mesh__recordOriginator mesh__D013918 SMH
% 223.05/223.20  |- mesh__publicMeSHNote mesh__D013918
% 223.05/223.20       91; was see under BLOOD COAGULATION TESTS 1980-90   
% 223.05/223.20  |- skos__scopeNote mesh__D013918
% 223.05/223.20       Clotting time of PLASMA mixed with a THROMBIN solution. It is a measure of the conversion of FIBRINOGEN to FIBRIN, which is prolonged by AFIBRINOGENEMIA, abnormal fibrinogen, or the presence of inhibitory substances, e.g., fibrin-fibrinogen degradation products, or HEPARIN. BATROXOBIN, a thrombin-like enzyme unaffected by the presence of heparin, may be used in place of thrombin.%A%    
% 223.05/223.20  |- skos__hiddenLabel mesh__D013918 Time, Reptilase
% 223.05/223.20  |- mesh__recordAuthorizer mesh__D013918 sjn
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D013918 2004
% 223.05/223.20  |- skos__hiddenLabel mesh__D013918 Reptilase Times
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D013918 2006
% 223.05/223.20  |- skos__prefLabel mesh__D013918 Thrombin Time
% 223.05/223.20  |- skos__broader mesh__D013918smesh__D001780
% 223.05/223.20  |- rdf__type mesh__D013918sskos__Concept
% 223.05/223.20  |- mesh__activeMeSHYear mesh__D013918 2005
% 223.05/223.20  |- skos__hiddenLabel mesh__D013918 Times, Thrombin
% 223.06/223.20  |- skos__related mesh__D013918smesh__D001777
% 223.06/223.20  |- mesh__recordMaintainer mesh__D013918 nns
% 223.06/223.20  |- skos__broader mesh__D013918smesh__D045122
% 223.06/223.20  |- skos__historyNote mesh__D013918
% 223.06/223.20       Blood Coagulation Tests %28%1966-1979%29%
% 223.06/223.20  |- skos__hiddenLabel mesh__D013918 Time, Thrombin
% 223.06/223.20  |- skos__altLabel mesh__D013918 Reptilase Time
% 223.06/223.20  |- skos__hiddenLabel mesh__D013918 Times, Reptilase
% 223.06/223.20  |- mesh__dateCreated mesh__D013918 1979-03-07
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D010620 2006
% 223.06/223.20  |- skos__prefLabel mesh__D010620 Phenazocine
% 223.06/223.20  |- mesh__dateRevised mesh__D010620 2005-06-30
% 223.06/223.20  |- rdf__type mesh__D010620sskos__Concept
% 223.06/223.20  |- skos__altLabel mesh__D010620 Phenethylazocine
% 223.06/223.20  |- skos__altLabel mesh__D010620 Phenbenzorphan
% 223.06/223.20  |- skos__broader mesh__D010620smesh__D001575
% 223.06/223.20  |- mesh__recordAuthorizer mesh__D010620 sjn
% 223.06/223.20  |- mesh__recordMaintainer mesh__D010620 lkw
% 223.06/223.20  |- skos__hiddenLabel mesh__D010620 Hydrobromide, Phenazocine
% 223.06/223.20  |- skos__scopeNote mesh__D010620
% 223.06/223.20       An opioid analgesic with actions and uses similar to MORPHINE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1095%29%%A%    
% 223.06/223.20  |- skos__altLabel mesh__D010620 Napp Brand of Phenazocine Hydrobromide
% 223.06/223.20  |- mesh__recordOriginator mesh__D010620 NLM
% 223.06/223.20  |- mesh__dateCreated mesh__D010620 1999-01-01
% 223.06/223.20  |- skos__hiddenLabel mesh__D051239
% 223.06/223.20       Pituitary Adenylate Cyclase Activating Peptide Receptor Type III
% 223.06/223.20  |- mesh__historyNote mesh__D051239 2006%28%1999%29%   
% 223.06/223.20  |- skos__altLabel mesh__D051239
% 223.06/223.20       Receptors, Pituitary Adenylate Cyclase-Activating Peptide, Type III
% 223.06/223.20  |- skos__altLabel mesh__D051239 PACAPR-3 Protein
% 223.06/223.20  |- mesh__dateCreated mesh__D051239 2005-06-30
% 223.06/223.20  |- skos__broader mesh__D051239smesh__D018005
% 223.06/223.20  |- skos__altLabel mesh__D051239 VIPR2 Protein
% 223.06/223.20  |- mesh__dateEstablished mesh__D051239 2006-01-01
% 223.06/223.20  |- skos__altLabel mesh__D051239 VIP Receptors, Type II
% 223.06/223.20  |- skos__altLabel mesh__D051239 VPAC2 Receptor
% 223.06/223.20  |- skos__hiddenLabel mesh__D051239 Receptor, VPAC2
% 223.06/223.20  |- skos__altLabel mesh__D051239 Vasoactive Intestinal Peptide Receptor 2
% 223.06/223.20  |- mesh__recordOriginator mesh__D051239 DRC
% 223.06/223.20  |- skos__altLabel mesh__D051239
% 223.06/223.20       Pituitary Adenylate Cyclase-Activating Peptide Receptor Type III
% 223.06/223.20  |- skos__prefLabel mesh__D051239
% 223.06/223.20       Receptors, Vasoactive Intestinal Peptide, Type II
% 223.06/223.20  |- skos__altLabel mesh__D051239 PACAP Type III Receptor
% 223.06/223.20  |- skos__altLabel mesh__D051239 Vasoactive Intestinal Peptide 2 Receptor
% 223.06/223.20  |- skos__hiddenLabel mesh__D051239 Receptors, VIP2
% 223.06/223.20  |- mesh__recordAuthorizer mesh__D051239 sjn
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D051239 2006
% 223.06/223.20  |- mesh__recordMaintainer mesh__D051239 DRC
% 223.06/223.20  |- skos__scopeNote mesh__D051239
% 223.06/223.20       A pituitary adenylate cyclase-activating peptide receptor subtype found in LYMPHOCYTES. It binds both PACAP and VASOACTIVE INTESTINAL PEPTIDE and regulates immune responses.%A%    
% 223.06/223.20  |- skos__broader mesh__D051239smesh__D051236
% 223.06/223.20  |- skos__hiddenLabel mesh__D051239 Receptor, VIP2
% 223.06/223.20  |- skos__altLabel mesh__D051239 PACAP Receptors, Type III
% 223.06/223.20  |- skos__hiddenLabel mesh__D051239 PACAPR 3 Protein
% 223.06/223.20  |- mesh__publicMeSHNote mesh__D051239
% 223.06/223.20       2006; VASOACTIVE INTESTINAL PEPTIDE 2 RECEPTOR was indexed under RECEPTORS, CELL SURFACE 1999-2005%A%  
% 223.06/223.20  |- skos__altLabel mesh__D051239
% 223.06/223.20       Vasoactive Intestinal Peptide Receptors, Type II
% 223.06/223.20  |- skos__altLabel mesh__D051239 VIP2 Receptors
% 223.06/223.20  |- skos__altLabel mesh__D051239 VIP2 Receptor
% 223.06/223.20  |- rdf__type mesh__D051239sskos__Concept
% 223.06/223.20  |- mesh__recordAuthorizer mesh__D048290 sjn
% 223.06/223.20  |- skos__altLabel mesh__D048290 MAPK11 Mitogen-Activated Protein Kinase
% 223.06/223.20  |- skos__hiddenLabel mesh__D048290 MAP Kinase, p38beta
% 223.06/223.20  |- skos__altLabel mesh__D048290 SAP Kinase-2
% 223.06/223.20  |- mesh__recordMaintainer mesh__D048290 jmp
% 223.06/223.20  |- skos__hiddenLabel mesh__D048290 Mitogen Activated Protein Kinase 11
% 223.06/223.20  |- skos__historyNote mesh__D048290
% 223.06/223.20       Mitogen-Activated Protein Kinases %28%2000-2004%29%
% 223.06/223.20  |- skos__hiddenLabel mesh__D048290 Stress Activated Protein Kinase 2
% 223.06/223.20  |- skos__altLabel mesh__D048290 Stress-Activated Protein Kinase 2
% 223.06/223.20  |- skos__broader mesh__D048290smesh__D048051
% 223.06/223.20  |- mesh__publicMeSHNote mesh__D048290
% 223.06/223.20       2005; MITOGEN-ACTIVATED PROTEIN KINASE 11, STRESS-ACTIVATED PROTEIN KINASE 2, SAPK2 %26% SAP KINASE-2 were indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004%A%  
% 223.06/223.20  |- skos__altLabel mesh__D048290 Stress-Activated Protein Kinase 2b
% 223.06/223.20  |- skos__scopeNote mesh__D048290
% 223.06/223.20       A 38-kDa mitogen-activated protein kinase that is expressed in a broad variety of cell types. It may play a role in regulating cell proliferation and TRANSCRIPTION FACTOR AP-1 dependent transcription.%A%    
% 223.06/223.20  |- skos__hiddenLabel mesh__D048290 Stress Activated Protein Kinase 2b
% 223.06/223.20  |- mesh__historyNote mesh__D048290 2005%28%2000%29%   
% 223.06/223.20  |- mesh__recordOriginator mesh__D048290 jmp
% 223.06/223.20  |- skos__altLabel mesh__D048290 p38beta MAP Kinase
% 223.06/223.20  |- skos__altLabel mesh__D048290 p38%28%beta%29% MAP Kinase
% 223.06/223.20  |- mesh__dateCreated mesh__D048290 2004-07-07
% 223.06/223.20  |- mesh__dateEstablished mesh__D048290 2005-01-01
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D048290 2006
% 223.06/223.20  |- rdf__type mesh__D048290sskos__Concept
% 223.06/223.20  |- skos__prefLabel mesh__D048290 Mitogen-Activated Protein Kinase 11
% 223.06/223.20  |- skos__altLabel mesh__D048290 SAPK2b
% 223.06/223.20  |- skos__hiddenLabel mesh__D048290 Mitogen Activated Protein Kinase Eleven
% 223.06/223.20  |- skos__altLabel mesh__D048290 SAPK2
% 223.06/223.20  |- skos__hiddenLabel mesh__D048290 MAPK11 Mitogen Activated Protein Kinase
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D048290 2005
% 223.06/223.20  |- skos__hiddenLabel mesh__D048290 Kinase, p38beta MAP
% 223.06/223.20  |- skos__hiddenLabel mesh__D048290 SAP Kinase 2
% 223.06/223.20  |- skos__altLabel mesh__D048290 Mitogen-Activated Protein Kinase Eleven
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D009877 2001
% 223.06/223.20  |- mesh__dateRevised mesh__D009877 1996-06-13
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D009877 2005
% 223.06/223.20  |- skos__broader mesh__D009877smesh__D015829
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D009877 1998
% 223.06/223.20  |- mesh__recordMaintainer mesh__D009877 PXP
% 223.06/223.20  |- mesh__recordOriginator mesh__D009877 NLM
% 223.06/223.20  |- skos__altLabel mesh__D009877 Ophthalmia
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D009877 2006
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D009877 1999
% 223.06/223.20  |- skos__hiddenLabel mesh__D009877 Ophthalmias
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D009877 2002
% 223.06/223.20  |- skos__scopeNote mesh__D009877
% 223.06/223.20       Suppurative inflammation of the tissues of the internal structures of the eye; not all layers of the uvea are affected. Fungi, necrosis of intraocular tumors, and retained intraocular foreign bodies often cause a purulent endophthalmitis.%A%    
% 223.06/223.20  |- skos__hiddenLabel mesh__D009877 Endophthalmitides
% 223.06/223.20  |- skos__related mesh__D009877smesh__D010202
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D009877 2003
% 223.06/223.20  |- mesh__historyNote mesh__D009877 90; was OPHTHALMIA 1966-89   
% 223.06/223.20  |- mesh__recordAuthorizer mesh__D009877 PLS
% 223.06/223.20  |- skos__prefLabel mesh__D009877 Endophthalmitis
% 223.06/223.20  |- mesh__publicMeSHNote mesh__D009877 90; was OPHTHALMIA 1966-89   
% 223.06/223.20  |- rdf__type mesh__D009877sskos__Concept
% 223.06/223.20  |- mesh__dateCreated mesh__D009877 1999-01-01
% 223.06/223.20  |- mesh__onlineNote mesh__D009877
% 223.06/223.20       use ENDOPHTHALMITIS to search OPHTHALMIA 1966-89   
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D009877 2004
% 223.06/223.20  |- skos__annotation mesh__D009877
% 223.06/223.20       a type of suppurative uveitis; restrict to endophthalmitis as a disease entity, not as a coord for inflamm of specific internal parts of the eye: these are available as -ITIS terms in C11; ophthalmitis goes here; PANOPHTHALMITIS is also available: inflamm of all struct of the eye%A%  
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D009877 1997
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D009877 2000
% 223.06/223.20  |- skos__historyNote mesh__D001894 Boron Compounds %28%1968-1970%29%
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D001894 2000
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D001894 1996
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D001894 1995
% 223.06/223.20  |- mesh__dateCreated mesh__D001894 1999-01-01
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D001894 2004
% 223.06/223.20  |- mesh__recordMaintainer mesh__D001894 TPW
% 223.06/223.20  |- skos__annotation mesh__D001894
% 223.06/223.20       do not confuse with boron hydrides, the collective name for BORANES%A%  
% 223.06/223.20  |- mesh__recordAuthorizer mesh__D001894 PLS
% 223.06/223.20  |- mesh__publicMeSHNote mesh__D001894 73   
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D001894 1994
% 223.06/223.20  |- skos__scopeNote mesh__D001894
% 223.06/223.20       A class of inorganic or organic compounds that contain the borohydride %28%BH4-%29% anion.%A%    
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D001894 2003
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D001894 1999
% 223.06/223.20  |- mesh__dateRevised mesh__D001894 1993-06-04
% 223.06/223.20  |- skos__broader mesh__D001894smesh__D001880
% 223.06/223.20  |- skos__prefLabel mesh__D001894 Borohydrides
% 223.06/223.20  |- mesh__recordOriginator mesh__D001894 NLM
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D001894 1998
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D001894 2002
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D001894 2006
% 223.06/223.20  |- rdf__type mesh__D001894sskos__Concept
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D001894 1997
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D001894 2001
% 223.06/223.20  |- mesh__dateEstablished mesh__D001894 1973-01-01
% 223.06/223.20  |- mesh__historyNote mesh__D001894 73%28%71%29%   
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D001894 2005
% 223.06/223.20  |- skos__hiddenLabel mesh__D009079 Clearance, Mucociliary
% 223.06/223.20  |- mesh__historyNote mesh__D009079 88   
% 223.06/223.20  |- skos__historyNote mesh__D009079
% 223.06/223.20       specific respiratory organ/tissue %28%1966-1987%29%
% 223.06/223.20  |- skos__broader mesh__D009079smesh__D003948
% 223.06/223.20  |- skos__historyNote mesh__D009079 Mucus %28%1966-1987%29%
% 223.06/223.20  |- rdf__type mesh__D009079sskos__Concept
% 223.06/223.20  |- skos__hiddenLabel mesh__D009079 Mucociliary Transports
% 223.06/223.20  |- mesh__recordOriginator mesh__D009079 SCD
% 223.06/223.20  |- mesh__dateCreated mesh__D009079 1987-03-25
% 223.06/223.20  |- mesh__publicMeSHNote mesh__D009079 88   
% 223.06/223.20  |- skos__historyNote mesh__D009079 Cilia %28%1966-1987%29%
% 223.06/223.20  |- mesh__recordMaintainer mesh__D009079 nns
% 223.06/223.20  |- mesh__dateEstablished mesh__D009079 1988-01-01
% 223.06/223.20  |- mesh__recordAuthorizer mesh__D009079 sjn
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D009079 2004
% 223.06/223.20  |- skos__prefLabel mesh__D009079 Mucociliary Clearance
% 223.06/223.20  |- skos__scopeNote mesh__D009079
% 223.06/223.20       A non-specific host defense mechanism that removes MUCUS and other material from the LUNGS by ciliary and secretory activity of the tracheobronchial submucosal glands. It is measured in vivo as mucus transfer, ciliary beat frequency, and clearance of radioactive tracers.%A%    
% 223.06/223.20  |- skos__broader mesh__D009079smesh__D044703
% 223.06/223.20  |- mesh__dateRevised mesh__D009079 2003-07-09
% 223.06/223.20  |- skos__hiddenLabel mesh__D009079 Mucociliary Clearances
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D009079 2006
% 223.06/223.20  |- skos__historyNote mesh__D009079 Biological Transport %28%1975-1987%29%
% 223.06/223.20  |- skos__altLabel mesh__D009079 Mucociliary Transport
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D009079 2005
% 223.06/223.20  |- skos__hiddenLabel mesh__D009079 Transports, Mucociliary
% 223.06/223.20  |- skos__hiddenLabel mesh__D009079 Transport, Mucociliary
% 223.06/223.20  |- skos__hiddenLabel mesh__D009079 Clearances, Mucociliary
% 223.06/223.20  |- mesh__recordMaintainer mesh__D001096 SYSTEM
% 223.06/223.20  |- mesh__dateEstablished mesh__D001096 1974-01-01
% 223.06/223.20  |- skos__broader mesh__D001096smesh__D001179
% 223.06/223.20  |- mesh__recordAuthorizer mesh__D001096 sjn
% 223.06/223.20  |- mesh__dateCreated mesh__D001096 1999-01-01
% 223.06/223.20  |- skos__hiddenLabel mesh__D001096 Arachnid Vector
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D001096 2006
% 223.06/223.20  |- skos__prefLabel mesh__D001096 Arachnid Vectors
% 223.06/223.20  |- skos__hiddenLabel mesh__D001096 Vector, Arachnid
% 223.06/223.20  |- mesh__historyNote mesh__D001096 74%28%71%29%   
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D001096 2005
% 223.06/223.20  |- mesh__activeMeSHYear mesh__D001096 2004
% 223.06/223.20  |- skos__hiddenLabel mesh__D001096 Vectors, Arachnid
% 223.06/223.20  |- mesh__dateRevised mesh__D001096 2003-07-09
% 223.06/223.20  |- rdf__type mesh__D001096sskos__Concept
% 223.06/223.20  |- skos__scopeNote mesh__D001096
% 223.06/223.20       Members of the class Arachnida, especially SPIDERS; SCORPIONS; MITES; and TICKS; which transmit infective organisms from one host to another or from an inanimate reservoir to an animate host.%A%    
% 223.06/223.20  |- skos__annotation mesh__D001096
% 223.06/223.20       coord IM with specific arachnid %28%IM%29%; specify both infecting organism %26% vector if pertinent; in the rickettsial-tick-dog relationship, the tick is the arachnid vector, not the dog%A%  
% 223.06/223.20  |- skos__historyNote mesh__D001096 Arthropod Vectors %28%1966-1970%29%
% 223.06/223.20  |- mesh__publicMeSHNote mesh__D001096 74   
% 223.06/223.20  |- mesh__recordOriginator mesh__D001096 NLM
% 223.06/223.20  |- mesh__recordOriginator mesh__D042702 jmp
% 223.06/223.20  |- mesh__dateRevised mesh__D042702 2005-06-30
% 223.06/223.20  |- skos__prefLabel mesh__D042702 Angiopoietin-2
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D042702 2006
% 223.06/223.21  |- skos__scopeNote mesh__D042702
% 223.06/223.21       An angiopoietin that is closely related to ANGIOPOIETIN-1. It binds to the TIE-2 RECEPTOR without receptor stimulation and antagonizes the effect of ANGIOPOIETIN-1. However its antagonistic effect may be limited to cell receptors that occur within the vasculature. Angiopoietin-2 may therefore play a role in down-regulation of BLOOD VESSEL branching and sprouting.%A%    
% 223.06/223.21  |- skos__altLabel mesh__D042702 Angiopoietin 2
% 223.06/223.21  |- mesh__recordAuthorizer mesh__D042702 sjn
% 223.06/223.21  |- mesh__recordMaintainer mesh__D042702 ssb
% 223.06/223.21  |- skos__historyNote mesh__D042702 Proteins %28%1999-2002%29%
% 223.06/223.21  |- mesh__publicMeSHNote mesh__D042702
% 223.06/223.21       2004; ANGIOPOIETIN-2 was indexed under PROTEINS 1999-2002 %26% ANGIOGENESIS FACTOR 2003%A%  
% 223.06/223.21  |- mesh__dateEstablished mesh__D042702 2004-01-01
% 223.06/223.21  |- mesh__historyNote mesh__D042702
% 223.06/223.21       2004; use ANGIOPOIETIN-2 %28%NM%29% 1997-2003   
% 223.06/223.21  |- skos__historyNote mesh__D042702 Angiogenesis Factor %28%2003%29%
% 223.06/223.21  |- mesh__dateCreated mesh__D042702 2003-07-09
% 223.06/223.21  |- skos__broader mesh__D042702smesh__D042682
% 223.06/223.21  |- rdf__type mesh__D042702sskos__Concept
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D020250 2005
% 223.06/223.21  |- skos__broader mesh__D020250smesh__D011183
% 223.06/223.21  |- mesh__dateRevised mesh__D020250 2003-07-09
% 223.06/223.21  |- mesh__dateEstablished mesh__D020250 1999-01-01
% 223.06/223.21  |- skos__altLabel mesh__D020250 Emesis, Postoperative
% 223.06/223.21  |- skos__altLabel mesh__D020250 PONV
% 223.06/223.21  |- mesh__historyNote mesh__D020250 99   
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D020250 2004
% 223.06/223.21  |- skos__historyNote mesh__D020250 Vomiting %28%1966-1998%29%
% 223.06/223.21  |- skos__altLabel mesh__D020250 Postoperative Emesis
% 223.06/223.21  |- skos__altLabel mesh__D020250 Postoperative Vomiting
% 223.06/223.21  |- mesh__recordMaintainer mesh__D020250 lkt
% 223.06/223.21  |- skos__hiddenLabel mesh__D020250 Postoperative Emeses
% 223.06/223.21  |- mesh__dateCreated mesh__D020250 1998-06-16
% 223.06/223.21  |- mesh__recordAuthorizer mesh__D020250 sjn
% 223.06/223.21  |- skos__broader mesh__D020250smesh__D009325
% 223.06/223.21  |- skos__altLabel mesh__D020250 Nausea, Postoperative
% 223.06/223.21  |- mesh__publicMeSHNote mesh__D020250 99   
% 223.06/223.21  |- skos__historyNote mesh__D020250
% 223.06/223.21       Postoperative Complications %28%1966-1998%29%
% 223.06/223.21  |- skos__altLabel mesh__D020250 Nausea and Vomiting, Postoperative
% 223.06/223.21  |- mesh__recordOriginator mesh__D020250 TPW
% 223.06/223.21  |- rdf__type mesh__D020250sskos__Concept
% 223.06/223.21  |- skos__historyNote mesh__D020250 Nausea %28%1966-1998%29%
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D020250 2006
% 223.06/223.21  |- skos__scopeNote mesh__D020250
% 223.06/223.21       Emesis and queasiness occurring after anesthesia.     
% 223.06/223.21  |- skos__prefLabel mesh__D020250 Postoperative Nausea and Vomiting
% 223.06/223.21  |- skos__broader mesh__D020250smesh__D014839
% 223.06/223.21  |- skos__hiddenLabel mesh__D020250 Emeses, Postoperative
% 223.06/223.21  |- mesh__recordMaintainer mesh__D014213 ssb
% 223.06/223.21  |- skos__hiddenLabel mesh__D014213 CV 705
% 223.06/223.21  |- skos__scopeNote mesh__D014213
% 223.06/223.21       An adrenergic beta-agonist used as a bronchodilator agent in asthma therapy.%A%    
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D014213 2004
% 223.06/223.21  |- skos__hiddenLabel mesh__D014213 AQ110
% 223.06/223.21  |- skos__altLabel mesh__D014213 Trimetoquinol
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D014213 2006
% 223.06/223.21  |- mesh__recordOriginator mesh__D014213 NLM
% 223.06/223.21  |- mesh__dateEstablished mesh__D014213 1991-01-01
% 223.06/223.21  |- skos__altLabel mesh__D014213 Tetroquinol
% 223.06/223.21  |- mesh__publicMeSHNote mesh__D014213
% 223.06/223.21       91; was see under ISOQUINOLINES 1975-90   
% 223.06/223.21  |- skos__broader mesh__D014213smesh__D044182
% 223.06/223.21  |- skos__hiddenLabel mesh__D014213 AQL208
% 223.06/223.21  |- skos__hiddenLabel mesh__D014213 AQL 208
% 223.06/223.21  |- skos__historyNote mesh__D014213 Isoquinolines %28%1971-1974%29%
% 223.06/223.21  |- skos__altLabel mesh__D014213 Tretoquinol Hydrochloride, %28%S%29%-Isomer
% 223.06/223.21  |- mesh__recordAuthorizer mesh__D014213 sjn
% 223.06/223.21  |- skos__prefLabel mesh__D014213 Tretoquinol
% 223.06/223.21  |- mesh__dateCreated mesh__D014213 1974-11-19
% 223.06/223.21  |- skos__hiddenLabel mesh__D014213 CV705
% 223.06/223.21  |- skos__hiddenLabel mesh__D014213 AQ 110
% 223.06/223.21  |- skos__historyNote mesh__D014213 Benzyl Compounds %28%1972-1974%29%
% 223.06/223.21  |- mesh__historyNote mesh__D014213
% 223.06/223.21       91%28%75%29%; was see under ISOQUINOLINES 1975-90   
% 223.06/223.21  |- mesh__dateRevised mesh__D014213 2003-07-09
% 223.06/223.21  |- rdf__type mesh__D014213sskos__Concept
% 223.06/223.21  |- skos__altLabel mesh__D014213 Trimethoquinol
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D014213 2005
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D005487 2005
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D005487 2004
% 223.06/223.21  |- skos__scopeNote mesh__D005487
% 223.06/223.21       Lipid-laden macrophages originating from monocytes or from smooth muscle cells.%A%    
% 223.06/223.21  |- skos__hiddenLabel mesh__D005487 Cell, Foam
% 223.06/223.21  |- mesh__publicMeSHNote mesh__D005487
% 223.06/223.21       91; was see under MACROPHAGES 1977-90   
% 223.06/223.21  |- skos__hiddenLabel mesh__D005487 Foam Cell
% 223.06/223.21  |- skos__prefLabel mesh__D005487 Foam Cells
% 223.06/223.21  |- mesh__recordOriginator mesh__D005487 VDK
% 223.06/223.21  |- mesh__dateRevised mesh__D005487 2003-07-09
% 223.06/223.21  |- mesh__recordMaintainer mesh__D005487 nns
% 223.06/223.21  |- skos__broader mesh__D005487smesh__D008264
% 223.06/223.21  |- mesh__dateCreated mesh__D005487 1976-04-16
% 223.06/223.21  |- mesh__recordAuthorizer mesh__D005487 sjn
% 223.06/223.21  |- rdf__type mesh__D005487sskos__Concept
% 223.06/223.21  |- mesh__dateEstablished mesh__D005487 1991-01-01
% 223.06/223.21  |- skos__hiddenLabel mesh__D005487 Cells, Foam
% 223.06/223.21  |- skos__annotation mesh__D005487
% 223.06/223.21       %22%lipid-laden macrophages%22%; A 11 qualif   
% 223.06/223.21  |- skos__historyNote mesh__D005487 Macrophages %28%1966-1976%29%
% 223.06/223.21  |- mesh__historyNote mesh__D005487
% 223.06/223.21       91%28%77%29%; was see under MACROPHAGES 1977-90   
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D005487 2006
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D013919 1997
% 223.06/223.21  |- mesh__dateRevised mesh__D013919 1991-06-19
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D013919 1999
% 223.06/223.21  |- skos__prefLabel mesh__D013919 Thromboangiitis Obliterans
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D013919 1992
% 223.06/223.21  |- skos__hiddenLabel mesh__D013919 Disease, Buerger%27%s
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D013919 2003
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D013919 1994
% 223.06/223.21  |- mesh__recordOriginator mesh__D013919 NLM
% 223.06/223.21  |- skos__altLabel mesh__D013919 Thromboangitis Obliterans
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D013919 2002
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D013919 2005
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D013919 1993
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D013919 2004
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D013919 1995
% 223.06/223.21  |- skos__altLabel mesh__D013919 Buerger%27%s Disease
% 223.06/223.21  |- skos__broader mesh__D013919smesh__D001157
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D013919 2006
% 223.06/223.21  |- skos__hiddenLabel mesh__D013919 Disease, Buerger
% 223.06/223.21  |- rdf__type mesh__D013919sskos__Concept
% 223.06/223.21  |- skos__hiddenLabel mesh__D013919 Buergers Disease
% 223.06/223.21  |- skos__annotation mesh__D013919
% 223.06/223.21       TN 11: differentiate from other obliterative dis   
% 223.06/223.21  |- mesh__recordMaintainer mesh__D013919 TGC
% 223.06/223.21  |- mesh__recordAuthorizer mesh__D013919 PLS
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D013919 2000
% 223.06/223.21  |- mesh__dateCreated mesh__D013919 1999-01-01
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D013919 1996
% 223.06/223.21  |- skos__altLabel mesh__D013919 Buerger Disease
% 223.06/223.21  |- skos__broader mesh__D013919smesh__D014657
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D013919 2001
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D013919 1998
% 223.06/223.21  |- skos__hiddenLabel mesh__D018604 Mappings, Epitope
% 223.06/223.21  |- mesh__historyNote mesh__D018604 95   
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D018604 2006
% 223.06/223.21  |- skos__hiddenLabel mesh__D018604 Epitope Mappings
% 223.06/223.21  |- mesh__publicMeSHNote mesh__D018604 95   
% 223.06/223.21  |- skos__broader mesh__D018604smesh__D025941
% 223.06/223.21  |- mesh__recordAuthorizer mesh__D018604 sjn
% 223.06/223.21  |- skos__prefLabel mesh__D018604 Epitope Mapping
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D018604 2002
% 223.06/223.21  |- mesh__dateRevised mesh__D018604 2001-07-25
% 223.06/223.21  |- skos__hiddenLabel mesh__D018604 Mapping, Epitope
% 223.06/223.21  |- mesh__recordOriginator mesh__D018604 PXP
% 223.06/223.21  |- rdf__type mesh__D018604sskos__Concept
% 223.06/223.21  |- skos__historyNote mesh__D018604 Antigenic Determinants %28%1982-1994%29%
% 223.06/223.21  |- mesh__dateEstablished mesh__D018604 1995-01-01
% 223.06/223.21  |- mesh__dateCreated mesh__D018604 1994-02-28
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D018604 2003
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D018604 2005
% 223.06/223.21  |- skos__broader mesh__D018604smesh__D007158
% 223.06/223.21  |- skos__scopeNote mesh__D018604
% 223.06/223.21       Methods used for studying the interactions of antibodies with specific regions of protein antigens. Important applications of epitope mapping are found within the area of immunochemistry.%A%    
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D018604 2004
% 223.06/223.21  |- mesh__recordMaintainer mesh__D018604 nns
% 223.06/223.21  |- mesh__dateEstablished mesh__D010621 1991-01-01
% 223.06/223.21  |- skos__scopeNote mesh__D010621
% 223.06/223.21       A local anesthetic that has been used in urinary tract disorders. Its use is limited by problems with toxicity %28%primarily blood disorders%29% and potential carcinogenicity.%A%    
% 223.06/223.21  |- skos__hiddenLabel mesh__D010621 Azo Dine
% 223.06/223.21  |- skos__altLabel mesh__D010621
% 223.06/223.21       Goldline Brand of Phenazopyridine Hydrochloride
% 223.06/223.21  |- skos__hiddenLabel mesh__D010621 Azo Standard
% 223.06/223.21  |- skos__annotation mesh__D010621 a local anesthetic   
% 223.06/223.21  |- skos__altLabel mesh__D010621
% 223.06/223.21       Edwards Brand of Phenazopyridine Hydrochloride
% 223.06/223.21  |- skos__hiddenLabel mesh__D010621 AzoNatural
% 223.06/223.21  |- skos__altLabel mesh__D010621
% 223.06/223.21       Rugby Brand of Phenazopyridine Hydrochloride
% 223.06/223.21  |- skos__hiddenLabel mesh__D010621 AzoGesic
% 223.06/223.21  |- mesh__dateCreated mesh__D010621 1977-12-07
% 223.06/223.21  |- skos__hiddenLabel mesh__D010621 Re Azo
% 223.06/223.21  |- skos__hiddenLabel mesh__D010621 Hydrochloride, Phenazopyridine
% 223.06/223.21  |- mesh__historyNote mesh__D010621
% 223.06/223.21       91%28%65%29%; was see under AMINOPYRIDINES 1979-90; was see under PYRIDINES 1975-78%A%  
% 223.06/223.21  |- skos__hiddenLabel mesh__D010621 Azo Natural
% 223.06/223.21  |- mesh__recordMaintainer mesh__D010621 lkw
% 223.06/223.21  |- skos__hiddenLabel mesh__D010621 Azo Gesic
% 223.06/223.21  |- skos__altLabel mesh__D010621
% 223.06/223.21       Major Brand of Phenazopyridine Hydrochloride
% 223.06/223.21  |- skos__altLabel mesh__D010621
% 223.06/223.21       Warner Chilcott Brand of Phenazopyridine Hydrochloride
% 223.06/223.21  |- skos__hiddenLabel mesh__D010621 ReAzo
% 223.06/223.21  |- rdf__type mesh__D010621sskos__Concept
% 223.06/223.21  |- skos__altLabel mesh__D010621
% 223.06/223.21       Reese Brand of Phenazopyridine Hydrochloride
% 223.06/223.21  |- skos__altLabel mesh__D010621
% 223.06/223.21       PolyMedica Brand of Phenazopyridine Hydrochloride
% 223.06/223.21  |- mesh__dateRevised mesh__D010621 2005-06-30
% 223.06/223.21  |- skos__altLabel mesh__D010621 ICN Brand of Phenazopyridine Hydrochloride
% 223.06/223.21  |- skos__hiddenLabel mesh__D010621 AzoDine
% 223.06/223.21  |- skos__altLabel mesh__D010621
% 223.06/223.21       United Research Brand of Phenazopyridine Hydrochloride
% 223.06/223.21  |- skos__altLabel mesh__D010621
% 223.06/223.21       Consumer Choice Brand of Phenazopyridine Hydrochloride
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D010621 2006
% 223.06/223.21  |- skos__altLabel mesh__D010621
% 223.06/223.21       Requa Brand of Phenazopyridine Hydrochloride
% 223.06/223.21  |- skos__hiddenLabel mesh__D010621 AzoStandard
% 223.06/223.21  |- mesh__recordOriginator mesh__D010621 SH
% 223.06/223.21  |- skos__altLabel mesh__D010621
% 223.06/223.21       Pfizer Brand of Phenazopyridine Hydrochloride
% 223.06/223.21  |- skos__altLabel mesh__D010621 Pyridiate
% 223.06/223.21  |- mesh__recordAuthorizer mesh__D010621 sjn
% 223.06/223.21  |- skos__altLabel mesh__D010621
% 223.06/223.21       Pfeiffer Brand of Phenazopyridine Hydrochloride
% 223.06/223.21  |- mesh__publicMeSHNote mesh__D010621
% 223.06/223.21       91; was see under AMINOPYRIDINES 1979-90; was see under PYRIDINES 1975-78%A%  
% 223.06/223.21  |- skos__altLabel mesh__D010621
% 223.06/223.21       Republic Drug Brand of Phenazopyridine Hydrochloride
% 223.06/223.21  |- skos__broader mesh__D010621smesh__D000631
% 223.06/223.21  |- skos__altLabel mesh__D010621
% 223.06/223.21       Cemco Brand of Phenazopyridine Hydrochloride
% 223.06/223.21  |- skos__prefLabel mesh__D010621 Phenazopyridine
% 223.06/223.21  |- mesh__historyNote mesh__D048291 2005%28%1996%29%   
% 223.06/223.21  |- skos__hiddenLabel mesh__D048291 Protein Kinase-3, Stress-Activated
% 223.06/223.21  |- skos__hiddenLabel mesh__D048291 Kinase-3, SAP
% 223.06/223.21  |- skos__historyNote mesh__D048291 Protein Kinases %28%1996-1999%29%
% 223.06/223.21  |- mesh__publicMeSHNote mesh__D048291
% 223.06/223.21       2005; MITOGEN-ACTIVATED PROTEIN KINASE 12 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004 %26% under MITOGEN-ACTIVATED PROTEIN KINASES 1996-1999%A%  
% 223.06/223.21  |- skos__altLabel mesh__D048291 Extracellular Signal-Regulated Kinase 6
% 223.06/223.21  |- skos__altLabel mesh__D048291 ERK6 Protein
% 223.06/223.21  |- skos__hiddenLabel mesh__D048291 Stress Activated Protein Kinase 3
% 223.06/223.21  |- skos__hiddenLabel mesh__D048291 Mitogen Activated Protein Kinase 12
% 223.06/223.21  |- skos__hiddenLabel mesh__D048291 Kinase, p38gamma MAP
% 223.06/223.21  |- mesh__recordAuthorizer mesh__D048291 sjn
% 223.06/223.21  |- skos__hiddenLabel mesh__D048291 Kinase 3, SAP
% 223.06/223.21  |- skos__hiddenLabel mesh__D048291 MAPK12 Mitogen Activated Protein Kinase
% 223.06/223.21  |- skos__altLabel mesh__D048291 SAPK3
% 223.06/223.21  |- skos__altLabel mesh__D048291 SAP Kinase-3
% 223.06/223.21  |- skos__altLabel mesh__D048291 Stress-Activated Protein Kinase-3
% 223.06/223.21  |- mesh__dateCreated mesh__D048291 2004-07-07
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D048291 2006
% 223.06/223.21  |- rdf__type mesh__D048291sskos__Concept
% 223.06/223.21  |- skos__broader mesh__D048291smesh__D048051
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D048291 2005
% 223.06/223.21  |- skos__altLabel mesh__D048291 p38gamma MAP Kinase
% 223.06/223.21  |- mesh__recordOriginator mesh__D048291 jmp
% 223.06/223.21  |- skos__prefLabel mesh__D048291 Mitogen-Activated Protein Kinase 12
% 223.06/223.21  |- skos__hiddenLabel mesh__D048291 MAP Kinase, p38gamma
% 223.06/223.21  |- mesh__dateEstablished mesh__D048291 2005-01-01
% 223.06/223.21  |- skos__altLabel mesh__D048291 MAPK12 Mitogen-Activated Protein Kinase
% 223.06/223.21  |- skos__scopeNote mesh__D048291
% 223.06/223.21       A 38-kDa mitogen-activated protein kinase found primarily in SKELETAL MUSCLE.%A%    
% 223.06/223.21  |- skos__altLabel mesh__D048291 SAP Kinase 3
% 223.06/223.21  |- mesh__recordMaintainer mesh__D048291 jmp
% 223.06/223.21  |- skos__hiddenLabel mesh__D048291 Extracellular Signal Regulated Kinase 6
% 223.06/223.21  |- skos__historyNote mesh__D048291
% 223.06/223.21       Mitogen-Activated Protein Kinases %28%2000-2004%29%
% 223.06/223.21  |- skos__hiddenLabel mesh__D048291 Kinase-3, Stress-Activated Protein
% 223.06/223.21  |- skos__scopeNote mesh__D009878
% 223.06/223.21       Acute conjunctival inflammation in the newborn, usually caused by maternal gonococcal infection. The causative agent is NEISSERIA GONORRHOEAE. The baby%27%s eyes are contaminated during passage through the birth canal.%A%    
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D009878 2003
% 223.06/223.21  |- rdf__type mesh__D009878sskos__Concept
% 223.06/223.21  |- skos__prefLabel mesh__D009878 Ophthalmia Neonatorum
% 223.06/223.21  |- mesh__dateCreated mesh__D009878 1999-01-01
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D009878 2002
% 223.06/223.21  |- skos__broader mesh__D009878smesh__D003234
% 223.06/223.21  |- skos__annotation mesh__D009878
% 223.06/223.21       bact conjunctivitis; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D009878 2006
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D009878 2001
% 223.06/223.21  |- mesh__recordAuthorizer mesh__D009878 sjn
% 223.06/223.21  |- skos__broader mesh__D009878smesh__D006069
% 223.06/223.21  |- mesh__recordMaintainer mesh__D009878 kle
% 223.06/223.21  |- mesh__recordOriginator mesh__D009878 NLM
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D009878 2004
% 223.06/223.21  |- mesh__dateRevised mesh__D009878 1999-11-03
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D009878 2005
% 223.06/223.21  |- skos__broader mesh__D009878smesh__D007232
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D009878 2000
% 223.06/223.21  |- skos__prefLabel mesh__D001895 Boron
% 223.06/223.21  |- mesh__dateRevised mesh__D001895 2005-06-30
% 223.06/223.21  |- skos__scopeNote mesh__D001895
% 223.06/223.21       A trace element with the atomic symbol B, atomic number 5, and atomic weight 10.81. Boron-10, an isotope of boron, is used as a neutron absorber in BORON NEUTRON CAPTURE THERAPY.%A%    
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D001895 2006
% 223.06/223.21  |- rdf__type mesh__D001895sskos__Concept
% 223.06/223.21  |- skos__broader mesh__D001895smesh__D004602
% 223.06/223.21  |- skos__annotation mesh__D001895
% 223.06/223.21       B-11; B-10 = BORON %28%IM%29% + ISOTOPES %28%NIM%29%; B-8, 9, 12, 13 = BORON %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 223.06/223.21  |- mesh__recordOriginator mesh__D001895 NLM
% 223.06/223.21  |- mesh__recordMaintainer mesh__D001895 ssb
% 223.06/223.21  |- mesh__recordAuthorizer mesh__D001895 sjn
% 223.06/223.21  |- mesh__dateCreated mesh__D001895 1999-01-01
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D001097 2006
% 223.06/223.21  |- mesh__recordOriginator mesh__D001097 NLM
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D001097 2005
% 223.06/223.21  |- skos__scopeNote mesh__D001097
% 223.06/223.21       A class of Arthropoda that includes SPIDERS; TICKS; MITES; and SCORPIONS.%A%    
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D001097 2004
% 223.06/223.21  |- mesh__recordAuthorizer mesh__D001097 sjn
% 223.06/223.21  |- skos__prefLabel mesh__D001097 Arachnida
% 223.06/223.21  |- mesh__dateRevised mesh__D001097 2003-07-09
% 223.06/223.21  |- rdf__type mesh__D001097sskos__Concept
% 223.06/223.21  |- skos__broader mesh__D001097smesh__D001181
% 223.06/223.21  |- skos__altLabel mesh__D001097 Arachnids
% 223.06/223.21  |- mesh__recordMaintainer mesh__D001097 ags
% 223.06/223.21  |- mesh__dateCreated mesh__D001097 1999-01-01
% 223.06/223.21  |- mesh__recordAuthorizer mesh__D006580 PLS
% 223.06/223.21  |- skos__hiddenLabel mesh__D006580 Genetic Carrier Detections
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D006580 1995
% 223.06/223.21  |- skos__altLabel mesh__D006580 Carrier Detection, Genetic
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D006580 2000
% 223.06/223.21  |- skos__hiddenLabel mesh__D006580 Genetic Carrier, Detection
% 223.06/223.21  |- rdf__type mesh__D006580sskos__Concept
% 223.06/223.21  |- mesh__publicMeSHNote mesh__D006580 79   
% 223.06/223.21  |- skos__hiddenLabel mesh__D006580 Heterozygote Detections
% 223.06/223.21  |- skos__altLabel mesh__D006580 Detection, Genetic Carrier
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D006580 1996
% 223.06/223.21  |- skos__hiddenLabel mesh__D006580 Carriers, Detection Genetic
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D006580 2001
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D006580 2003
% 223.06/223.21  |- skos__hiddenLabel mesh__D006580 Detection, Heterozygote
% 223.06/223.21  |- mesh__recordOriginator mesh__D006580 SMH
% 223.06/223.21  |- skos__scopeNote mesh__D006580
% 223.06/223.21       Identification of genetic carriers for a given trait.     
% 223.06/223.21  |- skos__hiddenLabel mesh__D006580 Detection Genetic Carriers
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D006580 1997
% 223.06/223.21  |- skos__altLabel mesh__D006580 Genetic Carrier Detection
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D006580 2002
% 223.06/223.21  |- skos__broader mesh__D006580smesh__D005821
% 223.06/223.21  |- skos__hiddenLabel mesh__D006580 Carrier Detections, Genetic
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D006580 2004
% 223.06/223.21  |- skos__hiddenLabel mesh__D006580 Detections, Heterozygote
% 223.06/223.21  |- skos__altLabel mesh__D006580 Carriers, Genetic, Detection
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D006580 1993
% 223.06/223.21  |- mesh__dateCreated mesh__D006580 1977-11-23
% 223.06/223.21  |- mesh__recordMaintainer mesh__D006580 TAP
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D006580 1998
% 223.06/223.21  |- skos__historyNote mesh__D006580 Heterozygote %28%1968-1978%29%
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D006580 2005
% 223.06/223.21  |- skos__altLabel mesh__D006580 Genetic Carriers, Detection
% 223.06/223.21  |- mesh__historyNote mesh__D006580 79   
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D006580 1994
% 223.06/223.21  |- skos__prefLabel mesh__D006580 Heterozygote Detection
% 223.06/223.21  |- skos__hiddenLabel mesh__D006580 Carrier, Detection Genetic
% 223.06/223.21  |- mesh__dateRevised mesh__D006580 1992-05-15
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D006580 1999
% 223.06/223.21  |- skos__hiddenLabel mesh__D006580 Detections, Genetic Carrier
% 223.06/223.21  |- mesh__dateEstablished mesh__D006580 1979-01-01
% 223.06/223.21  |- skos__hiddenLabel mesh__D006580 Detection Genetic Carrier
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D006580 2006
% 223.06/223.21  |- mesh__dateEstablished mesh__D014214 1991-01-01
% 223.06/223.21  |- mesh__dateCreated mesh__D014214 1974-11-11
% 223.06/223.21  |- skos__historyNote mesh__D014214 Allyl Compounds %28%1973-1974%29%
% 223.06/223.21  |- skos__altLabel mesh__D014214 Tri-allate
% 223.06/223.21  |- skos__broader mesh__D014214smesh__D013859
% 223.06/223.21  |- mesh__historyNote mesh__D014214
% 223.06/223.21       94; was TRI-ALLATE 1975-93 %28%see under THIOCARBAMATES 1975-90%29%%A%  
% 223.06/223.21  |- mesh__recordMaintainer mesh__D014214 ssb
% 223.06/223.21  |- mesh__dateRevised mesh__D014214 2004-07-07
% 223.06/223.21  |- mesh__onlineNote mesh__D014214
% 223.06/223.21       use TRIALLATE to search TRI-ALLATE 1975-93   
% 223.06/223.21  |- skos__hiddenLabel mesh__D014214 FarGo
% 223.06/223.21  |- mesh__recordOriginator mesh__D014214 NLM
% 223.06/223.21  |- skos__hiddenLabel mesh__D014214 Tri allate
% 223.06/223.21  |- rdf__type mesh__D014214sskos__Concept
% 223.06/223.21  |- mesh__recordAuthorizer mesh__D014214 sjn
% 223.06/223.21  |- skos__scopeNote mesh__D014214
% 223.06/223.21       A pre-emergence, selective herbicide for the control of wild oats in various crops.%A%    
% 223.06/223.21  |- mesh__publicMeSHNote mesh__D014214
% 223.06/223.21       94; was TRI-ALLATE 1975-93 %28%see under THIOCARBAMATES 1975-90%29%%A%  
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D014214 2005
% 223.06/223.21  |- skos__prefLabel mesh__D014214 Triallate
% 223.06/223.21  |- skos__historyNote mesh__D014214 Thiocarbamates %28%1970-1974%29%
% 223.06/223.21  |- skos__hiddenLabel mesh__D014214 Far Go
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D014214 2006
% 223.06/223.21  |- mesh__recordMaintainer mesh__D024642 DRC
% 223.06/223.21  |- skos__altLabel mesh__D024642 Voltage-Gated Potassium Channel
% 223.06/223.21  |- mesh__dateEstablished mesh__D024642 2002-01-01
% 223.06/223.21  |- skos__altLabel mesh__D024642 Potassium Channel, Voltage-Gated
% 223.06/223.21  |- skos__hiddenLabel mesh__D024642 Voltage Gated K+ Channels
% 223.06/223.21  |- skos__broader mesh__D024642smesh__D015221
% 223.06/223.21  |- skos__altLabel mesh__D024642 Voltage-Gated K+ Channels
% 223.06/223.21  |- skos__hiddenLabel mesh__D024642 Potassium Channels, Voltage Gated
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D024642 2006
% 223.06/223.21  |- mesh__recordOriginator mesh__D024642 ags
% 223.06/223.21  |- mesh__dateRevised mesh__D024642 2005-06-30
% 223.06/223.21  |- rdf__type mesh__D024642sskos__Concept
% 223.06/223.21  |- skos__hiddenLabel mesh__D024642 Potassium Channels, Kv
% 223.06/223.21  |- mesh__recordAuthorizer mesh__D024642 sjn
% 223.06/223.21  |- skos__altLabel mesh__D024642 Voltage-Gated Potassium Channels
% 223.06/223.21  |- skos__hiddenLabel mesh__D024642 Voltage Gated Potassium Channels
% 223.06/223.21  |- skos__hiddenLabel mesh__D024642 Voltage Gated Potassium Channel
% 223.06/223.21  |- mesh__historyNote mesh__D024642 2002   
% 223.06/223.21  |- mesh__dateCreated mesh__D024642 2001-08-03
% 223.06/223.21  |- skos__hiddenLabel mesh__D024642 K+ Channels, Voltage-Gated
% 223.06/223.21  |- skos__hiddenLabel mesh__D024642 Potassium Channel, Voltage Gated
% 223.06/223.21  |- skos__scopeNote mesh__D024642
% 223.06/223.21       Potassium channel whose permeability to ions is extremely sensitive to the transmembrane potential difference. The opening of these channels is induced by the membrane depolarization of the ACTION POTENTIAL.%A%    
% 223.06/223.21  |- skos__historyNote mesh__D024642 Potassium Channels %28%1981-2001%29%
% 223.06/223.21  |- skos__altLabel mesh__D024642 Kv Potassium Channels
% 223.06/223.21  |- skos__prefLabel mesh__D024642 Potassium Channels, Voltage-Gated
% 223.06/223.21  |- mesh__publicMeSHNote mesh__D024642 2002   
% 223.06/223.21  |- mesh__historyNote mesh__D002190 77   
% 223.06/223.21  |- skos__hiddenLabel mesh__D002190 Cannibalisms
% 223.06/223.21  |- mesh__recordMaintainer mesh__D002190 JLS
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D002190 2006
% 223.06/223.21  |- mesh__recordAuthorizer mesh__D002190 sjn
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D002190 2005
% 223.06/223.21  |- skos__broader mesh__D002190smesh__D005247
% 223.06/223.21  |- rdf__type mesh__D002190sskos__Concept
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D002190 2004
% 223.06/223.21  |- mesh__dateRevised mesh__D002190 2002-07-03
% 223.06/223.21  |- mesh__dateCreated mesh__D002190 1976-04-13
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D002190 2003
% 223.06/223.21  |- mesh__publicMeSHNote mesh__D002190 77   
% 223.06/223.21  |- skos__prefLabel mesh__D002190 Cannibalism
% 223.06/223.21  |- mesh__dateEstablished mesh__D002190 1977-01-01
% 223.06/223.21  |- skos__annotation mesh__D002190 animal and human   
% 223.06/223.21  |- mesh__recordOriginator mesh__D002190 EC
% 223.06/223.21  |- skos__scopeNote mesh__D002190
% 223.06/223.21       Eating other individuals of one%27%s own species.     
% 223.06/223.21  |- mesh__historyNote mesh__D018605 95   
% 223.06/223.21  |- skos__annotation mesh__D018605
% 223.06/223.21       material or human: read MeSH definition; only /hist   
% 223.06/223.21  |- mesh__publicMeSHNote mesh__D018605 95   
% 223.06/223.21  |- skos__hiddenLabel mesh__D018605 Human Combustibility, Preternatural
% 223.06/223.21  |- mesh__recordAuthorizer mesh__D018605 sjn
% 223.06/223.21  |- skos__scopeNote mesh__D018605
% 223.06/223.21       A circumstance where a substance or organism takes fire and burns without an exogenous source. Spontaneous human combustion differs from preternatural human combustibility in that in the latter, some spark or trivial flame sets the fire and the body tissues, which have a greatly enhanced inflammability, continue to undergo incineration without any external heat source or combustible materials. %28%Bergman NA. Spontaneous human combustion: its role in literature and science. Pharos 1988;Fall;51%28%4%29%:18-21%29%%A%    
% 223.06/223.21  |- mesh__activeMeSHYear mesh__D018605 2006
% 223.06/223.21  |- skos__hiddenLabel mesh__D018605 Spontaneous Combustions
% 223.06/223.21  |- rdf__type mesh__D018605sskos__Concept
% 223.06/223.21  |- skos__broader mesh__D018605smesh__D005390
% 223.06/223.21  |- skos__broader mesh__D018605smesh__D002627
% 223.06/223.21  |- skos__prefLabel mesh__D018605 Spontaneous Combustion
% 223.06/223.21  |- mesh__dateRevised mesh__D018605 2004-07-13
% 223.06/223.21  |- mesh__recordOriginator mesh__D018605 TGC
% 223.06/223.21  |- skos__hiddenLabel mesh__D018605 Combustibilities, Preternatural Human
% 223.06/223.21  |- mesh__dateEstablished mesh__D018605 1995-01-01
% 223.06/223.21  |- skos__hiddenLabel mesh__D018605 Combustibility, Preternatural Human
% 223.06/223.21  |- skos__hiddenLabel mesh__D018605 Combustion, Spontaneous
% 223.06/223.21  |- skos__hiddenLabel mesh__D018605 Preternatural Human Combustibilities
% 223.06/223.21  |- mesh__recordMaintainer mesh__D018605 sjn
% 223.06/223.21  |- mesh__dateCreated mesh__D018605 1994-04-19
% 223.06/223.21  |- skos__hiddenLabel mesh__D018605 Human Combustibilities, Preternatural
% 223.06/223.21  |- skos__hiddenLabel mesh__D018605 Combustions, Spontaneous
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D018605 2005
% 223.06/223.22  |- skos__scopeNote mesh__D010622
% 223.06/223.22       A hallucinogen formerly used as a veterinary anesthetic, and briefly as a general anesthetic for humans. Phencyclidine is similar to KETAMINE in structure and in many of its effects. Like ketamine, it can produce a dissociative state. It exerts its pharmacological action through inhibition of NMDA receptors %28%RECEPTORS, N-METHYL-D-ASPARTATE%29%. As a drug of abuse, it is known as PCP and Angel Dust.%A%    
% 223.06/223.22  |- mesh__dateEstablished mesh__D010622 1973-01-01
% 223.06/223.22  |- skos__hiddenLabel mesh__D010622 GP121
% 223.06/223.22  |- skos__hiddenLabel mesh__D010622 CL395
% 223.06/223.22  |- mesh__recordAuthorizer mesh__D010622 sjn
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D010622 2005
% 223.06/223.22  |- skos__hiddenLabel mesh__D010622 Dust, Angel
% 223.06/223.22  |- mesh__recordMaintainer mesh__D010622 sjn
% 223.06/223.22  |- mesh__historyNote mesh__D010622
% 223.06/223.22       73%28%64%29%; was see under PIPERIDINES 1969-72; was see under PIPERIDINES %26% ANESTHETICS 1968; was see under ANESTHETICS 1967%A%  
% 223.06/223.22  |- mesh__dateCreated mesh__D010622 1999-01-01
% 223.06/223.22  |- skos__historyNote mesh__D010622 Anesthetics %28%1966-1972%29%
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D010622 2006
% 223.06/223.22  |- skos__broader mesh__D010622smesh__D010880
% 223.06/223.22  |- skos__related mesh__D010622smesh__D017478
% 223.06/223.22  |- mesh__recordOriginator mesh__D010622 NLM
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D010622 2004
% 223.06/223.22  |- skos__altLabel mesh__D010622 1-%28%1-Phenylcyclohexyl%29%piperidine
% 223.06/223.22  |- skos__historyNote mesh__D010622 Piperidines %28%1968-1972%29%
% 223.06/223.22  |- mesh__publicMeSHNote mesh__D010622
% 223.06/223.22       73; was see under PIPERIDINES 1969-72; was see under PIPERIDINES %26% ANESTHETICS 1968; was see under ANESTHETICS 1967.%A%  
% 223.06/223.22  |- mesh__dateRevised mesh__D010622 2003-07-25
% 223.06/223.22  |- skos__hiddenLabel mesh__D010622 CL 395
% 223.06/223.22  |- skos__prefLabel mesh__D010622 Phencyclidine
% 223.06/223.22  |- rdf__type mesh__D010622sskos__Concept
% 223.06/223.22  |- skos__related mesh__D010622smesh__D010623
% 223.06/223.22  |- skos__altLabel mesh__D010622 Angel Dust
% 223.06/223.22  |- skos__hiddenLabel mesh__D010622 GP 121
% 223.06/223.22  |- mesh__recordOriginator mesh__D048292 jmp
% 223.06/223.22  |- skos__prefLabel mesh__D048292 Mitogen-Activated Protein Kinase 13
% 223.06/223.22  |- skos__altLabel mesh__D048292 p38delta MAP Kinase
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D048292 2006A
% 223.06/223.22  |- skos__historyNote mesh__D048292 Protein Kinases %28%1997-1999%29%
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D048292 2005
% 223.06/223.22  |- skos__altLabel mesh__D048292 Stress-Activated Protein Kinase 4
% 223.06/223.22  |- mesh__dateRevised mesh__D048292 2005-07-12
% 223.06/223.22  |- skos__hiddenLabel mesh__D048292 Kinase, p38delta MAP
% 223.06/223.22  |- mesh__recordAuthorizer mesh__D048292 ags
% 223.06/223.22  |- mesh__recordMaintainer mesh__D048292 ags
% 223.06/223.22  |- skos__scopeNote mesh__D048292
% 223.06/223.22       A 38-kDa mitogen-activated protein kinase found expressed at high levels in LUNG; KIDNEY; TESTIS; PANCREAS; and SMALL INTESTINE. It may play a role in regulating functions such as CELL DIFFERENTIATION and APOPTOSIS of EPITHELIAL CELLS.%A%    
% 223.06/223.22  |- skos__hiddenLabel mesh__D048292 MAP Kinase, p38delta
% 223.06/223.22  |- skos__altLabel mesh__D048292 SAPK4
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D048292 2006
% 223.06/223.22  |- rdf__type mesh__D048292sskos__Concept
% 223.06/223.22  |- skos__hiddenLabel mesh__D048292 Stress Activated Protein Kinase 4
% 223.06/223.22  |- mesh__historyNote mesh__D048292 2005%28%1997%29%   
% 223.06/223.22  |- skos__historyNote mesh__D048292
% 223.06/223.22       Mitogen-Activated Protein Kinases %28%2000-2004%29%
% 223.06/223.22  |- skos__broader mesh__D048292smesh__D048051
% 223.06/223.22  |- skos__altLabel mesh__D048292 p38delta
% 223.06/223.22  |- mesh__publicMeSHNote mesh__D048292
% 223.06/223.22       2005; MITOGEN-ACTIVATED PROTEIN KINASE 13 was indexed under MITOGEN-ACTIVATED KINASES 2000-2004; under PROTEIN KINASES 1997-1999%A%  
% 223.06/223.22  |- skos__hiddenLabel mesh__D048292 MAPK13 Mitogen Activated Protein Kinase
% 223.06/223.22  |- skos__hiddenLabel mesh__D048292 Mitogen Activated Protein Kinase 13
% 223.06/223.22  |- skos__altLabel mesh__D048292 MAPK13 Mitogen-Activated Protein Kinase
% 223.06/223.22  |- mesh__dateCreated mesh__D048292 2004-07-07
% 223.06/223.22  |- mesh__dateEstablished mesh__D048292 2005-01-01
% 223.06/223.22  |- mesh__recordOriginator mesh__D009879 NLM
% 223.06/223.22  |- skos__broader mesh__D009879smesh__D015864
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D009879 2000
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D009879 1995
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D009879 1991
% 223.06/223.22  |- skos__hiddenLabel mesh__D009879 Sympathetic Ophthalmias
% 223.06/223.22  |- skos__hiddenLabel mesh__D009879 Ophthalmias, Sympathetic
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D009879 1993
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D009879 1994
% 223.06/223.22  |- skos__hiddenLabel mesh__D009879 Sympathetic Uveitis
% 223.06/223.22  |- skos__hiddenLabel mesh__D009879 Sympathetic Uveitides
% 223.06/223.22  |- skos__hiddenLabel mesh__D009879 Sympathetic Ophthalmia
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D009879 2006
% 223.06/223.22  |- skos__altLabel mesh__D009879 Uveitis, Sympathetic
% 223.06/223.22  |- mesh__recordMaintainer mesh__D009879 PLS
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D009879 2002
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D009879 1999
% 223.06/223.22  |- mesh__dateRevised mesh__D009879 1990-05-29
% 223.06/223.22  |- skos__broader mesh__D009879smesh__D001327
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D009879 1992
% 223.06/223.22  |- skos__hiddenLabel mesh__D009879 Uveitides, Sympathetic
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D009879 2004
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D009879 2005
% 223.06/223.22  |- skos__prefLabel mesh__D009879 Ophthalmia, Sympathetic
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D009879 1997
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D009879 1998
% 223.06/223.22  |- skos__scopeNote mesh__D009879
% 223.06/223.22       Granulomatous uveitis which follows in one eye after a penetrating injury to the other eye; the secondarily affected eye is called the sympathizing eye, and the injured eye is called the exciting or activating eye.%A%    
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D009879 2003
% 223.06/223.22  |- rdf__type mesh__D009879sskos__Concept
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D009879 1996
% 223.06/223.22  |- mesh__recordAuthorizer mesh__D009879 NLM
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D009879 2001
% 223.06/223.22  |- mesh__dateCreated mesh__D009879 1999-01-01
% 223.06/223.22  |- skos__annotation mesh__D009879 a type of uveitis: note X ref   
% 223.06/223.22  |- skos__broader mesh__D001896smesh__D007287
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001896 1995
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001896 2004
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001896 2000
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001896 1999
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001896 1994
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001896 2003
% 223.06/223.22  |- mesh__dateEstablished mesh__D001896 1968-01-01
% 223.06/223.22  |- mesh__recordAuthorizer mesh__D001896 PLS
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001896 1998
% 223.06/223.22  |- mesh__historyNote mesh__D001896 68   
% 223.06/223.22  |- rdf__type mesh__D001896sskos__Concept
% 223.06/223.22  |- skos__prefLabel mesh__D001896 Boron Compounds
% 223.06/223.22  |- skos__scopeNote mesh__D001896
% 223.06/223.22       Inorganic or organic compounds that contain boron as an integral part of the molecule.%A%    
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001896 1997
% 223.06/223.22  |- mesh__recordOriginator mesh__D001896 NLM
% 223.06/223.22  |- mesh__publicMeSHNote mesh__D001896 68   
% 223.06/223.22  |- mesh__dateRevised mesh__D001896 1993-06-04
% 223.06/223.22  |- skos__historyNote mesh__D001896 Boron %28%1966-1967%29%
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001896 1996
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001896 2006
% 223.06/223.22  |- skos__hiddenLabel mesh__D001896 Compounds, Boron
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001896 2002
% 223.06/223.22  |- mesh__dateCreated mesh__D001896 1999-01-01
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001896 2005
% 223.06/223.22  |- skos__broader mesh__D001896smesh__D009930
% 223.06/223.22  |- skos__annotation mesh__D001896
% 223.06/223.22       GEN or unspecified; prefer specifics; DF: BORON CPDS   
% 223.06/223.22  |- mesh__recordMaintainer mesh__D001896 TPW
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001896 2001
% 223.06/223.22  |- skos__hiddenLabel mesh__D001098 Spider Bites
% 223.06/223.22  |- skos__prefLabel mesh__D001098 Arachnidism
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001098 2006
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001098 2004
% 223.06/223.22  |- mesh__dateRevised mesh__D001098 2003-07-09
% 223.06/223.22  |- rdf__type mesh__D001098sskos__Concept
% 223.06/223.22  |- skos__hiddenLabel mesh__D001098 Arachnidism, Necrotic
% 223.06/223.22  |- skos__hiddenLabel mesh__D001098 Bites, Spider
% 223.06/223.22  |- mesh__dateCreated mesh__D001098 1999-01-01
% 223.06/223.22  |- mesh__recordOriginator mesh__D001098 NLM
% 223.06/223.22  |- skos__hiddenLabel mesh__D001098 Bite, Spider
% 223.06/223.22  |- skos__broader mesh__D001098smesh__D001733
% 223.06/223.22  |- mesh__recordMaintainer mesh__D001098 ags
% 223.06/223.22  |- mesh__recordAuthorizer mesh__D001098 sjn
% 223.06/223.22  |- skos__related mesh__D001098smesh__D013111
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001098 2005
% 223.06/223.22  |- skos__scopeNote mesh__D001098
% 223.06/223.22       The effects, both local and systemic, caused by the bite of  venomous SPIDERS.%A%    
% 223.06/223.22  |- skos__altLabel mesh__D006581 HCB
% 223.06/223.22  |- mesh__recordMaintainer mesh__D006581 CCR
% 223.06/223.22  |- skos__broader mesh__D006581smesh__D002722
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D006581 2006
% 223.06/223.22  |- skos__prefLabel mesh__D006581 Hexachlorobenzene
% 223.06/223.22  |- skos__scopeNote mesh__D006581
% 223.06/223.22       An agricultural fungicide and seed treatment agent.     
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D006581 2002
% 223.06/223.22  |- mesh__dateEstablished mesh__D006581 1991-01-01
% 223.06/223.22  |- mesh__dateCreated mesh__D006581 1974-11-11
% 223.06/223.22  |- mesh__historyNote mesh__D006581
% 223.06/223.22       91%28%75%29%; was see under CHLOROBENZENES 1975-90   
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D006581 2005
% 223.06/223.22  |- skos__historyNote mesh__D006581 Chlorobenzenes %28%1974%29%
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D006581 2001
% 223.06/223.22  |- skos__annotation mesh__D006581
% 223.06/223.22       do not confuse with BENZENE HEXACHLORIDE see LINDANE; DF: note short X ref%A%  
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D006581 2004
% 223.06/223.22  |- mesh__dateRevised mesh__D006581 2000-06-22
% 223.06/223.22  |- mesh__recordAuthorizer mesh__D006581 sjn
% 223.06/223.22  |- mesh__recordOriginator mesh__D006581 NLM
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D006581 2003
% 223.06/223.22  |- mesh__publicMeSHNote mesh__D006581
% 223.06/223.22       91; was see under CHLOROBENZENES 1975-90   
% 223.06/223.22  |- rdf__type mesh__D006581sskos__Concept
% 223.06/223.22  |- mesh__publicMeSHNote mesh__D020252 99   
% 223.06/223.22  |- skos__hiddenLabel mesh__D020252 Vascular Ectasias, Antral
% 223.06/223.22  |- skos__hiddenLabel mesh__D020252 Stomach, Watermelon
% 223.06/223.22  |- mesh__recordAuthorizer mesh__D020252 sjn
% 223.06/223.22  |- skos__altLabel mesh__D020252 Antral Vascular Ectasia
% 223.06/223.22  |- skos__hiddenLabel mesh__D020252 Ectasia, Antral Vascular
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D020252 2006
% 223.06/223.22  |- rdf__type mesh__D020252sskos__Concept
% 223.06/223.22  |- skos__hiddenLabel mesh__D020252 Stomachs, Watermelon
% 223.06/223.22  |- skos__prefLabel mesh__D020252 Gastric Antral Vascular Ectasia
% 223.06/223.22  |- mesh__dateCreated mesh__D020252 1998-06-10
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D020252 2005
% 223.06/223.22  |- skos__historyNote mesh__D020252 Angiodysplasia %28%1992-1998%29%
% 223.06/223.22  |- mesh__dateEstablished mesh__D020252 1999-01-01
% 223.06/223.22  |- skos__broader mesh__D020252smesh__D013272
% 223.06/223.22  |- skos__hiddenLabel mesh__D020252 Vascular Ectasia, Antral
% 223.06/223.22  |- skos__hiddenLabel mesh__D020252 Ectasias, Antral Vascular
% 223.06/223.22  |- skos__altLabel mesh__D020252 Watermelon Stomach
% 223.06/223.22  |- skos__hiddenLabel mesh__D020252 Antral Vascular Ectasias
% 223.06/223.22  |- mesh__historyNote mesh__D020252 99   
% 223.06/223.22  |- skos__broader mesh__D020252smesh__D016888
% 223.06/223.22  |- mesh__recordOriginator mesh__D020252 NDW
% 223.06/223.22  |- mesh__recordMaintainer mesh__D020252 lkt
% 223.06/223.22  |- skos__scopeNote mesh__D020252
% 223.06/223.22       A distinct vascular lesion in the PYLORIC ANTRUM that is characterized by tortuous dilated blood vessels %28%ectasia%29% radiating outward from the PYLORUS. The vessel pattern resembles the stripes on the surface of a watermelon. This lesion causes both acute and chronic GASTROINTESTINAL HEMORRHAGE.%A%    
% 223.06/223.22  |- skos__hiddenLabel mesh__D020252 Watermelon Stomachs
% 223.06/223.22  |- mesh__dateRevised mesh__D020252 2004-07-07
% 223.06/223.22  |- skos__prefLabel mesh__D014215 Triacetin
% 223.06/223.22  |- mesh__recordAuthorizer mesh__D014215 sjn
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D014215 2006
% 223.06/223.22  |- mesh__recordMaintainer mesh__D014215 ssb
% 223.06/223.22  |- mesh__dateCreated mesh__D014215 1999-01-01
% 223.06/223.22  |- skos__broader mesh__D014215smesh__D014280
% 223.06/223.22  |- mesh__historyNote mesh__D014215
% 223.06/223.22       91%28%66%29%; was see under TRIGLYCERIDES 1966-90   
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D014215 2005
% 223.06/223.22  |- mesh__publicMeSHNote mesh__D014215
% 223.06/223.22       91; was see under TRIGLYCERIDES 1966-90   
% 223.06/223.22  |- mesh__dateEstablished mesh__D014215 1991-01-01
% 223.06/223.22  |- mesh__dateRevised mesh__D014215 2003-07-09
% 223.06/223.22  |- rdf__type mesh__D014215sskos__Concept
% 223.06/223.22  |- mesh__recordOriginator mesh__D014215 NLM
% 223.06/223.22  |- skos__scopeNote mesh__D014215
% 223.06/223.22       A triglyceride that is used as an antifungal agent.     
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D014215 2004
% 223.06/223.22  |- skos__broader mesh__D009136Q000662smesh__D009136
% 223.06/223.22  |- mesh__preferredCombination mesh__D009136Q000662smesh__D009137
% 223.06/223.22  |- rdf__type mesh__D009136Q000662smesh__CompoundConcept
% 223.06/223.22  |- mesh__dateCreated mesh__D005489 1984-04-05
% 223.06/223.22  |- rdf__type mesh__D005489sskos__Concept
% 223.06/223.22  |- skos__historyNote mesh__D005489
% 223.06/223.22       Abnormalities, Multiple %28%1968-1984%29%
% 223.06/223.22  |- skos__hiddenLabel mesh__D005489 Hypoplasias, Focal Dermal
% 223.06/223.22  |- mesh__publicMeSHNote mesh__D005489
% 223.06/223.22       91; was see under ECTODERMAL DYSPLASIA 1987-90, was see under ECTODERMAL DEFECT, CONGENITAL 1985-86; GOLTZ-GORLIN SYNDROME was see FOCAL DERMAL HYPOPLASIA 1985-92%A%  
% 223.06/223.22  |- mesh__onlineNote mesh__D005489
% 223.06/223.22       use FOCAL DERMAL HYPOPLASIA to search GOLTZ-GORLIN SYNDROME 1985-92%A%  
% 223.06/223.22  |- mesh__recordAuthorizer mesh__D005489 sjn
% 223.06/223.22  |- mesh__historyNote mesh__D005489
% 223.06/223.22       91%28%85%29%; was see under ECTODERMAL DYSPLASIA 1987-90, was see under ECTODERMAL DEFECT, CONGENITAL 1985-86; GOLTZ-GORLIN SYNDROME was see FOCAL DERMAL HYPOPLASIA 1985-92%A%  
% 223.06/223.22  |- skos__altLabel mesh__D005489 Goltz Syndrome
% 223.06/223.22  |- mesh__dateEstablished mesh__D005489 1991-01-01
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D005489 2006
% 223.06/223.22  |- skos__scopeNote mesh__D005489
% 223.06/223.22       A genetic skin disease characterized by hypoplasia of the dermis, herniations of fat, and hand anomalies. It is found exclusively in females and transmitted as an X-linked dominant trait.%A%    
% 223.06/223.22  |- skos__hiddenLabel mesh__D005489 Focal Dermal Hypoplasias
% 223.06/223.22  |- skos__hiddenLabel mesh__D005489 Hypoplasia, Focal Dermal
% 223.06/223.22  |- mesh__dateRevised mesh__D005489 2002-07-03
% 223.06/223.22  |- skos__hiddenLabel mesh__D005489 Syndrome, Goltz
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D005489 2004
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D005489 2005
% 223.06/223.22  |- mesh__recordOriginator mesh__D005489 RC
% 223.06/223.22  |- skos__broader mesh__D005489smesh__D004476
% 223.06/223.22  |- skos__hiddenLabel mesh__D005489 Goltzs Syndrome
% 223.06/223.22  |- skos__broader mesh__D005489smesh__D004413
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D005489 2003
% 223.06/223.22  |- skos__hiddenLabel mesh__D005489 Dermal Hypoplasias, Focal
% 223.06/223.22  |- skos__prefLabel mesh__D005489 Focal Dermal Hypoplasia
% 223.06/223.22  |- skos__altLabel mesh__D005489 Goltz%27%s Syndrome
% 223.06/223.22  |- skos__annotation mesh__D005489
% 223.06/223.22       sometimes called Goltz-Gorlin syndrome but do not confuse with Gorlin-Goltz syndrome which is same as GORLIN SYNDROME see BASAL CELL NEVUS SYNDROME; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 223.06/223.22  |- skos__hiddenLabel mesh__D005489 Syndrome, Goltz%27%s
% 223.06/223.22  |- skos__historyNote mesh__D005489 Skin %28%1966-1984%29%
% 223.06/223.22  |- mesh__recordMaintainer mesh__D005489 nns
% 223.06/223.22  |- skos__altLabel mesh__D005489 Dermal Hypoplasia, Focal
% 223.06/223.22  |- skos__historyNote mesh__D005489 Skin Diseases %28%1966-1984%29%
% 223.06/223.22  |- skos__broader mesh__D005489smesh__D040181
% 223.06/223.22  |- skos__broader mesh__D002191smesh__D011245
% 223.06/223.22  |- skos__historyNote mesh__D002191 Ketosteroids %28%1974%29%
% 223.06/223.22  |- skos__historyNote mesh__D002191 Pregnadienes %28%1974%29%
% 223.06/223.22  |- skos__altLabel mesh__D002191
% 223.06/223.22       Boehringer Mannheim Brand of Canrenoate Potassium
% 223.06/223.22  |- skos__altLabel mesh__D002191 Potassium Canrenoate
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D002191 2006
% 223.06/223.22  |- mesh__dateRevised mesh__D002191 2005-06-30
% 223.06/223.22  |- skos__scopeNote mesh__D002191
% 223.06/223.22       A synthetic pregnadiene derivative with anti-aldosterone activity.%A%    
% 223.06/223.22  |- mesh__publicMeSHNote mesh__D002191
% 223.06/223.22       91; was see under PREGNADIENES 1975-90   
% 223.06/223.22  |- skos__altLabel mesh__D002191 ratiopharm Brand of Canrenoate Potassium
% 223.06/223.22  |- skos__hiddenLabel mesh__D002191 SC14266
% 223.06/223.22  |- skos__altLabel mesh__D002191 Pharmacia Brand of Canrenoate Potassium
% 223.06/223.22  |- skos__hiddenLabel mesh__D002191 Canrenoate, Potassium
% 223.06/223.22  |- rdf__type mesh__D002191sskos__Concept
% 223.06/223.22  |- mesh__recordOriginator mesh__D002191 NLM
% 223.06/223.22  |- mesh__dateEstablished mesh__D002191 1991-01-01
% 223.06/223.22  |- mesh__dateCreated mesh__D002191 1974-11-11
% 223.06/223.22  |- mesh__recordMaintainer mesh__D002191 lkw
% 223.06/223.22  |- skos__altLabel mesh__D002191 Searle Brand of Canrenoate Potassium
% 223.06/223.22  |- mesh__recordAuthorizer mesh__D002191 sjn
% 223.06/223.22  |- skos__historyNote mesh__D002191 Carboxylic Acids %28%1974%29%
% 223.06/223.22  |- mesh__historyNote mesh__D002191
% 223.06/223.22       91%28%75%29%; was see under PREGNADIENES 1975-90   
% 223.06/223.22  |- skos__hiddenLabel mesh__D002191 SC 14266
% 223.06/223.22  |- skos__prefLabel mesh__D002191 Canrenoate Potassium
% 223.06/223.22  |- skos__hiddenLabel mesh__D002191 Acid, Canrenoic
% 223.06/223.22  |- skos__hiddenLabel mesh__D010623 Abuse, PCP
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D010623 2005
% 223.06/223.22  |- mesh__dateEstablished mesh__D010623 1981-01-01
% 223.06/223.22  |- skos__historyNote mesh__D010623 Substance Abuse %28%1968-1980%29%
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D010623 2003
% 223.06/223.22  |- skos__hiddenLabel mesh__D010623 Abuse, Phencyclidine
% 223.06/223.22  |- skos__altLabel mesh__D010623 Angel Dust Abuse
% 223.06/223.22  |- skos__scopeNote mesh__D010623
% 223.06/223.22       The misuse of phencyclidine with associated psychological symptoms and impairment in social or occupational functioning.%A%    
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D010623 2006
% 223.06/223.22  |- mesh__historyNote mesh__D010623 81   
% 223.06/223.22  |- mesh__dateRevised mesh__D010623 1999-11-03
% 223.06/223.22  |- skos__hiddenLabel mesh__D010623 Abuse, Angel Dust
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D010623 2004
% 223.06/223.22  |- skos__hiddenLabel mesh__D010623 Phencyclidine-Related Disorder
% 223.06/223.22  |- mesh__recordAuthorizer mesh__D010623 sjn
% 223.06/223.22  |- skos__hiddenLabel mesh__D010623 Phencyclidine Related Disorders
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D010623 2000
% 223.06/223.22  |- skos__broader mesh__D010623smesh__D019966
% 223.06/223.22  |- skos__hiddenLabel mesh__D010623 Phencyclidine Abuses
% 223.06/223.22  |- skos__historyNote mesh__D010623 Phencyclidine %28%1966-1980%29%
% 223.06/223.22  |- skos__altLabel mesh__D010623 PCP Abuse
% 223.06/223.22  |- mesh__dateCreated mesh__D010623 1980-05-21
% 223.06/223.22  |- skos__annotation mesh__D010623 DF: note short X ref   
% 223.06/223.22  |- rdf__type mesh__D010623sskos__Concept
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D010623 2001
% 223.06/223.22  |- mesh__recordMaintainer mesh__D010623 adp
% 223.06/223.22  |- skos__prefLabel mesh__D010623 Phencyclidine Abuse
% 223.06/223.22  |- mesh__recordOriginator mesh__D010623 EC
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D010623 2002
% 223.06/223.22  |- mesh__publicMeSHNote mesh__D010623 81   
% 223.06/223.22  |- mesh__recordMaintainer mesh__D048293 ags
% 223.06/223.22  |- skos__broader mesh__D048293smesh__D009893
% 223.06/223.22  |- mesh__historyNote mesh__D048293 2005; use OPOSSUMS 1968-2004   
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D048293 2006
% 223.06/223.22  |- rdf__type mesh__D048293sskos__Concept
% 223.06/223.22  |- mesh__dateEstablished mesh__D048293 2005-01-01
% 223.06/223.22  |- skos__hiddenLabel mesh__D048293 North American Opossum
% 223.06/223.22  |- skos__scopeNote mesh__D048293
% 223.06/223.22       A genus of large OPOSSUMS in the family Didelphidae, found in the Americas. The species Didelphis virginiana is prominent in North America.%A%    
% 223.06/223.22  |- skos__prefLabel mesh__D048293 Didelphis
% 223.06/223.22  |- skos__hiddenLabel mesh__D048293 North American Opossums
% 223.06/223.22  |- mesh__dateCreated mesh__D048293 2004-07-07
% 223.06/223.22  |- skos__historyNote mesh__D048293 Opossums %28%1966-2004%29%
% 223.06/223.22  |- mesh__recordAuthorizer mesh__D048293 sjn
% 223.06/223.22  |- skos__hiddenLabel mesh__D048293 Opossums, North American
% 223.06/223.22  |- mesh__publicMeSHNote mesh__D048293 2005; see OPOSSUMS 1968-2004   
% 223.06/223.22  |- skos__altLabel mesh__D048293 Opossum, North American
% 223.06/223.22  |- mesh__recordOriginator mesh__D048293 ags
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D048293 2005
% 223.06/223.22  |- mesh__dateRevised mesh__D001897 1993-06-04
% 223.06/223.22  |- skos__annotation mesh__D001897 do not confuse with BORINIC ACIDS   
% 223.06/223.22  |- rdf__type mesh__D001897sskos__Concept
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001897 1997
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001897 2002
% 223.06/223.22  |- mesh__publicMeSHNote mesh__D001897 68   
% 223.06/223.22  |- skos__hiddenLabel mesh__D001897 Acids, Boronic
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001897 1996
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001897 2006
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001897 2001
% 223.06/223.22  |- skos__scopeNote mesh__D001897
% 223.06/223.22       Inorganic or organic compounds that contain the basic structure RB%28%OH%29%2.%A%    
% 223.06/223.22  |- mesh__dateCreated mesh__D001897 1999-01-01
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001897 2005
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001897 2000
% 223.06/223.22  |- mesh__recordMaintainer mesh__D001897 TPW
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001897 1995
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001897 2004
% 223.06/223.22  |- mesh__recordAuthorizer mesh__D001897 PLS
% 223.06/223.22  |- skos__broader mesh__D001897smesh__D000148
% 223.06/223.22  |- skos__prefLabel mesh__D001897 Boronic Acids
% 223.06/223.22  |- skos__broader mesh__D001897smesh__D001896
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001897 1999
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001897 1994
% 223.06/223.22  |- mesh__historyNote mesh__D001897 68   
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001897 2003
% 223.06/223.22  |- skos__historyNote mesh__D001897 Boron %28%1966-1967%29%
% 223.06/223.22  |- mesh__dateEstablished mesh__D001897 1968-01-01
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001897 1998
% 223.06/223.22  |- mesh__recordOriginator mesh__D001897 NLM
% 223.06/223.22  |- mesh__recordMaintainer mesh__D001099 TAP
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001099 1998
% 223.06/223.22  |- mesh__recordAuthorizer mesh__D001099 PLS
% 223.06/223.22  |- skos__prefLabel mesh__D001099 Arachnoid
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001099 2004
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001099 1993
% 223.06/223.22  |- rdf__type mesh__D001099sskos__Concept
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001099 2000
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001099 1996
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001099 1999
% 223.06/223.22  |- mesh__dateCreated mesh__D001099 1999-01-01
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001099 2001
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001099 1997
% 223.06/223.22  |- skos__hiddenLabel mesh__D001099 Arachnoids
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001099 2002
% 223.06/223.22  |- skos__annotation mesh__D001099 inflammation = ARACHNOIDITIS   
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001099 2005
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001099 1994
% 223.06/223.22  |- skos__broader mesh__D001099smesh__D008578
% 223.06/223.22  |- mesh__recordOriginator mesh__D001099 NLM
% 223.06/223.22  |- mesh__dateRevised mesh__D001099 1992-03-25
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001099 2003
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001099 2006
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D001099 1995
% 223.06/223.22  |- mesh__recordOriginator mesh__D006582 NLM
% 223.06/223.22  |- skos__broader mesh__D006582smesh__D002733
% 223.06/223.22  |- skos__altLabel mesh__D006582 Hexachlorophane
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D006582 2006
% 223.06/223.22  |- mesh__recordMaintainer mesh__D006582 CCR
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D006582 2005
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D006582 2004
% 223.06/223.22  |- mesh__dateCreated mesh__D006582 1999-01-01
% 223.06/223.22  |- mesh__dateRevised mesh__D006582 2000-06-22
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D006582 2002
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D006582 2003
% 223.06/223.22  |- rdf__type mesh__D006582sskos__Concept
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D006582 2001
% 223.06/223.22  |- skos__scopeNote mesh__D006582
% 223.06/223.22       A chlorinated bisphenol antiseptic with a bacteriostatic action against Gram-positive organisms, but much less effective against Gram-negative organisms. It is mainly used in soaps and creams and is an ingredient of various preparations used for skin disorders. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p797%29%%A%    
% 223.06/223.22  |- skos__prefLabel mesh__D006582 Hexachlorophene
% 223.06/223.22  |- mesh__recordAuthorizer mesh__D006582 sjn
% 223.06/223.22  |- skos__historyNote mesh__D014216 Piperidones %28%1973-1974%29%
% 223.06/223.22  |- skos__broader mesh__D014216smesh__D010881
% 223.06/223.22  |- skos__scopeNote mesh__D014216
% 223.06/223.22       Cyclic N-oxide radical functioning as a spin label and radiation-sensitizing agent.%A%    
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D014216 2003
% 223.06/223.22  |- skos__prefLabel mesh__D014216 Triacetoneamine-N-Oxyl
% 223.06/223.22  |- skos__broader mesh__D014216smesh__D013113
% 223.06/223.22  |- skos__hiddenLabel mesh__D014216 Triacetoneamine N Oxyl
% 223.06/223.22  |- skos__altLabel mesh__D014216 TAN
% 223.06/223.22  |- mesh__historyNote mesh__D014216
% 223.06/223.22       91%28%75%29%; was see under CYCLIC N-OXIDES 1975-90   
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D014216 2002
% 223.06/223.22  |- mesh__dateEstablished mesh__D014216 1991-01-01
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D014216 2006
% 223.06/223.22  |- skos__broader mesh__D014216smesh__D003497
% 223.06/223.22  |- mesh__activeMeSHYear mesh__D014216 2005
% 223.06/223.22  |- mesh__recordMaintainer mesh__D014216 CCR
% 223.06/223.22  |- mesh__publicMeSHNote mesh__D014216
% 223.06/223.22       91; was see under CYCLIC N-OXIDES 1975-90   
% 223.06/223.23  |- mesh__dateCreated mesh__D014216 1974-11-19
% 223.06/223.23  |- mesh__recordOriginator mesh__D014216 NLM
% 223.06/223.23  |- rdf__type mesh__D014216sskos__Concept
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D014216 2001
% 223.06/223.23  |- skos__altLabel mesh__D014216 2,2,6,6-Tetramethyl-4-oxopiperidine-1-oxyl
% 223.06/223.23  |- skos__historyNote mesh__D014216 Cyclic N-Oxides %28%1972-1974%29%
% 223.06/223.23  |- mesh__recordAuthorizer mesh__D014216 sjn
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D014216 2004
% 223.06/223.23  |- mesh__dateRevised mesh__D014216 2000-06-22
% 223.06/223.23  |- mesh__publicMeSHNote mesh__D030681 2002   
% 223.06/223.23  |- skos__scopeNote mesh__D030681
% 223.06/223.23       A plant genus of the family MORACEAE.  It is the source of the familiar fig fruit and the latex from this tree contains FICAIN.%A%    
% 223.06/223.23  |- skos__broader mesh__D030681smesh__D029586
% 223.06/223.23  |- skos__altLabel mesh__D030681 Rubberplant
% 223.06/223.23  |- mesh__historyNote mesh__D030681 2002   
% 223.06/223.23  |- rdf__type mesh__D030681sskos__Concept
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D030681 2005
% 223.06/223.23  |- mesh__recordMaintainer mesh__D030681 ags
% 223.06/223.23  |- mesh__recordAuthorizer mesh__D030681 ags
% 223.06/223.23  |- mesh__dateRevised mesh__D030681 2005-07-29
% 223.06/223.23  |- mesh__dateEstablished mesh__D030681 2002-01-01
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D030681 2006
% 223.06/223.23  |- skos__prefLabel mesh__D030681 Ficus
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D030681 2003
% 223.06/223.23  |- skos__annotation mesh__D030681
% 223.06/223.23       X ref RUBBERPLANT: RUBBER TREE see HEVEA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D030681 2006A
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D030681 2004
% 223.06/223.23  |- mesh__dateCreated mesh__D030681 2001-07-25
% 223.06/223.23  |- mesh__recordOriginator mesh__D030681 ssb
% 223.06/223.23  |- mesh__recordAuthorizer mesh__D002990 sjn
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D002990 2004
% 223.06/223.23  |- rdf__type mesh__D002990sskos__Concept
% 223.06/223.23  |- skos__prefLabel mesh__D002990 Clobetasol
% 223.06/223.23  |- skos__historyNote mesh__D002990 Betamethasone %28%1974-1976%29%
% 223.06/223.23  |- mesh__dateEstablished mesh__D002990 1991-01-01
% 223.06/223.23  |- mesh__publicMeSHNote mesh__D002990
% 223.06/223.23       91; was see under BETAMETHASONE 1977-90   
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D002990 2006
% 223.06/223.23  |- mesh__historyNote mesh__D002990
% 223.06/223.23       91%28%77%29%; was see under BETAMETHASONE 1977-90   
% 223.06/223.23  |- skos__altLabel mesh__D002990 Clofenazon
% 223.06/223.23  |- skos__historyNote mesh__D002990 Steroids, Chlorinated %28%1974-1975%29%
% 223.06/223.23  |- mesh__recordOriginator mesh__D002990 SH
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D002990 2005
% 223.06/223.23  |- mesh__dateCreated mesh__D002990 1976-04-13
% 223.06/223.23  |- mesh__recordMaintainer mesh__D002990 ssb
% 223.06/223.23  |- mesh__dateRevised mesh__D002990 2003-07-09
% 223.06/223.23  |- skos__broader mesh__D002990smesh__D001623
% 223.06/223.23  |- skos__scopeNote mesh__D002990
% 223.06/223.23       Topical corticosteroid that is absorbed faster than FLUOCINONIDE. It is used in psoriasis, but may cause marked adrenocortical suppression.%A%    
% 223.06/223.23  |- skos__historyNote mesh__D002990 Propionates %28%1974%29%
% 223.06/223.23  |- mesh__dateRevised mesh__D002192 2000-06-21
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D002192 2003
% 223.06/223.23  |- skos__hiddenLabel mesh__D002192 R.P., 11614
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D002192 2004
% 223.06/223.23  |- rdf__type mesh__D002192sskos__Concept
% 223.06/223.23  |- mesh__dateEstablished mesh__D002192 1991-01-01
% 223.06/223.23  |- skos__historyNote mesh__D002192 Lactones %28%1974%29%
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D002192 2001
% 223.06/223.23  |- skos__prefLabel mesh__D002192 Canrenone
% 223.06/223.23  |- mesh__dateCreated mesh__D002192 1974-11-11
% 223.06/223.23  |- mesh__publicMeSHNote mesh__D002192
% 223.06/223.23       91; was see under PREGNADIENES 1975-90   
% 223.06/223.23  |- skos__scopeNote mesh__D002192
% 223.06/223.23       A synthetic pregnadiene compound with anti-aldosterone activity.%A%    
% 223.06/223.23  |- skos__hiddenLabel mesh__D002192 SC 9376
% 223.06/223.23  |- mesh__historyNote mesh__D002192
% 223.06/223.23       91%28%75%29%; was see under PREGNADIENES 1975-90   
% 223.06/223.23  |- skos__hiddenLabel mesh__D002192 SC9376
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D002192 2005
% 223.06/223.23  |- mesh__recordOriginator mesh__D002192 NLM
% 223.06/223.23  |- skos__broader mesh__D002192smesh__D011245
% 223.06/223.23  |- skos__altLabel mesh__D002192 Aldadiene
% 223.06/223.23  |- skos__historyNote mesh__D002192 Pregnadienes %28%1974%29%
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D002192 2002
% 223.06/223.23  |- skos__historyNote mesh__D002192 Ketosteroids %28%1974%29%
% 223.06/223.23  |- mesh__recordMaintainer mesh__D002192 TWD
% 223.06/223.23  |- mesh__recordAuthorizer mesh__D002192 sjn
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D002192 2006
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D018607 2005
% 223.06/223.23  |- mesh__recordMaintainer mesh__D018607 PXP
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D018607 2004
% 223.06/223.23  |- skos__prefLabel mesh__D018607 Pregnancy Reduction, Multifetal
% 223.06/223.23  |- mesh__dateEstablished mesh__D018607 1995-01-01
% 223.06/223.23  |- skos__hiddenLabel mesh__D018607 Selective Fetal Terminations
% 223.06/223.23  |- mesh__historyNote mesh__D018607 95   
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D018607 2002
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D018607 1999
% 223.06/223.23  |- skos__hiddenLabel mesh__D018607 Reductions, Multifetal Pregnancy
% 223.06/223.23  |- skos__altLabel mesh__D018607 Multifetal Pregnancy Reduction
% 223.06/223.23  |- skos__hiddenLabel mesh__D018607 Reductions, Embryo
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D018607 2003
% 223.06/223.23  |- skos__scopeNote mesh__D018607
% 223.06/223.23       Selective abortion of one or more embryos or fetuses in a multiple gestation pregnancy. The usual goal is to improve the outcome for the remaining embryos or fetuses.%A%    
% 223.06/223.23  |- skos__hiddenLabel mesh__D018607 Embryo Reductions
% 223.06/223.23  |- skos__broader mesh__D018607smesh__D000032
% 223.06/223.23  |- mesh__recordOriginator mesh__D018607 JLS
% 223.06/223.23  |- skos__annotation mesh__D018607
% 223.06/223.23       abortion of 1 or more embryos or fetus to improve outcome for remaining embryos or fetuses in multiple pregn; DF: PREGN REDUCTION MULTIFETAL%A%  
% 223.06/223.23  |- skos__hiddenLabel mesh__D018607 Termination, Selective Fetal
% 223.06/223.23  |- skos__hiddenLabel mesh__D018607 Terminations, Selective Fetal
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D018607 1998
% 223.06/223.23  |- skos__hiddenLabel mesh__D018607 Selective Fetal Termination
% 223.06/223.23  |- skos__hiddenLabel mesh__D018607 Reduction, Fetal
% 223.06/223.23  |- skos__hiddenLabel mesh__D018607 Reductions, Fetal
% 223.06/223.23  |- skos__broader mesh__D018607smesh__D000028
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D018607 2001
% 223.06/223.23  |- skos__historyNote mesh__D018607 Abortion, Induced %28%1984-1994%29%
% 223.06/223.23  |- mesh__recordAuthorizer mesh__D018607 SJN
% 223.06/223.23  |- skos__hiddenLabel mesh__D018607 Reduction, Embryo
% 223.06/223.23  |- skos__altLabel mesh__D018607 Fetal Reduction
% 223.06/223.23  |- rdf__type mesh__D018607sskos__Concept
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D018607 2000
% 223.06/223.23  |- mesh__publicMeSHNote mesh__D018607 95   
% 223.06/223.23  |- mesh__dateCreated mesh__D018607 1994-06-01
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D018607 2006
% 223.06/223.23  |- skos__hiddenLabel mesh__D018607 Pregnancy Reductions, Multifetal
% 223.06/223.23  |- skos__hiddenLabel mesh__D018607 Fetal Reductions
% 223.06/223.23  |- skos__historyNote mesh__D018607 Pregnancy, Multiple %28%1984-1994%29%
% 223.06/223.23  |- skos__hiddenLabel mesh__D018607 Fetal Terminations, Selective
% 223.06/223.23  |- skos__hiddenLabel mesh__D018607 Reduction, Multifetal Pregnancy
% 223.06/223.23  |- mesh__dateRevised mesh__D018607 1997-06-20
% 223.06/223.23  |- skos__hiddenLabel mesh__D018607 Multifetal Pregnancy Reductions
% 223.06/223.23  |- skos__hiddenLabel mesh__D010624 beta Phenylethylhydrazine
% 223.06/223.23  |- mesh__recordOriginator mesh__D010624 NLM
% 223.06/223.23  |- skos__altLabel mesh__D010624 Fenelzin
% 223.06/223.23  |- mesh__dateRevised mesh__D010624 2005-06-30
% 223.06/223.23  |- skos__altLabel mesh__D010624 Pfizer Brand of Phenelzine Sulfate
% 223.06/223.23  |- skos__altLabel mesh__D010624 United Drug Brand of Phenelzine Sulfate
% 223.06/223.23  |- skos__altLabel mesh__D010624 Phenethylhydrazine
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D010624 2006
% 223.06/223.23  |- skos__altLabel mesh__D010624 beta-Phenylethylhydrazine
% 223.06/223.23  |- skos__altLabel mesh__D010624 Parke Davis Brand of Phenelzine Sulfate
% 223.06/223.23  |- skos__broader mesh__D010624smesh__D006834
% 223.06/223.23  |- skos__prefLabel mesh__D010624 Phenelzine
% 223.06/223.23  |- mesh__recordMaintainer mesh__D010624 lkw
% 223.06/223.23  |- skos__hiddenLabel mesh__D010624 2 Phenethylhydrazine
% 223.06/223.23  |- mesh__recordAuthorizer mesh__D010624 sjn
% 223.06/223.23  |- skos__altLabel mesh__D010624 2-Phenethylhydrazine
% 223.06/223.23  |- skos__hiddenLabel mesh__D010624 Sulfate, Phenelzine
% 223.06/223.23  |- skos__scopeNote mesh__D010624
% 223.06/223.23       One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.%A%    
% 223.06/223.23  |- rdf__type mesh__D010624sskos__Concept
% 223.06/223.23  |- skos__altLabel mesh__D010624 Warner Chilcott Brand of Phenelzine Sulfate
% 223.06/223.23  |- mesh__dateCreated mesh__D010624 1999-01-01
% 223.06/223.23  |- skos__prefLabel mesh__D001898 Borrelia
% 223.06/223.23  |- skos__annotation mesh__D001898
% 223.06/223.23       B. burgdorferi or B. burgdorferi group infection = LYME DISEASE; infection by other species = probably RELAPSING FEVER, but if not, index under BORRELIA INFECTIONS%A%  
% 223.06/223.23  |- mesh__recordMaintainer mesh__D001898 SYSTEM
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D001898 2006
% 223.06/223.23  |- mesh__recordOriginator mesh__D001898 NLM
% 223.06/223.23  |- mesh__dateCreated mesh__D001898 1999-01-01
% 223.06/223.23  |- skos__broader mesh__D001898smesh__D013143
% 223.06/223.23  |- mesh__recordAuthorizer mesh__D001898 sjn
% 223.06/223.23  |- skos__scopeNote mesh__D001898
% 223.06/223.23       A genus of gram-negative, anaerobic, helical bacteria, various species of which produce RELAPSING FEVER in humans and other animals.%A%    
% 223.06/223.23  |- rdf__type mesh__D001898sskos__Concept
% 223.06/223.23  |- mesh__dateRevised mesh__D001898 2005-06-30
% 223.06/223.23  |- mesh__publicMeSHNote mesh__D006583
% 223.06/223.23       91; was see under POLYAMINES 1975-90   
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D006583 2006
% 223.06/223.23  |- skos__historyNote mesh__D006583 Polyamines %28%1972-1974%29%
% 223.06/223.23  |- mesh__dateCreated mesh__D006583 1974-11-19
% 223.06/223.23  |- skos__historyNote mesh__D006583 Hydrocarbons, Brominated %28%1974%29%
% 223.06/223.23  |- mesh__historyNote mesh__D006583
% 223.06/223.23       91%28%75%29%; was see under POLYAMINES 1975-90   
% 223.06/223.23  |- skos__annotation mesh__D006583 D25-26 qualif   
% 223.06/223.23  |- skos__scopeNote mesh__D006583
% 223.06/223.23       A synthetic polymer which agglutinates red blood cells.  It is used as a heparin antagonist.%A%    
% 223.06/223.23  |- mesh__recordAuthorizer mesh__D006583 sjn
% 223.06/223.23  |- skos__hiddenLabel mesh__D006583 Bromide, Hexadimethrine
% 223.06/223.23  |- mesh__recordOriginator mesh__D006583 NLM
% 223.06/223.23  |- skos__altLabel mesh__D006583 Hexadimethrine Bromide
% 223.06/223.23  |- mesh__dateEstablished mesh__D006583 1991-01-01
% 223.06/223.23  |- skos__broader mesh__D006583smesh__D011073
% 223.06/223.23  |- rdf__type mesh__D006583sskos__Concept
% 223.06/223.23  |- skos__historyNote mesh__D006583 Polymers %28%1972-1974%29%
% 223.06/223.23  |- skos__prefLabel mesh__D006583 Hexadimethrine
% 223.06/223.23  |- mesh__dateRevised mesh__D006583 2004-07-07
% 223.06/223.23  |- mesh__recordMaintainer mesh__D006583 jmp
% 223.06/223.23  |- skos__broader mesh__D006583smesh__D011108
% 223.06/223.23  |- skos__altLabel mesh__D006583
% 223.06/223.23       1,5-Dimethyl-1,5-Diazaundecamethylene Polymethobromide
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D006583 2005
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D020254 2006
% 223.06/223.23  |- rdf__type mesh__D020254sskos__Concept
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D020254 2001
% 223.06/223.23  |- skos__altLabel mesh__D020254 Ankylosis, Dentoalveolar
% 223.06/223.23  |- mesh__dateEstablished mesh__D020254 1999-01-01
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D020254 2003
% 223.06/223.23  |- skos__historyNote mesh__D020254 Tooth Abnormalities %28%1966-1967%29%
% 223.06/223.23  |- skos__scopeNote mesh__D020254
% 223.06/223.23       Solid fixation of a tooth resulting from fusion of the cementum and alveolar bone, with obliteration of the periodontal ligament. It is uncommon in the deciduous dentition and very rare in permanent teeth. %28%Jablonski%27%s Dictionary of Dentistry, 1992%29%%A%    
% 223.06/223.23  |- skos__prefLabel mesh__D020254 Tooth Ankylosis
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D020254 1999
% 223.06/223.23  |- mesh__publicMeSHNote mesh__D020254 99   
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D020254 2004
% 223.06/223.23  |- skos__hiddenLabel mesh__D020254 Ankyloses, Dentoalveolar
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D020254 2002
% 223.06/223.23  |- skos__altLabel mesh__D020254 Dentoalveolar Ankylosis
% 223.06/223.23  |- skos__broader mesh__D020254smesh__D014076
% 223.06/223.23  |- skos__hiddenLabel mesh__D020254 Dentoalveolar Ankyloses
% 223.06/223.23  |- skos__altLabel mesh__D020254 Ankylosis, Tooth
% 223.06/223.23  |- mesh__dateCreated mesh__D020254 1998-06-11
% 223.06/223.23  |- skos__historyNote mesh__D020254 Tooth Diseases %28%1968-1998%29%
% 223.06/223.23  |- skos__historyNote mesh__D020254 Ankylosis %28%1966-1998%29%
% 223.06/223.23  |- skos__hiddenLabel mesh__D020254 Tooth Ankyloses
% 223.06/223.23  |- skos__hiddenLabel mesh__D020254 Ankyloses, Tooth
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D020254 2005
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D020254 2000
% 223.06/223.23  |- mesh__historyNote mesh__D020254 99   
% 223.06/223.23  |- skos__scopeNote mesh__D014217
% 223.06/223.23       A macrolide antibiotic that is similar to ERYTHROMYCIN.%A%    
% 223.06/223.23  |- mesh__onlineNote mesh__D014217
% 223.06/223.23       use TROLEANDOMYCIN to search TRIACETYLOLEANDOMYCIN 1966-89%A%  
% 223.06/223.23  |- mesh__recordAuthorizer mesh__D014217 sjn
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D014217 2006
% 223.06/223.23  |- skos__altLabel mesh__D014217 Pfizer Brand of Troleandomycin
% 223.06/223.23  |- skos__broader mesh__D014217smesh__D009827
% 223.06/223.23  |- rdf__type mesh__D014217sskos__Concept
% 223.06/223.23  |- skos__altLabel mesh__D014217 Triacetyloleandomycin
% 223.06/223.23  |- skos__prefLabel mesh__D014217 Troleandomycin
% 223.06/223.23  |- mesh__recordMaintainer mesh__D014217 CCR
% 223.06/223.23  |- mesh__publicMeSHNote mesh__D014217
% 223.06/223.23       90; was TRIACETYLOLEANDOMYCIN 1964-89   
% 223.06/223.23  |- mesh__recordOriginator mesh__D014217 NLM
% 223.06/223.23  |- mesh__dateCreated mesh__D014217 1999-01-01
% 223.06/223.23  |- mesh__dateRevised mesh__D014217 2005-06-30
% 223.06/223.23  |- mesh__historyNote mesh__D014217 90; was TRIACETYLOLEANDOMYCIN 1964-89   
% 223.06/223.23  |- skos__prefLabel mesh__D019700 Thrombospondin 1
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D019700 2006
% 223.06/223.23  |- skos__altLabel mesh__D019700 TSP-1
% 223.06/223.23  |- mesh__dateCreated mesh__D019700 1997-06-20
% 223.06/223.23  |- rdf__type mesh__D019700sskos__Concept
% 223.06/223.23  |- skos__annotation mesh__D019700 a membrane glycoprotein   
% 223.06/223.23  |- skos__broader mesh__D019700smesh__D019699
% 223.06/223.23  |- skos__scopeNote mesh__D019700
% 223.06/223.23       An extracellular matrix glycoprotein from platelets and a variety of normal and transformed cells of both mesenchymal and epithelial origin. Thrombospondin-1 is believed to play a role in cell migration and proliferation, during embryogenesis and wound repair. Also, it has been studied for its use as a potential regulator of tumor growth and metastasis.%A%    
% 223.06/223.23  |- mesh__historyNote mesh__D019700
% 223.06/223.23       98; see THROMBOSPONDIN %28%NM%29% 1991-97   
% 223.06/223.23  |- mesh__dateEstablished mesh__D019700 1998-01-01
% 223.06/223.23  |- mesh__recordAuthorizer mesh__D019700 sjn
% 223.06/223.23  |- skos__historyNote mesh__D019700
% 223.06/223.23       Platelet Membrane Glycoproteins %28%1991-1993%29%
% 223.06/223.23  |- mesh__recordOriginator mesh__D019700 ADP
% 223.06/223.23  |- mesh__publicMeSHNote mesh__D019700
% 223.06/223.23       98; THROMBOSPONDIN 1 was indexed under MEMBRANE GLYCOPROTEINS 1993-97%26% PLATELET MEMBRANE GLYCOPROTEINS 1991-93%A%  
% 223.06/223.23  |- skos__hiddenLabel mesh__D019700 1, Thrombospondin
% 223.06/223.23  |- mesh__dateRevised mesh__D019700 2005-06-30
% 223.06/223.23  |- mesh__recordMaintainer mesh__D019700 SYSTEM
% 223.06/223.23  |- skos__historyNote mesh__D019700 Membrane Glycoproteins %28%1993-1997%29%
% 223.06/223.23  |- mesh__publicMeSHNote mesh__D052336 2006   
% 223.06/223.23  |- skos__broader mesh__D052336smesh__D036361
% 223.06/223.23  |- skos__altLabel mesh__D052336 Pre-Proglucagons
% 223.06/223.23  |- skos__altLabel mesh__D052336 Preproglucagon
% 223.06/223.23  |- skos__prefLabel mesh__D052336 Glucagon Precursors
% 223.06/223.23  |- skos__historyNote mesh__D052336 Enteroglucagon %28%1982-2005%29%
% 223.06/223.23  |- skos__historyNote mesh__D052336 Glucagon %28%1973-2005%29%
% 223.06/223.23  |- skos__hiddenLabel mesh__D052336 Pro Glucagon
% 223.06/223.23  |- mesh__historyNote mesh__D052336 2006   
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D052336 2006
% 223.06/223.23  |- skos__broader mesh__D052336smesh__D011498
% 223.06/223.23  |- skos__scopeNote mesh__D052336
% 223.06/223.23       Peptide precursors of GLUCAGON and GLUCAGON LIKE PEPTIDES.%A%    
% 223.06/223.23  |- skos__hiddenLabel mesh__D052336 Precursors, Glucagon
% 223.06/223.23  |- mesh__dateCreated mesh__D052336 2005-06-30
% 223.06/223.23  |- mesh__dateEstablished mesh__D052336 2006-01-01
% 223.06/223.23  |- mesh__recordOriginator mesh__D052336 ssb
% 223.06/223.23  |- skos__broader mesh__D052336smesh__D009479
% 223.06/223.23  |- mesh__recordAuthorizer mesh__D052336 sjn
% 223.06/223.23  |- skos__hiddenLabel mesh__D052336 Pre Proglucagons
% 223.06/223.23  |- rdf__type mesh__D052336sskos__Concept
% 223.06/223.23  |- skos__broader mesh__D052336smesh__D010187
% 223.06/223.23  |- skos__altLabel mesh__D052336 Pro-Glucagon
% 223.06/223.23  |- skos__broader mesh__D052336smesh__D005768
% 223.06/223.23  |- mesh__recordMaintainer mesh__D052336 ssb
% 223.06/223.23  |- rdf__type mesh__D002991sskos__Concept
% 223.06/223.23  |- skos__hiddenLabel mesh__D002991 B 663
% 223.06/223.23  |- skos__hiddenLabel mesh__D002991 G30,320
% 223.06/223.23  |- skos__hiddenLabel mesh__D002991 B663
% 223.06/223.23  |- skos__broader mesh__D002991smesh__D010619
% 223.06/223.23  |- skos__hiddenLabel mesh__D002991 G 30,320
% 223.06/223.23  |- mesh__recordMaintainer mesh__D002991 NLM
% 223.06/223.23  |- mesh__dateEstablished mesh__D002991 1974-01-01
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D002991 2006
% 223.06/223.23  |- mesh__publicMeSHNote mesh__D002991 74   
% 223.06/223.23  |- mesh__dateRevised mesh__D002991 2005-07-06
% 223.06/223.23  |- mesh__dateCreated mesh__D002991 1999-01-01
% 223.06/223.23  |- mesh__historyNote mesh__D002991 74   
% 223.06/223.23  |- skos__scopeNote mesh__D002991
% 223.06/223.23       A fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. %28%From AMA Drug Evaluations Annual, 1993, p1619%29%%A%    
% 223.06/223.23  |- skos__altLabel mesh__D002991
% 223.06/223.23       N,5-Bis%28%4-chlorophenyl%29%-3,5-dihydro-3-%28%%28%1-methylethyl%29%imino%29%-2-phenazinamine
% 223.06/223.23  |- mesh__recordOriginator mesh__D002991 NLM
% 223.06/223.23  |- mesh__recordAuthorizer mesh__D002991 NLM
% 223.06/223.23  |- skos__prefLabel mesh__D002991 Clofazimine
% 223.06/223.23  |- skos__scopeNote mesh__D002193
% 223.06/223.23       A toxic compound, isolated from the Spanish fly or blistering beetle %28%Lytta %28%Cantharis%29% vesicatoria%29% and other insects. It is a potent and specific inhibitor of protein phosphatases 1 %28%PP1%29% and 2A %28%PP2A%29%. This compound can produce severe skin inflammation, and is extremely toxic if ingested orally.%A%    
% 223.06/223.23  |- mesh__recordOriginator mesh__D002193 NLM
% 223.06/223.23  |- mesh__onlineNote mesh__D002193
% 223.06/223.23       use CANTHARIDIN to search CANTHARIDES 1966-78   
% 223.06/223.23  |- mesh__recordAuthorizer mesh__D002193 sjn
% 223.06/223.23  |- skos__broader mesh__D002193smesh__D001572
% 223.06/223.23  |- mesh__dateCreated mesh__D002193 1999-01-01
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D002193 2006
% 223.06/223.23  |- skos__prefLabel mesh__D002193 Cantharidin
% 223.06/223.23  |- mesh__publicMeSHNote mesh__D002193 79; was CANTHARIDES 1963-78   
% 223.06/223.23  |- mesh__dateRevised mesh__D002193 2005-06-30
% 223.06/223.23  |- skos__altLabel mesh__D002193 Cantharidine
% 223.06/223.23  |- mesh__recordMaintainer mesh__D002193 ssb
% 223.06/223.23  |- rdf__type mesh__D002193sskos__Concept
% 223.06/223.23  |- mesh__historyNote mesh__D002193 79; was CANTHARIDES 1963-78   
% 223.06/223.23  |- rdf__type mesh__D018608sskos__Concept
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D018608 2005
% 223.06/223.23  |- mesh__publicMeSHNote mesh__D018608 95   
% 223.06/223.23  |- skos__scopeNote mesh__D018608
% 223.06/223.23       Ultrasonography applying the Doppler effect, with frequency-shifted ultrasound reflections produced by moving targets %28%usually red blood cells%29% in the bloodstream along the ultrasound axis in direct proportion to the velocity of movement of the targets, to determine both direction and velocity of blood flow. %28%Stedman, 25th ed%29%%A%    
% 223.06/223.23  |- skos__historyNote mesh__D018608 Ultrasonography %28%1985-1994%29%
% 223.06/223.23  |- mesh__recordOriginator mesh__D018608 PXP
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D018608 2001
% 223.06/223.23  |- mesh__recordAuthorizer mesh__D018608 SJN
% 223.06/223.23  |- mesh__dateCreated mesh__D018608 1994-02-28
% 223.06/223.23  |- skos__prefLabel mesh__D018608 Ultrasonography, Doppler
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D018608 2000
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D018608 2004
% 223.06/223.23  |- mesh__recordMaintainer mesh__D018608 PXP
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D018608 2003
% 223.06/223.23  |- mesh__dateEstablished mesh__D018608 1995-01-01
% 223.06/223.23  |- mesh__historyNote mesh__D018608 95   
% 223.06/223.23  |- skos__historyNote mesh__D018608
% 223.06/223.23       Ultrasonics/diagnostic use %28%1974-1984%29%
% 223.06/223.23  |- skos__annotation mesh__D018608
% 223.06/223.23       GEN or unspecified; prefer specifics; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ULTRASONOGR DOPPLER%A%  
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D018608 1999
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D018608 2002
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D018608 2006
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D018608 1998
% 223.06/223.23  |- mesh__dateRevised mesh__D018608 1997-06-20
% 223.06/223.23  |- skos__altLabel mesh__D018608 Doppler Ultrasonography
% 223.06/223.23  |- skos__historyNote mesh__D018608 Blood Flow Velocity %28%1974-1994%29%
% 223.06/223.23  |- skos__broader mesh__D018608smesh__D014463
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D010625 2004
% 223.06/223.23  |- skos__altLabel mesh__D010625 Norepinephrine Methyltransferase
% 223.06/223.23  |- skos__altLabel mesh__D010625 Phenethanolamine N-Methyltransferase
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D010625 2006
% 223.06/223.23  |- mesh__recordOriginator mesh__D010625 NLM
% 223.06/223.23  |- mesh__dateRevised mesh__D010625 2003-07-09
% 223.06/223.23  |- skos__scopeNote mesh__D010625
% 223.06/223.23       A methyltransferase that catalyzes the reaction of S-adenosyl-L-methionine and phenylethanolamine to yield S-adenosyl-L-homocysteine and N-methylphenylethanolamine. It can act on various phenylethanolamines and converts norepinephrine into epinephrine. %28%From Enzyme Nomenclature, 1992%29% EC 2.1.1.28.%A%    
% 223.06/223.23  |- mesh__recordMaintainer mesh__D010625 ssb
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D010625 2005
% 223.06/223.23  |- skos__prefLabel mesh__D010625 Phenylethanolamine N-Methyltransferase
% 223.06/223.23  |- mesh__dateEstablished mesh__D010625 1974-01-01
% 223.06/223.23  |- mesh__publicMeSHNote mesh__D010625 74   
% 223.06/223.23  |- skos__altLabel mesh__D010625 Noradrenaline N-Methyltransferase
% 223.06/223.23  |- skos__broader mesh__D010625smesh__D008780
% 223.06/223.23  |- skos__hiddenLabel mesh__D010625 Phenylethanolamine N Methyltransferase
% 223.06/223.23  |- skos__hiddenLabel mesh__D010625 Noradrenalin N Methyltransferase
% 223.06/223.23  |- skos__altLabel mesh__D010625 Noradrenalin N-Methyltransferase
% 223.06/223.23  |- mesh__historyNote mesh__D010625 74%28%72%29%   
% 223.06/223.23  |- skos__historyNote mesh__D010625 Transferases %28%1966-1971%29%
% 223.06/223.23  |- skos__hiddenLabel mesh__D010625 Noradrenaline N Methyltransferase
% 223.06/223.23  |- rdf__type mesh__D010625sskos__Concept
% 223.06/223.23  |- mesh__dateCreated mesh__D010625 1999-01-01
% 223.06/223.23  |- skos__hiddenLabel mesh__D010625 Phenethanolamine N Methyltransferase
% 223.06/223.23  |- skos__altLabel mesh__D010625 Norepinephrine N-Methyltransferase
% 223.06/223.23  |- skos__historyNote mesh__D010625 Methyltransferases %28%1971%29%
% 223.06/223.23  |- skos__hiddenLabel mesh__D010625 Norepinephrine N Methyltransferase
% 223.06/223.23  |- skos__hiddenLabel mesh__D010625 Methyltransferase, Norepinephrine
% 223.06/223.23  |- mesh__recordAuthorizer mesh__D010625 sjn
% 223.06/223.23  |- skos__scopeNote mesh__D015310
% 223.06/223.23       One of the CEPHALOSPORINS that has a broad spectrum of activity against both gram-positive and gram-negative microorganisms.%A%    
% 223.06/223.23  |- skos__hiddenLabel mesh__D015310 CGP 14221 E
% 223.06/223.23  |- mesh__recordMaintainer mesh__D015310 ssb
% 223.06/223.23  |- rdf__type mesh__D015310sskos__Concept
% 223.06/223.23  |- mesh__dateCreated mesh__D015310 1988-05-31
% 223.06/223.23  |- mesh__recordAuthorizer mesh__D015310 sjn
% 223.06/223.23  |- mesh__dateRevised mesh__D015310 2004-07-07
% 223.06/223.23  |- skos__historyNote mesh__D015310 Cephalosporins %28%1979-1981%29%
% 223.06/223.23  |- skos__hiddenLabel mesh__D015310 Hydrochloride, Cefotiam
% 223.06/223.23  |- mesh__dateEstablished mesh__D015310 1989-01-01
% 223.06/223.23  |- skos__hiddenLabel mesh__D015310 CGP14221E
% 223.06/223.23  |- mesh__recordOriginator mesh__D015310 RLS
% 223.06/223.23  |- skos__historyNote mesh__D015310
% 223.06/223.23       Cefotaxime/analogs %26% derivatives %28%1982-1988%29%
% 223.06/223.23  |- skos__hiddenLabel mesh__D015310 Abbott 48999
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D015310 2006
% 223.06/223.23  |- mesh__publicMeSHNote mesh__D015310 89   
% 223.06/223.23  |- skos__hiddenLabel mesh__D015310 SCE 963
% 223.06/223.23  |- skos__broader mesh__D015310smesh__D002439
% 223.06/223.23  |- skos__prefLabel mesh__D015310 Cefotiam
% 223.06/223.23  |- skos__hiddenLabel mesh__D015310 SCE963
% 223.06/223.23  |- skos__hiddenLabel mesh__D015310 Abbott48999
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D015310 2005
% 223.06/223.23  |- mesh__historyNote mesh__D015310 89   
% 223.06/223.23  |- skos__altLabel mesh__D015310 Haloapor
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D001899 2006
% 223.06/223.23  |- skos__prefLabel mesh__D001899 Borrelia Infections
% 223.06/223.23  |- skos__annotation mesh__D001899
% 223.06/223.23       B. burgdorferi or B. burgdorferi group infection = LYME DISEASE; infection by other species = probably RELAPSING FEVER, but if not, index here%A%  
% 223.06/223.23  |- mesh__recordMaintainer mesh__D001899 ags
% 223.06/223.23  |- mesh__dateRevised mesh__D001899 2003-07-09
% 223.06/223.23  |- skos__broader mesh__D001899smesh__D013145
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D001899 2004
% 223.06/223.23  |- skos__hiddenLabel mesh__D001899 Borrelia Infection
% 223.06/223.23  |- mesh__recordOriginator mesh__D001899 NLM
% 223.06/223.23  |- skos__broader mesh__D001899smesh__D016905
% 223.06/223.23  |- skos__hiddenLabel mesh__D001899 Infection, Borrelia
% 223.06/223.23  |- skos__altLabel mesh__D001899 Infections, Borrelia
% 223.06/223.23  |- mesh__recordAuthorizer mesh__D001899 sjn
% 223.06/223.23  |- mesh__dateCreated mesh__D001899 1999-01-01
% 223.06/223.23  |- rdf__type mesh__D001899sskos__Concept
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D001899 2005
% 223.06/223.23  |- skos__scopeNote mesh__D001899
% 223.06/223.23       Infections with bacteria of the genus BORRELIA.     
% 223.06/223.23  |- skos__hiddenLabel mesh__D006584 Compounds, Hexamethonium
% 223.06/223.23  |- mesh__recordMaintainer mesh__D006584 ssb
% 223.06/223.23  |- rdf__type mesh__D006584sskos__Concept
% 223.06/223.23  |- skos__scopeNote mesh__D006584
% 223.06/223.23       Compounds containing the hexamethylenebis%28%trimethylammonium%29% cation. Members of this group frequently act as antihypertensive agents and selective ganglionic blocking agents.%A%    
% 223.06/223.23  |- mesh__recordAuthorizer mesh__D006584 sjn
% 223.06/223.23  |- mesh__recordOriginator mesh__D006584 NLM
% 223.06/223.23  |- skos__broader mesh__D006584smesh__D008725
% 223.06/223.23  |- skos__prefLabel mesh__D006584 Hexamethonium Compounds
% 223.06/223.23  |- skos__annotation mesh__D006584
% 223.06/223.23       antihypertensives; DF: HEXAMETHONIUM CPDS   
% 223.06/223.23  |- mesh__dateCreated mesh__D006584 1999-01-01
% 223.06/223.23  |- mesh__dateRevised mesh__D006584 2005-06-30
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D006584 2006
% 223.06/223.23  |- skos__hiddenLabel mesh__D020255 Detachments, Posterior Vitreous
% 223.06/223.23  |- mesh__activeMeSHYear mesh__D020255 2001
% 223.06/223.23  |- skos__hiddenLabel mesh__D020255 Vitreous Detachment, Posterior
% 223.06/223.24  |- skos__scopeNote mesh__D020255
% 223.06/223.24       Detachment of the corpus vitreum %28%VITREOUS BODY%29% from its normal attachments, especially the retina, due to shrinkage from degenerative or inflammatory conditions, trauma, myopia, or senility.%A%    
% 223.06/223.24  |- mesh__dateEstablished mesh__D020255 1999-01-01
% 223.06/223.24  |- mesh__historyNote mesh__D020255 99   
% 223.06/223.24  |- skos__hiddenLabel mesh__D020255 Detachment, Posterior Vitreous
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D020255 2006
% 223.06/223.24  |- skos__hiddenLabel mesh__D020255 Detachment, Vitreous
% 223.06/223.24  |- skos__hiddenLabel mesh__D020255 Vitreous Detachments, Posterior
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D020255 2003
% 223.06/223.24  |- skos__historyNote mesh__D020255 Vitreous Body %28%1968-1998%29%
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D020255 1999
% 223.06/223.24  |- skos__hiddenLabel mesh__D020255 Vitreous Detachments
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D020255 2002
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D020255 2004
% 223.06/223.24  |- mesh__publicMeSHNote mesh__D020255 99   
% 223.06/223.24  |- skos__hiddenLabel mesh__D020255 Detachments, Vitreous
% 223.06/223.24  |- mesh__dateCreated mesh__D020255 1998-06-11
% 223.06/223.24  |- skos__prefLabel mesh__D020255 Vitreous Detachment
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D020255 2000
% 223.06/223.24  |- rdf__type mesh__D020255sskos__Concept
% 223.06/223.24  |- skos__broader mesh__D020255smesh__D005128
% 223.06/223.24  |- skos__hiddenLabel mesh__D020255 Posterior Vitreous Detachments
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D020255 2005
% 223.06/223.24  |- rdf__type mesh__D014218sskos__Concept
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D014218 1994
% 223.06/223.24  |- skos__prefLabel mesh__D014218 Triage
% 223.06/223.24  |- skos__broader mesh__D014218smesh__D004632
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D014218 1997
% 223.06/223.24  |- mesh__publicMeSHNote mesh__D014218
% 223.06/223.24       91; was see under EMERGENCY MEDICAL SERVICES 1980-90; was see under EMERGENCY HEALTH SERVICES 1976-79%A%  
% 223.06/223.24  |- mesh__recordMaintainer mesh__D014218 TGC
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D014218 2001
% 223.06/223.24  |- mesh__dateRevised mesh__D014218 1992-05-18
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D014218 1996
% 223.06/223.24  |- mesh__dateCreated mesh__D014218 1975-07-23
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D014218 2004
% 223.06/223.24  |- mesh__historyNote mesh__D014218
% 223.06/223.24       91%28%76%29%; was see under EMERGENCY MEDICAL SERVICES 1980-90; was see under EMERGENCY HEALTH SERVICES 1976-79%A%  
% 223.06/223.24  |- skos__hiddenLabel mesh__D014218 Triages
% 223.06/223.24  |- mesh__recordAuthorizer mesh__D014218 PLS
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D014218 2000
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D014218 1993
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D014218 2003
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D014218 1999
% 223.06/223.24  |- skos__historyNote mesh__D014218 Emergencies %28%1966-1975%29%
% 223.06/223.24  |- skos__historyNote mesh__D014218
% 223.06/223.24       Emergency Service, Hospital %28%1966-1975%29%
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D014218 1998
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D014218 2006
% 223.06/223.24  |- skos__scopeNote mesh__D014218
% 223.06/223.24       The sorting out and classification of patients or casualties to determine priority of need and proper place of treatment.%A%    
% 223.06/223.24  |- mesh__recordOriginator mesh__D014218 EC
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D014218 2002
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D014218 1995
% 223.06/223.24  |- mesh__dateEstablished mesh__D014218 1991-01-01
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D014218 2005
% 223.06/223.24  |- skos__historyNote mesh__D019701 Chronic Disease %28%1983-1997%29%
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D019701 2005
% 223.06/223.24  |- rdf__type mesh__D019701sskos__Concept
% 223.06/223.24  |- mesh__historyNote mesh__D019701 98   
% 223.06/223.24  |- skos__hiddenLabel mesh__D019701 Delta Hepatitides, Chronic
% 223.06/223.24  |- mesh__dateRevised mesh__D019701 2004-07-13
% 223.06/223.24  |- skos__broader mesh__D019701smesh__D003699
% 223.06/223.24  |- skos__hiddenLabel mesh__D019701 Hepatitides, Chronic Delta
% 223.06/223.24  |- mesh__publicMeSHNote mesh__D019701 98   
% 223.06/223.24  |- mesh__dateCreated mesh__D019701 1997-06-20
% 223.06/223.24  |- skos__historyNote mesh__D019701
% 223.06/223.24       Hepatitis, Viral, Human %28%1983-1986%29%
% 223.06/223.24  |- skos__broader mesh__D019701smesh__D006521
% 223.06/223.24  |- skos__altLabel mesh__D019701 Delta Hepatitis, Chronic
% 223.06/223.24  |- skos__hiddenLabel mesh__D019701 Hepatitis, Chronic Delta
% 223.06/223.24  |- mesh__recordMaintainer mesh__D019701 sjn
% 223.06/223.24  |- skos__altLabel mesh__D019701 Chronic Delta Hepatitis
% 223.06/223.24  |- skos__historyNote mesh__D019701 Hepatitis D %28%1987-1997%29%
% 223.06/223.24  |- skos__altLabel mesh__D019701 Chronic Hepatitis D
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D019701 2006
% 223.06/223.24  |- mesh__recordAuthorizer mesh__D019701 sjn
% 223.06/223.24  |- skos__scopeNote mesh__D019701
% 223.06/223.24       INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS in conjunction with HEPATITIS B VIRUS and lasting six months or more.%A%    
% 223.06/223.24  |- mesh__dateEstablished mesh__D019701 1998-01-01
% 223.06/223.24  |- mesh__recordOriginator mesh__D019701 AGS
% 223.06/223.24  |- skos__prefLabel mesh__D019701 Hepatitis D, Chronic
% 223.06/223.24  |- skos__hiddenLabel mesh__D019701 Chronic Delta Hepatitides
% 223.06/223.24  |- skos__historyNote mesh__D002992 Butyrates %28%1971-1974%29%
% 223.06/223.24  |- skos__altLabel mesh__D002992 Methylclofenapate
% 223.06/223.24  |- mesh__dateRevised mesh__D002992 2000-06-22
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D002992 2001
% 223.06/223.24  |- mesh__recordOriginator mesh__D002992 NLM
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D002992 2006
% 223.06/223.24  |- mesh__recordMaintainer mesh__D002992 CCR
% 223.06/223.24  |- skos__prefLabel mesh__D002992 Clofenapate
% 223.06/223.24  |- skos__hiddenLabel mesh__D002992 Clofenapate, Methyl
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D002992 2002
% 223.06/223.24  |- mesh__dateCreated mesh__D002992 1974-11-19
% 223.06/223.24  |- skos__scopeNote mesh__D002992
% 223.06/223.24       An oral hypolipemic agent in dogs and rats.     
% 223.06/223.24  |- mesh__dateEstablished mesh__D002992 1991-01-01
% 223.06/223.24  |- skos__broader mesh__D002992smesh__D002995
% 223.06/223.24  |- mesh__recordAuthorizer mesh__D002992 sjn
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D002992 2003
% 223.06/223.24  |- skos__hiddenLabel mesh__D002992 ICI 55695
% 223.06/223.24  |- mesh__historyNote mesh__D002992
% 223.06/223.24       91%28%75%29%; was see under BUTYRATES 1975-90   
% 223.06/223.24  |- skos__altLabel mesh__D002992 Methyl Clofenapate
% 223.06/223.24  |- mesh__publicMeSHNote mesh__D002992
% 223.06/223.24       91; was see under BUTYRATES 1975-90   
% 223.06/223.24  |- skos__hiddenLabel mesh__D002992 ICI55695
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D002992 2004
% 223.06/223.24  |- rdf__type mesh__D002992sskos__Concept
% 223.06/223.24  |- skos__historyNote mesh__D002992 Biphenyl Compounds %28%1974%29%
% 223.06/223.24  |- skos__historyNote mesh__D002992 Ethers %28%1972-1974%29%
% 223.06/223.24  |- skos__broader mesh__D002992smesh__D002087
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D002992 2005
% 223.06/223.24  |- mesh__dateEstablished mesh__D002194 1991-01-01
% 223.06/223.24  |- mesh__dateCreated mesh__D002194 1981-02-26
% 223.06/223.24  |- skos__annotation mesh__D002194
% 223.06/223.24       a psychosis wherein patient thinks familiar persons are doubles of themselves or imposters%A%  
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D002194 2001
% 223.06/223.24  |- mesh__recordMaintainer mesh__D002194 jls
% 223.06/223.24  |- skos__hiddenLabel mesh__D002194 Syndrome, Capgras
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D002194 2005
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D002194 2006
% 223.06/223.24  |- skos__prefLabel mesh__D002194 Capgras Syndrome
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D002194 2002
% 223.06/223.24  |- mesh__dateRevised mesh__D002194 1999-11-03
% 223.06/223.24  |- mesh__recordAuthorizer mesh__D002194 sjn
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D002194 2003
% 223.06/223.24  |- mesh__recordOriginator mesh__D002194 EC
% 223.06/223.24  |- skos__scopeNote mesh__D002194
% 223.06/223.24       A psychotic disorder characterized by the patient%27%s belief that acquaintances or closely related persons have been replaced by doubles or imposters.%A%    
% 223.06/223.24  |- rdf__type mesh__D002194sskos__Concept
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D002194 2004
% 223.06/223.24  |- mesh__historyNote mesh__D002194
% 223.06/223.24       91%28%82%29%; was see under PSYCHOTIC DISORDERS 1982-90   
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D002194 2000
% 223.06/223.24  |- mesh__publicMeSHNote mesh__D002194
% 223.06/223.24       91; was see under PSYCHOTIC DISORDERS 1982-90   
% 223.06/223.24  |- skos__broader mesh__D002194smesh__D019967
% 223.06/223.24  |- skos__historyNote mesh__D002194 Psychoses %28%1966-1981%29%
% 223.06/223.24  |- mesh__dateCreated mesh__D018609 1994-06-14
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D018609 1997
% 223.06/223.24  |- mesh__dateRevised mesh__D018609 1995-03-13
% 223.06/223.24  |- skos__scopeNote mesh__D018609
% 223.06/223.24       A country of central Asia, nominally an autonomous region within Communist China. It first came under Chinese control during the Manchu dynasty in 1720 and was generally closed to foreigners until late in the nineteenth century. Tibetans are an ancient race of Mongolian type and their ruler is the Dalai Lama. Buddhism was introduced in the seventh century A.D. and most Tibetans are Buddhists. %28%From Webster%27%s New Geographical Dictionary, 1988%29%%A%    
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D018609 2004
% 223.06/223.24  |- skos__prefLabel mesh__D018609 Tibet
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D018609 1996
% 223.06/223.24  |- skos__historyNote mesh__D018609 China %28%1970-1994%29%
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D018609 2001
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D018609 2003
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D018609 1999
% 223.06/223.24  |- skos__broader mesh__D018609smesh__D002681
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D018609 2000
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D018609 2006
% 223.06/223.24  |- mesh__onlineNote mesh__D018609 use CHINA to search TIBET 1975-94   
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D018609 1998
% 223.06/223.24  |- mesh__recordAuthorizer mesh__D018609 PLS
% 223.06/223.24  |- rdf__type mesh__D018609sskos__Concept
% 223.06/223.24  |- mesh__dateEstablished mesh__D018609 1995-01-01
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D018609 2005
% 223.06/223.24  |- mesh__historyNote mesh__D018609 95; was see CHINA 1975-94   
% 223.06/223.24  |- mesh__recordMaintainer mesh__D018609 TGC
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D018609 2002
% 223.06/223.24  |- skos__annotation mesh__D018609 ancient %26% modern   
% 223.06/223.24  |- mesh__recordOriginator mesh__D018609 TGC
% 223.06/223.24  |- skos__historyNote mesh__D010626 Alcohol, Ethyl %28%1969-1974%29%
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D010626 2005
% 223.06/223.24  |- skos__altLabel mesh__D010626 Phenethyl Alcohol
% 223.06/223.24  |- skos__altLabel mesh__D010626 2-Phenylethanol
% 223.06/223.24  |- mesh__dateRevised mesh__D010626 2000-06-21
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D010626 2002
% 223.06/223.24  |- skos__hiddenLabel mesh__D010626 Alcohol, Phenethyl
% 223.06/223.24  |- skos__historyNote mesh__D010626 Benzene Derivatives %28%1972-1974%29%
% 223.06/223.24  |- mesh__dateCreated mesh__D010626 1974-11-19
% 223.06/223.24  |- rdf__type mesh__D010626sskos__Concept
% 223.06/223.24  |- mesh__recordAuthorizer mesh__D010626 sjn
% 223.06/223.24  |- skos__altLabel mesh__D010626 Phenylethanol
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D010626 2001
% 223.06/223.24  |- mesh__dateEstablished mesh__D010626 1991-01-01
% 223.06/223.24  |- skos__scopeNote mesh__D010626
% 223.06/223.24       An antimicrobial, antiseptic, and disinfectant that is used also as an aromatic essence and preservative in pharmaceutics and perfumery.%A%    
% 223.06/223.24  |- skos__hiddenLabel mesh__D010626 2 Phenylethanol
% 223.06/223.24  |- skos__broader mesh__D010626smesh__D000431
% 223.06/223.24  |- skos__altLabel mesh__D010626 beta-Phenylethanol
% 223.06/223.24  |- mesh__recordMaintainer mesh__D010626 CCR
% 223.06/223.24  |- mesh__historyNote mesh__D010626
% 223.06/223.24       96; was PHENETHYL ALCOHOL 1975-95 %28%see under ALCOHOL, ETHYL 1975-90%29%; PHENYLETHYL ALCOHOL was see PHENETHYL ALCOHOL 1975-95%A%  
% 223.06/223.24  |- mesh__recordOriginator mesh__D010626 NLM
% 223.06/223.24  |- skos__hiddenLabel mesh__D010626 beta Phenylethanol
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D010626 2004
% 223.06/223.24  |- skos__hiddenLabel mesh__D010626 Carbinol, Benzyl
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D010626 2006
% 223.06/223.24  |- skos__prefLabel mesh__D010626 Phenylethyl Alcohol
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D010626 2003
% 223.06/223.24  |- mesh__publicMeSHNote mesh__D010626
% 223.06/223.24       96; was PHENETHYL ALCOHOL 1975-95 %28%see under ALCOHOL, ETHYL 1975-90%29%; PHENYLETHYL ALCOHOL was see PHENETHYL ALCOHOL 1975-95%A%  
% 223.06/223.24  |- skos__hiddenLabel mesh__D010626 Alcohol, Phenylethyl
% 223.06/223.24  |- skos__altLabel mesh__D010626 Benzyl Carbinol
% 223.06/223.24  |- rdf__type mesh__D015311sskos__Concept
% 223.06/223.24  |- mesh__dateCreated mesh__D015311 1988-05-31
% 223.06/223.24  |- mesh__historyNote mesh__D015311 89   
% 223.06/223.24  |- skos__hiddenLabel mesh__D015311 Sodium, Cefmetazole
% 223.06/223.24  |- skos__altLabel mesh__D015311 Pharmacia Brand of Cefmetazole Sodium
% 223.06/223.24  |- skos__hiddenLabel mesh__D015311 CS1170
% 223.06/223.24  |- skos__hiddenLabel mesh__D015311 U72791A
% 223.06/223.24  |- mesh__dateEstablished mesh__D015311 1989-01-01
% 223.06/223.24  |- skos__broader mesh__D015311smesh__D002513
% 223.06/223.24  |- skos__prefLabel mesh__D015311 Cefmetazole
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D015311 2006
% 223.06/223.24  |- mesh__publicMeSHNote mesh__D015311 89   
% 223.06/223.24  |- mesh__recordAuthorizer mesh__D015311 sjn
% 223.06/223.24  |- mesh__recordMaintainer mesh__D015311 lkw
% 223.06/223.24  |- skos__hiddenLabel mesh__D015311 Monosodium Salt, Cefmetazole
% 223.06/223.24  |- skos__altLabel mesh__D015311 Cefmetazole Monosodium Salt
% 223.06/223.24  |- mesh__dateRevised mesh__D015311 2005-06-30
% 223.06/223.24  |- skos__scopeNote mesh__D015311
% 223.06/223.24       A semisynthetic cephamycin antibiotic with a broad spectrum of activity against both gram-positive and gram-negative microorganisms. It has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.%A%    
% 223.06/223.24  |- skos__historyNote mesh__D015311 Cephamycins %28%1979-1988%29%
% 223.06/223.24  |- skos__hiddenLabel mesh__D015311 Salt, Cefmetazole Monosodium
% 223.06/223.24  |- skos__hiddenLabel mesh__D015311 CS 1170
% 223.06/223.24  |- mesh__recordOriginator mesh__D015311 RLS
% 223.06/223.24  |- skos__hiddenLabel mesh__D015311 U 72791A
% 223.06/223.24  |- mesh__recordAuthorizer mesh__D006585 sjn
% 223.06/223.24  |- mesh__recordOriginator mesh__D006585 NLM
% 223.06/223.24  |- skos__historyNote mesh__D006585 Triazines %28%1970-1974%29%
% 223.06/223.24  |- skos__altLabel mesh__D006585 US Bioscience Brand of Altretamine
% 223.06/223.24  |- skos__altLabel mesh__D006585 Speywood Brand of Altretamine
% 223.06/223.24  |- skos__altLabel mesh__D006585 Bellon Brand of Altretamine
% 223.06/223.24  |- rdf__type mesh__D006585sskos__Concept
% 223.06/223.24  |- skos__altLabel mesh__D006585 Hemel
% 223.06/223.24  |- mesh__publicMeSHNote mesh__D006585
% 223.06/223.24       92; was HEXAMETHYLMELAMINE 1975-91 %28%see under TRIAZINES 1975-90%29%%A%  
% 223.06/223.24  |- skos__altLabel mesh__D006585 Chiesi Brand of Altretamine
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D006585 2005
% 223.06/223.24  |- mesh__dateEstablished mesh__D006585 1991-01-01
% 223.06/223.24  |- mesh__dateRevised mesh__D006585 2004-07-07
% 223.06/223.24  |- skos__scopeNote mesh__D006585
% 223.06/223.24       An alkylating agent proposed as an antineoplastic. It also acts as a chemosterilant for male houseflies and other insects.%A%    
% 223.06/223.24  |- mesh__historyNote mesh__D006585
% 223.06/223.24       92; was HEXAMETHYLMELAMINE 1975-91 %28%see under TRIAZINES 1975-90%29%%A%  
% 223.06/223.24  |- mesh__recordMaintainer mesh__D006585 mdb
% 223.06/223.24  |- skos__altLabel mesh__D006585 Lilly Brand of Altretamine
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D006585 2006
% 223.06/223.24  |- mesh__dateCreated mesh__D006585 1974-11-19
% 223.06/223.24  |- skos__altLabel mesh__D006585 Hexamethylmelamine
% 223.06/223.24  |- skos__historyNote mesh__D006585 Dimethylamines %28%1973-1974%29%
% 223.06/223.24  |- skos__hiddenLabel mesh__D006585
% 223.06/223.24       Rh%C3%%B4%ne Poulenc Rorer Brand of Altretamine
% 223.06/223.24  |- skos__hiddenLabel mesh__D006585 Altretamine Faulding Brand
% 223.06/223.24  |- skos__altLabel mesh__D006585 Wassermann Brand of Altretamine
% 223.06/223.24  |- skos__hiddenLabel mesh__D006585 Altretamine Lilly Brand
% 223.06/223.24  |- skos__hiddenLabel mesh__D006585 Altretamine Speywood Brand
% 223.06/223.24  |- skos__hiddenLabel mesh__D006585 Altretamine Chiesi Brand
% 223.06/223.24  |- skos__hiddenLabel mesh__D006585 Altretamine Bellon Brand
% 223.06/223.24  |- skos__broader mesh__D006585smesh__D014227
% 223.06/223.24  |- skos__hiddenLabel mesh__D006585 Altretamine Wassermann Brand
% 223.06/223.24  |- skos__altLabel mesh__D006585 Faulding Brand of Altretamine
% 223.06/223.24  |- skos__prefLabel mesh__D006585 Altretamine
% 223.06/223.24  |- mesh__onlineNote mesh__D006585
% 223.06/223.24       use ALTRETAMINE to search HEXAMETHYLMELAMINE 1975-91   
% 223.06/223.24  |- skos__altLabel mesh__D006585
% 223.06/223.24       Rh%C3%%B4%ne-Poulenc Rorer Brand of Altretamine
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D020256 2000
% 223.06/223.24  |- skos__prefLabel mesh__D020256 Choroidal Neovascularization
% 223.06/223.24  |- mesh__dateCreated mesh__D020256 1998-06-10
% 223.06/223.24  |- skos__historyNote mesh__D020256
% 223.06/223.24       Neovascularization, Pathologic %28%1980-1998%29%
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D020256 2003
% 223.06/223.24  |- skos__broader mesh__D020256smesh__D015862
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D020256 2001
% 223.06/223.24  |- skos__historyNote mesh__D020256 Choroid/blood supply %28%1980-1998%29%
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D020256 2004
% 223.06/223.24  |- mesh__dateEstablished mesh__D020256 1999-01-01
% 223.06/223.24  |- skos__altLabel mesh__D020256 Choroid Neovascularization
% 223.06/223.24  |- mesh__historyNote mesh__D020256 99   
% 223.06/223.24  |- mesh__recordMaintainer mesh__D020256 KEV
% 223.06/223.24  |- mesh__publicMeSHNote mesh__D020256 99   
% 223.06/223.24  |- skos__hiddenLabel mesh__D020256 Choroidal Neovascularizations
% 223.06/223.24  |- skos__altLabel mesh__D020256 Neovascularization, Choroidal
% 223.06/223.24  |- skos__broader mesh__D020256smesh__D009389
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D020256 2002
% 223.06/223.24  |- rdf__type mesh__D020256sskos__Concept
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D020256 2005
% 223.06/223.24  |- mesh__dateRevised mesh__D020256 1999-11-03
% 223.06/223.24  |- mesh__recordAuthorizer mesh__D020256 sjn
% 223.06/223.24  |- skos__altLabel mesh__D020256 Neovascularization, Choroid
% 223.06/223.24  |- mesh__recordOriginator mesh__D020256 NDW
% 223.06/223.24  |- skos__scopeNote mesh__D020256
% 223.06/223.24       A pathological process consisting of the formation of new blood vessels in the CHOROID.%A%    
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D020256 2006
% 223.06/223.24  |- skos__hiddenLabel mesh__D020256 Choroid Neovascularizations
% 223.06/223.24  |- skos__related mesh__D014219smesh__D036861
% 223.06/223.24  |- skos__hiddenLabel mesh__D014219 Labor Trials
% 223.06/223.24  |- mesh__recordOriginator mesh__D014219 EC
% 223.06/223.24  |- mesh__publicMeSHNote mesh__D014219 88   
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D014219 2004
% 223.06/223.24  |- skos__related mesh__D014219smesh__D002585
% 223.06/223.24  |- mesh__dateRevised mesh__D014219 2002-07-03
% 223.06/223.24  |- mesh__dateCreated mesh__D014219 1987-03-14
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D014219 2003
% 223.06/223.24  |- skos__broader mesh__D014219smesh__D007743
% 223.06/223.24  |- skos__scopeNote mesh__D014219
% 223.06/223.24       Allowing a woman to be in LABOR, OBSTETRIC long enough to determine if vaginal birth may be anticipated.%A%    
% 223.06/223.24  |- mesh__recordMaintainer mesh__D014219 sjn
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D014219 2006
% 223.06/223.24  |- mesh__recordAuthorizer mesh__D014219 sjn
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D014219 2005
% 223.06/223.24  |- mesh__dateEstablished mesh__D014219 1988-01-01
% 223.06/223.24  |- rdf__type mesh__D014219sskos__Concept
% 223.06/223.24  |- skos__prefLabel mesh__D014219 Trial of Labor
% 223.06/223.24  |- mesh__historyNote mesh__D014219 88   
% 223.06/223.24  |- skos__hiddenLabel mesh__D014219 Labor Trial
% 223.06/223.24  |- skos__broader mesh__D019702smesh__D006523
% 223.06/223.24  |- mesh__dateEstablished mesh__D019702 1998-01-01
% 223.06/223.24  |- mesh__recordMaintainer mesh__D019702 lkt
% 223.06/223.24  |- skos__scopeNote mesh__D019702
% 223.06/223.24       INFLAMMATION of the LIVER, lasting six months or more, and caused by an adverse drug effect. The adverse effect may result from a direct toxic effect of a drug or metabolite, or an idiosyncratic response to a drug or metabolite. The clinical and histological changes can mimic viral or autoimmune hepatitis.%A%    
% 223.06/223.24  |- skos__broader mesh__D019702smesh__D006521
% 223.06/223.24  |- mesh__recordAuthorizer mesh__D019702 sjn
% 223.06/223.24  |- mesh__recordOriginator mesh__D019702 AGS
% 223.06/223.24  |- skos__annotation mesh__D019702
% 223.06/223.24       coord IM with specific toxic agent /adv eff-pois-tox %28%IM%29%; HEPATITIS, ALCOHOLIC is also available%A%  
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D019702 2006
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D019702 2005
% 223.06/223.24  |- skos__altLabel mesh__D019702 Hepatitis, Chronic, Drug-Related
% 223.06/223.24  |- skos__historyNote mesh__D019702 Hepatitis, Toxic %28%1966-1997%29%
% 223.06/223.24  |- skos__historyNote mesh__D019702 Chronic Disease %28%1966-1997%29%
% 223.06/223.24  |- rdf__type mesh__D019702sskos__Concept
% 223.06/223.24  |- mesh__historyNote mesh__D019702 98   
% 223.06/223.24  |- mesh__publicMeSHNote mesh__D019702 98   
% 223.06/223.24  |- skos__prefLabel mesh__D019702 Hepatitis, Chronic, Drug-Induced
% 223.06/223.24  |- mesh__dateCreated mesh__D019702 1997-06-20
% 223.06/223.24  |- mesh__dateRevised mesh__D019702 2004-07-07
% 223.06/223.24  |- skos__altLabel mesh__D002195 Capillaria hepatica
% 223.06/223.24  |- skos__scopeNote mesh__D002195
% 223.06/223.24       A genus of trichuroid nematodes parasitic in the liver and intestines of many mammals and birds. Two species, C. hepatica and C. philippinensis, produce often fatal infections in man.%A%    
% 223.06/223.24  |- skos__broader mesh__D002195smesh__D014259
% 223.06/223.24  |- mesh__publicMeSHNote mesh__D002195
% 223.06/223.24       91; was see under TRICHUROIDEA 1967-90, was see under TRICHINELLOIDEA 1963-66; HEPATICOLA HEPATICA was see under TRICHUROIDEA 1967-78, was see under TRICHINELLOIDEA 1963-66%A%  
% 223.06/223.24  |- mesh__dateEstablished mesh__D002195 1991-01-01
% 223.06/223.24  |- skos__prefLabel mesh__D002195 Capillaria
% 223.06/223.24  |- skos__annotation mesh__D002195
% 223.06/223.24       a genus of nematodes in liver %26% intestines of birds %26% mammals including man; infection: coord IM with ENOPLIDA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 223.06/223.24  |- mesh__dateRevised mesh__D002195 2003-07-09
% 223.06/223.24  |- mesh__dateCreated mesh__D002195 1999-01-01
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D002195 2006
% 223.06/223.24  |- mesh__recordMaintainer mesh__D002195 ags
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D002195 2004
% 223.06/223.24  |- mesh__onlineNote mesh__D002195
% 223.06/223.24       search TRICHUROIDEA 1966-74; use CAPILLARIA to search HEPATICOLA HEPATICA 1975-78 %26% use TRICHUROIDEA 1966-74%A%  
% 223.06/223.24  |- mesh__recordOriginator mesh__D002195 NLM
% 223.06/223.24  |- mesh__historyNote mesh__D002195
% 223.06/223.24       91%28%75%29%; was see under TRICHUROIDEA 1967-90, was see under TRICHINELLOIDEA 1963-66; HEPATICOLA HEPATICA was see under TRICHUROIDEA 1967-78, was see under TRICHINELLOIDEA 1963-66%A%  
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D002195 2005
% 223.06/223.24  |- mesh__recordAuthorizer mesh__D002195 sjn
% 223.06/223.24  |- rdf__type mesh__D002195sskos__Concept
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D010627 1999
% 223.06/223.24  |- skos__altLabel mesh__D010627 Phenylethylamines
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D010627 1996
% 223.06/223.24  |- mesh__publicMeSHNote mesh__D010627 68; was PHENYLETHYLAMINES 1963-67   
% 223.06/223.24  |- mesh__recordAuthorizer mesh__D010627 PLS
% 223.06/223.24  |- mesh__historyNote mesh__D010627 68; was PHENYLETHYLAMINES 1963-67   
% 223.06/223.24  |- rdf__type mesh__D010627sskos__Concept
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D010627 1998
% 223.06/223.24  |- mesh__dateCreated mesh__D010627 1999-01-01
% 223.06/223.24  |- mesh__dateRevised mesh__D010627 1995-05-18
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D010627 2002
% 223.06/223.24  |- skos__prefLabel mesh__D010627 Phenethylamines
% 223.06/223.24  |- skos__broader mesh__D010627smesh__D005021
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D010627 2004
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D010627 2001
% 223.06/223.24  |- mesh__dateEstablished mesh__D010627 1968-01-01
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D010627 2006
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D010627 2003
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D010627 2005
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D010627 2000
% 223.06/223.24  |- mesh__recordOriginator mesh__D010627 NLM
% 223.06/223.24  |- mesh__recordMaintainer mesh__D010627 KEV
% 223.06/223.24  |- mesh__onlineNote mesh__D010627
% 223.06/223.24       use PHENETHYLAMINES to search PHENYLETHYLAMINES 1966-67   
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D010627 1997
% 223.06/223.24  |- skos__scopeNote mesh__D010627
% 223.06/223.24       A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. %28%From Merck Index, 11th ed%29%%A%    
% 223.06/223.24  |- rdf__type mesh__D015312sskos__Concept
% 223.06/223.24  |- mesh__dateCreated mesh__D015312 1988-05-31
% 223.06/223.24  |- mesh__recordOriginator mesh__D015312 EJB
% 223.06/223.24  |- skos__altLabel mesh__D015312 Dialysis Solutions, Hemodialysis
% 223.06/223.24  |- mesh__publicMeSHNote mesh__D015312
% 223.06/223.24       91; was see under DIALYSIS SOLUTIONS 1989-90   
% 223.06/223.24  |- skos__altLabel mesh__D015312 Solutions, Hemodialysis
% 223.06/223.24  |- skos__hiddenLabel mesh__D015312 Hemodialysis Dialysis Solutions
% 223.06/223.24  |- skos__hiddenLabel mesh__D015312 Solutions, Hemodialysis Dialysis
% 223.06/223.24  |- mesh__recordMaintainer mesh__D015312 ssb
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D015312 2006
% 223.06/223.24  |- skos__historyNote mesh__D015312 Hemodialysis %28%1967-1988%29%
% 223.06/223.24  |- mesh__dateEstablished mesh__D015312 1991-01-01
% 223.06/223.24  |- skos__scopeNote mesh__D015312
% 223.06/223.24       Solutions prepared for hemodialysis. The composition of the pre-dialysis solution may be varied in order to determine the effect of solvated metabolites on anoxia, malnutrition, acid-base balance, etc. Of principal interest are the effect of the choice of buffers %28%e.g., acetate or carbonate%29%, the addition of cations %28%Na+, K+, Ca2+%29%, and addition of carbohydrates %28%glucose%29%.%A%    
% 223.06/223.24  |- skos__altLabel mesh__D015312 Hemodialysates
% 223.06/223.24  |- skos__broader mesh__D015312smesh__D015314
% 223.06/223.24  |- mesh__historyNote mesh__D015312
% 223.06/223.24       91%28%89%29%; was see under DIALYSIS SOLUTIONS 1989-90   
% 223.06/223.24  |- mesh__recordAuthorizer mesh__D015312 sjn
% 223.06/223.24  |- skos__prefLabel mesh__D015312 Hemodialysis Solutions
% 223.06/223.24  |- skos__annotation mesh__D015312
% 223.06/223.24       D25-26 qualif; coord IM with specific substance in solution %28%IM%29%; DF: HEMODIALYSIS SOL%A%  
% 223.06/223.24  |- mesh__dateRevised mesh__D015312 2005-06-30
% 223.06/223.24  |- rdf__type mesh__D006586sskos__Concept
% 223.06/223.24  |- mesh__publicMeSHNote mesh__D006586 78   
% 223.06/223.24  |- skos__broader mesh__D006586smesh__D000473
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D006586 2005
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D006586 1997
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D006586 1994
% 223.06/223.24  |- mesh__dateRevised mesh__D006586 1992-05-19
% 223.06/223.24  |- skos__prefLabel mesh__D006586 Hexanes
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D006586 2006
% 223.06/223.24  |- skos__scopeNote mesh__D006586
% 223.06/223.24       Six-carbon saturated hydrocarbon group of the methane series. Include isomers and derivatives. Various polyneuropathies are caused by hexane poisoning.%A%    
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D006586 1995
% 223.06/223.24  |- skos__historyNote mesh__D006586 Alkanes %28%1966-1977%29%
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D006586 2002
% 223.06/223.24  |- mesh__recordMaintainer mesh__D006586 TGC
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D006586 1998
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D006586 2003
% 223.06/223.24  |- mesh__recordAuthorizer mesh__D006586 PLS
% 223.06/223.24  |- skos__historyNote mesh__D006586 Hydrocarbons %28%1966-1977%29%
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D006586 1999
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D006586 2004
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D006586 1993
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D006586 2000
% 223.06/223.24  |- mesh__dateEstablished mesh__D006586 1978-01-01
% 223.06/223.24  |- mesh__recordOriginator mesh__D006586 RLS
% 223.06/223.24  |- mesh__activeMeSHYear mesh__D006586 1996
% 223.06/223.24  |- mesh__dateCreated mesh__D006586 1977-05-20
% 223.06/223.25  |- mesh__historyNote mesh__D006586 78   
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D006586 2001
% 223.06/223.25  |- skos__annotation mesh__D006586
% 223.06/223.25       does not include hexenes %28% = ALKENES%29%, hexadienes %28% = ALKADIENES%29%, or hexatrienes %28% = POLYENES%29%; CYCLOHEXANES is also available%A%  
% 223.06/223.25  |- skos__altLabel mesh__D020257 Ventricle Remodeling
% 223.06/223.25  |- skos__broader mesh__D020257smesh__D016276
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Ventricular Cardiac Remodelings
% 223.06/223.25  |- mesh__recordOriginator mesh__D020257 NDW
% 223.06/223.25  |- rdf__type mesh__D020257sskos__Concept
% 223.06/223.25  |- skos__altLabel mesh__D020257 Left Ventricular Remodeling
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Ventricle Remodeling, Left
% 223.06/223.25  |- mesh__dateEstablished mesh__D020257 1999-01-01
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Remodeling, Ventricle
% 223.06/223.25  |- skos__scopeNote mesh__D020257
% 223.06/223.25       The geometric and structural changes that the HEART VENTRICLES undergo, usually following MYOCARDIAL INFARCTION. It comprises expansion of the infarct and dilatation of the healthy ventricle segments. While most prevalent in the left ventricle, it can also occur in the right ventricle.%A%    
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Cardiac Remodelings, Ventricular
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Left Ventricular Remodelings
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D020257 2004
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Myocardial Remodelings, Ventricular
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Ventricular Myocardial Remodelings
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Remodeling, Ventricular
% 223.06/223.25  |- skos__prefLabel mesh__D020257 Ventricular Remodeling
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Ventricular Remodelings, Left
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Remodeling, Ventricular Myocardial
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Ventricular Myocardial Remodeling
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Remodelings, Ventricular Myocardial
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Ventricular Remodeling, Left
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Ventricle Remodelings, Left
% 223.06/223.25  |- mesh__publicMeSHNote mesh__D020257 99   
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Ventricular Cardiac Remodeling
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Remodeling, Left Ventricular
% 223.06/223.25  |- mesh__recordMaintainer mesh__D020257 sjn
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Remodeling, Left Ventricle
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D020257 2006
% 223.06/223.25  |- mesh__recordAuthorizer mesh__D020257 sjn
% 223.06/223.25  |- mesh__dateRevised mesh__D020257 2003-07-25
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Remodelings, Left Ventricular
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Ventricle Remodelings
% 223.06/223.25  |- skos__altLabel mesh__D020257 Myocardial Remodeling, Ventricular
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Remodelings, Ventricular Cardiac
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Left Ventricle Remodelings
% 223.06/223.25  |- mesh__dateCreated mesh__D020257 1998-06-11
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Remodelings, Ventricular
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D020257 2005
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Remodeling, Ventricular Cardiac
% 223.06/223.25  |- skos__altLabel mesh__D020257 Cardiac Remodeling, Ventricular
% 223.06/223.25  |- skos__historyNote mesh__D020257 Heart Ventricle %28%1984-1998%29%
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Remodelings, Ventricle
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Remodelings, Left Ventricle
% 223.06/223.25  |- mesh__historyNote mesh__D020257 99   
% 223.06/223.25  |- skos__hiddenLabel mesh__D020257 Ventricular Remodelings
% 223.06/223.25  |- skos__altLabel mesh__D019703 PP2B
% 223.06/223.25  |- mesh__dateCreated mesh__D019703 1997-06-20
% 223.06/223.25  |- skos__broader mesh__D019703smesh__D010749
% 223.06/223.25  |- skos__hiddenLabel mesh__D019703 2B, Protein Phosphatase
% 223.06/223.25  |- skos__hiddenLabel mesh__D019703 A, Calcineurin
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D019703 2006
% 223.06/223.25  |- skos__annotation mesh__D019703
% 223.06/223.25       a calcium- %26% calmodulin-binding protein in the CNS; DF: note short X ref%A%  
% 223.06/223.25  |- mesh__publicMeSHNote mesh__D019703
% 223.06/223.25       98; CALCINEURIN was indexed under PHOSPHOPROTEIN PHOSPHATASE 1988-97 %26% CALMODULIN-BINDING PROTEINS 1986-97; CALCINEURIN B %28%now CALCINEURIN%29% was indexed under CALCIUM-BINDING PROTEINS 1994-97%A%  
% 223.06/223.25  |- mesh__dateEstablished mesh__D019703 1998-01-01
% 223.06/223.25  |- mesh__historyNote mesh__D019703
% 223.06/223.25       98; see CALCINEURIN %28%NM%29% 1987-97   
% 223.06/223.25  |- skos__altLabel mesh__D019703 Protein Phosphatase-2B
% 223.06/223.25  |- skos__scopeNote mesh__D019703
% 223.06/223.25       A calcium- and calmodulin-binding protein present in highest concentrations in the central nervous system. Calcineurin is composed of two subunits. A catalytic subunit, calcineurin A, and a regulatory subunit, calcineurin B, with molecular weights of about 60 kDa and 19 kDa, respectively. Calcineurin has been shown to dephosphorylate a number of phosphoproteins including histones, myosin light chain, and the regulatory subunit of cAMP-dependent protein kinase. It is involved in the regulation of signal transduction and is the target of an important class of immunophilin-immunosuppressive drug complexes in T-lymphocytes that act by inhibiting T-cell activation.%A%    
% 223.06/223.25  |- mesh__recordAuthorizer mesh__D019703 sjn
% 223.06/223.25  |- skos__historyNote mesh__D019703
% 223.06/223.25       Calcium-Binding Proteins %28%1986-1997%29%
% 223.06/223.25  |- rdf__type mesh__D019703sskos__Concept
% 223.06/223.25  |- skos__historyNote mesh__D019703
% 223.06/223.25       Calmodulin-Binding Proteins %28%1986-1997%29%
% 223.06/223.25  |- mesh__recordOriginator mesh__D019703 ADP
% 223.06/223.25  |- mesh__dateRevised mesh__D019703 2005-06-30
% 223.06/223.25  |- skos__hiddenLabel mesh__D019703 Phosphatase-2B, Protein
% 223.06/223.25  |- skos__altLabel mesh__D019703 Protein Phosphatase 2B
% 223.06/223.25  |- skos__historyNote mesh__D019703
% 223.06/223.25       Phosphoprotein Phosphatase %28%1988-1997%29%
% 223.06/223.25  |- mesh__recordMaintainer mesh__D019703 ags
% 223.06/223.25  |- skos__prefLabel mesh__D019703 Calcineurin
% 223.06/223.25  |- skos__hiddenLabel mesh__D019703 Phosphatase 2B, Protein
% 223.06/223.25  |- skos__hiddenLabel mesh__D019703 B, Calcineurin
% 223.06/223.25  |- skos__broader mesh__D011720smesh__D001393
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D011720 2006
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D011720 2006A
% 223.06/223.25  |- mesh__recordAuthorizer mesh__D011720 ags
% 223.06/223.25  |- mesh__dateRevised mesh__D011720 2005-09-30
% 223.06/223.25  |- skos__prefLabel mesh__D011720 Pyrazoles
% 223.06/223.25  |- rdf__type mesh__D011720sskos__Concept
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D011720 2006C
% 223.06/223.25  |- mesh__recordMaintainer mesh__D011720 ags
% 223.06/223.25  |- skos__annotation mesh__D011720
% 223.06/223.25       includes pyrazolines %26% pyrazolidines   
% 223.06/223.25  |- mesh__recordOriginator mesh__D011720 NLM
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D011720 2006B
% 223.06/223.25  |- skos__scopeNote mesh__D011720
% 223.06/223.25       Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.%A%    
% 223.06/223.25  |- mesh__dateCreated mesh__D011720 1999-01-01
% 223.06/223.25  |- mesh__historyNote mesh__D002994 72%28%69%29%   
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D002994 2003
% 223.06/223.25  |- skos__altLabel mesh__D002994 Miskleron
% 223.06/223.25  |- skos__altLabel mesh__D002994 Ethyl Chlorophenoxyisobutyrate
% 223.06/223.25  |- mesh__recordAuthorizer mesh__D002994 sjn
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D002994 2004
% 223.06/223.25  |- skos__prefLabel mesh__D002994 Clofibrate
% 223.06/223.25  |- rdf__type mesh__D002994sskos__Concept
% 223.06/223.25  |- skos__historyNote mesh__D002994
% 223.06/223.25       Anticholesteremic Agents %28%1966-1968%29%
% 223.06/223.25  |- skos__broader mesh__D002994smesh__D002087
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D002994 2005
% 223.06/223.25  |- mesh__dateEstablished mesh__D002994 1972-01-01
% 223.06/223.25  |- skos__hiddenLabel mesh__D002994 Chlorophenoxyisobutyrate, Ethyl
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D002994 2006
% 223.06/223.25  |- mesh__publicMeSHNote mesh__D002994 72   
% 223.06/223.25  |- skos__scopeNote mesh__D002994
% 223.06/223.25       A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p986%29%%A%    
% 223.06/223.25  |- mesh__recordOriginator mesh__D002994 NLM
% 223.06/223.25  |- mesh__recordMaintainer mesh__D002994 jmp
% 223.06/223.25  |- skos__historyNote mesh__D002994 Propionates %28%1966-1968%29%
% 223.06/223.25  |- mesh__dateCreated mesh__D002994 1999-01-01
% 223.06/223.25  |- skos__altLabel mesh__D002994 Clofibric Acid, Ethyl Ester
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D002994 2002
% 223.06/223.25  |- mesh__dateRevised mesh__D002994 2001-07-25
% 223.06/223.25  |- skos__broader mesh__D002994smesh__D002995
% 223.06/223.25  |- skos__altLabel mesh__D002994 Atromid S
% 223.06/223.25  |- mesh__recordOriginator mesh__D002196 NLM
% 223.06/223.25  |- skos__broader mesh__D002196smesh__D008833
% 223.06/223.25  |- skos__annotation mesh__D002196
% 223.06/223.25       IM GEN only; NIM as coord with specific organ /blood supply; not for lymphatic capillaries%A%  
% 223.06/223.25  |- mesh__recordAuthorizer mesh__D002196 sjn
% 223.06/223.25  |- mesh__dateRevised mesh__D002196 2003-07-09
% 223.06/223.25  |- mesh__recordMaintainer mesh__D002196 ssb
% 223.06/223.25  |- skos__scopeNote mesh__D002196
% 223.06/223.25       The minute vessels that connect the arterioles and venules.%A%    
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D002196 2006
% 223.06/223.25  |- mesh__dateCreated mesh__D002196 1999-01-01
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D002196 2005
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D002196 2004
% 223.06/223.25  |- skos__hiddenLabel mesh__D002196 Capillary
% 223.06/223.25  |- skos__prefLabel mesh__D002196 Capillaries
% 223.06/223.25  |- rdf__type mesh__D002196sskos__Concept
% 223.06/223.25  |- skos__prefLabel mesh__D043802 GTP-Binding Protein alpha Subunits, Gq-G11
% 223.06/223.25  |- mesh__dateRevised mesh__D043802 2004-07-07
% 223.06/223.25  |- skos__hiddenLabel mesh__D043802 G11 G-Protein
% 223.06/223.25  |- skos__hiddenLabel mesh__D043802
% 223.06/223.25       GTP Binding Protein alpha Subunits, Gq G11
% 223.06/223.25  |- skos__altLabel mesh__D043802 G alpha11 Protein
% 223.06/223.25  |- skos__hiddenLabel mesh__D043802 Protein, Galpha11
% 223.06/223.25  |- skos__hiddenLabel mesh__D043802 G Protein, Gq G11 alpha Family
% 223.06/223.25  |- skos__altLabel mesh__D043802 G-Protein, Gq-G11 alpha Family
% 223.06/223.25  |- skos__hiddenLabel mesh__D043802 Family, Gq-G11 G-Protein
% 223.06/223.25  |- mesh__recordMaintainer mesh__D043802 jmp
% 223.06/223.25  |- skos__hiddenLabel mesh__D043802 G Protein, Gq alpha Family
% 223.06/223.25  |- skos__hiddenLabel mesh__D043802 GTP Binding Protein alpha Subunit, Gq
% 223.06/223.25  |- skos__historyNote mesh__D043802 GTP-Binding Proteins %28%1999-2000%29%
% 223.06/223.25  |- skos__hiddenLabel mesh__D043802 Gq G11 G Proteins
% 223.06/223.25  |- skos__hiddenLabel mesh__D043802 G-Protein Family, Gq-G11
% 223.06/223.25  |- skos__hiddenLabel mesh__D043802 G Protein, Gq
% 223.06/223.25  |- skos__altLabel mesh__D043802 G-Protein, G11
% 223.06/223.25  |- skos__hiddenLabel mesh__D043802 Protein, G alpha11
% 223.06/223.25  |- skos__hiddenLabel mesh__D043802 alpha11 Protein, G
% 223.06/223.25  |- skos__hiddenLabel mesh__D043802 Gq-G11 G-Protein
% 223.06/223.25  |- skos__hiddenLabel mesh__D043802 G-Proteins, Gq-G11
% 223.06/223.25  |- skos__altLabel mesh__D043802 G-Protein, Gq-G11
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D043802 2005
% 223.06/223.25  |- skos__broader mesh__D043802smesh__D044385
% 223.06/223.25  |- skos__altLabel mesh__D043802 Gq-G11 G-Protein Family
% 223.06/223.25  |- mesh__dateCreated mesh__D043802 2003-07-09
% 223.06/223.25  |- skos__altLabel mesh__D043802 Galpha11 Protein
% 223.06/223.25  |- skos__altLabel mesh__D043802 G-Protein, Gq
% 223.06/223.25  |- mesh__publicMeSHNote mesh__D043802
% 223.06/223.25       2004; G ALPHA Q PROTEIN %28%now GTP-BINDING PROTEIN ALPHA SUBUNITS GQ-G11%29% was indexed under HETEROTRIMERIC GTP-BINDING PROTEINS 2001-2003; GTP-BINDING  PROTEINS 1999-2000%A%  
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D043802 2006
% 223.06/223.25  |- skos__hiddenLabel mesh__D043802 G Protein, Gq G11
% 223.06/223.25  |- mesh__recordOriginator mesh__D043802 jmp
% 223.06/223.25  |- skos__hiddenLabel mesh__D043802 Gq G11 G Protein Family
% 223.06/223.25  |- skos__altLabel mesh__D043802 G alpha Protein q
% 223.06/223.25  |- skos__hiddenLabel mesh__D043802 G Protein, G11
% 223.06/223.25  |- skos__historyNote mesh__D043802
% 223.06/223.25       Heterotrimeric GTP-Binding Proteins %28%2001-2003%29%
% 223.06/223.25  |- mesh__historyNote mesh__D043802
% 223.06/223.25       2004; use GTP-BINDING PROTEIN ALPHA SUBUNITS GQ-G11%28%NM%29% 1999-2003%A%  
% 223.06/223.25  |- skos__altLabel mesh__D043802 Gq-G11 G-Proteins
% 223.06/223.25  |- skos__altLabel mesh__D043802 G alpha q Protein
% 223.06/223.25  |- skos__hiddenLabel mesh__D043802 GTP Binding Protein alpha Subunit, G11
% 223.06/223.25  |- skos__hiddenLabel mesh__D043802 Gq G-Protein
% 223.06/223.25  |- skos__altLabel mesh__D043802 Galphaq Protein
% 223.06/223.25  |- mesh__recordAuthorizer mesh__D043802 sjn
% 223.06/223.25  |- skos__altLabel mesh__D043802 G-Protein, Gq alpha Family
% 223.06/223.25  |- skos__altLabel mesh__D043802 Gq Protein
% 223.06/223.25  |- rdf__type mesh__D043802sskos__Concept
% 223.06/223.25  |- skos__scopeNote mesh__D043802
% 223.06/223.25       A family of heterotrimeric GTP-binding protein alpha subunits that activate PHOSPHOLIPASE C dependent signaling pathways. The Gq-G11 part of the name is also spelled Gq/G11.%A%    
% 223.06/223.25  |- mesh__dateEstablished mesh__D043802 2004-01-01
% 223.06/223.25  |- mesh__historyNote mesh__D010628
% 223.06/223.25       91%28%75%29%; was see under AMINOPHENOLS 1979-90; was see under ANILINE COMPOUNDS 1975-78%A%  
% 223.06/223.25  |- skos__broader mesh__D010628smesh__D005019
% 223.06/223.25  |- skos__broader mesh__D010628smesh__D010647
% 223.06/223.25  |- rdf__type mesh__D010628sskos__Concept
% 223.06/223.25  |- skos__historyNote mesh__D010628 Aniline Compounds %28%1969-1974%29%
% 223.06/223.25  |- mesh__recordOriginator mesh__D010628 RS
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D010628 2003
% 223.06/223.25  |- skos__scopeNote mesh__D010628
% 223.06/223.25       Used in the manufacture of acetophenetidin.     
% 223.06/223.25  |- skos__historyNote mesh__D010628 Ethyl Ethers %28%1974%29%
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D010628 2002
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D010628 2005
% 223.06/223.25  |- mesh__recordMaintainer mesh__D010628 CCR
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D010628 2004
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D010628 2006
% 223.06/223.25  |- mesh__dateCreated mesh__D010628 1977-12-07
% 223.06/223.25  |- mesh__dateRevised mesh__D010628 2000-06-21
% 223.06/223.25  |- mesh__dateEstablished mesh__D010628 1991-01-01
% 223.06/223.25  |- skos__prefLabel mesh__D010628 Phenetidine
% 223.06/223.25  |- skos__altLabel mesh__D010628 Aminophenetole
% 223.06/223.25  |- skos__broader mesh__D010628smesh__D000627
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D010628 2001
% 223.06/223.25  |- skos__altLabel mesh__D010628 Ethoxyaniline
% 223.06/223.25  |- mesh__publicMeSHNote mesh__D010628
% 223.06/223.25       91; was see under AMINOPHENOLS 1979-90; was see under ANILINE COMPOUNDS 1975-78%A%  
% 223.06/223.25  |- mesh__recordAuthorizer mesh__D010628 sjn
% 223.06/223.25  |- skos__altLabel mesh__D015313 Astra Brand of Cefotetan Disodium
% 223.06/223.25  |- skos__hiddenLabel mesh__D015313 Disodium Salt, Cefotetan
% 223.06/223.25  |- mesh__recordAuthorizer mesh__D015313 sjn
% 223.06/223.25  |- skos__broader mesh__D015313smesh__D013777
% 223.06/223.25  |- mesh__dateEstablished mesh__D015313 1989-01-01
% 223.06/223.25  |- skos__scopeNote mesh__D015313
% 223.06/223.25       A semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms.%A%    
% 223.06/223.25  |- mesh__dateRevised mesh__D015313 2005-06-30
% 223.06/223.25  |- skos__altLabel mesh__D015313 Cefotan
% 223.06/223.25  |- skos__altLabel mesh__D015313 Cefotetan Disodium Salt
% 223.06/223.25  |- mesh__activeMeSHYear mesh__D015313 2006
% 223.06/223.25  |- mesh__publicMeSHNote mesh__D015313 89   
% 223.06/223.25  |- skos__historyNote mesh__D015313 Cephamycins %28%1982-1988%29%
% 223.06/223.25  |- skos__hiddenLabel mesh__D015313 ICI 156834
% 223.06/223.25  |- skos__hiddenLabel mesh__D015313 Salt, Cefotetan Disodium
% 223.06/223.25  |- skos__hiddenLabel mesh__D015313 ICI156834
% 223.06/223.25  |- skos__prefLabel mesh__D015313 Cefotetan
% 223.06/223.25  |- mesh__recordOriginator mesh__D015313 RLS
% 223.06/223.25  |- skos__broader mesh__D015313smesh__D002513
% 223.06/223.25  |- skos__altLabel mesh__D015313 AstraZeneca Brand of Cefotetan Disodium
% 223.06/223.25  |- mesh__historyNote mesh__D015313 89   
% 223.06/223.25  |- rdf__type mesh__D015313sskos__Concept
% 223.06/223.25  |- skos__hiddenLabel mesh__D015313 YM09330
% 223.06/223.25  |- skos__altLabel mesh__D015313 Lederle Brand of Cefotetan Disodium
% 223.06/223.25  |- mesh__dateCreated mesh__D015313 1988-05-31
% 223.06/223.25  |- skos__hiddenLabel mesh__D015313 YM 09330
% 223.06/223.25  |- skos__hiddenLabel mesh__D015313 Disodium, Cefotetan
% 223.06/223.25  |- mesh__recordMaintainer mesh__D015313 lkw
% 223.06/223.25  |- skos__altLabel mesh__D015313 Wyeth Brand of Cefotetan Disodium
% 223.06/223.25  |- skos__broader mesh__D035002Q000002smesh__D035002
% 223.06/223.26  |- mesh__preferredCombination mesh__D035002Q000002smesh__D038061
% 223.06/223.26  |- rdf__type mesh__D035002Q000002smesh__CompoundConcept
% 223.06/223.26  |- mesh__publicMeSHNote mesh__D039761 2003   
% 223.06/223.26  |- skos__broader mesh__D039761smesh__D007887
% 223.06/223.26  |- mesh__activeMeSHYear mesh__D039761 2005
% 223.06/223.26  |- rdf__type mesh__D039761sskos__Concept
% 223.06/223.27  |- skos__annotation mesh__D039761
% 223.06/223.27       X ref BROOM, DYERS: several other Broom terms are also available; check text and MeSH; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D039761 2003
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D039761 2006
% 223.06/223.27  |- skos__altLabel mesh__D039761 Gorse, Spanish
% 223.06/223.27  |- mesh__dateEstablished mesh__D039761 2003-01-01
% 223.06/223.27  |- mesh__historyNote mesh__D039761 2003   
% 223.06/223.27  |- skos__prefLabel mesh__D039761 Genista
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D039761 2004
% 223.06/223.27  |- skos__scopeNote mesh__D039761
% 223.06/223.27       A plant genus of the family FABACEAE. The common name of broom may be confused with Scotch Broom %28%CYTISUS%29% or Butcher%27%s Broom %28%RUSCUS%29% or Desert Broom %28%BACCHARIS%29% or Spanish Broom %28%SPARTIUM%29% or Brome %28%BROMUS%29%.%A%    
% 223.06/223.27  |- mesh__dateCreated mesh__D039761 2002-07-02
% 223.06/223.27  |- skos__altLabel mesh__D039761 Broom, Dyers
% 223.06/223.27  |- mesh__historyNote mesh__D006587
% 223.06/223.27       91%28%75%29%; was see under CAPROATES 1975-90   
% 223.06/223.27  |- mesh__publicMeSHNote mesh__D006587
% 223.06/223.27       91; was see under CAPROATES 1975-90   
% 223.06/223.27  |- rdf__type mesh__D006587sskos__Concept
% 223.06/223.27  |- skos__prefLabel mesh__D006587 Hexanoic Acids
% 223.06/223.27  |- skos__hiddenLabel mesh__D006587 Acid, Capronic
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D006587 2006
% 223.06/223.27  |- mesh__dateEstablished mesh__D006587 1991-01-01
% 223.06/223.27  |- mesh__recordAuthorizer mesh__D006587 sjn
% 223.06/223.27  |- mesh__recordOriginator mesh__D006587 NLM
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D006587 2005
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D006587 2004
% 223.06/223.27  |- mesh__dateCreated mesh__D006587 1999-01-01
% 223.06/223.27  |- skos__broader mesh__D006587smesh__D002208
% 223.06/223.27  |- mesh__recordMaintainer mesh__D006587 ssb
% 223.06/223.27  |- mesh__onlineNote mesh__D006587 search CAPROATES 1968-74   
% 223.06/223.27  |- skos__hiddenLabel mesh__D006587 Acids, Hexanoic
% 223.06/223.27  |- mesh__dateRevised mesh__D006587 2003-07-09
% 223.06/223.27  |- mesh__dateCreated mesh__D020258 1999-11-03
% 223.06/223.27  |- rdf__type mesh__D020258sskos__Concept
% 223.06/223.27  |- skos__hiddenLabel mesh__D020258 Neurotoxic Disorder
% 223.06/223.27  |- skos__hiddenLabel mesh__D020258 Nervous System Poisonings
% 223.06/223.27  |- skos__hiddenLabel mesh__D020258 Encephalopathies, Toxic
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D020258 2005
% 223.06/223.27  |- skos__hiddenLabel mesh__D020258 Neurotoxin Disorder
% 223.06/223.27  |- skos__altLabel mesh__D020258 Poisoning, Nervous System
% 223.06/223.27  |- skos__altLabel mesh__D020258 Neurotoxin Disorders
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D020258 2002
% 223.06/223.27  |- skos__hiddenLabel mesh__D020258 Toxic Encephalopathies
% 223.06/223.27  |- mesh__publicMeSHNote mesh__D020258 2000   
% 223.06/223.27  |- skos__hiddenLabel mesh__D020258 Syndromes, Neurotoxicity
% 223.06/223.27  |- skos__hiddenLabel mesh__D020258 Toxic Encephalopathy
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D020258 2006
% 223.06/223.27  |- skos__altLabel mesh__D020258 Nervous System Poisoning
% 223.06/223.27  |- skos__hiddenLabel mesh__D020258 Encephalitides, Toxic
% 223.06/223.27  |- mesh__dateEstablished mesh__D020258 2000-01-01
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D020258 2003
% 223.06/223.27  |- skos__hiddenLabel mesh__D020258 Neurotoxicity Syndrome
% 223.06/223.27  |- skos__altLabel mesh__D020258 Neurotoxic Disorders
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D020258 2000
% 223.06/223.27  |- mesh__historyNote mesh__D020258 2000   
% 223.06/223.27  |- skos__broader mesh__D020258smesh__D011041
% 223.06/223.27  |- skos__hiddenLabel mesh__D020258 Encephalitis, Toxic
% 223.06/223.27  |- skos__altLabel mesh__D020258 Neurotoxin Diseases
% 223.06/223.27  |- skos__prefLabel mesh__D020258 Neurotoxicity Syndromes
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D020258 2004
% 223.06/223.27  |- skos__hiddenLabel mesh__D020258 Toxic Encephalitides
% 223.06/223.27  |- skos__hiddenLabel mesh__D020258 Poisonings, Nervous System
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D020258 2001
% 223.06/223.27  |- skos__hiddenLabel mesh__D020258 Neurotoxin Disease
% 223.06/223.27  |- skos__scopeNote mesh__D020258
% 223.06/223.27       Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents.%A%    
% 223.06/223.27  |- skos__hiddenLabel mesh__D020258 Syndrome, Neurotoxicity
% 223.06/223.27  |- skos__broader mesh__D020258smesh__D009422
% 223.06/223.27  |- mesh__dateCreated mesh__D025741 2001-07-25
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D025741 2005
% 223.06/223.27  |- skos__altLabel mesh__D025741 HMG I-Y Phosphoprotein
% 223.06/223.27  |- rdf__type mesh__D025741sskos__Concept
% 223.06/223.27  |- mesh__dateRevised mesh__D025741 2004-07-07
% 223.06/223.27  |- mesh__publicMeSHNote mesh__D025741
% 223.06/223.27       2002; HMG I-TYPE PROTEIN was indexed under HIGH MOBILITY GROUP PROTEINS %26% TRANSCRIPTION FACTORS 1993-2001%A%  
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D025741 2006
% 223.06/223.27  |- skos__altLabel mesh__D025741 AT-Hook 1a Protein, High Mobility Group
% 223.06/223.27  |- skos__historyNote mesh__D025741
% 223.06/223.27       High Mobility Group Proteins %28%1993-2001%29%
% 223.06/223.27  |- mesh__historyNote mesh__D025741
% 223.06/223.27       2002; for HMG I-TYPE PROTEIN use HMGA1A PROTEIN %28%NM%29% 1993-2001%A%  
% 223.06/223.27  |- skos__hiddenLabel mesh__D025741 HMG I Y Phosphoprotein
% 223.06/223.27  |- skos__altLabel mesh__D025741 HMGI%28%Y%29% Gene Product
% 223.06/223.27  |- skos__scopeNote mesh__D025741
% 223.06/223.27       An 11-kDa AT-hook motif-containing %28%AT-HOOK MOTIFS%29% protein that binds to the minor grove of AT-rich regions of DNA. It is the full-length product of the alternatively-spliced HMGA1 gene and may function as an architectural chromatin binding protein that is involved in transcriptional regulation.%A%    
% 223.06/223.27  |- skos__broader mesh__D025741smesh__D024003
% 223.06/223.27  |- skos__altLabel mesh__D025741 HMGI Protein
% 223.06/223.27  |- mesh__recordAuthorizer mesh__D025741 sjn
% 223.06/223.27  |- skos__hiddenLabel mesh__D025741 HMG I Type Protein
% 223.06/223.27  |- mesh__recordOriginator mesh__D025741 jmp
% 223.06/223.27  |- mesh__recordMaintainer mesh__D025741 jmp
% 223.06/223.27  |- skos__prefLabel mesh__D025741 HMGA1a Protein
% 223.06/223.27  |- skos__hiddenLabel mesh__D025741 AT Hook 1a Protein, High Mobility Group
% 223.06/223.27  |- skos__altLabel mesh__D025741 HMG-I%28%Y%29% Protein
% 223.06/223.27  |- skos__altLabel mesh__D025741 High Mobility Group I%28%Y%29% Protein
% 223.06/223.27  |- skos__hiddenLabel mesh__D025741 Phosphoprotein, HMG I-Y
% 223.06/223.27  |- mesh__dateEstablished mesh__D025741 2002-01-01
% 223.06/223.27  |- skos__altLabel mesh__D025741 HMG I-Type Protein
% 223.06/223.27  |- skos__altLabel mesh__D019704 Trypanothione-Glutathione Thioltransferase
% 223.06/223.27  |- skos__hiddenLabel mesh__D019704 Thiol Disulfide Transhydrogenase
% 223.06/223.27  |- skos__hiddenLabel mesh__D019704 Protein, Glycosylation Site-Binding
% 223.06/223.27  |- skos__altLabel mesh__D019704 Erp59
% 223.06/223.27  |- skos__hiddenLabel mesh__D019704 Sulfhydryl Disulfide Interchange Enzyme
% 223.06/223.27  |- skos__hiddenLabel mesh__D019704 Gene Product, xprA
% 223.06/223.27  |- skos__hiddenLabel mesh__D019704 Gene Product, dsbC
% 223.06/223.27  |- skos__hiddenLabel mesh__D019704 Enzyme, Sulfhydryl-Disulfide Interchange
% 223.06/223.27  |- mesh__dateRevised mesh__D019704 2003-07-09
% 223.06/223.27  |- mesh__historyNote mesh__D019704
% 223.06/223.27       98; use PROTEIN DISULFIDE-ISOMERASE %28%NM%29% 1980-97   
% 223.06/223.27  |- skos__hiddenLabel mesh__D019704 Site-Binding Protein, Glycosylation
% 223.06/223.27  |- skos__altLabel mesh__D019704 dsbC Gene Product
% 223.06/223.27  |- mesh__dateEstablished mesh__D019704 1998-01-01
% 223.06/223.27  |- skos__altLabel mesh__D019704 Disulfide Isomerase
% 223.06/223.27  |- skos__altLabel mesh__D019704 Sulfhydryl-Disulfide Interchange Enzyme
% 223.06/223.27  |- skos__altLabel mesh__D019704 Thiol-Disulfide Transhydrogenase
% 223.06/223.27  |- mesh__dateCreated mesh__D019704 1997-06-20
% 223.06/223.27  |- skos__altLabel mesh__D019704 xprA Gene Product
% 223.06/223.27  |- skos__hiddenLabel mesh__D019704
% 223.06/223.27       Thioltransferase, Trypanothione-Glutathione
% 223.06/223.27  |- skos__broader mesh__D019704smesh__D019749
% 223.06/223.27  |- skos__altLabel mesh__D019704 ERp59 PDI
% 223.06/223.27  |- skos__hiddenLabel mesh__D019704 Transhydrogenase, Thiol-Disulfide
% 223.06/223.27  |- skos__prefLabel mesh__D019704 Protein Disulfide-Isomerase
% 223.06/223.27  |- skos__hiddenLabel mesh__D019704 Interchange Enzyme, Disulfide
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D019704 2006
% 223.06/223.27  |- skos__hiddenLabel mesh__D019704 Isomerase, Disulfide
% 223.06/223.27  |- mesh__publicMeSHNote mesh__D019704
% 223.06/223.27       98; PROTEIN DISULFIDE-ISOMERASE was indexed under ISOMERASES 1977-97, DISULFIDES 1974-82, %26% PROTEINS 1974-79%A%  
% 223.06/223.27  |- skos__related mesh__D019704smesh__D011393
% 223.06/223.27  |- skos__hiddenLabel mesh__D019704 Disulfide-Isomerase, Protein
% 223.06/223.27  |- skos__hiddenLabel mesh__D019704 Gene Product, dsbD
% 223.06/223.27  |- skos__altLabel mesh__D019704 Erp59-PDI
% 223.06/223.27  |- skos__altLabel mesh__D019704 Disulfide Interchange Enzyme
% 223.06/223.27  |- skos__altLabel mesh__D019704 Protein Disulfide Isomerase
% 223.06/223.27  |- mesh__recordAuthorizer mesh__D019704 sjn
% 223.06/223.27  |- skos__hiddenLabel mesh__D019704 Enzyme, Disulfide Interchange
% 223.06/223.27  |- skos__hiddenLabel mesh__D019704 Isomerase, Protein Disulfide
% 223.06/223.27  |- skos__altLabel mesh__D019704 dsbA Gene Product
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D019704 2005
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D019704 2004
% 223.06/223.27  |- skos__altLabel mesh__D019704 dsbD Gene Product
% 223.06/223.27  |- skos__scopeNote mesh__D019704
% 223.06/223.27       An enzyme that catalyzes the rearrangement of disulfide bonds within proteins during folding. It is a monomer identical to one of the subunits of PROCOLLAGEN-PROLINE DIOXYGENASE. %28%From Dorland, 28th ed%29% EC 5.3.4.1.%A%    
% 223.06/223.27  |- mesh__recordMaintainer mesh__D019704 ssb
% 223.06/223.27  |- skos__hiddenLabel mesh__D019704 Protein, dsbA
% 223.06/223.27  |- skos__hiddenLabel mesh__D019704 Disulfide Isomerase, Protein
% 223.06/223.27  |- skos__hiddenLabel mesh__D019704 Interchange Enzyme, Sulfhydryl-Disulfide
% 223.06/223.27  |- skos__hiddenLabel mesh__D019704 Gene Product, dsbA
% 223.06/223.27  |- skos__altLabel mesh__D019704 GSBP
% 223.06/223.27  |- skos__hiddenLabel mesh__D019704 Glycosylation Site Binding Protein
% 223.06/223.27  |- rdf__type mesh__D019704sskos__Concept
% 223.06/223.27  |- skos__altLabel mesh__D019704 dsbA Protein
% 223.06/223.27  |- skos__hiddenLabel mesh__D019704
% 223.06/223.27       Trypanothione Glutathione Thioltransferase
% 223.06/223.27  |- mesh__recordOriginator mesh__D019704 KEV
% 223.06/223.27  |- skos__altLabel mesh__D019704 Glycosylation Site-Binding Protein
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D011721 2001
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D011721 2003
% 223.06/223.27  |- mesh__recordOriginator mesh__D011721 NLM
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D011721 2006
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D011721 2002
% 223.06/223.27  |- mesh__recordMaintainer mesh__D011721 jmp
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D011721 2004
% 223.06/223.27  |- skos__scopeNote mesh__D011721
% 223.06/223.27       A group of condensed ring hydrocarbons.     
% 223.06/223.27  |- mesh__publicMeSHNote mesh__D011721 74   
% 223.06/223.27  |- mesh__dateEstablished mesh__D011721 1974-01-01
% 223.06/223.27  |- rdf__type mesh__D011721sskos__Concept
% 223.06/223.27  |- mesh__recordAuthorizer mesh__D011721 sjn
% 223.06/223.27  |- mesh__dateCreated mesh__D011721 1999-01-01
% 223.06/223.27  |- mesh__dateRevised mesh__D011721 1999-11-03
% 223.06/223.27  |- skos__annotation mesh__D011721
% 223.06/223.27       aromatic hydrocarbons; carcinogens; do not confuse with PYRANS or PYRONES%A%  
% 223.06/223.27  |- skos__broader mesh__D011721smesh__D011084
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D011721 2000
% 223.06/223.27  |- skos__prefLabel mesh__D011721 Pyrenes
% 223.06/223.27  |- mesh__historyNote mesh__D011721 74   
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D011721 2005
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D002995 2005
% 223.06/223.27  |- skos__altLabel mesh__D002995 p-Chlorophenoxyisobutyric Acid
% 223.06/223.27  |- skos__altLabel mesh__D002995
% 223.06/223.27       2-%28%4-Chlorophenoxy%29%-2-methylpropionic Acid
% 223.06/223.27  |- mesh__publicMeSHNote mesh__D002995
% 223.06/223.27       91; was see under CLOFIBRATE 1980-90   
% 223.06/223.27  |- skos__scopeNote mesh__D002995
% 223.06/223.27       An antilipemic agent and the biologically active metabolite of CLOFIBRATE.%A%    
% 223.06/223.27  |- skos__broader mesh__D002995smesh__D002088
% 223.06/223.27  |- mesh__recordMaintainer mesh__D002995 ssb
% 223.06/223.27  |- skos__historyNote mesh__D002995
% 223.06/223.27       Clofibrate %28%1969-1974%29% /AA %28%1975-1979%29%
% 223.06/223.27  |- skos__prefLabel mesh__D002995 Clofibric Acid
% 223.06/223.27  |- mesh__dateRevised mesh__D002995 2004-07-07
% 223.06/223.27  |- mesh__dateEstablished mesh__D002995 1991-01-01
% 223.06/223.27  |- mesh__dateCreated mesh__D002995 1979-02-21
% 223.06/223.27  |- rdf__type mesh__D002995sskos__Concept
% 223.06/223.27  |- skos__altLabel mesh__D002995 Clofibrinic Acid
% 223.06/223.27  |- mesh__recordAuthorizer mesh__D002995 sjn
% 223.06/223.27  |- mesh__historyNote mesh__D002995
% 223.06/223.27       91%28%80%29%; was see under CLOFIBRATE 1980-90   
% 223.06/223.27  |- mesh__recordOriginator mesh__D002995 RLS
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D002995 2006
% 223.06/223.27  |- skos__hiddenLabel mesh__D002995 NSC1149
% 223.06/223.27  |- skos__hiddenLabel mesh__D002995 NSC 1149
% 223.06/223.27  |- mesh__recordOriginator mesh__D043803 ssb
% 223.06/223.27  |- skos__scopeNote mesh__D043803
% 223.06/223.27       A group of AROMATIC HYDROCARBONS that have three rings joined as a triad around a single carbon atom so all three are conjoined, in contrast to a linear arrangement %28%ANTHRACENES%29% or angular arrangement %28%PHENANTHRENES%29%.%A%    
% 223.06/223.27  |- skos__broader mesh__D043803smesh__D011084
% 223.06/223.27  |- skos__prefLabel mesh__D043803 Phenalenes
% 223.06/223.27  |- mesh__recordMaintainer mesh__D043803 ssb
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D043803 2006
% 223.06/223.27  |- mesh__dateCreated mesh__D043803 2003-07-09
% 223.06/223.27  |- mesh__dateEstablished mesh__D043803 2004-01-01
% 223.06/223.27  |- skos__historyNote mesh__D043803
% 223.06/223.27       Polycyclic Hydrocarbons %28%1989-2003%29%
% 223.06/223.27  |- rdf__type mesh__D043803sskos__Concept
% 223.06/223.27  |- mesh__historyNote mesh__D043803 2004   
% 223.06/223.27  |- mesh__publicMeSHNote mesh__D043803 2004   
% 223.06/223.27  |- mesh__dateRevised mesh__D043803 2005-06-30
% 223.06/223.27  |- mesh__recordAuthorizer mesh__D043803 sjn
% 223.06/223.27  |- mesh__dateCreated mesh__D002197 1999-01-01
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D002197 1996
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D002197 2005
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D002197 2004
% 223.06/223.27  |- mesh__recordAuthorizer mesh__D002197 PLS
% 223.06/223.27  |- skos__hiddenLabel mesh__D002197 Capillarities
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D002197 2001
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D002197 2003
% 223.06/223.27  |- skos__annotation mesh__D002197 a surface property; NIM   
% 223.06/223.27  |- mesh__recordOriginator mesh__D002197 NLM
% 223.06/223.27  |- rdf__type mesh__D002197sskos__Concept
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D002197 2000
% 223.06/223.27  |- skos__scopeNote mesh__D002197
% 223.06/223.27       The action by which the surface of a liquid where it contacts a solid is elevated or depressed, because of the relative attraction of the molecules of the liquid for each other and for those of the solid. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 223.06/223.27  |- skos__prefLabel mesh__D002197 Capillarity
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D002197 1999
% 223.06/223.27  |- mesh__dateRevised mesh__D002197 1995-03-13
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D002197 2002
% 223.06/223.27  |- skos__broader mesh__D002197smesh__D013499
% 223.06/223.27  |- mesh__recordMaintainer mesh__D002197 TGC
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D002197 1998
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D002197 1997
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D002197 2006
% 223.06/223.27  |- skos__scopeNote mesh__D010629
% 223.06/223.27       A biguanide hypoglycemic agent with actions and uses similar to those of METFORMIN. Although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p290%29%%A%    
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D010629 2003
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D010629 2001
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D010629 2005
% 223.06/223.27  |- mesh__recordAuthorizer mesh__D010629 sjn
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D010629 2004
% 223.06/223.27  |- mesh__dateRevised mesh__D010629 2000-06-22
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D010629 2006
% 223.06/223.27  |- mesh__recordOriginator mesh__D010629 NLM
% 223.06/223.27  |- skos__altLabel mesh__D010629 Phenylethylbiguanide
% 223.06/223.27  |- skos__prefLabel mesh__D010629 Phenformin
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D010629 2002
% 223.06/223.27  |- mesh__recordMaintainer mesh__D010629 CCR
% 223.06/223.27  |- mesh__dateCreated mesh__D010629 1999-01-01
% 223.06/223.27  |- skos__broader mesh__D010629smesh__D001645
% 223.06/223.27  |- skos__altLabel mesh__D010629 Fenformin
% 223.06/223.27  |- rdf__type mesh__D010629sskos__Concept
% 223.06/223.27  |- mesh__dateCreated mesh__D007680 1999-01-01
% 223.06/223.27  |- skos__hiddenLabel mesh__D007680 Kidney Cancers
% 223.06/223.27  |- skos__altLabel mesh__D007680 Renal Cancer
% 223.06/223.27  |- mesh__dateRevised mesh__D007680 2005-06-30
% 223.06/223.27  |- skos__hiddenLabel mesh__D007680 Renal Neoplasm
% 223.06/223.27  |- skos__altLabel mesh__D007680 Renal Neoplasms
% 223.06/223.27  |- skos__altLabel mesh__D007680 Cancer of the Kidney
% 223.06/223.27  |- skos__hiddenLabel mesh__D007680 Cancer, Renal
% 223.06/223.27  |- mesh__recordMaintainer mesh__D007680 lkt
% 223.06/223.27  |- skos__annotation mesh__D007680
% 223.06/223.27       general prefer specifics; coordinate IM with histological type of neoplasm %28%IM%29%%A%  
% 223.06/223.27  |- skos__hiddenLabel mesh__D007680 Neoplasms, Renal
% 223.06/223.27  |- skos__hiddenLabel mesh__D007680 Renal Cancers
% 223.06/223.27  |- rdf__type mesh__D007680sskos__Concept
% 223.06/223.27  |- skos__prefLabel mesh__D007680 Kidney Neoplasms
% 223.06/223.27  |- skos__hiddenLabel mesh__D007680 Cancers, Kidney
% 223.06/223.27  |- mesh__recordAuthorizer mesh__D007680 sjn
% 223.06/223.27  |- skos__hiddenLabel mesh__D007680 Kidney Neoplasm
% 223.06/223.27  |- skos__hiddenLabel mesh__D007680 Cancers, Renal
% 223.06/223.27  |- skos__altLabel mesh__D007680 Neoplasms, Kidney
% 223.06/223.27  |- mesh__recordOriginator mesh__D007680 NLM
% 223.06/223.27  |- skos__altLabel mesh__D007680 Kidney Cancer
% 223.06/223.27  |- skos__hiddenLabel mesh__D007680 Neoplasm, Renal
% 223.06/223.27  |- skos__hiddenLabel mesh__D007680 Neoplasm, Kidney
% 223.06/223.27  |- skos__broader mesh__D007680smesh__D007674
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D007680 2006
% 223.06/223.27  |- skos__scopeNote mesh__D007680 Tumors or cancers of the KIDNEY.     
% 223.06/223.27  |- skos__hiddenLabel mesh__D007680 Cancer, Kidney
% 223.06/223.27  |- skos__broader mesh__D007680smesh__D014571
% 223.06/223.27  |- mesh__recordMaintainer mesh__D015314 ssb
% 223.06/223.27  |- mesh__historyNote mesh__D015314 89   
% 223.06/223.27  |- skos__historyNote mesh__D015314 Hemodialysis %28%1967-1988%29%
% 223.06/223.27  |- skos__scopeNote mesh__D015314
% 223.06/223.27       Solutions prepared for exchange across a semipermeable membrane of solutes below a molecular size determined by the cutoff threshold of the membrane material.%A%    
% 223.06/223.27  |- skos__prefLabel mesh__D015314 Dialysis Solutions
% 223.06/223.27  |- skos__broader mesh__D015314smesh__D019999
% 223.06/223.27  |- skos__historyNote mesh__D015314
% 223.06/223.27       Peritoneal Dialysis, Continuous Ambulatory %28%1982-1988%29%
% 223.06/223.27  |- rdf__type mesh__D015314sskos__Concept
% 223.06/223.27  |- mesh__recordAuthorizer mesh__D015314 sjn
% 223.06/223.27  |- mesh__recordOriginator mesh__D015314 EJB
% 223.06/223.27  |- mesh__dateCreated mesh__D015314 1988-05-31
% 223.06/223.27  |- skos__historyNote mesh__D015314 Peritoneal Dialysis %28%1966-1988%29%
% 223.06/223.27  |- mesh__dateRevised mesh__D015314 2005-06-30
% 223.06/223.27  |- skos__annotation mesh__D015314
% 223.06/223.27       D25-26 qualif; coord IM with specific substance in solution %28%IM%29%; DF: DIALYSIS SOL%A%  
% 223.06/223.27  |- mesh__dateEstablished mesh__D015314 1989-01-01
% 223.06/223.27  |- skos__hiddenLabel mesh__D015314 Solutions, Dialysis
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D015314 2006
% 223.06/223.27  |- skos__altLabel mesh__D015314 Dialysates
% 223.06/223.27  |- mesh__publicMeSHNote mesh__D015314 89   
% 223.06/223.27  |- skos__historyNote mesh__D015314 Dialysis %28%1966-1988%29%
% 223.06/223.27  |- skos__altLabel mesh__D015314 Dialyzates
% 223.06/223.27  |- skos__altLabel mesh__D039762 Ulex europeaus
% 223.06/223.27  |- mesh__publicMeSHNote mesh__D039762 2003   
% 223.06/223.27  |- skos__altLabel mesh__D039762 Ulex euroapaeus
% 223.06/223.27  |- skos__altLabel mesh__D039762 Ulex europeus
% 223.06/223.27  |- mesh__dateEstablished mesh__D039762 2003-01-01
% 223.06/223.27  |- skos__altLabel mesh__D039762 Gorse, Common
% 223.06/223.27  |- mesh__recordMaintainer mesh__D039762 ags
% 223.06/223.27  |- skos__prefLabel mesh__D039762 Ulex
% 223.06/223.27  |- skos__scopeNote mesh__D039762
% 223.06/223.27       A plant genus of the family FABACEAE %28%sometimes classified as Papilionaceae%29%. Members contain LECTINS.%A%    
% 223.06/223.27  |- mesh__recordAuthorizer mesh__D039762 ags
% 223.06/223.27  |- mesh__dateCreated mesh__D039762 2002-07-03
% 223.06/223.27  |- skos__altLabel mesh__D039762 Ulex europus
% 223.06/223.27  |- mesh__recordOriginator mesh__D039762 ssb
% 223.06/223.27  |- rdf__type mesh__D039762sskos__Concept
% 223.06/223.27  |- mesh__dateRevised mesh__D039762 2005-07-22
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D039762 2004
% 223.06/223.27  |- mesh__historyNote mesh__D039762 2003   
% 223.06/223.27  |- skos__altLabel mesh__D039762 Ulex eulopeus
% 223.06/223.27  |- skos__altLabel mesh__D039762 Ulex europeans
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D039762 2006
% 223.06/223.27  |- skos__altLabel mesh__D039762 Gorse, European
% 223.06/223.27  |- skos__altLabel mesh__D039762 Ulex europaes
% 223.06/223.27  |- skos__broader mesh__D039762smesh__D007887
% 223.06/223.27  |- skos__altLabel mesh__D039762 Ulex europoeus
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D039762 2003
% 223.06/223.27  |- skos__altLabel mesh__D039762 Ulex europhaeus
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D039762 2006A
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D039762 2005
% 223.06/223.27  |- skos__annotation mesh__D039762
% 223.06/223.27       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.06/223.27  |- rdf__type mesh__D006588sskos__Concept
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D006588 2000
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D006588 1996
% 223.06/223.27  |- skos__hiddenLabel mesh__D006588 Methyl Ketones, Butyl
% 223.06/223.27  |- skos__broader mesh__D006588smesh__D007659
% 223.06/223.27  |- mesh__dateCreated mesh__D006588 1974-11-11
% 223.06/223.27  |- skos__historyNote mesh__D006588 Ketones %28%1966-1974%29%
% 223.06/223.27  |- mesh__dateRevised mesh__D006588 1992-05-19
% 223.06/223.27  |- skos__prefLabel mesh__D006588 Hexanones
% 223.06/223.27  |- skos__hiddenLabel mesh__D006588 Ketones, Butyl Methyl
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D006588 2006
% 223.06/223.27  |- mesh__dateEstablished mesh__D006588 1991-01-01
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D006588 2002
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D006588 1995
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D006588 2005
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D006588 2004
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D006588 1994
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D006588 1993
% 223.06/223.27  |- skos__hiddenLabel mesh__D006588 Propyl Ketones, Ethyl
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D006588 2003
% 223.06/223.27  |- mesh__publicMeSHNote mesh__D006588 91; was see under KETONES 1975-90   
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D006588 1999
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D006588 2001
% 223.06/223.27  |- skos__hiddenLabel mesh__D006588 Ketones, Ethyl Propyl
% 223.06/223.27  |- skos__scopeNote mesh__D006588
% 223.06/223.27       6-carbon straight-chain or branched ketones.     
% 223.06/223.27  |- mesh__recordOriginator mesh__D006588 NLM
% 223.06/223.27  |- mesh__recordAuthorizer mesh__D006588 PLS
% 223.06/223.27  |- mesh__historyNote mesh__D006588
% 223.06/223.27       91%28%75%29%; was see under KETONES 1975-90   
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D006588 1998
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D006588 1997
% 223.06/223.27  |- mesh__recordMaintainer mesh__D006588 TGC
% 223.06/223.27  |- skos__altLabel mesh__D025742 AT-Hook 1b Protein, High Mobility Group
% 223.06/223.27  |- rdf__type mesh__D025742sskos__Concept
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D025742 2006
% 223.06/223.27  |- mesh__publicMeSHNote mesh__D025742
% 223.06/223.27       2002; HMGY PROTEIN was indexed under HIGH MOBILITY GROUP PROTEINS %26% TRANSCRIPTION FACTORS 1993-2001%A%  
% 223.06/223.27  |- mesh__dateCreated mesh__D025742 2001-07-25
% 223.06/223.27  |- skos__historyNote mesh__D025742
% 223.06/223.27       High Mobility Group Proteins %28%1993-2001%29%
% 223.06/223.27  |- skos__altLabel mesh__D025742 HMGY Protein
% 223.06/223.27  |- skos__broader mesh__D025742smesh__D024003
% 223.06/223.27  |- skos__historyNote mesh__D025742 Transcription Factors %28%1993-2001%29%
% 223.06/223.27  |- skos__prefLabel mesh__D025742 HMGA1b Protein
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D025742 2002
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D025742 2003
% 223.06/223.27  |- mesh__dateEstablished mesh__D025742 2002-01-01
% 223.06/223.27  |- mesh__historyNote mesh__D025742
% 223.06/223.27       2002; for HMGY PROTEIN use HMGA1B PROTEIN %28%NM%29% 1993-2001   
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D025742 2004
% 223.06/223.27  |- skos__hiddenLabel mesh__D025742 AT Hook 1b Protein, High Mobility Group
% 223.06/223.27  |- skos__scopeNote mesh__D025742
% 223.06/223.27       An AT-hook motif-containing protein %28%AT-HOOK MOTIFS%29% that binds to the minor grove of AT-rich regions of DNA. It is a truncated form of  HMGA1a protein that is produced by alternative-splicing of the HMGA1 gene. It may function as an architectural chromatin binding protein that is involved in transcriptional regulation.%A%    
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D025742 2005
% 223.06/223.27  |- mesh__historyNote mesh__D003290
% 223.06/223.27       91%28%85%29%; was see under EYE MOVEMENTS 1985-90   
% 223.06/223.27  |- mesh__recordAuthorizer mesh__D003290 sjn
% 223.06/223.27  |- mesh__publicMeSHNote mesh__D003290
% 223.06/223.27       91; was see under EYE MOVEMENTS 1985-90   
% 223.06/223.27  |- skos__scopeNote mesh__D003290
% 223.06/223.27       The turning inward of the lines of sight toward each other.%A%    
% 223.06/223.27  |- mesh__recordMaintainer mesh__D003290 nns
% 223.06/223.27  |- skos__historyNote mesh__D003290 Accommodation, Ocular %28%1966-1984%29%
% 223.06/223.27  |- skos__broader mesh__D003290smesh__D005133
% 223.06/223.27  |- skos__hiddenLabel mesh__D003290 Ocular Convergences
% 223.06/223.27  |- skos__hiddenLabel mesh__D003290 Convergences, Ocular
% 223.06/223.27  |- mesh__dateRevised mesh__D003290 2003-07-09
% 223.06/223.27  |- skos__prefLabel mesh__D003290 Convergence, Ocular
% 223.06/223.27  |- mesh__dateEstablished mesh__D003290 1991-01-01
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D003290 2006
% 223.06/223.27  |- skos__hiddenLabel mesh__D003290 Ocular Convergence
% 223.06/223.27  |- skos__historyNote mesh__D003290 Fixation, Ocular %28%1966-1984%29%
% 223.06/223.27  |- skos__annotation mesh__D003290
% 223.06/223.27       convergent squint = ESOTROPIA; convergence insufficiency = EXOTROPIA or STRABISMUS%A%  
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D003290 2005
% 223.06/223.27  |- mesh__dateCreated mesh__D003290 1984-04-30
% 223.06/223.27  |- rdf__type mesh__D003290sskos__Concept
% 223.06/223.27  |- skos__historyNote mesh__D003290 Eye Movements %28%1966-1984%29%
% 223.06/223.27  |- mesh__recordOriginator mesh__D003290 RC
% 223.06/223.27  |- mesh__activeMeSHYear mesh__D003290 2004
% 223.06/223.27  |- mesh__historyNote mesh__D011722 77   
% 223.06/223.27  |- skos__broader mesh__D011722smesh__D039821
% 223.06/223.27  |- skos__prefLabel mesh__D011722 Pyrethrins
% 223.06/223.27  |- skos__scopeNote mesh__D011722
% 223.06/223.27       The active insecticidal constituent of CHRYSANTHEMUM CINERARIIFOLIUM flowers. Pyrethrin I is the pyretholone ester of chrysanthemummonocarboxylic acid and pyrethrin II is the pyretholone ester of chrysanthemumdicarboxylic acid monomethyl ester.%A%    
% 223.06/223.27  |- mesh__recordOriginator mesh__D011722 RLS
% 223.06/223.27  |- rdf__type mesh__D011722sskos__Concept
% 223.06/223.27  |- skos__annotation mesh__D011722
% 223.06/223.27       for use as an insecticide, see note at INSECTICIDES   
% 223.06/223.27  |- mesh__recordMaintainer mesh__D011722 ssb
% 223.06/223.27  |- mesh__dateCreated mesh__D011722 1976-05-19
% 223.06/223.27  |- mesh__publicMeSHNote mesh__D011722 77   
% 223.06/223.27  |- mesh__dateRevised mesh__D011722 2004-07-07
% 223.06/223.27  |- skos__historyNote mesh__D011722 Pyrethrum %28%1966-1976%29%
% 223.06/223.27  |- mesh__dateEstablished mesh__D011722 1977-01-01
% 223.06/223.27  |- mesh__recordAuthorizer mesh__D011722 sjn
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D011722 2005
% 223.06/223.28  |- skos__historyNote mesh__D011722
% 223.06/223.28       Insecticides, Botanical %28%1973-1976%29%
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D011722 2006
% 223.06/223.28  |- skos__hiddenLabel mesh__D002996 trans Clomiphene Citrate
% 223.06/223.28  |- skos__altLabel mesh__D002996 Clomifen
% 223.06/223.28  |- skos__hiddenLabel mesh__D002996 Citrate, Clomiphene
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D002996 2005
% 223.06/223.28  |- skos__broader mesh__D002996smesh__D013267
% 223.06/223.28  |- skos__altLabel mesh__D002996 Chloramiphene
% 223.06/223.28  |- skos__prefLabel mesh__D002996 Clomiphene
% 223.06/223.28  |- skos__altLabel mesh__D002996 Zuclomifene
% 223.06/223.28  |- skos__altLabel mesh__D002996 Clomide
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D002996 2004
% 223.06/223.28  |- mesh__recordMaintainer mesh__D002996 ssb
% 223.06/223.28  |- skos__hiddenLabel mesh__D002996 En Clomiphene
% 223.06/223.28  |- rdf__type mesh__D002996sskos__Concept
% 223.06/223.28  |- skos__hiddenLabel mesh__D002996 Citrate, trans-Clomiphene
% 223.06/223.28  |- mesh__publicMeSHNote mesh__D002996 68; CLOMIFENE was CLOMIFEN 1978-91   
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D002996 2003
% 223.06/223.28  |- mesh__recordAuthorizer mesh__D002996 sjn
% 223.06/223.28  |- mesh__dateCreated mesh__D002996 1999-01-01
% 223.06/223.28  |- mesh__dateRevised mesh__D002996 2001-07-25
% 223.06/223.28  |- mesh__dateEstablished mesh__D002996 1968-01-01
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D002996 2002
% 223.06/223.28  |- mesh__historyNote mesh__D002996
% 223.06/223.28       68%28%64%29%; CLOMIFENE was CLOMIFEN 1978-91   
% 223.06/223.28  |- skos__altLabel mesh__D002996 Clomifene
% 223.06/223.28  |- skos__hiddenLabel mesh__D002996 Citrate, Enclomiphene
% 223.06/223.28  |- skos__hiddenLabel mesh__D002996 Hydrochloride, Clomiphene
% 223.06/223.28  |- skos__altLabel mesh__D002996 Enclomifene
% 223.06/223.28  |- skos__altLabel mesh__D002996 Enclomiphen
% 223.06/223.28  |- skos__scopeNote mesh__D002996
% 223.06/223.28       A triphenyl ethylene stilbene derivative which is an estrogen agonist or antagonist depending on the target tissue.%A%    
% 223.06/223.28  |- skos__altLabel mesh__D002996 Clostilbegit
% 223.06/223.28  |- skos__altLabel mesh__D002996 En-Clomiphene
% 223.06/223.28  |- mesh__recordOriginator mesh__D002996 NLM
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D002996 2006
% 223.06/223.28  |- skos__prefLabel mesh__D002198 Capillary Fragility
% 223.06/223.28  |- skos__broader mesh__D002198smesh__D003935
% 223.06/223.28  |- mesh__historyNote mesh__D002198 70%28%68%29%   
% 223.06/223.28  |- rdf__type mesh__D002198sskos__Concept
% 223.06/223.28  |- skos__historyNote mesh__D002198 Capillary Resistance %28%1966-1967%29%
% 223.06/223.28  |- mesh__publicMeSHNote mesh__D002198 70   
% 223.06/223.28  |- skos__historyNote mesh__D002198 Capillaries %28%1966-1967%29%
% 223.06/223.28  |- mesh__recordOriginator mesh__D002198 NLM
% 223.06/223.28  |- skos__scopeNote mesh__D002198
% 223.06/223.28       The susceptibility of CAPILLARIES, under conditions of increased stress, to leakage.%A%    
% 223.06/223.28  |- mesh__dateRevised mesh__D002198 2003-07-09
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D002198 2006
% 223.06/223.28  |- mesh__recordAuthorizer mesh__D002198 sjn
% 223.06/223.28  |- mesh__dateEstablished mesh__D002198 1970-01-01
% 223.06/223.28  |- skos__broader mesh__D002198smesh__D045124
% 223.06/223.28  |- mesh__dateCreated mesh__D002198 1999-01-01
% 223.06/223.28  |- mesh__recordMaintainer mesh__D002198 nns
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D002198 2005
% 223.06/223.28  |- skos__hiddenLabel mesh__D002198 Fragility, Capillary
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D002198 2004
% 223.06/223.28  |- mesh__onlineNote mesh__D007681
% 223.06/223.28       use KIDNEY PAPILLARY NECROSIS to search PYELONEPHRITIS, ACUTE NECROTIZING 1966%A%  
% 223.06/223.28  |- skos__hiddenLabel mesh__D007681 Kidney Papillary Necroses
% 223.06/223.28  |- skos__hiddenLabel mesh__D007681 Necrotizing Pyelonephritis, Acute
% 223.06/223.28  |- mesh__publicMeSHNote mesh__D007681
% 223.06/223.28       67; was PYELONEPHRITIS, ACUTE NECROTIZING 1963-66   
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D007681 2000
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D007681 1997
% 223.06/223.28  |- skos__hiddenLabel mesh__D007681 Pyelonephritides, Acute Necrotizing
% 223.06/223.28  |- skos__prefLabel mesh__D007681 Kidney Papillary Necrosis
% 223.06/223.28  |- skos__hiddenLabel mesh__D007681 Necrotizing Pyelonephritides, Acute
% 223.06/223.28  |- skos__hiddenLabel mesh__D007681 Papillitis, Necrotizing Renal
% 223.06/223.28  |- skos__hiddenLabel mesh__D007681 Papillitides, Necrotizing Renal
% 223.06/223.28  |- skos__hiddenLabel mesh__D007681 Pyelonephritis, Necrotizing
% 223.06/223.28  |- skos__hiddenLabel mesh__D007681 Necrotizing Pyelonephritides
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D007681 2001
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D007681 1998
% 223.06/223.28  |- skos__hiddenLabel mesh__D007681 Acute Necrotizing Pyelonephritis
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D007681 2003
% 223.06/223.28  |- skos__hiddenLabel mesh__D007681 Papillary Necroses, Kidney
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D007681 1992
% 223.06/223.28  |- skos__altLabel mesh__D007681 Renal Papillitis, Necrotizing
% 223.06/223.28  |- skos__hiddenLabel mesh__D007681 Papillary Necrosis, Kidney
% 223.06/223.28  |- skos__hiddenLabel mesh__D007681 Renal Papillitides, Necrotizing
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D007681 1994
% 223.06/223.28  |- skos__hiddenLabel mesh__D007681 Necrotizing Renal Papillitides
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D007681 2002
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D007681 1999
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D007681 2004
% 223.06/223.28  |- mesh__dateRevised mesh__D007681 1991-06-18
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D007681 1993
% 223.06/223.28  |- rdf__type mesh__D007681sskos__Concept
% 223.06/223.28  |- mesh__recordMaintainer mesh__D007681 PLS
% 223.06/223.28  |- mesh__historyNote mesh__D007681
% 223.06/223.28       67; was PYELONEPHRITIS, ACUTE NECROTIZING 1963-66   
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D007681 1995
% 223.06/223.28  |- skos__hiddenLabel mesh__D007681 Necrotizing Renal Papillitis
% 223.06/223.28  |- mesh__recordAuthorizer mesh__D007681 PLS
% 223.06/223.28  |- skos__altLabel mesh__D007681 Necrotizing Pyelonephritis
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D007681 2005
% 223.06/223.28  |- mesh__recordOriginator mesh__D007681 NLM
% 223.06/223.28  |- skos__broader mesh__D007681smesh__D007674
% 223.06/223.28  |- skos__hiddenLabel mesh__D007681 Acute Necrotizing Pyelonephritides
% 223.06/223.28  |- mesh__dateEstablished mesh__D007681 1967-01-01
% 223.06/223.28  |- skos__hiddenLabel mesh__D007681 Necroses, Kidney Papillary
% 223.06/223.28  |- mesh__dateCreated mesh__D007681 1999-01-01
% 223.06/223.28  |- skos__hiddenLabel mesh__D007681 Necrosis, Kidney Papillary
% 223.06/223.28  |- skos__altLabel mesh__D007681 Pyelonephritis, Acute Necrotizing
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D007681 1996
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D007681 2006
% 223.06/223.28  |- skos__hiddenLabel mesh__D007681 Pyelonephritides, Necrotizing
% 223.06/223.28  |- skos__scopeNote mesh__D007681
% 223.06/223.28       A form of acute kidney disease characterized by necrosis of the renal papillae. It is most frequently associated with diabetes mellitus because of the severe vascular disease present in the arteries and capillaries, particularly in the kidney. There is usually a large component of infection present, and in non-diabetics pyelonephritis and obstructive uropathy are the usual etiologic agents.%A%    
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D006589 2004
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D006589 2005
% 223.06/223.28  |- mesh__dateCreated mesh__D006589 1999-01-01
% 223.06/223.28  |- mesh__recordAuthorizer mesh__D006589 sjn
% 223.06/223.28  |- mesh__recordOriginator mesh__D006589 NLM
% 223.06/223.28  |- mesh__dateRevised mesh__D006589 2001-07-25
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D006589 2003
% 223.06/223.28  |- rdf__type mesh__D006589sskos__Concept
% 223.06/223.28  |- skos__scopeNote mesh__D006589
% 223.06/223.28       A synthetic estrogen that has been used as a hormonal antineoplastic agent.%A%    
% 223.06/223.28  |- skos__broader mesh__D006589smesh__D004054
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D006589 2002
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D006589 2006
% 223.06/223.28  |- skos__prefLabel mesh__D006589 Hexestrol
% 223.06/223.28  |- skos__altLabel mesh__D006589 Dihydrodiethylstilbestrol
% 223.06/223.28  |- mesh__recordMaintainer mesh__D006589 jmp
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D025743 2003
% 223.06/223.28  |- skos__altLabel mesh__D025743 HMGI-C Protein
% 223.06/223.28  |- skos__altLabel mesh__D025743 HMG I-C Protein
% 223.06/223.28  |- skos__hiddenLabel mesh__D025743 HMGI C Protein
% 223.06/223.28  |- skos__prefLabel mesh__D025743 HMGA2 Protein
% 223.06/223.28  |- mesh__dateCreated mesh__D025743 2001-07-25
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D025743 2002
% 223.06/223.28  |- mesh__recordAuthorizer mesh__D025743 sjn
% 223.06/223.28  |- rdf__type mesh__D025743sskos__Concept
% 223.06/223.28  |- skos__hiddenLabel mesh__D025743 HMG I C Protein
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D025743 2006
% 223.06/223.28  |- skos__broader mesh__D025743smesh__D024003
% 223.06/223.28  |- mesh__recordMaintainer mesh__D025743 jmp
% 223.06/223.28  |- skos__scopeNote mesh__D025743
% 223.06/223.28       An AT-hook-containing %28%AT-HOOK MOTIFS%29% nuclear protein that is expressed predominantly in proliferating and undifferentiated mesenchymal cells.%A%    
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D025743 2005
% 223.06/223.28  |- mesh__historyNote mesh__D025743
% 223.06/223.28       2002; for HMG I-C PROTEIN use HMGA1A PROTEIN %28%NM%29% 1993-2001; for HMGI-C PROTEIN use HMGA2 PROTEIN %28%NM%29% 1992-2001%A%  
% 223.06/223.28  |- mesh__dateEstablished mesh__D025743 2002-01-01
% 223.06/223.28  |- skos__historyNote mesh__D025743
% 223.06/223.28       High Mobility Group Proteins %28%1992-2001%29%
% 223.06/223.28  |- mesh__recordOriginator mesh__D025743 jmp
% 223.06/223.28  |- mesh__publicMeSHNote mesh__D025743
% 223.06/223.28       2002; HMG I-C PROTEIN was indexed under HIGH MOBILITY GROUP PROTEINS 1993-2001, under TRANSCRIPTION FACTORS 1993-2001; HMGI-C PROTEIN was indexed under HIGH MOBILITY GROUP PROTEINS 1992-2001%A%  
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D025743 2004
% 223.06/223.28  |- skos__scopeNote mesh__D003291
% 223.06/223.28       A disorder whose predominant feature is a loss or alteration in physical functioning that suggests a physical disorder but that is actually a direct expression of a psychological conflict or need.%A%    
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D003291 2001
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D003291 1999
% 223.06/223.28  |- mesh__recordMaintainer mesh__D003291 JLS
% 223.06/223.28  |- skos__prefLabel mesh__D003291 Conversion Disorder
% 223.06/223.28  |- mesh__dateCreated mesh__D003291 1999-01-01
% 223.06/223.28  |- skos__hiddenLabel mesh__D003291 Conversion Disorders
% 223.06/223.28  |- skos__altLabel mesh__D003291 Hysteria, Conversion
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D003291 2000
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D003291 1998
% 223.06/223.28  |- mesh__onlineNote mesh__D003291
% 223.06/223.28       use CONVERSION DISORDER to search CONVERSION REACTION %26% HYSTERIA, CONVERSION 1969-80, GLOBUS HYSTERICUS 1974-80, %26% ASTASIA-ABASIA 1970-78%A%  
% 223.06/223.28  |- mesh__historyNote mesh__D003291
% 223.06/223.28       81; was CONVERSION REACTION 1969-80; GLOBUS HYSTERICUS was see under CONVERSION REACTION 1974-80; ASTASIA-ABASIA was see under CONVERSION REACTION 1970-78; HYSTERIA, CONVERSION was see under CONVERSION REACTION 1969-78%A%  
% 223.06/223.28  |- skos__hiddenLabel mesh__D003291 Hysterias, Conversion
% 223.06/223.28  |- skos__hiddenLabel mesh__D003291 Conversion Reactions
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D003291 2006
% 223.06/223.28  |- mesh__recordOriginator mesh__D003291 NLM
% 223.06/223.28  |- skos__hiddenLabel mesh__D003291 Reaction, Conversion
% 223.06/223.28  |- skos__altLabel mesh__D003291 Conversion Reaction
% 223.06/223.28  |- mesh__dateRevised mesh__D003291 1997-06-20
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D003291 2005
% 223.06/223.28  |- skos__hiddenLabel mesh__D003291 Conversion Hysterias
% 223.06/223.28  |- skos__broader mesh__D003291smesh__D013001
% 223.06/223.28  |- rdf__type mesh__D003291sskos__Concept
% 223.06/223.28  |- mesh__publicMeSHNote mesh__D003291
% 223.06/223.28       81; was CONVERSION REACTION 1969-80   
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D003291 2004
% 223.06/223.28  |- skos__hiddenLabel mesh__D003291 Reactions, Conversion
% 223.06/223.28  |- skos__annotation mesh__D003291
% 223.06/223.28       use Cat F3 qualif; X ref GLOBUS HYSTERICUS: of psychogenic origin but globus sensation of non-psychogenic origin is indexed under DEGLUTITION DISORDERS or specific organ/dis or other disease heading%A%  
% 223.06/223.28  |- mesh__recordAuthorizer mesh__D003291 SJN
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D003291 2002
% 223.06/223.28  |- skos__historyNote mesh__D003291 Hysteria %28%1966-1968%29%
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D003291 2003
% 223.06/223.28  |- skos__hiddenLabel mesh__D003291 Conversion Hysteria
% 223.06/223.28  |- mesh__dateEstablished mesh__D003291 1969-01-01
% 223.06/223.28  |- skos__hiddenLabel mesh__D003291 Astasia Abasia
% 223.06/223.28  |- skos__broader mesh__D019706smesh__D005071
% 223.06/223.28  |- mesh__historyNote mesh__D019706 98   
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D019706 2006
% 223.06/223.28  |- rdf__type mesh__D019706sskos__Concept
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D019706 1999
% 223.06/223.28  |- mesh__dateCreated mesh__D019706 1997-06-20
% 223.06/223.28  |- skos__historyNote mesh__D019706 Evoked Potentials %28%1967-1997%29%
% 223.06/223.28  |- skos__hiddenLabel mesh__D019706 Potentials, Excitatory Postsynaptic
% 223.06/223.28  |- skos__scopeNote mesh__D019706
% 223.06/223.28       The change in potential produced in the membrane of the next neuron when an impulse which has an excitatory influence arrives at the synapse; it is a local change in the direction of depolarization; summation of these potentials can lead to discharge of an impulse by the neuron. %28%Stedman, 26th ed%29%%A%    
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D019706 2002
% 223.06/223.28  |- mesh__publicMeSHNote mesh__D019706 98   
% 223.06/223.28  |- skos__annotation mesh__D019706 DF: note short X ref   
% 223.06/223.28  |- mesh__dateEstablished mesh__D019706 1998-01-01
% 223.06/223.28  |- skos__altLabel mesh__D019706 EPSP
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D019706 2000
% 223.06/223.28  |- skos__hiddenLabel mesh__D019706 Postsynaptic Potential, Excitatory
% 223.06/223.28  |- skos__prefLabel mesh__D019706 Excitatory Postsynaptic Potentials
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D019706 2003
% 223.06/223.28  |- skos__hiddenLabel mesh__D019706 Potential, Excitatory Postsynaptic
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D019706 2001
% 223.06/223.28  |- skos__hiddenLabel mesh__D019706 Postsynaptic Potentials, Excitatory
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D019706 2005
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D019706 2004
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D019706 1998
% 223.06/223.28  |- skos__hiddenLabel mesh__D019706 Excitatory Postsynaptic Potential
% 223.06/223.28  |- mesh__historyNote mesh__D011723 2003%28%1963%29%   
% 223.06/223.28  |- skos__altLabel mesh__D011723 Pyrethum Daisy
% 223.06/223.28  |- mesh__recordMaintainer mesh__D011723 ags
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D011723 2006A
% 223.06/223.28  |- mesh__recordAuthorizer mesh__D011723 ags
% 223.06/223.28  |- mesh__dateEstablished mesh__D011723 1991-01-01
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D011723 2005
% 223.06/223.28  |- mesh__dateRevised mesh__D011723 2005-07-08
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D011723 2003
% 223.06/223.28  |- skos__altLabel mesh__D011723 Tanacetum cinerariifolium
% 223.06/223.28  |- skos__scopeNote mesh__D011723
% 223.06/223.28       A plant species of the genus CHRYSANTHEMUM, family ASTERACEAE. The flowers contain PYRETHRINS, cinerolones, and chrysanthemines which are powerful contact insecticides. Most in the old Pyrethrum genus are reclassified to TANACETUM; some to other ASTERACEAE genera.%A%    
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D011723 2006
% 223.06/223.28  |- skos__annotation mesh__D011723
% 223.06/223.28       for insecticides from this plant use PYRETHRINS; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D011723 2004
% 223.06/223.28  |- skos__prefLabel mesh__D011723 Chrysanthemum cinerariifolium
% 223.06/223.28  |- skos__altLabel mesh__D011723 Tanacetum coccineum
% 223.06/223.28  |- skos__broader mesh__D011723smesh__D031202
% 223.06/223.28  |- mesh__recordOriginator mesh__D011723 NLM
% 223.06/223.28  |- mesh__publicMeSHNote mesh__D011723
% 223.06/223.28       2003; see PYRETHRUM 1992-2002, see PLANTS 1986-1990, see PYRETHRUM 1963-1985%A%  
% 223.06/223.28  |- rdf__type mesh__D011723sskos__Concept
% 223.06/223.28  |- skos__altLabel mesh__D011723 Pyrethrum
% 223.06/223.28  |- mesh__dateCreated mesh__D011723 1999-01-01
% 223.06/223.28  |- skos__related mesh__D011723smesh__D011722
% 223.06/223.28  |- skos__hiddenLabel mesh__D002997 Hydrochloride, Clomipramine
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D002997 2004
% 223.06/223.28  |- mesh__publicMeSHNote mesh__D002997
% 223.06/223.28       80; was CHLORIMIPRAMINE see under DIBENZAZEPINES 1968-79   
% 223.06/223.28  |- skos__scopeNote mesh__D002997
% 223.06/223.28       A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.%A%    
% 223.06/223.28  |- mesh__recordOriginator mesh__D002997 NLM
% 223.06/223.28  |- skos__hiddenLabel mesh__D002997 Monohydrochloride, Clomipramine
% 223.06/223.28  |- rdf__type mesh__D002997sskos__Concept
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D002997 2003
% 223.06/223.28  |- mesh__dateCreated mesh__D002997 1999-01-01
% 223.06/223.28  |- skos__broader mesh__D002997smesh__D003984
% 223.06/223.28  |- mesh__historyNote mesh__D002997
% 223.06/223.28       80%28%75%29%; was CHLORIMIPRAMINE see under DIBENZAZEPINES 1968-79%A%  
% 223.06/223.28  |- mesh__dateEstablished mesh__D002997 1980-01-01
% 223.06/223.28  |- skos__historyNote mesh__D002997 Dibenzazepines %28%1968-1974%29%
% 223.06/223.28  |- skos__prefLabel mesh__D002997 Clomipramine
% 223.06/223.28  |- mesh__recordAuthorizer mesh__D002997 sjn
% 223.06/223.28  |- mesh__recordMaintainer mesh__D002997 CCR
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D002997 2006
% 223.06/223.28  |- mesh__dateRevised mesh__D002997 2001-07-25
% 223.06/223.28  |- skos__altLabel mesh__D002997 Chlorimipramine
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D002997 2002
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D002997 2005
% 223.06/223.28  |- skos__altLabel mesh__D002997 Chlomipramine
% 223.06/223.28  |- mesh__onlineNote mesh__D002997
% 223.06/223.28       use CLOMIPRAMINE to search CHLORIMIPRAMINE 1975-79; use DIBENZAZEPINES 1968-74%A%  
% 223.06/223.28  |- mesh__recordOriginator mesh__D002199 NLM
% 223.06/223.28  |- skos__hiddenLabel mesh__D002199 Permeabilities, Capillary
% 223.06/223.28  |- skos__related mesh__D002199smesh__D049428
% 223.06/223.28  |- mesh__dateRevised mesh__D002199 2004-07-07
% 223.06/223.28  |- skos__prefLabel mesh__D002199 Capillary Permeability
% 223.06/223.28  |- skos__hiddenLabel mesh__D002199 Permeabilities, Vascular
% 223.06/223.28  |- mesh__recordAuthorizer mesh__D002199 sjn
% 223.06/223.28  |- rdf__type mesh__D002199sskos__Concept
% 223.06/223.28  |- skos__hiddenLabel mesh__D002199 Microvascular Permeabilities
% 223.06/223.28  |- skos__related mesh__D002199smesh__D001814
% 223.06/223.28  |- skos__scopeNote mesh__D002199
% 223.06/223.28       The property of blood capillary ENDOTHELIUM that allows for the selective exchange of substances between the blood and surrounding tissues and through membranous barriers such as the BLOOD-AIR BARRIER; BLOOD-AQUEOUS BARRIER; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; BLOOD-RETINAL BARRIER; and BLOOD-TESTIS BARRIER. Small lipid-soluble molecules such as carbon dioxide and oxygen move freely by diffusion. Water and water-soluble molecules cannot pass through the endothelial walls and are dependent on microscopic pores. These pores show narrow areas %28%TIGHT JUNCTIONS%29% which may limit large molecule movement.%A%    
% 223.06/223.28  |- skos__hiddenLabel mesh__D002199 Permeabilities, Microvascular
% 223.06/223.28  |- skos__broader mesh__D002199smesh__D001692
% 223.06/223.28  |- skos__annotation mesh__D002199
% 223.06/223.28       coord IM with endogenous substance /metab %28%IM%29% or exogenous substance /pharmacokin %28%IM%29%%A%  
% 223.06/223.28  |- skos__broader mesh__D002199smesh__D045124
% 223.06/223.28  |- skos__related mesh__D002199smesh__D001813
% 223.06/223.28  |- skos__hiddenLabel mesh__D002199 Permeability, Vascular
% 223.06/223.28  |- skos__related mesh__D002199smesh__D015824
% 223.06/223.28  |- mesh__dateCreated mesh__D002199 1999-01-01
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D002199 2005
% 223.06/223.28  |- skos__altLabel mesh__D002199 Microvascular Permeability
% 223.06/223.28  |- skos__related mesh__D002199smesh__D018916
% 223.06/223.28  |- skos__related mesh__D002199smesh__D001812
% 223.06/223.28  |- skos__related mesh__D002199smesh__D019559
% 223.06/223.28  |- skos__hiddenLabel mesh__D002199 Vascular Permeabilities
% 223.06/223.28  |- skos__hiddenLabel mesh__D002199 Capillary Permeabilities
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D002199 2006
% 223.06/223.28  |- mesh__recordMaintainer mesh__D002199 ags
% 223.06/223.28  |- skos__altLabel mesh__D002199 Permeability, Capillary
% 223.06/223.28  |- skos__broader mesh__D007682smesh__D007668
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D007682 2006
% 223.06/223.28  |- mesh__recordOriginator mesh__D007682 NLM
% 223.06/223.28  |- skos__scopeNote mesh__D007682
% 223.06/223.28       The flattened, funnel-shaped expansion connecting the URETER to the KIDNEY CALICES.%A%    
% 223.06/223.28  |- skos__prefLabel mesh__D007682 Kidney Pelvis
% 223.06/223.28  |- mesh__dateCreated mesh__D007682 1999-01-01
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D007682 2005
% 223.06/223.28  |- mesh__considerAlso mesh__D007682 consider also terms at PYEL-   
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D007682 2004
% 223.06/223.28  |- skos__annotation mesh__D007682
% 223.06/223.28       do not confuse with pelvic kidney %28% = KIDNEY /abnorm%29%; inflammation = PYELITIS; nephrostomy: consider NEPHROSTOMY, PERCUTANEOUS%A%  
% 223.06/223.28  |- rdf__type mesh__D007682sskos__Concept
% 223.06/223.28  |- mesh__recordMaintainer mesh__D007682 mdb
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D007682 2003
% 223.06/223.28  |- mesh__dateRevised mesh__D007682 2002-07-03
% 223.06/223.28  |- mesh__recordAuthorizer mesh__D007682 sjn
% 223.06/223.28  |- skos__hiddenLabel mesh__D007682 Pelvis, Kidney
% 223.06/223.28  |- mesh__dateRevised mesh__D015316 2002-07-03
% 223.06/223.28  |- rdf__type mesh__D015316sskos__Concept
% 223.06/223.28  |- skos__related mesh__D015316smesh__D033142
% 223.06/223.28  |- skos__altLabel mesh__D015316 Therapy, DNA
% 223.06/223.28  |- skos__altLabel mesh__D015316 Therapy, Somatic Gene
% 223.06/223.28  |- skos__altLabel mesh__D015316 Therapy, Gene
% 223.06/223.28  |- skos__scopeNote mesh__D015316
% 223.06/223.28       The introduction of new genes into cells for the purpose of treating disease by restoring or adding gene expression. Techniques include insertion of retroviral vectors, transfection, homologous recombination, and injection of new genes into the nuclei of single cell embryos. The entire gene therapy process may consist of multiple steps. The new genes may be introduced into proliferating cells in vivo %28%e.g., bone marrow%29% or in vitro %28%e.g., fibroblast cultures%29% and the modified cells transferred to the site where the gene expression is required. Gene therapy may be particularly useful for treating enzyme deficiency diseases, hemoglobinopathies, and leukemias and may also prove useful in restoring drug sensitivity, particularly for leukemia.%A%    
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D015316 2003
% 223.06/223.28  |- mesh__dateCreated mesh__D015316 1988-05-31
% 223.06/223.28  |- mesh__historyNote mesh__D015316 89   
% 223.06/223.28  |- skos__altLabel mesh__D015316 DNA Therapy
% 223.06/223.28  |- mesh__recordAuthorizer mesh__D015316 sjn
% 223.06/223.28  |- skos__broader mesh__D015316smesh__D001691
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D015316 2005
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D015316 2004
% 223.06/223.28  |- mesh__recordMaintainer mesh__D015316 jrf
% 223.06/223.28  |- mesh__recordOriginator mesh__D015316 EJB
% 223.06/223.28  |- skos__altLabel mesh__D015316 Somatic Gene Therapy
% 223.06/223.28  |- mesh__dateEstablished mesh__D015316 1989-01-01
% 223.06/223.28  |- skos__prefLabel mesh__D015316 Gene Therapy
% 223.06/223.28  |- skos__broader mesh__D015316smesh__D005818
% 223.06/223.28  |- skos__historyNote mesh__D015316 Genetic Intervention %28%1973-1988%29%
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D015316 2006
% 223.06/223.28  |- mesh__publicMeSHNote mesh__D015316 89   
% 223.06/223.28  |- skos__scopeNote mesh__D031781
% 223.06/223.28       A plant genus of the family POACEAE that is used for forage.%A%    
% 223.06/223.28  |- mesh__dateEstablished mesh__D031781 2003-01-01
% 223.06/223.28  |- mesh__publicMeSHNote mesh__D031781 2003   
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D031781 2004
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D031781 2005
% 223.06/223.28  |- skos__annotation mesh__D031781
% 223.06/223.28       X ref MILLET, KUDO: other millet terms are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.06/223.28  |- skos__prefLabel mesh__D031781 Paspalum
% 223.06/223.28  |- skos__altLabel mesh__D031781 Millet, Kodo
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D031781 2003
% 223.06/223.28  |- skos__altLabel mesh__D031781 Bahiagrass
% 223.06/223.28  |- mesh__dateCreated mesh__D031781 2002-07-02
% 223.06/223.28  |- mesh__historyNote mesh__D031781 2003   
% 223.06/223.28  |- rdf__type mesh__D031781sskos__Concept
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D031781 2006
% 223.06/223.28  |- skos__broader mesh__D031781smesh__D006109
% 223.06/223.28  |- mesh__dateRevised mesh__D003292 2005-06-30
% 223.06/223.28  |- skos__prefLabel mesh__D003292 Convulsants
% 223.06/223.28  |- mesh__recordMaintainer mesh__D003292 ssb
% 223.06/223.28  |- skos__broader mesh__D003292smesh__D000697
% 223.06/223.28  |- mesh__dateEstablished mesh__D003292 1975-09-01
% 223.06/223.28  |- mesh__onlineNote mesh__D003292 search ANALEPTICS 1966-74   
% 223.06/223.28  |- mesh__dateCreated mesh__D003292 1974-11-27
% 223.06/223.28  |- skos__historyNote mesh__D003292
% 223.06/223.28       Central Nervous System Depressants %28%1966-1975%29%
% 223.06/223.28  |- skos__scopeNote mesh__D003292
% 223.06/223.28       Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools.%A%    
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D003292 2006
% 223.06/223.28  |- mesh__publicMeSHNote mesh__D003292 75; was see ANALEPTICS 1963-74   
% 223.06/223.28  |- mesh__historyNote mesh__D003292 75; was see ANALEPTICS 1963-74   
% 223.06/223.28  |- skos__related mesh__D003292smesh__D012640
% 223.06/223.28  |- mesh__recordAuthorizer mesh__D003292 sjn
% 223.06/223.28  |- rdf__type mesh__D003292sskos__Concept
% 223.06/223.28  |- mesh__recordOriginator mesh__D003292 NLM
% 223.06/223.28  |- skos__annotation mesh__D003292
% 223.06/223.28       GEN or unspecified; prefer specifics; consider also CONVULSIONS %28%see SEIZURES%29% /chem ind%A%  
% 223.06/223.28  |- mesh__recordOriginator mesh__D019707 AGS
% 223.06/223.28  |- skos__broader mesh__D019707smesh__D018121
% 223.06/223.28  |- mesh__dateRevised mesh__D019707 2003-07-09
% 223.06/223.28  |- skos__annotation mesh__D019707 immunol recept; DF: RECEPT CHEMOKINE   
% 223.06/223.28  |- skos__altLabel mesh__D019707 Chemokine Receptors
% 223.06/223.28  |- skos__prefLabel mesh__D019707 Receptors, Chemokine
% 223.06/223.28  |- mesh__recordMaintainer mesh__D019707 jmp
% 223.06/223.28  |- mesh__recordAuthorizer mesh__D019707 sjn
% 223.06/223.28  |- skos__historyNote mesh__D019707 Receptors, Cytokine %28%1993-1997%29%
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D019707 2005
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D019707 2004
% 223.06/223.28  |- mesh__dateCreated mesh__D019707 1997-06-20
% 223.06/223.28  |- skos__scopeNote mesh__D019707
% 223.06/223.28       Cell surface glycoproteins that bind to chemokines and thus mediate the migration of pro-inflammatory molecules. The receptors are members of the seven-transmembrane G protein-coupled receptor family. Like the CHEMOKINES themselves, the receptors can be divided into at least three structural branches: CR, CCR, and CXCR, according to variations in a shared cysteine motif.%A%    
% 223.06/223.28  |- mesh__dateEstablished mesh__D019707 1998-01-01
% 223.06/223.28  |- skos__broader mesh__D019707smesh__D043562
% 223.06/223.28  |- mesh__historyNote mesh__D019707 98   
% 223.06/223.28  |- rdf__type mesh__D019707sskos__Concept
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D019707 2006
% 223.06/223.28  |- mesh__publicMeSHNote mesh__D019707 98   
% 223.06/223.28  |- mesh__recordOriginator mesh__D011724 NLM
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D011724 1994
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D011724 2005
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D011724 1998
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D011724 1995
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D011724 2003
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D011724 1993
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D011724 1996
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D011724 2006
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D011724 1999
% 223.06/223.28  |- skos__broader mesh__D011724smesh__D006573
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D011724 2004
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D011724 1997
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D011724 2000
% 223.06/223.28  |- mesh__dateRevised mesh__D011724 1992-05-20
% 223.06/223.28  |- rdf__type mesh__D011724sskos__Concept
% 223.06/223.28  |- mesh__recordMaintainer mesh__D011724 TAP
% 223.06/223.28  |- mesh__dateCreated mesh__D011724 1999-01-01
% 223.06/223.28  |- skos__annotation mesh__D011724 do not confuse with PYRAZINES   
% 223.06/223.28  |- skos__prefLabel mesh__D011724 Pyridazines
% 223.06/223.28  |- mesh__recordAuthorizer mesh__D011724 PLS
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D011724 2001
% 223.06/223.28  |- mesh__publicMeSHNote mesh__D011724
% 223.06/223.28       PHTHALAZINES was see under HETEROCYCLIC COMPOUNDS 1966-74%A%  
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D011724 2002
% 223.06/223.28  |- mesh__recordAuthorizer mesh__D002998 sjn
% 223.06/223.28  |- mesh__recordMaintainer mesh__D002998 sjn
% 223.06/223.28  |- mesh__dateCreated mesh__D002998 1974-11-11
% 223.06/223.28  |- skos__broader mesh__D002998smesh__D001570
% 223.06/223.28  |- skos__historyNote mesh__D002998 Benzodiazepinones %28%1974%29%
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D002998 2002
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D002998 2006
% 223.06/223.28  |- skos__historyNote mesh__D002998 Nitro Compounds %28%1974%29%
% 223.06/223.28  |- mesh__recordOriginator mesh__D002998 NLM
% 223.06/223.28  |- mesh__activeMeSHYear mesh__D002998 2005
% 223.06/223.29  |- mesh__dateRevised mesh__D002998 2001-08-03
% 223.06/223.29  |- skos__historyNote mesh__D002998 Chlorobenzenes %28%1974%29%
% 223.06/223.29  |- skos__hiddenLabel mesh__D002998 Ro 54023
% 223.06/223.29  |- skos__prefLabel mesh__D002998 Clonazepam
% 223.06/223.29  |- mesh__dateEstablished mesh__D002998 1987-01-01
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D002998 2004
% 223.06/223.29  |- rdf__type mesh__D002998sskos__Concept
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D002998 2003
% 223.06/223.29  |- mesh__publicMeSHNote mesh__D002998
% 223.06/223.29       87; was see under BENZODIAZEPINONES 1975-86   
% 223.06/223.29  |- skos__scopeNote mesh__D002998
% 223.06/223.29       An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.%A%    
% 223.06/223.29  |- mesh__historyNote mesh__D002998
% 223.06/223.29       87%28%75%29%; was see under BENZODIAZEPINONES 1975-86   
% 223.06/223.29  |- mesh__publicMeSHNote mesh__D007683
% 223.06/223.29       91; was see under KIDNEY FAILURE, ACUTE 1975-90; LOWER NEPHRON NEPHROSIS was see under KIDNEY FAILURE, ACUTE 1971-78, was see KIDNEY FAILURE, ACUTE 1967-70, was see ACUTE RENAL FAILURE 1963-66%A%  
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D007683 2006
% 223.06/223.29  |- skos__hiddenLabel mesh__D007683 Nephrosis, Lower Nephron
% 223.06/223.29  |- mesh__dateEstablished mesh__D007683 1991-01-01
% 223.06/223.29  |- mesh__recordAuthorizer mesh__D007683 sjn
% 223.06/223.29  |- mesh__dateCreated mesh__D007683 1999-01-01
% 223.06/223.29  |- skos__broader mesh__D007683smesh__D007675
% 223.06/223.29  |- skos__altLabel mesh__D007683 Lower Nephron Nephrosis
% 223.06/223.29  |- skos__hiddenLabel mesh__D007683 Nephroses, Lower Nephron
% 223.06/223.29  |- skos__prefLabel mesh__D007683 Kidney Tubular Necrosis, Acute
% 223.06/223.29  |- rdf__type mesh__D007683sskos__Concept
% 223.06/223.29  |- skos__hiddenLabel mesh__D007683 Lower Nephron Nephroses
% 223.06/223.29  |- mesh__recordOriginator mesh__D007683 NLM
% 223.06/223.29  |- skos__scopeNote mesh__D007683
% 223.06/223.29       Acute kidney failure resulting from destruction of EPITHELIAL CELLS of the KIDNEY TUBULES. It is commonly attributed to exposure to toxic agents or renal ISCHEMIA following severe TRAUMA.%A%    
% 223.06/223.29  |- mesh__onlineNote mesh__D007683
% 223.06/223.29       use KIDNEY TUBULAR NECROSIS, ACUTE to search LOWER NEPHRON NEPHROSIS 1975-78; use KIDNEY FAILURE, ACUTE 1966-74%A%  
% 223.06/223.29  |- mesh__historyNote mesh__D007683
% 223.06/223.29       91%28%75%29%; was see under KIDNEY FAILURE, ACUTE 1975-90; LOWER NEPHRON NEPHROSIS was see under KIDNEY FAILURE, ACUTE 1971-78, was see KIDNEY FAILURE, ACUTE 1967-70, was see ACUTE RENAL FAILURE 1963-66%A%  
% 223.06/223.29  |- skos__hiddenLabel mesh__D007683 Nephron Nephrosis, Lower
% 223.06/223.29  |- mesh__recordMaintainer mesh__D007683 lkt
% 223.06/223.29  |- mesh__dateRevised mesh__D007683 2005-06-30
% 223.06/223.29  |- skos__altLabel mesh__D007683 Acute Kidney Tubular Necrosis
% 223.06/223.29  |- skos__hiddenLabel mesh__D007683 Nephron Nephroses, Lower
% 223.06/223.29  |- skos__altLabel mesh__D015317 Polyamines, Biogenic
% 223.06/223.29  |- skos__broader mesh__D015317smesh__D001679
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D015317 1997
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D015317 2006
% 223.06/223.29  |- mesh__historyNote mesh__D015317 89   
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D015317 1996
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D015317 2005
% 223.06/223.29  |- rdf__type mesh__D015317sskos__Concept
% 223.06/223.29  |- skos__historyNote mesh__D015317 Biogenic Amines %28%1971-1988%29%
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D015317 2001
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D015317 1993
% 223.06/223.29  |- mesh__dateRevised mesh__D015317 1992-05-08
% 223.06/223.29  |- mesh__dateCreated mesh__D015317 1988-05-31
% 223.06/223.29  |- mesh__recordMaintainer mesh__D015317 TAP
% 223.06/223.29  |- skos__prefLabel mesh__D015317 Biogenic Polyamines
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D015317 1999
% 223.06/223.29  |- mesh__recordAuthorizer mesh__D015317 PLS
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D015317 2000
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D015317 2004
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D015317 1998
% 223.06/223.29  |- mesh__dateEstablished mesh__D015317 1989-01-01
% 223.06/223.29  |- skos__scopeNote mesh__D015317
% 223.06/223.29       Biogenic amines having more than one amine group. These are long-chain aliphatic compounds that contain multiple amino and/or imino groups. Because of the linear arrangement of positive charge on these molecules, polyamines bind electrostatically to ribosomes, DNA, and RNA.%A%    
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D015317 2003
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D015317 1995
% 223.06/223.29  |- mesh__publicMeSHNote mesh__D015317 89   
% 223.06/223.29  |- mesh__recordOriginator mesh__D015317 EJB
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D015317 2002
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D015317 1994
% 223.06/223.29  |- skos__annotation mesh__D015317 GEN: prefer specifics   
% 223.06/223.29  |- skos__altLabel mesh__D031782 Millet, Pearl
% 223.06/223.29  |- mesh__publicMeSHNote mesh__D031782 2003   
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D031782 2004
% 223.06/223.29  |- skos__annotation mesh__D031782
% 223.06/223.29       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.06/223.29  |- skos__altLabel mesh__D031782 Grass, Fountain
% 223.06/223.29  |- mesh__dateEstablished mesh__D031782 2003-01-01
% 223.06/223.29  |- skos__altLabel mesh__D031782 Bajra
% 223.06/223.29  |- skos__prefLabel mesh__D031782 Pennisetum
% 223.06/223.29  |- mesh__dateCreated mesh__D031782 2002-07-02
% 223.06/223.29  |- skos__altLabel mesh__D031782 Fountaingrass
% 223.06/223.29  |- rdf__type mesh__D031782sskos__Concept
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D031782 2005
% 223.06/223.29  |- skos__scopeNote mesh__D031782
% 223.06/223.29       A plant genus of the family POACEAE. The seed is one of the millets used in CEREALS. It contains vitexin. The common name of buffelgrass is also used for CENCHRUS.%A%    
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D031782 2006
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D031782 2003
% 223.06/223.29  |- skos__broader mesh__D031782smesh__D006109
% 223.06/223.29  |- mesh__historyNote mesh__D031782 2003   
% 223.06/223.29  |- mesh__publicMeSHNote mesh__D019708 98   
% 223.06/223.29  |- skos__broader mesh__D019708smesh__D001105
% 223.06/223.29  |- mesh__recordMaintainer mesh__D019708 SYSTEM
% 223.06/223.29  |- mesh__recordOriginator mesh__D019708 AGS
% 223.06/223.29  |- skos__prefLabel mesh__D019708 Korarchaeota
% 223.06/223.29  |- mesh__recordAuthorizer mesh__D019708 sjn
% 223.06/223.29  |- mesh__historyNote mesh__D019708 98   
% 223.06/223.29  |- rdf__type mesh__D019708sskos__Concept
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D019708 2006
% 223.06/223.29  |- skos__scopeNote mesh__D019708
% 223.06/223.29       A kingdom in the domain ARCHAEA, comprising thermophilic organisms from the hot spring Obsidian Pool %28%Yellowstone National Park%29% that are among the most primitive of all life forms. They have undergone comparatively little evolutionary change since the last common ancestor of all extant life. %28%From ASM News, 1996; 62%28%9%29%:468-9%29%%A%    
% 223.06/223.29  |- skos__annotation mesh__D019708 a kingdom of Archaea   
% 223.06/223.29  |- mesh__dateCreated mesh__D019708 1997-06-20
% 223.06/223.29  |- mesh__dateRevised mesh__D019708 2005-06-30
% 223.06/223.29  |- mesh__dateEstablished mesh__D019708 1998-01-01
% 223.06/223.29  |- mesh__recordMaintainer mesh__D011725 ssb
% 223.06/223.29  |- mesh__dateRevised mesh__D011725 2004-07-07
% 223.06/223.29  |- mesh__recordOriginator mesh__D011725 NLM
% 223.06/223.29  |- skos__related mesh__D011725smesh__D010880
% 223.06/223.29  |- skos__prefLabel mesh__D011725 Pyridines
% 223.06/223.29  |- mesh__dateCreated mesh__D011725 1999-01-01
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D011725 2006
% 223.06/223.29  |- skos__annotation mesh__D011725
% 223.06/223.29       pyridine nucleotides will probably be NAD or NADP   
% 223.06/223.29  |- mesh__recordAuthorizer mesh__D011725 sjn
% 223.06/223.29  |- skos__broader mesh__D011725smesh__D006573
% 223.06/223.29  |- skos__scopeNote mesh__D011725
% 223.06/223.29       Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.%A%    
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D011725 2005
% 223.06/223.29  |- rdf__type mesh__D011725sskos__Concept
% 223.06/223.29  |- mesh__recordMaintainer mesh__D044101 jmp
% 223.06/223.29  |- skos__altLabel mesh__D044101 Melanocortin Receptors
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D044101 2005
% 223.06/223.29  |- skos__altLabel mesh__D044101 Receptor, Melanocortin
% 223.06/223.29  |- skos__broader mesh__D044101smesh__D043562
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D044101 2004
% 223.06/223.29  |- skos__annotation mesh__D044101 GEN or unspecified; prefer specifics   
% 223.06/223.29  |- skos__altLabel mesh__D044101 Melanocortin Receptor
% 223.06/223.29  |- mesh__dateEstablished mesh__D044101 2004-01-01
% 223.06/223.29  |- mesh__recordOriginator mesh__D044101 jmp
% 223.06/223.29  |- mesh__publicMeSHNote mesh__D044101
% 223.06/223.29       2004; MELANOCORTIN RECEPTOR %28%now RECEPTORS, MELANOCORTIN%29% was indexed under RECEPTORS, CORTICOTROPIN 1994-2003%A%  
% 223.06/223.29  |- mesh__recordAuthorizer mesh__D044101 sjn
% 223.06/223.29  |- mesh__historyNote mesh__D044101
% 223.06/223.29       2004; use RECEPTORS, MELANOCORTIN %28%NM%29% 1994-2003   
% 223.06/223.29  |- skos__historyNote mesh__D044101
% 223.06/223.29       Receptors, Corticotropin %28%1994-2003%29%
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D044101 2006
% 223.06/223.29  |- mesh__dateCreated mesh__D044101 2003-07-09
% 223.06/223.29  |- skos__broader mesh__D044101smesh__D018043
% 223.06/223.29  |- skos__scopeNote mesh__D044101
% 223.06/223.29       A family of G-protein-coupled receptors that have specificity for MELANOCYTE-STIMULATING HORMONES and CORTICOTROPIN. There are several subtypes of melanocortin receptors, each having a distinct ligand specificity profile and tissue localization.%A%    
% 223.06/223.29  |- rdf__type mesh__D044101sskos__Concept
% 223.06/223.29  |- skos__prefLabel mesh__D044101 Receptors, Melanocortin
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D016410 2002
% 223.06/223.29  |- skos__hiddenLabel mesh__D016410 Cutaneous T-Cell Lymphomas
% 223.06/223.29  |- mesh__recordMaintainer mesh__D016410 AGS
% 223.06/223.29  |- mesh__recordAuthorizer mesh__D016410 PLS
% 223.06/223.29  |- mesh__dateCreated mesh__D016410 1990-06-01
% 223.06/223.29  |- skos__altLabel mesh__D016410 Lymphoma, T Cell, Cutaneous
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D016410 2004
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D016410 2001
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D016410 2006
% 223.06/223.29  |- skos__altLabel mesh__D016410 Cutaneous T-Cell Lymphoma
% 223.06/223.29  |- skos__hiddenLabel mesh__D016410 T Cell Lymphoma, Cutaneous
% 223.06/223.29  |- skos__prefLabel mesh__D016410 Lymphoma, T-Cell, Cutaneous
% 223.06/223.29  |- skos__hiddenLabel mesh__D016410 Slack Skin, Granulomatous
% 223.06/223.29  |- skos__altLabel mesh__D016410 T-Cell Lymphoma, Cutaneous
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D016410 2003
% 223.06/223.29  |- skos__hiddenLabel mesh__D016410 Lymphoma, Cutaneous T-Cell
% 223.06/223.29  |- skos__scopeNote mesh__D016410
% 223.06/223.29       A group of lymphomas exhibiting clonal expansion of malignant T-lymphocytes arrested at varying stages of differentiation as well as malignant infiltration of the skin. MYCOSIS FUNGOIDES and SEZARY SYNDROME are the best characterized of these disorders.%A%    
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D016410 2005
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D016410 2000
% 223.06/223.29  |- skos__hiddenLabel mesh__D016410 Lymphomas, Cutaneous T-Cell
% 223.06/223.29  |- skos__hiddenLabel mesh__D016410 T-Cell Lymphomas, Cutaneous
% 223.06/223.29  |- skos__hiddenLabel mesh__D016410 Cutaneous T Cell Lymphoma
% 223.06/223.29  |- rdf__type mesh__D016410sskos__Concept
% 223.06/223.29  |- mesh__publicMeSHNote mesh__D016410 91   
% 223.06/223.29  |- mesh__dateEstablished mesh__D016410 1991-01-01
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D016410 1997
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D016410 1999
% 223.06/223.29  |- mesh__dateRevised mesh__D016410 1996-06-10
% 223.06/223.29  |- skos__broader mesh__D016410smesh__D016399
% 223.06/223.29  |- mesh__recordOriginator mesh__D016410 PLS
% 223.06/223.29  |- skos__annotation mesh__D016410
% 223.06/223.29       a non-Hodgkin%27%s lymphoma; coord IM with SKIN NEOPLASMS %28%IM%29%%A%  
% 223.06/223.29  |- mesh__historyNote mesh__D016410 91   
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D016410 1998
% 223.06/223.29  |- skos__hiddenLabel mesh__D002999 Clone
% 223.06/223.29  |- mesh__historyNote mesh__D002999 68%28%64%29%   
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D002999 2006
% 223.06/223.29  |- skos__altLabel mesh__D002999 Clones
% 223.06/223.29  |- mesh__recordAuthorizer mesh__D002999 SJN
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D002999 2005
% 223.06/223.29  |- skos__hiddenLabel mesh__D002999 Cells, Clone
% 223.06/223.29  |- mesh__recordMaintainer mesh__D002999 AGS
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D002999 1999
% 223.06/223.29  |- skos__scopeNote mesh__D002999
% 223.06/223.29       A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. %28%From King %26% Stansfield, Dictionary of Genetics, 4th ed%29%%A%    
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D002999 2002
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D002999 2004
% 223.06/223.29  |- mesh__dateRevised mesh__D002999 1997-06-20
% 223.06/223.29  |- mesh__publicMeSHNote mesh__D002999 68   
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D002999 1998
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D002999 2001
% 223.06/223.29  |- rdf__type mesh__D002999sskos__Concept
% 223.06/223.29  |- skos__prefLabel mesh__D002999 Clone Cells
% 223.06/223.29  |- skos__annotation mesh__D002999
% 223.06/223.29       NIM; A 11 qualif; cells derived by natural asexual reprod or by nuclear cloning; differentiate from CLONING, MOLECULAR and CLONING, ORGANISM; %22%clonal analysis%22% goes here%A%  
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D002999 2003
% 223.06/223.29  |- mesh__dateCreated mesh__D002999 1999-01-01
% 223.06/223.29  |- skos__hiddenLabel mesh__D002999 Clone Cell
% 223.06/223.29  |- mesh__recordOriginator mesh__D002999 NLM
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D002999 2000
% 223.06/223.29  |- mesh__dateEstablished mesh__D002999 1968-01-01
% 223.06/223.29  |- skos__hiddenLabel mesh__D002999 Cell, Clone
% 223.06/223.29  |- skos__broader mesh__D002999smesh__D002478
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D007684 2006
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D007684 1989
% 223.06/223.29  |- mesh__recordAuthorizer mesh__D007684 NLM
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D007684 2001
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D007684 1997
% 223.06/223.29  |- skos__broader mesh__D007684smesh__D009399
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D007684 2003
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D007684 1994
% 223.06/223.29  |- skos__hiddenLabel mesh__D007684 Tubule, Kidney
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D007684 2004
% 223.06/223.29  |- skos__prefLabel mesh__D007684 Kidney Tubules
% 223.06/223.29  |- rdf__type mesh__D007684sskos__Concept
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D007684 1995
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D007684 1990
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D007684 2002
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D007684 1992
% 223.06/223.29  |- mesh__recordMaintainer mesh__D007684 SMH
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D007684 1998
% 223.06/223.29  |- mesh__dateRevised mesh__D007684 1979-06-13
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D007684 1993
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D007684 1999
% 223.06/223.29  |- mesh__dateCreated mesh__D007684 1999-01-01
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D007684 2000
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D007684 2005
% 223.06/223.29  |- mesh__recordOriginator mesh__D007684 NLM
% 223.06/223.29  |- skos__hiddenLabel mesh__D007684 Kidney Tubule
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D007684 1991
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D007684 1996
% 223.06/223.29  |- skos__hiddenLabel mesh__D007684 Tubules, Kidney
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D015318 2005
% 223.06/223.29  |- mesh__recordOriginator mesh__D015318 EJB
% 223.06/223.29  |- skos__scopeNote mesh__D015318
% 223.06/223.29       Inherited abnormalities of fructose metabolism, which include three known autosomal recessive types: hepatic fructokinase deficiency %28%essential fructosuria%29%, hereditary fructose intolerance, and hereditary fructose-1,6-diphosphatase deficiency. Essential fructosuria is a benign asymptomatic metabolic disorder caused by deficiency in fructokinase, leading to decreased conversion of fructose to fructose-1-phosphate and alimentary hyperfructosemia, but with no clinical dysfunction; may produce a false-positive diabetes test.%A%    
% 223.06/223.29  |- rdf__type mesh__D015318sskos__Concept
% 223.06/223.29  |- mesh__recordAuthorizer mesh__D015318 sjn
% 223.06/223.29  |- mesh__onlineNote mesh__D015318
% 223.06/223.29       use CARBOHYDRATE METABOLISM, INBORN ERRORS to search FRUCTOSE METABOLISM, INBORN ERRORS 1966-74%A%  
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D015318 2002
% 223.06/223.29  |- mesh__dateCreated mesh__D015318 1988-05-31
% 223.06/223.29  |- skos__prefLabel mesh__D015318 Fructose Metabolism, Inborn Errors
% 223.06/223.29  |- mesh__recordMaintainer mesh__D015318 nns
% 223.06/223.29  |- skos__annotation mesh__D015318
% 223.06/223.29       an inborn error of carbohydrate metab; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: FRUCTOSE METAB INBORN ERR%A%  
% 223.06/223.29  |- skos__historyNote mesh__D015318
% 223.06/223.29       Carbohydrate Metabolism, Inborn Errors %28%1966-1988%29%
% 223.06/223.29  |- skos__broader mesh__D015318smesh__D002239
% 223.06/223.29  |- mesh__publicMeSHNote mesh__D015318
% 223.06/223.29       89; FRUCTOSE INTOLERANCE was see under CARBOHYDRATE METABOLISM, INBORN ERRORS 1967-88 %28%Prov 1964-66%29%%A%  
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D015318 2004
% 223.06/223.29  |- skos__historyNote mesh__D015318 Fructose %28%1966-1988%29%
% 223.06/223.29  |- mesh__dateEstablished mesh__D015318 1989-01-01
% 223.06/223.29  |- mesh__historyNote mesh__D015318
% 223.06/223.29       89; FRUCTOSE INTOLERANCE was see under CARBOHYDRATE METABOLISM, INBORN ERRORS 1967-88 %28%Prov 1964-66%29%%A%  
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D015318 2003
% 223.06/223.29  |- mesh__dateRevised mesh__D015318 2001-07-25
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D015318 2006
% 223.06/223.29  |- skos__broader mesh__D012020smesh__D012018
% 223.06/223.29  |- mesh__dateEstablished mesh__D012020 1991-01-01
% 223.06/223.29  |- skos__hiddenLabel mesh__D012020 Abdominal Reflex
% 223.06/223.29  |- mesh__recordOriginator mesh__D012020 NLM
% 223.06/223.29  |- rdf__type mesh__D012020sskos__Concept
% 223.06/223.29  |- skos__prefLabel mesh__D012020 Reflex, Abdominal
% 223.06/223.29  |- skos__historyNote mesh__D012020 Reflex %28%1966-1969%29%
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D012020 2004
% 223.06/223.29  |- mesh__dateCreated mesh__D012020 1999-01-01
% 223.06/223.29  |- mesh__dateRevised mesh__D012020 2002-07-02
% 223.06/223.29  |- skos__historyNote mesh__D012020 Abdominal Wall %28%1966-1969%29%
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D012020 2006
% 223.06/223.29  |- mesh__recordMaintainer mesh__D012020 mdb
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D012020 2003
% 223.06/223.29  |- mesh__recordAuthorizer mesh__D012020 sjn
% 223.06/223.29  |- mesh__publicMeSHNote mesh__D012020 91; was see under REFLEX 1970-90   
% 223.06/223.29  |- mesh__historyNote mesh__D012020
% 223.06/223.29       91%28%70%29%; was see under REFLEX 1970-90   
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D012020 2005
% 223.06/223.29  |- skos__annotation mesh__D012020
% 223.06/223.29       reflex contraction of abdom wall: read MeSH definition; not for reflex responses of organs within abdom cavity%A%  
% 223.06/223.29  |- skos__scopeNote mesh__D012020
% 223.06/223.29       Contractions of the abdominal muscles upon stimulation of the skin %28%superficial abdominal reflex%29% or tapping neighboring bony structures %28%deep abdominal reflex%29%. The superficial reflex may be weak or absent, for example, after a stroke, a sign of upper %28%suprasegmental%29% motor neuron lesions. %28%Stedman, 25th ed %26% Best %26% Taylor%27%s Physiological Basis of Medical Practice, 12th ed, p1073%29%%A%    
% 223.06/223.29  |- skos__altLabel mesh__D031783 Canary Grass
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D031783 2006
% 223.06/223.29  |- mesh__historyNote mesh__D031783 2003   
% 223.06/223.29  |- skos__annotation mesh__D031783
% 223.06/223.29       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D031783 2004
% 223.06/223.29  |- mesh__publicMeSHNote mesh__D031783 2003   
% 223.06/223.29  |- mesh__dateCreated mesh__D031783 2002-07-03
% 223.06/223.29  |- mesh__dateEstablished mesh__D031783 2003-01-01
% 223.06/223.29  |- skos__altLabel mesh__D031783 Grass, Canary
% 223.06/223.29  |- skos__scopeNote mesh__D031783 A plant genus of the family POACEAE.     
% 223.06/223.29  |- rdf__type mesh__D031783sskos__Concept
% 223.06/223.29  |- skos__altLabel mesh__D031783 Canarygrass
% 223.06/223.29  |- skos__prefLabel mesh__D031783 Phalaris
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D031783 2005
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D031783 2003
% 223.06/223.29  |- skos__broader mesh__D031783smesh__D006109
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D003294 2005
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Seizure, Febrile Convulsion
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D003294 2000
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Febrile Fits
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Seizures, Pyrexial
% 223.06/223.29  |- skos__prefLabel mesh__D003294 Seizures, Febrile
% 223.06/223.29  |- mesh__recordOriginator mesh__D003294 MM
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Fits, Febrile
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Fit, Febrile
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Febrile Convulsion
% 223.06/223.29  |- skos__altLabel mesh__D003294 Pyrexial Seizure
% 223.06/223.29  |- rdf__type mesh__D003294sskos__Concept
% 223.06/223.29  |- mesh__historyNote mesh__D003294 2000%28%1977%29%   
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Febrile Convulsions
% 223.06/223.29  |- skos__altLabel mesh__D003294 Febrile Fit
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Seizure, Fever
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Pyrexial Seizures
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Convulsion, Fever
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Seizure, Febrile
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D003294 2004
% 223.06/223.29  |- mesh__dateCreated mesh__D003294 1976-04-27
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Convulsion, Pyrexial
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D003294 2002
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Convulsions, Fever
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Fever Seizures
% 223.06/223.29  |- skos__altLabel mesh__D003294 Fever Seizure
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D003294 2003
% 223.06/223.29  |- skos__altLabel mesh__D003294 Convulsions, Febrile
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Febrile Seizure
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Fever Convulsions
% 223.06/223.29  |- skos__historyNote mesh__D003294 Convulsions %28%1966-1976%29%
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Febrile Convulsion Seizures
% 223.06/223.29  |- skos__altLabel mesh__D003294 Febrile Convulsion Seizure
% 223.06/223.29  |- skos__altLabel mesh__D003294 Febrile Seizures
% 223.06/223.29  |- skos__scopeNote mesh__D003294
% 223.06/223.29       Seizures that occur during a febrile episode. It is a common condition, affecting 2-5%25% of children aged 3 months to five years. An autosomal dominant pattern of inheritance has been identified in some families. The majority are simple febrile seizures %28%generally defined as generalized onset, single seizures with a duration of less than 30 minutes%29%. Complex febrile seizures are characterized by focal onset, duration greater than 30 minutes, and/or more than one seizure in a 24 hour period. The likelihood of developing epilepsy %28%i.e., a nonfebrile seizure disorder%29% following simple febrile seizures is low. Complex febrile seizures are associated with a moderately increased incidence of epilepsy. %28%From Menkes, Textbook of Child Neurology, 5th ed, p784%29%%A%    
% 223.06/223.29  |- mesh__recordMaintainer mesh__D003294 ags
% 223.06/223.29  |- mesh__publicMeSHNote mesh__D003294
% 223.06/223.29       2000; see CONVULSIONS, FEBRILE 1982-1999, see CONVULSIONS 1977-1981; for SEIZURES, FEBRILE see CONVULSIONS, FEBRILE 1982-1999%A%  
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Convulsion, Febrile
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Seizures, Febrile Convulsion
% 223.06/223.29  |- mesh__dateEstablished mesh__D003294 1982-01-01
% 223.06/223.29  |- mesh__recordAuthorizer mesh__D003294 ags
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D003294 2006
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Seizures, Fever
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Pyrexial Convulsions
% 223.06/223.29  |- skos__broader mesh__D003294smesh__D004827
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D003294 2001
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D003294 2000A
% 223.06/223.29  |- mesh__dateRevised mesh__D003294 1999-11-26
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Seizure, Pyrexial
% 223.06/223.29  |- skos__altLabel mesh__D003294 Pyrexial Convulsion
% 223.06/223.29  |- skos__hiddenLabel mesh__D003294 Convulsions, Pyrexial
% 223.06/223.29  |- skos__altLabel mesh__D003294 Fever Convulsion
% 223.06/223.29  |- mesh__recordOriginator mesh__D019709 AGS
% 223.06/223.29  |- mesh__dateEstablished mesh__D019709 1998-01-01
% 223.06/223.29  |- skos__annotation mesh__D019709
% 223.06/223.29       an order of the kingdom of Euryarchaeota, of the domain of Archaea%A%  
% 223.06/223.29  |- mesh__dateRevised mesh__D019709 2005-06-30
% 223.06/223.29  |- skos__broader mesh__D019709smesh__D019605
% 223.06/223.29  |- skos__scopeNote mesh__D019709
% 223.06/223.29       An order of strictly anaerobic, thermophilic archaea, in the kingdom EURYARCHAEOTA. Members exhibit heterotropic growth by sulfur respiration. There is a single family THERMOCOCCACEAE.%A%    
% 223.06/223.29  |- mesh__publicMeSHNote mesh__D019709 98   
% 223.06/223.29  |- mesh__recordMaintainer mesh__D019709 SYSTEM
% 223.06/223.29  |- skos__prefLabel mesh__D019709 Thermococcales
% 223.06/223.29  |- rdf__type mesh__D019709sskos__Concept
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D019709 2006
% 223.06/223.29  |- mesh__dateCreated mesh__D019709 1997-06-20
% 223.06/223.29  |- mesh__historyNote mesh__D019709 98   
% 223.06/223.29  |- mesh__recordAuthorizer mesh__D019709 sjn
% 223.06/223.29  |- mesh__recordAuthorizer mesh__D011726 PLS
% 223.06/223.29  |- mesh__dateEstablished mesh__D011726 1968-01-01
% 223.06/223.29  |- skos__historyNote mesh__D011726 Pyridines %28%1966-1967%29%
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D011726 2001
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D011726 2004
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D011726 1997
% 223.06/223.29  |- mesh__recordMaintainer mesh__D011726 TAP
% 223.06/223.29  |- skos__broader mesh__D011726smesh__D011725
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D011726 2000
% 223.06/223.29  |- mesh__dateCreated mesh__D011726 1999-01-01
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D011726 2006
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D011726 1999
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D011726 2003
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D011726 1996
% 223.06/223.29  |- skos__historyNote mesh__D011726 Ammonium Compounds %28%1966-1967%29%
% 223.06/223.29  |- mesh__publicMeSHNote mesh__D011726 68   
% 223.06/223.29  |- mesh__recordOriginator mesh__D011726 NLM
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D011726 1993
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D011726 2005
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D011726 1998
% 223.06/223.29  |- rdf__type mesh__D011726sskos__Concept
% 223.06/223.29  |- mesh__dateRevised mesh__D011726 1992-05-20
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D011726 1995
% 223.06/223.29  |- skos__hiddenLabel mesh__D011726 Compounds, Pyridinium
% 223.06/223.29  |- skos__prefLabel mesh__D011726 Pyridinium Compounds
% 223.06/223.29  |- skos__annotation mesh__D011726 DF: PYRIDINIUM CPDS   
% 223.06/223.29  |- mesh__historyNote mesh__D011726 68   
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D011726 2002
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D011726 1994
% 223.06/223.29  |- skos__historyNote mesh__D044102
% 223.06/223.29       Receptors, Corticotropin %28%1999-2003%29%
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D044102 2004
% 223.06/223.29  |- skos__hiddenLabel mesh__D044102 Receptor, Melanocortin 1
% 223.06/223.29  |- skos__prefLabel mesh__D044102 Receptor, Melanocortin, Type 1
% 223.06/223.29  |- skos__altLabel mesh__D044102 Melanocortin Receptor 1
% 223.06/223.29  |- skos__hiddenLabel mesh__D044102 Receptor 1, Melanocortin
% 223.06/223.29  |- skos__altLabel mesh__D044102 Melanocyte Melanocortin Receptor
% 223.06/223.29  |- mesh__publicMeSHNote mesh__D044102
% 223.06/223.29       2004; MELANOCORTIN-1 RECEPTOR %28%now RECEPTOR, MELANOCORTIN%29%%A%  
% 223.06/223.29  |- mesh__historyNote mesh__D044102
% 223.06/223.29       2004; use RECEPTOR, MELANOCORTIN, TYPE 1 %28%NM%29% 1999-2003   
% 223.06/223.29  |- skos__hiddenLabel mesh__D044102 Melanocortin 1 Receptor
% 223.06/223.29  |- skos__altLabel mesh__D044102 MC1 Receptor
% 223.06/223.29  |- skos__broader mesh__D044102smesh__D044101
% 223.06/223.29  |- skos__scopeNote mesh__D044102
% 223.06/223.29       A melanocortin receptor subtype found primarily in MELANOCYTES. It shows specificity for ALPHA-MSH and CORTICOTROPIN. Loss of function mutations of  the type 1 melanocortin receptor account for the majority of red hair and fair skin recessive traits in human.%A%    
% 223.06/223.29  |- skos__hiddenLabel mesh__D044102 Melanocortin Receptor, Melanocyte
% 223.06/223.29  |- skos__hiddenLabel mesh__D044102 Receptor, MC1
% 223.06/223.29  |- skos__altLabel mesh__D044102 Receptor, Melanocortin-1
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D044102 2006
% 223.06/223.29  |- mesh__dateCreated mesh__D044102 2003-07-09
% 223.06/223.29  |- mesh__dateEstablished mesh__D044102 2004-01-01
% 223.06/223.29  |- rdf__type mesh__D044102sskos__Concept
% 223.06/223.29  |- skos__altLabel mesh__D044102 Melanocortin-1 Receptor
% 223.06/223.29  |- skos__hiddenLabel mesh__D044102 Receptor, Melanocyte Melanocortin
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D044102 2005
% 223.06/223.29  |- mesh__activeMeSHYear mesh__D016411 2005
% 223.06/223.30  |- mesh__recordMaintainer mesh__D016411 KEV
% 223.06/223.30  |- mesh__publicMeSHNote mesh__D016411 91   
% 223.06/223.30  |- skos__hiddenLabel mesh__D016411 Lymphoma, Peripheral T-Cell
% 223.06/223.30  |- skos__prefLabel mesh__D016411 Lymphoma, T-Cell, Peripheral
% 223.06/223.30  |- skos__altLabel mesh__D016411 T-Cell Lymphoma, Peripheral
% 223.06/223.30  |- rdf__type mesh__D016411sskos__Concept
% 223.06/223.30  |- mesh__activeMeSHYear mesh__D016411 1997
% 223.06/223.30  |- mesh__activeMeSHYear mesh__D016411 2002
% 223.06/223.30  |- mesh__activeMeSHYear mesh__D016411 1999
% 223.06/223.30  |- skos__broader mesh__D016411smesh__D016399
% 223.06/223.30  |- skos__hiddenLabel mesh__D016411 T-Cell Lymphomas, Peripheral
% 223.06/223.30  |- mesh__dateCreated mesh__D016411 1990-06-01
% 223.06/223.30  |- mesh__recordAuthorizer mesh__D016411 PLS
% 223.06/223.30  |- mesh__recordOriginator mesh__D016411 PLS
% 223.06/223.30  |- mesh__activeMeSHYear mesh__D016411 1996
% 223.06/223.30  |- mesh__historyNote mesh__D016411 91   
% 223.06/223.30  |- mesh__dateEstablished mesh__D016411 1991-01-01
% 223.06/223.30  |- mesh__dateRevised mesh__D016411 1995-06-08
% 223.06/223.30  |- mesh__activeMeSHYear mesh__D016411 2001
% 223.06/223.30  |- mesh__activeMeSHYear mesh__D016411 1998
% 223.06/223.30  |- skos__hiddenLabel mesh__D016411 Peripheral T Cell Lymphoma
% 223.06/223.30  |- skos__hiddenLabel mesh__D016411 T Cell Lymphoma, Peripheral
% 223.06/223.30  |- skos__historyNote mesh__D016411 T-Lymphocytes %28%1977-1990%29%
% 223.06/223.30  |- skos__altLabel mesh__D016411 Peripheral T-Cell Lymphoma
% 223.06/223.30  |- skos__hiddenLabel mesh__D016411 Peripheral T-Cell Lymphomas
% 223.06/223.30  |- mesh__activeMeSHYear mesh__D016411 2004
% 223.06/223.30  |- mesh__activeMeSHYear mesh__D016411 2000
% 223.06/223.30  |- mesh__activeMeSHYear mesh__D016411 2006
% 223.06/223.30  |- skos__altLabel mesh__D016411 Lymphoma, T Cell, Peripheral
% 223.06/223.30  |- skos__annotation mesh__D016411 a non-Hodgkin%27%s lymphoma   
% 223.06/223.30  |- skos__hiddenLabel mesh__D016411 Lymphomas, Peripheral T-Cell
% 223.06/223.30  |- mesh__activeMeSHYear mesh__D016411 2003
% 223.06/223.30  |- skos__historyNote mesh__D016411
% 223.06/223.30       Lymphoma, Non-Hodgkin%27%s %28%1977-1990%29%
% 223.06/223.30  |- skos__scopeNote mesh__D016411
% 223.06/223.30       A group of malignant lymphomas thought to derive from peripheral T-lymphocytes in lymph nodes and other nonlymphoid sites. They include a broad spectrum of lymphocyte morphology, but in all instances express T-cell markers admixed with epithelioid histiocytes, plasma cells, and eosinophils. Although markedly similar to large-cell immunoblastic lymphoma %28%LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC%29%, this group%27%s unique features warrant separate treatment.%A%    
% 223.06/223.30  |- skos__hiddenLabel mesh__D007685 Collecting Kidney Tubule
% 223.06/223.30  |- mesh__historyNote mesh__D007685
% 223.06/223.30       91%28%79%29%; was see under KIDNEY TUBULES 1979-90   
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D007685 2001
% 223.15/223.30  |- mesh__dateCreated mesh__D007685 1978-01-23
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D007685 1996
% 223.15/223.30  |- mesh__dateEstablished mesh__D007685 1991-01-01
% 223.15/223.30  |- mesh__publicMeSHNote mesh__D007685
% 223.15/223.30       91; was see under KIDNEY TUBULES 1979-90   
% 223.15/223.30  |- skos__hiddenLabel mesh__D007685 Collecting Kidney Tubules
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D007685 1999
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D007685 2000
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D007685 2004
% 223.15/223.30  |- skos__hiddenLabel mesh__D007685 Kidney Collecting Duct
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D007685 1993
% 223.15/223.30  |- rdf__type mesh__D007685sskos__Concept
% 223.15/223.30  |- skos__historyNote mesh__D007685 Kidney %28%1966-1978%29%
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D007685 1995
% 223.15/223.30  |- skos__historyNote mesh__D007685 Kidney Tubules %28%1966-1978%29%
% 223.15/223.30  |- skos__altLabel mesh__D007685 Kidney Collecting Ducts
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D007685 1998
% 223.15/223.30  |- skos__hiddenLabel mesh__D007685 Ducts, Kidney Collecting
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D007685 2003
% 223.15/223.30  |- skos__hiddenLabel mesh__D007685 Collecting Duct, Kidney
% 223.15/223.30  |- mesh__dateRevised mesh__D007685 1991-01-07
% 223.15/223.30  |- skos__prefLabel mesh__D007685 Kidney Tubules, Collecting
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D007685 1992
% 223.15/223.30  |- skos__hiddenLabel mesh__D007685 Tubules, Collecting Kidney
% 223.15/223.30  |- skos__historyNote mesh__D007685 Kidney Tubules, Distal %28%1973-1978%29%
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D007685 1994
% 223.15/223.30  |- skos__hiddenLabel mesh__D007685 Tubule, Collecting Kidney
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D007685 2002
% 223.15/223.30  |- skos__hiddenLabel mesh__D007685 Duct, Kidney Collecting
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D007685 2006
% 223.15/223.30  |- mesh__recordMaintainer mesh__D007685 TGC
% 223.15/223.30  |- skos__hiddenLabel mesh__D007685 Kidney Tubule, Collecting
% 223.15/223.30  |- mesh__recordOriginator mesh__D007685 SMH
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D007685 1997
% 223.15/223.30  |- mesh__recordAuthorizer mesh__D007685 PLS
% 223.15/223.30  |- skos__hiddenLabel mesh__D007685 Collecting Ducts, Kidney
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D007685 2005
% 223.15/223.30  |- skos__historyNote mesh__D007685 Kidney Medulla %28%1973-1978%29%
% 223.15/223.30  |- skos__broader mesh__D007685smesh__D007684
% 223.15/223.30  |- skos__scopeNote mesh__D007685
% 223.15/223.30       Straight tubes commencing in the radiate part of the kidney cortex where they receive the curved ends of the distal convoluted tubules. In the medulla the collecting tubules of each pyramid converge to join a central tube %28%duct of Bellini%29% which opens on the summit of the papilla.%A%    
% 223.15/223.30  |- skos__hiddenLabel mesh__D015319 Deficiencies, Fructose-1,6-Diphosphatase
% 223.15/223.30  |- mesh__dateRevised mesh__D015319 2001-07-25
% 223.15/223.30  |- skos__altLabel mesh__D015319 Fructose-1,6-Bisphosphatase Deficiency
% 223.15/223.30  |- skos__historyNote mesh__D015319
% 223.15/223.30       Hexosediphosphatase/deficiency %28%1970-1988%29%
% 223.15/223.30  |- skos__altLabel mesh__D015319 Hexosediphosphatase Deficiency
% 223.15/223.30  |- skos__hiddenLabel mesh__D015319 Deficiency, Fructose-1,6-Bisphosphatase
% 223.15/223.30  |- skos__hiddenLabel mesh__D015319 Deficiencies, Fructose-Biphosphatase
% 223.15/223.30  |- skos__hiddenLabel mesh__D015319 Deficiency, Fructose-Biphosphatase
% 223.15/223.30  |- skos__hiddenLabel mesh__D015319 Deficiency, Fructose-1,6-Diphosphatase
% 223.15/223.30  |- skos__hiddenLabel mesh__D015319 Deficiencies, Fructosediphosphatase
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D015319 2005
% 223.15/223.30  |- skos__prefLabel mesh__D015319 Fructose-1,6-Diphosphatase Deficiency
% 223.15/223.30  |- skos__altLabel mesh__D015319 Fructose 1,6 Diphosphatase Deficiency
% 223.15/223.30  |- mesh__recordAuthorizer mesh__D015319 sjn
% 223.15/223.30  |- skos__hiddenLabel mesh__D015319 Fructose Biphosphatase Deficiency
% 223.15/223.30  |- skos__scopeNote mesh__D015319
% 223.15/223.30       An autosomal recessive fructose metabolism disorder due to absent or deficient fructose-1,6-diphosphatase activity. Gluconeogenesis is impaired, resulting in accumulation of gluconeogenic precursors %28%e.g., amino acids, lactate, ketones%29% and manifested as hypoglycemia, ketosis, and lactic acidosis. Episodes in the newborn infant are often lethal. Later episodes are often brought on by fasting and febrile infections. As patients age through early childhood, tolerance to fasting improves and development becomes normal.%A%    
% 223.15/223.30  |- skos__hiddenLabel mesh__D015319 Deficiencies, Hexosediphosphatase
% 223.15/223.30  |- skos__hiddenLabel mesh__D015319 Fructose-1,6-Bisphosphatase Deficiencies
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D015319 2006
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D015319 2002
% 223.15/223.30  |- mesh__historyNote mesh__D015319
% 223.15/223.30       91%28%89%29%; was see under FRUCTOSE METABOLISM, INBORN ERRORS 1989-90%A%  
% 223.15/223.30  |- skos__hiddenLabel mesh__D015319 Hexosediphosphatase Deficiencies
% 223.15/223.30  |- mesh__recordMaintainer mesh__D015319 nns
% 223.15/223.30  |- skos__hiddenLabel mesh__D015319 Fructosediphosphatase Deficiencies
% 223.15/223.30  |- skos__altLabel mesh__D015319 Fructose-Biphosphatase Deficiency
% 223.15/223.30  |- skos__hiddenLabel mesh__D015319 Fructose-Biphosphatase Deficiencies
% 223.15/223.30  |- skos__broader mesh__D015319smesh__D015318
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D015319 2003
% 223.15/223.30  |- skos__hiddenLabel mesh__D015319 Fructose-1,6-Diphosphatase Deficiencies
% 223.15/223.30  |- rdf__type mesh__D015319sskos__Concept
% 223.15/223.30  |- skos__annotation mesh__D015319
% 223.15/223.30       an inborn error of fructose metab; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: FDP DEFIC%A%  
% 223.15/223.30  |- skos__altLabel mesh__D015319 Fructosediphosphatase Deficiency
% 223.15/223.30  |- skos__hiddenLabel mesh__D015319 Deficiency, Fructosediphosphatase
% 223.15/223.30  |- mesh__publicMeSHNote mesh__D015319
% 223.15/223.30       91; was see under FRUCTOSE METABOLISM, INBORN ERRORS 1989-90%A%  
% 223.15/223.30  |- mesh__recordOriginator mesh__D015319 EJB
% 223.15/223.30  |- mesh__dateEstablished mesh__D015319 1991-01-01
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D015319 2004
% 223.15/223.30  |- skos__hiddenLabel mesh__D015319 Fructose 1,6 Bisphosphatase Deficiency
% 223.15/223.30  |- mesh__dateCreated mesh__D015319 1988-05-31
% 223.15/223.30  |- skos__hiddenLabel mesh__D015319
% 223.15/223.30       Deficiencies, Fructose-1,6-Bisphosphatase
% 223.15/223.30  |- skos__related mesh__D012021smesh__D020211
% 223.15/223.30  |- skos__hiddenLabel mesh__D012021 Absent Reflex
% 223.15/223.30  |- skos__hiddenLabel mesh__D012021 Reflex, Palmo-Mental
% 223.15/223.30  |- mesh__recordMaintainer mesh__D012021 mdb
% 223.15/223.30  |- skos__altLabel mesh__D012021 Reflex, Deep Tendon, Abnormal
% 223.15/223.30  |- skos__altLabel mesh__D012021 Abnormal Reflexes
% 223.15/223.30  |- mesh__recordAuthorizer mesh__D012021 sjn
% 223.15/223.30  |- mesh__dateCreated mesh__D012021 1999-01-01
% 223.15/223.30  |- skos__hiddenLabel mesh__D012021 Reflex, Hoffman%27%s
% 223.15/223.30  |- skos__broader mesh__D012021smesh__D012018
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D012021 2003
% 223.15/223.30  |- skos__hiddenLabel mesh__D012021 Palmo Mental Reflex
% 223.15/223.30  |- skos__altLabel mesh__D012021 Abnormal Reflex
% 223.15/223.30  |- skos__altLabel mesh__D012021 Reflexes, Abnormal
% 223.15/223.30  |- rdf__type mesh__D012021sskos__Concept
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D012021 2005
% 223.15/223.30  |- skos__scopeNote mesh__D012021
% 223.15/223.30       An abnormal response to a stimulus applied to the sensory components of the nervous system. This may take the form of increased, decreased, or absent reflexes.%A%    
% 223.15/223.30  |- skos__hiddenLabel mesh__D012021 Reflex, Decreased Bulbocavernosus
% 223.15/223.30  |- skos__hiddenLabel mesh__D012021 Pendular Reflex
% 223.15/223.30  |- skos__prefLabel mesh__D012021 Reflex, Abnormal
% 223.15/223.30  |- skos__hiddenLabel mesh__D012021 Decreased Reflex
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D012021 2004
% 223.15/223.30  |- mesh__dateRevised mesh__D012021 2002-07-02
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D012021 2006
% 223.15/223.30  |- skos__broader mesh__D012021smesh__D009461
% 223.15/223.30  |- skos__hiddenLabel mesh__D012021 Decreased Bulbocavernosus Reflex
% 223.15/223.30  |- skos__hiddenLabel mesh__D012021 Reflex Absent, Bulbocavernousus
% 223.15/223.30  |- mesh__recordOriginator mesh__D012021 NLM
% 223.15/223.30  |- skos__altLabel mesh__D012021 Reflex, Decreased
% 223.15/223.30  |- skos__annotation mesh__D012021 do not use Cat C or E qualif   
% 223.15/223.30  |- skos__broader mesh__D031784smesh__D006109
% 223.15/223.30  |- skos__altLabel mesh__D031784 Timothy Grass
% 223.15/223.30  |- mesh__historyNote mesh__D031784 2003   
% 223.15/223.30  |- rdf__type mesh__D031784sskos__Concept
% 223.15/223.30  |- mesh__dateCreated mesh__D031784 2002-07-03
% 223.15/223.30  |- mesh__dateEstablished mesh__D031784 2003-01-01
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D031784 2005
% 223.15/223.30  |- skos__prefLabel mesh__D031784 Phleum
% 223.15/223.30  |- skos__scopeNote mesh__D031784
% 223.15/223.30       A plant genus of the family POACEAE that contains the Phl p 4 allergen.%A%    
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D031784 2003
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D031784 2006
% 223.15/223.30  |- skos__altLabel mesh__D031784 Grass, Timothy
% 223.15/223.30  |- skos__annotation mesh__D031784
% 223.15/223.30       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D031784 2004
% 223.15/223.30  |- mesh__publicMeSHNote mesh__D031784 2003   
% 223.15/223.30  |- skos__altLabel mesh__D003295 Insulin Coma Therapy
% 223.15/223.30  |- skos__related mesh__D003295smesh__D007331
% 223.15/223.30  |- skos__prefLabel mesh__D003295 Convulsive Therapy
% 223.15/223.30  |- skos__hiddenLabel mesh__D003295 Therapies, Shock
% 223.15/223.30  |- skos__hiddenLabel mesh__D003295 Shock Therapies
% 223.15/223.30  |- skos__altLabel mesh__D003295 Therapy, Insulin Coma
% 223.15/223.30  |- skos__altLabel mesh__D003295 Shock Therapy, Insulin
% 223.15/223.30  |- mesh__publicMeSHNote mesh__D003295
% 223.15/223.30       81; was SHOCK THERAPY 1963-80; SHOCK THERAPY, INSULIN was heading 1963-80%A%  
% 223.15/223.30  |- mesh__onlineNote mesh__D003295
% 223.15/223.30       use CONVULSIVE THERAPY to search SHOCK THERAPY %26% SHOCK THERAPY, INSULIN 1966-80%A%  
% 223.15/223.30  |- skos__hiddenLabel mesh__D003295 Therapies, Insulin Coma
% 223.15/223.30  |- mesh__historyNote mesh__D003295
% 223.15/223.30       81; was SHOCK THERAPY 1963-80; SHOCK THERAPY, INSULIN was heading 1963-80%A%  
% 223.15/223.30  |- skos__broader mesh__D003295smesh__D013000
% 223.15/223.30  |- skos__hiddenLabel mesh__D003295 Therapies, Convulsive
% 223.15/223.30  |- skos__hiddenLabel mesh__D003295 Coma Therapies, Insulin
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D003295 2005
% 223.15/223.30  |- mesh__recordAuthorizer mesh__D003295 sjn
% 223.15/223.30  |- mesh__dateRevised mesh__D003295 2003-07-09
% 223.15/223.30  |- skos__altLabel mesh__D003295 Shock Therapy
% 223.15/223.30  |- mesh__recordMaintainer mesh__D003295 lkt
% 223.15/223.30  |- skos__altLabel mesh__D003295 Therapy, Insulin Shock
% 223.15/223.30  |- skos__altLabel mesh__D003295 Therapy, Shock
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D003295 2006
% 223.15/223.30  |- mesh__recordOriginator mesh__D003295 NLM
% 223.15/223.30  |- skos__scopeNote mesh__D003295
% 223.15/223.30       Convulsions induced in order to treat MENTAL DISORDERS. It is used primarily in the treatment of severe affective disorders and SCHIZOPHRENIA.%A%    
% 223.15/223.30  |- skos__annotation mesh__D003295
% 223.15/223.30       do not confuse with CONVULSIONS /ther; do not confuse X ref SHOCK THERAPY with SHOCK /ther nor X ref INSULIN COMA THERAPY with INSULIN COMA; DF: CONVULSIVE THER%A%  
% 223.15/223.30  |- skos__hiddenLabel mesh__D003295 Convulsive Therapies
% 223.15/223.30  |- rdf__type mesh__D003295sskos__Concept
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D003295 2004
% 223.15/223.30  |- skos__altLabel mesh__D003295 Therapy, Convulsive
% 223.15/223.30  |- skos__hiddenLabel mesh__D003295 Insulin Coma Therapies
% 223.15/223.30  |- mesh__dateCreated mesh__D003295 1999-01-01
% 223.15/223.30  |- mesh__dateCreated mesh__D011727 1999-01-01
% 223.15/223.30  |- mesh__recordOriginator mesh__D011727 NLM
% 223.15/223.30  |- mesh__publicMeSHNote mesh__D011727
% 223.15/223.30       91; was see under CARBAMATES 1973-90   
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D011727 2005A
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D011727 2005
% 223.15/223.30  |- mesh__dateEstablished mesh__D011727 1991-01-01
% 223.15/223.30  |- skos__hiddenLabel mesh__D011727 P23
% 223.15/223.30  |- rdf__type mesh__D011727sskos__Concept
% 223.15/223.30  |- skos__broader mesh__D011727smesh__D048448
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D011727 2005B
% 223.15/223.30  |- skos__prefLabel mesh__D011727 Pyridinolcarbamate
% 223.15/223.30  |- skos__altLabel mesh__D011727
% 223.15/223.30       2,6-Pyridinedimethanol-bis-%28%N-methylcarbamate%29%
% 223.15/223.30  |- mesh__historyNote mesh__D011727
% 223.15/223.30       91%28%73%29%; was see under CARBAMATES 1973-90   
% 223.15/223.30  |- skos__altLabel mesh__D011727 Pyricarbate
% 223.15/223.30  |- mesh__recordAuthorizer mesh__D011727 jls
% 223.15/223.30  |- skos__scopeNote mesh__D011727
% 223.15/223.30       A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1408%29%%A%    
% 223.15/223.30  |- mesh__dateRevised mesh__D011727 2004-07-30
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D011727 2006
% 223.15/223.30  |- skos__hiddenLabel mesh__D011727 P 23
% 223.15/223.30  |- mesh__recordMaintainer mesh__D011727 jls
% 223.15/223.30  |- skos__altLabel mesh__D044103 Melanocortin-2 Receptor
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D044103 2005
% 223.15/223.30  |- skos__altLabel mesh__D044103 Melanocortin Receptor 2
% 223.15/223.30  |- mesh__publicMeSHNote mesh__D044103
% 223.15/223.30       2004; MELANOCORTIN RECEPTOR 2 was indexed under RECEPTORS, CORTICOTROPIN 1994-2003 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1993%A%  
% 223.15/223.30  |- mesh__historyNote mesh__D044103
% 223.15/223.30       2004; use RECEPTOR, MELANOCORTIN, TYPE 2 %28%NM%29% 1993-2003   
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D044103 2004
% 223.15/223.30  |- skos__prefLabel mesh__D044103 Receptor, Melanocortin, Type 2
% 223.15/223.30  |- skos__hiddenLabel mesh__D044103 Receptor, Melanocortin 2
% 223.15/223.30  |- skos__altLabel mesh__D044103 MC2 Receptor
% 223.15/223.30  |- skos__historyNote mesh__D044103
% 223.15/223.30       Receptors, Endogenous Substances %28%1993%29%
% 223.15/223.30  |- skos__broader mesh__D044103smesh__D044101
% 223.15/223.30  |- skos__altLabel mesh__D044103 Receptor, Melanocortin-2
% 223.15/223.30  |- rdf__type mesh__D044103sskos__Concept
% 223.15/223.30  |- skos__scopeNote mesh__D044103
% 223.15/223.30       A melanocortin receptor subtype found primarily in the ADRENAL CORTEX. It shows specificity for CORTICOTROPIN.%A%    
% 223.15/223.30  |- mesh__dateCreated mesh__D044103 2003-07-09
% 223.15/223.30  |- skos__hiddenLabel mesh__D044103 Melanocortin 2 Receptor
% 223.15/223.30  |- skos__hiddenLabel mesh__D044103 Receptor, MC2
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D044103 2006
% 223.15/223.30  |- mesh__dateEstablished mesh__D044103 2004-01-01
% 223.15/223.30  |- skos__historyNote mesh__D044103
% 223.15/223.30       Receptors, Corticotropin %28%1994-2003%29%
% 223.15/223.30  |- skos__altLabel mesh__D007686 Distal Kidney Tubule
% 223.15/223.30  |- skos__historyNote mesh__D007686 Kidney Tubules %28%1966-1972%29%
% 223.15/223.30  |- mesh__dateEstablished mesh__D007686 1991-01-01
% 223.15/223.30  |- mesh__recordAuthorizer mesh__D007686 sjn
% 223.15/223.30  |- skos__scopeNote mesh__D007686
% 223.15/223.30       The portion of renal tubule that begins from the enlarged segment of the ascending limb of the LOOP OF HENLE. It reenters the KIDNEY CORTEX and forms the convoluted segments of the distal tubule.%A%    
% 223.15/223.30  |- skos__hiddenLabel mesh__D007686 Tubule, Distal Renal
% 223.15/223.30  |- mesh__dateCreated mesh__D007686 1999-01-01
% 223.15/223.30  |- skos__hiddenLabel mesh__D007686 Tubules, Distal Kidney
% 223.15/223.30  |- skos__hiddenLabel mesh__D007686 Kidney Tubule, Distal
% 223.15/223.30  |- skos__hiddenLabel mesh__D007686 Tubule, Distal Kidney
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D007686 2006
% 223.15/223.30  |- skos__prefLabel mesh__D007686 Kidney Tubules, Distal
% 223.15/223.30  |- skos__broader mesh__D007686smesh__D007684
% 223.15/223.30  |- mesh__recordOriginator mesh__D007686 NLM
% 223.15/223.30  |- mesh__publicMeSHNote mesh__D007686
% 223.15/223.30       91; was see under KIDNEY TUBULES 1973-90   
% 223.15/223.30  |- mesh__historyNote mesh__D007686
% 223.15/223.30       91%28%73%29%; was see under KIDNEY TUBULES 1973-90   
% 223.15/223.30  |- skos__hiddenLabel mesh__D007686 Renal Tubules, Distal
% 223.15/223.30  |- skos__hiddenLabel mesh__D007686 Distal Kidney Tubules
% 223.15/223.30  |- mesh__recordMaintainer mesh__D007686 lkt
% 223.15/223.30  |- skos__altLabel mesh__D007686 Distal Renal Tubule
% 223.15/223.30  |- mesh__dateRevised mesh__D007686 2005-06-30
% 223.15/223.30  |- skos__annotation mesh__D007686
% 223.15/223.30       %22%ascending tubules%22% = ASCENDING LIMB OF LOOP OF HENLE   
% 223.15/223.30  |- rdf__type mesh__D007686sskos__Concept
% 223.15/223.30  |- skos__hiddenLabel mesh__D007686 Renal Tubule, Distal
% 223.15/223.30  |- skos__hiddenLabel mesh__D007686 Tubules, Distal Renal
% 223.15/223.30  |- skos__hiddenLabel mesh__D007686 Distal Renal Tubules
% 223.15/223.30  |- skos__scopeNote mesh__D012820
% 223.15/223.30       Fodder converted into succulent feed for livestock through processes of anaerobic fermentation %28%as in a silo%29%.%A%    
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D012820 2006
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D012820 2001
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D012820 2004
% 223.15/223.30  |- mesh__publicMeSHNote mesh__D012820
% 223.15/223.30       91; was see under ANIMAL FEED 1964-90   
% 223.15/223.30  |- mesh__historyNote mesh__D012820
% 223.15/223.30       91%28%64%29%; was see under ANIMAL FEED 1964-90   
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D012820 2005
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D012820 2000
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D012820 2003
% 223.15/223.30  |- rdf__type mesh__D012820sskos__Concept
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D012820 1999
% 223.15/223.30  |- mesh__dateCreated mesh__D012820 1999-01-01
% 223.15/223.30  |- skos__prefLabel mesh__D012820 Silage
% 223.15/223.30  |- mesh__dateEstablished mesh__D012820 1991-01-01
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D012820 1998
% 223.15/223.30  |- mesh__dateRevised mesh__D012820 1997-06-20
% 223.15/223.30  |- skos__annotation mesh__D012820
% 223.15/223.30       %22%fodder converted into succulent feed for livestock%22%   
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D012820 2002
% 223.15/223.30  |- mesh__recordMaintainer mesh__D012820 JLS
% 223.15/223.30  |- mesh__recordAuthorizer mesh__D012820 SJN
% 223.15/223.30  |- mesh__recordOriginator mesh__D012820 NLM
% 223.15/223.30  |- skos__broader mesh__D012820smesh__D000821
% 223.15/223.30  |- mesh__dateCreated mesh__D012022 1978-12-14
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D012022 2003
% 223.15/223.30  |- mesh__dateEstablished mesh__D012022 1980-01-01
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D012022 2005
% 223.15/223.30  |- rdf__type mesh__D012022sskos__Concept
% 223.15/223.30  |- mesh__recordAuthorizer mesh__D012022 sjn
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D012022 2004
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D012022 2006
% 223.15/223.30  |- skos__broader mesh__D012022smesh__D012018
% 223.15/223.30  |- mesh__recordOriginator mesh__D012022 RC
% 223.15/223.30  |- mesh__historyNote mesh__D012022 80   
% 223.15/223.30  |- skos__hiddenLabel mesh__D012022 Acoustic Reflex
% 223.15/223.30  |- mesh__publicMeSHNote mesh__D012022 80   
% 223.15/223.30  |- skos__historyNote mesh__D012022 Sound %28%1966-1971%29%
% 223.15/223.30  |- skos__historyNote mesh__D012022 Reflex %28%1966-1979%29%
% 223.15/223.30  |- skos__scopeNote mesh__D012022
% 223.15/223.30       Intra-aural contraction of tensor tympani and stapedius in response to sound.%A%    
% 223.15/223.30  |- mesh__dateRevised mesh__D012022 2002-07-02
% 223.15/223.30  |- mesh__recordMaintainer mesh__D012022 mdb
% 223.15/223.30  |- skos__historyNote mesh__D012022 Acoustic Stimulation %28%1972-1979%29%
% 223.15/223.30  |- skos__prefLabel mesh__D012022 Reflex, Acoustic
% 223.15/223.30  |- mesh__dateCreated mesh__D031785 2002-07-02
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D031785 2005
% 223.15/223.30  |- skos__altLabel mesh__D031785 Kentucky Blue Grass
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D031785 2003
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D031785 2006
% 223.15/223.30  |- skos__altLabel mesh__D031785 Bluegrass
% 223.15/223.30  |- skos__annotation mesh__D031785
% 223.15/223.30       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.15/223.30  |- skos__broader mesh__D031785smesh__D006109
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D031785 2004
% 223.15/223.30  |- mesh__publicMeSHNote mesh__D031785 2003   
% 223.15/223.30  |- skos__altLabel mesh__D031785 Grass, Kentucky Blue
% 223.15/223.30  |- mesh__historyNote mesh__D031785 2003   
% 223.15/223.30  |- skos__prefLabel mesh__D031785 Poa
% 223.15/223.30  |- mesh__dateEstablished mesh__D031785 2003-01-01
% 223.15/223.30  |- rdf__type mesh__D031785sskos__Concept
% 223.15/223.30  |- skos__scopeNote mesh__D031785
% 223.15/223.30       A plant genus of the family POACEAE that contains the Poa p Ia allergen and allergen C KBGP.%A%    
% 223.15/223.30  |- mesh__dateRevised mesh__D003296 1999-11-03
% 223.15/223.30  |- skos__scopeNote mesh__D003296
% 223.15/223.30       The art or practice of cooking. It includes the preparation of special foods for diets in various diseases.%A%    
% 223.15/223.30  |- mesh__recordOriginator mesh__D003296 NLM
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D003296 2000
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D003296 2003
% 223.15/223.30  |- rdf__type mesh__D003296sskos__Concept
% 223.15/223.30  |- skos__annotation mesh__D003296
% 223.15/223.30       for articles on cooking, determine whether the point is COOKERY or HEAT%A%  
% 223.15/223.30  |- mesh__dateCreated mesh__D003296 1999-01-01
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D003296 2002
% 223.15/223.30  |- skos__broader mesh__D003296smesh__D005511
% 223.15/223.30  |- skos__hiddenLabel mesh__D003296 Cookbook
% 223.15/223.30  |- skos__hiddenLabel mesh__D003296 Recipe
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D003296 2006
% 223.15/223.30  |- skos__prefLabel mesh__D003296 Cookery
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D003296 2001
% 223.15/223.30  |- mesh__recordMaintainer mesh__D003296 kle
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D003296 2005
% 223.15/223.30  |- mesh__recordAuthorizer mesh__D003296 sjn
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D003296 2004
% 223.15/223.30  |- mesh__recordMaintainer mesh__D044902 jmp
% 223.15/223.30  |- skos__historyNote mesh__D044902 Mannosidases %28%1980-2003%29%
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D044902 2005
% 223.15/223.30  |- mesh__historyNote mesh__D044902
% 223.15/223.30       2004; use BETA-MANNOSIDASE %28%NM%29% 1980-2003   
% 223.15/223.30  |- skos__altLabel mesh__D044902 beta-D-Mannosidase
% 223.15/223.30  |- mesh__publicMeSHNote mesh__D044902
% 223.15/223.30       2004; BETA-MANNOSIDASE was indexed under MANNOSIDASES 1980-2003%A%  
% 223.15/223.30  |- mesh__recordOriginator mesh__D044902 jmp
% 223.15/223.30  |- skos__related mesh__D044902smesh__D044905
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D044902 2004
% 223.15/223.30  |- skos__hiddenLabel mesh__D044902 beta Mannosidase
% 223.15/223.30  |- skos__altLabel mesh__D044902 beta-Mannanase
% 223.15/223.30  |- skos__hiddenLabel mesh__D044902 beta Mannanase
% 223.15/223.30  |- skos__scopeNote mesh__D044902
% 223.15/223.30       An enzyme that catalyzes the hydrolysis of terminal, non-reducing beta-D-mannose residues in beta-D-mannosides. The enzyme plays a role in the lysosomal degradation of the N-glycosylprotein glycans. Defects in the lysosomal form of the enzyme in humans result in a buildup of mannoside intermediate metabolites and the disease BETA-MANNOSIDOSIS.%A%    
% 223.15/223.30  |- skos__altLabel mesh__D044902 manA protein %28%beta-Mannosidase%29%
% 223.15/223.30  |- mesh__dateCreated mesh__D044902 2003-07-09
% 223.15/223.30  |- skos__prefLabel mesh__D044902 beta-Mannosidase
% 223.15/223.30  |- mesh__recordAuthorizer mesh__D044902 sjn
% 223.15/223.30  |- skos__hiddenLabel mesh__D044902 beta D Mannosidase
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D044902 2006
% 223.15/223.30  |- skos__annotation mesh__D044902
% 223.15/223.30       /defic: consider also BETA-MANNOSIDOSIS   
% 223.15/223.30  |- mesh__dateEstablished mesh__D044902 2004-01-01
% 223.15/223.30  |- skos__broader mesh__D044902smesh__D008361
% 223.15/223.30  |- rdf__type mesh__D044902sskos__Concept
% 223.15/223.30  |- skos__altLabel mesh__D011728 Pyridinones
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D011728 1995
% 223.15/223.30  |- rdf__type mesh__D011728sskos__Concept
% 223.15/223.30  |- mesh__dateRevised mesh__D011728 1993-06-03
% 223.15/223.30  |- mesh__recordOriginator mesh__D011728 NLM
% 223.15/223.30  |- mesh__historyNote mesh__D011728 68; was PYRIDINONES 1966-67   
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D011728 1994
% 223.15/223.30  |- skos__prefLabel mesh__D011728 Pyridones
% 223.15/223.30  |- mesh__onlineNote mesh__D011728
% 223.15/223.30       use PYRIDONES to search PYRIDINONES 1966-67   
% 223.15/223.30  |- skos__scopeNote mesh__D011728
% 223.15/223.30       Pyridine derivatives with one or more keto groups on the ring.%A%    
% 223.15/223.30  |- mesh__dateEstablished mesh__D011728 1968-01-01
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D011728 2002
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D011728 2004
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D011728 2001
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D011728 1997
% 223.15/223.30  |- mesh__recordAuthorizer mesh__D011728 PLS
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D011728 2006
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D011728 1999
% 223.15/223.30  |- mesh__dateCreated mesh__D011728 1999-01-01
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D011728 2003
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D011728 1996
% 223.15/223.30  |- mesh__activeMeSHYear mesh__D011728 2005
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D011728 2000
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D011728 1998
% 223.15/223.31  |- skos__broader mesh__D011728smesh__D011725
% 223.15/223.31  |- mesh__publicMeSHNote mesh__D011728 68; was PYRIDINONES 1966-67   
% 223.15/223.31  |- mesh__recordMaintainer mesh__D011728 PLS
% 223.15/223.31  |- skos__altLabel mesh__D044104 Melanocortin Receptor 3
% 223.15/223.31  |- mesh__historyNote mesh__D044104
% 223.15/223.31       2004; use RECEPTOR, MELANOCORTIN, TYPE, 3 %28%NM%29% 1994-2003   
% 223.15/223.31  |- skos__altLabel mesh__D044104 MC3 Receptor
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D044104 2004
% 223.15/223.31  |- skos__altLabel mesh__D044104 Receptor, Melanocortin 3
% 223.15/223.31  |- skos__historyNote mesh__D044104
% 223.15/223.31       Receptors, Corticotropin %28%1994-2003%29%
% 223.15/223.31  |- mesh__publicMeSHNote mesh__D044104
% 223.15/223.31       2004; MELANOCORTIN RECEPTOR 3 was indexed under RECEPTORS, CORTICOTROPIN 1994-2003%A%  
% 223.15/223.31  |- skos__prefLabel mesh__D044104 Receptor, Melanocortin, Type 3
% 223.15/223.31  |- skos__scopeNote mesh__D044104
% 223.15/223.31       A melanocortin receptor subtype found primarily in BRAIN. It shows specificity for ALPHA-MSH; BETA-MSH; GAMMA-MSH and CORTICOTROPIN.%A%    
% 223.15/223.31  |- mesh__dateEstablished mesh__D044104 2004-01-01
% 223.15/223.31  |- skos__altLabel mesh__D044104 Melanocortin-3 Receptor
% 223.15/223.31  |- skos__broader mesh__D044104smesh__D044101
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D044104 2005
% 223.15/223.31  |- rdf__type mesh__D044104sskos__Concept
% 223.15/223.31  |- skos__hiddenLabel mesh__D044104 Receptor, Melanocortin-3
% 223.15/223.31  |- mesh__dateCreated mesh__D044104 2003-07-09
% 223.15/223.31  |- skos__hiddenLabel mesh__D044104 Receptor, MC3
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D044104 2006
% 223.15/223.31  |- skos__hiddenLabel mesh__D044104 Melanocortin 3 Receptor
% 223.15/223.31  |- skos__hiddenLabel mesh__D007687 Tubule, Proximal Renal
% 223.15/223.31  |- mesh__recordMaintainer mesh__D007687 lkt
% 223.15/223.31  |- mesh__dateCreated mesh__D007687 1999-01-01
% 223.15/223.31  |- mesh__dateRevised mesh__D007687 2005-06-30
% 223.15/223.31  |- skos__hiddenLabel mesh__D007687 Proximal Kidney Tubules
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D007687 2006
% 223.15/223.31  |- skos__hiddenLabel mesh__D007687 Tubule, Proximal Kidney
% 223.15/223.31  |- skos__hiddenLabel mesh__D007687 Tubules, Proximal Kidney
% 223.15/223.31  |- mesh__dateEstablished mesh__D007687 1974-01-01
% 223.15/223.31  |- skos__prefLabel mesh__D007687 Kidney Tubules, Proximal
% 223.15/223.31  |- skos__annotation mesh__D007687
% 223.15/223.31       %22%descending tubules%22% = DESCENDING LIMB OF LOOP OF HENLE   
% 223.15/223.31  |- mesh__recordAuthorizer mesh__D007687 sjn
% 223.15/223.31  |- skos__hiddenLabel mesh__D007687 Renal Tubules, Proximal
% 223.15/223.31  |- mesh__publicMeSHNote mesh__D007687 74   
% 223.15/223.31  |- skos__hiddenLabel mesh__D007687 Kidney Tubule, Proximal
% 223.15/223.31  |- skos__altLabel mesh__D007687 Proximal Kidney Tubule
% 223.15/223.31  |- skos__broader mesh__D007687smesh__D007684
% 223.15/223.31  |- rdf__type mesh__D007687sskos__Concept
% 223.15/223.31  |- skos__scopeNote mesh__D007687
% 223.15/223.31       The renal tubule portion that extends from the BOWMAN CAPSULE in the KIDNEY CORTEX into the KIDNEY MEDULLA. The proximal tubule consists of a convoluted proximal segment in the cortex, and a distal straight segment descending into the medulla where it forms the U-shaped LOOP OF HENLE.%A%    
% 223.15/223.31  |- mesh__recordOriginator mesh__D007687 NLM
% 223.15/223.31  |- skos__hiddenLabel mesh__D007687 Renal Tubule, Proximal
% 223.15/223.31  |- skos__altLabel mesh__D007687 Proximal Renal Tubule
% 223.15/223.31  |- skos__hiddenLabel mesh__D007687 Tubules, Proximal Renal
% 223.15/223.31  |- mesh__historyNote mesh__D007687 74%28%73%29%   
% 223.15/223.31  |- skos__hiddenLabel mesh__D007687 Proximal Renal Tubules
% 223.15/223.31  |- skos__historyNote mesh__D007687 Kidney Tubules %28%1966-1972%29%
% 223.15/223.31  |- skos__prefLabel mesh__D012821 Silanes
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012821 2006
% 223.15/223.31  |- skos__historyNote mesh__D012821 Silicon %28%1966-1974%29%
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012821 2002
% 223.15/223.31  |- skos__broader mesh__D012821smesh__D017655
% 223.15/223.31  |- mesh__recordOriginator mesh__D012821 NLM
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012821 2004
% 223.15/223.31  |- skos__scopeNote mesh__D012821
% 223.15/223.31       Compounds similar to hydrocarbons in which a tetravalent silicon atom replaces the carbon atom. They are very reactive, ignite in air, and form useful derivatives.%A%    
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012821 2005
% 223.15/223.31  |- mesh__dateCreated mesh__D012821 1974-11-19
% 223.15/223.31  |- rdf__type mesh__D012821sskos__Concept
% 223.15/223.31  |- mesh__onlineNote mesh__D012821
% 223.15/223.31       use SILANES to search HYDROSILICONS, SILICANS %26% SILICOHYDRIDES 1975-93%A%  
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012821 2003
% 223.15/223.31  |- mesh__historyNote mesh__D012821
% 223.15/223.31       91%28%75%29%; was see under SILICON 1975-90; HYDROSILICONS, SILICANS %26% SILICOHYDRIDES were see SILANES 1975-93%A%  
% 223.15/223.31  |- mesh__dateEstablished mesh__D012821 1991-01-01
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012821 2001
% 223.15/223.31  |- mesh__publicMeSHNote mesh__D012821
% 223.15/223.31       91; was see under SILICON 1975-90; HYDROSILICONS, SILICANS %26% SILICOHYDRIDES were see SILANES 1975-93%A%  
% 223.15/223.31  |- mesh__recordAuthorizer mesh__D012821 sjn
% 223.15/223.31  |- mesh__recordMaintainer mesh__D012821 CCR
% 223.15/223.31  |- mesh__dateRevised mesh__D012821 2000-06-22
% 223.15/223.31  |- skos__broader mesh__D012821smesh__D017646
% 223.15/223.31  |- skos__prefLabel mesh__D012023 Reflex, Monosynaptic
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012023 2006
% 223.15/223.31  |- mesh__recordAuthorizer mesh__D012023 SJN
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012023 2002
% 223.15/223.31  |- mesh__historyNote mesh__D012023 70%28%68%29%   
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012023 1999
% 223.15/223.31  |- mesh__recordMaintainer mesh__D012023 MSR
% 223.15/223.31  |- skos__hiddenLabel mesh__D012023 Monosynaptic Reflex
% 223.15/223.31  |- mesh__dateEstablished mesh__D012023 1970-01-01
% 223.15/223.31  |- mesh__recordOriginator mesh__D012023 NLM
% 223.15/223.31  |- skos__historyNote mesh__D012023 Reflex %28%1966-1967%29%
% 223.15/223.31  |- mesh__dateCreated mesh__D012023 1999-01-01
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012023 2000
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012023 2003
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012023 2001
% 223.15/223.31  |- mesh__publicMeSHNote mesh__D012023 70   
% 223.15/223.31  |- mesh__dateRevised mesh__D012023 1998-06-11
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012023 2005
% 223.15/223.31  |- rdf__type mesh__D012023sskos__Concept
% 223.15/223.31  |- skos__broader mesh__D012023smesh__D012018
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012023 2004
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D031786 2005
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D031786 2003
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D031786 2006
% 223.15/223.31  |- skos__annotation mesh__D031786
% 223.15/223.31       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D031786 2004
% 223.15/223.31  |- mesh__publicMeSHNote mesh__D031786 2003   
% 223.15/223.31  |- skos__scopeNote mesh__D031786
% 223.15/223.31       A plant genus of the family POACEAE widely cultivated in the tropics for the sweet cane that is processed into sugar.%A%    
% 223.15/223.31  |- skos__prefLabel mesh__D031786 Saccharum
% 223.15/223.31  |- skos__altLabel mesh__D031786 Sugarcane
% 223.15/223.31  |- skos__broader mesh__D031786smesh__D006109
% 223.15/223.31  |- rdf__type mesh__D031786sskos__Concept
% 223.15/223.31  |- mesh__historyNote mesh__D031786 2003   
% 223.15/223.31  |- mesh__dateCreated mesh__D031786 2002-07-03
% 223.15/223.31  |- mesh__dateEstablished mesh__D031786 2003-01-01
% 223.15/223.31  |- skos__prefLabel mesh__D050940 Betaine-Homocysteine S-Methyltransferase
% 223.15/223.31  |- skos__hiddenLabel mesh__D050940 Methyltransferase, Betaine-Homocysteine
% 223.15/223.31  |- rdf__type mesh__D050940sskos__Concept
% 223.15/223.31  |- skos__scopeNote mesh__D050940
% 223.15/223.31       A ZINC metalloenzyme that catalyzes the transfer of a methyl group from BETAINE to HOMOCYSTEINE to produce dimethylglycine and METHIONINE, respectively. This enzyme is a member of a family of ZINC-dependent METHYLTRANSFERASES that use THIOLS or selenols as methyl acceptors.%A%    
% 223.15/223.31  |- skos__hiddenLabel mesh__D050940
% 223.15/223.31       S-Methyltransferase, Betaine-Homocysteine
% 223.15/223.31  |- skos__altLabel mesh__D050940 Bet-HCys MTase
% 223.15/223.31  |- skos__broader mesh__D050940smesh__D008780
% 223.15/223.31  |- skos__hiddenLabel mesh__D050940
% 223.15/223.31       Methyltransferase-2, Betaine-Homocysteine
% 223.15/223.31  |- mesh__dateCreated mesh__D050940 2005-06-30
% 223.15/223.31  |- skos__hiddenLabel mesh__D050940 MTase, Bet-HCys
% 223.15/223.31  |- skos__altLabel mesh__D050940 Betaine Homocysteine Methyltransferase
% 223.15/223.31  |- mesh__recordMaintainer mesh__D050940 ags
% 223.15/223.31  |- skos__hiddenLabel mesh__D050940 Bet HCys MTase
% 223.15/223.31  |- skos__hiddenLabel mesh__D050940 Methyltransferase, Betaine Homocysteine
% 223.15/223.31  |- skos__hiddenLabel mesh__D050940
% 223.15/223.31       Methyltransferase 2, Betaine-Homocysteine
% 223.15/223.31  |- mesh__dateRevised mesh__D050940 2005-07-20
% 223.15/223.31  |- skos__hiddenLabel mesh__D050940 Betaine Homocysteine Methyltransferase 2
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D050940 2006A
% 223.15/223.31  |- skos__altLabel mesh__D050940 Betaine-Homocysteine Methyltransferase
% 223.15/223.31  |- mesh__recordOriginator mesh__D050940 AKE
% 223.15/223.31  |- skos__hiddenLabel mesh__D050940 Betaine Homocysteine S Methyltransferase
% 223.15/223.31  |- mesh__historyNote mesh__D050940 2006%28%1980%29%   
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D050940 2006
% 223.15/223.31  |- skos__hiddenLabel mesh__D050940 Homocysteine Methyltransferase, Betaine
% 223.15/223.31  |- mesh__publicMeSHNote mesh__D050940
% 223.15/223.31       2006; BETAINE-HOMOCYSTEINE S-METHYLTRANSFERASE was indexed under  METHYLTRANSFERASES 1980-2005, %26% under BETAINE %26% HOMOCYSTEINE 1980-1981%A%  
% 223.15/223.31  |- skos__altLabel mesh__D050940 Betaine-Homocysteine Methyltransferase-2
% 223.15/223.31  |- mesh__recordAuthorizer mesh__D050940 ags
% 223.15/223.31  |- mesh__dateEstablished mesh__D050940 2006-01-01
% 223.15/223.31  |- skos__broader mesh__D044903smesh__D002239
% 223.15/223.31  |- mesh__dateEstablished mesh__D044903 2004-01-01
% 223.15/223.31  |- skos__broader mesh__D044903smesh__D007003
% 223.15/223.31  |- skos__broader mesh__D044903smesh__D006946
% 223.15/223.31  |- skos__historyNote mesh__D044903 Hypoglycemia %28%1977-2003%29%
% 223.15/223.31  |- skos__altLabel mesh__D044903 PHHI Hypoglycemia
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D044903 2004
% 223.15/223.31  |- skos__hiddenLabel mesh__D044903 Hyperinsulinism, Congenital
% 223.15/223.31  |- mesh__historyNote mesh__D044903 2004   
% 223.15/223.31  |- skos__altLabel mesh__D044903 Hyperinsulinemia Hypoglycemia of Infancy
% 223.15/223.31  |- skos__altLabel mesh__D044903 Congenital Hyperinsulinism
% 223.15/223.31  |- mesh__dateCreated mesh__D044903 2003-07-09
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D044903 2006
% 223.15/223.31  |- skos__historyNote mesh__D044903 Hyperinsulinism %28%1977-2003%29%
% 223.15/223.31  |- skos__historyNote mesh__D044903
% 223.15/223.31       Chromosomes, Human, Pair 11 %28%1995-2003%29%
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D044903 2005
% 223.15/223.31  |- skos__hiddenLabel mesh__D044903 Infancy Hyperinsulinemia Hypoglycemia
% 223.15/223.31  |- mesh__publicMeSHNote mesh__D044903 2004   
% 223.15/223.31  |- rdf__type mesh__D044903sskos__Concept
% 223.15/223.31  |- skos__broader mesh__D044903smesh__D007232
% 223.15/223.31  |- skos__scopeNote mesh__D044903
% 223.15/223.31       A form of nontransient HYPOGLYCEMIA, unique to infancy, due to autosomal recessive mutations of the sulfonylurea receptor gene on CHROMOSOME 11. Defects in the sulfonylurea receptors %28%ATP-BINDING CASSETTE TRANSPORTERS%29% on the PANCREATIC BETA CELLS prevent negative feedback of GLUCOSE-regulated INSULIN release thus resulting in HYPERINSULINEMIA. Clinical phenotype includes SEIZURES; COMA; and often large BIRTH WEIGHT for GESTATIONAL AGE.%A%    
% 223.15/223.31  |- skos__prefLabel mesh__D044903
% 223.15/223.31       Persistent Hyperinsulinemia Hypoglycemia of Infancy
% 223.15/223.31  |- skos__hiddenLabel mesh__D044903 Hypoglycemia, PHHI
% 223.15/223.31  |- skos__hiddenLabel mesh__D003297 Utensil, Cooking
% 223.15/223.31  |- mesh__recordMaintainer mesh__D003297 JLS
% 223.15/223.31  |- mesh__dateCreated mesh__D003297 1999-01-01
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D003297 1999
% 223.15/223.31  |- skos__broader mesh__D003297smesh__D005511
% 223.15/223.31  |- mesh__recordOriginator mesh__D003297 NLM
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D003297 2000
% 223.15/223.31  |- skos__hiddenLabel mesh__D003297 Utensils, Eating
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D003297 1998
% 223.15/223.31  |- skos__broader mesh__D003297smesh__D008420
% 223.15/223.31  |- skos__hiddenLabel mesh__D003297 Utensil, Eating
% 223.15/223.31  |- skos__annotation mesh__D003297 DF: COOKING UTENSILS   
% 223.15/223.31  |- skos__hiddenLabel mesh__D003297 Cooking Utensil
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D003297 2006
% 223.15/223.31  |- skos__hiddenLabel mesh__D003297 Utensils, Cooking
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D003297 2002
% 223.15/223.31  |- mesh__dateRevised mesh__D003297 1997-06-20
% 223.15/223.31  |- skos__broader mesh__D003297smesh__D006794
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D003297 2005
% 223.15/223.31  |- skos__hiddenLabel mesh__D003297 Eating Utensil
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D003297 2004
% 223.15/223.31  |- skos__prefLabel mesh__D003297 Cooking and Eating Utensils
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D003297 2003
% 223.15/223.31  |- mesh__recordAuthorizer mesh__D003297 SJN
% 223.15/223.31  |- rdf__type mesh__D003297sskos__Concept
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D003297 2001
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D011729 2001
% 223.15/223.31  |- mesh__historyNote mesh__D011729
% 223.15/223.31       65; PYRIDOSTIGMINE was see under PARASYMPATHOMIMETICS 1963-64%A%  
% 223.15/223.31  |- skos__broader mesh__D011729smesh__D011726
% 223.15/223.31  |- rdf__type mesh__D011729sskos__Concept
% 223.15/223.31  |- mesh__publicMeSHNote mesh__D011729
% 223.15/223.31       65; PYRIDOSTIGMINE was see under PARASYMPATHOMIMETICS 1963-64%A%  
% 223.15/223.31  |- skos__annotation mesh__D011729 a cholinesterase inhib   
% 223.15/223.31  |- skos__scopeNote mesh__D011729
% 223.15/223.31       A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants.%A%    
% 223.15/223.31  |- mesh__dateCreated mesh__D011729 1999-01-01
% 223.15/223.31  |- skos__prefLabel mesh__D011729 Pyridostigmine Bromide
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D011729 2003
% 223.15/223.31  |- mesh__dateEstablished mesh__D011729 1965-01-01
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D011729 2002
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D011729 2005
% 223.15/223.31  |- skos__hiddenLabel mesh__D011729 Bromide, Pyridostigmine
% 223.15/223.31  |- mesh__recordOriginator mesh__D011729 NLM
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D011729 2004
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D011729 2006
% 223.15/223.31  |- mesh__dateRevised mesh__D011729 1999-11-03
% 223.15/223.31  |- mesh__recordAuthorizer mesh__D011729 sjn
% 223.15/223.31  |- mesh__recordMaintainer mesh__D011729 jmp
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D011729 2000
% 223.15/223.31  |- skos__scopeNote mesh__D008780
% 223.15/223.31       A subclass of enzymes of the transferase class that catalyze the transfer of a methyl group from one compound to another. %28%Dorland, 28th ed%29% EC 2.1.1.%A%    
% 223.15/223.31  |- mesh__historyNote mesh__D008780 72%28%71%29%   
% 223.15/223.31  |- mesh__dateRevised mesh__D008780 2003-07-09
% 223.15/223.31  |- mesh__dateEstablished mesh__D008780 1972-01-01
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D008780 2005
% 223.15/223.31  |- mesh__recordOriginator mesh__D008780 NLM
% 223.15/223.31  |- skos__broader mesh__D008780smesh__D019875
% 223.15/223.31  |- skos__historyNote mesh__D008780 Transferases %28%1966-1970%29%
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D008780 2006
% 223.15/223.31  |- mesh__recordMaintainer mesh__D008780 ssb
% 223.15/223.31  |- mesh__publicMeSHNote mesh__D008780 72   
% 223.15/223.31  |- mesh__dateCreated mesh__D008780 1999-01-01
% 223.15/223.31  |- mesh__recordAuthorizer mesh__D008780 sjn
% 223.15/223.31  |- rdf__type mesh__D008780sskos__Concept
% 223.15/223.31  |- skos__prefLabel mesh__D008780 Methyltransferases
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D008780 2004
% 223.15/223.31  |- skos__hiddenLabel mesh__D044105 Receptor 4, Melanocortin
% 223.15/223.31  |- skos__hiddenLabel mesh__D044105 Receptor, Melanocortin 4
% 223.15/223.31  |- skos__altLabel mesh__D044105 Melanocortin 4 Receptor
% 223.15/223.31  |- skos__altLabel mesh__D044105 Melanocortin Receptor 4
% 223.15/223.31  |- skos__altLabel mesh__D044105 Melanocortin-4 Receptor
% 223.15/223.31  |- mesh__recordOriginator mesh__D044105 jmp
% 223.15/223.31  |- skos__prefLabel mesh__D044105 Receptor, Melanocortin, Type 4
% 223.15/223.31  |- skos__broader mesh__D044105smesh__D044101
% 223.15/223.31  |- skos__scopeNote mesh__D044105
% 223.15/223.31       A melanocortin receptor subtype found primarily in BRAIN. It shows specificity for ALPHA-MSH; BETA-MSH and CORTICOTROPIN.%A%    
% 223.15/223.31  |- rdf__type mesh__D044105sskos__Concept
% 223.15/223.31  |- skos__hiddenLabel mesh__D044105 Receptor, MC4
% 223.15/223.31  |- skos__altLabel mesh__D044105 Receptor, Melanocortin-4
% 223.15/223.31  |- mesh__recordAuthorizer mesh__D044105 sjn
% 223.15/223.31  |- mesh__historyNote mesh__D044105
% 223.15/223.31       2004; use RECEPTOR, MELANOCORTIN, TYPE 4 %28%NM%29% 1993-2003   
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D044105 2005
% 223.15/223.31  |- mesh__recordMaintainer mesh__D044105 jmp
% 223.15/223.31  |- mesh__dateCreated mesh__D044105 2003-07-09
% 223.15/223.31  |- skos__historyNote mesh__D044105 Receptors, Peptide %28%1994-2002%29%
% 223.15/223.31  |- skos__altLabel mesh__D044105 MC4 Receptor
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D044105 2006
% 223.15/223.31  |- mesh__dateEstablished mesh__D044105 2004-01-01
% 223.15/223.31  |- skos__historyNote mesh__D044105
% 223.15/223.31       Receptors, Corticotropin %28%1995-2003%29%
% 223.15/223.31  |- skos__historyNote mesh__D044105 Receptors, Cell Surface %28%1993%29%
% 223.15/223.31  |- mesh__publicMeSHNote mesh__D044105
% 223.15/223.31       2004; MELANOCORTIN RECEPTOR 4 was indexed under RECEPTORS, CORTICOTROPIN 1995-2003;  RECEPTORS, PEPTIDE 1994-2002 %26% RECEPTORS, CELL SURFACE 1993%A%  
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D044105 2004
% 223.15/223.31  |- skos__related mesh__D016414smesh__D005066
% 223.15/223.31  |- skos__hiddenLabel mesh__D016414 Resuscitation Decision
% 223.15/223.31  |- skos__hiddenLabel mesh__D016414 Orders, Resuscitation
% 223.15/223.31  |- skos__hiddenLabel mesh__D016414 Decisions, Resuscitation
% 223.15/223.31  |- mesh__historyNote mesh__D016414 91   
% 223.15/223.31  |- skos__hiddenLabel mesh__D016414 Policies, Resuscitation
% 223.15/223.31  |- mesh__recordOriginator mesh__D016414 PLS
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D016414 2003
% 223.15/223.31  |- skos__historyNote mesh__D016414 Resuscitation %28%1975-1990%29%
% 223.15/223.31  |- skos__prefLabel mesh__D016414 Resuscitation Orders
% 223.15/223.31  |- skos__broader mesh__D016414smesh__D013727
% 223.15/223.31  |- mesh__dateRevised mesh__D016414 2002-10-31
% 223.15/223.31  |- skos__hiddenLabel mesh__D016414 Order, Resuscitation
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D016414 2005
% 223.15/223.31  |- skos__hiddenLabel mesh__D016414 Policy, Resuscitation
% 223.15/223.31  |- skos__scopeNote mesh__D016414
% 223.15/223.31       Instructions issued by a physician pertaining to the institution, continuation, or withdrawal of life support measures. The concept includes policies, laws, statutes, decisions, guidelines, and discussions that may affect the issuance of such orders.%A%    
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D016414 2004
% 223.15/223.31  |- skos__hiddenLabel mesh__D016414 Orders, Do-Not-Resuscitate
% 223.15/223.31  |- mesh__recordAuthorizer mesh__D016414 jls
% 223.15/223.31  |- skos__hiddenLabel mesh__D016414 Decision, Resuscitation
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D016414 2006
% 223.15/223.31  |- mesh__dateEstablished mesh__D016414 1991-01-01
% 223.15/223.31  |- skos__hiddenLabel mesh__D016414 Do-Not-Resuscitate Order
% 223.15/223.31  |- skos__broader mesh__D016414smesh__D012151
% 223.15/223.31  |- skos__related mesh__D016414smesh__D028761
% 223.15/223.31  |- skos__annotation mesh__D016414 DF: DNR ORDERS   
% 223.15/223.31  |- mesh__recordMaintainer mesh__D016414 jls
% 223.15/223.31  |- rdf__type mesh__D016414sskos__Concept
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D016414 2002
% 223.15/223.31  |- skos__broader mesh__D016414smesh__D007603
% 223.15/223.31  |- skos__hiddenLabel mesh__D016414 Resuscitation Policy
% 223.15/223.31  |- mesh__publicMeSHNote mesh__D016414 91   
% 223.15/223.31  |- mesh__dateCreated mesh__D016414 1990-06-01
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D016414 2003A
% 223.15/223.31  |- skos__related mesh__D016414smesh__D018447
% 223.15/223.31  |- skos__hiddenLabel mesh__D016414 Order, Do-Not-Resuscitate
% 223.15/223.31  |- skos__related mesh__D016414smesh__D024362
% 223.15/223.31  |- skos__hiddenLabel mesh__D016414 Resuscitation Order
% 223.15/223.31  |- skos__hiddenLabel mesh__D016414 Do Not Resuscitate Orders
% 223.15/223.31  |- skos__prefLabel mesh__D007688 Kidney, Artificial
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D007688 2002
% 223.15/223.31  |- mesh__recordOriginator mesh__D007688 NLM
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D007688 1999
% 223.15/223.31  |- mesh__recordMaintainer mesh__D007688 PXP
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D007688 1998
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D007688 2006
% 223.15/223.31  |- mesh__dateCreated mesh__D007688 1999-01-01
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D007688 2001
% 223.15/223.31  |- mesh__dateRevised mesh__D007688 1997-06-20
% 223.15/223.31  |- skos__hiddenLabel mesh__D007688 Artificial Kidneys
% 223.15/223.31  |- skos__altLabel mesh__D007688 Artificial Kidney
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D007688 2005
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D007688 2004
% 223.15/223.31  |- skos__broader mesh__D007688smesh__D001187
% 223.15/223.31  |- skos__hiddenLabel mesh__D007688 Kidneys, Artificial
% 223.15/223.31  |- skos__scopeNote mesh__D007688
% 223.15/223.31       Device%28%s%29% which can substitute for normally functioning kidneys in cleansing the blood.%A%    
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D007688 2000
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D007688 2003
% 223.15/223.31  |- skos__annotation mesh__D007688 /psychol permitted   
% 223.15/223.31  |- mesh__recordAuthorizer mesh__D007688 SJN
% 223.15/223.31  |- rdf__type mesh__D007688sskos__Concept
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D032081 2005
% 223.15/223.31  |- rdf__type mesh__D032081sskos__Concept
% 223.15/223.31  |- skos__annotation mesh__D032081
% 223.15/223.31       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.15/223.31  |- mesh__publicMeSHNote mesh__D032081 2003   
% 223.15/223.31  |- skos__prefLabel mesh__D032081 Casimiroa
% 223.15/223.31  |- mesh__dateCreated mesh__D032081 2002-07-03
% 223.15/223.31  |- mesh__dateEstablished mesh__D032081 2003-01-01
% 223.15/223.31  |- skos__broader mesh__D032081smesh__D027821
% 223.15/223.31  |- mesh__historyNote mesh__D032081 2003   
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D032081 2004
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D032081 2006
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D032081 2003
% 223.15/223.31  |- skos__scopeNote mesh__D032081
% 223.15/223.31       A plant genus of the family RUTACEAE.  The fruit is edible and the seed has cardiovascular activity.%A%    
% 223.15/223.31  |- mesh__historyNote mesh__D004390
% 223.15/223.31       96; was DURSBAN 1971-95 %28%Prov 1971-74%29%; CHLORPYRIFOS was see DURSBAN 1971-95%A%  
% 223.15/223.31  |- mesh__recordOriginator mesh__D004390 NLM
% 223.15/223.31  |- rdf__type mesh__D004390sskos__Concept
% 223.15/223.31  |- skos__broader mesh__D004390smesh__D009946
% 223.15/223.31  |- mesh__publicMeSHNote mesh__D004390
% 223.15/223.31       96; was DURSBAN 1971-95 %28%Prov 1971-74%29%; CHLORPYRIFOS was see DURSBAN 1971-95%A%  
% 223.15/223.31  |- skos__prefLabel mesh__D004390 Chlorpyrifos
% 223.15/223.31  |- mesh__recordAuthorizer mesh__D004390 sjn
% 223.15/223.31  |- mesh__dateCreated mesh__D004390 1999-01-01
% 223.15/223.31  |- mesh__dateEstablished mesh__D004390 1974-01-01
% 223.15/223.31  |- skos__historyNote mesh__D004390 Insecticides %28%1966-1970%29%
% 223.15/223.31  |- mesh__dateRevised mesh__D004390 2005-06-30
% 223.15/223.31  |- mesh__recordMaintainer mesh__D004390 ssb
% 223.15/223.31  |- skos__annotation mesh__D004390 TN 111 for eff on insects   
% 223.15/223.31  |- skos__scopeNote mesh__D004390
% 223.15/223.31       An organothiophosphate cholinesterase inhibitor that is used as an insecticide and as an acaricide.%A%    
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D004390 2006
% 223.15/223.31  |- mesh__dateCreated mesh__D012822 1999-01-01
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012822 2006
% 223.15/223.31  |- skos__altLabel mesh__D012822 Silica
% 223.15/223.31  |- skos__broader mesh__D012822smesh__D017655
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012822 2002
% 223.15/223.31  |- skos__annotation mesh__D012822
% 223.15/223.31       note X ref: do not confuse with SILICON; TN 172: differentiation among silic- terms; see MeSH definition for names of common forms of silicon dioxide%A%  
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012822 2004
% 223.15/223.31  |- skos__altLabel mesh__D012822 Tridymite
% 223.15/223.31  |- mesh__recordMaintainer mesh__D012822 ssb
% 223.15/223.31  |- mesh__recordAuthorizer mesh__D012822 sjn
% 223.15/223.31  |- mesh__publicMeSHNote mesh__D012822 94; was SILICA 1963-93   
% 223.15/223.31  |- rdf__type mesh__D012822sskos__Concept
% 223.15/223.31  |- skos__hiddenLabel mesh__D012822 Dioxide, Silicon
% 223.15/223.31  |- skos__scopeNote mesh__D012822
% 223.15/223.31       Transparent, tasteless crystals found in nature as agate, amethyst, chalcedony, cristobalite, flint, sand, QUARTZ, and tridymite. The compound is insoluble in water or acids except hydrofluoric acid.%A%    
% 223.15/223.31  |- mesh__dateRevised mesh__D012822 2001-07-25
% 223.15/223.31  |- mesh__onlineNote mesh__D012822
% 223.15/223.31       use SILICON DIOXIDE to search SILICA 1966-93   
% 223.15/223.31  |- mesh__recordOriginator mesh__D012822 NLM
% 223.15/223.31  |- skos__altLabel mesh__D012822 Quso G32
% 223.15/223.31  |- skos__altLabel mesh__D012822 Cristobalite
% 223.15/223.31  |- skos__broader mesh__D012822smesh__D010087
% 223.15/223.31  |- skos__broader mesh__D012822smesh__D008903
% 223.15/223.31  |- mesh__historyNote mesh__D012822 94; was SILICA 1963-93   
% 223.15/223.31  |- skos__altLabel mesh__D012822 Sand
% 223.15/223.31  |- skos__altLabel mesh__D012822 Aerosil 380
% 223.15/223.31  |- skos__prefLabel mesh__D012822 Silicon Dioxide
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012822 2005
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012822 2003
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012024 2001
% 223.15/223.31  |- skos__hiddenLabel mesh__D012024 Oculocardiac Reflex
% 223.15/223.31  |- mesh__dateCreated mesh__D012024 1975-07-25
% 223.15/223.31  |- skos__broader mesh__D012024smesh__D012018
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012024 1999
% 223.15/223.31  |- mesh__recordMaintainer mesh__D012024 MSR
% 223.15/223.31  |- mesh__historyNote mesh__D012024
% 223.15/223.31       91%28%76%29%; was see under REFLEX 1976-90   
% 223.15/223.31  |- mesh__publicMeSHNote mesh__D012024 91; was see under REFLEX 1976-90   
% 223.15/223.31  |- mesh__recordAuthorizer mesh__D012024 SJN
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012024 2002
% 223.15/223.31  |- mesh__recordOriginator mesh__D012024 SMH
% 223.15/223.31  |- skos__scopeNote mesh__D012024
% 223.15/223.31       Change of heartbeat induced by pressure on the eyeball, manipulation of extraocular muscles, or pressure upon the tissue remaining in the orbital apex after enucleation.%A%    
% 223.15/223.31  |- skos__prefLabel mesh__D012024 Reflex, Oculocardiac
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012024 2003
% 223.15/223.31  |- mesh__dateRevised mesh__D012024 1998-06-11
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012024 2005
% 223.15/223.31  |- rdf__type mesh__D012024sskos__Concept
% 223.15/223.31  |- skos__historyNote mesh__D012024 Reflex %28%1966-1975%29%
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012024 2004
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012024 2006
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D012024 2000
% 223.15/223.31  |- skos__historyNote mesh__D012024 Heart Rate %28%1966-1975%29%
% 223.15/223.31  |- mesh__dateEstablished mesh__D012024 1991-01-01
% 223.15/223.31  |- rdf__type mesh__D031787sskos__Concept
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D031787 2004
% 223.15/223.31  |- skos__altLabel mesh__D031787 Kumazasa
% 223.15/223.31  |- skos__broader mesh__D031787smesh__D006109
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D031787 2006
% 223.15/223.31  |- mesh__dateCreated mesh__D031787 2002-07-02
% 223.15/223.31  |- mesh__dateEstablished mesh__D031787 2003-01-01
% 223.15/223.31  |- mesh__activeMeSHYear mesh__D031787 2003
% 223.15/223.31  |- skos__prefLabel mesh__D031787 Sasa
% 223.15/223.32  |- skos__altLabel mesh__D031787 Grass, Bamboo
% 223.15/223.32  |- skos__scopeNote mesh__D031787
% 223.15/223.32       A plant genus of the family POACEAE. Folin is the water-soluble extract from Sasa albomarginata.  Sasa kurinensis is an ingredient of Sho-ju-sen, a Japanese herbal medicine.%A%    
% 223.15/223.32  |- mesh__publicMeSHNote mesh__D031787 2003   
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D031787 2005
% 223.15/223.32  |- skos__annotation mesh__D031787
% 223.15/223.32       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.15/223.32  |- mesh__historyNote mesh__D031787 2003   
% 223.15/223.32  |- skos__altLabel mesh__D031787 Bamboo Grass
% 223.15/223.32  |- mesh__historyNote mesh__D050941 2006%28%1980%29%   
% 223.15/223.32  |- mesh__dateEstablished mesh__D050941 2006-01-01
% 223.15/223.32  |- skos__hiddenLabel mesh__D050941
% 223.15/223.32       Phosphatidyl N Methylethanolamine Methyltransferase
% 223.15/223.32  |- skos__altLabel mesh__D050941 Phospholipid Methyltransferase
% 223.15/223.32  |- skos__hiddenLabel mesh__D050941
% 223.15/223.32       N-Methyltransferase, Phosphatidyl-N-Methylethanolamine
% 223.15/223.32  |- skos__altLabel mesh__D050941
% 223.15/223.32       Phosphatidyldimethylethanolamine Methyltransferase
% 223.15/223.32  |- skos__broader mesh__D050941smesh__D008780
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D050941 2006
% 223.15/223.32  |- skos__altLabel mesh__D050941 Methyltransferase II
% 223.15/223.32  |- mesh__recordAuthorizer mesh__D050941 sjn
% 223.15/223.32  |- skos__hiddenLabel mesh__D050941 Methyltransferase, Phospholipid
% 223.15/223.32  |- skos__hiddenLabel mesh__D050941
% 223.15/223.32       Methyltransferase I, Phosphatidylethanolamine
% 223.15/223.32  |- rdf__type mesh__D050941sskos__Concept
% 223.15/223.32  |- skos__prefLabel mesh__D050941
% 223.15/223.32       Phosphatidyl-N-Methylethanolamine N-Methyltransferase
% 223.15/223.32  |- mesh__publicMeSHNote mesh__D050941
% 223.15/223.32       2006; PHOSPHATIDYL-N-METHYLETHANOLAMINE N-METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1980-2004%A%  
% 223.15/223.32  |- skos__hiddenLabel mesh__D050941
% 223.15/223.32       Phosphatidyl N Methylethanolamine N Methyltransferase
% 223.15/223.32  |- mesh__dateCreated mesh__D050941 2005-06-30
% 223.15/223.32  |- skos__altLabel mesh__D050941 PDMEA Methyltransferase
% 223.15/223.32  |- mesh__recordMaintainer mesh__D050941 AKE
% 223.15/223.32  |- skos__hiddenLabel mesh__D050941
% 223.15/223.32       Methyltransferase, Phosphatidyldimethylethanolamine
% 223.15/223.32  |- skos__altLabel mesh__D050941
% 223.15/223.32       Phosphatidyl-N-Methylethanolamine Methyltransferase
% 223.15/223.32  |- skos__hiddenLabel mesh__D050941 Methyltransferase, PDMEA
% 223.15/223.32  |- skos__altLabel mesh__D050941
% 223.15/223.32       Phosphatidylethanolamine Methyltransferase I
% 223.15/223.32  |- skos__scopeNote mesh__D050941
% 223.15/223.32       An enzyme that catalyzes the METHYLATION of PHOSPHATIDYL-N-METHYLETHANOLAMINE to produce phosphatidyl-N-dimethylethanolamine. This enzyme can also methylate phosphatidyl-N-dimethylethanolamine to produce  phosphatidyl-N-trimethylethanolamine %28%PHOSPHATIDYLCHOLINE%29%.%A%    
% 223.15/223.32  |- mesh__recordOriginator mesh__D050941 AKE
% 223.15/223.32  |- skos__hiddenLabel mesh__D050941
% 223.15/223.32       Methyltransferase, Phosphatidyl-N-Methylethanolamine
% 223.15/223.32  |- skos__hiddenLabel mesh__D003298 Test, Antiglobulin
% 223.15/223.32  |- mesh__dateRevised mesh__D003298 1997-06-20
% 223.15/223.32  |- skos__hiddenLabel mesh__D003298 Tests, Antiglobulin
% 223.15/223.32  |- skos__hiddenLabel mesh__D003298 Test, Antiglobulin Consumption
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D003298 2006
% 223.15/223.32  |- skos__hiddenLabel mesh__D003298 Consumption Tests, Antiglobulin
% 223.15/223.32  |- skos__hiddenLabel mesh__D003298 Coomb Test
% 223.15/223.32  |- mesh__recordAuthorizer mesh__D003298 SJN
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D003298 2005
% 223.15/223.32  |- skos__altLabel mesh__D003298 Antiglobulin Test
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D003298 2004
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D003298 2001
% 223.15/223.32  |- skos__broader mesh__D003298smesh__D006386
% 223.15/223.32  |- skos__annotation mesh__D003298
% 223.15/223.32       for erythrocytes only: for lymphocytes consider HISTOCOMPATIBILITY TESTING or CYTOTOXICITY TESTS, IMMUNOLOGIC%A%  
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D003298 2003
% 223.15/223.32  |- rdf__type mesh__D003298sskos__Concept
% 223.15/223.32  |- skos__scopeNote mesh__D003298
% 223.15/223.32       Hemagglutination test in which Coombs%27% reagent %28%antiglobulin, or anti-human globulin rabbit immune serum%29% is added to detect incomplete %28%non-agglutinating, univalent, blocking%29% antibodies coating erythrocytes. The direct test is applied to red cells which have been coated with antibody in vivo %28%e.g., in hemolytic disease of newborn, autoimmune hemolytic anemia, and transfusion reactions%29%. The indirect test is applied to serum to detect the presence of antibody %28%e.g., in detection of incompatibility in cross-matching tests, detection and identification of irregular antibodies, and in detection of antibodies not identifiable by other means%29%.%A%    
% 223.15/223.32  |- skos__hiddenLabel mesh__D003298 Consumption Test, Antiglobulin
% 223.15/223.32  |- skos__hiddenLabel mesh__D003298 Antiglobulin Consumption Tests
% 223.15/223.32  |- skos__prefLabel mesh__D003298 Coombs%27% Test
% 223.15/223.32  |- skos__altLabel mesh__D003298 Antiglobulin Consumption Test
% 223.15/223.32  |- mesh__recordOriginator mesh__D003298 NLM
% 223.15/223.32  |- skos__altLabel mesh__D003298 Antihuman Globulin Consumption Test
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D003298 2000
% 223.15/223.32  |- skos__hiddenLabel mesh__D003298 Tests, Antiglobulin Consumption
% 223.15/223.32  |- skos__hiddenLabel mesh__D003298 Anti Human Globulin Consumption Test
% 223.15/223.32  |- mesh__recordMaintainer mesh__D003298 PXP
% 223.15/223.32  |- mesh__dateCreated mesh__D003298 1999-01-01
% 223.15/223.32  |- skos__hiddenLabel mesh__D003298 Antiglobulin Tests
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D003298 1999
% 223.15/223.32  |- skos__hiddenLabel mesh__D003298 Test, Coombs%27%
% 223.15/223.32  |- skos__hiddenLabel mesh__D003298 Coombs Test
% 223.15/223.32  |- skos__hiddenLabel mesh__D003298 Coomb%27%s Test
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D003298 1998
% 223.15/223.32  |- skos__altLabel mesh__D003298 Anti-Human Globulin Consumption Test
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D003298 2002
% 223.15/223.32  |- skos__related mesh__D044904smesh__D008361
% 223.15/223.32  |- skos__hiddenLabel mesh__D044904 Mannosidase Deficiency Syndrome
% 223.15/223.32  |- skos__altLabel mesh__D044904 Mannosidase Deficiency Syndromes
% 223.15/223.32  |- mesh__publicMeSHNote mesh__D044904 2004; see MANNOSIDOSIS 1984-2003   
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D044904 2004
% 223.15/223.32  |- skos__broader mesh__D044904smesh__D002239
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D044904 2005
% 223.15/223.32  |- skos__hiddenLabel mesh__D044904 Deficiency Syndromes, Mannosidase
% 223.15/223.32  |- skos__historyNote mesh__D044904 Mannosidosis %28%1984-2003%29%
% 223.15/223.32  |- mesh__dateCreated mesh__D044904 2003-07-09
% 223.15/223.32  |- skos__hiddenLabel mesh__D044904 Deficiency Diseases, Mannosidase
% 223.15/223.32  |- skos__scopeNote mesh__D044904
% 223.15/223.32       Diseases caused by the loss of one or more enzymes involved in the hydrolysis of mannoside linkages %28%MANNOSIDASES%29%. The defects in enzyme activity are primarily associated with genetic mutation of the genes that codes for a particular mannosidase isoenzyme.%A%    
% 223.15/223.32  |- mesh__dateEstablished mesh__D044904 2004-01-01
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D044904 2006
% 223.15/223.32  |- skos__hiddenLabel mesh__D044904 Mannosidoses
% 223.15/223.32  |- skos__altLabel mesh__D044904 Mannosidosis
% 223.15/223.32  |- skos__hiddenLabel mesh__D044904 Deficiency Disease, Mannosidase
% 223.15/223.32  |- mesh__historyNote mesh__D044904
% 223.15/223.32       2004; use MANNOSIDOSIS, ALPHA B, LYSOSOMAL 1984-2003   
% 223.15/223.32  |- rdf__type mesh__D044904sskos__Concept
% 223.15/223.32  |- skos__prefLabel mesh__D044904 Mannosidase Deficiency Diseases
% 223.15/223.32  |- skos__hiddenLabel mesh__D044904 Diseases, Mannosidase Deficiency
% 223.15/223.32  |- skos__hiddenLabel mesh__D044904 Deficiency Syndrome, Mannosidase
% 223.15/223.32  |- skos__hiddenLabel mesh__D044904 Mannosidase Deficiency Disease
% 223.15/223.32  |- skos__broader mesh__D044904smesh__D016464
% 223.15/223.32  |- rdf__type mesh__D008781sskos__Concept
% 223.15/223.32  |- mesh__recordAuthorizer mesh__D008781 sjn
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D008781 2003
% 223.15/223.32  |- mesh__publicMeSHNote mesh__D008781 68   
% 223.15/223.32  |- skos__scopeNote mesh__D008781
% 223.15/223.32       A group of compounds that are methyl derivatives of the amino acid TYROSINE.%A%    
% 223.15/223.32  |- mesh__dateRevised mesh__D008781 2001-07-25
% 223.15/223.32  |- mesh__historyNote mesh__D008781
% 223.15/223.32       68; was METHYLTYROSINE 1965-67 %28%Prov%29%   
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D008781 2002
% 223.15/223.32  |- mesh__dateCreated mesh__D008781 1999-01-01
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D008781 2006
% 223.15/223.32  |- mesh__onlineNote mesh__D008781
% 223.15/223.32       use METHYLTYROSINES to search METHYLTYROSINE 1966-67 %28%as Prov%29%%A%  
% 223.15/223.32  |- mesh__recordOriginator mesh__D008781 NLM
% 223.15/223.32  |- skos__prefLabel mesh__D008781 Methyltyrosines
% 223.15/223.32  |- mesh__recordMaintainer mesh__D008781 nns
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D008781 2005
% 223.15/223.32  |- skos__broader mesh__D008781smesh__D014443
% 223.15/223.32  |- mesh__dateEstablished mesh__D008781 1968-01-01
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D008781 2004
% 223.15/223.32  |- rdf__type mesh__D044106sskos__Concept
% 223.15/223.32  |- skos__prefLabel mesh__D044106 Wigglesworthia
% 223.15/223.32  |- mesh__dateCreated mesh__D044106 2003-07-09
% 223.15/223.32  |- skos__broader mesh__D044106smesh__D004755
% 223.15/223.32  |- mesh__recordMaintainer mesh__D044106 SYSTEM
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D044106 2006
% 223.15/223.32  |- skos__scopeNote mesh__D044106
% 223.15/223.32       A genus of gram-negative, rod-shaped bacteria in the family ENTEROBACTERIACEAE. They exist only as primary endosymbionts of five species of TSETSE FLIES, found in specialized organelles called mycetomes.  The bacteria supply crucial B vitamins %28%VITAMIN B COMPLEX%29% which the flies require for fertility.%A%    
% 223.15/223.32  |- mesh__dateRevised mesh__D044106 2005-06-30
% 223.15/223.32  |- mesh__publicMeSHNote mesh__D044106 2004   
% 223.15/223.32  |- mesh__recordOriginator mesh__D044106 ags
% 223.15/223.32  |- mesh__historyNote mesh__D044106 2004   
% 223.15/223.32  |- skos__historyNote mesh__D044106 Enterobacteriaceae %28%1995-2003%29%
% 223.15/223.32  |- mesh__recordAuthorizer mesh__D044106 sjn
% 223.15/223.32  |- mesh__dateEstablished mesh__D044106 2004-01-01
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D016415 2006
% 223.15/223.32  |- mesh__recordMaintainer mesh__D016415 TAP
% 223.15/223.32  |- skos__prefLabel mesh__D016415 Sequence Alignment
% 223.15/223.32  |- skos__annotation mesh__D016415
% 223.15/223.32       sequence refers to molec seq %28%amino acid or base%29%; note category; DF: SEQ ALIGNMENT%A%  
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D016415 2002
% 223.15/223.32  |- mesh__dateCreated mesh__D016415 1990-06-01
% 223.15/223.32  |- mesh__recordAuthorizer mesh__D016415 PLS
% 223.15/223.32  |- mesh__publicMeSHNote mesh__D016415 91   
% 223.15/223.32  |- skos__scopeNote mesh__D016415
% 223.15/223.32       The arrangement of two or more amino acid or base sequences from an organism or organisms in such a way as to align areas of the sequences sharing common properties. The degree of relatedness or homology between the sequences is predicted computationally or statistically based on weights assigned to the elements aligned between the sequences. This in turn can serve as a potential indicator of the genetic relatedness between the organisms.%A%    
% 223.15/223.32  |- mesh__dateEstablished mesh__D016415 1991-01-01
% 223.15/223.32  |- skos__hiddenLabel mesh__D016415 Sequence Homology Determinations
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D016415 1996
% 223.15/223.32  |- rdf__type mesh__D016415sskos__Concept
% 223.15/223.32  |- skos__altLabel mesh__D016415 Sequence Homology Determination
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D016415 1998
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D016415 1997
% 223.15/223.32  |- mesh__dateRevised mesh__D016415 1992-05-18
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D016415 1994
% 223.15/223.32  |- skos__hiddenLabel mesh__D016415 Alignments, Sequence
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D016415 1999
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D016415 2000
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D016415 1993
% 223.15/223.32  |- mesh__historyNote mesh__D016415 91   
% 223.15/223.32  |- mesh__recordOriginator mesh__D016415 PLS
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D016415 1995
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D016415 2003
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D016415 2001
% 223.15/223.32  |- skos__broader mesh__D016415smesh__D005821
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D016415 2005
% 223.15/223.32  |- skos__hiddenLabel mesh__D016415 Sequence Alignments
% 223.15/223.32  |- skos__hiddenLabel mesh__D016415 Determinations, Sequence Homology
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D016415 2004
% 223.15/223.32  |- skos__hiddenLabel mesh__D016415 Alignment, Sequence
% 223.15/223.32  |- skos__annotation mesh__D032082
% 223.15/223.32       as plant %26% fruit; juice: coord IM with BEVERAGES %28%IM%29%; do not confuse with Limetree = TILIA; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.15/223.32  |- mesh__publicMeSHNote mesh__D032082 2003   
% 223.15/223.32  |- skos__scopeNote mesh__D032082
% 223.15/223.32       A plant species of the genus CITRUS, family RUTACEAE that provides the familiar lime fruit.  Its common name of lime is similar to the limetree %28%TILIA%29%.%A%    
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D032082 2004
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D032082 2006
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D032082 2003
% 223.15/223.32  |- mesh__dateEstablished mesh__D032082 2003-01-01
% 223.15/223.32  |- mesh__dateCreated mesh__D032082 2002-07-03
% 223.15/223.32  |- mesh__historyNote mesh__D032082 2003   
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D032082 2005
% 223.15/223.32  |- rdf__type mesh__D032082sskos__Concept
% 223.15/223.32  |- skos__prefLabel mesh__D032082 Citrus aurantiifolia
% 223.15/223.32  |- skos__broader mesh__D032082smesh__D002957
% 223.15/223.32  |- mesh__dateRevised mesh__D004391 2004-07-13
% 223.15/223.32  |- mesh__recordMaintainer mesh__D004391 sjn
% 223.15/223.32  |- skos__annotation mesh__D004391
% 223.15/223.32       coord with specific substance yielding dust: GOLD + DUST; COAL + DUST; do not index here for specific dusts in pneumoconiosis: see note under PNEUMOCONIOSIS%A%  
% 223.15/223.32  |- mesh__dateCreated mesh__D004391 1999-01-01
% 223.15/223.32  |- skos__broader mesh__D004391smesh__D045424
% 223.15/223.32  |- skos__related mesh__D004391smesh__D039981
% 223.15/223.32  |- skos__scopeNote mesh__D004391
% 223.15/223.32       Earth or other matter in fine, dry particles. %28%Random House Unabridged Dictionary, 2d ed%29%%A%    
% 223.15/223.32  |- skos__broader mesh__D004391smesh__D000397
% 223.15/223.32  |- mesh__recordOriginator mesh__D004391 NLM
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D004391 2006
% 223.15/223.32  |- skos__prefLabel mesh__D004391 Dust
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D004391 2005
% 223.15/223.32  |- rdf__type mesh__D004391sskos__Concept
% 223.15/223.32  |- mesh__recordAuthorizer mesh__D004391 sjn
% 223.15/223.32  |- skos__hiddenLabel mesh__D004391 Dust, House
% 223.15/223.32  |- skos__related mesh__D004391smesh__D011009
% 223.15/223.32  |- skos__altLabel mesh__D004391 Housedust
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012823 1998
% 223.15/223.32  |- mesh__recordMaintainer mesh__D012823 ADP
% 223.15/223.32  |- rdf__type mesh__D012823sskos__Concept
% 223.15/223.32  |- skos__broader mesh__D012823smesh__D003738
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012823 2001
% 223.15/223.32  |- skos__prefLabel mesh__D012823 Silicate Cement
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012823 1999
% 223.15/223.32  |- mesh__historyNote mesh__D012823 65   
% 223.15/223.32  |- mesh__dateRevised mesh__D012823 1997-06-20
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012823 2002
% 223.15/223.32  |- mesh__recordAuthorizer mesh__D012823 SJN
% 223.15/223.32  |- mesh__publicMeSHNote mesh__D012823 65   
% 223.15/223.32  |- skos__scopeNote mesh__D012823
% 223.15/223.32       A relatively hard, translucent, restorative material used primarily in anterior teeth. %28%From Boucher%27%s Clinical Dental Terminology, 4th ed, p50%29%%A%    
% 223.15/223.32  |- mesh__dateEstablished mesh__D012823 1965-01-01
% 223.15/223.32  |- skos__hiddenLabel mesh__D012823 Cement, Silicate
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012823 2005
% 223.15/223.32  |- skos__annotation mesh__D012823 a dent cement; D25-26 qualif   
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012823 2003
% 223.15/223.32  |- mesh__recordOriginator mesh__D012823 NLM
% 223.15/223.32  |- mesh__dateCreated mesh__D012823 1999-01-01
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012823 2006
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012823 2000
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012823 2004
% 223.15/223.32  |- mesh__recordOriginator mesh__D012025 NLM
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012025 2006
% 223.15/223.32  |- mesh__historyNote mesh__D012025 74%28%70%29%   
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012025 2005
% 223.15/223.32  |- skos__prefLabel mesh__D012025 Reflex, Pupillary
% 223.15/223.32  |- mesh__recordAuthorizer mesh__D012025 sjn
% 223.15/223.32  |- skos__hiddenLabel mesh__D012025 Pupillary Reflex
% 223.15/223.32  |- skos__annotation mesh__D012025
% 223.15/223.32       contraction of pupil on exposure to light   
% 223.15/223.32  |- skos__historyNote mesh__D012025 Pupil %28%1966-1969%29%
% 223.15/223.32  |- skos__scopeNote mesh__D012025
% 223.15/223.32       Constriction of the pupil in response to light stimulation of the retina. It refers also to any reflex involving the iris, with resultant alteration of the diameter of the pupil. %28%Cline et al., Dictionary of Visual Science, 4th ed%29%%A%    
% 223.15/223.32  |- skos__broader mesh__D012025smesh__D012018
% 223.15/223.32  |- mesh__publicMeSHNote mesh__D012025 74   
% 223.15/223.32  |- mesh__dateEstablished mesh__D012025 1974-01-01
% 223.15/223.32  |- mesh__dateRevised mesh__D012025 2002-07-03
% 223.15/223.32  |- skos__historyNote mesh__D012025 Reflex %28%1966-1969%29%
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012025 2004
% 223.15/223.32  |- skos__related mesh__D012025smesh__D000270
% 223.15/223.32  |- mesh__dateCreated mesh__D012025 1999-01-01
% 223.15/223.32  |- rdf__type mesh__D012025sskos__Concept
% 223.15/223.32  |- mesh__recordMaintainer mesh__D012025 mdb
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012025 2003
% 223.15/223.32  |- skos__hiddenLabel mesh__D003299 Behaviors, Cooperative
% 223.15/223.32  |- skos__broader mesh__D003299smesh__D012919
% 223.15/223.32  |- skos__hiddenLabel mesh__D003299 Cooperative Behaviors
% 223.15/223.32  |- skos__hiddenLabel mesh__D003299 Behaviors, Compliant
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D003299 2005
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D003299 2004
% 223.15/223.32  |- skos__hiddenLabel mesh__D003299 Compliant Behaviors
% 223.15/223.32  |- skos__hiddenLabel mesh__D003299 Behavior, Cooperative
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D003299 2003
% 223.15/223.32  |- skos__annotation mesh__D003299 no qualif   
% 223.15/223.32  |- rdf__type mesh__D003299sskos__Concept
% 223.15/223.32  |- skos__prefLabel mesh__D003299 Cooperative Behavior
% 223.15/223.32  |- mesh__historyNote mesh__D003299 73%28%71%29%   
% 223.15/223.32  |- skos__related mesh__D003299smesh__D019058
% 223.15/223.32  |- mesh__recordMaintainer mesh__D003299 JLS
% 223.15/223.32  |- mesh__dateCreated mesh__D003299 1999-01-01
% 223.15/223.32  |- skos__hiddenLabel mesh__D003299 Collaborations
% 223.15/223.32  |- skos__historyNote mesh__D003299 Behavior %28%1966-1970%29%
% 223.15/223.32  |- mesh__publicMeSHNote mesh__D003299 73   
% 223.15/223.32  |- mesh__dateRevised mesh__D003299 2002-07-02
% 223.15/223.32  |- mesh__recordAuthorizer mesh__D003299 sjn
% 223.15/223.32  |- mesh__dateEstablished mesh__D003299 1973-01-01
% 223.15/223.32  |- skos__scopeNote mesh__D003299
% 223.15/223.32       The interaction of two or more persons or organizations directed toward a common goal which is mutually beneficial. An act or instance of working or acting together for a common purpose or benefit, i.e., joint action. %28%From Random House Dictionary Unabridged, 2d ed%29%%A%    
% 223.15/223.32  |- skos__historyNote mesh__D003299 Behavior, Animal %28%1966-1970%29%
% 223.15/223.32  |- skos__hiddenLabel mesh__D003299 Behavior, Compliant
% 223.15/223.32  |- mesh__recordOriginator mesh__D003299 NLM
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D003299 2006
% 223.15/223.32  |- skos__altLabel mesh__D044905 beta-Mannosidase Deficiency
% 223.15/223.32  |- mesh__historyNote mesh__D044905 2004   
% 223.15/223.32  |- skos__altLabel mesh__D044905 Mannosidosis, beta A, Lysosomal
% 223.15/223.32  |- skos__related mesh__D044905smesh__D044902
% 223.15/223.32  |- skos__hiddenLabel mesh__D044905 beta Mannosidosis
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D044905 2005
% 223.15/223.32  |- mesh__recordMaintainer mesh__D044905 sjn
% 223.15/223.32  |- skos__hiddenLabel mesh__D044905 Deficiency, beta-Mannosidase
% 223.15/223.32  |- mesh__dateCreated mesh__D044905 2003-07-09
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D044905 2006
% 223.15/223.32  |- skos__scopeNote mesh__D044905
% 223.15/223.32       An inborn error of metabolism marked by a defect in the lysosomal isoform of BETA-MANNOSIDASE that results in lysosomal accumulation of mannose-rich intermediate metabolites containing 1,4-beta linkages. The human disease occurs through autosomal recessive inheritance and manifests itself with variety of symptoms that depend upon the type of gene mutation.%A%    
% 223.15/223.32  |- skos__hiddenLabel mesh__D044905 beta-Mannosidase Deficiencies
% 223.15/223.32  |- rdf__type mesh__D044905sskos__Concept
% 223.15/223.32  |- mesh__publicMeSHNote mesh__D044905 2004   
% 223.15/223.32  |- mesh__recordAuthorizer mesh__D044905 sjn
% 223.15/223.32  |- skos__hiddenLabel mesh__D044905 beta Mannosidase Deficiency
% 223.15/223.32  |- skos__historyNote mesh__D044905
% 223.15/223.32       Mannosidase Deficiency Diseases %28%1984-2003%29%
% 223.15/223.32  |- mesh__dateEstablished mesh__D044905 2004-01-01
% 223.15/223.32  |- mesh__dateRevised mesh__D044905 2004-07-13
% 223.15/223.32  |- skos__broader mesh__D044905smesh__D044904
% 223.15/223.32  |- skos__prefLabel mesh__D044905 beta-Mannosidosis
% 223.15/223.32  |- mesh__recordOriginator mesh__D044905 jmp
% 223.15/223.32  |- skos__hiddenLabel mesh__D044905 beta-Mannosidoses
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D008782 2000
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D008782 1995
% 223.15/223.32  |- skos__scopeNote mesh__D008782
% 223.15/223.32       Urea compounds which are substituted with one or more methyl groups.%A%    
% 223.15/223.32  |- mesh__publicMeSHNote mesh__D008782 75   
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D008782 1994
% 223.15/223.32  |- skos__historyNote mesh__D008782 Urea %28%1966-1974%29%
% 223.15/223.32  |- mesh__historyNote mesh__D008782 75   
% 223.15/223.32  |- mesh__dateCreated mesh__D008782 1999-01-01
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D008782 1999
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D008782 1993
% 223.15/223.32  |- mesh__dateEstablished mesh__D008782 1975-09-01
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D008782 2006
% 223.15/223.32  |- mesh__recordAuthorizer mesh__D008782 PLS
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D008782 1998
% 223.15/223.32  |- mesh__recordMaintainer mesh__D008782 TAP
% 223.15/223.32  |- skos__annotation mesh__D008782 DF: METHYLUREA CPDS   
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D008782 2005
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D008782 2002
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D008782 1997
% 223.15/223.32  |- skos__prefLabel mesh__D008782 Methylurea Compounds
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D008782 2004
% 223.15/223.32  |- mesh__dateRevised mesh__D008782 1992-05-18
% 223.15/223.32  |- rdf__type mesh__D008782sskos__Concept
% 223.15/223.32  |- skos__broader mesh__D008782smesh__D014508
% 223.15/223.32  |- mesh__recordOriginator mesh__D008782 NLM
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D008782 2001
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D008782 1996
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D008782 2003
% 223.15/223.32  |- skos__hiddenLabel mesh__D008782 Compounds, Methylurea
% 223.15/223.32  |- skos__prefLabel mesh__D016416 Meeting Abstracts %5B%Publication Type%5D%
% 223.15/223.32  |- skos__related mesh__D016416smesh__D016423
% 223.15/223.32  |- skos__broader mesh__D016416smesh__D052180
% 223.15/223.32  |- mesh__dateCreated mesh__D016416 1995-06-23
% 223.15/223.32  |- skos__scopeNote mesh__D016416
% 223.15/223.32       For individual abstracts of presentations at meetings, congresses, conferences, symposia, colloquia, seminars, workshops, round tables, and other professional gatherings.%A%    
% 223.15/223.32  |- skos__altLabel mesh__D016416 Meeting Abstracts %28%PT%29%
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D016416 2006
% 223.15/223.32  |- mesh__recordAuthorizer mesh__D016416 sjn
% 223.15/223.32  |- rdf__type mesh__D016416sskos__Concept
% 223.15/223.32  |- mesh__dateRevised mesh__D016416 2005-06-30
% 223.15/223.32  |- skos__annotation mesh__D016416
% 223.15/223.32       publication type only; for abstracts of presentations at various types of meetings: not for designating abstracts accompanying journal articles; abstracts as a subject are indexed under the main heading ABSTRACTING AND INDEXING; CATALOG: do not use, use publication type CONGRESSES%A%  
% 223.15/223.32  |- skos__altLabel mesh__D016416 Meeting Abstract %28%PT%29%
% 223.15/223.32  |- mesh__recordOriginator mesh__D016416 TGC
% 223.15/223.32  |- mesh__dateEstablished mesh__D016416 1996-01-01
% 223.15/223.32  |- mesh__recordMaintainer mesh__D016416 jls
% 223.15/223.32  |- mesh__historyNote mesh__D016416
% 223.15/223.32       1999; was Abstract %28%Publication Type%29% 1991-1998   
% 223.15/223.32  |- mesh__historyNote mesh__D032083 2003   
% 223.15/223.32  |- skos__scopeNote mesh__D032083
% 223.15/223.32       A plant species of the genus CITRUS, family RUTACEAE that provides the familiar grapefruit. There is evidence that grapefruit juice inhibits CYTOCHROME P-450 isoform 3A4, resulting in delayed metabolism and higher blood levels of a variety of drugs.%A%    
% 223.15/223.32  |- mesh__publicMeSHNote mesh__D032083 2003   
% 223.15/223.32  |- mesh__dateCreated mesh__D032083 2002-07-03
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D032083 2003
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D032083 2005
% 223.15/223.32  |- skos__prefLabel mesh__D032083 Citrus paradisi
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D032083 2004
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D032083 2006
% 223.15/223.32  |- skos__altLabel mesh__D032083 Toronja
% 223.15/223.32  |- skos__annotation mesh__D032083
% 223.15/223.32       as plant %26% fruit; juice: coord IM with BEVERAGES %28%IM%29%; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.15/223.32  |- skos__broader mesh__D032083smesh__D002957
% 223.15/223.32  |- mesh__dateEstablished mesh__D032083 2003-01-01
% 223.15/223.32  |- rdf__type mesh__D032083sskos__Concept
% 223.15/223.32  |- mesh__dateRevised mesh__D004392 2005-06-30
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D004392 2006
% 223.15/223.32  |- skos__broader mesh__D004392smesh__D030342
% 223.15/223.32  |- skos__altLabel mesh__D004392 Nanism
% 223.15/223.32  |- skos__scopeNote mesh__D004392
% 223.15/223.32       A genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height.%A%    
% 223.15/223.32  |- skos__broader mesh__D004392smesh__D001848
% 223.15/223.32  |- rdf__type mesh__D004392sskos__Concept
% 223.15/223.32  |- mesh__recordOriginator mesh__D004392 NLM
% 223.15/223.32  |- mesh__recordMaintainer mesh__D004392 lkt
% 223.15/223.32  |- skos__broader mesh__D004392smesh__D004700
% 223.15/223.32  |- skos__prefLabel mesh__D004392 Dwarfism
% 223.15/223.32  |- mesh__dateCreated mesh__D004392 1999-01-01
% 223.15/223.32  |- mesh__recordAuthorizer mesh__D004392 sjn
% 223.15/223.32  |- skos__scopeNote mesh__D012824
% 223.15/223.32       Hydrated silicon dioxide that occurs in nature. It is insoluble in water or acids except hydrofluoric acid. %28%From Merck Index, 11th ed%29%%A%    
% 223.15/223.32  |- mesh__historyNote mesh__D012824
% 223.15/223.32       91%28%75%29%; was see under SILICA 1975-90   
% 223.15/223.32  |- mesh__dateRevised mesh__D012824 2001-07-25
% 223.15/223.32  |- mesh__recordOriginator mesh__D012824 NLM
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012824 2005
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012824 2003
% 223.15/223.32  |- skos__prefLabel mesh__D012824 Silicic Acid
% 223.15/223.32  |- mesh__dateCreated mesh__D012824 1999-01-01
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012824 2006
% 223.15/223.32  |- mesh__dateEstablished mesh__D012824 1991-01-01
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012824 2004
% 223.15/223.32  |- mesh__publicMeSHNote mesh__D012824 91; was see under SILICA 1975-90   
% 223.15/223.32  |- skos__broader mesh__D012824smesh__D000148
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012824 2002
% 223.15/223.32  |- rdf__type mesh__D012824sskos__Concept
% 223.15/223.32  |- mesh__onlineNote mesh__D012824 search SILICA 1966-74   
% 223.15/223.32  |- mesh__recordMaintainer mesh__D012824 ssb
% 223.15/223.32  |- mesh__recordAuthorizer mesh__D012824 sjn
% 223.15/223.32  |- skos__broader mesh__D012824smesh__D012822
% 223.15/223.32  |- skos__scopeNote mesh__D012026
% 223.15/223.32       Reflex contraction of a muscle in response to stretching, which stimulates muscle proprioceptors.%A%    
% 223.15/223.32  |- mesh__publicMeSHNote mesh__D012026 82; was REFLEX, TENDON 1965-81   
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012026 2000
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012026 2005
% 223.15/223.32  |- mesh__onlineNote mesh__D012026
% 223.15/223.32       use REFLEX, STRETCH to search REFLEX, TENDON 1966-81   
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012026 1999
% 223.15/223.32  |- mesh__historyNote mesh__D012026 82; was REFLEX, TENDON 1965-81   
% 223.15/223.32  |- mesh__recordOriginator mesh__D012026 NLM
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012026 2002
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012026 1998
% 223.15/223.32  |- mesh__recordMaintainer mesh__D012026 PXP
% 223.15/223.32  |- mesh__recordAuthorizer mesh__D012026 SJN
% 223.15/223.32  |- skos__hiddenLabel mesh__D012026 Stretch Reflex
% 223.15/223.32  |- skos__hiddenLabel mesh__D012026 Tendon Reflex
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012026 2004
% 223.15/223.32  |- mesh__dateCreated mesh__D012026 1999-01-01
% 223.15/223.32  |- mesh__dateRevised mesh__D012026 1997-06-20
% 223.15/223.32  |- rdf__type mesh__D012026sskos__Concept
% 223.15/223.32  |- skos__broader mesh__D012026smesh__D012018
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012026 2003
% 223.15/223.32  |- skos__prefLabel mesh__D012026 Reflex, Stretch
% 223.15/223.32  |- mesh__dateEstablished mesh__D012026 1965-01-01
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012026 2001
% 223.15/223.32  |- mesh__activeMeSHYear mesh__D012026 2006
% 223.15/223.32  |- mesh__dateEstablished mesh__D016417 1996-01-01
% 223.15/223.33  |- mesh__historyNote mesh__D016417 1991   
% 223.15/223.33  |- rdf__type mesh__D016417sskos__Concept
% 223.15/223.33  |- mesh__recordMaintainer mesh__D016417 ags
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D016417 2006A
% 223.15/223.33  |- mesh__dateCreated mesh__D016417 1995-06-23
% 223.15/223.33  |- skos__annotation mesh__D016417
% 223.15/223.33       publication type only; bibliography as a subject is indexed under the main heading BIBLIOGRAPHY; Manual 33.4-33.9;  CATALOG: use for lists of print or non-print materials. For annotated bibliographies use ABSTRACTS %5B%PUBLICATION TYPE%5D%%A%  
% 223.15/223.33  |- skos__related mesh__D016417smesh__D020507
% 223.15/223.33  |- skos__related mesh__D016417smesh__D020481
% 223.15/223.33  |- skos__related mesh__D016417smesh__D020467
% 223.15/223.33  |- skos__broader mesh__D016417smesh__D052181
% 223.15/223.33  |- mesh__dateRevised mesh__D016417 2005-07-07
% 223.15/223.33  |- mesh__recordOriginator mesh__D016417 TGC
% 223.15/223.33  |- skos__scopeNote mesh__D016417
% 223.15/223.33       A work consisting of a list of books, articles, documents, publications, and other items, usually on a single subject or related subjects.%A%    
% 223.15/223.33  |- mesh__recordAuthorizer mesh__D016417 ags
% 223.15/223.33  |- skos__related mesh__D016417smesh__D020504
% 223.15/223.33  |- skos__broader mesh__D016417smesh__D052180
% 223.15/223.33  |- skos__altLabel mesh__D016417 Bibliography %28%PT%29%
% 223.15/223.33  |- skos__prefLabel mesh__D016417 Bibliography %5B%Publication Type%5D%
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D016417 2006
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D032882 2004
% 223.15/223.33  |- skos__historyNote mesh__D032882 Cognition %28%1993-2002%29%
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D032882 2005
% 223.15/223.33  |- skos__broader mesh__D032882smesh__D003071
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D032882 2003
% 223.15/223.33  |- mesh__historyNote mesh__D032882 2003; use COGNITION 1993-2002   
% 223.15/223.33  |- skos__prefLabel mesh__D032882 Comprehension
% 223.15/223.33  |- rdf__type mesh__D032882sskos__Concept
% 223.15/223.33  |- skos__altLabel mesh__D032882 Understanding
% 223.15/223.33  |- mesh__dateCreated mesh__D032882 2002-07-03
% 223.15/223.33  |- skos__historyNote mesh__D032882 Mental Processes %28%1978-1992%29%
% 223.15/223.33  |- skos__scopeNote mesh__D032882
% 223.15/223.33       The act or fact of grasping the meaning, nature, or importance of; understanding. %28%American Heritage Dictionary, 4th ed%29% Includes understanding by a patient or research subject of information disclosed orally or in writing.%A%    
% 223.15/223.33  |- mesh__publicMeSHNote mesh__D032882 2003; see COGNITION 1993-2002   
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D032882 2006
% 223.15/223.33  |- skos__related mesh__D032882smesh__D016743
% 223.15/223.33  |- skos__related mesh__D032882smesh__D011939
% 223.15/223.33  |- mesh__dateEstablished mesh__D032882 2003-01-01
% 223.15/223.33  |- mesh__publicMeSHNote mesh__D032084 2003   
% 223.15/223.33  |- skos__broader mesh__D032084smesh__D002957
% 223.15/223.33  |- skos__scopeNote mesh__D032084
% 223.15/223.33       A plant species of the genus CITRUS, family RUTACEAE that provides the familiar orange fruit which is also a source of orange oil.%A%    
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D032084 2003
% 223.15/223.33  |- mesh__dateEstablished mesh__D032084 2003-01-01
% 223.15/223.33  |- skos__prefLabel mesh__D032084 Citrus sinensis
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D032084 2005
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D032084 2004
% 223.15/223.33  |- mesh__historyNote mesh__D032084 2003   
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D032084 2006
% 223.15/223.33  |- skos__altLabel mesh__D032084 Orange Tree
% 223.15/223.33  |- mesh__dateCreated mesh__D032084 2002-07-03
% 223.15/223.33  |- rdf__type mesh__D032084sskos__Concept
% 223.15/223.33  |- skos__annotation mesh__D032084
% 223.15/223.33       not the color; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.15/223.33  |- skos__altLabel mesh__D004393 Growth Hormone Deficiency Dwarfism
% 223.15/223.33  |- mesh__recordOriginator mesh__D004393 NLM
% 223.15/223.33  |- skos__broader mesh__D004393smesh__D004392
% 223.15/223.33  |- skos__altLabel mesh__D004393 Dwarfism, Growth Hormone Deficiency
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D004393 2006
% 223.15/223.33  |- skos__altLabel mesh__D004393 Pituitary Dwarf
% 223.15/223.33  |- mesh__recordMaintainer mesh__D004393 lkt
% 223.15/223.33  |- mesh__recordAuthorizer mesh__D004393 sjn
% 223.15/223.33  |- skos__altLabel mesh__D004393 Nanism, Pituitary
% 223.15/223.33  |- skos__broader mesh__D004393smesh__D001849
% 223.15/223.33  |- skos__hiddenLabel mesh__D004393 Pituitary Dwarfism
% 223.15/223.33  |- skos__broader mesh__D004393smesh__D007018
% 223.15/223.33  |- mesh__dateCreated mesh__D004393 1999-01-01
% 223.15/223.33  |- rdf__type mesh__D004393sskos__Concept
% 223.15/223.33  |- skos__altLabel mesh__D004393 Hyposomatotrophic Dwarfism
% 223.15/223.33  |- skos__prefLabel mesh__D004393 Dwarfism, Pituitary
% 223.15/223.33  |- mesh__dateRevised mesh__D004393 2005-06-30
% 223.15/223.33  |- skos__scopeNote mesh__D004393
% 223.15/223.33       A form of dwarfism caused by complete or partial GROWTH HORMONE deficiency, resulting from either the lack of GROWTH HORMONE-RELEASING FACTOR from the HYPOTHALAMUS or from the mutations in the growth hormone gene %28%GH1%29% in the PITUITARY GLAND. It is also known as Type I pituitary dwarfism. Human hypophysial dwarf is caused by a deficiency of HUMAN GROWTH HORMONE during development.%A%    
% 223.15/223.33  |- skos__hiddenLabel mesh__D004393 Pituitary Nanism
% 223.15/223.33  |- mesh__recordAuthorizer mesh__D012825 sjn
% 223.15/223.33  |- skos__related mesh__D012825smesh__D017646
% 223.15/223.33  |- skos__broader mesh__D012825smesh__D004602
% 223.15/223.33  |- mesh__dateCreated mesh__D012825 1999-01-01
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012825 2006
% 223.15/223.33  |- skos__annotation mesh__D012825
% 223.15/223.33       Si-28; do not confuse with SILICA or SILICONES; Si-29, 30 = SILICON %28%IM%29% + ISOTOPES %28%NIM%29%; Si-26, 27, 31, 32 = SILICON %28%IM%29% + RADIOISOTOPES %28%IM%29%; lung disease from various silicon dusts = SILICOSIS%A%  
% 223.15/223.33  |- mesh__recordOriginator mesh__D012825 NLM
% 223.15/223.33  |- skos__scopeNote mesh__D012825
% 223.15/223.33       A trace element that constitutes about 27.6%25% of the earth%27%s crust in the form of SILICON DIOXIDE. It does not occur free in nature. Silicon has the atomic symbol Si, atomic number 14, and atomic weight 28.09.%A%    
% 223.15/223.33  |- skos__prefLabel mesh__D012825 Silicon
% 223.15/223.33  |- mesh__dateRevised mesh__D012825 2005-06-30
% 223.15/223.33  |- rdf__type mesh__D012825sskos__Concept
% 223.15/223.33  |- mesh__recordMaintainer mesh__D012825 ssb
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012027 2000
% 223.15/223.33  |- skos__historyNote mesh__D012027 Vestibular Apparatus %28%1966-1986%29%
% 223.15/223.33  |- skos__altLabel mesh__D012027 Reflexes, Vestibuloocular
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012027 2005
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012027 1994
% 223.15/223.33  |- skos__historyNote mesh__D012027 Reflex %28%1966-1986%29%
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012027 2001
% 223.15/223.33  |- skos__hiddenLabel mesh__D012027 Vestibo-Ocular Reflexes
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012027 1998
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012027 2006
% 223.15/223.33  |- skos__hiddenLabel mesh__D012027 Reflexes, Vestibo Ocular
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012027 1995
% 223.15/223.33  |- skos__altLabel mesh__D012027 Vestibulo-Ocular Reflex
% 223.15/223.33  |- mesh__publicMeSHNote mesh__D012027 87   
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012027 1993
% 223.15/223.33  |- rdf__type mesh__D012027sskos__Concept
% 223.15/223.33  |- skos__altLabel mesh__D012027 Reflexes, Vestibo-Ocular
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012027 2003
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012027 1999
% 223.15/223.33  |- skos__hiddenLabel mesh__D012027 Vestibulo Ocular Reflex
% 223.15/223.33  |- mesh__recordMaintainer mesh__D012027 TAP
% 223.15/223.33  |- skos__hiddenLabel mesh__D012027 Reflex, Vestibulo Ocular
% 223.15/223.33  |- skos__historyNote mesh__D012027 Eye Movements %28%1966-1986%29%
% 223.15/223.33  |- skos__broader mesh__D012027smesh__D012018
% 223.15/223.33  |- skos__hiddenLabel mesh__D012027 Vestibuloocular Reflex
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012027 2002
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012027 1996
% 223.15/223.33  |- skos__altLabel mesh__D012027 Reflex, Vestibuloocular
% 223.15/223.33  |- mesh__dateCreated mesh__D012027 1986-03-28
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012027 2004
% 223.15/223.33  |- skos__hiddenLabel mesh__D012027 Vestibuloocular Reflexes
% 223.15/223.33  |- mesh__dateRevised mesh__D012027 1992-05-18
% 223.15/223.33  |- mesh__recordOriginator mesh__D012027 RC
% 223.15/223.33  |- mesh__recordAuthorizer mesh__D012027 PLS
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012027 1997
% 223.15/223.33  |- mesh__historyNote mesh__D012027 87   
% 223.15/223.33  |- skos__prefLabel mesh__D012027 Reflex, Vestibulo-Ocular
% 223.15/223.33  |- mesh__dateEstablished mesh__D012027 1987-01-01
% 223.15/223.33  |- skos__historyNote mesh__D012027 Nystagmus, Physiologic %28%1983-1986%29%
% 223.15/223.33  |- skos__scopeNote mesh__D012027
% 223.15/223.33       A reflex wherein impulses are conveyed from the cupulas of the SEMICIRCULAR CANALS and from the OTOLITHIC MEMBRANE of the SACCULE AND UTRICLE via the VESTIBULAR NUCLEI of the BRAIN STEM and the median longitudinal fasciculus to the OCULOMOTOR NERVE nuclei. It functions to maintain a stable retinal image during head rotation by generating appropriate compensatory EYE MOVEMENTS.%A%    
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017510 2002
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017510 1998
% 223.15/223.33  |- mesh__recordMaintainer mesh__D017510 ags
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017510 2001
% 223.15/223.33  |- skos__scopeNote mesh__D017510
% 223.15/223.33       A rapid biochemical reaction involved in the formation of proteins. It begins even before a protein has been completely synthesized and proceeds through discrete intermediates %28%primary, secondary, and tertiary structures%29% before the final structure %28%quaternary structure%29% is developed.%A%    
% 223.15/223.33  |- skos__hiddenLabel mesh__D017510 Protein Foldings
% 223.15/223.33  |- skos__hiddenLabel mesh__D017510 Globular Protein Foldings
% 223.15/223.33  |- skos__hiddenLabel mesh__D017510 Folding, Protein
% 223.15/223.33  |- mesh__dateRevised mesh__D017510 2005-07-28
% 223.15/223.33  |- skos__related mesh__D017510smesh__D011487
% 223.15/223.33  |- mesh__dateCreated mesh__D017510 1992-05-22
% 223.15/223.33  |- skos__hiddenLabel mesh__D017510 Protein Foldings, Globular
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017510 2006A
% 223.15/223.33  |- mesh__recordOriginator mesh__D017510 PXP
% 223.15/223.33  |- mesh__historyNote mesh__D017510 93   
% 223.15/223.33  |- skos__hiddenLabel mesh__D017510 Globular Protein Folding
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017510 2000
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017510 2004
% 223.15/223.33  |- mesh__recordAuthorizer mesh__D017510 ags
% 223.15/223.33  |- rdf__type mesh__D017510sskos__Concept
% 223.15/223.33  |- mesh__publicMeSHNote mesh__D017510 93   
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017510 2006
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017510 2003
% 223.15/223.33  |- skos__hiddenLabel mesh__D017510 Foldings, Protein
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017510 2005
% 223.15/223.33  |- skos__hiddenLabel mesh__D017510 Folding, Globular Protein
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017510 1999
% 223.15/223.33  |- mesh__dateEstablished mesh__D017510 1993-01-01
% 223.15/223.33  |- skos__broader mesh__D017510smesh__D001669
% 223.15/223.33  |- skos__prefLabel mesh__D017510 Protein Folding
% 223.15/223.33  |- skos__hiddenLabel mesh__D017510 Foldings, Globular Protein
% 223.15/223.33  |- skos__historyNote mesh__D017510 Protein Conformation %28%1971-1992%29%
% 223.15/223.33  |- skos__broader mesh__D008784smesh__D004873
% 223.15/223.33  |- rdf__type mesh__D008784sskos__Concept
% 223.15/223.33  |- mesh__dateRevised mesh__D008784 2005-06-30
% 223.15/223.33  |- skos__hiddenLabel mesh__D008784 Maleate, Methysergide
% 223.15/223.33  |- skos__hiddenLabel mesh__D008784 D%C3%%A9%sernil Sandoz
% 223.15/223.33  |- mesh__dateEstablished mesh__D008784 1965-01-01
% 223.15/223.33  |- mesh__publicMeSHNote mesh__D008784
% 223.15/223.33       65; METHYSERGIDE DERIVATIVES was see under METHYSERGIDE 1975-77; was see under ERGOLINES 1969-74%A%  
% 223.15/223.33  |- skos__altLabel mesh__D008784 Desril
% 223.15/223.33  |- skos__hiddenLabel mesh__D008784 UML491
% 223.15/223.33  |- mesh__recordOriginator mesh__D008784 NLM
% 223.15/223.33  |- skos__altLabel mesh__D008784 Dimethylergometrin
% 223.15/223.33  |- skos__altLabel mesh__D008784 Alliance Brand of Methysergide Maleate
% 223.15/223.33  |- skos__hiddenLabel mesh__D008784 UML 491
% 223.15/223.33  |- mesh__historyNote mesh__D008784
% 223.15/223.33       65%28%63%29%; METHYSERGIDE DERIVATIVES was see under METHYSERGIDE 1975-77; was see under ERGOLINES 1969-74%A%  
% 223.15/223.33  |- skos__altLabel mesh__D008784 Deseril
% 223.15/223.33  |- mesh__dateCreated mesh__D008784 1999-01-01
% 223.15/223.33  |- skos__prefLabel mesh__D008784 Methysergide
% 223.15/223.33  |- skos__altLabel mesh__D008784 Methylmethylergonovine
% 223.15/223.33  |- mesh__onlineNote mesh__D008784
% 223.15/223.33       use METHYSERGIDE/analogs %26% derivatives to search METHYSERGIDE DERIVATIVES 1975-77; use ERGOLINES 1969-74%A%  
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D008784 2006
% 223.15/223.33  |- mesh__recordMaintainer mesh__D008784 CCR
% 223.15/223.33  |- skos__altLabel mesh__D008784 Novartis Brand of Methysergide Maleate
% 223.15/223.33  |- skos__hiddenLabel mesh__D008784 Dimaleate, Methysergide
% 223.15/223.33  |- mesh__recordAuthorizer mesh__D008784 sjn
% 223.15/223.33  |- skos__altLabel mesh__D008784 D%C3%%A9%sernil-Sandoz
% 223.15/223.33  |- skos__scopeNote mesh__D008784
% 223.15/223.33       An ergot derivative that is a congener of LYSERGIC ACID DIETHYLAMIDE.  It antagonizes the effects of serotonin in blood vessels and gastrointestinal smooth muscle, but has few of the properties of other ergot alkaloids. Methysergide is used prophylactically in migraine and other vascular headaches and to antagonize serotonin in the carcinoid syndrome.%A%    
% 223.15/223.33  |- skos__broader mesh__D012469Q000530smesh__D012469
% 223.15/223.33  |- mesh__preferredCombination mesh__D012469Q000530smesh__D012796
% 223.15/223.33  |- rdf__type mesh__D012469Q000530smesh__CompoundConcept
% 223.15/223.33  |- skos__scopeNote mesh__D016418
% 223.15/223.33       Works consisting of collections of law reports or the published reports of decided cases and documents or filings related to those cases.%A%    
% 223.15/223.33  |- skos__related mesh__D016418smesh__D020485
% 223.15/223.33  |- skos__prefLabel mesh__D016418 Legal Cases %5B%Publication Type%5D%
% 223.15/223.33  |- skos__broader mesh__D016418smesh__D052180
% 223.15/223.33  |- mesh__historyNote mesh__D016418
% 223.15/223.33       1999; was Legal Brief %28%Publication Type%29% 1991-1998   
% 223.15/223.33  |- mesh__recordMaintainer mesh__D016418 jls
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D016418 2006
% 223.15/223.33  |- rdf__type mesh__D016418sskos__Concept
% 223.15/223.33  |- mesh__recordOriginator mesh__D016418 TGC
% 223.15/223.33  |- skos__annotation mesh__D016418
% 223.15/223.33       publication type only; legal cases, not clinical cases %28% = CASE REPORTS %5B%Publication Type%5D%%29%%A%  
% 223.15/223.33  |- skos__altLabel mesh__D016418 Legal Cases %28%PT%29%
% 223.15/223.33  |- mesh__dateCreated mesh__D016418 1995-06-23
% 223.15/223.33  |- skos__altLabel mesh__D016418 Legal Brief %28%Publication Type%29%
% 223.15/223.33  |- mesh__recordAuthorizer mesh__D016418 sjn
% 223.15/223.33  |- mesh__dateRevised mesh__D016418 2005-06-30
% 223.15/223.33  |- mesh__dateEstablished mesh__D016418 1996-01-01
% 223.15/223.33  |- skos__altLabel mesh__D013120
% 223.15/223.33       Spinal Cord Neoplasms, Intradural-Extramedullary
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D013120 2001
% 223.15/223.33  |- rdf__type mesh__D013120sskos__Concept
% 223.15/223.33  |- skos__hiddenLabel mesh__D013120 Neoplasm, Spinal Cord
% 223.15/223.33  |- skos__hiddenLabel mesh__D013120 Spinal Cord Tumors
% 223.15/223.33  |- mesh__recordOriginator mesh__D013120 NLM
% 223.15/223.33  |- skos__broader mesh__D013120smesh__D013118
% 223.15/223.33  |- skos__annotation mesh__D013120
% 223.15/223.33       coord IM with histol type of neopl %28%IM%29%; coord IM with specific vertebrae %28%NIM%29% to locate site on spinal cord%A%  
% 223.15/223.33  |- mesh__dateCreated mesh__D013120 1999-01-01
% 223.15/223.33  |- skos__hiddenLabel mesh__D013120
% 223.15/223.33       Intradural Extramedullary Spinal Cord Neoplasms
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D013120 2004
% 223.15/223.33  |- skos__prefLabel mesh__D013120 Spinal Cord Neoplasms
% 223.15/223.33  |- skos__altLabel mesh__D013120
% 223.15/223.33       Primary Spinal Cord Neoplasms, Intramedullary
% 223.15/223.33  |- skos__altLabel mesh__D013120 Neoplasms, Spinal Cord
% 223.15/223.33  |- skos__altLabel mesh__D013120
% 223.15/223.33       Spinal Cord Neoplasms, Primary Intramedullary
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D013120 2000
% 223.15/223.33  |- skos__altLabel mesh__D013120
% 223.15/223.33       Primary Intramedullary Spinal Cord Neoplasms
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D013120 2006
% 223.15/223.33  |- skos__broader mesh__D013120smesh__D016543
% 223.15/223.33  |- skos__hiddenLabel mesh__D013120
% 223.15/223.33       Spinal Cord Neoplasms, Intradural Extramedullary
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D013120 2003
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D013120 2005
% 223.15/223.33  |- skos__altLabel mesh__D013120 Spinal Cord Neoplasms, Intramedullary
% 223.15/223.33  |- mesh__recordMaintainer mesh__D013120 KEV
% 223.15/223.33  |- skos__hiddenLabel mesh__D013120 Tumor, Spinal Cord
% 223.15/223.33  |- skos__hiddenLabel mesh__D013120 Spinal Cord Tumor
% 223.15/223.33  |- mesh__dateRevised mesh__D013120 1999-11-03
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D013120 2002
% 223.15/223.33  |- mesh__recordAuthorizer mesh__D013120 sjn
% 223.15/223.33  |- skos__hiddenLabel mesh__D013120 Spinal Cord Neoplasm
% 223.15/223.33  |- skos__altLabel mesh__D013120 Tumors, Spinal Cord
% 223.15/223.33  |- skos__scopeNote mesh__D013120
% 223.15/223.33       Benign and malignant neoplasms which occur within the substance of the spinal cord %28%intramedullary neoplasms%29% or in the space between the dura and spinal cord %28%intradural extramedullary neoplasms%29%. The majority of intramedullary spinal tumors are primary CNS neoplasms including ASTROCYTOMA; EPENDYMOMA; and LIPOMA. Intramedullary neoplasms are often associated with SYRINGOMYELIA. The most frequent histologic types of intradural-extramedullary tumors are MENINGIOMA and NEUROFIBROMA.%A%    
% 223.15/223.33  |- skos__related mesh__D032085smesh__D001482
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D032085 2006
% 223.15/223.33  |- mesh__recordMaintainer mesh__D032085 nns
% 223.15/223.33  |- skos__broader mesh__D032085smesh__D004247
% 223.15/223.33  |- skos__prefLabel mesh__D032085 Isochores
% 223.15/223.33  |- skos__hiddenLabel mesh__D032085 Isochore
% 223.15/223.33  |- mesh__dateEstablished mesh__D032085 2003-01-01
% 223.15/223.33  |- rdf__type mesh__D032085sskos__Concept
% 223.15/223.33  |- mesh__recordOriginator mesh__D032085 nns
% 223.15/223.33  |- skos__related mesh__D032085smesh__D020862
% 223.15/223.33  |- mesh__recordAuthorizer mesh__D032085 sjn
% 223.15/223.33  |- mesh__publicMeSHNote mesh__D032085 2003   
% 223.15/223.33  |- mesh__dateRevised mesh__D032085 2005-06-30
% 223.15/223.33  |- mesh__historyNote mesh__D032085 2003   
% 223.15/223.33  |- skos__scopeNote mesh__D032085
% 223.15/223.33       Large regions of the GENOME that contain local similarities in BASE COMPOSITION.%A%    
% 223.15/223.33  |- skos__historyNote mesh__D032085 Base Composition %28%1990-2002%29%
% 223.15/223.33  |- mesh__dateCreated mesh__D032085 2002-07-03
% 223.15/223.33  |- skos__broader mesh__D032085smesh__D040481
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D004394 2006
% 223.15/223.33  |- mesh__recordMaintainer mesh__D004394 exl
% 223.15/223.33  |- skos__hiddenLabel mesh__D004394 6 Dehydro 9 beta 10 alpha progesterone
% 223.15/223.33  |- mesh__publicMeSHNote mesh__D004394 65   
% 223.15/223.33  |- mesh__recordOriginator mesh__D004394 NLM
% 223.15/223.33  |- skos__prefLabel mesh__D004394 Dydrogesterone
% 223.15/223.33  |- rdf__type mesh__D004394sskos__Concept
% 223.15/223.33  |- mesh__dateCreated mesh__D004394 1999-01-01
% 223.15/223.33  |- skos__scopeNote mesh__D004394
% 223.15/223.33       A synthetic progestational hormone with no androgenic or estrogenic properties. Unlike many other progestational compounds, dydrogesterone produces no increase in temperature and does not inhibit ovulation.%A%    
% 223.15/223.33  |- skos__altLabel mesh__D004394 6-Dehydro-9 beta-10 alpha-progesterone
% 223.15/223.33  |- mesh__historyNote mesh__D004394 65%28%63%29%   
% 223.15/223.33  |- mesh__recordAuthorizer mesh__D004394 sjn
% 223.15/223.33  |- skos__altLabel mesh__D004394 Isopregnenone
% 223.15/223.33  |- skos__broader mesh__D004394smesh__D011245
% 223.15/223.33  |- mesh__dateEstablished mesh__D004394 1965-01-01
% 223.15/223.33  |- skos__altLabel mesh__D004394 Solvay Brand of Dydrogesterone
% 223.15/223.33  |- mesh__dateRevised mesh__D004394 2005-06-30
% 223.15/223.33  |- skos__altLabel mesh__D004394 Dehydrogesterone
% 223.15/223.33  |- skos__annotation mesh__D012826
% 223.15/223.33       silicones in breast implants probably goes under SILICONE GELS or here if specified as elastomers; for prosthetic implants do not use /ther use; ELASTOMERS is available%A%  
% 223.15/223.33  |- skos__altLabel mesh__D012826 Elastomers, Silicone
% 223.15/223.33  |- skos__altLabel mesh__D012826 Rubber Silicone
% 223.15/223.33  |- mesh__historyNote mesh__D012826
% 223.15/223.33       72; SILASTICS was see SILICONE ELASTOMERS 1975-93; SILASTIC was %28%NM%29% 1988-93%A%  
% 223.15/223.33  |- skos__hiddenLabel mesh__D012826 Elastosils
% 223.15/223.33  |- mesh__dateCreated mesh__D012826 1999-01-01
% 223.15/223.33  |- skos__broader mesh__D012826smesh__D012828
% 223.15/223.33  |- mesh__publicMeSHNote mesh__D012826
% 223.15/223.33       72; SILASTICS was see SILICONE ELASTOMERS 1975-93; SILASTIC was indexed under SILICONES 1988-93%A%  
% 223.15/223.33  |- skos__hiddenLabel mesh__D012826 Microfils
% 223.15/223.33  |- skos__hiddenLabel mesh__D012826 Silicone Elastomer
% 223.15/223.33  |- mesh__recordAuthorizer mesh__D012826 sjn
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012826 2006
% 223.15/223.33  |- skos__broader mesh__D012826smesh__D020724
% 223.15/223.33  |- rdf__type mesh__D012826sskos__Concept
% 223.15/223.33  |- skos__scopeNote mesh__D012826
% 223.15/223.33       Polymers of silicone that are formed by crosslinking and treatment with amorphous silica to increase strength. They have properties similar to vulcanized natural rubber, in that they stretch under tension, retract rapidly, and fully recover to their original dimensions upon release. They are used in the encapsulation of surgical membranes and implants.%A%    
% 223.15/223.33  |- skos__prefLabel mesh__D012826 Silicone Elastomers
% 223.15/223.33  |- skos__hiddenLabel mesh__D012826 SE30
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012826 2005
% 223.15/223.33  |- skos__hiddenLabel mesh__D012826 SE 30
% 223.15/223.33  |- mesh__onlineNote mesh__D012826
% 223.15/223.33       use SILICONE ELASTOMERS to search SILASTICS 1975-93; use SILICONE ELASTOMERS %28%NM%29% to search SILASTIC 1988-93%A%  
% 223.15/223.33  |- mesh__dateEstablished mesh__D012826 1972-01-01
% 223.15/223.33  |- mesh__recordOriginator mesh__D012826 NLM
% 223.15/223.33  |- skos__related mesh__D012826smesh__D018427
% 223.15/223.33  |- skos__altLabel mesh__D012826 Silicone Rubber
% 223.15/223.33  |- mesh__dateRevised mesh__D012826 2004-07-07
% 223.15/223.33  |- mesh__recordMaintainer mesh__D012826 jmp
% 223.15/223.33  |- mesh__publicMeSHNote mesh__D045202 2004   
% 223.15/223.33  |- skos__broader mesh__D045202smesh__D017861
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D045202 2006
% 223.15/223.33  |- rdf__type mesh__D045202sskos__Concept
% 223.15/223.33  |- mesh__dateEstablished mesh__D045202 2004-01-01
% 223.15/223.33  |- mesh__dateRevised mesh__D045202 2005-06-30
% 223.15/223.33  |- skos__scopeNote mesh__D045202
% 223.15/223.33       A species of gram-negative bacteria in the genus PORPHYROMONAS, family Porphyromonadaceae. It is a key pathogen in endodontic infections.%A%    
% 223.15/223.33  |- mesh__historyNote mesh__D045202 2004   
% 223.15/223.33  |- skos__historyNote mesh__D045202 Porphyromonas %28%1993-2003%29%
% 223.15/223.33  |- skos__annotation mesh__D045202
% 223.15/223.33       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 223.15/223.33  |- mesh__recordMaintainer mesh__D045202 SYSTEM
% 223.15/223.33  |- mesh__recordOriginator mesh__D045202 ags
% 223.15/223.33  |- skos__prefLabel mesh__D045202 Porphyromonas endodontalis
% 223.15/223.33  |- mesh__dateCreated mesh__D045202 2003-07-09
% 223.15/223.33  |- mesh__recordAuthorizer mesh__D045202 sjn
% 223.15/223.33  |- mesh__dateCreated mesh__D012028 1999-01-01
% 223.15/223.33  |- rdf__type mesh__D012028sskos__Concept
% 223.15/223.33  |- skos__altLabel mesh__D012028 Therapy, Reflex
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012028 2004
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012028 2003
% 223.15/223.33  |- mesh__recordMaintainer mesh__D012028 ssb
% 223.15/223.33  |- skos__altLabel mesh__D012028 Reflex Therapy
% 223.15/223.33  |- mesh__recordOriginator mesh__D012028 NLM
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012028 2006
% 223.15/223.33  |- skos__scopeNote mesh__D012028
% 223.15/223.33       Treatment of some morbid condition by producing a reflex action, as in the household treatment of nosebleed by a piece of ice applied to the cervical spine. %28%Stedman, 27th ed%29%%A%    
% 223.15/223.33  |- skos__broader mesh__D012028smesh__D000529
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012028 2002
% 223.15/223.33  |- skos__annotation mesh__D012028
% 223.15/223.33       do not confuse with REFLEXOLOGY see MASSAGE; do not use /util except by MeSH definition; DF: REFLEXOTHER%A%  
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D012028 2005
% 223.15/223.33  |- mesh__recordAuthorizer mesh__D012028 sjn
% 223.15/223.33  |- skos__prefLabel mesh__D012028 Reflexotherapy
% 223.15/223.33  |- mesh__dateRevised mesh__D012028 2001-07-25
% 223.15/223.33  |- mesh__recordOriginator mesh__D017511 PLS
% 223.15/223.33  |- skos__scopeNote mesh__D017511
% 223.15/223.33       An idiopathic, rapidly evolving, and severely debilitating disease occurring most commonly in association with chronic ulcerative colitis. It is characterized by the presence of boggy, purplish ulcers with undermined borders, appearing mostly on the legs. The majority of cases are in people between 40 and 60 years old. Its etiology is unknown.%A%    
% 223.15/223.33  |- mesh__dateEstablished mesh__D017511 1993-01-01
% 223.15/223.33  |- mesh__historyNote mesh__D017511 93   
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017511 2002
% 223.15/223.33  |- skos__broader mesh__D017511smesh__D017445
% 223.15/223.33  |- skos__broader mesh__D017511smesh__D012883
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017511 2004
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017511 2001
% 223.15/223.33  |- rdf__type mesh__D017511sskos__Concept
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017511 2006
% 223.15/223.33  |- mesh__dateCreated mesh__D017511 1992-05-22
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017511 2003
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017511 1997
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017511 2005
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017511 2000
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017511 1999
% 223.15/223.33  |- skos__annotation mesh__D017511
% 223.15/223.33       severe type of skin ulcer appearing mostly on the legs   
% 223.15/223.33  |- mesh__dateRevised mesh__D017511 1993-06-02
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017511 1996
% 223.15/223.33  |- skos__broader mesh__D017511smesh__D011711
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017511 1995
% 223.15/223.33  |- skos__historyNote mesh__D017511 Pyoderma %28%1966-1992%29%
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017511 1998
% 223.15/223.33  |- skos__prefLabel mesh__D017511 Pyoderma Gangrenosum
% 223.15/223.33  |- mesh__recordAuthorizer mesh__D017511 PLS
% 223.15/223.33  |- mesh__publicMeSHNote mesh__D017511 93   
% 223.15/223.33  |- mesh__recordMaintainer mesh__D017511 TGC
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D017511 1994
% 223.15/223.33  |- mesh__dateCreated mesh__D008785 1974-11-19
% 223.15/223.33  |- skos__historyNote mesh__D008785 Imidazoles %28%1974%29%
% 223.15/223.33  |- skos__hiddenLabel mesh__D008785 Monohydrochloride, Metiamide
% 223.15/223.33  |- skos__historyNote mesh__D008785 Thiourea %28%1974%29%
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D008785 2004
% 223.15/223.33  |- skos__hiddenLabel mesh__D008785 SK%26%F 92058
% 223.15/223.33  |- rdf__type mesh__D008785sskos__Concept
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D008785 2002
% 223.15/223.33  |- skos__hiddenLabel mesh__D008785 SKF 92058
% 223.15/223.33  |- skos__altLabel mesh__D008785 SKF-92058
% 223.15/223.33  |- mesh__recordAuthorizer mesh__D008785 sjn
% 223.15/223.33  |- skos__hiddenLabel mesh__D008785 SK%26%F92058
% 223.15/223.33  |- skos__historyNote mesh__D008785 Sulfides %28%1974%29%
% 223.15/223.33  |- mesh__recordMaintainer mesh__D008785 CCR
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D008785 2005
% 223.15/223.33  |- skos__broader mesh__D008785smesh__D013890
% 223.15/223.33  |- skos__prefLabel mesh__D008785 Metiamide
% 223.15/223.33  |- mesh__dateRevised mesh__D008785 2000-06-22
% 223.15/223.33  |- mesh__dateEstablished mesh__D008785 1991-01-01
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D008785 2006
% 223.15/223.33  |- mesh__publicMeSHNote mesh__D008785 91; was see under THIOUREA 1975-90   
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D008785 2001
% 223.15/223.33  |- mesh__historyNote mesh__D008785
% 223.15/223.33       91%28%75%29%; was see under THIOUREA 1975-90   
% 223.15/223.33  |- skos__hiddenLabel mesh__D008785 SKF92058
% 223.15/223.33  |- mesh__recordOriginator mesh__D008785 NLM
% 223.15/223.33  |- skos__scopeNote mesh__D008785
% 223.15/223.33       A histamine H2 receptor antagonist that is used as an anti-ulcer agent.%A%    
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D008785 2003
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D016419 2006
% 223.15/223.33  |- mesh__recordAuthorizer mesh__D016419 sjn
% 223.15/223.33  |- rdf__type mesh__D016419sskos__Concept
% 223.15/223.33  |- skos__prefLabel mesh__D016419 Classical Article %5B%Publication Type%5D%
% 223.15/223.33  |- mesh__dateRevised mesh__D016419 2005-06-30
% 223.15/223.33  |- skos__scopeNote mesh__D016419
% 223.15/223.33       Works consisting of a current presentation of a previously printed seminal article marking a milestone in the history of medicine or science. It is usually accompanied by introductory remarks heralding its reprinting, often on the anniversary of its original publication or on an anniversary of the author%27%s birth or death. It is usually reprinted in full, with complete bibliographical reference to the original appearance.%A%    
% 223.15/223.33  |- mesh__dateEstablished mesh__D016419 1996-01-01
% 223.15/223.33  |- skos__broader mesh__D016419smesh__D016456
% 223.15/223.33  |- skos__annotation mesh__D016419
% 223.15/223.33       publication type only; add also HISTORICAL ARTICLE %5B%Publication Type%5D%; Manual 32.9+, 32.16.15;  CATALOG: do not use%A%  
% 223.15/223.33  |- mesh__recordMaintainer mesh__D016419 jls
% 223.15/223.33  |- mesh__recordOriginator mesh__D016419 TGC
% 223.15/223.33  |- mesh__historyNote mesh__D016419 1991   
% 223.15/223.33  |- skos__altLabel mesh__D016419 Classical Article %28%PT%29%
% 223.15/223.33  |- skos__altLabel mesh__D016419 Classical Article
% 223.15/223.33  |- skos__broader mesh__D016419smesh__D052180
% 223.15/223.33  |- mesh__dateCreated mesh__D016419 1995-06-23
% 223.15/223.33  |- mesh__dateCreated mesh__D027141 2001-07-25
% 223.15/223.33  |- mesh__activeMeSHYear mesh__D027141 2002
% 223.15/223.33  |- skos__hiddenLabel mesh__D027141 Hydrophobic Interaction
% 223.15/223.33  |- mesh__historyNote mesh__D027141 2002   
% 223.15/223.34  |- skos__broader mesh__D027141smesh__D002627
% 223.15/223.34  |- skos__hiddenLabel mesh__D027141 Interaction, Hydrophobic
% 223.15/223.34  |- skos__prefLabel mesh__D027141 Hydrophobicity
% 223.15/223.34  |- mesh__dateEstablished mesh__D027141 2002-01-01
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D027141 2005
% 223.15/223.34  |- skos__annotation mesh__D027141
% 223.15/223.34       do not confuse with HYDROPHOBIA see RABIES   
% 223.15/223.34  |- skos__hiddenLabel mesh__D027141 Interactions, Hydrophobic
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D027141 2006
% 223.15/223.34  |- rdf__type mesh__D027141sskos__Concept
% 223.15/223.34  |- skos__scopeNote mesh__D027141
% 223.15/223.34       The property of substances of reduced affinity for or repulsion of water.%A%    
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D027141 2003
% 223.15/223.34  |- mesh__publicMeSHNote mesh__D027141 2002   
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D027141 2004
% 223.15/223.34  |- mesh__dateEstablished mesh__D013121 1998-01-01
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013121 2004
% 223.15/223.34  |- skos__historyNote mesh__D013121 Lordosis %28%1966-1997%29%
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013121 2002
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013121 2006
% 223.15/223.34  |- skos__hiddenLabel mesh__D013121 Curvature, Spinal
% 223.15/223.34  |- mesh__dateRevised mesh__D013121 1997-06-20
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013121 2003
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013121 2001
% 223.15/223.34  |- mesh__recordMaintainer mesh__D013121 TGC
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013121 2005
% 223.15/223.34  |- mesh__recordOriginator mesh__D013121 NLM
% 223.15/223.34  |- skos__annotation mesh__D013121 GEN or unspecified; prefer specifics   
% 223.15/223.34  |- skos__scopeNote mesh__D013121
% 223.15/223.34       Deviations of the spine from its normal direction or position. %28%Dorland, 28th ed%29%%A%    
% 223.15/223.34  |- mesh__recordAuthorizer mesh__D013121 SJN
% 223.15/223.34  |- mesh__publicMeSHNote mesh__D013121 98   
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013121 2000
% 223.15/223.34  |- skos__prefLabel mesh__D013121 Spinal Curvatures
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013121 1999
% 223.15/223.34  |- skos__hiddenLabel mesh__D013121 Spinal Curvature
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013121 1998
% 223.15/223.34  |- skos__historyNote mesh__D013121 Kyphosis %28%1966-1997%29%
% 223.15/223.34  |- skos__broader mesh__D013121smesh__D013122
% 223.15/223.34  |- skos__historyNote mesh__D013121 Scoliosis %28%1966-1997%29%
% 223.15/223.34  |- rdf__type mesh__D013121sskos__Concept
% 223.15/223.34  |- mesh__historyNote mesh__D013121 98; use explode 1970-97   
% 223.15/223.34  |- skos__hiddenLabel mesh__D013121 Curvatures, Spinal
% 223.15/223.34  |- mesh__dateCreated mesh__D013121 1999-01-01
% 223.15/223.34  |- mesh__dateCreated mesh__D032086 2002-07-03
% 223.15/223.34  |- skos__altLabel mesh__D032086 Evodia rutaecarpa
% 223.15/223.34  |- skos__annotation mesh__D032086
% 223.15/223.34       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.15/223.34  |- rdf__type mesh__D032086sskos__Concept
% 223.15/223.34  |- skos__prefLabel mesh__D032086 Evodia
% 223.15/223.34  |- skos__broader mesh__D032086smesh__D027821
% 223.15/223.34  |- skos__altLabel mesh__D032086 Tetradium ruticarpum
% 223.15/223.34  |- mesh__publicMeSHNote mesh__D032086 2003   
% 223.15/223.34  |- skos__altLabel mesh__D032086 Euodia
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D032086 2003
% 223.15/223.34  |- mesh__dateEstablished mesh__D032086 2003-01-01
% 223.15/223.34  |- skos__altLabel mesh__D032086 Evodiae Fructus
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D032086 2005
% 223.15/223.34  |- skos__scopeNote mesh__D032086
% 223.15/223.34       A plant genus of the family RUTACEAE which is used in Chinese medicine %28%DRUGS, CHINESE HERBAL%29%. Evodiamine and other quinazoline alkaloids %28%QUINAZOLINES%29% are obtained from the fruit of E. ruticarpa.%A%    
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D032086 2004
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D032086 2006
% 223.15/223.34  |- mesh__historyNote mesh__D032086 2003   
% 223.15/223.34  |- skos__hiddenLabel mesh__D004395 Dye Dilution Technics
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D004395 2004
% 223.15/223.34  |- skos__hiddenLabel mesh__D004395 Techniques, Dye Dilution
% 223.15/223.34  |- skos__hiddenLabel mesh__D004395 Dilution Technique, Dye
% 223.15/223.34  |- mesh__onlineNote mesh__D004395
% 223.15/223.34       use DYE DILUTION TECHNIQUE to search DYE DILUTION TECHNIC 1966-90%A%  
% 223.15/223.34  |- skos__hiddenLabel mesh__D004395 Dilution Technics, Dye
% 223.15/223.34  |- skos__prefLabel mesh__D004395 Dye Dilution Technique
% 223.15/223.34  |- skos__hiddenLabel mesh__D004395 Technique, Dye Dilution
% 223.15/223.34  |- skos__annotation mesh__D004395
% 223.15/223.34       do not use /util except by MeSH definition   
% 223.15/223.34  |- mesh__recordMaintainer mesh__D004395 kle
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D004395 2002
% 223.15/223.34  |- skos__scopeNote mesh__D004395
% 223.15/223.34       Method for assessing flow through a system by injection of a known quantity of dye into the system and monitoring its concentration over time at a specific point in the system. %28%From Dorland, 28th ed%29%%A%    
% 223.15/223.34  |- skos__broader mesh__D004395smesh__D007201
% 223.15/223.34  |- skos__hiddenLabel mesh__D004395 Dye Dilution Techniques
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D004395 2005
% 223.15/223.34  |- skos__hiddenLabel mesh__D004395 Technic, Dye Dilution
% 223.15/223.34  |- skos__altLabel mesh__D004395 Dye Dilution Technic
% 223.15/223.34  |- skos__hiddenLabel mesh__D004395 Dilution Technic, Dye
% 223.15/223.34  |- mesh__historyNote mesh__D004395 91; was DYE DILUTION TECHNIC 1963-90   
% 223.15/223.34  |- mesh__dateRevised mesh__D004395 1999-11-03
% 223.15/223.34  |- skos__hiddenLabel mesh__D004395 Dilution Techniques, Dye
% 223.15/223.34  |- mesh__recordOriginator mesh__D004395 NLM
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D004395 2006
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D004395 2000
% 223.15/223.34  |- mesh__publicMeSHNote mesh__D004395
% 223.15/223.34       91; was DYE DILUTION TECHNIC 1963-90   
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D004395 2003
% 223.15/223.34  |- rdf__type mesh__D004395sskos__Concept
% 223.15/223.34  |- skos__hiddenLabel mesh__D004395 Technics, Dye Dilution
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D004395 2001
% 223.15/223.34  |- mesh__recordAuthorizer mesh__D004395 sjn
% 223.15/223.34  |- mesh__dateCreated mesh__D004395 1999-01-01
% 223.15/223.34  |- skos__broader mesh__D012827smesh__D012828
% 223.15/223.34  |- mesh__historyNote mesh__D012827 87   
% 223.15/223.34  |- mesh__dateEstablished mesh__D012827 1987-01-01
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D012827 2006
% 223.15/223.34  |- skos__prefLabel mesh__D012827 Silicone Oils
% 223.15/223.34  |- skos__historyNote mesh__D012827 Silicones %28%1966-1986%29%
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D012827 2005
% 223.15/223.34  |- rdf__type mesh__D012827sskos__Concept
% 223.15/223.34  |- mesh__publicMeSHNote mesh__D012827 87   
% 223.15/223.34  |- mesh__recordAuthorizer mesh__D012827 sjn
% 223.15/223.34  |- mesh__dateCreated mesh__D012827 1986-06-16
% 223.15/223.34  |- mesh__dateRevised mesh__D012827 2004-07-07
% 223.15/223.34  |- mesh__recordMaintainer mesh__D012827 jmp
% 223.15/223.34  |- skos__scopeNote mesh__D012827
% 223.15/223.34       Organic siloxanes which are polymerized to the oily stage. The oils have low surface tension and density less than 1. They are used in industrial applications and in the treatment of retinal detachment, complicated by proliferative vitreoretinopathy.%A%    
% 223.15/223.34  |- mesh__recordOriginator mesh__D012827 RLS
% 223.15/223.34  |- rdf__type mesh__D012029sskos__Concept
% 223.15/223.34  |- mesh__recordAuthorizer mesh__D012029 sjn
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D012029 2004
% 223.15/223.34  |- skos__hiddenLabel mesh__D012029 Refractions, Ocular
% 223.15/223.34  |- skos__broader mesh__D012029smesh__D014787
% 223.15/223.34  |- skos__hiddenLabel mesh__D012029 Ocular Refractions
% 223.15/223.34  |- skos__broader mesh__D012029smesh__D009906
% 223.15/223.34  |- skos__scopeNote mesh__D012029
% 223.15/223.34       Refraction of LIGHT effected by the media of the EYE.     
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D012029 2006
% 223.15/223.34  |- skos__altLabel mesh__D012029 Ocular Refraction
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D012029 2005
% 223.15/223.34  |- mesh__recordOriginator mesh__D012029 NLM
% 223.15/223.34  |- mesh__recordMaintainer mesh__D012029 lkt
% 223.15/223.34  |- skos__related mesh__D012029smesh__D042262
% 223.15/223.34  |- mesh__dateRevised mesh__D012029 2003-07-09
% 223.15/223.34  |- mesh__dateCreated mesh__D012029 1999-01-01
% 223.15/223.34  |- skos__broader mesh__D012029smesh__D043722
% 223.15/223.34  |- skos__prefLabel mesh__D012029 Refraction, Ocular
% 223.15/223.34  |- mesh__historyNote mesh__D009080
% 223.15/223.34       84%28%77%29%; was see under LYMPHATIC DISEASES 1977-83   
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D009080 1997
% 223.15/223.34  |- mesh__publicMeSHNote mesh__D009080
% 223.15/223.34       84; was see under LYMPHATIC DISEASES 1977-83   
% 223.15/223.34  |- mesh__dateEstablished mesh__D009080 1984-01-01
% 223.15/223.34  |- skos__annotation mesh__D009080 DF: MLNS or MCLS   
% 223.15/223.34  |- mesh__recordAuthorizer mesh__D009080 PLS
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D009080 2004
% 223.15/223.34  |- rdf__type mesh__D009080sskos__Concept
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D009080 2002
% 223.15/223.34  |- skos__broader mesh__D009080smesh__D017445
% 223.15/223.34  |- mesh__recordMaintainer mesh__D009080 AGS
% 223.15/223.34  |- skos__altLabel mesh__D009080 MCLS
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D009080 1998
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D009080 1995
% 223.15/223.34  |- skos__broader mesh__D009080smesh__D014657
% 223.15/223.34  |- mesh__dateCreated mesh__D009080 1976-05-19
% 223.15/223.34  |- skos__altLabel mesh__D009080 Kawasaki Disease
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D009080 2005
% 223.15/223.34  |- skos__broader mesh__D009080smesh__D008206
% 223.15/223.34  |- mesh__dateRevised mesh__D009080 1994-06-03
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D009080 1999
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D009080 2000
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D009080 2006
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D009080 2001
% 223.15/223.34  |- skos__scopeNote mesh__D009080
% 223.15/223.34       An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities.%A%    
% 223.15/223.34  |- skos__altLabel mesh__D009080 Lymph Node Syndrome, Mucocutaneous
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D009080 1996
% 223.15/223.34  |- skos__hiddenLabel mesh__D009080 Disease, Kawasaki
% 223.15/223.34  |- mesh__recordOriginator mesh__D009080 VDK
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D009080 2003
% 223.15/223.34  |- skos__prefLabel mesh__D009080 Mucocutaneous Lymph Node Syndrome
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017512 2000
% 223.15/223.34  |- rdf__type mesh__D017512sskos__Concept
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017512 2006
% 223.15/223.34  |- skos__hiddenLabel mesh__D017512 Lichenoid Eruption
% 223.15/223.34  |- skos__scopeNote mesh__D017512
% 223.15/223.34       Conditions in which there is histological damage to the lower epidermis along with a grouped chronic inflammatory infiltrate in the papillary dermis disturbing the interface between the epidermis and dermis. LICHEN PLANUS is the prototype of all lichenoid eruptions. %28%From Rook et al., Textbook of Dermatology, 4th ed, p398%29%%A%    
% 223.15/223.34  |- skos__hiddenLabel mesh__D017512 Eruptions, Lichenoid
% 223.15/223.34  |- mesh__recordMaintainer mesh__D017512 TAP
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017512 1997
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017512 2003
% 223.15/223.34  |- skos__broader mesh__D017512smesh__D017444
% 223.15/223.34  |- mesh__recordAuthorizer mesh__D017512 PLS
% 223.15/223.34  |- mesh__publicMeSHNote mesh__D017512 93   
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017512 1999
% 223.15/223.34  |- skos__altLabel mesh__D017512 Licheniform Eruptions
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017512 2005
% 223.15/223.34  |- skos__annotation mesh__D017512 GEN or unspecified; prefer specifics   
% 223.15/223.34  |- mesh__dateEstablished mesh__D017512 1993-01-01
% 223.15/223.34  |- skos__hiddenLabel mesh__D017512 Eruption, Lichenoid
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017512 1996
% 223.15/223.34  |- skos__hiddenLabel mesh__D017512 Eruption, Licheniform
% 223.15/223.34  |- skos__prefLabel mesh__D017512 Lichenoid Eruptions
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017512 1998
% 223.15/223.34  |- skos__hiddenLabel mesh__D017512 Eruptions, Licheniform
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017512 2002
% 223.15/223.34  |- mesh__recordOriginator mesh__D017512 PLS
% 223.15/223.34  |- mesh__historyNote mesh__D017512 93   
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017512 2001
% 223.15/223.34  |- skos__hiddenLabel mesh__D017512 Licheniform Eruption
% 223.15/223.34  |- mesh__dateCreated mesh__D017512 1992-05-22
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017512 2004
% 223.15/223.34  |- mesh__dateRevised mesh__D017512 1995-06-08
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D008786 2004
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D008786 2001
% 223.15/223.34  |- rdf__type mesh__D008786sskos__Concept
% 223.15/223.34  |- skos__historyNote mesh__D008786 Ferric Compounds %28%1975-1978%29%
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D008786 1991
% 223.15/223.34  |- mesh__recordOriginator mesh__D008786 RLS
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D008786 1995
% 223.15/223.34  |- skos__historyNote mesh__D008786 Hemeproteins %28%1973-1978%29%
% 223.15/223.34  |- mesh__recordAuthorizer mesh__D008786 PLS
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D008786 1998
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D008786 2005
% 223.15/223.34  |- skos__broader mesh__D008786smesh__D006420
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D008786 1992
% 223.15/223.34  |- skos__prefLabel mesh__D008786 Metmyoglobin
% 223.15/223.34  |- skos__historyNote mesh__D008786 Myoglobin %28%1966-1978%29%
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D008786 2002
% 223.15/223.34  |- mesh__historyNote mesh__D008786
% 223.15/223.34       91%28%79%29%; was see under HEMEPROTEINS 1979-90   
% 223.15/223.34  |- mesh__dateCreated mesh__D008786 1978-05-16
% 223.15/223.34  |- mesh__dateEstablished mesh__D008786 1991-01-01
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D008786 1999
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D008786 2006
% 223.15/223.34  |- mesh__dateRevised mesh__D008786 1990-06-19
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D008786 1993
% 223.15/223.34  |- skos__annotation mesh__D008786
% 223.15/223.34       /biosyn /physiol permitted; /urine = METMYOGLOBIN /urine %28%IM%29% + MYOGLOBINURIA %28%IM%29%%A%  
% 223.15/223.34  |- mesh__recordMaintainer mesh__D008786 TAP
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D008786 1996
% 223.15/223.34  |- skos__scopeNote mesh__D008786
% 223.15/223.34       Myoglobin which is in the oxidized ferric or hemin form. The oxidation causes a change in color from red to brown.%A%    
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D008786 2003
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D008786 2000
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D008786 1997
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D008786 1994
% 223.15/223.34  |- skos__altLabel mesh__D008786 Ferrimyoglobin
% 223.15/223.34  |- mesh__publicMeSHNote mesh__D008786
% 223.15/223.34       91; was see under HEMEPROTEINS 1979-90   
% 223.15/223.34  |- mesh__onlineNote mesh__D013920
% 223.15/223.34       use THROMBOCYTHEMIA, HEMORRHAGIC to search HEMORRHAGIC THROMBOCYTHEMIA 1966-85 %28%as Prov 1966%29%%A%  
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013920 2006
% 223.15/223.34  |- rdf__type mesh__D013920sskos__Concept
% 223.15/223.34  |- mesh__dateEstablished mesh__D013920 1967-01-01
% 223.15/223.34  |- skos__altLabel mesh__D013920 Thrombocythemia, Idiopathic
% 223.15/223.34  |- mesh__recordMaintainer mesh__D013920 NNS
% 223.15/223.34  |- skos__hiddenLabel mesh__D013920 Thrombocythemias, Primary
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013920 2004
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013920 2005
% 223.15/223.34  |- skos__broader mesh__D013920smesh__D013922
% 223.15/223.34  |- skos__altLabel mesh__D013920 Thrombocythemia, Essential
% 223.15/223.34  |- skos__broader mesh__D013920smesh__D001778
% 223.15/223.34  |- skos__hiddenLabel mesh__D013920 Thrombocythemias, Essential
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013920 2001
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013920 2003
% 223.15/223.34  |- mesh__dateCreated mesh__D013920 1999-01-01
% 223.15/223.34  |- skos__hiddenLabel mesh__D013920 Thrombocythemias, Hemorrhagic
% 223.15/223.34  |- skos__hiddenLabel mesh__D013920 Hemorrhagic Thrombocythemias
% 223.15/223.34  |- mesh__recordOriginator mesh__D013920 NLM
% 223.15/223.34  |- skos__prefLabel mesh__D013920 Thrombocythemia, Hemorrhagic
% 223.15/223.34  |- mesh__recordAuthorizer mesh__D013920 SJN
% 223.15/223.34  |- skos__hiddenLabel mesh__D013920 Primary Thrombocythemias
% 223.15/223.34  |- skos__altLabel mesh__D013920 Hemorrhagic Thrombocythemia
% 223.15/223.34  |- skos__broader mesh__D013920smesh__D006474
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013920 2000
% 223.15/223.34  |- mesh__dateRevised mesh__D013920 1998-06-11
% 223.15/223.34  |- mesh__historyNote mesh__D013920
% 223.15/223.34       86; was HEMORRHAGIC THROMBOCYTHEMIA 1963-85 %28%Prov 1963-66%29%%A%  
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013920 1999
% 223.15/223.34  |- skos__hiddenLabel mesh__D013920 Idiopathic Thrombocythemia
% 223.15/223.34  |- skos__altLabel mesh__D013920 Thrombocythemia, Primary
% 223.15/223.34  |- mesh__publicMeSHNote mesh__D013920
% 223.15/223.34       86; was HEMORRHAGIC THROMBOCYTHEMIA 1967-85   
% 223.15/223.34  |- skos__scopeNote mesh__D013920
% 223.15/223.34       A clinical syndrome characterized by repeated spontaneous hemorrhages and a remarkable increase in the number of circulating platelets.%A%    
% 223.15/223.34  |- skos__hiddenLabel mesh__D013920 Idiopathic Thrombocythemias
% 223.15/223.34  |- skos__hiddenLabel mesh__D013920 Essential Thrombocythemia
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013920 2002
% 223.15/223.34  |- skos__hiddenLabel mesh__D013920 Thrombocythemias, Idiopathic
% 223.15/223.34  |- skos__hiddenLabel mesh__D013920 Primary Thrombocythemia
% 223.15/223.34  |- skos__hiddenLabel mesh__D013920 Essential Thrombocythemias
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013122 2004
% 223.15/223.34  |- skos__hiddenLabel mesh__D013122 Spinal Disease
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013122 2002
% 223.15/223.34  |- skos__hiddenLabel mesh__D013122 Disease, Spinal
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013122 2006
% 223.15/223.34  |- mesh__dateRevised mesh__D013122 1998-06-11
% 223.15/223.34  |- skos__prefLabel mesh__D013122 Spinal Diseases
% 223.15/223.34  |- mesh__recordAuthorizer mesh__D013122 SJN
% 223.15/223.34  |- skos__broader mesh__D013122smesh__D001847
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013122 2000
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013122 1999
% 223.15/223.34  |- mesh__recordMaintainer mesh__D013122 MSR
% 223.15/223.34  |- mesh__dateCreated mesh__D013122 1999-01-01
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013122 2001
% 223.15/223.34  |- skos__hiddenLabel mesh__D013122 Diseases, Spinal
% 223.15/223.34  |- mesh__recordOriginator mesh__D013122 NLM
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013122 2003
% 223.15/223.34  |- rdf__type mesh__D013122sskos__Concept
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D013122 2005
% 223.15/223.34  |- skos__annotation mesh__D013122
% 223.15/223.34       coord IM with specific vertebrae %28%IM%29%   
% 223.15/223.34  |- skos__related mesh__D004396smesh__D010592
% 223.15/223.34  |- skos__related mesh__D004396smesh__D013194
% 223.15/223.34  |- skos__broader mesh__D004396smesh__D019995
% 223.15/223.34  |- mesh__recordAuthorizer mesh__D004396 sjn
% 223.15/223.34  |- skos__broader mesh__D004396smesh__D020313
% 223.15/223.34  |- mesh__recordMaintainer mesh__D004396 ssb
% 223.15/223.34  |- skos__scopeNote mesh__D004396
% 223.15/223.34       Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS.%A%    
% 223.15/223.34  |- skos__hiddenLabel mesh__D004396 Inorganic Pigments
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D004396 2006
% 223.15/223.34  |- skos__related mesh__D004396smesh__D010860
% 223.15/223.34  |- mesh__historyNote mesh__D004396
% 223.15/223.34       2006%28%1963%29%; for STAINS use STAINS AND STAINING 1991-1995   
% 223.15/223.34  |- mesh__dateRevised mesh__D004396 2005-06-30
% 223.15/223.34  |- mesh__publicMeSHNote mesh__D004396
% 223.15/223.34       2006%28%1963%29%; see DYES 1963-2005; for STAINS see STAINS AND STAINING 1991-1995%A%  
% 223.15/223.34  |- skos__hiddenLabel mesh__D004396 Pigments, Organic
% 223.15/223.34  |- skos__annotation mesh__D004396
% 223.15/223.34       differentiate from PIGMENTS, BIOLOGICAL   
% 223.15/223.34  |- mesh__dateCreated mesh__D004396 1999-01-01
% 223.15/223.34  |- rdf__type mesh__D004396sskos__Concept
% 223.15/223.34  |- skos__hiddenLabel mesh__D004396 Stains, Tissue
% 223.15/223.34  |- skos__prefLabel mesh__D004396 Coloring Agents
% 223.15/223.34  |- mesh__recordOriginator mesh__D004396 NLM
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D012828 2005
% 223.15/223.34  |- skos__prefLabel mesh__D012828 Silicones
% 223.15/223.34  |- mesh__recordAuthorizer mesh__D012828 sjn
% 223.15/223.34  |- rdf__type mesh__D012828sskos__Concept
% 223.15/223.34  |- mesh__dateRevised mesh__D012828 2004-07-07
% 223.15/223.34  |- skos__broader mesh__D012828smesh__D012833
% 223.15/223.34  |- mesh__recordOriginator mesh__D012828 NLM
% 223.15/223.34  |- skos__altLabel mesh__D012828 Silicone
% 223.15/223.34  |- mesh__recordMaintainer mesh__D012828 jmp
% 223.15/223.34  |- skos__annotation mesh__D012828
% 223.15/223.34       in breast implants use SILICONE GELS or SILICONE ELASTOMERS; do not confuse with SILICON%A%  
% 223.15/223.34  |- mesh__dateCreated mesh__D012828 1999-01-01
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D012828 2006
% 223.15/223.34  |- skos__scopeNote mesh__D012828
% 223.15/223.34       A broad family of synthetic organosiloxane polymers containing a repeating silicon-oxygen backbone with organic side groups attached via carbon-silicon bonds. Depending on their structure, they are classified as liquids, gels, and elastomers. %28%From Merck Index, 12th ed%29%%A%    
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Type IV Mucolipidoses
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Type I Mucolipidoses
% 223.15/223.34  |- skos__altLabel mesh__D009081 Mucolipidosis Type I
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Mucolipidosis, Type IV
% 223.15/223.34  |- mesh__publicMeSHNote mesh__D009081 2000   
% 223.15/223.34  |- skos__altLabel mesh__D009081 Mucolipidosis Type IV
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D009081 2006
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Mucolipidoses, Type I
% 223.15/223.34  |- skos__scopeNote mesh__D009081
% 223.15/223.34       A group of inherited metabolic diseases characterized by the accumulation of excessive amounts of acid mucopolysaccharides, sphingolipids, and/or glycolipids in visceral and mesenchymal cells. Abnormal amounts of sphingolipids or glycolipids are present in neural tissue. Mental retardation and skeletal changes, most notably dysostosis multiplex, occur frequently. %28%From Joynt, Clinical Neurology, 1992, Ch56, pp36-7%29%%A%    
% 223.15/223.34  |- skos__altLabel mesh__D009081 Deficiency Disease, Ganglioside Sialidase
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Disease, Inclusion Cell
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 I Cell Disease
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Mucolipidosis, Type I
% 223.15/223.34  |- skos__altLabel mesh__D009081 I-Cell Disease
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Polydystrophy, Pseudo-Hurler
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Psuedo Hurler Disease
% 223.15/223.34  |- skos__altLabel mesh__D009081 Mucolipidosis II
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Type III Mucolipidoses
% 223.15/223.34  |- skos__prefLabel mesh__D009081 Mucolipidoses
% 223.15/223.34  |- rdf__type mesh__D009081sskos__Concept
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D009081 2005
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Type II Mucolipidoses
% 223.15/223.34  |- mesh__dateEstablished mesh__D009081 1977-01-01
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Diseases, Inclusion Cell
% 223.15/223.34  |- skos__altLabel mesh__D009081 Mucolipidosis IV
% 223.15/223.34  |- skos__altLabel mesh__D009081 Mucolipidosis
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Mucolipidosis, Type II
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Pseudo Hurler Polydystrophy
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Diseases, I-Cell
% 223.15/223.34  |- mesh__recordAuthorizer mesh__D009081 sjn
% 223.15/223.34  |- skos__altLabel mesh__D009081 Ganglioside Sialidase Deficiency Disease
% 223.15/223.34  |- mesh__dateRevised mesh__D009081 2002-07-03
% 223.15/223.34  |- skos__altLabel mesh__D009081 Pseudo-Hurler Polydystrophy
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Lipomucopolysaccharidoses
% 223.15/223.34  |- skos__historyNote mesh__D009081
% 223.15/223.34       Lipid Metabolism, Inborn Errors %28%1966-1976%29%
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Disease, Psuedo-Hurler
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Mucolipidoses, Type IV
% 223.15/223.34  |- mesh__dateCreated mesh__D009081 1976-05-19
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Mucolipidoses, Type II
% 223.15/223.34  |- skos__altLabel mesh__D009081 Psuedo-Hurler Disease
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Mucolipidosis, Type III
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Mucolipidosis IIIs
% 223.15/223.34  |- skos__altLabel mesh__D009081 Inclusion Cell Disease
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Diseases, Psuedo-Hurler
% 223.15/223.34  |- skos__broader mesh__D009081smesh__D020140
% 223.15/223.34  |- skos__broader mesh__D009081smesh__D002239
% 223.15/223.34  |- skos__historyNote mesh__D009081 Lipoidosis %28%1966-1976%29%
% 223.15/223.34  |- skos__altLabel mesh__D009081 Myoclonus Cherry Red Spot Syndrome
% 223.15/223.34  |- mesh__recordOriginator mesh__D009081 VDK
% 223.15/223.34  |- mesh__historyNote mesh__D009081 2000%28%1977%29%   
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D009081 2004
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Sialidoses
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Mucolipidoses, Type III
% 223.15/223.34  |- skos__altLabel mesh__D009081 Mucolipidosis Type II
% 223.15/223.34  |- skos__altLabel mesh__D009081 Mucolipidosis III
% 223.15/223.34  |- mesh__recordMaintainer mesh__D009081 mdb
% 223.15/223.34  |- skos__broader mesh__D009081smesh__D001851
% 223.15/223.34  |- skos__historyNote mesh__D009081 Mucopolysaccharidosis %28%1974-1976%29%
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Disease, I-Cell
% 223.15/223.34  |- skos__altLabel mesh__D009081 Mucolipidosis Type III
% 223.15/223.34  |- skos__broader mesh__D009081smesh__D020739
% 223.15/223.34  |- skos__altLabel mesh__D009081 Mucolipidosis I
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Psuedo-Hurler Diseases
% 223.15/223.34  |- skos__historyNote mesh__D009081 Lipochondrodystrophy %28%1966-1976%29%
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 Inclusion Cell Diseases
% 223.15/223.34  |- skos__hiddenLabel mesh__D009081 IIIs, Mucolipidosis
% 223.15/223.34  |- skos__altLabel mesh__D009081 Cherry Red Spot Myoclonus Syndrome
% 223.15/223.34  |- skos__altLabel mesh__D009081 Sialidosis
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D009081 2003
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017513 2001
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017513 1999
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017513 2005
% 223.15/223.34  |- mesh__dateCreated mesh__D017513 1992-05-22
% 223.15/223.34  |- skos__broader mesh__D017513smesh__D017512
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017513 1993
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017513 1996
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017513 1995
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017513 2000
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017513 1998
% 223.15/223.34  |- skos__prefLabel mesh__D017513 Lichen Nitidus
% 223.15/223.34  |- skos__annotation mesh__D017513 a skin dis, not a plant   
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017513 1994
% 223.15/223.34  |- mesh__publicMeSHNote mesh__D017513 93   
% 223.15/223.34  |- mesh__dateEstablished mesh__D017513 1993-01-01
% 223.15/223.34  |- mesh__historyNote mesh__D017513 93   
% 223.15/223.34  |- skos__scopeNote mesh__D017513
% 223.15/223.34       A chronic inflammatory disease characterized by shiny, flat-topped, usually flesh-colored micropapules no larger than the head of a pin. Lesions are localized in the early stages, found chiefly on the lower abdomen, penis, and inner surface of the thighs. Distribution may become generalized as the disease progresses.%A%    
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017513 2004
% 223.15/223.34  |- mesh__activeMeSHYear mesh__D017513 2002
% 223.15/223.34  |- rdf__type mesh__D017513sskos__Concept
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D017513 2006
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D017513 1997
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D017513 2003
% 223.15/223.35  |- mesh__dateEstablished mesh__D008787 1974-01-01
% 223.15/223.35  |- skos__scopeNote mesh__D008787
% 223.15/223.35       A dopamine D2 antagonist that is used as an antiemetic.%A%    
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D008787 2006
% 223.15/223.35  |- skos__broader mesh__D008787smesh__D001549
% 223.15/223.35  |- skos__hiddenLabel mesh__D008787 Dihydrochloride, Metoclopramide
% 223.15/223.35  |- skos__prefLabel mesh__D008787 Metoclopramide
% 223.15/223.35  |- skos__altLabel mesh__D008787 Metaclopromide
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D008787 2003
% 223.15/223.35  |- skos__hiddenLabel mesh__D008787 Monohydrochloride, Metoclopramide
% 223.15/223.35  |- mesh__publicMeSHNote mesh__D008787 74   
% 223.15/223.35  |- mesh__historyNote mesh__D008787 74   
% 223.15/223.35  |- mesh__recordOriginator mesh__D008787 NLM
% 223.15/223.35  |- skos__altLabel mesh__D008787
% 223.15/223.35       Metoclopramide Monohydrochloride, Monohydrate
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D008787 2004
% 223.15/223.35  |- rdf__type mesh__D008787sskos__Concept
% 223.15/223.35  |- skos__hiddenLabel mesh__D008787 Hydrochloride, Metoclopramide
% 223.15/223.35  |- mesh__dateRevised mesh__D008787 2001-07-25
% 223.15/223.35  |- skos__altLabel mesh__D008787
% 223.15/223.35       4 Amino-5-chloro-N-%28%2-%28%diethylamino%29%ethyl%29%-2-methoxybenzamide
% 223.15/223.35  |- mesh__dateCreated mesh__D008787 1999-01-01
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D008787 2002
% 223.15/223.35  |- mesh__recordMaintainer mesh__D008787 ssb
% 223.15/223.35  |- mesh__recordAuthorizer mesh__D008787 sjn
% 223.15/223.35  |- skos__altLabel mesh__D008787 Metaclopramide
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D008787 2005
% 223.15/223.35  |- skos__scopeNote mesh__D013921
% 223.15/223.35       A decrease in the number of blood platelets.     
% 223.15/223.35  |- skos__altLabel mesh__D013921 Thrombopenia
% 223.15/223.35  |- mesh__dateRevised mesh__D013921 1998-06-11
% 223.15/223.35  |- mesh__onlineNote mesh__D013921
% 223.15/223.35       use THROMBOCYTOPENIA to search THROMBOPENIA 1966-84   
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013921 1999
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013921 2002
% 223.15/223.35  |- mesh__recordMaintainer mesh__D013921 NNS
% 223.15/223.35  |- skos__hiddenLabel mesh__D013921 Thrombopenias
% 223.15/223.35  |- skos__hiddenLabel mesh__D013921 Thrombocytopenias
% 223.15/223.35  |- skos__prefLabel mesh__D013921 Thrombocytopenia
% 223.15/223.35  |- mesh__publicMeSHNote mesh__D013921 85; was THROMBOPENIA 1963-84   
% 223.15/223.35  |- skos__broader mesh__D013921smesh__D001791
% 223.15/223.35  |- mesh__historyNote mesh__D013921 85; was THROMBOPENIA 1963-84   
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013921 2006
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013921 2001
% 223.15/223.35  |- rdf__type mesh__D013921sskos__Concept
% 223.15/223.35  |- mesh__recordOriginator mesh__D013921 NLM
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013921 2004
% 223.15/223.35  |- mesh__recordAuthorizer mesh__D013921 SJN
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013921 2005
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013921 2000
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013921 2003
% 223.15/223.35  |- mesh__dateCreated mesh__D013921 1999-01-01
% 223.15/223.35  |- skos__hiddenLabel mesh__D013123 Spondylosyndeses
% 223.15/223.35  |- skos__broader mesh__D013123smesh__D001174
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013123 1998
% 223.15/223.35  |- skos__hiddenLabel mesh__D013123 Spinal Fusions
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013123 2002
% 223.15/223.35  |- skos__prefLabel mesh__D013123 Spinal Fusion
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013123 1999
% 223.15/223.35  |- mesh__dateRevised mesh__D013123 1997-06-20
% 223.15/223.35  |- mesh__dateCreated mesh__D013123 1999-01-01
% 223.15/223.35  |- skos__hiddenLabel mesh__D013123 Fusions, Spinal
% 223.15/223.35  |- skos__hiddenLabel mesh__D013123 Fusion, Spinal
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013123 2003
% 223.15/223.35  |- mesh__recordAuthorizer mesh__D013123 SJN
% 223.15/223.35  |- rdf__type mesh__D013123sskos__Concept
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013123 2000
% 223.15/223.35  |- skos__scopeNote mesh__D013123
% 223.15/223.35       Operative immobilization or ankylosis of two or more vertebrae by fusion of the vertebral bodies with a short bone graft or often with diskectomy or laminectomy. %28%From Blauvelt %26% Nelson, A Manual of Orthopaedic Terminology, 5th ed, p236; Dorland, 28th ed%29%%A%    
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013123 2005
% 223.15/223.35  |- skos__related mesh__D013123smesh__D007796
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013123 2004
% 223.15/223.35  |- skos__hiddenLabel mesh__D013123 Spondylodeses
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013123 2001
% 223.15/223.35  |- mesh__recordMaintainer mesh__D013123 PXP
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013123 2006
% 223.15/223.35  |- mesh__recordOriginator mesh__D013123 NLM
% 223.15/223.35  |- skos__annotation mesh__D013123
% 223.15/223.35       do not use /util except by MeSH definition; X ref SPONDYLODESIS is found largely in lang of Germanic family as synonym for X ref SPONDYLOSYNDESIS%A%  
% 223.15/223.35  |- mesh__recordAuthorizer mesh__D051242 ags
% 223.15/223.35  |- skos__altLabel mesh__D051242 Vesicular Integral Membrane Protein 21 kDa
% 223.15/223.35  |- skos__scopeNote mesh__D051242
% 223.15/223.35       A tyrosine phosphoprotein that plays an essential role in CAVEOLAE formation. It binds CHOLESTEROL and is involved in LIPIDS transport, membrane traffic, and SIGNAL TRANSDUCTION.%A%    
% 223.15/223.35  |- mesh__dateEstablished mesh__D051242 2006-01-01
% 223.15/223.35  |- skos__hiddenLabel mesh__D051242 alpha Caveolin
% 223.15/223.35  |- mesh__recordOriginator mesh__D051242 DRC
% 223.15/223.35  |- mesh__recordMaintainer mesh__D051242 ags
% 223.15/223.35  |- skos__broader mesh__D051242smesh__D010750
% 223.15/223.35  |- mesh__dateRevised mesh__D051242 2005-07-19
% 223.15/223.35  |- skos__broader mesh__D051242smesh__D022461
% 223.15/223.35  |- skos__broader mesh__D051242smesh__D048868
% 223.15/223.35  |- skos__prefLabel mesh__D051242 Caveolin 1
% 223.15/223.35  |- skos__hiddenLabel mesh__D051242 beta Caveolin
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D051242 2006
% 223.15/223.35  |- mesh__dateCreated mesh__D051242 2005-06-30
% 223.15/223.35  |- mesh__historyNote mesh__D051242 2006%28%1992%29%   
% 223.15/223.35  |- mesh__publicMeSHNote mesh__D051242
% 223.15/223.35       2006; CAVEOLIN 1 was indexed under CAVEOLINS 2001-2005, %26% under MEMBRANE PROTEINS 1992-2000%A%  
% 223.15/223.35  |- skos__altLabel mesh__D051242 VIP21 Protein
% 223.15/223.35  |- skos__altLabel mesh__D051242 Caveolin-1
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D051242 2006A
% 223.15/223.35  |- rdf__type mesh__D051242sskos__Concept
% 223.15/223.35  |- rdf__type mesh__D004397sskos__Concept
% 223.15/223.35  |- skos__scopeNote mesh__D004397
% 223.15/223.35       An organothiophosphorus cholinesterase inhibitor that is used as an insecticide.%A%    
% 223.15/223.35  |- skos__hiddenLabel mesh__D004397 Stauffer N2790
% 223.15/223.35  |- skos__broader mesh__D004397smesh__D009946
% 223.15/223.35  |- mesh__dateCreated mesh__D004397 1999-01-01
% 223.15/223.35  |- mesh__recordMaintainer mesh__D004397 ssb
% 223.15/223.35  |- mesh__recordOriginator mesh__D004397 NLM
% 223.15/223.35  |- skos__annotation mesh__D004397 TN 111 for eff on insects   
% 223.15/223.35  |- skos__prefLabel mesh__D004397 Fonofos
% 223.15/223.35  |- skos__hiddenLabel mesh__D004397 Stauffer N 2790
% 223.15/223.35  |- mesh__historyNote mesh__D004397
% 223.15/223.35       96; was DYFONATE 1973-95 %28%see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1973-90%29%%A%  
% 223.15/223.35  |- mesh__recordAuthorizer mesh__D004397 sjn
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D004397 2006
% 223.15/223.35  |- mesh__publicMeSHNote mesh__D004397
% 223.15/223.35       96; was DYFONATE 1973-95 %28%see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1973-90%29%%A%  
% 223.15/223.35  |- mesh__dateEstablished mesh__D004397 1991-01-01
% 223.15/223.35  |- skos__altLabel mesh__D004397 Dyphonate
% 223.15/223.35  |- mesh__dateRevised mesh__D004397 2005-06-30
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D012829 1999
% 223.15/223.35  |- skos__broader mesh__D012829smesh__D011009
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D012829 1998
% 223.15/223.35  |- mesh__recordAuthorizer mesh__D012829 PLS
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D012829 2002
% 223.15/223.35  |- skos__scopeNote mesh__D012829
% 223.15/223.35       Pneumoconiosis due to the inhalation of dust of stone, sand, or flint containing silicon dioxide, with formation of generalized, nodular fibrotic changes in both lungs. %28%Dorland, 27th ed%29%%A%    
% 223.15/223.35  |- mesh__dateCreated mesh__D012829 1999-01-01
% 223.15/223.35  |- mesh__recordMaintainer mesh__D012829 TGC
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D012829 2004
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D012829 2001
% 223.15/223.35  |- mesh__dateRevised mesh__D012829 1996-06-10
% 223.15/223.35  |- mesh__recordOriginator mesh__D012829 NLM
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D012829 2006
% 223.15/223.35  |- skos__hiddenLabel mesh__D012829 Silicoses
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D012829 2003
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D012829 2005
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D012829 2000
% 223.15/223.35  |- skos__annotation mesh__D012829
% 223.15/223.35       pneumoconiosis from silicon dioxide %28%in stone, sand, flint%29%; do not use /chem ind for dust causing this dis: use /etiol; ANTHRACOSILICOSIS %26% SILICOTUBERCULOSIS are also available; do not coord with OCCUPATIONAL DISEASES%A%  
% 223.15/223.35  |- rdf__type mesh__D012829sskos__Concept
% 223.15/223.35  |- skos__prefLabel mesh__D012829 Silicosis
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D012829 1997
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009880 2000
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009880 1996
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009880 2004
% 223.15/223.35  |- skos__broader mesh__D009880smesh__D001158
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009880 2001
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009880 1997
% 223.15/223.35  |- skos__scopeNote mesh__D009880
% 223.15/223.35       Artery originating from the internal carotid artery and distributing to the eye, orbit and adjacent facial structures.%A%    
% 223.15/223.35  |- skos__hiddenLabel mesh__D009880 Artery, Ophthalmic
% 223.15/223.35  |- mesh__recordOriginator mesh__D009880 NLM
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009880 2005
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009880 1993
% 223.15/223.35  |- skos__hiddenLabel mesh__D009880 Ophthalmic Arteries
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009880 2002
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009880 1998
% 223.15/223.35  |- skos__prefLabel mesh__D009880 Ophthalmic Artery
% 223.15/223.35  |- mesh__dateRevised mesh__D009880 1992-05-15
% 223.15/223.35  |- mesh__recordAuthorizer mesh__D009880 PLS
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009880 2006
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009880 1994
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009880 1999
% 223.15/223.35  |- rdf__type mesh__D009880sskos__Concept
% 223.15/223.35  |- mesh__dateCreated mesh__D009880 1999-01-01
% 223.15/223.35  |- skos__hiddenLabel mesh__D009880 Arteries, Ophthalmic
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009880 1995
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009880 2003
% 223.15/223.35  |- mesh__recordMaintainer mesh__D009880 TAP
% 223.15/223.35  |- mesh__dateCreated mesh__D017514 1992-05-22
% 223.15/223.35  |- mesh__historyNote mesh__D017514 93   
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D017514 1997
% 223.15/223.35  |- mesh__dateEstablished mesh__D017514 1993-01-01
% 223.15/223.35  |- skos__altLabel mesh__D017514 Habermann Disease
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D017514 1996
% 223.15/223.35  |- rdf__type mesh__D017514sskos__Concept
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D017514 2001
% 223.15/223.35  |- skos__hiddenLabel mesh__D017514 Acute Pityriasis Lichenoides
% 223.15/223.35  |- skos__hiddenLabel mesh__D017514 Disease, Habermann
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D017514 2006
% 223.15/223.35  |- skos__prefLabel mesh__D017514 Pityriasis Lichenoides
% 223.15/223.35  |- skos__hiddenLabel mesh__D017514 Habermanns Disease
% 223.15/223.35  |- skos__hiddenLabel mesh__D017514 Mucha Habermann Disease
% 223.15/223.35  |- skos__historyNote mesh__D017514 Parapsoriasis %28%1966-1985%29%
% 223.15/223.35  |- skos__altLabel mesh__D017514 Pityriasis Lichenoides, Chronic
% 223.15/223.35  |- skos__broader mesh__D017514smesh__D017512
% 223.15/223.35  |- skos__hiddenLabel mesh__D017514 Disease, Habermann%27%s
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D017514 2000
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D017514 1995
% 223.15/223.35  |- mesh__dateRevised mesh__D017514 1993-06-04
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D017514 2005
% 223.15/223.35  |- mesh__recordOriginator mesh__D017514 PLS
% 223.15/223.35  |- mesh__publicMeSHNote mesh__D017514 93   
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D017514 2004
% 223.15/223.35  |- mesh__recordMaintainer mesh__D017514 AGS
% 223.15/223.35  |- skos__altLabel mesh__D017514 Mucha-Habermann Disease
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D017514 1999
% 223.15/223.35  |- skos__hiddenLabel mesh__D017514 Disease, Mucha-Habermann
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D017514 1994
% 223.15/223.35  |- skos__annotation mesh__D017514
% 223.15/223.35       a form of parapsoriasis %26% of pityriasis   
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D017514 2003
% 223.15/223.35  |- skos__historyNote mesh__D017514 Pityriasis %28%1977-1992%29%
% 223.15/223.35  |- skos__broader mesh__D017514smesh__D010267
% 223.15/223.35  |- skos__hiddenLabel mesh__D017514 Chronic Pityriasis Lichenoides
% 223.15/223.35  |- skos__scopeNote mesh__D017514
% 223.15/223.35       A subgroup of PARAPSORIASIS itself divided into acute and chronic forms. The acute form is characterized by the abrupt onset of a generalized, reddish-brown, maculopapular eruption. Lesions may be vesicular, hemorrhagic, crusted, or necrotic. Histologically the disease is characterized by epidermal necrolysis. The chronic form shows milder skin changes with necrosis. An important variant of the chronic form is LYMPHOMATOID PAPULOSIS.%A%    
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D017514 2002
% 223.15/223.35  |- skos__altLabel mesh__D017514 Pityriasis Lichenoides, Acute
% 223.15/223.35  |- skos__broader mesh__D017514smesh__D010915
% 223.15/223.35  |- mesh__recordAuthorizer mesh__D017514 PLS
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D017514 1998
% 223.15/223.35  |- skos__historyNote mesh__D008788 Diuretics, Sulfamyl %28%1974%29%
% 223.15/223.35  |- mesh__recordMaintainer mesh__D008788 ssb
% 223.15/223.35  |- mesh__historyNote mesh__D008788
% 223.15/223.35       91%28%75%29%; was see under DIURETICS, SULFAMYL 1975-90   
% 223.15/223.35  |- mesh__dateEstablished mesh__D008788 1991-01-01
% 223.15/223.35  |- mesh__recordAuthorizer mesh__D008788 sjn
% 223.15/223.35  |- mesh__publicMeSHNote mesh__D008788
% 223.15/223.35       91; was see under DIURETICS, SULFAMYL 1975-90   
% 223.15/223.35  |- skos__broader mesh__D008788smesh__D011799
% 223.15/223.35  |- skos__historyNote mesh__D008788 Quinazolines %28%1971-1974%29%
% 223.15/223.35  |- rdf__type mesh__D008788sskos__Concept
% 223.15/223.35  |- mesh__dateRevised mesh__D008788 2005-06-30
% 223.15/223.35  |- skos__hiddenLabel mesh__D008788 SR 720 22
% 223.15/223.35  |- skos__broader mesh__D008788smesh__D013449
% 223.15/223.35  |- mesh__recordOriginator mesh__D008788 NLM
% 223.15/223.35  |- skos__hiddenLabel mesh__D008788 SR72022
% 223.15/223.35  |- skos__prefLabel mesh__D008788 Metolazone
% 223.15/223.35  |- skos__scopeNote mesh__D008788
% 223.15/223.35       A quinazoline-sulfonamide that is considered a thiazide-like diuretic which is long-acting so useful in chronic RENAL FAILURE. It also tends to lower BLOOD PRESSURE and increase POTASSIUM loss.%A%    
% 223.15/223.35  |- mesh__dateCreated mesh__D008788 1974-11-11
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D008788 2006
% 223.15/223.35  |- skos__prefLabel mesh__D033181 Information Dissemination
% 223.15/223.35  |- mesh__recordAuthorizer mesh__D033181 jls
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D033181 2006
% 223.15/223.35  |- skos__hiddenLabel mesh__D033181 Distribution, Information
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D033181 2003
% 223.15/223.35  |- skos__related mesh__D033181smesh__D007255
% 223.15/223.35  |- mesh__recordOriginator mesh__D033181 jrf
% 223.15/223.35  |- mesh__historyNote mesh__D033181
% 223.15/223.35       2003; use INFORMATION SERVICES 1978-2002   
% 223.15/223.35  |- skos__historyNote mesh__D033181 Information Services %28%1968-2002%29%
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D033181 2005
% 223.15/223.35  |- skos__related mesh__D033181smesh__D004059
% 223.15/223.35  |- mesh__publicMeSHNote mesh__D033181
% 223.15/223.35       2003; see INFORMATION SERVICES 1978-2002   
% 223.15/223.35  |- mesh__dateCreated mesh__D033181 2002-07-03
% 223.15/223.35  |- mesh__dateEstablished mesh__D033181 2003-01-01
% 223.15/223.35  |- mesh__dateRevised mesh__D033181 2002-10-31
% 223.15/223.35  |- skos__hiddenLabel mesh__D033181 Dissemination, Information
% 223.15/223.35  |- rdf__type mesh__D033181sskos__Concept
% 223.15/223.35  |- mesh__recordMaintainer mesh__D033181 jls
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D033181 2003A
% 223.15/223.35  |- skos__scopeNote mesh__D033181
% 223.15/223.35       The circulation or wide dispersal of information.     
% 223.15/223.35  |- skos__broader mesh__D033181smesh__D003142
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D033181 2004
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D005490 2006
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D005490 2001
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D005490 1994
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D005490 2005
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D005490 2000
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D005490 1993
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D005490 1999
% 223.15/223.35  |- skos__broader mesh__D005490smesh__D007239
% 223.15/223.35  |- skos__hiddenLabel mesh__D005490 Infections, Focal
% 223.15/223.35  |- skos__prefLabel mesh__D005490 Focal Infection
% 223.15/223.35  |- skos__hiddenLabel mesh__D005490 Focal Infections
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D005490 2004
% 223.15/223.35  |- mesh__recordMaintainer mesh__D005490 SMH
% 223.15/223.35  |- skos__annotation mesh__D005490
% 223.15/223.35       IM; coord with precoord organ/dis site of infection %28%IM%29% + name of infection %28%IM%29%%A%  
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D005490 1992
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D005490 1998
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D005490 2003
% 223.15/223.35  |- mesh__dateRevised mesh__D005490 1981-05-21
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D005490 1989
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D005490 1997
% 223.15/223.35  |- mesh__recordAuthorizer mesh__D005490 MED
% 223.15/223.35  |- mesh__dateCreated mesh__D005490 1999-01-01
% 223.15/223.35  |- rdf__type mesh__D005490sskos__Concept
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D005490 1996
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D005490 1991
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D005490 2002
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D005490 1995
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D005490 1990
% 223.15/223.35  |- skos__hiddenLabel mesh__D005490 Infection, Focal
% 223.15/223.35  |- mesh__recordOriginator mesh__D005490 NLM
% 223.15/223.35  |- mesh__recordAuthorizer mesh__D013922 SJN
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013922 1999
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013922 2000
% 223.15/223.35  |- mesh__historyNote mesh__D013922 67%28%63%29%   
% 223.15/223.35  |- skos__hiddenLabel mesh__D013922 Thrombocythemias
% 223.15/223.35  |- skos__broader mesh__D013922smesh__D009196
% 223.15/223.35  |- skos__hiddenLabel mesh__D013922 Thrombocytoses
% 223.15/223.35  |- skos__broader mesh__D013922smesh__D001791
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013922 2006
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013922 2002
% 223.15/223.35  |- mesh__dateEstablished mesh__D013922 1967-01-01
% 223.15/223.35  |- mesh__recordMaintainer mesh__D013922 NNS
% 223.15/223.35  |- rdf__type mesh__D013922sskos__Concept
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013922 2004
% 223.15/223.35  |- skos__scopeNote mesh__D013922
% 223.15/223.35       Increased numbers of platelets in the peripheral blood. %28%Dorland, 27th ed%29%%A%    
% 223.15/223.35  |- skos__altLabel mesh__D013922 Thrombocythemia
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013922 2005
% 223.15/223.35  |- skos__annotation mesh__D013922
% 223.15/223.35       note X ref but hemorrhagic thrombocythemia = THROMBOCYTHEMIA, HEMORRHAGIC%A%  
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013922 2003
% 223.15/223.35  |- mesh__dateCreated mesh__D013922 1999-01-01
% 223.15/223.35  |- skos__prefLabel mesh__D013922 Thrombocytosis
% 223.15/223.35  |- mesh__publicMeSHNote mesh__D013922 67   
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013922 2001
% 223.15/223.35  |- mesh__dateRevised mesh__D013922 1998-06-11
% 223.15/223.35  |- mesh__recordOriginator mesh__D013922 NLM
% 223.15/223.35  |- mesh__recordAuthorizer mesh__D013124 SJN
% 223.15/223.35  |- skos__annotation mesh__D013124
% 223.15/223.35       do not confuse with SPINAL CORD INJURIES; GEN only, vertebrae unspecified%A%  
% 223.15/223.35  |- skos__prefLabel mesh__D013124 Spinal Injuries
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013124 2000
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013124 2003
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013124 2001
% 223.15/223.35  |- skos__hiddenLabel mesh__D013124 Spinal Injury
% 223.15/223.35  |- skos__altLabel mesh__D013124 Injuries, Spinal
% 223.15/223.35  |- rdf__type mesh__D013124sskos__Concept
% 223.15/223.35  |- skos__hiddenLabel mesh__D013124 Injury, Spinal
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013124 2005
% 223.15/223.35  |- skos__broader mesh__D013124smesh__D019567
% 223.15/223.35  |- mesh__recordOriginator mesh__D013124 NLM
% 223.15/223.35  |- skos__scopeNote mesh__D013124
% 223.15/223.35       Injuries involving the vertebral column.     
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013124 2004
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013124 2006
% 223.15/223.35  |- mesh__recordMaintainer mesh__D013124 TGC
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013124 2002
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013124 1998
% 223.15/223.35  |- mesh__dateRevised mesh__D013124 1997-06-20
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D013124 1999
% 223.15/223.35  |- skos__broader mesh__D013124smesh__D014947
% 223.15/223.35  |- mesh__dateCreated mesh__D013124 1999-01-01
% 223.15/223.35  |- mesh__recordOriginator mesh__D051243 DRC
% 223.15/223.35  |- skos__broader mesh__D051243smesh__D010750
% 223.15/223.35  |- mesh__historyNote mesh__D051243 2006%28%1997%29%   
% 223.15/223.35  |- skos__broader mesh__D051243smesh__D022461
% 223.15/223.35  |- skos__altLabel mesh__D051243 Caveolin-2
% 223.15/223.35  |- mesh__recordMaintainer mesh__D051243 DRC
% 223.15/223.35  |- mesh__dateEstablished mesh__D051243 2006-01-01
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D051243 2006
% 223.15/223.35  |- mesh__publicMeSHNote mesh__D051243
% 223.15/223.35       2006; CAVEOLIN 2 was indexed under CAVEOLINS 2001-2005, %26% under MEMBRANE PROTEINS 1997-2000%A%  
% 223.15/223.35  |- skos__scopeNote mesh__D051243
% 223.15/223.35       Caveolin 2 is a binding partner of CAVEOLIN 1. It undergoes tyrosine phosphorylation by C-SRC PROTEIN PP60 and plays a regulatory role in CAVEOLAE formation.%A%    
% 223.15/223.35  |- mesh__recordAuthorizer mesh__D051243 sjn
% 223.15/223.35  |- skos__broader mesh__D051243smesh__D048868
% 223.15/223.35  |- rdf__type mesh__D051243sskos__Concept
% 223.15/223.35  |- skos__prefLabel mesh__D051243 Caveolin 2
% 223.15/223.35  |- mesh__dateCreated mesh__D051243 2005-06-30
% 223.15/223.35  |- skos__altLabel mesh__D004398 ATPase, Dynein
% 223.15/223.35  |- skos__broader mesh__D004398smesh__D008868
% 223.15/223.35  |- mesh__dateRevised mesh__D004398 2005-06-30
% 223.15/223.35  |- mesh__onlineNote mesh__D004398
% 223.15/223.35       use DYNEIN ATPASE to search DYNEIN 1977-92   
% 223.15/223.35  |- skos__annotation mesh__D004398
% 223.15/223.35       a microtubule protein; /biosyn /physiol permitted   
% 223.15/223.35  |- skos__historyNote mesh__D004398
% 223.15/223.35       Adenosine Triphosphatase %28%1966-1976%29%
% 223.15/223.35  |- skos__altLabel mesh__D004398 Adenosinetriphosphatase, Dynein
% 223.15/223.35  |- skos__altLabel mesh__D004398 Dynein Adenosinetriphosphatase
% 223.15/223.35  |- skos__prefLabel mesh__D004398 Dynein ATPase
% 223.15/223.35  |- skos__historyNote mesh__D004398 Proteins %28%1966-1976%29%
% 223.15/223.35  |- mesh__dateCreated mesh__D004398 1976-05-19
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D004398 2006
% 223.15/223.35  |- mesh__recordMaintainer mesh__D004398 jmp
% 223.15/223.35  |- skos__altLabel mesh__D004398 Adenosine Triphosphatase, Dynein
% 223.15/223.35  |- skos__hiddenLabel mesh__D004398 Dynein Adenosine Triphosphatase
% 223.15/223.35  |- skos__broader mesh__D004398smesh__D011506
% 223.15/223.35  |- skos__broader mesh__D004398smesh__D000251
% 223.15/223.35  |- skos__altLabel mesh__D004398 Dynein
% 223.15/223.35  |- mesh__dateEstablished mesh__D004398 1991-01-01
% 223.15/223.35  |- skos__scopeNote mesh__D004398
% 223.15/223.35       A structural protein which forms the arms on the microtubule doublets of cilia and flagella. In the presence of divalent cations, dynein catalyzes the hydrolysis of ATP. This hydrolysis plays an important functional role in the motility process. This enzyme was formerly listed as EC 3.6.1.33.%A%    
% 223.15/223.35  |- mesh__publicMeSHNote mesh__D004398
% 223.15/223.35       93; was DYNEIN 1977-92 %28%see under ADENOSINE TRIPHOSPHATASE 1977-90%29%%A%  
% 223.15/223.35  |- mesh__historyNote mesh__D004398
% 223.15/223.35       93; was DYNEIN 1977-92 %28%see under ADENOSINE TRIPHOSPHATASE 1977-90%29%%A%  
% 223.15/223.35  |- mesh__recordOriginator mesh__D004398 RLS
% 223.15/223.35  |- mesh__recordAuthorizer mesh__D004398 sjn
% 223.15/223.35  |- rdf__type mesh__D004398sskos__Concept
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009881 1997
% 223.15/223.35  |- skos__hiddenLabel mesh__D009881 Assistant, Ophthalmic
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009881 2005
% 223.15/223.35  |- mesh__recordMaintainer mesh__D009881 TAP
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009881 1993
% 223.15/223.35  |- skos__scopeNote mesh__D009881
% 223.15/223.35       Persons academically trained to care for patients with eye diseases or structural defects of the eye, under the supervision of an ophthalmologist.%A%    
% 223.15/223.35  |- mesh__historyNote mesh__D009881
% 223.15/223.35       91%28%75%29%; was see under PHYSICIANS%27% ASSISTANTS 1975-90   
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009881 2000
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009881 1998
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009881 2006
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009881 1994
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009881 1999
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009881 2001
% 223.15/223.35  |- mesh__publicMeSHNote mesh__D009881
% 223.15/223.35       91; was see under PHYSICIANS%27% ASSISTANTS 1975-90   
% 223.15/223.35  |- rdf__type mesh__D009881sskos__Concept
% 223.15/223.35  |- skos__hiddenLabel mesh__D009881 Assistants, Ophthalmic
% 223.15/223.35  |- mesh__dateCreated mesh__D009881 1999-01-01
% 223.15/223.35  |- skos__broader mesh__D009881smesh__D010823
% 223.15/223.35  |- mesh__recordOriginator mesh__D009881 NLM
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009881 1995
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009881 2002
% 223.15/223.35  |- mesh__dateRevised mesh__D009881 1992-05-15
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009881 2003
% 223.15/223.35  |- mesh__recordAuthorizer mesh__D009881 PLS
% 223.15/223.35  |- mesh__onlineNote mesh__D009881
% 223.15/223.35       search PHYSICIANS%27% ASSISTANTS 1971-74   
% 223.15/223.35  |- mesh__dateEstablished mesh__D009881 1991-01-01
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009881 1996
% 223.15/223.35  |- skos__hiddenLabel mesh__D009881 Ophthalmic Assistant
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009881 2004
% 223.15/223.35  |- skos__prefLabel mesh__D009881 Ophthalmic Assistants
% 223.15/223.35  |- skos__scopeNote mesh__D009083
% 223.15/223.35       Group of lysosomal storage diseases each caused by an inherited deficiency of an enzyme involved in the degradation of glycosaminoglycans %28%mucopolysaccharides%29%. The diseases are progressive and often display a wide spectrum of clinical severity within one enzyme deficiency.%A%    
% 223.15/223.35  |- skos__broader mesh__D009083smesh__D002239
% 223.15/223.35  |- rdf__type mesh__D009083sskos__Concept
% 223.15/223.35  |- mesh__onlineNote mesh__D009083
% 223.15/223.35       use MUCOPOLYSACCHARIDOSES to search MUCOPOLYSACCHARIDOSIS 1974-91%A%  
% 223.15/223.35  |- skos__prefLabel mesh__D009083 Mucopolysaccharidoses
% 223.15/223.35  |- mesh__dateEstablished mesh__D009083 1974-01-01
% 223.15/223.35  |- mesh__activeMeSHYear mesh__D009083 2002
% 223.15/223.35  |- mesh__dateRevised mesh__D009083 2001-07-25
% 223.15/223.36  |- skos__annotation mesh__D009083
% 223.15/223.36       lysosomal storage dis; types I through VII except V are available as main headings: V = MUCOPOLYSACCHARIDOSIS V see MUCOPOLYSACCHARIDOSIS I; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 223.15/223.36  |- mesh__publicMeSHNote mesh__D009083
% 223.15/223.36       92; was MUCOPOLYSACCHARIDOSIS 1974-91   
% 223.15/223.36  |- skos__broader mesh__D009083smesh__D017520
% 223.15/223.36  |- mesh__recordAuthorizer mesh__D009083 sjn
% 223.15/223.36  |- skos__broader mesh__D009083smesh__D016464
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D009083 2006
% 223.15/223.36  |- mesh__dateCreated mesh__D009083 1999-01-01
% 223.15/223.36  |- mesh__recordMaintainer mesh__D009083 nns
% 223.15/223.36  |- mesh__recordOriginator mesh__D009083 NLM
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D009083 2004
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D009083 2005
% 223.15/223.36  |- skos__altLabel mesh__D009083 Mucopolysaccharidosis
% 223.15/223.36  |- mesh__historyNote mesh__D009083 92; was MUCOPOLYSACCHARIDOSIS 1974-91   
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D009083 2003
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017515 2002
% 223.15/223.36  |- mesh__publicMeSHNote mesh__D017515 93   
% 223.15/223.36  |- mesh__dateEstablished mesh__D017515 1993-01-01
% 223.15/223.36  |- mesh__historyNote mesh__D017515 93   
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017515 2003
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017515 2000
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017515 2005
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017515 2004
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017515 1996
% 223.15/223.36  |- rdf__type mesh__D017515sskos__Concept
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017515 2001
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017515 2006
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017515 1998
% 223.15/223.36  |- skos__scopeNote mesh__D017515
% 223.15/223.36       A mild exanthematous inflammation of unknown etiology. It is characterized by the presence of salmon-colored maculopapular lesions. The most striking feature is the arrangement of the lesions such that the long axis is parallel to the lines of cleavage. The eruptions are usually generalized, affecting chiefly the trunk, and the course is often self-limiting.%A%    
% 223.15/223.36  |- mesh__dateCreated mesh__D017515 1992-05-22
% 223.15/223.36  |- skos__historyNote mesh__D017515 Pityriasis %28%1966-1992%29%
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017515 1997
% 223.15/223.36  |- skos__broader mesh__D017515smesh__D010915
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017515 1994
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017515 1999
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017515 1993
% 223.15/223.36  |- skos__prefLabel mesh__D017515 Pityriasis Rosea
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017515 1995
% 223.15/223.36  |- mesh__historyNote mesh__D033182 2003; use MOTIVATION 1993-2002   
% 223.15/223.36  |- skos__related mesh__D033182smesh__D006040
% 223.15/223.36  |- skos__related mesh__D033182smesh__D001290
% 223.15/223.36  |- skos__prefLabel mesh__D033182 Intention
% 223.15/223.36  |- skos__hiddenLabel mesh__D033182 Intentions
% 223.15/223.36  |- skos__broader mesh__D033182smesh__D008606
% 223.15/223.36  |- mesh__publicMeSHNote mesh__D033182 2003; see MOTIVATION 1993-2002   
% 223.15/223.36  |- rdf__type mesh__D033182sskos__Concept
% 223.15/223.36  |- skos__related mesh__D033182smesh__D034723
% 223.15/223.36  |- mesh__recordOriginator mesh__D033182 jrf
% 223.15/223.36  |- mesh__recordAuthorizer mesh__D033182 sjn
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D033182 2004
% 223.15/223.36  |- skos__broader mesh__D033182smesh__D009042
% 223.15/223.36  |- mesh__recordMaintainer mesh__D033182 hjn
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D033182 2006
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D033182 2003
% 223.15/223.36  |- mesh__dateEstablished mesh__D033182 2003-01-01
% 223.15/223.36  |- skos__scopeNote mesh__D033182
% 223.15/223.36       What a person has in mind to do or bring about.     
% 223.15/223.36  |- mesh__dateCreated mesh__D033182 2002-07-03
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D033182 2005
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D005491 2005
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D005491 1993
% 223.15/223.36  |- mesh__dateRevised mesh__D005491 1990-05-29
% 223.15/223.36  |- mesh__publicMeSHNote mesh__D005491 64   
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D005491 1999
% 223.15/223.36  |- skos__altLabel mesh__D005491 Infection, Dental Focal
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D005491 2002
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D005491 2004
% 223.15/223.36  |- mesh__recordOriginator mesh__D005491 NLM
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D005491 1992
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D005491 1998
% 223.15/223.36  |- skos__prefLabel mesh__D005491 Focal Infection, Dental
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D005491 2001
% 223.15/223.36  |- mesh__recordAuthorizer mesh__D005491 PLS
% 223.15/223.36  |- skos__altLabel mesh__D005491 Dental Focal Infections
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D005491 2003
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D005491 1997
% 223.15/223.36  |- skos__annotation mesh__D005491
% 223.15/223.36       IM; coord with precoord organ/dis site of infection %28%IM%29% + name of infection %28%IM%29%; DF: FOCAL INFECT DENT%A%  
% 223.15/223.36  |- mesh__dateCreated mesh__D005491 1999-01-01
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D005491 2000
% 223.15/223.36  |- rdf__type mesh__D005491sskos__Concept
% 223.15/223.36  |- mesh__recordMaintainer mesh__D005491 TAP
% 223.15/223.36  |- skos__altLabel mesh__D005491 Infections, Dental Focal
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D005491 1996
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D005491 1995
% 223.15/223.36  |- mesh__historyNote mesh__D005491 64   
% 223.15/223.36  |- skos__broader mesh__D005491smesh__D014076
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D005491 2006
% 223.15/223.36  |- skos__altLabel mesh__D005491 Dental Focal Infection
% 223.15/223.36  |- skos__altLabel mesh__D005491 Focal Infections, Dental
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D005491 1994
% 223.15/223.36  |- skos__scopeNote mesh__D005491
% 223.15/223.36       Secondary or systemic infections due to dissemination throughout the body of microorganisms whose primary focus of infection lies in the periodontal tissues.%A%    
% 223.15/223.36  |- skos__broader mesh__D005491smesh__D005490
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D005491 1991
% 223.15/223.36  |- mesh__dateEstablished mesh__D005491 1964-01-01
% 223.15/223.36  |- mesh__recordAuthorizer mesh__D013923 SJN
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013923 1999
% 223.15/223.36  |- skos__hiddenLabel mesh__D013923 Thromboembolisms
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013923 2000
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013923 2005
% 223.15/223.36  |- skos__broader mesh__D013923smesh__D013927
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013923 2001
% 223.15/223.36  |- mesh__dateCreated mesh__D013923 1999-01-01
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013923 2003
% 223.15/223.36  |- mesh__recordOriginator mesh__D013923 NLM
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013923 2006
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013923 2002
% 223.15/223.36  |- skos__prefLabel mesh__D013923 Thromboembolism
% 223.15/223.36  |- rdf__type mesh__D013923sskos__Concept
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013923 2004
% 223.15/223.36  |- mesh__dateRevised mesh__D013923 1997-06-20
% 223.15/223.36  |- skos__scopeNote mesh__D013923
% 223.15/223.36       Obstruction of a vessel by a blood clot that has been transported from a distant site by the blood stream.%A%    
% 223.15/223.36  |- skos__broader mesh__D013923smesh__D004617
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013923 1998
% 223.15/223.36  |- mesh__recordMaintainer mesh__D013923 TGC
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013125 2003
% 223.15/223.36  |- rdf__type mesh__D013125sskos__Concept
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013125 2005
% 223.15/223.36  |- skos__hiddenLabel mesh__D013125 Neoplasms, Spinal
% 223.15/223.36  |- skos__prefLabel mesh__D013125 Spinal Neoplasms
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013125 2004
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013125 2006
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013125 2000
% 223.15/223.36  |- skos__broader mesh__D013125smesh__D001859
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013125 2001
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013125 1996
% 223.15/223.36  |- mesh__recordMaintainer mesh__D013125 KEV
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013125 1998
% 223.15/223.36  |- mesh__recordOriginator mesh__D013125 NLM
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013125 1997
% 223.15/223.36  |- skos__hiddenLabel mesh__D013125 Neoplasm, Spinal
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013125 1999
% 223.15/223.36  |- mesh__dateCreated mesh__D013125 1999-01-01
% 223.15/223.36  |- mesh__dateRevised mesh__D013125 1995-06-08
% 223.15/223.36  |- skos__hiddenLabel mesh__D013125 Spinal Neoplasm
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013125 2002
% 223.15/223.36  |- mesh__recordAuthorizer mesh__D013125 PLS
% 223.15/223.36  |- skos__annotation mesh__D013125
% 223.15/223.36       do not confuse with SPINAL CORD NEOPLASMS; coord IM with specific vertebrae %28%IM%29% + histol type of neopl %28%IM%29%; /blood supply /chem /second /secret /ultrastruct permitted%A%  
% 223.15/223.36  |- skos__broader mesh__D013125smesh__D013122
% 223.15/223.36  |- mesh__dateEstablished mesh__D051244 2006-01-01
% 223.15/223.36  |- mesh__recordOriginator mesh__D051244 DRC
% 223.15/223.36  |- rdf__type mesh__D051244sskos__Concept
% 223.15/223.36  |- skos__altLabel mesh__D051244 Caveolin-3
% 223.15/223.36  |- mesh__historyNote mesh__D051244 2006%28%1996%29%   
% 223.15/223.36  |- skos__hiddenLabel mesh__D051244 Caveolin, Muscle
% 223.15/223.36  |- skos__altLabel mesh__D051244 M-Caveolin
% 223.15/223.36  |- mesh__publicMeSHNote mesh__D051244
% 223.15/223.36       2006 CAVEOLIN 3 was indexed under CAVEOLINS 2005, %26% under MEMBRANE PROTEINS 2000%A%  
% 223.15/223.36  |- skos__scopeNote mesh__D051244
% 223.15/223.36       A caveolin that is expressed exclusively in MUSCLE CELLS and is sufficient to form CAVEOLAE in SARCOLEMMA. Mutations in caveolin 3 are associated with multiple muscle diseases including DISTAL MYOPATHY and LIMB-GIRDLE MUSCULAR DYSTROPHY.%A%    
% 223.15/223.36  |- skos__altLabel mesh__D051244 Muscle Caveolin
% 223.15/223.36  |- skos__broader mesh__D051244smesh__D009124
% 223.15/223.36  |- mesh__recordMaintainer mesh__D051244 DRC
% 223.15/223.36  |- skos__broader mesh__D051244smesh__D022461
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D051244 2006
% 223.15/223.36  |- mesh__dateCreated mesh__D051244 2005-06-30
% 223.15/223.36  |- skos__prefLabel mesh__D051244 Caveolin 3
% 223.15/223.36  |- mesh__recordAuthorizer mesh__D051244 sjn
% 223.15/223.36  |- mesh__recordOriginator mesh__D004399 RLS
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D004399 2006
% 223.15/223.36  |- mesh__publicMeSHNote mesh__D004399 95; was DYNORPHIN 1985-94   
% 223.15/223.36  |- mesh__recordAuthorizer mesh__D004399 sjn
% 223.15/223.36  |- skos__scopeNote mesh__D004399
% 223.15/223.36       A class of opioid peptides including dynorphin A, dynorphin B, and smaller fragments of these peptides. Dynorphins prefer kappa-opioid receptors %28%RECEPTORS, OPIOID, KAPPA%29% and have been shown to play a role as central nervous system transmitters.%A%    
% 223.15/223.36  |- skos__related mesh__D004399smesh__D017473
% 223.15/223.36  |- skos__altLabel mesh__D004399 Dynorphin A
% 223.15/223.36  |- mesh__dateCreated mesh__D004399 1984-05-25
% 223.15/223.36  |- rdf__type mesh__D004399sskos__Concept
% 223.15/223.36  |- skos__broader mesh__D004399smesh__D018847
% 223.15/223.36  |- skos__historyNote mesh__D004399 Peptides %28%1966-Jul 1977%29%
% 223.15/223.36  |- mesh__dateRevised mesh__D004399 2005-06-30
% 223.15/223.36  |- mesh__onlineNote mesh__D004399
% 223.15/223.36       use DYNORPHINS to search DYNORPHIN 1985-94   
% 223.15/223.36  |- mesh__historyNote mesh__D004399 95; was DYNORPHIN 1985-94   
% 223.15/223.36  |- skos__altLabel mesh__D004399 Dynorphin
% 223.15/223.36  |- mesh__dateEstablished mesh__D004399 1985-01-01
% 223.15/223.36  |- mesh__recordMaintainer mesh__D004399 ssb
% 223.15/223.36  |- skos__prefLabel mesh__D004399 Dynorphins
% 223.15/223.36  |- skos__altLabel mesh__D004399 Dynorphin A %28%1-17%29%
% 223.15/223.36  |- skos__historyNote mesh__D004399 Endorphins %28%Jul 1977-1984%29%
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D009882 2003
% 223.15/223.36  |- skos__broader mesh__D009882smesh__D014276
% 223.15/223.36  |- skos__prefLabel mesh__D009882 Ophthalmic Nerve
% 223.15/223.36  |- mesh__dateCreated mesh__D009882 1999-01-01
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D009882 2002
% 223.15/223.36  |- mesh__recordMaintainer mesh__D009882 MSR
% 223.15/223.36  |- skos__annotation mesh__D009882
% 223.15/223.36       a branch of the trigeminal %28%5th cranial%29% nerve; dis: coord IM with CRANIAL NERVE DISEASES %28%IM%29%; neopl: coord IM with CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D009882 2006
% 223.15/223.36  |- skos__hiddenLabel mesh__D009882 Nerves, Ophthalmic
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D009882 2001
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D009882 1999
% 223.15/223.36  |- skos__hiddenLabel mesh__D009882 Ophthalmic Nerves
% 223.15/223.36  |- rdf__type mesh__D009882sskos__Concept
% 223.15/223.36  |- mesh__dateRevised mesh__D009882 1998-06-10
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D009882 2000
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D009882 2005
% 223.15/223.36  |- skos__hiddenLabel mesh__D009882 Nerve, Ophthalmic
% 223.15/223.36  |- mesh__recordAuthorizer mesh__D009882 SJN
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D009882 2004
% 223.15/223.36  |- mesh__recordOriginator mesh__D009882 NLM
% 223.15/223.36  |- skos__scopeNote mesh__D009882
% 223.15/223.36       A sensory branch of the trigeminal %28%5th cranial%29% nerve. The ophthalmic nerve carries general afferents from the superficial division of the face including the eyeball, conjunctiva, upper eyelid, upper nose, nasal mucosa, and scalp.%A%    
% 223.15/223.36  |- mesh__recordOriginator mesh__D009084 NLM
% 223.15/223.36  |- skos__prefLabel mesh__D009084 Mucopolysaccharidosis III
% 223.15/223.36  |- mesh__historyNote mesh__D009084
% 223.15/223.36       92; was MUCOPOLYSACCHARIDOSIS 3 1991; was see under MUCOPOLYSACCHARIDOSIS 1975-90%A%  
% 223.15/223.36  |- skos__historyNote mesh__D009084 Mental Retardation %28%1966-1976%29%
% 223.15/223.36  |- skos__historyNote mesh__D009084
% 223.15/223.36       Carbohydrate Metabolism, Inborn Errors %28%1966-1976%29%
% 223.15/223.36  |- skos__hiddenLabel mesh__D009084 Syndrome, San Filippo%27%s
% 223.15/223.36  |- skos__hiddenLabel mesh__D009084 Oligophrenias, Polydystrophic
% 223.15/223.36  |- skos__altLabel mesh__D009084 Sanfilippo%27%s Syndrome
% 223.15/223.36  |- skos__altLabel mesh__D009084 Polydystrophic Oligophrenia
% 223.15/223.36  |- skos__altLabel mesh__D009084 Mucopolysaccharidosis 3
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D009084 2006
% 223.15/223.36  |- mesh__dateEstablished mesh__D009084 1991-01-01
% 223.15/223.36  |- mesh__onlineNote mesh__D009084
% 223.15/223.36       use MUCOPOLYSACCHARIDOSIS III to search MUCOPOLYSACCHARIDOSIS 3 1975-91%A%  
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D009084 2004
% 223.15/223.36  |- skos__hiddenLabel mesh__D009084 Syndrome, Sanfilippo%27%s
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D009084 2005
% 223.15/223.36  |- skos__hiddenLabel mesh__D009084 San Filippos Syndrome
% 223.15/223.36  |- skos__historyNote mesh__D009084 Mucopolysaccharidosis %28%1974%29%
% 223.15/223.36  |- skos__hiddenLabel mesh__D009084 IIIs, Mucopolysaccharidosis
% 223.15/223.36  |- mesh__dateCreated mesh__D009084 1974-12-12
% 223.15/223.36  |- skos__scopeNote mesh__D009084
% 223.15/223.36       Mucopolysaccharidosis characterized by heparitin sulfate in the urine, progressive mental retardation, mild dwarfism, and other skeletal disorders. There are four clinically indistinguishable but biochemically distinct forms, each due to a deficiency of a different enzyme.%A%    
% 223.15/223.36  |- skos__hiddenLabel mesh__D009084 Polydystrophic Oligophrenias
% 223.15/223.36  |- skos__hiddenLabel mesh__D009084 Sanfilippo Syndrome
% 223.15/223.36  |- mesh__publicMeSHNote mesh__D009084
% 223.15/223.36       92; was MUCOPOLYSACCHARIDOSIS 3 1991; was see under MUCOPOLYSACCHARIDOSIS 1975-90%A%  
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D009084 2003
% 223.15/223.36  |- rdf__type mesh__D009084sskos__Concept
% 223.15/223.36  |- skos__broader mesh__D009084smesh__D009083
% 223.15/223.36  |- skos__historyNote mesh__D009084
% 223.15/223.36       Mucopolysaccharides/metabolism %28%1966-1974%29%
% 223.15/223.36  |- skos__hiddenLabel mesh__D009084 San Filippo Syndrome
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D009084 2002
% 223.15/223.36  |- mesh__recordMaintainer mesh__D009084 nns
% 223.15/223.36  |- mesh__dateRevised mesh__D009084 2001-07-25
% 223.15/223.36  |- skos__hiddenLabel mesh__D009084 Mucopolysaccharidosis IIIs
% 223.15/223.36  |- skos__hiddenLabel mesh__D009084 Oligophrenia, Polydystrophic
% 223.15/223.36  |- mesh__recordAuthorizer mesh__D009084 sjn
% 223.15/223.36  |- skos__annotation mesh__D009084
% 223.15/223.36       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: MPS III%A%  
% 223.15/223.36  |- skos__hiddenLabel mesh__D009084 Sanfilippos Syndrome
% 223.15/223.36  |- skos__altLabel mesh__D009084 San Filippo%27%s Syndrome
% 223.15/223.36  |- mesh__dateCreated mesh__D017516 1992-05-20
% 223.15/223.36  |- mesh__recordAuthorizer mesh__D017516 SJN
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017516 2000
% 223.15/223.36  |- mesh__recordMaintainer mesh__D017516 TGC
% 223.15/223.36  |- mesh__dateEstablished mesh__D017516 1998-01-01
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017516 2003
% 223.15/223.36  |- rdf__type mesh__D017516sskos__Concept
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017516 2001
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017516 2005
% 223.15/223.36  |- mesh__historyNote mesh__D017516 98; use explode 1993-97   
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017516 1998
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017516 2004
% 223.15/223.36  |- skos__scopeNote mesh__D017516
% 223.15/223.36       Countries known in remote history %28%as BYZANTIUM%29% or former names of countries reflecting political changes in the 20th century %28%as GERMANY, EAST%29%.%A%    
% 223.15/223.36  |- mesh__recordOriginator mesh__D017516 TGC
% 223.15/223.36  |- mesh__dateRevised mesh__D017516 1997-06-20
% 223.15/223.36  |- skos__annotation mesh__D017516
% 223.15/223.36       %22%historical%22% refers to the more remote or recent past or to a term with historic significance aside from its location; all historical %26% century check tags apply%A%  
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017516 2006
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017516 1999
% 223.15/223.36  |- skos__prefLabel mesh__D017516 Historical Geographic Locations
% 223.15/223.36  |- skos__historyNote mesh__D017516
% 223.15/223.36       specific geographic location %28%1966-1997%29%
% 223.15/223.36  |- skos__broader mesh__D017516smesh__D005842
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D017516 2002
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D033981 2005
% 223.15/223.36  |- mesh__dateCreated mesh__D033981 2002-07-02
% 223.15/223.36  |- mesh__publicMeSHNote mesh__D033981
% 223.15/223.36       2003; DELTA-ADAPTIN %28%now ADAPTOR PROTEIN COMPLEX DELTA SUBUNITS%29% was indexed under MEMBRANE PROTEINS 1997-2002%A%  
% 223.15/223.36  |- rdf__type mesh__D033981sskos__Concept
% 223.15/223.36  |- mesh__historyNote mesh__D033981
% 223.15/223.36       2003; use ADAPTOR PROTEIN COMPLEX DELTA SUBUNITS %28%NM%29% 1997-2002%A%  
% 223.15/223.36  |- mesh__dateRevised mesh__D033981 2004-07-07
% 223.15/223.36  |- skos__broader mesh__D033981smesh__D034001
% 223.15/223.36  |- skos__scopeNote mesh__D033981
% 223.15/223.36       A family of large adaptin protein subunits of approximately 130-kDa in size. They have been primarily found as components of ADAPTOR PROTEIN COMPLEX 3.%A%    
% 223.15/223.36  |- skos__altLabel mesh__D033981 delta-Adaptin
% 223.15/223.36  |- skos__prefLabel mesh__D033981 Adaptor Protein Complex delta Subunits
% 223.15/223.36  |- mesh__recordAuthorizer mesh__D033981 sjn
% 223.15/223.36  |- skos__historyNote mesh__D033981 Membrane Proteins %28%1997-2002%29%
% 223.15/223.36  |- mesh__dateEstablished mesh__D033981 2003-01-01
% 223.15/223.36  |- mesh__recordMaintainer mesh__D033981 jmp
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D033981 2006
% 223.15/223.36  |- skos__hiddenLabel mesh__D033981 delta Adaptin
% 223.15/223.36  |- mesh__recordOriginator mesh__D033981 jmp
% 223.15/223.36  |- skos__hiddenLabel mesh__D033183 Cross Disciplinary Communication
% 223.15/223.36  |- skos__hiddenLabel mesh__D033183 Communications, Cross-Disciplinary
% 223.15/223.36  |- skos__hiddenLabel mesh__D033183 Multidisciplinary Communications
% 223.15/223.36  |- skos__hiddenLabel mesh__D033183 Communication, Cross-Disciplinary
% 223.15/223.36  |- mesh__publicMeSHNote mesh__D033183
% 223.15/223.36       2003; see INTERPROFESSIONAL RELATIONS 1992-2002   
% 223.15/223.36  |- skos__related mesh__D033183smesh__D007400
% 223.15/223.36  |- mesh__dateCreated mesh__D033183 2002-07-03
% 223.15/223.36  |- rdf__type mesh__D033183sskos__Concept
% 223.15/223.36  |- skos__annotation mesh__D033183
% 223.15/223.36       use only for communication across disciplines; for relations between individuals in different disciplines, use instead INTERPROFESSIONAL RELATIONS; coord IM with specific disciplines %28%IM%29%%A%  
% 223.15/223.36  |- skos__broader mesh__D033183smesh__D003142
% 223.15/223.36  |- skos__altLabel mesh__D033183 Multidisciplinary Communication
% 223.15/223.36  |- skos__hiddenLabel mesh__D033183 Communications, Multidisciplinary
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D033183 2004
% 223.15/223.36  |- skos__hiddenLabel mesh__D033183 Interdisciplinary Communications
% 223.15/223.36  |- skos__hiddenLabel mesh__D033183 Cross-Disciplinary Communications
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D033183 2006
% 223.15/223.36  |- mesh__historyNote mesh__D033183
% 223.15/223.36       2003; use INTERPROFESSIONAL RELATIONS 1992-2002   
% 223.15/223.36  |- skos__hiddenLabel mesh__D033183 Communication, Interdisciplinary
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D033183 2003
% 223.15/223.36  |- skos__hiddenLabel mesh__D033183 Communications, Interdisciplinary
% 223.15/223.36  |- skos__historyNote mesh__D033183
% 223.15/223.36       Interprofessional Relations %28%1974-2002%29%
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D033183 2005
% 223.15/223.36  |- skos__broader mesh__D033183smesh__D007400
% 223.15/223.36  |- skos__hiddenLabel mesh__D033183 Communication, Multidisciplinary
% 223.15/223.36  |- skos__altLabel mesh__D033183 Cross-Disciplinary Communication
% 223.15/223.36  |- skos__scopeNote mesh__D033183
% 223.15/223.36       Communication, in the sense of cross-fertilization of ideas, involving two or more academic disciplines %28%such as the disciplines that comprise the cross-disciplinary field of bioethics, including the health and biological sciences, the humanities, and the social sciences and law%29%.  Also includes problems in communication stemming from differences in patterns of language usage in different academic or medical disciplines.%A%    
% 223.15/223.36  |- mesh__dateEstablished mesh__D033183 2003-01-01
% 223.15/223.36  |- skos__prefLabel mesh__D033183 Interdisciplinary Communication
% 223.15/223.36  |- mesh__dateCreated mesh__D005492 1999-01-01
% 223.15/223.36  |- rdf__type mesh__D005492sskos__Concept
% 223.15/223.36  |- skos__prefLabel mesh__D005492 Folic Acid
% 223.15/223.36  |- skos__hiddenLabel mesh__D005492 Acid, Pteroylglutamic
% 223.15/223.36  |- skos__hiddenLabel mesh__D005492 Level, Serum Folate
% 223.15/223.36  |- skos__altLabel mesh__D005492 Vitamin M
% 223.15/223.36  |- mesh__dateRevised mesh__D005492 2005-06-30
% 223.15/223.36  |- mesh__recordMaintainer mesh__D005492 ssb
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D005492 2006
% 223.15/223.36  |- mesh__onlineNote mesh__D005492
% 223.15/223.36       use FOLIC ACID/AA to search HOMOFOLIC ACID 1975-84   
% 223.15/223.36  |- mesh__historyNote mesh__D005492 HOMOFOLIC ACID was heading 1975-84   
% 223.15/223.36  |- mesh__publicMeSHNote mesh__D005492 HOMOFOLIC ACID was heading 1975-84   
% 223.15/223.36  |- mesh__recordOriginator mesh__D005492 NLM
% 223.15/223.36  |- skos__scopeNote mesh__D005492
% 223.15/223.36       A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses %28%POACEAE%29%. Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia.%A%    
% 223.15/223.36  |- skos__altLabel mesh__D005492 Pteroylglutamic Acid
% 223.15/223.36  |- skos__hiddenLabel mesh__D005492 Acid, Folic
% 223.15/223.36  |- mesh__recordAuthorizer mesh__D005492 sjn
% 223.15/223.36  |- skos__broader mesh__D005492smesh__D011622
% 223.15/223.36  |- skos__related mesh__D013924smesh__D016306
% 223.15/223.36  |- skos__broader mesh__D013924smesh__D010689
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013924 2005
% 223.15/223.36  |- mesh__recordAuthorizer mesh__D013924 sjn
% 223.15/223.36  |- mesh__dateCreated mesh__D013924 1999-01-01
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013924 2003
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013924 2006
% 223.15/223.36  |- rdf__type mesh__D013924sskos__Concept
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013924 2004
% 223.15/223.36  |- mesh__historyNote mesh__D013924
% 223.15/223.36       PHLEGMASIA ALBA DOLENS was see under THROMBOPHLEBITIS 1963-78%A%  
% 223.15/223.36  |- skos__annotation mesh__D013924
% 223.15/223.36       assume to be of the legs so do not coord with LEG   
% 223.15/223.36  |- mesh__recordOriginator mesh__D013924 NLM
% 223.15/223.36  |- mesh__dateRevised mesh__D013924 2002-07-03
% 223.15/223.36  |- skos__scopeNote mesh__D013924
% 223.15/223.36       Inflammation of a vein associated with thrombus formation.%A%    
% 223.15/223.36  |- skos__hiddenLabel mesh__D013924 Thrombophlebitides
% 223.15/223.36  |- mesh__onlineNote mesh__D013924
% 223.15/223.36       use THROMBOPHLEBITIS to search PHLEGMASIA ALBA DOLENS 1966-78%A%  
% 223.15/223.36  |- mesh__recordMaintainer mesh__D013924 mdb
% 223.15/223.36  |- skos__broader mesh__D013924smesh__D020246
% 223.15/223.36  |- skos__hiddenLabel mesh__D013924 Dolens, Phlegmasia Alba
% 223.15/223.36  |- skos__prefLabel mesh__D013924 Thrombophlebitis
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013126 2000
% 223.15/223.36  |- skos__hiddenLabel mesh__D013126 Roots, Ventral
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013126 1997
% 223.15/223.36  |- skos__hiddenLabel mesh__D013126 Roots, Spinal Nerve
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013126 2005
% 223.15/223.36  |- mesh__publicMeSHNote mesh__D013126 73   
% 223.15/223.36  |- skos__hiddenLabel mesh__D013126 Root, Spinal Nerve
% 223.15/223.36  |- mesh__recordAuthorizer mesh__D013126 PLS
% 223.15/223.36  |- mesh__dateCreated mesh__D013126 1999-01-01
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013126 2001
% 223.15/223.36  |- skos__hiddenLabel mesh__D013126 Root, Spinal
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013126 2006
% 223.15/223.36  |- mesh__dateEstablished mesh__D013126 1973-01-01
% 223.15/223.36  |- skos__prefLabel mesh__D013126 Spinal Nerve Roots
% 223.15/223.36  |- skos__hiddenLabel mesh__D013126 Dorsal Root
% 223.15/223.36  |- skos__altLabel mesh__D013126 Spinal Roots
% 223.15/223.36  |- skos__hiddenLabel mesh__D013126 Nerve Root, Spinal
% 223.15/223.36  |- skos__related mesh__D013126smesh__D011843
% 223.15/223.36  |- skos__hiddenLabel mesh__D013126 Spinal Root
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013126 1998
% 223.15/223.36  |- skos__broader mesh__D013126smesh__D013127
% 223.15/223.36  |- skos__hiddenLabel mesh__D013126 Nerve Roots, Spinal
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013126 2003
% 223.15/223.36  |- skos__hiddenLabel mesh__D013126 Ventral Root
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013126 2002
% 223.15/223.36  |- skos__annotation mesh__D013126
% 223.15/223.36       /surg: consider also RHIZOTOMY; DORSAL ROOT GANGLIA is see GANGLIA, SPINAL; inflammation = RADICULITIS %28%single root%29% or POLYRADICULITIS %28%several roots%29% or POLYRADICULONEURITIS %28%nerve roots %26% peripheral nerves%29%; do not use vertebra headings to locate area of spinal nerves; nerve root compression: coord IM with NERVE COMPRESSION SYNDROMES %28%IM%29%, not SPINAL CORD COMPRESSION%A%  
% 223.15/223.36  |- skos__hiddenLabel mesh__D013126 Spinal Nerve Root
% 223.15/223.36  |- skos__scopeNote mesh__D013126
% 223.15/223.36       The paired bundles of nerve fibers entering and leaving the spinal cord at each segment. The dorsal and ventral nerve roots join to form the mixed segmental spinal nerves. The dorsal roots are generally afferent, formed by the central projections of the spinal %28%dorsal root%29% ganglia sensory cells, and the ventral roots efferent, comprising the axons of spinal motor and autonomic preganglionic neurons. There are, however, some exceptions to this afferent/efferent rule.%A%    
% 223.15/223.36  |- skos__related mesh__D013126smesh__D011128
% 223.15/223.36  |- mesh__recordOriginator mesh__D013126 NLM
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013126 1999
% 223.15/223.36  |- skos__historyNote mesh__D013126 Spinal Nerves %28%1966-1969%29%
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013126 2004
% 223.15/223.36  |- skos__hiddenLabel mesh__D013126 Root, Dorsal
% 223.15/223.36  |- mesh__historyNote mesh__D013126 73%28%70%29%   
% 223.15/223.36  |- rdf__type mesh__D013126sskos__Concept
% 223.15/223.36  |- skos__hiddenLabel mesh__D013126 Roots, Dorsal
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D013126 1996
% 223.15/223.36  |- skos__hiddenLabel mesh__D013126 Roots, Spinal
% 223.15/223.36  |- mesh__dateRevised mesh__D013126 1995-05-31
% 223.15/223.36  |- skos__related mesh__D013126smesh__D019051
% 223.15/223.36  |- mesh__recordMaintainer mesh__D013126 TGC
% 223.15/223.36  |- skos__hiddenLabel mesh__D013126 Root, Ventral
% 223.15/223.36  |- skos__broader mesh__D051245smesh__D007395
% 223.15/223.36  |- mesh__recordOriginator mesh__D051245 ags
% 223.15/223.36  |- mesh__dateCreated mesh__D051245 2005-06-30
% 223.15/223.36  |- skos__altLabel mesh__D051245 Bipolar Cells, Retinal
% 223.15/223.36  |- mesh__dateEstablished mesh__D051245 2006-01-01
% 223.15/223.36  |- mesh__recordAuthorizer mesh__D051245 sjn
% 223.15/223.36  |- skos__broader mesh__D051245smesh__D012160
% 223.15/223.36  |- skos__prefLabel mesh__D051245 Retinal Bipolar Cells
% 223.15/223.36  |- skos__historyNote mesh__D051245 Neurons %28%1967-2005%29%
% 223.15/223.36  |- skos__scopeNote mesh__D051245
% 223.15/223.36       INTERNEURONS of the vertebrate RETINA containing two processes. They receive input from the VERTEBRATE PHOTORECEPTORS and send output to the RETINAL GANGLION CELLS. The bipolar cells also make lateral connections in the retina with the RETINAL HORIZONTAL CELLS and with the AMACRINE CELLS.%A%    
% 223.15/223.36  |- skos__hiddenLabel mesh__D051245 Cell, Retinal Bipolar
% 223.15/223.36  |- skos__hiddenLabel mesh__D051245 Bipolar Cell, Retinal
% 223.15/223.36  |- mesh__recordMaintainer mesh__D051245 ags
% 223.15/223.36  |- mesh__activeMeSHYear mesh__D051245 2006
% 223.15/223.38  |- skos__hiddenLabel mesh__D051245 Cells, Retinal Bipolar
% 223.15/223.38  |- mesh__historyNote mesh__D051245 2006   
% 223.15/223.38  |- skos__hiddenLabel mesh__D051245 Retinal Bipolar Cell
% 223.15/223.38  |- mesh__publicMeSHNote mesh__D051245 2006   
% 223.15/223.38  |- rdf__type mesh__D051245sskos__Concept
% 223.15/223.38  |- mesh__recordAuthorizer mesh__D009883 sjn
% 223.15/223.38  |- skos__prefLabel mesh__D009883 Ophthalmic Solutions
% 223.15/223.38  |- mesh__recordOriginator mesh__D009883 NLM
% 223.15/223.38  |- mesh__dateCreated mesh__D009883 1999-01-01
% 223.15/223.38  |- skos__scopeNote mesh__D009883
% 223.15/223.38       Sterile solutions, essentially free from foreign particles and suitably compounded and dispensed, for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS. %28%From Dorland, 27th ed%29%%A%    
% 223.15/223.38  |- skos__altLabel mesh__D009883 Eye Drops
% 223.15/223.38  |- mesh__dateRevised mesh__D009883 2005-06-30
% 223.15/223.38  |- mesh__historyNote mesh__D009883 67; was SOLUTIONS, OPHTHALMIC 1963-66   
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D009883 2006
% 223.15/223.38  |- rdf__type mesh__D009883sskos__Concept
% 223.15/223.38  |- skos__hiddenLabel mesh__D009883 Solutions, Ophthalmic
% 223.15/223.38  |- mesh__onlineNote mesh__D009883
% 223.15/223.38       use OPHTHALMIC SOLUTIONS to search SOLUTIONS, OPHTHALMIC 1966%A%  
% 223.15/223.38  |- skos__hiddenLabel mesh__D009883 Drops, Eye
% 223.15/223.38  |- mesh__dateEstablished mesh__D009883 1967-01-01
% 223.15/223.38  |- skos__annotation mesh__D009883
% 223.15/223.38       sterile solutions for instillation into the eyes: not for solutions for cleaning eyeglass lenses %28% = SOLUTIONS + specific type of lens%29%; not for cleaning contact lenses %28% = CONTACT LENS SOLUTIONS%29%; D25-26 qualif if IM %26% GEN; NIM coord with no qualif + specific drug IM; DF: OPHTHALMIC SOL%A%  
% 223.15/223.38  |- mesh__publicMeSHNote mesh__D009883
% 223.15/223.38       67; was SOLUTIONS, OPHTHALMIC 1963-66   
% 223.15/223.38  |- skos__broader mesh__D009883smesh__D019999
% 223.15/223.38  |- mesh__recordMaintainer mesh__D009883 ssb
% 223.15/223.38  |- skos__altLabel mesh__D009883 Artificial Tears
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D009085 2004
% 223.15/223.38  |- skos__prefLabel mesh__D009085 Mucopolysaccharidosis IV
% 223.15/223.38  |- mesh__dateCreated mesh__D009085 1999-01-01
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D009085 2005
% 223.15/223.38  |- skos__hiddenLabel mesh__D009085 Syndrome, Morquio%27%s
% 223.15/223.38  |- skos__altLabel mesh__D009085 Mucopolysaccharidosis 4
% 223.15/223.38  |- mesh__recordMaintainer mesh__D009085 nns
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D009085 2002
% 223.15/223.38  |- skos__altLabel mesh__D009085 Morquio%27%s Disease
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D009085 2003
% 223.15/223.38  |- mesh__recordAuthorizer mesh__D009085 sjn
% 223.15/223.38  |- mesh__recordOriginator mesh__D009085 NLM
% 223.15/223.38  |- skos__scopeNote mesh__D009085
% 223.15/223.38       Genetic disorder of mucopolysaccharide metabolism characterized by skeletal abnormalities, joint instability, development of cervical myelopathy, and excessive urinary keratan sulfate. There are two biochemically distinct forms, each due to a deficiency of a different enzyme.%A%    
% 223.15/223.38  |- skos__annotation mesh__D009085
% 223.15/223.38       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: MPS IV%A%  
% 223.15/223.38  |- skos__hiddenLabel mesh__D009085 Eccentroosteochondrodysplasias
% 223.15/223.38  |- skos__hiddenLabel mesh__D009085 Morquio Syndrome
% 223.15/223.38  |- skos__broader mesh__D009085smesh__D009083
% 223.15/223.38  |- skos__altLabel mesh__D009085 Morquio%27%s Syndrome
% 223.15/223.38  |- mesh__historyNote mesh__D009085
% 223.15/223.38       92; was MUCOPOLYSACCHARIDOSIS 4 1980-91, was ECCENTROOSTEOCHONDRODYSPLASIA 1963-79; MORQUIO%27%S DISEASE was MORQUIO DISEASE see MUCOPOLYSACCHARIDOSIS 4 1980-91%A%  
% 223.15/223.38  |- skos__altLabel mesh__D009085 Eccentro-Osteochondrodysplasia
% 223.15/223.38  |- skos__altLabel mesh__D009085 Morquio Disease
% 223.15/223.38  |- rdf__type mesh__D009085sskos__Concept
% 223.15/223.38  |- skos__altLabel mesh__D009085 Eccentroosteochondrodysplasia
% 223.15/223.38  |- skos__hiddenLabel mesh__D009085 Eccentro-Osteochondrodysplasias
% 223.15/223.38  |- skos__hiddenLabel mesh__D009085 Morquios Disease
% 223.15/223.38  |- skos__hiddenLabel mesh__D009085 Morquios Syndrome
% 223.15/223.38  |- skos__hiddenLabel mesh__D009085 Eccentro Osteochondrodysplasia
% 223.15/223.38  |- skos__hiddenLabel mesh__D009085 Disease, Morquio%27%s
% 223.15/223.38  |- mesh__onlineNote mesh__D009085
% 223.15/223.38       use MUCOPOLYSACCHARIDOSIS IV to search MUCOPOLYSACCHARIDOSIS 4 1980-91 %26% ECCENTROOSTEOCHONDRODYSPLASIA 1966-79%A%  
% 223.15/223.38  |- mesh__publicMeSHNote mesh__D009085
% 223.15/223.38       92; was MUCOPOLYSACCHARIDOSIS 4 1980-91, was ECCENTROOSTEOCHONDRODYSPLASIA 1963-79; MORQUIO%27%S DISEASE was MORQUIO DISEASE see MUCOPOLYSACCHARIDOSIS 4 1980-91%A%  
% 223.15/223.38  |- mesh__dateRevised mesh__D009085 2001-07-25
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D009085 2006
% 223.15/223.38  |- skos__hiddenLabel mesh__D009085 Disease, Morquio
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D017517 1996
% 223.15/223.38  |- mesh__historyNote mesh__D017517 93   
% 223.15/223.38  |- mesh__recordOriginator mesh__D017517 TGC
% 223.15/223.38  |- rdf__type mesh__D017517sskos__Concept
% 223.15/223.38  |- mesh__recordMaintainer mesh__D017517 TGC
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D017517 2005
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D017517 1998
% 223.15/223.38  |- mesh__dateCreated mesh__D017517 1992-05-14
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D017517 2004
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D017517 1997
% 223.15/223.38  |- skos__altLabel mesh__D017517 CIS Nations
% 223.15/223.38  |- skos__prefLabel mesh__D017517 Commonwealth of Independent States
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D017517 2002
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D017517 2006
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D017517 1999
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D017517 1994
% 223.15/223.38  |- mesh__dateEstablished mesh__D017517 1993-01-01
% 223.15/223.38  |- skos__broader mesh__D017517smesh__D017516
% 223.15/223.38  |- skos__historyNote mesh__D017517 USSR %28%1975-1992%29%
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D017517 2000
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D017517 1995
% 223.15/223.38  |- skos__historyNote mesh__D017517
% 223.15/223.38       specific Soviet republic %28%1975-1992%29%
% 223.15/223.38  |- mesh__dateRevised mesh__D017517 1993-03-03
% 223.15/223.38  |- mesh__recordAuthorizer mesh__D017517 PLS
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D017517 2001
% 223.15/223.38  |- skos__annotation mesh__D017517
% 223.15/223.38       each independent state is available; consider also RUSSIA %28%PRE-1917%29% %26% USSR for historical material; DF: note short X ref       CATALOG: use NAF entry%A%  
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D017517 2003
% 223.15/223.38  |- mesh__recordAuthorizer mesh__D033982 sjn
% 223.15/223.38  |- mesh__dateEstablished mesh__D033982 2003-01-01
% 223.15/223.38  |- mesh__dateRevised mesh__D033982 2004-07-07
% 223.15/223.38  |- skos__broader mesh__D033982smesh__D034001
% 223.15/223.38  |- skos__prefLabel mesh__D033982 Adaptor Protein Complex gamma Subunits
% 223.15/223.38  |- mesh__recordOriginator mesh__D033982 jmp
% 223.15/223.38  |- skos__historyNote mesh__D033982 Proteins %28%1991-1994%29%
% 223.15/223.38  |- skos__hiddenLabel mesh__D033982 gamma Adaptin
% 223.15/223.38  |- skos__scopeNote mesh__D033982
% 223.15/223.38       A family of large adaptin protein subunits of approximately 90 KDa in size. They have been primarily found as components of ADAPTOR PROTEIN COMPLEX 1.%A%    
% 223.15/223.38  |- mesh__historyNote mesh__D033982
% 223.15/223.38       2003; use ADAPTOR PROTEIN COMPLEX GAMMA SUBUNITS %28%NM%29% 1991-2001%A%  
% 223.15/223.38  |- mesh__publicMeSHNote mesh__D033982
% 223.15/223.38       2003; GAMMA-ADAPTIN %28%now ADAPTOR PROTEIN COMPLEX GAMMA SUBUNITS%29% was indexed under MEMBRANE PROTEINS 1995-2002, PROTEINS 1991-1994%A%  
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D033982 2006
% 223.15/223.38  |- skos__altLabel mesh__D033982 gamma-Adaptin
% 223.15/223.38  |- mesh__recordMaintainer mesh__D033982 jmp
% 223.15/223.38  |- mesh__dateCreated mesh__D033982 2002-07-02
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D033982 2005
% 223.15/223.38  |- skos__historyNote mesh__D033982 Membrane Proteins %28%1995-2002%29%
% 223.15/223.38  |- rdf__type mesh__D033982sskos__Concept
% 223.15/223.38  |- mesh__recordAuthorizer mesh__D005493 sjn
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D005493 2006
% 223.15/223.38  |- skos__scopeNote mesh__D005493
% 223.15/223.38       Inhibitors of the enzyme, dihydrofolate reductase %28%TETRAHYDROFOLATE DEHYDROGENASE%29%, which converts dihydrofolate %28%FH2%29% to tetrahydrofolate %28%FH4%29%. They are frequently used in cancer chemotherapy. %28%From AMA, Drug Evaluations Annual, 1994, p2033%29%%A%    
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D005493 2005
% 223.15/223.38  |- skos__broader mesh__D005493smesh__D004791
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D005493 2004
% 223.15/223.38  |- mesh__recordMaintainer mesh__D005493 ssb
% 223.15/223.38  |- skos__annotation mesh__D005493 DF: FOLIC ACID ANTAG   
% 223.15/223.38  |- skos__hiddenLabel mesh__D005493 Antagonists, Folic Acid
% 223.15/223.38  |- skos__altLabel mesh__D005493 Antifolates
% 223.15/223.38  |- skos__hiddenLabel mesh__D005493 Acid Antagonists, Folic
% 223.15/223.38  |- mesh__dateCreated mesh__D005493 1999-01-01
% 223.15/223.38  |- mesh__recordOriginator mesh__D005493 NLM
% 223.15/223.38  |- skos__prefLabel mesh__D005493 Folic Acid Antagonists
% 223.15/223.38  |- rdf__type mesh__D005493sskos__Concept
% 223.15/223.38  |- mesh__dateRevised mesh__D005493 2003-07-09
% 223.15/223.38  |- mesh__recordOriginator mesh__D013925 NLM
% 223.15/223.38  |- skos__altLabel mesh__D013925 Tissue Factor Procoagulant
% 223.15/223.38  |- skos__altLabel mesh__D013925 Tissue Factor
% 223.15/223.38  |- skos__altLabel mesh__D013925 Blood Coagulation Factor III
% 223.15/223.38  |- mesh__recordMaintainer mesh__D013925 ssb
% 223.15/223.38  |- skos__altLabel mesh__D013925 Tissue Thromboplastin
% 223.15/223.38  |- skos__altLabel mesh__D013925 Glomerular Procoagulant Activity
% 223.15/223.38  |- skos__altLabel mesh__D013925 CD142 Antigens
% 223.15/223.38  |- skos__hiddenLabel mesh__D013925 Factor III, Coagulation
% 223.15/223.38  |- skos__altLabel mesh__D013925 Prothrombinase
% 223.15/223.38  |- skos__prefLabel mesh__D013925 Thromboplastin
% 223.15/223.38  |- mesh__dateRevised mesh__D013925 2005-06-30
% 223.15/223.38  |- skos__altLabel mesh__D013925 Coagulin
% 223.15/223.38  |- skos__hiddenLabel mesh__D013925 Thromboplastin, Tissue
% 223.15/223.38  |- mesh__recordAuthorizer mesh__D013925 sjn
% 223.15/223.38  |- skos__hiddenLabel mesh__D013925 Activity, Glomerular Procoagulant
% 223.15/223.38  |- skos__altLabel mesh__D013925 Factor III
% 223.15/223.38  |- mesh__dateCreated mesh__D013925 1999-01-01
% 223.15/223.38  |- skos__scopeNote mesh__D013925
% 223.15/223.38       Constituent composed of protein and phospholipid that is widely distributed in many tissues. It serves as a cofactor with factor VIIa to activate factor X in the extrinsic pathway of blood coagulation.%A%    
% 223.15/223.38  |- skos__related mesh__D013925smesh__D003029
% 223.15/223.38  |- skos__altLabel mesh__D013925 Urothromboplastin
% 223.15/223.38  |- skos__altLabel mesh__D013925 Coagulation Factor III
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D013925 2006
% 223.15/223.38  |- skos__broader mesh__D013925smesh__D001779
% 223.15/223.38  |- rdf__type mesh__D013925sskos__Concept
% 223.15/223.38  |- skos__hiddenLabel mesh__D013925 Procoagulant Activity, Glomerular
% 223.15/223.38  |- skos__hiddenLabel mesh__D013925 Procoagulant, Tissue Factor
% 223.15/223.38  |- skos__altLabel mesh__D013925 Antigens, CD142
% 223.15/223.38  |- mesh__dateCreated mesh__D013127 1999-01-01
% 223.15/223.38  |- skos__hiddenLabel mesh__D013127 Spinal Nerve
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D013127 1998
% 223.15/223.38  |- skos__broader mesh__D013127smesh__D010525
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D013127 2000
% 223.15/223.38  |- rdf__type mesh__D013127sskos__Concept
% 223.15/223.38  |- skos__annotation mesh__D013127
% 223.15/223.38       peripheral nerves; do not use vertebra headings to locate area of spinal nerves%A%  
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D013127 2004
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D013127 1995
% 223.15/223.38  |- mesh__recordMaintainer mesh__D013127 RAZ
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D013127 1994
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D013127 2003
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D013127 1997
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D013127 2002
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D013127 1996
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D013127 2006
% 223.15/223.38  |- skos__prefLabel mesh__D013127 Spinal Nerves
% 223.15/223.38  |- mesh__recordAuthorizer mesh__D013127 PLS
% 223.15/223.38  |- mesh__recordOriginator mesh__D013127 NLM
% 223.15/223.38  |- skos__hiddenLabel mesh__D013127 Nerves, Spinal
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D013127 2005
% 223.15/223.38  |- mesh__dateRevised mesh__D013127 1993-06-21
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D013127 1999
% 223.15/223.38  |- skos__hiddenLabel mesh__D013127 Nerve, Spinal
% 223.15/223.38  |- skos__scopeNote mesh__D013127
% 223.15/223.38       The 31 paired peripheral nerves formed by the union of the dorsal and ventral spinal roots from each spinal cord segment. The spinal nerve plexuses and the spinal roots are also included.%A%    
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D013127 2001
% 223.15/223.38  |- skos__altLabel mesh__D018610 Bypass, Right Heart
% 223.15/223.38  |- skos__hiddenLabel mesh__D018610 Anastomoses, Cavopulmonary
% 223.15/223.38  |- skos__altLabel mesh__D018610 Cavopulmonary Shunt
% 223.15/223.38  |- mesh__recordOriginator mesh__D018610 AGS
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D018610 2005
% 223.15/223.38  |- mesh__dateCreated mesh__D018610 1994-02-28
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D018610 2002
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D018610 1998
% 223.15/223.38  |- mesh__recordAuthorizer mesh__D018610 SJN
% 223.15/223.38  |- skos__broader mesh__D018610smesh__D006348
% 223.15/223.38  |- skos__broader mesh__D018610smesh__D000714
% 223.15/223.38  |- skos__altLabel mesh__D018610 Cavopulmonary Anastomosis
% 223.15/223.38  |- skos__hiddenLabel mesh__D018610 Cavopulmonary Shunts
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D018610 2003
% 223.15/223.38  |- skos__prefLabel mesh__D018610 Heart Bypass, Right
% 223.15/223.38  |- skos__altLabel mesh__D018610 Shunt, Cavopulmonary
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D018610 2006
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D018610 1999
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D018610 2004
% 223.15/223.38  |- skos__hiddenLabel mesh__D018610 Bypasses, Right Heart
% 223.15/223.38  |- skos__altLabel mesh__D018610 Anastomosis, Cavopulmonary
% 223.15/223.38  |- skos__scopeNote mesh__D018610
% 223.15/223.38       Diversion of the flow of blood from the entrance to the right atrium directly to the pulmonary arteries, avoiding the right atrium and right ventricle %28%Dorland, 28th ed%29%. This a permanent procedure often performed to bypass a congenitally deformed right atrium or right ventricle.%A%    
% 223.15/223.38  |- mesh__dateEstablished mesh__D018610 1995-01-01
% 223.15/223.38  |- skos__altLabel mesh__D018610 Right Heart Bypass
% 223.15/223.38  |- mesh__recordMaintainer mesh__D018610 PXP
% 223.15/223.38  |- rdf__type mesh__D018610sskos__Concept
% 223.15/223.38  |- mesh__publicMeSHNote mesh__D018610 95   
% 223.15/223.38  |- mesh__historyNote mesh__D018610 95   
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D018610 2000
% 223.15/223.38  |- skos__hiddenLabel mesh__D018610 Shunts, Cavopulmonary
% 223.15/223.38  |- skos__annotation mesh__D018610
% 223.15/223.38       a form of heart surg; permanent: differentiate from HEART BYPASS, LEFT, temporary, a form of extracorp circ, %26% from CARDIOPULMONARY BYPASS, another type of extracorp circ%A%  
% 223.15/223.38  |- mesh__dateRevised mesh__D018610 1997-06-20
% 223.15/223.38  |- skos__hiddenLabel mesh__D018610 Cavopulmonary Anastomoses
% 223.15/223.38  |- skos__hiddenLabel mesh__D018610 Right Heart Bypasses
% 223.15/223.38  |- skos__hiddenLabel mesh__D018610 Heart Bypasses, Right
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D018610 2001
% 223.15/223.38  |- mesh__historyNote mesh__D051246 2006%28%1985%29%   
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D051246 2006
% 223.15/223.38  |- mesh__recordMaintainer mesh__D051246 DRC
% 223.15/223.38  |- skos__altLabel mesh__D051246 Glucose Transporter
% 223.15/223.38  |- skos__scopeNote mesh__D051246
% 223.15/223.38       A family of monosaccharide transport proteins characterized by 12 membrane spanning helices. They facilitate passive diffusion of GLUCOSE across the CELL MEMBRANE.%A%    
% 223.15/223.38  |- mesh__dateEstablished mesh__D051246 2006-01-01
% 223.15/223.38  |- mesh__dateCreated mesh__D051246 2005-06-30
% 223.15/223.38  |- rdf__type mesh__D051246sskos__Concept
% 223.15/223.38  |- mesh__recordOriginator mesh__D051246 DRC
% 223.15/223.38  |- skos__altLabel mesh__D051246 Glucose Transport Facilitators
% 223.15/223.38  |- mesh__recordAuthorizer mesh__D051246 sjn
% 223.15/223.38  |- mesh__publicMeSHNote mesh__D051246
% 223.15/223.38       2006; for GLUCOSE TRANSPORT PROTEINS, FACILITATIVE see MONOSACCHARIDE TRANSPORT PROTEINS 1985-2005%A%  
% 223.15/223.38  |- skos__prefLabel mesh__D051246 Glucose Transport Proteins, Facilitative
% 223.15/223.38  |- skos__altLabel mesh__D051246 SLC2A Proteins
% 223.15/223.38  |- skos__altLabel mesh__D051246 GLUT Proteins
% 223.15/223.38  |- skos__broader mesh__D051246smesh__D009004
% 223.15/223.38  |- skos__altLabel mesh__D051246 Glucose Transport Protein
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D009884 2002
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D009884 1999
% 223.15/223.38  |- skos__broader mesh__D009884smesh__D003941
% 223.15/223.38  |- mesh__publicMeSHNote mesh__D009884 67   
% 223.15/223.38  |- rdf__type mesh__D009884sskos__Concept
% 223.15/223.38  |- mesh__historyNote mesh__D009884 67%28%64%29%   
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D009884 2005
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D009884 2001
% 223.15/223.38  |- skos__scopeNote mesh__D009884
% 223.15/223.38       Measurement of the blood pressure of the retinal vessels. It is used also for the determination of the near point of convergence %28%CONVERGENCE, OCULAR%29%. %28%From Cline, et al., Dictionary of Visual Science, 4th ed%29%%A%    
% 223.15/223.38  |- mesh__dateEstablished mesh__D009884 1967-01-01
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D009884 2004
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D009884 1998
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D009884 2000
% 223.15/223.38  |- mesh__recordAuthorizer mesh__D009884 SJN
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D009884 2003
% 223.15/223.38  |- mesh__recordOriginator mesh__D009884 NLM
% 223.15/223.38  |- mesh__recordMaintainer mesh__D009884 PXP
% 223.15/223.38  |- skos__hiddenLabel mesh__D009884 Ophthalmodynamometries
% 223.15/223.38  |- skos__prefLabel mesh__D009884 Ophthalmodynamometry
% 223.15/223.38  |- mesh__dateRevised mesh__D009884 1997-06-20
% 223.15/223.38  |- mesh__dateCreated mesh__D009884 1999-01-01
% 223.15/223.38  |- skos__annotation mesh__D009884
% 223.15/223.38       to measure retinal arterial pressure; do not use /util except by MeSH definition%A%  
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D009884 2006
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D014220 1998
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D014220 2005
% 223.15/223.38  |- mesh__recordAuthorizer mesh__D014220 PLS
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D014220 2000
% 223.15/223.38  |- mesh__recordOriginator mesh__D014220 NLM
% 223.15/223.38  |- mesh__dateEstablished mesh__D014220 1975-09-01
% 223.15/223.38  |- skos__annotation mesh__D014220 DF: TRIALKYLTIN CPDS   
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D014220 1994
% 223.15/223.38  |- skos__broader mesh__D014220smesh__D009947
% 223.15/223.38  |- mesh__dateCreated mesh__D014220 1974-11-11
% 223.15/223.38  |- skos__hiddenLabel mesh__D014220 Compounds, Trialkyltin
% 223.15/223.38  |- rdf__type mesh__D014220sskos__Concept
% 223.15/223.38  |- mesh__dateRevised mesh__D014220 1992-05-20
% 223.15/223.38  |- skos__prefLabel mesh__D014220 Trialkyltin Compounds
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D014220 2002
% 223.15/223.38  |- skos__scopeNote mesh__D014220
% 223.15/223.38       Organometallic compounds which contain tin and three alkyl groups.%A%    
% 223.15/223.38  |- mesh__recordMaintainer mesh__D014220 TAP
% 223.15/223.38  |- mesh__historyNote mesh__D014220 75   
% 223.15/223.38  |- mesh__publicMeSHNote mesh__D014220 75   
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D014220 1997
% 223.15/223.38  |- skos__historyNote mesh__D014220 Tin %28%1968-1974%29%
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D014220 2004
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D014220 2001
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D014220 1999
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D014220 2006
% 223.15/223.38  |- skos__historyNote mesh__D014220
% 223.15/223.38       Organometallic Compounds %28%1968-1974%29%
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D014220 1996
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D014220 1993
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D014220 2003
% 223.15/223.38  |- mesh__activeMeSHYear mesh__D014220 1995
% 223.15/223.38  |- skos__hiddenLabel mesh__D033983 mu Adaptin
% 223.15/223.38  |- mesh__dateRevised mesh__D033983 2004-07-07
% 223.15/223.38  |- mesh__dateEstablished mesh__D033983 2003-01-01
% 223.15/223.38  |- skos__broader mesh__D033983smesh__D034001
% 223.15/223.38  |- mesh__recordOriginator mesh__D033983 jmp
% 223.15/223.39  |- skos__prefLabel mesh__D033983 Adaptor Protein Complex mu Subunits
% 223.15/223.39  |- mesh__publicMeSHNote mesh__D033983 2003   
% 223.15/223.39  |- mesh__historyNote mesh__D033983 2003   
% 223.15/223.39  |- mesh__recordMaintainer mesh__D033983 jmp
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D033983 2006
% 223.15/223.39  |- mesh__dateCreated mesh__D033983 2002-07-02
% 223.15/223.39  |- skos__scopeNote mesh__D033983
% 223.15/223.39       A family of medium adaptin protein subunits of approximately 45 KDa in size. They have been primarily found as components of ADAPTOR PROTEIN COMPLEX 3 and ADAPTOR PROTEIN COMPLEX 4.%A%    
% 223.15/223.39  |- skos__historyNote mesh__D033983 Adaptor Proteins %28%1997-2002%29%
% 223.15/223.39  |- rdf__type mesh__D033983sskos__Concept
% 223.15/223.39  |- mesh__recordAuthorizer mesh__D033983 sjn
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D033983 2005
% 223.15/223.39  |- skos__altLabel mesh__D033983 mu-Adaptin
% 223.15/223.39  |- skos__hiddenLabel mesh__D000200 Potentials, Spike
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D000200 2002
% 223.15/223.39  |- skos__annotation mesh__D000200
% 223.15/223.39       do not confuse with SYNAPTIC POTENTIALS see SYNAPTIC TRANSMISSION%A%  
% 223.15/223.39  |- skos__historyNote mesh__D000200 Electrophysiology %28%1966%29%
% 223.15/223.39  |- mesh__dateRevised mesh__D000200 1998-06-10
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D000200 1999
% 223.15/223.39  |- mesh__recordOriginator mesh__D000200 NLM
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D000200 2006
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D000200 2001
% 223.15/223.39  |- skos__scopeNote mesh__D000200
% 223.15/223.39       The electric response of a nerve or muscle to its stimulation.%A%    
% 223.15/223.39  |- mesh__historyNote mesh__D000200 68%28%67%29%   
% 223.15/223.39  |- skos__prefLabel mesh__D000200 Action Potentials
% 223.15/223.39  |- skos__hiddenLabel mesh__D000200 Action Potential
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D000200 2005
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D000200 2000
% 223.15/223.39  |- mesh__dateCreated mesh__D000200 1999-01-01
% 223.15/223.39  |- rdf__type mesh__D000200sskos__Concept
% 223.15/223.39  |- mesh__publicMeSHNote mesh__D000200 68   
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D000200 2004
% 223.15/223.39  |- skos__hiddenLabel mesh__D000200 Spike Potential
% 223.15/223.39  |- skos__hiddenLabel mesh__D000200 Potential, Spike
% 223.15/223.39  |- skos__broader mesh__D000200smesh__D008564
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D000200 2003
% 223.15/223.39  |- mesh__recordMaintainer mesh__D000200 PXP
% 223.15/223.39  |- skos__hiddenLabel mesh__D000200 Potentials, Action
% 223.15/223.39  |- skos__hiddenLabel mesh__D000200 Potential, Action
% 223.15/223.39  |- mesh__recordAuthorizer mesh__D000200 SJN
% 223.15/223.39  |- mesh__dateEstablished mesh__D000200 1968-01-01
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D005494 2005
% 223.15/223.39  |- skos__prefLabel mesh__D005494 Folic Acid Deficiency
% 223.15/223.39  |- skos__altLabel mesh__D005494 Deficiency, Folic Acid
% 223.15/223.39  |- skos__scopeNote mesh__D005494
% 223.15/223.39       A nutritional condition produced by a deficiency of FOLIC ACID in the diet. Many plant and animal tissues contain folic acid, abundant in green leafy vegetables, yeast, liver, and mushrooms but destroyed by long-term cooking. Alcohol interferes with its intermediate metabolism and absorption. Folic acid deficiency may develop in long-term anticonvulsant therapy or with use of oral contraceptives. This deficiency causes anemia, macrocytic anemia, and megaloblastic anemia. It is indistinguishable from vitamin B 12 deficiency in peripheral blood and bone marrow findings, but the neurologic lesions seen in B 12 deficiency do not occur. %28%Merck Manual, 16th ed%29%%A%    
% 223.15/223.39  |- skos__related mesh__D005494smesh__D000756
% 223.15/223.39  |- mesh__recordOriginator mesh__D005494 NLM
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D005494 2006
% 223.15/223.39  |- mesh__recordMaintainer mesh__D005494 lkt
% 223.15/223.39  |- mesh__dateEstablished mesh__D005494 1966-01-01
% 223.15/223.39  |- skos__hiddenLabel mesh__D005494 Deficiencies, Folic Acid
% 223.15/223.39  |- mesh__dateCreated mesh__D005494 1999-01-01
% 223.15/223.39  |- skos__broader mesh__D005494smesh__D014804
% 223.15/223.39  |- skos__hiddenLabel mesh__D005494 Folic Acid Deficiencies
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D005494 2004
% 223.15/223.39  |- mesh__recordAuthorizer mesh__D005494 sjn
% 223.15/223.39  |- skos__annotation mesh__D005494
% 223.15/223.39       a vitamin B defic; DF: FOLIC ACID DEFIC   
% 223.15/223.39  |- skos__related mesh__D005494smesh__D005365
% 223.15/223.39  |- skos__hiddenLabel mesh__D005494 Acid Deficiency, Folic
% 223.15/223.39  |- mesh__publicMeSHNote mesh__D005494 66   
% 223.15/223.39  |- rdf__type mesh__D005494sskos__Concept
% 223.15/223.39  |- skos__hiddenLabel mesh__D005494 Acid Deficiencies, Folic
% 223.15/223.39  |- mesh__dateRevised mesh__D005494 2003-07-09
% 223.15/223.39  |- mesh__historyNote mesh__D005494 66%28%64%29%   
% 223.15/223.39  |- mesh__historyNote mesh__D013926
% 223.15/223.39       91%28%66%29%; was see under GLYCOPROTEINS 1976-90; was see under BLOOD PLATELETS 1975%A%  
% 223.15/223.39  |- mesh__publicMeSHNote mesh__D013926
% 223.15/223.39       91; was see under GLYCOPROTEINS 1976-90; was see under BLOOD PLATELETS 1975%A%  
% 223.15/223.39  |- skos__prefLabel mesh__D013926 Thrombopoietin
% 223.15/223.39  |- mesh__recordOriginator mesh__D013926 NLM
% 223.15/223.39  |- skos__hiddenLabel mesh__D013926 Thrombocytopoiesis Stimulating Factor
% 223.15/223.39  |- skos__altLabel mesh__D013926 c-mpl Ligand
% 223.15/223.39  |- mesh__recordMaintainer mesh__D013926 ssb
% 223.15/223.39  |- skos__scopeNote mesh__D013926
% 223.15/223.39       A humoral factor that stimulates the production of  thrombocytes %28%BLOOD PLATELETS%29%. Thrombopoietin stimulates the proliferation of bone marrow MEGAKARYOCYTES and their release of blood platelets. The process is called THROMBOPOIESIS.%A%    
% 223.15/223.39  |- mesh__dateCreated mesh__D013926 1999-01-01
% 223.15/223.39  |- skos__broader mesh__D013926smesh__D006023
% 223.15/223.39  |- mesh__dateRevised mesh__D013926 2005-06-30
% 223.15/223.39  |- skos__hiddenLabel mesh__D013926 Ligand, mpl
% 223.15/223.39  |- skos__broader mesh__D013926smesh__D003115
% 223.15/223.39  |- skos__hiddenLabel mesh__D013926 Ligand, c-mpl
% 223.15/223.39  |- mesh__dateEstablished mesh__D013926 1991-01-01
% 223.15/223.39  |- skos__altLabel mesh__D013926 Megakaryocyte Growth and Development Factor
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013926 2006
% 223.15/223.39  |- skos__altLabel mesh__D013926 mpl Ligand
% 223.15/223.39  |- rdf__type mesh__D013926sskos__Concept
% 223.15/223.39  |- skos__altLabel mesh__D013926 Thrombocytopoietin
% 223.15/223.39  |- skos__altLabel mesh__D013926
% 223.15/223.39       Myeloproliferative Leukemia Virus Oncogene Ligand
% 223.15/223.39  |- mesh__recordAuthorizer mesh__D013926 sjn
% 223.15/223.39  |- skos__altLabel mesh__D013926 Thrombocytopoiesis-Stimulating Factor
% 223.15/223.39  |- skos__altLabel mesh__D013926 Megakaryocyte Colony Stimulating Factor
% 223.15/223.39  |- skos__altLabel mesh__D013926 MGDF Factor
% 223.15/223.39  |- mesh__dateEstablished mesh__D013128 1965-01-01
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013128 2004
% 223.15/223.39  |- skos__hiddenLabel mesh__D013128 Spondyloses
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013128 2001
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013128 2003
% 223.15/223.39  |- mesh__publicMeSHNote mesh__D013128
% 223.15/223.39       65; BARRE-LIEOU SYNDROME was heading 1967-96 %28%see under SPINAL OSTEOPHYTOSIS 1967-71%29%; POSTERIOR CERVICAL SYMPATHETIC SYNDROME was see BARRE-LIEOU SYNDROME 1975-96%A%  
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013128 1997
% 223.15/223.39  |- skos__annotation mesh__D013128
% 223.15/223.39       coord IM with specific vertebrae %28%IM%29%   
% 223.15/223.39  |- skos__broader mesh__D013128smesh__D010003
% 223.15/223.39  |- skos__hiddenLabel mesh__D013128 Spinal Osteophytoses
% 223.15/223.39  |- skos__hiddenLabel mesh__D013128 Osteophytoses, Spinal
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013128 2000
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013128 2006
% 223.15/223.39  |- skos__broader mesh__D013128smesh__D013122
% 223.15/223.39  |- skos__altLabel mesh__D013128 Osteophytosis, Spinal
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013128 2005
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013128 1999
% 223.15/223.39  |- mesh__historyNote mesh__D013128
% 223.15/223.39       65; BARRE-LIEOU SYNDROME was heading 1967-96 %28%see under SPINAL OSTEOPHYTOSIS 1967-71%29%; POSTERIOR CERVICAL SYMPATHETIC SYNDROME was see BARRE-LIEOU SYNDROME 1975-96%A%  
% 223.15/223.39  |- mesh__dateRevised mesh__D013128 1996-06-10
% 223.15/223.39  |- skos__hiddenLabel mesh__D013128 Syndrome, Barre-Lieou
% 223.15/223.39  |- skos__hiddenLabel mesh__D013128 Barre Lieou Syndrome
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013128 2002
% 223.15/223.39  |- mesh__dateCreated mesh__D013128 1999-01-01
% 223.15/223.39  |- skos__prefLabel mesh__D013128 Spinal Osteophytosis
% 223.15/223.39  |- mesh__recordMaintainer mesh__D013128 PXP
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013128 1998
% 223.15/223.39  |- skos__scopeNote mesh__D013128
% 223.15/223.39       Outgrowth of immature bony processes from the vertebrae, reflecting the presence of degenerative disease and calcification. It includes cervical and lumbar spondylosis.%A%    
% 223.15/223.39  |- mesh__recordAuthorizer mesh__D013128 PLS
% 223.15/223.39  |- mesh__recordOriginator mesh__D013128 NLM
% 223.15/223.39  |- rdf__type mesh__D013128sskos__Concept
% 223.15/223.39  |- skos__altLabel mesh__D018611 Bypass, Left Heart
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018611 2001
% 223.15/223.39  |- skos__altLabel mesh__D018611 Left Heart Bypass
% 223.15/223.39  |- mesh__publicMeSHNote mesh__D018611 95   
% 223.15/223.39  |- skos__annotation mesh__D018611
% 223.15/223.39       temporary, a form of extracorp circ diverting blood from left atrium: differentiate from HEART BYPASS, RIGHT, a permanent form of heart surg, %26% from CARDIOPULMONARY BYPASS, another type of extracorp circ diverting blood from right atrium%A%  
% 223.15/223.39  |- skos__hiddenLabel mesh__D018611 Left Heart Bypasses
% 223.15/223.39  |- skos__broader mesh__D018611smesh__D005112
% 223.15/223.39  |- skos__hiddenLabel mesh__D018611 Bypasses, Left Heart
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018611 2000
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018611 2004
% 223.15/223.39  |- skos__hiddenLabel mesh__D018611 Heart Bypasses, Left
% 223.15/223.39  |- mesh__dateCreated mesh__D018611 1994-02-28
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018611 2006
% 223.15/223.39  |- mesh__dateEstablished mesh__D018611 1995-01-01
% 223.15/223.39  |- mesh__historyNote mesh__D018611 95   
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018611 1997
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018611 2003
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018611 1999
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018611 2005
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018611 1996
% 223.15/223.39  |- skos__scopeNote mesh__D018611
% 223.15/223.39       Diversion of the flow of blood from the pulmonary veins directly to the aorta, avoiding the left atrium and the left ventricle %28%Dorland, 27th ed%29%. This is a temporary procedure usually performed to assist other surgical procedures.%A%    
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018611 1995
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018611 1998
% 223.15/223.39  |- skos__prefLabel mesh__D018611 Heart Bypass, Left
% 223.15/223.39  |- rdf__type mesh__D018611sskos__Concept
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018611 2002
% 223.15/223.39  |- skos__altLabel mesh__D051247 Sodium Glucose Cotransporters
% 223.15/223.39  |- skos__prefLabel mesh__D051247 Sodium-Glucose Transport Proteins
% 223.15/223.39  |- skos__altLabel mesh__D051247 Sodium Glucose Transporters
% 223.15/223.39  |- skos__broader mesh__D051247smesh__D009004
% 223.15/223.39  |- rdf__type mesh__D051247sskos__Concept
% 223.15/223.39  |- mesh__recordOriginator mesh__D051247 DRC
% 223.15/223.39  |- mesh__publicMeSHNote mesh__D051247
% 223.15/223.39       2006; see MONOSACCHARIDE TRANSPORT PROTEINS 1986-2005   
% 223.15/223.39  |- skos__altLabel mesh__D051247 Sodium-Glucose Transport System
% 223.15/223.39  |- mesh__recordMaintainer mesh__D051247 DRC
% 223.15/223.39  |- skos__altLabel mesh__D051247 Glucose Sodium Transport System
% 223.15/223.39  |- skos__broader mesh__D051247smesh__D027981
% 223.15/223.39  |- skos__scopeNote mesh__D051247
% 223.15/223.39       Monosaccharide transport proteins that function as active symporters. They utilize SODIUM or HYDROGEN IONS to transport GLUCOSE across CELL MEMBRANES.%A%    
% 223.15/223.39  |- skos__altLabel mesh__D051247 SGLT Proteins
% 223.15/223.39  |- skos__hiddenLabel mesh__D051247 Sodium Sugar Transporter
% 223.15/223.39  |- skos__annotation mesh__D051247 general; prefer specifics   
% 223.15/223.39  |- mesh__dateEstablished mesh__D051247 2006-01-01
% 223.15/223.39  |- mesh__dateCreated mesh__D051247 2005-06-30
% 223.15/223.39  |- skos__hiddenLabel mesh__D051247 Glucose Transporters, Sodium
% 223.15/223.39  |- mesh__recordAuthorizer mesh__D051247 sjn
% 223.15/223.39  |- skos__altLabel mesh__D051247 Glucose-Sodium Transport System
% 223.15/223.39  |- skos__hiddenLabel mesh__D051247 Sodium Glucose Transport Proteins
% 223.15/223.39  |- skos__hiddenLabel mesh__D051247 Transporter, Sodium-Sugar
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D051247 2006
% 223.15/223.39  |- skos__hiddenLabel mesh__D051247 Glucose Cotransporters, Sodium
% 223.15/223.39  |- mesh__historyNote mesh__D051247 2006%28%1986%29%   
% 223.15/223.39  |- skos__altLabel mesh__D051247 Sodium Glucose Transport System
% 223.15/223.39  |- skos__related mesh__D009885smesh__D013508
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D009885 1998
% 223.15/223.39  |- rdf__type mesh__D009885sskos__Concept
% 223.15/223.39  |- mesh__dateRevised mesh__D009885 1997-06-20
% 223.15/223.39  |- skos__prefLabel mesh__D009885 Ophthalmology
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D009885 2004
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D009885 2002
% 223.15/223.39  |- skos__related mesh__D009885smesh__D014785
% 223.15/223.39  |- skos__broader mesh__D009885smesh__D013043
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D009885 2003
% 223.15/223.39  |- skos__scopeNote mesh__D009885
% 223.15/223.39       A surgical specialty concerned with the structure and function of the eye and the medical and surgical treatment of its defects and diseases.%A%    
% 223.15/223.39  |- skos__annotation mesh__D009885 SPEC: SPEC qualif; DF: OPHTHALMOL   
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D009885 2001
% 223.15/223.39  |- skos__related mesh__D009885smesh__D005128
% 223.15/223.39  |- skos__related mesh__D009885smesh__D009988
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D009885 2000
% 223.15/223.39  |- mesh__dateCreated mesh__D009885 1999-01-01
% 223.15/223.39  |- mesh__recordAuthorizer mesh__D009885 SJN
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D009885 2006
% 223.15/223.39  |- mesh__recordOriginator mesh__D009885 NLM
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D009885 1999
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D009885 2005
% 223.15/223.39  |- mesh__recordMaintainer mesh__D009885 TGC
% 223.15/223.39  |- skos__historyNote mesh__D009087 Mucopolysaccharidosis %28%1974%29%
% 223.15/223.39  |- mesh__historyNote mesh__D009087
% 223.15/223.39       92; was MUCOPOLYSACCHARIDOSIS 6 1991; was see under MUCOPOLYSACCHARIDOSIS 1975-90%A%  
% 223.15/223.39  |- skos__historyNote mesh__D009087 Chondroitin %28%1966-1974%29%
% 223.15/223.39  |- mesh__dateRevised mesh__D009087 2001-07-25
% 223.15/223.39  |- skos__hiddenLabel mesh__D009087 Syndrome, Maroteaux-Lamy
% 223.15/223.39  |- mesh__dateCreated mesh__D009087 1974-12-12
% 223.15/223.39  |- mesh__publicMeSHNote mesh__D009087
% 223.15/223.39       92; was MUCOPOLYSACCHARIDOSIS 6 1991; was see under MUCOPOLYSACCHARIDOSIS 1975-90%A%  
% 223.15/223.39  |- mesh__dateEstablished mesh__D009087 1991-01-01
% 223.15/223.39  |- rdf__type mesh__D009087sskos__Concept
% 223.15/223.39  |- skos__prefLabel mesh__D009087 Mucopolysaccharidosis VI
% 223.15/223.39  |- skos__hiddenLabel mesh__D009087 Mucopolysaccharidosis VIs
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D009087 2002
% 223.15/223.39  |- skos__altLabel mesh__D009087 Maroteaux-Lamy Syndrome
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D009087 2005
% 223.15/223.39  |- mesh__recordMaintainer mesh__D009087 nns
% 223.15/223.39  |- skos__broader mesh__D009087smesh__D009083
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D009087 2003
% 223.15/223.39  |- skos__altLabel mesh__D009087 Polydystrophic Dwarfism
% 223.15/223.39  |- mesh__onlineNote mesh__D009087
% 223.15/223.39       use MUCOPOLYSACCHARIDOSIS VI to search MUCOPOLYSACCHARIDOSIS 6 1975-91%A%  
% 223.15/223.39  |- skos__scopeNote mesh__D009087
% 223.15/223.39       Mucopolysaccharidosis with excessive chondroitin sulfate B in urine, characterized by dwarfism and deafness. It is caused by a deficiency of N-acetylgalactosamine-4-sulfatase %28%arylsulfatase B%29%.%A%    
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D009087 2006
% 223.15/223.39  |- skos__hiddenLabel mesh__D009087 Maroteaux Lamy Syndrome
% 223.15/223.39  |- skos__hiddenLabel mesh__D009087 VIs, Mucopolysaccharidosis
% 223.15/223.39  |- mesh__recordAuthorizer mesh__D009087 sjn
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D009087 2004
% 223.15/223.39  |- mesh__recordOriginator mesh__D009087 NLM
% 223.15/223.39  |- skos__historyNote mesh__D009087
% 223.15/223.39       Mucopolysaccharides/metabolism %28%1966-1974%29%
% 223.15/223.39  |- skos__altLabel mesh__D009087 Mucopolysaccharidosis 6
% 223.15/223.39  |- skos__hiddenLabel mesh__D009087 Dwarfism, Polydystrophic
% 223.15/223.39  |- skos__historyNote mesh__D009087
% 223.15/223.39       Carbohydrate Metabolism, Inborn Errors %28%1966-1974%29%
% 223.15/223.39  |- skos__annotation mesh__D009087
% 223.15/223.39       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: MPS VI%A%  
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D028241 2006
% 223.15/223.39  |- mesh__publicMeSHNote mesh__D028241 2002; see TEA 1999-2001   
% 223.15/223.39  |- skos__related mesh__D028241smesh__D013662
% 223.15/223.39  |- skos__annotation mesh__D028241
% 223.15/223.39       coord with TEA or specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.15/223.39  |- skos__scopeNote mesh__D028241
% 223.15/223.39       Camellia sinensis L. %28%formerly Thea sinensis%29% is an evergreen Asiatic shrub of the THEACEAE family. The infusion of leaves of this plant is used as Oriental TEA which contains CAFFEINE; THEOPHYLLINE; and epigallocatechin gallate.%A%    
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D028241 2005
% 223.15/223.39  |- mesh__historyNote mesh__D028241 2002; use TEA 1999-2001   
% 223.15/223.39  |- skos__historyNote mesh__D028241 Theales %28%1999-2001%29%
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D028241 2004
% 223.15/223.39  |- mesh__recordMaintainer mesh__D028241 ags
% 223.15/223.39  |- skos__altLabel mesh__D028241 Thea sinensis
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D028241 2002
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D028241 2003
% 223.15/223.39  |- mesh__dateCreated mesh__D028241 2001-07-25
% 223.15/223.39  |- mesh__recordAuthorizer mesh__D028241 ags
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D028241 2006A
% 223.15/223.39  |- mesh__dateEstablished mesh__D028241 2002-01-01
% 223.15/223.39  |- mesh__recordOriginator mesh__D028241 ssb
% 223.15/223.39  |- skos__broader mesh__D028241smesh__D028244
% 223.15/223.39  |- mesh__dateRevised mesh__D028241 2005-07-08
% 223.15/223.39  |- rdf__type mesh__D028241sskos__Concept
% 223.15/223.39  |- skos__prefLabel mesh__D028241 Camellia sinensis
% 223.15/223.39  |- rdf__type mesh__D014221sskos__Concept
% 223.15/223.39  |- skos__broader mesh__D014221smesh__D013259
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D014221 2004
% 223.15/223.39  |- skos__scopeNote mesh__D014221
% 223.15/223.39       A glucocorticoid given, as the free alcohol or in esterified form, orally, intramuscularly, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p739%29%%A%    
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D014221 2006
% 223.15/223.39  |- mesh__recordOriginator mesh__D014221 NLM
% 223.15/223.39  |- skos__prefLabel mesh__D014221 Triamcinolone
% 223.15/223.39  |- skos__broader mesh__D014221smesh__D011245
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D014221 2005
% 223.15/223.39  |- mesh__recordMaintainer mesh__D014221 ssb
% 223.15/223.39  |- mesh__dateCreated mesh__D014221 1999-01-01
% 223.15/223.39  |- mesh__recordAuthorizer mesh__D014221 sjn
% 223.15/223.39  |- mesh__dateRevised mesh__D014221 2003-07-09
% 223.15/223.39  |- mesh__dateEstablished mesh__D000201 1967-01-01
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D000201 2005
% 223.15/223.39  |- skos__prefLabel mesh__D000201 Activation Analysis
% 223.15/223.39  |- mesh__dateCreated mesh__D000201 1999-01-01
% 223.15/223.39  |- mesh__publicMeSHNote mesh__D000201 67   
% 223.15/223.39  |- rdf__type mesh__D000201sskos__Concept
% 223.15/223.39  |- mesh__recordOriginator mesh__D000201 NLM
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D000201 2004
% 223.15/223.39  |- skos__hiddenLabel mesh__D000201 Activation Analyses
% 223.15/223.39  |- skos__altLabel mesh__D000201 Analysis, Activation
% 223.15/223.39  |- mesh__recordAuthorizer mesh__D000201 sjn
% 223.15/223.39  |- skos__scopeNote mesh__D000201
% 223.15/223.39       A method of chemical analysis based on the detection of characteristic radionuclides following a nuclear bombardment. It is also known as radioactivity analysis. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D000201 2003
% 223.15/223.39  |- skos__hiddenLabel mesh__D000201 Analyses, Activation
% 223.15/223.39  |- skos__broader mesh__D000201smesh__D002623
% 223.15/223.39  |- mesh__recordMaintainer mesh__D000201 lkt
% 223.15/223.39  |- mesh__dateRevised mesh__D000201 2002-07-02
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D000201 2006
% 223.15/223.39  |- mesh__historyNote mesh__D000201 67%28%63%29%   
% 223.15/223.39  |- skos__annotation mesh__D000201
% 223.15/223.39       an anal chem technique; NIM; DF: ACTIVATION ANAL   
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D005495 2006
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D005495 1992
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D005495 1998
% 223.15/223.39  |- mesh__recordAuthorizer mesh__D005495 PLS
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D005495 2003
% 223.15/223.39  |- skos__hiddenLabel mesh__D005495 Folklores
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D005495 1999
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D005495 1993
% 223.15/223.39  |- mesh__dateRevised mesh__D005495 1991-11-09
% 223.15/223.39  |- skos__prefLabel mesh__D005495 Folklore
% 223.15/223.39  |- mesh__dateCreated mesh__D005495 1999-01-01
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D005495 2000
% 223.15/223.39  |- mesh__recordMaintainer mesh__D005495 PLS
% 223.15/223.39  |- skos__broader mesh__D005495smesh__D003469
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D005495 2004
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D005495 1990
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D005495 1996
% 223.15/223.39  |- mesh__recordOriginator mesh__D005495 NLM
% 223.15/223.39  |- skos__annotation mesh__D005495 no qualif   
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D005495 2001
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D005495 1997
% 223.15/223.39  |- rdf__type mesh__D005495sskos__Concept
% 223.15/223.39  |- skos__scopeNote mesh__D005495
% 223.15/223.39       The common orally transmitted traditions, myths, festivals, songs, superstitions, and stories of all peoples.%A%    
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D005495 1994
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D005495 1991
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D005495 2005
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D005495 1995
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D005495 2002
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013927 2005
% 223.15/223.39  |- rdf__type mesh__D013927sskos__Concept
% 223.15/223.39  |- skos__related mesh__D013927smesh__D017131
% 223.15/223.39  |- mesh__recordAuthorizer mesh__D013927 sjn
% 223.15/223.39  |- mesh__dateRevised mesh__D013927 2003-07-09
% 223.15/223.39  |- mesh__recordMaintainer mesh__D013927 lkt
% 223.15/223.39  |- mesh__dateCreated mesh__D013927 1999-01-01
% 223.15/223.39  |- skos__annotation mesh__D013927
% 223.15/223.39       GEN: prefer specifics; mural thrombus: coord IM with HEART DIS %28%IM%29%%A%  
% 223.15/223.39  |- mesh__recordOriginator mesh__D013927 NLM
% 223.15/223.39  |- skos__scopeNote mesh__D013927
% 223.15/223.39       Formation and development of a THROMBUS or blood clot in the blood vessel.%A%    
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013927 2004
% 223.15/223.39  |- skos__hiddenLabel mesh__D013927 Thromboses
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013927 2006
% 223.15/223.39  |- skos__prefLabel mesh__D013927 Thrombosis
% 223.15/223.39  |- skos__broader mesh__D013927smesh__D016769
% 223.15/223.39  |- skos__hiddenLabel mesh__D013129 Punctures, Lumbar
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013129 2006
% 223.15/223.39  |- skos__scopeNote mesh__D013129
% 223.15/223.39       Tapping of the subarachnoid space in the lumbar region, usually between the third and fourth lumbar vertebrae.%A%    
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013129 2002
% 223.15/223.39  |- skos__broader mesh__D013129smesh__D003943
% 223.15/223.39  |- mesh__recordMaintainer mesh__D013129 PXP
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013129 2005
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013129 1999
% 223.15/223.39  |- mesh__recordOriginator mesh__D013129 NLM
% 223.15/223.39  |- skos__hiddenLabel mesh__D013129 Puncture, Spinal
% 223.15/223.39  |- skos__annotation mesh__D013129
% 223.15/223.39       /drug eff /rad eff permitted; do not use /util except by MeSH definition%A%  
% 223.15/223.39  |- mesh__dateCreated mesh__D013129 1999-01-01
% 223.15/223.39  |- skos__hiddenLabel mesh__D013129 Lumbar Punctures
% 223.15/223.39  |- mesh__dateRevised mesh__D013129 1997-06-20
% 223.15/223.39  |- skos__prefLabel mesh__D013129 Spinal Puncture
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013129 1998
% 223.15/223.39  |- rdf__type mesh__D013129sskos__Concept
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013129 2001
% 223.15/223.39  |- skos__broader mesh__D013129smesh__D011677
% 223.15/223.39  |- skos__broader mesh__D013129smesh__D003581
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013129 2004
% 223.15/223.39  |- skos__altLabel mesh__D013129 Lumbar Puncture
% 223.15/223.39  |- skos__hiddenLabel mesh__D013129 Puncture, Lumbar
% 223.15/223.39  |- mesh__recordAuthorizer mesh__D013129 SJN
% 223.15/223.39  |- skos__hiddenLabel mesh__D013129 Punctures, Spinal
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013129 2000
% 223.15/223.39  |- skos__hiddenLabel mesh__D013129 Spinal Punctures
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D013129 2003
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018612 2002
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018612 2004
% 223.15/223.39  |- mesh__dateCreated mesh__D018612 1994-04-19
% 223.15/223.39  |- skos__prefLabel mesh__D018612 Byzantium
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018612 2001
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018612 2006
% 223.15/223.39  |- mesh__historyNote mesh__D018612 95   
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018612 1997
% 223.15/223.39  |- skos__broader mesh__D018612smesh__D018436
% 223.15/223.39  |- skos__scopeNote mesh__D018612
% 223.15/223.39       An ancient city, the site of modern Istanbul. From the 4th to 15th centuries the empire extended from southeastern Europe to western Asia, reaching its greatest extent under Justinian %28%527-565%29%. By about 1000 A.D. it comprised the southern Balkans, Greece, Asia Minor, and parts of southern Italy. The capture of Constantinople in 1453 marked the formal end of the Byzantine Empire. %28%From Webster%27%s New Geographical Dictionary, 1988%29%%A%    
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018612 2003
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018612 1999
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018612 2000
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018612 2005
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018612 1996
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018612 1995
% 223.15/223.39  |- skos__annotation mesh__D018612 the ancient city or empire: note X ref   
% 223.15/223.39  |- mesh__activeMeSHYear mesh__D018612 1998
% 223.15/223.39  |- rdf__type mesh__D018612sskos__Concept
% 223.15/223.39  |- mesh__dateEstablished mesh__D018612 1995-01-01
% 223.15/223.39  |- skos__altLabel mesh__D018612 Byzantine Empire
% 223.15/223.39  |- mesh__dateCreated mesh__D051248 2005-06-30
% 223.15/223.39  |- mesh__recordOriginator mesh__D051248 ags
% 223.15/223.39  |- skos__hiddenLabel mesh__D051248 Horizontal Cell, Retinal
% 223.15/223.39  |- skos__scopeNote mesh__D051248
% 223.15/223.39       NEURONS in the inner nuclear layer of the RETINA that synapse with both the VERTEBRATE PHOTORECEPTORS and the RETINAL BIPOLAR CELLS, as well as other horizontal cells. The horizontal cells modulate the sensory signal.%A%    
% 223.15/223.39  |- skos__broader mesh__D051248smesh__D009475
% 223.15/223.39  |- mesh__dateEstablished mesh__D051248 2006-01-01
% 223.15/223.39  |- mesh__recordAuthorizer mesh__D051248 sjn
% 223.15/223.39  |- skos__broader mesh__D051248smesh__D012160
% 223.15/223.39  |- mesh__publicMeSHNote mesh__D051248 2006   
% 223.15/223.40  |- rdf__type mesh__D051248sskos__Concept
% 223.15/223.40  |- skos__prefLabel mesh__D051248 Retinal Horizontal Cells
% 223.15/223.40  |- skos__historyNote mesh__D051248 Retina/cytology %28%1966-2005%29%
% 223.15/223.40  |- skos__hiddenLabel mesh__D051248 Cell, Retinal Horizontal
% 223.15/223.40  |- skos__hiddenLabel mesh__D051248 Retinal Horizontal Cell
% 223.15/223.40  |- mesh__historyNote mesh__D051248 2006   
% 223.15/223.40  |- skos__hiddenLabel mesh__D051248 Cells, Retinal Horizontal
% 223.15/223.40  |- skos__altLabel mesh__D051248 Horizontal Cells, Retinal
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D051248 2006
% 223.15/223.40  |- mesh__recordMaintainer mesh__D051248 ags
% 223.15/223.40  |- skos__historyNote mesh__D051248 Neurons %28%1966-2005%29%
% 223.15/223.40  |- rdf__type mesh__D009886sskos__Concept
% 223.15/223.40  |- skos__hiddenLabel mesh__D009886 Paralysis, Oculomotor
% 223.15/223.40  |- mesh__recordAuthorizer mesh__D009886 sjn
% 223.15/223.40  |- mesh__dateRevised mesh__D009886 1999-11-03
% 223.15/223.40  |- skos__broader mesh__D009886smesh__D015835
% 223.15/223.40  |- skos__annotation mesh__D009886
% 223.15/223.40       do not confuse X ref OCULOMOTOR PARALYSIS with OCULOMOTOR NERVE PARALYSIS%A%  
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D009886 2004
% 223.15/223.40  |- skos__altLabel mesh__D009886 Oculomotor Paralysis
% 223.15/223.40  |- mesh__recordOriginator mesh__D009886 NLM
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D009886 2002
% 223.15/223.40  |- mesh__dateCreated mesh__D009886 1999-01-01
% 223.15/223.40  |- skos__hiddenLabel mesh__D009886 Ophthalmoplegias, External
% 223.15/223.40  |- mesh__publicMeSHNote mesh__D009886
% 223.15/223.40       1979; was OCULOMOTOR PARALYSIS 1963-1978   
% 223.15/223.40  |- skos__scopeNote mesh__D009886
% 223.15/223.40       Paralysis of one or more of the ocular muscles due to disorders of the eye muscles, neuromuscular junction, supporting soft tissue, tendons, or innervation to the muscles.%A%    
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D009886 2005
% 223.15/223.40  |- skos__hiddenLabel mesh__D009886 Internal Ophthalmoplegias
% 223.15/223.40  |- skos__hiddenLabel mesh__D009886 External Ophthalmoplegias
% 223.15/223.40  |- skos__broader mesh__D009886smesh__D010243
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D009886 2000
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D009886 2006
% 223.15/223.40  |- skos__hiddenLabel mesh__D009886 Ophthalmoplegias
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D009886 2001
% 223.15/223.40  |- skos__related mesh__D009886smesh__D015840
% 223.15/223.40  |- skos__hiddenLabel mesh__D009886 Ophthalmoplegia, Internal
% 223.15/223.40  |- skos__prefLabel mesh__D009886 Ophthalmoplegia
% 223.15/223.40  |- mesh__onlineNote mesh__D009886
% 223.15/223.40       use OPHTHALMOPLEGIA to search OCULOMOTOR PARALYSIS 1966-78%A%  
% 223.15/223.40  |- mesh__historyNote mesh__D009886
% 223.15/223.40       1979; was OCULOMOTOR PARALYSIS 1963-1978   
% 223.15/223.40  |- skos__hiddenLabel mesh__D009886 Ophthalmoplegia, External
% 223.15/223.40  |- skos__hiddenLabel mesh__D009886 Ophthalmopareses
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D009886 2003
% 223.15/223.40  |- skos__hiddenLabel mesh__D009886 Ophthalmoplegias, Internal
% 223.15/223.40  |- mesh__recordMaintainer mesh__D009886 KEV
% 223.15/223.40  |- mesh__dateCreated mesh__D009088 1999-01-01
% 223.15/223.40  |- skos__broader mesh__D009088smesh__D006023
% 223.15/223.40  |- mesh__recordAuthorizer mesh__D009088 sjn
% 223.15/223.40  |- mesh__recordOriginator mesh__D009088 NLM
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D009088 2006
% 223.15/223.40  |- skos__prefLabel mesh__D009088 Mucoproteins
% 223.15/223.40  |- skos__scopeNote mesh__D009088
% 223.15/223.40       Conjugated proteins in which mucopolysaccharides are combined with proteins. The mucopolysaccharide moiety is the predominant group with the protein making up only a small percentage of the total weight.%A%    
% 223.15/223.40  |- skos__annotation mesh__D009088 includes mucoids %26% mucopeptides   
% 223.15/223.40  |- mesh__dateRevised mesh__D009088 2005-06-30
% 223.15/223.40  |- rdf__type mesh__D009088sskos__Concept
% 223.15/223.40  |- mesh__recordMaintainer mesh__D009088 SYSTEM
% 223.15/223.40  |- mesh__recordAuthorizer mesh__D028242 sjn
% 223.15/223.40  |- mesh__recordMaintainer mesh__D028242 ssb
% 223.15/223.40  |- mesh__dateEstablished mesh__D028242 2002-01-01
% 223.15/223.40  |- mesh__publicMeSHNote mesh__D028242 2002; see Theales 1999-2001   
% 223.15/223.40  |- mesh__recordOriginator mesh__D028242 ssb
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D028242 2003
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D028242 2004
% 223.15/223.40  |- skos__annotation mesh__D028242
% 223.15/223.40       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.15/223.40  |- mesh__dateCreated mesh__D028242 2001-07-25
% 223.15/223.40  |- mesh__historyNote mesh__D028242 2002; use Theales 1999-2001   
% 223.15/223.40  |- skos__prefLabel mesh__D028242 Theaceae
% 223.15/223.40  |- mesh__dateRevised mesh__D028242 2002-07-03
% 223.15/223.40  |- skos__historyNote mesh__D028242 Theales %28%1999-2001%29%
% 223.15/223.40  |- rdf__type mesh__D028242sskos__Concept
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D028242 2005
% 223.15/223.40  |- skos__scopeNote mesh__D028242
% 223.15/223.40       A plant family of the order THEALES, subclass Dilleniidae, class Magnoliopsida, best known for CAMELLIA SINENSIS, which is the source of Oriental TEA.%A%    
% 223.15/223.40  |- skos__broader mesh__D028242smesh__D020448
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D028242 2006
% 223.15/223.40  |- skos__broader mesh__D014222smesh__D014221
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D014222 2004
% 223.15/223.40  |- skos__hiddenLabel mesh__D014222 40, Kenalog
% 223.15/223.40  |- skos__prefLabel mesh__D014222 Triamcinolone Acetonide
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D014222 2006
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D014222 2005
% 223.15/223.40  |- skos__hiddenLabel mesh__D014222 Tricort 40
% 223.15/223.40  |- mesh__dateCreated mesh__D014222 1999-01-01
% 223.15/223.40  |- skos__hiddenLabel mesh__D014222 Acetonide, Triamcinolone
% 223.15/223.40  |- mesh__recordOriginator mesh__D014222 NLM
% 223.15/223.40  |- mesh__dateRevised mesh__D014222 2003-07-09
% 223.15/223.40  |- skos__hiddenLabel mesh__D014222 A, Kenacort
% 223.15/223.40  |- skos__scopeNote mesh__D014222
% 223.15/223.40       An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions.%A%    
% 223.15/223.40  |- rdf__type mesh__D014222sskos__Concept
% 223.15/223.40  |- mesh__recordMaintainer mesh__D014222 ssb
% 223.15/223.40  |- skos__hiddenLabel mesh__D014222 Tricort40
% 223.15/223.40  |- mesh__recordAuthorizer mesh__D014222 sjn
% 223.15/223.40  |- skos__hiddenLabel mesh__D000202 Jumper, Jasper
% 223.15/223.40  |- skos__broader mesh__D000202smesh__D017289
% 223.15/223.40  |- skos__hiddenLabel mesh__D000202 Appliances, Activator
% 223.15/223.40  |- skos__hiddenLabel mesh__D000202 Appliance, Andresen
% 223.15/223.40  |- skos__hiddenLabel mesh__D000202 Appliance, Activator Orthodontic
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D000202 2006
% 223.15/223.40  |- skos__hiddenLabel mesh__D000202 Activator, Function
% 223.15/223.40  |- mesh__dateRevised mesh__D000202 2000-06-21
% 223.15/223.40  |- mesh__recordOriginator mesh__D000202 NLM
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D000202 2002
% 223.15/223.40  |- mesh__dateCreated mesh__D000202 1974-12-12
% 223.15/223.40  |- skos__hiddenLabel mesh__D000202 Appliances, Activator Orthodontic
% 223.15/223.40  |- rdf__type mesh__D000202sskos__Concept
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D000202 2005
% 223.15/223.40  |- mesh__recordAuthorizer mesh__D000202 sjn
% 223.15/223.40  |- skos__altLabel mesh__D000202 Orthodontic Appliances, Activator
% 223.15/223.40  |- skos__prefLabel mesh__D000202 Activator Appliances
% 223.15/223.40  |- skos__hiddenLabel mesh__D000202 Activator Orthodontic Appliance
% 223.15/223.40  |- skos__scopeNote mesh__D000202
% 223.15/223.40       Loose-fitting removable orthodontic appliances which redirect the pressures of the facial and masticatory muscles onto the teeth and their supporting structures to produce improvements in tooth arrangements and occlusal relations.%A%    
% 223.15/223.40  |- skos__hiddenLabel mesh__D000202 Function Activators
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D000202 2001
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D000202 2004
% 223.15/223.40  |- skos__hiddenLabel mesh__D000202 Activator Orthodontic Appliances
% 223.15/223.40  |- mesh__historyNote mesh__D000202
% 223.15/223.40       91%28%75%29%; was see under ORTHODONTIC APPLIANCES, REMOVABLE 1975-90%A%  
% 223.15/223.40  |- skos__broader mesh__D000202smesh__D009968
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D000202 2003
% 223.15/223.40  |- mesh__dateEstablished mesh__D000202 1991-01-01
% 223.15/223.40  |- skos__hiddenLabel mesh__D000202 Bionators
% 223.15/223.40  |- skos__hiddenLabel mesh__D000202 Orthodontic Appliance, Activator
% 223.15/223.40  |- mesh__recordMaintainer mesh__D000202 nns
% 223.15/223.40  |- skos__altLabel mesh__D000202 Function Activator
% 223.15/223.40  |- mesh__publicMeSHNote mesh__D000202
% 223.15/223.40       91; was see under ORTHODONTIC APPLIANCES, REMOVABLE 1975-90%A%  
% 223.15/223.40  |- skos__hiddenLabel mesh__D000202 Activator Appliance
% 223.15/223.40  |- skos__hiddenLabel mesh__D000202 Activators, Function
% 223.15/223.40  |- skos__hiddenLabel mesh__D000202 Activator, Harvold
% 223.15/223.40  |- skos__hiddenLabel mesh__D000202 Appliance, Activator
% 223.15/223.40  |- skos__broader mesh__D005496smesh__D005498
% 223.15/223.40  |- mesh__dateEstablished mesh__D005496 1991-01-01
% 223.15/223.40  |- mesh__dateRevised mesh__D005496 2004-07-07
% 223.15/223.40  |- mesh__recordOriginator mesh__D005496 EC
% 223.15/223.40  |- skos__altLabel mesh__D005496 Atresia, Follicular
% 223.15/223.40  |- mesh__recordAuthorizer mesh__D005496 sjn
% 223.15/223.40  |- mesh__historyNote mesh__D005496
% 223.15/223.40       91%28%85%29%; was see under FOLLICULAR PHASE 1985-90   
% 223.15/223.40  |- skos__prefLabel mesh__D005496 Follicular Atresia
% 223.15/223.40  |- rdf__type mesh__D005496sskos__Concept
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D005496 2005
% 223.15/223.40  |- skos__hiddenLabel mesh__D005496 Atresias, Follicular
% 223.15/223.40  |- skos__historyNote mesh__D005496 Graafian Follicle %28%1966-1984%29%
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D005496 2006
% 223.15/223.40  |- skos__scopeNote mesh__D005496
% 223.15/223.40       The degeneration and resorption of an OVARIAN FOLLICLE before it reaches maturity and ruptures.%A%    
% 223.15/223.40  |- mesh__recordMaintainer mesh__D005496 lkt
% 223.15/223.40  |- skos__historyNote mesh__D005496 Ovulation %28%1966-1984%29%
% 223.15/223.40  |- mesh__dateCreated mesh__D005496 1984-05-31
% 223.15/223.40  |- skos__hiddenLabel mesh__D005496 Follicular Atresias
% 223.15/223.40  |- mesh__publicMeSHNote mesh__D005496
% 223.15/223.40       91; was see under FOLLICULAR PHASE 1985-90   
% 223.15/223.40  |- skos__prefLabel mesh__D013928 Thromboxane A2
% 223.15/223.40  |- skos__hiddenLabel mesh__D013928 A2, Thromboxane
% 223.15/223.40  |- mesh__historyNote mesh__D013928
% 223.15/223.40       86%28%78%29%; was see under THROMBOXANES 1978-85   
% 223.15/223.40  |- mesh__dateRevised mesh__D013928 2005-06-30
% 223.15/223.40  |- skos__broader mesh__D013928smesh__D013931
% 223.15/223.40  |- mesh__recordAuthorizer mesh__D013928 sjn
% 223.15/223.40  |- mesh__dateCreated mesh__D013928 1977-05-23
% 223.15/223.40  |- skos__annotation mesh__D013928 /biosyn /physiol permitted   
% 223.15/223.40  |- mesh__recordOriginator mesh__D013928 RLS
% 223.15/223.40  |- mesh__dateEstablished mesh__D013928 1986-01-01
% 223.15/223.40  |- mesh__publicMeSHNote mesh__D013928
% 223.15/223.40       86; was see under THROMBOXANES 1978-85   
% 223.15/223.40  |- skos__scopeNote mesh__D013928
% 223.15/223.40       An unstable intermediate between the prostaglandin endoperoxides and thromboxane B2. The compound has a bicyclic oxaneoxetane structure. It is a potent inducer of platelet aggregation and causes vasoconstriction. It is the principal component of rabbit aorta contracting substance %28%RCS%29%.%A%    
% 223.15/223.40  |- skos__historyNote mesh__D013928 Pyrans %28%1966-1977%29%
% 223.15/223.40  |- skos__historyNote mesh__D013928
% 223.15/223.40       Fatty Acids, Unsaturated %28%1973-1974%29%
% 223.15/223.40  |- mesh__recordMaintainer mesh__D013928 ssb
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D013928 2006
% 223.15/223.40  |- skos__historyNote mesh__D013928 Hydroxy Acids %28%1975-1977%29%
% 223.15/223.40  |- rdf__type mesh__D013928sskos__Concept
% 223.15/223.40  |- skos__prefLabel mesh__D018613 Microscopy, Confocal
% 223.15/223.40  |- skos__hiddenLabel mesh__D018613 Microscopy, Laser
% 223.15/223.40  |- mesh__recordOriginator mesh__D018613 PXP
% 223.15/223.40  |- skos__hiddenLabel mesh__D018613 Scanning Microscopy, Laser
% 223.15/223.40  |- skos__hiddenLabel mesh__D018613 Confocal Microscopies
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D018613 2005
% 223.15/223.40  |- skos__altLabel mesh__D018613 Confocal Laser Scanning Microscopy
% 223.15/223.40  |- rdf__type mesh__D018613sskos__Concept
% 223.15/223.40  |- skos__historyNote mesh__D018613 Microscopy %28%1985-1994%29%
% 223.15/223.40  |- skos__scopeNote mesh__D018613
% 223.15/223.40       A light microscopic technique in which only a small spot is illuminated and observed at a time. An image is constructed through point-by-point scanning of the field in this manner. Light sources may be conventional or laser, and fluorescence or transmitted observations are possible.%A%    
% 223.15/223.40  |- skos__hiddenLabel mesh__D018613 Microscopies, Laser Scanning
% 223.15/223.40  |- skos__annotation mesh__D018613 NIM   
% 223.15/223.40  |- skos__historyNote mesh__D018613
% 223.15/223.40       Microscopy, Fluorescence %28%1985-1994%29%
% 223.15/223.40  |- skos__altLabel mesh__D018613 Confocal Microscopy, Scanning Laser
% 223.15/223.40  |- skos__hiddenLabel mesh__D018613 Laser Scanning Microscopies
% 223.15/223.40  |- skos__hiddenLabel mesh__D018613 Scanning Microscopies, Laser
% 223.15/223.40  |- skos__altLabel mesh__D018613 Laser Scanning Confocal Microscopy
% 223.15/223.40  |- mesh__dateCreated mesh__D018613 1994-04-16
% 223.15/223.40  |- mesh__publicMeSHNote mesh__D018613 95   
% 223.15/223.40  |- mesh__dateRevised mesh__D018613 2004-07-07
% 223.15/223.40  |- skos__hiddenLabel mesh__D018613 Microscopies, Laser
% 223.15/223.40  |- mesh__recordMaintainer mesh__D018613 nns
% 223.15/223.40  |- skos__altLabel mesh__D018613 Confocal Microscopy
% 223.15/223.40  |- skos__broader mesh__D018613smesh__D008853
% 223.15/223.40  |- skos__hiddenLabel mesh__D018613 Microscopy, Laser Scanning
% 223.15/223.40  |- skos__hiddenLabel mesh__D018613 Microscopies, Confocal
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D018613 2006
% 223.15/223.40  |- mesh__dateEstablished mesh__D018613 1995-01-01
% 223.15/223.40  |- mesh__historyNote mesh__D018613 95   
% 223.15/223.40  |- skos__hiddenLabel mesh__D018613 Laser Microscopies
% 223.15/223.40  |- mesh__recordAuthorizer mesh__D018613 sjn
% 223.15/223.40  |- mesh__dateCreated mesh__D010630 1999-01-01
% 223.15/223.40  |- skos__altLabel mesh__D010630
% 223.15/223.40       Merck Lipha Sant%C3%%A9% Brand of Phenindione
% 223.15/223.40  |- skos__altLabel mesh__D010630 Boots Brand of Phenindione
% 223.15/223.40  |- skos__hiddenLabel mesh__D010630 2 Phenyl 1,3 indandione
% 223.15/223.40  |- rdf__type mesh__D010630sskos__Concept
% 223.15/223.40  |- skos__prefLabel mesh__D010630 Phenindione
% 223.15/223.40  |- mesh__recordAuthorizer mesh__D010630 sjn
% 223.15/223.40  |- skos__altLabel mesh__D010630 2-Phenyl-1,3-indandione
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D010630 2006
% 223.15/223.40  |- mesh__recordOriginator mesh__D010630 NLM
% 223.15/223.40  |- mesh__recordMaintainer mesh__D010630 lkw
% 223.15/223.40  |- skos__scopeNote mesh__D010630
% 223.15/223.40       An indandione that has been used as an anticoagulant. Phenindione has actions similar to WARFARIN, but it is now rarely employed because of its higher incidence of severe adverse effects. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p234%29%%A%    
% 223.15/223.40  |- skos__altLabel mesh__D010630 Phenylindanedione
% 223.15/223.40  |- skos__broader mesh__D010630smesh__D007189
% 223.15/223.40  |- skos__altLabel mesh__D010630 Goldshield Brand of Phenindione
% 223.15/223.40  |- mesh__dateRevised mesh__D010630 2005-06-30
% 223.15/223.40  |- skos__scopeNote mesh__D009887
% 223.15/223.40       Examination of the interior of the eye with an ophthalmoscope.%A%    
% 223.15/223.40  |- mesh__dateCreated mesh__D009887 1999-01-01
% 223.15/223.40  |- mesh__recordMaintainer mesh__D009887 lkt
% 223.15/223.40  |- mesh__dateRevised mesh__D009887 2001-07-25
% 223.15/223.40  |- mesh__recordAuthorizer mesh__D009887 sjn
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D009887 2005
% 223.15/223.40  |- mesh__recordOriginator mesh__D009887 NLM
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D009887 2002
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D009887 2006
% 223.15/223.40  |- skos__broader mesh__D009887smesh__D003941
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D009887 2003
% 223.15/223.40  |- skos__hiddenLabel mesh__D009887 Ophthalmoscopies
% 223.15/223.40  |- rdf__type mesh__D009887sskos__Concept
% 223.15/223.40  |- skos__prefLabel mesh__D009887 Ophthalmoscopy
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D009887 2004
% 223.15/223.40  |- mesh__dateRevised mesh__D009089 2005-06-30
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D009089 2006
% 223.15/223.40  |- skos__broader mesh__D009089smesh__D009090
% 223.15/223.40  |- mesh__recordAuthorizer mesh__D009089 sjn
% 223.15/223.40  |- skos__annotation mesh__D009089 a zygomycete; infection = MUCORMYCOSIS   
% 223.15/223.40  |- mesh__recordOriginator mesh__D009089 NLM
% 223.15/223.40  |- rdf__type mesh__D009089sskos__Concept
% 223.15/223.40  |- skos__scopeNote mesh__D009089
% 223.15/223.40       A genus of zygomycetous fungi of the family Mucoraceae, order Mucorales. It is primarily saprophytic, but may cause MUCORMYCOSIS in man from spores germinating in the lungs.%A%    
% 223.15/223.40  |- mesh__recordMaintainer mesh__D009089 SYSTEM
% 223.15/223.40  |- mesh__dateCreated mesh__D009089 1999-01-01
% 223.15/223.40  |- skos__prefLabel mesh__D009089 Mucor
% 223.15/223.40  |- mesh__recordAuthorizer mesh__D028243 ags
% 223.15/223.40  |- mesh__historyNote mesh__D028243
% 223.15/223.40       2002; for CEREBRAL AMYLOID ANGIOPATHY, FAMILIAL use CEREBRAL AMYLOID ANGIOPATHY 2000-2001%A%  
% 223.15/223.40  |- skos__hiddenLabel mesh__D028243 Amyloidosis, Icelandic Type
% 223.15/223.40  |- skos__historyNote mesh__D028243
% 223.15/223.40       Cerebrovascular Disorders %28%1974-1991%29%
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D028243 2004
% 223.15/223.40  |- skos__prefLabel mesh__D028243 Cerebral Amyloid Angiopathy, Familial
% 223.15/223.40  |- skos__altLabel mesh__D028243
% 223.15/223.40       Icelandic Type Hereditary Cerebral Amyloid Angiopathy
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D028243 2006A
% 223.15/223.40  |- mesh__recordOriginator mesh__D028243 nns
% 223.15/223.40  |- mesh__dateRevised mesh__D028243 2005-07-08
% 223.15/223.40  |- skos__broader mesh__D028243smesh__D016657
% 223.15/223.40  |- skos__altLabel mesh__D028243 Icelandic Type Amyloidosis
% 223.15/223.40  |- skos__broader mesh__D028243smesh__D028226
% 223.15/223.40  |- skos__historyNote mesh__D028243 Amyloidosis %28%1974-1991%29%
% 223.15/223.40  |- skos__altLabel mesh__D028243
% 223.15/223.40       Dutch Type Hereditary Cerebral Amyloid Angiopathy
% 223.15/223.40  |- skos__historyNote mesh__D028243
% 223.15/223.40       Cerebral Amyloid Angiopathy %28%1992-2001%29%
% 223.15/223.40  |- skos__scopeNote mesh__D028243
% 223.15/223.40       A familial condition marked by the deposition of AMYLOID in the walls of small blood vessels in the cerebral cortex and meninges and characterized clinically by cerebral ischemia %28%see BRAIN ISCHEMIA%29%; CEREBRAL INFARCTION; and CEREBRAL HEMORRHAGE..%A%    
% 223.15/223.40  |- rdf__type mesh__D028243sskos__Concept
% 223.15/223.40  |- skos__altLabel mesh__D028243 Hereditary Cerebral Amyloid Angiopathy
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D028243 2005
% 223.15/223.40  |- skos__broader mesh__D028243smesh__D020739
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D028243 2002
% 223.15/223.40  |- skos__altLabel mesh__D028243 Familial Cerebral Amyloid Angiopathy
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D028243 2006
% 223.15/223.40  |- mesh__dateCreated mesh__D028243 2001-07-25
% 223.15/223.40  |- mesh__publicMeSHNote mesh__D028243
% 223.15/223.40       2002; for CEREBRAL AMYLOID ANGIOPATHY, FAMILIAL see CEREBRAL AMYLOID ANGIOPATHY 2000-2001%A%  
% 223.15/223.40  |- mesh__dateEstablished mesh__D028243 2002-01-01
% 223.15/223.40  |- mesh__recordMaintainer mesh__D028243 ags
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D028243 2003
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D020260 2001
% 223.15/223.40  |- mesh__historyNote mesh__D020260 2000   
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D020260 2005
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D020260 2002
% 223.15/223.40  |- skos__altLabel mesh__D020260 Poisoning, Heavy Metals, Nervous System
% 223.15/223.40  |- mesh__recordMaintainer mesh__D020260 ags
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D020260 2006
% 223.15/223.40  |- rdf__type mesh__D020260sskos__Concept
% 223.15/223.40  |- skos__historyNote mesh__D020260
% 223.15/223.40       Metals, Heavy/poisoning %28%1997-1999%29%
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D020260 2000A
% 223.15/223.40  |- skos__prefLabel mesh__D020260 Heavy Metal Poisoning, Nervous System
% 223.15/223.40  |- skos__scopeNote mesh__D020260
% 223.15/223.40       Conditions associated with damage or dysfunction of the nervous system caused by exposure to heavy metals, which may cause a variety of central, peripheral, or autonomic nervous system injuries.%A%    
% 223.15/223.40  |- mesh__publicMeSHNote mesh__D020260 2000   
% 223.15/223.40  |- mesh__dateCreated mesh__D020260 1999-11-08
% 223.15/223.40  |- mesh__recordAuthorizer mesh__D020260 ags
% 223.15/223.40  |- mesh__dateRevised mesh__D020260 1999-12-16
% 223.15/223.40  |- skos__broader mesh__D020260smesh__D020258
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D020260 2003
% 223.15/223.40  |- mesh__recordOriginator mesh__D020260 KEV
% 223.15/223.40  |- skos__historyNote mesh__D020260
% 223.15/223.40       Metals or specifics/poisoning %28%1966-1999%29%
% 223.15/223.40  |- mesh__dateEstablished mesh__D020260 2000-01-01
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D020260 2000
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D020260 2004
% 223.15/223.40  |- skos__annotation mesh__D020260 GEN: prefer specifics   
% 223.15/223.40  |- skos__altLabel mesh__D014223 Goldshield Brand of Triamterene
% 223.15/223.40  |- mesh__recordMaintainer mesh__D014223 CCR
% 223.15/223.40  |- skos__broader mesh__D014223smesh__D011621
% 223.15/223.40  |- mesh__recordOriginator mesh__D014223 NLM
% 223.15/223.40  |- mesh__dateCreated mesh__D014223 1999-01-01
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D014223 2006
% 223.15/223.40  |- skos__scopeNote mesh__D014223
% 223.15/223.40       A pteridine that is used as a mild diuretic.     
% 223.15/223.40  |- skos__altLabel mesh__D014223 Wellspring Brand of Triamterene
% 223.15/223.40  |- mesh__recordAuthorizer mesh__D014223 sjn
% 223.15/223.40  |- skos__prefLabel mesh__D014223 Triamterene
% 223.15/223.40  |- mesh__publicMeSHNote mesh__D014223 65   
% 223.15/223.40  |- skos__altLabel mesh__D014223 SmithKline Beecham Brand of Triamterene
% 223.15/223.40  |- rdf__type mesh__D014223sskos__Concept
% 223.15/223.40  |- mesh__historyNote mesh__D014223 65%28%63%29%   
% 223.15/223.40  |- skos__altLabel mesh__D014223 Jorba Brand of Triamterene
% 223.15/223.40  |- mesh__dateRevised mesh__D014223 2005-06-30
% 223.15/223.40  |- mesh__dateEstablished mesh__D014223 1965-01-01
% 223.15/223.40  |- skos__historyNote mesh__D000203 Rehabilitation %28%1966-1967%29%
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D000203 2004
% 223.15/223.40  |- skos__prefLabel mesh__D000203 Activities of Daily Living
% 223.15/223.40  |- skos__hiddenLabel mesh__D000203 Activity, Daily Living
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D000203 2003
% 223.15/223.40  |- skos__hiddenLabel mesh__D000203 Living Activity, Daily
% 223.15/223.40  |- skos__broader mesh__D000203smesh__D006802
% 223.15/223.40  |- skos__hiddenLabel mesh__D000203 Self Cares %28%Rehabilitation%29%
% 223.15/223.40  |- mesh__dateRevised mesh__D000203 1997-06-20
% 223.15/223.40  |- mesh__recordAuthorizer mesh__D000203 SJN
% 223.15/223.40  |- skos__scopeNote mesh__D000203
% 223.15/223.40       The performance of the basic activities of self care, such as dressing, ambulation, eating, etc., in rehabilitation.%A%    
% 223.15/223.40  |- skos__related mesh__D000203smesh__D018434
% 223.15/223.40  |- skos__related mesh__D000203smesh__D017567
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D000203 1999
% 223.15/223.40  |- skos__hiddenLabel mesh__D000203 Living Activities, Daily
% 223.15/223.40  |- skos__hiddenLabel mesh__D000203 Daily Living Activity
% 223.15/223.40  |- mesh__dateEstablished mesh__D000203 1968-01-01
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D000203 2002
% 223.15/223.40  |- mesh__recordOriginator mesh__D000203 NLM
% 223.15/223.40  |- mesh__recordMaintainer mesh__D000203 PXP
% 223.15/223.40  |- skos__annotation mesh__D000203 IM; DF: note short X ref   
% 223.15/223.40  |- skos__broader mesh__D000203smesh__D012046
% 223.15/223.40  |- skos__altLabel mesh__D000203 ADL
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D000203 1998
% 223.15/223.40  |- skos__hiddenLabel mesh__D000203 Care, Self %28%Rehabilitation%29%
% 223.15/223.40  |- mesh__historyNote mesh__D000203
% 223.15/223.40       68; SELF CARE %28%REHABILITATION%29% was SELF CARE see ACTIVITIES OF DAILY LIVING 1979-80%A%  
% 223.15/223.40  |- skos__hiddenLabel mesh__D000203 Cares, Self %28%Rehabilitation%29%
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D000203 2006
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D000203 2001
% 223.15/223.40  |- mesh__dateCreated mesh__D000203 1999-01-01
% 223.15/223.40  |- rdf__type mesh__D000203sskos__Concept
% 223.15/223.40  |- mesh__onlineNote mesh__D000203
% 223.15/223.40       use ACTIVITIES OF DAILY LIVING to search SELF CARE 1979-80%A%  
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D000203 2005
% 223.15/223.40  |- skos__altLabel mesh__D000203 Activities, Daily Living
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D000203 2000
% 223.15/223.40  |- skos__hiddenLabel mesh__D000203 Daily Living Activities
% 223.15/223.40  |- mesh__publicMeSHNote mesh__D000203
% 223.15/223.40       68; SELF CARE %28%REHABILITATION%29% was SELF CARE see ACTIVITIES OF DAILY LIVING 1979-80%A%  
% 223.15/223.40  |- skos__hiddenLabel mesh__D000203 Living, Independent
% 223.15/223.40  |- skos__altLabel mesh__D000203 Chronic Limitation of Activity
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D005497 2001
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D005497 1997
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D005497 1994
% 223.15/223.40  |- rdf__type mesh__D005497sskos__Concept
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D005497 2005
% 223.15/223.40  |- mesh__dateRevised mesh__D005497 1992-05-20
% 223.15/223.40  |- skos__hiddenLabel mesh__D005497 Cysts, Follicular
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D005497 1995
% 223.15/223.40  |- skos__annotation mesh__D005497
% 223.15/223.40       non-neoplastic; /blood supply /chem /secret /ultrastruct permitted%A%  
% 223.15/223.40  |- mesh__historyNote mesh__D005497 87   
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D005497 2006
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D005497 1998
% 223.15/223.40  |- skos__broader mesh__D005497smesh__D003560
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D005497 2002
% 223.15/223.40  |- skos__scopeNote mesh__D005497
% 223.15/223.40       Cyst due to the occlusion of the duct of a follicle or small gland.%A%    
% 223.15/223.40  |- mesh__dateEstablished mesh__D005497 1987-01-01
% 223.15/223.40  |- mesh__publicMeSHNote mesh__D005497 87   
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D005497 2003
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D005497 1999
% 223.15/223.40  |- skos__hiddenLabel mesh__D005497 Follicular Cysts
% 223.15/223.40  |- mesh__dateCreated mesh__D005497 1986-06-23
% 223.15/223.40  |- skos__hiddenLabel mesh__D005497 Cyst, Follicular
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D005497 1993
% 223.15/223.40  |- skos__prefLabel mesh__D005497 Follicular Cyst
% 223.15/223.40  |- mesh__recordAuthorizer mesh__D005497 PLS
% 223.15/223.40  |- mesh__activeMeSHYear mesh__D005497 2004
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D005497 1996
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D005497 2000
% 223.15/223.41  |- mesh__recordOriginator mesh__D005497 VDK
% 223.15/223.41  |- mesh__recordMaintainer mesh__D005497 TGC
% 223.15/223.41  |- mesh__recordMaintainer mesh__D013929 ssb
% 223.15/223.41  |- skos__annotation mesh__D013929 /biosyn /physiol permitted   
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D013929 2006
% 223.15/223.41  |- mesh__dateCreated mesh__D013929 1977-05-24
% 223.15/223.41  |- skos__historyNote mesh__D013929 Hydroxy Acids %28%1975-1977%29%
% 223.15/223.41  |- rdf__type mesh__D013929sskos__Concept
% 223.15/223.41  |- mesh__recordOriginator mesh__D013929 RLS
% 223.15/223.41  |- mesh__dateEstablished mesh__D013929 1986-01-01
% 223.15/223.41  |- mesh__dateRevised mesh__D013929 2005-06-30
% 223.15/223.41  |- skos__historyNote mesh__D013929 Pyrans %28%1966-1977%29%
% 223.15/223.41  |- skos__broader mesh__D013929smesh__D013931
% 223.15/223.41  |- skos__hiddenLabel mesh__D013929 B2, Thromboxane
% 223.15/223.41  |- mesh__recordAuthorizer mesh__D013929 sjn
% 223.15/223.41  |- mesh__historyNote mesh__D013929
% 223.15/223.41       86%28%78%29%; was see under THROMBOXANES 1978-85   
% 223.15/223.41  |- mesh__publicMeSHNote mesh__D013929
% 223.15/223.41       86; was see under THROMBOXANES 1978-85   
% 223.15/223.41  |- skos__scopeNote mesh__D013929
% 223.15/223.41       A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction %28%release of ADP and serotonin%29%.%A%    
% 223.15/223.41  |- skos__historyNote mesh__D013929
% 223.15/223.41       Fatty Acids, Unsaturated %28%1973-1974%29%
% 223.15/223.41  |- skos__prefLabel mesh__D013929 Thromboxane B2
% 223.15/223.41  |- rdf__type mesh__D018614sskos__Concept
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D018614 2000
% 223.15/223.41  |- skos__broader mesh__D018614smesh__D005334
% 223.15/223.41  |- mesh__dateEstablished mesh__D018614 1995-01-01
% 223.15/223.41  |- skos__prefLabel mesh__D018614 Sweating Sickness
% 223.15/223.41  |- mesh__recordAuthorizer mesh__D018614 sjn
% 223.15/223.41  |- skos__hiddenLabel mesh__D018614 Sickness, Sweating
% 223.15/223.41  |- skos__altLabel mesh__D018614 English Sweating Sickness
% 223.15/223.41  |- skos__scopeNote mesh__D018614
% 223.15/223.41       A clinical condition characterized by fever and profuse sweating and associated with high mortality. It occurred in epidemic form five times in the fifteenth and sixteenth centuries in England, first in 1485 and last in 1551, specially during the summer and early autumn, attacking the relatively affluent adult male population. The etiology was unknown.%A%    
% 223.15/223.41  |- mesh__recordMaintainer mesh__D018614 KEV
% 223.15/223.41  |- skos__annotation mesh__D018614 a hist epidemic dis   
% 223.15/223.41  |- mesh__recordOriginator mesh__D018614 TGC
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D018614 2004
% 223.15/223.41  |- skos__altLabel mesh__D018614 Sudor Anglicus
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D018614 2002
% 223.15/223.41  |- mesh__dateCreated mesh__D018614 1994-04-19
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D018614 2006
% 223.15/223.41  |- mesh__historyNote mesh__D018614 95   
% 223.15/223.41  |- mesh__dateRevised mesh__D018614 1999-11-03
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D018614 2003
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D018614 2001
% 223.15/223.41  |- mesh__publicMeSHNote mesh__D018614 95   
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D018614 2005
% 223.15/223.41  |- skos__prefLabel mesh__D009888 Opipramol
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D009888 2006
% 223.15/223.41  |- mesh__publicMeSHNote mesh__D009888 66   
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D009888 2003
% 223.15/223.41  |- mesh__dateEstablished mesh__D009888 1966-01-01
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D009888 2001
% 223.15/223.41  |- rdf__type mesh__D009888sskos__Concept
% 223.15/223.41  |- skos__hiddenLabel mesh__D009888 Hydrochloride, Opipramol
% 223.15/223.41  |- skos__scopeNote mesh__D009888
% 223.15/223.41       A tricyclic antidepressant with actions similar to AMITRIPTYLINE.%A%    
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D009888 2004
% 223.15/223.41  |- mesh__historyNote mesh__D009888 66   
% 223.15/223.41  |- mesh__recordAuthorizer mesh__D009888 sjn
% 223.15/223.41  |- mesh__dateCreated mesh__D009888 1999-01-01
% 223.15/223.41  |- mesh__recordMaintainer mesh__D009888 TWD
% 223.15/223.41  |- skos__broader mesh__D009888smesh__D003984
% 223.15/223.41  |- mesh__recordOriginator mesh__D009888 NLM
% 223.15/223.41  |- mesh__dateRevised mesh__D009888 2000-06-21
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D009888 2002
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D009888 2005
% 223.15/223.41  |- mesh__dateEstablished mesh__D034281 2003-01-01
% 223.15/223.41  |- mesh__recordMaintainer mesh__D034281 jmp
% 223.15/223.41  |- mesh__recordAuthorizer mesh__D034281 sjn
% 223.15/223.41  |- skos__broader mesh__D034281smesh__D033921
% 223.15/223.41  |- skos__altLabel mesh__D034281 Dynamin, Alanine44 Substituted With Lysine
% 223.15/223.41  |- mesh__dateRevised mesh__D034281 2005-06-30
% 223.15/223.41  |- skos__broader mesh__D034281smesh__D008869
% 223.15/223.41  |- skos__prefLabel mesh__D034281 Dynamins
% 223.15/223.41  |- rdf__type mesh__D034281sskos__Concept
% 223.15/223.41  |- skos__hiddenLabel mesh__D034281 Dynamin, GTPase-Deficient
% 223.15/223.41  |- mesh__historyNote mesh__D034281
% 223.15/223.41       2003; use DYNAMINS %28%NM%29% 1989-2002   
% 223.15/223.41  |- skos__broader mesh__D034281smesh__D020558
% 223.15/223.41  |- skos__historyNote mesh__D034281
% 223.15/223.41       Ca%28%2+%29% Mg%28%2+%29%-ATPase %28%1989-1994%29%
% 223.15/223.41  |- skos__altLabel mesh__D034281 Dephosphin
% 223.15/223.41  |- mesh__recordOriginator mesh__D034281 jmp
% 223.15/223.41  |- skos__altLabel mesh__D034281 Dynamin
% 223.15/223.41  |- skos__altLabel mesh__D034281 Dynamin K44A
% 223.15/223.41  |- skos__annotation mesh__D034281
% 223.15/223.41       GEN: prefer specifics; see SCR for organism-specific dynamins%A%  
% 223.15/223.41  |- mesh__dateCreated mesh__D034281 2002-07-03
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D034281 2006
% 223.15/223.41  |- skos__historyNote mesh__D034281 GTP Phosphohydrolases %28%1994-2002%29%
% 223.15/223.41  |- skos__scopeNote mesh__D034281
% 223.15/223.41       A family of high molecular weight GTP phosphohydrolases that play a direct role in vesicle transport. They associate with microtubule bundles %28%MICROTUBULES%29% and are believed to produce mechanical force via a process linked to GTP hydrolysis. This enzyme was formerly listed as EC 3.6.1.50.%A%    
% 223.15/223.41  |- skos__altLabel mesh__D034281 Dynamin, Mutated Form, K44A
% 223.15/223.41  |- skos__hiddenLabel mesh__D034281 GTPase Deficient Dynamin
% 223.15/223.41  |- mesh__publicMeSHNote mesh__D034281
% 223.15/223.41       2003; DYNAMIN %28%now DYNAMINS%29% was indexed under GTP PHOSPHOHYDROLASES 1 1994-2002 %26% CA%28%2+%29% MG%28%2+%29%-ATPASE 1989-1993%A%  
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D028244 2002
% 223.15/223.41  |- mesh__publicMeSHNote mesh__D028244
% 223.15/223.41       2002; for CAMELLIA %26% THEA see Theales 1999-2001, see TEA 1986-1998%A%  
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D028244 2005
% 223.15/223.41  |- mesh__dateCreated mesh__D028244 2001-07-25
% 223.15/223.41  |- skos__scopeNote mesh__D028244
% 223.15/223.41       A plant genus in the family THEACEAE, order THEALES best known for CAMELLIA SINENSIS which is the source of Oriental TEA.%A%    
% 223.15/223.41  |- rdf__type mesh__D028244sskos__Concept
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D028244 2006
% 223.15/223.41  |- skos__historyNote mesh__D028244 Theales %28%1999-2001%29%
% 223.15/223.41  |- skos__altLabel mesh__D028244 Thea
% 223.15/223.41  |- skos__annotation mesh__D028244
% 223.15/223.41       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.15/223.41  |- skos__broader mesh__D028244smesh__D028242
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D028244 2003
% 223.15/223.41  |- mesh__historyNote mesh__D028244
% 223.15/223.41       2002; for CAMELLIA %26% THEA use Theales 1999-2001, use TEA 1986-1998%A%  
% 223.15/223.41  |- mesh__dateEstablished mesh__D028244 2002-01-01
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D028244 2004
% 223.15/223.41  |- skos__prefLabel mesh__D028244 Camellia
% 223.15/223.41  |- skos__broader mesh__D004041Q000172smesh__D004041
% 223.15/223.41  |- mesh__preferredCombination mesh__D004041Q000172smesh__D008055Q000172
% 223.15/223.41  |- rdf__type mesh__D004041Q000172smesh__CompoundConcept
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D006590 2005
% 223.15/223.41  |- skos__altLabel mesh__D006590 Drossapharm Brand of Hexetidine
% 223.15/223.41  |- skos__hiddenLabel mesh__D006590 Vagi Hex
% 223.15/223.41  |- skos__altLabel mesh__D006590 Elsix
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D006590 2005A
% 223.15/223.41  |- mesh__dateCreated mesh__D006590 1999-01-01
% 223.15/223.41  |- skos__altLabel mesh__D006590 Rentschler Brand of Hexetidine
% 223.15/223.41  |- skos__altLabel mesh__D006590 Oralspray
% 223.15/223.41  |- mesh__dateEstablished mesh__D006590 1973-01-01
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D006590 2006
% 223.15/223.41  |- skos__altLabel mesh__D006590 Warner-Lambert Brand of Hexetidine
% 223.15/223.41  |- mesh__publicMeSHNote mesh__D006590 73   
% 223.15/223.41  |- skos__altLabel mesh__D006590 Stada Brand of Hexetidine
% 223.15/223.41  |- skos__prefLabel mesh__D006590 Hexetidine
% 223.15/223.41  |- skos__altLabel mesh__D006590 Hexoral
% 223.15/223.41  |- mesh__recordOriginator mesh__D006590 NLM
% 223.15/223.41  |- skos__hiddenLabel mesh__D006590 Hexetidine Warner-Lambert Brand
% 223.15/223.41  |- skos__hiddenLabel mesh__D006590 Hexetidine Rentschler Brand
% 223.15/223.41  |- skos__altLabel mesh__D006590 Collu-Hextril
% 223.15/223.41  |- skos__broader mesh__D006590smesh__D011743
% 223.15/223.41  |- skos__altLabel mesh__D006590 Warner Wellcome Brand of Hexetidine
% 223.15/223.41  |- skos__altLabel mesh__D006590 Hextril
% 223.15/223.41  |- mesh__recordAuthorizer mesh__D006590 jls
% 223.15/223.41  |- skos__altLabel mesh__D006590 Hexigel
% 223.15/223.41  |- rdf__type mesh__D006590sskos__Concept
% 223.15/223.41  |- mesh__dateRevised mesh__D006590 2004-07-28
% 223.15/223.41  |- skos__hiddenLabel mesh__D006590 Warner Lambert Brand of Hexetidine
% 223.15/223.41  |- skos__hiddenLabel mesh__D006590 VagiHex
% 223.15/223.41  |- skos__altLabel mesh__D006590 Warner Chilcott Brand of Hexetidine
% 223.15/223.41  |- skos__altLabel mesh__D006590 Parke Davis Brand of Hexetidine
% 223.15/223.41  |- skos__altLabel mesh__D006590 Duranil
% 223.15/223.41  |- skos__altLabel mesh__D006590 Oraldine
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D006590 2004
% 223.15/223.41  |- skos__altLabel mesh__D006590 Steri/sol
% 223.15/223.41  |- skos__scopeNote mesh__D006590
% 223.15/223.41       A bactericidal and fungicidal antiseptic. It is used as a 0.1%25% mouthwash for local infections and oral hygiene. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p797%29%%A%    
% 223.15/223.41  |- mesh__recordMaintainer mesh__D006590 jls
% 223.15/223.41  |- mesh__historyNote mesh__D006590 73%28%66%29%   
% 223.15/223.41  |- skos__hiddenLabel mesh__D006590 Collu Hextril
% 223.15/223.41  |- skos__scopeNote mesh__D020261
% 223.15/223.41       Disorders associated with acute or chronic exposure to compounds containing ARSENIC %28%ARSENICALS%29% which may be fatal. Acute oral ingestion is associated with gastrointestinal symptoms and an encephalopathy which may manifest as SEIZURES, mental status changes, and COMA. Chronic exposure is associated with mucosal irritation, desquamating rash, myalgias, peripheral neuropathy, and white transverse %28%Mees%29% lines in the fingernails. %28%Adams et al., Principles of Neurology, 6th ed, p1212%29%%A%    
% 223.15/223.41  |- skos__broader mesh__D020261smesh__D020260
% 223.15/223.41  |- rdf__type mesh__D020261sskos__Concept
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D020261 2005
% 223.15/223.41  |- skos__altLabel mesh__D020261 Nervous System Poisoning, Arsenic
% 223.15/223.41  |- skos__hiddenLabel mesh__D020261 Arsenic Poisonings, Inorganic
% 223.15/223.41  |- mesh__historyNote mesh__D020261 2000   
% 223.15/223.41  |- skos__hiddenLabel mesh__D020261 Poisoning, Arsenic
% 223.15/223.41  |- skos__hiddenLabel mesh__D020261 Arsenical Neurotoxicity Syndrome
% 223.15/223.41  |- skos__prefLabel mesh__D020261 Arsenic Poisoning
% 223.15/223.41  |- skos__hiddenLabel mesh__D020261 Arsenic Poisonings, Organic
% 223.15/223.41  |- skos__altLabel mesh__D020261 Polyneuropathy, Arsenic-Induced
% 223.15/223.41  |- skos__hiddenLabel mesh__D020261 Poisonings, Arsenic
% 223.15/223.41  |- mesh__activeMeSHYear mesh__D020261 2004
% 223.15/223.41  |- skos__hiddenLabel mesh__D020261 Inorganic Arsenic Poisonings
% 223.15/223.41  |- skos__hiddenLabel mesh__D020261 Neurotoxicity Syndromes, Arsenical
% 223.15/223.41  |- skos__hiddenLabel mesh__D020261 Arsenic-Induced Polyneuropathies
% 223.15/223.41  |- skos__altLabel mesh__D020261 Inorganic Arsenic Poisoning
% 223.15/223.41  |- skos__altLabel mesh__D020261 Arsenic Poisoning, Nervous System
% 223.15/223.41  |- skos__hiddenLabel mesh__D020261 Poisoning, Inorganic Arsenic
% 223.15/223.41  |- skos__hiddenLabel mesh__D020261 Organic Arsenic Poisonings
% 223.15/223.41  |- skos__hiddenLabel mesh__D020261 Syndromes, Arsenical Neurotoxicity
% 223.15/223.41  |- mesh__dateCreated mesh__D020261 1999-11-04
% 223.27/223.41  |- skos__hiddenLabel mesh__D020261 Arsenic Encephalopathies
% 223.27/223.41  |- skos__hiddenLabel mesh__D020261 Poisonings, Inorganic Arsenic
% 223.27/223.41  |- skos__hiddenLabel mesh__D020261 Poisonings, Organic Arsenic
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D020261 2002
% 223.27/223.41  |- skos__altLabel mesh__D020261 Neurotoxicity Syndrome, Arsenical
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D020261 2003
% 223.27/223.41  |- skos__hiddenLabel mesh__D020261 Polyneuropathy, Arsenic Induced
% 223.27/223.41  |- mesh__dateEstablished mesh__D020261 2000-01-01
% 223.27/223.41  |- skos__annotation mesh__D020261
% 223.27/223.41       coord IM with specific arsenic cpd %28%IM%29% if given   
% 223.27/223.41  |- skos__hiddenLabel mesh__D020261 Encephalopathies, Arsenic
% 223.27/223.41  |- skos__altLabel mesh__D020261 Organic Arsenic Poisoning, Nervous System
% 223.27/223.41  |- skos__historyNote mesh__D020261 Arsenicals/poisoning %28%1966-1999%29%
% 223.27/223.41  |- skos__hiddenLabel mesh__D020261 Organic Arsenic Poisoning
% 223.27/223.41  |- skos__hiddenLabel mesh__D020261 Poisoning, Organic Arsenic
% 223.27/223.41  |- mesh__publicMeSHNote mesh__D020261 2000   
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D020261 2001
% 223.27/223.41  |- skos__hiddenLabel mesh__D020261 Arsenic-Induced Polyneuropathy
% 223.27/223.41  |- skos__hiddenLabel mesh__D020261 Syndrome, Arsenical Neurotoxicity
% 223.27/223.41  |- skos__broader mesh__D020261smesh__D011041
% 223.27/223.41  |- skos__altLabel mesh__D020261 Arsenic Poisoning, Organic
% 223.27/223.41  |- skos__altLabel mesh__D020261 Encephalopathy, Arsenic
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D020261 2006
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D020261 2000
% 223.27/223.41  |- skos__altLabel mesh__D020261 Poisoning, Arsenic, Nervous System
% 223.27/223.41  |- skos__hiddenLabel mesh__D020261 Arsenic Poisonings
% 223.27/223.41  |- skos__hiddenLabel mesh__D020261 Arsenical Neurotoxicity Syndromes
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D014224 2006
% 223.27/223.41  |- skos__annotation mesh__D014224
% 223.27/223.41       vector of Trypanosoma cruzi; do not use /drug eff for insecticides: TN 111%A%  
% 223.27/223.41  |- skos__broader mesh__D014224smesh__D014225
% 223.27/223.41  |- skos__scopeNote mesh__D014224
% 223.27/223.41       A genus of the subfamily TRIATOMINAE. Several species are vectors of TRYPANOSOMA CRUZI.%A%    
% 223.27/223.41  |- mesh__recordOriginator mesh__D014224 NLM
% 223.27/223.41  |- skos__prefLabel mesh__D014224 Triatoma
% 223.27/223.41  |- mesh__recordMaintainer mesh__D014224 ags
% 223.27/223.41  |- mesh__dateRevised mesh__D014224 2003-07-09
% 223.27/223.41  |- mesh__recordAuthorizer mesh__D014224 sjn
% 223.27/223.41  |- rdf__type mesh__D014224sskos__Concept
% 223.27/223.41  |- mesh__onlineNote mesh__D014224
% 223.27/223.41       use TRIATOMINAE to search TRIATOMA 1973-74   
% 223.27/223.41  |- mesh__historyNote mesh__D014224
% 223.27/223.41       91%28%75%29%; was see under TRIATOMIDAE 1979-90; was see under TRIATOMINAE 1973-78%A%  
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D014224 2005
% 223.27/223.41  |- mesh__dateEstablished mesh__D014224 1991-01-01
% 223.27/223.41  |- mesh__dateCreated mesh__D014224 1999-01-01
% 223.27/223.41  |- mesh__publicMeSHNote mesh__D014224
% 223.27/223.41       91; was see under TRIATOMIDAE 1979-90; was see under TRIATOMINAE 1973-78%A%  
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D014224 2004
% 223.27/223.41  |- mesh__onlineNote mesh__D000204 search CIRCADIAN RHYTHM 1968-74   
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D000204 2003
% 223.27/223.41  |- skos__prefLabel mesh__D000204 Activity Cycles
% 223.27/223.41  |- skos__annotation mesh__D000204 less than 24 hours   
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D000204 2000
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D000204 1995
% 223.27/223.41  |- mesh__publicMeSHNote mesh__D000204
% 223.27/223.41       91; was see under CIRCADIAN RHYTHM 1975-90   
% 223.27/223.41  |- mesh__dateEstablished mesh__D000204 1991-01-01
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D000204 1999
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D000204 1994
% 223.27/223.41  |- skos__broader mesh__D000204smesh__D002940
% 223.27/223.41  |- skos__hiddenLabel mesh__D000204 Cycles, Activity
% 223.27/223.41  |- mesh__dateRevised mesh__D000204 1992-05-18
% 223.27/223.41  |- mesh__historyNote mesh__D000204
% 223.27/223.41       91%28%75%29%; was see under CIRCADIAN RHYTHM 1975-90   
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D000204 1998
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D000204 1993
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D000204 2006
% 223.27/223.41  |- skos__hiddenLabel mesh__D000204 Cycle, Activity
% 223.27/223.41  |- mesh__dateCreated mesh__D000204 1999-01-01
% 223.27/223.41  |- rdf__type mesh__D000204sskos__Concept
% 223.27/223.41  |- skos__scopeNote mesh__D000204
% 223.27/223.41       Bouts of physical irritability or movement alternating with periods of quiescence. It includes biochemical activity and hormonal activity which may be cellular. These cycles are shorter than 24 hours and include sleep-wakefulness cycles and the periodic activation of the digestive system.%A%    
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D000204 1997
% 223.27/223.41  |- skos__hiddenLabel mesh__D000204 Activity Cycle
% 223.27/223.41  |- mesh__recordAuthorizer mesh__D000204 PLS
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D000204 2005
% 223.27/223.41  |- skos__hiddenLabel mesh__D000204 Ultradian Cycle
% 223.27/223.41  |- mesh__recordOriginator mesh__D000204 NLM
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D000204 2002
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D000204 1996
% 223.27/223.41  |- mesh__recordMaintainer mesh__D000204 TAP
% 223.27/223.41  |- skos__hiddenLabel mesh__D000204 Cycles, Ultradian
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D000204 2004
% 223.27/223.41  |- skos__hiddenLabel mesh__D000204 Cycle, Ultradian
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D000204 2001
% 223.27/223.41  |- skos__hiddenLabel mesh__D005498 Phase, Preovulatory
% 223.27/223.41  |- skos__altLabel mesh__D005498 Menstrual Cycle, Proliferative Phase
% 223.27/223.41  |- mesh__publicMeSHNote mesh__D005498
% 223.27/223.41       1985; was MENSTRUATION, FOLLICULAR PHASE see under MENSTRUATION 1975-1984; for MENSTRUAL PROLIFERATIVE PHASE see MENSTRUAL CYCLE 1985-2002%A%  
% 223.27/223.41  |- skos__prefLabel mesh__D005498 Follicular Phase
% 223.27/223.41  |- mesh__dateEstablished mesh__D005498 1985-01-01
% 223.27/223.41  |- mesh__dateRevised mesh__D005498 2004-07-07
% 223.27/223.41  |- skos__broader mesh__D005498smesh__D008597
% 223.27/223.41  |- rdf__type mesh__D005498sskos__Concept
% 223.27/223.41  |- mesh__recordOriginator mesh__D005498 NLM
% 223.27/223.41  |- skos__hiddenLabel mesh__D005498 Phase, Menstrual Proliferative
% 223.27/223.41  |- skos__altLabel mesh__D005498 Menstrual Proliferative Phase
% 223.27/223.41  |- mesh__recordMaintainer mesh__D005498 lkt
% 223.27/223.41  |- skos__hiddenLabel mesh__D005498 Phase, Follicular
% 223.27/223.41  |- skos__altLabel mesh__D005498 Preovulatory Phase
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D005498 2006
% 223.27/223.41  |- skos__scopeNote mesh__D005498
% 223.27/223.41       The period of the MENSTRUAL CYCLE representing follicular growth, increase in ovarian estrogen %28%ESTROGENS%29% production, and epithelial proliferation of the ENDOMETRIUM. Follicular phase begins with the onset of MENSTRUATION and ends with OVULATION.%A%    
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D005498 2005
% 223.27/223.41  |- mesh__recordAuthorizer mesh__D005498 sjn
% 223.27/223.41  |- mesh__historyNote mesh__D005498
% 223.27/223.41       1985%28%1975%29%; was MENSTRUATION, FOLLICULAR PHASE see under MENSTRUATION 1975-1984; for MENSTRUAL PROLIFERATIVE PHASE use MENSTRUAL CYCLE 1985-2002%A%  
% 223.27/223.41  |- skos__hiddenLabel mesh__D005498 Proliferative Phase, Menstrual
% 223.27/223.41  |- mesh__dateCreated mesh__D005498 1974-11-11
% 223.27/223.41  |- skos__altLabel mesh__D005498 Menstrual Cycle, Follicular Phase
% 223.27/223.41  |- skos__historyNote mesh__D018615 Ultrasonography %28%1985-1994%29%
% 223.27/223.41  |- rdf__type mesh__D018615sskos__Concept
% 223.27/223.41  |- skos__altLabel mesh__D018615 Doppler Ultrasonography, Color
% 223.27/223.41  |- skos__altLabel mesh__D018615 Ultrasonography, Doppler Color
% 223.27/223.41  |- skos__altLabel mesh__D018615 Ultrasonography, Color Doppler
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D018615 2000
% 223.27/223.41  |- skos__prefLabel mesh__D018615 Ultrasonography, Doppler, Color
% 223.27/223.41  |- mesh__recordOriginator mesh__D018615 PXP
% 223.27/223.41  |- skos__broader mesh__D018615smesh__D018616
% 223.27/223.41  |- skos__historyNote mesh__D018615 Blood Flow Velocity %28%1985-1994%29%
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D018615 2001
% 223.27/223.41  |- mesh__publicMeSHNote mesh__D018615 95   
% 223.27/223.41  |- mesh__dateCreated mesh__D018615 1994-02-28
% 223.27/223.41  |- skos__scopeNote mesh__D018615
% 223.27/223.41       Ultrasonography applying the Doppler effect, with the superposition of flow information as colors on a gray scale in a real-time image. This type of ultrasonography is well-suited to identifying the location of high-velocity flow %28%such as in a stenosis%29% or of mapping the extent of flow in a certain region.%A%    
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D018615 2003
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D018615 2005
% 223.27/223.41  |- skos__altLabel mesh__D018615 Color Ultrasonography, Doppler
% 223.27/223.41  |- skos__altLabel mesh__D018615 Doppler Color Ultrasonography
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D018615 2004
% 223.27/223.41  |- skos__altLabel mesh__D018615 Color Doppler Ultrasonography
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D018615 2002
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D018615 1998
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D018615 2006
% 223.27/223.41  |- mesh__historyNote mesh__D018615 95   
% 223.27/223.41  |- mesh__dateEstablished mesh__D018615 1995-01-01
% 223.27/223.41  |- mesh__dateRevised mesh__D018615 1997-06-20
% 223.27/223.41  |- skos__annotation mesh__D018615
% 223.27/223.41       /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ULTRASONOGR DOPPLER COLOR%A%  
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D018615 1999
% 223.27/223.41  |- mesh__recordAuthorizer mesh__D018615 SJN
% 223.27/223.41  |- mesh__recordMaintainer mesh__D018615 PXP
% 223.27/223.41  |- mesh__recordAuthorizer mesh__D010632 sjn
% 223.27/223.41  |- skos__hiddenLabel mesh__D010632 Bimaleate, Pheniramine
% 223.27/223.41  |- mesh__recordMaintainer mesh__D010632 lkw
% 223.27/223.41  |- skos__prefLabel mesh__D010632 Pheniramine
% 223.27/223.41  |- mesh__recordOriginator mesh__D010632 NLM
% 223.27/223.41  |- mesh__dateCreated mesh__D010632 1999-01-01
% 223.27/223.41  |- skos__altLabel mesh__D010632 Propheniramine
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D010632 2006
% 223.27/223.41  |- skos__altLabel mesh__D010632 Pheniramine Bimaleate
% 223.27/223.41  |- mesh__dateRevised mesh__D010632 2005-06-30
% 223.27/223.41  |- skos__altLabel mesh__D010632 Prophenpyridamine
% 223.27/223.41  |- skos__hiddenLabel mesh__D010632 Maleate, Pheniramine
% 223.27/223.41  |- skos__altLabel mesh__D010632 Daneral
% 223.27/223.41  |- skos__broader mesh__D010632smesh__D011725
% 223.27/223.41  |- skos__scopeNote mesh__D010632
% 223.27/223.41       One of the HISTAMINE H1 ANTAGONISTS with little sedative action. It is used in treatment of hay fever, rhinitis, allergic dermatoses, and pruritus.%A%    
% 223.27/223.41  |- rdf__type mesh__D010632sskos__Concept
% 223.27/223.41  |- skos__altLabel mesh__D010632 Aventis Brand of Pheniramine Maleate
% 223.27/223.41  |- skos__hiddenLabel mesh__D009889 Opisthorchiases
% 223.27/223.41  |- mesh__recordOriginator mesh__D009889 NLM
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D009889 1999
% 223.27/223.41  |- mesh__dateRevised mesh__D009889 1993-06-02
% 223.27/223.41  |- mesh__recordMaintainer mesh__D009889 TGC
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D009889 2003
% 223.27/223.41  |- rdf__type mesh__D009889sskos__Concept
% 223.27/223.41  |- skos__annotation mesh__D009889
% 223.27/223.41       trematode infect caused by genus OPISTHORCHIS but not OPISTHORCHIS SINENSIS %28% = CLONORCHIS SINENSIS, causing CLONORCHIASIS%29%%A%  
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D009889 1996
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D009889 2004
% 223.27/223.41  |- mesh__recordAuthorizer mesh__D009889 PLS
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D009889 2000
% 223.27/223.41  |- mesh__dateCreated mesh__D009889 1999-01-01
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D009889 1997
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D009889 1994
% 223.27/223.41  |- skos__historyNote mesh__D009889 Trematode Infections %28%1966-1967%29%
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D009889 2001
% 223.27/223.41  |- skos__broader mesh__D009889smesh__D014201
% 223.27/223.41  |- skos__prefLabel mesh__D009889 Opisthorchiasis
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D009889 1995
% 223.27/223.41  |- mesh__publicMeSHNote mesh__D009889 68   
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D009889 2005
% 223.27/223.41  |- skos__scopeNote mesh__D009889
% 223.27/223.41       Infection with flukes of the genus Opisthorchis.     
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D009889 1998
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D009889 2006
% 223.27/223.41  |- mesh__historyNote mesh__D009889 68   
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D009889 2002
% 223.27/223.41  |- mesh__dateEstablished mesh__D009889 1968-01-01
% 223.27/223.41  |- skos__prefLabel mesh__D006591 Hexobarbital
% 223.27/223.41  |- skos__broader mesh__D006591smesh__D001463
% 223.27/223.41  |- mesh__dateRevised mesh__D006591 2003-07-09
% 223.27/223.41  |- skos__scopeNote mesh__D006591
% 223.27/223.41       A barbiturate that is effective as a hypnotic and sedative.%A%    
% 223.27/223.41  |- skos__hiddenLabel mesh__D006591 Hexobarbital, Sodium
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D006591 2006
% 223.27/223.41  |- mesh__recordMaintainer mesh__D006591 ssb
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D006591 2005
% 223.27/223.41  |- mesh__recordAuthorizer mesh__D006591 sjn
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D006591 2004
% 223.27/223.41  |- mesh__recordOriginator mesh__D006591 NLM
% 223.27/223.41  |- rdf__type mesh__D006591sskos__Concept
% 223.27/223.41  |- skos__altLabel mesh__D006591 Hexobarbitone
% 223.27/223.41  |- mesh__dateCreated mesh__D006591 1999-01-01
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D020262 2004
% 223.27/223.41  |- mesh__dateEstablished mesh__D020262 2000-01-01
% 223.27/223.41  |- skos__altLabel mesh__D020262 Mercury Poisoning, Inorganic
% 223.27/223.41  |- mesh__dateRevised mesh__D020262 2005-07-21
% 223.27/223.41  |- skos__scopeNote mesh__D020262
% 223.27/223.41       Neurologic disorders associated with exposure to inorganic and organic forms of MERCURY. Acute intoxication may be associated with gastrointestinal disturbances, mental status changes, and PARAPARESIS. Chronic exposure to inorganic mercury usually occurs in industrial workers, and manifests as mental confusion, prominent behavioral changes %28%including psychosis%29%, DYSKINESIAS, and NEURITIS. Alkyl mercury poisoning may occur through ingestion of contaminated seafood or grain, and its characteristic features include POLYNEUROPATHY; ATAXIA; vision loss; NYSTAGMUS, PATHOLOGIC; and DEAFNESS. %28%From Joynt, Clinical Neurology, 1997, Ch20, pp10-15%29%%A%    
% 223.27/223.41  |- skos__hiddenLabel mesh__D020262 Nervous System Mercurialism
% 223.27/223.41  |- skos__hiddenLabel mesh__D020262 Poisoning, Organic Mercury
% 223.27/223.41  |- skos__broader mesh__D020262smesh__D008630
% 223.27/223.41  |- skos__altLabel mesh__D020262 Mercurialism, Nervous System
% 223.27/223.41  |- mesh__activeMeSHYear mesh__D020262 2005
% 223.27/223.41  |- skos__hiddenLabel mesh__D020262 Psychosis, Mercury
% 223.27/223.41  |- skos__hiddenLabel mesh__D020262 System Mercurialism, Nervous
% 223.27/223.41  |- skos__altLabel mesh__D020262 Nervous System Diseases, Mercury-Induced
% 223.27/223.41  |- skos__annotation mesh__D020262
% 223.27/223.41       coord IM with specific mercury cpd %28%IM%29% if given   
% 223.27/223.41  |- skos__hiddenLabel mesh__D020262 Poisoning, Inorganic Mercury
% 223.27/223.41  |- skos__hiddenLabel mesh__D020262 Mercury Neurotoxicity Syndromes
% 223.27/223.42  |- skos__altLabel mesh__D020262 Nervous System Poisoning, Mercury
% 223.27/223.42  |- skos__hiddenLabel mesh__D020262 Neuroanesthenia, Mercurial
% 223.27/223.42  |- skos__altLabel mesh__D020262 Poisoning, Mercury, Neurologic
% 223.27/223.42  |- skos__hiddenLabel mesh__D020262 Nervous System Diseases, Mercury Induced
% 223.27/223.42  |- skos__altLabel mesh__D020262 Mercurialism, Neurologic
% 223.27/223.42  |- skos__hiddenLabel mesh__D020262 Neurotoxicity Syndromes, Mercury
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D020262 2006
% 223.27/223.42  |- skos__hiddenLabel mesh__D020262 Mad Hatter Diseases
% 223.27/223.42  |- skos__hiddenLabel mesh__D020262 Poisoning, Neurologic Mercury
% 223.27/223.42  |- skos__altLabel mesh__D020262 Poisoning, Mercury, Nervous System
% 223.27/223.42  |- mesh__dateCreated mesh__D020262 1999-11-08
% 223.27/223.42  |- skos__prefLabel mesh__D020262 Mercury Poisoning, Nervous System
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D020262 2000
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D020262 2006A
% 223.27/223.42  |- skos__altLabel mesh__D020262 Mercury-Induced Nervous System Diseases
% 223.27/223.42  |- skos__hiddenLabel mesh__D020262 Mercury Induced Nervous System Diseases
% 223.27/223.42  |- skos__altLabel mesh__D020262 Organic Mercury Poisoning
% 223.27/223.42  |- skos__altLabel mesh__D020262 Mercury Poisoning, Neurologic
% 223.27/223.42  |- skos__hiddenLabel mesh__D020262 Neurologic Mercurialism
% 223.27/223.42  |- skos__altLabel mesh__D020262 Neurotoxicity Syndrome, Mercury
% 223.27/223.42  |- rdf__type mesh__D020262sskos__Concept
% 223.27/223.42  |- skos__altLabel mesh__D020262 Mercurial Psychosis
% 223.27/223.42  |- skos__hiddenLabel mesh__D020262 Psychosis, Mercurial
% 223.27/223.42  |- mesh__historyNote mesh__D020262
% 223.27/223.42       2000; for MINAMATA DISEASE use MERCURY POISONING 1977-1999%A%  
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D020262 2001
% 223.27/223.42  |- skos__hiddenLabel mesh__D020262 Syndrome, Mercury Neurotoxicity
% 223.27/223.42  |- skos__altLabel mesh__D020262 Encephalopathy, Mercury
% 223.27/223.42  |- skos__hiddenLabel mesh__D020262 Syndromes, Mercury Neurotoxicity
% 223.27/223.42  |- mesh__recordOriginator mesh__D020262 KEV
% 223.27/223.42  |- skos__hiddenLabel mesh__D020262 Neurologic Mercury Poisoning
% 223.27/223.42  |- mesh__publicMeSHNote mesh__D020262
% 223.27/223.42       2000; for MINAMATA DISEASE see MERCURY POISONING 1977-1999%A%  
% 223.27/223.42  |- mesh__recordMaintainer mesh__D020262 ags
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D020262 2003
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D020262 2002
% 223.27/223.42  |- skos__hiddenLabel mesh__D020262 Mad Hatters Disease
% 223.27/223.42  |- skos__hiddenLabel mesh__D020262 Mercury Neurotoxicity Syndrome
% 223.27/223.42  |- skos__altLabel mesh__D020262 Mad Hatter%27%s Disease
% 223.27/223.42  |- skos__broader mesh__D020262smesh__D020260
% 223.27/223.42  |- skos__historyNote mesh__D020262 Mercury Poisoning %28%1966-1999%29%
% 223.27/223.42  |- mesh__recordAuthorizer mesh__D020262 ags
% 223.27/223.42  |- skos__historyNote mesh__D014225 Insect Vectors %28%1966%29%
% 223.27/223.42  |- mesh__dateEstablished mesh__D014225 1973-01-01
% 223.27/223.42  |- skos__annotation mesh__D014225
% 223.27/223.42       vectors of Trypanosoma cruzi; do not use /drug eff for insecticides: TN 111%A%  
% 223.27/223.42  |- mesh__dateRevised mesh__D014225 2003-07-09
% 223.27/223.42  |- rdf__type mesh__D014225sskos__Concept
% 223.27/223.42  |- mesh__publicMeSHNote mesh__D014225
% 223.27/223.42       91; see TRIATOMIDAE 1979-90, see TRIATOMINAE 1973-78; for TRIATOMIDAE see TRIATOMINAE 1991-98%A%  
% 223.27/223.42  |- mesh__recordMaintainer mesh__D014225 ags
% 223.27/223.42  |- skos__broader mesh__D014225smesh__D020064
% 223.27/223.42  |- skos__scopeNote mesh__D014225
% 223.27/223.42       A subfamily of assassin bugs %28%REDUVIIDAE%29% that are obligate blood-suckers of vertebrates. Included are the genera TRIATOMA; RHODNIUS; and PANSTRONGYLUS, which are vectors of TRYPANOSOMA CRUZI, the agent of CHAGAS DISEASE in humans.%A%    
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D014225 2005
% 223.27/223.42  |- mesh__dateCreated mesh__D014225 1999-01-01
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D014225 2004
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D014225 2006
% 223.27/223.42  |- mesh__historyNote mesh__D014225 91%28%67%29%   
% 223.27/223.42  |- mesh__recordOriginator mesh__D014225 NLM
% 223.27/223.42  |- skos__prefLabel mesh__D014225 Triatominae
% 223.27/223.42  |- skos__historyNote mesh__D014225 Insects %28%1966%29%
% 223.27/223.42  |- mesh__recordAuthorizer mesh__D014225 sjn
% 223.27/223.42  |- skos__scopeNote mesh__D000205
% 223.27/223.42       A protein complex of actin and MYOSINS occurring in muscle. It is the essential contractile substance of muscle.%A%    
% 223.27/223.42  |- mesh__recordOriginator mesh__D000205 NLM
% 223.27/223.42  |- mesh__dateCreated mesh__D000205 1999-01-01
% 223.27/223.42  |- skos__historyNote mesh__D000205 Muscle Proteins %28%1966-1970%29%
% 223.27/223.42  |- mesh__recordAuthorizer mesh__D000205 sjn
% 223.27/223.42  |- mesh__dateEstablished mesh__D000205 1973-01-01
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D000205 2005
% 223.27/223.42  |- mesh__dateRevised mesh__D000205 2001-08-03
% 223.27/223.42  |- mesh__publicMeSHNote mesh__D000205
% 223.27/223.42       73; was see under MUSCLE PROTEINS 1963-72   
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D000205 2006
% 223.27/223.42  |- rdf__type mesh__D000205sskos__Concept
% 223.27/223.42  |- mesh__historyNote mesh__D000205
% 223.27/223.42       73%28%71%29%; was see under MUSCLE PROTEINS 1963-72   
% 223.27/223.42  |- skos__broader mesh__D000205smesh__D009124
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D000205 2003
% 223.27/223.42  |- skos__annotation mesh__D000205
% 223.27/223.42       a muscle protein; /biosyn /physiol permitted   
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D000205 2002
% 223.27/223.42  |- mesh__recordMaintainer mesh__D000205 sjn
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D000205 2004
% 223.27/223.42  |- mesh__onlineNote mesh__D000205 search MUSCLE PROTEINS 1966-70   
% 223.27/223.42  |- skos__prefLabel mesh__D000205 Actomyosin
% 223.27/223.42  |- mesh__recordAuthorizer mesh__D005499 sjn
% 223.27/223.42  |- rdf__type mesh__D005499sskos__Concept
% 223.27/223.42  |- skos__prefLabel mesh__D005499 Folliculitis
% 223.27/223.42  |- skos__scopeNote mesh__D005499
% 223.27/223.42       Inflammation of follicles, primarily hair follicles.     
% 223.27/223.42  |- mesh__onlineNote mesh__D005499
% 223.27/223.42       use FOLLICULITIS to search SYCOSIS 1966-77   
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D005499 2006
% 223.27/223.42  |- skos__hiddenLabel mesh__D005499 Sycoses
% 223.27/223.42  |- mesh__historyNote mesh__D005499 SYCOSIS was heading 1963-77   
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D005499 2002
% 223.27/223.42  |- skos__hiddenLabel mesh__D005499 Folliculitides
% 223.27/223.42  |- mesh__dateRevised mesh__D005499 2001-07-25
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D005499 2005
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D005499 2004
% 223.27/223.42  |- mesh__recordOriginator mesh__D005499 NLM
% 223.27/223.42  |- mesh__publicMeSHNote mesh__D005499 SYCOSIS was heading 1963-77   
% 223.27/223.42  |- mesh__recordMaintainer mesh__D005499 lkt
% 223.27/223.42  |- skos__broader mesh__D005499smesh__D006201
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D005499 2003
% 223.27/223.42  |- mesh__dateCreated mesh__D005499 1999-01-01
% 223.27/223.42  |- skos__annotation mesh__D005499 inflammation of hair follicles   
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D018616 2000
% 223.27/223.42  |- skos__altLabel mesh__D018616 Duplex Ultrasonography, Doppler
% 223.27/223.42  |- mesh__recordOriginator mesh__D018616 PXP
% 223.27/223.42  |- mesh__recordMaintainer mesh__D018616 PXP
% 223.27/223.42  |- mesh__dateCreated mesh__D018616 1994-02-28
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D018616 2001
% 223.27/223.42  |- skos__annotation mesh__D018616
% 223.27/223.42       /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ULTRASONOGR DOPPLER DUPLEX%A%  
% 223.27/223.42  |- mesh__publicMeSHNote mesh__D018616 95   
% 223.27/223.42  |- skos__historyNote mesh__D018616 Blood Flow Velocity %28%1982-1994%29%
% 223.27/223.42  |- skos__altLabel mesh__D018616 Duplex Doppler Ultrasonography
% 223.27/223.42  |- skos__broader mesh__D018616smesh__D018608
% 223.27/223.42  |- skos__altLabel mesh__D018616 Ultrasonography, Duplex Doppler
% 223.27/223.42  |- skos__historyNote mesh__D018616 Ultrasonography %28%1984-1994%29%
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D018616 2003
% 223.27/223.42  |- skos__altLabel mesh__D018616 Doppler Duplex Ultrasonography
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D018616 1998
% 223.27/223.42  |- mesh__dateRevised mesh__D018616 1997-06-20
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D018616 2002
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D018616 2005
% 223.27/223.42  |- skos__scopeNote mesh__D018616
% 223.27/223.42       Ultrasonography applying the Doppler effect combined with real-time imaging. The real-time image is created by rapid movement of the ultrasound beam. A powerful advantage of this technique is the ability to estimate the velocity of flow from the Doppler shift frequency.%A%    
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D018616 2004
% 223.27/223.42  |- mesh__historyNote mesh__D018616 95   
% 223.27/223.42  |- mesh__recordAuthorizer mesh__D018616 SJN
% 223.27/223.42  |- mesh__dateEstablished mesh__D018616 1995-01-01
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D018616 1999
% 223.27/223.42  |- skos__historyNote mesh__D018616
% 223.27/223.42       Ultrasonics/diagnostic use %28%1981-1984%29%
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D018616 2006
% 223.27/223.42  |- skos__altLabel mesh__D018616 Ultrasonography, Doppler Duplex
% 223.27/223.42  |- skos__prefLabel mesh__D018616 Ultrasonography, Doppler, Duplex
% 223.27/223.42  |- skos__altLabel mesh__D018616 Doppler Ultrasonography, Duplex
% 223.27/223.42  |- rdf__type mesh__D018616sskos__Concept
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D010633 2005
% 223.27/223.42  |- skos__hiddenLabel mesh__D010633 Hydrochloride, Phenmetrazine
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D010633 2003
% 223.27/223.42  |- mesh__recordMaintainer mesh__D010633 TWD
% 223.27/223.42  |- skos__broader mesh__D010633smesh__D009025
% 223.27/223.42  |- mesh__dateCreated mesh__D010633 1999-01-01
% 223.27/223.42  |- mesh__recordAuthorizer mesh__D010633 sjn
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D010633 2006
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D010633 2004
% 223.27/223.42  |- skos__altLabel mesh__D010633 Defenmetrazin
% 223.27/223.42  |- skos__altLabel mesh__D010633 Oxazimedrine
% 223.27/223.42  |- mesh__dateRevised mesh__D010633 2000-06-22
% 223.27/223.42  |- mesh__recordOriginator mesh__D010633 NLM
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D010633 2001
% 223.27/223.42  |- skos__prefLabel mesh__D010633 Phenmetrazine
% 223.27/223.42  |- skos__scopeNote mesh__D010633
% 223.27/223.42       A sympathomimetic drug used primarily as an appetite depressant. Its actions and mechanisms are similar to DEXTROAMPHETAMINE.%A%    
% 223.27/223.42  |- skos__altLabel mesh__D010633 Fenmetrazin
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D010633 2002
% 223.27/223.42  |- rdf__type mesh__D010633sskos__Concept
% 223.27/223.42  |- skos__altLabel mesh__D010633 Phenmetraline
% 223.27/223.42  |- mesh__recordOriginator mesh__D006592 NLM
% 223.27/223.42  |- mesh__historyNote mesh__D006592
% 223.27/223.42       91%28%75%29%; was see under BENZOATES 1975-90   
% 223.27/223.42  |- skos__historyNote mesh__D006592 Benzoates %28%1969-1974%29%
% 223.27/223.42  |- skos__historyNote mesh__D006592 Ethylenediamines %28%1971-1974%29%
% 223.27/223.42  |- mesh__dateEstablished mesh__D006592 1991-01-01
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D006592 2006
% 223.27/223.42  |- mesh__dateRevised mesh__D006592 2000-06-21
% 223.27/223.42  |- mesh__recordMaintainer mesh__D006592 CCR
% 223.27/223.42  |- mesh__dateCreated mesh__D006592 1974-11-11
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D006592 2005
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D006592 2002
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D006592 2004
% 223.27/223.42  |- mesh__publicMeSHNote mesh__D006592
% 223.27/223.42       91; was see under BENZOATES 1975-90   
% 223.27/223.42  |- rdf__type mesh__D006592sskos__Concept
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D006592 2001
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D006592 2003
% 223.27/223.42  |- skos__prefLabel mesh__D006592 Hexobendine
% 223.27/223.42  |- skos__broader mesh__D006592smesh__D020185
% 223.27/223.42  |- mesh__recordAuthorizer mesh__D006592 sjn
% 223.27/223.42  |- skos__scopeNote mesh__D006592
% 223.27/223.42       A potent vasoactive agent that dilates cerebral and coronary arteries, but slightly constricts femoral arteries, without any effects on heart rate, blood pressure or cardiac output.%A%    
% 223.27/223.42  |- skos__scopeNote mesh__D020263
% 223.27/223.42       Injury to the nervous system secondary to exposure to lead compounds. Two distinct clinical patterns occur in children %28%LEAD POISONING, NERVOUS SYSTEM, CHILDHOOD%29% and adults %28%LEAD POISONING, NERVOUS SYSTEM, ADULT%29%. In children, lead poisoning typically produces an encephalopathy. In adults, exposure to toxic levels of lead is associated with a peripheral neuropathy.%A%    
% 223.27/223.42  |- skos__hiddenLabel mesh__D020263 Lead Neurotoxicity Syndromes
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D020263 2005
% 223.27/223.42  |- skos__hiddenLabel mesh__D020263 Syndromes, Lead Neurotoxicity
% 223.27/223.42  |- skos__altLabel mesh__D020263 Neurotoxicity Syndrome, Lead
% 223.27/223.42  |- mesh__publicMeSHNote mesh__D020263 2000   
% 223.27/223.42  |- skos__hiddenLabel mesh__D020263 Syndrome, Lead Neurotoxicity
% 223.27/223.42  |- skos__hiddenLabel mesh__D020263 Neurotoxicity Syndromes, Lead
% 223.27/223.42  |- mesh__dateRevised mesh__D020263 2005-07-18
% 223.27/223.42  |- skos__annotation mesh__D020263
% 223.27/223.42       prefer specifics: in infant or child = LEAD POISONING, NERVOUS SYSTEM, CHILDHOOD; in adolescent or adult = LEAD POISONING, NERVOUS SYSTEM, ADULT%A%  
% 223.27/223.42  |- skos__hiddenLabel mesh__D020263 Nervous System Plumbism
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D020263 2006
% 223.27/223.42  |- skos__hiddenLabel mesh__D020263 Neurologic Lead Poisoning
% 223.27/223.42  |- skos__broader mesh__D020263smesh__D007855
% 223.27/223.42  |- skos__altLabel mesh__D020263 Lead Poisoning, Neurologic
% 223.27/223.42  |- mesh__historyNote mesh__D020263 2000   
% 223.27/223.42  |- skos__hiddenLabel mesh__D020263 Lead Neurotoxicity Syndrome
% 223.27/223.42  |- skos__altLabel mesh__D020263 Nervous System Diseases, Lead-Induced
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D020263 2000
% 223.27/223.42  |- skos__altLabel mesh__D020263 Poisoning, Lead, Neurologic
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D020263 2006A
% 223.27/223.42  |- mesh__dateCreated mesh__D020263 1999-11-03
% 223.27/223.42  |- rdf__type mesh__D020263sskos__Concept
% 223.27/223.42  |- skos__hiddenLabel mesh__D020263 Neurologic Plumbism
% 223.27/223.42  |- skos__altLabel mesh__D020263 Plumbism, Neurologic
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D020263 2001
% 223.27/223.42  |- mesh__recordMaintainer mesh__D020263 ags
% 223.27/223.42  |- skos__altLabel mesh__D020263 Plumbism, Nervous System
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D020263 2003
% 223.27/223.42  |- skos__altLabel mesh__D020263 Lead-Induced Nervous System Diseases
% 223.27/223.42  |- skos__prefLabel mesh__D020263 Lead Poisoning, Nervous System
% 223.27/223.42  |- skos__altLabel mesh__D020263 Nervous System Poisoning, Lead
% 223.27/223.42  |- skos__historyNote mesh__D020263 Lead Poisoning %28%1966-1999%29%
% 223.27/223.42  |- skos__altLabel mesh__D020263 Poisoning, Lead, Nervous System
% 223.27/223.42  |- mesh__recordOriginator mesh__D020263 KEV
% 223.27/223.42  |- skos__broader mesh__D020263smesh__D020260
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D020263 2002
% 223.27/223.42  |- mesh__recordAuthorizer mesh__D020263 ags
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D020263 2004
% 223.27/223.42  |- mesh__dateEstablished mesh__D020263 2000-01-01
% 223.27/223.42  |- rdf__type mesh__D014226sskos__Concept
% 223.27/223.42  |- skos__hiddenLabel mesh__D014226 Compounds, Diazoamino
% 223.27/223.42  |- mesh__recordAuthorizer mesh__D014226 sjn
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D014226 2005
% 223.27/223.42  |- mesh__dateCreated mesh__D014226 1999-01-01
% 223.27/223.42  |- mesh__dateEstablished mesh__D014226 1973-01-01
% 223.27/223.42  |- skos__historyNote mesh__D014226 Azo Compounds %28%1966-1971%29%
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D014226 2006
% 223.27/223.42  |- mesh__publicMeSHNote mesh__D014226 73   
% 223.27/223.42  |- skos__broader mesh__D014226smesh__D009930
% 223.27/223.42  |- mesh__recordMaintainer mesh__D014226 ssb
% 223.27/223.42  |- mesh__dateRevised mesh__D014226 2004-07-07
% 223.27/223.42  |- skos__annotation mesh__D014226 do not confuse with TRIAZINES   
% 223.27/223.42  |- skos__scopeNote mesh__D014226
% 223.27/223.42       Compounds with three contiguous nitrogen atoms in linear format, H2N-N=NH, and hydrocarbyl derivatives.%A%    
% 223.27/223.42  |- mesh__recordOriginator mesh__D014226 NLM
% 223.27/223.42  |- mesh__historyNote mesh__D014226 73%28%72%29%   
% 223.27/223.42  |- skos__prefLabel mesh__D014226 Triazenes
% 223.27/223.42  |- mesh__historyNote mesh__D000206 79   
% 223.27/223.42  |- mesh__dateRevised mesh__D000206 1992-05-13
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D000206 1999
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D000206 2005
% 223.27/223.42  |- skos__scopeNote mesh__D000206
% 223.27/223.42       The application of probability and statistical methods to calculate the risk of occurrence of any event, such as onset of illness, recurrent disease, hospitalization, disability, or death. It may include calculation of the anticipated money costs of such events and of the premiums necessary to provide for payment of such costs.%A%    
% 223.27/223.42  |- mesh__recordOriginator mesh__D000206 EC
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D000206 1996
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D000206 1993
% 223.27/223.42  |- skos__annotation mesh__D000206 IM; few qualif apply   
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D000206 2006
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D000206 2000
% 223.27/223.42  |- mesh__dateCreated mesh__D000206 1978-05-08
% 223.27/223.42  |- skos__broader mesh__D000206smesh__D013223
% 223.27/223.42  |- mesh__publicMeSHNote mesh__D000206 79   
% 223.27/223.42  |- rdf__type mesh__D000206sskos__Concept
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D000206 1997
% 223.27/223.42  |- mesh__dateEstablished mesh__D000206 1979-01-01
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D000206 2003
% 223.27/223.42  |- skos__prefLabel mesh__D000206 Actuarial Analysis
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D000206 2001
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D000206 2004
% 223.27/223.42  |- skos__altLabel mesh__D000206 Analysis, Actuarial
% 223.27/223.42  |- skos__hiddenLabel mesh__D000206 Actuarial Analyses
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D000206 1994
% 223.27/223.42  |- skos__hiddenLabel mesh__D000206 Analyses, Actuarial
% 223.27/223.42  |- mesh__recordAuthorizer mesh__D000206 PLS
% 223.27/223.42  |- mesh__recordMaintainer mesh__D000206 PLS
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D000206 1998
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D000206 1995
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D000206 2002
% 223.27/223.42  |- mesh__recordOriginator mesh__D046308 ags
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D046308 2006
% 223.27/223.42  |- skos__historyNote mesh__D046308 Mole Rats %28%1997-2004%29%
% 223.27/223.42  |- mesh__recordAuthorizer mesh__D046308 sjn
% 223.27/223.42  |- skos__prefLabel mesh__D046308 Spalax
% 223.27/223.42  |- rdf__type mesh__D046308sskos__Concept
% 223.27/223.42  |- mesh__dateEstablished mesh__D046308 2005-01-01
% 223.27/223.42  |- skos__scopeNote mesh__D046308
% 223.27/223.42       A genus of blind, subterranean MOLE RATS, in the subfamily Spalacidae, family MURIDAE, used as a animal model in neurophysiology. There are at least five different species described, all found in the Ukraine.%A%    
% 223.27/223.42  |- mesh__historyNote mesh__D046308 2005; use MOLE RATS 1998-2004   
% 223.27/223.42  |- mesh__recordMaintainer mesh__D046308 ags
% 223.27/223.42  |- skos__broader mesh__D046308smesh__D009115
% 223.27/223.42  |- mesh__publicMeSHNote mesh__D046308 2005; see MOLE RATS 1998-2004   
% 223.27/223.42  |- mesh__dateCreated mesh__D046308 2004-07-07
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D046308 2005
% 223.27/223.42  |- skos__broader mesh__D046308smesh__D019577
% 223.27/223.42  |- skos__historyNote mesh__D046308 Rodentia %28%1966-1997%29%
% 223.27/223.42  |- skos__altLabel mesh__D018617 Doppler Pulsed Ultrasonography
% 223.27/223.42  |- mesh__dateEstablished mesh__D018617 1995-01-01
% 223.27/223.42  |- skos__altLabel mesh__D018617 Ultrasonography, Doppler Pulsed
% 223.27/223.42  |- skos__altLabel mesh__D018617 Ultrasonography, Pulsed Doppler
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D018617 2000
% 223.27/223.42  |- skos__historyNote mesh__D018617 Ultrasonics %28%1974-1994%29%
% 223.27/223.42  |- skos__prefLabel mesh__D018617 Ultrasonography, Doppler, Pulsed
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D018617 2003
% 223.27/223.42  |- mesh__recordMaintainer mesh__D018617 PXP
% 223.27/223.42  |- skos__annotation mesh__D018617
% 223.27/223.42       /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ULTRASONOGR DOPPLER PULSED%A%  
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D018617 2001
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D018617 1998
% 223.27/223.42  |- skos__altLabel mesh__D018617 Pulsed Doppler Ultrasonography
% 223.27/223.42  |- skos__historyNote mesh__D018617 Blood Flow Velocity %28%1974-1994%29%
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D018617 2005
% 223.27/223.42  |- mesh__publicMeSHNote mesh__D018617 95   
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D018617 2004
% 223.27/223.42  |- mesh__historyNote mesh__D018617 95   
% 223.27/223.42  |- skos__broader mesh__D018617smesh__D018608
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D018617 1999
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D018617 2006
% 223.27/223.42  |- skos__altLabel mesh__D018617 Pulsed Ultrasonography, Doppler
% 223.27/223.42  |- rdf__type mesh__D018617sskos__Concept
% 223.27/223.42  |- skos__scopeNote mesh__D018617
% 223.27/223.42       Ultrasonography applying the Doppler effect, with velocity detection combined with range discrimination. Short bursts of ultrasound are transmitted at regular intervals and the echoes are demodulated as they return.%A%    
% 223.27/223.42  |- mesh__dateRevised mesh__D018617 1997-06-20
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D018617 2002
% 223.27/223.42  |- mesh__recordOriginator mesh__D018617 PXP
% 223.27/223.42  |- skos__historyNote mesh__D018617 Ultrasonography %28%1985-1994%29%
% 223.27/223.42  |- mesh__recordAuthorizer mesh__D018617 SJN
% 223.27/223.42  |- skos__altLabel mesh__D018617 Doppler Ultrasonography, Pulsed
% 223.27/223.42  |- mesh__dateCreated mesh__D018617 1994-02-28
% 223.27/223.42  |- skos__hiddenLabel mesh__D010634 Sodium, Phenobarbital
% 223.27/223.42  |- skos__hiddenLabel mesh__D010634 Acid, Phenylethylbarbituric
% 223.27/223.42  |- skos__altLabel mesh__D010634 Phenobarbitone
% 223.27/223.42  |- skos__altLabel mesh__D010634 Phenobarbital, Monosodium Salt
% 223.27/223.42  |- skos__altLabel mesh__D010634 Phenylethylbarbituric Acid
% 223.27/223.42  |- skos__scopeNote mesh__D010634
% 223.27/223.42       A barbituric acid derivative that acts as a nonselective central nervous system depressant. It promotes binding to inhibitory GAMMA-AMINOBUTYRIC ACID subtype receptors, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.%A%    
% 223.27/223.42  |- skos__broader mesh__D010634smesh__D001463
% 223.27/223.42  |- rdf__type mesh__D010634sskos__Concept
% 223.27/223.42  |- mesh__recordMaintainer mesh__D010634 ssb
% 223.27/223.42  |- mesh__recordAuthorizer mesh__D010634 sjn
% 223.27/223.42  |- mesh__dateRevised mesh__D010634 2003-07-09
% 223.27/223.42  |- skos__altLabel mesh__D010634 Phenylbarbital
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D010634 2005
% 223.27/223.42  |- skos__altLabel mesh__D010634 Phenemal
% 223.27/223.42  |- mesh__dateCreated mesh__D010634 1999-01-01
% 223.27/223.42  |- skos__hiddenLabel mesh__D010634 Monosodium Salt Phenobarbital
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D010634 2006
% 223.27/223.42  |- skos__prefLabel mesh__D010634 Phenobarbital
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D010634 2004
% 223.27/223.42  |- mesh__recordOriginator mesh__D010634 NLM
% 223.27/223.42  |- mesh__recordAuthorizer mesh__D034284 sjn
% 223.27/223.42  |- skos__scopeNote mesh__D034284
% 223.27/223.42       A subtype of dynamin found primarily in the NEURONS of the brain.%A%    
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D034284 2005
% 223.27/223.42  |- mesh__publicMeSHNote mesh__D034284
% 223.27/223.42       2003; DYNAMIN I %26% DYNAMIN-1 were indexed under GTP PHOSPHOHYDROLASES 1994-2002 %26% CA%28%2+%29% MG%28%2+%29%-ATPASE 1989-1993%A%  
% 223.27/223.42  |- skos__hiddenLabel mesh__D034284 Dynamin 1
% 223.27/223.42  |- mesh__dateRevised mesh__D034284 2004-07-07
% 223.27/223.42  |- skos__altLabel mesh__D034284 DNM1 Gene Product, Dynamin
% 223.27/223.42  |- mesh__recordOriginator mesh__D034284 jmp
% 223.27/223.42  |- skos__historyNote mesh__D034284 GTP Phosphohydrolases %28%1994-2002%29%
% 223.27/223.42  |- skos__prefLabel mesh__D034284 Dynamin I
% 223.27/223.42  |- skos__historyNote mesh__D034284
% 223.27/223.42       Ca%28%2+%29% Mg%28%2+%29%-ATPase %28%1989-1993%29%
% 223.27/223.42  |- skos__altLabel mesh__D034284 Dynamin-1
% 223.27/223.42  |- mesh__recordMaintainer mesh__D034284 jmp
% 223.27/223.42  |- mesh__dateEstablished mesh__D034284 2003-01-01
% 223.27/223.42  |- mesh__historyNote mesh__D034284
% 223.27/223.42       2003; for DYNAMIN I %26% DYNAMIN-1 use DYNAMINS %28%NM%29% 1997-2002%A%  
% 223.27/223.42  |- mesh__dateCreated mesh__D034284 2002-07-03
% 223.27/223.42  |- skos__altLabel mesh__D034284 Dynamin D100
% 223.27/223.42  |- skos__broader mesh__D034284smesh__D034281
% 223.27/223.42  |- rdf__type mesh__D034284sskos__Concept
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D034284 2006
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D006593 2005
% 223.27/223.42  |- mesh__recordMaintainer mesh__D006593 ssb
% 223.27/223.42  |- skos__prefLabel mesh__D006593 Hexokinase
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D006593 2004
% 223.27/223.42  |- mesh__recordAuthorizer mesh__D006593 sjn
% 223.27/223.42  |- skos__scopeNote mesh__D006593
% 223.27/223.42       An enzyme that catalyzes the conversion of ATP and a D-hexose to ADP and a D-hexose 6-phosphate. D-Glucose, D-mannose, D-fructose, sorbitol, and D-glucosamine can act as acceptors; ITP and dATP can act as donors. The liver isoenzyme has sometimes been called glucokinase. %28%From Enzyme Nomenclature, 1992%29% EC 2.7.1.1.%A%    
% 223.27/223.42  |- skos__altLabel mesh__D006593 Hexokinase D
% 223.27/223.42  |- rdf__type mesh__D006593sskos__Concept
% 223.27/223.42  |- mesh__dateCreated mesh__D006593 1999-01-01
% 223.27/223.42  |- mesh__recordOriginator mesh__D006593 NLM
% 223.27/223.42  |- skos__broader mesh__D006593smesh__D017853
% 223.27/223.42  |- mesh__dateRevised mesh__D006593 2003-07-09
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D006593 2006
% 223.27/223.42  |- skos__historyNote mesh__D020264 Lead Poisoning %28%1966-1999%29%
% 223.27/223.42  |- skos__altLabel mesh__D020264 Nervous System Poisoning, Lead, Childhood
% 223.27/223.42  |- skos__hiddenLabel mesh__D020264 Encephalopathy, Childhood Saturine
% 223.27/223.42  |- skos__altLabel mesh__D020264 Plumbism, Neurologic, Childhood
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D020264 2004
% 223.27/223.42  |- mesh__dateCreated mesh__D020264 1999-11-08
% 223.27/223.42  |- skos__hiddenLabel mesh__D020264 Saturnism, Childhood Neurologic
% 223.27/223.42  |- skos__hiddenLabel mesh__D020264
% 223.27/223.42       Lead Induced Nervous System Disease, Childhood
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D020264 2000
% 223.27/223.42  |- skos__altLabel mesh__D020264 Poisoning, Lead, Nervous System, Childhood
% 223.27/223.42  |- skos__altLabel mesh__D020264 Neurotoxicity Syndrome, Lead, Childhood
% 223.27/223.42  |- skos__hiddenLabel mesh__D020264 Childhood Saturine Encephalopathy
% 223.27/223.42  |- skos__hiddenLabel mesh__D020264 Encephalopathy, Childhood Lead
% 223.27/223.42  |- skos__altLabel mesh__D020264
% 223.27/223.42       Lead-Induced Nervous System Disease, Childhood
% 223.27/223.42  |- skos__altLabel mesh__D020264
% 223.27/223.42       Nervous System Disease, Lead-Induced, Childhood
% 223.27/223.42  |- skos__broader mesh__D020264smesh__D020263
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D020264 2003
% 223.27/223.42  |- skos__scopeNote mesh__D020264
% 223.27/223.42       Neurologic disorders occurring in children following lead exposure. The most frequent manifestation of childhood lead toxicity is an encephalopathy associated with chronic ingestion of lead that usually presents between the ages of 1 and 3 years. Clinical manifestations include behavioral changes followed by lethargy; CONVULSIONS; HALLUCINATIONS; DELIRIUM; ATAXIA; and vomiting. Elevated intracranial pressure %28%HYPERTENSION, INTRACRANIAL%29% and CEREBRAL EDEMA may occur. %28%From Adams et al., Principles of Neurology, 6th ed, p1210-2%29%%A%    
% 223.27/223.42  |- mesh__dateEstablished mesh__D020264 2000-01-01
% 223.27/223.42  |- skos__altLabel mesh__D020264 Lead Poisoning, Neurologic, Childhood
% 223.27/223.42  |- skos__hiddenLabel mesh__D020264 Childhood Lead Encephalopathy
% 223.27/223.42  |- skos__annotation mesh__D020264
% 223.27/223.42       includes infant as well as child; coord with specific nervous system symptoms if emphasized%A%  
% 223.27/223.42  |- mesh__historyNote mesh__D020264 2000   
% 223.27/223.42  |- skos__altLabel mesh__D020264 Neurologic Saturnism, Childhood
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D020264 2006
% 223.27/223.42  |- skos__prefLabel mesh__D020264 Lead Poisoning, Nervous System, Childhood
% 223.27/223.42  |- rdf__type mesh__D020264sskos__Concept
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D020264 2002
% 223.27/223.42  |- skos__altLabel mesh__D020264 Saturine Encephalopathy, Childhood
% 223.27/223.42  |- skos__altLabel mesh__D020264 Poisoning, Lead, Neurologic, Childhood
% 223.27/223.42  |- mesh__publicMeSHNote mesh__D020264 2000   
% 223.27/223.42  |- mesh__activeMeSHYear mesh__D020264 2005
% 223.27/223.43  |- skos__hiddenLabel mesh__D020264 Childhood Neurologic Saturnism
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D020264 2001
% 223.27/223.43  |- mesh__recordAuthorizer mesh__D014227 sjn
% 223.27/223.43  |- skos__broader mesh__D014227smesh__D006573
% 223.27/223.43  |- mesh__dateCreated mesh__D014227 1999-01-01
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D014227 2005
% 223.27/223.43  |- skos__scopeNote mesh__D014227
% 223.27/223.43       Heterocyclic rings containing three nitrogen atoms, commonly in 1,2,4 or 1,3,5 or 2,4,6 formats. Some are used as HERBICIDES.%A%    
% 223.27/223.43  |- mesh__recordMaintainer mesh__D014227 ssb
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D014227 2006
% 223.27/223.43  |- skos__prefLabel mesh__D014227 Triazines
% 223.27/223.43  |- skos__annotation mesh__D014227 do not confuse with TRIAZENES   
% 223.27/223.43  |- mesh__recordOriginator mesh__D014227 NLM
% 223.27/223.43  |- mesh__dateRevised mesh__D014227 2004-07-07
% 223.27/223.43  |- rdf__type mesh__D014227sskos__Concept
% 223.27/223.43  |- mesh__dateCreated mesh__D019710 1997-06-20
% 223.27/223.43  |- mesh__recordOriginator mesh__D019710 AGS
% 223.27/223.43  |- skos__broader mesh__D019710smesh__D019709
% 223.27/223.43  |- skos__scopeNote mesh__D019710
% 223.27/223.43       A family of anaerobic THERMOCOCCALES found in hot environments. There are two genera: PYROCOCCUS and THERMOCOCCUS.%A%    
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D019710 2006
% 223.27/223.43  |- mesh__recordAuthorizer mesh__D019710 sjn
% 223.27/223.43  |- mesh__publicMeSHNote mesh__D019710 98   
% 223.27/223.43  |- skos__annotation mesh__D019710 a family of the order Thermococcales   
% 223.27/223.43  |- mesh__recordMaintainer mesh__D019710 SYSTEM
% 223.27/223.43  |- skos__prefLabel mesh__D019710 Thermococcaceae
% 223.27/223.43  |- mesh__dateEstablished mesh__D019710 1998-01-01
% 223.27/223.43  |- rdf__type mesh__D019710sskos__Concept
% 223.27/223.43  |- mesh__historyNote mesh__D019710 98   
% 223.27/223.43  |- mesh__dateRevised mesh__D019710 2005-06-30
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D018618 1998
% 223.27/223.43  |- skos__historyNote mesh__D018618
% 223.27/223.43       Echocardiography, Doppler %28%1989-1994%29%
% 223.27/223.43  |- skos__hiddenLabel mesh__D018618 Color Flow Echocardiographies
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D018618 2005
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D018618 2004
% 223.27/223.43  |- mesh__historyNote mesh__D018618
% 223.27/223.43       95; was ECHOCARDIOGRAPHY, DOPPLER COLOR see ECHOCARDIOGRAPHY, DOPPLER 1989-94%A%  
% 223.27/223.43  |- skos__hiddenLabel mesh__D018618 Flow Echocardiographies, Color
% 223.27/223.43  |- mesh__dateRevised mesh__D018618 1997-06-20
% 223.27/223.43  |- mesh__dateEstablished mesh__D018618 1995-01-01
% 223.27/223.43  |- skos__historyNote mesh__D018618 Echocardiography %28%1985-1988%29%
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D018618 1999
% 223.27/223.43  |- skos__broader mesh__D018618smesh__D015150
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D018618 2002
% 223.27/223.43  |- skos__altLabel mesh__D018618 Doppler Color Echocardiography
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D018618 2006
% 223.27/223.43  |- skos__annotation mesh__D018618
% 223.27/223.43       /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ECHOCARDIOGR DOPPLER COLOR%A%  
% 223.27/223.43  |- mesh__recordAuthorizer mesh__D018618 SJN
% 223.27/223.43  |- rdf__type mesh__D018618sskos__Concept
% 223.27/223.43  |- skos__altLabel mesh__D018618 Color Flow Echocardiography
% 223.27/223.43  |- skos__prefLabel mesh__D018618 Echocardiography, Doppler, Color
% 223.27/223.43  |- mesh__publicMeSHNote mesh__D018618
% 223.27/223.43       95; was ECHOCARDIOGRAPHY, DOPPLER COLOR see ECHOCARDIOGRAPHY, DOPPLER 1989-94%A%  
% 223.27/223.43  |- skos__broader mesh__D018618smesh__D018615
% 223.27/223.43  |- skos__altLabel mesh__D018618 Echocardiography, Doppler Color
% 223.27/223.43  |- skos__hiddenLabel mesh__D018618 Flow Echocardiography, Color
% 223.27/223.43  |- mesh__dateCreated mesh__D018618 1994-02-28
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D018618 2000
% 223.27/223.43  |- skos__altLabel mesh__D018618 Echocardiography, Color Flow
% 223.27/223.43  |- skos__altLabel mesh__D018618 Echocardiography, Color Doppler
% 223.27/223.43  |- skos__altLabel mesh__D018618 Doppler Echocardiography, Color
% 223.27/223.43  |- skos__altLabel mesh__D018618 Color Echocardiography, Doppler
% 223.27/223.43  |- mesh__recordOriginator mesh__D018618 PXP
% 223.27/223.43  |- mesh__recordMaintainer mesh__D018618 PXP
% 223.27/223.43  |- skos__altLabel mesh__D018618 Color Doppler Echocardiography
% 223.27/223.43  |- mesh__onlineNote mesh__D018618
% 223.27/223.43       use ECHOCARDIOGRAPHY, DOPPLER to search ECHOCARDIOGRAPHY, DOPPLER, COLOR 1989-94%A%  
% 223.27/223.43  |- skos__scopeNote mesh__D018618
% 223.27/223.43       Echocardiography applying the Doppler effect, with the superposition of flow information as colors on a gray scale in a real-time image.%A%    
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D018618 2001
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D018618 2003
% 223.27/223.43  |- skos__hiddenLabel mesh__D018618 Echocardiographies, Color Flow
% 223.27/223.43  |- skos__annotation mesh__D010635 PHENOLPHTHALEIN is also available   
% 223.27/223.43  |- mesh__recordMaintainer mesh__D010635 sjn
% 223.27/223.43  |- mesh__recordOriginator mesh__D010635 NLM
% 223.27/223.43  |- rdf__type mesh__D010635sskos__Concept
% 223.27/223.43  |- mesh__dateRevised mesh__D010635 2005-07-01
% 223.27/223.43  |- skos__prefLabel mesh__D010635 Phenolphthaleins
% 223.27/223.43  |- skos__broader mesh__D010635smesh__D010636
% 223.27/223.43  |- mesh__dateCreated mesh__D010635 1999-01-01
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D010635 2006
% 223.27/223.43  |- skos__scopeNote mesh__D010635
% 223.27/223.43       A family of 3,3-bis%28%p-hydroxyphenyl%29%phthalides. They are used as CATHARTICS, indicators, and COLORING AGENTS.%A%    
% 223.27/223.43  |- mesh__recordAuthorizer mesh__D010635 sjn
% 223.27/223.43  |- skos__historyNote mesh__D015320 Neuropeptides %28%1987-1988%29%
% 223.27/223.43  |- skos__historyNote mesh__D015320 Peptides %28%1966-1988%29%
% 223.27/223.43  |- mesh__recordMaintainer mesh__D015320 ssb
% 223.27/223.43  |- skos__historyNote mesh__D015320 Nerve Tissue Proteins %28%1966-1988%29%
% 223.27/223.43  |- skos__scopeNote mesh__D015320
% 223.27/223.43       A family of biologically active peptides sharing a common conserved C-terminal sequence, -Phe-X-Gly-Leu-Met-NH2, where X is either an aromatic or a branched aliphatic amino acid. Members of this family have been found in mammals, amphibians, and mollusks. Tachykinins have diverse pharmacological actions in the central nervous system and the cardiovascular, genitourinary, respiratory, and gastrointestinal systems, as well as in glandular tissues. This diversity of activity is due to the existence of three or more subtypes of tachykinin receptors.%A%    
% 223.27/223.43  |- mesh__recordAuthorizer mesh__D015320 sjn
% 223.27/223.43  |- mesh__dateRevised mesh__D015320 2005-06-30
% 223.27/223.43  |- rdf__type mesh__D015320sskos__Concept
% 223.27/223.43  |- skos__altLabel mesh__D015320 Tachykinin
% 223.27/223.43  |- skos__broader mesh__D015320smesh__D009479
% 223.27/223.43  |- mesh__dateCreated mesh__D015320 1988-05-31
% 223.27/223.43  |- skos__broader mesh__D015320smesh__D007705
% 223.27/223.43  |- skos__historyNote mesh__D015320 Kinins %28%1966-1988%29%
% 223.27/223.43  |- skos__related mesh__D015320smesh__D018039
% 223.27/223.43  |- skos__annotation mesh__D015320 GEN or unspecified; prefer specifics   
% 223.27/223.43  |- mesh__recordOriginator mesh__D015320 RLS
% 223.27/223.43  |- skos__historyNote mesh__D015320 Oligopeptides %28%1966-1988%29%
% 223.27/223.43  |- mesh__historyNote mesh__D015320
% 223.27/223.43       89; PHYSALAEMIN was see under KININS 1977-88   
% 223.27/223.43  |- mesh__dateEstablished mesh__D015320 1989-01-01
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D015320 2006
% 223.27/223.43  |- skos__prefLabel mesh__D015320 Tachykinins
% 223.27/223.43  |- skos__broader mesh__D015320smesh__D009842
% 223.27/223.43  |- mesh__publicMeSHNote mesh__D015320
% 223.27/223.43       89; PHYSALAEMIN was see under KININS 1977-88   
% 223.27/223.43  |- skos__hiddenLabel mesh__D034285 Dynamin, DYNII
% 223.27/223.43  |- skos__altLabel mesh__D034285 DYNII Dynamin
% 223.27/223.43  |- skos__broader mesh__D034285smesh__D034281
% 223.27/223.43  |- mesh__recordMaintainer mesh__D034285 jmp
% 223.27/223.43  |- skos__altLabel mesh__D034285 Dynamin-2
% 223.27/223.43  |- mesh__recordAuthorizer mesh__D034285 sjn
% 223.27/223.43  |- skos__altLabel mesh__D034285 DNM2 Protein
% 223.27/223.43  |- skos__scopeNote mesh__D034285
% 223.27/223.43       A subtype of dynamin found ubiquitously expressed in a variety of tissues.%A%    
% 223.27/223.43  |- mesh__publicMeSHNote mesh__D034285
% 223.27/223.43       2003: DYNAMIN-2 was indexed under GTP PHOSPHOHYDROLASES 1998-2002%A%  
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D034285 2005
% 223.27/223.43  |- mesh__recordOriginator mesh__D034285 jmp
% 223.27/223.43  |- mesh__dateEstablished mesh__D034285 2003-01-01
% 223.27/223.43  |- rdf__type mesh__D034285sskos__Concept
% 223.27/223.43  |- mesh__dateRevised mesh__D034285 2004-07-07
% 223.27/223.43  |- mesh__historyNote mesh__D034285
% 223.27/223.43       2003; for DYNAMIN-2 use DYNAMINS %28%NM%29% 1998-2002   
% 223.27/223.43  |- skos__altLabel mesh__D034285 Dynamin 2
% 223.27/223.43  |- skos__altLabel mesh__D034285 DynII Protein
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D034285 2006
% 223.27/223.43  |- skos__historyNote mesh__D034285 GTP Phosphohydrolases %28%1998-2002%29%
% 223.27/223.43  |- skos__prefLabel mesh__D034285 Dynamin II
% 223.27/223.43  |- mesh__dateCreated mesh__D034285 2002-07-03
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D001300 1999
% 223.27/223.43  |- skos__hiddenLabel mesh__D001300 Electroencephalic Response Audiometry
% 223.27/223.43  |- skos__hiddenLabel mesh__D001300 Response Audiometries, Evoked
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D001300 2006
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D001300 2000
% 223.27/223.43  |- skos__hiddenLabel mesh__D001300 Electrocochleographies
% 223.27/223.43  |- skos__hiddenLabel mesh__D001300 Audiometries, Evoked Response
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D001300 2001
% 223.27/223.43  |- rdf__type mesh__D001300sskos__Concept
% 223.27/223.43  |- skos__hiddenLabel mesh__D001300 Evoked Response Audiometries
% 223.27/223.43  |- skos__annotation mesh__D001300
% 223.27/223.43       do not use /util except by MeSH definition; also called %22%electric response audiometry%22%%A%  
% 223.27/223.43  |- skos__broader mesh__D001300smesh__D001299
% 223.27/223.43  |- mesh__dateCreated mesh__D001300 1979-02-21
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D001300 2002
% 223.27/223.43  |- mesh__recordMaintainer mesh__D001300 PXP
% 223.27/223.43  |- mesh__recordOriginator mesh__D001300 RC
% 223.27/223.43  |- mesh__publicMeSHNote mesh__D001300
% 223.27/223.43       86; was see under AUDIOMETRY 1980-85   
% 223.27/223.43  |- skos__hiddenLabel mesh__D001300 Audiometries, Electroencephalic Response
% 223.27/223.43  |- skos__scopeNote mesh__D001300
% 223.27/223.43       A form of electrophysiologic audiometry in which an analog computer is included in the circuit to average out ongoing or spontaneous brain wave activity. A characteristic pattern of response to a sound stimulus may then become evident. Evoked response audiometry is known also as electric response audiometry.%A%    
% 223.27/223.43  |- mesh__historyNote mesh__D001300
% 223.27/223.43       86%28%80%29%; was see under AUDIOMETRY 1980-85   
% 223.27/223.43  |- skos__prefLabel mesh__D001300 Audiometry, Evoked Response
% 223.27/223.43  |- mesh__recordAuthorizer mesh__D001300 SJN
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D001300 2003
% 223.27/223.43  |- skos__hiddenLabel mesh__D001300 Electroencephalic Response Audiometries
% 223.27/223.43  |- skos__historyNote mesh__D001300 Evoked Potentials %28%1967-1979%29%
% 223.27/223.43  |- skos__hiddenLabel mesh__D001300 Response Audiometry, Evoked
% 223.27/223.43  |- skos__altLabel mesh__D001300 Evoked Response Audiometry
% 223.27/223.43  |- skos__altLabel mesh__D001300 Audiometry, Electroencephalic Response
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D001300 2004
% 223.27/223.43  |- skos__historyNote mesh__D001300 Audiometry %28%1966-1979%29%
% 223.27/223.43  |- mesh__dateEstablished mesh__D001300 1986-01-01
% 223.27/223.43  |- skos__hiddenLabel mesh__D001300 Response Audiometry, Electroencephalic
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D001300 1998
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D001300 2005
% 223.27/223.43  |- skos__hiddenLabel mesh__D001300 Response Audiometries, Electroencephalic
% 223.27/223.43  |- mesh__dateRevised mesh__D001300 1997-06-20
% 223.27/223.43  |- skos__hiddenLabel mesh__D006594 Sulfate, Hexoprenaline
% 223.27/223.43  |- skos__broader mesh__D006594smesh__D010627
% 223.27/223.43  |- rdf__type mesh__D006594sskos__Concept
% 223.27/223.43  |- skos__historyNote mesh__D006594 Ethanolamines %28%1973-1974%29%
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D006594 2002
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D006594 2003
% 223.27/223.43  |- skos__historyNote mesh__D006594 Catechols %28%1973-1974%29%
% 223.27/223.43  |- mesh__recordMaintainer mesh__D006594 ssb
% 223.27/223.43  |- mesh__historyNote mesh__D006594
% 223.27/223.43       91%28%75%29%; was see under PHENETHYLAMINES 1975-90   
% 223.27/223.43  |- skos__altLabel mesh__D006594 Gynipral
% 223.27/223.43  |- mesh__dateRevised mesh__D006594 2001-07-25
% 223.27/223.43  |- skos__scopeNote mesh__D006594
% 223.27/223.43       Stimulant of adrenergic beta 2 receptors. It is used as a bronchodilator, antiasthmatic agent, and tocolytic agent.%A%    
% 223.27/223.43  |- mesh__recordAuthorizer mesh__D006594 sjn
% 223.27/223.43  |- skos__hiddenLabel mesh__D006594 St1512
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D006594 2006
% 223.27/223.43  |- mesh__recordOriginator mesh__D006594 NLM
% 223.27/223.43  |- skos__prefLabel mesh__D006594 Hexoprenaline
% 223.27/223.43  |- mesh__dateEstablished mesh__D006594 1991-01-01
% 223.27/223.43  |- mesh__dateCreated mesh__D006594 1974-11-11
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D006594 2005
% 223.27/223.43  |- skos__historyNote mesh__D006594 Phenethylamines %28%1972-1974%29%
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D006594 2004
% 223.27/223.43  |- mesh__publicMeSHNote mesh__D006594
% 223.27/223.43       91; was see under PHENETHYLAMINES 1975-90   
% 223.27/223.43  |- skos__hiddenLabel mesh__D006594 St 1512
% 223.27/223.43  |- mesh__publicMeSHNote mesh__D020265 2000   
% 223.27/223.43  |- skos__broader mesh__D020265smesh__D020263
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D020265 2003
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D020265 2001
% 223.27/223.43  |- mesh__dateEstablished mesh__D020265 2000-01-01
% 223.27/223.43  |- skos__altLabel mesh__D020265 Polyneuropathy, Lead-Induced
% 223.27/223.43  |- skos__altLabel mesh__D020265 Lead Poisoning, Neurologic, Adult
% 223.27/223.43  |- skos__altLabel mesh__D020265 Nervous System Toxicity, Lead, Adult
% 223.27/223.43  |- skos__hiddenLabel mesh__D020265 Polyneuropathy, Lead
% 223.27/223.43  |- skos__hiddenLabel mesh__D020265 Lead-Induced Polyneuropathies
% 223.27/223.43  |- skos__altLabel mesh__D020265 Poisoning, Lead, Neurologic, Adult
% 223.27/223.43  |- mesh__dateCreated mesh__D020265 1999-11-03
% 223.27/223.43  |- skos__annotation mesh__D020265
% 223.27/223.43       includes adolescent as well as adult; coord with specific nervous system symptoms if emphasized%A%  
% 223.27/223.43  |- skos__hiddenLabel mesh__D020265 Polyneuropathy, Lead Induced
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D020265 2000
% 223.27/223.43  |- mesh__historyNote mesh__D020265 2000   
% 223.27/223.43  |- skos__altLabel mesh__D020265 Neurotoxicity Syndrome, Lead, Adult
% 223.27/223.43  |- skos__hiddenLabel mesh__D020265 Lead Induced Polyneuropathy
% 223.27/223.43  |- skos__altLabel mesh__D020265 Poisoning, Lead, Nervous System, Adult
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D020265 2006
% 223.27/223.43  |- skos__altLabel mesh__D020265 Neurologic Saturnism, Adult
% 223.27/223.43  |- skos__altLabel mesh__D020265 Plumbism, Neurologic, Adult
% 223.27/223.43  |- skos__altLabel mesh__D020265 Nervous System Poisoning, Lead, Adult
% 223.27/223.43  |- rdf__type mesh__D020265sskos__Concept
% 223.27/223.43  |- skos__altLabel mesh__D020265 Lead-Induced Polyneuropathy
% 223.27/223.43  |- skos__hiddenLabel mesh__D020265 Saturnism, Adult Neurologic
% 223.27/223.43  |- skos__prefLabel mesh__D020265 Lead Poisoning, Nervous System, Adult
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D020265 2005
% 223.27/223.43  |- skos__scopeNote mesh__D020265
% 223.27/223.43       Neurologic conditions in adults associated with acute or chronic exposure to lead or any of its salts. The most common lead related neurologic syndrome in adults consists of a polyneuropathy involving motor fibers. This tends to affect distal nerves and may present as wrist drop due to RADIAL NEUROPATHY. Additional features of chronic lead exposure include ANEMIA; CONSTIPATION; colicky abdominal pain; a bluish lead line of the gums; interstitial nephritis %28%NEPHRITIS, INTERSTITIAL%29%; and saturnine gout. An encephalopathy may rarely occur. %28%From Adams et al., Principles of Neurology, 6th ed, p1212%29%%A%    
% 223.27/223.43  |- skos__hiddenLabel mesh__D020265 Adult Neurologic Saturnism
% 223.27/223.43  |- skos__historyNote mesh__D020265 Lead Poisoning %28%1966-1999%29%
% 223.27/223.43  |- skos__hiddenLabel mesh__D020265 Polyneuropathies, Lead-Induced
% 223.27/223.43  |- skos__altLabel mesh__D020265
% 223.27/223.43       Nervous System Diseases, Lead Induced, Adult
% 223.27/223.43  |- skos__altLabel mesh__D020265 Lead Induced Nervous System Diseases, Adult
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D020265 2004
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D020265 2002
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D014228 2005
% 223.27/223.43  |- mesh__recordOriginator mesh__D014228 NLM
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D014228 2001
% 223.27/223.43  |- rdf__type mesh__D014228sskos__Concept
% 223.27/223.43  |- skos__scopeNote mesh__D014228
% 223.27/223.43       Alkylating antineoplastic agent used mainly for ovarian tumors. It is toxic to skin, gastrointestinal tract, bone marrow and kidneys.%A%    
% 223.27/223.43  |- skos__altLabel mesh__D014228 2,3,5-Tris%28%ethyleneimine%29%benzoquinone
% 223.27/223.43  |- mesh__recordAuthorizer mesh__D014228 sjn
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D014228 2004
% 223.27/223.43  |- mesh__dateRevised mesh__D014228 2000-06-22
% 223.27/223.43  |- mesh__dateCreated mesh__D014228 1999-01-01
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D014228 2003
% 223.27/223.43  |- mesh__historyNote mesh__D014228 67%28%64%29%   
% 223.27/223.43  |- skos__broader mesh__D014228smesh__D001388
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D014228 2002
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D014228 2006
% 223.27/223.43  |- mesh__publicMeSHNote mesh__D014228 67   
% 223.27/223.43  |- mesh__recordMaintainer mesh__D014228 TWD
% 223.27/223.43  |- skos__prefLabel mesh__D014228 Triaziquone
% 223.27/223.43  |- mesh__dateEstablished mesh__D014228 1967-01-01
% 223.27/223.43  |- skos__prefLabel mesh__D019711 Pyrococcus
% 223.27/223.43  |- skos__scopeNote mesh__D019711
% 223.27/223.43       A genus of strictly anaerobic ultrathermophilic archaea, in the family THERMOCOCCACEAE, occurring in heated seawaters. They exhibit heterotrophic growth at an optimum temperature of 100 degrees C.%A%    
% 223.27/223.43  |- mesh__dateCreated mesh__D019711 1997-06-20
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D019711 2006
% 223.27/223.43  |- skos__broader mesh__D019711smesh__D019710
% 223.27/223.43  |- mesh__recordOriginator mesh__D019711 AGS
% 223.27/223.43  |- mesh__recordMaintainer mesh__D019711 SYSTEM
% 223.27/223.43  |- mesh__historyNote mesh__D019711 98   
% 223.27/223.43  |- rdf__type mesh__D019711sskos__Concept
% 223.27/223.43  |- mesh__publicMeSHNote mesh__D019711 98   
% 223.27/223.43  |- skos__historyNote mesh__D019711 Archaea %28%1989-1997%29%
% 223.27/223.43  |- mesh__recordAuthorizer mesh__D019711 sjn
% 223.27/223.43  |- skos__annotation mesh__D019711
% 223.27/223.43       a genus of archaea found in heated seawaters; THERMOCOCCUS, found in heated seawater, is also available%A%  
% 223.27/223.43  |- mesh__dateEstablished mesh__D019711 1998-01-01
% 223.27/223.43  |- mesh__dateRevised mesh__D019711 2005-06-30
% 223.27/223.43  |- skos__hiddenLabel mesh__D000208 Disease, Acute
% 223.27/223.43  |- skos__prefLabel mesh__D000208 Acute Disease
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D000208 2004
% 223.27/223.43  |- mesh__recordAuthorizer mesh__D000208 sjn
% 223.27/223.43  |- mesh__dateEstablished mesh__D000208 1968-01-01
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D000208 2001
% 223.27/223.43  |- mesh__historyNote mesh__D000208 68   
% 223.27/223.43  |- skos__annotation mesh__D000208
% 223.27/223.43       IM GEN only; usually NIM with specific dis IM; no qualif when NIM; Manual 23.16+%A%  
% 223.27/223.43  |- skos__broader mesh__D000208smesh__D020969
% 223.27/223.43  |- mesh__recordMaintainer mesh__D000208 KEV
% 223.27/223.43  |- mesh__dateCreated mesh__D000208 1999-01-01
% 223.27/223.43  |- mesh__dateRevised mesh__D000208 1999-11-08
% 223.27/223.43  |- skos__hiddenLabel mesh__D000208 Acute Diseases
% 223.27/223.43  |- skos__hiddenLabel mesh__D000208 Diseases, Acute
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D000208 2005
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D000208 2002
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D000208 2006
% 223.27/223.43  |- skos__scopeNote mesh__D000208
% 223.27/223.43       Disease having a short and relatively severe course.     
% 223.27/223.43  |- rdf__type mesh__D000208sskos__Concept
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D000208 2003
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D000208 2000
% 223.27/223.43  |- mesh__recordOriginator mesh__D000208 NLM
% 223.27/223.43  |- mesh__publicMeSHNote mesh__D000208 68   
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D018619 2001
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D018619 1999
% 223.27/223.43  |- skos__annotation mesh__D018619
% 223.27/223.43       /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ECHOCARDIOGR DOPPLER PULSED%A%  
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D018619 2006
% 223.27/223.43  |- skos__altLabel mesh__D018619 Doppler Echocardiography, Pulsed
% 223.27/223.43  |- rdf__type mesh__D018619sskos__Concept
% 223.27/223.43  |- skos__altLabel mesh__D018619 Doppler Pulsed Echocardiography
% 223.27/223.43  |- skos__altLabel mesh__D018619 Echocardiography, Doppler Pulsed
% 223.27/223.43  |- mesh__dateCreated mesh__D018619 1994-02-28
% 223.27/223.43  |- mesh__onlineNote mesh__D018619
% 223.27/223.43       use ECHOCARDIOGRAPHY, DOPPLER to search ECHOCARDIOGRAPHY, DOPPLER, PULSED 1989-94%A%  
% 223.27/223.43  |- mesh__dateEstablished mesh__D018619 1995-01-01
% 223.27/223.43  |- mesh__dateRevised mesh__D018619 1997-06-20
% 223.27/223.43  |- skos__historyNote mesh__D018619 Echocardiography %28%1972-1988%29%
% 223.27/223.43  |- skos__broader mesh__D018619smesh__D015150
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D018619 2002
% 223.27/223.43  |- skos__prefLabel mesh__D018619 Echocardiography, Doppler, Pulsed
% 223.27/223.43  |- mesh__recordOriginator mesh__D018619 PXP
% 223.27/223.43  |- mesh__historyNote mesh__D018619
% 223.27/223.43       95; was ECHOCARDIOGRAPHY, PULSED DOPPLER see ECHOCARDIOGRAPHY, DOPPLER 1989-94%A%  
% 223.27/223.43  |- skos__scopeNote mesh__D018619
% 223.27/223.43       Echocardiography applying the Doppler effect, with velocity detection combined with range discrimination. Short bursts of ultrasound are transmitted at regular intervals and the echoes are demodulated as they return.%A%    
% 223.27/223.43  |- skos__altLabel mesh__D018619 Pulsed Echocardiography, Doppler
% 223.27/223.43  |- mesh__recordAuthorizer mesh__D018619 SJN
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D018619 2003
% 223.27/223.43  |- skos__altLabel mesh__D018619 Pulsed Doppler Echocardiography
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D018619 2000
% 223.27/223.43  |- skos__altLabel mesh__D018619 Echocardiography, Pulsed Doppler
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D018619 1998
% 223.27/223.43  |- skos__historyNote mesh__D018619
% 223.27/223.43       Echocardiography, Doppler %28%1989-1994%29%
% 223.27/223.43  |- skos__broader mesh__D018619smesh__D018617
% 223.27/223.43  |- mesh__publicMeSHNote mesh__D018619
% 223.27/223.43       95; was ECHOCARDIOGRAPHY, PULSED DOPPLER see ECHOCARDIOGRAPHY, DOPPLER 1989-94%A%  
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D018619 2005
% 223.27/223.43  |- mesh__recordMaintainer mesh__D018619 PXP
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D018619 2004
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D010636 2002
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D010636 2005
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D010636 1997
% 223.27/223.43  |- skos__altLabel mesh__D010636 Carbol
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D010636 2001
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D010636 1999
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D010636 2000
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D010636 1996
% 223.27/223.43  |- mesh__recordMaintainer mesh__D010636 TAP
% 223.27/223.43  |- rdf__type mesh__D010636sskos__Concept
% 223.27/223.43  |- mesh__dateCreated mesh__D010636 1999-01-01
% 223.27/223.43  |- mesh__recordOriginator mesh__D010636 NLM
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D010636 1993
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D010636 1998
% 223.27/223.43  |- skos__broader mesh__D010636smesh__D009930
% 223.27/223.43  |- skos__prefLabel mesh__D010636 Phenols
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D010636 1995
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D010636 2004
% 223.27/223.43  |- mesh__dateRevised mesh__D010636 1992-05-19
% 223.27/223.43  |- mesh__recordAuthorizer mesh__D010636 PLS
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D010636 2006
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D010636 1994
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D010636 2003
% 223.27/223.43  |- skos__annotation mesh__D029341
% 223.27/223.43       infection: coord IM with CALICIVIRIDAE INFECTIONS + probably GASTROENTERITIS %28%IM%29%%A%  
% 223.27/223.43  |- mesh__dateCreated mesh__D029341 2001-07-25
% 223.27/223.43  |- mesh__historyNote mesh__D029341 2004 %28%2002%29%   
% 223.27/223.43  |- mesh__recordMaintainer mesh__D029341 sjn
% 223.27/223.43  |- skos__broader mesh__D029341smesh__D002139
% 223.27/223.43  |- skos__prefLabel mesh__D029341 Sapovirus
% 223.27/223.43  |- skos__altLabel mesh__D029341 Sapporo-like Viruses
% 223.27/223.43  |- mesh__dateEstablished mesh__D029341 2002-01-01
% 223.27/223.43  |- skos__hiddenLabel mesh__D029341 Sapporo like Viruses
% 223.27/223.43  |- rdf__type mesh__D029341sskos__Concept
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D029341 2006
% 223.27/223.43  |- skos__hiddenLabel mesh__D029341 Sapoviruses
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D029341 2005
% 223.27/223.43  |- mesh__publicMeSHNote mesh__D029341
% 223.27/223.43       2004; see SAPPORO-LIKE VIRUSES 2002-2003   
% 223.27/223.43  |- mesh__recordAuthorizer mesh__D029341 sjn
% 223.27/223.43  |- mesh__dateRevised mesh__D029341 2004-07-13
% 223.27/223.43  |- skos__scopeNote mesh__D029341
% 223.27/223.43       A genus of the family CALICIVIRIDAE associated with worldwide sporadic outbreaks of GASTROENTERITIS in humans. The first recorded outbreak was in human infants in Sapporo, Japan in 1977. The genus is comprised of a single species, Sapporo virus, containing multiple strains.%A%    
% 223.27/223.43  |- mesh__recordOriginator mesh__D029341 ags
% 223.27/223.43  |- mesh__recordOriginator mesh__D015321 EJB
% 223.27/223.43  |- mesh__dateCreated mesh__D015321 1988-05-31
% 223.27/223.43  |- skos__hiddenLabel mesh__D015321 Gene Rearrangements
% 223.27/223.43  |- skos__hiddenLabel mesh__D015321 Rearrangement, DNA
% 223.27/223.43  |- skos__altLabel mesh__D015321 DNA Rearrangement
% 223.27/223.43  |- skos__annotation mesh__D015321 DF: GENE REARR   
% 223.27/223.43  |- mesh__recordAuthorizer mesh__D015321 NLM
% 223.27/223.43  |- mesh__dateRevised mesh__D015321 2004-07-20
% 223.27/223.43  |- skos__related mesh__D015321smesh__D005803
% 223.27/223.43  |- skos__historyNote mesh__D015321 DNA/genetics %28%1977-1988%29%
% 223.27/223.43  |- skos__related mesh__D015321smesh__D045567
% 223.27/223.43  |- skos__historyNote mesh__D015321 Genes or specific gene %28%1977-1988%29%
% 223.27/223.43  |- mesh__dateEstablished mesh__D015321 1989-01-01
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D015321 2006
% 223.27/223.43  |- mesh__publicMeSHNote mesh__D015321 89   
% 223.27/223.43  |- skos__related mesh__D015321smesh__D000916
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D015321 2005
% 223.27/223.43  |- skos__hiddenLabel mesh__D015321 Rearrangements, DNA
% 223.27/223.43  |- skos__prefLabel mesh__D015321 Gene Rearrangement
% 223.27/223.43  |- skos__broader mesh__D015321smesh__D039361
% 223.27/223.43  |- skos__related mesh__D015321smesh__D007135
% 223.27/223.43  |- skos__related mesh__D015321smesh__D014178
% 223.27/223.43  |- skos__hiddenLabel mesh__D015321 Rearrangement, Gene
% 223.27/223.43  |- skos__hiddenLabel mesh__D015321 DNA Rearrangements
% 223.27/223.43  |- mesh__recordMaintainer mesh__D015321 NLM
% 223.27/223.43  |- skos__scopeNote mesh__D015321
% 223.27/223.43       The ordered rearrangement of gene regions by DNA recombination such as that which occurs normally during development.%A%    
% 223.27/223.43  |- mesh__historyNote mesh__D015321 89   
% 223.27/223.43  |- skos__hiddenLabel mesh__D015321 Rearrangements, Gene
% 223.27/223.43  |- rdf__type mesh__D015321sskos__Concept
% 223.27/223.43  |- mesh__recordMaintainer mesh__D034286 jmp
% 223.27/223.43  |- mesh__dateCreated mesh__D034286 2002-07-03
% 223.27/223.43  |- skos__altLabel mesh__D034286 T-Dynamin
% 223.27/223.43  |- skos__altLabel mesh__D034286 Dynamin, Testicular
% 223.27/223.43  |- skos__hiddenLabel mesh__D034286 Testicular Dynamin
% 223.27/223.43  |- mesh__publicMeSHNote mesh__D034286
% 223.27/223.43       2003; DYNAMIN III was indexed under GTP PHOSPHOHYDROLASES 1999-2002%A%  
% 223.27/223.43  |- skos__broader mesh__D034286smesh__D034281
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D034286 2005
% 223.27/223.43  |- skos__prefLabel mesh__D034286 Dynamin III
% 223.27/223.43  |- mesh__historyNote mesh__D034286
% 223.27/223.43       2003; for DYNAMIN III use DYNAMINS %28%NM%29% 1999-2002   
% 223.27/223.43  |- rdf__type mesh__D034286sskos__Concept
% 223.27/223.43  |- mesh__dateRevised mesh__D034286 2004-07-07
% 223.27/223.43  |- mesh__recordAuthorizer mesh__D034286 sjn
% 223.27/223.43  |- skos__historyNote mesh__D034286 GTP Phosphohydrolases %28%1999-2002%29%
% 223.27/223.43  |- mesh__activeMeSHYear mesh__D034286 2006
% 223.27/223.43  |- skos__altLabel mesh__D034286 Dynamin 3
% 223.27/223.43  |- skos__scopeNote mesh__D034286
% 223.27/223.43       A subtype of dynamin found expressed exclusively in the testis, lung and brain.%A%    
% 223.27/223.43  |- mesh__recordOriginator mesh__D034286 jmp
% 223.27/223.43  |- mesh__dateEstablished mesh__D034286 2003-01-01
% 223.27/223.43  |- skos__scopeNote mesh__D001301
% 223.27/223.43       Measurement of hearing based on the use of pure tones of various frequencies and intensities as auditory stimuli.%A%    
% 223.27/223.43  |- skos__prefLabel mesh__D001301 Audiometry, Pure-Tone
% 223.27/223.44  |- mesh__dateEstablished mesh__D001301 1991-01-01
% 223.27/223.44  |- mesh__recordAuthorizer mesh__D001301 sjn
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001301 2002
% 223.27/223.44  |- mesh__historyNote mesh__D001301
% 223.27/223.44       91%28%80%29%; was see under AUDIOMETRY 1980-90   
% 223.27/223.44  |- skos__historyNote mesh__D001301 Audiometry %28%1966-1979%29%
% 223.27/223.44  |- skos__annotation mesh__D001301
% 223.27/223.44       do not use /util except by MeSH definition; note X ref: spell in titles %26% translations with accents: B%C3%%A9%k%C3%%A9%sy%A%  
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001301 2006
% 223.27/223.44  |- skos__hiddenLabel mesh__D001301 Pure-Tone Audiometry
% 223.27/223.44  |- rdf__type mesh__D001301sskos__Concept
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001301 2005
% 223.27/223.44  |- mesh__recordOriginator mesh__D001301 RC
% 223.27/223.44  |- skos__hiddenLabel mesh__D001301 Bekesy Audiometry
% 223.27/223.44  |- mesh__publicMeSHNote mesh__D001301
% 223.27/223.44       91; was see under AUDIOMETRY 1980-90   
% 223.27/223.44  |- mesh__recordMaintainer mesh__D001301 jls
% 223.27/223.44  |- skos__hiddenLabel mesh__D001301 Audiometry, Pure Tone
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001301 2004
% 223.27/223.44  |- mesh__dateCreated mesh__D001301 1978-12-14
% 223.27/223.44  |- mesh__dateRevised mesh__D001301 2001-08-13
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001301 2003
% 223.27/223.44  |- skos__broader mesh__D001301smesh__D001299
% 223.27/223.44  |- mesh__recordOriginator mesh__D006595 NLM
% 223.27/223.44  |- rdf__type mesh__D006595sskos__Concept
% 223.27/223.44  |- mesh__dateRevised mesh__D006595 2004-07-07
% 223.27/223.44  |- skos__broader mesh__D006595smesh__D000606
% 223.27/223.44  |- mesh__recordMaintainer mesh__D006595 ssb
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D006595 2005
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D006595 2006
% 223.27/223.44  |- mesh__dateCreated mesh__D006595 1999-01-01
% 223.27/223.44  |- skos__prefLabel mesh__D006595 Hexosamines
% 223.27/223.44  |- mesh__recordAuthorizer mesh__D006595 sjn
% 223.27/223.44  |- mesh__dateEstablished mesh__D020266 1999-01-01
% 223.27/223.44  |- mesh__dateRevised mesh__D020266 2005-06-30
% 223.27/223.44  |- mesh__recordOriginator mesh__D020266 AGS
% 223.27/223.44  |- skos__scopeNote mesh__D020266
% 223.27/223.44       Radiotherapy where there is improved dose homogeneity within the tumor and reduced dosage to uninvolved structures. The precise shaping of dose distribution is achieved via the use of computer-controlled multileaf collimators.%A%    
% 223.27/223.44  |- skos__historyNote mesh__D020266
% 223.27/223.44       Radiotherapy, Computer-Assisted %28%1988-1998%29%
% 223.27/223.44  |- mesh__dateCreated mesh__D020266 1998-06-11
% 223.27/223.44  |- skos__prefLabel mesh__D020266 Radiotherapy, Conformal
% 223.27/223.44  |- skos__historyNote mesh__D020266
% 223.27/223.44       Radiotherapy Planning, Computer-Assisted %28%1988-1998%29%
% 223.27/223.44  |- rdf__type mesh__D020266sskos__Concept
% 223.27/223.44  |- mesh__publicMeSHNote mesh__D020266 99   
% 223.27/223.44  |- skos__related mesh__D020266smesh__D011879
% 223.27/223.44  |- mesh__recordMaintainer mesh__D020266 lkt
% 223.27/223.44  |- mesh__historyNote mesh__D020266 99   
% 223.27/223.44  |- mesh__recordAuthorizer mesh__D020266 sjn
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D020266 2006
% 223.27/223.44  |- skos__altLabel mesh__D020266 Conformal Radiotherapy
% 223.27/223.44  |- skos__hiddenLabel mesh__D020266 Conformal Radiotherapies
% 223.27/223.44  |- skos__related mesh__D020266smesh__D011880
% 223.27/223.44  |- skos__broader mesh__D020266smesh__D011881
% 223.27/223.44  |- skos__hiddenLabel mesh__D020266 Radiotherapies, Conformal
% 223.27/223.44  |- mesh__historyNote mesh__D014229
% 223.27/223.44       86%28%77%29%; was see under BENZODIAZEPINE TRANQUILIZERS 1977-85%A%  
% 223.27/223.44  |- skos__altLabel mesh__D014229 Pharmacia Brand of Triazolam
% 223.27/223.44  |- skos__altLabel mesh__D014229 Apotex Brand of Triazolam
% 223.27/223.44  |- mesh__publicMeSHNote mesh__D014229
% 223.27/223.44       86; was see under BENZODIAZEPINE TRANQUILIZERS 1977-85   
% 223.27/223.44  |- skos__historyNote mesh__D014229 Benzazepines %28%1974%29%
% 223.27/223.44  |- skos__prefLabel mesh__D014229 Triazolam
% 223.27/223.44  |- mesh__dateCreated mesh__D014229 1976-04-16
% 223.27/223.44  |- mesh__recordMaintainer mesh__D014229 CCR
% 223.27/223.44  |- skos__broader mesh__D014229smesh__D001569
% 223.27/223.44  |- mesh__dateEstablished mesh__D014229 1986-01-01
% 223.27/223.44  |- skos__hiddenLabel mesh__D014229 U 33,030
% 223.27/223.44  |- skos__altLabel mesh__D014229 Gerard Brand of Triazolam
% 223.27/223.44  |- skos__altLabel mesh__D014229 Genpharm Brand of Triazolam
% 223.27/223.44  |- mesh__dateRevised mesh__D014229 2005-06-30
% 223.27/223.44  |- skos__historyNote mesh__D014229 Benzodiazepines %28%1975-1976%29%
% 223.27/223.44  |- mesh__recordAuthorizer mesh__D014229 sjn
% 223.27/223.44  |- skos__hiddenLabel mesh__D014229 Apo Triazo
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D014229 2006
% 223.27/223.44  |- skos__scopeNote mesh__D014229
% 223.27/223.44       A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.%A%    
% 223.27/223.44  |- skos__hiddenLabel mesh__D014229 U33,030
% 223.27/223.44  |- skos__hiddenLabel mesh__D014229 Gen Triazolam
% 223.27/223.44  |- skos__historyNote mesh__D014229 Triazoles %28%1974-1976%29%
% 223.27/223.44  |- mesh__recordOriginator mesh__D014229 SH
% 223.27/223.44  |- skos__altLabel mesh__D014229 Pharmacia Spain Brand of Triazolam
% 223.27/223.44  |- rdf__type mesh__D014229sskos__Concept
% 223.27/223.44  |- skos__broader mesh__D019712smesh__D019710
% 223.27/223.44  |- mesh__recordAuthorizer mesh__D019712 sjn
% 223.27/223.44  |- mesh__dateEstablished mesh__D019712 1998-01-01
% 223.27/223.44  |- mesh__recordOriginator mesh__D019712 AGS
% 223.27/223.44  |- skos__scopeNote mesh__D019712
% 223.27/223.44       A genus of extremely thermophilic heterotrophic archaea, in the family THERMOCOCCACEAE, occurring in heated sea flows. They are anerobic chemoorganotropic sulfidogens.%A%    
% 223.27/223.44  |- skos__annotation mesh__D019712
% 223.27/223.44       a genus of archaea found in heated sea flows;  PYROCOCCUS, found in heated seawater, is also available%A%  
% 223.27/223.44  |- mesh__dateRevised mesh__D019712 2005-06-30
% 223.27/223.44  |- mesh__recordMaintainer mesh__D019712 SYSTEM
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D019712 2006
% 223.27/223.44  |- skos__prefLabel mesh__D019712 Thermococcus
% 223.27/223.44  |- mesh__publicMeSHNote mesh__D019712 98   
% 223.27/223.44  |- mesh__dateCreated mesh__D019712 1997-06-20
% 223.27/223.44  |- mesh__historyNote mesh__D019712 98   
% 223.27/223.44  |- rdf__type mesh__D019712sskos__Concept
% 223.27/223.44  |- skos__historyNote mesh__D019712 Archaea %28%1988-1997%29%
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D000209 2004
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D000209 1996
% 223.27/223.44  |- skos__altLabel mesh__D000209 Acute-Phase Reactants
% 223.27/223.44  |- skos__hiddenLabel mesh__D000209 Proteins, Acute Phase
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D000209 2005
% 223.27/223.44  |- skos__historyNote mesh__D000209 Blood Proteins %28%1966-1986%29%
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D000209 2003
% 223.27/223.44  |- skos__altLabel mesh__D000209 Proteins, Acute-Phase
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D000209 2002
% 223.27/223.44  |- mesh__recordOriginator mesh__D000209 RLS
% 223.27/223.44  |- mesh__historyNote mesh__D000209 87   
% 223.27/223.44  |- skos__prefLabel mesh__D000209 Acute-Phase Proteins
% 223.27/223.44  |- mesh__recordMaintainer mesh__D000209 JRT
% 223.27/223.44  |- skos__historyNote mesh__D000209 Glycoproteins %28%1966-1986%29%
% 223.27/223.44  |- skos__hiddenLabel mesh__D000209 Acute Phase Protein
% 223.27/223.44  |- mesh__publicMeSHNote mesh__D000209 87   
% 223.27/223.44  |- mesh__recordAuthorizer mesh__D000209 PLS
% 223.27/223.44  |- mesh__dateCreated mesh__D000209 1986-04-14
% 223.27/223.44  |- skos__hiddenLabel mesh__D000209 Acute Phase Reactants
% 223.27/223.44  |- skos__hiddenLabel mesh__D000209 Acute Phase Proteins
% 223.27/223.44  |- mesh__dateEstablished mesh__D000209 1987-01-01
% 223.27/223.44  |- skos__scopeNote mesh__D000209
% 223.27/223.44       Proteins that are secreted into the blood in increased or decreased quantities by hepatocytes in response to trauma, inflammation, or disease. These proteins can serve as inhibitors or mediators of the inflammatory processes. Certain acute-phase proteins have been used to diagnose and follow the course of diseases or as tumor markers.%A%    
% 223.27/223.44  |- skos__broader mesh__D000209smesh__D001798
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D000209 1999
% 223.27/223.44  |- skos__altLabel mesh__D000209 Acute-Phase Protein
% 223.27/223.44  |- skos__historyNote mesh__D000209 C-Reactive Protein %28%1966-1986%29%
% 223.27/223.44  |- skos__hiddenLabel mesh__D000209 Glycoproteins, Acute-Phase
% 223.27/223.44  |- skos__hiddenLabel mesh__D000209 Acute Phase Glycoproteins
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D000209 1997
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D000209 2001
% 223.27/223.44  |- skos__hiddenLabel mesh__D000209 Reactants, Acute Phase
% 223.27/223.44  |- skos__hiddenLabel mesh__D000209 Protein, Acute-Phase
% 223.27/223.44  |- skos__altLabel mesh__D000209 Reactants, Acute-Phase
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D000209 2006
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D000209 2000
% 223.27/223.44  |- skos__annotation mesh__D000209
% 223.27/223.44       blood proteins; /biosyn /drug eff /physiol permitted   
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D000209 1998
% 223.27/223.44  |- mesh__dateRevised mesh__D000209 1995-06-02
% 223.27/223.44  |- rdf__type mesh__D000209sskos__Concept
% 223.27/223.44  |- mesh__recordMaintainer mesh__D010637 NLM
% 223.27/223.44  |- skos__altLabel mesh__D010637 Sulphonthal
% 223.27/223.44  |- mesh__dateEstablished mesh__D010637 1991-01-01
% 223.27/223.44  |- skos__prefLabel mesh__D010637 Phenolsulfonphthalein
% 223.27/223.44  |- rdf__type mesh__D010637sskos__Concept
% 223.27/223.44  |- skos__historyNote mesh__D010637 Phenolphthaleins %28%1966-1974%29%
% 223.27/223.44  |- mesh__dateCreated mesh__D010637 1999-01-01
% 223.27/223.44  |- skos__altLabel mesh__D010637 Phenol Red
% 223.27/223.44  |- mesh__publicMeSHNote mesh__D010637
% 223.27/223.44       91; was see under PHENOLPHTHALEINS 1975-90   
% 223.27/223.44  |- mesh__dateRevised mesh__D010637 2005-07-06
% 223.27/223.44  |- skos__scopeNote mesh__D010637
% 223.27/223.44       Red dye, pH indicator, and diagnostic aid for determination of renal function. It is used also for studies of the gastrointestinal and other systems.%A%    
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D010637 2006
% 223.27/223.44  |- mesh__onlineNote mesh__D010637 search PHENOLPHTHALEINS 1966-74   
% 223.27/223.44  |- mesh__recordOriginator mesh__D010637 NLM
% 223.27/223.44  |- mesh__historyNote mesh__D010637
% 223.27/223.44       91%28%75%29%; was see under PHENOLPHTHALEINS 1975-90   
% 223.27/223.44  |- skos__broader mesh__D010637smesh__D010635
% 223.27/223.44  |- mesh__recordAuthorizer mesh__D010637 NLM
% 223.27/223.44  |- mesh__dateEstablished mesh__D029342 2002-01-01
% 223.27/223.44  |- mesh__recordAuthorizer mesh__D029342 sjn
% 223.27/223.44  |- mesh__dateRevised mesh__D029342 2004-07-13
% 223.27/223.44  |- rdf__type mesh__D029342sskos__Concept
% 223.27/223.44  |- mesh__recordOriginator mesh__D029342 ags
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D029342 2006
% 223.27/223.44  |- mesh__historyNote mesh__D029342 2002   
% 223.27/223.44  |- skos__hiddenLabel mesh__D029342 Vesiviruses
% 223.27/223.44  |- mesh__dateCreated mesh__D029342 2001-07-25
% 223.27/223.44  |- mesh__recordMaintainer mesh__D029342 sjn
% 223.27/223.44  |- skos__broader mesh__D029342smesh__D002139
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D029342 2005
% 223.27/223.44  |- skos__scopeNote mesh__D029342
% 223.27/223.44       A genus of the family CALICIVIRIDAE comprised of species infecting a wide range of organisms. Most members of this genus can be readily propagated in cell culture %28%as opposed to other genera of Caliciviridae%29%. The type species is VESICULAR EXANTHEMA OF SWINE VIRUS.%A%    
% 223.27/223.44  |- mesh__publicMeSHNote mesh__D029342 2002   
% 223.27/223.44  |- skos__annotation mesh__D029342
% 223.27/223.44       infection: coord IM with CALICIVIRIDAE INFECTIONS %28%IM%29%   
% 223.27/223.44  |- skos__prefLabel mesh__D029342 Vesivirus
% 223.27/223.44  |- skos__hiddenLabel mesh__D015322 Rearrangement, B-Cell Gene
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D015322 2004
% 223.27/223.44  |- mesh__dateEstablished mesh__D015322 1989-01-01
% 223.27/223.44  |- skos__altLabel mesh__D015322 B-Cell Gene Rearrangement
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D015322 2006
% 223.27/223.44  |- skos__hiddenLabel mesh__D015322 B-Lymphocyte Gene Rearrangements
% 223.27/223.44  |- mesh__publicMeSHNote mesh__D015322 89   
% 223.27/223.44  |- skos__hiddenLabel mesh__D015322 Gene Rearrangement, B Lymphocyte
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D015322 2003
% 223.27/223.44  |- mesh__recordOriginator mesh__D015322 EJB
% 223.27/223.44  |- skos__prefLabel mesh__D015322 Gene Rearrangement, B-Lymphocyte
% 223.27/223.44  |- skos__scopeNote mesh__D015322
% 223.27/223.44       Ordered rearrangement of B-lymphocyte variable gene regions coding for the immunoglobulin chains, thereby contributing to antibody diversity. It occurs during the differentiation of the immature B-lymphocyte.%A%    
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D015322 2005
% 223.27/223.44  |- skos__altLabel mesh__D015322 B-Lymphocyte Gene Rearrangement
% 223.27/223.44  |- mesh__historyNote mesh__D015322 89   
% 223.27/223.44  |- skos__hiddenLabel mesh__D015322 Gene Rearrangement, B Cell
% 223.27/223.44  |- mesh__recordMaintainer mesh__D015322 nns
% 223.27/223.44  |- skos__hiddenLabel mesh__D015322 Gene Rearrangements, B-Cell
% 223.27/223.44  |- skos__hiddenLabel mesh__D015322 B Cell Gene Rearrangement
% 223.27/223.44  |- skos__historyNote mesh__D015322
% 223.27/223.44       B-Lymphocytes/immunology %28%1977-1988%29%
% 223.27/223.44  |- skos__historyNote mesh__D015322 Genes, Immunoglobulin %28%1977-1988%29%
% 223.27/223.44  |- rdf__type mesh__D015322sskos__Concept
% 223.27/223.44  |- skos__hiddenLabel mesh__D015322 Rearrangements, B-Cell Gene
% 223.27/223.44  |- skos__altLabel mesh__D015322 Gene Rearrangement, B-Cell
% 223.27/223.44  |- mesh__dateRevised mesh__D015322 2002-07-02
% 223.27/223.44  |- skos__annotation mesh__D015322 DF: GENE REARR B CELL   
% 223.27/223.44  |- skos__broader mesh__D015322smesh__D007125
% 223.27/223.44  |- skos__hiddenLabel mesh__D015322 Rearrangements, B-Lymphocyte Gene
% 223.27/223.44  |- skos__hiddenLabel mesh__D015322 B-Cell Gene Rearrangements
% 223.27/223.44  |- mesh__dateCreated mesh__D015322 1988-05-31
% 223.27/223.44  |- skos__hiddenLabel mesh__D015322 B Lymphocyte Gene Rearrangement
% 223.27/223.44  |- mesh__recordAuthorizer mesh__D015322 sjn
% 223.27/223.44  |- skos__historyNote mesh__D015322 DNA/genetics %28%1977-1988%29%
% 223.27/223.44  |- skos__hiddenLabel mesh__D015322 Rearrangement, B-Lymphocyte Gene
% 223.27/223.44  |- skos__broader mesh__D015322smesh__D015321
% 223.27/223.44  |- skos__related mesh__D015322smesh__D027041
% 223.27/223.44  |- skos__hiddenLabel mesh__D015322 Gene Rearrangements, B-Lymphocyte
% 223.27/223.44  |- skos__hiddenLabel mesh__D001302 Speech Audiometries
% 223.27/223.44  |- skos__broader mesh__D001302smesh__D001299
% 223.27/223.44  |- skos__historyNote mesh__D001302 Audiometry %28%1966-1979%29%
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001302 2002
% 223.27/223.44  |- mesh__recordMaintainer mesh__D001302 PXP
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001302 1999
% 223.27/223.44  |- skos__historyNote mesh__D001302 Speech %28%1966-1979%29%
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001302 2001
% 223.27/223.44  |- skos__prefLabel mesh__D001302 Audiometry, Speech
% 223.27/223.44  |- mesh__publicMeSHNote mesh__D001302 80   
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001302 1998
% 223.27/223.44  |- rdf__type mesh__D001302sskos__Concept
% 223.27/223.44  |- skos__scopeNote mesh__D001302
% 223.27/223.44       Measurement of the ability to hear speech under various conditions of intensity and noise interference using sound-field as well as earphones and bone oscillators.%A%    
% 223.27/223.44  |- skos__hiddenLabel mesh__D001302 Audiometries, Speech
% 223.27/223.44  |- mesh__recordAuthorizer mesh__D001302 SJN
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001302 2006
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001302 2000
% 223.27/223.44  |- skos__hiddenLabel mesh__D001302 Speech Audiometry
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001302 2005
% 223.27/223.44  |- mesh__recordOriginator mesh__D001302 RC
% 223.27/223.44  |- mesh__historyNote mesh__D001302 80   
% 223.27/223.44  |- mesh__dateCreated mesh__D001302 1978-12-14
% 223.27/223.44  |- mesh__dateEstablished mesh__D001302 1980-01-01
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001302 2004
% 223.27/223.44  |- mesh__dateRevised mesh__D001302 1997-06-20
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001302 2003
% 223.27/223.44  |- skos__altLabel mesh__D006596 Hexosaminidase
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D006596 2005
% 223.27/223.44  |- skos__broader mesh__D006596smesh__D006026
% 223.27/223.44  |- mesh__recordOriginator mesh__D006596 NLM
% 223.27/223.44  |- skos__altLabel mesh__D006596 Glucosaminidase
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D006596 2006
% 223.27/223.44  |- skos__related mesh__D006596smesh__D005733
% 223.27/223.44  |- mesh__dateRevised mesh__D006596 2005-07-15
% 223.27/223.44  |- skos__prefLabel mesh__D006596 Hexosaminidases
% 223.27/223.44  |- mesh__dateCreated mesh__D006596 1999-01-01
% 223.27/223.44  |- skos__historyNote mesh__D006596 Glycoside Hydrolases %28%1966-1970%29%
% 223.27/223.44  |- skos__altLabel mesh__D006596 Galactosaminidase
% 223.27/223.44  |- skos__scopeNote mesh__D006596
% 223.27/223.44       Enzymes that catalyze the hydrolysis of N-acylhexosamine residues in N-acylhexosamides. Hexosaminidases also act on GLUCOSIDES; GALACTOSIDES; and several OLIGOSACCHARIDES.%A%    
% 223.27/223.44  |- mesh__recordMaintainer mesh__D006596 ags
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D006596 2006A
% 223.27/223.44  |- mesh__recordAuthorizer mesh__D006596 ags
% 223.27/223.44  |- mesh__publicMeSHNote mesh__D006596
% 223.27/223.44       1973; for GALACTOSAMINIDASE see GALACTOAMINIDASE 1973-2004; for GLUCOSAMINIDASE see GLUCOSAMINIDASE 1973-2004; for HEXOAMINIDASE see BETA-N-ACETYLHEXOSAMINIDASE 1987-2004%A%  
% 223.27/223.44  |- rdf__type mesh__D006596sskos__Concept
% 223.27/223.44  |- mesh__historyNote mesh__D006596
% 223.27/223.44       1973%28%1971%29%; for HEXOAMINIDASE use BETA-N-ACETYLHEXOSAMINIDASE 1987-2004%A%  
% 223.27/223.44  |- mesh__dateEstablished mesh__D006596 1973-01-01
% 223.27/223.44  |- skos__altLabel mesh__D020267 Neurotoxicity Syndrome, MPTP
% 223.27/223.44  |- mesh__recordAuthorizer mesh__D020267 sjn
% 223.27/223.44  |- skos__historyNote mesh__D020267
% 223.27/223.44       Parkinson Disease, Secondary %28%1983-1999%29%
% 223.27/223.44  |- skos__broader mesh__D020267smesh__D010302
% 223.27/223.44  |- skos__prefLabel mesh__D020267 MPTP Poisoning
% 223.27/223.44  |- skos__altLabel mesh__D020267
% 223.27/223.44       Poisoning, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
% 223.27/223.44  |- mesh__recordOriginator mesh__D020267 KEV
% 223.27/223.44  |- skos__broader mesh__D020267smesh__D020258
% 223.27/223.44  |- skos__hiddenLabel mesh__D020267
% 223.27/223.44       MPTP Induced Degeneration of the Striatum
% 223.27/223.44  |- skos__altLabel mesh__D020267 MPTP Neurotoxicity Syndrome
% 223.27/223.44  |- skos__related mesh__D020267smesh__D015655
% 223.27/223.44  |- skos__altLabel mesh__D020267 MPTP-Induced Parkinsonism
% 223.27/223.44  |- rdf__type mesh__D020267sskos__Concept
% 223.27/223.44  |- mesh__dateCreated mesh__D020267 1999-11-08
% 223.27/223.44  |- skos__hiddenLabel mesh__D020267 Poisoning, MPTP
% 223.27/223.44  |- mesh__dateRevised mesh__D020267 2005-06-30
% 223.27/223.44  |- skos__hiddenLabel mesh__D020267 Neurotoxicity Syndromes, MPTP
% 223.27/223.44  |- skos__historyNote mesh__D020267
% 223.27/223.44       1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/poisoning %28%1990-1999%29%
% 223.27/223.44  |- mesh__dateEstablished mesh__D020267 2000-01-01
% 223.27/223.44  |- skos__scopeNote mesh__D020267
% 223.27/223.44       A condition caused by the neurotoxin MPTP which causes selective destruction of nigrostriatal dopaminergic neurons. Clinical features include irreversible parkinsonian signs including rigidity and bradykinesia %28%PARKINSON DISEASE, SECONDARY%29%. MPTP toxicity is also used as an animal model for the study of PARKINSON DISEASE. %28%Adams et al., Principles of Neurology, 6th ed, p1072; Neurology 1986 Feb;36%28%2%29%:250-8%29%%A%    
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D020267 2006
% 223.27/223.44  |- mesh__recordMaintainer mesh__D020267 ssb
% 223.27/223.44  |- skos__hiddenLabel mesh__D020267 MPTP Neurotoxicity Syndromes
% 223.27/223.44  |- skos__hiddenLabel mesh__D020267 Parkinsonism, MPTP-Induced
% 223.27/223.44  |- mesh__historyNote mesh__D020267 2000   
% 223.27/223.44  |- skos__hiddenLabel mesh__D020267 MPTP Induced Parkinsonism
% 223.27/223.44  |- mesh__publicMeSHNote mesh__D020267 2000   
% 223.27/223.44  |- skos__historyNote mesh__D019713 Receptors, HIV %28%1997%29%
% 223.27/223.44  |- skos__annotation mesh__D019713 chemokine recept; DF: RECEPT CCR5   
% 223.27/223.44  |- skos__broader mesh__D019713smesh__D015728
% 223.27/223.44  |- skos__prefLabel mesh__D019713 Receptors, CCR5
% 223.27/223.44  |- skos__altLabel mesh__D019713 CKR5 Receptors
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D019713 2004
% 223.27/223.44  |- skos__altLabel mesh__D019713 CCR5 Receptors
% 223.27/223.44  |- skos__hiddenLabel mesh__D019713 Receptor, CCR5
% 223.27/223.44  |- skos__altLabel mesh__D019713 CCR5 Receptor
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D019713 2006
% 223.27/223.44  |- mesh__dateEstablished mesh__D019713 1998-01-01
% 223.27/223.44  |- skos__altLabel mesh__D019713 CC-CKR5
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D019713 2005
% 223.27/223.44  |- rdf__type mesh__D019713sskos__Concept
% 223.27/223.44  |- skos__altLabel mesh__D019713 Receptors, CKR5
% 223.27/223.44  |- mesh__historyNote mesh__D019713
% 223.27/223.44       98; use RECEPTORS, CCR5 %28%NM%29% 1996-97   
% 223.27/223.44  |- skos__altLabel mesh__D019713 CC Chemokine Receptor 5
% 223.27/223.44  |- mesh__dateRevised mesh__D019713 2003-07-09
% 223.27/223.44  |- skos__scopeNote mesh__D019713
% 223.27/223.44       Seven-transmembrane G protein-coupled receptors for beta-chemokines. They also function as fusion cofactors for macrophage-tropic HIV-1 strains.%A%    
% 223.27/223.44  |- skos__historyNote mesh__D019713 Receptors, Cytokine %28%1996-1997%29%
% 223.27/223.44  |- mesh__publicMeSHNote mesh__D019713
% 223.27/223.44       98; CC CHEMOKINE RECEPTOR 5 %28%now RECEPTORS, CCR5%29% was indexed under RECEPTORS, HIV 1997 %26% RECEPTORS, CYTOKINE 1996-97%A%  
% 223.27/223.44  |- mesh__dateCreated mesh__D019713 1997-06-20
% 223.27/223.44  |- skos__broader mesh__D019713smesh__D019707
% 223.27/223.44  |- mesh__recordMaintainer mesh__D011730 ssb
% 223.27/223.44  |- skos__prefLabel mesh__D011730 Pyridoxal
% 223.27/223.44  |- skos__historyNote mesh__D011730 Pyridoxine %28%1966-1971%29%
% 223.27/223.44  |- mesh__dateEstablished mesh__D011730 1974-01-01
% 223.27/223.44  |- skos__historyNote mesh__D011730 Picolines %28%1966-1971%29%
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D011730 2006
% 223.27/223.44  |- skos__scopeNote mesh__D011730
% 223.27/223.44       The 4-carboxyaldehyde form of VITAMIN B 6 which is converted to PYRIDOXAL PHOSPHATE which is a coenzyme for synthesis of amino acids, neurotransmitters %28%serotonin, norepinephrine%29%, sphingolipids, aminolevulinic acid.%A%    
% 223.27/223.44  |- mesh__dateRevised mesh__D011730 2005-06-30
% 223.27/223.44  |- mesh__historyNote mesh__D011730 74%28%72%29%   
% 223.27/223.44  |- rdf__type mesh__D011730sskos__Concept
% 223.27/223.44  |- skos__annotation mesh__D011730
% 223.27/223.44       deficiency: coordinate PYRIDOXAL /defic %28%IM%29% with VITAMIN B 6 DEFICIENCY %28%IM%29%%A%  
% 223.27/223.44  |- mesh__recordOriginator mesh__D011730 NLM
% 223.27/223.44  |- mesh__publicMeSHNote mesh__D011730 74   
% 223.27/223.44  |- skos__broader mesh__D011730smesh__D025101
% 223.27/223.44  |- mesh__dateCreated mesh__D011730 1999-01-01
% 223.27/223.44  |- mesh__recordAuthorizer mesh__D011730 sjn
% 223.27/223.44  |- mesh__dateEstablished mesh__D010638 1974-01-01
% 223.27/223.44  |- skos__scopeNote mesh__D010638
% 223.27/223.44       A narcotic analgesic partly metabolized to meperidine in the liver. It is similar to morphine in action and used for neuroleptanalgesia, usually with droperidol.%A%    
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D010638 2004
% 223.27/223.44  |- mesh__recordOriginator mesh__D010638 NLM
% 223.27/223.44  |- mesh__recordMaintainer mesh__D010638 TWD
% 223.27/223.44  |- skos__broader mesh__D010638smesh__D007540
% 223.27/223.44  |- mesh__historyNote mesh__D010638 74%28%64%29%   
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D010638 2006
% 223.27/223.44  |- mesh__publicMeSHNote mesh__D010638 74   
% 223.27/223.44  |- skos__prefLabel mesh__D010638 Phenoperidine
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D010638 2003
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D010638 2005
% 223.27/223.44  |- skos__hiddenLabel mesh__D010638 R 1406
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D010638 2002
% 223.27/223.44  |- skos__hiddenLabel mesh__D010638 R1406
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D010638 2001
% 223.27/223.44  |- mesh__dateRevised mesh__D010638 2000-06-22
% 223.27/223.44  |- skos__hiddenLabel mesh__D010638 Hydrochloride, Phenoperidine
% 223.27/223.44  |- mesh__recordAuthorizer mesh__D010638 sjn
% 223.27/223.44  |- rdf__type mesh__D010638sskos__Concept
% 223.27/223.44  |- mesh__dateCreated mesh__D010638 1999-01-01
% 223.27/223.44  |- skos__altLabel mesh__D010638 Fenoperidine
% 223.27/223.44  |- mesh__publicMeSHNote mesh__D015323 89   
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D015323 2003
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D015323 2005
% 223.27/223.44  |- skos__annotation mesh__D015323
% 223.27/223.44       an inborn error of carbohydrate metab; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: PYRUVATE METAB INBORN ERR%A%  
% 223.27/223.44  |- skos__scopeNote mesh__D015323
% 223.27/223.44       Hereditary disorders of pyruvate metabolism. They are difficult to diagnose and describe because pyruvate is a key intermediate in glycolysis, gluconeogenesis, and the tricarboxylic acid cycle. Some inherited metabolic disorders may alter pyruvate metabolism indirectly. Disorders in pyruvate metabolism appear to lead to deficiencies in neurotransmitter synthesis and, consequently, to nervous system disorders.%A%    
% 223.27/223.44  |- skos__historyNote mesh__D015323
% 223.27/223.44       Carbohydrate Metabolism, Inborn Errors %28%1966-1988%29%
% 223.27/223.44  |- rdf__type mesh__D015323sskos__Concept
% 223.27/223.44  |- mesh__recordOriginator mesh__D015323 EJB
% 223.27/223.44  |- mesh__dateCreated mesh__D015323 1988-05-31
% 223.27/223.44  |- mesh__historyNote mesh__D015323 89   
% 223.27/223.44  |- skos__historyNote mesh__D015323 Pyruvates %28%1966-1988%29%
% 223.27/223.44  |- mesh__recordMaintainer mesh__D015323 nns
% 223.27/223.44  |- skos__prefLabel mesh__D015323 Pyruvate Metabolism, Inborn Errors
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D015323 2004
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D015323 2002
% 223.27/223.44  |- skos__broader mesh__D015323smesh__D002239
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D015323 2006
% 223.27/223.44  |- mesh__dateEstablished mesh__D015323 1989-01-01
% 223.27/223.44  |- mesh__recordAuthorizer mesh__D015323 sjn
% 223.27/223.44  |- mesh__dateRevised mesh__D015323 2001-07-25
% 223.27/223.44  |- mesh__dateCreated mesh__D001303 1999-01-01
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001303 1999
% 223.27/223.44  |- skos__scopeNote mesh__D001303
% 223.27/223.44       Area of the temporal lobe concerned with hearing.     
% 223.27/223.44  |- rdf__type mesh__D001303sskos__Concept
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001303 2006
% 223.27/223.44  |- mesh__publicMeSHNote mesh__D001303 70   
% 223.27/223.44  |- skos__annotation mesh__D001303
% 223.27/223.44       dis: coord NIM with AUDITORY DISEASES, CENTRAL %28%IM%29%   
% 223.27/223.44  |- skos__prefLabel mesh__D001303 Auditory Cortex
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001303 2002
% 223.27/223.44  |- skos__related mesh__D001303smesh__D001304
% 223.27/223.44  |- mesh__dateRevised mesh__D001303 1998-06-10
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001303 2005
% 223.27/223.44  |- mesh__recordOriginator mesh__D001303 NLM
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001303 2001
% 223.27/223.44  |- skos__broader mesh__D001303smesh__D013702
% 223.27/223.44  |- skos__hiddenLabel mesh__D001303 Cortex, Auditory
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001303 2004
% 223.27/223.44  |- mesh__recordAuthorizer mesh__D001303 SJN
% 223.27/223.44  |- mesh__recordMaintainer mesh__D001303 MSR
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001303 2000
% 223.27/223.44  |- skos__historyNote mesh__D001303 Hearing %28%1966-1967%29%
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D001303 2003
% 223.27/223.44  |- skos__historyNote mesh__D001303 Cerebral Cortex %28%1966-1967%29%
% 223.27/223.44  |- mesh__historyNote mesh__D001303 70%28%68%29%   
% 223.27/223.44  |- mesh__dateEstablished mesh__D001303 1970-01-01
% 223.27/223.44  |- mesh__recordMaintainer mesh__D006597 ssb
% 223.27/223.44  |- skos__altLabel mesh__D006597
% 223.27/223.44       D-Fructose-1,6-Bisphosphate 1-Phosphohydrolase
% 223.27/223.44  |- skos__scopeNote mesh__D006597
% 223.27/223.44       An enzyme that catalyzes the conversion of D-fructose 1,6-bisphosphate and water to D-fructose 6-phosphate and orthophosphate. EC 3.1.3.11.%A%    
% 223.27/223.44  |- skos__hiddenLabel mesh__D006597 Fructose 1,6 Bisphosphatase
% 223.27/223.44  |- mesh__dateCreated mesh__D006597 1999-01-01
% 223.27/223.44  |- skos__altLabel mesh__D006597 FDPase
% 223.27/223.44  |- mesh__onlineNote mesh__D006597
% 223.27/223.44       use FRUCTOSE-BISPHOSPHATASE to search FRUCTOSE-1,6-DIPHOSPHATASE 1989-93 %26% HEXOSEDIPHOSPHATASE 1966-88%A%  
% 223.27/223.44  |- skos__hiddenLabel mesh__D006597
% 223.27/223.44       1-Phosphohydrolase, D-Fructose-1,6-Bisphosphate
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D006597 2004
% 223.27/223.44  |- skos__hiddenLabel mesh__D006597 Fructose 1,6 Biphosphatase
% 223.27/223.44  |- mesh__publicMeSHNote mesh__D006597
% 223.27/223.44       94; was FRUCTOSE-1,6-DIPHOSPHATASE 1989-93; was HEXOSEDIPHOSPHATASE 1965-88%A%  
% 223.27/223.44  |- skos__prefLabel mesh__D006597 Fructose-Bisphosphatase
% 223.27/223.44  |- skos__hiddenLabel mesh__D006597
% 223.27/223.44       D Fructose 1,6 Bisphosphate 1 Phosphohydrolase
% 223.27/223.44  |- skos__altLabel mesh__D006597 Fructose-1,6-Diphosphatase
% 223.27/223.44  |- mesh__recordAuthorizer mesh__D006597 sjn
% 223.27/223.44  |- skos__hiddenLabel mesh__D006597 Fructose Bisphosphatase
% 223.27/223.44  |- rdf__type mesh__D006597sskos__Concept
% 223.27/223.44  |- skos__altLabel mesh__D006597 Fructose-1,6-Bisphosphatase
% 223.27/223.44  |- mesh__recordOriginator mesh__D006597 NLM
% 223.27/223.44  |- skos__hiddenLabel mesh__D006597 Fructose 1,6 Diphosphatase
% 223.27/223.44  |- mesh__dateRevised mesh__D006597 2003-07-09
% 223.27/223.44  |- mesh__dateEstablished mesh__D006597 1965-01-01
% 223.27/223.44  |- mesh__activeMeSHYear mesh__D006597 2005
% 223.27/223.44  |- skos__altLabel mesh__D006597 Hexosediphosphatase
% 223.27/223.45  |- skos__broader mesh__D006597smesh__D010744
% 223.27/223.45  |- mesh__historyNote mesh__D006597
% 223.27/223.45       94; was FRUCTOSE-1,6-DIPHOSPHATASE 1989-93; was HEXOSEDIPHOSPHATASE 1965-88%A%  
% 223.27/223.45  |- skos__altLabel mesh__D006597 Fructosediphosphatase
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D006597 2006
% 223.27/223.45  |- skos__altLabel mesh__D006597 Fructose-1,6-Biphosphatase
% 223.27/223.45  |- skos__altLabel mesh__D020268 Ethyl Alcohol Abuse Neurologic Syndromes
% 223.27/223.45  |- skos__altLabel mesh__D020268 Ethanol-Induced Disorders, Nervous System
% 223.27/223.45  |- skos__altLabel mesh__D020268 Nervous System Disorders, Ethanol-Induced
% 223.27/223.45  |- mesh__dateCreated mesh__D020268 1999-11-03
% 223.27/223.45  |- skos__historyNote mesh__D020268 Alcoholism %28%1966-1999%29%
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D020268 2002
% 223.27/223.45  |- skos__hiddenLabel mesh__D020268
% 223.27/223.45       Nervous System Disorders, Ethanol Induced
% 223.27/223.45  |- mesh__publicMeSHNote mesh__D020268 2000   
% 223.27/223.45  |- rdf__type mesh__D020268sskos__Concept
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D020268 2005
% 223.27/223.45  |- skos__altLabel mesh__D020268 Alcohol Abuse, Nervous System
% 223.27/223.45  |- skos__altLabel mesh__D020268 Ethanol Induced Nervous System Disorders
% 223.27/223.45  |- skos__broader mesh__D020268smesh__D020258
% 223.27/223.45  |- mesh__dateEstablished mesh__D020268 2000-01-01
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D020268 2006
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D020268 2000
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D020268 2003
% 223.27/223.45  |- skos__altLabel mesh__D020268 Ethanol-Induced Nervous System Disorders
% 223.27/223.45  |- skos__prefLabel mesh__D020268 Alcohol-Induced Disorders, Nervous System
% 223.27/223.45  |- skos__hiddenLabel mesh__D020268
% 223.27/223.45       Ethanol Induced Disorders, Nervous System
% 223.27/223.45  |- mesh__historyNote mesh__D020268 2000   
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D020268 2001
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D020268 2004
% 223.27/223.45  |- skos__broader mesh__D020268smesh__D020751
% 223.27/223.45  |- skos__scopeNote mesh__D020268
% 223.27/223.45       Acute and chronic neurologic disorders associated with the various neurologic effects of ETHANOL. Primary sites of injury include the brain and peripheral nerves.%A%    
% 223.27/223.45  |- skos__hiddenLabel mesh__D020268
% 223.27/223.45       Alcohol Induced Disorders, Nervous System
% 223.27/223.45  |- mesh__recordAuthorizer mesh__D019714 ags
% 223.27/223.45  |- rdf__type mesh__D019714sskos__Concept
% 223.27/223.45  |- skos__hiddenLabel mesh__D019714 Metalloproteinases Tissue Inhibitor
% 223.27/223.45  |- mesh__historyNote mesh__D019714
% 223.27/223.45       98; see TISSUE INHIBITOR OF METALLOPROTEINASES %28%NM%29% 1980-97%A%  
% 223.27/223.45  |- mesh__dateCreated mesh__D019714 1997-06-20
% 223.27/223.45  |- skos__scopeNote mesh__D019714
% 223.27/223.45       A family of secreted proteins %28%TIMP-1; TIMP-2; and TIMP-3%29% that play a crucial role in regulating the activity of the secreted METALLOENDOPEPTIDASES; %28%COLLAGENASES; stromelysins; GELATINASES%29%. Of the three characterized, only TIMP-1 and TIMP-2 appear to have related primary structures and inhibitory properties. They influence the activation of the prometalloproteinase and act to modulate proteolysis of extracellular matrix, notably during tissue remodeling and inflammatory processes. On certain cell types, they can exhibit growth factor-like activity, and they can inhibit the tumorigenic and metastatic phenotype in cancer cells. %28%Pharmacol Ther 1993;59:329-41%29%%A%    
% 223.27/223.45  |- skos__broader mesh__D019714smesh__D011506
% 223.27/223.45  |- mesh__dateEstablished mesh__D019714 1998-01-01
% 223.27/223.45  |- skos__annotation mesh__D019714
% 223.27/223.45       a family of protease inhibitors; GEN or unspecified; prefer specifics; DF: TIMP%A%  
% 223.27/223.45  |- mesh__recordMaintainer mesh__D019714 ags
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D019714 2006A
% 223.27/223.45  |- skos__hiddenLabel mesh__D019714 Inhibitor, Collagenase
% 223.27/223.45  |- skos__historyNote mesh__D019714 Enzyme Inhibitors %28%1989-1997%29%
% 223.27/223.45  |- mesh__publicMeSHNote mesh__D019714
% 223.27/223.45       98; COLLAGENASE INHIBITOR %28%now TISSUE INHIBITOR OF METALLOPROTEINASES%29% was indexed under GLYCOPROTEINS 1989-97 %26% ENZYME INHIBITORS 1980-90%A%  
% 223.27/223.45  |- skos__prefLabel mesh__D019714 Tissue Inhibitor of Metalloproteinases
% 223.27/223.45  |- mesh__dateRevised mesh__D019714 2005-07-20
% 223.27/223.45  |- mesh__recordOriginator mesh__D019714 ADP
% 223.27/223.45  |- skos__altLabel mesh__D019714 TIMP
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D019714 2006
% 223.27/223.45  |- skos__historyNote mesh__D019714 Glycoproteins %28%1980-1990%29%
% 223.27/223.45  |- mesh__dateEstablished mesh__D011731 1991-01-01
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D011731 2005
% 223.27/223.45  |- skos__hiddenLabel mesh__D011731 Phosphokinase, Pyridoxal
% 223.27/223.45  |- mesh__historyNote mesh__D011731
% 223.27/223.45       91%28%79%29%; was see under PHOSPHOTRANSFERASES, ATP 1979-90   
% 223.27/223.45  |- rdf__type mesh__D011731sskos__Concept
% 223.27/223.45  |- skos__broader mesh__D011731smesh__D017853
% 223.27/223.45  |- skos__historyNote mesh__D011731 Pyridoxal %28%1972-1978%29%
% 223.27/223.45  |- skos__prefLabel mesh__D011731 Pyridoxal Kinase
% 223.27/223.45  |- mesh__dateRevised mesh__D011731 2003-07-09
% 223.27/223.45  |- skos__hiddenLabel mesh__D011731 Kinase, Pyridoxamine
% 223.27/223.45  |- mesh__recordAuthorizer mesh__D011731 sjn
% 223.27/223.45  |- skos__hiddenLabel mesh__D011731 Kinase, Pyridoxine
% 223.27/223.45  |- skos__altLabel mesh__D011731 Pyridoxal Phosphokinase
% 223.27/223.45  |- mesh__dateCreated mesh__D011731 1977-12-15
% 223.27/223.45  |- mesh__recordMaintainer mesh__D011731 ssb
% 223.27/223.45  |- skos__hiddenLabel mesh__D011731 Kinase, Pyridoxal
% 223.27/223.45  |- skos__scopeNote mesh__D011731
% 223.27/223.45       An enzyme that catalyzes reversibly the phosphorylation of pyridoxal in the presence of ATP with the formation of pyridoxal 5-phosphate and ADP. Pyridoxine, pyridoxamine and various derivatives can also act as acceptors. EC 2.7.1.35.%A%    
% 223.27/223.45  |- mesh__recordOriginator mesh__D011731 RLS
% 223.27/223.45  |- mesh__publicMeSHNote mesh__D011731
% 223.27/223.45       91; was see under PHOSPHOTRANSFERASES, ATP 1979-90   
% 223.27/223.45  |- skos__historyNote mesh__D011731
% 223.27/223.45       Phosphotransferases, ATP %28%1974-1978%29%
% 223.27/223.45  |- skos__altLabel mesh__D011731 Pyridoxamine Kinase
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D011731 2006
% 223.27/223.45  |- skos__historyNote mesh__D011731 Phosphotransferases %28%1966-1973%29%
% 223.27/223.45  |- skos__altLabel mesh__D011731 Pyridoxine Kinase
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D011731 2004
% 223.27/223.45  |- skos__scopeNote mesh__D035381
% 223.27/223.45       Factors that associate with TATA-BOX BINDING FACTOR. Many of them are components of TRANSCRIPTION FACTOR TFIID%A%    
% 223.27/223.45  |- skos__altLabel mesh__D035381 TAF %28%TATA-Associated Factors%29%
% 223.27/223.45  |- rdf__type mesh__D035381sskos__Concept
% 223.27/223.45  |- skos__broader mesh__D035381smesh__D035165
% 223.27/223.45  |- skos__hiddenLabel mesh__D035381 TATA Binding Protein Associated Factors
% 223.27/223.45  |- skos__altLabel mesh__D035381 TBP-Associated Factor
% 223.27/223.45  |- mesh__dateEstablished mesh__D035381 2003-01-01
% 223.27/223.45  |- skos__hiddenLabel mesh__D035381 TBP Associated Factors
% 223.27/223.45  |- mesh__recordMaintainer mesh__D035381 ags
% 223.27/223.45  |- mesh__historyNote mesh__D035381 2003   
% 223.27/223.45  |- skos__hiddenLabel mesh__D035381 TBP Associated Factor
% 223.27/223.45  |- skos__prefLabel mesh__D035381 TATA-Binding Protein Associated Factors
% 223.27/223.45  |- mesh__dateRevised mesh__D035381 2005-06-30
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D035381 2006
% 223.27/223.45  |- mesh__recordAuthorizer mesh__D035381 sjn
% 223.27/223.45  |- mesh__recordOriginator mesh__D035381 jmp
% 223.27/223.45  |- skos__altLabel mesh__D035381 TBP-Associated Factors
% 223.27/223.45  |- mesh__publicMeSHNote mesh__D035381 2003   
% 223.27/223.45  |- mesh__dateCreated mesh__D035381 2002-07-03
% 223.27/223.45  |- skos__hiddenLabel mesh__D007690 Kidney Disease, Polycystic
% 223.27/223.45  |- skos__hiddenLabel mesh__D007690 Renal Diseases, Polycystic
% 223.27/223.45  |- skos__annotation mesh__D007690
% 223.27/223.45       KIDNEY, CYSTIC and MULTICYSTIC DYSPLASTIC KIDNEY are also available; prefer specifics%A%  
% 223.27/223.45  |- mesh__recordAuthorizer mesh__D007690 sjn
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D007690 2006
% 223.27/223.45  |- skos__hiddenLabel mesh__D007690 Disease, Polycystic Renal
% 223.27/223.45  |- skos__altLabel mesh__D007690 Polycystic Renal Disease
% 223.27/223.45  |- skos__hiddenLabel mesh__D007690 Kidneys, Polycystic
% 223.27/223.45  |- skos__hiddenLabel mesh__D007690 Polycystic Renal Diseases
% 223.27/223.45  |- skos__hiddenLabel mesh__D007690 Diseases, Polycystic Kidney
% 223.27/223.45  |- skos__altLabel mesh__D007690 Polycystic Kidney
% 223.27/223.45  |- skos__hiddenLabel mesh__D007690 Renal Disease, Polycystic
% 223.27/223.45  |- mesh__recordOriginator mesh__D007690 NLM
% 223.27/223.45  |- skos__prefLabel mesh__D007690 Polycystic Kidney Diseases
% 223.27/223.45  |- skos__hiddenLabel mesh__D007690 Diseases, Polycystic Renal
% 223.27/223.45  |- mesh__historyNote mesh__D007690 1991   
% 223.27/223.45  |- skos__hiddenLabel mesh__D007690 Polycystic Kidney Disease
% 223.27/223.45  |- skos__scopeNote mesh__D007690
% 223.27/223.45       Hereditary diseases that are characterized by the progressive expansion of a large number of tightly packed CYSTS within the KIDNEYS. They include diseases with autosomal dominant and autosomal recessive inheritance.%A%    
% 223.27/223.45  |- skos__hiddenLabel mesh__D007690 Disease, Polycystic Kidney
% 223.27/223.45  |- rdf__type mesh__D007690sskos__Concept
% 223.27/223.45  |- skos__hiddenLabel mesh__D007690 Kidney Diseases, Polycystic
% 223.27/223.45  |- skos__broader mesh__D007690smesh__D052177
% 223.27/223.45  |- mesh__recordMaintainer mesh__D007690 lkt
% 223.27/223.45  |- mesh__dateCreated mesh__D007690 1999-01-01
% 223.27/223.45  |- mesh__publicMeSHNote mesh__D007690
% 223.27/223.45       1991; see POLYCYSTIC KIDNEY 1991-2000   
% 223.27/223.45  |- skos__hiddenLabel mesh__D007690 Polycystic Kidneys
% 223.27/223.45  |- mesh__dateRevised mesh__D007690 2005-06-30
% 223.27/223.45  |- mesh__publicMeSHNote mesh__D021361 2001   
% 223.27/223.45  |- skos__hiddenLabel mesh__D021361 Bone, Scaphoid
% 223.27/223.45  |- skos__altLabel mesh__D021361 Os Naviculare Manus
% 223.27/223.45  |- skos__altLabel mesh__D021361 Os Scaphoideum
% 223.27/223.45  |- skos__hiddenLabel mesh__D021361 Hand Navicular Bone
% 223.27/223.45  |- mesh__historyNote mesh__D021361 2001   
% 223.27/223.45  |- mesh__dateCreated mesh__D021361 2000-06-22
% 223.27/223.45  |- skos__scopeNote mesh__D021361
% 223.27/223.45       The bone which is located most lateral in the proximal row of CARPAL BONES.%A%    
% 223.27/223.45  |- skos__prefLabel mesh__D021361 Scaphoid Bone
% 223.27/223.45  |- mesh__dateEstablished mesh__D021361 2001-01-01
% 223.27/223.45  |- rdf__type mesh__D021361sskos__Concept
% 223.27/223.45  |- skos__hiddenLabel mesh__D021361 Bones, Scaphoid
% 223.27/223.45  |- mesh__recordOriginator mesh__D021361 nns
% 223.27/223.45  |- skos__hiddenLabel mesh__D021361 Hand Navicular Bones
% 223.27/223.45  |- mesh__dateRevised mesh__D021361 2005-06-30
% 223.27/223.45  |- skos__broader mesh__D021361smesh__D002348
% 223.27/223.45  |- skos__historyNote mesh__D021361 Carpal Bones %28%1972-2000%29%
% 223.27/223.45  |- skos__historyNote mesh__D021361 Wrist Joint %28%1966-1971%29%
% 223.27/223.45  |- skos__altLabel mesh__D021361 Navicular Bone of Hand
% 223.27/223.45  |- skos__historyNote mesh__D021361 Wrist %28%1966-1971%29%
% 223.27/223.45  |- skos__hiddenLabel mesh__D021361 Scaphoid Bones
% 223.27/223.45  |- mesh__recordAuthorizer mesh__D021361 sjn
% 223.27/223.45  |- mesh__recordMaintainer mesh__D021361 ags
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D021361 2006
% 223.27/223.45  |- mesh__dateEstablished mesh__D015324 1991-01-01
% 223.27/223.45  |- skos__altLabel mesh__D015324 Ataxia with Lactic Acidosis, Type II
% 223.27/223.45  |- skos__scopeNote mesh__D015324
% 223.27/223.45       An autosomal recessive metabolic disorder caused by absent or decreased PYRUVATE CARBOXYLASE activity, the enzyme that regulates gluconeogenesis, lipogenesis, and neurotransmitter synthesis. Clinical manifestations include lactic acidosis, seizures, respiratory distress, marked psychomotor delay, periodic HYPOGLYCEMIA, and hypotonia. The clinical course may be similar to LEIGH DISEASE. %28%From Am J Hum Genet 1998 Jun;62%28%6%29%:1312-9%29%%A%    
% 223.27/223.45  |- mesh__recordAuthorizer mesh__D015324 sjn
% 223.27/223.45  |- skos__altLabel mesh__D015324 Lactic Acidosis with Ataxia, Type II
% 223.27/223.45  |- rdf__type mesh__D015324sskos__Concept
% 223.27/223.45  |- mesh__historyNote mesh__D015324
% 223.27/223.45       2000%28%1989%29%; use PYRUVATE METABOLISM, INBORN ERRORS 1989-1990%A%  
% 223.27/223.45  |- skos__broader mesh__D015324smesh__D028361
% 223.27/223.45  |- skos__broader mesh__D015324smesh__D020739
% 223.27/223.45  |- skos__broader mesh__D015324smesh__D015323
% 223.27/223.45  |- mesh__publicMeSHNote mesh__D015324
% 223.27/223.45       2000; see PYRUVATE CARBOXYLASE DEFICIENCY 1991-1999; see PYRUVATE METABOLISM, INBORN ERRORS 1989-1990%A%  
% 223.27/223.45  |- skos__altLabel mesh__D015324 Type II Ataxia with Lactic Acidosis
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D015324 2003
% 223.27/223.45  |- mesh__recordOriginator mesh__D015324 EJB
% 223.27/223.45  |- mesh__dateCreated mesh__D015324 1988-06-01
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D015324 2005
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D015324 2004
% 223.27/223.45  |- mesh__recordMaintainer mesh__D015324 nns
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D015324 2002
% 223.27/223.45  |- skos__altLabel mesh__D015324 Deficiency Disease, Pyruvate Carboxylase
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D015324 2006
% 223.27/223.45  |- skos__historyNote mesh__D015324
% 223.27/223.45       Pyruvate Carboxylase/deficiency %28%1974-1988%29%
% 223.27/223.45  |- mesh__dateRevised mesh__D015324 2001-07-25
% 223.27/223.45  |- skos__prefLabel mesh__D015324 Pyruvate Carboxylase Deficiency Disease
% 223.27/223.45  |- skos__hiddenLabel mesh__D001304 Central Auditory Disease
% 223.27/223.45  |- skos__hiddenLabel mesh__D001304 Auditory Cortex Disorders
% 223.27/223.45  |- skos__altLabel mesh__D001304 Central Auditory Pathway Disorders
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D001304 2005
% 223.27/223.45  |- skos__broader mesh__D001304smesh__D001927
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D001304 2000
% 223.27/223.45  |- mesh__recordOriginator mesh__D001304 RC
% 223.27/223.45  |- skos__hiddenLabel mesh__D001304 Dysfunctions, Central Auditory
% 223.27/223.45  |- skos__broader mesh__D001304smesh__D012181
% 223.27/223.45  |- skos__annotation mesh__D001304 Coord IM with site %28%IM%29%   
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D001304 2004
% 223.27/223.45  |- mesh__historyNote mesh__D001304 1980   
% 223.27/223.45  |- skos__altLabel mesh__D001304 Auditory Dysfunction, Central
% 223.27/223.45  |- skos__hiddenLabel mesh__D001304 Cortex Disorder, Auditory
% 223.27/223.45  |- skos__hiddenLabel mesh__D001304 Cortex Disorders, Auditory
% 223.27/223.45  |- skos__altLabel mesh__D001304 Central Auditory Diseases
% 223.27/223.45  |- skos__altLabel mesh__D001304 Auditory Pathway Disorders, Central
% 223.27/223.45  |- mesh__dateEstablished mesh__D001304 1980-01-01
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D001304 2003
% 223.27/223.45  |- skos__scopeNote mesh__D001304
% 223.27/223.45       Disorders of hearing or auditory perception resulting from disease of the central auditory pathways or auditory association cortical areas. These include HEARING LOSS, CENTRAL; cortical deafness; and AUDITORY PERCEPTUAL DISORDERS. Above the level of the pons, bilateral lesions are usually required to produce auditory dysfunction.%A%    
% 223.27/223.45  |- mesh__recordMaintainer mesh__D001304 KEV
% 223.27/223.45  |- mesh__dateCreated mesh__D001304 1978-12-22
% 223.27/223.45  |- mesh__publicMeSHNote mesh__D001304 1980   
% 223.27/223.45  |- skos__hiddenLabel mesh__D001304 Auditory Disease, Central
% 223.27/223.45  |- skos__hiddenLabel mesh__D001304 Central Auditory Dysfunction
% 223.27/223.45  |- mesh__recordAuthorizer mesh__D001304 sjn
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D001304 2002
% 223.27/223.45  |- rdf__type mesh__D001304sskos__Concept
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D001304 2006
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D001304 2001
% 223.27/223.45  |- mesh__dateRevised mesh__D001304 1999-11-03
% 223.27/223.45  |- skos__prefLabel mesh__D001304 Auditory Diseases, Central
% 223.27/223.45  |- skos__hiddenLabel mesh__D001304 Dysfunction, Central Auditory
% 223.27/223.45  |- mesh__dateCreated mesh__D006598 1999-01-01
% 223.27/223.45  |- mesh__recordMaintainer mesh__D006598 ssb
% 223.27/223.45  |- rdf__type mesh__D006598sskos__Concept
% 223.27/223.45  |- mesh__historyNote mesh__D006598 73   
% 223.27/223.45  |- mesh__dateEstablished mesh__D006598 1973-01-01
% 223.27/223.45  |- skos__historyNote mesh__D006598 Hexosephosphates %28%1966-1972%29%
% 223.27/223.45  |- mesh__publicMeSHNote mesh__D006598 73   
% 223.27/223.45  |- skos__broader mesh__D006598smesh__D006600
% 223.27/223.45  |- mesh__dateRevised mesh__D006598 2004-07-07
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D006598 2005
% 223.27/223.45  |- mesh__recordAuthorizer mesh__D006598 sjn
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D006598 2006
% 223.27/223.45  |- mesh__recordOriginator mesh__D006598 NLM
% 223.27/223.45  |- skos__prefLabel mesh__D006598 Hexosediphosphates
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269
% 223.27/223.45       Autonomic Polyneuropathies, Alcohol-Related
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Alcohol Related Polyneuropathy
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Alcoholic Polyneuritis
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Alcoholic Polyneuritides
% 223.27/223.45  |- mesh__dateEstablished mesh__D020269 2000-01-01
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Alcoholic Polyneuropathy
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D020269 2003
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269
% 223.27/223.45       Polyneuropathies, Alcohol-Related Autonomic
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269
% 223.27/223.45       Polyneuropathy, Alcohol-Related Autonomic
% 223.27/223.45  |- skos__altLabel mesh__D020269 Polyneuropathy, Alcoholic
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Polyneuropathy, Alcohol-Related
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Alcohol-Related Polyneuropathies
% 223.27/223.45  |- skos__altLabel mesh__D020269 Alcohol-Related Polyneuropathy
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269
% 223.27/223.45       Alcohol-Related Autonomic Polyneuropathies
% 223.27/223.45  |- mesh__publicMeSHNote mesh__D020269 2000   
% 223.27/223.45  |- skos__altLabel mesh__D020269 Alcohol-Related Autonomic Polyneuropathy
% 223.27/223.45  |- skos__historyNote mesh__D020269
% 223.27/223.45       Alcoholism/complications %28%1966-1999%29%
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Polyneuropathy, Alcohol-Induced
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D020269 2001
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D020269 2006
% 223.27/223.45  |- mesh__dateCreated mesh__D020269 1999-11-03
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Alcohol Induced Polyneuropathy
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Alcoholic Axonal Neuropathies
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Peripheral Neuropathy, Alcohol Induced
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Neuropathies, Alcoholic
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Polyneuropathies, Alcohol-Related
% 223.27/223.45  |- rdf__type mesh__D020269sskos__Concept
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Alcohol Induced Peripheral Neuropathy
% 223.27/223.45  |- skos__altLabel mesh__D020269 Peripheral Neuropathy, Alcohol-Induced
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D020269 2000
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Polyneuropathies, Alcohol-Induced
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D020269 2005
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Alcohol-Induced Polyneuropathies
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Polyneuropathies, Alcoholic
% 223.27/223.45  |- skos__altLabel mesh__D020269 Alcohol-Induced Polyneuropathy
% 223.27/223.45  |- skos__altLabel mesh__D020269 Polyneuritis, Alcoholic
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Neuropathy, Alcoholic Axonal
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Alcoholic Polyneuropathies
% 223.27/223.45  |- skos__prefLabel mesh__D020269 Alcoholic Neuropathy
% 223.27/223.45  |- skos__altLabel mesh__D020269 Neuropathy, Alcoholic
% 223.27/223.45  |- skos__historyNote mesh__D020269
% 223.27/223.45       Peripheral Nervous System Diseases/etiology %28%1966-1999%29%
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Neuropathies, Alcoholic Axonal
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Neuropathy, Alcohol-Induced Peripheral
% 223.27/223.45  |- mesh__historyNote mesh__D020269 2000   
% 223.27/223.45  |- skos__broader mesh__D020269smesh__D011115
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Peripheral Neuropathies, Alcohol-Induced
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Alcoholic Neuropathies
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Axonal Neuropathy, Alcoholic
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Axonal Neuropathies, Alcoholic
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Polyneuritides, Alcoholic
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Alcohol Related Autonomic Polyneuropathy
% 223.27/223.45  |- skos__scopeNote mesh__D020269
% 223.27/223.45       A condition where damage to the peripheral nervous system %28%including the peripheral elements of the autonomic nervous system%29% is associated with chronic ingestion of alcoholic beverages. The disorder may be caused by a direct effect of alcohol, an associated nutritional deficiency, or a combination of factors. Clinical manifestations include variable degrees of weakness; ATROPHY; PARESTHESIAS; pain; loss of reflexes; sensory loss; diaphoresis; and postural hypotension. %28%From Arch Neurol 1995;52%28%1%29%:45-51; Adams et al., Principles of Neurology, 6th ed, p1146%29%%A%    
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D020269 2004
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Alcohol-Induced Peripheral Neuropathies
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269 Neuropathies, Alcohol-Induced Peripheral
% 223.27/223.45  |- skos__broader mesh__D020269smesh__D020268
% 223.27/223.45  |- skos__hiddenLabel mesh__D020269
% 223.27/223.45       Autonomic Polyneuropathy, Alcohol-Related
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D020269 2002
% 223.27/223.45  |- skos__altLabel mesh__D020269 Alcohol-Induced Peripheral Neuropathy
% 223.27/223.45  |- rdf__type mesh__D019715sskos__Concept
% 223.27/223.45  |- mesh__recordOriginator mesh__D019715 ADP
% 223.27/223.45  |- mesh__dateRevised mesh__D019715 2005-06-30
% 223.27/223.45  |- mesh__publicMeSHNote mesh__D019715
% 223.27/223.45       98; COLLAGENASE INHIBITOR %28%now TISSUE-INHIBITOR OF METALLOPROTEINASE-1%29% was indexed under GLYCOPROTEINS 1990-97%A%  
% 223.27/223.45  |- mesh__historyNote mesh__D019715
% 223.27/223.45       98; see TISSUE-INHIBITOR OF METALLOPROTEINASE-1 %28%NM%29% 1980-97%A%  
% 223.27/223.45  |- skos__hiddenLabel mesh__D019715 Metalloproteinase-1 Tissue Inhibitor
% 223.27/223.45  |- skos__hiddenLabel mesh__D019715 Tissue Inhibitor of Metalloproteinase 1
% 223.27/223.45  |- skos__altLabel mesh__D019715 TIMP-1
% 223.27/223.45  |- skos__broader mesh__D019715smesh__D019714
% 223.27/223.45  |- skos__scopeNote mesh__D019715
% 223.27/223.45       A member of the family of TISSUE INHIBITOR OF METALLOPROTEINASES. It is a N-glycosylated protein, molecular weight 28 kD, produced by a vast range of cell types and found in a variety of tissues and body fluids. It has been shown to suppress metastasis and inhibit tumor invasion in vitro.%A%    
% 223.27/223.45  |- skos__annotation mesh__D019715 DF: note short X ref   
% 223.27/223.45  |- mesh__dateCreated mesh__D019715 1997-06-20
% 223.27/223.45  |- skos__historyNote mesh__D019715 Glycoproteins %28%1990-1997%29%
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D019715 2006
% 223.27/223.45  |- mesh__recordMaintainer mesh__D019715 SYSTEM
% 223.27/223.45  |- mesh__dateEstablished mesh__D019715 1998-01-01
% 223.27/223.45  |- mesh__recordAuthorizer mesh__D019715 sjn
% 223.27/223.45  |- skos__prefLabel mesh__D019715 Tissue Inhibitor of Metalloproteinase-1
% 223.27/223.45  |- skos__hiddenLabel mesh__D011732 Pyridoxal P
% 223.27/223.45  |- skos__hiddenLabel mesh__D011732 Phosphate, Pyridoxal
% 223.27/223.45  |- skos__broader mesh__D011732smesh__D011730
% 223.27/223.45  |- mesh__dateRevised mesh__D011732 2005-06-30
% 223.27/223.45  |- skos__altLabel mesh__D011732 Pyridoxal 5-Phosphate
% 223.27/223.45  |- skos__altLabel mesh__D011732 Pyridoxal-P
% 223.27/223.45  |- mesh__recordOriginator mesh__D011732 NLM
% 223.27/223.45  |- skos__broader mesh__D011732smesh__D003067
% 223.27/223.45  |- mesh__dateCreated mesh__D011732 1999-01-01
% 223.27/223.45  |- mesh__recordAuthorizer mesh__D011732 sjn
% 223.27/223.45  |- skos__annotation mesh__D011732
% 223.27/223.45       deficiency: coordinate PYRIDOXAL PHOSPHATE /defic %28%IM%29% with VITAMIN B 6 DEFICIENCY %28%IM%29%%A%  
% 223.27/223.45  |- skos__scopeNote mesh__D011732
% 223.27/223.45       This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters %28%serotonin, norepinephrine%29%, sphingolipids, aminolevulinic acid.  During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate %28%PYRIDOXAMINE%29%.%A%    
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D011732 2006
% 223.27/223.45  |- mesh__recordMaintainer mesh__D011732 ssb
% 223.27/223.45  |- skos__hiddenLabel mesh__D011732 Pyridoxal 5 Phosphate
% 223.27/223.45  |- skos__prefLabel mesh__D011732 Pyridoxal Phosphate
% 223.27/223.45  |- rdf__type mesh__D011732sskos__Concept
% 223.27/223.45  |- skos__broader mesh__D007691smesh__D052177
% 223.27/223.45  |- mesh__recordMaintainer mesh__D007691 lkt
% 223.27/223.45  |- skos__scopeNote mesh__D007691
% 223.27/223.45       A non-hereditary KIDNEY disorder characterized by the abnormally dilated %28%ECTASIA%29% medullary and inner papillary portions of the collecting ducts. These collecting ducts usually contain CYSTS or DIVERTICULA filled with jelly-like material or small calculi %28%KIDNEY STONES%29% leading to infections or obstruction. It should be distinguished from congenital or hereditary POLYCYSTIC KIDNEY DISEASES.%A%    
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D007691 2006
% 223.27/223.45  |- mesh__dateRevised mesh__D007691 2005-06-30
% 223.27/223.45  |- skos__altLabel mesh__D007691 Kidney, Sponge
% 223.27/223.45  |- mesh__publicMeSHNote mesh__D007691 2006; see KIDNEY, SPONGE 1965-2005   
% 223.27/223.45  |- skos__prefLabel mesh__D007691 Medullary Sponge Kidney
% 223.27/223.45  |- skos__hiddenLabel mesh__D007691 Sponge Kidneys
% 223.27/223.45  |- mesh__recordAuthorizer mesh__D007691 sjn
% 223.27/223.45  |- rdf__type mesh__D007691sskos__Concept
% 223.27/223.45  |- skos__hiddenLabel mesh__D007691 Medullary Sponge Kidneys
% 223.27/223.45  |- skos__hiddenLabel mesh__D007691 Kidneys, Sponge
% 223.27/223.45  |- skos__hiddenLabel mesh__D007691 Sponge Kidney, Medullary
% 223.27/223.45  |- skos__hiddenLabel mesh__D007691 Sponge Kidneys, Medullary
% 223.27/223.45  |- mesh__dateCreated mesh__D007691 1999-01-01
% 223.27/223.45  |- mesh__dateEstablished mesh__D007691 1965-01-01
% 223.27/223.45  |- mesh__recordOriginator mesh__D007691 NLM
% 223.27/223.45  |- skos__hiddenLabel mesh__D007691 Sponge Kidney
% 223.27/223.45  |- mesh__historyNote mesh__D007691 2006 %28%1965%29%   
% 223.27/223.45  |- skos__broader mesh__D021362smesh__D007568
% 223.27/223.45  |- mesh__dateEstablished mesh__D021362 2001-01-01
% 223.27/223.45  |- skos__hiddenLabel mesh__D021362 Bone, Palatine
% 223.27/223.45  |- skos__scopeNote mesh__D021362
% 223.27/223.45       The anteriorly located rigid section of the PALATE.     
% 223.27/223.45  |- rdf__type mesh__D021362sskos__Concept
% 223.27/223.45  |- skos__altLabel mesh__D021362 Hard Palate
% 223.27/223.45  |- mesh__dateRevised mesh__D021362 2003-07-09
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D021362 2004
% 223.27/223.45  |- skos__hiddenLabel mesh__D021362 Hard Palates
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D021362 2005
% 223.27/223.45  |- skos__prefLabel mesh__D021362 Palate, Hard
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D021362 2006
% 223.27/223.45  |- skos__hiddenLabel mesh__D021362 Palates, Hard
% 223.27/223.45  |- mesh__historyNote mesh__D021362 2001; use PALATE 1998-2000   
% 223.27/223.45  |- skos__broader mesh__D021362smesh__D010159
% 223.27/223.45  |- skos__historyNote mesh__D021362 Palate %28%1966-2000%29%
% 223.27/223.45  |- mesh__publicMeSHNote mesh__D021362 2001; see PALATE 1998-2000   
% 223.27/223.45  |- mesh__dateCreated mesh__D021362 2000-06-22
% 223.27/223.45  |- mesh__recordAuthorizer mesh__D015325 ags
% 223.27/223.45  |- skos__broader mesh__D015325smesh__D038901
% 223.27/223.45  |- skos__related mesh__D015325smesh__D011768
% 223.27/223.45  |- rdf__type mesh__D015325sskos__Concept
% 223.27/223.45  |- skos__altLabel mesh__D015325
% 223.27/223.45       Pyruvate Dehydrogenase Complex Deficiency Disease, Juvenile
% 223.27/223.45  |- skos__altLabel mesh__D015325 Type I Ataxia with Lactic Acidosis
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D015325 2006A
% 223.27/223.45  |- skos__broader mesh__D015325smesh__D020739
% 223.27/223.45  |- skos__broader mesh__D015325smesh__D015323
% 223.27/223.45  |- skos__related mesh__D015325smesh__D007888
% 223.27/223.45  |- skos__hiddenLabel mesh__D015325 Deficiency Diseases, PDHC
% 223.27/223.45  |- skos__historyNote mesh__D015325
% 223.27/223.45       Pyruvate Dehydrogenase Complex/deficiency %28%1974-1988%29%
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D015325 2003
% 223.27/223.45  |- mesh__dateCreated mesh__D015325 1988-06-01
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D015325 2005
% 223.27/223.45  |- mesh__historyNote mesh__D015325
% 223.27/223.45       2000%28%1989%29%; use PYRUVATE METABOLISM, INBORN ERRORS 1989-1990%A%  
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D015325 2004
% 223.27/223.45  |- skos__prefLabel mesh__D015325
% 223.27/223.45       Pyruvate Dehydrogenase Complex Deficiency Disease
% 223.27/223.45  |- mesh__recordMaintainer mesh__D015325 ags
% 223.27/223.45  |- skos__hiddenLabel mesh__D015325 Deficiency Disease, PDHC
% 223.27/223.45  |- skos__broader mesh__D015325smesh__D028361
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D015325 2006
% 223.27/223.45  |- mesh__publicMeSHNote mesh__D015325
% 223.27/223.45       2000; see PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY 1991-1999; see PYRUVATE METABOLISM, INBORN ERRORS 1989-1990%A%  
% 223.27/223.45  |- mesh__dateRevised mesh__D015325 2005-07-08
% 223.27/223.45  |- skos__scopeNote mesh__D015325
% 223.27/223.45       An inherited metabolic disorder caused by deficient enzyme activity in the PYRUVATE DEHYDROGENASE COMPLEX, resulting in deficiency of acetyl CoA and reduced synthesis of acetylcholine. Two clinical forms are recognized: neonatal and juvenile. The neonatal form is a relatively common cause of lactic acidosis in the first weeks of life and may also feature an erythematous rash. The juvenile form presents with lactic acidosis, alopecia, intermittent ATAXIA; SEIZURES; and an erythematous rash. %28%From J Inherit Metab Dis 1996;19%28%4%29%:452-62%29% Autosomal recessive and X-linked forms are caused by mutations in the genes for the three different enzyme components of this multisubunit pyruvate dehydrogenase complex. One of the mutations at Xp22.2-p22.1 in the gene for the E1 alpha component of the complex leads to LEIGH DISEASE.%A%    
% 223.27/223.45  |- skos__hiddenLabel mesh__D015325 PDHC Deficiency Diseases
% 223.27/223.45  |- mesh__recordOriginator mesh__D015325 EJB
% 223.27/223.45  |- skos__altLabel mesh__D015325
% 223.27/223.45       Neonatal Pyruvate Dehydrogenase Complex Deficiency Disease
% 223.27/223.45  |- skos__altLabel mesh__D015325 PDHC Deficiency Disease
% 223.27/223.45  |- mesh__dateEstablished mesh__D015325 1991-01-01
% 223.27/223.45  |- skos__altLabel mesh__D015325 Lactic Acidosis with Ataxia, Type I
% 223.27/223.45  |- skos__annotation mesh__D015325 DF: PDHC DEFIC DIS   
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D001305 2004
% 223.27/223.45  |- skos__scopeNote mesh__D001305
% 223.27/223.45       Loss of sensitivity to sounds as a result of auditory stimulation, manifesting as a temporary shift in auditory threshold. The temporary threshold shift, TTS, is expressed in decibels.%A%    
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D001305 2001
% 223.27/223.45  |- mesh__publicMeSHNote mesh__D001305 80   
% 223.27/223.45  |- mesh__dateEstablished mesh__D001305 1980-01-01
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D001305 2003
% 223.27/223.45  |- skos__historyNote mesh__D001305 Auditory Threshold %28%1968-1979%29%
% 223.27/223.45  |- skos__hiddenLabel mesh__D001305 Auditory Fatigues
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D001305 1995
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D001305 2000
% 223.27/223.45  |- skos__historyNote mesh__D001305 Hearing %28%1966-1967%29%
% 223.27/223.45  |- skos__hiddenLabel mesh__D001305 Fatigues, Auditory
% 223.27/223.45  |- mesh__dateCreated mesh__D001305 1978-12-14
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D001305 1999
% 223.27/223.45  |- skos__prefLabel mesh__D001305 Auditory Fatigue
% 223.27/223.45  |- mesh__recordAuthorizer mesh__D001305 PLS
% 223.27/223.45  |- mesh__activeMeSHYear mesh__D001305 1998
% 223.27/223.46  |- rdf__type mesh__D001305sskos__Concept
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001305 2006
% 223.27/223.46  |- mesh__dateRevised mesh__D001305 1994-05-12
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001305 1997
% 223.27/223.46  |- skos__historyNote mesh__D001305 Fatigue %28%1966-1979%29%
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001305 2005
% 223.27/223.46  |- skos__broader mesh__D001305smesh__D001309
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001305 1996
% 223.27/223.46  |- mesh__recordOriginator mesh__D001305 RC
% 223.27/223.46  |- skos__altLabel mesh__D001305 Fatigue, Auditory
% 223.27/223.46  |- mesh__recordMaintainer mesh__D001305 PXP
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001305 2002
% 223.27/223.46  |- mesh__historyNote mesh__D001305 80   
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D006599 2006
% 223.27/223.46  |- skos__historyNote mesh__D006599
% 223.27/223.46       Uridine Diphosphate Sugars %28%1970-1974%29%
% 223.27/223.46  |- skos__altLabel mesh__D006599 Uridyl Transferase
% 223.27/223.46  |- mesh__dateEstablished mesh__D006599 1991-01-01
% 223.27/223.46  |- mesh__recordAuthorizer mesh__D006599 sjn
% 223.27/223.46  |- skos__related mesh__D006599smesh__D005693
% 223.27/223.46  |- skos__broader mesh__D006599smesh__D009713
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D006599 2005
% 223.27/223.46  |- mesh__dateCreated mesh__D006599 1974-11-19
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D006599 2004
% 223.27/223.46  |- skos__historyNote mesh__D006599 Hexosephosphates %28%1970-1974%29%
% 223.27/223.46  |- mesh__recordMaintainer mesh__D006599 ssb
% 223.27/223.46  |- mesh__recordOriginator mesh__D006599 NLM
% 223.27/223.46  |- skos__hiddenLabel mesh__D006599 Uridylyltransferase, Hexosephosphate
% 223.27/223.46  |- skos__hiddenLabel mesh__D006599 Transferase, Uridyl
% 223.27/223.46  |- skos__hiddenLabel mesh__D006599
% 223.27/223.46       Uridylyltransferase, UDPglucose-Hexose-1-Phosphate
% 223.27/223.46  |- skos__altLabel mesh__D006599 Phosphogalactose Uridyl Transferase
% 223.27/223.46  |- skos__scopeNote mesh__D006599
% 223.27/223.46       An enzyme that catalyzes the transfer of UMP from UDPglucose to galactose 1-phosphate, forming UDPgalactose and glucose 1-phosphate. Deficiency in this enzyme is the major cause of GALACTOSEMIA. EC 2.7.7.12.%A%    
% 223.27/223.46  |- mesh__dateRevised mesh__D006599 2003-07-09
% 223.27/223.46  |- mesh__publicMeSHNote mesh__D006599
% 223.27/223.46       98; see HEXOSEPHOSPHATE URIDYLYLTRANSFERASE 1991-97; see NUCLEOTIDYLTRANSFERASES 1975-90%A%  
% 223.27/223.46  |- rdf__type mesh__D006599sskos__Concept
% 223.27/223.46  |- skos__historyNote mesh__D006599
% 223.27/223.46       Nucleotidyltransferases %28%1970-1974%29%
% 223.27/223.46  |- skos__hiddenLabel mesh__D006599 Galactose 1 P Uridyltransferase
% 223.27/223.46  |- skos__historyNote mesh__D006599 Galactose %28%1970-1974%29%
% 223.27/223.46  |- mesh__historyNote mesh__D006599 98%28%75%29%   
% 223.27/223.46  |- skos__altLabel mesh__D006599 Galactose-1-P-Uridyltransferase
% 223.27/223.46  |- skos__altLabel mesh__D006599 Hexosephosphate Uridylyltransferase
% 223.27/223.46  |- skos__annotation mesh__D006599
% 223.27/223.46       /defic: consider GALACTOSEMIAS; DF: note short X ref   
% 223.27/223.46  |- skos__hiddenLabel mesh__D006599 Transferase, Phosphogalactose Uridyl
% 223.27/223.46  |- skos__hiddenLabel mesh__D006599 Uridyl Transferase, Phosphogalactose
% 223.27/223.46  |- skos__prefLabel mesh__D006599
% 223.27/223.46       UDPglucose-Hexose-1-Phosphate Uridylyltransferase
% 223.27/223.46  |- mesh__recordOriginator mesh__D019716 ADP
% 223.27/223.46  |- skos__historyNote mesh__D019716 Proteins %28%1990-1997%29%
% 223.27/223.46  |- skos__historyNote mesh__D019716 Neoplasm Proteins %28%1989-1993%29%
% 223.27/223.46  |- mesh__publicMeSHNote mesh__D019716
% 223.27/223.46       1998; TISSUE INHIBITOR OF METALLOPROTEINASE 2 was indexed under PROTEINS 1990-97 %26% NEOPLASM PROTEINS 1989-1993%A%  
% 223.27/223.46  |- mesh__dateRevised mesh__D019716 2005-06-30
% 223.27/223.46  |- skos__prefLabel mesh__D019716 Tissue Inhibitor of Metalloproteinase-2
% 223.27/223.46  |- skos__altLabel mesh__D019716 TIMP-2
% 223.27/223.46  |- skos__scopeNote mesh__D019716
% 223.27/223.46       A member of the family of TISSUE INHIBITOR OF METALLOPROTEINASES. It is a 21-kDa nonglycosylated protein found in tissue fluid and is secreted as a complex with progelatinase A by human fibroblast and uncomplexed from alveolar macrophages. An overexpression of TIMP-2 has been shown to inhibit invasive and metastatic activity of tumor cells and decrease tumor growth in vivo.%A%    
% 223.27/223.46  |- skos__annotation mesh__D019716 DF: note short X ref   
% 223.27/223.46  |- mesh__dateEstablished mesh__D019716 1998-01-01
% 223.27/223.46  |- skos__broader mesh__D019716smesh__D019714
% 223.27/223.46  |- skos__hiddenLabel mesh__D019716 Tissue Inhibitor of Metalloproteinase 2
% 223.27/223.46  |- skos__hiddenLabel mesh__D019716 Metalloproteinase-2 Tissue Inhibitor
% 223.27/223.46  |- mesh__recordAuthorizer mesh__D019716 sjn
% 223.27/223.46  |- mesh__dateCreated mesh__D019716 1997-06-30
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D019716 2006
% 223.27/223.46  |- mesh__recordMaintainer mesh__D019716 SYSTEM
% 223.27/223.46  |- rdf__type mesh__D019716sskos__Concept
% 223.27/223.46  |- mesh__historyNote mesh__D019716
% 223.27/223.46       1998; see TISSUE INHIBITOR OF METALLOPROTEINASE-2 %28%NM%29% 1989-1997%A%  
% 223.27/223.46  |- mesh__dateCreated mesh__D011733 1999-01-01
% 223.27/223.46  |- mesh__historyNote mesh__D011733 74%28%72%29%   
% 223.27/223.46  |- skos__broader mesh__D011733smesh__D025101
% 223.27/223.46  |- skos__historyNote mesh__D011733 Pyridoxine %28%1966-1971%29%
% 223.27/223.46  |- skos__annotation mesh__D011733
% 223.27/223.46       deficiency: coordinate PYRIDOXAMINE /defic %28%IM%29% with VITAMIN B 6 DEFICIENCY %28%IM%29%%A%  
% 223.27/223.46  |- skos__prefLabel mesh__D011733 Pyridoxamine
% 223.27/223.46  |- mesh__dateRevised mesh__D011733 2005-06-30
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D011733 2006
% 223.27/223.46  |- mesh__recordOriginator mesh__D011733 NLM
% 223.27/223.46  |- mesh__recordMaintainer mesh__D011733 ssb
% 223.27/223.46  |- mesh__publicMeSHNote mesh__D011733 74   
% 223.27/223.46  |- mesh__dateEstablished mesh__D011733 1974-01-01
% 223.27/223.46  |- skos__historyNote mesh__D011733 Picolines %28%1966-1971%29%
% 223.27/223.46  |- skos__scopeNote mesh__D011733
% 223.27/223.46       The 4-aminomethyl form of VITAMIN B 6.  During transamination of amino acids, PYRIDOXAL PHOSPHATE is transiently converted into pyridoxamine phosphate.%A%    
% 223.27/223.46  |- rdf__type mesh__D011733sskos__Concept
% 223.27/223.46  |- mesh__recordAuthorizer mesh__D011733 sjn
% 223.27/223.46  |- mesh__publicMeSHNote mesh__D007692 91; was see under SILICA 1975-90   
% 223.27/223.46  |- skos__hiddenLabel mesh__D007692 P, Chromosorb
% 223.27/223.46  |- mesh__recordMaintainer mesh__D007692 ssb
% 223.27/223.46  |- mesh__dateEstablished mesh__D007692 1991-01-01
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D007692 2002
% 223.27/223.46  |- mesh__recordOriginator mesh__D007692 NLM
% 223.27/223.46  |- skos__hiddenLabel mesh__D007692 Earth, Infusorial
% 223.27/223.46  |- skos__altLabel mesh__D007692 Kieselguhr
% 223.27/223.46  |- skos__hiddenLabel mesh__D007692 Earth, Diatomaceous
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D007692 2006
% 223.27/223.46  |- skos__hiddenLabel mesh__D007692 545, Celite
% 223.27/223.46  |- mesh__historyNote mesh__D007692
% 223.27/223.46       91%28%75%29%; was see under SILICA 1975-90   
% 223.27/223.46  |- mesh__dateCreated mesh__D007692 1999-01-01
% 223.27/223.46  |- skos__scopeNote mesh__D007692
% 223.27/223.46       A form of SILICON DIOXIDE composed of skeletons of prehistoric aquatic plants which is used for its ABSORPTION quality, taking up 1.5-4 times its weight in water.  The microscopic sharp edges are useful for insect control but can also be an inhalation hazard.  It has been used in baked goods and animal feed.  Kieselguhr is German for flint + earthy sediment.%A%    
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D007692 2005
% 223.27/223.46  |- mesh__dateRevised mesh__D007692 2001-07-25
% 223.27/223.46  |- mesh__onlineNote mesh__D007692
% 223.27/223.46       use SILICA to search KIESELGUHR 1968-74   
% 223.27/223.46  |- skos__altLabel mesh__D007692 Infusorial Earth
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D007692 2004
% 223.27/223.46  |- skos__hiddenLabel mesh__D007692 560, Celite
% 223.27/223.46  |- rdf__type mesh__D007692sskos__Concept
% 223.27/223.46  |- skos__prefLabel mesh__D007692 Diatomaceous Earth
% 223.27/223.46  |- skos__broader mesh__D007692smesh__D012822
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D007692 2003
% 223.27/223.46  |- mesh__recordAuthorizer mesh__D007692 sjn
% 223.27/223.46  |- skos__historyNote mesh__D015326 DNA/genetics %28%1977-1988%29%
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D015326 2003
% 223.27/223.46  |- mesh__recordOriginator mesh__D015326 EJB
% 223.27/223.46  |- skos__scopeNote mesh__D015326
% 223.27/223.46       Ordered rearrangement of B-lymphocyte variable gene regions thereby contributing to antibody diversity. It occurs during the first stage of differentiation of the immature B-lymphocyte.%A%    
% 223.27/223.46  |- mesh__dateCreated mesh__D015326 1988-06-01
% 223.27/223.46  |- skos__historyNote mesh__D015326
% 223.27/223.46       Immunoglobulins, Heavy Chain/genetics %28%1977-1988%29%
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D015326 2005
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D015326 2004
% 223.27/223.46  |- skos__broader mesh__D015326smesh__D015322
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D015326 2006
% 223.27/223.46  |- mesh__dateEstablished mesh__D015326 1989-01-01
% 223.27/223.46  |- mesh__recordMaintainer mesh__D015326 TAP
% 223.27/223.46  |- mesh__publicMeSHNote mesh__D015326 89   
% 223.27/223.46  |- mesh__dateRevised mesh__D015326 2002-07-02
% 223.27/223.46  |- skos__prefLabel mesh__D015326
% 223.27/223.46       Gene Rearrangement, B-Lymphocyte, Heavy Chain
% 223.27/223.46  |- skos__hiddenLabel mesh__D015326 B Lymphocyte Mu Chain Gene Rearrangement
% 223.27/223.46  |- skos__annotation mesh__D015326 DF: GENE REARR HEAVY CHAIN   
% 223.27/223.46  |- mesh__historyNote mesh__D015326 89   
% 223.27/223.46  |- skos__historyNote mesh__D015326 Genes, Immunoglobulin %28%1977-1988%29%
% 223.27/223.46  |- skos__altLabel mesh__D015326 B-Cell Heavy Chain Gene Rearrangement
% 223.27/223.46  |- rdf__type mesh__D015326sskos__Concept
% 223.27/223.46  |- skos__historyNote mesh__D015326
% 223.27/223.46       B Lymphocytes/immunology %28%1977-1988%29%
% 223.27/223.46  |- skos__altLabel mesh__D015326 B-Lymphocyte Heavy Chain Gene Rearrangement
% 223.27/223.46  |- skos__altLabel mesh__D015326 B Lymphocyte Heavy Chain Gene Rearrangement
% 223.27/223.46  |- skos__altLabel mesh__D015326 B Cell Heavy Chain Gene Rearrangement
% 223.27/223.46  |- mesh__recordAuthorizer mesh__D015326 sjn
% 223.27/223.46  |- skos__altLabel mesh__D015326 B Cell Mu Chain Gene Rearrangement
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001306 1994
% 223.27/223.46  |- skos__prefLabel mesh__D001306 Auditory Pathways
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001306 1998
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001306 1995
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001306 2000
% 223.27/223.46  |- mesh__dateRevised mesh__D001306 1992-03-25
% 223.27/223.46  |- mesh__publicMeSHNote mesh__D001306 72   
% 223.27/223.46  |- skos__annotation mesh__D001306
% 223.27/223.46       dis: coord NIM with AUDITORY DISEASES, CENTRAL %28%IM%29%   
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001306 1999
% 223.27/223.46  |- skos__related mesh__D001306smesh__D001304
% 223.27/223.46  |- mesh__recordMaintainer mesh__D001306 TAP
% 223.27/223.46  |- skos__hiddenLabel mesh__D001306 Pathway, Auditory
% 223.27/223.46  |- skos__historyNote mesh__D001306 Central Nervous System %28%1966-1970%29%
% 223.27/223.46  |- mesh__recordOriginator mesh__D001306 NLM
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001306 2005
% 223.27/223.46  |- mesh__recordAuthorizer mesh__D001306 PLS
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001306 2001
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001306 1993
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001306 1996
% 223.27/223.46  |- rdf__type mesh__D001306sskos__Concept
% 223.27/223.46  |- skos__hiddenLabel mesh__D001306 Pathways, Auditory
% 223.27/223.46  |- mesh__historyNote mesh__D001306 72%28%71%29%   
% 223.27/223.46  |- skos__hiddenLabel mesh__D001306 Auditory Pathway
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001306 2006
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001306 1997
% 223.27/223.46  |- skos__historyNote mesh__D001306 Auditory Cortex %28%1968-1970%29%
% 223.27/223.46  |- mesh__dateEstablished mesh__D001306 1972-01-01
% 223.27/223.46  |- skos__broader mesh__D001306smesh__D000344
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001306 2003
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001306 2002
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001306 2004
% 223.27/223.46  |- mesh__dateCreated mesh__D001306 1999-01-01
% 223.27/223.46  |- mesh__publicMeSHNote mesh__D047408 2005   
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D047408 2005
% 223.27/223.46  |- skos__historyNote mesh__D047408 Oligosaccharides %28%1974-2004%29%
% 223.27/223.46  |- mesh__recordMaintainer mesh__D047408 ssb
% 223.27/223.46  |- skos__broader mesh__D047408smesh__D003505
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D047408 2006
% 223.27/223.46  |- mesh__recordOriginator mesh__D047408 ssb
% 223.27/223.46  |- rdf__type mesh__D047408sskos__Concept
% 223.27/223.46  |- skos__hiddenLabel mesh__D047408 gamma Cyclodextrins
% 223.27/223.46  |- mesh__recordAuthorizer mesh__D047408 sjn
% 223.27/223.46  |- mesh__dateEstablished mesh__D047408 2005-01-01
% 223.27/223.46  |- skos__prefLabel mesh__D047408 gamma-Cyclodextrins
% 223.27/223.46  |- skos__historyNote mesh__D047408 Cyclodextrins %28%1980-2004%29%
% 223.27/223.46  |- skos__scopeNote mesh__D047408
% 223.27/223.46       Cyclic GLUCANS consisting of eight %28%8%29% glucopyranose units linked by 1,4-glycosidic bonds.%A%    
% 223.27/223.46  |- mesh__dateCreated mesh__D047408 2004-07-07
% 223.27/223.46  |- mesh__historyNote mesh__D047408 2005   
% 223.27/223.46  |- mesh__historyNote mesh__D019717
% 223.27/223.46       1998; see TISSUE INHIBITOR OF METALLOPROTEINASE-3 %28%NM%29% 1992-1997%A%  
% 223.27/223.46  |- skos__historyNote mesh__D019717 Proteins %28%1995-1997%29%
% 223.27/223.46  |- mesh__recordMaintainer mesh__D019717 DRC
% 223.27/223.46  |- mesh__recordAuthorizer mesh__D019717 sjn
% 223.27/223.46  |- skos__altLabel mesh__D019717 TIMP-3 Protein
% 223.27/223.46  |- skos__hiddenLabel mesh__D019717 TIMP 3 Protein
% 223.27/223.46  |- mesh__recordOriginator mesh__D019717 ADP
% 223.27/223.46  |- skos__hiddenLabel mesh__D019717 Metalloproteinase-3 Tissue Inhibitor
% 223.27/223.46  |- skos__historyNote mesh__D019717 Neoplasm Proteins %28%1992-1995%29%
% 223.27/223.46  |- mesh__publicMeSHNote mesh__D019717
% 223.27/223.46       1998; TISSUE INHIBITOR OF METALLOPROTEINASE 3 was indexed under PROTEINS 1995-97 %26% NEOPLASM PROTEINS 1992-1995%A%  
% 223.27/223.46  |- skos__broader mesh__D019717smesh__D019714
% 223.27/223.46  |- mesh__dateRevised mesh__D019717 2005-06-30
% 223.27/223.46  |- skos__altLabel mesh__D019717 TIMP3 Protein
% 223.27/223.46  |- skos__prefLabel mesh__D019717 Tissue Inhibitor of Metalloproteinase-3
% 223.27/223.46  |- skos__scopeNote mesh__D019717
% 223.27/223.46       A member of the family of tissue inhibitor of metalloproteinases. Mutations of the gene for TIMP3 protein causes Sorsby fundus dystrophy.%A%    
% 223.27/223.46  |- mesh__dateEstablished mesh__D019717 1998-01-01
% 223.27/223.46  |- mesh__dateCreated mesh__D019717 1997-06-30
% 223.27/223.46  |- skos__hiddenLabel mesh__D019717 Tissue Inhibitor of Metalloproteinase 3
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D019717 2006
% 223.27/223.46  |- rdf__type mesh__D019717sskos__Concept
% 223.27/223.46  |- mesh__recordAuthorizer mesh__D011734 sjn
% 223.27/223.46  |- skos__broader mesh__D011734smesh__D000587
% 223.27/223.46  |- skos__historyNote mesh__D011734 Pyridoxamine %28%1973-1974%29%
% 223.27/223.46  |- skos__scopeNote mesh__D011734
% 223.27/223.46       An enzyme catalyzing the deamination of pyridoxaminephosphate to pyridoxal phosphate. It is a flavoprotein that also oxidizes pyridoxine-5-phosphate and pyridoxine. EC 1.4.3.5.%A%    
% 223.27/223.46  |- mesh__dateCreated mesh__D011734 1974-11-19
% 223.27/223.46  |- skos__historyNote mesh__D011734 Oxidoreductases %28%1973-1974%29%
% 223.27/223.46  |- skos__hiddenLabel mesh__D011734 Oxidase, Pyridoxaminephosphate
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D011734 2006
% 223.27/223.46  |- skos__hiddenLabel mesh__D011734 Oxidase, Pyridoxine-5-Phosphate
% 223.27/223.46  |- skos__hiddenLabel mesh__D011734 Oxidase, Pyridoxinephosphate
% 223.27/223.46  |- mesh__recordMaintainer mesh__D011734 jmp
% 223.27/223.46  |- mesh__dateRevised mesh__D011734 2005-06-30
% 223.27/223.46  |- rdf__type mesh__D011734sskos__Concept
% 223.27/223.46  |- mesh__publicMeSHNote mesh__D011734
% 223.27/223.46       91; was see under AMINE OXIDOREDUCTASES 1975-90   
% 223.27/223.46  |- mesh__historyNote mesh__D011734
% 223.27/223.46       91%28%75%29%; was see under AMINE OXIDOREDUCTASES 1975-90   
% 223.27/223.46  |- skos__prefLabel mesh__D011734 Pyridoxaminephosphate Oxidase
% 223.27/223.46  |- skos__altLabel mesh__D011734 Pyridoxinephosphate Oxidase
% 223.27/223.46  |- mesh__recordOriginator mesh__D011734 NLM
% 223.27/223.46  |- skos__hiddenLabel mesh__D011734 Pyridoxine 5 Phosphate Oxidase
% 223.27/223.46  |- mesh__dateEstablished mesh__D011734 1991-01-01
% 223.27/223.46  |- mesh__recordOriginator mesh__D007693 VDK
% 223.27/223.46  |- skos__related mesh__D007693smesh__D000920
% 223.27/223.46  |- mesh__recordAuthorizer mesh__D007693 sjn
% 223.27/223.46  |- skos__hiddenLabel mesh__D007693 Cell, K
% 223.27/223.46  |- skos__hiddenLabel mesh__D007693 Killer Cell
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D007693 2006
% 223.27/223.46  |- skos__hiddenLabel mesh__D007693 K Cell
% 223.27/223.46  |- skos__hiddenLabel mesh__D007693 Cells, K
% 223.27/223.46  |- mesh__recordMaintainer mesh__D007693 jmp
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D007693 2005
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D007693 2004
% 223.27/223.46  |- skos__hiddenLabel mesh__D007693 Cell, Killer
% 223.27/223.46  |- mesh__publicMeSHNote mesh__D007693 78   
% 223.27/223.46  |- rdf__type mesh__D007693sskos__Concept
% 223.27/223.46  |- skos__historyNote mesh__D007693 T Lymphocytes %28%1973-1977%29%
% 223.27/223.46  |- skos__prefLabel mesh__D007693 Killer Cells
% 223.27/223.46  |- mesh__dateRevised mesh__D007693 2003-07-09
% 223.27/223.46  |- skos__broader mesh__D007693smesh__D008214
% 223.27/223.46  |- skos__hiddenLabel mesh__D007693 Cells, Killer
% 223.27/223.46  |- mesh__historyNote mesh__D007693 78   
% 223.27/223.46  |- skos__annotation mesh__D007693
% 223.27/223.46       lymphocytes, monocytes, macrophages or polynuclear leukocytes mediating ANTIBODY-DEPENDENT CELL CYTOTOXICITY; A 11 qualif; subpopulations: coord IM with LYMPHOCYTE SUBSETS %28%IM%29%%A%  
% 223.27/223.46  |- mesh__dateCreated mesh__D007693 1977-04-27
% 223.27/223.46  |- skos__historyNote mesh__D007693 Lymphocytes %28%1966-1977%29%
% 223.27/223.46  |- skos__scopeNote mesh__D007693
% 223.27/223.46       Lymphocyte-like effector cells which mediate antibody-dependent cell cytotoxicity. They kill antibody-coated target cells which they bind with their Fc receptors.%A%    
% 223.27/223.46  |- mesh__dateEstablished mesh__D007693 1978-01-01
% 223.27/223.46  |- skos__altLabel mesh__D007693 K Cells
% 223.27/223.46  |- mesh__recordMaintainer mesh__D001307 KEV
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001307 2002
% 223.27/223.46  |- skos__historyNote mesh__D001307 Perception %28%1966%29%
% 223.27/223.46  |- skos__prefLabel mesh__D001307 Auditory Perception
% 223.27/223.46  |- skos__broader mesh__D001307smesh__D010465
% 223.27/223.46  |- skos__related mesh__D001307smesh__D001308
% 223.27/223.46  |- skos__hiddenLabel mesh__D001307 Auditory Perceptions
% 223.27/223.46  |- skos__historyNote mesh__D001307 Hearing %28%1966%29%
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001307 2005
% 223.27/223.46  |- mesh__recordAuthorizer mesh__D001307 sjn
% 223.27/223.46  |- mesh__historyNote mesh__D001307 68%28%67%29%   
% 223.27/223.46  |- rdf__type mesh__D001307sskos__Concept
% 223.27/223.46  |- skos__scopeNote mesh__D001307
% 223.27/223.46       The process whereby auditory stimuli are selected, organized and interpreted by the organism; includes speech discrimination.%A%    
% 223.27/223.46  |- skos__hiddenLabel mesh__D001307 Perceptions, Auditory
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001307 2006
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001307 2000
% 223.27/223.46  |- skos__broader mesh__D001307smesh__D006309
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001307 2003
% 223.27/223.46  |- mesh__publicMeSHNote mesh__D001307 68   
% 223.27/223.46  |- mesh__recordOriginator mesh__D001307 NLM
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001307 2001
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D001307 2004
% 223.27/223.46  |- mesh__dateCreated mesh__D001307 1999-01-01
% 223.27/223.46  |- skos__annotation mesh__D001307
% 223.27/223.46       differentiate from HEARING: aud percept takes place in the brain, hearing takes place in the ear: TN 98%A%  
% 223.27/223.46  |- skos__hiddenLabel mesh__D001307 Perception, Auditory
% 223.27/223.46  |- mesh__dateRevised mesh__D001307 1999-11-08
% 223.27/223.46  |- mesh__dateEstablished mesh__D001307 1968-01-01
% 223.27/223.46  |- mesh__dateEstablished mesh__D019718 1998-01-01
% 223.27/223.46  |- skos__broader mesh__D019718smesh__D019707
% 223.27/223.46  |- skos__scopeNote mesh__D019718
% 223.27/223.46       Seven-transmembrane G protein-coupled receptors for alpha-chemokines. They also function as fusion cofactors for T-cell-tropic HIV-1 strains.%A%    
% 223.27/223.46  |- mesh__dateRevised mesh__D019718 2003-07-09
% 223.27/223.46  |- mesh__recordOriginator mesh__D019718 AGS
% 223.27/223.46  |- skos__altLabel mesh__D019718 Receptor, LESTR
% 223.27/223.46  |- skos__altLabel mesh__D019718 Fusin
% 223.27/223.46  |- skos__altLabel mesh__D019718 CXCR4 Receptors
% 223.27/223.46  |- skos__altLabel mesh__D019718 LESTR Receptor
% 223.27/223.46  |- mesh__recordAuthorizer mesh__D019718 sjn
% 223.27/223.46  |- skos__prefLabel mesh__D019718 Receptors, CXCR4
% 223.27/223.46  |- mesh__historyNote mesh__D019718
% 223.27/223.46       98; use RECEPTORS, CXCR4 %28%NM%29% 1994-97   
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D019718 2005
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D019718 2004
% 223.27/223.46  |- skos__historyNote mesh__D019718 Membrane Proteins %28%1996-1997%29%
% 223.27/223.46  |- skos__altLabel mesh__D019718
% 223.27/223.46       Leukocyte-Derived Seven-Transmembrane Domain Receptor
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D019718 2006
% 223.27/223.46  |- skos__hiddenLabel mesh__D019718 Receptor, CXCR4
% 223.27/223.46  |- rdf__type mesh__D019718sskos__Concept
% 223.27/223.46  |- mesh__dateCreated mesh__D019718 1997-06-20
% 223.27/223.46  |- mesh__publicMeSHNote mesh__D019718
% 223.27/223.46       98; FUSIN %28%now RECEPTORS, CXCR4%29% was indexed under RECEPTORS, HIV 1997 %26% MEMBRANE PROTEINS 1996-97; LESTR RECEPTOR %28%now RECEPTORS, CXCR4%29% was indexed under RECEPTORS, IMMUNOLOGIC 1994-97%A%  
% 223.27/223.46  |- skos__altLabel mesh__D019718 CXCR4 Receptor
% 223.27/223.46  |- skos__historyNote mesh__D019718 Receptors, Immunologic %28%1994-1997%29%
% 223.27/223.46  |- skos__hiddenLabel mesh__D019718
% 223.27/223.46       Leukocyte Derived Seven Transmembrane Domain Receptor
% 223.27/223.46  |- skos__broader mesh__D019718smesh__D015728
% 223.27/223.46  |- skos__annotation mesh__D019718 chemokine recept; DF: RECEPT CXCR4   
% 223.27/223.46  |- mesh__recordMaintainer mesh__D019718 jmp
% 223.27/223.46  |- skos__historyNote mesh__D019718 Receptors, HIV %28%1997%29%
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D011735 2006
% 223.27/223.46  |- skos__altLabel mesh__D011735 4-Pyridoxylic Acid
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D011735 2004
% 223.27/223.46  |- mesh__dateRevised mesh__D011735 2005-08-03
% 223.27/223.46  |- skos__altLabel mesh__D011735 4-Pyridoxinic Acid
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D011735 2002
% 223.27/223.46  |- skos__broader mesh__D011735smesh__D007539
% 223.27/223.46  |- mesh__recordOriginator mesh__D011735 NLM
% 223.27/223.46  |- skos__prefLabel mesh__D011735 Pyridoxic Acid
% 223.27/223.46  |- rdf__type mesh__D011735sskos__Concept
% 223.27/223.46  |- mesh__publicMeSHNote mesh__D011735
% 223.27/223.46       91; was see under ISONICOTINIC ACIDS 1975-90   
% 223.27/223.46  |- mesh__dateCreated mesh__D011735 1974-11-19
% 223.27/223.46  |- skos__altLabel mesh__D011735 Pyridoxinecarboxylic Acid
% 223.27/223.46  |- skos__scopeNote mesh__D011735
% 223.27/223.46       The catabolic product of most of VITAMIN B 6; %28%PYRIDOXINE; PYRIDOXAL; and PYRIDOXAMINE%29% which is excreted in the urine.%A%    
% 223.27/223.46  |- skos__historyNote mesh__D011735 Isonicotinic Acids %28%1969-1974%29%
% 223.27/223.46  |- skos__hiddenLabel mesh__D011735 4 Pyridoxylic Acid
% 223.27/223.46  |- skos__altLabel mesh__D011735 4-Pyridoxic Acid
% 223.27/223.46  |- mesh__recordMaintainer mesh__D011735 ags
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D011735 2006A
% 223.27/223.46  |- mesh__recordAuthorizer mesh__D011735 ags
% 223.27/223.46  |- skos__historyNote mesh__D011735 Alcohol, Methyl %28%1974%29%
% 223.27/223.46  |- mesh__dateEstablished mesh__D011735 1991-01-01
% 223.27/223.46  |- skos__hiddenLabel mesh__D011735 4 Pyridoxinic Acid
% 223.27/223.46  |- mesh__historyNote mesh__D011735
% 223.27/223.46       91%28%75%29%; was see under ISONICOTINIC ACIDS 1975-90   
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D011735 2005
% 223.27/223.46  |- skos__broader mesh__D011735smesh__D010848
% 223.27/223.46  |- skos__hiddenLabel mesh__D011735 4 Pyridoxic Acid
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D011735 2003
% 223.27/223.46  |- mesh__dateCreated mesh__D016420 1995-06-23
% 223.27/223.46  |- rdf__type mesh__D016420sskos__Concept
% 223.27/223.46  |- skos__broader mesh__D016420smesh__D052181
% 223.27/223.46  |- skos__altLabel mesh__D016420 Viewpoint %28%PT%29%
% 223.27/223.46  |- skos__altLabel mesh__D016420 Commentary
% 223.27/223.46  |- skos__broader mesh__D016420smesh__D052180
% 223.27/223.46  |- mesh__recordOriginator mesh__D016420 TGC
% 223.27/223.46  |- skos__altLabel mesh__D016420 Editorial Comment %28%PT%29%
% 223.27/223.46  |- skos__scopeNote mesh__D016420
% 223.27/223.46       Work consisting of a critical or explanatory note written to discuss, support, or dispute an article or other presentation previously published. It may take the form of an article, letter, editorial, etc. It appears in publications under a variety of names: comment, commentary, editorial comment, viewpoint, etc.%A%    
% 223.27/223.46  |- mesh__historyNote mesh__D016420 1991   
% 223.27/223.46  |- mesh__recordMaintainer mesh__D016420 jls
% 223.27/223.46  |- skos__altLabel mesh__D016420 Viewpoint
% 223.27/223.46  |- mesh__dateRevised mesh__D016420 2005-06-30
% 223.27/223.46  |- skos__altLabel mesh__D016420 Editorial Comment
% 223.27/223.46  |- mesh__dateEstablished mesh__D016420 1996-01-01
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D016420 2006
% 223.27/223.46  |- skos__altLabel mesh__D016420 Commentary %28%PT%29%
% 223.27/223.46  |- mesh__recordAuthorizer mesh__D016420 sjn
% 223.27/223.46  |- skos__prefLabel mesh__D016420 Comment %5B%Publication Type%5D%
% 223.27/223.46  |- skos__annotation mesh__D016420
% 223.27/223.46       publication type only; for critical or explanatory remarks on  previously published articles; Manual section 39; CATALOG: do not use%A%  
% 223.27/223.46  |- skos__altLabel mesh__D016420 Comment %28%PT%29%
% 223.27/223.46  |- skos__altLabel mesh__D016420 Comment
% 223.27/223.46  |- skos__scopeNote mesh__D002400
% 223.27/223.46       Agents that promote and/or ease defecation by accelerating the passage of feces through the large intestine, by influencing the consistency and amount of stool, and by facilitating the elimination of feces from the rectum. The terms laxative and cathartic reflect the typical intensity and latency of effect. A cathartic usually produces prompt fluid evacuation, while a laxative usually produces a soft formed stool over a protracted period; the same drug may act as a laxative or a cathartic depending on the dose administered or individual patient sensitivity. %28%From AMA Drug Evaluations Annual, 1994, p941%29%%A%    
% 223.27/223.46  |- mesh__dateCreated mesh__D002400 1999-01-01
% 223.27/223.46  |- skos__prefLabel mesh__D002400 Cathartics
% 223.27/223.46  |- mesh__recordMaintainer mesh__D002400 ssb
% 223.27/223.46  |- mesh__dateRevised mesh__D002400 2005-06-30
% 223.27/223.46  |- skos__altLabel mesh__D002400 Purgatives
% 223.27/223.46  |- rdf__type mesh__D002400sskos__Concept
% 223.27/223.46  |- skos__broader mesh__D002400smesh__D005765
% 223.27/223.46  |- mesh__recordOriginator mesh__D002400 NLM
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D002400 2006
% 223.27/223.46  |- mesh__recordAuthorizer mesh__D002400 sjn
% 223.27/223.46  |- skos__related mesh__D002400smesh__D004043
% 223.27/223.46  |- skos__hiddenLabel mesh__D007694 Cell, Natural Killer
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D007694 2004
% 223.27/223.46  |- mesh__recordMaintainer mesh__D007694 jmp
% 223.27/223.46  |- skos__hiddenLabel mesh__D007694 Cells, Natural Killer
% 223.27/223.46  |- skos__prefLabel mesh__D007694 Killer Cells, Natural
% 223.27/223.46  |- rdf__type mesh__D007694sskos__Concept
% 223.27/223.46  |- mesh__publicMeSHNote mesh__D007694 83   
% 223.27/223.46  |- skos__historyNote mesh__D007694 Immunity, Cellular %28%1976-1982%29%
% 223.27/223.46  |- mesh__dateRevised mesh__D007694 2003-07-09
% 223.27/223.46  |- skos__scopeNote mesh__D007694
% 223.27/223.46       Cells responsible for spontaneous cytotoxicity of a variety of tumor cells without prior immunization. These natural killer cells are found in non-immune humans and experimental animals and are thought by some to be the same as KILLER CELLS %28%killing by antibody-dependent cell cytotoxicity%29%, but they can also kill in the absence of antibody.%A%    
% 223.27/223.46  |- skos__broader mesh__D007694smesh__D008214
% 223.27/223.46  |- mesh__recordOriginator mesh__D007694 SAG
% 223.27/223.46  |- mesh__dateEstablished mesh__D007694 1983-01-01
% 223.27/223.46  |- mesh__recordAuthorizer mesh__D007694 sjn
% 223.27/223.46  |- skos__hiddenLabel mesh__D007694 Natural Killer Cell
% 223.27/223.46  |- mesh__dateCreated mesh__D007694 1982-04-29
% 223.27/223.46  |- skos__altLabel mesh__D007694 NK Cells
% 223.27/223.46  |- skos__historyNote mesh__D007694 Killer Cells %28%1978-1982%29%
% 223.27/223.46  |- skos__hiddenLabel mesh__D007694 Cell, NK
% 223.27/223.46  |- skos__altLabel mesh__D007694 Natural Killer Cells
% 223.27/223.46  |- skos__hiddenLabel mesh__D007694 Killer Cell, Natural
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D007694 2006
% 223.27/223.46  |- skos__hiddenLabel mesh__D007694 Cells, NK
% 223.27/223.46  |- skos__hiddenLabel mesh__D007694 NK Cell
% 223.27/223.46  |- mesh__historyNote mesh__D007694 83   
% 223.27/223.46  |- skos__annotation mesh__D007694
% 223.27/223.46       cells spontaneously cytotoxic to tumor cells; A 11 qualif; subpopulations: coord IM with LYMPHOCYTE SUBSETS %28%IM%29%%A%  
% 223.27/223.46  |- skos__historyNote mesh__D007694
% 223.27/223.46       Cytotoxicity, Immunologic %28%1978-1982%29%
% 223.27/223.46  |- mesh__activeMeSHYear mesh__D007694 2005
% 223.27/223.46  |- skos__hiddenLabel mesh__D015328 B Cell kappa Chain Gene Rearrangement
% 223.27/223.47  |- mesh__recordAuthorizer mesh__D015328 sjn
% 223.27/223.47  |- skos__altLabel mesh__D015328 B Cell kappa-Chain Gene Rearrangement
% 223.27/223.47  |- skos__hiddenLabel mesh__D015328 B Cell lambda Chain Gene Rearrangement
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D015328 2005
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D015328 2004
% 223.27/223.47  |- skos__hiddenLabel mesh__D015328
% 223.27/223.47       B Lymphocyte lambda Chain Gene Rearrangement
% 223.27/223.47  |- skos__historyNote mesh__D015328 DNA/genetics %28%1977-1988%29%
% 223.27/223.47  |- skos__historyNote mesh__D015328
% 223.27/223.47       Immunoglobulins, Light Chain/genetics %28%1977-1988%29%
% 223.27/223.47  |- mesh__recordOriginator mesh__D015328 EJB
% 223.27/223.47  |- mesh__dateEstablished mesh__D015328 1989-01-01
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D015328 2006
% 223.27/223.47  |- skos__altLabel mesh__D015328 B-Lymphocyte Light Chain Gene Rearrangement
% 223.27/223.47  |- mesh__publicMeSHNote mesh__D015328 89   
% 223.27/223.47  |- rdf__type mesh__D015328sskos__Concept
% 223.27/223.47  |- skos__historyNote mesh__D015328
% 223.27/223.47       B Lymphocytes/immunology %28%1977-1988%29%
% 223.27/223.47  |- skos__hiddenLabel mesh__D015328
% 223.27/223.47       B Lymphocyte kappa Chain Gene Rearrangement
% 223.27/223.47  |- skos__altLabel mesh__D015328 B Lymphocyte Light Chain Gene Rearrangement
% 223.27/223.47  |- skos__altLabel mesh__D015328 B Cell Light Chain Gene Rearrangement
% 223.27/223.47  |- skos__prefLabel mesh__D015328
% 223.27/223.47       Gene Rearrangement, B-Lymphocyte, Light Chain
% 223.27/223.47  |- skos__annotation mesh__D015328 DF: GENE REARR LIGHT CHAIN   
% 223.27/223.47  |- skos__historyNote mesh__D015328 Genes, Immunoglobulin %28%1977-1988%29%
% 223.27/223.47  |- mesh__recordMaintainer mesh__D015328 AGS
% 223.27/223.47  |- mesh__dateRevised mesh__D015328 2002-07-02
% 223.27/223.47  |- skos__altLabel mesh__D015328 B-Cell Light Chain Gene Rearrangement
% 223.27/223.47  |- skos__altLabel mesh__D015328 B Cell lambda-Chain Gene Rearrangement
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D015328 2003
% 223.27/223.47  |- mesh__historyNote mesh__D015328 89   
% 223.27/223.47  |- skos__broader mesh__D015328smesh__D015322
% 223.27/223.47  |- skos__scopeNote mesh__D015328
% 223.27/223.47       Ordered rearrangement of B-lymphocyte variable gene regions coding for the kappa or lambda light chains, thereby contributing to antibody diversity. It occurs during the second stage of differentiation of the immature B-lymphocyte.%A%    
% 223.27/223.47  |- mesh__dateCreated mesh__D015328 1988-06-01
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Disorders, Auditory Processing
% 223.27/223.47  |- mesh__dateRevised mesh__D001308 1999-11-03
% 223.27/223.47  |- skos__altLabel mesh__D001308 Auditory Comprehension Disorder
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Processing Disorders, Auditory
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Disorder, Auditory Processing
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Disorder, Auditory Comprehension
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Comprehension Disorder, Auditory
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Perceptual Disorder, Acoustic
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D001308 2004
% 223.27/223.47  |- skos__broader mesh__D001308smesh__D001304
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D001308 2002
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Disorder, Acoustic Perceptual
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Perceptual Disorders, Acoustic
% 223.27/223.47  |- skos__historyNote mesh__D001308 Perception %28%1966-1968%29%
% 223.27/223.47  |- skos__prefLabel mesh__D001308 Auditory Perceptual Disorders
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Disorder, Psychoacoustical
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D001308 2003
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Disorders, Auditory Comprehension
% 223.27/223.47  |- skos__scopeNote mesh__D001308
% 223.27/223.47       Acquired or developmental cognitive disorders of AUDITORY PERCEPTION characterized by a reduced ability to perceive information contained in auditory stimuli despite intact auditory pathways. Affected individuals have difficulty with speech perception, sound localization, and comprehending the meaning of inflections of speech.%A%    
% 223.27/223.47  |- mesh__recordOriginator mesh__D001308 RC
% 223.27/223.47  |- mesh__publicMeSHNote mesh__D001308
% 223.27/223.47       91; was see under PERCEPTUAL DISORDERS 1980-90   
% 223.27/223.47  |- mesh__recordMaintainer mesh__D001308 KEV
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Auditory Inattentions
% 223.27/223.47  |- skos__related mesh__D001308smesh__D001307
% 223.27/223.47  |- skos__historyNote mesh__D001308 Auditory Perception %28%1967-1979%29%
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Inattentions, Auditory
% 223.27/223.47  |- skos__broader mesh__D001308smesh__D010468
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Disorders, Psychoacoustical
% 223.27/223.47  |- skos__historyNote mesh__D001308 Perceptual Disorders %28%1969-1979%29%
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D001308 2001
% 223.27/223.47  |- skos__altLabel mesh__D001308 Acoustic Perceptual Disorder
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Psychoacoustical Disorder
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D001308 2006
% 223.27/223.47  |- rdf__type mesh__D001308sskos__Concept
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Processing Disorder, Auditory
% 223.27/223.47  |- mesh__recordAuthorizer mesh__D001308 sjn
% 223.27/223.47  |- skos__altLabel mesh__D001308 Psychoacoustical Disorders
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Auditory Comprehension Disorders
% 223.27/223.47  |- mesh__dateCreated mesh__D001308 1978-12-14
% 223.27/223.47  |- skos__historyNote mesh__D001308 Hearing %28%1966%29%
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Inattention, Auditory
% 223.27/223.47  |- skos__altLabel mesh__D001308 Perceptual Disorders, Auditory
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Acoustic Perceptual Disorders
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Perceptual Disorder, Auditory
% 223.27/223.47  |- skos__broader mesh__D001308smesh__D003072
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D001308 2000
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D001308 2005
% 223.27/223.47  |- skos__altLabel mesh__D001308 Auditory Processing Disorder
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Comprehension Disorders, Auditory
% 223.27/223.47  |- mesh__dateEstablished mesh__D001308 1991-01-01
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Auditory Perceptual Disorder
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Disorders, Acoustic Perceptual
% 223.27/223.47  |- mesh__historyNote mesh__D001308
% 223.27/223.47       91%28%80%29%; was see under PERCEPTUAL DISORDERS 1980-90   
% 223.27/223.47  |- skos__hiddenLabel mesh__D001308 Auditory Processing Disorders
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012030 1997
% 223.27/223.47  |- skos__hiddenLabel mesh__D012030 Disorder, Refractive
% 223.27/223.47  |- skos__hiddenLabel mesh__D012030 Refractive Disorder
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012030 1999
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012030 1996
% 223.27/223.47  |- mesh__recordMaintainer mesh__D012030 TGC
% 223.27/223.47  |- skos__scopeNote mesh__D012030
% 223.27/223.47       Deviations from the average or standard indices of refraction of the eye through its dioptric or refractive apparatus.%A%    
% 223.27/223.47  |- skos__prefLabel mesh__D012030 Refractive Errors
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012030 1995
% 223.27/223.47  |- skos__hiddenLabel mesh__D012030 Errors, Refractive
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012030 1998
% 223.27/223.47  |- skos__hiddenLabel mesh__D012030 Ametropias
% 223.27/223.47  |- skos__annotation mesh__D012030
% 223.27/223.47       deviations from standard refraction of eye; DF: REFRACTIVE ERR%A%  
% 223.27/223.47  |- mesh__recordAuthorizer mesh__D012030 PLS
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012030 1994
% 223.27/223.47  |- rdf__type mesh__D012030sskos__Concept
% 223.27/223.47  |- mesh__recordOriginator mesh__D012030 NLM
% 223.27/223.47  |- skos__hiddenLabel mesh__D012030 Refractive Error
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012030 2002
% 223.27/223.47  |- skos__altLabel mesh__D012030 Refractive Disorders
% 223.27/223.47  |- skos__hiddenLabel mesh__D012030 Disorders, Refractive
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012030 2004
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012030 2001
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012030 2006
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012030 2003
% 223.27/223.47  |- skos__broader mesh__D012030smesh__D005128
% 223.27/223.47  |- mesh__dateCreated mesh__D012030 1999-01-01
% 223.27/223.47  |- mesh__dateRevised mesh__D012030 1993-06-02
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012030 2005
% 223.27/223.47  |- skos__hiddenLabel mesh__D012030 Error, Refractive
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012030 2000
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D019719 2005
% 223.27/223.47  |- mesh__dateCreated mesh__D019719 1997-06-20
% 223.27/223.47  |- mesh__dateEstablished mesh__D019719 1998-01-01
% 223.27/223.47  |- mesh__recordOriginator mesh__D019719 PXP
% 223.27/223.47  |- mesh__historyNote mesh__D019719 98   
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D019719 2006
% 223.27/223.47  |- rdf__type mesh__D019719sskos__Concept
% 223.27/223.47  |- mesh__publicMeSHNote mesh__D019719 98   
% 223.27/223.47  |- skos__altLabel mesh__D019719 Equipment, Diagnostic
% 223.27/223.47  |- mesh__dateRevised mesh__D019719 2004-07-19
% 223.27/223.47  |- skos__hiddenLabel mesh__D019719 Diagnostic Equipments
% 223.27/223.47  |- skos__prefLabel mesh__D019719 Diagnostic Equipment
% 223.27/223.47  |- mesh__recordAuthorizer mesh__D019719 sjn
% 223.27/223.47  |- skos__annotation mesh__D019719
% 223.27/223.47       do not use /util except by MeSH definition; DF: DIAG EQUIPMENT%A%  
% 223.27/223.47  |- mesh__recordMaintainer mesh__D019719 jls
% 223.27/223.47  |- skos__hiddenLabel mesh__D019719 Equipments, Diagnostic
% 223.27/223.47  |- skos__broader mesh__D019719smesh__D004864
% 223.27/223.47  |- skos__scopeNote mesh__D019719
% 223.27/223.47       Nonexpendable items used in examination.     
% 223.27/223.47  |- skos__scopeNote mesh__D011736
% 223.27/223.47       The 4-methanol form of VITAMIN B 6 which is converted to PYRIDOXAL PHOSPHATE which is a coenzyme for synthesis of amino acids, neurotransmitters %28%serotonin, norepinephrine%29%, sphingolipids, aminolevulinic acid.  Although pyridoxine and Vitamin B 6 are still frequently used as synonyms, especially by medical researchers, this practice is erroneous and sometimes misleading %28%EE Snell; Ann NY Acad Sci, vol 585 pg 1, 1990%29%.%A%    
% 223.27/223.47  |- rdf__type mesh__D011736sskos__Concept
% 223.27/223.47  |- mesh__dateCreated mesh__D011736 1999-01-01
% 223.27/223.47  |- skos__altLabel mesh__D011736 Pyridoxol
% 223.27/223.47  |- skos__altLabel mesh__D011736 Pyridoxol Hydrochloride
% 223.27/223.47  |- mesh__dateRevised mesh__D011736 2005-06-30
% 223.27/223.47  |- skos__annotation mesh__D011736
% 223.27/223.47       deficiency: coordinate PYRIDOXINE /defic %28%IM%29% with VITAMIN B 6 DEFICIENCY %28%IM%29%%A%  
% 223.27/223.47  |- skos__broader mesh__D011736smesh__D025101
% 223.27/223.47  |- mesh__recordMaintainer mesh__D011736 ssb
% 223.27/223.47  |- mesh__recordOriginator mesh__D011736 NLM
% 223.27/223.47  |- skos__prefLabel mesh__D011736 Pyridoxine
% 223.27/223.47  |- mesh__recordAuthorizer mesh__D011736 sjn
% 223.27/223.47  |- skos__altLabel mesh__D011736 Pyridoxin
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D011736 2006
% 223.27/223.47  |- mesh__dateRevised mesh__D016421 2005-06-30
% 223.27/223.47  |- skos__annotation mesh__D016421
% 223.27/223.47       publication type only; CATALOG: do not use   
% 223.27/223.47  |- skos__altLabel mesh__D016421 Editorial
% 223.27/223.47  |- mesh__recordAuthorizer mesh__D016421 sjn
% 223.27/223.47  |- mesh__dateEstablished mesh__D016421 1996-01-01
% 223.27/223.47  |- skos__broader mesh__D016421smesh__D052181
% 223.27/223.47  |- mesh__recordMaintainer mesh__D016421 jls
% 223.27/223.47  |- skos__scopeNote mesh__D016421
% 223.27/223.47       Work consisting of a statement of the opinions, beliefs, and policy of the editor or publisher of a journal, usually on current matters of medical or scientific significance to the medical community or society at large. The editorials published by editors of journals representing the official organ of a society or organization are generally substantive.%A%    
% 223.27/223.47  |- skos__prefLabel mesh__D016421 Editorial %5B%Publication Type%5D%
% 223.27/223.47  |- rdf__type mesh__D016421sskos__Concept
% 223.27/223.47  |- mesh__historyNote mesh__D016421 1991   
% 223.27/223.47  |- skos__altLabel mesh__D016421 Editorial %28%PT%29%
% 223.27/223.47  |- mesh__recordOriginator mesh__D016421 TAP
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D016421 2006
% 223.27/223.47  |- mesh__dateCreated mesh__D016421 1995-06-23
% 223.27/223.47  |- skos__broader mesh__D016421smesh__D052180
% 223.27/223.47  |- mesh__historyNote mesh__D002401 87   
% 223.27/223.47  |- mesh__dateRevised mesh__D002401 2003-07-09
% 223.27/223.47  |- skos__hiddenLabel mesh__D002401 Cathepsin B Like Proteinase
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D002401 2004
% 223.27/223.47  |- rdf__type mesh__D002401sskos__Concept
% 223.27/223.47  |- skos__hiddenLabel mesh__D002401 Proteinase, Cathepsin B-Like
% 223.27/223.47  |- skos__historyNote mesh__D002401 Cathepsins %28%1966-1986%29%
% 223.27/223.47  |- skos__scopeNote mesh__D002401
% 223.27/223.47       A lysosomal cysteine proteinase which hydrolyzes proteins, with a specificity resembling that of papain. The enzyme is present in a variety of tissues and is important in many physiological and pathological processes. In pathology, cathepsin B has been found to be involved in demyelination, emphysema, rheumatoid arthritis, and neoplastic infiltration. EC 3.4.22.1.%A%    
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D002401 2005
% 223.27/223.47  |- mesh__dateCreated mesh__D002401 1986-06-16
% 223.27/223.47  |- skos__hiddenLabel mesh__D002401 B, Cathepsin
% 223.27/223.47  |- mesh__recordMaintainer mesh__D002401 ssb
% 223.27/223.47  |- mesh__recordOriginator mesh__D002401 RLS
% 223.27/223.47  |- skos__hiddenLabel mesh__D002401 Cathepsin B Like Activity
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D002401 2006
% 223.27/223.47  |- skos__broader mesh__D002401smesh__D003546
% 223.27/223.47  |- skos__hiddenLabel mesh__D002401 B-Like Activity, Cathepsin
% 223.27/223.47  |- skos__hiddenLabel mesh__D002401 B-Like Proteinase, Cathepsin
% 223.27/223.47  |- mesh__publicMeSHNote mesh__D002401 87   
% 223.27/223.47  |- mesh__dateEstablished mesh__D002401 1987-01-01
% 223.27/223.47  |- skos__hiddenLabel mesh__D002401 B1, Cathepsin
% 223.27/223.47  |- skos__altLabel mesh__D002401 Cathepsin B1
% 223.27/223.47  |- skos__broader mesh__D002401smesh__D002403
% 223.27/223.47  |- skos__hiddenLabel mesh__D002401 Activity, Cathepsin B-Like
% 223.27/223.47  |- mesh__recordAuthorizer mesh__D002401 sjn
% 223.27/223.47  |- skos__prefLabel mesh__D002401 Cathepsin B
% 223.27/223.47  |- mesh__recordOriginator mesh__D007695 NLM
% 223.27/223.47  |- mesh__dateRevised mesh__D007695 2003-07-09
% 223.27/223.47  |- skos__scopeNote mesh__D007695
% 223.27/223.47       Small oviparous fishes in the family Cyprinodontidae, usually striped or barred black. They are much used in mosquito control.%A%    
% 223.27/223.47  |- mesh__publicMeSHNote mesh__D007695
% 223.27/223.47       2002; see KILLIFISH 1991-2001, see CYPRINODONTIFORMES 1987-1990, was see FISHES 1975-1986%A%  
% 223.27/223.47  |- skos__annotation mesh__D007695
% 223.27/223.47       KILLIFISH; ATLANTIC KILLIFISH; GULF KILLIFISH see FUNDULIDAE and JAPANESE KILLIFISH see ORYZIAS are available; killifish unspecified goes here%A%  
% 223.27/223.47  |- skos__broader mesh__D007695smesh__D003532
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D007695 2006
% 223.27/223.47  |- mesh__dateEstablished mesh__D007695 1991-01-01
% 223.27/223.47  |- mesh__historyNote mesh__D007695
% 223.27/223.47       2002%28%1975%29%; was see under CYPRINODONTIFORMES 1987-90; was see under FISHES 1975-86%A%  
% 223.27/223.47  |- skos__altLabel mesh__D007695 Pupfishes
% 223.27/223.47  |- mesh__recordMaintainer mesh__D007695 ags
% 223.27/223.47  |- skos__altLabel mesh__D007695 Cyprinodontidae
% 223.27/223.47  |- mesh__recordAuthorizer mesh__D007695 sjn
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D007695 2005
% 223.27/223.47  |- skos__prefLabel mesh__D007695 Killifishes
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D007695 2004
% 223.27/223.47  |- rdf__type mesh__D007695sskos__Concept
% 223.27/223.47  |- skos__hiddenLabel mesh__D007695 Cyprinodons
% 223.27/223.47  |- mesh__dateCreated mesh__D007695 1974-12-12
% 223.27/223.47  |- skos__hiddenLabel mesh__D015329 Rearrangements, T-Lymphocyte Gene
% 223.27/223.47  |- skos__broader mesh__D015329smesh__D007125
% 223.27/223.47  |- skos__altLabel mesh__D015329 T-Cell Gene Rearrangement
% 223.27/223.47  |- skos__historyNote mesh__D015329 Genes or specific gene %28%1977-1988%29%
% 223.27/223.47  |- skos__hiddenLabel mesh__D015329 T-Lymphocyte Gene Rearrangements
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D015329 2006
% 223.27/223.47  |- skos__historyNote mesh__D015329
% 223.27/223.47       Receptors, Antigen, T-Cell/genetics %28%1977-1988%29%
% 223.27/223.47  |- skos__hiddenLabel mesh__D015329 Gene Rearrangement, T Cell
% 223.27/223.47  |- skos__altLabel mesh__D015329 T-Lymphocyte Gene Rearrangement
% 223.27/223.47  |- mesh__recordAuthorizer mesh__D015329 sjn
% 223.27/223.47  |- skos__hiddenLabel mesh__D015329 Gene Rearrangements, T-Lymphocyte
% 223.27/223.47  |- skos__prefLabel mesh__D015329 Gene Rearrangement, T-Lymphocyte
% 223.27/223.47  |- skos__hiddenLabel mesh__D015329 Rearrangement, T-Lymphocyte Gene
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D015329 2003
% 223.27/223.47  |- skos__hiddenLabel mesh__D015329 Rearrangement, T-Cell Gene
% 223.27/223.47  |- rdf__type mesh__D015329sskos__Concept
% 223.27/223.47  |- skos__hiddenLabel mesh__D015329 Rearrangements, T-Cell Gene
% 223.27/223.47  |- skos__historyNote mesh__D015329 DNA/genetics %28%1977-1988%29%
% 223.27/223.47  |- skos__hiddenLabel mesh__D015329
% 223.27/223.47       Gene Rearrangement, T Cell Antigen Receptor
% 223.27/223.47  |- skos__broader mesh__D015329smesh__D015321
% 223.27/223.47  |- mesh__recordOriginator mesh__D015329 EJB
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D015329 2004
% 223.27/223.47  |- mesh__historyNote mesh__D015329 89   
% 223.27/223.47  |- skos__hiddenLabel mesh__D015329 Gene Rearrangement, T Lymphocyte
% 223.27/223.47  |- skos__hiddenLabel mesh__D015329 T Cell Gene Rearrangement
% 223.27/223.47  |- skos__scopeNote mesh__D015329
% 223.27/223.47       Ordered rearrangement of T-cell variable gene regions coding for the antigen receptors.%A%    
% 223.27/223.47  |- skos__hiddenLabel mesh__D015329 Gene Rearrangements, T-Cell
% 223.27/223.47  |- mesh__dateCreated mesh__D015329 1988-06-01
% 223.27/223.47  |- mesh__recordMaintainer mesh__D015329 AGS
% 223.27/223.47  |- skos__annotation mesh__D015329 DF: GENE REARR T CELL   
% 223.27/223.47  |- skos__altLabel mesh__D015329 Gene Rearrangement, T-Cell Antigen Receptor
% 223.27/223.47  |- mesh__dateEstablished mesh__D015329 1989-01-01
% 223.27/223.47  |- skos__hiddenLabel mesh__D015329 T Lymphocyte Gene Rearrangement
% 223.27/223.47  |- skos__historyNote mesh__D015329
% 223.27/223.47       T Lymphocytes/immunology %28%1977-1988%29%
% 223.27/223.47  |- mesh__publicMeSHNote mesh__D015329 89   
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D015329 2005
% 223.27/223.47  |- skos__related mesh__D015329smesh__D019672
% 223.27/223.47  |- mesh__dateRevised mesh__D015329 2002-07-03
% 223.27/223.47  |- skos__hiddenLabel mesh__D015329 T-Cell Gene Rearrangements
% 223.27/223.47  |- skos__altLabel mesh__D015329 Gene Rearrangement, T-Cell
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D001309 2003
% 223.27/223.47  |- mesh__historyNote mesh__D001309 68   
% 223.27/223.47  |- skos__prefLabel mesh__D001309 Auditory Threshold
% 223.27/223.47  |- mesh__publicMeSHNote mesh__D001309 68   
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D001309 2000
% 223.27/223.47  |- skos__historyNote mesh__D001309 Hearing %28%1966-1967%29%
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D001309 2004
% 223.27/223.47  |- mesh__recordMaintainer mesh__D001309 TAP
% 223.27/223.47  |- mesh__dateCreated mesh__D001309 1999-01-01
% 223.27/223.47  |- mesh__recordOriginator mesh__D001309 NLM
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D001309 1994
% 223.27/223.47  |- mesh__recordAuthorizer mesh__D001309 PLS
% 223.27/223.47  |- mesh__dateEstablished mesh__D001309 1968-01-01
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D001309 2001
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D001309 1998
% 223.27/223.47  |- skos__broader mesh__D001309smesh__D001307
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D001309 1995
% 223.27/223.47  |- skos__hiddenLabel mesh__D001309 Thresholds, Auditory
% 223.27/223.47  |- mesh__dateRevised mesh__D001309 1992-03-25
% 223.27/223.47  |- skos__related mesh__D001309smesh__D001299
% 223.27/223.47  |- skos__hiddenLabel mesh__D001309 Auditory Thresholds
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D001309 1999
% 223.27/223.47  |- skos__scopeNote mesh__D001309
% 223.27/223.47       The audibility limit of discriminating sound intensity and pitch.%A%    
% 223.27/223.47  |- skos__broader mesh__D001309smesh__D012684
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D001309 2005
% 223.27/223.47  |- skos__hiddenLabel mesh__D001309 Threshold, Auditory
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D001309 2002
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D001309 1993
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D001309 1996
% 223.27/223.47  |- rdf__type mesh__D001309sskos__Concept
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D001309 2006
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D001309 1997
% 223.27/223.47  |- mesh__recordOriginator mesh__D012031 VDK
% 223.27/223.47  |- mesh__recordMaintainer mesh__D012031 TGC
% 223.27/223.47  |- skos__broader mesh__D012031smesh__D009906
% 223.27/223.47  |- skos__annotation mesh__D012031
% 223.27/223.47       an anal chem technique; do not use for refractometry in REFRACTION, OCULAR%A%  
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012031 2001
% 223.27/223.47  |- mesh__dateRevised mesh__D012031 1994-05-12
% 223.27/223.47  |- rdf__type mesh__D012031sskos__Concept
% 223.27/223.47  |- skos__hiddenLabel mesh__D012031 Index, Refractive
% 223.27/223.47  |- mesh__publicMeSHNote mesh__D012031 79   
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012031 2004
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012031 2000
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012031 2006
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012031 2003
% 223.27/223.47  |- skos__prefLabel mesh__D012031 Refractometry
% 223.27/223.47  |- skos__hiddenLabel mesh__D012031 Indices, Refractive
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012031 2005
% 223.27/223.47  |- skos__hiddenLabel mesh__D012031 Refractive Indices
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012031 1997
% 223.27/223.47  |- mesh__dateCreated mesh__D012031 1978-05-19
% 223.27/223.47  |- skos__broader mesh__D012031smesh__D002623
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012031 1999
% 223.27/223.47  |- mesh__dateEstablished mesh__D012031 1979-01-01
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012031 1996
% 223.27/223.47  |- mesh__recordAuthorizer mesh__D012031 PLS
% 223.27/223.47  |- skos__scopeNote mesh__D012031
% 223.27/223.47       Measurement of the index of refraction %28%the ratio of the velocity of light or other radiation in the first of two media to its velocity in the second as it passes from one into the other%29%.%A%    
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012031 1995
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012031 2002
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012031 1998
% 223.27/223.47  |- mesh__historyNote mesh__D012031 79   
% 223.27/223.47  |- skos__historyNote mesh__D050150 Growth Inhibitors %28%1993-2005%29%
% 223.27/223.47  |- mesh__recordMaintainer mesh__D050150 ssb
% 223.27/223.47  |- mesh__publicMeSHNote mesh__D050150
% 223.27/223.47       2006, 1969-1992; see GROWTH INHIBITORS 1993-2005   
% 223.27/223.47  |- skos__annotation mesh__D050150 do not confuse with CHALCONES   
% 223.27/223.47  |- mesh__recordOriginator mesh__D050150 ssb
% 223.27/223.47  |- rdf__type mesh__D050150sskos__Concept
% 223.27/223.47  |- skos__prefLabel mesh__D050150 Chalones
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D050150 2006
% 223.27/223.47  |- mesh__historyNote mesh__D050150
% 223.27/223.47       2006, 1969-1992; use GROWTH INHIBITORS 1993-2005   
% 223.27/223.47  |- mesh__dateEstablished mesh__D050150 2006-01-01
% 223.27/223.47  |- skos__broader mesh__D050150smesh__D009842
% 223.27/223.47  |- skos__scopeNote mesh__D050150
% 223.27/223.47       Peptides that inhibit mitosis %28%ANTIMITOTICS%29%. During the 1960%27%s the term referred to crude extracts that inhibited cell proliferation; the activity was later attributed to PYROGLUTAMATE type oligopeptides.%A%    
% 223.27/223.47  |- mesh__dateCreated mesh__D050150 2005-06-30
% 223.27/223.47  |- mesh__recordAuthorizer mesh__D050150 sjn
% 223.27/223.47  |- mesh__dateRevised mesh__D016422 2005-07-12
% 223.27/223.47  |- rdf__type mesh__D016422sskos__Concept
% 223.27/223.47  |- mesh__dateCreated mesh__D016422 1995-06-23
% 223.27/223.47  |- skos__prefLabel mesh__D016422 Letter %5B%Publication Type%5D%
% 223.27/223.47  |- mesh__recordAuthorizer mesh__D016422 ags
% 223.27/223.47  |- mesh__dateEstablished mesh__D016422 1996-01-01
% 223.27/223.47  |- mesh__recordOriginator mesh__D016422 TAP
% 223.27/223.47  |- skos__scopeNote mesh__D016422
% 223.27/223.47       Work consisting of written or printed communication between individuals or between persons and representatives of corporate bodies. The correspondence may be personal or professional. In medical and other scientific publications the letter is usually from one or more authors to the editor of the journal or book publishing the item being commented upon or discussed. LETTER %5B%PUBLICATION TYPE%5D% is often accompanied by COMMENT %5B%PUBLICATION TYPE%5D%.%A%    
% 223.27/223.47  |- skos__related mesh__D016422smesh__D020505
% 223.27/223.47  |- mesh__historyNote mesh__D016422 1991   
% 223.27/223.47  |- skos__broader mesh__D016422smesh__D019502
% 223.27/223.47  |- skos__altLabel mesh__D016422 Letter %28%PT%29%
% 223.27/223.47  |- skos__annotation mesh__D016422
% 223.27/223.47       publication type only; letters %26% correspondence as a subject are indexed under the main heading CORRESPONDENCE;  CATALOG: do not use for collections of letters, use COLLECTED CORRESPONDENCE %5B%PUBLICATION TYPE%5D%%A%  
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D016422 2006
% 223.27/223.47  |- mesh__recordMaintainer mesh__D016422 ags
% 223.27/223.47  |- skos__broader mesh__D016422smesh__D052180
% 223.27/223.47  |- skos__altLabel mesh__D016422 Letter
% 223.27/223.47  |- skos__broader mesh__D016422smesh__D052181
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D016422 2006A
% 223.27/223.47  |- skos__broader mesh__D014404Q000037smesh__D014404
% 223.27/223.47  |- mesh__preferredCombination mesh__D014404Q000037smesh__D050257
% 223.27/223.47  |- rdf__type mesh__D014404Q000037smesh__CompoundConcept
% 223.27/223.47  |- mesh__historyNote mesh__D002402 85   
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D002402 2004
% 223.27/223.47  |- mesh__dateRevised mesh__D002402 2003-07-09
% 223.27/223.47  |- mesh__recordMaintainer mesh__D002402 ssb
% 223.27/223.47  |- skos__broader mesh__D002402smesh__D016282
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D002402 2005
% 223.27/223.47  |- mesh__recordOriginator mesh__D002402 RLS
% 223.27/223.47  |- skos__scopeNote mesh__D002402
% 223.27/223.47       An intracellular proteinase found in a variety of tissue. It has specificity similar to but narrower than that of pepsin A. The enzyme is involved in catabolism of cartilage and connective tissue. EC 3.4.23.5. %28%Formerly EC 3.4.4.23%29%.%A%    
% 223.27/223.47  |- mesh__dateEstablished mesh__D002402 1985-01-01
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D002402 2006
% 223.27/223.47  |- mesh__dateCreated mesh__D002402 1984-05-24
% 223.27/223.47  |- skos__historyNote mesh__D002402 Cathepsins %28%1966-1984%29%
% 223.27/223.47  |- skos__prefLabel mesh__D002402 Cathepsin D
% 223.27/223.47  |- mesh__recordAuthorizer mesh__D002402 sjn
% 223.27/223.47  |- skos__broader mesh__D002402smesh__D002403
% 223.27/223.47  |- mesh__publicMeSHNote mesh__D002402 85   
% 223.27/223.47  |- rdf__type mesh__D002402sskos__Concept
% 223.27/223.47  |- skos__scopeNote mesh__D007696
% 223.27/223.47       A phenomenon in which there is a relatively profound alteration in brain function resulting from repeated electrical or chemical stimulation and culminating in the appearance of electrographic and behavioral convulsions whenever the stimulus is re-applied. It is used as an experimental model for epilepsy.%A%    
% 223.27/223.47  |- rdf__type mesh__D007696sskos__Concept
% 223.27/223.47  |- skos__annotation mesh__D007696 DF: KINDLING   
% 223.27/223.47  |- skos__broader mesh__D007696smesh__D009424
% 223.27/223.47  |- mesh__recordAuthorizer mesh__D007696 sjn
% 223.27/223.47  |- mesh__recordOriginator mesh__D007696 RC
% 223.27/223.47  |- skos__historyNote mesh__D007696 Amygdaloid Body %28%1966-1981%29%
% 223.27/223.47  |- mesh__dateCreated mesh__D007696 1981-02-24
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D007696 2005
% 223.27/223.47  |- skos__historyNote mesh__D007696 Electric Stimulation %28%1966-1981%29%
% 223.27/223.47  |- mesh__publicMeSHNote mesh__D007696 82   
% 223.27/223.47  |- skos__prefLabel mesh__D007696 Kindling %28%Neurology%29%
% 223.27/223.47  |- mesh__dateRevised mesh__D007696 2004-07-07
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D007696 2006
% 223.27/223.47  |- mesh__historyNote mesh__D007696 82   
% 223.27/223.47  |- mesh__dateEstablished mesh__D007696 1982-01-01
% 223.27/223.47  |- skos__hiddenLabel mesh__D007696 Kindlings %28%Neurology%29%
% 223.27/223.47  |- skos__historyNote mesh__D007696 Convulsions %28%1966-1981%29%
% 223.27/223.47  |- skos__related mesh__D007696smesh__D012640
% 223.27/223.47  |- mesh__recordMaintainer mesh__D007696 lkt
% 223.27/223.47  |- skos__altLabel mesh__D040521 Hypodermis
% 223.27/223.47  |- skos__scopeNote mesh__D040521
% 223.27/223.47       Loose connective tissue lying under the DERMIS, which binds SKIN loosely to subjacent tissues. It may contain a pad of ADIPOCYTES, which vary in number according to the area of the body and vary in size according to the nutritional state.%A%    
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D040521 2004
% 223.27/223.47  |- skos__hiddenLabel mesh__D040521 Tissue, Subcutaneous
% 223.27/223.47  |- mesh__dateEstablished mesh__D040521 2003-01-01
% 223.27/223.47  |- skos__prefLabel mesh__D040521 Subcutaneous Tissue
% 223.27/223.47  |- skos__hiddenLabel mesh__D040521 Tissues, Subcutaneous
% 223.27/223.47  |- mesh__publicMeSHNote mesh__D040521 2003   
% 223.27/223.47  |- skos__hiddenLabel mesh__D040521 Subcutaneous Tissues
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D040521 2003
% 223.27/223.47  |- mesh__historyNote mesh__D040521 2003   
% 223.27/223.47  |- skos__altLabel mesh__D040521 Fascia, Superficial
% 223.27/223.47  |- mesh__dateCreated mesh__D040521 2002-07-03
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D040521 2006
% 223.27/223.47  |- skos__broader mesh__D040521smesh__D003238
% 223.27/223.47  |- rdf__type mesh__D040521sskos__Concept
% 223.27/223.47  |- skos__altLabel mesh__D040521 Tela Subcutanea
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D040521 2005
% 223.27/223.47  |- skos__hiddenLabel mesh__D040521 Superficial Fascia
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012830 1996
% 223.27/223.47  |- mesh__activeMeSHYear mesh__D012830 2001
% 223.27/223.47  |- skos__broader mesh__D012830smesh__D012829
% 223.27/223.48  |- mesh__recordAuthorizer mesh__D012830 PLS
% 223.27/223.48  |- skos__scopeNote mesh__D012830 Tuberculosis of the silicotic lung.     
% 223.27/223.48  |- mesh__recordMaintainer mesh__D012830 TAP
% 223.27/223.48  |- skos__hiddenLabel mesh__D012830 Silicotuberculoses
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012830 2006
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012830 2000
% 223.27/223.48  |- skos__prefLabel mesh__D012830 Silicotuberculosis
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012830 2004
% 223.27/223.48  |- skos__annotation mesh__D012830
% 223.27/223.48       tuberc in the silicotic lung; do not coord with OCCUPATIONAL DISEASES%A%  
% 223.27/223.48  |- rdf__type mesh__D012830sskos__Concept
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012830 2005
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012830 2003
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012830 1995
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012830 1999
% 223.27/223.48  |- mesh__dateRevised mesh__D012830 1993-03-03
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012830 1994
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012830 2002
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012830 1997
% 223.27/223.48  |- mesh__dateCreated mesh__D012830 1999-01-01
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012830 1998
% 223.27/223.48  |- skos__broader mesh__D012830smesh__D014397
% 223.27/223.48  |- mesh__recordOriginator mesh__D012830 NLM
% 223.27/223.48  |- skos__historyNote mesh__D012032 Neural Conduction %28%1966-1971%29%
% 223.27/223.48  |- skos__hiddenLabel mesh__D012032 Period, Neurological Refractory
% 223.27/223.48  |- mesh__recordAuthorizer mesh__D012032 PLS
% 223.27/223.48  |- mesh__recordOriginator mesh__D012032 NLM
% 223.27/223.48  |- skos__altLabel mesh__D012032 Neurologic Refractory Periods
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012032 2004
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012032 2002
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012032 2006
% 223.27/223.48  |- skos__broader mesh__D012032smesh__D009431
% 223.27/223.48  |- mesh__historyNote mesh__D012032
% 223.27/223.48       91%28%72%29%; was see under NEURAL CONDUCTION 1972-90   
% 223.27/223.48  |- skos__hiddenLabel mesh__D012032 Periods, Neurological Refractory
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012032 2003
% 223.27/223.48  |- skos__altLabel mesh__D012032 Refractory Periods, Neurologic
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012032 2001
% 223.27/223.48  |- mesh__dateCreated mesh__D012032 1999-01-01
% 223.27/223.48  |- skos__hiddenLabel mesh__D012032 Neurological Refractory Period
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012032 2005
% 223.27/223.48  |- skos__annotation mesh__D012032 DF: REFRACTORY PERIOD NEUROL   
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012032 1997
% 223.27/223.48  |- skos__hiddenLabel mesh__D012032 Neurological Refractory Periods
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012032 2000
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012032 1999
% 223.27/223.48  |- mesh__dateRevised mesh__D012032 1993-06-04
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012032 1996
% 223.27/223.48  |- skos__altLabel mesh__D012032 Periods, Neurologic Refractory
% 223.27/223.48  |- skos__altLabel mesh__D012032 Period, Neurologic Refractory
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012032 1995
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012032 1998
% 223.27/223.48  |- skos__altLabel mesh__D012032 Neurologic Refractory Period
% 223.27/223.48  |- mesh__dateEstablished mesh__D012032 1991-01-01
% 223.27/223.48  |- skos__altLabel mesh__D012032 Refractory Period, Neurological
% 223.27/223.48  |- skos__prefLabel mesh__D012032 Refractory Period, Neurologic
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012032 1994
% 223.27/223.48  |- rdf__type mesh__D012032sskos__Concept
% 223.27/223.48  |- mesh__publicMeSHNote mesh__D012032
% 223.27/223.48       91; was see under NEURAL CONDUCTION 1972-90   
% 223.27/223.48  |- skos__hiddenLabel mesh__D012032 Refractory Periods, Neurological
% 223.27/223.48  |- mesh__recordMaintainer mesh__D012032 JLS
% 223.27/223.48  |- mesh__dateCreated mesh__D050151 2005-06-30
% 223.27/223.48  |- mesh__recordAuthorizer mesh__D050151 sjn
% 223.27/223.48  |- rdf__type mesh__D050151sskos__Concept
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D050151 2006
% 223.27/223.48  |- skos__hiddenLabel mesh__D050151 Fats, Subcutaneous
% 223.27/223.48  |- mesh__recordMaintainer mesh__D050151 lkt
% 223.27/223.48  |- mesh__publicMeSHNote mesh__D050151 2006   
% 223.27/223.48  |- skos__scopeNote mesh__D050151
% 223.27/223.48       Fatty tissue under the SKIN through out the body.     
% 223.27/223.48  |- skos__hiddenLabel mesh__D050151 Subcutaneous Fats
% 223.27/223.48  |- skos__historyNote mesh__D050151 Adipose Tissue %28%1965-2005%29%
% 223.27/223.48  |- skos__prefLabel mesh__D050151 Subcutaneous Fat
% 223.27/223.48  |- skos__broader mesh__D050151smesh__D000273
% 223.27/223.48  |- mesh__recordOriginator mesh__D050151 lkt
% 223.27/223.48  |- skos__altLabel mesh__D050151 Subcutaneous Adipose Tissue
% 223.27/223.48  |- mesh__historyNote mesh__D050151 2006   
% 223.27/223.48  |- mesh__dateEstablished mesh__D050151 2006-01-01
% 223.27/223.48  |- skos__altLabel mesh__D050151 Adipose Tissue, Subcutaneous
% 223.27/223.48  |- skos__altLabel mesh__D050151 Fat, Subcutaneous
% 223.27/223.48  |- mesh__publicMeSHNote mesh__D011738
% 223.27/223.48       91; was see under AMINOPYRIDINES 1979-90; was see under PYRIDINES 1975-78%A%  
% 223.27/223.48  |- skos__historyNote mesh__D011738 Pyridines %28%1970-1974%29%
% 223.27/223.48  |- mesh__recordOriginator mesh__D011738 NLM
% 223.27/223.48  |- skos__altLabel mesh__D011738 Aventis Pharma Brand of Mepyramine Maleate
% 223.27/223.48  |- skos__hiddenLabel mesh__D011738
% 223.27/223.48       Whitehall Robins Brand of Mepyramine Maleate
% 223.27/223.48  |- skos__historyNote mesh__D011738 Ethylenediamines %28%1972-1974%29%
% 223.27/223.48  |- skos__altLabel mesh__D011738 Pyranisamine
% 223.27/223.48  |- mesh__recordMaintainer mesh__D011738 CCR
% 223.27/223.48  |- rdf__type mesh__D011738sskos__Concept
% 223.27/223.48  |- mesh__dateCreated mesh__D011738 1974-11-19
% 223.27/223.48  |- mesh__recordAuthorizer mesh__D011738 sjn
% 223.27/223.48  |- skos__altLabel mesh__D011738
% 223.27/223.48       Whitehall-Robins Brand of Mepyramine Maleate
% 223.27/223.48  |- skos__hiddenLabel mesh__D011738 Maleate, Pyrilamine
% 223.27/223.48  |- mesh__historyNote mesh__D011738
% 223.27/223.48       91%28%75%29%; was see under AMINOPYRIDINES 1979-90; was see under PYRIDINES 1975-78%A%  
% 223.27/223.48  |- skos__altLabel mesh__D011738 Boots Brand of Mepyramine Maleate
% 223.27/223.48  |- skos__broader mesh__D011738smesh__D000631
% 223.27/223.48  |- skos__altLabel mesh__D011738 Aventis Brand of Mepyramine Maleate
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D011738 2006
% 223.27/223.48  |- skos__scopeNote mesh__D011738
% 223.27/223.48       A histamine H1 antagonist. It has mild hypnotic properties and some local anesthetic action and is used for allergies %28%including skin eruptions%29% both parenterally and locally. It is a common ingredient of cold remedies.%A%    
% 223.27/223.48  |- skos__annotation mesh__D011738 a histamine H1 antag   
% 223.27/223.48  |- skos__historyNote mesh__D011738 Benzyl Compounds %28%1972-1974%29%
% 223.27/223.48  |- skos__altLabel mesh__D011738 Pyrilamine Maleate
% 223.27/223.48  |- skos__hiddenLabel mesh__D011738 Maleate, Mepyramine
% 223.27/223.48  |- skos__altLabel mesh__D011738 Mepyramine
% 223.27/223.48  |- mesh__dateEstablished mesh__D011738 1991-01-01
% 223.27/223.48  |- skos__prefLabel mesh__D011738 Pyrilamine
% 223.27/223.48  |- mesh__dateRevised mesh__D011738 2005-06-30
% 223.27/223.48  |- skos__scopeNote mesh__D016423
% 223.27/223.48       Published records of the papers delivered at or issued on the occasion of individual congresses, symposia, and meetings; abstracts of papers delivered at such congresses; reports of the officers and delegates of such congresses; combinations of the foregoing; or proceedings of the conference of a society if they are not limited to matters of internal organization.%A%    
% 223.27/223.48  |- skos__related mesh__D016423smesh__D016416
% 223.27/223.48  |- skos__altLabel mesh__D016423 Congresses %28%PT%29%
% 223.27/223.48  |- skos__prefLabel mesh__D016423 Congresses %5B%Publication Type%5D%
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D016423 2006
% 223.27/223.48  |- mesh__recordOriginator mesh__D016423 TAP
% 223.27/223.48  |- skos__broader mesh__D016423smesh__D052180
% 223.27/223.48  |- mesh__historyNote mesh__D016423
% 223.27/223.48       1999; MEETING REPORT %28%PT%29% was Publication Type 1995-1998; CONGRESS %28%PT%29% was Publication Type 1991-1994%A%  
% 223.27/223.48  |- skos__altLabel mesh__D016423 Meeting Report %28%Publication Type%29%
% 223.27/223.48  |- mesh__dateEstablished mesh__D016423 1996-01-01
% 223.27/223.48  |- mesh__dateCreated mesh__D016423 1995-06-23
% 223.27/223.48  |- mesh__dateRevised mesh__D016423 2005-06-30
% 223.27/223.48  |- mesh__recordAuthorizer mesh__D016423 sjn
% 223.27/223.48  |- mesh__recordMaintainer mesh__D016423 jls
% 223.27/223.48  |- skos__altLabel mesh__D016423 Meeting Report %28%PT%29%
% 223.27/223.48  |- rdf__type mesh__D016423sskos__Concept
% 223.27/223.48  |- skos__annotation mesh__D016423
% 223.27/223.48       congresses as a subject are indexed under the main heading CONGRESSES; CATALOG: Use for proceedings of a conference, works that are based on a conference or that consist of expanded %28%updated%29% papers from a conference, or abstracts of papers from a conference. Do not use Publication Type MEETING ABSTRACTS. Do not use for works containing only one or two papers from a conference, or for personally authored summaries of a conferences%A%  
% 223.27/223.48  |- skos__altLabel mesh__D002403 Cathepsin
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D002403 2004
% 223.27/223.48  |- mesh__recordAuthorizer mesh__D002403 sjn
% 223.27/223.48  |- rdf__type mesh__D002403sskos__Concept
% 223.27/223.48  |- mesh__dateEstablished mesh__D002403 1965-01-01
% 223.27/223.48  |- mesh__recordMaintainer mesh__D002403 ssb
% 223.27/223.48  |- mesh__historyNote mesh__D002403
% 223.27/223.48       79; was CATHEPSIN 1963-78 %28%Prov 1963-64%29%   
% 223.27/223.48  |- skos__broader mesh__D002403smesh__D010450
% 223.27/223.48  |- mesh__dateCreated mesh__D002403 1999-01-01
% 223.27/223.48  |- skos__scopeNote mesh__D002403
% 223.27/223.48       A group of lysosomal proteinases or endopeptidases found in aqueous extracts of a variety of animal tissue. They function optimally within an acidic pH range.%A%    
% 223.27/223.48  |- mesh__dateRevised mesh__D002403 2003-07-09
% 223.27/223.48  |- mesh__onlineNote mesh__D002403
% 223.27/223.48       use CATHEPSINS to search CATHEPSIN 1966-78   
% 223.27/223.48  |- mesh__publicMeSHNote mesh__D002403 79; was CATHEPSIN 1965-78   
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D002403 2006
% 223.27/223.48  |- skos__prefLabel mesh__D002403 Cathepsins
% 223.27/223.48  |- mesh__recordOriginator mesh__D002403 NLM
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D002403 2005
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D007697 2005
% 223.27/223.48  |- skos__annotation mesh__D007697
% 223.27/223.48       no qualif; do not confuse with KINETICS or KINESIS: kinesics = %22%use of posture or gesture for communication%22%%A%  
% 223.27/223.48  |- skos__prefLabel mesh__D007697 Kinesics
% 223.27/223.48  |- mesh__recordMaintainer mesh__D007697 TGC
% 223.27/223.48  |- skos__scopeNote mesh__D007697
% 223.27/223.48       Systematic study of the body and the use of its static and dynamic position as a means of communication.%A%    
% 223.27/223.48  |- mesh__dateCreated mesh__D007697 1999-01-01
% 223.27/223.48  |- skos__historyNote mesh__D007697 Communication %28%1966-1967%29%
% 223.27/223.48  |- mesh__historyNote mesh__D007697 68   
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D007697 2006
% 223.27/223.48  |- mesh__recordAuthorizer mesh__D007697 sjn
% 223.27/223.48  |- mesh__dateRevised mesh__D007697 2002-07-02
% 223.27/223.48  |- skos__hiddenLabel mesh__D007697 Language, Body
% 223.27/223.48  |- mesh__dateEstablished mesh__D007697 1968-01-01
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D007697 2003
% 223.27/223.48  |- skos__hiddenLabel mesh__D007697 Body Languages
% 223.27/223.48  |- mesh__recordOriginator mesh__D007697 NLM
% 223.27/223.48  |- skos__hiddenLabel mesh__D007697 Languages, Body
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D007697 2004
% 223.27/223.48  |- skos__broader mesh__D007697smesh__D009633
% 223.27/223.48  |- rdf__type mesh__D007697sskos__Concept
% 223.27/223.48  |- mesh__publicMeSHNote mesh__D007697 68   
% 223.27/223.48  |- skos__historyNote mesh__D007697 Behavior, Animal %28%1966-1967%29%
% 223.27/223.48  |- skos__scopeNote mesh__D012831
% 223.27/223.48       A genus of silkworm MOTHS in the family Bombycidae of the order LEPIDOPTERA. The family contains a single species, Bombyx mori from the Greek for silkworm + mulberry tree %28%on which it feeds%29%. A native of Asia, it is sometimes reared in this country. It has long been raised for its SILK and after centuries of domestication it probably does not exist in nature. It is used extensively in experimental GENETICS. %28%From Borror et al., An Introduction to the Study of Insects, 4th ed, p519%29%%A%    
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012831 2006
% 223.27/223.48  |- mesh__recordOriginator mesh__D012831 NLM
% 223.27/223.48  |- skos__altLabel mesh__D012831 Silkworms
% 223.27/223.48  |- rdf__type mesh__D012831sskos__Concept
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012831 2005
% 223.27/223.48  |- skos__altLabel mesh__D012831 Silkworm
% 223.27/223.48  |- skos__altLabel mesh__D012831 Silkmoths
% 223.27/223.48  |- mesh__publicMeSHNote mesh__D012831 2005; use SILKWORMS 1963-2004   
% 223.27/223.48  |- skos__prefLabel mesh__D012831 Bombyx
% 223.27/223.48  |- mesh__dateCreated mesh__D012831 1999-01-01
% 223.27/223.48  |- skos__altLabel mesh__D012831 Silkmoth
% 223.27/223.48  |- mesh__recordAuthorizer mesh__D012831 sjn
% 223.27/223.48  |- skos__broader mesh__D012831smesh__D009036
% 223.27/223.48  |- mesh__historyNote mesh__D012831 2005 %28%1963%29%   
% 223.27/223.48  |- mesh__dateRevised mesh__D012831 2004-07-07
% 223.27/223.48  |- mesh__recordMaintainer mesh__D012831 ags
% 223.27/223.48  |- skos__hiddenLabel mesh__D012033 Psychologic Refractory Periods
% 223.27/223.48  |- mesh__onlineNote mesh__D012033
% 223.27/223.48       use REFRACTORY PERIOD, PSYCHOLOGICAL to search REFRACTORY PERIOD, PSYCHOLOGIC 1972-78 %28%as Prov 72-74%29%%A%  
% 223.27/223.48  |- mesh__recordAuthorizer mesh__D012033 PLS
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012033 2004
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012033 2002
% 223.27/223.48  |- mesh__activeMeSHYear mesh__D012033 2006
% 223.27/223.48  |- mesh__dateEstablished mesh__D012033 1991-01-01
% 223.27/223.49  |- skos__hiddenLabel mesh__D012033 Period, Psychologic Refractory
% 223.27/223.49  |- mesh__activeMeSHYear mesh__D012033 1996
% 223.27/223.49  |- skos__broader mesh__D012033smesh__D011930
% 223.27/223.49  |- skos__hiddenLabel mesh__D012033 Psychologic Refractory Period
% 223.27/223.49  |- mesh__activeMeSHYear mesh__D012033 1998
% 223.27/223.49  |- skos__altLabel mesh__D012033 Psychological Refractory Periods
% 223.27/223.49  |- skos__altLabel mesh__D012033 Periods, Psychological Refractory
% 223.27/223.49  |- mesh__activeMeSHYear mesh__D012033 1997
% 223.27/223.49  |- skos__prefLabel mesh__D012033 Refractory Period, Psychological
% 223.27/223.49  |- mesh__recordOriginator mesh__D012033 NLM
% 223.27/223.49  |- mesh__activeMeSHYear mesh__D012033 1994
% 223.27/223.49  |- mesh__recordMaintainer mesh__D012033 JLS
% 223.27/223.49  |- skos__altLabel mesh__D012033 Period, Psychological Refractory
% 223.27/223.49  |- mesh__activeMeSHYear mesh__D012033 1999
% 223.27/223.49  |- mesh__historyNote mesh__D012033
% 223.27/223.49       91%28%79%29%; was see under REACTION TIME 1979-90; was REFRACTORY PERIOD, PSYCHOLOGIC see under REACTION TIME 1975-78; was REFRACTORY PERIOD, PSYCHOLOGIC 1972-74 %28%Prov%29%%A%  
% 223.27/223.49  |- mesh__activeMeSHYear mesh__D012033 2000
% 223.27/223.49  |- mesh__dateRevised mesh__D012033 1993-06-04
% 223.27/223.49  |- skos__altLabel mesh__D012033 Refractory Periods, Psychological
% 223.27/223.49  |- skos__altLabel mesh__D012033 Psychological Refractory Period
% 223.27/223.49  |- mesh__activeMeSHYear mesh__D012033 2001
% 223.27/223.49  |- mesh__activeMeSHYear mesh__D012033 1995
% 223.27/223.49  |- skos__hiddenLabel mesh__D012033 Refractory Periods, Psychologic
% 223.27/223.49  |- skos__scopeNote mesh__D012033
% 223.27/223.49       A delayed response interval occurring when two stimuli are presented in close succession.%A%    
% 223.27/223.49  |- skos__historyNote mesh__D012033 Reaction Time %28%1966-1971%29%
% 223.27/223.49  |- skos__annotation mesh__D012033
% 223.27/223.49       human %26% animal; DF: REFRACTORY PERIOD PSYCHOL   
% 223.27/223.49  |- mesh__activeMeSHYear mesh__D012033 2003
% 223.27/223.49  |- rdf__type mesh__D012033sskos__Concept
% 223.27/223.49  |- mesh__dateCreated mesh__D012033 1999-01-01
% 223.27/223.49  |- skos__altLabel mesh__D012033 Refractory Period, Psychologic
% 223.27/223.49  |- mesh__activeMeSHYear mesh__D012033 2005
% 223.27/223.49  |- skos__hiddenLabel mesh__D012033 Periods, Psychologic Refractory
% 223.27/223.49  |- mesh__publicMeSHNote mesh__D012033
% 223.27/223.49       91; was see under REACTION TIME 1979-90; was REFRACTORY PERIOD, PSYCHOLOGIC see under REACTION TIME 1975-78%A%  
% 223.27/223.49  |- mesh__historyNote mesh__D036481 2003   
% 223.27/223.49  |- mesh__activeMeSHYear mesh__D036481 2005
% 223.27/223.49  |- mesh__publicMeSHNote mesh__D036481 2003   
% 223.27/223.49  |- mesh__activeMeSHYear mesh__D036481 2003
% 223.27/223.49  |- mesh__activeMeSHYear mesh__D036481 2006
% 223.27/223.49  |- skos__annotation mesh__D036481
% 223.27/223.49       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.27/223.49  |- mesh__activeMeSHYear mesh__D036481 2004
% 223.27/223.49  |- mesh__dateEstablished mesh__D036481 2003-01-01
% 223.27/223.49  |- mesh__dateCreated mesh__D036481 2002-07-02
% 223.27/223.49  |- rdf__type mesh__D036481sskos__Concept
% 223.27/223.49  |- skos__scopeNote mesh__D036481
% 223.27/223.49       A plant genus of the family FABACEAE. Members contain isoacteoside, luteolin, indole-3-carboxylic acid.%A%    
% 223.27/223.49  |- skos__prefLabel mesh__D036481 Bauhinia
% 223.27/223.49  |- skos__broader mesh__D036481smesh__D007887
% 223.27/223.49  |- skos__scopeNote mesh__D050152
% 223.27/223.49       Fatty tissue inside the ABDOMINAL CAVITY, including visceral fat and retroperitoneal fat. It is the most metabolically active fat in the body and easily accessible for LIPOLYSIS. Increased visceral fat is associated with metabolic complications of OBESITY.%A%    
% 223.27/223.49  |- mesh__historyNote mesh__D050152 2006   
% 223.27/223.49  |- mesh__dateEstablished mesh__D050152 2006-01-01
% 223.27/223.49  |- skos__hiddenLabel mesh__D050152 Fat, Visceral
% 223.27/223.49  |- skos__hiddenLabel mesh__D050152 Visceral Fats
% 223.27/223.49  |- mesh__recordOriginator mesh__D050152 lkt
% 223.27/223.49  |- skos__hiddenLabel mesh__D050152 Adipose Tissue, Visceral
% 223.27/223.49  |- skos__hiddenLabel mesh__D050152 Fats, Intra-Abdominal
% 223.27/223.49  |- skos__hiddenLabel mesh__D050152 Fats, Retroperitoneal
% 223.27/223.49  |- skos__historyNote mesh__D050152 Adipose Tissue %28%1975-2005%29%
% 223.27/223.49  |- skos__hiddenLabel mesh__D050152 Intra-Abdominal Fats
% 223.27/223.49  |- skos__altLabel mesh__D050152 Visceral Adipose Tissue
% 223.27/223.49  |- mesh__dateCreated mesh__D050152 2005-06-30
% 223.27/223.49  |- mesh__recordAuthorizer mesh__D050152 sjn
% 223.27/223.49  |- skos__hiddenLabel mesh__D050152 Fat, Retroperitoneal
% 223.27/223.49  |- skos__hiddenLabel mesh__D050152 Intra Abdominal Fat
% 223.27/223.49  |- skos__altLabel mesh__D050152 Fat, Intra-Abdominal
% 223.27/223.49  |- mesh__recordMaintainer mesh__D050152 lkt
% 223.27/223.49  |- skos__hiddenLabel mesh__D050152 Fat, Abdominal Visceral
% 223.27/223.49  |- skos__hiddenLabel mesh__D050152 Fats, Visceral
% 223.27/223.49  |- skos__hiddenLabel mesh__D050152 Retroperitoneal Fats
% 223.27/223.49  |- skos__broader mesh__D050152smesh__D050153
% 223.27/223.49  |- skos__altLabel mesh__D050152 Intra-Abdominal Adipose Tissue
% 223.27/223.49  |- skos__altLabel mesh__D050152 Abdominal Visceral Fat
% 223.27/223.50  |- skos__prefLabel mesh__D050152 Intra-Abdominal Fat
% 223.27/223.50  |- rdf__type mesh__D050152sskos__Concept
% 223.27/223.50  |- skos__hiddenLabel mesh__D050152 Adipose Tissue, Retroperitoneal
% 223.27/223.50  |- skos__hiddenLabel mesh__D050152 Adipose Tissue, Intra-Abdominal
% 223.27/223.50  |- skos__altLabel mesh__D050152 Retroperitoneal Adipose Tissue
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D050152 2006
% 223.27/223.50  |- skos__hiddenLabel mesh__D050152 Intra Abdominal Adipose Tissue
% 223.27/223.50  |- skos__hiddenLabel mesh__D050152 Fat, Intra Abdominal
% 223.27/223.50  |- skos__hiddenLabel mesh__D050152 Fats, Abdominal Visceral
% 223.27/223.50  |- mesh__publicMeSHNote mesh__D050152 2006   
% 223.27/223.50  |- skos__hiddenLabel mesh__D050152 Abdominal Visceral Fats
% 223.27/223.50  |- skos__altLabel mesh__D011739 Aventis Brand of Pyrimethamine
% 223.27/223.50  |- skos__scopeNote mesh__D011739
% 223.27/223.50       One of the FOLIC ACID ANTAGONISTS that is used as an antimalarial or with a sulfonamide to treat toxoplasmosis.%A%    
% 223.27/223.50  |- mesh__dateRevised mesh__D011739 2005-06-30
% 223.27/223.50  |- skos__altLabel mesh__D011739 GlaxoSmithKline Brand of Pyrimethamine
% 223.27/223.50  |- skos__altLabel mesh__D011739 Glaxo Wellcome Brand of Pyrimethamine
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D011739 2006
% 223.27/223.50  |- mesh__recordOriginator mesh__D011739 NLM
% 223.27/223.50  |- mesh__dateCreated mesh__D011739 1999-01-01
% 223.27/223.50  |- skos__prefLabel mesh__D011739 Pyrimethamine
% 223.27/223.50  |- skos__altLabel mesh__D011739 Wellcome Brand of Pyrimethamine
% 223.27/223.50  |- mesh__recordMaintainer mesh__D011739 lkw
% 223.27/223.50  |- mesh__recordAuthorizer mesh__D011739 sjn
% 223.27/223.50  |- rdf__type mesh__D011739sskos__Concept
% 223.27/223.50  |- skos__broader mesh__D011739smesh__D011743
% 223.27/223.50  |- skos__altLabel mesh__D008790 Spesikor
% 223.27/223.50  |- skos__hiddenLabel mesh__D008790 CGP2175
% 223.27/223.50  |- skos__hiddenLabel mesh__D008790 Betaloc Astra
% 223.27/223.50  |- skos__hiddenLabel mesh__D008790 Beloc Duriles
% 223.27/223.50  |- skos__hiddenLabel mesh__D008790 BetalocAstra
% 223.27/223.50  |- skos__hiddenLabel mesh__D008790 H 93 26
% 223.27/223.50  |- mesh__historyNote mesh__D008790
% 223.27/223.50       84%28%77%29%; was see under PROPANOLAMINES 1977-83   
% 223.27/223.50  |- skos__broader mesh__D008790smesh__D011412
% 223.27/223.50  |- skos__broader mesh__D008790smesh__D050198
% 223.27/223.50  |- skos__scopeNote mesh__D008790
% 223.27/223.50       A selective adrenergic beta-1-blocking agent with no stimulatory action. It%27%s binding to plasma albumin is weaker than alprenolol and it may be useful in angina pectoris, hypertension, or cardiac arrhythmias.%A%    
% 223.27/223.50  |- mesh__dateEstablished mesh__D008790 1984-01-01
% 223.27/223.50  |- skos__historyNote mesh__D008790 Propanolamines %28%1974-1976%29%
% 223.27/223.50  |- mesh__recordMaintainer mesh__D008790 ssb
% 223.27/223.50  |- skos__hiddenLabel mesh__D008790 CGP 2175
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D008790 2006
% 223.27/223.50  |- skos__historyNote mesh__D008790 Phenyl Ethers %28%1975%29%
% 223.27/223.50  |- mesh__recordAuthorizer mesh__D008790 sjn
% 223.27/223.50  |- mesh__publicMeSHNote mesh__D008790
% 223.27/223.50       84; was see under PROPANOLAMINES 1977-83   
% 223.27/223.50  |- skos__historyNote mesh__D008790 Propylamines %28%1974-1976%29%
% 223.27/223.50  |- skos__hiddenLabel mesh__D008790 Tartrate, Metoprolol
% 223.27/223.50  |- skos__hiddenLabel mesh__D008790 BelocDuriles
% 223.27/223.50  |- skos__prefLabel mesh__D008790 Metoprolol
% 223.27/223.50  |- mesh__dateCreated mesh__D008790 1976-04-13
% 223.27/223.50  |- skos__hiddenLabel mesh__D008790 H 9326
% 223.27/223.50  |- mesh__recordOriginator mesh__D008790 SH
% 223.27/223.50  |- rdf__type mesh__D008790sskos__Concept
% 223.27/223.50  |- mesh__dateRevised mesh__D008790 2005-06-30
% 223.27/223.50  |- skos__altLabel mesh__D008790 Betaloc
% 223.27/223.50  |- mesh__dateCreated mesh__D022461 2000-06-22
% 223.27/223.50  |- skos__prefLabel mesh__D022461 Caveolins
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D022461 2006
% 223.27/223.50  |- mesh__historyNote mesh__D022461 2001   
% 223.27/223.50  |- skos__scopeNote mesh__D022461
% 223.27/223.50       The main structural proteins of CAVEOLAE. Several distinct genes for caveolins have been identified.%A%    
% 223.27/223.50  |- skos__broader mesh__D022461smesh__D033921
% 223.27/223.50  |- mesh__recordOriginator mesh__D022461 nns
% 223.27/223.50  |- skos__hiddenLabel mesh__D022461 Proteins, Caveolin
% 223.27/223.50  |- rdf__type mesh__D022461sskos__Concept
% 223.27/223.50  |- mesh__dateRevised mesh__D022461 2005-06-30
% 223.27/223.50  |- skos__altLabel mesh__D022461 Caveolin Proteins
% 223.27/223.50  |- mesh__recordMaintainer mesh__D022461 SYSTEM
% 223.27/223.50  |- mesh__publicMeSHNote mesh__D022461 2001   
% 223.27/223.50  |- mesh__dateEstablished mesh__D022461 2001-01-01
% 223.27/223.50  |- skos__related mesh__D022461smesh__D021941
% 223.27/223.50  |- mesh__recordAuthorizer mesh__D022461 sjn
% 223.27/223.50  |- skos__historyNote mesh__D022461 Membrane Proteins %28%1992-2000%29%
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D016424 2006
% 223.27/223.50  |- mesh__recordOriginator mesh__D016424 TAP
% 223.27/223.50  |- mesh__historyNote mesh__D016424 1991   
% 223.27/223.50  |- skos__broader mesh__D016424smesh__D052180
% 223.27/223.50  |- rdf__type mesh__D016424sskos__Concept
% 223.27/223.50  |- skos__altLabel mesh__D016424 Overall
% 223.27/223.50  |- skos__broader mesh__D016424smesh__D016423
% 223.27/223.50  |- skos__prefLabel mesh__D016424 Overall %5B%Publication Type%5D%
% 223.27/223.50  |- skos__altLabel mesh__D016424 Overall %28%PT%29%
% 223.27/223.50  |- mesh__dateEstablished mesh__D016424 1996-01-01
% 223.27/223.50  |- mesh__dateCreated mesh__D016424 1995-06-23
% 223.27/223.50  |- mesh__dateRevised mesh__D016424 2005-06-30
% 223.27/223.50  |- mesh__recordAuthorizer mesh__D016424 sjn
% 223.27/223.50  |- mesh__recordMaintainer mesh__D016424 jls
% 223.27/223.50  |- skos__scopeNote mesh__D016424
% 223.27/223.50       A single citation covering several articles of various degrees of specificity or a single citation covering papers or abstracts presented at a meeting. A subject overall refers to a series of articles on a single subject; a congress overall refers to papers presented at a formal local, regional, national, or international gathering; a society overall refers to papers presented at an annual, semi-annual, monthly, weekly, or other meeting of a society, academy, institute, hospital, etc. The publication type may be used for a single citation with or without the additional indexing or cataloging of individual papers. The individual papers, however, are not labeled OVERALL.%A%    
% 223.27/223.50  |- mesh__onlineNote mesh__D016424
% 223.27/223.50       search policy: Online Manual; use: main heading AND OVERALL %28%PT%29%%A%  
% 223.27/223.50  |- rdf__type mesh__D002404sskos__Concept
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D002404 2000
% 223.27/223.50  |- skos__hiddenLabel mesh__D002404 Cannulations
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D002404 2003
% 223.27/223.50  |- mesh__recordOriginator mesh__D002404 NLM
% 223.27/223.50  |- mesh__dateRevised mesh__D002404 1999-11-03
% 223.27/223.50  |- skos__scopeNote mesh__D002404
% 223.27/223.50       Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions.%A%    
% 223.27/223.50  |- skos__hiddenLabel mesh__D002404 Cannulas
% 223.27/223.50  |- mesh__dateCreated mesh__D002404 1999-01-01
% 223.27/223.50  |- mesh__recordAuthorizer mesh__D002404 sjn
% 223.27/223.50  |- skos__hiddenLabel mesh__D002404 Catheterizations
% 223.27/223.50  |- mesh__recordMaintainer mesh__D002404 ags
% 223.27/223.50  |- skos__broader mesh__D002404smesh__D013812
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D002404 2006
% 223.27/223.50  |- skos__prefLabel mesh__D002404 Catheterization
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D002404 2002
% 223.27/223.50  |- skos__broader mesh__D002404smesh__D008919
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D002404 2005
% 223.27/223.50  |- skos__related mesh__D002404smesh__D002408
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D002404 2001
% 223.27/223.50  |- skos__annotation mesh__D002404
% 223.27/223.50       GEN or unspecified; prefer specifics; do not use /util except by MeSH definition; DF: CATH%A%  
% 223.27/223.50  |- skos__hiddenLabel mesh__D002404 Catheters
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D002404 2004
% 223.27/223.50  |- skos__related mesh__D002404smesh__D016748
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007698 2000
% 223.27/223.50  |- skos__prefLabel mesh__D007698 Kinesis
% 223.27/223.50  |- mesh__recordOriginator mesh__D007698 NLM
% 223.27/223.50  |- mesh__recordAuthorizer mesh__D007698 PLS
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007698 2003
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007698 1997
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007698 1994
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007698 2001
% 223.27/223.50  |- skos__broader mesh__D007698smesh__D009949
% 223.27/223.50  |- skos__scopeNote mesh__D007698
% 223.27/223.50       Locomotor behavior not involving a steering reaction, but in which there may be a turning random in direction. It includes orthokinesis, the rate of movement and klinokinesis, the amount of turning, which are related to the intensity of stimulation.%A%    
% 223.27/223.50  |- mesh__historyNote mesh__D007698
% 223.27/223.50       91%28%75%29%; was see under ORIENTATION 1975-90   
% 223.27/223.50  |- mesh__publicMeSHNote mesh__D007698
% 223.27/223.50       91; was see under ORIENTATION 1975-90   
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007698 2004
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007698 1995
% 223.27/223.50  |- mesh__recordMaintainer mesh__D007698 TAP
% 223.27/223.50  |- skos__hiddenLabel mesh__D007698 Kineses
% 223.27/223.50  |- rdf__type mesh__D007698sskos__Concept
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007698 1998
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007698 2002
% 223.27/223.50  |- skos__annotation mesh__D007698
% 223.27/223.50       do not confuse with KINETICS or KINESICS   
% 223.27/223.50  |- mesh__dateEstablished mesh__D007698 1991-01-01
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007698 1999
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007698 2005
% 223.27/223.50  |- mesh__onlineNote mesh__D007698 search ORIENTATION 1968-74   
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007698 1993
% 223.27/223.50  |- mesh__dateCreated mesh__D007698 1999-01-01
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007698 1996
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007698 2006
% 223.27/223.50  |- mesh__dateRevised mesh__D007698 1992-05-14
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012832 2003
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012832 1995
% 223.27/223.50  |- mesh__historyNote mesh__D012832
% 223.27/223.50       91%28%64%29%; was see under LUNG DISEASES 1964-90   
% 223.27/223.50  |- skos__hiddenLabel mesh__D012832 Disease, Silo Filler
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012832 1999
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012832 1994
% 223.27/223.50  |- skos__hiddenLabel mesh__D012832 Disease, Silo Fillers%27%
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012832 1997
% 223.27/223.50  |- mesh__dateEstablished mesh__D012832 1991-01-01
% 223.27/223.50  |- mesh__dateCreated mesh__D012832 1999-01-01
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012832 1998
% 223.27/223.50  |- skos__scopeNote mesh__D012832
% 223.27/223.50       Pneumonia or bronchiolitis caused by inhalation of nitrogen dioxide released by silage.%A%    
% 223.27/223.50  |- skos__hiddenLabel mesh__D012832 Disease, Silo Filler%27%s
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012832 2002
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012832 1996
% 223.27/223.50  |- skos__altLabel mesh__D012832 Silo Fillers%27% Disease
% 223.27/223.50  |- skos__hiddenLabel mesh__D012832 Disease, Silo Fillers
% 223.27/223.50  |- skos__broader mesh__D012832smesh__D008171
% 223.27/223.50  |- skos__prefLabel mesh__D012832 Silo Filler%27%s Disease
% 223.27/223.50  |- skos__broader mesh__D012832smesh__D000382
% 223.27/223.50  |- mesh__recordOriginator mesh__D012832 NLM
% 223.27/223.50  |- skos__altLabel mesh__D012832 Silo Filler Disease
% 223.27/223.50  |- mesh__publicMeSHNote mesh__D012832
% 223.27/223.50       91; was see under LUNG DISEASES 1964-90   
% 223.27/223.50  |- skos__annotation mesh__D012832
% 223.27/223.50       agric worker%27%s pneumonia or bronchiolitis from silage inhalation%A%  
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012832 2006
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012832 2001
% 223.27/223.50  |- mesh__dateRevised mesh__D012832 1993-06-03
% 223.27/223.50  |- skos__altLabel mesh__D012832 Silo Fillers Disease
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012832 2004
% 223.27/223.50  |- mesh__recordAuthorizer mesh__D012832 PLS
% 223.27/223.50  |- rdf__type mesh__D012832sskos__Concept
% 223.27/223.50  |- mesh__recordMaintainer mesh__D012832 TGC
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012832 2005
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012832 2000
% 223.27/223.50  |- skos__broader mesh__D012034smesh__D011309
% 223.27/223.50  |- skos__hiddenLabel mesh__D012034 Cold Chains
% 223.27/223.50  |- skos__related mesh__D012034smesh__D007036
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012034 2002
% 223.27/223.50  |- mesh__recordMaintainer mesh__D012034 nns
% 223.27/223.50  |- skos__prefLabel mesh__D012034 Refrigeration
% 223.27/223.50  |- mesh__historyNote mesh__D012034
% 223.27/223.50       was in Cat E %26% J 1967-81, was in Cat G only 1963-66   
% 223.27/223.50  |- skos__hiddenLabel mesh__D012034 Chains, Cold
% 223.27/223.50  |- rdf__type mesh__D012034sskos__Concept
% 223.27/223.50  |- mesh__dateCreated mesh__D012034 1999-01-01
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012034 2003
% 223.27/223.50  |- mesh__recordOriginator mesh__D012034 NLM
% 223.27/223.50  |- skos__hiddenLabel mesh__D012034 Chain, Cold
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012034 2005
% 223.27/223.50  |- mesh__recordAuthorizer mesh__D012034 sjn
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012034 2004
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012034 2006
% 223.27/223.50  |- mesh__dateRevised mesh__D012034 2001-07-25
% 223.27/223.50  |- skos__broader mesh__D050153smesh__D000273
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D050153 2006
% 223.27/223.50  |- mesh__historyNote mesh__D050153 2006   
% 223.27/223.50  |- skos__altLabel mesh__D050153 Abdominal Adipose Tissue
% 223.27/223.50  |- mesh__recordOriginator mesh__D050153 lkt
% 223.27/223.50  |- mesh__dateEstablished mesh__D050153 2006-01-01
% 223.27/223.50  |- mesh__recordAuthorizer mesh__D050153 sjn
% 223.27/223.50  |- skos__historyNote mesh__D050153 Adipose Tissue %28%1966-2005%29%
% 223.27/223.50  |- skos__altLabel mesh__D050153 Adipose Tissue, Abdominal
% 223.27/223.50  |- mesh__recordMaintainer mesh__D050153 lkt
% 223.27/223.50  |- mesh__dateCreated mesh__D050153 2005-06-30
% 223.27/223.50  |- rdf__type mesh__D050153sskos__Concept
% 223.27/223.50  |- skos__scopeNote mesh__D050153
% 223.27/223.50       Fatty tissue in the region of the ABDOMEN. It includes the ABDOMINAL SUBCUTANEOUS FAT and the INTRA-ABDOMINAL FAT.%A%    
% 223.27/223.50  |- skos__prefLabel mesh__D050153 Abdominal Fat
% 223.27/223.50  |- skos__altLabel mesh__D050153 Fat, Abdominal
% 223.27/223.50  |- skos__hiddenLabel mesh__D050153 Fats, Abdominal
% 223.27/223.50  |- skos__hiddenLabel mesh__D050153 Abdominal Fats
% 223.27/223.50  |- mesh__publicMeSHNote mesh__D050153 2006   
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D008791 1990
% 223.27/223.50  |- skos__broader mesh__D008791smesh__D000825
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D008791 2002
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D008791 1994
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D008791 2006
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D008791 1999
% 223.27/223.50  |- mesh__recordAuthorizer mesh__D008791 NLM
% 223.27/223.50  |- mesh__publicMeSHNote mesh__D008791 75   
% 223.27/223.50  |- mesh__historyNote mesh__D008791 75   
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D008791 1991
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D008791 1989
% 223.27/223.50  |- skos__hiddenLabel mesh__D008791 Glands, Metrial
% 223.27/223.50  |- skos__annotation mesh__D008791 female; animal only   
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D008791 1995
% 223.27/223.50  |- skos__scopeNote mesh__D008791
% 223.27/223.50       Collection of granular epithelial cells in the uterine muscle beneath the placenta that develop during pregnancy in certain species of animals.%A%    
% 223.27/223.50  |- skos__historyNote mesh__D008791 Uterus %28%1966-1974%29%
% 223.27/223.50  |- mesh__dateEstablished mesh__D008791 1975-09-01
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D008791 2003
% 223.27/223.50  |- rdf__type mesh__D008791sskos__Concept
% 223.27/223.50  |- mesh__recordOriginator mesh__D008791 NLM
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D008791 1996
% 223.27/223.50  |- mesh__recordMaintainer mesh__D008791 GJB
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D008791 2000
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D008791 1992
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D008791 2004
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D008791 1997
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D008791 2001
% 223.27/223.50  |- skos__hiddenLabel mesh__D008791 Gland, Metrial
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D008791 1993
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D008791 2005
% 223.27/223.50  |- mesh__dateCreated mesh__D008791 1974-11-11
% 223.27/223.50  |- skos__hiddenLabel mesh__D008791 Metrial Glands
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D008791 1998
% 223.27/223.50  |- mesh__dateRevised mesh__D008791 1978-12-07
% 223.27/223.50  |- skos__prefLabel mesh__D008791 Metrial Gland
% 223.27/223.50  |- rdf__type mesh__D022462sskos__Concept
% 223.27/223.50  |- skos__broader mesh__D022462smesh__D014614
% 223.27/223.50  |- skos__prefLabel mesh__D022462 Vaccines, Edible
% 223.27/223.50  |- mesh__recordAuthorizer mesh__D022462 sjn
% 223.27/223.50  |- skos__annotation mesh__D022462
% 223.27/223.50       IM general only; coord NIM with specific vaccine %28%IM%29%   
% 223.27/223.50  |- mesh__recordOriginator mesh__D022462 ags
% 223.27/223.50  |- skos__scopeNote mesh__D022462
% 223.27/223.50       Vaccines or candidate vaccines derived from edible plants. Transgenic plants %28%PLANTS, TRANSGENIC%29% are used as recombinant protein production systems and the edible plant tissue functions as an oral vaccine.%A%    
% 223.27/223.50  |- skos__hiddenLabel mesh__D022462 Edible Vaccines
% 223.27/223.50  |- mesh__dateEstablished mesh__D022462 2001-01-01
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D022462 2006
% 223.27/223.50  |- mesh__dateCreated mesh__D022462 2000-06-22
% 223.27/223.50  |- mesh__historyNote mesh__D022462 2001   
% 223.27/223.50  |- mesh__dateRevised mesh__D022462 2005-06-30
% 223.27/223.50  |- skos__broader mesh__D022462smesh__D022223
% 223.27/223.50  |- mesh__recordMaintainer mesh__D022462 ssb
% 223.27/223.50  |- mesh__publicMeSHNote mesh__D022462 2001   
% 223.27/223.50  |- skos__broader mesh__D016425smesh__D052181
% 223.27/223.50  |- skos__scopeNote mesh__D016425
% 223.27/223.50       Work consisting of an acknowledgment of an error, issued by a publisher, editor, or author. It customarily cites the source where the error occurred, giving complete bibliographic data for retrieval. In the case of books and monographs, author, title, imprint, paging, and other helpful references will be given; in the case of journal articles, the author, title, paging, and journal reference will be shown. An erratum notice is variously cited as Errata or Corrigenda.%A%    
% 223.27/223.50  |- mesh__recordMaintainer mesh__D016425 jls
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D016425 2006
% 223.27/223.50  |- skos__broader mesh__D016425smesh__D052180
% 223.27/223.50  |- skos__altLabel mesh__D016425 Published Erratum
% 223.27/223.50  |- skos__altLabel mesh__D016425 Corrigenda
% 223.27/223.50  |- mesh__dateCreated mesh__D016425 1995-06-23
% 223.27/223.50  |- mesh__dateRevised mesh__D016425 2005-06-30
% 223.27/223.50  |- mesh__recordAuthorizer mesh__D016425 sjn
% 223.27/223.50  |- skos__annotation mesh__D016425
% 223.27/223.50       publication type only; see also CORRECTED AND REPUBLISHED ARTICLE %5B%Publication Type%5D%;  CATALOG: do not use%A%  
% 223.27/223.50  |- skos__altLabel mesh__D016425 Errata
% 223.27/223.50  |- skos__altLabel mesh__D016425 Corrigenda %28%PT%29%
% 223.27/223.50  |- rdf__type mesh__D016425sskos__Concept
% 223.27/223.50  |- mesh__historyNote mesh__D016425 1991   
% 223.27/223.50  |- skos__altLabel mesh__D016425 Published Erratum %28%PT%29%
% 223.27/223.50  |- skos__prefLabel mesh__D016425 Published Erratum %5B%Publication Type%5D%
% 223.27/223.50  |- skos__altLabel mesh__D016425 Errata %28%PT%29%
% 223.27/223.50  |- mesh__recordOriginator mesh__D016425 TAP
% 223.27/223.50  |- mesh__dateEstablished mesh__D016425 1996-01-01
% 223.27/223.50  |- skos__hiddenLabel mesh__D002405 Venous Catheterizations, Central
% 223.27/223.50  |- skos__hiddenLabel mesh__D002405 Catheterizations, Central
% 223.27/223.50  |- mesh__dateRevised mesh__D002405 1993-02-20
% 223.27/223.50  |- mesh__dateEstablished mesh__D002405 1988-01-01
% 223.27/223.50  |- skos__altLabel mesh__D002405 Venous Catheterization, Central
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D002405 1998
% 223.27/223.50  |- skos__prefLabel mesh__D002405 Catheterization, Central Venous
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D002405 2002
% 223.27/223.50  |- mesh__publicMeSHNote mesh__D002405 88   
% 223.27/223.50  |- skos__historyNote mesh__D002405 Catheterization %28%1966-1987%29%
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D002405 2006
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D002405 1997
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D002405 2001
% 223.27/223.50  |- skos__altLabel mesh__D002405 Catheterization, Central
% 223.27/223.50  |- skos__broader mesh__D002405smesh__D002404
% 223.27/223.50  |- skos__related mesh__D002405smesh__D016748
% 223.27/223.50  |- skos__altLabel mesh__D002405 Central Venous Catheterization
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D002405 2005
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D002405 1996
% 223.27/223.50  |- skos__scopeNote mesh__D002405
% 223.27/223.50       Placement of an intravenous catheter in the subclavian, jugular, or other central vein for central venous pressure determination, chemotherapy, hemodialysis, or hyperalimentation.%A%    
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D002405 2000
% 223.27/223.50  |- mesh__recordAuthorizer mesh__D002405 NLM
% 223.27/223.50  |- mesh__recordOriginator mesh__D002405 SCD
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D002405 2004
% 223.27/223.50  |- rdf__type mesh__D002405sskos__Concept
% 223.27/223.50  |- mesh__recordMaintainer mesh__D002405 PLS
% 223.27/223.50  |- mesh__dateCreated mesh__D002405 1987-05-09
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D002405 2003
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D002405 1995
% 223.27/223.50  |- skos__historyNote mesh__D002405 Catheters, Indwelling %28%1978-1987%29%
% 223.27/223.50  |- skos__hiddenLabel mesh__D002405 Central Venous Catheterizations
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D002405 1999
% 223.27/223.50  |- skos__annotation mesh__D002405
% 223.27/223.50       do not use /util except by MeSH definition; DF: CATH CENTRAL%A%  
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D002405 1994
% 223.27/223.50  |- skos__hiddenLabel mesh__D002405 Central Catheterizations
% 223.27/223.50  |- skos__altLabel mesh__D002405 Central Catheterization
% 223.27/223.50  |- mesh__historyNote mesh__D002405 88   
% 223.27/223.50  |- skos__hiddenLabel mesh__D002405 Catheterizations, Central Venous
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007699 2004
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007699 1995
% 223.27/223.50  |- skos__scopeNote mesh__D007699
% 223.27/223.50       The sense by which muscular motion, weight, position, etc., are perceived.%A%    
% 223.27/223.50  |- skos__annotation mesh__D007699
% 223.27/223.50       TN 129: definition %26% relation to MOTION PERCEPTION   
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007699 2000
% 223.27/223.50  |- rdf__type mesh__D007699sskos__Concept
% 223.27/223.50  |- mesh__recordOriginator mesh__D007699 NLM
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007699 1998
% 223.27/223.50  |- mesh__recordAuthorizer mesh__D007699 PLS
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007699 2001
% 223.27/223.50  |- mesh__recordMaintainer mesh__D007699 PLS
% 223.27/223.50  |- skos__prefLabel mesh__D007699 Kinesthesis
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007699 1999
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007699 2005
% 223.27/223.50  |- mesh__dateCreated mesh__D007699 1999-01-01
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007699 1996
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007699 2006
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007699 2002
% 223.27/223.50  |- skos__broader mesh__D007699smesh__D011434
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007699 1997
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D007699 2003
% 223.27/223.50  |- mesh__dateRevised mesh__D007699 1994-06-28
% 223.27/223.50  |- skos__hiddenLabel mesh__D007699 Kinestheses
% 223.27/223.50  |- mesh__publicMeSHNote mesh__D012833
% 223.27/223.50       91; was see under SILICONES 1975-90   
% 223.27/223.50  |- mesh__dateEstablished mesh__D012833 1991-01-01
% 223.27/223.50  |- mesh__dateCreated mesh__D012833 1974-11-11
% 223.27/223.50  |- mesh__recordMaintainer mesh__D012833 jmp
% 223.27/223.50  |- skos__prefLabel mesh__D012833 Siloxanes
% 223.27/223.50  |- mesh__dateRevised mesh__D012833 2004-07-07
% 223.27/223.50  |- skos__altLabel mesh__D012833 Polysiloxane
% 223.27/223.50  |- mesh__recordAuthorizer mesh__D012833 sjn
% 223.27/223.50  |- mesh__historyNote mesh__D012833
% 223.27/223.50       91%28%75%29%; was see under SILICONES 1975-90   
% 223.27/223.50  |- skos__annotation mesh__D012833 silicon polymers; D25-26 qualif   
% 223.27/223.50  |- skos__broader mesh__D012833smesh__D017646
% 223.27/223.50  |- skos__historyNote mesh__D012833 Silicones %28%1968-1974%29%
% 223.27/223.50  |- skos__broader mesh__D012833smesh__D017655
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012833 2006
% 223.27/223.50  |- rdf__type mesh__D012833sskos__Concept
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012833 2005
% 223.27/223.50  |- mesh__recordOriginator mesh__D012833 NLM
% 223.27/223.50  |- skos__broader mesh__D012833smesh__D011108
% 223.27/223.50  |- skos__scopeNote mesh__D012833
% 223.27/223.50       Silicon polymers that contain alternate silicon and oxygen atoms in linear or cyclic molecular structures.%A%    
% 223.27/223.50  |- skos__altLabel mesh__D012035 Phytanic Acid Storage Disease
% 223.27/223.50  |- mesh__recordAuthorizer mesh__D012035 sjn
% 223.27/223.50  |- skos__altLabel mesh__D012035 Refsum-Thiebaut Syndrome
% 223.27/223.50  |- skos__hiddenLabel mesh__D012035 Syndrome, Refsum%27%s
% 223.27/223.50  |- mesh__dateCreated mesh__D012035 1999-01-01
% 223.27/223.50  |- skos__scopeNote mesh__D012035
% 223.27/223.50       An autosomal recessive familial disorder that usually presents in childhood with POLYNEUROPATHY, sensorineural DEAFNESS; ICHTHYOSIS; ATAXIA; RETINITIS PIGMENTOSA; and cardiomyopathy. CEREBROSPINAL FLUID PROTEINS and serum PHYTANIC ACID are generally elevated. This condition is associated with the impaired metabolism of phytanic acid in PEROXISOMES. %28%From Joynt, Clinical Neurology, 1991, Ch37, p58-9; Rev Med Interne 1996;17%28%5%29%:391-8%29%%A%    
% 223.27/223.50  |- mesh__historyNote mesh__D012035
% 223.27/223.50       96; was REFSUM%27%S DISEASE 1991-95; was REFSUM%27%S SYNDROME 1964-90 %28%Prov 1964-66%29%%A%  
% 223.27/223.50  |- skos__altLabel mesh__D012035 HMSN Type IV
% 223.27/223.50  |- skos__hiddenLabel mesh__D012035
% 223.27/223.50       Heredoataxia Polyneuritiformis, Hemeralopia
% 223.27/223.50  |- skos__altLabel mesh__D012035 Heredopathia Atactica Polyneuritiformis
% 223.27/223.50  |- skos__altLabel mesh__D012035
% 223.27/223.50       Hereditary Type IV Motor and Sensory Neuropathy
% 223.27/223.50  |- skos__broader mesh__D012035smesh__D018901
% 223.27/223.50  |- skos__hiddenLabel mesh__D012035 Refsum Thiebaut Syndrome
% 223.27/223.50  |- mesh__publicMeSHNote mesh__D012035
% 223.27/223.50       96; was REFSUM%27%S DISEASE 1991-95; was REFSUM%27%S SYNDROME 1967-90%A%  
% 223.27/223.50  |- skos__broader mesh__D012035smesh__D015417
% 223.27/223.50  |- skos__broader mesh__D012035smesh__D008064
% 223.27/223.50  |- skos__annotation mesh__D012035
% 223.27/223.50       do not confuse with REFSUM DISEASE, INFANTILE see PEROXISOMAL DISORDERS%A%  
% 223.27/223.50  |- mesh__dateRevised mesh__D012035 2002-07-03
% 223.27/223.50  |- skos__hiddenLabel mesh__D012035 Syndromes, Refsum-Thiebaut
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012035 2006
% 223.27/223.50  |- skos__hiddenLabel mesh__D012035 Polyneuritiformis, Heredopathia Atactica
% 223.27/223.50  |- mesh__dateEstablished mesh__D012035 1967-01-01
% 223.27/223.50  |- mesh__recordMaintainer mesh__D012035 mdb
% 223.27/223.50  |- skos__hiddenLabel mesh__D012035 Refsums Disease
% 223.27/223.50  |- skos__altLabel mesh__D012035 Hemeralopia Heredoataxia Polyneuritiformis
% 223.27/223.50  |- skos__altLabel mesh__D012035 Refsum%27%s Disease
% 223.27/223.50  |- skos__altLabel mesh__D012035 Refsum%27%s Syndrome
% 223.27/223.50  |- skos__altLabel mesh__D012035
% 223.27/223.50       Hereditary-Motor and Sensory-Neuropathy Type IV
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012035 2005
% 223.27/223.50  |- rdf__type mesh__D012035sskos__Concept
% 223.27/223.50  |- skos__hiddenLabel mesh__D012035
% 223.27/223.50       Polyneuritiformis, Hemeralopia Heredoataxia
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012035 2004
% 223.27/223.50  |- skos__prefLabel mesh__D012035 Refsum Disease
% 223.27/223.50  |- mesh__recordOriginator mesh__D012035 NLM
% 223.27/223.50  |- skos__hiddenLabel mesh__D012035 Refsum-Thiebaut Syndromes
% 223.27/223.50  |- mesh__onlineNote mesh__D012035
% 223.27/223.50       use REFSUM DISEASE to search REFSUM%27%S SYNDROME 1966-90   
% 223.27/223.50  |- skos__hiddenLabel mesh__D012035 Refsum Syndrome
% 223.27/223.50  |- mesh__activeMeSHYear mesh__D012035 2003
% 223.27/223.50  |- skos__hiddenLabel mesh__D012035 Refsums Syndrome
% 223.27/223.50  |- skos__hiddenLabel mesh__D012035 Syndrome, Refsum-Thiebaut
% 223.27/223.50  |- skos__altLabel mesh__D012035
% 223.27/223.50       Neuropathy, Hereditary Motor and Sensory, Type IV
% 223.27/223.50  |- mesh__historyNote mesh__D050154 2006   
% 223.27/223.50  |- skos__prefLabel mesh__D050154 Adiposity
% 223.27/223.50  |- skos__annotation mesh__D050154 index body fat at ADIPOSE TISSUE   
% 223.27/223.50  |- mesh__dateEstablished mesh__D050154 2006-01-01
% 223.27/223.50  |- rdf__type mesh__D050154sskos__Concept
% 223.27/223.50  |- skos__broader mesh__D050154smesh__D050218
% 223.27/223.50  |- skos__historyNote mesh__D050154 Obesity %28%1965-2005%29%
% 223.27/223.50  |- mesh__recordAuthorizer mesh__D050154 sjn
% 223.27/223.51  |- mesh__publicMeSHNote mesh__D050154 2006   
% 223.27/223.51  |- skos__scopeNote mesh__D050154
% 223.27/223.51       The amount of fat or lipid deposit at a site or an organ in the body, an indicator of body fat status.%A%    
% 223.27/223.51  |- mesh__recordMaintainer mesh__D050154 lkt
% 223.27/223.51  |- mesh__dateCreated mesh__D050154 2005-06-30
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D050154 2006
% 223.27/223.51  |- mesh__recordOriginator mesh__D050154 lkt
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D008792 2001
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D008792 1995
% 223.27/223.51  |- mesh__dateRevised mesh__D008792 1992-05-15
% 223.27/223.51  |- mesh__dateCreated mesh__D008792 1999-01-01
% 223.27/223.51  |- skos__broader mesh__D008792smesh__D014894
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D008792 2002
% 223.27/223.51  |- skos__hiddenLabel mesh__D008792 Metric Systems
% 223.27/223.51  |- skos__hiddenLabel mesh__D008792 Systems, Metric
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D008792 2003
% 223.27/223.51  |- rdf__type mesh__D008792sskos__Concept
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D008792 1996
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D008792 2004
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D008792 1997
% 223.27/223.51  |- skos__hiddenLabel mesh__D008792 System, Metric
% 223.27/223.51  |- mesh__recordMaintainer mesh__D008792 TAP
% 223.27/223.51  |- mesh__publicMeSHNote mesh__D008792 74   
% 223.27/223.51  |- mesh__dateEstablished mesh__D008792 1974-01-01
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D008792 1993
% 223.27/223.51  |- mesh__recordAuthorizer mesh__D008792 PLS
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D008792 2005
% 223.27/223.51  |- mesh__recordOriginator mesh__D008792 NLM
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D008792 1998
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D008792 2000
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D008792 2006
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D008792 1994
% 223.27/223.51  |- skos__prefLabel mesh__D008792 Metric System
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D008792 1999
% 223.27/223.51  |- mesh__historyNote mesh__D008792 74   
% 223.27/223.51  |- mesh__dateEstablished mesh__D016426 1996-01-01
% 223.27/223.51  |- skos__annotation mesh__D016426
% 223.27/223.51       publication type only; for reports of questionable data identified by the UNITED STATES OFFICE OF RESEARCH INTEGRITY and carried in the NIH Guide to Grants and Contracts; not a review article; for scientific integrity as a subject, consider main heading SCIENTIFIC MISCONDUCT%A%  
% 223.27/223.51  |- mesh__recordMaintainer mesh__D016426 jls
% 223.27/223.51  |- rdf__type mesh__D016426sskos__Concept
% 223.27/223.51  |- mesh__dateCreated mesh__D016426 1995-06-23
% 223.27/223.51  |- mesh__dateRevised mesh__D016426 2005-06-30
% 223.27/223.51  |- skos__altLabel mesh__D016426 Scientific Integrity Review %28%PT%29%
% 223.27/223.51  |- mesh__recordAuthorizer mesh__D016426 sjn
% 223.27/223.51  |- skos__prefLabel mesh__D016426
% 223.27/223.51       Scientific Integrity Review %5B%Publication Type%5D%
% 223.27/223.51  |- skos__altLabel mesh__D016426 Scientific Integrity Review
% 223.27/223.51  |- mesh__recordOriginator mesh__D016426 TAP
% 223.27/223.51  |- skos__scopeNote mesh__D016426
% 223.27/223.51       Work consisting of reports by the United States Office of Research Integrity, identifying questionable research published in articles or books. Notification of the questionable data is carried in the NIH Guide for Grants and Contracts.%A%    
% 223.27/223.51  |- mesh__historyNote mesh__D016426 1991   
% 223.27/223.51  |- skos__broader mesh__D016426smesh__D052182
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D016426 2006
% 223.27/223.51  |- skos__annotation mesh__D002406
% 223.27/223.51       do not use /util except by MeSH definition; DF: CATH PERIPHERAL%A%  
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D002406 2005
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D002406 2000
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D002406 1996
% 223.27/223.51  |- skos__hiddenLabel mesh__D002406 Bronchial Catheterizations
% 223.27/223.51  |- mesh__recordMaintainer mesh__D002406 PLS
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D002406 2006
% 223.27/223.51  |- skos__historyNote mesh__D002406 Heart Catheterization %28%1966-1987%29%
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D002406 2001
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D002406 1997
% 223.27/223.51  |- skos__hiddenLabel mesh__D002406 Peripheral Catheterizations
% 223.27/223.51  |- skos__hiddenLabel mesh__D002406 Arterial Catheterizations, Peripheral
% 223.27/223.51  |- skos__scopeNote mesh__D002406
% 223.27/223.51       Insertion of a catheter into a peripheral artery, vein, or airway for diagnostic or therapeutic purposes.%A%    
% 223.27/223.51  |- mesh__dateCreated mesh__D002406 1987-05-09
% 223.27/223.51  |- rdf__type mesh__D002406sskos__Concept
% 223.27/223.51  |- skos__hiddenLabel mesh__D002406 Catheterizations, Bronchial
% 223.27/223.51  |- skos__broader mesh__D002406smesh__D002404
% 223.27/223.51  |- mesh__dateRevised mesh__D002406 1993-02-20
% 223.27/223.51  |- skos__historyNote mesh__D002406 Catheters, Indwelling %28%1978-1987%29%
% 223.27/223.51  |- skos__hiddenLabel mesh__D002406 Catheterizations, Peripheral Venous
% 223.27/223.51  |- mesh__recordAuthorizer mesh__D002406 NLM
% 223.27/223.51  |- skos__altLabel mesh__D002406 Catheterization, Peripheral Venous
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D002406 2002
% 223.27/223.51  |- skos__altLabel mesh__D002406 Arterial Catheterization, Peripheral
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D002406 1998
% 223.27/223.51  |- skos__historyNote mesh__D002406 Bronchi %28%1966-1987%29%
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D002406 2003
% 223.27/223.51  |- mesh__recordOriginator mesh__D002406 SCD
% 223.27/223.51  |- skos__altLabel mesh__D002406 Peripheral Arterial Catheterization
% 223.27/223.51  |- skos__hiddenLabel mesh__D002406 Catheterizations, Peripheral Arterial
% 223.27/223.51  |- skos__historyNote mesh__D002406 Bronchoscopy %28%1966-1987%29%
% 223.27/223.51  |- skos__hiddenLabel mesh__D002406 Peripheral Arterial Catheterizations
% 223.27/223.51  |- skos__hiddenLabel mesh__D002406 Venous Catheterizations, Peripheral
% 223.27/223.51  |- skos__altLabel mesh__D002406 Venous Catheterization, Peripheral
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D002406 1994
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D002406 1999
% 223.27/223.51  |- skos__altLabel mesh__D002406 Bronchial Catheterization
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D002406 2004
% 223.27/223.51  |- mesh__dateEstablished mesh__D002406 1988-01-01
% 223.27/223.51  |- skos__prefLabel mesh__D002406 Catheterization, Peripheral
% 223.27/223.51  |- skos__altLabel mesh__D002406 Peripheral Catheterization
% 223.27/223.51  |- skos__hiddenLabel mesh__D002406 Peripheral Venous Catheterizations
% 223.27/223.51  |- mesh__historyNote mesh__D002406 88   
% 223.27/223.51  |- skos__historyNote mesh__D002406 Catheterization %28%1966-1987%29%
% 223.27/223.51  |- skos__hiddenLabel mesh__D002406 Catheterizations, Peripheral
% 223.27/223.51  |- mesh__publicMeSHNote mesh__D002406 88   
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D002406 1995
% 223.27/223.51  |- mesh__dateEstablished mesh__D048508 2005-01-01
% 223.27/223.51  |- mesh__publicMeSHNote mesh__D048508 2005   
% 223.27/223.51  |- mesh__recordMaintainer mesh__D048508 ags
% 223.27/223.51  |- mesh__recordAuthorizer mesh__D048508 sjn
% 223.27/223.51  |- skos__prefLabel mesh__D048508 Rhipicephalus sanguineus
% 223.27/223.51  |- skos__altLabel mesh__D048508 Brown Dog Tick
% 223.27/223.51  |- skos__scopeNote mesh__D048508
% 223.27/223.51       A species of tick %28%TICKS%29% in the family IXODIDAE, distributed throughout the world but abundant in southern Europe. It will feed on a wide variety of MAMMALS, but DOGS are its preferred host. It transmits a large number of diseases including BABESIOSIS; THEILERIASIS; EHRLICHIOSIS; and MEDITERRANEAN SPOTTED FEVER.%A%    
% 223.27/223.51  |- skos__historyNote mesh__D048508 Ticks %28%1966-2001%29%
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D048508 2005
% 223.27/223.51  |- rdf__type mesh__D048508sskos__Concept
% 223.27/223.51  |- mesh__dateCreated mesh__D048508 2004-07-07
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D048508 2006
% 223.27/223.51  |- skos__broader mesh__D048508smesh__D048494
% 223.27/223.51  |- mesh__recordOriginator mesh__D048508 ags
% 223.27/223.51  |- skos__historyNote mesh__D048508 Ixodidae %28%2002-2004%29%
% 223.27/223.51  |- mesh__historyNote mesh__D048508 2005   
% 223.27/223.51  |- mesh__dateRevised mesh__D012834 2001-07-25
% 223.27/223.51  |- skos__broader mesh__D012834smesh__D028561
% 223.27/223.51  |- mesh__recordMaintainer mesh__D012834 jmp
% 223.27/223.51  |- mesh__recordOriginator mesh__D012834 NLM
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D012834 2005
% 223.27/223.51  |- skos__annotation mesh__D012834
% 223.27/223.51       Ag-107; Ag-109 = SILVER %28%IM%29% + ISOTOPES %28%NIM%29%; Ag-102-106, 108, 110-117 = SILVER %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D012834 2003
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D012834 2006
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D012834 2002
% 223.27/223.51  |- skos__scopeNote mesh__D012834
% 223.27/223.51       Silver. An element with the atomic symbol Ag, atomic number 47, and atomic weight 107.87. It is a soft metal that is used medically in surgical instruments, dental prostheses, and alloys. Long-continued use of silver salts can lead to a form of poisoning known as ARGYRIA.%A%    
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D012834 2004
% 223.27/223.51  |- mesh__dateCreated mesh__D012834 1999-01-01
% 223.27/223.51  |- rdf__type mesh__D012834sskos__Concept
% 223.27/223.51  |- mesh__recordAuthorizer mesh__D012834 sjn
% 223.27/223.51  |- skos__broader mesh__D012834smesh__D019216
% 223.27/223.51  |- skos__prefLabel mesh__D012834 Silver
% 223.27/223.51  |- skos__prefLabel mesh__D012036 Refugees
% 223.27/223.51  |- rdf__type mesh__D012036sskos__Concept
% 223.27/223.51  |- mesh__dateCreated mesh__D012036 1999-01-01
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D012036 2003
% 223.27/223.51  |- skos__scopeNote mesh__D012036
% 223.27/223.51       Persons fleeing to a place of safety, especially those who flee to a foreign country or power to escape danger or persecution in their own country or habitual residence because of race, religion, or political belief. %28%Webster, 3d ed%29%%A%    
% 223.27/223.51  |- skos__hiddenLabel mesh__D012036 Refugee Camp
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D012036 2005
% 223.27/223.51  |- skos__hiddenLabel mesh__D012036 Camp, Refugee
% 223.27/223.51  |- skos__hiddenLabel mesh__D012036 Refugee
% 223.27/223.51  |- skos__hiddenLabel mesh__D012036 Camps, Refugee
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D012036 2004
% 223.27/223.51  |- mesh__recordOriginator mesh__D012036 NLM
% 223.27/223.51  |- mesh__dateRevised mesh__D012036 1999-11-03
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D012036 2006
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D012036 2000
% 223.27/223.51  |- mesh__recordAuthorizer mesh__D012036 sjn
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D012036 2001
% 223.27/223.51  |- skos__annotation mesh__D012036 specify geog   
% 223.27/223.51  |- skos__broader mesh__D012036smesh__D009272
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D012036 2002
% 223.27/223.51  |- mesh__recordMaintainer mesh__D012036 kle
% 223.27/223.51  |- mesh__publicMeSHNote mesh__D050155 2006   
% 223.27/223.51  |- rdf__type mesh__D050155sskos__Concept
% 223.27/223.51  |- mesh__recordMaintainer mesh__D050155 lkt
% 223.27/223.51  |- skos__hiddenLabel mesh__D050155 Lipogeneses
% 223.27/223.51  |- skos__broader mesh__D050155smesh__D050356
% 223.27/223.51  |- skos__annotation mesh__D050155
% 223.27/223.51       do not confuse with ADIPOGENESIS, the differentiation of ADIPOCYTES%A%  
% 223.27/223.51  |- mesh__dateCreated mesh__D050155 2005-06-30
% 223.27/223.51  |- mesh__historyNote mesh__D050155 2006   
% 223.27/223.51  |- mesh__dateEstablished mesh__D050155 2006-01-01
% 223.27/223.51  |- mesh__recordOriginator mesh__D050155 lkt
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D050155 2006
% 223.27/223.51  |- skos__scopeNote mesh__D050155
% 223.27/223.51       De novo fat synthesis in the body. This includes the synthetic processes of FATTY ACIDS and subsequent TRIGLYCERIDES in the LIVER and the ADIPOSE TISSUE. Lipogenesis is regulated by numerous factors, including nutritional, hormonal, and genetic elements.%A%    
% 223.27/223.51  |- skos__historyNote mesh__D050155 Fatty Acids %28%1965-2005%29%
% 223.27/223.51  |- mesh__recordAuthorizer mesh__D050155 sjn
% 223.27/223.51  |- skos__prefLabel mesh__D050155 Lipogenesis
% 223.27/223.51  |- mesh__publicMeSHNote mesh__D008793
% 223.27/223.51       78; was see under IODOBENZOATES 1975-77   
% 223.27/223.51  |- mesh__dateRevised mesh__D008793 2004-07-07
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D008793 2006
% 223.27/223.51  |- mesh__recordOriginator mesh__D008793 NLM
% 223.27/223.51  |- skos__prefLabel mesh__D008793 Metrizamide
% 223.27/223.51  |- mesh__dateEstablished mesh__D008793 1978-01-01
% 223.27/223.51  |- mesh__activeMeSHYear mesh__D008793 2005
% 223.27/223.51  |- skos__historyNote mesh__D008793 Benzamides %28%1973-1977%29%
% 223.27/223.51  |- skos__historyNote mesh__D008793 Acetamides %28%1971-1977%29%
% 223.27/223.51  |- skos__scopeNote mesh__D008793
% 223.27/223.51       A solute for density gradient centrifugation offering higher maximum solution density without the problems of increased viscosity. It is also used as a resorbable, non-ionic contrast medium.%A%    
% 223.27/223.51  |- skos__historyNote mesh__D008793 Glucosamine %28%1966-1977%29%
% 223.27/223.51  |- skos__historyNote mesh__D008793 Iodobenzoates %28%1972-1977%29%
% 223.27/223.51  |- rdf__type mesh__D008793sskos__Concept
% 223.27/223.51  |- mesh__historyNote mesh__D008793
% 223.27/223.51       78%28%75%29%; was see under IODOBENZOATES 1975-77   
% 223.27/223.51  |- mesh__recordAuthorizer mesh__D008793 sjn
% 223.27/223.51  |- skos__altLabel mesh__D008793 Amipaque
% 223.27/223.51  |- mesh__dateCreated mesh__D008793 1974-11-19
% 223.27/223.51  |- skos__broader mesh__D008793smesh__D000617
% 223.37/223.51  |- mesh__recordMaintainer mesh__D008793 ssb
% 223.37/223.51  |- skos__broader mesh__D008793smesh__D014283
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D016427 2006
% 223.37/223.51  |- mesh__dateEstablished mesh__D016427 1996-01-01
% 223.37/223.51  |- mesh__recordMaintainer mesh__D016427 jls
% 223.37/223.51  |- skos__annotation mesh__D016427 publication type only   
% 223.37/223.51  |- mesh__dateCreated mesh__D016427 1995-06-23
% 223.37/223.51  |- rdf__type mesh__D016427sskos__Concept
% 223.37/223.51  |- mesh__recordAuthorizer mesh__D016427 sjn
% 223.37/223.51  |- skos__prefLabel mesh__D016427 Technical Report %5B%Publication Type%5D%
% 223.37/223.51  |- mesh__dateRevised mesh__D016427 2005-06-30
% 223.37/223.51  |- skos__altLabel mesh__D016427 Technical Report
% 223.37/223.51  |- skos__altLabel mesh__D016427 Technical Report %28%PT%29%
% 223.37/223.51  |- mesh__recordOriginator mesh__D016427 TAP
% 223.37/223.51  |- mesh__historyNote mesh__D016427 1991   
% 223.37/223.51  |- skos__scopeNote mesh__D016427
% 223.37/223.51       Work consisting of a formal report giving details of the investigation and results of a medical or other scientific problem. When issued by a government agency or comparable official body, its contents may be classified, unclassified, or declassified with regard to security clearance. This publication type may also cover a scientific paper or article that records the current state or current position of scientific research and development. If so labeled by the editor or publisher, this publication type may be properly used for journal articles.%A%    
% 223.37/223.51  |- skos__broader mesh__D016427smesh__D052180
% 223.37/223.51  |- skos__related mesh__D002407smesh__D011669
% 223.37/223.51  |- skos__annotation mesh__D002407 DF: CATH SWAN GANZ   
% 223.37/223.51  |- mesh__dateRevised mesh__D002407 1999-11-08
% 223.37/223.51  |- mesh__dateCreated mesh__D002407 1987-05-09
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D002407 2003
% 223.37/223.51  |- skos__broader mesh__D002407smesh__D002406
% 223.37/223.51  |- skos__hiddenLabel mesh__D002407 Swan Ganz Catheterization
% 223.37/223.51  |- skos__hiddenLabel mesh__D002407 Artery Catheterizations, Pulmonary
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D002407 2002
% 223.37/223.51  |- skos__scopeNote mesh__D002407
% 223.37/223.51       Placement of a balloon-tipped catheter into the pulmonary artery through the antecubital, subclavian, and sometimes the femoral vein. It is used to measure pulmonary artery pressure and pulmonary artery wedge pressure which reflects left atrial pressure and left ventricular end-diastolic pressure. The catheter is threaded into the right atrium, the balloon is inflated and the catheter follows the blood flow through the tricuspid valve into the right ventricle and out into the pulmonary artery.%A%    
% 223.37/223.51  |- skos__altLabel mesh__D002407 Swan-Ganz Catheterization
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D002407 2004
% 223.37/223.51  |- mesh__recordOriginator mesh__D002407 SCD
% 223.37/223.51  |- mesh__recordAuthorizer mesh__D002407 sjn
% 223.37/223.51  |- rdf__type mesh__D002407sskos__Concept
% 223.37/223.51  |- mesh__dateEstablished mesh__D002407 1988-01-01
% 223.37/223.51  |- skos__hiddenLabel mesh__D002407 Pulmonary Artery Catheterizations
% 223.37/223.51  |- mesh__historyNote mesh__D002407 88   
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D002407 2000
% 223.37/223.51  |- mesh__recordMaintainer mesh__D002407 adp
% 223.37/223.51  |- skos__historyNote mesh__D002407 Heart Catheterization %28%1971-1987%29%
% 223.37/223.51  |- skos__broader mesh__D002407smesh__D006328
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D002407 2005
% 223.37/223.51  |- skos__hiddenLabel mesh__D002407 Catheterizations, Pulmonary Artery
% 223.37/223.51  |- skos__hiddenLabel mesh__D002407 Artery Catheterization, Pulmonary
% 223.37/223.51  |- skos__altLabel mesh__D002407 Catheterization, Pulmonary Artery
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D002407 2001
% 223.37/223.51  |- skos__prefLabel mesh__D002407 Catheterization, Swan-Ganz
% 223.37/223.51  |- skos__hiddenLabel mesh__D002407 Catheterization, Swan Ganz
% 223.37/223.51  |- mesh__publicMeSHNote mesh__D002407 88   
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D002407 2006
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D012835 2005
% 223.37/223.51  |- mesh__recordMaintainer mesh__D012835 ags
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D012835 2003
% 223.37/223.51  |- skos__hiddenLabel mesh__D012835 Silver Nitrate, Alcoholic
% 223.37/223.51  |- skos__broader mesh__D012835smesh__D009566
% 223.37/223.51  |- skos__scopeNote mesh__D012835
% 223.37/223.51       A silver salt with powerful germicidal activity. It has been used topically to prevent OPHTHALMIA NEONATORUM.%A%    
% 223.37/223.51  |- mesh__recordAuthorizer mesh__D012835 ags
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D012835 2006
% 223.37/223.51  |- mesh__recordOriginator mesh__D012835 NLM
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D012835 2004
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D012835 2006A
% 223.37/223.51  |- mesh__dateCreated mesh__D012835 1999-01-01
% 223.37/223.51  |- rdf__type mesh__D012835sskos__Concept
% 223.37/223.51  |- skos__annotation mesh__D012835
% 223.37/223.51       a local anti-infective agent; /diag use: this is probably SILVER STAINING %28%see note there%29%%A%  
% 223.37/223.51  |- mesh__dateRevised mesh__D012835 2005-07-22
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D012835 2002
% 223.37/223.51  |- skos__broader mesh__D012835smesh__D018030
% 223.37/223.51  |- skos__prefLabel mesh__D012835 Silver Nitrate
% 223.37/223.51  |- skos__hiddenLabel mesh__D012037 Refuse Disposals
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D012037 1995
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D012037 2001
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D012037 1998
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D012037 2004
% 223.37/223.51  |- skos__hiddenLabel mesh__D012037 Disposal, Refuse
% 223.37/223.51  |- rdf__type mesh__D012037sskos__Concept
% 223.37/223.51  |- skos__broader mesh__D012037smesh__D018505
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D012037 2000
% 223.37/223.51  |- skos__hiddenLabel mesh__D012037 Disposals, Solid Waste
% 223.37/223.51  |- mesh__dateCreated mesh__D012037 1999-01-01
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D012037 2003
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D012037 2006
% 223.37/223.51  |- skos__prefLabel mesh__D012037 Refuse Disposal
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D012037 1997
% 223.37/223.51  |- skos__hiddenLabel mesh__D012037 Solid Waste Disposals
% 223.37/223.51  |- mesh__recordOriginator mesh__D012037 NLM
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D012037 2002
% 223.37/223.51  |- mesh__recordMaintainer mesh__D012037 JLS
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D012037 2005
% 223.37/223.51  |- skos__hiddenLabel mesh__D012037 Waste Disposals, Solid
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D012037 1996
% 223.37/223.51  |- mesh__recordAuthorizer mesh__D012037 PLS
% 223.37/223.51  |- skos__broader mesh__D012037smesh__D012498
% 223.37/223.51  |- skos__hiddenLabel mesh__D012037 Solid Waste Disposal
% 223.37/223.51  |- skos__hiddenLabel mesh__D012037 Disposals, Refuse
% 223.37/223.51  |- skos__scopeNote mesh__D012037
% 223.37/223.51       The discarding or destroying of garbage, sewage, or other waste matter or its transformation into something useful or innocuous.%A%    
% 223.37/223.51  |- skos__hiddenLabel mesh__D012037 Disposal, Solid Waste
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D012037 1999
% 223.37/223.51  |- mesh__dateRevised mesh__D012037 1994-02-28
% 223.37/223.51  |- rdf__type mesh__D017520sskos__Concept
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D017520 2003
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D017520 1998
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D017520 2006
% 223.37/223.51  |- skos__altLabel mesh__D017520 Mucinosis
% 223.37/223.51  |- skos__scopeNote mesh__D017520
% 223.37/223.51       Mucoid states characterized by the elevated deposition and accumulation of mucin %28%mucopolysaccharides%29% in dermal tissue. The fibroblasts are responsible for the production of acid mucopolysaccharides %28%GLYCOSAMINOGLYCANS%29% in the ground substance of the connective tissue system. When fibroblasts produce abnormally large quantities of mucopolysaccharides as hyaluronic acid, chondroitin sulfate, or heparin, they accumulate in large amounts in the dermis.%A%    
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D017520 2000
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D017520 1996
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D017520 2004
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D017520 1999
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D017520 2001
% 223.37/223.51  |- mesh__historyNote mesh__D017520 93   
% 223.37/223.51  |- mesh__recordMaintainer mesh__D017520 TAP
% 223.37/223.51  |- skos__historyNote mesh__D017520 Skin Diseases %28%1966-1992%29%
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D017520 1997
% 223.37/223.51  |- mesh__recordOriginator mesh__D017520 PLS
% 223.37/223.51  |- mesh__dateRevised mesh__D017520 1993-06-02
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D017520 2002
% 223.37/223.51  |- mesh__publicMeSHNote mesh__D017520 93   
% 223.37/223.51  |- skos__historyNote mesh__D017520 Mucins %28%1966-1992%29%
% 223.37/223.51  |- skos__broader mesh__D017520smesh__D003240
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D017520 1994
% 223.37/223.51  |- skos__prefLabel mesh__D017520 Mucinoses
% 223.37/223.51  |- skos__annotation mesh__D017520 elevated deposition of mucin in skin   
% 223.37/223.51  |- mesh__dateEstablished mesh__D017520 1993-01-01
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D017520 2005
% 223.37/223.51  |- mesh__recordAuthorizer mesh__D017520 PLS
% 223.37/223.51  |- mesh__dateCreated mesh__D017520 1992-05-22
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D017520 1995
% 223.37/223.51  |- rdf__type mesh__D003500sskos__Concept
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D003500 2003
% 223.37/223.51  |- mesh__recordMaintainer mesh__D003500 PXP
% 223.37/223.51  |- mesh__historyNote mesh__D003500 74%28%71%29%   
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D003500 2004
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D003500 1998
% 223.37/223.51  |- mesh__recordOriginator mesh__D003500 NLM
% 223.37/223.51  |- skos__broader mesh__D003500smesh__D008660
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D003500 2000
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D003500 2005
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D003500 1999
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D003500 2001
% 223.37/223.51  |- skos__prefLabel mesh__D003500 Cyclization
% 223.37/223.51  |- skos__historyNote mesh__D003500 Chemistry, Organic %28%1966-1970%29%
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D003500 2006
% 223.37/223.51  |- mesh__publicMeSHNote mesh__D003500 74   
% 223.37/223.51  |- skos__broader mesh__D003500smesh__D002625
% 223.37/223.51  |- skos__hiddenLabel mesh__D003500 Cyclizations
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D003500 2002
% 223.37/223.51  |- mesh__dateCreated mesh__D003500 1999-01-01
% 223.37/223.51  |- mesh__dateEstablished mesh__D003500 1974-01-01
% 223.37/223.51  |- mesh__recordAuthorizer mesh__D003500 SJN
% 223.37/223.51  |- skos__annotation mesh__D003500
% 223.37/223.51       almost never IM; enzymatic cyclization: coord NIM with specific enzyme %28%IM%29% + substrate %28%NIM%29%%A%  
% 223.37/223.51  |- skos__scopeNote mesh__D003500
% 223.37/223.51       Changing an open-chain hydrocarbon to a closed ring. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A%    
% 223.37/223.51  |- mesh__dateRevised mesh__D003500 1997-06-20
% 223.37/223.51  |- mesh__recordAuthorizer mesh__D050156 sjn
% 223.37/223.51  |- mesh__recordMaintainer mesh__D050156 lkt
% 223.37/223.51  |- skos__scopeNote mesh__D050156
% 223.37/223.51       The differentiation of pre-adipocytes into mature ADIPOCYTES.%A%    
% 223.37/223.51  |- mesh__recordOriginator mesh__D050156 lkt
% 223.37/223.51  |- skos__prefLabel mesh__D050156 Adipogenesis
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D050156 2006
% 223.37/223.51  |- mesh__dateCreated mesh__D050156 2005-06-30
% 223.37/223.51  |- skos__historyNote mesh__D050156 Adipose Tissue %28%1968-2005%29%
% 223.37/223.51  |- mesh__historyNote mesh__D050156 2006   
% 223.37/223.51  |- skos__broader mesh__D050156smesh__D002454
% 223.37/223.51  |- skos__annotation mesh__D050156
% 223.37/223.51       do not confuse with metabolic process LIPOGENESIS.   
% 223.37/223.51  |- skos__hiddenLabel mesh__D050156 Adipogeneses
% 223.37/223.51  |- mesh__dateEstablished mesh__D050156 2006-01-01
% 223.37/223.51  |- mesh__publicMeSHNote mesh__D050156 2006   
% 223.37/223.51  |- rdf__type mesh__D050156sskos__Concept
% 223.37/223.51  |- mesh__dateCreated mesh__D008794 1974-11-19
% 223.37/223.51  |- mesh__recordMaintainer mesh__D008794 ssb
% 223.37/223.51  |- skos__broader mesh__D008794smesh__D014283
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D008794 2005
% 223.37/223.51  |- mesh__dateRevised mesh__D008794 2001-07-25
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D008794 2002
% 223.37/223.51  |- mesh__dateEstablished mesh__D008794 1991-01-01
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D008794 2004
% 223.37/223.51  |- rdf__type mesh__D008794sskos__Concept
% 223.37/223.51  |- mesh__recordOriginator mesh__D008794 NLM
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D008794 2003
% 223.37/223.51  |- skos__prefLabel mesh__D008794 Metrizoate
% 223.37/223.51  |- skos__scopeNote mesh__D008794
% 223.37/223.51       A diagnostic radiopaque that usually occurs as the sodium salt.%A%    
% 223.37/223.51  |- skos__historyNote mesh__D008794 Diatrizoate %28%1972-1974%29%
% 223.37/223.51  |- mesh__historyNote mesh__D008794
% 223.37/223.51       91%28%75%29%; was see under IODOBENZOATES 1975-90   
% 223.37/223.51  |- skos__historyNote mesh__D008794 Salts %28%1972-1974%29%
% 223.37/223.51  |- mesh__publicMeSHNote mesh__D008794
% 223.37/223.51       91; was see under IODOBENZOATES 1975-90   
% 223.37/223.51  |- mesh__recordAuthorizer mesh__D008794 sjn
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D008794 2006
% 223.37/223.51  |- skos__hiddenLabel mesh__D008794 Sodium, Metrizoate
% 223.37/223.51  |- skos__scopeNote mesh__D016428
% 223.37/223.51       The predominant publication type for articles and other items indexed for NLM databases.%A%    
% 223.37/223.51  |- mesh__dateEstablished mesh__D016428 1996-01-01
% 223.37/223.51  |- mesh__historyNote mesh__D016428 1991   
% 223.37/223.51  |- mesh__recordMaintainer mesh__D016428 jls
% 223.37/223.51  |- skos__altLabel mesh__D016428 Journal Article %28%PT%29%
% 223.37/223.51  |- skos__prefLabel mesh__D016428 Journal Article %5B%Publication Type%5D%
% 223.37/223.51  |- mesh__recordOriginator mesh__D016428 TAP
% 223.37/223.51  |- skos__broader mesh__D016428smesh__D052180
% 223.37/223.51  |- mesh__dateCreated mesh__D016428 1995-06-23
% 223.37/223.51  |- mesh__activeMeSHYear mesh__D016428 2006
% 223.37/223.51  |- skos__annotation mesh__D016428
% 223.37/223.51       publication type only;  for original full text research, review or other reports published in a journal; CATALOG: do not use%A%  
% 223.37/223.51  |- mesh__recordAuthorizer mesh__D016428 sjn
% 223.37/223.51  |- skos__altLabel mesh__D016428 Journal Article
% 223.37/223.51  |- rdf__type mesh__D016428sskos__Concept
% 223.37/223.51  |- mesh__dateRevised mesh__D016428 2005-06-30
% 223.37/223.51  |- mesh__recordMaintainer mesh__D002408 PXP
% 223.37/223.51  |- skos__hiddenLabel mesh__D002408 Reservoirs, Venous
% 223.37/223.52  |- mesh__publicMeSHNote mesh__D002408
% 223.37/223.52       78; was INDWELLING CATHETER see under URINARY CATHETERIZATION 1963-77%A%  
% 223.37/223.52  |- mesh__onlineNote mesh__D002408
% 223.37/223.52       use CATHETERS, INDWELLING to search INDWELLING CATHETER 1975-77; use URINARY CATHETERIZATION 1966-74%A%  
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Catheters, Implantable
% 223.37/223.52  |- skos__related mesh__D002408smesh__D015918
% 223.37/223.52  |- mesh__recordAuthorizer mesh__D002408 SJN
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Indwelling Catheters
% 223.37/223.52  |- rdf__type mesh__D002408sskos__Concept
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D002408 2005
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D002408 2001
% 223.37/223.52  |- skos__broader mesh__D002408smesh__D004864
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Intra Arterial Lines
% 223.37/223.52  |- mesh__dateEstablished mesh__D002408 1978-01-01
% 223.37/223.52  |- skos__altLabel mesh__D002408 Venous Reservoirs
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Access Port, Vascular
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Line, Arterial
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Ports, Vascular Access
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Catheter, Indwelling
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Line, Intra-Arterial
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D002408 2000
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Catheters, In-Dwelling
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Implantable Catheter
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D002408 1999
% 223.37/223.52  |- skos__historyNote mesh__D002408 Heart Catheterization %28%1966-1974%29%
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D002408 2004
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Indwelling Catheter
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Vascular Access Port
% 223.37/223.52  |- skos__annotation mesh__D002408
% 223.37/223.52       NIM; when IM, coord with specific site %28%NIM%29% if pertinent%A%  
% 223.37/223.52  |- mesh__recordOriginator mesh__D002408 NLM
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Venous Reservoir
% 223.37/223.52  |- skos__scopeNote mesh__D002408
% 223.37/223.52       Catheters designed to be left within an organ or passage for an extended period of time.%A%    
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 In-Dwelling Catheter
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Reservoir, Venous
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Access Ports, Vascular
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Arterial Line
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D002408 1998
% 223.37/223.52  |- mesh__historyNote mesh__D002408
% 223.37/223.52       78; was INDWELLING CATHETER see under URINARY CATHETERIZATION 1963-77%A%  
% 223.37/223.52  |- skos__historyNote mesh__D002408
% 223.37/223.52       Urinary Catheterization %28%1966-1974%29%
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D002408 2003
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Port, Vascular Access
% 223.37/223.52  |- mesh__dateRevised mesh__D002408 1997-06-20
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Intra-Arterial Line
% 223.37/223.52  |- skos__altLabel mesh__D002408 Implantable Catheters
% 223.37/223.52  |- skos__altLabel mesh__D002408 Arterial Lines
% 223.37/223.52  |- skos__altLabel mesh__D002408 In-Dwelling Catheters
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D002408 2002
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Catheter, In-Dwelling
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Catheter, Implantable
% 223.37/223.52  |- mesh__dateCreated mesh__D002408 1999-01-01
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D002408 2006
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Lines, Arterial
% 223.37/223.52  |- skos__historyNote mesh__D002408 Catheterization %28%1966-1974%29%
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 Lines, Intra-Arterial
% 223.37/223.52  |- skos__prefLabel mesh__D002408 Catheters, Indwelling
% 223.37/223.52  |- skos__hiddenLabel mesh__D002408 In Dwelling Catheters
% 223.37/223.52  |- skos__broader mesh__D013130smesh__D013122
% 223.37/223.52  |- skos__prefLabel mesh__D013130 Spinal Stenosis
% 223.37/223.52  |- mesh__recordMaintainer mesh__D013130 lkt
% 223.37/223.52  |- rdf__type mesh__D013130sskos__Concept
% 223.37/223.52  |- skos__historyNote mesh__D013130 Lumbar Vertebrae %28%1966-1982%29%
% 223.37/223.52  |- mesh__dateEstablished mesh__D013130 1983-01-01
% 223.37/223.52  |- skos__hiddenLabel mesh__D013130 Stenosis, Spinal
% 223.37/223.52  |- mesh__dateRevised mesh__D013130 2005-06-30
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D013130 2006
% 223.37/223.52  |- mesh__dateCreated mesh__D013130 1982-04-22
% 223.37/223.52  |- mesh__publicMeSHNote mesh__D013130 83   
% 223.37/223.52  |- skos__annotation mesh__D013130
% 223.37/223.52       coordinate with vertebrae headings if appropriate   
% 223.37/223.52  |- mesh__historyNote mesh__D013130 83   
% 223.37/223.52  |- skos__historyNote mesh__D013130 Spinal Canal %28%1966-1982%29%
% 223.37/223.52  |- skos__historyNote mesh__D013130 Spinal Diseases %28%1966-1982%29%
% 223.37/223.52  |- mesh__recordOriginator mesh__D013130 RC
% 223.37/223.52  |- mesh__recordAuthorizer mesh__D013130 sjn
% 223.37/223.52  |- skos__hiddenLabel mesh__D013130 Stenoses, Spinal
% 223.37/223.52  |- skos__historyNote mesh__D013130
% 223.37/223.52       Constriction, Pathologic %28%1976-1982%29%
% 223.37/223.52  |- skos__scopeNote mesh__D013130 Narrowing of the spinal canal.     
% 223.37/223.52  |- skos__hiddenLabel mesh__D013130 Spinal Stenoses
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D012836 2001
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D012836 2004
% 223.37/223.52  |- rdf__type mesh__D012836sskos__Concept
% 223.37/223.52  |- mesh__dateCreated mesh__D012836 1999-01-01
% 223.37/223.52  |- skos__broader mesh__D012836smesh__D011506
% 223.37/223.52  |- mesh__recordMaintainer mesh__D012836 JRT
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D012836 1998
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D012836 2002
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D012836 1996
% 223.37/223.52  |- skos__scopeNote mesh__D012836
% 223.37/223.52       Compounds of silver and proteins used as topical anti-infective agents.%A%    
% 223.37/223.52  |- skos__prefLabel mesh__D012836 Silver Proteins
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D012836 1999
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D012836 1997
% 223.37/223.52  |- skos__hiddenLabel mesh__D012836 Proteins, Silver
% 223.37/223.52  |- mesh__recordAuthorizer mesh__D012836 PLS
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D012836 2000
% 223.37/223.52  |- mesh__recordOriginator mesh__D012836 NLM
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D012836 2005
% 223.37/223.52  |- skos__annotation mesh__D012836 anti-infective agents   
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D012836 2003
% 223.37/223.52  |- skos__hiddenLabel mesh__D012836 Proteinate, Silver
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D012836 2006
% 223.37/223.52  |- mesh__dateRevised mesh__D012836 1995-06-08
% 223.37/223.52  |- skos__related mesh__D012038smesh__D014945
% 223.37/223.52  |- rdf__type mesh__D012038sskos__Concept
% 223.37/223.52  |- skos__prefLabel mesh__D012038 Regeneration
% 223.37/223.52  |- mesh__dateCreated mesh__D012038 1999-01-01
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D012038 2004
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D012038 2003
% 223.37/223.52  |- skos__annotation mesh__D012038
% 223.37/223.52       IM; coord IM with organ /physiol %28%IM%29%, not /growth; available also are BONE REGENERATION; LIVER REGENERATION %26% NERVE REGENERATION%A%  
% 223.37/223.52  |- mesh__recordMaintainer mesh__D012038 mdb
% 223.37/223.52  |- mesh__recordOriginator mesh__D012038 NLM
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D012038 2002
% 223.37/223.52  |- mesh__recordAuthorizer mesh__D012038 sjn
% 223.37/223.52  |- mesh__dateRevised mesh__D012038 2001-07-25
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D012038 2006
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D012038 2005
% 223.37/223.52  |- skos__hiddenLabel mesh__D012038 Regenerations
% 223.37/223.52  |- skos__broader mesh__D012038smesh__D001686
% 223.37/223.52  |- skos__broader mesh__D003501smesh__D010879
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D003501 2006
% 223.37/223.52  |- skos__scopeNote mesh__D003501
% 223.37/223.52       A histamine H1 antagonist given by mouth or parenterally for the control of postoperative and drug-induced vomiting and in motion sickness. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p935%29%%A%    
% 223.37/223.52  |- mesh__recordMaintainer mesh__D003501 tpw
% 223.37/223.52  |- skos__hiddenLabel mesh__D003501 Hydrochloride, Cyclizine
% 223.37/223.52  |- mesh__dateCreated mesh__D003501 1999-01-01
% 223.37/223.52  |- skos__altLabel mesh__D003501 Cyclizine HCl
% 223.37/223.52  |- skos__prefLabel mesh__D003501 Cyclizine
% 223.37/223.52  |- skos__hiddenLabel mesh__D003501 HCl, Cyclizine
% 223.37/223.52  |- rdf__type mesh__D003501sskos__Concept
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D003501 2003
% 223.37/223.52  |- mesh__recordOriginator mesh__D003501 NLM
% 223.37/223.52  |- mesh__recordAuthorizer mesh__D003501 sjn
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D003501 2004
% 223.37/223.52  |- mesh__dateRevised mesh__D003501 2002-07-03
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D003501 2005
% 223.37/223.52  |- skos__hiddenLabel mesh__D008795 Phosphoester, Metronidazole
% 223.37/223.52  |- mesh__recordAuthorizer mesh__D008795 sjn
% 223.37/223.52  |- skos__hiddenLabel mesh__D008795 2 Methyl 5 nitroimidazole 1 ethanol
% 223.37/223.52  |- skos__hiddenLabel mesh__D008795 Phosphate, Metronidazole
% 223.37/223.52  |- skos__broader mesh__D008795smesh__D009593
% 223.37/223.52  |- skos__hiddenLabel mesh__D008795 Hydrochloride, Metronidazole
% 223.37/223.52  |- skos__prefLabel mesh__D008795 Metronidazole
% 223.37/223.52  |- skos__scopeNote mesh__D008795
% 223.37/223.52       A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. It has also been proposed as a radiation sensitizer for hypoxic cells. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985, p133%29%, this substance may reasonably be anticipated to be a carcinogen %28%Merck, 11th ed%29%.%A%    
% 223.37/223.52  |- mesh__dateCreated mesh__D008795 1999-01-01
% 223.37/223.52  |- mesh__recordMaintainer mesh__D008795 ssb
% 223.37/223.52  |- skos__hiddenLabel mesh__D008795 Monohydrochloride, Metronidazole
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D008795 2006
% 223.37/223.52  |- mesh__dateRevised mesh__D008795 2005-06-30
% 223.37/223.52  |- mesh__historyNote mesh__D008795 64   
% 223.37/223.52  |- mesh__dateEstablished mesh__D008795 1965-01-01
% 223.37/223.52  |- mesh__recordOriginator mesh__D008795 NLM
% 223.37/223.52  |- skos__altLabel mesh__D008795 Metronidazole Phosphoester
% 223.37/223.52  |- skos__altLabel mesh__D008795 Metronidazole Monohydrochloride
% 223.37/223.52  |- rdf__type mesh__D008795sskos__Concept
% 223.37/223.52  |- skos__altLabel mesh__D008795 2-Methyl-5-nitroimidazole-1-ethanol
% 223.37/223.52  |- skos__altLabel mesh__D016429 Clinico-Pathological Conference
% 223.37/223.52  |- mesh__dateRevised mesh__D016429 2005-06-30
% 223.37/223.52  |- skos__altLabel mesh__D016429 Clinico-Pathologic Conference
% 223.37/223.52  |- skos__broader mesh__D016429smesh__D052182
% 223.37/223.52  |- mesh__recordOriginator mesh__D016429 TGC
% 223.37/223.52  |- skos__altLabel mesh__D016429 Clinical Conference %28%PT%29%
% 223.37/223.52  |- skos__altLabel mesh__D016429 Clinical Conference
% 223.37/223.52  |- mesh__dateCreated mesh__D016429 1995-06-27
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D016429 2006
% 223.37/223.52  |- mesh__dateEstablished mesh__D016429 1996-01-01
% 223.37/223.52  |- mesh__historyNote mesh__D016429 1991   
% 223.37/223.52  |- mesh__recordMaintainer mesh__D016429 jls
% 223.37/223.52  |- skos__annotation mesh__D016429
% 223.37/223.52       publication type only;  CATALOG: Do not use   
% 223.37/223.52  |- rdf__type mesh__D016429sskos__Concept
% 223.37/223.52  |- skos__scopeNote mesh__D016429
% 223.37/223.52       Work that consists of a conference of physicians on their observations of a patient at the bedside, regarding the physical state, laboratory and other diagnostic findings, clinical manifestations, results of current therapy, etc. A clinical conference usually ends with a confirmation or correction of clinical findings by a pathological diagnosis performed by a pathologist. %22%Clinical conference%22% is often referred to as a %22%clinico-pathological conference.%22%%A%    
% 223.37/223.52  |- skos__altLabel mesh__D016429 Clinico-Pathologic Conference %28%PT%29%
% 223.37/223.52  |- skos__altLabel mesh__D016429 Clinical Conference %5B%Pub Type%5D%
% 223.37/223.52  |- skos__prefLabel mesh__D016429
% 223.37/223.52       Clinical Conference %5B%Publication Type%5D%
% 223.37/223.52  |- mesh__recordAuthorizer mesh__D016429 sjn
% 223.37/223.52  |- skos__altLabel mesh__D016429 Clinico-Pathological Conference %28%PT%29%
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D002409 1999
% 223.37/223.52  |- skos__prefLabel mesh__D002409 Cathexis
% 223.37/223.52  |- mesh__dateEstablished mesh__D002409 1991-01-01
% 223.37/223.52  |- skos__scopeNote mesh__D002409
% 223.37/223.52       Attachment, conscious or unconscious, of emotional feeling and significance to an idea, object or most commonly a person.%A%    
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D002409 2000
% 223.37/223.52  |- mesh__publicMeSHNote mesh__D002409
% 223.37/223.52       91; was see under DISPLACEMENT %28%PSYCHOLOGY%29% 1975-90   
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D002409 2005
% 223.37/223.52  |- mesh__onlineNote mesh__D002409
% 223.37/223.52       search DISPLACEMENT %28%PSYCHOLOGY%29% 1974   
% 223.37/223.52  |- mesh__dateRevised mesh__D002409 1997-06-20
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D002409 2006
% 223.37/223.52  |- skos__broader mesh__D002409smesh__D004208
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D002409 2001
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D002409 2003
% 223.37/223.52  |- mesh__historyNote mesh__D002409
% 223.37/223.52       91%28%75%29%; was see under DISPLACEMENT %28%PSYCHOLOGY%29% 1975-90   
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D002409 2004
% 223.37/223.52  |- mesh__recordOriginator mesh__D002409 NLM
% 223.37/223.52  |- mesh__dateCreated mesh__D002409 1999-01-01
% 223.37/223.52  |- rdf__type mesh__D002409sskos__Concept
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D002409 2002
% 223.37/223.52  |- mesh__recordMaintainer mesh__D002409 JLS
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D002409 1998
% 223.37/223.52  |- mesh__recordAuthorizer mesh__D002409 SJN
% 223.37/223.52  |- skos__annotation mesh__D002409 no qualif   
% 223.37/223.52  |- rdf__type mesh__D013131sskos__Concept
% 223.37/223.52  |- mesh__dateCreated mesh__D013131 1999-01-01
% 223.37/223.52  |- skos__broader mesh__D013131smesh__D001842
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D013131 2004
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D013131 2001
% 223.37/223.52  |- skos__altLabel mesh__D013131 Spinal Column
% 223.37/223.52  |- skos__altLabel mesh__D013131 Vertebral Column
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D013131 2006
% 223.37/223.52  |- skos__hiddenLabel mesh__D013131 Column, Spinal
% 223.37/223.52  |- skos__hiddenLabel mesh__D013131 Spinal Columns
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D013131 2003
% 223.37/223.52  |- skos__prefLabel mesh__D013131 Spine
% 223.37/223.52  |- mesh__recordOriginator mesh__D013131 NLM
% 223.37/223.52  |- skos__hiddenLabel mesh__D013131 Columns, Spinal
% 223.37/223.52  |- skos__altLabel mesh__D013131 Vertebrae
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D013131 2005
% 223.37/223.52  |- skos__scopeNote mesh__D013131 The spinal or vertebral column.     
% 223.37/223.52  |- mesh__dateRevised mesh__D013131 1999-11-09
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D013131 2000
% 223.37/223.52  |- skos__related mesh__D013131smesh__D007796
% 223.37/223.52  |- skos__annotation mesh__D013131
% 223.37/223.52       GEN or unspecified: specific groups of vertebrae are available; /inj = SPINAL INJURIES for GEN or unspecified vertebrae but specific vertebrae are available with /inj; /transpl of the whole spine is unlikely: use /transpl with specific vertebra terms instead; inflammation = SPONDYLITIS; spondylosis = SPONDYLOSIS %28%see SPINAL OSTEOPHYTOSIS%29% %28%IM%29% + specific vertebrae %28%IM%29%%A%  
% 223.37/223.52  |- skos__hiddenLabel mesh__D013131 Columns, Vertebral
% 223.37/223.52  |- skos__hiddenLabel mesh__D013131 Vertebral Columns
% 223.37/223.52  |- mesh__recordMaintainer mesh__D013131 jls
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D013131 2002
% 223.37/223.52  |- mesh__recordAuthorizer mesh__D013131 sjn
% 223.37/223.52  |- mesh__considerAlso mesh__D013131
% 223.37/223.52       consider also terms at SPONDYL- and VERTEBRAL   
% 223.37/223.52  |- skos__hiddenLabel mesh__D013131 Column, Vertebral
% 223.37/223.52  |- skos__altLabel mesh__D012837 Pharmascience Brand of Silver Sulfadiazine
% 223.37/223.52  |- skos__altLabel mesh__D012837 Par Brand 1 of Silver Sulfadiazine
% 223.37/223.52  |- skos__broader mesh__D012837smesh__D013411
% 223.37/223.52  |- skos__altLabel mesh__D012837 Sicazine
% 223.37/223.52  |- skos__altLabel mesh__D012837 medphano Brand of Silver Sulfadiazine
% 223.37/223.52  |- skos__altLabel mesh__D012837 Aldo Brand of Silver Sulfadiazine
% 223.37/223.52  |- skos__hiddenLabel mesh__D012837 Sulfadiazine, Silver
% 223.37/223.52  |- skos__altLabel mesh__D012837 Solvay Brand of Silver Sulfadiazine
% 223.37/223.52  |- skos__altLabel mesh__D012837 Major Brand of Silver Sulfadiazine
% 223.37/223.52  |- skos__altLabel mesh__D012837 Flammazine
% 223.37/223.52  |- skos__hiddenLabel mesh__D012837
% 223.37/223.52       Rh%C3%%B4%ne Poulenc Rorer Brand of Silver Sulfadiazine
% 223.37/223.52  |- skos__altLabel mesh__D012837 Sulfafdiazine, Silver
% 223.37/223.52  |- mesh__recordOriginator mesh__D012837 SH
% 223.37/223.52  |- skos__altLabel mesh__D012837
% 223.37/223.52       Rh%C3%%B4%ne-Poulenc Rorer Brand of Silver Sulfadiazine
% 223.37/223.52  |- skos__altLabel mesh__D012837 Monarch Brand of Silver Sulfadiazine
% 223.37/223.52  |- mesh__historyNote mesh__D012837
% 223.37/223.52       91%28%77%29%; was see under SULFADIAZINE 1977-90   
% 223.37/223.52  |- skos__historyNote mesh__D012837 Silver %28%1966-1976%29%
% 223.37/223.52  |- mesh__publicMeSHNote mesh__D012837
% 223.37/223.52       91; was see under SULFADIAZINE 1977-90   
% 223.37/223.52  |- skos__altLabel mesh__D012837 Par Brand 3 of Silver Sulfadiazine
% 223.37/223.52  |- skos__historyNote mesh__D012837 Sulfadiazine %28%1966-1976%29%
% 223.37/223.52  |- mesh__recordMaintainer mesh__D012837 CCR
% 223.37/223.52  |- mesh__recordAuthorizer mesh__D012837 sjn
% 223.37/223.52  |- skos__altLabel mesh__D012837 Zenith Brand of Silver Sulfadiazine
% 223.37/223.52  |- skos__altLabel mesh__D012837 Abbott Brand of Silver Sulfadiazine
% 223.37/223.52  |- skos__prefLabel mesh__D012837 Silver Sulfadiazine
% 223.37/223.52  |- skos__altLabel mesh__D012837 Sherwood Brand of Silver Sulfadiazine
% 223.37/223.52  |- skos__scopeNote mesh__D012837
% 223.37/223.52       Antibacterial used topically in burn therapy.     
% 223.37/223.52  |- mesh__dateCreated mesh__D012837 1976-05-03
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D012837 2006
% 223.37/223.52  |- skos__altLabel mesh__D012837
% 223.37/223.52       Smith %26% Nephew Brand of Silver Sulfadiazine
% 223.37/223.52  |- skos__hiddenLabel mesh__D012837 Silver Sulfafdiazine
% 223.37/223.52  |- mesh__dateRevised mesh__D012837 2005-06-30
% 223.37/223.52  |- mesh__dateEstablished mesh__D012837 1991-01-01
% 223.37/223.52  |- rdf__type mesh__D012837sskos__Concept
% 223.37/223.52  |- skos__altLabel mesh__D012837 Par Brand 2 of Silver Sulfadiazine
% 223.37/223.52  |- mesh__recordMaintainer mesh__D012039 nns
% 223.37/223.52  |- mesh__dateCreated mesh__D012039 1999-01-01
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D012039 2004
% 223.37/223.52  |- skos__annotation mesh__D012039
% 223.37/223.52       always NIM; coord NIM with organ /blood supply %28%IM%29% or specific artery or vein /physiol %28%IM%29%; Manual 19.8.11; specifics available are CEREBROVASCULAR CIRCULATION; CORONARY CIRCULATION; LIVER CIRCULATION; PULMONARY CIRCULATION; RENAL CIRCULATION; SPLANCHNIC CIRCULATION; also available are COLLATERAL CIRCULATION; MICROCIRCULATION %26% PORTAL SYSTEM; Manual 21.4.2, 21.6; taking of pulse at wrist is not REGIONAL BLOOD FLOW: it is PULSE%A%  
% 223.37/223.52  |- mesh__publicMeSHNote mesh__D012039 67   
% 223.37/223.52  |- mesh__dateEstablished mesh__D012039 1967-01-01
% 223.37/223.52  |- skos__hiddenLabel mesh__D012039 Blood Flow, Regional
% 223.37/223.52  |- skos__prefLabel mesh__D012039 Regional Blood Flow
% 223.37/223.52  |- skos__hiddenLabel mesh__D012039 Regional Blood Flows
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D012039 2006
% 223.37/223.52  |- mesh__historyNote mesh__D012039 67%28%64%29%   
% 223.37/223.52  |- skos__scopeNote mesh__D012039
% 223.37/223.52       The flow of BLOOD through or around an organ or region of the body.%A%    
% 223.37/223.52  |- skos__hiddenLabel mesh__D012039 Blood Flows, Regional
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D012039 2005
% 223.37/223.52  |- mesh__recordOriginator mesh__D012039 NLM
% 223.37/223.52  |- skos__hiddenLabel mesh__D012039 Flows, Regional Blood
% 223.37/223.52  |- mesh__recordAuthorizer mesh__D012039 sjn
% 223.37/223.52  |- skos__broader mesh__D012039smesh__D001775
% 223.37/223.52  |- skos__hiddenLabel mesh__D012039 Flow, Regional Blood
% 223.37/223.52  |- rdf__type mesh__D012039sskos__Concept
% 223.37/223.52  |- mesh__dateRevised mesh__D012039 2003-07-09
% 223.37/223.52  |- skos__scopeNote mesh__D009090
% 223.37/223.52       An order of zygomycetous fungi, usually saprophytic, causing damage to food in storage, but which may cause respiratory infection or MUCORMYCOSIS in persons suffering from other debilitating diseases.%A%    
% 223.37/223.52  |- mesh__historyNote mesh__D009090 79; use FUNGI 1963-78   
% 223.37/223.52  |- skos__historyNote mesh__D009090 Phycomyces %28%1966-1974%29%
% 223.37/223.52  |- skos__prefLabel mesh__D009090 Mucorales
% 223.37/223.52  |- mesh__publicMeSHNote mesh__D009090
% 223.37/223.52       79; see PHYCOMYCETES 1963-78; for PHYCOMYCES see PHYCOMYCETES 1975-85%A%  
% 223.37/223.52  |- skos__annotation mesh__D009090 infection = MUCORMYCOSIS   
% 223.37/223.52  |- rdf__type mesh__D009090sskos__Concept
% 223.37/223.52  |- mesh__dateEstablished mesh__D009090 1979-01-01
% 223.37/223.52  |- skos__broader mesh__D009090smesh__D015052
% 223.37/223.52  |- mesh__dateRevised mesh__D009090 2005-06-30
% 223.37/223.52  |- mesh__recordMaintainer mesh__D009090 SYSTEM
% 223.37/223.52  |- mesh__recordAuthorizer mesh__D009090 sjn
% 223.37/223.52  |- mesh__recordOriginator mesh__D009090 NLM
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D009090 2006
% 223.37/223.52  |- mesh__dateCreated mesh__D009090 1999-01-01
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D017522 2004
% 223.37/223.52  |- mesh__onlineNote mesh__D017522
% 223.37/223.52       use YUGOSLAVIA to search BOSNIA-HERZEGOVINA 1966-92   
% 223.37/223.52  |- mesh__recordAuthorizer mesh__D017522 PLS
% 223.37/223.52  |- mesh__dateCreated mesh__D017522 1992-05-20
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D017522 2006
% 223.37/223.52  |- rdf__type mesh__D017522sskos__Concept
% 223.37/223.52  |- skos__altLabel mesh__D017522 Bosnia
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D017522 2003
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D017522 2005
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D017522 1997
% 223.37/223.52  |- skos__annotation mesh__D017522
% 223.37/223.52       formerly provinces of Yugoslavia; use this spelling in translations: z, not c%A%  
% 223.37/223.52  |- mesh__dateEstablished mesh__D017522 1993-01-01
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D017522 1999
% 223.37/223.52  |- skos__altLabel mesh__D017522 Bosnia and Hercegovina
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D017522 2002
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D017522 1996
% 223.37/223.52  |- mesh__dateRevised mesh__D017522 1995-02-17
% 223.37/223.52  |- skos__broader mesh__D017522smesh__D005061
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D017522 1998
% 223.37/223.52  |- skos__historyNote mesh__D017522 Yugoslavia %28%1966-1992%29%
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D017522 2001
% 223.37/223.52  |- mesh__recordMaintainer mesh__D017522 PLS
% 223.37/223.52  |- mesh__recordOriginator mesh__D017522 PLS
% 223.37/223.52  |- skos__broader mesh__D017522smesh__D015022
% 223.37/223.52  |- skos__prefLabel mesh__D017522 Bosnia-Herzegovina
% 223.37/223.52  |- skos__altLabel mesh__D017522 Bosnia and Herzegovina
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D017522 2000
% 223.37/223.52  |- mesh__historyNote mesh__D017522 93   
% 223.37/223.52  |- skos__scopeNote mesh__D017522
% 223.37/223.52       A country of eastern Europe, formerly the province of Bosnia in Yugoslavia, uniting with the province of Herzegovina to form the Republic of Bosnia and Herzegovina in 1946. It was created 7 April 1992 as a result of the division of Yugoslavia and recognized by the United States as an independent state. Bosnia takes is name from the river Bosna, in turn from the Indoeuropean root bhog, %22%current%22%; Herzegovina is from the Serbian herceg %28%duke%29% + -ov %28%the possessive%29% + -ina %28%country or territory%29%.%A%    
% 223.37/223.52  |- skos__prefLabel mesh__D050956 HSP40 Heat-Shock Proteins
% 223.37/223.52  |- mesh__recordMaintainer mesh__D050956 DRC
% 223.37/223.52  |- mesh__historyNote mesh__D050956 2006%28%1986%29%   
% 223.37/223.52  |- skos__altLabel mesh__D050956 Heat-Shock Protein 40
% 223.37/223.52  |- skos__altLabel mesh__D050956 HSP40 Proteins
% 223.37/223.52  |- skos__broader mesh__D050956smesh__D006360
% 223.37/223.52  |- skos__hiddenLabel mesh__D050956 Heat Shock Proteins 40
% 223.37/223.52  |- skos__hiddenLabel mesh__D050956 Heat Shock Protein 40
% 223.37/223.52  |- skos__altLabel mesh__D050956 Heat Shock Protein 40 Family
% 223.37/223.52  |- mesh__publicMeSHNote mesh__D050956
% 223.37/223.52       2006; HEAT-SHOCK PROTEINS 40 was indexed under HEAT-SHOCK PROTEINS 1986-2005%A%  
% 223.37/223.52  |- skos__scopeNote mesh__D050956
% 223.37/223.52       A family of heat-shock proteins that contain a 70 amino-acid consensus sequence known as the J domain. The J domain of HSP40 heat shock proteins interacts with HSP70 HEAT-SHOCK PROTEINS.  HSP40 heat-shock proteins play a role in regulating the ADENOSINETRIPHOSPHATASE activity of HSP70 heat-shock proteins.%A%    
% 223.37/223.52  |- skos__altLabel mesh__D050956 HSP40 Protein Family
% 223.37/223.52  |- skos__hiddenLabel mesh__D050956 HSP40 Heat Shock Proteins
% 223.37/223.52  |- mesh__recordOriginator mesh__D050956 DRC
% 223.37/223.52  |- skos__altLabel mesh__D050956 DnaJ Proteins
% 223.37/223.52  |- skos__hiddenLabel mesh__D050956 Proteins, HSP40 Heat-Shock
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D050956 2006
% 223.37/223.52  |- mesh__dateCreated mesh__D050956 2005-06-30
% 223.37/223.52  |- mesh__dateEstablished mesh__D050956 2006-01-01
% 223.37/223.52  |- mesh__recordAuthorizer mesh__D050956 sjn
% 223.37/223.52  |- skos__hiddenLabel mesh__D050956 Heat-Shock Proteins, HSP40
% 223.37/223.52  |- skos__altLabel mesh__D050956 Heat-Shock Proteins 40
% 223.37/223.52  |- rdf__type mesh__D050956sskos__Concept
% 223.37/223.52  |- skos__altLabel mesh__D008796 Bleeding Between Periods
% 223.37/223.52  |- skos__altLabel mesh__D008796 Dysfunctional Uterine Bleeding
% 223.37/223.52  |- skos__prefLabel mesh__D008796 Metrorrhagia
% 223.37/223.52  |- skos__hiddenLabel mesh__D008796 Dysfunctional Uterine Bleedings
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D008796 2006
% 223.37/223.52  |- mesh__dateCreated mesh__D008796 1999-01-01
% 223.37/223.52  |- mesh__publicMeSHNote mesh__D008796
% 223.37/223.52       1963; for BREAKTHROUGH BLEEDING %26% SPOTTING see UTERINE HEMORRHAGE 1980-2005%A%  
% 223.37/223.52  |- mesh__recordAuthorizer mesh__D008796 sjn
% 223.37/223.52  |- mesh__recordMaintainer mesh__D008796 lkt
% 223.37/223.52  |- skos__hiddenLabel mesh__D008796 Uterine Bleeding, Dysfunctional
% 223.37/223.52  |- skos__hiddenLabel mesh__D008796 Bleeding, Breakthrough
% 223.37/223.52  |- skos__altLabel mesh__D008796 Breakthrough Bleeding
% 223.37/223.52  |- skos__broader mesh__D008796smesh__D014592
% 223.37/223.52  |- mesh__historyNote mesh__D008796
% 223.37/223.52       1963; for BREAKTHROUGH BLEEDING %26% SPOTTING use UTERINE HEMORRHAGE 1980-2005%A%  
% 223.37/223.52  |- skos__altLabel mesh__D008796 Intermenstrual Bleeding
% 223.37/223.52  |- mesh__dateRevised mesh__D008796 2005-06-30
% 223.37/223.52  |- rdf__type mesh__D008796sskos__Concept
% 223.37/223.52  |- skos__annotation mesh__D008796 do not confuse with MENORRHAGIA   
% 223.37/223.52  |- skos__scopeNote mesh__D008796
% 223.37/223.52       Abnormal uterine bleeding that is not related to MENSTRUATION, usually in females without regular MENSTRUAL CYCLE. The irregular and unpredictable bleeding usually comes from a dysfunctional ENDOMETRIUM.%A%    
% 223.37/223.52  |- skos__altLabel mesh__D008796 Spotting
% 223.37/223.52  |- mesh__recordOriginator mesh__D008796 NLM
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D041621 2005
% 223.37/223.52  |- skos__broader mesh__D041621smesh__D031642
% 223.37/223.52  |- mesh__publicMeSHNote mesh__D041621 2004   
% 223.37/223.52  |- mesh__historyNote mesh__D041621 2004   
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D041621 2004
% 223.37/223.52  |- mesh__dateCreated mesh__D041621 2003-07-09
% 223.37/223.52  |- skos__annotation mesh__D041621
% 223.37/223.52       EREMOPHILA ALPESTRIS see SONGBIRDS and EREMOPHILUS MUTISII see CATFISHES are also available; eremophilane compounds %28%NM%29% is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.37/223.52  |- mesh__dateEstablished mesh__D041621 2004-01-01
% 223.37/223.52  |- rdf__type mesh__D041621sskos__Concept
% 223.37/223.52  |- skos__scopeNote mesh__D041621
% 223.37/223.52       A plant genus of the family MYOPORACEAE. Members have been used in FOLK MEDICINE.%A%    
% 223.37/223.52  |- skos__prefLabel mesh__D041621 Eremophila Plant
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D041621 2006
% 223.37/223.52  |- skos__historyNote mesh__D013930 Oxidoreductases %28%1966-1977%29%
% 223.37/223.52  |- mesh__dateCreated mesh__D013930 1977-05-24
% 223.37/223.52  |- skos__hiddenLabel mesh__D013930 Synthase, Thromboxane A
% 223.37/223.52  |- skos__annotation mesh__D013930 found in platelet microsomes   
% 223.37/223.52  |- mesh__recordMaintainer mesh__D013930 ssb
% 223.37/223.52  |- skos__altLabel mesh__D013930 Thromboxane A2 Synthetase
% 223.37/223.52  |- mesh__activeMeSHYear mesh__D013930 2005
% 223.37/223.52  |- skos__historyNote mesh__D013930 Hydroxy Acids %28%1975-1977%29%
% 223.37/223.52  |- skos__historyNote mesh__D013930 Pyrans %28%1966-1977%29%
% 223.37/223.52  |- skos__scopeNote mesh__D013930
% 223.37/223.52       An enzyme found predominantly in platelet microsomes. It catalyzes the conversion of PGG%28%2%29% and PGH%28%2%29% %28%prostaglandin endoperoxides%29% to thromboxane A2. EC 5.3.99.5.%A%    
% 223.37/223.52  |- skos__hiddenLabel mesh__D013930 Synthase, Thromboxane-A
% 223.37/223.53  |- mesh__publicMeSHNote mesh__D013930
% 223.37/223.53       98; see THROMBOXANE SYNTHETASE 1986-97; see OXIDOREDUCTASES 1978-85%A%  
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013930 2006
% 223.37/223.53  |- skos__broader mesh__D013930smesh__D019746
% 223.37/223.53  |- rdf__type mesh__D013930sskos__Concept
% 223.37/223.53  |- mesh__historyNote mesh__D013930 98%28%78%29%   
% 223.37/223.53  |- skos__hiddenLabel mesh__D013930 A2 Synthetase, Thromboxane
% 223.37/223.53  |- skos__altLabel mesh__D013930 Thromboxane A Synthase
% 223.37/223.53  |- mesh__recordOriginator mesh__D013930 RLS
% 223.37/223.53  |- skos__altLabel mesh__D013930 Thromboxane Synthetase
% 223.37/223.53  |- mesh__recordAuthorizer mesh__D013930 sjn
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013930 2004
% 223.37/223.53  |- mesh__dateEstablished mesh__D013930 1986-01-01
% 223.37/223.53  |- skos__prefLabel mesh__D013930 Thromboxane-A Synthase
% 223.37/223.53  |- skos__hiddenLabel mesh__D013930 Synthetase, Thromboxane A2
% 223.37/223.53  |- mesh__dateRevised mesh__D013930 2003-07-09
% 223.37/223.53  |- skos__hiddenLabel mesh__D013930 Synthetase, Thromboxane
% 223.37/223.53  |- mesh__recordAuthorizer mesh__D013132 sjn
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Corticostriatal-Spinal Degenerations
% 223.37/223.53  |- skos__altLabel mesh__D013132 Late Onset Cerebellar Ataxia
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Degeneration, Primary Cerebellar
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Cerebellar Ataxia, Marie%27%s
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Degenerations, Spino-Cerebellar
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Familial Spinocerebellar Degeneration
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132
% 223.37/223.53       Spinocerebellar Degenerations, Hereditary
% 223.37/223.53  |- skos__altLabel mesh__D013132 Marie%27%s Cerebellar Ataxia
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Syndrome, Marinesco-Sjogren
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Degeneration, Spino Cerebellar
% 223.37/223.53  |- skos__broader mesh__D013132smesh__D020271
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Hereditary Ataxias
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Degeneration, Spino-Cerebellar
% 223.37/223.53  |- skos__historyNote mesh__D013132 Cerebellar Ataxia %28%1968-1986%29%
% 223.37/223.53  |- skos__historyNote mesh__D013132 Spinal Cord Diseases %28%1966-1986%29%
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Marinesco Sjogren Syndrome
% 223.37/223.53  |- mesh__dateRevised mesh__D013132 2001-07-25
% 223.37/223.53  |- skos__altLabel mesh__D013132 Spinocerebellar Diseases
% 223.37/223.53  |- skos__altLabel mesh__D013132 Early Onset Cerebellar Ataxia
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Degeneration, Familial Spinocerebellar
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Cerebellar Degeneration, Primary
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Inherited Spinocerebellar Degeneration
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Spino-Cerebellar Degeneration
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Maries Cerebellar Ataxia
% 223.37/223.53  |- mesh__recordOriginator mesh__D013132 RC
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Degenerations, Spinocerebellar
% 223.37/223.53  |- mesh__recordMaintainer mesh__D013132 nns
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Degenerations, Spino Cerebellar
% 223.37/223.53  |- skos__altLabel mesh__D013132 Familial Spinocerebellar Degenerations
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Spinocerebellar Degenerations, Inherited
% 223.37/223.53  |- skos__altLabel mesh__D013132 Spino Cerebellar Degenerations
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013132 2005
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Cerebellar Ataxia, Marie
% 223.37/223.53  |- skos__altLabel mesh__D013132 Spino-Cerebellar Degenerations
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Degeneration, Corticostriatal-Spinal
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Hereditary Ataxia
% 223.37/223.53  |- mesh__historyNote mesh__D013132 2000%28%1987%29%   
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Degenerations, Familial Spinocerebellar
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Spinocerebellar Disease
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Spino Cerebellar Degeneration
% 223.37/223.53  |- skos__prefLabel mesh__D013132 Spinocerebellar Degenerations
% 223.37/223.53  |- skos__broader mesh__D013132smesh__D013118
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Ataxia, Hereditary
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013132 2002
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Primary Cerebellar Degenerations
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132
% 223.37/223.53       Degenerations, Hereditary Spinocerebellar
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Degeneration, Inherited Spinocerebellar
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013132 2006
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Spinocerebellar Degeneration, Familial
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Degeneration, Spinocerebellar
% 223.37/223.53  |- skos__altLabel mesh__D013132 Inherited Spinocerebellar Degenerations
% 223.37/223.53  |- mesh__publicMeSHNote mesh__D013132
% 223.37/223.53       2000; see SPINOCEREBELLAR DEGENERATION 1989-1999, see SPINOCEREBELLAR DEGENERATIONS 1987-1988%A%  
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Hereditary Spinocerebellar Degeneration
% 223.37/223.53  |- mesh__dateEstablished mesh__D013132 1987-01-01
% 223.37/223.53  |- skos__historyNote mesh__D013132 Cerebellar Diseases %28%1966-1986%29%
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Spinocerebellar Degeneration, Hereditary
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013132 2003
% 223.37/223.53  |- skos__altLabel mesh__D013132 Hereditary Spinocerebellar Degenerations
% 223.37/223.53  |- skos__scopeNote mesh__D013132
% 223.37/223.53       A heterogenous group of degenerative syndromes marked by progressive cerebellar dysfunction either in isolation or combined with other neurologic manifestations. Sporadic and inherited subtypes occur. Inheritance patterns include autosomal dominant, autosomal recessive, and X-linked.%A%    
% 223.37/223.53  |- skos__broader mesh__D013132smesh__D002526
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Spinocerebellar Degenerations, Familial
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Degenerations, Corticostriatal-Spinal
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Corticostriatal Spinal Degeneration
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Spinocerebellar Degeneration, Inherited
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Degenerations, Inherited Spinocerebellar
% 223.37/223.53  |- rdf__type mesh__D013132sskos__Concept
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Primary Cerebellar Degeneration
% 223.37/223.53  |- skos__altLabel mesh__D013132 Spinocerebellar Degeneration
% 223.37/223.53  |- mesh__dateCreated mesh__D013132 1986-03-31
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013132 2004
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Degeneration, Hereditary Spinocerebellar
% 223.37/223.53  |- skos__hiddenLabel mesh__D013132 Degenerations, Primary Cerebellar
% 223.37/223.53  |- mesh__dateCreated mesh__D012838 1974-11-19
% 223.37/223.53  |- mesh__historyNote mesh__D012838
% 223.37/223.53       91%28%75%29%; was see under FLAVONES 1975-90   
% 223.37/223.53  |- skos__related mesh__D012838smesh__D020944
% 223.37/223.53  |- rdf__type mesh__D012838sskos__Concept
% 223.37/223.53  |- skos__scopeNote mesh__D012838
% 223.37/223.53       A mixture of flavonoids extracted from seeds of the MILK THISTLE, Silybum marianum. It consists primarily of silybin and its isomers, silicristin and silidianin. Silymarin displays antioxidant and membrane stabilizing activity. It protects various tissues and organs against chemical injury, and shows potential as an antihepatoxic agent.%A%    
% 223.37/223.53  |- mesh__dateRevised mesh__D012838 2005-06-30
% 223.37/223.53  |- skos__altLabel mesh__D012838 Silimarin
% 223.37/223.53  |- mesh__dateEstablished mesh__D012838 1991-01-01
% 223.37/223.53  |- mesh__publicMeSHNote mesh__D012838 91; was see under FLAVONES 1975-90   
% 223.37/223.53  |- mesh__recordOriginator mesh__D012838 NLM
% 223.37/223.53  |- skos__historyNote mesh__D012838 Alcohols %28%1971-1974%29%
% 223.37/223.53  |- mesh__recordMaintainer mesh__D012838 ssb
% 223.37/223.53  |- skos__prefLabel mesh__D012838 Silymarin
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D012838 2006
% 223.37/223.53  |- mesh__recordAuthorizer mesh__D012838 sjn
% 223.37/223.53  |- skos__historyNote mesh__D012838 Flavones %28%1971-1974%29%
% 223.37/223.53  |- skos__broader mesh__D012838smesh__D044947
% 223.37/223.53  |- rdf__type mesh__D009091sskos__Concept
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D009091 2004
% 223.37/223.53  |- skos__broader mesh__D009091smesh__D020096
% 223.37/223.53  |- mesh__recordAuthorizer mesh__D009091 SJN
% 223.37/223.53  |- skos__annotation mesh__D009091 fungus dis caused by various MUCORALES   
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D009091 2002
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D009091 2005
% 223.37/223.53  |- skos__prefLabel mesh__D009091 Mucormycosis
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D009091 1999
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D009091 2006
% 223.37/223.53  |- mesh__dateCreated mesh__D009091 1999-01-01
% 223.37/223.53  |- skos__scopeNote mesh__D009091
% 223.37/223.53       Infection in humans and animals caused by any fungus in the order Mucorales %28%e.g., Absidia, Mucor, Rhizopus etc.%29% There are many clinical types associated with infection of the central nervous system, lung, gastrointestinal tract, skin, orbit and paranasal sinuses. In humans, it usually occurs as an opportunistic infection in patients with a chronic debilitating disease, particularly uncontrolled diabetes, or who are receiving immunosuppressive agents. %28%From Dorland, 28th ed%29%%A%    
% 223.37/223.53  |- mesh__dateRevised mesh__D009091 1998-06-10
% 223.37/223.53  |- skos__hiddenLabel mesh__D009091 Mucormycoses
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D009091 2000
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D009091 2003
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D009091 2001
% 223.37/223.53  |- mesh__recordMaintainer mesh__D009091 AGS
% 223.37/223.53  |- mesh__recordOriginator mesh__D009091 NLM
% 223.37/223.53  |- mesh__recordMaintainer mesh__D017523 PLS
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017523 2003
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017523 2000
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017523 1997
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017523 2005
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017523 1999
% 223.37/223.53  |- mesh__recordAuthorizer mesh__D017523 PLS
% 223.37/223.53  |- mesh__dateCreated mesh__D017523 1992-05-20
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017523 1996
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017523 1998
% 223.37/223.53  |- mesh__dateEstablished mesh__D017523 1993-01-01
% 223.37/223.53  |- mesh__recordOriginator mesh__D017523 PLS
% 223.37/223.53  |- skos__broader mesh__D017523smesh__D015022
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017523 2002
% 223.37/223.53  |- mesh__historyNote mesh__D017523 93   
% 223.37/223.53  |- skos__broader mesh__D017523smesh__D005061
% 223.37/223.53  |- skos__historyNote mesh__D017523 Yugoslavia %28%1966-1992%29%
% 223.37/223.53  |- skos__scopeNote mesh__D017523
% 223.37/223.53       Created 7 April 1992 as a result of the division of Yugoslavia.%A%    
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017523 2004
% 223.37/223.53  |- mesh__onlineNote mesh__D017523
% 223.37/223.53       use YUGOSLAVIA to search CROATIA 1966-92   
% 223.37/223.53  |- mesh__dateRevised mesh__D017523 1995-06-08
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017523 2001
% 223.37/223.53  |- skos__prefLabel mesh__D017523 Croatia
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017523 2006
% 223.37/223.53  |- rdf__type mesh__D017523sskos__Concept
% 223.37/223.53  |- mesh__dateCreated mesh__D050957 2005-06-30
% 223.37/223.53  |- mesh__historyNote mesh__D050957 2006%28%1995%29%   
% 223.37/223.53  |- skos__scopeNote mesh__D050957
% 223.37/223.53       A group of eukaryotic high-molecular mass heat-shock proteins that represent a subfamily of HSP70 HEAT-SHOCK PROTEINS. Hsp110 proteins prevent protein aggregation and can maintain denatured proteins in folding-competent states.%A%    
% 223.37/223.53  |- skos__altLabel mesh__D050957 Heat-Shock Proteins 110
% 223.37/223.53  |- mesh__recordAuthorizer mesh__D050957 sjn
% 223.37/223.53  |- skos__altLabel mesh__D050957 Heat-Shock Protein 110
% 223.37/223.53  |- mesh__recordOriginator mesh__D050957 DRC
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D050957 2006
% 223.37/223.53  |- mesh__recordMaintainer mesh__D050957 DRC
% 223.37/223.53  |- skos__hiddenLabel mesh__D050957 Proteins, HSP110 Heat-Shock
% 223.37/223.53  |- skos__altLabel mesh__D050957 110-kDa Heat Shock Protein
% 223.37/223.53  |- skos__prefLabel mesh__D050957 HSP110 Heat-Shock Proteins
% 223.37/223.53  |- rdf__type mesh__D050957sskos__Concept
% 223.37/223.53  |- skos__hiddenLabel mesh__D050957 Heat-Shock Proteins, HSP110
% 223.37/223.53  |- mesh__publicMeSHNote mesh__D050957
% 223.37/223.53       2006; HEAT-SHOCK PROTEINS 110 was indexed under HEAT-SHOCK PROTEINS 70 1995-2005%A%  
% 223.37/223.53  |- skos__hiddenLabel mesh__D050957 HSP110 Heat Shock Proteins
% 223.37/223.53  |- skos__broader mesh__D050957smesh__D018840
% 223.37/223.53  |- mesh__dateEstablished mesh__D050957 2006-01-01
% 223.37/223.53  |- skos__hiddenLabel mesh__D050957 Heat Shock Proteins 110
% 223.37/223.53  |- skos__hiddenLabel mesh__D050957 Heat Shock Protein 110
% 223.37/223.53  |- skos__historyNote mesh__D003503 Cycloparaffins %28%1966-1971%29%
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D003503 2006
% 223.37/223.53  |- mesh__publicMeSHNote mesh__D003503 74   
% 223.37/223.53  |- mesh__dateEstablished mesh__D003503 1974-01-01
% 223.37/223.53  |- skos__prefLabel mesh__D003503 Cyclobutanes
% 223.37/223.53  |- rdf__type mesh__D003503sskos__Concept
% 223.37/223.53  |- mesh__dateRevised mesh__D003503 2004-07-07
% 223.37/223.53  |- mesh__recordMaintainer mesh__D003503 ssb
% 223.37/223.53  |- mesh__historyNote mesh__D003503 74%28%72%29%   
% 223.37/223.53  |- skos__broader mesh__D003503smesh__D003516
% 223.37/223.53  |- mesh__recordOriginator mesh__D003503 NLM
% 223.37/223.53  |- mesh__recordAuthorizer mesh__D003503 sjn
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D003503 2005
% 223.37/223.53  |- skos__annotation mesh__D003503 includes cyclobutenes   
% 223.37/223.53  |- mesh__dateCreated mesh__D003503 1999-01-01
% 223.37/223.53  |- skos__scopeNote mesh__D008797
% 223.37/223.53       An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.%A%    
% 223.37/223.53  |- skos__altLabel mesh__D008797 Methbipyranone
% 223.37/223.53  |- skos__hiddenLabel mesh__D008797 Metyrapone Alliance Brand
% 223.37/223.53  |- skos__altLabel mesh__D008797 Methopyrapone
% 223.37/223.53  |- mesh__recordAuthorizer mesh__D008797 ags
% 223.37/223.53  |- mesh__dateEstablished mesh__D008797 1966-01-01
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D008797 2006
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D008797 2006A
% 223.37/223.53  |- skos__hiddenLabel mesh__D008797 Metyrapone Novartis Brand
% 223.37/223.53  |- skos__altLabel mesh__D008797 Alliance Brand of Metyrapone
% 223.37/223.53  |- mesh__recordOriginator mesh__D008797 NLM
% 223.37/223.53  |- skos__prefLabel mesh__D008797 Metyrapone
% 223.37/223.53  |- skos__altLabel mesh__D008797 Novartis Brand of Metyrapone
% 223.37/223.53  |- skos__altLabel mesh__D008797 M%C3%%A9%topirone
% 223.37/223.53  |- mesh__publicMeSHNote mesh__D008797 66   
% 223.37/223.53  |- skos__hiddenLabel mesh__D008797 4885, SU
% 223.37/223.53  |- skos__altLabel mesh__D008797 Metopiron
% 223.37/223.53  |- mesh__historyNote mesh__D008797 66%28%64%29%   
% 223.37/223.53  |- mesh__dateRevised mesh__D008797 2005-08-01
% 223.37/223.53  |- rdf__type mesh__D008797sskos__Concept
% 223.37/223.53  |- mesh__dateCreated mesh__D008797 1999-01-01
% 223.37/223.53  |- mesh__recordMaintainer mesh__D008797 ags
% 223.37/223.53  |- skos__broader mesh__D008797smesh__D011725
% 223.37/223.53  |- skos__historyNote mesh__D041622 Tomography %28%1982-2003%29%
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D041622 2004
% 223.37/223.53  |- skos__scopeNote mesh__D041622
% 223.37/223.53       Projection of near-IR light %28%INFRARED RAYS%29%, in the 700-1000 nm region, across an object in parallel beams to an array of sensitive photodetectors.  This is repeated at various angles and a mathematical reconstruction provides three dimensional MEDICAL IMAGING of tissues.  Based on the relative transparency of tissues to this spectra, it has been used to monitor local oxygenation, brain and joints.%A%    
% 223.37/223.53  |- mesh__dateCreated mesh__D041622 2003-07-09
% 223.37/223.53  |- mesh__historyNote mesh__D041622 2004   
% 223.37/223.53  |- rdf__type mesh__D041622sskos__Concept
% 223.37/223.53  |- skos__prefLabel mesh__D041622 Tomography, Optical
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D041622 2006
% 223.37/223.53  |- skos__altLabel mesh__D041622 Optical Tomography
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D041622 2005
% 223.37/223.53  |- mesh__dateEstablished mesh__D041622 2004-01-01
% 223.37/223.53  |- skos__broader mesh__D041622smesh__D014054
% 223.37/223.53  |- mesh__publicMeSHNote mesh__D041622 2004   
% 223.37/223.53  |- mesh__dateEstablished mesh__D013931 1978-01-01
% 223.37/223.53  |- mesh__dateRevised mesh__D013931 2005-06-30
% 223.37/223.53  |- skos__broader mesh__D013931smesh__D015777
% 223.37/223.53  |- skos__historyNote mesh__D013931 Pyrans %28%1966-1977%29%
% 223.37/223.53  |- mesh__dateCreated mesh__D013931 1977-05-23
% 223.37/223.53  |- skos__broader mesh__D013931smesh__D001095
% 223.37/223.53  |- mesh__recordMaintainer mesh__D013931 ssb
% 223.37/223.53  |- mesh__recordAuthorizer mesh__D013931 sjn
% 223.37/223.53  |- skos__related mesh__D013931smesh__D017482
% 223.37/223.53  |- skos__scopeNote mesh__D013931
% 223.37/223.53       Physiologically active compounds found in many organs of the body. They are formed in vivo from the prostaglandin endoperoxides and cause platelet aggregation, contraction of arteries, and other biological effects. Thromboxanes are important mediators of the actions of polyunsaturated fatty acids transformed by cyclooxygenase.%A%    
% 223.37/223.53  |- mesh__publicMeSHNote mesh__D013931 78   
% 223.37/223.53  |- skos__historyNote mesh__D013931
% 223.37/223.53       Fatty Acids, Unsaturated %28%1973-1974%29%
% 223.37/223.53  |- skos__annotation mesh__D013931 /biosyn /physiol permitted   
% 223.37/223.53  |- mesh__recordOriginator mesh__D013931 RLS
% 223.37/223.53  |- mesh__historyNote mesh__D013931 78   
% 223.37/223.53  |- skos__historyNote mesh__D013931 Hydroxy Acids %28%1975-1977%29%
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013931 2006
% 223.37/223.53  |- skos__prefLabel mesh__D013931 Thromboxanes
% 223.37/223.53  |- rdf__type mesh__D013931sskos__Concept
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013133 1999
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013133 1996
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013133 1993
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013133 1995
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013133 1998
% 223.37/223.53  |- skos__historyNote mesh__D013133 Spinal Cord %28%1966-1970%29%
% 223.37/223.53  |- skos__prefLabel mesh__D013133 Spinothalamic Tracts
% 223.37/223.53  |- skos__hiddenLabel mesh__D013133 Tract, Spinothalamic
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013133 1994
% 223.37/223.53  |- skos__broader mesh__D013133smesh__D013116
% 223.37/223.53  |- rdf__type mesh__D013133sskos__Concept
% 223.37/223.53  |- mesh__dateCreated mesh__D013133 1999-01-01
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013133 2004
% 223.37/223.53  |- skos__hiddenLabel mesh__D013133 Tracts, Spinothalamic
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013133 2002
% 223.37/223.53  |- mesh__recordAuthorizer mesh__D013133 PLS
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013133 2006
% 223.37/223.53  |- mesh__recordMaintainer mesh__D013133 TAP
% 223.37/223.53  |- skos__hiddenLabel mesh__D013133 Spinothalamic Tract
% 223.37/223.53  |- mesh__dateRevised mesh__D013133 1992-05-18
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013133 2003
% 223.37/223.53  |- mesh__dateEstablished mesh__D013133 1971-01-01
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013133 2001
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013133 2005
% 223.37/223.53  |- mesh__publicMeSHNote mesh__D013133 71   
% 223.37/223.53  |- skos__broader mesh__D013133smesh__D000344
% 223.37/223.53  |- mesh__recordOriginator mesh__D013133 NLM
% 223.37/223.53  |- mesh__historyNote mesh__D013133 71   
% 223.37/223.53  |- skos__historyNote mesh__D013133 Thalamus %28%1966-1970%29%
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013133 1997
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D013133 2000
% 223.37/223.53  |- rdf__type mesh__D012839sskos__Concept
% 223.37/223.53  |- skos__scopeNote mesh__D012839 A triazine herbicide.     
% 223.37/223.53  |- skos__hiddenLabel mesh__D012839 Herbazin 50
% 223.37/223.53  |- skos__prefLabel mesh__D012839 Simazine
% 223.37/223.53  |- mesh__dateEstablished mesh__D012839 1991-01-01
% 223.37/223.53  |- mesh__recordAuthorizer mesh__D012839 sjn
% 223.37/223.53  |- mesh__publicMeSHNote mesh__D012839
% 223.37/223.53       91; was see under HERBICIDES, TRIAZINE 1972-90   
% 223.37/223.53  |- skos__broader mesh__D012839smesh__D014227
% 223.37/223.53  |- skos__hiddenLabel mesh__D012839 Herbazin50
% 223.37/223.53  |- mesh__historyNote mesh__D012839
% 223.37/223.53       91%28%72%29%; was see under HERBICIDES, TRIAZINE 1972-90   
% 223.37/223.53  |- skos__historyNote mesh__D012839 Triazines %28%1966-1971%29%
% 223.37/223.53  |- mesh__dateRevised mesh__D012839 2004-07-07
% 223.37/223.53  |- skos__historyNote mesh__D012839 Herbicides %28%1966-1971%29%
% 223.37/223.53  |- mesh__dateCreated mesh__D012839 1999-01-01
% 223.37/223.53  |- mesh__recordOriginator mesh__D012839 NLM
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D012839 2006
% 223.37/223.53  |- mesh__recordMaintainer mesh__D012839 ssb
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D012839 2005
% 223.37/223.53  |- skos__broader mesh__D009890smesh__D014200
% 223.37/223.53  |- mesh__historyNote mesh__D009890 82   
% 223.37/223.53  |- mesh__recordAuthorizer mesh__D009890 sjn
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D009890 2004
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D009890 2005
% 223.37/223.53  |- skos__historyNote mesh__D009890 Trematoda %28%1966-1981%29%
% 223.37/223.53  |- mesh__recordOriginator mesh__D009890 EC
% 223.37/223.53  |- mesh__recordMaintainer mesh__D009890 ags
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D009890 2006
% 223.37/223.53  |- mesh__publicMeSHNote mesh__D009890 82   
% 223.37/223.53  |- skos__annotation mesh__D009890
% 223.37/223.53       a family of trematodes; infection: coord IM with TREMATODE INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 223.37/223.53  |- skos__scopeNote mesh__D009890
% 223.37/223.53       A family of lanceolate liver flukes of the class Trematoda which occurs in animals and man. There are several genera including Amphimerus, Cyclorchis, Delphinicola, Metorchis, Parametorchis, Phocitrema, Clonorchis, and Opisthorchis.%A%    
% 223.37/223.53  |- mesh__dateCreated mesh__D009890 1981-05-15
% 223.37/223.53  |- mesh__dateRevised mesh__D009890 2003-07-09
% 223.37/223.53  |- rdf__type mesh__D009890sskos__Concept
% 223.37/223.53  |- skos__prefLabel mesh__D009890 Opisthorchidae
% 223.37/223.53  |- mesh__dateEstablished mesh__D009890 1982-01-01
% 223.37/223.53  |- skos__scopeNote mesh__D009092
% 223.37/223.53       An EPITHELIUM with MUCUS-secreting cells, such as GOBLET CELLS. It forms the lining of many body cavities, such as the DIGESTIVE TRACT, the RESPIRATORY TRACT, and the reproductive tract. Mucosa, rich in blood and lymph vessels, comprises an inner epithelium, a middle layer %28%lamina propria%29% of loose CONNECTIVE TISSUE, and an outer layer %28%muscularis mucosae%29% of smooth muscle cells that separates the mucosa from submucosa.%A%    
% 223.37/223.53  |- skos__altLabel mesh__D009092 Mucosal Tissue
% 223.37/223.53  |- skos__hiddenLabel mesh__D009092 Mucosal Tissues
% 223.37/223.53  |- skos__broader mesh__D009092smesh__D008566
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D009092 2006
% 223.37/223.53  |- mesh__recordMaintainer mesh__D009092 lkt
% 223.37/223.53  |- mesh__recordAuthorizer mesh__D009092 sjn
% 223.37/223.53  |- mesh__dateCreated mesh__D009092 1999-01-01
% 223.37/223.53  |- skos__hiddenLabel mesh__D009092 Membrane, Mucous
% 223.37/223.53  |- skos__altLabel mesh__D009092 Mucous Membranes
% 223.37/223.53  |- mesh__recordOriginator mesh__D009092 NLM
% 223.37/223.53  |- skos__hiddenLabel mesh__D009092 Mucosae, Muscularis
% 223.37/223.53  |- rdf__type mesh__D009092sskos__Concept
% 223.37/223.53  |- skos__prefLabel mesh__D009092 Mucous Membrane
% 223.37/223.53  |- skos__hiddenLabel mesh__D009092 Membranes, Mucous
% 223.37/223.53  |- skos__altLabel mesh__D009092 Mucosa
% 223.37/223.53  |- skos__hiddenLabel mesh__D009092 Tissues, Mucosal
% 223.37/223.53  |- skos__hiddenLabel mesh__D009092 Tissue, Mucosal
% 223.37/223.53  |- skos__hiddenLabel mesh__D009092 Propria, Lamina
% 223.37/223.53  |- mesh__dateRevised mesh__D009092 2005-06-30
% 223.37/223.53  |- skos__annotation mesh__D009092
% 223.37/223.53       general or unspecified; prefer specifics; coordinate NIM with specific organ %28%IM%29%%A%  
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017524 1998
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017524 2002
% 223.37/223.53  |- skos__historyNote mesh__D017524 Yugoslavia %28%1966-1992%29%
% 223.37/223.53  |- mesh__recordMaintainer mesh__D017524 PLS
% 223.37/223.53  |- mesh__recordOriginator mesh__D017524 PLS
% 223.37/223.53  |- skos__broader mesh__D017524smesh__D015022
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017524 2001
% 223.37/223.53  |- mesh__historyNote mesh__D017524 93   
% 223.37/223.53  |- mesh__dateCreated mesh__D017524 1992-05-22
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017524 2004
% 223.37/223.53  |- mesh__dateRevised mesh__D017524 1995-06-08
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017524 2000
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017524 2006
% 223.37/223.53  |- rdf__type mesh__D017524sskos__Concept
% 223.37/223.53  |- skos__scopeNote mesh__D017524
% 223.37/223.53       Created 7 April 1992 as a result of the division of Yugoslavia.%A%    
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017524 2003
% 223.37/223.53  |- skos__prefLabel mesh__D017524 Slovenia
% 223.37/223.53  |- mesh__recordAuthorizer mesh__D017524 PLS
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017524 1997
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017524 2005
% 223.37/223.53  |- mesh__dateEstablished mesh__D017524 1993-01-01
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017524 1999
% 223.37/223.53  |- mesh__onlineNote mesh__D017524
% 223.37/223.53       use YUGOSLAVIA to search SLOVENIA 1966-92   
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D017524 1996
% 223.37/223.53  |- skos__broader mesh__D017524smesh__D005061
% 223.37/223.53  |- mesh__recordOriginator mesh__D050958 DRC
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D050958 2006
% 223.37/223.53  |- mesh__publicMeSHNote mesh__D050958
% 223.37/223.53       2006; HEAT-SHOCK PROTEIN  47 was indexed under HEAT-SHOCK PROTEINS 1993-2005%A%  
% 223.37/223.53  |- skos__hiddenLabel mesh__D050958 Heat-Shock Proteins, HSP47
% 223.37/223.53  |- mesh__dateEstablished mesh__D050958 2006-01-01
% 223.37/223.53  |- skos__altLabel mesh__D050958 Heat Shock Protein 47
% 223.37/223.53  |- mesh__recordMaintainer mesh__D050958 ags
% 223.37/223.53  |- mesh__dateCreated mesh__D050958 2005-06-30
% 223.37/223.53  |- rdf__type mesh__D050958sskos__Concept
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D050958 2006A
% 223.37/223.53  |- skos__broader mesh__D050958smesh__D018832
% 223.37/223.53  |- skos__hiddenLabel mesh__D050958 HSP47 Heat Shock Proteins
% 223.37/223.53  |- skos__prefLabel mesh__D050958 HSP47 Heat-Shock Proteins
% 223.37/223.53  |- skos__broader mesh__D050958smesh__D015843
% 223.37/223.53  |- skos__broader mesh__D050958smesh__D006360
% 223.37/223.53  |- mesh__historyNote mesh__D050958 2006%28%1993%29%   
% 223.37/223.53  |- skos__scopeNote mesh__D050958
% 223.37/223.53       Basic glycoprotein members of the SERPIN SUPERFAMILY that function as COLLAGEN-specific MOLECULAR CHAPERONES in the ENDOPLASMIC RETICULUM.%A%    
% 223.37/223.53  |- skos__hiddenLabel mesh__D050958 Proteins, HSP47 Heat-Shock
% 223.37/223.53  |- mesh__dateRevised mesh__D050958 2005-07-29
% 223.37/223.53  |- mesh__recordAuthorizer mesh__D050958 ags
% 223.37/223.53  |- skos__altLabel mesh__D050958 Heat-Shock Protein 47
% 223.37/223.53  |- skos__prefLabel mesh__D003504 Ancitabine
% 223.37/223.53  |- skos__hiddenLabel mesh__D003504 U 33624A
% 223.37/223.53  |- mesh__recordOriginator mesh__D003504 SH
% 223.37/223.53  |- skos__hiddenLabel mesh__D003504 U 33,624A
% 223.37/223.53  |- skos__hiddenLabel mesh__D003504 NSC145,668
% 223.37/223.53  |- mesh__recordAuthorizer mesh__D003504 sjn
% 223.37/223.53  |- mesh__publicMeSHNote mesh__D003504
% 223.37/223.53       96; was CYCLOCYTIDINE 1977-95 %28%see under CYTARABINE 1977-90%29%%A%  
% 223.37/223.53  |- skos__hiddenLabel mesh__D003504 NSC 145668
% 223.37/223.53  |- mesh__dateCreated mesh__D003504 1976-04-13
% 223.37/223.53  |- skos__broader mesh__D003504smesh__D003561
% 223.37/223.53  |- mesh__historyNote mesh__D003504
% 223.37/223.53       96; was CYCLOCYTIDINE 1977-95 %28%see under CYTARABINE 1977-90%29%%A%  
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D003504 2006
% 223.37/223.53  |- skos__hiddenLabel mesh__D003504 NSC145668
% 223.37/223.53  |- skos__hiddenLabel mesh__D003504 CycloC
% 223.37/223.53  |- skos__hiddenLabel mesh__D003504 U33,624A
% 223.37/223.53  |- skos__scopeNote mesh__D003504
% 223.37/223.53       Congener of CYTARABINE that is metabolized to cytarabine and thereby maintains a more constant antineoplastic action.%A%    
% 223.37/223.53  |- skos__altLabel mesh__D003504 NSC-145668
% 223.37/223.53  |- skos__hiddenLabel mesh__D003504 Cyclo C
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D003504 2005
% 223.37/223.53  |- rdf__type mesh__D003504sskos__Concept
% 223.37/223.53  |- skos__altLabel mesh__D003504 Anhydro-Ara-C
% 223.37/223.53  |- mesh__dateRevised mesh__D003504 2003-07-09
% 223.37/223.53  |- mesh__recordMaintainer mesh__D003504 ssb
% 223.37/223.53  |- skos__hiddenLabel mesh__D003504 NSC 145,668
% 223.37/223.53  |- mesh__dateEstablished mesh__D003504 1991-01-01
% 223.37/223.53  |- mesh__activeMeSHYear mesh__D003504 2004
% 223.37/223.53  |- skos__altLabel mesh__D003504 U-33624A
% 223.37/223.53  |- skos__historyNote mesh__D003504 Anhydrides %28%1974-1975%29%
% 223.37/223.53  |- skos__historyNote mesh__D003504 Cytidine %28%1973%29%
% 223.37/223.53  |- skos__historyNote mesh__D003504 Cytarabine %28%1974-1976%29%
% 223.37/223.53  |- skos__altLabel mesh__D003504 Cyclocytidine
% 223.37/223.54  |- skos__hiddenLabel mesh__D003504 U33624A
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D008798 2006
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D008798 1999
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D008798 1993
% 223.37/223.54  |- skos__hiddenLabel mesh__D008798 Acid, Mevalonic
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D008798 2003
% 223.37/223.54  |- mesh__recordMaintainer mesh__D008798 TGC
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D008798 1996
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D008798 2000
% 223.37/223.54  |- skos__broader mesh__D008798smesh__D006880
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D008798 2004
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D008798 2001
% 223.37/223.54  |- skos__prefLabel mesh__D008798 Mevalonic Acid
% 223.37/223.54  |- mesh__recordOriginator mesh__D008798 NLM
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D008798 1997
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D008798 1994
% 223.37/223.54  |- rdf__type mesh__D008798sskos__Concept
% 223.37/223.54  |- mesh__dateCreated mesh__D008798 1999-01-01
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D008798 1995
% 223.37/223.54  |- mesh__recordAuthorizer mesh__D008798 PLS
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D008798 2005
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D008798 1998
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D008798 2002
% 223.37/223.54  |- mesh__dateRevised mesh__D008798 1992-05-18
% 223.37/223.54  |- skos__prefLabel mesh__D041623 Tomography, Optical Coherence
% 223.37/223.54  |- mesh__dateEstablished mesh__D041623 2004-01-01
% 223.37/223.54  |- rdf__type mesh__D041623sskos__Concept
% 223.37/223.54  |- skos__historyNote mesh__D041623 Tomography %28%1991-2003%29%
% 223.37/223.54  |- skos__scopeNote mesh__D041623
% 223.37/223.54       An imaging method using LASERS that is used for mapping subsurface structure. When a reflective site in the sample is at the same optical path length %28%coherence%29% as the reference mirror, the detector observes interference fringes.%A%    
% 223.37/223.54  |- skos__hiddenLabel mesh__D041623 Tomography, OCT
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D041623 2006
% 223.37/223.54  |- skos__altLabel mesh__D041623 OCT Tomography
% 223.37/223.54  |- skos__broader mesh__D041623smesh__D041622
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D041623 2005
% 223.37/223.54  |- mesh__publicMeSHNote mesh__D041623 2004   
% 223.37/223.54  |- mesh__historyNote mesh__D041623 2004   
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D041623 2004
% 223.37/223.54  |- skos__altLabel mesh__D041623 Optical Coherence Tomography
% 223.37/223.54  |- mesh__dateCreated mesh__D041623 2003-07-09
% 223.37/223.54  |- skos__hiddenLabel mesh__D041623 Coherence Tomography, Optical
% 223.37/223.54  |- skos__scopeNote mesh__D013932
% 223.37/223.54       Thulium. An element of the rare earth family of metals. It has the atomic symbol Tm, atomic number 69, and atomic weight 168.93.%A%    
% 223.37/223.54  |- mesh__recordMaintainer mesh__D013932 jmp
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D013932 2002
% 223.37/223.54  |- mesh__recordAuthorizer mesh__D013932 sjn
% 223.37/223.54  |- skos__broader mesh__D013932smesh__D028581
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D013932 2006
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D013932 2004
% 223.37/223.54  |- mesh__dateRevised mesh__D013932 2001-07-25
% 223.37/223.54  |- rdf__type mesh__D013932sskos__Concept
% 223.37/223.54  |- skos__prefLabel mesh__D013932 Thulium
% 223.37/223.54  |- skos__annotation mesh__D013932
% 223.37/223.54       a rare earth metal; Tm-169; Tm-161-168, 170-176 = THULIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D013932 2005
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D013932 2003
% 223.37/223.54  |- mesh__dateCreated mesh__D013932 1999-01-01
% 223.37/223.54  |- mesh__recordOriginator mesh__D013932 NLM
% 223.37/223.54  |- skos__altLabel mesh__D013134 Spiroperidol
% 223.37/223.54  |- skos__historyNote mesh__D013134 Butyrophenones %28%1966-1974%29%
% 223.37/223.54  |- skos__prefLabel mesh__D013134 Spiperone
% 223.37/223.54  |- skos__scopeNote mesh__D013134
% 223.37/223.54       A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.%A%    
% 223.37/223.54  |- mesh__recordOriginator mesh__D013134 NLM
% 223.37/223.54  |- mesh__dateCreated mesh__D013134 1974-11-19
% 223.37/223.54  |- mesh__dateRevised mesh__D013134 2003-07-09
% 223.37/223.54  |- rdf__type mesh__D013134sskos__Concept
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D013134 2005
% 223.37/223.54  |- skos__altLabel mesh__D013134 Spiroperone
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D013134 2004
% 223.37/223.54  |- mesh__dateEstablished mesh__D013134 1987-01-01
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D013134 2006
% 223.37/223.54  |- mesh__recordMaintainer mesh__D013134 ssb
% 223.37/223.54  |- skos__historyNote mesh__D013134 Spiro Compounds %28%1966-1974%29%
% 223.37/223.54  |- skos__historyNote mesh__D013134 Benzoates %28%1966-1974%29%
% 223.37/223.54  |- skos__broader mesh__D013134smesh__D002090
% 223.37/223.54  |- mesh__recordAuthorizer mesh__D013134 sjn
% 223.37/223.54  |- mesh__publicMeSHNote mesh__D013134
% 223.37/223.54       87; was see under BUTYROPHENONES 1975-86   
% 223.37/223.54  |- skos__broader mesh__D013134smesh__D013141
% 223.37/223.54  |- mesh__historyNote mesh__D013134
% 223.37/223.54       87%28%75%29%; was see under BUTYROPHENONES 1975-86   
% 223.37/223.54  |- skos__related mesh__D037582smesh__D037601
% 223.37/223.54  |- skos__hiddenLabel mesh__D037582
% 223.37/223.54       Mannan Binding Lectin Pathway %28%Complement Activation%29%
% 223.37/223.54  |- mesh__dateEstablished mesh__D037582 2003-01-01
% 223.37/223.54  |- mesh__recordOriginator mesh__D037582 jmp
% 223.37/223.54  |- skos__hiddenLabel mesh__D037582 Mannan Binding Lectin Complement Pathway
% 223.37/223.54  |- skos__altLabel mesh__D037582 Lectin-Complement Pathway
% 223.37/223.54  |- mesh__recordAuthorizer mesh__D037582 sjn
% 223.37/223.54  |- mesh__recordMaintainer mesh__D037582 lkt
% 223.37/223.54  |- skos__hiddenLabel mesh__D037582
% 223.37/223.54       Pathways, Mannan-Binding Lectin %28%Complement Activation%29%
% 223.37/223.54  |- skos__hiddenLabel mesh__D037582
% 223.37/223.54       Lectin Pathway, Mannan-Binding %28%Complement Activation%29%
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D037582 2006
% 223.37/223.54  |- skos__altLabel mesh__D037582 Mannan-Binding Lectin Complement Pathway
% 223.37/223.54  |- skos__hiddenLabel mesh__D037582 Pathway, Lectin-Complement
% 223.37/223.54  |- skos__broader mesh__D037582smesh__D003167
% 223.37/223.54  |- mesh__dateRevised mesh__D037582 2005-06-30
% 223.37/223.54  |- skos__prefLabel mesh__D037582 Complement Pathway, Mannose-Binding Lectin
% 223.37/223.54  |- skos__hiddenLabel mesh__D037582
% 223.37/223.54       Mannan-Binding Lectin Pathways %28%Complement Activation%29%
% 223.37/223.54  |- mesh__historyNote mesh__D037582 2003   
% 223.37/223.54  |- mesh__dateCreated mesh__D037582 2002-07-03
% 223.37/223.54  |- skos__scopeNote mesh__D037582
% 223.37/223.54       Complement activation triggered by the interaction of microbial POLYSACCHARIDES with serum MANNOSE-BINDING LECTIN resulting in the activation of MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES %28%MASP%29%. As in the classical pathway, MASPs cleave COMPLEMENT C4 and COMPLEMENT C2 to form C3 CONVERTASE %28%C4B2A%29% and the subsequent C5 CONVERTASE %28%C4B2A3B%29% leading to cleavage of COMPLEMENT C5 and assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX.%A%    
% 223.37/223.54  |- skos__altLabel mesh__D037582 Mannose-Binding Lectin Complement Pathway
% 223.37/223.54  |- skos__hiddenLabel mesh__D037582
% 223.37/223.54       Mannose Binding Lectin Complement Pathway
% 223.37/223.54  |- skos__hiddenLabel mesh__D037582 Lectin-Complement Pathways
% 223.37/223.54  |- skos__hiddenLabel mesh__D037582 Lectin Complement Pathway
% 223.37/223.54  |- rdf__type mesh__D037582sskos__Concept
% 223.37/223.54  |- skos__hiddenLabel mesh__D037582
% 223.37/223.54       Lectin Pathways, Mannan-Binding %28%Complement Activation%29%
% 223.37/223.54  |- skos__altLabel mesh__D037582
% 223.37/223.54       Mannan-Binding Lectin Pathway %28%Complement Activation%29%
% 223.37/223.54  |- skos__hiddenLabel mesh__D037582 Pathways, Lectin-Complement
% 223.37/223.54  |- skos__hiddenLabel mesh__D037582
% 223.37/223.54       Pathway, Mannan-Binding Lectin %28%Complement Activation%29%
% 223.37/223.54  |- mesh__publicMeSHNote mesh__D037582 2003   
% 223.37/223.54  |- skos__hiddenLabel mesh__D037582
% 223.37/223.54       Complement Pathway, Mannose Binding Lectin
% 223.37/223.54  |- skos__historyNote mesh__D037582 Complement Activation %28%1989-2002%29%
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D009891 2004
% 223.37/223.54  |- skos__scopeNote mesh__D009891
% 223.37/223.54       A genus of trematode liver flukes of the family Opisthorchidae. It consists of the following species: O. felineus, O. noverca %28%Amphimerus noverca%29%, and O. viverrini. The intermediate hosts are snails, fish, and amphibia.%A%    
% 223.37/223.54  |- skos__annotation mesh__D009891
% 223.37/223.54       infection = OPISTHORCHIASIS but note OPISTHORCHIS SINENSIS see CLONORCHIS SINENSIS: O. sinensis infection = CLONORCHIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D009891 2005
% 223.37/223.54  |- skos__prefLabel mesh__D009891 Opisthorchis
% 223.37/223.54  |- mesh__recordAuthorizer mesh__D009891 sjn
% 223.37/223.54  |- mesh__recordMaintainer mesh__D009891 ags
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D009891 2006
% 223.37/223.54  |- mesh__recordOriginator mesh__D009891 NLM
% 223.37/223.54  |- mesh__dateRevised mesh__D009891 2003-07-09
% 223.37/223.54  |- mesh__dateCreated mesh__D009891 1999-01-01
% 223.37/223.54  |- rdf__type mesh__D009891sskos__Concept
% 223.37/223.54  |- skos__broader mesh__D009891smesh__D009890
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D009093 2006
% 223.37/223.54  |- mesh__dateCreated mesh__D009093 1999-01-01
% 223.37/223.54  |- mesh__recordMaintainer mesh__D009093 KEV
% 223.37/223.54  |- skos__scopeNote mesh__D009093
% 223.37/223.54       The viscous secretion of mucous membranes. It contains mucin, white blood cells, water, inorganic salts, and exfoliated cells.%A%    
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D009093 2003
% 223.37/223.54  |- skos__annotation mesh__D009093
% 223.37/223.54       mucus glands: index MUCUS %28%IM%29% + EXOCRINE GLANDS %28%IM%29%   
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D009093 2000
% 223.37/223.54  |- skos__broader mesh__D009093smesh__D012634
% 223.37/223.54  |- rdf__type mesh__D009093sskos__Concept
% 223.37/223.54  |- mesh__publicMeSHNote mesh__D009093 66   
% 223.37/223.54  |- mesh__recordAuthorizer mesh__D009093 sjn
% 223.37/223.54  |- mesh__dateEstablished mesh__D009093 1966-01-01
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D009093 2004
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D009093 2001
% 223.37/223.54  |- mesh__recordOriginator mesh__D009093 NLM
% 223.37/223.54  |- mesh__dateRevised mesh__D009093 1999-11-03
% 223.37/223.54  |- skos__related mesh__D009093smesh__D015916
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D009093 2005
% 223.37/223.54  |- skos__prefLabel mesh__D009093 Mucus
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D009093 2002
% 223.37/223.54  |- mesh__historyNote mesh__D009093 66%28%63%29%   
% 223.37/223.54  |- skos__broader mesh__D050959smesh__D009097
% 223.37/223.54  |- mesh__activeMeSHYear mesh__D050959 2006
% 223.37/223.54  |- mesh__historyNote mesh__D050959 2006%28%2004%29%   
% 223.37/223.54  |- rdf__type mesh__D050959sskos__Concept
% 223.37/223.54  |- skos__prefLabel mesh__D050959 Glycine Decarboxylase Complex
% 223.37/223.54  |- skos__broader mesh__D050959smesh__D000594
% 223.37/223.54  |- mesh__recordOriginator mesh__D050959 jmp
% 223.37/223.54  |- skos__hiddenLabel mesh__D050959 Decarboxylase Complex, Glycine
% 223.37/223.54  |- mesh__recordMaintainer mesh__D050959 jmp
% 223.37/223.54  |- mesh__dateCreated mesh__D050959 2005-06-30
% 223.37/223.54  |- mesh__dateEstablished mesh__D050959 2006-01-01
% 223.37/223.54  |- mesh__recordAuthorizer mesh__D050959 sjn
% 223.37/223.54  |- skos__scopeNote mesh__D050959
% 223.37/223.54       A enzyme complex that catalyzes the oxidative DECARBOXYLATION and DEAMINATION of GLYCINE into CARBON DIOXIDE; AMMONIA; NADH; and N5N10-methylenetetrahydrofolate. It is composed of four different component protein components referred to as H, P, L, and T.%A%    
% 223.37/223.54  |- mesh__publicMeSHNote mesh__D050959
% 223.37/223.54       2006; GLYCINE DECARBOXYLASE COMPLEX was indexed under AMINO ACID OXIDOREDUCTASES 2004-2005%A%  
% 223.37/223.54  |- skos__altLabel mesh__D050959 Glycine Cleavage System Complex
% 223.37/223.54  |- skos__broader mesh__D003505smesh__D003912
% 223.37/223.54  |- mesh__publicMeSHNote mesh__D003505 91; was see under DEXTRINS 1980-90   
% 223.37/223.55  |- mesh__dateCreated mesh__D003505 1979-05-23
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D003505 2006
% 223.37/223.55  |- skos__altLabel mesh__D003505 Cycloamylose
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D003505 2005
% 223.37/223.55  |- rdf__type mesh__D003505sskos__Concept
% 223.37/223.55  |- mesh__recordAuthorizer mesh__D003505 sjn
% 223.37/223.55  |- skos__prefLabel mesh__D003505 Cyclodextrins
% 223.37/223.55  |- mesh__dateEstablished mesh__D003505 1991-01-01
% 223.37/223.55  |- skos__annotation mesh__D003505 note specifics   
% 223.37/223.55  |- skos__historyNote mesh__D003505 Polysaccharides %28%1966-1974%29%
% 223.37/223.55  |- skos__broader mesh__D003505smesh__D047028
% 223.37/223.55  |- mesh__historyNote mesh__D003505
% 223.37/223.55       91%28%80%29%; was see under DEXTRINS 1980-90   
% 223.37/223.55  |- mesh__dateRevised mesh__D003505 2004-07-07
% 223.37/223.55  |- skos__scopeNote mesh__D003505
% 223.37/223.55       A homologous group of cyclic GLUCANS consisting of alpha-1,4 bound glucose units obtained by the action of cyclodextrin glucanotransferase on starch or similar substrates. The enzyme is produced by certain species of Bacillus. Cyclodextrins form inclusion complexes with a wide variety of substances.%A%    
% 223.37/223.55  |- mesh__recordMaintainer mesh__D003505 ssb
% 223.37/223.55  |- skos__altLabel mesh__D003505 Cyclomaltooligosaccharides
% 223.37/223.55  |- skos__historyNote mesh__D003505 Dextrins %28%1975-1979%29%
% 223.37/223.55  |- mesh__recordOriginator mesh__D003505 RLS
% 223.37/223.55  |- skos__altLabel mesh__D008799 Phosdrin
% 223.37/223.55  |- mesh__publicMeSHNote mesh__D008799
% 223.37/223.55       91; was see under INSECTICIDES, ORGANOPHOSPHATE 1973-90   
% 223.37/223.55  |- skos__annotation mesh__D008799 TN 111 for eff on insects   
% 223.37/223.55  |- skos__broader mesh__D008799smesh__D009943
% 223.37/223.55  |- rdf__type mesh__D008799sskos__Concept
% 223.37/223.55  |- mesh__dateCreated mesh__D008799 1999-01-01
% 223.37/223.55  |- mesh__dateRevised mesh__D008799 2004-07-07
% 223.37/223.55  |- mesh__recordMaintainer mesh__D008799 ssb
% 223.37/223.55  |- mesh__recordAuthorizer mesh__D008799 sjn
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D008799 2005
% 223.37/223.55  |- skos__scopeNote mesh__D008799
% 223.37/223.55       An organophosphate cholinesterase inhibitor that is used as an insecticide.%A%    
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D008799 2006
% 223.37/223.55  |- skos__prefLabel mesh__D008799 Mevinphos
% 223.37/223.55  |- skos__altLabel mesh__D008799 Fosdrine
% 223.37/223.55  |- mesh__dateEstablished mesh__D008799 1991-01-01
% 223.37/223.55  |- mesh__historyNote mesh__D008799
% 223.37/223.55       91%28%73%29%; was see under INSECTICIDES, ORGANOPHOSPHATE 1973-90%A%  
% 223.37/223.55  |- mesh__recordOriginator mesh__D008799 NLM
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D013933 2006
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D013933 2004
% 223.37/223.55  |- rdf__type mesh__D013933sskos__Concept
% 223.37/223.55  |- mesh__recordOriginator mesh__D013933 NLM
% 223.37/223.55  |- skos__annotation mesh__D013933
% 223.37/223.55       primates only; /inj permitted: do not convert to FINGER INJURIES%A%  
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D013933 2005
% 223.37/223.55  |- skos__hiddenLabel mesh__D013933 Thumbs
% 223.37/223.55  |- mesh__dateRevised mesh__D013933 2002-07-03
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D013933 2003
% 223.37/223.55  |- mesh__dateCreated mesh__D013933 1999-01-01
% 223.37/223.55  |- skos__broader mesh__D013933smesh__D005385
% 223.37/223.55  |- skos__prefLabel mesh__D013933 Thumb
% 223.37/223.55  |- mesh__recordMaintainer mesh__D013933 TGC
% 223.37/223.55  |- mesh__recordAuthorizer mesh__D013933 sjn
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D009892 2006
% 223.37/223.55  |- skos__altLabel mesh__D009892 Roche Brand of Papaveretum
% 223.37/223.55  |- skos__scopeNote mesh__D009892
% 223.37/223.55       The air-dried exudate from the unripe seed capsule of the opium poppy, Papaver somniferum, or its variant, P. album. It contains a number of alkaloids, but only a few - MORPHINE; CODEINE; and PAPAVERINE - have clinical significance. Opium has been used as an analgesic, antitussive, antidiarrheal, and antispasmodic.%A%    
% 223.37/223.55  |- mesh__onlineNote mesh__D009892 use OPIUM to search PANTOPON 1966-79   
% 223.37/223.55  |- mesh__dateCreated mesh__D009892 1999-01-01
% 223.37/223.55  |- rdf__type mesh__D009892sskos__Concept
% 223.37/223.55  |- mesh__historyNote mesh__D009892 PANTOPON was see under OPIUM 1963-79   
% 223.37/223.55  |- mesh__publicMeSHNote mesh__D009892
% 223.37/223.55       PANTOPON was see under OPIUM 1963-79   
% 223.37/223.55  |- mesh__recordAuthorizer mesh__D009892 sjn
% 223.37/223.55  |- skos__prefLabel mesh__D009892 Opium
% 223.37/223.55  |- skos__annotation mesh__D009892
% 223.37/223.55       a narcotic analgesic from the poppy, Papaver; opium addiction: coord IM with OPIOID-RELATED DISORDERS %28%IM%29%%A%  
% 223.37/223.55  |- mesh__recordOriginator mesh__D009892 NLM
% 223.37/223.55  |- mesh__recordMaintainer mesh__D009892 lkw
% 223.37/223.55  |- skos__broader mesh__D009892smesh__D000470
% 223.37/223.55  |- mesh__dateRevised mesh__D009892 2005-06-30
% 223.37/223.55  |- mesh__recordOriginator mesh__D009094 NLM
% 223.37/223.55  |- skos__altLabel mesh__D009094 Therapy, Peloid
% 223.37/223.55  |- skos__altLabel mesh__D009094 Therapy, Peat
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D009094 2006
% 223.37/223.55  |- skos__hiddenLabel mesh__D009094 Pack, Mud
% 223.37/223.55  |- skos__altLabel mesh__D009094 Peloid Therapy
% 223.37/223.55  |- mesh__dateCreated mesh__D009094 1999-01-01
% 223.37/223.55  |- skos__hiddenLabel mesh__D009094 Mud Pack
% 223.37/223.55  |- skos__altLabel mesh__D009094 Therapy, Mud
% 223.37/223.55  |- skos__scopeNote mesh__D009094
% 223.37/223.55       The therapeutic use of mud in packs or baths taking advantage of the absorptive qualities of the mud.  It has been used for rheumatism and skin problems.%A%    
% 223.37/223.55  |- skos__hiddenLabel mesh__D009094 Packs, Mud
% 223.37/223.55  |- mesh__dateRevised mesh__D009094 2005-06-30
% 223.37/223.55  |- rdf__type mesh__D009094sskos__Concept
% 223.37/223.55  |- skos__hiddenLabel mesh__D009094 Bath, Mud
% 223.37/223.55  |- skos__broader mesh__D009094smesh__D001452
% 223.37/223.55  |- skos__hiddenLabel mesh__D009094 Mud Bath
% 223.37/223.55  |- skos__prefLabel mesh__D009094 Mud Therapy
% 223.37/223.55  |- mesh__recordAuthorizer mesh__D009094 sjn
% 223.37/223.55  |- skos__annotation mesh__D009094 includes earth %26% clay   
% 223.37/223.55  |- skos__altLabel mesh__D009094 Pelotherapy
% 223.37/223.55  |- mesh__recordMaintainer mesh__D009094 lkt
% 223.37/223.55  |- skos__hiddenLabel mesh__D017526 Receptor, IGF I
% 223.37/223.55  |- skos__altLabel mesh__D017526 Receptor, Insulin-Like Growth Factor Type 1
% 223.37/223.55  |- skos__prefLabel mesh__D017526 Receptor, IGF Type 1
% 223.37/223.55  |- mesh__historyNote mesh__D017526 2000%28%1993%29%;   
% 223.37/223.55  |- skos__altLabel mesh__D017526 IGF Type 1 Receptor
% 223.37/223.55  |- skos__annotation mesh__D017526 DF: RECEPT IGF 1   
% 223.37/223.55  |- skos__altLabel mesh__D017526 Receptor, IGF-I
% 223.37/223.55  |- skos__altLabel mesh__D017526 Receptors, IGF-1
% 223.37/223.55  |- mesh__dateRevised mesh__D017526 2005-06-30
% 223.37/223.55  |- skos__altLabel mesh__D017526 Insulin-Like-Growth Factor I Receptor
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D017526 2006
% 223.37/223.55  |- rdf__type mesh__D017526sskos__Concept
% 223.37/223.55  |- skos__broader mesh__D017526smesh__D020794
% 223.37/223.55  |- skos__hiddenLabel mesh__D017526 Receptors, IGF 1
% 223.37/223.55  |- skos__scopeNote mesh__D017526
% 223.37/223.55       A protein-tyrosine kinase receptor that is closely related in structure to the INSULIN RECEPTOR. Although commonly referred to as the IGF-I receptor, it binds both IGF-I and IGF-II with high affinity. It is comprised of a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precusor protein. The beta subunit contains an intrinsic tyrosine kinase domain.%A%    
% 223.37/223.55  |- skos__hiddenLabel mesh__D017526 IGF I Receptor
% 223.37/223.55  |- skos__altLabel mesh__D017526 IGF-1 Receptor
% 223.37/223.55  |- mesh__publicMeSHNote mesh__D017526
% 223.37/223.55       2000; see RECEPTOR, INSULIN-LIKE-GROWTH FACTOR I 1993-1999%A%  
% 223.37/223.55  |- skos__hiddenLabel mesh__D017526 Receptor, IGF-1
% 223.37/223.55  |- skos__related mesh__D017526smesh__D007334
% 223.37/223.55  |- skos__hiddenLabel mesh__D017526 Insulin Like Growth Factor I Receptor
% 223.37/223.55  |- mesh__dateEstablished mesh__D017526 1993-01-01
% 223.37/223.55  |- skos__broader mesh__D017526smesh__D017451
% 223.37/223.55  |- mesh__dateCreated mesh__D017526 1992-05-29
% 223.37/223.55  |- mesh__recordOriginator mesh__D017526 PXP
% 223.37/223.55  |- skos__hiddenLabel mesh__D017526 IGF-1 Receptors
% 223.37/223.55  |- skos__altLabel mesh__D017526 Receptor, Insulin-Like Growth Factor I
% 223.37/223.55  |- skos__altLabel mesh__D017526 IGF-I Receptor
% 223.37/223.55  |- skos__hiddenLabel mesh__D017526 IGF 1 Receptor
% 223.37/223.55  |- mesh__recordMaintainer mesh__D017526 jmp
% 223.37/223.55  |- skos__altLabel mesh__D017526 Receptors, Insulin-Like-Growth Factor I
% 223.37/223.55  |- mesh__recordAuthorizer mesh__D017526 sjn
% 223.37/223.55  |- skos__historyNote mesh__D017526
% 223.37/223.55       Receptors, Endogenous Substances %28%1986-1992%29%
% 223.37/223.55  |- skos__related mesh__D017526smesh__D007335
% 223.37/223.55  |- skos__hiddenLabel mesh__D003506 F 6066
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D003506 2004
% 223.37/223.55  |- mesh__dateRevised mesh__D003506 2000-06-22
% 223.37/223.55  |- skos__historyNote mesh__D003506 Phenols %28%1969-1971%29%
% 223.37/223.55  |- mesh__recordMaintainer mesh__D003506 CCR
% 223.37/223.55  |- skos__altLabel mesh__D003506
% 223.37/223.55       4-%28%%28%4-%28%Acetyloxy%29%phenyl%29%cyclohexylidenemethyl%29%phenol Acetate
% 223.37/223.55  |- mesh__dateEstablished mesh__D003506 1991-01-01
% 223.37/223.55  |- mesh__dateCreated mesh__D003506 1999-01-01
% 223.37/223.55  |- skos__historyNote mesh__D003506 Cresols %28%1969-1971%29%
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D003506 2003
% 223.37/223.55  |- skos__broader mesh__D003506smesh__D003408
% 223.37/223.55  |- mesh__historyNote mesh__D003506
% 223.37/223.55       91%28%72%29%; was see under CRESOLS 1972-90   
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D003506 2002
% 223.37/223.55  |- skos__historyNote mesh__D003506 Cyclohexanes %28%1969-1971%29%
% 223.37/223.55  |- skos__altLabel mesh__D003506 Cyclophenil
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D003506 2006
% 223.37/223.55  |- skos__hiddenLabel mesh__D003506 F6066
% 223.37/223.55  |- mesh__recordOriginator mesh__D003506 NLM
% 223.37/223.55  |- mesh__recordAuthorizer mesh__D003506 sjn
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D003506 2001
% 223.37/223.55  |- skos__scopeNote mesh__D003506
% 223.37/223.55       A gonadal stimulant and inducer of ovulation. It is used in the treatment of infertility and amenorrhea, but is thought to be less effective than CLOMIPHENE.%A%    
% 223.37/223.55  |- rdf__type mesh__D003506sskos__Concept
% 223.37/223.55  |- skos__prefLabel mesh__D003506 Cyclofenil
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D003506 2005
% 223.37/223.55  |- mesh__publicMeSHNote mesh__D003506 91; was see under CRESOLS 1972-90   
% 223.37/223.55  |- mesh__recordMaintainer mesh__D013934 PXP
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D013934 2004
% 223.37/223.55  |- rdf__type mesh__D013934sskos__Concept
% 223.37/223.55  |- mesh__dateRevised mesh__D013934 1997-06-20
% 223.37/223.55  |- skos__scopeNote mesh__D013934
% 223.37/223.55       Surgical removal of the thymus gland. %28%Dorland, 28th ed%29%%A%    
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D013934 2005
% 223.37/223.55  |- mesh__historyNote mesh__D013934 65%28%64%29%   
% 223.37/223.55  |- mesh__dateCreated mesh__D013934 1999-01-01
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D013934 2003
% 223.37/223.55  |- mesh__dateEstablished mesh__D013934 1965-01-01
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D013934 2001
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D013934 1999
% 223.37/223.55  |- skos__hiddenLabel mesh__D013934 Thymectomies
% 223.37/223.55  |- mesh__recordAuthorizer mesh__D013934 SJN
% 223.37/223.55  |- mesh__activeMeSHYear mesh__D013934 2000
% 223.37/223.55  |- mesh__recordOriginator mesh__D013934 NLM
% 223.37/223.55  |- skos__broader mesh__D013934smesh__D019616
% 223.37/223.56  |- mesh__publicMeSHNote mesh__D013934 65   
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013934 1998
% 223.37/223.56  |- skos__prefLabel mesh__D013934 Thymectomy
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013934 2006
% 223.37/223.56  |- skos__annotation mesh__D013934
% 223.37/223.56       do not use /util except by MeSH definition   
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013934 2002
% 223.37/223.56  |- skos__scopeNote mesh__D013136
% 223.37/223.56       The sensory ganglion of the COCHLEAR NERVE. The cells of the spiral ganglion send fibers peripherally to the cochlear hair cells and centrally to the cochlear nuclei %28%COCHLEAR NUCLEUS%29% of the BRAIN STEM.%A%    
% 223.37/223.56  |- skos__historyNote mesh__D013136 Cochlea %28%1966-1978%29%
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013136 2002
% 223.37/223.56  |- skos__historyNote mesh__D013136 Cochlear Nerve %28%1966-1978%29%
% 223.37/223.56  |- skos__annotation mesh__D013136 sensory ganglion of the cochlear nerve   
% 223.37/223.56  |- mesh__recordMaintainer mesh__D013136 ags
% 223.37/223.56  |- mesh__historyNote mesh__D013136
% 223.37/223.56       91%28%79%29%; was see under COCHLEA 1979-90   
% 223.37/223.56  |- skos__historyNote mesh__D013136 Organ of Corti %28%1968-1978%29%
% 223.37/223.56  |- skos__historyNote mesh__D013136 Ganglia %28%1966-1978%29%
% 223.37/223.56  |- mesh__dateEstablished mesh__D013136 1991-01-01
% 223.37/223.56  |- skos__altLabel mesh__D013136 Ganglion of Corti
% 223.37/223.56  |- mesh__recordAuthorizer mesh__D013136 sjn
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013136 2000
% 223.37/223.56  |- mesh__dateRevised mesh__D013136 1999-11-03
% 223.37/223.56  |- mesh__dateCreated mesh__D013136 1978-05-19
% 223.37/223.56  |- skos__hiddenLabel mesh__D013136 Ganglia, Spiral
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013136 2003
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013136 2001
% 223.37/223.56  |- skos__broader mesh__D013136smesh__D003051
% 223.37/223.56  |- skos__altLabel mesh__D013136 Spiral Ganglia
% 223.37/223.56  |- rdf__type mesh__D013136sskos__Concept
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013136 2005
% 223.37/223.56  |- skos__prefLabel mesh__D013136 Spiral Ganglion
% 223.37/223.56  |- skos__broader mesh__D013136smesh__D003056
% 223.37/223.56  |- mesh__publicMeSHNote mesh__D013136 91; was see under COCHLEA 1979-90   
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013136 2004
% 223.37/223.56  |- mesh__recordOriginator mesh__D013136 RC
% 223.37/223.56  |- skos__broader mesh__D013136smesh__D017950
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013136 2006
% 223.37/223.56  |- skos__hiddenLabel mesh__D013136 Ganglion, Spiral
% 223.37/223.56  |- mesh__dateCreated mesh__D009893 1999-01-01
% 223.37/223.56  |- mesh__recordMaintainer mesh__D009893 ags
% 223.37/223.56  |- rdf__type mesh__D009893sskos__Concept
% 223.37/223.56  |- mesh__historyNote mesh__D009893 1968   
% 223.37/223.56  |- mesh__recordOriginator mesh__D009893 NLM
% 223.37/223.56  |- skos__prefLabel mesh__D009893 Opossums
% 223.37/223.56  |- mesh__publicMeSHNote mesh__D009893 1968   
% 223.37/223.56  |- skos__hiddenLabel mesh__D009893 Opossum
% 223.37/223.56  |- mesh__dateRevised mesh__D009893 2004-07-07
% 223.37/223.56  |- skos__annotation mesh__D009893
% 223.37/223.56       possums are indexed under PHALANGERIDAE or specifics   
% 223.37/223.56  |- skos__altLabel mesh__D009893 Didelphidae
% 223.37/223.56  |- skos__historyNote mesh__D009893 Marsupialia %28%1966-1967%29%
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009893 2005
% 223.37/223.56  |- skos__scopeNote mesh__D009893
% 223.37/223.56       New World marsupials of the family Didelphidae. Opossums are omnivorous, largely nocturnal and arboreal MAMMALS, grow to about three feet in length, including the scaly prehensile tail, and have an abdominal pouch in which the young are carried at birth.%A%    
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009893 2006
% 223.37/223.56  |- mesh__recordAuthorizer mesh__D009893 sjn
% 223.37/223.56  |- mesh__dateEstablished mesh__D009893 1968-01-01
% 223.37/223.56  |- skos__broader mesh__D009893smesh__D008394
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009095 1993
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009095 2006
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009095 1994
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009095 1990
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009095 1998
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009095 1997
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009095 1992
% 223.37/223.56  |- mesh__recordOriginator mesh__D009095 NLM
% 223.37/223.56  |- mesh__recordAuthorizer mesh__D009095 PLS
% 223.37/223.56  |- mesh__dateCreated mesh__D009095 1999-01-01
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009095 2004
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009095 2005
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009095 2001
% 223.37/223.56  |- skos__broader mesh__D009095smesh__D004622
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009095 1996
% 223.37/223.56  |- rdf__type mesh__D009095sskos__Concept
% 223.37/223.56  |- mesh__dateRevised mesh__D009095 1989-03-29
% 223.37/223.56  |- skos__hiddenLabel mesh__D009095 Mullerian Duct
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009095 2003
% 223.37/223.56  |- skos__hiddenLabel mesh__D009095 Ducts, Mullerian
% 223.37/223.56  |- mesh__historyNote mesh__D009095 72%28%65%29%   
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009095 2000
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009095 1991
% 223.37/223.56  |- mesh__publicMeSHNote mesh__D009095 72   
% 223.37/223.56  |- skos__scopeNote mesh__D009095
% 223.37/223.56       Two ducts of the embryo which empty into the cloaca, and which in the female develop into vagina, uterus and oviducts; in the male they disappear except for the vestigial vagina masculina and the appendix testis.%A%    
% 223.37/223.56  |- skos__hiddenLabel mesh__D009095 Duct, Mullerian
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009095 1995
% 223.37/223.56  |- mesh__dateEstablished mesh__D009095 1972-01-01
% 223.37/223.56  |- skos__prefLabel mesh__D009095 Mullerian Ducts
% 223.37/223.56  |- mesh__recordMaintainer mesh__D009095 TGC
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009095 2002
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009095 1999
% 223.37/223.56  |- skos__historyNote mesh__D017527
% 223.37/223.56       Receptors, Endogenous Substances %28%1981-1992%29%
% 223.37/223.56  |- skos__broader mesh__D017527smesh__D017451
% 223.37/223.56  |- mesh__recordOriginator mesh__D017527 PXP
% 223.37/223.56  |- skos__scopeNote mesh__D017527
% 223.37/223.56       A receptor that is specific for IGF-II and mannose-6-phosphate. The receptor is a 250-kDa single chain polypeptide which is unrelated in structure to the type 1 IGF receptor %28%RECEPTOR, IGF TYPE 1%29% and does not have a tyrosine kinase domain.%A%    
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D017527 2006
% 223.37/223.56  |- mesh__publicMeSHNote mesh__D017527
% 223.37/223.56       2000; MANNOSE-6-PHOSPHATE RECEPTOR %28%now RECEPTOR, IGF TYPE 2%29% was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-1992%A%  
% 223.37/223.56  |- mesh__dateRevised mesh__D017527 2004-07-07
% 223.37/223.56  |- skos__altLabel mesh__D017527 Receptor, Mannose-6-Phosphate
% 223.37/223.56  |- skos__hiddenLabel mesh__D017527 IGF 2 Receptor
% 223.37/223.56  |- skos__hiddenLabel mesh__D017527 IGF II Receptor
% 223.37/223.56  |- skos__hiddenLabel mesh__D017527 Insulin Like Growth Factor II Receptor
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D017527 2005
% 223.37/223.56  |- skos__altLabel mesh__D017527 IGF Type 2 Receptor
% 223.37/223.56  |- skos__hiddenLabel mesh__D017527 Receptors, Insulin Like Growth Factor II
% 223.37/223.56  |- skos__hiddenLabel mesh__D017527 Receptor, IGF II
% 223.37/223.56  |- skos__altLabel mesh__D017527 Insulin-Like-Growth-Factor II Receptor
% 223.37/223.56  |- mesh__historyNote mesh__D017527
% 223.37/223.56       2000%28%1993%29%; use RECEPTOR, IGF TYPE 2 %28%NM%29% 1981-1992   
% 223.37/223.56  |- skos__hiddenLabel mesh__D017527 Mannose 6 Phosphate Receptor
% 223.37/223.56  |- rdf__type mesh__D017527sskos__Concept
% 223.37/223.56  |- skos__altLabel mesh__D017527 IGF-2 Receptor
% 223.37/223.56  |- skos__prefLabel mesh__D017527 Receptor, IGF Type 2
% 223.37/223.56  |- skos__altLabel mesh__D017527 Receptor, Insulin-Like Growth Factor Type 2
% 223.37/223.56  |- skos__altLabel mesh__D017527 Receptors, IGF-2
% 223.37/223.56  |- skos__hiddenLabel mesh__D017527 IGF-2 Receptors
% 223.37/223.56  |- skos__hiddenLabel mesh__D017527 Receptor, Insulin-Like-Growth-Factor II
% 223.37/223.56  |- skos__annotation mesh__D017527 DF: RECEPT IGF 2   
% 223.37/223.56  |- skos__related mesh__D017527smesh__D007335
% 223.37/223.56  |- mesh__recordAuthorizer mesh__D017527 sjn
% 223.37/223.56  |- skos__hiddenLabel mesh__D017527 Receptors, IGF 2
% 223.37/223.56  |- mesh__dateEstablished mesh__D017527 1993-01-01
% 223.37/223.56  |- skos__hiddenLabel mesh__D017527 Receptor, Insulin Like Growth Factor II
% 223.37/223.56  |- skos__altLabel mesh__D017527 Receptor, Insulin-Like Growth Factor II
% 223.37/223.56  |- skos__hiddenLabel mesh__D017527 Receptor, IGF-2
% 223.37/223.56  |- mesh__recordMaintainer mesh__D017527 jmp
% 223.37/223.56  |- mesh__dateCreated mesh__D017527 1992-05-29
% 223.37/223.56  |- skos__altLabel mesh__D017527 Mannose-6-Phosphate Receptor
% 223.37/223.56  |- skos__altLabel mesh__D017527 Receptors, Insulin-Like Growth Factor II
% 223.37/223.56  |- skos__altLabel mesh__D017527 IGF-II Receptor
% 223.37/223.56  |- skos__hiddenLabel mesh__D017527
% 223.37/223.56       Receptor, Insulin Like Growth Factor Type 2
% 223.37/223.56  |- skos__altLabel mesh__D017527 Receptor, IGF-II
% 223.37/223.56  |- skos__hiddenLabel mesh__D017527 Receptor, Mannose 6 Phosphate
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013935 1998
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013935 2004
% 223.37/223.56  |- skos__prefLabel mesh__D013935 Thymic Factor, Circulating
% 223.37/223.56  |- skos__hiddenLabel mesh__D013935 Thymic Factor, Serum
% 223.37/223.56  |- skos__scopeNote mesh__D013935
% 223.37/223.56       A thymus-dependent nonapeptide found in normal blood. Stimulates the formation of E rosettes and is believed to be involved in T-cell differentiation.%A%    
% 223.37/223.56  |- skos__altLabel mesh__D013935 Serum Thymic Factor
% 223.37/223.56  |- skos__historyNote mesh__D013935 Hormones %28%1966-1976%29%
% 223.37/223.56  |- skos__broader mesh__D013935smesh__D013951
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013935 1994
% 223.37/223.56  |- skos__annotation mesh__D013935
% 223.37/223.56       /biosyn /physiol permitted; DF: THYMIC FACTOR CIRC   
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013935 2003
% 223.37/223.56  |- skos__altLabel mesh__D013935 Nonathymulin
% 223.37/223.56  |- skos__altLabel mesh__D013935 Thymuline
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013935 2002
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013935 2006
% 223.37/223.56  |- skos__hiddenLabel mesh__D013935 Factor, Serum Thymic
% 223.37/223.56  |- skos__hiddenLabel mesh__D013935 Thymique Serique, Facteur
% 223.37/223.56  |- skos__historyNote mesh__D013935 Peptides %28%1966-1972%29%
% 223.37/223.56  |- mesh__dateRevised mesh__D013935 1993-06-04
% 223.37/223.56  |- skos__broader mesh__D013935smesh__D009842
% 223.37/223.56  |- mesh__recordAuthorizer mesh__D013935 PLS
% 223.37/223.56  |- skos__altLabel mesh__D013935 Facteur Thymique Serique
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013935 2001
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013935 2005
% 223.37/223.56  |- skos__hiddenLabel mesh__D013935 Factor, Circulating Thymic
% 223.37/223.56  |- mesh__dateCreated mesh__D013935 1979-05-23
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013935 1997
% 223.37/223.56  |- rdf__type mesh__D013935sskos__Concept
% 223.37/223.56  |- skos__altLabel mesh__D013935 Thymulin
% 223.37/223.56  |- skos__historyNote mesh__D013935 Oligopeptides %28%1973-1979%29%
% 223.37/223.56  |- mesh__historyNote mesh__D013935
% 223.37/223.56       91%28%80%29%; was see under THYMUS HORMONES 1980-90   
% 223.37/223.56  |- skos__historyNote mesh__D013935 Thymus Gland %28%1966-1976%29%
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013935 2000
% 223.37/223.56  |- mesh__dateEstablished mesh__D013935 1991-01-01
% 223.37/223.56  |- mesh__recordOriginator mesh__D013935 RLS
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013935 1996
% 223.37/223.56  |- mesh__publicMeSHNote mesh__D013935
% 223.37/223.56       91; was see under THYMUS HORMONES 1980-90   
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013935 1999
% 223.37/223.56  |- skos__historyNote mesh__D013935 Thymus Hormones %28%1977-1979%29%
% 223.37/223.56  |- skos__altLabel mesh__D013935 Circulating Factor, Thymic
% 223.37/223.56  |- skos__altLabel mesh__D013935 Thymic Serum Factor
% 223.37/223.56  |- skos__hiddenLabel mesh__D013935 Thymic Circulating Factor
% 223.37/223.56  |- skos__hiddenLabel mesh__D013935 Serique, Facteur Thymique
% 223.37/223.56  |- skos__hiddenLabel mesh__D013935 Circulating Thymic Factor
% 223.37/223.56  |- skos__hiddenLabel mesh__D013935 Factor, Thymic Serum
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013935 1995
% 223.37/223.56  |- skos__hiddenLabel mesh__D013935 Serum Factor, Thymic
% 223.37/223.56  |- skos__altLabel mesh__D013935 Factor, Thymic Circulating
% 223.37/223.56  |- mesh__recordMaintainer mesh__D013935 JLS
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013137 1998
% 223.37/223.56  |- mesh__publicMeSHNote mesh__D013137 91; was see under COCHLEA 1979-90   
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013137 1997
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013137 1992
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013137 1994
% 223.37/223.56  |- mesh__historyNote mesh__D013137
% 223.37/223.56       91%28%79%29%; was see under COCHLEA 1979-90   
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013137 1999
% 223.37/223.56  |- mesh__dateEstablished mesh__D013137 1991-01-01
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013137 1993
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013137 1995
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013137 2002
% 223.37/223.56  |- mesh__recordAuthorizer mesh__D013137 PLS
% 223.37/223.56  |- skos__hiddenLabel mesh__D013137 Spiral Laminas
% 223.37/223.56  |- skos__hiddenLabel mesh__D013137 Laminas, Spiral
% 223.37/223.56  |- mesh__recordMaintainer mesh__D013137 NLM
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013137 2003
% 223.37/223.56  |- rdf__type mesh__D013137sskos__Concept
% 223.37/223.56  |- skos__scopeNote mesh__D013137
% 223.37/223.56       The bony plate which extends outwards from the modiolus. It is part of the structure which divides trhe cochlea into sections.%A%    
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013137 2005
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013137 2004
% 223.37/223.56  |- mesh__recordOriginator mesh__D013137 RC
% 223.37/223.56  |- skos__hiddenLabel mesh__D013137 Lamina, Spiral
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013137 2006
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013137 2000
% 223.37/223.56  |- mesh__dateCreated mesh__D013137 1978-05-19
% 223.37/223.56  |- skos__prefLabel mesh__D013137 Spiral Lamina
% 223.37/223.56  |- mesh__dateRevised mesh__D013137 1990-04-13
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013137 2001
% 223.37/223.56  |- skos__historyNote mesh__D013137 Cochlea %28%1966-1978%29%
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013137 1996
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D013137 1991
% 223.37/223.56  |- skos__broader mesh__D013137smesh__D003051
% 223.37/223.56  |- mesh__onlineNote mesh__D018620
% 223.37/223.56       use PRIONS to search SCRAPIE AGENT, SCRAPIE PRION, %26% SCRAPIE VIRUS 1966-94, and RIDA VIRUS 1976-91; use PRPSC PROTEINS %28%NM%29% to search SCRAPIE PRP 1988-94%A%  
% 223.37/223.56  |- mesh__dateRevised mesh__D018620 2005-06-30
% 223.37/223.56  |- mesh__recordOriginator mesh__D018620 AGS
% 223.37/223.56  |- mesh__dateCreated mesh__D018620 1994-04-16
% 223.37/223.56  |- skos__altLabel mesh__D018620 Scrapie PrP 33-35
% 223.37/223.56  |- skos__broader mesh__D018620smesh__D011328
% 223.37/223.56  |- skos__historyNote mesh__D018620 Viral Proteins %28%1989-1991%29%
% 223.37/223.56  |- skos__altLabel mesh__D018620 Scrapie Virus
% 223.37/223.56  |- skos__altLabel mesh__D018620 PrP-res
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D018620 2006
% 223.37/223.56  |- skos__annotation mesh__D018620
% 223.37/223.56       prion proteins; PrPSc stands for PRion Protein SCrapie; do not confuse with PRPC PROTEINS; /pathogen permitted; DF: PRPSC%A%  
% 223.37/223.56  |- mesh__publicMeSHNote mesh__D018620
% 223.37/223.56       95; SCRAPIE AGENT was see PRIONS 1992-94, was heading 1987-91, was SCRAPIE PRION 1986, was SCRAPIE VIRUS 1966-85; SCRAPIE PRP was indexed under PRIONS 1992-94 %26% VIRAL PROTEINS 1989-91; SCRAPIE VIRUS was see PRIONS 1992-94, was see SCRAPIE AGENT 1987-91, was see SCRAPIE PRION 1986, was heading 1966-85; RIDA VIRUS was see SCRAPIE AGENT 1976-91%A%  
% 223.37/223.56  |- skos__prefLabel mesh__D018620 PrPSc Proteins
% 223.37/223.56  |- mesh__dateEstablished mesh__D018620 1995-01-01
% 223.37/223.56  |- mesh__historyNote mesh__D018620
% 223.37/223.56       95; SCRAPIE AGENT was see PRIONS 1992-94, was heading 1987-91, was SCRAPIE PRION 1986, was SCRAPIE VIRUS 1966-85; SCRAPIE PRP was NM 1988-94; SCRAPIE VIRUS was see PRIONS 1992-94, was see SCRAPIE AGENT 1987-91, was see SCRAPIE PRION 1986, was heading 1966-85; RIDA VIRUS was see SCRAPIE AGENT 1976-91%A%  
% 223.37/223.56  |- mesh__recordMaintainer mesh__D018620 SYSTEM
% 223.37/223.56  |- rdf__type mesh__D018620sskos__Concept
% 223.37/223.56  |- skos__altLabel mesh__D018620 Scrapie PrP
% 223.37/223.56  |- skos__hiddenLabel mesh__D018620 PrP res
% 223.37/223.56  |- skos__historyNote mesh__D018620 Prions %28%1992-1994%29%
% 223.37/223.56  |- skos__altLabel mesh__D018620 Sp 33-35
% 223.37/223.56  |- skos__altLabel mesh__D018620 PrP 33-35
% 223.37/223.56  |- mesh__recordAuthorizer mesh__D018620 sjn
% 223.37/223.56  |- skos__scopeNote mesh__D018620
% 223.37/223.56       Abnormal isoform of prion proteins %28%PRIONS%29% resulting from a posttranslational modification of the cellular prion protein %28%PRPC PROTEINS%29%. PrPSc are disease-specific proteins seen in certain human and animal neurodegenerative diseases %28%PRION DISEASES%29%.%A%    
% 223.37/223.56  |- skos__altLabel mesh__D018620 HaSp 33-37
% 223.37/223.56  |- rdf__type mesh__D004600sskos__Concept
% 223.37/223.56  |- skos__broader mesh__D004600smesh__D015320
% 223.37/223.56  |- mesh__recordAuthorizer mesh__D004600 sjn
% 223.37/223.56  |- mesh__historyNote mesh__D004600 65%28%63%29%   
% 223.37/223.56  |- skos__scopeNote mesh__D004600
% 223.37/223.56       A peptide extracted from the posterior salivary glands of certain small octopi %28%Eledone spp., Mollusca%29%, or obtained by synthesis. Its actions resemble those of SUBSTANCE P; it is a potent vasodilator and increases capillary permeability. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1364%29%%A%    
% 223.37/223.56  |- mesh__dateRevised mesh__D004600 2005-06-30
% 223.37/223.56  |- mesh__recordOriginator mesh__D004600 NLM
% 223.37/223.56  |- mesh__publicMeSHNote mesh__D004600 65   
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D004600 2006
% 223.37/223.56  |- mesh__recordMaintainer mesh__D004600 ssb
% 223.37/223.56  |- mesh__dateCreated mesh__D004600 1999-01-01
% 223.37/223.56  |- skos__prefLabel mesh__D004600 Eledoisin
% 223.37/223.56  |- mesh__dateEstablished mesh__D004600 1965-01-01
% 223.37/223.56  |- skos__broader mesh__D004600smesh__D008978
% 223.37/223.56  |- skos__broader mesh__D051256smesh__D015682
% 223.37/223.56  |- skos__hiddenLabel mesh__D051256 Oncogene Protein, v-maf
% 223.37/223.56  |- skos__altLabel mesh__D051256 maf Oncogene Protein
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D051256 2006
% 223.37/223.56  |- skos__broader mesh__D051256smesh__D051473
% 223.37/223.56  |- mesh__recordMaintainer mesh__D051256 ags
% 223.37/223.56  |- mesh__dateRevised mesh__D051256 2005-07-08
% 223.37/223.56  |- skos__scopeNote mesh__D051256
% 223.37/223.56       An oncogene protein that was originally isolated from a spontaneous musculo-aponeurotic FIBROSARCOMA in CHICKEN and shown to be the transforming gene of the avian retrovirus AS42. It is a basic leucine zipper TRANSCRIPTION FACTOR and the founding member of the MAF TRANSCRIPTION FACTORS.%A%    
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D051256 2006A
% 223.37/223.56  |- skos__prefLabel mesh__D051256 Oncogene Protein v-maf
% 223.37/223.56  |- mesh__dateCreated mesh__D051256 2005-06-30
% 223.37/223.56  |- mesh__recordAuthorizer mesh__D051256 ags
% 223.37/223.56  |- mesh__dateEstablished mesh__D051256 2006-01-01
% 223.37/223.56  |- mesh__historyNote mesh__D051256 2006%28%1993%29%   
% 223.37/223.56  |- mesh__recordOriginator mesh__D051256 DRC
% 223.37/223.56  |- rdf__type mesh__D051256sskos__Concept
% 223.37/223.56  |- skos__hiddenLabel mesh__D051256 Oncogene Protein v maf
% 223.37/223.56  |- skos__altLabel mesh__D051256 v-maf Protein
% 223.37/223.56  |- mesh__publicMeSHNote mesh__D051256
% 223.37/223.56       2006; ONCOGENE PROTEIN V-MAF was indexed under DNA-BINDING PROTEINS %26% ONCOGENE PROTEINS, VIRAL %26% VIRAL PROTEINS 1993-2005%A%  
% 223.37/223.56  |- skos__hiddenLabel mesh__D051256 v-maf, Oncogene Protein
% 223.37/223.56  |- skos__hiddenLabel mesh__D051256 Oncogene Protein, maf
% 223.37/223.56  |- skos__altLabel mesh__D051256 v-maf Oncogene Protein
% 223.37/223.56  |- skos__broader mesh__D009894smesh__D014777
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009894 1992
% 223.37/223.56  |- skos__prefLabel mesh__D009894 Opportunistic Infections
% 223.37/223.56  |- skos__scopeNote mesh__D009894
% 223.37/223.56       An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.%A%    
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009894 1997
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009894 1991
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009894 2001
% 223.37/223.56  |- skos__hiddenLabel mesh__D009894 Opportunistic Infection
% 223.37/223.56  |- skos__historyNote mesh__D009894 Infection %28%1966-1986%29%
% 223.37/223.56  |- mesh__recordOriginator mesh__D009894 RC
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009894 1993
% 223.37/223.56  |- mesh__publicMeSHNote mesh__D009894 87   
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009894 2003
% 223.37/223.56  |- skos__historyNote mesh__D009894 specific infection %28%1966-1986%29%
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009894 1998
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009894 2002
% 223.37/223.56  |- mesh__dateRevised mesh__D009894 1988-06-08
% 223.37/223.56  |- skos__broader mesh__D009894smesh__D007239
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009894 1994
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009894 2004
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009894 1999
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009894 1989
% 223.37/223.56  |- mesh__recordMaintainer mesh__D009894 NSC
% 223.37/223.56  |- skos__hiddenLabel mesh__D009894 Infections, Opportunistic
% 223.37/223.56  |- mesh__dateEstablished mesh__D009894 1987-01-01
% 223.37/223.56  |- skos__historyNote mesh__D009894 Bacterial Infections %28%1972-1986%29%
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009894 1995
% 223.37/223.56  |- skos__hiddenLabel mesh__D009894 Infection, Opportunistic
% 223.37/223.56  |- mesh__recordAuthorizer mesh__D009894 NLM
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009894 2005
% 223.37/223.56  |- mesh__dateCreated mesh__D009894 1986-04-01
% 223.37/223.56  |- skos__historyNote mesh__D009894
% 223.37/223.56       Acquired Immunodeficiency Syndrome %28%1983-1986%29%
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009894 1996
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009894 2006
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009894 1990
% 223.37/223.56  |- skos__broader mesh__D009894smesh__D010272
% 223.37/223.56  |- skos__annotation mesh__D009894
% 223.37/223.56       %22%an infect caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression%22%; coord IM with specific name of opportunistic infect %28%IM%29% + specific infect to which it is opportunistic %28%IM%29%, using /compl for all 3%A%  
% 223.37/223.56  |- rdf__type mesh__D009894sskos__Concept
% 223.37/223.56  |- mesh__historyNote mesh__D009894 87   
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009894 2000
% 223.37/223.56  |- mesh__historyNote mesh__D009096 80   
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009096 2000
% 223.37/223.56  |- skos__annotation mesh__D009096
% 223.37/223.56       IM; coord with institutions or specialty %28%IM%29%; specify geog%A%  
% 223.37/223.56  |- skos__hiddenLabel mesh__D009096 System, Multi Hospital
% 223.37/223.56  |- rdf__type mesh__D009096sskos__Concept
% 223.37/223.56  |- skos__hiddenLabel mesh__D009096 System, Multihospital
% 223.37/223.56  |- skos__scopeNote mesh__D009096
% 223.37/223.56       Institutional systems consisting of more than one health facility which have cooperative administrative arrangements through merger, affiliation, shared services, or other collective ventures.%A%    
% 223.37/223.56  |- skos__hiddenLabel mesh__D009096 Multi Institutional System
% 223.37/223.56  |- skos__prefLabel mesh__D009096 Multi-Institutional Systems
% 223.37/223.56  |- mesh__recordMaintainer mesh__D009096 kle
% 223.37/223.56  |- skos__altLabel mesh__D009096 Systems, Multi-Institutional
% 223.37/223.56  |- skos__altLabel mesh__D009096 Multi-Institutional System
% 223.37/223.56  |- skos__hiddenLabel mesh__D009096 Systems, Multihospital
% 223.37/223.56  |- mesh__recordOriginator mesh__D009096 EC
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009096 2002
% 223.37/223.56  |- skos__hiddenLabel mesh__D009096 Multi Institutional Systems
% 223.37/223.56  |- mesh__recordAuthorizer mesh__D009096 sjn
% 223.37/223.56  |- skos__altLabel mesh__D009096 System, Multi-Institutional
% 223.37/223.56  |- skos__hiddenLabel mesh__D009096 System, Multi Institutional
% 223.37/223.56  |- skos__hiddenLabel mesh__D009096 Multi-Hospital System
% 223.37/223.56  |- mesh__dateEstablished mesh__D009096 1980-01-01
% 223.37/223.56  |- skos__hiddenLabel mesh__D009096 Systems, Multi-Hospital
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009096 2006
% 223.37/223.56  |- skos__hiddenLabel mesh__D009096 Multihospital System
% 223.37/223.56  |- mesh__publicMeSHNote mesh__D009096 80   
% 223.37/223.56  |- skos__altLabel mesh__D009096 Multihospital Systems
% 223.37/223.56  |- skos__altLabel mesh__D009096 Multi-Hospital Systems
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009096 2004
% 223.37/223.56  |- mesh__dateRevised mesh__D009096 1999-11-03
% 223.37/223.56  |- skos__hiddenLabel mesh__D009096 Systems, Multi Institutional
% 223.37/223.56  |- skos__historyNote mesh__D009096
% 223.37/223.56       Hospital Shared Services %28%1968-1979%29%
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009096 2005
% 223.37/223.56  |- skos__hiddenLabel mesh__D009096 Multi Hospital Systems
% 223.37/223.56  |- skos__broader mesh__D009096smesh__D009934
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009096 2001
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D009096 2003
% 223.37/223.56  |- mesh__dateCreated mesh__D009096 1979-06-01
% 223.37/223.56  |- skos__historyNote mesh__D009096
% 223.37/223.56       Hospital Administration %28%1966-1979%29%
% 223.37/223.56  |- mesh__publicMeSHNote mesh__D003508 68   
% 223.37/223.56  |- mesh__dateEstablished mesh__D003508 1968-01-01
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D003508 2005
% 223.37/223.56  |- mesh__recordOriginator mesh__D003508 NLM
% 223.37/223.56  |- mesh__recordAuthorizer mesh__D003508 sjn
% 223.37/223.56  |- mesh__recordMaintainer mesh__D003508 ssb
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D003508 2006
% 223.37/223.56  |- skos__annotation mesh__D003508
% 223.37/223.56       includes cycloheptenes, cycloheptadienes, cycloheptatrienes%A%  
% 223.37/223.56  |- mesh__dateRevised mesh__D003508 2004-07-07
% 223.37/223.56  |- mesh__dateCreated mesh__D003508 1999-01-01
% 223.37/223.56  |- skos__broader mesh__D003508smesh__D003516
% 223.37/223.56  |- rdf__type mesh__D003508sskos__Concept
% 223.37/223.56  |- mesh__historyNote mesh__D003508 68   
% 223.37/223.56  |- skos__prefLabel mesh__D003508 Cycloheptanes
% 223.37/223.56  |- mesh__recordOriginator mesh__D014230 NLM
% 223.37/223.56  |- skos__annotation mesh__D014230 includes triazolines, triazolidines   
% 223.37/223.56  |- skos__broader mesh__D014230smesh__D001393
% 223.37/223.56  |- mesh__recordAuthorizer mesh__D014230 sjn
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D014230 2006
% 223.37/223.56  |- mesh__recordMaintainer mesh__D014230 ssb
% 223.37/223.56  |- skos__prefLabel mesh__D014230 Triazoles
% 223.37/223.56  |- mesh__dateRevised mesh__D014230 2005-06-30
% 223.37/223.56  |- rdf__type mesh__D014230sskos__Concept
% 223.37/223.56  |- mesh__dateCreated mesh__D014230 1999-01-01
% 223.37/223.56  |- rdf__type mesh__D000210sskos__Concept
% 223.37/223.56  |- skos__hiddenLabel mesh__D000210 Reaction, Acute Phase
% 223.37/223.56  |- mesh__recordAuthorizer mesh__D000210 sjn
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D000210 2003
% 223.37/223.56  |- skos__hiddenLabel mesh__D000210 Acute Phase Reaction
% 223.37/223.56  |- mesh__dateRevised mesh__D000210 1999-11-03
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D000210 2000
% 223.37/223.56  |- skos__annotation mesh__D000210
% 223.37/223.56       note category: in presence of a dis, use /etiol, not /compl%A%  
% 223.37/223.56  |- skos__altLabel mesh__D000210 Acute-Phase State
% 223.37/223.56  |- mesh__recordOriginator mesh__D000210 SH
% 223.37/223.56  |- mesh__publicMeSHNote mesh__D000210
% 223.37/223.56       92; was ACUTE PHASE REACTION 1987-91 %28%see under INFLAMMATION 1987-90%29%%A%  
% 223.37/223.56  |- mesh__activeMeSHYear mesh__D000210 2004
% 223.37/223.56  |- skos__hiddenLabel mesh__D000210 State, Acute-Phase
% 223.37/223.56  |- mesh__recordMaintainer mesh__D000210 KEV
% 223.37/223.57  |- skos__altLabel mesh__D000210 Response, Acute-Phase
% 223.37/223.57  |- mesh__dateEstablished mesh__D000210 1991-01-01
% 223.37/223.57  |- skos__altLabel mesh__D000210 Reaction, Acute-Phase
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D000210 2001
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D000210 2005
% 223.37/223.57  |- skos__historyNote mesh__D000210 Acute Disease %28%1968-1986%29%
% 223.37/223.57  |- skos__broader mesh__D000210smesh__D007249
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D000210 2002
% 223.37/223.57  |- skos__scopeNote mesh__D000210
% 223.37/223.57       An early local inflammatory reaction to insult or injury that consists of fever, an increase in inflammatory humoral factors, and an increased synthesis by hepatocytes of a number of proteins or glycoproteins usually found in the plasma.%A%    
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D000210 2006
% 223.37/223.57  |- mesh__dateCreated mesh__D000210 1986-03-25
% 223.37/223.57  |- skos__hiddenLabel mesh__D000210 Response, Acute Phase
% 223.37/223.57  |- mesh__onlineNote mesh__D000210
% 223.37/223.57       use ACUTE-PHASE REACTION to search ACUTE PHASE REACTION 1987-91%A%  
% 223.37/223.57  |- skos__historyNote mesh__D000210 Inflammation %28%1966-1986%29%
% 223.37/223.57  |- skos__prefLabel mesh__D000210 Acute-Phase Reaction
% 223.37/223.57  |- skos__hiddenLabel mesh__D000210 Acute-Phase Response
% 223.37/223.57  |- skos__hiddenLabel mesh__D000210 Acute Phase State
% 223.37/223.57  |- mesh__historyNote mesh__D000210
% 223.37/223.57       92; was ACUTE PHASE REACTION 1987-91 %28%see under INFLAMMATION 1987-90%29%%A%  
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D013936 1994
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D013936 2001
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D013936 1992
% 223.37/223.57  |- skos__broader mesh__D013936smesh__D011741
% 223.37/223.57  |- mesh__recordOriginator mesh__D013936 NLM
% 223.37/223.57  |- skos__annotation mesh__D013936
% 223.37/223.57       /biosyn /physiol permitted; %22%tritiated thymidine%22% as a research technique is probably NIM if indexed at all%A%  
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D013936 1998
% 223.37/223.57  |- skos__prefLabel mesh__D013936 Thymidine
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D013936 1995
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D013936 2002
% 223.37/223.57  |- skos__altLabel mesh__D013936 Deoxythymidine
% 223.37/223.57  |- mesh__recordAuthorizer mesh__D013936 PLS
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D013936 1996
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D013936 1993
% 223.37/223.57  |- mesh__dateRevised mesh__D013936 1990-02-16
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D013936 1999
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D013936 1997
% 223.37/223.57  |- mesh__recordMaintainer mesh__D013936 PLS
% 223.37/223.57  |- skos__hiddenLabel mesh__D013936 2%27% Deoxythymidine
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D013936 2005
% 223.37/223.57  |- mesh__dateCreated mesh__D013936 1999-01-01
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D013936 1991
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D013936 2003
% 223.37/223.57  |- skos__broader mesh__D013936smesh__D003853
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D013936 2006
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D013936 2000
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D013936 2004
% 223.37/223.57  |- rdf__type mesh__D013936sskos__Concept
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D018621 2006
% 223.37/223.57  |- skos__prefLabel mesh__D018621 PrPC Proteins
% 223.37/223.57  |- skos__altLabel mesh__D018621 Scrapie Amyloid Precursor Protein
% 223.37/223.57  |- skos__hiddenLabel mesh__D018621 PrP sen
% 223.37/223.57  |- mesh__historyNote mesh__D018621
% 223.37/223.57       95; SCRAPIE AMYLOID PRECURSOR PROTEIN was NM 1989-94   
% 223.37/223.57  |- skos__altLabel mesh__D018621 Cp 33-35
% 223.37/223.57  |- mesh__recordAuthorizer mesh__D018621 sjn
% 223.37/223.57  |- rdf__type mesh__D018621sskos__Concept
% 223.37/223.57  |- mesh__recordOriginator mesh__D018621 AGS
% 223.37/223.57  |- skos__altLabel mesh__D018621 Cp33-35, Scrapie
% 223.37/223.57  |- mesh__dateRevised mesh__D018621 2005-06-30
% 223.37/223.57  |- mesh__recordMaintainer mesh__D018621 SYSTEM
% 223.37/223.57  |- skos__historyNote mesh__D018621 Prions %28%1992-1994%29%
% 223.37/223.57  |- skos__annotation mesh__D018621
% 223.37/223.57       PrPC stands for PRion Protein Cellular; do not confuse with PRPSC PROTEINS which are scrapie prions; /pathogen permitted; DF: PRPC%A%  
% 223.37/223.57  |- skos__broader mesh__D018621smesh__D011328
% 223.37/223.57  |- skos__altLabel mesh__D018621 PrP-sen
% 223.37/223.57  |- mesh__dateCreated mesh__D018621 1994-04-16
% 223.37/223.57  |- mesh__dateEstablished mesh__D018621 1995-01-01
% 223.37/223.57  |- skos__scopeNote mesh__D018621
% 223.37/223.57       Normal cellular isoform of prion proteins %28%PRIONS%29% encoded by a chromosomal gene and found in normal and scrapie-infected brain tissue, and other normal tissue. PrPC are protease-sensitive proteins whose function is unknown. Posttranslational modification of PrPC into PrPSC leads to infectivity.%A%    
% 223.37/223.57  |- mesh__onlineNote mesh__D018621
% 223.37/223.57       use PRPC PROTEINS %28%NM%29% to search SCRAPIE AMYLOID PRECURSOR PROTEIN 1989-94%A%  
% 223.37/223.57  |- mesh__publicMeSHNote mesh__D018621
% 223.37/223.57       95; SCRAPIE AMYLOID PRECURSOR PROTEIN was indexed under PRIONS %26% PROTEIN PRECURSORS 1992-94 and under VIRAL PROTEINS 1989-91%A%  
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D004601 1997
% 223.37/223.57  |- skos__hiddenLabel mesh__D004601 Particles, Fundamental
% 223.37/223.57  |- skos__prefLabel mesh__D004601 Elementary Particles
% 223.37/223.57  |- mesh__recordAuthorizer mesh__D004601 PLS
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D004601 2004
% 223.37/223.57  |- mesh__historyNote mesh__D004601
% 223.37/223.57       75%28%71%29%; BARYONS was heading 1975-84   
% 223.37/223.57  |- skos__broader mesh__D004601smesh__D009686
% 223.37/223.57  |- skos__hiddenLabel mesh__D004601 Particles, Elementary
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D004601 1998
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D004601 2000
% 223.37/223.57  |- skos__hiddenLabel mesh__D004601 Baryon
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D004601 2005
% 223.37/223.57  |- skos__annotation mesh__D004601
% 223.37/223.57       IM; includes nucleons, quarks, gluons, neutrinos, strange particles, antiparticles%A%  
% 223.37/223.57  |- skos__scopeNote mesh__D004601
% 223.37/223.57       Individual components of atoms, usually subatomic; subnuclear particles are usually detected only when the atomic nucleus decays and then only transiently, as most of them are unstable, often yielding pure energy without substance, i.e., radiation.%A%    
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D004601 1994
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D004601 1999
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D004601 2001
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D004601 2006
% 223.37/223.57  |- mesh__publicMeSHNote mesh__D004601 75; BARYONS was heading 1975-84   
% 223.37/223.57  |- mesh__onlineNote mesh__D004601
% 223.37/223.57       use ELEMENTARY PARTICLES to search BARYONS 1975-84   
% 223.37/223.57  |- skos__hiddenLabel mesh__D004601 Particle, Elementary
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D004601 1995
% 223.37/223.57  |- mesh__dateCreated mesh__D004601 1999-01-01
% 223.37/223.57  |- skos__hiddenLabel mesh__D004601 Fundamental Particle
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D004601 2002
% 223.37/223.57  |- mesh__recordOriginator mesh__D004601 NLM
% 223.37/223.57  |- skos__hiddenLabel mesh__D004601 Particle, Fundamental
% 223.37/223.57  |- skos__hiddenLabel mesh__D004601 Elementary Particle
% 223.37/223.57  |- rdf__type mesh__D004601sskos__Concept
% 223.37/223.57  |- mesh__dateRevised mesh__D004601 1993-05-27
% 223.37/223.57  |- mesh__recordMaintainer mesh__D004601 PLS
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D004601 1996
% 223.37/223.57  |- skos__historyNote mesh__D004601 Nuclear Physics %28%1966-1970%29%
% 223.37/223.57  |- skos__altLabel mesh__D004601 Fundamental Particles
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D004601 2003
% 223.37/223.57  |- mesh__dateEstablished mesh__D004601 1975-01-01
% 223.37/223.57  |- mesh__dateRevised mesh__D051257 2005-07-18
% 223.37/223.57  |- mesh__recordMaintainer mesh__D051257 ags
% 223.37/223.57  |- skos__broader mesh__D051257smesh__D011518
% 223.37/223.57  |- skos__scopeNote mesh__D051257
% 223.37/223.57       Maf proto-oncogene protein is the major cellular homolog of the V-MAF ONCOGENE PROTEIN. It was the first mammalian MAF TRANSCRIPTION FACTOR identified, and it is induced in activated T-LYMPHOCYTES and regulates GENETIC TRANSCRIPTION of INTERLEUKIN-4. c-maf is frequently translocated to an immunoglobulin locus in MULTIPLE MYELOMA.%A%    
% 223.37/223.57  |- mesh__recordAuthorizer mesh__D051257 ags
% 223.37/223.57  |- skos__hiddenLabel mesh__D051257 Proto-Oncogene Protein, maf
% 223.37/223.57  |- skos__hiddenLabel mesh__D051257 c-maf, Proto-Oncogene Proteins
% 223.37/223.57  |- skos__hiddenLabel mesh__D051257 c-maf, Proto-Oncogene Protein
% 223.37/223.57  |- rdf__type mesh__D051257sskos__Concept
% 223.37/223.57  |- mesh__recordOriginator mesh__D051257 DRC
% 223.37/223.57  |- mesh__publicMeSHNote mesh__D051257
% 223.37/223.57       2006 PROTO-ONCOGENE PROTEIN C-MAF was indexed under DNA-BINDING PROTEINS %26% PROTO-ONCOGENE PROTEINS 1994-2005%A%  
% 223.37/223.57  |- skos__broader mesh__D051257smesh__D051473
% 223.37/223.57  |- skos__hiddenLabel mesh__D051257 Proto-Oncogene Protein, c-maf
% 223.37/223.57  |- mesh__historyNote mesh__D051257 2006%28%1994%29%   
% 223.37/223.57  |- skos__hiddenLabel mesh__D051257 Proteins c-maf, Proto-Oncogene
% 223.37/223.57  |- skos__altLabel mesh__D051257 maf Proto-Oncogene Protein
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D051257 2006A
% 223.37/223.57  |- mesh__dateCreated mesh__D051257 2005-06-30
% 223.37/223.57  |- skos__hiddenLabel mesh__D051257 Proto Oncogene Proteins c maf
% 223.37/223.57  |- mesh__dateEstablished mesh__D051257 2006-01-01
% 223.37/223.57  |- skos__prefLabel mesh__D051257 Proto-Oncogene Proteins c-maf
% 223.37/223.57  |- skos__hiddenLabel mesh__D051257 maf Proto Oncogene Protein
% 223.37/223.57  |- skos__hiddenLabel mesh__D051257 Proto Oncogene Protein c maf
% 223.37/223.57  |- skos__altLabel mesh__D051257 c-maf Proto-Oncogene Protein
% 223.37/223.57  |- skos__altLabel mesh__D051257 c-maf Protein
% 223.37/223.57  |- skos__altLabel mesh__D051257 Proto-Oncogene Protein c-maf
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D051257 2006
% 223.37/223.57  |- rdf__type mesh__D009895sskos__Concept
% 223.37/223.57  |- skos__broader mesh__D009895smesh__D007162
% 223.37/223.57  |- skos__broader mesh__D009895smesh__D000906
% 223.37/223.57  |- skos__altLabel mesh__D009895 Opsonins
% 223.37/223.57  |- skos__scopeNote mesh__D009895
% 223.37/223.57       Proteins that bind to particles and cells to increase susceptibility to PHAGOCYTOSIS, especially ANTIBODIES bound to EPITOPES that attach to FC RECEPTORS. COMPLEMENT C3B may also participate.%A%    
% 223.37/223.57  |- mesh__recordMaintainer mesh__D009895 sjn
% 223.37/223.57  |- mesh__recordAuthorizer mesh__D009895 sjn
% 223.37/223.57  |- skos__prefLabel mesh__D009895 Opsonin Proteins
% 223.37/223.57  |- skos__hiddenLabel mesh__D009895 Proteins, Opsonin
% 223.37/223.57  |- mesh__dateEstablished mesh__D009895 1965-01-01
% 223.37/223.57  |- mesh__dateCreated mesh__D009895 1999-01-01
% 223.37/223.57  |- mesh__recordOriginator mesh__D009895 NLM
% 223.37/223.57  |- skos__related mesh__D009895smesh__D010587
% 223.37/223.57  |- mesh__publicMeSHNote mesh__D009895 2006; see OPSONINS 1965-2004   
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D009895 2006
% 223.37/223.57  |- mesh__historyNote mesh__D009895 2006%28%1964%29%   
% 223.37/223.57  |- mesh__dateRevised mesh__D009895 2005-07-01
% 223.37/223.57  |- skos__annotation mesh__D009895
% 223.37/223.57       coordinate with ANTIBODIES or specific antibody term if relevant%A%  
% 223.37/223.57  |- skos__hiddenLabel mesh__D009097 Complexes, Multienzyme
% 223.37/223.57  |- skos__historyNote mesh__D009097
% 223.37/223.57       specific enzymes or enzyme groups %28%1966-1973%29%
% 223.37/223.57  |- mesh__recordAuthorizer mesh__D009097 jls
% 223.37/223.57  |- mesh__publicMeSHNote mesh__D009097 73   
% 223.37/223.57  |- skos__broader mesh__D009097smesh__D004798
% 223.37/223.57  |- skos__annotation mesh__D009097
% 223.37/223.57       MULTIPROTEIN COMPLEXES is also available   
% 223.37/223.57  |- mesh__dateEstablished mesh__D009097 1973-01-01
% 223.37/223.57  |- skos__prefLabel mesh__D009097 Multienzyme Complexes
% 223.37/223.57  |- skos__scopeNote mesh__D009097
% 223.37/223.57       Systems of enzymes which function sequentially by catalyzing consecutive reactions linked by common metabolic intermediates. They may involve simply a transfer of water molecules or hydrogen atoms and may be associated with large supramolecular structures such as MITOCHONDRIA or RIBOSOMES.%A%    
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D009097 2006
% 223.37/223.57  |- mesh__historyNote mesh__D009097 73   
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D009097 2005
% 223.37/223.57  |- skos__broader mesh__D009097smesh__D046912
% 223.37/223.57  |- mesh__dateCreated mesh__D009097 1999-01-01
% 223.37/223.57  |- mesh__recordMaintainer mesh__D009097 jls
% 223.37/223.57  |- mesh__recordOriginator mesh__D009097 NLM
% 223.37/223.57  |- mesh__dateRevised mesh__D009097 2004-07-29
% 223.37/223.57  |- rdf__type mesh__D009097sskos__Concept
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D009097 2005A
% 223.37/223.57  |- skos__broader mesh__D002304Q000295smesh__D002304
% 223.37/223.57  |- mesh__preferredCombination mesh__D002304Q000295smesh__D010138
% 223.37/223.57  |- rdf__type mesh__D002304Q000295smesh__CompoundConcept
% 223.37/223.57  |- mesh__historyNote mesh__D003509 68   
% 223.37/223.57  |- skos__prefLabel mesh__D003509 Cyclohexanecarboxylic Acids
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D003509 2005
% 223.37/223.57  |- mesh__dateEstablished mesh__D003509 1968-01-01
% 223.37/223.57  |- skos__broader mesh__D003509smesh__D003510
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D003509 2006
% 223.37/223.57  |- mesh__dateRevised mesh__D003509 2004-07-07
% 223.37/223.57  |- mesh__dateCreated mesh__D003509 1999-01-01
% 223.37/223.57  |- rdf__type mesh__D003509sskos__Concept
% 223.37/223.57  |- mesh__recordOriginator mesh__D003509 NLM
% 223.37/223.57  |- mesh__recordAuthorizer mesh__D003509 sjn
% 223.37/223.57  |- mesh__recordMaintainer mesh__D003509 ssb
% 223.37/223.57  |- skos__hiddenLabel mesh__D003509 Acids, Cyclohexanecarboxylic
% 223.37/223.57  |- skos__broader mesh__D003509smesh__D000146
% 223.37/223.57  |- mesh__publicMeSHNote mesh__D003509 68   
% 223.37/223.57  |- mesh__recordMaintainer mesh__D014231 ags
% 223.37/223.57  |- mesh__publicMeSHNote mesh__D014231 72   
% 223.37/223.57  |- skos__broader mesh__D014231smesh__D001517
% 223.37/223.57  |- rdf__type mesh__D014231sskos__Concept
% 223.37/223.57  |- mesh__dateRevised mesh__D014231 2004-07-07
% 223.37/223.57  |- mesh__recordOriginator mesh__D014231 NLM
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D014231 2006
% 223.37/223.57  |- skos__historyNote mesh__D014231 Beetles %28%1966-1971%29%
% 223.37/223.57  |- mesh__recordAuthorizer mesh__D014231 sjn
% 223.37/223.57  |- skos__scopeNote mesh__D014231
% 223.37/223.57       A genus of small beetles of the family Tenebrionidae; T. confusum is the %22%confused flour beetle%22%.%A%    
% 223.37/223.57  |- mesh__dateEstablished mesh__D014231 1972-01-01
% 223.37/223.57  |- mesh__historyNote mesh__D014231 72   
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D014231 2005
% 223.37/223.57  |- skos__prefLabel mesh__D014231 Tribolium
% 223.37/223.57  |- mesh__dateCreated mesh__D014231 1999-01-01
% 223.37/223.57  |- skos__annotation mesh__D014231
% 223.37/223.57       %22%confused flour beetle%22%; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111%A%  
% 223.37/223.57  |- mesh__recordAuthorizer mesh__D013937 sjn
% 223.37/223.57  |- skos__hiddenLabel mesh__D013937 Kinase, Deoxythymidine
% 223.37/223.57  |- skos__hiddenLabel mesh__D013937 Kinase, Deoxypyrimidine
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D013937 2005
% 223.37/223.57  |- mesh__historyNote mesh__D013937 65   
% 223.37/223.57  |- mesh__dateCreated mesh__D013937 1999-01-01
% 223.37/223.57  |- skos__prefLabel mesh__D013937 Thymidine Kinase
% 223.37/223.57  |- mesh__publicMeSHNote mesh__D013937 65   
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D013937 2006
% 223.37/223.57  |- skos__hiddenLabel mesh__D013937 Kinase, Thymidine
% 223.37/223.57  |- mesh__dateEstablished mesh__D013937 1965-01-01
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D013937 2004
% 223.37/223.57  |- rdf__type mesh__D013937sskos__Concept
% 223.37/223.57  |- skos__altLabel mesh__D013937 Deoxypyrimidine Kinase
% 223.37/223.57  |- mesh__recordOriginator mesh__D013937 NLM
% 223.37/223.57  |- mesh__dateRevised mesh__D013937 2003-07-09
% 223.37/223.57  |- mesh__recordMaintainer mesh__D013937 ssb
% 223.37/223.57  |- skos__broader mesh__D013937smesh__D017853
% 223.37/223.57  |- skos__scopeNote mesh__D013937
% 223.37/223.57       An enzyme that catalyzes the conversion of ATP and thymidine to ADP and thymidine 5%27%-phosphate. Deoxyuridine can also act as an acceptor and dGTP as a donor. %28%From Enzyme Nomenclature, 1992%29% EC 2.7.1.21.%A%    
% 223.37/223.57  |- skos__altLabel mesh__D013937 Deoxythymidine Kinase
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D013139 2006
% 223.37/223.57  |- mesh__recordOriginator mesh__D013139 NLM
% 223.37/223.57  |- skos__prefLabel mesh__D013139 Spirillum
% 223.37/223.57  |- skos__annotation mesh__D013139
% 223.37/223.57       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29% or RAT-BITE FEVER %28%IM%29%%A%  
% 223.37/223.57  |- skos__scopeNote mesh__D013139
% 223.37/223.57       A genus of gram-negative, curved and spiral-shaped bacteria found in stagnant, freshwater environments. These organisms are motile by bipolar tufts of flagella having a long wavelength and about one helical turn. Some species of Spirillum cause a form of RAT-BITE FEVER.%A%    
% 223.37/223.57  |- mesh__dateCreated mesh__D013139 1999-01-01
% 223.37/223.57  |- mesh__recordMaintainer mesh__D013139 SYSTEM
% 223.37/223.57  |- rdf__type mesh__D013139sskos__Concept
% 223.37/223.57  |- mesh__dateRevised mesh__D013139 2005-06-30
% 223.37/223.57  |- mesh__recordAuthorizer mesh__D013139 sjn
% 223.37/223.57  |- skos__broader mesh__D013139smesh__D043167
% 223.37/223.57  |- mesh__dateEstablished mesh__D018622 1995-01-01
% 223.37/223.57  |- skos__scopeNote mesh__D018622
% 223.37/223.57       Protease-resistant core of PrPSC, the abnormal isoform of prion proteins %28%PRIONS%29%. PrP 27-30 is produced by limited proteolysis of the N-terminus of PrPSc.%A%    
% 223.37/223.57  |- mesh__publicMeSHNote mesh__D018622
% 223.37/223.57       95; SCRAPIE-ASSOCIATED FIBRILS was see PRIONS 1992-94, was see SCRAPIE AGENT 1987-91; SCRAPIE PRP 27-30 PROTEIN was indexed under PRIONS 1992-94 %26% VIRAL PROTEINS 1985-91; SCRAPIE ASSOCIATED FIBRIL-PROTEIN was indexed under NERVE TISSUE PROTEINS 1984-94%A%  
% 223.37/223.57  |- skos__altLabel mesh__D018622 Scrapie-Associated Fibril-Protein
% 223.37/223.57  |- skos__altLabel mesh__D018622 Fibrils, Scrapie-Associated
% 223.37/223.57  |- rdf__type mesh__D018622sskos__Concept
% 223.37/223.57  |- skos__hiddenLabel mesh__D018622 PrP 27 30 Protein
% 223.37/223.57  |- skos__annotation mesh__D018622
% 223.37/223.57       protease-resistant core of PRPSC proteins; PRP stands for Prion Protein; /pathogen permitted%A%  
% 223.37/223.57  |- skos__hiddenLabel mesh__D018622 Scrapie Associated Fibrils
% 223.37/223.57  |- mesh__recordMaintainer mesh__D018622 SYSTEM
% 223.37/223.57  |- skos__historyNote mesh__D018622 Prions %28%1992-1994%29%
% 223.37/223.57  |- skos__historyNote mesh__D018622 Viral Proteins %28%1985-1991%29%
% 223.37/223.57  |- skos__hiddenLabel mesh__D018622 Fibrils, Scrapie Associated
% 223.37/223.57  |- skos__altLabel mesh__D018622 Scrapie PrP 27-30 Protein
% 223.37/223.57  |- skos__altLabel mesh__D018622 Scrapie Associated Fibril-Protein
% 223.37/223.57  |- mesh__recordAuthorizer mesh__D018622 sjn
% 223.37/223.57  |- skos__altLabel mesh__D018622 Scrapie-Associated Fibrils
% 223.37/223.57  |- mesh__dateCreated mesh__D018622 1994-05-23
% 223.37/223.57  |- mesh__recordOriginator mesh__D018622 AGS
% 223.37/223.57  |- skos__hiddenLabel mesh__D018622 Associated Fibril-Protein, Scrapie
% 223.37/223.57  |- mesh__dateRevised mesh__D018622 2005-06-30
% 223.37/223.57  |- skos__hiddenLabel mesh__D018622 Fibril Protein, Scrapie Associated
% 223.37/223.57  |- skos__hiddenLabel mesh__D018622 Scrapie PrP 27 30 Protein
% 223.37/223.57  |- skos__broader mesh__D018622smesh__D018620
% 223.37/223.57  |- skos__prefLabel mesh__D018622 PrP 27-30 Protein
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D018622 2006
% 223.37/223.57  |- mesh__historyNote mesh__D018622
% 223.37/223.57       95; SCRAPIE-ASSOCIATED FIBRILS was see PRIONS 1992-94, was see SCRAPIE AGENT 1987-91; SCRAPIE PRP 27-30 PROTEIN was NM 1985-94; SCRAPIE ASSOCIATED FIBRIL-PROTEIN was NM 1984-94%A%  
% 223.37/223.57  |- skos__hiddenLabel mesh__D018622 Fibril-Protein, Scrapie Associated
% 223.37/223.57  |- mesh__onlineNote mesh__D018622
% 223.37/223.57       use PRIONS to search SCRAPIE-ASSOCIATED FIBRILS 1987-94; use PRP 27-30 PROTEIN %28%NM%29% to search SCRAPIE PRP 27-30 PROTEIN 1985-94 %26% SCRAPIE ASSOCIATED FIBRIL-PROTEIN 1984-94%A%  
% 223.37/223.57  |- skos__altLabel mesh__D018622 Fibril-Protein, Scrapie-Associated
% 223.37/223.57  |- skos__hiddenLabel mesh__D018622 Scrapie Associated Fibril Protein
% 223.37/223.57  |- mesh__dateRevised mesh__D004602 2000-06-22
% 223.37/223.57  |- skos__related mesh__D004602smesh__D011868
% 223.37/223.57  |- mesh__recordMaintainer mesh__D004602 adp
% 223.37/223.57  |- skos__prefLabel mesh__D004602 Elements
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D004602 2004
% 223.37/223.57  |- mesh__recordAuthorizer mesh__D004602 sjn
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D004602 2001
% 223.37/223.57  |- skos__annotation mesh__D004602
% 223.37/223.57       GEN only; prefer specifics; ISOTOPES %28%little used%29% %26% RADIOISOTOPES %26% many specifics are also available; m for metastable = RADIOISOTOPES or specific pre-coord radioisotope%A%  
% 223.37/223.57  |- skos__related mesh__D004602smesh__D007554
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D004602 2005
% 223.37/223.57  |- mesh__dateCreated mesh__D004602 1999-01-01
% 223.37/223.57  |- mesh__recordOriginator mesh__D004602 NLM
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D004602 2002
% 223.37/223.57  |- skos__broader mesh__D004602smesh__D007287
% 223.37/223.57  |- skos__scopeNote mesh__D004602
% 223.37/223.57       Substances that comprise all matter. Each element is made up of atoms that are identical in number of electrons and protons and in nuclear charge, but may differ in mass or number of neutrons.%A%    
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D004602 2006
% 223.37/223.57  |- rdf__type mesh__D004602sskos__Concept
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D004602 2003
% 223.37/223.57  |- skos__hiddenLabel mesh__D051258 Transcription Factors, MafB
% 223.37/223.57  |- skos__altLabel mesh__D051258 MafB Proteins
% 223.37/223.57  |- mesh__dateRevised mesh__D051258 2005-07-13
% 223.37/223.57  |- skos__hiddenLabel mesh__D051258 Proteins, MafB
% 223.37/223.57  |- skos__scopeNote mesh__D051258
% 223.37/223.57       A large maf protein that regulates HINDBRAIN development, contributes to CELL DIFFERENTIATION of MONOCYTES, and interacts with ETS-1 TRANSCRIPTION FACTOR.%A%    
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D051258 2006
% 223.37/223.57  |- mesh__historyNote mesh__D051258 2006   
% 223.37/223.57  |- skos__altLabel mesh__D051258 MafB Transcription Factors
% 223.37/223.57  |- mesh__recordAuthorizer mesh__D051258 ags
% 223.37/223.57  |- skos__broader mesh__D051258smesh__D051473
% 223.37/223.57  |- mesh__dateEstablished mesh__D051258 2006-01-01
% 223.37/223.57  |- mesh__recordMaintainer mesh__D051258 ags
% 223.37/223.57  |- skos__hiddenLabel mesh__D051258 Transcription Factor, MafB
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D051258 2006A
% 223.37/223.57  |- mesh__dateCreated mesh__D051258 2005-06-30
% 223.37/223.57  |- mesh__publicMeSHNote mesh__D051258 2006   
% 223.37/223.57  |- skos__prefLabel mesh__D051258 MafB Transcription Factor
% 223.37/223.57  |- rdf__type mesh__D051258sskos__Concept
% 223.37/223.57  |- mesh__recordOriginator mesh__D051258 DRC
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D009896 2003
% 223.37/223.57  |- mesh__recordOriginator mesh__D009896 NLM
% 223.37/223.57  |- skos__scopeNote mesh__D009896
% 223.37/223.57       Atrophy of the optic disk which may be congenital or acquired. This condition indicates a deficiency in the number of nerve fibers which arise in the RETINA and converge to form the OPTIC DISK; OPTIC NERVE; OPTIC CHIASM; and optic tracts. GLAUCOMA; ISCHEMIA; inflammation, a chronic elevation of intracranial pressure, toxins, optic nerve compression, and inherited conditions %28%see OPTIC ATROPHIES, HEREDITARY%29% are relatively common causes of this condition.%A%    
% 223.37/223.57  |- mesh__recordMaintainer mesh__D009896 ags
% 223.37/223.57  |- skos__annotation mesh__D009896
% 223.37/223.57       /genet permitted but do not confuse with OPTIC ATROPHIES, HEREDITARY%A%  
% 223.37/223.57  |- skos__broader mesh__D009896smesh__D009901
% 223.37/223.57  |- skos__prefLabel mesh__D009896 Optic Atrophy
% 223.37/223.57  |- mesh__dateCreated mesh__D009896 1999-01-01
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D009896 2006
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D009896 2002
% 223.37/223.57  |- skos__hiddenLabel mesh__D009896 Atrophy, Optic
% 223.37/223.57  |- mesh__dateRevised mesh__D009896 2005-07-15
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D009896 2005
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D009896 2006A
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D009896 2001
% 223.37/223.57  |- rdf__type mesh__D009896sskos__Concept
% 223.37/223.57  |- mesh__recordAuthorizer mesh__D009896 ags
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D009896 2004
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D009896 2000
% 223.37/223.57  |- skos__hiddenLabel mesh__D009098 Multiphasic Screenings
% 223.37/223.57  |- mesh__recordMaintainer mesh__D009098 PXP
% 223.37/223.57  |- skos__scopeNote mesh__D009098
% 223.37/223.57       The simultaneous use of multiple laboratory procedures for the detection of various diseases. These are usually performed on groups of people.%A%    
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D009098 2005
% 223.37/223.57  |- mesh__recordOriginator mesh__D009098 NLM
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D009098 2000
% 223.37/223.57  |- skos__broader mesh__D009098smesh__D008403
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D009098 2003
% 223.37/223.57  |- mesh__dateCreated mesh__D009098 1999-01-01
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D009098 1998
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D009098 2006
% 223.37/223.57  |- skos__historyNote mesh__D009098 Diagnosis %28%1966-1967%29%
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D009098 2001
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D009098 2004
% 223.37/223.57  |- skos__historyNote mesh__D009098 Mass Screening %28%1966-1967%29%
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D009098 1999
% 223.37/223.57  |- mesh__recordAuthorizer mesh__D009098 SJN
% 223.37/223.57  |- mesh__dateRevised mesh__D009098 1997-06-20
% 223.37/223.57  |- mesh__activeMeSHYear mesh__D009098 2002
% 223.37/223.57  |- skos__hiddenLabel mesh__D009098 Screenings, Multiphasic
% 223.37/223.57  |- skos__hiddenLabel mesh__D009098 Screening, Multiphasic
% 223.37/223.57  |- mesh__dateEstablished mesh__D009098 1968-01-01
% 223.37/223.57  |- mesh__publicMeSHNote mesh__D009098 68   
% 223.37/223.57  |- skos__historyNote mesh__D009098 Physical Examination %28%1966-1967%29%
% 223.37/223.57  |- skos__prefLabel mesh__D009098 Multiphasic Screening
% 223.37/223.57  |- mesh__historyNote mesh__D009098 68   
% 223.37/223.57  |- rdf__type mesh__D009098sskos__Concept
% 223.37/223.57  |- skos__altLabel mesh__D000212 curasan Brand of Aciclovir Sodium Salt
% 223.37/223.57  |- skos__altLabel mesh__D000212 Lichtenstein Brand of Aciclovir
% 223.37/223.57  |- skos__altLabel mesh__D000212 Hexal Brand of Aciclovir
% 223.37/223.57  |- skos__hiddenLabel mesh__D000212 Aci Sanorania
% 223.37/223.57  |- skos__hiddenLabel mesh__D000212 Sodium, Acyclovir
% 223.37/223.57  |- skos__hiddenLabel mesh__D000212 Aciclovir Hexal Brand
% 223.37/223.57  |- skos__altLabel mesh__D000212 Liomont Brand of Aciclovir
% 223.37/223.57  |- skos__altLabel mesh__D000212 Acycloguanosine
% 223.37/223.57  |- skos__altLabel mesh__D000212 Pisa Brand of Aciclovir
% 223.37/223.57  |- skos__hiddenLabel mesh__D000212 Aciclovir Betapharm Brand
% 223.37/223.57  |- skos__hiddenLabel mesh__D000212 Aciclovir Azupharma Brand
% 223.37/223.57  |- skos__altLabel mesh__D000212 Fabrigen Brand of Aciclovir
% 223.37/223.57  |- skos__prefLabel mesh__D000212 Acyclovir
% 223.37/223.57  |- skos__altLabel mesh__D000212 Britisfarma Brand of Aciclovir
% 223.37/223.57  |- skos__scopeNote mesh__D000212
% 223.37/223.57       A GUANOSINE analog that acts as an antimetabolite.  Viruses are especially susceptible. Used especially against herpes.%A%    
% 223.37/223.57  |- skos__altLabel mesh__D000212 Glaxo Wellcome Brand of Aciclovir
% 223.37/223.57  |- skos__hiddenLabel mesh__D000212 Aciclovir Lichtenstein Brand
% 223.37/223.57  |- skos__altLabel mesh__D000212 Ursapharm Brand of Aciclovir
% 223.37/223.57  |- skos__altLabel mesh__D000212 Wellcome Brand of Aciclovir
% 223.37/223.57  |- skos__altLabel mesh__D000212 Warner-Lambert Brand of Aciclovir
% 223.37/223.57  |- skos__altLabel mesh__D000212 Mann Brand of Aciclovir
% 223.37/223.57  |- skos__hiddenLabel mesh__D000212 Aciclovir Grin Brand
% 223.37/223.57  |- skos__altLabel mesh__D000212 Alphapharm Brand of Aciclovir
% 223.37/223.57  |- skos__hiddenLabel mesh__D000212 Aciclovir TAD Brand
% 223.37/223.57  |- skos__hiddenLabel mesh__D000212 Aciclovir Kendrick Brand
% 223.37/223.57  |- skos__altLabel mesh__D000212 Zyma Brand of Aciclovir
% 223.37/223.57  |- skos__hiddenLabel mesh__D000212 Aciclovir Sanorania Brand
% 223.37/223.57  |- skos__hiddenLabel mesh__D000212 Aciclovir Menarini Brand
% 223.37/223.57  |- skos__hiddenLabel mesh__D000212 Aciclovir Fustery Brand
% 223.37/223.57  |- skos__hiddenLabel mesh__D000212 Aciclovir Abello Brand
% 223.37/223.57  |- skos__altLabel mesh__D000212 Alcon Brand of Aciclovir
% 223.37/223.57  |- mesh__publicMeSHNote mesh__D000212 83   
% 223.37/223.57  |- skos__hiddenLabel mesh__D000212 Aciclovir Novartis Brand
% 223.37/223.57  |- skos__altLabel mesh__D000212 Clonmel Brand of Aciclovir
% 223.37/223.57  |- skos__altLabel mesh__D000212 Stada Brand of Aciclovir
% 223.37/223.57  |- skos__altLabel mesh__D000212 Isis Brand of Aciclovir
% 223.37/223.57  |- skos__hiddenLabel mesh__D000212 Aciclovir Warner-Lambert Brand
% 223.37/223.57  |- skos__altLabel mesh__D000212 Hexal Brand of Aciclovir Sodium Salt
% 223.37/223.57  |- skos__hiddenLabel mesh__D000212 Aciclovir Stada Brand
% 223.37/223.57  |- skos__hiddenLabel mesh__D000212 Aciclovir Novag Brand
% 223.37/223.57  |- skos__altLabel mesh__D000212 Britisfarma Brand of Aciclovir Sodium Salt
% 223.37/223.57  |- skos__hiddenLabel mesh__D000212 Aciclovir Pensa Brand
% 223.37/223.57  |- skos__hiddenLabel mesh__D000212 Aciclovir Isis Brand
% 223.37/223.58  |- skos__altLabel mesh__D000212 Alonga Brand of Aciclovir Sodium Salt
% 223.37/223.58  |- skos__altLabel mesh__D000212
% 223.37/223.58       Glaxo Wellcome Brand of Aciclovir Sodium Salt
% 223.37/223.58  |- skos__altLabel mesh__D000212 Pharma Investi Brand of Aciclovir
% 223.37/223.58  |- mesh__recordAuthorizer mesh__D000212 sjn
% 223.37/223.58  |- skos__altLabel mesh__D000212 Fustery Brand of Aciclovir
% 223.37/223.58  |- skos__altLabel mesh__D000212 Yamanouchi Brand of Aciclovir
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Virax Puren
% 223.37/223.58  |- skos__altLabel mesh__D000212 Wellcome Brand of Aciclovir Sodium Salt
% 223.37/223.58  |- skos__altLabel mesh__D000212 Bull Brand of Aciclovir
% 223.37/223.58  |- skos__altLabel mesh__D000212 Grin Brand of Aciclovir
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Aciclovir Wellcome Brand
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Aciclovir Alcon Brand
% 223.37/223.58  |- mesh__dateEstablished mesh__D000212 1983-01-01
% 223.37/223.58  |- skos__altLabel mesh__D000212
% 223.37/223.58       9-%28%%28%2-Hydroxyethoxy%29%methyl%29%guanine
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Acyclo V
% 223.37/223.58  |- skos__altLabel mesh__D000212 Rentschler Brand of Aciclovir
% 223.37/223.58  |- skos__altLabel mesh__D000212 Niddapharm Brand of Aciclovir
% 223.37/223.58  |- skos__altLabel mesh__D000212 Warner Wellcome Brand of Aciclovir
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Aciclovir Ursapharm Brand
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Aciclovir Rentschler Brand
% 223.37/223.58  |- skos__altLabel mesh__D000212 Novag Brand of Aciclovir
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Warner Lambert Brand of Aciclovir
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Aciclovir Alphapharm Brand
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Wellcome 248U
% 223.37/223.58  |- skos__altLabel mesh__D000212 Pensa Brand of Aciclovir Sodium Salt
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D000212 2006
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Aciclovir Pisa Brand
% 223.37/223.58  |- skos__altLabel mesh__D000212 Betapharm Brand of Aciclovir
% 223.37/223.58  |- skos__altLabel mesh__D000212 Parke Davis Brand of Aciclovir
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Aciclovir Sanorania
% 223.37/223.58  |- skos__altLabel mesh__D000212 Abello Brand of Aciclovir
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Wellcome248U
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Aciclovir Zyma Brand
% 223.37/223.58  |- skos__broader mesh__D000212smesh__D006147
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 ViraxPuren
% 223.37/223.58  |- skos__altLabel mesh__D000212 Menarini Brand of Aciclovir
% 223.37/223.58  |- skos__altLabel mesh__D000212 aciclovir von ct
% 223.37/223.58  |- skos__altLabel mesh__D000212 Aciclovir-Sanorania
% 223.37/223.58  |- skos__altLabel mesh__D000212 Sanorania Brand of Aciclovir
% 223.37/223.58  |- skos__historyNote mesh__D000212 Guanine %28%1966-1982%29%
% 223.37/223.58  |- skos__altLabel mesh__D000212 Menarini Brand of Aciclovir Sodium Salt
% 223.37/223.58  |- skos__altLabel mesh__D000212 TAD Brand of Aciclovir
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Solutab, Acipen
% 223.37/223.58  |- mesh__dateCreated mesh__D000212 1982-05-05
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Aciclovir Clonmel Brand
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Aciclovir Mann Brand
% 223.37/223.58  |- skos__altLabel mesh__D000212 Aciclovir
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Aciclovir Liomont Brand
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Aciclovir Gr%C3%%BC%nenthal Brand
% 223.37/223.58  |- mesh__recordMaintainer mesh__D000212 CCR
% 223.37/223.58  |- skos__altLabel mesh__D000212 Azupharma Brand of Aciclovir
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Aciclovir Niddapharm Brand
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Aciclovir Wolff Brand
% 223.37/223.58  |- skos__altLabel mesh__D000212 Novartis Brand of Aciclovir
% 223.37/223.58  |- mesh__historyNote mesh__D000212 83   
% 223.37/223.58  |- skos__altLabel mesh__D000212 Gr%C3%%BC%nenthal Brand of Aciclovir
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 ct Arzneimittel Brand of Aciclovir
% 223.37/223.58  |- skos__altLabel mesh__D000212 Wolff Brand of Aciclovir
% 223.37/223.58  |- skos__altLabel mesh__D000212 Sanorania Brand of Aciclovir Sodium Salt
% 223.37/223.58  |- mesh__recordOriginator mesh__D000212 SH
% 223.37/223.58  |- skos__altLabel mesh__D000212 Alonga Brand of Aciclovir
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Aciclovir Dermapharm Brand
% 223.37/223.58  |- rdf__type mesh__D000212sskos__Concept
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Aciclovir Britisfarma Brand
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Aciclovir Fabrigen Brand
% 223.37/223.58  |- skos__altLabel mesh__D000212 Dermapharm Brand of Aciclovir
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Aciclovir Yamanouchi Brand
% 223.37/223.58  |- mesh__dateRevised mesh__D000212 2005-06-30
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Aciclovir ct-Arzneimittel Brand
% 223.37/223.58  |- skos__altLabel mesh__D000212
% 223.37/223.58       Gr%C3%%BC%nenthal Brand of Aciclovir Sodium Salt
% 223.37/223.58  |- skos__altLabel mesh__D000212 Amrad Brand of Aciclovir
% 223.37/223.58  |- skos__altLabel mesh__D000212 ct-Arzneimittel Brand of Aciclovir
% 223.37/223.58  |- skos__altLabel mesh__D000212 Zovirax for Injection
% 223.37/223.58  |- skos__altLabel mesh__D000212 Rentschler Brand of Aciclovir Sodium Salt
% 223.37/223.58  |- skos__altLabel mesh__D000212 Kendrick Brand of Aciclovir
% 223.37/223.58  |- skos__altLabel mesh__D000212 Pensa Brand of Aciclovir
% 223.37/223.58  |- skos__hiddenLabel mesh__D000212 Aciclovir Amrad Brand
% 223.37/223.58  |- skos__annotation mesh__D013938 /biosyn /physiol permitted   
% 223.37/223.58  |- skos__hiddenLabel mesh__D013938 Acid, Thymidylic
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D013938 2003
% 223.37/223.58  |- mesh__dateCreated mesh__D013938 1999-01-01
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D013938 2006
% 223.37/223.58  |- mesh__recordMaintainer mesh__D013938 NLM
% 223.37/223.58  |- skos__hiddenLabel mesh__D013938 Acids, Thymidylic
% 223.37/223.58  |- skos__prefLabel mesh__D013938 Thymidine Monophosphate
% 223.37/223.58  |- mesh__dateEstablished mesh__D013938 1991-01-01
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D013938 1991
% 223.37/223.58  |- mesh__publicMeSHNote mesh__D013938
% 223.37/223.58       91; was see under THYMINE NUCLEOTIDES 1978-90; was THYMIDYLIC ACIDS see under THYMINE NUCLEOTIDES 1972-77, see under NUCLEOTIDES 1963-71%A%  
% 223.37/223.58  |- skos__broader mesh__D013938smesh__D013942
% 223.37/223.58  |- skos__historyNote mesh__D013938 Nucleotides %28%1966-1971%29%
% 223.37/223.58  |- skos__hiddenLabel mesh__D013938 Monophosphate, Thymidine
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D013938 2004
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D013938 1994
% 223.37/223.58  |- rdf__type mesh__D013938sskos__Concept
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D013938 2000
% 223.37/223.58  |- skos__scopeNote mesh__D013938
% 223.37/223.58       5-Thymidylic acid. A thymine nucleotide containing one phosphate group esterified to the deoxyribose moiety.%A%    
% 223.37/223.58  |- skos__historyNote mesh__D013938 Thymine Nucleotides %28%1972-1974%29%
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D013938 1998
% 223.37/223.58  |- mesh__onlineNote mesh__D013938
% 223.37/223.58       use THYMIDINE MONOPHOSPHATE to search THYMIDYLIC ACIDS 1975-78, use THYMINE NUCLEOTIDES 1972-74 %26% NUCLEOTIDES 1966-71%A%  
% 223.37/223.58  |- skos__altLabel mesh__D013938 Thymidylic Acid
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D013938 1992
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D013938 2001
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D013938 1995
% 223.37/223.58  |- skos__altLabel mesh__D013938 DTMP
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D013938 1996
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D013938 1999
% 223.37/223.58  |- skos__altLabel mesh__D013938 TMP
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D013938 2002
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D013938 1993
% 223.37/223.58  |- mesh__recordOriginator mesh__D013938 NLM
% 223.37/223.58  |- mesh__dateRevised mesh__D013938 1990-06-07
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D013938 1997
% 223.37/223.58  |- mesh__recordAuthorizer mesh__D013938 PLS
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D013938 2005
% 223.37/223.58  |- mesh__historyNote mesh__D013938
% 223.37/223.58       91%28%78%29%; was see under THYMINE NUCLEOTIDES 1978-90; was THYMIDYLIC ACIDS see under THYMINE NUCLEOTIDES 1972-77, see under NUCLEOTIDES 1963-71%A%  
% 223.37/223.58  |- mesh__dateCreated mesh__D010640 1999-01-01
% 223.37/223.58  |- mesh__recordOriginator mesh__D010640 NLM
% 223.37/223.58  |- mesh__dateRevised mesh__D010640 2005-06-30
% 223.37/223.58  |- skos__scopeNote mesh__D010640
% 223.37/223.58       Compounds containing dibenzo-1,4-thiazine. Some of them are neuroactive.%A%    
% 223.37/223.58  |- rdf__type mesh__D010640sskos__Concept
% 223.37/223.58  |- skos__prefLabel mesh__D010640 Phenothiazines
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D010640 2006
% 223.37/223.58  |- mesh__recordAuthorizer mesh__D010640 sjn
% 223.37/223.58  |- skos__broader mesh__D010640smesh__D013457
% 223.37/223.58  |- mesh__recordMaintainer mesh__D010640 ssb
% 223.37/223.58  |- skos__broader mesh__D010640smesh__D006575
% 223.37/223.58  |- skos__related mesh__D010640smesh__D014150
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D004603 2005
% 223.37/223.58  |- mesh__dateCreated mesh__D004603 1999-01-01
% 223.37/223.58  |- mesh__publicMeSHNote mesh__D004603 98   
% 223.37/223.58  |- mesh__historyNote mesh__D004603 98; use explode 1967-97   
% 223.37/223.58  |- skos__broader mesh__D004603smesh__D004602
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D004603 2006
% 223.37/223.58  |- rdf__type mesh__D004603sskos__Concept
% 223.37/223.58  |- skos__scopeNote mesh__D004603
% 223.37/223.58       Elements which exhibit atomic emission due to natural or artificial nuclear transformation. These elements spontaneously undergo radioactive decay.%A%    
% 223.37/223.58  |- skos__annotation mesh__D004603
% 223.37/223.58       GEN; prefer specifics; these are naturally radioactive   
% 223.37/223.58  |- skos__altLabel mesh__D004603 Radioactive Elements
% 223.37/223.58  |- skos__related mesh__D004603smesh__D011868
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D004603 2003
% 223.37/223.58  |- mesh__recordAuthorizer mesh__D004603 sjn
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D004603 2001
% 223.37/223.58  |- mesh__dateRevised mesh__D004603 2000-06-22
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D004603 2004
% 223.37/223.58  |- skos__prefLabel mesh__D004603 Elements, Radioactive
% 223.37/223.58  |- mesh__dateEstablished mesh__D004603 1998-01-01
% 223.37/223.58  |- mesh__recordOriginator mesh__D004603 NLM
% 223.37/223.58  |- mesh__recordMaintainer mesh__D004603 adp
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D004603 2002
% 223.37/223.58  |- mesh__dateEstablished mesh__D051259 2006-01-01
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D051259 2006A
% 223.37/223.58  |- mesh__dateCreated mesh__D051259 2005-06-30
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D051259 2006
% 223.37/223.58  |- mesh__dateRevised mesh__D051259 2005-07-13
% 223.37/223.58  |- skos__hiddenLabel mesh__D051259 Transcription Factor, MafG
% 223.37/223.58  |- skos__prefLabel mesh__D051259 MafG Transcription Factor
% 223.37/223.58  |- mesh__recordAuthorizer mesh__D051259 ags
% 223.37/223.58  |- mesh__recordMaintainer mesh__D051259 ags
% 223.37/223.58  |- mesh__publicMeSHNote mesh__D051259 2006   
% 223.37/223.58  |- rdf__type mesh__D051259sskos__Concept
% 223.37/223.58  |- mesh__recordOriginator mesh__D051259 DRC
% 223.37/223.58  |- mesh__historyNote mesh__D051259 2006   
% 223.37/223.58  |- skos__scopeNote mesh__D051259
% 223.37/223.58       MafG is a ubiquitously expressed small maf protein that is involved in CELL DIFFERENTIATION of ERYTHROCYTES. It dimerizes with P45 NF-E2 PROTEIN and activates expression of ALPHA-GLOBIN and BETA-GLOBIN.%A%    
% 223.37/223.58  |- skos__broader mesh__D051259smesh__D050978
% 223.37/223.58  |- skos__hiddenLabel mesh__D009897 Opticum, Chiasma
% 223.37/223.58  |- skos__prefLabel mesh__D009897 Optic Chiasm
% 223.37/223.58  |- skos__annotation mesh__D009897
% 223.37/223.58       neopl: coord IM with OPTIC NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 223.37/223.58  |- skos__hiddenLabel mesh__D009897 Decussations, Optic
% 223.37/223.58  |- mesh__dateCreated mesh__D009897 1999-01-01
% 223.37/223.58  |- mesh__recordAuthorizer mesh__D009897 sjn
% 223.37/223.58  |- skos__hiddenLabel mesh__D009897 Decussation, Optic
% 223.37/223.58  |- skos__altLabel mesh__D009897 Chiasma Opticum
% 223.37/223.58  |- skos__hiddenLabel mesh__D009897 Chiasms, Optic
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D009897 2006
% 223.37/223.58  |- mesh__dateEstablished mesh__D009897 1966-01-01
% 223.37/223.58  |- skos__hiddenLabel mesh__D009897 Chiasma, Optic
% 223.37/223.58  |- mesh__recordOriginator mesh__D009897 NLM
% 223.37/223.58  |- mesh__publicMeSHNote mesh__D009897 66   
% 223.37/223.58  |- skos__hiddenLabel mesh__D009897 Chiasmas, Optic
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D009897 2005
% 223.37/223.58  |- skos__hiddenLabel mesh__D009897 Optic Chiasms
% 223.37/223.58  |- skos__hiddenLabel mesh__D009897 Optic Decussations
% 223.37/223.58  |- mesh__historyNote mesh__D009897 66%28%64%29%   
% 223.37/223.58  |- mesh__dateRevised mesh__D009897 2001-07-25
% 223.37/223.58  |- rdf__type mesh__D009897sskos__Concept
% 223.37/223.58  |- skos__altLabel mesh__D009897 Optic Chiasma
% 223.37/223.58  |- skos__scopeNote mesh__D009897
% 223.37/223.58       The X-shaped structure formed by the meeting of the two optic nerves. At the optic chiasm the fibers from the medial part of each retina cross to project to the other side of the brain while the lateral retinal fibers continue on the same side. As a result each half of the brain receives information about the contralateral visual field from both eyes.%A%    
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D009897 2004
% 223.37/223.58  |- mesh__recordMaintainer mesh__D009897 jmp
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D009897 2002
% 223.37/223.58  |- skos__hiddenLabel mesh__D009897 Optic Chiasmas
% 223.37/223.58  |- skos__altLabel mesh__D009897 Optic Decussation
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D009897 2003
% 223.37/223.58  |- skos__hiddenLabel mesh__D009897 Chiasma Opticums
% 223.37/223.58  |- skos__broader mesh__D009897smesh__D009900
% 223.37/223.58  |- skos__hiddenLabel mesh__D009897 Opticums, Chiasma
% 223.37/223.58  |- skos__hiddenLabel mesh__D009897 Chiasm, Optic
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D009099 2005
% 223.37/223.58  |- skos__historyNote mesh__D009099
% 223.37/223.58       specific multiple birth %28%1966-1997%29%
% 223.37/223.58  |- mesh__recordMaintainer mesh__D009099 sjn
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D009099 2003
% 223.37/223.58  |- mesh__dateCreated mesh__D009099 1999-01-01
% 223.37/223.58  |- skos__scopeNote mesh__D009099
% 223.37/223.58       The offspring in multiple pregnancies %28%PREGNANCY, MULTIPLE%29%: TWINS; TRIPLETS; QUADRUPLETS; QUINTUPLETS; etc.%A%    
% 223.37/223.58  |- skos__annotation mesh__D009099
% 223.37/223.58       human %26% animal; these are the offspring %28%TWINS, etc.%29%: PREGNANCY, MULTIPLE is the mother %28%see note there%29%; for animals, consider also LITTER SIZE%A%  
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D009099 2006
% 223.37/223.58  |- mesh__dateRevised mesh__D009099 2002-10-24
% 223.37/223.58  |- mesh__recordAuthorizer mesh__D009099 sjn
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D009099 2004
% 223.37/223.58  |- skos__hiddenLabel mesh__D009099 Birth Offspring, Multiple
% 223.37/223.58  |- skos__altLabel mesh__D009099 Multiple Births
% 223.37/223.58  |- skos__hiddenLabel mesh__D009099 Offspring, Multiple Birth
% 223.37/223.58  |- mesh__recordOriginator mesh__D009099 NLM
% 223.37/223.58  |- skos__broader mesh__D009099smesh__D009272
% 223.37/223.58  |- skos__historyNote mesh__D009099 Pregnancy, Multiple %28%1966-1997%29%
% 223.37/223.58  |- skos__prefLabel mesh__D009099 Multiple Birth Offspring
% 223.37/223.58  |- mesh__historyNote mesh__D009099 98; use explode 1975-97   
% 223.37/223.58  |- rdf__type mesh__D009099sskos__Concept
% 223.37/223.58  |- skos__hiddenLabel mesh__D009099 Sextuplet
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D009099 2003A
% 223.37/223.58  |- skos__altLabel mesh__D009099 Multiple Birth
% 223.37/223.58  |- skos__hiddenLabel mesh__D009099 Birth, Multiple
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D009099 2002
% 223.37/223.58  |- mesh__dateEstablished mesh__D009099 1998-01-01
% 223.37/223.58  |- mesh__publicMeSHNote mesh__D009099 98   
% 223.37/223.58  |- mesh__publicMeSHNote mesh__D020270 2000   
% 223.37/223.58  |- skos__altLabel mesh__D020270
% 223.37/223.58       Major Motor Seizure, Alcohol Withdrawal-Induced
% 223.37/223.58  |- skos__hiddenLabel mesh__D020270 Withdrawal Seizures, Alcohol
% 223.37/223.58  |- skos__historyNote mesh__D020270 Psychoses, Alcoholic %28%1966-1999%29%
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D020270 2003
% 223.37/223.58  |- skos__hiddenLabel mesh__D020270 Seizures, Alcohol Withdrawal-Induced
% 223.37/223.58  |- skos__altLabel mesh__D020270 Seizures, Alcoholic
% 223.37/223.58  |- skos__scopeNote mesh__D020270
% 223.37/223.58       A condition where seizures occur in association with ethanol abuse %28%ALCOHOLISM%29% without other identifiable causes. Seizures usually occur within the first 6-48 hours after the cessation of alcohol intake, but may occur during periods of alcohol intoxication. Single generalized tonic-clonic motor seizures are the most common subtype, however, STATUS EPILEPTICUS may occur. %28%Adams et al., Principles of Neurology, 6th ed, p1174%29%%A%    
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D020270 2000A
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D020270 2002
% 223.37/223.58  |- skos__altLabel mesh__D020270 Alcohol Withdrawal-Induced Seizure
% 223.37/223.58  |- skos__broader mesh__D020270smesh__D020268
% 223.37/223.58  |- skos__hiddenLabel mesh__D020270 Alcohol Withdrawal-Induced Seizures
% 223.37/223.58  |- skos__hiddenLabel mesh__D020270 Withdrawal-Induced Seizure, Alcohol
% 223.37/223.58  |- mesh__dateEstablished mesh__D020270 2000-01-01
% 223.37/223.58  |- skos__historyNote mesh__D020270 Epilepsy/etiology %28%1966-1999%29%
% 223.37/223.58  |- skos__altLabel mesh__D020270
% 223.37/223.58       Alcohol Withdrawal-Induced Status Epilepticus
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D020270 2001
% 223.37/223.58  |- skos__hiddenLabel mesh__D020270 Alcoholic Seizure
% 223.37/223.58  |- mesh__historyNote mesh__D020270 2000   
% 223.37/223.58  |- mesh__recordAuthorizer mesh__D020270 ags
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D020270 2006
% 223.37/223.58  |- skos__broader mesh__D020270smesh__D012640
% 223.37/223.58  |- mesh__recordMaintainer mesh__D020270 ags
% 223.37/223.58  |- skos__hiddenLabel mesh__D020270 Withdrawal Seizure, Alcohol
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D020270 2000
% 223.37/223.58  |- skos__hiddenLabel mesh__D020270 Seizures, Alcohol Withdrawal
% 223.37/223.58  |- skos__hiddenLabel mesh__D020270 Withdrawal-Induced Seizures, Alcohol
% 223.37/223.58  |- skos__hiddenLabel mesh__D020270
% 223.37/223.58       Major Motor Seizure, Alcohol Withdrawal Induced
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D020270 2005
% 223.37/223.58  |- rdf__type mesh__D020270sskos__Concept
% 223.37/223.58  |- skos__prefLabel mesh__D020270 Alcohol Withdrawal Seizures
% 223.37/223.58  |- mesh__dateRevised mesh__D020270 1999-12-16
% 223.37/223.58  |- skos__hiddenLabel mesh__D020270 Alcohol Withdrawal Seizure
% 223.37/223.58  |- skos__hiddenLabel mesh__D020270
% 223.37/223.58       Alcohol Withdrawal Induced Status Epilepticus
% 223.37/223.58  |- skos__hiddenLabel mesh__D020270
% 223.37/223.58       Alcohol Withdrawal Induced Major Motor Seizure
% 223.37/223.58  |- mesh__recordOriginator mesh__D020270 KEV
% 223.37/223.58  |- skos__hiddenLabel mesh__D020270 Seizure, Alcohol Withdrawal-Induced
% 223.37/223.58  |- skos__annotation mesh__D020270
% 223.37/223.58       ALCOHOL WITHDRAWAL DELIRIUM is available   
% 223.37/223.58  |- mesh__dateCreated mesh__D020270 1999-11-04
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D020270 2004
% 223.37/223.58  |- skos__hiddenLabel mesh__D020270 Seizure, Alcohol Withdrawal
% 223.37/223.58  |- skos__hiddenLabel mesh__D020270 Alcoholic Seizures
% 223.37/223.58  |- skos__hiddenLabel mesh__D020270
% 223.37/223.58       Status Epilepticus, Alcohol Withdrawal Induced
% 223.37/223.58  |- skos__broader mesh__D020270smesh__D013375
% 223.37/223.58  |- skos__hiddenLabel mesh__D020270 Seizure, Alcoholic
% 223.37/223.58  |- skos__hiddenLabel mesh__D020270 Alcohol Withdrawal Induced Seizure
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D014233 1999
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D014233 2003
% 223.37/223.58  |- skos__historyNote mesh__D014233 Acids %28%1966-1970%29%
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D014233 1996
% 223.37/223.58  |- mesh__dateEstablished mesh__D014233 1972-01-01
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D014233 2005
% 223.37/223.58  |- skos__broader mesh__D014233smesh__D000144
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D014233 1998
% 223.37/223.58  |- skos__annotation mesh__D014233
% 223.37/223.58       /metab is probably TRICARBOXYLIC ACID CYCLE   
% 223.37/223.58  |- mesh__dateCreated mesh__D014233 1999-01-01
% 223.37/223.58  |- skos__scopeNote mesh__D014233
% 223.37/223.58       Organic compounds that are acyclic and contain three acid groups. A member of this class is citric acid which is the first product formed by reaction of pyruvate and oxaloacetate. %28%From Lehninger, Principles of Biochemistry, 1982, p443%29%%A%    
% 223.37/223.58  |- mesh__publicMeSHNote mesh__D014233 72; was ACIDS, TRICARBOXYLIC 1971   
% 223.37/223.58  |- skos__prefLabel mesh__D014233 Tricarboxylic Acids
% 223.37/223.58  |- mesh__dateRevised mesh__D014233 1995-05-18
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D014233 2002
% 223.37/223.58  |- mesh__historyNote mesh__D014233 72; was ACIDS, TRICARBOXYLIC 1971   
% 223.37/223.58  |- rdf__type mesh__D014233sskos__Concept
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D014233 2001
% 223.37/223.58  |- mesh__recordMaintainer mesh__D014233 KEV
% 223.37/223.58  |- mesh__onlineNote mesh__D014233
% 223.37/223.58       use TRICARBOXYLIC ACIDS to search ACIDS, TRICARBOXYLIC 1971%A%  
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D014233 2004
% 223.37/223.58  |- skos__hiddenLabel mesh__D014233 Acids, Tricarboxylic
% 223.37/223.58  |- mesh__recordOriginator mesh__D014233 NLM
% 223.37/223.58  |- mesh__recordAuthorizer mesh__D014233 PLS
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D014233 1997
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D014233 2000
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D014233 2006
% 223.37/223.58  |- skos__broader mesh__D000213smesh__D002352
% 223.37/223.58  |- mesh__publicMeSHNote mesh__D000213 78   
% 223.37/223.58  |- skos__hiddenLabel mesh__D000213 Myristoyl ACP
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D000213 2004
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D000213 1996
% 223.37/223.58  |- mesh__recordOriginator mesh__D000213 RLS
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D000213 2003
% 223.37/223.58  |- mesh__recordAuthorizer mesh__D000213 PLS
% 223.37/223.58  |- mesh__historyNote mesh__D000213 78   
% 223.37/223.58  |- skos__annotation mesh__D000213 /biosyn /physiol permitted   
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D000213 2002
% 223.37/223.58  |- skos__scopeNote mesh__D000213
% 223.37/223.58       Consists of a polypeptide chain and 4%27%-phosphopantetheine linked to a serine residue by a phosphodiester bond. Acyl groups are bound as thiol esters to the pantothenyl group. Acyl carrier protein is involved in every step of fatty acid synthesis by the cytoplasmic system.%A%    
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D000213 1995
% 223.37/223.58  |- mesh__dateEstablished mesh__D000213 1978-01-01
% 223.37/223.58  |- skos__historyNote mesh__D000213 Carrier Proteins %28%1971-1977%29%
% 223.37/223.58  |- mesh__recordMaintainer mesh__D000213 TAP
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D000213 2001
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D000213 1999
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D000213 1994
% 223.37/223.58  |- skos__hiddenLabel mesh__D000213 Carrier Protein, Acyl
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D000213 2006
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D000213 2000
% 223.37/223.58  |- mesh__dateRevised mesh__D000213 1992-05-22
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D000213 1993
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D000213 1998
% 223.37/223.58  |- mesh__dateCreated mesh__D000213 1977-05-20
% 223.37/223.58  |- skos__hiddenLabel mesh__D000213 Protein, Acyl Carrier
% 223.37/223.58  |- rdf__type mesh__D000213sskos__Concept
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D000213 2005
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D000213 1997
% 223.37/223.58  |- skos__prefLabel mesh__D000213 Acyl Carrier Protein
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D038681 2006
% 223.37/223.58  |- mesh__historyNote mesh__D038681
% 223.37/223.58       2003; use FOLLISTATIN %28%NM%29% 1988-2002   
% 223.37/223.58  |- mesh__publicMeSHNote mesh__D038681
% 223.37/223.58       2003; was indexed under FOLLISTATIN %28%NM%29% 1988-2002   
% 223.37/223.58  |- skos__historyNote mesh__D038681 Glycoproteins %28%1987-2001%29%
% 223.37/223.58  |- skos__altLabel mesh__D038681 Activin-Binding Protein
% 223.37/223.58  |- skos__historyNote mesh__D038681 Activins %28%2002%29%
% 223.37/223.58  |- rdf__type mesh__D038681sskos__Concept
% 223.37/223.58  |- mesh__dateCreated mesh__D038681 2002-07-02
% 223.37/223.58  |- mesh__recordMaintainer mesh__D038681 jmp
% 223.37/223.58  |- mesh__dateRevised mesh__D038681 2004-07-07
% 223.37/223.58  |- skos__broader mesh__D038681smesh__D002352
% 223.37/223.58  |- mesh__recordAuthorizer mesh__D038681 sjn
% 223.37/223.58  |- skos__prefLabel mesh__D038681 Follistatin
% 223.37/223.58  |- mesh__dateEstablished mesh__D038681 2003-01-01
% 223.37/223.58  |- skos__hiddenLabel mesh__D038681 Activin Binding Protein
% 223.37/223.58  |- mesh__recordOriginator mesh__D038681 lkt
% 223.37/223.58  |- skos__historyNote mesh__D038681 Inhibins %28%1987-2001%29%
% 223.37/223.58  |- skos__scopeNote mesh__D038681
% 223.37/223.58       A broadly distributed protein that binds directly to ACTIVINS. It functions as an activin antagonist, inhibits FOLLICLE STIMULATING HORMONE secretion, regulates CELL DIFFERENTIATION, and plays an important role in embryogenesis. Follistatin is a single glycosylated polypeptide chain of approximately 37-kDa and is not a member of the inhibin family %28%INHIBINS%29%. Follistatin also binds and neutralizes many members of the TRANSFORMING GROWTH FACTOR BETA family.%A%    
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D038681 2005
% 223.37/223.58  |- skos__hiddenLabel mesh__D013939
% 223.37/223.58       Platelet Derived Endothelial Cell Growth Factor
% 223.37/223.58  |- skos__altLabel mesh__D013939 Gliostatin
% 223.37/223.58  |- rdf__type mesh__D013939sskos__Concept
% 223.37/223.58  |- skos__prefLabel mesh__D013939 Thymidine Phosphorylase
% 223.37/223.58  |- mesh__dateCreated mesh__D013939 1974-11-19
% 223.37/223.58  |- skos__historyNote mesh__D013939 Phosphates %28%1973-1974%29%
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D013939 2005
% 223.37/223.58  |- skos__altLabel mesh__D013939 PD-ECGF
% 223.37/223.58  |- skos__historyNote mesh__D013939 Pentosyltransferases %28%1973-1974%29%
% 223.37/223.58  |- skos__altLabel mesh__D013939 Pyrimidine Phosphorylase
% 223.37/223.58  |- skos__hiddenLabel mesh__D013939 Phosphorylase, Pyrimidine
% 223.37/223.58  |- mesh__dateEstablished mesh__D013939 1991-01-01
% 223.37/223.58  |- skos__broader mesh__D013939smesh__D010430
% 223.37/223.58  |- skos__historyNote mesh__D013939 Thymidine %28%1973-1974%29%
% 223.37/223.58  |- mesh__recordMaintainer mesh__D013939 ssb
% 223.37/223.58  |- skos__scopeNote mesh__D013939
% 223.37/223.58       The enzyme catalyzing the transfer of 2-deoxy-D-ribose from thymidine to orthophosphate, thereby liberating thymidine. EC 2.4.2.4.%A%    
% 223.37/223.58  |- skos__altLabel mesh__D013939
% 223.37/223.58       Platelet-Derived Endothelial Cell Growth Factor
% 223.37/223.58  |- mesh__historyNote mesh__D013939
% 223.37/223.58       91%28%75%29%; for GLIOSTATIN use THYMIDINE PHOSPHORYLASE %28%NM%29% 1992-98%A%  
% 223.37/223.58  |- mesh__publicMeSHNote mesh__D013939
% 223.37/223.58       91; see PENTOSYLTRANSFERASES 1975-90; GLIOSTATIN was indexed under NERVE TISSUE PROTEINS 1992-98%A%  
% 223.37/223.58  |- skos__hiddenLabel mesh__D013939 Phosphorylase, Thymidine
% 223.37/223.58  |- mesh__recordOriginator mesh__D013939 NLM
% 223.37/223.58  |- mesh__recordAuthorizer mesh__D013939 sjn
% 223.37/223.58  |- mesh__dateRevised mesh__D013939 2003-07-09
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D013939 2004
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D013939 2006
% 223.37/223.58  |- skos__altLabel mesh__D024661 Inwardly Rectifying Postassium Channels
% 223.37/223.58  |- skos__broader mesh__D024661smesh__D015221
% 223.37/223.58  |- mesh__historyNote mesh__D024661 2002   
% 223.37/223.58  |- skos__altLabel mesh__D024661 Inwardly Rectifying Potassium Channel
% 223.37/223.58  |- skos__hiddenLabel mesh__D024661 Channel, IRK1
% 223.37/223.58  |- skos__altLabel mesh__D024661 Inward Rectifier Potassium Channels
% 223.37/223.58  |- skos__altLabel mesh__D024661 Inward Rectifier K+ Channels
% 223.37/223.58  |- mesh__dateEstablished mesh__D024661 2002-01-01
% 223.37/223.58  |- skos__altLabel mesh__D024661 Potassium Channel, Inwardly Rectifying
% 223.37/223.58  |- skos__prefLabel mesh__D024661 Potassium Channels, Inwardly Rectifying
% 223.37/223.58  |- skos__altLabel mesh__D024661 Inward Rectifier Potassium Channel
% 223.37/223.58  |- mesh__recordMaintainer mesh__D024661 jmp
% 223.37/223.58  |- skos__altLabel mesh__D024661 K+ Channels, Inwardly Rectifying
% 223.37/223.58  |- mesh__recordOriginator mesh__D024661 ags
% 223.37/223.58  |- mesh__recordAuthorizer mesh__D024661 sjn
% 223.37/223.58  |- mesh__dateRevised mesh__D024661 2005-06-30
% 223.37/223.58  |- mesh__activeMeSHYear mesh__D024661 2006
% 223.37/223.58  |- skos__scopeNote mesh__D024661
% 223.37/223.58       Potassium channels where the flow of K+ ions into the cell is greater than the outward flow.%A%    
% 223.37/223.58  |- mesh__dateCreated mesh__D024661 2001-07-25
% 223.37/223.58  |- skos__altLabel mesh__D024661 Inward Rectifier K+ Channel
% 223.37/223.58  |- skos__altLabel mesh__D024661 IRK1 Channel
% 223.37/223.58  |- rdf__type mesh__D024661sskos__Concept
% 223.37/223.58  |- mesh__publicMeSHNote mesh__D024661
% 223.37/223.58       2002; INWARD RECTIFIER POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, INWARDLY RECTIFYING 2003-2005, POTASSIUM CHANNELS 1999-2002, %26% MEMBRANE PROTEINS 1993%A%  
% 223.37/223.59  |- skos__historyNote mesh__D024661 Potassium Channels %28%1989-2001%29%
% 223.37/223.59  |- rdf__type mesh__D010641sskos__Concept
% 223.37/223.59  |- skos__related mesh__D010641smesh__D013008
% 223.37/223.59  |- mesh__publicMeSHNote mesh__D010641 68   
% 223.37/223.59  |- mesh__dateRevised mesh__D010641 2002-07-03
% 223.37/223.59  |- mesh__recordAuthorizer mesh__D010641 sjn
% 223.37/223.59  |- mesh__dateEstablished mesh__D010641 1968-01-01
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D010641 2006
% 223.37/223.59  |- skos__broader mesh__D010641smesh__D040341
% 223.37/223.59  |- skos__scopeNote mesh__D010641
% 223.37/223.59       The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.%A%    
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D010641 2004
% 223.37/223.59  |- mesh__recordMaintainer mesh__D010641 nns
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D010641 2005
% 223.37/223.59  |- mesh__historyNote mesh__D010641 68   
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D010641 2003
% 223.37/223.59  |- skos__historyNote mesh__D010641 Genetics %28%1966-1967%29%
% 223.37/223.59  |- mesh__recordOriginator mesh__D010641 NLM
% 223.37/223.59  |- skos__hiddenLabel mesh__D010641 Phenotypes
% 223.37/223.59  |- mesh__dateCreated mesh__D010641 1999-01-01
% 223.37/223.59  |- skos__prefLabel mesh__D010641 Phenotype
% 223.37/223.59  |- rdf__type mesh__D004604sskos__Concept
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D004604 2006
% 223.37/223.59  |- mesh__dateEstablished mesh__D004604 1991-01-01
% 223.37/223.59  |- skos__prefLabel mesh__D004604 Elephantiasis
% 223.37/223.59  |- mesh__dateRevised mesh__D004604 1994-05-24
% 223.37/223.59  |- mesh__publicMeSHNote mesh__D004604
% 223.37/223.59       91; was see under LYMPHEDEMA 1975-90; was see FILARIASIS %26% LYMPHEDEMA 1963-74%A%  
% 223.37/223.59  |- mesh__recordOriginator mesh__D004604 NLM
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D004604 1995
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D004604 1996
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D004604 2002
% 223.37/223.59  |- mesh__recordMaintainer mesh__D004604 TGC
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D004604 1997
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D004604 2003
% 223.37/223.59  |- skos__scopeNote mesh__D004604
% 223.37/223.59       Hypertrophy and thickening of the tissues from any cause. Elephantiasis caused by filarial infection is ELEPHANTIASIS, FILARIAL. %28%From Dorland, 27th ed%29%%A%    
% 223.37/223.59  |- skos__annotation mesh__D004604
% 223.37/223.59       a form of lymphedema; for elephantiasis of any cause other than filarial; ELEPHANTIASIS, FILARIAL is available%A%  
% 223.37/223.59  |- mesh__historyNote mesh__D004604
% 223.37/223.59       91%28%75%29%; was see under LYMPHEDEMA 1975-90; was see FILARIASIS %26% LYMPHEDEMA 1963-74%A%  
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D004604 1998
% 223.37/223.59  |- mesh__recordAuthorizer mesh__D004604 PLS
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D004604 2004
% 223.37/223.59  |- skos__hiddenLabel mesh__D004604 Elephantiases
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D004604 2000
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D004604 1999
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D004604 2005
% 223.37/223.59  |- mesh__onlineNote mesh__D004604
% 223.37/223.59       search FILARIASIS %26% LYMPHEDEMA 1966-74   
% 223.37/223.59  |- mesh__dateCreated mesh__D004604 1999-01-01
% 223.37/223.59  |- skos__broader mesh__D004604smesh__D008209
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D004604 2001
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D009898 2005
% 223.37/223.59  |- skos__hiddenLabel mesh__D009898 Disks, Optic
% 223.37/223.59  |- skos__prefLabel mesh__D009898 Optic Disk
% 223.37/223.59  |- skos__broader mesh__D009898smesh__D012160
% 223.37/223.59  |- skos__hiddenLabel mesh__D009898 Nerve Head, Optic
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D009898 2006
% 223.37/223.59  |- skos__hiddenLabel mesh__D009898 Head, Optic Nerve
% 223.37/223.59  |- skos__altLabel mesh__D009898 Optic Papilla
% 223.37/223.59  |- skos__hiddenLabel mesh__D009898 Spots, Blind
% 223.37/223.59  |- skos__hiddenLabel mesh__D009898 Optic Disks
% 223.37/223.59  |- mesh__publicMeSHNote mesh__D009898
% 223.37/223.59       78; was see under OPTIC NERVE 1975-77   
% 223.37/223.59  |- skos__scopeNote mesh__D009898
% 223.37/223.59       The portion of the optic nerve seen in the fundus with the ophthalmoscope. It is formed by the meeting of all the retinal ganglion cell axons as they enter the optic nerve.%A%    
% 223.37/223.59  |- skos__hiddenLabel mesh__D009898 Nerve Heads, Optic
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D009898 2003
% 223.37/223.59  |- mesh__dateCreated mesh__D009898 1974-12-12
% 223.37/223.59  |- skos__hiddenLabel mesh__D009898 Papilla, Optic
% 223.37/223.59  |- skos__broader mesh__D009898smesh__D009900
% 223.37/223.59  |- mesh__dateRevised mesh__D009898 2001-07-25
% 223.37/223.59  |- rdf__type mesh__D009898sskos__Concept
% 223.37/223.59  |- mesh__recordAuthorizer mesh__D009898 sjn
% 223.37/223.59  |- skos__hiddenLabel mesh__D009898 Papillas, Optic
% 223.37/223.59  |- skos__hiddenLabel mesh__D009898 Optic Nerve Heads
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D009898 2004
% 223.37/223.59  |- skos__hiddenLabel mesh__D009898 Optic Papillas
% 223.37/223.59  |- mesh__recordOriginator mesh__D009898 NLM
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D009898 2002
% 223.37/223.59  |- skos__hiddenLabel mesh__D009898 Heads, Optic Nerve
% 223.37/223.59  |- skos__hiddenLabel mesh__D009898 Disk, Optic
% 223.37/223.59  |- skos__hiddenLabel mesh__D009898 Blind Spots
% 223.37/223.59  |- mesh__recordMaintainer mesh__D009898 ags
% 223.37/223.59  |- skos__hiddenLabel mesh__D009898 Spot, Blind
% 223.37/223.59  |- skos__annotation mesh__D009898
% 223.37/223.59       neopl: coord IM with OPTIC NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%; do not confuse %22%optic cup%22% %28% = EYE /embryol%29% with %22%optic disk cupping%22% %28% = OPTIC DISK + GLAUCOMA%29%; inflammation = RETINITIS + OPTIC NEURITIS%A%  
% 223.37/223.59  |- skos__altLabel mesh__D009898 Optic Nerve Head
% 223.37/223.59  |- mesh__dateEstablished mesh__D009898 1977-01-01
% 223.37/223.59  |- mesh__historyNote mesh__D009898
% 223.37/223.59       78%28%75%29%; was see under OPTIC NERVE 1975-77   
% 223.37/223.59  |- mesh__recordOriginator mesh__D020271 KEV
% 223.37/223.59  |- skos__hiddenLabel mesh__D020271 Neurodegenerative Hereditary Diseases
% 223.37/223.59  |- skos__hiddenLabel mesh__D020271 Hereditary Disease, Neurodegenerative
% 223.37/223.59  |- skos__altLabel mesh__D020271
% 223.37/223.59       Nervous System Degenerative Hereditary Diseases
% 223.37/223.59  |- skos__hiddenLabel mesh__D020271 Diseases, Neurodegenerative Hereditary
% 223.37/223.59  |- rdf__type mesh__D020271sskos__Concept
% 223.37/223.59  |- skos__hiddenLabel mesh__D020271 Disease, Neurodegenerative Hereditary
% 223.37/223.59  |- skos__hiddenLabel mesh__D020271 Disease, Hereditary Neurodegenerative
% 223.37/223.59  |- skos__altLabel mesh__D020271
% 223.37/223.59       Degenerative Hereditary Disorders, Nervous System
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D020271 2006
% 223.37/223.59  |- skos__altLabel mesh__D020271
% 223.37/223.59       Hereditary-Degenerative Disorders, Nervous System
% 223.37/223.59  |- skos__altLabel mesh__D020271 Hereditary Diseases, Neurodegenerative
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D020271 2002
% 223.37/223.59  |- skos__altLabel mesh__D020271
% 223.37/223.59       Nervous System Diseases, Degenerative, Hereditary
% 223.37/223.59  |- mesh__recordAuthorizer mesh__D020271 sjn
% 223.37/223.59  |- skos__hiddenLabel mesh__D020271 Neurodegenerative Hereditary Disease
% 223.37/223.59  |- skos__altLabel mesh__D020271 Hereditary Neurodegenerative Diseases
% 223.37/223.59  |- skos__altLabel mesh__D020271
% 223.37/223.59       Degenerative Disease, Nervous System, Hereditary
% 223.37/223.59  |- skos__hiddenLabel mesh__D020271 Hereditary Neurodegenerative Disease
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D020271 2003
% 223.37/223.59  |- mesh__dateEstablished mesh__D020271 2000-01-01
% 223.37/223.59  |- mesh__dateCreated mesh__D020271 1999-11-04
% 223.37/223.59  |- skos__hiddenLabel mesh__D020271 Neurodegenerative Disease, Hereditary
% 223.37/223.59  |- skos__altLabel mesh__D020271
% 223.37/223.59       Degenerative Hereditary Diseases, Nervous System
% 223.37/223.59  |- skos__hiddenLabel mesh__D020271
% 223.37/223.59       Hereditary Degenerative Disorders, Nervous System
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D020271 2004
% 223.37/223.59  |- mesh__publicMeSHNote mesh__D020271 2000   
% 223.37/223.59  |- mesh__historyNote mesh__D020271 2000   
% 223.37/223.59  |- skos__hiddenLabel mesh__D020271 Diseases, Hereditary Neurodegenerative
% 223.37/223.59  |- mesh__recordMaintainer mesh__D020271 nns
% 223.37/223.59  |- skos__broader mesh__D020271smesh__D030342
% 223.37/223.59  |- skos__altLabel mesh__D020271
% 223.37/223.59       Nervous System Hereditary Degenerative Diseases
% 223.37/223.59  |- skos__altLabel mesh__D020271 Neurodegenerative Diseases, Hereditary
% 223.37/223.59  |- skos__broader mesh__D020271smesh__D019636
% 223.37/223.59  |- skos__prefLabel mesh__D020271
% 223.37/223.59       Heredodegenerative Disorders, Nervous System
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D020271 2005
% 223.37/223.59  |- skos__scopeNote mesh__D020271
% 223.37/223.59       Inherited disorders characterized by progressive atrophy and dysfunction of anatomically or physiologically related neurologic systems.%A%    
% 223.37/223.59  |- mesh__dateRevised mesh__D020271 2001-07-25
% 223.37/223.59  |- mesh__recordOriginator mesh__D014234 NLM
% 223.37/223.59  |- skos__scopeNote mesh__D014234
% 223.37/223.59       A genus of parasitic nematodes that causes TRICHINOSIS in man and carnivores.%A%    
% 223.37/223.59  |- skos__broader mesh__D014234smesh__D014259
% 223.37/223.59  |- mesh__dateRevised mesh__D014234 2003-07-09
% 223.37/223.59  |- skos__altLabel mesh__D014234 Trichina
% 223.37/223.59  |- rdf__type mesh__D014234sskos__Concept
% 223.37/223.59  |- mesh__recordMaintainer mesh__D014234 ags
% 223.37/223.59  |- mesh__recordAuthorizer mesh__D014234 sjn
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D014234 2004
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D014234 2006
% 223.37/223.59  |- skos__prefLabel mesh__D014234 Trichinella
% 223.37/223.59  |- skos__annotation mesh__D014234
% 223.37/223.59       a genus of nematodes; infection = TRICHINOSIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D014234 2005
% 223.37/223.59  |- mesh__dateCreated mesh__D014234 1999-01-01
% 223.37/223.59  |- skos__broader mesh__D000214smesh__D003065
% 223.37/223.59  |- skos__altLabel mesh__D000214 Fatty Acyl CoA
% 223.37/223.59  |- skos__scopeNote mesh__D000214
% 223.37/223.59       S-Acyl coenzyme A. Fatty acid coenzyme A derivatives that are involved in the biosynthesis and oxidation of fatty acids as well as in ceramide formation.%A%    
% 223.37/223.59  |- skos__hiddenLabel mesh__D000214 Acyl CoA, Long-Chain
% 223.37/223.59  |- skos__hiddenLabel mesh__D000214 Long Chain Acyl CoA
% 223.37/223.59  |- mesh__dateEstablished mesh__D000214 1978-01-01
% 223.37/223.59  |- mesh__dateRevised mesh__D000214 2003-07-09
% 223.37/223.59  |- skos__annotation mesh__D000214 do not confuse with ACETYL COENZYME A   
% 223.37/223.59  |- skos__hiddenLabel mesh__D000214 Coenzyme A, Acyl
% 223.37/223.59  |- skos__altLabel mesh__D000214 Acyl CoA
% 223.37/223.59  |- mesh__recordOriginator mesh__D000214 RLS
% 223.37/223.59  |- skos__hiddenLabel mesh__D000214 Acyl CoA, Fatty
% 223.37/223.59  |- skos__hiddenLabel mesh__D000214 CoA, Long-Chain Acyl
% 223.37/223.59  |- skos__prefLabel mesh__D000214 Acyl Coenzyme A
% 223.37/223.59  |- mesh__historyNote mesh__D000214 78   
% 223.37/223.59  |- skos__hiddenLabel mesh__D000214 CoA, Acyl
% 223.37/223.59  |- skos__altLabel mesh__D000214 Long-Chain Acyl CoA
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D000214 2006
% 223.37/223.59  |- mesh__dateCreated mesh__D000214 1977-05-20
% 223.37/223.59  |- rdf__type mesh__D000214sskos__Concept
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D000214 2005
% 223.37/223.59  |- mesh__recordAuthorizer mesh__D000214 sjn
% 223.37/223.59  |- skos__hiddenLabel mesh__D000214 CoA, Fatty Acyl
% 223.37/223.59  |- skos__historyNote mesh__D000214 Coenzyme A %28%1966-1977%29%
% 223.37/223.59  |- mesh__publicMeSHNote mesh__D000214 78   
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D000214 2004
% 223.37/223.59  |- mesh__recordMaintainer mesh__D000214 ssb
% 223.37/223.59  |- skos__hiddenLabel mesh__D018625 Microscopies, Atomic Force
% 223.37/223.59  |- skos__hiddenLabel mesh__D018625 Microscopies, Force
% 223.37/223.59  |- skos__hiddenLabel mesh__D018625 Microscopies, Scanning Force
% 223.37/223.59  |- skos__hiddenLabel mesh__D018625 Microscopy, Scanning Force
% 223.37/223.59  |- mesh__dateCreated mesh__D018625 1994-04-16
% 223.37/223.59  |- skos__scopeNote mesh__D018625
% 223.37/223.59       A type of scanning probe microscopy in which a probe systematically rides across the surface of a sample being scanned in a raster pattern. The vertical position is recorded as a spring attached to the probe rises and falls in response to peaks and valleys on the surface. These deflections produce a topographic map of the sample.%A%    
% 223.37/223.59  |- skos__historyNote mesh__D018625
% 223.37/223.59       Microscopy, Scanning Tunneling %28%1988-1994%29%
% 223.37/223.59  |- skos__hiddenLabel mesh__D018625 Force Microscopy, Scanning
% 223.37/223.59  |- mesh__publicMeSHNote mesh__D018625 95   
% 223.37/223.59  |- skos__hiddenLabel mesh__D018625 Force Microscopies, Scanning
% 223.37/223.59  |- skos__altLabel mesh__D018625 Force Microscopy
% 223.37/223.59  |- skos__prefLabel mesh__D018625 Microscopy, Atomic Force
% 223.37/223.59  |- mesh__dateRevised mesh__D018625 2004-07-07
% 223.37/223.59  |- mesh__recordMaintainer mesh__D018625 nns
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D018625 2006
% 223.37/223.59  |- mesh__recordAuthorizer mesh__D018625 sjn
% 223.37/223.59  |- mesh__dateEstablished mesh__D018625 1995-01-01
% 223.37/223.59  |- mesh__historyNote mesh__D018625 95   
% 223.37/223.59  |- skos__hiddenLabel mesh__D018625 Force Microscopies
% 223.37/223.59  |- skos__altLabel mesh__D018625 Scanning Force Microscopy
% 223.37/223.59  |- mesh__recordOriginator mesh__D018625 PXP
% 223.37/223.59  |- skos__altLabel mesh__D018625 Atomic Force Microscopy
% 223.37/223.59  |- skos__hiddenLabel mesh__D018625 Atomic Force Microscopies
% 223.37/223.59  |- skos__hiddenLabel mesh__D018625 Scanning Force Microscopies
% 223.37/223.59  |- skos__broader mesh__D018625smesh__D020527
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D018625 2005
% 223.37/223.59  |- skos__hiddenLabel mesh__D018625 Microscopy, Force
% 223.37/223.59  |- rdf__type mesh__D018625sskos__Concept
% 223.37/223.59  |- skos__related mesh__D018625smesh__D016252
% 223.37/223.59  |- skos__historyNote mesh__D018625 Microscopy %28%1988-1994%29%
% 223.37/223.59  |- skos__broader mesh__D010642smesh__D006016
% 223.37/223.59  |- mesh__publicMeSHNote mesh__D010642
% 223.37/223.59       91; was see under GLYCOLATES 1975-90   
% 223.37/223.59  |- skos__prefLabel mesh__D010642 Phenoxyacetates
% 223.37/223.59  |- mesh__recordMaintainer mesh__D010642 TAP
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D010642 2006
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D010642 2001
% 223.37/223.59  |- mesh__recordAuthorizer mesh__D010642 PLS
% 223.37/223.59  |- mesh__recordOriginator mesh__D010642 NLM
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D010642 2004
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D010642 2005
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D010642 2000
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D010642 2003
% 223.37/223.59  |- mesh__onlineNote mesh__D010642 search GLYCOLATES 1966-74   
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D010642 1995
% 223.37/223.59  |- mesh__dateCreated mesh__D010642 1999-01-01
% 223.37/223.59  |- mesh__dateRevised mesh__D010642 1992-05-19
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D010642 1993
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D010642 1999
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D010642 1994
% 223.37/223.59  |- rdf__type mesh__D010642sskos__Concept
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D010642 1997
% 223.37/223.59  |- mesh__dateEstablished mesh__D010642 1991-01-01
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D010642 2002
% 223.37/223.59  |- mesh__historyNote mesh__D010642
% 223.37/223.59       91%28%75%29%; was see under GLYCOLATES 1975-90   
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D010642 1998
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D010642 1996
% 223.37/223.59  |- skos__annotation mesh__D004605
% 223.37/223.59       specify BRUGIA or species or WUCHERERIA BANCROFTI %28%IM%29% if pertinent; drug ther: consider FILARICIDES%A%  
% 223.37/223.59  |- skos__hiddenLabel mesh__D004605 Filarial Elephantiases
% 223.37/223.59  |- mesh__historyNote mesh__D004605
% 223.37/223.59       91%28%87%29%; was see under FILARIASIS 1988-90; was see under LYMPHEDEMA 1987%A%  
% 223.37/223.59  |- skos__historyNote mesh__D004605 Filariasis %28%1966-1986%29%
% 223.37/223.59  |- skos__historyNote mesh__D004605 Elephantiasis %28%1975-1986%29%
% 223.37/223.59  |- mesh__dateCreated mesh__D004605 1986-03-27
% 223.37/223.59  |- skos__hiddenLabel mesh__D004605 Filariases, Lymphatic
% 223.37/223.59  |- skos__altLabel mesh__D004605 Filarial Elephantiasis
% 223.37/223.59  |- skos__altLabel mesh__D004605 Filariasis, Lymphatic
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D004605 2006
% 223.37/223.59  |- skos__altLabel mesh__D004605 Bancroftian Elephantiasis
% 223.37/223.59  |- rdf__type mesh__D004605sskos__Concept
% 223.37/223.59  |- skos__hiddenLabel mesh__D004605 Elephantiases, Bancroftian
% 223.37/223.59  |- mesh__recordAuthorizer mesh__D004605 sjn
% 223.37/223.59  |- mesh__recordMaintainer mesh__D004605 sjn
% 223.37/223.59  |- skos__scopeNote mesh__D004605
% 223.37/223.59       Parasitic infestation of the human lymphatic system by WUCHERERIA BANCROFTI or BRUGIA MALAYI. It is also called lymphatic filariasis.%A%    
% 223.37/223.59  |- skos__altLabel mesh__D004605 Lymphatic Filariasis
% 223.37/223.59  |- skos__broader mesh__D004605smesh__D004604
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D004605 2005
% 223.37/223.59  |- mesh__dateEstablished mesh__D004605 1991-01-01
% 223.37/223.59  |- skos__broader mesh__D004605smesh__D005368
% 223.37/223.59  |- mesh__dateRevised mesh__D004605 2004-07-13
% 223.37/223.59  |- skos__prefLabel mesh__D004605 Elephantiasis, Filarial
% 223.37/223.59  |- skos__hiddenLabel mesh__D004605 Elephantiases, Filarial
% 223.37/223.59  |- mesh__recordOriginator mesh__D004605 RC
% 223.37/223.59  |- skos__hiddenLabel mesh__D004605 Bancroftian Elephantiases
% 223.37/223.59  |- skos__altLabel mesh__D004605 Elephantiasis, Bancroftian
% 223.37/223.59  |- mesh__publicMeSHNote mesh__D004605
% 223.37/223.59       91; was see under FILARIASIS 1988-90; was see under LYMPHEDEMA 1987%A%  
% 223.37/223.59  |- skos__hiddenLabel mesh__D004605 Lymphatic Filariases
% 223.37/223.59  |- skos__scopeNote mesh__D009899
% 223.37/223.59       In invertebrate zoology, a lateral lobe of the FOREBRAIN in certain ARTHROPODS. In vertebrate zoology, either of the corpora bigemina of non-mammalian VERTEBRATES. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1329%29%%A%    
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D009899 2006
% 223.37/223.59  |- mesh__dateEstablished mesh__D009899 1970-01-01
% 223.37/223.59  |- skos__prefLabel mesh__D009899 Optic Lobe
% 223.37/223.59  |- rdf__type mesh__D009899sskos__Concept
% 223.37/223.59  |- mesh__dateRevised mesh__D009899 2003-07-09
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D009899 2004
% 223.37/223.59  |- skos__broader mesh__D009899smesh__D000825
% 223.37/223.59  |- skos__hiddenLabel mesh__D009899 Lobes, Optic
% 223.37/223.59  |- skos__hiddenLabel mesh__D009899 Lobe, Optic
% 223.37/223.59  |- mesh__historyNote mesh__D009899 70%28%64%29%   
% 223.37/223.59  |- mesh__dateCreated mesh__D009899 1999-01-01
% 223.37/223.59  |- skos__altLabel mesh__D009899 Corpora Bigemina
% 223.37/223.59  |- skos__hiddenLabel mesh__D009899 Optic Lobes
% 223.37/223.59  |- mesh__recordMaintainer mesh__D009899 ags
% 223.37/223.59  |- skos__hiddenLabel mesh__D009899 Bigemina, Corpora
% 223.37/223.59  |- mesh__recordAuthorizer mesh__D009899 sjn
% 223.37/223.59  |- skos__annotation mesh__D009899
% 223.37/223.59       in invertebrates and non-mammalian vertebrates; do not confuse with optic lobe in humans and other mammals %28% = CORPORA QUADRIGEMINA%29%%A%  
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D009899 2005
% 223.37/223.59  |- mesh__publicMeSHNote mesh__D009899 70   
% 223.37/223.59  |- mesh__recordOriginator mesh__D009899 NLM
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D042724 2006
% 223.37/223.59  |- mesh__historyNote mesh__D042724 2004   
% 223.37/223.59  |- skos__prefLabel mesh__D042724 Estrogens, Esterified %28%USP%29%
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D042724 2005
% 223.37/223.59  |- mesh__dateEstablished mesh__D042724 2004-01-01
% 223.37/223.59  |- skos__altLabel mesh__D042724 Esterified Estrogens %28%USP%29%
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D042724 2004
% 223.37/223.59  |- skos__broader mesh__D042724smesh__D045166
% 223.37/223.59  |- mesh__dateCreated mesh__D042724 2003-07-09
% 223.37/223.59  |- rdf__type mesh__D042724sskos__Concept
% 223.37/223.59  |- mesh__publicMeSHNote mesh__D042724 2004   
% 223.37/223.59  |- skos__scopeNote mesh__D042724
% 223.37/223.59       A pharmaceutical preparation containing a mixture of esterified estrogens derived from estrogen sulfates, principally from ESTRONE sulfate. Esterified estrogen content should be 75-85%25% of the estrone sulfate and 6-15%25% of the EQUILIN sulfate.%A%    
% 223.37/223.59  |- skos__historyNote mesh__D042724 Estrogens, Conjugated %28%1975-2003%29%
% 223.37/223.59  |- skos__altLabel mesh__D014235 Trichinelliasis
% 223.37/223.59  |- mesh__recordAuthorizer mesh__D014235 PLS
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D014235 2000
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D014235 2001
% 223.37/223.59  |- mesh__recordMaintainer mesh__D014235 TGC
% 223.37/223.59  |- skos__annotation mesh__D014235
% 223.37/223.59       nematode infect caused by Trichina or Trichinella: do not confuse with TRICHURIASIS, caused by Trichuris%A%  
% 223.37/223.59  |- rdf__type mesh__D014235sskos__Concept
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D014235 2003
% 223.37/223.59  |- skos__prefLabel mesh__D014235 Trichinosis
% 223.37/223.59  |- skos__hiddenLabel mesh__D014235 Trichinoses
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D014235 1996
% 223.37/223.59  |- mesh__dateRevised mesh__D014235 1993-06-03
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D014235 2005
% 223.37/223.59  |- mesh__recordOriginator mesh__D014235 NLM
% 223.37/223.59  |- mesh__dateCreated mesh__D014235 1999-01-01
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D014235 1998
% 223.37/223.59  |- skos__broader mesh__D014235smesh__D017189
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D014235 2004
% 223.37/223.59  |- skos__scopeNote mesh__D014235
% 223.37/223.59       A disease due to infection with TRICHINELLA SPIRALIS. It is caused by eating undercooked meat, usually pork.%A%    
% 223.37/223.59  |- skos__hiddenLabel mesh__D014235 Trichinelliases
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D014235 1997
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D014235 2002
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D014235 2006
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D014235 1994
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D014235 1999
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D014235 1995
% 223.37/223.59  |- mesh__recordOriginator mesh__D000215 NLM
% 223.37/223.59  |- mesh__publicMeSHNote mesh__D000215 74   
% 223.37/223.59  |- skos__historyNote mesh__D000215 Chemistry, Organic %28%1966-1970%29%
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D000215 2002
% 223.37/223.59  |- mesh__recordAuthorizer mesh__D000215 sjn
% 223.37/223.59  |- skos__prefLabel mesh__D000215 Acylation
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D000215 2006
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D000215 2001
% 223.37/223.59  |- mesh__dateCreated mesh__D000215 1999-01-01
% 223.37/223.59  |- rdf__type mesh__D000215sskos__Concept
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D000215 2005
% 223.37/223.59  |- skos__annotation mesh__D000215
% 223.37/223.59       almost never IM; enzymatic acylation: coord NIM with ACYLTRANSFERASES %28%IM%29% + substrate %28%NIM%29% or specific acyltransferase %28%IM%29%; ACETYLATION %26% ACETYLTRANSFERASES are also available%A%  
% 223.37/223.59  |- mesh__dateEstablished mesh__D000215 1974-01-01
% 223.37/223.59  |- mesh__dateRevised mesh__D000215 2000-06-21
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D000215 2004
% 223.37/223.59  |- skos__broader mesh__D000215smesh__D008660
% 223.37/223.59  |- mesh__historyNote mesh__D000215 74%28%71%29%   
% 223.37/223.59  |- skos__scopeNote mesh__D000215
% 223.37/223.59       The addition of an organic acid radical into a molecule.%A%    
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D000215 2003
% 223.37/223.59  |- skos__broader mesh__D000215smesh__D002625
% 223.37/223.59  |- mesh__recordMaintainer mesh__D000215 adp
% 223.37/223.59  |- skos__hiddenLabel mesh__D018626 Element, Retrovirus-like
% 223.37/223.59  |- skos__hiddenLabel mesh__D018626 Transposon, Ty1
% 223.37/223.59  |- skos__hiddenLabel mesh__D018626 Retrotransposons, MDG1
% 223.37/223.59  |- skos__broader mesh__D018626smesh__D020071
% 223.37/223.59  |- skos__related mesh__D018626smesh__D016254
% 223.37/223.59  |- mesh__recordOriginator mesh__D018626 AGS
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D018626 2006
% 223.37/223.59  |- mesh__publicMeSHNote mesh__D018626
% 223.37/223.59       99; see RETROTRANSPOSONS 1995-98; for MOBILE DISPERSED GENETIC ELEMENTS see DNA INSERTION ELEMENTS 1982-98; for TY1 TRANSPOSON see DNA INSERTION ELEMENTS 1988-98%A%  
% 223.37/223.59  |- skos__related mesh__D018626smesh__D004251
% 223.37/223.59  |- skos__prefLabel mesh__D018626 Retroelements
% 223.37/223.59  |- skos__hiddenLabel mesh__D018626 Retrotransposon
% 223.37/223.59  |- skos__hiddenLabel mesh__D018626 Ty1 Transposons
% 223.37/223.59  |- skos__hiddenLabel mesh__D018626 Retroposon
% 223.37/223.59  |- skos__hiddenLabel mesh__D018626 Retrotransposon, MDG1
% 223.37/223.59  |- mesh__recordMaintainer mesh__D018626 nns
% 223.37/223.59  |- skos__hiddenLabel mesh__D018626 Retroelement
% 223.37/223.59  |- rdf__type mesh__D018626sskos__Concept
% 223.37/223.59  |- skos__hiddenLabel mesh__D018626 Retrovirus-like Element
% 223.37/223.59  |- mesh__dateEstablished mesh__D018626 1995-01-01
% 223.37/223.59  |- mesh__recordAuthorizer mesh__D018626 sjn
% 223.37/223.59  |- skos__hiddenLabel mesh__D018626 MDG1 Retrotransposon
% 223.37/223.59  |- skos__hiddenLabel mesh__D018626 Elements, Retrovirus-like
% 223.37/223.59  |- skos__historyNote mesh__D018626 DNA Insertion Elements %28%1985-1994%29%
% 223.37/223.59  |- mesh__dateCreated mesh__D018626 1994-06-03
% 223.37/223.59  |- skos__broader mesh__D018626smesh__D004247
% 223.37/223.59  |- mesh__dateRevised mesh__D018626 2005-06-30
% 223.37/223.59  |- skos__scopeNote mesh__D018626
% 223.37/223.59       Elements that are transcribed into RNA, reverse-transcribed into DNA and then inserted into a new site in the genome. Long terminal repeats %28%LTRs%29% similar to those from retroviruses are contained in retrotransposons and retrovirus-like elements. Retroposons, such as LONG INTERSPERSED NUCLEOTIDE ELEMENTS and SHORT INTERSPERSED NUCLEOTIDE ELEMENTS do not contain LTRs.%A%    
% 223.37/223.59  |- skos__hiddenLabel mesh__D018626 Transposons, Ty1
% 223.37/223.59  |- skos__hiddenLabel mesh__D018626 Retrovirus like Elements
% 223.37/223.59  |- mesh__historyNote mesh__D018626
% 223.37/223.59       99%28%95%29%; for MOBILE DISPERSED GENETIC ELEMENTS use DNA TRANSPOSABLE ELEMENTS 1982-98; for TY1 TRANSPOSON use DNA TRANSPOSABLE ELEMENTS 1988-98%A%  
% 223.37/223.59  |- skos__hiddenLabel mesh__D010643 Hydrochloride, Phenoxybenzamine
% 223.37/223.59  |- skos__prefLabel mesh__D010643 Phenoxybenzamine
% 223.37/223.59  |- mesh__recordAuthorizer mesh__D010643 sjn
% 223.37/223.59  |- skos__altLabel mesh__D010643
% 223.37/223.59       Goldshield Brand of Phenoxybenzamine Hydrochloride
% 223.37/223.59  |- mesh__dateCreated mesh__D010643 1999-01-01
% 223.37/223.59  |- skos__altLabel mesh__D010643 Dibenzyline
% 223.37/223.59  |- mesh__recordOriginator mesh__D010643 NLM
% 223.37/223.59  |- mesh__recordMaintainer mesh__D010643 lkw
% 223.37/223.59  |- rdf__type mesh__D010643sskos__Concept
% 223.37/223.59  |- skos__altLabel mesh__D010643 Dibenylene
% 223.37/223.59  |- skos__altLabel mesh__D010643
% 223.37/223.59       esparma Brand of Phenoxybenzamine Hydrochloride
% 223.37/223.59  |- skos__scopeNote mesh__D010643
% 223.37/223.59       An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.%A%    
% 223.37/223.59  |- mesh__dateRevised mesh__D010643 2005-06-30
% 223.37/223.59  |- skos__broader mesh__D010643smesh__D005021
% 223.37/223.59  |- skos__altLabel mesh__D010643
% 223.37/223.59       Link Brand of Phenoxybenzamine Hydrochloride
% 223.37/223.59  |- skos__altLabel mesh__D010643
% 223.37/223.59       Wellspring Brand of Phenoxybenzamine Hydrochloride
% 223.37/223.59  |- skos__altLabel mesh__D010643 Dibenzyran
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D010643 2006
% 223.37/223.59  |- skos__prefLabel mesh__D004606 Elephants
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D004606 2006
% 223.37/223.59  |- skos__hiddenLabel mesh__D004606 Elephant
% 223.37/223.59  |- rdf__type mesh__D004606sskos__Concept
% 223.37/223.59  |- mesh__recordMaintainer mesh__D004606 ags
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D004606 2005
% 223.37/223.59  |- mesh__dateRevised mesh__D004606 2003-07-09
% 223.37/223.59  |- mesh__activeMeSHYear mesh__D004606 2004
% 223.37/223.59  |- mesh__dateCreated mesh__D004606 1999-01-01
% 223.37/223.59  |- skos__broader mesh__D004606smesh__D008322
% 223.37/223.59  |- mesh__recordAuthorizer mesh__D004606 sjn
% 223.37/223.59  |- mesh__recordOriginator mesh__D004606 NLM
% 223.37/223.59  |- skos__scopeNote mesh__D004606
% 223.37/223.59       Large mammals with columnar limbs, bulky bodies, and elongated snouts.  They are the only surviving members of the Proboscidea; others of which %28%mastodon%29% are extinct.  Do not confuse with the Proboscidea plant genus %28%PEDALIACEAE%29%.%A%    
% 223.37/223.59  |- mesh__recordOriginator mesh__D042725 ags
% 223.37/223.59  |- mesh__recordAuthorizer mesh__D042725 sjn
% 223.37/223.59  |- skos__annotation mesh__D042725
% 223.37/223.59       infection: coord IM with BURKHOLDERIA INFECTIONS %28%IM%29%   
% 223.37/223.59  |- skos__scopeNote mesh__D042725
% 223.37/223.59       A species of gram-negative, aerobic bacteria that acts as both a human and plant pathogen.%A%    
% 223.37/223.59  |- mesh__dateCreated mesh__D042725 2003-07-09
% 223.37/223.60  |- mesh__dateRevised mesh__D042725 2005-06-30
% 223.37/223.60  |- mesh__historyNote mesh__D042725 2004   
% 223.37/223.60  |- rdf__type mesh__D042725sskos__Concept
% 223.37/223.60  |- mesh__dateEstablished mesh__D042725 2004-01-01
% 223.37/223.60  |- skos__broader mesh__D042725smesh__D019117
% 223.37/223.60  |- mesh__recordMaintainer mesh__D042725 SYSTEM
% 223.37/223.60  |- mesh__publicMeSHNote mesh__D042725 2004   
% 223.37/223.60  |- skos__historyNote mesh__D042725 Burkholderia %28%1996-2003%29%
% 223.37/223.60  |- mesh__activeMeSHYear mesh__D042725 2006
% 223.37/223.60  |- skos__prefLabel mesh__D042725 Burkholderia gladioli
% 223.37/223.60  |- skos__altLabel mesh__D042725 Burkholderia cocovenenans
% 223.37/223.60  |- mesh__activeMeSHYear mesh__D020273 1999
% 223.37/223.60  |- mesh__publicMeSHNote mesh__D020273 99   
% 223.37/223.60  |- mesh__activeMeSHYear mesh__D020273 2003
% 223.37/223.60  |- skos__hiddenLabel mesh__D020273 Implants, Orbital
% 223.37/223.60  |- skos__historyNote mesh__D020273
% 223.37/223.60       Prostheses and Implants %28%1966-1998%29%
% 223.37/223.60  |- skos__hiddenLabel mesh__D020273 Orbital Implant
% 223.37/223.60  |- mesh__activeMeSHYear mesh__D020273 2004
% 223.37/223.60  |- skos__scopeNote mesh__D020273
% 223.37/223.60       Rounded objects made of coral, teflon, or alloplastic polymer and covered with sclera, and which are implanted in the orbit following enucleation. An artificial eye %28%EYE, ARTIFICIAL%29% is usually attached to the anterior of the orbital implant for cosmetic purposes.%A%    
% 223.37/223.60  |- skos__hiddenLabel mesh__D020273 Implant, Orbital
% 223.37/223.60  |- mesh__dateCreated mesh__D020273 1998-06-10
% 223.37/223.60  |- mesh__activeMeSHYear mesh__D020273 2005
% 223.37/223.60  |- skos__prefLabel mesh__D020273 Orbital Implants
% 223.37/223.60  |- mesh__dateEstablished mesh__D020273 1999-01-01
% 223.37/223.60  |- rdf__type mesh__D020273sskos__Concept
% 223.37/223.60  |- mesh__activeMeSHYear mesh__D020273 2006
% 223.37/223.60  |- mesh__activeMeSHYear mesh__D020273 2000
% 223.37/223.60  |- skos__broader mesh__D020273smesh__D019736
% 223.37/223.60  |- mesh__activeMeSHYear mesh__D020273 2001
% 223.37/223.60  |- mesh__historyNote mesh__D020273 99   
% 223.37/223.60  |- mesh__activeMeSHYear mesh__D020273 2002
% 223.37/223.60  |- skos__related mesh__D020273smesh__D005137
% 223.37/223.60  |- skos__scopeNote mesh__D014236
% 223.37/223.60       A organochlorophosphate cholinesterase inhibitor that is used as an insecticide for the control of flies and roaches. It is also used in anthelmintic compositions for animals. %28%From Merck, 11th ed%29%%A%    
% 223.37/223.60  |- mesh__recordAuthorizer mesh__D014236 sjn
% 223.37/223.60  |- skos__altLabel mesh__D014236 Metrifonate
% 223.37/223.60  |- rdf__type mesh__D014236sskos__Concept
% 223.37/223.60  |- skos__altLabel mesh__D014236 Trichlorphon
% 223.37/223.60  |- skos__broader mesh__D014236smesh__D010745
% 223.37/223.60  |- mesh__activeMeSHYear mesh__D014236 2005
% 223.37/223.60  |- mesh__dateCreated mesh__D014236 1999-01-01
% 223.37/223.60  |- mesh__activeMeSHYear mesh__D014236 2006
% 223.37/223.60  |- mesh__historyNote mesh__D014236 74%28%71%29%   
% 223.37/223.60  |- skos__annotation mesh__D014236 TN 111 for eff on insects   
% 223.37/223.60  |- mesh__publicMeSHNote mesh__D014236 74   
% 223.37/223.60  |- mesh__recordMaintainer mesh__D014236 ssb
% 223.37/223.60  |- skos__altLabel mesh__D014236 Chlorofos
% 223.37/223.60  |- skos__prefLabel mesh__D014236 Trichlorfon
% 223.37/223.60  |- mesh__recordOriginator mesh__D014236 NLM
% 223.37/223.60  |- mesh__dateEstablished mesh__D014236 1974-01-01
% 223.37/223.60  |- mesh__dateRevised mesh__D014236 2004-07-07
% 223.37/223.60  |- skos__historyNote mesh__D014236 Insecticides %28%1966-1971%29%
% 223.37/223.60  |- skos__altLabel mesh__D014236 Chlorophos
% 223.37/223.60  |- skos__altLabel mesh__D014236 Metriphonate
% 223.37/223.60  |- mesh__activeMeSHYear mesh__D000216 2006
% 223.37/223.60  |- skos__altLabel mesh__D000216 CMP Sialate Synthase
% 223.37/223.60  |- mesh__dateCreated mesh__D000216 1974-11-19
% 223.37/223.60  |- skos__altLabel mesh__D000216 CMP-Sialic Acid Synthetase
% 223.37/223.60  |- rdf__type mesh__D000216sskos__Concept
% 223.37/223.60  |- mesh__publicMeSHNote mesh__D000216
% 223.37/223.60       98; see ACYLNEURAMINATE CYTIDYLYLTRANSFERASE 1991-97; see NUCLEOTIDYLTRANSFERASES 1975-90%A%  
% 223.37/223.60  |- skos__historyNote mesh__D000216
% 223.37/223.60       Nucleotidyltransferases %28%1973-1974%29%
% 223.37/223.60  |- skos__hiddenLabel mesh__D000216 Synthetase, CMP-N-Acetylneuraminic Acid
% 223.37/223.60  |- skos__hiddenLabel mesh__D000216 Synthase, Cytidine 5-Monophosphosialate
% 223.37/223.60  |- skos__hiddenLabel mesh__D000216 Cytidylyltransferase, N-Acylneuraminate
% 223.37/223.60  |- mesh__activeMeSHYear mesh__D000216 2005
% 223.37/223.60  |- mesh__recordOriginator mesh__D000216 NLM
% 223.37/223.60  |- skos__hiddenLabel mesh__D000216 Synthase, CMP Sialate
% 223.37/223.60  |- skos__altLabel mesh__D000216 CMP-N-Acetylneuraminic Acid Synthetase
% 223.37/223.60  |- skos__hiddenLabel mesh__D000216 Sialate Synthase, CMP
% 223.37/223.60  |- mesh__historyNote mesh__D000216
% 223.37/223.60       98%28%75%29%; see NUCLEOTIDYLTRANSFERASES 1975-90   
% 223.37/223.60  |- skos__altLabel mesh__D000216
% 223.37/223.60       Cytidine 5%27%-Monophosphosialic Acid Synthetase
% 223.37/223.60  |- mesh__activeMeSHYear mesh__D000216 2004
% 223.37/223.60  |- skos__broader mesh__D000216smesh__D009713
% 223.37/223.60  |- mesh__recordAuthorizer mesh__D000216 sjn
% 223.37/223.60  |- skos__hiddenLabel mesh__D000216 Synthetase, CMP-Sialic Acid
% 223.37/223.60  |- skos__hiddenLabel mesh__D000216 Sialate Pyrophosphorylase, CMP
% 223.37/223.60  |- skos__hiddenLabel mesh__D000216 Cytidylyltransferase, Acylneuraminate
% 223.37/223.60  |- skos__altLabel mesh__D000216 CMP Sialate Pyrophosphorylase
% 223.37/223.60  |- skos__hiddenLabel mesh__D000216 Pyrophosphorylase, CMP Sialate
% 223.37/223.60  |- skos__hiddenLabel mesh__D000216 CMP Sialic Acid Synthetase
% 223.37/223.60  |- skos__historyNote mesh__D000216 Neuraminic Acids %28%1973-1974%29%
% 223.37/223.60  |- skos__historyNote mesh__D000216 Cytosine Nucleotides %28%1973-1974%29%
% 223.37/223.60  |- mesh__recordMaintainer mesh__D000216 ssb
% 223.37/223.60  |- skos__hiddenLabel mesh__D000216 N Acylneuraminate Cytidylyltransferase
% 223.37/223.60  |- skos__hiddenLabel mesh__D000216
% 223.37/223.60       Cytidine 5%27% Monophosphosialic Acid Synthetase
% 223.37/223.60  |- skos__altLabel mesh__D000216 Acylneuraminate Cytidylyltransferase
% 223.37/223.60  |- skos__scopeNote mesh__D000216
% 223.37/223.60       An enzyme that forms CMP-acylneuraminic acids, which donate the N-acylneuraminic acid residues to the terminal sugar residue of a ganglioside or glycoprotein. EC 2.7.7.43.%A%    
% 223.37/223.60  |- skos__prefLabel mesh__D000216 N-Acylneuraminate Cytidylyltransferase
% 223.37/223.60  |- mesh__dateRevised mesh__D000216 2003-07-09
% 223.37/223.60  |- skos__hiddenLabel mesh__D000216 CMP N Acetylneuraminic Acid Synthetase
% 223.37/223.60  |- mesh__dateEstablished mesh__D000216 1991-01-01
% 223.37/223.60  |- skos__altLabel mesh__D000216 Cytidine 5-Monophosphosialate Synthase
% 223.37/223.60  |- skos__hiddenLabel mesh__D000216 Cytidine 5 Monophosphosialate Synthase
% 223.37/223.60  |- skos__broader mesh__D010644smesh__D015110
% 223.37/223.60  |- mesh__dateRevised mesh__D010644 2005-06-30
% 223.37/223.60  |- skos__historyNote mesh__D010644 Benzyl Compounds %28%1972-1976%29%
% 223.37/223.60  |- skos__altLabel mesh__D010644 W%C3%%B6%rwag Brand of Phenprocoumon
% 223.37/223.60  |- skos__scopeNote mesh__D010644
% 223.37/223.60       Coumarin derivative that acts as a long acting oral anticoagulant.%A%    
% 223.37/223.60  |- skos__historyNote mesh__D010644 Coumarins %28%1966-1974%29%
% 223.37/223.60  |- skos__historyNote mesh__D010644 Benzene Derivatives %28%1968-1971%29%
% 223.37/223.60  |- mesh__historyNote mesh__D010644
% 223.37/223.60       91%28%75%29%; was see under 4-HYDROXYCOUMARINS 1977-90; was see under COUMARINS 1975-76%A%  
% 223.46/223.61  |- skos__altLabel mesh__D010644 Roche Brand of Phenprocoumon
% 223.46/223.61  |- rdf__type mesh__D010644sskos__Concept
% 223.46/223.61  |- mesh__publicMeSHNote mesh__D010644
% 223.46/223.61       91; was see under 4-HYDROXYCOUMARINS 1977-90; was see under COUMARINS 1975-76%A%  
% 223.46/223.61  |- mesh__recordAuthorizer mesh__D010644 sjn
% 223.46/223.61  |- skos__altLabel mesh__D010644 Phenylpropylhydroxycumarinum
% 223.46/223.61  |- skos__altLabel mesh__D010644 Phenprocoumalol
% 223.46/223.61  |- mesh__recordMaintainer mesh__D010644 lkw
% 223.46/223.61  |- skos__altLabel mesh__D010644 Marcumar
% 223.46/223.61  |- skos__historyNote mesh__D010644 Benzene %28%1966-1967%29%
% 223.46/223.61  |- skos__altLabel mesh__D010644 Hexal Brand of Phenprocoumon
% 223.46/223.61  |- mesh__dateCreated mesh__D010644 1974-11-19
% 223.46/223.61  |- skos__altLabel mesh__D010644 Phenprocoumarol
% 223.46/223.61  |- mesh__recordOriginator mesh__D010644 NLM
% 223.46/223.61  |- skos__prefLabel mesh__D010644 Phenprocoumon
% 223.46/223.61  |- mesh__dateEstablished mesh__D010644 1991-01-01
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D010644 2006
% 223.46/223.61  |- mesh__dateEstablished mesh__D004607 1991-01-01
% 223.46/223.61  |- mesh__dateRevised mesh__D004607 1992-05-15
% 223.46/223.61  |- skos__hiddenLabel mesh__D004607 Escalators and Elevators
% 223.46/223.61  |- mesh__recordAuthorizer mesh__D004607 PLS
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004607 2003
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004607 1995
% 223.46/223.61  |- mesh__publicMeSHNote mesh__D004607
% 223.46/223.61       91; was see under FACILITY DESIGN AND CONSTRUCTION Aug 1977-90%A%  
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004607 1999
% 223.46/223.61  |- mesh__historyNote mesh__D004607
% 223.46/223.61       91%28%Aug 77%29%; was see under FACILITY DESIGN AND CONSTRUCTION 1977-90%A%  
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004607 1994
% 223.46/223.61  |- skos__scopeNote mesh__D004607
% 223.46/223.61       Mechanical ascending and descending devices which convey objects and/or people.%A%    
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004607 2002
% 223.46/223.61  |- skos__annotation mesh__D004607 for people or equipment; DF: ELEVATORS   
% 223.46/223.61  |- skos__broader mesh__D004607smesh__D005160
% 223.46/223.61  |- skos__hiddenLabel mesh__D004607 Escalator
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004607 1993
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004607 1998
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004607 2006
% 223.46/223.61  |- mesh__recordMaintainer mesh__D004607 TGC
% 223.46/223.61  |- skos__prefLabel mesh__D004607 Elevators and Escalators
% 223.46/223.61  |- rdf__type mesh__D004607sskos__Concept
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004607 1997
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004607 2001
% 223.46/223.61  |- skos__hiddenLabel mesh__D004607 Elevator
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004607 2000
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004607 2005
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004607 1996
% 223.46/223.61  |- mesh__dateCreated mesh__D004607 1977-05-05
% 223.46/223.61  |- mesh__recordOriginator mesh__D004607 EC
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004607 2004
% 223.46/223.61  |- mesh__publicMeSHNote mesh__D042726 2004; see PSEUDOMONAS 2003   
% 223.46/223.61  |- mesh__recordMaintainer mesh__D042726 SYSTEM
% 223.46/223.61  |- skos__prefLabel mesh__D042726 Burkholderia mallei
% 223.46/223.61  |- mesh__dateEstablished mesh__D042726 2004-01-01
% 223.46/223.61  |- skos__broader mesh__D042726smesh__D019117
% 223.46/223.61  |- skos__scopeNote mesh__D042726
% 223.46/223.61       A species of gram-negative bacteria parasitic on HORSES and DONKEYS causing GLANDERS, which can be transmitted to humans.%A%    
% 223.46/223.61  |- mesh__dateCreated mesh__D042726 2003-07-09
% 223.46/223.61  |- skos__annotation mesh__D042726 infection = GLANDERS   
% 223.46/223.61  |- skos__historyNote mesh__D042726 Burkholderia %28%1998-2003%29%
% 223.46/223.61  |- mesh__recordOriginator mesh__D042726 ags
% 223.46/223.61  |- mesh__recordAuthorizer mesh__D042726 sjn
% 223.46/223.61  |- rdf__type mesh__D042726sskos__Concept
% 223.46/223.61  |- skos__historyNote mesh__D042726 Pseudomonas %28%1983-1997%29%
% 223.46/223.61  |- skos__altLabel mesh__D042726 Pseudomonas mallei
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D042726 2006
% 223.46/223.61  |- mesh__dateRevised mesh__D042726 2005-06-30
% 223.46/223.61  |- mesh__historyNote mesh__D042726 2004; use PSEUDOMONAS 2003   
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D020274 2000
% 223.46/223.61  |- skos__broader mesh__D020274smesh__D009422
% 223.46/223.61  |- skos__hiddenLabel mesh__D020274 Neurologic Autoimmune Disease
% 223.46/223.61  |- skos__annotation mesh__D020274 DF: AUTOIMMUNE DIS NERVOUS SYSTEM   
% 223.46/223.61  |- skos__broader mesh__D020274smesh__D001327
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D020274 2004
% 223.46/223.61  |- skos__hiddenLabel mesh__D020274 Autoimmune Disease, Neurologic
% 223.46/223.61  |- mesh__dateCreated mesh__D020274 1999-11-08
% 223.46/223.61  |- skos__altLabel mesh__D020274 Immune Diseases, Nervous System
% 223.46/223.61  |- skos__altLabel mesh__D020274 Neurologic Autoimmune Diseases
% 223.46/223.61  |- mesh__dateEstablished mesh__D020274 2000-01-01
% 223.46/223.61  |- skos__altLabel mesh__D020274 Autoimmune Diseases, Neurologic
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D020274 2003
% 223.46/223.61  |- skos__altLabel mesh__D020274 Nervous System Immune Disorders
% 223.46/223.61  |- skos__scopeNote mesh__D020274
% 223.46/223.61       Disorders caused by cellular or humoral immune responses primarily directed towards nervous system autoantigens. The immune response may be directed towards specific tissue components %28%e.g., myelin%29% and may be limited to the central nervous system %28%e.g., MULTIPLE SCLEROSIS%29% or the peripheral nervous system %28%e.g., GUILLAIN-BARRE SYNDROME%29%.%A%    
% 223.46/223.61  |- skos__altLabel mesh__D020274 Autoimmune Disorders of the Nervous System
% 223.46/223.61  |- skos__altLabel mesh__D020274 Autoimmune Disorders, Nervous System
% 223.46/223.61  |- skos__historyNote mesh__D020274 Autoimmune Diseases %28%1966-1999%29%
% 223.46/223.61  |- skos__altLabel mesh__D020274 Nervous System Immune Diseases
% 223.46/223.61  |- mesh__historyNote mesh__D020274 2000   
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D020274 2002
% 223.46/223.61  |- rdf__type mesh__D020274sskos__Concept
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D020274 2006
% 223.46/223.61  |- skos__hiddenLabel mesh__D020274 Disease, Neurologic Autoimmune
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D020274 2001
% 223.46/223.61  |- skos__hiddenLabel mesh__D020274 Diseases, Neurologic Autoimmune
% 223.46/223.61  |- skos__prefLabel mesh__D020274 Autoimmune Diseases of the Nervous System
% 223.46/223.61  |- skos__altLabel mesh__D020274 Autoimmune Nervous System Diseases
% 223.46/223.61  |- skos__altLabel mesh__D020274 Autoimmune Diseases, Nervous System
% 223.46/223.61  |- mesh__publicMeSHNote mesh__D020274 2000   
% 223.46/223.61  |- skos__altLabel mesh__D020274 Nervous System Autoimmune Diseases
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D020274 2005
% 223.46/223.61  |- mesh__dateCreated mesh__D014237 1999-01-01
% 223.46/223.61  |- mesh__dateRevised mesh__D014237 2005-06-30
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D014237 2006
% 223.46/223.61  |- mesh__recordOriginator mesh__D014237 NLM
% 223.46/223.61  |- mesh__recordAuthorizer mesh__D014237 sjn
% 223.46/223.61  |- skos__altLabel mesh__D014237 Trichloromethiazide
% 223.46/223.61  |- skos__broader mesh__D014237smesh__D006852
% 223.46/223.61  |- skos__scopeNote mesh__D014237
% 223.46/223.61       A thiazide diuretic with properties similar to those of HYDROCHLOROTHIAZIDE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p830%29%%A%    
% 223.46/223.61  |- rdf__type mesh__D014237sskos__Concept
% 223.46/223.61  |- skos__prefLabel mesh__D014237 Trichlormethiazide
% 223.46/223.61  |- mesh__recordMaintainer mesh__D014237 ssb
% 223.46/223.61  |- skos__related mesh__D019720smesh__D038781
% 223.46/223.61  |- skos__historyNote mesh__D019720
% 223.46/223.61       Otolaryngology/instrumentation %28%1968-1997%29%
% 223.46/223.61  |- skos__scopeNote mesh__D019720
% 223.46/223.61       Instruments designed to inspect or auscultate the ear. They are designed primarily to examine the outer ear canal and tympanic membrane by means of light and air under moderate pressure, as with a pneumatic otoscope. %28%UMDNS, 1999%29%%A%    
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D019720 2005
% 223.46/223.61  |- skos__broader mesh__D019720smesh__D019719
% 223.46/223.61  |- mesh__dateRevised mesh__D019720 2002-07-03
% 223.46/223.61  |- mesh__publicMeSHNote mesh__D019720 98   
% 223.46/223.61  |- mesh__recordAuthorizer mesh__D019720 sjn
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D019720 2003
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D019720 2006
% 223.46/223.61  |- mesh__recordMaintainer mesh__D019720 ags
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D019720 2004
% 223.46/223.61  |- skos__altLabel mesh__D019720 Otoscope
% 223.46/223.61  |- mesh__dateEstablished mesh__D019720 1998-01-01
% 223.46/223.61  |- mesh__historyNote mesh__D019720 98   
% 223.46/223.61  |- rdf__type mesh__D019720sskos__Concept
% 223.46/223.61  |- skos__prefLabel mesh__D019720 Otoscopes
% 223.46/223.61  |- mesh__recordOriginator mesh__D019720 PXP
% 223.46/223.61  |- mesh__dateCreated mesh__D019720 1997-06-20
% 223.46/223.61  |- rdf__type mesh__D000217sskos__Concept
% 223.46/223.61  |- skos__broader mesh__D000217smesh__D014166
% 223.46/223.61  |- mesh__dateEstablished mesh__D000217 1964-01-01
% 223.46/223.61  |- skos__prefLabel mesh__D000217 Acyltransferases
% 223.46/223.61  |- mesh__publicMeSHNote mesh__D000217 64   
% 223.46/223.61  |- mesh__historyNote mesh__D000217 64   
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D000217 2004
% 223.46/223.61  |- mesh__recordMaintainer mesh__D000217 ssb
% 223.46/223.61  |- mesh__dateCreated mesh__D000217 1999-01-01
% 223.46/223.61  |- mesh__recordOriginator mesh__D000217 NLM
% 223.46/223.61  |- skos__scopeNote mesh__D000217
% 223.46/223.61       Enzymes from the transferase class that catalyze the transfer of acyl groups from donor to acceptor, forming either esters or amides. %28%From Enzyme Nomenclature 1992%29% EC 2.3.%A%    
% 223.46/223.61  |- mesh__recordAuthorizer mesh__D000217 sjn
% 223.46/223.61  |- mesh__dateRevised mesh__D000217 2003-07-09
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D000217 2005
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D000217 2006
% 223.46/223.61  |- mesh__recordMaintainer mesh__D005700 ssb
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D005700 2005
% 223.46/223.61  |- rdf__type mesh__D005700sskos__Concept
% 223.46/223.61  |- mesh__dateRevised mesh__D005700 2003-07-09
% 223.46/223.61  |- mesh__dateCreated mesh__D005700 1975-07-25
% 223.46/223.61  |- skos__broader mesh__D005700smesh__D006602
% 223.46/223.61  |- mesh__historyNote mesh__D005700 76   
% 223.46/223.61  |- mesh__recordAuthorizer mesh__D005700 sjn
% 223.46/223.61  |- mesh__dateEstablished mesh__D005700 1976-01-01
% 223.46/223.61  |- skos__prefLabel mesh__D005700 Galactosyltransferases
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D005700 2004
% 223.46/223.61  |- skos__historyNote mesh__D005700 Galactose %28%1972-1975%29%
% 223.46/223.61  |- skos__scopeNote mesh__D005700
% 223.46/223.61       Enzymes that catalyze the transfer of galactose from a nucleoside diphosphate galactose to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-.%A%    
% 223.46/223.61  |- skos__historyNote mesh__D005700 Hexosyltransferases %28%1972-1975%29%
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D005700 2006
% 223.46/223.61  |- mesh__recordOriginator mesh__D005700 RLS
% 223.46/223.61  |- skos__hiddenLabel mesh__D018628 Numbers, Gene Copy
% 223.46/223.61  |- skos__altLabel mesh__D018628 Gene Copy Number
% 223.46/223.61  |- skos__hiddenLabel mesh__D018628 Copy Numbers, Gene
% 223.46/223.61  |- skos__hiddenLabel mesh__D018628 Number, Gene Copy
% 223.46/223.61  |- skos__broader mesh__D018628smesh__D005838
% 223.46/223.61  |- mesh__historyNote mesh__D018628 95   
% 223.46/223.61  |- skos__hiddenLabel mesh__D018628 Copy Number, Gene
% 223.46/223.61  |- skos__hiddenLabel mesh__D018628 Dosages, Gene
% 223.46/223.61  |- mesh__dateRevised mesh__D018628 2005-06-30
% 223.46/223.61  |- mesh__dateEstablished mesh__D018628 1995-01-01
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D018628 2006
% 223.46/223.61  |- rdf__type mesh__D018628sskos__Concept
% 223.46/223.61  |- skos__scopeNote mesh__D018628
% 223.46/223.61       The number of copies of a given gene present in the cell of an organism. An increase in gene dosage %28%by GENE DUPLICATION for example%29% can result in higher levels of gene product formation. GENE DOSAGE COMPENSATION mechanisms result in adjustments to the level GENE EXPRESSION when there are changes or differences in gene dosage.%A%    
% 223.46/223.61  |- skos__annotation mesh__D018628
% 223.46/223.61       do not confuse with DOSAGE COMPENSATION, GENETIC   
% 223.46/223.61  |- skos__hiddenLabel mesh__D018628 Dosage, Gene
% 223.46/223.61  |- mesh__recordOriginator mesh__D018628 PXP
% 223.46/223.61  |- mesh__recordMaintainer mesh__D018628 nns
% 223.46/223.61  |- mesh__dateCreated mesh__D018628 1994-04-16
% 223.46/223.61  |- mesh__publicMeSHNote mesh__D018628 95   
% 223.46/223.61  |- mesh__recordAuthorizer mesh__D018628 sjn
% 223.46/223.61  |- skos__prefLabel mesh__D018628 Gene Dosage
% 223.46/223.61  |- skos__hiddenLabel mesh__D018628 Gene Copy Numbers
% 223.46/223.61  |- skos__hiddenLabel mesh__D018628 Gene Dosages
% 223.46/223.61  |- mesh__publicMeSHNote mesh__D010645 74   
% 223.46/223.61  |- mesh__recordOriginator mesh__D010645 NLM
% 223.46/223.61  |- skos__hiddenLabel mesh__D010645 Hydrochloride, Phentermine
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D010645 2002
% 223.46/223.61  |- mesh__dateEstablished mesh__D010645 1974-01-01
% 223.46/223.61  |- skos__prefLabel mesh__D010645 Phentermine
% 223.46/223.61  |- rdf__type mesh__D010645sskos__Concept
% 223.46/223.61  |- skos__hiddenLabel mesh__D010645 Adipex P
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D010645 2005
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D010645 2003
% 223.46/223.61  |- mesh__dateCreated mesh__D010645 1999-01-01
% 223.46/223.61  |- mesh__recordMaintainer mesh__D010645 CCR
% 223.46/223.61  |- mesh__recordAuthorizer mesh__D010645 sjn
% 223.46/223.61  |- skos__scopeNote mesh__D010645
% 223.46/223.61       A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity.%A%    
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D010645 2006
% 223.46/223.61  |- skos__hiddenLabel mesh__D010645 AdipexP
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D010645 2004
% 223.46/223.61  |- mesh__dateRevised mesh__D010645 2001-07-25
% 223.46/223.61  |- mesh__historyNote mesh__D010645 74%28%66%29%   
% 223.46/223.61  |- skos__broader mesh__D010645smesh__D000662
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004608 2003
% 223.46/223.61  |- skos__scopeNote mesh__D004608
% 223.46/223.61       Criteria to determine eligibility of patients for medical care programs and services.%A%    
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004608 2000
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004608 1995
% 223.46/223.61  |- skos__hiddenLabel mesh__D004608 Determinations, Eligibility
% 223.46/223.61  |- skos__hiddenLabel mesh__D004608 Eligibility Determinations
% 223.46/223.61  |- mesh__publicMeSHNote mesh__D004608 68   
% 223.46/223.61  |- mesh__historyNote mesh__D004608 68   
% 223.46/223.61  |- skos__broader mesh__D004608smesh__D009934
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004608 1999
% 223.46/223.61  |- skos__hiddenLabel mesh__D004608 Determination, Eligibility
% 223.46/223.61  |- mesh__recordOriginator mesh__D004608 NLM
% 223.46/223.61  |- mesh__recordAuthorizer mesh__D004608 PLS
% 223.46/223.61  |- mesh__dateRevised mesh__D004608 1994-05-05
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004608 1998
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004608 2006
% 223.46/223.61  |- mesh__recordMaintainer mesh__D004608 TGC
% 223.46/223.61  |- skos__prefLabel mesh__D004608 Eligibility Determination
% 223.46/223.61  |- rdf__type mesh__D004608sskos__Concept
% 223.46/223.61  |- skos__related mesh__D004608smesh__D004185
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004608 1997
% 223.46/223.61  |- skos__historyNote mesh__D004608 Patients %28%1966-1967%29%
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004608 2005
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004608 2002
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004608 1996
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004608 2004
% 223.46/223.61  |- mesh__dateCreated mesh__D004608 1999-01-01
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D004608 2001
% 223.46/223.61  |- mesh__dateEstablished mesh__D004608 1968-01-01
% 223.46/223.61  |- mesh__dateRevised mesh__D001310 2005-06-30
% 223.46/223.61  |- skos__altLabel mesh__D001310 Robapharm Brand of Auranofin
% 223.46/223.61  |- mesh__recordOriginator mesh__D001310 RLS
% 223.46/223.61  |- mesh__recordMaintainer mesh__D001310 ssb
% 223.46/223.61  |- skos__prefLabel mesh__D001310 Auranofin
% 223.46/223.61  |- mesh__activeMeSHYear mesh__D001310 2006
% 223.46/223.61  |- skos__historyNote mesh__D001310
% 223.46/223.61       Gold Thioglucose/analogs %26% derivatives %28%1975-1986%29%
% 223.46/223.61  |- skos__scopeNote mesh__D001310
% 223.46/223.61       An oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. Its exact mechanism of action is unknown, but it is believed to act via immunological mechanisms and alteration of lysosomal enzyme activity. Its efficacy is slightly less than that of injected gold salts, but it is better tolerated, and side effects which occur are potentially less serious.%A%    
% 223.46/223.61  |- skos__hiddenLabel mesh__D001310 Auranofin Recordati Brand
% 223.46/223.61  |- mesh__historyNote mesh__D001310 87   
% 223.46/223.62  |- rdf__type mesh__D001310sskos__Concept
% 223.46/223.62  |- skos__altLabel mesh__D001310 Rubio Brand of Auranofin
% 223.46/223.62  |- skos__hiddenLabel mesh__D001310 Auranofin Robapharm Brand
% 223.46/223.62  |- skos__altLabel mesh__D001310 SK%26%F-39162
% 223.46/223.62  |- skos__hiddenLabel mesh__D001310 SK%26%F39162
% 223.46/223.62  |- skos__altLabel mesh__D001310 SmithKline Beecham Brand of Auranofin
% 223.46/223.62  |- skos__broader mesh__D001310smesh__D006051
% 223.46/223.62  |- mesh__dateEstablished mesh__D001310 1987-01-01
% 223.46/223.62  |- mesh__recordAuthorizer mesh__D001310 sjn
% 223.46/223.62  |- skos__historyNote mesh__D001310 Gold %28%1966-1974%29%
% 223.46/223.62  |- mesh__dateCreated mesh__D001310 1986-06-16
% 223.46/223.62  |- skos__hiddenLabel mesh__D001310 SK%26%F 39162
% 223.46/223.62  |- skos__altLabel mesh__D001310 Recordati Brand of Auranofin
% 223.46/223.62  |- skos__hiddenLabel mesh__D001310 Auranofin Rubio Brand
% 223.46/223.62  |- skos__altLabel mesh__D001310 Yamanouchi Brand of Auranofin
% 223.46/223.62  |- skos__hiddenLabel mesh__D001310 Auranofin Yamanouchi Brand
% 223.46/223.62  |- mesh__publicMeSHNote mesh__D001310 87   
% 223.46/223.62  |- skos__altLabel mesh__D020275 Landry-Guillain-Barre Syndrome
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D020275 2006
% 223.46/223.62  |- skos__broader mesh__D020275smesh__D010523
% 223.46/223.62  |- skos__prefLabel mesh__D020275 Guillain-Barre Syndrome
% 223.46/223.62  |- skos__hiddenLabel mesh__D020275 Autoimmune Neuropathy, Acute
% 223.46/223.62  |- skos__altLabel mesh__D020275 Acute Autoimmune Neuropathy
% 223.46/223.62  |- skos__hiddenLabel mesh__D020275 Guillain Barre Syndrome
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D020275 2000
% 223.46/223.62  |- skos__hiddenLabel mesh__D020275 Syndrome, Landry-Guillain-Barre
% 223.46/223.62  |- mesh__dateCreated mesh__D020275 1999-11-03
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D020275 2006A
% 223.46/223.62  |- skos__hiddenLabel mesh__D020275 Guillaine Barre Syndrome
% 223.46/223.62  |- rdf__type mesh__D020275sskos__Concept
% 223.46/223.62  |- skos__hiddenLabel mesh__D020275 Acute Inflammatory Polyneuropathies
% 223.46/223.62  |- skos__hiddenLabel mesh__D020275 Syndrome, Guillain-Barre
% 223.46/223.62  |- skos__altLabel mesh__D020275 Acute Inflammatory Polyneuropathy
% 223.46/223.62  |- skos__hiddenLabel mesh__D020275 Acute Autoimmune Neuropathies
% 223.46/223.62  |- skos__hiddenLabel mesh__D020275 Neuropathy, Acute Autoimmune
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D020275 2001
% 223.46/223.62  |- skos__broader mesh__D020275smesh__D011129
% 223.46/223.62  |- skos__altLabel mesh__D020275
% 223.46/223.62       Acute Inflammatory Demyelinating Polyradiculoneuropathy
% 223.46/223.62  |- mesh__recordMaintainer mesh__D020275 ags
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D020275 2003
% 223.46/223.62  |- skos__hiddenLabel mesh__D020275
% 223.46/223.62       Inflammatory Polyradiculoneuropathies, Acute
% 223.46/223.62  |- mesh__recordOriginator mesh__D020275 KEV
% 223.46/223.62  |- skos__hiddenLabel mesh__D020275
% 223.46/223.62       Polyradiculoneuropathies, Acute Inflammatory
% 223.46/223.62  |- skos__hiddenLabel mesh__D020275 Syndrome, Guillaine-Barre
% 223.46/223.62  |- skos__altLabel mesh__D020275 Acute Inflammatory Polyradiculoneuropathy
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D020275 2002
% 223.46/223.62  |- skos__altLabel mesh__D020275
% 223.46/223.62       Inflammatory Demyelinating Polyradiculoneuropathy, Acute
% 223.46/223.62  |- mesh__historyNote mesh__D020275
% 223.46/223.62       2000; use POLYRADICULONEUROPATHY 1979-1999   
% 223.46/223.62  |- mesh__dateEstablished mesh__D020275 2000-01-01
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D020275 2004
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D020275 2000A
% 223.46/223.62  |- skos__scopeNote mesh__D020275
% 223.46/223.62       An acute inflammatory autoimmune neuritis caused by T cell- mediated cellular immune response directed towards peripheral myelin. Demyelination occurs in peripheral nerves and nerve roots. The process is often preceded by a viral or bacterial infection, surgery, immunization, lymphoma, or exposure to toxins. Common clinical manifestations include progressive weakness, loss of sensation, and loss of deep tendon reflexes. Weakness of respiratory muscles and autonomic dysfunction may occur. %28%From Adams et al., Principles of Neurology, 6th ed, pp1312-1314%29%%A%    
% 223.46/223.62  |- skos__hiddenLabel mesh__D020275 Neuropathies, Acute Autoimmune
% 223.46/223.62  |- skos__hiddenLabel mesh__D020275 Inflammatory Polyneuropathies, Acute
% 223.46/223.62  |- skos__hiddenLabel mesh__D020275 Autoimmune Neuropathies, Acute
% 223.46/223.62  |- skos__altLabel mesh__D020275 Guillaine-Barre Syndrome
% 223.46/223.62  |- skos__altLabel mesh__D020275 AIDP
% 223.46/223.62  |- mesh__publicMeSHNote mesh__D020275
% 223.46/223.62       2000; see POLYRADICULONEURITIS 1979-1999   
% 223.46/223.62  |- skos__altLabel mesh__D020275 Inflammatory Polyneuropathy Acute
% 223.46/223.62  |- skos__altLabel mesh__D020275 Polyneuropathy, Acute Inflammatory
% 223.46/223.62  |- skos__altLabel mesh__D020275
% 223.46/223.62       Polyradiculoneuropathy, Acute Inflammatory Demyelinating
% 223.46/223.62  |- mesh__dateRevised mesh__D020275 2005-07-27
% 223.46/223.62  |- skos__hiddenLabel mesh__D020275 Inflammatory Polyneuropathy, Acute
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D020275 2005
% 223.46/223.62  |- skos__hiddenLabel mesh__D020275
% 223.46/223.62       Acute Inflammatory Polyradiculoneuropathies
% 223.46/223.62  |- skos__altLabel mesh__D020275 Polyradiculoneuropathy, Acute Inflammatory
% 223.46/223.62  |- skos__altLabel mesh__D020275
% 223.46/223.62       Demyelinating Polyradiculoneuropathy, Acute Inflammatory
% 223.46/223.62  |- mesh__recordAuthorizer mesh__D020275 ags
% 223.46/223.62  |- skos__hiddenLabel mesh__D020275 Polyneuropathies, Acute Inflammatory
% 223.46/223.62  |- skos__historyNote mesh__D020275 Polyradiculoneuropathy %28%1966-1999%29%
% 223.46/223.62  |- skos__hiddenLabel mesh__D020275 Landry Guillain Barre Syndrome
% 223.46/223.62  |- skos__annotation mesh__D020275
% 223.46/223.62       do not confuse X ref POLYRADICULONEUROPATHY, ACUTE INFLAMMATORY with POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY see POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING%A%  
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D014238 2005
% 223.46/223.62  |- mesh__dateRevised mesh__D014238 1998-06-11
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D014238 2004
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D014238 1999
% 223.46/223.62  |- mesh__recordMaintainer mesh__D014238 ADP
% 223.46/223.62  |- skos__hiddenLabel mesh__D014238 Trichloroacetate, Rubidium
% 223.46/223.62  |- skos__prefLabel mesh__D014238 Trichloroacetic Acid
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D014238 2002
% 223.46/223.62  |- skos__hiddenLabel mesh__D014238 Trichloroacetate, Sodium
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D014238 2006
% 223.46/223.62  |- skos__scopeNote mesh__D014238
% 223.46/223.62       A strong acid used as a protein precipitant in clinical chemistry and also as a caustic for removing warts.%A%    
% 223.46/223.62  |- mesh__recordAuthorizer mesh__D014238 SJN
% 223.46/223.62  |- skos__broader mesh__D014238smesh__D000088
% 223.46/223.62  |- skos__hiddenLabel mesh__D014238 Acid, Trichloroacetic
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D014238 2000
% 223.46/223.62  |- rdf__type mesh__D014238sskos__Concept
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D014238 2001
% 223.46/223.62  |- mesh__dateCreated mesh__D014238 1999-01-01
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D014238 2003
% 223.46/223.62  |- mesh__recordOriginator mesh__D014238 NLM
% 223.46/223.62  |- skos__scopeNote mesh__D019721
% 223.46/223.62       Devices for examining the interior of the eye, permitting the clear visualization of the structures of the eye at any depth. %28%UMDNS, 1999%29%%A%    
% 223.46/223.62  |- mesh__dateEstablished mesh__D019721 1998-01-01
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D019721 2002
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D019721 2005
% 223.46/223.62  |- mesh__dateCreated mesh__D019721 1997-06-20
% 223.46/223.62  |- mesh__dateRevised mesh__D019721 1999-11-03
% 223.46/223.62  |- skos__hiddenLabel mesh__D019721 Funduscope
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D019721 2003
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D019721 2006
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D019721 2004
% 223.46/223.62  |- mesh__recordMaintainer mesh__D019721 kle
% 223.46/223.62  |- skos__prefLabel mesh__D019721 Ophthalmoscopes
% 223.46/223.62  |- skos__broader mesh__D019721smesh__D019719
% 223.46/223.62  |- rdf__type mesh__D019721sskos__Concept
% 223.46/223.62  |- skos__hiddenLabel mesh__D019721 Ophthalmoscope
% 223.46/223.62  |- skos__altLabel mesh__D019721 Funduscopes
% 223.46/223.62  |- mesh__historyNote mesh__D019721 98   
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D019721 2000
% 223.46/223.62  |- mesh__publicMeSHNote mesh__D019721 98   
% 223.46/223.62  |- mesh__recordAuthorizer mesh__D019721 sjn
% 223.46/223.62  |- mesh__recordOriginator mesh__D019721 PXP
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D019721 2001
% 223.46/223.62  |- skos__historyNote mesh__D019721
% 223.46/223.62       Ophthalmoscopy/instrumentation %28%1966-1997%29%
% 223.46/223.62  |- skos__scopeNote mesh__D000218 A tricyclo bridged hydrocarbon.     
% 223.46/223.62  |- skos__historyNote mesh__D000218 Cycloparaffins %28%1966-1974%29%
% 223.46/223.62  |- mesh__dateEstablished mesh__D000218 1980-01-01
% 223.46/223.62  |- skos__broader mesh__D000218smesh__D003516
% 223.46/223.62  |- skos__altLabel mesh__D000218 Diamantane
% 223.46/223.62  |- mesh__historyNote mesh__D000218
% 223.46/223.62       80%28%75%29%; was see under BRIDGED COMPOUNDS 1975-79; DIAMANTANE was see ADAMANTANE 1975-95%A%  
% 223.46/223.62  |- mesh__dateCreated mesh__D000218 1974-11-19
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D000218 2005
% 223.46/223.62  |- skos__annotation mesh__D000218 a cycloparaffin   
% 223.46/223.62  |- skos__historyNote mesh__D000218 Bridged Compounds %28%1966-1974%29%
% 223.46/223.62  |- mesh__recordMaintainer mesh__D000218 ssb
% 223.46/223.62  |- skos__prefLabel mesh__D000218 Adamantane
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D000218 2006
% 223.46/223.62  |- mesh__dateRevised mesh__D000218 2004-07-07
% 223.46/223.62  |- mesh__recordOriginator mesh__D000218 NLM
% 223.46/223.62  |- skos__broader mesh__D000218smesh__D001952
% 223.46/223.62  |- rdf__type mesh__D000218sskos__Concept
% 223.46/223.62  |- mesh__recordAuthorizer mesh__D000218 sjn
% 223.46/223.62  |- mesh__onlineNote mesh__D000218
% 223.46/223.62       use ADAMANTANE to search DIAMANTANE 1975-95   
% 223.46/223.62  |- mesh__publicMeSHNote mesh__D000218
% 223.46/223.62       80; was see under BRIDGED COMPOUNDS 1975-79; DIAMANTANE was see ADAMANTANE 1975-95%A%  
% 223.46/223.62  |- skos__altLabel mesh__D005701 Galagos
% 223.46/223.62  |- skos__altLabel mesh__D005701 Bush Babies
% 223.46/223.62  |- mesh__dateCreated mesh__D005701 1974-11-11
% 223.46/223.62  |- skos__hiddenLabel mesh__D005701 Baby, Bush
% 223.46/223.62  |- skos__scopeNote mesh__D005701
% 223.46/223.62       A genus of the family Lorisidae having four species which inhabit the forests and bush regions of Africa south of the Sahara and some nearby islands. The four species are G. alleni, G. crassicaudatus, G. demidovii, and G. senegalensis. There is another genus, Euoticus, containing two species which some authors have included in the Galago genus.%A%    
% 223.46/223.62  |- rdf__type mesh__D005701sskos__Concept
% 223.46/223.62  |- mesh__dateRevised mesh__D005701 2003-07-09
% 223.46/223.62  |- skos__hiddenLabel mesh__D005701 Babies, Bush
% 223.46/223.62  |- mesh__onlineNote mesh__D005701 use GALAGO to search GALAGOS 1975-80   
% 223.46/223.62  |- skos__annotation mesh__D005701 prosimian; IM; qualif permitted   
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D005701 2004
% 223.46/223.62  |- skos__historyNote mesh__D005701 Anthropoidea %28%1966-1974%29%
% 223.46/223.62  |- skos__broader mesh__D005701smesh__D008142
% 223.46/223.62  |- mesh__publicMeSHNote mesh__D005701
% 223.46/223.62       81; was GALAGOS 1978-80, was GALAGOS see under MONKEYS 1975-77%A%  
% 223.46/223.62  |- skos__prefLabel mesh__D005701 Galago
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D005701 2005
% 223.46/223.62  |- mesh__dateEstablished mesh__D005701 1978-01-01
% 223.46/223.62  |- skos__hiddenLabel mesh__D005701 Bush Baby
% 223.46/223.62  |- mesh__recordOriginator mesh__D005701 NLM
% 223.46/223.62  |- mesh__recordAuthorizer mesh__D005701 sjn
% 223.46/223.62  |- mesh__recordMaintainer mesh__D005701 ags
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D005701 2006
% 223.46/223.62  |- mesh__historyNote mesh__D005701
% 223.46/223.62       81; was GALAGOS 1978-80, was GALAGOS see under MONKEYS 1975-77%A%  
% 223.46/223.62  |- mesh__dateCreated mesh__D018629 1994-05-12
% 223.46/223.62  |- mesh__publicMeSHNote mesh__D018629 95   
% 223.46/223.62  |- mesh__historyNote mesh__D018629 95   
% 223.46/223.62  |- skos__altLabel mesh__D018629 Mass Spectroscopy, Secondary Ion
% 223.46/223.62  |- skos__historyNote mesh__D018629
% 223.46/223.62       Spectrum Analysis, Mass %28%1976-1994%29%
% 223.46/223.62  |- mesh__recordAuthorizer mesh__D018629 sjn
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D018629 2006
% 223.46/223.62  |- mesh__dateRevised mesh__D018629 2002-07-03
% 223.46/223.62  |- skos__altLabel mesh__D018629 Secondary Ion Mass Spectroscopy
% 223.46/223.62  |- rdf__type mesh__D018629sskos__Concept
% 223.46/223.62  |- skos__scopeNote mesh__D018629
% 223.46/223.62       A mass-spectrometric technique that is used for microscopic chemical analysis. A beam of primary ions with an energy of 5-20 kiloelectronvolts %28%keV%29% bombards a small spot on the surface of the sample under ultra-high vacuum conditions. Positive and negative secondary ions sputtered from the surface are analyzed in a mass spectrometer in regards to their mass-to-charge ratio. Digital imaging can be generated from the secondary ion beams and their intensity can be measured. Ionic images can be correlated with images from light or other microscopy providing useful tools in the study of molecular and drug actions.%A%    
% 223.46/223.62  |- mesh__recordOriginator mesh__D018629 PXP
% 223.46/223.62  |- mesh__dateEstablished mesh__D018629 1995-01-01
% 223.46/223.62  |- skos__prefLabel mesh__D018629 Spectrometry, Mass, Secondary Ion
% 223.46/223.62  |- skos__altLabel mesh__D018629 SIMS Microscopy
% 223.46/223.62  |- skos__altLabel mesh__D018629 Secondary Ion Mass Spectroscopy Microscopy
% 223.46/223.62  |- skos__altLabel mesh__D018629 Secondary Ion Mass Spectrometry
% 223.46/223.62  |- mesh__recordMaintainer mesh__D018629 lkt
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D018629 2003
% 223.46/223.62  |- skos__broader mesh__D018629smesh__D013058
% 223.46/223.62  |- skos__annotation mesh__D018629
% 223.46/223.62       for SIMS microscopy, coordinate with type of microscopy   
% 223.46/223.62  |- skos__altLabel mesh__D018629 Spectroscopy, Mass, Secondary Ion
% 223.46/223.62  |- skos__altLabel mesh__D018629 Secondary Ion Mass Spectrometry Microscopy
% 223.46/223.62  |- skos__altLabel mesh__D018629 Mass Spectrometry, Secondary Ion
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D018629 2005
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D018629 2004
% 223.46/223.62  |- mesh__recordMaintainer mesh__D010646 lkw
% 223.46/223.62  |- mesh__recordAuthorizer mesh__D010646 sjn
% 223.46/223.62  |- mesh__historyNote mesh__D010646
% 223.46/223.62       PHENTOLAMINE MESYLATE was %28%NM%29% 1981-95   
% 223.46/223.62  |- skos__altLabel mesh__D010646 Regityn
% 223.46/223.62  |- skos__altLabel mesh__D010646 Phentolamine Methanesulfonate
% 223.46/223.62  |- skos__altLabel mesh__D010646 Phentolamine Mesilate
% 223.46/223.62  |- skos__altLabel mesh__D010646 Fentolamin
% 223.46/223.62  |- mesh__dateCreated mesh__D010646 1999-01-01
% 223.46/223.62  |- skos__altLabel mesh__D010646 Novartis Brand of Phentolamine Mesylate
% 223.46/223.62  |- skos__altLabel mesh__D010646
% 223.46/223.62       Schering-Plough Brand of Phentolamine Mesylate
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D010646 2006
% 223.46/223.62  |- skos__broader mesh__D010646smesh__D007093
% 223.46/223.62  |- mesh__recordOriginator mesh__D010646 NLM
% 223.46/223.62  |- mesh__publicMeSHNote mesh__D010646
% 223.46/223.62       PHENTOLAMINE MESYLATE was indexed under PHENTOLAMINE/analogs %26% derivatives 1981-95%A%  
% 223.46/223.62  |- mesh__dateRevised mesh__D010646 2005-06-30
% 223.46/223.62  |- skos__hiddenLabel mesh__D010646 Mono-hydrochloride, Phentolamine
% 223.46/223.62  |- skos__hiddenLabel mesh__D010646 Phentolamine Mono hydrochloride
% 223.46/223.62  |- skos__hiddenLabel mesh__D010646 Mesilate, Phentolamine
% 223.46/223.62  |- skos__hiddenLabel mesh__D010646 Mesylate, Phentolamine
% 223.46/223.62  |- skos__prefLabel mesh__D010646 Phentolamine
% 223.46/223.62  |- skos__hiddenLabel mesh__D010646 Methanesulfonate, Phentolamine
% 223.46/223.62  |- skos__altLabel mesh__D010646 Alliance Brand of Phentolamine Mesylate
% 223.46/223.62  |- skos__scopeNote mesh__D010646
% 223.46/223.62       A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.%A%    
% 223.46/223.62  |- skos__altLabel mesh__D010646 Paladin Brand of Phentolamine Mesylate
% 223.46/223.62  |- rdf__type mesh__D010646sskos__Concept
% 223.46/223.62  |- skos__hiddenLabel mesh__D004609 Animal Eliminative Behaviors
% 223.46/223.62  |- skos__hiddenLabel mesh__D004609 Animal Eliminative Behavior
% 223.46/223.62  |- mesh__dateEstablished mesh__D004609 1991-01-01
% 223.46/223.62  |- mesh__recordMaintainer mesh__D004609 TAP
% 223.46/223.62  |- mesh__dateRevised mesh__D004609 2002-07-02
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D004609 2005
% 223.46/223.62  |- mesh__publicMeSHNote mesh__D004609
% 223.46/223.62       91; was see under BEHAVIOR, ANIMAL 1979-90; was ELIMINATIVE BEHAVIOR see under BEHAVIOR, ANIMAL 1968-78%A%  
% 223.46/223.62  |- skos__hiddenLabel mesh__D004609 Behaviors, Eliminative
% 223.46/223.62  |- skos__hiddenLabel mesh__D004609 Eliminative Behaviors
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D004609 2006
% 223.46/223.62  |- rdf__type mesh__D004609sskos__Concept
% 223.46/223.62  |- mesh__recordAuthorizer mesh__D004609 sjn
% 223.46/223.62  |- mesh__dateCreated mesh__D004609 1999-01-01
% 223.46/223.62  |- skos__prefLabel mesh__D004609 Eliminative Behavior, Animal
% 223.46/223.62  |- mesh__historyNote mesh__D004609
% 223.46/223.62       91%28%79%29%; was see under BEHAVIOR, ANIMAL 1979-90; was ELIMINATIVE BEHAVIOR see under BEHAVIOR, ANIMAL 1968-78%A%  
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D004609 2003
% 223.46/223.62  |- skos__scopeNote mesh__D004609
% 223.46/223.62       Behavior associated with the elimination of feces and urine from the body.%A%    
% 223.46/223.62  |- mesh__recordOriginator mesh__D004609 NLM
% 223.46/223.62  |- skos__hiddenLabel mesh__D004609 Behavior, Animal Eliminative
% 223.46/223.62  |- skos__broader mesh__D004609smesh__D001522
% 223.46/223.62  |- mesh__onlineNote mesh__D004609
% 223.46/223.62       use ELIMINATIVE BEHAVIOR, ANIMAL to search ELIMINATIVE BEHAVIOR 1975-78; use BEHAVIOR, ANIMAL 1968-74%A%  
% 223.46/223.62  |- skos__hiddenLabel mesh__D004609 Eliminative Behaviors, Animal
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D004609 2004
% 223.46/223.62  |- skos__annotation mesh__D004609 elimination of urine or feces   
% 223.46/223.62  |- skos__hiddenLabel mesh__D004609 Behavior, Eliminative
% 223.46/223.62  |- skos__hiddenLabel mesh__D004609 Behaviors, Animal Eliminative
% 223.46/223.62  |- skos__hiddenLabel mesh__D015331 Cohort Study
% 223.46/223.62  |- mesh__recordMaintainer mesh__D015331 ags
% 223.46/223.62  |- skos__hiddenLabel mesh__D015331 Studies, Incidence
% 223.46/223.62  |- rdf__type mesh__D015331sskos__Concept
% 223.46/223.62  |- mesh__dateRevised mesh__D015331 2001-07-25
% 223.46/223.62  |- skos__hiddenLabel mesh__D015331 Studies, Cohort
% 223.46/223.62  |- skos__altLabel mesh__D015331 Studies, Closed Cohort
% 223.46/223.62  |- skos__historyNote mesh__D015331 Epidemiologic Methods %28%1971-1988%29%
% 223.46/223.62  |- mesh__recordAuthorizer mesh__D015331 sjn
% 223.46/223.62  |- skos__hiddenLabel mesh__D015331 Study, Concurrent
% 223.46/223.62  |- skos__annotation mesh__D015331
% 223.46/223.62       IM GEN only; coord NIM with specific disease %28%IM%29%; no qualif; specify geog if pertinent%A%  
% 223.46/223.62  |- skos__altLabel mesh__D015331 Studies, Concurrent
% 223.46/223.62  |- skos__historyNote mesh__D015331 Prospective Studies %28%1966-1988%29%
% 223.46/223.62  |- skos__hiddenLabel mesh__D015331 Study, Historical Cohort
% 223.46/223.62  |- mesh__publicMeSHNote mesh__D015331
% 223.46/223.62       89; INCIDENCE STUDIES was heading 1989   
% 223.46/223.62  |- mesh__dateCreated mesh__D015331 1988-06-01
% 223.46/223.62  |- skos__hiddenLabel mesh__D015331 Concurrent Study
% 223.46/223.62  |- mesh__onlineNote mesh__D015331
% 223.46/223.62       use COHORT STUDIES to search INCIDENCE STUDIES 1989   
% 223.46/223.62  |- skos__altLabel mesh__D015331 Concurrent Studies
% 223.46/223.62  |- skos__hiddenLabel mesh__D015331 Incidence Study
% 223.46/223.62  |- skos__hiddenLabel mesh__D015331 Study, Closed Cohort
% 223.46/223.62  |- skos__altLabel mesh__D015331 Cohort Analysis
% 223.46/223.62  |- mesh__recordOriginator mesh__D015331 EC
% 223.46/223.62  |- mesh__historyNote mesh__D015331
% 223.46/223.62       89; INCIDENCE STUDIES was heading 1989   
% 223.46/223.62  |- skos__historyNote mesh__D015331 Follow-Up Studies %28%1966-1988%29%
% 223.46/223.62  |- skos__hiddenLabel mesh__D015331 Historical Cohort Study
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D015331 2004
% 223.46/223.62  |- skos__scopeNote mesh__D015331
% 223.46/223.62       Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.%A%    
% 223.46/223.62  |- skos__hiddenLabel mesh__D015331 Cohort Study, Historical
% 223.46/223.62  |- skos__altLabel mesh__D015331 Cohort Studies, Closed
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D015331 2002
% 223.46/223.62  |- mesh__dateEstablished mesh__D015331 1989-01-01
% 223.46/223.62  |- skos__prefLabel mesh__D015331 Cohort Studies
% 223.46/223.62  |- skos__hiddenLabel mesh__D015331 Closed Cohort Study
% 223.46/223.62  |- skos__altLabel mesh__D015331 Cohort Studies, Historical
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D015331 2003
% 223.46/223.62  |- skos__hiddenLabel mesh__D015331 Cohort Analyses
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D015331 2006
% 223.46/223.62  |- skos__hiddenLabel mesh__D015331 Study, Incidence
% 223.46/223.62  |- skos__altLabel mesh__D015331 Studies, Historical Cohort
% 223.46/223.62  |- skos__broader mesh__D015331smesh__D016021
% 223.46/223.62  |- skos__hiddenLabel mesh__D015331 Analyses, Cohort
% 223.46/223.62  |- skos__hiddenLabel mesh__D015331 Study, Cohort
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D015331 2005
% 223.46/223.62  |- skos__hiddenLabel mesh__D015331 Cohort Study, Closed
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 HIV Non Progressors
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 HIV-1 Nonprogressor
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D020276 2000
% 223.46/223.62  |- skos__altLabel mesh__D020276 HIV Nonprogressors
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 HIV Long-Term Survivor
% 223.46/223.62  |- mesh__historyNote mesh__D020276 99   
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 Non-Progressors, HIV
% 223.46/223.62  |- mesh__dateEstablished mesh__D020276 1999-01-01
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 Long-Term Survivor, HIV
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D020276 2006
% 223.46/223.62  |- mesh__dateCreated mesh__D020276 1998-06-10
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 Nonprogressor, HIV-1
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D020276 2001
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 Nonprogressors, HIV-1
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 HIV-1 Long-Term Survivor
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 Long-Term Survivors, HIV-1
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 HIV 1 Nonprogressors
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 Nonprogressor, HIV
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 Survivors, HIV Long-Term
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 Long-Term Survivor, AIDS
% 223.46/223.62  |- rdf__type mesh__D020276sskos__Concept
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 Survivors, HIV-1 Long-Term
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D020276 2002
% 223.46/223.62  |- skos__altLabel mesh__D020276 Long-Term Survivors, HIV
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 Survivor, HIV Long-Term
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D020276 1999
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 Long-Term Survivors, AIDS
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 Long-Term Survivor, HIV-1
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 HIV Long Term Survivors
% 223.46/223.62  |- skos__broader mesh__D020276smesh__D017741
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 Nonprogressors, HIV
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 HIV-1 Non-Progressor
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 HIV 1 Non Progressors
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D020276 2003
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 AIDS Long Term Survivors
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 Non-Progressor, HIV-1
% 223.46/223.62  |- skos__scopeNote mesh__D020276
% 223.46/223.62       Persons who have experienced prolonged survival of HIV infection. This includes the full spectrum of untreated, HIV-infected long-term asymptomatics to those with AIDS who have survived due to successful treatment.%A%    
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 Survivor, HIV-1 Long-Term
% 223.46/223.62  |- skos__prefLabel mesh__D020276 HIV Long-Term Survivors
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 Survivors, AIDS Long-Term
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 Long Term Survivors, HIV
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D020276 2004
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 HIV 1 Long Term Survivors
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 HIV Nonprogressor
% 223.46/223.62  |- skos__altLabel mesh__D020276 HIV-1 Long-Term Survivors
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 Non-Progressor, HIV
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 Non-Progressors, HIV-1
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 Survivor, AIDS Long-Term
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 HIV Non-Progressor
% 223.46/223.62  |- mesh__publicMeSHNote mesh__D020276 99   
% 223.46/223.62  |- skos__hiddenLabel mesh__D020276 AIDS Long-Term Survivor
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D020276 2005
% 223.46/223.62  |- skos__altLabel mesh__D020276 HIV-1 Non-Progressors
% 223.46/223.62  |- mesh__recordMaintainer mesh__D014239 ssb
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D014239 2006
% 223.46/223.62  |- skos__hiddenLabel mesh__D014239 Oxide, Trichloropropylene
% 223.46/223.62  |- mesh__recordOriginator mesh__D014239 RLS
% 223.46/223.62  |- mesh__dateRevised mesh__D014239 2004-07-07
% 223.46/223.62  |- skos__broader mesh__D014239smesh__D004852
% 223.46/223.62  |- skos__altLabel mesh__D014239 Trichloropropane Oxide
% 223.46/223.62  |- skos__historyNote mesh__D014239
% 223.46/223.62       Hydrocarbons, Halogenated %28%1966-1973%29%
% 223.46/223.62  |- rdf__type mesh__D014239sskos__Concept
% 223.46/223.62  |- mesh__recordAuthorizer mesh__D014239 sjn
% 223.46/223.62  |- skos__historyNote mesh__D014239 Epoxy Compounds %28%1975-1979%29%
% 223.46/223.62  |- skos__hiddenLabel mesh__D014239 Oxide, Trichloropropene
% 223.46/223.62  |- skos__hiddenLabel mesh__D014239 Oxide, Trichloropropane
% 223.46/223.62  |- skos__broader mesh__D014239smesh__D006843
% 223.46/223.62  |- skos__historyNote mesh__D014239 Ethers, Cyclic %28%1966-1974%29%
% 223.46/223.62  |- skos__altLabel mesh__D014239 1,2-Epoxy-3,3,3-Trichloropropane
% 223.46/223.62  |- mesh__historyNote mesh__D014239
% 223.46/223.62       91%28%80%29%; was see under HYDROCARBONS, CHLORINATED 1980-90   
% 223.46/223.62  |- mesh__dateCreated mesh__D014239 1979-02-21
% 223.46/223.62  |- skos__historyNote mesh__D014239
% 223.46/223.62       Hydrocarbons, Chlorinated %28%1974-1979%29%
% 223.46/223.62  |- skos__altLabel mesh__D014239 Trichloropropene Oxide
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D014239 2005
% 223.46/223.62  |- skos__altLabel mesh__D014239 1,1,1-Trichloropropene-2,3-oxide
% 223.46/223.62  |- mesh__dateEstablished mesh__D014239 1991-01-01
% 223.46/223.62  |- skos__altLabel mesh__D014239 Trichloropropylene Oxide
% 223.46/223.62  |- mesh__publicMeSHNote mesh__D014239
% 223.46/223.62       91; was see under HYDROCARBONS, CHLORINATED 1980-90   
% 223.46/223.62  |- skos__scopeNote mesh__D014239
% 223.46/223.62       A potent epoxide hydrase and aryl hydrocarbon hydroxylase inhibitor. It enhances the tumor-initiating ability of certain carcinogens.%A%    
% 223.46/223.62  |- skos__prefLabel mesh__D014239 Trichloroepoxypropane
% 223.46/223.62  |- skos__broader mesh__D019722smesh__D019719
% 223.46/223.62  |- skos__prefLabel mesh__D019722 Sphygmomanometers
% 223.46/223.62  |- mesh__publicMeSHNote mesh__D019722 98   
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D019722 2000
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D019722 2004
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D019722 2001
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D019722 1999
% 223.46/223.62  |- mesh__dateEstablished mesh__D019722 1998-01-01
% 223.46/223.62  |- mesh__historyNote mesh__D019722 98   
% 223.46/223.62  |- rdf__type mesh__D019722sskos__Concept
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D019722 2002
% 223.46/223.62  |- skos__hiddenLabel mesh__D019722 Sphygmomanometer
% 223.46/223.62  |- mesh__dateCreated mesh__D019722 1997-06-20
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D019722 2005
% 223.46/223.62  |- skos__scopeNote mesh__D019722
% 223.46/223.62       Instruments for measuring arterial blood pressure consisting of an inflatable cuff, inflating bulb, and a gauge showing the blood pressure. %28%Stedman, 26th ed%29%%A%    
% 223.46/223.62  |- skos__historyNote mesh__D019722
% 223.46/223.62       Blood Pressure Determination/instrumentation %28%1966-1997%29%
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D019722 2003
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D019722 2006
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D019722 1998
% 223.46/223.62  |- mesh__dateCreated mesh__D000219 1999-01-01
% 223.46/223.62  |- mesh__historyNote mesh__D000219
% 223.46/223.62       65%28%63%29%; was see under HEART BLOCK 1963-64   
% 223.46/223.62  |- skos__hiddenLabel mesh__D000219 Attacks, Adam-Stokes
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D000219 2000
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D000219 2005
% 223.46/223.62  |- mesh__recordOriginator mesh__D000219 NLM
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D000219 2005A
% 223.46/223.62  |- skos__scopeNote mesh__D000219
% 223.46/223.62       Transient asystole or ventricular fibrillation in the presence of atrioventricular block.%A%    
% 223.46/223.62  |- skos__hiddenLabel mesh__D000219 Syndrome, Stokes-Adams
% 223.46/223.62  |- skos__altLabel mesh__D000219 Stokes-Adams Syndrome
% 223.46/223.62  |- mesh__recordMaintainer mesh__D000219 jls
% 223.46/223.62  |- skos__hiddenLabel mesh__D000219 Stokes Adams Syndrome
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D000219 2006
% 223.46/223.62  |- skos__altLabel mesh__D000219 Adam-Stokes Attacks
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D000219 2001
% 223.46/223.62  |- skos__prefLabel mesh__D000219 Adams-Stokes Syndrome
% 223.46/223.62  |- skos__hiddenLabel mesh__D000219 Stokes Adams Attacks
% 223.46/223.62  |- skos__annotation mesh__D000219
% 223.46/223.62       transient asystole or ventric fibrillation in AV block   
% 223.46/223.62  |- rdf__type mesh__D000219sskos__Concept
% 223.46/223.62  |- skos__hiddenLabel mesh__D000219 Adams Stokes Syndrome
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D000219 2003
% 223.46/223.62  |- skos__altLabel mesh__D000219 Stokes-Adams Attacks
% 223.46/223.62  |- mesh__publicMeSHNote mesh__D000219
% 223.46/223.62       65; was see under HEART BLOCK 1963-64   
% 223.46/223.62  |- skos__hiddenLabel mesh__D000219 Adam Stokes Attacks
% 223.46/223.62  |- skos__hiddenLabel mesh__D000219 Attacks, Stokes-Adams
% 223.46/223.62  |- mesh__dateRevised mesh__D000219 2004-08-03
% 223.46/223.62  |- mesh__activeMeSHYear mesh__D000219 2004
% 223.46/223.63  |- skos__hiddenLabel mesh__D000219 Syndrome, Adams-Stokes
% 223.46/223.63  |- mesh__recordAuthorizer mesh__D000219 jls
% 223.46/223.63  |- skos__broader mesh__D000219smesh__D006327
% 223.46/223.63  |- mesh__dateEstablished mesh__D000219 1965-01-01
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D000219 2002
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D005702 2006
% 223.46/223.63  |- rdf__type mesh__D005702sskos__Concept
% 223.46/223.63  |- skos__scopeNote mesh__D005702
% 223.46/223.63       A benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor that has been used to reverse the muscular effects of GALLAMINE TRIETHIODIDE and TUBOCURARINE and has been studied as a treatment for ALZHEIMER DISEASE and other central nervous system disorders.%A%    
% 223.46/223.63  |- mesh__dateRevised mesh__D005702 2004-07-07
% 223.46/223.63  |- mesh__dateCreated mesh__D005702 1999-01-01
% 223.46/223.63  |- skos__altLabel mesh__D005702 Galantamin
% 223.46/223.63  |- skos__altLabel mesh__D005702 Nivalin
% 223.46/223.63  |- skos__altLabel mesh__D005702 Lycoremine
% 223.46/223.63  |- skos__broader mesh__D005702smesh__D047151
% 223.46/223.63  |- skos__altLabel mesh__D005702 Galanthamine
% 223.46/223.63  |- mesh__recordOriginator mesh__D005702 NLM
% 223.46/223.63  |- mesh__recordAuthorizer mesh__D005702 sjn
% 223.46/223.63  |- mesh__historyNote mesh__D005702 2004%28%1999%29%   
% 223.46/223.63  |- skos__broader mesh__D005702smesh__D001552
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D005702 2005
% 223.46/223.63  |- skos__prefLabel mesh__D005702 Galantamine
% 223.46/223.63  |- mesh__publicMeSHNote mesh__D005702 2004; see GALANTHAMINE 1999-2003   
% 223.46/223.63  |- mesh__recordMaintainer mesh__D005702 ssb
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010647 2003
% 223.46/223.63  |- mesh__dateCreated mesh__D010647 1999-01-01
% 223.46/223.63  |- skos__prefLabel mesh__D010647 Phenyl Ethers
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010647 2006
% 223.46/223.63  |- mesh__recordAuthorizer mesh__D010647 PLS
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010647 2004
% 223.46/223.63  |- skos__hiddenLabel mesh__D010647 Ethers, Phenyl
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010647 1994
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010647 2000
% 223.46/223.63  |- mesh__historyNote mesh__D010647 74   
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010647 1998
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010647 1995
% 223.46/223.63  |- mesh__dateRevised mesh__D010647 1992-05-19
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010647 1996
% 223.46/223.63  |- mesh__recordMaintainer mesh__D010647 TAP
% 223.46/223.63  |- skos__broader mesh__D010647smesh__D004987
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010647 1993
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010647 1999
% 223.46/223.63  |- mesh__dateEstablished mesh__D010647 1974-01-01
% 223.46/223.63  |- rdf__type mesh__D010647sskos__Concept
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010647 2001
% 223.46/223.63  |- mesh__publicMeSHNote mesh__D010647 74   
% 223.46/223.63  |- mesh__recordOriginator mesh__D010647 NLM
% 223.46/223.63  |- skos__hiddenLabel mesh__D010647 Oxides, Diphenyl
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010647 1997
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010647 2002
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010647 2005
% 223.46/223.63  |- mesh__dateRevised mesh__D015332 2002-07-03
% 223.46/223.63  |- skos__hiddenLabel mesh__D015332
% 223.46/223.63       T Lymphocyte Antigen Receptor alpha Chain Gene Rearrangement
% 223.46/223.63  |- skos__prefLabel mesh__D015332
% 223.46/223.63       Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor
% 223.46/223.63  |- skos__hiddenLabel mesh__D015332 T Cell alpha Chain Gene Rearrangement
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D015332 2004
% 223.46/223.63  |- skos__historyNote mesh__D015332 Genes or specific gene %28%1977-1988%29%
% 223.46/223.63  |- skos__altLabel mesh__D015332 T Lymphocyte alpha-Chain Gene Rearrangement
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D015332 2006
% 223.46/223.63  |- skos__historyNote mesh__D015332
% 223.46/223.63       T Lymphocytes/immunology %28%1977-1988%29%
% 223.46/223.63  |- mesh__historyNote mesh__D015332 89   
% 223.46/223.63  |- skos__hiddenLabel mesh__D015332
% 223.46/223.63       Gene Rearrangement, alpha Chain T Cell Antigen Receptor
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D015332 2003
% 223.46/223.63  |- mesh__publicMeSHNote mesh__D015332 89   
% 223.46/223.63  |- skos__hiddenLabel mesh__D015332
% 223.46/223.63       T Cell Antigen Receptor alpha Chain Gene Rearrangement
% 223.46/223.63  |- mesh__recordOriginator mesh__D015332 EJB
% 223.46/223.63  |- skos__altLabel mesh__D015332 T Cell alpha-Chain Gene Rearrangement
% 223.46/223.63  |- skos__altLabel mesh__D015332
% 223.46/223.63       Gene Rearrangement, alpha-Chain T Cell Antigen Receptor
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D015332 2005
% 223.46/223.63  |- skos__hiddenLabel mesh__D015332
% 223.46/223.63       T Lymphocyte alpha Chain Gene Rearrangement
% 223.46/223.63  |- skos__broader mesh__D015332smesh__D015329
% 223.46/223.63  |- skos__annotation mesh__D015332 DF: GENE REARR ALPHA CHAIN   
% 223.46/223.63  |- mesh__dateEstablished mesh__D015332 1988-01-01
% 223.46/223.63  |- mesh__recordAuthorizer mesh__D015332 sjn
% 223.46/223.63  |- rdf__type mesh__D015332sskos__Concept
% 223.46/223.63  |- mesh__recordMaintainer mesh__D015332 TPW
% 223.46/223.63  |- skos__altLabel mesh__D015332
% 223.46/223.63       T-Cell Antigen Receptor alpha-Chain Gene Rearrangement
% 223.46/223.63  |- skos__historyNote mesh__D015332
% 223.46/223.63       Receptors, Antigen, T-Cell/genetics %28%1977-1988%29%
% 223.46/223.63  |- skos__historyNote mesh__D015332 DNA/genetics %28%1977-1988%29%
% 223.46/223.63  |- skos__scopeNote mesh__D015332
% 223.46/223.63       Ordered rearrangement of T-cell variable gene regions coding for the alpha-chain of antigen receptors.%A%    
% 223.46/223.63  |- skos__altLabel mesh__D015332
% 223.46/223.63       T-Lymphocyte Antigen Receptor alpha-Chain Gene Rearrangement
% 223.46/223.63  |- mesh__dateCreated mesh__D015332 1988-06-01
% 223.46/223.63  |- skos__altLabel mesh__D001312 Aluminon
% 223.46/223.63  |- skos__historyNote mesh__D001312 Benzoates %28%1972-1974%29%
% 223.46/223.63  |- skos__prefLabel mesh__D001312 Aurintricarboxylic Acid
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D001312 2003
% 223.46/223.63  |- skos__historyNote mesh__D001312
% 223.46/223.63       Cyclohexanecarboxylic Acids %28%1969-1974%29%
% 223.46/223.63  |- mesh__recordMaintainer mesh__D001312 CCR
% 223.46/223.63  |- mesh__dateEstablished mesh__D001312 1991-01-01
% 223.46/223.63  |- skos__hiddenLabel mesh__D001312 Acid, Aurintricarboxylic
% 223.46/223.63  |- mesh__dateCreated mesh__D001312 1974-11-19
% 223.46/223.63  |- mesh__recordAuthorizer mesh__D001312 sjn
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D001312 2004
% 223.46/223.63  |- skos__broader mesh__D001312smesh__D003509
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D001312 2005
% 223.46/223.63  |- mesh__dateRevised mesh__D001312 2000-06-21
% 223.46/223.63  |- mesh__recordOriginator mesh__D001312 NLM
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D001312 2006
% 223.46/223.63  |- skos__altLabel mesh__D001312 Aurintricarboxylic Acid, Triammonium Salt
% 223.46/223.63  |- mesh__historyNote mesh__D001312
% 223.46/223.63       91%28%75%29%; was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90%A%  
% 223.46/223.63  |- skos__scopeNote mesh__D001312
% 223.46/223.63       A dye which inhibits protein biosynthesis at the initial stages. The ammonium salt %28%aluminon%29% is a reagent for the colorimetric estimation of aluminum in water, foods, and tissues.%A%    
% 223.46/223.63  |- skos__hiddenLabel mesh__D001312 Acid, Aurin Tricarboxylic
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D001312 2001
% 223.46/223.63  |- skos__altLabel mesh__D001312 Aurin Tricarboxylic Acid
% 223.46/223.63  |- rdf__type mesh__D001312sskos__Concept
% 223.46/223.63  |- skos__historyNote mesh__D001312 Phenols %28%1972-1974%29%
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D001312 2002
% 223.46/223.63  |- mesh__publicMeSHNote mesh__D001312
% 223.46/223.63       91; was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90   
% 223.46/223.63  |- skos__altLabel mesh__D020277
% 223.46/223.63       Chronic Inflammatory Demyelinating Polyradiculoneuropathy
% 223.46/223.63  |- skos__hiddenLabel mesh__D020277
% 223.46/223.63       Inflammatory Polyradiculopathies, Chronic
% 223.46/223.63  |- skos__hiddenLabel mesh__D020277
% 223.46/223.63       Polyradiculopathies, Chronic Inflammatory
% 223.46/223.63  |- skos__altLabel mesh__D020277
% 223.46/223.63       Polyradiculoneuropathy, Chronic Inflammatory
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D020277 2002
% 223.46/223.63  |- skos__historyNote mesh__D020277 Polyradiculopathy %28%1975-1999%29%
% 223.46/223.63  |- skos__annotation mesh__D020277
% 223.46/223.63       do not confuse X ref CHRONIC INFLAMMATORY POLYRADICULONEUROPATHY with POLYRADICULONEUROPATHY, ACUTE INFLAMMATORY see GUILLAIN-BARRE SYNDROME%A%  
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D020277 2006
% 223.46/223.63  |- skos__prefLabel mesh__D020277
% 223.46/223.63       Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
% 223.46/223.63  |- skos__altLabel mesh__D020277 Inflammatory Polyradiculopathy, Chronic
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D020277 2001
% 223.46/223.63  |- skos__hiddenLabel mesh__D020277 Chronic Inflammatory Polyradiculopathies
% 223.46/223.63  |- mesh__publicMeSHNote mesh__D020277 2000   
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D020277 2005
% 223.46/223.63  |- mesh__recordMaintainer mesh__D020277 sjn
% 223.46/223.63  |- skos__hiddenLabel mesh__D020277
% 223.46/223.63       Polyradiculoneuropathies, Chronic Inflammatory
% 223.46/223.63  |- skos__hiddenLabel mesh__D020277
% 223.46/223.63       Chronic Inflammatory Polyradiculoneuropathies
% 223.46/223.63  |- skos__scopeNote mesh__D020277
% 223.46/223.63       A slowly progressive autoimmune demyelinating disease of peripheral nerves and nerve roots. Clinical manifestations include weakness and sensory loss in the extremities and enlargement of peripheral nerves. The course may be relapsing-remitting or demonstrate a step-wise progression. Protein is usually elevated in the spinal fluid and cranial nerves are typically spared. GUILLAIN-BARRE SYNDROME features a relatively rapid progression of disease which distinguishes it from this condition. %28%Adams et al., Principles of Neurology, 6th ed, p1337%29%%A%    
% 223.46/223.63  |- skos__broader mesh__D020277smesh__D011129
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D020277 2004
% 223.46/223.63  |- mesh__recordOriginator mesh__D020277 KEV
% 223.46/223.63  |- skos__altLabel mesh__D020277 CIDP
% 223.46/223.63  |- mesh__dateCreated mesh__D020277 1999-11-05
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D020277 2003
% 223.46/223.63  |- mesh__historyNote mesh__D020277 2000   
% 223.46/223.63  |- skos__hiddenLabel mesh__D020277 Chronic Inflammatory Polyradiculopathy
% 223.46/223.63  |- mesh__recordAuthorizer mesh__D020277 sjn
% 223.46/223.63  |- rdf__type mesh__D020277sskos__Concept
% 223.46/223.63  |- skos__altLabel mesh__D020277 Chronic Inflammatory Polyradiculoneuropathy
% 223.46/223.63  |- mesh__dateEstablished mesh__D020277 2000-01-01
% 223.46/223.63  |- mesh__dateRevised mesh__D020277 2000-06-22
% 223.46/223.63  |- skos__hiddenLabel mesh__D020277 Polyradiculopathy, Chronic Inflammatory
% 223.46/223.63  |- mesh__historyNote mesh__D019723 98   
% 223.46/223.63  |- rdf__type mesh__D019723sskos__Concept
% 223.46/223.63  |- mesh__recordMaintainer mesh__D019723 lkt
% 223.46/223.63  |- mesh__dateRevised mesh__D019723 2002-07-03
% 223.46/223.63  |- mesh__recordAuthorizer mesh__D019723 sjn
% 223.46/223.63  |- skos__hiddenLabel mesh__D019723 Endoscope
% 223.46/223.63  |- skos__broader mesh__D019723smesh__D019719
% 223.46/223.63  |- mesh__recordOriginator mesh__D019723 PXP
% 223.46/223.63  |- mesh__publicMeSHNote mesh__D019723 98   
% 223.46/223.63  |- skos__historyNote mesh__D019723
% 223.46/223.63       Laparoscopy/instrumentation %28%1966-1997%29%
% 223.46/223.63  |- skos__historyNote mesh__D019723
% 223.46/223.63       Colonoscopy/instrumentation %28%1966-1997%29%
% 223.46/223.63  |- mesh__dateEstablished mesh__D019723 1998-01-01
% 223.46/223.63  |- skos__scopeNote mesh__D019723
% 223.46/223.63       Instruments for the visual examination of interior structures of the body. There are rigid endoscopes and flexible fiberoptic endoscopes for various types of viewing in ENDOSCOPY.%A%    
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D019723 2005
% 223.46/223.63  |- skos__historyNote mesh__D019723
% 223.46/223.63       Gastroscopy/instrumentation %28%1966-1997%29%
% 223.46/223.63  |- mesh__dateCreated mesh__D019723 1997-06-20
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D019723 2006
% 223.46/223.63  |- skos__historyNote mesh__D019723
% 223.46/223.63       Cystoscopy/instrumentation %28%1966-1997%29%
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D019723 2003
% 223.46/223.63  |- skos__broader mesh__D019723smesh__D013523
% 223.46/223.63  |- skos__historyNote mesh__D019723
% 223.46/223.63       Sigmoidoscopy/instrumentation %28%1966-1997%29%
% 223.46/223.63  |- skos__annotation mesh__D019723 GEN: prefer specifics   
% 223.46/223.63  |- skos__prefLabel mesh__D019723 Endoscopes
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D019723 2004
% 223.46/223.63  |- skos__historyNote mesh__D019723
% 223.46/223.63       Endoscopy/instrumentation %28%1966-1997%29%
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D011740 2005
% 223.46/223.63  |- skos__hiddenLabel mesh__D011740 Dimers, Thymine
% 223.46/223.63  |- mesh__dateCreated mesh__D011740 1976-04-16
% 223.46/223.63  |- skos__altLabel mesh__D011740 Thymine Dimers
% 223.46/223.63  |- skos__hiddenLabel mesh__D011740 Dimers, Cyclobutane-Pyrimidine
% 223.46/223.63  |- skos__scopeNote mesh__D011740
% 223.46/223.63       Dimers found in DNA chains damaged by ULTRAVIOLET RAYS. They consist of two adjacent PYRIMIDINE NUCLEOTIDES, usually THYMINE nucleotides, in which the pyrimidine residues are covalently joined by a cyclobutane ring. These dimers block DNA REPLICATION.%A%    
% 223.46/223.63  |- skos__hiddenLabel mesh__D011740 Cyclobutane Pyrimidine Dimers
% 223.46/223.63  |- skos__hiddenLabel mesh__D011740 Cyclobutane Dimer, Thymine-Thymine
% 223.46/223.63  |- skos__hiddenLabel mesh__D011740 Dimer, Thymine-Cyclobutane
% 223.46/223.63  |- mesh__dateRevised mesh__D011740 2003-07-09
% 223.46/223.63  |- skos__historyNote mesh__D011740 Thymine Nucleotides %28%1972-1976%29%
% 223.46/223.63  |- skos__hiddenLabel mesh__D011740 Dimers, Cytosine-Thymine
% 223.46/223.63  |- mesh__recordAuthorizer mesh__D011740 sjn
% 223.46/223.63  |- rdf__type mesh__D011740sskos__Concept
% 223.46/223.63  |- skos__hiddenLabel mesh__D011740 Dimers, Pyrimidine
% 223.46/223.63  |- mesh__dateEstablished mesh__D011740 1977-01-01
% 223.46/223.63  |- skos__hiddenLabel mesh__D011740 Thymine Cyclobutane Dimer
% 223.46/223.63  |- skos__altLabel mesh__D011740 Cyclobutane-Pyrimidine Dimers
% 223.46/223.63  |- skos__broader mesh__D011740smesh__D009841
% 223.46/223.63  |- skos__hiddenLabel mesh__D011740 Thymine Thymine Cyclobutane Dimer
% 223.46/223.63  |- skos__hiddenLabel mesh__D011740 Cytosine Thymine Dimers
% 223.46/223.63  |- mesh__publicMeSHNote mesh__D011740 77   
% 223.46/223.63  |- mesh__recordOriginator mesh__D011740 RLS
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D011740 2006
% 223.46/223.63  |- mesh__historyNote mesh__D011740 77   
% 223.46/223.63  |- skos__related mesh__D011740smesh__D004249
% 223.46/223.63  |- skos__broader mesh__D011740smesh__D011742
% 223.46/223.63  |- skos__hiddenLabel mesh__D011740 Dimer, Thymine-Thymine Cyclobutane
% 223.46/223.63  |- skos__historyNote mesh__D011740 Pyrimidine Nucleotides %28%1974-1976%29%
% 223.46/223.63  |- skos__prefLabel mesh__D011740 Pyrimidine Dimers
% 223.46/223.63  |- mesh__recordMaintainer mesh__D011740 nns
% 223.46/223.63  |- skos__altLabel mesh__D011740 Thymine-Thymine Cyclobutane Dimer
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D011740 2004
% 223.46/223.63  |- skos__hiddenLabel mesh__D005703 Triethochloride, Gallamine
% 223.46/223.63  |- skos__hiddenLabel mesh__D005703 Iodide, Gallamonium
% 223.46/223.63  |- skos__altLabel mesh__D005703 Gallamonium Iodide
% 223.46/223.63  |- mesh__recordMaintainer mesh__D005703 ssb
% 223.46/223.63  |- skos__hiddenLabel mesh__D005703 Triethyl Iodide, Gallamine
% 223.46/223.63  |- skos__broader mesh__D005703smesh__D000644
% 223.46/223.63  |- skos__scopeNote mesh__D005703
% 223.46/223.63       A synthetic nondepolarizing blocking drug. The actions of gallamine triethiodide are similar to those of TUBOCURARINE, but this agent blocks the cardiac vagus and may cause sinus tachycardia and, occasionally, hypertension and increased cardiac output. It should be used cautiously in patients at risk from increased heart rate but may be preferred for patients with bradycardia. %28%From AMA Drug Evaluations Annual, 1992, p198%29%%A%    
% 223.46/223.63  |- skos__altLabel mesh__D005703 Gallamine Triethyl Iodide
% 223.46/223.63  |- mesh__dateRevised mesh__D005703 2005-06-30
% 223.46/223.63  |- skos__hiddenLabel mesh__D005703 Iodide, Gallamine Triethyl
% 223.46/223.63  |- mesh__recordOriginator mesh__D005703 NLM
% 223.46/223.63  |- rdf__type mesh__D005703sskos__Concept
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D005703 2006
% 223.46/223.63  |- mesh__recordAuthorizer mesh__D005703 sjn
% 223.46/223.63  |- skos__hiddenLabel mesh__D005703 Triethiodide, Gallamine
% 223.46/223.63  |- skos__prefLabel mesh__D005703 Gallamine Triethiodide
% 223.46/223.63  |- mesh__dateCreated mesh__D005703 1999-01-01
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D043822 2006
% 223.46/223.63  |- rdf__type mesh__D043822sskos__Concept
% 223.46/223.63  |- mesh__dateCreated mesh__D043822 2003-07-09
% 223.46/223.63  |- mesh__recordOriginator mesh__D043822 ssb
% 223.46/223.63  |- mesh__dateRevised mesh__D043822 2004-07-07
% 223.46/223.63  |- mesh__publicMeSHNote mesh__D043822 2004   
% 223.46/223.63  |- mesh__recordAuthorizer mesh__D043822 sjn
% 223.46/223.63  |- mesh__historyNote mesh__D043822 2004   
% 223.46/223.63  |- mesh__recordMaintainer mesh__D043822 ssb
% 223.46/223.63  |- skos__broader mesh__D043822smesh__D003516
% 223.46/223.63  |- skos__prefLabel mesh__D043822 Cyclodecanes
% 223.46/223.63  |- skos__scopeNote mesh__D043822 Compounds with a 10-carbon ring.     
% 223.46/223.63  |- mesh__dateEstablished mesh__D043822 2004-01-01
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D043822 2005
% 223.46/223.63  |- mesh__recordAuthorizer mesh__D010648 PLS
% 223.46/223.63  |- mesh__recordOriginator mesh__D010648 NLM
% 223.46/223.63  |- mesh__dateRevised mesh__D010648 1992-05-19
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010648 1994
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010648 2004
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010648 2006
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010648 2003
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010648 1997
% 223.46/223.63  |- skos__prefLabel mesh__D010648 Phenylacetates
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010648 2002
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010648 2005
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010648 1999
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010648 1996
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010648 2001
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010648 1993
% 223.46/223.63  |- rdf__type mesh__D010648sskos__Concept
% 223.46/223.63  |- mesh__dateCreated mesh__D010648 1999-01-01
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010648 1998
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010648 2000
% 223.46/223.63  |- skos__broader mesh__D010648smesh__D000146
% 223.46/223.63  |- mesh__recordMaintainer mesh__D010648 TAP
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D010648 1995
% 223.46/223.63  |- skos__historyNote mesh__D015333 Genes or specific gene %28%1977-1988%29%
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D015333 2006
% 223.46/223.63  |- skos__historyNote mesh__D015333
% 223.46/223.63       T Lymphocytes/immunology %28%1977-1988%29%
% 223.46/223.63  |- skos__altLabel mesh__D015333
% 223.46/223.63       T-Lymphocyte Antigen Receptor beta-Chain Gene Rearrangement
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D015333 2003
% 223.46/223.63  |- mesh__publicMeSHNote mesh__D015333 89   
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D015333 2005
% 223.46/223.63  |- mesh__dateRevised mesh__D015333 2002-07-03
% 223.46/223.63  |- skos__hiddenLabel mesh__D015333
% 223.46/223.63       Gene Rearrangement, beta Chain T Cell Antigen Receptor
% 223.46/223.63  |- skos__hiddenLabel mesh__D015333
% 223.46/223.63       T Cell Antigen Receptor beta Chain Gene Rearrangement
% 223.46/223.63  |- skos__prefLabel mesh__D015333
% 223.46/223.63       Gene Rearrangement, beta-Chain T-Cell Antigen Receptor
% 223.46/223.63  |- skos__annotation mesh__D015333 DF: GENE REARR BETA CHAIN   
% 223.46/223.63  |- mesh__historyNote mesh__D015333 89   
% 223.46/223.63  |- rdf__type mesh__D015333sskos__Concept
% 223.46/223.63  |- mesh__recordMaintainer mesh__D015333 TPW
% 223.46/223.63  |- skos__scopeNote mesh__D015333
% 223.46/223.63       Ordered rearrangement of T-cell variable gene regions coding for the beta-chain of antigen receptors.%A%    
% 223.46/223.63  |- skos__historyNote mesh__D015333
% 223.46/223.63       Receptors, Antigen, T-Cell/genetics %28%1977-1988%29%
% 223.46/223.63  |- mesh__recordOriginator mesh__D015333 EJB
% 223.46/223.63  |- skos__hiddenLabel mesh__D015333 T Cell beta Chain Gene Rearrangement
% 223.46/223.63  |- skos__altLabel mesh__D015333
% 223.46/223.63       Gene Rearrangement, beta-Chain T Cell Antigen Receptor
% 223.46/223.63  |- skos__hiddenLabel mesh__D015333
% 223.46/223.63       T Lymphocyte beta Chain Gene Rearrangement
% 223.46/223.63  |- skos__hiddenLabel mesh__D015333
% 223.46/223.63       T Lymphocyte Antigen Receptor beta Chain Gene Rearrangement
% 223.46/223.63  |- skos__altLabel mesh__D015333 T Lymphocyte beta-Chain Gene Rearrangement
% 223.46/223.63  |- skos__broader mesh__D015333smesh__D015329
% 223.46/223.63  |- mesh__dateEstablished mesh__D015333 1988-01-01
% 223.46/223.63  |- mesh__dateCreated mesh__D015333 1988-06-01
% 223.46/223.63  |- mesh__recordAuthorizer mesh__D015333 sjn
% 223.46/223.63  |- skos__altLabel mesh__D015333 T Cell beta-Chain Gene Rearrangement
% 223.46/223.63  |- skos__altLabel mesh__D015333
% 223.46/223.63       T-Cell Antigen Receptor beta-Chain Gene Rearrangement
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D015333 2004
% 223.46/223.63  |- skos__historyNote mesh__D015333 DNA/genetics %28%1977-1988%29%
% 223.46/223.63  |- mesh__dateEstablished mesh__D001313 1991-01-01
% 223.46/223.63  |- mesh__onlineNote mesh__D001313
% 223.46/223.63       use AUROVERTINS to search AUROVERTIN 1975-79   
% 223.46/223.63  |- mesh__recordAuthorizer mesh__D001313 sjn
% 223.46/223.63  |- mesh__dateCreated mesh__D001313 1974-11-19
% 223.46/223.63  |- skos__annotation mesh__D001313 uncoupling agents; D25-26 qualif   
% 223.46/223.63  |- skos__scopeNote mesh__D001313
% 223.46/223.63       Very toxic and complex pyrone derivatives from the fungus Calcarisporium arbuscula. They bind to and inhibit mitochondrial ATPase, thereby uncoupling oxidative phosphorylation. They are used as biochemical tools.%A%    
% 223.46/223.63  |- skos__altLabel mesh__D001313 Aurovertin
% 223.46/223.63  |- mesh__recordOriginator mesh__D001313 NLM
% 223.46/223.63  |- skos__broader mesh__D001313smesh__D011714
% 223.46/223.63  |- mesh__recordMaintainer mesh__D001313 ssb
% 223.46/223.63  |- mesh__dateRevised mesh__D001313 2005-06-30
% 223.46/223.63  |- skos__prefLabel mesh__D001313 Aurovertins
% 223.46/223.63  |- rdf__type mesh__D001313sskos__Concept
% 223.46/223.63  |- mesh__publicMeSHNote mesh__D001313
% 223.46/223.63       91; was see under PYRANS 1980-90; was AUROVERTIN see under ANTIBIOTICS 1975-79%A%  
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D001313 2006
% 223.46/223.63  |- skos__historyNote mesh__D001313 Antibiotics %28%1968-1974%29%
% 223.46/223.63  |- mesh__historyNote mesh__D001313
% 223.46/223.63       91%28%80%29%; was see under PYRANS 1980-90; was AUROVERTIN see under ANTIBIOTICS 1975-79%A%  
% 223.46/223.63  |- rdf__type mesh__D039781sskos__Concept
% 223.46/223.63  |- mesh__dateEstablished mesh__D039781 2003-01-01
% 223.46/223.63  |- skos__historyNote mesh__D039781 MEDLINE %28%1999-2002%29%
% 223.46/223.63  |- skos__related mesh__D039781smesh__D016239
% 223.46/223.63  |- mesh__recordOriginator mesh__D039781 ags
% 223.46/223.63  |- mesh__dateCreated mesh__D039781 2002-07-03
% 223.46/223.63  |- skos__broader mesh__D039781smesh__D016206
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D039781 2006
% 223.46/223.63  |- skos__prefLabel mesh__D039781 PubMed
% 223.46/223.63  |- skos__scopeNote mesh__D039781
% 223.46/223.63       A bibliographic database that includes MEDLINE as its primary subset. It is produced by the National Center for Biotechnology Information %28%NCBI%29%, part of the NATIONAL LIBRARY OF MEDICINE. PubMed, which is searchable through  NLM%27%s Web site, also includes access to additional citations to selected life sciences journals not in MEDLINE, and links to other resources such as the full-text of articles at participating publishers%27% Web sites, NCBI%27%s molecular biology databases, and PubMed Central.%A%    
% 223.46/223.63  |- skos__broader mesh__D039781smesh__D016247
% 223.46/223.63  |- skos__annotation mesh__D039781 CATALOG: use NAF entry   
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D039781 2005
% 223.46/223.63  |- skos__broader mesh__D039781smesh__D009862
% 223.46/223.63  |- mesh__recordAuthorizer mesh__D039781 sjn
% 223.46/223.63  |- mesh__recordMaintainer mesh__D039781 jls
% 223.46/223.63  |- mesh__historyNote mesh__D039781 2003   
% 223.46/223.63  |- mesh__publicMeSHNote mesh__D039781 2003   
% 223.46/223.63  |- mesh__dateRevised mesh__D039781 2004-07-07
% 223.46/223.63  |- skos__altLabel mesh__D020278 Autoimmune Demyelinating Disorders, CNS
% 223.46/223.63  |- skos__altLabel mesh__D020278 Demyelinating Autoimmune Diseases, Cerebral
% 223.46/223.63  |- skos__scopeNote mesh__D020278
% 223.46/223.63       Conditions characterized by loss or dysfunction of myelin %28%see MYELIN SHEATH%29% in the brain, spinal cord, or optic nerves secondary to autoimmune mediated processes. This may take the form of a humoral or cellular immune response directed toward myelin or OLIGODENDROGLIA associated autoantigens.%A%    
% 223.46/223.63  |- skos__altLabel mesh__D020278 CNS Autoimmune Demyelinating Disorders
% 223.46/223.63  |- skos__prefLabel mesh__D020278 Demyelinating Autoimmune Diseases, CNS
% 223.46/223.63  |- mesh__recordAuthorizer mesh__D020278 ags
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D020278 2006
% 223.46/223.63  |- skos__altLabel mesh__D020278 Cerebral Demyelinating Diseases, Autoimmune
% 223.46/223.63  |- skos__altLabel mesh__D020278 CNS Demyelinating Autoimmune Diseases
% 223.46/223.63  |- mesh__dateRevised mesh__D020278 2005-07-27
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D020278 2005
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D020278 2006A
% 223.46/223.63  |- mesh__recordMaintainer mesh__D020278 ags
% 223.46/223.63  |- skos__broader mesh__D020278smesh__D020274
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D020278 2004
% 223.46/223.63  |- skos__altLabel mesh__D020278
% 223.46/223.63       Demyelinating Autoimmune Diseases, Spinal Cord
% 223.46/223.63  |- skos__altLabel mesh__D020278
% 223.46/223.63       Demyelinating Autoimmune Diseases, Central Nervous System
% 223.46/223.63  |- skos__broader mesh__D020278smesh__D003711
% 223.46/223.63  |- mesh__publicMeSHNote mesh__D020278 2000   
% 223.46/223.63  |- mesh__historyNote mesh__D020278 2000   
% 223.46/223.63  |- skos__altLabel mesh__D020278 Brain Autoimmune Demyelinating Diseases
% 223.46/223.63  |- skos__altLabel mesh__D020278
% 223.46/223.63       Autoimmune Demyelinating Diseases, Central Nervous System
% 223.46/223.63  |- skos__altLabel mesh__D020278 Demyelinating Disease, Autoimmune, CNS
% 223.46/223.63  |- mesh__dateEstablished mesh__D020278 2000-01-01
% 223.46/223.63  |- skos__altLabel mesh__D020278 Demyelinating Autoimmune Disorders, CNS
% 223.46/223.63  |- rdf__type mesh__D020278sskos__Concept
% 223.46/223.63  |- mesh__dateCreated mesh__D020278 1999-11-08
% 223.46/223.63  |- skos__altLabel mesh__D020278 Autoimmune Demyelinating Diseases, CNS
% 223.46/223.63  |- skos__altLabel mesh__D020278 Demyelinating Autoimmune Diseases, Brain
% 223.46/223.63  |- skos__annotation mesh__D020278
% 223.46/223.63       for central nervous system diseases only; for demyelinating diseases of the peripheral nervous system consider POLYRADICULONEURITIS; GUILLAIN-BARRE SYNDROME; and CHRONIC INFLAMMATORY POLYRADICULONEUROPATHY; for demyelinating autoimmune diseases of the brain or spinal cord not otherwise specified coord with BRAIN DISEASES or SPINAL CORD DISEASES; DF: DEMYELINATING AUTOIMMUNE DIS CNS%A%  
% 223.46/223.63  |- mesh__recordOriginator mesh__D020278 KEV
% 223.46/223.63  |- skos__altLabel mesh__D020278
% 223.46/223.63       Autoimmune Demyelinating Diseases, Spinal Cord
% 223.46/223.63  |- skos__broader mesh__D025761smesh__D025361
% 223.46/223.63  |- mesh__publicMeSHNote mesh__D025761
% 223.46/223.63       2002;  see VIRGINIAMYCIN 1991-2001, see VIRGINIAMYCINS 1981-1990 , see MIKAMYCINS 1975-1980%A%  
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D025761 2006
% 223.46/223.63  |- mesh__dateCreated mesh__D025761 2001-07-25
% 223.46/223.63  |- rdf__type mesh__D025761sskos__Concept
% 223.46/223.63  |- mesh__dateEstablished mesh__D025761 2002-01-01
% 223.46/223.63  |- skos__altLabel mesh__D025761 Mikamycins
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D025761 2006A
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D025761 2005
% 223.46/223.63  |- skos__prefLabel mesh__D025761 Mikamycin
% 223.46/223.63  |- mesh__recordOriginator mesh__D025761 jmp
% 223.46/223.63  |- skos__historyNote mesh__D025761 Virginiamycin %28%1991-2001%29%
% 223.46/223.63  |- mesh__recordMaintainer mesh__D025761 ags
% 223.46/223.63  |- skos__scopeNote mesh__D025761
% 223.46/223.63       An antibiotic complex originally isolated from Streptomyces mitakaenis. It contains two principle ingredients: STREPTOGRAMIN A %28%mikamycin A%29% and STREPTOGRAMIN B %28%mikamycin B%29%.%A%    
% 223.46/223.63  |- mesh__recordAuthorizer mesh__D025761 ags
% 223.46/223.63  |- mesh__historyNote mesh__D025761
% 223.46/223.63       2002%28%1975%29%; use VIRGINIAMYCIN 1981-2001   
% 223.46/223.63  |- mesh__dateRevised mesh__D025761 2005-07-11
% 223.46/223.63  |- mesh__publicMeSHNote mesh__D019724 99   
% 223.46/223.63  |- skos__hiddenLabel mesh__D019724 Consent, Presumed
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D019724 2003
% 223.46/223.63  |- skos__prefLabel mesh__D019724 Presumed Consent
% 223.46/223.63  |- mesh__recordOriginator mesh__D019724 JLS
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D019724 2005
% 223.46/223.63  |- rdf__type mesh__D019724sskos__Concept
% 223.46/223.63  |- mesh__recordMaintainer mesh__D019724 jls
% 223.46/223.63  |- skos__historyNote mesh__D019724 Informed Consent %28%1986-1998%29%
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D019724 2002
% 223.46/223.63  |- skos__scopeNote mesh__D019724
% 223.46/223.63       An institutional policy of granting authority to health personnel to perform procedures on patients or to remove organs from cadavers for transplantation unless an objection is registered by family members or by the patient prior to death. This also includes emergency care of minors without prior parental consent.%A%    
% 223.46/223.63  |- mesh__dateEstablished mesh__D019724 1999-01-01
% 223.46/223.63  |- skos__broader mesh__D019724smesh__D007603
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D019724 2001
% 223.46/223.63  |- mesh__recordAuthorizer mesh__D019724 jls
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D019724 2000
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D019724 2004
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D019724 2003A
% 223.46/223.63  |- mesh__historyNote mesh__D019724 99   
% 223.46/223.63  |- mesh__dateCreated mesh__D019724 1998-06-10
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D019724 2006
% 223.46/223.63  |- mesh__dateRevised mesh__D019724 2002-10-31
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D011741 2004
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D011741 1999
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D011741 1994
% 223.46/223.63  |- skos__prefLabel mesh__D011741 Pyrimidine Nucleosides
% 223.46/223.63  |- mesh__recordMaintainer mesh__D011741 TGC
% 223.46/223.63  |- mesh__publicMeSHNote mesh__D011741 74   
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D011741 2005
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D011741 1997
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D011741 2003
% 223.46/223.63  |- mesh__recordAuthorizer mesh__D011741 PLS
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D011741 1998
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D011741 1996
% 223.46/223.63  |- rdf__type mesh__D011741sskos__Concept
% 223.46/223.63  |- mesh__activeMeSHYear mesh__D011741 2002
% 223.46/223.63  |- skos__hiddenLabel mesh__D011741 Nucleosides, Pyrimidine
% 223.46/223.63  |- mesh__dateEstablished mesh__D011741 1974-01-01
% 223.46/223.63  |- mesh__historyNote mesh__D011741 74   
% 223.46/223.64  |- mesh__dateCreated mesh__D011741 1999-01-01
% 223.46/223.64  |- mesh__dateRevised mesh__D011741 1992-05-20
% 223.46/223.64  |- skos__broader mesh__D011741smesh__D009705
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011741 2001
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011741 1995
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011741 2006
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011741 2000
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011741 1993
% 223.46/223.64  |- mesh__recordOriginator mesh__D011741 NLM
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D005704 2004
% 223.46/223.64  |- skos__related mesh__D005704smesh__D002767
% 223.46/223.64  |- skos__related mesh__D005704smesh__D002763
% 223.46/223.64  |- mesh__recordOriginator mesh__D005704 NLM
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D005704 2005
% 223.46/223.64  |- mesh__recordAuthorizer mesh__D005704 sjn
% 223.46/223.64  |- mesh__considerAlso mesh__D005704 consider also terms at CHOLECYST-   
% 223.46/223.64  |- skos__related mesh__D005704smesh__D002765
% 223.46/223.64  |- skos__annotation mesh__D005704
% 223.46/223.64       /surg: consider also CHOLECYSTECTOMY %26% CHOLECYSTOSTOMY; calculi = GALLSTONES but consider also CHOLECYSTOLITHIASIS; inflammation = CHOLECYSTITIS%A%  
% 223.46/223.64  |- rdf__type mesh__D005704sskos__Concept
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D005704 2006
% 223.46/223.64  |- skos__prefLabel mesh__D005704 Gallbladder
% 223.46/223.64  |- skos__scopeNote mesh__D005704
% 223.46/223.64       A storage reservoir for BILE secretion. Gallbladder allows the delivery of bile acids at a high concentration and in a controlled manner, via the CYSTIC DUCT to the DUODENUM, for degradation of dietary lipid.%A%    
% 223.46/223.64  |- mesh__dateCreated mesh__D005704 1999-01-01
% 223.46/223.64  |- skos__broader mesh__D005704smesh__D001659
% 223.46/223.64  |- mesh__dateRevised mesh__D005704 2003-07-09
% 223.46/223.64  |- skos__hiddenLabel mesh__D005704 Gallbladders
% 223.46/223.64  |- mesh__recordMaintainer mesh__D005704 lkt
% 223.46/223.64  |- skos__broader mesh__D043823smesh__D004224
% 223.46/223.64  |- mesh__dateCreated mesh__D043823 2003-07-09
% 223.46/223.64  |- skos__broader mesh__D043823smesh__D043822
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D043823 2006
% 223.46/223.64  |- rdf__type mesh__D043823sskos__Concept
% 223.46/223.64  |- mesh__recordOriginator mesh__D043823 ssb
% 223.46/223.64  |- skos__historyNote mesh__D043823 Paclitaxel %28%1992-2003%29%
% 223.46/223.64  |- skos__annotation mesh__D043823 ROTAXANES is also available   
% 223.46/223.64  |- mesh__dateEstablished mesh__D043823 2004-01-01
% 223.46/223.64  |- mesh__recordMaintainer mesh__D043823 ssb
% 223.46/223.64  |- mesh__publicMeSHNote mesh__D043823 2004   
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D043823 2005
% 223.46/223.64  |- skos__prefLabel mesh__D043823 Taxoids
% 223.46/223.64  |- mesh__dateRevised mesh__D043823 2004-07-07
% 223.46/223.64  |- skos__scopeNote mesh__D043823
% 223.46/223.64       A group of diterpenoid CYCLODECANES named for the taxanes that were discovered in the TAXUS tree. The action on MICROTUBULES has made some of them useful as ANTINEOPLASTIC AGENTS.%A%    
% 223.46/223.64  |- mesh__recordAuthorizer mesh__D043823 sjn
% 223.46/223.64  |- mesh__historyNote mesh__D043823 2004   
% 223.46/223.64  |- skos__broader mesh__D010649smesh__D024322
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D010649 2004
% 223.46/223.64  |- mesh__recordMaintainer mesh__D010649 ags
% 223.46/223.64  |- skos__hiddenLabel mesh__D010649 Phenylalanine, L Isomer
% 223.46/223.64  |- skos__prefLabel mesh__D010649 Phenylalanine
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D010649 2006
% 223.46/223.64  |- skos__altLabel mesh__D010649 L-Phenylalanine
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D010649 2003
% 223.46/223.64  |- skos__hiddenLabel mesh__D010649 L-Isomer Phenylalanine
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D010649 2006A
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D010649 2005
% 223.46/223.64  |- skos__broader mesh__D010649smesh__D000601
% 223.46/223.64  |- skos__altLabel mesh__D010649 Phenylalanine, L-Isomer
% 223.46/223.64  |- mesh__recordOriginator mesh__D010649 NLM
% 223.46/223.64  |- skos__scopeNote mesh__D010649
% 223.46/223.64       An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin %28%NOREPINEPHRINE%29%, and THYROXINE.%A%    
% 223.46/223.64  |- mesh__dateCreated mesh__D010649 1999-01-01
% 223.46/223.64  |- rdf__type mesh__D010649sskos__Concept
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D010649 2002
% 223.46/223.64  |- mesh__recordAuthorizer mesh__D010649 ags
% 223.46/223.64  |- mesh__dateRevised mesh__D010649 2005-07-19
% 223.46/223.64  |- skos__broader mesh__D043025smesh__D015415
% 223.46/223.64  |- skos__hiddenLabel mesh__D043025 Bands, Oligoclonal
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D043025 2006
% 223.46/223.64  |- skos__hiddenLabel mesh__D043025 IgG, Oligoclonal
% 223.46/223.64  |- rdf__type mesh__D043025sskos__Concept
% 223.46/223.64  |- skos__scopeNote mesh__D043025
% 223.46/223.64       Multiple protein bands serving as markers of specific ANTIBODIES and detected by ELECTROPHORESIS of CEREBROSPINAL FLUID or serum. The bands are most often seen during inflammatory or immune processes and are found in most patients with MULTIPLE SCLEROSIS.%A%    
% 223.46/223.64  |- mesh__recordAuthorizer mesh__D043025 sjn
% 223.46/223.64  |- mesh__publicMeSHNote mesh__D043025
% 223.46/223.64       2004; OLIGOCLONAL IMMUNOGLOBULINS was indexed under IMMUNOGLOBULINS 1981-2003%A%  
% 223.46/223.64  |- mesh__recordOriginator mesh__D043025 ags
% 223.46/223.64  |- skos__related mesh__D043025smesh__D010266
% 223.46/223.64  |- skos__altLabel mesh__D043025 Immunoglobulins, Oligoclonal
% 223.46/223.64  |- skos__historyNote mesh__D043025 Immunoglobulins %28%1978-2003%29%
% 223.46/223.64  |- mesh__recordMaintainer mesh__D043025 ssb
% 223.46/223.64  |- mesh__dateCreated mesh__D043025 2003-07-09
% 223.46/223.64  |- skos__hiddenLabel mesh__D043025 IgM, Oligoclonal
% 223.46/223.64  |- mesh__dateRevised mesh__D043025 2005-06-30
% 223.46/223.64  |- skos__prefLabel mesh__D043025 Oligoclonal Bands
% 223.46/223.64  |- skos__broader mesh__D043025smesh__D000906
% 223.46/223.64  |- skos__altLabel mesh__D043025 Oligoclonal Immunoglobulins
% 223.46/223.64  |- mesh__dateEstablished mesh__D043025 2004-01-01
% 223.46/223.64  |- mesh__historyNote mesh__D043025
% 223.46/223.64       2004; use OLIGOCLONAL BANDS %28%NM%29% 1981-2003   
% 223.46/223.64  |- skos__broader mesh__D015334smesh__D015329
% 223.46/223.64  |- rdf__type mesh__D015334sskos__Concept
% 223.46/223.64  |- skos__hiddenLabel mesh__D015334
% 223.46/223.64       T Cell Antigen Receptor gamma Chain Gene Rearrangement
% 223.46/223.64  |- skos__hiddenLabel mesh__D015334
% 223.46/223.64       Gene Rearrangement, gamma Chain T Cell Antigen Receptor
% 223.46/223.64  |- mesh__recordMaintainer mesh__D015334 TPW
% 223.46/223.64  |- skos__prefLabel mesh__D015334
% 223.46/223.64       Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor
% 223.46/223.64  |- skos__scopeNote mesh__D015334
% 223.46/223.64       Ordered rearrangement of T-cell variable gene regions coding for the gamma-chain of antigen receptors.%A%    
% 223.46/223.64  |- skos__altLabel mesh__D015334
% 223.46/223.64       Gene Rearrangement, gamma-Chain T Cell Antigen Receptor
% 223.46/223.64  |- mesh__recordAuthorizer mesh__D015334 sjn
% 223.46/223.64  |- skos__altLabel mesh__D015334
% 223.46/223.64       T-Lymphocyte Antigen Receptor gamma-Chain Gene Rearrangement
% 223.46/223.64  |- skos__altLabel mesh__D015334 T Lymphocyte gamma-Chain Gene Rearrangement
% 223.46/223.64  |- skos__historyNote mesh__D015334
% 223.46/223.64       Receptors, Antigen, T-Cell/genetics %28%1977-1988%29%
% 223.46/223.64  |- skos__hiddenLabel mesh__D015334 T Cell gamma Chain Gene Rearrangement
% 223.46/223.64  |- skos__historyNote mesh__D015334 DNA/genetics %28%1977-1988%29%
% 223.46/223.64  |- mesh__dateCreated mesh__D015334 1988-06-01
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D015334 2004
% 223.46/223.64  |- mesh__dateRevised mesh__D015334 2002-07-03
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D015334 2006
% 223.46/223.64  |- skos__historyNote mesh__D015334 Genes or specific gene %28%1977-1988%29%
% 223.46/223.64  |- skos__altLabel mesh__D015334 T Cell gamma-Chain Gene Rearrangement
% 223.46/223.64  |- skos__historyNote mesh__D015334
% 223.46/223.64       T Lymphocytes/immunology %28%1977-1988%29%
% 223.46/223.64  |- skos__altLabel mesh__D015334
% 223.46/223.64       T-Cell Antigen Receptor gamma-Chain Gene Rearrangement
% 223.46/223.64  |- skos__annotation mesh__D015334 DF: GENE REARR GAMMA CHAIN   
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D015334 2003
% 223.46/223.64  |- mesh__publicMeSHNote mesh__D015334 89   
% 223.46/223.64  |- mesh__recordOriginator mesh__D015334 EJB
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D015334 2005
% 223.46/223.64  |- skos__hiddenLabel mesh__D015334
% 223.46/223.64       T Lymphocyte gamma Chain Gene Rearrangement
% 223.46/223.64  |- skos__hiddenLabel mesh__D015334
% 223.46/223.64       T Lymphocyte Antigen Receptor gamma Chain Gene Rearrangement
% 223.46/223.64  |- mesh__historyNote mesh__D015334 89   
% 223.46/223.64  |- mesh__dateEstablished mesh__D015334 1988-01-01
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D001314 2005
% 223.46/223.64  |- skos__related mesh__D001314smesh__D006326
% 223.46/223.64  |- skos__broader mesh__D001314smesh__D010808
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D001314 2004
% 223.46/223.64  |- skos__scopeNote mesh__D001314
% 223.46/223.64       Act of listening for sounds within the body.     
% 223.46/223.64  |- mesh__dateRevised mesh__D001314 1997-06-20
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D001314 2003
% 223.46/223.64  |- skos__related mesh__D001314smesh__D019023
% 223.46/223.64  |- skos__prefLabel mesh__D001314 Auscultation
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D001314 2002
% 223.46/223.64  |- mesh__recordMaintainer mesh__D001314 PXP
% 223.46/223.64  |- mesh__dateCreated mesh__D001314 1999-01-01
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D001314 1999
% 223.46/223.64  |- mesh__recordOriginator mesh__D001314 NLM
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D001314 2001
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D001314 1998
% 223.46/223.64  |- skos__annotation mesh__D001314
% 223.46/223.64       /instrum: STETHOSCOPES is also available   
% 223.46/223.64  |- skos__hiddenLabel mesh__D001314 Auscultations
% 223.46/223.64  |- rdf__type mesh__D001314sskos__Concept
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D001314 2006
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D001314 2000
% 223.46/223.64  |- mesh__recordAuthorizer mesh__D001314 SJN
% 223.46/223.64  |- skos__altLabel mesh__D020279
% 223.46/223.64       Hereditary Demyelinating Diseases, Central Nervous System
% 223.46/223.64  |- mesh__dateRevised mesh__D020279 2001-07-25
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D020279 2006
% 223.46/223.64  |- mesh__dateEstablished mesh__D020279 2000-01-01
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D020279 2003
% 223.46/223.64  |- skos__altLabel mesh__D020279
% 223.46/223.64       Central Nervous System Demyelinating Hereditary Diseases
% 223.46/223.64  |- mesh__historyNote mesh__D020279 2000   
% 223.46/223.64  |- skos__prefLabel mesh__D020279
% 223.46/223.64       Hereditary Central Nervous System Demyelinating Diseases
% 223.46/223.64  |- skos__broader mesh__D020279smesh__D020271
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D020279 2002
% 223.46/223.64  |- mesh__recordOriginator mesh__D020279 KEV
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D020279 2004
% 223.46/223.64  |- mesh__recordAuthorizer mesh__D020279 sjn
% 223.46/223.64  |- mesh__dateCreated mesh__D020279 1999-11-03
% 223.46/223.64  |- skos__broader mesh__D020279smesh__D003711
% 223.46/223.64  |- skos__altLabel mesh__D020279
% 223.46/223.64       Demyelinating Diseases, Central Nervous System, Hereditary
% 223.46/223.64  |- mesh__publicMeSHNote mesh__D020279 2000   
% 223.46/223.64  |- skos__altLabel mesh__D020279
% 223.46/223.64       Central Nervous System Hereditary Demyelinating Diseases
% 223.46/223.64  |- mesh__recordMaintainer mesh__D020279 nns
% 223.46/223.64  |- rdf__type mesh__D020279sskos__Concept
% 223.46/223.64  |- skos__altLabel mesh__D020279
% 223.46/223.64       Central Nervous System Demyelinating Diseases, Hereditary
% 223.46/223.64  |- skos__altLabel mesh__D020279
% 223.46/223.64       Demyelinating Central Nervous System Diseases, Hereditary
% 223.46/223.64  |- skos__scopeNote mesh__D020279
% 223.46/223.64       Inherited conditions characterized by a loss of myelin in the central nervous system.%A%    
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D020279 2005
% 223.46/223.64  |- skos__scopeNote mesh__D025762
% 223.46/223.64       An antibiotic mixture originally isolated from Streptomyces pristinaspiralis. It is a mixture of compounds from STREPTOGRAMIN GROUP A: pristinamycin IIA and IIB and from STREPTOGRAMIN GROUP B: pristinamycin IA, pristinamycin IB, pristinamycin IC.%A%    
% 223.46/223.64  |- skos__altLabel mesh__D025762 Aventis Brand of Pristinamycin
% 223.46/223.64  |- skos__altLabel mesh__D025762 RP7293
% 223.46/223.64  |- skos__historyNote mesh__D025762 Virginiamycin %28%1994-2001%29%
% 223.46/223.64  |- skos__broader mesh__D025762smesh__D025361
% 223.46/223.64  |- mesh__recordAuthorizer mesh__D025762 ags
% 223.46/223.64  |- mesh__dateCreated mesh__D025762 2001-07-25
% 223.46/223.64  |- mesh__dateRevised mesh__D025762 2005-07-18
% 223.46/223.64  |- mesh__recordMaintainer mesh__D025762 ags
% 223.46/223.64  |- skos__prefLabel mesh__D025762 Pristinamycin
% 223.46/223.64  |- mesh__historyNote mesh__D025762
% 223.46/223.64       2002; use VIRGINIAMYCIN 1994-2001; for RP7293 and RP 7293 use VIRGINIAMYCIN 1998-2001%A%  
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D025762 2006A
% 223.46/223.64  |- mesh__recordOriginator mesh__D025762 jmp
% 223.46/223.64  |- mesh__publicMeSHNote mesh__D025762
% 223.46/223.64       2002; see VIRGINIAMYCIN 1994-2001, see PRISTINAMYCINS 1981-1993; for RP7293 and RP 7293 see VIRGINIAMYCIN 1998-2001%A%  
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D025762 2006
% 223.46/223.64  |- rdf__type mesh__D025762sskos__Concept
% 223.46/223.64  |- mesh__dateEstablished mesh__D025762 2002-01-01
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011742 1998
% 223.46/223.64  |- mesh__historyNote mesh__D011742 74%28%72%29%   
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011742 1996
% 223.46/223.64  |- rdf__type mesh__D011742sskos__Concept
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011742 2000
% 223.46/223.64  |- mesh__recordOriginator mesh__D011742 NLM
% 223.46/223.64  |- mesh__publicMeSHNote mesh__D011742 74   
% 223.46/223.64  |- mesh__recordAuthorizer mesh__D011742 PLS
% 223.46/223.64  |- skos__hiddenLabel mesh__D011742 Nucleotides, Pyrimidine
% 223.46/223.64  |- mesh__dateCreated mesh__D011742 1999-01-01
% 223.46/223.64  |- skos__prefLabel mesh__D011742 Pyrimidine Nucleotides
% 223.46/223.64  |- skos__broader mesh__D011742smesh__D009711
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011742 2002
% 223.46/223.64  |- mesh__dateEstablished mesh__D011742 1974-01-01
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011742 1995
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011742 2006
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011742 1993
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011742 2004
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011742 1999
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011742 1994
% 223.46/223.64  |- mesh__dateRevised mesh__D011742 1992-05-20
% 223.46/223.64  |- mesh__recordMaintainer mesh__D011742 TGC
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011742 2005
% 223.46/223.64  |- skos__historyNote mesh__D011742 Nucleotides %28%1966-1971%29%
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011742 1997
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011742 2003
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011742 2001
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D005705 2005
% 223.46/223.64  |- skos__hiddenLabel mesh__D005705 Disease, Gall Bladder
% 223.46/223.64  |- mesh__recordMaintainer mesh__D005705 lkt
% 223.46/223.64  |- rdf__type mesh__D005705sskos__Concept
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D005705 2006
% 223.46/223.64  |- skos__hiddenLabel mesh__D005705 Disease, Gallbladder
% 223.46/223.64  |- skos__hiddenLabel mesh__D005705 Diseases, Gallbladder
% 223.46/223.64  |- skos__hiddenLabel mesh__D005705 Bladder Disease, Gall
% 223.46/223.64  |- mesh__recordOriginator mesh__D005705 NLM
% 223.46/223.64  |- mesh__dateCreated mesh__D005705 1999-01-01
% 223.46/223.64  |- skos__hiddenLabel mesh__D005705 Gall Bladder Disease
% 223.46/223.64  |- mesh__recordAuthorizer mesh__D005705 sjn
% 223.46/223.64  |- skos__altLabel mesh__D005705 Gall Bladder Diseases
% 223.46/223.64  |- mesh__dateRevised mesh__D005705 2003-07-09
% 223.46/223.64  |- skos__prefLabel mesh__D005705 Gallbladder Diseases
% 223.46/223.64  |- skos__hiddenLabel mesh__D005705 Gallbladder Disease
% 223.46/223.64  |- skos__hiddenLabel mesh__D005705 Bladder Diseases, Gall
% 223.46/223.64  |- skos__broader mesh__D005705smesh__D001660
% 223.46/223.64  |- skos__scopeNote mesh__D005705
% 223.46/223.64       Diseases of the GALLBLADDER. They generally involve the impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, neoplasms, or other diseases.%A%    
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D005705 2004
% 223.46/223.64  |- skos__annotation mesh__D005705
% 223.46/223.64       inflamm dis = CHOLECYSTITIS; calculi = GALLSTONES but consider also CHOLECYSTOLITHIASIS%A%  
% 223.46/223.64  |- skos__hiddenLabel mesh__D005705 Diseases, Gall Bladder
% 223.46/223.64  |- mesh__recordOriginator mesh__D015335 EJB
% 223.46/223.64  |- mesh__historyNote mesh__D015335 89   
% 223.46/223.64  |- skos__broader mesh__D015335smesh__D019995
% 223.46/223.64  |- mesh__recordMaintainer mesh__D015335 nns
% 223.46/223.64  |- skos__prefLabel mesh__D015335 Molecular Probes
% 223.46/223.64  |- mesh__dateCreated mesh__D015335 1988-06-01
% 223.46/223.64  |- skos__scopeNote mesh__D015335
% 223.46/223.64       A group of atoms or molecules attached to other molecules or cellular structures and used in studying the properties of these molecules and structures. Radioactive DNA or RNA sequences are used in MOLECULAR GENETICS to detect the presence of a complementary sequence by NUCLEIC ACID HYBRIDIZATION.%A%    
% 223.46/223.64  |- skos__annotation mesh__D015335
% 223.46/223.64       MOLECULAR PROBE TECHNIQUES is also available; DF: MOL PROBES%A%  
% 223.46/223.64  |- mesh__dateEstablished mesh__D015335 1989-01-01
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D015335 2006
% 223.46/223.64  |- skos__altLabel mesh__D015335 Probes, Molecular
% 223.46/223.64  |- mesh__recordAuthorizer mesh__D015335 sjn
% 223.46/223.64  |- mesh__dateRevised mesh__D015335 2005-06-30
% 223.46/223.64  |- skos__altLabel mesh__D015335 Probe, Molecular
% 223.46/223.64  |- mesh__publicMeSHNote mesh__D015335 89   
% 223.46/223.64  |- skos__altLabel mesh__D015335 Molecular Probe
% 223.46/223.64  |- rdf__type mesh__D015335sskos__Concept
% 223.46/223.64  |- skos__prefLabel mesh__D001315 Australia
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D001315 2004
% 223.46/223.64  |- skos__broader mesh__D001315smesh__D044362
% 223.46/223.64  |- mesh__recordMaintainer mesh__D001315 jls
% 223.46/223.64  |- mesh__dateRevised mesh__D001315 2003-07-09
% 223.46/223.64  |- skos__broader mesh__D001315smesh__D005842
% 223.46/223.64  |- mesh__dateCreated mesh__D001315 1999-01-01
% 223.46/223.64  |- skos__scopeNote mesh__D001315
% 223.46/223.64       The smallest continent and an independent country, comprising six states and two territories. Its capital is Canberra.%A%    
% 223.46/223.64  |- skos__annotation mesh__D001315
% 223.46/223.64       each of the states is available; Australasia = Oceania + Australia + New Zealand: do not confuse with Australia, check text %26% index probably under AUSTRALIA or NEW ZEALAND or both%A%  
% 223.46/223.64  |- mesh__recordAuthorizer mesh__D001315 sjn
% 223.46/223.64  |- rdf__type mesh__D001315sskos__Concept
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D001315 2006
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D001315 2005
% 223.46/223.64  |- mesh__recordOriginator mesh__D001315 NLM
% 223.46/223.64  |- skos__broader mesh__D001652Q000530smesh__D001652
% 223.46/223.64  |- mesh__preferredCombination mesh__D001652Q000530smesh__D002758
% 223.46/223.64  |- rdf__type mesh__D001652Q000530smesh__CompoundConcept
% 223.46/223.64  |- skos__broader mesh__D006000smesh__D002793
% 223.46/223.64  |- skos__altLabel mesh__D006000 Glycocholic Acid, Sodium Salt
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D006000 2004
% 223.46/223.64  |- mesh__historyNote mesh__D006000 78%28%73%29%   
% 223.46/223.64  |- rdf__type mesh__D006000sskos__Concept
% 223.46/223.64  |- skos__altLabel mesh__D006000 Glycocholate
% 223.46/223.64  |- mesh__publicMeSHNote mesh__D006000 78   
% 223.46/223.64  |- mesh__dateRevised mesh__D006000 2003-07-09
% 223.46/223.64  |- skos__altLabel mesh__D006000 Cholylglycine
% 223.46/223.64  |- mesh__recordMaintainer mesh__D006000 jmp
% 223.46/223.64  |- skos__scopeNote mesh__D006000
% 223.46/223.64       The glycine conjugate of CHOLIC ACID. It acts as a detergent to solubilize fats for absorption and is itself absorbed.%A%    
% 223.46/223.64  |- skos__broader mesh__D006000smesh__D034442
% 223.46/223.64  |- mesh__dateCreated mesh__D006000 1999-01-01
% 223.46/223.64  |- mesh__recordOriginator mesh__D006000 NLM
% 223.46/223.64  |- mesh__recordAuthorizer mesh__D006000 sjn
% 223.46/223.64  |- skos__prefLabel mesh__D006000 Glycocholic Acid
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D006000 2006
% 223.46/223.64  |- mesh__dateEstablished mesh__D006000 1978-01-01
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D006000 2005
% 223.46/223.64  |- mesh__recordAuthorizer mesh__D025763 sjn
% 223.46/223.64  |- mesh__recordOriginator mesh__D025763 jmp
% 223.46/223.64  |- mesh__dateCreated mesh__D025763 2001-07-25
% 223.46/223.64  |- mesh__dateEstablished mesh__D025763 2002-01-01
% 223.46/223.64  |- mesh__historyNote mesh__D025763 2002; use VIRGINIAMYCIN 1994-2001   
% 223.46/223.64  |- mesh__recordMaintainer mesh__D025763 ssb
% 223.46/223.64  |- mesh__publicMeSHNote mesh__D025763 2002; see VIRGINIAMYCIN 1994-2001   
% 223.46/223.64  |- skos__scopeNote mesh__D025763
% 223.46/223.64       An antibiotic mixture originally isolated from Streptomyces loidensis. It contains a mixture of compounds belonging to STREPTOGRAMIN GROUP A and STREPTOGRAMIN GROUP B.%A%    
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D025763 2005
% 223.46/223.64  |- skos__prefLabel mesh__D025763 Vernamycin B
% 223.46/223.64  |- skos__broader mesh__D025763smesh__D025361
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D025763 2006
% 223.46/223.64  |- mesh__dateRevised mesh__D025763 2004-07-07
% 223.46/223.64  |- rdf__type mesh__D025763sskos__Concept
% 223.46/223.64  |- skos__historyNote mesh__D025763 Virginiamycin %28%1993-2001%29%
% 223.46/223.64  |- skos__annotation mesh__D019726
% 223.46/223.64       add UNITED STATES %28%NIM%29%      CATALOG: use NAF entry   
% 223.46/223.64  |- mesh__dateRevised mesh__D019726 2001-07-25
% 223.46/223.64  |- skos__hiddenLabel mesh__D019726
% 223.46/223.64       United States Patient Self Determination Act
% 223.46/223.64  |- skos__prefLabel mesh__D019726 Patient Self-Determination Act
% 223.46/223.64  |- skos__hiddenLabel mesh__D019726 101-508, Public Law
% 223.46/223.64  |- mesh__recordAuthorizer mesh__D019726 sjn
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D019726 2004
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D019726 2006
% 223.46/223.64  |- skos__hiddenLabel mesh__D019726 PL 101 508
% 223.46/223.64  |- skos__scopeNote mesh__D019726
% 223.46/223.64       The purpose of this 1990 federal act is to assure that individuals receiving health care services will be given an opportunity to participate in and direct health care decisions affecting themselves. Under this act, hospitals, health care agencies, and health maintenance organizations are responsible for developing patient information for distribution. The information must include patients%27% rights, advance directives, living wills, ethics committees%27% consultation and education functions, limited medical treatment %28%support/comfort care only%29%, mental health treatment, resuscitation, restraints, surrogate decision making and transfer of care. %28%from JCAHO, Lexicon, 1994%29%%A%    
% 223.46/223.64  |- mesh__publicMeSHNote mesh__D019726 99   
% 223.46/223.64  |- skos__related mesh__D019726smesh__D016223
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D019726 2003
% 223.46/223.64  |- mesh__historyNote mesh__D019726 99   
% 223.46/223.64  |- mesh__dateCreated mesh__D019726 1998-06-10
% 223.46/223.64  |- mesh__recordOriginator mesh__D019726 JLS
% 223.46/223.64  |- skos__altLabel mesh__D019726 PL 101-508
% 223.46/223.64  |- rdf__type mesh__D019726sskos__Concept
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D019726 2005
% 223.46/223.64  |- skos__hiddenLabel mesh__D019726 Public Law 101 508
% 223.46/223.64  |- skos__hiddenLabel mesh__D019726 Patient Self Determination Act
% 223.46/223.64  |- skos__hiddenLabel mesh__D019726 PL101 508
% 223.46/223.64  |- mesh__recordMaintainer mesh__D019726 jls
% 223.46/223.64  |- skos__hiddenLabel mesh__D019726 Law 101-508, Public
% 223.46/223.64  |- skos__broader mesh__D019726smesh__D007882
% 223.46/223.64  |- skos__altLabel mesh__D019726 PSDA
% 223.46/223.64  |- mesh__dateEstablished mesh__D019726 1999-01-01
% 223.46/223.64  |- skos__hiddenLabel mesh__D019726 Self-Determination Act, Patient
% 223.46/223.64  |- skos__altLabel mesh__D019726 Public Law 101-508
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D019726 2002
% 223.46/223.64  |- skos__altLabel mesh__D019726 PL101-508
% 223.46/223.64  |- skos__altLabel mesh__D019726
% 223.46/223.64       United States Patient Self-Determination Act
% 223.46/223.64  |- mesh__dateCreated mesh__D011743 1999-01-01
% 223.46/223.64  |- skos__scopeNote mesh__D011743
% 223.46/223.64       A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents %28%CYTOSINE; THYMINE; and URACIL%29% and form the basic structure of the barbiturates.%A%    
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011743 2006
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011743 2004
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011743 2005
% 223.46/223.64  |- mesh__recordOriginator mesh__D011743 NLM
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011743 2003
% 223.46/223.64  |- mesh__historyNote mesh__D011743
% 223.46/223.64       THONZYLAMINE was heading 1972-84 %28%Prov 1972%29%   
% 223.46/223.64  |- skos__prefLabel mesh__D011743 Pyrimidines
% 223.46/223.64  |- rdf__type mesh__D011743sskos__Concept
% 223.46/223.64  |- mesh__dateRevised mesh__D011743 2001-07-25
% 223.46/223.64  |- mesh__recordMaintainer mesh__D011743 mdb
% 223.46/223.64  |- mesh__recordAuthorizer mesh__D011743 sjn
% 223.46/223.64  |- mesh__onlineNote mesh__D011743
% 223.46/223.64       use PYRIMIDINES to search THONZYLAMINE 1972-84 %28%as Prov 1972%29%%A%  
% 223.46/223.64  |- skos__broader mesh__D011743smesh__D006573
% 223.46/223.64  |- mesh__publicMeSHNote mesh__D011743 THONZYLAMINE was heading 1973-84   
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D011743 2002
% 223.46/223.64  |- mesh__dateRevised mesh__D005706 2003-07-09
% 223.46/223.64  |- skos__broader mesh__D005706smesh__D001661
% 223.46/223.64  |- skos__altLabel mesh__D005706 Cancer of the Gallbladder
% 223.46/223.64  |- skos__prefLabel mesh__D005706 Gallbladder Neoplasms
% 223.46/223.64  |- skos__hiddenLabel mesh__D005706 Gallbladder Neoplasm
% 223.46/223.64  |- mesh__dateCreated mesh__D005706 1999-01-01
% 223.46/223.64  |- skos__broader mesh__D005706smesh__D005705
% 223.46/223.64  |- skos__scopeNote mesh__D005706 Tumors or cancer of the gallbladder.     
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D005706 2006
% 223.46/223.64  |- rdf__type mesh__D005706sskos__Concept
% 223.46/223.64  |- skos__hiddenLabel mesh__D005706 Neoplasm, Gallbladder
% 223.46/223.64  |- skos__annotation mesh__D005706
% 223.46/223.64       coord IM with histol type of neopl %28%IM%29%   
% 223.46/223.64  |- skos__hiddenLabel mesh__D005706 Gallbladder Cancers
% 223.46/223.64  |- skos__hiddenLabel mesh__D005706 Cancers, Gallbladder
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D005706 2005
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D005706 2004
% 223.46/223.64  |- mesh__recordAuthorizer mesh__D005706 sjn
% 223.46/223.64  |- mesh__recordOriginator mesh__D005706 NLM
% 223.46/223.64  |- skos__hiddenLabel mesh__D005706 Cancer, Gallbladder
% 223.46/223.64  |- mesh__recordMaintainer mesh__D005706 lkt
% 223.46/223.64  |- skos__altLabel mesh__D005706 Neoplasms, Gallbladder
% 223.46/223.64  |- skos__altLabel mesh__D005706 Gallbladder Cancer
% 223.46/223.64  |- skos__broader mesh__D011766Q000172smesh__D011766
% 223.46/223.64  |- mesh__preferredCombination mesh__D011766Q000172smesh__D015324
% 223.46/223.64  |- rdf__type mesh__D011766Q000172smesh__CompoundConcept
% 223.46/223.64  |- mesh__publicMeSHNote mesh__D015336
% 223.46/223.64       91; was MOLECULAR PROBE TECHNICS 1989-90   
% 223.46/223.64  |- skos__annotation mesh__D015336
% 223.46/223.64       specific probes are indented under MOLECULAR PROBES; DF: MOL PROBE TECHNIQUES%A%  
% 223.46/223.64  |- skos__broader mesh__D015336smesh__D005821
% 223.46/223.64  |- skos__altLabel mesh__D015336 Molecular Probe Technic
% 223.46/223.64  |- skos__altLabel mesh__D015336 Molecular Probe Technics
% 223.46/223.64  |- skos__hiddenLabel mesh__D015336 Probe Techniques, Molecular
% 223.46/223.64  |- mesh__recordOriginator mesh__D015336 EJB
% 223.46/223.64  |- mesh__dateCreated mesh__D015336 1988-06-01
% 223.46/223.64  |- skos__scopeNote mesh__D015336
% 223.46/223.64       The use of devices which use detector molecules to detect, investigate, or analyze other molecules, macromolecules, molecular aggregates, or organisms.%A%    
% 223.46/223.64  |- skos__altLabel mesh__D015336 Technics, Molecular Probe
% 223.46/223.64  |- skos__hiddenLabel mesh__D015336 Probe Technic, Molecular
% 223.46/223.64  |- skos__altLabel mesh__D015336 Technique, Molecular Probe
% 223.46/223.64  |- mesh__recordMaintainer mesh__D015336 nns
% 223.46/223.64  |- skos__altLabel mesh__D015336 Technic, Molecular Probe
% 223.46/223.64  |- mesh__dateEstablished mesh__D015336 1989-01-01
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D015336 2006
% 223.46/223.64  |- skos__hiddenLabel mesh__D015336 Probe Technique, Molecular
% 223.46/223.64  |- skos__hiddenLabel mesh__D015336 Probe Technics, Molecular
% 223.46/223.64  |- mesh__onlineNote mesh__D015336
% 223.46/223.64       use MOLECULAR PROBE TECHNIQUES to search MOLECULAR PROBE TECHNICS 1989-90%A%  
% 223.46/223.64  |- mesh__recordAuthorizer mesh__D015336 sjn
% 223.46/223.64  |- rdf__type mesh__D015336sskos__Concept
% 223.46/223.64  |- mesh__dateRevised mesh__D015336 2005-06-30
% 223.46/223.64  |- skos__altLabel mesh__D015336 Techniques, Molecular Probe
% 223.46/223.64  |- skos__broader mesh__D015336smesh__D008919
% 223.46/223.64  |- skos__prefLabel mesh__D015336 Molecular Probe Techniques
% 223.46/223.64  |- skos__altLabel mesh__D015336 Molecular Probe Technique
% 223.46/223.64  |- mesh__historyNote mesh__D015336
% 223.46/223.64       91; was MOLECULAR PROBE TECHNICS 1989-90   
% 223.46/223.64  |- skos__historyNote mesh__D006001 Peptidoglycan %28%1971-1987%29%
% 223.46/223.64  |- skos__historyNote mesh__D006001 Glycoproteins %28%1966-1987%29%
% 223.46/223.64  |- skos__broader mesh__D006001smesh__D002241
% 223.46/223.64  |- skos__prefLabel mesh__D006001 Glycoconjugates
% 223.46/223.64  |- mesh__dateRevised mesh__D006001 2004-07-07
% 223.46/223.64  |- mesh__dateEstablished mesh__D006001 1988-01-01
% 223.46/223.64  |- skos__annotation mesh__D006001 GEN: prefer specific glycoconjugate   
% 223.46/223.64  |- skos__historyNote mesh__D006001 Glycolipids %28%1966-1987%29%
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D006001 2006
% 223.46/223.64  |- skos__scopeNote mesh__D006001
% 223.46/223.64       Carbohydrates covalently linked to a nonsugar moiety %28%lipids or proteins%29%. The major glycoconjugates are glycoproteins, glycopeptides, peptidoglycans, glycolipids, and lipopolysaccharides. %28%From Biochemical Nomenclature and Related Documents, 2d ed; From Principles of Biochemistry, 2d ed%29%%A%    
% 223.46/223.64  |- mesh__recordOriginator mesh__D006001 RLS
% 223.46/223.64  |- mesh__activeMeSHYear mesh__D006001 2005
% 223.46/223.64  |- mesh__dateCreated mesh__D006001 1987-03-23
% 223.46/223.65  |- skos__historyNote mesh__D006001 Glycopeptides %28%1971-1987%29%
% 223.46/223.65  |- mesh__historyNote mesh__D006001 88   
% 223.46/223.65  |- mesh__recordMaintainer mesh__D006001 ssb
% 223.46/223.65  |- mesh__publicMeSHNote mesh__D006001 88   
% 223.46/223.65  |- mesh__recordAuthorizer mesh__D006001 sjn
% 223.46/223.65  |- skos__historyNote mesh__D006001 Lipopolysaccharides %28%1966-1987%29%
% 223.46/223.65  |- rdf__type mesh__D006001sskos__Concept
% 223.46/223.65  |- skos__broader mesh__D025764smesh__D024003
% 223.46/223.65  |- skos__scopeNote mesh__D025764
% 223.46/223.65       An AT-hook-containing %28%AT-HOOK MOTIFS%29% nuclear protein that may be involved in retinoid-dependent transcriptional activity.%A%    
% 223.46/223.65  |- skos__historyNote mesh__D025764
% 223.46/223.65       High Mobility Group Proteins %28%1995-2001%29%
% 223.46/223.65  |- skos__hiddenLabel mesh__D025764 AT Hook 1c Protein, High Mobility Group
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D025764 2003
% 223.46/223.65  |- mesh__dateEstablished mesh__D025764 2002-01-01
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D025764 2004
% 223.46/223.65  |- skos__hiddenLabel mesh__D025764 HMG I/R Protein
% 223.46/223.65  |- mesh__historyNote mesh__D025764 2002   
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D025764 2005
% 223.46/223.65  |- mesh__dateCreated mesh__D025764 2001-07-25
% 223.46/223.65  |- skos__prefLabel mesh__D025764 HMGA1c Protein
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D025764 2006
% 223.46/223.65  |- rdf__type mesh__D025764sskos__Concept
% 223.46/223.65  |- skos__altLabel mesh__D025764 AT-Hook 1c Protein, High Mobility Group
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D025764 2002
% 223.46/223.65  |- skos__altLabel mesh__D025764 HMG-I/R Protein
% 223.46/223.65  |- mesh__publicMeSHNote mesh__D025764 2002   
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D019727 2001
% 223.46/223.65  |- skos__prefLabel mesh__D019727 Proxy
% 223.46/223.65  |- mesh__dateCreated mesh__D019727 1998-06-18
% 223.46/223.65  |- mesh__recordAuthorizer mesh__D019727 sjn
% 223.46/223.65  |- skos__hiddenLabel mesh__D019727 Proxies
% 223.46/223.65  |- skos__related mesh__D019727smesh__D020458
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D019727 2000
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D019727 2004
% 223.46/223.65  |- skos__related mesh__D019727smesh__D016312
% 223.46/223.65  |- rdf__type mesh__D019727sskos__Concept
% 223.46/223.65  |- skos__scopeNote mesh__D019727
% 223.46/223.65       A person authorized to decide or act for another person, for example, a person having durable power of attorney.%A%    
% 223.46/223.65  |- skos__hiddenLabel mesh__D019727 Agents, Patient
% 223.46/223.65  |- mesh__recordMaintainer mesh__D019727 jls
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D019727 2003
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D019727 2006
% 223.46/223.65  |- skos__hiddenLabel mesh__D019727 Agent, Patient
% 223.46/223.65  |- mesh__publicMeSHNote mesh__D019727 99   
% 223.46/223.65  |- mesh__dateRevised mesh__D019727 1999-11-03
% 223.46/223.65  |- mesh__recordOriginator mesh__D019727 JLS
% 223.46/223.65  |- mesh__historyNote mesh__D019727 99   
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D019727 2005
% 223.46/223.65  |- mesh__dateEstablished mesh__D019727 1999-01-01
% 223.46/223.65  |- skos__broader mesh__D019727smesh__D007872
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D019727 2002
% 223.46/223.65  |- mesh__recordAuthorizer mesh__D011744 PLS
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011744 1995
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011744 2006
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011744 1993
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011744 2002
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011744 2004
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011744 1999
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011744 1994
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011744 2005
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011744 1997
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011744 2003
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011744 1998
% 223.46/223.65  |- mesh__dateRevised mesh__D011744 1992-05-20
% 223.46/223.65  |- mesh__recordMaintainer mesh__D011744 TAP
% 223.46/223.65  |- rdf__type mesh__D011744sskos__Concept
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011744 1996
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011744 2001
% 223.46/223.65  |- mesh__recordOriginator mesh__D011744 NLM
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011744 2000
% 223.46/223.65  |- mesh__publicMeSHNote mesh__D011744 68   
% 223.46/223.65  |- skos__prefLabel mesh__D011744 Pyrimidinones
% 223.46/223.65  |- mesh__dateEstablished mesh__D011744 1968-01-01
% 223.46/223.65  |- mesh__dateCreated mesh__D011744 1999-01-01
% 223.46/223.65  |- skos__broader mesh__D011744smesh__D011743
% 223.46/223.65  |- mesh__historyNote mesh__D011744 68%28%66%29%   
% 223.46/223.65  |- mesh__recordOriginator mesh__D005707 NLM
% 223.46/223.65  |- mesh__dateCreated mesh__D005707 1999-01-01
% 223.46/223.65  |- skos__prefLabel mesh__D005707 Gallic Acid
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D005707 2006
% 223.46/223.65  |- rdf__type mesh__D005707sskos__Concept
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D005707 2002
% 223.46/223.65  |- mesh__recordAuthorizer mesh__D005707 SJN
% 223.46/223.65  |- skos__altLabel mesh__D005707 3,4,5-Trihydroxybenzoic Acid
% 223.46/223.65  |- mesh__recordMaintainer mesh__D005707 ADP
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D005707 2005
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D005707 1999
% 223.46/223.65  |- skos__broader mesh__D005707smesh__D006883
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D005707 2001
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D005707 2004
% 223.46/223.65  |- skos__hiddenLabel mesh__D005707 Acid, Gallic
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D005707 2000
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D005707 2003
% 223.46/223.65  |- skos__scopeNote mesh__D005707
% 223.46/223.65       A colorless or slightly yellow crystalline compound obtained from nutgalls. It is used in photography, pharmaceuticals, and as an analytical reagent.%A%    
% 223.46/223.65  |- mesh__dateRevised mesh__D005707 1998-06-10
% 223.46/223.65  |- mesh__dateCreated mesh__D015337 1988-06-01
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D015337 2005
% 223.46/223.65  |- mesh__recordAuthorizer mesh__D015337 sjn
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D015337 2004
% 223.46/223.65  |- skos__related mesh__D015337smesh__D017327
% 223.46/223.65  |- skos__hiddenLabel mesh__D015337 Studies, Multicentre
% 223.46/223.65  |- skos__prefLabel mesh__D015337 Multicenter Studies
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D015337 2006
% 223.46/223.65  |- mesh__recordMaintainer mesh__D015337 ags
% 223.46/223.65  |- mesh__dateEstablished mesh__D015337 1989-01-01
% 223.46/223.65  |- skos__altLabel mesh__D015337 Multicenter Study
% 223.46/223.65  |- skos__scopeNote mesh__D015337
% 223.46/223.65       Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children.%A%    
% 223.46/223.65  |- mesh__publicMeSHNote mesh__D015337 89   
% 223.46/223.65  |- skos__altLabel mesh__D015337 Multicentre Trials
% 223.46/223.65  |- skos__related mesh__D015337smesh__D017326
% 223.46/223.65  |- skos__hiddenLabel mesh__D015337 Multicentre Study
% 223.46/223.65  |- skos__altLabel mesh__D015337 Multicentre Studies
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D015337 2002
% 223.46/223.65  |- skos__hiddenLabel mesh__D015337 Multicentre Trial
% 223.46/223.65  |- rdf__type mesh__D015337sskos__Concept
% 223.46/223.65  |- mesh__dateRevised mesh__D015337 2001-07-25
% 223.46/223.65  |- skos__hiddenLabel mesh__D015337 Trials, Multicenter
% 223.46/223.65  |- mesh__historyNote mesh__D015337 89   
% 223.46/223.65  |- mesh__recordOriginator mesh__D015337 EC
% 223.46/223.65  |- skos__hiddenLabel mesh__D015337 Trials, Multicentre
% 223.46/223.65  |- skos__broader mesh__D015337smesh__D002986
% 223.46/223.65  |- skos__annotation mesh__D015337
% 223.46/223.65       IM as a method in med research: do not confuse with Publication Type MULTICENTER STUDY; specify geog if pertinent%A%  
% 223.46/223.65  |- skos__hiddenLabel mesh__D015337 Studies, Multicenter
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D015337 2003
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001317 1991
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001317 1993
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001317 1998
% 223.46/223.65  |- rdf__type mesh__D001317sskos__Concept
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001317 2006
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001317 1997
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001317 1990
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001317 1992
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001317 2005
% 223.46/223.65  |- skos__broader mesh__D001317smesh__D005060
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001317 2002
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001317 1996
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001317 2004
% 223.46/223.65  |- mesh__recordOriginator mesh__D001317 NLM
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001317 2001
% 223.46/223.65  |- skos__prefLabel mesh__D001317 Austria
% 223.46/223.65  |- mesh__recordMaintainer mesh__D001317 PLS
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001317 2003
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001317 1989
% 223.46/223.65  |- mesh__dateRevised mesh__D001317 1991-11-02
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001317 1995
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001317 2000
% 223.46/223.65  |- mesh__dateCreated mesh__D001317 1999-01-01
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001317 1999
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001317 1994
% 223.46/223.65  |- mesh__recordAuthorizer mesh__D001317 PLS
% 223.46/223.65  |- mesh__recordOriginator mesh__D006800 RC
% 223.46/223.65  |- mesh__dateEstablished mesh__D006800 1987-01-01
% 223.46/223.65  |- skos__prefLabel mesh__D006800 Deltaretrovirus Infections
% 223.46/223.65  |- skos__broader mesh__D006800smesh__D012192
% 223.46/223.65  |- mesh__recordAuthorizer mesh__D006800 sjn
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D006800 2006
% 223.46/223.65  |- skos__broader mesh__D006800smesh__D007153
% 223.46/223.65  |- mesh__dateRevised mesh__D006800 2004-07-13
% 223.46/223.65  |- mesh__recordMaintainer mesh__D006800 sjn
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D006800 2005
% 223.46/223.65  |- mesh__historyNote mesh__D006800 2002 %28%1987%29%   
% 223.46/223.65  |- mesh__dateCreated mesh__D006800 1986-06-17
% 223.46/223.65  |- skos__hiddenLabel mesh__D006800 Infections, Deltaretrovirus
% 223.46/223.65  |- skos__hiddenLabel mesh__D006800 HTLV BLV Infections
% 223.46/223.65  |- skos__annotation mesh__D006800
% 223.46/223.65       GEN or unspecified only: prefer specifics; do not confuse X ref BLV INFECTIONS with ENZOOTIC BOVINE LEUKOSIS %28%see MeSH definition%29%; DF: HTLV INFECT%A%  
% 223.46/223.65  |- skos__historyNote mesh__D006800
% 223.46/223.65       Human T-Cell Leukemia Virus %28%1984-1986%29%
% 223.46/223.65  |- skos__historyNote mesh__D006800 Retrovirus Infections %28%1981-1986%29%
% 223.46/223.65  |- skos__hiddenLabel mesh__D006800 HTLV Infection
% 223.46/223.65  |- skos__hiddenLabel mesh__D006800 BLV Infection
% 223.46/223.65  |- skos__hiddenLabel mesh__D006800 Infection, Deltaretrovirus
% 223.46/223.65  |- skos__scopeNote mesh__D006800
% 223.46/223.65       Infections caused by the HTLV or BLV deltaretroviruses. They include human T-cell leukemia-lymphoma %28%LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED%29%.%A%    
% 223.46/223.65  |- mesh__publicMeSHNote mesh__D006800
% 223.46/223.65       2002; see HTLV-BLV INFECTIONS 1995-2001, see HTLV INFECTIONS 1987-1994%A%  
% 223.46/223.65  |- skos__altLabel mesh__D006800 HTLV-BLV Infections
% 223.46/223.65  |- skos__hiddenLabel mesh__D006800 HTLV-BLV Infection
% 223.46/223.65  |- rdf__type mesh__D006800sskos__Concept
% 223.46/223.65  |- skos__hiddenLabel mesh__D006800 Deltaretrovirus Infection
% 223.46/223.65  |- skos__annotation mesh__D006002
% 223.46/223.65       a bile acid; /biosyn /physiol permitted   
% 223.46/223.65  |- skos__broader mesh__D006002smesh__D006000
% 223.46/223.65  |- rdf__type mesh__D006002sskos__Concept
% 223.46/223.65  |- skos__historyNote mesh__D006002 Glycine %28%1966-1977%29%
% 223.46/223.65  |- skos__hiddenLabel mesh__D006002 Acid, Glycodeoxycholic
% 223.46/223.65  |- mesh__publicMeSHNote mesh__D006002
% 223.46/223.65       91; was see under DEOXYCHOLIC ACID 1978-90   
% 223.46/223.65  |- mesh__recordOriginator mesh__D006002 SH
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D006002 2005
% 223.46/223.65  |- skos__prefLabel mesh__D006002 Glycodeoxycholic Acid
% 223.46/223.65  |- mesh__recordAuthorizer mesh__D006002 sjn
% 223.46/223.65  |- skos__historyNote mesh__D006002 Bile Acids and Salts %28%1966-1972%29%
% 223.46/223.65  |- mesh__historyNote mesh__D006002
% 223.46/223.65       91%28%78%29%; was see under DEOXYCHOLIC ACID 1978-90   
% 223.46/223.65  |- skos__broader mesh__D006002smesh__D003840
% 223.46/223.65  |- skos__scopeNote mesh__D006002
% 223.46/223.65       A bile salt formed in the liver by conjugation of deoxycholate with glycine, usually as the sodium salt. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and choleretic.%A%    
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D006002 2006
% 223.46/223.65  |- mesh__dateCreated mesh__D006002 1977-03-01
% 223.46/223.65  |- skos__historyNote mesh__D006002 Glycocholic Acid %28%1973-1977%29%
% 223.46/223.65  |- skos__altLabel mesh__D006002 Glycodeoxycholate
% 223.46/223.65  |- mesh__dateEstablished mesh__D006002 1991-01-01
% 223.46/223.65  |- skos__altLabel mesh__D006002 Deoxycholylglycine
% 223.46/223.65  |- skos__hiddenLabel mesh__D006002 Deoxycholate, Glycine
% 223.46/223.65  |- mesh__recordMaintainer mesh__D006002 jmp
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D006002 2004
% 223.46/223.65  |- mesh__dateRevised mesh__D006002 2003-07-09
% 223.46/223.65  |- skos__historyNote mesh__D006002 Deoxycholic Acid %28%1973-1977%29%
% 223.46/223.65  |- mesh__dateEstablished mesh__D025765 2002-01-01
% 223.46/223.65  |- skos__altLabel mesh__D025765 Box Protein 3, High Mobility Group
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D025765 2005
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D025765 2002
% 223.46/223.65  |- skos__historyNote mesh__D025765
% 223.46/223.65       High Mobility Group Proteins %28%1998-2001%29%
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D025765 2006
% 223.46/223.65  |- rdf__type mesh__D025765sskos__Concept
% 223.46/223.65  |- skos__prefLabel mesh__D025765 HMGB3 Protein
% 223.46/223.65  |- mesh__publicMeSHNote mesh__D025765 2002   
% 223.46/223.65  |- skos__altLabel mesh__D025765 HMG-4
% 223.46/223.65  |- skos__altLabel mesh__D025765 HMG2a
% 223.46/223.65  |- skos__scopeNote mesh__D025765
% 223.46/223.65       An HMG-box domain %28%HMG-BOX DOMAINS%29% found highly expressed in embryonic tissue and in placenta.%A%    
% 223.46/223.65  |- skos__broader mesh__D025765smesh__D024002
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D025765 2003
% 223.46/223.65  |- skos__altLabel mesh__D025765 HMG2a Protein
% 223.46/223.65  |- mesh__historyNote mesh__D025765 2002   
% 223.46/223.65  |- mesh__dateCreated mesh__D025765 2001-07-25
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D025765 2004
% 223.46/223.65  |- skos__altLabel mesh__D019728 LMWK
% 223.46/223.65  |- mesh__publicMeSHNote mesh__D019728 98; see KININOGENS 1989-97   
% 223.46/223.65  |- skos__altLabel mesh__D019728 Low-Molecular-Weight Kininogens
% 223.46/223.65  |- skos__scopeNote mesh__D019728
% 223.46/223.65       A protein, molecular weight 50 kD, located in various normal tissues. Upon cleavage by KALLIKREINS, it forms KALLIDIN. Kallidin, in turn, is converted into BRADYKININ. %28%From Stedman, 25th ed%29%%A%    
% 223.46/223.65  |- mesh__recordAuthorizer mesh__D019728 sjn
% 223.46/223.65  |- rdf__type mesh__D019728sskos__Concept
% 223.46/223.65  |- mesh__recordMaintainer mesh__D019728 ssb
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D019728 2006
% 223.46/223.65  |- mesh__dateEstablished mesh__D019728 1998-01-01
% 223.46/223.65  |- mesh__recordOriginator mesh__D019728 ADP
% 223.46/223.65  |- skos__prefLabel mesh__D019728 Kininogen, Low-Molecular-Weight
% 223.46/223.65  |- mesh__historyNote mesh__D019728 98; use KININOGENS 1989-97   
% 223.46/223.65  |- skos__annotation mesh__D019728 DF: LMWK   
% 223.46/223.65  |- skos__broader mesh__D019728smesh__D007704
% 223.46/223.65  |- skos__altLabel mesh__D019728 Low-Molecular-Weight Kininogen
% 223.46/223.65  |- skos__hiddenLabel mesh__D019728 Kininogen, Low Molecular Weight
% 223.46/223.65  |- skos__altLabel mesh__D019728 Low Molecular Weight Kininogen
% 223.46/223.65  |- mesh__dateCreated mesh__D019728 1997-06-20
% 223.46/223.65  |- mesh__dateRevised mesh__D019728 2005-06-30
% 223.46/223.65  |- skos__historyNote mesh__D019728 Kininogens %28%1975-1997%29%
% 223.46/223.65  |- skos__altLabel mesh__D019728 Low Molecular Weight Kininogens
% 223.46/223.65  |- skos__hiddenLabel mesh__D019728 Kininogens, Low-Molecular-Weight
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011745 2001
% 223.46/223.65  |- skos__altLabel mesh__D011745 Heterovitamin B 1
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011745 2003
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011745 1998
% 223.46/223.65  |- mesh__historyNote mesh__D011745
% 223.46/223.65       91%28%77%29%; was see under PYRIDINIUM COMPOUNDS 1977-90   
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011745 2006
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011745 1996
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011745 2002
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011745 2004
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011745 1999
% 223.46/223.65  |- skos__broader mesh__D011745smesh__D011726
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011745 1997
% 223.46/223.65  |- skos__broader mesh__D011745smesh__D011743
% 223.46/223.65  |- mesh__dateRevised mesh__D011745 1995-06-08
% 223.46/223.65  |- skos__prefLabel mesh__D011745 Pyrithiamine
% 223.46/223.65  |- skos__historyNote mesh__D011745 Pyridinium Compounds %28%1974-1976%29%
% 223.46/223.65  |- rdf__type mesh__D011745sskos__Concept
% 223.46/223.65  |- skos__annotation mesh__D011745 a thiamine antag   
% 223.46/223.65  |- mesh__dateCreated mesh__D011745 1976-04-13
% 223.46/223.65  |- skos__scopeNote mesh__D011745
% 223.46/223.65       A thiamine antagonist due to its inhibition of thiamine pyrophosphorylation. It is used to produce thiamine deficiency.%A%    
% 223.46/223.65  |- skos__hiddenLabel mesh__D011745 B 1, Heterovitamin
% 223.46/223.65  |- mesh__publicMeSHNote mesh__D011745
% 223.46/223.65       91; was see under PYRIDINIUM COMPOUNDS 1977-90   
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011745 2000
% 223.46/223.65  |- mesh__dateEstablished mesh__D011745 1991-01-01
% 223.46/223.65  |- mesh__recordOriginator mesh__D011745 SH
% 223.46/223.65  |- skos__historyNote mesh__D011745 Pyrimidines %28%1974-1976%29%
% 223.46/223.65  |- mesh__recordMaintainer mesh__D011745 JRT
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D011745 2005
% 223.46/223.65  |- skos__hiddenLabel mesh__D011745 1, Heterovitamin B
% 223.46/223.65  |- mesh__recordAuthorizer mesh__D011745 PLS
% 223.46/223.65  |- skos__altLabel mesh__D011745 Neopyrithiamine
% 223.46/223.65  |- skos__broader mesh__D005708smesh__D019216
% 223.46/223.65  |- mesh__recordMaintainer mesh__D005708 adp
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D005708 2005
% 223.46/223.65  |- skos__related mesh__D005708smesh__D005710
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D005708 2004
% 223.46/223.65  |- skos__scopeNote mesh__D005708
% 223.46/223.65       A rare, metallic element designated by the symbol, Ga, atomic number 31, and atomic weight 69.72.%A%    
% 223.46/223.65  |- mesh__dateRevised mesh__D005708 2000-06-22
% 223.46/223.65  |- mesh__recordOriginator mesh__D005708 NLM
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D005708 2003
% 223.46/223.65  |- mesh__recordAuthorizer mesh__D005708 sjn
% 223.46/223.65  |- skos__related mesh__D005708smesh__D005709
% 223.46/223.65  |- skos__prefLabel mesh__D005708 Gallium
% 223.46/223.65  |- mesh__dateCreated mesh__D005708 1999-01-01
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D005708 2002
% 223.46/223.65  |- rdf__type mesh__D005708sskos__Concept
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D005708 2006
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D005708 2001
% 223.46/223.65  |- skos__altLabel mesh__D016430 Clinical Trial %28%PT%29%
% 223.46/223.65  |- skos__altLabel mesh__D016430 Clinical Trial
% 223.46/223.65  |- rdf__type mesh__D016430sskos__Concept
% 223.46/223.65  |- skos__scopeNote mesh__D016430
% 223.46/223.65       Work that is the report of a pre-planned clinical study of the safety, efficacy, or optimum dosage schedule of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in humans selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. While most clinical trials concern humans, this publication type may be used for clinical veterinary articles meeting the requisites for humans. Specific headings for specific types and phases of clinical trials are also available.%A%    
% 223.46/223.65  |- skos__annotation mesh__D016430
% 223.46/223.65       publication type only; general only: prefer specific clinical trial publication type; clinical trials as a subject are indexed under the main heading CLINICAL TRIALS; Manual 26.26;  CATALOG: do not use%A%  
% 223.46/223.65  |- mesh__recordOriginator mesh__D016430 TGC
% 223.46/223.65  |- skos__related mesh__D016430smesh__D023362
% 223.46/223.65  |- skos__prefLabel mesh__D016430 Clinical Trial %5B%Publication Type%5D%
% 223.46/223.65  |- mesh__historyNote mesh__D016430 1991   
% 223.46/223.65  |- skos__related mesh__D016430smesh__D023361
% 223.46/223.65  |- mesh__dateRevised mesh__D016430 2005-06-30
% 223.46/223.65  |- skos__broader mesh__D016430smesh__D052182
% 223.46/223.65  |- mesh__recordAuthorizer mesh__D016430 sjn
% 223.46/223.65  |- mesh__recordMaintainer mesh__D016430 jls
% 223.46/223.65  |- mesh__dateEstablished mesh__D016430 1996-01-01
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D016430 2006
% 223.46/223.65  |- mesh__dateCreated mesh__D016430 1995-06-23
% 223.46/223.65  |- skos__broader mesh__D030101smesh__D018165
% 223.46/223.65  |- mesh__dateEstablished mesh__D030101 2002-01-01
% 223.46/223.65  |- skos__hiddenLabel mesh__D030101 Reovirus, Avian
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D030101 2003
% 223.46/223.65  |- skos__historyNote mesh__D030101 Orthoreovirus %28%1995-2001%29%
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D030101 2006
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D030101 2002
% 223.46/223.65  |- skos__altLabel mesh__D030101 Avian Reoviruses
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D030101 2004
% 223.46/223.65  |- skos__hiddenLabel mesh__D030101 Avian Reovirus
% 223.46/223.65  |- mesh__dateCreated mesh__D030101 2001-07-25
% 223.46/223.65  |- skos__altLabel mesh__D030101 Avian orthoreovirus
% 223.46/223.65  |- rdf__type mesh__D030101sskos__Concept
% 223.46/223.65  |- skos__hiddenLabel mesh__D030101 Reoviruses, Avian
% 223.46/223.65  |- skos__historyNote mesh__D030101 Reoviridae %28%1967-1994%29%
% 223.46/223.65  |- mesh__publicMeSHNote mesh__D030101 2002; see ORTHOREOVIRUS 1997-2001   
% 223.46/223.65  |- skos__prefLabel mesh__D030101 Orthoreovirus, Avian
% 223.46/223.65  |- skos__annotation mesh__D030101
% 223.46/223.65       infection: coord IM with REOVIRIDAE INFECTIONS %28%IM%29%   
% 223.46/223.65  |- mesh__historyNote mesh__D030101 2002; use ORTHOREOVIRUS 1997-2001   
% 223.46/223.65  |- skos__scopeNote mesh__D030101
% 223.46/223.65       A species of ORTHOREOVIRUS infecting birds, with outcomes ranging from inapparent to lethal depending on the virus strain and age of the host bird. This species does not infect mammals.%A%    
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D030101 2005
% 223.46/223.65  |- skos__altLabel mesh__D002410 Roman Catholicism
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D002410 2002
% 223.46/223.65  |- skos__hiddenLabel mesh__D002410 Catholic, Roman
% 223.46/223.65  |- mesh__recordMaintainer mesh__D002410 kle
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D002410 2005
% 223.46/223.65  |- mesh__recordOriginator mesh__D002410 NLM
% 223.46/223.65  |- skos__hiddenLabel mesh__D002410 Ethics, Roman Catholic
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D002410 2006
% 223.46/223.65  |- skos__hiddenLabel mesh__D002410 Roman Catholic Ethic
% 223.46/223.65  |- skos__annotation mesh__D002410 IM; specify geog if pertinent   
% 223.46/223.65  |- skos__hiddenLabel mesh__D002410 Catholics, Roman
% 223.46/223.65  |- mesh__dateRevised mesh__D002410 1999-11-03
% 223.46/223.65  |- skos__broader mesh__D002410smesh__D002835
% 223.46/223.65  |- skos__prefLabel mesh__D002410 Catholicism
% 223.46/223.65  |- skos__scopeNote mesh__D002410
% 223.46/223.65       The Christian faith, practice, or system of the Catholic Church, specifically the Roman Catholic, the Christian church that is characterized by a hierarchic structure of bishops and priests in which doctrinal and disciplinary authority are dependent upon apostolic succession, with the pope as head of the episcopal college. %28%From Webster, 3d ed; American Heritage Dictionary, 2d college ed%29%%A%    
% 223.46/223.65  |- skos__hiddenLabel mesh__D002410 Catholicism, Roman
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D002410 2000
% 223.46/223.65  |- skos__hiddenLabel mesh__D002410 Roman Catholic
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D002410 2003
% 223.46/223.65  |- mesh__recordAuthorizer mesh__D002410 sjn
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D002410 2001
% 223.46/223.65  |- rdf__type mesh__D002410sskos__Concept
% 223.46/223.65  |- skos__hiddenLabel mesh__D002410 Ethic, Roman Catholic
% 223.46/223.65  |- mesh__dateCreated mesh__D002410 1999-01-01
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D002410 2004
% 223.46/223.65  |- mesh__recordOriginator mesh__D001318 NLM
% 223.46/223.65  |- skos__prefLabel mesh__D001318 Authoritarianism
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001318 1996
% 223.46/223.65  |- skos__annotation mesh__D001318 no qualif   
% 223.46/223.65  |- skos__broader mesh__D001318smesh__D010551
% 223.46/223.65  |- rdf__type mesh__D001318sskos__Concept
% 223.46/223.65  |- skos__hiddenLabel mesh__D001318 Authoritarianisms
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001318 2006
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001318 1997
% 223.46/223.65  |- skos__scopeNote mesh__D001318
% 223.46/223.65       The personality pattern or syndrome consisting of behavioral and attitudinal characteristics reflecting a preoccupation with the factors of power and authority in interpersonal relationships.%A%    
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001318 2003
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001318 2002
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001318 2004
% 223.46/223.65  |- mesh__dateCreated mesh__D001318 1999-01-01
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001318 1998
% 223.46/223.65  |- mesh__recordMaintainer mesh__D001318 KEV
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001318 2000
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001318 1999
% 223.46/223.65  |- mesh__dateRevised mesh__D001318 1995-05-23
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001318 2005
% 223.46/223.65  |- mesh__activeMeSHYear mesh__D001318 2001
% 223.46/223.67  |- mesh__recordAuthorizer mesh__D001318 PLS
% 223.46/223.67  |- skos__hiddenLabel mesh__D012040 Implementation Plan, Annual
% 223.46/223.67  |- skos__hiddenLabel mesh__D012040 Planning, Regional Health
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D012040 2005
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D012040 2002
% 223.46/223.67  |- skos__broader mesh__D012040smesh__D006285
% 223.46/223.67  |- skos__hiddenLabel mesh__D012040 Plan, Annual Implementation
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D012040 2003
% 223.46/223.67  |- skos__altLabel mesh__D012040 Review, Appropriateness
% 223.46/223.67  |- skos__scopeNote mesh__D012040
% 223.46/223.67       Planning for health resources at a regional or multi-state level.%A%    
% 223.46/223.67  |- skos__hiddenLabel mesh__D012040 Reviews, Appropriateness
% 223.46/223.67  |- skos__hiddenLabel mesh__D012040 Annual Implementation Plan
% 223.46/223.67  |- mesh__recordOriginator mesh__D012040 EC
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D012040 2006
% 223.46/223.67  |- mesh__dateCreated mesh__D012040 1976-04-13
% 223.46/223.67  |- mesh__historyNote mesh__D012040
% 223.46/223.67       77; was AREAWIDE PLANNING see under HEALTH AND WELFARE PLANNING 1968-76; ANNUAL IMPLEMENTATION PLANS was see under REGIONAL HEALTH PLANNING 1981-85, was see under STATE HEALTH PLANS 1980; APPROPRIATENESS REVIEW was APPROPRIATENESS REVIEW %28%HEALTH CARE%29% see under REGIONAL HEALTH PLANNING 1980-85; COMPREHENSIVE HEALTH PLANNING was heading 1969-77 %28%Prov 1969-71%29%%A%  
% 223.46/223.67  |- mesh__publicMeSHNote mesh__D012040
% 223.46/223.67       77; was AREAWIDE PLANNING see under HEALTH AND WELFARE PLANNING 1968-76; ANNUAL IMPLEMENTATION PLANS was see under REGIONAL HEALTH PLANNING 1981-85, was see under STATE HEALTH PLANS 1980; APPROPRIATENESS REVIEW was APPROPRIATENESS REVIEW %28%HEALTH CARE%29% see under REGIONAL HEALTH PLANNING 1980-85; COMPREHENSIVE HEALTH PLANNING was heading 1972-77%A%  
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D012040 2004
% 223.46/223.67  |- skos__historyNote mesh__D012040 Health Planning %28%1968-1974%29%
% 223.46/223.67  |- skos__hiddenLabel mesh__D012040 Implementation Plans, Annual
% 223.46/223.67  |- skos__prefLabel mesh__D012040 Regional Health Planning
% 223.46/223.67  |- mesh__dateEstablished mesh__D012040 1977-01-01
% 223.46/223.67  |- mesh__dateRevised mesh__D012040 1999-11-03
% 223.46/223.67  |- mesh__recordAuthorizer mesh__D012040 sjn
% 223.46/223.67  |- mesh__recordMaintainer mesh__D012040 kle
% 223.46/223.67  |- mesh__onlineNote mesh__D012040
% 223.46/223.67       use REGIONAL HEALTH PLANNING to search APPROPRIATENESS REVIEW %28%HEALTH CARE%29% 1980-85 %26% COMPREHENSIVE HEALTH PLANNING 1969-77 %28%as Prov 1969-71%29%; use REGIONAL HEALTH PLANNING to search AREAWIDE PLANNING 1975-76 %28%use HEALTH AND WELFARE PLANNING 1968-74%29%; use REGIONAL HEALTH PLANNING to search ANNUAL IMPLEMENTATION PLANS 1981-85 %28%use STATE HEALTH PLANS 1980%29%%A%  
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D012040 2000
% 223.46/223.67  |- rdf__type mesh__D012040sskos__Concept
% 223.46/223.67  |- skos__hiddenLabel mesh__D012040 Planning, Comprehensive Health
% 223.46/223.67  |- skos__hiddenLabel mesh__D012040 Planning, Areawide
% 223.46/223.67  |- skos__hiddenLabel mesh__D012040 Health Planning, Regional
% 223.46/223.67  |- skos__hiddenLabel mesh__D012040 Health Planning, Comprehensive
% 223.46/223.67  |- skos__hiddenLabel mesh__D012040 Appropriateness Reviews
% 223.46/223.67  |- skos__annotation mesh__D012040 specify geog   
% 223.46/223.67  |- skos__hiddenLabel mesh__D012040 Plans, Annual Implementation
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D012040 2001
% 223.46/223.67  |- skos__altLabel mesh__D006801 Man, Modern
% 223.46/223.67  |- skos__broader mesh__D006801smesh__D015186
% 223.46/223.67  |- skos__annotation mesh__D006801
% 223.46/223.67       NIM as check tag only; Manual 18.8+; neanderthals are indexed with both HUMANS + HOMINIDAE but other extinct humans %28%Homo sp. other  than Homo sapiens%29% are indexed HOMO see HOMINIDAE%A%  
% 223.46/223.67  |- skos__altLabel mesh__D006801 Human
% 223.46/223.67  |- mesh__dateCreated mesh__D006801 1999-01-01
% 223.46/223.67  |- mesh__recordMaintainer mesh__D006801 ags
% 223.46/223.67  |- skos__altLabel mesh__D006801 Man %28%Taxonomy%29%
% 223.46/223.67  |- skos__scopeNote mesh__D006801 Members of the species Homo sapiens.     
% 223.46/223.67  |- skos__altLabel mesh__D006801 Homo sapiens
% 223.46/223.67  |- mesh__recordAuthorizer mesh__D006801 sjn
% 223.46/223.67  |- mesh__dateRevised mesh__D006801 2005-06-30
% 223.46/223.67  |- mesh__historyNote mesh__D006801
% 223.46/223.67       2005 %28%1966%29%; was check tag only %28%not a descriptor%29% 1966-2004; for HOMO SAPIENS use HOMINIDAE 1989-2004; for MAN %28%TAXONOMY%29% use HOMINIDAE 1998-2004%A%  
% 223.46/223.67  |- rdf__type mesh__D006801sskos__Concept
% 223.46/223.67  |- mesh__recordOriginator mesh__D006801 NLM
% 223.46/223.67  |- skos__prefLabel mesh__D006801 Humans
% 223.46/223.67  |- mesh__publicMeSHNote mesh__D006801
% 223.46/223.67       2005; for HOMO SAPIENS see HOMINIDAE 1989-2004; for MAN %28%TAXONOMY%29% see HOMINIDAE 1998-2004%A%  
% 223.46/223.67  |- skos__hiddenLabel mesh__D006801 Modern Man
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D006801 2006
% 223.46/223.67  |- skos__broader mesh__D006003smesh__D005936
% 223.46/223.67  |- mesh__recordMaintainer mesh__D006003 lkt
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D006003 2006
% 223.46/223.67  |- skos__annotation mesh__D006003
% 223.46/223.67       /metab consider also GLYCOGENOLYSIS or GLYCOGEN STORAGE DISEASE and specifics%A%  
% 223.46/223.67  |- mesh__dateRevised mesh__D006003 2005-06-30
% 223.46/223.67  |- mesh__recordOriginator mesh__D006003 NLM
% 223.46/223.67  |- mesh__recordAuthorizer mesh__D006003 sjn
% 223.46/223.67  |- skos__prefLabel mesh__D006003 Glycogen
% 223.46/223.67  |- mesh__dateCreated mesh__D006003 1999-01-01
% 223.46/223.67  |- rdf__type mesh__D006003sskos__Concept
% 223.46/223.67  |- skos__annotation mesh__D019729
% 223.46/223.67       do not confuse with CARBON-OXYGEN LYASES; DF: C O LIGASES%A%  
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D019729 2005
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D019729 2004
% 223.46/223.67  |- skos__hiddenLabel mesh__D019729 Carbon Oxygen Ligases
% 223.46/223.67  |- skos__scopeNote mesh__D019729
% 223.46/223.67       Enzymes that catalyze the joining of two molecules by the formation of a carbon-oxygen bond. EC 6.1.%A%    
% 223.46/223.67  |- skos__hiddenLabel mesh__D019729 Ligases, Carbon-Oxygen
% 223.46/223.67  |- rdf__type mesh__D019729sskos__Concept
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D019729 2006
% 223.46/223.67  |- mesh__dateEstablished mesh__D019729 1998-01-01
% 223.46/223.67  |- mesh__historyNote mesh__D019729 98   
% 223.46/223.67  |- skos__broader mesh__D019729smesh__D008025
% 223.46/223.67  |- mesh__dateRevised mesh__D019729 2003-07-09
% 223.46/223.67  |- skos__prefLabel mesh__D019729 Carbon-Oxygen Ligases
% 223.46/223.67  |- mesh__dateCreated mesh__D019729 1997-06-20
% 223.46/223.67  |- mesh__publicMeSHNote mesh__D019729 98   
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D011746 2004
% 223.46/223.67  |- skos__altLabel mesh__D011746 Pyridoxinedisulfide
% 223.46/223.67  |- mesh__recordMaintainer mesh__D011746 jmp
% 223.46/223.67  |- mesh__dateRevised mesh__D011746 2002-07-02
% 223.46/223.67  |- skos__historyNote mesh__D011746 Pyridines %28%1974%29%
% 223.46/223.67  |- skos__altLabel mesh__D011746 Piritinol
% 223.46/223.67  |- rdf__type mesh__D011746sskos__Concept
% 223.46/223.67  |- skos__altLabel mesh__D011746 Dipyridoxolyldisulfide
% 223.46/223.67  |- mesh__recordOriginator mesh__D011746 NLM
% 223.46/223.67  |- skos__historyNote mesh__D011746 Disulfides %28%1974%29%
% 223.46/223.67  |- mesh__dateEstablished mesh__D011746 1991-01-01
% 223.46/223.67  |- mesh__historyNote mesh__D011746
% 223.46/223.67       91%28%75%29%; was see under PYRIDINES 1975-90   
% 223.46/223.67  |- skos__broader mesh__D011746smesh__D011725
% 223.46/223.67  |- mesh__recordAuthorizer mesh__D011746 sjn
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D011746 2005
% 223.46/223.67  |- skos__prefLabel mesh__D011746 Pyrithioxin
% 223.46/223.67  |- skos__altLabel mesh__D011746 Pyrithioxine
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D011746 2003
% 223.46/223.67  |- mesh__dateCreated mesh__D011746 1974-11-19
% 223.46/223.67  |- skos__altLabel mesh__D011746 Pyritinol
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D011746 2006
% 223.46/223.67  |- mesh__publicMeSHNote mesh__D011746
% 223.46/223.67       91; was see under PYRIDINES 1975-90   
% 223.46/223.67  |- skos__scopeNote mesh__D011746
% 223.46/223.67       A neurotropic agent which reduces permeability of blood-brain barrier to phosphate. It has no vitamin B6 activity.%A%    
% 223.46/223.67  |- skos__historyNote mesh__D044122
% 223.46/223.67       Receptors, Cell Surface %28%1996-2003%29%
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D044122 2005
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D044122 2006
% 223.46/223.67  |- mesh__dateEstablished mesh__D044122 2004-01-01
% 223.46/223.67  |- rdf__type mesh__D044122sskos__Concept
% 223.46/223.67  |- skos__historyNote mesh__D044122
% 223.46/223.67       Receptors, Cytoplasmic and Nuclear %28%1996-2003%29%
% 223.46/223.67  |- mesh__dateCreated mesh__D044122 2003-07-09
% 223.46/223.67  |- skos__hiddenLabel mesh__D044122 Receptor, MT1
% 223.46/223.67  |- skos__altLabel mesh__D044122 MT1 Receptor
% 223.46/223.67  |- skos__altLabel mesh__D044122 Mel%28%1a%29%-Melatonin Receptor
% 223.46/223.67  |- skos__prefLabel mesh__D044122 Receptor, Melatonin, MT1
% 223.46/223.67  |- skos__hiddenLabel mesh__D044122 MT1 Receptor, Melatonin
% 223.46/223.67  |- skos__altLabel mesh__D044122 Melatonin MT1 Receptor
% 223.46/223.67  |- mesh__publicMeSHNote mesh__D044122
% 223.46/223.67       2004; MEL%28%1A%29%-MELATONIN RECEPTOR was indexed under RECEPTORS, CELL SURFACE %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1996-2003%A%  
% 223.46/223.67  |- skos__broader mesh__D044122smesh__D044094
% 223.46/223.67  |- skos__scopeNote mesh__D044122
% 223.46/223.67       A melatonin receptor subtype that is primarily found in the HYPOTHALAMUS and in the KIDNEY.%A%    
% 223.46/223.67  |- skos__hiddenLabel mesh__D044122 Receptor, Melatonin MT1
% 223.46/223.67  |- mesh__historyNote mesh__D044122
% 223.46/223.67       2004; for MEL%28%1A%29%-MELATONIN RECEPTOR use MELATONIN RECEPTORS %28%NM%29% 1996-2003%A%  
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D044122 2004
% 223.46/223.67  |- skos__broader mesh__D002784Q000037smesh__D002784
% 223.46/223.67  |- mesh__preferredCombination mesh__D002784Q000037smesh__D000924
% 223.46/223.67  |- rdf__type mesh__D002784Q000037smesh__CompoundConcept
% 223.46/223.67  |- mesh__recordMaintainer mesh__D005709 nns
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D005709 2001
% 223.46/223.67  |- mesh__dateEstablished mesh__D005709 1975-09-01
% 223.46/223.67  |- mesh__dateRevised mesh__D005709 2000-06-22
% 223.46/223.67  |- skos__annotation mesh__D005709 Ga-71; NIM   
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D005709 2003
% 223.46/223.67  |- mesh__dateCreated mesh__D005709 1974-11-11
% 223.46/223.67  |- skos__broader mesh__D005709smesh__D007554
% 223.46/223.67  |- skos__hiddenLabel mesh__D005709 Isotopes, Gallium
% 223.46/223.67  |- skos__prefLabel mesh__D005709 Gallium Isotopes
% 223.46/223.67  |- mesh__publicMeSHNote mesh__D005709 75   
% 223.46/223.67  |- mesh__recordOriginator mesh__D005709 NLM
% 223.46/223.67  |- mesh__recordAuthorizer mesh__D005709 sjn
% 223.46/223.67  |- rdf__type mesh__D005709sskos__Concept
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D005709 2006
% 223.46/223.67  |- skos__historyNote mesh__D005709 Gallium %28%1966-1974%29%
% 223.46/223.67  |- skos__scopeNote mesh__D005709
% 223.46/223.67       Stable gallium atoms that have the same atomic number as the element gallium, but differ in atomic weight. Ga-71 is a stable gallium isotope.%A%    
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D005709 2005
% 223.46/223.67  |- mesh__historyNote mesh__D005709 75   
% 223.46/223.67  |- skos__historyNote mesh__D005709 Isotopes %28%1974%29%
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D005709 2002
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D005709 2004
% 223.46/223.67  |- skos__historyNote mesh__D005709 Radioisotopes %28%1966-1973%29%
% 223.46/223.67  |- skos__broader mesh__D016431smesh__D052180
% 223.46/223.67  |- mesh__recordAuthorizer mesh__D016431 sjn
% 223.46/223.67  |- skos__scopeNote mesh__D016431
% 223.46/223.67       Work consisting of a set of statements, directions, or principles presenting current or future rules or policy. Guidelines may be developed by government agencies at any level, institutions, organizations such as professional societies or governing boards, or by the convening of expert panels. The text may be cursive or in outline form, but it is generally a comprehensive guide to problems and approaches in any discipline or activity. This concept relates to the general conduct and administration of health care activities rather than to specific decisions for a particular clinical condition. For that aspect, PRACTICE GUIDELINE %5B%PUBLICATION TYPE%5D% is available.%A%    
% 223.46/223.67  |- mesh__dateCreated mesh__D016431 1995-06-23
% 223.46/223.67  |- skos__prefLabel mesh__D016431 Guideline %5B%Publication Type%5D%
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D016431 2006
% 223.46/223.67  |- skos__altLabel mesh__D016431 Guideline
% 223.46/223.67  |- skos__altLabel mesh__D016431 Guideline %28%PT%29%
% 223.46/223.67  |- mesh__historyNote mesh__D016431 1991   
% 223.46/223.67  |- rdf__type mesh__D016431sskos__Concept
% 223.46/223.67  |- skos__annotation mesh__D016431
% 223.46/223.67       publication type only; in any field or discipline: for clinical practice %26% delivery of health care, use PRACTICE GUIDELINE  %5B%Publication Type%5D%; guidelines as a subject are indexed under the main heading GUIDELINES%A%  
% 223.46/223.67  |- mesh__recordMaintainer mesh__D016431 jls
% 223.46/223.67  |- mesh__recordOriginator mesh__D016431 TAP
% 223.46/223.67  |- mesh__dateRevised mesh__D016431 2005-06-30
% 223.46/223.67  |- mesh__dateEstablished mesh__D016431 1996-01-01
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D030102 2006
% 223.46/223.67  |- skos__annotation mesh__D030102
% 223.46/223.67       infection: coord IM with REOVIRIDAE INFECTIONS %28%IM%29%   
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D030102 2004
% 223.46/223.67  |- skos__broader mesh__D030102smesh__D018165
% 223.46/223.67  |- mesh__recordAuthorizer mesh__D030102 sjn
% 223.46/223.67  |- rdf__type mesh__D030102sskos__Concept
% 223.46/223.67  |- skos__prefLabel mesh__D030102 Orthoreovirus, Mammalian
% 223.46/223.67  |- skos__altLabel mesh__D030102 Reovirus Type 1
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D030102 2002
% 223.46/223.67  |- skos__scopeNote mesh__D030102
% 223.46/223.67       A species of ORTHOREOVIRUS infecting mammals %28%other than baboons%29%. There are three serotypes. In humans they are generally benign but may sometimes cause upper respiratory tract illness or enteritis in infants and children. REOVIRUS 3 is a very pathogenic virus in laboratory rodents.%A%    
% 223.46/223.67  |- mesh__historyNote mesh__D030102
% 223.46/223.67       2002; for REOVIRUS 1 %26% REOVIRUS 2 use ORTHOREOVIRUS 1994-2001%A%  
% 223.46/223.67  |- mesh__dateCreated mesh__D030102 2001-07-25
% 223.46/223.67  |- skos__altLabel mesh__D030102 Reovirus Type 2
% 223.46/223.67  |- mesh__recordOriginator mesh__D030102 ags
% 223.46/223.67  |- mesh__publicMeSHNote mesh__D030102
% 223.46/223.67       2002; for REOVIRUS 1 %26% REOVIRUS 2 see ORTHOREOVIRUS 1994-2001%A%  
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D030102 2005
% 223.46/223.67  |- mesh__dateEstablished mesh__D030102 2002-01-01
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D030102 2003
% 223.46/223.67  |- skos__altLabel mesh__D030102 Mammalian orthoreovirus
% 223.46/223.67  |- mesh__recordMaintainer mesh__D030102 ags
% 223.46/223.67  |- skos__hiddenLabel mesh__D002411 Resins, Cation Exchange
% 223.46/223.67  |- mesh__recordAuthorizer mesh__D002411 sjn
% 223.46/223.67  |- mesh__dateEstablished mesh__D002411 1991-01-01
% 223.46/223.67  |- mesh__historyNote mesh__D002411
% 223.46/223.67       91%28%75%29%; was see under ION EXCHANGE RESINS 1975-90   
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D002411 2006
% 223.46/223.67  |- skos__hiddenLabel mesh__D002411 Exchange Resins, Cation
% 223.46/223.67  |- mesh__publicMeSHNote mesh__D002411
% 223.46/223.67       91; was see under ION EXCHANGE RESINS 1975-90   
% 223.46/223.67  |- mesh__recordOriginator mesh__D002411 NLM
% 223.46/223.67  |- skos__scopeNote mesh__D002411
% 223.46/223.67       High molecular weight insoluble polymers which contain functional anionic groups that are capable of undergoing exchange reactions with cations.%A%    
% 223.46/223.67  |- skos__altLabel mesh__D002411 Cation Exchangers %28%Resins%29%
% 223.46/223.67  |- skos__prefLabel mesh__D002411 Cation Exchange Resins
% 223.46/223.67  |- mesh__recordMaintainer mesh__D002411 ssb
% 223.46/223.67  |- mesh__onlineNote mesh__D002411 search ION EXCHANGE RESINS 1966-74   
% 223.46/223.67  |- rdf__type mesh__D002411sskos__Concept
% 223.46/223.67  |- mesh__dateCreated mesh__D002411 1999-01-01
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D002411 2004
% 223.46/223.67  |- skos__broader mesh__D002411smesh__D007475
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D002411 2005
% 223.46/223.67  |- mesh__dateRevised mesh__D002411 2003-07-09
% 223.46/223.67  |- mesh__recordMaintainer mesh__D001319 jls
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D001319 2003
% 223.46/223.67  |- mesh__recordOriginator mesh__D001319 NLM
% 223.46/223.67  |- skos__hiddenLabel mesh__D001319 Authorships
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D001319 2001
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D001319 2004
% 223.46/223.67  |- mesh__dateCreated mesh__D001319 1999-01-01
% 223.46/223.67  |- skos__broader mesh__D001319smesh__D014956
% 223.46/223.67  |- skos__annotation mesh__D001319
% 223.46/223.67       identity or establishment of being the author; do not confuse with WRITING or PUBLISHING: see notes there; no qualif%A%  
% 223.46/223.67  |- skos__prefLabel mesh__D001319 Authorship
% 223.46/223.67  |- skos__related mesh__D001319smesh__D015714
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D001319 2002
% 223.46/223.67  |- skos__scopeNote mesh__D001319
% 223.46/223.67       The profession of writing. Also the identity of the writer as the creator of a literary production.%A%    
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D001319 2005
% 223.46/223.67  |- mesh__recordAuthorizer mesh__D001319 sjn
% 223.46/223.67  |- rdf__type mesh__D001319sskos__Concept
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D001319 2006
% 223.46/223.67  |- mesh__dateRevised mesh__D001319 1999-11-05
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D001319 2000
% 223.46/223.67  |- mesh__dateRevised mesh__D012041 1999-11-03
% 223.46/223.67  |- skos__historyNote mesh__D012041 Legislation, Medical %28%1966%29%
% 223.46/223.67  |- skos__altLabel mesh__D012041 Medical Program, Regional
% 223.46/223.67  |- rdf__type mesh__D012041sskos__Concept
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D012041 2000
% 223.46/223.67  |- skos__historyNote mesh__D012041 Public Health %28%1966%29%
% 223.46/223.67  |- skos__altLabel mesh__D012041 Programs, Regional Medical
% 223.46/223.67  |- mesh__dateEstablished mesh__D012041 1968-01-01
% 223.46/223.67  |- skos__historyNote mesh__D012041
% 223.46/223.67       United States Public Health Service %28%1966%29%
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D012041 2004
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D012041 2006
% 223.46/223.67  |- mesh__recordMaintainer mesh__D012041 kle
% 223.46/223.67  |- skos__annotation mesh__D012041
% 223.46/223.67       specify geog; TN 163: restricted definition %26% use; DF: REGIONAL MED PROGRAMS%A%  
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D012041 2003
% 223.46/223.67  |- skos__scopeNote mesh__D012041
% 223.46/223.67       Coordination of activities and programs among health care institutions within defined geographic areas for the purpose of improving delivery and quality of medical care to the patients. These programs are mandated under U.S. Public Law 89-239.%A%    
% 223.46/223.67  |- mesh__dateCreated mesh__D012041 1999-01-01
% 223.46/223.67  |- skos__prefLabel mesh__D012041 Regional Medical Programs
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D012041 2005
% 223.46/223.67  |- mesh__historyNote mesh__D012041 68%28%67%29%   
% 223.46/223.67  |- mesh__publicMeSHNote mesh__D012041 68   
% 223.46/223.67  |- skos__broader mesh__D012041smesh__D012040
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D012041 2002
% 223.46/223.67  |- mesh__recordOriginator mesh__D012041 NLM
% 223.46/223.67  |- skos__altLabel mesh__D012041 Medical Programs, Regional
% 223.46/223.67  |- skos__altLabel mesh__D012041 Program, Regional Medical
% 223.46/223.67  |- mesh__recordAuthorizer mesh__D012041 sjn
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D012041 2001
% 223.46/223.67  |- mesh__dateCreated mesh__D006802 1999-01-01
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D006802 2001
% 223.46/223.67  |- skos__annotation mesh__D006802 GEN or unspecified; prefer specifics   
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D006802 2006
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D006802 2000
% 223.46/223.67  |- skos__scopeNote mesh__D006802 Activities performed by humans.     
% 223.46/223.67  |- mesh__dateRevised mesh__D006802 1997-06-20
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D006802 2005
% 223.46/223.67  |- mesh__runningHead mesh__D006802 I3 - HUMAN ACTIVITIES   
% 223.46/223.67  |- mesh__recordAuthorizer mesh__D006802 SJN
% 223.46/223.67  |- skos__prefLabel mesh__D006802 Human Activities
% 223.46/223.67  |- mesh__historyNote mesh__D006802 98; use explode 1975-97   
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D006802 1999
% 223.46/223.67  |- mesh__publicMeSHNote mesh__D006802 98   
% 223.46/223.67  |- skos__hiddenLabel mesh__D006802 Activity, Human
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D006802 2002
% 223.46/223.67  |- mesh__recordOriginator mesh__D006802 NLM
% 223.46/223.67  |- rdf__type mesh__D006802sskos__Concept
% 223.46/223.67  |- skos__hiddenLabel mesh__D006802 Human Activity
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D006802 2004
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D006802 1998
% 223.46/223.67  |- mesh__dateEstablished mesh__D006802 1998-01-01
% 223.46/223.67  |- mesh__recordMaintainer mesh__D006802 TGC
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D006802 2003
% 223.46/223.67  |- skos__hiddenLabel mesh__D006802 Activities, Human
% 223.46/223.67  |- skos__historyNote mesh__D006004 Glycogen %28%1973-1975%29%
% 223.46/223.67  |- skos__historyNote mesh__D006004 Glucosidase %28%1973-1975%29%
% 223.46/223.67  |- skos__hiddenLabel mesh__D006004 Transfer Glucosidase
% 223.46/223.67  |- skos__broader mesh__D006004smesh__D005964
% 223.46/223.67  |- mesh__onlineNote mesh__D006004
% 223.46/223.67       use GLYCOGEN DEBRANCHING ENZYME SYSTEM to search GLYCOGEN DEBRANCHING ENZYME 1976-88%A%  
% 223.46/223.67  |- skos__historyNote mesh__D006004 Glucosyltransferases %28%1973-1975%29%
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D006004 2004
% 223.46/223.67  |- mesh__dateRevised mesh__D006004 2003-07-09
% 223.46/223.67  |- rdf__type mesh__D006004sskos__Concept
% 223.46/223.67  |- skos__hiddenLabel mesh__D006004 Enzyme, Glycogen Debranching
% 223.46/223.67  |- skos__scopeNote mesh__D006004
% 223.46/223.67       1,4-alpha-D-Glucan-1,4-alpha-D-glucan 4-alpha-D-glucosyltransferase/dextrin 6 alpha-D-glucanohydrolase. An enzyme system having both 4-alpha-glucanotransferase %28%EC 2.4.1.25%29% and amylo-1,6-glucosidase %28%EC 3.2.1.33%29% activities. As a transferase it transfers a segment of a 1,4-alpha-D-glucan to a new 4-position in an acceptor, which may be glucose or another 1,4-alpha-D-glucan. As a glucosidase it catalyzes the endohydrolysis of 1,6-alpha-D-glucoside linkages at points of branching in chains of 1,4-linked alpha-D-glucose residues. Amylo-1,6-glucosidase activity is deficient in glycogen storage disease type III.%A%    
% 223.46/223.67  |- mesh__recordMaintainer mesh__D006004 ssb
% 223.46/223.67  |- skos__annotation mesh__D006004
% 223.46/223.67       /defic: consider also GLYCOGEN STORAGE DISEASE TYPE III   
% 223.46/223.67  |- mesh__recordOriginator mesh__D006004 RLS
% 223.46/223.67  |- mesh__publicMeSHNote mesh__D006004
% 223.46/223.67       89; was GLYCOGEN DEBRANCHING ENZYME see under GLUCOSYLTRANSFERASES 1976-88%A%  
% 223.46/223.67  |- skos__hiddenLabel mesh__D006004 Debranching Enzyme, Glycogen
% 223.46/223.67  |- skos__prefLabel mesh__D006004 Glycogen Debranching Enzyme System
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D006004 2005
% 223.46/223.67  |- mesh__dateEstablished mesh__D006004 1989-01-01
% 223.46/223.67  |- mesh__historyNote mesh__D006004
% 223.46/223.67       89%28%76%29%; was GLYCOGEN DEBRANCHING ENZYME see under GLUCOSYLTRANSFERASES 1976-88%A%  
% 223.46/223.67  |- skos__broader mesh__D006004smesh__D005959
% 223.46/223.67  |- skos__related mesh__D006004smesh__D006010
% 223.46/223.67  |- skos__altLabel mesh__D006004 Transfer-Glucosidase
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D006004 2006
% 223.46/223.67  |- mesh__recordAuthorizer mesh__D006004 sjn
% 223.46/223.67  |- mesh__dateCreated mesh__D006004 1975-07-21
% 223.46/223.67  |- skos__hiddenLabel mesh__D044123 Receptor, Melatonin 1b
% 223.46/223.67  |- skos__altLabel mesh__D044123 MT2 Receptor
% 223.46/223.67  |- mesh__dateEstablished mesh__D044123 2004-01-01
% 223.46/223.67  |- skos__altLabel mesh__D044123 Melatonin MT2 Receptor
% 223.46/223.67  |- skos__scopeNote mesh__D044123
% 223.46/223.67       A melatonin receptor subtype primarily found expressed in the BRAIN and RETINA.%A%    
% 223.46/223.67  |- skos__hiddenLabel mesh__D044123 MT2 Receptor, Melatonin
% 223.46/223.67  |- mesh__publicMeSHNote mesh__D044123
% 223.46/223.67       2004; MELATONIN 1B RECEPTOR was indexed under RECEPTORS, CELL SURFACE %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1996-2003%A%  
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D044123 2006
% 223.46/223.67  |- mesh__dateCreated mesh__D044123 2003-07-09
% 223.46/223.67  |- rdf__type mesh__D044123sskos__Concept
% 223.46/223.67  |- skos__historyNote mesh__D044123
% 223.46/223.67       Receptors, Cell Surface %28%1996-2003%29%
% 223.46/223.67  |- skos__altLabel mesh__D044123 Melatonin 1b Receptor
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D044123 2005
% 223.46/223.67  |- skos__prefLabel mesh__D044123 Receptor, Melatonin, MT2
% 223.46/223.67  |- skos__broader mesh__D044123smesh__D044094
% 223.46/223.67  |- skos__hiddenLabel mesh__D044123 Receptor, Melatonin MT2
% 223.46/223.67  |- mesh__historyNote mesh__D044123
% 223.46/223.67       2004; for MELATONIN 1B RECEPTOR use RECEPTORS, MELATONIN %28%NM%29% 1996-2003%A%  
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D044123 2004
% 223.46/223.67  |- skos__hiddenLabel mesh__D044123 Receptor, MT2
% 223.46/223.67  |- skos__altLabel mesh__D044123 Mel 1b Receptor
% 223.46/223.67  |- skos__historyNote mesh__D044123
% 223.46/223.67       Receptors, Cytoplasmic and Nuclear %28%1996-2003%29%
% 223.46/223.67  |- skos__broader mesh__D002412smesh__D007477
% 223.46/223.67  |- skos__scopeNote mesh__D002412
% 223.46/223.67       Positively charged atoms, radicals or groups of atoms which travel to the cathode or negative pole during electrolysis.%A%    
% 223.46/223.67  |- skos__historyNote mesh__D002412 Cations, Monovalent %28%1973-1977%29%
% 223.46/223.67  |- mesh__historyNote mesh__D002412 78   
% 223.46/223.67  |- rdf__type mesh__D002412sskos__Concept
% 223.46/223.67  |- mesh__dateRevised mesh__D002412 2004-07-19
% 223.46/223.67  |- mesh__dateCreated mesh__D002412 1977-04-22
% 223.46/223.67  |- skos__historyNote mesh__D002412 Ions %28%1966-1977%29%
% 223.46/223.67  |- mesh__recordAuthorizer mesh__D002412 sjn
% 223.46/223.67  |- skos__prefLabel mesh__D002412 Cations
% 223.46/223.67  |- mesh__dateEstablished mesh__D002412 1978-01-01
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D002412 2005
% 223.46/223.67  |- mesh__recordOriginator mesh__D002412 RLS
% 223.46/223.67  |- skos__annotation mesh__D002412
% 223.46/223.67       GEN or unspecified; avoid as too general: prefer specifics; use qualif discreetly: few apply%A%  
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D002412 2006
% 223.46/223.67  |- skos__historyNote mesh__D002412 Cations, Divalent %28%1973-1977%29%
% 223.46/223.67  |- mesh__publicMeSHNote mesh__D002412 78   
% 223.46/223.67  |- mesh__recordMaintainer mesh__D002412 jls
% 223.46/223.67  |- skos__annotation mesh__D012840
% 223.46/223.67       infection: coord IM with BUNYAVIRIDAE INFECTIONS %28%IM%29%   
% 223.46/223.67  |- mesh__dateRevised mesh__D012840 2004-07-07
% 223.46/223.67  |- skos__scopeNote mesh__D012840
% 223.46/223.67       A species in the ORTHOBUNYAVIRUS genus of the family BUNYAVIRIDAE family. Previously a large group of serotypes, most are now considered separate species.%A%    
% 223.46/223.67  |- mesh__recordOriginator mesh__D012840 NLM
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D012840 2005
% 223.46/223.67  |- mesh__dateCreated mesh__D012840 1974-12-12
% 223.46/223.67  |- mesh__publicMeSHNote mesh__D012840
% 223.46/223.67       2002; see SIMBU VIRUS GROUP 1991-2001, see BUNYAVIRIDAE 1981-1990, see ARBOVIRUSES 1975-1980%A%  
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D012840 2006
% 223.46/223.67  |- skos__broader mesh__D012840smesh__D016851
% 223.46/223.67  |- mesh__recordMaintainer mesh__D012840 ags
% 223.46/223.67  |- skos__prefLabel mesh__D012840 Simbu virus
% 223.46/223.67  |- mesh__recordAuthorizer mesh__D012840 sjn
% 223.46/223.67  |- mesh__dateEstablished mesh__D012840 1991-01-01
% 223.46/223.67  |- mesh__historyNote mesh__D012840 2002 %28%1975%29%   
% 223.46/223.67  |- rdf__type mesh__D012840sskos__Concept
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D012042 2002
% 223.46/223.67  |- mesh__recordOriginator mesh__D012042 NLM
% 223.46/223.67  |- skos__hiddenLabel mesh__D012042 Registers, Population
% 223.46/223.67  |- skos__hiddenLabel mesh__D012042 Register, Parish
% 223.46/223.67  |- skos__broader mesh__D012042smesh__D003625
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D012042 2004
% 223.46/223.67  |- mesh__historyNote mesh__D012042 72%28%69%29%   
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D012042 2001
% 223.46/223.67  |- skos__hiddenLabel mesh__D012042 Register, Population
% 223.46/223.67  |- skos__hiddenLabel mesh__D012042 Parish Register
% 223.46/223.67  |- mesh__activeMeSHYear mesh__D012042 2006
% 223.46/223.67  |- skos__prefLabel mesh__D012042 Registries
% 223.46/223.67  |- skos__hiddenLabel mesh__D012042 Registry
% 223.46/223.67  |- skos__hiddenLabel mesh__D012042 Population Registers
% 223.46/223.67  |- skos__hiddenLabel mesh__D012042 Registers, Parish
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D012042 2003
% 223.46/223.68  |- mesh__dateCreated mesh__D012042 1999-01-01
% 223.46/223.68  |- skos__historyNote mesh__D012042 Statistics %28%1966-1968%29%
% 223.46/223.68  |- skos__historyNote mesh__D012042 Records %28%1966-1968%29%
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D012042 2005
% 223.46/223.68  |- mesh__publicMeSHNote mesh__D012042 72   
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D012042 2000
% 223.46/223.68  |- mesh__recordAuthorizer mesh__D012042 jls
% 223.46/223.68  |- skos__historyNote mesh__D012042 Information Systems %28%1966-1968%29%
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D012042 2003A
% 223.46/223.68  |- skos__historyNote mesh__D012042
% 223.46/223.68       specific drug group/adverse effects %28%1966-1968%29%
% 223.46/223.68  |- skos__historyNote mesh__D012042 Medical Records %28%1966-1968%29%
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D012042 2000A
% 223.46/223.68  |- skos__historyNote mesh__D012042 Drugs/adverse effects %28%1966-1968%29%
% 223.46/223.68  |- mesh__dateRevised mesh__D012042 2002-10-31
% 223.46/223.68  |- skos__broader mesh__D012042smesh__D011996
% 223.46/223.68  |- mesh__dateEstablished mesh__D012042 1972-01-01
% 223.46/223.68  |- skos__scopeNote mesh__D012042
% 223.46/223.68       The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers.%A%    
% 223.46/223.68  |- mesh__recordMaintainer mesh__D012042 jls
% 223.46/223.68  |- skos__annotation mesh__D012042
% 223.46/223.68       IM; coord with specific population or disease registered %28%IM%29%%A%  
% 223.46/223.68  |- rdf__type mesh__D012042sskos__Concept
% 223.46/223.68  |- skos__historyNote mesh__D012042
% 223.46/223.68       specific heading/epidemiology %28%1966-1968%29%
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D006803 2006
% 223.46/223.68  |- skos__hiddenLabel mesh__D006803 Development, Human
% 223.46/223.68  |- mesh__dateRevised mesh__D006803 2004-07-07
% 223.46/223.68  |- skos__prefLabel mesh__D006803 Human Development
% 223.46/223.68  |- skos__scopeNote mesh__D006803
% 223.46/223.68       Continuous sequential changes which occur in the physiological and psychological functions during the life-time of an individual.%A%    
% 223.46/223.68  |- mesh__dateEstablished mesh__D006803 1978-01-01
% 223.46/223.68  |- mesh__recordMaintainer mesh__D006803 lkt
% 223.46/223.68  |- mesh__publicMeSHNote mesh__D006803 78   
% 223.46/223.68  |- mesh__recordAuthorizer mesh__D006803 sjn
% 223.46/223.68  |- rdf__type mesh__D006803sskos__Concept
% 223.46/223.68  |- mesh__recordOriginator mesh__D006803 EC
% 223.46/223.68  |- mesh__dateCreated mesh__D006803 1977-04-22
% 223.46/223.68  |- skos__broader mesh__D006803smesh__D001520
% 223.46/223.68  |- mesh__historyNote mesh__D006803 78   
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D006803 2005
% 223.46/223.68  |- skos__broader mesh__D006803smesh__D048788
% 223.46/223.68  |- skos__broader mesh__D006005smesh__D005964
% 223.46/223.68  |- skos__altLabel mesh__D006005 Glucan Phosphorylase
% 223.46/223.68  |- mesh__recordOriginator mesh__D006005 NLM
% 223.46/223.68  |- mesh__publicMeSHNote mesh__D006005
% 223.46/223.68       98; see GLYCOGEN PHOSPHORYLASE 1971-97   
% 223.46/223.68  |- skos__altLabel mesh__D006005 alpha-Glucan Phosphorylases
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D006005 2004
% 223.46/223.68  |- mesh__dateCreated mesh__D006005 1999-01-01
% 223.46/223.68  |- mesh__dateRevised mesh__D006005 2004-07-30
% 223.46/223.68  |- rdf__type mesh__D006005sskos__Concept
% 223.46/223.68  |- mesh__historyNote mesh__D006005 98%28%71%29%   
% 223.46/223.68  |- skos__annotation mesh__D006005 GEN or unspecified; prefer specifics   
% 223.46/223.68  |- skos__scopeNote mesh__D006005
% 223.46/223.68       A class of glucosyltransferases that catalyzes the degradation of storage polysaccharides, such as glucose polymers, by phosphorolysis in animals  %28%GLYCOGEN PHOSPHORYLASE%29% and in plants %28%STARCH PHOSPHORYLASE%29%.%A%    
% 223.46/223.68  |- skos__prefLabel mesh__D006005 Phosphorylases
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D006005 2005
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D006005 2005A
% 223.46/223.68  |- mesh__recordMaintainer mesh__D006005 jls
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D006005 2006
% 223.46/223.68  |- skos__historyNote mesh__D006005 Glucosyltransferases %28%1966-1970%29%
% 223.46/223.68  |- mesh__recordAuthorizer mesh__D006005 jls
% 223.46/223.68  |- mesh__dateEstablished mesh__D006005 1973-01-01
% 223.46/223.68  |- skos__annotation mesh__D044922
% 223.46/223.68       infection: coord IM with HELICOBACTER INFECTIONS %28%IM%29%   
% 223.46/223.68  |- skos__broader mesh__D044922smesh__D016998
% 223.46/223.68  |- skos__historyNote mesh__D044922 Helicobacter %28%1992-2003%29%
% 223.46/223.68  |- mesh__recordOriginator mesh__D044922 ags
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D044922 2006
% 223.46/223.68  |- mesh__dateEstablished mesh__D044922 2004-01-01
% 223.46/223.68  |- skos__scopeNote mesh__D044922
% 223.46/223.68       A species of HELICOBACTER that colonizes in the STOMACH of laboratory MICE; CATS; and DOGS. It is associated with lymphoid follicular hyperplasia and mild GASTRITIS in CATS.%A%    
% 223.46/223.68  |- mesh__recordAuthorizer mesh__D044922 sjn
% 223.46/223.68  |- mesh__publicMeSHNote mesh__D044922 2004   
% 223.46/223.68  |- rdf__type mesh__D044922sskos__Concept
% 223.46/223.68  |- mesh__dateCreated mesh__D044922 2003-07-09
% 223.46/223.68  |- mesh__recordMaintainer mesh__D044922 SYSTEM
% 223.46/223.68  |- mesh__dateRevised mesh__D044922 2005-06-30
% 223.46/223.68  |- skos__prefLabel mesh__D044922 Helicobacter felis
% 223.46/223.68  |- mesh__historyNote mesh__D044922 2004   
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D011748 2005
% 223.46/223.68  |- mesh__recordAuthorizer mesh__D011748 sjn
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D011748 2003
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D011748 2006
% 223.46/223.68  |- mesh__recordMaintainer mesh__D011748 CCR
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D011748 2004
% 223.46/223.68  |- skos__altLabel mesh__D011748 Pyrogallic acid
% 223.46/223.68  |- mesh__dateCreated mesh__D011748 1999-01-01
% 223.46/223.68  |- rdf__type mesh__D011748sskos__Concept
% 223.46/223.68  |- skos__altLabel mesh__D011748 1,2,3-Trihydroxybenzene
% 223.46/223.68  |- mesh__dateRevised mesh__D011748 2000-06-21
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D011748 2001
% 223.46/223.68  |- skos__broader mesh__D011748smesh__D010636
% 223.46/223.68  |- skos__prefLabel mesh__D011748 Pyrogallol
% 223.46/223.68  |- skos__hiddenLabel mesh__D011748 acid, Pyrogallic
% 223.46/223.68  |- mesh__recordOriginator mesh__D011748 NLM
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D011748 2002
% 223.46/223.68  |- mesh__historyNote mesh__D044124 2004   
% 223.46/223.68  |- skos__annotation mesh__D044124
% 223.46/223.68       infection: coord IM with YERSINIA INFECTIONS %28%IM%29%   
% 223.46/223.68  |- skos__prefLabel mesh__D044124 Yersinia rucker
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D044124 2006
% 223.46/223.68  |- mesh__recordOriginator mesh__D044124 ags
% 223.46/223.68  |- mesh__recordAuthorizer mesh__D044124 sjn
% 223.46/223.68  |- mesh__dateCreated mesh__D044124 2003-07-09
% 223.46/223.68  |- mesh__dateEstablished mesh__D044124 2004-01-01
% 223.46/223.68  |- skos__broader mesh__D044124smesh__D015007
% 223.46/223.68  |- rdf__type mesh__D044124sskos__Concept
% 223.46/223.68  |- mesh__recordMaintainer mesh__D044124 SYSTEM
% 223.46/223.68  |- skos__scopeNote mesh__D044124
% 223.46/223.68       A species of gram-negative bacteria responsible for red mouth disease in rainbow trout %28%ONCORHYNCHUS MYKISS%29%. The bacteria is a natural component of fresh water ecosystems in the United States and Canada.%A%    
% 223.46/223.68  |- skos__historyNote mesh__D044124 Yersinia %28%1979-2003%29%
% 223.46/223.68  |- mesh__publicMeSHNote mesh__D044124 2004   
% 223.46/223.68  |- mesh__dateRevised mesh__D044124 2005-06-30
% 223.46/223.68  |- skos__broader mesh__D016433smesh__D052180
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D016433 2006
% 223.46/223.68  |- mesh__dateCreated mesh__D016433 1995-06-23
% 223.46/223.68  |- mesh__dateRevised mesh__D016433 2005-06-30
% 223.46/223.68  |- skos__broader mesh__D016433smesh__D052181
% 223.46/223.68  |- rdf__type mesh__D016433sskos__Concept
% 223.46/223.68  |- mesh__historyNote mesh__D016433 1991   
% 223.46/223.68  |- mesh__dateEstablished mesh__D016433 1996-01-01
% 223.46/223.68  |- mesh__recordOriginator mesh__D016433 TAP
% 223.46/223.68  |- skos__altLabel mesh__D016433 Press Releases
% 223.46/223.68  |- skos__altLabel mesh__D016433 News %28%PT%29%
% 223.46/223.68  |- skos__annotation mesh__D016433
% 223.46/223.68       publication type only; for news items indexed from journals; do not confuse with NEWSPAPER ARTICLE %5B%Publication Type%5D% for news indexed from newspapers;  CATALOG: do not use%A%  
% 223.46/223.68  |- mesh__recordAuthorizer mesh__D016433 sjn
% 223.46/223.68  |- mesh__recordMaintainer mesh__D016433 jls
% 223.46/223.68  |- skos__altLabel mesh__D016433 News
% 223.46/223.68  |- skos__prefLabel mesh__D016433 News %5B%Publication Type%5D%
% 223.46/223.68  |- skos__scopeNote mesh__D016433
% 223.46/223.68       Works consisting of an announcement or statement of recent or current events of new data and matters of interest in the field of medicine or science. In some publications, such as %22%Nature%22% or %22%Science,%22% the news reports are substantively written and herald medical and scientific data of vital or controversial importance.%A%    
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D002413 1993
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D002413 1999
% 223.46/223.68  |- skos__hiddenLabel mesh__D002413 Divalent Cations
% 223.46/223.68  |- rdf__type mesh__D002413sskos__Concept
% 223.46/223.68  |- skos__historyNote mesh__D002413 Metals %28%1966-1972%29%
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D002413 2000
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D002413 2003
% 223.46/223.68  |- mesh__dateRevised mesh__D002413 1992-05-11
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D002413 1994
% 223.46/223.68  |- mesh__dateCreated mesh__D002413 1999-01-01
% 223.46/223.68  |- skos__historyNote mesh__D002413 specific element%28%1966-1972%29%
% 223.46/223.68  |- mesh__recordAuthorizer mesh__D002413 PLS
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D002413 2001
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D002413 2004
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D002413 1995
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D002413 1996
% 223.46/223.68  |- skos__broader mesh__D002413smesh__D002412
% 223.46/223.68  |- mesh__recordOriginator mesh__D002413 NLM
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D002413 2002
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D002413 2005
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D002413 1997
% 223.46/223.68  |- mesh__recordMaintainer mesh__D002413 TAP
% 223.46/223.68  |- mesh__historyNote mesh__D002413 73   
% 223.46/223.68  |- skos__scopeNote mesh__D002413
% 223.46/223.68       Positively charged atoms, radicals or groups of atoms with a valence of plus 2, which travel to the cathode or negative pole during electrolysis.%A%    
% 223.46/223.68  |- mesh__publicMeSHNote mesh__D002413 73   
% 223.46/223.68  |- skos__historyNote mesh__D002413 Ions %28%1966-1972%29%
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D002413 2006
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D002413 1998
% 223.46/223.68  |- skos__annotation mesh__D002413
% 223.46/223.68       NIM: avoid as IM except when general only: prefer specifics; use qualif discreetly: few apply%A%  
% 223.46/223.68  |- mesh__dateEstablished mesh__D002413 1973-01-01
% 223.46/223.68  |- skos__prefLabel mesh__D002413 Cations, Divalent
% 223.46/223.68  |- skos__altLabel mesh__D026861 Ticks, Relapsing Fever
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D026861 2004
% 223.46/223.68  |- skos__annotation mesh__D026861
% 223.46/223.68       infestation: coord IM with TICK INFESTATIONS %28%IM%29%   
% 223.46/223.68  |- skos__historyNote mesh__D026861 Ticks %28%1964-2001%29%
% 223.46/223.68  |- skos__scopeNote mesh__D026861
% 223.46/223.68       A genus of softbacked TICKS, in the family ARGASIDAE, serving as the vector of BORRELIA, causing RELAPSING FEVER, and of  the AFRICAN SWINE FEVER VIRUS.%A%    
% 223.46/223.68  |- skos__prefLabel mesh__D026861 Ornithodoros
% 223.46/223.68  |- mesh__publicMeSHNote mesh__D026861 2002   
% 223.46/223.68  |- rdf__type mesh__D026861sskos__Concept
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D026861 2006
% 223.46/223.68  |- mesh__dateCreated mesh__D026861 2001-07-25
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D026861 2005
% 223.46/223.68  |- mesh__dateRevised mesh__D026861 2003-07-09
% 223.46/223.68  |- skos__broader mesh__D026861smesh__D026862
% 223.46/223.68  |- skos__altLabel mesh__D026861 Relapsing Fever Ticks
% 223.46/223.68  |- mesh__historyNote mesh__D026861 2002   
% 223.46/223.68  |- mesh__dateEstablished mesh__D026861 2002-01-01
% 223.46/223.68  |- mesh__recordOriginator mesh__D012841 NLM
% 223.46/223.68  |- mesh__historyNote mesh__D012841
% 223.46/223.68       91%28%75%29%; was see under SILICONES 1975-90   
% 223.46/223.68  |- skos__scopeNote mesh__D012841
% 223.46/223.68       A mixture of dimethicone and SILICA GEL used as an antiflatulent. Dimethicone is used as an ointment base ingredient and skin protectant.%A%    
% 223.46/223.68  |- mesh__dateRevised mesh__D012841 2004-07-07
% 223.46/223.68  |- mesh__recordMaintainer mesh__D012841 jmp
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D012841 2005
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D012841 2006
% 223.46/223.68  |- mesh__recordAuthorizer mesh__D012841 sjn
% 223.46/223.68  |- mesh__dateCreated mesh__D012841 1974-11-19
% 223.46/223.68  |- mesh__dateEstablished mesh__D012841 1991-01-01
% 223.46/223.68  |- skos__historyNote mesh__D012841 Silicones %28%1972-1974%29%
% 223.46/223.68  |- skos__prefLabel mesh__D012841 Simethicone
% 223.46/223.68  |- rdf__type mesh__D012841sskos__Concept
% 223.46/223.68  |- mesh__publicMeSHNote mesh__D012841
% 223.46/223.68       91; was see under SILICONES 1975-90   
% 223.46/223.68  |- skos__broader mesh__D012841smesh__D004129
% 223.46/223.68  |- mesh__historyNote mesh__D012043 80; was REGRESSION 1963-79   
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D012043 2005
% 223.46/223.68  |- skos__scopeNote mesh__D012043
% 223.46/223.68       A return to earlier, especially to infantile, patterns of thought or behavior, or stage of functioning, e.g., feelings of helplessness and dependency in a patient with a serious physical illness. %28%From APA, Thesaurus of Psychological Index Terms, 1994%29%.%A%    
% 223.46/223.68  |- mesh__recordAuthorizer mesh__D012043 SJN
% 223.46/223.68  |- skos__broader mesh__D012043smesh__D003674
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D012043 1999
% 223.46/223.68  |- mesh__recordMaintainer mesh__D012043 JLS
% 223.46/223.68  |- mesh__onlineNote mesh__D012043
% 223.46/223.68       use REGRESSION %28%PSYCHOLOGY%29% to search REGRESSION 1966-79   
% 223.46/223.68  |- skos__prefLabel mesh__D012043 Regression %28%Psychology%29%
% 223.46/223.68  |- mesh__recordOriginator mesh__D012043 NLM
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D012043 2002
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D012043 1998
% 223.46/223.68  |- mesh__publicMeSHNote mesh__D012043 80; was REGRESSION 1963-79   
% 223.46/223.68  |- mesh__dateRevised mesh__D012043 1997-06-20
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D012043 2001
% 223.46/223.68  |- skos__hiddenLabel mesh__D012043 Regressions %28%Psychology%29%
% 223.46/223.68  |- rdf__type mesh__D012043sskos__Concept
% 223.46/223.68  |- skos__annotation mesh__D012043
% 223.46/223.68       note category; no qualif; do not confuse with REMISSION %28%Cat C%29%; DF: REGRESSION%A%  
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D012043 2004
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D012043 2000
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D012043 2006
% 223.46/223.68  |- skos__altLabel mesh__D012043 Regression
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D012043 2003
% 223.46/223.68  |- mesh__dateCreated mesh__D012043 1999-01-01
% 223.46/223.68  |- skos__annotation mesh__D006804
% 223.46/223.68       %22%medical ergonomics%22%: index here but do not coord with MEDICINE%A%  
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D006804 1998
% 223.46/223.68  |- skos__scopeNote mesh__D006804
% 223.46/223.68       The science of designing, building or equipping mechanical devices or artificial environments to the anthropometric, physiological, or psychological requirements of the people who will use them.%A%    
% 223.46/223.68  |- skos__broader mesh__D006804smesh__D011585
% 223.46/223.68  |- mesh__recordOriginator mesh__D006804 NLM
% 223.46/223.68  |- mesh__onlineNote mesh__D006804
% 223.46/223.68       use HUMAN ENGINEERING to search ENGINEERING PSYCHOLOGY 1969-78%A%  
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D006804 2003
% 223.46/223.68  |- mesh__recordAuthorizer mesh__D006804 PLS
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D006804 1999
% 223.46/223.68  |- mesh__dateRevised mesh__D006804 1993-06-04
% 223.46/223.68  |- mesh__dateCreated mesh__D006804 1999-01-01
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D006804 2000
% 223.46/223.68  |- rdf__type mesh__D006804sskos__Concept
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D006804 1994
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D006804 2004
% 223.46/223.68  |- skos__related mesh__D006804smesh__D011590
% 223.46/223.68  |- mesh__historyNote mesh__D006804
% 223.46/223.68       ENGINEERING PSYCHOLOGY was see under HUMAN ENGINEERING 1969-78%A%  
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D006804 2001
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D006804 1995
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D006804 1996
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D006804 2005
% 223.46/223.68  |- skos__prefLabel mesh__D006804 Human Engineering
% 223.46/223.68  |- skos__broader mesh__D006804smesh__D004738
% 223.46/223.68  |- mesh__recordMaintainer mesh__D006804 JLS
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D006804 2002
% 223.46/223.68  |- skos__hiddenLabel mesh__D006804 Engineering, Human
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D006804 1997
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D006804 2006
% 223.46/223.68  |- skos__altLabel mesh__D006804 Psychology, Engineering
% 223.46/223.68  |- skos__hiddenLabel mesh__D050960 Aminomethyltransferase, Tetrahydrofolate
% 223.46/223.68  |- skos__prefLabel mesh__D050960 Aminomethyltransferase
% 223.46/223.68  |- mesh__recordMaintainer mesh__D050960 jmp
% 223.46/223.68  |- skos__hiddenLabel mesh__D050960 Glycine Decarboxylase Complex T Protein
% 223.46/223.68  |- mesh__publicMeSHNote mesh__D050960
% 223.46/223.68       2006; AMINOMETHYLTRANSFERASE was indexed under HYDROXYMETHYL AND FORMYL TRANSFERASES 1983-2005, under TRANSFERASES 1975-1997, CARBOXY-LYASES 1973-1974, under GLYCINE 1975-1982%A%  
% 223.46/223.68  |- skos__historyNote mesh__D050960 Glycine %28%1975-1979%29%
% 223.46/223.68  |- skos__historyNote mesh__D050960
% 223.46/223.68       Hydroxymethyl and Formyl Transferases %28%1980-2005%29%
% 223.46/223.68  |- skos__historyNote mesh__D050960 Carboxy-Lyases %28%1973-1974%29%
% 223.46/223.68  |- skos__historyNote mesh__D050960 Transferases %28%1975-1979%29%
% 223.46/223.68  |- skos__altLabel mesh__D050960 Glycine Synthase
% 223.46/223.68  |- skos__hiddenLabel mesh__D050960 Synthase, Glycine
% 223.46/223.68  |- skos__altLabel mesh__D050960 T-Protein, Glycine Cleavage System
% 223.46/223.68  |- skos__broader mesh__D050960smesh__D050959
% 223.46/223.68  |- skos__broader mesh__D050960smesh__D019877
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D050960 2006
% 223.46/223.68  |- mesh__historyNote mesh__D050960 2006%28%1975%29%   
% 223.46/223.68  |- rdf__type mesh__D050960sskos__Concept
% 223.46/223.68  |- skos__altLabel mesh__D050960 Tetrahydrofolate Aminomethyltransferase
% 223.46/223.68  |- mesh__dateEstablished mesh__D050960 2006-01-01
% 223.46/223.68  |- mesh__recordOriginator mesh__D050960 jmp
% 223.46/223.68  |- mesh__recordAuthorizer mesh__D050960 sjn
% 223.46/223.68  |- skos__altLabel mesh__D050960 Glycine Decarboxylase Complex T-Protein
% 223.46/223.68  |- mesh__dateCreated mesh__D050960 2005-06-30
% 223.46/223.68  |- skos__hiddenLabel mesh__D050960 T Protein, Glycine Cleavage System
% 223.46/223.68  |- skos__scopeNote mesh__D050960
% 223.46/223.68       A one-carbon group transferase that transfers lipoamide-linked methylamine groups to tetrahydrofolate %28%TETRAHYDROFOLATES%29% to form methylenetetrahydrofolate and AMMONIA. It is one of four components of the glycine decarboxylase complex.%A%    
% 223.46/223.68  |- skos__hiddenLabel mesh__D006006 Synthase, Glycogen
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D006006 2004
% 223.46/223.68  |- mesh__activeMeSHYear mesh__D006006 2005
% 223.46/223.68  |- mesh__dateRevised mesh__D006006 2003-07-09
% 223.54/223.68  |- mesh__historyNote mesh__D006006
% 223.54/223.68       92; was GLYCOGEN SYNTHETASE 1972-91 %28%Prov 1972-73%29%; GLYCOGEN SYNTHASE was see GLYCOGEN SYNTHETASE 1975-91%A%  
% 223.54/223.68  |- skos__scopeNote mesh__D006006
% 223.54/223.68       An enzyme that catalyzes the transfer of D-glucose from UDPglucose into 1,4-alpha-D-glucosyl chains. EC 2.4.1.11.%A%    
% 223.54/223.68  |- skos__broader mesh__D006006smesh__D005964
% 223.54/223.68  |- rdf__type mesh__D006006sskos__Concept
% 223.54/223.68  |- skos__altLabel mesh__D006006 Glycogen %28%Starch%29% Synthase
% 223.54/223.68  |- mesh__recordAuthorizer mesh__D006006 sjn
% 223.54/223.68  |- mesh__dateCreated mesh__D006006 1999-01-01
% 223.54/223.68  |- mesh__recordOriginator mesh__D006006 NLM
% 223.54/223.68  |- skos__historyNote mesh__D006006 Glucosyltransferases %28%1966-1971%29%
% 223.54/223.68  |- mesh__onlineNote mesh__D006006
% 223.54/223.68       use GLYCOGEN SYNTHASE to search GLYCOGEN SYNTHETASE 1972-91 %28%as Prov 1972-73%29%%A%  
% 223.54/223.68  |- mesh__dateEstablished mesh__D006006 1974-01-01
% 223.54/223.68  |- mesh__recordMaintainer mesh__D006006 ssb
% 223.54/223.68  |- skos__hiddenLabel mesh__D006006
% 223.54/223.68       UDP Glucose Glycogen Glucosyl Transferase
% 223.54/223.68  |- skos__altLabel mesh__D006006 UDP-Glucose Glycogen Glucosyl Transferase
% 223.54/223.68  |- skos__hiddenLabel mesh__D006006 Synthetase, Glycogen
% 223.54/223.68  |- mesh__publicMeSHNote mesh__D006006
% 223.54/223.68       92; was GLYCOGEN SYNTHETASE 1974-91; GLYCOGEN SYNTHASE was see GLYCOGEN SYNTHETASE 1975-91%A%  
% 223.54/223.68  |- mesh__activeMeSHYear mesh__D006006 2006
% 223.54/223.68  |- skos__prefLabel mesh__D006006 Glycogen Synthase
% 223.54/223.68  |- skos__altLabel mesh__D006006 Glycogen Synthetase
% 223.54/223.68  |- mesh__historyNote mesh__D044923 2004   
% 223.54/223.68  |- skos__historyNote mesh__D044923 Helicobacter %28%1994-2003%29%
% 223.54/223.68  |- mesh__activeMeSHYear mesh__D044923 2006
% 223.54/223.68  |- skos__annotation mesh__D044923
% 223.54/223.68       infection: coord IM with HELICOBACTER INFECTIONS %28%IM%29%   
% 223.54/223.68  |- skos__scopeNote mesh__D044923
% 223.54/223.68       A species of HELICOBACTER that colonizes the CECUM and COLON of several strains of MICE, and is associated with HEPATITIS and carcinogenesis.%A%    
% 223.54/223.68  |- skos__prefLabel mesh__D044923 Helicobacter hepaticus
% 223.54/223.68  |- mesh__recordOriginator mesh__D044923 ags
% 223.54/223.68  |- rdf__type mesh__D044923sskos__Concept
% 223.54/223.68  |- mesh__publicMeSHNote mesh__D044923 2004   
% 223.54/223.68  |- mesh__dateCreated mesh__D044923 2003-07-09
% 223.54/223.68  |- mesh__recordMaintainer mesh__D044923 SYSTEM
% 223.54/223.68  |- mesh__dateEstablished mesh__D044923 2004-01-01
% 223.54/223.68  |- mesh__recordAuthorizer mesh__D044923 sjn
% 223.54/223.68  |- skos__broader mesh__D044923smesh__D016998
% 223.54/223.68  |- mesh__dateRevised mesh__D044923 2005-06-30
% 223.54/223.68  |- rdf__type mesh__D011749sskos__Concept
% 223.54/223.68  |- mesh__recordMaintainer mesh__D011749 ssb
% 223.54/223.68  |- skos__broader mesh__D011749smesh__D009676
% 223.54/223.68  |- mesh__dateRevised mesh__D011749 2005-06-30
% 223.54/223.68  |- mesh__recordOriginator mesh__D011749 NLM
% 223.54/223.68  |- skos__related mesh__D011749smesh__D004731
% 223.54/223.68  |- mesh__activeMeSHYear mesh__D011749 2006
% 223.54/223.68  |- skos__prefLabel mesh__D011749 Pyrogens
% 223.54/223.68  |- mesh__dateCreated mesh__D011749 1999-01-01
% 223.54/223.68  |- mesh__recordAuthorizer mesh__D011749 sjn
% 223.54/223.68  |- skos__scopeNote mesh__D011749
% 223.54/223.68       Substances capable of increasing BODY TEMPERATURE and cause FEVER and may be used for FEVER THERAPY. They may be of microbial origin, often POLYSACCHARIDES, and may contaminate distilled water.%A%    
% 223.54/223.68  |- skos__scopeNote mesh__D044125
% 223.54/223.68       A family of gram-negative bacteria in the order Legionellales. It includes genera COXIELLA and Rickettsiella.%A%    
% 223.54/223.68  |- mesh__historyNote mesh__D044125 2004   
% 223.54/223.68  |- mesh__recordAuthorizer mesh__D044125 sjn
% 223.54/223.68  |- mesh__recordOriginator mesh__D044125 ags
% 223.54/223.68  |- rdf__type mesh__D044125sskos__Concept
% 223.54/223.68  |- skos__broader mesh__D044125smesh__D020563
% 223.54/223.68  |- mesh__dateCreated mesh__D044125 2003-07-09
% 223.54/223.68  |- mesh__activeMeSHYear mesh__D044125 2006
% 223.54/223.68  |- mesh__dateEstablished mesh__D044125 2004-01-01
% 223.54/223.68  |- mesh__recordMaintainer mesh__D044125 SYSTEM
% 223.54/223.68  |- mesh__publicMeSHNote mesh__D044125 2004   
% 223.54/223.68  |- skos__prefLabel mesh__D044125 Coxiellaceae
% 223.54/223.68  |- mesh__dateRevised mesh__D044125 2005-06-30
% 223.54/223.68  |- skos__broader mesh__D044125smesh__D016946
% 223.54/223.68  |- mesh__activeMeSHYear mesh__D002414 2003
% 223.54/223.68  |- mesh__activeMeSHYear mesh__D002414 1994
% 223.54/223.68  |- mesh__dateCreated mesh__D002414 1999-01-01
% 223.54/223.68  |- mesh__publicMeSHNote mesh__D002414 73   
% 223.54/223.68  |- skos__historyNote mesh__D002414 Ions %28%1966-1972%29%
% 223.54/223.68  |- skos__annotation mesh__D002414
% 223.54/223.68       NIM: avoid as IM except when general only: prefer specifics; use qualif discreetly: few apply%A%  
% 223.54/223.68  |- mesh__dateEstablished mesh__D002414 1973-01-01
% 223.54/223.68  |- mesh__activeMeSHYear mesh__D002414 2004
% 223.54/223.68  |- mesh__activeMeSHYear mesh__D002414 1995
% 223.54/223.68  |- mesh__activeMeSHYear mesh__D002414 1996
% 223.54/223.68  |- skos__broader mesh__D002414smesh__D002412
% 223.54/223.68  |- skos__historyNote mesh__D002414 Metals %28%1966-1972%29%
% 223.54/223.68  |- mesh__activeMeSHYear mesh__D002414 2000
% 223.54/223.68  |- mesh__dateRevised mesh__D002414 1992-05-11
% 223.54/223.68  |- mesh__activeMeSHYear mesh__D002414 2005
% 223.54/223.68  |- mesh__activeMeSHYear mesh__D002414 1997
% 223.54/223.68  |- skos__prefLabel mesh__D002414 Cations, Monovalent
% 223.54/223.68  |- mesh__historyNote mesh__D002414 73   
% 223.54/223.68  |- skos__historyNote mesh__D002414 specific element %28%  -  %29%
% 223.54/223.68  |- mesh__recordAuthorizer mesh__D002414 PLS
% 223.54/223.68  |- mesh__activeMeSHYear mesh__D002414 2001
% 223.54/223.68  |- skos__hiddenLabel mesh__D002414 Monovalent Cations
% 223.54/223.68  |- mesh__activeMeSHYear mesh__D002414 2006
% 223.54/223.68  |- mesh__activeMeSHYear mesh__D002414 1998
% 223.54/223.68  |- mesh__recordOriginator mesh__D002414 NLM
% 223.54/223.68  |- mesh__activeMeSHYear mesh__D002414 2002
% 223.54/223.68  |- mesh__activeMeSHYear mesh__D002414 1993
% 223.54/223.68  |- skos__scopeNote mesh__D002414
% 223.54/223.68       Positively charged atoms, radicals or group of atoms with a valence of plus 1, which travel to the cathode or negative pole during electrolysis.%A%    
% 223.54/223.68  |- mesh__recordMaintainer mesh__D002414 TAP
% 223.54/223.68  |- mesh__activeMeSHYear mesh__D002414 1999
% 223.54/223.68  |- rdf__type mesh__D002414sskos__Concept
% 223.54/223.68  |- mesh__dateCreated mesh__D026862 2001-07-25
% 223.54/223.68  |- rdf__type mesh__D026862sskos__Concept
% 223.54/223.68  |- mesh__activeMeSHYear mesh__D026862 2006
% 223.54/223.68  |- skos__scopeNote mesh__D026862
% 223.54/223.68       A family of softbacked TICKS, in the subclass ACARI. Genera include ARGAS and ORNITHODOROS among others.%A%    
% 223.54/223.68  |- skos__altLabel mesh__D026862 Soft Ticks
% 223.54/223.68  |- mesh__historyNote mesh__D026862 2002   
% 223.54/223.68  |- mesh__activeMeSHYear mesh__D026862 2005
% 223.54/223.68  |- mesh__dateRevised mesh__D026862 2003-07-09
% 223.54/223.68  |- skos__historyNote mesh__D026862 Ticks %28%1964-2001%29%
% 223.54/223.68  |- skos__annotation mesh__D026862
% 223.54/223.68       infestation: coord IM with TICK INFESTATIONS %28%IM%29%   
% 223.54/223.68  |- skos__altLabel mesh__D026862 Ticks, Softbacked
% 223.54/223.68  |- mesh__dateEstablished mesh__D026862 2002-01-01
% 223.54/223.68  |- skos__prefLabel mesh__D026862 Argasidae
% 223.54/223.68  |- skos__broader mesh__D026862smesh__D013987
% 223.54/223.68  |- mesh__activeMeSHYear mesh__D026862 2004
% 223.54/223.68  |- mesh__publicMeSHNote mesh__D026862 2002   
% 223.54/223.68  |- skos__altLabel mesh__D012842 Simian Sarcoma Viruses
% 223.54/223.68  |- skos__altLabel mesh__D012842 Sarcoma Viruses, Simian
% 223.54/223.68  |- rdf__type mesh__D012842sskos__Concept
% 223.54/223.68  |- mesh__recordAuthorizer mesh__D012842 sjn
% 223.54/223.68  |- skos__hiddenLabel mesh__D012842 Sarcoma Virus, Simian
% 223.54/223.68  |- skos__broader mesh__D012842smesh__D017988
% 223.54/223.68  |- mesh__recordOriginator mesh__D012842 AEP
% 223.54/223.68  |- mesh__dateEstablished mesh__D012842 1991-01-01
% 223.54/223.68  |- mesh__dateRevised mesh__D012842 2005-06-30
% 223.54/223.68  |- skos__prefLabel mesh__D012842 Sarcoma Virus, Woolly Monkey
% 223.54/223.68  |- skos__annotation mesh__D012842
% 223.54/223.68       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%; DF: SSV%A%  
% 223.54/223.68  |- mesh__publicMeSHNote mesh__D012842
% 223.54/223.68       2002; see SARCOMA VIRUSES, SIMIAN 1994-2001, see SIMIAN SARCOMA VIRUSES 1991-1993, see BUNYAVIRIDAE 1989-1990, see RETROVIRIDAE 1981-1988, see LEUKOVIRUSES 1978-1980%A%  
% 223.54/223.68  |- skos__historyNote mesh__D012842 Oncogenic Viruses %28%1966-1977%29%
% 223.54/223.68  |- skos__altLabel mesh__D012842 Woolly Monkey Virus
% 223.54/223.69  |- mesh__historyNote mesh__D012842
% 223.54/223.69       2002 %28%1978%29%; was SIMIAN SARCOMA VIRUSES 1978-93 %28%see under BUNYAVIRIDAE 1989-90, see under RETROVIRIDAE 1981-88, see under LEUKOVIRUSES 1978-80%29%%A%  
% 223.54/223.69  |- skos__broader mesh__D012842smesh__D015301
% 223.54/223.69  |- skos__scopeNote mesh__D012842
% 223.54/223.69       A species of GAMMARETROVIRUS producing tumors in primates. Originally isolated from a fibrosarcoma in a woolly monkey, WMSV is a replication-defective v-onc virus which carries the sis oncogene. In order to propagate, WMSV requires a replication-competent helper virus.%A%    
% 223.54/223.69  |- skos__altLabel mesh__D012842 Wooley monkey sarcoma virus
% 223.54/223.69  |- mesh__recordMaintainer mesh__D012842 ags
% 223.54/223.69  |- skos__historyNote mesh__D012842 Retroviridae %28%1972-1977%29%
% 223.54/223.69  |- skos__hiddenLabel mesh__D012842 Simian Sarcoma Virus
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D012842 2006
% 223.54/223.69  |- mesh__dateCreated mesh__D012842 1977-05-13
% 223.54/223.69  |- skos__annotation mesh__D012044
% 223.54/223.69       IM GEN only; coord NIM with specific disease or other concept %28%IM%29%; no qualif; specify geog if pertinent%A%  
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D012044 2000
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D012044 1999
% 223.54/223.69  |- skos__hiddenLabel mesh__D012044 Statistical Regressions
% 223.54/223.69  |- skos__hiddenLabel mesh__D012044 Diagnostics, Regression
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D012044 1996
% 223.54/223.69  |- skos__hiddenLabel mesh__D012044 Regression Analyses
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D012044 1995
% 223.54/223.69  |- mesh__publicMeSHNote mesh__D012044
% 223.54/223.69       80; was see under STATISTICS 1975-79   
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D012044 1998
% 223.54/223.69  |- skos__scopeNote mesh__D012044
% 223.54/223.69       Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression %28%see LINEAR MODELS%29% the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression %28%see LOGISTIC MODELS%29% the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable.%A%    
% 223.54/223.69  |- mesh__dateRevised mesh__D012044 2005-07-20
% 223.54/223.69  |- skos__broader mesh__D012044smesh__D013223
% 223.54/223.69  |- skos__hiddenLabel mesh__D012044 Analyses, Regression
% 223.54/223.69  |- rdf__type mesh__D012044sskos__Concept
% 223.54/223.69  |- skos__hiddenLabel mesh__D012044 Regression, Statistical
% 223.54/223.69  |- skos__altLabel mesh__D012044 Statistical Regression
% 223.54/223.69  |- mesh__dateEstablished mesh__D012044 1980-01-01
% 223.54/223.69  |- skos__prefLabel mesh__D012044 Regression Analysis
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D012044 2004
% 223.54/223.69  |- mesh__recordOriginator mesh__D012044 NLM
% 223.54/223.69  |- skos__historyNote mesh__D012044 Statistics %28%1966-1972%29%
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D012044 2002
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D012044 2006
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D012044 2006A
% 223.54/223.69  |- mesh__recordAuthorizer mesh__D012044 ags
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D012044 2003
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D012044 2001
% 223.54/223.69  |- mesh__dateCreated mesh__D012044 1999-01-01
% 223.54/223.69  |- skos__altLabel mesh__D012044 Analysis, Regression
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D012044 2005
% 223.54/223.69  |- skos__hiddenLabel mesh__D012044 Regressions, Statistical
% 223.54/223.69  |- mesh__historyNote mesh__D012044
% 223.54/223.69       80%28%73%29%; was see under STATISTICS 1975-79   
% 223.54/223.69  |- mesh__recordMaintainer mesh__D012044 ags
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D012044 1997
% 223.54/223.69  |- skos__altLabel mesh__D012044 Regression Diagnostics
% 223.54/223.69  |- skos__related mesh__D006805smesh__D026688
% 223.54/223.69  |- mesh__dateEstablished mesh__D006805 1966-01-01
% 223.54/223.69  |- mesh__dateCreated mesh__D006805 1999-01-01
% 223.54/223.69  |- rdf__type mesh__D006805sskos__Concept
% 223.54/223.69  |- skos__annotation mesh__D006805
% 223.54/223.69       IM for moral, legal, ethical, sociolog, religious aspect of experiments on humans; coord IM with aspect %28%IM%29%; do not routinely add for research involving human disease, therapy or physiology%A%  
% 223.54/223.69  |- skos__broader mesh__D006805smesh__D035843
% 223.54/223.69  |- skos__broader mesh__D006805smesh__D008919
% 223.54/223.69  |- mesh__recordAuthorizer mesh__D006805 sjn
% 223.54/223.69  |- skos__related mesh__D006805smesh__D032984
% 223.54/223.69  |- mesh__recordMaintainer mesh__D006805 sjn
% 223.54/223.69  |- skos__scopeNote mesh__D006805
% 223.54/223.69       The use of humans as investigational subjects.     
% 223.54/223.69  |- mesh__dateRevised mesh__D006805 2004-07-13
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D006805 2005
% 223.54/223.69  |- skos__related mesh__D006805smesh__D006381
% 223.54/223.69  |- skos__hiddenLabel mesh__D006805 Human Volunteer
% 223.54/223.69  |- skos__prefLabel mesh__D006805 Human Experimentation
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D006805 2006
% 223.54/223.69  |- skos__related mesh__D006805smesh__D033042
% 223.54/223.69  |- skos__hiddenLabel mesh__D006805 Volunteer, Human
% 223.54/223.69  |- skos__hiddenLabel mesh__D006805 Volunteers, Human
% 223.54/223.69  |- mesh__recordOriginator mesh__D006805 NLM
% 223.54/223.69  |- skos__related mesh__D006805smesh__D035842
% 223.54/223.69  |- mesh__publicMeSHNote mesh__D006805 66   
% 223.54/223.69  |- skos__related mesh__D006805smesh__D033041
% 223.54/223.69  |- mesh__historyNote mesh__D006805 66   
% 223.54/223.69  |- skos__hiddenLabel mesh__D006805 Experimentation, Human
% 223.54/223.69  |- mesh__publicMeSHNote mesh__D050961
% 223.54/223.69       2006; H-PROTEIN, GLYCINE DECARBOXYLASE SYSTEM was indexed under AMINO ACID OXIDOREDUCTASES 1990-2005%A%  
% 223.54/223.69  |- mesh__recordOriginator mesh__D050961 jmp
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D050961 2006
% 223.54/223.69  |- mesh__recordAuthorizer mesh__D050961 sjn
% 223.54/223.69  |- skos__broader mesh__D050961smesh__D050959
% 223.54/223.69  |- mesh__dateCreated mesh__D050961 2005-06-30
% 223.54/223.69  |- rdf__type mesh__D050961sskos__Concept
% 223.54/223.69  |- mesh__historyNote mesh__D050961 2006%28%1990%29%   
% 223.54/223.69  |- skos__hiddenLabel mesh__D050961 H Protein, Glycine Decarboxylase Complex
% 223.54/223.69  |- skos__hiddenLabel mesh__D050961 Glycine Decarboxylase Complex H Protein
% 223.54/223.69  |- skos__altLabel mesh__D050961 H-Protein, Glycine Decarboxylase Complex
% 223.54/223.69  |- skos__scopeNote mesh__D050961
% 223.54/223.69       A LIPOIC ACID-containing protein that plays the pivotal role in the transfer of methylamine groups and reducing equivalents between the three enzymatic components of the glycine decarboxylase complex.%A%    
% 223.54/223.69  |- skos__altLabel mesh__D050961 H-Protein, Glycine Cleavage System
% 223.54/223.69  |- skos__prefLabel mesh__D050961 Glycine Decarboxylase Complex H-Protein
% 223.54/223.69  |- mesh__recordMaintainer mesh__D050961 jmp
% 223.54/223.69  |- skos__hiddenLabel mesh__D050961 H Protein, Glycine Cleavage System
% 223.54/223.69  |- mesh__dateEstablished mesh__D050961 2006-01-01
% 223.54/223.69  |- skos__hiddenLabel mesh__D006007 Phosphatase G, Protein
% 223.54/223.69  |- skos__altLabel mesh__D006007 Glycogen Synthetase Phosphatase
% 223.54/223.69  |- mesh__publicMeSHNote mesh__D006007
% 223.54/223.69       92; was GLYCOGEN SYNTHETASE PHOSPHATASE 1975-91 %28%see under PHOSPHOPROTEIN PHOSPHATASES 1979-90, see under PHOSPHOMONOESTERASES 1975-78%29%%A%  
% 223.54/223.69  |- mesh__dateCreated mesh__D006007 1974-11-19
% 223.54/223.69  |- rdf__type mesh__D006007sskos__Concept
% 223.54/223.69  |- mesh__dateEstablished mesh__D006007 1991-01-01
% 223.54/223.69  |- skos__hiddenLabel mesh__D006007 Phosphatase, Glycogen Synthetase
% 223.54/223.69  |- skos__historyNote mesh__D006007 Glycogen Synthetase %28%1973-1974%29%
% 223.54/223.69  |- skos__broader mesh__D006007smesh__D010749
% 223.54/223.69  |- mesh__historyNote mesh__D006007
% 223.54/223.69       92; was GLYCOGEN SYNTHETASE PHOSPHATASE 1975-91 %28%see under PHOSPHOPROTEIN PHOSPHATASES 1979-90, see under PHOSPHOMONOESTERASES 1975-78%29%%A%  
% 223.54/223.69  |- mesh__recordOriginator mesh__D006007 NLM
% 223.54/223.69  |- mesh__recordAuthorizer mesh__D006007 sjn
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D006007 2006
% 223.54/223.69  |- skos__hiddenLabel mesh__D006007 Synthetase Phosphatase, Glycogen
% 223.54/223.69  |- mesh__onlineNote mesh__D006007
% 223.54/223.69       use GLYCOGEN-SYNTHASE-D PHOSPHATASE to search GLYCOGEN SYNTHETASE PHOSPHATASE 1975-91%A%  
% 223.54/223.69  |- skos__scopeNote mesh__D006007
% 223.54/223.69       An enzyme that catalyzes the conversion of phosphorylated, inactive glycogen synthase D to active dephosphoglycogen synthase I. EC 3.1.3.42.%A%    
% 223.54/223.69  |- skos__prefLabel mesh__D006007 Glycogen-Synthase-D Phosphatase
% 223.54/223.69  |- mesh__recordMaintainer mesh__D006007 ssb
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D006007 2004
% 223.54/223.69  |- skos__hiddenLabel mesh__D006007 Phosphatase, Glycogen-Synthase-D
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D006007 2005
% 223.54/223.69  |- mesh__dateRevised mesh__D006007 2003-07-09
% 223.54/223.69  |- skos__hiddenLabel mesh__D006007 Glycogen Synthase D Phosphatase
% 223.54/223.69  |- mesh__recordOriginator mesh__D016435 TAP
% 223.54/223.69  |- mesh__recordMaintainer mesh__D016435 jls
% 223.54/223.69  |- skos__prefLabel mesh__D016435 Directory %5B%Publication Type%5D%
% 223.54/223.69  |- mesh__recordAuthorizer mesh__D016435 sjn
% 223.54/223.69  |- skos__annotation mesh__D016435
% 223.54/223.69       publication type only; for directories as a subject, index under main heading DIRECTORIES; Manual 33.13, 36.21%A%  
% 223.54/223.69  |- skos__altLabel mesh__D016435 Registers %28%PT%29%
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D016435 2006
% 223.54/223.69  |- skos__broader mesh__D016435smesh__D052180
% 223.54/223.69  |- skos__altLabel mesh__D016435 Directory %28%PT%29%
% 223.54/223.69  |- skos__altLabel mesh__D016435 Directory
% 223.54/223.69  |- mesh__dateRevised mesh__D016435 2005-06-30
% 223.54/223.69  |- mesh__dateCreated mesh__D016435 1995-06-23
% 223.54/223.69  |- rdf__type mesh__D016435sskos__Concept
% 223.54/223.69  |- mesh__dateEstablished mesh__D016435 1996-01-01
% 223.54/223.69  |- skos__related mesh__D016435smesh__D020507
% 223.54/223.69  |- mesh__historyNote mesh__D016435 1991   
% 223.54/223.69  |- skos__scopeNote mesh__D016435
% 223.54/223.69       Work consisting of an alphabetical or classified list of names, organizations, subjects, etc., giving usually titles, addresses, affiliations, and other professional data.%A%    
% 223.54/223.69  |- skos__altLabel mesh__D002415 Felis domesticus
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D002415 2005
% 223.54/223.69  |- mesh__recordOriginator mesh__D002415 NLM
% 223.54/223.69  |- skos__scopeNote mesh__D002415
% 223.54/223.69       The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. %28%From Walker%27%s Mammals of the World, 6th ed, p801%29%%A%    
% 223.54/223.69  |- rdf__type mesh__D002415sskos__Concept
% 223.54/223.69  |- skos__altLabel mesh__D002415 Domestic Cats
% 223.54/223.69  |- skos__hiddenLabel mesh__D002415 Cats, Domestic
% 223.54/223.69  |- skos__altLabel mesh__D002415 Felis catus
% 223.54/223.69  |- skos__annotation mesh__D002415
% 223.54/223.69       check tag: no qualifiers; restrict to domestic cat   
% 223.54/223.69  |- mesh__recordMaintainer mesh__D002415 ags
% 223.54/223.69  |- skos__hiddenLabel mesh__D002415 Cat
% 223.54/223.69  |- skos__altLabel mesh__D002415 Felis domestica
% 223.54/223.69  |- mesh__dateRevised mesh__D002415 2004-07-07
% 223.54/223.69  |- skos__altLabel mesh__D002415 Felis sylvestris catus
% 223.54/223.69  |- skos__broader mesh__D002415smesh__D045991
% 223.54/223.69  |- mesh__considerAlso mesh__D002415 consider also terms at FELINE   
% 223.54/223.69  |- skos__hiddenLabel mesh__D002415 Domestic Cat
% 223.54/223.69  |- skos__prefLabel mesh__D002415 Cats
% 223.54/223.69  |- mesh__recordAuthorizer mesh__D002415 sjn
% 223.54/223.69  |- mesh__dateCreated mesh__D002415 1999-01-01
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D002415 2006
% 223.54/223.69  |- skos__hiddenLabel mesh__D002415 Cat, Domestic
% 223.54/223.69  |- skos__historyNote mesh__D007100 Behavior, Animal %28%1966-1967%29%
% 223.54/223.69  |- skos__hiddenLabel mesh__D007100 Behaviors, Imitative
% 223.54/223.69  |- mesh__dateEstablished mesh__D007100 1968-01-01
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D007100 2003
% 223.54/223.69  |- skos__prefLabel mesh__D007100 Imitative Behavior
% 223.54/223.69  |- mesh__recordOriginator mesh__D007100 NLM
% 223.54/223.69  |- mesh__dateCreated mesh__D007100 1999-01-01
% 223.54/223.69  |- skos__broader mesh__D007100smesh__D001519
% 223.54/223.69  |- mesh__publicMeSHNote mesh__D007100 68   
% 223.54/223.69  |- mesh__dateRevised mesh__D007100 2002-07-02
% 223.54/223.69  |- skos__historyNote mesh__D007100 Behavior %28%1966-1967%29%
% 223.54/223.69  |- skos__hiddenLabel mesh__D007100 Behavior, Imitative
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D007100 2006
% 223.54/223.69  |- skos__hiddenLabel mesh__D007100 Imitative Behaviors
% 223.54/223.69  |- skos__scopeNote mesh__D007100
% 223.54/223.69       The mimicking of the behavior of one individual by another.%A%    
% 223.54/223.69  |- mesh__recordMaintainer mesh__D007100 TAP
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D007100 2005
% 223.54/223.69  |- rdf__type mesh__D007100sskos__Concept
% 223.54/223.69  |- mesh__historyNote mesh__D007100 68   
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D007100 2004
% 223.54/223.69  |- skos__annotation mesh__D007100 human %26% animal   
% 223.54/223.69  |- mesh__recordAuthorizer mesh__D007100 sjn
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D026863 2005
% 223.54/223.69  |- mesh__dateRevised mesh__D026863 2003-07-09
% 223.54/223.69  |- mesh__dateCreated mesh__D026863 2001-07-25
% 223.54/223.69  |- mesh__historyNote mesh__D026863 2002   
% 223.54/223.69  |- mesh__dateEstablished mesh__D026863 2002-01-01
% 223.54/223.69  |- skos__altLabel mesh__D026863 Ticks, Hardbacked
% 223.54/223.69  |- skos__altLabel mesh__D026863 Hard Ticks
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D026863 2004
% 223.54/223.69  |- skos__annotation mesh__D026863
% 223.54/223.69       infestation: coord IM with TICK INFESTATIONS %28%IM%29%   
% 223.54/223.69  |- skos__prefLabel mesh__D026863 Ixodidae
% 223.54/223.69  |- mesh__publicMeSHNote mesh__D026863 2002   
% 223.54/223.69  |- skos__broader mesh__D026863smesh__D013987
% 223.54/223.69  |- rdf__type mesh__D026863sskos__Concept
% 223.54/223.69  |- skos__scopeNote mesh__D026863
% 223.54/223.69       A family of hardbacked TICKS, in the subclass ACARI. Genera include DERMACENTOR and IXODES among others.%A%    
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D026863 2006
% 223.54/223.69  |- skos__historyNote mesh__D026863 Ticks %28%1965-2001%29%
% 223.54/223.69  |- skos__broader mesh__D012843smesh__D004175
% 223.54/223.69  |- skos__altLabel mesh__D012843 Blackflies
% 223.54/223.69  |- skos__historyNote mesh__D012843 Diptera %28%1966-1983%29%
% 223.54/223.69  |- mesh__recordAuthorizer mesh__D012843 sjn
% 223.54/223.69  |- mesh__dateRevised mesh__D012843 2003-07-09
% 223.54/223.69  |- skos__scopeNote mesh__D012843
% 223.54/223.69       Several species of the genus Simulium %28%family Simuliidae%29% that act as intermediate hosts %28%vectors%29% for the parasitic disease ONCHOCERCIASIS.%A%    
% 223.54/223.69  |- mesh__dateEstablished mesh__D012843 1984-01-01
% 223.54/223.69  |- mesh__recordMaintainer mesh__D012843 ags
% 223.54/223.69  |- skos__altLabel mesh__D012843 Black Flies
% 223.54/223.69  |- skos__prefLabel mesh__D012843 Simuliidae
% 223.54/223.69  |- mesh__dateCreated mesh__D012843 1983-06-06
% 223.54/223.69  |- mesh__historyNote mesh__D012843 84   
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D012843 2006
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D012843 2004
% 223.54/223.69  |- mesh__publicMeSHNote mesh__D012843 84   
% 223.54/223.69  |- skos__annotation mesh__D012843
% 223.54/223.69       a family of flies, including black flies %26% buffalo gnats; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111%A%  
% 223.54/223.69  |- rdf__type mesh__D012843sskos__Concept
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D012843 2005
% 223.54/223.69  |- mesh__recordOriginator mesh__D012843 EC
% 223.54/223.69  |- skos__altLabel mesh__D012045 Regions, Regulatory
% 223.54/223.69  |- mesh__recordAuthorizer mesh__D012045 sjn
% 223.54/223.69  |- skos__altLabel mesh__D012045 Regulatory Regions
% 223.54/223.69  |- skos__altLabel mesh__D012045 Nucleic Acid Regulatory Sequences
% 223.54/223.69  |- skos__altLabel mesh__D012045 Regulatory Region
% 223.54/223.69  |- skos__broader mesh__D012045smesh__D001483
% 223.54/223.69  |- skos__prefLabel mesh__D012045 Regulatory Sequences, Nucleic Acid
% 223.54/223.69  |- skos__altLabel mesh__D012045
% 223.54/223.69       Regulatory Regions, Nucleic Acid %28%Genetics%29%
% 223.54/223.69  |- mesh__dateEstablished mesh__D012045 1988-01-01
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D012045 2003
% 223.54/223.69  |- rdf__type mesh__D012045sskos__Concept
% 223.54/223.69  |- mesh__dateCreated mesh__D012045 1987-05-09
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D012045 2005
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D012045 2004
% 223.54/223.69  |- skos__historyNote mesh__D012045 DNA or specific %28%1977-1987%29%
% 223.54/223.69  |- mesh__historyNote mesh__D012045 88   
% 223.54/223.69  |- mesh__dateRevised mesh__D012045 2002-07-03
% 223.54/223.69  |- skos__historyNote mesh__D012045 Base Sequence %28%1977-1987%29%
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D012045 2006
% 223.54/223.69  |- skos__scopeNote mesh__D012045
% 223.54/223.69       Nucleic acid sequences involved in regulating the expression of genes.%A%    
% 223.54/223.69  |- mesh__publicMeSHNote mesh__D012045 88   
% 223.54/223.69  |- skos__altLabel mesh__D012045 Region, Regulatory
% 223.54/223.69  |- skos__altLabel mesh__D012045 Regulator Regions, Nucleic Acid
% 223.54/223.69  |- mesh__recordMaintainer mesh__D012045 NNS
% 223.54/223.69  |- mesh__recordOriginator mesh__D012045 SCD
% 223.54/223.69  |- skos__annotation mesh__D012045
% 223.54/223.69       coord IM with DNA or RNA or specific %28%NIM%29%; DF: REG SEQ   
% 223.54/223.69  |- skos__related mesh__D006806smesh__D002961
% 223.54/223.69  |- skos__hiddenLabel mesh__D006806 Right, Human
% 223.54/223.69  |- mesh__historyNote mesh__D006806 73   
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D006806 2005
% 223.54/223.69  |- mesh__publicMeSHNote mesh__D006806 73   
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D006806 2006
% 223.54/223.69  |- skos__scopeNote mesh__D006806
% 223.54/223.69       The rights of the individual to cultural, social, economic, and educational opportunities as provided by society, e.g., right to work, right to education, and right to social security.%A%    
% 223.54/223.69  |- mesh__recordAuthorizer mesh__D006806 sjn
% 223.54/223.69  |- skos__prefLabel mesh__D006806 Human Rights
% 223.54/223.69  |- skos__related mesh__D006806smesh__D014933
% 223.54/223.69  |- skos__annotation mesh__D006806
% 223.54/223.69       specify geog if pertinent; HUMAN RIGHTS ABUSES is also available%A%  
% 223.54/223.69  |- mesh__dateRevised mesh__D006806 2004-07-13
% 223.54/223.69  |- mesh__recordMaintainer mesh__D006806 sjn
% 223.54/223.69  |- skos__historyNote mesh__D006806 Civil Rights %28%1968-1972%29%
% 223.54/223.69  |- skos__broader mesh__D006806smesh__D012926
% 223.54/223.69  |- skos__hiddenLabel mesh__D006806 Human Right
% 223.54/223.69  |- mesh__dateCreated mesh__D006806 1999-01-01
% 223.54/223.69  |- skos__hiddenLabel mesh__D006806 Rights, Human
% 223.54/223.69  |- rdf__type mesh__D006806sskos__Concept
% 223.54/223.69  |- mesh__recordOriginator mesh__D006806 NLM
% 223.54/223.69  |- mesh__dateEstablished mesh__D006806 1973-01-01
% 223.54/223.69  |- skos__related mesh__D006806smesh__D045809
% 223.54/223.69  |- mesh__recordOriginator mesh__D006008 NLM
% 223.54/223.69  |- skos__broader mesh__D006008smesh__D002239
% 223.54/223.69  |- mesh__recordAuthorizer mesh__D006008 sjn
% 223.54/223.69  |- mesh__dateRevised mesh__D006008 2001-07-25
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D006008 2002
% 223.54/223.69  |- skos__hiddenLabel mesh__D006008 Diseases, Glycogen Storage
% 223.54/223.69  |- mesh__recordMaintainer mesh__D006008 nns
% 223.54/223.69  |- mesh__publicMeSHNote mesh__D006008 89; was GLYCOGENOSIS 1963-88   
% 223.54/223.69  |- skos__hiddenLabel mesh__D006008 Glycogenoses
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D006008 2006
% 223.54/223.69  |- mesh__historyNote mesh__D006008 89; was GLYCOGENOSIS 1963-88   
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D006008 2004
% 223.54/223.69  |- skos__hiddenLabel mesh__D006008 Storage Diseases, Glycogen
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D006008 2005
% 223.54/223.69  |- mesh__onlineNote mesh__D006008
% 223.54/223.69       use GLYCOGEN STORAGE DISEASE to search GLYCOGENOSIS 1966-88%A%  
% 223.54/223.69  |- skos__prefLabel mesh__D006008 Glycogen Storage Disease
% 223.54/223.69  |- skos__altLabel mesh__D006008 Glycogenosis
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D006008 2003
% 223.54/223.69  |- skos__hiddenLabel mesh__D006008 Glycogen Storage Diseases
% 223.54/223.69  |- rdf__type mesh__D006008sskos__Concept
% 223.54/223.69  |- skos__hiddenLabel mesh__D006008 Disease, Glycogen Storage
% 223.54/223.69  |- skos__annotation mesh__D006008
% 223.54/223.69       an inborn error of carbohydrate metab; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 223.54/223.69  |- skos__scopeNote mesh__D006008
% 223.54/223.69       A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalized storage of glycogen occurs, sometimes with prominent cardiac involvement.%A%    
% 223.54/223.69  |- mesh__dateCreated mesh__D006008 1999-01-01
% 223.54/223.69  |- skos__hiddenLabel mesh__D006008 Storage Disease, Glycogen
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D044925 2006
% 223.54/223.69  |- mesh__dateCreated mesh__D044925 2003-07-09
% 223.54/223.69  |- mesh__recordMaintainer mesh__D044925 jmp
% 223.54/223.69  |- skos__annotation mesh__D044925 GEN; prefer specifics   
% 223.54/223.69  |- mesh__recordAuthorizer mesh__D044925 sjn
% 223.54/223.69  |- mesh__publicMeSHNote mesh__D044925 2004   
% 223.54/223.69  |- rdf__type mesh__D044925sskos__Concept
% 223.54/223.69  |- skos__prefLabel mesh__D044925
% 223.54/223.69       Oxidoreductases Acting on CH-CH Group Donors
% 223.54/223.69  |- mesh__dateRevised mesh__D044925 2005-06-30
% 223.54/223.69  |- mesh__dateEstablished mesh__D044925 2004-01-01
% 223.54/223.69  |- skos__broader mesh__D044925smesh__D010088
% 223.54/223.69  |- skos__scopeNote mesh__D044925
% 223.54/223.69       A subclass of enzymes which includes all dehydrogenases acting on carbon-carbon bonds. This enzyme group includes all the enzymes that introduce double bonds into substrates by direct dehydrogenation of carbon-carbon single bonds.%A%    
% 223.54/223.69  |- skos__hiddenLabel mesh__D044925
% 223.54/223.69       Oxidoreductases Acting on CH CH Group Donors
% 223.54/223.69  |- mesh__recordOriginator mesh__D044925 jmp
% 223.54/223.69  |- mesh__historyNote mesh__D044925 2004   
% 223.54/223.69  |- skos__historyNote mesh__D044925 Oxidoreductases %28%1963-2003%29%
% 223.54/223.69  |- skos__related mesh__D044127smesh__D019175
% 223.54/223.69  |- mesh__publicMeSHNote mesh__D044127 2004   
% 223.54/223.69  |- skos__prefLabel mesh__D044127 Epigenesis, Genetic
% 223.54/223.69  |- skos__related mesh__D044127smesh__D018392
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D044127 2004
% 223.54/223.69  |- skos__broader mesh__D044127smesh__D005786
% 223.54/223.69  |- skos__scopeNote mesh__D044127
% 223.54/223.69       The genetic process by which the adult organism is realized via gradual increases in complexity of structure as opposed to a mere increase in size of preexisting structures. It includes those mechanisms causing the selective gene repression or derepression that restricts the possible fates of cells and eventually leads to their differentiated state.%A%    
% 223.54/223.69  |- skos__related mesh__D044127smesh__D020868
% 223.54/223.69  |- skos__hiddenLabel mesh__D044127 Genetic Epigenesis
% 223.54/223.69  |- rdf__type mesh__D044127sskos__Concept
% 223.54/223.69  |- mesh__historyNote mesh__D044127 2004   
% 223.54/223.69  |- skos__related mesh__D044127smesh__D009024
% 223.54/223.69  |- mesh__dateCreated mesh__D044127 2003-07-09
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D044127 2006
% 223.54/223.69  |- mesh__dateEstablished mesh__D044127 2004-01-01
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D044127 2005
% 223.54/223.69  |- skos__prefLabel mesh__D002416 Cattell Personality Factor Questionnaire
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D002416 2004
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D002416 2000
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D002416 1993
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D002416 1998
% 223.54/223.69  |- mesh__historyNote mesh__D002416
% 223.54/223.69       91%28%75%29%; was see under PERSONALITY INVENTORY 1975-90   
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D002416 2003
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D002416 1997
% 223.54/223.69  |- mesh__publicMeSHNote mesh__D002416
% 223.54/223.69       91; was see under PERSONALITY INVENTORY 1975-90   
% 223.54/223.69  |- mesh__recordOriginator mesh__D002416 NLM
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D002416 1996
% 223.54/223.69  |- mesh__recordMaintainer mesh__D002416 TAP
% 223.54/223.69  |- mesh__dateRevised mesh__D002416 1992-05-07
% 223.54/223.69  |- skos__broader mesh__D002416smesh__D010555
% 223.54/223.69  |- mesh__dateCreated mesh__D002416 1999-01-01
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D002416 2006
% 223.54/223.69  |- mesh__dateEstablished mesh__D002416 1991-01-01
% 223.54/223.69  |- mesh__recordAuthorizer mesh__D002416 PLS
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D002416 2002
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D002416 1995
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D002416 2005
% 223.54/223.69  |- skos__scopeNote mesh__D002416
% 223.54/223.69       Self report questionnaire which yields 16 scores on personality traits, such as reserved vs. outgoing, humble vs. assertive, etc.%A%    
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D002416 1999
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D002416 2001
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D002416 1994
% 223.54/223.69  |- rdf__type mesh__D002416sskos__Concept
% 223.54/223.69  |- mesh__onlineNote mesh__D002416 search PERSONALITY INVENTORY 1968-74   
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D007101 1998
% 223.54/223.69  |- mesh__recordAuthorizer mesh__D007101 PLS
% 223.54/223.69  |- mesh__recordMaintainer mesh__D007101 TAP
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D007101 2006
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D007101 1997
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D007101 2002
% 223.54/223.69  |- skos__historyNote mesh__D007101 Diving %28%1966%29%
% 223.54/223.69  |- skos__hiddenLabel mesh__D007101 Submersions
% 223.54/223.69  |- mesh__dateEstablished mesh__D007101 1967-01-01
% 223.54/223.69  |- mesh__publicMeSHNote mesh__D007101 67   
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D007101 2005
% 223.54/223.69  |- rdf__type mesh__D007101sskos__Concept
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D007101 1996
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D007101 2001
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D007101 2004
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D007101 1995
% 223.54/223.69  |- skos__related mesh__D007101smesh__D004242
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D007101 2000
% 223.54/223.69  |- mesh__recordOriginator mesh__D007101 NLM
% 223.54/223.69  |- skos__prefLabel mesh__D007101 Immersion
% 223.54/223.69  |- skos__scopeNote mesh__D007101
% 223.54/223.69       The placing of a body or a part thereof into a liquid.     
% 223.54/223.69  |- mesh__historyNote mesh__D007101 67   
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D007101 2003
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D007101 1994
% 223.54/223.69  |- mesh__dateCreated mesh__D007101 1999-01-01
% 223.54/223.69  |- skos__related mesh__D007101smesh__D004332
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D007101 1999
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D007101 1993
% 223.54/223.69  |- mesh__dateRevised mesh__D007101 1992-05-14
% 223.54/223.69  |- skos__broader mesh__D007101smesh__D008919
% 223.54/223.69  |- skos__hiddenLabel mesh__D007101 Immersions
% 223.54/223.69  |- skos__broader mesh__D026864smesh__D026862
% 223.54/223.69  |- mesh__dateRevised mesh__D026864 2003-07-09
% 223.54/223.69  |- skos__scopeNote mesh__D026864
% 223.54/223.69       A genus of softbacked TICKS in the family ARGASIDAE. Most infect birds or bats but a few parasitize terrestrial mammals.%A%    
% 223.54/223.69  |- mesh__dateCreated mesh__D026864 2001-07-25
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D026864 2004
% 223.54/223.69  |- skos__historyNote mesh__D026864 Ticks %28%1965-2001%29%
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D026864 2005
% 223.54/223.69  |- mesh__publicMeSHNote mesh__D026864 2002   
% 223.54/223.69  |- skos__annotation mesh__D026864
% 223.54/223.69       infestation: coord IM with TICK INFESTATIONS %28%IM%29%   
% 223.54/223.69  |- mesh__historyNote mesh__D026864 2002   
% 223.54/223.69  |- mesh__dateEstablished mesh__D026864 2002-01-01
% 223.54/223.69  |- rdf__type mesh__D026864sskos__Concept
% 223.54/223.69  |- mesh__activeMeSHYear mesh__D026864 2006
% 223.54/223.69  |- skos__prefLabel mesh__D026864 Argas
% 223.54/223.69  |- skos__altLabel mesh__D012844
% 223.54/223.69       H-Asp-Tyr%28%SO3H%29%-Met-Gly-Trp-Met-Asp-Phe-NH2
% 223.54/223.69  |- skos__hiddenLabel mesh__D012844 SQ19,844
% 223.54/223.69  |- skos__hiddenLabel mesh__D012844 SQ 19,844
% 223.54/223.69  |- skos__annotation mesh__D012844
% 223.54/223.69       do not confuse with Sincaline %28% = CHOLINE%29%   
% 223.54/223.70  |- skos__altLabel mesh__D012844 Syncalide
% 223.54/223.70  |- skos__related mesh__D012844smesh__D005765
% 223.54/223.70  |- mesh__publicMeSHNote mesh__D012844 84   
% 223.54/223.70  |- mesh__historyNote mesh__D012844 84   
% 223.54/223.70  |- skos__altLabel mesh__D012844 CCK-OP
% 223.54/223.70  |- skos__altLabel mesh__D012844 Bracco Brand of Sincalide
% 223.54/223.70  |- skos__broader mesh__D012844smesh__D002766
% 223.54/223.70  |- skos__scopeNote mesh__D012844
% 223.54/223.70       An octapeptide hormone present in the intestine and brain. When secreted from the gastric mucosa, it stimulates the release of bile from the gallbladder and digestive enzymes from the pancreas.%A%    
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D012844 2006
% 223.54/223.70  |- skos__altLabel mesh__D012844 SQ-19844
% 223.54/223.70  |- rdf__type mesh__D012844sskos__Concept
% 223.54/223.70  |- skos__altLabel mesh__D012844
% 223.54/223.70       Cholecystokinin Pancreozymin C-Terminal Octapeptide
% 223.54/223.70  |- skos__altLabel mesh__D012844 Cholecystokinin Octapeptide
% 223.54/223.70  |- skos__historyNote mesh__D012844 Peptides %28%1966-1972%29%
% 223.54/223.70  |- skos__related mesh__D012844smesh__D001067
% 223.54/223.70  |- skos__hiddenLabel mesh__D012844 SQ19844
% 223.54/223.70  |- skos__historyNote mesh__D012844 Cholecystokinin %28%1966-1983%29%
% 223.54/223.70  |- skos__hiddenLabel mesh__D012844 SQ 19844
% 223.54/223.70  |- mesh__dateEstablished mesh__D012844 1984-01-01
% 223.54/223.70  |- mesh__recordAuthorizer mesh__D012844 sjn
% 223.54/223.70  |- mesh__recordMaintainer mesh__D012844 CCR
% 223.54/223.70  |- skos__hiddenLabel mesh__D012844
% 223.54/223.70       Cholecystokinin Pancreozymin C Terminal Octapeptide
% 223.54/223.70  |- skos__prefLabel mesh__D012844 Sincalide
% 223.54/223.70  |- skos__historyNote mesh__D012844 Peptide Fragments %28%1979-1983%29%
% 223.54/223.70  |- mesh__recordOriginator mesh__D012844 SH
% 223.54/223.70  |- mesh__dateCreated mesh__D012844 1983-06-13
% 223.54/223.70  |- skos__altLabel mesh__D012844 OP-CCK
% 223.54/223.70  |- skos__historyNote mesh__D012844 Oligopeptides %28%1973-1978%29%
% 223.54/223.70  |- skos__altLabel mesh__D012844 CCK-8
% 223.54/223.70  |- mesh__dateRevised mesh__D012844 2005-06-30
% 223.54/223.70  |- skos__broader mesh__D012046smesh__D013812
% 223.54/223.70  |- skos__related mesh__D012046smesh__D004185
% 223.54/223.70  |- mesh__dateCreated mesh__D012046 1999-01-01
% 223.54/223.70  |- rdf__type mesh__D012046sskos__Concept
% 223.54/223.70  |- skos__related mesh__D012046smesh__D018479
% 223.54/223.70  |- mesh__recordOriginator mesh__D012046 NLM
% 223.54/223.70  |- mesh__recordMaintainer mesh__D012046 lkt
% 223.54/223.70  |- mesh__recordAuthorizer mesh__D012046 sjn
% 223.54/223.70  |- skos__broader mesh__D012046smesh__D006296
% 223.54/223.70  |- skos__related mesh__D012046smesh__D006208
% 223.54/223.70  |- skos__related mesh__D012046smesh__D020127
% 223.54/223.70  |- skos__scopeNote mesh__D012046
% 223.54/223.70       Restoration of human functions to the maximum degree possible in a person or persons suffering from disease or injury.%A%    
% 223.54/223.70  |- skos__annotation mesh__D012046
% 223.54/223.70       general only: prefer /rehabil with diseases: Manual 19.7+, 19.8.64; differentiate from AFTERCARE; DF: REHABIL%A%  
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D012046 2006
% 223.54/223.70  |- skos__broader mesh__D012046smesh__D010810
% 223.54/223.70  |- skos__prefLabel mesh__D012046 Rehabilitation
% 223.54/223.70  |- mesh__dateRevised mesh__D012046 2005-06-30
% 223.54/223.70  |- skos__altLabel mesh__D006009 Generalized Glycogenosis
% 223.54/223.70  |- skos__hiddenLabel mesh__D006009
% 223.54/223.70       Lysosomal alpha 1,4 Glucosidase Deficiency Disease
% 223.54/223.70  |- skos__altLabel mesh__D006009 Deficiency Disease, Acid Maltase
% 223.54/223.70  |- skos__hiddenLabel mesh__D006009 Glycogenosis Type IIs
% 223.54/223.70  |- skos__related mesh__D006009smesh__D005087
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D006009 2005A
% 223.54/223.70  |- skos__altLabel mesh__D006009 Glycogenosis 2
% 223.54/223.70  |- mesh__recordMaintainer mesh__D006009 ags
% 223.54/223.70  |- skos__altLabel mesh__D006009 Glycogen Storage Disease Type II, Adult
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D006009 2003
% 223.54/223.70  |- mesh__publicMeSHNote mesh__D006009 1989; see GLYCOGENOSIS 1975-88   
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D006009 2006A
% 223.54/223.70  |- skos__hiddenLabel mesh__D006009 IIs, Glycogenosis Type
% 223.54/223.70  |- skos__historyNote mesh__D006009
% 223.54/223.70       Glucosidases/metabolism %28%1966-1974%29%
% 223.54/223.70  |- rdf__type mesh__D006009sskos__Concept
% 223.54/223.70  |- mesh__dateEstablished mesh__D006009 1989-01-01
% 223.54/223.70  |- skos__altLabel mesh__D006009 Acid Maltase Deficiency Disease
% 223.54/223.70  |- skos__scopeNote mesh__D006009
% 223.54/223.70       An autosomal recessively inherited glycogen storage disease caused by GLUCAN 1,4-ALPHA-GLUCOSIDASE deficiency. Large amounts of GLYCOGEN accumulate in the LYSOSOMES of skeletal muscle %28%MUSCLE, SKELETAL%29%; HEART; LIVER; SPINAL CORD; and BRAIN. Three forms have been described: infantile, childhood, and adult. The infantile form is fatal in infancy and presents with hypotonia and a hypertrophic cardiomyopathy %28%CARDIOMYOPATHY, HYPERTROPHIC%29%. The childhood form usually presents in the second year of life with proximal weakness and respiratory symptoms. The adult form consists of a slowly progressive proximal myopathy. %28%From Muscle Nerve 1995;3:S61-9; Menkes, Textbook of Child Neurology, 5th ed, pp73-4%29%%A%    
% 223.54/223.70  |- mesh__recordAuthorizer mesh__D006009 ags
% 223.54/223.70  |- skos__hiddenLabel mesh__D006009 Type II, Glycogenosis
% 223.54/223.70  |- skos__hiddenLabel mesh__D006009 Glycogenosis, Generalized
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D006009 2004
% 223.54/223.70  |- mesh__recordOriginator mesh__D006009 NLM
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D006009 2005
% 223.54/223.70  |- mesh__dateRevised mesh__D006009 2005-07-15
% 223.54/223.70  |- skos__altLabel mesh__D006009
% 223.54/223.70       Deficiency Disease, Lysosomal alpha-1,4-Glucosidase
% 223.54/223.70  |- skos__historyNote mesh__D006009 Glycogenosis %28%1966-1974%29%
% 223.54/223.70  |- skos__hiddenLabel mesh__D006009 Pompes Disease
% 223.54/223.70  |- mesh__dateCreated mesh__D006009 1974-12-12
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D006009 2006
% 223.54/223.70  |- skos__altLabel mesh__D006009 Pompe%27%s Disease
% 223.54/223.70  |- skos__altLabel mesh__D006009 Pompe Disease
% 223.54/223.70  |- skos__altLabel mesh__D006009 Infantile Glycogen Storage Disease Type II
% 223.54/223.70  |- skos__altLabel mesh__D006009
% 223.54/223.70       Lysosomal alpha-1,4-Glucosidase Deficiency Disease
% 223.54/223.70  |- skos__broader mesh__D006009smesh__D020739
% 223.54/223.70  |- skos__broader mesh__D006009smesh__D020140
% 223.54/223.70  |- skos__hiddenLabel mesh__D006009 Type IIs, Glycogenosis
% 223.54/223.70  |- skos__historyNote mesh__D006009 Heart Diseases %28%1966-1974%29%
% 223.54/223.70  |- skos__broader mesh__D006009smesh__D006008
% 223.54/223.70  |- skos__prefLabel mesh__D006009 Glycogen Storage Disease Type II
% 223.54/223.70  |- skos__altLabel mesh__D006009 Glycogenosis Type II
% 223.54/223.70  |- mesh__historyNote mesh__D006009
% 223.54/223.70       1989%28%1975%29%; use GLYCOGENOSIS 1975-1988   
% 223.54/223.70  |- skos__altLabel mesh__D006009 Juvenile Glycogen Storage Disease Type II
% 223.54/223.70  |- mesh__recordMaintainer mesh__D044926 jmp
% 223.54/223.70  |- skos__historyNote mesh__D044926 Oxidoreductases %28%1974-2003%29%
% 223.54/223.70  |- rdf__type mesh__D044926sskos__Concept
% 223.54/223.70  |- skos__historyNote mesh__D044926 Coenzyme A %28%1974-1978%29%
% 223.54/223.70  |- mesh__recordOriginator mesh__D044926 jmp
% 223.54/223.70  |- skos__broader mesh__D044926smesh__D005420
% 223.54/223.70  |- skos__altLabel mesh__D044926 Short-Chain Acyl-CoA Dehydrogenase
% 223.54/223.70  |- skos__scopeNote mesh__D044926
% 223.54/223.70       A flavoprotein oxidoreductase that has specificity for short-chain fatty acids. It forms a complex with ELECTRON-TRANSFERRING FLAVOPROTEINS and conveys reducing equivalents to UBIQUINONE.%A%    
% 223.54/223.70  |- skos__hiddenLabel mesh__D044926 Butyryl Coenzyme A Dehydrogenase
% 223.54/223.70  |- mesh__historyNote mesh__D044926
% 223.54/223.70       2004; use BUTYRYL-COA DEHYDROGENASE %28%NM%29% 1980-2003, for SHORT-CHAIN ACETYL-COA DEHYDROGENASE use ACYL-COA DEHYDROGENASE %28%NM%29% 1981-2003%A%  
% 223.54/223.70  |- skos__broader mesh__D044926smesh__D044944
% 223.54/223.70  |- skos__altLabel mesh__D044926 Butyryl-Coenzyme A Dehydrogenase
% 223.54/223.70  |- skos__historyNote mesh__D044926 Butyrates %28%1974-2003%29%
% 223.54/223.70  |- mesh__publicMeSHNote mesh__D044926
% 223.54/223.70       2004; BUTYL-CAO DEHYDROGENASE was indexed under FATTY ACID DESATURASES 1980-2003; under OXIDOREDUCTASES 1974-1978; under BUTYRATES 1974-1980 %26% under COENZYME A 1974-1978; SHORT-CHAIN ACETYL-COA DEHYDROGENASE was indexed under FATTY ACID DESATURASES 1981-2003%A%  
% 223.54/223.70  |- skos__prefLabel mesh__D044926 Butyryl-CoA Dehydrogenase
% 223.54/223.70  |- skos__hiddenLabel mesh__D044926 Short Chain Acyl CoA Dehydrogenase
% 223.54/223.70  |- skos__hiddenLabel mesh__D044926 Dehydrogenase, Short-Chain Acyl-CoA
% 223.54/223.70  |- skos__hiddenLabel mesh__D044926 Acyl-CoA Dehydrogenase, Short-Chain
% 223.54/223.70  |- skos__historyNote mesh__D044926 Fatty Acid Desaturases %28%1980-2003%29%
% 223.54/223.70  |- skos__hiddenLabel mesh__D044926 Butyryl CoA Dehydrogenase
% 223.54/223.70  |- skos__hiddenLabel mesh__D044926 Dehydrogenase, Butyryl
% 223.54/223.70  |- skos__altLabel mesh__D044926 Butyryl Dehydrogenase
% 223.54/223.70  |- skos__hiddenLabel mesh__D044926 Dehydrogenase, Butyryl-Coenzyme A
% 223.54/223.70  |- skos__hiddenLabel mesh__D044926 Dehydrogenase, Butyryl-CoA
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D044926 2006
% 223.54/223.70  |- mesh__dateCreated mesh__D044926 2003-07-09
% 223.54/223.70  |- mesh__recordAuthorizer mesh__D044926 sjn
% 223.54/223.70  |- mesh__dateEstablished mesh__D044926 2004-01-01
% 223.54/223.70  |- mesh__dateRevised mesh__D044926 2005-06-30
% 223.54/223.70  |- mesh__publicMeSHNote mesh__D044128 2004   
% 223.54/223.70  |- mesh__historyNote mesh__D044128 2004   
% 223.54/223.70  |- mesh__recordOriginator mesh__D044128 ags
% 223.54/223.70  |- mesh__recordAuthorizer mesh__D044128 sjn
% 223.54/223.70  |- skos__prefLabel mesh__D044128 Legionella longbeachae
% 223.54/223.70  |- skos__historyNote mesh__D044128 Legionella %28%1981-2003%29%
% 223.54/223.70  |- mesh__dateEstablished mesh__D044128 2004-01-01
% 223.54/223.70  |- skos__annotation mesh__D044128
% 223.54/223.70       infection: coord IM with LEGIONELLOSIS %28%IM%29%   
% 223.54/223.70  |- mesh__recordMaintainer mesh__D044128 SYSTEM
% 223.54/223.70  |- rdf__type mesh__D044128sskos__Concept
% 223.54/223.70  |- mesh__dateCreated mesh__D044128 2003-07-09
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D044128 2006
% 223.54/223.70  |- mesh__dateRevised mesh__D044128 2005-06-30
% 223.54/223.70  |- skos__broader mesh__D044128smesh__D007875
% 223.54/223.70  |- skos__scopeNote mesh__D044128
% 223.54/223.70       A species of gram-negative, aerobic bacteria in the genus LEGIONELLA, first isolated in Long Beach, California. Infection is associated with the use of potting SOIL.%A%    
% 223.54/223.70  |- skos__related mesh__D016437smesh__D020502
% 223.54/223.70  |- skos__annotation mesh__D016437
% 223.54/223.70       publication type only; for dictionaries as a subject, index under main heading DICTIONARIES; Manual 33.14, 36.27%A%  
% 223.54/223.70  |- skos__prefLabel mesh__D016437 Dictionary %5B%Publication Type%5D%
% 223.54/223.70  |- skos__broader mesh__D016437smesh__D052180
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D016437 2006
% 223.54/223.70  |- mesh__dateEstablished mesh__D016437 1996-01-01
% 223.54/223.70  |- mesh__dateRevised mesh__D016437 2005-06-30
% 223.54/223.70  |- mesh__dateCreated mesh__D016437 1995-06-23
% 223.54/223.70  |- skos__altLabel mesh__D016437 Dictionary %28%PT%29%
% 223.54/223.70  |- skos__scopeNote mesh__D016437
% 223.54/223.70       A reference book containing a list of words - usually in alphabetical order - giving information about form, pronunciation, etymology, grammar, and meaning. A foreign-language dictionary is an alphabetical list of words of one language with their meaning and equivalents in another language.%A%    
% 223.54/223.70  |- skos__altLabel mesh__D016437 Dictionary
% 223.54/223.70  |- rdf__type mesh__D016437sskos__Concept
% 223.54/223.70  |- mesh__historyNote mesh__D016437 1991   
% 223.54/223.70  |- mesh__recordMaintainer mesh__D016437 jls
% 223.54/223.70  |- mesh__recordOriginator mesh__D016437 TAP
% 223.54/223.70  |- mesh__recordAuthorizer mesh__D016437 sjn
% 223.54/223.70  |- mesh__recordMaintainer mesh__D002417 ags
% 223.54/223.70  |- skos__hiddenLabel mesh__D002417 Domestic Cow
% 223.54/223.70  |- skos__hiddenLabel mesh__D002417 Zebus
% 223.54/223.70  |- skos__prefLabel mesh__D002417 Cattle
% 223.54/223.70  |- skos__altLabel mesh__D002417 Cow, Domestic
% 223.54/223.70  |- mesh__dateCreated mesh__D002417 1999-01-01
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D002417 2006
% 223.54/223.70  |- mesh__considerAlso mesh__D002417 consider also terms at BOVINE   
% 223.54/223.70  |- skos__scopeNote mesh__D002417
% 223.54/223.70       Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor.%A%    
% 223.54/223.70  |- mesh__dateRevised mesh__D002417 2003-07-09
% 223.54/223.70  |- skos__annotation mesh__D002417
% 223.54/223.70       not for all Bovidae: only cows, yaks %26% zebus   
% 223.54/223.70  |- mesh__recordAuthorizer mesh__D002417 sjn
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D002417 2005
% 223.54/223.70  |- skos__altLabel mesh__D002417 Yak
% 223.54/223.70  |- rdf__type mesh__D002417sskos__Concept
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D002417 2004
% 223.54/223.70  |- skos__hiddenLabel mesh__D002417 Yaks
% 223.54/223.70  |- skos__altLabel mesh__D002417 Zebu
% 223.54/223.70  |- skos__broader mesh__D002417smesh__D012418
% 223.54/223.70  |- skos__hiddenLabel mesh__D002417 Cows, Domestic
% 223.54/223.70  |- mesh__recordOriginator mesh__D002417 NLM
% 223.54/223.70  |- skos__hiddenLabel mesh__D002417 Domestic Cows
% 223.54/223.70  |- mesh__onlineNote mesh__D007900 use LEMUR to search LEMURS 1975-80   
% 223.54/223.70  |- mesh__historyNote mesh__D007900
% 223.54/223.70       91%28%81%29%; was see under LEMURIDAE 1981-90; was LEMURS see under PROSIMIANS 1975-80%A%  
% 223.54/223.70  |- mesh__recordAuthorizer mesh__D007900 sjn
% 223.54/223.70  |- mesh__dateRevised mesh__D007900 2003-07-09
% 223.54/223.70  |- skos__prefLabel mesh__D007900 Lemur
% 223.54/223.70  |- rdf__type mesh__D007900sskos__Concept
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D007900 2004
% 223.54/223.70  |- mesh__dateEstablished mesh__D007900 1991-01-01
% 223.54/223.70  |- mesh__recordOriginator mesh__D007900 NLM
% 223.54/223.70  |- mesh__dateCreated mesh__D007900 1974-11-27
% 223.54/223.70  |- mesh__publicMeSHNote mesh__D007900
% 223.54/223.70       91; was see under LEMURIDAE 1981-90; was LEMURS see under PROSIMIANS 1975-80%A%  
% 223.54/223.70  |- skos__altLabel mesh__D007900 Lemurs
% 223.54/223.70  |- skos__broader mesh__D007900smesh__D007901
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D007900 2006
% 223.54/223.70  |- mesh__recordMaintainer mesh__D007900 ags
% 223.54/223.70  |- skos__annotation mesh__D007900
% 223.54/223.70       a genus; do not confuse with LEMUR, DWARF see CHEIROGALEIDAE or LEMUR, MOUSE see CHEIROGALEIDAE; IM; qualif permitted%A%  
% 223.54/223.70  |- skos__scopeNote mesh__D007900
% 223.54/223.70       A genus of the family Lemuridae consisting of five species: L. catta %28%ring-tailed lemur%29%, L. fulvus, L. macaco %28%acoumba or black lemur%29%, L. mongoz %28%mongoose lemur%29%, and L. variegatus %28%white lemur%29%. Most members of this genus occur in forested areas on Madagascar and the Comoro Islands.%A%    
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D007900 2005
% 223.54/223.70  |- mesh__historyNote mesh__D007102 TRENCH FOOT was heading 1963-94   
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D007102 2005
% 223.54/223.70  |- skos__altLabel mesh__D007102 Immersion Feet
% 223.54/223.70  |- mesh__dateRevised mesh__D007102 1999-11-03
% 223.54/223.70  |- rdf__type mesh__D007102sskos__Concept
% 223.54/223.70  |- mesh__publicMeSHNote mesh__D007102 TRENCH FOOT was heading 1963-94   
% 223.54/223.70  |- skos__broader mesh__D007102smesh__D005534
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D007102 2004
% 223.54/223.70  |- skos__altLabel mesh__D007102 Trench Foot
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D007102 2002
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D007102 2003
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D007102 2001
% 223.54/223.70  |- skos__prefLabel mesh__D007102 Immersion Foot
% 223.54/223.70  |- mesh__recordAuthorizer mesh__D007102 sjn
% 223.54/223.70  |- mesh__dateCreated mesh__D007102 1999-01-01
% 223.54/223.70  |- skos__hiddenLabel mesh__D007102 Feet, Trench
% 223.54/223.70  |- skos__scopeNote mesh__D007102
% 223.54/223.70       A condition of the feet produced by prolonged exposure of the feet to water. Exposure for 48 hours or more to warm water causes tropical immersion foot or warm-water immersion foot common in Vietnam where troops were exposed to prolonged or repeated wading in paddy fields or streams. Trench foot results from prolonged exposure to cold, without actual freezing. It was common in trench warfare during World War I, when soldiers stood, sometimes for hours, in trenches with a few inches of cold water in them. %28%Andrews%27% Diseases of the Skin, 8th ed, p27%29%%A%    
% 223.54/223.70  |- skos__hiddenLabel mesh__D007102 Foot, Trench
% 223.54/223.70  |- mesh__recordOriginator mesh__D007102 NLM
% 223.54/223.70  |- skos__hiddenLabel mesh__D007102 Foot, Immersion
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D007102 2000
% 223.54/223.70  |- skos__hiddenLabel mesh__D007102 Feet, Immersion
% 223.54/223.70  |- mesh__onlineNote mesh__D007102
% 223.54/223.70       use IMMERSION FOOT to search TRENCH FOOT 1966-94   
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D007102 2006
% 223.54/223.70  |- mesh__recordMaintainer mesh__D007102 PXP
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D012845 2006
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D012845 2002
% 223.54/223.70  |- skos__prefLabel mesh__D012845 Sindbis Virus
% 223.54/223.70  |- mesh__recordMaintainer mesh__D012845 ags
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D012845 2004
% 223.54/223.70  |- skos__annotation mesh__D012845
% 223.54/223.70       infection: coord IM with ALPHAVIRUS INFECTIONS %28%IM%29%   
% 223.54/223.70  |- rdf__type mesh__D012845sskos__Concept
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D012845 2005
% 223.54/223.70  |- skos__scopeNote mesh__D012845
% 223.54/223.70       The type species of ALPHAVIRUS normally transmitted to birds by CULEX mosquitoes in Egypt, South Africa, India, Malaya, the Philippines, and Australia. It may be associated with fever in humans. Serotypes %28%differing by less than 17%25% in nucleotide sequence%29% include Babanki, Kyzylagach, and Ockelbo viruses.%A%    
% 223.54/223.70  |- mesh__recordOriginator mesh__D012845 NLM
% 223.54/223.70  |- mesh__historyNote mesh__D012845
% 223.54/223.70       1973 %28%1971%29%; for OCKELBO VIRUS use ALPHAVIRUS 1994-2001   
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D012845 2003
% 223.54/223.70  |- mesh__dateEstablished mesh__D012845 1973-01-01
% 223.54/223.70  |- mesh__dateRevised mesh__D012845 2001-07-25
% 223.54/223.70  |- mesh__publicMeSHNote mesh__D012845
% 223.54/223.70       1973; for OCKLEBO VIRUS see ALPHAVIRUS 1994-2001   
% 223.54/223.70  |- mesh__dateCreated mesh__D012845 1999-01-01
% 223.54/223.70  |- skos__broader mesh__D012845smesh__D000524
% 223.54/223.70  |- mesh__recordAuthorizer mesh__D012845 sjn
% 223.54/223.70  |- skos__historyNote mesh__D012845 Arboviruses %28%1966-1970%29%
% 223.54/223.70  |- skos__historyNote mesh__D012047 Hospitals %28%1966-1967%29%
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D012047 2006
% 223.54/223.70  |- skos__scopeNote mesh__D012047
% 223.54/223.70       Facilities which provide programs for rehabilitating the mentally or physically disabled individuals.%A%    
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D012047 2002
% 223.54/223.70  |- mesh__recordMaintainer mesh__D012047 kle
% 223.54/223.70  |- mesh__publicMeSHNote mesh__D012047 68   
% 223.54/223.70  |- skos__historyNote mesh__D012047 Rehabilitation %28%1966-1967%29%
% 223.54/223.70  |- skos__hiddenLabel mesh__D012047 Rehabilitation Center
% 223.54/223.70  |- mesh__dateEstablished mesh__D012047 1968-01-01
% 223.54/223.70  |- skos__altLabel mesh__D012047 Centers, Rehabilitation
% 223.54/223.70  |- skos__hiddenLabel mesh__D012047 Center, Rehabilitation
% 223.54/223.70  |- mesh__historyNote mesh__D012047 68   
% 223.54/223.70  |- mesh__recordOriginator mesh__D012047 NLM
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D012047 2000
% 223.54/223.70  |- mesh__dateRevised mesh__D012047 1999-11-03
% 223.54/223.70  |- skos__annotation mesh__D012047 IM   
% 223.54/223.70  |- mesh__recordAuthorizer mesh__D012047 sjn
% 223.54/223.70  |- rdf__type mesh__D012047sskos__Concept
% 223.54/223.70  |- mesh__dateCreated mesh__D012047 1999-01-01
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D012047 2003
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D012047 2001
% 223.54/223.70  |- skos__broader mesh__D012047smesh__D006268
% 223.54/223.70  |- skos__prefLabel mesh__D012047 Rehabilitation Centers
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D012047 2005
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D012047 2004
% 223.54/223.70  |- mesh__dateEstablished mesh__D006808 1978-01-01
% 223.54/223.70  |- skos__historyNote mesh__D006808 Philosophy, Medical %28%1966-1977%29%
% 223.54/223.70  |- skos__historyNote mesh__D006808 Philosophy %28%1966-1977%29%
% 223.54/223.70  |- skos__prefLabel mesh__D006808 Humanism
% 223.54/223.70  |- skos__historyNote mesh__D006808 Ethics %28%1966-1977%29%
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D006808 2006
% 223.54/223.70  |- skos__scopeNote mesh__D006808
% 223.54/223.70       An ethical system which emphasizes human values and the personal worth of each individual, as well as concern for the dignity and freedom of humankind.%A%    
% 223.54/223.70  |- mesh__publicMeSHNote mesh__D006808 78   
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D006808 2005
% 223.54/223.70  |- mesh__dateRevised mesh__D006808 2004-07-13
% 223.54/223.70  |- skos__broader mesh__D006808smesh__D004989
% 223.54/223.70  |- mesh__recordMaintainer mesh__D006808 sjn
% 223.54/223.70  |- skos__historyNote mesh__D006808 Ethics, Medical %28%1966-1977%29%
% 223.54/223.70  |- mesh__dateCreated mesh__D006808 1977-04-22
% 223.54/223.70  |- rdf__type mesh__D006808sskos__Concept
% 223.54/223.70  |- mesh__recordOriginator mesh__D006808 EC
% 223.54/223.70  |- mesh__historyNote mesh__D006808 78   
% 223.54/223.70  |- mesh__recordAuthorizer mesh__D006808 sjn
% 223.54/223.70  |- mesh__recordMaintainer mesh__D017530 TGC
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D017530 2000
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D017530 2003
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D017530 2006
% 223.54/223.70  |- skos__prefLabel mesh__D017530
% 223.54/223.70       Health Care Quality, Access, and Evaluation
% 223.54/223.70  |- rdf__type mesh__D017530sskos__Concept
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D017530 2001
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D017530 1998
% 223.54/223.70  |- skos__annotation mesh__D017530
% 223.54/223.70       not used for indexing      CATALOG: do not use   
% 223.54/223.70  |- mesh__runningHead mesh__D017530
% 223.54/223.70       N5 - HEALTH CARE QUALITY, ACCESS, AND EVALUATION   
% 223.54/223.70  |- skos__scopeNote mesh__D017530
% 223.54/223.70       The concept concerned with all aspects of the quality, accessibility, and appraisal of health care and health care delivery.%A%    
% 223.54/223.70  |- skos__altLabel mesh__D017530 Healthcare Quality, Access, and Evaluation
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D017530 2004
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D017530 2002
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D017530 1999
% 223.54/223.70  |- mesh__dateRevised mesh__D017530 1997-06-26
% 223.54/223.70  |- mesh__dateCreated mesh__D017530 1992-06-25
% 223.54/223.70  |- mesh__recordAuthorizer mesh__D017530 SJN
% 223.54/223.70  |- mesh__recordOriginator mesh__D017530 PLS
% 223.54/223.70  |- mesh__dateEstablished mesh__D017530 1998-01-01
% 223.54/223.70  |- mesh__publicMeSHNote mesh__D017530 98   
% 223.54/223.70  |- mesh__historyNote mesh__D017530 98; use explode   
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D017530 2005
% 223.54/223.70  |- mesh__onlineNote mesh__D003510
% 223.54/223.70       use CYCLOHEXANES to search CYCLOHEXANE 1966-74   
% 223.54/223.70  |- mesh__dateRevised mesh__D003510 2004-07-07
% 223.54/223.70  |- skos__broader mesh__D003510smesh__D003516
% 223.54/223.70  |- mesh__recordAuthorizer mesh__D003510 sjn
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D003510 2006
% 223.54/223.70  |- mesh__recordOriginator mesh__D003510 NLM
% 223.54/223.70  |- mesh__recordMaintainer mesh__D003510 ssb
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D003510 2005
% 223.54/223.70  |- mesh__publicMeSHNote mesh__D003510 75; was CYCLOHEXANE 1963-74   
% 223.54/223.70  |- mesh__historyNote mesh__D003510 75; was CYCLOHEXANE 1963-74   
% 223.54/223.70  |- skos__annotation mesh__D003510 includes cyclohexenes, cyclohexadienes   
% 223.54/223.70  |- rdf__type mesh__D003510sskos__Concept
% 223.54/223.70  |- mesh__dateCreated mesh__D003510 1999-01-01
% 223.54/223.70  |- skos__scopeNote mesh__D003510
% 223.54/223.70       A group of alicyclic hydrocarbons with the general formula R-C6H11.%A%    
% 223.54/223.70  |- skos__prefLabel mesh__D003510 Cyclohexanes
% 223.54/223.70  |- skos__hiddenLabel mesh__D044927 Electron Transferring Flavoprotein
% 223.54/223.70  |- mesh__dateEstablished mesh__D044927 2004-01-01
% 223.54/223.70  |- skos__broader mesh__D044927smesh__D045222
% 223.54/223.70  |- skos__related mesh__D044927smesh__D004579
% 223.54/223.70  |- skos__hiddenLabel mesh__D044927 Flavoprotein, Electron Transfer
% 223.54/223.70  |- skos__historyNote mesh__D044927 Flavoproteins %28%1983-2003%29%
% 223.54/223.70  |- skos__altLabel mesh__D044927 ET Flavoprotein
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D044927 2004
% 223.54/223.70  |- skos__prefLabel mesh__D044927 Electron-Transferring Flavoproteins
% 223.54/223.70  |- skos__altLabel mesh__D044927 Electron-Transferring Flavoprotein
% 223.54/223.70  |- skos__hiddenLabel mesh__D044927 Flavoprotein, ET
% 223.54/223.70  |- skos__hiddenLabel mesh__D044927 Transfer Flavoprotein, Electron
% 223.54/223.70  |- skos__scopeNote mesh__D044927
% 223.54/223.70       Flavoproteins that serve as specific electron acceptors for a variety of DEHYDROGENASES. They participate in the transfer of electrons to a variety of redox acceptors that occur in the respiratory chain.%A%    
% 223.54/223.70  |- mesh__historyNote mesh__D044927
% 223.54/223.70       2004; use ELECTRON-TRANSFERRING FLAVOPROTEINS %28%NM%29% 1983-2003%A%  
% 223.54/223.70  |- skos__hiddenLabel mesh__D044927 Electron Transferring Flavoproteins
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D044927 2006
% 223.54/223.70  |- mesh__dateCreated mesh__D044927 2003-07-09
% 223.54/223.70  |- skos__hiddenLabel mesh__D044927 Flavoproteins, Electron-Transferring
% 223.54/223.70  |- mesh__publicMeSHNote mesh__D044927
% 223.54/223.70       2004; ELECTRON-TRANSFERRING FLAVOPROTEINS was indexed under FLAVOPROTEINS 1983-2003%A%  
% 223.54/223.70  |- skos__altLabel mesh__D044927 Electron Transfer Flavoprotein
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D044927 2005
% 223.54/223.70  |- skos__hiddenLabel mesh__D044927 Flavoprotein, Electron-Transferring
% 223.54/223.70  |- rdf__type mesh__D044927sskos__Concept
% 223.54/223.70  |- skos__broader mesh__D044927smesh__D005420
% 223.54/223.70  |- mesh__dateRevised mesh__D044129 2005-06-30
% 223.54/223.70  |- skos__historyNote mesh__D044129 Gammaproteobacteria %28%1997-2003%29%
% 223.54/223.70  |- skos__broader mesh__D044129smesh__D020563
% 223.54/223.70  |- mesh__historyNote mesh__D044129 2004   
% 223.54/223.70  |- mesh__recordAuthorizer mesh__D044129 sjn
% 223.54/223.70  |- mesh__recordOriginator mesh__D044129 ags
% 223.54/223.70  |- mesh__recordMaintainer mesh__D044129 SYSTEM
% 223.54/223.70  |- rdf__type mesh__D044129sskos__Concept
% 223.54/223.70  |- mesh__dateCreated mesh__D044129 2003-07-09
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D044129 2006
% 223.54/223.70  |- skos__prefLabel mesh__D044129 Halomonadaceae
% 223.54/223.70  |- skos__broader mesh__D044129smesh__D016946
% 223.54/223.70  |- mesh__dateEstablished mesh__D044129 2004-01-01
% 223.54/223.70  |- skos__scopeNote mesh__D044129
% 223.54/223.70       A family of gram-negative, moderately halophilic bacteria in the order Oceanospirillales. Members of the family have been isolated from temperate and Antarctic saline lakes, solar salt facilities, saline soils, and marine environments.%A%    
% 223.54/223.70  |- mesh__publicMeSHNote mesh__D044129 2004   
% 223.54/223.70  |- mesh__dateCreated mesh__D016438 1995-06-23
% 223.54/223.70  |- mesh__dateEstablished mesh__D016438 1996-01-01
% 223.54/223.70  |- skos__broader mesh__D016438smesh__D052180
% 223.54/223.70  |- mesh__dateRevised mesh__D016438 2005-06-30
% 223.54/223.70  |- skos__prefLabel mesh__D016438
% 223.54/223.70       Duplicate Publication %5B%Publication Type%5D%
% 223.54/223.70  |- rdf__type mesh__D016438sskos__Concept
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D016438 2006
% 223.54/223.70  |- mesh__recordMaintainer mesh__D016438 jls
% 223.54/223.70  |- skos__altLabel mesh__D016438 Duplicate Publication %28%PT%29%
% 223.54/223.70  |- mesh__recordAuthorizer mesh__D016438 sjn
% 223.54/223.70  |- mesh__historyNote mesh__D016438 1991   
% 223.54/223.70  |- mesh__recordOriginator mesh__D016438 TAP
% 223.54/223.70  |- skos__scopeNote mesh__D016438
% 223.54/223.70       Work consisting of an article or book of identical or nearly identical material published simultaneously or successively to material previously published elsewhere, without acknowledgment of the prior publication.%A%    
% 223.54/223.70  |- mesh__onlineNote mesh__D016438
% 223.54/223.70       search policy: Online Manual; use: main heading AND DUPLICATE PUBLICATION %28%PT%29%%A%  
% 223.54/223.70  |- mesh__dateCreated mesh__D002418 1999-01-01
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D002418 2006
% 223.54/223.70  |- skos__hiddenLabel mesh__D002418 Diseases, Cattle
% 223.54/223.70  |- skos__altLabel mesh__D002418 Bovine Diseases
% 223.54/223.70  |- skos__prefLabel mesh__D002418 Cattle Diseases
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D002418 2005
% 223.54/223.70  |- skos__broader mesh__D002418smesh__D000820
% 223.54/223.70  |- skos__hiddenLabel mesh__D002418 Disease, Cattle
% 223.54/223.70  |- rdf__type mesh__D002418sskos__Concept
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D002418 2004
% 223.54/223.70  |- skos__scopeNote mesh__D002418
% 223.54/223.70       Diseases of domestic cattle of the genus Bos. It includes diseases of cows, yaks, and zebus.%A%    
% 223.54/223.70  |- mesh__dateRevised mesh__D002418 2003-07-30
% 223.54/223.70  |- skos__hiddenLabel mesh__D002418 Diseases, Bovine
% 223.54/223.70  |- mesh__recordAuthorizer mesh__D002418 sjn
% 223.54/223.70  |- skos__hiddenLabel mesh__D002418 Bovine Disease
% 223.54/223.70  |- skos__hiddenLabel mesh__D002418 Cattle Disease
% 223.54/223.70  |- mesh__recordMaintainer mesh__D002418 ags
% 223.54/223.70  |- skos__hiddenLabel mesh__D002418 Disease, Bovine
% 223.54/223.70  |- skos__annotation mesh__D002418
% 223.54/223.70       IM GEN or unspecified; coord IM with specific dis /vet %28%IM%29% or specific cattle dis %28%IM%29%; for abnormalities or injuries, index under CATTLE /abnorm or CATTLE /inj; includes diseases of yaks %26% zebus but does not include diseases of BISON or BUFFALOES; don%27%t forget also check tags CATTLE %28%NIM%29% %26% ANIMALS; DF: CATTLE DIS%A%  
% 223.54/223.70  |- mesh__recordOriginator mesh__D002418 NLM
% 223.54/223.70  |- mesh__dateCreated mesh__D013140 1999-01-01
% 223.54/223.70  |- skos__broader mesh__D013140smesh__D012072
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D013140 2001
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D013140 2002
% 223.54/223.70  |- skos__annotation mesh__D013140
% 223.54/223.70       IM; specify geog if pertinent; do not confuse with SPIRITUAL HEALING see MENTAL HEALING%A%  
% 223.54/223.70  |- skos__scopeNote mesh__D013140
% 223.54/223.70       Religious philosophy expressing the fundamental belief that departed spirits may be contacted by the living through a medium.%A%    
% 223.54/223.70  |- rdf__type mesh__D013140sskos__Concept
% 223.54/223.70  |- mesh__recordAuthorizer mesh__D013140 sjn
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D013140 2005
% 223.54/223.70  |- mesh__dateRevised mesh__D013140 1999-11-03
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D013140 2003
% 223.54/223.70  |- mesh__activeMeSHYear mesh__D013140 2006
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D013140 2000
% 223.54/223.71  |- skos__prefLabel mesh__D013140 Spiritualism
% 223.54/223.71  |- mesh__recordOriginator mesh__D013140 NLM
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D013140 2004
% 223.54/223.71  |- mesh__recordMaintainer mesh__D013140 kle
% 223.54/223.71  |- mesh__dateCreated mesh__D007901 1980-05-07
% 223.54/223.71  |- rdf__type mesh__D007901sskos__Concept
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D007901 2004
% 223.54/223.71  |- mesh__historyNote mesh__D007901 81   
% 223.54/223.71  |- skos__hiddenLabel mesh__D007901 Lepilemurs
% 223.54/223.71  |- skos__scopeNote mesh__D007901
% 223.54/223.71       A family of the order PRIMATES, suborder Strepsirhini %28%PROSIMII%29%, containing four genera which inhabit Madagascar and the Comoro Island. Most of the lemurs prefer wooded areas. The four genera are Hapalemur, LEMUR, Lepilemur, and Varecia.%A%    
% 223.54/223.71  |- skos__prefLabel mesh__D007901 Lemuridae
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D007901 2006
% 223.54/223.71  |- mesh__recordOriginator mesh__D007901 EC
% 223.54/223.71  |- skos__broader mesh__D007901smesh__D011443
% 223.54/223.71  |- mesh__publicMeSHNote mesh__D007901 81   
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D007901 2005
% 223.54/223.71  |- mesh__recordMaintainer mesh__D007901 ags
% 223.54/223.71  |- mesh__recordAuthorizer mesh__D007901 sjn
% 223.54/223.71  |- skos__annotation mesh__D007901 prosimians; IM; qualif permitted   
% 223.54/223.71  |- skos__hiddenLabel mesh__D007901 Varecias
% 223.54/223.71  |- mesh__dateEstablished mesh__D007901 1981-01-01
% 223.54/223.71  |- skos__hiddenLabel mesh__D007901 Hapalemurs
% 223.54/223.71  |- mesh__dateRevised mesh__D007901 2003-07-09
% 223.54/223.71  |- skos__broader mesh__D007103smesh__D008919
% 223.54/223.71  |- mesh__recordAuthorizer mesh__D007103 sjn
% 223.54/223.71  |- skos__related mesh__D007103smesh__D046352
% 223.54/223.71  |- mesh__recordOriginator mesh__D007103 NLM
% 223.54/223.71  |- skos__annotation mesh__D007103
% 223.54/223.71       in Russian lit %22%hypokinesia%22% = IMMOBILIZATION, not see related HYPOKINESIA; immobilization of animals for easy handling can go here if by methods other than RESTRAINT, PHYSICAL %28%see note there%29%; %22%bedridden patients%22% can go here; not for immobilization of fractures %28% = FRACTURE FIXATION: see TN 87%29%; TN 166: do not confuse with BED REST%A%  
% 223.54/223.71  |- mesh__dateCreated mesh__D007103 1999-01-01
% 223.54/223.71  |- rdf__type mesh__D007103sskos__Concept
% 223.54/223.71  |- skos__prefLabel mesh__D007103 Immobilization
% 223.54/223.71  |- skos__hiddenLabel mesh__D007103 Experimental Hypokinesias
% 223.54/223.71  |- skos__related mesh__D007103smesh__D006233
% 223.54/223.71  |- mesh__publicMeSHNote mesh__D007103
% 223.54/223.71       1967; for HYPOKINESIA, EXPERIMENTAL see HYPOKINESIA 2000-2004%A%  
% 223.54/223.71  |- skos__related mesh__D007103smesh__D018476
% 223.54/223.71  |- skos__related mesh__D007103smesh__D046353
% 223.54/223.71  |- skos__related mesh__D007103smesh__D009984
% 223.54/223.71  |- mesh__historyNote mesh__D007103
% 223.54/223.71       1967%28%1964%29%; for HYPOKINESIA, EXPERIMENTAL use HYPOKINESIA 2000-2004%A%  
% 223.54/223.71  |- skos__hiddenLabel mesh__D007103 Experimental Hypokinesia
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D007103 2005
% 223.54/223.71  |- mesh__recordMaintainer mesh__D007103 nns
% 223.54/223.71  |- skos__scopeNote mesh__D007103
% 223.54/223.71       The restriction of the MOVEMENT of whole or part of the body by physical means %28%RESTRAINT, PHYSICAL%29% or chemically by ANALGESIA, or the use of TRANQUILIZING AGENTS or NEUROMUSCULAR NONDEPOLARIZING AGENTS. It includes experimental protocols used to evaluate the physiologic effects of immobility.%A%    
% 223.54/223.71  |- skos__related mesh__D007103smesh__D005592
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D007103 2006
% 223.54/223.71  |- skos__hiddenLabel mesh__D007103 Hypokinesias, Experimental
% 223.54/223.71  |- mesh__dateRevised mesh__D007103 2004-07-07
% 223.54/223.71  |- mesh__dateEstablished mesh__D007103 1967-01-01
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D012846 2006
% 223.54/223.71  |- skos__prefLabel mesh__D012846 Singapore
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D012846 2002
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D012846 2004
% 223.54/223.71  |- mesh__dateCreated mesh__D012846 1999-01-01
% 223.54/223.71  |- rdf__type mesh__D012846sskos__Concept
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D012846 1998
% 223.54/223.71  |- mesh__dateRevised mesh__D012846 1995-05-23
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D012846 1996
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D012846 1999
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D012846 1997
% 223.54/223.71  |- mesh__recordAuthorizer mesh__D012846 PLS
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D012846 2000
% 223.54/223.71  |- skos__broader mesh__D012846smesh__D001210
% 223.54/223.71  |- mesh__recordOriginator mesh__D012846 NLM
% 223.54/223.71  |- mesh__recordMaintainer mesh__D012846 KEV
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D012846 2005
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D012846 2001
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D012846 2003
% 223.54/223.71  |- mesh__dateCreated mesh__D045222 2003-07-09
% 223.54/223.71  |- rdf__type mesh__D045222sskos__Concept
% 223.54/223.71  |- mesh__dateEstablished mesh__D045222 2004-01-01
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D045222 2006
% 223.54/223.71  |- mesh__publicMeSHNote mesh__D045222 2004   
% 223.54/223.71  |- skos__broader mesh__D045222smesh__D009097
% 223.54/223.71  |- mesh__recordAuthorizer mesh__D045222 sjn
% 223.54/223.71  |- skos__annotation mesh__D045222 GEN: prefer specifics   
% 223.54/223.71  |- mesh__recordOriginator mesh__D045222 jmp
% 223.54/223.71  |- skos__scopeNote mesh__D045222
% 223.54/223.71       A complex of enzymes and PROTON PUMPS located on the inner membrane of the MITOCHONDRIA and in bacterial membranes. The protein complex provides energy in the form of an electrochemical gradient, which may be used by either MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES or BACTERIAL PROTON-TRANSLOCATING ATPASES.%A%    
% 223.54/223.71  |- mesh__historyNote mesh__D045222 2004   
% 223.54/223.71  |- mesh__dateRevised mesh__D045222 2005-06-30
% 223.54/223.71  |- mesh__recordMaintainer mesh__D045222 SYSTEM
% 223.54/223.71  |- skos__prefLabel mesh__D045222 Electron Transport Chain Complex Proteins
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D012048 2001
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D012048 1998
% 223.54/223.71  |- skos__historyNote mesh__D012048
% 223.54/223.71       Hearing Disorders/rehabilitation %28%1966-1997%29%
% 223.54/223.71  |- skos__broader mesh__D012048smesh__D012046
% 223.54/223.71  |- mesh__recordAuthorizer mesh__D012048 SJN
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D012048 1999
% 223.54/223.71  |- skos__altLabel mesh__D012048 Hearing Impaired Rehabilitation
% 223.54/223.71  |- skos__historyNote mesh__D012048
% 223.54/223.71       Deafness/rehabilitation %28%1966-1997%29%
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D012048 2002
% 223.54/223.71  |- mesh__dateEstablished mesh__D012048 1998-01-01
% 223.54/223.71  |- mesh__recordMaintainer mesh__D012048 TGC
% 223.54/223.71  |- mesh__dateRevised mesh__D012048 1997-06-20
% 223.54/223.71  |- rdf__type mesh__D012048sskos__Concept
% 223.54/223.71  |- mesh__dateCreated mesh__D012048 1999-01-01
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D012048 2003
% 223.54/223.71  |- skos__annotation mesh__D012048
% 223.54/223.71       GEN or unspecified; prefer specifics; coord IM with type of hearing disord /rehabil %28%IM%29%; DF: REHABIL HEARING IMPAIRED%A%  
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D012048 2005
% 223.54/223.71  |- skos__scopeNote mesh__D012048
% 223.54/223.71       Procedures for assisting a person with a hearing disorder to maximum comprehension in communication.%A%    
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D012048 2004
% 223.54/223.71  |- mesh__historyNote mesh__D012048 98; use explode 1975-97   
% 223.54/223.71  |- mesh__publicMeSHNote mesh__D012048 98   
% 223.54/223.71  |- mesh__recordOriginator mesh__D012048 NLM
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D012048 2006
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D012048 2000
% 223.54/223.71  |- skos__hiddenLabel mesh__D012048 Rehabilitation, Hearing Impaired
% 223.54/223.71  |- skos__prefLabel mesh__D012048 Rehabilitation of Hearing Impaired
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D006809 2001
% 223.54/223.71  |- mesh__dateCreated mesh__D006809 1999-01-01
% 223.54/223.71  |- mesh__recordMaintainer mesh__D006809 TAP
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D006809 2000
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D006809 2005
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D006809 1995
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D006809 2004
% 223.54/223.71  |- skos__prefLabel mesh__D006809 Humanities
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D006809 1999
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D006809 1994
% 223.54/223.71  |- rdf__type mesh__D006809sskos__Concept
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D006809 2003
% 223.54/223.71  |- mesh__recordAuthorizer mesh__D006809 PLS
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D006809 1993
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D006809 1998
% 223.54/223.71  |- mesh__runningHead mesh__D006809
% 223.54/223.71       K1 - HUMANITIES-ART, HISTORY, PHILOSOPHY AND RELIGIONS   
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D006809 1997
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D006809 2002
% 223.54/223.71  |- mesh__recordOriginator mesh__D006809 NLM
% 223.54/223.71  |- mesh__dateRevised mesh__D006809 1992-05-15
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D006809 1996
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D006809 2006
% 223.54/223.71  |- rdf__type mesh__D017531sskos__Concept
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D017531 1998
% 223.54/223.71  |- skos__broader mesh__D017531smesh__D011787
% 223.54/223.71  |- mesh__recordMaintainer mesh__D017531 TPW
% 223.54/223.71  |- mesh__historyNote mesh__D017531 98; use explode   
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D017531 2004
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D017531 1999
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D017531 2000
% 223.54/223.71  |- mesh__dateRevised mesh__D017531 1997-06-26
% 223.54/223.71  |- skos__hiddenLabel mesh__D017531 Mechanism, Healthcare Evaluation
% 223.54/223.71  |- skos__scopeNote mesh__D017531
% 223.54/223.71       Methods and techniques used in evaluating the quality of health care, its planning, and delivery.%A%    
% 223.54/223.71  |- mesh__recordOriginator mesh__D017531 PLS
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D017531 2001
% 223.54/223.71  |- skos__annotation mesh__D017531 not used for indexing   
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D017531 2002
% 223.54/223.71  |- skos__prefLabel mesh__D017531 Health Care Evaluation Mechanisms
% 223.54/223.71  |- skos__historyNote mesh__D017531 Quality of Health Care %28%1966-1997%29%
% 223.54/223.71  |- mesh__dateCreated mesh__D017531 1992-05-20
% 223.54/223.71  |- skos__hiddenLabel mesh__D017531 Mechanisms, Healthcare Evaluation
% 223.54/223.71  |- skos__hiddenLabel mesh__D017531 Evaluation Mechanisms, Healthcare
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D017531 2005
% 223.54/223.71  |- skos__hiddenLabel mesh__D017531 Healthcare Evaluation Mechanism
% 223.54/223.71  |- skos__altLabel mesh__D017531 Healthcare Evaluation Mechanisms
% 223.54/223.71  |- mesh__recordAuthorizer mesh__D017531 SJN
% 223.54/223.71  |- skos__hiddenLabel mesh__D017531 Evaluation Mechanism, Healthcare
% 223.54/223.71  |- mesh__dateEstablished mesh__D017531 1998-01-01
% 223.54/223.71  |- mesh__publicMeSHNote mesh__D017531 98   
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D017531 2003
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D017531 2006
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D031202 2006
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D031202 2004
% 223.54/223.71  |- mesh__recordMaintainer mesh__D031202 ssb
% 223.54/223.71  |- rdf__type mesh__D031202sskos__Concept
% 223.54/223.71  |- skos__prefLabel mesh__D031202 Chrysanthemum
% 223.54/223.71  |- mesh__publicMeSHNote mesh__D031202 2003; see PYRETHRUM 1977-2002   
% 223.54/223.71  |- mesh__dateCreated mesh__D031202 2002-07-03
% 223.54/223.71  |- skos__annotation mesh__D031202
% 223.54/223.71       CHRYSANTHEMUM PARTHENIUM see TANACETUM PARTHENIUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.54/223.71  |- mesh__recordAuthorizer mesh__D031202 sjn
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D031202 2005
% 223.54/223.71  |- mesh__historyNote mesh__D031202 2003; use PYRETHRUM 1977-2002   
% 223.54/223.71  |- skos__historyNote mesh__D031202 Pyrethrum %28%1977-2002%29%
% 223.54/223.71  |- mesh__dateEstablished mesh__D031202 2003-01-01
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D031202 2003
% 223.54/223.71  |- skos__scopeNote mesh__D031202
% 223.54/223.71       A plant genus of the family ASTERACEAE. The common names of daisy or marguerite are easily confused with other plants. Some species in this genus have been reclassified to TANACETUM.%A%    
% 223.54/223.71  |- mesh__recordOriginator mesh__D031202 ssb
% 223.54/223.71  |- skos__broader mesh__D031202smesh__D019659
% 223.54/223.71  |- skos__historyNote mesh__D003511 Cyclohexanes %28%1966-1971%29%
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D003511 2005
% 223.54/223.71  |- mesh__onlineNote mesh__D003511
% 223.54/223.71       use CYCLOHEXANOLS to search CYCLOHEXANOL 1972-74 %28%as Prov 1972-73%29%%A%  
% 223.54/223.71  |- skos__broader mesh__D003511smesh__D003510
% 223.54/223.71  |- mesh__dateEstablished mesh__D003511 1974-01-01
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D003511 2006
% 223.54/223.71  |- mesh__publicMeSHNote mesh__D003511 75; was CYCLOHEXANOL 1974   
% 223.54/223.71  |- skos__prefLabel mesh__D003511 Cyclohexanols
% 223.54/223.71  |- mesh__dateCreated mesh__D003511 1999-01-01
% 223.54/223.71  |- mesh__recordMaintainer mesh__D003511 ssb
% 223.54/223.71  |- mesh__recordAuthorizer mesh__D003511 sjn
% 223.54/223.71  |- mesh__recordOriginator mesh__D003511 NLM
% 223.54/223.71  |- skos__broader mesh__D003511smesh__D000441
% 223.54/223.71  |- skos__scopeNote mesh__D003511
% 223.54/223.71       Monohydroxy derivatives of cyclohexanes that contain the general formula R-C6H11O. They have a camphorlike odor and are used in making soaps, insecticides, germicides, dry cleaning, and plasticizers.%A%    
% 223.54/223.71  |- mesh__dateRevised mesh__D003511 2004-07-07
% 223.54/223.71  |- rdf__type mesh__D003511sskos__Concept
% 223.54/223.71  |- skos__annotation mesh__D003511 do not confuse with CYCLOHEXANONES   
% 223.54/223.71  |- mesh__historyNote mesh__D003511
% 223.54/223.71       75; was CYCLOHEXANOL 1972-74 %28%Prov 1972-73%29%   
% 223.54/223.71  |- skos__historyNote mesh__D003511 Alcohols %28%1966-1971%29%
% 223.54/223.71  |- skos__annotation mesh__D016439
% 223.54/223.71       publication  type only; see also PUBLISHED ERRATUM %5B%Publication Type%5D%; CATALOG: do not use%A%  
% 223.54/223.71  |- skos__scopeNote mesh__D016439
% 223.54/223.71       Work that is the republication of an article to correct, amplify, or restore text and data of the originally published article.%A%    
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D016439 2006
% 223.54/223.71  |- rdf__type mesh__D016439sskos__Concept
% 223.54/223.71  |- mesh__dateCreated mesh__D016439 1995-06-23
% 223.54/223.71  |- mesh__dateEstablished mesh__D016439 1996-01-01
% 223.54/223.71  |- mesh__dateRevised mesh__D016439 2005-06-30
% 223.54/223.71  |- mesh__recordOriginator mesh__D016439 TGC
% 223.54/223.71  |- skos__altLabel mesh__D016439 Corrected and Republished Article
% 223.54/223.71  |- skos__altLabel mesh__D016439 Republished Article
% 223.54/223.71  |- mesh__recordMaintainer mesh__D016439 jls
% 223.54/223.71  |- skos__prefLabel mesh__D016439
% 223.54/223.71       Corrected and Republished Article %5B%Publication Type%5D%
% 223.54/223.71  |- mesh__recordAuthorizer mesh__D016439 sjn
% 223.54/223.71  |- mesh__historyNote mesh__D016439 1991   
% 223.54/223.71  |- skos__altLabel mesh__D016439
% 223.54/223.71       Corrected and Republished Article %28%PT%29%
% 223.54/223.71  |- skos__broader mesh__D016439smesh__D052180
% 223.54/223.71  |- skos__hiddenLabel mesh__D027161 Perineuronal Satellite Cell
% 223.54/223.71  |- mesh__historyNote mesh__D027161 2002   
% 223.54/223.71  |- mesh__recordAuthorizer mesh__D027161 sjn
% 223.54/223.71  |- mesh__dateCreated mesh__D027161 2001-07-25
% 223.54/223.71  |- skos__scopeNote mesh__D027161
% 223.54/223.71       The non-neuronal cells that surround the neuronal cell bodies of the GANGLIA. They are distinguished from the perineuronal satellite oligodendrocytes %28%OLIGODENDROGLIA%29% found in the central nervous system.%A%    
% 223.54/223.71  |- mesh__recordMaintainer mesh__D027161 ags
% 223.54/223.71  |- skos__altLabel mesh__D027161 Perineuronal Satellite Cells
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D027161 2006
% 223.54/223.71  |- mesh__recordOriginator mesh__D027161 nns
% 223.54/223.71  |- mesh__dateRevised mesh__D027161 2002-07-03
% 223.54/223.71  |- skos__prefLabel mesh__D027161 Satellite Cells, Perineuronal
% 223.54/223.71  |- rdf__type mesh__D027161sskos__Concept
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D027161 2005
% 223.54/223.71  |- mesh__publicMeSHNote mesh__D027161 2002   
% 223.54/223.71  |- mesh__dateEstablished mesh__D027161 2002-01-01
% 223.54/223.71  |- skos__broader mesh__D027161smesh__D009457
% 223.54/223.71  |- skos__hiddenLabel mesh__D027161 Satellite Cell, Perineuronal
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D027161 2004
% 223.54/223.71  |- skos__hiddenLabel mesh__D027161 Cells, Perineuronal Satellite
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D027161 2003
% 223.54/223.71  |- skos__broader mesh__D027161smesh__D005724
% 223.54/223.71  |- skos__hiddenLabel mesh__D027161 Cell, Perineuronal Satellite
% 223.54/223.71  |- mesh__dateRevised mesh__D013141 1993-06-03
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D013141 1996
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D013141 1999
% 223.54/223.71  |- skos__broader mesh__D013141smesh__D011084
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D013141 2000
% 223.54/223.71  |- mesh__recordOriginator mesh__D013141 NLM
% 223.54/223.71  |- skos__prefLabel mesh__D013141 Spiro Compounds
% 223.54/223.71  |- mesh__recordAuthorizer mesh__D013141 PLS
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D013141 1997
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D013141 2001
% 223.54/223.71  |- skos__scopeNote mesh__D013141
% 223.54/223.71       A group of compounds consisting in part of two rings sharing one carbon atom in common.%A%    
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D013141 2005
% 223.54/223.71  |- rdf__type mesh__D013141sskos__Concept
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D013141 2002
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D013141 1994
% 223.54/223.71  |- mesh__recordMaintainer mesh__D013141 PLS
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D013141 2003
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D013141 2006
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D013141 1995
% 223.54/223.71  |- skos__annotation mesh__D013141 DF: SPIRO CPDS   
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D013141 2004
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D013141 1998
% 223.54/223.71  |- mesh__dateCreated mesh__D013141 1999-01-01
% 223.54/223.71  |- skos__hiddenLabel mesh__D013141 Compounds, Spiro
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D007902 2001
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D007902 1998
% 223.54/223.71  |- mesh__historyNote mesh__D007902 72%28%69%29%   
% 223.54/223.71  |- mesh__dateEstablished mesh__D007902 1972-01-01
% 223.54/223.71  |- mesh__dateCreated mesh__D007902 1999-01-01
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D007902 2004
% 223.54/223.71  |- mesh__dateRevised mesh__D007902 1997-06-20
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D007902 2000
% 223.54/223.71  |- mesh__recordMaintainer mesh__D007902 PXP
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D007902 2003
% 223.54/223.71  |- mesh__publicMeSHNote mesh__D007902 72   
% 223.54/223.71  |- skos__scopeNote mesh__D007902
% 223.54/223.71       The period of confinement of a patient to a hospital or other health facility.%A%    
% 223.54/223.71  |- skos__prefLabel mesh__D007902 Length of Stay
% 223.54/223.71  |- skos__broader mesh__D007902smesh__D006760
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D007902 2006
% 223.54/223.71  |- skos__hiddenLabel mesh__D007902 Stay Length
% 223.54/223.71  |- skos__historyNote mesh__D007902 Hospitalization %28%1966-1968%29%
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D007902 2002
% 223.54/223.71  |- skos__hiddenLabel mesh__D007902 Stay Lengths
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D007902 2005
% 223.54/223.71  |- skos__annotation mesh__D007902 length of stay in hosp, clinics, etc.   
% 223.54/223.71  |- mesh__recordOriginator mesh__D007902 NLM
% 223.54/223.71  |- mesh__recordAuthorizer mesh__D007902 SJN
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D007902 1999
% 223.54/223.71  |- rdf__type mesh__D007902sskos__Concept
% 223.54/223.71  |- skos__historyNote mesh__D007104
% 223.54/223.71       Antigen-Antibody Reactions %28%1966-1970%29%
% 223.54/223.71  |- skos__hiddenLabel mesh__D007104 Reaction, Immune Adherence
% 223.54/223.71  |- rdf__type mesh__D007104sskos__Concept
% 223.54/223.71  |- skos__scopeNote mesh__D007104
% 223.54/223.71       A method for the detection of very small quantities of antibody in which the antigen-antibody-complement complex adheres to indicator cells, usually primate erythrocytes or nonprimate blood platelets. The reaction is dependent on the number of bound C3 molecules on the C3b receptor sites of the indicator cell.%A%    
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D007104 2000
% 223.54/223.71  |- mesh__dateCreated mesh__D007104 1999-01-01
% 223.54/223.71  |- mesh__dateRevised mesh__D007104 1997-06-20
% 223.54/223.71  |- skos__hiddenLabel mesh__D007104 Adherence Reactions, Immune
% 223.54/223.71  |- mesh__recordMaintainer mesh__D007104 PXP
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D007104 2004
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D007104 2001
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D007104 1998
% 223.54/223.71  |- skos__broader mesh__D007104smesh__D007159
% 223.54/223.71  |- skos__prefLabel mesh__D007104 Immune Adherence Reaction
% 223.54/223.71  |- mesh__recordOriginator mesh__D007104 NLM
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D007104 1999
% 223.54/223.71  |- skos__hiddenLabel mesh__D007104 Immune Adherence Reactions
% 223.54/223.71  |- mesh__activeMeSHYear mesh__D007104 2005
% 223.54/223.72  |- skos__hiddenLabel mesh__D007104 Adherence Reaction, Immune
% 223.54/223.72  |- skos__broader mesh__D007104smesh__D007158
% 223.54/223.72  |- mesh__dateEstablished mesh__D007104 1973-01-01
% 223.54/223.72  |- mesh__activeMeSHYear mesh__D007104 2002
% 223.54/223.72  |- skos__hiddenLabel mesh__D007104 Reactions, Immune Adherence
% 223.54/223.72  |- mesh__activeMeSHYear mesh__D007104 2006
% 223.54/223.72  |- mesh__recordAuthorizer mesh__D007104 SJN
% 223.54/223.72  |- mesh__historyNote mesh__D007104 73%28%71%29%   
% 223.54/223.72  |- mesh__activeMeSHYear mesh__D007104 2003
% 223.54/223.72  |- mesh__publicMeSHNote mesh__D007104 73   
% 223.54/223.72  |- mesh__recordOriginator mesh__D051260 DRC
% 223.54/223.72  |- skos__hiddenLabel mesh__D051260 Maf, Transcription Factor
% 223.54/223.72  |- skos__hiddenLabel mesh__D051260 Transcription Factor, MafF
% 223.54/223.72  |- mesh__historyNote mesh__D051260 2006   
% 223.54/223.72  |- rdf__type mesh__D051260sskos__Concept
% 223.54/223.72  |- mesh__recordMaintainer mesh__D051260 ags
% 223.54/223.72  |- mesh__activeMeSHYear mesh__D051260 2006A
% 223.54/223.72  |- mesh__recordAuthorizer mesh__D051260 ags
% 223.54/223.72  |- mesh__dateRevised mesh__D051260 2005-08-03
% 223.54/223.72  |- mesh__activeMeSHYear mesh__D051260 2006
% 223.54/223.72  |- skos__hiddenLabel mesh__D051260 Factor Maf, Transcription
% 223.54/223.72  |- mesh__dateEstablished mesh__D051260 2006-01-01
% 223.54/223.72  |- mesh__publicMeSHNote mesh__D051260 2006   
% 223.54/223.72  |- skos__prefLabel mesh__D051260 MafF Transcription Factor
% 223.54/223.72  |- skos__broader mesh__D051260smesh__D050978
% 223.54/223.72  |- skos__scopeNote mesh__D051260
% 223.54/223.72       A small maf protein that forms dimers with NRF1 PROTEIN; NRF2 PROTEIN; and P45 NF-E2 PROTEIN. MafF complexes bind Maf recognition elements to regulate tissue-specific GENETIC TRANSCRIPTION.%A%    
% 223.54/223.72  |- skos__altLabel mesh__D051260 Transcription Factor Maf
% 223.54/223.72  |- mesh__dateCreated mesh__D051260 2005-06-30
% 223.54/223.72  |- mesh__dateEstablished mesh__D012847 1968-01-01
% 223.54/223.72  |- mesh__activeMeSHYear mesh__D012847 1998
% 223.54/223.72  |- mesh__activeMeSHYear mesh__D012847 2001
% 223.54/223.72  |- skos__annotation mesh__D012847
% 223.54/223.72       /psychol permitted; does not include %22%celibacy%22%: CELIBACY see SEXUAL ABSTINENCE; %22%unwed parent%22% = PARENTS %28%IM%29% + ILLEGITIMACY %28%IM%29%; SINGLE PARENT is also available%A%  
% 223.54/223.72  |- mesh__activeMeSHYear mesh__D012847 1999
% 223.54/223.72  |- mesh__recordAuthorizer mesh__D012847 SJN
% 223.54/223.72  |- mesh__dateRevised mesh__D012847 1997-06-20
% 223.54/223.72  |- mesh__activeMeSHYear mesh__D012847 2002
% 223.54/223.72  |- skos__altLabel mesh__D012847 Maritally Unattached
% 223.54/223.72  |- skos__scopeNote mesh__D012847 The unmarried man or woman.     
% 223.54/223.72  |- skos__hiddenLabel mesh__D012847 Single Persons
% 223.54/223.72  |- mesh__activeMeSHYear mesh__D012847 2005
% 223.54/223.72  |- skos__broader mesh__D012847smesh__D009272
% 223.54/223.72  |- skos__related mesh__D012847smesh__D017805
% 223.54/223.72  |- skos__hiddenLabel mesh__D012847 Person, Single
% 223.54/223.72  |- mesh__activeMeSHYear mesh__D012847 2003
% 223.54/223.72  |- mesh__publicMeSHNote mesh__D012847 68   
% 223.54/223.72  |- mesh__recordMaintainer mesh__D012847 TGC
% 223.54/223.72  |- skos__prefLabel mesh__D012847 Single Person
% 223.54/223.72  |- mesh__activeMeSHYear mesh__D012847 2006
% 223.54/223.72  |- skos__hiddenLabel mesh__D012847 Persons, Single
% 223.54/223.72  |- mesh__activeMeSHYear mesh__D012847 2000
% 223.54/223.72  |- mesh__recordOriginator mesh__D012847 NLM
% 223.54/223.72  |- mesh__activeMeSHYear mesh__D012847 2004
% 223.54/223.72  |- skos__broader mesh__D012847smesh__D017533
% 223.54/223.72  |- rdf__type mesh__D012847sskos__Concept
% 223.54/223.72  |- mesh__dateCreated mesh__D012847 1999-01-01
% 223.54/223.72  |- skos__historyNote mesh__D012847 Illegitimacy %28%1966-1967%29%
% 223.54/223.72  |- mesh__historyNote mesh__D012847 68   
% 223.54/223.72  |- skos__historyNote mesh__D012847 Marriage %28%1966-1967%29%
% 223.54/223.72  |- mesh__historyNote mesh__D012049 98; use explode 1975-79   
% 223.54/223.72  |- skos__historyNote mesh__D012049
% 223.54/223.72       Speech Disorders/rehabilitation %28%1966-1997%29%
% 223.54/223.72  |- mesh__recordAuthorizer mesh__D012049 SJN
% 223.54/223.72  |- skos__prefLabel mesh__D012049
% 223.54/223.72       Rehabilitation of Speech and Language Disorders
% 223.54/223.72  |- skos__annotation mesh__D012049
% 223.54/223.72       not used for indexing; DF: REHABIL SPEECH LANGUAGE DIS       CATALOG: do not use%A%  
% 223.54/223.72  |- mesh__activeMeSHYear mesh__D012049 1999
% 223.54/223.72  |- skos__broader mesh__D012049smesh__D012046
% 223.54/223.72  |- mesh__dateEstablished mesh__D012049 1998-01-01
% 223.54/223.72  |- mesh__activeMeSHYear mesh__D012049 2002
% 223.54/223.72  |- mesh__dateCreated mesh__D012049 1999-01-01
% 223.54/223.72  |- mesh__dateRevised mesh__D012049 1998-06-18
% 223.54/223.72  |- rdf__type mesh__D012049sskos__Concept
% 223.54/223.72  |- mesh__recordMaintainer mesh__D012049 JLS
% 223.54/223.72  |- skos__historyNote mesh__D012049
% 223.54/223.72       Language Disorders/rehabilitation %28%1967-1997%29%
% 223.54/223.72  |- skos__altLabel mesh__D012049 Language and Speech Disorder Rehabilitation
% 223.54/223.72  |- mesh__activeMeSHYear mesh__D012049 2003
% 223.54/223.72  |- mesh__publicMeSHNote mesh__D012049 98   
% 223.54/223.72  |- mesh__recordOriginator mesh__D012049 NLM
% 223.54/223.72  |- skos__altLabel mesh__D012049 Speech and Language Disorder Rehabilitation
% 223.54/223.72  |- mesh__activeMeSHYear mesh__D012049 2000
% 223.54/223.72  |- mesh__activeMeSHYear mesh__D012049 2005
% 223.54/223.73  |- skos__scopeNote mesh__D012049
% 223.54/223.73       Procedures for assisting a person with a speech or language disorder to communicate with maximum efficiency.%A%    
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D012049 2004
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D012049 2001
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D012049 2006
% 223.54/223.73  |- skos__annotation mesh__D031203
% 223.54/223.73       TANACETUM CINERARIIFOLIUM and TANACETUM COCCINEUM see CHRYSANTHEMUM CINERARIIFOLIUM are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.54/223.73  |- mesh__dateEstablished mesh__D031203 2003-01-01
% 223.54/223.73  |- skos__prefLabel mesh__D031203 Tanacetum
% 223.54/223.73  |- rdf__type mesh__D031203sskos__Concept
% 223.54/223.73  |- mesh__historyNote mesh__D031203 2003   
% 223.54/223.73  |- mesh__publicMeSHNote mesh__D031203 2003   
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D031203 2005
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D031203 2003
% 223.54/223.73  |- skos__scopeNote mesh__D031203
% 223.54/223.73       A plant genus of the family ASTERACEAE. Some species of the CHRYSANTHEMUM and the old Pyrethrum genera have been reclassified to this genus. The common name of tansy usually refers to this but also forms part of the common name of other plants such as Tansy Ragwort %28%SENECIO%29% and Tansyaster %28%HAPLOPAPPUS%29%.%A%    
% 223.54/223.73  |- skos__broader mesh__D031203smesh__D019659
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D031203 2006
% 223.54/223.73  |- mesh__dateCreated mesh__D031203 2002-07-03
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D031203 2004
% 223.54/223.73  |- skos__altLabel mesh__D031203 Tansy
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D003512 2006
% 223.54/223.73  |- skos__prefLabel mesh__D003512 Cyclohexanones
% 223.54/223.73  |- mesh__dateEstablished mesh__D003512 1991-01-01
% 223.54/223.73  |- skos__historyNote mesh__D003512 Cyclohexanes %28%1969-1974%29%
% 223.54/223.73  |- mesh__dateCreated mesh__D003512 1974-11-27
% 223.54/223.73  |- mesh__dateRevised mesh__D003512 2004-07-07
% 223.54/223.73  |- skos__broader mesh__D003512smesh__D007659
% 223.54/223.73  |- rdf__type mesh__D003512sskos__Concept
% 223.54/223.73  |- skos__annotation mesh__D003512 do not confuse with CYCLOHEXANOLS   
% 223.54/223.73  |- mesh__recordMaintainer mesh__D003512 ssb
% 223.54/223.73  |- skos__historyNote mesh__D003512 Ketones %28%1969-1974%29%
% 223.54/223.73  |- mesh__recordOriginator mesh__D003512 NLM
% 223.54/223.73  |- mesh__recordAuthorizer mesh__D003512 sjn
% 223.54/223.73  |- mesh__publicMeSHNote mesh__D003512
% 223.54/223.73       91; was see under CYCLOHEXANES 1975-90   
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D003512 2005
% 223.54/223.73  |- skos__scopeNote mesh__D003512
% 223.54/223.73       Cyclohexane ring substituted by one or more ketones in any position.%A%    
% 223.54/223.73  |- skos__broader mesh__D003512smesh__D003510
% 223.54/223.73  |- mesh__historyNote mesh__D003512
% 223.54/223.73       91%28%75%29%; was see under CYCLOHEXANES 1975-90   
% 223.54/223.73  |- mesh__publicMeSHNote mesh__D013940
% 223.54/223.73       98%28%86%29%; see METHYLTRANSFERASES 1975-85, see THYMIDYLATE SYNTHETASE 1985-97%A%  
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013940 2004
% 223.54/223.73  |- skos__historyNote mesh__D013940 Transferases %28%1969-1972%29%
% 223.54/223.73  |- skos__historyNote mesh__D013940 Methyltransferases %28%1971-1972%29%
% 223.54/223.73  |- mesh__recordMaintainer mesh__D013940 ssb
% 223.54/223.73  |- mesh__historyNote mesh__D013940 98; see METHYLTRANSFERASES 1975-85   
% 223.54/223.73  |- mesh__recordOriginator mesh__D013940 NLM
% 223.54/223.73  |- mesh__recordAuthorizer mesh__D013940 sjn
% 223.54/223.73  |- skos__altLabel mesh__D013940 Thymidylate Synthetase
% 223.54/223.73  |- mesh__dateCreated mesh__D013940 1999-01-01
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013940 2005
% 223.54/223.73  |- skos__scopeNote mesh__D013940
% 223.54/223.73       An enzyme of the transferase class that catalyzes the reaction 5,10-methylenetetrahydrofolate and dUMP to dihydrofolate and dTMP in the synthesis of thymidine triphosphate. %28%From Dorland, 27th ed%29% EC 2.1.1.45.%A%    
% 223.54/223.73  |- mesh__dateRevised mesh__D013940 2003-07-09
% 223.54/223.73  |- skos__prefLabel mesh__D013940 Thymidylate Synthase
% 223.54/223.73  |- skos__broader mesh__D013940smesh__D008780
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013940 2006
% 223.54/223.73  |- skos__hiddenLabel mesh__D013940 Synthase, Thymidylate
% 223.54/223.73  |- mesh__dateEstablished mesh__D013940 1986-01-01
% 223.54/223.73  |- skos__hiddenLabel mesh__D013940 Synthetase, Thymidylate
% 223.54/223.73  |- skos__historyNote mesh__D013940 Ligases %28%1966-1970%29%
% 223.54/223.73  |- rdf__type mesh__D013940sskos__Concept
% 223.54/223.73  |- mesh__dateRevised mesh__D013142 2005-06-30
% 223.54/223.73  |- mesh__recordAuthorizer mesh__D013142 sjn
% 223.54/223.73  |- skos__annotation mesh__D013142
% 223.54/223.73       a genus of the family SPIROCHAETACEAE of the order SPIROCHAETALES; do not confuse with SPIROCHETES see SPIROCHAETALES; found in mud %26% slime%A%  
% 223.54/223.73  |- skos__prefLabel mesh__D013142 Spirochaeta
% 223.54/223.73  |- mesh__recordMaintainer mesh__D013142 SYSTEM
% 223.54/223.73  |- skos__broader mesh__D013142smesh__D013143
% 223.54/223.73  |- mesh__dateCreated mesh__D013142 1999-01-01
% 223.54/223.73  |- rdf__type mesh__D013142sskos__Concept
% 223.54/223.73  |- mesh__recordOriginator mesh__D013142 NLM
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013142 2006
% 223.54/223.73  |- skos__scopeNote mesh__D013142
% 223.54/223.73       A genus of flexible, spiral rods found in hydrogen sulfide-containing mud, sewage, and polluted water. None of the species properly referred to in this genus are pathogenic.%A%    
% 223.54/223.73  |- skos__related mesh__D007903smesh__D019923
% 223.54/223.73  |- skos__hiddenLabel mesh__D007903 Crystalline Lens Capsules
% 223.54/223.73  |- skos__historyNote mesh__D007903 Lens, Crystalline %28%1966-1982%29%
% 223.54/223.73  |- skos__hiddenLabel mesh__D007903 Capsules, Crystalline Lens
% 223.54/223.73  |- mesh__dateRevised mesh__D007903 2005-06-30
% 223.54/223.73  |- mesh__recordOriginator mesh__D007903 RC
% 223.54/223.73  |- mesh__historyNote mesh__D007903
% 223.54/223.73       91%28%83%29%; was see under LENS, CRYSTALLINE 1983-90   
% 223.54/223.73  |- skos__prefLabel mesh__D007903 Lens Capsule, Crystalline
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D007903 2006
% 223.54/223.73  |- mesh__publicMeSHNote mesh__D007903
% 223.54/223.73       91; was see under LENS, CRYSTALLINE 1983-90   
% 223.54/223.73  |- skos__hiddenLabel mesh__D007903 Crystalline Lens Capsule
% 223.54/223.73  |- rdf__type mesh__D007903sskos__Concept
% 223.54/223.73  |- mesh__recordAuthorizer mesh__D007903 sjn
% 223.54/223.73  |- skos__scopeNote mesh__D007903
% 223.54/223.73       The thin noncellular outer covering of the CRYSTALLINE LENS composed mainly of COLLAGEN TYPE IV and GLYCOSAMINOGLYCANS. It is secreted by the embryonic anterior and posterior epithelium. The embryonic posterior epithelium later disappears.%A%    
% 223.54/223.73  |- skos__hiddenLabel mesh__D007903 Lens Capsules, Crystalline
% 223.54/223.73  |- skos__broader mesh__D007903smesh__D007908
% 223.54/223.73  |- mesh__recordMaintainer mesh__D007903 ssb
% 223.54/223.73  |- skos__hiddenLabel mesh__D007903 Capsule, Crystalline Lens
% 223.54/223.73  |- mesh__dateCreated mesh__D007903 1982-04-28
% 223.54/223.73  |- mesh__dateEstablished mesh__D007903 1991-01-01
% 223.54/223.73  |- skos__annotation mesh__D007105
% 223.54/223.73       dis caused by deposition of antigen-antibody complexes with resultant damage to tissue; %22%immune complex%22% = IMMUNE COMPLEX see ANTIGEN-ANTIBODY COMPLEX%A%  
% 223.54/223.73  |- mesh__publicMeSHNote mesh__D007105
% 223.54/223.73       93; was IMMUNE COMPLEX DISEASE 1974-92   
% 223.54/223.73  |- skos__altLabel mesh__D007105 Type III Hypersensitivity
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D007105 2005
% 223.54/223.73  |- skos__altLabel mesh__D007105 Hypersensitivity, Type III
% 223.54/223.73  |- skos__hiddenLabel mesh__D007105 Diseases, Immune Complex
% 223.54/223.73  |- skos__prefLabel mesh__D007105 Immune Complex Diseases
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D007105 2006
% 223.54/223.73  |- skos__hiddenLabel mesh__D007105 Hypersensitivities, Type III
% 223.54/223.73  |- skos__hiddenLabel mesh__D007105 Disease, Immune Complex
% 223.54/223.73  |- skos__historyNote mesh__D007105 Immunologic Diseases %28%1971%29%
% 223.54/223.73  |- skos__broader mesh__D007105smesh__D006967
% 223.54/223.73  |- mesh__recordAuthorizer mesh__D007105 sjn
% 223.54/223.73  |- skos__scopeNote mesh__D007105
% 223.54/223.73       Group of diseases mediated by the deposition of large soluble complexes of antigen and antibody with resultant damage to tissue. Besides SERUM SICKNESS and the ARTHUS REACTION, evidence supports a pathogenic role for immune complexes in many other IMMUNE SYSTEM DISEASES including GLOMERULONEPHRITIS, systemic lupus erythematosus %28%LUPUS ERYTHEMATOSUS, SYSTEMIC%29% and POLYARTERITIS NODOSA.%A%    
% 223.54/223.73  |- rdf__type mesh__D007105sskos__Concept
% 223.54/223.73  |- mesh__dateCreated mesh__D007105 1999-01-01
% 223.54/223.73  |- mesh__recordOriginator mesh__D007105 NLM
% 223.54/223.73  |- mesh__recordMaintainer mesh__D007105 sjn
% 223.54/223.73  |- mesh__onlineNote mesh__D007105
% 223.54/223.73       use IMMUNE COMPLEX DISEASES to search IMMUNE COMPLEX DISEASE 1972-92 %28%as Prov 1972-73%29%%A%  
% 223.54/223.73  |- mesh__historyNote mesh__D007105
% 223.54/223.73       93; was IMMUNE COMPLEX DISEASE 1972-92 %28%Prov 1972-73%29%   
% 223.54/223.73  |- mesh__dateEstablished mesh__D007105 1974-01-01
% 223.54/223.73  |- mesh__dateRevised mesh__D007105 2004-07-13
% 223.54/223.73  |- skos__hiddenLabel mesh__D007105 Type III Hypersensitivities
% 223.54/223.73  |- skos__hiddenLabel mesh__D007105 Immune Complex Disease
% 223.54/223.73  |- skos__altLabel mesh__D051261 Orofacial Granulomatosis
% 223.54/223.73  |- skos__prefLabel mesh__D051261 Granulomatosis, Orofacial
% 223.54/223.73  |- skos__scopeNote mesh__D051261
% 223.54/223.73       A condition characterized by persistent or recurrent labial enlargement, ORAL ULCER, and other orofacial manifestations in the absence of identifiable CROHN DISEASE; or SARCOIDOSIS. There is no consensus on whether orofacial granulomatosis is a distinct clinical disorder or an initial presentation of Crohn disease.%A%    
% 223.54/223.73  |- mesh__recordOriginator mesh__D051261 ags
% 223.54/223.73  |- skos__hiddenLabel mesh__D051261 Granulomatoses, Orofacial
% 223.54/223.73  |- skos__broader mesh__D051261smesh__D010335
% 223.54/223.73  |- mesh__recordMaintainer mesh__D051261 ags
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D051261 2006
% 223.54/223.73  |- skos__hiddenLabel mesh__D051261 Orofacial Granulomatoses
% 223.54/223.73  |- mesh__recordAuthorizer mesh__D051261 sjn
% 223.54/223.73  |- mesh__publicMeSHNote mesh__D051261 2006   
% 223.54/223.73  |- mesh__dateCreated mesh__D051261 2005-06-30
% 223.54/223.73  |- mesh__historyNote mesh__D051261 2006   
% 223.54/223.73  |- mesh__dateEstablished mesh__D051261 2006-01-01
% 223.54/223.73  |- rdf__type mesh__D051261sskos__Concept
% 223.54/223.73  |- mesh__recordMaintainer mesh__D012848 PLS
% 223.54/223.73  |- skos__hiddenLabel mesh__D012848 Block, Sinoatrial
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D012848 2000
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D012848 2005
% 223.54/223.73  |- mesh__recordOriginator mesh__D012848 NLM
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D012848 2003
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D012848 2006
% 223.54/223.73  |- skos__hiddenLabel mesh__D012848 Sinoatrial Blocks
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D012848 2004
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D012848 2001
% 223.54/223.73  |- mesh__publicMeSHNote mesh__D012848
% 223.54/223.73       91; was see under HEART BLOCK 1975-90   
% 223.54/223.73  |- mesh__dateRevised mesh__D012848 1999-11-03
% 223.54/223.73  |- mesh__dateEstablished mesh__D012848 1991-01-01
% 223.54/223.73  |- skos__broader mesh__D012848smesh__D006327
% 223.54/223.73  |- rdf__type mesh__D012848sskos__Concept
% 223.54/223.73  |- mesh__dateCreated mesh__D012848 1974-11-11
% 223.54/223.73  |- mesh__historyNote mesh__D012848
% 223.54/223.73       91%28%75%29%; was see under HEART BLOCK 1975-90   
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D012848 2002
% 223.54/223.73  |- skos__scopeNote mesh__D012848
% 223.54/223.73       Disturbance of heart conduction in which the atrial response is delayed or omitted because of partial or complete interference with the propagation of impulses from the sinoatrial node to the atria.%A%    
% 223.54/223.73  |- mesh__recordAuthorizer mesh__D012848 sjn
% 223.54/223.73  |- skos__hiddenLabel mesh__D012848 Blocks, Sinoatrial
% 223.54/223.73  |- skos__prefLabel mesh__D012848 Sinoatrial Block
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017533 2001
% 223.54/223.73  |- skos__scopeNote mesh__D017533
% 223.54/223.73       A demographic parameter indicating a person%27%s status with respect to marriage, divorce, widowhood, singleness, etc.%A%    
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017533 1994
% 223.54/223.73  |- mesh__publicMeSHNote mesh__D017533 93; was see MARRIAGE 1990-92   
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017533 2005
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017533 2002
% 223.54/223.73  |- skos__historyNote mesh__D017533 Marriage %28%1966-1992%29%
% 223.54/223.73  |- skos__prefLabel mesh__D017533 Marital Status
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017533 1995
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017533 2003
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017533 2006
% 223.54/223.73  |- mesh__onlineNote mesh__D017533
% 223.54/223.73       use MARRIAGE to search MARITAL STATUS 1990-92   
% 223.54/223.73  |- rdf__type mesh__D017533sskos__Concept
% 223.54/223.73  |- skos__annotation mesh__D017533
% 223.54/223.73       a demographic %26% statist concept: differentiate from MARRIAGE, a sociol %26% anthropol concept; includes marital state, divorce, widowhood, singleness%A%  
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017533 1998
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017533 1993
% 223.54/223.73  |- mesh__dateEstablished mesh__D017533 1993-01-01
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017533 2004
% 223.54/223.73  |- mesh__historyNote mesh__D017533 93; was see MARRIAGE 1990-92   
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017533 1996
% 223.54/223.73  |- mesh__dateCreated mesh__D017533 1992-05-22
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017533 1999
% 223.54/223.73  |- skos__hiddenLabel mesh__D017533 Status, Marital
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017533 1997
% 223.54/223.73  |- skos__broader mesh__D017533smesh__D005191
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017533 2000
% 223.54/223.73  |- mesh__dateCreated mesh__D031204 2002-07-03
% 223.54/223.73  |- mesh__publicMeSHNote mesh__D031204 2003   
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D031204 2005
% 223.54/223.73  |- skos__prefLabel mesh__D031204 Caloric Restriction
% 223.54/223.73  |- skos__scopeNote mesh__D031204
% 223.54/223.73       Reduction in caloric intake without reduction in adequate nutrition. In experimental animals, caloric restriction has been shown to extend lifespan and enhance other physiological variables.%A%    
% 223.54/223.73  |- mesh__dateEstablished mesh__D031204 2003-01-01
% 223.54/223.73  |- skos__broader mesh__D031204smesh__D004035
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D031204 2006
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D031204 2004
% 223.54/223.73  |- mesh__dateRevised mesh__D031204 2003-07-09
% 223.54/223.73  |- rdf__type mesh__D031204sskos__Concept
% 223.54/223.73  |- skos__broader mesh__D031204smesh__D002149
% 223.54/223.73  |- mesh__historyNote mesh__D031204 2003   
% 223.54/223.73  |- skos__hiddenLabel mesh__D031204 Restriction, Caloric
% 223.54/223.73  |- mesh__historyNote mesh__D003513 68%28%66%29%   
% 223.54/223.73  |- mesh__dateRevised mesh__D003513 2001-07-25
% 223.54/223.73  |- mesh__dateEstablished mesh__D003513 1968-01-01
% 223.54/223.73  |- mesh__dateCreated mesh__D003513 1999-01-01
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D003513 2002
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D003513 2006
% 223.54/223.73  |- skos__prefLabel mesh__D003513 Cycloheximide
% 223.54/223.73  |- mesh__publicMeSHNote mesh__D003513 68   
% 223.54/223.73  |- skos__broader mesh__D003513smesh__D010881
% 223.54/223.73  |- rdf__type mesh__D003513sskos__Concept
% 223.54/223.73  |- mesh__recordMaintainer mesh__D003513 ssb
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D003513 2003
% 223.54/223.73  |- skos__scopeNote mesh__D003513
% 223.54/223.73       Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis.%A%    
% 223.54/223.73  |- mesh__recordOriginator mesh__D003513 NLM
% 223.54/223.73  |- skos__altLabel mesh__D003513 Cicloheximide
% 223.54/223.73  |- mesh__recordAuthorizer mesh__D003513 sjn
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D003513 2004
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D003513 2005
% 223.54/223.73  |- skos__hiddenLabel mesh__D027961 Antiporters, Potassium-Hydrogen
% 223.54/223.73  |- mesh__dateEstablished mesh__D027961 2002-01-01
% 223.54/223.73  |- skos__prefLabel mesh__D027961 Potassium-Hydrogen Antiporters
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D027961 2006
% 223.54/223.73  |- mesh__dateRevised mesh__D027961 2005-06-30
% 223.54/223.73  |- skos__historyNote mesh__D027961 Antiporters %28%1994-2001%29%
% 223.54/223.73  |- mesh__recordMaintainer mesh__D027961 jmp
% 223.54/223.73  |- skos__broader mesh__D027961smesh__D017920
% 223.54/223.73  |- mesh__publicMeSHNote mesh__D027961
% 223.54/223.73       2002; POTASSIUM-HYDROGEN ANTIPORTER %28%now POTASSIUM-HYDROGEN ANTIPORTERS%29% was indexed under ANTIPORTERS 1994-2001 %26% under CARRIER PROTEINS %28%1982-1993%29%%A%  
% 223.54/223.73  |- mesh__recordOriginator mesh__D027961 jmp
% 223.54/223.73  |- skos__altLabel mesh__D027961 Potassium-Hydrogen Exchanger
% 223.54/223.73  |- skos__scopeNote mesh__D027961
% 223.54/223.73       Membrane proteins that allow the exchange of hydrogen ions for potassium ions across the cellular membrane. The action of these antiporters influences intracellular pH and potassium ion homeostasis.%A%    
% 223.54/223.73  |- skos__altLabel mesh__D027961 Potassium-Hydrogen Antiporter
% 223.54/223.73  |- rdf__type mesh__D027961sskos__Concept
% 223.54/223.73  |- skos__hiddenLabel mesh__D027961 Potassium Hydrogen Antiporters
% 223.54/223.73  |- mesh__historyNote mesh__D027961
% 223.54/223.73       2002; use POTASSIUM-HYDROGEN ANTIPORTERS 1982-2001   
% 223.54/223.73  |- mesh__recordAuthorizer mesh__D027961 sjn
% 223.54/223.73  |- skos__historyNote mesh__D027961 Carrier Proteins %28%1982-1993%29%
% 223.54/223.73  |- skos__hiddenLabel mesh__D027961 Potassium Hydrogen Exchanger
% 223.54/223.73  |- skos__hiddenLabel mesh__D027961 Antiporter, Potassium-Hydrogen
% 223.54/223.73  |- skos__altLabel mesh__D027961 K%28%+%29%-H%28%+%29%-Exchanger
% 223.54/223.73  |- skos__hiddenLabel mesh__D027961 Potassium Hydrogen Antiporter
% 223.54/223.73  |- mesh__dateCreated mesh__D027961 2001-07-25
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013941 1990
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013941 1995
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013941 1992
% 223.54/223.73  |- mesh__recordOriginator mesh__D013941 NLM
% 223.54/223.73  |- skos__hiddenLabel mesh__D013941 5 Methyluracil
% 223.54/223.73  |- mesh__dateRevised mesh__D013941 1989-10-31
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013941 2004
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013941 1999
% 223.54/223.73  |- mesh__dateCreated mesh__D013941 1999-01-01
% 223.54/223.73  |- skos__broader mesh__D013941smesh__D014498
% 223.54/223.73  |- skos__prefLabel mesh__D013941 Thymine
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013941 1996
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013941 2002
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013941 1993
% 223.54/223.73  |- mesh__recordAuthorizer mesh__D013941 PLS
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013941 1991
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013941 1997
% 223.54/223.73  |- skos__annotation mesh__D013941
% 223.54/223.73       /biosyn /physiol permitted; thymine deoxyriboside, thymine deoxyribonucleoside = THYMIDINE%A%  
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013941 2005
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013941 2000
% 223.54/223.73  |- skos__altLabel mesh__D013941 5-Methyluracil
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013941 1989
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013941 1994
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013941 2006
% 223.54/223.73  |- rdf__type mesh__D013941sskos__Concept
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013941 2001
% 223.54/223.73  |- mesh__recordMaintainer mesh__D013941 PLS
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013941 2003
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013941 1998
% 223.54/223.73  |- skos__annotation mesh__D013143
% 223.54/223.73       a family in the order SPIROCHAETALES; in stagnant water %26% in bivalve mollusks%A%  
% 223.54/223.73  |- mesh__recordMaintainer mesh__D013143 SYSTEM
% 223.54/223.73  |- mesh__dateRevised mesh__D013143 2005-06-30
% 223.54/223.73  |- rdf__type mesh__D013143sskos__Concept
% 223.54/223.73  |- mesh__dateCreated mesh__D013143 1999-01-01
% 223.54/223.73  |- skos__broader mesh__D013143smesh__D013144
% 223.54/223.73  |- mesh__recordAuthorizer mesh__D013143 sjn
% 223.54/223.73  |- mesh__dateEstablished mesh__D013143 1975-01-01
% 223.54/223.73  |- skos__scopeNote mesh__D013143
% 223.54/223.73       A family of spiral bacteria of the order SPIROCHAETALES.%A%    
% 223.54/223.73  |- mesh__historyNote mesh__D013143 75   
% 223.54/223.73  |- skos__broader mesh__D013143smesh__D016965
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D013143 2006
% 223.54/223.73  |- mesh__publicMeSHNote mesh__D013143 75   
% 223.54/223.73  |- skos__historyNote mesh__D013143 Bacteria %28%1966-1974%29%
% 223.54/223.73  |- mesh__recordOriginator mesh__D013143 NLM
% 223.54/223.73  |- skos__prefLabel mesh__D013143 Spirochaetaceae
% 223.54/223.73  |- mesh__historyNote mesh__D007904
% 223.54/223.73       91%28%83%29%; was see under LENS, CRYSTALLINE 1983-90   
% 223.54/223.73  |- skos__hiddenLabel mesh__D007904 Cortex, Crystalline Lens
% 223.54/223.73  |- mesh__recordAuthorizer mesh__D007904 SJN
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D007904 2005
% 223.54/223.73  |- mesh__dateRevised mesh__D007904 1998-06-10
% 223.54/223.73  |- skos__broader mesh__D007904smesh__D007908
% 223.54/223.73  |- skos__hiddenLabel mesh__D007904 Crystalline Lens Cortex
% 223.54/223.73  |- skos__scopeNote mesh__D007904
% 223.54/223.73       The portion of the crystalline lens surrounding the nucleus and bound anteriorly by the epithelium and posteriorly by the capsule. It contains lens fibers and amorphous, intercellular substance.%A%    
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D007904 2006
% 223.54/223.73  |- skos__historyNote mesh__D007904 Lens, Crystalline %28%1966-1982%29%
% 223.54/223.73  |- mesh__dateEstablished mesh__D007904 1991-01-01
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D007904 2000
% 223.54/223.73  |- mesh__dateCreated mesh__D007904 1982-04-28
% 223.54/223.73  |- mesh__recordMaintainer mesh__D007904 MSR
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D007904 2001
% 223.54/223.73  |- rdf__type mesh__D007904sskos__Concept
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D007904 1999
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D007904 2003
% 223.54/223.73  |- mesh__recordOriginator mesh__D007904 RC
% 223.54/223.73  |- skos__prefLabel mesh__D007904 Lens Cortex, Crystalline
% 223.54/223.73  |- mesh__publicMeSHNote mesh__D007904
% 223.54/223.73       91; was see under LENS, CRYSTALLINE 1983-90   
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D007904 2002
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D007904 2004
% 223.54/223.73  |- mesh__recordOriginator mesh__D007106 NLM
% 223.54/223.73  |- mesh__recordMaintainer mesh__D007106 ssb
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D007106 2006
% 223.54/223.73  |- mesh__dateRevised mesh__D007106 2005-06-30
% 223.54/223.73  |- skos__prefLabel mesh__D007106 Immune Sera
% 223.54/223.73  |- skos__scopeNote mesh__D007106
% 223.54/223.73       Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen.%A%    
% 223.54/223.73  |- skos__related mesh__D007106smesh__D007116
% 223.54/223.73  |- skos__altLabel mesh__D007106 Antisera
% 223.54/223.73  |- mesh__publicMeSHNote mesh__D007106
% 223.54/223.73       80; was IMMUNE SERUMS 1963-79; IMMUNE SERUM GLOBULIN was heading 1965%A%  
% 223.54/223.73  |- mesh__dateCreated mesh__D007106 1999-01-01
% 223.54/223.73  |- rdf__type mesh__D007106sskos__Concept
% 223.54/223.73  |- skos__broader mesh__D007106smesh__D000906
% 223.54/223.73  |- skos__altLabel mesh__D007106 Immune Serums
% 223.54/223.73  |- skos__hiddenLabel mesh__D007106 Serums, Immune
% 223.54/223.73  |- mesh__onlineNote mesh__D007106
% 223.54/223.73       use IMMUNE SERA to search IMMUNE SERUMS 1966-79   
% 223.54/223.73  |- skos__hiddenLabel mesh__D007106 Sera, Immune
% 223.54/223.73  |- mesh__recordAuthorizer mesh__D007106 sjn
% 223.54/223.73  |- skos__broader mesh__D007106smesh__D001688
% 223.54/223.73  |- skos__broader mesh__D007106smesh__D044967
% 223.54/223.73  |- mesh__historyNote mesh__D007106
% 223.54/223.73       80; was IMMUNE SERUMS 1963-79; IMMUNE SERUM GLOBULIN was heading 1965%A%  
% 223.54/223.73  |- skos__altLabel mesh__D012849 Sinuatrial Node
% 223.54/223.73  |- mesh__recordAuthorizer mesh__D012849 sjn
% 223.54/223.73  |- skos__hiddenLabel mesh__D012849 Sinus Nodes
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D012849 2006
% 223.54/223.73  |- mesh__publicMeSHNote mesh__D012849 78; was SINO-ATRIAL NODE 1970-77   
% 223.54/223.73  |- skos__hiddenLabel mesh__D012849 Node, Sino-Atrial
% 223.54/223.73  |- skos__hiddenLabel mesh__D012849 Sino Atrial Node
% 223.54/223.73  |- mesh__onlineNote mesh__D012849
% 223.54/223.73       use SINOATRIAL NODE to search SINO-ATRIAL NODE 1966-77 %28%as Prov 1966-69%29%%A%  
% 223.54/223.73  |- skos__hiddenLabel mesh__D012849 Nodes, Sinuatrial
% 223.54/223.73  |- skos__altLabel mesh__D012849 Sino-Atrial Node
% 223.54/223.73  |- mesh__recordMaintainer mesh__D012849 ags
% 223.54/223.73  |- skos__hiddenLabel mesh__D012849 Nodes, Sino-Atrial
% 223.54/223.73  |- skos__prefLabel mesh__D012849 Sinoatrial Node
% 223.54/223.73  |- skos__hiddenLabel mesh__D012849 Node, Sinuatrial
% 223.54/223.73  |- skos__hiddenLabel mesh__D012849 Node, Sinoatrial
% 223.54/223.73  |- mesh__dateRevised mesh__D012849 2005-06-30
% 223.54/223.73  |- mesh__dateCreated mesh__D012849 1999-01-01
% 223.54/223.73  |- skos__hiddenLabel mesh__D012849 Nodes, Sinu-Atrial
% 223.54/223.73  |- rdf__type mesh__D012849sskos__Concept
% 223.54/223.73  |- skos__scopeNote mesh__D012849
% 223.54/223.73       The small mass of modified cardiac muscle fibers located at the junction of the superior vena cava %28%VENA CAVA, SUPERIOR%29% and right atrium. Contraction impulses probably start in this node, spread over the atrium %28%HEART ATRIUM%29% and are then transmitted by the atrioventricular bundle %28%BUNDLE OF HIS%29% to the ventricle %28%HEART VENTRICLE%29%.%A%    
% 223.54/223.73  |- skos__hiddenLabel mesh__D012849 Sinuatrial Nodes
% 223.54/223.73  |- skos__hiddenLabel mesh__D012849 Sino-Atrial Nodes
% 223.54/223.73  |- mesh__recordOriginator mesh__D012849 NLM
% 223.54/223.73  |- skos__hiddenLabel mesh__D012849 Node, Sinus
% 223.54/223.73  |- mesh__dateEstablished mesh__D012849 1970-01-01
% 223.54/223.73  |- skos__hiddenLabel mesh__D012849 Sinoatrial Nodes
% 223.54/223.73  |- mesh__historyNote mesh__D012849
% 223.54/223.73       78; was SINO-ATRIAL NODE 1964-77 %28%Prov 1964-69%29%   
% 223.54/223.73  |- skos__hiddenLabel mesh__D012849 Sinu Atrial Node
% 223.54/223.73  |- skos__hiddenLabel mesh__D012849 Nodes, Sinus
% 223.54/223.73  |- skos__hiddenLabel mesh__D012849 Sinu-Atrial Nodes
% 223.54/223.73  |- skos__hiddenLabel mesh__D012849 Node, Sinu-Atrial
% 223.54/223.73  |- skos__hiddenLabel mesh__D012849 Nodes, Sinoatrial
% 223.54/223.73  |- skos__altLabel mesh__D012849 Sinu-Atrial Node
% 223.54/223.73  |- skos__broader mesh__D012849smesh__D006329
% 223.54/223.73  |- skos__altLabel mesh__D012849 Sinus Node
% 223.54/223.73  |- mesh__dateRevised mesh__D017534 1998-06-11
% 223.54/223.73  |- mesh__recordMaintainer mesh__D017534 MSR
% 223.54/223.73  |- skos__annotation mesh__D017534
% 223.54/223.73       diseases: coord IM with PERIPHERAL VASCULAR DISEASES %28%IM%29%%A%  
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017534 2001
% 223.54/223.73  |- skos__hiddenLabel mesh__D017534 Radial Arteries
% 223.54/223.73  |- skos__scopeNote mesh__D017534
% 223.54/223.73       The direct continuation of the brachial trunk, originating at the bifurcation of the brachial artery opposite the neck of the radius. Its branches may be divided into three groups corresponding to the three regions in which the vessel is situated, the forearm, wrist, and hand.%A%    
% 223.54/223.73  |- mesh__dateCreated mesh__D017534 1992-05-22
% 223.54/223.73  |- skos__historyNote mesh__D017534 Forearm/blood supply %28%1966-1992%29%
% 223.54/223.73  |- skos__historyNote mesh__D017534 Arteries %28%1966-1992%29%
% 223.54/223.73  |- mesh__recordOriginator mesh__D017534 PLS
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017534 2000
% 223.54/223.73  |- mesh__historyNote mesh__D017534 93   
% 223.54/223.73  |- skos__historyNote mesh__D017534 Hand/blood supply %28%1966-1992%29%
% 223.54/223.73  |- mesh__recordAuthorizer mesh__D017534 SJN
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017534 2004
% 223.54/223.73  |- skos__hiddenLabel mesh__D017534 Arteries, Radial
% 223.54/223.73  |- mesh__publicMeSHNote mesh__D017534 93   
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017534 2006
% 223.54/223.73  |- rdf__type mesh__D017534sskos__Concept
% 223.54/223.73  |- skos__hiddenLabel mesh__D017534 Artery, Radial
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017534 2003
% 223.54/223.73  |- skos__broader mesh__D017534smesh__D001158
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017534 2005
% 223.54/223.73  |- skos__prefLabel mesh__D017534 Radial Artery
% 223.54/223.73  |- mesh__dateEstablished mesh__D017534 1993-01-01
% 223.54/223.73  |- skos__historyNote mesh__D017534 Arm/blood supply %28%1966-1992%29%
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017534 1999
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D017534 2002
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D031205 2005
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D031205 2003
% 223.54/223.73  |- mesh__historyNote mesh__D031205 2003   
% 223.54/223.73  |- skos__broader mesh__D031205smesh__D019659
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D031205 2006
% 223.54/223.73  |- skos__prefLabel mesh__D031205 Taraxacum
% 223.54/223.73  |- mesh__activeMeSHYear mesh__D031205 2004
% 223.54/223.73  |- skos__scopeNote mesh__D031205
% 223.54/223.73       A plant genus of the family ASTERACEAE. Members contain chicoric and chlorogenic acids and germacrane- and eudesmane-type SESQUITERPENES.%A%    
% 223.54/223.73  |- mesh__dateCreated mesh__D031205 2002-07-03
% 223.54/223.73  |- mesh__dateEstablished mesh__D031205 2003-01-01
% 223.54/223.73  |- rdf__type mesh__D031205sskos__Concept
% 223.54/223.73  |- skos__altLabel mesh__D031205 Dandelion
% 223.54/223.73  |- skos__annotation mesh__D031205
% 223.54/223.73       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.54/223.73  |- mesh__publicMeSHNote mesh__D031205 2003   
% 223.54/223.73  |- rdf__type mesh__D003514sskos__Concept
% 223.54/223.73  |- skos__historyNote mesh__D003514 Amines %28%1966-1970%29%
% 223.54/223.73  |- mesh__recordOriginator mesh__D003514 NLM
% 223.54/223.74  |- mesh__recordAuthorizer mesh__D003514 sjn
% 223.54/223.74  |- mesh__onlineNote mesh__D003514
% 223.54/223.74       use CYCLOHEXYLAMINES to search CYCLOHEXYLAMINE 1971-74 %28%as Prov 1971-72%29%%A%  
% 223.54/223.74  |- skos__scopeNote mesh__D003514
% 223.54/223.74       A family of alicyclic hydrocarbons containing an amine group with the general formula R-C6H10NH2.%A%    
% 223.54/223.74  |- skos__historyNote mesh__D003514 Cyclohexanes %28%1966-1970%29%
% 223.54/223.74  |- mesh__dateRevised mesh__D003514 2004-07-07
% 223.54/223.74  |- mesh__publicMeSHNote mesh__D003514 75; was CYCLOHEXYLAMINE 1973-74   
% 223.54/223.74  |- mesh__historyNote mesh__D003514
% 223.54/223.74       75; was CYCLOHEXYLAMINE 1971-74 %28%Prov 1971-72%29%   
% 223.54/223.74  |- mesh__dateEstablished mesh__D003514 1973-01-01
% 223.54/223.74  |- skos__prefLabel mesh__D003514 Cyclohexylamines
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D003514 2005
% 223.54/223.74  |- skos__broader mesh__D003514smesh__D000588
% 223.54/223.74  |- skos__broader mesh__D003514smesh__D003510
% 223.54/223.74  |- mesh__dateCreated mesh__D003514 1999-01-01
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D003514 2006
% 223.54/223.74  |- mesh__recordMaintainer mesh__D003514 ssb
% 223.54/223.74  |- mesh__dateCreated mesh__D013942 1999-01-01
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013942 2001
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013942 1996
% 223.54/223.74  |- mesh__dateRevised mesh__D013942 1995-05-18
% 223.54/223.74  |- skos__altLabel mesh__D013942 Thymidine Phosphates
% 223.54/223.74  |- skos__historyNote mesh__D013942 Nucleotides %28%1966-1970%29%
% 223.54/223.74  |- skos__broader mesh__D013942smesh__D003854
% 223.54/223.74  |- skos__scopeNote mesh__D013942
% 223.54/223.74       Phosphate esters of THYMIDINE in N-glycosidic linkage with ribose or deoxyribose, as occurs in nucleic acids. %28%From Dorland, 28th ed, p1154%29%%A%    
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013942 1997
% 223.54/223.74  |- mesh__recordMaintainer mesh__D013942 KEV
% 223.54/223.74  |- mesh__recordOriginator mesh__D013942 NLM
% 223.54/223.74  |- skos__prefLabel mesh__D013942 Thymine Nucleotides
% 223.54/223.74  |- mesh__onlineNote mesh__D013942
% 223.54/223.74       to search THYMIDINE PHOSPHATES use NUCLEOTIDES 1966-71   
% 223.54/223.74  |- mesh__historyNote mesh__D013942
% 223.54/223.74       72%28%71%29%; THYMIDINE PHOSPHATES was see under NUCLEOTIDES 1963-71%A%  
% 223.54/223.74  |- skos__hiddenLabel mesh__D013942 Phosphates, Thymidine
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013942 2005
% 223.54/223.74  |- mesh__publicMeSHNote mesh__D013942
% 223.54/223.74       72; THYMIDINE PHOSPHATES was see under NUCLEOTIDES 1963-71%A%  
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013942 2002
% 223.54/223.74  |- mesh__recordAuthorizer mesh__D013942 PLS
% 223.54/223.74  |- skos__annotation mesh__D013942 /biosyn /physiol permitted   
% 223.54/223.74  |- rdf__type mesh__D013942sskos__Concept
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013942 2006
% 223.54/223.74  |- skos__hiddenLabel mesh__D013942 Nucleotides, Thymine
% 223.54/223.74  |- skos__broader mesh__D013942smesh__D011742
% 223.54/223.74  |- mesh__dateEstablished mesh__D013942 1972-01-01
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013942 2003
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013942 1998
% 223.54/223.74  |- skos__historyNote mesh__D013942 Thymine %28%1966-1970%29%
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013942 2000
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013942 2004
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013942 1999
% 223.54/223.74  |- mesh__dateCreated mesh__D013144 1999-01-01
% 223.54/223.74  |- mesh__recordOriginator mesh__D013144 NLM
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013144 2006
% 223.54/223.74  |- skos__prefLabel mesh__D013144 Spirochaetales
% 223.54/223.74  |- skos__scopeNote mesh__D013144
% 223.54/223.74       An order of slender, flexuous, helically coiled bacteria, with one or more complete turns in the helix.%A%    
% 223.54/223.74  |- skos__annotation mesh__D013144
% 223.54/223.74       pathogenic %26% non-pathogenic; infection = SPIROCHAETALES INFECTIONS%A%  
% 223.54/223.74  |- skos__altLabel mesh__D013144 Spirochete
% 223.54/223.74  |- mesh__publicMeSHNote mesh__D013144
% 223.54/223.74       76; was see under SCHIZOMYCETES 1975, was see under BACTERIA 1966-74%A%  
% 223.54/223.74  |- skos__broader mesh__D013144smesh__D001419
% 223.54/223.74  |- skos__altLabel mesh__D013144 Spirochetes
% 223.54/223.74  |- mesh__dateEstablished mesh__D013144 1976-01-01
% 223.54/223.74  |- mesh__historyNote mesh__D013144
% 223.54/223.74       76%28%66%29%; was see under SCHIZOMYCETES 1975, was see under BACTERIA 1966-74%A%  
% 223.54/223.74  |- mesh__dateRevised mesh__D013144 2005-06-30
% 223.54/223.74  |- mesh__recordAuthorizer mesh__D013144 sjn
% 223.54/223.74  |- mesh__recordMaintainer mesh__D013144 SYSTEM
% 223.54/223.74  |- rdf__type mesh__D013144sskos__Concept
% 223.54/223.74  |- mesh__historyNote mesh__D007905 78   
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007905 1997
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007905 2002
% 223.54/223.74  |- skos__historyNote mesh__D007905 Eye Diseases %28%1966-1977%29%
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007905 2006
% 223.54/223.74  |- skos__hiddenLabel mesh__D007905 Lens Disease
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007905 1992
% 223.54/223.74  |- skos__broader mesh__D007905smesh__D005128
% 223.54/223.74  |- skos__annotation mesh__D007905
% 223.54/223.74       GEN or unspecified only: prefer specifics   
% 223.54/223.74  |- mesh__dateRevised mesh__D007905 1990-05-29
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007905 1998
% 223.54/223.74  |- skos__prefLabel mesh__D007905 Lens Diseases
% 223.54/223.74  |- mesh__dateEstablished mesh__D007905 1978-01-01
% 223.54/223.74  |- mesh__publicMeSHNote mesh__D007905 78   
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007905 1993
% 223.54/223.74  |- rdf__type mesh__D007905sskos__Concept
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007905 1999
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007905 2003
% 223.54/223.74  |- skos__historyNote mesh__D007905 Lens, Crystalline %28%1966-1977%29%
% 223.54/223.74  |- mesh__recordMaintainer mesh__D007905 PLS
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007905 1994
% 223.54/223.74  |- mesh__recordOriginator mesh__D007905 RC
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007905 2000
% 223.54/223.74  |- skos__hiddenLabel mesh__D007905 Diseases, Lens
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007905 2004
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007905 1991
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007905 1995
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007905 1996
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007905 2001
% 223.54/223.74  |- mesh__dateCreated mesh__D007905 1977-04-11
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007905 2005
% 223.54/223.74  |- mesh__recordAuthorizer mesh__D007905 NLM
% 223.54/223.74  |- skos__hiddenLabel mesh__D007905 Disease, Lens
% 223.54/223.74  |- skos__scopeNote mesh__D007107
% 223.54/223.74       The body%27%s defense mechanism against foreign organisms or substances and deviant native cells. It includes the humoral immune response and the cell-mediated response and consists of a complex of interrelated cellular, molecular, and genetic components.%A%    
% 223.54/223.74  |- skos__historyNote mesh__D007107 Lymphocytes %28%1966-1984%29%
% 223.54/223.74  |- mesh__dateEstablished mesh__D007107 1985-01-01
% 223.54/223.74  |- mesh__dateRevised mesh__D007107 1999-11-03
% 223.54/223.74  |- mesh__onlineNote mesh__D007107
% 223.54/223.74       pre-explosion = IMMUNE SYSTEM %28%PX%29%   
% 223.54/223.74  |- mesh__recordMaintainer mesh__D007107 KEV
% 223.54/223.74  |- skos__historyNote mesh__D007107 T Lymphocytes %28%1973-1984%29%
% 223.54/223.74  |- mesh__recordAuthorizer mesh__D007107 sjn
% 223.54/223.74  |- skos__historyNote mesh__D007107 B Lymphocytes %28%1973-1984%29%
% 223.54/223.74  |- skos__hiddenLabel mesh__D007107 Immune Systems
% 223.54/223.74  |- skos__hiddenLabel mesh__D007107 System, Immune
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007107 2006
% 223.54/223.74  |- mesh__historyNote mesh__D007107 85   
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007107 2001
% 223.54/223.74  |- mesh__recordOriginator mesh__D007107 AEP
% 223.54/223.74  |- mesh__publicMeSHNote mesh__D007107 85   
% 223.54/223.74  |- skos__historyNote mesh__D007107 Immunity %28%1966-1984%29%
% 223.54/223.74  |- skos__broader mesh__D007107smesh__D006424
% 223.54/223.74  |- skos__annotation mesh__D007107
% 223.54/223.74       GEN: prefer specifics; /physiol: consider also IMMUNITY %26% its indentions%A%  
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007107 2004
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007107 2005
% 223.54/223.74  |- skos__historyNote mesh__D007107 Antibody Formation %28%1966-1984%29%
% 223.54/223.74  |- skos__prefLabel mesh__D007107 Immune System
% 223.54/223.74  |- skos__historyNote mesh__D007107
% 223.54/223.74       Lymphocyte Transformation %28%1969-1984%29%
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007107 2000
% 223.54/223.74  |- skos__historyNote mesh__D007107 Immunity, Cellular %28%1970-1984%29%
% 223.54/223.74  |- rdf__type mesh__D007107sskos__Concept
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007107 2003
% 223.54/223.74  |- skos__hiddenLabel mesh__D007107 Systems, Immune
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007107 2002
% 223.54/223.74  |- mesh__dateCreated mesh__D007107 1984-05-30
% 223.54/223.74  |- mesh__publicMeSHNote mesh__D051263
% 223.54/223.74       2006; D-ALANINE TRANSAMINASE was indexed under ALANINE TRANSAMINASE 1974-2005, %26% under TRANSAMINASES 1977-2005%A%  
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D051263 2006
% 223.54/223.74  |- skos__hiddenLabel mesh__D051263 D Glutamate D Alanine Transaminase
% 223.54/223.74  |- skos__altLabel mesh__D051263 D-Glutamate-D-Alanine Transaminase
% 223.54/223.74  |- skos__hiddenLabel mesh__D051263 D Alanine Transaminase
% 223.54/223.74  |- skos__broader mesh__D051263smesh__D000637
% 223.54/223.74  |- skos__prefLabel mesh__D051263 D-Alanine Transaminase
% 223.54/223.74  |- mesh__dateRevised mesh__D051263 2005-07-13
% 223.54/223.74  |- mesh__recordOriginator mesh__D051263 AKE
% 223.54/223.74  |- skos__hiddenLabel mesh__D051263 D Alanine Aminotransferase
% 223.54/223.74  |- mesh__historyNote mesh__D051263
% 223.54/223.74       2006%28%1980%29%; use ALANINE TRANSAMINASE 1974-1979, %26% TRANSAMINASES 1977-1979%A%  
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D051263 2006A
% 223.54/223.74  |- mesh__recordAuthorizer mesh__D051263 ags
% 223.54/223.74  |- skos__scopeNote mesh__D051263
% 223.54/223.74       A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the reversible transfer of an amino group between D-Alanine and ALPHA-KETOGLUTARATE to form PYRUVATE and D-GLUTAMATE, respectively. It plays a role in the synthesis of the bacterial CELL WALL. This enzyme was formerly classified as EC 2.6.1.10.%A%    
% 223.54/223.74  |- skos__hiddenLabel mesh__D051263 Transaminase, D-Alanine
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D051263 2006B
% 223.54/223.74  |- skos__hiddenLabel mesh__D051263 Aminotransferase, D-Alanine
% 223.54/223.74  |- mesh__dateEstablished mesh__D051263 2006-01-01
% 223.54/223.74  |- rdf__type mesh__D051263sskos__Concept
% 223.54/223.74  |- mesh__recordMaintainer mesh__D051263 ags
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D051263 2006C
% 223.54/223.74  |- skos__altLabel mesh__D051263 D-Alanine Aminotransferase
% 223.54/223.74  |- skos__hiddenLabel mesh__D051263 Transaminase, D-Glutamate-D-Alanine
% 223.54/223.74  |- mesh__dateCreated mesh__D051263 2005-06-30
% 223.54/223.74  |- mesh__dateEstablished mesh__D017535 1993-01-01
% 223.54/223.74  |- skos__historyNote mesh__D017535 Forearm/blood supply %28%1966-1992%29%
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D017535 2002
% 223.54/223.74  |- mesh__recordOriginator mesh__D017535 PLS
% 223.54/223.74  |- skos__hiddenLabel mesh__D017535 Ulnar Arteries
% 223.54/223.74  |- mesh__historyNote mesh__D017535 93   
% 223.54/223.74  |- skos__scopeNote mesh__D017535
% 223.54/223.74       The larger of the two terminal branches of the brachial artery, beginning about one centimeter distal to the bend of the elbow. Like the RADIAL ARTERY, its branches may be divided into three groups corresponding to their locations in the forearm, wrist, and hand.%A%    
% 223.54/223.74  |- skos__historyNote mesh__D017535 Hand/blood supply %28%1966-1992%29%
% 223.54/223.74  |- skos__hiddenLabel mesh__D017535 Artery, Ulnar
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D017535 2004
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D017535 2001
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D017535 2006
% 223.54/223.74  |- mesh__dateCreated mesh__D017535 1992-05-22
% 223.54/223.74  |- rdf__type mesh__D017535sskos__Concept
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D017535 2003
% 223.54/223.74  |- skos__historyNote mesh__D017535 Arteries %28%1966-1992%29%
% 223.54/223.74  |- skos__broader mesh__D017535smesh__D001158
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D017535 2000
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D017535 2005
% 223.54/223.74  |- mesh__recordAuthorizer mesh__D017535 SJN
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D017535 1999
% 223.54/223.74  |- mesh__publicMeSHNote mesh__D017535 93   
% 223.54/223.74  |- mesh__dateRevised mesh__D017535 1998-06-11
% 223.54/223.74  |- mesh__recordMaintainer mesh__D017535 MSR
% 223.54/223.74  |- skos__annotation mesh__D017535
% 223.54/223.74       diseases: coord IM with PERIPHERAL VASCULAR DISEASES %28%IM%29%%A%  
% 223.54/223.74  |- skos__hiddenLabel mesh__D017535 Arteries, Ulnar
% 223.54/223.74  |- skos__prefLabel mesh__D017535 Ulnar Artery
% 223.54/223.74  |- mesh__historyNote mesh__D031206 2003   
% 223.54/223.74  |- skos__broader mesh__D031206smesh__D019659
% 223.54/223.74  |- mesh__publicMeSHNote mesh__D031206 2003   
% 223.54/223.74  |- skos__scopeNote mesh__D031206
% 223.54/223.74       A plant genus of the family ASTERACEAE. Many of the member species have been reclassified to other genera such as Machaeranthera, Isocoma, Ericameria, etc. Ingestion of the plant has been associated with MILK SICKNESS.%A%    
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D031206 2004
% 223.54/223.74  |- skos__annotation mesh__D031206
% 223.54/223.74       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.54/223.74  |- mesh__dateCreated mesh__D031206 2002-07-03
% 223.54/223.74  |- skos__prefLabel mesh__D031206 Haplopappus
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D031206 2006
% 223.54/223.74  |- skos__altLabel mesh__D031206 Tansyaster
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D031206 2005
% 223.54/223.74  |- rdf__type mesh__D031206sskos__Concept
% 223.54/223.74  |- mesh__recordAuthorizer mesh__D031206 sjn
% 223.54/223.74  |- mesh__recordMaintainer mesh__D031206 ssb
% 223.54/223.74  |- mesh__dateEstablished mesh__D031206 2003-01-01
% 223.54/223.74  |- mesh__dateRevised mesh__D031206 2003-07-09
% 223.54/223.74  |- mesh__recordOriginator mesh__D031206 ssb
% 223.54/223.74  |- skos__broader mesh__D003515smesh__D003517
% 223.54/223.74  |- mesh__recordMaintainer mesh__D003515 ssb
% 223.54/223.74  |- skos__hiddenLabel mesh__D003515 1026, NSC
% 223.54/223.74  |- skos__altLabel mesh__D003515 1-Aminocyclopentanecarboxylic Acid
% 223.54/223.74  |- skos__historyNote mesh__D003515 Amino Acids %28%1971-1974%29%
% 223.54/223.74  |- skos__broader mesh__D003515smesh__D000598
% 223.54/223.74  |- skos__scopeNote mesh__D003515
% 223.54/223.74       An amino acid formed by cyclization of leucine. It has cytostatic, immunosuppressive and antineoplastic activities.%A%    
% 223.54/223.74  |- mesh__recordOriginator mesh__D003515 NLM
% 223.54/223.74  |- skos__altLabel mesh__D003515 Aminocyclopentanecarboxylic Acid
% 223.54/223.74  |- mesh__recordAuthorizer mesh__D003515 sjn
% 223.54/223.74  |- mesh__historyNote mesh__D003515
% 223.54/223.74       91%28%75%29%; was see under AMINO ACIDS 1975-90   
% 223.54/223.74  |- mesh__publicMeSHNote mesh__D003515
% 223.54/223.74       91; was see under AMINO ACIDS 1975-90   
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D003515 2005
% 223.54/223.74  |- skos__historyNote mesh__D003515 Cyclopentanes %28%1970-1974%29%
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D003515 2006
% 223.54/223.74  |- mesh__dateEstablished mesh__D003515 1991-01-01
% 223.54/223.74  |- skos__hiddenLabel mesh__D003515 1 Aminocyclopentanecarboxylic Acid
% 223.54/223.74  |- skos__hiddenLabel mesh__D003515 Acid, 1-Aminocyclopentanecarboxylic
% 223.54/223.74  |- rdf__type mesh__D003515sskos__Concept
% 223.54/223.74  |- skos__prefLabel mesh__D003515 Cycloleucine
% 223.54/223.74  |- skos__hiddenLabel mesh__D003515 Acid, Aminocyclopentanecarboxylic
% 223.54/223.74  |- mesh__dateCreated mesh__D003515 1974-11-27
% 223.54/223.74  |- mesh__dateRevised mesh__D003515 2004-07-07
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D008200 2001
% 223.54/223.74  |- mesh__dateRevised mesh__D008200 1999-11-03
% 223.54/223.74  |- rdf__type mesh__D008200sskos__Concept
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D008200 2000
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D008200 2005
% 223.54/223.74  |- skos__prefLabel mesh__D008200 Lymphangiectasis
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D008200 2004
% 223.54/223.74  |- mesh__recordOriginator mesh__D008200 NLM
% 223.54/223.74  |- mesh__recordAuthorizer mesh__D008200 sjn
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D008200 2003
% 223.54/223.74  |- skos__hiddenLabel mesh__D008200 Lymphangiectases
% 223.54/223.74  |- mesh__recordMaintainer mesh__D008200 KEV
% 223.54/223.74  |- skos__broader mesh__D008200smesh__D008206
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D008200 2002
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D008200 2006
% 223.54/223.74  |- skos__scopeNote mesh__D008200
% 223.54/223.74       A transient dilatation of the lymphatic vessels.     
% 223.54/223.74  |- mesh__dateCreated mesh__D008200 1999-01-01
% 223.54/223.74  |- mesh__historyNote mesh__D027963
% 223.54/223.74       2002; use CHLORIDE-BICARBONATE ANTIPORTERS %28%NM%29% 1984-2001%A%  
% 223.54/223.74  |- mesh__recordOriginator mesh__D027963 jmp
% 223.54/223.74  |- skos__altLabel mesh__D027963 Chloride-Bicarbonate Exchangers
% 223.54/223.74  |- skos__hiddenLabel mesh__D027963 Exchangers, Chloride-Bicarbonate
% 223.54/223.74  |- skos__historyNote mesh__D027963 Carrier Proteins %28%1984-1993%29%
% 223.54/223.74  |- skos__hiddenLabel mesh__D027963 Chloride Bicarbonate Exchangers
% 223.54/223.74  |- skos__hiddenLabel mesh__D027963 Antiport, Bicarbonate-Chloride
% 223.54/223.74  |- skos__altLabel mesh__D027963 Bicarbonate-Chloride Antiport
% 223.54/223.74  |- mesh__recordAuthorizer mesh__D027963 sjn
% 223.54/223.74  |- skos__altLabel mesh__D027963 Cl%28%-%29%-HCO3%28%-%29%-Exchanger
% 223.54/223.74  |- skos__hiddenLabel mesh__D027963 Exchanger, Chloride-Bicarbonate
% 223.54/223.74  |- skos__prefLabel mesh__D027963 Chloride-Bicarbonate Antiporters
% 223.54/223.74  |- mesh__publicMeSHNote mesh__D027963
% 223.54/223.74       2002; CHLORIDE-BICARBONATE EXCHANGER %28%now CHLORIDE-BICARBONATE ANTIPORTERS%29% was indexed under ANTIPORTERS 1994-2001 %26% under CARRIER PROTEINS 1984-1993%A%  
% 223.54/223.74  |- skos__hiddenLabel mesh__D027963 Bicarbonate Chloride Antiport
% 223.54/223.74  |- skos__scopeNote mesh__D027963
% 223.54/223.74       Membrane proteins that allow the exchange of chloride ions for bicarbonate ions across the cellular membrane. The action of specific antiporters in this class serve important functions such as allowing the efficient exchange of bicarbonate across red blood cell membranes as they passage through capillaries and the reabsorption of bicarbonate ions by the kidney.%A%    
% 223.54/223.74  |- skos__hiddenLabel mesh__D027963 Antiporters, Chloride-Bicarbonate
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D027963 2006
% 223.54/223.74  |- mesh__dateCreated mesh__D027963 2001-07-25
% 223.54/223.74  |- skos__altLabel mesh__D027963 Cl- HCO3- Exchanger
% 223.54/223.74  |- mesh__dateEstablished mesh__D027963 2002-01-01
% 223.54/223.74  |- skos__historyNote mesh__D027963 Antiporters %28%1994-2001%29%
% 223.54/223.74  |- skos__hiddenLabel mesh__D027963 Chloride Bicarbonate Exchanger
% 223.54/223.74  |- skos__altLabel mesh__D027963 Chloride-Bicarbonate Exchanger
% 223.54/223.74  |- mesh__dateRevised mesh__D027963 2005-06-30
% 223.54/223.74  |- skos__broader mesh__D027963smesh__D017920
% 223.54/223.74  |- skos__hiddenLabel mesh__D027963 Chloride Bicarbonate Antiporters
% 223.54/223.74  |- rdf__type mesh__D027963sskos__Concept
% 223.54/223.74  |- mesh__recordMaintainer mesh__D027963 jmp
% 223.54/223.74  |- skos__scopeNote mesh__D013943
% 223.54/223.74       A phenol obtained from thyme oil or other volatile oils. It is used as a stabilizer in pharmaceutic preparations. It has been used for its antiseptic, antibacterial, and antifungal actions, and was formerly used as a vermifuge. %28%Dorland, 28th ed%29%%A%    
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013943 2005
% 223.54/223.74  |- skos__annotation mesh__D013943 an antiseptic %26% deodorizer   
% 223.54/223.74  |- mesh__recordMaintainer mesh__D013943 ssb
% 223.54/223.74  |- skos__broader mesh__D013943smesh__D039821
% 223.54/223.74  |- mesh__dateCreated mesh__D013943 1999-01-01
% 223.54/223.74  |- mesh__dateRevised mesh__D013943 2003-07-09
% 223.54/223.74  |- mesh__recordOriginator mesh__D013943 NLM
% 223.54/223.74  |- mesh__recordAuthorizer mesh__D013943 sjn
% 223.54/223.74  |- skos__prefLabel mesh__D013943 Thymol
% 223.54/223.74  |- rdf__type mesh__D013943sskos__Concept
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013943 2006
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013943 2004
% 223.54/223.74  |- mesh__publicMeSHNote mesh__D013145
% 223.54/223.74       79; was SPIROCHETE INFECTIONS 1972-78   
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013145 2006
% 223.54/223.74  |- skos__hiddenLabel mesh__D013145 Infection, Spirochete
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013145 1997
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013145 2003
% 223.54/223.74  |- mesh__recordMaintainer mesh__D013145 TAP
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013145 2001
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013145 1999
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013145 2005
% 223.54/223.74  |- skos__altLabel mesh__D013145 Spirochete Infections
% 223.54/223.74  |- skos__altLabel mesh__D013145 Infections, Spirochete
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013145 1996
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013145 1995
% 223.54/223.74  |- mesh__historyNote mesh__D013145 79; was SPIROCHETE INFECTIONS 1972-78   
% 223.54/223.74  |- skos__broader mesh__D013145smesh__D001424
% 223.54/223.74  |- mesh__onlineNote mesh__D013145
% 223.54/223.74       use SPIROCHAETALES INFECTIONS to search SPIROCHETE INFECTIONS 1972-78%A%  
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013145 2000
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013145 1998
% 223.54/223.74  |- skos__hiddenLabel mesh__D013145 Spirochaetales Infection
% 223.54/223.74  |- mesh__recordOriginator mesh__D013145 NLM
% 223.54/223.74  |- skos__hiddenLabel mesh__D013145 Infection, Spirochaetales
% 223.54/223.74  |- skos__altLabel mesh__D013145 Infections, Spirochaetales
% 223.54/223.74  |- skos__hiddenLabel mesh__D013145 Spirochete Infection
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013145 1994
% 223.54/223.74  |- skos__historyNote mesh__D013145 Spirochaeta %28%1966-1971%29%
% 223.54/223.74  |- rdf__type mesh__D013145sskos__Concept
% 223.54/223.74  |- mesh__dateCreated mesh__D013145 1999-01-01
% 223.54/223.74  |- skos__prefLabel mesh__D013145 Spirochaetales Infections
% 223.54/223.74  |- skos__scopeNote mesh__D013145
% 223.54/223.74       Infections with bacteria of the order SPIROCHAETALES.     
% 223.54/223.74  |- mesh__recordAuthorizer mesh__D013145 PLS
% 223.54/223.74  |- mesh__dateRevised mesh__D013145 1993-06-03
% 223.54/223.74  |- mesh__dateEstablished mesh__D013145 1972-01-01
% 223.54/223.74  |- skos__annotation mesh__D013145
% 223.54/223.74       infect by %22%spirochetes%22%; GEN or unspecified only: prefer specific spirochete infection%A%  
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013145 2004
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D013145 2002
% 223.54/223.74  |- skos__hiddenLabel mesh__D007906 Dislocations, Lens
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007906 1999
% 223.54/223.74  |- mesh__recordMaintainer mesh__D007906 TGC
% 223.54/223.74  |- rdf__type mesh__D007906sskos__Concept
% 223.54/223.74  |- skos__hiddenLabel mesh__D007906 Lens Dislocations
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007906 2003
% 223.54/223.74  |- mesh__dateRevised mesh__D007906 1992-03-25
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007906 1994
% 223.54/223.74  |- mesh__recordOriginator mesh__D007906 RC
% 223.54/223.74  |- mesh__historyNote mesh__D007906
% 223.54/223.74       90; was LENS DISLOCATION AND SUBLUXATION 1978-89   
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007906 2001
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007906 2004
% 223.54/223.74  |- skos__prefLabel mesh__D007906 Lens Subluxation
% 223.54/223.74  |- skos__hiddenLabel mesh__D007906 Lens Subluxations
% 223.54/223.74  |- skos__broader mesh__D007906smesh__D007905
% 223.54/223.74  |- skos__historyNote mesh__D007906 Lens, Crystalline %28%1966-1977%29%
% 223.54/223.74  |- skos__scopeNote mesh__D007906
% 223.54/223.74       Incomplete rupture of the zonule with the displaced lens remaining behind the pupil. In dislocation, or complete rupture, the lens is displaced forward into the anterior chamber or backward into the vitreous body. When congenital, this condition is known as ECTOPIA LENTIS.%A%    
% 223.54/223.74  |- skos__annotation mesh__D007906
% 223.54/223.74       spontaneous or traumatic; luxation = total disloc, subluxation = partial disloc%A%  
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007906 1995
% 223.54/223.74  |- skos__historyNote mesh__D007906 Eye Injuries %28%1966-1977%29%
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007906 2002
% 223.54/223.74  |- skos__hiddenLabel mesh__D007906 Subluxation, Lens
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007906 1996
% 223.54/223.74  |- mesh__dateCreated mesh__D007906 1977-04-11
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007906 2005
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007906 1997
% 223.54/223.74  |- skos__hiddenLabel mesh__D007906 Subluxations, Lens
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007906 2006
% 223.54/223.74  |- mesh__publicMeSHNote mesh__D007906
% 223.54/223.74       90; was LENS DISLOCATION AND SUBLUXATION 1978-89   
% 223.54/223.74  |- skos__historyNote mesh__D007906 Eye Diseases %28%1966-1977%29%
% 223.54/223.74  |- skos__hiddenLabel mesh__D007906 Dislocation, Lens
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007906 1998
% 223.54/223.74  |- mesh__dateEstablished mesh__D007906 1978-01-01
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007906 1993
% 223.54/223.74  |- mesh__onlineNote mesh__D007906
% 223.54/223.74       use LENS SUBLUXATION to search LENS DISLOCATION AND SUBLUXATION 1978-89%A%  
% 223.54/223.74  |- mesh__recordAuthorizer mesh__D007906 PLS
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007906 2000
% 223.54/223.74  |- skos__related mesh__D007108smesh__D016867
% 223.54/223.74  |- mesh__publicMeSHNote mesh__D007108 66   
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007108 2006
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007108 2002
% 223.54/223.74  |- mesh__dateRevised mesh__D007108 1998-06-10
% 223.54/223.74  |- skos__prefLabel mesh__D007108 Immune Tolerance
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007108 2004
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007108 2005
% 223.54/223.74  |- skos__related mesh__D007108smesh__D006086
% 223.54/223.74  |- skos__scopeNote mesh__D007108
% 223.54/223.74       The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual %28%fetus or neonate%29% or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc.%A%    
% 223.54/223.74  |- rdf__type mesh__D007108sskos__Concept
% 223.54/223.74  |- skos__related mesh__D007108smesh__D007165
% 223.54/223.74  |- mesh__dateEstablished mesh__D007108 1966-01-01
% 223.54/223.74  |- mesh__recordAuthorizer mesh__D007108 SJN
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007108 2003
% 223.54/223.74  |- mesh__historyNote mesh__D007108 66%28%64%29%   
% 223.54/223.74  |- mesh__recordMaintainer mesh__D007108 AGS
% 223.54/223.74  |- mesh__recordOriginator mesh__D007108 NLM
% 223.54/223.74  |- mesh__dateCreated mesh__D007108 1999-01-01
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007108 2001
% 223.54/223.74  |- skos__broader mesh__D007108smesh__D007109
% 223.54/223.74  |- skos__annotation mesh__D007108
% 223.54/223.74       do not confuse X ref IMMUNOSUPPRESSION %28%PHYSIOLOGY%29% with the Cat E immunol technique IMMUNOSUPPRESSION: Manual 28.21.1%A%  
% 223.54/223.74  |- skos__hiddenLabel mesh__D007108 Immunosuppressions %28%Physiology%29%
% 223.54/223.74  |- skos__hiddenLabel mesh__D007108 Tolerance, Immune
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007108 1999
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D007108 2000
% 223.54/223.74  |- mesh__dateCreated mesh__D051264 2005-06-30
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D051264 2006
% 223.54/223.74  |- skos__hiddenLabel mesh__D051264 Respiratory Factors, Nuclear
% 223.54/223.74  |- mesh__publicMeSHNote mesh__D051264
% 223.54/223.74       2006; NUCLEAR RESPIRATORY FACTORS was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1994-2005, %26% under TRANSCRIPTION FACTORS 1993%A%  
% 223.54/223.74  |- mesh__historyNote mesh__D051264 2006%28%1993%29%   
% 223.54/223.74  |- skos__altLabel mesh__D051264 Nuclear Respiratory Factor
% 223.54/223.74  |- skos__broader mesh__D051264smesh__D004268
% 223.54/223.74  |- rdf__type mesh__D051264sskos__Concept
% 223.54/223.74  |- skos__hiddenLabel mesh__D051264 Respiratory Factor, Nuclear
% 223.54/223.74  |- skos__prefLabel mesh__D051264 Nuclear Respiratory Factors
% 223.54/223.74  |- mesh__recordAuthorizer mesh__D051264 sjn
% 223.54/223.74  |- mesh__dateEstablished mesh__D051264 2006-01-01
% 223.54/223.74  |- mesh__recordMaintainer mesh__D051264 DRC
% 223.54/223.74  |- skos__scopeNote mesh__D051264
% 223.54/223.74       A family of transcription factors that control expression of a variety of nuclear GENES encoding proteins that function in the RESPIRATORY CHAIN of the MITOCHONDRIA.%A%    
% 223.54/223.74  |- skos__broader mesh__D051264smesh__D014157
% 223.54/223.74  |- mesh__recordOriginator mesh__D051264 DRC
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D017536 2006
% 223.54/223.74  |- rdf__type mesh__D017536sskos__Concept
% 223.54/223.74  |- skos__historyNote mesh__D017536 Carotid Arteries %28%1966-1992%29%
% 223.54/223.74  |- mesh__activeMeSHYear mesh__D017536 2003
% 223.54/223.74  |- skos__hiddenLabel mesh__D017536 Common Carotid Artery
% 223.54/223.74  |- mesh__publicMeSHNote mesh__D017536 93   
% 223.54/223.75  |- skos__hiddenLabel mesh__D017536 Common Carotid Arteries
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D017536 2005
% 223.54/223.75  |- mesh__dateCreated mesh__D017536 1992-05-20
% 223.54/223.75  |- mesh__dateEstablished mesh__D017536 1993-01-01
% 223.54/223.75  |- skos__annotation mesh__D017536
% 223.54/223.75       disease: coord NIM with CAROTID ARTERY DISEASES %28%IM%29%/ inj: consider CAROTID ARTERY INJURIES and specifics%A%  
% 223.54/223.75  |- skos__scopeNote mesh__D017536
% 223.54/223.75       The two principal arteries supplying the structures of the head and neck. They ascend in the neck, one on each side, and at the level of the upper border of the thyroid cartilage, each divides into two branches, the external %28%CAROTID ARTERY, EXTERNAL%29% and internal %28%CAROTID ARTERY, INTERNAL%29% carotid arteries.%A%    
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D017536 2003A
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D017536 2002
% 223.54/223.75  |- skos__hiddenLabel mesh__D017536 Arteries, Common Carotid
% 223.54/223.75  |- skos__hiddenLabel mesh__D017536 Carotid Arteries, Common
% 223.54/223.75  |- mesh__dateRevised mesh__D017536 2002-09-24
% 223.54/223.75  |- mesh__recordMaintainer mesh__D017536 sjn
% 223.54/223.75  |- mesh__recordOriginator mesh__D017536 PLS
% 223.54/223.75  |- mesh__recordAuthorizer mesh__D017536 sjn
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D017536 2001
% 223.54/223.75  |- mesh__historyNote mesh__D017536 93   
% 223.54/223.75  |- skos__prefLabel mesh__D017536 Carotid Artery, Common
% 223.54/223.75  |- skos__hiddenLabel mesh__D017536 Artery, Common Carotid
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D017536 2004
% 223.54/223.75  |- skos__broader mesh__D017536smesh__D002339
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D017536 2000
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D031207 2004
% 223.54/223.75  |- skos__annotation mesh__D031207
% 223.54/223.75       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.54/223.75  |- mesh__dateEstablished mesh__D031207 2003-01-01
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D031207 2006
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D031207 2003
% 223.54/223.75  |- mesh__historyNote mesh__D031207 2003   
% 223.54/223.75  |- skos__scopeNote mesh__D031207
% 223.54/223.75       A plant genus of the family ASTERACEAE.  Flower buds contain farfaratin %28%SESQUITERPENES%29% and bisabolene epoxide.%A%    
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D031207 2005
% 223.54/223.75  |- mesh__dateCreated mesh__D031207 2002-07-03
% 223.54/223.75  |- skos__prefLabel mesh__D031207 Tussilago
% 223.54/223.75  |- rdf__type mesh__D031207sskos__Concept
% 223.54/223.75  |- skos__broader mesh__D031207smesh__D019659
% 223.54/223.75  |- skos__altLabel mesh__D031207 Coltsfoot
% 223.54/223.75  |- mesh__publicMeSHNote mesh__D031207 2003   
% 223.54/223.75  |- rdf__type mesh__D003516sskos__Concept
% 223.54/223.75  |- mesh__recordMaintainer mesh__D003516 ssb
% 223.54/223.75  |- skos__hiddenLabel mesh__D003516 Alkenes, Cyclic
% 223.54/223.75  |- skos__hiddenLabel mesh__D003516 Olefins, Cyclic
% 223.54/223.75  |- mesh__dateCreated mesh__D003516 1999-01-01
% 223.54/223.75  |- skos__scopeNote mesh__D003516
% 223.54/223.75       Alicyclic hydrocarbons in which three or more of the carbon atoms in each molecule are united in a ring structure and each of the ring carbon atoms is joined to two hydrogen atoms or alkyl groups. The simplest members are cyclopropane %28%C3H6%29%, cyclobutane %28%C4H8%29%, cyclohexane %28%C6H12%29%, and derivatives of these such as methylcyclohexane %28%C6H11CH3%29%. %28%From Sax, et al., Hawley%27%s Condensed Chemical Dictionary, 11th ed%29%%A%    
% 223.54/223.75  |- skos__broader mesh__D003516smesh__D047028
% 223.54/223.75  |- mesh__dateRevised mesh__D003516 2004-07-07
% 223.54/223.75  |- skos__altLabel mesh__D003516 Cyclic Acetylenes
% 223.54/223.75  |- skos__altLabel mesh__D003516 Cyclic Olefins
% 223.54/223.75  |- skos__prefLabel mesh__D003516 Cycloparaffins
% 223.54/223.75  |- mesh__recordOriginator mesh__D003516 NLM
% 223.54/223.75  |- mesh__recordAuthorizer mesh__D003516 sjn
% 223.54/223.75  |- skos__altLabel mesh__D003516 Cycloalkanes
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D003516 2006
% 223.54/223.75  |- skos__altLabel mesh__D003516 Cyclic Alkenes
% 223.54/223.75  |- skos__broader mesh__D003516smesh__D006840
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D003516 2005
% 223.54/223.75  |- skos__scopeNote mesh__D008201
% 223.54/223.75       Dilatation of the intestinal lymphatic system usually caused by an obstruction in the intestinal wall. It may be congenital or acquired and is characterized by DIARRHEA; HYPOPROTEINEMIA; peripheral and/or abdominal EDEMA; and PROTEIN-LOSING ENTEROPATHIES.%A%    
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D008201 2004
% 223.54/223.75  |- mesh__dateRevised mesh__D008201 2003-07-09
% 223.54/223.75  |- mesh__publicMeSHNote mesh__D008201
% 223.54/223.75       91; was see under PROTEIN-LOSING ENTEROPATHIES 1975-90   
% 223.54/223.75  |- skos__altLabel mesh__D008201 Intestinal Lymphangiectasis
% 223.54/223.75  |- mesh__dateEstablished mesh__D008201 1991-01-01
% 223.54/223.75  |- skos__hiddenLabel mesh__D008201 Intestinal Lymphangiectases
% 223.54/223.75  |- mesh__onlineNote mesh__D008201
% 223.54/223.75       search PROTEIN-LOSING ENTEROPATHIES 1966-74   
% 223.54/223.75  |- mesh__historyNote mesh__D008201
% 223.54/223.75       91%28%75%29%; was see under PROTEIN-LOSING ENTEROPATHIES 1975-90%A%  
% 223.54/223.75  |- skos__broader mesh__D008201smesh__D044148
% 223.54/223.75  |- mesh__recordOriginator mesh__D008201 NLM
% 223.54/223.75  |- mesh__recordAuthorizer mesh__D008201 sjn
% 223.54/223.75  |- skos__prefLabel mesh__D008201 Lymphangiectasis, Intestinal
% 223.54/223.75  |- skos__broader mesh__D008201smesh__D008200
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D008201 2006
% 223.54/223.75  |- mesh__dateCreated mesh__D008201 1999-01-01
% 223.54/223.75  |- mesh__recordMaintainer mesh__D008201 lkt
% 223.54/223.75  |- rdf__type mesh__D008201sskos__Concept
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D008201 2005
% 223.54/223.75  |- skos__hiddenLabel mesh__D008201 Lymphangiectases, Intestinal
% 223.54/223.75  |- mesh__dateEstablished mesh__D013944 1991-01-01
% 223.54/223.75  |- mesh__publicMeSHNote mesh__D013944
% 223.54/223.75       91; was see under PHENOLPHTHALEINS 1975-90   
% 223.54/223.75  |- mesh__historyNote mesh__D013944
% 223.54/223.75       91%28%75%29%; was see under PHENOLPHTHALEINS 1975-90   
% 223.54/223.75  |- mesh__recordAuthorizer mesh__D013944 NLM
% 223.54/223.75  |- skos__scopeNote mesh__D013944
% 223.54/223.75       Used as a pH indicator and as a reagent for blood after decolorizing the alkaline solution by boiling with zinc dust.%A%    
% 223.54/223.75  |- mesh__dateRevised mesh__D013944 2005-07-06
% 223.54/223.75  |- skos__broader mesh__D013944smesh__D010635
% 223.54/223.75  |- mesh__recordMaintainer mesh__D013944 NLM
% 223.54/223.75  |- rdf__type mesh__D013944sskos__Concept
% 223.54/223.75  |- skos__historyNote mesh__D013944 Phenolphthaleins %28%1969-1974%29%
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D013944 2006
% 223.54/223.75  |- skos__prefLabel mesh__D013944 Thymolphthalein
% 223.54/223.75  |- mesh__recordOriginator mesh__D013944 NLM
% 223.54/223.75  |- mesh__dateCreated mesh__D013944 1974-11-19
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D013146 2006
% 223.54/223.75  |- mesh__publicMeSHNote mesh__D013146
% 223.54/223.75       91,79-85; was see under CESTODA 1986-90; was heading 1979-85; was see SPARGANUM 1975-78%A%  
% 223.54/223.75  |- skos__scopeNote mesh__D013146
% 223.54/223.75       A genus of tapeworms of the family Diphyllobothriidae, which are parasites of fish-eating cats, dogs, and birds. Infection in man is caused by eating undercooked fish. The larval form is called SPARGANUM.%A%    
% 223.54/223.75  |- skos__prefLabel mesh__D013146 Spirometra
% 223.54/223.75  |- mesh__recordAuthorizer mesh__D013146 sjn
% 223.54/223.75  |- mesh__dateCreated mesh__D013146 1978-01-30
% 223.54/223.75  |- mesh__recordMaintainer mesh__D013146 ags
% 223.54/223.75  |- skos__broader mesh__D013146smesh__D002589
% 223.54/223.75  |- mesh__historyNote mesh__D013146
% 223.54/223.75       91%28%86%29%79; was see under CESTODA 1986-90; was heading 1979-85; was see SPARGANUM 1975-78%A%  
% 223.54/223.75  |- rdf__type mesh__D013146sskos__Concept
% 223.54/223.75  |- skos__historyNote mesh__D013146 Sparganum %28%1975-1978%29%
% 223.54/223.75  |- skos__historyNote mesh__D013146 Cestoda %28%1966-1978%29%
% 223.54/223.75  |- mesh__recordOriginator mesh__D013146 AEP
% 223.54/223.75  |- skos__annotation mesh__D013146
% 223.54/223.75       a genus of tapeworm of Diphyllobothriidae; found in fish; larval form is SPARGANUM; infection: coord IM with CESTODE INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D013146 2005
% 223.54/223.75  |- mesh__onlineNote mesh__D013146
% 223.54/223.75       use SPARGANUM to search SPIROMETRA 1975-78   
% 223.54/223.75  |- mesh__dateRevised mesh__D013146 2003-07-09
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D013146 2004
% 223.54/223.75  |- mesh__dateEstablished mesh__D013146 1979-01-01
% 223.54/223.75  |- skos__broader mesh__D007907smesh__D007908
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D007907 1994
% 223.54/223.75  |- mesh__recordOriginator mesh__D007907 RC
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D007907 2004
% 223.54/223.75  |- mesh__recordMaintainer mesh__D007907 NLM
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D007907 1995
% 223.54/223.75  |- mesh__recordAuthorizer mesh__D007907 PLS
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D007907 2000
% 223.54/223.75  |- mesh__publicMeSHNote mesh__D007907
% 223.54/223.75       91; was see under LENS, CRYSTALLINE 1983-90   
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D007907 1996
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D007907 1991
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D007907 2005
% 223.54/223.75  |- skos__hiddenLabel mesh__D007907 Nucleus, Crystalline Lens
% 223.54/223.75  |- mesh__historyNote mesh__D007907
% 223.54/223.75       91%28%83%29%; was see under LENS, CRYSTALLINE 1983-90   
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D007907 1997
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D007907 2001
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D007907 2006
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D007907 1992
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D007907 2002
% 223.54/223.75  |- skos__scopeNote mesh__D007907
% 223.54/223.75       The core of the crystalline lens, surrounded by the cortex.%A%    
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D007907 1998
% 223.54/223.75  |- mesh__dateRevised mesh__D007907 1990-04-13
% 223.54/223.75  |- skos__hiddenLabel mesh__D007907 Crystalline Lens Nucleus
% 223.54/223.75  |- mesh__dateCreated mesh__D007907 1982-04-28
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D007907 1993
% 223.54/223.75  |- mesh__dateEstablished mesh__D007907 1991-01-01
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D007907 1999
% 223.54/223.75  |- rdf__type mesh__D007907sskos__Concept
% 223.54/223.75  |- skos__prefLabel mesh__D007907 Lens Nucleus, Crystalline
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D007907 2003
% 223.54/223.75  |- skos__historyNote mesh__D007907 Lens, Crystalline %28%1966-1982%29%
% 223.54/223.75  |- mesh__recordOriginator mesh__D007109 NLM
% 223.54/223.75  |- rdf__type mesh__D007109sskos__Concept
% 223.54/223.75  |- mesh__historyNote mesh__D007109
% 223.54/223.75       RADIATION IMMUNOLOGY was heading 1964-66   
% 223.54/223.75  |- skos__broader mesh__D007109smesh__D001687
% 223.54/223.75  |- mesh__dateCreated mesh__D007109 1999-01-01
% 223.54/223.75  |- skos__related mesh__D007109smesh__D019139
% 223.54/223.75  |- skos__annotation mesh__D007109
% 223.54/223.75       IM GEN only for %22%immunity%22% or %22%immune process%22%; NIM with specific disease /immunol %28%IM%29%; %22%immune response%22%: index under ANTIBODY FORMATION %28%usually discusses B-lymphocytes%29% or IMMUNITY, CELLULAR %28%usually discusses T-lymphocytes%29%; TN 242%A%  
% 223.54/223.75  |- mesh__recordMaintainer mesh__D007109 ags
% 223.54/223.75  |- skos__scopeNote mesh__D007109
% 223.54/223.75       Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances.%A%    
% 223.54/223.75  |- mesh__onlineNote mesh__D007109 pre-explosion = IMMUNITY %28%PX%29%   
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D007109 2006
% 223.54/223.75  |- mesh__recordAuthorizer mesh__D007109 sjn
% 223.54/223.75  |- mesh__publicMeSHNote mesh__D007109
% 223.54/223.75       RADIATION IMMUNOLOGY was heading 1964-66   
% 223.54/223.75  |- skos__related mesh__D007109smesh__D007158
% 223.54/223.75  |- skos__prefLabel mesh__D007109 Immunity
% 223.54/223.75  |- mesh__dateRevised mesh__D007109 2004-07-07
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D007109 2005
% 223.54/223.75  |- mesh__recordAuthorizer mesh__D051265 sjn
% 223.54/223.75  |- mesh__recordMaintainer mesh__D051265 DRC
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D051265 2006
% 223.54/223.75  |- skos__scopeNote mesh__D051265
% 223.54/223.75       A basic-leucine zipper transcription factor that is involved in regulating inflammatory responses, MORPHOGENESIS, and HEME biosynthesis.%A%    
% 223.54/223.75  |- skos__altLabel mesh__D051265 Nfe2l1 Protein
% 223.54/223.75  |- skos__altLabel mesh__D051265 NRF-1 Protein
% 223.54/223.75  |- mesh__publicMeSHNote mesh__D051265
% 223.54/223.75       2006; NF-E2-RELATED FACTOR 1 was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1994-2005, %26% under TRANSCRIPTION FACTORS 1993%A%  
% 223.54/223.75  |- mesh__dateCreated mesh__D051265 2005-06-30
% 223.54/223.75  |- rdf__type mesh__D051265sskos__Concept
% 223.54/223.75  |- mesh__historyNote mesh__D051265 2006%28%1993%29%   
% 223.54/223.75  |- skos__hiddenLabel mesh__D051265 NRF 1 Protein
% 223.54/223.75  |- skos__hiddenLabel mesh__D051265 NF E2 Related Factor 1
% 223.54/223.75  |- skos__altLabel mesh__D051265
% 223.54/223.75       Nuclear Factor %28%Erythroid-Derived 2%29%-Like 1 Protein
% 223.54/223.75  |- mesh__recordOriginator mesh__D051265 DRC
% 223.54/223.75  |- skos__prefLabel mesh__D051265 NF-E2-Related Factor 1
% 223.54/223.75  |- skos__broader mesh__D051265smesh__D050976
% 223.54/223.75  |- mesh__dateEstablished mesh__D051265 2006-01-01
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D017537 1997
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D017537 2005
% 223.54/223.75  |- mesh__dateCreated mesh__D017537 1992-05-22
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D017537 1999
% 223.54/223.75  |- skos__scopeNote mesh__D017537
% 223.54/223.75       The artery supplying nearly all the left half of the transverse colon, the whole of the descending colon, the sigmoid colon, and the greater part of the rectum. It is smaller than the superior mesenteric artery %28%MESENTERIC ARTERY, SUPERIOR%29% and arises from the aorta above its bifurcation into the common iliac arteries.%A%    
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D017537 2006A
% 223.54/223.75  |- skos__hiddenLabel mesh__D017537 Artery, Inferior Mesenteric
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D017537 1993
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D017537 2000
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D017537 1996
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D017537 1995
% 223.54/223.75  |- mesh__dateRevised mesh__D017537 2005-08-02
% 223.54/223.75  |- skos__hiddenLabel mesh__D017537 Mesenteric Arteries, Inferior
% 223.54/223.75  |- skos__historyNote mesh__D017537 Mesenteric Arteries %28%1966-1992%29%
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D017537 1998
% 223.54/223.75  |- skos__prefLabel mesh__D017537 Mesenteric Artery, Inferior
% 223.54/223.75  |- mesh__publicMeSHNote mesh__D017537 93   
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D017537 1994
% 223.54/223.75  |- mesh__dateEstablished mesh__D017537 1993-01-01
% 223.54/223.75  |- skos__hiddenLabel mesh__D017537 Inferior Mesenteric Artery
% 223.54/223.75  |- mesh__recordMaintainer mesh__D017537 ags
% 223.54/223.75  |- mesh__recordOriginator mesh__D017537 PLS
% 223.54/223.75  |- skos__annotation mesh__D017537
% 223.54/223.75       disease is usually MESENTERIC VASCULAR OCCLUSION but coord IM with MESENTERIC ARTERY, INFERIOR %28%NIM%29%; embolism or thrombosis: coord NIM with MESENTERIC VASCULAR OCCLUSION %28%IM%29% + EMBOLISM or THROMBOSIS %28%IM%29%%A%  
% 223.54/223.75  |- skos__hiddenLabel mesh__D017537 Inferior Mesenteric Arteries
% 223.54/223.75  |- skos__hiddenLabel mesh__D017537 Arteries, Inferior Mesenteric
% 223.54/223.75  |- mesh__historyNote mesh__D017537 93   
% 223.54/223.75  |- skos__broader mesh__D017537smesh__D008638
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D017537 2004
% 223.54/223.75  |- mesh__recordAuthorizer mesh__D017537 ags
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D017537 2002
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D017537 2006
% 223.54/223.75  |- rdf__type mesh__D017537sskos__Concept
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D017537 2003
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D017537 2001
% 223.54/223.75  |- rdf__type mesh__D031208sskos__Concept
% 223.54/223.75  |- mesh__dateEstablished mesh__D031208 2003-01-01
% 223.54/223.75  |- skos__scopeNote mesh__D031208
% 223.54/223.75       A plant genus of the family ASTERACEAE. Members contain galegine %28%GUANIDINES%29%.%A%    
% 223.54/223.75  |- mesh__publicMeSHNote mesh__D031208 2003   
% 223.54/223.75  |- mesh__historyNote mesh__D031208 2003   
% 223.54/223.75  |- skos__broader mesh__D031208smesh__D019659
% 223.54/223.75  |- skos__annotation mesh__D031208
% 223.54/223.75       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D031208 2004
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D031208 2006
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D031208 2003
% 223.54/223.75  |- mesh__dateCreated mesh__D031208 2002-07-03
% 223.54/223.75  |- skos__prefLabel mesh__D031208 Verbesina
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D031208 2005
% 223.54/223.75  |- mesh__dateCreated mesh__D003517 1999-01-01
% 223.54/223.75  |- skos__prefLabel mesh__D003517 Cyclopentanes
% 223.54/223.75  |- mesh__dateRevised mesh__D003517 2004-07-07
% 223.54/223.75  |- skos__broader mesh__D003517smesh__D003516
% 223.54/223.75  |- mesh__recordMaintainer mesh__D003517 ssb
% 223.54/223.75  |- mesh__dateEstablished mesh__D003517 1966-01-01
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D003517 2006
% 223.54/223.75  |- mesh__publicMeSHNote mesh__D003517 75; was CYCLOPENTANE 1966-74   
% 223.54/223.75  |- mesh__historyNote mesh__D003517 75; was CYCLOPENTANE 1966-74   
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D003517 2005
% 223.54/223.75  |- mesh__recordAuthorizer mesh__D003517 sjn
% 223.54/223.75  |- rdf__type mesh__D003517sskos__Concept
% 223.54/223.75  |- mesh__recordOriginator mesh__D003517 NLM
% 223.54/223.75  |- skos__scopeNote mesh__D003517
% 223.54/223.75       A group of alicyclic hydrocarbons with the general formula R-C5H9.%A%    
% 223.54/223.75  |- skos__prefLabel mesh__D008202 Lymphangioma
% 223.54/223.75  |- skos__hiddenLabel mesh__D008202 Lymphangiomas, Cavernous
% 223.54/223.75  |- skos__hiddenLabel mesh__D008202 Lymphangioendotheliomas
% 223.54/223.75  |- mesh__dateRevised mesh__D008202 1995-06-08
% 223.54/223.75  |- mesh__recordMaintainer mesh__D008202 KEV
% 223.54/223.75  |- skos__hiddenLabel mesh__D008202 Lymphangiomas
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D008202 1996
% 223.54/223.75  |- skos__broader mesh__D008202smesh__D018190
% 223.54/223.75  |- skos__annotation mesh__D008202
% 223.54/223.75       /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 223.54/223.75  |- mesh__recordAuthorizer mesh__D008202 PLS
% 223.54/223.75  |- skos__hiddenLabel mesh__D008202 Cavernous Lymphangiomas
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D008202 2006
% 223.54/223.75  |- skos__hiddenLabel mesh__D008202 Cavernous Lymphangioma
% 223.54/223.75  |- mesh__onlineNote mesh__D008202
% 223.54/223.75       use LYMPHANGIOMA to search LYMPHANGIOENDOTHELIOMA 1966-83%A%  
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D008202 2002
% 223.54/223.75  |- skos__scopeNote mesh__D008202
% 223.54/223.75       A benign tumor representing a congenital malformation of the lymphatic system and made up of newly formed lymph-containing vascular spaces and channels. Lymphangioendothelioma is a type of lymphangioma in which endothelial cells are the dominant component. %28%From Dorland, 27th ed%29%%A%    
% 223.54/223.75  |- mesh__dateCreated mesh__D008202 1999-01-01
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D008202 2005
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D008202 1999
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D008202 2001
% 223.54/223.75  |- rdf__type mesh__D008202sskos__Concept
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D008202 1998
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D008202 2004
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D008202 2000
% 223.54/223.75  |- mesh__publicMeSHNote mesh__D008202
% 223.54/223.75       LYMPHANGIOENDOTHELIOMA was heading 1963-83   
% 223.54/223.75  |- mesh__recordOriginator mesh__D008202 NLM
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D008202 2003
% 223.54/223.75  |- mesh__historyNote mesh__D008202
% 223.54/223.75       LYMPHANGIOENDOTHELIOMA was heading 1963-83   
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D008202 1997
% 223.54/223.75  |- skos__broader mesh__D013945smesh__D018193
% 223.54/223.75  |- skos__hiddenLabel mesh__D013945 Thymomas
% 223.54/223.75  |- skos__broader mesh__D013945smesh__D013953
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D013945 2006
% 223.54/223.75  |- rdf__type mesh__D013945sskos__Concept
% 223.54/223.75  |- mesh__dateRevised mesh__D013945 2000-06-22
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D013945 2004
% 223.54/223.75  |- mesh__recordAuthorizer mesh__D013945 sjn
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D013945 2001
% 223.54/223.75  |- mesh__recordOriginator mesh__D013945 NLM
% 223.54/223.75  |- mesh__recordMaintainer mesh__D013945 jmp
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D013945 2005
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D013945 2003
% 223.54/223.75  |- skos__prefLabel mesh__D013945 Thymoma
% 223.54/223.75  |- skos__hiddenLabel mesh__D013945 Thymic Carcinoma
% 223.54/223.75  |- skos__scopeNote mesh__D013945
% 223.54/223.75       A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant and probably not neoplastic. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin%27%s disease %28%previously termed granulomatous thymoma%29%, should not be regarded as thymoma. %28%Stedman, 25th ed%29%%A%    
% 223.54/223.75  |- skos__hiddenLabel mesh__D013945 Carcinomas, Thymic
% 223.54/223.75  |- mesh__dateCreated mesh__D013945 1999-01-01
% 223.54/223.75  |- skos__hiddenLabel mesh__D013945 Thymic Carcinomas
% 223.54/223.75  |- skos__annotation mesh__D013945
% 223.54/223.75       coord  IM with THYMUS NEOPLASMS %28%IM%29%   
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D013945 2002
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D013147 1999
% 223.54/223.75  |- mesh__recordOriginator mesh__D013147 NLM
% 223.54/223.75  |- skos__annotation mesh__D013147
% 223.54/223.75       NIM; do not use /util except by MeSH definition; BRONCHOSPIROMETRY is also available%A%  
% 223.54/223.75  |- skos__prefLabel mesh__D013147 Spirometry
% 223.54/223.75  |- mesh__dateCreated mesh__D013147 1999-01-01
% 223.54/223.75  |- skos__scopeNote mesh__D013147
% 223.54/223.75       Measurement of volume of air inhaled or exhaled by the lung.%A%    
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D013147 2002
% 223.54/223.75  |- skos__broader mesh__D013147smesh__D012129
% 223.54/223.75  |- mesh__dateRevised mesh__D013147 1997-06-20
% 223.54/223.75  |- rdf__type mesh__D013147sskos__Concept
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D013147 2003
% 223.54/223.75  |- skos__hiddenLabel mesh__D013147 Spirometries
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D013147 2000
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D013147 2005
% 223.54/223.75  |- mesh__recordMaintainer mesh__D013147 PXP
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D013147 2004
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D013147 2001
% 223.54/223.75  |- mesh__recordAuthorizer mesh__D013147 SJN
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D013147 2006
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D013147 1998
% 223.54/223.75  |- skos__altLabel mesh__D007908 Crystalline Lens
% 223.54/223.75  |- skos__prefLabel mesh__D007908 Lens, Crystalline
% 223.54/223.75  |- rdf__type mesh__D007908sskos__Concept
% 223.54/223.75  |- skos__altLabel mesh__D007908 Lens, Eye
% 223.54/223.75  |- mesh__recordAuthorizer mesh__D007908 sjn
% 223.54/223.75  |- mesh__dateCreated mesh__D007908 1999-01-01
% 223.54/223.75  |- mesh__recordOriginator mesh__D007908 NLM
% 223.54/223.75  |- mesh__recordMaintainer mesh__D007908 ssb
% 223.54/223.75  |- skos__annotation mesh__D007908
% 223.54/223.75       of the eye; congenital absence = APHAKIA /congen; APHAKIA, POSTCATARACT is also available; replacement by intraocular lens = LENSES, INTRAOCULAR; extraction = probably CATARACT EXTRACTION%A%  
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D007908 2006
% 223.54/223.75  |- mesh__dateRevised mesh__D007908 2005-06-30
% 223.54/223.75  |- skos__related mesh__D007908smesh__D001035
% 223.54/223.75  |- skos__broader mesh__D007908smesh__D005123
% 223.54/223.75  |- skos__scopeNote mesh__D007908
% 223.54/223.75       A transparent, biconvex structure of the EYE, enclosed in a capsule and situated behind the IRIS and in front of the vitreous humor %28%VITREOUS BODY%29%. It is slightly overlapped at its margin by the ciliary processes. Adaptation by the CILIARY BODY is crucial for OCULAR ACCOMMODATION.%A%    
% 223.54/223.75  |- skos__altLabel mesh__D007908 Eye Lens
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D018630 2000
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D018630 2006
% 223.54/223.75  |- skos__annotation mesh__D018630
% 223.54/223.75       shrinkage of vitreoretinal membrane after prolif of retinal pigment cells%A%  
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D018630 1999
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D018630 2005
% 223.54/223.75  |- skos__broader mesh__D018630smesh__D012164
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D018630 2004
% 223.54/223.75  |- mesh__dateEstablished mesh__D018630 1995-01-01
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D018630 2002
% 223.54/223.75  |- mesh__dateCreated mesh__D018630 1994-02-28
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D018630 1998
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D018630 1997
% 223.54/223.75  |- skos__broader mesh__D018630smesh__D005128
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D018630 2003
% 223.54/223.75  |- skos__hiddenLabel mesh__D018630 Proliferative Vitreoretinopathies
% 223.54/223.75  |- rdf__type mesh__D018630sskos__Concept
% 223.54/223.75  |- skos__historyNote mesh__D018630 Vitreous Body %28%1981-1994%29%
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D018630 1996
% 223.54/223.75  |- mesh__publicMeSHNote mesh__D018630 95   
% 223.54/223.75  |- skos__prefLabel mesh__D018630 Vitreoretinopathy, Proliferative
% 223.54/223.75  |- mesh__historyNote mesh__D018630 95   
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D018630 2001
% 223.54/223.75  |- skos__scopeNote mesh__D018630
% 223.54/223.75       Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.%A%    
% 223.54/223.75  |- skos__historyNote mesh__D018630 Eye Diseases %28%1981-1994%29%
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D018630 1995
% 223.54/223.75  |- skos__historyNote mesh__D018630 Retinal Diseases %28%1983-1994%29%
% 223.54/223.75  |- skos__hiddenLabel mesh__D018630 Proliferative Vitreoretinopathy
% 223.54/223.75  |- skos__hiddenLabel mesh__D018630 Vitreoretinopathies, Proliferative
% 223.54/223.75  |- rdf__type mesh__D032301sskos__Concept
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D032301 2005
% 223.54/223.75  |- skos__scopeNote mesh__D032301
% 223.54/223.75       A plant genus of the family SOLANACEAE. Members contain steroidal saponins and cause CALCINOSIS in grazing livestock due to high levels of 1 ALPHA,25-DIHYDROXYVITAMIN D3.%A%    
% 223.54/223.75  |- skos__altLabel mesh__D032301 Cestrium
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D032301 2003
% 223.54/223.75  |- mesh__publicMeSHNote mesh__D032301 2003   
% 223.54/223.75  |- skos__annotation mesh__D032301
% 223.54/223.75       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.54/223.75  |- mesh__dateCreated mesh__D032301 2002-07-03
% 223.54/223.75  |- skos__broader mesh__D032301smesh__D019657
% 223.54/223.75  |- skos__altLabel mesh__D032301 Jessamine
% 223.54/223.75  |- skos__prefLabel mesh__D032301 Cestrum
% 223.54/223.75  |- mesh__dateEstablished mesh__D032301 2003-01-01
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D032301 2006
% 223.54/223.75  |- mesh__historyNote mesh__D032301 2003   
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D032301 2004
% 223.54/223.75  |- mesh__dateEstablished mesh__D004610 1991-01-01
% 223.54/223.75  |- mesh__recordAuthorizer mesh__D004610 sjn
% 223.54/223.75  |- mesh__dateRevised mesh__D004610 2005-06-30
% 223.54/223.75  |- mesh__recordOriginator mesh__D004610 NLM
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D004610 2006
% 223.54/223.75  |- skos__historyNote mesh__D004610 Benzopyrans %28%1969-1974%29%
% 223.54/223.75  |- skos__prefLabel mesh__D004610 Ellagic Acid
% 223.54/223.75  |- mesh__historyNote mesh__D004610
% 223.54/223.75       91%28%75%29%; was see under BENZOPYRANS 1975-90   
% 223.54/223.75  |- mesh__publicMeSHNote mesh__D004610
% 223.54/223.75       91; was see under BENZOPYRANS 1975-90   
% 223.54/223.75  |- skos__scopeNote mesh__D004610
% 223.54/223.75       A fused four ring compound occurring free or combined in galls. Isolated from the kino of Eucalyptus maculata Hook and E. Hemipholia F. Muell. Activates Factor XII of the blood clotting system which also causes kinin release; used in research and as a dye.%A%    
% 223.54/223.75  |- skos__broader mesh__D004610smesh__D001578
% 223.54/223.75  |- skos__hiddenLabel mesh__D004610 Acid, Ellagic
% 223.54/223.75  |- rdf__type mesh__D004610sskos__Concept
% 223.54/223.75  |- skos__hiddenLabel mesh__D004610 Acid, Benzoaric
% 223.54/223.75  |- mesh__dateCreated mesh__D004610 1974-11-19
% 223.54/223.75  |- mesh__recordMaintainer mesh__D004610 ssb
% 223.54/223.75  |- skos__altLabel mesh__D004610 Benzoaric Acid
% 223.54/223.75  |- rdf__type mesh__D051266sskos__Concept
% 223.54/223.75  |- skos__broader mesh__D051266smesh__D051264
% 223.54/223.75  |- mesh__recordMaintainer mesh__D051266 DRC
% 223.54/223.75  |- mesh__dateEstablished mesh__D051266 2006-01-01
% 223.54/223.75  |- mesh__recordOriginator mesh__D051266 DRC
% 223.54/223.75  |- skos__prefLabel mesh__D051266 Nuclear Respiratory Factor 1
% 223.54/223.75  |- mesh__recordAuthorizer mesh__D051266 sjn
% 223.54/223.75  |- mesh__activeMeSHYear mesh__D051266 2006
% 223.54/223.75  |- skos__scopeNote mesh__D051266
% 223.54/223.75       A transcription factor that controls the expression of variety of proteins including CYTOCHROME C and 5-AMINOLEVULINATE SYNTHETASE. It plays an important role in maintenance of the RESPIRATORY CHAIN of MITOCHONDRIA.%A%    
% 223.54/223.75  |- skos__hiddenLabel mesh__D051266 Transcription Factor, NRF1
% 223.54/223.75  |- mesh__dateCreated mesh__D051266 2005-06-30
% 223.54/223.75  |- skos__altLabel mesh__D051266 NRF1 Transcription Factor
% 223.54/223.75  |- mesh__publicMeSHNote mesh__D051266
% 223.54/223.75       2006; NUCLEAR RESPIRATORY FACTOR 1 was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 2005%A%  
% 223.54/223.75  |- mesh__historyNote mesh__D051266 2006%28%2005%29%   
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017538 1996
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017538 2000
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017538 1999
% 223.54/223.76  |- mesh__dateCreated mesh__D017538 1992-05-22
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017538 2005
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017538 1998
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017538 1993
% 223.54/223.76  |- skos__historyNote mesh__D017538 Mesenteric Arteries %28%1966-1992%29%
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017538 1995
% 223.54/223.76  |- skos__related mesh__D017538smesh__D013478
% 223.54/223.76  |- mesh__publicMeSHNote mesh__D017538 93   
% 223.54/223.76  |- skos__hiddenLabel mesh__D017538 Mesenteric Arteries, Superior
% 223.54/223.76  |- skos__annotation mesh__D017538
% 223.54/223.76       disease is usually MESENTERIC VASCULAR OCCLUSION but coord IM with MESENTERIC ARTERY, SUPERIOR %28%NIM%29%; embolism or thrombosis: coord NIM with MESENTERIC VASCULAR OCCLUSION %28%IM%29% + EMBOLISM or THROMBOSIS %28%IM%29%; duodenal compression by this artery = SUPERIOR MESENTERIC ARTERY SYNDROME%A%  
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017538 1994
% 223.54/223.76  |- skos__prefLabel mesh__D017538 Mesenteric Artery, Superior
% 223.54/223.76  |- mesh__dateEstablished mesh__D017538 1993-01-01
% 223.54/223.76  |- skos__hiddenLabel mesh__D017538 Arteries, Superior Mesenteric
% 223.54/223.76  |- mesh__historyNote mesh__D017538 93   
% 223.54/223.76  |- skos__broader mesh__D017538smesh__D008638
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017538 2002
% 223.54/223.76  |- skos__hiddenLabel mesh__D017538 Superior Mesenteric Artery
% 223.54/223.76  |- rdf__type mesh__D017538sskos__Concept
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017538 2004
% 223.54/223.76  |- skos__hiddenLabel mesh__D017538 Artery, Superior Mesenteric
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017538 1997
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017538 2001
% 223.54/223.76  |- skos__scopeNote mesh__D017538
% 223.54/223.76       A large vessel supplying the whole length of the small intestine except the superior part of the duodenum. It also supplies the cecum and the ascending part of the colon and about half the transverse part of the colon. It arises from the anterior surface of the aorta below the celiac artery at the level of the first lumbar vertebra.%A%    
% 223.54/223.76  |- skos__hiddenLabel mesh__D017538 Superior Mesenteric Arteries
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017538 2003
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017538 2006
% 223.54/223.76  |- rdf__type mesh__D031209sskos__Concept
% 223.54/223.76  |- skos__scopeNote mesh__D031209
% 223.54/223.76       A plant genus of the family ASTERACEAE. Members contain wedelolactone and wedeloside.%A%    
% 223.54/223.76  |- mesh__dateCreated mesh__D031209 2002-07-03
% 223.54/223.76  |- skos__prefLabel mesh__D031209 Wedelia
% 223.54/223.76  |- mesh__publicMeSHNote mesh__D031209 2003   
% 223.54/223.76  |- skos__broader mesh__D031209smesh__D019659
% 223.54/223.76  |- skos__annotation mesh__D031209
% 223.54/223.76       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.54/223.76  |- mesh__dateEstablished mesh__D031209 2003-01-01
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D031209 2004
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D031209 2006
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D031209 2003
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D031209 2005
% 223.54/223.76  |- mesh__historyNote mesh__D031209 2003   
% 223.54/223.76  |- mesh__dateRevised mesh__D003518 2005-06-30
% 223.54/223.76  |- skos__prefLabel mesh__D003518 Cyclopenthiazide
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D003518 2006
% 223.54/223.76  |- mesh__recordAuthorizer mesh__D003518 sjn
% 223.54/223.76  |- mesh__recordOriginator mesh__D003518 NLM
% 223.54/223.76  |- skos__altLabel mesh__D003518 Cyclomethiazide
% 223.54/223.76  |- rdf__type mesh__D003518sskos__Concept
% 223.54/223.76  |- skos__historyNote mesh__D003518 Cyclic S-Oxides %28%1974%29%
% 223.54/223.76  |- skos__historyNote mesh__D003518 Cyclopentanes %28%1974%29%
% 223.54/223.76  |- mesh__recordMaintainer mesh__D003518 ssb
% 223.54/223.76  |- skos__historyNote mesh__D003518 Diuretics, Thiazide %28%1974%29%
% 223.54/223.76  |- mesh__dateEstablished mesh__D003518 1991-01-01
% 223.54/223.76  |- mesh__historyNote mesh__D003518
% 223.54/223.76       91%28%75%29%; was see under DIURETICS, THIAZIDE 1975-90   
% 223.54/223.76  |- mesh__publicMeSHNote mesh__D003518
% 223.54/223.76       91; was see under DIURETICS, THIAZIDE 1975-90   
% 223.54/223.76  |- skos__scopeNote mesh__D003518
% 223.54/223.76       Thiazide diuretic also used as an antihypertensive agent.%A%    
% 223.54/223.76  |- skos__broader mesh__D003518smesh__D001581
% 223.54/223.76  |- mesh__dateCreated mesh__D003518 1974-11-19
% 223.54/223.76  |- mesh__historyNote mesh__D014240
% 223.54/223.76       91%28%77%29%; was see under HYDROCARBONS, CHLORINATED 1977-90   
% 223.54/223.76  |- mesh__publicMeSHNote mesh__D014240
% 223.54/223.76       91; was see under HYDROCARBONS, CHLORINATED 1977-90   
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D014240 2002
% 223.54/223.76  |- mesh__recordAuthorizer mesh__D014240 PLS
% 223.54/223.76  |- mesh__recordOriginator mesh__D014240 RLS
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D014240 1995
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D014240 1993
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D014240 2005
% 223.54/223.76  |- mesh__dateEstablished mesh__D014240 1991-01-01
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D014240 1998
% 223.54/223.76  |- skos__broader mesh__D014240smesh__D006843
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D014240 2003
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D014240 1996
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D014240 2006
% 223.54/223.76  |- mesh__dateCreated mesh__D014240 1976-04-16
% 223.54/223.76  |- skos__scopeNote mesh__D014240
% 223.54/223.76       Chlorinated ethanes which are used extensively as industrial solvents. They have been utilized in numerous home-use products including spot remover preparations and inhalant decongestant sprays. These compounds cause central nervous system and cardiovascular depression and are hepatotoxic. Include 1,1,1- and 1,1,2-isomers.%A%    
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D014240 1999
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D014240 2004
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D014240 1997
% 223.54/223.76  |- mesh__recordMaintainer mesh__D014240 TAP
% 223.54/223.76  |- skos__historyNote mesh__D014240
% 223.54/223.76       Hydrocarbons, Chlorinated %28%1974-1976%29%
% 223.54/223.76  |- skos__prefLabel mesh__D014240 Trichloroethanes
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D014240 2000
% 223.54/223.76  |- mesh__dateRevised mesh__D014240 1992-05-20
% 223.54/223.76  |- skos__historyNote mesh__D014240 Ethane %28%1974-1975%29%
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D014240 2001
% 223.54/223.76  |- rdf__type mesh__D014240sskos__Concept
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D014240 1994
% 223.54/223.76  |- skos__annotation mesh__D008203
% 223.54/223.76       differentiate from LYMPHANGIOMYOMATOSIS; coordinate IM with precoordinated  organ/neoplasm terms %28%IM%29%%A%  
% 223.54/223.76  |- mesh__dateCreated mesh__D008203 1979-05-24
% 223.54/223.76  |- skos__broader mesh__D008203smesh__D008232
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D008203 2006
% 223.54/223.76  |- mesh__recordAuthorizer mesh__D008203 sjn
% 223.54/223.76  |- mesh__recordMaintainer mesh__D008203 lkt
% 223.54/223.76  |- skos__historyNote mesh__D008203 Lymphatic Diseases %28%1968-1979%29%
% 223.54/223.76  |- rdf__type mesh__D008203sskos__Concept
% 223.54/223.76  |- skos__hiddenLabel mesh__D008203 Lymphangioleiomyomas
% 223.54/223.76  |- skos__historyNote mesh__D008203 Lymphangioma %28%1966-1979%29%
% 223.54/223.76  |- skos__altLabel mesh__D008203 Lymphangioleiomyoma
% 223.54/223.76  |- skos__prefLabel mesh__D008203 Lymphangiomyoma
% 223.54/223.76  |- mesh__recordOriginator mesh__D008203 VDK
% 223.54/223.76  |- mesh__publicMeSHNote mesh__D008203
% 223.54/223.76       91; was see under LYMPHOPROLIFERATIVE DISORDERS 1980-90   
% 223.54/223.76  |- skos__hiddenLabel mesh__D008203 Lymphangiomyomas
% 223.54/223.76  |- mesh__dateEstablished mesh__D008203 1991-01-01
% 223.54/223.76  |- mesh__historyNote mesh__D008203
% 223.54/223.76       91%28%80%29%; was see under LYMPHOPROLIFERATIVE DISORDERS 1980-90%A%  
% 223.54/223.76  |- skos__broader mesh__D008203smesh__D018190
% 223.54/223.76  |- mesh__dateRevised mesh__D008203 2005-06-30
% 223.54/223.76  |- skos__scopeNote mesh__D008203
% 223.54/223.76       A tumorlike condition characterized by smooth muscle and endothelium proliferation of lymphatic vessels and lymph nodes in the mediastinum and retroperitoneum, also in the lung. It may be manifested by chylous pleural effusion and ascites.%A%    
% 223.54/223.76  |- rdf__type mesh__D000220sskos__Concept
% 223.54/223.76  |- skos__altLabel mesh__D000220 Biological Adaptation
% 223.54/223.76  |- skos__broader mesh__D000220smesh__D001686
% 223.54/223.76  |- mesh__dateRevised mesh__D000220 2003-07-09
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D000220 2004
% 223.54/223.76  |- mesh__dateCreated mesh__D000220 1999-01-01
% 223.54/223.76  |- mesh__recordMaintainer mesh__D000220 lkt
% 223.54/223.76  |- skos__related mesh__D000220smesh__D000222
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D000220 2005
% 223.54/223.76  |- skos__hiddenLabel mesh__D000220 Biologic Adaptation
% 223.54/223.76  |- skos__altLabel mesh__D000220 Adaptation, Biologic
% 223.54/223.76  |- skos__scopeNote mesh__D000220
% 223.54/223.76       Changes in biological features that help an organism cope with its ENVIRONMENT. These changes include physiological %28%ADAPTATION, PHYSIOLOGICAL%29%, phenotypic and genetic changes.%A%    
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D000220 2006
% 223.54/223.76  |- skos__annotation mesh__D000220
% 223.54/223.76       much of biol adapt will be ADAPTATION, PHYSIOLOGICAL as more specific; mimicry except for MOLECULAR MIMICRY goes here; DF: ADAPTATION BIOL%A%  
% 223.54/223.76  |- skos__prefLabel mesh__D000220 Adaptation, Biological
% 223.54/223.76  |- mesh__recordOriginator mesh__D000220 NLM
% 223.54/223.76  |- mesh__recordAuthorizer mesh__D000220 sjn
% 223.54/223.76  |- rdf__type mesh__D013946sskos__Concept
% 223.54/223.76  |- skos__annotation mesh__D013946
% 223.54/223.76       /biosyn /physiol permitted; do not confuse X ref THYMINS with THYMINE%A%  
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D013946 2006
% 223.54/223.76  |- skos__historyNote mesh__D013946 Hormones %28%1966-1976%29%
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D013946 2002
% 223.54/223.76  |- skos__altLabel mesh__D013946 Thymins
% 223.54/223.76  |- skos__hiddenLabel mesh__D013946 TP 49
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D013946 2004
% 223.54/223.76  |- skos__altLabel mesh__D013946 TP-49
% 223.54/223.76  |- skos__broader mesh__D013946smesh__D013951
% 223.54/223.76  |- skos__historyNote mesh__D013946 Thymus Extracts %28%1974%29%
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D013946 1995
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D013946 2005
% 223.54/223.76  |- mesh__dateRevised mesh__D013946 1992-05-20
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D013946 1993
% 223.54/223.76  |- mesh__publicMeSHNote mesh__D013946
% 223.54/223.76       91; was see under THYMUS HORMONES 1977-90   
% 223.54/223.76  |- mesh__recordAuthorizer mesh__D013946 PLS
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D013946 2003
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D013946 1999
% 223.54/223.76  |- mesh__historyNote mesh__D013946
% 223.54/223.76       91%28%77%29%; was see under THYMUS HORMONES 1977-90   
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D013946 1994
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D013946 1997
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D013946 2001
% 223.54/223.76  |- skos__hiddenLabel mesh__D013946 I, Thymopoietin
% 223.54/223.76  |- mesh__dateEstablished mesh__D013946 1991-01-01
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D013946 1998
% 223.54/223.76  |- mesh__recordMaintainer mesh__D013946 TGC
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D013946 2000
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D013946 1996
% 223.54/223.76  |- skos__scopeNote mesh__D013946
% 223.54/223.76       Two closely related polypeptides %28%molecular weight 7,000%29% isolated from the thymus gland. These hormones induce the differentiation of prothymocytes to thymocytes within the thymus. They also cause a delayed impairment of neuromuscular transmission in vivo and are therefore believed to be the agent responsible for myasthenia gravis.%A%    
% 223.54/223.76  |- skos__hiddenLabel mesh__D013946 II, Thymopoietin
% 223.54/223.76  |- mesh__dateCreated mesh__D013946 1976-04-19
% 223.54/223.76  |- skos__prefLabel mesh__D013946 Thymopoietins
% 223.54/223.76  |- mesh__recordOriginator mesh__D013946 RLS
% 223.54/223.76  |- skos__historyNote mesh__D013946 Thymus Gland %28%1966-1976%29%
% 223.54/223.76  |- skos__altLabel mesh__D013148 Novopharm Brand of Spironolactone
% 223.54/223.76  |- skos__hiddenLabel mesh__D013148 Spirono Isis
% 223.54/223.76  |- skos__altLabel mesh__D013148 betapharm Brand of Spironolactone
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D013148 2006
% 223.54/223.76  |- skos__hiddenLabel mesh__D013148 SC 9420
% 223.54/223.76  |- skos__altLabel mesh__D013148 Cardel Brand of Spironolactone
% 223.54/223.76  |- skos__altLabel mesh__D013148 Ashbourne Brand of Spironolactone
% 223.54/223.76  |- skos__altLabel mesh__D013148 ct-Arzneimittel Brand of Spironolactone
% 223.54/223.76  |- skos__altLabel mesh__D013148 Dexo Brand of Spironolactone
% 223.54/223.76  |- skos__hiddenLabel mesh__D013148 ct Arzneimittel Brand of Spironolactone
% 223.54/223.76  |- skos__altLabel mesh__D013148 Hormosan Brand of Spironolactone
% 223.54/223.76  |- rdf__type mesh__D013148sskos__Concept
% 223.54/223.76  |- skos__broader mesh__D013148smesh__D011283
% 223.54/223.76  |- skos__altLabel mesh__D013148 Pharmafrid Brand of Spironolactone
% 223.54/223.76  |- skos__altLabel mesh__D013148 Alpharma Brand of Spironolactone
% 223.54/223.76  |- skos__altLabel mesh__D013148 Mundogen Brand of Spironolactone
% 223.54/223.76  |- skos__altLabel mesh__D013148 W%C3%%B6%rwag Brand of Spironolactone
% 223.54/223.76  |- mesh__recordAuthorizer mesh__D013148 sjn
% 223.54/223.76  |- skos__hiddenLabel mesh__D013148 Novo Spiroton
% 223.54/223.76  |- skos__hiddenLabel mesh__D013148 von ct, spiro
% 223.54/223.76  |- skos__hiddenLabel mesh__D013148 SC9420
% 223.54/223.76  |- skos__altLabel mesh__D013148 Generosan Brand of Spironolactone
% 223.54/223.76  |- skos__prefLabel mesh__D013148 Spironolactone
% 223.54/223.76  |- mesh__dateCreated mesh__D013148 1999-01-01
% 223.54/223.76  |- skos__altLabel mesh__D013148 Jenapharm Brand of Spironolactone
% 223.54/223.76  |- skos__altLabel mesh__D013148 Verospirone
% 223.54/223.76  |- skos__altLabel mesh__D013148 Spirolactone
% 223.54/223.76  |- mesh__recordMaintainer mesh__D013148 CCR
% 223.54/223.76  |- skos__altLabel mesh__D013148 Veroshpiron
% 223.54/223.76  |- skos__altLabel mesh__D013148 Merck dura Brand of Spironolactone
% 223.54/223.76  |- skos__altLabel mesh__D013148 Azupharma Brand of Spironolactone
% 223.54/223.76  |- mesh__recordOriginator mesh__D013148 NLM
% 223.54/223.76  |- skos__altLabel mesh__D013148 Pharmacia Spain Brand of Spironolactone
% 223.54/223.76  |- skos__hiddenLabel mesh__D013148 NovoSpiroton
% 223.54/223.76  |- mesh__dateRevised mesh__D013148 2005-06-30
% 223.54/223.76  |- skos__altLabel mesh__D013148 Searle Brand of Spironolactone
% 223.54/223.76  |- skos__scopeNote mesh__D013148
% 223.54/223.76       A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p827%29%%A%    
% 223.54/223.76  |- skos__altLabel mesh__D013148 Mayoly-Spindler Brand of Spironolactone
% 223.54/223.76  |- skos__altLabel mesh__D013148 Pharmacia Brand of Spironolactone
% 223.54/223.76  |- skos__broader mesh__D013148smesh__D007783
% 223.54/223.76  |- skos__altLabel mesh__D013148 Alter Brand of Spironolactone
% 223.54/223.76  |- skos__altLabel mesh__D013148 Alphapharm Brand of Spironolactone
% 223.54/223.76  |- skos__altLabel mesh__D013148 Roche Brand of Spironolactone
% 223.54/223.76  |- mesh__dateRevised mesh__D007909 2002-07-03
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D007909 2003
% 223.54/223.76  |- skos__scopeNote mesh__D007909
% 223.54/223.76       Pieces of glass or other transparent materials used for magnification or increased visual acuity.%A%    
% 223.54/223.76  |- skos__prefLabel mesh__D007909 Lenses
% 223.54/223.76  |- mesh__dateCreated mesh__D007909 1999-01-01
% 223.54/223.76  |- skos__broader mesh__D007909smesh__D004864
% 223.54/223.76  |- mesh__recordAuthorizer mesh__D007909 sjn
% 223.54/223.76  |- mesh__recordMaintainer mesh__D007909 mdb
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D007909 2006
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D007909 2005
% 223.54/223.76  |- mesh__recordOriginator mesh__D007909 NLM
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D007909 2004
% 223.54/223.76  |- rdf__type mesh__D007909sskos__Concept
% 223.54/223.76  |- skos__annotation mesh__D007909
% 223.54/223.76       for microscopes, magnifying glasses, telescopes, etc. but not for eyeglasses or sunglasses %28% = EYEGLASSES%29%; see next entry%A%  
% 223.54/223.76  |- mesh__publicMeSHNote mesh__D018631 95   
% 223.54/223.76  |- mesh__recordMaintainer mesh__D018631 ags
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D018631 2006
% 223.54/223.76  |- skos__hiddenLabel mesh__D018631 ras Gene Products
% 223.54/223.76  |- mesh__recordOriginator mesh__D018631 AGS
% 223.54/223.76  |- skos__broader mesh__D018631smesh__D020559
% 223.54/223.76  |- mesh__recordAuthorizer mesh__D018631 ags
% 223.54/223.76  |- rdf__type mesh__D018631sskos__Concept
% 223.54/223.76  |- mesh__dateRevised mesh__D018631 2005-07-22
% 223.54/223.76  |- skos__scopeNote mesh__D018631
% 223.54/223.76       Small, monomeric GTP-binding proteins encoded by ras genes %28%GENES, RAS%29%. The protooncogene-derived protein, PROTO-ONCOGENE PROTEIN P21%28%RAS%29%, plays a role in normal cellular growth, differentiation and development. The oncogene-derived protein %28%ONCOGENE PROTEIN P21%28%RAS%29%%29% can play a role in aberrant cellular regulation during neoplastic cell transformation %28%CELL TRANSFORMATION, NEOPLASTIC%29%. This enzyme was formerly listed as EC 3.6.1.47.%A%    
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D018631 2006A
% 223.54/223.76  |- mesh__historyNote mesh__D018631 95   
% 223.54/223.76  |- skos__annotation mesh__D018631 ras derived from %22%Rat Sarcoma%22%   
% 223.54/223.76  |- skos__prefLabel mesh__D018631 ras Proteins
% 223.54/223.76  |- skos__related mesh__D018631smesh__D011905
% 223.54/223.76  |- mesh__dateEstablished mesh__D018631 1995-01-01
% 223.54/223.76  |- skos__altLabel mesh__D018631 Gene Products, ras
% 223.54/223.76  |- mesh__dateCreated mesh__D018631 1994-02-28
% 223.54/223.76  |- skos__scopeNote mesh__D032302
% 223.54/223.76       A plant genus of the family SOLANACEAE. Members contain TROPANES. The common name of trumpet flower is also sometimes used for GELSEMIUM.%A%    
% 223.54/223.76  |- mesh__dateEstablished mesh__D032302 2003-01-01
% 223.54/223.76  |- mesh__historyNote mesh__D032302 2003%28%1974%29%   
% 223.54/223.76  |- skos__annotation mesh__D032302
% 223.54/223.76       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.54/223.76  |- skos__broader mesh__D032302smesh__D019657
% 223.54/223.76  |- mesh__publicMeSHNote mesh__D032302
% 223.54/223.76       2003; see DATURA STRAMONIUM 1974-2002   
% 223.54/223.76  |- skos__prefLabel mesh__D032302 Datura
% 223.54/223.76  |- skos__historyNote mesh__D032302 Datura stramonium %28%1974-2002%29%
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D032302 2006
% 223.54/223.76  |- mesh__dateCreated mesh__D032302 2002-07-03
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D032302 2004
% 223.54/223.76  |- rdf__type mesh__D032302sskos__Concept
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D032302 2005
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D032302 2003
% 223.54/223.76  |- skos__scopeNote mesh__D004611
% 223.54/223.76       Pyrido-CARBAZOLES originally discovered in the bark of OCHROSIA ELLIPTICA. They inhibit DNA and RNA synthesis and have immunosuppressive properties.%A%    
% 223.54/223.76  |- skos__prefLabel mesh__D004611 Ellipticines
% 223.54/223.76  |- mesh__dateRevised mesh__D004611 2004-07-07
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D004611 2006
% 223.54/223.76  |- mesh__recordMaintainer mesh__D004611 ssb
% 223.54/223.76  |- skos__broader mesh__D004611smesh__D002227
% 223.54/223.76  |- skos__historyNote mesh__D004611 Carbazoles %28%1971-1974%29%
% 223.54/223.76  |- mesh__recordAuthorizer mesh__D004611 sjn
% 223.54/223.76  |- skos__historyNote mesh__D004611 Pyridines %28%1972-1974%29%
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D004611 2005
% 223.54/223.76  |- skos__historyNote mesh__D004611 Alkaloids %28%1971-1974%29%
% 223.54/223.76  |- skos__broader mesh__D004611smesh__D046948
% 223.54/223.76  |- mesh__recordOriginator mesh__D004611 NLM
% 223.54/223.76  |- mesh__dateCreated mesh__D004611 1974-11-11
% 223.54/223.76  |- rdf__type mesh__D004611sskos__Concept
% 223.54/223.76  |- mesh__publicMeSHNote mesh__D004611
% 223.54/223.76       91; was see under ALKALOIDS 1975-90   
% 223.54/223.76  |- mesh__historyNote mesh__D004611
% 223.54/223.76       91%28%75%29%; was see under ALKALOIDS 1975-90   
% 223.54/223.76  |- mesh__dateEstablished mesh__D004611 1991-01-01
% 223.54/223.76  |- skos__hiddenLabel mesh__D051267 NF E2 Related Factor 2
% 223.54/223.76  |- skos__altLabel mesh__D051267 Nrf2 Protein
% 223.54/223.76  |- skos__scopeNote mesh__D051267
% 223.54/223.76       A basic-leucine zipper transcription factor that was originally described as a transcriptional regulator controlling expression of the BETA-GLOBIN gene. It may regulate the expression of a wide variety of genes that play a role in protecting cells from oxidative damage.%A%    
% 223.54/223.76  |- mesh__recordOriginator mesh__D051267 DRC
% 223.54/223.76  |- mesh__historyNote mesh__D051267 2006%28%1994%29%   
% 223.54/223.76  |- mesh__recordMaintainer mesh__D051267 DRC
% 223.54/223.76  |- mesh__dateEstablished mesh__D051267 2006-01-01
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D051267 2006
% 223.54/223.76  |- skos__altLabel mesh__D051267 Nfe2l2 Protein
% 223.54/223.76  |- skos__broader mesh__D051267smesh__D050976
% 223.54/223.76  |- skos__altLabel mesh__D051267
% 223.54/223.76       Nuclear Factor %28%Erythroid-Derived 2%29%-Like 2 Protein
% 223.54/223.76  |- mesh__publicMeSHNote mesh__D051267
% 223.54/223.76       2006; NF-E2-RELATED FACTOR 2 was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1994-2005%A%  
% 223.54/223.76  |- mesh__recordAuthorizer mesh__D051267 sjn
% 223.54/223.76  |- rdf__type mesh__D051267sskos__Concept
% 223.54/223.76  |- skos__prefLabel mesh__D051267 NF-E2-Related Factor 2
% 223.54/223.76  |- mesh__dateCreated mesh__D051267 2005-06-30
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017539 1999
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017539 2000
% 223.54/223.76  |- skos__hiddenLabel mesh__D017539 Venous Intimas
% 223.54/223.76  |- skos__altLabel mesh__D017539 Vascular Intima
% 223.54/223.76  |- skos__broader mesh__D017539smesh__D004730
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017539 1994
% 223.54/223.76  |- mesh__dateEstablished mesh__D017539 1993-01-01
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017539 1993
% 223.54/223.76  |- skos__scopeNote mesh__D017539
% 223.54/223.76       The innermost coat of blood vessels, consisting of a thin lining of endothelial cells longitudinally oriented and continuous with the endothelium of capillaries on the one hand and the endocardium of the heart on the other.%A%    
% 223.54/223.76  |- skos__hiddenLabel mesh__D017539 Intimas, Arterial
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017539 2001
% 223.54/223.76  |- skos__historyNote mesh__D017539 Endothelium, Vascular %28%1988-1992%29%
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017539 1995
% 223.54/223.76  |- skos__hiddenLabel mesh__D017539 Intimas, Vascular
% 223.54/223.76  |- skos__hiddenLabel mesh__D017539 Intima, Arterial
% 223.54/223.76  |- skos__broader mesh__D017539smesh__D001808
% 223.54/223.76  |- mesh__dateCreated mesh__D017539 1992-05-22
% 223.54/223.76  |- skos__hiddenLabel mesh__D017539 Intima, Venous
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017539 2003
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017539 1996
% 223.54/223.76  |- mesh__historyNote mesh__D017539 93   
% 223.54/223.76  |- rdf__type mesh__D017539sskos__Concept
% 223.54/223.76  |- skos__annotation mesh__D017539
% 223.54/223.76       /pathol is more likely than %22%diseases of the tunica intima%22%; coord IM with specific blood vessel %28%IM%29%%A%  
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017539 2002
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017539 2005
% 223.54/223.76  |- skos__historyNote mesh__D017539 specific blood vessel %28%1966-1987%29%
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017539 2004
% 223.54/223.76  |- skos__hiddenLabel mesh__D017539 Arterial Intimas
% 223.54/223.76  |- skos__hiddenLabel mesh__D017539 Vascular Intimas
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017539 1998
% 223.54/223.76  |- mesh__publicMeSHNote mesh__D017539 93   
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017539 1997
% 223.54/223.76  |- skos__hiddenLabel mesh__D017539 Intima, Vascular
% 223.54/223.76  |- skos__prefLabel mesh__D017539 Tunica Intima
% 223.54/223.76  |- skos__hiddenLabel mesh__D017539 Intimas, Venous
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D017539 2006
% 223.54/223.76  |- skos__altLabel mesh__D017539 Tunica Intima Vasorum
% 223.54/223.76  |- mesh__historyNote mesh__D003519
% 223.54/223.76       91%28%75%29%; was see under PHENYLACETATES 1975-90   
% 223.54/223.76  |- mesh__dateCreated mesh__D003519 1974-11-19
% 223.54/223.76  |- skos__prefLabel mesh__D003519 Cyclopentolate
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D003519 2005
% 223.54/223.76  |- rdf__type mesh__D003519sskos__Concept
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D003519 2002
% 223.54/223.76  |- skos__historyNote mesh__D003519 Cyclopentanes %28%1969-1974%29%
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D003519 2004
% 223.54/223.76  |- mesh__dateRevised mesh__D003519 2000-06-22
% 223.54/223.76  |- skos__scopeNote mesh__D003519
% 223.54/223.76       A parasympatholytic anticholinergic used solely to obtain mydriasis or cycloplegia.%A%    
% 223.54/223.76  |- mesh__recordAuthorizer mesh__D003519 sjn
% 223.54/223.76  |- mesh__recordOriginator mesh__D003519 NLM
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D003519 2001
% 223.54/223.76  |- mesh__dateEstablished mesh__D003519 1991-01-01
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D003519 2003
% 223.54/223.76  |- mesh__publicMeSHNote mesh__D003519
% 223.54/223.76       91; was see under PHENYLACETATES 1975-90   
% 223.54/223.76  |- skos__broader mesh__D003519smesh__D010648
% 223.54/223.76  |- skos__historyNote mesh__D003519 Phenylacetates %28%1969-1974%29%
% 223.54/223.76  |- skos__historyNote mesh__D003519 Dimethylamines %28%1974%29%
% 223.54/223.76  |- mesh__recordMaintainer mesh__D003519 CCR
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D003519 2006
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D014241 2006
% 223.54/223.76  |- skos__scopeNote mesh__D014241
% 223.54/223.76       A highly volatile inhalation anesthetic used mainly in short surgical procedures where light anesthesia with good analgesia is required. It is also used as an industrial solvent. Prolonged exposure to high concentrations of the vapor can lead to cardiotoxicity and neurological impairment.%A%    
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D014241 2004
% 223.54/223.76  |- mesh__dateRevised mesh__D014241 2000-06-22
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D014241 2001
% 223.54/223.76  |- mesh__recordOriginator mesh__D014241 NLM
% 223.54/223.76  |- skos__prefLabel mesh__D014241 Trichloroethylene
% 223.54/223.76  |- skos__altLabel mesh__D014241 Ethinyl Trichloride
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D014241 2002
% 223.54/223.76  |- skos__altLabel mesh__D014241 Trichloroethene
% 223.54/223.76  |- mesh__recordMaintainer mesh__D014241 CCR
% 223.54/223.76  |- mesh__recordAuthorizer mesh__D014241 sjn
% 223.54/223.76  |- mesh__dateCreated mesh__D014241 1999-01-01
% 223.54/223.76  |- rdf__type mesh__D014241sskos__Concept
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D014241 2005
% 223.54/223.76  |- skos__hiddenLabel mesh__D014241 Trichloride, Ethinyl
% 223.54/223.76  |- skos__broader mesh__D014241smesh__D006843
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D014241 2003
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D008204 2000
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D008204 1998
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D008204 2006
% 223.54/223.76  |- skos__hiddenLabel mesh__D008204 Lymphangioendotheliomas, Malignant
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D008204 2001
% 223.54/223.76  |- skos__broader mesh__D008204smesh__D012509
% 223.54/223.76  |- skos__scopeNote mesh__D008204
% 223.54/223.76       A malignant tumor originating from the endothelial cells of lymphatic vessels. Most lymphangiosarcomas arise in an arm secondary to radical mastectomy but they sometimes complicate idiopathic lymphedema. The lymphedema has usually been present for 6 to 10 years before malignant changes develop. %28%From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1866%29%%A%    
% 223.54/223.76  |- skos__altLabel mesh__D008204 Lymphangioendothelioma, Malignant
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D008204 1999
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D008204 2003
% 223.54/223.76  |- skos__hiddenLabel mesh__D008204 Malignant Lymphangioendothelioma
% 223.54/223.76  |- rdf__type mesh__D008204sskos__Concept
% 223.54/223.76  |- skos__hiddenLabel mesh__D008204 Malignant Lymphangioendotheliomas
% 223.54/223.76  |- mesh__recordOriginator mesh__D008204 NLM
% 223.54/223.76  |- mesh__recordAuthorizer mesh__D008204 PLS
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D008204 1996
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D008204 2004
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D008204 2002
% 223.54/223.76  |- skos__prefLabel mesh__D008204 Lymphangiosarcoma
% 223.54/223.76  |- skos__broader mesh__D008204smesh__D018190
% 223.54/223.76  |- skos__hiddenLabel mesh__D008204 Lymphangiosarcomas
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D008204 1997
% 223.54/223.76  |- mesh__recordMaintainer mesh__D008204 KEV
% 223.54/223.76  |- mesh__dateCreated mesh__D008204 1999-01-01
% 223.54/223.76  |- mesh__dateRevised mesh__D008204 1995-06-08
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D008204 2005
% 223.54/223.76  |- skos__annotation mesh__D008204
% 223.54/223.76       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 223.54/223.76  |- mesh__dateRevised mesh__D000221 2003-07-09
% 223.54/223.76  |- skos__annotation mesh__D000221
% 223.54/223.76       adjustment of eye to variations in intensity of light; do not confuse with ACCOMMODATION, OCULAR, adjustment of lens to distance%A%  
% 223.54/223.76  |- mesh__recordOriginator mesh__D000221 NLM
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D000221 2004
% 223.54/223.76  |- mesh__recordAuthorizer mesh__D000221 sjn
% 223.54/223.76  |- mesh__dateCreated mesh__D000221 1999-01-01
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D000221 2005
% 223.54/223.76  |- mesh__recordMaintainer mesh__D000221 nns
% 223.54/223.76  |- skos__prefLabel mesh__D000221 Adaptation, Ocular
% 223.54/223.76  |- mesh__activeMeSHYear mesh__D000221 2006
% 223.54/223.77  |- skos__hiddenLabel mesh__D000221 Adaptations, Ocular
% 223.54/223.77  |- skos__scopeNote mesh__D000221
% 223.54/223.77       The adjustment of the eye to variations in the intensity of light. Light adaptation is the adjustment of the eye when the light threshold is increased; DARK ADAPTATION when the light is greatly reduced. %28%From Cline et al., Dictionary of Visual Science, 4th ed%29%%A%    
% 223.54/223.77  |- skos__hiddenLabel mesh__D000221 Adaptations, Light
% 223.54/223.77  |- skos__hiddenLabel mesh__D000221 Adaptation, Light
% 223.54/223.77  |- skos__hiddenLabel mesh__D000221 Ocular Adaptation
% 223.54/223.77  |- skos__broader mesh__D000221smesh__D043723
% 223.54/223.77  |- skos__hiddenLabel mesh__D000221 Light Adaptations
% 223.54/223.77  |- skos__hiddenLabel mesh__D000221 Ocular Adaptations
% 223.54/223.77  |- rdf__type mesh__D000221sskos__Concept
% 223.54/223.77  |- rdf__type mesh__D013947sskos__Concept
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D013947 2006
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D013947 2004
% 223.54/223.77  |- skos__historyNote mesh__D013947 Thymus Gland %28%1973-1974%29%
% 223.54/223.77  |- skos__historyNote mesh__D013947 Glycoproteins %28%1973-1974%29%
% 223.54/223.77  |- skos__broader mesh__D013947smesh__D011506
% 223.54/223.77  |- skos__scopeNote mesh__D013947
% 223.54/223.77       Thymosin. A family of heat-stable, polypeptide hormones secreted by the thymus gland. Their biological activities include lymphocytopoiesis, restoration of immunological competence and enhancement of expression of T-cell characteristics and function. They have therapeutic potential in patients having primary or secondary immunodeficiency diseases, cancer or diseases related to aging.%A%    
% 223.54/223.77  |- skos__prefLabel mesh__D013947 Thymosin
% 223.54/223.77  |- skos__altLabel mesh__D013947 Thymosins
% 223.54/223.77  |- skos__historyNote mesh__D013947 Tissue Extracts %28%1973-1974%29%
% 223.54/223.77  |- mesh__historyNote mesh__D013947
% 223.54/223.77       84%28%75%29%; was see under THYMUS HORMONES 1977-83, was see under THYMUS EXTRACTS 1975-76%A%  
% 223.54/223.77  |- mesh__publicMeSHNote mesh__D013947
% 223.54/223.77       84; was see under THYMUS HORMONES 1977-83, was see under THYMUS EXTRACTS 1975-76%A%  
% 223.54/223.77  |- mesh__dateCreated mesh__D013947 1974-11-19
% 223.54/223.77  |- skos__annotation mesh__D013947 /biosyn /physiol permitted   
% 223.54/223.77  |- skos__broader mesh__D013947smesh__D036361
% 223.54/223.77  |- skos__broader mesh__D013947smesh__D013951
% 223.54/223.77  |- mesh__recordMaintainer mesh__D013947 TPW
% 223.54/223.77  |- mesh__dateEstablished mesh__D013947 1984-01-01
% 223.54/223.77  |- skos__historyNote mesh__D013947 Thymus Extracts %28%1974%29%
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D013947 2005
% 223.54/223.77  |- mesh__recordAuthorizer mesh__D013947 sjn
% 223.54/223.77  |- mesh__recordOriginator mesh__D013947 NLM
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D013947 2003
% 223.54/223.77  |- mesh__dateRevised mesh__D013947 2002-07-03
% 223.54/223.77  |- rdf__type mesh__D013149sskos__Concept
% 223.54/223.77  |- mesh__historyNote mesh__D013149 76   
% 223.54/223.77  |- mesh__dateEstablished mesh__D013149 1976-01-01
% 223.54/223.77  |- skos__historyNote mesh__D013149 Mycoplasmatales %28%1975%29%
% 223.54/223.77  |- skos__historyNote mesh__D013149 Bacteria %28%1966-1974%29%
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D013149 2006
% 223.54/223.77  |- skos__scopeNote mesh__D013149
% 223.54/223.77       A genus of gram-negative, helical bacteria, in the family SPIROPLASMATACEAE, order Entomoplasmatales, causing disease in PLANTS. It has been isolated from TICKS; INSECTS; and PLANTS.%A%    
% 223.54/223.77  |- mesh__dateCreated mesh__D013149 1975-07-23
% 223.54/223.77  |- mesh__dateRevised mesh__D013149 2005-06-30
% 223.54/223.77  |- mesh__recordAuthorizer mesh__D013149 sjn
% 223.54/223.77  |- skos__prefLabel mesh__D013149 Spiroplasma
% 223.54/223.77  |- mesh__recordOriginator mesh__D013149 JW
% 223.54/223.77  |- mesh__publicMeSHNote mesh__D013149 76   
% 223.54/223.77  |- mesh__recordMaintainer mesh__D013149 SYSTEM
% 223.54/223.77  |- skos__broader mesh__D013149smesh__D016991
% 223.54/223.77  |- skos__scopeNote mesh__D018632
% 223.54/223.77       Mice selectively bred for hypersusceptibility to two-stage chemical skin carcinogenesis. They are also hypersusceptible to UV radiation tumorigenesis with single high-dose, but not chronic low-dose, exposures. SENCAR %28%SENsitive to CARcinogenesis%29% mice are used in research as an animal model for tumor production.%A%    
% 223.54/223.77  |- skos__altLabel mesh__D018632 Mice, SENCAR
% 223.54/223.77  |- skos__altLabel mesh__D018632 Mouse, Inbred SENCAR
% 223.54/223.77  |- mesh__dateEstablished mesh__D018632 1995-01-01
% 223.54/223.77  |- skos__historyNote mesh__D018632 Mice %28%1981-1994%29%
% 223.54/223.77  |- mesh__publicMeSHNote mesh__D018632 95   
% 223.54/223.77  |- rdf__type mesh__D018632sskos__Concept
% 223.54/223.77  |- skos__annotation mesh__D018632
% 223.54/223.77       NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE; SENCAR stands for SENsitive to CARcinogenesis%A%  
% 223.54/223.77  |- skos__altLabel mesh__D018632 Mouse, SENCAR
% 223.54/223.77  |- skos__prefLabel mesh__D018632 Mice, Inbred SENCAR
% 223.54/223.77  |- skos__hiddenLabel mesh__D018632 Inbred SENCAR Mouse
% 223.54/223.77  |- mesh__recordAuthorizer mesh__D018632 sjn
% 223.54/223.77  |- skos__hiddenLabel mesh__D018632 SENCAR Mouse
% 223.54/223.77  |- mesh__historyNote mesh__D018632 95   
% 223.54/223.77  |- mesh__dateCreated mesh__D018632 1994-04-16
% 223.54/223.77  |- skos__broader mesh__D018632smesh__D008815
% 223.54/223.77  |- mesh__dateRevised mesh__D018632 2005-06-30
% 223.54/223.77  |- skos__hiddenLabel mesh__D018632 SENCAR Mice
% 223.54/223.77  |- mesh__recordOriginator mesh__D018632 PXP
% 223.54/223.77  |- skos__hiddenLabel mesh__D018632 SENCAR Mice, Inbred
% 223.54/223.77  |- skos__hiddenLabel mesh__D018632 SENCAR Mouse, Inbred
% 223.54/223.77  |- mesh__recordMaintainer mesh__D018632 ags
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D018632 2006
% 223.54/223.77  |- skos__hiddenLabel mesh__D018632 Inbred SENCAR Mice
% 223.54/223.77  |- mesh__publicMeSHNote mesh__D032303 2003   
% 223.54/223.77  |- skos__annotation mesh__D032303
% 223.54/223.77       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.54/223.77  |- mesh__dateCreated mesh__D032303 2002-07-03
% 223.54/223.77  |- mesh__dateEstablished mesh__D032303 2003-01-01
% 223.54/223.77  |- skos__broader mesh__D032303smesh__D019657
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D032303 2005
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D032303 2003
% 223.54/223.77  |- mesh__historyNote mesh__D032303 2003   
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D032303 2006
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D032303 2004
% 223.54/223.77  |- rdf__type mesh__D032303sskos__Concept
% 223.54/223.77  |- skos__prefLabel mesh__D032303 Duboisia
% 223.54/223.77  |- skos__scopeNote mesh__D032303
% 223.54/223.77       A plant genus of the family SOLANACEAE that is a source of SCOPOLAMINE and other TROPANES.%A%    
% 223.54/223.77  |- mesh__dateRevised mesh__D004612 2001-07-25
% 223.54/223.77  |- skos__broader mesh__D004612smesh__D000745
% 223.54/223.77  |- skos__hiddenLabel mesh__D004612 Hereditary Ovalocytosis
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D004612 2006
% 223.54/223.77  |- mesh__publicMeSHNote mesh__D004612 65   
% 223.54/223.77  |- mesh__recordMaintainer mesh__D004612 nns
% 223.54/223.77  |- skos__hiddenLabel mesh__D004612 Hereditary Elliptocytoses
% 223.54/223.77  |- mesh__dateCreated mesh__D004612 1999-01-01
% 223.54/223.77  |- mesh__dateEstablished mesh__D004612 1965-01-01
% 223.54/223.77  |- skos__hiddenLabel mesh__D004612 Elliptocytoses, Hereditary
% 223.54/223.77  |- skos__related mesh__D004612smesh__D000756
% 223.54/223.77  |- skos__annotation mesh__D004612
% 223.54/223.77       a congen hemolytic anemia; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 223.54/223.77  |- rdf__type mesh__D004612sskos__Concept
% 223.54/223.77  |- skos__hiddenLabel mesh__D004612 Hereditary Elliptocytosis
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D004612 2003
% 223.54/223.77  |- skos__altLabel mesh__D004612 Ovalocytosis, Hereditary
% 223.54/223.77  |- mesh__recordAuthorizer mesh__D004612 sjn
% 223.54/223.77  |- skos__scopeNote mesh__D004612
% 223.54/223.77       An intrinsic defect of erythrocytes inherited as an autosomal dominant trait. The erythrocytes assume an oval or elliptical shape.%A%    
% 223.54/223.77  |- skos__hiddenLabel mesh__D004612 Hereditary Ovalocytoses
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D004612 2004
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D004612 2002
% 223.54/223.77  |- mesh__recordOriginator mesh__D004612 NLM
% 223.54/223.77  |- mesh__historyNote mesh__D004612 65%28%64%29%   
% 223.54/223.77  |- skos__hiddenLabel mesh__D004612 Ovalocytoses, Hereditary
% 223.54/223.77  |- skos__prefLabel mesh__D004612 Elliptocytosis, Hereditary
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D004612 2005
% 223.54/223.77  |- skos__hiddenLabel mesh__D051268 GA Binding Protein Transcription Factor
% 223.54/223.77  |- skos__hiddenLabel mesh__D051268 GA Binding Protein, Beta Subunit
% 223.54/223.77  |- skos__altLabel mesh__D051268 Nuclear Respiratory Factor 2, Beta Subunit
% 223.54/223.77  |- mesh__dateRevised mesh__D051268 2005-07-27
% 223.54/223.77  |- skos__altLabel mesh__D051268 Nuclear Respiratory Factor 2, Alpha Subunit
% 223.54/223.77  |- skos__altLabel mesh__D051268 Nuclear Respiratory Factor-2
% 223.54/223.77  |- skos__altLabel mesh__D051268 Nuclear Respiratory Factor 2
% 223.54/223.77  |- mesh__recordMaintainer mesh__D051268 ags
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D051268 2006
% 223.54/223.77  |- skos__prefLabel mesh__D051268 GA-Binding Protein Transcription Factor
% 223.54/223.77  |- mesh__historyNote mesh__D051268 2006%28%1991%29%   
% 223.54/223.77  |- skos__scopeNote mesh__D051268
% 223.54/223.77       A heterotetrameric transcription factor composed of two distinct proteins. Its name refers to the fact it binds to DNA sequences rich in GUANINE and ADENINE. GA-binding protein integrates a variety of SIGNAL TRANSDUCTION PATHWAYS and regulates expression of GENES involved in CELL CYCLE control, PROTEIN BIOSYNTHESIS, and cellular METABOLISM.%A%    
% 223.54/223.77  |- skos__altLabel mesh__D051268 GABP Transcription Factor
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D051268 2006A
% 223.54/223.77  |- mesh__recordAuthorizer mesh__D051268 ags
% 223.54/223.77  |- skos__broader mesh__D051268smesh__D051264
% 223.54/223.77  |- mesh__publicMeSHNote mesh__D051268
% 223.54/223.77       2006; GA-BINDING PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1991-2005%A%  
% 223.54/223.77  |- mesh__dateCreated mesh__D051268 2005-06-30
% 223.54/223.77  |- skos__hiddenLabel mesh__D051268 GA Binding Protein, Alpha Subunit
% 223.54/223.77  |- skos__hiddenLabel mesh__D051268 Transcription Factor, GABP
% 223.54/223.77  |- skos__altLabel mesh__D051268 GA-Binding Protein
% 223.54/223.77  |- rdf__type mesh__D051268sskos__Concept
% 223.54/223.77  |- mesh__dateEstablished mesh__D051268 2006-01-01
% 223.54/223.77  |- mesh__recordOriginator mesh__D051268 DRC
% 223.54/223.77  |- skos__hiddenLabel mesh__D051268 GA Binding Protein
% 223.54/223.77  |- skos__hiddenLabel mesh__D051268 Respiratory Factor-2, Nuclear
% 223.54/223.77  |- mesh__historyNote mesh__D014242 91%28%75%29%   
% 223.54/223.77  |- mesh__recordMaintainer mesh__D014242 SYSTEM
% 223.54/223.77  |- skos__scopeNote mesh__D014242
% 223.54/223.77       A mitosporic fungal genus frequently found in soil and on wood. It is sometimes used for controlling pathogenic fungi. Its teleomorph is HYPOCREA.%A%    
% 223.54/223.77  |- mesh__dateRevised mesh__D014242 2005-06-30
% 223.54/223.77  |- mesh__recordOriginator mesh__D014242 NLM
% 223.54/223.77  |- rdf__type mesh__D014242sskos__Concept
% 223.54/223.77  |- skos__annotation mesh__D014242
% 223.54/223.77       infection: coord IM with MYCOSES or specifics   
% 223.54/223.77  |- mesh__recordAuthorizer mesh__D014242 sjn
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D014242 2006
% 223.54/223.77  |- skos__prefLabel mesh__D014242 Trichoderma
% 223.54/223.77  |- mesh__dateEstablished mesh__D014242 1991-01-01
% 223.54/223.77  |- mesh__dateCreated mesh__D014242 1974-12-12
% 223.54/223.77  |- mesh__publicMeSHNote mesh__D014242
% 223.54/223.77       91; see HYPHOMYCETES 1986-90, see MONILIALES 1975-85   
% 223.54/223.77  |- skos__broader mesh__D014242smesh__D003904
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D008205 1999
% 223.54/223.77  |- mesh__publicMeSHNote mesh__D008205
% 223.54/223.77       LYMPHANGITIS, EPIZOOTIC was heading 1970-81   
% 223.54/223.77  |- mesh__dateRevised mesh__D008205 1990-05-29
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D008205 2003
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D008205 1993
% 223.54/223.77  |- rdf__type mesh__D008205sskos__Concept
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D008205 2000
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D008205 1996
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D008205 2004
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D008205 2001
% 223.54/223.77  |- skos__prefLabel mesh__D008205 Lymphangitis
% 223.54/223.77  |- skos__annotation mesh__D008205
% 223.54/223.77       inflamm of lymphatic vessels; do not confuse with LYMPHADENITIS, inflamm of lymph nodes%A%  
% 223.54/223.77  |- mesh__historyNote mesh__D008205
% 223.54/223.77       LYMPHANGITIS, EPIZOOTIC was heading 1970-81   
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D008205 1997
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D008205 1994
% 223.54/223.77  |- mesh__recordMaintainer mesh__D008205 PLS
% 223.54/223.77  |- mesh__onlineNote mesh__D008205
% 223.54/223.77       use LYMPHANGITIS /VE to search LYMPHANGITIS, EPIZOOTIC 1970-81%A%  
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D008205 1991
% 223.54/223.77  |- mesh__dateCreated mesh__D008205 1999-01-01
% 223.54/223.77  |- mesh__recordOriginator mesh__D008205 NLM
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D008205 2005
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D008205 1995
% 223.54/223.77  |- skos__broader mesh__D008205smesh__D008206
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D008205 2002
% 223.54/223.77  |- skos__hiddenLabel mesh__D008205 Lymphangitides
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D008205 1998
% 223.54/223.77  |- mesh__recordAuthorizer mesh__D008205 NLM
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D008205 2006
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D008205 1992
% 223.54/223.77  |- skos__hiddenLabel mesh__D000222 Physiologic Adaptation
% 223.54/223.77  |- mesh__activeMeSHYear mesh__D000222 2006
% 223.54/223.77  |- skos__altLabel mesh__D000222 Adaptations, Physiological
% 223.54/223.77  |- skos__hiddenLabel mesh__D000222 Physiological Adaptations
% 223.54/223.77  |- skos__altLabel mesh__D000222 Physiological Adaptation
% 223.54/223.77  |- skos__broader mesh__D000222smesh__D000220
% 223.54/223.77  |- skos__altLabel mesh__D000222 Adaptation, Physiologic
% 223.54/223.77  |- skos__hiddenLabel mesh__D000222 Physiologic Adaptations
% 223.54/223.77  |- skos__altLabel mesh__D000222 Adaptations, Physiologic
% 223.64/223.78  |- mesh__recordOriginator mesh__D000222 NLM
% 223.64/223.78  |- rdf__type mesh__D000222sskos__Concept
% 223.64/223.78  |- mesh__recordAuthorizer mesh__D000222 sjn
% 223.64/223.78  |- skos__prefLabel mesh__D000222 Adaptation, Physiological
% 223.64/223.78  |- mesh__dateRevised mesh__D000222 2003-07-09
% 223.64/223.78  |- skos__annotation mesh__D000222 DF: ADAPTATION PHYSIOL   
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D000222 2004
% 223.64/223.78  |- mesh__recordMaintainer mesh__D000222 lkt
% 223.64/223.78  |- mesh__dateCreated mesh__D000222 1999-01-01
% 223.64/223.78  |- skos__broader mesh__D000222smesh__D010829
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D000222 2005
% 223.64/223.78  |- skos__historyNote mesh__D013948 Sympatholytics %28%1966-1971%29%
% 223.64/223.78  |- mesh__dateEstablished mesh__D013948 1973-01-01
% 223.64/223.78  |- mesh__recordMaintainer mesh__D013948 CCR
% 223.64/223.78  |- mesh__recordOriginator mesh__D013948 NLM
% 223.64/223.78  |- mesh__recordAuthorizer mesh__D013948 sjn
% 223.64/223.78  |- skos__broader mesh__D013948smesh__D004123
% 223.64/223.78  |- skos__prefLabel mesh__D013948 Moxisylyte
% 223.64/223.78  |- skos__altLabel mesh__D013948 Acetoxythymoxamine
% 223.64/223.78  |- skos__scopeNote mesh__D013948
% 223.64/223.78       An alpha-adrenergic blocking agent that is used in Raynaud%27%s disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1312%29%%A%    
% 223.64/223.78  |- skos__altLabel mesh__D013948 Viatris Brand of Moxisylyte Hydrochloride
% 223.64/223.78  |- mesh__onlineNote mesh__D013948
% 223.64/223.78       use MOXISYLYTE to search THYMOXAMINE 1972-92 %28%as Prov 1972%29%%A%  
% 223.64/223.78  |- skos__altLabel mesh__D013948 Thymoxyalcylamine
% 223.64/223.78  |- skos__altLabel mesh__D013948
% 223.64/223.78       Arkopharma Brand of Moxisylyte Hydrochloride
% 223.64/223.78  |- mesh__dateRevised mesh__D013948 2005-06-30
% 223.64/223.78  |- skos__hiddenLabel mesh__D013948 Hydrochloride, Moxisylyte
% 223.64/223.78  |- skos__altLabel mesh__D013948 Hansam Brand of Moxisylyte Hydrochloride
% 223.64/223.78  |- rdf__type mesh__D013948sskos__Concept
% 223.64/223.78  |- skos__historyNote mesh__D013948 Carvacrol %28%1966-1971%29%
% 223.64/223.78  |- skos__altLabel mesh__D013948 Thymoxamine
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D013948 2006
% 223.64/223.78  |- mesh__publicMeSHNote mesh__D013948
% 223.64/223.78       93; was THYMOXAMINE 1972-92; MOXISYLYTE was see THYMOXAMINE 1976-92%A%  
% 223.64/223.78  |- mesh__historyNote mesh__D013948
% 223.64/223.78       93; was THYMOXAMINE 1972-92 %28%Prov 1972%29%; MOXISYLYTE was see THYMOXAMINE 1976-92%A%  
% 223.64/223.78  |- mesh__dateCreated mesh__D013948 1999-01-01
% 223.64/223.78  |- skos__broader mesh__D018633smesh__D006349
% 223.64/223.78  |- mesh__historyNote mesh__D018633 95   
% 223.64/223.78  |- skos__scopeNote mesh__D018633
% 223.64/223.78       Congenital absence of the normal valvular orifice into the pulmonary artery. This condition is characterized by cardiomegaly, reduced pulmonary vascularity, and right ventricular atrophy. %28%From Stedman, 25th ed; Dorland, 27th ed%29%%A%    
% 223.64/223.78  |- skos__altLabel mesh__D018633 Pulmonary Atresias
% 223.64/223.78  |- skos__altLabel mesh__D018633 Atresia, Pulmonary
% 223.64/223.78  |- skos__prefLabel mesh__D018633 Pulmonary Atresia
% 223.64/223.78  |- skos__hiddenLabel mesh__D018633 Valve Atresia, Pulmonary
% 223.64/223.78  |- skos__hiddenLabel mesh__D018633 Valve Atresias, Pulmonary
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D018633 2005
% 223.64/223.78  |- mesh__dateEstablished mesh__D018633 1995-01-01
% 223.64/223.78  |- skos__historyNote mesh__D018633
% 223.64/223.78       Pulmonary Valve/abnormalities %28%1966-1994%29%
% 223.64/223.78  |- skos__broader mesh__D018633smesh__D018376
% 223.64/223.78  |- skos__annotation mesh__D018633
% 223.64/223.78       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: PULM ATRESIA%A%  
% 223.64/223.78  |- mesh__recordMaintainer mesh__D018633 kle
% 223.64/223.78  |- skos__altLabel mesh__D018633 Atresias, Pulmonary
% 223.64/223.78  |- skos__altLabel mesh__D018633 Pulmonary Valve Atresias
% 223.64/223.78  |- skos__altLabel mesh__D018633 Atresia, Pulmonary Valve
% 223.64/223.78  |- mesh__dateRevised mesh__D018633 1999-11-03
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D018633 2003
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D018633 2006
% 223.64/223.78  |- mesh__recordOriginator mesh__D018633 PXP
% 223.64/223.78  |- mesh__publicMeSHNote mesh__D018633 95   
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D018633 2000
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D018633 2004
% 223.64/223.78  |- skos__altLabel mesh__D018633 Pulmonary Valve Atresia
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D018633 2001
% 223.64/223.78  |- mesh__recordAuthorizer mesh__D018633 sjn
% 223.64/223.78  |- rdf__type mesh__D018633sskos__Concept
% 223.64/223.78  |- skos__altLabel mesh__D018633 Atresias, Pulmonary Valve
% 223.64/223.78  |- mesh__dateCreated mesh__D018633 1994-05-23
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D018633 2002
% 223.64/223.78  |- skos__historyNote mesh__D018633
% 223.64/223.78       Pulmonary Artery/abnormalities %28%1966-1994%29%
% 223.64/223.78  |- mesh__recordOriginator mesh__D010650 NLM
% 223.64/223.78  |- skos__historyNote mesh__D010650 Ammonia-Lyases %28%1973-1974%29%
% 223.64/223.78  |- mesh__recordMaintainer mesh__D010650 ssb
% 223.64/223.78  |- mesh__publicMeSHNote mesh__D010650
% 223.64/223.78       91; was see under AMMONIA-LYASES 1975-90   
% 223.64/223.78  |- mesh__dateEstablished mesh__D010650 1991-01-01
% 223.64/223.78  |- skos__broader mesh__D010650smesh__D000642
% 223.64/223.78  |- mesh__historyNote mesh__D010650
% 223.64/223.78       91%28%75%29%; was see under AMMONIA-LYASES 1975-90   
% 223.64/223.78  |- skos__historyNote mesh__D010650 Phenylalanine %28%1973-1974%29%
% 223.64/223.78  |- skos__prefLabel mesh__D010650 Phenylalanine Ammonia-Lyase
% 223.64/223.78  |- skos__hiddenLabel mesh__D010650 Phenylalanine Ammonia Lyase
% 223.64/223.78  |- skos__annotation mesh__D010650 an antineoplastic   
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D010650 2004
% 223.64/223.78  |- mesh__dateCreated mesh__D010650 1974-11-19
% 223.64/223.78  |- rdf__type mesh__D010650sskos__Concept
% 223.64/223.78  |- mesh__recordAuthorizer mesh__D010650 sjn
% 223.64/223.78  |- skos__scopeNote mesh__D010650
% 223.64/223.78       An enzyme that catalyzes the deamination of L-phenylalanine to form trans-cinnamate and ammonia. It may also act on L-tyrosine. Since the enzyme deprives neoplastic tissue of phenylalanine, it has been used experimentally in the treatment of acute lymphoblastic leukemia. The enzyme is obtained from many plants. EC 4.3.1.5.%A%    
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D010650 2005
% 223.64/223.78  |- skos__hiddenLabel mesh__D010650 Ammonia-Lyase, Phenylalanine
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D010650 2006
% 223.64/223.78  |- mesh__dateRevised mesh__D010650 2003-07-09
% 223.64/223.78  |- skos__scopeNote mesh__D032304
% 223.64/223.78       A plant genus of the family SOLANACEAE which contains TROPANES.%A%    
% 223.64/223.78  |- skos__broader mesh__D032304smesh__D019657
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D032304 2005
% 223.64/223.78  |- mesh__dateCreated mesh__D032304 2002-07-03
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D032304 2003
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D032304 2006
% 223.64/223.78  |- mesh__dateEstablished mesh__D032304 2003-01-01
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D032304 2004
% 223.64/223.78  |- skos__altLabel mesh__D032304 Henbane
% 223.64/223.78  |- rdf__type mesh__D032304sskos__Concept
% 223.64/223.78  |- mesh__historyNote mesh__D032304 2003   
% 223.64/223.78  |- skos__annotation mesh__D032304
% 223.64/223.78       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.64/223.78  |- mesh__publicMeSHNote mesh__D032304 2003   
% 223.64/223.78  |- skos__prefLabel mesh__D032304 Hyoscyamus
% 223.64/223.78  |- skos__broader mesh__D003739Q000254smesh__D003739
% 223.64/223.78  |- mesh__preferredCombination mesh__D003739Q000254smesh__D025021
% 223.64/223.78  |- rdf__type mesh__D003739Q000254smesh__CompoundConcept
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D004613 2005
% 223.64/223.78  |- mesh__dateRevised mesh__D004613 2001-07-25
% 223.64/223.78  |- mesh__dateCreated mesh__D004613 1999-01-01
% 223.64/223.78  |- skos__scopeNote mesh__D004613
% 223.64/223.78       Dwarfism occurring in association with defective development of skin, hair, and teeth, polydactyly, and defect of the cardiac septum. %28%Dorland, 27th ed%29%%A%    
% 223.64/223.78  |- mesh__recordMaintainer mesh__D004613 nns
% 223.64/223.78  |- mesh__dateEstablished mesh__D004613 1965-01-01
% 223.64/223.78  |- skos__hiddenLabel mesh__D004613 Chondroectodermal Dysplasias
% 223.64/223.78  |- skos__prefLabel mesh__D004613 Ellis-Van Creveld Syndrome
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D004613 2006
% 223.64/223.78  |- rdf__type mesh__D004613sskos__Concept
% 223.64/223.78  |- skos__altLabel mesh__D004613 Chondroectodermal Dysplasia
% 223.64/223.78  |- skos__broader mesh__D004613smesh__D004476
% 223.64/223.78  |- skos__hiddenLabel mesh__D004613 Ellis Van Creveld Syndrome
% 223.64/223.78  |- mesh__recordAuthorizer mesh__D004613 sjn
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D004613 2003
% 223.64/223.78  |- skos__annotation mesh__D004613
% 223.64/223.78       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 223.64/223.78  |- mesh__recordOriginator mesh__D004613 NLM
% 223.64/223.78  |- skos__hiddenLabel mesh__D004613 Dysplasias, Chondroectodermal
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D004613 2002
% 223.64/223.78  |- mesh__historyNote mesh__D004613 65%28%63%29%   
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D004613 2004
% 223.64/223.78  |- skos__hiddenLabel mesh__D004613 Syndrome, Ellis-Van Creveld
% 223.64/223.78  |- skos__hiddenLabel mesh__D004613 Dysplasia, Chondroectodermal
% 223.64/223.78  |- skos__broader mesh__D004613smesh__D010009
% 223.64/223.78  |- mesh__publicMeSHNote mesh__D004613 65   
% 223.64/223.78  |- mesh__dateCreated mesh__D051269 2005-06-30
% 223.64/223.78  |- skos__scopeNote mesh__D051269
% 223.64/223.78       The founding member of the sodium glucose transport proteins. It is predominately expressed in the INTESTINAL MUCOSA of the SMALL INTESTINE.%A%    
% 223.64/223.78  |- mesh__dateEstablished mesh__D051269 2006-01-01
% 223.64/223.78  |- mesh__recordAuthorizer mesh__D051269 sjn
% 223.64/223.78  |- mesh__historyNote mesh__D051269 2006%28%1993%29%   
% 223.64/223.78  |- skos__altLabel mesh__D051269 SGLT1 Protein
% 223.64/223.78  |- mesh__publicMeSHNote mesh__D051269
% 223.64/223.78       2006; SODIUM-GLUCOSE TRANSPORTER 1 was indexed under MEMBRANE GLYCOPROTEINS 1997-2005, %26% under MONOSACCHARIDE TRANSPORT PROTEINS 1996-2005, %26% under MEMBRANE PROTEINS 1993-1996, %26% under CARRIER PROTEINS 1993-1995%A%  
% 223.64/223.78  |- skos__hiddenLabel mesh__D051269 Sodium Glucose Transporter 1
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D051269 2006
% 223.64/223.78  |- skos__prefLabel mesh__D051269 Sodium-Glucose Transporter 1
% 223.64/223.78  |- skos__altLabel mesh__D051269 SLC5A1 Protein
% 223.64/223.78  |- skos__altLabel mesh__D051269 Sodium-Glucose Cotransporter 1
% 223.64/223.78  |- rdf__type mesh__D051269sskos__Concept
% 223.64/223.78  |- mesh__recordOriginator mesh__D051269 DRC
% 223.64/223.78  |- skos__broader mesh__D051269smesh__D051247
% 223.64/223.78  |- skos__hiddenLabel mesh__D051269 Sodium Glucose Cotransporter 1
% 223.64/223.78  |- mesh__recordMaintainer mesh__D051269 DRC
% 223.64/223.78  |- skos__altLabel mesh__D020280 Altruline
% 223.64/223.78  |- skos__altLabel mesh__D020280 Genpharm Brand of Sertraline Hydrochloride
% 223.64/223.78  |- skos__altLabel mesh__D020280 Besitran
% 223.64/223.78  |- skos__altLabel mesh__D020280 Lacer Brand of Sertraline Hydrochloride
% 223.64/223.78  |- mesh__recordMaintainer mesh__D020280 CCR
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D020280 2006
% 223.64/223.78  |- skos__hiddenLabel mesh__D020280 Hydrochloride, Sertraline
% 223.64/223.78  |- skos__hiddenLabel mesh__D020280 Gen Sertraline
% 223.64/223.78  |- skos__altLabel mesh__D020280
% 223.64/223.78       Sertraline Hydrochloride %28%1S-cis%29%-Isomer
% 223.64/223.78  |- mesh__recordAuthorizer mesh__D020280 sjn
% 223.64/223.78  |- skos__altLabel mesh__D020280 Pfizer Brand of Sertraline Hydrochloride
% 223.64/223.78  |- skos__prefLabel mesh__D020280 Sertraline
% 223.64/223.78  |- mesh__recordOriginator mesh__D020280 ADP
% 223.64/223.78  |- mesh__dateRevised mesh__D020280 2005-06-30
% 223.64/223.78  |- skos__hiddenLabel mesh__D020280 Novo Sertraline
% 223.64/223.78  |- skos__altLabel mesh__D020280
% 223.64/223.78       Rhoxalpharma Brand of Sertraline Hydrochloride
% 223.64/223.78  |- skos__broader mesh__D020280smesh__D015057
% 223.64/223.78  |- skos__hiddenLabel mesh__D020280 Rhoxal sertraline
% 223.64/223.78  |- skos__altLabel mesh__D020280 Lustral
% 223.64/223.78  |- skos__altLabel mesh__D020280 Apotex Brand of Sertraline Hydrochloride
% 223.64/223.78  |- skos__hiddenLabel mesh__D020280 Apo Sertraline
% 223.64/223.78  |- skos__altLabel mesh__D020280 Esteve Brand of Sertraline Hydrochloride
% 223.64/223.78  |- mesh__historyNote mesh__D020280 99; use SERTRALINE %28%NM%29% 1983-98   
% 223.64/223.78  |- skos__altLabel mesh__D020280
% 223.64/223.78       Boehringer Ingelheim Brand of Sertraline Hydrochloride
% 223.64/223.78  |- mesh__publicMeSHNote mesh__D020280
% 223.64/223.78       99; SERTRALINE was indexed under 1-NAPHTHYLAMINE/analogs %26% derivatives 1983-98%A%  
% 223.64/223.78  |- skos__altLabel mesh__D020280 Novopharm Brand of Sertraline Hydrochloride
% 223.64/223.78  |- mesh__dateEstablished mesh__D020280 1999-01-01
% 223.64/223.78  |- skos__scopeNote mesh__D020280
% 223.64/223.78       A selective serotonin uptake inhibitor that is used in the treatment of depression.%A%    
% 223.64/223.78  |- skos__altLabel mesh__D020280 Roerig Brand of Sertraline Hydrochloride
% 223.64/223.78  |- skos__historyNote mesh__D020280
% 223.64/223.78       1-Naphthylamine/analogs %26% derivatives %28%1983-1998%29%
% 223.64/223.78  |- skos__altLabel mesh__D020280
% 223.64/223.78       Parke Davis Brand of Sertraline Hydrochloride
% 223.64/223.78  |- mesh__dateCreated mesh__D020280 1998-06-11
% 223.64/223.78  |- rdf__type mesh__D020280sskos__Concept
% 223.64/223.78  |- skos__altLabel mesh__D020280
% 223.64/223.78       Ratiopharm Brand of Sertraline Hydrochloride
% 223.64/223.78  |- skos__hiddenLabel mesh__D020280 ratio Sertraline
% 223.64/223.78  |- skos__historyNote mesh__D014243 Sesquiterpenes %28%1974%29%
% 223.64/223.78  |- mesh__activeMeSHYear mesh__D014243 2006
% 223.64/223.78  |- mesh__recordMaintainer mesh__D014243 ssb
% 223.64/223.78  |- mesh__recordAuthorizer mesh__D014243 sjn
% 223.64/223.78  |- mesh__dateEstablished mesh__D014243 1991-01-01
% 223.64/223.78  |- skos__broader mesh__D014243smesh__D014255
% 223.64/223.78  |- skos__scopeNote mesh__D014243
% 223.64/223.78       Antifungal metabolite from several fungi, mainly Trichoderma viride; inhibits protein synthesis by binding to ribosomes; proposed as antifungal and antineoplastic; used as tool in cellular biochemistry.%A%    
% 223.64/223.78  |- mesh__historyNote mesh__D014243
% 223.64/223.78       91%28%75%29%; was see under SESQUITERPENES 1975-90   
% 223.64/223.78  |- rdf__type mesh__D014243sskos__Concept
% 223.64/223.78  |- skos__prefLabel mesh__D014243 Trichodermin
% 223.64/223.79  |- mesh__dateCreated mesh__D014243 1974-11-19
% 223.64/223.79  |- mesh__dateRevised mesh__D014243 2005-06-30
% 223.64/223.79  |- mesh__recordOriginator mesh__D014243 NLM
% 223.64/223.79  |- mesh__publicMeSHNote mesh__D014243
% 223.64/223.79       91; was see under SESQUITERPENES 1975-90   
% 223.64/223.79  |- skos__hiddenLabel mesh__D008206 Lymphadenopathies
% 223.64/223.79  |- mesh__recordAuthorizer mesh__D008206 sjn
% 223.64/223.79  |- mesh__recordOriginator mesh__D008206 NLM
% 223.64/223.79  |- mesh__dateEstablished mesh__D008206 1970-01-01
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D008206 2002
% 223.64/223.79  |- mesh__dateCreated mesh__D008206 1999-01-01
% 223.64/223.79  |- skos__historyNote mesh__D008206 Lymphatic System %28%1966-1967%29%
% 223.64/223.79  |- skos__hiddenLabel mesh__D008206 Lymphatic Disease
% 223.64/223.79  |- skos__broader mesh__D008206smesh__D006425
% 223.64/223.79  |- skos__hiddenLabel mesh__D008206 Diseases, Lymphatic
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D008206 2005
% 223.64/223.79  |- skos__related mesh__D008206smesh__D008223
% 223.64/223.79  |- mesh__recordMaintainer mesh__D008206 mdb
% 223.64/223.79  |- skos__annotation mesh__D008206
% 223.64/223.79       note X ref LYMPHADENOPATHY: unspecified goes here but note LYMPHADENOPATHY SYNDROME see AIDS-RELATED COMPLEX %26% consider IMMUNOBLASTIC LYMPHADENOPATHY; SEZARY SYNDROME %26% other specifics indented here; inflamm dis = LYMPHANGITIS%A%  
% 223.64/223.79  |- mesh__dateRevised mesh__D008206 2001-07-25
% 223.64/223.79  |- mesh__onlineNote mesh__D008206
% 223.64/223.79       use LYMPHATIC DISEASES to search LYMPHATISM 1966-78   
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D008206 2006
% 223.64/223.79  |- skos__prefLabel mesh__D008206 Lymphatic Diseases
% 223.64/223.79  |- mesh__historyNote mesh__D008206
% 223.64/223.79       70%28%68%29%; LYMPHATISM was heading 1963-78   
% 223.64/223.79  |- skos__scopeNote mesh__D008206 Diseases of lymph or lymph vessels.     
% 223.64/223.79  |- skos__altLabel mesh__D008206 Lymphadenopathy
% 223.64/223.79  |- skos__related mesh__D008206smesh__D007945
% 223.64/223.79  |- skos__related mesh__D008206smesh__D002916
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D008206 2003
% 223.64/223.79  |- rdf__type mesh__D008206sskos__Concept
% 223.64/223.79  |- mesh__publicMeSHNote mesh__D008206 70; LYMPHATISM was heading 1963-78   
% 223.64/223.79  |- skos__hiddenLabel mesh__D008206 Disease, Lymphatic
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D008206 2004
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D000223 2001
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D000223 2002
% 223.64/223.79  |- skos__hiddenLabel mesh__D000223 Behaviors, Coping
% 223.64/223.79  |- skos__altLabel mesh__D000223 Adjustment, Psychological
% 223.64/223.79  |- skos__prefLabel mesh__D000223 Adaptation, Psychological
% 223.64/223.79  |- skos__altLabel mesh__D000223 Adaptation, Psychologic
% 223.64/223.79  |- rdf__type mesh__D000223sskos__Concept
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D000223 2003
% 223.64/223.79  |- skos__hiddenLabel mesh__D000223 Adaptive Behavior
% 223.64/223.79  |- mesh__dateRevised mesh__D000223 1999-11-08
% 223.64/223.79  |- skos__broader mesh__D000223smesh__D001520
% 223.64/223.79  |- skos__related mesh__D000223smesh__D012917
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D000223 2004
% 223.64/223.79  |- mesh__recordMaintainer mesh__D000223 KEV
% 223.64/223.79  |- skos__hiddenLabel mesh__D000223 Psychologic Adaptation
% 223.64/223.79  |- mesh__dateCreated mesh__D000223 1999-01-01
% 223.64/223.79  |- skos__hiddenLabel mesh__D000223 Coping Behaviors
% 223.64/223.79  |- skos__altLabel mesh__D000223 Psychological Adaptation
% 223.64/223.79  |- skos__scopeNote mesh__D000223
% 223.64/223.79       A state of harmony between internal needs and external demands and the processes used in achieving this condition. %28%From APA Thesaurus of Psychological Index Terms, 8th ed%29%%A%    
% 223.64/223.79  |- skos__hiddenLabel mesh__D000223 Skills, Coping
% 223.64/223.79  |- skos__hiddenLabel mesh__D000223 Behavior, Coping
% 223.64/223.79  |- mesh__recordOriginator mesh__D000223 NLM
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D000223 2005
% 223.64/223.79  |- skos__hiddenLabel mesh__D000223 Behaviors, Adaptive
% 223.64/223.79  |- skos__hiddenLabel mesh__D000223 Adaptive Behaviors
% 223.64/223.79  |- mesh__recordAuthorizer mesh__D000223 sjn
% 223.64/223.79  |- skos__hiddenLabel mesh__D000223 Skill, Coping
% 223.64/223.79  |- skos__hiddenLabel mesh__D000223 Coping Skill
% 223.64/223.79  |- skos__altLabel mesh__D000223 Psychological Adjustment
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D000223 2006
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D000223 2000
% 223.64/223.79  |- skos__annotation mesh__D000223
% 223.64/223.79       human %26% animal; DF: ADAPTATION PSYCHOL   
% 223.64/223.79  |- skos__hiddenLabel mesh__D000223 Adjustments, Psychological
% 223.64/223.79  |- mesh__dateRevised mesh__D013949 2005-06-30
% 223.64/223.79  |- skos__broader mesh__D013949smesh__D014020
% 223.64/223.79  |- skos__scopeNote mesh__D013949
% 223.64/223.79       Extracts of the thymus that contain specific, but uncharacterized factors or proteins with specific activities; three distinct substances are already known: thymotoxin, thymin and thymosin.%A%    
% 223.64/223.79  |- mesh__historyNote mesh__D013949 74   
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D013949 2006
% 223.64/223.79  |- rdf__type mesh__D013949sskos__Concept
% 223.64/223.79  |- skos__prefLabel mesh__D013949 Thymus Extracts
% 223.64/223.79  |- mesh__recordOriginator mesh__D013949 NLM
% 223.64/223.79  |- mesh__recordAuthorizer mesh__D013949 sjn
% 223.64/223.79  |- mesh__dateCreated mesh__D013949 1999-01-01
% 223.64/223.79  |- mesh__dateEstablished mesh__D013949 1974-01-01
% 223.64/223.79  |- skos__annotation mesh__D013949
% 223.64/223.79       extracts of thymus or thymus fractions containing uncharacterized factors; do not confuse with chemical substances %22%extracted%22% from the thymus, as %22%peptides extracted from the mouse thymus%22% %28% = PEPTIDES /anal + THYMUS GLAND /anal%29%%A%  
% 223.64/223.79  |- mesh__publicMeSHNote mesh__D013949 74   
% 223.64/223.79  |- mesh__recordMaintainer mesh__D013949 ssb
% 223.64/223.79  |- skos__hiddenLabel mesh__D013949 Extracts, Thymus
% 223.64/223.79  |- mesh__recordAuthorizer mesh__D018634 sjn
% 223.64/223.79  |- skos__annotation mesh__D018634 IM   
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D018634 2005
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D018634 2002
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D018634 2006
% 223.64/223.79  |- skos__broader mesh__D018634smesh__D006282
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D018634 2003
% 223.64/223.79  |- skos__hiddenLabel mesh__D018634 Veterinarian
% 223.64/223.79  |- skos__scopeNote mesh__D018634
% 223.64/223.79       Individuals with a degree in veterinary medicine that provides them with training and qualifications to treat diseases and injuries of animals.%A%    
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D018634 2004
% 223.64/223.79  |- mesh__dateRevised mesh__D018634 1999-11-04
% 223.64/223.79  |- mesh__dateEstablished mesh__D018634 1995-01-01
% 223.64/223.79  |- rdf__type mesh__D018634sskos__Concept
% 223.64/223.79  |- mesh__recordOriginator mesh__D018634 TGC
% 223.64/223.79  |- skos__historyNote mesh__D018634 Veterinary Medicine %28%1966-1994%29%
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D018634 2000
% 223.64/223.79  |- mesh__publicMeSHNote mesh__D018634 95   
% 223.64/223.79  |- skos__prefLabel mesh__D018634 Veterinarians
% 223.64/223.79  |- mesh__recordMaintainer mesh__D018634 KEV
% 223.64/223.79  |- mesh__historyNote mesh__D018634 95   
% 223.64/223.79  |- skos__related mesh__D018634smesh__D017750
% 223.64/223.79  |- mesh__dateCreated mesh__D018634 1994-04-16
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D018634 2001
% 223.64/223.79  |- skos__annotation mesh__D010651
% 223.64/223.79       /defic: consider also PHENYLKETONURIAS and PHENYLKETONURIA, MATERNAL%A%  
% 223.64/223.79  |- skos__hiddenLabel mesh__D010651 4-Hydroxylase, Phenylalanine
% 223.64/223.79  |- skos__prefLabel mesh__D010651 Phenylalanine Hydroxylase
% 223.64/223.79  |- skos__hiddenLabel mesh__D010651 Hydroxylase, Phenylalanine
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D010651 2006
% 223.64/223.79  |- skos__altLabel mesh__D010651 Phenylalanine 4-Monooxygenase
% 223.64/223.79  |- mesh__dateEstablished mesh__D010651 1973-01-01
% 223.64/223.79  |- mesh__recordMaintainer mesh__D010651 ssb
% 223.64/223.79  |- skos__related mesh__D010651smesh__D017042
% 223.64/223.79  |- skos__historyNote mesh__D010651 Hydroxylases %28%1966-1970%29%
% 223.64/223.79  |- skos__broader mesh__D010651smesh__D006899
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D010651 2005
% 223.64/223.79  |- skos__related mesh__D010651smesh__D010661
% 223.64/223.79  |- mesh__dateRevised mesh__D010651 2004-07-07
% 223.64/223.79  |- mesh__recordOriginator mesh__D010651 NLM
% 223.64/223.79  |- skos__altLabel mesh__D010651 Phenylalanine 4-Hydroxylase
% 223.64/223.79  |- mesh__dateCreated mesh__D010651 1999-01-01
% 223.64/223.79  |- skos__hiddenLabel mesh__D010651 Phenylalanine 4 Monooxygenase
% 223.64/223.79  |- mesh__publicMeSHNote mesh__D010651 73   
% 223.64/223.79  |- rdf__type mesh__D010651sskos__Concept
% 223.64/223.79  |- skos__hiddenLabel mesh__D010651 4-Monooxygenase, Phenylalanine
% 223.64/223.79  |- skos__scopeNote mesh__D010651
% 223.64/223.79       An enzyme of the oxidoreductase class that catalyzes the formation of L-TYROSINE, dihydrobiopterin, and water from L-PHENYLALANINE, tetrahydrobiopterin, and oxygen. Deficiency of this enzyme may cause PHENYLKETONURIAS and PHENYLKETONURIA, MATERNAL. EC 1.14.16.1.%A%    
% 223.64/223.79  |- mesh__historyNote mesh__D010651 73%28%71%29%   
% 223.64/223.79  |- skos__hiddenLabel mesh__D010651 Phenylalanine 4 Hydroxylase
% 223.64/223.79  |- mesh__recordAuthorizer mesh__D010651 sjn
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D032305 2006
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D032305 2004
% 223.64/223.79  |- mesh__historyNote mesh__D032305 2003   
% 223.64/223.79  |- rdf__type mesh__D032305sskos__Concept
% 223.64/223.79  |- skos__prefLabel mesh__D032305 Lycium
% 223.64/223.79  |- skos__altLabel mesh__D032305 Wolfberry
% 223.64/223.79  |- skos__annotation mesh__D032305
% 223.64/223.79       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.64/223.79  |- mesh__publicMeSHNote mesh__D032305 2003   
% 223.64/223.79  |- skos__scopeNote mesh__D032305
% 223.64/223.79       A plant genus of the family SOLANACEAE. Members contain CEREBROSIDES and SCOPOLETIN.%A%    
% 223.64/223.79  |- mesh__dateCreated mesh__D032305 2002-07-03
% 223.64/223.79  |- mesh__dateEstablished mesh__D032305 2003-01-01
% 223.64/223.79  |- skos__broader mesh__D032305smesh__D019657
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D032305 2005
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D032305 2003
% 223.64/223.79  |- skos__broader mesh__D004614smesh__D015431
% 223.64/223.79  |- skos__related mesh__D004614smesh__D019282
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D004614 2006
% 223.64/223.79  |- rdf__type mesh__D004614sskos__Concept
% 223.64/223.79  |- mesh__recordMaintainer mesh__D004614 nns
% 223.64/223.79  |- skos__hiddenLabel mesh__D004614 Emaciations
% 223.64/223.79  |- skos__scopeNote mesh__D004614
% 223.64/223.79       Clinical manifestation of excessive LEANNESS usually caused by disease or a lack of nutrition %28%MALNUTRITION%29%.%A%    
% 223.64/223.79  |- mesh__dateRevised mesh__D004614 2004-07-07
% 223.64/223.79  |- skos__related mesh__D004614smesh__D019247
% 223.64/223.79  |- skos__related mesh__D004614smesh__D011502
% 223.64/223.79  |- mesh__recordAuthorizer mesh__D004614 sjn
% 223.64/223.79  |- skos__prefLabel mesh__D004614 Emaciation
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D004614 2005
% 223.64/223.79  |- mesh__dateCreated mesh__D004614 1999-01-01
% 223.64/223.79  |- mesh__recordOriginator mesh__D004614 NLM
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D014244 2005
% 223.64/223.79  |- mesh__recordOriginator mesh__D014244 NLM
% 223.64/223.79  |- skos__related mesh__D014244smesh__D000994
% 223.64/223.79  |- mesh__dateCreated mesh__D014244 1999-01-01
% 223.64/223.79  |- skos__annotation mesh__D014244
% 223.64/223.79       infection = TRICHOMONAS INFECTIONS; trichomonicides = ANTITRICHOMONAL AGENTS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 223.64/223.79  |- mesh__recordMaintainer mesh__D014244 ags
% 223.64/223.79  |- mesh__recordAuthorizer mesh__D014244 sjn
% 223.64/223.79  |- mesh__dateRevised mesh__D014244 2003-07-09
% 223.64/223.79  |- skos__prefLabel mesh__D014244 Trichomonas
% 223.64/223.79  |- rdf__type mesh__D014244sskos__Concept
% 223.64/223.79  |- skos__scopeNote mesh__D014244
% 223.64/223.79       A genus of parasitic flagellate protozoans distinguished by the presence of four anterior flagella, an undulating membrane, and a trailing flagellum.%A%    
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D014244 2004
% 223.64/223.79  |- skos__broader mesh__D014244smesh__D016834
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D014244 2006
% 223.64/223.79  |- mesh__dateCreated mesh__D008207 1999-01-01
% 223.64/223.79  |- mesh__recordMaintainer mesh__D008207 KEV
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D008207 2005
% 223.64/223.79  |- skos__hiddenLabel mesh__D008207 Lymphatic Metastases
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D008207 2006
% 223.64/223.79  |- skos__prefLabel mesh__D008207 Lymphatic Metastasis
% 223.64/223.79  |- mesh__recordAuthorizer mesh__D008207 sjn
% 223.64/223.79  |- mesh__recordOriginator mesh__D008207 NLM
% 223.64/223.79  |- mesh__dateRevised mesh__D008207 2000-06-22
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D008207 2002
% 223.64/223.79  |- skos__scopeNote mesh__D008207
% 223.64/223.79       Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system.%A%    
% 223.64/223.79  |- skos__annotation mesh__D008207
% 223.64/223.79       NIM, no qualif; IM for GEN or lymphatic metastatic process; when IM, qualif permitted; policy on metastases: Manual 24.3.1, 24.4.1.3+, 24.4.1.4%A%  
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D008207 2003
% 223.64/223.79  |- rdf__type mesh__D008207sskos__Concept
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D008207 2004
% 223.64/223.79  |- skos__hiddenLabel mesh__D008207 Metastasis, Lymphatic
% 223.64/223.79  |- skos__hiddenLabel mesh__D008207 Metastases, Lymphatic
% 223.64/223.79  |- skos__broader mesh__D008207smesh__D009362
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D008207 2001
% 223.64/223.79  |- skos__hiddenLabel mesh__D000224 Adrenocortical Insufficiency, Primary
% 223.64/223.79  |- mesh__recordMaintainer mesh__D000224 lkt
% 223.64/223.79  |- skos__hiddenLabel mesh__D000224 Addisons Disease
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D000224 2006
% 223.64/223.79  |- skos__hiddenLabel mesh__D000224 Hypoadrenalisms, Primary
% 223.64/223.79  |- skos__altLabel mesh__D000224 Primary Adrenal Insufficiency
% 223.64/223.79  |- skos__hiddenLabel mesh__D000224 Adrenal Insufficiency, Primary
% 223.64/223.79  |- skos__hiddenLabel mesh__D000224 Disease, Addison
% 223.64/223.79  |- mesh__publicMeSHNote mesh__D000224
% 223.64/223.79       2005; see ADDISON%27%S DISEASE 1966-2004   
% 223.64/223.79  |- skos__hiddenLabel mesh__D000224 Primary Adrenocortical Insufficiencies
% 223.64/223.79  |- rdf__type mesh__D000224sskos__Concept
% 223.64/223.79  |- skos__scopeNote mesh__D000224
% 223.64/223.79       An adrenal disease characterized by the progressive destruction of the ADRENAL CORTEX, resulting in insufficient production of ALDOSTERONE and HYDROCORTISONE. Clinical symptoms include ANOREXIA; NAUSEA; WEIGHT LOSS; MUSCLE WEAKNESS; and HYPERPIGMENTATION of the SKIN due to increase in circulating levels of ACTH precursor hormone which stimulates MELANOCYTES.%A%    
% 223.64/223.79  |- skos__altLabel mesh__D000224 Primary Hypoadrenalism
% 223.64/223.79  |- mesh__dateRevised mesh__D000224 2004-07-07
% 223.64/223.79  |- mesh__dateCreated mesh__D000224 1999-01-01
% 223.64/223.79  |- mesh__historyNote mesh__D000224 2005 %28%1963%29%   
% 223.64/223.79  |- mesh__recordOriginator mesh__D000224 NLM
% 223.64/223.79  |- skos__prefLabel mesh__D000224 Addison Disease
% 223.64/223.79  |- skos__hiddenLabel mesh__D000224 Adrenocortical Insufficiencies, Primary
% 223.64/223.79  |- mesh__recordAuthorizer mesh__D000224 sjn
% 223.64/223.79  |- skos__broader mesh__D000224smesh__D001327
% 223.64/223.79  |- skos__hiddenLabel mesh__D000224 Insufficiencies, Primary Adrenocortical
% 223.64/223.79  |- skos__hiddenLabel mesh__D000224 Hypoadrenalism, Primary
% 223.64/223.79  |- skos__altLabel mesh__D000224 Primary Adrenocortical Insufficiency
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D000224 2005
% 223.64/223.79  |- skos__hiddenLabel mesh__D000224 Insufficiency, Primary Adrenocortical
% 223.64/223.79  |- skos__altLabel mesh__D000224 Addison%27%s Disease
% 223.64/223.79  |- skos__broader mesh__D000224smesh__D000309
% 223.64/223.79  |- skos__annotation mesh__D018635
% 223.64/223.79       not restricted to med emerg; not restricted to organized services%A%  
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D018635 2001
% 223.64/223.79  |- mesh__publicMeSHNote mesh__D018635 95   
% 223.64/223.79  |- skos__prefLabel mesh__D018635 Rescue Work
% 223.64/223.79  |- skos__hiddenLabel mesh__D018635 Work, Rescue
% 223.64/223.79  |- mesh__dateRevised mesh__D018635 1999-11-03
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D018635 2000
% 223.64/223.79  |- mesh__dateCreated mesh__D018635 1994-04-16
% 223.64/223.79  |- mesh__recordAuthorizer mesh__D018635 sjn
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D018635 2004
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D018635 2006
% 223.64/223.79  |- skos__related mesh__D018635smesh__D012066
% 223.64/223.79  |- mesh__recordMaintainer mesh__D018635 kle
% 223.64/223.79  |- skos__historyNote mesh__D018635
% 223.64/223.79       Emergency Medical Services %28%1968-1994%29%
% 223.64/223.79  |- mesh__dateEstablished mesh__D018635 1995-01-01
% 223.64/223.79  |- mesh__historyNote mesh__D018635 95   
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D018635 2003
% 223.64/223.79  |- skos__broader mesh__D018635smesh__D004190
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D018635 2005
% 223.64/223.79  |- mesh__activeMeSHYear mesh__D018635 2002
% 223.64/223.79  |- skos__scopeNote mesh__D018635
% 223.64/223.79       Activities devoted to freeing persons or animals from danger to life or well-being in accidents, fires, bombings, floods, earthquakes, other disasters and life-threatening conditions. While usually performed by team efforts, rescue work is not restricted to organized services.%A%    
% 223.65/223.79  |- mesh__recordOriginator mesh__D018635 TGC
% 223.65/223.79  |- rdf__type mesh__D018635sskos__Concept
% 223.65/223.79  |- mesh__recordMaintainer mesh__D010652 ssb
% 223.65/223.79  |- mesh__dateRevised mesh__D010652 2003-07-09
% 223.65/223.79  |- skos__hiddenLabel mesh__D010652 Synthetase, Phenylalanyl-tRNA
% 223.65/223.79  |- mesh__historyNote mesh__D010652 98%28%75%29%   
% 223.65/223.79  |- mesh__dateCreated mesh__D010652 1974-11-19
% 223.65/223.79  |- skos__broader mesh__D010652smesh__D000604
% 223.65/223.79  |- skos__hiddenLabel mesh__D010652 Phenylalanyl tRNA Synthetase
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D010652 2006
% 223.65/223.79  |- mesh__recordOriginator mesh__D010652 NLM
% 223.65/223.79  |- skos__altLabel mesh__D010652 Phenylalanyl-tRNA Synthetase
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D010652 2004
% 223.65/223.79  |- skos__hiddenLabel mesh__D010652 Phe tRNA Ligase
% 223.65/223.79  |- mesh__dateEstablished mesh__D010652 1991-01-01
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D010652 2005
% 223.65/223.79  |- skos__historyNote mesh__D010652 Phenylalanine %28%1973-1974%29%
% 223.65/223.79  |- skos__hiddenLabel mesh__D010652 Ligase, Phe-tRNA
% 223.65/223.79  |- skos__altLabel mesh__D010652 Phe-tRNA Ligase
% 223.65/223.79  |- skos__hiddenLabel mesh__D010652 Phenylalanine tRNA Ligase
% 223.65/223.79  |- skos__altLabel mesh__D010652 Phenylalanyl T RNA Synthetase
% 223.65/223.79  |- skos__scopeNote mesh__D010652
% 223.65/223.79       An enzyme that activates phenylalanine with its specific transfer RNA. EC 6.1.1.20.%A%    
% 223.65/223.79  |- rdf__type mesh__D010652sskos__Concept
% 223.65/223.79  |- skos__hiddenLabel mesh__D010652 Ligase, Phenylalanine-tRNA
% 223.65/223.79  |- skos__historyNote mesh__D010652
% 223.65/223.79       Amino Acyl T RNA Synthetases %28%1973-1974%29%
% 223.65/223.79  |- mesh__publicMeSHNote mesh__D010652
% 223.65/223.79       98; see PHENYLALANYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-1990%A%  
% 223.65/223.79  |- mesh__recordAuthorizer mesh__D010652 sjn
% 223.65/223.79  |- skos__prefLabel mesh__D010652 Phenylalanine-tRNA Ligase
% 223.65/223.79  |- skos__scopeNote mesh__D032306
% 223.65/223.79       A plant genus of the family SOLANACEAE. Members contain steroidal glycosides.%A%    
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D032306 2006A
% 223.65/223.79  |- mesh__recordMaintainer mesh__D032306 ags
% 223.65/223.79  |- skos__annotation mesh__D032306
% 223.65/223.79       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.65/223.79  |- mesh__publicMeSHNote mesh__D032306 2003   
% 223.65/223.79  |- mesh__historyNote mesh__D032306 2003   
% 223.65/223.79  |- mesh__recordAuthorizer mesh__D032306 ags
% 223.65/223.79  |- skos__broader mesh__D032306smesh__D019657
% 223.65/223.79  |- mesh__recordOriginator mesh__D032306 ssb
% 223.65/223.79  |- skos__prefLabel mesh__D032306 Petunia
% 223.65/223.79  |- mesh__dateRevised mesh__D032306 2005-07-22
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D032306 2005
% 223.65/223.79  |- skos__related mesh__D032306smesh__D027901
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D032306 2006
% 223.65/223.79  |- mesh__dateCreated mesh__D032306 2002-07-03
% 223.65/223.79  |- mesh__dateEstablished mesh__D032306 2003-01-01
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D032306 2004
% 223.65/223.79  |- rdf__type mesh__D032306sskos__Concept
% 223.65/223.79  |- skos__prefLabel mesh__D004615 Embalming
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D004615 2000
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D004615 2003
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D004615 1997
% 223.65/223.79  |- skos__scopeNote mesh__D004615
% 223.65/223.79       Process of preserving a dead body to protect it from decay.%A%    
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D004615 2001
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D004615 2004
% 223.65/223.79  |- skos__hiddenLabel mesh__D004615 Embalmings
% 223.65/223.79  |- mesh__recordOriginator mesh__D004615 NLM
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D004615 1998
% 223.65/223.79  |- skos__related mesh__D004615smesh__D009106
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D004615 2002
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D004615 1993
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D004615 2005
% 223.65/223.79  |- mesh__dateCreated mesh__D004615 1999-01-01
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D004615 1999
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D004615 1994
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D004615 2006
% 223.65/223.79  |- rdf__type mesh__D004615sskos__Concept
% 223.65/223.79  |- mesh__dateRevised mesh__D004615 1992-05-15
% 223.65/223.79  |- mesh__recordAuthorizer mesh__D004615 PLS
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D004615 1995
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D004615 1996
% 223.65/223.79  |- skos__broader mesh__D004615smesh__D009027
% 223.65/223.79  |- mesh__recordMaintainer mesh__D004615 TAP
% 223.65/223.79  |- mesh__dateCreated mesh__D009300 1999-01-01
% 223.65/223.79  |- rdf__type mesh__D009300sskos__Concept
% 223.65/223.79  |- skos__broader mesh__D009300smesh__D051457
% 223.65/223.79  |- skos__prefLabel mesh__D009300 Nasal Septum
% 223.65/223.79  |- mesh__recordAuthorizer mesh__D009300 sjn
% 223.65/223.79  |- skos__hiddenLabel mesh__D009300 Septum, Nasal
% 223.65/223.79  |- skos__hiddenLabel mesh__D009300 Vomers
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D009300 2006
% 223.65/223.79  |- skos__hiddenLabel mesh__D009300 Nasal Septums
% 223.65/223.79  |- mesh__dateRevised mesh__D009300 2005-06-30
% 223.65/223.79  |- mesh__recordOriginator mesh__D009300 NLM
% 223.65/223.79  |- skos__hiddenLabel mesh__D009300 Septums, Nasal
% 223.65/223.79  |- skos__broader mesh__D009300smesh__D009666
% 223.65/223.79  |- skos__scopeNote mesh__D009300
% 223.65/223.79       The partition separating the two nasal cavities in the midplane, composed of cartilaginous, membranous and bony parts.%A%    
% 223.65/223.79  |- mesh__recordMaintainer mesh__D009300 ags
% 223.65/223.79  |- skos__broader mesh__D014245smesh__D016772
% 223.65/223.79  |- rdf__type mesh__D014245sskos__Concept
% 223.65/223.79  |- skos__annotation mesh__D014245
% 223.65/223.79       protozoan infect; /drug ther: consider also ANTITRICHOMONAL AGENTS%A%  
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D014245 2001
% 223.65/223.79  |- mesh__recordMaintainer mesh__D014245 TGC
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D014245 2004
% 223.65/223.79  |- mesh__recordAuthorizer mesh__D014245 PLS
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D014245 1997
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D014245 2000
% 223.65/223.79  |- mesh__onlineNote mesh__D014245
% 223.65/223.79       use TRICHOMONAS INFECTIONS to search TRICHOMONAS CYSTITIS, TRICHOMONAS PROSTATO-SEMINO-VESICULITIS %26% TRICHOMONAS URETHRITIS 1966-71%A%  
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D014245 2006
% 223.65/223.79  |- skos__related mesh__D014245smesh__D000994
% 223.65/223.79  |- mesh__dateRevised mesh__D014245 1993-06-03
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D014245 1999
% 223.65/223.79  |- mesh__recordOriginator mesh__D014245 NLM
% 223.65/223.79  |- skos__hiddenLabel mesh__D014245 Infection, Trichomonas
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D014245 2003
% 223.65/223.79  |- skos__scopeNote mesh__D014245
% 223.65/223.79       Infections in birds and mammals produced by various species of Trichomonas.%A%    
% 223.65/223.79  |- mesh__historyNote mesh__D014245
% 223.65/223.79       TRICHOMONAS CYSTITIS, TRICHOMONAS PROSTATO-SEMINO-VESICULITIS %26% TRICHOMONAS URETHRITIS were headings 1963-71%A%  
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D014245 1996
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D014245 1995
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D014245 2005
% 223.65/223.79  |- mesh__dateCreated mesh__D014245 1999-01-01
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D014245 1998
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D014245 1994
% 223.65/223.79  |- skos__altLabel mesh__D014245 Infections, Trichomonas
% 223.65/223.79  |- skos__hiddenLabel mesh__D014245 Trichomonas Infection
% 223.65/223.79  |- mesh__publicMeSHNote mesh__D014245
% 223.65/223.79       TRICHOMONAS CYSTITIS, TRICHOMONAS PROSTATO-SEMINO-VESICULITIS %26% TRICHOMONAS URETHRITIS were headings 1963-71%A%  
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D014245 2002
% 223.65/223.79  |- skos__prefLabel mesh__D014245 Trichomonas Infections
% 223.65/223.79  |- skos__annotation mesh__D008208
% 223.65/223.79       LYMPHOID TISSUE %26% LYMPH NODES are available; inflammation = LYMPHANGITIS%A%  
% 223.65/223.79  |- skos__prefLabel mesh__D008208 Lymphatic System
% 223.65/223.79  |- mesh__dateCreated mesh__D008208 1999-01-01
% 223.65/223.79  |- skos__broader mesh__D008208smesh__D007107
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D008208 2006
% 223.65/223.79  |- mesh__dateRevised mesh__D008208 2003-07-09
% 223.65/223.79  |- skos__scopeNote mesh__D008208
% 223.65/223.79       A system of organs and tissues that process and transport immune cells and LYMPH.%A%    
% 223.65/223.79  |- mesh__recordOriginator mesh__D008208 NLM
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D008208 2004
% 223.65/223.79  |- mesh__recordMaintainer mesh__D008208 jmp
% 223.65/223.79  |- mesh__recordAuthorizer mesh__D008208 sjn
% 223.65/223.79  |- skos__hiddenLabel mesh__D008208 Lymphatic Systems
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D008208 2005
% 223.65/223.79  |- rdf__type mesh__D008208sskos__Concept
% 223.65/223.79  |- skos__related mesh__D008208smesh__D008220
% 223.65/223.79  |- mesh__recordAuthorizer mesh__D000225 sjn
% 223.65/223.79  |- skos__scopeNote mesh__D000225
% 223.65/223.79       A purine base and a fundamental unit of ADENINE NUCLEOTIDES.%A%    
% 223.65/223.79  |- mesh__activeMeSHYear mesh__D000225 2006
% 223.65/223.79  |- mesh__dateCreated mesh__D000225 1999-01-01
% 223.65/223.79  |- skos__broader mesh__D000225smesh__D011687
% 223.65/223.79  |- skos__hiddenLabel mesh__D000225 4, Vitamin B
% 223.65/223.79  |- rdf__type mesh__D000225sskos__Concept
% 223.65/223.79  |- skos__altLabel mesh__D000225 Vitamin B 4
% 223.65/223.79  |- skos__annotation mesh__D000225 /biosyn/physiol permitted   
% 223.65/223.79  |- skos__prefLabel mesh__D000225 Adenine
% 223.65/223.79  |- skos__hiddenLabel mesh__D000225 B 4, Vitamin
% 223.65/223.80  |- mesh__recordMaintainer mesh__D000225 ags
% 223.65/223.80  |- mesh__dateRevised mesh__D000225 2005-06-30
% 223.65/223.80  |- mesh__recordOriginator mesh__D000225 NLM
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D018636 2002
% 223.65/223.80  |- skos__scopeNote mesh__D018636
% 223.65/223.80       A condition characterized by underdevelopment of the left cardiac chambers, atresia or stenosis of the aorta or mitral valve or both, and hypoplasia of the aorta. These anomalies are a common cause of heart failure in early infancy.%A%    
% 223.65/223.80  |- mesh__dateCreated mesh__D018636 1994-04-16
% 223.65/223.80  |- skos__historyNote mesh__D018636
% 223.65/223.80       Heart Defects, Congenital %28%1966-1994%29%
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D018636 2004
% 223.65/223.80  |- mesh__recordOriginator mesh__D018636 PXP
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D018636 2001
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D018636 2006
% 223.65/223.80  |- mesh__publicMeSHNote mesh__D018636 95   
% 223.65/223.80  |- skos__altLabel mesh__D018636 Left Heart Syndrome, Hypoplastic
% 223.65/223.80  |- skos__broader mesh__D018636smesh__D006330
% 223.65/223.80  |- mesh__historyNote mesh__D018636 95   
% 223.65/223.80  |- mesh__dateRevised mesh__D018636 1999-11-03
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D018636 2003
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D018636 2000
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D018636 2005
% 223.65/223.80  |- mesh__recordAuthorizer mesh__D018636 sjn
% 223.65/223.80  |- skos__prefLabel mesh__D018636 Hypoplastic Left Heart Syndrome
% 223.65/223.80  |- rdf__type mesh__D018636sskos__Concept
% 223.65/223.80  |- mesh__recordMaintainer mesh__D018636 kle
% 223.65/223.80  |- mesh__dateEstablished mesh__D018636 1995-01-01
% 223.65/223.80  |- skos__annotation mesh__D018636
% 223.65/223.80       a congen heart defect; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 223.65/223.80  |- mesh__recordAuthorizer mesh__D010653 sjn
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D010653 2006
% 223.65/223.80  |- skos__prefLabel mesh__D010653 Phenylbutazone
% 223.65/223.80  |- skos__altLabel mesh__D010653 Butadion
% 223.65/223.80  |- skos__annotation mesh__D010653 a non-steroidal anti-inflamm agent   
% 223.65/223.80  |- mesh__recordMaintainer mesh__D010653 ssb
% 223.65/223.80  |- mesh__dateCreated mesh__D010653 1999-01-01
% 223.65/223.80  |- skos__scopeNote mesh__D010653
% 223.65/223.80       A drug that has anti-inflammatory, antipyretic, and analgesic activities. It is especially effective in the treatment of ankylosing spondylitis. It also is useful in rheumatoid arthritis and Reiter%27%s syndrome %28%investigational indication%29%. Although phenylbutazone is effective in gouty arthritis, risk/benefit considerations indicate that this drug should not be employed for this disease. %28%From AMA Drug Evaluations Annual, 1994, p1822%29%%A%    
% 223.65/223.80  |- skos__altLabel mesh__D010653 Diphenylbutazone
% 223.65/223.80  |- skos__broader mesh__D010653smesh__D047069
% 223.65/223.80  |- mesh__recordOriginator mesh__D010653 NLM
% 223.65/223.80  |- rdf__type mesh__D010653sskos__Concept
% 223.65/223.80  |- skos__altLabel mesh__D010653 Butapirazol
% 223.65/223.80  |- mesh__dateRevised mesh__D010653 2005-06-30
% 223.65/223.80  |- mesh__recordMaintainer mesh__D004616 jls
% 223.65/223.80  |- mesh__dateEstablished mesh__D004616 1978-01-01
% 223.65/223.80  |- skos__hiddenLabel mesh__D004616 Emblem
% 223.65/223.80  |- skos__related mesh__D004616smesh__D005789
% 223.65/223.80  |- skos__altLabel mesh__D004616 Insignia
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D004616 2005
% 223.65/223.80  |- mesh__recordAuthorizer mesh__D004616 sjn
% 223.65/223.80  |- mesh__onlineNote mesh__D004616
% 223.65/223.80       use EMBLEMS AND INSIGNIA to search CADUCEUS 1966-78 %28%as Prov 1966-74%29%%A%  
% 223.65/223.80  |- mesh__dateCreated mesh__D004616 1977-05-12
% 223.65/223.80  |- skos__hiddenLabel mesh__D004616 Insignias
% 223.65/223.80  |- mesh__publicMeSHNote mesh__D004616
% 223.65/223.80       78; CADUCEUS was see under HISTORY OF MEDICINE 1975-77; INSIGNIA AND DECORATIONS was heading 1963-65%A%  
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D004616 2006
% 223.65/223.80  |- mesh__recordOriginator mesh__D004616 EC
% 223.65/223.80  |- rdf__type mesh__D004616sskos__Concept
% 223.65/223.80  |- mesh__historyNote mesh__D004616
% 223.65/223.80       78; CADUCEUS was see under HISTORY OF MEDICINE 1975-77, was Prov 1966-74; INSIGNIA AND DECORATIONS was heading 1963-65%A%  
% 223.65/223.80  |- skos__annotation mesh__D004616 DF: EMBLEMS   
% 223.65/223.80  |- skos__scopeNote mesh__D004616
% 223.65/223.80       Figures or symbols identifying or representing organizations or societies.%A%    
% 223.65/223.80  |- skos__prefLabel mesh__D004616 Emblems and Insignia
% 223.65/223.80  |- skos__hiddenLabel mesh__D004616 Insignia and Emblems
% 223.65/223.80  |- skos__broader mesh__D004616smesh__D006664
% 223.65/223.80  |- mesh__dateRevised mesh__D004616 2004-07-07
% 223.65/223.80  |- mesh__historyNote mesh__D009301
% 223.65/223.80       91%28%75%29%; was see under LACRIMAL APPARATUS 1975-90   
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009301 1992
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009301 1998
% 223.65/223.80  |- skos__hiddenLabel mesh__D009301 Nasolacrimal Ducts
% 223.65/223.80  |- mesh__dateRevised mesh__D009301 1990-04-13
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009301 2003
% 223.65/223.80  |- mesh__recordOriginator mesh__D009301 NLM
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009301 1997
% 223.65/223.80  |- rdf__type mesh__D009301sskos__Concept
% 223.65/223.80  |- skos__hiddenLabel mesh__D009301 Duct, Nasolacrimal
% 223.65/223.80  |- mesh__publicMeSHNote mesh__D009301
% 223.65/223.80       91; was see under LACRIMAL APPARATUS 1975-90   
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009301 1991
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009301 1996
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009301 2002
% 223.65/223.80  |- skos__prefLabel mesh__D009301 Nasolacrimal Duct
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009301 1995
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009301 2006
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009301 2001
% 223.65/223.80  |- skos__broader mesh__D009301smesh__D007765
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009301 1994
% 223.65/223.80  |- skos__hiddenLabel mesh__D009301 Ducts, Nasolacrimal
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009301 2000
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009301 2005
% 223.65/223.80  |- mesh__recordAuthorizer mesh__D009301 PLS
% 223.65/223.80  |- mesh__onlineNote mesh__D009301 search LACRIMAL APPARATUS 1966-74   
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009301 1993
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009301 1999
% 223.65/223.80  |- mesh__dateEstablished mesh__D009301 1991-01-01
% 223.65/223.80  |- mesh__dateCreated mesh__D009301 1999-01-01
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009301 2004
% 223.65/223.80  |- mesh__recordMaintainer mesh__D009301 NLM
% 223.65/223.80  |- skos__altLabel mesh__D020283 Photoreceptor, Microbial
% 223.65/223.80  |- skos__broader mesh__D020283smesh__D011506
% 223.65/223.80  |- skos__annotation mesh__D020283 coord with specific organism   
% 223.65/223.80  |- mesh__dateRevised mesh__D020283 2005-06-30
% 223.65/223.80  |- mesh__publicMeSHNote mesh__D020283 99   
% 223.65/223.80  |- skos__scopeNote mesh__D020283
% 223.65/223.80       Light absorbing proteins and protein prosthetic groups found in certain microorganisms. Some microbial photoreceptors initiate specific chemical reactions which signal a change in the environment, while others generate energy by pumping specific ions across a cellular membrane.%A%    
% 223.65/223.80  |- mesh__dateCreated mesh__D020283 1998-06-10
% 223.65/223.80  |- skos__hiddenLabel mesh__D020283 Microbial Photoreceptor
% 223.65/223.80  |- mesh__recordMaintainer mesh__D020283 SYSTEM
% 223.65/223.80  |- rdf__type mesh__D020283sskos__Concept
% 223.65/223.80  |- mesh__dateEstablished mesh__D020283 1999-01-01
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D020283 2006
% 223.65/223.80  |- mesh__historyNote mesh__D020283 99   
% 223.65/223.80  |- mesh__recordOriginator mesh__D020283 NDW
% 223.65/223.80  |- skos__prefLabel mesh__D020283 Photoreceptors, Microbial
% 223.65/223.80  |- skos__hiddenLabel mesh__D020283 Microbial Photoreceptors
% 223.65/223.80  |- mesh__recordAuthorizer mesh__D020283 sjn
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D014246 2004
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D014246 2006
% 223.65/223.80  |- skos__historyNote mesh__D014246 Trichomonas %28%1966-1971%29%
% 223.65/223.80  |- skos__annotation mesh__D014246
% 223.65/223.80       an organism: do not confuse with the disease TRICHOMONAS VAGINITIS; infection = probably TRICHOMONAS VAGINITIS but if not, coord IM with TRICHOMONAS INFECTIONS %28%IM%29% + precoord organ/dis term %28%IM%29%; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 223.65/223.80  |- mesh__publicMeSHNote mesh__D014246 72   
% 223.65/223.80  |- mesh__historyNote mesh__D014246 72   
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D014246 2005
% 223.65/223.80  |- mesh__dateCreated mesh__D014246 1999-01-01
% 223.65/223.80  |- mesh__recordOriginator mesh__D014246 NLM
% 223.65/223.80  |- skos__scopeNote mesh__D014246
% 223.65/223.80       A species of TRICHOMONAS that produces a refractory vaginal discharge in females, as well as bladder and urethral infections in males.%A%    
% 223.65/223.80  |- mesh__dateRevised mesh__D014246 2003-07-09
% 223.65/223.80  |- mesh__dateEstablished mesh__D014246 1972-01-01
% 223.65/223.80  |- skos__broader mesh__D014246smesh__D014244
% 223.65/223.80  |- mesh__recordAuthorizer mesh__D014246 sjn
% 223.65/223.80  |- rdf__type mesh__D014246sskos__Concept
% 223.65/223.80  |- mesh__recordMaintainer mesh__D014246 ags
% 223.65/223.80  |- skos__prefLabel mesh__D014246 Trichomonas vaginalis
% 223.65/223.80  |- skos__hiddenLabel mesh__D008209 Lymphedemas
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D008209 2000
% 223.65/223.80  |- skos__hiddenLabel mesh__D008209 Disease, Milroy
% 223.65/223.80  |- skos__prefLabel mesh__D008209 Lymphedema
% 223.65/223.80  |- skos__altLabel mesh__D008209 Milroy%27%s Disease
% 223.65/223.80  |- mesh__dateCreated mesh__D008209 1999-01-01
% 223.65/223.80  |- skos__broader mesh__D008209smesh__D008206
% 223.65/223.80  |- skos__hiddenLabel mesh__D008209 Disease, Milroy%27%s
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D008209 2006
% 223.65/223.80  |- mesh__recordMaintainer mesh__D008209 TGC
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D008209 2002
% 223.65/223.80  |- mesh__publicMeSHNote mesh__D008209
% 223.65/223.80       MILROY%27%S DISEASE was heading 1963-83   
% 223.65/223.80  |- skos__hiddenLabel mesh__D008209 Milroys Disease
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D008209 2004
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D008209 1999
% 223.65/223.80  |- mesh__recordAuthorizer mesh__D008209 PLS
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D008209 2005
% 223.65/223.80  |- mesh__historyNote mesh__D008209
% 223.65/223.80       MILROY%27%S DISEASE was heading 1963-83   
% 223.65/223.80  |- rdf__type mesh__D008209sskos__Concept
% 223.65/223.80  |- mesh__onlineNote mesh__D008209
% 223.65/223.80       use LYMPHEDEMA/congenital to search MILROY%27%S DISEASE 1966-83%A%  
% 223.65/223.80  |- mesh__dateRevised mesh__D008209 1995-05-31
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D008209 1997
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D008209 2003
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D008209 1998
% 223.65/223.80  |- skos__annotation mesh__D008209
% 223.65/223.80       edema of arms or legs caused by obstruct or dis of lymph nodes or vessels; X ref MILROY%27%S DISEASE goes under LYMPHEDEMA /congen%A%  
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D008209 2001
% 223.65/223.80  |- skos__scopeNote mesh__D008209
% 223.65/223.80       Edema due to obstruction of lymph vessels or disorders of the lymph nodes.%A%    
% 223.65/223.80  |- mesh__recordOriginator mesh__D008209 NLM
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D008209 1996
% 223.65/223.80  |- skos__scopeNote mesh__D000226
% 223.65/223.80       A class of nucleotide translocases found abundantly in mitochondria that function as integral components of the inner mitochondrial membrane. They facilitate the exchange of ADP and ATP between the cytosol and the mitochondria, thereby linking the subcellular compartments of ATP production to those of ATP utilization.%A%    
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D000226 2006
% 223.65/223.80  |- mesh__dateRevised mesh__D000226 2005-06-30
% 223.65/223.80  |- skos__prefLabel mesh__D000226 Mitochondrial ADP, ATP Translocases
% 223.65/223.80  |- skos__altLabel mesh__D000226 ADP,ATP Carrier
% 223.65/223.80  |- rdf__type mesh__D000226sskos__Concept
% 223.65/223.80  |- mesh__recordAuthorizer mesh__D000226 sjn
% 223.65/223.80  |- skos__broader mesh__D000226smesh__D017920
% 223.65/223.80  |- skos__altLabel mesh__D000226
% 223.65/223.80       Adenine Nucleotide Carrier %28%Mitochondrial%29%
% 223.65/223.80  |- skos__hiddenLabel mesh__D000226 Mitochondrial ADP ATP Carriers
% 223.65/223.80  |- skos__altLabel mesh__D000226 ADP Translocase
% 223.65/223.80  |- skos__broader mesh__D000226smesh__D033704
% 223.65/223.80  |- skos__historyNote mesh__D000226
% 223.65/223.80       Nucleotidyltransferases %28%1972-1975%29%
% 223.65/223.80  |- skos__altLabel mesh__D000226 ATP,ADP-Carrier
% 223.65/223.80  |- mesh__historyNote mesh__D000226 2003%28%1976%29%   
% 223.65/223.80  |- mesh__publicMeSHNote mesh__D000226
% 223.65/223.80       2003; see ADENINE NUCLEOTIDE TRANSLOCASE 1991-2002 %26% NUCLEOTIDYLTRANSFERASES 1976-1990%A%  
% 223.65/223.80  |- mesh__recordMaintainer mesh__D000226 SYSTEM
% 223.65/223.80  |- mesh__dateEstablished mesh__D000226 1991-01-01
% 223.65/223.80  |- skos__altLabel mesh__D000226 ATP-ADP Translocase
% 223.65/223.80  |- skos__altLabel mesh__D000226 Mitochondrial ADP-ATP Carriers
% 223.65/223.80  |- skos__broader mesh__D000226smesh__D033681
% 223.65/223.80  |- mesh__dateCreated mesh__D000226 1975-07-18
% 223.65/223.80  |- skos__hiddenLabel mesh__D000226 ADP-ATP Carriers, Mitochondrial
% 223.65/223.80  |- mesh__recordOriginator mesh__D000226 RLS
% 223.65/223.80  |- skos__altLabel mesh__D000226 ATP Translocase
% 223.65/223.80  |- skos__altLabel mesh__D000226 ADP,ATP Translocator Protein
% 223.65/223.80  |- skos__historyNote mesh__D000226 Adenine Nucleotides %28%1972-1975%29%
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D046328 2005
% 223.65/223.80  |- mesh__recordMaintainer mesh__D046328 ags
% 223.65/223.80  |- skos__broader mesh__D046328smesh__D012377
% 223.65/223.80  |- skos__historyNote mesh__D046328 Rodentia %28%1966-2004%29%
% 223.65/223.80  |- skos__prefLabel mesh__D046328 Porcupines
% 223.65/223.80  |- mesh__historyNote mesh__D046328
% 223.65/223.80       2005; use RODENTIA 1982-2004; for COENDOU %26% HYSTRIX use RODENTIA 1982-2004%A%  
% 223.65/223.80  |- skos__hiddenLabel mesh__D046328 Porcupine
% 223.65/223.80  |- mesh__dateEstablished mesh__D046328 2005-01-01
% 223.65/223.80  |- mesh__publicMeSHNote mesh__D046328
% 223.65/223.80       2005; see RODENTIA 1982-2004; for COENDOU %26% HYSTRIX see RODENTIA 1982-2004%A%  
% 223.65/223.80  |- skos__scopeNote mesh__D046328
% 223.65/223.80       Common name for large, quilled rodents %28%RODENTIA%29% comprised of two families: Old World porcupines %28%Hystricidae%29% and New World porcupines %28%Erethizontidae%29%.%A%    
% 223.65/223.80  |- mesh__recordOriginator mesh__D046328 ags
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D046328 2006
% 223.65/223.80  |- mesh__dateCreated mesh__D046328 2004-07-07
% 223.65/223.80  |- rdf__type mesh__D046328sskos__Concept
% 223.65/223.80  |- mesh__recordAuthorizer mesh__D046328 sjn
% 223.65/223.80  |- skos__prefLabel mesh__D010654 Phenylbutyrates
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D010654 1998
% 223.65/223.80  |- rdf__type mesh__D010654sskos__Concept
% 223.65/223.80  |- skos__broader mesh__D010654smesh__D000146
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D010654 1996
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D010654 2002
% 223.65/223.80  |- mesh__recordAuthorizer mesh__D010654 PLS
% 223.65/223.80  |- mesh__recordMaintainer mesh__D010654 TAP
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D010654 2006
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D010654 2001
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D010654 2004
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D010654 1995
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D010654 1993
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D010654 2005
% 223.65/223.80  |- mesh__recordOriginator mesh__D010654 NLM
% 223.65/223.80  |- mesh__dateCreated mesh__D010654 1999-01-01
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D010654 2000
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D010654 1999
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D010654 2003
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D010654 1994
% 223.65/223.80  |- mesh__dateRevised mesh__D010654 1992-05-19
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D010654 1997
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D004617 2004
% 223.65/223.80  |- skos__related mesh__D004617smesh__D017128
% 223.65/223.80  |- mesh__dateCreated mesh__D004617 1999-01-01
% 223.65/223.80  |- skos__scopeNote mesh__D004617
% 223.65/223.80       Blocking of a blood vessel by a blood clot or foreign matter that has been transported from a distant site by the blood stream.%A%    
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D004617 2003
% 223.65/223.80  |- skos__hiddenLabel mesh__D004617 Embolisms
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D004617 2002
% 223.65/223.80  |- mesh__dateRevised mesh__D004617 2001-07-25
% 223.65/223.80  |- mesh__recordMaintainer mesh__D004617 nns
% 223.65/223.80  |- skos__prefLabel mesh__D004617 Embolism
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D004617 2006
% 223.65/223.80  |- mesh__recordAuthorizer mesh__D004617 sjn
% 223.65/223.80  |- skos__broader mesh__D004617smesh__D016769
% 223.65/223.80  |- rdf__type mesh__D004617sskos__Concept
% 223.65/223.80  |- skos__annotation mesh__D004617
% 223.65/223.80       coord with specific vessel; pulm embolism = PULMONARY EMBOLISM; cerebral embolism = INTRACRANIAL EMBOLISM%A%  
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D004617 2005
% 223.65/223.80  |- mesh__recordOriginator mesh__D004617 NLM
% 223.65/223.80  |- skos__hiddenLabel mesh__D009302 Diseases, Nasopharyngeal
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009302 2000
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009302 1997
% 223.65/223.80  |- mesh__publicMeSHNote mesh__D009302 66   
% 223.65/223.80  |- mesh__recordMaintainer mesh__D009302 PLS
% 223.65/223.80  |- mesh__recordAuthorizer mesh__D009302 PLS
% 223.65/223.80  |- mesh__dateRevised mesh__D009302 1992-05-26
% 223.65/223.80  |- rdf__type mesh__D009302sskos__Concept
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009302 1996
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009302 1995
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009302 2006
% 223.65/223.80  |- mesh__dateEstablished mesh__D009302 1966-01-01
% 223.65/223.80  |- mesh__recordOriginator mesh__D009302 NLM
% 223.65/223.80  |- skos__broader mesh__D009302smesh__D010608
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009302 1994
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009302 2005
% 223.65/223.80  |- skos__prefLabel mesh__D009302 Nasopharyngeal Diseases
% 223.65/223.80  |- skos__hiddenLabel mesh__D009302 Nasopharyngeal Disease
% 223.65/223.80  |- mesh__historyNote mesh__D009302
% 223.65/223.80       66; NASOPHARYNGITIS was see under PHARYNGITIS 1965-89   
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009302 2002
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009302 1999
% 223.65/223.80  |- skos__annotation mesh__D009302 inflamm dis = NASOPHARYNGITIS   
% 223.65/223.80  |- skos__scopeNote mesh__D009302
% 223.65/223.80       General or unspecified diseases of the nasopharynx.     
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009302 1993
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009302 2004
% 223.65/223.80  |- mesh__dateCreated mesh__D009302 1999-01-01
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009302 2001
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009302 1998
% 223.65/223.80  |- skos__hiddenLabel mesh__D009302 Disease, Nasopharyngeal
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D009302 2003
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D014247 1996
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D014247 2005
% 223.65/223.80  |- mesh__recordOriginator mesh__D014247 NLM
% 223.65/223.80  |- skos__broader mesh__D014247smesh__D014627
% 223.65/223.80  |- mesh__dateCreated mesh__D014247 1999-01-01
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D014247 1998
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D014247 2004
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D014247 2002
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D014247 1997
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D014247 1992
% 223.65/223.80  |- skos__scopeNote mesh__D014247
% 223.65/223.80       Inflammation of the vagina, marked by a purulent discharge. This disease is caused by the protozoan TRICHOMONAS VAGINALIS.%A%    
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D014247 2006
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D014247 1994
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D014247 1999
% 223.65/223.80  |- skos__hiddenLabel mesh__D014247 Vaginitides, Trichomonas
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D014247 1993
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D014247 1995
% 223.65/223.80  |- mesh__recordAuthorizer mesh__D014247 PLS
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D014247 2000
% 223.65/223.80  |- skos__prefLabel mesh__D014247 Trichomonas Vaginitis
% 223.65/223.80  |- mesh__recordMaintainer mesh__D014247 PXP
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D014247 2001
% 223.65/223.80  |- skos__hiddenLabel mesh__D014247 Vaginitis, Trichomonas
% 223.65/223.80  |- skos__annotation mesh__D014247
% 223.65/223.80       do not confuse with the organism TRICHOMONAS VAGINALIS   
% 223.65/223.80  |- skos__broader mesh__D014247smesh__D014245
% 223.65/223.80  |- mesh__dateRevised mesh__D014247 1991-05-02
% 223.65/223.80  |- rdf__type mesh__D014247sskos__Concept
% 223.65/223.80  |- skos__hiddenLabel mesh__D014247 Trichomonas Vaginitides
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D014247 2003
% 223.65/223.80  |- mesh__dateCreated mesh__D019730 1997-06-20
% 223.65/223.80  |- mesh__publicMeSHNote mesh__D019730 98   
% 223.65/223.80  |- skos__broader mesh__D019730smesh__D008025
% 223.65/223.80  |- mesh__dateEstablished mesh__D019730 1998-01-01
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D019730 2006
% 223.65/223.80  |- skos__hiddenLabel mesh__D019730 Carbon Sulfur Ligases
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D019730 2005
% 223.65/223.80  |- rdf__type mesh__D019730sskos__Concept
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D019730 2004
% 223.65/223.80  |- skos__hiddenLabel mesh__D019730 Ligases, Carbon-Sulfur
% 223.65/223.80  |- mesh__dateRevised mesh__D019730 2003-07-09
% 223.65/223.80  |- skos__prefLabel mesh__D019730 Carbon-Sulfur Ligases
% 223.65/223.80  |- skos__annotation mesh__D019730 DF: C S LIGASES   
% 223.65/223.80  |- skos__scopeNote mesh__D019730
% 223.65/223.80       Enzymes that catalyze the joining of two molecules by the formation of a carbon-sulfur bond. EC 6.2.%A%    
% 223.65/223.80  |- mesh__historyNote mesh__D019730 98   
% 223.65/223.80  |- skos__hiddenLabel mesh__D033401 Biomicroscopy, Ultrasound
% 223.65/223.80  |- skos__hiddenLabel mesh__D033401 Biomicroscopies, Ultrasonographic
% 223.65/223.80  |- skos__hiddenLabel mesh__D033401 Biomicroscopies, Ultrasonic
% 223.65/223.80  |- skos__altLabel mesh__D033401 Scanning Acoustic Microscopy
% 223.65/223.80  |- skos__broader mesh__D033401smesh__D014463
% 223.65/223.80  |- skos__altLabel mesh__D033401 Ultrasonic Biomicroscopy
% 223.65/223.80  |- skos__altLabel mesh__D033401 Acoustic Microscopy
% 223.65/223.80  |- skos__historyNote mesh__D033401 Microscopy %28%1972-2002%29%
% 223.65/223.80  |- mesh__recordOriginator mesh__D033401 lkt
% 223.65/223.80  |- mesh__dateEstablished mesh__D033401 2003-01-01
% 223.65/223.80  |- skos__hiddenLabel mesh__D033401 Acoustic Microscopies, Scanning
% 223.65/223.80  |- skos__prefLabel mesh__D033401 Microscopy, Acoustic
% 223.65/223.80  |- skos__hiddenLabel mesh__D033401 Scanning Acoustic Microscopies
% 223.65/223.80  |- skos__hiddenLabel mesh__D033401 Microscopies, Acoustic
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D033401 2006
% 223.65/223.80  |- skos__scopeNote mesh__D033401
% 223.65/223.80       A scientific tool based on ULTRASONOGRAPHY and used not only for the observation of microstructure in metalwork but also in living tissue. In biomedical application, the acoustic propagation speed in normal and abnormal tissues can be quantified to distinguish their tissue elasticity and other properties.%A%    
% 223.65/223.80  |- skos__hiddenLabel mesh__D033401 Ultrasonographic Biomicroscopies
% 223.65/223.80  |- mesh__dateCreated mesh__D033401 2002-07-02
% 223.65/223.80  |- rdf__type mesh__D033401sskos__Concept
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D033401 2005
% 223.65/223.80  |- mesh__recordMaintainer mesh__D033401 nns
% 223.65/223.80  |- mesh__publicMeSHNote mesh__D033401 2003   
% 223.65/223.80  |- skos__hiddenLabel mesh__D033401 Biomicroscopy, Ultrasonic
% 223.65/223.80  |- mesh__recordAuthorizer mesh__D033401 sjn
% 223.65/223.80  |- skos__hiddenLabel mesh__D033401 Biomicroscopies, Ultrasound
% 223.65/223.80  |- skos__hiddenLabel mesh__D033401 Acoustic Microscopy, Scanning
% 223.65/223.80  |- skos__hiddenLabel mesh__D033401 Acoustic Microscopies
% 223.65/223.80  |- mesh__historyNote mesh__D033401 2003   
% 223.65/223.80  |- skos__hiddenLabel mesh__D033401 Ultrasound Biomicroscopies
% 223.65/223.80  |- skos__hiddenLabel mesh__D033401 Ultrasonic Biomicroscopies
% 223.65/223.80  |- mesh__dateRevised mesh__D033401 2004-07-07
% 223.65/223.80  |- skos__hiddenLabel mesh__D033401 Microscopies, Scanning Acoustic
% 223.65/223.80  |- skos__broader mesh__D033401smesh__D008853
% 223.65/223.80  |- skos__hiddenLabel mesh__D033401 Biomicroscopy, Ultrasonographic
% 223.65/223.80  |- skos__altLabel mesh__D033401 Ultrasonographic Biomicroscopy
% 223.65/223.80  |- skos__historyNote mesh__D033401 Acoustics %28%1972-2002%29%
% 223.65/223.80  |- skos__hiddenLabel mesh__D000227 Phosphates, Adenosine
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D000227 2004
% 223.65/223.80  |- skos__prefLabel mesh__D000227 Adenine Nucleotides
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D000227 1996
% 223.65/223.80  |- skos__altLabel mesh__D000227 Adenosine Phosphates
% 223.65/223.80  |- mesh__dateRevised mesh__D000227 1992-05-07
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D000227 2003
% 223.65/223.80  |- skos__broader mesh__D000227smesh__D011685
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D000227 1995
% 223.65/223.80  |- mesh__recordAuthorizer mesh__D000227 PLS
% 223.65/223.80  |- skos__broader mesh__D000227smesh__D012265
% 223.65/223.80  |- skos__annotation mesh__D000227 /biosyn /physiol permitted   
% 223.65/223.80  |- mesh__recordOriginator mesh__D000227 NLM
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D000227 2002
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D000227 1999
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D000227 1994
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D000227 2006
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D000227 2001
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D000227 1998
% 223.65/223.80  |- mesh__dateCreated mesh__D000227 1999-01-01
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D000227 1993
% 223.65/223.80  |- mesh__recordMaintainer mesh__D000227 TGC
% 223.65/223.80  |- skos__hiddenLabel mesh__D000227 Nucleotides, Adenine
% 223.65/223.80  |- rdf__type mesh__D000227sskos__Concept
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D000227 2005
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D000227 2000
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D000227 1997
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D005710 1997
% 223.65/223.80  |- skos__annotation mesh__D005710
% 223.65/223.80       Ga-63-68, 70, 72-76; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D005710 2000
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D005710 2005
% 223.65/223.80  |- skos__broader mesh__D005710smesh__D005709
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D005710 1996
% 223.65/223.80  |- rdf__type mesh__D005710sskos__Concept
% 223.65/223.80  |- mesh__recordOriginator mesh__D005710 NLM
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D005710 1999
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D005710 2002
% 223.65/223.80  |- mesh__publicMeSHNote mesh__D005710 75   
% 223.65/223.80  |- mesh__dateCreated mesh__D005710 1974-11-11
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D005710 1995
% 223.65/223.80  |- mesh__activeMeSHYear mesh__D005710 1998
% 223.65/223.81  |- skos__historyNote mesh__D005710 Radioisotopes %28%1966-1974%29%
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D005710 2004
% 223.65/223.81  |- skos__scopeNote mesh__D005710
% 223.65/223.81       Unstable isotopes of gallium that decay or disintegrate emitting radiation. Ga atoms with atomic weights 63-68, 70 and 72-76 are radioactive gallium isotopes.%A%    
% 223.65/223.81  |- skos__historyNote mesh__D005710 Gallium %28%1966-1974%29%
% 223.65/223.81  |- mesh__recordMaintainer mesh__D005710 TPW
% 223.65/223.81  |- skos__broader mesh__D005710smesh__D011868
% 223.65/223.81  |- skos__hiddenLabel mesh__D005710 Radioisotopes, Gallium
% 223.65/223.81  |- mesh__historyNote mesh__D005710 75   
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D005710 1994
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D005710 2003
% 223.65/223.81  |- skos__prefLabel mesh__D005710 Gallium Radioisotopes
% 223.65/223.81  |- mesh__dateRevised mesh__D005710 1993-06-01
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D005710 2001
% 223.65/223.81  |- mesh__recordAuthorizer mesh__D005710 PLS
% 223.65/223.81  |- mesh__dateEstablished mesh__D005710 1975-09-01
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D005710 2006
% 223.65/223.81  |- skos__broader mesh__D046329smesh__D012377
% 223.65/223.81  |- mesh__recordOriginator mesh__D046329 ags
% 223.65/223.81  |- mesh__recordAuthorizer mesh__D046329 sjn
% 223.65/223.81  |- skos__historyNote mesh__D046329 Rodentia %28%1968-2004%29%
% 223.65/223.81  |- skos__scopeNote mesh__D046329
% 223.65/223.81       A genus of diurnal rats in the family Octodonidae, found in South America. The species Octodon degus is frequently used for research.%A%    
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D046329 2006
% 223.65/223.81  |- mesh__historyNote mesh__D046329 2005; use RODENTIA 1982-2004   
% 223.65/223.81  |- mesh__dateCreated mesh__D046329 2004-07-07
% 223.65/223.81  |- rdf__type mesh__D046329sskos__Concept
% 223.65/223.81  |- mesh__dateEstablished mesh__D046329 2005-01-01
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D046329 2005
% 223.65/223.81  |- mesh__publicMeSHNote mesh__D046329 2005; see RODENTIA 1982-2004   
% 223.65/223.81  |- skos__prefLabel mesh__D046329 Octodon
% 223.65/223.81  |- mesh__recordMaintainer mesh__D046329 ags
% 223.65/223.81  |- mesh__recordOriginator mesh__D010655 NLM
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D010655 2000
% 223.65/223.81  |- mesh__publicMeSHNote mesh__D010655 74   
% 223.65/223.81  |- skos__broader mesh__D010655smesh__D000814
% 223.65/223.81  |- mesh__historyNote mesh__D010655 74   
% 223.65/223.81  |- skos__broader mesh__D010655smesh__D003959
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D010655 2006
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D010655 2002
% 223.65/223.81  |- mesh__dateEstablished mesh__D010655 1974-01-01
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D010655 2004
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D010655 1995
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D010655 1993
% 223.65/223.81  |- skos__prefLabel mesh__D010655 Phenylenediamines
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D010655 2005
% 223.65/223.81  |- mesh__dateCreated mesh__D010655 1999-01-01
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D010655 1999
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D010655 2003
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D010655 1994
% 223.65/223.81  |- mesh__dateRevised mesh__D010655 1992-05-19
% 223.65/223.81  |- mesh__recordAuthorizer mesh__D010655 PLS
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D010655 1997
% 223.65/223.81  |- mesh__recordMaintainer mesh__D010655 TAP
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D010655 1998
% 223.65/223.81  |- rdf__type mesh__D010655sskos__Concept
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D010655 2001
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D010655 1996
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D004618 2003
% 223.65/223.81  |- skos__altLabel mesh__D004618 Air Embolism
% 223.65/223.81  |- skos__hiddenLabel mesh__D004618 Embolisms, Air
% 223.65/223.81  |- skos__hiddenLabel mesh__D004618 Embolisms, Gas
% 223.65/223.81  |- mesh__recordOriginator mesh__D004618 NLM
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D004618 1995
% 223.65/223.81  |- skos__altLabel mesh__D004618 Embolism, Gas
% 223.65/223.81  |- mesh__recordAuthorizer mesh__D004618 PLS
% 223.65/223.81  |- mesh__dateRevised mesh__D004618 1994-06-07
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D004618 1999
% 223.65/223.81  |- skos__hiddenLabel mesh__D004618 Air Embolisms
% 223.65/223.81  |- mesh__recordMaintainer mesh__D004618 JLS
% 223.65/223.81  |- skos__broader mesh__D004618smesh__D004617
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D004618 2006
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D004618 1998
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D004618 2002
% 223.65/223.81  |- rdf__type mesh__D004618sskos__Concept
% 223.65/223.81  |- skos__prefLabel mesh__D004618 Embolism, Air
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D004618 1997
% 223.65/223.81  |- skos__hiddenLabel mesh__D004618 Gas Embolism
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D004618 2005
% 223.65/223.81  |- skos__scopeNote mesh__D004618
% 223.65/223.81       Embolism due to air bubbles entering the blood vessels after trauma, surgical procedures, or changes in atmospheric pressure.%A%    
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D004618 2001
% 223.65/223.81  |- skos__hiddenLabel mesh__D004618 Gas Embolisms
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D004618 2004
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D004618 1996
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D004618 2000
% 223.65/223.81  |- mesh__dateCreated mesh__D004618 1999-01-01
% 223.65/223.81  |- skos__related mesh__D004618smesh__D003665
% 223.65/223.81  |- mesh__historyNote mesh__D015340 98; use explode 1989-97   
% 223.65/223.81  |- mesh__dateCreated mesh__D015340 1988-06-01
% 223.65/223.81  |- skos__historyNote mesh__D015340 Epidemiologic Methods %28%1970-1997%29%
% 223.65/223.81  |- skos__prefLabel mesh__D015340 Epidemiologic Research Design
% 223.65/223.81  |- skos__broader mesh__D015340smesh__D017531
% 223.65/223.81  |- skos__altLabel mesh__D015340 Designs, Epidemiologic Research
% 223.65/223.81  |- skos__broader mesh__D015340smesh__D004812
% 223.65/223.81  |- skos__hiddenLabel mesh__D015340 Epidemiological Research Designs
% 223.65/223.81  |- skos__hiddenLabel mesh__D015340 Research Design, Epidemiological
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D015340 2005
% 223.65/223.81  |- mesh__recordOriginator mesh__D015340 EC
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D015340 2003
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D015340 2006
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D015340 2004
% 223.65/223.81  |- mesh__publicMeSHNote mesh__D015340 98   
% 223.65/223.81  |- skos__historyNote mesh__D015340 Research Design %28%1971-1997%29%
% 223.65/223.81  |- mesh__dateEstablished mesh__D015340 1998-01-01
% 223.65/223.81  |- skos__scopeNote mesh__D015340
% 223.65/223.81       The form and structure of analytic studies in epidemiologic and clinical research.%A%    
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D015340 2002
% 223.65/223.81  |- skos__hiddenLabel mesh__D015340 Research Designs, Epidemiological
% 223.65/223.81  |- skos__altLabel mesh__D015340 Epidemiological Research Design
% 223.65/223.81  |- rdf__type mesh__D015340sskos__Concept
% 223.65/223.81  |- skos__altLabel mesh__D015340 Epidemiologic Research Designs
% 223.65/223.81  |- skos__altLabel mesh__D015340 Design, Epidemiologic Research
% 223.65/223.81  |- mesh__recordMaintainer mesh__D015340 ags
% 223.65/223.81  |- mesh__onlineNote mesh__D015340
% 223.65/223.81       restrict to study design of EPIDEMIOLOGIC METHODS   
% 223.65/223.81  |- skos__altLabel mesh__D015340 Research Design, Epidemiologic
% 223.65/223.81  |- skos__annotation mesh__D015340
% 223.65/223.81       GEN or unspecified; prefer specifics; coord IM with subject of research %28%IM%29%%A%  
% 223.65/223.81  |- mesh__dateRevised mesh__D015340 2001-07-25
% 223.65/223.81  |- mesh__recordAuthorizer mesh__D015340 sjn
% 223.65/223.81  |- skos__hiddenLabel mesh__D015340 Designs, Epidemiological Research
% 223.65/223.81  |- skos__hiddenLabel mesh__D015340 Design, Epidemiological Research
% 223.65/223.81  |- skos__altLabel mesh__D015340 Research Designs, Epidemiologic
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D009303 2002
% 223.65/223.81  |- skos__broader mesh__D009303smesh__D010610
% 223.65/223.81  |- skos__hiddenLabel mesh__D009303 Neoplasm, Nasopharyngeal
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D009303 2005
% 223.65/223.81  |- skos__hiddenLabel mesh__D009303 Nasopharyngeal Cancers
% 223.65/223.81  |- skos__altLabel mesh__D009303 Cancer of the Nasopharynx
% 223.65/223.81  |- skos__hiddenLabel mesh__D009303 Cancers, Nasopharynx
% 223.65/223.81  |- skos__altLabel mesh__D009303 Nasopharynx Cancer
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D009303 2001
% 223.65/223.81  |- skos__hiddenLabel mesh__D009303 Cancer, Nasopharyngeal
% 223.65/223.81  |- skos__altLabel mesh__D009303 Neoplasms, Nasopharyngeal
% 223.65/223.81  |- mesh__recordAuthorizer mesh__D009303 sjn
% 223.65/223.81  |- mesh__dateCreated mesh__D009303 1999-01-01
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D009303 2004
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D009303 2000
% 223.65/223.81  |- skos__hiddenLabel mesh__D009303 Neoplasm, Nasopharynx
% 223.65/223.81  |- skos__prefLabel mesh__D009303 Nasopharyngeal Neoplasms
% 223.65/223.81  |- skos__hiddenLabel mesh__D009303 Nasopharyngeal Neoplasm
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D009303 2003
% 223.65/223.81  |- skos__altLabel mesh__D009303 Nasopharynx Neoplasms
% 223.65/223.81  |- skos__altLabel mesh__D009303 Nasopharyngeal Cancer
% 223.65/223.81  |- skos__hiddenLabel mesh__D009303 Nasopharynx Neoplasm
% 223.65/223.81  |- skos__scopeNote mesh__D009303 Tumors or cancer of the NASOPHARYNX.     
% 223.65/223.81  |- skos__broader mesh__D009303smesh__D009302
% 223.65/223.81  |- mesh__recordMaintainer mesh__D009303 nns
% 223.65/223.81  |- rdf__type mesh__D009303sskos__Concept
% 223.65/223.81  |- mesh__recordOriginator mesh__D009303 NLM
% 223.65/223.81  |- skos__annotation mesh__D009303
% 223.65/223.81       coord IM with histol type of neopl %28%IM%29%   
% 223.65/223.81  |- skos__hiddenLabel mesh__D009303 Cancer, Nasopharynx
% 223.65/223.81  |- skos__hiddenLabel mesh__D009303 Nasopharynx Cancers
% 223.65/223.81  |- mesh__dateRevised mesh__D009303 1999-11-05
% 223.65/223.81  |- skos__hiddenLabel mesh__D009303 Neoplasms, Nasopharynx
% 223.65/223.81  |- skos__hiddenLabel mesh__D009303 Cancers, Nasopharyngeal
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D009303 2006
% 223.65/223.81  |- rdf__type mesh__D020285sskos__Concept
% 223.65/223.81  |- mesh__dateEstablished mesh__D020285 1999-01-01
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D020285 2006
% 223.65/223.81  |- skos__hiddenLabel mesh__D020285 Cryomicroscopies, Electron
% 223.65/223.81  |- skos__hiddenLabel mesh__D020285 Cryoelectron Microscopies
% 223.65/223.81  |- skos__broader mesh__D020285smesh__D008854
% 223.65/223.81  |- skos__hiddenLabel mesh__D020285 Electron Cryomicroscopies
% 223.65/223.81  |- mesh__historyNote mesh__D020285 99   
% 223.65/223.81  |- skos__hiddenLabel mesh__D020285 Microscopies, Cryoelectron
% 223.65/223.81  |- skos__hiddenLabel mesh__D020285 Cryo-electron Microscopies
% 223.65/223.81  |- skos__historyNote mesh__D020285 Microscopy, Electron %28%1986-1998%29%
% 223.65/223.81  |- skos__historyNote mesh__D020285 Freezing %28%1986-1998%29%
% 223.65/223.81  |- skos__altLabel mesh__D020285 Electron Cryomicroscopy
% 223.65/223.81  |- mesh__publicMeSHNote mesh__D020285 99   
% 223.65/223.81  |- mesh__recordAuthorizer mesh__D020285 sjn
% 223.65/223.81  |- mesh__dateRevised mesh__D020285 2004-07-07
% 223.65/223.81  |- mesh__recordOriginator mesh__D020285 AGS
% 223.65/223.81  |- skos__hiddenLabel mesh__D020285 Cryo electron Microscopy
% 223.65/223.81  |- skos__prefLabel mesh__D020285 Cryoelectron Microscopy
% 223.65/223.81  |- skos__hiddenLabel mesh__D020285 Microscopy, Cryoelectron
% 223.65/223.81  |- skos__scopeNote mesh__D020285
% 223.65/223.81       Electron microscopy involving rapid freezing of the samples. The imaging of frozen-hydrated molecules and organelles permits the best possible resolution closest to the living state, free of chemical fixatives or stains.%A%    
% 223.65/223.81  |- skos__hiddenLabel mesh__D020285 Cryomicroscopy, Electron
% 223.65/223.81  |- mesh__recordMaintainer mesh__D020285 nns
% 223.65/223.81  |- skos__altLabel mesh__D020285 Cryo-electron Microscopy
% 223.65/223.81  |- mesh__dateCreated mesh__D020285 1998-06-10
% 223.65/223.81  |- mesh__activeMeSHYear mesh__D020285 2005
% 223.65/223.81  |- skos__hiddenLabel mesh__D020285 Microscopies, Cryo-electron
% 223.67/223.81  |- skos__hiddenLabel mesh__D020285 Microscopy, Cryo-electron
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D014248 2006
% 223.67/223.81  |- skos__annotation mesh__D014248
% 223.67/223.81       do not confuse with TRICHOPHYTON, an organism   
% 223.67/223.81  |- mesh__recordMaintainer mesh__D014248 ssb
% 223.67/223.81  |- skos__broader mesh__D014248smesh__D000946
% 223.67/223.81  |- mesh__dateRevised mesh__D014248 2005-06-30
% 223.67/223.81  |- mesh__recordOriginator mesh__D014248 NLM
% 223.67/223.81  |- skos__scopeNote mesh__D014248
% 223.67/223.81       Antigens from the genus TRICHOPHYTON. Trichophytin has been used in studies of immunological responses to these dermatophytes.%A%    
% 223.67/223.81  |- mesh__recordAuthorizer mesh__D014248 sjn
% 223.67/223.81  |- mesh__publicMeSHNote mesh__D014248
% 223.67/223.81       91; was see under ANTIGENS, FUNGAL 1986-90; was heading 1963-85%A%  
% 223.67/223.81  |- rdf__type mesh__D014248sskos__Concept
% 223.67/223.81  |- mesh__historyNote mesh__D014248
% 223.67/223.81       91%28%86%29%63; was see under ANTIGENS, FUNGAL 1986-90; was heading 1963-85%A%  
% 223.67/223.81  |- skos__prefLabel mesh__D014248 Trichophytin
% 223.67/223.81  |- mesh__dateCreated mesh__D014248 1999-01-01
% 223.67/223.81  |- mesh__dateEstablished mesh__D014248 1991-01-01
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D019731 2006
% 223.67/223.81  |- skos__hiddenLabel mesh__D019731 Carbon Nitrogen Ligases
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D019731 2005
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D019731 2004
% 223.67/223.81  |- mesh__dateRevised mesh__D019731 2003-07-09
% 223.67/223.81  |- rdf__type mesh__D019731sskos__Concept
% 223.67/223.81  |- mesh__dateCreated mesh__D019731 1997-06-20
% 223.67/223.81  |- mesh__publicMeSHNote mesh__D019731 98   
% 223.67/223.81  |- skos__scopeNote mesh__D019731
% 223.67/223.81       Enzymes that catalyze the joining of two molecules by the formation of a carbon-nitrogen bond. EC 6.3.%A%    
% 223.67/223.81  |- skos__broader mesh__D019731smesh__D008025
% 223.67/223.81  |- skos__hiddenLabel mesh__D019731 Ligases, Carbon-Nitrogen
% 223.67/223.81  |- mesh__dateEstablished mesh__D019731 1998-01-01
% 223.67/223.81  |- skos__annotation mesh__D019731 DF: C N LIGASES   
% 223.67/223.81  |- mesh__historyNote mesh__D019731 98   
% 223.67/223.81  |- skos__prefLabel mesh__D019731 Carbon-Nitrogen Ligases
% 223.67/223.81  |- skos__broader mesh__D000228smesh__D010430
% 223.67/223.81  |- mesh__recordMaintainer mesh__D000228 ssb
% 223.67/223.81  |- skos__hiddenLabel mesh__D000228 Phosphoribosyltransferase, Adenine
% 223.67/223.81  |- skos__altLabel mesh__D000228 Transphosphoribosidase
% 223.67/223.81  |- skos__prefLabel mesh__D000228 Adenine Phosphoribosyltransferase
% 223.67/223.81  |- skos__historyNote mesh__D000228 Pentosephosphates %28%1972-1974%29%
% 223.67/223.81  |- mesh__dateEstablished mesh__D000228 1991-01-01
% 223.67/223.81  |- mesh__dateRevised mesh__D000228 2003-07-09
% 223.67/223.81  |- skos__annotation mesh__D000228 DF: APRT   
% 223.67/223.81  |- skos__scopeNote mesh__D000228
% 223.67/223.81       An enzyme catalyzing the formation of AMP from adenine and phosphoribosylpyrophosphate. It can act as a salvage enzyme for recycling of adenine into nucleic acids. EC 2.4.2.7.%A%    
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D000228 2006
% 223.67/223.81  |- skos__hiddenLabel mesh__D000228 Pyrophosphorylase, AMP
% 223.67/223.81  |- skos__historyNote mesh__D000228 Adenine %28%1972-1974%29%
% 223.67/223.81  |- mesh__publicMeSHNote mesh__D000228
% 223.67/223.81       91; was see under PENTOSYLTRANSFERASES 1975-90   
% 223.67/223.81  |- mesh__dateCreated mesh__D000228 1974-11-19
% 223.67/223.81  |- rdf__type mesh__D000228sskos__Concept
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D000228 2005
% 223.67/223.81  |- mesh__recordOriginator mesh__D000228 NLM
% 223.67/223.81  |- mesh__historyNote mesh__D000228
% 223.67/223.81       91%28%75%29%; was see under PENTOSYLTRANSFERASES 1975-90   
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D000228 2004
% 223.67/223.81  |- skos__altLabel mesh__D000228 APRTase
% 223.67/223.81  |- mesh__recordAuthorizer mesh__D000228 sjn
% 223.67/223.81  |- skos__historyNote mesh__D000228 Pyrophosphoric Acids %28%1972-1974%29%
% 223.67/223.81  |- skos__historyNote mesh__D000228 Pentosyltransferases %28%1972-1974%29%
% 223.67/223.81  |- skos__altLabel mesh__D000228 AMP Pyrophosphorylase
% 223.67/223.81  |- skos__broader mesh__D005711smesh__D014700
% 223.67/223.81  |- skos__historyNote mesh__D005711 Iproveratril %28%1973-1974%29%
% 223.67/223.81  |- skos__scopeNote mesh__D005711
% 223.67/223.81       Coronary vasodilator that is an analog of iproveratril %28%VERAPAMIL%29% with one more methoxy group on the benzene ring.%A%    
% 223.67/223.81  |- skos__altLabel mesh__D005711 betapharm Brand of Gallopamil Hydrochloride
% 223.67/223.81  |- mesh__historyNote mesh__D005711
% 223.67/223.81       87%28%84%29%; was see under VERAPAMIL 1984-86; was D 600 see under IPROVERATRIL 1975-83%A%  
% 223.67/223.81  |- mesh__dateRevised mesh__D005711 2005-06-30
% 223.67/223.81  |- skos__hiddenLabel mesh__D005711 D 600
% 223.67/223.81  |- skos__altLabel mesh__D005711 D600
% 223.67/223.81  |- skos__hiddenLabel mesh__D005711 Hydrochloride, Gallopamil
% 223.67/223.81  |- mesh__publicMeSHNote mesh__D005711
% 223.67/223.81       87; was see under VERAPAMIL 1984-86; was D 600 see under IPROVERATRIL 1975-83%A%  
% 223.67/223.81  |- mesh__dateCreated mesh__D005711 1974-11-19
% 223.67/223.81  |- skos__altLabel mesh__D005711 Abbott Brand of Gallopamil Hydrochloride
% 223.67/223.81  |- skos__altLabel mesh__D005711
% 223.67/223.81       ct-Arzneimittel Brand of Gallopamil Hydrochloride
% 223.67/223.81  |- skos__hiddenLabel mesh__D005711
% 223.67/223.81       ct Arzneimittel Brand of Gallopamil Hydrochloride
% 223.67/223.81  |- skos__prefLabel mesh__D005711 Gallopamil
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D005711 2006
% 223.67/223.81  |- skos__altLabel mesh__D005711 Methoxyverapamil
% 223.67/223.81  |- mesh__recordMaintainer mesh__D005711 CCR
% 223.67/223.81  |- mesh__recordAuthorizer mesh__D005711 sjn
% 223.67/223.81  |- mesh__dateEstablished mesh__D005711 1987-01-01
% 223.67/223.81  |- mesh__recordOriginator mesh__D005711 NLM
% 223.67/223.81  |- skos__altLabel mesh__D005711 Elgiprona
% 223.67/223.81  |- rdf__type mesh__D005711sskos__Concept
% 223.67/223.81  |- mesh__onlineNote mesh__D005711 use GALLOPAMIL to search D 600 1975-83   
% 223.67/223.81  |- skos__altLabel mesh__D005711 Procorum
% 223.67/223.81  |- rdf__type mesh__D018639sskos__Concept
% 223.67/223.81  |- mesh__recordAuthorizer mesh__D018639 sjn
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D018639 2005
% 223.67/223.81  |- skos__hiddenLabel mesh__D018639 Lens Cleaners, Contact
% 223.67/223.81  |- skos__altLabel mesh__D018639 Contact Lens Disinfectant Solutions
% 223.67/223.81  |- skos__scopeNote mesh__D018639
% 223.67/223.81       Sterile solutions used to clean and disinfect contact lenses.%A%    
% 223.67/223.81  |- mesh__recordOriginator mesh__D018639 TPW
% 223.67/223.81  |- skos__hiddenLabel mesh__D018639 Lens Disinfectants, Contact
% 223.67/223.81  |- skos__hiddenLabel mesh__D018639 Lens Solution, Contact
% 223.67/223.81  |- mesh__dateEstablished mesh__D018639 1995-01-01
% 223.67/223.81  |- skos__broader mesh__D018639smesh__D004202
% 223.67/223.81  |- skos__historyNote mesh__D018639 Contact Lenses %28%1966-1994%29%
% 223.67/223.81  |- skos__historyNote mesh__D018639 Solutions %28%1966-1994%29%
% 223.67/223.81  |- skos__hiddenLabel mesh__D018639 Solutions, Contact Lens
% 223.67/223.81  |- skos__hiddenLabel mesh__D018639 Cleaners, Contact Lens
% 223.67/223.81  |- mesh__recordMaintainer mesh__D018639 ssb
% 223.67/223.81  |- skos__prefLabel mesh__D018639 Contact Lens Solutions
% 223.67/223.81  |- mesh__dateCreated mesh__D018639 1994-02-28
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D018639 2004
% 223.67/223.81  |- skos__altLabel mesh__D018639 Contact Lens Solution
% 223.67/223.81  |- mesh__historyNote mesh__D018639 95   
% 223.67/223.81  |- skos__broader mesh__D018639smesh__D012996
% 223.67/223.81  |- skos__hiddenLabel mesh__D018639 Solution, Contact Lens
% 223.67/223.81  |- mesh__publicMeSHNote mesh__D018639 95   
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D018639 2006
% 223.67/223.81  |- skos__hiddenLabel mesh__D018639 Contact Lens Disinfectants
% 223.67/223.81  |- mesh__dateRevised mesh__D018639 2003-07-09
% 223.67/223.81  |- skos__annotation mesh__D018639 D25-26 qualif; DF: CONTACT LENS SOL   
% 223.67/223.81  |- skos__hiddenLabel mesh__D018639 Lens Solutions, Contact
% 223.67/223.81  |- skos__hiddenLabel mesh__D010656 Neo Synephrine
% 223.67/223.81  |- skos__hiddenLabel mesh__D010656 Tannate, Phenylephrine
% 223.67/223.81  |- skos__altLabel mesh__D010656
% 223.67/223.81       %28%R%29%-3-Hydroxy-alpha-%28%%28%methylamino%29%methyl%29%benzenemethanol
% 223.67/223.81  |- mesh__dateCreated mesh__D010656 1999-01-01
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D010656 2005
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D010656 2003
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D010656 2006
% 223.67/223.81  |- mesh__dateRevised mesh__D010656 2002-07-02
% 223.67/223.81  |- mesh__recordOriginator mesh__D010656 NLM
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D010656 2004
% 223.67/223.81  |- mesh__onlineNote mesh__D010656
% 223.67/223.81       use PHENYLEPHRINE to search METASYMPATOL 1975-91   
% 223.67/223.81  |- mesh__historyNote mesh__D010656
% 223.67/223.81       METASYMPATOL was see PHENYLEPHRINE 1975-91   
% 223.67/223.81  |- skos__scopeNote mesh__D010656
% 223.67/223.81       An alpha-adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent.%A%    
% 223.67/223.81  |- skos__prefLabel mesh__D010656 Phenylephrine
% 223.67/223.81  |- rdf__type mesh__D010656sskos__Concept
% 223.67/223.81  |- skos__altLabel mesh__D010656 Neosynephrine
% 223.67/223.81  |- skos__broader mesh__D010656smesh__D004983
% 223.67/223.81  |- mesh__publicMeSHNote mesh__D010656
% 223.67/223.81       METASYMPATOL was see PHENYLEPHRINE 1975-91   
% 223.67/223.81  |- mesh__recordMaintainer mesh__D010656 tpw
% 223.67/223.81  |- mesh__recordAuthorizer mesh__D010656 sjn
% 223.67/223.81  |- skos__hiddenLabel mesh__D004619 Amniotic Fluid Embolisms
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D004619 2006
% 223.67/223.81  |- skos__prefLabel mesh__D004619 Embolism, Amniotic Fluid
% 223.67/223.81  |- rdf__type mesh__D004619sskos__Concept
% 223.67/223.81  |- skos__scopeNote mesh__D004619
% 223.67/223.81       Blocking of maternal circulation by AMNIOTIC FLUID that is forced into uterine VEINS by strong UTERINE CONTRACTION near the end of pregnancy. It is characterized by the sudden onset of severe respiratory distress and HYPOTENSION that can lead to maternal DEATH.%A%    
% 223.67/223.81  |- mesh__recordAuthorizer mesh__D004619 sjn
% 223.67/223.81  |- skos__broader mesh__D004619smesh__D011249
% 223.67/223.81  |- skos__altLabel mesh__D004619 Amniotic Fluid Embolism
% 223.67/223.81  |- mesh__recordOriginator mesh__D004619 NLM
% 223.67/223.81  |- mesh__dateCreated mesh__D004619 1999-01-01
% 223.67/223.81  |- skos__hiddenLabel mesh__D004619 Embolisms, Amniotic Fluid
% 223.67/223.81  |- mesh__dateRevised mesh__D004619 2005-06-30
% 223.67/223.81  |- mesh__recordMaintainer mesh__D004619 lkt
% 223.67/223.81  |- skos__broader mesh__D004619smesh__D004617
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D015341 2006
% 223.67/223.81  |- skos__annotation mesh__D015341
% 223.67/223.81       GEN: prefer specific DNA %26% RNA probes; usually no qualif   
% 223.67/223.81  |- skos__prefLabel mesh__D015341 Nucleic Acid Probes
% 223.67/223.81  |- mesh__recordAuthorizer mesh__D015341 sjn
% 223.67/223.81  |- skos__broader mesh__D015341smesh__D009696
% 223.67/223.81  |- mesh__recordOriginator mesh__D015341 EJB
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D015341 2004
% 223.67/223.81  |- mesh__dateEstablished mesh__D015341 1989-01-01
% 223.67/223.81  |- skos__related mesh__D015341smesh__D009693
% 223.67/223.81  |- mesh__recordMaintainer mesh__D015341 ssb
% 223.67/223.81  |- skos__historyNote mesh__D015341
% 223.67/223.81       Nucleic Acids or specific nucleic acid %28%1972-1988%29%
% 223.67/223.81  |- skos__hiddenLabel mesh__D015341 Probes, Nucleic Acid
% 223.67/223.81  |- mesh__historyNote mesh__D015341 89   
% 223.67/223.81  |- rdf__type mesh__D015341sskos__Concept
% 223.67/223.81  |- skos__hiddenLabel mesh__D015341 Acid Probes, Nucleic
% 223.67/223.81  |- skos__historyNote mesh__D015341
% 223.67/223.81       Nucleic Acid Hybridization %28%1972-1988%29%
% 223.67/223.81  |- mesh__dateRevised mesh__D015341 2003-07-09
% 223.67/223.81  |- skos__broader mesh__D015341smesh__D015335
% 223.67/223.81  |- mesh__dateCreated mesh__D015341 1988-06-01
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D015341 2005
% 223.67/223.81  |- mesh__publicMeSHNote mesh__D015341 89   
% 223.67/223.81  |- skos__scopeNote mesh__D015341
% 223.67/223.81       Nucleic acid which complements a specific mRNA or DNA molecule, or fragment thereof; used for hybridization studies in order to identify microorganisms and for genetic studies.%A%    
% 223.67/223.81  |- mesh__recordOriginator mesh__D009304 NLM
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D009304 1999
% 223.67/223.81  |- mesh__dateCreated mesh__D009304 1999-01-01
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D009304 2004
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D009304 1998
% 223.67/223.81  |- skos__hiddenLabel mesh__D009304 Nasopharyngitides
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D009304 2002
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D009304 2003
% 223.67/223.81  |- mesh__dateEstablished mesh__D009304 1991-01-01
% 223.67/223.81  |- skos__scopeNote mesh__D009304 Inflammation of the nasopharynx.     
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D009304 2001
% 223.67/223.81  |- mesh__recordMaintainer mesh__D009304 TGC
% 223.67/223.81  |- skos__prefLabel mesh__D009304 Nasopharyngitis
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D009304 1997
% 223.67/223.81  |- skos__broader mesh__D009304smesh__D009302
% 223.67/223.81  |- rdf__type mesh__D009304sskos__Concept
% 223.67/223.81  |- mesh__dateRevised mesh__D009304 1993-06-02
% 223.67/223.81  |- mesh__onlineNote mesh__D009304 search PHARYNGITIS 1966-74   
% 223.67/223.81  |- mesh__publicMeSHNote mesh__D009304
% 223.67/223.81       91; was see under NASOPHARYNGEAL DISEASES 1990; was see under PHARYNGITIS 1965-89%A%  
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D009304 1996
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D009304 2000
% 223.67/223.81  |- mesh__recordAuthorizer mesh__D009304 PLS
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D009304 1995
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D009304 2006
% 223.67/223.81  |- skos__annotation mesh__D009304
% 223.67/223.81       inflamm of nasopharynx, not nose %26% pharynx   
% 223.67/223.81  |- mesh__historyNote mesh__D009304
% 223.67/223.81       91%28%65%29%; was see under NASOPHARYNGEAL DISEASES 1990; was see under PHARYNGITIS 1965-89%A%  
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D009304 1994
% 223.67/223.81  |- mesh__activeMeSHYear mesh__D009304 2005
% 223.67/223.81  |- skos__broader mesh__D001321smesh__D002659
% 223.67/223.81  |- mesh__historyNote mesh__D001321 1981%28%1966%29%   
% 223.67/223.81  |- skos__hiddenLabel mesh__D001321 Disorders, Autistic
% 223.67/223.81  |- rdf__type mesh__D001321sskos__Concept
% 223.67/223.81  |- skos__hiddenLabel mesh__D001321 Kanners Syndrome
% 223.67/223.81  |- mesh__recordOriginator mesh__D001321 NLM
% 223.67/223.81  |- skos__historyNote mesh__D001321 Autism %28%1966-1970%29%
% 223.67/223.81  |- mesh__dateCreated mesh__D001321 1999-01-01
% 223.67/223.81  |- skos__historyNote mesh__D001321
% 223.67/223.81       Schizophrenia, Childhood %28%1966-1970%29%
% 223.67/223.81  |- skos__hiddenLabel mesh__D001321 Infantile Autism, Early
% 223.67/223.81  |- mesh__recordMaintainer mesh__D001321 jls
% 223.67/223.81  |- mesh__dateRevised mesh__D001321 2005-06-30
% 223.67/223.82  |- skos__altLabel mesh__D001321 Kanner%27%s Syndrome
% 223.67/223.82  |- skos__altLabel mesh__D001321 Autism, Infantile
% 223.67/223.82  |- skos__hiddenLabel mesh__D001321 Disorder, Autistic
% 223.67/223.82  |- skos__hiddenLabel mesh__D001321 Autisms
% 223.67/223.82  |- mesh__publicMeSHNote mesh__D001321
% 223.67/223.82       1999; see AUTISM INFANTILE 1981-1998; see AUTISM, EARLY INFANTILE 1971-1980; see SCHIZOPHRENIA, CHILDHOOD 1968-1970; AUTISM was heading 1966-1998%A%  
% 223.67/223.82  |- skos__prefLabel mesh__D001321 Autistic Disorder
% 223.67/223.82  |- skos__hiddenLabel mesh__D001321 Kanner Syndrome
% 223.67/223.82  |- skos__altLabel mesh__D001321 Autism, Early Infantile
% 223.67/223.82  |- mesh__onlineNote mesh__D001321
% 223.67/223.82       use AUTISM, INFANTILE to search AUTISM, EARLY INFANTILE 1971-80; use SCHIZOPHRENIA, CHILDHOOD 1968-70%A%  
% 223.67/223.82  |- skos__hiddenLabel mesh__D001321 Infantile Autism
% 223.67/223.82  |- skos__altLabel mesh__D001321 Autism
% 223.67/223.82  |- skos__hiddenLabel mesh__D001321 Syndrome, Kanner%27%s
% 223.67/223.82  |- skos__scopeNote mesh__D001321
% 223.67/223.82       A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. %28%DSM-IV%29%%A%    
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D001321 2006
% 223.67/223.82  |- mesh__recordAuthorizer mesh__D001321 sjn
% 223.67/223.82  |- skos__hiddenLabel mesh__D001321 Early Infantile Autism
% 223.67/223.82  |- mesh__dateEstablished mesh__D001321 1971-01-01
% 223.67/223.82  |- skos__hiddenLabel mesh__D020286 Cells, Rouget
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D020286 2002
% 223.67/223.82  |- mesh__publicMeSHNote mesh__D020286 99   
% 223.67/223.82  |- skos__broader mesh__D020286smesh__D004730
% 223.67/223.82  |- skos__historyNote mesh__D020286 Capillaries %28%1970-1998%29%
% 223.67/223.82  |- skos__scopeNote mesh__D020286
% 223.67/223.82       Slender, contractile, mesenchymal-like cells found in close association with capillary walls. They are relatively undifferentiated and may become fibroblasts, macrophages, or smooth muscle cells. %28%From Stedman, 26th ed%29%%A%    
% 223.67/223.82  |- skos__broader mesh__D020286smesh__D008648
% 223.67/223.82  |- rdf__type mesh__D020286sskos__Concept
% 223.67/223.82  |- mesh__dateCreated mesh__D020286 1998-06-10
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D020286 2006
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D020286 2001
% 223.67/223.82  |- skos__altLabel mesh__D020286 Rouget Cells
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D020286 2005
% 223.67/223.82  |- skos__prefLabel mesh__D020286 Pericytes
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D020286 2000
% 223.67/223.82  |- mesh__historyNote mesh__D020286 99   
% 223.67/223.82  |- mesh__dateEstablished mesh__D020286 1999-01-01
% 223.67/223.82  |- skos__hiddenLabel mesh__D020286 Pericyte
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D020286 2004
% 223.67/223.82  |- skos__broader mesh__D020286smesh__D002477
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D020286 1999
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D020286 2003
% 223.67/223.82  |- skos__scopeNote mesh__D014249
% 223.67/223.82       A mitosporic fungal genus and an anamorphic form of Arthroderma. Various species attack the skin, nails, and hair.%A%    
% 223.67/223.82  |- skos__prefLabel mesh__D014249 Trichophyton
% 223.67/223.82  |- mesh__recordOriginator mesh__D014249 NLM
% 223.67/223.82  |- skos__altLabel mesh__D014249 Trychophyton
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D014249 2006
% 223.67/223.82  |- mesh__dateRevised mesh__D014249 2005-06-30
% 223.67/223.82  |- mesh__recordAuthorizer mesh__D014249 sjn
% 223.67/223.82  |- rdf__type mesh__D014249sskos__Concept
% 223.67/223.82  |- skos__altLabel mesh__D014249 Endodermophyton
% 223.67/223.82  |- mesh__dateCreated mesh__D014249 1999-01-01
% 223.67/223.82  |- skos__broader mesh__D014249smesh__D003904
% 223.67/223.82  |- mesh__recordMaintainer mesh__D014249 SYSTEM
% 223.67/223.82  |- skos__annotation mesh__D014249
% 223.67/223.82       do not confuse with TRICHOPHYTIN, a fungal antigen; infection = TRICHOPHYTOSIS see TINEA%A%  
% 223.67/223.82  |- skos__hiddenLabel mesh__D019732 Ligases, Acid-Amide
% 223.67/223.82  |- skos__altLabel mesh__D019732 Acid-Ammonia Ligases
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D019732 2006
% 223.67/223.82  |- skos__hiddenLabel mesh__D019732 Acid Amide Ligases
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D019732 2004
% 223.67/223.82  |- rdf__type mesh__D019732sskos__Concept
% 223.67/223.82  |- mesh__dateRevised mesh__D019732 2003-07-09
% 223.67/223.82  |- mesh__dateCreated mesh__D019732 1997-06-20
% 223.67/223.82  |- skos__hiddenLabel mesh__D019732 Acid Ammonia Ligases
% 223.67/223.82  |- skos__broader mesh__D019732smesh__D019731
% 223.67/223.82  |- skos__prefLabel mesh__D019732 Amide Synthases
% 223.67/223.82  |- mesh__dateEstablished mesh__D019732 1998-01-01
% 223.67/223.82  |- mesh__historyNote mesh__D019732 98   
% 223.67/223.82  |- mesh__publicMeSHNote mesh__D019732 98   
% 223.67/223.82  |- skos__hiddenLabel mesh__D019732 Ligases, Acid-Ammonia
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D019732 2005
% 223.67/223.82  |- skos__altLabel mesh__D019732 Acid-Amide Ligases
% 223.67/223.82  |- skos__hiddenLabel mesh__D019732 Synthases, Amide
% 223.67/223.82  |- skos__scopeNote mesh__D019732
% 223.67/223.82       Enzymes that catalyze the joining of either ammonia or an amide with another molecule, in which the linkage is in the form of a carbon-nitrogen bond. EC 6.3.1.%A%    
% 223.67/223.82  |- mesh__onlineNote mesh__D000229
% 223.67/223.82       use DEPENDOVIRUS to search ADENO-ASSOCIATED VIRUSES 1979-93; use SATELLITE VIRUSES 1975-78; use PARVOVIRIDAE to search DEPENDOVIRUS 1992-93%A%  
% 223.67/223.82  |- mesh__recordOriginator mesh__D000229 AEP
% 223.67/223.82  |- mesh__dateRevised mesh__D000229 2005-06-30
% 223.67/223.82  |- skos__broader mesh__D000229smesh__D019219
% 223.67/223.82  |- mesh__recordMaintainer mesh__D000229 DRC
% 223.67/223.82  |- mesh__dateCreated mesh__D000229 1977-12-05
% 223.67/223.82  |- mesh__recordAuthorizer mesh__D000229 sjn
% 223.67/223.82  |- skos__scopeNote mesh__D000229
% 223.67/223.82       A genus of the family PARVOVIRIDAE, subfamily PARVOVIRINAE, which are dependent on a coinfection with helper adenoviruses or herpesviruses for their efficient replication. The type species is Adeno-associated virus 2.%A%    
% 223.67/223.82  |- mesh__historyNote mesh__D000229
% 223.67/223.82       94; was ADENO-ASSOCIATED VIRUSES 1979-93; was ADENO-ASSOCIATED VIRUSES see SATELLITE VIRUSES 1975-78; DEPENDOVIRUS was see PARVOVIRIDAE 1992-93%A%  
% 223.67/223.82  |- skos__annotation mesh__D000229
% 223.67/223.82       infection: coord IM with PARVOVIRIDAE INFECTIONS %28%IM%29%   
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D000229 2006
% 223.67/223.82  |- skos__prefLabel mesh__D000229 Dependovirus
% 223.67/223.82  |- skos__altLabel mesh__D000229 Adeno-Associated Viruses
% 223.67/223.82  |- mesh__dateEstablished mesh__D000229 1979-01-01
% 223.67/223.82  |- rdf__type mesh__D000229sskos__Concept
% 223.67/223.82  |- skos__hiddenLabel mesh__D000229 Dependoviruses
% 223.67/223.82  |- skos__altLabel mesh__D000229 Viruses, Adeno-Associated
% 223.67/223.82  |- mesh__publicMeSHNote mesh__D000229
% 223.67/223.82       94; was ADENO-ASSOCIATED VIRUSES 1979-93; was ADENO-ASSOCIATED VIRUSES see SATELLITE VIRUSES 1975-78; DEPENDOVIRUS was see PARVOVIRIDAE 1992-93%A%  
% 223.67/223.82  |- skos__altLabel mesh__D000229 Virus, Adeno-Associated
% 223.67/223.82  |- skos__historyNote mesh__D000229 Satellite Viruses %28%1967-1978%29%
% 223.67/223.82  |- skos__historyNote mesh__D000229 Viruses %28%1966%29%
% 223.67/223.82  |- skos__historyNote mesh__D000229 Adenoviridae %28%1966%29%
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D005712 2004
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D005712 2002
% 223.67/223.82  |- skos__hiddenLabel mesh__D005712 Responses, Galvanic Skin
% 223.67/223.82  |- skos__broader mesh__D005712smesh__D012879
% 223.67/223.82  |- mesh__dateRevised mesh__D005712 1998-06-10
% 223.67/223.82  |- mesh__dateCreated mesh__D005712 1999-01-01
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D005712 2003
% 223.67/223.82  |- skos__prefLabel mesh__D005712 Galvanic Skin Response
% 223.67/223.82  |- skos__hiddenLabel mesh__D005712 Responses, Electrodermal
% 223.67/223.82  |- skos__hiddenLabel mesh__D005712 Electrodermal Responses
% 223.67/223.82  |- skos__hiddenLabel mesh__D005712 Electric Conductances, Skin
% 223.67/223.82  |- skos__hiddenLabel mesh__D005712 Response, Electrodermal
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D005712 2006
% 223.67/223.82  |- skos__hiddenLabel mesh__D005712 Galvanic Skin Responses
% 223.67/223.82  |- skos__altLabel mesh__D005712 Skin Electric Conductance
% 223.67/223.82  |- skos__scopeNote mesh__D005712
% 223.67/223.82       A change in electrical resistance of the skin, occurring in emotion and in certain other conditions.%A%    
% 223.67/223.82  |- mesh__recordMaintainer mesh__D005712 MSR
% 223.67/223.82  |- skos__hiddenLabel mesh__D005712 Psychogalvanic Reflex
% 223.67/223.82  |- skos__altLabel mesh__D005712 Electrodermal Response
% 223.67/223.82  |- skos__altLabel mesh__D005712 Reflex, Psychogalvanic
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D005712 2001
% 223.67/223.82  |- skos__hiddenLabel mesh__D005712 Response, Galvanic Skin
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D005712 2005
% 223.67/223.82  |- skos__hiddenLabel mesh__D005712 Skin Responses, Galvanic
% 223.67/223.82  |- skos__altLabel mesh__D005712 Electric Conductance, Skin
% 223.67/223.82  |- rdf__type mesh__D005712sskos__Concept
% 223.67/223.82  |- skos__hiddenLabel mesh__D005712 Conductances, Skin Electric
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D005712 2000
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D005712 1999
% 223.67/223.82  |- skos__hiddenLabel mesh__D005712 Conductance, Skin Electric
% 223.67/223.82  |- mesh__recordOriginator mesh__D005712 NLM
% 223.67/223.82  |- skos__broader mesh__D005712smesh__D011580
% 223.67/223.82  |- skos__hiddenLabel mesh__D005712 Skin Response, Galvanic
% 223.67/223.82  |- skos__broader mesh__D005712smesh__D012018
% 223.67/223.82  |- mesh__recordAuthorizer mesh__D005712 SJN
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D010657 2005
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D010657 2003
% 223.67/223.82  |- mesh__recordAuthorizer mesh__D010657 sjn
% 223.67/223.82  |- mesh__dateRevised mesh__D010657 2000-06-22
% 223.67/223.82  |- mesh__dateCreated mesh__D010657 1974-11-19
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D010657 2006
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D010657 2004
% 223.67/223.82  |- skos__historyNote mesh__D010657 Amides %28%1972-1974%29%
% 223.67/223.82  |- mesh__recordMaintainer mesh__D010657 CCR
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D010657 2001
% 223.67/223.82  |- skos__altLabel mesh__D010657 2-Ethyl-2-Phenylmalonamide
% 223.67/223.82  |- rdf__type mesh__D010657sskos__Concept
% 223.67/223.82  |- skos__historyNote mesh__D010657 Malonates %28%1972-1974%29%
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D010657 2002
% 223.67/223.82  |- mesh__recordOriginator mesh__D010657 NLM
% 223.67/223.82  |- skos__prefLabel mesh__D010657 Phenylethylmalonamide
% 223.67/223.82  |- skos__broader mesh__D010657smesh__D008314
% 223.67/223.82  |- skos__altLabel mesh__D010657 Phenylethylmalondiamide
% 223.67/223.82  |- skos__altLabel mesh__D010657 Ethylphenylmalonamide
% 223.67/223.82  |- mesh__publicMeSHNote mesh__D010657
% 223.67/223.82       91; was see under MALONATES 1975-90   
% 223.67/223.82  |- skos__scopeNote mesh__D010657 A metabolite of primidone.     
% 223.67/223.82  |- skos__hiddenLabel mesh__D010657 2 Ethyl 2 Phenylmalonamide
% 223.67/223.82  |- mesh__historyNote mesh__D010657
% 223.67/223.82       91%28%75%29%; was see under MALONATES 1975-90   
% 223.67/223.82  |- mesh__dateEstablished mesh__D010657 1991-01-01
% 223.67/223.82  |- mesh__dateRevised mesh__D029362 2005-06-30
% 223.67/223.82  |- skos__broader mesh__D029362smesh__D027361
% 223.67/223.82  |- mesh__recordOriginator mesh__D029362 jmp
% 223.67/223.82  |- mesh__dateCreated mesh__D029362 2001-07-25
% 223.67/223.82  |- rdf__type mesh__D029362sskos__Concept
% 223.67/223.82  |- skos__scopeNote mesh__D029362
% 223.67/223.82       A subclass of ORGANIC ANION TRANSPORTERS that do not rely directly or indirectly upon sodium ion gradients for the transport of organic ions.%A%    
% 223.67/223.82  |- skos__hiddenLabel mesh__D029362
% 223.67/223.82       Sodium Independent Organic Anion Transporters
% 223.67/223.82  |- mesh__recordMaintainer mesh__D029362 SYSTEM
% 223.67/223.82  |- mesh__publicMeSHNote mesh__D029362 2002   
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D029362 2006
% 223.67/223.82  |- mesh__dateEstablished mesh__D029362 2002-01-01
% 223.67/223.82  |- skos__prefLabel mesh__D029362
% 223.67/223.82       Organic Anion Transporters, Sodium-Independent
% 223.67/223.82  |- skos__hiddenLabel mesh__D029362
% 223.67/223.82       Organic Anion Transporters, Sodium Independent
% 223.67/223.82  |- skos__altLabel mesh__D029362
% 223.67/223.82       Sodium-Independent Organic Anion Transporters
% 223.67/223.82  |- skos__historyNote mesh__D029362 Carrier Proteins %28%1980-2001%29%
% 223.67/223.82  |- skos__historyNote mesh__D029362 Ion Pumps %28%1994-2001%29%
% 223.67/223.82  |- mesh__recordAuthorizer mesh__D029362 sjn
% 223.67/223.82  |- mesh__historyNote mesh__D029362 2002   
% 223.67/223.82  |- skos__historyNote mesh__D015342
% 223.67/223.82       Nucleic Acid Hybridization %28%1972-1988%29%
% 223.67/223.82  |- skos__hiddenLabel mesh__D015342 Probes, Whole Chromosomal
% 223.67/223.82  |- skos__broader mesh__D015342smesh__D015341
% 223.67/223.82  |- skos__hiddenLabel mesh__D015342 Probes, DNA
% 223.67/223.82  |- rdf__type mesh__D015342sskos__Concept
% 223.67/223.82  |- skos__altLabel mesh__D015342 DNA Hybridization Probes
% 223.67/223.82  |- skos__hiddenLabel mesh__D015342 Gene Probes, Conserved
% 223.67/223.82  |- skos__hiddenLabel mesh__D015342 DNA Gene Probes
% 223.67/223.82  |- mesh__recordMaintainer mesh__D015342 ags
% 223.67/223.82  |- mesh__dateCreated mesh__D015342 1988-06-01
% 223.67/223.82  |- mesh__recordOriginator mesh__D015342 EJB
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D015342 2005
% 223.67/223.82  |- skos__annotation mesh__D015342
% 223.67/223.82       GEN or unspecified; prefer specifics; /drug eff /ultrastruct permitted; CDNA PROBES see DNA, COMPLEMENTARY is also available%A%  
% 223.67/223.82  |- mesh__publicMeSHNote mesh__D015342 89   
% 223.67/223.82  |- skos__hiddenLabel mesh__D015342 Probes, DNA Gene
% 223.67/223.82  |- mesh__recordAuthorizer mesh__D015342 ags
% 223.67/223.82  |- skos__hiddenLabel mesh__D015342 Probes, DNA Hybridization
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D015342 2006
% 223.67/223.82  |- skos__hiddenLabel mesh__D015342 Probes, Conserved Gene
% 223.67/223.82  |- skos__prefLabel mesh__D015342 DNA Probes
% 223.67/223.82  |- skos__scopeNote mesh__D015342
% 223.67/223.82       Species- or subspecies-specific DNA %28%including COMPLEMENTARY DNA;  conserved genes, whole chromosomes, or whole genomes%29% used in hybridization studies in order to identify microorganisms, to measure DNA-DNA homologies, to group subspecies, etc. The DNA probe hybridizes with a specific mRNA, if present. Conventional techniques used for testing for the hybridization product include dot blot assays, Southern blot assays, and DNA:RNA hybrid-specific antibody tests. Conventional labels for the DNA probe include the radioisotope labels 32P and 125I and the chemical label biotin. The use of DNA probes provides a specific, sensitive, rapid, and inexpensive replacement for cell culture techniques for diagnosing infections.%A%    
% 223.67/223.82  |- skos__hiddenLabel mesh__D015342 Hybridization Probes, DNA
% 223.67/223.82  |- skos__hiddenLabel mesh__D015342 Chromosomal Probes, Whole
% 223.67/223.82  |- mesh__dateRevised mesh__D015342 2005-07-27
% 223.67/223.82  |- mesh__historyNote mesh__D015342 89   
% 223.67/223.82  |- mesh__dateEstablished mesh__D015342 1989-01-01
% 223.67/223.82  |- skos__hiddenLabel mesh__D015342 Probes, Chromosomal
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D015342 2006A
% 223.67/223.82  |- skos__historyNote mesh__D015342 DNA or specific DNA %28%1972-1988%29%
% 223.67/223.82  |- skos__related mesh__D015342smesh__D016386
% 223.67/223.82  |- skos__annotation mesh__D009305 inflammation = NASOPHARYNGITIS   
% 223.67/223.82  |- mesh__recordMaintainer mesh__D009305 lkt
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D009305 2004
% 223.67/223.82  |- skos__altLabel mesh__D009305 Nasopharynges
% 223.67/223.82  |- skos__broader mesh__D009305smesh__D010614
% 223.67/223.82  |- mesh__recordOriginator mesh__D009305 NLM
% 223.67/223.82  |- skos__altLabel mesh__D009305 Rhinopharynx
% 223.67/223.82  |- skos__altLabel mesh__D009305 Rhinopharynxes
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D009305 2005
% 223.67/223.82  |- mesh__dateRevised mesh__D009305 2003-07-09
% 223.67/223.82  |- rdf__type mesh__D009305sskos__Concept
% 223.67/223.82  |- skos__scopeNote mesh__D009305
% 223.67/223.82       The nasal part of the pharynx, lying above the level of the soft palate.%A%    
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D009305 2006
% 223.67/223.82  |- mesh__dateCreated mesh__D009305 1999-01-01
% 223.67/223.82  |- skos__altLabel mesh__D009305 Rhinopharynges
% 223.67/223.82  |- skos__altLabel mesh__D009305 Nasopharynxes
% 223.67/223.82  |- skos__prefLabel mesh__D009305 Nasopharynx
% 223.67/223.82  |- mesh__recordAuthorizer mesh__D009305 sjn
% 223.67/223.82  |- mesh__dateCreated mesh__D001322 1999-01-01
% 223.67/223.82  |- skos__historyNote mesh__D001322 Computers %28%1966%29%
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D001322 2003
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D001322 1996
% 223.67/223.82  |- mesh__recordAuthorizer mesh__D001322 PLS
% 223.67/223.82  |- mesh__recordMaintainer mesh__D001322 TAP
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D001322 2004
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D001322 1997
% 223.67/223.82  |- mesh__recordOriginator mesh__D001322 NLM
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D001322 2000
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D001322 1993
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D001322 2005
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D001322 1998
% 223.67/223.82  |- skos__historyNote mesh__D001322 Chemistry, Analytical %28%1966%29%
% 223.67/223.82  |- skos__broader mesh__D001322smesh__D008919
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D001322 2006
% 223.67/223.82  |- skos__annotation mesh__D001322 NIM   
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D001322 2001
% 223.67/223.82  |- mesh__dateRevised mesh__D001322 1992-03-25
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D001322 1994
% 223.67/223.82  |- mesh__historyNote mesh__D001322 67   
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D001322 1999
% 223.67/223.82  |- mesh__dateEstablished mesh__D001322 1967-01-01
% 223.67/223.82  |- skos__historyNote mesh__D001322 Automation %28%1966%29%
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D001322 2002
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D001322 1995
% 223.67/223.82  |- skos__prefLabel mesh__D001322 Autoanalysis
% 223.67/223.82  |- skos__hiddenLabel mesh__D001322 Autoanalyses
% 223.67/223.82  |- rdf__type mesh__D001322sskos__Concept
% 223.67/223.82  |- mesh__publicMeSHNote mesh__D001322 67   
% 223.67/223.82  |- skos__scopeNote mesh__D020287
% 223.67/223.82       An in situ method for detecting areas of DNA which are nicked during apoptosis. Terminal deoxynucleotidyl transferase is used to add labeled dUTP, in a template-independent manner, to the 3 prime OH ends of either single- or double-stranded DNA. The terminal deoxynucleotidyl transferase nick end labeling, or TUNEL, assay labels apoptosis on a single-cell level, making it more sensitive than agarose gel electrophoresis for analysis of DNA fragmentation.%A%    
% 223.67/223.82  |- rdf__type mesh__D020287sskos__Concept
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D020287 2006
% 223.67/223.82  |- skos__altLabel mesh__D020287 In Situ Nick End Labeling
% 223.67/223.82  |- skos__altLabel mesh__D020287 Nick End-Labelling, In Situ
% 223.67/223.82  |- skos__hiddenLabel mesh__D020287 Nick End Labeling, In Situ
% 223.67/223.82  |- skos__related mesh__D020287smesh__D019510
% 223.67/223.82  |- skos__historyNote mesh__D020287 Apoptosis %28%1994-1998%29%
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D020287 2005
% 223.67/223.82  |- skos__broader mesh__D020287smesh__D005821
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D020287 2002
% 223.67/223.82  |- skos__altLabel mesh__D020287 In Situ Nick End Labelling
% 223.67/223.82  |- skos__related mesh__D020287smesh__D017209
% 223.67/223.82  |- mesh__dateCreated mesh__D020287 1998-06-10
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D020287 2004
% 223.67/223.82  |- skos__altLabel mesh__D020287 Nick End-Labeling, In Situ
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D020287 1999
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D020287 2001
% 223.67/223.82  |- skos__altLabel mesh__D020287 TUNEL
% 223.67/223.82  |- skos__altLabel mesh__D020287 In Situ Nick End-Labelling
% 223.67/223.82  |- skos__altLabel mesh__D020287 Nick-End Labelling, In Situ
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D020287 2003
% 223.67/223.82  |- skos__hiddenLabel mesh__D020287 Nick End Labelling, In Situ
% 223.67/223.82  |- skos__altLabel mesh__D020287 Nick-End Labeling, In Situ
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D020287 2000
% 223.67/223.82  |- mesh__historyNote mesh__D020287 99   
% 223.67/223.82  |- skos__prefLabel mesh__D020287 In Situ Nick-End Labeling
% 223.67/223.82  |- mesh__dateEstablished mesh__D020287 1999-01-01
% 223.67/223.82  |- skos__altLabel mesh__D020287 In Situ Nick-End Labelling
% 223.67/223.82  |- mesh__publicMeSHNote mesh__D020287 99   
% 223.67/223.82  |- skos__altLabel mesh__D020287 In Situ Nick End-Labeling
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D019733 2004
% 223.67/223.82  |- rdf__type mesh__D019733sskos__Concept
% 223.67/223.82  |- mesh__dateRevised mesh__D019733 2003-07-09
% 223.67/223.82  |- skos__annotation mesh__D019733 DF: C N LIGASES GLN DONOR   
% 223.67/223.82  |- skos__prefLabel mesh__D019733
% 223.67/223.82       Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor
% 223.67/223.82  |- skos__broader mesh__D019733smesh__D019731
% 223.67/223.82  |- skos__scopeNote mesh__D019733
% 223.67/223.82       Enzymes that catalyze the joining of glutamine-derived ammonia and another molecule. The linkage is in the form of a carbon-nitrogen bond. EC 6.3.5.%A%    
% 223.67/223.82  |- mesh__historyNote mesh__D019733 98   
% 223.67/223.82  |- mesh__dateCreated mesh__D019733 1997-06-20
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D019733 2005
% 223.67/223.82  |- mesh__dateEstablished mesh__D019733 1998-01-01
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D019733 2006
% 223.67/223.82  |- skos__hiddenLabel mesh__D019733
% 223.67/223.82       Carbon Nitrogen Ligases with Glutamine as Amide N Donor
% 223.67/223.82  |- mesh__publicMeSHNote mesh__D019733 98   
% 223.67/223.82  |- skos__historyNote mesh__D011750 Precipitation %28%1972-1975%29%
% 223.67/223.82  |- mesh__publicMeSHNote mesh__D011750
% 223.67/223.82       91; was see under PARAPROTEINS 1976-90   
% 223.67/223.82  |- mesh__dateCreated mesh__D011750 1975-08-01
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D011750 2006
% 223.67/223.82  |- mesh__recordOriginator mesh__D011750 RLS
% 223.67/223.82  |- skos__prefLabel mesh__D011750 Pyroglobulins
% 223.67/223.82  |- mesh__recordAuthorizer mesh__D011750 sjn
% 223.67/223.82  |- skos__historyNote mesh__D011750 Heat %28%1972-1975%29%
% 223.67/223.82  |- mesh__dateEstablished mesh__D011750 1991-01-01
% 223.67/223.82  |- skos__historyNote mesh__D011750 Immunoglobulins %28%1972-1975%29%
% 223.67/223.82  |- mesh__dateRevised mesh__D011750 2005-06-30
% 223.67/223.82  |- skos__scopeNote mesh__D011750
% 223.67/223.82       Atypical gamma immunoglobulins characterized by their irreversible heat denaturation at 56-degrees C. Pyroprecipitation is inhibited at pH below 3 and above 9. The presence of pyroglobulins in the serum is the cause of pyroglobulinemia. They are frequently present in multiple myeloma and the pyroglobulin precipitate binds complement, reacts with rheumatoid factor, produces passive cutaneous anaphylaxis, generalized passive anaphylaxis and passive Arthus-type phenomena.%A%    
% 223.67/223.82  |- mesh__historyNote mesh__D011750
% 223.67/223.82       91%28%76%29%; was see under PARAPROTEINS 1976-90   
% 223.67/223.82  |- mesh__recordMaintainer mesh__D011750 ssb
% 223.67/223.82  |- skos__broader mesh__D011750smesh__D010266
% 223.67/223.82  |- rdf__type mesh__D011750sskos__Concept
% 223.67/223.82  |- mesh__dateRevised mesh__D010658 2000-06-22
% 223.67/223.82  |- mesh__historyNote mesh__D010658
% 223.67/223.82       91%28%80%29%; was see under ALDEHYDES 1980-90   
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D010658 2002
% 223.67/223.82  |- mesh__recordOriginator mesh__D010658 RLS
% 223.67/223.82  |- skos__prefLabel mesh__D010658 Phenylglyoxal
% 223.67/223.82  |- rdf__type mesh__D010658sskos__Concept
% 223.67/223.82  |- skos__historyNote mesh__D010658 Aldehydes %28%1966-1972%29%
% 223.67/223.82  |- skos__broader mesh__D010658smesh__D006037
% 223.67/223.82  |- skos__historyNote mesh__D010658
% 223.67/223.82       Glyoxal %28%1973-1974%29% /AA %28%1975-1979%29%
% 223.67/223.82  |- mesh__dateCreated mesh__D010658 1979-05-23
% 223.67/223.82  |- mesh__recordAuthorizer mesh__D010658 sjn
% 223.67/223.82  |- mesh__recordMaintainer mesh__D010658 CCR
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D010658 2005
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D010658 2003
% 223.67/223.82  |- mesh__publicMeSHNote mesh__D010658
% 223.67/223.82       91; was see under ALDEHYDES 1980-90   
% 223.67/223.82  |- mesh__dateEstablished mesh__D010658 1991-01-01
% 223.67/223.82  |- skos__scopeNote mesh__D010658
% 223.67/223.82       A reagent that is highly selective for the modification of arginyl residues. It is used to selectively inhibit various enzymes and acts as an energy transfer inhibitor in photophosphorylation.%A%    
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D010658 2006
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D010658 2001
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D010658 2004
% 223.67/223.82  |- skos__historyNote mesh__D029363 Ion Pumps %28%1994-2001%29%
% 223.67/223.82  |- skos__historyNote mesh__D029363 Carrier Proteins %28%1980-2001%29%
% 223.67/223.82  |- mesh__recordAuthorizer mesh__D029363 sjn
% 223.67/223.82  |- mesh__historyNote mesh__D029363 2002   
% 223.67/223.82  |- mesh__recordOriginator mesh__D029363 jmp
% 223.67/223.82  |- skos__broader mesh__D029363smesh__D027361
% 223.67/223.82  |- mesh__dateRevised mesh__D029363 2005-06-30
% 223.67/223.82  |- mesh__publicMeSHNote mesh__D029363 2002   
% 223.67/223.82  |- skos__prefLabel mesh__D029363
% 223.67/223.82       Organic Anion Transporters, Sodium-Dependent
% 223.67/223.82  |- skos__hiddenLabel mesh__D029363
% 223.67/223.82       Organic Anion Transporters, Sodium Dependent
% 223.67/223.82  |- mesh__dateCreated mesh__D029363 2001-07-25
% 223.67/223.82  |- mesh__recordMaintainer mesh__D029363 SYSTEM
% 223.67/223.82  |- mesh__dateEstablished mesh__D029363 2002-01-01
% 223.67/223.82  |- skos__scopeNote mesh__D029363
% 223.67/223.82       A subclass of ORGANIC ANION TRANSPORTERS whose transport of organic anions is driven either directly or indirectly by a gradient of sodium ions.%A%    
% 223.67/223.82  |- rdf__type mesh__D029363sskos__Concept
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D029363 2006
% 223.67/223.82  |- skos__altLabel mesh__D015343 DNA Probes, Histocompatibility Antigen
% 223.67/223.82  |- skos__altLabel mesh__D015343 HLA DNA Probes
% 223.67/223.82  |- skos__hiddenLabel mesh__D015343 DNA Probes, HLA-A
% 223.67/223.82  |- skos__hiddenLabel mesh__D015343 DNA Probes, HLA-Dw
% 223.67/223.82  |- skos__altLabel mesh__D015343 Human Leukocyte Antigen DNA Probes
% 223.67/223.82  |- skos__altLabel mesh__D015343 Histocompatibility Antigen DNA Probes
% 223.67/223.82  |- skos__hiddenLabel mesh__D015343 HLA C DNA Probes
% 223.67/223.82  |- skos__historyNote mesh__D015343 HLA Antigens %28%1974-1988%29%
% 223.67/223.82  |- skos__scopeNote mesh__D015343
% 223.67/223.82       DNA probes specific for the human leukocyte antigen genes, which represent the major histocompatibility determinants in humans. The four known loci are designated as A, B, C, and D. Specific antigens are identified by a locus notation and number, e.g., HLA-A11. The inheritance of certain HLA alleles is associated with increased risk for certain diseases %28%e.g., insulin-dependent diabetes mellitus%29%.%A%    
% 223.67/223.82  |- skos__hiddenLabel mesh__D015343 HLA DR DNA Probes
% 223.67/223.82  |- skos__hiddenLabel mesh__D015343 Probes, HLA-Dw DNA
% 223.67/223.82  |- skos__historyNote mesh__D015343 DNA or specific DNA %28%1972-1988%29%
% 223.67/223.82  |- skos__hiddenLabel mesh__D015343 DNA Probes, HLA-B
% 223.67/223.82  |- skos__prefLabel mesh__D015343 DNA Probes, HLA
% 223.67/223.82  |- mesh__publicMeSHNote mesh__D015343
% 223.67/223.82       91; was see under DNA PROBES 1989-90   
% 223.67/223.82  |- rdf__type mesh__D015343sskos__Concept
% 223.67/223.82  |- skos__hiddenLabel mesh__D015343 HLA A DNA Probes
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D015343 2006
% 223.67/223.82  |- skos__hiddenLabel mesh__D015343 Probes, HLA-B DNA
% 223.67/223.82  |- skos__hiddenLabel mesh__D015343 Probes, HLA-D DNA
% 223.67/223.82  |- mesh__dateRevised mesh__D015343 2004-07-13
% 223.67/223.82  |- skos__hiddenLabel mesh__D015343 DNA Probes, HLA-C
% 223.67/223.82  |- mesh__recordMaintainer mesh__D015343 sjn
% 223.67/223.82  |- skos__annotation mesh__D015343
% 223.67/223.82       /drug eff /ultrastruct permitted; HLA-A, -B, -C, -D, -DR, %26% -Dw probes go here; DF: HLA PROBES%A%  
% 223.67/223.82  |- skos__hiddenLabel mesh__D015343 Probes, HLA-A DNA
% 223.67/223.82  |- mesh__activeMeSHYear mesh__D015343 2005
% 223.67/223.82  |- mesh__dateEstablished mesh__D015343 1991-01-01
% 223.67/223.82  |- skos__hiddenLabel mesh__D015343 DNA Probes, HLA-DR
% 223.67/223.82  |- skos__hiddenLabel mesh__D015343 DNA Probes, HLA-D
% 223.67/223.83  |- skos__hiddenLabel mesh__D015343 HLA Dw DNA Probes
% 223.67/223.83  |- skos__hiddenLabel mesh__D015343 HLA B DNA Probes
% 223.67/223.83  |- skos__hiddenLabel mesh__D015343 Probes, HLA-DR DNA
% 223.67/223.83  |- skos__hiddenLabel mesh__D015343 HLA D DNA Probes
% 223.67/223.83  |- mesh__recordAuthorizer mesh__D015343 sjn
% 223.67/223.83  |- skos__hiddenLabel mesh__D015343 Probes, HLA DNA
% 223.67/223.83  |- skos__hiddenLabel mesh__D015343 Probes, HLA-C DNA
% 223.67/223.83  |- skos__broader mesh__D015343smesh__D015342
% 223.67/223.83  |- mesh__dateCreated mesh__D015343 1988-06-01
% 223.67/223.83  |- skos__historyNote mesh__D015343
% 223.67/223.83       Nucleic Acid Hybridization %28%1972-1988%29%
% 223.67/223.83  |- mesh__historyNote mesh__D015343
% 223.67/223.83       91%28%89%29%; was see under DNA PROBES 1989-90   
% 223.67/223.83  |- mesh__recordOriginator mesh__D015343 EJB
% 223.67/223.83  |- mesh__recordAuthorizer mesh__D009306 sjn
% 223.67/223.83  |- skos__prefLabel mesh__D009306 Natal Teeth
% 223.67/223.83  |- skos__scopeNote mesh__D009306
% 223.67/223.83       Predeciduous teeth present at birth. They may be well formed and normal or may represent hornified epithelial structures without roots. They are found on the gingivae over the crest of the ridge and arise from accessory buds of the dental lamina ahead of the deciduous buds or from buds of the accessory dental lamina. %28%From Jablonski, Dictionary of Dentistry, 1992%29%%A%    
% 223.67/223.83  |- rdf__type mesh__D009306sskos__Concept
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D009306 2005
% 223.67/223.83  |- mesh__recordMaintainer mesh__D009306 lkt
% 223.67/223.83  |- mesh__dateRevised mesh__D009306 2003-07-09
% 223.67/223.83  |- skos__annotation mesh__D009306
% 223.67/223.83       %22%predeciduous teeth present at birth%22%   
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D009306 2006
% 223.67/223.83  |- mesh__dateEstablished mesh__D009306 1991-01-01
% 223.67/223.83  |- mesh__dateCreated mesh__D009306 1999-01-01
% 223.67/223.83  |- skos__broader mesh__D009306smesh__D014094
% 223.67/223.83  |- skos__hiddenLabel mesh__D009306 Teeth, Natal
% 223.67/223.83  |- mesh__recordOriginator mesh__D009306 NLM
% 223.67/223.83  |- mesh__historyNote mesh__D009306
% 223.67/223.83       91%28%75%29%; was see under TOOTH, DECIDUOUS 1975-90   
% 223.67/223.83  |- mesh__publicMeSHNote mesh__D009306
% 223.67/223.83       91; was see under TOOTH, DECIDUOUS 1975-90   
% 223.67/223.83  |- skos__hiddenLabel mesh__D009306 Natal Tooth
% 223.67/223.83  |- skos__altLabel mesh__D009306 Tooth, Natal
% 223.67/223.83  |- mesh__onlineNote mesh__D009306 search TOOTH, DECIDUOUS 1966-74   
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D009306 2004
% 223.67/223.83  |- skos__related mesh__D001323smesh__D001327
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D001323 2006
% 223.67/223.83  |- skos__related mesh__D001323smesh__D015551
% 223.67/223.83  |- mesh__recordAuthorizer mesh__D001323 sjn
% 223.67/223.83  |- rdf__type mesh__D001323sskos__Concept
% 223.67/223.83  |- skos__prefLabel mesh__D001323 Autoantibodies
% 223.67/223.83  |- mesh__dateCreated mesh__D001323 1999-01-01
% 223.67/223.83  |- skos__broader mesh__D001323smesh__D000906
% 223.67/223.83  |- mesh__recordOriginator mesh__D001323 NLM
% 223.67/223.83  |- skos__annotation mesh__D001323
% 223.67/223.83       do not confuse with ANTIBODIES, ANTI-IDIOTYPIC   
% 223.67/223.83  |- skos__scopeNote mesh__D001323
% 223.67/223.83       Antibodies that react with self-antigens %28%AUTOANTIGENS%29% of the organism that produced them.%A%    
% 223.67/223.83  |- mesh__dateRevised mesh__D001323 2005-06-30
% 223.67/223.83  |- mesh__recordMaintainer mesh__D001323 ssb
% 223.67/223.83  |- skos__historyNote mesh__D020288 Glioma %28%1994-1999%29%
% 223.67/223.83  |- mesh__dateCreated mesh__D020288 1999-11-03
% 223.67/223.83  |- mesh__historyNote mesh__D020288 2000; use GLIOMA 1994-1999   
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D020288 2006
% 223.67/223.83  |- skos__hiddenLabel mesh__D020288 Papillomas, Choroid Plexus
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D020288 2002
% 223.67/223.83  |- mesh__publicMeSHNote mesh__D020288 2000; see GLIOMA 1994-1999   
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D020288 2005
% 223.67/223.83  |- skos__altLabel mesh__D020288 Choroid Plexus Papilloma
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D020288 2001
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D020288 2004
% 223.67/223.83  |- skos__hiddenLabel mesh__D020288 Choroid Plexus Papillomas
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D020288 2000
% 223.67/223.83  |- mesh__dateEstablished mesh__D020288 2000-01-01
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D020288 2003
% 223.67/223.83  |- skos__prefLabel mesh__D020288 Papilloma, Choroid Plexus
% 223.67/223.83  |- skos__broader mesh__D020288smesh__D016545
% 223.67/223.83  |- rdf__type mesh__D020288sskos__Concept
% 223.67/223.83  |- skos__historyNote mesh__D020288
% 223.67/223.83       Cerebral Ventricle Neoplasms %28%1966-1993%29%
% 223.67/223.83  |- skos__scopeNote mesh__D020288
% 223.67/223.83       A usually benign neoplasm that arises from the cuboidal epithelium of the choroid plexus and takes the form of an enlarged CHOROID PLEXUS, which may be associated with oversecretion of CSF. The tumor usually presents in the first decade of life with signs of increased intracranial pressure including HEADACHES; ATAXIA; DIPLOPIA; and alterations of mental status. In children it is most common in the lateral ventricles and in adults it tends to arise in the fourth ventricle. Malignant transformation to choroid plexus carcinomas may rarely occur. %28%Adams et al., Principles of Neurology, 6th ed, p667; DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2072%29%%A%    
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D011751 2006
% 223.67/223.83  |- skos__historyNote mesh__D011751 Aminopeptidases %28%1970-1974%29%
% 223.67/223.83  |- mesh__onlineNote mesh__D011751
% 223.67/223.83       use PYROGLUTAMYL-PEPTIDASE I to search 5-OXOPROLYL-PEPTIDASE 1991-94 %26% PYROGLUTAMATE AMINOPEPTIDASE 1975-90%A%  
% 223.67/223.83  |- skos__scopeNote mesh__D011751
% 223.67/223.83       An enzyme that catalyzes the release of a N-terminal pyroglutamyl group from a polypeptide provided the next residue is not proline. It is inhibited by thiol-blocking reagents and occurs in mammalian tissues, microorganisms, and plants. %28%From Enzyme Nomenclature, 1992%29% EC 3.4.19.3.%A%    
% 223.67/223.83  |- mesh__dateEstablished mesh__D011751 1991-01-01
% 223.67/223.83  |- skos__altLabel mesh__D011751 Pyrrolidonyl Peptidase
% 223.67/223.83  |- skos__altLabel mesh__D011751 Pyroglutamyl-Peptide Hydrolase
% 223.67/223.83  |- mesh__recordOriginator mesh__D011751 NLM
% 223.67/223.83  |- skos__altLabel mesh__D011751 Pyrrolidonecarboxylate Peptidase
% 223.67/223.83  |- skos__hiddenLabel mesh__D011751 Aminopeptidase, Pyroglutamate
% 223.67/223.83  |- skos__broader mesh__D011751smesh__D000626
% 223.67/223.83  |- mesh__dateCreated mesh__D011751 1974-11-19
% 223.67/223.83  |- skos__hiddenLabel mesh__D011751 I, Pyroglutamyl-Peptidase
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D011751 2004
% 223.67/223.83  |- mesh__recordMaintainer mesh__D011751 jmp
% 223.67/223.83  |- mesh__recordAuthorizer mesh__D011751 sjn
% 223.67/223.83  |- skos__historyNote mesh__D011751
% 223.67/223.83       Pyrrolidonecarboxylic Acid %28%1972-1974%29%
% 223.67/223.83  |- skos__prefLabel mesh__D011751 Pyroglutamyl-Peptidase I
% 223.67/223.83  |- skos__hiddenLabel mesh__D011751 Pyroglutamyl Peptidase I
% 223.67/223.83  |- skos__hiddenLabel mesh__D011751 Peptidase, Pyrrolidonecarboxylate
% 223.67/223.83  |- rdf__type mesh__D011751sskos__Concept
% 223.67/223.83  |- skos__hiddenLabel mesh__D011751 Peptidase, Pyrrolidonyl
% 223.67/223.83  |- skos__hiddenLabel mesh__D011751 5 Oxoprolyl Peptidase
% 223.67/223.83  |- skos__hiddenLabel mesh__D011751 Pyroglutamyl Peptide Hydrolase
% 223.67/223.83  |- mesh__publicMeSHNote mesh__D011751
% 223.67/223.83       95: was 5-OXOPROLYL-PEPTIDASE 1991-94; was PYROGLUTAMATE AMINOPEPTIDASE see under AMINOPEPTIDASES 1975-90%A%  
% 223.67/223.83  |- mesh__dateRevised mesh__D011751 2003-07-09
% 223.67/223.83  |- skos__altLabel mesh__D011751 5-Oxoprolyl-Peptidase
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D011751 2005
% 223.67/223.83  |- skos__altLabel mesh__D011751 Pyroglutamate Aminopeptidase
% 223.67/223.83  |- mesh__historyNote mesh__D011751
% 223.67/223.83       95: was 5-OXOPROLYL-PEPTIDASE 1991-94; was PYROGLUTAMATE AMINOPEPTIDASE see under AMINOPEPTIDASES 1975-90%A%  
% 223.67/223.83  |- skos__broader mesh__D002342Q000293smesh__D002342
% 223.67/223.83  |- mesh__preferredCombination mesh__D002342Q000293smesh__D020212
% 223.67/223.83  |- rdf__type mesh__D002342Q000293smesh__CompoundConcept
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D005714 2002
% 223.67/223.83  |- skos__annotation mesh__D005714 a republic in western Africa   
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D005714 2004
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D005714 1996
% 223.67/223.83  |- skos__broader mesh__D005714smesh__D000354
% 223.67/223.83  |- mesh__recordOriginator mesh__D005714 NLM
% 223.67/223.83  |- mesh__recordMaintainer mesh__D005714 TGC
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D005714 2005
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D005714 1997
% 223.67/223.83  |- mesh__recordAuthorizer mesh__D005714 PLS
% 223.67/223.83  |- skos__prefLabel mesh__D005714 Gambia
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D005714 2006
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D005714 1998
% 223.67/223.83  |- rdf__type mesh__D005714sskos__Concept
% 223.67/223.83  |- mesh__dateRevised mesh__D005714 1995-02-17
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D005714 2000
% 223.67/223.83  |- skos__scopeNote mesh__D005714
% 223.67/223.83       A republic in western Africa, constituting an enclave within SENEGAL extending on both sides of the Gambia River. Its capital is Banjul, formerly Bathurst. The mouth of the river was discovered in 1455 by the Portuguese and the English ascended the river 1618-19. The British claim to the region was recognized by the Treaty of Versailles in 1783. Its status under the British and Sierra Leone changed several times from 1807 until 1965 when it became independent. The country is named for the river and is a Portuguese corruption of the native name Ba-Dimma, meaning river. %28%From Webster%27%s New Geographical Dictionary, 1988, p426 %26% Room, Brewer%27%s Dictionary of Names, 1992, p200%29%%A%    
% 223.67/223.83  |- mesh__dateCreated mesh__D005714 1999-01-01
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D005714 1999
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D005714 2001
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D005714 2003
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D029364 2002
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D029364 2004
% 223.67/223.83  |- skos__prefLabel mesh__D029364 Tenuivirus
% 223.67/223.83  |- mesh__publicMeSHNote mesh__D029364 2002   
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D029364 2003
% 223.67/223.83  |- skos__historyNote mesh__D029364 Plant Viruses %28%1992-2001%29%
% 223.67/223.83  |- skos__historyNote mesh__D029364 RNA Viruses %28%1995-2001%29%
% 223.67/223.83  |- mesh__dateEstablished mesh__D029364 2002-01-01
% 223.67/223.83  |- mesh__historyNote mesh__D029364 2002   
% 223.67/223.83  |- rdf__type mesh__D029364sskos__Concept
% 223.67/223.83  |- skos__scopeNote mesh__D029364
% 223.67/223.83       A genus of RNA plant viruses as yet unassigned to any family. Plant hosts are all in the family Poaceae. Each species is transmitted by a particular species of planthopper. The type species is Rice stripe virus.%A%    
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D029364 2006
% 223.67/223.83  |- mesh__dateCreated mesh__D029364 2001-07-25
% 223.67/223.83  |- skos__hiddenLabel mesh__D029364 Tenuiviruses
% 223.67/223.83  |- skos__broader mesh__D029364smesh__D010942
% 223.67/223.83  |- skos__broader mesh__D029364smesh__D012328
% 223.67/223.83  |- skos__annotation mesh__D029364 coord IM with specific plant /virol   
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D029364 2005
% 223.67/223.83  |- rdf__type mesh__D010659sskos__Concept
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D010659 2001
% 223.67/223.83  |- mesh__recordOriginator mesh__D010659 NLM
% 223.67/223.83  |- mesh__activeMeSHYear mesh__D010659 2002
% 223.67/223.83  |- skos__broader mesh__D010659smesh__D006834
% 223.67/223.83  |- skos__scopeNote mesh__D010659
% 223.67/223.83       Diazo derivatives of aniline, used as a reagent for sugars, ketones, and aldehydes. %28%Dorland, 28th ed%29%%A%    
% 223.67/223.83  |- mesh__onlineNote mesh__D010659
% 223.67/223.83       use PHENYLHYDRAZINES to search PHENYLHYDRAZINE 1966-74   
% 223.67/223.84  |- mesh__recordMaintainer mesh__D010659 KEV
% 223.67/223.84  |- mesh__dateCreated mesh__D010659 1999-01-01
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D010659 2005
% 223.67/223.84  |- mesh__dateRevised mesh__D010659 1995-05-18
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D010659 2003
% 223.67/223.84  |- mesh__recordAuthorizer mesh__D010659 PLS
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D010659 2006
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D010659 1998
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D010659 2004
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D010659 1996
% 223.67/223.84  |- skos__prefLabel mesh__D010659 Phenylhydrazines
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D010659 2000
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D010659 1999
% 223.67/223.84  |- mesh__historyNote mesh__D010659 75; was PHENYLHYDRAZINE 1963-74   
% 223.67/223.84  |- mesh__publicMeSHNote mesh__D010659 75; was PHENYLHYDRAZINE 1963-74   
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D010659 1997
% 223.67/223.84  |- skos__altLabel mesh__D021381 Protein Trafficking
% 223.67/223.84  |- mesh__recordMaintainer mesh__D021381 nns
% 223.67/223.84  |- skos__annotation mesh__D021381
% 223.67/223.84       coordinate NIM with specific protein/metab %28%IM%29% or /pharmacokin %28%IM%29%%A%  
% 223.67/223.84  |- skos__hiddenLabel mesh__D021381 Targeting, Protein
% 223.67/223.84  |- skos__hiddenLabel mesh__D021381 Trafficking, Protein
% 223.67/223.84  |- skos__hiddenLabel mesh__D021381 Protein Transports
% 223.67/223.84  |- skos__hiddenLabel mesh__D021381 Protein Sortings
% 223.67/223.84  |- skos__hiddenLabel mesh__D021381 Protein Traffickings
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D021381 2006
% 223.67/223.84  |- skos__hiddenLabel mesh__D021381 Protein Transport, Gated
% 223.67/223.84  |- skos__broader mesh__D021381smesh__D001692
% 223.67/223.84  |- skos__scopeNote mesh__D021381
% 223.67/223.84       The process of moving proteins from one cellular compartment %28%including extracellular%29% to another by various sorting and transport mechanisms such as gated transport, protein translocation, and  vesicular transport.%A%    
% 223.67/223.84  |- mesh__historyNote mesh__D021381 2001   
% 223.67/223.84  |- skos__altLabel mesh__D021381 Protein Localization Processes, Cellular
% 223.67/223.84  |- skos__altLabel mesh__D021381 Transmembrane Protein Transport
% 223.67/223.84  |- skos__hiddenLabel mesh__D021381 Traffickings, Protein
% 223.67/223.84  |- mesh__publicMeSHNote mesh__D021381 2001   
% 223.67/223.84  |- mesh__dateCreated mesh__D021381 2000-07-05
% 223.67/223.84  |- mesh__recordAuthorizer mesh__D021381 sjn
% 223.67/223.84  |- mesh__dateEstablished mesh__D021381 2001-01-01
% 223.67/223.84  |- skos__hiddenLabel mesh__D021381 Protein Transport, Vesicular
% 223.67/223.84  |- rdf__type mesh__D021381sskos__Concept
% 223.67/223.84  |- skos__historyNote mesh__D021381 Biological Transport %28%1964-2000%29%
% 223.67/223.84  |- mesh__recordOriginator mesh__D021381 nns
% 223.67/223.84  |- skos__prefLabel mesh__D021381 Protein Transport
% 223.67/223.84  |- skos__hiddenLabel mesh__D021381 Protein Transport, Transmembrane
% 223.67/223.84  |- skos__related mesh__D021381smesh__D021382
% 223.67/223.84  |- skos__historyNote mesh__D021381 Proteins/metabolism %28%1964-2000%29%
% 223.67/223.84  |- skos__hiddenLabel mesh__D021381 Transmembrane Protein Transports
% 223.67/223.84  |- mesh__dateRevised mesh__D021381 2005-06-30
% 223.67/223.84  |- skos__prefLabel mesh__D015344 DNA Probes, HPV
% 223.67/223.84  |- mesh__historyNote mesh__D015344
% 223.67/223.84       91%28%89%29%; was see under DNA PROBES 1989-90   
% 223.67/223.84  |- mesh__recordAuthorizer mesh__D015344 sjn
% 223.67/223.84  |- rdf__type mesh__D015344sskos__Concept
% 223.67/223.84  |- skos__scopeNote mesh__D015344
% 223.67/223.84       DNA probes specific for the identification of human papilloma virus.%A%    
% 223.67/223.84  |- mesh__dateEstablished mesh__D015344 1991-01-01
% 223.67/223.84  |- skos__broader mesh__D015344smesh__D015342
% 223.67/223.84  |- skos__hiddenLabel mesh__D015344 Probes, HPV DNA
% 223.67/223.84  |- mesh__dateCreated mesh__D015344 1988-06-01
% 223.67/223.84  |- skos__altLabel mesh__D015344 Human Papilloma Virus DNA Probes
% 223.67/223.84  |- mesh__publicMeSHNote mesh__D015344
% 223.67/223.84       91; was see under DNA PROBES 1989-90   
% 223.67/223.84  |- skos__annotation mesh__D015344
% 223.67/223.84       /drug eff /ultrastruct permitted; DF: HPV PROBES   
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D015344 2006
% 223.67/223.84  |- skos__historyNote mesh__D015344
% 223.67/223.84       Nucleic Acid Hybridization %28%1972-1988%29%
% 223.67/223.84  |- mesh__dateRevised mesh__D015344 2004-07-13
% 223.67/223.84  |- skos__altLabel mesh__D015344 HPV DNA Probes
% 223.67/223.84  |- mesh__recordOriginator mesh__D015344 EJB
% 223.67/223.84  |- skos__altLabel mesh__D015344 Papilloma Virus DNA Probes
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D015344 2005
% 223.67/223.84  |- mesh__recordMaintainer mesh__D015344 sjn
% 223.67/223.84  |- skos__historyNote mesh__D015344 DNA or specific DNA %28%1972-1988%29%
% 223.67/223.84  |- skos__historyNote mesh__D015344 Papilloma Viruses %28%1972-1988%29%
% 223.67/223.84  |- rdf__type mesh__D009307sskos__Concept
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D009307 1995
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D009307 2006
% 223.67/223.84  |- skos__scopeNote mesh__D009307
% 223.67/223.84       A United States organization of distinguished scientists and engineers established for the purpose of investigating and reporting upon any subject of art or science as requested by any department of government. The National Research Council organized by NAS serves as the principal operating agency to stimulate and support research.%A%    
% 223.67/223.84  |- skos__hiddenLabel mesh__D009307 Sciences National Academy %28%U.S.%29%
% 223.67/223.84  |- skos__altLabel mesh__D009307 National Research Council %28%U.S.%29%
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D009307 2000
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D009307 1998
% 223.67/223.84  |- mesh__recordAuthorizer mesh__D009307 PLS
% 223.67/223.84  |- skos__prefLabel mesh__D009307 National Academy of Sciences %28%U.S.%29%
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D009307 2003
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D009307 2001
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D009307 1999
% 223.67/223.84  |- skos__annotation mesh__D009307
% 223.67/223.84       add UNITED STATES %28%NIM%29%; research support by this agency is checked as NON-US GOVT SUP; DF: NAS NRC    CATALOG: use NAF entry%A%  
% 223.67/223.84  |- mesh__dateEstablished mesh__D009307 1990-01-01
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D009307 1993
% 223.67/223.84  |- mesh__historyNote mesh__D009307
% 223.67/223.84       90%28%82%29%; was see under ORGANIZATIONS 1982-89; was NATIONAL ACADEMY OF SCIENCES see under ORGANIZATIONS 1980-81%A%  
% 223.67/223.84  |- skos__hiddenLabel mesh__D009307 Council, National Research %28%U.S.%29%
% 223.67/223.84  |- skos__altLabel mesh__D009307 United States National Academy of Sciences
% 223.67/223.84  |- mesh__dateRevised mesh__D009307 1992-05-15
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D009307 2004
% 223.67/223.84  |- skos__hiddenLabel mesh__D009307 Sciences National Academies %28%U.S.%29%
% 223.67/223.84  |- skos__hiddenLabel mesh__D009307 Councils, National Research %28%U.S.%29%
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D009307 1996
% 223.67/223.84  |- skos__hiddenLabel mesh__D009307 National Research Councils %28%U.S.%29%
% 223.67/223.84  |- skos__altLabel mesh__D009307 National Academy of Sciences
% 223.67/223.84  |- mesh__dateCreated mesh__D009307 1978-12-22
% 223.67/223.84  |- mesh__recordMaintainer mesh__D009307 TAP
% 223.67/223.84  |- skos__broader mesh__D009307smesh__D009938
% 223.67/223.84  |- skos__hiddenLabel mesh__D009307 Research Council, National %28%U.S.%29%
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D009307 2002
% 223.67/223.84  |- mesh__recordOriginator mesh__D009307 EC
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D009307 1997
% 223.67/223.84  |- mesh__publicMeSHNote mesh__D009307
% 223.67/223.84       90; was see under ORGANIZATIONS 1982-89; was NATIONAL ACADEMY OF SCIENCES see under ORGANIZATIONS 1980-81%A%  
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D009307 1994
% 223.67/223.84  |- mesh__onlineNote mesh__D009307
% 223.67/223.84       use NATIONAL ACADEMY OF SCIENCES %28%U.S.%29% to search NATIONAL ACADEMY OF SCIENCES 1980-82%A%  
% 223.67/223.84  |- skos__hiddenLabel mesh__D009307 Research Councils, National %28%U.S.%29%
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D009307 2005
% 223.67/223.84  |- mesh__publicMeSHNote mesh__D001324 87; was see under ANTIGENS 1973-86   
% 223.67/223.84  |- skos__hiddenLabel mesh__D001324 Self Antigens
% 223.67/223.84  |- skos__prefLabel mesh__D001324 Autoantigens
% 223.67/223.84  |- mesh__dateEstablished mesh__D001324 1987-01-01
% 223.67/223.84  |- mesh__historyNote mesh__D001324
% 223.67/223.84       87%28%73%29%; was see under ANTIGENS 1973-86   
% 223.67/223.84  |- skos__scopeNote mesh__D001324
% 223.67/223.84       Endogenous tissue constituents that have the ability to interact with AUTOANTIBODIES and cause an immune response.%A%    
% 223.67/223.84  |- mesh__recordAuthorizer mesh__D001324 sjn
% 223.67/223.84  |- skos__historyNote mesh__D001324 Antigens %28%1966-1972%29%
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D001324 2006
% 223.67/223.84  |- rdf__type mesh__D001324sskos__Concept
% 223.67/223.84  |- mesh__dateCreated mesh__D001324 1999-01-01
% 223.67/223.84  |- mesh__recordOriginator mesh__D001324 NLM
% 223.67/223.84  |- skos__altLabel mesh__D001324 Self-Antigens
% 223.67/223.84  |- skos__altLabel mesh__D001324 Autologous Antigens
% 223.67/223.84  |- skos__broader mesh__D001324smesh__D000941
% 223.67/223.84  |- skos__hiddenLabel mesh__D001324 Antigens, Autologous
% 223.67/223.84  |- mesh__recordMaintainer mesh__D001324 ssb
% 223.67/223.84  |- mesh__dateRevised mesh__D001324 2005-06-30
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D019735 2005
% 223.67/223.84  |- mesh__dateCreated mesh__D019735 1997-06-20
% 223.67/223.84  |- skos__prefLabel mesh__D019735 Carbon-Carbon Ligases
% 223.67/223.84  |- skos__broader mesh__D019735smesh__D008025
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D019735 2006
% 223.67/223.84  |- mesh__dateEstablished mesh__D019735 1998-01-01
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D019735 2004
% 223.67/223.84  |- rdf__type mesh__D019735sskos__Concept
% 223.67/223.84  |- mesh__dateRevised mesh__D019735 2003-07-09
% 223.67/223.84  |- skos__annotation mesh__D019735 DF: C C LIGASES   
% 223.67/223.84  |- skos__hiddenLabel mesh__D019735 Ligases, Carbon-Carbon
% 223.67/223.84  |- mesh__publicMeSHNote mesh__D019735 98   
% 223.67/223.84  |- skos__scopeNote mesh__D019735
% 223.67/223.84       Enzymes that catalyze the joining of two molecules by the formation of a carbon-carbon bond. These are the carboxylating enzymes and are mostly biotinyl-proteins. EC 6.4.%A%    
% 223.67/223.84  |- mesh__historyNote mesh__D019735 98   
% 223.67/223.84  |- skos__hiddenLabel mesh__D019735 Carbon Carbon Ligases
% 223.67/223.84  |- mesh__dateEstablished mesh__D011752 1991-01-01
% 223.67/223.84  |- mesh__recordOriginator mesh__D011752 NLM
% 223.67/223.84  |- skos__prefLabel mesh__D011752 Pyroglutamate Hydrolase
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D011752 2006
% 223.67/223.84  |- skos__hiddenLabel mesh__D011752 5 Oxoprolinase
% 223.67/223.84  |- mesh__publicMeSHNote mesh__D011752
% 223.67/223.84       91; was see under AMIDOHYDROLASES 1975-90   
% 223.67/223.84  |- skos__altLabel mesh__D011752 5-Oxoprolinase
% 223.67/223.84  |- mesh__dateCreated mesh__D011752 1974-11-19
% 223.67/223.84  |- mesh__recordAuthorizer mesh__D011752 sjn
% 223.67/223.84  |- mesh__historyNote mesh__D011752
% 223.67/223.84       91%28%75%29%; was see under AMIDOHYDROLASES 1975-90   
% 223.67/223.84  |- skos__historyNote mesh__D011752 Amidohydrolases %28%1974%29%
% 223.67/223.84  |- skos__altLabel mesh__D011752 Oxoprolinase
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D011752 2004
% 223.67/223.84  |- rdf__type mesh__D011752sskos__Concept
% 223.67/223.84  |- skos__scopeNote mesh__D011752
% 223.67/223.84       Hydrolyzes pyroglutamic acid in the presence of ATP to glutamate plus ADP and inorganic phosphate. Deficiency leads to pyroglutamic acidurea.%A%    
% 223.67/223.84  |- skos__historyNote mesh__D011752 Pyrrolidonecarboxylic Acid %28%1974%29%
% 223.67/223.84  |- skos__broader mesh__D011752smesh__D000581
% 223.67/223.84  |- mesh__recordMaintainer mesh__D011752 ssb
% 223.67/223.84  |- mesh__dateRevised mesh__D011752 2003-07-09
% 223.67/223.84  |- skos__hiddenLabel mesh__D011752 Hydrolase, Pyroglutamate
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D011752 2005
% 223.67/223.84  |- skos__hiddenLabel mesh__D005715 Pathological Gamblings
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D005715 2005
% 223.67/223.84  |- mesh__dateEstablished mesh__D005715 1968-01-01
% 223.67/223.84  |- mesh__recordMaintainer mesh__D005715 JLS
% 223.67/223.84  |- skos__hiddenLabel mesh__D005715 Gamblings, Pathological
% 223.67/223.84  |- skos__broader mesh__D005715smesh__D007174
% 223.67/223.84  |- mesh__historyNote mesh__D005715
% 223.67/223.84       91%28%79%29%68; was see under RISK-TAKING 1979-90; was heading 1968-78%A%  
% 223.67/223.84  |- mesh__recordOriginator mesh__D005715 NLM
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D005715 2006
% 223.67/223.84  |- mesh__recordAuthorizer mesh__D005715 sjn
% 223.67/223.84  |- rdf__type mesh__D005715sskos__Concept
% 223.67/223.84  |- mesh__dateRevised mesh__D005715 2002-07-03
% 223.67/223.84  |- skos__prefLabel mesh__D005715 Gambling
% 223.67/223.84  |- skos__broader mesh__D005715smesh__D012309
% 223.67/223.84  |- mesh__dateCreated mesh__D005715 1999-01-01
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D005715 2003
% 223.67/223.84  |- skos__altLabel mesh__D005715 Pathological Gambling
% 223.67/223.84  |- skos__hiddenLabel mesh__D005715 Gamblings
% 223.67/223.84  |- skos__scopeNote mesh__D005715
% 223.67/223.84       An activity distinguished primarily by an element of risk in trying to obtain a desired goal, e.g., playing a game of chance for money.%A%    
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D005715 2004
% 223.67/223.84  |- mesh__publicMeSHNote mesh__D005715
% 223.67/223.84       91; was see under RISK-TAKING 1979-90; was heading 1968-78%A%  
% 223.67/223.84  |- mesh__dateRevised mesh__D029365 2005-06-30
% 223.67/223.84  |- rdf__type mesh__D029365sskos__Concept
% 223.67/223.84  |- mesh__recordMaintainer mesh__D029365 SYSTEM
% 223.67/223.84  |- mesh__dateCreated mesh__D029365 2001-07-25
% 223.67/223.84  |- skos__altLabel mesh__D029365 ATP-Dependent Organic Anion Transporters
% 223.67/223.84  |- skos__scopeNote mesh__D029365
% 223.67/223.84       A subclass of ORGANIC ANION TRANSPORTERS whose transport of organic anions is linked directly to the hydrolysis of ATP. The subclass includes those ATP-BINDING CASSETTE TRANSPORTERS that transport organic ions.%A%    
% 223.67/223.84  |- skos__prefLabel mesh__D029365 Organic Anion Transporters, ATP-Dependent
% 223.67/223.84  |- mesh__dateEstablished mesh__D029365 2002-01-01
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D029365 2006
% 223.67/223.84  |- skos__historyNote mesh__D029365 Ion Pumps %28%1994-2001%29%
% 223.67/223.84  |- skos__broader mesh__D029365smesh__D027361
% 223.67/223.84  |- skos__hiddenLabel mesh__D029365 ATP Dependent Organic Anion Transporters
% 223.67/223.84  |- skos__hiddenLabel mesh__D029365
% 223.67/223.84       Organic Anion Transporters, ATP Dependent
% 223.67/223.84  |- skos__historyNote mesh__D029365 Carrier Proteins %28%1980-2001%29%
% 223.67/223.84  |- mesh__recordAuthorizer mesh__D029365 sjn
% 223.67/223.84  |- mesh__publicMeSHNote mesh__D029365 2002   
% 223.67/223.84  |- mesh__historyNote mesh__D029365 2002   
% 223.67/223.84  |- mesh__recordOriginator mesh__D029365 jmp
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Peptide, Leader
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Signal Peptide, Leader
% 223.67/223.84  |- mesh__recordOriginator mesh__D021382 nns
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D021382 2003
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Signal Sequence
% 223.67/223.84  |- mesh__recordAuthorizer mesh__D021382 jls
% 223.67/223.84  |- skos__altLabel mesh__D021382 Signal Sequences, Peptide
% 223.67/223.84  |- mesh__dateCreated mesh__D021382 2000-07-06
% 223.67/223.84  |- skos__prefLabel mesh__D021382 Protein Sorting Signals
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Sequence, Peptide Leader
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Sequences, Signal
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Leader Peptides
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Peptide, Signal
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Peptide Leader Sequence
% 223.67/223.84  |- skos__altLabel mesh__D021382 Leader Peptide
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Peptides, Signal
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D021382 2004
% 223.67/223.84  |- mesh__dateEstablished mesh__D021382 2001-01-01
% 223.67/223.84  |- mesh__dateRevised mesh__D021382 2004-07-30
% 223.67/223.84  |- skos__altLabel mesh__D021382 Signal Sequence, Peptide
% 223.67/223.84  |- skos__altLabel mesh__D021382 Leader Sequences, Peptide
% 223.67/223.84  |- skos__scopeNote mesh__D021382
% 223.67/223.84       Amino acid sequences found in transported proteins that selectively guide the distribution of the proteins to specific cellular compartments.%A%    
% 223.67/223.84  |- skos__broader mesh__D021382smesh__D000595
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Peptide Signal Sequence
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Peptides, Leader Signal
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Leader Signal Peptide
% 223.67/223.84  |- mesh__historyNote mesh__D021382 2001%28%1986%29%   
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Sequences, Peptide Signal
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D021382 2005A
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D021382 2005
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Leader Sequence, Peptide
% 223.67/223.84  |- skos__altLabel mesh__D021382 Signal Sequences
% 223.67/223.84  |- mesh__recordMaintainer mesh__D021382 jls
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Sequence, Peptide Signal
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Peptides, Leader
% 223.67/223.84  |- skos__altLabel mesh__D021382 Peptide Signal Sequences
% 223.67/223.84  |- skos__broader mesh__D021382smesh__D010455
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Sequences, Peptide Leader
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Signals, Protein Sorting
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Sorting Signals, Protein
% 223.67/223.84  |- skos__altLabel mesh__D021382 Peptide Leader Sequences
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Sorting Signal, Protein
% 223.67/223.84  |- skos__altLabel mesh__D021382 Signal Peptide
% 223.67/223.84  |- skos__related mesh__D021382smesh__D021381
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D021382 2006
% 223.67/223.84  |- skos__related mesh__D021382smesh__D018271
% 223.67/223.84  |- rdf__type mesh__D021382sskos__Concept
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Signal Peptides, Leader
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Sequence, Signal
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Peptide, Leader Signal
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Protein Sorting Signal
% 223.67/223.84  |- skos__hiddenLabel mesh__D021382 Signal, Protein Sorting
% 223.67/223.84  |- mesh__publicMeSHNote mesh__D021382
% 223.67/223.84       2001; see Signal Peptides 1986-2000   
% 223.67/223.84  |- skos__hiddenLabel mesh__D015345 Probes, Oligonucleotide
% 223.67/223.84  |- rdf__type mesh__D015345sskos__Concept
% 223.67/223.84  |- skos__scopeNote mesh__D015345
% 223.67/223.84       Synthetic or natural oligonucleotides used in hybridization studies in order to identify and study specific nucleic acid fragments, e.g., DNA segments near or within a specific gene locus or gene. The probe hybridizes with a specific mRNA, if present. Conventional techniques used for testing for the hybridization product include dot blot assays, Southern blot assays, and DNA:RNA hybrid-specific antibody tests. Conventional labels for the probe include the radioisotope labels 32P and 125I and the chemical label biotin.%A%    
% 223.67/223.84  |- mesh__recordOriginator mesh__D015345 EJB
% 223.67/223.84  |- skos__broader mesh__D015345smesh__D015341
% 223.67/223.84  |- skos__historyNote mesh__D015345 Oligonucleotides %28%1972-1988%29%
% 223.67/223.84  |- skos__hiddenLabel mesh__D015345 Probes, Oligoribonucleotide
% 223.67/223.84  |- mesh__recordMaintainer mesh__D015345 ssb
% 223.67/223.84  |- mesh__recordAuthorizer mesh__D015345 sjn
% 223.67/223.84  |- mesh__dateCreated mesh__D015345 1988-06-01
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D015345 2004
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D015345 2006
% 223.67/223.84  |- skos__related mesh__D015345smesh__D009693
% 223.67/223.84  |- mesh__dateRevised mesh__D015345 2003-07-09
% 223.67/223.84  |- mesh__dateEstablished mesh__D015345 1989-01-01
% 223.67/223.84  |- skos__hiddenLabel mesh__D015345 Probes, Oligodeoxyribonucleotide
% 223.67/223.84  |- skos__related mesh__D015345smesh__D020411
% 223.67/223.84  |- mesh__publicMeSHNote mesh__D015345 89   
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D015345 2005
% 223.67/223.84  |- skos__prefLabel mesh__D015345 Oligonucleotide Probes
% 223.67/223.84  |- skos__annotation mesh__D015345
% 223.67/223.84       usually no qualif; /drug eff /ultrastruct permitted   
% 223.67/223.84  |- skos__historyNote mesh__D015345
% 223.67/223.84       Nucleic Acid Hybridization %28%1972-1988%29%
% 223.67/223.84  |- mesh__historyNote mesh__D015345 89   
% 223.67/223.84  |- mesh__recordOriginator mesh__D009308 EC
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D009308 2002
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D009308 1998
% 223.67/223.84  |- skos__altLabel mesh__D009308
% 223.67/223.84       National Center for Health Care Technology %28%U.S.%29%
% 223.67/223.84  |- mesh__dateCreated mesh__D009308 1981-05-19
% 223.67/223.84  |- mesh__dateEstablished mesh__D009308 1991-01-01
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D009308 2003
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D009308 1999
% 223.67/223.84  |- skos__broader mesh__D009308smesh__D014492
% 223.67/223.84  |- skos__scopeNote mesh__D009308
% 223.67/223.84       A center in the PUBLIC HEALTH SERVICE which coordinates and administers a program of research, demonstrations, and evaluations of medical technologies and assessments of health care technology.%A%    
% 223.67/223.84  |- mesh__recordAuthorizer mesh__D009308 SJN
% 223.67/223.84  |- skos__prefLabel mesh__D009308 National Center for Health Care Technology
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D009308 2004
% 223.67/223.84  |- mesh__activeMeSHYear mesh__D009308 2000
% 223.67/223.85  |- mesh__historyNote mesh__D009308
% 223.67/223.85       91%28%82%29%; was see under UNITED STATES PUBLIC HEALTH SERVICE 1982-90%A%  
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D009308 2001
% 223.67/223.85  |- mesh__dateRevised mesh__D009308 1997-06-20
% 223.67/223.85  |- rdf__type mesh__D009308sskos__Concept
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D009308 2005
% 223.67/223.85  |- skos__altLabel mesh__D009308
% 223.67/223.85       United States Nat%27%l Center for Health Care Technology
% 223.67/223.85  |- mesh__recordMaintainer mesh__D009308 PXP
% 223.67/223.85  |- mesh__publicMeSHNote mesh__D009308
% 223.67/223.85       91; was see under UNITED STATES PUBLIC HEALTH SERVICE 1982-90%A%  
% 223.67/223.85  |- skos__annotation mesh__D009308
% 223.67/223.85       add UNITED STATES %28%NIM%29%; research support by this agency is checked as NIH/PHS SUP; DF: NCHCT      CATALOG: use NAF entry%A%  
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D009308 2006
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D001325 2005
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D001325 1999
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D001325 2001
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D001325 2006
% 223.67/223.85  |- mesh__recordMaintainer mesh__D001325 TGC
% 223.67/223.85  |- rdf__type mesh__D001325sskos__Concept
% 223.67/223.85  |- mesh__dateRevised mesh__D001325 1994-05-31
% 223.67/223.85  |- mesh__dateCreated mesh__D001325 1999-01-01
% 223.67/223.85  |- skos__broader mesh__D001325smesh__D001680
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D001325 2002
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D001325 1995
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D001325 1996
% 223.67/223.85  |- skos__scopeNote mesh__D001325
% 223.67/223.85       The life of a person written by himself or herself. %28%Harrod%27%s Librarians%27% Glossary, 7th ed%29%%A%    
% 223.67/223.85  |- skos__prefLabel mesh__D001325 Autobiography
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D001325 2003
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D001325 1997
% 223.67/223.85  |- skos__annotation mesh__D001325
% 223.67/223.85       IM as literary form only; NIM for specific biographee; no qualif; Manual 32.11, 32.18.7; includes memoirs; DF: AUTOBIOG or AUTOBIOGR%A%  
% 223.67/223.85  |- mesh__recordAuthorizer mesh__D001325 PLS
% 223.67/223.85  |- skos__altLabel mesh__D001325 Autobiographies
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D001325 2004
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D001325 1998
% 223.67/223.85  |- mesh__recordOriginator mesh__D001325 NLM
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D001325 2000
% 223.67/223.85  |- skos__historyNote mesh__D006010
% 223.67/223.85       Glucosidases/metabolism %28%1966-1974%29%
% 223.67/223.85  |- skos__hiddenLabel mesh__D006010 Disease, Cori
% 223.67/223.85  |- skos__hiddenLabel mesh__D006010 Coris Disease
% 223.67/223.85  |- skos__altLabel mesh__D006010 Forbes Disease
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D006010 2005
% 223.67/223.85  |- skos__altLabel mesh__D006010 Debrancher Deficiency
% 223.67/223.85  |- skos__hiddenLabel mesh__D006010 Disease, Forbes
% 223.67/223.85  |- skos__altLabel mesh__D006010 Deficiency, Debrancher
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D006010 2004
% 223.67/223.85  |- skos__historyNote mesh__D006010 Liver Diseases %28%1966-1974%29%
% 223.67/223.85  |- skos__historyNote mesh__D006010 Glycogenosis %28%1966-1974%29%
% 223.67/223.85  |- skos__hiddenLabel mesh__D006010 Disease, Cori%27%s
% 223.67/223.85  |- skos__hiddenLabel mesh__D006010 Debrancher Deficiencies
% 223.67/223.85  |- skos__altLabel mesh__D006010 Cori Disease
% 223.67/223.85  |- rdf__type mesh__D006010sskos__Concept
% 223.67/223.85  |- mesh__publicMeSHNote mesh__D006010
% 223.67/223.85       91; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 3 see under GLYCOGENOSIS 1975-88%A%  
% 223.67/223.85  |- skos__hiddenLabel mesh__D006010 Limit Dextrinoses
% 223.67/223.85  |- mesh__dateEstablished mesh__D006010 1991-01-01
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D006010 2003
% 223.67/223.85  |- skos__altLabel mesh__D006010 Cori%27%s Disease
% 223.67/223.85  |- mesh__historyNote mesh__D006010
% 223.67/223.85       91%28%89%29%; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 3 see under GLYCOGENOSIS 1975-88%A%  
% 223.67/223.85  |- skos__hiddenLabel mesh__D006010 Dextrinosis, Limit
% 223.67/223.85  |- mesh__dateRevised mesh__D006010 2001-07-25
% 223.67/223.85  |- skos__altLabel mesh__D006010 Glycogenosis 3
% 223.67/223.85  |- mesh__dateCreated mesh__D006010 1974-12-12
% 223.67/223.85  |- skos__hiddenLabel mesh__D006010 Dextrinoses, Limit
% 223.67/223.85  |- skos__altLabel mesh__D006010 Glycogen Debranching Enzyme Deficiency
% 223.67/223.85  |- mesh__recordAuthorizer mesh__D006010 sjn
% 223.67/223.85  |- mesh__recordOriginator mesh__D006010 NLM
% 223.67/223.85  |- skos__annotation mesh__D006010
% 223.67/223.85       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 223.67/223.85  |- skos__scopeNote mesh__D006010
% 223.67/223.85       An autosomal recessive metabolic disorder due to deficient expression of amylo-1,6-glucosidase %28%one part of the glycogen debranching enzyme system%29%. The clinical course of the disease is similar to that of glycogen storage disease type I, but milder. Massive hepatomegaly, which is present in young children, diminishes and occasionally disappears with age. Levels of glycogen with short outer branches are elevated in muscle, liver, and erythrocytes. Six subgroups have been identified, with subgroups Type IIIa and Type IIIb being the most prevalent.%A%    
% 223.67/223.85  |- mesh__recordMaintainer mesh__D006010 nns
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D006010 2002
% 223.67/223.85  |- skos__prefLabel mesh__D006010 Glycogen Storage Disease Type III
% 223.67/223.85  |- skos__hiddenLabel mesh__D006010 Deficiencies, Debrancher
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D006010 2006
% 223.67/223.85  |- skos__broader mesh__D006010smesh__D006008
% 223.67/223.85  |- skos__altLabel mesh__D006010 Limit Dextrinosis
% 223.67/223.85  |- mesh__onlineNote mesh__D006010
% 223.67/223.85       use GLYCOGEN STORAGE DISEASE TYPE III to search GLYCOGENOSIS 3 1975-88%A%  
% 223.67/223.85  |- mesh__historyNote mesh__D019736 98   
% 223.67/223.85  |- mesh__recordAuthorizer mesh__D019736 sjn
% 223.67/223.85  |- skos__hiddenLabel mesh__D019736 Artificial Implant
% 223.67/223.85  |- skos__hiddenLabel mesh__D019736 Implant, Artificial
% 223.67/223.85  |- skos__historyNote mesh__D019736 specific prosthesis %28%1966-1997%29%
% 223.67/223.85  |- mesh__recordMaintainer mesh__D019736 ssb
% 223.67/223.85  |- skos__prefLabel mesh__D019736 Prostheses and Implants
% 223.67/223.85  |- skos__broader mesh__D019736smesh__D004864
% 223.67/223.85  |- skos__annotation mesh__D019736
% 223.67/223.85       GEN: prefer specifics; coord IM with prosthetic or implant material %28%IM or NIM%29%; adv eff: consider PROSTHESIS-RELATED INFECTIONS; BIOPROSTHESIS is also available%A%  
% 223.67/223.85  |- skos__hiddenLabel mesh__D019736 Prostheses
% 223.67/223.85  |- skos__hiddenLabel mesh__D019736 Artificial Implants
% 223.67/223.85  |- mesh__dateEstablished mesh__D019736 1998-01-01
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D019736 2006
% 223.67/223.85  |- skos__historyNote mesh__D019736 specific implant %28%1966-1997%29%
% 223.67/223.85  |- mesh__publicMeSHNote mesh__D019736
% 223.67/223.85       98; IMPLANTS, ARTIFICIAL was heading 1981-97; PROSTHESIS was heading 1963-97%A%  
% 223.67/223.85  |- mesh__dateRevised mesh__D019736 2005-06-30
% 223.67/223.85  |- skos__hiddenLabel mesh__D019736 Implants and Prostheses
% 223.67/223.85  |- mesh__dateCreated mesh__D019736 1997-06-20
% 223.67/223.85  |- skos__related mesh__D019736smesh__D020878
% 223.67/223.85  |- mesh__recordOriginator mesh__D019736 PXP
% 223.67/223.85  |- rdf__type mesh__D019736sskos__Concept
% 223.67/223.85  |- skos__scopeNote mesh__D019736
% 223.67/223.85       Artificial substitutes for body parts, and materials inserted into tissue for functional, cosmetic, or therapeutic purposes. Prostheses can be functional, as in the case of artificial arms and legs, or cosmetic, as in the case of an artificial eye. Implants, all surgically inserted or grafted into the body, tend to be used therapeutically. IMPLANTS, EXPERIMENTAL is available for those used experimentally.%A%    
% 223.67/223.85  |- skos__broader mesh__D011753smesh__D011714
% 223.67/223.85  |- mesh__dateCreated mesh__D011753 1999-01-01
% 223.67/223.85  |- skos__scopeNote mesh__D011753 Keto-pyrans.     
% 223.67/223.85  |- mesh__onlineNote mesh__D011753 search PYRANS 1966-74   
% 223.67/223.85  |- mesh__dateRevised mesh__D011753 2005-06-30
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D011753 2006
% 223.67/223.85  |- mesh__publicMeSHNote mesh__D011753 91; was see under PYRANS 1975-90   
% 223.67/223.85  |- mesh__dateEstablished mesh__D011753 1991-01-01
% 223.67/223.85  |- mesh__recordOriginator mesh__D011753 NLM
% 223.67/223.85  |- skos__prefLabel mesh__D011753 Pyrones
% 223.67/223.85  |- mesh__recordAuthorizer mesh__D011753 sjn
% 223.67/223.85  |- skos__annotation mesh__D011753
% 223.67/223.85       1,2-BENZOPYRONES is available; pyran-2-ones: index PYRONES + LACTONES%A%  
% 223.67/223.85  |- rdf__type mesh__D011753sskos__Concept
% 223.67/223.85  |- mesh__historyNote mesh__D011753
% 223.67/223.85       91%28%75%29%; was see under PYRANS 1975-90   
% 223.67/223.85  |- mesh__recordMaintainer mesh__D011753 ssb
% 223.67/223.85  |- skos__related mesh__D011753smesh__D003374
% 223.67/223.85  |- skos__hiddenLabel mesh__D005716 Game Theories
% 223.67/223.85  |- mesh__dateEstablished mesh__D005716 1969-01-01
% 223.67/223.85  |- skos__prefLabel mesh__D005716 Game Theory
% 223.67/223.85  |- mesh__dateRevised mesh__D005716 1999-11-03
% 223.67/223.85  |- mesh__dateCreated mesh__D005716 1999-01-01
% 223.67/223.85  |- skos__hiddenLabel mesh__D005716 Prisoner Dilemmas
% 223.67/223.85  |- skos__historyNote mesh__D005716 Group Processes %28%1966-1968%29%
% 223.67/223.85  |- skos__historyNote mesh__D005716 Operations Research %28%1966-1968%29%
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D005716 2000
% 223.67/223.85  |- skos__hiddenLabel mesh__D005716 Theories, Game
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D005716 2003
% 223.67/223.85  |- skos__hiddenLabel mesh__D005716 Dilemmas, Prisoner
% 223.67/223.85  |- skos__hiddenLabel mesh__D005716 Prisoners Dilemmas
% 223.67/223.85  |- skos__hiddenLabel mesh__D005716 Dilemma, Prisoner%27%s
% 223.67/223.85  |- skos__hiddenLabel mesh__D005716 Prisoner%27%s Dilemmas
% 223.67/223.85  |- skos__hiddenLabel mesh__D005716 Dilemmas, Prisoner%27%s
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D005716 2001
% 223.67/223.85  |- skos__altLabel mesh__D005716 Prisoners Dilemma
% 223.67/223.85  |- skos__hiddenLabel mesh__D005716 Dilemmas, Prisoners
% 223.67/223.85  |- skos__hiddenLabel mesh__D005716 Dilemma, Prisoners
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D005716 2004
% 223.67/223.85  |- mesh__publicMeSHNote mesh__D005716 69   
% 223.67/223.85  |- skos__annotation mesh__D005716 no qualif   
% 223.67/223.85  |- skos__altLabel mesh__D005716 Prisoner%27%s Dilemma
% 223.67/223.85  |- skos__broader mesh__D005716smesh__D008433
% 223.67/223.85  |- skos__hiddenLabel mesh__D005716 Dilemma, Prisoner
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D005716 2002
% 223.67/223.85  |- mesh__recordMaintainer mesh__D005716 jls
% 223.67/223.85  |- mesh__onlineNote mesh__D005716
% 223.67/223.85       use GAME THEORY to search PRISONER%27%S DILEMMA 1969-78   
% 223.67/223.85  |- mesh__recordOriginator mesh__D005716 NLM
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D005716 2005
% 223.67/223.85  |- mesh__recordAuthorizer mesh__D005716 sjn
% 223.67/223.85  |- skos__historyNote mesh__D005716
% 223.67/223.85       Interpersonal Relations %28%1966-1968%29%
% 223.67/223.85  |- skos__hiddenLabel mesh__D005716 Theory, Game
% 223.67/223.85  |- skos__scopeNote mesh__D005716
% 223.67/223.85       Theoretical construct used in applied mathematics to analyze certain situations in which there is an interplay between parties that may have similar, opposed, or mixed interests. In a typical game, decision-making %22%players,%22% who each have their own goals, try to gain advantage over the other parties by anticipating each other%27%s decisions; the game is finally resolved as a consequence of the players%27% decisions.%A%    
% 223.67/223.85  |- mesh__historyNote mesh__D005716
% 223.67/223.85       69; PRISONER%27%S DILEMMA was see under GAME THEORY 1969-78   
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D005716 2006
% 223.67/223.85  |- rdf__type mesh__D005716sskos__Concept
% 223.67/223.85  |- mesh__recordOriginator mesh__D009309 EC
% 223.67/223.85  |- rdf__type mesh__D009309sskos__Concept
% 223.67/223.85  |- mesh__publicMeSHNote mesh__D009309
% 223.67/223.85       91; was see under UNITED STATES PUBLIC HEALTH SERVICE 1982-90%A%  
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D009309 2006
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D009309 2001
% 223.67/223.85  |- mesh__recordAuthorizer mesh__D009309 SJN
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D009309 2004
% 223.67/223.85  |- mesh__historyNote mesh__D009309
% 223.67/223.85       91%28%82%29%; was see under UNITED STATES PUBLIC HEALTH SERVICE 1982-90%A%  
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D009309 2005
% 223.67/223.85  |- skos__scopeNote mesh__D009309
% 223.67/223.85       A center in the PUBLIC HEALTH SERVICE which is primarily concerned with the collection, analysis, and dissemination of health statistics on vital events and health activities to reflect the health status of people, health needs, and health resources.%A%    
% 223.67/223.85  |- skos__altLabel mesh__D009309 National Center for Health Statistics
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D009309 1999
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D009309 2000
% 223.67/223.85  |- skos__broader mesh__D009309smesh__D014492
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D009309 2003
% 223.67/223.85  |- mesh__dateEstablished mesh__D009309 1991-01-01
% 223.67/223.85  |- skos__annotation mesh__D009309
% 223.67/223.85       add UNITED STATES %28%NIM%29%; research support by this agency is checked as NIH/PHS SUP; DF: NCHS      CATALOG: use NAF entry%A%  
% 223.67/223.85  |- skos__altLabel mesh__D009309
% 223.67/223.85       United States National Center for Health Statistics
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D009309 1998
% 223.67/223.85  |- mesh__dateRevised mesh__D009309 1997-06-20
% 223.67/223.85  |- mesh__dateCreated mesh__D009309 1981-05-19
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D009309 2002
% 223.67/223.85  |- mesh__recordMaintainer mesh__D009309 PXP
% 223.67/223.85  |- skos__prefLabel mesh__D009309
% 223.67/223.85       National Center for Health Statistics %28%U.S.%29%
% 223.67/223.85  |- skos__scopeNote mesh__D001326
% 223.67/223.85       Technique based on muscle relaxation during self-hypnotic exercises. It is used in conjunction with psychotherapy.%A%    
% 223.67/223.85  |- mesh__historyNote mesh__D001326 66%28%63%29%   
% 223.67/223.85  |- mesh__recordMaintainer mesh__D001326 ssb
% 223.67/223.85  |- skos__broader mesh__D001326smesh__D006990
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D001326 2002
% 223.67/223.85  |- mesh__dateCreated mesh__D001326 1999-01-01
% 223.67/223.85  |- mesh__recordOriginator mesh__D001326 NLM
% 223.67/223.85  |- mesh__dateEstablished mesh__D001326 1966-01-01
% 223.67/223.85  |- skos__hiddenLabel mesh__D001326 Autogenic Trainings
% 223.67/223.85  |- skos__hiddenLabel mesh__D001326 Training, Autogenic
% 223.67/223.85  |- mesh__dateRevised mesh__D001326 2001-07-25
% 223.67/223.85  |- skos__annotation mesh__D001326 a psychother technique   
% 223.67/223.85  |- rdf__type mesh__D001326sskos__Concept
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D001326 2006
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D001326 2005
% 223.67/223.85  |- skos__broader mesh__D001326smesh__D011613
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D001326 2004
% 223.67/223.85  |- mesh__publicMeSHNote mesh__D001326 66   
% 223.67/223.85  |- skos__hiddenLabel mesh__D001326 Trainings, Autogenic
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D001326 2003
% 223.67/223.85  |- skos__prefLabel mesh__D001326 Autogenic Training
% 223.67/223.85  |- mesh__recordAuthorizer mesh__D001326 sjn
% 223.67/223.85  |- skos__altLabel mesh__D006011 Andersen%27%s Disease
% 223.67/223.85  |- skos__altLabel mesh__D006011 Deficiency, Brancher
% 223.67/223.85  |- rdf__type mesh__D006011sskos__Concept
% 223.67/223.85  |- mesh__dateEstablished mesh__D006011 1991-01-01
% 223.67/223.85  |- skos__altLabel mesh__D006011 Amylopectinosis
% 223.67/223.85  |- skos__altLabel mesh__D006011 Glycogenosis 4
% 223.67/223.85  |- skos__hiddenLabel mesh__D006011 Andersens Disease
% 223.67/223.85  |- mesh__dateCreated mesh__D006011 1974-12-12
% 223.67/223.85  |- skos__hiddenLabel mesh__D006011 Disease, Andersen
% 223.67/223.85  |- skos__scopeNote mesh__D006011
% 223.67/223.85       An autosomal recessive metabolic disorder due to a deficiency in expression of GLYCOGEN BRANCHING ENZYME 1 %28%alpha-1,4-glucan-6-alpha-glucosyltransferase%29%, resulting in an accumulation of abnormal GLYCOGEN with long outer branches. Clinical features are MUSCLE HYPOTONIA and CIRRHOSIS. Death from liver disease usually occurs before age 2.%A%    
% 223.67/223.85  |- skos__historyNote mesh__D006011 Glycogenosis %28%1966-1974%29%
% 223.67/223.85  |- skos__historyNote mesh__D006011 Liver Diseases %28%1966-1974%29%
% 223.67/223.85  |- mesh__onlineNote mesh__D006011
% 223.67/223.85       use GLYCOGEN STORAGE DISEASE TYPE IV to search GLYCOGENOSIS 4 1975-88%A%  
% 223.67/223.85  |- skos__altLabel mesh__D006011 Brancher Deficiency
% 223.67/223.85  |- skos__annotation mesh__D006011
% 223.67/223.85       do not confuse with ANDERSEN SYNDROME, a potassium-sensitive familial periodic paralysis%A%  
% 223.67/223.85  |- skos__hiddenLabel mesh__D006011 Brancher Deficiencies
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D006011 2006
% 223.67/223.85  |- skos__altLabel mesh__D006011 Andersen Disease
% 223.67/223.85  |- mesh__dateRevised mesh__D006011 2005-06-30
% 223.67/223.85  |- skos__broader mesh__D006011smesh__D006008
% 223.67/223.85  |- skos__hiddenLabel mesh__D006011 Amylopectinoses
% 223.67/223.85  |- skos__altLabel mesh__D006011 Type IV Glycogenosis
% 223.67/223.85  |- mesh__recordAuthorizer mesh__D006011 sjn
% 223.67/223.85  |- mesh__recordOriginator mesh__D006011 NLM
% 223.67/223.85  |- mesh__publicMeSHNote mesh__D006011
% 223.67/223.85       91; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 4 see under GLYCOGENOSIS 1975-88%A%  
% 223.67/223.85  |- skos__prefLabel mesh__D006011 Glycogen Storage Disease Type IV
% 223.67/223.85  |- skos__hiddenLabel mesh__D006011 Disease, Andersen%27%s
% 223.67/223.85  |- mesh__recordMaintainer mesh__D006011 nns
% 223.67/223.85  |- skos__historyNote mesh__D006011
% 223.67/223.85       Glucosyltransferases/metabolism %28%1966-1974%29%
% 223.67/223.85  |- skos__hiddenLabel mesh__D006011 Glycogenosis, Type IV
% 223.67/223.85  |- mesh__historyNote mesh__D006011
% 223.67/223.85       91%28%89%29%; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 4 see under GLYCOGENOSIS 1975-88%A%  
% 223.67/223.85  |- skos__hiddenLabel mesh__D006011 Deficiencies, Brancher
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D047428 2006
% 223.67/223.85  |- mesh__recordAuthorizer mesh__D047428 sjn
% 223.67/223.85  |- rdf__type mesh__D047428sskos__Concept
% 223.67/223.85  |- mesh__recordMaintainer mesh__D047428 ags
% 223.67/223.85  |- skos__hiddenLabel mesh__D047428 Kinase Inhibitors, Protein
% 223.67/223.85  |- mesh__dateRevised mesh__D047428 2005-06-30
% 223.67/223.85  |- mesh__historyNote mesh__D047428 2005   
% 223.67/223.85  |- skos__hiddenLabel mesh__D047428 Inhibitors, Protein Kinase
% 223.67/223.85  |- mesh__recordOriginator mesh__D047428 ssb
% 223.67/223.85  |- skos__scopeNote mesh__D047428 Agents that inhibit PROTEIN KINASES.     
% 223.67/223.85  |- mesh__dateEstablished mesh__D047428 2005-01-01
% 223.67/223.85  |- skos__broader mesh__D047428smesh__D004791
% 223.67/223.85  |- skos__prefLabel mesh__D047428 Protein Kinase Inhibitors
% 223.67/223.85  |- skos__historyNote mesh__D047428 Protein Kinases %28%1973-2004%29%
% 223.67/223.85  |- mesh__publicMeSHNote mesh__D047428 2005   
% 223.67/223.85  |- mesh__dateCreated mesh__D047428 2004-07-07
% 223.67/223.85  |- skos__hiddenLabel mesh__D019737 Transplant, Tissue
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D019737 2002
% 223.67/223.85  |- skos__hiddenLabel mesh__D019737 Transplants, Organ
% 223.67/223.85  |- skos__hiddenLabel mesh__D019737 Grafts, Tissue
% 223.67/223.85  |- skos__broader mesh__D019737smesh__D004864
% 223.67/223.85  |- skos__hiddenLabel mesh__D019737 Organ Transplant
% 223.67/223.85  |- skos__hiddenLabel mesh__D019737 Transplant
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D019737 2004
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D019737 2001
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D019737 2006
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D019737 1999
% 223.67/223.85  |- skos__altLabel mesh__D019737 Grafts
% 223.67/223.85  |- skos__hiddenLabel mesh__D019737 Organ Graft
% 223.67/223.85  |- skos__hiddenLabel mesh__D019737 Transplants, Tissue
% 223.67/223.85  |- skos__hiddenLabel mesh__D019737 Tissue Graft
% 223.67/223.85  |- skos__hiddenLabel mesh__D019737 Transplant, Cell
% 223.67/223.85  |- skos__hiddenLabel mesh__D019737 Tissue Transplant
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D019737 2003
% 223.67/223.85  |- skos__hiddenLabel mesh__D019737 Transplant, Organ
% 223.67/223.85  |- skos__hiddenLabel mesh__D019737 Graft, Organ
% 223.67/223.85  |- skos__hiddenLabel mesh__D019737 Cell Transplant
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D019737 2000
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D019737 2005
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D019737 1998
% 223.67/223.85  |- skos__prefLabel mesh__D019737 Transplants
% 223.67/223.85  |- rdf__type mesh__D019737sskos__Concept
% 223.67/223.85  |- skos__hiddenLabel mesh__D019737 Graft
% 223.67/223.85  |- skos__altLabel mesh__D019737 Organ Grafts
% 223.67/223.85  |- mesh__dateEstablished mesh__D019737 1998-01-01
% 223.67/223.85  |- skos__hiddenLabel mesh__D019737 Transplants, Cell
% 223.67/223.85  |- skos__scopeNote mesh__D019737
% 223.67/223.85       Organs, tissues, or cells taken from the body for grafting into another area of the same body or into another individual. %28%From Dorland, 28th ed%29%%A%    
% 223.67/223.85  |- mesh__dateCreated mesh__D019737 1997-06-20
% 223.67/223.85  |- skos__annotation mesh__D019737
% 223.67/223.85       the transplant itself: do not confuse with TRANSPLANTATION, the surg procedure %28%see note there%29%; coord IM with organ /transpl %28%IM%29% or precoord organ/transpl term %28%IM%29%%A%  
% 223.67/223.85  |- mesh__publicMeSHNote mesh__D019737
% 223.67/223.85       98; ORGAN TRANSPLANTS was see ORGAN TRANSPLANTATION 1991-97, was see TRANSPLANTATION 1990%A%  
% 223.67/223.85  |- mesh__historyNote mesh__D019737
% 223.67/223.85       98; ORGAN TRANSPLANTS was see ORGAN TRANSPLANTATION 1991-97, was see TRANSPLANTATION 1990%A%  
% 223.67/223.85  |- skos__hiddenLabel mesh__D019737 Graft, Tissue
% 223.67/223.85  |- skos__hiddenLabel mesh__D019737 Grafts, Organ
% 223.67/223.85  |- skos__historyNote mesh__D011754 Ammonium Compounds %28%1969-1974%29%
% 223.67/223.85  |- mesh__dateRevised mesh__D011754 2005-07-06
% 223.67/223.85  |- skos__scopeNote mesh__D011754
% 223.67/223.85       Xanthene dye used as a bacterial and biological stain. Synonyms: Pyronin; Pyronine G; Pyronine Y. Use also for Pyronine B. which is diethyl-rather than dimethylamino-.%A%    
% 223.67/223.85  |- mesh__publicMeSHNote mesh__D011754
% 223.67/223.85       91; was see under XANTHENES 1975-90   
% 223.67/223.85  |- mesh__recordMaintainer mesh__D011754 NLM
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D011754 2006
% 223.67/223.85  |- mesh__dateEstablished mesh__D011754 1991-01-01
% 223.67/223.85  |- mesh__dateCreated mesh__D011754 1974-11-19
% 223.67/223.85  |- skos__altLabel mesh__D011754 Pyronine G
% 223.67/223.85  |- rdf__type mesh__D011754sskos__Concept
% 223.67/223.85  |- skos__historyNote mesh__D011754 Xanthenes %28%1971-1974%29%
% 223.67/223.85  |- skos__annotation mesh__D011754 D25-26 qualif   
% 223.67/223.85  |- mesh__recordOriginator mesh__D011754 NLM
% 223.67/223.85  |- mesh__historyNote mesh__D011754
% 223.67/223.85       91%28%75%29%; was see under XANTHENES 1975-90   
% 223.67/223.85  |- skos__prefLabel mesh__D011754 Pyronine
% 223.67/223.85  |- skos__broader mesh__D011754smesh__D014966
% 223.67/223.85  |- skos__hiddenLabel mesh__D011754 Y, Pyronin
% 223.67/223.85  |- mesh__recordAuthorizer mesh__D011754 NLM
% 223.67/223.85  |- skos__hiddenLabel mesh__D011754 G, Pyronine
% 223.67/223.85  |- skos__altLabel mesh__D011754 Pyronin Y
% 223.67/223.85  |- mesh__recordAuthorizer mesh__D044130 sjn
% 223.67/223.85  |- skos__scopeNote mesh__D044130
% 223.67/223.85       A family of gram-negative bacteria in the order Oceanospirillales.%A%    
% 223.67/223.85  |- mesh__recordMaintainer mesh__D044130 SYSTEM
% 223.67/223.85  |- mesh__publicMeSHNote mesh__D044130 2004   
% 223.67/223.85  |- skos__prefLabel mesh__D044130 Oceanospirillaceae
% 223.67/223.85  |- mesh__dateRevised mesh__D044130 2005-06-30
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D044130 2006
% 223.67/223.85  |- skos__broader mesh__D044130smesh__D020563
% 223.67/223.85  |- mesh__dateEstablished mesh__D044130 2004-01-01
% 223.67/223.85  |- rdf__type mesh__D044130sskos__Concept
% 223.67/223.85  |- skos__broader mesh__D044130smesh__D006090
% 223.67/223.85  |- mesh__historyNote mesh__D044130 2004   
% 223.67/223.85  |- mesh__dateCreated mesh__D044130 2003-07-09
% 223.67/223.85  |- mesh__recordOriginator mesh__D044130 ags
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D005717 2003
% 223.67/223.85  |- mesh__historyNote mesh__D005717
% 223.67/223.85       91%28%75%29%; was see under GAME THEORY 1975-90   
% 223.67/223.85  |- mesh__publicMeSHNote mesh__D005717
% 223.67/223.85       91; was see under GAME THEORY 1975-90   
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D005717 2004
% 223.67/223.85  |- skos__annotation mesh__D005717 no qualif; DF: GAMES EXPER   
% 223.67/223.85  |- skos__broader mesh__D005717smesh__D005716
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D005717 2000
% 223.67/223.85  |- mesh__onlineNote mesh__D005717 search GAME THEORY 1969-74   
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D005717 2005
% 223.67/223.85  |- skos__scopeNote mesh__D005717
% 223.67/223.85       Games designed to provide information on hypotheses, policies, procedure or strategies.%A%    
% 223.67/223.85  |- mesh__recordMaintainer mesh__D005717 PXP
% 223.67/223.85  |- skos__altLabel mesh__D005717 Game, Experimental
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D005717 2001
% 223.67/223.85  |- mesh__recordAuthorizer mesh__D005717 SJN
% 223.67/223.85  |- skos__altLabel mesh__D005717 Experimental Games
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D005717 2006
% 223.67/223.85  |- rdf__type mesh__D005717sskos__Concept
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D005717 1998
% 223.67/223.85  |- mesh__dateEstablished mesh__D005717 1991-01-01
% 223.67/223.85  |- skos__prefLabel mesh__D005717 Games, Experimental
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D005717 2002
% 223.67/223.85  |- mesh__dateCreated mesh__D005717 1999-01-01
% 223.67/223.85  |- skos__altLabel mesh__D005717 Experimental Game
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D005717 1999
% 223.67/223.85  |- mesh__recordOriginator mesh__D005717 NLM
% 223.67/223.85  |- mesh__dateRevised mesh__D005717 1997-06-20
% 223.67/223.85  |- mesh__publicMeSHNote mesh__D015347 89   
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D015347 2005
% 223.67/223.85  |- skos__historyNote mesh__D015347 RNA, Messenger %28%1972-1988%29%
% 223.67/223.85  |- skos__hiddenLabel mesh__D015347 RNA Gene Probes
% 223.67/223.85  |- skos__annotation mesh__D015347
% 223.67/223.85       usually no qualif: /drug eff /ultrastruct permitted   
% 223.67/223.85  |- skos__prefLabel mesh__D015347 RNA Probes
% 223.67/223.85  |- rdf__type mesh__D015347sskos__Concept
% 223.67/223.85  |- mesh__recordOriginator mesh__D015347 EJB
% 223.67/223.85  |- skos__broader mesh__D015347smesh__D015341
% 223.67/223.85  |- skos__altLabel mesh__D015347 Gene Probes, RNA
% 223.67/223.85  |- skos__historyNote mesh__D015347
% 223.67/223.85       Nucleic Acid Hybridization %28%1972-1988%29%
% 223.67/223.85  |- mesh__historyNote mesh__D015347 89   
% 223.67/223.85  |- skos__hiddenLabel mesh__D015347 Probes, RNA Gene
% 223.67/223.85  |- mesh__recordMaintainer mesh__D015347 ssb
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D015347 2004
% 223.67/223.85  |- skos__hiddenLabel mesh__D015347 Probes, RNA
% 223.67/223.85  |- skos__scopeNote mesh__D015347
% 223.67/223.85       RNA, usually prepared by transcription from cloned DNA, which complements a specific mRNA or DNA and is generally used for studies of virus genes, distribution of specific RNA in tissues and cells, integration of viral DNA into genomes, transcription, etc. Whereas DNA PROBES are preferred for use at a more macroscopic level for detection of the presence of DNA/RNA from specific species or subspecies, RNA probes are preferred for genetic studies. Conventional labels for the RNA probe include radioisotope labels 32P and 125I and the chemical label biotin. RNA probes may be further divided by category into plus-sense RNA probes, minus-sense RNA probes, and antisense RNA probes.%A%    
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D015347 2006
% 223.67/223.85  |- mesh__recordAuthorizer mesh__D015347 sjn
% 223.67/223.85  |- mesh__dateRevised mesh__D015347 2003-07-09
% 223.67/223.85  |- mesh__dateCreated mesh__D015347 1988-06-02
% 223.67/223.85  |- mesh__dateEstablished mesh__D015347 1989-01-01
% 223.67/223.85  |- skos__hiddenLabel mesh__D034501 alpha Telomere Binding Protein
% 223.67/223.85  |- mesh__dateRevised mesh__D034501 2005-06-30
% 223.67/223.85  |- rdf__type mesh__D034501sskos__Concept
% 223.67/223.85  |- skos__hiddenLabel mesh__D034501 Telomere-Binding Proteins, Mitochondrial
% 223.67/223.85  |- skos__broader mesh__D034501smesh__D004268
% 223.67/223.85  |- skos__hiddenLabel mesh__D034501 Mitochondrial Telomere Binding Proteins
% 223.67/223.85  |- mesh__dateCreated mesh__D034501 2002-07-02
% 223.67/223.85  |- skos__hiddenLabel mesh__D034501
% 223.67/223.85       Telomere-Binding Protein, Single-Stranded
% 223.67/223.85  |- skos__hiddenLabel mesh__D034501 Single Stranded Telomere Binding Protein
% 223.67/223.85  |- skos__altLabel mesh__D034501 alpha-Telomere-Binding Protein
% 223.67/223.85  |- skos__prefLabel mesh__D034501 Telomere-Binding Proteins
% 223.67/223.85  |- skos__scopeNote mesh__D034501
% 223.67/223.85       Proteins that specifically bind to TELOMERES. Proteins in this class include those that perform functions such as telomere capping, telomere maintenance and telomere stabilization.%A%    
% 223.67/223.85  |- skos__hiddenLabel mesh__D034501 alpha-Subunit Telomer-Binding Protein
% 223.67/223.85  |- skos__hiddenLabel mesh__D034501
% 223.67/223.85       Double Stranded Telomeric Binding Protein
% 223.67/223.85  |- skos__altLabel mesh__D034501 Telomere-Binding Proteins, Double Stranded
% 223.67/223.85  |- skos__hiddenLabel mesh__D034501
% 223.67/223.85       Telomere Binding Proteins, Single Stranded
% 223.67/223.85  |- skos__altLabel mesh__D034501 Telomere End-Binding Protein %28%TEBP%29%
% 223.67/223.85  |- skos__hiddenLabel mesh__D034501 beta Telomere Binding Protein
% 223.67/223.85  |- skos__hiddenLabel mesh__D034501
% 223.67/223.85       Telomere-Binding Proteins, Double-Stranded
% 223.67/223.85  |- skos__hiddenLabel mesh__D034501
% 223.67/223.85       Single Stranded Telomere Binding Proteins
% 223.67/223.85  |- mesh__recordAuthorizer mesh__D034501 sjn
% 223.67/223.85  |- mesh__recordMaintainer mesh__D034501 ags
% 223.67/223.85  |- skos__altLabel mesh__D034501 Mitochondrial Telomere-Binding Protein
% 223.67/223.85  |- skos__annotation mesh__D034501
% 223.67/223.85       coordinate with MITOCHONDRIAL PROTEINS %28%IM%29% if from MITOCHONDRIA; see SCR for specific terms%A%  
% 223.67/223.85  |- skos__hiddenLabel mesh__D034501 Telomer Binding Protein, beta Subunit
% 223.67/223.85  |- mesh__publicMeSHNote mesh__D034501
% 223.67/223.85       2003; TELOMERE-BINDING PROTEINS was indexed under DNA-BINDING PROTEINS 1991-2002%A%  
% 223.67/223.85  |- mesh__activeMeSHYear mesh__D034501 2006
% 223.67/223.85  |- skos__hiddenLabel mesh__D034501 Mitochondrial Telomere Binding Protein
% 223.67/223.85  |- skos__altLabel mesh__D034501 beta-Telomere-Binding Protein
% 223.67/223.85  |- skos__broader mesh__D034501smesh__D002868
% 223.67/223.85  |- skos__altLabel mesh__D034501 Telomere-Binding Proteins, Single-Stranded
% 223.67/223.85  |- skos__altLabel mesh__D034501 Telomere Repeat Binding Factors
% 223.67/223.85  |- skos__hiddenLabel mesh__D034501 Telomere Binding Proteins
% 223.67/223.85  |- skos__altLabel mesh__D034501 Double-Stranded Telomeric Binding Protein
% 223.67/223.85  |- skos__hiddenLabel mesh__D034501
% 223.67/223.85       Double Stranded Telomere Binding Proteins
% 223.67/223.85  |- skos__hiddenLabel mesh__D034501 Telomer Binding Protein, alpha Subunit
% 223.67/223.85  |- skos__hiddenLabel mesh__D034501 beta-Subunit Telomer-Binding Protein
% 223.67/223.85  |- skos__hiddenLabel mesh__D034501 Telomere-Binding Protein, Mitochondrial
% 223.67/223.86  |- skos__altLabel mesh__D034501 Single-Stranded Telomere-Binding Protein
% 223.67/223.86  |- skos__altLabel mesh__D034501 mtTBP Protein
% 223.67/223.86  |- skos__historyNote mesh__D034501 DNA-Binding Proteins %28%1991-2002%29%
% 223.67/223.86  |- mesh__recordOriginator mesh__D034501 jmp
% 223.67/223.86  |- skos__altLabel mesh__D034501 Telomere Repeat Binding Factor
% 223.67/223.86  |- mesh__dateEstablished mesh__D034501 2003-01-01
% 223.67/223.86  |- mesh__historyNote mesh__D034501
% 223.67/223.86       2003; use TELOMERE-BINDING PROTEINS %28%NM%29% 1991-2002   
% 223.67/223.86  |- skos__hiddenLabel mesh__D034501
% 223.67/223.86       Telomere Binding Proteins, Double Stranded
% 223.67/223.86  |- mesh__recordAuthorizer mesh__D001327 sjn
% 223.67/223.86  |- rdf__type mesh__D001327sskos__Concept
% 223.67/223.86  |- skos__hiddenLabel mesh__D001327 Disease, Autoimmune
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D001327 2006
% 223.67/223.86  |- skos__broader mesh__D001327smesh__D007154
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D001327 2002
% 223.67/223.86  |- mesh__recordOriginator mesh__D001327 NLM
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D001327 2005
% 223.67/223.86  |- skos__hiddenLabel mesh__D001327 Diseases, Autoimmune
% 223.67/223.86  |- skos__hiddenLabel mesh__D001327 Autoimmune Disease
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D001327 2001
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D001327 2004
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D001327 2000
% 223.67/223.86  |- mesh__dateRevised mesh__D001327 1999-11-03
% 223.67/223.86  |- skos__annotation mesh__D001327
% 223.67/223.86       AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM is available   
% 223.67/223.86  |- skos__scopeNote mesh__D001327
% 223.67/223.86       Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.%A%    
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D001327 2003
% 223.67/223.86  |- skos__related mesh__D001327smesh__D001323
% 223.67/223.86  |- skos__related mesh__D001327smesh__D015551
% 223.67/223.86  |- skos__prefLabel mesh__D001327 Autoimmune Diseases
% 223.67/223.86  |- mesh__recordMaintainer mesh__D001327 KEV
% 223.67/223.86  |- mesh__dateCreated mesh__D001327 1999-01-01
% 223.67/223.86  |- skos__hiddenLabel mesh__D006810 Fractures, Humeral
% 223.67/223.86  |- mesh__recordAuthorizer mesh__D006810 sjn
% 223.67/223.86  |- mesh__dateRevised mesh__D006810 2005-06-30
% 223.67/223.86  |- skos__hiddenLabel mesh__D006810 Humeral Fracture
% 223.67/223.86  |- skos__annotation mesh__D006810
% 223.67/223.86       fract of humerus except of proximal humerus %28% = SHOULDER FRACTURES which includes humeral head, neck %26% tuberosities%29%%A%  
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D006810 2006
% 223.67/223.86  |- mesh__recordMaintainer mesh__D006810 ssb
% 223.67/223.86  |- skos__broader mesh__D006810smesh__D001134
% 223.67/223.86  |- skos__hiddenLabel mesh__D006810 Fracture, Humeral
% 223.67/223.86  |- mesh__dateCreated mesh__D006810 1999-01-01
% 223.67/223.86  |- skos__broader mesh__D006810smesh__D050723
% 223.67/223.86  |- mesh__recordOriginator mesh__D006810 NLM
% 223.67/223.86  |- skos__prefLabel mesh__D006810 Humeral Fractures
% 223.67/223.86  |- rdf__type mesh__D006810sskos__Concept
% 223.67/223.86  |- mesh__onlineNote mesh__D006012
% 223.67/223.86       use GLYCOGEN STORAGE DISEASE TYPE V to search GLYCOGENOSIS 5 1975-88%A%  
% 223.67/223.86  |- mesh__dateRevised mesh__D006012 2001-07-25
% 223.67/223.86  |- mesh__dateEstablished mesh__D006012 1989-01-01
% 223.67/223.86  |- mesh__recordMaintainer mesh__D006012 nns
% 223.67/223.86  |- skos__hiddenLabel mesh__D006012 Glycogenosis 5s
% 223.67/223.86  |- mesh__recordAuthorizer mesh__D006012 sjn
% 223.67/223.86  |- mesh__recordOriginator mesh__D006012 NLM
% 223.67/223.86  |- mesh__publicMeSHNote mesh__D006012
% 223.67/223.86       89; was GLYCOGENOSIS 5 see under GLYCOGENOSIS 1975-88   
% 223.67/223.86  |- mesh__historyNote mesh__D006012
% 223.67/223.86       89%28%75%29%; was GLYCOGENOSIS 5 see under GLYCOGENOSIS 1975-88%A%  
% 223.67/223.86  |- skos__annotation mesh__D006012
% 223.67/223.86       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D006012 2006
% 223.67/223.86  |- skos__altLabel mesh__D006012 McArdle%27%s Disease
% 223.67/223.86  |- skos__altLabel mesh__D006012 Glycogenosis 5
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D006012 2002
% 223.67/223.86  |- skos__broader mesh__D006012smesh__D006008
% 223.67/223.86  |- skos__hiddenLabel mesh__D006012 Phosphorylase Deficiencies, Muscle
% 223.67/223.86  |- skos__hiddenLabel mesh__D006012 Phosphorylase Deficiency, Muscle
% 223.67/223.86  |- skos__hiddenLabel mesh__D006012 5s, Glycogenosis
% 223.67/223.86  |- skos__scopeNote mesh__D006012
% 223.67/223.86       Glycogenosis due to muscle phosphorylase deficiency. Characterized by painful cramps following sustained exercise.%A%    
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D006012 2005
% 223.67/223.86  |- skos__hiddenLabel mesh__D006012 Disease, McArdle
% 223.67/223.86  |- skos__hiddenLabel mesh__D006012 5, Glycogenosis
% 223.67/223.86  |- skos__historyNote mesh__D006012
% 223.67/223.86       Glucosyltransferases/metabolism %28%1966-1974%29%
% 223.67/223.86  |- skos__hiddenLabel mesh__D006012 Muscle Phosphorylase Deficiencies
% 223.67/223.86  |- skos__hiddenLabel mesh__D006012 Disease, McArdle%27%s
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D006012 2004
% 223.67/223.86  |- skos__historyNote mesh__D006012 Muscular Diseases %28%1966-1974%29%
% 223.67/223.86  |- skos__hiddenLabel mesh__D006012 McArdles Disease
% 223.67/223.86  |- skos__historyNote mesh__D006012 Glycogenosis %28%1966-1974%29%
% 223.67/223.86  |- rdf__type mesh__D006012sskos__Concept
% 223.67/223.86  |- skos__altLabel mesh__D006012 McArdle Disease
% 223.67/223.86  |- skos__hiddenLabel mesh__D006012 Deficiencies, Muscle Phosphorylase
% 223.67/223.86  |- skos__altLabel mesh__D006012 Muscle Phosphorylase Deficiency
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D006012 2003
% 223.67/223.86  |- skos__altLabel mesh__D006012 Deficiency, Muscle Phosphorylase
% 223.67/223.86  |- skos__prefLabel mesh__D006012 Glycogen Storage Disease Type V
% 223.67/223.86  |- mesh__dateCreated mesh__D006012 1974-12-12
% 223.67/223.86  |- skos__broader mesh__D019738smesh__D014024
% 223.67/223.86  |- skos__annotation mesh__D019738
% 223.67/223.86       GEN or unspecified; prefer specifics; coord IM with organ or tissue /surg %28%IM%29% or specific surg procedure %28%IM%29%; DF: SURG CREATED STRUCTURES%A%  
% 223.67/223.86  |- skos__hiddenLabel mesh__D019738 Structures, Surgically Created
% 223.67/223.86  |- skos__altLabel mesh__D019738 Structure, Surgically-Created
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D019738 2001
% 223.67/223.86  |- skos__broader mesh__D019738smesh__D004864
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D019738 1999
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D019738 2004
% 223.67/223.86  |- skos__scopeNote mesh__D019738
% 223.67/223.86       Organs or parts of organs surgically formed from nearby tissue to function as substitutes for diseased or surgically removed tissue.%A%    
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D019738 2000
% 223.67/223.86  |- rdf__type mesh__D019738sskos__Concept
% 223.67/223.86  |- skos__hiddenLabel mesh__D019738 Surgically Created Structure
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D019738 1998
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D019738 2003
% 223.67/223.86  |- skos__hiddenLabel mesh__D019738 Surgically Created Structures
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D019738 2006
% 223.67/223.86  |- mesh__publicMeSHNote mesh__D019738 98   
% 223.67/223.86  |- mesh__dateEstablished mesh__D019738 1998-01-01
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D019738 2005
% 223.67/223.86  |- skos__prefLabel mesh__D019738 Surgically-Created Structures
% 223.67/223.86  |- skos__altLabel mesh__D019738 Surgically-Created Structure
% 223.67/223.86  |- mesh__historyNote mesh__D019738 98   
% 223.67/223.86  |- skos__hiddenLabel mesh__D019738 Structure, Surgically Created
% 223.67/223.86  |- mesh__dateCreated mesh__D019738 1997-06-20
% 223.67/223.86  |- skos__altLabel mesh__D019738 Structures, Surgically-Created
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D019738 2002
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D011755 2005
% 223.67/223.86  |- mesh__recordOriginator mesh__D011755 NLM
% 223.67/223.86  |- skos__scopeNote mesh__D011755
% 223.67/223.86       A group of enzymes within the class EC 3.6.1.- that catalyze the hydrolysis of diphosphate bonds, chiefly in nucleoside di- and triphosphates. They may liberate either a mono- or diphosphate. EC 3.6.1.-.%A%    
% 223.67/223.86  |- rdf__type mesh__D011755sskos__Concept
% 223.67/223.86  |- skos__prefLabel mesh__D011755 Pyrophosphatases
% 223.67/223.86  |- mesh__recordAuthorizer mesh__D011755 sjn
% 223.67/223.86  |- mesh__dateRevised mesh__D011755 2003-07-09
% 223.67/223.86  |- mesh__recordMaintainer mesh__D011755 ssb
% 223.67/223.86  |- mesh__dateCreated mesh__D011755 1999-01-01
% 223.67/223.86  |- mesh__onlineNote mesh__D011755
% 223.67/223.86       use PYROPHOSPHATASES to search PYROPHOSPHATASE 1966-72   
% 223.67/223.86  |- skos__broader mesh__D011755smesh__D017766
% 223.67/223.86  |- mesh__historyNote mesh__D011755 73; was PYROPHOSPHATASE 1963-72   
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D011755 2006
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D011755 2004
% 223.67/223.86  |- mesh__publicMeSHNote mesh__D011755 73; was PYROPHOSPHATASE 1963-72   
% 223.67/223.86  |- skos__scopeNote mesh__D044131
% 223.67/223.86       A genus of gram-negative bacteria in the genus ACTINOBACILLUS, which is pathogenic for HORSES and PIGS.%A%    
% 223.67/223.86  |- mesh__historyNote mesh__D044131 2004   
% 223.67/223.86  |- mesh__dateEstablished mesh__D044131 2004-01-01
% 223.67/223.86  |- skos__broader mesh__D044131smesh__D000188
% 223.67/223.86  |- mesh__recordOriginator mesh__D044131 ags
% 223.67/223.86  |- mesh__publicMeSHNote mesh__D044131 2004   
% 223.67/223.86  |- mesh__recordAuthorizer mesh__D044131 sjn
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D044131 2006
% 223.67/223.86  |- skos__prefLabel mesh__D044131 Actinobacillus equuli
% 223.67/223.86  |- skos__historyNote mesh__D044131 Actinobacillus %28%1971-2003%29%
% 223.67/223.86  |- skos__annotation mesh__D044131
% 223.67/223.86       infection: coord IM with ACTINOBACILLUS INFECTIONS %28%IM%29%   
% 223.67/223.86  |- rdf__type mesh__D044131sskos__Concept
% 223.67/223.86  |- mesh__recordMaintainer mesh__D044131 SYSTEM
% 223.67/223.86  |- mesh__dateCreated mesh__D044131 2003-07-09
% 223.67/223.86  |- mesh__dateRevised mesh__D044131 2005-06-30
% 223.67/223.86  |- skos__prefLabel mesh__D005718 Gametogenesis
% 223.67/223.86  |- skos__broader mesh__D005718smesh__D012098
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D005718 2005
% 223.67/223.86  |- mesh__dateRevised mesh__D005718 2004-07-07
% 223.67/223.86  |- mesh__recordOriginator mesh__D005718 EC
% 223.67/223.86  |- mesh__recordAuthorizer mesh__D005718 sjn
% 223.67/223.86  |- mesh__dateEstablished mesh__D005718 1985-01-01
% 223.67/223.86  |- mesh__recordMaintainer mesh__D005718 lkt
% 223.67/223.86  |- mesh__dateCreated mesh__D005718 1984-05-25
% 223.67/223.86  |- mesh__historyNote mesh__D005718 1985   
% 223.67/223.86  |- skos__scopeNote mesh__D005718
% 223.67/223.86       The process of germ cell development from the primordial germ cells to the mature haploid gametes: ova in the female %28%OOGENESIS%29% or sperm in the male %28%SPERMATOGENESIS%29%.%A%    
% 223.67/223.86  |- skos__hiddenLabel mesh__D005718 Gametogeneses
% 223.67/223.86  |- mesh__publicMeSHNote mesh__D005718 1985   
% 223.67/223.86  |- skos__broader mesh__D005718smesh__D002454
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D005718 2006
% 223.67/223.86  |- rdf__type mesh__D005718sskos__Concept
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D016440 2006
% 223.67/223.86  |- rdf__type mesh__D016440sskos__Concept
% 223.67/223.86  |- mesh__recordOriginator mesh__D016440 TGC
% 223.67/223.86  |- skos__scopeNote mesh__D016440
% 223.67/223.86       Work consisting of a statement issued by one or more authors of an article or a book, withdrawing or disavowing acknowledgment of their participation in performing research or writing the results of their study. In indexing, the retraction is sent to the editor of the publication in which the article appeared and is published under the rubric %22%retraction%22% or in the form of a letter. This publication type designates the author%27%s statement of retraction: it should be differentiated from RETRACTED PUBLICATION %5B%PUBLICATION TYPE%5D% which labels the retracted publication.%A%    
% 223.67/223.86  |- mesh__dateCreated mesh__D016440 1995-06-23
% 223.67/223.86  |- mesh__recordAuthorizer mesh__D016440 sjn
% 223.67/223.86  |- skos__altLabel mesh__D016440 Retraction of Publication %28%PT%29%
% 223.67/223.86  |- skos__broader mesh__D016440smesh__D052180
% 223.67/223.86  |- mesh__recordMaintainer mesh__D016440 jls
% 223.67/223.86  |- mesh__dateEstablished mesh__D016440 1996-01-01
% 223.67/223.86  |- mesh__historyNote mesh__D016440 1991   
% 223.67/223.86  |- skos__prefLabel mesh__D016440
% 223.67/223.86       Retraction of Publication %5B%Publication Type%5D%
% 223.67/223.86  |- skos__broader mesh__D016440smesh__D052181
% 223.67/223.86  |- mesh__dateRevised mesh__D016440 2005-06-30
% 223.67/223.86  |- skos__annotation mesh__D016440
% 223.67/223.86       publication type only; do not confuse with Publication Type RETRACTED PUBLICATION which labels the article being retracted; Manual 33.16+; do not confuse with Publication Type PUBLISHED ERRATUM; publication retraction as a subject is indexed under the main heading RETRACTION OF PUBLICATION; CATALOG: do not use%A%  
% 223.67/223.86  |- mesh__dateCreated mesh__D002420 1999-01-01
% 223.67/223.86  |- mesh__onlineNote mesh__D002420
% 223.67/223.86       use CAUDA EQUINA to search FILUM TERMINALE 1966-78   
% 223.67/223.86  |- mesh__recordOriginator mesh__D002420 NLM
% 223.67/223.86  |- mesh__publicMeSHNote mesh__D002420
% 223.67/223.86       FILUM TERMINALE was see under CAUDA EQUINA 1963-78   
% 223.67/223.86  |- skos__broader mesh__D002420smesh__D013126
% 223.67/223.86  |- mesh__recordMaintainer mesh__D002420 ags
% 223.67/223.86  |- skos__hiddenLabel mesh__D002420 Equina, Cauda
% 223.67/223.86  |- skos__prefLabel mesh__D002420 Cauda Equina
% 223.67/223.86  |- skos__scopeNote mesh__D002420
% 223.67/223.86       The lower part of the SPINAL CORD consisting of the lumbar, sacral, and coccygeal nerve roots.%A%    
% 223.67/223.86  |- mesh__dateRevised mesh__D002420 2005-06-30
% 223.67/223.86  |- rdf__type mesh__D002420sskos__Concept
% 223.67/223.86  |- skos__annotation mesh__D002420
% 223.67/223.86       disease: coordinate IM with PERIPHERAL NERVOUS SYSTEM DISEASES %28%IM%29%; neoplasms: coordinate IM with PERIPHERAL NERVOUS SYSTEM NEOPLASMS %28%IM%29%; cauda equina syndrome: CAUDA EQUINA SYNDROME see POLYRADICULOPATHY is available%A%  
% 223.67/223.86  |- skos__hiddenLabel mesh__D002420 Terminale, Filum
% 223.67/223.86  |- mesh__recordAuthorizer mesh__D002420 sjn
% 223.67/223.86  |- mesh__historyNote mesh__D002420
% 223.67/223.86       FILUM TERMINALE was see under CAUDA EQUINA 1963-78   
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D002420 2006
% 223.67/223.86  |- mesh__publicMeSHNote mesh__D015348 89   
% 223.67/223.86  |- skos__historyNote mesh__D015348 Visual Perception %28%1966-1988%29%
% 223.67/223.86  |- skos__historyNote mesh__D015348 Vision %28%1966-1988%29%
% 223.67/223.86  |- skos__historyNote mesh__D015348 Accommodation, Ocular %28%1967-1988%29%
% 223.67/223.86  |- mesh__recordAuthorizer mesh__D015348 sjn
% 223.67/223.86  |- skos__hiddenLabel mesh__D015348 Visions, Binocular
% 223.67/223.86  |- skos__broader mesh__D015348smesh__D014785
% 223.67/223.86  |- rdf__type mesh__D015348sskos__Concept
% 223.67/223.86  |- mesh__dateCreated mesh__D015348 1988-06-02
% 223.67/223.86  |- skos__hiddenLabel mesh__D015348 Binocular Visions
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D015348 2005
% 223.67/223.86  |- skos__historyNote mesh__D015348 Convergence, Ocular %28%1985-1988%29%
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D015348 2004
% 223.67/223.86  |- mesh__recordMaintainer mesh__D015348 nns
% 223.67/223.86  |- skos__scopeNote mesh__D015348
% 223.67/223.86       The blending of separate images seen by each eye into one composite image.%A%    
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D015348 2006
% 223.67/223.86  |- skos__prefLabel mesh__D015348 Vision, Binocular
% 223.67/223.86  |- mesh__dateEstablished mesh__D015348 1989-01-01
% 223.67/223.86  |- mesh__dateRevised mesh__D015348 2003-07-09
% 223.67/223.86  |- mesh__historyNote mesh__D015348 89   
% 223.67/223.86  |- mesh__recordOriginator mesh__D015348 EC
% 223.67/223.86  |- skos__altLabel mesh__D015348 Binocular Vision
% 223.67/223.86  |- rdf__type mesh__D034502sskos__Concept
% 223.67/223.86  |- skos__annotation mesh__D034502 see SCR for specific hnRNP entries   
% 223.67/223.86  |- skos__historyNote mesh__D034502 Ribonucleoproteins %28%1998-2002%29%
% 223.67/223.86  |- skos__broader mesh__D034502smesh__D034441
% 223.67/223.86  |- skos__prefLabel mesh__D034502 Heterogeneous-Nuclear Ribonucleoprotein D
% 223.67/223.86  |- skos__altLabel mesh__D034502 HNRNP D
% 223.67/223.86  |- mesh__dateEstablished mesh__D034502 2003-01-01
% 223.67/223.86  |- skos__hiddenLabel mesh__D034502
% 223.67/223.86       Ribonucleoprotein D, Heterogeneous-Nuclear
% 223.67/223.86  |- skos__scopeNote mesh__D034502
% 223.67/223.86       A heterogeneous-nuclear ribonucleoprotein that has specificity for AU-rich elements found in the 3%27%-region of mRNA and may play a role in RNA stability. Several isoforms of hnRNP D protein have been found to occur due to alternative mRNA splicing %28%RNA SPLICING%29%.%A%    
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D034502 2006
% 223.67/223.86  |- mesh__publicMeSHNote mesh__D034502 2003   
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D034502 2004
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D034502 2005
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D034502 2003
% 223.67/223.86  |- mesh__historyNote mesh__D034502 2003   
% 223.67/223.86  |- mesh__dateCreated mesh__D034502 2002-07-03
% 223.67/223.86  |- skos__hiddenLabel mesh__D034502
% 223.67/223.86       Heterogeneous Nuclear Ribonucleoprotein D
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D012050 2002
% 223.67/223.86  |- skos__related mesh__D012050smesh__D004651
% 223.67/223.86  |- skos__hiddenLabel mesh__D012050 Vocational Rehabilitations
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D012050 2005
% 223.67/223.86  |- mesh__publicMeSHNote mesh__D012050 67   
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D012050 1994
% 223.67/223.86  |- mesh__dateEstablished mesh__D012050 1967-01-01
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D012050 2003
% 223.67/223.86  |- skos__prefLabel mesh__D012050 Rehabilitation, Vocational
% 223.67/223.86  |- mesh__recordOriginator mesh__D012050 NLM
% 223.67/223.86  |- mesh__dateRevised mesh__D012050 1992-05-18
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D012050 2006
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D012050 1995
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D012050 2004
% 223.67/223.86  |- skos__related mesh__D012050smesh__D012759
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D012050 1993
% 223.67/223.86  |- mesh__historyNote mesh__D012050 67%28%66%29%   
% 223.67/223.86  |- mesh__recordAuthorizer mesh__D012050 PLS
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D012050 1998
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D012050 2000
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D012050 1996
% 223.67/223.86  |- mesh__recordMaintainer mesh__D012050 TAP
% 223.67/223.86  |- skos__scopeNote mesh__D012050
% 223.67/223.86       Training of the mentally or physically disabled in work skills so they may be returned to regular employment utilizing these skills.%A%    
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D012050 1999
% 223.67/223.86  |- mesh__dateCreated mesh__D012050 1999-01-01
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D012050 1997
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D012050 2001
% 223.67/223.86  |- skos__broader mesh__D012050smesh__D012046
% 223.67/223.86  |- skos__altLabel mesh__D012050 Vocational Rehabilitation
% 223.67/223.86  |- skos__hiddenLabel mesh__D012050 Rehabilitations, Vocational
% 223.67/223.86  |- rdf__type mesh__D012050sskos__Concept
% 223.67/223.86  |- mesh__recordMaintainer mesh__D006811 ags
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D006811 2006
% 223.67/223.86  |- skos__broader mesh__D006811smesh__D050280
% 223.67/223.86  |- mesh__recordAuthorizer mesh__D006811 sjn
% 223.67/223.86  |- mesh__dateRevised mesh__D006811 2005-06-30
% 223.67/223.86  |- skos__annotation mesh__D006811
% 223.67/223.86       disloc at shoulder = SHOULDER DISLOCATION: do not add HUMERUS%A%  
% 223.67/223.86  |- mesh__dateCreated mesh__D006811 1999-01-01
% 223.67/223.86  |- skos__prefLabel mesh__D006811 Humerus
% 223.67/223.86  |- rdf__type mesh__D006811sskos__Concept
% 223.67/223.86  |- mesh__recordOriginator mesh__D006811 NLM
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D006013 2006
% 223.67/223.86  |- skos__altLabel mesh__D006013 Glycogenosis 6
% 223.67/223.86  |- skos__historyNote mesh__D006013 Liver Diseases %28%1966-1974%29%
% 223.67/223.86  |- mesh__onlineNote mesh__D006013
% 223.67/223.86       use GLYCOGEN STORAGE DISEASE TYPE VI to search GLYCOGENOSIS 6 1975-88%A%  
% 223.67/223.86  |- skos__hiddenLabel mesh__D006013 Her Disease
% 223.67/223.86  |- skos__hiddenLabel mesh__D006013 Disease, Hers%27%
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D006013 2005
% 223.67/223.86  |- skos__historyNote mesh__D006013
% 223.67/223.86       Glucosyltransferases/metabolism %28%1966-1974%29%
% 223.67/223.86  |- skos__broader mesh__D006013smesh__D006008
% 223.67/223.86  |- mesh__publicMeSHNote mesh__D006013
% 223.67/223.86       91; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 6 see under GLYCOGENOSIS 1975-88%A%  
% 223.67/223.86  |- skos__hiddenLabel mesh__D006013 Disease, Hers
% 223.67/223.86  |- skos__hiddenLabel mesh__D006013 Type VI, Glycogenosis
% 223.67/223.86  |- skos__altLabel mesh__D006013 Hers%27% Disease
% 223.67/223.86  |- mesh__recordOriginator mesh__D006013 NLM
% 223.67/223.86  |- mesh__recordAuthorizer mesh__D006013 sjn
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D006013 2004
% 223.67/223.86  |- skos__prefLabel mesh__D006013 Glycogen Storage Disease Type VI
% 223.67/223.86  |- rdf__type mesh__D006013sskos__Concept
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D006013 2003
% 223.67/223.86  |- mesh__dateCreated mesh__D006013 1974-12-12
% 223.67/223.86  |- skos__scopeNote mesh__D006013
% 223.67/223.86       A hepatic GLYCOGEN STORAGE DISEASE in which there is an apparent deficiency of hepatic phosphorylase %28%GLYCOGEN PHOSPHORYLASE, LIVER FORM%29% activity.%A%    
% 223.67/223.86  |- mesh__historyNote mesh__D006013
% 223.67/223.86       91%28%89%29%; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 6 see under GLYCOGENOSIS 1975-88%A%  
% 223.67/223.86  |- skos__altLabel mesh__D006013 Glycogenosis VI
% 223.67/223.86  |- skos__altLabel mesh__D006013 Glycogenosis Type VI
% 223.67/223.86  |- mesh__dateRevised mesh__D006013 2002-07-03
% 223.67/223.86  |- mesh__dateEstablished mesh__D006013 1991-01-01
% 223.67/223.86  |- skos__historyNote mesh__D006013 Glycogenosis %28%1966-1974%29%
% 223.67/223.86  |- mesh__recordMaintainer mesh__D006013 lkt
% 223.67/223.86  |- skos__altLabel mesh__D006013 Hers Disease
% 223.67/223.86  |- skos__related mesh__D006013smesh__D025001
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D019739 2003
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D019739 2006
% 223.67/223.86  |- skos__historyNote mesh__D019739 Cardiomyoplasty %28%1995-1997%29%
% 223.67/223.86  |- skos__broader mesh__D019739smesh__D019738
% 223.67/223.86  |- skos__hiddenLabel mesh__D019739 Muscle Ventricles, Skeletal
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D019739 2005
% 223.67/223.86  |- mesh__dateCreated mesh__D019739 1997-06-20
% 223.67/223.86  |- skos__prefLabel mesh__D019739 Skeletal Muscle Ventricle
% 223.67/223.86  |- skos__scopeNote mesh__D019739
% 223.67/223.86       Autologous skeletal muscle that is wrapped around the heart and electrically stimulated in order to provide mechanical heart assistance. The latissimus dorsi muscle is commonly used to form this ventricle that functions to independently augment cardiac performance by pumping in series with the heart.%A%    
% 223.67/223.86  |- skos__hiddenLabel mesh__D019739 Ventricle, Skeletal Muscle
% 223.67/223.86  |- skos__historyNote mesh__D019739 Muscles %28%1989-1994%29%
% 223.67/223.86  |- skos__hiddenLabel mesh__D019739 Muscle Ventricle, Skeletal
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D019739 2002
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D019739 2001
% 223.67/223.86  |- skos__annotation mesh__D019739
% 223.67/223.86       autol skeletal musc wrapped around heart %26% electrically stimulated to provide mechanical heart assist%A%  
% 223.67/223.86  |- skos__hiddenLabel mesh__D019739 Ventricles, Skeletal Muscle
% 223.67/223.86  |- mesh__historyNote mesh__D019739 98; was see CARDIOMYOPLASTY 1995-97   
% 223.67/223.86  |- mesh__dateEstablished mesh__D019739 1998-01-01
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D019739 2000
% 223.67/223.86  |- mesh__publicMeSHNote mesh__D019739
% 223.67/223.86       98; was see CARDIOMYOPLASTY 1995-97   
% 223.67/223.86  |- skos__hiddenLabel mesh__D019739 Skeletal Muscle Ventricles
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D019739 1999
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D019739 2004
% 223.67/223.86  |- skos__related mesh__D019739smesh__D018421
% 223.67/223.86  |- rdf__type mesh__D019739sskos__Concept
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D019739 1998
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D011756 1996
% 223.67/223.86  |- rdf__type mesh__D011756sskos__Concept
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D011756 2001
% 223.67/223.86  |- mesh__recordMaintainer mesh__D011756 TPW
% 223.67/223.86  |- skos__prefLabel mesh__D011756 Diphosphates
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D011756 2000
% 223.67/223.86  |- skos__altLabel mesh__D011756 Pyrophosphates
% 223.67/223.86  |- mesh__recordOriginator mesh__D011756 NLM
% 223.67/223.86  |- mesh__dateCreated mesh__D011756 1999-01-01
% 223.67/223.86  |- mesh__recordAuthorizer mesh__D011756 PLS
% 223.67/223.86  |- skos__broader mesh__D011756smesh__D011122
% 223.67/223.86  |- skos__scopeNote mesh__D011756
% 223.67/223.86       Inorganic salts of phosphoric acid that contain two phosphate groups.%A%    
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D011756 1995
% 223.67/223.86  |- mesh__publicMeSHNote mesh__D011756 94; was PYROPHOSPHATES 1963-93   
% 223.67/223.86  |- mesh__onlineNote mesh__D011756
% 223.67/223.86       use DIPHOSPHATES to search PYROPHOSPHATES 1966-93   
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D011756 2006
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D011756 2002
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D011756 2004
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D011756 1999
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D011756 1994
% 223.67/223.86  |- mesh__dateRevised mesh__D011756 1993-06-04
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D011756 1997
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D011756 2005
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D011756 2003
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D011756 1998
% 223.67/223.86  |- mesh__historyNote mesh__D011756 94; was PYROPHOSPHATES 1963-93   
% 223.67/223.86  |- mesh__dateRevised mesh__D044132 2005-06-30
% 223.67/223.86  |- skos__broader mesh__D044132smesh__D000188
% 223.67/223.86  |- mesh__publicMeSHNote mesh__D044132 2004   
% 223.67/223.86  |- skos__historyNote mesh__D044132 Actinobacillus %28%1974-2003%29%
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D044132 2006
% 223.67/223.86  |- skos__prefLabel mesh__D044132 Actinobacillus suis
% 223.67/223.86  |- skos__scopeNote mesh__D044132
% 223.67/223.86       A species of gram-negative bacteria in the genus ACTINOBACILLUS. It is mainly a pathogen of PIGS, but also can infect HORSES.%A%    
% 223.67/223.86  |- mesh__historyNote mesh__D044132 2004   
% 223.67/223.86  |- mesh__dateEstablished mesh__D044132 2004-01-01
% 223.67/223.86  |- skos__annotation mesh__D044132
% 223.67/223.86       infection: coord IM with ACTINOBACILLUS INFECTIONS %28%IM%29%   
% 223.67/223.86  |- rdf__type mesh__D044132sskos__Concept
% 223.67/223.86  |- mesh__recordOriginator mesh__D044132 ags
% 223.67/223.86  |- mesh__recordAuthorizer mesh__D044132 sjn
% 223.67/223.86  |- mesh__recordMaintainer mesh__D044132 SYSTEM
% 223.67/223.86  |- mesh__dateCreated mesh__D044132 2003-07-09
% 223.67/223.86  |- mesh__historyNote mesh__D005719 1996 %28%1963%29%   
% 223.67/223.86  |- mesh__recordMaintainer mesh__D005719 nns
% 223.67/223.86  |- mesh__dateRevised mesh__D005719 2005-06-30
% 223.67/223.86  |- skos__prefLabel mesh__D005719 gamma-Globulins
% 223.67/223.86  |- mesh__publicMeSHNote mesh__D005719
% 223.67/223.86       1996; see GAMMA GLOBULINS 1975-1995, see GAMMA GLOBULIN 1963-1974; /deficiency see GAMMA GLOBULIN DEFICIENCY see AGAMMAGLOBULINEMIA 1963-1967%A%  
% 223.67/223.86  |- skos__altLabel mesh__D005719 gamma-Globulin
% 223.67/223.86  |- mesh__recordAuthorizer mesh__D005719 sjn
% 223.67/223.86  |- mesh__recordOriginator mesh__D005719 NLM
% 223.67/223.86  |- mesh__dateCreated mesh__D005719 1999-01-01
% 223.67/223.86  |- skos__scopeNote mesh__D005719
% 223.67/223.86       Serum globulins that migrate to the gamma region %28%most positively charged%29% upon ELECTROPHORESIS. At one time, gamma-globulins came to be used as a synonym for immunoglobulins since most immunoglobulins are gamma globulins and conversely most gamma globulins are immunoglobulins. But since some immunoglobulins exhibit an alpha or beta electrophoretic mobility, that usage is in decline.%A%    
% 223.67/223.86  |- skos__annotation mesh__D005719
% 223.67/223.86       /defic = AGAMMAGLOBULINEMIA or DYSGAMMAGLOBULINEMIA; index under IMMUNIZATION, PASSIVE for therapy with gamma-globulins in general or unspecified; anti-gamma globulin antibodies = ANTI-ANTIBODIES %28%IM%29% + GAMMA-GLOBULINS %28%IM%29%; gammopathies: coordinate GAMMA-GLOBULINS %28%IM%29% with PARAPROTEINEMIAS %28%IM%29% but consider also HYPERGAMMAGLOBULINEMIA, follow text%A%  
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D005719 2006
% 223.67/223.86  |- rdf__type mesh__D005719sskos__Concept
% 223.67/223.86  |- skos__hiddenLabel mesh__D005719 gamma Globulin
% 223.67/223.86  |- skos__broader mesh__D005719smesh__D007136
% 223.67/223.86  |- skos__hiddenLabel mesh__D005719 gamma Globulins
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D016441 2006
% 223.67/223.86  |- rdf__type mesh__D016441sskos__Concept
% 223.67/223.86  |- mesh__dateRevised mesh__D016441 2005-06-30
% 223.67/223.86  |- skos__altLabel mesh__D016441 Retracted Publication
% 223.67/223.86  |- skos__annotation mesh__D016441
% 223.67/223.86       publication type only; designates an article or book cited by the author or author%27%s representative as having been retracted after formal notice by the publication type RETRACTION OF PUBLICATION; Manual 33.16+%A%  
% 223.67/223.86  |- skos__altLabel mesh__D016441 Retracted Publication %28%PT%29%
% 223.67/223.86  |- skos__prefLabel mesh__D016441
% 223.67/223.86       Retracted Publication %5B%Publication Type%5D%
% 223.67/223.86  |- skos__broader mesh__D016441smesh__D052180
% 223.67/223.86  |- skos__scopeNote mesh__D016441
% 223.67/223.86       Work consisting of the designation of an article or book as retracted in whole or in part by an author or authors or an authorized representative. It identifies a citation previously published and now retracted through a formal issuance from the author, publisher, or other authorized agent, and is distinguished from RETRACTION OF PUBLICATION %5B%PUBLICATION TYPE%5D%, which identifies the citation retracting the original published item.%A%    
% 223.67/223.86  |- mesh__dateEstablished mesh__D016441 1996-01-01
% 223.67/223.86  |- mesh__dateCreated mesh__D016441 1995-06-23
% 223.67/223.86  |- mesh__recordOriginator mesh__D016441 TGC
% 223.67/223.86  |- mesh__historyNote mesh__D016441
% 223.67/223.86       1989; for both publication type %26% main heading 1989-1990; publication type only 1991 forward%A%  
% 223.67/223.86  |- mesh__recordMaintainer mesh__D016441 jls
% 223.67/223.86  |- mesh__recordAuthorizer mesh__D016441 sjn
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D002421 2005
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D002421 1993
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D002421 1996
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D002421 2000
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D002421 1999
% 223.67/223.86  |- mesh__dateRevised mesh__D002421 1992-05-07
% 223.67/223.86  |- mesh__recordOriginator mesh__D002421 NLM
% 223.67/223.86  |- mesh__recordAuthorizer mesh__D002421 PLS
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D002421 1995
% 223.67/223.86  |- rdf__type mesh__D002421sskos__Concept
% 223.67/223.86  |- mesh__activeMeSHYear mesh__D002421 1998
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002421 2004
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002421 2002
% 223.67/223.87  |- skos__annotation mesh__D002421 part of the neostriatum   
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002421 1994
% 223.67/223.87  |- skos__scopeNote mesh__D002421
% 223.67/223.87       Elongated gray mass of the neostriatum located adjacent to the lateral ventricle of the brain.%A%    
% 223.67/223.87  |- skos__hiddenLabel mesh__D002421 Nucleus, Caudate
% 223.67/223.87  |- mesh__recordMaintainer mesh__D002421 AGS
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002421 2003
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002421 2006
% 223.67/223.87  |- mesh__dateCreated mesh__D002421 1999-01-01
% 223.67/223.87  |- skos__broader mesh__D002421smesh__D017072
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002421 1997
% 223.67/223.87  |- skos__prefLabel mesh__D002421 Caudate Nucleus
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002421 2001
% 223.67/223.87  |- skos__altLabel mesh__D015349 Monocular Vision
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D015349 2006
% 223.67/223.87  |- mesh__dateRevised mesh__D015349 2003-07-09
% 223.67/223.87  |- mesh__historyNote mesh__D015349 89   
% 223.67/223.87  |- mesh__dateEstablished mesh__D015349 1989-01-01
% 223.67/223.87  |- skos__historyNote mesh__D015349 Vision %28%1966-1988%29%
% 223.67/223.87  |- mesh__publicMeSHNote mesh__D015349 89   
% 223.67/223.87  |- mesh__recordAuthorizer mesh__D015349 sjn
% 223.67/223.87  |- rdf__type mesh__D015349sskos__Concept
% 223.67/223.87  |- skos__historyNote mesh__D015349 Sensory Deprivation %28%1972-1988%29%
% 223.67/223.87  |- skos__broader mesh__D015349smesh__D014785
% 223.67/223.87  |- skos__prefLabel mesh__D015349 Vision, Monocular
% 223.67/223.87  |- mesh__dateCreated mesh__D015349 1988-06-02
% 223.67/223.87  |- skos__hiddenLabel mesh__D015349 Monocular Visions
% 223.67/223.87  |- mesh__recordMaintainer mesh__D015349 nns
% 223.67/223.87  |- skos__hiddenLabel mesh__D015349 Visions, Monocular
% 223.67/223.87  |- skos__scopeNote mesh__D015349
% 223.67/223.87       Vision with one eye or the affecting of one eye.     
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D015349 2005
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D015349 2004
% 223.67/223.87  |- mesh__recordOriginator mesh__D015349 EC
% 223.67/223.87  |- mesh__recordOriginator mesh__D001329 NLM
% 223.67/223.87  |- skos__scopeNote mesh__D001329
% 223.67/223.87       The spontaneous disintegration of tissues or cells by the action of their own autogenous enzymes.%A%    
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D001329 2001
% 223.67/223.87  |- mesh__historyNote mesh__D001329 72%28%68%29%   
% 223.67/223.87  |- mesh__dateRevised mesh__D001329 1999-11-03
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D001329 2003
% 223.67/223.87  |- skos__hiddenLabel mesh__D001329 Autolyses
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D001329 2000
% 223.67/223.87  |- mesh__recordMaintainer mesh__D001329 KEV
% 223.67/223.87  |- mesh__dateCreated mesh__D001329 1999-01-01
% 223.67/223.87  |- skos__historyNote mesh__D001329 Postmortem Changes %28%1966-1967%29%
% 223.67/223.87  |- skos__annotation mesh__D001329
% 223.67/223.87       restrict to humans and higher animals; BACTERIOLYSIS is also available%A%  
% 223.67/223.87  |- mesh__dateEstablished mesh__D001329 1972-01-01
% 223.67/223.87  |- skos__broader mesh__D001329smesh__D011180
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D001329 2006
% 223.67/223.87  |- rdf__type mesh__D001329sskos__Concept
% 223.67/223.87  |- skos__prefLabel mesh__D001329 Autolysis
% 223.67/223.87  |- mesh__recordAuthorizer mesh__D001329 sjn
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D001329 2005
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D001329 2002
% 223.67/223.87  |- mesh__publicMeSHNote mesh__D001329 72   
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D001329 2004
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012051 2004
% 223.67/223.87  |- skos__prefLabel mesh__D012051 Reimbursement Mechanisms
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012051 1998
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012051 2001
% 223.67/223.87  |- mesh__dateRevised mesh__D012051 1993-09-16
% 223.67/223.87  |- skos__hiddenLabel mesh__D012051 Mechanism, Reimbursement
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012051 1996
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012051 1999
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012051 2002
% 223.67/223.87  |- mesh__recordMaintainer mesh__D012051 PLS
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012051 1997
% 223.67/223.87  |- skos__broader mesh__D012051smesh__D007349
% 223.67/223.87  |- mesh__dateCreated mesh__D012051 1978-05-09
% 223.67/223.87  |- rdf__type mesh__D012051sskos__Concept
% 223.67/223.87  |- mesh__recordOriginator mesh__D012051 EC
% 223.67/223.87  |- mesh__historyNote mesh__D012051 79   
% 223.67/223.87  |- mesh__recordAuthorizer mesh__D012051 NLM
% 223.67/223.87  |- mesh__publicMeSHNote mesh__D012051 79   
% 223.67/223.87  |- mesh__dateEstablished mesh__D012051 1979-01-01
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012051 2005
% 223.67/223.87  |- skos__scopeNote mesh__D012051
% 223.67/223.87       Processes or methods of reimbursement for services rendered or equipment.%A%    
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012051 2003
% 223.67/223.87  |- skos__hiddenLabel mesh__D012051 Reimbursement Mechanism
% 223.67/223.87  |- skos__historyNote mesh__D012051 Financing, Organized %28%1968-1978%29%
% 223.67/223.87  |- skos__hiddenLabel mesh__D012051 Mechanisms, Reimbursement
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012051 2006
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012051 2000
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012051 1995
% 223.67/223.87  |- mesh__dateCreated mesh__D006812 1999-01-01
% 223.67/223.87  |- mesh__dateRevised mesh__D006812 2004-07-07
% 223.67/223.87  |- mesh__historyNote mesh__D006812 2005%28%1963%29%   
% 223.67/223.87  |- mesh__recordOriginator mesh__D006812 NLM
% 223.67/223.87  |- skos__hiddenLabel mesh__D006812 Huminate, Sodium
% 223.67/223.87  |- skos__broader mesh__D006812smesh__D010636
% 223.67/223.87  |- skos__hiddenLabel mesh__D006812 Substances, Humic
% 223.67/223.87  |- mesh__publicMeSHNote mesh__D006812 2005; see HUMIC ACIDS 1963-2004   
% 223.67/223.87  |- rdf__type mesh__D006812sskos__Concept
% 223.67/223.87  |- skos__broader mesh__D006812smesh__D002264
% 223.67/223.87  |- skos__scopeNote mesh__D006812
% 223.67/223.87       Organic matter in a state of advanced decay, after passing through the stages of COMPOST and PEAT and before becoming lignite %28%COAL%29%. It is composed of a heterogenous mixture of compounds including phenolic radicals and acids that polymerize and are not easily separated nor analyzed. %28%E.A. Ghabbour %26% G. Davies, eds. Humic Substances, 2001%29%.%A%    
% 223.67/223.87  |- mesh__recordAuthorizer mesh__D006812 sjn
% 223.67/223.87  |- skos__broader mesh__D006812smesh__D012987
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006812 2006
% 223.67/223.87  |- skos__hiddenLabel mesh__D006812 Acids, Humic
% 223.67/223.87  |- skos__prefLabel mesh__D006812 Humic Substances
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006812 2005
% 223.67/223.87  |- mesh__recordMaintainer mesh__D006812 ssb
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006014 2006
% 223.67/223.87  |- skos__historyNote mesh__D006014 Glycogenosis %28%1966-1974%29%
% 223.67/223.87  |- skos__altLabel mesh__D006014 Deficiency, Muscle Phosphofructokinase
% 223.67/223.87  |- skos__hiddenLabel mesh__D006014 Deficiencies, Muscle Phosphofructokinase
% 223.67/223.87  |- skos__scopeNote mesh__D006014
% 223.67/223.87       An autosomal recessive glycogen storage disease in which there is deficient expression of 6-phosphofructose 1-kinase in muscle %28%PHOSPHOFRUCTOKINASE-1, MUSCLE TYPE%29% resulting in abnormal deposition of glycogen in muscle tissue. These patients have severe congenital muscular dystrophy and are exercise intolerant.%A%    
% 223.67/223.87  |- skos__altLabel mesh__D006014 Muscle Phosphofructokinase Deficiency
% 223.67/223.87  |- mesh__dateEstablished mesh__D006014 1991-01-01
% 223.67/223.87  |- skos__broader mesh__D006014smesh__D006008
% 223.67/223.87  |- skos__hiddenLabel mesh__D006014 Muscle Phosphofructokinase Deficiencies
% 223.67/223.87  |- skos__hiddenLabel mesh__D006014 Phosphofructokinase Deficiency, Muscle
% 223.67/223.87  |- skos__hiddenLabel mesh__D006014 Disease, Tarui
% 223.67/223.87  |- skos__altLabel mesh__D006014 Glycogenosis 7
% 223.67/223.87  |- skos__altLabel mesh__D006014 Tarui Disease
% 223.67/223.87  |- skos__hiddenLabel mesh__D006014 Disease, Tarui%27%s
% 223.67/223.87  |- mesh__recordMaintainer mesh__D006014 lkt
% 223.67/223.87  |- mesh__onlineNote mesh__D006014
% 223.67/223.87       use GLYCOGEN STORAGE DISEASE TYPE VII to search GLYCOGENOSIS 7 1975-88%A%  
% 223.67/223.87  |- mesh__dateRevised mesh__D006014 2004-07-07
% 223.67/223.87  |- rdf__type mesh__D006014sskos__Concept
% 223.67/223.87  |- mesh__dateCreated mesh__D006014 1974-12-12
% 223.67/223.87  |- skos__broader mesh__D006014smesh__D009136
% 223.67/223.87  |- skos__hiddenLabel mesh__D006014 Taruis Disease
% 223.67/223.87  |- mesh__historyNote mesh__D006014
% 223.67/223.87       91%28%89%29%; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 7 see under GLYCOGENOSIS 1975-88%A%  
% 223.67/223.87  |- skos__annotation mesh__D006014
% 223.67/223.87       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006014 2005
% 223.67/223.87  |- skos__prefLabel mesh__D006014 Glycogen Storage Disease Type VII
% 223.67/223.87  |- skos__altLabel mesh__D006014 Tarui%27%s Disease
% 223.67/223.87  |- mesh__recordOriginator mesh__D006014 NLM
% 223.67/223.87  |- mesh__recordAuthorizer mesh__D006014 sjn
% 223.67/223.87  |- mesh__publicMeSHNote mesh__D006014
% 223.67/223.87       91; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 7 see under GLYCOGENOSIS 1975-88%A%  
% 223.67/223.87  |- skos__hiddenLabel mesh__D006014 Phosphofructokinase Deficiencies, Muscle
% 223.67/223.87  |- mesh__recordAuthorizer mesh__D044133 sjn
% 223.67/223.87  |- skos__historyNote mesh__D044133 Actinobacillus %28%1966-2003%29%
% 223.67/223.87  |- rdf__type mesh__D044133sskos__Concept
% 223.67/223.87  |- mesh__dateCreated mesh__D044133 2003-07-09
% 223.67/223.87  |- skos__scopeNote mesh__D044133
% 223.67/223.87       A species of gram-negative bacteria in the genus ACTINOBACILLUS, which causes EPIDIDYMITIS in SHEEP.%A%    
% 223.67/223.87  |- mesh__recordMaintainer mesh__D044133 SYSTEM
% 223.67/223.87  |- mesh__dateRevised mesh__D044133 2005-06-30
% 223.67/223.87  |- mesh__dateEstablished mesh__D044133 2004-01-01
% 223.67/223.87  |- skos__broader mesh__D044133smesh__D000188
% 223.67/223.87  |- mesh__publicMeSHNote mesh__D044133 2004   
% 223.67/223.87  |- mesh__historyNote mesh__D044133 2004   
% 223.67/223.87  |- skos__prefLabel mesh__D044133 Actinobacillus seminis
% 223.67/223.87  |- skos__annotation mesh__D044133
% 223.67/223.87       infection: coord IM with ACTINOBACILLUS INFECTIONS %28%IM%29% + EPIDIDYMITIS %28%IM%29% if pertinent%A%  
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D044133 2006
% 223.67/223.87  |- mesh__recordOriginator mesh__D044133 ags
% 223.67/223.87  |- skos__hiddenLabel mesh__D002422 Syndrome, Causalgia
% 223.67/223.87  |- mesh__dateRevised mesh__D002422 1999-11-03
% 223.67/223.87  |- skos__hiddenLabel mesh__D002422 Syndromes, Causalgia
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002422 2000
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002422 2003
% 223.67/223.87  |- skos__prefLabel mesh__D002422 Causalgia
% 223.67/223.87  |- mesh__recordAuthorizer mesh__D002422 sjn
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002422 2001
% 223.67/223.87  |- rdf__type mesh__D002422sskos__Concept
% 223.67/223.87  |- mesh__recordMaintainer mesh__D002422 KEV
% 223.67/223.87  |- skos__altLabel mesh__D002422 Causalgia Syndrome
% 223.67/223.87  |- skos__hiddenLabel mesh__D002422 Causalgia Syndromes
% 223.67/223.87  |- mesh__dateCreated mesh__D002422 1999-01-01
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002422 2004
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002422 2002
% 223.67/223.87  |- skos__altLabel mesh__D002422 Deafferentation Pain
% 223.67/223.87  |- skos__altLabel mesh__D002422 Type II Complex Regional Pain Syndrome
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002422 2005
% 223.67/223.87  |- mesh__recordOriginator mesh__D002422 NLM
% 223.67/223.87  |- skos__broader mesh__D002422smesh__D009437
% 223.67/223.87  |- skos__altLabel mesh__D002422 CRPS Type II
% 223.67/223.87  |- mesh__dateEstablished mesh__D002422 1991-01-01
% 223.67/223.87  |- mesh__publicMeSHNote mesh__D002422
% 223.67/223.87       1991; was see under NEURALGIA 1971-1990   
% 223.67/223.87  |- skos__historyNote mesh__D002422 Neuralgia %28%1966-1970%29%
% 223.67/223.87  |- skos__annotation mesh__D002422
% 223.67/223.87       coord IM with specific nerve %28%IM%29%   
% 223.67/223.87  |- mesh__historyNote mesh__D002422
% 223.67/223.87       1991%28%1971%29%; was see under NEURALGIA 1971-1990   
% 223.67/223.87  |- skos__scopeNote mesh__D002422
% 223.67/223.87       A complex regional pain syndrome characterized by burning pain and marked sensitivity to touch %28%HYPERESTHESIA%29% in the distribution of an injured peripheral nerve. Autonomic dysfunction in the form of sudomotor %28%i.e., sympathetic innervation to sweat glands%29%, vasomotor, and trophic skin changes may also occur. %28%Adams et al., Principles of Neurology, 6th ed, p1359%29%%A%    
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002422 2006
% 223.67/223.87  |- skos__broader mesh__D002422smesh__D020918
% 223.67/223.87  |- skos__hiddenLabel mesh__D002422 Pain, Deafferentation
% 223.67/223.87  |- skos__altLabel mesh__D002422 Complex Regional Pain Syndrome Type II
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D040541 2005
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D040541 2004
% 223.67/223.87  |- skos__annotation mesh__D040541
% 223.67/223.87       MARKETING OF HEALTH SERVICES and SOCIAL MARKETING are also available%A%  
% 223.67/223.87  |- rdf__type mesh__D040541sskos__Concept
% 223.67/223.87  |- skos__prefLabel mesh__D040541 Marketing
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D040541 2006
% 223.67/223.87  |- skos__hiddenLabel mesh__D040541 Research, Market
% 223.67/223.87  |- skos__broader mesh__D040541smesh__D003132
% 223.67/223.87  |- mesh__recordAuthorizer mesh__D040541 sjn
% 223.67/223.87  |- mesh__publicMeSHNote mesh__D040541
% 223.67/223.87       2003; see under MARKETING OF HEALTH SERVICES 1979-2002   
% 223.67/223.87  |- mesh__dateCreated mesh__D040541 2002-07-02
% 223.67/223.87  |- mesh__dateEstablished mesh__D040541 2003-01-01
% 223.67/223.87  |- mesh__recordOriginator mesh__D040541 jls
% 223.67/223.87  |- skos__historyNote mesh__D040541
% 223.67/223.87       Marketing of Health Services %28%1979-2002%29%
% 223.67/223.87  |- skos__hiddenLabel mesh__D040541 Research, Audience
% 223.67/223.87  |- skos__scopeNote mesh__D040541
% 223.67/223.87       Activity involved in transfer of goods from producer to consumer or in the exchange of services.%A%    
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D040541 2003
% 223.67/223.87  |- mesh__recordMaintainer mesh__D040541 jls
% 223.67/223.87  |- mesh__historyNote mesh__D040541
% 223.67/223.87       2003; use MARKETING OF HEALTH SERVICES 1979-2002   
% 223.67/223.87  |- skos__scopeNote mesh__D012850
% 223.67/223.87       The dilatation of the aortic wall behind each of the cusps of the aortic valve.%A%    
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012850 2001
% 223.67/223.87  |- mesh__dateRevised mesh__D012850 1991-01-08
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012850 1998
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012850 1992
% 223.67/223.87  |- skos__annotation mesh__D012850
% 223.67/223.87       aneurysm: coord IM with AORTIC ANEURYSM %28%IM%29%; ruptured aneurysm of sinus: coord IM with AORTIC RUPTURE %28%IM%29%%A%  
% 223.67/223.87  |- skos__hiddenLabel mesh__D012850 Sinus, Aortic
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012850 1999
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012850 1993
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012850 2005
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012850 2002
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012850 1996
% 223.67/223.87  |- skos__broader mesh__D012850smesh__D001011
% 223.67/223.87  |- mesh__historyNote mesh__D012850 79   
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012850 2006
% 223.67/223.87  |- mesh__dateCreated mesh__D012850 1978-05-19
% 223.67/223.87  |- mesh__publicMeSHNote mesh__D012850 79   
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012850 1997
% 223.67/223.87  |- skos__hiddenLabel mesh__D012850 Valsalva Sinus
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012850 1994
% 223.67/223.87  |- skos__prefLabel mesh__D012850 Sinus of Valsalva
% 223.67/223.87  |- mesh__recordAuthorizer mesh__D012850 PLS
% 223.67/223.87  |- mesh__recordMaintainer mesh__D012850 TGC
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012850 2003
% 223.67/223.87  |- skos__altLabel mesh__D012850 Aortic Sinus
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012850 2000
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012850 1995
% 223.67/223.87  |- mesh__recordOriginator mesh__D012850 VDK
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012850 2004
% 223.67/223.87  |- rdf__type mesh__D012850sskos__Concept
% 223.67/223.87  |- mesh__dateEstablished mesh__D012850 1979-01-01
% 223.67/223.87  |- skos__altLabel mesh__D012052 Incentive Reimbursement
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012052 1996
% 223.67/223.87  |- mesh__historyNote mesh__D012052
% 223.67/223.87       91%28%79%29%; was see under REIMBURSEMENT MECHANISMS 1979-90   
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012052 1999
% 223.67/223.87  |- skos__hiddenLabel mesh__D012052 Reimbursements, Incentive
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012052 2000
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012052 1997
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012052 2001
% 223.67/223.87  |- mesh__recordAuthorizer mesh__D012052 NLM
% 223.67/223.87  |- rdf__type mesh__D012052sskos__Concept
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012052 2005
% 223.67/223.87  |- mesh__dateRevised mesh__D012052 1993-09-16
% 223.67/223.87  |- skos__scopeNote mesh__D012052
% 223.67/223.87       A scheme which provides reimbursement for the health services rendered, generally by an institution, and which provides added financial rewards if certain conditions are met. Such a scheme is intended to promote and reward increased efficiency and cost containment, with better care, or at least without adverse effect on the quality of the care rendered.%A%    
% 223.67/223.87  |- skos__prefLabel mesh__D012052 Reimbursement, Incentive
% 223.67/223.87  |- mesh__recordMaintainer mesh__D012052 PLS
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012052 2002
% 223.67/223.87  |- mesh__dateCreated mesh__D012052 1978-05-09
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012052 2003
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012052 2006
% 223.67/223.87  |- skos__hiddenLabel mesh__D012052 Incentive Reimbursements
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012052 1995
% 223.67/223.87  |- mesh__publicMeSHNote mesh__D012052
% 223.67/223.87       91; was see under REIMBURSEMENT MECHANISMS 1979-90   
% 223.67/223.87  |- mesh__recordOriginator mesh__D012052 EC
% 223.67/223.87  |- skos__broader mesh__D012052smesh__D012051
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012052 1998
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012052 2004
% 223.67/223.87  |- mesh__dateEstablished mesh__D012052 1991-01-01
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006813 2005
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006813 1996
% 223.67/223.87  |- skos__prefLabel mesh__D006813 Humidity
% 223.67/223.87  |- mesh__recordOriginator mesh__D006813 NLM
% 223.67/223.87  |- skos__broader mesh__D006813smesh__D004780
% 223.67/223.87  |- mesh__recordMaintainer mesh__D006813 TAP
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006813 1993
% 223.67/223.87  |- rdf__type mesh__D006813sskos__Concept
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006813 1999
% 223.67/223.87  |- skos__hiddenLabel mesh__D006813 Humidities
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006813 2001
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006813 2004
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006813 1998
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006813 2000
% 223.67/223.87  |- mesh__recordAuthorizer mesh__D006813 PLS
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006813 2003
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006813 1995
% 223.67/223.87  |- mesh__dateRevised mesh__D006813 1992-05-15
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006813 1994
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006813 2006
% 223.67/223.87  |- mesh__dateCreated mesh__D006813 1999-01-01
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006813 1997
% 223.67/223.87  |- skos__broader mesh__D006813smesh__D014887
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006813 2002
% 223.67/223.87  |- mesh__recordOriginator mesh__D006015 NLM
% 223.67/223.87  |- skos__broader mesh__D006015smesh__D006008
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006015 2003
% 223.67/223.87  |- mesh__recordAuthorizer mesh__D006015 sjn
% 223.67/223.87  |- mesh__dateEstablished mesh__D006015 1991-01-01
% 223.67/223.87  |- mesh__onlineNote mesh__D006015
% 223.67/223.87       use GLYCOGEN STORAGE DISEASE TYPE VIII to search GLYCOGENOSIS 8 1975-88%A%  
% 223.67/223.87  |- skos__broader mesh__D006015smesh__D040181
% 223.67/223.87  |- skos__scopeNote mesh__D006015
% 223.67/223.87       An x-linked recessive hepatic glycogen storage disease resulting from lack of expression of phosphorylase-b-kinase activity. Symptoms are relatively mild; hepatomegaly, increased liver glycogen, and decreased leukocyte phosphorylase are present. Liver shrinkage occurs in response to glucagon.%A%    
% 223.67/223.87  |- skos__prefLabel mesh__D006015 Glycogen Storage Disease Type VIII
% 223.67/223.87  |- mesh__publicMeSHNote mesh__D006015
% 223.67/223.87       91; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 8 see under GLYCOGENOSIS 1975-88%A%  
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006015 2004
% 223.67/223.87  |- skos__historyNote mesh__D006015 Glycogenosis %28%1966-1974%29%
% 223.67/223.87  |- mesh__historyNote mesh__D006015
% 223.67/223.87       91%28%89%29%; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 8 see under GLYCOGENOSIS 1975-88%A%  
% 223.67/223.87  |- mesh__dateRevised mesh__D006015 2002-07-03
% 223.67/223.87  |- rdf__type mesh__D006015sskos__Concept
% 223.67/223.87  |- mesh__dateCreated mesh__D006015 1974-12-12
% 223.67/223.87  |- skos__annotation mesh__D006015
% 223.67/223.87       do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006015 2005
% 223.67/223.87  |- mesh__recordMaintainer mesh__D006015 nns
% 223.67/223.87  |- skos__altLabel mesh__D006015 Glycogenosis 8
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D006015 2006
% 223.67/223.87  |- skos__annotation mesh__D050171 general; prefer specifics   
% 223.67/223.87  |- skos__historyNote mesh__D050171 Hyperlipidemia %28%1972-2005%29%
% 223.67/223.87  |- skos__scopeNote mesh__D050171
% 223.67/223.87       Abnormalities in the serum levels of LIPIDS. Dyslipidemias are disorders of lipid and LIPOPROTEIN metabolism, including overproduction or deficiency.  Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and normal to elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.%A%    
% 223.67/223.87  |- mesh__dateEstablished mesh__D050171 2006-01-01
% 223.67/223.87  |- skos__broader mesh__D050171smesh__D008659
% 223.67/223.87  |- mesh__historyNote mesh__D050171 2006; use HYPERLIPIDEMIA 1995-2005   
% 223.67/223.87  |- mesh__recordOriginator mesh__D050171 lkt
% 223.67/223.87  |- skos__prefLabel mesh__D050171 Dyslipidemias
% 223.67/223.87  |- rdf__type mesh__D050171sskos__Concept
% 223.67/223.87  |- mesh__publicMeSHNote mesh__D050171 2006; see HYPERLIPIDEMIA 1995-2005   
% 223.67/223.87  |- mesh__dateCreated mesh__D050171 2005-06-30
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D050171 2006
% 223.67/223.87  |- skos__altLabel mesh__D050171 Dyslipidemia
% 223.67/223.87  |- mesh__recordAuthorizer mesh__D050171 sjn
% 223.67/223.87  |- skos__historyNote mesh__D050171 Lipids %28%1968-2005%29%
% 223.67/223.87  |- mesh__recordMaintainer mesh__D050171 lkt
% 223.67/223.87  |- mesh__recordAuthorizer mesh__D011758 sjn
% 223.67/223.87  |- skos__broader mesh__D011758smesh__D001393
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D011758 2006
% 223.67/223.87  |- skos__prefLabel mesh__D011758 Pyrroles
% 223.67/223.87  |- mesh__dateCreated mesh__D011758 1999-01-01
% 223.67/223.87  |- skos__scopeNote mesh__D011758
% 223.67/223.87       Azoles of one NITROGEN and two double bonds that have aromatic chemical properties.%A%    
% 223.67/223.87  |- mesh__dateRevised mesh__D011758 2005-06-30
% 223.67/223.87  |- rdf__type mesh__D011758sskos__Concept
% 223.67/223.87  |- mesh__recordMaintainer mesh__D011758 ssb
% 223.67/223.87  |- mesh__recordOriginator mesh__D011758 NLM
% 223.67/223.87  |- mesh__dateCreated mesh__D044134 2003-07-09
% 223.67/223.87  |- mesh__recordOriginator mesh__D044134 ags
% 223.67/223.87  |- mesh__recordMaintainer mesh__D044134 SYSTEM
% 223.67/223.87  |- skos__historyNote mesh__D044134 Haemophilus %28%1977-2003%29%
% 223.67/223.87  |- mesh__recordAuthorizer mesh__D044134 sjn
% 223.67/223.87  |- mesh__publicMeSHNote mesh__D044134 2004   
% 223.67/223.87  |- skos__annotation mesh__D044134
% 223.67/223.87       infection: coord IM with HAEMOPHILUS INFECTIONS %28%IM%29%   
% 223.67/223.87  |- skos__altLabel mesh__D044134 Hemophilus paragallinarum
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D044134 2006
% 223.67/223.87  |- mesh__dateRevised mesh__D044134 2005-06-30
% 223.67/223.87  |- mesh__dateEstablished mesh__D044134 2004-01-01
% 223.67/223.87  |- skos__prefLabel mesh__D044134 Haemophilus paragallinarum
% 223.67/223.87  |- rdf__type mesh__D044134sskos__Concept
% 223.67/223.87  |- skos__broader mesh__D044134smesh__D006190
% 223.67/223.87  |- skos__scopeNote mesh__D044134
% 223.67/223.87       A species of gram-negative bacteria in the genus HAEMOPHILUS, causing respiratory tract disease in CHICKENS known as infectious coryza.%A%    
% 223.67/223.87  |- mesh__historyNote mesh__D044134 2004   
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002423 1999
% 223.67/223.87  |- skos__annotation mesh__D002423
% 223.67/223.87       note categories; do not use for cause of death in every clinical case; restrict to cause of death as an epidemiological consideration: %22%mortality by cause of death%22%, %22%certification of cause of death%22%; probably IM in such cases; coord NIM with specific disease /mortal %28%IM%29%; specify geog if pertinent%A%  
% 223.67/223.87  |- mesh__recordMaintainer mesh__D002423 PLS
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002423 2003
% 223.67/223.87  |- mesh__dateEstablished mesh__D002423 1988-01-01
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002423 1995
% 223.67/223.87  |- rdf__type mesh__D002423sskos__Concept
% 223.67/223.87  |- mesh__recordOriginator mesh__D002423 EC
% 223.67/223.87  |- skos__hiddenLabel mesh__D002423 Death Causes
% 223.67/223.87  |- mesh__publicMeSHNote mesh__D002423 88   
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002423 2004
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002423 2000
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002423 2005
% 223.67/223.87  |- skos__hiddenLabel mesh__D002423 Death Cause
% 223.67/223.87  |- skos__broader mesh__D002423smesh__D009026
% 223.67/223.87  |- mesh__dateCreated mesh__D002423 1987-05-13
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002423 1996
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002423 2001
% 223.67/223.87  |- mesh__recordAuthorizer mesh__D002423 PLS
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002423 2006
% 223.67/223.87  |- skos__historyNote mesh__D002423 Mortality %28%1966-1987%29%
% 223.67/223.87  |- skos__altLabel mesh__D002423 Causes of Death
% 223.67/223.87  |- mesh__dateRevised mesh__D002423 1992-05-13
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002423 1997
% 223.67/223.87  |- skos__scopeNote mesh__D002423
% 223.67/223.87       Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint.%A%    
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002423 2002
% 223.67/223.87  |- mesh__historyNote mesh__D002423 88   
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002423 1998
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002423 1993
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D002423 1994
% 223.67/223.87  |- skos__prefLabel mesh__D002423 Cause of Death
% 223.67/223.87  |- skos__altLabel mesh__D040542 Cellular Mechanotransduction
% 223.67/223.87  |- skos__prefLabel mesh__D040542 Mechanotransduction, Cellular
% 223.67/223.87  |- skos__hiddenLabel mesh__D040542 Mechanical Signal Transduction
% 223.67/223.87  |- skos__historyNote mesh__D040542 Signal Transduction %28%1973-2002%29%
% 223.67/223.87  |- skos__altLabel mesh__D040542 Mechanosensory Transduction
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D040542 2003
% 223.67/223.87  |- skos__scopeNote mesh__D040542
% 223.67/223.87       The process by which cells convert mechanical stimuli into a chemical response. It can occur in both cells specialized for sensing mechanical cues such as MECHANORECEPTORS, and in parenchymal cells whose primary function is not mechanosensory.%A%    
% 223.67/223.87  |- mesh__historyNote mesh__D040542 2003   
% 223.67/223.87  |- skos__altLabel mesh__D040542 Signal Transduction, Mechanical
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D040542 2005
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D040542 2004
% 223.67/223.87  |- skos__hiddenLabel mesh__D040542 Transduction, Mechanosensory
% 223.67/223.87  |- mesh__publicMeSHNote mesh__D040542 2003   
% 223.67/223.87  |- rdf__type mesh__D040542sskos__Concept
% 223.67/223.87  |- mesh__dateEstablished mesh__D040542 2003-01-01
% 223.67/223.87  |- mesh__dateCreated mesh__D040542 2002-07-03
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D040542 2006
% 223.67/223.87  |- skos__broader mesh__D040542smesh__D015398
% 223.67/223.87  |- skos__related mesh__D040542smesh__D008465
% 223.67/223.87  |- mesh__historyNote mesh__D012851 2000%28%1964%29%   
% 223.67/223.87  |- skos__scopeNote mesh__D012851
% 223.67/223.87       Thrombus formation in an intracranial venous sinus, including the superior sagittal, cavernous, lateral, and petrous sinuses. Etiologies include thrombosis due to infection, DEHYDRATION, coagulation disorders %28%see THROMBOPHILIA%29%, and CRANIOCEREBRAL TRAUMA.%A%    
% 223.67/223.87  |- skos__hiddenLabel mesh__D012851 Thrombosis, Intracranial Sinus
% 223.67/223.87  |- mesh__activeMeSHYear mesh__D012851 2003
% 223.67/223.87  |- mesh__publicMeSHNote mesh__D012851
% 223.67/223.87       2000; see SINUS THROMBOSIS 1964-1999   
% 223.67/223.87  |- skos__hiddenLabel mesh__D012851 Sinus Thromboses, Intracranial
% 223.67/223.87  |- skos__hiddenLabel mesh__D012851 Thrombosis, Cranial Sinus
% 223.67/223.87  |- skos__hiddenLabel mesh__D012851 Sinus Thromboses
% 223.67/223.87  |- skos__hiddenLabel mesh__D012851 Thrombophlebitis, Petrous Sinus
% 223.67/223.87  |- skos__hiddenLabel mesh__D012851 Sinus Thrombophlebitis, Intracranial
% 223.67/223.87  |- mesh__recordOriginator mesh__D012851 NLM
% 223.67/223.88  |- skos__broader mesh__D012851smesh__D002542
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012851 2006
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012851 2001
% 223.67/223.88  |- mesh__recordAuthorizer mesh__D012851 sjn
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Thrombophlebitis, Intracranial Sinus
% 223.67/223.88  |- skos__prefLabel mesh__D012851 Sinus Thrombosis, Intracranial
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Petrous Sinus Thromboses
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Thromboses, Cranial Sinus
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Sinus Thromboses, Petrous
% 223.67/223.88  |- mesh__dateCreated mesh__D012851 1999-01-01
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Sinus Thromboses, Cranial
% 223.67/223.88  |- skos__annotation mesh__D012851 note specific indentions   
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Sinus Thrombophlebitides, Intracranial
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012851 2005
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Sinus Thrombosis, Cranial
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012851 2000
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Intracranial Sinus Thrombophlebitides
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Petrous Sinus Thrombophlebitides
% 223.67/223.88  |- mesh__recordMaintainer mesh__D012851 KEV
% 223.67/223.88  |- skos__altLabel mesh__D012851 Cranial Sinus Thrombosis
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Sinus Thrombophlebitides, Petrous
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Thromboses, Sinus
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Thrombosis, Petrous Sinus
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Thromboses, Intracranial Sinus
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Thrombosis, Sinus
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012851 2004
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Thromboses, Petrous Sinus
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Cranial Sinus Thromboses
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Sinus Thrombophlebitis, Petrous
% 223.67/223.88  |- mesh__dateRevised mesh__D012851 1999-11-03
% 223.67/223.88  |- rdf__type mesh__D012851sskos__Concept
% 223.67/223.88  |- skos__altLabel mesh__D012851 Sinus Thrombosis
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012851 2002
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Intracranial Sinus Thrombosis
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Thrombophlebitides, Intracranial Sinus
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Intracranial Sinus Thromboses
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Sinus Thrombosis, Petrous
% 223.67/223.88  |- skos__hiddenLabel mesh__D012851 Thrombophlebitides, Petrous Sinus
% 223.67/223.88  |- skos__broader mesh__D011968Q000819smesh__D011968
% 223.67/223.88  |- mesh__preferredCombination mesh__D011968Q000819smesh__D017442
% 223.67/223.88  |- rdf__type mesh__D011968Q000819smesh__CompoundConcept
% 223.67/223.88  |- mesh__dateCreated mesh__D012053 1999-01-01
% 223.67/223.88  |- mesh__recordMaintainer mesh__D012053 ags
% 223.67/223.88  |- mesh__historyNote mesh__D012053
% 223.67/223.88       68; CARIBOU was heading 1975-94 %28%see under REINDEER 1975-90%29%%A%  
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012053 2005
% 223.67/223.88  |- mesh__onlineNote mesh__D012053 use REINDEER to search CARIBOU 1975-94   
% 223.67/223.88  |- skos__broader mesh__D012053smesh__D003670
% 223.67/223.88  |- mesh__recordOriginator mesh__D012053 NLM
% 223.67/223.88  |- skos__scopeNote mesh__D012053
% 223.67/223.88       A genus of deer, Rangifer, that inhabits the northern parts of Europe, Asia, and America. Caribou is the North American name; reindeer, the European. They are often domesticated and used, especially in Lapland, for drawing sleds and as a source of food. Rangifer is the only genus of the deer family in which both sexes are antlered. Most caribou inhabit arctic tundra and surrounding arboreal coniferous forests and most have seasonal shifts in migration. They are hunted extensively for their meat, skin, antlers, and other parts. %28%From Webster, 3d ed; Walker%27%s Mammals of the World, 5th ed, p1397%29%%A%    
% 223.67/223.88  |- skos__annotation mesh__D012053 IM; qualif permitted   
% 223.67/223.88  |- skos__altLabel mesh__D012053 Caribou
% 223.67/223.88  |- mesh__recordAuthorizer mesh__D012053 sjn
% 223.67/223.88  |- skos__historyNote mesh__D012053 Artiodactyla %28%1966-1967%29%
% 223.67/223.88  |- skos__prefLabel mesh__D012053 Reindeer
% 223.67/223.88  |- mesh__dateRevised mesh__D012053 2003-07-09
% 223.67/223.88  |- rdf__type mesh__D012053sskos__Concept
% 223.67/223.88  |- mesh__dateEstablished mesh__D012053 1968-01-01
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012053 2004
% 223.67/223.88  |- mesh__publicMeSHNote mesh__D012053
% 223.67/223.88       68; CARIBOU was heading 1975-94 %28%see under REINDEER 1975-90%29%%A%  
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012053 2006
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006814 1993
% 223.67/223.88  |- rdf__type mesh__D006814sskos__Concept
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006814 1999
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006814 2002
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006814 2004
% 223.67/223.88  |- mesh__recordOriginator mesh__D006814 NLM
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006814 1998
% 223.67/223.88  |- skos__broader mesh__D006814smesh__D005061
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006814 2003
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006814 1995
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006814 2001
% 223.67/223.88  |- skos__prefLabel mesh__D006814 Hungary
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006814 1994
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006814 2006
% 223.67/223.88  |- mesh__dateCreated mesh__D006814 1999-01-01
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006814 1997
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006814 2000
% 223.67/223.88  |- mesh__dateRevised mesh__D006814 1992-05-20
% 223.67/223.88  |- mesh__recordAuthorizer mesh__D006814 PLS
% 223.67/223.88  |- mesh__recordMaintainer mesh__D006814 PLS
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006814 2005
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006814 1996
% 223.67/223.88  |- skos__annotation mesh__D006814
% 223.67/223.88       in translations of historical articles use spelling People%27%s Republic, not Peoples%27% nor Peoples%A%  
% 223.67/223.88  |- skos__broader mesh__D006016smesh__D006880
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006016 1993
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006016 2002
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006016 1996
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006016 2005
% 223.67/223.88  |- mesh__dateRevised mesh__D006016 1992-05-19
% 223.67/223.88  |- mesh__publicMeSHNote mesh__D006016
% 223.67/223.88       CENTROPHENOXINE was see under ACETIC ACIDS 1968-74   
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006016 1997
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006016 1994
% 223.67/223.88  |- mesh__recordAuthorizer mesh__D006016 PLS
% 223.67/223.88  |- mesh__recordOriginator mesh__D006016 NLM
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006016 2006
% 223.67/223.88  |- skos__prefLabel mesh__D006016 Glycolates
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006016 2000
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006016 1995
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006016 2003
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006016 2001
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006016 1998
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006016 2004
% 223.67/223.88  |- mesh__dateCreated mesh__D006016 1999-01-01
% 223.67/223.88  |- mesh__recordMaintainer mesh__D006016 TGC
% 223.67/223.88  |- skos__related mesh__D006016smesh__D011100
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006016 1999
% 223.67/223.88  |- rdf__type mesh__D006016sskos__Concept
% 223.67/223.88  |- skos__hiddenLabel mesh__D050172 Traits, X Linked
% 223.67/223.88  |- rdf__type mesh__D050172sskos__Concept
% 223.67/223.88  |- skos__broader mesh__D050172smesh__D040582
% 223.67/223.88  |- skos__altLabel mesh__D050172 Genes, X-Chromosome
% 223.67/223.88  |- mesh__recordMaintainer mesh__D050172 nns
% 223.67/223.88  |- skos__hiddenLabel mesh__D050172 Gene, X-Chromosome
% 223.67/223.88  |- skos__related mesh__D050172smesh__D040181
% 223.67/223.88  |- skos__hiddenLabel mesh__D050172 X-Linked Alleles
% 223.67/223.88  |- mesh__recordAuthorizer mesh__D050172 sjn
% 223.67/223.88  |- skos__hiddenLabel mesh__D050172 Gene, X-Linked
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D050172 2006
% 223.67/223.88  |- skos__hiddenLabel mesh__D050172 X-Chromosome Gene
% 223.67/223.88  |- mesh__publicMeSHNote mesh__D050172 2006   
% 223.67/223.88  |- skos__hiddenLabel mesh__D050172 X Linked Inheritance
% 223.67/223.88  |- skos__hiddenLabel mesh__D050172 Genes, X Chromosome
% 223.67/223.88  |- mesh__dateEstablished mesh__D050172 2006-01-01
% 223.67/223.88  |- skos__altLabel mesh__D050172 X-Linked Inheritance
% 223.67/223.88  |- skos__altLabel mesh__D050172 X-Linked Genes
% 223.67/223.88  |- skos__hiddenLabel mesh__D050172 X-Linked Trait
% 223.67/223.88  |- skos__altLabel mesh__D050172 Traits, X-Linked
% 223.67/223.88  |- skos__hiddenLabel mesh__D050172 Allele, X-Linked
% 223.67/223.88  |- skos__altLabel mesh__D050172 X-Chromosome Genes
% 223.67/223.88  |- mesh__recordOriginator mesh__D050172 nns
% 223.67/223.88  |- mesh__historyNote mesh__D050172 2006   
% 223.67/223.88  |- skos__hiddenLabel mesh__D050172 X-Linked Gene
% 223.67/223.88  |- skos__hiddenLabel mesh__D050172 Trait, X-Linked
% 223.67/223.88  |- skos__prefLabel mesh__D050172 Genes, X-Linked
% 223.67/223.88  |- skos__hiddenLabel mesh__D050172 Genes, X Linked
% 223.67/223.88  |- skos__hiddenLabel mesh__D050172 X Chromosome Genes
% 223.67/223.88  |- skos__hiddenLabel mesh__D050172 X Linked Traits
% 223.67/223.88  |- skos__hiddenLabel mesh__D050172 X Linked Genes
% 223.67/223.88  |- skos__hiddenLabel mesh__D050172 Alleles, X Linked
% 223.67/223.88  |- mesh__dateCreated mesh__D050172 2005-06-30
% 223.67/223.88  |- skos__hiddenLabel mesh__D050172 Inheritance, X Linked
% 223.67/223.88  |- skos__scopeNote mesh__D050172
% 223.67/223.88       Genes that are located on the X CHROMOSOME.     
% 223.67/223.88  |- skos__hiddenLabel mesh__D050172 X-Linked Allele
% 223.67/223.88  |- mesh__recordMaintainer mesh__D011759 TAP
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D011759 1996
% 223.67/223.88  |- skos__annotation mesh__D011759
% 223.67/223.88       do not confuse with PYRROLIDONES or PYRROLIDINONES   
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D011759 1993
% 223.67/223.88  |- mesh__recordAuthorizer mesh__D011759 PLS
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D011759 2004
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D011759 2001
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D011759 1999
% 223.67/223.88  |- skos__prefLabel mesh__D011759 Pyrrolidines
% 223.67/223.88  |- mesh__historyNote mesh__D011759 66   
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D011759 1997
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D011759 2002
% 223.67/223.88  |- mesh__recordOriginator mesh__D011759 NLM
% 223.67/223.88  |- mesh__dateCreated mesh__D011759 1999-01-01
% 223.67/223.88  |- rdf__type mesh__D011759sskos__Concept
% 223.67/223.88  |- mesh__dateEstablished mesh__D011759 1966-01-01
% 223.67/223.88  |- skos__broader mesh__D011759smesh__D006573
% 223.67/223.88  |- mesh__publicMeSHNote mesh__D011759 66   
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D011759 1994
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D011759 2000
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D011759 2005
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D011759 2003
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D011759 1998
% 223.67/223.88  |- mesh__dateRevised mesh__D011759 1992-05-20
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D011759 1995
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D011759 2006
% 223.67/223.88  |- mesh__dateCreated mesh__D044135 2003-07-09
% 223.67/223.88  |- mesh__dateRevised mesh__D044135 2005-06-30
% 223.67/223.88  |- skos__altLabel mesh__D044135 Hemophilius parainfluenzae
% 223.67/223.88  |- rdf__type mesh__D044135sskos__Concept
% 223.67/223.88  |- mesh__recordMaintainer mesh__D044135 SYSTEM
% 223.67/223.88  |- skos__scopeNote mesh__D044135
% 223.67/223.88       A species of gram-negative bacteria in the genus HAEMOPHILUS, ubiquitous in the human ORAL CAVITY and PHARYNX. It has low pathogenicity but is occasionally implicated in ENDOCARDITIS in humans.%A%    
% 223.67/223.88  |- mesh__publicMeSHNote mesh__D044135 2004   
% 223.67/223.88  |- skos__prefLabel mesh__D044135 Haemophilus parainfluenzae
% 223.67/223.88  |- skos__broader mesh__D044135smesh__D006190
% 223.67/223.88  |- mesh__historyNote mesh__D044135 2004   
% 223.67/223.88  |- mesh__recordOriginator mesh__D044135 ags
% 223.67/223.88  |- mesh__recordAuthorizer mesh__D044135 sjn
% 223.67/223.88  |- mesh__dateEstablished mesh__D044135 2004-01-01
% 223.67/223.88  |- skos__historyNote mesh__D044135 Haemophilus %28%1966-2003%29%
% 223.67/223.88  |- skos__annotation mesh__D044135
% 223.67/223.88       infection: coord IM with HAEMOPHILUS INFECTIONS %28%IM%29%   
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D044135 2006
% 223.67/223.88  |- rdf__type mesh__D002424sskos__Concept
% 223.67/223.88  |- mesh__dateCreated mesh__D002424 1999-01-01
% 223.67/223.88  |- mesh__recordAuthorizer mesh__D002424 sjn
% 223.67/223.88  |- mesh__dateRevised mesh__D002424 2005-06-30
% 223.67/223.88  |- skos__broader mesh__D002424smesh__D009676
% 223.67/223.88  |- mesh__recordOriginator mesh__D002424 NLM
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D002424 2006
% 223.67/223.88  |- mesh__recordMaintainer mesh__D002424 ags
% 223.67/223.88  |- skos__annotation mesh__D002424
% 223.67/223.88       caustic injury: index CAUSTICS /tox + BURNS, CHEMICAL + organ /inj; see also note on ESOPHAGEAL STENOSIS%A%  
% 223.67/223.88  |- skos__scopeNote mesh__D002424
% 223.67/223.88       Strong alkaline chemicals that destroy soft body tissues resulting in a deep, penetrating type of burn, in contrast to corrosives, that result in a more superficial type of damage via chemical means or inflammation. Caustics are usually hydroxides of light metals. SODIUM HYDROXIDE and potassium hydroxide are the most widely used caustic agents in industry. Medically, they have been used externally to remove diseased or dead tissues and destroy warts and small tumors. The accidental ingestion of products %28%household and industrial%29% containing caustic ingredients results in thousands of injuries per year.%A%    
% 223.67/223.88  |- skos__broader mesh__D002424smesh__D020313
% 223.67/223.88  |- skos__prefLabel mesh__D002424 Caustics
% 223.67/223.88  |- mesh__recordAuthorizer mesh__D012852 PLS
% 223.67/223.88  |- skos__hiddenLabel mesh__D012852 Sinusitides
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012852 2005
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012852 1997
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012852 2000
% 223.67/223.88  |- skos__broader mesh__D012852smesh__D012141
% 223.67/223.88  |- skos__broader mesh__D012852smesh__D010254
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012852 2006
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012852 2001
% 223.67/223.88  |- mesh__recordOriginator mesh__D012852 NLM
% 223.67/223.88  |- skos__annotation mesh__D012852
% 223.67/223.88       IM; sinusitis of specific sinus is also available %28%e.g., ETHMOID SINUSITIS%29%%A%  
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012852 2003
% 223.67/223.88  |- rdf__type mesh__D012852sskos__Concept
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012852 1998
% 223.67/223.88  |- skos__scopeNote mesh__D012852
% 223.67/223.88       An inflammatory process of the mucous membranes of the paranasal sinuses that occurs in three stages: acute, subacute, and chronic. Sinusitis results from any condition causing ostial obstruction or from pathophysiologic changes in the mucociliary transport mechanism.%A%    
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012852 2004
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012852 1995
% 223.67/223.88  |- mesh__dateCreated mesh__D012852 1999-01-01
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012852 1999
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012852 2002
% 223.67/223.88  |- mesh__recordMaintainer mesh__D012852 PXP
% 223.67/223.88  |- mesh__dateRevised mesh__D012852 1994-05-23
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012852 1996
% 223.67/223.88  |- skos__prefLabel mesh__D012852 Sinusitis
% 223.67/223.88  |- skos__hiddenLabel mesh__D012054 Reinforcements, Negative
% 223.67/223.88  |- mesh__recordMaintainer mesh__D012054 KEV
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012054 1997
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012054 1999
% 223.67/223.88  |- skos__scopeNote mesh__D012054
% 223.67/223.88       The strengthening of a conditioned response.     
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012054 1996
% 223.67/223.88  |- skos__prefLabel mesh__D012054 Reinforcement %28%Psychology%29%
% 223.67/223.88  |- skos__hiddenLabel mesh__D012054 Reinforcement, Negative
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012054 1998
% 223.67/223.88  |- mesh__recordAuthorizer mesh__D012054 PLS
% 223.67/223.88  |- mesh__recordOriginator mesh__D012054 NLM
% 223.67/223.88  |- skos__annotation mesh__D012054
% 223.67/223.88       human %26% animal; no qualif; DF: REINFORCEMENT   
% 223.67/223.88  |- mesh__historyNote mesh__D012054
% 223.67/223.88       65; was REINFORCEMENT LEARNING 1963-64   
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012054 2002
% 223.67/223.88  |- rdf__type mesh__D012054sskos__Concept
% 223.67/223.88  |- skos__broader mesh__D012054smesh__D007858
% 223.67/223.88  |- skos__hiddenLabel mesh__D012054 Reinforcement, Positive
% 223.67/223.88  |- skos__altLabel mesh__D012054 Reinforcement
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012054 2004
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012054 2001
% 223.67/223.88  |- skos__hiddenLabel mesh__D012054 Reinforcements %28%Psychology%29%
% 223.67/223.88  |- skos__hiddenLabel mesh__D012054 Positive Reinforcements
% 223.67/223.88  |- skos__hiddenLabel mesh__D012054 Negative Reinforcements
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012054 2006
% 223.67/223.88  |- mesh__publicMeSHNote mesh__D012054
% 223.67/223.88       65; was REINFORCEMENT LEARNING 1963-64   
% 223.67/223.88  |- skos__hiddenLabel mesh__D012054 Reinforcements
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012054 2003
% 223.67/223.88  |- skos__hiddenLabel mesh__D012054 Reinforcements, Positive
% 223.67/223.88  |- mesh__dateCreated mesh__D012054 1999-01-01
% 223.67/223.88  |- mesh__dateRevised mesh__D012054 1995-05-23
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012054 2005
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D012054 2000
% 223.67/223.88  |- skos__prefLabel mesh__D006815 Hunger
% 223.67/223.88  |- skos__broader mesh__D006815smesh__D004328
% 223.67/223.88  |- rdf__type mesh__D006815sskos__Concept
% 223.67/223.88  |- mesh__dateRevised mesh__D006815 2003-07-09
% 223.67/223.88  |- mesh__recordMaintainer mesh__D006815 lkt
% 223.67/223.88  |- mesh__recordAuthorizer mesh__D006815 sjn
% 223.67/223.88  |- skos__scopeNote mesh__D006815
% 223.67/223.88       The desire for FOOD generated by a sensation arising from the lack of food in the STOMACH.%A%    
% 223.67/223.88  |- skos__broader mesh__D006815smesh__D004068
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006815 2004
% 223.67/223.88  |- mesh__dateCreated mesh__D006815 1999-01-01
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006815 2005
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006815 2006
% 223.67/223.88  |- mesh__recordOriginator mesh__D006815 NLM
% 223.67/223.88  |- mesh__publicMeSHNote mesh__D006017 66; was see under LIPIDS 1963-65   
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006017 2005
% 223.67/223.88  |- mesh__dateEstablished mesh__D006017 1966-01-01
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D006017 2006
% 223.67/223.88  |- mesh__recordMaintainer mesh__D006017 ssb
% 223.67/223.88  |- skos__prefLabel mesh__D006017 Glycolipids
% 223.67/223.88  |- mesh__recordAuthorizer mesh__D006017 sjn
% 223.67/223.88  |- mesh__dateCreated mesh__D006017 1999-01-01
% 223.67/223.88  |- mesh__recordOriginator mesh__D006017 NLM
% 223.67/223.88  |- mesh__dateRevised mesh__D006017 2004-07-07
% 223.67/223.88  |- rdf__type mesh__D006017sskos__Concept
% 223.67/223.88  |- skos__scopeNote mesh__D006017
% 223.67/223.88       Any compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic moiety such as an acylglycerol %28%see GLYCERIDES%29%, a sphingoid, a ceramide %28%CERAMIDES%29% %28%N-acylsphingoid%29% or a prenyl phosphate. %28%From IUPAC%27%s webpage%29%%A%    
% 223.67/223.88  |- mesh__historyNote mesh__D006017
% 223.67/223.88       66%28%63%29%; was see under LIPIDS 1963-65   
% 223.67/223.88  |- skos__broader mesh__D006017smesh__D008055
% 223.67/223.88  |- skos__broader mesh__D006017smesh__D006001
% 223.67/223.88  |- skos__altLabel mesh__D050173 Y-Linked Genes
% 223.67/223.88  |- skos__altLabel mesh__D050173 Inheritance, Holandric
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D050173 2006
% 223.67/223.88  |- skos__hiddenLabel mesh__D050173 Y Linked Traits
% 223.67/223.88  |- mesh__publicMeSHNote mesh__D050173 2006   
% 223.67/223.88  |- mesh__dateCreated mesh__D050173 2005-06-30
% 223.67/223.88  |- skos__hiddenLabel mesh__D050173 Y-Linked Trait
% 223.67/223.88  |- skos__hiddenLabel mesh__D050173 Traits, Y Linked
% 223.67/223.88  |- skos__hiddenLabel mesh__D050173 Y-Linked Inheritances
% 223.67/223.88  |- skos__hiddenLabel mesh__D050173 Gene, Y-Chromosome
% 223.67/223.88  |- skos__hiddenLabel mesh__D050173 Y-Linked Gene
% 223.67/223.88  |- mesh__recordMaintainer mesh__D050173 nns
% 223.67/223.88  |- skos__hiddenLabel mesh__D050173 Genes, Y Chromosome
% 223.67/223.88  |- skos__hiddenLabel mesh__D050173 Y Linked Genes
% 223.67/223.88  |- skos__hiddenLabel mesh__D050173 Y Linked Inheritance
% 223.67/223.88  |- skos__hiddenLabel mesh__D050173 Y-Linked Alleles
% 223.67/223.88  |- skos__hiddenLabel mesh__D050173 Inheritances, Y-Linked
% 223.67/223.88  |- skos__hiddenLabel mesh__D050173 Gene, Y-Linked
% 223.67/223.88  |- skos__hiddenLabel mesh__D050173 Alleles, Y Linked
% 223.67/223.88  |- mesh__recordAuthorizer mesh__D050173 sjn
% 223.67/223.88  |- skos__altLabel mesh__D050173 Y-Linked Inheritance
% 223.67/223.88  |- mesh__recordOriginator mesh__D050173 nns
% 223.67/223.88  |- skos__hiddenLabel mesh__D050173 Inheritance, Y Linked
% 223.67/223.88  |- skos__hiddenLabel mesh__D050173 Y-Chromosome Genes
% 223.67/223.88  |- skos__hiddenLabel mesh__D050173 Trait, Y-Linked
% 223.67/223.88  |- skos__hiddenLabel mesh__D050173 Genes, Y Linked
% 223.67/223.88  |- skos__altLabel mesh__D050173 Holandric Inheritance
% 223.67/223.88  |- mesh__dateEstablished mesh__D050173 2006-01-01
% 223.67/223.88  |- skos__scopeNote mesh__D050173
% 223.67/223.88       Genes that are located on the Y CHROMOSOME.     
% 223.67/223.88  |- skos__altLabel mesh__D050173 Traits, Y-Linked
% 223.67/223.88  |- rdf__type mesh__D050173sskos__Concept
% 223.67/223.88  |- skos__broader mesh__D050173smesh__D040582
% 223.67/223.88  |- skos__prefLabel mesh__D050173 Genes, Y-Linked
% 223.67/223.88  |- skos__hiddenLabel mesh__D050173 Y-Chromosome Gene
% 223.67/223.88  |- mesh__historyNote mesh__D050173 2006   
% 223.67/223.88  |- skos__hiddenLabel mesh__D050173 Allele, Y-Linked
% 223.67/223.88  |- skos__altLabel mesh__D050173 Genes, Y-Chromosome
% 223.67/223.88  |- skos__hiddenLabel mesh__D050173 Y-Linked Allele
% 223.67/223.88  |- rdf__type mesh__D022482sskos__Concept
% 223.67/223.88  |- mesh__historyNote mesh__D022482 2001   
% 223.67/223.88  |- mesh__dateCreated mesh__D022482 2000-06-22
% 223.67/223.88  |- mesh__recordAuthorizer mesh__D022482 sjn
% 223.67/223.88  |- mesh__publicMeSHNote mesh__D022482 2001   
% 223.67/223.88  |- mesh__recordMaintainer mesh__D022482 ssb
% 223.67/223.88  |- mesh__recordOriginator mesh__D022482 ags
% 223.67/223.88  |- skos__broader mesh__D022482smesh__D014765
% 223.67/223.88  |- mesh__dateEstablished mesh__D022482 2001-01-01
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D022482 2006
% 223.67/223.88  |- skos__hiddenLabel mesh__D022482 Vaccines, Cytomegalovirus
% 223.67/223.88  |- skos__prefLabel mesh__D022482 Cytomegalovirus Vaccines
% 223.67/223.88  |- mesh__dateRevised mesh__D022482 2005-06-30
% 223.67/223.88  |- skos__scopeNote mesh__D022482
% 223.67/223.88       Vaccines or candidate vaccines used to prevent infection with CYTOMEGALOVIRUS.%A%    
% 223.67/223.88  |- skos__historyNote mesh__D022482 Viral Vaccines %28%1974-2000%29%
% 223.67/223.88  |- rdf__type mesh__D044136sskos__Concept
% 223.67/223.88  |- mesh__dateCreated mesh__D044136 2003-07-09
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D044136 2006
% 223.67/223.88  |- mesh__dateRevised mesh__D044136 2005-06-30
% 223.67/223.88  |- skos__altLabel mesh__D044136 Hemophilus paraphrophilus
% 223.67/223.88  |- mesh__recordMaintainer mesh__D044136 SYSTEM
% 223.67/223.88  |- mesh__publicMeSHNote mesh__D044136 2004   
% 223.67/223.88  |- mesh__historyNote mesh__D044136 2004   
% 223.67/223.88  |- skos__broader mesh__D044136smesh__D006190
% 223.67/223.88  |- mesh__recordOriginator mesh__D044136 ags
% 223.67/223.88  |- mesh__recordAuthorizer mesh__D044136 sjn
% 223.67/223.88  |- skos__prefLabel mesh__D044136 Haemophilus paraphrophilus
% 223.67/223.88  |- skos__historyNote mesh__D044136 Haemophilus %28%1968-2003%29%
% 223.67/223.88  |- mesh__dateEstablished mesh__D044136 2004-01-01
% 223.67/223.88  |- skos__annotation mesh__D044136
% 223.67/223.88       infection: coord IM with HAEMOPHILUS INFECTIONS %28%IM%29%   
% 223.67/223.88  |- skos__scopeNote mesh__D044136
% 223.67/223.88       A species of gram-negative bacteria in the genus HAEMOPHILUS, found in the normal flora of the human ORAL CAVITY and PHARYNX. It can cause SUBACUTE BACTERIAL ENDOCARDITIS; and BRAIN ABSCESS, among other conditions.%A%    
% 223.67/223.88  |- mesh__recordOriginator mesh__D002425 NLM
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D002425 2002
% 223.67/223.88  |- skos__hiddenLabel mesh__D002425 Cauteries
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D002425 2005
% 223.67/223.88  |- mesh__dateRevised mesh__D002425 1997-06-20
% 223.67/223.88  |- skos__prefLabel mesh__D002425 Cautery
% 223.67/223.88  |- mesh__recordAuthorizer mesh__D002425 SJN
% 223.67/223.88  |- skos__broader mesh__D002425smesh__D013812
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D002425 2006
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D002425 1998
% 223.67/223.88  |- skos__scopeNote mesh__D002425
% 223.67/223.88       The application of a caustic substance, a hot instrument, an electric current, or other agent to destroy tissue. %28%Dorland, 27th ed%29%%A%    
% 223.67/223.88  |- skos__annotation mesh__D002425
% 223.67/223.88       do not use /util except by MeSH definition; coord Cat A or C term with /surg%A%  
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D002425 1999
% 223.67/223.88  |- skos__related mesh__D002425smesh__D004564
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D002425 2000
% 223.67/223.88  |- rdf__type mesh__D002425sskos__Concept
% 223.67/223.88  |- mesh__activeMeSHYear mesh__D002425 2003
% 223.67/223.88  |- mesh__dateCreated mesh__D002425 1999-01-01
% 223.67/223.88  |- mesh__recordMaintainer mesh__D002425 TGC
% 223.67/223.89  |- mesh__activeMeSHYear mesh__D002425 2001
% 223.67/223.89  |- mesh__activeMeSHYear mesh__D002425 2004
% 223.67/223.89  |- mesh__activeMeSHYear mesh__D007110 2006
% 223.67/223.89  |- mesh__dateCreated mesh__D007110 1999-01-01
% 223.67/223.89  |- mesh__recordOriginator mesh__D007110 NLM
% 223.67/223.89  |- skos__hiddenLabel mesh__D007110 Active Immunities
% 223.67/223.89  |- mesh__dateRevised mesh__D007110 1992-05-14
% 223.67/223.89  |- mesh__historyNote mesh__D007110 67%28%65%29%   
% 223.67/223.89  |- mesh__activeMeSHYear mesh__D007110 2001
% 223.67/223.89  |- mesh__activeMeSHYear mesh__D007110 1996
% 223.67/223.89  |- mesh__dateEstablished mesh__D007110 1967-01-01
% 223.67/223.89  |- skos__annotation mesh__D007110
% 223.67/223.89       IM general only, NIM with specific disease /immunol %28%IM%29%: TN 242%A%  
% 223.67/223.89  |- mesh__publicMeSHNote mesh__D007110 67   
% 223.67/223.89  |- rdf__type mesh__D007110sskos__Concept
% 223.67/223.89  |- skos__hiddenLabel mesh__D007110 Active Immunity
% 223.67/223.89  |- mesh__activeMeSHYear mesh__D007110 2002
% 223.67/223.89  |- mesh__activeMeSHYear mesh__D007110 1997
% 223.67/223.89  |- mesh__activeMeSHYear mesh__D007110 2003
% 223.67/223.89  |- skos__broader mesh__D007110smesh__D007109
% 223.67/223.89  |- mesh__activeMeSHYear mesh__D007110 1993
% 223.67/223.89  |- skos__hiddenLabel mesh__D007110 Immunities, Active
% 223.67/223.89  |- skos__scopeNote mesh__D007110
% 223.67/223.89       Resistance to a disease agent resulting from the production of specific antibodies by the host, either after exposure to the disease or after vaccination.%A%    
% 223.67/223.89  |- mesh__activeMeSHYear mesh__D007110 2004
% 223.67/223.89  |- skos__prefLabel mesh__D007110 Immunity, Active
% 223.67/223.89  |- mesh__activeMeSHYear mesh__D007110 1998
% 223.67/223.89  |- mesh__recordMaintainer mesh__D007110 PLS
% 223.67/223.89  |- mesh__activeMeSHYear mesh__D007110 1994
% 223.67/223.89  |- mesh__activeMeSHYear mesh__D007110 1999
% 223.67/223.89  |- mesh__activeMeSHYear mesh__D007110 2005
% 223.67/223.89  |- mesh__activeMeSHYear mesh__D007110 2000
% 223.67/223.89  |- mesh__activeMeSHYear mesh__D007110 1995
% 223.67/223.89  |- mesh__recordAuthorizer mesh__D007110 PLS
% 223.67/223.89  |- skos__related mesh__D007110smesh__D007167
% 223.67/223.89  |- mesh__historyNote mesh__D012853
% 223.67/223.89       84%28%75%29%; was see under GENTAMICINS 1978-83, was see under ANTIBIOTICS 1975-77%A%  
% 223.67/223.89  |- skos__hiddenLabel mesh__D012853 Sch 13475
% 223.67/223.89  |- skos__altLabel mesh__D012853 Sisomycin
% 223.67/223.89  |- mesh__activeMeSHYear mesh__D012853 2006
% 223.67/223.89  |- skos__historyNote mesh__D012853 Glycosides %28%1966-1973%29%
% 223.67/223.89  |- mesh__recordAuthorizer mesh__D012853 sjn
% 223.67/223.89  |- skos__altLabel mesh__D012853 Rickamicin
% 223.67/223.89  |- skos__hiddenLabel mesh__D012853 6640, Antibiotic
% 223.67/223.89  |- mesh__dateCreated mesh__D012853 1974-11-19
% 223.67/223.89  |- skos__hiddenLabel mesh__D012853 Sch13475
% 223.67/223.89  |- mesh__publicMeSHNote mesh__D012853
% 223.67/223.89       84; was see under GENTAMICINS 1978-83, was see under ANTIBIOTICS 1975-77%A%  
% 223.67/223.89  |- skos__historyNote mesh__D012853 Antibiotics %28%1966-1974%29%
% 223.67/223.89  |- skos__broader mesh__D012853smesh__D005839
% 223.67/223.89  |- rdf__type mesh__D012853sskos__Concept
% 223.67/223.89  |- skos__historyNote mesh__D012853 Aminoglycosides %28%1974%29%
% 223.67/223.89  |- skos__altLabel mesh__D012853 Sizomycin
% 223.67/223.89  |- skos__prefLabel mesh__D012853 Sisomicin
% 223.67/223.89  |- mesh__recordOriginator mesh__D012853 NLM
% 223.67/223.89  |- mesh__dateEstablished mesh__D012853 1984-01-01
% 223.67/223.89  |- skos__scopeNote mesh__D012853
% 223.67/223.89       Antibiotic produced by Micromonospora inyoensis. It is closely related to gentamicin C1A, one of the components of the gentamicin complex %28%GENTAMICINS%29%.%A%    
% 223.67/223.89  |- skos__hiddenLabel mesh__D012853 4,5 Dehydrogentamicin
% 223.67/223.89  |- mesh__dateRevised mesh__D012853 2004-07-07
% 223.67/223.89  |- skos__altLabel mesh__D012853 4,5-Dehydrogentamicin
% 223.67/223.89  |- skos__altLabel mesh__D012853 Sissomicin
% 223.67/223.89  |- mesh__recordMaintainer mesh__D012853 ssb
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D012853 2005
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D012055 1992
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D012055 2001
% 223.67/223.90  |- mesh__recordMaintainer mesh__D012055 TGC
% 223.67/223.90  |- skos__hiddenLabel mesh__D012055 Schedule, Reinforcement
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D012055 1994
% 223.67/223.90  |- rdf__type mesh__D012055sskos__Concept
% 223.67/223.90  |- skos__scopeNote mesh__D012055
% 223.67/223.90       A schedule prescribing when the subject is to be reinforced or rewarded in terms of temporal interval in psychological experiments. The schedule may be continuous or intermittent.%A%    
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D012055 2004
% 223.67/223.90  |- mesh__dateEstablished mesh__D012055 1969-01-01
% 223.67/223.90  |- skos__annotation mesh__D012055 human %26% animal; no qualif   
% 223.67/223.90  |- skos__prefLabel mesh__D012055 Reinforcement Schedule
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D012055 2000
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D012055 2006
% 223.67/223.90  |- skos__hiddenLabel mesh__D012055 Reinforcement Schedules
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D012055 2003
% 223.67/223.90  |- skos__hiddenLabel mesh__D012055 Schedules, Reinforcement
% 223.67/223.90  |- mesh__publicMeSHNote mesh__D012055 69   
% 223.67/223.90  |- mesh__dateCreated mesh__D012055 1999-01-01
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D012055 1991
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D012055 2005
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D012055 1990
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D012055 1997
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D012055 1999
% 223.67/223.90  |- mesh__recordAuthorizer mesh__D012055 PLS
% 223.67/223.90  |- mesh__historyNote mesh__D012055 69%28%66%29%   
% 223.67/223.90  |- mesh__dateRevised mesh__D012055 1989-05-16
% 223.67/223.90  |- mesh__recordOriginator mesh__D012055 NLM
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D012055 1993
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D012055 1996
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D012055 2002
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D012055 1995
% 223.67/223.90  |- skos__broader mesh__D012055smesh__D012054
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D012055 1998
% 223.67/223.90  |- skos__hiddenLabel mesh__D006816 Chorea, Huntington
% 223.67/223.90  |- skos__altLabel mesh__D006816 Huntington%27%s Chorea
% 223.67/223.90  |- skos__broader mesh__D006816smesh__D003072
% 223.67/223.90  |- mesh__publicMeSHNote mesh__D006816
% 223.67/223.90       2000; see HUNTINGTON%27%S DISEASE 1993-1999; for HUNTINGTON DISEASE see HUNTINGTON%27%S DISEASE 1993-1999, see HUNTINGTON CHOREA 1977-1992, see CHOREA, HEREDITARY 1963-1976%A%  
% 223.67/223.90  |- skos__hiddenLabel mesh__D006816
% 223.67/223.90       Akinetic Rigid Variant of Huntington Disease
% 223.67/223.90  |- skos__altLabel mesh__D006816
% 223.67/223.90       Huntington Chronic Progressive Hereditary Chorea
% 223.67/223.90  |- mesh__dateCreated mesh__D006816 1999-01-01
% 223.67/223.90  |- skos__prefLabel mesh__D006816 Huntington Disease
% 223.67/223.90  |- skos__altLabel mesh__D006816
% 223.67/223.90       Progressive Chorea, Hereditary, Chronic %28%Huntington%29%
% 223.67/223.90  |- skos__broader mesh__D006816smesh__D020822
% 223.67/223.90  |- skos__altLabel mesh__D006816 Huntington Disease, Juvenile-Onset
% 223.67/223.90  |- skos__hiddenLabel mesh__D006816
% 223.67/223.90       Huntington Disease, Akinetic Rigid Variant
% 223.67/223.90  |- skos__hiddenLabel mesh__D006816 Late Onset Huntington Disease
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D006816 2005
% 223.67/223.90  |- skos__broader mesh__D006816smesh__D020271
% 223.67/223.90  |- skos__broader mesh__D006816smesh__D003704
% 223.67/223.90  |- mesh__recordMaintainer mesh__D006816 nns
% 223.67/223.90  |- mesh__recordAuthorizer mesh__D006816 sjn
% 223.67/223.90  |- skos__hiddenLabel mesh__D006816 Juvenile Onset Huntington Disease
% 223.67/223.90  |- skos__hiddenLabel mesh__D006816 Huntington Disease, Late-Onset
% 223.67/223.90  |- mesh__historyNote mesh__D006816 2000%28%1963%29%   
% 223.67/223.90  |- skos__scopeNote mesh__D006816
% 223.67/223.90       A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. %28%From Adams et al., Principles of Neurology, 6th ed, pp1060-4%29%%A%    
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D006816 2006
% 223.67/223.90  |- mesh__dateRevised mesh__D006816 2004-07-07
% 223.67/223.90  |- skos__broader mesh__D006816smesh__D001480
% 223.67/223.90  |- skos__altLabel mesh__D006816 Late-Onset Huntington Disease
% 223.67/223.90  |- skos__hiddenLabel mesh__D006816 Chorea, Huntington%27%s
% 223.67/223.90  |- skos__altLabel mesh__D006816 Huntington Disease, Juvenile
% 223.67/223.90  |- rdf__type mesh__D006816sskos__Concept
% 223.67/223.90  |- skos__hiddenLabel mesh__D006816 Huntington Disease, Juvenile Onset
% 223.67/223.90  |- skos__altLabel mesh__D006816
% 223.67/223.90       Chronic Progressive Hereditary Chorea %28%Huntington%29%
% 223.67/223.90  |- skos__altLabel mesh__D006816 Juvenile-Onset Huntington Disease
% 223.67/223.90  |- skos__altLabel mesh__D006816
% 223.67/223.90       Chorea, Chronic Progressive Hereditary %28%Huntington%29%
% 223.67/223.90  |- mesh__recordOriginator mesh__D006816 NLM
% 223.67/223.90  |- skos__altLabel mesh__D006816 Huntington Disease, Akinetic-Rigid Variant
% 223.67/223.90  |- skos__altLabel mesh__D006816 Huntington%27%s Disease
% 223.67/223.90  |- skos__altLabel mesh__D006816
% 223.67/223.90       Progressive Chorea, Chronic Hereditary %28%Huntington%29%
% 223.67/223.90  |- skos__altLabel mesh__D006816 Huntington Chorea
% 223.67/223.90  |- mesh__recordOriginator mesh__D006018 NLM
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D006018 2002
% 223.67/223.90  |- skos__prefLabel mesh__D006018 Glycols
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D006018 1998
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D006018 2006
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D006018 2001
% 223.67/223.90  |- skos__scopeNote mesh__D006018
% 223.67/223.90       A generic grouping for dihydric alcohols with the hydroxy groups %28%-OH%29% located on different carbon atoms. They are viscous liquids with high boiling points for their molecular weights.%A%    
% 223.67/223.90  |- mesh__dateRevised mesh__D006018 1997-06-20
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D006018 2004
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D006018 2005
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D006018 2000
% 223.67/223.90  |- mesh__recordMaintainer mesh__D006018 ADP
% 223.67/223.90  |- skos__broader mesh__D006018smesh__D000438
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D006018 2003
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D006018 1999
% 223.67/223.90  |- mesh__recordAuthorizer mesh__D006018 SJN
% 223.67/223.90  |- rdf__type mesh__D006018sskos__Concept
% 223.67/223.90  |- mesh__dateCreated mesh__D006018 1999-01-01
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D050174 2006
% 223.67/223.90  |- mesh__recordOriginator mesh__D050174 nns
% 223.67/223.90  |- mesh__publicMeSHNote mesh__D050174 2006   
% 223.67/223.90  |- skos__historyNote mesh__D050174 Y Chromosome %28%1984-2005%29%
% 223.67/223.90  |- skos__hiddenLabel mesh__D050174 Y Linked Genetic Diseases
% 223.67/223.90  |- mesh__dateEstablished mesh__D050174 2006-01-01
% 223.67/223.90  |- mesh__historyNote mesh__D050174 2006   
% 223.67/223.90  |- skos__altLabel mesh__D050174 Genetic Diseases, Y-Chromosome Linked
% 223.67/223.90  |- skos__prefLabel mesh__D050174 Genetic Diseases, Y-Linked
% 223.67/223.90  |- skos__broader mesh__D050174smesh__D030342
% 223.67/223.90  |- skos__hiddenLabel mesh__D050174 Genetic Disease, Y-Linked
% 223.67/223.90  |- skos__altLabel mesh__D050174 Y-Linked Genetic Diseases
% 223.67/223.90  |- mesh__recordMaintainer mesh__D050174 nns
% 223.67/223.90  |- skos__hiddenLabel mesh__D050174 Y-Linked Genetic Disease
% 223.67/223.90  |- skos__hiddenLabel mesh__D050174 Diseases, Y-Linked Genetic
% 223.67/223.90  |- skos__hiddenLabel mesh__D050174 Genetic Diseases, Y Linked
% 223.67/223.90  |- mesh__dateCreated mesh__D050174 2005-06-30
% 223.67/223.90  |- skos__related mesh__D050174smesh__D050173
% 223.67/223.90  |- skos__scopeNote mesh__D050174
% 223.67/223.90       Genetic diseases that are linked to mutant ALLELES on the Y CHROMOSOME in humans %28%Y CHROMOSOME, HUMAN%29% or the Y chromosome in other species. Included here are animal models of human Y-linked diseases.%A%    
% 223.67/223.90  |- rdf__type mesh__D050174sskos__Concept
% 223.67/223.90  |- mesh__recordAuthorizer mesh__D050174 sjn
% 223.67/223.90  |- skos__hiddenLabel mesh__D050174 Genetic Diseases, Y Chromosome Linked
% 223.67/223.90  |- skos__hiddenLabel mesh__D050174 Disease, Y-Linked Genetic
% 223.67/223.90  |- mesh__dateEstablished mesh__D044137 2004-01-01
% 223.67/223.90  |- skos__annotation mesh__D044137
% 223.67/223.90       infection: coord IM with HAEMOPHILUS INFECTIONS %28%IM%29%   
% 223.67/223.90  |- mesh__recordMaintainer mesh__D044137 SYSTEM
% 223.67/223.90  |- mesh__publicMeSHNote mesh__D044137 2004   
% 223.67/223.90  |- skos__prefLabel mesh__D044137 Haemophilus parasuis
% 223.67/223.90  |- skos__broader mesh__D044137smesh__D006190
% 223.67/223.90  |- mesh__dateRevised mesh__D044137 2005-06-30
% 223.67/223.90  |- skos__scopeNote mesh__D044137
% 223.67/223.90       A species of gram-negative bacteria in the genus HAEMOPHILUS found, in the normal upper respiratory tract of SWINE.%A%    
% 223.67/223.90  |- skos__historyNote mesh__D044137 Haemophilus %28%1974-2003%29%
% 223.67/223.90  |- mesh__historyNote mesh__D044137 2004   
% 223.67/223.90  |- mesh__recordAuthorizer mesh__D044137 sjn
% 223.67/223.90  |- skos__altLabel mesh__D044137 Hemophilus parasuis
% 223.67/223.90  |- mesh__recordOriginator mesh__D044137 ags
% 223.67/223.90  |- rdf__type mesh__D044137sskos__Concept
% 223.67/223.90  |- mesh__dateCreated mesh__D044137 2003-07-09
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D044137 2006
% 223.67/223.90  |- mesh__dateEstablished mesh__D016446 1996-01-01
% 223.67/223.90  |- skos__prefLabel mesh__D016446
% 223.67/223.90       Consensus Development Conference %5B%Publication Type%5D%
% 223.67/223.90  |- skos__broader mesh__D016446smesh__D016454
% 223.67/223.90  |- mesh__recordAuthorizer mesh__D016446 sjn
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D016446 2006
% 223.67/223.90  |- skos__broader mesh__D016446smesh__D052182
% 223.67/223.90  |- mesh__recordMaintainer mesh__D016446 jls
% 223.67/223.90  |- rdf__type mesh__D016446sskos__Concept
% 223.67/223.90  |- skos__altLabel mesh__D016446 Consensus Development Conference
% 223.67/223.90  |- mesh__dateRevised mesh__D016446 2005-06-30
% 223.67/223.90  |- skos__scopeNote mesh__D016446
% 223.67/223.90       A work that consists of summary statements representing the majority and current agreement of physicians, scientists, and other professionals meeting to reach a consensus on a selected subject.%A%    
% 223.67/223.90  |- skos__annotation mesh__D016446
% 223.67/223.90       publication type only; consensus conferences as a subject or means of scientific communication are indexed under the main heading CONSENSUS DEVELOPMENT CONFERENCES; Manual 35.8.2; considered as a type of review; CONSENSUS DEVELOPMENT CONFERENCE, NIH %5B%Publication Type%5D% is also available%A%  
% 223.67/223.90  |- mesh__dateCreated mesh__D016446 1995-06-27
% 223.67/223.90  |- mesh__historyNote mesh__D016446 1991   
% 223.67/223.90  |- skos__altLabel mesh__D016446 Consensus Development Conference %28%PT%29%
% 223.67/223.90  |- mesh__recordOriginator mesh__D016446 TGC
% 223.67/223.90  |- mesh__recordAuthorizer mesh__D002426 PLS
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D002426 2001
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D002426 2006
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D002426 1998
% 223.67/223.90  |- mesh__recordOriginator mesh__D002426 NLM
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D002426 2002
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D002426 1993
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D002426 1999
% 223.67/223.90  |- skos__annotation mesh__D002426
% 223.67/223.90       a cranial sinus; thrombosis: coord IM with SINUS THROMBOSIS %28%IM%29%%A%  
% 223.67/223.90  |- rdf__type mesh__D002426sskos__Concept
% 223.67/223.90  |- skos__broader mesh__D002426smesh__D003392
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D002426 2003
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D002426 1994
% 223.67/223.90  |- mesh__dateCreated mesh__D002426 1999-01-01
% 223.67/223.90  |- skos__prefLabel mesh__D002426 Cavernous Sinus
% 223.67/223.90  |- mesh__dateRevised mesh__D002426 1992-05-07
% 223.67/223.90  |- mesh__recordMaintainer mesh__D002426 TGC
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D002426 2004
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D002426 1995
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D002426 1996
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D002426 2000
% 223.67/223.90  |- skos__scopeNote mesh__D002426
% 223.67/223.90       An irregularly shaped venous space in the dura mater at either side of the sphenoid bone.%A%    
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D002426 2005
% 223.67/223.90  |- skos__hiddenLabel mesh__D002426 Sinus, Cavernous
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D002426 1997
% 223.67/223.90  |- skos__related mesh__D007111smesh__D006968
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D007111 1999
% 223.67/223.90  |- skos__historyNote mesh__D007111 Immunity %28%1966-1969%29%
% 223.67/223.90  |- skos__hiddenLabel mesh__D007111 Cellular Immunities
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D007111 2002
% 223.67/223.90  |- skos__altLabel mesh__D007111 Cell-Mediated Immunity
% 223.67/223.90  |- skos__hiddenLabel mesh__D007111 Cellular Immunity
% 223.67/223.90  |- skos__hiddenLabel mesh__D007111 Immunities, Cell-Mediated
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D007111 1998
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D007111 2006
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D007111 2001
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D007111 1997
% 223.67/223.90  |- mesh__dateEstablished mesh__D007111 1972-01-01
% 223.67/223.90  |- mesh__recordOriginator mesh__D007111 NLM
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D007111 2005
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D007111 2000
% 223.67/223.90  |- skos__prefLabel mesh__D007111 Immunity, Cellular
% 223.67/223.90  |- rdf__type mesh__D007111sskos__Concept
% 223.67/223.90  |- mesh__recordMaintainer mesh__D007111 PLS
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D007111 1996
% 223.67/223.90  |- mesh__activeMeSHYear mesh__D007111 2004
% 223.75/223.90  |- skos__hiddenLabel mesh__D007111 Cell Mediated Immunity
% 223.75/223.90  |- mesh__publicMeSHNote mesh__D007111 72   
% 223.75/223.90  |- skos__broader mesh__D007111smesh__D007109
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D007111 1995
% 223.75/223.90  |- skos__hiddenLabel mesh__D007111 Immunity, Cell-Mediated
% 223.75/223.90  |- skos__hiddenLabel mesh__D007111 Immunities, Cellular
% 223.75/223.90  |- skos__hiddenLabel mesh__D007111 Cell-Mediated Immunities
% 223.75/223.90  |- mesh__dateRevised mesh__D007111 1992-05-14
% 223.75/223.90  |- skos__scopeNote mesh__D007111
% 223.75/223.90       Those manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role.%A%    
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D007111 2003
% 223.75/223.90  |- skos__annotation mesh__D007111
% 223.75/223.90       IM general only, NIM with specific disease /immunol %28%IM%29%: TN 242%A%  
% 223.75/223.90  |- mesh__dateCreated mesh__D007111 1999-01-01
% 223.75/223.90  |- mesh__historyNote mesh__D007111 72%28%70%29%   
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D007111 1994
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D007111 1993
% 223.75/223.90  |- mesh__recordAuthorizer mesh__D007111 PLS
% 223.75/223.90  |- mesh__recordMaintainer mesh__D048528 ags
% 223.75/223.90  |- mesh__recordAuthorizer mesh__D048528 sjn
% 223.75/223.90  |- skos__historyNote mesh__D048528 Papio %28%1972-2004%29%
% 223.75/223.90  |- mesh__dateRevised mesh__D048528 2005-06-30
% 223.75/223.90  |- mesh__dateEstablished mesh__D048528 2005-01-01
% 223.75/223.90  |- skos__scopeNote mesh__D048528
% 223.75/223.90       A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, comprising two species: the drill %28%M. leucophaeus%29% and the mandrill %28%M. sphinx%29%. They are usually found in thick rainforest and have a gentle disposition despite their ferocious reputation. Some authors consider Mandrillus a subgenus of PAPIO.%A%    
% 223.75/223.90  |- skos__altLabel mesh__D048528 Mandrillus sphinx
% 223.75/223.90  |- mesh__publicMeSHNote mesh__D048528
% 223.75/223.90       2005; see PAPIO 1992-2004; for DRILL and MANDRILL use PAPIO 1981-2004%A%  
% 223.75/223.90  |- rdf__type mesh__D048528sskos__Concept
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D048528 2006
% 223.75/223.90  |- mesh__recordOriginator mesh__D048528 ags
% 223.75/223.90  |- skos__altLabel mesh__D048528 Mandrillus leucophaeus
% 223.75/223.90  |- skos__prefLabel mesh__D048528 Mandrillus
% 223.75/223.90  |- skos__hiddenLabel mesh__D048528 Mandrills
% 223.75/223.90  |- mesh__historyNote mesh__D048528
% 223.75/223.90       2005; use PAPIO 1992-2004; for DRILL and MANDRILL use PAPIO 1981-2004%A%  
% 223.75/223.90  |- skos__broader mesh__D048528smesh__D016663
% 223.75/223.90  |- mesh__dateCreated mesh__D048528 2004-07-07
% 223.75/223.90  |- skos__hiddenLabel mesh__D048528 Drills
% 223.75/223.90  |- skos__hiddenLabel mesh__D012854 Sister Chromatid Exchanges
% 223.75/223.90  |- skos__hiddenLabel mesh__D012854 Chromatid Exchange, Sister
% 223.75/223.90  |- skos__historyNote mesh__D012854 Genetics %28%1966%29%
% 223.75/223.90  |- skos__historyNote mesh__D012854 Chromosome Aberrations %28%1968-1979%29%
% 223.75/223.90  |- mesh__dateRevised mesh__D012854 2004-07-07
% 223.75/223.90  |- skos__historyNote mesh__D012854 Chromatids %28%1968-1979%29%
% 223.75/223.90  |- mesh__dateCreated mesh__D012854 1978-12-21
% 223.75/223.90  |- skos__broader mesh__D012854smesh__D011995
% 223.75/223.90  |- skos__scopeNote mesh__D012854
% 223.75/223.90       An exchange of segments between the sister chromatids of a chromosome, either between the sister chromatids of a meiotic tetrad or between the sister chromatids of a duplicated somatic chromosome. Its frequency is increased by ultraviolet and ionizing radiation and other mutagenic agents and is particularly high in BLOOM SYNDROME.%A%    
% 223.75/223.90  |- mesh__recordMaintainer mesh__D012854 nns
% 223.75/223.90  |- mesh__publicMeSHNote mesh__D012854
% 223.75/223.90       85; was see under CROSSING OVER %28%GENETICS%29% 1980-84   
% 223.75/223.90  |- skos__prefLabel mesh__D012854 Sister Chromatid Exchange
% 223.75/223.90  |- mesh__dateEstablished mesh__D012854 1985-01-01
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D012854 2006
% 223.75/223.90  |- skos__historyNote mesh__D012854
% 223.75/223.90       Crossing Over %28%Genetics%29% %28%1968-1979%29%
% 223.75/223.90  |- skos__hiddenLabel mesh__D012854 Chromatid Exchanges, Sister
% 223.75/223.90  |- rdf__type mesh__D012854sskos__Concept
% 223.75/223.90  |- skos__historyNote mesh__D012854 Cytogenetics %28%1967%29%
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D012854 2005
% 223.75/223.90  |- skos__hiddenLabel mesh__D012854 Exchanges, Sister Chromatid
% 223.75/223.90  |- mesh__recordAuthorizer mesh__D012854 sjn
% 223.75/223.90  |- skos__hiddenLabel mesh__D012854 Exchange, Sister Chromatid
% 223.75/223.90  |- mesh__historyNote mesh__D012854
% 223.75/223.90       85%28%80%29%; was see under CROSSING OVER %28%GENETICS%29% 1980-84   
% 223.75/223.90  |- mesh__recordOriginator mesh__D012854 AEP
% 223.75/223.90  |- skos__related mesh__D012854smesh__D003434
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D012056 2004
% 223.75/223.90  |- mesh__publicMeSHNote mesh__D012056 1969   
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D012056 2002
% 223.75/223.90  |- mesh__recordOriginator mesh__D012056 NLM
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D012056 2006
% 223.75/223.90  |- mesh__dateEstablished mesh__D012056 1969-01-01
% 223.75/223.90  |- mesh__recordAuthorizer mesh__D012056 ags
% 223.75/223.90  |- skos__historyNote mesh__D012056
% 223.75/223.90       Reinforcement %28%Psychology%29% %28%1966-1968%29%
% 223.75/223.90  |- mesh__dateCreated mesh__D012056 1999-01-01
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D012056 2003
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D012056 2001
% 223.75/223.90  |- skos__hiddenLabel mesh__D012056 Social Reinforcements
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D012056 2005
% 223.75/223.90  |- mesh__dateRevised mesh__D012056 1999-12-16
% 223.75/223.90  |- mesh__historyNote mesh__D012056 1969   
% 223.75/223.90  |- skos__scopeNote mesh__D012056
% 223.75/223.90       The strengthening of a response with a social reward such as a nod of approval, a parent%27%s love or attention.%A%    
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D012056 2000
% 223.75/223.90  |- skos__prefLabel mesh__D012056 Reinforcement, Social
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D012056 1997
% 223.75/223.90  |- mesh__recordMaintainer mesh__D012056 ags
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D012056 1999
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D012056 1993
% 223.75/223.90  |- skos__altLabel mesh__D012056 Social Reinforcement
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D012056 2000A
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D012056 1996
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D012056 1995
% 223.75/223.90  |- skos__broader mesh__D012056smesh__D012054
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D012056 1998
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D012056 1992
% 223.75/223.90  |- skos__historyNote mesh__D012056
% 223.75/223.90       Interpersonal Relations %28%1966-1968%29%
% 223.75/223.90  |- skos__annotation mesh__D012056 no qualif   
% 223.75/223.90  |- rdf__type mesh__D012056sskos__Concept
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D012056 1994
% 223.75/223.90  |- skos__hiddenLabel mesh__D012056 Reinforcements, Social
% 223.75/223.90  |- mesh__dateCreated mesh__D031210 2002-07-03
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D031210 2004
% 223.75/223.90  |- skos__scopeNote mesh__D031210
% 223.75/223.90       A plant genus of the family ASTERACEAE. The name %22%prickly burweed%22% is sometimes used but causes confusion with AMSINCKIA.%A%    
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D031210 2005
% 223.75/223.90  |- skos__altLabel mesh__D031210 Cocklebur
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D031210 2003
% 223.75/223.90  |- rdf__type mesh__D031210sskos__Concept
% 223.75/223.90  |- skos__prefLabel mesh__D031210 Xanthium
% 223.75/223.90  |- mesh__dateEstablished mesh__D031210 2003-01-01
% 223.75/223.90  |- mesh__publicMeSHNote mesh__D031210 2003   
% 223.75/223.90  |- mesh__historyNote mesh__D031210 2003   
% 223.75/223.90  |- skos__annotation mesh__D031210
% 223.75/223.90       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.75/223.90  |- skos__altLabel mesh__D031210 Cocklebur, Spiny
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D031210 2006
% 223.75/223.90  |- skos__broader mesh__D031210smesh__D019659
% 223.75/223.90  |- mesh__dateRevised mesh__D006019 2005-06-30
% 223.75/223.90  |- skos__scopeNote mesh__D006019
% 223.75/223.90       A metabolic process that converts GLUCOSE into two molecules of PYRUVIC ACID through a series of enzymatic reactions. Energy generated by this process is conserved in two molecules of ATP. Glycolysis is the universal catabolic pathway for glucose, free glucose, or glucose derived from complex CARBOHYDRATES, such as GLYCOGEN and STARCH.%A%    
% 223.75/223.90  |- skos__hiddenLabel mesh__D006019 Embden Meyerhof Parnas Pathway
% 223.75/223.90  |- skos__prefLabel mesh__D006019 Glycolysis
% 223.75/223.90  |- mesh__recordOriginator mesh__D006019 NLM
% 223.75/223.90  |- mesh__recordAuthorizer mesh__D006019 sjn
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D006019 2006
% 223.75/223.90  |- mesh__dateEstablished mesh__D006019 1966-01-01
% 223.75/223.90  |- skos__broader mesh__D006019smesh__D004734
% 223.75/223.90  |- mesh__historyNote mesh__D006019 66%28%64%29%   
% 223.75/223.90  |- skos__altLabel mesh__D006019 Embden-Meyerhof-Parnas Pathway
% 223.75/223.90  |- mesh__publicMeSHNote mesh__D006019 66   
% 223.75/223.90  |- skos__hiddenLabel mesh__D006019 Pathway, Embden-Meyerhof-Parnas
% 223.75/223.90  |- skos__hiddenLabel mesh__D006019 Embden-Meyerhof Pathways
% 223.75/223.90  |- skos__hiddenLabel mesh__D006019 Pathways, Embden-Meyerhof
% 223.75/223.90  |- skos__broader mesh__D006019smesh__D050260
% 223.75/223.90  |- skos__hiddenLabel mesh__D006019 Embden Meyerhof Pathway
% 223.75/223.90  |- rdf__type mesh__D006019sskos__Concept
% 223.75/223.90  |- mesh__dateCreated mesh__D006019 1999-01-01
% 223.75/223.90  |- skos__hiddenLabel mesh__D006019 Pathway, Embden-Meyerhof
% 223.75/223.90  |- mesh__recordMaintainer mesh__D006019 lkt
% 223.75/223.90  |- mesh__publicMeSHNote mesh__D050175 2006   
% 223.75/223.90  |- skos__prefLabel mesh__D050175 Pansporablastina
% 223.75/223.90  |- skos__annotation mesh__D050175
% 223.75/223.90       infection: coordinate IM with MICROSPORIDIOSIS %28%IM%29%; coordinate with specific fungal terms %28%ANTIGENS, FUNGAL, etc%29% if pertinent%A%  
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D050175 2006
% 223.75/223.90  |- mesh__historyNote mesh__D050175 2006   
% 223.75/223.90  |- mesh__dateEstablished mesh__D050175 2006-01-01
% 223.75/223.90  |- mesh__recordOriginator mesh__D050175 ags
% 223.75/223.90  |- rdf__type mesh__D050175sskos__Concept
% 223.75/223.90  |- mesh__recordAuthorizer mesh__D050175 sjn
% 223.75/223.90  |- mesh__recordMaintainer mesh__D050175 ags
% 223.75/223.90  |- mesh__dateCreated mesh__D050175 2005-06-30
% 223.75/223.90  |- skos__broader mesh__D050175smesh__D016816
% 223.75/223.90  |- skos__scopeNote mesh__D050175
% 223.75/223.90       A suborder of FUNGI in the phylum MICROSPORIDIA, possessing a pansporoblastic membrane.%A%    
% 223.75/223.90  |- skos__altLabel mesh__D044138 Hemophilus somnus
% 223.75/223.90  |- skos__broader mesh__D044138smesh__D006190
% 223.75/223.90  |- mesh__historyNote mesh__D044138 2004   
% 223.75/223.90  |- mesh__recordOriginator mesh__D044138 ags
% 223.75/223.90  |- mesh__recordAuthorizer mesh__D044138 sjn
% 223.75/223.90  |- mesh__dateEstablished mesh__D044138 2004-01-01
% 223.75/223.90  |- skos__prefLabel mesh__D044138 Haemophilus somnus
% 223.75/223.90  |- rdf__type mesh__D044138sskos__Concept
% 223.75/223.90  |- skos__annotation mesh__D044138
% 223.75/223.90       infection: coord IM with HAEMOPHILUS INFECTIONS %28%IM%29%   
% 223.75/223.90  |- skos__historyNote mesh__D044138 Haemophilus %28%1973-2003%29%
% 223.75/223.90  |- mesh__dateCreated mesh__D044138 2003-07-09
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D044138 2006
% 223.75/223.90  |- skos__scopeNote mesh__D044138
% 223.75/223.90       A species of gram-negative bacteria %28%currently incertae sedis%29% causing multisystem disease in CATTLE.%A%    
% 223.75/223.90  |- mesh__dateRevised mesh__D044138 2005-06-30
% 223.75/223.90  |- mesh__publicMeSHNote mesh__D044138 2004   
% 223.75/223.90  |- mesh__recordMaintainer mesh__D044138 SYSTEM
% 223.75/223.90  |- skos__annotation mesh__D016447
% 223.75/223.90       publication type only; NIH consensus conferences as a subject or means of  scientific communication are indexed under the main heading CONSENSUS DEVELOPMENT CONFERENCES, NIH; Manual 35.8.2; considered as a type of review; CONSENSUS DEVELOPMENT CONFERENCE %5B%Publication Type%5D% is also available%A%  
% 223.75/223.90  |- skos__prefLabel mesh__D016447
% 223.75/223.90       Consensus Development Conference, NIH %5B%Publication Type%5D%
% 223.75/223.90  |- skos__scopeNote mesh__D016447
% 223.75/223.90       Work consisting of summary statements, from a conference sponsored by NIH, representing the majority of current opinion of physicians, scientists, and other professionals on a selected subject.%A%    
% 223.75/223.90  |- mesh__dateCreated mesh__D016447 1995-06-23
% 223.75/223.90  |- mesh__dateRevised mesh__D016447 2005-06-30
% 223.75/223.90  |- rdf__type mesh__D016447sskos__Concept
% 223.75/223.90  |- skos__altLabel mesh__D016447 Consensus Development Conference, NIH
% 223.75/223.90  |- skos__altLabel mesh__D016447
% 223.75/223.90       Consensus Development Conference, NIH %28%PT%29%
% 223.75/223.90  |- mesh__dateEstablished mesh__D016447 1996-01-01
% 223.75/223.90  |- mesh__recordOriginator mesh__D016447 TGC
% 223.75/223.90  |- mesh__historyNote mesh__D016447 2005   
% 223.75/223.90  |- mesh__recordMaintainer mesh__D016447 jls
% 223.75/223.90  |- mesh__recordAuthorizer mesh__D016447 sjn
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D016447 2006
% 223.75/223.90  |- skos__broader mesh__D016447smesh__D016446
% 223.75/223.90  |- skos__scopeNote mesh__D002427
% 223.75/223.90       A family of New World monkeys in the infraorder PLATYRRHINI, consisting of nine subfamilies: ALOUATTINAE; AOTINAE; Atelinae; Callicebinae; CALLIMICONINAE; CALLITRICHINAE; CEBINAE; Pithecinae; and SAIMIRINAE. They inhabit the forests of South and Central America, comprising the largest family of South American monkeys.%A%    
% 223.75/223.90  |- skos__hiddenLabel mesh__D002427 Spider Monkeys
% 223.75/223.90  |- mesh__recordOriginator mesh__D002427 EC
% 223.75/223.90  |- skos__hiddenLabel mesh__D002427 Platyrrhinas
% 223.75/223.90  |- skos__hiddenLabel mesh__D002427 Bracytele
% 223.75/223.90  |- skos__hiddenLabel mesh__D002427 Woolly Monkeys
% 223.75/223.90  |- skos__prefLabel mesh__D002427 Cebidae
% 223.75/223.90  |- skos__altLabel mesh__D002427 Ateles
% 223.75/223.90  |- skos__altLabel mesh__D002427 Monkey, Woolly
% 223.75/223.90  |- skos__annotation mesh__D002427
% 223.75/223.90       diseases: coordinate IM with MONKEY DISEASES %28%IM%29%   
% 223.75/223.90  |- mesh__recordAuthorizer mesh__D002427 sjn
% 223.75/223.90  |- skos__broader mesh__D002427smesh__D051078
% 223.75/223.90  |- mesh__activeMeSHYear mesh__D002427 2006
% 223.75/223.90  |- mesh__dateRevised mesh__D002427 2005-06-30
% 223.75/223.90  |- mesh__publicMeSHNote mesh__D002427 81   
% 223.75/223.90  |- skos__hiddenLabel mesh__D002427 Cacajaos
% 223.75/223.91  |- mesh__dateEstablished mesh__D002427 1981-01-01
% 223.75/223.91  |- skos__hiddenLabel mesh__D002427 Monkeys, Spider
% 223.75/223.91  |- rdf__type mesh__D002427sskos__Concept
% 223.75/223.91  |- skos__hiddenLabel mesh__D002427 Lagothrices
% 223.75/223.91  |- skos__hiddenLabel mesh__D002427 Monkeys, Woolly
% 223.75/223.91  |- mesh__historyNote mesh__D002427 81   
% 223.75/223.91  |- skos__altLabel mesh__D002427 Platyrrhina
% 223.75/223.91  |- skos__altLabel mesh__D002427 Monkey, Spider
% 223.75/223.91  |- mesh__recordMaintainer mesh__D002427 ags
% 223.75/223.91  |- skos__altLabel mesh__D002427 Lagothrix
% 223.75/223.91  |- mesh__dateCreated mesh__D002427 1980-05-07
% 223.75/223.91  |- mesh__dateCreated mesh__D007910 1978-01-26
% 223.75/223.91  |- skos__historyNote mesh__D007910 Cataract Extraction %28%1966-1978%29%
% 223.75/223.91  |- skos__hiddenLabel mesh__D007910 Intraocular Lens
% 223.75/223.91  |- skos__prefLabel mesh__D007910 Lenses, Intraocular
% 223.75/223.91  |- mesh__recordAuthorizer mesh__D007910 sjn
% 223.75/223.91  |- mesh__dateEstablished mesh__D007910 1979-01-01
% 223.75/223.91  |- skos__altLabel mesh__D007910 Lens, Intraocular
% 223.75/223.91  |- skos__hiddenLabel mesh__D007910 Lens, Implantable Contact
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007910 2006
% 223.75/223.91  |- skos__historyNote mesh__D007910 Lenses %28%1966-1978%29%
% 223.75/223.91  |- mesh__dateRevised mesh__D007910 2005-06-30
% 223.75/223.91  |- skos__hiddenLabel mesh__D007910 Intraocular Lenses
% 223.75/223.91  |- skos__hiddenLabel mesh__D007910 Contact Lens, Implantable
% 223.75/223.91  |- mesh__recordOriginator mesh__D007910 SMH
% 223.75/223.91  |- mesh__recordMaintainer mesh__D007910 ssb
% 223.75/223.91  |- skos__annotation mesh__D007910
% 223.75/223.91       artificial lens: do not confuse with LENS, CRYSTALLINE %28%Category A%29%; commonly used after cataract extraction but do not coordinate with CATARACT EXTRACTION unless particularly discussed; PSEUDOPHAKIA is available for the state of the eye in the presence of an intraocular lens after cataract extraction%A%  
% 223.75/223.91  |- mesh__publicMeSHNote mesh__D007910 79   
% 223.75/223.91  |- skos__historyNote mesh__D007910 Prosthesis %28%1966-1978%29%
% 223.75/223.91  |- skos__scopeNote mesh__D007910 Artificial implanted lenses.     
% 223.75/223.91  |- rdf__type mesh__D007910sskos__Concept
% 223.75/223.91  |- skos__broader mesh__D007910smesh__D007909
% 223.75/223.91  |- mesh__historyNote mesh__D007910 79   
% 223.75/223.91  |- skos__broader mesh__D007910smesh__D019736
% 223.75/223.91  |- skos__hiddenLabel mesh__D007112 Neonatal Immunity, Maternally Acquired
% 223.75/223.91  |- skos__hiddenLabel mesh__D007112 Fetal Immunities, Maternally-Acquired
% 223.75/223.91  |- skos__hiddenLabel mesh__D007112 Immunity, Maternally-Acquired Neonatal
% 223.75/223.91  |- skos__altLabel mesh__D007112 Maternally-Acquired Immunity
% 223.75/223.91  |- mesh__onlineNote mesh__D007112
% 223.75/223.91       use IMMUNITY, MATERNALLY-ACQUIRED to search IMMUNITY, PASSIVE 1966-82 %28%as Prov 1966%29%%A%  
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007112 2001
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007112 1998
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007112 2003
% 223.75/223.91  |- skos__hiddenLabel mesh__D007112 Maternally-Acquired Fetal Immunities
% 223.75/223.91  |- skos__broader mesh__D007112smesh__D007109
% 223.75/223.91  |- mesh__recordAuthorizer mesh__D007112 PLS
% 223.75/223.91  |- skos__hiddenLabel mesh__D007112 Maternally-Acquired Immunities
% 223.75/223.91  |- mesh__dateEstablished mesh__D007112 1967-01-01
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007112 1994
% 223.75/223.91  |- skos__hiddenLabel mesh__D007112 Immunity, Maternally-Acquired Fetal
% 223.75/223.91  |- skos__hiddenLabel mesh__D007112 Immunities, Maternally-Acquired
% 223.75/223.91  |- mesh__historyNote mesh__D007112
% 223.75/223.91       83; was IMMUNITY, PASSIVE 1966-82 %28%Prov 1966%29%   
% 223.75/223.91  |- mesh__dateCreated mesh__D007112 1999-01-01
% 223.75/223.91  |- skos__scopeNote mesh__D007112
% 223.75/223.91       Resistance to a disease-causing agent induced by the introduction of maternal immunity into the fetus by transplacental transfer or into the neonate through colostrum and milk.%A%    
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007112 2002
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007112 1999
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007112 2004
% 223.75/223.91  |- skos__hiddenLabel mesh__D007112 Fetal Immunity, Maternally Acquired
% 223.75/223.91  |- skos__prefLabel mesh__D007112 Immunity, Maternally-Acquired
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007112 1993
% 223.75/223.91  |- mesh__recordMaintainer mesh__D007112 PLS
% 223.75/223.91  |- rdf__type mesh__D007112sskos__Concept
% 223.75/223.91  |- skos__hiddenLabel mesh__D007112 Maternally-Acquired Neonatal Immunities
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007112 1995
% 223.75/223.91  |- skos__annotation mesh__D007112
% 223.75/223.91       of fetus by transplacental transfer or of neonate through colostrum or milk; do not add MATERNAL-FETAL EXCHANGE; note category: do not confuse with IMMUNIZATION, PASSIVE %28%Cat E%29%; TN 242%A%  
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007112 2005
% 223.75/223.91  |- mesh__dateRevised mesh__D007112 1994-09-23
% 223.75/223.91  |- skos__hiddenLabel mesh__D007112 Immunities, Maternally-Acquired Neonatal
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007112 1996
% 223.75/223.91  |- mesh__publicMeSHNote mesh__D007112 83; was IMMUNITY, PASSIVE 1967-82   
% 223.75/223.91  |- skos__hiddenLabel mesh__D007112 Maternally-Acquired Neonatal Immunity
% 223.75/223.91  |- skos__hiddenLabel mesh__D007112 Maternally Acquired Immunities
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007112 2006
% 223.75/223.91  |- skos__hiddenLabel mesh__D007112 Maternally Acquired Immunity
% 223.75/223.91  |- mesh__recordOriginator mesh__D007112 NLM
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007112 2000
% 223.75/223.91  |- skos__hiddenLabel mesh__D007112 Immunities, Maternally-Acquired Fetal
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007112 1997
% 223.75/223.91  |- skos__hiddenLabel mesh__D007112 Immunities, Maternally Acquired
% 223.75/223.91  |- skos__hiddenLabel mesh__D007112 Maternally-Acquired Fetal Immunity
% 223.75/223.91  |- skos__related mesh__D007112smesh__D007116
% 223.75/223.91  |- skos__hiddenLabel mesh__D007112 Neonatal Immunities, Maternally-Acquired
% 223.75/223.91  |- skos__altLabel mesh__D007112 Immunity, Maternally Acquired
% 223.75/223.91  |- mesh__publicMeSHNote mesh__D048529 2005; see PAPIO 1975-2004   
% 223.75/223.91  |- mesh__recordAuthorizer mesh__D048529 sjn
% 223.75/223.91  |- skos__hiddenLabel mesh__D048529 Baboons, Hamadryas
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D048529 2006
% 223.75/223.91  |- rdf__type mesh__D048529sskos__Concept
% 223.75/223.91  |- skos__altLabel mesh__D048529 Hamadryas Baboon
% 223.75/223.91  |- mesh__dateRevised mesh__D048529 2005-06-30
% 223.75/223.91  |- skos__hiddenLabel mesh__D048529 Hamadryas Baboons
% 223.75/223.91  |- skos__hiddenLabel mesh__D048529 hamadryas, Papio
% 223.75/223.91  |- skos__broader mesh__D048529smesh__D010215
% 223.75/223.91  |- mesh__dateEstablished mesh__D048529 2005-01-01
% 223.75/223.91  |- skos__prefLabel mesh__D048529 Papio hamadryas
% 223.75/223.91  |- mesh__historyNote mesh__D048529 2005; use PAPIO 1975-2004   
% 223.75/223.91  |- skos__altLabel mesh__D048529 Hamadryas
% 223.75/223.91  |- skos__hiddenLabel mesh__D048529 Baboon, Hamadryas
% 223.75/223.91  |- mesh__dateCreated mesh__D048529 2004-07-07
% 223.75/223.91  |- mesh__recordOriginator mesh__D048529 ags
% 223.75/223.91  |- skos__historyNote mesh__D048529 Papio %28%1972-2004%29%
% 223.75/223.91  |- mesh__recordMaintainer mesh__D048529 ags
% 223.75/223.91  |- skos__scopeNote mesh__D048529
% 223.75/223.91       A species of baboon in the family CERCOPITHECIDAE, which has a well-studied trilevel social structure consisting of troops, bands, and clans.%A%    
% 223.75/223.91  |- skos__historyNote mesh__D048529 Haplorhini %28%1966-1971%29%
% 223.75/223.91  |- skos__historyNote mesh__D012855 Sterols %28%1966-1971%29%
% 223.75/223.91  |- skos__annotation mesh__D012855 plant sterols   
% 223.75/223.91  |- mesh__recordOriginator mesh__D012855 NLM
% 223.75/223.91  |- skos__scopeNote mesh__D012855
% 223.75/223.91       A family of sterols commonly found in plants and plant oils. Alpha-, beta-, and gamma-isomers have been characterized.%A%    
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012855 2006
% 223.75/223.91  |- skos__broader mesh__D012855smesh__D002782
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012855 2004
% 223.75/223.91  |- mesh__recordMaintainer mesh__D012855 PLS
% 223.75/223.91  |- skos__broader mesh__D012855smesh__D010840
% 223.75/223.91  |- skos__historyNote mesh__D012855 Estrogens %28%1966-1971%29%
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012855 2005
% 223.75/223.91  |- rdf__type mesh__D012855sskos__Concept
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012855 2001
% 223.75/223.91  |- mesh__dateEstablished mesh__D012855 1974-01-01
% 223.75/223.91  |- mesh__dateRevised mesh__D012855 1993-06-03
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012855 2003
% 223.75/223.91  |- mesh__historyNote mesh__D012855 74%28%72%29%   
% 223.75/223.91  |- mesh__recordAuthorizer mesh__D012855 PLS
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012855 1995
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012855 2000
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012855 1999
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012855 1994
% 223.75/223.91  |- mesh__dateCreated mesh__D012855 1999-01-01
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012855 1997
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012855 1998
% 223.75/223.91  |- mesh__publicMeSHNote mesh__D012855 74   
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012855 1996
% 223.75/223.91  |- skos__prefLabel mesh__D012855 Sitosterols
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012855 2002
% 223.75/223.91  |- mesh__recordAuthorizer mesh__D012057 PLS
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012057 2004
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012057 2002
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012057 2006
% 223.75/223.91  |- mesh__dateEstablished mesh__D012057 1969-01-01
% 223.75/223.91  |- skos__hiddenLabel mesh__D012057 Verbal Reinforcement
% 223.75/223.91  |- skos__prefLabel mesh__D012057 Reinforcement, Verbal
% 223.75/223.91  |- skos__hiddenLabel mesh__D012057 Reinforcements, Verbal
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012057 1990
% 223.75/223.91  |- mesh__publicMeSHNote mesh__D012057 69   
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012057 1996
% 223.75/223.91  |- skos__broader mesh__D012057smesh__D012054
% 223.75/223.91  |- mesh__historyNote mesh__D012057 69%28%66%29%   
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012057 1998
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012057 1992
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012057 1997
% 223.75/223.91  |- mesh__recordOriginator mesh__D012057 NLM
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012057 2000
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012057 1994
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012057 1999
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012057 1993
% 223.75/223.91  |- mesh__dateRevised mesh__D012057 1989-05-16
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012057 2001
% 223.75/223.91  |- mesh__recordMaintainer mesh__D012057 TGC
% 223.75/223.91  |- skos__annotation mesh__D012057 no qualif   
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012057 1991
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012057 1995
% 223.75/223.91  |- skos__scopeNote mesh__D012057
% 223.75/223.91       Use of word stimulus to strengthen a response during learning.%A%    
% 223.75/223.91  |- mesh__dateCreated mesh__D012057 1999-01-01
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012057 2003
% 223.75/223.91  |- skos__hiddenLabel mesh__D012057 Verbal Reinforcements
% 223.75/223.91  |- rdf__type mesh__D012057sskos__Concept
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D012057 2005
% 223.75/223.91  |- skos__altLabel mesh__D006818 Hyaline
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D006818 2003
% 223.75/223.91  |- rdf__type mesh__D006818sskos__Concept
% 223.75/223.91  |- skos__hiddenLabel mesh__D006818 Hyalins
% 223.75/223.91  |- skos__scopeNote mesh__D006818
% 223.75/223.91       A clear, homogenous, structureless, eosinophilic substance occurring in pathological degeneration of tissues.%A%    
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D006818 2004
% 223.75/223.91  |- mesh__dateCreated mesh__D006818 1999-01-01
% 223.75/223.91  |- mesh__recordOriginator mesh__D006818 NLM
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D006818 2000
% 223.75/223.91  |- mesh__recordMaintainer mesh__D006818 KEV
% 223.75/223.91  |- mesh__dateEstablished mesh__D006818 1965-01-01
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D006818 2005
% 223.75/223.91  |- skos__altLabel mesh__D006818 Hyaline Substance
% 223.75/223.91  |- skos__hiddenLabel mesh__D006818 Substance, Hyalin
% 223.75/223.91  |- skos__altLabel mesh__D006818 Hyalin Substance
% 223.75/223.91  |- mesh__historyNote mesh__D006818 96; was HYALIN SUBSTANCE 1965-95   
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D006818 2001
% 223.75/223.91  |- mesh__publicMeSHNote mesh__D006818 96; was HYALIN SUBSTANCE 1965-95   
% 223.75/223.91  |- skos__hiddenLabel mesh__D006818 Substance, Hyaline
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D006818 2006
% 223.75/223.91  |- skos__prefLabel mesh__D006818 Hyalin
% 223.75/223.91  |- mesh__recordAuthorizer mesh__D006818 sjn
% 223.75/223.91  |- skos__broader mesh__D006818smesh__D005441
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D006818 2002
% 223.75/223.91  |- mesh__dateRevised mesh__D006818 1999-11-03
% 223.75/223.91  |- skos__hiddenLabel mesh__D017540 Medias, Arterial
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D017540 2004
% 223.75/223.91  |- skos__hiddenLabel mesh__D017540 Media, Vascular
% 223.75/223.91  |- skos__altLabel mesh__D017540 Vascular Media
% 223.75/223.91  |- mesh__dateRevised mesh__D017540 2001-07-25
% 223.75/223.91  |- skos__scopeNote mesh__D017540
% 223.75/223.91       The middle coat of blood vessel walls, composed principally of thin, cylindrical, smooth muscle cells and elastic tissue. It accounts for the bulk of the wall of most arteries. The smooth muscle cells are arranged in circular layers around the vessel, and the thickness of the coat varies with the size of the vessel.%A%    
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D017540 2005
% 223.75/223.91  |- mesh__historyNote mesh__D017540 93   
% 223.75/223.91  |- skos__broader mesh__D017540smesh__D009131
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D017540 2003
% 223.75/223.91  |- skos__hiddenLabel mesh__D017540 Medias, Vascular
% 223.75/223.91  |- skos__hiddenLabel mesh__D017540 Media, Venous
% 223.75/223.91  |- mesh__publicMeSHNote mesh__D017540 93   
% 223.75/223.91  |- mesh__recordOriginator mesh__D017540 PLS
% 223.75/223.91  |- skos__annotation mesh__D017540
% 223.75/223.91       /pathol is more likely than %22%diseases of the tunica media%22%; coord IM with specific blood vessel %28%IM%29%; /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 223.75/223.91  |- skos__hiddenLabel mesh__D017540 Medias, Venous
% 223.75/223.91  |- skos__historyNote mesh__D017540 specific blood vessel %28%1966-1992%29%
% 223.75/223.91  |- mesh__recordMaintainer mesh__D017540 nns
% 223.75/223.91  |- skos__historyNote mesh__D017540
% 223.75/223.91       Muscle, Smooth, Vascular %28%1980-1992%29%
% 223.75/223.91  |- skos__hiddenLabel mesh__D017540 Vascular Medias
% 223.75/223.91  |- skos__hiddenLabel mesh__D017540 Media, Arterial
% 223.75/223.91  |- skos__prefLabel mesh__D017540 Tunica Media
% 223.75/223.91  |- mesh__dateCreated mesh__D017540 1992-05-22
% 223.75/223.91  |- mesh__dateEstablished mesh__D017540 1993-01-01
% 223.75/223.91  |- skos__hiddenLabel mesh__D017540 Venous Medias
% 223.75/223.91  |- skos__historyNote mesh__D017540 Muscle, Smooth %28%1966-1979%29%
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D017540 2002
% 223.75/223.91  |- mesh__recordAuthorizer mesh__D017540 sjn
% 223.75/223.91  |- rdf__type mesh__D017540sskos__Concept
% 223.75/223.91  |- skos__hiddenLabel mesh__D017540 Arterial Medias
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D017540 2006
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D031211 2006
% 223.75/223.91  |- mesh__dateCreated mesh__D031211 2002-07-03
% 223.75/223.91  |- skos__broader mesh__D031211smesh__D029401
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D031211 2004
% 223.75/223.91  |- skos__altLabel mesh__D031211 Hazelnuts
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D031211 2005
% 223.75/223.91  |- skos__altLabel mesh__D031211 Hazelnut
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D031211 2003
% 223.75/223.91  |- skos__scopeNote mesh__D031211
% 223.75/223.91       A plant genus of the family BETULACEAE known for the edible nuts.%A%    
% 223.75/223.91  |- rdf__type mesh__D031211sskos__Concept
% 223.75/223.91  |- skos__altLabel mesh__D031211 Filberts
% 223.75/223.91  |- skos__annotation mesh__D031211
% 223.75/223.91       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.75/223.91  |- mesh__dateEstablished mesh__D031211 2003-01-01
% 223.75/223.91  |- mesh__publicMeSHNote mesh__D031211 2003   
% 223.75/223.91  |- mesh__historyNote mesh__D031211 2003   
% 223.75/223.91  |- skos__prefLabel mesh__D031211 Corylus
% 223.75/223.91  |- mesh__dateCreated mesh__D003520 1999-01-01
% 223.75/223.91  |- mesh__recordAuthorizer mesh__D003520 sjn
% 223.75/223.91  |- mesh__recordOriginator mesh__D003520 NLM
% 223.75/223.91  |- mesh__recordMaintainer mesh__D003520 ssb
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D003520 2006
% 223.75/223.91  |- skos__altLabel mesh__D003520 Cytophosphan
% 223.75/223.91  |- skos__broader mesh__D003520smesh__D010752
% 223.75/223.91  |- skos__prefLabel mesh__D003520 Cyclophosphamide
% 223.75/223.91  |- skos__hiddenLabel mesh__D003520 Monohydrate, Cyclophosphamide
% 223.75/223.91  |- mesh__dateRevised mesh__D003520 2005-06-30
% 223.75/223.91  |- skos__scopeNote mesh__D003520
% 223.75/223.91       Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active ALDOPHOSPHAMIDE. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.%A%    
% 223.75/223.91  |- rdf__type mesh__D003520sskos__Concept
% 223.75/223.91  |- skos__altLabel mesh__D003520 Cyclophosphane
% 223.75/223.91  |- skos__scopeNote mesh__D044139
% 223.75/223.91       An angiotensin receptor subtype that is expressed at high levels in fetal tissues. Many effects of the angiotensin type 2 receptor such as VASODILATION and sodium loss are the opposite of that of the ANGIOTENSIN TYPE 1 RECEPTOR.%A%    
% 223.75/223.91  |- skos__broader mesh__D044139smesh__D011945
% 223.75/223.91  |- skos__altLabel mesh__D044139 Angiotensin II Type 2 Receptor
% 223.75/223.91  |- rdf__type mesh__D044139sskos__Concept
% 223.75/223.91  |- mesh__dateCreated mesh__D044139 2003-07-09
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D044139 2006
% 223.75/223.91  |- skos__hiddenLabel mesh__D044139 AT2 Receptor, Angiotensin
% 223.75/223.91  |- mesh__historyNote mesh__D044139
% 223.75/223.91       2004; use RECEPTOR, ANGIOTENSIN, TYPE 2 %28%NM%29% 1996-2003   
% 223.75/223.91  |- mesh__dateEstablished mesh__D044139 2004-01-01
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D044139 2005
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D044139 2004
% 223.75/223.91  |- mesh__publicMeSHNote mesh__D044139
% 223.75/223.91       2004; ANGIOTENSIN II TYPE 2 RECEPTOR %28%now RECEPTOR, ANGIOTENSIN, TYPE 2%29% was indexed under RECEPTORS, ANGIOTENSIN 1996-2003%A%  
% 223.75/223.91  |- skos__historyNote mesh__D044139 Receptors, Angiotensin %28%1996-2003%29%
% 223.75/223.91  |- skos__altLabel mesh__D044139 Angiotensin Type 2 Receptor
% 223.75/223.91  |- skos__altLabel mesh__D044139 Angiotensin AT2 Receptor
% 223.75/223.91  |- skos__prefLabel mesh__D044139 Receptor, Angiotensin, Type 2
% 223.75/223.91  |- skos__hiddenLabel mesh__D044139 Receptor, Angiotensin AT2
% 223.75/223.91  |- skos__altLabel mesh__D044139 Receptor, Angiotensin II Type 2
% 223.75/223.91  |- rdf__type mesh__D016448sskos__Concept
% 223.75/223.91  |- skos__prefLabel mesh__D016448 Multicenter Study %5B%Publication Type%5D%
% 223.75/223.91  |- skos__altLabel mesh__D016448 Multicenter Study %28%PT%29%
% 223.75/223.91  |- mesh__dateCreated mesh__D016448 1995-06-23
% 223.75/223.91  |- mesh__dateRevised mesh__D016448 2005-06-30
% 223.75/223.91  |- mesh__dateEstablished mesh__D016448 1996-01-01
% 223.75/223.91  |- skos__annotation mesh__D016448
% 223.75/223.91       publication type only; multicenter studies as a subject or form of research are indexed under the main heading MULTICENTER STUDIES; specify geographical term if pertinent; add CLINICAL TRIAL %5B%Publication Type%5D% or specific if appropriate; Manual 26.26.3+%A%  
% 223.75/223.91  |- mesh__recordOriginator mesh__D016448 TGC
% 223.75/223.91  |- mesh__historyNote mesh__D016448 1991   
% 223.75/223.91  |- skos__broader mesh__D016448smesh__D016430
% 223.75/223.91  |- skos__broader mesh__D016448smesh__D052182
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D016448 2006
% 223.75/223.91  |- mesh__recordMaintainer mesh__D016448 jls
% 223.75/223.91  |- mesh__recordAuthorizer mesh__D016448 sjn
% 223.75/223.91  |- skos__scopeNote mesh__D016448
% 223.75/223.91       Work consisting of a controlled study executed by several cooperating institutions.%A%    
% 223.75/223.91  |- skos__scopeNote mesh__D035602
% 223.75/223.91       Transcription factors whose primary function is to regulate the rate in which RNA is transcribed.%A%    
% 223.75/223.91  |- mesh__dateCreated mesh__D035602 2002-07-03
% 223.75/223.91  |- mesh__dateRevised mesh__D035602 2005-06-30
% 223.75/223.91  |- skos__hiddenLabel mesh__D035602 Elongation Factors, Transcriptional
% 223.75/223.91  |- rdf__type mesh__D035602sskos__Concept
% 223.75/223.91  |- mesh__historyNote mesh__D035602 2003   
% 223.75/223.91  |- mesh__recordMaintainer mesh__D035602 SYSTEM
% 223.75/223.91  |- skos__broader mesh__D035602smesh__D014157
% 223.75/223.91  |- mesh__dateEstablished mesh__D035602 2003-01-01
% 223.75/223.91  |- mesh__recordOriginator mesh__D035602 jmp
% 223.75/223.91  |- mesh__publicMeSHNote mesh__D035602 2003   
% 223.75/223.91  |- skos__prefLabel mesh__D035602 Transcriptional Elongation Factors
% 223.75/223.91  |- mesh__recordAuthorizer mesh__D035602 sjn
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D035602 2006
% 223.75/223.91  |- skos__altLabel mesh__D002428 Monkey, Ring-Tail
% 223.75/223.91  |- skos__prefLabel mesh__D002428 Cebus
% 223.75/223.91  |- skos__hiddenLabel mesh__D002428 Capuchin Monkeys
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D002428 2006
% 223.75/223.91  |- skos__scopeNote mesh__D002428
% 223.75/223.91       A genus of the family CEBIDAE, subfamily CEBINAE, consisting of four species which are divided into two groups, the tufted and untufted. C. apella has tufts of hair over the eyes and sides of the head. The remaining species are without tufts - C. capucinus, C. nigrivultatus, and C. albifrons. Cebus inhabits the forests of Central and South America.%A%    
% 223.75/223.91  |- mesh__dateEstablished mesh__D002428 1991-01-01
% 223.75/223.91  |- mesh__recordOriginator mesh__D002428 EC
% 223.75/223.91  |- skos__hiddenLabel mesh__D002428 Monkey, Ring Tail
% 223.75/223.91  |- skos__historyNote mesh__D002428 Anthropoidea %28%1966-1980%29%
% 223.75/223.91  |- skos__hiddenLabel mesh__D002428 Monkey, Ring Tailed
% 223.75/223.91  |- skos__annotation mesh__D002428
% 223.75/223.91       New World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 223.75/223.91  |- skos__hiddenLabel mesh__D002428 Ring-Tailed Monkeys
% 223.75/223.91  |- rdf__type mesh__D002428sskos__Concept
% 223.75/223.91  |- skos__altLabel mesh__D002428 Monkey, Capuchin
% 223.75/223.91  |- skos__altLabel mesh__D002428 Monkey, Ring-Tailed
% 223.75/223.91  |- mesh__recordAuthorizer mesh__D002428 sjn
% 223.75/223.91  |- mesh__dateRevised mesh__D002428 2005-06-30
% 223.75/223.91  |- skos__hiddenLabel mesh__D002428 Capuchin Monkey
% 223.75/223.91  |- skos__hiddenLabel mesh__D002428 Monkeys, Ring-Tailed
% 223.75/223.91  |- mesh__publicMeSHNote mesh__D002428 91; was see under CEBIDAE 1981-90   
% 223.75/223.91  |- skos__hiddenLabel mesh__D002428 Monkeys, Ring-Tail
% 223.75/223.91  |- skos__hiddenLabel mesh__D002428 Ring-Tail Monkeys
% 223.75/223.91  |- mesh__recordMaintainer mesh__D002428 ags
% 223.75/223.91  |- mesh__dateCreated mesh__D002428 1980-05-07
% 223.75/223.91  |- skos__hiddenLabel mesh__D002428 Monkeys, Capuchin
% 223.75/223.91  |- mesh__historyNote mesh__D002428
% 223.75/223.91       91%28%81%29%; was see under CEBIDAE 1981-90   
% 223.75/223.91  |- skos__hiddenLabel mesh__D002428 Ring-Tailed Monkey
% 223.75/223.91  |- skos__hiddenLabel mesh__D002428 Ring-Tail Monkey
% 223.75/223.91  |- skos__broader mesh__D002428smesh__D016646
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D013150 2004
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D013150 2001
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D013150 1996
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D013150 1999
% 223.75/223.91  |- skos__prefLabel mesh__D013150 Spirostans
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D013150 2002
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D013150 1997
% 223.75/223.91  |- mesh__recordMaintainer mesh__D013150 PLS
% 223.75/223.91  |- mesh__dateEstablished mesh__D013150 1968-01-01
% 223.75/223.91  |- mesh__historyNote mesh__D013150 68   
% 223.75/223.91  |- skos__scopeNote mesh__D013150
% 223.75/223.91       Steroid derivatives containing a fused lactone ring at the 16,17-position and a spiroglycosidic linkage at C-22. The most common representatives in this group are the plant-derived SAPOGENINS.%A%    
% 223.75/223.91  |- rdf__type mesh__D013150sskos__Concept
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D013150 1994
% 223.75/223.91  |- mesh__recordAuthorizer mesh__D013150 PLS
% 223.75/223.91  |- mesh__dateRevised mesh__D013150 1993-06-03
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D013150 2005
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D013150 2000
% 223.75/223.91  |- skos__annotation mesh__D013150
% 223.75/223.91       includes spirostenes, spirostadienes, spirostatrienes   
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D013150 1995
% 223.75/223.91  |- mesh__publicMeSHNote mesh__D013150 68   
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D013150 2003
% 223.75/223.91  |- skos__broader mesh__D013150smesh__D013256
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D013150 2006
% 223.75/223.91  |- mesh__recordOriginator mesh__D013150 NLM
% 223.75/223.91  |- mesh__dateCreated mesh__D013150 1999-01-01
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D013150 1998
% 223.75/223.91  |- skos__altLabel mesh__D007911 Lentiginosis
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007911 2001
% 223.75/223.91  |- rdf__type mesh__D007911sskos__Concept
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007911 2004
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007911 1995
% 223.75/223.91  |- skos__annotation mesh__D007911 a form of melanosis   
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007911 1998
% 223.75/223.91  |- mesh__recordAuthorizer mesh__D007911 PLS
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007911 2000
% 223.75/223.91  |- mesh__dateCreated mesh__D007911 1999-01-01
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007911 2003
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007911 1994
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007911 2006
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007911 2002
% 223.75/223.91  |- skos__prefLabel mesh__D007911 Lentigo
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007911 2005
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007911 1997
% 223.75/223.91  |- skos__scopeNote mesh__D007911
% 223.75/223.91       Small circumscribed melanoses resembling, but differing histologically from, freckles. The concept includes senile lentigo %28%%27%liver spots%27%%29% and nevoid lentigo %28%nevus spilus, lentigo simplex%29% and may also occur in association with multiple congenital defects or congenital syndromes %28%e.g., Peutz-Jeghers syndrome%29%.%A%    
% 223.75/223.91  |- skos__broader mesh__D007911smesh__D008548
% 223.75/223.91  |- mesh__dateRevised mesh__D007911 1993-06-02
% 223.75/223.91  |- skos__hiddenLabel mesh__D007911 Lentiginoses
% 223.75/223.91  |- mesh__recordOriginator mesh__D007911 NLM
% 223.75/223.91  |- mesh__recordMaintainer mesh__D007911 TAP
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007911 1996
% 223.75/223.91  |- skos__hiddenLabel mesh__D007911 Lentigos
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007911 1999
% 223.75/223.91  |- skos__altLabel mesh__D007113 Immunity, Innate
% 223.75/223.91  |- skos__prefLabel mesh__D007113 Immunity, Natural
% 223.75/223.91  |- skos__hiddenLabel mesh__D007113 Native Immunity
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007113 2004
% 223.75/223.91  |- skos__altLabel mesh__D007113 Immunity, Non-Specific
% 223.75/223.91  |- skos__annotation mesh__D007113
% 223.75/223.91       coord IM or NIM with specific disease /immunol %28%IM%29%   
% 223.75/223.91  |- skos__broader mesh__D007113smesh__D007109
% 223.75/223.91  |- skos__hiddenLabel mesh__D007113 Non-Specific Immunity
% 223.75/223.91  |- skos__hiddenLabel mesh__D007113 Natural Resistance
% 223.75/223.91  |- mesh__historyNote mesh__D007113 78   
% 223.75/223.91  |- mesh__activeMeSHYear mesh__D007113 2003
% 223.75/223.91  |- skos__hiddenLabel mesh__D007113 Natural Immunity
% 223.75/223.92  |- skos__hiddenLabel mesh__D007113 Immunity, Non Specific
% 223.75/223.92  |- mesh__publicMeSHNote mesh__D007113 78   
% 223.75/223.92  |- mesh__recordMaintainer mesh__D007113 ags
% 223.75/223.92  |- mesh__dateCreated mesh__D007113 1977-03-01
% 223.75/223.92  |- skos__altLabel mesh__D007113 Resistance, Disease
% 223.75/223.92  |- skos__historyNote mesh__D007113 Immunity %28%1966-1977%29%
% 223.75/223.92  |- mesh__dateRevised mesh__D007113 2002-07-03
% 223.75/223.92  |- mesh__dateEstablished mesh__D007113 1978-01-01
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D007113 2006
% 223.75/223.92  |- skos__scopeNote mesh__D007113
% 223.75/223.92       The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from non-specific mechanisms such as naturally occurring antiviral and bactericidal substances, PHAGOCYTOSIS, and constitutional factors such as BODY TEMPERATURE, oxygen tension, and age.%A%    
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D007113 2005
% 223.75/223.92  |- skos__historyNote mesh__D007113
% 223.75/223.92       specific term/immunology %28%1966-1977%29%
% 223.75/223.92  |- mesh__recordAuthorizer mesh__D007113 sjn
% 223.75/223.92  |- rdf__type mesh__D007113sskos__Concept
% 223.75/223.92  |- skos__hiddenLabel mesh__D007113 Innate Immunity
% 223.75/223.92  |- skos__altLabel mesh__D007113 Immunity, Native
% 223.75/223.92  |- mesh__recordOriginator mesh__D007113 AEP
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012856 2003
% 223.75/223.92  |- mesh__recordAuthorizer mesh__D012856 sjn
% 223.75/223.92  |- skos__hiddenLabel mesh__D012856 Disodium Salt, SITS
% 223.75/223.92  |- mesh__publicMeSHNote mesh__D012856
% 223.75/223.92       2001; see SITS 1991-2000 %26% STILBENES 1980-90   
% 223.75/223.92  |- skos__altLabel mesh__D012856 SITS Disodium Salt
% 223.75/223.92  |- skos__historyNote mesh__D012856 Stilbenes %28%1966-1979%29%
% 223.75/223.92  |- mesh__dateEstablished mesh__D012856 1991-01-01
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012856 2002
% 223.75/223.92  |- mesh__historyNote mesh__D012856 2001%28%1980%29%;   
% 223.75/223.92  |- skos__hiddenLabel mesh__D012856
% 223.75/223.92       4 Acetamido 4%27% isothiocyanatostilbene 2,2%27% disulfonic Acid
% 223.75/223.92  |- mesh__recordMaintainer mesh__D012856 jmp
% 223.75/223.92  |- mesh__dateRevised mesh__D012856 2000-06-21
% 223.75/223.92  |- skos__historyNote mesh__D012856 Thiocyanates %28%1966-1975%29%
% 223.75/223.92  |- mesh__recordOriginator mesh__D012856 RLS
% 223.75/223.92  |- skos__broader mesh__D012856smesh__D017879
% 223.75/223.92  |- skos__prefLabel mesh__D012856
% 223.75/223.92       4-Acetamido-4%27%-isothiocyanatostilbene-2,2%27%-disulfonic Acid
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012856 2006
% 223.75/223.92  |- skos__scopeNote mesh__D012856
% 223.75/223.92       A non-penetrating amino reagent %28%commonly called SITS%29% which acts as an inhibitor of anion transport in erythrocytes and other cells.%A%    
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012856 2001
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012856 2004
% 223.75/223.92  |- mesh__dateCreated mesh__D012856 1979-02-22
% 223.75/223.92  |- skos__broader mesh__D012856smesh__D013267
% 223.75/223.92  |- skos__altLabel mesh__D012856 SITS
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012856 2005
% 223.75/223.92  |- rdf__type mesh__D012856sskos__Concept
% 223.75/223.92  |- skos__broader mesh__D012058smesh__D001327
% 223.75/223.92  |- mesh__recordMaintainer mesh__D012058 ags
% 223.75/223.92  |- skos__altLabel mesh__D012058 Reiter%27%s Disease
% 223.75/223.92  |- skos__hiddenLabel mesh__D012058 Reiters Disease
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012058 2002
% 223.75/223.92  |- skos__broader mesh__D012058smesh__D003231
% 223.75/223.92  |- skos__broader mesh__D012058smesh__D025242
% 223.75/223.92  |- skos__prefLabel mesh__D012058 Reiter Disease
% 223.75/223.92  |- skos__broader mesh__D012058smesh__D014526
% 223.75/223.92  |- skos__broader mesh__D012058smesh__D001168
% 223.75/223.92  |- skos__scopeNote mesh__D012058
% 223.75/223.92       A triad of nongonococcal urethritis followed by conjunctivitis and arthritis, of unknown etiology.%A%    
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012058 2003
% 223.75/223.92  |- mesh__dateCreated mesh__D012058 1999-01-01
% 223.75/223.92  |- mesh__recordOriginator mesh__D012058 NLM
% 223.75/223.92  |- mesh__historyNote mesh__D012058 2002 %28%1963%29%   
% 223.75/223.92  |- rdf__type mesh__D012058sskos__Concept
% 223.75/223.92  |- skos__broader mesh__D012058smesh__D007239
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012058 2005
% 223.75/223.92  |- mesh__recordAuthorizer mesh__D012058 sjn
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012058 2004
% 223.75/223.92  |- mesh__publicMeSHNote mesh__D012058
% 223.75/223.92       2002; see REITER%27%S DISEASE 1963-2001   
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012058 2006
% 223.75/223.92  |- mesh__dateRevised mesh__D012058 2001-07-25
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D006819 2006
% 223.75/223.92  |- skos__broader mesh__D006819smesh__D012127
% 223.75/223.92  |- skos__annotation mesh__D006819
% 223.75/223.92        a resp distress syndrome; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; check tags  HUMANS %26% INFANT, NEWBORN%A%  
% 223.75/223.92  |- skos__hiddenLabel mesh__D006819 Hyaline Membrane Diseases
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D006819 2005
% 223.75/223.92  |- mesh__recordAuthorizer mesh__D006819 sjn
% 223.75/223.92  |- mesh__dateCreated mesh__D006819 1999-01-01
% 223.75/223.92  |- skos__scopeNote mesh__D006819
% 223.75/223.92       A disorder affecting newborn infants %28%usually premature%29% characterized pathologically by the development of a hyaline-like membrane lining the terminal respiratory passages. Extensive atelectasis is attributed to the lack of surfactant. %28%Dorland, 27th ed%29%%A%    
% 223.75/223.92  |- rdf__type mesh__D006819sskos__Concept
% 223.75/223.92  |- skos__hiddenLabel mesh__D006819 Disease, Hyaline Membrane
% 223.75/223.92  |- skos__hiddenLabel mesh__D006819 Diseases, Hyaline Membrane
% 223.75/223.92  |- skos__prefLabel mesh__D006819 Hyaline Membrane Disease
% 223.75/223.92  |- mesh__recordOriginator mesh__D006819 NLM
% 223.75/223.92  |- mesh__recordMaintainer mesh__D006819 sjn
% 223.75/223.92  |- mesh__dateRevised mesh__D006819 2004-07-13
% 223.75/223.92  |- mesh__historyNote mesh__D017541 93   
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017541 2003
% 223.75/223.92  |- skos__broader mesh__D017541smesh__D000783
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017541 1998
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017541 1997
% 223.75/223.92  |- mesh__recordOriginator mesh__D017541 PLS
% 223.75/223.92  |- skos__annotation mesh__D017541
% 223.75/223.92       IM; coord with specific vessel %28%IM%29% or precoord vasc dis if available %28%IM%29%%A%  
% 223.75/223.92  |- mesh__recordAuthorizer mesh__D017541 PLS
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017541 2001
% 223.75/223.92  |- mesh__dateRevised mesh__D017541 1996-06-10
% 223.75/223.92  |- skos__historyNote mesh__D017541 Aneurysm %28%1966-1992%29%
% 223.75/223.92  |- skos__hiddenLabel mesh__D017541 Pseudoaneurysms
% 223.75/223.92  |- mesh__publicMeSHNote mesh__D017541 93   
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017541 2000
% 223.75/223.92  |- mesh__dateCreated mesh__D017541 1992-05-20
% 223.75/223.92  |- skos__hiddenLabel mesh__D017541 False Aneurysms
% 223.75/223.92  |- skos__prefLabel mesh__D017541 Aneurysm, False
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017541 2006
% 223.75/223.92  |- rdf__type mesh__D017541sskos__Concept
% 223.75/223.92  |- mesh__recordMaintainer mesh__D017541 TGC
% 223.75/223.92  |- skos__hiddenLabel mesh__D017541 Aneurysms, False
% 223.75/223.92  |- skos__hiddenLabel mesh__D017541 False Aneurysm
% 223.75/223.92  |- skos__scopeNote mesh__D017541
% 223.75/223.92       An aneurysm in which the entire wall is injured and the blood is contained by the surrounding tissues, with eventual formation of a sac communicating with the artery or heart. %28%Dorland, 28th ed%29%%A%    
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017541 2005
% 223.75/223.92  |- mesh__dateEstablished mesh__D017541 1993-01-01
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017541 2004
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017541 2002
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017541 1999
% 223.75/223.92  |- rdf__type mesh__D031212sskos__Concept
% 223.75/223.92  |- skos__altLabel mesh__D031212 Kondagogu
% 223.75/223.92  |- mesh__historyNote mesh__D031212 2003   
% 223.75/223.92  |- skos__broader mesh__D031212smesh__D019684
% 223.75/223.92  |- mesh__dateCreated mesh__D031212 2002-07-02
% 223.75/223.92  |- skos__annotation mesh__D031212
% 223.75/223.92       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.75/223.92  |- mesh__publicMeSHNote mesh__D031212 2003   
% 223.75/223.92  |- skos__prefLabel mesh__D031212 Bixaceae
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D031212 2006
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D031212 2004
% 223.75/223.92  |- skos__scopeNote mesh__D031212
% 223.75/223.92       A plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida.  Bixa contains bixin.  Cochlospermum contains arjunolic acid and gum kondagogu %28%POLYSACCHARIDES%29%.%A%    
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D031212 2005
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D031212 2003
% 223.75/223.92  |- mesh__dateEstablished mesh__D031212 2003-01-01
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D003521 2005
% 223.75/223.92  |- mesh__onlineNote mesh__D003521
% 223.75/223.92       use CYCLOPROPANES to search CYCLOPROPANE 1966-74   
% 223.75/223.92  |- skos__annotation mesh__D003521 includes cyclopropenes   
% 223.75/223.92  |- rdf__type mesh__D003521sskos__Concept
% 223.75/223.92  |- mesh__recordAuthorizer mesh__D003521 sjn
% 223.75/223.92  |- skos__broader mesh__D003521smesh__D003516
% 223.75/223.92  |- skos__prefLabel mesh__D003521 Cyclopropanes
% 223.75/223.92  |- mesh__dateCreated mesh__D003521 1999-01-01
% 223.75/223.92  |- mesh__recordOriginator mesh__D003521 NLM
% 223.75/223.92  |- mesh__recordMaintainer mesh__D003521 ssb
% 223.75/223.92  |- mesh__dateRevised mesh__D003521 2004-07-07
% 223.75/223.92  |- mesh__publicMeSHNote mesh__D003521 75; was CYCLOPROPANE 1963-74   
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D003521 2006
% 223.75/223.92  |- mesh__historyNote mesh__D003521 75; was CYCLOPROPANE 1963-74   
% 223.75/223.92  |- mesh__recordOriginator mesh__D050177 lkt
% 223.75/223.92  |- rdf__type mesh__D050177sskos__Concept
% 223.75/223.92  |- skos__scopeNote mesh__D050177
% 223.75/223.92       A status with BODY WEIGHT that is above certain standard of acceptable or desirable weight. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat %28%ADIPOSE TISSUE%29%, hence overweight does not equal %22%over fat%22%.%A%    
% 223.75/223.92  |- mesh__recordAuthorizer mesh__D050177 sjn
% 223.75/223.92  |- mesh__dateCreated mesh__D050177 2005-06-30
% 223.75/223.92  |- mesh__recordMaintainer mesh__D050177 lkt
% 223.75/223.92  |- skos__broader mesh__D050177smesh__D001835
% 223.75/223.92  |- mesh__publicMeSHNote mesh__D050177 2006   
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D050177 2006
% 223.75/223.92  |- mesh__dateEstablished mesh__D050177 2006-01-01
% 223.75/223.92  |- skos__prefLabel mesh__D050177 Overweight
% 223.75/223.92  |- skos__historyNote mesh__D050177 Obesity %28%1965-2005%29%
% 223.75/223.92  |- mesh__historyNote mesh__D050177 2006   
% 223.75/223.92  |- skos__prefLabel mesh__D016449
% 223.75/223.92       Randomized Controlled Trial %5B%Publication Type%5D%
% 223.75/223.92  |- mesh__dateCreated mesh__D016449 1995-06-23
% 223.75/223.92  |- mesh__dateEstablished mesh__D016449 1996-01-01
% 223.75/223.92  |- mesh__dateRevised mesh__D016449 2005-06-30
% 223.75/223.92  |- mesh__recordOriginator mesh__D016449 TGC
% 223.75/223.92  |- skos__annotation mesh__D016449
% 223.75/223.92       publication type only; randomized controlled trials as a subject are indexed under the main heading RANDOMIZED CONTROLLED TRIALS; do not confuse with the Publication Type CONTROLLED CLINICAL TRIAL; Manual 26.26.3;  CATALOG: do not use%A%  
% 223.75/223.92  |- skos__scopeNote mesh__D016449
% 223.75/223.92       Work consisting of a clinical trial that involves at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.%A%    
% 223.75/223.92  |- skos__broader mesh__D016449smesh__D016430
% 223.75/223.92  |- mesh__recordMaintainer mesh__D016449 jls
% 223.75/223.92  |- mesh__recordAuthorizer mesh__D016449 sjn
% 223.75/223.92  |- mesh__historyNote mesh__D016449 1991   
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D016449 2006
% 223.75/223.92  |- skos__altLabel mesh__D016449 Randomized Controlled Trial %28%PT%29%
% 223.75/223.92  |- rdf__type mesh__D016449sskos__Concept
% 223.75/223.92  |- skos__annotation mesh__D002429
% 223.75/223.92       GEN: prefer specifics; cecitis = CECAL DISEASES %28%IM%29% + GASTROENTERITIS %28%IM%29%%A%  
% 223.75/223.92  |- skos__broader mesh__D002429smesh__D007410
% 223.75/223.92  |- rdf__type mesh__D002429sskos__Concept
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D002429 2004
% 223.75/223.92  |- skos__hiddenLabel mesh__D002429 Cecal Disease
% 223.75/223.92  |- skos__hiddenLabel mesh__D002429 Diseases, Cecal
% 223.75/223.92  |- skos__prefLabel mesh__D002429 Cecal Diseases
% 223.75/223.92  |- mesh__recordOriginator mesh__D002429 NLM
% 223.75/223.92  |- mesh__recordMaintainer mesh__D002429 lkt
% 223.75/223.92  |- mesh__dateCreated mesh__D002429 1999-01-01
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D002429 2006
% 223.75/223.92  |- skos__hiddenLabel mesh__D002429 Disease, Cecal
% 223.75/223.92  |- skos__scopeNote mesh__D002429
% 223.75/223.92       Pathological developments in the CECUM.     
% 223.75/223.92  |- mesh__dateRevised mesh__D002429 2003-07-09
% 223.75/223.92  |- mesh__recordAuthorizer mesh__D002429 sjn
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D002429 2005
% 223.75/223.92  |- mesh__historyNote mesh__D013151
% 223.75/223.92       GONGYLONEMA %26% PHYSALOPTERA were see under SPIRUROIDEA 1963-85; FILARIA LABIALIS was see under SPIRUROIDEA 1963-78%A%  
% 223.75/223.92  |- mesh__recordOriginator mesh__D013151 NLM
% 223.75/223.92  |- skos__broader mesh__D013151smesh__D017177
% 223.75/223.92  |- rdf__type mesh__D013151sskos__Concept
% 223.75/223.92  |- skos__annotation mesh__D013151
% 223.75/223.92       a superfamily of nematodes; do not confuse with the order SPIRURIDA or the suborder SPIRURINA; infection: coord IM with SPIRURIDA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 223.75/223.92  |- skos__prefLabel mesh__D013151 Spiruroidea
% 223.75/223.92  |- mesh__publicMeSHNote mesh__D013151
% 223.75/223.92       GONGYLONEMA %26% PHYSALOPTERA were see under SPIRUROIDEA 1963-85; FILARIA LABIALIS was see under SPIRUROIDEA 1963-78%A%  
% 223.75/223.92  |- mesh__dateRevised mesh__D013151 2003-07-09
% 223.75/223.92  |- skos__scopeNote mesh__D013151
% 223.75/223.92       A superfamily of parasitic nematodes which requires one or two intermediate arthropod hosts before finally being eaten by the final host. Its organisms occur rarely in man.%A%    
% 223.75/223.92  |- mesh__recordMaintainer mesh__D013151 ags
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D013151 2005
% 223.75/223.92  |- mesh__recordAuthorizer mesh__D013151 sjn
% 223.75/223.92  |- mesh__onlineNote mesh__D013151
% 223.75/223.92       use SPIRUROIDEA to search GONGYLONEMA %26% PHYSALOPTERA 1966-85 %26% FILARIA LABIALIS 1966-78%A%  
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D013151 2006
% 223.75/223.92  |- mesh__dateCreated mesh__D013151 1999-01-01
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D013151 2004
% 223.75/223.92  |- mesh__dateEstablished mesh__D007912 1991-01-01
% 223.75/223.92  |- mesh__recordOriginator mesh__D007912 NLM
% 223.75/223.92  |- skos__scopeNote mesh__D007912
% 223.75/223.92       Polysaccharide isolated from the edible mushroom LENTINULA EDODES. The exact composition is unknown.%A%    
% 223.75/223.92  |- mesh__dateRevised mesh__D007912 2004-07-13
% 223.75/223.92  |- skos__prefLabel mesh__D007912 Lentinan
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D007912 2006
% 223.75/223.92  |- skos__broader mesh__D007912smesh__D047071
% 223.75/223.92  |- mesh__historyNote mesh__D007912 91%28%71%29%   
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D007912 2005
% 223.75/223.92  |- skos__historyNote mesh__D007912 Polysaccharides %28%1972-1974%29%
% 223.75/223.92  |- mesh__dateCreated mesh__D007912 1974-11-19
% 223.75/223.92  |- mesh__publicMeSHNote mesh__D007912
% 223.75/223.92       91; was see under POLYSACCHARIDES 1975-90   
% 223.75/223.92  |- mesh__recordAuthorizer mesh__D007912 sjn
% 223.75/223.92  |- mesh__recordMaintainer mesh__D007912 ssb
% 223.75/223.92  |- rdf__type mesh__D007912sskos__Concept
% 223.75/223.92  |- skos__hiddenLabel mesh__D007114 Sensitizations, Immunological
% 223.75/223.92  |- skos__scopeNote mesh__D007114
% 223.75/223.92       Deliberate stimulation of the host%27%s immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts %28%e.g., transfer factor, immune RNA%29% or transplantation of immunocompetent cell producing tissue %28%thymus or bone marrow%29%.%A%    
% 223.75/223.92  |- skos__altLabel mesh__D007114 Stimulation, Immunologic
% 223.75/223.92  |- mesh__recordAuthorizer mesh__D007114 sjn
% 223.75/223.92  |- mesh__dateCreated mesh__D007114 1999-01-01
% 223.75/223.92  |- mesh__recordOriginator mesh__D007114 NLM
% 223.75/223.92  |- mesh__recordMaintainer mesh__D007114 ags
% 223.75/223.92  |- skos__hiddenLabel mesh__D007114 Variolations
% 223.75/223.92  |- skos__altLabel mesh__D007114 Immunostimulation
% 223.75/223.92  |- skos__broader mesh__D007114smesh__D007167
% 223.75/223.92  |- skos__hiddenLabel mesh__D007114 Stimulation, Immunological
% 223.75/223.92  |- skos__hiddenLabel mesh__D007114 Immunological Sensitizations
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D007114 2006
% 223.75/223.92  |- skos__broader mesh__D007114smesh__D003140
% 223.75/223.92  |- skos__altLabel mesh__D007114 Sensitization, Immunological
% 223.75/223.92  |- mesh__dateRevised mesh__D007114 2005-06-30
% 223.75/223.92  |- skos__hiddenLabel mesh__D007114 Immunological Sensitization
% 223.75/223.92  |- skos__altLabel mesh__D007114 Immunological Stimulation
% 223.75/223.92  |- skos__prefLabel mesh__D007114 Immunization
% 223.75/223.92  |- skos__hiddenLabel mesh__D007114 Immunological Stimulations
% 223.75/223.92  |- skos__broader mesh__D007114smesh__D007158
% 223.75/223.92  |- skos__altLabel mesh__D007114 Sensitization, Immunologic
% 223.75/223.92  |- skos__altLabel mesh__D007114 Immunologic Stimulation
% 223.75/223.92  |- skos__broader mesh__D007114smesh__D011322
% 223.75/223.92  |- rdf__type mesh__D007114sskos__Concept
% 223.75/223.92  |- skos__hiddenLabel mesh__D007114 Immunizations
% 223.75/223.92  |- skos__hiddenLabel mesh__D007114 Stimulations, Immunological
% 223.75/223.92  |- skos__altLabel mesh__D007114 Immunologic Sensitization
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Disorder, Primary Headache
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Primary Headache Disorder
% 223.75/223.92  |- skos__scopeNote mesh__D051270
% 223.75/223.92       Conditions in which the primary symptom is HEADACHE and the headache cannot be attributed to any known causes.%A%    
% 223.75/223.92  |- mesh__dateCreated mesh__D051270 2005-06-30
% 223.75/223.92  |- skos__historyNote mesh__D051270 Headache %28%1979-2005%29%
% 223.75/223.92  |- skos__altLabel mesh__D051270 Cough Headache
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Ice Pick Headache
% 223.75/223.92  |- skos__altLabel mesh__D051270 Stabbing Headache
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Cough Headache, Benign
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D051270 2006
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Ice-Pick Headaches
% 223.75/223.92  |- skos__altLabel mesh__D051270 Primary Headache Disorders
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Headache, Cough
% 223.75/223.92  |- mesh__dateEstablished mesh__D051270 2006-01-01
% 223.75/223.92  |- skos__altLabel mesh__D051270 Alarm Clock Headache
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Headache, Primary Stabbing
% 223.75/223.92  |- skos__altLabel mesh__D051270 Benign Exertional Headache
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Headache, Primary Exertional
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Exertional Headaches, Benign
% 223.75/223.92  |- skos__annotation mesh__D051270
% 223.75/223.92       for Valsalva maneuver headache coordinate with VALSALVA MANEUVER%A%  
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Disorders, Primary Headache
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Headache, Primary Thunderclap
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Headache Disorder, Primary
% 223.75/223.92  |- rdf__type mesh__D051270sskos__Concept
% 223.75/223.92  |- mesh__recordMaintainer mesh__D051270 lkt
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Headache Syndromes, Hypnic
% 223.75/223.92  |- skos__prefLabel mesh__D051270 Headache Disorders, Primary
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Headache, Benign Cough
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Benign Cough Headaches
% 223.75/223.92  |- mesh__recordAuthorizer mesh__D051270 sjn
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Headache, Primary Cough
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Headaches, Benign Exertional
% 223.75/223.92  |- skos__broader mesh__D051270smesh__D020773
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Headaches, Benign Cough
% 223.75/223.92  |- skos__altLabel mesh__D051270 Thunderclap Headache
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Headache, Hypnic
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Clock Headaches, Alarm
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Clock Headache, Alarm
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Headache, Ice-Pick
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Alarm Clock Headaches
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Headache, Stabbing
% 223.75/223.92  |- mesh__publicMeSHNote mesh__D051270
% 223.75/223.92       2006;  for COUGH HEADACHE; HEADACHE, THUNDERCLAP; and STABBING HEADACHE see HEADACHE 2000-2005; for BENIGN EXERTIONAL HEADACHE and HYPNIC HEADACHE SYNDROME see HEADACHE DISORDERS 2000-2005%A%  
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Benign Exertional Headaches
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Cough Headaches, Benign
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Hypnic Headache Syndromes
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Headache, Alarm Clock
% 223.75/223.92  |- skos__altLabel mesh__D051270 Benign Cough Headache
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Exertional Headache, Benign
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Headaches, Alarm Clock
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Headaches, Ice-Pick
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Headache, Benign Exertional
% 223.75/223.92  |- skos__hiddenLabel mesh__D051270 Headache Syndrome, Hypnic
% 223.75/223.92  |- mesh__historyNote mesh__D051270
% 223.75/223.92       2006;  for COUGH HEADACHE; HEADACHE, THUNDERCLAP; and STABBING HEADACHE use HEADACHE 2000-2005; for BENIGN EXERTIONAL HEADACHE and HYPNIC HEADACHE SYNDROME use HEADACHE DISORDERS 2000-2005%A%  
% 223.75/223.92  |- skos__altLabel mesh__D051270 Hypnic Headache Syndrome
% 223.75/223.92  |- mesh__recordOriginator mesh__D051270 lkt
% 223.75/223.92  |- skos__altLabel mesh__D051270 Ice-Pick Headache
% 223.75/223.92  |- skos__altLabel mesh__D051270 Headache, Thunderclap
% 223.75/223.92  |- mesh__dateCreated mesh__D012857 1999-01-01
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012857 2000
% 223.75/223.92  |- skos__scopeNote mesh__D012857
% 223.75/223.92       Lateral transposition of the viscera of the thorax and abdomen. It has a familial pattern and consanguineous parents have been reported. %28%From Dorland, 27th ed%29%%A%    
% 223.75/223.92  |- skos__annotation mesh__D012857
% 223.75/223.92       lateral transposition of the viscera; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 223.75/223.92  |- mesh__recordAuthorizer mesh__D012857 sjn
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012857 2006
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012857 2002
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012857 2004
% 223.75/223.92  |- mesh__recordMaintainer mesh__D012857 kle
% 223.75/223.92  |- skos__broader mesh__D012857smesh__D000013
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012857 2005
% 223.75/223.92  |- rdf__type mesh__D012857sskos__Concept
% 223.75/223.92  |- mesh__recordOriginator mesh__D012857 NLM
% 223.75/223.92  |- skos__prefLabel mesh__D012857 Situs Inversus
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012857 2003
% 223.75/223.92  |- skos__hiddenLabel mesh__D012857 Inversus, Situs
% 223.75/223.92  |- mesh__dateRevised mesh__D012857 1999-11-03
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012857 2001
% 223.75/223.92  |- skos__broader mesh__D012059smesh__D012919
% 223.75/223.92  |- mesh__recordOriginator mesh__D012059 NLM
% 223.75/223.92  |- mesh__dateEstablished mesh__D012059 1975-09-01
% 223.75/223.92  |- mesh__recordAuthorizer mesh__D012059 sjn
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012059 2003
% 223.75/223.92  |- rdf__type mesh__D012059sskos__Concept
% 223.75/223.92  |- skos__hiddenLabel mesh__D012059 Rejections
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012059 2005
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012059 2004
% 223.75/223.92  |- skos__prefLabel mesh__D012059 Rejection %28%Psychology%29%
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D012059 2006
% 223.75/223.92  |- skos__annotation mesh__D012059 no qualif; DF: REJECTION   
% 223.75/223.92  |- skos__historyNote mesh__D012059 Attitude %28%1966-1974%29%
% 223.75/223.92  |- skos__altLabel mesh__D012059 Rejection
% 223.75/223.92  |- mesh__dateRevised mesh__D012059 2002-07-03
% 223.75/223.92  |- mesh__dateCreated mesh__D012059 1975-02-04
% 223.75/223.92  |- mesh__publicMeSHNote mesh__D012059 75   
% 223.75/223.92  |- skos__hiddenLabel mesh__D012059 Rejections %28%Psychology%29%
% 223.75/223.92  |- mesh__historyNote mesh__D012059 75   
% 223.75/223.92  |- mesh__recordMaintainer mesh__D012059 JLS
% 223.75/223.92  |- skos__scopeNote mesh__D012059
% 223.75/223.92       Non-acceptance, negative attitudes, hostility or excessive criticism of the individual which may precipitate feelings of rejection.%A%    
% 223.75/223.92  |- skos__historyNote mesh__D017542 Aneurysm %28%1966-1992%29%
% 223.75/223.92  |- skos__broader mesh__D017542smesh__D000783
% 223.75/223.92  |- skos__hiddenLabel mesh__D017542 Ruptured Aneurysm
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017542 1997
% 223.75/223.92  |- skos__hiddenLabel mesh__D017542 Ruptured Aneurysms
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017542 1994
% 223.75/223.92  |- skos__hiddenLabel mesh__D017542 Aneurysms, Ruptured
% 223.75/223.92  |- skos__prefLabel mesh__D017542 Aneurysm, Ruptured
% 223.75/223.92  |- mesh__dateEstablished mesh__D017542 1993-01-01
% 223.75/223.92  |- skos__historyNote mesh__D017542 Rupture, Spontaneous %28%1968-1992%29%
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017542 2005
% 223.75/223.92  |- skos__annotation mesh__D017542
% 223.75/223.92       IM; coord with specific vessel %28%IM%29% or precoord vasc dis if available %28%IM%29%; if spontaneous, coord with RUPTURE, SPONTANEOUS %28%NIM%29%%A%  
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017542 2000
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017542 1995
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017542 2003
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017542 2006
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017542 2001
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017542 1998
% 223.75/223.92  |- rdf__type mesh__D017542sskos__Concept
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017542 1993
% 223.75/223.92  |- skos__scopeNote mesh__D017542
% 223.75/223.92       The tearing or herniation of the weakened wall of the aneurysmal sac.%A%    
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017542 2004
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017542 2002
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017542 1996
% 223.75/223.92  |- mesh__publicMeSHNote mesh__D017542 93   
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D017542 1999
% 223.75/223.92  |- mesh__dateCreated mesh__D017542 1992-05-20
% 223.75/223.92  |- mesh__historyNote mesh__D017542 93   
% 223.75/223.92  |- skos__broader mesh__D031213smesh__D028082
% 223.75/223.92  |- skos__annotation mesh__D031213
% 223.75/223.92       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.75/223.92  |- mesh__dateEstablished mesh__D031213 2003-01-01
% 223.75/223.92  |- mesh__publicMeSHNote mesh__D031213 2003   
% 223.75/223.92  |- mesh__historyNote mesh__D031213 2003   
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D031213 2006
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D031213 2004
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D031213 2005
% 223.75/223.92  |- mesh__dateCreated mesh__D031213 2002-07-03
% 223.75/223.92  |- skos__altLabel mesh__D031213 Manjack
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D031213 2003
% 223.75/223.92  |- skos__scopeNote mesh__D031213
% 223.75/223.92       A plant genus of the family BORAGINACEAE. Members contain TRITERPENES and naphthoxirene.%A%    
% 223.75/223.92  |- rdf__type mesh__D031213sskos__Concept
% 223.75/223.92  |- skos__prefLabel mesh__D031213 Cordia
% 223.75/223.92  |- mesh__historyNote mesh__D050976 2006   
% 223.75/223.92  |- mesh__recordOriginator mesh__D050976 DRC
% 223.75/223.92  |- skos__scopeNote mesh__D050976
% 223.75/223.92       A large superfamily of transcription factors that contain a region rich in BASIC AMINO ACID residues followed by a LEUCINE ZIPPER domain.%A%    
% 223.75/223.92  |- skos__hiddenLabel mesh__D050976
% 223.75/223.92       Basic Leucine Zipper Transcription Factors
% 223.75/223.92  |- mesh__activeMeSHYear mesh__D050976 2006
% 223.75/223.92  |- skos__broader mesh__D050976smesh__D004268
% 223.75/223.92  |- mesh__recordMaintainer mesh__D050976 DRC
% 223.75/223.92  |- skos__prefLabel mesh__D050976 Basic-Leucine Zipper Transcription Factors
% 223.75/223.92  |- skos__altLabel mesh__D050976 bZIP Transcription Factors
% 223.75/223.92  |- skos__broader mesh__D050976smesh__D014157
% 223.75/223.92  |- skos__hiddenLabel mesh__D050976 bZIP G Box Binding Factors
% 223.75/223.92  |- mesh__dateEstablished mesh__D050976 2006-01-01
% 223.75/223.92  |- rdf__type mesh__D050976sskos__Concept
% 223.75/223.92  |- mesh__dateCreated mesh__D050976 2005-06-30
% 223.75/223.92  |- mesh__recordAuthorizer mesh__D050976 sjn
% 223.75/223.92  |- skos__altLabel mesh__D050976 GBF bZIP Transcription Factors
% 223.75/223.92  |- skos__altLabel mesh__D050976 bZIP Proteins
% 223.75/223.92  |- skos__altLabel mesh__D050976 bZIP G-Box Binding Factors
% 223.75/223.92  |- mesh__publicMeSHNote mesh__D050976 2006   
% 223.75/223.92  |- skos__hiddenLabel mesh__D050976 Transcription Factors, bZIP
% 223.75/223.92  |- mesh__publicMeSHNote mesh__D050178
% 223.75/223.92       2006; see GLYCERIDES %28%1963-2005%29%   
% 223.75/223.92  |- mesh__recordOriginator mesh__D050178 ssb
% 223.75/223.93  |- mesh__historyNote mesh__D050178
% 223.75/223.93       2006; use GLYCERIDES %28%1963-2005%29%   
% 223.75/223.93  |- mesh__recordMaintainer mesh__D050178 ssb
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D050178 2006
% 223.75/223.93  |- mesh__recordAuthorizer mesh__D050178 sjn
% 223.75/223.93  |- skos__altLabel mesh__D050178 Monoacylglycerols
% 223.75/223.93  |- mesh__dateCreated mesh__D050178 2005-06-30
% 223.75/223.93  |- skos__broader mesh__D050178smesh__D005989
% 223.75/223.93  |- skos__prefLabel mesh__D050178 Monoglycerides
% 223.75/223.93  |- skos__scopeNote mesh__D050178
% 223.75/223.93       GLYCEROL esterified with a single acyl %28%FATTY ACIDS%29% chain.%A%    
% 223.75/223.93  |- skos__historyNote mesh__D050178 Glycerides %28%1963-2005%29%
% 223.75/223.93  |- rdf__type mesh__D050178sskos__Concept
% 223.75/223.93  |- mesh__dateEstablished mesh__D050178 2006-01-01
% 223.75/223.93  |- skos__prefLabel mesh__D041641 Musculoskeletal Development
% 223.75/223.93  |- skos__hiddenLabel mesh__D041641 System Development, Musculoskeletal
% 223.75/223.93  |- skos__hiddenLabel mesh__D041641 Development, Musculoskeletal System
% 223.75/223.93  |- skos__broader mesh__D041641smesh__D043702
% 223.75/223.93  |- skos__historyNote mesh__D041641
% 223.75/223.93       Musculoskeletal System/growth %26% development %28%1991-2003%29%
% 223.75/223.93  |- skos__hiddenLabel mesh__D041641 Development, Musculoskeletal
% 223.75/223.93  |- mesh__historyNote mesh__D041641 2004   
% 223.75/223.93  |- skos__scopeNote mesh__D041641
% 223.75/223.93       The morphologic and physiological changes of the MUSCLES, bones %28%BONE AND BONES%29%, and CARTILAGE of the body, i.e., MUSCULOSKELETAL SYSTEM, during the prenatal and postnatal stages of development.%A%    
% 223.75/223.93  |- skos__broader mesh__D041641smesh__D038081
% 223.75/223.93  |- skos__related mesh__D041641smesh__D009141
% 223.75/223.93  |- mesh__recordAuthorizer mesh__D041641 sjn
% 223.75/223.93  |- mesh__dateEstablished mesh__D041641 2004-01-01
% 223.75/223.93  |- mesh__recordMaintainer mesh__D041641 lkt
% 223.75/223.93  |- mesh__dateRevised mesh__D041641 2004-07-08
% 223.75/223.93  |- rdf__type mesh__D041641sskos__Concept
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D041641 2005
% 223.75/223.93  |- mesh__dateCreated mesh__D041641 2003-07-09
% 223.75/223.93  |- skos__annotation mesh__D041641 GEN: prefer specifics   
% 223.75/223.93  |- mesh__recordOriginator mesh__D041641 nns
% 223.75/223.93  |- mesh__publicMeSHNote mesh__D041641 2004   
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D041641 2006
% 223.75/223.93  |- skos__altLabel mesh__D041641 Musculoskeletal System Development
% 223.75/223.93  |- skos__hiddenLabel mesh__D013950 Thymus Glands
% 223.75/223.93  |- mesh__recordMaintainer mesh__D013950 lkt
% 223.75/223.93  |- skos__related mesh__D013950smesh__D013934
% 223.75/223.93  |- rdf__type mesh__D013950sskos__Concept
% 223.75/223.93  |- mesh__recordAuthorizer mesh__D013950 sjn
% 223.75/223.93  |- mesh__dateRevised mesh__D013950 2004-07-07
% 223.75/223.93  |- mesh__recordOriginator mesh__D013950 NLM
% 223.75/223.93  |- skos__related mesh__D013950smesh__D002060
% 223.75/223.93  |- skos__scopeNote mesh__D013950
% 223.75/223.93       A single, unpaired primary lymphoid organ situated in the MEDIASTINUM, extending superiorly into the neck to the lower edge of the THYROID GLAND and inferiorly to the fourth costal cartilage. It is necessary for normal development of immunologic function early in life. By puberty, it begins to involute and much of the tissue is replaced by fat.%A%    
% 223.75/223.93  |- mesh__dateCreated mesh__D013950 1999-01-01
% 223.75/223.93  |- skos__altLabel mesh__D013950 Thymus
% 223.75/223.93  |- skos__annotation mesh__D013950
% 223.75/223.93       dis: coord IM with LYMPHATIC DISEASES %28%IM%29%; /surg: probably THYMECTOMY; thymocyte in immunol context is probably T-LYMPHOCYTES; agenesis, aplasia, dysplasia = DIGEORGE SYNDROME; thymic cyst = THYMIC CYST see MEDIASTINAL CYST%A%  
% 223.75/223.93  |- skos__hiddenLabel mesh__D013950 Gland, Thymus
% 223.75/223.93  |- skos__broader mesh__D013950smesh__D008221
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013950 2005
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013950 2006
% 223.75/223.93  |- skos__prefLabel mesh__D013950 Thymus Gland
% 223.75/223.93  |- skos__hiddenLabel mesh__D013950 Glands, Thymus
% 223.75/223.93  |- skos__broader mesh__D013152smesh__D001775
% 223.75/223.93  |- rdf__type mesh__D013152sskos__Concept
% 223.75/223.93  |- skos__hiddenLabel mesh__D013152 Circulations, Splanchnic
% 223.75/223.93  |- skos__hiddenLabel mesh__D013152 Mesenteric Circulations
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013152 2005
% 223.75/223.93  |- mesh__publicMeSHNote mesh__D013152 81   
% 223.75/223.93  |- mesh__recordAuthorizer mesh__D013152 sjn
% 223.75/223.93  |- mesh__dateCreated mesh__D013152 1980-05-15
% 223.75/223.93  |- skos__altLabel mesh__D013152 Mesenteric Circulation
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013152 2006
% 223.75/223.93  |- skos__altLabel mesh__D013152 Circulation, Splanchnic
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013152 2004
% 223.75/223.93  |- mesh__recordMaintainer mesh__D013152 nns
% 223.75/223.93  |- mesh__historyNote mesh__D013152 81   
% 223.75/223.93  |- skos__scopeNote mesh__D013152
% 223.75/223.93       The circulation of blood through the BLOOD VESSELS supplying the abdominal VISCERA.%A%    
% 223.75/223.93  |- skos__hiddenLabel mesh__D013152 Splanchnic Circulations
% 223.75/223.93  |- mesh__recordOriginator mesh__D013152 VDK
% 223.75/223.93  |- mesh__dateEstablished mesh__D013152 1981-01-01
% 223.75/223.93  |- skos__annotation mesh__D013152 DF: SPLANCHNIC CIRC   
% 223.75/223.93  |- skos__prefLabel mesh__D013152 Splanchnic Circulation
% 223.75/223.93  |- skos__altLabel mesh__D013152 Circulation, Mesenteric
% 223.75/223.93  |- mesh__dateRevised mesh__D013152 2003-07-09
% 223.75/223.93  |- skos__hiddenLabel mesh__D013152 Circulations, Mesenteric
% 223.75/223.93  |- skos__scopeNote mesh__D007913
% 223.75/223.93       A species of the family HERPESVIRIDAE, whose genus is so far unassigned. It is probably the causative agent of ADENOMA or ADENOCARCINOMA in the kidneys of certain frogs.%A%    
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007913 2003
% 223.75/223.93  |- skos__altLabel mesh__D007913 Lucke frog herpesvirus
% 223.75/223.93  |- mesh__publicMeSHNote mesh__D007913
% 223.75/223.93       94; was LEOPARD FROG CARCINOMA VIRUS 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%%A%  
% 223.75/223.93  |- skos__prefLabel mesh__D007913 Herpesvirus 1, Ranid
% 223.75/223.93  |- skos__broader mesh__D007913smesh__D004263
% 223.75/223.93  |- skos__broader mesh__D007913smesh__D006564
% 223.75/223.93  |- skos__hiddenLabel mesh__D007913 Tumor Virus, Lucke
% 223.75/223.93  |- mesh__recordMaintainer mesh__D007913 ags
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007913 2006
% 223.75/223.93  |- mesh__onlineNote mesh__D007913
% 223.75/223.93       use HERPESVIRUS 1, RANID to search LEOPARD FROG CARCINOMA VIRUS 1975-93%A%  
% 223.75/223.93  |- skos__hiddenLabel mesh__D007913 Lucke frog herpesviruses
% 223.75/223.93  |- skos__altLabel mesh__D007913 Leopard Frog Carcinoma Virus
% 223.75/223.93  |- skos__altLabel mesh__D007913 Lucke Tumor Virus
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007913 2005
% 223.75/223.93  |- mesh__recordAuthorizer mesh__D007913 sjn
% 223.75/223.93  |- mesh__historyNote mesh__D007913
% 223.75/223.93       94; was LEOPARD FROG CARCINOMA VIRUS 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%%A%  
% 223.75/223.93  |- skos__annotation mesh__D007913
% 223.75/223.93       infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%%A%  
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007913 2002
% 223.75/223.93  |- rdf__type mesh__D007913sskos__Concept
% 223.75/223.93  |- mesh__dateCreated mesh__D007913 1974-12-12
% 223.75/223.93  |- mesh__dateEstablished mesh__D007913 1991-01-01
% 223.75/223.93  |- mesh__recordOriginator mesh__D007913 NLM
% 223.75/223.93  |- mesh__dateRevised mesh__D007913 2001-07-25
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007913 2004
% 223.75/223.93  |- skos__altLabel mesh__D007913 Ranid herpesvirus 1
% 223.75/223.93  |- mesh__recordAuthorizer mesh__D007115 SJN
% 223.75/223.93  |- skos__prefLabel mesh__D007115 Immunization Schedule
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007115 1999
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007115 2005
% 223.75/223.93  |- skos__hiddenLabel mesh__D007115 Schedule, Immunization
% 223.75/223.93  |- skos__broader mesh__D007115smesh__D007114
% 223.75/223.93  |- skos__annotation mesh__D007115 no qualif   
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007115 2000
% 223.75/223.93  |- mesh__dateRevised mesh__D007115 1998-06-10
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007115 2006
% 223.75/223.93  |- skos__scopeNote mesh__D007115
% 223.75/223.93       Schedule giving optimum times usually for primary and/or secondary immunization.%A%    
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007115 2001
% 223.75/223.93  |- mesh__recordMaintainer mesh__D007115 AGS
% 223.75/223.93  |- skos__hiddenLabel mesh__D007115 Schedules, Immunization
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007115 2003
% 223.75/223.93  |- mesh__recordOriginator mesh__D007115 NLM
% 223.75/223.93  |- skos__hiddenLabel mesh__D007115 Immunization Schedules
% 223.75/223.93  |- mesh__dateCreated mesh__D007115 1999-01-01
% 223.75/223.93  |- rdf__type mesh__D007115sskos__Concept
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007115 2004
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007115 2002
% 223.75/223.93  |- skos__hiddenLabel mesh__D051271 Secondary Headache Disorder
% 223.75/223.93  |- mesh__dateEstablished mesh__D051271 2006-01-01
% 223.75/223.93  |- skos__hiddenLabel mesh__D051271 Headache Disorder, Secondary
% 223.75/223.93  |- skos__scopeNote mesh__D051271
% 223.75/223.93       Conditions with HEADACHE symptom that can be attributed to a variety of causes including BRAIN VASCULAR DISORDERS; WOUNDS AND INJURIES; INFECTION; drug use or its withdrawal.%A%    
% 223.75/223.93  |- skos__hiddenLabel mesh__D051271 Disorders, Secondary Headache
% 223.75/223.93  |- skos__hiddenLabel mesh__D051271 Analgesic Rebound Headaches
% 223.75/223.93  |- mesh__recordAuthorizer mesh__D051271 sjn
% 223.75/223.93  |- mesh__dateCreated mesh__D051271 2005-06-30
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D051271 2006
% 223.75/223.93  |- skos__hiddenLabel mesh__D051271 Disorder, Secondary Headache
% 223.75/223.93  |- skos__hiddenLabel mesh__D051271 Headaches, Analgesic Rebound
% 223.75/223.93  |- skos__hiddenLabel mesh__D051271 Headache, Analgesic Overuse
% 223.75/223.93  |- skos__historyNote mesh__D051271 Headache %28%1993-2005%29%
% 223.75/223.93  |- mesh__historyNote mesh__D051271
% 223.75/223.93       2006; use HEADACHE DISORDERS 2000-2005   
% 223.75/223.93  |- skos__prefLabel mesh__D051271 Headache Disorders, Secondary
% 223.75/223.93  |- mesh__recordOriginator mesh__D051271 lkt
% 223.75/223.93  |- skos__altLabel mesh__D051271 Secondary Headache Disorders
% 223.75/223.93  |- mesh__recordMaintainer mesh__D051271 lkt
% 223.75/223.93  |- skos__hiddenLabel mesh__D051271 Headache, Analgesic Rebound
% 223.75/223.93  |- skos__hiddenLabel mesh__D051271 Analgesic Overuse Headaches
% 223.75/223.93  |- skos__broader mesh__D051271smesh__D020773
% 223.75/223.93  |- skos__hiddenLabel mesh__D051271 Headaches, Analgesic Overuse
% 223.75/223.93  |- rdf__type mesh__D051271sskos__Concept
% 223.75/223.93  |- mesh__publicMeSHNote mesh__D051271
% 223.75/223.93       2006; see HEADACHE DISORDERS 2000-2005   
% 223.75/223.93  |- skos__hiddenLabel mesh__D012858 Perceptions, Size
% 223.75/223.93  |- mesh__recordAuthorizer mesh__D012858 PLS
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D012858 1997
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D012858 2000
% 223.75/223.93  |- mesh__recordOriginator mesh__D012858 NLM
% 223.75/223.93  |- skos__broader mesh__D012858smesh__D010465
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D012858 2005
% 223.75/223.93  |- skos__hiddenLabel mesh__D012858 Perception, Size
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D012858 2001
% 223.75/223.93  |- mesh__dateRevised mesh__D012858 1992-05-18
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D012858 2003
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D012858 2006
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D012858 2002
% 223.75/223.93  |- mesh__recordMaintainer mesh__D012858 TAP
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D012858 2004
% 223.75/223.93  |- skos__prefLabel mesh__D012858 Size Perception
% 223.75/223.93  |- mesh__dateCreated mesh__D012858 1999-01-01
% 223.75/223.93  |- skos__hiddenLabel mesh__D012858 Size Perceptions
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D012858 1994
% 223.75/223.93  |- rdf__type mesh__D012858sskos__Concept
% 223.75/223.93  |- skos__scopeNote mesh__D012858
% 223.75/223.93       The sensory interpretation of the dimensions of objects.%A%    
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D012858 1998
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D012858 1995
% 223.75/223.93  |- skos__broader mesh__D012858smesh__D013028
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D012858 1993
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D012858 1996
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D012858 1999
% 223.75/223.93  |- mesh__recordMaintainer mesh__D017543 TAP
% 223.75/223.93  |- mesh__dateRevised mesh__D017543 1993-06-02
% 223.75/223.93  |- skos__historyNote mesh__D017543 Iliac Artery %28%1966-1992%29%
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D017543 2002
% 223.75/223.93  |- mesh__publicMeSHNote mesh__D017543 93   
% 223.75/223.93  |- mesh__dateCreated mesh__D017543 1992-05-20
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D017543 1994
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D017543 2005
% 223.75/223.93  |- skos__annotation mesh__D017543
% 223.75/223.93       aneurysm of an iliac artery; dissecting aneurysm: coord IM with ANEURYSM, DISSECTING %28%IM%29%; rupture: coord with ANEURYSM, RUPTURED %28%IM%29% or if spontaneous, with RUPTURE, SPONTANEOUS %28%NIM%29%%A%  
% 223.75/223.93  |- skos__scopeNote mesh__D017543
% 223.75/223.93       An aneurysm of the common, internal, or external iliac arteries.%A%    
% 223.75/223.93  |- skos__hiddenLabel mesh__D017543 Iliac Aneurysms
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D017543 1995
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D017543 2003
% 223.75/223.93  |- skos__prefLabel mesh__D017543 Iliac Aneurysm
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D017543 2006
% 223.75/223.93  |- mesh__recordAuthorizer mesh__D017543 PLS
% 223.75/223.93  |- rdf__type mesh__D017543sskos__Concept
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D017543 1998
% 223.75/223.93  |- skos__hiddenLabel mesh__D017543 Aneurysms, Iliac
% 223.75/223.93  |- mesh__dateEstablished mesh__D017543 1993-01-01
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D017543 2004
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D017543 1996
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D017543 1999
% 223.75/223.93  |- mesh__historyNote mesh__D017543 93   
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D017543 2000
% 223.75/223.93  |- skos__hiddenLabel mesh__D017543 Aneurysm, Iliac
% 223.75/223.93  |- skos__broader mesh__D017543smesh__D000783
% 223.75/223.93  |- skos__historyNote mesh__D017543 Aneurysm %28%1966-1992%29%
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D017543 2001
% 223.75/223.93  |- mesh__recordOriginator mesh__D017543 PLS
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D017543 1997
% 223.75/223.93  |- skos__scopeNote mesh__D031214
% 223.75/223.93       A plant genus of the family BRASSICACEAE. Member species are ornamentals grown for their numerous small white, yellow, pink, or purplish flowers.%A%    
% 223.75/223.93  |- skos__broader mesh__D031214smesh__D019607
% 223.75/223.93  |- skos__annotation mesh__D031214
% 223.75/223.93       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.75/223.93  |- skos__altLabel mesh__D031214 Cress, Rock
% 223.75/223.93  |- mesh__publicMeSHNote mesh__D031214 2003   
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D031214 2005
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D031214 2003
% 223.75/223.93  |- mesh__dateEstablished mesh__D031214 2003-01-01
% 223.75/223.93  |- mesh__dateCreated mesh__D031214 2002-07-02
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D031214 2006
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D031214 2004
% 223.75/223.93  |- skos__prefLabel mesh__D031214 Arabis
% 223.75/223.93  |- mesh__historyNote mesh__D031214 2003   
% 223.75/223.93  |- rdf__type mesh__D031214sskos__Concept
% 223.75/223.93  |- rdf__type mesh__D050977sskos__Concept
% 223.75/223.93  |- skos__scopeNote mesh__D050977
% 223.75/223.93       Maf transcription factors are a family of basic-leucine zipper transcription factors that are closely related to V-MAF ONCOGENE PROTEIN. The C-MAF PROTO-ONCOGENE PROTEIN was the first mammalian Maf transcription factor identified, and now the family is known to include a variety of other Maf proteins such as MAFB TRANSCRIPTION FACTOR; MAFF TRANSCRIPTION FACTOR; MAFG TRANSCRIPTION FACTOR; and MAFK TRANSCRIPTION FACTOR.%A%    
% 223.75/223.93  |- skos__prefLabel mesh__D050977 Maf Transcription Factors
% 223.75/223.93  |- mesh__historyNote mesh__D050977 2006   
% 223.75/223.93  |- skos__hiddenLabel mesh__D050977 Transcription Factors, Maf
% 223.75/223.93  |- mesh__recordMaintainer mesh__D050977 DRC
% 223.75/223.93  |- skos__altLabel mesh__D050977
% 223.75/223.93       Musculoaponeurotic Fibrosarcoma Protein Family
% 223.75/223.93  |- mesh__publicMeSHNote mesh__D050977 2006   
% 223.75/223.93  |- mesh__recordOriginator mesh__D050977 DRC
% 223.75/223.93  |- skos__altLabel mesh__D050977 Maf Proteins
% 223.75/223.93  |- mesh__dateEstablished mesh__D050977 2006-01-01
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D050977 2006
% 223.75/223.93  |- skos__broader mesh__D050977smesh__D050976
% 223.75/223.93  |- mesh__dateCreated mesh__D050977 2005-06-30
% 223.75/223.93  |- mesh__recordAuthorizer mesh__D050977 sjn
% 223.75/223.93  |- mesh__dateCreated mesh__D003523 1999-01-01
% 223.75/223.93  |- mesh__recordAuthorizer mesh__D003523 sjn
% 223.75/223.93  |- rdf__type mesh__D003523sskos__Concept
% 223.75/223.93  |- skos__altLabel mesh__D003523 R-4-Amino-3-isoxazolidinone
% 223.75/223.93  |- mesh__recordOriginator mesh__D003523 NLM
% 223.75/223.93  |- skos__prefLabel mesh__D003523 Cycloserine
% 223.75/223.93  |- skos__broader mesh__D003523smesh__D012694
% 223.75/223.93  |- mesh__dateRevised mesh__D003523 2005-06-30
% 223.75/223.93  |- skos__broader mesh__D003523smesh__D023303
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D003523 2006
% 223.75/223.93  |- skos__scopeNote mesh__D003523
% 223.75/223.93       Antibiotic substance produced by Streptomyces garyphalus.%A%    
% 223.75/223.93  |- mesh__recordMaintainer mesh__D003523 ssb
% 223.75/223.93  |- skos__broader mesh__D003523smesh__D007555
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013951 2001
% 223.75/223.93  |- skos__altLabel mesh__D013951 Thymic Hormones
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013951 1999
% 223.75/223.93  |- mesh__publicMeSHNote mesh__D013951 77   
% 223.75/223.93  |- mesh__recordMaintainer mesh__D013951 TGC
% 223.75/223.93  |- mesh__historyNote mesh__D013951 77   
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013951 1993
% 223.75/223.93  |- skos__annotation mesh__D013951 /biosyn /physiol permitted   
% 223.75/223.93  |- skos__hiddenLabel mesh__D013951 Hormones, Thymus
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013951 2005
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013951 1996
% 223.75/223.93  |- skos__prefLabel mesh__D013951 Thymus Hormones
% 223.75/223.93  |- mesh__dateCreated mesh__D013951 1976-04-16
% 223.75/223.93  |- skos__scopeNote mesh__D013951
% 223.75/223.93       Humoral factors secreted by the thymus gland. They participate in the development of the lymphoid system and the maturation of the cellular immune response.%A%    
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013951 2002
% 223.75/223.93  |- mesh__recordOriginator mesh__D013951 RLS
% 223.75/223.93  |- skos__historyNote mesh__D013951 Hormones %28%1966-1976%29%
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013951 1997
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013951 2006
% 223.75/223.93  |- mesh__recordAuthorizer mesh__D013951 PLS
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013951 1994
% 223.75/223.93  |- skos__hiddenLabel mesh__D013951 Hormones, Thymic
% 223.75/223.93  |- mesh__dateEstablished mesh__D013951 1977-01-01
% 223.75/223.93  |- skos__historyNote mesh__D013951 Thymus Gland %28%1966-1976%29%
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013951 1995
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013951 2003
% 223.75/223.93  |- rdf__type mesh__D013951sskos__Concept
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013951 2000
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013951 1998
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013951 2004
% 223.75/223.93  |- mesh__dateRevised mesh__D013951 1992-05-20
% 223.75/223.93  |- skos__broader mesh__D013951smesh__D006728
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013153 2003
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013153 1998
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013153 2006
% 223.75/223.93  |- mesh__dateCreated mesh__D013153 1999-01-01
% 223.75/223.93  |- skos__broader mesh__D013153smesh__D017776
% 223.75/223.93  |- skos__hiddenLabel mesh__D013153 Nerve, Splanchnic
% 223.75/223.93  |- skos__prefLabel mesh__D013153 Splanchnic Nerves
% 223.75/223.93  |- skos__broader mesh__D013153smesh__D013564
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013153 1996
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013153 2004
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013153 1999
% 223.75/223.93  |- skos__scopeNote mesh__D013153
% 223.75/223.93       The major nerves supplying sympathetic innervation to the abdomen. The greater, lesser, and lowest %28%or smallest%29% splanchnic nerves are formed by preganglionic fibers from the spinal cord which pass through the paravertebral ganglia and then to the celiac ganglia and plexuses. The lumbar splanchnic nerves carry fibers which pass through the lumbar paravertebral ganglia to the mesenteric and hypogastric ganglia.%A%    
% 223.75/223.93  |- skos__hiddenLabel mesh__D013153 Splanchnic Nerve
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013153 1997
% 223.75/223.93  |- mesh__recordAuthorizer mesh__D013153 PLS
% 223.75/223.93  |- skos__hiddenLabel mesh__D013153 Nerves, Splanchnic
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013153 2000
% 223.75/223.93  |- mesh__dateRevised mesh__D013153 1993-06-21
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013153 2001
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013153 1994
% 223.75/223.93  |- mesh__recordOriginator mesh__D013153 NLM
% 223.75/223.93  |- rdf__type mesh__D013153sskos__Concept
% 223.75/223.93  |- mesh__recordMaintainer mesh__D013153 RAZ
% 223.75/223.93  |- skos__annotation mesh__D013153
% 223.75/223.93       major nerves of sympath innerv of abdomen   
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013153 2005
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013153 2002
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D013153 1995
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007914 2006
% 223.75/223.93  |- skos__hiddenLabel mesh__D007914 Colonies, Leper
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007914 2002
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007914 2005
% 223.75/223.93  |- mesh__recordMaintainer mesh__D007914 kle
% 223.75/223.93  |- mesh__recordOriginator mesh__D007914 NLM
% 223.75/223.93  |- rdf__type mesh__D007914sskos__Concept
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007914 2001
% 223.75/223.93  |- mesh__dateCreated mesh__D007914 1999-01-01
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007914 2004
% 223.75/223.93  |- skos__scopeNote mesh__D007914
% 223.75/223.93       Residential treatment centers for individuals with leprosy.%A%    
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007914 2000
% 223.75/223.93  |- skos__prefLabel mesh__D007914 Leper Colonies
% 223.75/223.93  |- skos__hiddenLabel mesh__D007914 Colony, Leper
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007914 2003
% 223.75/223.93  |- skos__annotation mesh__D007914 specify geog   
% 223.75/223.93  |- skos__hiddenLabel mesh__D007914 Leper Colony
% 223.75/223.93  |- skos__broader mesh__D007914smesh__D006268
% 223.75/223.93  |- mesh__dateRevised mesh__D007914 1999-11-03
% 223.75/223.93  |- mesh__recordAuthorizer mesh__D007914 sjn
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007116 1999
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007116 2000
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007116 2004
% 223.75/223.93  |- mesh__historyNote mesh__D007116
% 223.75/223.93       80; was PASSIVE TRANSFER 1970-79 %28%Prov 1970-72%29%; IMMUNOTHERAPY, PASSIVE was see IMMUNOTHERAPY, ADOPTIVE 1991-96, was see IMMUNIZATION, PASSIVE 1983-90; IMMUNE SERUM GLOBULIN THERAPY was see IMMUNIZATION, PASSIVE 1983-91; SEROTHERAPY was heading 1963-82%A%  
% 223.75/223.93  |- skos__hiddenLabel mesh__D007116 Immunizations, Passive
% 223.75/223.93  |- skos__broader mesh__D007116smesh__D007114
% 223.75/223.93  |- mesh__dateRevised mesh__D007116 1996-06-10
% 223.75/223.93  |- skos__altLabel mesh__D007116 Passive Transfer of Immunity
% 223.75/223.93  |- skos__hiddenLabel mesh__D007116 Immunoglobulin Therapies
% 223.75/223.93  |- skos__hiddenLabel mesh__D007116 Serotherapies
% 223.75/223.93  |- rdf__type mesh__D007116sskos__Concept
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007116 1998
% 223.75/223.93  |- skos__hiddenLabel mesh__D007116 Passive Immunotherapies
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007116 2003
% 223.75/223.93  |- mesh__dateEstablished mesh__D007116 1973-01-01
% 223.75/223.93  |- mesh__recordAuthorizer mesh__D007116 PLS
% 223.75/223.93  |- skos__hiddenLabel mesh__D007116 Passive Immunization
% 223.75/223.93  |- skos__hiddenLabel mesh__D007116 Passive Immunizations
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007116 2002
% 223.75/223.93  |- mesh__dateCreated mesh__D007116 1999-01-01
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007116 2006
% 223.75/223.93  |- skos__hiddenLabel mesh__D007116 Transfer, Passive Antibody
% 223.75/223.93  |- skos__hiddenLabel mesh__D007116 Passive Antibody Transfers
% 223.75/223.93  |- skos__altLabel mesh__D007116 Therapy, Immunoglobulin
% 223.75/223.93  |- skos__hiddenLabel mesh__D007116 Transfers, Passive Antibody
% 223.75/223.93  |- skos__prefLabel mesh__D007116 Immunization, Passive
% 223.75/223.93  |- mesh__recordOriginator mesh__D007116 NLM
% 223.75/223.93  |- skos__hiddenLabel mesh__D007116 Therapies, Immunoglobulin
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007116 1997
% 223.75/223.93  |- skos__hiddenLabel mesh__D007116 Antibody Transfer, Passive
% 223.75/223.93  |- mesh__recordMaintainer mesh__D007116 AGS
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007116 2005
% 223.75/223.93  |- mesh__onlineNote mesh__D007116
% 223.75/223.93       use IMMUNIZATION, PASSIVE to search PASSIVE TRANSFER 1970-79 %28%Prov 1970-72%29%, IMMUNOTHERAPY, PASSIVE 1983-90, IMMUNE SERUM GLOBULIN THERAPY 1983-91, %26% SEROTHERAPY 1966-82; use IMMUNOTHERAPY, ADOPTIVE to search IMMUNOTHERAPY, PASSIVE 1991-96%A%  
% 223.75/223.93  |- skos__scopeNote mesh__D007116
% 223.75/223.93       Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes %28%ADOPTIVE TRANSFER%29%.%A%    
% 223.75/223.93  |- skos__hiddenLabel mesh__D007116 Immunotherapies, Passive
% 223.75/223.93  |- mesh__publicMeSHNote mesh__D007116
% 223.75/223.93       80; was PASSIVE TRANSFER 1973-79; IMMUNOTHERAPY, PASSIVE was see IMMUNOTHERAPY, ADOPTIVE 1991-96, was see IMMUNIZATION, PASSIVE 1983-90; IMMUNE SERUM GLOBULIN THERAPY was see IMMUNIZATION, PASSIVE 1983-91; SEROTHERAPY was heading 1963-82%A%  
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D007116 2001
% 223.75/223.93  |- skos__annotation mesh__D007116
% 223.75/223.93       IM; note category: do not confuse with IMMUNITY, MATERNALLY-ACQUIRED %28%Cat G%29% nor X ref PASSIVE TRANSFER OF IMMUNITY with passive transfer of immune tolerance %28% = IMMUNOSUPPRESSION%29% nor X ref IMMUNOGLOBULIN THERAPY with IMMUNOGLOBULINS, INTRAVENOUS%A%  
% 223.75/223.93  |- skos__hiddenLabel mesh__D007116 Antibody Transfers, Passive
% 223.75/223.93  |- skos__historyNote mesh__D007116
% 223.75/223.93       Immunity, Maternally-Acquired %28%1966-1969%29%
% 223.75/223.93  |- skos__altLabel mesh__D007116 Passive Immunotherapy
% 223.75/223.93  |- skos__altLabel mesh__D051272 GLUT1 Protein
% 223.75/223.93  |- mesh__historyNote mesh__D051272 2006%28%1992%29%   
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D051272 2006
% 223.75/223.93  |- skos__altLabel mesh__D051272 SLC2A1 Protein
% 223.75/223.93  |- skos__hiddenLabel mesh__D051272 GLUT 1 Protein
% 223.75/223.93  |- mesh__dateEstablished mesh__D051272 2006-01-01
% 223.75/223.93  |- skos__broader mesh__D051272smesh__D051246
% 223.75/223.93  |- mesh__recordOriginator mesh__D051272 DRC
% 223.75/223.93  |- mesh__publicMeSHNote mesh__D051272
% 223.75/223.93       2006; GLUCOSE TRANSPORTER TYPE 1 was indexed under MONOSACCHARIDE TRANSPORT PROTEINS 1992-2005%A%  
% 223.75/223.93  |- mesh__recordAuthorizer mesh__D051272 sjn
% 223.75/223.93  |- mesh__dateCreated mesh__D051272 2005-06-30
% 223.75/223.93  |- skos__prefLabel mesh__D051272 Glucose Transporter Type 1
% 223.75/223.93  |- skos__scopeNote mesh__D051272
% 223.75/223.93       A ubiquitously expressed glucose transporter that is important for constitutive, basal GLUCOSE transport. It is predominately expressed in ENDOTHELIAL CELLS and ERYTHROCYTES at the BLOOD-BRAIN BARRIER and is responsible for GLUCOSE entry into the BRAIN.%A%    
% 223.75/223.93  |- rdf__type mesh__D051272sskos__Concept
% 223.75/223.93  |- mesh__recordMaintainer mesh__D051272 DRC
% 223.75/223.93  |- skos__altLabel mesh__D051272 Erythrocyte Glucose Transporter
% 223.75/223.93  |- skos__hiddenLabel mesh__D051272 Glucose Transporter, Erythrocyte
% 223.75/223.93  |- skos__altLabel mesh__D051272
% 223.75/223.93       Solute Carrier Family 2, Facilitated Glucose Transporter, Member 1 Protein
% 223.75/223.93  |- skos__altLabel mesh__D051272 GLUT-1 Protein
% 223.75/223.93  |- skos__hiddenLabel mesh__D012859 Syndrome, Sjogren%27%s
% 223.75/223.93  |- skos__scopeNote mesh__D012859
% 223.75/223.93       Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.%A%    
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D012859 2005
% 223.75/223.93  |- skos__broader mesh__D012859smesh__D014987
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D012859 2003
% 223.75/223.93  |- mesh__recordAuthorizer mesh__D012859 PLS
% 223.75/223.93  |- skos__broader mesh__D012859smesh__D001172
% 223.75/223.93  |- skos__annotation mesh__D012859
% 223.75/223.93       a form of rheum arthritis; do not confuse with SJOGREN-LARSSON SYNDROME, a form of ichthyosis; in titles %26% translations, use diacrit: Sjogren%A%  
% 223.75/223.93  |- skos__hiddenLabel mesh__D012859 Syndrome, Sicca
% 223.75/223.93  |- mesh__activeMeSHYear mesh__D012859 2006
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D012859 2000
% 223.75/223.94  |- mesh__recordMaintainer mesh__D012859 TGC
% 223.75/223.94  |- mesh__recordOriginator mesh__D012859 NLM
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D012859 2004
% 223.75/223.94  |- mesh__dateCreated mesh__D012859 1999-01-01
% 223.75/223.94  |- skos__hiddenLabel mesh__D012859 Sjogrens Syndrome
% 223.75/223.94  |- rdf__type mesh__D012859sskos__Concept
% 223.75/223.94  |- mesh__dateRevised mesh__D012859 1996-06-10
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D012859 2001
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D012859 1998
% 223.75/223.94  |- skos__hiddenLabel mesh__D012859 Sjogren Syndrome
% 223.75/223.94  |- skos__related mesh__D012859smesh__D007638
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D012859 2002
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D012859 1999
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D012859 1997
% 223.75/223.94  |- skos__prefLabel mesh__D012859 Sjogren%27%s Syndrome
% 223.75/223.94  |- skos__broader mesh__D012859smesh__D015352
% 223.75/223.94  |- skos__related mesh__D023581smesh__D008561
% 223.75/223.94  |- mesh__recordAuthorizer mesh__D023581 sjn
% 223.75/223.94  |- mesh__dateRevised mesh__D023581 2004-07-07
% 223.75/223.94  |- skos__historyNote mesh__D023581 Anti-HIV Agents %28%1998-2001%29%
% 223.75/223.94  |- skos__broader mesh__D023581smesh__D019380
% 223.75/223.94  |- mesh__historyNote mesh__D023581 2002   
% 223.75/223.94  |- skos__scopeNote mesh__D023581
% 223.75/223.94       Inhibitors of the fusion of HIV to host cells, preventing viral entry. This includes compounds that block attachment of HIV ENVELOPE PROTEIN GP120 to CD4 RECEPTORS.%A%    
% 223.75/223.94  |- skos__broader mesh__D023581smesh__D045504
% 223.75/223.94  |- skos__hiddenLabel mesh__D023581 Entry Inhibitors, HIV
% 223.75/223.94  |- skos__altLabel mesh__D023581 HIV Cell Fusion Inhibitors
% 223.75/223.94  |- mesh__recordOriginator mesh__D023581 ags
% 223.75/223.94  |- mesh__dateEstablished mesh__D023581 2002-01-01
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D023581 2006
% 223.75/223.94  |- mesh__dateCreated mesh__D023581 2001-07-25
% 223.75/223.94  |- skos__prefLabel mesh__D023581 HIV Fusion Inhibitors
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D023581 2005
% 223.75/223.94  |- mesh__recordMaintainer mesh__D023581 ssb
% 223.75/223.94  |- skos__altLabel mesh__D023581 Fusion Inhibitors, HIV
% 223.75/223.94  |- rdf__type mesh__D023581sskos__Concept
% 223.75/223.94  |- mesh__publicMeSHNote mesh__D023581 2002   
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017544 1995
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017544 2003
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017544 2006
% 223.75/223.94  |- skos__broader mesh__D017544smesh__D001014
% 223.75/223.94  |- rdf__type mesh__D017544sskos__Concept
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017544 1998
% 223.75/223.94  |- skos__annotation mesh__D017544
% 223.75/223.94       dissecting aneurysm: coord IM with ANEURYSM, DISSECTING %28%IM%29%; rupture: coord IM with AORTIC RUPTURE %28%IM%29%%A%  
% 223.75/223.94  |- skos__hiddenLabel mesh__D017544 Abdominal Aortic Aneurysm
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017544 2000
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017544 1993
% 223.75/223.94  |- skos__hiddenLabel mesh__D017544 Abdominal Aortic Aneurysms
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017544 2004
% 223.75/223.94  |- skos__hiddenLabel mesh__D017544 Aneurysm, Abdominal Aortic
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017544 2001
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017544 1996
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017544 1999
% 223.75/223.94  |- mesh__historyNote mesh__D017544 93   
% 223.75/223.94  |- skos__hiddenLabel mesh__D017544 Aortic Aneurysms, Abdominal
% 223.75/223.94  |- skos__hiddenLabel mesh__D017544 Aneurysms, Abdominal Aortic
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017544 2002
% 223.75/223.94  |- mesh__publicMeSHNote mesh__D017544 93   
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017544 1997
% 223.75/223.94  |- skos__prefLabel mesh__D017544 Aortic Aneurysm, Abdominal
% 223.75/223.94  |- mesh__dateCreated mesh__D017544 1992-05-20
% 223.75/223.94  |- skos__historyNote mesh__D017544 Aortic Aneurysm %28%1966-1992%29%
% 223.75/223.94  |- skos__scopeNote mesh__D017544
% 223.75/223.94       An aneurysm in that part of the aorta continuing from the thoracic region and giving rise to the inferior phrenic, lumbar, median sacral, mesenteric, renal, and ovarian or testicular arteries.%A%    
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017544 1994
% 223.75/223.94  |- mesh__dateEstablished mesh__D017544 1993-01-01
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017544 2005
% 223.75/223.94  |- mesh__publicMeSHNote mesh__D031215 2003   
% 223.75/223.94  |- mesh__historyNote mesh__D031215 2003   
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D031215 2005
% 223.75/223.94  |- skos__annotation mesh__D031215
% 223.75/223.94       Japanese Horseradish = WASABIA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.75/223.94  |- mesh__recordOriginator mesh__D031215 ssb
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D031215 2006
% 223.75/223.94  |- skos__broader mesh__D031215smesh__D019607
% 223.75/223.94  |- mesh__recordAuthorizer mesh__D031215 sjn
% 223.75/223.94  |- mesh__dateRevised mesh__D031215 2004-07-07
% 223.75/223.94  |- mesh__dateEstablished mesh__D031215 2003-01-01
% 223.75/223.94  |- rdf__type mesh__D031215sskos__Concept
% 223.75/223.94  |- mesh__dateCreated mesh__D031215 2002-07-02
% 223.75/223.94  |- skos__scopeNote mesh__D031215
% 223.75/223.94       A plant genus of the family BRASSICACEAE known for the root used in hot SPICES and is the source of HORSERADISH PEROXIDASE which is widely used in laboratories.%A%    
% 223.75/223.94  |- mesh__recordMaintainer mesh__D031215 ssb
% 223.75/223.94  |- skos__prefLabel mesh__D031215 Armoracia
% 223.75/223.94  |- skos__altLabel mesh__D050978 Small Maf Transcription Factors
% 223.75/223.94  |- mesh__dateCreated mesh__D050978 2005-06-30
% 223.75/223.94  |- mesh__recordAuthorizer mesh__D050978 sjn
% 223.75/223.94  |- skos__scopeNote mesh__D050978
% 223.75/223.94       A family of Maf Transcription Factors that lack activation domains. Small Maf proteins function as transcriptional repressors or form heterodimeric complexes to serve as transcriptional coactivators. Small Maf proteins include MafF, MafG, and MafK.%A%    
% 223.75/223.94  |- mesh__publicMeSHNote mesh__D050978 2006   
% 223.75/223.94  |- skos__broader mesh__D050978smesh__D050977
% 223.75/223.94  |- skos__broader mesh__D050978smesh__D050983
% 223.75/223.94  |- mesh__recordOriginator mesh__D050978 DRC
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D050978 2006
% 223.75/223.94  |- mesh__historyNote mesh__D050978 2006   
% 223.75/223.94  |- mesh__recordMaintainer mesh__D050978 DRC
% 223.75/223.94  |- skos__prefLabel mesh__D050978 Maf Transcription Factors, Small
% 223.75/223.94  |- mesh__dateEstablished mesh__D050978 2006-01-01
% 223.75/223.94  |- rdf__type mesh__D050978sskos__Concept
% 223.75/223.94  |- rdf__type mesh__D003524sskos__Concept
% 223.75/223.94  |- mesh__dateRevised mesh__D003524 2004-07-07
% 223.75/223.94  |- skos__historyNote mesh__D003524
% 223.75/223.94       Immunosuppressive Agents %28%1966-1981%29%
% 223.75/223.94  |- skos__scopeNote mesh__D003524
% 223.75/223.94       A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection.%A%    
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D003524 2005
% 223.75/223.94  |- skos__annotation mesh__D003524
% 223.75/223.94       immunosuppressants; do not confuse with CYCLOSPORINE, a specific drug, or its X ref CYCLOSPORIN%A%  
% 223.75/223.94  |- mesh__recordOriginator mesh__D003524 SH
% 223.75/223.94  |- skos__altLabel mesh__D003524 Cyclosporines
% 223.75/223.94  |- mesh__dateEstablished mesh__D003524 1982-01-01
% 223.75/223.94  |- mesh__recordMaintainer mesh__D003524 ssb
% 223.75/223.94  |- skos__historyNote mesh__D003524 Peptides, Cyclic %28%1971-1981%29%
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D003524 2006
% 223.75/223.94  |- mesh__dateCreated mesh__D003524 1981-05-14
% 223.75/223.94  |- skos__prefLabel mesh__D003524 Cyclosporins
% 223.75/223.94  |- mesh__publicMeSHNote mesh__D003524 82   
% 223.75/223.94  |- mesh__recordAuthorizer mesh__D003524 sjn
% 223.75/223.94  |- skos__historyNote mesh__D003524 Peptides %28%1966-1970%29%
% 223.75/223.94  |- mesh__historyNote mesh__D003524 82   
% 223.75/223.94  |- skos__broader mesh__D003524smesh__D010456
% 223.75/223.94  |- mesh__dateRevised mesh__D013952 2004-07-07
% 223.75/223.94  |- mesh__dateCreated mesh__D013952 1999-01-01
% 223.75/223.94  |- mesh__recordAuthorizer mesh__D013952 sjn
% 223.75/223.94  |- mesh__recordOriginator mesh__D013952 NLM
% 223.75/223.94  |- mesh__recordMaintainer mesh__D013952 lkt
% 223.75/223.94  |- skos__hiddenLabel mesh__D013952 Hyperplasia, Thymus
% 223.75/223.94  |- skos__related mesh__D013952smesh__D009157
% 223.75/223.94  |- skos__scopeNote mesh__D013952
% 223.75/223.94       Enlargement of the thymus. A condition described in the late 1940%27%s and 1950%27%s as pathological thymic hypertrophy was status thymolymphaticus and was treated with radiotherapy. Unnecessary removal of the thymus was also practiced. It later became apparent that the thymus undergoes normal physiological hypertrophy, reaching a maximum at puberty and involuting thereafter. The concept of status thymolymphaticus has been abandoned. Thymus hyperplasia is present in two thirds of all patients with myasthenia gravis. %28%From Segen, Dictionary of Modern Medicine, 1992; Cecil Textbook of Medicine, 19th ed, p1486%29%%A%    
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D013952 2005
% 223.75/223.94  |- skos__prefLabel mesh__D013952 Thymus Hyperplasia
% 223.75/223.94  |- skos__broader mesh__D013952smesh__D008206
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D013952 2006
% 223.75/223.94  |- rdf__type mesh__D013952sskos__Concept
% 223.75/223.94  |- mesh__dateCreated mesh__D013154 1999-01-01
% 223.75/223.94  |- rdf__type mesh__D013154sskos__Concept
% 223.75/223.94  |- mesh__recordOriginator mesh__D013154 NLM
% 223.75/223.94  |- mesh__dateRevised mesh__D013154 2003-07-09
% 223.75/223.94  |- skos__broader mesh__D013154smesh__D008221
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D013154 2004
% 223.75/223.94  |- skos__prefLabel mesh__D013154 Spleen
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D013154 2006
% 223.75/223.94  |- skos__annotation mesh__D013154
% 223.75/223.94       /inj: consider also SPLENIC RUPTURE but traumatic spleen perforation is indexed under SPLEEN /inj; accessory spleen: index under SPLEEN /abnorm%A%  
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D013154 2005
% 223.75/223.94  |- skos__related mesh__D013154smesh__D013156
% 223.75/223.94  |- mesh__recordMaintainer mesh__D013154 jmp
% 223.75/223.94  |- mesh__recordAuthorizer mesh__D013154 sjn
% 223.75/223.94  |- skos__hiddenLabel mesh__D013154 Spleens
% 223.75/223.94  |- mesh__publicMeSHNote mesh__D007915 75   
% 223.75/223.94  |- mesh__historyNote mesh__D007915 75   
% 223.75/223.94  |- mesh__recordAuthorizer mesh__D007915 sjn
% 223.75/223.94  |- rdf__type mesh__D007915sskos__Concept
% 223.75/223.94  |- mesh__dateEstablished mesh__D007915 1975-01-01
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D007915 2004
% 223.75/223.94  |- mesh__dateCreated mesh__D007915 1999-01-01
% 223.75/223.94  |- mesh__dateRevised mesh__D007915 2003-07-09
% 223.75/223.94  |- skos__broader mesh__D007915smesh__D007313
% 223.75/223.94  |- mesh__recordOriginator mesh__D007915 NLM
% 223.75/223.94  |- skos__historyNote mesh__D007915 Insects %28%1966-1974%29%
% 223.75/223.94  |- skos__prefLabel mesh__D007915 Lepidoptera
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D007915 2006
% 223.75/223.94  |- skos__annotation mesh__D007915
% 223.75/223.94       includes BUTTERFLIES %26% MOTHS; don%27%t forget SILKWORMS; /microbiol /parasitol /virol permitted%A%  
% 223.75/223.94  |- skos__scopeNote mesh__D007915
% 223.75/223.94       A large order of insects comprising the butterflies and moths.%A%    
% 223.75/223.94  |- mesh__recordMaintainer mesh__D007915 ags
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D007915 2005
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D007117 2003
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D007117 1994
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D007117 2001
% 223.75/223.94  |- skos__altLabel mesh__D007117 Secondary Immunization
% 223.75/223.94  |- mesh__dateCreated mesh__D007117 1999-01-01
% 223.75/223.94  |- skos__historyNote mesh__D007117 Immunization %28%1966-1970%29%
% 223.75/223.94  |- rdf__type mesh__D007117sskos__Concept
% 223.75/223.94  |- skos__hiddenLabel mesh__D007117 Immunizations, Booster
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D007117 2004
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D007117 1995
% 223.75/223.94  |- mesh__recordOriginator mesh__D007117 NLM
% 223.75/223.94  |- mesh__dateEstablished mesh__D007117 1973-01-01
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D007117 1998
% 223.75/223.94  |- mesh__recordAuthorizer mesh__D007117 PLS
% 223.75/223.94  |- skos__altLabel mesh__D007117 Immunization, Booster
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D007117 2002
% 223.75/223.94  |- mesh__dateRevised mesh__D007117 1992-05-14
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D007117 1999
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D007117 1993
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D007117 2005
% 223.75/223.94  |- skos__hiddenLabel mesh__D007117 Immunizations, Secondary
% 223.75/223.94  |- skos__hiddenLabel mesh__D007117 Booster Immunizations
% 223.75/223.94  |- skos__hiddenLabel mesh__D007117 Booster Immunization
% 223.75/223.94  |- skos__prefLabel mesh__D007117 Immunization, Secondary
% 223.75/223.94  |- skos__broader mesh__D007117smesh__D007114
% 223.75/223.94  |- mesh__publicMeSHNote mesh__D007117 73   
% 223.75/223.94  |- mesh__historyNote mesh__D007117 73%28%71%29%   
% 223.75/223.94  |- skos__hiddenLabel mesh__D007117 Secondary Immunizations
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D007117 2006
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D007117 1996
% 223.75/223.94  |- mesh__recordMaintainer mesh__D007117 TAP
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D007117 2000
% 223.75/223.94  |- skos__scopeNote mesh__D007117
% 223.75/223.94       Any immunization following a primary immunization and involving exposure to the same or a closely related antigen.%A%    
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D007117 1997
% 223.75/223.94  |- mesh__recordOriginator mesh__D051273 DRC
% 223.75/223.94  |- skos__hiddenLabel mesh__D051273 GLUT 2 Protein
% 223.75/223.94  |- skos__altLabel mesh__D051273 SLC2A2 Protein
% 223.75/223.94  |- mesh__publicMeSHNote mesh__D051273
% 223.75/223.94       2006; GLUCOSE TRANSPORTER TYPE 2 was indexed under MONOSACCHARIDE TRANSPORT PROTEINS 2003-2005, %26% under MEMBRANE TRANSPORT PROTEINS 1992-2002%A%  
% 223.75/223.94  |- skos__prefLabel mesh__D051273 Glucose Transporter Type 2
% 223.75/223.94  |- skos__altLabel mesh__D051273
% 223.75/223.94       Solute Carrier Family 2, Facilitated Glucose Transporter, Member 2 Protein
% 223.75/223.94  |- rdf__type mesh__D051273sskos__Concept
% 223.75/223.94  |- skos__altLabel mesh__D051273 GLUT2 Protein
% 223.75/223.94  |- mesh__historyNote mesh__D051273 2006%28%1992%29%   
% 223.75/223.94  |- mesh__dateEstablished mesh__D051273 2006-01-01
% 223.75/223.94  |- skos__scopeNote mesh__D051273
% 223.75/223.94       A glucose transport facilitator that is expressed primarily in PANCREATIC BETA CELLS; LIVER; and KIDNEYS. It may function as a GLUCOSE sensor to regulate INSULIN release and glucose HOMEOSTASIS.%A%    
% 223.75/223.94  |- skos__broader mesh__D051273smesh__D051246
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D051273 2006
% 223.75/223.94  |- skos__altLabel mesh__D051273 GLUT-2 Protein
% 223.75/223.94  |- mesh__recordAuthorizer mesh__D051273 sjn
% 223.75/223.94  |- mesh__dateCreated mesh__D051273 2005-06-30
% 223.75/223.94  |- mesh__recordMaintainer mesh__D051273 DRC
% 223.75/223.94  |- skos__historyNote mesh__D023582 Vaccines %28%1999-2001%29%
% 223.75/223.94  |- mesh__recordMaintainer mesh__D023582 ssb
% 223.75/223.94  |- skos__prefLabel mesh__D023582 Alzheimer Vaccines
% 223.75/223.94  |- mesh__recordAuthorizer mesh__D023582 sjn
% 223.75/223.94  |- skos__broader mesh__D023582smesh__D014612
% 223.75/223.94  |- mesh__dateEstablished mesh__D023582 2002-01-01
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D023582 2006
% 223.75/223.94  |- mesh__dateRevised mesh__D023582 2005-06-30
% 223.75/223.94  |- skos__hiddenLabel mesh__D023582 Vaccines, Alzheimer
% 223.75/223.94  |- skos__scopeNote mesh__D023582
% 223.75/223.94       Vaccines or candidate vaccines used to prevent or treat ALZHEIMER DISEASE.%A%    
% 223.75/223.94  |- mesh__historyNote mesh__D023582 2002   
% 223.75/223.94  |- rdf__type mesh__D023582sskos__Concept
% 223.75/223.94  |- mesh__recordOriginator mesh__D023582 ags
% 223.75/223.94  |- mesh__publicMeSHNote mesh__D023582 2002   
% 223.75/223.94  |- mesh__dateCreated mesh__D023582 2001-07-25
% 223.75/223.94  |- mesh__dateEstablished mesh__D017545 1993-01-01
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017545 2004
% 223.75/223.94  |- skos__prefLabel mesh__D017545 Aortic Aneurysm, Thoracic
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017545 1999
% 223.75/223.94  |- skos__annotation mesh__D017545
% 223.75/223.94       dissecting aneurysm, coord IM with ANEURYSM, DISSECTING %28%IM%29%; rupture: coord IM with AORTIC RUPTURE %28%IM%29%%A%  
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017545 1996
% 223.75/223.94  |- mesh__historyNote mesh__D017545 93   
% 223.75/223.94  |- skos__hiddenLabel mesh__D017545 Aneurysm, Thoracic Aortic
% 223.75/223.94  |- skos__hiddenLabel mesh__D017545 Thoracic Aortic Aneurysm
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017545 1997
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017545 2000
% 223.75/223.94  |- skos__historyNote mesh__D017545 Aortic Aneurysm %28%1966-1992%29%
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017545 2001
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017545 1994
% 223.75/223.94  |- skos__hiddenLabel mesh__D017545 Thoracic Aortic Aneurysms
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017545 2005
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017545 2002
% 223.75/223.94  |- mesh__publicMeSHNote mesh__D017545 93   
% 223.75/223.94  |- skos__scopeNote mesh__D017545
% 223.75/223.94       An aneurysm in the proximal portion of the descending aorta proceeding from the arch of the aorta and giving rise to the bronchial, esophageal, pericardiac, and mediastinal branches.%A%    
% 223.75/223.94  |- skos__hiddenLabel mesh__D017545 Aortic Aneurysms, Thoracic
% 223.75/223.94  |- mesh__dateCreated mesh__D017545 1992-05-20
% 223.75/223.94  |- skos__hiddenLabel mesh__D017545 Aneurysms, Thoracic Aortic
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017545 1995
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017545 2006
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017545 2003
% 223.75/223.94  |- skos__broader mesh__D017545smesh__D001014
% 223.75/223.94  |- rdf__type mesh__D017545sskos__Concept
% 223.75/223.94  |- mesh__activeMeSHYear mesh__D017545 1998
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D017545 1993
% 223.75/223.95  |- skos__altLabel mesh__D031216 Cress, Upland
% 223.75/223.95  |- mesh__dateCreated mesh__D031216 2002-07-02
% 223.75/223.95  |- rdf__type mesh__D031216sskos__Concept
% 223.75/223.95  |- mesh__historyNote mesh__D031216 2003   
% 223.75/223.95  |- skos__annotation mesh__D031216
% 223.75/223.95       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.75/223.95  |- skos__scopeNote mesh__D031216
% 223.75/223.95       A plant genus of the family BRASSICACEAE. Members contain glucobrassicin.%A%    
% 223.75/223.95  |- mesh__publicMeSHNote mesh__D031216 2003   
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D031216 2005
% 223.75/223.95  |- skos__broader mesh__D031216smesh__D019607
% 223.75/223.95  |- skos__altLabel mesh__D031216 Rocket, Yellow
% 223.75/223.95  |- skos__altLabel mesh__D031216 Yellow Rocket
% 223.75/223.95  |- mesh__dateEstablished mesh__D031216 2003-01-01
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D031216 2003
% 223.75/223.95  |- skos__altLabel mesh__D031216 Cress, Winter
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D031216 2006
% 223.75/223.95  |- skos__prefLabel mesh__D031216 Barbarea
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D031216 2004
% 223.75/223.95  |- mesh__recordAuthorizer mesh__D003525 PLS
% 223.75/223.95  |- mesh__recordMaintainer mesh__D003525 PLS
% 223.75/223.95  |- skos__broader mesh__D003525smesh__D013256
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D003525 2000
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D003525 1998
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D003525 2004
% 223.75/223.95  |- mesh__recordOriginator mesh__D003525 NLM
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D003525 2001
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D003525 1999
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D003525 2005
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D003525 1994
% 223.75/223.95  |- mesh__historyNote mesh__D003525 68   
% 223.75/223.95  |- mesh__dateRevised mesh__D003525 1993-06-03
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D003525 2002
% 223.75/223.95  |- mesh__dateEstablished mesh__D003525 1968-01-01
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D003525 2006
% 223.75/223.95  |- mesh__dateCreated mesh__D003525 1999-01-01
% 223.75/223.95  |- skos__scopeNote mesh__D003525
% 223.75/223.95       Steroid derivatives in which one or more bridges is formed between carbon atoms at any locant in any of the rings.%A%    
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D003525 1995
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D003525 1996
% 223.75/223.95  |- rdf__type mesh__D003525sskos__Concept
% 223.75/223.95  |- mesh__publicMeSHNote mesh__D003525 68   
% 223.75/223.95  |- skos__prefLabel mesh__D003525 Cyclosteroids
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D003525 1997
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D003525 2003
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D008210 2000
% 223.75/223.95  |- mesh__publicMeSHNote mesh__D008210
% 223.75/223.95       91; was see under LYMPHATIC DISEASES 1988-90; was see under LYMPHANGIOMA 1966-87%A%  
% 223.75/223.95  |- skos__altLabel mesh__D008210 Lymphocoele
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D008210 1996
% 223.75/223.95  |- skos__broader mesh__D008210smesh__D008206
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D008210 2006
% 223.75/223.95  |- skos__scopeNote mesh__D008210
% 223.75/223.95       Cystic mass containing lymph from diseased lymphatic channels or following surgical trauma or other injury.%A%    
% 223.75/223.95  |- rdf__type mesh__D008210sskos__Concept
% 223.75/223.95  |- mesh__dateEstablished mesh__D008210 1991-01-01
% 223.75/223.95  |- mesh__dateRevised mesh__D008210 1991-07-23
% 223.75/223.95  |- skos__hiddenLabel mesh__D008210 Lymphatic Cysts
% 223.75/223.95  |- skos__altLabel mesh__D008210 Cyst, Lymphatic
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D008210 1995
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D008210 2005
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D008210 1993
% 223.75/223.95  |- skos__hiddenLabel mesh__D008210 Lymphocoeles
% 223.75/223.95  |- skos__historyNote mesh__D008210 Lymph %28%1966-1980%29%
% 223.75/223.95  |- skos__prefLabel mesh__D008210 Lymphocele
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D008210 1999
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D008210 1994
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D008210 2004
% 223.75/223.95  |- skos__annotation mesh__D008210
% 223.75/223.95       non-neoplastic; /blood supply /chem /secret /ultrastruct permitted; coord IM with organ/dis term %28%IM%29% if relevant%A%  
% 223.75/223.95  |- skos__altLabel mesh__D008210 Lymphatic Cyst
% 223.75/223.95  |- skos__hiddenLabel mesh__D008210 Lymphoceles
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D008210 1992
% 223.75/223.95  |- skos__broader mesh__D008210smesh__D003560
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D008210 2002
% 223.75/223.95  |- skos__historyNote mesh__D008210 Lymphatic Diseases %28%1966-1987%29%
% 223.75/223.95  |- mesh__dateCreated mesh__D008210 1987-03-25
% 223.75/223.95  |- mesh__recordAuthorizer mesh__D008210 PLS
% 223.75/223.95  |- skos__historyNote mesh__D008210 Lymphangioma %28%1975-1983%29%
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D008210 1998
% 223.75/223.95  |- mesh__historyNote mesh__D008210
% 223.75/223.95       91%28%88%29%; was see under LYMPHATIC DISEASES 1988-90; was see under LYMPHANGIOMA 1966-87%A%  
% 223.75/223.95  |- mesh__recordOriginator mesh__D008210 SCD
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D008210 2003
% 223.75/223.95  |- skos__hiddenLabel mesh__D008210 Cysts, Lymphatic
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D008210 2001
% 223.75/223.95  |- mesh__onlineNote mesh__D008210
% 223.75/223.95       use LYMPHANGIOMA to search LYMPHOCELE 1966-74   
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D008210 1997
% 223.75/223.95  |- mesh__recordMaintainer mesh__D008210 PLS
% 223.75/223.95  |- skos__hiddenLabel mesh__D013953 Tumor, Thymus
% 223.75/223.95  |- skos__hiddenLabel mesh__D013953 Neoplasm, Thymic
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D013953 2005
% 223.75/223.95  |- skos__altLabel mesh__D013953 Neoplasms, Thymus
% 223.75/223.95  |- skos__altLabel mesh__D013953 Thymus Cancer
% 223.75/223.95  |- skos__hiddenLabel mesh__D013953 Thymus Cancers
% 223.75/223.95  |- skos__hiddenLabel mesh__D013953 Thymic Cancers
% 223.75/223.95  |- skos__altLabel mesh__D013953 Neoplasms, Thymic
% 223.75/223.95  |- skos__hiddenLabel mesh__D013953 Cancer, Thymus
% 223.75/223.95  |- skos__broader mesh__D013953smesh__D008206
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D013953 2006
% 223.75/223.95  |- rdf__type mesh__D013953sskos__Concept
% 223.75/223.95  |- skos__prefLabel mesh__D013953 Thymus Neoplasms
% 223.75/223.95  |- skos__hiddenLabel mesh__D013953 Thymus Neoplasm
% 223.75/223.95  |- skos__altLabel mesh__D013953 Cancer of the Thymus
% 223.75/223.95  |- skos__altLabel mesh__D013953 Thymic Neoplasms
% 223.75/223.95  |- skos__hiddenLabel mesh__D013953 Tumor, Thymic
% 223.75/223.95  |- skos__altLabel mesh__D013953 Thymus Tumors
% 223.75/223.95  |- mesh__recordMaintainer mesh__D013953 lkt
% 223.75/223.95  |- skos__hiddenLabel mesh__D013953 Thymus Tumor
% 223.75/223.95  |- skos__altLabel mesh__D013953 Thymic Tumors
% 223.75/223.95  |- skos__altLabel mesh__D013953 Thymic Cancer
% 223.75/223.95  |- skos__hiddenLabel mesh__D013953 Neoplasm, Thymus
% 223.75/223.95  |- skos__hiddenLabel mesh__D013953 Tumors, Thymic
% 223.75/223.95  |- mesh__recordAuthorizer mesh__D013953 sjn
% 223.75/223.95  |- mesh__recordOriginator mesh__D013953 NLM
% 223.75/223.95  |- skos__hiddenLabel mesh__D013953 Thymic Neoplasm
% 223.75/223.95  |- mesh__dateRevised mesh__D013953 2004-07-07
% 223.75/223.95  |- mesh__dateCreated mesh__D013953 1999-01-01
% 223.75/223.95  |- skos__annotation mesh__D013953
% 223.75/223.95       coord IM with histol type of neopl %28%IM%29%   
% 223.75/223.95  |- skos__hiddenLabel mesh__D013953 Thymic Tumor
% 223.75/223.95  |- skos__hiddenLabel mesh__D013953 Cancers, Thymic
% 223.75/223.95  |- skos__broader mesh__D013953smesh__D013899
% 223.75/223.95  |- skos__hiddenLabel mesh__D013953 Tumors, Thymus
% 223.75/223.95  |- skos__hiddenLabel mesh__D013953 Cancers, Thymus
% 223.75/223.95  |- skos__hiddenLabel mesh__D013953 Cancer, Thymic
% 223.75/223.95  |- skos__scopeNote mesh__D013953 Tumors or cancer of the THYMUS GLAND.     
% 223.75/223.95  |- skos__prefLabel mesh__D013155 Spleen Focus-Forming Viruses
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D013155 2004
% 223.75/223.95  |- mesh__dateRevised mesh__D013155 2002-07-03
% 223.75/223.95  |- skos__annotation mesh__D013155
% 223.75/223.95       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% + LEUKEMIA, EXPERIMENTAL %28%IM%29% or LEUKEMIA, ERYTHROBLASTIC, ACUTE %28%IM%29% %28%for spontaneous erythroleukemia%29%; DF: SFFV%A%  
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D013155 2006
% 223.75/223.95  |- mesh__historyNote mesh__D013155
% 223.75/223.95       91%28%86%29%; was see under MOUSE LEUKEMIA VIRUSES 1986-90   
% 223.75/223.95  |- skos__scopeNote mesh__D013155
% 223.75/223.95       Strains of Murine leukemia virus %28%LEUKEMIA VIRUS, MURINE%29% that are replication-defective and rapidly transforming. The envelope gene plays an essential role in initiating erythroleukemia %28%LEUKEMIA, ERYTHROBLASTIC, ACUTE%29%, manifested by splenic foci, SPLENOMEGALY, and POLYCYTHEMIA. Spleen focus-forming viruses are generated by recombination with other viral types.%A%    
% 223.75/223.95  |- skos__hiddenLabel mesh__D013155 Spleen Focus Forming Viruses
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D013155 2003
% 223.75/223.95  |- skos__broader mesh__D013155smesh__D009052
% 223.75/223.95  |- skos__hiddenLabel mesh__D013155 Focus-Forming Virus, Spleen
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D013155 2005
% 223.75/223.95  |- skos__hiddenLabel mesh__D013155 Spleen Focus-Forming Virus
% 223.75/223.95  |- skos__historyNote mesh__D013155 Mouse Leukemia Viruses %28%1966-1985%29%
% 223.75/223.95  |- mesh__recordMaintainer mesh__D013155 ags
% 223.75/223.95  |- skos__historyNote mesh__D013155 Leukemia, Experimental %28%1966-1985%29%
% 223.75/223.95  |- mesh__publicMeSHNote mesh__D013155
% 223.75/223.95       91; was see under MOUSE LEUKEMIA VIRUSES 1986-90   
% 223.75/223.95  |- mesh__recordOriginator mesh__D013155 RC
% 223.75/223.95  |- mesh__dateEstablished mesh__D013155 1991-01-01
% 223.75/223.95  |- skos__hiddenLabel mesh__D013155 Focus-Forming Viruses, Spleen
% 223.75/223.95  |- skos__historyNote mesh__D013155 Friend Virus %28%1966-1985%29%
% 223.75/223.95  |- mesh__dateCreated mesh__D013155 1985-05-09
% 223.75/223.95  |- rdf__type mesh__D013155sskos__Concept
% 223.75/223.95  |- mesh__recordAuthorizer mesh__D013155 sjn
% 223.75/223.95  |- mesh__historyNote mesh__D007916 73%28%65%29%   
% 223.75/223.95  |- skos__prefLabel mesh__D007916 Lepromin
% 223.75/223.95  |- mesh__publicMeSHNote mesh__D007916 73   
% 223.75/223.95  |- mesh__dateRevised mesh__D007916 2005-06-30
% 223.75/223.95  |- rdf__type mesh__D007916sskos__Concept
% 223.75/223.95  |- mesh__recordMaintainer mesh__D007916 ssb
% 223.75/223.95  |- skos__annotation mesh__D007916
% 223.75/223.95       for lepromin test or lepromin reaction do not coord with SKIN TESTS%A%  
% 223.75/223.95  |- mesh__recordAuthorizer mesh__D007916 sjn
% 223.75/223.95  |- skos__broader mesh__D007916smesh__D000942
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D007916 2006
% 223.75/223.95  |- mesh__recordOriginator mesh__D007916 NLM
% 223.75/223.95  |- mesh__dateEstablished mesh__D007916 1973-01-01
% 223.75/223.95  |- mesh__dateCreated mesh__D007916 1999-01-01
% 223.75/223.95  |- skos__broader mesh__D007118smesh__D007159
% 223.75/223.95  |- mesh__recordAuthorizer mesh__D007118 sjn
% 223.75/223.95  |- skos__prefLabel mesh__D007118 Immunoassay
% 223.75/223.95  |- skos__annotation mesh__D007118
% 223.75/223.95       GEN or unspecified; prefer specifics; NIM   
% 223.75/223.95  |- mesh__historyNote mesh__D007118 67%28%66%29%   
% 223.75/223.95  |- mesh__recordOriginator mesh__D007118 NLM
% 223.75/223.95  |- mesh__recordMaintainer mesh__D007118 ags
% 223.75/223.95  |- skos__broader mesh__D007118smesh__D007158
% 223.75/223.95  |- skos__scopeNote mesh__D007118
% 223.75/223.95       A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance.%A%    
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D007118 2006
% 223.75/223.95  |- mesh__dateRevised mesh__D007118 2005-06-30
% 223.75/223.95  |- skos__broader mesh__D007118smesh__D015336
% 223.75/223.95  |- mesh__dateEstablished mesh__D007118 1967-01-01
% 223.75/223.95  |- mesh__publicMeSHNote mesh__D007118 67   
% 223.75/223.95  |- skos__hiddenLabel mesh__D007118 Immunoassays
% 223.75/223.95  |- mesh__dateCreated mesh__D007118 1999-01-01
% 223.75/223.95  |- rdf__type mesh__D007118sskos__Concept
% 223.75/223.95  |- mesh__recordAuthorizer mesh__D051274 sjn
% 223.75/223.95  |- skos__hiddenLabel mesh__D051274 GLUT 3 Protein
% 223.75/223.95  |- rdf__type mesh__D051274sskos__Concept
% 223.75/223.95  |- skos__altLabel mesh__D051274 GLUT-3 Protein
% 223.75/223.95  |- skos__altLabel mesh__D051274
% 223.75/223.95       Solute Carrier Family 2, Facilitated Glucose Transporter, Member 3 Protein
% 223.75/223.95  |- mesh__dateCreated mesh__D051274 2005-06-30
% 223.75/223.95  |- mesh__recordMaintainer mesh__D051274 DRC
% 223.75/223.95  |- skos__scopeNote mesh__D051274
% 223.75/223.95       A major glucose transporter found in NEURONS.     
% 223.75/223.95  |- skos__prefLabel mesh__D051274 Glucose Transporter Type 3
% 223.75/223.95  |- skos__altLabel mesh__D051274 GLUT3 Protein
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D051274 2006
% 223.75/223.95  |- mesh__dateEstablished mesh__D051274 2006-01-01
% 223.75/223.95  |- mesh__publicMeSHNote mesh__D051274
% 223.75/223.95       2006; GLUCOSE TRANSPORTER TYPE 3 was indexed under MONOSACCHARIDE TRANSPORT PROTEINS %26% NERVE TISSUE PROTEINS 2005, %26% under MEMBRANE PROTEINS 1991-2004%A%  
% 223.75/223.95  |- mesh__recordOriginator mesh__D051274 DRC
% 223.75/223.95  |- skos__broader mesh__D051274smesh__D009419
% 223.75/223.95  |- skos__altLabel mesh__D051274 SLC2A3 Protein
% 223.75/223.95  |- mesh__historyNote mesh__D051274 2006%28%1991%29%   
% 223.75/223.95  |- skos__broader mesh__D051274smesh__D051246
% 223.75/223.95  |- skos__broader mesh__D005187Q000530smesh__D005187
% 223.75/223.95  |- mesh__preferredCombination mesh__D005187Q000530smesh__D007047
% 223.75/223.95  |- rdf__type mesh__D005187Q000530smesh__CompoundConcept
% 223.75/223.95  |- skos__scopeNote mesh__D017546
% 223.75/223.95       Endoscopic examination, therapy or surgery performed on the interior of blood vessels.%A%    
% 223.75/223.95  |- rdf__type mesh__D017546sskos__Concept
% 223.75/223.95  |- mesh__publicMeSHNote mesh__D017546 93   
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D017546 2006
% 223.75/223.95  |- mesh__recordMaintainer mesh__D017546 nns
% 223.75/223.95  |- skos__hiddenLabel mesh__D017546 Angioscopic Surgical Procedure
% 223.75/223.95  |- mesh__activeMeSHYear mesh__D017546 2003
% 223.75/223.95  |- skos__hiddenLabel mesh__D017546 Surgeries, Angioscopic
% 223.75/223.95  |- skos__altLabel mesh__D017546 Angioscopic Surgery
% 223.75/223.95  |- skos__hiddenLabel mesh__D017546 Surgery Angioscopics
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D017546 2005
% 223.75/223.96  |- skos__broader mesh__D017546smesh__D004724
% 223.75/223.96  |- mesh__dateEstablished mesh__D017546 1993-01-01
% 223.75/223.96  |- skos__hiddenLabel mesh__D017546 Procedures, Angioscopic Surgical
% 223.75/223.96  |- skos__hiddenLabel mesh__D017546 Procedure, Angioscopic Surgical
% 223.75/223.96  |- skos__hiddenLabel mesh__D017546 Angioscopics, Surgery
% 223.75/223.96  |- skos__prefLabel mesh__D017546 Angioscopy
% 223.75/223.96  |- skos__hiddenLabel mesh__D017546 Angioscopic Surgeries
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D017546 2002
% 223.75/223.96  |- skos__hiddenLabel mesh__D017546 Angioscopies
% 223.75/223.96  |- skos__hiddenLabel mesh__D017546 Surgical Procedure, Angioscopic
% 223.75/223.96  |- mesh__recordAuthorizer mesh__D017546 sjn
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D017546 2001
% 223.75/223.96  |- skos__altLabel mesh__D017546 Surgical Procedures, Angioscopic
% 223.75/223.96  |- skos__hiddenLabel mesh__D017546 Angioscopic, Surgery
% 223.75/223.96  |- mesh__recordOriginator mesh__D017546 PLS
% 223.75/223.96  |- skos__broader mesh__D017546smesh__D014656
% 223.75/223.96  |- skos__annotation mesh__D017546
% 223.75/223.96       coord with specific vessel %28%IM%29%; do not confuse with MICROSCOPIC ANGIOSCOPY%A%  
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D017546 2000
% 223.75/223.96  |- skos__historyNote mesh__D017546 Endoscopy %28%1977-1992%29%
% 223.75/223.96  |- skos__broader mesh__D017546smesh__D003935
% 223.75/223.96  |- skos__hiddenLabel mesh__D017546 Surgery, Angioscopic
% 223.75/223.96  |- skos__altLabel mesh__D017546 Surgery Angioscopic
% 223.75/223.96  |- mesh__historyNote mesh__D017546 93   
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D017546 2004
% 223.75/223.96  |- mesh__dateRevised mesh__D017546 1999-11-03
% 223.75/223.96  |- mesh__dateCreated mesh__D017546 1992-05-20
% 223.75/223.96  |- rdf__type mesh__D031217sskos__Concept
% 223.75/223.96  |- skos__prefLabel mesh__D031217 Cardamine
% 223.75/223.96  |- skos__altLabel mesh__D031217 Cress, Bitter
% 223.75/223.96  |- skos__annotation mesh__D031217
% 223.75/223.96       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.75/223.96  |- mesh__publicMeSHNote mesh__D031217 2003   
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D031217 2005
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D031217 2003
% 223.75/223.96  |- skos__scopeNote mesh__D031217
% 223.75/223.96       A plant genus of the family BRASSICACEAE that is low-growing in damp meadows of the Northern Hemisphere and has pinnately divided leaves and small white to rose flowers.%A%    
% 223.75/223.96  |- mesh__historyNote mesh__D031217 2003   
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D031217 2006
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D031217 2004
% 223.75/223.96  |- mesh__dateCreated mesh__D031217 2002-07-03
% 223.75/223.96  |- skos__altLabel mesh__D031217 Cress, Meadow
% 223.75/223.96  |- skos__broader mesh__D031217smesh__D019607
% 223.75/223.96  |- mesh__dateEstablished mesh__D031217 2003-01-01
% 223.75/223.96  |- skos__scopeNote mesh__D008211
% 223.75/223.96       T-cell enhancement of the B-cell response to thymic-dependent antigens.%A%    
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008211 2005
% 223.75/223.96  |- skos__historyNote mesh__D008211 T-Lymphocytes %28%1973-1977%29%
% 223.75/223.96  |- mesh__dateEstablished mesh__D008211 1978-01-01
% 223.75/223.96  |- mesh__historyNote mesh__D008211 78   
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008211 2000
% 223.75/223.96  |- mesh__recordAuthorizer mesh__D008211 PLS
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008211 1993
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008211 2006
% 223.75/223.96  |- skos__broader mesh__D008211smesh__D002468
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008211 1998
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008211 2001
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008211 1994
% 223.75/223.96  |- skos__historyNote mesh__D008211 Lymphocytes %28%1966-1972%29%
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008211 1999
% 223.75/223.96  |- mesh__recordOriginator mesh__D008211 AEP
% 223.75/223.96  |- rdf__type mesh__D008211sskos__Concept
% 223.75/223.96  |- skos__hiddenLabel mesh__D008211 Cooperation, Lymphocyte
% 223.75/223.96  |- skos__prefLabel mesh__D008211 Lymphocyte Cooperation
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008211 2002
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008211 1995
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008211 2003
% 223.75/223.96  |- skos__broader mesh__D008211smesh__D007109
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008211 2004
% 223.75/223.96  |- skos__hiddenLabel mesh__D008211 Cooperations, Lymphocyte
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008211 1996
% 223.75/223.96  |- mesh__dateCreated mesh__D008211 1977-03-01
% 223.75/223.96  |- mesh__publicMeSHNote mesh__D008211 78   
% 223.75/223.96  |- mesh__dateRevised mesh__D008211 1992-05-22
% 223.75/223.96  |- skos__historyNote mesh__D008211 B-Lymphocytes %28%1973-1977%29%
% 223.75/223.96  |- skos__hiddenLabel mesh__D008211 Lymphocyte Cooperations
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008211 1997
% 223.75/223.96  |- mesh__recordMaintainer mesh__D008211 TAP
% 223.75/223.96  |- skos__hiddenLabel mesh__D049628 Sizes, Body
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D049628 2005
% 223.75/223.96  |- rdf__type mesh__D049628sskos__Concept
% 223.75/223.96  |- skos__broader mesh__D049628smesh__D001837
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D049628 2006
% 223.75/223.96  |- skos__hiddenLabel mesh__D049628 Body Sizes
% 223.75/223.96  |- skos__prefLabel mesh__D049628 Body Size
% 223.75/223.96  |- mesh__publicMeSHNote mesh__D049628
% 223.75/223.96       2005; see BODY  CONSTITUTION 1984-2004   
% 223.75/223.96  |- mesh__dateCreated mesh__D049628 2004-07-07
% 223.75/223.96  |- mesh__recordAuthorizer mesh__D049628 sjn
% 223.75/223.96  |- skos__hiddenLabel mesh__D049628 Size, Body
% 223.75/223.96  |- mesh__dateEstablished mesh__D049628 2005-01-01
% 223.75/223.96  |- skos__scopeNote mesh__D049628 The physical measurements of a body.     
% 223.75/223.96  |- mesh__historyNote mesh__D049628 2005; use BODY CONSTITUTION 1984-2004   
% 223.75/223.96  |- skos__broader mesh__D049628smesh__D006128
% 223.75/223.96  |- mesh__recordMaintainer mesh__D049628 nns
% 223.75/223.96  |- mesh__recordOriginator mesh__D049628 nns
% 223.75/223.96  |- skos__broader mesh__D013954smesh__D006023
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013954 2002
% 223.75/223.96  |- mesh__recordAuthorizer mesh__D013954 PLS
% 223.75/223.96  |- skos__annotation mesh__D013954 /biosyn /physiol permitted   
% 223.75/223.96  |- mesh__recordMaintainer mesh__D013954 TAP
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013954 1994
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013954 2006
% 223.75/223.96  |- rdf__type mesh__D013954sskos__Concept
% 223.75/223.96  |- skos__broader mesh__D013954smesh__D007467
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013954 1991
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013954 2003
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013954 1998
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013954 1995
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013954 2000
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013954 1992
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013954 2004
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013954 1999
% 223.75/223.96  |- mesh__dateCreated mesh__D013954 1999-01-01
% 223.75/223.96  |- mesh__dateRevised mesh__D013954 1990-06-19
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013954 2001
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013954 1996
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013954 1993
% 223.75/223.96  |- skos__broader mesh__D013954smesh__D005916
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013954 1997
% 223.75/223.96  |- mesh__recordOriginator mesh__D013954 NLM
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013954 2005
% 223.75/223.96  |- skos__prefLabel mesh__D013954 Thyroglobulin
% 223.75/223.96  |- skos__prefLabel mesh__D046330 Myoxidae
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D046330 2005
% 223.75/223.96  |- mesh__publicMeSHNote mesh__D046330 2005; see RODENTIA 1982-2004   
% 223.75/223.96  |- skos__broader mesh__D046330smesh__D012377
% 223.75/223.96  |- mesh__historyNote mesh__D046330 2005; use RODENTIA 1982-2004   
% 223.75/223.96  |- mesh__dateEstablished mesh__D046330 2005-01-01
% 223.75/223.96  |- skos__scopeNote mesh__D046330
% 223.75/223.96       A family of nocturnal rodents, similar in appearance to SQUIRRELS, but smaller. There are 28 species, half of which are found in Africa.%A%    
% 223.75/223.96  |- rdf__type mesh__D046330sskos__Concept
% 223.75/223.96  |- skos__historyNote mesh__D046330 Rodentia %28%1966-2004%29%
% 223.75/223.96  |- mesh__recordOriginator mesh__D046330 ags
% 223.75/223.96  |- skos__altLabel mesh__D046330 Dormouse
% 223.75/223.96  |- skos__altLabel mesh__D046330 Dormice
% 223.75/223.96  |- mesh__recordMaintainer mesh__D046330 ags
% 223.75/223.96  |- mesh__dateCreated mesh__D046330 2004-07-07
% 223.75/223.96  |- mesh__recordAuthorizer mesh__D046330 sjn
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D046330 2006
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013156 1993
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013156 1996
% 223.75/223.96  |- mesh__recordMaintainer mesh__D013156 NSC
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013156 1995
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013156 1998
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013156 1992
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013156 2002
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013156 1994
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013156 1989
% 223.75/223.96  |- mesh__dateCreated mesh__D013156 1999-01-01
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013156 2001
% 223.75/223.96  |- rdf__type mesh__D013156sskos__Concept
% 223.75/223.96  |- skos__prefLabel mesh__D013156 Splenectomy
% 223.75/223.96  |- skos__broader mesh__D013156smesh__D013514
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013156 2004
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013156 1991
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013156 2000
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013156 2006
% 223.75/223.96  |- mesh__recordAuthorizer mesh__D013156 NLM
% 223.75/223.96  |- mesh__recordOriginator mesh__D013156 NLM
% 223.75/223.96  |- skos__annotation mesh__D013156
% 223.75/223.96       do not use /util except by MeSH definition; coord IM with non-splenic dis /surg %28%IM%29%, not /ther%A%  
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013156 2003
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013156 1997
% 223.75/223.96  |- skos__hiddenLabel mesh__D013156 Splenectomies
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013156 1990
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013156 1999
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013156 2005
% 223.75/223.96  |- mesh__dateRevised mesh__D013156 1988-06-20
% 223.75/223.96  |- skos__prefLabel mesh__D007917 Leprostatic Agents
% 223.75/223.96  |- mesh__recordOriginator mesh__D007917 NLM
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D007917 2004
% 223.75/223.96  |- mesh__dateRevised mesh__D007917 2003-07-09
% 223.75/223.96  |- skos__broader mesh__D007917smesh__D000900
% 223.75/223.96  |- skos__historyNote mesh__D007917 Anti-Infective Agents %28%1966-1974%29%
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D007917 2005
% 223.75/223.96  |- skos__hiddenLabel mesh__D007917 Agents, Antileprotic
% 223.75/223.96  |- mesh__dateEstablished mesh__D007917 1975-09-01
% 223.75/223.96  |- skos__hiddenLabel mesh__D007917 Agents, Leprostatic
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D007917 2006
% 223.75/223.96  |- mesh__recordMaintainer mesh__D007917 ssb
% 223.75/223.96  |- skos__scopeNote mesh__D007917
% 223.75/223.96       Substances that suppress Mycobacterium leprae, ameliorate the clinical manifestations of leprosy, and/or reduce the incidence and severity of leprous reactions.%A%    
% 223.75/223.96  |- mesh__publicMeSHNote mesh__D007917 75   
% 223.75/223.96  |- skos__annotation mesh__D007917
% 223.75/223.96       -static or -cidal; consider also MYCOBACTERIUM LEPRAE /drug eff %26% LEPROSY /drug ther%A%  
% 223.75/223.96  |- mesh__dateCreated mesh__D007917 1999-01-01
% 223.75/223.96  |- mesh__recordAuthorizer mesh__D007917 sjn
% 223.75/223.96  |- mesh__historyNote mesh__D007917 75   
% 223.75/223.96  |- skos__altLabel mesh__D007917 Leprostatics
% 223.75/223.96  |- rdf__type mesh__D007917sskos__Concept
% 223.75/223.96  |- skos__altLabel mesh__D007917 Antileprotic Agents
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D007119 1996
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D007119 2004
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D007119 2005
% 223.75/223.96  |- skos__hiddenLabel mesh__D007119 Lymphadenopathy, Angioimmunoblastic
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D007119 2000
% 223.75/223.96  |- mesh__recordOriginator mesh__D007119 VDK
% 223.75/223.96  |- skos__broader mesh__D007119smesh__D008232
% 223.75/223.96  |- rdf__type mesh__D007119sskos__Concept
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D007119 2003
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D007119 1995
% 223.75/223.96  |- mesh__recordMaintainer mesh__D007119 TGC
% 223.75/223.96  |- mesh__dateRevised mesh__D007119 1991-06-18
% 223.75/223.96  |- mesh__dateCreated mesh__D007119 1978-05-19
% 223.75/223.96  |- skos__hiddenLabel mesh__D007119 Lymphadenopathies, Angioimmunoblastic
% 223.75/223.96  |- skos__prefLabel mesh__D007119 Immunoblastic Lymphadenopathy
% 223.75/223.96  |- skos__hiddenLabel mesh__D007119 Immunoblastic Lymphadenopathies
% 223.75/223.96  |- skos__scopeNote mesh__D007119
% 223.75/223.96       A disorder characterized by proliferation of arborizing small vessels, prominent immunoblastic proliferations and amorphous acidophilic interstitial material. Clinical manifestations include fever, sweats, weight loss, generalized lymphadenopathy and frequently hepatosplenomegaly.%A%    
% 223.75/223.96  |- skos__hiddenLabel mesh__D007119 Angioimmunoblastic Lymphadenopathies
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D007119 1993
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D007119 2002
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D007119 1994
% 223.75/223.96  |- mesh__publicMeSHNote mesh__D007119 79   
% 223.75/223.96  |- mesh__dateEstablished mesh__D007119 1979-01-01
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D007119 1999
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D007119 1992
% 223.75/223.96  |- mesh__recordAuthorizer mesh__D007119 PLS
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D007119 1997
% 223.75/223.96  |- skos__altLabel mesh__D007119 Lymphadenopathy, Immunoblastic
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D007119 1998
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D007119 2006
% 223.75/223.96  |- skos__hiddenLabel mesh__D007119 Lymphadenopathies, Immunoblastic
% 223.75/223.96  |- skos__altLabel mesh__D007119 Angioimmunoblastic Lymphadenopathy
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D007119 2001
% 223.75/223.96  |- mesh__historyNote mesh__D007119 79   
% 223.75/223.96  |- rdf__type mesh__D051275sskos__Concept
% 223.75/223.96  |- mesh__publicMeSHNote mesh__D051275
% 223.75/223.96       2006; GLUCOSE TRANSPORTER TYPE 4 was indexed under MONOSACCHARIDE TRANSPORT PROTEINS %26% MUSCLE PROTEINS 1992-2005%A%  
% 223.75/223.96  |- skos__hiddenLabel mesh__D051275 Insulin Responsive Glucose Transporter
% 223.75/223.96  |- skos__broader mesh__D051275smesh__D051246
% 223.75/223.96  |- mesh__recordMaintainer mesh__D051275 DRC
% 223.75/223.96  |- mesh__dateCreated mesh__D051275 2005-06-30
% 223.75/223.96  |- skos__hiddenLabel mesh__D051275 GLUT 4 Protein
% 223.75/223.96  |- skos__scopeNote mesh__D051275
% 223.75/223.96       A glucose transport protein found in mature MUSCLE CELLS and ADIPOCYTES. It promotes transport of glucose from the BLOOD into target TISSUES. The inactive form of the protein is localized in CYTOPLASMIC VESICLES. In response to INSULIN, it is translocated to the PLASMA MEMBRANE where it facilitates glucose uptake.%A%    
% 223.75/223.96  |- skos__altLabel mesh__D051275 SLC2A4 Protein
% 223.75/223.96  |- skos__hiddenLabel mesh__D051275 Glucose Transporter, Insulin-Responsive
% 223.75/223.96  |- mesh__historyNote mesh__D051275 2006%28%1992%29%   
% 223.75/223.96  |- mesh__dateEstablished mesh__D051275 2006-01-01
% 223.75/223.96  |- skos__altLabel mesh__D051275 Insulin-Responsive Glucose Transporter
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D051275 2006
% 223.75/223.96  |- mesh__recordOriginator mesh__D051275 DRC
% 223.75/223.96  |- skos__prefLabel mesh__D051275 Glucose Transporter Type 4
% 223.75/223.96  |- skos__altLabel mesh__D051275 GLUT4 Protein
% 223.75/223.96  |- mesh__recordAuthorizer mesh__D051275 sjn
% 223.75/223.96  |- skos__altLabel mesh__D051275 GLUT-4 Protein
% 223.75/223.96  |- skos__altLabel mesh__D051275
% 223.75/223.96       Solute Carrier Family 2, Facilitated Glucose Transporter, Member 4 Protein
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D031218 2005
% 223.75/223.96  |- rdf__type mesh__D031218sskos__Concept
% 223.75/223.96  |- mesh__publicMeSHNote mesh__D031218 2005; see CRAMBE 2003-2004   
% 223.75/223.96  |- mesh__dateRevised mesh__D031218 2004-07-13
% 223.75/223.96  |- mesh__recordMaintainer mesh__D031218 sjn
% 223.75/223.96  |- mesh__recordAuthorizer mesh__D031218 sjn
% 223.75/223.96  |- mesh__historyNote mesh__D031218 2005 %28%2003%29%   
% 223.75/223.96  |- mesh__recordOriginator mesh__D031218 ssb
% 223.75/223.96  |- mesh__dateEstablished mesh__D031218 2003-01-01
% 223.75/223.96  |- skos__scopeNote mesh__D031218
% 223.75/223.96       A plant genus of the family BRASSICACEAE. Members contain crambin.%A%    
% 223.75/223.96  |- mesh__dateCreated mesh__D031218 2002-07-03
% 223.75/223.96  |- skos__annotation mesh__D031218
% 223.75/223.96       do not confuse with CRAMBE SPONGE, an invertebrate; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D031218 2006
% 223.75/223.96  |- skos__broader mesh__D031218smesh__D019607
% 223.75/223.96  |- skos__prefLabel mesh__D031218 Crambe Plant
% 223.75/223.96  |- mesh__historyNote mesh__D036701 2003   
% 223.75/223.96  |- skos__altLabel mesh__D036701 Tetranortriterpenoids
% 223.75/223.96  |- mesh__recordOriginator mesh__D036701 ssb
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D036701 2006A
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D036701 2005
% 223.75/223.96  |- skos__altLabel mesh__D036701 Limonoids
% 223.75/223.96  |- mesh__publicMeSHNote mesh__D036701 2003   
% 223.75/223.96  |- mesh__dateCreated mesh__D036701 2002-07-03
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D036701 2006
% 223.75/223.96  |- skos__historyNote mesh__D036701 Triterpenes %28%1974-2002%29%
% 223.75/223.96  |- mesh__recordAuthorizer mesh__D036701 ags
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D036701 2003
% 223.75/223.96  |- mesh__dateRevised mesh__D036701 2005-07-11
% 223.75/223.96  |- mesh__dateEstablished mesh__D036701 2003-01-01
% 223.75/223.96  |- rdf__type mesh__D036701sskos__Concept
% 223.75/223.96  |- skos__broader mesh__D036701smesh__D014315
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D036701 2004
% 223.75/223.96  |- skos__prefLabel mesh__D036701 Limonins
% 223.75/223.96  |- mesh__recordMaintainer mesh__D036701 ags
% 223.75/223.96  |- skos__scopeNote mesh__D036701
% 223.75/223.96       A group of degraded TRITERPENES in which the four terminal carbons of the C17 side chain have been removed, and the remaining portion often forming C17 furans.%A%    
% 223.75/223.96  |- skos__scopeNote mesh__D003527
% 223.75/223.96       An affective disorder characterized by periods of depression and hypomania. These may be separated by periods of normal mood.%A%    
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D003527 2006
% 223.75/223.96  |- skos__hiddenLabel mesh__D003527 Disorder, Cyclothymic
% 223.75/223.96  |- mesh__dateCreated mesh__D003527 1999-01-01
% 223.75/223.96  |- skos__hiddenLabel mesh__D003527 Cyclothymic Disorders
% 223.75/223.96  |- mesh__recordAuthorizer mesh__D003527 SJN
% 223.75/223.96  |- rdf__type mesh__D003527sskos__Concept
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D003527 2002
% 223.75/223.96  |- skos__altLabel mesh__D003527 Cyclothymic Personality
% 223.75/223.96  |- mesh__dateEstablished mesh__D003527 1991-01-01
% 223.75/223.96  |- mesh__publicMeSHNote mesh__D003527
% 223.75/223.96       91; was see under AFFECTIVE DISORDERS 1981-90; was CYCLOTHYMIC PERSONALITY see under PERSONALITY DISORDERS 1968-80%A%  
% 223.75/223.96  |- skos__hiddenLabel mesh__D003527 Personality, Cyclothymic
% 223.75/223.96  |- skos__hiddenLabel mesh__D003527 Disorders, Cyclothymic
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D003527 2003
% 223.75/223.96  |- skos__prefLabel mesh__D003527 Cyclothymic Disorder
% 223.75/223.96  |- mesh__dateRevised mesh__D003527 1997-06-20
% 223.75/223.96  |- skos__hiddenLabel mesh__D003527 Cyclothymic Personalities
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D003527 1998
% 223.75/223.96  |- skos__hiddenLabel mesh__D003527 Personalities, Cyclothymic
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D003527 2004
% 223.75/223.96  |- skos__broader mesh__D003527smesh__D001714
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D003527 2000
% 223.75/223.96  |- mesh__onlineNote mesh__D003527
% 223.75/223.96       use CYCLOTHYMIC DISORDER to search CYCLOTHYMIC PERSONALITY 1975-80; use PERSONALITY DISORDERS 1968-74%A%  
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D003527 1999
% 223.75/223.96  |- mesh__recordOriginator mesh__D003527 NLM
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D003527 2005
% 223.75/223.96  |- mesh__historyNote mesh__D003527
% 223.75/223.96       91%28%81%29%; was see under AFFECTIVE DISORDERS 1981-90; was CYCLOTHYMIC PERSONALITY see under PERSONALITY DISORDERS 1968-80%A%  
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D003527 2001
% 223.75/223.96  |- mesh__recordMaintainer mesh__D003527 JLS
% 223.75/223.96  |- mesh__dateRevised mesh__D008212 1992-05-22
% 223.75/223.96  |- skos__scopeNote mesh__D008212
% 223.75/223.96       Immunosuppression by reduction of circulating lymphocytes or by T-cell depletion of bone marrow. The former may be accomplished in vivo by thoracic duct drainage or administration of antilymphocyte serum. The latter is performed ex vivo on bone marrow before its transplantation.%A%    
% 223.75/223.96  |- mesh__recordAuthorizer mesh__D008212 PLS
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008212 1996
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008212 1995
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008212 2002
% 223.75/223.96  |- mesh__recordMaintainer mesh__D008212 TAP
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008212 2006
% 223.75/223.96  |- mesh__dateCreated mesh__D008212 1999-01-01
% 223.75/223.96  |- skos__hiddenLabel mesh__D008212 Depletion, Lymphocyte
% 223.75/223.96  |- skos__historyNote mesh__D008212 Immunosuppression %28%1971%29%
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008212 1994
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008212 2001
% 223.75/223.96  |- skos__broader mesh__D008212smesh__D007165
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008212 1993
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008212 1999
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008212 2000
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008212 2005
% 223.75/223.96  |- rdf__type mesh__D008212sskos__Concept
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008212 2004
% 223.75/223.96  |- mesh__recordOriginator mesh__D008212 NLM
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008212 1998
% 223.75/223.96  |- mesh__publicMeSHNote mesh__D008212 74   
% 223.75/223.96  |- skos__prefLabel mesh__D008212 Lymphocyte Depletion
% 223.75/223.96  |- mesh__historyNote mesh__D008212 74%28%72%29%   
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008212 1997
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D008212 2003
% 223.75/223.96  |- mesh__dateEstablished mesh__D008212 1974-01-01
% 223.75/223.96  |- skos__scopeNote mesh__D049629
% 223.75/223.96       The waist circumference measurement divided by the hip circumference measurement. For both men and women, a waist-to-hip ratio %28%WHR%29% of 1.0 or higher is considered %22%at risk%22% for undesirable health consequences, such as heart disease and ailments associated with OVERWEIGHT. A healthy WHR is 0.90 or less for men, and 0.80 or less for women. %28%National Center for Chronic Disease Prevention and Health Promotion, 2004%29%%A%    
% 223.75/223.96  |- skos__hiddenLabel mesh__D049629 Ratios, Waist-to-Hip
% 223.75/223.96  |- mesh__dateCreated mesh__D049629 2004-07-07
% 223.75/223.96  |- skos__related mesh__D049629smesh__D050218
% 223.75/223.96  |- mesh__recordOriginator mesh__D049629 nns
% 223.75/223.96  |- rdf__type mesh__D049629sskos__Concept
% 223.75/223.96  |- skos__altLabel mesh__D049629 Waist-to-Hip Ratio
% 223.75/223.96  |- skos__hiddenLabel mesh__D049629 Waist-Hip Ratios
% 223.75/223.96  |- skos__broader mesh__D049629smesh__D001837
% 223.75/223.96  |- mesh__publicMeSHNote mesh__D049629
% 223.75/223.96       2005; see BODY CONSTITUTION 1994-2004   
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D049629 2006
% 223.75/223.96  |- mesh__recordMaintainer mesh__D049629 lkt
% 223.75/223.96  |- skos__hiddenLabel mesh__D049629 Waist to Hip Ratio
% 223.75/223.96  |- mesh__historyNote mesh__D049629 2005; use BODY CONSTITUTION 1994-2004   
% 223.75/223.96  |- mesh__dateRevised mesh__D049629 2005-06-30
% 223.75/223.96  |- mesh__dateEstablished mesh__D049629 2005-01-01
% 223.75/223.96  |- skos__hiddenLabel mesh__D049629 Ratio, Waist-Hip
% 223.75/223.96  |- mesh__recordAuthorizer mesh__D049629 sjn
% 223.75/223.96  |- skos__hiddenLabel mesh__D049629 Ratios, Waist-Hip
% 223.75/223.96  |- skos__hiddenLabel mesh__D049629 Waist-to-Hip Ratios
% 223.75/223.96  |- skos__hiddenLabel mesh__D049629 Waist Hip Ratio
% 223.75/223.96  |- skos__hiddenLabel mesh__D049629 Ratio, Waist-to-Hip
% 223.75/223.96  |- skos__prefLabel mesh__D049629 Waist-Hip Ratio
% 223.75/223.96  |- skos__annotation mesh__D013955
% 223.75/223.96       non-neoplastic; /blood supply /chem /secret /ultrastruct permitted; %22%thyroglossal duct%22% probably goes here%A%  
% 223.75/223.96  |- skos__prefLabel mesh__D013955 Thyroglossal Cyst
% 223.75/223.96  |- skos__scopeNote mesh__D013955
% 223.75/223.96       A cyst in the neck caused by persistence of portions of, or by lack of closure of, the primitive thyroglossal duct. %28%Dorland, 27th ed%29%%A%    
% 223.75/223.96  |- skos__hiddenLabel mesh__D013955 Cyst, Thyrolingual
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013955 2001
% 223.75/223.96  |- skos__hiddenLabel mesh__D013955 Cysts, Thyrolingual
% 223.75/223.96  |- mesh__recordOriginator mesh__D013955 NLM
% 223.75/223.96  |- skos__hiddenLabel mesh__D013955 Cysts, Thyroglossal
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013955 2006
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013955 2000
% 223.75/223.96  |- rdf__type mesh__D013955sskos__Concept
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013955 2004
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013955 2005
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013955 2003
% 223.75/223.96  |- skos__altLabel mesh__D013955 Thyrolingual Cyst
% 223.75/223.96  |- skos__hiddenLabel mesh__D013955 Thyroglossal Cysts
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013955 1999
% 223.75/223.96  |- mesh__recordMaintainer mesh__D013955 TGC
% 223.75/223.96  |- skos__hiddenLabel mesh__D013955 Cyst, Thyroglossal Duct
% 223.75/223.96  |- skos__hiddenLabel mesh__D013955 Cysts, Thyroglossal Duct
% 223.75/223.96  |- skos__hiddenLabel mesh__D013955 Cyst, Thyroglossal
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013955 2002
% 223.75/223.96  |- mesh__dateRevised mesh__D013955 1997-06-20
% 223.75/223.96  |- skos__altLabel mesh__D013955 Thyroglossal Duct Cyst
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013955 1998
% 223.75/223.96  |- mesh__dateCreated mesh__D013955 1999-01-01
% 223.75/223.96  |- skos__broader mesh__D013955smesh__D003560
% 223.75/223.96  |- skos__hiddenLabel mesh__D013955 Thyroglossal Duct Cysts
% 223.75/223.96  |- mesh__recordAuthorizer mesh__D013955 SJN
% 223.75/223.96  |- skos__hiddenLabel mesh__D013955 Thyrolingual Cysts
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013157 1994
% 223.75/223.96  |- skos__hiddenLabel mesh__D013157 Splenic Arteries
% 223.75/223.96  |- mesh__dateCreated mesh__D013157 1999-01-01
% 223.75/223.96  |- rdf__type mesh__D013157sskos__Concept
% 223.75/223.96  |- skos__hiddenLabel mesh__D013157 Arteries, Splenic
% 223.75/223.96  |- mesh__recordAuthorizer mesh__D013157 PLS
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013157 2004
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013157 2002
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013157 2006
% 223.75/223.96  |- skos__prefLabel mesh__D013157 Splenic Artery
% 223.75/223.96  |- skos__hiddenLabel mesh__D013157 Artery, Splenic
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013157 1997
% 223.75/223.96  |- mesh__dateRevised mesh__D013157 1992-05-18
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013157 2003
% 223.75/223.96  |- skos__broader mesh__D013157smesh__D001158
% 223.75/223.96  |- mesh__activeMeSHYear mesh__D013157 2001
% 223.75/223.97  |- mesh__recordMaintainer mesh__D013157 TAP
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013157 1999
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013157 2005
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013157 1993
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013157 1996
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013157 1995
% 223.75/223.97  |- skos__scopeNote mesh__D013157
% 223.75/223.97       The largest branch of the celiac trunk with distribution to the spleen, pancreas, stomach and greater omentum.%A%    
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013157 2000
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013157 1998
% 223.75/223.97  |- mesh__recordOriginator mesh__D013157 NLM
% 223.75/223.97  |- skos__hiddenLabel mesh__D007918 Leprosies
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D007918 2005
% 223.75/223.97  |- skos__altLabel mesh__D007918 Hansen Disease
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D007918 1997
% 223.75/223.97  |- skos__hiddenLabel mesh__D007918 Disease, Hansen
% 223.75/223.97  |- skos__hiddenLabel mesh__D007918 Hansens Disease
% 223.75/223.97  |- skos__scopeNote mesh__D007918
% 223.75/223.97       A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid.%A%    
% 223.75/223.97  |- skos__annotation mesh__D007918
% 223.75/223.97       caused by Mycobacterium leprae; GEN or unspecified: prefer specifics; rat leprosy = MYCOBACTERIUM INFECTIONS %28%IM%29% + MYCOBACTERIUM LEPRAEMURIUM %28%IM%29%; /drug ther: consider also LEPROSTATIC AGENTS; ENL %28%erythema nodosum leprosum%29%: see note at LEPROSY, LEPROMATOUS%A%  
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D007918 2006
% 223.75/223.97  |- mesh__recordMaintainer mesh__D007918 PLS
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D007918 1998
% 223.75/223.97  |- mesh__dateCreated mesh__D007918 1999-01-01
% 223.75/223.97  |- skos__altLabel mesh__D007918 Hansen%27%s Disease
% 223.75/223.97  |- mesh__recordAuthorizer mesh__D007918 PLS
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D007918 2000
% 223.75/223.97  |- mesh__recordOriginator mesh__D007918 NLM
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D007918 1999
% 223.75/223.97  |- rdf__type mesh__D007918sskos__Concept
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D007918 2003
% 223.75/223.97  |- skos__hiddenLabel mesh__D007918 Disease, Hansen%27%s
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D007918 2001
% 223.75/223.97  |- skos__prefLabel mesh__D007918 Leprosy
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D007918 2004
% 223.75/223.97  |- skos__related mesh__D007918smesh__D007917
% 223.75/223.97  |- mesh__dateRevised mesh__D007918 1995-05-25
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D007918 2002
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D007918 1996
% 223.75/223.97  |- skos__broader mesh__D007918smesh__D009164
% 223.75/223.97  |- mesh__publicMeSHNote mesh__D018640 98   
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D018640 2006
% 223.75/223.97  |- skos__historyNote mesh__D018640 Jaw/abnormalities %28%1966-1974%29%
% 223.75/223.97  |- skos__hiddenLabel mesh__D018640 Stomatognathic System Abnormality
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D018640 2002
% 223.75/223.97  |- skos__prefLabel mesh__D018640 Stomatognathic System Abnormalities
% 223.75/223.97  |- skos__altLabel mesh__D018640 Abnormalities, Stomatognathic System
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D018640 2004
% 223.75/223.97  |- mesh__dateEstablished mesh__D018640 1998-01-01
% 223.75/223.97  |- skos__hiddenLabel mesh__D018640 Abnormality, Stomatognathic System
% 223.75/223.97  |- mesh__recordOriginator mesh__D018640 PXP
% 223.75/223.97  |- skos__historyNote mesh__D018640 Mouth/abnormalities %28%1966-1974%29%
% 223.75/223.97  |- mesh__recordMaintainer mesh__D018640 kle
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D018640 2005
% 223.75/223.97  |- skos__historyNote mesh__D018640 Jaw Abnormalities %28%1975-1997%29%
% 223.75/223.97  |- skos__broader mesh__D018640smesh__D009057
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D018640 2003
% 223.75/223.97  |- rdf__type mesh__D018640sskos__Concept
% 223.75/223.97  |- mesh__dateRevised mesh__D018640 1999-11-03
% 223.75/223.97  |- skos__historyNote mesh__D018640 Mouth Abnormalities %28%1975-1997%29%
% 223.75/223.97  |- skos__annotation mesh__D018640
% 223.75/223.97       for congen struct abnorm only; GEN or unspecified; prefer specifics or specific organ /abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: STOMATOGNATHIC SYSTEM ABNORM%A%  
% 223.75/223.97  |- mesh__recordAuthorizer mesh__D018640 sjn
% 223.75/223.97  |- skos__scopeNote mesh__D018640
% 223.75/223.97       Congenital structural abnormalities of the mouth and jaws, including the dentition.%A%    
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D018640 2001
% 223.75/223.97  |- mesh__dateCreated mesh__D018640 1994-06-03
% 223.75/223.97  |- mesh__historyNote mesh__D018640 98; use explode 1995-97   
% 223.75/223.97  |- skos__broader mesh__D018640smesh__D000013
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D018640 2000
% 223.75/223.97  |- mesh__recordAuthorizer mesh__D004620 sjn
% 223.75/223.97  |- skos__hiddenLabel mesh__D004620 Fat Embolisms
% 223.75/223.97  |- skos__hiddenLabel mesh__D004620 Fat Embolism
% 223.75/223.97  |- mesh__recordOriginator mesh__D004620 NLM
% 223.75/223.97  |- mesh__recordMaintainer mesh__D004620 jls
% 223.75/223.97  |- skos__scopeNote mesh__D004620
% 223.75/223.97       Embolism caused by fat entering the circulation. It is often seen after fractures of large bones or after corticosteroid administration.%A%    
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D004620 2006
% 223.75/223.97  |- mesh__dateRevised mesh__D004620 2004-07-19
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D004620 2005
% 223.75/223.97  |- skos__hiddenLabel mesh__D004620 Embolisms, Fat
% 223.75/223.97  |- skos__broader mesh__D004620smesh__D004617
% 223.75/223.97  |- rdf__type mesh__D004620sskos__Concept
% 223.75/223.97  |- skos__annotation mesh__D004620
% 223.75/223.97       embolism from fat entering circ; do not confuse with EMBOLISM, CHOLESTEROL, lipid debris from atheroma%A%  
% 223.75/223.97  |- mesh__dateCreated mesh__D004620 1999-01-01
% 223.75/223.97  |- skos__prefLabel mesh__D004620 Embolism, Fat
% 223.75/223.97  |- rdf__type mesh__D051276sskos__Concept
% 223.75/223.97  |- skos__hiddenLabel mesh__D051276 Aminotransferase, Leucine
% 223.75/223.97  |- mesh__historyNote mesh__D051276
% 223.75/223.97       2006%28%1980%29%; use TRANSAMINASES 1973-1979, %26% KETOGLUTARIC ACID 1973-1979%A%  
% 223.75/223.97  |- skos__altLabel mesh__D051276 Leucine Aminotransferase
% 223.75/223.97  |- skos__hiddenLabel mesh__D051276 Transaminase, Leucine
% 223.75/223.97  |- mesh__dateEstablished mesh__D051276 2006-01-01
% 223.75/223.97  |- mesh__recordAuthorizer mesh__D051276 sjn
% 223.75/223.97  |- skos__altLabel mesh__D051276
% 223.75/223.97       Leucine alpha Ketoglutarate Aminotransferase
% 223.75/223.97  |- skos__prefLabel mesh__D051276 Leucine Transaminase
% 223.75/223.97  |- skos__scopeNote mesh__D051276
% 223.75/223.97       A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the reversible transamination of branched-chain AMINO ACIDS to 2-OXOGLUTARATE.%A%    
% 223.75/223.97  |- mesh__recordMaintainer mesh__D051276 AKE
% 223.75/223.97  |- mesh__dateCreated mesh__D051276 2005-06-30
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D051276 2006
% 223.75/223.97  |- mesh__publicMeSHNote mesh__D051276
% 223.75/223.97       2006; LEUCINE TRANSAMINASE was indexed under TRANSAMINASES 1973-2005 %26% under KETOGLUTARIC ACID 1973-1979%A%  
% 223.75/223.97  |- skos__broader mesh__D051276smesh__D000637
% 223.75/223.97  |- mesh__recordOriginator mesh__D051276 AKE
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D017548 2002
% 223.75/223.97  |- mesh__dateRevised mesh__D017548 1997-06-20
% 223.75/223.97  |- mesh__dateCreated mesh__D017548 1993-06-18
% 223.75/223.97  |- skos__altLabel mesh__D017548 Transesophageal Echocardiography
% 223.75/223.97  |- mesh__dateEstablished mesh__D017548 1994-01-01
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D017548 1998
% 223.75/223.97  |- mesh__historyNote mesh__D017548 94   
% 223.75/223.97  |- skos__scopeNote mesh__D017548
% 223.75/223.97       Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues using a transducer placed in the esophagus.%A%    
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D017548 2001
% 223.75/223.97  |- mesh__recordMaintainer mesh__D017548 PXP
% 223.75/223.97  |- mesh__recordOriginator mesh__D017548 RAZ
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D017548 2004
% 223.75/223.97  |- mesh__recordAuthorizer mesh__D017548 SJN
% 223.75/223.97  |- rdf__type mesh__D017548sskos__Concept
% 223.75/223.97  |- skos__annotation mesh__D017548
% 223.75/223.97       coord IM with specific type of echocardiogr %28%IM%29% if pertinent; coord IM with specific heart dis /ultrasonogr %28%IM%29%; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: TEE%A%  
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D017548 2000
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D017548 2006
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D017548 2003
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D017548 2005
% 223.75/223.97  |- skos__broader mesh__D017548smesh__D004452
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D017548 1999
% 223.75/223.97  |- skos__historyNote mesh__D017548 Echocardiography %28%1977-1993%29%
% 223.75/223.97  |- mesh__publicMeSHNote mesh__D017548 94   
% 223.75/223.97  |- skos__prefLabel mesh__D017548 Echocardiography, Transesophageal
% 223.75/223.97  |- mesh__dateCreated mesh__D031219 2002-07-03
% 223.75/223.97  |- skos__broader mesh__D031219smesh__D019607
% 223.75/223.97  |- rdf__type mesh__D031219sskos__Concept
% 223.75/223.97  |- skos__altLabel mesh__D031219 Woad
% 223.75/223.97  |- mesh__publicMeSHNote mesh__D031219 2003   
% 223.75/223.97  |- skos__annotation mesh__D031219
% 223.75/223.97       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D031219 2004
% 223.75/223.97  |- mesh__dateEstablished mesh__D031219 2003-01-01
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D031219 2006
% 223.75/223.97  |- mesh__historyNote mesh__D031219 2003   
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D031219 2003
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D031219 2005
% 223.75/223.97  |- skos__scopeNote mesh__D031219
% 223.75/223.97       A plant genus of the family BRASSICACEAE that is an ingredient of the preparation PC-SPES that is used to treat PROSTATIC HYPERPLASIA.%A%    
% 223.75/223.97  |- skos__prefLabel mesh__D031219 Isatis
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D036702 2005
% 223.75/223.97  |- mesh__publicMeSHNote mesh__D036702 2003   
% 223.75/223.97  |- mesh__historyNote mesh__D036702 2003   
% 223.75/223.97  |- skos__prefLabel mesh__D036702 Quassins
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D036702 2006
% 223.75/223.97  |- skos__scopeNote mesh__D036702
% 223.75/223.97       A group of degraded TRITERPENES which have lost ten carbons %28%8 from the side chain, C17, and one from C4%29% so have C20 skeletons which could be misinterpreted as DITERPENES. They especially occur in plants of the SIMAROUBACEAE family.%A%    
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D036702 2003
% 223.75/223.97  |- rdf__type mesh__D036702sskos__Concept
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D036702 2004
% 223.75/223.97  |- mesh__dateCreated mesh__D036702 2002-07-03
% 223.75/223.97  |- skos__altLabel mesh__D036702 Quassinoids
% 223.75/223.97  |- mesh__dateEstablished mesh__D036702 2003-01-01
% 223.75/223.97  |- skos__broader mesh__D036702smesh__D014315
% 223.75/223.97  |- skos__hiddenLabel mesh__D003528 Adenoid Cystic Carcinoma
% 223.75/223.97  |- mesh__recordMaintainer mesh__D003528 KEV
% 223.75/223.97  |- skos__hiddenLabel mesh__D003528 Cystic Carcinomas, Adenoid
% 223.75/223.97  |- mesh__publicMeSHNote mesh__D003528 94; was CYLINDROMA 1963-93   
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D003528 2001
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D003528 1998
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D003528 2006
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D003528 2000
% 223.75/223.97  |- mesh__recordOriginator mesh__D003528 NLM
% 223.75/223.97  |- skos__hiddenLabel mesh__D003528 Cylindromas
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D003528 1997
% 223.75/223.97  |- skos__hiddenLabel mesh__D003528 Adenoid Cystic Carcinomas
% 223.75/223.97  |- rdf__type mesh__D003528sskos__Concept
% 223.75/223.97  |- mesh__historyNote mesh__D003528 94; was CYLINDROMA 1963-93   
% 223.75/223.97  |- skos__hiddenLabel mesh__D003528 Cystic Carcinoma, Adenoid
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D003528 2005
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D003528 1996
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D003528 2004
% 223.75/223.97  |- mesh__recordAuthorizer mesh__D003528 PLS
% 223.75/223.97  |- skos__annotation mesh__D003528
% 223.75/223.97       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 223.75/223.97  |- mesh__onlineNote mesh__D003528
% 223.75/223.97       use CARCINOMA, ADENOID CYSTIC to search CYLINDROMA 1966-93%A%  
% 223.75/223.97  |- skos__hiddenLabel mesh__D003528 Carcinomas, Adenoid Cystic
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D003528 2003
% 223.75/223.97  |- skos__scopeNote mesh__D003528
% 223.75/223.97       Carcinoma characterized by bands or cylinders of hyalinized or mucinous stroma separating or surrounded by nests or cords of small epithelial cells. When the cylinders occur within masses of epithelial cells, they give the tissue a perforated, sievelike, or cribriform appearance. Such tumors occur in the mammary glands, the mucous glands of the upper and lower respiratory tract, and the salivary glands. They are malignant but slow-growing, and tend to spread locally via the nerves. %28%Dorland, 27th ed%29%%A%    
% 223.75/223.97  |- skos__prefLabel mesh__D003528 Carcinoma, Adenoid Cystic
% 223.75/223.97  |- skos__altLabel mesh__D003528 Cylindroma
% 223.75/223.97  |- skos__broader mesh__D003528smesh__D000230
% 223.75/223.97  |- mesh__dateCreated mesh__D003528 1999-01-01
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D003528 2002
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D003528 1999
% 223.75/223.97  |- mesh__dateRevised mesh__D003528 1995-06-08
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D014250 2006
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D014250 2006A
% 223.75/223.97  |- skos__broader mesh__D014250smesh__D003904
% 223.75/223.97  |- mesh__dateCreated mesh__D014250 1985-02-12
% 223.75/223.97  |- skos__broader mesh__D014250smesh__D015003
% 223.75/223.97  |- mesh__recordMaintainer mesh__D014250 ags
% 223.75/223.97  |- mesh__dateEstablished mesh__D014250 1991-01-01
% 223.75/223.97  |- mesh__publicMeSHNote mesh__D014250 91; see HYPHOMYCETES 1986-90   
% 223.75/223.97  |- skos__scopeNote mesh__D014250
% 223.75/223.97       A mitosporic fungal genus causing opportunistic infections, endocarditis, fungemia, and white PIEDRA.%A%    
% 223.75/223.97  |- mesh__recordOriginator mesh__D014250 RC
% 223.75/223.97  |- rdf__type mesh__D014250sskos__Concept
% 223.75/223.97  |- skos__prefLabel mesh__D014250 Trichosporon
% 223.75/223.97  |- skos__annotation mesh__D014250
% 223.75/223.97       infection: coord IM with MYCOSES %28%IM%29% or specific mycosis %28%IM%29%%A%  
% 223.75/223.97  |- mesh__dateRevised mesh__D014250 2005-07-27
% 223.75/223.97  |- mesh__historyNote mesh__D014250 91%28%86%29%   
% 223.75/223.97  |- skos__historyNote mesh__D014250 Hyphomycetes %28%1966-1985%29%
% 223.75/223.97  |- mesh__recordAuthorizer mesh__D014250 ags
% 223.75/223.97  |- mesh__historyNote mesh__D008213
% 223.75/223.97       2003 %28%1969%29%; for BLAST TRANSFORMATION use BLAST CRISIS 1987-1992%A%  
% 223.75/223.97  |- skos__altLabel mesh__D008213 Transformation, Blast
% 223.75/223.97  |- mesh__recordOriginator mesh__D008213 NLM
% 223.75/223.97  |- skos__broader mesh__D008213smesh__D007111
% 223.75/223.97  |- mesh__recordMaintainer mesh__D008213 ags
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D008213 2006A
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D008213 2006
% 223.75/223.97  |- skos__altLabel mesh__D008213 Transformation, Lymphocyte
% 223.75/223.97  |- skos__altLabel mesh__D008213 Lymphocyte Stimulation
% 223.75/223.97  |- mesh__dateEstablished mesh__D008213 1972-01-01
% 223.75/223.97  |- mesh__dateCreated mesh__D008213 1999-01-01
% 223.75/223.97  |- skos__prefLabel mesh__D008213 Lymphocyte Activation
% 223.75/223.97  |- skos__scopeNote mesh__D008213
% 223.75/223.97       Morphologic alteration of small lymphocytes in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific antigens. It may also occur in vivo, as in GRAFT REJECTION and chronic myelogenous leukemia %28%LEUKEMIA, MYELOID, CHRONIC%29%.%A%    
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D008213 2005
% 223.75/223.97  |- skos__altLabel mesh__D008213 Transformation, Lymphoblast
% 223.75/223.97  |- rdf__type mesh__D008213sskos__Concept
% 223.75/223.97  |- skos__hiddenLabel mesh__D008213 Stimulation, Lymphocyte
% 223.75/223.97  |- skos__altLabel mesh__D008213 Blast Transformation
% 223.75/223.97  |- skos__broader mesh__D008213smesh__D007158
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D008213 2004
% 223.75/223.97  |- mesh__publicMeSHNote mesh__D008213
% 223.75/223.97       2003; see LYMPHOCYTE TRANSFORMATION 1972-2002; for BLAST TRANSFORMATION see BLAST CRISIS 1987-1992%A%  
% 223.75/223.97  |- mesh__dateRevised mesh__D008213 2005-07-18
% 223.75/223.97  |- mesh__recordAuthorizer mesh__D008213 ags
% 223.75/223.97  |- skos__altLabel mesh__D008213 Lymphoblast Transformation
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D008213 2003
% 223.75/223.97  |- skos__historyNote mesh__D008213 Lymphocytes/immunology %28%1966-1968%29%
% 223.75/223.97  |- skos__altLabel mesh__D008213 Lymphocyte Transformation
% 223.75/223.97  |- skos__annotation mesh__D008213
% 223.75/223.97       lymphocyte transformation test goes here but do not index under specific agent inducing transformation unless particularly discussed; do not use for neoplastic or viral transformation of lymphocytes; DF: LYMPHOCYTE TRANSFORM%A%  
% 223.75/223.97  |- skos__hiddenLabel mesh__D008213 Activation, Lymphocyte
% 223.75/223.97  |- skos__altLabel mesh__D008213 Blastogenesis
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D000230 2000
% 223.75/223.97  |- skos__prefLabel mesh__D000230 Adenocarcinoma
% 223.75/223.97  |- mesh__dateCreated mesh__D000230 1999-01-01
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Tubular Adenocarcinoma
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Tubular Adenocarcinomas
% 223.75/223.97  |- skos__altLabel mesh__D000230 Carcinoma, Tubular
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Adenocarcinomas, Oxyphilic
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D000230 2001
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Carcinomas, Tubular
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Granular Cell Adenocarcinomas
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D000230 2005
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Carcinomas, Cribriform
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Tubular Carcinomas
% 223.75/223.97  |- skos__altLabel mesh__D000230 Adenoma, Malignant
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Basal Cell Adenocarcinomas
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Adenocarcinomas, Basal Cell
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Granular Cell Carcinomas
% 223.75/223.97  |- mesh__recordOriginator mesh__D000230 NLM
% 223.75/223.97  |- skos__scopeNote mesh__D000230
% 223.75/223.97       A malignant epithelial tumor with a glandular organization.%A%    
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Oxyphilic Adenocarcinomas
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D000230 2006
% 223.75/223.97  |- rdf__type mesh__D000230sskos__Concept
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Cribriform Carcinoma
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Granular Cell Carcinoma
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Malignant Adenoma
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D000230 2002
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Cribriform Carcinomas
% 223.75/223.97  |- mesh__recordMaintainer mesh__D000230 jls
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Granular Cell Adenocarcinoma
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Adenocarcinomas, Granular Cell
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Tubular Carcinoma
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D000230 2003
% 223.75/223.97  |- skos__annotation mesh__D000230
% 223.75/223.97       coord IM with precoord organ/neopl term %28%IM%29%   
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Adenocarcinomas
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Adenocarcinomas, Tubular
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Adenomas, Malignant
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Basal Cell Adenocarcinoma
% 223.75/223.97  |- skos__altLabel mesh__D000230 Adenocarcinoma, Granular Cell
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Carcinomas, Granular Cell
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Oxyphilic Adenocarcinoma
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D000230 2004
% 223.75/223.97  |- skos__broader mesh__D000230smesh__D002277
% 223.75/223.97  |- skos__hiddenLabel mesh__D000230 Malignant Adenomas
% 223.75/223.97  |- mesh__dateRevised mesh__D000230 1999-11-03
% 223.75/223.97  |- mesh__recordAuthorizer mesh__D000230 sjn
% 223.75/223.97  |- mesh__recordMaintainer mesh__D013956 ssb
% 223.75/223.97  |- skos__scopeNote mesh__D013956
% 223.75/223.97       Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones.%A%    
% 223.75/223.97  |- skos__altLabel mesh__D013956 Thyroid Antagonists
% 223.75/223.97  |- skos__hiddenLabel mesh__D013956 Agents, Antithyroid
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013956 2006
% 223.75/223.97  |- mesh__publicMeSHNote mesh__D013956
% 223.75/223.97       96; was THYROID ANTAGONISTS 1963-95; GOITROGENS was heading 1963-66; ANTITHYROID DRUGS was see THYROID ANTAGONISTS 1975-95%A%  
% 223.75/223.97  |- rdf__type mesh__D013956sskos__Concept
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013956 2004
% 223.75/223.97  |- skos__hiddenLabel mesh__D013956 Drugs, Antithyroid
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013956 2005
% 223.75/223.97  |- mesh__recordAuthorizer mesh__D013956 sjn
% 223.75/223.97  |- skos__altLabel mesh__D013956 Antithyroid Drugs
% 223.75/223.97  |- mesh__recordOriginator mesh__D013956 NLM
% 223.75/223.97  |- skos__hiddenLabel mesh__D013956 Antagonists, Thyroid
% 223.75/223.97  |- mesh__dateCreated mesh__D013956 1999-01-01
% 223.75/223.97  |- mesh__onlineNote mesh__D013956
% 223.75/223.97       use ANTITHYROID AGENTS to search GOITROGENS 1966   
% 223.75/223.97  |- mesh__dateRevised mesh__D013956 2003-07-09
% 223.75/223.97  |- skos__broader mesh__D013956smesh__D006727
% 223.75/223.97  |- skos__annotation mesh__D013956
% 223.75/223.97       consider also HYPERTHYROIDISM /drug ther   
% 223.75/223.97  |- mesh__historyNote mesh__D013956
% 223.75/223.97       96; was THYROID ANTAGONISTS 1963-95; GOITROGENS was heading 1963-66; ANTITHYROID DRUGS was see THYROID ANTAGONISTS 1975-95%A%  
% 223.75/223.97  |- skos__prefLabel mesh__D013956 Antithyroid Agents
% 223.75/223.97  |- mesh__publicMeSHNote mesh__D013158 66   
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013158 2001
% 223.75/223.97  |- mesh__historyNote mesh__D013158 66   
% 223.75/223.97  |- rdf__type mesh__D013158sskos__Concept
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013158 2003
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013158 2005
% 223.75/223.97  |- mesh__recordAuthorizer mesh__D013158 PLS
% 223.75/223.97  |- mesh__recordOriginator mesh__D013158 NLM
% 223.75/223.97  |- mesh__recordMaintainer mesh__D013158 TGC
% 223.75/223.97  |- skos__related mesh__D013158smesh__D017890
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013158 2004
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013158 1996
% 223.75/223.97  |- mesh__dateRevised mesh__D013158 1993-02-16
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013158 2002
% 223.75/223.97  |- skos__broader mesh__D013158smesh__D008206
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013158 2006
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013158 1998
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013158 1997
% 223.75/223.97  |- skos__hiddenLabel mesh__D013158 Splenic Disease
% 223.75/223.97  |- mesh__dateEstablished mesh__D013158 1966-01-01
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013158 1994
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013158 1999
% 223.75/223.97  |- skos__hiddenLabel mesh__D013158 Disease, Splenic
% 223.75/223.97  |- skos__hiddenLabel mesh__D013158 Diseases, Splenic
% 223.75/223.97  |- skos__prefLabel mesh__D013158 Splenic Diseases
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013158 1995
% 223.75/223.97  |- mesh__dateCreated mesh__D013158 1999-01-01
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D013158 2000
% 223.75/223.97  |- skos__scopeNote mesh__D007919
% 223.75/223.97       A genus of aerobic, helical spirochetes, some species of which are pathogenic, others free-living or saprophytic.%A%    
% 223.75/223.97  |- mesh__dateCreated mesh__D007919 1999-01-01
% 223.75/223.97  |- mesh__recordAuthorizer mesh__D007919 sjn
% 223.75/223.97  |- rdf__type mesh__D007919sskos__Concept
% 223.75/223.97  |- skos__broader mesh__D007919smesh__D016953
% 223.75/223.97  |- mesh__recordMaintainer mesh__D007919 SYSTEM
% 223.75/223.97  |- skos__prefLabel mesh__D007919 Leptospira
% 223.75/223.97  |- mesh__recordOriginator mesh__D007919 NLM
% 223.75/223.97  |- skos__annotation mesh__D007919 infection = LEPTOSPIROSIS   
% 223.75/223.97  |- mesh__dateRevised mesh__D007919 2005-06-30
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D007919 2006
% 223.75/223.97  |- mesh__dateCreated mesh__D004621 1975-07-25
% 223.75/223.97  |- mesh__recordMaintainer mesh__D004621 sjn
% 223.75/223.97  |- skos__hiddenLabel mesh__D004621 Embolotherapies
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D004621 2003
% 223.75/223.97  |- skos__historyNote mesh__D004621
% 223.75/223.97       specific heading/surgery %28%1966-1975%29%
% 223.75/223.97  |- skos__altLabel mesh__D004621 Embolotherapy
% 223.75/223.97  |- mesh__historyNote mesh__D004621 76   
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D004621 2001
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D004621 2006
% 223.75/223.97  |- mesh__recordAuthorizer mesh__D004621 sjn
% 223.75/223.97  |- mesh__dateRevised mesh__D004621 1997-06-20
% 223.75/223.97  |- mesh__publicMeSHNote mesh__D004621 76   
% 223.75/223.97  |- skos__altLabel mesh__D004621 Therapeutic Embolization
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D004621 2005
% 223.75/223.97  |- skos__annotation mesh__D004621
% 223.75/223.97       coord IM with disease /ther %28%IM%29%, not /surg   
% 223.75/223.97  |- skos__hiddenLabel mesh__D004621 Therapeutic Embolizations
% 223.75/223.97  |- mesh__dateEstablished mesh__D004621 1976-01-01
% 223.75/223.97  |- mesh__recordOriginator mesh__D004621 SMB
% 223.75/223.97  |- skos__broader mesh__D004621smesh__D006489
% 223.75/223.97  |- rdf__type mesh__D004621sskos__Concept
% 223.75/223.97  |- skos__historyNote mesh__D004621 Embolism %28%1966-1975%29%
% 223.75/223.97  |- skos__historyNote mesh__D004621
% 223.75/223.97       specific heading/therapy %28%1966-1975%29%
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D004621 2002
% 223.75/223.97  |- skos__prefLabel mesh__D004621 Embolization, Therapeutic
% 223.75/223.97  |- skos__hiddenLabel mesh__D004621 Embolizations, Therapeutic
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D004621 2004
% 223.75/223.97  |- skos__scopeNote mesh__D004621
% 223.75/223.97       A method of hemostasis utilizing various agents such as Gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. It has been used in the treatment of spinal cord and INTRACRANIAL ARTERIOVENOUS MALFORMATIONS, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumors, traumatic rupture of blood vessels, and control of operative hemorrhage.%A%    
% 223.75/223.97  |- skos__hiddenLabel mesh__D051277
% 223.75/223.97       Aminotransferase, Succinyldiaminopimelate
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D051277 2006A
% 223.75/223.97  |- skos__altLabel mesh__D051277
% 223.75/223.97       N-Succinyl Diaminopimelic Acid Aminotransferase
% 223.75/223.97  |- skos__prefLabel mesh__D051277 Succinyldiaminopimelate Transaminase
% 223.75/223.97  |- skos__scopeNote mesh__D051277
% 223.75/223.97       A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the transfer amino group from N-succinyl-L-2,6-diaminoheptanedioate to 2-OXOLGLUTARATE in order to generate N-succinyl-2-L-amino-6-oxoheptanedioate and L-GLUTAMATE, respectively.%A%    
% 223.75/223.97  |- skos__broader mesh__D051277smesh__D000637
% 223.75/223.97  |- mesh__recordOriginator mesh__D051277 AKE
% 223.75/223.97  |- skos__hiddenLabel mesh__D051277 Transaminase, Succinyldiaminopimelate
% 223.75/223.97  |- skos__altLabel mesh__D051277 Succinyldiaminopimelate Aminotransferase
% 223.75/223.97  |- skos__hiddenLabel mesh__D051277
% 223.75/223.97       N Succinyl Diaminopimelic Acid Aminotransferase
% 223.75/223.97  |- mesh__publicMeSHNote mesh__D051277
% 223.75/223.97       2006; SUCCINYLDIAMINOPIMELATE TRANSAMINASE was indexed under TRANSAMINASES 1999-2005%A%  
% 223.75/223.97  |- mesh__dateEstablished mesh__D051277 2006-01-01
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D051277 2006
% 223.75/223.97  |- mesh__historyNote mesh__D051277 2006%28%1999%29%   
% 223.75/223.97  |- rdf__type mesh__D051277sskos__Concept
% 223.75/223.97  |- mesh__dateRevised mesh__D051277 2005-07-07
% 223.75/223.97  |- mesh__recordAuthorizer mesh__D051277 ags
% 223.75/223.97  |- mesh__dateCreated mesh__D051277 2005-06-30
% 223.75/223.97  |- mesh__recordMaintainer mesh__D051277 ags
% 223.75/223.97  |- mesh__historyNote mesh__D036703 2003; use BLASTOCYST 1980-2002   
% 223.75/223.97  |- skos__prefLabel mesh__D036703 Blastula
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D036703 2006
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D036703 2004
% 223.75/223.97  |- skos__scopeNote mesh__D036703
% 223.75/223.97       An early non-mammalian embryo %28%EMBRYO, NONMAMMALIAN%29% that follows the MORULA stage. Blastula is usually a spherical structure containing a single layer of cells with a hollow cavity.%A%    
% 223.75/223.97  |- mesh__publicMeSHNote mesh__D036703 2003; see BLASTOCYST 1980-2002   
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D036703 2005
% 223.75/223.97  |- skos__broader mesh__D036703smesh__D002970
% 223.75/223.97  |- rdf__type mesh__D036703sskos__Concept
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D036703 2003
% 223.75/223.97  |- skos__annotation mesh__D036703
% 223.75/223.97       non-mammalian only; mammalian, use BLASTOCYST   
% 223.75/223.97  |- skos__altLabel mesh__D036703 Blastulae
% 223.75/223.97  |- skos__historyNote mesh__D036703 Embryo, Nonmammalian %28%1975-2002%29%
% 223.75/223.97  |- mesh__dateCreated mesh__D036703 2002-07-02
% 223.75/223.97  |- skos__historyNote mesh__D036703 Blastocyst %28%1980-2002%29%
% 223.75/223.97  |- mesh__dateEstablished mesh__D036703 2003-01-01
% 223.75/223.97  |- mesh__activeMeSHYear mesh__D003529 2006
% 223.75/223.97  |- skos__altLabel mesh__D003529 Cymarin
% 223.75/223.97  |- skos__scopeNote mesh__D003529
% 223.75/223.97       A cardiotonic cardiac glycoside found in STROPHANTHUS. The aglycone is STROPHANTHIN.%A%    
% 223.75/223.97  |- skos__prefLabel mesh__D003529 Cymarine
% 223.75/223.97  |- skos__altLabel mesh__D003529 Zimarin
% 223.75/223.97  |- mesh__dateCreated mesh__D003529 1974-11-19
% 223.75/223.98  |- rdf__type mesh__D003529sskos__Concept
% 223.75/223.98  |- skos__hiddenLabel mesh__D003529 h Strophanthin
% 223.75/223.98  |- mesh__recordAuthorizer mesh__D003529 sjn
% 223.75/223.98  |- mesh__dateEstablished mesh__D003529 1991-01-01
% 223.75/223.98  |- mesh__recordOriginator mesh__D003529 NLM
% 223.75/223.98  |- skos__altLabel mesh__D003529 h-Strophanthin
% 223.75/223.98  |- mesh__publicMeSHNote mesh__D003529
% 223.75/223.98       91; was see under STROPHANTHINS 1975-90; TSIMARIN was see CYMARINE 1975-92%A%  
% 223.75/223.98  |- skos__historyNote mesh__D003529 Cardiac Glycosides %28%1974%29%
% 223.75/223.98  |- skos__hiddenLabel mesh__D003529 k Strophanthin alpha
% 223.75/223.98  |- skos__historyNote mesh__D003529 Cardanolides %28%1971-1974%29%
% 223.75/223.98  |- mesh__recordMaintainer mesh__D003529 ssb
% 223.75/223.98  |- skos__altLabel mesh__D003529 Tsimarin
% 223.75/223.98  |- skos__broader mesh__D003529smesh__D013328
% 223.75/223.98  |- mesh__historyNote mesh__D003529
% 223.75/223.98       91%28%75%29%; was see under STROPHANTHINS 1975-90; TSIMARIN was see CYMARINE 1975-92%A%  
% 223.75/223.98  |- mesh__onlineNote mesh__D003529
% 223.75/223.98       use CYMARINE to search TSIMARIN 1975-92   
% 223.75/223.98  |- skos__altLabel mesh__D003529 k-Strophanthin-alpha
% 223.75/223.98  |- mesh__dateRevised mesh__D003529 2005-06-30
% 223.75/223.98  |- mesh__recordMaintainer mesh__D014251 ags
% 223.75/223.98  |- skos__scopeNote mesh__D014251
% 223.75/223.98       A superfamily of nematodes. Most are intestinal parasites of ruminants and accidentally in humans. This superfamily includes seven genera: DICTYOCAULUS; HAEMONCHUS; Cooperia, OSTERTAGIA; Nematodirus, TRICHOSTRONGYLUS; and Hyostrongylus.%A%    
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D014251 2006
% 223.75/223.98  |- mesh__recordOriginator mesh__D014251 NLM
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D014251 2004
% 223.75/223.98  |- mesh__recordAuthorizer mesh__D014251 sjn
% 223.75/223.98  |- mesh__dateRevised mesh__D014251 2003-07-09
% 223.75/223.98  |- skos__prefLabel mesh__D014251 Trichostrongyloidea
% 223.75/223.98  |- mesh__dateCreated mesh__D014251 1999-01-01
% 223.75/223.98  |- rdf__type mesh__D014251sskos__Concept
% 223.75/223.98  |- skos__broader mesh__D014251smesh__D017183
% 223.75/223.98  |- skos__annotation mesh__D014251
% 223.75/223.98       a superfamily of nematodes; infection = TRICHOSTRONGYLOIDIASIS%A%  
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D014251 2005
% 223.75/223.98  |- skos__hiddenLabel mesh__D008214 Lymphocyte
% 223.75/223.98  |- mesh__dateRevised mesh__D008214 2003-07-09
% 223.75/223.98  |- rdf__type mesh__D008214sskos__Concept
% 223.75/223.98  |- skos__prefLabel mesh__D008214 Lymphocytes
% 223.75/223.98  |- mesh__recordMaintainer mesh__D008214 jmp
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D008214 2004
% 223.75/223.98  |- skos__related mesh__D008214smesh__D000961
% 223.75/223.98  |- skos__hiddenLabel mesh__D008214 Cell, Lymphoid
% 223.75/223.98  |- skos__scopeNote mesh__D008214
% 223.75/223.98       White blood cells formed in the body%27%s lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic %28%if any%29% granules. Most lymphocytes can be classified as either T or B %28%with subpopulations of each%29%; those with characteristics of neither major class are called null cells.%A%    
% 223.75/223.98  |- mesh__recordOriginator mesh__D008214 NLM
% 223.75/223.98  |- mesh__recordAuthorizer mesh__D008214 sjn
% 223.75/223.98  |- skos__annotation mesh__D008214
% 223.75/223.98       A 11 qualif;  decrease in number = LYMPHOPENIA; excess number = LYMPHOCYTOSIS; LYMPHOCYTE COUNT is also available; LYMPHOCYTE CULTURE TEST, MIXED is also available%A%  
% 223.75/223.98  |- skos__hiddenLabel mesh__D008214 Cells, Lymphoid
% 223.75/223.98  |- skos__broader mesh__D008214smesh__D007963
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D008214 2006
% 223.75/223.98  |- skos__hiddenLabel mesh__D008214 Lymphoid Cell
% 223.75/223.98  |- mesh__dateCreated mesh__D008214 1999-01-01
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D008214 2005
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000231 2003
% 223.75/223.98  |- mesh__recordOriginator mesh__D000231 NLM
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000231 2006
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000231 1996
% 223.75/223.98  |- skos__broader mesh__D000231smesh__D000230
% 223.75/223.98  |- mesh__dateRevised mesh__D000231 1995-06-08
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000231 1999
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000231 2001
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000231 2005
% 223.75/223.98  |- mesh__dateCreated mesh__D000231 1999-01-01
% 223.75/223.98  |- skos__annotation mesh__D000231
% 223.75/223.98       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 223.75/223.98  |- skos__hiddenLabel mesh__D000231 Adenocarcinomas, Papillary
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000231 1998
% 223.75/223.98  |- rdf__type mesh__D000231sskos__Concept
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000231 2000
% 223.75/223.98  |- skos__hiddenLabel mesh__D000231 Papillary Adenocarcinoma
% 223.75/223.98  |- skos__hiddenLabel mesh__D000231 Papillary Adenocarcinomas
% 223.75/223.98  |- mesh__recordAuthorizer mesh__D000231 PLS
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000231 2004
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000231 2002
% 223.75/223.98  |- skos__scopeNote mesh__D000231
% 223.75/223.98       An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. %28%Stedman, 25th ed%29%%A%    
% 223.75/223.98  |- mesh__recordMaintainer mesh__D000231 KEV
% 223.75/223.98  |- skos__prefLabel mesh__D000231 Adenocarcinoma, Papillary
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000231 1997
% 223.75/223.98  |- mesh__recordOriginator mesh__D013957 RC
% 223.75/223.98  |- mesh__dateEstablished mesh__D013957 1991-01-01
% 223.75/223.98  |- mesh__dateRevised mesh__D013957 2005-06-30
% 223.75/223.98  |- mesh__historyNote mesh__D013957
% 223.75/223.98       91%28%79%29%; was see under LARYNGEAL CARTILAGES 1979-90   
% 223.75/223.98  |- mesh__publicMeSHNote mesh__D013957
% 223.75/223.98       91; was see under LARYNGEAL CARTILAGES 1979-90   
% 223.75/223.98  |- skos__scopeNote mesh__D013957
% 223.75/223.98       The largest cartilage of the larynx consisting of two laminae fusing anteriorly at an acute angle in the midline of the neck. The point of fusion forms a subcutaneous projection known as the Adam%27%s apple.%A%    
% 223.75/223.98  |- skos__broader mesh__D013957smesh__D007817
% 223.75/223.98  |- mesh__recordMaintainer mesh__D013957 ags
% 223.75/223.98  |- skos__hiddenLabel mesh__D013957 Cartilage, Thyroid
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D013957 2006
% 223.75/223.98  |- skos__hiddenLabel mesh__D013957 Cartilages, Thyroid
% 223.75/223.98  |- skos__prefLabel mesh__D013957 Thyroid Cartilage
% 223.75/223.98  |- rdf__type mesh__D013957sskos__Concept
% 223.75/223.98  |- skos__annotation mesh__D013957
% 223.75/223.98       a laryngeal cartilage: nothing to do with THYROID GLAND   
% 223.75/223.98  |- mesh__recordAuthorizer mesh__D013957 sjn
% 223.75/223.98  |- mesh__dateCreated mesh__D013957 1978-05-19
% 223.75/223.98  |- skos__historyNote mesh__D013957 Laryngeal Cartilages %28%1966-1978%29%
% 223.75/223.98  |- skos__hiddenLabel mesh__D013957 Thyroid Cartilages
% 223.75/223.98  |- skos__hiddenLabel mesh__D013159 Infarctions, Splenic
% 223.75/223.98  |- rdf__type mesh__D013159sskos__Concept
% 223.75/223.98  |- mesh__recordAuthorizer mesh__D013159 sjn
% 223.75/223.98  |- skos__annotation mesh__D013159 DF: SPLENIC INFARCT   
% 223.75/223.98  |- skos__broader mesh__D013159smesh__D007238
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D013159 2006
% 223.75/223.98  |- skos__scopeNote mesh__D013159
% 223.75/223.98       Insufficiency of arterial or venous blood supply to the spleen due to emboli, thrombi, vascular torsion, or pressure that produces a macroscopic area of necrosis. %28%From Stedman, 25th ed%29%%A%    
% 223.75/223.98  |- mesh__recordOriginator mesh__D013159 NLM
% 223.75/223.98  |- mesh__dateCreated mesh__D013159 1999-01-01
% 223.75/223.98  |- mesh__recordMaintainer mesh__D013159 ssb
% 223.75/223.98  |- skos__prefLabel mesh__D013159 Splenic Infarction
% 223.75/223.98  |- skos__hiddenLabel mesh__D013159 Splenic Infarctions
% 223.75/223.98  |- skos__broader mesh__D013159smesh__D013158
% 223.75/223.98  |- mesh__dateRevised mesh__D013159 2005-06-30
% 223.75/223.98  |- skos__hiddenLabel mesh__D013159 Infarction, Splenic
% 223.75/223.98  |- skos__broader mesh__D004622smesh__D004628
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D004622 2005
% 223.75/223.98  |- skos__related mesh__D004622smesh__D033041
% 223.75/223.98  |- skos__annotation mesh__D004622
% 223.75/223.98       mammalian only; EMBRYO, NON-MAMMALIAN is also available; human: 0-2 mos; IM when embryo itself as an organic entity or a tissue; prefer /embryol with organs or organisms; relation to /embryol: Manual 21.54; for plants, PLANT EMBRYOS see SEEDS is available; embryonic tissue or cells in tissue %26% cell cultures: coord EMBRYO + tissues or cell without qualif %28%not with /embryol%29% + culture term, all probably NIM%A%  
% 223.75/223.98  |- skos__related mesh__D004622smesh__D002454
% 223.75/223.98  |- skos__related mesh__D004622smesh__D005333
% 223.75/223.98  |- rdf__type mesh__D004622sskos__Concept
% 223.75/223.98  |- mesh__recordMaintainer mesh__D004622 sjn
% 223.75/223.98  |- skos__related mesh__D004622smesh__D005865
% 223.75/223.98  |- mesh__dateCreated mesh__D004622 1999-01-01
% 223.75/223.98  |- skos__prefLabel mesh__D004622 Embryo
% 223.75/223.98  |- skos__scopeNote mesh__D004622
% 223.75/223.98       The early developmental stage of MAMMALS. It generally defines the period from cleavage into two BLASTOMERES to the end of embryonic differentiation of basic structures. In the human, the embryo represents the first two months of intrauterine development preceding the stages of the FETUS.%A%    
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D004622 2005A
% 223.75/223.98  |- skos__altLabel mesh__D004622 Embryos
% 223.75/223.98  |- mesh__historyNote mesh__D004622
% 223.75/223.98       PRENATAL INFLUENCES was heading 1963-72   
% 223.75/223.98  |- mesh__recordAuthorizer mesh__D004622 sjn
% 223.75/223.98  |- mesh__dateRevised mesh__D004622 2004-10-20
% 223.75/223.98  |- mesh__recordOriginator mesh__D004622 NLM
% 223.75/223.98  |- mesh__onlineNote mesh__D004622
% 223.75/223.98       search PRENATAL INFLUENCES under PREGNANCY 1966-72   
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D004622 2006
% 223.75/223.98  |- mesh__publicMeSHNote mesh__D004622
% 223.75/223.98       PRENATAL INFLUENCES was heading 1963-72   
% 223.75/223.98  |- mesh__recordMaintainer mesh__D051278 AKE
% 223.75/223.98  |- mesh__publicMeSHNote mesh__D051278
% 223.75/223.98       2006; BETA-ALANINE-PYRUVATE TRANSAMINASE was indexed under TRANSAMINASES 1980-2005%A%  
% 223.75/223.98  |- skos__hiddenLabel mesh__D051278 beta Alanine Pyruvate Transaminase
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D051278 2006
% 223.75/223.98  |- mesh__historyNote mesh__D051278 2006%28%1980%29%   
% 223.75/223.98  |- skos__hiddenLabel mesh__D051278 beta Alanine Pyruvate Aminotransferase
% 223.75/223.98  |- mesh__dateCreated mesh__D051278 2005-06-30
% 223.75/223.98  |- mesh__recordOriginator mesh__D051278 AKE
% 223.75/223.98  |- rdf__type mesh__D051278sskos__Concept
% 223.75/223.98  |- skos__broader mesh__D051278smesh__D000637
% 223.75/223.98  |- skos__altLabel mesh__D051278 beta-Alanine - Pyruvate Transaminase
% 223.75/223.98  |- skos__hiddenLabel mesh__D051278 beta Alanine   Pyruvate Transaminase
% 223.75/223.98  |- skos__scopeNote mesh__D051278
% 223.75/223.98       A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the transfer of an amino group from L-ALANINE to 3-oxopropanoate to generate PYRUVATE and BETA-ALANINE.%A%    
% 223.75/223.98  |- mesh__dateEstablished mesh__D051278 2006-01-01
% 223.75/223.98  |- skos__prefLabel mesh__D051278 beta-Alanine-Pyruvate Transaminase
% 223.75/223.98  |- skos__hiddenLabel mesh__D051278 Pyruvate Aminotransferase, beta-Alanine
% 223.75/223.98  |- skos__hiddenLabel mesh__D051278 Transaminase, beta-Alanine-Pyruvate
% 223.75/223.98  |- mesh__recordAuthorizer mesh__D051278 sjn
% 223.75/223.98  |- skos__hiddenLabel mesh__D051278 Aminotransferase, beta-Alanine Pyruvate
% 223.75/223.98  |- skos__altLabel mesh__D051278 beta-Alanine Pyruvate Aminotransferase
% 223.75/223.98  |- skos__prefLabel mesh__D014252 Trichostrongyloidiasis
% 223.75/223.98  |- skos__broader mesh__D014252smesh__D017206
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D014252 2004
% 223.75/223.98  |- skos__hiddenLabel mesh__D014252 Trichostrongyloidiases
% 223.75/223.98  |- mesh__dateEstablished mesh__D014252 1968-01-01
% 223.75/223.98  |- skos__annotation mesh__D014252
% 223.75/223.98       roundworm infect; caused by various genera of the superfamily TRICHOSTRONGYLOIDEA: do not confuse with TRICHOSTRONGYLOSIS, caused by the genus TRICHOSTRONGYLUS%A%  
% 223.75/223.98  |- skos__scopeNote mesh__D014252
% 223.75/223.98       Infection by roundworms of the superfamily TRICHOSTRONGYLOIDEA, including the genera TRICHOSTRONGYLUS; OSTERTAGIA; Cooperia, HAEMONCHUS; Nematodirus, Hyostrongylus, and DICTYOCAULUS.%A%    
% 223.75/223.98  |- mesh__recordMaintainer mesh__D014252 mdb
% 223.75/223.98  |- mesh__recordOriginator mesh__D014252 NLM
% 223.75/223.98  |- skos__historyNote mesh__D014252 Nematode Infections %28%1966-1967%29%
% 223.75/223.98  |- mesh__dateCreated mesh__D014252 1999-01-01
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D014252 2002
% 223.75/223.98  |- rdf__type mesh__D014252sskos__Concept
% 223.75/223.98  |- mesh__historyNote mesh__D014252 68   
% 223.75/223.98  |- mesh__publicMeSHNote mesh__D014252 68   
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D014252 2005
% 223.75/223.98  |- mesh__recordAuthorizer mesh__D014252 sjn
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D014252 2003
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D014252 2006
% 223.75/223.98  |- mesh__dateRevised mesh__D014252 2001-07-25
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D008215 2004
% 223.75/223.98  |- skos__prefLabel mesh__D008215 Lymphocytes, Null
% 223.75/223.98  |- skos__annotation mesh__D008215
% 223.75/223.98       A 11 qualif; subpopulations: coord IM with LYMPHOCYTE SUBSETS %28%IM%29%%A%  
% 223.75/223.98  |- skos__historyNote mesh__D008215 B Lymphocytes %28%1973-1981%29%
% 223.75/223.98  |- skos__hiddenLabel mesh__D008215 Cell, Null
% 223.75/223.98  |- skos__historyNote mesh__D008215 T Lymphocytes %28%1973-1981%29%
% 223.75/223.98  |- skos__hiddenLabel mesh__D008215 Null Lymphocytes
% 223.75/223.98  |- skos__hiddenLabel mesh__D008215 Cells, Null
% 223.75/223.98  |- mesh__recordOriginator mesh__D008215 SAG
% 223.75/223.98  |- skos__altLabel mesh__D008215 Null Cells
% 223.75/223.98  |- skos__scopeNote mesh__D008215
% 223.75/223.98       A class of lymphocytes characterized by the lack of surface markers specific for either T or B lymphocytes.%A%    
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D008215 2006
% 223.75/223.98  |- mesh__recordAuthorizer mesh__D008215 sjn
% 223.75/223.98  |- skos__hiddenLabel mesh__D008215 Null Cell
% 223.75/223.98  |- skos__hiddenLabel mesh__D008215 Lymphocyte, Null
% 223.75/223.98  |- skos__historyNote mesh__D008215 Lymphocytes %28%1973-1981%29%
% 223.75/223.98  |- mesh__dateEstablished mesh__D008215 1982-01-01
% 223.75/223.98  |- skos__broader mesh__D008215smesh__D008214
% 223.75/223.98  |- skos__hiddenLabel mesh__D008215 Null Lymphocyte
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D008215 2005
% 223.75/223.98  |- mesh__historyNote mesh__D008215 82   
% 223.75/223.98  |- mesh__dateRevised mesh__D008215 2003-07-09
% 223.75/223.98  |- rdf__type mesh__D008215sskos__Concept
% 223.75/223.98  |- mesh__publicMeSHNote mesh__D008215 82   
% 223.75/223.98  |- mesh__dateCreated mesh__D008215 1981-05-20
% 223.75/223.98  |- mesh__recordMaintainer mesh__D008215 jmp
% 223.75/223.98  |- mesh__dateCreated mesh__D000232 1999-01-01
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000232 1998
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000232 2006
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000232 1999
% 223.75/223.98  |- mesh__dateRevised mesh__D000232 1995-06-08
% 223.75/223.98  |- skos__prefLabel mesh__D000232 Adenofibroma
% 223.75/223.98  |- mesh__recordOriginator mesh__D000232 NLM
% 223.75/223.98  |- rdf__type mesh__D000232sskos__Concept
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000232 2000
% 223.75/223.98  |- skos__broader mesh__D000232smesh__D018225
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000232 2003
% 223.75/223.98  |- skos__hiddenLabel mesh__D000232 Adenofibromas
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000232 2001
% 223.75/223.98  |- skos__scopeNote mesh__D000232
% 223.75/223.98       A benign neoplasm composed of glandular and fibrous tissues, with a relatively large proportion of glands. %28%Stedman, 25th ed%29%%A%    
% 223.75/223.98  |- mesh__recordAuthorizer mesh__D000232 PLS
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000232 1996
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000232 2004
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000232 2002
% 223.75/223.98  |- mesh__recordMaintainer mesh__D000232 KEV
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000232 1997
% 223.75/223.98  |- skos__annotation mesh__D000232
% 223.75/223.98       do not confuse with FIBROADENOMA; /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D000232 2005
% 223.75/223.98  |- mesh__recordAuthorizer mesh__D013958 sjn
% 223.75/223.98  |- mesh__dateCreated mesh__D013958 1999-01-01
% 223.75/223.98  |- skos__altLabel mesh__D013958 Thyrotoxic Crisis
% 223.75/223.98  |- mesh__recordOriginator mesh__D013958 NLM
% 223.75/223.98  |- skos__prefLabel mesh__D013958 Thyroid Crisis
% 223.75/223.98  |- skos__altLabel mesh__D013958 Crisis, Thyrotoxic
% 223.75/223.98  |- skos__altLabel mesh__D013958 Thyroid Storm
% 223.75/223.98  |- skos__broader mesh__D013958smesh__D013971
% 223.75/223.98  |- skos__hiddenLabel mesh__D013958 Crisis, Thyroid
% 223.75/223.98  |- skos__hiddenLabel mesh__D013958 Storm, Thyroid
% 223.75/223.98  |- mesh__dateRevised mesh__D013958 2005-06-30
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D013958 2006
% 223.75/223.98  |- rdf__type mesh__D013958sskos__Concept
% 223.75/223.98  |- skos__hiddenLabel mesh__D013958 Storm, Thyrotoxic
% 223.75/223.98  |- skos__altLabel mesh__D013958 Thyrotoxic Storm
% 223.75/223.98  |- skos__scopeNote mesh__D013958
% 223.75/223.98       A dangerous life-threatening hypermetabolic condition characterized by high FEVER and dysfunction of the cardiovascular, the nervous, and the gastrointestinal systems.%A%    
% 223.75/223.98  |- mesh__recordMaintainer mesh__D013958 lkt
% 223.75/223.98  |- rdf__type mesh__D018643sskos__Concept
% 223.75/223.98  |- mesh__recordMaintainer mesh__D018643 TAP
% 223.75/223.98  |- mesh__dateRevised mesh__D018643 1995-06-08
% 223.75/223.98  |- mesh__historyNote mesh__D018643 95   
% 223.75/223.98  |- skos__scopeNote mesh__D018643
% 223.75/223.98       A historical and cultural entity dispersed across a wide geographical area under the administrative, intellectual, social, and cultural domination of the Arab empire. The Arab world, under the impetus of Islam, by the eighth century A.D., extended from Arabia in the Middle East to all of northern Africa, southern Spain, Sardinia, and Sicily. Close contact was maintained with Greek and Jewish culture. While the principal service of the Arabs to medicine was the preservation of Greek culture, the Arabs themselves were the originators of algebra, chemistry, geology, and many of the refinements of civilization. %28%From A. Castiglioni, A History of Medicine, 2d ed, p260; from F. H. Garrison, An Introduction to the History of Medicine, 4th ed, p126%29%%A%    
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D018643 2005
% 223.75/223.98  |- mesh__recordAuthorizer mesh__D018643 PLS
% 223.75/223.98  |- mesh__dateEstablished mesh__D018643 1995-01-01
% 223.75/223.98  |- mesh__recordOriginator mesh__D018643 TGC
% 223.75/223.98  |- mesh__publicMeSHNote mesh__D018643 95   
% 223.75/223.98  |- skos__annotation mesh__D018643
% 223.75/223.98       note category; lands %26% peoples under influence of Arab civilization %26% culture; IM; not restricted to hist articles; do not confuse with ARABIA, a Category Z hist geog term%A%  
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D018643 2000
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D018643 2006
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D018643 2003
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D018643 1998
% 223.75/223.98  |- mesh__dateCreated mesh__D018643 1994-06-22
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D018643 2001
% 223.75/223.98  |- skos__broader mesh__D018643smesh__D002962
% 223.75/223.98  |- skos__prefLabel mesh__D018643 Arab World
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D018643 2004
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D018643 1996
% 223.75/223.98  |- mesh__activeMeSHYear mesh__D018643 1999
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D018643 2002
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D018643 1997
% 223.84/223.98  |- mesh__dateEstablished mesh__D010660 1991-01-01
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D010660 1995
% 223.84/223.98  |- mesh__historyNote mesh__D010660
% 223.84/223.98       91%28%75%29%; was see under ADENOSINE 1975-90   
% 223.84/223.98  |- skos__historyNote mesh__D010660 Propylamines %28%1972-1974%29%
% 223.84/223.98  |- skos__historyNote mesh__D010660 Adenosine %28%1972-1974%29%
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D010660 2003
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D010660 1998
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D010660 2000
% 223.84/223.98  |- mesh__dateRevised mesh__D010660 1992-05-19
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D010660 2004
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D010660 1999
% 223.84/223.98  |- skos__broader mesh__D010660smesh__D000241
% 223.84/223.98  |- mesh__dateCreated mesh__D010660 1974-11-19
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D010660 2001
% 223.84/223.98  |- mesh__publicMeSHNote mesh__D010660
% 223.84/223.98       91; was see under ADENOSINE 1975-90   
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D010660 1993
% 223.84/223.98  |- skos__altLabel mesh__D010660 L-Phenylisopropyladenosine
% 223.84/223.98  |- skos__prefLabel mesh__D010660 Phenylisopropyladenosine
% 223.84/223.98  |- skos__hiddenLabel mesh__D010660 L Phenylisopropyladenosine
% 223.84/223.98  |- mesh__recordMaintainer mesh__D010660 TGC
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D010660 1996
% 223.84/223.98  |- skos__annotation mesh__D010660 an antilipemic   
% 223.84/223.98  |- rdf__type mesh__D010660sskos__Concept
% 223.84/223.98  |- skos__scopeNote mesh__D010660
% 223.84/223.98       N-Isopropyl-N-phenyl-adenosine. Antilipemic agent. Synonym: TH 162.%A%    
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D010660 2005
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D010660 1997
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D010660 2002
% 223.84/223.98  |- skos__altLabel mesh__D010660 Isopropylphenyladenosine
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D010660 1994
% 223.84/223.98  |- skos__altLabel mesh__D010660 N%28%6%29%-Phenylisopropyl-Adenosine
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D010660 2006
% 223.84/223.98  |- mesh__recordOriginator mesh__D010660 NLM
% 223.84/223.98  |- mesh__recordAuthorizer mesh__D010660 PLS
% 223.84/223.98  |- mesh__publicMeSHNote mesh__D051279
% 223.84/223.98       2006; TRYPTOPHAN TRANSAMINASES was indexed under TRANSAMINASES 1975-2005, %26% under TRYPTOPHAN 1975-1980; TRYPTOPHAN AMINOTRANSFERASE was indexed under TRANSAMINASES 1976-2005%A%  
% 223.84/223.98  |- rdf__type mesh__D051279sskos__Concept
% 223.84/223.98  |- mesh__recordAuthorizer mesh__D051279 ags
% 223.84/223.98  |- mesh__dateRevised mesh__D051279 2005-07-07
% 223.84/223.98  |- mesh__historyNote mesh__D051279
% 223.84/223.98       2006%28%1980%29%; use TRANSAMINASES %26% TRYPTOPHAN 1975-1979   
% 223.84/223.98  |- skos__prefLabel mesh__D051279 Tryptophan Transaminase
% 223.84/223.98  |- skos__hiddenLabel mesh__D051279 Aminotransferase, L-Tryptophan
% 223.84/223.98  |- mesh__dateCreated mesh__D051279 2005-06-30
% 223.84/223.98  |- skos__scopeNote mesh__D051279
% 223.84/223.98       A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the transfer amino group from L-TRYPTOPHAN to 2-OXOGLUTARATE in order to generate indolepyruvate and L-GLUTAMATE.%A%    
% 223.84/223.98  |- skos__altLabel mesh__D051279 L-Tryptophan Aminotransferase
% 223.84/223.98  |- mesh__recordMaintainer mesh__D051279 ags
% 223.84/223.98  |- mesh__recordOriginator mesh__D051279 AKE
% 223.84/223.98  |- skos__hiddenLabel mesh__D051279 Transaminase, Tryptophan
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D051279 2006A
% 223.84/223.98  |- skos__broader mesh__D051279smesh__D000637
% 223.84/223.98  |- skos__altLabel mesh__D051279 Tryptophan Aminotransferase
% 223.84/223.98  |- skos__hiddenLabel mesh__D051279 Aminotransferase, Tryptophan
% 223.84/223.98  |- skos__hiddenLabel mesh__D051279 L Tryptophan Aminotransferase
% 223.84/223.98  |- mesh__dateEstablished mesh__D051279 2006-01-01
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D051279 2006
% 223.84/223.98  |- mesh__dateCreated mesh__D042742 2003-07-09
% 223.84/223.98  |- mesh__publicMeSHNote mesh__D042742 2004   
% 223.84/223.98  |- mesh__recordAuthorizer mesh__D042742 sjn
% 223.84/223.98  |- skos__broader mesh__D042742smesh__D042621
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D042742 2006
% 223.84/223.98  |- mesh__recordOriginator mesh__D042742 ags
% 223.84/223.98  |- mesh__historyNote mesh__D042742 2004   
% 223.84/223.98  |- skos__scopeNote mesh__D042742
% 223.84/223.98       A genus of gram-negative, strictly aerobic chemoorganotrophic bacteria, in the family COMAMONADACEAE.%A%    
% 223.84/223.98  |- mesh__recordMaintainer mesh__D042742 SYSTEM
% 223.84/223.98  |- mesh__dateRevised mesh__D042742 2005-06-30
% 223.84/223.98  |- skos__prefLabel mesh__D042742 Delftia
% 223.84/223.98  |- mesh__dateEstablished mesh__D042742 2004-01-01
% 223.84/223.98  |- rdf__type mesh__D042742sskos__Concept
% 223.84/223.98  |- skos__broader mesh__D006629Q000627smesh__D006629
% 223.84/223.98  |- mesh__preferredCombination mesh__D006629Q000627smesh__D024764
% 223.84/223.98  |- rdf__type mesh__D006629Q000627smesh__CompoundConcept
% 223.84/223.98  |- mesh__recordAuthorizer mesh__D014253 sjn
% 223.84/223.98  |- mesh__dateCreated mesh__D014253 1999-01-01
% 223.84/223.98  |- rdf__type mesh__D014253sskos__Concept
% 223.84/223.98  |- mesh__recordMaintainer mesh__D014253 sjn
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D014253 2005
% 223.84/223.98  |- mesh__onlineNote mesh__D014253
% 223.84/223.98       use TRICHOSTRONGYLOIDIASIS to search TRICHOSTRONGYLOSIS 1966-74%A%  
% 223.84/223.98  |- skos__scopeNote mesh__D014253
% 223.84/223.98       Infestation with nematode worms of the genus TRICHOSTRONGYLUS. Man and animals become infected by swallowing larvae, usually with contaminated food or drink, although the larvae may penetrate human skin.%A%    
% 223.84/223.98  |- mesh__dateRevised mesh__D014253 2004-07-13
% 223.84/223.98  |- mesh__publicMeSHNote mesh__D014253
% 223.84/223.98       91,63-67; was see under TRICHOSTRONGYLOIDIASIS 1968-90; was heading 1963-67%A%  
% 223.84/223.98  |- skos__prefLabel mesh__D014253 Trichostrongylosis
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D014253 2006
% 223.84/223.98  |- skos__annotation mesh__D014253
% 223.84/223.98       nematode infect caused by TRICHOSTRONGYLUS, a genus: do not confuse with TRICHOSTRONGYLOIDIASIS, caused by genera of the superfamily TRICHOSTRONGYLOIDEA%A%  
% 223.84/223.98  |- mesh__historyNote mesh__D014253
% 223.84/223.98       91%28%75%29%63-67; was see under TRICHOSTRONGYLOIDIASIS 1968-90; was heading 1963-67%A%  
% 223.84/223.98  |- mesh__dateEstablished mesh__D014253 1991-01-01
% 223.84/223.98  |- skos__broader mesh__D014253smesh__D014252
% 223.84/223.98  |- mesh__recordOriginator mesh__D014253 NLM
% 223.84/223.98  |- skos__hiddenLabel mesh__D014253 Trichostrongyloses
% 223.84/223.98  |- mesh__recordOriginator mesh__D008216 NLM
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D008216 2004
% 223.84/223.98  |- skos__broader mesh__D008216smesh__D008587
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D008216 2002
% 223.84/223.98  |- skos__hiddenLabel mesh__D008216 Choriomeningitis, Lymphocytic
% 223.84/223.98  |- skos__broader mesh__D008216smesh__D001117
% 223.84/223.98  |- skos__altLabel mesh__D008216 Armstrong%27%s Syndrome
% 223.84/223.98  |- skos__hiddenLabel mesh__D008216 Syndrome, Armstrong
% 223.84/223.98  |- skos__altLabel mesh__D008216
% 223.84/223.98       Encephalomyelitis, Lymphocytic Choriomeningitis Virus
% 223.84/223.98  |- mesh__dateCreated mesh__D008216 1999-01-01
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D008216 2005
% 223.84/223.98  |- skos__hiddenLabel mesh__D008216 Syndrome, Armstrong%27%s
% 223.84/223.98  |- skos__scopeNote mesh__D008216
% 223.84/223.98       A form of meningitis caused by LYMPHOCYTIC CHORIOMENINGITIS VIRUS. MICE and other rodents serve as the natural hosts, and infection in humans usually occurs through inhalation or ingestion of infectious particles. Clinical manifestations include an influenza-like syndrome followed by stiff neck, alterations of mentation, ATAXIA, and incontinence. Maternal infections may result in fetal malformations and injury, including neonatal HYDROCEPHALUS, aqueductal stenosis, CHORIORETINITIS, and MICROCEPHALY. %28%From Joynt, Clinical Neurology, 1996, Ch26, pp1-3%29%%A%    
% 223.84/223.98  |- mesh__recordMaintainer mesh__D008216 ags
% 223.84/223.98  |- skos__prefLabel mesh__D008216 Lymphocytic Choriomeningitis
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D008216 2000
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D008216 2006
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D008216 2001
% 223.84/223.98  |- skos__altLabel mesh__D008216 Armstrong Syndrome
% 223.84/223.98  |- mesh__recordAuthorizer mesh__D008216 ags
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D008216 2000A
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D008216 2003
% 223.84/223.98  |- mesh__dateRevised mesh__D008216 1999-11-24
% 223.84/223.98  |- skos__altLabel mesh__D008216
% 223.84/223.98       Lymphocytic Choriomeningitis Virus Encephalomyelitis
% 223.84/223.98  |- rdf__type mesh__D008216sskos__Concept
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D000233 2002
% 223.84/223.98  |- mesh__activeMeSHYear mesh__D000233 1999
% 223.84/223.98  |- mesh__recordMaintainer mesh__D000233 PXP
% 223.84/223.98  |- skos__annotation mesh__D000233
% 223.84/223.98       do not use /util except by MeSH definition   
% 223.84/223.98  |- skos__broader mesh__D000233smesh__D013517
% 223.84/223.98  |- rdf__type mesh__D000233sskos__Concept
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D000233 2003
% 223.84/223.99  |- skos__scopeNote mesh__D000233
% 223.84/223.99       Excision of the adenoids. %28%Dorland, 28th ed%29%     
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D000233 2004
% 223.84/223.99  |- skos__hiddenLabel mesh__D000233 Adenoidectomies
% 223.84/223.99  |- mesh__recordOriginator mesh__D000233 NLM
% 223.84/223.99  |- mesh__recordAuthorizer mesh__D000233 SJN
% 223.84/223.99  |- skos__prefLabel mesh__D000233 Adenoidectomy
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D000233 2000
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D000233 2005
% 223.84/223.99  |- mesh__dateCreated mesh__D000233 1999-01-01
% 223.84/223.99  |- mesh__dateRevised mesh__D000233 1997-06-20
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D000233 2001
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D000233 1998
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D000233 2006
% 223.84/223.99  |- skos__hiddenLabel mesh__D013959 Thyroid Disease
% 223.84/223.99  |- mesh__recordAuthorizer mesh__D013959 sjn
% 223.84/223.99  |- mesh__recordOriginator mesh__D013959 NLM
% 223.84/223.99  |- skos__hiddenLabel mesh__D013959 Disease, Thyroid
% 223.84/223.99  |- mesh__recordMaintainer mesh__D013959 lkt
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D013959 2006
% 223.84/223.99  |- rdf__type mesh__D013959sskos__Concept
% 223.84/223.99  |- skos__scopeNote mesh__D013959
% 223.84/223.99       Pathological processes involving the THYROID GLAND.     
% 223.84/223.99  |- skos__hiddenLabel mesh__D013959 Diseases, Thyroid
% 223.84/223.99  |- mesh__dateCreated mesh__D013959 1999-01-01
% 223.84/223.99  |- skos__prefLabel mesh__D013959 Thyroid Diseases
% 223.84/223.99  |- skos__broader mesh__D013959smesh__D004700
% 223.84/223.99  |- mesh__dateRevised mesh__D013959 2005-06-30
% 223.84/223.99  |- skos__annotation mesh__D013959
% 223.84/223.99       general or unspecified; prefer specifics; inflammatory disease %28%-itis%29% = THYROIDITIS or specifics%A%  
% 223.84/223.99  |- skos__altLabel mesh__D024681 Ca2+-Activated K+ Channels
% 223.84/223.99  |- skos__scopeNote mesh__D024681
% 223.84/223.99       Potassium channels whose activation is dependent on intracellular calcium concentrations.%A%    
% 223.84/223.99  |- skos__hiddenLabel mesh__D024681 K+ Channels, Calcium Activated
% 223.84/223.99  |- skos__altLabel mesh__D024681 K+ Channels, Calcium-Activated
% 223.84/223.99  |- skos__hiddenLabel mesh__D024681 Calcium-Activated K+ Channels
% 223.84/223.99  |- skos__historyNote mesh__D024681 Potassium Channels %28%1988-2001%29%
% 223.84/223.99  |- mesh__dateEstablished mesh__D024681 2002-01-01
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D024681 2006
% 223.84/223.99  |- skos__altLabel mesh__D024681 Calcium-Activated Potassium Channel
% 223.84/223.99  |- skos__altLabel mesh__D024681 Calcium-Activated Potassium Channels
% 223.84/223.99  |- skos__hiddenLabel mesh__D024681 Calcium Activated Potassium Channels
% 223.84/223.99  |- skos__prefLabel mesh__D024681 Potassium Channels, Calcium-Activated
% 223.84/223.99  |- skos__hiddenLabel mesh__D024681 K+ Channels, Ca2+ Activated
% 223.84/223.99  |- skos__hiddenLabel mesh__D024681 Potassium Channels, Calcium Activated
% 223.84/223.99  |- rdf__type mesh__D024681sskos__Concept
% 223.84/223.99  |- skos__hiddenLabel mesh__D024681 Potassium Channel, Calcium Activated
% 223.84/223.99  |- mesh__recordAuthorizer mesh__D024681 sjn
% 223.84/223.99  |- mesh__recordOriginator mesh__D024681 ags
% 223.84/223.99  |- mesh__publicMeSHNote mesh__D024681 2002   
% 223.84/223.99  |- skos__altLabel mesh__D024681 Potassium Channel, Calcium-Activated
% 223.84/223.99  |- skos__broader mesh__D024681smesh__D015221
% 223.84/223.99  |- mesh__recordMaintainer mesh__D024681 SYSTEM
% 223.84/223.99  |- skos__historyNote mesh__D024681 Ion Channels %28%1982-1988%29%
% 223.84/223.99  |- mesh__dateRevised mesh__D024681 2005-06-30
% 223.84/223.99  |- mesh__dateCreated mesh__D024681 2001-07-25
% 223.84/223.99  |- mesh__historyNote mesh__D024681 2002   
% 223.84/223.99  |- skos__altLabel mesh__D024681 K+ Channels, Ca2+-Activated
% 223.84/223.99  |- skos__hiddenLabel mesh__D024681 Calcium Activated Potassium Channel
% 223.84/223.99  |- skos__hiddenLabel mesh__D024681 Ca2+ Activated K+ Channels
% 223.84/223.99  |- mesh__historyNote mesh__D018644 95   
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D018644 2002
% 223.84/223.99  |- mesh__recordMaintainer mesh__D018644 TGC
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D018644 2005
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D018644 2003
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D018644 2006
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D018644 1998
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D018644 2004
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D018644 1999
% 223.84/223.99  |- mesh__recordAuthorizer mesh__D018644 PLS
% 223.84/223.99  |- mesh__dateEstablished mesh__D018644 1995-01-01
% 223.84/223.99  |- mesh__recordOriginator mesh__D018644 TGC
% 223.84/223.99  |- mesh__publicMeSHNote mesh__D018644 95   
% 223.84/223.99  |- skos__broader mesh__D018644smesh__D019366
% 223.84/223.99  |- skos__prefLabel mesh__D018644 Roman World
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D018644 2000
% 223.84/223.99  |- skos__annotation mesh__D018644
% 223.84/223.99       note category; lands %26% peoples under influence of Roman civilization %26% culture; IM; do not confuse with ROME, the city, a Category Z term for the ancient %26% modern city%A%  
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D018644 1997
% 223.84/223.99  |- mesh__dateCreated mesh__D018644 1994-06-22
% 223.84/223.99  |- rdf__type mesh__D018644sskos__Concept
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D018644 2001
% 223.84/223.99  |- skos__scopeNote mesh__D018644
% 223.84/223.99       A historical and cultural entity dispersed across a wide geographical area under the political domination and influence of ancient Rome, bringing to the conquered people the Roman civilization and culture from 753 B.C. to the beginning of the imperial rule under Augustus in 27 B.C. The early city built on seven hills grew to conquer Sicily, Sardinia, Carthage, Gaul, Spain, Britain, Greece, Asia Minor, etc., and extended ultimately from Mesopotamia to the Atlantic. Roman medicine was almost entirely in Greek hands, but Rome, with its superior water system, remains a model of sanitation and hygiene. %28%From A. Castiglioni, A History of Medicine, 2d ed pp196-99; from F. H. Garrison, An Introduction to the History of Medicine, 4th ed, pp107-120%29%%A%    
% 223.84/223.99  |- mesh__dateRevised mesh__D018644 1996-06-10
% 223.84/223.99  |- skos__hiddenLabel mesh__D010661
% 223.84/223.99       Hyperphenylalaninemia, Non Phenylketonuric
% 223.84/223.99  |- skos__hiddenLabel mesh__D010661 Hyperphenylalaninaemias
% 223.84/223.99  |- skos__prefLabel mesh__D010661 Phenylketonurias
% 223.84/223.99  |- skos__altLabel mesh__D010661 Phenylketonuria
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D010661 2006
% 223.84/223.99  |- skos__hiddenLabel mesh__D010661 Disease, Folling
% 223.84/223.99  |- skos__altLabel mesh__D010661
% 223.84/223.99       Dihydropteridine Reductase Deficiency Disease
% 223.84/223.99  |- skos__altLabel mesh__D010661
% 223.84/223.99       Deficiency Disease, Phenylalanine Hydroxylase, Severe
% 223.84/223.99  |- mesh__recordMaintainer mesh__D010661 nns
% 223.84/223.99  |- skos__hiddenLabel mesh__D010661
% 223.84/223.99       Non-Phenylketonuric Hyperphenylalaninemia
% 223.84/223.99  |- skos__altLabel mesh__D010661 Folling%27%s Disease
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D010661 2005
% 223.84/223.99  |- skos__hiddenLabel mesh__D010661 Phenylketonuria Is
% 223.84/223.99  |- skos__hiddenLabel mesh__D010661 Phenylketonurias, Classical
% 223.84/223.99  |- skos__hiddenLabel mesh__D010661 Classical Phenylketonurias
% 223.84/223.99  |- skos__altLabel mesh__D010661
% 223.84/223.99       Deficiency Disease, Phenylalanine Hydroxylase
% 223.84/223.99  |- skos__altLabel mesh__D010661
% 223.84/223.99       Phenylalanine Hydroxylase Deficiency Disease
% 223.84/223.99  |- skos__hiddenLabel mesh__D010661 Disease, Folling%27%s
% 223.84/223.99  |- skos__hiddenLabel mesh__D010661 IIs, Phenylketonuria
% 223.84/223.99  |- skos__related mesh__D010661smesh__D010651
% 223.84/223.99  |- mesh__publicMeSHNote mesh__D010661
% 223.84/223.99       2000; see PHENYLKETONURIA 1974-1999   
% 223.84/223.99  |- skos__hiddenLabel mesh__D010661 Diseases, Folling
% 223.84/223.99  |- skos__altLabel mesh__D010661 Phenylketonuria, Classical
% 223.84/223.99  |- mesh__historyNote mesh__D010661 2000%28%1974%29%   
% 223.84/223.99  |- skos__altLabel mesh__D010661 Phenylketonuria, Atypical
% 223.84/223.99  |- skos__hiddenLabel mesh__D010661
% 223.84/223.99       Hyperphenylalaninemias, Non-Phenylketonuric
% 223.84/223.99  |- skos__hiddenLabel mesh__D010661 Phenylketonurias, Atypical
% 223.84/223.99  |- skos__altLabel mesh__D010661
% 223.84/223.99       Deficiency Disease, Dihydropteridine Reductase
% 223.84/223.99  |- mesh__dateCreated mesh__D010661 1999-01-01
% 223.84/223.99  |- skos__altLabel mesh__D010661 Folling Disease
% 223.84/223.99  |- skos__scopeNote mesh__D010661
% 223.84/223.99       A group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE %28%i.e., atypical phenylketonuria%29%. Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. %28%From Adams et al., Principles of Neurology, 6th ed, p952%29%.%A%    
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D010661 2004
% 223.84/223.99  |- skos__annotation mesh__D010661
% 223.84/223.99       GEN: prefer specifics; note X refs: consider also PHENYLALANINE HYDROXYLASE /defic and DIHYDROPTERIDINE REDUCTASE /defic; DF: PKU%A%  
% 223.84/223.99  |- skos__broader mesh__D010661smesh__D020739
% 223.84/223.99  |- skos__hiddenLabel mesh__D010661 Folling Diseases
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D010661 2002
% 223.84/223.99  |- skos__hiddenLabel mesh__D010661 Is, Phenylketonuria
% 223.84/223.99  |- mesh__recordOriginator mesh__D010661 NLM
% 223.84/223.99  |- skos__broader mesh__D010661smesh__D000592
% 223.84/223.99  |- skos__altLabel mesh__D010661
% 223.84/223.99       Phenylalanine Hydroxylase Deficiency Disease, Severe
% 223.84/223.99  |- skos__hiddenLabel mesh__D010661 Atypical Phenylketonurias
% 223.84/223.99  |- mesh__dateRevised mesh__D010661 2001-07-25
% 223.84/223.99  |- mesh__recordAuthorizer mesh__D010661 sjn
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D010661 2003
% 223.84/223.99  |- skos__hiddenLabel mesh__D010661
% 223.84/223.99       Non-Phenylketonuric Hyperphenylalaninemias
% 223.84/223.99  |- skos__hiddenLabel mesh__D010661 Classical Phenylketonuria
% 223.84/223.99  |- rdf__type mesh__D010661sskos__Concept
% 223.84/223.99  |- skos__hiddenLabel mesh__D010661 Phenylketonuria IIs
% 223.84/223.99  |- skos__hiddenLabel mesh__D010661 Atypical Phenylketonuria
% 223.84/223.99  |- mesh__publicMeSHNote mesh__D004624 1980   
% 223.84/223.99  |- skos__annotation mesh__D004624
% 223.84/223.99       mammalian only; transfer of non-mammalian embryo = EMBRYO, NONMAMMALIAN /transpl or CHICK EMBRYO /transpl%A%  
% 223.84/223.99  |- mesh__recordOriginator mesh__D004624 SMH
% 223.84/223.99  |- skos__broader mesh__D004624smesh__D027724
% 223.84/223.99  |- mesh__dateCreated mesh__D004624 1979-05-25
% 223.84/223.99  |- skos__historyNote mesh__D004624
% 223.84/223.99       Blastocyst/transplantation %28%1974-1979%29%
% 223.84/223.99  |- skos__scopeNote mesh__D004624
% 223.84/223.99       The transfer of mammalian embryos from an in vivo or in vitro environment to a suitable host to improve pregnancy or gestational outcome in human or animal. In human fertility treatment programs, preimplantation embryos ranging from the 4-cell stage to the blastocyst stage are transferred to the uterine cavity between 3-5 days after FERTILIZATION IN VITRO.%A%    
% 223.84/223.99  |- skos__altLabel mesh__D004624 Tubal Embryo Stage Transfer
% 223.84/223.99  |- skos__hiddenLabel mesh__D004624 Transfer, Embryo
% 223.84/223.99  |- skos__prefLabel mesh__D004624 Embryo Transfer
% 223.84/223.99  |- skos__historyNote mesh__D004624 Embryo/transplantation %28%1966-1979%29%
% 223.84/223.99  |- skos__hiddenLabel mesh__D004624 Transfers, Embryo
% 223.84/223.99  |- mesh__historyNote mesh__D004624 1980   
% 223.84/223.99  |- mesh__dateRevised mesh__D004624 2004-07-13
% 223.84/223.99  |- mesh__recordMaintainer mesh__D004624 sjn
% 223.84/223.99  |- mesh__recordAuthorizer mesh__D004624 sjn
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D004624 2006
% 223.84/223.99  |- mesh__dateEstablished mesh__D004624 1980-01-01
% 223.84/223.99  |- rdf__type mesh__D004624sskos__Concept
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D004624 2005
% 223.84/223.99  |- skos__hiddenLabel mesh__D004624 Embryo Transfers
% 223.84/223.99  |- skos__scopeNote mesh__D042743
% 223.84/223.99       A genus of gram-negative, sheathed, rod-shaped bacteria in the family COMAMONADACEAE.%A%    
% 223.84/223.99  |- skos__prefLabel mesh__D042743 Leptothrix
% 223.84/223.99  |- mesh__recordAuthorizer mesh__D042743 sjn
% 223.84/223.99  |- mesh__recordMaintainer mesh__D042743 SYSTEM
% 223.84/223.99  |- skos__broader mesh__D042743smesh__D042621
% 223.84/223.99  |- skos__historyNote mesh__D042743
% 223.84/223.99       Gram-Negative Aerobic Bacteria %28%1965-2003%29%
% 223.84/223.99  |- mesh__recordOriginator mesh__D042743 ags
% 223.84/223.99  |- mesh__historyNote mesh__D042743 2004   
% 223.84/223.99  |- skos__annotation mesh__D042743
% 223.84/223.99       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 223.84/223.99  |- mesh__dateRevised mesh__D042743 2005-06-30
% 223.84/223.99  |- rdf__type mesh__D042743sskos__Concept
% 223.84/223.99  |- mesh__publicMeSHNote mesh__D042743 2004   
% 223.84/223.99  |- mesh__dateEstablished mesh__D042743 2004-01-01
% 223.84/223.99  |- mesh__dateCreated mesh__D042743 2003-07-09
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D042743 2006
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D014254 2005
% 223.84/223.99  |- skos__historyNote mesh__D014254 Trichostrongyloidea %28%1966-1985%29%
% 223.84/223.99  |- mesh__recordAuthorizer mesh__D014254 sjn
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D014254 2006
% 223.84/223.99  |- mesh__publicMeSHNote mesh__D014254 86   
% 223.84/223.99  |- mesh__recordMaintainer mesh__D014254 ags
% 223.84/223.99  |- mesh__dateCreated mesh__D014254 1985-03-11
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D014254 2004
% 223.84/223.99  |- mesh__dateRevised mesh__D014254 2003-07-09
% 223.84/223.99  |- mesh__recordOriginator mesh__D014254 EC
% 223.84/223.99  |- skos__prefLabel mesh__D014254 Trichostrongylus
% 223.84/223.99  |- skos__scopeNote mesh__D014254
% 223.84/223.99       A genus of  parasitic nematodes found in the digestive tract of herbivorous animals. They cause incidental infections in humans from the following species: Trichostrongylus colubriformis, T. orientalis, T. axei, and T. probolurus.%A%    
% 223.84/223.99  |- skos__broader mesh__D014254smesh__D014251
% 223.84/223.99  |- skos__annotation mesh__D014254
% 223.84/223.99       infection = TRICHOSTRONGYLOSIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 223.84/223.99  |- mesh__dateEstablished mesh__D014254 1986-01-01
% 223.84/223.99  |- mesh__historyNote mesh__D014254 86   
% 223.84/223.99  |- rdf__type mesh__D014254sskos__Concept
% 223.84/223.99  |- skos__hiddenLabel mesh__D008217 Lymphocytic choriomeningitis viruses
% 223.84/223.99  |- mesh__dateCreated mesh__D008217 1999-01-01
% 223.84/223.99  |- skos__scopeNote mesh__D008217
% 223.84/223.99       The type species of ARENAVIRUS, part of the Old World Arenaviruses %28%ARENAVIRUSES, OLD WORLD%29%, producing a silent infection in house and laboratory mice. In humans, infection with LCMV can be inapparent, or can present with an influenza-like illness, a benign aseptic meningitis, or a severe meningoencephalomyelitis. The virus can also infect monkeys, dogs, field mice, guinea pigs, and hamsters, the latter an epidemiologically important host.%A%    
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D008217 2005
% 223.84/223.99  |- mesh__recordAuthorizer mesh__D008217 sjn
% 223.84/223.99  |- skos__hiddenLabel mesh__D008217 LCM Virus
% 223.84/223.99  |- mesh__recordOriginator mesh__D008217 NLM
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D008217 2002
% 223.84/223.99  |- skos__annotation mesh__D008217
% 223.84/223.99       infection = LYMPHOCYTIC CHORIOMENINGITIS or LYMPHOCYTIC CHORIOMENINGITIS VIRUS %28%IM%29% + ARENAVIRIDAE INFECTIONS %28%IM%29%; DF: LCMV%A%  
% 223.84/223.99  |- mesh__recordMaintainer mesh__D008217 ags
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D008217 2006
% 223.84/223.99  |- skos__broader mesh__D008217smesh__D018049
% 223.84/223.99  |- mesh__publicMeSHNote mesh__D008217 73   
% 223.84/223.99  |- mesh__dateRevised mesh__D008217 2001-07-25
% 223.84/223.99  |- skos__altLabel mesh__D008217 LCMV
% 223.84/223.99  |- mesh__dateEstablished mesh__D008217 1973-01-01
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D008217 2003
% 223.84/223.99  |- skos__prefLabel mesh__D008217 Lymphocytic choriomeningitis virus
% 223.84/223.99  |- rdf__type mesh__D008217sskos__Concept
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D008217 2004
% 223.84/223.99  |- skos__altLabel mesh__D008217 LCM Viruses
% 223.84/223.99  |- mesh__historyNote mesh__D008217 73%28%65%29%   
% 223.84/223.99  |- mesh__recordMaintainer mesh__D000234 jmp
% 223.84/223.99  |- mesh__recordAuthorizer mesh__D000234 sjn
% 223.84/223.99  |- mesh__recordOriginator mesh__D000234 NLM
% 223.84/223.99  |- skos__broader mesh__D000234smesh__D008221
% 223.84/223.99  |- skos__altLabel mesh__D000234 Pharyngeal Tonsil
% 223.84/223.99  |- mesh__dateRevised mesh__D000234 2003-07-09
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D000234 2004
% 223.84/223.99  |- skos__annotation mesh__D000234 surg: probably ADENOIDECTOMY   
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D000234 2005
% 223.84/223.99  |- mesh__dateCreated mesh__D000234 1999-01-01
% 223.84/223.99  |- skos__hiddenLabel mesh__D000234 Pharyngeal Tonsils
% 223.84/223.99  |- skos__hiddenLabel mesh__D000234 Tonsils, Pharyngeal
% 223.84/223.99  |- skos__prefLabel mesh__D000234 Adenoids
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D000234 2006
% 223.84/223.99  |- skos__altLabel mesh__D000234 Tonsil, Pharyngeal
% 223.84/223.99  |- skos__hiddenLabel mesh__D000234 Adenoid
% 223.84/223.99  |- skos__related mesh__D000234smesh__D000233
% 223.84/223.99  |- rdf__type mesh__D000234sskos__Concept
% 223.84/223.99  |- skos__scopeNote mesh__D024682
% 223.84/223.99       A large, nuclear protein, encoded by the BRCA2 gene %28%GENE, BRCA2%29%. Mutations in this gene predispose humans to breast and ovarian cancer. The BRCA2 protein is an essential component of DNA repair pathways, suppressing the formation of gross chromosomal rearrangements. %28%from Genes Dev. 2000;14%28%11%29%:1400-6%29%%A%    
% 223.84/223.99  |- skos__altLabel mesh__D024682 FANCD1 Protein
% 223.84/223.99  |- skos__historyNote mesh__D024682 Transcription Factors %28%1995-2001%29%
% 223.84/223.99  |- skos__altLabel mesh__D024682
% 223.84/223.99       Fanconi Anemia Complementation Group D1 Protein
% 223.84/223.99  |- mesh__recordMaintainer mesh__D024682 DRC
% 223.84/223.99  |- mesh__dateRevised mesh__D024682 2005-06-30
% 223.84/223.99  |- skos__altLabel mesh__D024682
% 223.84/223.99       Fanconi Anemia Group D1 Complementing Protein
% 223.84/223.99  |- skos__broader mesh__D024682smesh__D051856
% 223.84/223.99  |- skos__altLabel mesh__D024682 Fanconi Anemia Group D1 Protein
% 223.84/223.99  |- skos__altLabel mesh__D024682 Breast Cancer 2 Gene Product
% 223.84/223.99  |- mesh__publicMeSHNote mesh__D024682
% 223.84/223.99       2002; BCRA2 PROTEIN was indexed under NEOPLASM PROTEINS %26% TRANSCRIPTION FACTORS 1995-2001%A%  
% 223.84/223.99  |- mesh__historyNote mesh__D024682
% 223.84/223.99       2002; use BRCA2 PROTEIN %28%NM%29% 1995-2001   
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D024682 2006
% 223.84/223.99  |- rdf__type mesh__D024682sskos__Concept
% 223.84/223.99  |- mesh__dateEstablished mesh__D024682 2002-01-01
% 223.84/223.99  |- skos__prefLabel mesh__D024682 BRCA2 Protein
% 223.84/223.99  |- skos__historyNote mesh__D024682 Neoplasm Proteins %28%1995-2001%29%
% 223.84/223.99  |- mesh__dateCreated mesh__D024682 2001-07-25
% 223.84/223.99  |- skos__altLabel mesh__D024682 BRCA2 Gene Product
% 223.84/223.99  |- mesh__recordOriginator mesh__D024682 nns
% 223.84/223.99  |- mesh__recordAuthorizer mesh__D024682 sjn
% 223.84/223.99  |- skos__broader mesh__D024682smesh__D025521
% 223.84/223.99  |- skos__broader mesh__D024682smesh__D009687
% 223.84/223.99  |- skos__altLabel mesh__D024682 Breast Cancer 2 Protein
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D018645 1998
% 223.84/223.99  |- mesh__publicMeSHNote mesh__D018645 95   
% 223.84/223.99  |- mesh__recordOriginator mesh__D018645 TGC
% 223.84/223.99  |- skos__prefLabel mesh__D018645 Greek World
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D018645 2000
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D018645 2004
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D018645 1999
% 223.84/223.99  |- mesh__dateCreated mesh__D018645 1994-06-22
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D018645 2001
% 223.84/223.99  |- mesh__dateRevised mesh__D018645 1996-06-10
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D018645 1997
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D018645 2002
% 223.84/223.99  |- rdf__type mesh__D018645sskos__Concept
% 223.84/223.99  |- mesh__historyNote mesh__D018645 95   
% 223.84/223.99  |- skos__scopeNote mesh__D018645
% 223.84/223.99       A historical and cultural entity dispersed across a wide geographical area under the influence of Greek civilization, culture, and science. The Greek Empire extended from the Greek mainland and the Aegean islands from the 16th century B.C., to the Indus Valley in the 4th century under Alexander the Great, and to southern Italy and Sicily. Greek medicine began with Homeric and Aesculapian medicine and continued unbroken to Hippocrates %28%480-355 B.C.%29%. The classic period of Greek medicine was 460-136 B.C. and the Graeco-Roman period, 156 B.C.-576 A.D. %28%From A. Castiglioni, A History of Medicine, 2d ed; from F. H. Garrison, An Introduction to the History of Medicine, 4th ed%29%%A%    
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D018645 2005
% 223.84/223.99  |- mesh__dateEstablished mesh__D018645 1995-01-01
% 223.84/223.99  |- skos__annotation mesh__D018645
% 223.84/223.99       note category; lands %26% peoples under influence of Greek civilization %26% culture; IM; do not confuse with GREECE, a Category Z term for ancient %26% modern Greece%A%  
% 223.84/223.99  |- skos__broader mesh__D018645smesh__D019366
% 223.84/223.99  |- mesh__recordMaintainer mesh__D018645 TGC
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D018645 2006
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D018645 2003
% 223.84/223.99  |- mesh__recordAuthorizer mesh__D018645 PLS
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D010662 2001
% 223.84/223.99  |- mesh__recordOriginator mesh__D010662 RLS
% 223.84/223.99  |- mesh__recordAuthorizer mesh__D010662 sjn
% 223.84/223.99  |- rdf__type mesh__D010662sskos__Concept
% 223.84/223.99  |- mesh__recordMaintainer mesh__D010662 CCR
% 223.84/223.99  |- skos__historyNote mesh__D010662
% 223.84/223.99       Organometallic Compounds %28%1968-1976%29%
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D010662 2005
% 223.84/223.99  |- mesh__dateRevised mesh__D010662 2000-06-21
% 223.84/223.99  |- mesh__publicMeSHNote mesh__D010662
% 223.84/223.99       91; was see under PHENYLMERCURY COMPOUNDS 1980-90; was see under PHENYL MERCURY COMPOUNDS 1977-79%A%  
% 223.84/223.99  |- skos__scopeNote mesh__D010662
% 223.84/223.99       A phenyl mercury compound used mainly as a fungicide. Has also been used as a herbicide, slimicide, and bacteriocide.%A%    
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D010662 2006
% 223.84/223.99  |- mesh__dateCreated mesh__D010662 1976-04-19
% 223.84/223.99  |- skos__altLabel mesh__D010662 Acetoxyphenylmercury
% 223.84/223.99  |- skos__hiddenLabel mesh__D010662 Acetate, Phenylmercuric
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D010662 2002
% 223.84/223.99  |- skos__broader mesh__D010662smesh__D010663
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D010662 2003
% 223.84/223.99  |- mesh__dateEstablished mesh__D010662 1991-01-01
% 223.84/223.99  |- skos__historyNote mesh__D010662 Mercury %28%1968-1976%29%
% 223.84/223.99  |- mesh__historyNote mesh__D010662
% 223.84/223.99       91%28%77%29%; was see under PHENYLMERCURY COMPOUNDS 1980-90; was see under PHENYL MERCURY COMPOUNDS 1977-79%A%  
% 223.84/223.99  |- skos__hiddenLabel mesh__D010662 FalisanNassbeize
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D010662 2004
% 223.84/223.99  |- skos__prefLabel mesh__D010662 Phenylmercuric Acetate
% 223.84/223.99  |- skos__hiddenLabel mesh__D010662 Falisan Nassbeize
% 223.84/223.99  |- skos__scopeNote mesh__D004625
% 223.84/223.99       The embryo of species other than mammals. For the chicken, use the specific CHICK EMBRYO.%A%    
% 223.84/223.99  |- mesh__recordAuthorizer mesh__D004625 sjn
% 223.84/223.99  |- mesh__dateEstablished mesh__D004625 1975-09-01
% 223.84/223.99  |- skos__hiddenLabel mesh__D004625 Nonmammalian Embryos
% 223.84/223.99  |- skos__broader mesh__D004625smesh__D004622
% 223.84/223.99  |- skos__prefLabel mesh__D004625 Embryo, Nonmammalian
% 223.84/223.99  |- mesh__dateRevised mesh__D004625 2004-10-20
% 223.84/223.99  |- skos__hiddenLabel mesh__D004625 Embryos, Non-Mammalian
% 223.84/223.99  |- skos__broader mesh__D004625smesh__D000825
% 223.84/223.99  |- skos__hiddenLabel mesh__D004625 Nonmammalian Embryo
% 223.84/223.99  |- skos__historyNote mesh__D004625 Embryo %28%1966-1974%29%
% 223.84/223.99  |- skos__hiddenLabel mesh__D004625 Embryos, Nonmammalian
% 223.84/223.99  |- mesh__recordOriginator mesh__D004625 NLM
% 223.84/223.99  |- skos__hiddenLabel mesh__D004625 Embryo, Non Mammalian
% 223.84/223.99  |- skos__altLabel mesh__D004625 Embryo, Non-Mammalian
% 223.84/223.99  |- mesh__publicMeSHNote mesh__D004625 75   
% 223.84/223.99  |- skos__hiddenLabel mesh__D004625 Non-Mammalian Embryo
% 223.84/223.99  |- skos__annotation mesh__D004625
% 223.84/223.99       IM only when point of article irrespective of species; if NIM, coord with exper non-mammalian organism /embryol or Cat A or Cat B term with /embryol; for chicken use CHICK EMBRYO; /transpl permitted: do not use EMBRYO TRANSFER since this is restricted to mammalian embryos%A%  
% 223.84/223.99  |- mesh__dateCreated mesh__D004625 1974-11-11
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D004625 2005
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D004625 2006
% 223.84/223.99  |- skos__hiddenLabel mesh__D004625 Non-Mammalian Embryos
% 223.84/223.99  |- mesh__recordMaintainer mesh__D004625 sjn
% 223.84/223.99  |- rdf__type mesh__D004625sskos__Concept
% 223.84/223.99  |- mesh__historyNote mesh__D004625 75   
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D004625 2005A
% 223.84/223.99  |- skos__altLabel mesh__D037001 Prescriptive Counseling
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D037001 2005
% 223.84/223.99  |- rdf__type mesh__D037001sskos__Concept
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D037001 2003
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D037001 2006
% 223.84/223.99  |- skos__prefLabel mesh__D037001 Directive Counseling
% 223.84/223.99  |- skos__related mesh__D037001smesh__D005817
% 223.84/223.99  |- skos__hiddenLabel mesh__D037001 Counseling, Directive
% 223.84/223.99  |- mesh__recordMaintainer mesh__D037001 jls
% 223.84/223.99  |- mesh__dateCreated mesh__D037001 2002-07-03
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D037001 2004
% 223.84/223.99  |- mesh__dateRevised mesh__D037001 2002-10-31
% 223.84/223.99  |- mesh__historyNote mesh__D037001 2003; use COUNSELING 2001-2002   
% 223.84/223.99  |- mesh__recordAuthorizer mesh__D037001 jls
% 223.84/223.99  |- mesh__recordOriginator mesh__D037001 hjn
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D037001 2003A
% 223.84/223.99  |- mesh__publicMeSHNote mesh__D037001 2003; see COUNSELING 2001-2002   
% 223.84/223.99  |- skos__scopeNote mesh__D037001
% 223.84/223.99       Counseling during which a professional plays an active role in a client%27%s or patient%27%s decision making by offering advice, guidance, and/or recommendations.%A%    
% 223.84/223.99  |- skos__broader mesh__D037001smesh__D003376
% 223.84/223.99  |- mesh__dateEstablished mesh__D037001 2003-01-01
% 223.84/223.99  |- skos__hiddenLabel mesh__D037001 Counseling, Prescriptive
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D009310 2004
% 223.84/223.99  |- rdf__type mesh__D009310sskos__Concept
% 223.84/223.99  |- mesh__recordAuthorizer mesh__D009310 NLM
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D009310 2000
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D009310 1996
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D009310 2005
% 223.84/223.99  |- skos__historyNote mesh__D009310
% 223.84/223.99       National Health Programs %28%1975-1977%29%
% 223.84/223.99  |- mesh__recordMaintainer mesh__D009310 PLS
% 223.84/223.99  |- skos__prefLabel mesh__D009310 National Health Insurance, United States
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D009310 1997
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D009310 2001
% 223.84/223.99  |- mesh__publicMeSHNote mesh__D009310 78   
% 223.84/223.99  |- mesh__dateRevised mesh__D009310 1993-09-16
% 223.84/223.99  |- mesh__recordOriginator mesh__D009310 EC
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D009310 2006
% 223.84/223.99  |- skos__annotation mesh__D009310
% 223.84/223.99       add UNITED STATES %28%NIM%29%; DF: NATL HEALTH INSUR US   
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D009310 2002
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D009310 1998
% 223.84/223.99  |- skos__broader mesh__D009310smesh__D009313
% 223.84/223.99  |- mesh__dateCreated mesh__D009310 1977-05-13
% 223.84/223.99  |- mesh__dateEstablished mesh__D009310 1978-01-01
% 223.84/223.99  |- skos__altLabel mesh__D009310 United States National Health Insurance
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D009310 1999
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D009310 2003
% 223.84/223.99  |- mesh__historyNote mesh__D009310 78   
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D009310 1995
% 223.84/223.99  |- skos__broader mesh__D009310smesh__D007348
% 223.84/223.99  |- skos__altLabel mesh__D009310
% 223.84/223.99       Federal Health Insurance Plans, United States
% 223.84/223.99  |- mesh__dateEstablished mesh__D042744 2004-01-01
% 223.84/223.99  |- mesh__recordMaintainer mesh__D042744 SYSTEM
% 223.84/223.99  |- skos__historyNote mesh__D042744
% 223.84/223.99       Gram-Negative Aerobic Bacteria %28%1966-2003%29%
% 223.84/223.99  |- skos__scopeNote mesh__D042744
% 223.84/223.99       A genus of gram-negative, sheathed, rod-shaped bacteria in the family COMAMONADACEAE. They are closely related to LEPTOTHRIX.%A%    
% 223.84/223.99  |- rdf__type mesh__D042744sskos__Concept
% 223.84/223.99  |- mesh__publicMeSHNote mesh__D042744 2004   
% 223.84/223.99  |- mesh__dateCreated mesh__D042744 2003-07-09
% 223.84/223.99  |- skos__prefLabel mesh__D042744 Sphaerotilus
% 223.84/223.99  |- mesh__activeMeSHYear mesh__D042744 2006
% 223.84/223.99  |- mesh__recordAuthorizer mesh__D042744 sjn
% 223.84/223.99  |- skos__broader mesh__D042744smesh__D042621
% 223.84/223.99  |- skos__annotation mesh__D042744
% 223.84/223.99       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 223.84/223.99  |- mesh__recordOriginator mesh__D042744 ags
% 223.84/223.99  |- mesh__historyNote mesh__D042744 2004   
% 223.84/224.00  |- mesh__dateRevised mesh__D042744 2005-06-30
% 223.84/224.00  |- rdf__type mesh__D014255sskos__Concept
% 223.84/224.00  |- mesh__dateRevised mesh__D014255 2005-06-30
% 223.84/224.00  |- skos__historyNote mesh__D014255 Ethers, Cyclic %28%1966-1974%29%
% 223.84/224.00  |- skos__altLabel mesh__D014255 Epoxytrichothecenes
% 223.84/224.00  |- skos__historyNote mesh__D014255 Benzoxepins %28%1968-1974%29%
% 223.84/224.00  |- mesh__dateCreated mesh__D014255 1974-11-19
% 223.84/224.00  |- skos__historyNote mesh__D014255 Terpenes %28%1966-1973%29%
% 223.84/224.00  |- mesh__recordOriginator mesh__D014255 NLM
% 223.84/224.00  |- skos__broader mesh__D014255smesh__D009183
% 223.84/224.00  |- mesh__recordMaintainer mesh__D014255 ssb
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D014255 2006
% 223.84/224.00  |- skos__historyNote mesh__D014255 Sesquiterpenes %28%1974%29%
% 223.84/224.00  |- skos__broader mesh__D014255smesh__D012717
% 223.84/224.00  |- mesh__historyNote mesh__D014255
% 223.84/224.00       91%28%81%29%; was see under SESQUITERPENES 1981-90; was EPOXYTRICHOTHECENES see under SESQUITERPENES 1975-80%A%  
% 223.84/224.00  |- skos__prefLabel mesh__D014255 Trichothecenes
% 223.84/224.00  |- mesh__recordAuthorizer mesh__D014255 sjn
% 223.84/224.00  |- skos__hiddenLabel mesh__D014255 Epoxides, Trichothecene
% 223.84/224.00  |- skos__broader mesh__D014255smesh__D047028
% 223.84/224.00  |- mesh__dateEstablished mesh__D014255 1991-01-01
% 223.84/224.00  |- mesh__onlineNote mesh__D014255
% 223.84/224.00       use TRICHOTHECENES to search EPOXYTRICHOTHECENES 1975-80   
% 223.84/224.00  |- skos__scopeNote mesh__D014255
% 223.84/224.00       Usually 12,13-epoxytrichothecenes, produced by Fusaria, Stachybotrys, Trichoderma and other fungi, and some higher plants. They may contaminate food or feed grains, induce emesis and hemorrhage in lungs and brain, and damage bone marrow due to protein and DNA synthesis inhibition.%A%    
% 223.84/224.00  |- mesh__publicMeSHNote mesh__D014255
% 223.84/224.00       91; was see under SESQUITERPENES 1981-90; was EPOXYTRICHOTHECENES see under SESQUITERPENES 1975-80%A%  
% 223.84/224.00  |- skos__broader mesh__D019354Q000031smesh__D019354
% 223.84/224.00  |- mesh__preferredCombination mesh__D019354Q000031smesh__D007773
% 223.84/224.00  |- rdf__type mesh__D019354Q000031smesh__CompoundConcept
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D008218 2000
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D008218 1999
% 223.84/224.00  |- skos__hiddenLabel mesh__D008218 Lymphocytoses
% 223.84/224.00  |- skos__annotation mesh__D008218 increase in number of lymphocytes   
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D008218 2003
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D008218 2001
% 223.84/224.00  |- skos__prefLabel mesh__D008218 Lymphocytosis
% 223.84/224.00  |- rdf__type mesh__D008218sskos__Concept
% 223.84/224.00  |- mesh__dateRevised mesh__D008218 1994-05-24
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D008218 2004
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D008218 1996
% 223.84/224.00  |- mesh__recordMaintainer mesh__D008218 TGC
% 223.84/224.00  |- skos__broader mesh__D008218smesh__D007964
% 223.84/224.00  |- mesh__recordAuthorizer mesh__D008218 PLS
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D008218 1997
% 223.84/224.00  |- mesh__recordOriginator mesh__D008218 NLM
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D008218 2002
% 223.84/224.00  |- mesh__dateCreated mesh__D008218 1999-01-01
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D008218 2005
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D008218 1995
% 223.84/224.00  |- skos__scopeNote mesh__D008218
% 223.84/224.00       Excess of normal lymphocytes in the blood or in any effusion.%A%    
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D008218 2006
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D008218 1998
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D000235 2000
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D000235 1996
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D000235 2003
% 223.84/224.00  |- skos__altLabel mesh__D000235 Warthin Tumor
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D000235 2001
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D000235 1997
% 223.84/224.00  |- mesh__recordAuthorizer mesh__D000235 PLS
% 223.84/224.00  |- skos__broader mesh__D000235smesh__D018193
% 223.84/224.00  |- mesh__dateCreated mesh__D000235 1999-01-01
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D000235 2004
% 223.84/224.00  |- mesh__recordMaintainer mesh__D000235 KEV
% 223.84/224.00  |- skos__hiddenLabel mesh__D000235 Tumor, Warthin
% 223.84/224.00  |- skos__prefLabel mesh__D000235 Adenolymphoma
% 223.84/224.00  |- skos__hiddenLabel mesh__D000235 Papillary Cystadenoma Lymphomatosum
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D000235 2002
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D000235 1998
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D000235 2005
% 223.84/224.00  |- mesh__dateRevised mesh__D000235 1995-06-08
% 223.84/224.00  |- skos__altLabel mesh__D000235 Cystadenoma Lymphomatosum, Papillary
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D000235 1999
% 223.84/224.00  |- skos__scopeNote mesh__D000235
% 223.84/224.00       A benign tumor characterized histologically by tall columnar epithelium within a lymphoid tissue stroma. It is usually found in the salivary glands, especially the parotid.%A%    
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D000235 2006
% 223.84/224.00  |- rdf__type mesh__D000235sskos__Concept
% 223.84/224.00  |- skos__hiddenLabel mesh__D000235 Adenolymphomas
% 223.84/224.00  |- mesh__recordOriginator mesh__D000235 NLM
% 223.84/224.00  |- skos__annotation mesh__D000235
% 223.84/224.00       /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 223.84/224.00  |- mesh__dateCreated mesh__D024683 2001-07-25
% 223.84/224.00  |- skos__altLabel mesh__D024683 Potassium Channel, Background
% 223.84/224.00  |- skos__hiddenLabel mesh__D024683 Background Potassium Channels
% 223.84/224.00  |- skos__altLabel mesh__D024683 Tandem Pore Domain Potassium Channels
% 223.84/224.00  |- mesh__recordAuthorizer mesh__D024683 sjn
% 223.84/224.00  |- mesh__recordOriginator mesh__D024683 ags
% 223.84/224.00  |- skos__hiddenLabel mesh__D024683 Background Potassium Channel
% 223.84/224.00  |- skos__altLabel mesh__D024683 K+ Channels, Tandem Pore Domain
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D024683 2006
% 223.84/224.00  |- skos__scopeNote mesh__D024683
% 223.84/224.00       Potassium channels that contain two pores in tandem. They are responsible for baseline or leak currents and may be the most numerous of all K channels.%A%    
% 223.84/224.00  |- mesh__dateRevised mesh__D024683 2005-06-30
% 223.84/224.00  |- skos__altLabel mesh__D024683 Potassium Channel, Leak
% 223.84/224.00  |- skos__altLabel mesh__D024683 Potassium Channel, Baseline
% 223.84/224.00  |- skos__altLabel mesh__D024683 Potassium Channel, Tandem Pore Domain
% 223.84/224.00  |- mesh__historyNote mesh__D024683 2002   
% 223.84/224.00  |- rdf__type mesh__D024683sskos__Concept
% 223.84/224.00  |- skos__altLabel mesh__D024683 Potassium Channels, Background
% 223.84/224.00  |- skos__hiddenLabel mesh__D024683 Baseline Potassium Channels
% 223.84/224.00  |- mesh__dateEstablished mesh__D024683 2002-01-01
% 223.84/224.00  |- skos__prefLabel mesh__D024683 Potassium Channels, Tandem Pore Domain
% 223.84/224.00  |- skos__hiddenLabel mesh__D024683 Baseline Potassium Channel
% 223.84/224.00  |- skos__altLabel mesh__D024683 Potassium Channels, Leak
% 223.84/224.00  |- mesh__publicMeSHNote mesh__D024683 2002   
% 223.84/224.00  |- skos__historyNote mesh__D024683 Potassium Channels %28%1995-2001%29%
% 223.84/224.00  |- skos__broader mesh__D024683smesh__D015221
% 223.84/224.00  |- skos__hiddenLabel mesh__D024683 Leak Potassium Channel
% 223.84/224.00  |- skos__altLabel mesh__D024683 Potassium Channels, Baseline
% 223.84/224.00  |- skos__altLabel mesh__D024683 Tandem Pore Domain Potassium Channel
% 223.84/224.00  |- skos__hiddenLabel mesh__D024683 Leak Potassium Channels
% 223.84/224.00  |- mesh__recordMaintainer mesh__D024683 SYSTEM
% 223.84/224.00  |- skos__broader mesh__D005169Q000172smesh__D005169
% 223.84/224.00  |- mesh__preferredCombination mesh__D005169Q000172smesh__D006467
% 223.84/224.00  |- rdf__type mesh__D005169Q000172smesh__CompoundConcept
% 223.84/224.00  |- mesh__dateEstablished mesh__D018646 1995-01-01
% 223.84/224.00  |- skos__scopeNote mesh__D018646
% 223.84/224.00       An extract of absinthium and other bitter herbs, containing 60%25% alcohol. Prolonged ingestion causes nervousness, convulsions, trismus, amblyopia, optic neuritis, and mental deterioration. %28%Dorland, 27th ed%29%%A%    
% 223.84/224.00  |- rdf__type mesh__D018646sskos__Concept
% 223.84/224.00  |- mesh__publicMeSHNote mesh__D018646 95   
% 223.84/224.00  |- mesh__recordOriginator mesh__D018646 TGC
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D018646 2000
% 223.84/224.00  |- mesh__historyNote mesh__D018646 95   
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D018646 2001
% 223.84/224.00  |- mesh__dateRevised mesh__D018646 1997-06-20
% 223.84/224.00  |- mesh__dateCreated mesh__D018646 1994-04-19
% 223.84/224.00  |- skos__prefLabel mesh__D018646 Absinthe
% 223.84/224.00  |- mesh__recordAuthorizer mesh__D018646 SJN
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D018646 2005
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D018646 2002
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D018646 2006
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D018646 2003
% 223.84/224.00  |- skos__annotation mesh__D018646 an alcoholic beverage   
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D018646 1998
% 223.84/224.00  |- mesh__recordMaintainer mesh__D018646 JLS
% 223.84/224.00  |- skos__broader mesh__D018646smesh__D000434
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D018646 2004
% 223.84/224.00  |- mesh__activeMeSHYear mesh__D018646 1999
% 223.84/224.01  |- skos__hiddenLabel mesh__D010663 Compounds, Phenylmercury
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D010663 1997
% 223.84/224.01  |- skos__historyNote mesh__D010663
% 223.84/224.01       Organometallic Compounds %28%1968-1976%29%
% 223.84/224.01  |- skos__altLabel mesh__D010663 Phenylmercurials
% 223.84/224.01  |- mesh__dateCreated mesh__D010663 1976-04-16
% 223.84/224.01  |- mesh__recordOriginator mesh__D010663 RLS
% 223.84/224.01  |- skos__broader mesh__D010663smesh__D009941
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D010663 2005
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D010663 2002
% 223.84/224.01  |- mesh__dateRevised mesh__D010663 1995-05-18
% 223.84/224.01  |- mesh__dateEstablished mesh__D010663 1977-01-01
% 223.84/224.01  |- skos__altLabel mesh__D010663 Phenyl Mercury Compounds
% 223.84/224.01  |- mesh__recordAuthorizer mesh__D010663 PLS
% 223.84/224.01  |- skos__scopeNote mesh__D010663
% 223.84/224.01       Organic mercury compounds in which the mercury is attached to a phenyl group. Often used as fungicides and seed treatment agents.%A%    
% 223.84/224.01  |- skos__prefLabel mesh__D010663 Phenylmercury Compounds
% 223.84/224.01  |- skos__annotation mesh__D010663
% 223.84/224.01       agric fungicides; DF: PHENYLMERCURY CPDS   
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D010663 2006
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D010663 1998
% 223.84/224.01  |- skos__hiddenLabel mesh__D010663 Compounds, Phenyl Mercury
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D010663 2003
% 223.84/224.01  |- mesh__onlineNote mesh__D010663
% 223.84/224.01       use PHENYLMERCURY COMPOUNDS to search PHENYL MERCURY COMPOUNDS 1977-79%A%  
% 223.84/224.01  |- mesh__historyNote mesh__D010663
% 223.84/224.01       80; was PHENYL MERCURY COMPOUNDS 1977-79   
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D010663 2000
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D010663 1999
% 223.84/224.01  |- skos__historyNote mesh__D010663 Mercury %28%1968-1976%29%
% 223.84/224.01  |- mesh__recordMaintainer mesh__D010663 JRT
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D010663 2004
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D010663 1996
% 223.84/224.01  |- skos__hiddenLabel mesh__D010663 Mercury Compounds, Phenyl
% 223.84/224.01  |- mesh__publicMeSHNote mesh__D010663
% 223.84/224.01       80; was PHENYL MERCURY COMPOUNDS 1977-79; CHLOROMERCURIPHENYLSULFONATE was see under ORGANOMETALLIC COMPOUNDS 1975-76%A%  
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D010663 2001
% 223.84/224.01  |- rdf__type mesh__D010663sskos__Concept
% 223.84/224.01  |- skos__broader mesh__D004626smesh__D015509
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D004626 2004
% 223.84/224.01  |- mesh__recordMaintainer mesh__D004626 jls
% 223.84/224.01  |- mesh__recordAuthorizer mesh__D004626 sjn
% 223.84/224.01  |- skos__prefLabel mesh__D004626 Embryology
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D004626 2005
% 223.84/224.01  |- mesh__dateCreated mesh__D004626 1999-01-01
% 223.84/224.01  |- mesh__recordOriginator mesh__D004626 NLM
% 223.84/224.01  |- skos__annotation mesh__D004626
% 223.84/224.01       SPEC only, SPEC qualif; prefer /embryol: Manual 19.7+, 19.8.29; DF: EMBRYOL%A%  
% 223.84/224.01  |- skos__hiddenLabel mesh__D004626 Embryologies
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D004626 2002
% 223.84/224.01  |- skos__broader mesh__D004626smesh__D000715
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D004626 2006
% 223.84/224.01  |- rdf__type mesh__D004626sskos__Concept
% 223.84/224.01  |- skos__scopeNote mesh__D004626
% 223.84/224.01       The study of the development of an organism during the embryonic and fetal stages of life.%A%    
% 223.84/224.01  |- mesh__dateRevised mesh__D004626 2001-07-25
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D004626 2003
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D020293 2004
% 223.84/224.01  |- skos__hiddenLabel mesh__D020293 Arteritis, Granulomatous
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D020293 2002
% 223.84/224.01  |- skos__broader mesh__D020293smesh__D002561
% 223.84/224.01  |- skos__altLabel mesh__D020293 Vasculitis, CNS, Secondary
% 223.84/224.01  |- skos__altLabel mesh__D020293 Central Nervous System Angiitis
% 223.84/224.01  |- skos__broader mesh__D020293smesh__D014657
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D020293 2003
% 223.84/224.01  |- skos__hiddenLabel mesh__D020293 CNS Vasculitis, Secondary
% 223.84/224.01  |- skos__altLabel mesh__D020293 Angiitis, Central Nervous System
% 223.84/224.01  |- skos__altLabel mesh__D020293 Central Nervous System Vasculitis
% 223.84/224.01  |- skos__historyNote mesh__D020293
% 223.84/224.01       Cerebrovascular Disorders %28%1966-1999%29%
% 223.84/224.01  |- rdf__type mesh__D020293sskos__Concept
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D020293 2006
% 223.84/224.01  |- skos__prefLabel mesh__D020293 Vasculitis, Central Nervous System
% 223.84/224.01  |- skos__hiddenLabel mesh__D020293 Vasculitis, CNS
% 223.84/224.01  |- skos__broader mesh__D020293smesh__D020274
% 223.84/224.01  |- skos__altLabel mesh__D020293 Granulomatous Arteritis
% 223.84/224.01  |- mesh__dateEstablished mesh__D020293 2000-01-01
% 223.84/224.01  |- skos__hiddenLabel mesh__D020293 Vasculitis, Cerebral
% 223.84/224.01  |- skos__hiddenLabel mesh__D020293 Angiitis, Cerebral
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D020293 2001
% 223.84/224.01  |- skos__altLabel mesh__D020293 CNS Vasculitis
% 223.84/224.01  |- mesh__historyNote mesh__D020293 2000   
% 223.84/224.01  |- skos__hiddenLabel mesh__D020293 Vasculitis, Secondary CNS
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D020293 2005
% 223.84/224.01  |- skos__hiddenLabel mesh__D020293 Arteritis, Postzoster
% 223.84/224.01  |- skos__altLabel mesh__D020293 Cerebral Vasculitis
% 223.84/224.01  |- mesh__dateCreated mesh__D020293 1999-11-08
% 223.84/224.01  |- mesh__publicMeSHNote mesh__D020293 2000   
% 223.84/224.01  |- skos__hiddenLabel mesh__D020293 CNS Vasculitis, Primary
% 223.84/224.01  |- skos__hiddenLabel mesh__D020293 Vasculitis, Primary CNS
% 223.84/224.01  |- skos__historyNote mesh__D020293
% 223.84/224.01       Cerebral Arterial Diseases %28%1965-1999%29%
% 223.84/224.01  |- skos__historyNote mesh__D020293 Brain Diseases %28%1966-1999%29%
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D020293 2000
% 223.84/224.01  |- skos__scopeNote mesh__D020293
% 223.84/224.01       Inflammation of blood vessels within the central nervous system. Etiologies include autoimmune disorders %28%see also LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYARTERITIS NODOSA; WEGENER%27%S GRANULOMATOSIS%29%, infections, exposure to radiation or toxins, and other conditions. Autoimmune or idiopathic vasculitides limited to the central nervous system are referred to as primary CNS vasculitides. CNS vasculitides associated with a systemic process or known pathogens are referred to as secondary CNS vasculitides. Clinical manifestations are highly variable but include headaches; SEIZURES; behavioral alterations; INTRACRANIAL HEMORRHAGES; transient ischemic attacks %28%ISCHEMIC ATTACK, TRANSIENT%29%; and BRAIN INFARCTION. %28%From Adams et al., Principles of Neurology, 6th ed, pp856-61%29%%A%    
% 223.84/224.01  |- skos__hiddenLabel mesh__D020293 Angiitis, Granulomatous
% 223.84/224.01  |- skos__annotation mesh__D020293 DF: note short X refs   
% 223.84/224.01  |- skos__altLabel mesh__D020293 Primary Central Nervous System Vasculitis
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D014256 2002
% 223.84/224.01  |- skos__prefLabel mesh__D014256 Trichotillomania
% 223.84/224.01  |- skos__hiddenLabel mesh__D014256 Trichotillomanias
% 223.84/224.01  |- mesh__recordAuthorizer mesh__D014256 SJN
% 223.84/224.01  |- mesh__dateRevised mesh__D014256 1997-06-20
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D014256 2004
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D014256 2001
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D014256 2006
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D014256 2003
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D014256 1999
% 223.84/224.01  |- mesh__historyNote mesh__D014256
% 223.84/224.01       91%28%75%29%; was see under OBSESSIVE-COMPULSIVE DISORDER 1981-90; was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-80; was in Cat F only 1975-79%A%  
% 223.84/224.01  |- mesh__publicMeSHNote mesh__D014256
% 223.84/224.01       91; was see under OBSESSIVE-COMPULSIVE DISORDER 1981-90; was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-80; was in Cat F only 1975-79%A%  
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D014256 2000
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D014256 2005
% 223.84/224.01  |- mesh__recordMaintainer mesh__D014256 JLS
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D014256 1998
% 223.84/224.01  |- mesh__onlineNote mesh__D014256
% 223.84/224.01       use OBSESSIVE-COMPULSIVE DISORDER to search TRICHOTILLOMANIA 1966-74%A%  
% 223.84/224.01  |- mesh__dateEstablished mesh__D014256 1991-01-01
% 223.84/224.01  |- mesh__recordOriginator mesh__D014256 NLM
% 223.84/224.01  |- mesh__dateCreated mesh__D014256 1999-01-01
% 223.84/224.01  |- skos__broader mesh__D014256smesh__D007174
% 223.84/224.01  |- rdf__type mesh__D014256sskos__Concept
% 223.84/224.01  |- skos__scopeNote mesh__D014256 Compulsion to pull out one%27%s hair.     
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D008219 2003
% 223.84/224.01  |- rdf__type mesh__D008219sskos__Concept
% 223.84/224.01  |- skos__annotation mesh__D008219 caused by Chlamydia trachomatis   
% 223.84/224.01  |- mesh__dateRevised mesh__D008219 1997-06-20
% 223.84/224.01  |- skos__scopeNote mesh__D008219
% 223.84/224.01       Subacute inflammation of the inguinal lymph glands caused by certain immunotypes of CHLAMYDIA TRACHOMATIS. It is a sexually transmitted disease in the U.S. but is more widespread in developing countries. It is distinguished from granuloma venereum %28%see GRANULOMA INGUINALE%29%, which is caused by Calymmatobacterium granulomatis.%A%    
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D008219 2004
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D008219 2000
% 223.84/224.01  |- skos__altLabel mesh__D008219 Lymphogranuloma Inguinale
% 223.84/224.01  |- mesh__recordMaintainer mesh__D008219 PXP
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D008219 2001
% 223.84/224.01  |- mesh__dateCreated mesh__D008219 1999-01-01
% 223.84/224.01  |- skos__prefLabel mesh__D008219 Lymphogranuloma Venereum
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D008219 2005
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D008219 2006
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D008219 1998
% 223.84/224.01  |- mesh__recordAuthorizer mesh__D008219 SJN
% 223.84/224.01  |- mesh__recordOriginator mesh__D008219 NLM
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D008219 2002
% 223.84/224.01  |- skos__broader mesh__D008219smesh__D002690
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D008219 1999
% 223.84/224.01  |- skos__hiddenLabel mesh__D000236 Adenomas, Papillary
% 223.84/224.01  |- skos__hiddenLabel mesh__D000236 Adenomas, Follicular
% 223.84/224.01  |- skos__hiddenLabel mesh__D000236 Microcystic Adenoma
% 223.84/224.01  |- mesh__dateCreated mesh__D000236 1999-01-01
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D000236 2004
% 223.84/224.01  |- mesh__recordAuthorizer mesh__D000236 sjn
% 223.84/224.01  |- mesh__recordOriginator mesh__D000236 NLM
% 223.84/224.01  |- skos__hiddenLabel mesh__D000236 Adenomas, Basal Cell
% 223.84/224.01  |- skos__hiddenLabel mesh__D000236 Papillary Adenoma
% 223.84/224.01  |- skos__hiddenLabel mesh__D000236 Monomorphic Adenomas
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D000236 2000
% 223.84/224.01  |- skos__hiddenLabel mesh__D000236 Papillary Adenomas
% 223.84/224.01  |- skos__hiddenLabel mesh__D000236 Basal Cell Adenomas
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D000236 2005
% 223.84/224.01  |- skos__broader mesh__D000236smesh__D009375
% 223.84/224.01  |- skos__hiddenLabel mesh__D000236 Adenomas
% 223.84/224.01  |- skos__hiddenLabel mesh__D000236 Monomorphic Adenoma
% 223.84/224.01  |- mesh__recordMaintainer mesh__D000236 jls
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D000236 2001
% 223.84/224.01  |- skos__hiddenLabel mesh__D000236 Adenomas, Monomorphic
% 223.84/224.01  |- rdf__type mesh__D000236sskos__Concept
% 223.84/224.01  |- skos__scopeNote mesh__D000236
% 223.84/224.01       A benign epithelial tumor with a glandular organization.%A%    
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D000236 2006
% 223.84/224.01  |- skos__hiddenLabel mesh__D000236 Basal Cell Adenoma
% 223.84/224.01  |- skos__hiddenLabel mesh__D000236 Follicular Adenoma
% 223.84/224.01  |- skos__hiddenLabel mesh__D000236 Adenomas, Trabecular
% 223.84/224.01  |- skos__hiddenLabel mesh__D000236 Trabecular Adenoma
% 223.84/224.01  |- skos__annotation mesh__D000236
% 223.84/224.01       GEN or unspecified; prefer specifics; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 223.84/224.01  |- skos__hiddenLabel mesh__D000236 Trabecular Adenomas
% 223.84/224.01  |- skos__hiddenLabel mesh__D000236 Adenomas, Microcystic
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D000236 2002
% 223.84/224.01  |- skos__hiddenLabel mesh__D000236 Microcystic Adenomas
% 223.84/224.01  |- skos__prefLabel mesh__D000236 Adenoma
% 223.84/224.01  |- skos__hiddenLabel mesh__D000236 Follicular Adenomas
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D000236 2003
% 223.84/224.01  |- mesh__dateRevised mesh__D000236 1999-11-09
% 223.84/224.01  |- mesh__dateCreated mesh__D018647 1994-04-19
% 223.84/224.01  |- mesh__dateRevised mesh__D018647 2005-06-30
% 223.84/224.01  |- mesh__dateEstablished mesh__D018647 1995-01-01
% 223.84/224.01  |- mesh__historyNote mesh__D018647 95   
% 223.84/224.01  |- mesh__recordOriginator mesh__D018647 TGC
% 223.84/224.01  |- mesh__recordMaintainer mesh__D018647 ssb
% 223.84/224.01  |- rdf__type mesh__D018647sskos__Concept
% 223.84/224.01  |- skos__annotation mesh__D018647
% 223.84/224.01       a resin; do not confuse with AMBER %28%Advanced Multiple Beam Equalization Radiography%29% or amber codon or amber suppressor; D25-26 qualif%A%  
% 223.84/224.01  |- skos__scopeNote mesh__D018647
% 223.84/224.01       A yellowish fossil resin, the gum of several species of coniferous trees, found in the alluvial deposits of northeastern Germany. It is used in molecular biology in the analysis of organic matter fossilized in amber.%A%    
% 223.84/224.01  |- mesh__publicMeSHNote mesh__D018647 95   
% 223.84/224.01  |- skos__broader mesh__D018647smesh__D012116
% 223.84/224.01  |- mesh__recordAuthorizer mesh__D018647 sjn
% 223.84/224.01  |- skos__historyNote mesh__D018647 Resins %28%1969-1994%29%
% 223.84/224.01  |- skos__prefLabel mesh__D018647 Amber
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D018647 2006
% 223.84/224.01  |- mesh__historyNote mesh__D010664
% 223.84/224.01       91%28%75%29%; was see under SULFONES 1975-90   
% 223.84/224.01  |- skos__broader mesh__D010664smesh__D013450
% 223.84/224.01  |- mesh__dateRevised mesh__D010664 2000-06-22
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D010664 2002
% 223.84/224.01  |- rdf__type mesh__D010664sskos__Concept
% 223.84/224.01  |- skos__historyNote mesh__D010664 Benzyl Compounds %28%1973-1974%29%
% 223.84/224.01  |- skos__prefLabel mesh__D010664 Phenylmethylsulfonyl Fluoride
% 223.84/224.01  |- skos__historyNote mesh__D010664 Fluorine %28%1974%29%
% 223.84/224.01  |- mesh__recordAuthorizer mesh__D010664 sjn
% 223.84/224.01  |- mesh__publicMeSHNote mesh__D010664 91; was see under SULFONES 1975-90   
% 223.84/224.01  |- skos__scopeNote mesh__D010664
% 223.84/224.01       An enzyme inhibitor that inactivates IRC-50 arvin, subtilisin, and the fatty acid synthetase complex.%A%    
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D010664 2001
% 223.84/224.01  |- mesh__recordMaintainer mesh__D010664 CCR
% 223.84/224.01  |- skos__hiddenLabel mesh__D010664 Fluoride, Phenylmethanesulfonyl
% 223.84/224.01  |- mesh__dateCreated mesh__D010664 1974-11-19
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D010664 2006
% 223.84/224.01  |- skos__altLabel mesh__D010664 Phenylmethanesulfonyl Fluoride
% 223.84/224.01  |- skos__hiddenLabel mesh__D010664 Fluoride, Phenylmethylsulfonyl
% 223.84/224.01  |- mesh__recordOriginator mesh__D010664 NLM
% 223.84/224.01  |- skos__altLabel mesh__D010664 Benzenemethanesulfonyl Fluoride
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D010664 2004
% 223.84/224.01  |- mesh__dateEstablished mesh__D010664 1991-01-01
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D010664 2005
% 223.84/224.01  |- skos__hiddenLabel mesh__D010664 Fluoride, Benzenemethanesulfonyl
% 223.84/224.01  |- skos__historyNote mesh__D010664 Sulfones %28%1973-1974%29%
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D010664 2003
% 223.84/224.01  |- skos__prefLabel mesh__D037801 Hammer Toe Syndrome
% 223.84/224.01  |- skos__altLabel mesh__D037801 Clawtoe
% 223.84/224.01  |- rdf__type mesh__D037801sskos__Concept
% 223.84/224.01  |- skos__hiddenLabel mesh__D037801 Toe, Mallet
% 223.84/224.01  |- skos__hiddenLabel mesh__D037801 Syndromes, Hammertoe
% 223.84/224.01  |- skos__hiddenLabel mesh__D037801 Hammertoe Syndromes
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D037801 2004
% 223.84/224.01  |- skos__hiddenLabel mesh__D037801 Toe, Claw
% 223.84/224.01  |- skos__historyNote mesh__D037801 Foot Deformities %28%1979-2002%29%
% 223.84/224.01  |- skos__hiddenLabel mesh__D037801 Hammer Toes
% 223.84/224.01  |- mesh__publicMeSHNote mesh__D037801 2003   
% 223.84/224.01  |- skos__hiddenLabel mesh__D037801 Syndrome, Hammer Toe
% 223.84/224.01  |- skos__hiddenLabel mesh__D037801 Mallet Toes
% 223.84/224.01  |- skos__historyNote mesh__D037801 Toes/abnormalities %28%1966-2002%29%
% 223.84/224.01  |- skos__hiddenLabel mesh__D037801 Syndrome, Hammertoe
% 223.84/224.01  |- mesh__dateCreated mesh__D037801 2002-07-03
% 223.84/224.01  |- skos__hiddenLabel mesh__D037801 Toes, Claw
% 223.84/224.01  |- skos__hiddenLabel mesh__D037801 Toes, Mallet
% 223.84/224.01  |- skos__hiddenLabel mesh__D037801 Clawtoes
% 223.84/224.01  |- skos__hiddenLabel mesh__D037801 Toes, Hammer
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D037801 2005
% 223.84/224.01  |- mesh__dateEstablished mesh__D037801 2003-01-01
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D037801 2006
% 223.84/224.01  |- mesh__historyNote mesh__D037801 2003   
% 223.84/224.01  |- skos__hiddenLabel mesh__D037801 Toe, Hammer
% 223.84/224.01  |- skos__hiddenLabel mesh__D037801 Claw Toes
% 223.84/224.01  |- skos__broader mesh__D037801smesh__D005530
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D037801 2003
% 223.84/224.01  |- skos__altLabel mesh__D037801 Hammertoe Syndrome
% 223.84/224.01  |- skos__scopeNote mesh__D037801
% 223.84/224.01       A condition characterized by a series of interrelated digital symptoms and joint changes of the lesser digits and METATARSOPHALANGEAL JOINTS of the FOOT. The syndrome can include some or all of the following conditions: hammer toe, claw toe, mallet toe, overlapping fifth toe, curly toe, EXOSTOSIS, HYPEROSTOSIS, interdigital heloma, or contracted toe.%A%    
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D004627 2005
% 223.84/224.01  |- mesh__recordMaintainer mesh__D004627 lkt
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D004627 2006
% 223.84/224.01  |- mesh__dateEstablished mesh__D004627 1991-01-01
% 223.84/224.01  |- rdf__type mesh__D004627sskos__Concept
% 223.84/224.01  |- skos__broader mesh__D004627smesh__D019521
% 223.84/224.01  |- skos__hiddenLabel mesh__D004627 Induction, Embryonic
% 223.84/224.01  |- skos__broader mesh__D004627smesh__D002450
% 223.84/224.01  |- skos__broader mesh__D004627smesh__D047108
% 223.84/224.01  |- skos__prefLabel mesh__D004627 Embryonic Induction
% 223.84/224.01  |- skos__broader mesh__D004627smesh__D002454
% 223.84/224.01  |- skos__scopeNote mesh__D004627
% 223.84/224.01       The complex processes of initiating CELL DIFFERENTIATION in the EMBRYO. The precise regulation by cell interactions leads to diversity of cell types and specific pattern of organization %28%EMBRYOGENESIS%29%.%A%    
% 223.84/224.01  |- mesh__recordAuthorizer mesh__D004627 sjn
% 223.84/224.01  |- mesh__dateRevised mesh__D004627 2004-07-07
% 223.84/224.01  |- mesh__recordOriginator mesh__D004627 NLM
% 223.84/224.01  |- skos__hiddenLabel mesh__D004627 Inductions, Embryonic
% 223.84/224.01  |- mesh__historyNote mesh__D004627
% 223.84/224.01       91%28%75%29%; was see under CELL DIFFERENTIATION 1975-90   
% 223.84/224.01  |- mesh__publicMeSHNote mesh__D004627
% 223.84/224.01       91; was see under CELL DIFFERENTIATION 1975-90   
% 223.84/224.01  |- mesh__dateCreated mesh__D004627 1974-11-11
% 223.84/224.01  |- skos__related mesh__D004627smesh__D020897
% 223.84/224.01  |- skos__hiddenLabel mesh__D004627 Embryonic Inductions
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D009312 2001
% 223.84/224.01  |- mesh__recordAuthorizer mesh__D009312 SJN
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D009312 1998
% 223.84/224.01  |- mesh__dateEstablished mesh__D009312 1991-01-01
% 223.84/224.01  |- mesh__recordMaintainer mesh__D009312 PXP
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D009312 2002
% 223.84/224.01  |- skos__scopeNote mesh__D009312
% 223.84/224.01       A center in the HEALTH RESOURCES ADMINISTRATION Division of Planning Methods and Technology which provides access to current information on health planning and resources development.%A%    
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D009312 1999
% 223.84/224.01  |- skos__annotation mesh__D009312
% 223.84/224.01       add UNITED STATES %28%NIM%29%; research support by this agency is checked as NIH/PHS SUP; DF: note short X ref      CATALOG: use NAF entry%A%  
% 223.84/224.01  |- skos__prefLabel mesh__D009312
% 223.84/224.01       National Health Planning Information Center
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D009312 2003
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D009312 2004
% 223.84/224.01  |- rdf__type mesh__D009312sskos__Concept
% 223.84/224.01  |- mesh__dateRevised mesh__D009312 1997-06-20
% 223.84/224.01  |- mesh__publicMeSHNote mesh__D009312
% 223.84/224.01       91; was see under UNITED STATES HEALTH RESOURCES AND SERVICES ADMINISTRATION 1980-90%A%  
% 223.84/224.01  |- skos__broader mesh__D009312smesh__D014488
% 223.84/224.01  |- skos__altLabel mesh__D009312 NHPIC
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D009312 2005
% 223.84/224.01  |- mesh__dateCreated mesh__D009312 1979-06-01
% 223.84/224.01  |- mesh__historyNote mesh__D009312
% 223.84/224.01       91%28%80%29%; was see under UNITED STATES HEALTH RESOURCES AND SERVICES ADMINISTRATION 1980-90%A%  
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D009312 2000
% 223.84/224.01  |- mesh__recordOriginator mesh__D009312 EC
% 223.84/224.01  |- skos__altLabel mesh__D009312
% 223.84/224.01       United States National Health Planning Information Center
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D009312 2006
% 223.84/224.01  |- skos__altLabel mesh__D009312
% 223.84/224.01       National Health Planning Information Center %28%U.S.%29%
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D020294 2004
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D020294 2002
% 223.84/224.01  |- skos__altLabel mesh__D020294 Congenital Myasthenic Syndromes
% 223.84/224.01  |- mesh__historyNote mesh__D020294 2000   
% 223.84/224.01  |- skos__hiddenLabel mesh__D020294
% 223.84/224.01       Congenital Slow Channel Myasthenic Syndromes
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D020294 2005
% 223.84/224.01  |- skos__hiddenLabel mesh__D020294 Myasthenic Syndrome, Congenital
% 223.84/224.01  |- skos__altLabel mesh__D020294
% 223.84/224.01       Postsynaptic Congenital Myasthenic Syndromes
% 223.84/224.01  |- mesh__recordAuthorizer mesh__D020294 sjn
% 223.84/224.01  |- skos__broader mesh__D020294smesh__D020511
% 223.84/224.01  |- skos__hiddenLabel mesh__D020294 Syndrome, Congenital Myasthenic
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D020294 2006
% 223.84/224.01  |- rdf__type mesh__D020294sskos__Concept
% 223.84/224.01  |- skos__historyNote mesh__D020294
% 223.84/224.01       Myasthenia Gravis/congenital %28%1970-1999%29%
% 223.84/224.01  |- skos__scopeNote mesh__D020294
% 223.84/224.01       A heterogeneous group of disorders characterized by a congenital defect in neuromuscular transmission at the NEUROMUSCULAR JUNCTION. This includes presynaptic, synaptic, and postsynaptic disorders %28%that are not of autoimmune origin%29%. The majority of these diseases are caused by mutations of various subunits of the nicotinic acetylcholine receptor %28%RECEPTORS, NICOTINIC%29% on the postsynaptic surface of the junction. %28%From Arch Neurol 1999 Feb;56%28%2%29%:163-7%29%%A%    
% 223.84/224.01  |- skos__hiddenLabel mesh__D020294
% 223.84/224.01       Slow Channel Congenital Myasthenic Syndromes
% 223.84/224.01  |- skos__prefLabel mesh__D020294 Myasthenic Syndromes, Congenital
% 223.84/224.01  |- skos__altLabel mesh__D020294 Congenital Myasthenia Gravis
% 223.84/224.01  |- mesh__publicMeSHNote mesh__D020294 2000   
% 223.84/224.01  |- mesh__recordMaintainer mesh__D020294 nns
% 223.84/224.01  |- skos__broader mesh__D020294smesh__D030342
% 223.84/224.01  |- skos__related mesh__D020294smesh__D009157
% 223.84/224.01  |- skos__annotation mesh__D020294
% 223.84/224.01       do not confuse with MYASTHENIA GRAVIS, NEONATAL, a transient condition seen in neonates born to myasthenic mothers%A%  
% 223.84/224.01  |- skos__hiddenLabel mesh__D020294 Syndromes, Congenital Myasthenic
% 223.84/224.01  |- mesh__dateRevised mesh__D020294 2001-07-25
% 223.84/224.01  |- skos__hiddenLabel mesh__D020294 Congenital Myasthenic Syndrome
% 223.84/224.01  |- mesh__dateCreated mesh__D020294 1999-11-08
% 223.84/224.01  |- skos__altLabel mesh__D020294
% 223.84/224.01       Slow-Channel Congenital Myasthenic Syndromes
% 223.84/224.01  |- mesh__activeMeSHYear mesh__D020294 2003
% 223.84/224.01  |- skos__altLabel mesh__D020294
% 223.84/224.01       Congenital Slow-Channel Myasthenic Syndromes
% 223.84/224.01  |- mesh__dateEstablished mesh__D020294 2000-01-01
% 223.84/224.01  |- mesh__recordOriginator mesh__D020294 KEV
% 223.84/224.01  |- skos__altLabel mesh__D020294 Presynaptic Congenital Myasthenic Syndromes
% 223.84/224.01  |- skos__altLabel mesh__D020294 Myasthenia Gravis, Congenital
% 223.84/224.02  |- mesh__recordAuthorizer mesh__D014257 PLS
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D014257 2003
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D014257 1999
% 223.84/224.02  |- skos__scopeNote mesh__D014257
% 223.84/224.02       Infection with nematodes of the genus TRICHURIS, formerly called Trichocephalus.%A%    
% 223.84/224.02  |- mesh__recordOriginator mesh__D014257 NLM
% 223.84/224.02  |- skos__hiddenLabel mesh__D014257 Trichuriases
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D014257 2005
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D014257 1996
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D014257 1995
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D014257 1998
% 223.84/224.02  |- skos__broader mesh__D014257smesh__D017189
% 223.84/224.02  |- mesh__dateCreated mesh__D014257 1999-01-01
% 223.84/224.02  |- skos__annotation mesh__D014257
% 223.84/224.02       nematode infect caused by Trichuris: do not confuse with TRICHINOSIS, caused by Trichina or Trichinella%A%  
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D014257 1994
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D014257 2002
% 223.84/224.02  |- skos__altLabel mesh__D014257 Trichocephaliasis
% 223.84/224.02  |- rdf__type mesh__D014257sskos__Concept
% 223.84/224.02  |- skos__hiddenLabel mesh__D014257 Trichocephaliases
% 223.84/224.02  |- mesh__recordMaintainer mesh__D014257 TGC
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D014257 2001
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D014257 2004
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D014257 2000
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D014257 2006
% 223.84/224.02  |- mesh__dateRevised mesh__D014257 1993-06-03
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D014257 1997
% 223.84/224.02  |- skos__prefLabel mesh__D014257 Trichuriasis
% 223.84/224.02  |- mesh__publicMeSHNote mesh__D019740 98   
% 223.84/224.02  |- mesh__dateCreated mesh__D019740 1997-06-20
% 223.84/224.02  |- skos__altLabel mesh__D019740 Stomata
% 223.84/224.02  |- skos__broader mesh__D019740smesh__D019738
% 223.84/224.02  |- mesh__dateEstablished mesh__D019740 1998-01-01
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D019740 2006
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D019740 1999
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D019740 2004
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D019740 2001
% 223.84/224.02  |- skos__hiddenLabel mesh__D019740 Stoma
% 223.84/224.02  |- skos__scopeNote mesh__D019740
% 223.84/224.02       Artificial openings between two cavities or canals, or between such and the surface of the body. %28%Stedman, 26th ed%29%%A%    
% 223.84/224.02  |- rdf__type mesh__D019740sskos__Concept
% 223.84/224.02  |- skos__prefLabel mesh__D019740 Stomas
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D019740 2005
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D019740 2000
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D019740 1998
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D019740 2003
% 223.84/224.02  |- mesh__historyNote mesh__D019740 98   
% 223.84/224.02  |- skos__annotation mesh__D019740
% 223.84/224.02       surgically-created opening; coord IM with organ /surg %28%IM%29% or surg procedure %28%IM%29% or organ /surg %28%IM%29% if proced is not available%A%  
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D019740 2002
% 223.84/224.02  |- mesh__historyNote mesh__D000237 94; was ADENOMA, BASOPHILIC 1963-93   
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D000237 2004
% 223.84/224.02  |- skos__related mesh__D000237smesh__D010911
% 223.84/224.02  |- mesh__onlineNote mesh__D000237
% 223.84/224.02       use ADENOMA, BASOPHIL to search ADENOMA, BASOPHILIC 1966-93%A%  
% 223.84/224.02  |- skos__altLabel mesh__D000237 Adenoma, Basophilic
% 223.84/224.02  |- skos__hiddenLabel mesh__D000237 Basophilic Adenomas
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D000237 2003
% 223.84/224.02  |- skos__hiddenLabel mesh__D000237 Basophil Adenoma
% 223.84/224.02  |- skos__scopeNote mesh__D000237
% 223.84/224.02       A small tumor of the anterior lobe of the pituitary gland whose cells stain with basic dyes. It may give rise to excessive secretion of ACTH, resulting in CUSHING SYNDROME. %28%Dorland, 27th ed%29%%A%    
% 223.84/224.02  |- skos__hiddenLabel mesh__D000237 Adenomas, Basophil
% 223.84/224.02  |- skos__annotation mesh__D000237
% 223.84/224.02       /blood supply /chem /secret /ultrastruct permitted; coord IM with PITUITARY NEOPLASMS %28%IM%29%%A%  
% 223.84/224.02  |- skos__hiddenLabel mesh__D000237 Adenomas, Basophilic
% 223.84/224.02  |- mesh__dateRevised mesh__D000237 1999-11-08
% 223.84/224.02  |- skos__related mesh__D000237smesh__D003480
% 223.84/224.02  |- skos__hiddenLabel mesh__D000237 Basophil Adenomas
% 223.84/224.02  |- skos__prefLabel mesh__D000237 Adenoma, Basophil
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D000237 2002
% 223.84/224.02  |- mesh__recordOriginator mesh__D000237 NLM
% 223.84/224.02  |- mesh__recordAuthorizer mesh__D000237 sjn
% 223.84/224.02  |- mesh__recordMaintainer mesh__D000237 KEV
% 223.84/224.02  |- mesh__publicMeSHNote mesh__D000237
% 223.84/224.02       94; was ADENOMA, BASOPHILIC 1963-93   
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D000237 2001
% 223.84/224.02  |- skos__hiddenLabel mesh__D000237 Basophilic Adenoma
% 223.84/224.02  |- skos__broader mesh__D000237smesh__D000236
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D000237 2006
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D000237 2000
% 223.84/224.02  |- skos__broader mesh__D000237smesh__D018358
% 223.84/224.02  |- rdf__type mesh__D000237sskos__Concept
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D000237 2005
% 223.84/224.02  |- mesh__dateCreated mesh__D000237 1999-01-01
% 223.84/224.02  |- mesh__historyNote mesh__D005720
% 223.84/224.02       91%28%75%29%; was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1963-75%A%  
% 223.84/224.02  |- skos__hiddenLabel mesh__D005720 Radiations, Gamma
% 223.84/224.02  |- mesh__onlineNote mesh__D005720 search RADIATION 1966-74   
% 223.84/224.02  |- skos__broader mesh__D005720smesh__D011839
% 223.84/224.02  |- mesh__dateCreated mesh__D005720 1999-01-01
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D005720 2003
% 223.84/224.02  |- mesh__recordOriginator mesh__D005720 NLM
% 223.84/224.02  |- mesh__recordAuthorizer mesh__D005720 PLS
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D005720 2005
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D005720 2004
% 223.84/224.02  |- skos__annotation mesh__D005720
% 223.84/224.02       IM: Manual 28.11; TN 158: how to index gamma rays   
% 223.84/224.02  |- skos__altLabel mesh__D005720 Gamma Radiation
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D005720 2006
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D005720 2000
% 223.84/224.02  |- skos__hiddenLabel mesh__D005720 Gamma Ray
% 223.84/224.02  |- mesh__publicMeSHNote mesh__D005720
% 223.84/224.02       91; was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1963-75%A%  
% 223.84/224.02  |- skos__altLabel mesh__D005720 Radiation, Gamma
% 223.84/224.02  |- skos__hiddenLabel mesh__D005720 Rays, Gamma
% 223.84/224.02  |- skos__hiddenLabel mesh__D005720 Gamma Radiations
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D005720 2001
% 223.84/224.02  |- mesh__recordMaintainer mesh__D005720 TGC
% 223.84/224.02  |- skos__hiddenLabel mesh__D005720 Ray, Gamma
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D005720 1998
% 223.84/224.02  |- rdf__type mesh__D005720sskos__Concept
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D005720 1997
% 223.84/224.02  |- mesh__dateEstablished mesh__D005720 1991-01-01
% 223.84/224.02  |- skos__scopeNote mesh__D005720
% 223.84/224.02       Very powerful and penetrating, high-energy electromagnetic radiation of shorter wavelength than that of x-rays. They are emitted by a decaying nucleus, usually between 0.01 and 10 MeV. They are also called nuclear x-rays.%A%    
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D005720 1999
% 223.84/224.02  |- skos__prefLabel mesh__D005720 Gamma Rays
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D005720 2002
% 223.84/224.02  |- mesh__dateRevised mesh__D005720 1996-06-10
% 223.84/224.02  |- mesh__recordAuthorizer mesh__D018648 sjn
% 223.84/224.02  |- skos__related mesh__D018648smesh__D050661
% 223.84/224.02  |- rdf__type mesh__D018648sskos__Concept
% 223.84/224.02  |- mesh__dateRevised mesh__D018648 2005-06-30
% 223.84/224.02  |- mesh__recordMaintainer mesh__D018648 ags
% 223.84/224.02  |- mesh__dateEstablished mesh__D018648 1995-01-01
% 223.84/224.02  |- mesh__publicMeSHNote mesh__D018648 1995   
% 223.84/224.02  |- mesh__historyNote mesh__D018648 1995   
% 223.84/224.02  |- skos__scopeNote mesh__D018648
% 223.84/224.02       A gray substance found in the GASTROINTESTINAL TRACT of the SPERM WHALE.%A%    
% 223.84/224.02  |- mesh__recordOriginator mesh__D018648 TGC
% 223.84/224.02  |- skos__prefLabel mesh__D018648 Ambergris
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D018648 2006
% 223.84/224.02  |- skos__broader mesh__D018648smesh__D045424
% 223.84/224.02  |- mesh__dateCreated mesh__D018648 1994-04-19
% 223.84/224.02  |- skos__scopeNote mesh__D010665
% 223.84/224.02       A sympathomimetic that acts mainly by causing release of NOREPINEPHRINE but also has direct agonist activity at some adrenergic receptors. It is most commonly used as a nasal vasoconstrictor and an appetite depressant.%A%    
% 223.84/224.02  |- mesh__dateRevised mesh__D010665 2001-07-25
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D010665 2002
% 223.84/224.02  |- mesh__publicMeSHNote mesh__D010665
% 223.84/224.02       74; was see under SYMPATHOMIMETICS 1963-73   
% 223.84/224.02  |- skos__hiddenLabel mesh__D010665 Hydrochloride, Phenylpropanolamine
% 223.84/224.02  |- skos__altLabel mesh__D010665 Norephedrine
% 223.84/224.02  |- mesh__historyNote mesh__D010665
% 223.84/224.02       74%28%63%29%; was see under SYMPATHOMIMETICS 1963-73   
% 223.84/224.02  |- mesh__recordAuthorizer mesh__D010665 sjn
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D010665 2006
% 223.84/224.02  |- skos__broader mesh__D010665smesh__D011412
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D010665 2004
% 223.84/224.02  |- mesh__dateEstablished mesh__D010665 1974-01-01
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D010665 2005
% 223.84/224.02  |- mesh__dateCreated mesh__D010665 1999-01-01
% 223.84/224.02  |- mesh__recordMaintainer mesh__D010665 CCR
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D010665 2003
% 223.84/224.02  |- skos__prefLabel mesh__D010665 Phenylpropanolamine
% 223.84/224.02  |- mesh__recordOriginator mesh__D010665 NLM
% 223.84/224.02  |- rdf__type mesh__D010665sskos__Concept
% 223.84/224.02  |- skos__prefLabel mesh__D004628 Embryonic Structures
% 223.84/224.02  |- skos__historyNote mesh__D004628
% 223.84/224.02       specific organ/embryology %28%1968-1997%29%
% 223.84/224.02  |- mesh__dateEstablished mesh__D004628 1998-01-01
% 223.84/224.02  |- skos__hiddenLabel mesh__D004628 Structures, Embryonic
% 223.84/224.02  |- mesh__recordOriginator mesh__D004628 NLM
% 223.84/224.02  |- rdf__type mesh__D004628sskos__Concept
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D004628 2002
% 223.84/224.02  |- skos__hiddenLabel mesh__D004628 Structures, Fetal
% 223.84/224.02  |- mesh__historyNote mesh__D004628 98; use explode 1974-97   
% 223.84/224.02  |- skos__historyNote mesh__D004628
% 223.84/224.02       specific organism/embryology %28%1975-1997%29%
% 223.84/224.02  |- mesh__publicMeSHNote mesh__D004628 98   
% 223.84/224.02  |- skos__scopeNote mesh__D004628
% 223.84/224.02       The anatomical parts that make up an organism in the early stages of development.%A%    
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D004628 2003
% 223.84/224.02  |- mesh__runningHead mesh__D004628 A16 - ANATOMY-EMBRYONIC STRUCTURES   
% 223.84/224.02  |- mesh__dateRevised mesh__D004628 1999-11-03
% 223.84/224.02  |- skos__hiddenLabel mesh__D004628 Structure, Embryonic
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D004628 2004
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D004628 2000
% 223.84/224.02  |- skos__historyNote mesh__D004628 Embryo %28%1966-1997%29%
% 223.84/224.02  |- skos__hiddenLabel mesh__D004628 Structure, Prenatal
% 223.84/224.02  |- skos__hiddenLabel mesh__D004628 Structure, Fetal
% 223.84/224.02  |- skos__hiddenLabel mesh__D004628 Prenatal Structure
% 223.84/224.02  |- mesh__dateCreated mesh__D004628 1999-01-01
% 223.84/224.02  |- skos__annotation mesh__D004628
% 223.84/224.02       avoid: too inclusive; prefer EMBRYO %26% specific embryonic stage or Cat A %26% Cat B with /embryol; for plants, PLANT EMBRYOS see SEEDS is available%A%  
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D004628 2005
% 223.84/224.02  |- mesh__recordMaintainer mesh__D004628 KEV
% 223.84/224.02  |- mesh__recordAuthorizer mesh__D004628 sjn
% 223.84/224.02  |- skos__hiddenLabel mesh__D004628 Embryonic Structure
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D004628 2001
% 223.84/224.02  |- skos__hiddenLabel mesh__D004628 Fetal Structure
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D004628 2006
% 223.84/224.02  |- skos__hiddenLabel mesh__D004628 Structures, Prenatal
% 223.84/224.02  |- skos__historyNote mesh__D015350 Visual Perception %28%1972-1988%29%
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D015350 2006
% 223.84/224.02  |- skos__hiddenLabel mesh__D015350 Sensitivity, Visual Contrast
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D015350 2004
% 223.84/224.02  |- skos__altLabel mesh__D015350 Visual Contrast Sensitivity
% 223.84/224.02  |- skos__related mesh__D015350smesh__D005556
% 223.84/224.02  |- skos__historyNote mesh__D015350 Form Perception %28%1969-1988%29%
% 223.84/224.02  |- mesh__recordOriginator mesh__D015350 EC
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D015350 2005
% 223.84/224.02  |- skos__historyNote mesh__D015350 Visual Acuity %28%1972-1988%29%
% 223.84/224.02  |- mesh__historyNote mesh__D015350 89   
% 223.84/224.02  |- mesh__dateEstablished mesh__D015350 1989-01-01
% 223.84/224.02  |- skos__prefLabel mesh__D015350 Contrast Sensitivity
% 223.84/224.02  |- rdf__type mesh__D015350sskos__Concept
% 223.84/224.02  |- skos__broader mesh__D015350smesh__D005556
% 223.84/224.02  |- skos__hiddenLabel mesh__D015350 Sensitivity, Contrast
% 223.84/224.02  |- mesh__dateRevised mesh__D015350 2003-07-09
% 223.84/224.02  |- mesh__recordAuthorizer mesh__D015350 sjn
% 223.84/224.02  |- mesh__recordMaintainer mesh__D015350 nns
% 223.84/224.02  |- skos__broader mesh__D015350smesh__D014792
% 223.84/224.02  |- skos__hiddenLabel mesh__D015350 Contrast Sensitivity, Visual
% 223.84/224.02  |- mesh__publicMeSHNote mesh__D015350 89   
% 223.84/224.02  |- mesh__dateCreated mesh__D015350 1988-06-02
% 223.84/224.02  |- skos__scopeNote mesh__D015350
% 223.84/224.02       The ability to detect sharp boundaries %28%stimuli%29% and to detect slight changes in luminance at regions without distinct contours. Psychophysical measurements of this visual function are used to evaluate visual acuity and to detect eye disease.%A%    
% 223.84/224.02  |- skos__historyNote mesh__D015350 Sensory Thresholds %28%1979-1988%29%
% 223.84/224.02  |- skos__hiddenLabel mesh__D009313 Health Service, National
% 223.84/224.02  |- skos__altLabel mesh__D009313 National Health Services
% 223.84/224.02  |- skos__hiddenLabel mesh__D009313 Programs, National Health
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D009313 2006
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D009313 2001
% 223.84/224.02  |- skos__hiddenLabel mesh__D009313 National Health Service
% 223.84/224.02  |- skos__scopeNote mesh__D009313
% 223.84/224.02       Components of a national health care system which administer specific services, e.g., national health insurance.%A%    
% 223.84/224.02  |- skos__hiddenLabel mesh__D009313 Health Insurance, National
% 223.84/224.02  |- skos__prefLabel mesh__D009313 National Health Programs
% 223.84/224.02  |- mesh__recordMaintainer mesh__D009313 kle
% 223.84/224.02  |- mesh__dateRevised mesh__D009313 1999-11-03
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D009313 2005
% 223.84/224.02  |- mesh__recordAuthorizer mesh__D009313 sjn
% 223.84/224.02  |- skos__annotation mesh__D009313 specify country   
% 223.84/224.02  |- skos__hiddenLabel mesh__D009313 National Health Program
% 223.84/224.02  |- skos__hiddenLabel mesh__D009313 Insurance, National Health
% 223.84/224.02  |- mesh__dateEstablished mesh__D009313 1977-01-01
% 223.84/224.02  |- skos__hiddenLabel mesh__D009313 Health Programs, National
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D009313 2000
% 223.84/224.02  |- skos__broader mesh__D009313smesh__D006285
% 223.84/224.02  |- skos__altLabel mesh__D009313 National Health Insurance, Non U.S.
% 223.84/224.02  |- skos__altLabel mesh__D009313 Services, National Health
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D009313 2004
% 223.84/224.02  |- mesh__historyNote mesh__D009313
% 223.84/224.02       77%28%75%29%; was see under STATE MEDICINE 1963-76   
% 223.84/224.02  |- skos__related mesh__D009313smesh__D006078
% 223.84/224.02  |- skos__hiddenLabel mesh__D009313 Health Program, National
% 223.84/224.02  |- mesh__dateCreated mesh__D009313 1999-01-01
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D009313 2003
% 223.84/224.02  |- skos__hiddenLabel mesh__D009313 Service, National Health
% 223.84/224.02  |- skos__hiddenLabel mesh__D009313 Program, National Health
% 223.84/224.02  |- mesh__publicMeSHNote mesh__D009313
% 223.84/224.02       77; was see under STATE MEDICINE 1963-76   
% 223.84/224.02  |- mesh__onlineNote mesh__D009313 search STATE MEDICINE 1966-74   
% 223.84/224.02  |- rdf__type mesh__D009313sskos__Concept
% 223.84/224.02  |- mesh__recordOriginator mesh__D009313 NLM
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D009313 2002
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 Code, Bar
% 223.84/224.02  |- skos__altLabel mesh__D001330 Data Processing, Automatic
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 Processing, Information
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D001330 2005
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 Processing, Automatic Information
% 223.84/224.02  |- mesh__recordMaintainer mesh__D001330 jls
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 Readers, Optical
% 223.84/224.02  |- rdf__type mesh__D001330sskos__Concept
% 223.84/224.02  |- skos__altLabel mesh__D001330 Electronic Data Processing
% 223.84/224.02  |- skos__prefLabel mesh__D001330 Automatic Data Processing
% 223.84/224.02  |- skos__broader mesh__D001330smesh__D003205
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 Files, Data
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 Data Processing, Computer
% 223.84/224.02  |- mesh__recordAuthorizer mesh__D001330 sjn
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 Data Processing, Electronic
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 Processing, Automatic Data
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 Files, Machine-Readable Data
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 Data File
% 223.84/224.02  |- skos__scopeNote mesh__D001330
% 223.84/224.02       Data processing largely performed by automatic means.     
% 223.84/224.02  |- skos__altLabel mesh__D001330 Computer Data Processing
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 Data Files, Machine-Readable
% 223.84/224.02  |- skos__annotation mesh__D001330
% 223.84/224.02       GEN %26% unspecified only: prefer specific informatics %26% computer terms available%A%  
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 Machine-Readable Data File
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 Codes, Bar
% 223.84/224.02  |- mesh__dateRevised mesh__D001330 2004-07-07
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 Reader, Optical
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 Processing, Electronic Data
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 Processing, Computer Data
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 Bar Code
% 223.84/224.02  |- mesh__recordOriginator mesh__D001330 NLM
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 Optical Reader
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 File, Machine-Readable Data
% 223.84/224.02  |- mesh__dateCreated mesh__D001330 1999-01-01
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 File, Data
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 Machine Readable Data Files
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 Data File, Machine-Readable
% 223.84/224.02  |- skos__hiddenLabel mesh__D001330 Automatic Information Processing
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D001330 2006
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Tumors, Midbrain
% 223.84/224.02  |- skos__altLabel mesh__D020295 Neoplasms, Medullary
% 223.84/224.02  |- skos__altLabel mesh__D020295 Brainstem Neoplasms
% 223.84/224.02  |- mesh__historyNote mesh__D020295 2000   
% 223.84/224.02  |- skos__broader mesh__D020295smesh__D015192
% 223.84/224.02  |- skos__historyNote mesh__D020295 Brain Neoplasms %28%1970-1999%29%
% 223.84/224.02  |- mesh__dateCreated mesh__D020295 1999-11-08
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Mesencephalic Neoplasm
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D020295 2004
% 223.84/224.02  |- skos__altLabel mesh__D020295 Medullary Tumors
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Neoplasm, Pontine
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Neoplasm, Medullary
% 223.84/224.02  |- skos__altLabel mesh__D020295 Neoplasms, Brainstem
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Brainstem Neoplasm
% 223.84/224.02  |- skos__altLabel mesh__D020295 Neoplasms, Pontine
% 223.84/224.02  |- rdf__type mesh__D020295sskos__Concept
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Neoplasm, Mesencephalic
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Medullary Neoplasm
% 223.84/224.02  |- skos__altLabel mesh__D020295 Midbrain Neoplasms
% 223.84/224.02  |- skos__altLabel mesh__D020295 Pontine Neoplasms
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D020295 2003
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Tumor, Midbrain
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Neoplasm, Brainstem
% 223.84/224.02  |- skos__altLabel mesh__D020295 Brainstem Tumors
% 223.84/224.02  |- mesh__publicMeSHNote mesh__D020295 2000   
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Tumor, Pontine
% 223.84/224.02  |- skos__prefLabel mesh__D020295 Brain Stem Neoplasms
% 223.84/224.02  |- skos__altLabel mesh__D020295 Neoplasms, Mesencephalic
% 223.84/224.02  |- skos__annotation mesh__D020295
% 223.84/224.02       coord IM with histol type of neopl %28%IM%29%   
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D020295 2002
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Neoplasm, Midbrain
% 223.84/224.02  |- mesh__dateEstablished mesh__D020295 2000-01-01
% 223.84/224.02  |- skos__altLabel mesh__D020295 Brain Stem Tumors
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Brainstem Tumor
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Midbrain Neoplasm
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Medullary Tumor
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Tumor, Brain Stem
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Neoplasm, Brain Stem
% 223.84/224.02  |- skos__altLabel mesh__D020295 Brainstem Neoplasms, Primary
% 223.84/224.02  |- skos__scopeNote mesh__D020295
% 223.84/224.02       Benign and malignant intra-axial tumors of the MESENCEPHALON; PONS; or MEDULLA OBLONGATA of the BRAIN STEM. Primary and metastatic neoplasms may occur in this location. Clinical features include ATAXIA, cranial neuropathies %28%see CRANIAL NERVE DISEASES%29%, NAUSEA, hemiparesis %28%see HEMIPLEGIA%29%, and quadriparesis. Primary brain stem neoplasms are more frequent in children. Histologic subtypes include GLIOMA; HEMANGIOBLASTOMA; GANGLIOGLIOMA; and EPENDYMOMA.%A%    
% 223.84/224.02  |- skos__altLabel mesh__D020295 Midbrain Tumors
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Brainstem Neoplasm, Primary
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D020295 2006
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D020295 2001
% 223.84/224.02  |- skos__historyNote mesh__D020295 Brain Stem %28%1966-1999%29%
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Brain Stem Neoplasm
% 223.84/224.02  |- skos__altLabel mesh__D020295 Neoplasms, Brainstem, Primary
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Tumor, Medullary
% 223.84/224.02  |- skos__altLabel mesh__D020295 Primary Brain Stem Neoplasms
% 223.84/224.02  |- skos__altLabel mesh__D020295 Neoplasms, Midbrain
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Brain Stem Tumor
% 223.84/224.02  |- skos__altLabel mesh__D020295 Neoplasms, Brain Stem
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Midbrain Tumor
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Tumors, Pontine
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Pontine Neoplasm
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Primary Brainstem Neoplasm
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Pontine Tumor
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D020295 2005
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Tumors, Medullary
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Neoplasm, Primary Brainstem
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D020295 2000
% 223.84/224.02  |- skos__hiddenLabel mesh__D020295 Neoplasms, Primary Brainstem
% 223.84/224.02  |- skos__altLabel mesh__D020295 Primary Brainstem Neoplasms
% 223.84/224.02  |- skos__scopeNote mesh__D014258
% 223.84/224.02       A genus of nematode worms comprising the whipworms.     
% 223.84/224.02  |- mesh__onlineNote mesh__D014258
% 223.84/224.02       search TRICHUROIDEA 1966-71; use TRICHUROIDEA to search TRICHOCEPHALUS 1966-73%A%  
% 223.84/224.02  |- mesh__dateCreated mesh__D014258 1999-01-01
% 223.84/224.02  |- skos__broader mesh__D014258smesh__D014259
% 223.84/224.02  |- skos__altLabel mesh__D014258 Trichocephalus
% 223.84/224.02  |- mesh__recordOriginator mesh__D014258 NLM
% 223.84/224.02  |- rdf__type mesh__D014258sskos__Concept
% 223.84/224.02  |- mesh__recordMaintainer mesh__D014258 ags
% 223.84/224.02  |- mesh__historyNote mesh__D014258
% 223.84/224.02       72; was see under TRICHUROIDEA 1967-71, was see under TRICHINELLOIDEA 1963-66; TRICHOCEPHALUS was see under TRICHURIS 1974-78, was see under TRICHUROIDEA 1967-73, was see under TRICHINELLOIDEA 1963-66%A%  
% 223.84/224.02  |- mesh__dateRevised mesh__D014258 2003-07-09
% 223.84/224.02  |- mesh__dateEstablished mesh__D014258 1972-01-01
% 223.84/224.02  |- mesh__recordAuthorizer mesh__D014258 sjn
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D014258 2004
% 223.84/224.02  |- skos__annotation mesh__D014258
% 223.84/224.02       a genus of nematodes called whipworms; infection = TRICHURIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D014258 2006
% 223.84/224.02  |- mesh__publicMeSHNote mesh__D014258
% 223.84/224.02       72; was see under TRICHUROIDEA 1967-71, was see under TRICHINELLOIDEA 1963-66; TRICHOCEPHALUS was see under TRICHUROIDEA 1967-73, was see under TRICHINELLOIDEA 1963-66%A%  
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D014258 2005
% 223.84/224.02  |- skos__prefLabel mesh__D014258 Trichuris
% 223.84/224.02  |- skos__altLabel mesh__D019741 Hemophilus influenzae type b
% 223.84/224.02  |- skos__broader mesh__D019741smesh__D006193
% 223.84/224.02  |- skos__historyNote mesh__D019741 Haemophilus influenzae %28%1966-1997%29%
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D019741 2006
% 223.84/224.02  |- skos__annotation mesh__D019741
% 223.84/224.02       infection: coord IM with HAEMOPHILUS INFECTIONS %28%IM%29% or MENINGITIS, HAEMOPHILUS %28%IM%29%; vaccine = HAEMOPHILUS VACCINES%A%  
% 223.84/224.02  |- mesh__publicMeSHNote mesh__D019741 98   
% 223.84/224.02  |- mesh__dateCreated mesh__D019741 1997-06-20
% 223.84/224.02  |- skos__scopeNote mesh__D019741
% 223.84/224.02       A type of H. influenzae isolated most frequently from biotype I. Prior to vaccine availability, it was a leading cause of childhood meningitis.%A%    
% 223.84/224.02  |- mesh__recordOriginator mesh__D019741 NDW
% 223.84/224.02  |- rdf__type mesh__D019741sskos__Concept
% 223.84/224.02  |- mesh__recordAuthorizer mesh__D019741 sjn
% 223.84/224.02  |- mesh__dateEstablished mesh__D019741 1998-01-01
% 223.84/224.02  |- mesh__recordMaintainer mesh__D019741 SYSTEM
% 223.84/224.02  |- skos__related mesh__D019741smesh__D008583
% 223.84/224.02  |- mesh__historyNote mesh__D019741 98   
% 223.84/224.02  |- skos__prefLabel mesh__D019741 Haemophilus influenzae type b
% 223.84/224.02  |- skos__altLabel mesh__D019741 Hib
% 223.84/224.02  |- mesh__dateRevised mesh__D019741 2005-06-30
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D000238 2003
% 223.84/224.02  |- skos__prefLabel mesh__D000238 Adenoma, Chromophobe
% 223.84/224.02  |- mesh__dateRevised mesh__D000238 1999-11-03
% 223.84/224.02  |- mesh__recordMaintainer mesh__D000238 jls
% 223.84/224.02  |- skos__hiddenLabel mesh__D000238 Chromophobe Adenomas
% 223.84/224.02  |- skos__related mesh__D000238smesh__D010911
% 223.84/224.02  |- skos__annotation mesh__D000238
% 223.84/224.02       coord IM with PITUITARY NEOPLASMS %28%IM%29%   
% 223.84/224.02  |- skos__hiddenLabel mesh__D000238 Chromophobe Adenoma
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D000238 2006
% 223.84/224.02  |- skos__broader mesh__D000238smesh__D018358
% 223.84/224.02  |- rdf__type mesh__D000238sskos__Concept
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D000238 2002
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D000238 2005
% 223.84/224.02  |- mesh__recordOriginator mesh__D000238 NLM
% 223.84/224.02  |- mesh__recordAuthorizer mesh__D000238 sjn
% 223.84/224.02  |- mesh__dateCreated mesh__D000238 1999-01-01
% 223.84/224.02  |- mesh__activeMeSHYear mesh__D000238 2001
% 223.84/224.03  |- skos__broader mesh__D000238smesh__D000236
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D000238 2004
% 223.84/224.03  |- skos__hiddenLabel mesh__D000238 Adenomas, Chromophobe
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D000238 2000
% 223.84/224.03  |- skos__scopeNote mesh__D000238
% 223.84/224.03       A benign tumor of the anterior pituitary in which the cells do not stain with acidic or basic dyes.%A%    
% 223.84/224.03  |- skos__historyNote mesh__D005721 Peptide Synthetases %28%1973-1976%29%
% 223.84/224.03  |- skos__hiddenLabel mesh__D005721 Synthetase, gamma-Glutamyl-Cysteine
% 223.84/224.03  |- mesh__dateRevised mesh__D005721 2003-07-09
% 223.84/224.03  |- skos__prefLabel mesh__D005721 Glutamate-Cysteine Ligase
% 223.84/224.03  |- skos__hiddenLabel mesh__D005721 Synthetase, Glutamylcysteine
% 223.84/224.03  |- mesh__dateCreated mesh__D005721 1976-05-19
% 223.84/224.03  |- skos__hiddenLabel mesh__D005721 gamma Glutamyl Cysteine Synthetase
% 223.84/224.03  |- skos__historyNote mesh__D005721 Cysteine %28%1973-1976%29%
% 223.84/224.03  |- skos__historyNote mesh__D005721 Glutamates %28%1973-1976%29%
% 223.84/224.03  |- mesh__dateEstablished mesh__D005721 1991-01-01
% 223.84/224.03  |- skos__altLabel mesh__D005721 Glutamylcysteine Synthetase
% 223.84/224.03  |- mesh__recordMaintainer mesh__D005721 ssb
% 223.84/224.03  |- mesh__historyNote mesh__D005721 98%28%77%29%   
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D005721 2004
% 223.84/224.03  |- mesh__recordOriginator mesh__D005721 RLS
% 223.84/224.03  |- mesh__recordAuthorizer mesh__D005721 sjn
% 223.84/224.03  |- skos__hiddenLabel mesh__D005721 Ligase, Glutamate-Cysteine
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D005721 2006
% 223.84/224.03  |- skos__altLabel mesh__D005721 gamma-Glutamyl-Cysteine Synthetase
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D005721 2005
% 223.84/224.03  |- skos__scopeNote mesh__D005721
% 223.84/224.03       One of the enzymes active in the gamma-glutamyl cycle. It catalyzes the synthesis of gamma-glutamylcysteine from glutamate and cysteine in the presence of ATP with the formation of ADP and orthophosphate. EC 6.3.2.2.%A%    
% 223.84/224.03  |- skos__hiddenLabel mesh__D005721 Glutamate Cysteine Ligase
% 223.84/224.03  |- skos__broader mesh__D005721smesh__D010453
% 223.84/224.03  |- rdf__type mesh__D005721sskos__Concept
% 223.84/224.03  |- mesh__publicMeSHNote mesh__D005721
% 223.84/224.03       98; see GAMMA-GLUTAMYL-CYSTEINE SYNTHETASE 1991-97; see PEPTIDE SYNTHETASES 1977-90%A%  
% 223.84/224.03  |- mesh__historyNote mesh__D018649 2003%28%1995%29%   
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D018649 2005
% 223.84/224.03  |- rdf__type mesh__D018649sskos__Concept
% 223.84/224.03  |- skos__scopeNote mesh__D018649
% 223.84/224.03       A plant species of the genus OCIMUM, family LAMIACEAE. It is a condiment with carminative properties.%A%    
% 223.84/224.03  |- skos__altLabel mesh__D018649 Sweet Basil
% 223.84/224.03  |- mesh__recordOriginator mesh__D018649 TPW
% 223.84/224.03  |- skos__annotation mesh__D018649
% 223.84/224.03       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.84/224.03  |- mesh__dateEstablished mesh__D018649 1995-01-01
% 223.84/224.03  |- skos__altLabel mesh__D018649 Basil
% 223.84/224.03  |- mesh__recordMaintainer mesh__D018649 ssb
% 223.84/224.03  |- mesh__dateRevised mesh__D018649 2002-07-02
% 223.84/224.03  |- mesh__publicMeSHNote mesh__D018649 2003; see BASIL 1995-2002   
% 223.84/224.03  |- mesh__dateCreated mesh__D018649 1994-04-19
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D018649 2004
% 223.84/224.03  |- mesh__recordAuthorizer mesh__D018649 sjn
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D018649 2003
% 223.84/224.03  |- skos__broader mesh__D018649smesh__D031339
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D018649 2006
% 223.84/224.03  |- skos__prefLabel mesh__D018649 Ocimum basilicum
% 223.84/224.03  |- mesh__recordAuthorizer mesh__D010666 PLS
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010666 2006
% 223.84/224.03  |- mesh__historyNote mesh__D010666 74   
% 223.84/224.03  |- mesh__recordMaintainer mesh__D010666 TAP
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010666 2001
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010666 2004
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010666 1995
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010666 2005
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010666 1993
% 223.84/224.03  |- mesh__dateCreated mesh__D010666 1999-01-01
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010666 2000
% 223.84/224.03  |- mesh__recordOriginator mesh__D010666 NLM
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010666 1999
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010666 2003
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010666 1994
% 223.84/224.03  |- skos__prefLabel mesh__D010666 Phenylpropionates
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010666 1997
% 223.84/224.03  |- mesh__dateRevised mesh__D010666 1992-05-19
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010666 1998
% 223.84/224.03  |- mesh__publicMeSHNote mesh__D010666
% 223.84/224.03       74; KETOPROFEN was see under BENZOPHENONES 1975-77   
% 223.84/224.03  |- rdf__type mesh__D010666sskos__Concept
% 223.84/224.03  |- skos__broader mesh__D010666smesh__D000146
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010666 1996
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010666 2002
% 223.84/224.03  |- mesh__dateEstablished mesh__D010666 1974-01-01
% 223.84/224.03  |- skos__historyNote mesh__D004629 Benzene Derivatives %28%1974%29%
% 223.84/224.03  |- mesh__historyNote mesh__D004629
% 223.84/224.03       91%28%75%29%; was see under AMMONIUM COMPOUNDS 1975-90   
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D004629 2006
% 223.84/224.03  |- mesh__recordAuthorizer mesh__D004629 sjn
% 223.84/224.03  |- mesh__publicMeSHNote mesh__D004629
% 223.84/224.03       91; was see under AMMONIUM COMPOUNDS 1975-90   
% 223.84/224.03  |- rdf__type mesh__D004629sskos__Concept
% 223.84/224.03  |- mesh__recordMaintainer mesh__D004629 ssb
% 223.84/224.03  |- skos__prefLabel mesh__D004629 Emepronium
% 223.84/224.03  |- mesh__dateEstablished mesh__D004629 1991-01-01
% 223.84/224.03  |- mesh__recordOriginator mesh__D004629 NLM
% 223.84/224.03  |- skos__historyNote mesh__D004629 Ammonium Compounds %28%1970-1974%29%
% 223.84/224.03  |- mesh__dateRevised mesh__D004629 2005-06-30
% 223.84/224.03  |- skos__broader mesh__D004629smesh__D000644
% 223.84/224.03  |- skos__hiddenLabel mesh__D004629 Bromide, Emepronium
% 223.84/224.03  |- skos__scopeNote mesh__D004629
% 223.84/224.03       A muscarinic antagonist used mainly in the treatment of urinary syndromes. It is incompletely absorbed from the gastrointestinal tract and does not cross the blood-brain barrier.%A%    
% 223.84/224.03  |- mesh__dateCreated mesh__D004629 1974-11-19
% 223.84/224.03  |- skos__hiddenLabel mesh__D015351 Vision Screenings
% 223.84/224.03  |- mesh__recordAuthorizer mesh__D015351 sjn
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D015351 2005
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D015351 2002
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D015351 2003
% 223.84/224.03  |- mesh__dateEstablished mesh__D015351 1989-01-01
% 223.84/224.03  |- rdf__type mesh__D015351sskos__Concept
% 223.84/224.03  |- skos__scopeNote mesh__D015351
% 223.84/224.03       Application of tests and examinations to identify visual defects or vision disorders occurring in specific populations, as in school children, the elderly, etc. It is differentiated from VISION TESTS, which are given to evaluate/measure individual visual performance not related to a specific population.%A%    
% 223.84/224.03  |- skos__historyNote mesh__D015351 Vision Tests %28%1966-1988%29%
% 223.84/224.03  |- mesh__recordOriginator mesh__D015351 EC
% 223.84/224.03  |- mesh__historyNote mesh__D015351 89   
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D015351 2001
% 223.84/224.03  |- skos__prefLabel mesh__D015351 Vision Screening
% 223.84/224.03  |- skos__hiddenLabel mesh__D015351 Screenings, Vision
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D015351 2000
% 223.84/224.03  |- mesh__publicMeSHNote mesh__D015351 89   
% 223.84/224.03  |- mesh__dateCreated mesh__D015351 1988-06-02
% 223.84/224.03  |- skos__hiddenLabel mesh__D015351 Screening, Vision
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D015351 2006
% 223.84/224.03  |- mesh__recordMaintainer mesh__D015351 kle
% 223.84/224.03  |- mesh__dateRevised mesh__D015351 1999-11-03
% 223.84/224.03  |- skos__historyNote mesh__D015351 Mass Screening %28%1966-1988%29%
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D015351 2004
% 223.84/224.03  |- skos__annotation mesh__D015351
% 223.84/224.03       on an epidemiol or population level: do not confuse with VISION TESTS on a personal level; coord with disease /diag or /epidemiol or /prev%A%  
% 223.84/224.03  |- skos__broader mesh__D015351smesh__D014787
% 223.84/224.03  |- skos__broader mesh__D015351smesh__D008403
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D009314 2005
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D009314 2002
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D009314 1999
% 223.84/224.03  |- skos__annotation mesh__D009314
% 223.84/224.03       add UNITED STATES %28%NIM%29%; research support by this agency is checked as NIH/PHS SUP; DF: NIOSH      CATALOG: use NAF entry%A%  
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D009314 2004
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D009314 2001
% 223.84/224.03  |- mesh__recordAuthorizer mesh__D009314 SJN
% 223.84/224.03  |- mesh__dateEstablished mesh__D009314 1991-01-01
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D009314 1998
% 223.84/224.03  |- mesh__publicMeSHNote mesh__D009314
% 223.84/224.03       91; was see under CENTERS FOR DISEASE CONTROL %28%U.S.%29% 1984-90%A%  
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D009314 2003
% 223.84/224.03  |- mesh__recordOriginator mesh__D009314 EC
% 223.84/224.03  |- skos__broader mesh__D009314smesh__D002487
% 223.84/224.03  |- skos__scopeNote mesh__D009314
% 223.84/224.03       An institute of the CENTERS FOR DISEASE CONTROL AND PREVENTION which is responsible for assuring safe and healthful working conditions and for developing standards of safety and health. Research activities are carried out pertinent to these goals.%A%    
% 223.84/224.03  |- mesh__dateCreated mesh__D009314 1983-06-13
% 223.84/224.03  |- skos__altLabel mesh__D009314
% 223.84/224.03       National Institute for Occupational Safety and Health %28%U.S.%29%
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D009314 2000
% 223.84/224.03  |- rdf__type mesh__D009314sskos__Concept
% 223.84/224.03  |- mesh__dateRevised mesh__D009314 1997-06-20
% 223.84/224.03  |- skos__prefLabel mesh__D009314
% 223.84/224.03       National Institute for Occupational Safety and Health
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D009314 2006
% 223.84/224.03  |- mesh__historyNote mesh__D009314
% 223.84/224.03       91%28%84%29%; was see under CENTERS FOR DISEASE CONTROL %28%U.S.%29% 1984-90%A%  
% 223.84/224.03  |- mesh__recordMaintainer mesh__D009314 PXP
% 223.84/224.03  |- skos__prefLabel mesh__D001331 Automation
% 223.84/224.03  |- mesh__recordOriginator mesh__D001331 NLM
% 223.84/224.03  |- skos__scopeNote mesh__D001331
% 223.84/224.03       Controlled operation of an apparatus, process, or system by mechanical or electronic devices that take the place of human organs of observation, effort, and decision. %28%From Webster%27%s Collegiate Dictionary, 1993%29%%A%    
% 223.84/224.03  |- mesh__dateCreated mesh__D001331 1999-01-01
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D001331 2006
% 223.84/224.03  |- skos__broader mesh__D001331smesh__D013672
% 223.84/224.03  |- mesh__recordMaintainer mesh__D001331 sjn
% 223.84/224.03  |- skos__hiddenLabel mesh__D001331 Automations
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D001331 2005
% 223.84/224.03  |- mesh__recordAuthorizer mesh__D001331 sjn
% 223.84/224.03  |- mesh__dateRevised mesh__D001331 2004-07-13
% 223.84/224.03  |- skos__annotation mesh__D001331
% 223.84/224.03       for automation as a concept in technol: not for %22%automated%22% equipment or %22%automated%22% processes %26% techniques %28% = specific technique without AUTOMATION unless especially discussed%29%%A%  
% 223.84/224.03  |- rdf__type mesh__D001331sskos__Concept
% 223.84/224.03  |- skos__hiddenLabel mesh__D020296 Congenic Animal
% 223.84/224.03  |- mesh__recordMaintainer mesh__D020296 nns
% 223.84/224.03  |- mesh__dateCreated mesh__D020296 1998-06-10
% 223.84/224.03  |- mesh__recordOriginator mesh__D020296 NDW
% 223.84/224.03  |- skos__altLabel mesh__D020296 Animals, Coisogenic
% 223.84/224.03  |- mesh__publicMeSHNote mesh__D020296 99   
% 223.84/224.03  |- mesh__dateEstablished mesh__D020296 1999-01-01
% 223.84/224.03  |- mesh__dateRevised mesh__D020296 2004-07-07
% 223.84/224.03  |- skos__hiddenLabel mesh__D020296 Coisogenic Animal
% 223.84/224.03  |- skos__scopeNote mesh__D020296
% 223.84/224.03       Inbred strains of animals that are genetically identical except at a single locus, or a few specified loci, so that their known genetic differences are expressed in the same genetic background. A congenic strain is produced by outbreeding a strain and then eliminating the background by many generations of backcrosses while maintaining the desired genetic differences by selection of progeny. %28%Dorland, 28th ed%29%%A%    
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D020296 2005
% 223.84/224.03  |- skos__annotation mesh__D020296
% 223.84/224.03       coord with specific congenic animal; NIM when exper animal%A%  
% 223.84/224.03  |- mesh__historyNote mesh__D020296 99   
% 223.84/224.03  |- skos__hiddenLabel mesh__D020296 Congenic Animals
% 223.84/224.03  |- skos__broader mesh__D020296smesh__D000830
% 223.84/224.03  |- skos__prefLabel mesh__D020296 Animals, Congenic
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D020296 2006
% 223.84/224.03  |- skos__hiddenLabel mesh__D020296 Coisogenic Animals
% 223.84/224.03  |- rdf__type mesh__D020296sskos__Concept
% 223.84/224.03  |- mesh__recordAuthorizer mesh__D020296 sjn
% 223.84/224.03  |- skos__hiddenLabel mesh__D020296 Animal, Coisogenic
% 223.84/224.03  |- skos__broader mesh__D020296smesh__D017849
% 223.84/224.03  |- skos__hiddenLabel mesh__D020296 Animal, Congenic
% 223.84/224.03  |- mesh__dateEstablished mesh__D014259 1967-01-01
% 223.84/224.03  |- mesh__historyNote mesh__D014259
% 223.84/224.03       67; was TRICHINELLOIDEA 1963-66; TRICHINELLOIDEA was see TRICHUROIDEA 1967-92%A%  
% 223.84/224.03  |- mesh__recordMaintainer mesh__D014259 ags
% 223.84/224.03  |- skos__broader mesh__D014259smesh__D017158
% 223.84/224.03  |- skos__scopeNote mesh__D014259
% 223.84/224.03       A superfamily of nematodes of the order ENOPLIDA. Its organisms have a well developed intestine and rectum.%A%    
% 223.84/224.03  |- mesh__onlineNote mesh__D014259
% 223.84/224.03       use TRICHUROIDEA to search TRICHINELLOIDEA 1966-92   
% 223.84/224.03  |- rdf__type mesh__D014259sskos__Concept
% 223.84/224.03  |- mesh__dateRevised mesh__D014259 2003-07-09
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D014259 2005
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D014259 2004
% 223.84/224.03  |- mesh__recordOriginator mesh__D014259 NLM
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D014259 2006
% 223.84/224.03  |- skos__annotation mesh__D014259
% 223.84/224.03       a superfamily of nematodes; infection: coord IM with ENOPLIDA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 223.84/224.03  |- mesh__dateCreated mesh__D014259 1999-01-01
% 223.84/224.03  |- mesh__publicMeSHNote mesh__D014259
% 223.84/224.03       67; was TRICHINELLOIDEA 1963-66; TRICHINELLOIDEA was see TRICHUROIDEA 1967-92%A%  
% 223.84/224.03  |- mesh__recordAuthorizer mesh__D014259 sjn
% 223.84/224.03  |- skos__prefLabel mesh__D014259 Trichuroidea
% 223.84/224.03  |- rdf__type mesh__D019742sskos__Concept
% 223.84/224.03  |- skos__altLabel mesh__D019742 beta-Chemokines
% 223.84/224.03  |- skos__scopeNote mesh__D019742
% 223.84/224.03       Group of chemokines with adjacent cysteines that are chemoattractants for lymphocytes, monocytes, eosinophils, basophils but not neutrophils.%A%    
% 223.84/224.03  |- skos__historyNote mesh__D019742 Chemotactic Factors %28%1992-1997%29%
% 223.84/224.03  |- mesh__dateRevised mesh__D019742 2005-06-30
% 223.84/224.03  |- mesh__historyNote mesh__D019742 98   
% 223.84/224.03  |- skos__hiddenLabel mesh__D019742 C C Chemokines
% 223.84/224.03  |- skos__prefLabel mesh__D019742 Chemokines, CC
% 223.84/224.03  |- skos__historyNote mesh__D019742 Cytokines %28%1992-1995%29%
% 223.84/224.03  |- skos__altLabel mesh__D019742 C-C Chemokines
% 223.84/224.03  |- skos__broader mesh__D019742smesh__D018925
% 223.84/224.03  |- skos__historyNote mesh__D019742 Chemokines %28%1996-1997%29%
% 223.84/224.03  |- skos__hiddenLabel mesh__D019742 Chemokines, C-C
% 223.84/224.03  |- mesh__recordMaintainer mesh__D019742 ssb
% 223.84/224.03  |- mesh__publicMeSHNote mesh__D019742 98   
% 223.84/224.03  |- mesh__dateCreated mesh__D019742 1997-06-20
% 223.84/224.03  |- mesh__recordOriginator mesh__D019742 AGS
% 223.84/224.03  |- skos__annotation mesh__D019742
% 223.84/224.03       do not confuse with CHEMOKINES, C or CHEMOKINES, CXC   
% 223.84/224.03  |- mesh__dateEstablished mesh__D019742 1998-01-01
% 223.84/224.03  |- skos__hiddenLabel mesh__D019742 beta Chemokines
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D019742 2006
% 223.84/224.03  |- mesh__recordAuthorizer mesh__D019742 sjn
% 223.84/224.03  |- skos__altLabel mesh__D019742 CC Chemokines
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D000239 2002
% 223.84/224.03  |- skos__altLabel mesh__D000239 Adenoma, Acidophilic
% 223.84/224.03  |- mesh__historyNote mesh__D000239 94; was ADENOMA, EOSINOPHILIC 1963-93   
% 223.84/224.03  |- mesh__onlineNote mesh__D000239
% 223.84/224.03       use ADENOMA, ACIDOPHIL to search ADENOMA, EOSINOPHILIC 1966-93%A%  
% 223.84/224.03  |- mesh__publicMeSHNote mesh__D000239
% 223.84/224.03       94; was ADENOMA, EOSINOPHILIC 1963-93   
% 223.84/224.03  |- mesh__recordAuthorizer mesh__D000239 sjn
% 223.84/224.03  |- skos__hiddenLabel mesh__D000239 Adenomas, Acidophil
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D000239 2006
% 223.84/224.03  |- mesh__recordOriginator mesh__D000239 NLM
% 223.84/224.03  |- rdf__type mesh__D000239sskos__Concept
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D000239 2001
% 223.84/224.03  |- skos__hiddenLabel mesh__D000239 Acidophil Adenomas
% 223.84/224.03  |- skos__broader mesh__D000239smesh__D018358
% 223.84/224.03  |- skos__hiddenLabel mesh__D000239 Eosinophilic Adenomas
% 223.84/224.03  |- skos__broader mesh__D000239smesh__D000236
% 223.84/224.03  |- mesh__dateCreated mesh__D000239 1999-01-01
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D000239 2000
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D000239 2005
% 223.84/224.03  |- skos__hiddenLabel mesh__D000239 Acidophil Adenoma
% 223.84/224.03  |- skos__altLabel mesh__D000239 Adenoma, Eosinophilic
% 223.84/224.03  |- skos__hiddenLabel mesh__D000239 Acidophilic Adenoma
% 223.84/224.03  |- skos__hiddenLabel mesh__D000239 Eosinophil Adenomas
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D000239 2004
% 223.84/224.03  |- skos__hiddenLabel mesh__D000239 Eosinophil Adenoma
% 223.84/224.03  |- skos__hiddenLabel mesh__D000239 Acidophilic Adenomas
% 223.84/224.03  |- skos__altLabel mesh__D000239 Adenoma, Eosinophil
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D000239 2003
% 223.84/224.03  |- skos__hiddenLabel mesh__D000239 Adenomas, Eosinophilic
% 223.84/224.03  |- mesh__dateRevised mesh__D000239 1999-11-08
% 223.84/224.03  |- skos__hiddenLabel mesh__D000239 Eosinophilic Adenoma
% 223.84/224.03  |- skos__related mesh__D000239smesh__D010911
% 223.84/224.03  |- skos__annotation mesh__D000239
% 223.84/224.03       /blood supply /chem /secret /ultrastruct permitted; coord IM with PITUITARY NEOPLASMS %28%IM%29%%A%  
% 223.84/224.03  |- skos__related mesh__D000239smesh__D005877
% 223.84/224.03  |- skos__prefLabel mesh__D000239 Adenoma, Acidophil
% 223.84/224.03  |- skos__related mesh__D000239smesh__D000172
% 223.84/224.03  |- skos__hiddenLabel mesh__D000239 Adenomas, Eosinophil
% 223.84/224.03  |- skos__scopeNote mesh__D000239
% 223.84/224.03       A benign tumor, usually found in the anterior lobe of the pituitary gland, whose cells stain with acid dyes. Such pituitary tumors may give rise to excessive secretion of growth hormone, resulting in gigantism or acromegaly. A specific type of acidophil adenoma may give rise to nonpuerperal galactorrhea. %28%Dorland, 27th ed%29%%A%    
% 223.84/224.03  |- skos__hiddenLabel mesh__D000239 Adenomas, Acidophilic
% 223.84/224.03  |- mesh__recordMaintainer mesh__D000239 KEV
% 223.84/224.03  |- skos__broader mesh__D005722smesh__D019881
% 223.84/224.03  |- mesh__dateEstablished mesh__D005722 1991-01-01
% 223.84/224.03  |- skos__hiddenLabel mesh__D005722 Cyclotransferase, gamma-Glutamylamine
% 223.84/224.03  |- skos__hiddenLabel mesh__D005722 gamma Glutamylamine Cyclotransferase
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D005722 2004
% 223.84/224.03  |- skos__annotation mesh__D005722
% 223.84/224.03       do not confuse with GAMMA-GLUTAMYLTRANSFERASE   
% 223.84/224.03  |- skos__historyNote mesh__D005722 Glutamates %28%1970-1974%29%
% 223.84/224.03  |- skos__altLabel mesh__D005722 gamma-Glutamylamine Cyclotransferase
% 223.84/224.03  |- skos__hiddenLabel mesh__D005722 gamma Glutamylcyclotransferase
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D005722 2006
% 223.84/224.03  |- mesh__recordMaintainer mesh__D005722 ssb
% 223.84/224.03  |- skos__scopeNote mesh__D005722
% 223.84/224.03       An enzyme that catalyzes the synthesis of pyroglutamate from a gamma-glutamyl-amino acid, also releasing the free amino acid. The enzyme acts on derivatives of glutamate, 2-aminobutyrate, alanine and glycine. The enzyme has been proposed to have a role in a gamma-glutamyl cycle for amino acid transport into cells in the intestines. EC 2.3.2.4.%A%    
% 223.84/224.03  |- mesh__publicMeSHNote mesh__D005722
% 223.84/224.03       91; was see under ACYLTRANSFERASES 1975-90   
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D005722 2005
% 223.84/224.03  |- skos__historyNote mesh__D005722
% 223.84/224.03       Pyrrolidonecarboxylic Acid %28%1972-1974%29%
% 223.84/224.03  |- mesh__recordAuthorizer mesh__D005722 sjn
% 223.84/224.03  |- mesh__recordOriginator mesh__D005722 NLM
% 223.84/224.03  |- mesh__dateCreated mesh__D005722 1974-11-19
% 223.84/224.03  |- skos__historyNote mesh__D005722 Acyltransferases %28%1970-1974%29%
% 223.84/224.03  |- rdf__type mesh__D005722sskos__Concept
% 223.84/224.03  |- mesh__historyNote mesh__D005722
% 223.84/224.03       91%28%75%29%; was see under ACYLTRANSFERASES 1975-90   
% 223.84/224.03  |- mesh__dateRevised mesh__D005722 2003-07-09
% 223.84/224.03  |- skos__prefLabel mesh__D005722 gamma-Glutamylcyclotransferase
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010667 2004
% 223.84/224.03  |- mesh__dateCreated mesh__D010667 1999-01-01
% 223.84/224.03  |- mesh__onlineNote mesh__D010667
% 223.84/224.03       use PHENYLPYRUVIC ACIDS to search PHENYLPYRUVIC ACID 1966-74%A%  
% 223.84/224.03  |- skos__hiddenLabel mesh__D010667 Acids, Phenylpyruvic
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010667 2005
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010667 1999
% 223.84/224.03  |- skos__prefLabel mesh__D010667 Phenylpyruvic Acids
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010667 2003
% 223.84/224.03  |- mesh__recordAuthorizer mesh__D010667 PLS
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010667 1997
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010667 1998
% 223.84/224.03  |- mesh__historyNote mesh__D010667 75; was PHENYLPYRUVIC ACID 1963-74   
% 223.84/224.03  |- rdf__type mesh__D010667sskos__Concept
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010667 2001
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010667 1996
% 223.84/224.03  |- skos__broader mesh__D010667smesh__D000146
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010667 2000
% 223.84/224.03  |- mesh__recordOriginator mesh__D010667 NLM
% 223.84/224.03  |- mesh__publicMeSHNote mesh__D010667 75; was PHENYLPYRUVIC ACID 1963-74   
% 223.84/224.03  |- mesh__recordMaintainer mesh__D010667 KEV
% 223.84/224.03  |- mesh__dateRevised mesh__D010667 1995-05-18
% 223.84/224.03  |- skos__scopeNote mesh__D010667
% 223.84/224.03       A group of compounds that are derivatives of phenylpyruvic acid which has the general formula C6H5CH2COCOOH, and is a metabolite of phenylalanine. %28%From Dorland, 28th ed%29%%A%    
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010667 2006
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D010667 2002
% 223.84/224.03  |- skos__broader mesh__D010667smesh__D011773
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D015352 2002
% 223.84/224.03  |- mesh__recordMaintainer mesh__D015352 PLS
% 223.84/224.03  |- mesh__dateEstablished mesh__D015352 1989-01-01
% 223.84/224.03  |- mesh__dateRevised mesh__D015352 1993-05-27
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D015352 1995
% 223.84/224.03  |- skos__broader mesh__D015352smesh__D007766
% 223.84/224.03  |- skos__hiddenLabel mesh__D015352 Syndromes, Dry Eye
% 223.84/224.03  |- skos__scopeNote mesh__D015352
% 223.84/224.03       Corneal and conjunctival dryness due to deficient tear production, predominantly in menopausal and post-menopausal women. Filamentary keratitis or erosion of the conjunctival and corneal epithelium may be caused by these disorders. Sensation of the presence of a foreign body in the eye and burning of the eyes may occur.%A%    
% 223.84/224.03  |- mesh__recordAuthorizer mesh__D015352 PLS
% 223.84/224.03  |- skos__hiddenLabel mesh__D015352 Dry Eye Syndrome
% 223.84/224.03  |- rdf__type mesh__D015352sskos__Concept
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D015352 1998
% 223.84/224.03  |- mesh__dateCreated mesh__D015352 1988-06-02
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D015352 1996
% 223.84/224.03  |- skos__hiddenLabel mesh__D015352 Syndrome, Dry Eye
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D015352 1999
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D015352 2005
% 223.84/224.03  |- mesh__recordOriginator mesh__D015352 EC
% 223.84/224.03  |- mesh__publicMeSHNote mesh__D015352 89   
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D015352 2000
% 223.84/224.03  |- skos__prefLabel mesh__D015352 Dry Eye Syndromes
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D015352 1997
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D015352 2003
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D015352 2006
% 223.84/224.03  |- mesh__historyNote mesh__D015352 89   
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D015352 2001
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D015352 2004
% 223.84/224.03  |- skos__annotation mesh__D015352
% 223.84/224.03       defic tear production; GEN or unspecified: prefer specifics; do not confuse with XEROPHTHALMIA: read MeSH definitions%A%  
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D015352 1994
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D009315 1998
% 223.84/224.03  |- mesh__dateCreated mesh__D009315 1999-01-01
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D009315 2003
% 223.84/224.03  |- skos__prefLabel mesh__D009315
% 223.84/224.03       National Institute of Mental Health %28%U.S.%29%
% 223.84/224.03  |- mesh__dateEstablished mesh__D009315 1991-01-01
% 223.84/224.03  |- rdf__type mesh__D009315sskos__Concept
% 223.84/224.03  |- mesh__dateRevised mesh__D009315 1997-06-20
% 223.84/224.03  |- mesh__publicMeSHNote mesh__D009315
% 223.84/224.03       91; was see under UNITED STATES ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1982-90; was UNITED STATES NATIONAL INSTITUTE OF MENTAL HEALTH see under UNITED STATES ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1978-81; was NATIONAL INSTITUTE OF MENTAL HEALTH see under UNITED STATES HEALTH SER AND MENTAL HEALTH AD 1973-74%A%  
% 223.84/224.03  |- mesh__recordMaintainer mesh__D009315 PXP
% 223.84/224.03  |- skos__scopeNote mesh__D009315
% 223.84/224.03       A component of the NATIONAL INSTITUTES OF HEALTH concerned with research, overall planning, promoting, and administering mental health programs and research.%A%    
% 223.84/224.03  |- mesh__recordOriginator mesh__D009315 NLM
% 223.84/224.03  |- mesh__historyNote mesh__D009315
% 223.84/224.03       91%28%82%29%; was see under UNITED STATES ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1982-90; was UNITED STATES NATIONAL INSTITUTE OF MENTAL HEALTH see under UNITED STATES ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1978-81; was NATIONAL INSTITUTE OF MENTAL HEALTH see under ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1975-77; was NATIONAL INSTITUTE OF MENTAL HEALTH see under UNITED STATES HEALTH SER AND MENTAL HEALTH AD 1973-74%A%  
% 223.84/224.03  |- skos__altLabel mesh__D009315 National Institute of Mental Health
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D009315 2006
% 223.84/224.03  |- skos__broader mesh__D009315smesh__D009316
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D009315 2002
% 223.84/224.03  |- skos__altLabel mesh__D009315
% 223.84/224.03       United States National Institute of Mental Health
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D009315 2005
% 223.84/224.03  |- skos__annotation mesh__D009315
% 223.84/224.03       add UNITED STATES %28%NIM%29%; research support by this agency is checked as NIH/PHS SUP; DF: NIMH      CATALOG: use NAF entry%A%  
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D009315 2001
% 223.84/224.03  |- mesh__recordAuthorizer mesh__D009315 SJN
% 223.84/224.03  |- mesh__onlineNote mesh__D009315
% 223.84/224.03       use NATIONAL INSTITUTE OF MENTAL HEALTH %28%U.S.%29% to search UNITED STATES NATIONAL INSTITUTE OF MENTAL HEALTH %26% NATIONAL INSTITUTE OF MENTAL HEALTH 1975-81; use UNITED STATES ALCOHOL, DRUG ABUSE, and MENTAL HEALTH ADMINISTRATION 1973-74%A%  
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D009315 1999
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D009315 2004
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D009315 2000
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D001332 2004
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D001332 2002
% 223.84/224.03  |- skos__prefLabel mesh__D001332 Automatism
% 223.84/224.03  |- mesh__dateCreated mesh__D001332 1999-01-01
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D001332 2003
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D001332 2006
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D001332 1999
% 223.84/224.03  |- mesh__recordAuthorizer mesh__D001332 SJN
% 223.84/224.03  |- mesh__recordOriginator mesh__D001332 NLM
% 223.84/224.03  |- skos__broader mesh__D001332smesh__D003213
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D001332 2001
% 223.84/224.03  |- skos__scopeNote mesh__D001332
% 223.84/224.03       Automatic, mechanical, and apparently undirected behavior which is outside of conscious control.%A%    
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D001332 2005
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D001332 1998
% 223.84/224.03  |- rdf__type mesh__D001332sskos__Concept
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D001332 2000
% 223.84/224.03  |- mesh__dateRevised mesh__D001332 1997-06-20
% 223.84/224.03  |- mesh__recordMaintainer mesh__D001332 JLS
% 223.84/224.03  |- mesh__recordAuthorizer mesh__D020297 sjn
% 223.84/224.03  |- skos__broader mesh__D020297smesh__D051379
% 223.84/224.03  |- mesh__publicMeSHNote mesh__D020297 99   
% 223.84/224.03  |- skos__scopeNote mesh__D020297
% 223.84/224.03       Mouse strains constructed to possess identical genotypes except for a difference at a single gene locus.%A%    
% 223.84/224.03  |- mesh__dateRevised mesh__D020297 2005-06-30
% 223.84/224.03  |- mesh__dateCreated mesh__D020297 1998-06-10
% 223.84/224.03  |- skos__annotation mesh__D020297 NIM when exper animal; check tag MICE   
% 223.84/224.03  |- mesh__recordMaintainer mesh__D020297 ags
% 223.84/224.03  |- mesh__activeMeSHYear mesh__D020297 2006
% 223.84/224.03  |- rdf__type mesh__D020297sskos__Concept
% 223.84/224.03  |- mesh__dateEstablished mesh__D020297 1999-01-01
% 223.84/224.03  |- skos__hiddenLabel mesh__D020297 Congenic Mice
% 223.84/224.03  |- skos__prefLabel mesh__D020297 Mice, Congenic
% 223.84/224.03  |- mesh__historyNote mesh__D020297 99   
% 223.84/224.03  |- skos__broader mesh__D020297smesh__D020296
% 223.84/224.03  |- mesh__recordOriginator mesh__D020297 NDW
% 223.84/224.03  |- skos__historyNote mesh__D020297 Mice %28%1966-1998%29%
% 223.84/224.03  |- skos__hiddenLabel mesh__D019743 Chemokines, C-X-C
% 223.84/224.04  |- mesh__recordAuthorizer mesh__D019743 sjn
% 223.84/224.04  |- mesh__historyNote mesh__D019743 98   
% 223.84/224.04  |- skos__altLabel mesh__D019743 C-X-C Chemokines
% 223.84/224.04  |- skos__annotation mesh__D019743
% 223.84/224.04       do not confuse with CHEMOKINES, C or CHEMOKINES, CC   
% 223.84/224.04  |- skos__historyNote mesh__D019743 Cytokines %28%1993-1997%29%
% 223.84/224.04  |- skos__historyNote mesh__D019743 Chemokines %28%1996-1997%29%
% 223.84/224.04  |- skos__prefLabel mesh__D019743 Chemokines, CXC
% 223.84/224.04  |- skos__historyNote mesh__D019743 Chemotactic Factors %28%1994-1997%29%
% 223.84/224.04  |- mesh__dateRevised mesh__D019743 2005-06-30
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D019743 2006
% 223.84/224.04  |- skos__broader mesh__D019743smesh__D018925
% 223.84/224.04  |- skos__hiddenLabel mesh__D019743 alpha Chemokines
% 223.84/224.04  |- skos__altLabel mesh__D019743 CXC Chemokines
% 223.84/224.04  |- rdf__type mesh__D019743sskos__Concept
% 223.84/224.04  |- mesh__publicMeSHNote mesh__D019743 98   
% 223.84/224.04  |- mesh__recordOriginator mesh__D019743 AGS
% 223.84/224.04  |- mesh__dateCreated mesh__D019743 1997-06-20
% 223.84/224.04  |- mesh__recordMaintainer mesh__D019743 ssb
% 223.84/224.04  |- skos__scopeNote mesh__D019743
% 223.84/224.04       Group of chemokines with paired cysteines separated by a different amino acid. CXC chemokines are chemoattractants for neutrophils but not monocytes.%A%    
% 223.84/224.04  |- mesh__dateEstablished mesh__D019743 1998-01-01
% 223.84/224.04  |- skos__altLabel mesh__D019743 alpha-Chemokines
% 223.84/224.04  |- skos__prefLabel mesh__D011760 Pyrrolidinones
% 223.84/224.04  |- mesh__recordOriginator mesh__D011760 NLM
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D011760 1997
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D011760 2005
% 223.84/224.04  |- skos__altLabel mesh__D011760 Pyrrolidones
% 223.84/224.04  |- mesh__onlineNote mesh__D011760
% 223.84/224.04       use PYRROLIDINONES to search PYRROLIDONES 1966-67   
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D011760 2000
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D011760 2006
% 223.84/224.04  |- mesh__dateCreated mesh__D011760 1999-01-01
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D011760 2001
% 223.84/224.04  |- mesh__recordMaintainer mesh__D011760 KEV
% 223.84/224.04  |- mesh__dateRevised mesh__D011760 1995-05-18
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D011760 1998
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D011760 2003
% 223.84/224.04  |- skos__broader mesh__D011760smesh__D011759
% 223.84/224.04  |- mesh__recordAuthorizer mesh__D011760 PLS
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D011760 1999
% 223.84/224.04  |- mesh__historyNote mesh__D011760 68; was PYRROLIDONES 1963-67   
% 223.84/224.04  |- skos__scopeNote mesh__D011760
% 223.84/224.04       A group of compounds that are derivatives of oxo-pyrrolidines. A member of this group is 2-oxo pyrrolidine, which is an intermediate in the manufacture of polyvinylpyrrolidone. %28%From Merck Index, 11th ed%29%%A%    
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D011760 2004
% 223.84/224.04  |- mesh__dateEstablished mesh__D011760 1968-01-01
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D011760 2002
% 223.84/224.04  |- mesh__publicMeSHNote mesh__D011760 68; was PYRROLIDONES 1963-67   
% 223.84/224.04  |- rdf__type mesh__D011760sskos__Concept
% 223.84/224.04  |- skos__annotation mesh__D011760
% 223.84/224.04       pyrrolidinediones = SUCCINIMIDES; do not confuse with PYRROLIDINES%A%  
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D011760 1996
% 223.84/224.04  |- mesh__dateEstablished mesh__D005723 1974-01-01
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D005723 2006
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D005723 2006A
% 223.84/224.04  |- mesh__recordOriginator mesh__D005723 NLM
% 223.84/224.04  |- skos__broader mesh__D005723smesh__D019881
% 223.84/224.04  |- mesh__historyNote mesh__D005723
% 223.84/224.04       84; was GLUTAMYL TRANSPEPTIDASE 1972-83   
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D005723 2005
% 223.84/224.04  |- mesh__recordMaintainer mesh__D005723 ags
% 223.84/224.04  |- skos__hiddenLabel mesh__D005723 Transpeptidase, gamma-Glutamyl
% 223.84/224.04  |- skos__altLabel mesh__D005723 GGTP
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D005723 2006C
% 223.84/224.04  |- rdf__type mesh__D005723sskos__Concept
% 223.84/224.04  |- skos__altLabel mesh__D005723 Glutamyl Transpeptidase
% 223.84/224.04  |- skos__scopeNote mesh__D005723
% 223.84/224.04       An enzyme, sometimes called GGT, with a key role in the synthesis and degradation of GLUTATHIONE; %28%GSH, a tripeptide that protects cells from many toxins%29%. It catalyzes the transfer of the gamma-glutamyl moiety to an acceptor amino acid.%A%    
% 223.84/224.04  |- skos__annotation mesh__D005723
% 223.84/224.04       do not confuse with PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASES or GLUTAMINYL-PEPTIDE GAMMA-GLUTAMYLTRANSFERASES see TRANSGLUTAMINASES which crosslinks proteins nor with GAMMA-GLUTAMYLCYCLOTRANSFERASE%A%  
% 223.84/224.04  |- skos__hiddenLabel mesh__D005723 gamma Glutamyltransferase
% 223.84/224.04  |- mesh__recordAuthorizer mesh__D005723 ags
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D005723 2006B
% 223.84/224.04  |- skos__hiddenLabel mesh__D005723 Transpeptidase, Glutamyl
% 223.84/224.04  |- skos__prefLabel mesh__D005723 gamma-Glutamyltransferase
% 223.84/224.04  |- skos__altLabel mesh__D005723 gamma-Glutamyl Transpeptidase
% 223.84/224.04  |- skos__altLabel mesh__D005723 gammaglutamyltransferase
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D005723 2004
% 223.84/224.04  |- mesh__publicMeSHNote mesh__D005723
% 223.84/224.04       84; was GLUTAMYL TRANSPEPTIDASE 1972-83   
% 223.84/224.04  |- skos__historyNote mesh__D005723 Acyltransferases %28%1966-1971%29%
% 223.84/224.04  |- mesh__dateCreated mesh__D005723 1999-01-01
% 223.84/224.04  |- mesh__dateRevised mesh__D005723 2005-08-02
% 223.84/224.04  |- mesh__onlineNote mesh__D005723
% 223.84/224.04       use GAMMA-GLUTAMYLTRANSFERASE to search GLUTAMYL TRANSPEPTIDASE 1972-83%A%  
% 223.84/224.04  |- skos__hiddenLabel mesh__D005723 gamma Glutamyl Transpeptidase
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D043842 2005
% 223.84/224.04  |- mesh__historyNote mesh__D043842 2004   
% 223.84/224.04  |- mesh__publicMeSHNote mesh__D043842 2004   
% 223.84/224.04  |- skos__broader mesh__D043842smesh__D019684
% 223.84/224.04  |- mesh__dateEstablished mesh__D043842 2004-01-01
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D043842 2004
% 223.84/224.04  |- skos__prefLabel mesh__D043842 Ochnaceae
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D043842 2006
% 223.84/224.04  |- skos__annotation mesh__D043842
% 223.84/224.04       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.84/224.04  |- rdf__type mesh__D043842sskos__Concept
% 223.84/224.04  |- skos__scopeNote mesh__D043842
% 223.84/224.04       A plant family of the order THEALES, subclass Dilleniidae, class Magnoliopsida that have evergreen, alternate leaves.%A%    
% 223.84/224.04  |- mesh__dateCreated mesh__D043842 2003-07-09
% 223.84/224.04  |- skos__hiddenLabel mesh__D010668 U 14,624
% 223.84/224.04  |- skos__scopeNote mesh__D010668
% 223.84/224.04       A dopamine-beta-hydroxylase inhibitor.     
% 223.84/224.04  |- skos__historyNote mesh__D010668 Phenylthiourea %28%1972-1974%29%
% 223.84/224.04  |- skos__hiddenLabel mesh__D010668 U14,624
% 223.84/224.04  |- skos__broader mesh__D010668smesh__D010670
% 223.84/224.04  |- rdf__type mesh__D010668sskos__Concept
% 223.84/224.04  |- skos__prefLabel mesh__D010668 Phenylthiazolylthiourea
% 223.84/224.04  |- mesh__recordAuthorizer mesh__D010668 sjn
% 223.84/224.04  |- mesh__dateCreated mesh__D010668 1974-11-19
% 223.84/224.04  |- mesh__publicMeSHNote mesh__D010668
% 223.84/224.04       91; was see under PHENYLTHIOUREA 1975-90   
% 223.84/224.04  |- mesh__dateEstablished mesh__D010668 1991-01-01
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D010668 2005
% 223.84/224.04  |- mesh__recordMaintainer mesh__D010668 CCR
% 223.84/224.04  |- mesh__historyNote mesh__D010668
% 223.84/224.04       91%28%75%29%; was see under PHENYLTHIOUREA 1975-90   
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D010668 2001
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D010668 2003
% 223.84/224.04  |- skos__historyNote mesh__D010668 Thiazoles %28%1972-1974%29%
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D010668 2006
% 223.84/224.04  |- mesh__dateRevised mesh__D010668 2000-06-22
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D010668 2002
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D010668 2004
% 223.84/224.04  |- mesh__recordOriginator mesh__D010668 NLM
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D015353 2001
% 223.84/224.04  |- skos__hiddenLabel mesh__D015353 Enucleations, Eye
% 223.84/224.04  |- skos__hiddenLabel mesh__D015353 Eye Enucleations
% 223.84/224.04  |- rdf__type mesh__D015353sskos__Concept
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D015353 1998
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D015353 2002
% 223.84/224.04  |- mesh__dateCreated mesh__D015353 1988-06-02
% 223.84/224.04  |- skos__prefLabel mesh__D015353 Eye Enucleation
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D015353 1999
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D015353 2005
% 223.84/224.04  |- skos__hiddenLabel mesh__D015353 Enucleation, Eye
% 223.84/224.04  |- mesh__recordAuthorizer mesh__D015353 SJN
% 223.84/224.04  |- mesh__dateRevised mesh__D015353 1997-06-20
% 223.84/224.04  |- skos__broader mesh__D015353smesh__D013508
% 223.84/224.04  |- mesh__publicMeSHNote mesh__D015353
% 223.84/224.04       89; ENUCLEATION, EYE was see EYE ENUCLEATION 1989-92   
% 223.84/224.04  |- skos__scopeNote mesh__D015353
% 223.84/224.04       The surgical removal of the eyeball leaving the eye muscles and remaining orbital contents intact.%A%    
% 223.84/224.04  |- skos__historyNote mesh__D015353 Eye/surgery %28%1966-1988%29%
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D015353 2003
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D015353 2006
% 223.84/224.04  |- skos__annotation mesh__D015353
% 223.84/224.04       %22%removal of eyeball leaving eye musc %26% remaining orbital contents intact%22%: do not confuse with EYE EVISCERATION %28%%22%removal of inner contents of eye, leaving sclera intact%22%%29%; do not use /util except by MeSH definition%A%  
% 223.84/224.04  |- mesh__onlineNote mesh__D015353
% 223.84/224.04       use EYE ENUCLEATON to search ENUCLEATION, EYE 1989-92   
% 223.84/224.04  |- mesh__historyNote mesh__D015353
% 223.84/224.04       89; ENUCLEATION, EYE was see EYE ENUCLEATION 1989-92   
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D015353 2004
% 223.84/224.04  |- mesh__recordOriginator mesh__D015353 EC
% 223.84/224.04  |- mesh__recordMaintainer mesh__D015353 PXP
% 223.84/224.04  |- mesh__dateEstablished mesh__D015353 1989-01-01
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D015353 2000
% 223.84/224.04  |- skos__broader mesh__D009316smesh__D014492
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D009316 2000
% 223.84/224.04  |- mesh__dateEstablished mesh__D009316 1966-01-01
% 223.84/224.04  |- skos__annotation mesh__D009316
% 223.84/224.04       add UNITED STATES %28%NIM%29%; CONSENSUS DEVELOPMENT CONFERENCES, NIH is available: see note there; research support by this agency is checked as NIH/PHS SUP; DF: NIH        CATALOG: use NAF entry%A%  
% 223.84/224.04  |- skos__altLabel mesh__D009316 United States National Institutes of Health
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D009316 2006
% 223.84/224.04  |- skos__prefLabel mesh__D009316 National Institutes of Health %28%U.S.%29%
% 223.84/224.04  |- mesh__onlineNote mesh__D009316
% 223.84/224.04       use NATIONAL INSTITUTES OF HEALTH %28%U.S.%29% to search UNITED STATES NATIONAL INSTITUTES OF HEALTH 1966-81%A%  
% 223.84/224.04  |- mesh__dateRevised mesh__D009316 1997-06-20
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D009316 2005
% 223.84/224.04  |- mesh__recordMaintainer mesh__D009316 PXP
% 223.84/224.04  |- skos__altLabel mesh__D009316 National Institutes of Health
% 223.84/224.04  |- mesh__recordOriginator mesh__D009316 NLM
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D009316 1999
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D009316 2004
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D009316 2002
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D009316 1998
% 223.84/224.04  |- mesh__historyNote mesh__D009316
% 223.84/224.04       82; was UNITED STATES NATIONAL INSTITUTES OF HEALTH 1966-81%A%  
% 223.84/224.04  |- mesh__dateCreated mesh__D009316 1999-01-01
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D009316 2003
% 223.84/224.04  |- mesh__publicMeSHNote mesh__D009316
% 223.84/224.04       82; was UNITED STATES NATIONAL INSTITUTES OF HEALTH 1966-81%A%  
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D009316 2001
% 223.84/224.04  |- mesh__recordAuthorizer mesh__D009316 SJN
% 223.84/224.04  |- skos__scopeNote mesh__D009316
% 223.84/224.04       An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to health and medical research.%A%    
% 223.84/224.04  |- rdf__type mesh__D009316sskos__Concept
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D001333 2004
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D001333 1997
% 223.84/224.04  |- skos__scopeNote mesh__D001333
% 223.84/224.04       Government required written and driving test given to individuals prior to obtaining an operator%27%s license.%A%    
% 223.84/224.04  |- skos__hiddenLabel mesh__D001333 Examinations, Automobile Driver
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D001333 2002
% 223.84/224.04  |- skos__hiddenLabel mesh__D001333 Driver Examinations, Automobile
% 223.84/224.04  |- mesh__recordMaintainer mesh__D001333 TGC
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D001333 2005
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D001333 1998
% 223.84/224.04  |- skos__hiddenLabel mesh__D001333 Automobile Driver Examinations
% 223.84/224.04  |- skos__annotation mesh__D001333 DF: AUTO DRIVER EXAM   
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D001333 2006
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D001333 1999
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D001333 1995
% 223.84/224.04  |- mesh__recordAuthorizer mesh__D001333 PLS
% 223.84/224.04  |- skos__prefLabel mesh__D001333 Automobile Driver Examination
% 223.84/224.04  |- mesh__dateRevised mesh__D001333 1994-05-12
% 223.84/224.04  |- rdf__type mesh__D001333sskos__Concept
% 223.84/224.04  |- skos__altLabel mesh__D001333 Examination, Automobile Driver
% 223.84/224.04  |- skos__altLabel mesh__D001333 Driver Examination, Automobile
% 223.84/224.04  |- mesh__recordOriginator mesh__D001333 NLM
% 223.84/224.04  |- mesh__dateCreated mesh__D001333 1999-01-01
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D001333 2000
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D001333 2003
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D001333 1996
% 223.84/224.04  |- skos__broader mesh__D001333smesh__D001334
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D001333 2001
% 223.84/224.04  |- skos__historyNote mesh__D020298 Cell Line %28%1981-1998%29%
% 223.84/224.04  |- mesh__recordMaintainer mesh__D020298 ags
% 223.84/224.04  |- mesh__recordOriginator mesh__D020298 NDW
% 223.84/224.04  |- mesh__historyNote mesh__D020298 99   
% 223.84/224.04  |- skos__broader mesh__D020298smesh__D009000
% 223.84/224.04  |- skos__broader mesh__D020298smesh__D045744
% 223.84/224.04  |- mesh__dateEstablished mesh__D020298 1999-01-01
% 223.84/224.04  |- skos__hiddenLabel mesh__D020298 Cells, U937
% 223.84/224.04  |- skos__hiddenLabel mesh__D020298 U937 Cell
% 223.84/224.04  |- mesh__dateCreated mesh__D020298 1998-06-11
% 223.84/224.04  |- skos__prefLabel mesh__D020298 U937 Cells
% 223.84/224.04  |- mesh__recordAuthorizer mesh__D020298 sjn
% 223.84/224.04  |- mesh__dateRevised mesh__D020298 2005-06-30
% 223.84/224.04  |- skos__scopeNote mesh__D020298
% 223.84/224.04       A human cell line established from a diffuse histiocytic lymphoma %28%HISTIOCYTIC LYMPHOMA, DIFFUSE%29% and displaying many monocytic characteristics. It serves as an in vitro model for MONOCYTE and MACROPHAGE differentiation.%A%    
% 223.84/224.04  |- mesh__publicMeSHNote mesh__D020298 99   
% 223.84/224.04  |- skos__annotation mesh__D020298
% 223.84/224.04       almost always NIM with no subheadings; check HUMAN; do not routinely add LYMPHOMA, LARGE-CELL, DIFFUSE%A%  
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D020298 2006
% 223.84/224.04  |- rdf__type mesh__D020298sskos__Concept
% 223.84/224.04  |- skos__hiddenLabel mesh__D020298 Cell, U937
% 223.84/224.04  |- skos__annotation mesh__D025781
% 223.84/224.04       do not confuse with HYDROXYMETHYLGLUTARYL-COA-REDUCTASES, NADP-DEPENDENT%A%  
% 223.84/224.04  |- skos__altLabel mesh__D025781
% 223.84/224.04       3-Hydroxy-3-methylglutaryl CoA-Reductase, NAD-Dependent
% 223.84/224.04  |- mesh__publicMeSHNote mesh__D025781 2002   
% 223.84/224.04  |- skos__hiddenLabel mesh__D025781
% 223.84/224.04       NAD-Dependent 3-Hydroxy-3-methylglutaryl CoA-Reductase
% 223.84/224.04  |- skos__hiddenLabel mesh__D025781
% 223.84/224.04       CoA-Reductase, NAD-Dependent 3-Hydroxy-3-methylglutaryl
% 223.84/224.04  |- mesh__recordOriginator mesh__D025781 jmp
% 223.84/224.04  |- skos__scopeNote mesh__D025781
% 223.84/224.04       Specific hydroxymethylglutaryl CoA reductases that utilize the cofactor NAD. This class of enzymes performs a catabolic role in microorganisms such as Pseudomonas mevalonii where it oxidatively acetylates MEVALONIC ACID to form 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A and NADH.%A%    
% 223.84/224.04  |- skos__altLabel mesh__D025781
% 223.84/224.04       Hydroxymethylglutaryl CoA Reductase, NAD-Dependent
% 223.84/224.04  |- skos__altLabel mesh__D025781 HMG CoA Reductase, NAD-Dependent
% 223.84/224.04  |- mesh__dateEstablished mesh__D025781 2002-01-01
% 223.84/224.04  |- mesh__historyNote mesh__D025781 2002   
% 223.84/224.04  |- mesh__dateCreated mesh__D025781 2001-07-25
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D025781 2005
% 223.84/224.04  |- skos__hiddenLabel mesh__D025781 HMG CoA Reductases, NAD Dependent
% 223.84/224.04  |- skos__historyNote mesh__D025781
% 223.84/224.04       Hydroxymethylglutaryl CoA Reductases %28%1989-2001%29%
% 223.84/224.04  |- skos__hiddenLabel mesh__D025781 HMG CoA Reductase, NAD Dependent
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D025781 2004
% 223.84/224.04  |- rdf__type mesh__D025781sskos__Concept
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D025781 2006
% 223.84/224.04  |- mesh__dateRevised mesh__D025781 2005-07-18
% 223.84/224.04  |- mesh__recordAuthorizer mesh__D025781 ags
% 223.84/224.04  |- skos__hiddenLabel mesh__D025781
% 223.84/224.04       NAD-Dependent Hydroxymethylglutaryl-CoA Reductases
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D025781 2006A
% 223.84/224.04  |- skos__altLabel mesh__D025781 HMG CoA Reductases, NAD-Dependent
% 223.84/224.04  |- skos__prefLabel mesh__D025781
% 223.84/224.04       Hydroxymethylglutaryl-CoA Reductases, NAD-Dependent
% 223.84/224.04  |- skos__broader mesh__D025781smesh__D006903
% 223.84/224.04  |- skos__hiddenLabel mesh__D025781
% 223.84/224.04       Hydroxymethylglutaryl CoA Reductase, NAD Dependent
% 223.84/224.04  |- mesh__recordMaintainer mesh__D025781 ags
% 223.84/224.04  |- skos__prefLabel mesh__D019744 Chemokines, C
% 223.84/224.04  |- mesh__dateEstablished mesh__D019744 1998-01-01
% 223.84/224.04  |- mesh__historyNote mesh__D019744 98   
% 223.84/224.04  |- skos__broader mesh__D019744smesh__D018925
% 223.84/224.04  |- mesh__publicMeSHNote mesh__D019744 98   
% 223.84/224.04  |- skos__historyNote mesh__D019744 Chemokines %28%1996-1997%29%
% 223.84/224.04  |- skos__altLabel mesh__D019744 C Chemokines
% 223.84/224.04  |- skos__altLabel mesh__D019744 gamma-Chemokines
% 223.84/224.04  |- mesh__recordAuthorizer mesh__D019744 sjn
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D019744 2006
% 223.84/224.04  |- skos__historyNote mesh__D019744 Cytokines %28%1995%29%
% 223.84/224.04  |- skos__scopeNote mesh__D019744
% 223.84/224.04       Group of chemokines without adjacent cysteines that are chemoattractants for lymphocytes only.%A%    
% 223.84/224.04  |- rdf__type mesh__D019744sskos__Concept
% 223.84/224.04  |- skos__annotation mesh__D019744
% 223.84/224.04       do not confuse with CHEMOKINES, CC or CHEMOKINES, CXC   
% 223.84/224.04  |- mesh__recordOriginator mesh__D019744 AGS
% 223.84/224.04  |- mesh__dateCreated mesh__D019744 1997-06-20
% 223.84/224.04  |- mesh__recordMaintainer mesh__D019744 ssb
% 223.84/224.04  |- mesh__dateRevised mesh__D019744 2005-06-30
% 223.84/224.04  |- skos__hiddenLabel mesh__D019744 gamma Chemokines
% 223.84/224.04  |- mesh__historyNote mesh__D011761 91%28%72%29%   
% 223.84/224.04  |- skos__altLabel mesh__D011761 Pidolic Acid
% 223.84/224.04  |- skos__hiddenLabel mesh__D011761 Acid, Pyroglutamic
% 223.84/224.04  |- skos__altLabel mesh__D011761 5-Oxopyrrolidine-2-Carboxylic Acid
% 223.84/224.04  |- skos__scopeNote mesh__D011761
% 223.84/224.04       A cyclized derivative of L-GLUTAMIC ACID. Elevated blood levels may be associated with problems of GLUTAMINE or GLUTATHIONE metabolism.%A%    
% 223.84/224.04  |- skos__historyNote mesh__D011761 Pyrrolidinones %28%1966-1971%29%
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D011761 2006
% 223.84/224.04  |- mesh__dateCreated mesh__D011761 1999-01-01
% 223.84/224.04  |- mesh__dateEstablished mesh__D011761 1991-01-01
% 223.84/224.04  |- skos__altLabel mesh__D011761 5-Ketoproline
% 223.84/224.04  |- skos__broader mesh__D011761smesh__D007098
% 223.84/224.04  |- mesh__recordOriginator mesh__D011761 NLM
% 223.84/224.04  |- skos__hiddenLabel mesh__D011761 Acid, Pyrrolidonecarboxylic
% 223.84/224.04  |- skos__altLabel mesh__D011761 Pyroglutamic Acid
% 223.84/224.04  |- mesh__recordAuthorizer mesh__D011761 sjn
% 223.84/224.04  |- mesh__publicMeSHNote mesh__D011761
% 223.84/224.04       91; see PYRROLIDINONES 1972-90; MAGNESIUM PIDOLATE was indexed under PYRROLIDONECARBOXYLIC ACID/analogs %26% derivatives 1995-97%A%  
% 223.84/224.04  |- skos__broader mesh__D011761smesh__D018698
% 223.84/224.04  |- skos__prefLabel mesh__D011761 Pyrrolidonecarboxylic Acid
% 223.84/224.04  |- skos__historyNote mesh__D011761 Amino Acids %28%1966-1971%29%
% 223.84/224.04  |- rdf__type mesh__D011761sskos__Concept
% 223.84/224.04  |- mesh__dateRevised mesh__D011761 2005-06-30
% 223.84/224.04  |- mesh__recordMaintainer mesh__D011761 ssb
% 223.84/224.04  |- skos__hiddenLabel mesh__D011761 Pidolate, Magnesium
% 223.84/224.04  |- skos__altLabel mesh__D011761 5-Oxoproline
% 223.84/224.04  |- skos__broader mesh__D011761smesh__D011760
% 223.84/224.04  |- mesh__recordMaintainer mesh__D005724 sjn
% 223.84/224.04  |- skos__annotation mesh__D005724
% 223.84/224.04       GEN or unspecified; prefer specifics; wrist ganglion is indexed under WRIST %28%IM%29% + SYNOVIAL CYST %28%IM%29%;%A%  
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D005724 2006
% 223.84/224.04  |- rdf__type mesh__D005724sskos__Concept
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D005724 2002
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D005724 2005
% 223.84/224.04  |- skos__broader mesh__D005724smesh__D009420
% 223.84/224.04  |- mesh__dateRevised mesh__D005724 2002-10-24
% 223.84/224.04  |- skos__scopeNote mesh__D005724
% 223.84/224.04       Clusters of multipolar neurons surrounded by a capsule of loosely organized CONNECTIVE TISSUE located outside the CENTRAL NERVOUS SYSTEM.%A%    
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D005724 2001
% 223.84/224.04  |- mesh__dateCreated mesh__D005724 1999-01-01
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D005724 2004
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D005724 2000
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D005724 2003A
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D005724 2003
% 223.84/224.04  |- skos__prefLabel mesh__D005724 Ganglia
% 223.84/224.04  |- mesh__recordOriginator mesh__D005724 NLM
% 223.84/224.04  |- mesh__recordAuthorizer mesh__D005724 sjn
% 223.84/224.04  |- mesh__publicMeSHNote mesh__D043843 2004   
% 223.84/224.04  |- skos__prefLabel mesh__D043843 Leuzea
% 223.84/224.04  |- skos__annotation mesh__D043843
% 223.84/224.04       X ref RHAPONTICUM: RHEUM RHAPONTICUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.84/224.04  |- mesh__historyNote mesh__D043843 2004   
% 223.84/224.04  |- skos__altLabel mesh__D043843 Rhaponticum
% 223.84/224.04  |- skos__altLabel mesh__D043843 Rhaponticum carthamoides
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D043843 2004
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D043843 2005
% 223.84/224.04  |- skos__broader mesh__D043843smesh__D019659
% 223.84/224.04  |- skos__scopeNote mesh__D043843
% 223.84/224.04       A plant genus of the family ASTERACEAE. ECDYSONE has been found in seeds of some members.%A%    
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D043843 2006
% 223.84/224.04  |- rdf__type mesh__D043843sskos__Concept
% 223.84/224.04  |- mesh__dateEstablished mesh__D043843 2004-01-01
% 223.84/224.04  |- mesh__dateCreated mesh__D043843 2003-07-09
% 223.84/224.04  |- mesh__historyNote mesh__D010669
% 223.84/224.04       91%28%75%29%; was see under HYDANTOINS 1975-90   
% 223.84/224.04  |- rdf__type mesh__D010669sskos__Concept
% 223.84/224.04  |- skos__prefLabel mesh__D010669 Phenylthiohydantoin
% 223.84/224.04  |- mesh__recordOriginator mesh__D010669 NLM
% 223.84/224.04  |- skos__historyNote mesh__D010669 Hydantoins %28%1971-1972%29%
% 223.84/224.04  |- skos__scopeNote mesh__D010669 Thiohydantoin benzene derivative.     
% 223.84/224.04  |- skos__historyNote mesh__D010669 Thiohydantoins %28%1973-1974%29%
% 223.84/224.04  |- mesh__publicMeSHNote mesh__D010669
% 223.84/224.04       91; was see under HYDANTOINS 1975-90   
% 223.84/224.04  |- mesh__dateRevised mesh__D010669 2005-06-30
% 223.84/224.04  |- mesh__dateEstablished mesh__D010669 1991-01-01
% 223.84/224.04  |- mesh__recordMaintainer mesh__D010669 ssb
% 223.84/224.04  |- mesh__recordAuthorizer mesh__D010669 sjn
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D010669 2006
% 223.84/224.04  |- mesh__dateCreated mesh__D010669 1974-11-19
% 223.84/224.04  |- skos__broader mesh__D010669smesh__D013867
% 223.84/224.04  |- mesh__recordOriginator mesh__D015354 EC
% 223.84/224.04  |- mesh__historyNote mesh__D015354 2000%28%1989%29%   
% 223.84/224.04  |- mesh__publicMeSHNote mesh__D015354
% 223.84/224.04       2000; see VISION, SUBNORMAL 1990-1999, see VISION, LOW 1989; for VISION, LOW see VISION, SUBNORMAL 1990-1999%A%  
% 223.84/224.04  |- mesh__recordAuthorizer mesh__D015354 sjn
% 223.84/224.04  |- skos__hiddenLabel mesh__D015354 Low Vision
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D015354 2003
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D015354 2006
% 223.84/224.04  |- skos__broader mesh__D015354smesh__D014786
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D015354 2000
% 223.84/224.04  |- skos__scopeNote mesh__D015354
% 223.84/224.04       Vision considered to be inferior to normal vision as represented by accepted standards of acuity, field of vision, or motility. Low vision generally refers to visual disorders that are caused by diseases that cannot be corrected by refraction %28%e.g., MACULAR DEGENERATION; RETINITIS PIGMENTOSA; DIABETIC RETINOPATHY, etc.%29%.%A%    
% 223.84/224.04  |- skos__hiddenLabel mesh__D015354 Diminished Vision
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D015354 2004
% 223.84/224.04  |- mesh__recordMaintainer mesh__D015354 KEV
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D015354 2001
% 223.84/224.04  |- skos__hiddenLabel mesh__D015354 Subnormal Vision
% 223.84/224.04  |- skos__annotation mesh__D015354
% 223.84/224.04       do not make a diagnosis: use term of author   
% 223.84/224.04  |- mesh__dateEstablished mesh__D015354 1989-01-01
% 223.84/224.04  |- skos__prefLabel mesh__D015354 Vision, Low
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D015354 2002
% 223.84/224.04  |- skos__hiddenLabel mesh__D015354 Reduced Vision
% 223.84/224.04  |- skos__altLabel mesh__D015354 Vision, Diminished
% 223.84/224.04  |- rdf__type mesh__D015354sskos__Concept
% 223.84/224.04  |- mesh__dateRevised mesh__D015354 1999-11-03
% 223.84/224.04  |- skos__historyNote mesh__D015354 Visual Acuity %28%1969-1988%29%
% 223.84/224.04  |- mesh__dateCreated mesh__D015354 1988-06-02
% 223.84/224.04  |- skos__altLabel mesh__D015354 Vision, Reduced
% 223.84/224.04  |- skos__altLabel mesh__D015354 Vision, Subnormal
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D015354 2005
% 223.84/224.04  |- skos__historyNote mesh__D015354 Vision Disorders %28%1967-1988%29%
% 223.84/224.04  |- skos__altLabel mesh__D009317 United States National Library of Medicine
% 223.84/224.04  |- mesh__recordOriginator mesh__D009317 NLM
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D009317 2005
% 223.84/224.04  |- skos__broader mesh__D009317smesh__D007993
% 223.84/224.04  |- skos__related mesh__D009317smesh__D016240
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D009317 2000
% 223.84/224.04  |- mesh__onlineNote mesh__D009317
% 223.84/224.04       use NATIONAL LIBRARY OF MEDICINE %28%U.S.%29% to search UNITED STATES NATIONAL LIBRARY OF MEDICINE 1966-81%A%  
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D009317 2006
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D009317 2001
% 223.84/224.04  |- mesh__historyNote mesh__D009317
% 223.84/224.04       82; was UNITED STATES NATIONAL LIBRARY OF MEDICINE 1965-81 %28%Prov 1965%29%%A%  
% 223.84/224.04  |- mesh__dateEstablished mesh__D009317 1966-01-01
% 223.84/224.04  |- mesh__dateRevised mesh__D009317 1997-06-20
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D009317 1998
% 223.84/224.04  |- mesh__dateCreated mesh__D009317 1999-01-01
% 223.84/224.04  |- mesh__recordMaintainer mesh__D009317 PXP
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D009317 2003
% 223.84/224.04  |- skos__scopeNote mesh__D009317
% 223.84/224.04       An agency of the NATIONAL INSTITUTES OF HEALTH concerned with overall planning, promoting, and administering programs pertaining to various aspects of documentation and library services in the field of medicine.%A%    
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D009317 1999
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D009317 2004
% 223.84/224.04  |- skos__related mesh__D009317smesh__D008523
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D009317 2002
% 223.84/224.04  |- skos__altLabel mesh__D009317 National Library of Medicine
% 223.84/224.04  |- skos__prefLabel mesh__D009317 National Library of Medicine %28%U.S.%29%
% 223.84/224.04  |- skos__related mesh__D009317smesh__D017432
% 223.84/224.04  |- skos__annotation mesh__D009317
% 223.84/224.04       add UNITED STATES %28%NIM%29%; research support by this agency is checked as NIH/PHS SUP; DF: NLM      CATALOG: use NAF entry%A%  
% 223.84/224.04  |- mesh__publicMeSHNote mesh__D009317
% 223.84/224.04       82; was UNITED STATES NATIONAL LIBRARY OF MEDICINE 1966-81%A%  
% 223.84/224.04  |- mesh__recordAuthorizer mesh__D009317 SJN
% 223.84/224.04  |- skos__altLabel mesh__D009317 National Medical Library
% 223.84/224.04  |- skos__broader mesh__D009317smesh__D009316
% 223.84/224.04  |- rdf__type mesh__D009317sskos__Concept
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D001334 2001
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D001334 2006
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D001334 1999
% 223.84/224.04  |- mesh__dateEstablished mesh__D001334 1967-01-01
% 223.84/224.04  |- skos__related mesh__D001334smesh__D000063
% 223.84/224.04  |- mesh__recordMaintainer mesh__D001334 TPW
% 223.84/224.04  |- mesh__activeMeSHYear mesh__D001334 2002
% 223.84/224.05  |- skos__related mesh__D001334smesh__D018986
% 223.84/224.05  |- skos__scopeNote mesh__D001334
% 223.84/224.05       The effect of environmental or physiological factors on the driver and driving ability. Included are driving fatigue, and the effect of drugs, disease, and physical disabilities on driving.%A%    
% 223.84/224.05  |- skos__hiddenLabel mesh__D001334 Automobile Drivings
% 223.84/224.05  |- rdf__type mesh__D001334sskos__Concept
% 223.84/224.05  |- mesh__publicMeSHNote mesh__D001334 67   
% 223.84/224.05  |- mesh__historyNote mesh__D001334 67%28%64%29%   
% 223.84/224.05  |- skos__hiddenLabel mesh__D001334 Drivings, Automobile
% 223.84/224.05  |- mesh__dateCreated mesh__D001334 1999-01-01
% 223.84/224.05  |- mesh__recordAuthorizer mesh__D001334 SJN
% 223.84/224.05  |- skos__broader mesh__D001334smesh__D006802
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D001334 2003
% 223.84/224.05  |- skos__hiddenLabel mesh__D001334 Driving, Automobile
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D001334 2004
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D001334 2000
% 223.84/224.05  |- mesh__recordOriginator mesh__D001334 NLM
% 223.84/224.05  |- skos__prefLabel mesh__D001334 Automobile Driving
% 223.84/224.05  |- mesh__dateRevised mesh__D001334 1997-06-20
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D001334 2005
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D001334 1998
% 223.84/224.05  |- skos__historyNote mesh__D020299 Hypertension %28%1966-1999%29%
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D020299 2004
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Intracranial Hypertensive Hemorrhage
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Intracranial Hemorrhages, Hypertensive
% 223.84/224.05  |- skos__prefLabel mesh__D020299 Intracranial Hemorrhage, Hypertensive
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Hypertensive Intracerebral Hemorrhage
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Cerebral Hypertensive Hemorrhages
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D020299 2005
% 223.84/224.05  |- skos__altLabel mesh__D020299 Hypertensive Hemorrhage, Intracranial
% 223.84/224.05  |- skos__historyNote mesh__D020299 Cerebral Hemorrhage %28%1966-1999%29%
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Hypertensive Cerebral Hemorrhages
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Intracranial Hypertensive Hemorrhages
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Hemorrhages, Hypertensive Intracranial
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D020299 2000
% 223.84/224.05  |- mesh__historyNote mesh__D020299 2000   
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Hemorrhages, Hypertensive Cerebral
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D020299 2006
% 223.84/224.05  |- skos__historyNote mesh__D020299
% 223.84/224.05       Hypertension/complications %28%1972-1999%29%
% 223.84/224.05  |- mesh__dateCreated mesh__D020299 1999-11-03
% 223.84/224.05  |- skos__altLabel mesh__D020299 Intracerebral Hemorrhage, Hypertensive
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Hemorrhage, Hypertensive Intracranial
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Hypertensive Intracerebral Hemorrhages
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Hypertensive Hemorrhages, Intracranial
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Hypertensive Cerebral Hemorrhage
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D020299 2001
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Hemorrhage, Intracranial Hypertensive
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Cerebral Hemorrhages, Hypertensive
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Hypertensive Hemorrhages, Cerebral
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Cerebral Hypertensive Hemorrhage
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Intracerebral Hemorrhages, Hypertensive
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Hemorrhage, Hypertensive Intracerebral
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D020299 2003
% 223.84/224.05  |- skos__altLabel mesh__D020299 Hypertensive Hemorrhage, Cerebral
% 223.84/224.05  |- mesh__publicMeSHNote mesh__D020299 2000   
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D020299 2002
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Hemorrhages, Cerebral Hypertensive
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Hemorrhage, Hypertensive Cerebral
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Hemorrhages, Intracranial Hypertensive
% 223.84/224.05  |- skos__broader mesh__D020299smesh__D020300
% 223.84/224.05  |- rdf__type mesh__D020299sskos__Concept
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Hypertensive Intracranial Hemorrhages
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Hemorrhages, Hypertensive Intracerebral
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Hypertensive Intracranial Hemorrhage
% 223.84/224.05  |- skos__scopeNote mesh__D020299
% 223.84/224.05       Bleeding within the brain or adjacent structures which results from systemic HYPERTENSION, usually in association with INTRACRANIAL ARTERIOSCLEROSIS. Hypertensive hemorrhages are most frequent in the BASAL GANGLIA; CEREBELLUM; PONS; and THALAMUS; but may also involve the CEREBRAL CORTEX, subcortical white matter, and other brain structures.%A%    
% 223.84/224.05  |- skos__hiddenLabel mesh__D020299 Hemorrhage, Cerebral Hypertensive
% 223.84/224.05  |- mesh__dateEstablished mesh__D020299 2000-01-01
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D025782 2006A
% 223.84/224.05  |- skos__historyNote mesh__D025782
% 223.84/224.05       Hydroxymethylglutaryl CoA Reductases %28%1987-2001%29%
% 223.84/224.05  |- skos__hiddenLabel mesh__D025782
% 223.84/224.05       NADP-dependent Hydroxymethylglutaryl-CoA-Reductases
% 223.84/224.05  |- skos__altLabel mesh__D025782
% 223.84/224.05       Hydroxymethylglutaryl-Coenzyme A Reductase %28%NADP%29%
% 223.84/224.05  |- skos__broader mesh__D025782smesh__D006903
% 223.84/224.05  |- skos__altLabel mesh__D025782
% 223.84/224.05       Hydroxymethylglutaryl-CoA-Reductase %28%NADP%29%
% 223.84/224.05  |- mesh__dateEstablished mesh__D025782 2002-01-01
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D025782 2005
% 223.84/224.05  |- skos__prefLabel mesh__D025782
% 223.84/224.05       Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent
% 223.84/224.05  |- mesh__publicMeSHNote mesh__D025782
% 223.84/224.05       2002; hydroxymethylglutaryl-CoA-reductase %28%NADP%29% now HYDROXYMETHYLGLUTARYL-COA-REDUCTASES, NADP-DEPENDENT was indexed under HYDROXYMETHYLGLUTARYL COA REDUCTASES 1981-2001%A%  
% 223.84/224.05  |- mesh__dateCreated mesh__D025782 2001-08-03
% 223.84/224.05  |- rdf__type mesh__D025782sskos__Concept
% 223.84/224.05  |- skos__altLabel mesh__D025782
% 223.84/224.05       3-Hydroxy-3-methylglutaryl-coenzyme A reductase, NADP-dependent
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D025782 2004
% 223.84/224.05  |- mesh__recordOriginator mesh__D025782 jmp
% 223.84/224.05  |- skos__hiddenLabel mesh__D025782 HMG CoA Reductases, NADP Dependent
% 223.84/224.05  |- skos__hiddenLabel mesh__D025782
% 223.84/224.05       3 Hydroxy 3 methylglutaryl coenzyme A reductase, NADP dependent
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D025782 2006
% 223.84/224.05  |- mesh__dateRevised mesh__D025782 2005-07-18
% 223.84/224.05  |- mesh__recordAuthorizer mesh__D025782 ags
% 223.84/224.05  |- skos__hiddenLabel mesh__D025782 CoA-Reductases, NADP-Dependent HMG
% 223.84/224.05  |- skos__scopeNote mesh__D025782
% 223.84/224.05       Specific hydroxymethylglutaryl CoA reductases that utilize the cofactor NAD. In liver enzymes of this class are involved in cholesterol biosynthesis.%A%    
% 223.84/224.05  |- skos__altLabel mesh__D025782 HMG CoA-Reductases, NADP-Dependent
% 223.84/224.05  |- mesh__recordMaintainer mesh__D025782 ags
% 223.84/224.05  |- skos__hiddenLabel mesh__D025782 NADP-Dependent HMG CoA-Reductases
% 223.84/224.05  |- mesh__historyNote mesh__D025782
% 223.84/224.05       2002;  use HYDROXYMETHYLGLUTARYL COA REDUCTASES %28%NM%29% 1981-2001%A%  
% 223.84/224.05  |- skos__annotation mesh__D025782
% 223.84/224.05       do not confuse with HYDROXYMETHYLGLUTARYL-COA REDUCTASES, NAD-DEPENDENT%A%  
% 223.84/224.05  |- mesh__dateCreated mesh__D019745 1997-06-20
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D019745 2005
% 223.84/224.05  |- mesh__dateEstablished mesh__D019745 1998-01-01
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D019745 2006
% 223.84/224.05  |- skos__historyNote mesh__D019745 Amino Acid Isomerases %28%1985-1997%29%
% 223.84/224.05  |- mesh__publicMeSHNote mesh__D019745 98   
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D019745 2004
% 223.84/224.05  |- skos__hiddenLabel mesh__D019745 Isomerases, cis trans
% 223.84/224.05  |- skos__broader mesh__D019745smesh__D007535
% 223.84/224.05  |- mesh__dateRevised mesh__D019745 2003-07-09
% 223.84/224.05  |- rdf__type mesh__D019745sskos__Concept
% 223.84/224.05  |- skos__historyNote mesh__D019745 Isomerases %28%1966-1997%29%
% 223.84/224.05  |- skos__prefLabel mesh__D019745 cis-trans-Isomerases
% 223.84/224.05  |- skos__hiddenLabel mesh__D019745 cis trans Isomerases
% 223.84/224.05  |- skos__hiddenLabel mesh__D019745 cis-trans Isomerases
% 223.84/224.05  |- skos__altLabel mesh__D019745 Isomerases, cis-trans
% 223.84/224.05  |- skos__scopeNote mesh__D019745
% 223.84/224.05       Enzymes that catalyze the rearrangement of geometry about double bonds. EC 5.2.%A%    
% 223.84/224.05  |- mesh__historyNote mesh__D019745 98   
% 223.84/224.05  |- mesh__dateRevised mesh__D011762 2005-06-30
% 223.84/224.05  |- mesh__recordMaintainer mesh__D011762 jmp
% 223.84/224.05  |- rdf__type mesh__D011762sskos__Concept
% 223.84/224.05  |- skos__historyNote mesh__D011762 Oxidoreductases %28%1966-1974%29%
% 223.84/224.05  |- skos__scopeNote mesh__D011762
% 223.84/224.05       A group of enzymes that catalyze the reduction of 1-pyrroline carboxylate to proline in the presence of NAD%28%P%29%H. Includes both the 2-oxidoreductase %28%EC 1.5.1.1%29% and the 5-oxidoreductase %28%EC 1.5.1.2%29%. The former also reduces 1-piperidine-2-carboxylate to pipecolate and the latter also reduces 1-pyrroline-3-hydroxy-5-carboxylate to hydroxyproline.%A%    
% 223.84/224.05  |- skos__prefLabel mesh__D011762 Pyrroline Carboxylate Reductases
% 223.84/224.05  |- skos__hiddenLabel mesh__D011762 Carboxylate Reductases, Pyrroline
% 223.84/224.05  |- skos__broader mesh__D011762smesh__D000587
% 223.84/224.05  |- mesh__recordOriginator mesh__D011762 RLS
% 223.84/224.05  |- mesh__historyNote mesh__D011762
% 223.84/224.05       91%28%77%29%; was see under AMINE OXIDOREDUCTASES 1977-90   
% 223.84/224.05  |- skos__historyNote mesh__D011762 Amine Oxidoreductases %28%1975-1976%29%
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D011762 2006
% 223.84/224.05  |- mesh__recordAuthorizer mesh__D011762 sjn
% 223.84/224.05  |- mesh__dateEstablished mesh__D011762 1991-01-01
% 223.84/224.05  |- mesh__dateCreated mesh__D011762 1976-05-19
% 223.84/224.05  |- skos__hiddenLabel mesh__D011762 Reductases, Pyrroline Carboxylate
% 223.84/224.05  |- mesh__publicMeSHNote mesh__D011762
% 223.84/224.05       91; was see under AMINE OXIDOREDUCTASES 1977-90   
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005725 1996
% 223.84/224.05  |- skos__hiddenLabel mesh__D005725 Autonomic Ganglion
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005725 2000
% 223.84/224.05  |- rdf__type mesh__D005725sskos__Concept
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005725 2005
% 223.84/224.05  |- mesh__recordOriginator mesh__D005725 NLM
% 223.84/224.05  |- skos__altLabel mesh__D005725 Ganglion, Autonomic
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005725 1999
% 223.84/224.05  |- mesh__dateRevised mesh__D005725 1994-04-11
% 223.84/224.05  |- skos__broader mesh__D005725smesh__D001341
% 223.84/224.05  |- skos__broader mesh__D005725smesh__D005724
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005725 1998
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005725 2002
% 223.84/224.05  |- mesh__dateCreated mesh__D005725 1999-01-01
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005725 2004
% 223.84/224.05  |- skos__altLabel mesh__D005725 Autonomic Ganglia
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005725 1995
% 223.84/224.05  |- skos__prefLabel mesh__D005725 Ganglia, Autonomic
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005725 2003
% 223.84/224.05  |- mesh__recordAuthorizer mesh__D005725 PLS
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005725 1997
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005725 2001
% 223.84/224.05  |- skos__scopeNote mesh__D005725
% 223.84/224.05       Clusters of neurons and their processes in the autonomic nervous system. In the autonomic ganglia, the preganglionic fibers from the central nervous system synapse onto the neurons whose axons are the postganglionic fibers innervating target organs. The ganglia also contain intrinsic neurons and supporting cells and preganglionic fibers passing through to other ganglia.%A%    
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005725 2006
% 223.84/224.05  |- mesh__recordMaintainer mesh__D005725 TGC
% 223.84/224.05  |- skos__hiddenLabel mesh__D038101 Element, Insulator
% 223.84/224.05  |- mesh__recordOriginator mesh__D038101 nns
% 223.84/224.05  |- skos__hiddenLabel mesh__D038101 Boundary Element
% 223.84/224.05  |- mesh__dateCreated mesh__D038101 2002-07-02
% 223.84/224.05  |- mesh__dateEstablished mesh__D038101 2003-01-01
% 223.84/224.05  |- skos__hiddenLabel mesh__D038101 Insulator Element
% 223.84/224.05  |- skos__hiddenLabel mesh__D038101 Elements, Boundary
% 223.84/224.05  |- mesh__recordAuthorizer mesh__D038101 sjn
% 223.84/224.05  |- skos__prefLabel mesh__D038101 Insulator Elements
% 223.84/224.05  |- skos__hiddenLabel mesh__D038101 Elements, Insulator
% 223.84/224.05  |- skos__broader mesh__D038101smesh__D012045
% 223.84/224.05  |- rdf__type mesh__D038101sskos__Concept
% 223.84/224.05  |- mesh__historyNote mesh__D038101 2003   
% 223.84/224.05  |- mesh__dateRevised mesh__D038101 2005-06-30
% 223.84/224.05  |- mesh__recordMaintainer mesh__D038101 nns
% 223.84/224.05  |- mesh__publicMeSHNote mesh__D038101 2003   
% 223.84/224.05  |- skos__hiddenLabel mesh__D038101 Element, Boundary
% 223.84/224.05  |- skos__broader mesh__D038101smesh__D040481
% 223.84/224.05  |- skos__scopeNote mesh__D038101
% 223.84/224.05       Nucleic acid regulatory sequences that limit or oppose the action of ENHANCER ELEMENTS and define the boundary between differentially regulated gene loci.%A%    
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D038101 2006
% 223.84/224.05  |- mesh__dateEstablished mesh__D043844 2004-01-01
% 223.84/224.05  |- skos__hiddenLabel mesh__D043844 Crown Ethers, Oxa-Thia
% 223.84/224.05  |- skos__scopeNote mesh__D043844
% 223.84/224.05       Macrocyclic polyethers with the repeating unit of %28%-CH2-CH2-O%29%n where n is greater than 2 and some oxygens may be replaced by nitrogen, sulfur or phosphorus. These compounds are useful for coordinating CATIONS. The nomenclature uses a prefix to indicate the size of the ring and a suffix for the number of heteroatoms.%A%    
% 223.84/224.05  |- skos__hiddenLabel mesh__D043844 Ethers, Aza-Oxa Crown
% 223.84/224.05  |- skos__hiddenLabel mesh__D043844 Crown Ethers, Aza-Oxa
% 223.84/224.05  |- skos__broader mesh__D043844smesh__D004988
% 223.84/224.05  |- skos__hiddenLabel mesh__D043844 Oxa Thia Crown Ethers
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D043844 2005
% 223.84/224.05  |- skos__prefLabel mesh__D043844 Crown Ethers
% 223.84/224.05  |- mesh__recordOriginator mesh__D043844 ssb
% 223.84/224.05  |- mesh__publicMeSHNote mesh__D043844
% 223.84/224.05       2004; see ETHERS, CYCLIC 1993-2003; CROWN COMPOUNDS was indexed under ETHERS, CYCLIC 1976-1992%A%  
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D043844 2006
% 223.84/224.05  |- mesh__recordAuthorizer mesh__D043844 sjn
% 223.84/224.05  |- rdf__type mesh__D043844sskos__Concept
% 223.84/224.05  |- skos__hiddenLabel mesh__D043844 Aza Oxa Crown Ethers
% 223.84/224.05  |- mesh__recordMaintainer mesh__D043844 ssb
% 223.84/224.05  |- skos__historyNote mesh__D043844 Ethers, Cyclic %28%1974-2003%29%
% 223.84/224.05  |- mesh__dateCreated mesh__D043844 2003-07-09
% 223.84/224.05  |- mesh__dateRevised mesh__D043844 2004-07-07
% 223.84/224.05  |- skos__broader mesh__D043844smesh__D047248
% 223.84/224.05  |- skos__hiddenLabel mesh__D043844 Ethers, Crown
% 223.84/224.05  |- skos__hiddenLabel mesh__D043844 Ethers, Oxa-Thia Crown
% 223.84/224.05  |- mesh__historyNote mesh__D043844
% 223.84/224.05       2004; use ETHERS, CYCLIC 1993-2003; CROWN COMPOUNDS was NM 1976-1992%A%  
% 223.84/224.05  |- skos__scopeNote mesh__D015355
% 223.84/224.05       A form of secondary glaucoma which develops as a consequence of another ocular disease and is attributed to the forming of new vessels in the angle of the anterior chamber.%A%    
% 223.84/224.05  |- skos__hiddenLabel mesh__D015355 Glaucomas, Neovascular
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015355 2004
% 223.84/224.05  |- mesh__recordOriginator mesh__D015355 EC
% 223.84/224.05  |- mesh__recordAuthorizer mesh__D015355 sjn
% 223.84/224.05  |- mesh__dateEstablished mesh__D015355 1989-01-01
% 223.84/224.05  |- skos__broader mesh__D015355smesh__D005901
% 223.84/224.05  |- skos__hiddenLabel mesh__D015355 Neovascular Glaucoma
% 223.84/224.05  |- skos__historyNote mesh__D015355 Glaucoma %28%1966-1988%29%
% 223.84/224.05  |- skos__prefLabel mesh__D015355 Glaucoma, Neovascular
% 223.84/224.05  |- rdf__type mesh__D015355sskos__Concept
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015355 2000
% 223.84/224.05  |- mesh__historyNote mesh__D015355 89   
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015355 2001
% 223.84/224.05  |- mesh__dateCreated mesh__D015355 1988-06-02
% 223.84/224.05  |- skos__historyNote mesh__D015355 Neovascularization %28%1979-1988%29%
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015355 2005
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015355 2002
% 223.84/224.05  |- skos__hiddenLabel mesh__D015355 Neovascular Glaucomas
% 223.84/224.05  |- mesh__publicMeSHNote mesh__D015355 89   
% 223.84/224.05  |- mesh__recordMaintainer mesh__D015355 jmp
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015355 2003
% 223.84/224.05  |- mesh__dateRevised mesh__D015355 1999-11-03
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015355 2006
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D009318 2006A
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D009318 2006
% 223.84/224.05  |- skos__annotation mesh__D009318
% 223.84/224.05       differentiate from SODIUM /urine in that in natriuresis emphasis is on the physiol process of urinary excretion of sodium; NATRIURETIC HORMONES is available%A%  
% 223.84/224.05  |- skos__broader mesh__D009318smesh__D004231
% 223.84/224.05  |- mesh__dateCreated mesh__D009318 1999-01-01
% 223.84/224.05  |- mesh__recordOriginator mesh__D009318 NLM
% 223.84/224.05  |- skos__prefLabel mesh__D009318 Natriuresis
% 223.84/224.05  |- mesh__dateRevised mesh__D009318 2005-07-21
% 223.84/224.05  |- mesh__recordAuthorizer mesh__D009318 ags
% 223.84/224.05  |- rdf__type mesh__D009318sskos__Concept
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D009318 2005
% 223.84/224.05  |- skos__hiddenLabel mesh__D009318 Natriureses
% 223.84/224.05  |- mesh__recordMaintainer mesh__D009318 ags
% 223.84/224.05  |- skos__hiddenLabel mesh__D001335 Vehicle Emission
% 223.84/224.05  |- skos__prefLabel mesh__D001335 Vehicle Emissions
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D001335 2005
% 223.84/224.05  |- skos__hiddenLabel mesh__D001335 Emissions, Vehicular
% 223.84/224.05  |- skos__hiddenLabel mesh__D001335 Emissions, Vehicle
% 223.84/224.05  |- mesh__historyNote mesh__D001335
% 223.84/224.05       96; was AUTOMOBILE EXHAUST 1963-95; was in Cat G only 1968-74, was in Cat G %26% J 1963-67%A%  
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D001335 2006
% 223.84/224.05  |- skos__scopeNote mesh__D001335
% 223.84/224.05       Gases, fumes, vapors, and odors escaping from the cylinders of a gasoline or diesel internal-combustion engine. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed %26% Random House Unabridged Dictionary, 2d ed%29%%A%    
% 223.84/224.05  |- skos__hiddenLabel mesh__D001335 Exhaust, Engine
% 223.84/224.05  |- rdf__type mesh__D001335sskos__Concept
% 223.84/224.05  |- mesh__dateCreated mesh__D001335 1999-01-01
% 223.84/224.05  |- mesh__recordAuthorizer mesh__D001335 sjn
% 223.84/224.05  |- skos__altLabel mesh__D001335 Vehicular Emissions
% 223.84/224.05  |- skos__hiddenLabel mesh__D001335 Exhaust, Diesel
% 223.84/224.05  |- mesh__dateRevised mesh__D001335 2003-07-09
% 223.84/224.05  |- skos__broader mesh__D001335smesh__D000397
% 223.84/224.05  |- skos__hiddenLabel mesh__D001335 Exhaust, Automobile
% 223.84/224.05  |- mesh__publicMeSHNote mesh__D001335 96; was AUTOMOBILE EXHAUST 1963-95   
% 223.84/224.05  |- skos__hiddenLabel mesh__D001335 Emission, Vehicular
% 223.84/224.05  |- mesh__recordOriginator mesh__D001335 NLM
% 223.84/224.05  |- skos__hiddenLabel mesh__D001335 Vehicular Emission
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D001335 2004
% 223.84/224.05  |- mesh__recordMaintainer mesh__D001335 ssb
% 223.84/224.05  |- skos__hiddenLabel mesh__D001335 Emission, Vehicle
% 223.84/224.05  |- mesh__publicMeSHNote mesh__D006020 73   
% 223.84/224.05  |- skos__broader mesh__D006020smesh__D010455
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D006020 2005
% 223.84/224.05  |- skos__prefLabel mesh__D006020 Glycopeptides
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D006020 2006
% 223.84/224.05  |- mesh__dateEstablished mesh__D006020 1973-01-01
% 223.84/224.05  |- mesh__recordAuthorizer mesh__D006020 sjn
% 223.84/224.05  |- mesh__historyNote mesh__D006020 73%28%71%29%   
% 223.84/224.05  |- mesh__dateCreated mesh__D006020 1999-01-01
% 223.84/224.05  |- skos__broader mesh__D006020smesh__D006001
% 223.84/224.05  |- mesh__recordOriginator mesh__D006020 NLM
% 223.84/224.05  |- rdf__type mesh__D006020sskos__Concept
% 223.84/224.05  |- skos__scopeNote mesh__D006020
% 223.84/224.05       Proteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight.%A%    
% 223.84/224.05  |- skos__historyNote mesh__D006020
% 223.84/224.05       specific polysaccharide %28%1966-1970%29%
% 223.84/224.05  |- mesh__recordMaintainer mesh__D006020 ssb
% 223.84/224.05  |- mesh__dateRevised mesh__D006020 2004-07-07
% 223.84/224.05  |- skos__historyNote mesh__D006020 Peptides %28%1966-1970%29%
% 223.84/224.05  |- skos__historyNote mesh__D006020 Polysaccharides %28%1966-1970%29%
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D019746 2004
% 223.84/224.05  |- skos__broader mesh__D019746smesh__D007535
% 223.84/224.05  |- mesh__dateRevised mesh__D019746 2003-07-09
% 223.84/224.05  |- rdf__type mesh__D019746sskos__Concept
% 223.84/224.05  |- mesh__dateCreated mesh__D019746 1997-06-20
% 223.84/224.05  |- mesh__dateEstablished mesh__D019746 1998-01-01
% 223.84/224.05  |- mesh__historyNote mesh__D019746 98   
% 223.84/224.05  |- skos__prefLabel mesh__D019746 Intramolecular Oxidoreductases
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D019746 2005
% 223.84/224.05  |- skos__hiddenLabel mesh__D019746 Oxidoreductases, Intramolecular
% 223.84/224.05  |- mesh__publicMeSHNote mesh__D019746 98   
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D019746 2006
% 223.84/224.05  |- skos__scopeNote mesh__D019746
% 223.84/224.05       Enzymes of the isomerase class that catalyze the oxidation of one part of a molecule with a corresponding reduction of another part of the same molecule. They include enzymes converting aldoses to ketoses %28%ALDOSE-KETOSE ISOMERASES%29%, enzymes shifting a carbon-carbon double bond %28%CARBON-CARBON DOUBLE BOND ISOMERASES%29%, and enzymes transposing S-S bonds %28%SULFUR-SULFUR BOND ISOMERASES%29%. %28%From Enzyme Nomenclature, 1992%29% EC 5.3.%A%    
% 223.84/224.05  |- skos__prefLabel mesh__D011763 Pyrrolizidine Alkaloids
% 223.84/224.05  |- mesh__recordMaintainer mesh__D011763 ssb
% 223.84/224.05  |- rdf__type mesh__D011763sskos__Concept
% 223.84/224.05  |- skos__hiddenLabel mesh__D011763 Alkaloids, Pyrrolizidine
% 223.84/224.05  |- skos__hiddenLabel mesh__D011763 Alkaloids, Senecio
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D011763 2004
% 223.84/224.05  |- skos__historyNote mesh__D011763 Alkaloids %28%1966-1970%29%
% 223.84/224.05  |- skos__historyNote mesh__D011763 Heterocyclic Compounds %28%1966-1970%29%
% 223.84/224.05  |- mesh__dateEstablished mesh__D011763 1973-01-01
% 223.84/224.05  |- skos__broader mesh__D011763smesh__D000470
% 223.84/224.05  |- skos__broader mesh__D011763smesh__D006574
% 223.84/224.05  |- mesh__publicMeSHNote mesh__D011763 73   
% 223.84/224.05  |- mesh__recordOriginator mesh__D011763 NLM
% 223.84/224.05  |- mesh__dateCreated mesh__D011763 1999-01-01
% 223.84/224.05  |- mesh__recordAuthorizer mesh__D011763 sjn
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D011763 2005
% 223.84/224.05  |- mesh__dateRevised mesh__D011763 2003-07-09
% 223.84/224.05  |- skos__scopeNote mesh__D011763
% 223.84/224.05       A group of ALKALOIDS, characterized by a nitrogen-containing necine, occurring mainly in plants of the BORAGINACEAE; COMPOSITAE; and LEGUMINOSAE plant families. They can be activated in the liver by hydrolysis of the ester and desaturation of the necine base to reactive electrophilic pyrrolic CYTOTOXINS.%A%    
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D011763 2006
% 223.84/224.05  |- mesh__historyNote mesh__D011763 73%28%71%29%   
% 223.84/224.05  |- skos__annotation mesh__D005726
% 223.84/224.05       includes ciliary, pterygopalatine, submandibular, otic ganglia%A%  
% 223.84/224.05  |- rdf__type mesh__D005726sskos__Concept
% 223.84/224.05  |- skos__historyNote mesh__D005726
% 223.84/224.05       Parasympathetic Nervous System %28%1966-1979%29%
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005726 1998
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005726 2000
% 223.84/224.05  |- skos__altLabel mesh__D005726 Ganglion, Parasympathetic
% 223.84/224.05  |- skos__broader mesh__D005726smesh__D010275
% 223.84/224.05  |- skos__scopeNote mesh__D005726
% 223.84/224.05       Ganglia of the parasympathetic nervous system, including the ciliary, pterygopalatine, submandibular, and otic ganglia in the cranial region and intrinsic %28%terminal%29% ganglia associated with target organs in the thorax and abdomen.%A%    
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005726 2003
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005726 1999
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005726 2001
% 223.84/224.05  |- mesh__dateRevised mesh__D005726 1994-04-11
% 223.84/224.05  |- skos__prefLabel mesh__D005726 Ganglia, Parasympathetic
% 223.84/224.05  |- skos__hiddenLabel mesh__D005726 Parasympathetic Ganglion
% 223.84/224.05  |- skos__historyNote mesh__D005726 Ganglia, Autonomic %28%1966-1979%29%
% 223.84/224.05  |- mesh__dateCreated mesh__D005726 1979-05-22
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005726 2002
% 223.84/224.05  |- mesh__historyNote mesh__D005726 80   
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005726 2004
% 223.84/224.05  |- skos__broader mesh__D005726smesh__D005725
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005726 1995
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005726 1996
% 223.84/224.05  |- mesh__dateEstablished mesh__D005726 1980-01-01
% 223.84/224.05  |- mesh__recordOriginator mesh__D005726 RC
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005726 2005
% 223.84/224.05  |- mesh__publicMeSHNote mesh__D005726 80   
% 223.84/224.05  |- mesh__recordMaintainer mesh__D005726 TGC
% 223.84/224.05  |- skos__altLabel mesh__D005726 Parasympathetic Ganglia
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005726 1997
% 223.84/224.05  |- mesh__recordAuthorizer mesh__D005726 PLS
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D005726 2006
% 223.84/224.05  |- skos__broader mesh__D006728Q000037smesh__D006728
% 223.84/224.05  |- mesh__preferredCombination mesh__D006728Q000037smesh__D006727
% 223.84/224.05  |- rdf__type mesh__D006728Q000037smesh__CompoundConcept
% 223.84/224.05  |- skos__historyNote mesh__D048530 Papio %28%1972-2004%29%
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D048530 2006
% 223.84/224.05  |- skos__hiddenLabel mesh__D048530 Olive Baboons
% 223.84/224.05  |- skos__scopeNote mesh__D048530
% 223.84/224.05       A species of baboon in the family CERCOPITHECIDAE with a somewhat different social structure than PAPIO HAMADRYAS. They inhabit several areas in Africa south of the Sahara.%A%    
% 223.84/224.05  |- mesh__dateCreated mesh__D048530 2004-07-07
% 223.84/224.05  |- mesh__recordMaintainer mesh__D048530 ags
% 223.84/224.05  |- mesh__recordOriginator mesh__D048530 ags
% 223.84/224.05  |- rdf__type mesh__D048530sskos__Concept
% 223.84/224.05  |- skos__hiddenLabel mesh__D048530 Baboon, Olive
% 223.84/224.05  |- skos__hiddenLabel mesh__D048530 Baboons, Olive
% 223.84/224.05  |- mesh__publicMeSHNote mesh__D048530 2005   
% 223.84/224.05  |- skos__historyNote mesh__D048530 Haplorhini %28%1966-1971%29%
% 223.84/224.05  |- skos__altLabel mesh__D048530 Olive Baboon
% 223.84/224.05  |- skos__prefLabel mesh__D048530 Papio anubis
% 223.84/224.05  |- skos__broader mesh__D048530smesh__D010215
% 223.84/224.05  |- mesh__historyNote mesh__D048530 2005   
% 223.84/224.05  |- mesh__recordAuthorizer mesh__D048530 sjn
% 223.84/224.05  |- mesh__dateEstablished mesh__D048530 2005-01-01
% 223.84/224.05  |- mesh__dateRevised mesh__D048530 2005-06-30
% 223.84/224.05  |- skos__broader mesh__D015356smesh__D012164
% 223.84/224.05  |- skos__hiddenLabel mesh__D015356 Occlusion, Retinal Artery
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015356 1993
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015356 2004
% 223.84/224.05  |- mesh__recordAuthorizer mesh__D015356 PLS
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015356 1996
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015356 1995
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015356 1998
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015356 2006
% 223.84/224.05  |- mesh__dateCreated mesh__D015356 1988-06-02
% 223.84/224.05  |- skos__hiddenLabel mesh__D015356 Retinal Artery Occlusions
% 223.84/224.05  |- mesh__dateEstablished mesh__D015356 1989-01-01
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015356 1992
% 223.84/224.05  |- mesh__historyNote mesh__D015356 89   
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015356 2003
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015356 1994
% 223.84/224.05  |- skos__scopeNote mesh__D015356
% 223.84/224.05       Occlusion or closure of the central retinal artery causing sudden, usually nearly complete, loss of vision in one eye. Occlusion of the branch retinal artery causes sudden visual loss in only a portion of the visual field.%A%    
% 223.84/224.05  |- skos__historyNote mesh__D015356 Retinal Artery %28%1973-1988%29%
% 223.84/224.05  |- mesh__publicMeSHNote mesh__D015356 89   
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015356 2005
% 223.84/224.05  |- skos__historyNote mesh__D015356
% 223.84/224.05       Arterial Occlusive Diseases %28%1972-1988%29%
% 223.84/224.05  |- skos__historyNote mesh__D015356 Retinal Diseases %28%1972-1988%29%
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015356 2002
% 223.84/224.05  |- skos__broader mesh__D015356smesh__D001157
% 223.84/224.05  |- skos__hiddenLabel mesh__D015356 Occlusions, Retinal Artery
% 223.84/224.05  |- mesh__recordOriginator mesh__D015356 EC
% 223.84/224.05  |- rdf__type mesh__D015356sskos__Concept
% 223.84/224.05  |- mesh__dateRevised mesh__D015356 1991-06-18
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015356 2001
% 223.84/224.05  |- skos__prefLabel mesh__D015356 Retinal Artery Occlusion
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015356 1997
% 223.84/224.05  |- mesh__recordMaintainer mesh__D015356 TGC
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015356 1999
% 223.84/224.05  |- mesh__activeMeSHYear mesh__D015356 2000
% 223.84/224.05  |- mesh__dateCreated mesh__D001336 1999-01-01
% 223.84/224.06  |- mesh__activeMeSHYear mesh__D001336 1996
% 223.84/224.06  |- mesh__recordOriginator mesh__D001336 NLM
% 223.84/224.06  |- skos__related mesh__D001336smesh__D012622
% 223.84/224.06  |- skos__scopeNote mesh__D001336
% 223.84/224.06       A usually four-wheeled automotive vehicle designed for passenger transportation and commonly propelled by an internal-combustion engine using a volatile fuel. %28%Webster, 1973%29%%A%    
% 223.84/224.06  |- mesh__activeMeSHYear mesh__D001336 2000
% 223.84/224.06  |- mesh__activeMeSHYear mesh__D001336 2003
% 223.84/224.06  |- mesh__activeMeSHYear mesh__D001336 1997
% 223.84/224.06  |- skos__hiddenLabel mesh__D001336 Automobile
% 223.84/224.06  |- mesh__activeMeSHYear mesh__D001336 2001
% 223.84/224.06  |- mesh__activeMeSHYear mesh__D001336 2004
% 223.84/224.06  |- mesh__activeMeSHYear mesh__D001336 1998
% 223.84/224.06  |- skos__broader mesh__D001336smesh__D018986
% 223.84/224.06  |- mesh__activeMeSHYear mesh__D001336 2002
% 223.84/224.06  |- mesh__dateRevised mesh__D001336 1995-05-31
% 223.84/224.06  |- skos__prefLabel mesh__D001336 Automobiles
% 223.84/224.06  |- mesh__activeMeSHYear mesh__D001336 2005
% 223.84/224.06  |- mesh__activeMeSHYear mesh__D001336 1999
% 223.84/224.06  |- mesh__recordMaintainer mesh__D001336 JLS
% 223.84/224.06  |- mesh__activeMeSHYear mesh__D001336 2006
% 223.84/224.06  |- skos__related mesh__D001336smesh__D017278
% 223.84/224.06  |- mesh__recordAuthorizer mesh__D001336 PLS
% 223.84/224.06  |- rdf__type mesh__D001336sskos__Concept
% 223.84/224.06  |- skos__historyNote mesh__D006021 Glycoproteins %28%1966-1976%29%
% 223.84/224.06  |- skos__scopeNote mesh__D006021
% 223.84/224.06       The major sialoglycoprotein of the human erythrocyte membrane. It consists of at least two sialoglycopeptides and is composed of 60%25% carbohydrate including sialic acid and 40%25% protein. It is involved in a number of different biological activities including the binding of MN blood groups, influenza viruses, kidney bean phytohemagglutinin, and wheat germ agglutinin.%A%    
% 223.84/224.06  |- skos__hiddenLabel mesh__D006021 Sialoglycoprotein, Ss
% 223.84/224.06  |- mesh__dateRevised mesh__D006021 2004-07-13
% 223.84/224.06  |- mesh__activeMeSHYear mesh__D006021 2006
% 223.84/224.06  |- skos__prefLabel mesh__D006021 Glycophorin
% 223.84/224.06  |- skos__annotation mesh__D006021 an erythrocyte protein   
% 223.84/224.06  |- skos__historyNote mesh__D006021 Erythrocytes %28%1966-1976%29%
% 223.84/224.06  |- mesh__dateCreated mesh__D006021 1976-05-05
% 223.84/224.06  |- skos__historyNote mesh__D006021 Neuraminic Acids %28%1966-1976%29%
% 223.84/224.06  |- skos__altLabel mesh__D006021 beta-Sialoglycoprotein
% 223.84/224.06  |- skos__broader mesh__D006021smesh__D001798
% 223.84/224.06  |- mesh__publicMeSHNote mesh__D006021
% 223.84/224.06       91; was see under SIALOGLYCOPROTEINS 1977-90   
% 223.84/224.06  |- skos__altLabel mesh__D006021 MN Sialoglycoprotein
% 223.84/224.06  |- skos__altLabel mesh__D006021 Red Blood Cell Membrane Sialoglycoprotein
% 223.84/224.06  |- skos__hiddenLabel mesh__D006021 Sialoglycoprotein, MN
% 223.84/224.06  |- skos__broader mesh__D006021smesh__D012795
% 223.84/224.06  |- rdf__type mesh__D006021sskos__Concept
% 223.84/224.06  |- skos__hiddenLabel mesh__D006021 Sialoglycoprotein, Erythrocyte
% 223.84/224.06  |- mesh__dateEstablished mesh__D006021 1991-01-01
% 223.84/224.06  |- skos__altLabel mesh__D006021 Erythrocyte Sialoglycoprotein
% 223.84/224.06  |- mesh__recordOriginator mesh__D006021 RLS
% 223.84/224.06  |- skos__hiddenLabel mesh__D006021 beta Sialoglycoprotein
% 223.84/224.06  |- skos__altLabel mesh__D006021 Glycoconnectin
% 223.84/224.06  |- mesh__recordAuthorizer mesh__D006021 sjn
% 223.84/224.06  |- skos__historyNote mesh__D006021 Sialic Acids %28%1975-1976%29%
% 223.84/224.06  |- skos__altLabel mesh__D006021 Ss Sialoglycoprotein
% 223.84/224.06  |- mesh__historyNote mesh__D006021
% 223.84/224.06       91%28%77%29%; was see under SIALOGLYCOPROTEINS 1977-90   
% 223.84/224.06  |- skos__historyNote mesh__D006021 Glycopeptides %28%1973-1976%29%
% 223.84/224.06  |- mesh__activeMeSHYear mesh__D006021 2005
% 223.84/224.06  |- mesh__recordMaintainer mesh__D006021 sjn
% 223.84/224.06  |- skos__broader mesh__D019747smesh__D019746
% 223.84/224.06  |- mesh__publicMeSHNote mesh__D019747 98   
% 223.84/224.06  |- skos__hiddenLabel mesh__D019747 Aldose Ketose Isomerases
% 223.84/224.06  |- mesh__historyNote mesh__D019747 98   
% 223.84/224.06  |- skos__altLabel mesh__D019747 Ketose-Aldose Isomerases
% 223.84/224.06  |- mesh__activeMeSHYear mesh__D019747 2005
% 223.84/224.06  |- mesh__dateCreated mesh__D019747 1997-06-20
% 223.84/224.06  |- mesh__activeMeSHYear mesh__D019747 2006
% 223.84/224.06  |- mesh__dateEstablished mesh__D019747 1998-01-01
% 223.84/224.06  |- skos__prefLabel mesh__D019747 Aldose-Ketose Isomerases
% 223.84/224.06  |- skos__scopeNote mesh__D019747
% 223.84/224.06       Enzymes that catalyze the interconversion of aldoses and ketoses. EC 5.3.1.%A%    
% 223.84/224.06  |- mesh__activeMeSHYear mesh__D019747 2004
% 223.84/224.06  |- rdf__type mesh__D019747sskos__Concept
% 223.84/224.06  |- skos__hiddenLabel mesh__D019747 Isomerases, Aldose-Ketose
% 223.84/224.06  |- skos__hiddenLabel mesh__D019747 Ketose Aldose Isomerases
% 223.84/224.06  |- skos__hiddenLabel mesh__D019747 Isomerases, Ketose-Aldose
% 223.84/224.06  |- mesh__dateRevised mesh__D019747 2003-07-09
% 223.84/224.06  |- skos__annotation mesh__D011764 an antifungal antibiotic   
% 223.84/224.06  |- skos__historyNote mesh__D011764 Nitrobenzenes %28%1972-1974%29%
% 223.84/224.06  |- mesh__recordMaintainer mesh__D011764 ssb
% 223.84/224.06  |- mesh__dateRevised mesh__D011764 2005-06-30
% 223.84/224.06  |- skos__scopeNote mesh__D011764
% 223.84/224.06       3-Chloro-4-%28%3-chloro-2-nitrophenyl%29%pyrrole. Antifungal antibiotic isolated from Pseudomonas pyrrocinia. It is effective mainly against Trichophyton, Microsporium, Epidermophyton, and Penicillium.%A%    
% 223.84/224.06  |- skos__historyNote mesh__D011764
% 223.84/224.06       Antibiotics, Antifungal %28%1972-1974%29%
% 223.84/224.06  |- mesh__dateEstablished mesh__D011764 1991-01-01
% 223.84/224.07  |- skos__historyNote mesh__D011764 Pyrroles %28%1969-1974%29%
% 223.84/224.07  |- mesh__recordOriginator mesh__D011764 NLM
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D011764 2006
% 223.84/224.07  |- skos__prefLabel mesh__D011764 Pyrrolnitrin
% 223.84/224.07  |- mesh__recordAuthorizer mesh__D011764 sjn
% 223.84/224.07  |- skos__broader mesh__D011764smesh__D011758
% 223.84/224.07  |- mesh__dateCreated mesh__D011764 1974-11-19
% 223.84/224.07  |- mesh__publicMeSHNote mesh__D011764
% 223.84/224.07       91; was see under ANTIBIOTICS, ANTIFUNGAL 1975-90   
% 223.84/224.07  |- mesh__historyNote mesh__D011764
% 223.84/224.07       91%28%75%29%; was see under ANTIBIOTICS, ANTIFUNGAL 1975-90   
% 223.84/224.07  |- rdf__type mesh__D011764sskos__Concept
% 223.84/224.07  |- skos__altLabel mesh__D044140 Angiotensin II Type 1a Receptor
% 223.84/224.07  |- skos__altLabel mesh__D044140 Receptor, Angiotensin II Type 1b
% 223.84/224.07  |- skos__hiddenLabel mesh__D044140 AT1b Receptor, Angiotensin
% 223.84/224.07  |- skos__hiddenLabel mesh__D044140 AT1a Receptor, Angiotensin
% 223.84/224.07  |- mesh__dateEstablished mesh__D044140 2004-01-01
% 223.84/224.07  |- skos__altLabel mesh__D044140 Angiotensin AT1 Receptor
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D044140 2006
% 223.84/224.07  |- skos__altLabel mesh__D044140 Receptor, Angiotensin II Type 1
% 223.84/224.07  |- mesh__recordOriginator mesh__D044140 jmp
% 223.84/224.07  |- skos__altLabel mesh__D044140 Angiotensin Type 1 Receptor
% 223.84/224.07  |- mesh__dateRevised mesh__D044140 2004-10-20
% 223.84/224.07  |- rdf__type mesh__D044140sskos__Concept
% 223.84/224.07  |- skos__altLabel mesh__D044140 Angiotensin AT1b Receptor
% 223.84/224.07  |- skos__broader mesh__D044140smesh__D011945
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D044140 2005A
% 223.84/224.07  |- mesh__publicMeSHNote mesh__D044140
% 223.84/224.07       2004; ANGIOTENSIN II TYPE 1 RECEPTOR %28%now RECEPTOR, ANGIOTENSIN, TYPE 1%29% was indexed under RECEPTORS, ANGIOTENSIN 1996-2003; ANGIOTENSIN II TYPE 1A RECEPTOR was indexed under RECEPTORS, ANGIOTENSIN 1995-2003; ANGIOTENSIN II TYPE 1B RECEPTOR was indexed under RECEPTORS, ANGIOTENSIN 1997-2003%A%  
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D044140 2005
% 223.84/224.07  |- skos__hiddenLabel mesh__D044140 Receptor, Angiotensin AT1a
% 223.84/224.07  |- skos__altLabel mesh__D044140 Angiotensin II Type 1 Receptor
% 223.84/224.07  |- mesh__dateCreated mesh__D044140 2003-07-09
% 223.84/224.07  |- skos__prefLabel mesh__D044140 Receptor, Angiotensin, Type 1
% 223.84/224.07  |- skos__historyNote mesh__D044140 Receptors, Angiotensin %28%1996-2003%29%
% 223.84/224.07  |- skos__hiddenLabel mesh__D044140 Receptor, Angiotensin AT1b
% 223.84/224.07  |- skos__scopeNote mesh__D044140
% 223.84/224.07       An angiotensin receptor subtype that is expressed at high levels in a variety of adult tissues including the CARDIOVASCULAR SYSTEM, the KIDNEY, the ENDOCRINE SYSTEM and the NERVOUS SYSTEM. Activation of the type 1 angiotensin receptor causes VASOCONSTRICTION and sodium retention.%A%    
% 223.84/224.07  |- skos__altLabel mesh__D044140 Receptor, Angiotensin II Type 1a
% 223.84/224.07  |- skos__hiddenLabel mesh__D044140 AT1 Receptor, Angiotensin
% 223.84/224.07  |- skos__altLabel mesh__D044140 Angiotensin AT1a Receptor
% 223.84/224.07  |- skos__hiddenLabel mesh__D044140 Receptor, Angiotensin AT1
% 223.84/224.07  |- skos__altLabel mesh__D044140 Angiotensin Type 1b Receptor
% 223.84/224.07  |- skos__altLabel mesh__D044140 Angiotensin II Type 1b Receptor
% 223.84/224.07  |- mesh__historyNote mesh__D044140
% 223.84/224.07       2004; use RECEPTOR, ANGIOTENSIN, TYPE 1%28%NM%29% 1996-2003   
% 223.84/224.07  |- mesh__recordAuthorizer mesh__D044140 sjn
% 223.84/224.07  |- skos__altLabel mesh__D044140 Angiotensin Type 1a Receptor
% 223.84/224.07  |- mesh__recordMaintainer mesh__D044140 sjn
% 223.84/224.07  |- skos__prefLabel mesh__D038901 Mental Retardation, X-Linked
% 223.84/224.07  |- skos__altLabel mesh__D038901 X-Linked Mental Retardation Syndromes
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D038901 2006
% 223.84/224.07  |- skos__hiddenLabel mesh__D038901 X Linked Mental Retardation Syndromes
% 223.84/224.07  |- mesh__dateCreated mesh__D038901 2002-07-03
% 223.84/224.07  |- rdf__type mesh__D038901sskos__Concept
% 223.84/224.07  |- mesh__recordMaintainer mesh__D038901 jls
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D038901 2003
% 223.84/224.07  |- skos__broader mesh__D038901smesh__D020271
% 223.84/224.07  |- skos__historyNote mesh__D038901
% 223.84/224.07       Mental Retardation/genetics %28%1971-2002%29%
% 223.84/224.07  |- skos__broader mesh__D038901smesh__D040181
% 223.84/224.07  |- mesh__dateEstablished mesh__D038901 2003-01-01
% 223.84/224.07  |- skos__hiddenLabel mesh__D038901 X Linked Mental Retardation
% 223.84/224.07  |- mesh__dateRevised mesh__D038901 2004-07-28
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D038901 2004
% 223.84/224.07  |- mesh__publicMeSHNote mesh__D038901 2003   
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D038901 2005A
% 223.84/224.07  |- skos__scopeNote mesh__D038901
% 223.84/224.07       A class of genetic disorders resulting in mental retardation that is associated either with mutations of GENES located on the X CHROMOSOME or aberrations in the structure of the X chromosome %28%SEX CHROMOSOME ABERRATIONS%29%.%A%    
% 223.84/224.07  |- skos__hiddenLabel mesh__D038901 Mental Retardation, X Linked
% 223.84/224.07  |- mesh__historyNote mesh__D038901 2003   
% 223.84/224.07  |- mesh__recordOriginator mesh__D038901 jmp
% 223.84/224.07  |- skos__hiddenLabel mesh__D038901 Retardation, X-Linked Mental
% 223.84/224.07  |- skos__hiddenLabel mesh__D038901 X-Linked Mental Retardations
% 223.84/224.07  |- skos__altLabel mesh__D038901 X-Linked Mental Retardation
% 223.84/224.07  |- mesh__recordAuthorizer mesh__D038901 jls
% 223.84/224.07  |- skos__hiddenLabel mesh__D038901 X Linked Mental Retardation Disorders
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D038901 2005
% 223.84/224.07  |- skos__altLabel mesh__D038901 X-Linked Mental Retardation Disorders
% 223.84/224.07  |- skos__broader mesh__D038901smesh__D008607
% 223.84/224.07  |- mesh__recordAuthorizer mesh__D005727 PLS
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005727 1999
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005727 2003
% 223.84/224.07  |- skos__scopeNote mesh__D005727
% 223.84/224.07       Sensory ganglia located on the dorsal spinal roots within the vertebral column. The spinal ganglion cells are pseudounipolar. The single primary branch bifurcates sending a peripheral process to carry sensory information from the periphery and a central branch which relays that information to the spinal cord or brain.%A%    
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005727 2000
% 223.84/224.07  |- skos__broader mesh__D005727smesh__D013126
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005727 2004
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005727 1995
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005727 1996
% 223.84/224.07  |- skos__annotation mesh__D005727 sensory ganglia on spinal nerve roots   
% 223.84/224.07  |- skos__hiddenLabel mesh__D005727 Ganglion, Dorsal Root
% 223.84/224.07  |- skos__broader mesh__D005727smesh__D017950
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005727 2001
% 223.84/224.07  |- skos__prefLabel mesh__D005727 Ganglia, Spinal
% 223.84/224.07  |- skos__altLabel mesh__D005727 Dorsal Root Ganglia
% 223.84/224.07  |- skos__altLabel mesh__D005727 Spinal Ganglia
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005727 2005
% 223.84/224.07  |- mesh__recordMaintainer mesh__D005727 TGC
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005727 1997
% 223.84/224.07  |- skos__hiddenLabel mesh__D005727 Spinal Ganglion
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005727 2002
% 223.84/224.07  |- mesh__recordOriginator mesh__D005727 NLM
% 223.84/224.07  |- skos__altLabel mesh__D005727 Dorsal Root Ganglion
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005727 2006
% 223.84/224.07  |- skos__hiddenLabel mesh__D005727 Ganglia, Dorsal Root
% 223.84/224.07  |- skos__altLabel mesh__D005727 Ganglion, Spinal
% 223.84/224.07  |- rdf__type mesh__D005727sskos__Concept
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005727 1998
% 223.84/224.07  |- mesh__dateRevised mesh__D005727 1994-06-03
% 223.84/224.07  |- mesh__dateCreated mesh__D005727 1999-01-01
% 223.84/224.07  |- skos__historyNote mesh__D048531 Haplorhini %28%1966-1971%29%
% 223.84/224.07  |- skos__historyNote mesh__D048531 Papio %28%1972-2004%29%
% 223.84/224.07  |- mesh__dateEstablished mesh__D048531 2005-01-01
% 223.84/224.07  |- skos__prefLabel mesh__D048531 Papio papio
% 223.84/224.07  |- mesh__historyNote mesh__D048531 2005   
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D048531 2006
% 223.84/224.07  |- mesh__recordAuthorizer mesh__D048531 sjn
% 223.84/224.07  |- mesh__dateRevised mesh__D048531 2005-06-30
% 223.84/224.07  |- skos__hiddenLabel mesh__D048531 Baboon, Guinea
% 223.84/224.07  |- mesh__recordMaintainer mesh__D048531 ags
% 223.84/224.07  |- mesh__dateCreated mesh__D048531 2004-07-07
% 223.84/224.07  |- skos__altLabel mesh__D048531 Guinea Baboon
% 223.84/224.07  |- rdf__type mesh__D048531sskos__Concept
% 223.84/224.07  |- skos__scopeNote mesh__D048531
% 223.84/224.07       A species of baboon in the family CERCOPITHECIDAE, often used as an animal model for cognitive studies.%A%    
% 223.84/224.07  |- mesh__recordOriginator mesh__D048531 ags
% 223.84/224.07  |- skos__broader mesh__D048531smesh__D010215
% 223.84/224.07  |- mesh__publicMeSHNote mesh__D048531 2005   
% 223.84/224.07  |- skos__hiddenLabel mesh__D015357 Vision Disparities
% 223.84/224.07  |- skos__hiddenLabel mesh__D015357 Visual Disparities
% 223.84/224.07  |- skos__hiddenLabel mesh__D015357 Ocular Parallax
% 223.84/224.07  |- skos__hiddenLabel mesh__D015357 Disparity, Retinal
% 223.84/224.07  |- skos__hiddenLabel mesh__D015357 Retinal Disparities
% 223.84/224.07  |- skos__hiddenLabel mesh__D015357 Disparities, Retinal
% 223.84/224.07  |- mesh__publicMeSHNote mesh__D015357 89   
% 223.84/224.07  |- skos__broader mesh__D015357smesh__D043722
% 223.84/224.07  |- mesh__dateCreated mesh__D015357 1988-06-02
% 223.84/224.07  |- skos__hiddenLabel mesh__D015357 Disparities, Ocular
% 223.84/224.07  |- skos__altLabel mesh__D015357 Ocular Disparity
% 223.84/224.07  |- skos__altLabel mesh__D015357 Fixation Disparity
% 223.84/224.07  |- mesh__recordOriginator mesh__D015357 EC
% 223.84/224.07  |- skos__scopeNote mesh__D015357
% 223.84/224.07       The difference between two images on the retina when looking at a visual stimulus. This occurs since the two retinas do not have the same view of the stimulus because of the location of our eyes. Thus the left eye does not get exactly the same view as the right eye.%A%    
% 223.84/224.07  |- mesh__dateRevised mesh__D015357 2003-07-09
% 223.84/224.07  |- mesh__dateEstablished mesh__D015357 1989-01-01
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D015357 2005
% 223.84/224.07  |- skos__hiddenLabel mesh__D015357 Disparity, Fixation
% 223.84/224.07  |- skos__hiddenLabel mesh__D015357 Disparity, Visual
% 223.84/224.07  |- skos__hiddenLabel mesh__D015357 Binocular Disparities
% 223.84/224.07  |- skos__altLabel mesh__D015357 Visual Disparity
% 223.84/224.07  |- skos__hiddenLabel mesh__D015357 Disparities, Binocular
% 223.84/224.07  |- skos__prefLabel mesh__D015357 Vision Disparity
% 223.84/224.07  |- skos__hiddenLabel mesh__D015357 Fixation Disparities
% 223.84/224.07  |- skos__altLabel mesh__D015357 Binocular Disparity
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D015357 2006
% 223.84/224.07  |- skos__hiddenLabel mesh__D015357 Disparity, Vision
% 223.84/224.07  |- skos__hiddenLabel mesh__D015357 Disparities, Visual
% 223.84/224.07  |- skos__hiddenLabel mesh__D015357 Disparities, Vision
% 223.84/224.07  |- skos__hiddenLabel mesh__D015357 Ocular Disparities
% 223.84/224.07  |- mesh__recordAuthorizer mesh__D015357 sjn
% 223.84/224.07  |- mesh__historyNote mesh__D015357 89   
% 223.84/224.07  |- skos__altLabel mesh__D015357 Parallax, Ocular
% 223.84/224.07  |- skos__broader mesh__D015357smesh__D003867
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D015357 2004
% 223.84/224.07  |- mesh__recordMaintainer mesh__D015357 nns
% 223.84/224.07  |- skos__hiddenLabel mesh__D015357 Disparity, Binocular
% 223.84/224.07  |- skos__hiddenLabel mesh__D015357 Disparity, Ocular
% 223.84/224.07  |- rdf__type mesh__D015357sskos__Concept
% 223.84/224.07  |- skos__hiddenLabel mesh__D015357 Disparities, Fixation
% 223.84/224.07  |- skos__altLabel mesh__D015357 Retinal Disparity
% 223.84/224.07  |- skos__broader mesh__D001337smesh__D018373
% 223.84/224.07  |- skos__altLabel mesh__D001337 Autonomic Drugs
% 223.84/224.07  |- mesh__recordMaintainer mesh__D001337 jls
% 223.84/224.07  |- mesh__historyNote mesh__D001337 82; was AUTONOMIC DRUGS 1963-81   
% 223.84/224.07  |- skos__scopeNote mesh__D001337
% 223.84/224.07       Agents affecting the function of, or mimicking the actions of, the autonomic nervous system and thereby having an effect on such processes as respiration, circulation, digestion, body temperature regulation, certain endocrine gland secretions, etc.%A%    
% 223.84/224.07  |- skos__annotation mesh__D001337
% 223.84/224.07       GEN: avoid; prefer specifics; consider also AUTONOMIC NERVOUS SYSTEM /drug eff%A%  
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D001337 2006A
% 223.84/224.07  |- mesh__recordOriginator mesh__D001337 NLM
% 223.84/224.07  |- skos__prefLabel mesh__D001337 Autonomic Agents
% 223.84/224.07  |- mesh__onlineNote mesh__D001337
% 223.84/224.07       use AUTONOMIC AGENTS to search AUTONOMIC DRUGS 1966-81   
% 223.84/224.07  |- mesh__recordAuthorizer mesh__D001337 jls
% 223.84/224.07  |- skos__hiddenLabel mesh__D001337 Agents, Autonomic
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D001337 2006
% 223.84/224.07  |- mesh__publicMeSHNote mesh__D001337 82; was AUTONOMIC DRUGS 1963-81   
% 223.84/224.07  |- rdf__type mesh__D001337sskos__Concept
% 223.84/224.07  |- skos__hiddenLabel mesh__D001337 Drugs, Autonomic
% 223.84/224.07  |- mesh__dateCreated mesh__D001337 1999-01-01
% 223.84/224.07  |- mesh__dateRevised mesh__D001337 2005-07-29
% 223.84/224.07  |- skos__broader mesh__D006820smesh__D006025
% 223.84/224.07  |- mesh__dateRevised mesh__D006820 2004-07-07
% 223.84/224.07  |- mesh__publicMeSHNote mesh__D006820
% 223.84/224.07       2002; for BIOLON see POLYMETHYL METHACRYLATE 1977-2001   
% 223.84/224.07  |- skos__hiddenLabel mesh__D006820 Vitrax, Amo
% 223.84/224.07  |- rdf__type mesh__D006820sskos__Concept
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D006820 2005
% 223.84/224.07  |- skos__prefLabel mesh__D006820 Hyaluronic Acid
% 223.84/224.07  |- mesh__recordOriginator mesh__D006820 NLM
% 223.84/224.07  |- mesh__historyNote mesh__D006820
% 223.84/224.07       2002; for BIOLON use POLYMETHYL METHACRYLATE 1977-2001   
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D006820 2006
% 223.84/224.07  |- mesh__recordMaintainer mesh__D006820 ssb
% 223.84/224.07  |- skos__hiddenLabel mesh__D006820 Hyaluronate, Sodium
% 223.84/224.07  |- mesh__dateCreated mesh__D006820 1999-01-01
% 223.84/224.07  |- mesh__recordAuthorizer mesh__D006820 sjn
% 223.84/224.07  |- skos__scopeNote mesh__D006820
% 223.84/224.07       A natural high-viscosity mucopolysaccharide with alternating beta %28%1-3%29% glucuronide and beta %28%1-4%29% glucosaminidic bonds. It is found in the umbilical cord, in vitreous humor, in synovial fluid, in pathologic joints, in group A and C hemolytic streptococci, and in Wharton%27%s jelly. A high urinary level is found in PROGERIA.%A%    
% 223.84/224.07  |- skos__hiddenLabel mesh__D006820 Acid, Hyaluronic
% 223.84/224.07  |- skos__hiddenLabel mesh__D006022
% 223.84/224.07       beta N Acetylglucosaminylglycopeptide beta 1,4 Galactosyltransferase
% 223.84/224.07  |- mesh__recordAuthorizer mesh__D006022 sjn
% 223.84/224.07  |- mesh__historyNote mesh__D006022 98%28%76%29%   
% 223.84/224.07  |- skos__broader mesh__D006022smesh__D005700
% 223.84/224.07  |- skos__historyNote mesh__D006022 Hexosyltransferases %28%1973-1975%29%
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D006022 2006
% 223.84/224.07  |- skos__hiddenLabel mesh__D006022 Galactosyltransferase, Thyroid
% 223.84/224.07  |- skos__prefLabel mesh__D006022
% 223.84/224.07       beta-N-Acetylglucosaminylglycopeptide beta-1,4-Galactosyltransferase
% 223.84/224.07  |- skos__hiddenLabel mesh__D006022
% 223.84/224.07       beta N Acetylglucosaminide beta 1 4 Galactosyltransferase
% 223.84/224.07  |- skos__scopeNote mesh__D006022
% 223.84/224.07       An enzyme that catalyzes the transfer of galactose from UDP-galactose to a specific glycoprotein receptor, 2-acetamido-2-deoxy-D-glucosyl-glycopeptide, during glycopeptide synthesis. EC 2.4.1.38.%A%    
% 223.84/224.07  |- skos__hiddenLabel mesh__D006022 beta-Galactosyltransferase, Glycoprotein
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D006022 2005
% 223.84/224.07  |- mesh__publicMeSHNote mesh__D006022
% 223.84/224.07       98; see GLYCOPROTEIN 4-BETA-GALACTOSYLTRANSFERASE 1992-97; see GLYCOPROTEIN BETA-GALACTOSYLTRANSFERASE 1991; see GALACTOSYLTRANSFERASES 1976-90%A%  
% 223.84/224.07  |- rdf__type mesh__D006022sskos__Concept
% 223.84/224.07  |- skos__historyNote mesh__D006022 Galactose %28%1973-1975%29%
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D006022 2004
% 223.84/224.07  |- mesh__dateCreated mesh__D006022 1975-08-01
% 223.84/224.07  |- skos__altLabel mesh__D006022 Glycoprotein beta-Galactosyltransferase
% 223.84/224.07  |- skos__hiddenLabel mesh__D006022
% 223.84/224.07       beta-1,4-Galactosyltransferase, beta-N-Acetylglucosaminylglycopeptide
% 223.84/224.07  |- skos__historyNote mesh__D006022 Glycoproteins %28%1973-1975%29%
% 223.84/224.07  |- skos__hiddenLabel mesh__D006022 Glycoprotein beta Galactosyltransferase
% 223.84/224.07  |- mesh__dateRevised mesh__D006022 2003-07-09
% 223.84/224.07  |- mesh__recordOriginator mesh__D006022 RLS
% 223.84/224.07  |- mesh__dateEstablished mesh__D006022 1991-01-01
% 223.84/224.07  |- mesh__recordMaintainer mesh__D006022 ssb
% 223.84/224.07  |- skos__prefLabel mesh__D019748 Carbon-Carbon Double Bond Isomerases
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D019748 2005
% 223.84/224.07  |- mesh__dateCreated mesh__D019748 1997-06-20
% 223.84/224.07  |- rdf__type mesh__D019748sskos__Concept
% 223.84/224.07  |- skos__hiddenLabel mesh__D019748 Carbon Carbon Double Bond Isomerases
% 223.84/224.07  |- skos__historyNote mesh__D019748 Isomerases %28%1980-1997%29%
% 223.84/224.07  |- mesh__dateRevised mesh__D019748 2003-07-09
% 223.84/224.07  |- mesh__historyNote mesh__D019748 98   
% 223.84/224.07  |- skos__broader mesh__D019748smesh__D019746
% 223.84/224.07  |- skos__scopeNote mesh__D019748
% 223.84/224.07       Enzymes that catalyze the shifting of a carbon-carbon double bond from one position to another within the same molecule. EC 5.3.3.%A%    
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D019748 2004
% 223.84/224.07  |- mesh__dateEstablished mesh__D019748 1998-01-01
% 223.84/224.07  |- skos__altLabel mesh__D019748 C-C Double Bond Isomerases
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D019748 2006
% 223.84/224.07  |- mesh__publicMeSHNote mesh__D019748 98   
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D011765 2004
% 223.84/224.07  |- mesh__dateEstablished mesh__D011765 1991-01-01
% 223.84/224.07  |- mesh__recordOriginator mesh__D011765 NLM
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D011765 2005
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D011765 1999
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D011765 2003
% 223.84/224.07  |- rdf__type mesh__D011765sskos__Concept
% 223.84/224.07  |- skos__altLabel mesh__D011765 Acetylformaldehyde
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D011765 1998
% 223.84/224.07  |- skos__altLabel mesh__D011765 Methylglyoxal
% 223.84/224.07  |- mesh__recordAuthorizer mesh__D011765 SJN
% 223.84/224.07  |- mesh__dateRevised mesh__D011765 1997-06-20
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D011765 2002
% 223.84/224.07  |- mesh__publicMeSHNote mesh__D011765
% 223.84/224.07       91; was see under ALDEHYDES 1975-90   
% 223.84/224.07  |- mesh__recordMaintainer mesh__D011765 TPW
% 223.84/224.07  |- skos__altLabel mesh__D011765 Pyruvic Aldehyde
% 223.84/224.07  |- skos__hiddenLabel mesh__D011765 Aldehyde, Pyruvic
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D011765 2001
% 223.84/224.07  |- skos__prefLabel mesh__D011765 Pyruvaldehyde
% 223.84/224.07  |- mesh__historyNote mesh__D011765
% 223.84/224.07       91%28%75%29%; was see under ALDEHYDES 1975-90   
% 223.84/224.07  |- mesh__dateCreated mesh__D011765 1974-11-19
% 223.84/224.07  |- skos__scopeNote mesh__D011765
% 223.84/224.07       An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals.%A%    
% 223.84/224.07  |- skos__broader mesh__D011765smesh__D006037
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D011765 2006
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D011765 2000
% 223.84/224.07  |- skos__historyNote mesh__D011765 Glyoxal %28%1973-1974%29%
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005728 1995
% 223.84/224.07  |- mesh__onlineNote mesh__D005728
% 223.84/224.07       use GANGLIA, AUTONOMIC to search SYMPATHETIC GANGLIA 1966-79; use CELIAC PLEXUS to search CELIAC GANGLIA 1966-79%A%  
% 223.84/224.07  |- mesh__dateRevised mesh__D005728 1994-06-15
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005728 1996
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005728 2002
% 223.84/224.07  |- skos__historyNote mesh__D005728 Ganglia, Autonomic %28%1966-1979%29%
% 223.84/224.07  |- mesh__recordOriginator mesh__D005728 RC
% 223.84/224.07  |- skos__broader mesh__D005728smesh__D013564
% 223.84/224.07  |- skos__broader mesh__D005728smesh__D005725
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005728 2005
% 223.84/224.07  |- skos__annotation mesh__D005728
% 223.84/224.07       /surg = probably GANGLIONECTOMY; includes cervical, mesenteric %26% celiac ganglia but SUPERIOR CERVICAL GANGLION is available; STELLATE GANGLION is also available%A%  
% 223.84/224.07  |- mesh__historyNote mesh__D005728
% 223.84/224.07       80; SYMPATHETIC GANGLIA was see GANGLIA, AUTONOMIC 1975-79, was see under GANGLIA, AUTONOMIC 1963-74; CELIAC GANGLIA was see CELIAC PLEXUS 1975-79, was see under CELIAC PLEXUS 1963-74%A%  
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005728 1997
% 223.84/224.07  |- mesh__dateEstablished mesh__D005728 1980-01-01
% 223.84/224.07  |- skos__prefLabel mesh__D005728 Ganglia, Sympathetic
% 223.84/224.07  |- skos__hiddenLabel mesh__D005728 Ganglia, Celiac
% 223.84/224.07  |- skos__altLabel mesh__D005728 Sympathetic Ganglia
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005728 2006
% 223.84/224.07  |- skos__altLabel mesh__D005728 Ganglion, Sympathetic
% 223.84/224.07  |- mesh__recordAuthorizer mesh__D005728 PLS
% 223.84/224.07  |- rdf__type mesh__D005728sskos__Concept
% 223.84/224.07  |- mesh__publicMeSHNote mesh__D005728
% 223.84/224.07       80; SYMPATHETIC GANGLIA was see GANGLIA, AUTONOMIC 1975-79, was see under GANGLIA, AUTONOMIC 1963-74; CELIAC GANGLIA was see CELIAC PLEXUS 1975-79, was see under CELIAC PLEXUS 1963-74%A%  
% 223.84/224.07  |- skos__altLabel mesh__D005728 Celiac Ganglion
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005728 1998
% 223.84/224.07  |- skos__scopeNote mesh__D005728
% 223.84/224.07       Ganglia of the sympathetic nervous system including the paravertebral and the prevertebral ganglia. Among these are the sympathetic chain ganglia, the superior, middle, and inferior cervical ganglia, and the aorticorenal, celiac, and stellate ganglia.%A%    
% 223.84/224.07  |- mesh__recordMaintainer mesh__D005728 PLS
% 223.84/224.07  |- skos__hiddenLabel mesh__D005728 Ganglion, Celiac
% 223.84/224.07  |- skos__historyNote mesh__D005728
% 223.84/224.07       Sympathetic Nervous System %28%1966-1979%29%
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005728 2000
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005728 1999
% 223.84/224.07  |- skos__related mesh__D005728smesh__D015171
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005728 2003
% 223.84/224.07  |- skos__hiddenLabel mesh__D005728 Sympathetic Ganglion
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005728 2001
% 223.84/224.07  |- mesh__dateCreated mesh__D005728 1979-05-22
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D005728 2004
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D030121 2006
% 223.84/224.07  |- skos__altLabel mesh__D030121 Oncoviruses Type B, Mammalian
% 223.84/224.07  |- skos__prefLabel mesh__D030121 Betaretrovirus
% 223.84/224.07  |- skos__broader mesh__D030121smesh__D012190
% 223.84/224.07  |- skos__hiddenLabel mesh__D030121 Type D Oncornavirus
% 223.84/224.07  |- skos__hiddenLabel mesh__D030121 Type B Oncovirus
% 223.84/224.07  |- skos__hiddenLabel mesh__D030121 Oncovirus, Type B
% 223.84/224.07  |- mesh__dateEstablished mesh__D030121 2002-01-01
% 223.84/224.07  |- skos__annotation mesh__D030121
% 223.84/224.07       infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%%A%  
% 223.84/224.07  |- skos__hiddenLabel mesh__D030121 Oncornavirus, Type D
% 223.84/224.07  |- skos__altLabel mesh__D030121 Mammalian Type B Retroviruses
% 223.84/224.07  |- rdf__type mesh__D030121sskos__Concept
% 223.84/224.07  |- skos__hiddenLabel mesh__D030121 Type B, Oncoviruses
% 223.84/224.07  |- skos__altLabel mesh__D030121 Type B Retroviruses, Mammalian
% 223.84/224.07  |- skos__altLabel mesh__D030121 Type B Oncoviruses
% 223.84/224.07  |- skos__hiddenLabel mesh__D030121 Type D Oncovirus
% 223.84/224.07  |- skos__hiddenLabel mesh__D030121 Betaretroviruses
% 223.84/224.07  |- mesh__recordOriginator mesh__D030121 ags
% 223.84/224.07  |- mesh__publicMeSHNote mesh__D030121
% 223.84/224.07       2002; for RETROVIRUSES TYPE D see RETROVIRUSES TYPE D 1999-2001, see RETROVIRUSES, TYPE D 1994-1998, see ONCOVIRUSES, TYPE D 1991-1993; for FIBROBLAST VIRUS, HUMAN, PERMANENT see RETROVIRUSES TYPE D 1994-2001, see FIBROBLAST VIRUS, HUMAN, PERMANENT 1991-1993; for RETROVIRUSES TYPE B, MAMMALIAN see RETROVIRUSES TYPE D MAMMALIAN 1994-2001, see ONCOVIRUSES TYPE B, MAMMALIAN 1994-1996, see  MAMMARY CANCER VIRUS 1991-1993; for TYPE B ONCOVIRUSES MAMMALIAN see MAMMARY CANCER VIRUS 1991-1993%A%  
% 223.84/224.07  |- mesh__recordMaintainer mesh__D030121 ags
% 223.84/224.07  |- skos__hiddenLabel mesh__D030121 Retrovirus, Type D
% 223.84/224.07  |- skos__altLabel mesh__D030121 Type D Retroviruses
% 223.84/224.07  |- mesh__recordAuthorizer mesh__D030121 sjn
% 223.84/224.07  |- skos__altLabel mesh__D030121 Type D Oncornaviruses
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D030121 2003
% 223.84/224.07  |- skos__hiddenLabel mesh__D030121 Oncovirus, Type D
% 223.84/224.07  |- skos__hiddenLabel mesh__D030121 Oncornaviruses, Type D
% 223.84/224.07  |- skos__hiddenLabel mesh__D030121 Oncoviruses, Type B
% 223.84/224.07  |- mesh__dateCreated mesh__D030121 2001-07-25
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D030121 2002
% 223.84/224.07  |- skos__altLabel mesh__D030121 Type B Oncoviruses, Mammalian
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D030121 2004
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D030121 2005
% 223.84/224.07  |- skos__hiddenLabel mesh__D030121 Type D Retrovirus
% 223.84/224.07  |- skos__altLabel mesh__D030121 Oncoviruses, Type D
% 223.84/224.07  |- mesh__historyNote mesh__D030121 2002   
% 223.84/224.07  |- skos__altLabel mesh__D030121 Oncoviruses Type B
% 223.84/224.07  |- skos__altLabel mesh__D030121 Retroviruses, Type D
% 223.84/224.07  |- skos__altLabel mesh__D030121 Type D Oncoviruses
% 223.84/224.07  |- skos__scopeNote mesh__D030121
% 223.84/224.07       A genus of the family RETROVIRIDAE consisting of viruses with either type B or type D morphology.  This includes a few exogenous, vertically transmitted and endogenous viruses of mice %28%type B%29% and some primate and sheep viruses %28%type D%29%. MAMMARY TUMOR VIRUS, MOUSE is the type species.%A%    
% 223.84/224.07  |- mesh__dateRevised mesh__D002430 2003-07-09
% 223.84/224.07  |- skos__prefLabel mesh__D002430 Cecal Neoplasms
% 223.84/224.07  |- skos__hiddenLabel mesh__D002430 Neoplasm, Cecal
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D002430 2006
% 223.84/224.07  |- skos__altLabel mesh__D002430 Cecal Cancer
% 223.84/224.07  |- skos__broader mesh__D002430smesh__D002429
% 223.84/224.07  |- mesh__dateCreated mesh__D002430 1999-01-01
% 223.84/224.07  |- skos__altLabel mesh__D002430 Cancer of the Cecum
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D002430 2005
% 223.84/224.07  |- skos__broader mesh__D002430smesh__D007414
% 223.84/224.07  |- skos__altLabel mesh__D002430 Cancer, Cecal
% 223.84/224.07  |- skos__hiddenLabel mesh__D002430 Cecal Neoplasm
% 223.84/224.07  |- mesh__recordAuthorizer mesh__D002430 sjn
% 223.84/224.07  |- rdf__type mesh__D002430sskos__Concept
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D002430 2004
% 223.84/224.07  |- skos__scopeNote mesh__D002430 Tumors or cancer of the CECUM.     
% 223.84/224.07  |- skos__annotation mesh__D002430
% 223.84/224.07       coord IM with histol type of neopl %28%IM%29%   
% 223.84/224.07  |- mesh__recordOriginator mesh__D002430 NLM
% 223.84/224.07  |- mesh__recordMaintainer mesh__D002430 lkt
% 223.84/224.07  |- skos__altLabel mesh__D002430 Neoplasms, Cecal
% 223.84/224.07  |- skos__hiddenLabel mesh__D001338 Postganglionic Autonomic Fibers
% 223.84/224.07  |- skos__broader mesh__D001338smesh__D017776
% 223.84/224.07  |- skos__hiddenLabel mesh__D001338 Postganglionic Autonomic Fiber
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D001338 1997
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D001338 2005
% 223.84/224.07  |- skos__scopeNote mesh__D001338
% 223.84/224.07       Nerve fibers which project from cell bodies of autonomic ganglia to synapses on target organs.%A%    
% 223.84/224.07  |- mesh__recordAuthorizer mesh__D001338 PLS
% 223.84/224.07  |- skos__annotation mesh__D001338
% 223.84/224.07       do not confuse with AUTONOMIC FIBERS, PREGANGLIONIC   
% 223.84/224.07  |- skos__historyNote mesh__D001338 Ganglia, Autonomic %28%1966-1970%29%
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D001338 1996
% 223.84/224.07  |- skos__prefLabel mesh__D001338 Autonomic Fibers, Postganglionic
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D001338 2004
% 223.84/224.07  |- skos__broader mesh__D001338smesh__D009412
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D001338 2003
% 223.84/224.07  |- skos__broader mesh__D001338smesh__D009474
% 223.84/224.07  |- skos__hiddenLabel mesh__D001338 Autonomic Fiber, Postganglionic
% 223.84/224.07  |- mesh__publicMeSHNote mesh__D001338 71   
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D001338 1995
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D001338 2002
% 223.84/224.07  |- mesh__dateCreated mesh__D001338 1999-01-01
% 223.84/224.07  |- skos__hiddenLabel mesh__D001338 Fibers, Postganglionic Autonomic
% 223.84/224.07  |- mesh__recordOriginator mesh__D001338 NLM
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D001338 1999
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D001338 1994
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D001338 2001
% 223.84/224.07  |- mesh__recordMaintainer mesh__D001338 RAZ
% 223.84/224.07  |- mesh__dateEstablished mesh__D001338 1971-01-01
% 223.84/224.07  |- mesh__historyNote mesh__D001338 71   
% 223.84/224.07  |- skos__hiddenLabel mesh__D001338 Fiber, Postganglionic Autonomic
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D001338 1998
% 223.84/224.07  |- mesh__dateRevised mesh__D001338 1993-06-18
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D001338 2006
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D001338 2000
% 223.84/224.07  |- rdf__type mesh__D001338sskos__Concept
% 223.84/224.07  |- mesh__activeMeSHYear mesh__D012060 2006
% 223.84/224.07  |- mesh__recordMaintainer mesh__D012060 lkt
% 223.84/224.07  |- mesh__recordOriginator mesh__D012060 NLM
% 223.84/224.07  |- mesh__recordAuthorizer mesh__D012060 sjn
% 223.84/224.07  |- skos__scopeNote mesh__D012060
% 223.84/224.07       The phenomenon of youthfulness, vitality, and freshness being restored. This can apply to appearance, TISSUES, organ functions, or other areas.%A%    
% 223.84/224.07  |- rdf__type mesh__D012060sskos__Concept
% 223.84/224.07  |- skos__prefLabel mesh__D012060 Rejuvenation
% 223.84/224.07  |- mesh__dateCreated mesh__D012060 1999-01-01
% 223.84/224.07  |- skos__broader mesh__D012060smesh__D013812
% 223.84/224.07  |- skos__broader mesh__D012060smesh__D000529
% 223.84/224.07  |- mesh__dateRevised mesh__D012060 2005-06-30
% 223.84/224.08  |- mesh__publicMeSHNote mesh__D006821 98; see HYALURONIDASE 1963-97   
% 223.84/224.08  |- skos__altLabel mesh__D006821 Hyaglosidase
% 223.84/224.08  |- mesh__recordAuthorizer mesh__D006821 sjn
% 223.84/224.08  |- skos__altLabel mesh__D006821 Duran-Reynals Permeability Factor
% 223.84/224.08  |- mesh__dateRevised mesh__D006821 2003-07-09
% 223.84/224.08  |- skos__hiddenLabel mesh__D006821 Permeability Factor, Duran-Reynals
% 223.84/224.08  |- rdf__type mesh__D006821sskos__Concept
% 223.84/224.08  |- skos__hiddenLabel mesh__D006821 Duran Reynals Permeability Factor
% 223.84/224.08  |- skos__altLabel mesh__D006821 GL Enzyme
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D006821 2005
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D006821 2004
% 223.84/224.08  |- mesh__historyNote mesh__D006821 98%28%63%29%   
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D006821 2006
% 223.84/224.08  |- skos__altLabel mesh__D006821 Hyaluronate Hydrolase
% 223.84/224.08  |- skos__prefLabel mesh__D006821 Hyaluronoglucosaminidase
% 223.84/224.08  |- skos__altLabel mesh__D006821 Hyaluronidase
% 223.84/224.08  |- skos__hiddenLabel mesh__D006821 Hydrolase, Hyaluronate
% 223.84/224.08  |- mesh__dateCreated mesh__D006821 1999-01-01
% 223.84/224.08  |- mesh__recordOriginator mesh__D006821 NLM
% 223.84/224.08  |- skos__scopeNote mesh__D006821
% 223.84/224.08       An enzyme that catalyzes the random hydrolysis of 1,4-linkages between N-acetyl-beta-D-glucosamine and D-glucuronate residues in hyaluronate. %28%From Enzyme Nomenclature, 1992%29%%A%    
% 223.84/224.08  |- skos__broader mesh__D006821smesh__D011133
% 223.84/224.08  |- mesh__recordMaintainer mesh__D006821 ssb
% 223.84/224.08  |- skos__hiddenLabel mesh__D006821 Factor, Duran-Reynals Permeability
% 223.84/224.08  |- skos__broader mesh__D006821smesh__D006026
% 223.84/224.08  |- mesh__dateRevised mesh__D006023 2005-06-30
% 223.84/224.08  |- mesh__recordMaintainer mesh__D006023 SYSTEM
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D006023 2006
% 223.84/224.08  |- skos__broader mesh__D006023smesh__D006001
% 223.84/224.08  |- mesh__recordAuthorizer mesh__D006023 sjn
% 223.84/224.08  |- mesh__recordOriginator mesh__D006023 NLM
% 223.84/224.08  |- rdf__type mesh__D006023sskos__Concept
% 223.84/224.08  |- mesh__publicMeSHNote mesh__D006023
% 223.84/224.08       THROMBOPOIETIN was see under BLOOD PLATELETS 1975   
% 223.84/224.08  |- skos__scopeNote mesh__D006023
% 223.84/224.08       Conjugated protein-carbohydrate compounds including mucins, mucoid, and amyloid glycoproteins.%A%    
% 223.84/224.08  |- skos__altLabel mesh__D006023 Glycoprotein
% 223.84/224.08  |- skos__broader mesh__D006023smesh__D011506
% 223.84/224.08  |- skos__annotation mesh__D006023 GEN; prefer specifics   
% 223.84/224.08  |- skos__prefLabel mesh__D006023 Glycoproteins
% 223.84/224.08  |- mesh__dateCreated mesh__D006023 1999-01-01
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D019749 2006
% 223.84/224.08  |- rdf__type mesh__D019749sskos__Concept
% 223.84/224.08  |- mesh__dateCreated mesh__D019749 1997-07-14
% 223.84/224.08  |- skos__hiddenLabel mesh__D019749 Sulfur Sulfur Bond Isomerases
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D019749 2005
% 223.84/224.08  |- skos__hiddenLabel mesh__D019749 Isomerases, Sulfur-Sulfur Bond
% 223.84/224.08  |- mesh__historyNote mesh__D019749 98   
% 223.84/224.08  |- skos__prefLabel mesh__D019749 Sulfur-Sulfur Bond Isomerases
% 223.84/224.08  |- skos__historyNote mesh__D019749 Isomerases %28%1977-1997%29%
% 223.84/224.08  |- mesh__dateRevised mesh__D019749 2003-07-09
% 223.84/224.08  |- skos__altLabel mesh__D019749 S-S Bond Isomerases
% 223.84/224.08  |- skos__scopeNote mesh__D019749
% 223.84/224.08       Enzymes that catalyze the transposition of a sulfur-sulfur bond. EC 5.3.4.%A%    
% 223.84/224.08  |- mesh__dateEstablished mesh__D019749 1998-01-01
% 223.84/224.08  |- skos__hiddenLabel mesh__D019749 Bond Isomerases, Sulfur-Sulfur
% 223.84/224.08  |- skos__hiddenLabel mesh__D019749 Isomerases, S-S Bond
% 223.84/224.08  |- mesh__publicMeSHNote mesh__D019749 98   
% 223.84/224.08  |- skos__broader mesh__D019749smesh__D019746
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D019749 2004
% 223.84/224.08  |- skos__hiddenLabel mesh__D019749 Bond Isomerases, S-S
% 223.84/224.08  |- skos__related mesh__D011766smesh__D015324
% 223.84/224.08  |- skos__broader mesh__D011766smesh__D019735
% 223.84/224.08  |- mesh__recordOriginator mesh__D011766 NLM
% 223.84/224.08  |- mesh__publicMeSHNote mesh__D011766 74   
% 223.84/224.08  |- mesh__dateRevised mesh__D011766 2003-07-09
% 223.84/224.08  |- skos__prefLabel mesh__D011766 Pyruvate Carboxylase
% 223.84/224.08  |- mesh__recordAuthorizer mesh__D011766 sjn
% 223.84/224.08  |- mesh__historyNote mesh__D011766 74   
% 223.84/224.08  |- mesh__recordMaintainer mesh__D011766 ssb
% 223.84/224.08  |- mesh__dateCreated mesh__D011766 1999-01-01
% 223.84/224.08  |- skos__scopeNote mesh__D011766
% 223.84/224.08       A biotin-dependent enzyme belonging to the ligase family that catalyzes the addition of CARBON DIOXIDE to pyruvate. It is occurs in both plants and animals. Deficiency of this enzyme causes severe psychomotor retardation and ACIDOSIS, LACTIC in infants. EC 6.4.1.1.%A%    
% 223.84/224.08  |- mesh__dateEstablished mesh__D011766 1974-01-01
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D011766 2006
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D011766 2004
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D011766 2005
% 223.84/224.08  |- skos__hiddenLabel mesh__D011766 Carboxylase, Pyruvate
% 223.84/224.08  |- rdf__type mesh__D011766sskos__Concept
% 223.84/224.08  |- skos__historyNote mesh__D044142 Pasteurella %28%1969-2003%29%
% 223.84/224.08  |- mesh__publicMeSHNote mesh__D044142 2004   
% 223.84/224.08  |- skos__prefLabel mesh__D044142 Pasteurella pneumotropica
% 223.84/224.08  |- mesh__recordMaintainer mesh__D044142 SYSTEM
% 223.84/224.08  |- mesh__recordOriginator mesh__D044142 ags
% 223.84/224.08  |- mesh__recordAuthorizer mesh__D044142 sjn
% 223.84/224.08  |- mesh__dateRevised mesh__D044142 2005-06-30
% 223.84/224.08  |- mesh__dateEstablished mesh__D044142 2004-01-01
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D044142 2006
% 223.84/224.08  |- skos__broader mesh__D044142smesh__D010325
% 223.84/224.08  |- rdf__type mesh__D044142sskos__Concept
% 223.84/224.08  |- mesh__historyNote mesh__D044142 2004   
% 223.84/224.08  |- mesh__dateCreated mesh__D044142 2003-07-09
% 223.84/224.08  |- skos__scopeNote mesh__D044142
% 223.84/224.08       A species of gram-negative bacteria in the genus PASTEURELLA, found in the  NASOPHARYNX of normal GUINEA PIGS; RATS; HAMSTERS; MICE; DOGS; and CATS. When associated with disease, it is usually a secondary invader. Occasional infections have been reported in humans.%A%    
% 223.84/224.08  |- skos__annotation mesh__D044142
% 223.84/224.08       infection: coord IM with PASTEURELLA INFECTIONS %28%IM%29%   
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D005729 2001
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D005729 2006
% 223.84/224.08  |- mesh__dateRevised mesh__D005729 1999-11-08
% 223.84/224.08  |- skos__hiddenLabel mesh__D005729 Gangliocytomas
% 223.84/224.08  |- rdf__type mesh__D005729sskos__Concept
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D005729 2002
% 223.84/224.08  |- skos__prefLabel mesh__D005729 Ganglioneuroma
% 223.84/224.08  |- mesh__recordMaintainer mesh__D005729 adp
% 223.84/224.08  |- skos__altLabel mesh__D005729 Gangliocytoma
% 223.84/224.08  |- mesh__dateCreated mesh__D005729 1999-01-01
% 223.84/224.08  |- skos__broader mesh__D005729smesh__D018302
% 223.84/224.08  |- mesh__recordAuthorizer mesh__D005729 sjn
% 223.84/224.08  |- mesh__recordOriginator mesh__D005729 NLM
% 223.84/224.08  |- skos__hiddenLabel mesh__D005729 Ganglioneuromas
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D005729 2003
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D005729 2004
% 223.84/224.08  |- skos__scopeNote mesh__D005729
% 223.84/224.08       A benign neoplasm that usually arises from the sympathetic trunk in the mediastinum. Histologic features include spindle cell proliferation %28%resembling a neurofibroma%29% and the presence of large ganglion cells. The tumor may present clinically with HORNER SYNDROME or diarrhea due to ectopic production of vasoactive intestinal peptide. %28%From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p966%29%%A%    
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D005729 2000
% 223.84/224.08  |- skos__annotation mesh__D005729
% 223.84/224.08       coord IM with precoord organ/neopl term %28%IM%29%   
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D005729 2005
% 223.84/224.08  |- skos__hiddenLabel mesh__D002431 Cecostomy, Tube
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D002431 2000
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D002431 2005
% 223.84/224.08  |- skos__hiddenLabel mesh__D002431 Cecostomies
% 223.84/224.08  |- mesh__publicMeSHNote mesh__D002431
% 223.84/224.08       91; was see under ENTEROSTOMY 1988-90   
% 223.84/224.08  |- skos__historyNote mesh__D002431 Cecum/surgery %28%1966-1987%29%
% 223.84/224.08  |- mesh__recordMaintainer mesh__D002431 PXP
% 223.84/224.08  |- skos__annotation mesh__D002431
% 223.84/224.08       do not use /util except by MeSH definition   
% 223.84/224.08  |- mesh__historyNote mesh__D002431
% 223.84/224.08       91%28%88%29%; was see under ENTEROSTOMY 1988-90   
% 223.84/224.08  |- mesh__dateEstablished mesh__D002431 1991-01-01
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D002431 1999
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D002431 2002
% 223.84/224.08  |- rdf__type mesh__D002431sskos__Concept
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D002431 2004
% 223.84/224.08  |- mesh__dateCreated mesh__D002431 1987-03-19
% 223.84/224.08  |- skos__prefLabel mesh__D002431 Cecostomy
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D002431 1998
% 223.84/224.08  |- mesh__recordOriginator mesh__D002431 SCD
% 223.84/224.08  |- mesh__dateRevised mesh__D002431 1997-06-20
% 223.84/224.08  |- skos__broader mesh__D002431smesh__D004766
% 223.84/224.08  |- skos__hiddenLabel mesh__D002431 Cecostomies, Tube
% 223.84/224.08  |- skos__historyNote mesh__D002431 Cecal Diseases/surgery %28%1966-1987%29%
% 223.84/224.08  |- mesh__recordAuthorizer mesh__D002431 SJN
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D002431 2003
% 223.84/224.08  |- skos__scopeNote mesh__D002431
% 223.84/224.08       Surgical construction of an opening into the cecum with a tube through the abdominal wall %28%tube cecostomy%29% or by skin level approach, in which the cecum is sewn to the surrounding peritoneum. Its primary purpose is decompression of colonic obstruction.%A%    
% 223.84/224.08  |- skos__hiddenLabel mesh__D002431 Tube Cecostomies
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D002431 2001
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D002431 2006
% 223.84/224.08  |- mesh__historyNote mesh__D015359 89   
% 223.84/224.08  |- skos__historyNote mesh__D015359 Mycobacterium %28%1966-1988%29%
% 223.84/224.08  |- skos__historyNote mesh__D015359
% 223.84/224.08       Mycobacterium, Atypical %28%1966-1988%29%
% 223.84/224.08  |- skos__prefLabel mesh__D015359 Mycobacterium scrofulaceum
% 223.84/224.08  |- mesh__recordOriginator mesh__D015359 EC
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D015359 2006
% 223.84/224.08  |- mesh__recordMaintainer mesh__D015359 SYSTEM
% 223.84/224.08  |- mesh__recordAuthorizer mesh__D015359 sjn
% 223.84/224.08  |- mesh__dateCreated mesh__D015359 1988-06-02
% 223.84/224.08  |- mesh__dateEstablished mesh__D015359 1989-01-01
% 223.84/224.08  |- mesh__dateRevised mesh__D015359 2005-06-30
% 223.84/224.08  |- skos__scopeNote mesh__D015359
% 223.84/224.08       A non-tuberculous mycobacterium causing cervical lymphadenitis in children. It very rarely causes pulmonary disease, and is believed to be non-pathogenic in animals.%A%    
% 223.84/224.08  |- mesh__publicMeSHNote mesh__D015359 89   
% 223.84/224.08  |- skos__annotation mesh__D015359
% 223.84/224.08       infection: coord IM with MYCOBACTERIUM INFECTIONS, ATYPICAL %28%IM%29%; DF: MYCOBACT SCROFULACEUM%A%  
% 223.84/224.08  |- rdf__type mesh__D015359sskos__Concept
% 223.84/224.08  |- skos__broader mesh__D015359smesh__D009170
% 223.84/224.08  |- mesh__dateEstablished mesh__D001339 1971-01-01
% 223.84/224.08  |- skos__broader mesh__D001339smesh__D002799
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D001339 2004
% 223.84/224.08  |- skos__broader mesh__D001339smesh__D009412
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D001339 2003
% 223.84/224.08  |- skos__hiddenLabel mesh__D001339 Fiber, Preganglionic Autonomic
% 223.84/224.08  |- skos__hiddenLabel mesh__D001339 Fibers, Preganglionic Autonomic
% 223.84/224.08  |- mesh__dateCreated mesh__D001339 1999-01-01
% 223.84/224.08  |- skos__hiddenLabel mesh__D001339 Preganglionic Autonomic Fibers
% 223.84/224.08  |- skos__hiddenLabel mesh__D001339 Autonomic Fiber, Preganglionic
% 223.84/224.08  |- mesh__recordMaintainer mesh__D001339 lkt
% 223.84/224.08  |- mesh__dateRevised mesh__D001339 2002-07-02
% 223.84/224.08  |- skos__annotation mesh__D001339
% 223.84/224.08       do not confuse with AUTONOMIC FIBERS, POSTGANGLIONIC   
% 223.84/224.08  |- mesh__recordAuthorizer mesh__D001339 sjn
% 223.84/224.08  |- mesh__historyNote mesh__D001339 71   
% 223.84/224.08  |- skos__broader mesh__D001339smesh__D009474
% 223.84/224.08  |- skos__hiddenLabel mesh__D001339 Preganglionic Autonomic Fiber
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D001339 2006
% 223.84/224.08  |- mesh__publicMeSHNote mesh__D001339 71   
% 223.84/224.08  |- rdf__type mesh__D001339sskos__Concept
% 223.84/224.08  |- skos__scopeNote mesh__D001339
% 223.84/224.08       Nerve fibers which project from the central nervous system to autonomic ganglia. In the sympathetic division most preganglionic fibers originate with neurons in the intermediolateral column of the spinal cord, exit via ventral roots from upper thoracic through lower lumbar segments, and project to the paravertebral ganglia; there they either terminate in synapses or continue through the splanchnic nerves to the prevertebral ganglia. In the parasympathetic division the fibers originate in neurons of the brain stem and sacral spinal cord. In both divisions the principal transmitter is acetylcholine but peptide cotransmitters may also be released.%A%    
% 223.84/224.08  |- skos__broader mesh__D001339smesh__D017776
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D001339 2005
% 223.84/224.08  |- skos__prefLabel mesh__D001339 Autonomic Fibers, Preganglionic
% 223.84/224.08  |- skos__historyNote mesh__D001339 Ganglia, Autonomic %28%1966-1970%29%
% 223.84/224.08  |- mesh__recordOriginator mesh__D001339 NLM
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D012061 2006
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D012061 2004
% 223.84/224.08  |- skos__broader mesh__D012061smesh__D001899
% 223.84/224.08  |- skos__scopeNote mesh__D012061
% 223.84/224.08       An acute infection characterized by recurrent episodes of PYREXIA alternating with asymptomatic intervals of apparent recovery. This condition is caused by SPIROCHETES of the genus BORRELIA. It is transmitted by the BITES of either the body louse %28%PEDICULUS humanus corporis%29%, for which humans are the reservoir, or by soft ticks of the genus ORNITHODOROS, for which rodents and other animals are the principal reservoirs.%A%    
% 223.84/224.08  |- skos__hiddenLabel mesh__D012061 Relapsing Fevers
% 223.84/224.08  |- mesh__dateCreated mesh__D012061 1999-01-01
% 223.84/224.08  |- skos__hiddenLabel mesh__D012061 Fevers, Relapsing
% 223.84/224.08  |- mesh__recordOriginator mesh__D012061 NLM
% 223.84/224.08  |- mesh__dateRevised mesh__D012061 2003-07-09
% 223.84/224.08  |- mesh__recordMaintainer mesh__D012061 ags
% 223.84/224.08  |- mesh__recordAuthorizer mesh__D012061 sjn
% 223.84/224.08  |- rdf__type mesh__D012061sskos__Concept
% 223.84/224.08  |- skos__hiddenLabel mesh__D012061 Fever, Relapsing
% 223.84/224.08  |- skos__prefLabel mesh__D012061 Relapsing Fever
% 223.84/224.08  |- skos__broader mesh__D012061smesh__D017282
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D012061 2005
% 223.84/224.08  |- skos__annotation mesh__D012061
% 223.84/224.08       not for %22%recurrent fever%22% %28% = FEVER %28%IM%29% + RECURRENCE %28%NIM%29% %29%; infections by Borrelia species other than B. burgdorferi or B. burgdorferi group  %28%which cause LYME DISEASE%29%  probably go here, otherwise index under BORRELIA INFECTIONS%A%  
% 223.84/224.08  |- skos__hiddenLabel mesh__D006822 Hybrid Cell
% 223.84/224.08  |- skos__hiddenLabel mesh__D006822 Cell Hybrids, Somatic
% 223.84/224.08  |- mesh__dateCreated mesh__D006822 1999-01-01
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D006822 1997
% 223.84/224.08  |- skos__hiddenLabel mesh__D006822 Cell Hybrid, Somatic
% 223.84/224.08  |- mesh__recordMaintainer mesh__D006822 TGC
% 223.84/224.08  |- mesh__dateRevised mesh__D006822 1991-01-07
% 223.84/224.08  |- mesh__recordOriginator mesh__D006822 NLM
% 223.84/224.08  |- skos__altLabel mesh__D006822 Somatic Cell Hybrids
% 223.84/224.08  |- skos__historyNote mesh__D006822 Hybridization %28%1966-1971%29%
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D006822 1993
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D006822 2001
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D006822 1996
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D006822 2004
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D006822 1999
% 223.84/224.08  |- skos__broader mesh__D006822smesh__D002478
% 223.84/224.08  |- rdf__type mesh__D006822sskos__Concept
% 223.84/224.08  |- skos__hiddenLabel mesh__D006822 Cells, Hybrid
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D006822 1992
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D006822 2000
% 223.84/224.08  |- mesh__recordAuthorizer mesh__D006822 PLS
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D006822 1995
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D006822 2003
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D006822 1998
% 223.84/224.08  |- skos__historyNote mesh__D006822 Tissue Culture %28%1966-1971%29%
% 223.84/224.08  |- skos__annotation mesh__D006822 A 11 qualif; not for micro-organisms   
% 223.84/224.08  |- skos__hiddenLabel mesh__D006822 Cell, Hybrid
% 223.84/224.08  |- skos__hiddenLabel mesh__D006822 Somatic Cell Hybrid
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D006822 2006
% 223.84/224.08  |- mesh__dateEstablished mesh__D006822 1972-01-01
% 223.84/224.08  |- mesh__historyNote mesh__D006822 72   
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D006822 1994
% 223.84/224.08  |- mesh__publicMeSHNote mesh__D006822 72   
% 223.84/224.08  |- skos__prefLabel mesh__D006822 Hybrid Cells
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D006822 2002
% 223.84/224.08  |- skos__hiddenLabel mesh__D006822 Hybrids, Somatic Cell
% 223.84/224.08  |- skos__hiddenLabel mesh__D006822 Hybrid, Somatic Cell
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D006822 2005
% 223.84/224.08  |- skos__altLabel mesh__D006024 Glycopyrronium Bromide
% 223.84/224.08  |- skos__broader mesh__D006024smesh__D011759
% 223.84/224.08  |- rdf__type mesh__D006024sskos__Concept
% 223.84/224.08  |- mesh__historyNote mesh__D006024
% 223.84/224.08       91%28%64%29%; was see under PYRROLIDINES 1964-90   
% 223.84/224.08  |- skos__prefLabel mesh__D006024 Glycopyrrolate
% 223.84/224.08  |- skos__hiddenLabel mesh__D006024 Bromide, Glycopyrronium
% 223.84/224.08  |- mesh__dateRevised mesh__D006024 2005-06-30
% 223.84/224.08  |- mesh__dateEstablished mesh__D006024 1991-01-01
% 223.84/224.08  |- mesh__dateCreated mesh__D006024 1999-01-01
% 223.84/224.08  |- mesh__recordMaintainer mesh__D006024 ssb
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D006024 2006
% 223.84/224.08  |- mesh__recordAuthorizer mesh__D006024 sjn
% 223.84/224.08  |- skos__broader mesh__D006024smesh__D000644
% 223.84/224.08  |- skos__scopeNote mesh__D006024
% 223.84/224.08       A muscarinic antagonist used as an antispasmodic, in some disorders of the gastrointestinal tract, and to reduce salivation with some anesthetics.%A%    
% 223.84/224.08  |- mesh__recordOriginator mesh__D006024 NLM
% 223.84/224.08  |- mesh__publicMeSHNote mesh__D006024
% 223.84/224.08       91; was see under PYRROLIDINES 1964-90   
% 223.84/224.08  |- skos__hiddenLabel mesh__D011767 Decarboxylase, Pyruvate
% 223.84/224.08  |- skos__hiddenLabel mesh__D011767 Decarboxylase, Pyruvic
% 223.84/224.08  |- skos__altLabel mesh__D011767 alpha-Ketoacid Carboxylase
% 223.84/224.08  |- mesh__dateCreated mesh__D011767 1974-11-19
% 223.84/224.08  |- skos__prefLabel mesh__D011767 Pyruvate Decarboxylase
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D011767 2006
% 223.84/224.08  |- skos__hiddenLabel mesh__D011767 Carboxy-Lyase, 2-Oxo Acid
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D011767 2004
% 223.84/224.08  |- skos__altLabel mesh__D011767 2-Oxo Acid Carboxy-Lyase
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D011767 2005
% 223.84/224.08  |- mesh__dateEstablished mesh__D011767 1991-01-01
% 223.84/224.08  |- rdf__type mesh__D011767sskos__Concept
% 223.84/224.08  |- mesh__historyNote mesh__D011767
% 223.84/224.08       91%28%75%29%; was see under CARBOXY-LYASES 1975-90   
% 223.84/224.08  |- skos__historyNote mesh__D011767 Pyruvates %28%1973-1974%29%
% 223.84/224.08  |- skos__broader mesh__D011767smesh__D002262
% 223.84/224.08  |- mesh__recordOriginator mesh__D011767 NLM
% 223.84/224.08  |- skos__hiddenLabel mesh__D011767 alpha Ketoacid Carboxylase
% 223.84/224.08  |- skos__hiddenLabel mesh__D011767 Carboxylase, alpha-Ketoacid
% 223.84/224.08  |- skos__altLabel mesh__D011767 Pyruvic Decarboxylase
% 223.84/224.08  |- mesh__publicMeSHNote mesh__D011767
% 223.84/224.08       91; was see under CARBOXY-LYASES 1975-90   
% 223.84/224.08  |- mesh__recordAuthorizer mesh__D011767 sjn
% 223.84/224.08  |- skos__hiddenLabel mesh__D011767 Acid Carboxy-Lyase, 2-Oxo
% 223.84/224.08  |- skos__scopeNote mesh__D011767
% 223.84/224.08       Catalyzes the decarboxylation of an alpha keto acid to an aldehyde and carbon dioxide. Thiamine pyrophosphate is an essential cofactor. In lower organisms, which ferment glucose to ethanol and carbon dioxide, the enzyme irreversibly decarboxylates pyruvate to acetaldehyde. EC 4.1.1.1.%A%    
% 223.84/224.08  |- mesh__recordMaintainer mesh__D011767 ssb
% 223.84/224.08  |- skos__hiddenLabel mesh__D011767 alpha Carboxylase
% 223.84/224.08  |- skos__hiddenLabel mesh__D011767 2 Oxo Acid Carboxy Lyase
% 223.84/224.08  |- skos__altLabel mesh__D011767 alpha-Carboxylase
% 223.84/224.08  |- mesh__dateRevised mesh__D011767 2003-07-09
% 223.84/224.08  |- skos__historyNote mesh__D011767 Carboxy-Lyases %28%1973-1974%29%
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D030921 2005
% 223.84/224.08  |- skos__broader mesh__D030921smesh__D019684
% 223.84/224.08  |- skos__scopeNote mesh__D030921
% 223.84/224.08       A plant family of the order Linales, subclass Rosidae, class Magnoliopsida best known for the coca plant.%A%    
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D030921 2004
% 223.84/224.08  |- mesh__dateEstablished mesh__D030921 2002-01-01
% 223.84/224.08  |- skos__prefLabel mesh__D030921 Erythroxylaceae
% 223.84/224.08  |- mesh__historyNote mesh__D030921 2002   
% 223.84/224.08  |- skos__annotation mesh__D030921
% 223.84/224.08       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D030921 2003
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D030921 2002
% 223.84/224.08  |- mesh__publicMeSHNote mesh__D030921 2002   
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D030921 2006
% 223.84/224.08  |- rdf__type mesh__D030921sskos__Concept
% 223.84/224.08  |- mesh__dateCreated mesh__D030921 2001-07-25
% 223.84/224.08  |- skos__broader mesh__D002432smesh__D007420
% 223.84/224.08  |- rdf__type mesh__D002432sskos__Concept
% 223.84/224.08  |- skos__related mesh__D002432smesh__D002431
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D002432 2004
% 223.84/224.08  |- mesh__recordAuthorizer mesh__D002432 sjn
% 223.84/224.08  |- mesh__recordMaintainer mesh__D002432 lkt
% 223.84/224.08  |- mesh__dateRevised mesh__D002432 2003-07-09
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D002432 2006
% 223.84/224.08  |- skos__prefLabel mesh__D002432 Cecum
% 223.84/224.08  |- skos__annotation mesh__D002432
% 223.84/224.08       cecitis = CECAL DISEASES %28%IM%29% + GASTROENTERITIS %28%IM%29%   
% 223.84/224.08  |- mesh__recordOriginator mesh__D002432 NLM
% 223.84/224.08  |- mesh__dateCreated mesh__D002432 1999-01-01
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D002432 2005
% 223.84/224.08  |- skos__scopeNote mesh__D002432
% 223.84/224.08       The blind sac or outpouching area of the LARGE INTESTINE that is below the entrance of the SMALL INTESTINE. It has a worm-like extension, the vermiform APPENDIX.%A%    
% 223.84/224.08  |- skos__hiddenLabel mesh__D002432 Cecums
% 223.84/224.08  |- skos__historyNote mesh__D026082 Oxygen %28%1967-2001%29%
% 223.84/224.08  |- mesh__recordOriginator mesh__D026082 lkt
% 223.84/224.08  |- mesh__historyNote mesh__D026082 2002; use OXYGEN %28%NM%29% 1974-2001   
% 223.84/224.08  |- skos__hiddenLabel mesh__D026082 Dioxygen, Singlet
% 223.84/224.08  |- mesh__publicMeSHNote mesh__D026082
% 223.84/224.08       2002; SINGLET OXYGEN was indexed under OXYGEN 1974-2001   
% 223.84/224.08  |- mesh__recordMaintainer mesh__D026082 ags
% 223.84/224.08  |- skos__altLabel mesh__D026082 Singlet Dioxygen
% 223.84/224.08  |- skos__scopeNote mesh__D026082
% 223.84/224.08       An excited state of molecular oxygen generated photochemically or chemically. Singlet oxygen reacts with a variety of biological molecules such as NUCLEIC ACIDS; PROTEINS; and LIPIDS; causing oxidative damages.%A%    
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D026082 2006
% 223.84/224.08  |- mesh__dateRevised mesh__D026082 2005-07-21
% 223.84/224.08  |- mesh__recordAuthorizer mesh__D026082 ags
% 223.84/224.08  |- mesh__dateEstablished mesh__D026082 2002-01-01
% 223.84/224.08  |- skos__broader mesh__D026082smesh__D017382
% 223.84/224.08  |- rdf__type mesh__D026082sskos__Concept
% 223.84/224.08  |- mesh__dateCreated mesh__D026082 2001-07-25
% 223.84/224.08  |- skos__prefLabel mesh__D026082 Singlet Oxygen
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D026082 2006A
% 223.84/224.08  |- skos__hiddenLabel mesh__D026082 Oxygen, Singlet
% 223.84/224.08  |- skos__historyNote mesh__D012860 Fishes %28%1966-1986%29%
% 223.84/224.08  |- mesh__dateEstablished mesh__D012860 1991-01-01
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D012860 2006
% 223.84/224.08  |- mesh__publicMeSHNote mesh__D012860
% 223.84/224.08       91; was see under ELECTRIC FISH 1987-90   
% 223.84/224.08  |- mesh__dateCreated mesh__D012860 1986-04-15
% 223.84/224.08  |- mesh__historyNote mesh__D012860
% 223.84/224.08       91%28%87%29%; was see under ELECTRIC FISH 1987-90   
% 223.84/224.08  |- skos__broader mesh__D012860smesh__D018940
% 223.84/224.08  |- skos__hiddenLabel mesh__D012860 Ray %28%Fish%29%
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D012860 2005
% 223.84/224.08  |- mesh__recordMaintainer mesh__D012860 ags
% 223.84/224.08  |- skos__altLabel mesh__D012860 Rajidae
% 223.84/224.08  |- skos__altLabel mesh__D012860 Rajiformes
% 223.84/224.08  |- skos__hiddenLabel mesh__D012860 Skate %28%Fish%29%
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D012860 2004
% 223.84/224.08  |- skos__broader mesh__D012860smesh__D004555
% 223.84/224.08  |- rdf__type mesh__D012860sskos__Concept
% 223.84/224.08  |- skos__prefLabel mesh__D012860 Skates %28%Fish%29%
% 223.84/224.08  |- skos__annotation mesh__D012860
% 223.84/224.08       do not confuse X ref RAYS %28%FISH%29% with ELECTRIC RAYS see TORPEDO%A%  
% 223.84/224.08  |- mesh__recordAuthorizer mesh__D012860 ags
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D012860 2006A
% 223.84/224.08  |- mesh__dateRevised mesh__D012860 2005-07-13
% 223.84/224.08  |- mesh__recordOriginator mesh__D012860 EC
% 223.84/224.08  |- skos__scopeNote mesh__D012860
% 223.84/224.08       The common name for all members of the Rajidae family. Skates and rays are members of the same order %28%Rajiformes%29%. Skates have weak electric organs.%A%    
% 223.84/224.08  |- mesh__recordAuthorizer mesh__D012062 PLS
% 223.84/224.08  |- mesh__dateCreated mesh__D012062 1976-04-16
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D012062 2000
% 223.84/224.08  |- skos__hiddenLabel mesh__D012062 Effectiveness, Relative Biologic
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D012062 1998
% 223.84/224.08  |- mesh__dateEstablished mesh__D012062 1977-01-01
% 223.84/224.08  |- mesh__dateRevised mesh__D012062 1993-06-04
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D012062 1996
% 223.84/224.08  |- skos__hiddenLabel mesh__D012062 Relative Effectiveness, Biologic
% 223.84/224.08  |- skos__broader mesh__D012062smesh__D011829
% 223.84/224.08  |- skos__hiddenLabel mesh__D012062 Biological Relative Effectiveness
% 223.84/224.08  |- mesh__activeMeSHYear mesh__D012062 1999
% 223.84/224.08  |- skos__altLabel mesh__D012062 Relative Biologic Effectiveness
% 223.84/224.09  |- skos__historyNote mesh__D012062
% 223.84/224.09       Dose-Response Relationship, Radiation %28%1973-1976%29%
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012062 2001
% 223.84/224.09  |- skos__hiddenLabel mesh__D012062 Biologic Effectiveness, Relative
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012062 1997
% 223.84/224.09  |- skos__altLabel mesh__D012062 Effectiveness, Biologic Relative
% 223.84/224.09  |- mesh__historyNote mesh__D012062 77   
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012062 2002
% 223.84/224.09  |- skos__annotation mesh__D012062 NIM; no qualif; DF: RBE   
% 223.84/224.09  |- rdf__type mesh__D012062sskos__Concept
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012062 2005
% 223.84/224.09  |- skos__hiddenLabel mesh__D012062 Biologic Relative Effectiveness
% 223.84/224.09  |- skos__altLabel mesh__D012062 Effectiveness, Biological Relative
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012062 2003
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012062 1994
% 223.84/224.09  |- skos__prefLabel mesh__D012062 Relative Biological Effectiveness
% 223.84/224.09  |- mesh__recordMaintainer mesh__D012062 JLS
% 223.84/224.09  |- mesh__recordOriginator mesh__D012062 EC
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012062 2006
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012062 2004
% 223.84/224.09  |- mesh__publicMeSHNote mesh__D012062 77   
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012062 1995
% 223.84/224.09  |- skos__altLabel mesh__D012062 Biological Effectiveness, Relative
% 223.84/224.09  |- skos__scopeNote mesh__D012062
% 223.84/224.09       The ratio of radiation dosages required to produce identical change based on a formula comparing other types of radiation with that of gamma or roentgen rays.%A%    
% 223.84/224.09  |- skos__hiddenLabel mesh__D012062 Effectiveness, Relative Biological
% 223.84/224.09  |- skos__prefLabel mesh__D006823 Hybrid Vigor
% 223.84/224.09  |- mesh__dateEstablished mesh__D006823 1991-01-01
% 223.84/224.09  |- mesh__recordMaintainer mesh__D006823 nns
% 223.84/224.09  |- skos__scopeNote mesh__D006823
% 223.84/224.09       The adaptive superiority of the heterozygous GENOTYPE with respect to one or more characters in comparison with the corresponding HOMOZYGOTE.%A%    
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D006823 2004
% 223.84/224.09  |- mesh__historyNote mesh__D006823
% 223.84/224.09       91%28%68%29%; was see under HYBRIDIZATION 1968-90   
% 223.84/224.09  |- rdf__type mesh__D006823sskos__Concept
% 223.84/224.09  |- mesh__recordOriginator mesh__D006823 NLM
% 223.84/224.09  |- skos__altLabel mesh__D006823 Heterosis
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D006823 2003
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D006823 2006
% 223.84/224.09  |- skos__related mesh__D006823smesh__D040741
% 223.84/224.09  |- mesh__dateRevised mesh__D006823 2002-07-03
% 223.84/224.09  |- skos__broader mesh__D006823smesh__D040341
% 223.84/224.09  |- skos__hiddenLabel mesh__D006823 Vigor, Hybrid
% 223.84/224.09  |- mesh__recordAuthorizer mesh__D006823 sjn
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D006823 2005
% 223.84/224.09  |- skos__historyNote mesh__D006823 Hybridization %28%1966-1967%29%
% 223.84/224.09  |- mesh__dateCreated mesh__D006823 1999-01-01
% 223.84/224.09  |- skos__related mesh__D006823smesh__D006824
% 223.84/224.09  |- mesh__publicMeSHNote mesh__D006823
% 223.84/224.09       91; was see under HYBRIDIZATION 1968-90   
% 223.84/224.09  |- mesh__recordOriginator mesh__D006025 NLM
% 223.84/224.09  |- skos__altLabel mesh__D006025 Mucopolysaccharides
% 223.84/224.09  |- skos__historyNote mesh__D006025 Mucopolysaccharides %28%1966-1974%29%
% 223.84/224.09  |- mesh__dateRevised mesh__D006025 2004-07-07
% 223.84/224.09  |- skos__scopeNote mesh__D006025
% 223.84/224.09       Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine or N-acetylgalactosamine.%A%    
% 223.84/224.09  |- mesh__historyNote mesh__D006025
% 223.84/224.09       77%28%75%29%; was see under MUCOPOLYSACCHARIDES 1969-76; MUCOPOLYSACCHARIDES was heading 1963-92%A%  
% 223.84/224.09  |- mesh__dateCreated mesh__D006025 1999-01-01
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D006025 2006
% 223.84/224.09  |- skos__broader mesh__D006025smesh__D011134
% 223.84/224.09  |- skos__annotation mesh__D006025 polysaccharides; note X ref   
% 223.84/224.09  |- skos__prefLabel mesh__D006025 Glycosaminoglycans
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D006025 2005
% 223.84/224.09  |- mesh__onlineNote mesh__D006025
% 223.84/224.09       use GLYCOSAMINOGLYCANS to search MUCOPOLYSACCHARIDES 1966-92%A%  
% 223.84/224.09  |- mesh__dateEstablished mesh__D006025 1977-01-01
% 223.84/224.09  |- mesh__publicMeSHNote mesh__D006025
% 223.84/224.09       77; was see under MUCOPOLYSACCHARIDES 1969-76; MUCOPOLYSACCHARIDES was heading 1963-92%A%  
% 223.84/224.09  |- mesh__recordMaintainer mesh__D006025 ssb
% 223.84/224.09  |- mesh__recordAuthorizer mesh__D006025 sjn
% 223.84/224.09  |- rdf__type mesh__D006025sskos__Concept
% 223.84/224.09  |- skos__broader mesh__D044942smesh__D044944
% 223.84/224.09  |- skos__historyNote mesh__D044942 Fatty Acid Desaturases %28%1988-2003%29%
% 223.84/224.09  |- skos__hiddenLabel mesh__D044942 Very Long Chain Acyl CoA Dehydrogenase
% 223.84/224.09  |- skos__hiddenLabel mesh__D044942 CoA Dehydrogenase, Decanoyl
% 223.84/224.09  |- skos__hiddenLabel mesh__D044942 CoA-Dehydrogenase, Decanoyl
% 223.84/224.09  |- skos__hiddenLabel mesh__D044942 Long Chain Acyl CoA Dehydrogenase
% 223.84/224.09  |- skos__annotation mesh__D044942
% 223.84/224.09       ACYL-COA DEHYDROGENASE is also available   
% 223.84/224.09  |- skos__altLabel mesh__D044942 Very-Long-Chain Acyl-CoA Dehydrogenase
% 223.84/224.09  |- mesh__recordMaintainer mesh__D044942 jmp
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D044942 2006
% 223.84/224.09  |- rdf__type mesh__D044942sskos__Concept
% 223.84/224.09  |- mesh__dateCreated mesh__D044942 2003-07-09
% 223.84/224.09  |- skos__hiddenLabel mesh__D044942
% 223.84/224.09       Dehydrogenase, Long-Chain-Acyl-Coenzyme A
% 223.84/224.09  |- mesh__dateEstablished mesh__D044942 2004-01-01
% 223.84/224.09  |- mesh__recordAuthorizer mesh__D044942 sjn
% 223.84/224.09  |- skos__hiddenLabel mesh__D044942 Dehydrogenase, Very-Long-Chain Acyl-CoA
% 223.84/224.09  |- skos__scopeNote mesh__D044942
% 223.84/224.09       A flavoprotein oxidoreductase that has specificity for long-chain fatty acids. It forms a complex with ELECTRON-TRANSFERRING FLAVOPROTEINS and conveys reducing equivalents to UBIQUINONE.%A%    
% 223.84/224.09  |- skos__altLabel mesh__D044942 Long-Chain-Acyl-Coenzyme A Dehydrogenase
% 223.84/224.09  |- skos__hiddenLabel mesh__D044942 Dehydrogenase, Long-Chain Acyl-CoA
% 223.84/224.09  |- skos__altLabel mesh__D044942 VLCAD
% 223.84/224.09  |- mesh__historyNote mesh__D044942
% 223.84/224.09       2004; use LONG-CHAIN-ACYL-COA DEHYDROGENASE %28%NM%29% 1988-2003; for DECONOYL COA DEHYDROGENASE use LONG-CHAIN-ACYL-COA DEHYDROGENASE 1990-2003%A%  
% 223.84/224.09  |- skos__hiddenLabel mesh__D044942 Dehydrogenase, Long-Chain-Acyl-CoA
% 223.84/224.09  |- skos__broader mesh__D044942smesh__D005420
% 223.84/224.09  |- skos__hiddenLabel mesh__D044942 Acyl-CoA Dehydrogenase, Very-Long-Chain
% 223.84/224.09  |- skos__hiddenLabel mesh__D044942 Long Chain Acyl Coenzyme A Dehydrogenase
% 223.84/224.09  |- mesh__publicMeSHNote mesh__D044942
% 223.84/224.09       2004; LONG-CHAIN-ACYL-COA DEHYDROGENASE was indexed under FATTY ACID DESATURASES 1988-2003; for DECONOYL COA DEHYDROGENASE see FATTY ACID DESATURASES 1990-2003%A%  
% 223.84/224.09  |- mesh__recordOriginator mesh__D044942 jmp
% 223.84/224.09  |- mesh__dateRevised mesh__D044942 2005-06-30
% 223.84/224.09  |- skos__hiddenLabel mesh__D044942 Acyl CoA Dehydrogenase, Long Chain
% 223.84/224.09  |- skos__altLabel mesh__D044942 Decanoyl CoA-Dehydrogenase
% 223.84/224.09  |- skos__altLabel mesh__D044942 Long-Chain-Acyl-CoA Dehydrogenase
% 223.84/224.09  |- skos__hiddenLabel mesh__D044942 Dehydrogenase, Decanoyl CoA
% 223.84/224.09  |- skos__prefLabel mesh__D044942 Acyl-CoA Dehydrogenase, Long-Chain
% 223.84/224.09  |- skos__hiddenLabel mesh__D044942 Long-Chain Acyl-CoA Dehydrogenase
% 223.84/224.09  |- mesh__dateEstablished mesh__D011768 1974-01-01
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D011768 2006
% 223.84/224.09  |- mesh__recordAuthorizer mesh__D011768 ags
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D011768 2006A
% 223.84/224.09  |- mesh__historyNote mesh__D011768 74%28%73%29%   
% 223.84/224.09  |- skos__hiddenLabel mesh__D011768 Complex, Pyruvate Dehydrogenase
% 223.84/224.09  |- skos__historyNote mesh__D011768 Oxidoreductases %28%1966-1972%29%
% 223.84/224.09  |- skos__prefLabel mesh__D011768 Pyruvate Dehydrogenase Complex
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D011768 2005
% 223.84/224.09  |- rdf__type mesh__D011768sskos__Concept
% 223.84/224.09  |- skos__hiddenLabel mesh__D011768 Dehydrogenase Complex, Pyruvate
% 223.84/224.09  |- skos__broader mesh__D011768smesh__D009097
% 223.84/224.09  |- mesh__recordMaintainer mesh__D011768 ags
% 223.84/224.09  |- skos__scopeNote mesh__D011768
% 223.84/224.09       A multienzyme complex responsible for the formation of ACETYL COENZYME A from pyruvate. The enzyme components are PYRUVATE DEHYDROGENASE %28%LIPOAMIDE%29%; dihydrolipoamide acetyltransferase; and LIPOAMIDE DEHYDROGENASE.  Pyruvate dehydrogenase complex is subject to three types of control: inhibited by acetyl-CoA and NADH; influenced by the energy state of the cell; and inhibited when a specific serine residue in the pyruvate decarboxylase is phoshorylated by ATP. PYRUVATE DEHYDROGENASE %28%LIPOAMIDE%29%-PHOSPHATASE catalyzes reactivation of the complex. %28%From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed%29%%A%    
% 223.84/224.09  |- skos__historyNote mesh__D011768 Pyruvates %28%1966-1972%29%
% 223.84/224.09  |- mesh__publicMeSHNote mesh__D011768 74   
% 223.84/224.09  |- mesh__recordOriginator mesh__D011768 NLM
% 223.84/224.09  |- skos__historyNote mesh__D011768 Pyruvate Oxidase %28%1966-1972%29%
% 223.84/224.09  |- mesh__dateCreated mesh__D011768 1999-01-01
% 223.84/224.09  |- mesh__dateRevised mesh__D011768 2005-07-28
% 223.84/224.09  |- skos__annotation mesh__D016453 publication type only   
% 223.84/224.09  |- skos__broader mesh__D016453smesh__D052180
% 223.84/224.09  |- skos__scopeNote mesh__D016453
% 223.84/224.09       Work consisting of  a subject approach to the contents of a periodical issuing an annual, biennial, quinquennial, decennial, etc., index. The heading is used for the overall body of articles published by a periodical in the same sense that BIBLIOGRAPHY %5B%PUBLICATION TYPE%5D% is useful when published as a single article.%A%    
% 223.84/224.09  |- mesh__dateEstablished mesh__D016453 1996-01-01
% 223.84/224.09  |- mesh__historyNote mesh__D016453
% 223.84/224.09       1990; was PERIODICAL INDEXES as both main heading %26% publication type 1990; publication type only from 1991 forward%A%  
% 223.84/224.09  |- skos__prefLabel mesh__D016453 Periodical Index %5B%Publication Type%5D%
% 223.84/224.09  |- mesh__dateCreated mesh__D016453 1995-06-23
% 223.84/224.09  |- mesh__recordAuthorizer mesh__D016453 sjn
% 223.84/224.09  |- mesh__recordMaintainer mesh__D016453 jls
% 223.84/224.09  |- skos__historyNote mesh__D016453 Bibliography %28%1968-1989%29%
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D016453 2006
% 223.84/224.09  |- skos__altLabel mesh__D016453 Periodical Index
% 223.84/224.09  |- skos__altLabel mesh__D016453 Periodical Index %28%PT%29%
% 223.84/224.09  |- rdf__type mesh__D016453sskos__Concept
% 223.84/224.09  |- skos__related mesh__D016453smesh__D020481
% 223.84/224.09  |- mesh__dateRevised mesh__D016453 2005-06-30
% 223.84/224.09  |- mesh__recordOriginator mesh__D016453 PLS
% 223.84/224.09  |- mesh__dateCreated mesh__D002433 1979-03-01
% 223.84/224.09  |- skos__scopeNote mesh__D002433
% 223.84/224.09       Semisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN.%A%    
% 223.84/224.09  |- mesh__historyNote mesh__D002433
% 223.84/224.09       91%28%80%29%; was see under CEPHALEXIN 1980-90   
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D002433 2006
% 223.84/224.09  |- mesh__recordMaintainer mesh__D002433 ssb
% 223.84/224.09  |- mesh__recordAuthorizer mesh__D002433 sjn
% 223.84/224.09  |- mesh__recordOriginator mesh__D002433 SH
% 223.84/224.09  |- mesh__dateRevised mesh__D002433 2004-07-07
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D002433 2005
% 223.84/224.09  |- skos__hiddenLabel mesh__D002433 S6472
% 223.84/224.09  |- mesh__publicMeSHNote mesh__D002433
% 223.84/224.09       91; was see under CEPHALEXIN 1980-90   
% 223.84/224.09  |- skos__broader mesh__D002433smesh__D002506
% 223.84/224.09  |- skos__prefLabel mesh__D002433 Cefaclor
% 223.84/224.09  |- skos__historyNote mesh__D002433 Cephalosporins %28%1966-1979%29%
% 223.84/224.09  |- mesh__dateEstablished mesh__D002433 1991-01-01
% 223.84/224.09  |- skos__hiddenLabel mesh__D002433 S 6472
% 223.84/224.09  |- rdf__type mesh__D002433sskos__Concept
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D026881 2006
% 223.84/224.09  |- skos__historyNote mesh__D026881
% 223.84/224.09       Acupuncture Therapy/trends %28%1978-2001%29%
% 223.84/224.09  |- mesh__dateEstablished mesh__D026881 2002-01-01
% 223.84/224.09  |- rdf__type mesh__D026881sskos__Concept
% 223.84/224.09  |- skos__prefLabel mesh__D026881 Acupuncture
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D026881 2002
% 223.84/224.09  |- skos__broader mesh__D026881smesh__D006281
% 223.84/224.09  |- mesh__historyNote mesh__D026881 2002   
% 223.84/224.09  |- skos__annotation mesh__D026881
% 223.84/224.09       SPEC only; do not confuse with ACUPUNCTURE THERAPY   
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D026881 2003
% 223.84/224.09  |- skos__scopeNote mesh__D026881
% 223.84/224.09       The occupational discipline of the traditional Chinese methods of ACUPUNCTURE THERAPY for treating disease by inserting needles along specific pathways or meridians.%A%    
% 223.84/224.09  |- mesh__dateCreated mesh__D026881 2001-07-25
% 223.84/224.09  |- skos__related mesh__D026881smesh__D015670
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D026881 2005
% 223.84/224.09  |- mesh__publicMeSHNote mesh__D026881 2002   
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D026881 2004
% 223.84/224.09  |- skos__scopeNote mesh__D012861
% 223.84/224.09       Using ice skates, roller skates, or skateboards in racing or other competition or for recreation.%A%    
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012861 2005
% 223.84/224.09  |- mesh__recordAuthorizer mesh__D012861 PLS
% 223.84/224.09  |- mesh__recordOriginator mesh__D012861 JW
% 223.84/224.09  |- skos__hiddenLabel mesh__D012861 Ice Skatings
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012861 2000
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012861 2006
% 223.84/224.09  |- skos__hiddenLabel mesh__D012861 Skateboardings
% 223.84/224.09  |- mesh__historyNote mesh__D012861
% 223.84/224.09       90%28%76%29%; was see under SPORTS 1976-89   
% 223.84/224.09  |- skos__annotation mesh__D012861
% 223.84/224.09       /inj: coord IM with specific inj %28%IM%29%; /physiol permitted; Manual 30.15.1%A%  
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012861 2001
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012861 1997
% 223.84/224.09  |- mesh__dateRevised mesh__D012861 1996-06-10
% 223.84/224.09  |- skos__prefLabel mesh__D012861 Skating
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012861 2003
% 223.84/224.09  |- skos__hiddenLabel mesh__D012861 Skatings, Ice
% 223.84/224.09  |- skos__hiddenLabel mesh__D012861 Skating, Ice
% 223.84/224.09  |- skos__hiddenLabel mesh__D012861 Skatings
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012861 2004
% 223.84/224.09  |- mesh__publicMeSHNote mesh__D012861 90; was see under SPORTS 1976-89   
% 223.84/224.09  |- mesh__dateCreated mesh__D012861 1975-07-23
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012861 2002
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012861 1998
% 223.84/224.09  |- mesh__recordMaintainer mesh__D012861 TAP
% 223.84/224.09  |- rdf__type mesh__D012861sskos__Concept
% 223.84/224.09  |- skos__historyNote mesh__D012861 Sports %28%1966-1975%29%
% 223.84/224.09  |- skos__broader mesh__D012861smesh__D013177
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012861 1999
% 223.84/224.09  |- mesh__dateEstablished mesh__D012861 1990-01-01
% 223.84/224.09  |- mesh__recordMaintainer mesh__D012063 ssb
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012063 2005
% 223.84/224.09  |- mesh__recordOriginator mesh__D012063 NLM
% 223.84/224.09  |- rdf__type mesh__D012063sskos__Concept
% 223.84/224.09  |- skos__hiddenLabel mesh__D012063 Relaxations
% 223.84/224.09  |- skos__scopeNote mesh__D012063
% 223.84/224.09       Activity which reduces feelings of tension.     
% 223.84/224.09  |- skos__broader mesh__D012063smesh__D007899
% 223.84/224.09  |- mesh__recordAuthorizer mesh__D012063 sjn
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012063 2003
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012063 2006
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012063 2004
% 223.84/224.09  |- skos__prefLabel mesh__D012063 Relaxation
% 223.84/224.09  |- skos__annotation mesh__D012063
% 223.84/224.09       note category: not for muscle relaxation %28% =  MUSCLE RELAXATION%29%; /physiol /psychol permitted%A%  
% 223.84/224.09  |- mesh__dateRevised mesh__D012063 2001-07-25
% 223.84/224.09  |- skos__broader mesh__D012063smesh__D026441
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D012063 2002
% 223.84/224.09  |- mesh__dateCreated mesh__D012063 1999-01-01
% 223.84/224.09  |- skos__broader mesh__D012063smesh__D026241
% 223.84/224.09  |- skos__hiddenLabel mesh__D006824 Hybridizations, Genetic
% 223.84/224.09  |- skos__altLabel mesh__D006824 Crossbreeding
% 223.84/224.09  |- rdf__type mesh__D006824sskos__Concept
% 223.84/224.09  |- skos__hiddenLabel mesh__D006824 Intraspecies Hybridization
% 223.84/224.09  |- skos__hiddenLabel mesh__D006824 Crossbreedings
% 223.84/224.09  |- skos__hiddenLabel mesh__D006824 Genetic Hybridizations
% 223.84/224.09  |- mesh__recordOriginator mesh__D006824 NLM
% 223.84/224.09  |- skos__annotation mesh__D006824
% 223.84/224.09       GEN or unspecified production of hybrids; for hybrid nucleic acids use NUCLEIC ACID HYBRIDIZATION, for hybrid proteins use PROTEIN HYBRIDIZATION: see notes there%A%  
% 223.84/224.09  |- skos__broader mesh__D006824smesh__D001947
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D006824 2004
% 223.84/224.09  |- skos__hiddenLabel mesh__D006824 Hybridizations, Intraspecies
% 223.84/224.09  |- skos__related mesh__D006824smesh__D006823
% 223.84/224.09  |- skos__prefLabel mesh__D006824 Hybridization, Genetic
% 223.84/224.09  |- mesh__publicMeSHNote mesh__D006824
% 223.84/224.09       2003; HYBRIDIZATION was heading 1966-2002   
% 223.84/224.09  |- skos__scopeNote mesh__D006824
% 223.84/224.09       The genetic process of crossbreeding between genetically dissimilar parents to produce a hybrid.%A%    
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D006824 2003
% 223.84/224.09  |- mesh__recordAuthorizer mesh__D006824 sjn
% 223.84/224.09  |- skos__related mesh__D006824smesh__D003433
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D006824 2006
% 223.84/224.09  |- mesh__dateRevised mesh__D006824 2002-07-03
% 223.84/224.09  |- mesh__dateCreated mesh__D006824 1999-01-01
% 223.84/224.09  |- skos__hiddenLabel mesh__D006824 Intraspecies Hybridizations
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D006824 2005
% 223.84/224.09  |- mesh__recordMaintainer mesh__D006824 adp
% 223.84/224.09  |- skos__hiddenLabel mesh__D006824 Genetic Hybridization
% 223.84/224.09  |- mesh__recordMaintainer mesh__D050980 DRC
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D050980 2006
% 223.84/224.09  |- skos__altLabel mesh__D050980 GATA Factors
% 223.84/224.09  |- mesh__historyNote mesh__D050980 2006   
% 223.84/224.09  |- mesh__dateCreated mesh__D050980 2005-06-30
% 223.84/224.09  |- skos__broader mesh__D050980smesh__D004268
% 223.84/224.09  |- rdf__type mesh__D050980sskos__Concept
% 223.84/224.09  |- mesh__publicMeSHNote mesh__D050980 2006   
% 223.84/224.09  |- mesh__dateEstablished mesh__D050980 2006-01-01
% 223.84/224.09  |- mesh__recordAuthorizer mesh__D050980 sjn
% 223.84/224.09  |- skos__prefLabel mesh__D050980 GATA Transcription Factors
% 223.84/224.09  |- skos__hiddenLabel mesh__D050980 Transcription Factors, GATA
% 223.84/224.09  |- mesh__recordOriginator mesh__D050980 DRC
% 223.84/224.09  |- skos__scopeNote mesh__D050980
% 223.84/224.09       A family of transcription factors that contain two ZINC FINGER MOTIFS and bind to the DNA sequence %28%A/T%29%GATA%28%A/G%29%.%A%    
% 223.84/224.09  |- skos__broader mesh__D050980smesh__D014157
% 223.84/224.09  |- skos__altLabel mesh__D006026 Glycohydrolases
% 223.84/224.09  |- mesh__dateRevised mesh__D006026 2003-07-09
% 223.84/224.09  |- mesh__dateCreated mesh__D006026 1999-01-01
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D006026 2005
% 223.84/224.09  |- mesh__recordAuthorizer mesh__D006026 sjn
% 223.84/224.09  |- mesh__recordOriginator mesh__D006026 NLM
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D006026 2006
% 223.84/224.09  |- skos__hiddenLabel mesh__D006026 Hydrolases, Glycoside
% 223.84/224.09  |- skos__altLabel mesh__D006026 Glycosidases
% 223.84/224.09  |- skos__prefLabel mesh__D006026 Glycoside Hydrolases
% 223.84/224.09  |- skos__broader mesh__D006026smesh__D006867
% 223.84/224.09  |- mesh__recordMaintainer mesh__D006026 ssb
% 223.84/224.09  |- rdf__type mesh__D006026sskos__Concept
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D006026 2004
% 223.84/224.09  |- mesh__recordOriginator mesh__D044943 jmp
% 223.84/224.09  |- rdf__type mesh__D044943sskos__Concept
% 223.84/224.09  |- skos__altLabel mesh__D044943 Enoyl CoA Reductases
% 223.84/224.09  |- mesh__dateCreated mesh__D044943 2003-07-09
% 223.84/224.09  |- skos__historyNote mesh__D044943 Fatty Acid Desaturases %28%1974-2003%29%
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D044943 2005
% 223.84/224.09  |- skos__altLabel mesh__D044943 Fatty Acid Desaturating Enzymes
% 223.84/224.09  |- skos__prefLabel mesh__D044943 Fatty Acid Desaturases
% 223.84/224.09  |- mesh__dateRevised mesh__D044943 2004-07-07
% 223.84/224.09  |- mesh__publicMeSHNote mesh__D044943 2004   
% 223.84/224.09  |- skos__hiddenLabel mesh__D044943 Reductases, Enoyl CoA
% 223.84/224.09  |- mesh__dateEstablished mesh__D044943 2004-01-01
% 223.84/224.09  |- mesh__recordAuthorizer mesh__D044943 sjn
% 223.84/224.09  |- skos__broader mesh__D044943smesh__D006899
% 223.84/224.09  |- skos__scopeNote mesh__D044943
% 223.84/224.09       A family of enzymes that catalyze the stereoselective, regioselective, or chemoselective syn-dehydrogenation reactions. They function by a mechanism that is linked directly to reduction of molecular OXYGEN.%A%    
% 223.84/224.09  |- skos__hiddenLabel mesh__D044943 Desaturases, Fatty Acid
% 223.84/224.09  |- mesh__historyNote mesh__D044943 2004   
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D044943 2006
% 223.84/224.09  |- mesh__recordMaintainer mesh__D044943 ssb
% 223.84/224.09  |- mesh__publicMeSHNote mesh__D011769
% 223.84/224.09       94; was PYRUVATE DEHYDROGENASE PHOSPHATASE 1975-93 %28%see under PHOSPHOPROTEIN PHOSPHATASES 1979-90, see under PHOSPHOMONOESTERASES 1975-78%29%%A%  
% 223.84/224.09  |- skos__prefLabel mesh__D011769
% 223.84/224.09       Pyruvate Dehydrogenase %28%Lipoamide%29%-Phosphatase
% 223.84/224.09  |- skos__historyNote mesh__D011769 Pyruvates %28%1973-1974%29%
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D011769 2006
% 223.84/224.09  |- mesh__recordMaintainer mesh__D011769 ssb
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D011769 2004
% 223.84/224.09  |- skos__altLabel mesh__D011769 Pyruvate Dehydrogenase Phosphatase
% 223.84/224.09  |- mesh__recordOriginator mesh__D011769 NLM
% 223.84/224.09  |- mesh__onlineNote mesh__D011769
% 223.84/224.09       use PYRUVATE DEHYDROGENASE %28%LIPOAMIDE%29%-PHOSPHATASE to search PYRUVATE DEHYDROGENASE PHOSPHATASE 1975-93%A%  
% 223.84/224.09  |- rdf__type mesh__D011769sskos__Concept
% 223.84/224.09  |- mesh__recordAuthorizer mesh__D011769 sjn
% 223.84/224.09  |- skos__hiddenLabel mesh__D011769 Phosphatase, PDH
% 223.84/224.09  |- skos__altLabel mesh__D011769 PDH Phosphatase
% 223.84/224.09  |- mesh__dateCreated mesh__D011769 1974-11-19
% 223.84/224.09  |- skos__historyNote mesh__D011769 Ketone Oxidoreductases %28%1973-1974%29%
% 223.84/224.09  |- skos__broader mesh__D011769smesh__D010749
% 223.84/224.09  |- skos__scopeNote mesh__D011769
% 223.84/224.09       %28%Pyruvate dehydrogenase %28%lipoamide%29%%29%-phosphate phosphohydrolase. A mitochondrial enzyme that catalyzes the hydrolytic removal of a phosphate on a specific seryl hydroxyl group of pyruvate dehydrogenase, reactivating the enzyme complex. EC 3.1.3.43.%A%    
% 223.84/224.09  |- mesh__dateRevised mesh__D011769 2003-07-09
% 223.84/224.09  |- skos__historyNote mesh__D011769 Phosphatases %28%1972-1974%29%
% 223.84/224.09  |- mesh__historyNote mesh__D011769
% 223.84/224.09       94; was PYRUVATE DEHYDROGENASE PHOSPHATASE 1975-93 %28%see under PHOSPHOPROTEIN PHOSPHATASES 1979-90, see under PHOSPHOMONOESTERASES 1975-78%29%%A%  
% 223.84/224.09  |- skos__hiddenLabel mesh__D011769 Phosphatase, Pyruvate Dehydrogenase
% 223.84/224.09  |- skos__annotation mesh__D011769 DF: note short X ref   
% 223.84/224.09  |- mesh__dateEstablished mesh__D011769 1991-01-01
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D011769 2005
% 223.84/224.09  |- skos__altLabel mesh__D011769
% 223.84/224.09       Pyruvate Dehydrogenase Phosphate Phosphatase
% 223.84/224.09  |- mesh__onlineNote mesh__D016454
% 223.84/224.09       search policy: Online Manual; use: main heading AND REVIEW %28%PT%29%%A%  
% 223.84/224.09  |- skos__broader mesh__D016454smesh__D016428
% 223.84/224.09  |- skos__altLabel mesh__D016454 Review %28%PT%29%
% 223.84/224.09  |- skos__altLabel mesh__D016454 Review
% 223.84/224.09  |- mesh__dateRevised mesh__D016454 2005-06-30
% 223.84/224.09  |- skos__altLabel mesh__D016454 Review, Systematic %28%PT%29%
% 223.84/224.09  |- skos__altLabel mesh__D016454 Review, Multicase %28%PT%29%
% 223.84/224.09  |- skos__annotation mesh__D016454
% 223.84/224.09       publication type only; for review articles as a bibliographic form, index under main heading REVIEW LITERATURE; Manual 17.105%A%  
% 223.84/224.09  |- skos__altLabel mesh__D016454 Review, Systematic
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D016454 2006
% 223.84/224.09  |- skos__altLabel mesh__D016454 Review, Academic %28%PT%29%
% 223.84/224.09  |- skos__altLabel mesh__D016454 Review, Academic
% 223.84/224.09  |- skos__altLabel mesh__D016454 Review of Reported Cases %28%PT%29%
% 223.84/224.09  |- mesh__dateEstablished mesh__D016454 1996-01-01
% 223.84/224.09  |- skos__altLabel mesh__D016454 Review, Tutorial %28%PT%29%
% 223.84/224.09  |- skos__altLabel mesh__D016454 Review, Multicase
% 223.84/224.09  |- mesh__dateCreated mesh__D016454 1995-06-23
% 223.84/224.09  |- skos__scopeNote mesh__D016454
% 223.84/224.09       An article or book published after examination of published material on a subject. It may be comprehensive to various degrees and the time range of material scrutinized may be broad or narrow, but the reviews most often desired are reviews of the current literature. The textual material examined may be equally broad and can encompass, in medicine specifically, clinical material as well as experimental research or case reports. State-of-the-art reviews tend to address more current matters. A review of the literature must be differentiated from HISTORICAL ARTICLE %5B%PUBLICATION TYPE%5D% on the same subject, but a review of historical literature is also within the scope of this publication type.%A%    
% 223.84/224.09  |- mesh__recordMaintainer mesh__D016454 jls
% 223.84/224.09  |- mesh__recordAuthorizer mesh__D016454 sjn
% 223.84/224.09  |- skos__prefLabel mesh__D016454 Review %5B%Publication Type%5D%
% 223.84/224.09  |- rdf__type mesh__D016454sskos__Concept
% 223.84/224.09  |- skos__altLabel mesh__D016454 Review Literature %28%PT%29%
% 223.84/224.09  |- mesh__recordOriginator mesh__D016454 PLS
% 223.84/224.09  |- skos__altLabel mesh__D016454 Review of Reported Cases
% 223.84/224.09  |- skos__altLabel mesh__D016454 Review, Tutorial
% 223.84/224.09  |- mesh__historyNote mesh__D016454 91; was Citation Type REVIEW 1966-90   
% 223.84/224.09  |- skos__broader mesh__D016454smesh__D052180
% 223.84/224.09  |- skos__altLabel mesh__D016454 Literature Review %28%PT%29%
% 223.84/224.09  |- skos__hiddenLabel mesh__D002434 BLS 578
% 223.84/224.09  |- mesh__dateRevised mesh__D002434 2004-07-07
% 223.84/224.09  |- skos__altLabel mesh__D002434 4-Hydroxycephalexin
% 223.84/224.09  |- skos__altLabel mesh__D002434 S-578
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D002434 2005
% 223.84/224.09  |- skos__altLabel mesh__D002434 S578
% 223.84/224.09  |- skos__hiddenLabel mesh__D002434 S 578
% 223.84/224.09  |- skos__hiddenLabel mesh__D002434 BL S 578
% 223.84/224.09  |- mesh__activeMeSHYear mesh__D002434 2006
% 223.84/224.09  |- skos__historyNote mesh__D002434 Cephalosporins %28%1966-1971%29%
% 223.84/224.09  |- mesh__recordMaintainer mesh__D002434 ssb
% 223.84/224.09  |- skos__hiddenLabel mesh__D002434 4 Hydroxycephalexin
% 223.84/224.09  |- mesh__recordOriginator mesh__D002434 SH
% 223.84/224.09  |- skos__hiddenLabel mesh__D002434 BLS578
% 223.84/224.09  |- skos__hiddenLabel mesh__D002434 BL S578
% 223.84/224.09  |- mesh__publicMeSHNote mesh__D002434 84   
% 223.84/224.09  |- mesh__dateCreated mesh__D002434 1983-06-10
% 223.84/224.09  |- mesh__historyNote mesh__D002434 84   
% 223.84/224.09  |- skos__prefLabel mesh__D002434 Cefadroxil
% 223.84/224.09  |- mesh__recordAuthorizer mesh__D002434 sjn
% 223.84/224.09  |- mesh__dateEstablished mesh__D002434 1984-01-01
% 223.84/224.09  |- rdf__type mesh__D002434sskos__Concept
% 223.84/224.10  |- skos__historyNote mesh__D002434 Cephalexin %28%1972-1974%29%
% 223.84/224.10  |- skos__altLabel mesh__D002434 BL-S578
% 223.84/224.10  |- skos__historyNote mesh__D002434
% 223.84/224.10       Cephalexin/analogs %26% derivatives %28%1975-1983%29%
% 223.84/224.10  |- skos__broader mesh__D002434smesh__D002506
% 223.84/224.10  |- skos__scopeNote mesh__D002434
% 223.84/224.10       Long-acting, broad-spectrum, water-soluble, CEPHALEXIN derivative.%A%    
% 223.84/224.10  |- skos__altLabel mesh__D002434 Cephadroxyl
% 223.84/224.10  |- mesh__dateRevised mesh__D026882 2005-06-30
% 223.84/224.10  |- skos__scopeNote mesh__D026882
% 223.84/224.10       Spinal adjustments made by a chiropractor to relieve pressures on the spinal cord for improvement of health.%A%    
% 223.84/224.10  |- skos__broader mesh__D026882smesh__D026201
% 223.84/224.10  |- mesh__publicMeSHNote mesh__D026882
% 223.84/224.10       2002; MANIPULATION, CHIROPRACTIC see CHIROPRACTIC 1992-1998%A%  
% 223.84/224.10  |- mesh__dateCreated mesh__D026882 2001-07-25
% 223.84/224.10  |- skos__related mesh__D026882smesh__D026301
% 223.84/224.10  |- skos__related mesh__D026882smesh__D008349
% 223.84/224.10  |- mesh__recordOriginator mesh__D026882 ssb
% 223.84/224.10  |- mesh__historyNote mesh__D026882
% 223.84/224.10       2002; MANIPULATION, CHIROPRACTIC see CHIROPRACTIC 1992-1998%A%  
% 223.84/224.10  |- skos__altLabel mesh__D026882 Spinal Adjustment, Chiropractic
% 223.84/224.10  |- skos__hiddenLabel mesh__D026882 Chiropractic Manipulation
% 223.84/224.10  |- skos__historyNote mesh__D026882 Manipulation, Spinal %28%1999-2001%29%
% 223.84/224.10  |- skos__annotation mesh__D026882
% 223.84/224.10       do not confuse with CHIROPRACTIC, the specialty   
% 223.84/224.10  |- mesh__activeMeSHYear mesh__D026882 2006
% 223.84/224.10  |- skos__related mesh__D026882smesh__D002684
% 223.84/224.10  |- skos__prefLabel mesh__D026882 Manipulation, Chiropractic
% 223.84/224.10  |- rdf__type mesh__D026882sskos__Concept
% 223.84/224.10  |- skos__hiddenLabel mesh__D026882 Adjustment, Chiropractic
% 223.84/224.10  |- skos__historyNote mesh__D026882 Chiropractic %28%1992-1998%29%
% 223.84/224.10  |- skos__altLabel mesh__D026882 Chiropractic Adjustment
% 223.84/224.10  |- mesh__dateEstablished mesh__D026882 2002-01-01
% 223.84/224.10  |- skos__broader mesh__D026882smesh__D020393
% 223.84/224.10  |- mesh__recordAuthorizer mesh__D026882 sjn
% 223.84/224.10  |- mesh__recordMaintainer mesh__D026882 lkt
% 223.84/224.10  |- mesh__activeMeSHYear mesh__D012862 2006
% 223.96/224.10  |- skos__broader mesh__D012862smesh__D007211
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012862 1997
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012862 1994
% 223.96/224.10  |- mesh__recordAuthorizer mesh__D012862 PLS
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012862 2003
% 223.96/224.10  |- mesh__historyNote mesh__D012862
% 223.96/224.10       91%28%64%29%; was see under INDOLES 1964-90   
% 223.96/224.10  |- mesh__dateEstablished mesh__D012862 1991-01-01
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012862 2000
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012862 1995
% 223.96/224.10  |- skos__altLabel mesh__D012862 3-Methylindole
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012862 2004
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012862 2001
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012862 1998
% 223.96/224.10  |- mesh__publicMeSHNote mesh__D012862 91; was see under INDOLES 1964-90   
% 223.96/224.10  |- rdf__type mesh__D012862sskos__Concept
% 223.96/224.10  |- mesh__recordOriginator mesh__D012862 NLM
% 223.96/224.10  |- mesh__dateRevised mesh__D012862 1992-05-20
% 223.96/224.10  |- skos__hiddenLabel mesh__D012862 3 Methylindole
% 223.96/224.10  |- skos__prefLabel mesh__D012862 Skatole
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012862 1999
% 223.96/224.10  |- mesh__dateCreated mesh__D012862 1999-01-01
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012862 1993
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012862 2005
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012862 2002
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012862 1996
% 223.96/224.10  |- mesh__recordMaintainer mesh__D012862 TAP
% 223.96/224.10  |- mesh__dateEstablished mesh__D012064 1976-01-01
% 223.96/224.10  |- skos__annotation mesh__D012064
% 223.96/224.10       a behavior ther technique: do not confuse with RELAXATION in category I3; not for physiological relaxation of muscles %28%= MUSCLE RELAXATION%29%%A%  
% 223.96/224.10  |- mesh__historyNote mesh__D012064 91; was RELAXATION TECHNICS 1976-90   
% 223.96/224.10  |- mesh__recordMaintainer mesh__D012064 ags
% 223.96/224.10  |- skos__hiddenLabel mesh__D012064 Technique, Relaxation
% 223.96/224.10  |- skos__broader mesh__D012064smesh__D001521
% 223.96/224.10  |- skos__broader mesh__D012064smesh__D026241
% 223.96/224.10  |- mesh__onlineNote mesh__D012064
% 223.96/224.10       use RELAXATION TECHNIQUES to search RELAXATION TECHNICS 1976-90%A%  
% 223.96/224.10  |- skos__altLabel mesh__D012064 Relaxation Technics
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012064 2006
% 223.96/224.10  |- mesh__recordOriginator mesh__D012064 EC
% 223.96/224.10  |- skos__hiddenLabel mesh__D012064 Techniques, Relaxation
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012064 2006A
% 223.96/224.10  |- skos__hiddenLabel mesh__D012064 Technic, Relaxation
% 223.96/224.10  |- skos__altLabel mesh__D012064 Relaxation Therapy
% 223.96/224.10  |- mesh__publicMeSHNote mesh__D012064
% 223.96/224.10       91; was RELAXATION TECHNICS 1976-90   
% 223.96/224.10  |- skos__prefLabel mesh__D012064 Relaxation Techniques
% 223.96/224.10  |- mesh__recordAuthorizer mesh__D012064 ags
% 223.96/224.10  |- skos__hiddenLabel mesh__D012064 Relaxation Technique
% 223.96/224.10  |- skos__scopeNote mesh__D012064
% 223.96/224.10       The use of muscular relaxation techniques in treatment.%A%    
% 223.96/224.10  |- skos__broader mesh__D012064smesh__D026441
% 223.96/224.10  |- mesh__dateCreated mesh__D012064 1975-07-25
% 223.96/224.10  |- skos__historyNote mesh__D012064 Relaxation %28%1966-1975%29%
% 223.96/224.10  |- skos__broader mesh__D012064smesh__D026201
% 223.96/224.10  |- skos__hiddenLabel mesh__D012064 Technics, Relaxation
% 223.96/224.10  |- skos__hiddenLabel mesh__D012064 Relaxation Technic
% 223.96/224.10  |- rdf__type mesh__D012064sskos__Concept
% 223.96/224.10  |- mesh__dateRevised mesh__D012064 2005-07-28
% 223.96/224.10  |- mesh__recordAuthorizer mesh__D006825 PLS
% 223.96/224.10  |- mesh__historyNote mesh__D006825 82   
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006825 2003
% 223.96/224.10  |- mesh__dateEstablished mesh__D006825 1982-01-01
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006825 1995
% 223.96/224.10  |- skos__prefLabel mesh__D006825 Hybridomas
% 223.96/224.10  |- mesh__dateRevised mesh__D006825 1990-06-05
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006825 1991
% 223.96/224.10  |- mesh__recordOriginator mesh__D006825 AEP
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006825 1994
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006825 2006
% 223.96/224.10  |- mesh__dateCreated mesh__D006825 1981-05-20
% 223.96/224.10  |- skos__historyNote mesh__D006825 Clone Cells %28%1975-1981%29%
% 223.96/224.10  |- skos__historyNote mesh__D006825 Cell Fusion %28%1975-1981%29%
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006825 1997
% 223.96/224.10  |- skos__historyNote mesh__D006825 Hybrid Cells %28%1975-1981%29%
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006825 2002
% 223.96/224.10  |- skos__historyNote mesh__D006825 Cell Line %28%1975-1981%29%
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006825 2005
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006825 1996
% 223.96/224.10  |- skos__annotation mesh__D006825
% 223.96/224.10       note category: not a tumor but %22%cells artif created by fusion of activated lymphocytes with neoplastic cells%22%; A 11 qualif%A%  
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006825 1993
% 223.96/224.10  |- rdf__type mesh__D006825sskos__Concept
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006825 1999
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006825 2001
% 223.96/224.10  |- skos__broader mesh__D006825smesh__D006822
% 223.96/224.10  |- skos__related mesh__D006825smesh__D000911
% 223.96/224.10  |- skos__scopeNote mesh__D006825
% 223.96/224.10       Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure or %22%monoclonal%22% antibodies or T-cell products, identical to those produced by the immunologically competent parent, and continually grow and divide as the neoplastic parent.%A%    
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006825 2004
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006825 1992
% 223.96/224.10  |- mesh__recordMaintainer mesh__D006825 TGC
% 223.96/224.10  |- mesh__publicMeSHNote mesh__D006825 82   
% 223.96/224.10  |- skos__broader mesh__D006825smesh__D002999
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006825 1998
% 223.96/224.10  |- skos__altLabel mesh__D006825 Hybridoma
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006825 2000
% 223.96/224.10  |- mesh__recordAuthorizer mesh__D050981 sjn
% 223.96/224.10  |- mesh__historyNote mesh__D050981 2006%28%1980%29%   
% 223.96/224.10  |- skos__hiddenLabel mesh__D050981 DNA-Binding Factors, Erythroid-Specific
% 223.96/224.10  |- mesh__recordMaintainer mesh__D050981 DRC
% 223.96/224.10  |- mesh__publicMeSHNote mesh__D050981
% 223.96/224.10       2006; ERYTHROID-SPECIFIC DNA-BINDING FACTORS was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1980-2005%A%  
% 223.96/224.10  |- mesh__recordOriginator mesh__D050981 DRC
% 223.96/224.10  |- skos__broader mesh__D050981smesh__D014157
% 223.96/224.10  |- skos__hiddenLabel mesh__D050981 Erythroid Specific DNA Binding Factors
% 223.96/224.10  |- skos__altLabel mesh__D050981 Erythroid-Specific Nuclear Factors
% 223.96/224.10  |- mesh__dateCreated mesh__D050981 2005-06-30
% 223.96/224.10  |- skos__scopeNote mesh__D050981
% 223.96/224.10       A group of transcription factors that were originally described as being specific to ERYTHROID CELLS.%A%    
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D050981 2006
% 223.96/224.10  |- mesh__dateEstablished mesh__D050981 2006-01-01
% 223.96/224.10  |- skos__hiddenLabel mesh__D050981 Erythroid Specific Nuclear Factors
% 223.96/224.10  |- skos__prefLabel mesh__D050981 Erythroid-Specific DNA-Binding Factors
% 223.96/224.10  |- skos__broader mesh__D050981smesh__D004268
% 223.96/224.10  |- rdf__type mesh__D050981sskos__Concept
% 223.96/224.10  |- skos__hiddenLabel mesh__D050981 Nuclear Factors, Erythroid-Specific
% 223.96/224.10  |- skos__broader mesh__D039201smesh__D017474
% 223.96/224.10  |- mesh__dateEstablished mesh__D039201 2003-01-01
% 223.96/224.10  |- mesh__historyNote mesh__D039201
% 223.96/224.10       2003; use INTEGRIN ALPHA3BETA1 %28%NM%29% 1992-2002   
% 223.96/224.10  |- mesh__recordOriginator mesh__D039201 MDJ
% 223.96/224.10  |- skos__hiddenLabel mesh__D039201 Epiligrin Receptor, alpha3beta1
% 223.96/224.10  |- skos__broader mesh__D039201smesh__D016029
% 223.96/224.10  |- skos__altLabel mesh__D039201 Integrin alpha%28%3%29%beta%28%1%29%
% 223.96/224.10  |- skos__broader mesh__D039201smesh__D038981
% 223.96/224.10  |- skos__scopeNote mesh__D039201
% 223.96/224.10       Cell surface receptor for LAMININ, epiligrin, FIBRONECTINS, entactin, and COLLAGEN.  Integrin alpha3beta1 is the major integrin present in EPITHELIAL CELLS, where it plays a role in the assembly of BASEMENT MEMBRANE as well as in cell migration, and may regulate the functions of other integrins.  Two alternatively spliced isoforms of the alpha subunit %28%INTEGRIN ALPHA3%29%, are differentially expressed in different cell types.%A%    
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D039201 2006
% 223.96/224.10  |- mesh__recordMaintainer mesh__D039201 jmp
% 223.96/224.10  |- skos__hiddenLabel mesh__D039201 Integrin, alpha3beta1
% 223.96/224.10  |- mesh__dateRevised mesh__D039201 2005-06-30
% 223.96/224.10  |- mesh__publicMeSHNote mesh__D039201
% 223.96/224.10       2003; INTEGRIN ALPHA3BETA1 was indexed under INTEGRINS 1992-2002%A%  
% 223.96/224.10  |- skos__altLabel mesh__D039201 Gap b3
% 223.96/224.10  |- skos__altLabel mesh__D039201 alpha3beta1 Epiligrin Receptor
% 223.96/224.10  |- skos__altLabel mesh__D039201 VLA-3
% 223.96/224.10  |- skos__historyNote mesh__D039201 Integrins %28%1992-2002%29%
% 223.96/224.10  |- skos__altLabel mesh__D039201 Epiligrin Receptor
% 223.96/224.10  |- skos__hiddenLabel mesh__D039201 alpha3beta1, Integrin
% 223.96/224.10  |- skos__prefLabel mesh__D039201 Integrin alpha3beta1
% 223.96/224.10  |- mesh__dateCreated mesh__D039201 2002-07-02
% 223.96/224.10  |- skos__hiddenLabel mesh__D039201 Receptor, Epiligrin
% 223.96/224.10  |- skos__altLabel mesh__D039201 alpha3beta1 Integrin
% 223.96/224.10  |- skos__altLabel mesh__D039201 Galactoprotein b3
% 223.96/224.10  |- mesh__recordAuthorizer mesh__D039201 sjn
% 223.96/224.10  |- skos__altLabel mesh__D039201
% 223.96/224.10       Laminin-5 Receptor %28%alpha3beta1 integrin%29%
% 223.96/224.10  |- skos__altLabel mesh__D039201 CD49c-CD29
% 223.96/224.10  |- rdf__type mesh__D039201sskos__Concept
% 223.96/224.10  |- skos__hiddenLabel mesh__D039201 Receptor, alpha3beta1 Epiligrin
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006027 2005
% 223.96/224.10  |- mesh__recordMaintainer mesh__D006027 ssb
% 223.96/224.10  |- skos__scopeNote mesh__D006027
% 223.96/224.10       Any compound that contains a constituent sugar, in which the hydroxyl group attached to the first carbon is substituted by an alcoholic, phenolic, or other group. They are named specifically for the sugar contained, such as glucoside %28%glucose%29%, pentoside %28%pentose%29%, fructoside %28%fructose%29%, etc. Upon hydrolysis, a sugar and nonsugar component %28%aglycone%29% are formed. %28%From Dorland, 28th ed; From Miall%27%s Dictionary of Chemistry, 5th ed%29%%A%    
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006027 2006
% 223.96/224.10  |- skos__broader mesh__D006027smesh__D002241
% 223.96/224.10  |- mesh__recordAuthorizer mesh__D006027 sjn
% 223.96/224.10  |- mesh__recordOriginator mesh__D006027 NLM
% 223.96/224.10  |- mesh__dateRevised mesh__D006027 2004-07-07
% 223.96/224.10  |- rdf__type mesh__D006027sskos__Concept
% 223.96/224.10  |- skos__prefLabel mesh__D006027 Glycosides
% 223.96/224.10  |- mesh__dateCreated mesh__D006027 1999-01-01
% 223.96/224.10  |- skos__annotation mesh__D006027
% 223.96/224.10       coordinate with compound %28%aglycone%29% that is glycosylated; GEN; do not confuse with GLUCOSIDES; glucides is a European term for CARBOHYDRATES%A%  
% 223.96/224.10  |- rdf__type mesh__D044944sskos__Concept
% 223.96/224.10  |- mesh__dateCreated mesh__D044944 2003-07-09
% 223.96/224.10  |- mesh__dateEstablished mesh__D044944 2004-01-01
% 223.96/224.10  |- skos__hiddenLabel mesh__D044944 Dehydrogenases, Acyl-CoA
% 223.96/224.10  |- mesh__historyNote mesh__D044944
% 223.96/224.10       2004; use FATTY ACID DESATURASES 1977-2003   
% 223.96/224.10  |- skos__prefLabel mesh__D044944 Acyl-CoA Dehydrogenases
% 223.96/224.10  |- mesh__dateRevised mesh__D044944 2005-06-30
% 223.96/224.10  |- skos__broader mesh__D044944smesh__D044925
% 223.96/224.10  |- mesh__recordOriginator mesh__D044944 jmp
% 223.96/224.10  |- mesh__publicMeSHNote mesh__D044944
% 223.96/224.10       2004; see FATTY ACID DESATURASES 1977-2003   
% 223.96/224.10  |- skos__scopeNote mesh__D044944
% 223.96/224.10       Enzymes that catalyze the first step in the beta-oxidation of FATTY ACIDS.%A%    
% 223.96/224.10  |- skos__historyNote mesh__D044944 Fatty Acid Desaturases %28%1977-2003%29%
% 223.96/224.10  |- skos__hiddenLabel mesh__D044944 Acyl CoA Dehydrogenases
% 223.96/224.10  |- mesh__recordMaintainer mesh__D044944 jmp
% 223.96/224.10  |- skos__annotation mesh__D044944
% 223.96/224.10       ACYL-COA DEHYDROGENASE and other specifics are also available%A%  
% 223.96/224.10  |- mesh__recordAuthorizer mesh__D044944 sjn
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D044944 2006
% 223.96/224.10  |- mesh__dateCreated mesh__D002435 1977-04-22
% 223.96/224.10  |- mesh__dateRevised mesh__D002435 2004-07-07
% 223.96/224.10  |- skos__historyNote mesh__D002435 Cephalosporins %28%1966-1977%29%
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D002435 2005
% 223.96/224.10  |- mesh__recordMaintainer mesh__D002435 ssb
% 223.96/224.10  |- mesh__publicMeSHNote mesh__D002435
% 223.96/224.10       84; was see under CEPHALOSPORINS 1978-83   
% 223.96/224.10  |- mesh__recordOriginator mesh__D002435 SH
% 223.96/224.10  |- skos__prefLabel mesh__D002435 Cefamandole
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D002435 2006
% 223.96/224.10  |- skos__altLabel mesh__D002435 Cephamandole
% 223.96/224.10  |- mesh__recordAuthorizer mesh__D002435 sjn
% 223.96/224.10  |- mesh__historyNote mesh__D002435
% 223.96/224.10       84%28%78%29%; was see under CEPHALOSPORINS 1978-83   
% 223.96/224.10  |- rdf__type mesh__D002435sskos__Concept
% 223.96/224.10  |- skos__scopeNote mesh__D002435
% 223.96/224.10       Semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. It is used also as the nafate.%A%    
% 223.96/224.10  |- skos__broader mesh__D002435smesh__D002511
% 223.96/224.10  |- mesh__dateEstablished mesh__D002435 1984-01-01
% 223.96/224.10  |- mesh__dateEstablished mesh__D007120 1966-01-01
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D007120 2006
% 223.96/224.10  |- mesh__dateCreated mesh__D007120 1999-01-01
% 223.96/224.10  |- mesh__dateRevised mesh__D007120 2001-07-25
% 223.96/224.10  |- skos__broader mesh__D007120smesh__D001671
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D007120 2002
% 223.96/224.10  |- skos__related mesh__D007120smesh__D007158
% 223.96/224.10  |- skos__annotation mesh__D007120
% 223.96/224.10       GEN; avoid as coord; SPEC qualif when IM; no qualif when NIM%A%  
% 223.96/224.10  |- rdf__type mesh__D007120sskos__Concept
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D007120 2003
% 223.96/224.10  |- mesh__historyNote mesh__D007120 66%28%64%29%   
% 223.96/224.10  |- skos__broader mesh__D007120smesh__D002623
% 223.96/224.10  |- mesh__publicMeSHNote mesh__D007120 66   
% 223.96/224.10  |- skos__related mesh__D007120smesh__D015151
% 223.96/224.10  |- skos__scopeNote mesh__D007120
% 223.96/224.10       Field of chemistry that pertains to immunological phenomena and the study of chemical reactions related to antigen stimulation of tissues. It includes physicochemical interactions between antigens and antibodies.%A%    
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D007120 2004
% 223.96/224.10  |- mesh__recordMaintainer mesh__D007120 jls
% 223.96/224.10  |- mesh__recordAuthorizer mesh__D007120 sjn
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D007120 2005
% 223.96/224.10  |- skos__prefLabel mesh__D007120 Immunochemistry
% 223.96/224.10  |- mesh__recordOriginator mesh__D007120 NLM
% 223.96/224.10  |- skos__annotation mesh__D012863
% 223.96/224.10       the bony frame as a whole; avoid: use BONE AND BONES; %22%skeletal%22% in titles is probably %22%bone%22%, %22%bone tissue%22% or %22%osseous%22% which = BONE AND BONES: TN 173; no qualif%A%  
% 223.96/224.10  |- mesh__recordAuthorizer mesh__D012863 PLS
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012863 2006
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012863 2000
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012863 2003
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012863 1994
% 223.96/224.10  |- mesh__dateRevised mesh__D012863 1991-06-20
% 223.96/224.10  |- rdf__type mesh__D012863sskos__Concept
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012863 2001
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012863 1998
% 223.96/224.10  |- mesh__recordOriginator mesh__D012863 NLM
% 223.96/224.10  |- skos__prefLabel mesh__D012863 Skeleton
% 223.96/224.10  |- mesh__recordMaintainer mesh__D012863 TGC
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012863 2004
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012863 1995
% 223.96/224.10  |- mesh__dateCreated mesh__D012863 1999-01-01
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012863 1992
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012863 1999
% 223.96/224.10  |- skos__broader mesh__D012863smesh__D009141
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012863 1996
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012863 1993
% 223.96/224.10  |- skos__related mesh__D012863smesh__D001842
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012863 2002
% 223.96/224.10  |- skos__hiddenLabel mesh__D012863 Skeletons
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012863 2005
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012863 1997
% 223.96/224.10  |- skos__annotation mesh__D012065 /biosyn /physiol permitted   
% 223.96/224.10  |- skos__prefLabel mesh__D012065 Relaxin
% 223.96/224.10  |- mesh__dateRevised mesh__D012065 2004-07-13
% 223.96/224.10  |- rdf__type mesh__D012065sskos__Concept
% 223.96/224.10  |- skos__scopeNote mesh__D012065
% 223.96/224.10       A water-soluble polypeptide %28%molecular weight approximately 8,000%29% extractable from the corpus luteum of pregnancy. It produces relaxation of the pubic symphysis and dilation of the uterine cervix in certain animal species. Its role in the human pregnant female is uncertain. %28%Dorland, 28th ed%29%%A%    
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012065 2006
% 223.96/224.10  |- mesh__recordMaintainer mesh__D012065 sjn
% 223.96/224.10  |- skos__hiddenLabel mesh__D012065 B, Relaxin
% 223.96/224.10  |- mesh__dateCreated mesh__D012065 1999-01-01
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D012065 2005
% 223.96/224.10  |- skos__broader mesh__D012065smesh__D036361
% 223.96/224.10  |- mesh__recordOriginator mesh__D012065 NLM
% 223.96/224.10  |- skos__broader mesh__D012065smesh__D003339
% 223.96/224.10  |- mesh__recordAuthorizer mesh__D012065 sjn
% 223.96/224.10  |- skos__historyNote mesh__D006826 Ethylenediamines %28%1974%29%
% 223.96/224.10  |- skos__historyNote mesh__D006826 Thioxanthenes %28%1974%29%
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006826 2001
% 223.96/224.10  |- mesh__recordMaintainer mesh__D006826 TWD
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006826 2006
% 223.96/224.10  |- mesh__recordAuthorizer mesh__D006826 sjn
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006826 2005
% 223.96/224.10  |- mesh__historyNote mesh__D006826
% 223.96/224.10       91%28%75%29%; was see under THIOXANTHENES 1975-90   
% 223.96/224.10  |- mesh__dateEstablished mesh__D006826 1991-01-01
% 223.96/224.10  |- rdf__type mesh__D006826sskos__Concept
% 223.96/224.10  |- mesh__publicMeSHNote mesh__D006826
% 223.96/224.10       91; was see under THIOXANTHENES 1975-90   
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006826 2002
% 223.96/224.10  |- mesh__dateRevised mesh__D006826 2000-06-22
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006826 2004
% 223.96/224.10  |- skos__broader mesh__D006826smesh__D013892
% 223.96/224.10  |- mesh__dateCreated mesh__D006826 1974-11-19
% 223.96/224.10  |- mesh__recordOriginator mesh__D006826 NLM
% 223.96/224.10  |- skos__scopeNote mesh__D006826
% 223.96/224.10       Potentially toxic, but effective antischistosomal agent, it is a metabolite of LUCANTHONE.%A%    
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006826 2003
% 223.96/224.10  |- skos__prefLabel mesh__D006826 Hycanthone
% 223.96/224.10  |- skos__scopeNote mesh__D050982
% 223.96/224.10       A GATA transcription factor that is specifically expressed in hematopoietic lineages and plays an important role in the CELL DIFFERENTIATION of ERYTHROID CELLS and MEGAKARYOCYTES.%A%    
% 223.96/224.10  |- skos__altLabel mesh__D050982 Transcription Factor GATA1
% 223.96/224.10  |- skos__hiddenLabel mesh__D050982 GATA1, Transcription Factor
% 223.96/224.10  |- skos__altLabel mesh__D050982 Globin Transcription Factor 1
% 223.96/224.10  |- mesh__recordOriginator mesh__D050982 DRC
% 223.96/224.10  |- skos__altLabel mesh__D050982 Erythroid Transcription Factor 1
% 223.96/224.10  |- mesh__recordAuthorizer mesh__D050982 sjn
% 223.96/224.10  |- skos__hiddenLabel mesh__D050982 NFE-1, Transcription Factor
% 223.96/224.10  |- mesh__historyNote mesh__D050982 2006%28%1980%29%   
% 223.96/224.10  |- skos__hiddenLabel mesh__D050982 Transcription Factor, GATA1
% 223.96/224.10  |- skos__prefLabel mesh__D050982 GATA1 Transcription Factor
% 223.96/224.10  |- skos__broader mesh__D050982smesh__D050981
% 223.96/224.10  |- skos__altLabel mesh__D050982
% 223.96/224.10       NF-E1 Erythroid-Specific Transcription Factor
% 223.96/224.10  |- skos__hiddenLabel mesh__D050982
% 223.96/224.10       Eryf1 Erythroid Specific Transcription Factor
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D050982 2006
% 223.96/224.10  |- mesh__recordMaintainer mesh__D050982 DRC
% 223.96/224.10  |- skos__broader mesh__D050982smesh__D050980
% 223.96/224.10  |- skos__hiddenLabel mesh__D050982 Nuclear Factor Erythroid 1
% 223.96/224.10  |- skos__hiddenLabel mesh__D050982 Factor GATA1, Transcription
% 223.96/224.10  |- skos__hiddenLabel mesh__D050982
% 223.96/224.10       NF E1 Erythroid Specific Transcription Factor
% 223.96/224.10  |- skos__altLabel mesh__D050982 Transcription Factor NFE-1
% 223.96/224.10  |- rdf__type mesh__D050982sskos__Concept
% 223.96/224.10  |- skos__altLabel mesh__D050982
% 223.96/224.10       Eryf1 Erythroid-Specific Transcription Factor
% 223.96/224.10  |- mesh__dateCreated mesh__D050982 2005-06-30
% 223.96/224.10  |- mesh__publicMeSHNote mesh__D050982
% 223.96/224.10       2006; GATA1 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1980-2005%A%  
% 223.96/224.10  |- mesh__dateEstablished mesh__D050982 2006-01-01
% 223.96/224.10  |- skos__altLabel mesh__D050982 Nuclear Factor-Erythroid 1
% 223.96/224.10  |- mesh__recordOriginator mesh__D006028 NLM
% 223.96/224.10  |- skos__broader mesh__D006028smesh__D006017
% 223.96/224.10  |- skos__scopeNote mesh__D006028
% 223.96/224.10       Lipids containing at least one monosaccharide residue and either a sphingoid or a ceramide %28%CERAMIDES%29%. They are subdivided into NEUTRAL GLYCOSPHINGOLIPIDS comprising monoglycosyl- and oligoglycosylsphingoids and monoglycosyl- and oligoglycosylceramides; and ACIDIC GLYCOSPHINGOLIPIDS which comprises sialosylglycosylsphingolipids %28%GANGLIOSIDES%29%; SULFOGLYCOSYLSPHINGOLIPIDS %28%formerly known as sulfatides%29%, glycuronoglycosphingolipids, and phospho- and phosphonoglycosphingolipids. %28%From IUPAC%27%s webpage%29%%A%    
% 223.96/224.10  |- mesh__dateRevised mesh__D006028 2004-07-07
% 223.96/224.10  |- rdf__type mesh__D006028sskos__Concept
% 223.96/224.10  |- skos__historyNote mesh__D006028 Sphingolipids %28%1972-1974%29%
% 223.96/224.10  |- skos__historyNote mesh__D006028 Glycolipids %28%1966-1974%29%
% 223.96/224.10  |- mesh__dateEstablished mesh__D006028 1975-09-01
% 223.96/224.10  |- skos__altLabel mesh__D006028 Sphingoglycolipids
% 223.96/224.10  |- mesh__historyNote mesh__D006028 75   
% 223.96/224.10  |- skos__broader mesh__D006028smesh__D013107
% 223.96/224.10  |- mesh__recordMaintainer mesh__D006028 ssb
% 223.96/224.10  |- mesh__publicMeSHNote mesh__D006028 75   
% 223.96/224.10  |- skos__altLabel mesh__D006028 Asialogangliosides
% 223.96/224.10  |- mesh__dateCreated mesh__D006028 1974-11-11
% 223.96/224.10  |- skos__prefLabel mesh__D006028 Glycosphingolipids
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006028 2005
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D006028 2006
% 223.96/224.10  |- mesh__recordAuthorizer mesh__D006028 sjn
% 223.96/224.10  |- mesh__publicMeSHNote mesh__D044945
% 223.96/224.10       2004; PROANTHOCYANIDINS was indexed under ANTHOCYANIDINS 1977-2003%A%  
% 223.96/224.10  |- skos__altLabel mesh__D044945 Condensed Tannin
% 223.96/224.10  |- skos__prefLabel mesh__D044945 Proanthocyanidins
% 223.96/224.10  |- skos__broader mesh__D044945smesh__D005419
% 223.96/224.10  |- mesh__recordAuthorizer mesh__D044945 sjn
% 223.96/224.10  |- skos__altLabel mesh__D044945 Anthocyanidin Polymers
% 223.96/224.10  |- mesh__recordMaintainer mesh__D044945 ssb
% 223.96/224.10  |- skos__hiddenLabel mesh__D044945 Tannins, Condensed
% 223.96/224.10  |- mesh__dateEstablished mesh__D044945 2004-01-01
% 223.96/224.10  |- skos__altLabel mesh__D044945 Condensed Tannins
% 223.96/224.10  |- skos__hiddenLabel mesh__D044945 Polymers, Anthocyanidin
% 223.96/224.10  |- mesh__dateRevised mesh__D044945 2005-06-30
% 223.96/224.10  |- mesh__recordOriginator mesh__D044945 ssb
% 223.96/224.10  |- skos__altLabel mesh__D044945 Tannin, Condensed
% 223.96/224.10  |- skos__historyNote mesh__D044945 Anthocyanidins %28%1977-2003%29%
% 223.96/224.10  |- mesh__historyNote mesh__D044945
% 223.96/224.10       2004; use PROANTHOCYANIDIN %28%NM%29% 1977-2003   
% 223.96/224.10  |- mesh__activeMeSHYear mesh__D044945 2006
% 223.96/224.10  |- skos__broader mesh__D044945smesh__D013634
% 223.96/224.10  |- rdf__type mesh__D044945sskos__Concept
% 223.96/224.10  |- mesh__dateCreated mesh__D044945 2003-07-09
% 223.96/224.10  |- skos__scopeNote mesh__D044945
% 223.96/224.10       Dimers and oligomers of flavan-3-ol units %28%CATECHIN analogs%29% linked mainly through C4 to C8 bonds to leucoanthocyanidins. They are structurally similar to ANTHOCYANINS but are the result of a different fork in biosynthetic pathways.%A%    
% 223.96/224.10  |- mesh__dateCreated mesh__D044147 2003-07-09
% 223.96/224.10  |- mesh__publicMeSHNote mesh__D044147 2004   
% 223.96/224.10  |- skos__broader mesh__D044147smesh__D006090
% 223.96/224.10  |- mesh__recordMaintainer mesh__D044147 SYSTEM
% 223.96/224.10  |- skos__annotation mesh__D044147
% 223.96/224.10       infection = PISCIRICKETTSIACEAE INFECTIONS   
% 223.96/224.10  |- mesh__recordAuthorizer mesh__D044147 sjn
% 223.96/224.10  |- skos__scopeNote mesh__D044147
% 223.96/224.10       A family of gram-negative bacteria, in the order Thiotrichales.%A%    
% 223.96/224.10  |- mesh__recordOriginator mesh__D044147 ags
% 223.96/224.10  |- rdf__type mesh__D044147sskos__Concept
% 223.96/224.10  |- skos__prefLabel mesh__D044147 Piscirickettsiaceae
% 223.96/224.10  |- mesh__dateRevised mesh__D044147 2005-06-30
% 223.96/224.10  |- skos__broader mesh__D044147smesh__D020563
% 223.96/224.11  |- mesh__dateEstablished mesh__D044147 2004-01-01
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D044147 2006
% 223.96/224.11  |- mesh__historyNote mesh__D044147 2004   
% 223.96/224.11  |- skos__annotation mesh__D049630
% 223.96/224.11       diseases: coordinate IM with ESOPHAGEAL DISEASES %28%IM%29% or specific esophageal disease %28%IM%29%; neoplasms: coordinate IM with STOMACH NEOPLASMS %28%IM%29% or ESOPHAGEAL NEOPLASMS %28%IM%29% depending on text%A%  
% 223.96/224.11  |- mesh__dateEstablished mesh__D049630 2005-01-01
% 223.96/224.11  |- skos__related mesh__D049630smesh__D005764
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D049630 2006
% 223.96/224.11  |- skos__altLabel mesh__D049630 Lower Esophageal Sphincter
% 223.96/224.11  |- skos__broader mesh__D049630smesh__D004943
% 223.96/224.11  |- skos__broader mesh__D049630smesh__D009130
% 223.96/224.11  |- skos__hiddenLabel mesh__D049630 Sphincter, Lower Esophageal
% 223.96/224.11  |- rdf__type mesh__D049630sskos__Concept
% 223.96/224.11  |- skos__prefLabel mesh__D049630 Esophageal Sphincter, Lower
% 223.96/224.11  |- mesh__historyNote mesh__D049630 2005   
% 223.96/224.11  |- mesh__recordAuthorizer mesh__D049630 sjn
% 223.96/224.11  |- mesh__dateCreated mesh__D049630 2004-07-07
% 223.96/224.11  |- mesh__recordOriginator mesh__D049630 ags
% 223.96/224.11  |- mesh__publicMeSHNote mesh__D049630 2005   
% 223.96/224.11  |- mesh__recordMaintainer mesh__D049630 ags
% 223.96/224.11  |- skos__historyNote mesh__D049630
% 223.96/224.11       Esophagogastric Junction %28%1966-2004%29%
% 223.96/224.11  |- skos__scopeNote mesh__D049630
% 223.96/224.11       The physiologic or functional barrier to GASTROESOPHAGEAL REFLUX at the esophagogastric junction. Sphincteric muscles remain tonically contracted during the resting state and form the high-pressure zone separating the lumen of the ESOPHAGUS from that of the STOMACH. %28%Haubrich et al, Bockus Gastroenterology, 5th ed., pp399, 415%29%%A%    
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D049630 2005
% 223.96/224.11  |- mesh__recordMaintainer mesh__D016456 jls
% 223.96/224.11  |- rdf__type mesh__D016456sskos__Concept
% 223.96/224.11  |- mesh__recordOriginator mesh__D016456 PLS
% 223.96/224.11  |- mesh__recordAuthorizer mesh__D016456 sjn
% 223.96/224.11  |- skos__altLabel mesh__D016456 Historical Article %28%PT%29%
% 223.96/224.11  |- skos__broader mesh__D016456smesh__D052180
% 223.96/224.11  |- skos__prefLabel mesh__D016456
% 223.96/224.11       Historical Article %5B%Publication Type%5D%
% 223.96/224.11  |- mesh__dateCreated mesh__D016456 1995-06-27
% 223.96/224.11  |- skos__annotation mesh__D016456
% 223.96/224.11       publication type only; check appropriate century tags; CATALOG: do not use%A%  
% 223.96/224.11  |- mesh__historyNote mesh__D016456
% 223.96/224.11       1991; was Citation Type HISTORICAL ARTICLE 1966-1990   
% 223.96/224.11  |- mesh__dateRevised mesh__D016456 2005-06-30
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D016456 2006
% 223.96/224.11  |- skos__scopeNote mesh__D016456
% 223.96/224.11       An article or portion of an article giving an account of past events or circumstances significant in a field of study, a profession, a discovery, an invention, etc. The concept of history is very wide, ranging from the dawn of time to the present. This publication type is often checked in conjunction with BIOGRAPHY %5B%PUBLICATION TYPE%5D%.%A%    
% 223.96/224.11  |- mesh__dateEstablished mesh__D016456 1996-01-01
% 223.96/224.11  |- skos__altLabel mesh__D016456 Historical Article
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D002436 2005
% 223.96/224.11  |- mesh__historyNote mesh__D002436
% 223.96/224.11       91%28%78%29%; was see under CEPHALOSPORINS 1978-90   
% 223.96/224.11  |- skos__hiddenLabel mesh__D002436 SK%26%F 60771
% 223.96/224.11  |- skos__hiddenLabel mesh__D002436 BLS640
% 223.96/224.11  |- mesh__recordOriginator mesh__D002436 SH
% 223.96/224.11  |- skos__hiddenLabel mesh__D002436 SKF60771
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D002436 2006
% 223.96/224.11  |- skos__hiddenLabel mesh__D002436 S 640P
% 223.96/224.11  |- skos__prefLabel mesh__D002436 Cefatrizine
% 223.96/224.11  |- skos__broader mesh__D002436smesh__D002434
% 223.96/224.11  |- skos__historyNote mesh__D002436 Cephalosporins %28%1966-1977%29%
% 223.96/224.11  |- skos__hiddenLabel mesh__D002436 SK%26%F60771
% 223.96/224.11  |- mesh__recordMaintainer mesh__D002436 ssb
% 223.96/224.11  |- skos__hiddenLabel mesh__D002436 BL S640
% 223.96/224.11  |- rdf__type mesh__D002436sskos__Concept
% 223.96/224.11  |- skos__hiddenLabel mesh__D002436 SKF 60771
% 223.96/224.11  |- skos__scopeNote mesh__D002436
% 223.96/224.11       Orally active semisynthetic cephalosporin antibiotic with broad-spectrum activity.%A%    
% 223.96/224.11  |- skos__altLabel mesh__D002436 BL-S640
% 223.96/224.11  |- mesh__publicMeSHNote mesh__D002436
% 223.96/224.11       91; was see under CEPHALOSPORINS 1978-90   
% 223.96/224.11  |- skos__hiddenLabel mesh__D002436 S 640 P
% 223.96/224.11  |- skos__hiddenLabel mesh__D002436 BLS 640
% 223.96/224.11  |- skos__hiddenLabel mesh__D002436 BL S 640
% 223.96/224.11  |- mesh__dateCreated mesh__D002436 1977-04-22
% 223.96/224.11  |- mesh__recordAuthorizer mesh__D002436 sjn
% 223.96/224.11  |- skos__hiddenLabel mesh__D002436 S640P
% 223.96/224.11  |- mesh__dateRevised mesh__D002436 2004-07-07
% 223.96/224.11  |- skos__altLabel mesh__D002436 SKF-60771
% 223.96/224.11  |- skos__altLabel mesh__D002436 S-640P
% 223.96/224.11  |- mesh__dateEstablished mesh__D002436 1991-01-01
% 223.96/224.11  |- rdf__type mesh__D007121sskos__Concept
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D007121 1997
% 223.96/224.11  |- mesh__historyNote mesh__D007121 80   
% 223.96/224.11  |- mesh__publicMeSHNote mesh__D007121 80   
% 223.96/224.11  |- skos__altLabel mesh__D007121 Immunological Competence
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D007121 2003
% 223.96/224.11  |- mesh__dateCreated mesh__D007121 1979-05-23
% 223.96/224.11  |- skos__broader mesh__D007121smesh__D007109
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D007121 2000
% 223.96/224.11  |- skos__historyNote mesh__D007121 B Lymphocytes %28%1973-1979%29%
% 223.96/224.11  |- mesh__recordAuthorizer mesh__D007121 PLS
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D007121 2004
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D007121 1998
% 223.96/224.11  |- mesh__dateEstablished mesh__D007121 1980-01-01
% 223.96/224.11  |- skos__historyNote mesh__D007121 Lymphocytes %28%1966-1979%29%
% 223.96/224.11  |- skos__historyNote mesh__D007121 Immunity, Cellular %28%1970-1979%29%
% 223.96/224.11  |- skos__altLabel mesh__D007121 Immunologic Competence
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D007121 1994
% 223.96/224.11  |- mesh__recordOriginator mesh__D007121 AEP
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D007121 2001
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D007121 1999
% 223.96/224.11  |- skos__historyNote mesh__D007121 Antibody Formation %28%1966-1979%29%
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D007121 2005
% 223.96/224.11  |- skos__annotation mesh__D007121
% 223.96/224.11       %22%immunologically competent cells%22% = B-LYMPHOCYTES or T-LYMPHOCYTES but do not add IMMUNOCOMPETENCE%A%  
% 223.96/224.11  |- skos__hiddenLabel mesh__D007121 Competence, Immunological
% 223.96/224.11  |- skos__altLabel mesh__D007121 Competence, Immunologic
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D007121 1995
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D007121 2002
% 223.96/224.11  |- skos__prefLabel mesh__D007121 Immunocompetence
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D007121 2006
% 223.96/224.11  |- skos__historyNote mesh__D007121 T Lymphocytes %28%1973-1979%29%
% 223.96/224.11  |- mesh__dateRevised mesh__D007121 1993-06-02
% 223.96/224.11  |- mesh__recordMaintainer mesh__D007121 TGC
% 223.96/224.11  |- skos__historyNote mesh__D007121 Immunity %28%1966-1972%29%
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D007121 1996
% 223.96/224.11  |- skos__scopeNote mesh__D007121
% 223.96/224.11       The ability of lymphoid cells to mount a humoral or cellular immune response when challenged by antigen.%A%    
% 223.96/224.11  |- mesh__historyNote mesh__D012066
% 223.96/224.11       91%28%75%29%; was see under DISASTERS 1968-90; was see under DISASTERS %26% INDIGENT CARE 1963-67%A%  
% 223.96/224.11  |- rdf__type mesh__D012066sskos__Concept
% 223.96/224.11  |- skos__scopeNote mesh__D012066
% 223.96/224.11       Assistance, such as money, food, or shelter, given to the needy, aged, or victims of disaster. It is usually granted on a temporary basis. %28%From The American Heritage Dictionary, 2d college ed%29%%A%    
% 223.96/224.11  |- mesh__recordAuthorizer mesh__D012066 sjn
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D012066 2004
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D012066 2001
% 223.96/224.11  |- mesh__dateRevised mesh__D012066 1999-11-03
% 223.96/224.11  |- skos__hiddenLabel mesh__D012066 Works, Relief
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D012066 2006
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D012066 2003
% 223.96/224.11  |- skos__annotation mesh__D012066
% 223.96/224.11       coord IM with agency supplying the relief %28%IM%29% if pertinent; specify geog if pertinent%A%  
% 223.96/224.11  |- mesh__dateCreated mesh__D012066 1999-01-01
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D012066 2005
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D012066 2000
% 223.96/224.11  |- skos__prefLabel mesh__D012066 Relief Work
% 223.96/224.11  |- skos__broader mesh__D012066smesh__D004190
% 223.96/224.11  |- mesh__recordMaintainer mesh__D012066 kle
% 223.96/224.11  |- mesh__dateEstablished mesh__D012066 1991-01-01
% 223.96/224.11  |- skos__broader mesh__D012066smesh__D012946
% 223.96/224.11  |- mesh__publicMeSHNote mesh__D012066
% 223.96/224.11       91; was see under DISASTERS 1968-90; was see under DISASTERS %26% INDIGENT CARE 1963-67%A%  
% 223.96/224.11  |- skos__hiddenLabel mesh__D012066 Relief Works
% 223.96/224.11  |- skos__hiddenLabel mesh__D012066 Work, Relief
% 223.96/224.11  |- mesh__onlineNote mesh__D012066
% 223.96/224.11       search DISASTERS 1968-74 %26% DISASTERS %26% INDIGENT CARE 1966-67%A%  
% 223.96/224.11  |- mesh__recordOriginator mesh__D012066 NLM
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D012066 2002
% 223.96/224.11  |- skos__broader mesh__D006827smesh__D007093
% 223.96/224.11  |- rdf__type mesh__D006827sskos__Concept
% 223.96/224.11  |- skos__prefLabel mesh__D006827 Hydantoins
% 223.96/224.11  |- mesh__recordOriginator mesh__D006827 NLM
% 223.96/224.11  |- mesh__recordMaintainer mesh__D006827 ssb
% 223.96/224.11  |- mesh__recordAuthorizer mesh__D006827 sjn
% 223.96/224.11  |- mesh__dateRevised mesh__D006827 2005-06-30
% 223.96/224.11  |- mesh__dateCreated mesh__D006827 1999-01-01
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D006827 2006
% 223.96/224.11  |- mesh__recordOriginator mesh__D050983 DRC
% 223.96/224.11  |- skos__altLabel mesh__D050983
% 223.96/224.11       Nuclear Factor-Erythroid 2 Transcription Factor
% 223.96/224.11  |- skos__broader mesh__D050983smesh__D050976
% 223.96/224.11  |- skos__hiddenLabel mesh__D050983 Transcription Factor, NF-E2
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D050983 2006A
% 223.96/224.11  |- mesh__publicMeSHNote mesh__D050983
% 223.96/224.11       2006; NF-E2 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1980-2005%A%  
% 223.96/224.11  |- skos__broader mesh__D050983smesh__D050981
% 223.96/224.11  |- mesh__dateEstablished mesh__D050983 2006-01-01
% 223.96/224.11  |- mesh__dateRevised mesh__D050983 2005-07-29
% 223.96/224.11  |- mesh__historyNote mesh__D050983 2006%28%1980%29%   
% 223.96/224.11  |- mesh__recordAuthorizer mesh__D050983 ags
% 223.96/224.11  |- skos__prefLabel mesh__D050983 NF-E2 Transcription Factor
% 223.96/224.11  |- mesh__recordMaintainer mesh__D050983 ags
% 223.96/224.11  |- skos__hiddenLabel mesh__D050983 Factor, NFE2 Transcription
% 223.96/224.11  |- mesh__dateCreated mesh__D050983 2005-06-30
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D050983 2006
% 223.96/224.11  |- skos__hiddenLabel mesh__D050983 Transcription Factor, NFE2
% 223.96/224.11  |- skos__altLabel mesh__D050983 NFE2 Transcription Factor
% 223.96/224.11  |- skos__scopeNote mesh__D050983
% 223.96/224.11       A basic-leucine zipper transcription factor that regulates GLOBIN gene expression and is related to TRANSCRIPTION FACTOR AP-1. NF-E2 consists of a small MAF protein subunit and a tissue-restricted 45 kDa subunit.%A%    
% 223.96/224.11  |- skos__hiddenLabel mesh__D050983
% 223.96/224.11       Nuclear Factor Erythroid 2 Transcription Factor
% 223.96/224.11  |- skos__hiddenLabel mesh__D050983 NF E2 Transcription Factor
% 223.96/224.11  |- rdf__type mesh__D050983sskos__Concept
% 223.96/224.11  |- rdf__type mesh__D031220sskos__Concept
% 223.96/224.11  |- skos__scopeNote mesh__D031220
% 223.96/224.11       A plant species of the genus LEPIDIUM, family BRASSICACEAE that is a fast-growing, often weedy native of western Asia. It is widely grown, especially in its curl-leaved form, and used as a garnish%A%    
% 223.96/224.11  |- mesh__publicMeSHNote mesh__D031220 2003   
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D031220 2005
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D031220 2006
% 223.96/224.11  |- skos__altLabel mesh__D031220 Cress, Common Garden
% 223.96/224.11  |- skos__altLabel mesh__D031220 Peppergrass
% 223.96/224.11  |- skos__altLabel mesh__D031220 Pepperweed
% 223.96/224.11  |- skos__annotation mesh__D031220
% 223.96/224.11       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.96/224.11  |- skos__altLabel mesh__D031220 Gardencress
% 223.96/224.11  |- skos__altLabel mesh__D031220 Cress, Garden
% 223.96/224.11  |- skos__prefLabel mesh__D031220 Lepidium sativum
% 223.96/224.11  |- mesh__historyNote mesh__D031220 2003   
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D031220 2003
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D031220 2004
% 223.96/224.11  |- mesh__dateCreated mesh__D031220 2002-07-03
% 223.96/224.11  |- mesh__dateEstablished mesh__D031220 2003-01-01
% 223.96/224.11  |- skos__broader mesh__D031220smesh__D029686
% 223.96/224.11  |- mesh__recordAuthorizer mesh__D006029 sjn
% 223.96/224.11  |- mesh__activeMeSHYear mesh__D006029 2004
% 223.96/224.11  |- rdf__type mesh__D006029sskos__Concept
% 223.96/224.11  |- mesh__recordOriginator mesh__D006029 NLM
% 223.96/224.11  |- mesh__dateRevised mesh__D006029 2003-07-09
% 223.96/224.11  |- mesh__dateCreated mesh__D006029 1999-01-01
% 223.96/224.11  |- skos__annotation mesh__D006029
% 223.96/224.11       note category; presence of glucose %28%sugar%29% in urine   
% 223.97/224.11  |- skos__prefLabel mesh__D006029 Glycosuria
% 223.97/224.11  |- skos__broader mesh__D006029smesh__D044882
% 223.97/224.11  |- mesh__activeMeSHYear mesh__D006029 2005
% 223.97/224.11  |- mesh__activeMeSHYear mesh__D006029 2006
% 223.97/224.11  |- mesh__recordMaintainer mesh__D006029 lkt
% 223.97/224.11  |- skos__scopeNote mesh__D006029
% 223.97/224.11       The presence of glucose in the urine, especially the excretion of an abnormally large amount of sugar %28%glucose%29% in the urine. %28%Dorland, 27th ed%29%%A%    
% 223.97/224.11  |- skos__scopeNote mesh__D044946
% 223.97/224.11       Dimers %28%homo and hetero%29% of FLAVONOIDS.     
% 223.97/224.11  |- mesh__recordOriginator mesh__D044946 ssb
% 223.97/224.11  |- mesh__activeMeSHYear mesh__D044946 2006
% 223.97/224.11  |- skos__prefLabel mesh__D044946 Biflavonoids
% 223.97/224.11  |- skos__broader mesh__D044946smesh__D005419
% 223.97/224.11  |- rdf__type mesh__D044946sskos__Concept
% 223.97/224.11  |- mesh__dateCreated mesh__D044946 2003-07-09
% 223.97/224.11  |- skos__historyNote mesh__D044946 Flavones %28%1970-2003%29%
% 223.97/224.11  |- mesh__dateEstablished mesh__D044946 2004-01-01
% 223.97/224.11  |- mesh__recordAuthorizer mesh__D044946 sjn
% 223.97/224.11  |- mesh__recordMaintainer mesh__D044946 ssb
% 223.97/224.11  |- mesh__historyNote mesh__D044946 2004   
% 223.97/224.11  |- mesh__publicMeSHNote mesh__D044946 2004   
% 223.97/224.11  |- mesh__dateRevised mesh__D044946 2005-06-30
% 223.97/224.11  |- mesh__dateCreated mesh__D044148 2003-07-09
% 223.97/224.11  |- mesh__publicMeSHNote mesh__D044148 2004   
% 223.97/224.11  |- mesh__activeMeSHYear mesh__D044148 2006
% 223.97/224.11  |- skos__hiddenLabel mesh__D044148 Lymphatic Abnormality
% 223.97/224.11  |- mesh__activeMeSHYear mesh__D044148 2005
% 223.97/224.11  |- skos__hiddenLabel mesh__D044148 Abnormalities, Lymphatic
% 223.97/224.11  |- mesh__historyNote mesh__D044148 2004   
% 223.97/224.11  |- skos__broader mesh__D044148smesh__D008206
% 223.97/224.11  |- mesh__activeMeSHYear mesh__D044148 2004
% 223.97/224.11  |- mesh__dateEstablished mesh__D044148 2004-01-01
% 223.97/224.11  |- skos__prefLabel mesh__D044148 Lymphatic Abnormalities
% 223.97/224.11  |- skos__scopeNote mesh__D044148
% 223.97/224.11       Congenital or acquired structural abnormalities of the lymphatic system %28%LYMPHOID TISSUE%29% including the lymph vessels.%A%    
% 223.97/224.11  |- skos__broader mesh__D044148smesh__D000013
% 223.97/224.11  |- skos__hiddenLabel mesh__D044148 Abnormality, Lymphatic
% 223.97/224.11  |- rdf__type mesh__D044148sskos__Concept
% 223.97/224.11  |- skos__hiddenLabel mesh__D049631 Cricopharyngeus Muscles
% 223.97/224.11  |- rdf__type mesh__D049631sskos__Concept
% 223.97/224.11  |- skos__scopeNote mesh__D049631
% 223.97/224.11       The structure at the pharyngoesophageal junction consisting chiefly of the cricopharyngeus muscle. It normally occludes the lumen of the ESOPHAGUS, except during SWALLOWING.%A%    
% 223.97/224.11  |- skos__hiddenLabel mesh__D049631 Muscles, Cricopharyngeus
% 223.97/224.11  |- skos__hiddenLabel mesh__D049631 Muscle, Cricopharyngeus
% 223.97/224.11  |- mesh__dateEstablished mesh__D049631 2005-01-01
% 223.97/224.11  |- skos__annotation mesh__D049631
% 223.97/224.11       diseases: coordinate IM with ESOPHAGEAL DISEASES %28%IM%29% or specific esophageal disease %28%IM%29%; neoplasms: coordinate IM with ESOPHAGEAL NEOPLASMS %28%IM%29%%A%  
% 223.97/224.11  |- skos__altLabel mesh__D049631 Upper Esophageal Sphincter
% 223.97/224.11  |- mesh__dateCreated mesh__D049631 2004-07-07
% 223.97/224.11  |- skos__prefLabel mesh__D049631 Esophageal Sphincter, Upper
% 223.97/224.11  |- mesh__publicMeSHNote mesh__D049631 2005   
% 223.97/224.11  |- skos__historyNote mesh__D049631 Esophagus %28%1966-2004%29%
% 223.97/224.11  |- skos__broader mesh__D049631smesh__D004947
% 223.97/224.11  |- mesh__activeMeSHYear mesh__D049631 2005A
% 223.97/224.11  |- skos__hiddenLabel mesh__D049631 Sphincter, Upper Esophageal
% 223.97/224.11  |- mesh__historyNote mesh__D049631 2005   
% 223.97/224.11  |- mesh__activeMeSHYear mesh__D049631 2005
% 223.97/224.11  |- mesh__recordOriginator mesh__D049631 ags
% 223.97/224.11  |- mesh__recordMaintainer mesh__D049631 jls
% 223.97/224.11  |- mesh__dateRevised mesh__D049631 2004-07-27
% 223.97/224.11  |- mesh__recordAuthorizer mesh__D049631 jls
% 223.97/224.11  |- skos__broader mesh__D049631smesh__D010609
% 223.97/224.11  |- mesh__activeMeSHYear mesh__D049631 2006
% 223.97/224.11  |- skos__historyNote mesh__D002437 Thiadiazoles %28%1973-1974%29%
% 223.97/224.11  |- skos__historyNote mesh__D002437 Sulfides %28%1973-1974%29%
% 223.97/224.11  |- mesh__historyNote mesh__D002437
% 223.97/224.11       80%28%75%29%; was see under CEPHALOSPORINS 1975-79   
% 223.97/224.11  |- rdf__type mesh__D002437sskos__Concept
% 223.97/224.11  |- mesh__recordAuthorizer mesh__D002437 sjn
% 223.97/224.11  |- skos__broader mesh__D002437smesh__D002511
% 223.97/224.11  |- mesh__dateEstablished mesh__D002437 1980-01-01
% 223.97/224.11  |- skos__historyNote mesh__D002437 Cephalosporins %28%1970-1974%29%
% 223.97/224.11  |- skos__altLabel mesh__D002437 Cephazolin Sodium
% 223.97/224.11  |- skos__altLabel mesh__D002437 Cephamezine
% 223.97/224.11  |- skos__historyNote mesh__D002437 Tetrazoles %28%1973-1974%29%
% 223.97/224.11  |- skos__hiddenLabel mesh__D002437 Sodium, Cephazolin
% 223.97/224.11  |- mesh__recordOriginator mesh__D002437 NLM
% 223.97/224.11  |- mesh__dateRevised mesh__D002437 2004-07-07
% 223.97/224.11  |- skos__hiddenLabel mesh__D002437 Cephazolin, Sodium
% 223.97/224.11  |- mesh__dateCreated mesh__D002437 1974-11-11
% 223.97/224.11  |- skos__scopeNote mesh__D002437
% 223.97/224.11       A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine.%A%    
% 223.97/224.11  |- mesh__activeMeSHYear mesh__D002437 2005
% 223.97/224.11  |- skos__hiddenLabel mesh__D002437 Sodium, Cefazolin
% 223.97/224.11  |- skos__altLabel mesh__D002437 Cephazolin
% 223.97/224.11  |- mesh__recordMaintainer mesh__D002437 ssb
% 223.97/224.11  |- mesh__activeMeSHYear mesh__D002437 2006
% 223.97/224.11  |- skos__altLabel mesh__D002437 Sodium Cephazolin
% 223.97/224.11  |- skos__prefLabel mesh__D002437 Cefazolin
% 223.97/224.11  |- mesh__publicMeSHNote mesh__D002437
% 223.97/224.11       80; was see under CEPHALOSPORINS 1975-79   
% 223.97/224.11  |- skos__annotation mesh__D007122
% 223.97/224.11       GEN or unspecified; prefer specifics; NIM   
% 223.97/224.11  |- skos__broader mesh__D007122smesh__D005779
% 223.97/224.11  |- mesh__recordMaintainer mesh__D007122 nns
% 223.97/224.11  |- mesh__activeMeSHYear mesh__D007122 2005
% 223.97/224.11  |- mesh__recordAuthorizer mesh__D007122 sjn
% 223.97/224.11  |- mesh__dateCreated mesh__D007122 1999-01-01
% 223.97/224.11  |- mesh__activeMeSHYear mesh__D007122 2006
% 223.97/224.11  |- mesh__recordOriginator mesh__D007122 NLM
% 223.97/224.11  |- skos__scopeNote mesh__D007122
% 223.97/224.11       A technique that combines protein electrophoresis and double immunodiffusion. In this procedure proteins are first separated by gel electrophoresis %28%usually agarose%29%, then made visible by immunodiffusion of specific antibodies. A distinct elliptical precipitin arc results for each protein detectable by the antisera.%A%    
% 223.97/224.11  |- skos__related mesh__D007122smesh__D001797
% 223.97/224.11  |- skos__prefLabel mesh__D007122 Immunoelectrophoresis
% 223.97/224.11  |- mesh__dateRevised mesh__D007122 2004-07-07
% 223.97/224.11  |- skos__broader mesh__D007122smesh__D004586
% 223.97/224.11  |- rdf__type mesh__D007122sskos__Concept
% 223.97/224.11  |- mesh__recordOriginator mesh__D012865 NLM
% 223.97/224.11  |- skos__annotation mesh__D012865
% 223.97/224.11       /inj: coord IM with specific inj %28%IM%29%; /physiol permitted; does not include water-skiing %28%index under SPORTS%29%%A%  
% 223.97/224.11  |- mesh__recordMaintainer mesh__D012865 ssb
% 223.97/224.11  |- skos__broader mesh__D012865smesh__D038161
% 223.97/224.11  |- mesh__activeMeSHYear mesh__D012865 2005
% 223.97/224.11  |- skos__altLabel mesh__D012865 Snow Skiing
% 223.97/224.11  |- mesh__activeMeSHYear mesh__D012865 2006
% 223.97/224.11  |- skos__hiddenLabel mesh__D012865 Skiing, Snow
% 223.97/224.11  |- mesh__recordAuthorizer mesh__D012865 sjn
% 223.97/224.11  |- skos__scopeNote mesh__D012865
% 223.97/224.11       A snow sport which uses skis to glide over the snow. It does not include water-skiing.%A%    
% 223.97/224.11  |- skos__hiddenLabel mesh__D012865 Skiings, Snow
% 223.97/224.11  |- mesh__activeMeSHYear mesh__D012865 2003
% 223.97/224.11  |- skos__prefLabel mesh__D012865 Skiing
% 223.97/224.11  |- rdf__type mesh__D012865sskos__Concept
% 223.97/224.11  |- mesh__dateRevised mesh__D012865 2002-07-03
% 223.97/224.11  |- mesh__activeMeSHYear mesh__D012865 2004
% 223.97/224.11  |- skos__hiddenLabel mesh__D012865 Snow Skiings
% 223.97/224.11  |- mesh__dateCreated mesh__D012865 1999-01-01
% 223.97/224.11  |- mesh__activeMeSHYear mesh__D012067 2005
% 223.97/224.11  |- skos__hiddenLabel mesh__D012067 Prayers
% 223.97/224.11  |- mesh__recordMaintainer mesh__D012067 hjn
% 223.97/224.11  |- skos__hiddenLabel mesh__D012067 Religions
% 223.97/224.11  |- skos__prefLabel mesh__D012067 Religion
% 223.97/224.11  |- mesh__recordOriginator mesh__D012067 NLM
% 223.97/224.11  |- mesh__recordAuthorizer mesh__D012067 sjn
% 223.97/224.11  |- skos__related mesh__D012067smesh__D008602
% 223.97/224.11  |- skos__hiddenLabel mesh__D012067 Beliefs, Religious
% 223.97/224.11  |- mesh__publicMeSHNote mesh__D012067
% 223.97/224.11       RELIGION AND SOCIOLOGY was heading 1963-65   
% 223.97/224.11  |- mesh__dateRevised mesh__D012067 2002-07-02
% 223.97/224.11  |- mesh__historyNote mesh__D012067
% 223.97/224.11       RELIGION AND SOCIOLOGY was heading 1963-65   
% 223.97/224.11  |- skos__related mesh__D012067smesh__D035621
% 223.97/224.11  |- rdf__type mesh__D012067sskos__Concept
% 223.97/224.11  |- skos__broader mesh__D012067smesh__D006809
% 223.97/224.11  |- mesh__activeMeSHYear mesh__D012067 2004
% 223.97/224.11  |- skos__scopeNote mesh__D012067
% 223.97/224.11       A set of beliefs concerning the nature, cause, and purpose of the universe, especially when considered as the creation of a superhuman agency. It usually involves devotional and ritual observances and often a moral code for the conduct of human affairs. %28%Random House Collegiate Dictionary, rev. ed.%29%%A%    
% 223.97/224.11  |- skos__hiddenLabel mesh__D012067 Ethic, Religious
% 223.97/224.11  |- mesh__activeMeSHYear mesh__D012067 2006
% 223.97/224.11  |- mesh__dateCreated mesh__D012067 1999-01-01
% 223.97/224.11  |- mesh__activeMeSHYear mesh__D012067 2003
% 223.97/224.11  |- skos__hiddenLabel mesh__D012067 Religious Belief
% 223.97/224.11  |- skos__hiddenLabel mesh__D006828 Mole, Hydatidiform
% 223.97/224.11  |- mesh__recordMaintainer mesh__D006828 sjn
% 223.97/224.11  |- skos__altLabel mesh__D006828 Pregnancy, Molar
% 223.97/224.11  |- skos__hiddenLabel mesh__D006828 Hydatidiform Moles, Complete
% 223.97/224.11  |- skos__hiddenLabel mesh__D006828 Molar Pregnancies
% 223.97/224.11  |- rdf__type mesh__D006828sskos__Concept
% 223.97/224.11  |- skos__hiddenLabel mesh__D006828 Mole, Complete Hydatidiform
% 223.97/224.11  |- mesh__recordOriginator mesh__D006828 NLM
% 223.97/224.11  |- skos__hiddenLabel mesh__D006828 Partial Hydatidiform Mole
% 223.97/224.11  |- skos__hiddenLabel mesh__D006828 Complete Hydatidiform Mole
% 223.97/224.11  |- skos__hiddenLabel mesh__D006828 Hydatidiform Moles, Partial
% 223.97/224.11  |- skos__hiddenLabel mesh__D006828 Mole, Hydatid
% 223.97/224.11  |- skos__scopeNote mesh__D006828
% 223.97/224.11       Trophoblastic hyperplasia associated with normal gestation, or molar pregnancy. It is characterized by the swelling of the CHORIONIC VILLI and elevated human CHORIONIC GONADOTROPIN. Hydatidiform moles or molar pregnancy may be categorized as complete or partial based on their gross morphology, histopathology, and karyotype.%A%    
% 223.97/224.11  |- skos__hiddenLabel mesh__D006828 Moles, Partial Hydatidiform
% 223.97/224.12  |- skos__altLabel mesh__D006828 Hydatid Mole
% 223.97/224.12  |- mesh__dateCreated mesh__D006828 1999-01-01
% 223.97/224.12  |- skos__hiddenLabel mesh__D006828 Moles, Complete Hydatidiform
% 223.97/224.12  |- skos__hiddenLabel mesh__D006828 Mole, Partial Hydatidiform
% 223.97/224.12  |- mesh__activeMeSHYear mesh__D006828 2005
% 223.97/224.12  |- skos__hiddenLabel mesh__D006828 Pregnancies, Molar
% 223.97/224.12  |- mesh__recordAuthorizer mesh__D006828 sjn
% 223.97/224.12  |- skos__altLabel mesh__D006828 Molar Pregnancy
% 223.97/224.12  |- skos__hiddenLabel mesh__D006828 Moles, Hydatid
% 223.97/224.12  |- skos__annotation mesh__D006828
% 223.97/224.12       do not confuse with HYDATID CYST see ECHINOCOCCOSIS or specifics; coord IM with UTERINE NEOPLASMS %28%IM%29%; check the tags FEMALE and PREGNANCY%A%  
% 223.97/224.12  |- skos__hiddenLabel mesh__D006828 Partial Hydatidiform Moles
% 223.97/224.12  |- skos__hiddenLabel mesh__D006828 Moles, Hydatidiform
% 223.97/224.12  |- skos__hiddenLabel mesh__D006828 Hydatid Moles
% 223.97/224.12  |- skos__prefLabel mesh__D006828 Hydatidiform Mole
% 223.97/224.12  |- skos__hiddenLabel mesh__D006828 Hydatidiform Moles
% 223.97/224.12  |- skos__hiddenLabel mesh__D006828 Complete Hydatidiform Moles
% 223.97/224.12  |- mesh__activeMeSHYear mesh__D006828 2006
% 223.97/224.12  |- skos__broader mesh__D006828smesh__D031901
% 223.97/224.12  |- mesh__dateRevised mesh__D006828 2004-07-13
% 223.97/224.12  |- mesh__activeMeSHYear mesh__D017550 2006
% 223.97/224.12  |- skos__altLabel mesh__D017550 Spectroscopy, Infrared, Fourier Transform
% 223.97/224.12  |- mesh__activeMeSHYear mesh__D017550 2004
% 223.97/224.12  |- skos__altLabel mesh__D017550 Fourier Transform Infrared Spectroscopy
% 223.97/224.12  |- skos__scopeNote mesh__D017550
% 223.97/224.12       A spectroscopic technique in which a range of wavelengths is presented simultaneously with an interferometer and the spectrum is mathematically derived from the pattern thus obtained.%A%    
% 223.97/224.12  |- mesh__activeMeSHYear mesh__D017550 2005
% 223.97/224.12  |- mesh__dateCreated mesh__D017550 1993-06-21
% 223.97/224.12  |- mesh__activeMeSHYear mesh__D017550 2003
% 223.97/224.12  |- mesh__recordMaintainer mesh__D017550 lkt
% 223.97/224.12  |- mesh__recordOriginator mesh__D017550 RAZ
% 223.97/224.12  |- mesh__historyNote mesh__D017550 94   
% 223.97/224.12  |- skos__annotation mesh__D017550
% 223.97/224.12       a type of spectrum anal; NIM; DF: note short X ref   
% 223.97/224.12  |- mesh__recordAuthorizer mesh__D017550 sjn
% 223.97/224.12  |- mesh__dateRevised mesh__D017550 2002-07-03
% 223.97/224.12  |- skos__altLabel mesh__D017550 FTIR
% 223.97/224.12  |- skos__broader mesh__D017550smesh__D013055
% 223.97/224.12  |- rdf__type mesh__D017550sskos__Concept
% 223.97/224.12  |- skos__prefLabel mesh__D017550 Spectroscopy, Fourier Transform Infrared
% 223.97/224.12  |- mesh__publicMeSHNote mesh__D017550 94   
% 223.97/224.12  |- skos__historyNote mesh__D017550
% 223.97/224.12       Spectrophotometry, Infrared %28%1972-1993%29%
% 223.97/224.12  |- mesh__dateEstablished mesh__D017550 1994-01-01
% 223.97/224.12  |- mesh__historyNote mesh__D031221 2003   
% 223.97/224.12  |- skos__prefLabel mesh__D031221 Knee Dislocation
% 223.97/224.12  |- skos__scopeNote mesh__D031221 Slippage of the FEMUR off the TIBIA.     
% 223.97/224.12  |- skos__annotation mesh__D031221
% 223.97/224.12       do not confuse with PATELLAR DISLOCATION, which is displacement of the patella %28%knee cap%29% from the femoral groove%A%  
% 223.97/224.12  |- skos__hiddenLabel mesh__D031221 Dislocations, Knee
% 223.97/224.12  |- rdf__type mesh__D031221sskos__Concept
% 223.97/224.12  |- skos__historyNote mesh__D031221 Knee Joint %28%1966-2002%29%
% 223.97/224.12  |- mesh__dateCreated mesh__D031221 2002-07-03
% 223.97/224.12  |- mesh__publicMeSHNote mesh__D031221 2003   
% 223.97/224.12  |- skos__broader mesh__D031221smesh__D004204
% 223.97/224.12  |- mesh__activeMeSHYear mesh__D031221 2006
% 223.97/224.12  |- skos__hiddenLabel mesh__D031221 Knee Dislocations
% 223.97/224.12  |- skos__hiddenLabel mesh__D031221 Dislocation, Knee
% 223.97/224.12  |- mesh__activeMeSHYear mesh__D031221 2004
% 223.97/224.12  |- mesh__activeMeSHYear mesh__D031221 2005
% 223.97/224.12  |- skos__broader mesh__D031221smesh__D007718
% 223.97/224.12  |- mesh__dateEstablished mesh__D031221 2003-01-01
% 223.97/224.12  |- skos__historyNote mesh__D031221 Knee Injuries %28%1965-2002%29%
% 223.97/224.12  |- skos__historyNote mesh__D031221 Dislocations %28%1965-2002%29%
% 223.97/224.12  |- mesh__activeMeSHYear mesh__D031221 2003
% 223.97/224.12  |- mesh__historyNote mesh__D050984 2006%28%2005%29%   
% 223.97/224.12  |- skos__hiddenLabel mesh__D050984 NF-E2 Protein, p45
% 223.97/224.12  |- skos__broader mesh__D050984smesh__D050983
% 223.97/224.12  |- mesh__publicMeSHNote mesh__D050984
% 223.97/224.12       2006; NF-E2 TRANSCRIPTION FACTOR, P45 SUBUNIT was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 2005%A%  
% 223.97/224.12  |- skos__altLabel mesh__D050984
% 223.97/224.12       Nuclear Factor %28%Erythroid-Derived 2%29%, 45kDa
% 223.97/224.12  |- mesh__dateRevised mesh__D050984 2005-07-29
% 223.97/224.12  |- mesh__recordAuthorizer mesh__D050984 ags
% 223.97/224.12  |- mesh__recordMaintainer mesh__D050984 ags
% 223.97/224.12  |- mesh__activeMeSHYear mesh__D050984 2006
% 223.97/224.12  |- mesh__activeMeSHYear mesh__D050984 2006A
% 223.97/224.12  |- skos__scopeNote mesh__D050984
% 223.97/224.12       A tissue-specific subunit of NF-E2 transcription factor that interacts with small MAF PROTEINS to regulate gene expression. P45 NF-E2 protein is expressed primarily in MEGAKARYOCYTES; ERYTHROID CELLS; and MAST CELLS.%A%    
% 223.97/224.12  |- mesh__dateEstablished mesh__D050984 2006-01-01
% 223.97/224.12  |- rdf__type mesh__D050984sskos__Concept
% 223.97/224.12  |- skos__hiddenLabel mesh__D050984 p45 NF E2 Protein
% 223.97/224.12  |- mesh__recordOriginator mesh__D050984 DRC
% 223.97/224.12  |- skos__prefLabel mesh__D050984 NF-E2 Transcription Factor, p45 Subunit
% 223.97/224.12  |- skos__hiddenLabel mesh__D050984 NF E2 Transcription Factor, p45 Subunit
% 223.97/224.12  |- mesh__dateCreated mesh__D050984 2005-06-30
% 223.97/224.12  |- skos__altLabel mesh__D050984 p45 NF-E2 Protein
% 223.97/224.12  |- mesh__recordAuthorizer mesh__D003530 sjn
% 223.97/224.12  |- skos__broader mesh__D003530smesh__D003531
% 223.97/224.12  |- mesh__dateRevised mesh__D003530 2003-07-09
% 223.97/224.12  |- skos__prefLabel mesh__D003530 Cyprinidae
% 223.97/224.12  |- mesh__recordOriginator mesh__D003530 NLM
% 223.97/224.12  |- skos__hiddenLabel mesh__D003530 Shiners
% 223.97/224.12  |- skos__altLabel mesh__D003530 Barbus
% 223.97/224.12  |- rdf__type mesh__D003530sskos__Concept
% 223.97/224.12  |- mesh__dateCreated mesh__D003530 1999-01-01
% 223.97/224.12  |- skos__hiddenLabel mesh__D003530 tinca, Tinca
% 223.97/224.12  |- mesh__activeMeSHYear mesh__D003530 2005
% 223.97/224.12  |- mesh__recordMaintainer mesh__D003530 ags
% 223.97/224.12  |- skos__historyNote mesh__D003530 Fishes %28%1966-1967%29%
% 223.97/224.12  |- mesh__historyNote mesh__D003530 1968   
% 223.97/224.12  |- skos__hiddenLabel mesh__D003530 Tinca tincas
% 223.97/224.12  |- mesh__activeMeSHYear mesh__D003530 2004
% 223.97/224.12  |- skos__scopeNote mesh__D003530
% 223.97/224.12       A family of freshwater fish comprising the minnows or CARPS.%A%    
% 223.97/224.12  |- skos__altLabel mesh__D003530 Tench
% 223.97/224.12  |- skos__hiddenLabel mesh__D003530 Chubs
% 223.97/224.12  |- skos__annotation mesh__D003530
% 223.97/224.12       GEN or unspecified; prefer specifics; note X ref; MUDMINNOWS see UMBRIDAE is also available%A%  
% 223.97/224.12  |- mesh__activeMeSHYear mesh__D003530 2006
% 223.97/224.12  |- skos__hiddenLabel mesh__D003530 tincas, Tinca
% 223.97/224.12  |- mesh__dateEstablished mesh__D003530 1968-01-01
% 223.97/224.12  |- skos__altLabel mesh__D003530 Rutilus rutilus
% 223.97/224.12  |- mesh__publicMeSHNote mesh__D003530 1968   
% 223.97/224.12  |- mesh__historyNote mesh__D044947 2004   
% 223.97/224.12  |- mesh__recordOriginator mesh__D044947 ssb
% 223.97/224.12  |- mesh__activeMeSHYear mesh__D044947 2006
% 223.97/224.12  |- skos__scopeNote mesh__D044947
% 223.97/224.12       Heterodimers of FLAVONOIDS bound to LIGNANS.     
% 223.97/224.12  |- mesh__dateRevised mesh__D044947 2005-06-30
% 223.97/224.12  |- mesh__dateCreated mesh__D044947 2003-07-09
% 223.97/224.12  |- rdf__type mesh__D044947sskos__Concept
% 223.97/224.12  |- skos__broader mesh__D044947smesh__D017705
% 223.97/224.12  |- skos__prefLabel mesh__D044947 Flavonolignans
% 223.97/224.12  |- mesh__publicMeSHNote mesh__D044947 2004   
% 223.97/224.12  |- skos__broader mesh__D044947smesh__D005419
% 223.97/224.12  |- mesh__dateEstablished mesh__D044947 2004-01-01
% 223.97/224.12  |- mesh__recordAuthorizer mesh__D044947 sjn
% 223.97/224.12  |- skos__historyNote mesh__D044947 Flavones %28%1974-2003%29%
% 223.97/224.12  |- mesh__recordMaintainer mesh__D044947 ssb
% 223.97/224.12  |- mesh__recordMaintainer mesh__D044149 SYSTEM
% 223.97/224.12  |- skos__historyNote mesh__D044149 Vibrio %28%1969-2003%29%
% 223.97/224.12  |- mesh__recordAuthorizer mesh__D044149 sjn
% 223.97/224.12  |- mesh__recordOriginator mesh__D044149 ags
% 223.97/224.12  |- skos__annotation mesh__D044149
% 223.97/224.12       infection: coord IM with VIBRIO INFECTIONS %28%IM%29%   
% 223.97/224.12  |- skos__scopeNote mesh__D044149
% 223.97/224.12       A species of gram-negative, halophilic bacteria, in the genus VIBRIO. It is considered part of normal marine flora and commonly associated with ear infections and superficial wounds exposed to contaminated water sources.%A%    
% 223.97/224.12  |- skos__prefLabel mesh__D044149 Vibrio alginolyticus
% 223.97/224.12  |- mesh__dateRevised mesh__D044149 2005-06-30
% 223.97/224.12  |- mesh__historyNote mesh__D044149 2004   
% 223.97/224.12  |- rdf__type mesh__D044149sskos__Concept
% 223.97/224.12  |- skos__broader mesh__D044149smesh__D014733
% 223.97/224.12  |- mesh__dateCreated mesh__D044149 2003-07-09
% 223.97/224.12  |- mesh__publicMeSHNote mesh__D044149 2004   
% 223.97/224.12  |- mesh__dateEstablished mesh__D044149 2004-01-01
% 223.97/224.12  |- mesh__activeMeSHYear mesh__D044149 2006
% 223.97/224.12  |- skos__altLabel mesh__D002438 T-1551
% 223.97/224.12  |- skos__altLabel mesh__D002438 C%C3%%A9%fobis
% 223.97/224.12  |- skos__altLabel mesh__D002438 Cefoperazon
% 223.97/224.13  |- skos__hiddenLabel mesh__D002438 Sodium, Cefoperazone
% 223.97/224.13  |- mesh__publicMeSHNote mesh__D002438 84   
% 223.97/224.13  |- skos__hiddenLabel mesh__D002438 T 1551
% 223.97/224.13  |- mesh__recordAuthorizer mesh__D002438 sjn
% 223.97/224.13  |- mesh__dateCreated mesh__D002438 1983-04-04
% 223.97/224.13  |- mesh__recordMaintainer mesh__D002438 lkw
% 223.97/224.13  |- mesh__recordOriginator mesh__D002438 SH
% 223.97/224.13  |- mesh__dateRevised mesh__D002438 2005-06-30
% 223.97/224.13  |- mesh__dateEstablished mesh__D002438 1984-01-01
% 223.97/224.13  |- skos__broader mesh__D002438smesh__D002435
% 223.97/224.13  |- skos__scopeNote mesh__D002438
% 223.97/224.13       Semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It has been proposed especially against Pseudomonas infections.%A%    
% 223.97/224.13  |- skos__prefLabel mesh__D002438 Cefoperazone
% 223.97/224.13  |- mesh__activeMeSHYear mesh__D002438 2006
% 223.97/224.13  |- skos__altLabel mesh__D002438 Farmasierra Brand of Cefoperazone Sodium
% 223.97/224.13  |- skos__hiddenLabel mesh__D002438 Salt, Cefoperazone Sodium
% 223.97/224.13  |- skos__historyNote mesh__D002438 Cephalosporins %28%1966-1983%29%
% 223.97/224.13  |- skos__altLabel mesh__D002438 Cefoperazone Sodium Salt
% 223.97/224.13  |- mesh__historyNote mesh__D002438 84   
% 223.97/224.13  |- skos__hiddenLabel mesh__D002438 Sodium Salt, Cefoperazone
% 223.97/224.13  |- skos__altLabel mesh__D002438 Pfizer Brand of Cefoperazone Sodium
% 223.97/224.13  |- rdf__type mesh__D002438sskos__Concept
% 223.97/224.13  |- mesh__dateRevised mesh__D013160 1999-11-08
% 223.97/224.13  |- mesh__dateCreated mesh__D013160 1999-01-01
% 223.97/224.13  |- mesh__activeMeSHYear mesh__D013160 2000
% 223.97/224.13  |- skos__broader mesh__D013160smesh__D009371
% 223.97/224.13  |- skos__hiddenLabel mesh__D013160 Cancer, Splenic
% 223.97/224.13  |- mesh__recordMaintainer mesh__D013160 adp
% 223.97/224.13  |- skos__scopeNote mesh__D013160 Tumors or cancer of the SPLEEN.     
% 223.97/224.13  |- skos__hiddenLabel mesh__D013160 Cancer, Spleen
% 223.97/224.13  |- skos__hiddenLabel mesh__D013160 Spleen Cancers
% 223.97/224.13  |- skos__altLabel mesh__D013160 Cancer of the Spleen
% 223.97/224.13  |- skos__hiddenLabel mesh__D013160 Spleen Neoplasm
% 223.97/224.13  |- rdf__type mesh__D013160sskos__Concept
% 223.97/224.13  |- skos__hiddenLabel mesh__D013160 Splenic Cancers
% 223.97/224.13  |- skos__broader mesh__D013160smesh__D013158
% 223.97/224.13  |- skos__prefLabel mesh__D013160 Splenic Neoplasms
% 223.97/224.13  |- mesh__recordAuthorizer mesh__D013160 sjn
% 223.97/224.13  |- skos__hiddenLabel mesh__D013160 Neoplasms, Spleen
% 223.97/224.13  |- mesh__activeMeSHYear mesh__D013160 2002
% 223.97/224.13  |- skos__altLabel mesh__D013160 Neoplasms, Splenic
% 223.97/224.13  |- skos__altLabel mesh__D013160 Splenic Cancer
% 223.97/224.13  |- skos__annotation mesh__D013160
% 223.97/224.13       coord IM with histol type of neopl %28%IM%29%   
% 223.97/224.13  |- mesh__activeMeSHYear mesh__D013160 2006
% 223.97/224.13  |- skos__altLabel mesh__D013160 Spleen Neoplasms
% 223.97/224.13  |- mesh__activeMeSHYear mesh__D013160 2004
% 223.97/224.13  |- skos__hiddenLabel mesh__D013160 Cancers, Splenic
% 223.97/224.13  |- skos__hiddenLabel mesh__D013160 Neoplasm, Splenic
% 223.97/224.13  |- skos__hiddenLabel mesh__D013160 Neoplasm, Spleen
% 223.97/224.13  |- skos__hiddenLabel mesh__D013160 Cancers, Spleen
% 223.97/224.13  |- mesh__activeMeSHYear mesh__D013160 2005
% 223.97/224.13  |- mesh__recordOriginator mesh__D013160 NLM
% 223.97/224.13  |- skos__altLabel mesh__D013160 Spleen Cancer
% 223.97/224.13  |- mesh__activeMeSHYear mesh__D013160 2001
% 223.97/224.13  |- mesh__activeMeSHYear mesh__D013160 2003
% 223.97/224.13  |- skos__hiddenLabel mesh__D013160 Splenic Neoplasm
% 223.97/224.13  |- rdf__type mesh__D007921sskos__Concept
% 223.97/224.13  |- skos__scopeNote mesh__D007921
% 223.97/224.13       A genus of question mark-shaped bacteria spirochetes which is found in fresh water that is contaminated by animal urine. It causes LEPTOSPIROSIS.%A%    
% 223.97/224.13  |- mesh__dateEstablished mesh__D007921 1976-01-01
% 223.97/224.13  |- mesh__historyNote mesh__D007921 1976 %28%1963%29%   
% 223.97/224.13  |- mesh__dateRevised mesh__D007921 2005-06-30
% 223.97/224.13  |- skos__annotation mesh__D007921
% 223.97/224.13       Leptospira interrogans seroGROUPS go here; infection: coord IM with probably LEPTOSPIROSIS %28%IM%29%%A%  
% 223.97/224.13  |- mesh__recordOriginator mesh__D007921 JW
% 223.97/224.13  |- mesh__recordAuthorizer mesh__D007921 sjn
% 223.97/224.13  |- mesh__activeMeSHYear mesh__D007921 2006
% 223.97/224.13  |- mesh__dateCreated mesh__D007921 1975-07-25
% 223.97/224.13  |- skos__broader mesh__D007921smesh__D007919
% 223.97/224.13  |- mesh__publicMeSHNote mesh__D007921
% 223.97/224.13       1976; use LEPTOSPIRA ICTEROHAEMORRHAGIAE 1963-1975   
% 223.97/224.13  |- mesh__recordMaintainer mesh__D007921 SYSTEM
% 223.97/224.13  |- skos__prefLabel mesh__D007921 Leptospira interrogans
% 223.97/224.13  |- rdf__type mesh__D007123sskos__Concept
% 223.97/224.13  |- mesh__recordMaintainer mesh__D007123 nns
% 223.97/224.13  |- mesh__publicMeSHNote mesh__D007123
% 223.97/224.13       91; was see under IMMUNOELECTROPHORESIS 1976-90   
% 223.97/224.13  |- skos__broader mesh__D007123smesh__D007122
% 223.97/224.13  |- skos__hiddenLabel mesh__D007123 Immunoelectrophoresis, 2 D
% 223.97/224.13  |- skos__altLabel mesh__D007123 Immunoelectrophoresis, 2D
% 223.97/224.13  |- mesh__dateRevised mesh__D007123 2004-07-07
% 223.97/224.13  |- skos__hiddenLabel mesh__D007123 2-D Immunoelectrophoresis
% 223.97/224.13  |- mesh__dateEstablished mesh__D007123 1991-01-01
% 223.97/224.13  |- skos__prefLabel mesh__D007123 Immunoelectrophoresis, Two-Dimensional
% 223.97/224.13  |- skos__altLabel mesh__D007123 Immunoelectrophoresis, 2-D
% 223.97/224.13  |- skos__altLabel mesh__D007123 Immunoelectrophoresis, Crossed
% 223.97/224.13  |- skos__historyNote mesh__D007123 Immunoelectrophoresis %28%1966-1975%29%
% 223.97/224.13  |- skos__hiddenLabel mesh__D007123 Two-Dimensional Immunoelectrophoresis
% 223.97/224.13  |- mesh__historyNote mesh__D007123
% 223.97/224.13       91%28%76%29%; was see under IMMUNOELECTROPHORESIS 1976-90   
% 223.97/224.13  |- mesh__recordOriginator mesh__D007123 SMH
% 223.97/224.13  |- mesh__activeMeSHYear mesh__D007123 2006
% 223.97/224.13  |- mesh__recordAuthorizer mesh__D007123 sjn
% 223.97/224.13  |- mesh__dateCreated mesh__D007123 1975-07-25
% 223.97/224.13  |- skos__hiddenLabel mesh__D007123 Immunoelectrophoresis, Two Dimensional
% 223.97/224.13  |- skos__hiddenLabel mesh__D007123 Crossed Immunoelectrophoresis
% 223.97/224.13  |- skos__scopeNote mesh__D007123
% 223.97/224.13       Immunoelectrophoresis in which a second electrophoretic transport is performed on the initially separated antigen fragments into an antibody-containing medium in a direction perpendicular to the first electrophoresis.%A%    
% 223.97/224.13  |- skos__hiddenLabel mesh__D007123 2D Immunoelectrophoresis
% 223.97/224.13  |- skos__annotation mesh__D007123
% 223.97/224.13       NIM; do not confuse X ref IMMUNOELECTROPHORESIS, CROSSED with IMMUNOELECTROPHORESIS, CROSSOVER see COUNTERIMMUNOELECTROPHORESIS; DF: IMMUNOELECTROPHORESIS 2D%A%  
% 223.97/224.13  |- mesh__activeMeSHYear mesh__D007123 2005
% 223.97/224.13  |- mesh__dateRevised mesh__D012866 1992-05-18
% 223.97/224.13  |- rdf__type mesh__D012866sskos__Concept
% 223.97/224.13  |- mesh__activeMeSHYear mesh__D012866 2003
% 223.97/224.13  |- skos__hiddenLabel mesh__D012866 Skilled Nursing Facility
% 223.97/224.13  |- mesh__historyNote mesh__D012866
% 223.97/224.13       79; was EXTENDED CARE FACILITIES 1968-78   
% 223.97/224.13  |- mesh__activeMeSHYear mesh__D012866 1995
% 223.97/224.13  |- mesh__publicMeSHNote mesh__D012866
% 223.97/224.13       79; was EXTENDED CARE FACILITIES 1968-78   
% 223.97/224.13  |- mesh__activeMeSHYear mesh__D012866 1993
% 223.97/224.13  |- mesh__activeMeSHYear mesh__D012866 2002
% 223.97/224.13  |- skos__hiddenLabel mesh__D012866 Nursing Facility, Skilled
% 223.97/224.13  |- mesh__activeMeSHYear mesh__D012866 1999
% 223.97/224.13  |- mesh__activeMeSHYear mesh__D012866 1994
% 223.97/224.13  |- mesh__dateCreated mesh__D012866 1999-01-01
% 223.97/224.13  |- skos__prefLabel mesh__D012866 Skilled Nursing Facilities
% 223.97/224.13  |- skos__broader mesh__D012866smesh__D009735
% 223.97/224.13  |- skos__altLabel mesh__D012866 Nursing Facilities, Skilled
% 223.97/224.13  |- skos__hiddenLabel mesh__D012866 Facility, Skilled Nursing
% 223.97/224.13  |- mesh__activeMeSHYear mesh__D012866 1997
% 223.97/224.13  |- mesh__dateEstablished mesh__D012866 1968-01-01
% 223.97/224.13  |- skos__altLabel mesh__D012866 Extended Care Facilities
% 223.97/224.13  |- mesh__recordOriginator mesh__D012866 NLM
% 223.97/224.13  |- mesh__activeMeSHYear mesh__D012866 1998
% 223.97/224.13  |- skos__altLabel mesh__D012866 Facilities, Skilled Nursing
% 223.99/224.13  |- skos__hiddenLabel mesh__D012866 Care Facilities, Extended
% 223.99/224.13  |- skos__scopeNote mesh__D012866
% 223.99/224.13       Extended care facilities which provide skilled nursing care or rehabilitation services for inpatients on a daily basis.%A%    
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D012866 1996
% 223.99/224.13  |- skos__hiddenLabel mesh__D012866 Extended Care Facility
% 223.99/224.13  |- skos__hiddenLabel mesh__D012866 Care Facility, Extended
% 223.99/224.13  |- skos__hiddenLabel mesh__D012866 Facilities, Extended Care
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D012866 2001
% 223.99/224.13  |- mesh__recordAuthorizer mesh__D012866 PLS
% 223.99/224.13  |- mesh__onlineNote mesh__D012866
% 223.99/224.13       use SKILLED NURSING FACILITIES to search EXTENDED CARE FACILITIES 1968-78%A%  
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D012866 2006
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D012866 2000
% 223.99/224.13  |- mesh__recordMaintainer mesh__D012866 TGC
% 223.99/224.13  |- skos__hiddenLabel mesh__D012866 Facility, Extended Care
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D012866 2004
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D012866 2005
% 223.99/224.13  |- skos__historyNote mesh__D012866 Hospitals %28%1966-1967%29%
% 223.99/224.13  |- mesh__recordMaintainer mesh__D045242 SYSTEM
% 223.99/224.13  |- skos__broader mesh__D045242smesh__D018720
% 223.99/224.13  |- mesh__dateCreated mesh__D045242 2003-07-09
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D045242 2006
% 223.99/224.13  |- rdf__type mesh__D045242sskos__Concept
% 223.99/224.13  |- mesh__dateEstablished mesh__D045242 2004-01-01
% 223.99/224.13  |- mesh__publicMeSHNote mesh__D045242 2004   
% 223.99/224.13  |- mesh__recordOriginator mesh__D045242 ags
% 223.99/224.13  |- skos__scopeNote mesh__D045242
% 223.99/224.13       A species of gram-negative bacteria in the family Prevotellaceae. It is the  species most commonly isolated from endodontic infections %28%PULPITIS%29%.%A%    
% 223.99/224.13  |- mesh__recordAuthorizer mesh__D045242 sjn
% 223.99/224.13  |- skos__historyNote mesh__D045242 Prevotella %28%1992-2003%29%
% 223.99/224.13  |- mesh__historyNote mesh__D045242 2004   
% 223.99/224.13  |- skos__prefLabel mesh__D045242 Prevotella nigrescens
% 223.99/224.13  |- mesh__dateRevised mesh__D045242 2005-06-30
% 223.99/224.13  |- skos__annotation mesh__D045242
% 223.99/224.13       infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A%  
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D012068 1999
% 223.99/224.13  |- skos__altLabel mesh__D012068 Medicine and Religion
% 223.99/224.13  |- skos__scopeNote mesh__D012068
% 223.99/224.13       The interrelationship of medicine and religion.     
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D012068 1996
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D012068 1998
% 223.99/224.13  |- skos__broader mesh__D012068smesh__D012067
% 223.99/224.13  |- rdf__type mesh__D012068sskos__Concept
% 223.99/224.13  |- mesh__recordAuthorizer mesh__D012068 PLS
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D012068 2004
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D012068 2002
% 223.99/224.13  |- mesh__recordMaintainer mesh__D012068 PLS
% 223.99/224.13  |- skos__prefLabel mesh__D012068 Religion and Medicine
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D012068 2006
% 223.99/224.13  |- mesh__recordOriginator mesh__D012068 NLM
% 223.99/224.13  |- mesh__dateCreated mesh__D012068 1999-01-01
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D012068 2003
% 223.99/224.13  |- mesh__dateRevised mesh__D012068 1995-06-08
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D012068 2001
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D012068 2005
% 223.99/224.13  |- skos__annotation mesh__D012068
% 223.99/224.13       no qualif; coord IM with medical aspect %28%IM%29%; X ref PRAYER HEALING see MENTAL HEALING is available; DF: RELIGION MED%A%  
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D012068 1997
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D012068 2000
% 223.99/224.13  |- mesh__dateEstablished mesh__D006829 1972-01-01
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D006829 2004
% 223.99/224.13  |- mesh__dateCreated mesh__D006829 1999-01-01
% 223.99/224.13  |- mesh__recordAuthorizer mesh__D006829 sjn
% 223.99/224.13  |- skos__prefLabel mesh__D006829 Hydra
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D006829 2005
% 223.99/224.13  |- mesh__historyNote mesh__D006829 72   
% 223.99/224.13  |- skos__scopeNote mesh__D006829
% 223.99/224.13       A genus of freshwater polyps in the family Hydridae, order Hydroida, class HYDROZOA. They are of special interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals.%A%    
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D006829 2006
% 223.99/224.13  |- mesh__recordMaintainer mesh__D006829 ags
% 223.99/224.13  |- skos__historyNote mesh__D006829 Coelenterata %28%1966-1971%29%
% 223.99/224.13  |- mesh__publicMeSHNote mesh__D006829 72   
% 223.99/224.13  |- mesh__recordOriginator mesh__D006829 NLM
% 223.99/224.13  |- skos__broader mesh__D006829smesh__D037402
% 223.99/224.13  |- rdf__type mesh__D006829sskos__Concept
% 223.99/224.13  |- mesh__dateRevised mesh__D006829 2003-07-09
% 223.99/224.13  |- skos__broader mesh__D017551smesh__D003956
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D017551 2005
% 223.99/224.13  |- mesh__publicMeSHNote mesh__D017551 94   
% 223.99/224.13  |- skos__prefLabel mesh__D017551 Microdialysis
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D017551 2003
% 223.99/224.13  |- mesh__dateEstablished mesh__D017551 1994-01-01
% 223.99/224.13  |- mesh__historyNote mesh__D017551 94   
% 223.99/224.13  |- mesh__recordMaintainer mesh__D017551 lkt
% 223.99/224.13  |- skos__historyNote mesh__D017551 Dialysis %28%1966-1993%29%
% 223.99/224.13  |- rdf__type mesh__D017551sskos__Concept
% 223.99/224.13  |- skos__scopeNote mesh__D017551
% 223.99/224.13       A technique for measuring extracellular concentrations of substances in tissues, usually in vivo, by means of a small probe equipped with a semipermeable membrane. Substances may also be introduced into the extracellular space through the membrane.%A%    
% 223.99/224.13  |- mesh__dateCreated mesh__D017551 1992-12-28
% 223.99/224.13  |- mesh__recordOriginator mesh__D017551 RAZ
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D017551 2006
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D017551 2004
% 223.99/224.13  |- mesh__recordAuthorizer mesh__D017551 sjn
% 223.99/224.13  |- mesh__dateRevised mesh__D017551 2002-07-03
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D031222 2003
% 223.99/224.13  |- mesh__dateEstablished mesh__D031222 2003-01-01
% 223.99/224.13  |- skos__historyNote mesh__D031222 Dislocations %28%1965-2002%29%
% 223.99/224.13  |- skos__annotation mesh__D031222
% 223.99/224.13       do not confuse with KNEE DISLOCATION, which is slippage of the femur off the tibia%A%  
% 223.99/224.13  |- mesh__historyNote mesh__D031222 2003   
% 223.99/224.13  |- rdf__type mesh__D031222sskos__Concept
% 223.99/224.13  |- skos__hiddenLabel mesh__D031222 Dislocations, Patellar
% 223.99/224.13  |- skos__scopeNote mesh__D031222
% 223.99/224.13       Displacement of the PATELLA from the femoral groove.     
% 223.99/224.13  |- skos__prefLabel mesh__D031222 Patellar Dislocation
% 223.99/224.13  |- mesh__dateCreated mesh__D031222 2002-07-03
% 223.99/224.13  |- skos__historyNote mesh__D031222 Patella %28%1965-2002%29%
% 223.99/224.13  |- mesh__publicMeSHNote mesh__D031222 2003   
% 223.99/224.13  |- skos__broader mesh__D031222smesh__D004204
% 223.99/224.13  |- skos__broader mesh__D031222smesh__D007718
% 223.99/224.13  |- skos__hiddenLabel mesh__D031222 Patellar Dislocations
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D031222 2006
% 223.99/224.13  |- skos__hiddenLabel mesh__D031222 Dislocation, Patellar
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D031222 2004
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D031222 2005
% 223.99/224.13  |- skos__broader mesh__D050985smesh__D050978
% 223.99/224.13  |- skos__scopeNote mesh__D050985
% 223.99/224.13       A small Maf protein involved in differentiation of ERYTHROID CELLS. MafK was originally described as the small subunit of the NF-E2 Transcription Factor, but other small MAF PROTEINS also serve as NF-E2 subunits.%A%    
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D050985 2006
% 223.99/224.13  |- skos__hiddenLabel mesh__D050985 p18 NF E2 Protein
% 223.99/224.13  |- skos__altLabel mesh__D050985 p18 NF-E2 Protein
% 223.99/224.13  |- mesh__recordMaintainer mesh__D050985 ags
% 223.99/224.13  |- mesh__dateCreated mesh__D050985 2005-06-30
% 223.99/224.13  |- rdf__type mesh__D050985sskos__Concept
% 223.99/224.13  |- skos__hiddenLabel mesh__D050985 Transcription Factor, MafK
% 223.99/224.13  |- mesh__recordOriginator mesh__D050985 DRC
% 223.99/224.13  |- skos__hiddenLabel mesh__D050985 NF-E2 Protein, p18
% 223.99/224.13  |- mesh__historyNote mesh__D050985 2006%28%1993%29%   
% 223.99/224.13  |- skos__prefLabel mesh__D050985 MafK Transcription Factor
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D050985 2006B
% 223.99/224.13  |- skos__altLabel mesh__D050985 MafK Protein
% 223.99/224.13  |- skos__hiddenLabel mesh__D050985 Factor, MafK Transcription
% 223.99/224.13  |- mesh__publicMeSHNote mesh__D050985
% 223.99/224.13       2006; MAFK PROTEIN was indexed under NUCLEAR PROTEINS 1993-2005%A%  
% 223.99/224.13  |- mesh__dateEstablished mesh__D050985 2006-01-01
% 223.99/224.13  |- mesh__dateRevised mesh__D050985 2005-07-29
% 223.99/224.13  |- skos__altLabel mesh__D050985 NF-E2 Transcription Factor, p18 Subunit
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D050985 2006A
% 223.99/224.13  |- mesh__recordAuthorizer mesh__D050985 ags
% 223.99/224.13  |- mesh__recordOriginator mesh__D003531 EC
% 223.99/224.13  |- mesh__dateRevised mesh__D003531 2003-07-09
% 223.99/224.13  |- skos__altLabel mesh__D003531 Catostomidae
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D003531 2005
% 223.99/224.13  |- skos__prefLabel mesh__D003531 Cypriniformes
% 223.99/224.13  |- mesh__dateCreated mesh__D003531 1986-04-15
% 223.99/224.13  |- skos__hiddenLabel mesh__D003531 Sucker %28%Fish%29%
% 223.99/224.13  |- mesh__recordAuthorizer mesh__D003531 sjn
% 223.99/224.13  |- skos__altLabel mesh__D003531 Cobitidae
% 223.99/224.13  |- skos__scopeNote mesh__D003531
% 223.99/224.13       An order of fish with 26 families and over 3,000 species. This order includes the families CYPRINIDAE %28%minnows and CARPS%29%, Cobitidae %28%loaches%29%, and Catostomidae %28%suckers%29%.%A%    
% 223.99/224.13  |- rdf__type mesh__D003531sskos__Concept
% 223.99/224.13  |- mesh__dateEstablished mesh__D003531 1987-01-01
% 223.99/224.13  |- mesh__publicMeSHNote mesh__D003531 1987   
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D003531 2004
% 223.99/224.13  |- mesh__recordMaintainer mesh__D003531 ags
% 223.99/224.13  |- mesh__historyNote mesh__D003531 1987   
% 223.99/224.13  |- skos__broader mesh__D003531smesh__D005399
% 223.99/224.13  |- skos__annotation mesh__D003531 do not confuse with CYPRINODONTIFORMES   
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D003531 2006
% 223.99/224.13  |- skos__broader mesh__D044948smesh__D005419
% 223.99/224.13  |- skos__altLabel mesh__D044948 2-Phenyl-3-Hydroxy-Benzopyran-4-Ones
% 223.99/224.13  |- mesh__recordAuthorizer mesh__D044948 sjn
% 223.99/224.13  |- mesh__recordOriginator mesh__D044948 ssb
% 223.99/224.13  |- mesh__dateCreated mesh__D044948 2003-07-09
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D044948 2006
% 223.99/224.13  |- mesh__publicMeSHNote mesh__D044948
% 223.99/224.13       2004; FLAVONOLS was indexed under FLAVONES 1977-2003   
% 223.99/224.13  |- skos__hiddenLabel mesh__D044948 2 Phenyl 3 Hydroxy Benzopyran 4 Ones
% 223.99/224.13  |- mesh__dateEstablished mesh__D044948 2004-01-01
% 223.99/224.13  |- mesh__historyNote mesh__D044948
% 223.99/224.13       2004; for FLAVONOLS use FLAVONOLS %28%NM%29% 1977-2003   
% 223.99/224.13  |- rdf__type mesh__D044948sskos__Concept
% 223.99/224.13  |- mesh__dateRevised mesh__D044948 2005-06-30
% 223.99/224.13  |- skos__scopeNote mesh__D044948
% 223.99/224.13       A group of 3-hydroxy-4-keto-FLAVONOIDS.     
% 223.99/224.13  |- skos__prefLabel mesh__D044948 Flavonols
% 223.99/224.13  |- mesh__recordMaintainer mesh__D044948 ssb
% 223.99/224.13  |- skos__hiddenLabel mesh__D044948 3 hydroxy 4 keto Flavonoids
% 223.99/224.13  |- skos__altLabel mesh__D044948 3-hydroxy-4-keto-Flavonoids
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D016459 2001
% 223.99/224.13  |- mesh__recordAuthorizer mesh__D016459 sjn
% 223.99/224.13  |- mesh__recordOriginator mesh__D016459 AGS
% 223.99/224.13  |- skos__altLabel mesh__D016459 Infections, Prosthesis-Related
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D016459 2004
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D016459 2000
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D016459 2006
% 223.99/224.13  |- mesh__recordMaintainer mesh__D016459 KEV
% 223.99/224.13  |- mesh__publicMeSHNote mesh__D016459 92   
% 223.99/224.13  |- skos__prefLabel mesh__D016459 Prosthesis-Related Infections
% 223.99/224.13  |- skos__related mesh__D016459smesh__D018441
% 223.99/224.13  |- skos__hiddenLabel mesh__D016459 Prosthesis-Related Infection
% 223.99/224.13  |- skos__hiddenLabel mesh__D016459 Prosthesis Related Infections
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D016459 2003
% 223.99/224.13  |- mesh__dateCreated mesh__D016459 1991-01-03
% 223.99/224.13  |- mesh__dateRevised mesh__D016459 1999-11-08
% 223.99/224.13  |- skos__broader mesh__D016459smesh__D007239
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D016459 2005
% 223.99/224.13  |- skos__scopeNote mesh__D016459
% 223.99/224.13       Infections resulting from the implantation of prosthetic devices. The infections may be acquired from intraoperative contamination %28%early%29% or hematogenously acquired from other sites %28%late%29%.%A%    
% 223.99/224.13  |- skos__annotation mesh__D016459
% 223.99/224.13       coord IM with specific infect %28%IM%29% + specific prosthesis /adv eff %28%IM%29%, as EYE, ARTIFICIAL /adv eff; infect by biofilm: coord IM with BIOFILMS %28%IM%29% but see note there; DF: PROSTHESIS RELAT INFECT%A%  
% 223.99/224.13  |- skos__broader mesh__D016459smesh__D011183
% 223.99/224.13  |- mesh__historyNote mesh__D016459 92   
% 223.99/224.13  |- rdf__type mesh__D016459sskos__Concept
% 223.99/224.13  |- mesh__dateEstablished mesh__D016459 1992-01-01
% 223.99/224.13  |- skos__historyNote mesh__D016459 Infection %28%1966-1991%29%
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D016459 2002
% 223.99/224.13  |- skos__historyNote mesh__D016459
% 223.99/224.13       specific prosthesis/adverse effects %28%1966-1991%29%
% 223.99/224.13  |- skos__altLabel mesh__D002439 Pisa Brand of Cefotaxime Sodium
% 223.99/224.13  |- skos__altLabel mesh__D002439 Merck Brand of Cefotaxime Sodium
% 223.99/224.13  |- skos__altLabel mesh__D002439 Aventis Brand of Cefotaxime Sodium
% 223.99/224.13  |- rdf__type mesh__D002439sskos__Concept
% 223.99/224.13  |- skos__altLabel mesh__D002439 Cefotaxim
% 223.99/224.13  |- skos__historyNote mesh__D002439 Cephalosporins %28%1966-1981%29%
% 223.99/224.13  |- skos__hiddenLabel mesh__D002439 Sodium, Cefotaxime
% 223.99/224.13  |- skos__altLabel mesh__D002439 Aventis Pharma Brand of Cefotaxime Sodium
% 223.99/224.13  |- mesh__dateCreated mesh__D002439 1981-05-13
% 223.99/224.13  |- skos__altLabel mesh__D002439 Hoechst Brand of Cefotaxime Sodium
% 223.99/224.13  |- skos__altLabel mesh__D002439 Primafen
% 223.99/224.13  |- skos__prefLabel mesh__D002439 Cefotaxime
% 223.99/224.13  |- skos__hiddenLabel mesh__D002439 HR 756
% 223.99/224.13  |- skos__altLabel mesh__D002439 Galen Brand of Cefotaxime Sodium
% 223.99/224.13  |- skos__hiddenLabel mesh__D002439 Ru24756
% 223.99/224.13  |- mesh__dateEstablished mesh__D002439 1982-01-01
% 223.99/224.13  |- skos__hiddenLabel mesh__D002439 Ru 24756
% 223.99/224.13  |- skos__altLabel mesh__D002439 Viken Brand of Cefotaxime Sodium
% 223.99/224.13  |- skos__altLabel mesh__D002439 Liomont Brand of Cefotaxime Sodium
% 223.99/224.13  |- mesh__recordMaintainer mesh__D002439 lkw
% 223.99/224.13  |- mesh__historyNote mesh__D002439 82   
% 223.99/224.13  |- skos__altLabel mesh__D002439 Cephotaxim
% 223.99/224.13  |- skos__altLabel mesh__D002439 Klaforan
% 223.99/224.13  |- skos__scopeNote mesh__D002439
% 223.99/224.13       Semisynthetic broad-spectrum cephalosporin.     
% 223.99/224.13  |- mesh__recordOriginator mesh__D002439 SH
% 223.99/224.13  |- mesh__recordAuthorizer mesh__D002439 sjn
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D002439 2006
% 223.99/224.13  |- skos__broader mesh__D002439smesh__D002505
% 223.99/224.13  |- mesh__dateRevised mesh__D002439 2005-06-30
% 223.99/224.13  |- mesh__publicMeSHNote mesh__D002439 82   
% 223.99/224.13  |- skos__hiddenLabel mesh__D002439 HR756
% 223.99/224.13  |- skos__altLabel mesh__D002439 Fustery Brand of Cefotaxime Sodium
% 223.99/224.13  |- skos__hiddenLabel mesh__D013161 Ruptures, Splenic
% 223.99/224.13  |- skos__hiddenLabel mesh__D013161 Rupture, Splenic
% 223.99/224.13  |- mesh__recordOriginator mesh__D013161 NLM
% 223.99/224.13  |- rdf__type mesh__D013161sskos__Concept
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D013161 2001
% 223.99/224.13  |- mesh__recordMaintainer mesh__D013161 PLS
% 223.99/224.13  |- skos__broader mesh__D013161smesh__D013158
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D013161 2000
% 223.99/224.13  |- skos__broader mesh__D013161smesh__D000007
% 223.99/224.13  |- skos__broader mesh__D013161smesh__D012421
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D013161 1995
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D013161 1993
% 223.99/224.13  |- skos__hiddenLabel mesh__D013161 Splenic Ruptures
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D013161 2006
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D013161 1994
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D013161 1991
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D013161 2004
% 223.99/224.13  |- skos__annotation mesh__D013161
% 223.99/224.13       traumatic or spontaneous; if spontaneous coord IM with RUPTURE, SPONTANEOUS %28%NIM%29%; differentiate from traumatic spleen perforation %28% = SPLEEN /inj%29%%A%  
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D013161 1992
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D013161 1999
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D013161 2005
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D013161 2002
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D013161 1997
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D013161 2003
% 223.99/224.13  |- mesh__dateCreated mesh__D013161 1999-01-01
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D013161 1998
% 223.99/224.13  |- mesh__recordAuthorizer mesh__D013161 NLM
% 223.99/224.13  |- mesh__dateRevised mesh__D013161 1990-05-29
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D013161 1996
% 223.99/224.13  |- skos__prefLabel mesh__D013161 Splenic Rupture
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D007922 2003
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D007922 2005
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D007922 2004
% 223.99/224.13  |- mesh__dateCreated mesh__D007922 1999-01-01
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D007922 2006
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D007922 2000
% 223.99/224.13  |- skos__scopeNote mesh__D007922
% 223.99/224.13       Infections with bacteria of the genus LEPTOSPIRA.     
% 223.99/224.13  |- mesh__activeMeSHYear mesh__D007922 1996
% 223.99/224.13  |- mesh__dateRevised mesh__D007922 1993-06-02
% 223.99/224.13  |- mesh__recordOriginator mesh__D007922 NLM
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D007922 1998
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D007922 2001
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D007922 1997
% 223.99/224.14  |- mesh__recordAuthorizer mesh__D007922 PLS
% 223.99/224.14  |- skos__hiddenLabel mesh__D007922 Leptospiroses
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D007922 1994
% 223.99/224.14  |- skos__annotation mesh__D007922
% 223.99/224.14       gram-neg bact infect; a spirochete infect   
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D007922 1999
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D007922 1995
% 223.99/224.14  |- rdf__type mesh__D007922sskos__Concept
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D007922 2002
% 223.99/224.14  |- skos__prefLabel mesh__D007922 Leptospirosis
% 223.99/224.14  |- skos__broader mesh__D007922smesh__D016905
% 223.99/224.14  |- skos__broader mesh__D007922smesh__D013145
% 223.99/224.14  |- mesh__recordMaintainer mesh__D007922 TAP
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Techniques, Enzyme-Labeled Antibody
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D007124 2004
% 223.99/224.14  |- skos__historyNote mesh__D007124 Peroxidases %28%1966-1976%29%
% 223.99/224.14  |- skos__altLabel mesh__D007124 Peroxidase-Labeled Antibody Technic
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Technic, Peroxidase-Labeled Antibody
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Technic, Immunoperoxidase
% 223.99/224.14  |- skos__prefLabel mesh__D007124 Immunoenzyme Techniques
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124
% 223.99/224.14       Peroxidase Antiperoxidase Complex Technic
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Antibody Technique, Enzyme-Labeled
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124
% 223.99/224.14       Techniques, Peroxidase-Antiperoxidase Complex
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Technics, Immunoenzyme
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Peroxidase Labeled Antibody Technic
% 223.99/224.14  |- mesh__publicMeSHNote mesh__D007124
% 223.99/224.14       91; was IMMUNOENZYME TECHNICS 1977-90   
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D007124 2005
% 223.99/224.14  |- mesh__onlineNote mesh__D007124
% 223.99/224.14       use IMMUNOENZYME TECHNIQUES to search IMMUNOENZYME TECHNICS 1977-90%A%  
% 223.99/224.14  |- skos__historyNote mesh__D007124 Enzymes %28%1966-1976%29%
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Peroxidase-Labeled Antibody Techniques
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Antibody Techniques, Enzyme-Labeled
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124
% 223.99/224.14       Technics, Peroxidase-Antiperoxidase Complex
% 223.99/224.14  |- skos__altLabel mesh__D007124 Immunoassay, Enzyme
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Technique, Immunoperoxidase
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Technique, Enzyme-Labeled Antibody
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124
% 223.99/224.14       Technic, Peroxidase-Antiperoxidase Complex
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Technic, Enzyme-Labeled Antibody
% 223.99/224.14  |- mesh__dateEstablished mesh__D007124 1977-01-01
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Technics, Immunoperoxidase
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Immunoperoxidase Technic
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Peroxidase-Labeled Antibody Technics
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Immunoassays, Enzyme
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Techniques, Immunoperoxidase
% 223.99/224.14  |- skos__historyNote mesh__D007124 Immunologic Techniques %28%1973-1976%29%
% 223.99/224.14  |- mesh__recordAuthorizer mesh__D007124 ags
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D007124 2006
% 223.99/224.14  |- mesh__historyNote mesh__D007124 91; was IMMUNOENZYME TECHNICS 1977-90   
% 223.99/224.14  |- skos__broader mesh__D007124smesh__D007118
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Enzyme-Labeled Antibody Technics
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Enzyme Labeled Antibody Technic
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Antibody Technics, Enzyme-Labeled
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Antibody Technic, Peroxidase-Labeled
% 223.99/224.14  |- mesh__recordOriginator mesh__D007124 SMH
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D007124 2006A
% 223.99/224.14  |- skos__scopeNote mesh__D007124
% 223.99/224.14       Immunologic techniques based on the use of: %28%1%29% enzyme-antibody conjugates; %28%2%29% enzyme-antigen conjugates; %28%3%29% antienzyme antibody followed by its homologous enzyme; or %28%4%29% enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens.%A%    
% 223.99/224.14  |- skos__altLabel mesh__D007124 Peroxidase-Antiperoxidase Complex Technic
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Antibody Technic, Enzyme-Labeled
% 223.99/224.14  |- skos__annotation mesh__D007124
% 223.99/224.14       coord with specific enzyme with no qualif %28%NIM%29% but do not bother to add PEROXIDASES or specific; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE is available%A%  
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Technics, Enzyme-Labeled Antibody
% 223.99/224.14  |- skos__altLabel mesh__D007124 Antibody Enzyme Technic, Unlabeled
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Immunoenzyme Technique
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Antibody Technique, Peroxidase-Labeled
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Technique, Immunoenzyme
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Technics, Peroxidase-Labeled Antibody
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Antibody Technics, Peroxidase-Labeled
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Enzyme Immunoassays
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124
% 223.99/224.14       Peroxidase Antiperoxidase Complex Technique
% 223.99/224.14  |- rdf__type mesh__D007124sskos__Concept
% 223.99/224.14  |- skos__altLabel mesh__D007124 Immunoenzyme Technics
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D007124 2003
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124
% 223.99/224.14       Peroxidase-Antiperoxidase Complex Technics
% 223.99/224.14  |- mesh__dateCreated mesh__D007124 1976-05-19
% 223.99/224.14  |- mesh__recordMaintainer mesh__D007124 ags
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124
% 223.99/224.14       Technique, Peroxidase-Antiperoxidase Complex
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Technic, Immunoenzyme
% 223.99/224.14  |- skos__altLabel mesh__D007124 Enzyme-Labeled Antibody Technic
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124
% 223.99/224.14       Peroxidase-Antiperoxidase Complex Techniques
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Technique, Peroxidase-Labeled Antibody
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Peroxidase Labeled Antibody Technique
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Immunoenzyme Technic
% 223.99/224.14  |- mesh__dateRevised mesh__D007124 2005-07-13
% 223.99/224.14  |- skos__broader mesh__D007124smesh__D007150
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Enzyme Labeled Antibody Technique
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Antibody Techniques, Peroxidase-Labeled
% 223.99/224.14  |- skos__altLabel mesh__D007124 Immunoperoxidase Technics
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Immunoperoxidase Technique
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Enzyme-Labeled Antibody Techniques
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Techniques, Peroxidase-Labeled Antibody
% 223.99/224.14  |- skos__hiddenLabel mesh__D007124 Techniques, Immunoenzyme
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D007124 2002
% 223.99/224.14  |- mesh__dateCreated mesh__D012867 1999-01-01
% 223.99/224.14  |- skos__related mesh__D012867smesh__D015603
% 223.99/224.14  |- skos__scopeNote mesh__D012867
% 223.99/224.14       The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.%A%    
% 223.99/224.14  |- skos__annotation mesh__D012867
% 223.99/224.14       for animal tissue in wound ther see note on BIOLOGICAL DRESSINGS; inflammation = DERMATITIS %26% its specifics; dryness of skin: index under SKIN DISEASES %26% do not interpret as XERODERMA see ICHTHYOSIS without clues from text%A%  
% 223.99/224.14  |- mesh__recordAuthorizer mesh__D012867 sjn
% 223.99/224.14  |- mesh__dateRevised mesh__D012867 2002-07-03
% 223.99/224.14  |- mesh__publicMeSHNote mesh__D012867
% 223.99/224.14       /transplantation was SKIN TRANSPLANTATION 1963-65; was SKIN/transplantation 1966-89%A%  
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D012867 2006
% 223.99/224.14  |- mesh__recordOriginator mesh__D012867 NLM
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D012867 2004
% 223.99/224.14  |- skos__prefLabel mesh__D012867 Skin
% 223.99/224.14  |- skos__related mesh__D012867smesh__D012877
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D012867 2005
% 223.99/224.14  |- mesh__considerAlso mesh__D012867
% 223.99/224.14       consider also terms at CUTANEOUS, CUTIS, and DERMAT-   
% 223.99/224.14  |- rdf__type mesh__D012867sskos__Concept
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D012867 2003
% 223.99/224.14  |- skos__related mesh__D012867smesh__D003879
% 223.99/224.14  |- skos__broader mesh__D012867smesh__D034582
% 223.99/224.14  |- mesh__historyNote mesh__D012867
% 223.99/224.14       /transplantation was SKIN TRANSPLANTATION 1963-65; was SKIN/transplantation 1966-89%A%  
% 223.99/224.14  |- mesh__recordMaintainer mesh__D012867 nns
% 223.99/224.14  |- mesh__publicMeSHNote mesh__D045243 2004   
% 223.99/224.14  |- skos__prefLabel mesh__D045243 Prevotella ruminicola
% 223.99/224.14  |- mesh__dateEstablished mesh__D045243 2004-01-01
% 223.99/224.14  |- mesh__recordOriginator mesh__D045243 ags
% 223.99/224.14  |- mesh__recordAuthorizer mesh__D045243 sjn
% 223.99/224.14  |- skos__historyNote mesh__D045243 Prevotella %28%1992-2003%29%
% 223.99/224.14  |- mesh__historyNote mesh__D045243 2004   
% 223.99/224.14  |- skos__broader mesh__D045243smesh__D018720
% 223.99/224.14  |- mesh__recordMaintainer mesh__D045243 SYSTEM
% 223.99/224.14  |- mesh__dateRevised mesh__D045243 2005-06-30
% 223.99/224.14  |- mesh__dateCreated mesh__D045243 2003-07-09
% 223.99/224.14  |- skos__scopeNote mesh__D045243
% 223.99/224.14       A saccharolytic species of gram-negative bacteria in the family Prevotellaceae. It ferments a wide range of CARBOHYDRATES in the RUMEN of animals.%A%    
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D045243 2006
% 223.99/224.14  |- rdf__type mesh__D045243sskos__Concept
% 223.99/224.14  |- skos__altLabel mesh__D012069 Psychology, Religion
% 223.99/224.14  |- mesh__recordAuthorizer mesh__D012069 sjn
% 223.99/224.14  |- mesh__dateRevised mesh__D012069 2001-07-25
% 223.99/224.14  |- skos__altLabel mesh__D012069 Religion, Psychology
% 223.99/224.14  |- mesh__dateCreated mesh__D012069 1999-01-01
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D012069 2003
% 223.99/224.14  |- skos__broader mesh__D012069smesh__D012067
% 223.99/224.14  |- skos__scopeNote mesh__D012069
% 223.99/224.14       The interrelationship of psychology and religion.     
% 223.99/224.14  |- rdf__type mesh__D012069sskos__Concept
% 223.99/224.14  |- mesh__recordMaintainer mesh__D012069 jrf
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D012069 2005
% 223.99/224.14  |- skos__prefLabel mesh__D012069 Religion and Psychology
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D012069 2004
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D012069 2002
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D012069 2006
% 223.99/224.14  |- skos__altLabel mesh__D012069 Psychology and Religion
% 223.99/224.14  |- skos__annotation mesh__D012069
% 223.99/224.14       no qualif; coord IM with psychol aspect %28%IM%29%; X ref PRAYER HEALING see MENTAL HEALING is available; DF: RELIGION PSYCHOL%A%  
% 223.99/224.14  |- mesh__recordOriginator mesh__D012069 NLM
% 223.99/224.14  |- skos__broader mesh__D012069smesh__D011579
% 223.99/224.14  |- mesh__historyNote mesh__D017552 94   
% 223.99/224.14  |- skos__altLabel mesh__D017552 Nucleus Tractus Solitarii
% 223.99/224.14  |- skos__altLabel mesh__D017552 Nucleus of the Solitary Tract
% 223.99/224.14  |- mesh__recordOriginator mesh__D017552 RAZ
% 223.99/224.14  |- skos__prefLabel mesh__D017552 Solitary Nucleus
% 223.99/224.14  |- mesh__dateCreated mesh__D017552 1992-12-28
% 223.99/224.14  |- rdf__type mesh__D017552sskos__Concept
% 223.99/224.14  |- skos__hiddenLabel mesh__D017552 Nucleus Tractus Solitarius
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D017552 2006
% 223.99/224.14  |- mesh__recordAuthorizer mesh__D017552 sjn
% 223.99/224.14  |- mesh__dateEstablished mesh__D017552 1994-01-01
% 223.99/224.14  |- skos__historyNote mesh__D017552 Medulla Oblongata %28%1966-1993%29%
% 223.99/224.14  |- mesh__publicMeSHNote mesh__D017552 94   
% 223.99/224.14  |- mesh__recordMaintainer mesh__D017552 ags
% 223.99/224.14  |- skos__scopeNote mesh__D017552
% 223.99/224.14       Gray matter located in the dorsomedial part of the MEDULLA OBLONGATA associated with the solitary tract. The solitary nucleus receives inputs from most organ systems including the terminations of the facial, glossopharyngeal, and vagus nerves. It is a major coordinator of AUTONOMIC NERVOUS SYSTEM regulation of cardiovascular, respiratory, gustatory, gastrointestinal, and chemoreceptive aspects of HOMEOSTASIS. The solitary nucleus is also notable for the large number of NEUROTRANSMITTERS which are found therein.%A%    
% 223.99/224.14  |- skos__altLabel mesh__D017552 Solitary Tract Nucleus
% 223.99/224.14  |- skos__hiddenLabel mesh__D017552 Nucleus, Solitary Tract
% 223.99/224.14  |- mesh__dateRevised mesh__D017552 2005-06-30
% 223.99/224.14  |- skos__altLabel mesh__D017552 Nucleus Solitarius
% 223.99/224.14  |- skos__hiddenLabel mesh__D017552 Nucleus, Solitary
% 223.99/224.14  |- skos__broader mesh__D017552smesh__D008526
% 223.99/224.14  |- skos__altLabel mesh__D031223 Rorippa nasturtium-aquaticum
% 223.99/224.14  |- skos__prefLabel mesh__D031223 Nasturtium
% 223.99/224.14  |- skos__annotation mesh__D031223
% 223.99/224.14       NASTURTIUM, GARDEN see TROPAEOLUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.99/224.14  |- mesh__dateEstablished mesh__D031223 2003-01-01
% 223.99/224.14  |- mesh__publicMeSHNote mesh__D031223 2003   
% 223.99/224.14  |- mesh__historyNote mesh__D031223 2003   
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D031223 2006
% 223.99/224.14  |- mesh__dateCreated mesh__D031223 2002-07-03
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D031223 2004
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D031223 2005
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D031223 2003
% 223.99/224.14  |- skos__scopeNote mesh__D031223
% 223.99/224.14       A plant genus of the family BRASSICACEAE. Nasturtium is also used as a common name for TROPAEOLUM. The common name of watercress is also used for RORIPPA %26% TROPAEOLUM. This is the most popular of the edible cresses, is a hardy creeping perennial plant, native to Europe but extensively naturalized elsewhere in moist places.%A%    
% 223.99/224.14  |- rdf__type mesh__D031223sskos__Concept
% 223.99/224.14  |- skos__broader mesh__D031223smesh__D019607
% 223.99/224.14  |- skos__hiddenLabel mesh__D050986 Transcription Factor, YY1
% 223.99/224.14  |- skos__hiddenLabel mesh__D050986 Transcription Factor, Delta
% 223.99/224.14  |- mesh__recordOriginator mesh__D050986 DRC
% 223.99/224.14  |- mesh__dateEstablished mesh__D050986 2006-01-01
% 223.99/224.14  |- skos__altLabel mesh__D050986 Nuclear Matrix Protein 1
% 223.99/224.14  |- mesh__historyNote mesh__D050986 2006%28%1980%29%   
% 223.99/224.14  |- rdf__type mesh__D050986sskos__Concept
% 223.99/224.14  |- skos__broader mesh__D050986smesh__D050981
% 223.99/224.14  |- mesh__recordMaintainer mesh__D050986 DRC
% 223.99/224.14  |- skos__scopeNote mesh__D050986
% 223.99/224.14       A ubiquitously expressed zinc finger-containing protein that acts both as a repressor and activator of transcription. It interacts with key regulatory proteins such as TATA-BINDING PROTEIN; TFIIB; and ADENOVIRUS E1A PROTEINS.%A%    
% 223.99/224.14  |- skos__hiddenLabel mesh__D050986 Yin Yang 1 Protein
% 223.99/224.14  |- mesh__recordAuthorizer mesh__D050986 sjn
% 223.99/224.14  |- mesh__dateCreated mesh__D050986 2005-06-30
% 223.99/224.14  |- mesh__publicMeSHNote mesh__D050986
% 223.99/224.14       2006; YY1 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1980-2005%A%  
% 223.99/224.14  |- skos__altLabel mesh__D050986 Delta Transcription Factor
% 223.99/224.14  |- skos__prefLabel mesh__D050986 YY1 Transcription Factor
% 223.99/224.14  |- skos__hiddenLabel mesh__D050986 Nuclear Factor, NF-D
% 223.99/224.14  |- skos__altLabel mesh__D050986 Yin-Yang-1 Protein
% 223.99/224.14  |- skos__hiddenLabel mesh__D050986 NF D Nuclear Factor
% 223.99/224.14  |- skos__altLabel mesh__D050986 NF-D Nuclear Factor
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D050986 2006
% 223.99/224.14  |- skos__annotation mesh__D003532
% 223.99/224.14       GEN; prefer specifics; do not confuse with CYPRINIDAE or CYPRINIFORMES or CYPRINODON see KILLIFISHES%A%  
% 223.99/224.14  |- skos__hiddenLabel mesh__D003532 Fish, Mosquito
% 223.99/224.14  |- mesh__dateCreated mesh__D003532 1986-04-15
% 223.99/224.14  |- skos__prefLabel mesh__D003532 Cyprinodontiformes
% 223.99/224.14  |- skos__broader mesh__D003532smesh__D023701
% 223.99/224.14  |- mesh__publicMeSHNote mesh__D003532
% 223.99/224.14       1987; for MOSQUITO FISH see FISHES 1975-86   
% 223.99/224.14  |- mesh__recordOriginator mesh__D003532 EC
% 223.99/224.14  |- rdf__type mesh__D003532sskos__Concept
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D003532 2004
% 223.99/224.14  |- skos__scopeNote mesh__D003532
% 223.99/224.14       An order of fish with eight families and numerous species of both egg-laying and livebearing fish. Families include Cyprinodontidae %28%egg-laying KILLIFISHES%29%, FUNDULIDAE %28%topminnows%29%, Goodeidae %28%Mexican livebearers%29%, Jenynsiidae %28%jenynsiids%29%, Poeciliidae %28%livebearers%29%, Profundulidae %28%Middle American killifishes%29%, Aplocheilidae, and Rivulidae %28%rivulines%29%. In the family Poeciliidae, the guppy and molly belong to the genus POECILIA.%A%    
% 223.99/224.14  |- skos__historyNote mesh__D003532 Fishes %28%1966-1986%29%
% 223.99/224.14  |- mesh__recordMaintainer mesh__D003532 ags
% 223.99/224.14  |- mesh__recordAuthorizer mesh__D003532 sjn
% 223.99/224.14  |- skos__hiddenLabel mesh__D003532 Gambusias
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D003532 2006
% 223.99/224.14  |- mesh__dateEstablished mesh__D003532 1987-01-01
% 223.99/224.14  |- mesh__dateRevised mesh__D003532 2003-07-09
% 223.99/224.14  |- mesh__historyNote mesh__D003532 1987%28%1975%29%   
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D003532 2005
% 223.99/224.14  |- skos__scopeNote mesh__D044949
% 223.99/224.14       A group of FLAVONOLS based on kaempferol. They are derived from naringenin and can be hydroxylated to QUERCETIN or reduced to leucopelargonidin.%A%    
% 223.99/224.14  |- mesh__recordMaintainer mesh__D044949 ssb
% 223.99/224.14  |- mesh__recordOriginator mesh__D044949 ssb
% 223.99/224.14  |- mesh__dateCreated mesh__D044949 2003-07-09
% 223.99/224.14  |- skos__prefLabel mesh__D044949 Kaempferols
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D044949 2006
% 223.99/224.14  |- rdf__type mesh__D044949sskos__Concept
% 223.99/224.14  |- mesh__recordAuthorizer mesh__D044949 sjn
% 223.99/224.14  |- mesh__historyNote mesh__D044949 2004   
% 223.99/224.14  |- mesh__publicMeSHNote mesh__D044949 2004   
% 223.99/224.14  |- skos__historyNote mesh__D044949 Flavones %28%1969-2003%29%
% 223.99/224.14  |- mesh__dateEstablished mesh__D044949 2004-01-01
% 223.99/224.14  |- mesh__dateRevised mesh__D044949 2005-06-30
% 223.99/224.14  |- skos__broader mesh__D044949smesh__D044948
% 223.99/224.14  |- mesh__recordOriginator mesh__D027182 jmp
% 223.99/224.14  |- skos__altLabel mesh__D027182 System y+ Transporter
% 223.99/224.14  |- skos__hiddenLabel mesh__D027182 Transporter, System y+
% 223.99/224.14  |- skos__scopeNote mesh__D027182
% 223.99/224.14       A sodium-independent, basic amino acid transport system with a high-affinity for LYSINE; ARGININE; and ORNITHINE.%A%    
% 223.99/224.14  |- skos__historyNote mesh__D027182 Amino Acids/metabolism %28%1975-2001%29%
% 223.99/224.14  |- skos__prefLabel mesh__D027182 Amino Acid Transport System y+
% 223.99/224.14  |- skos__historyNote mesh__D027182 Carrier Proteins %28%1975-2001%29%
% 223.99/224.14  |- skos__hiddenLabel mesh__D027182 Amino Acid Transport System y Plus
% 223.99/224.14  |- mesh__recordMaintainer mesh__D027182 ags
% 223.99/224.14  |- mesh__dateCreated mesh__D027182 2001-07-25
% 223.99/224.14  |- mesh__recordAuthorizer mesh__D027182 ags
% 223.99/224.14  |- skos__altLabel mesh__D027182 Amino Acid Transport System y-Plus
% 223.99/224.14  |- mesh__publicMeSHNote mesh__D027182 2002   
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D027182 2006
% 223.99/224.14  |- rdf__type mesh__D027182sskos__Concept
% 223.99/224.14  |- skos__hiddenLabel mesh__D027182 y+ Transporter, System
% 223.99/224.14  |- mesh__dateEstablished mesh__D027182 2002-01-01
% 223.99/224.14  |- skos__broader mesh__D027182smesh__D026923
% 223.99/224.14  |- mesh__dateRevised mesh__D027182 2005-07-19
% 223.99/224.14  |- mesh__historyNote mesh__D027182 2002   
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D027182 2006A
% 223.99/224.14  |- mesh__publicMeSHNote mesh__D013960
% 223.99/224.14       77,63-67; was THYROID GLAND FUNCTION TESTS 1968-76; PROTEIN-BOUND IODINE TEST was heading 1963-95%A%  
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013960 1999
% 223.99/224.14  |- mesh__recordOriginator mesh__D013960 NLM
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013960 2003
% 223.99/224.14  |- mesh__historyNote mesh__D013960
% 223.99/224.14       77,63-67; was THYROID GLAND FUNCTION TESTS 1968-76; PROTEIN-BOUND IODINE TEST was heading 1963-95%A%  
% 223.99/224.14  |- skos__hiddenLabel mesh__D013960 Function Test, Thyroid
% 223.99/224.14  |- skos__hiddenLabel mesh__D013960 Thyroid Function Test
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013960 1998
% 223.99/224.14  |- skos__hiddenLabel mesh__D013960 Tests, Protein-Bound Iodine
% 223.99/224.14  |- skos__hiddenLabel mesh__D013960 Iodine Tests, Protein-Bound
% 223.99/224.14  |- skos__hiddenLabel mesh__D013960 Protein Bound Iodine Test
% 223.99/224.14  |- mesh__dateRevised mesh__D013960 1997-06-20
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013960 2006
% 223.99/224.14  |- skos__broader mesh__D013960smesh__D003940
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013960 2002
% 223.99/224.14  |- mesh__dateCreated mesh__D013960 1999-01-01
% 223.99/224.14  |- mesh__recordMaintainer mesh__D013960 PXP
% 223.99/224.14  |- skos__hiddenLabel mesh__D013960 Tests, Thyroid Function
% 223.99/224.14  |- mesh__recordAuthorizer mesh__D013960 SJN
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013960 2005
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013960 2001
% 223.99/224.14  |- skos__hiddenLabel mesh__D013960 Test, Thyroid Function
% 223.99/224.14  |- rdf__type mesh__D013960sskos__Concept
% 223.99/224.14  |- skos__hiddenLabel mesh__D013960 Test, Protein-Bound Iodine
% 223.99/224.14  |- skos__hiddenLabel mesh__D013960 Iodine Test, Protein-Bound
% 223.99/224.14  |- skos__hiddenLabel mesh__D013960 Function Tests, Thyroid
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013960 2004
% 223.99/224.14  |- skos__prefLabel mesh__D013960 Thyroid Function Tests
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013960 2000
% 223.99/224.14  |- mesh__dateEstablished mesh__D013960 1968-01-01
% 223.99/224.14  |- skos__altLabel mesh__D013960 Thyroid Gland Function Tests
% 223.99/224.14  |- skos__hiddenLabel mesh__D013960 Protein-Bound Iodine Tests
% 223.99/224.14  |- rdf__type mesh__D013162sskos__Concept
% 223.99/224.14  |- skos__hiddenLabel mesh__D013162 Vein, Splenic
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013162 1994
% 223.99/224.14  |- mesh__recordAuthorizer mesh__D013162 PLS
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013162 2005
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013162 2000
% 223.99/224.14  |- mesh__recordMaintainer mesh__D013162 TAP
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013162 1995
% 223.99/224.14  |- skos__hiddenLabel mesh__D013162 Splenic Veins
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013162 2003
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013162 1993
% 223.99/224.14  |- skos__scopeNote mesh__D013162
% 223.99/224.14       Vein formed by the union %28%at the hilus of the spleen%29% of several small veins from the stomach, pancreas, spleen and mesentery.%A%    
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013162 2006
% 223.99/224.14  |- mesh__dateCreated mesh__D013162 1999-01-01
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013162 1998
% 223.99/224.14  |- mesh__recordOriginator mesh__D013162 NLM
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013162 2004
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013162 2001
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013162 1996
% 223.99/224.14  |- skos__prefLabel mesh__D013162 Splenic Vein
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013162 1999
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013162 2002
% 223.99/224.14  |- skos__broader mesh__D013162smesh__D011168
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D013162 1997
% 223.99/224.14  |- skos__hiddenLabel mesh__D013162 Veins, Splenic
% 223.99/224.14  |- mesh__dateRevised mesh__D013162 1992-05-18
% 223.99/224.14  |- skos__prefLabel mesh__D007125 Immunogenetics
% 223.99/224.14  |- skos__historyNote mesh__D007125 Allergy and Immunology %28%1966-1970%29%
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D007125 2006
% 223.99/224.14  |- mesh__dateRevised mesh__D007125 2002-07-03
% 223.99/224.14  |- skos__annotation mesh__D007125
% 223.99/224.14       GEN or SPEC; prefer specifics: Manual 28.22.5, 28.24.6   
% 223.99/224.14  |- skos__scopeNote mesh__D007125
% 223.99/224.14       A subdiscipline of genetics which deals with the genetic basis of the immune response %28%IMMUNITY%29%.%A%    
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D007125 2005
% 223.99/224.14  |- mesh__recordAuthorizer mesh__D007125 sjn
% 223.99/224.14  |- mesh__historyNote mesh__D007125 71   
% 223.99/224.14  |- rdf__type mesh__D007125sskos__Concept
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D007125 2004
% 223.99/224.14  |- mesh__dateEstablished mesh__D007125 1971-01-01
% 223.99/224.14  |- mesh__recordOriginator mesh__D007125 NLM
% 223.99/224.14  |- skos__broader mesh__D007125smesh__D007109
% 223.99/224.14  |- skos__hiddenLabel mesh__D007125 Immunogenetic
% 223.99/224.14  |- mesh__publicMeSHNote mesh__D007125 71   
% 223.99/224.14  |- skos__historyNote mesh__D007125 Genetics %28%1966-1970%29%
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D007125 2003
% 223.99/224.14  |- mesh__dateCreated mesh__D007125 1999-01-01
% 223.99/224.14  |- skos__broader mesh__D007125smesh__D005823
% 223.99/224.14  |- mesh__recordMaintainer mesh__D007125 TGC
% 223.99/224.14  |- mesh__dateCreated mesh__D012868 1984-05-02
% 223.99/224.14  |- mesh__recordMaintainer mesh__D012868 nns
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D012868 2006
% 223.99/224.14  |- mesh__dateRevised mesh__D012868 2001-07-25
% 223.99/224.14  |- mesh__publicMeSHNote mesh__D012868 98   
% 223.99/224.14  |- skos__broader mesh__D012868smesh__D012871
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D012868 2004
% 223.99/224.14  |- skos__hiddenLabel mesh__D012868 Skin Abnormality
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D012868 2005
% 223.99/224.14  |- skos__broader mesh__D012868smesh__D000013
% 223.99/224.14  |- rdf__type mesh__D012868sskos__Concept
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D012868 2003
% 223.99/224.14  |- mesh__recordAuthorizer mesh__D012868 sjn
% 223.99/224.14  |- mesh__historyNote mesh__D012868 98; use explode 1985-97   
% 223.99/224.14  |- skos__prefLabel mesh__D012868 Skin Abnormalities
% 223.99/224.14  |- skos__altLabel mesh__D012868 Abnormalities, Skin
% 223.99/224.14  |- mesh__recordOriginator mesh__D012868 AEP
% 223.99/224.14  |- skos__annotation mesh__D012868
% 223.99/224.14       for congen struct abnorm only; GEN or unspecified; prefer specifics; DF: SKIN ABNORM%A%  
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D012868 2002
% 223.99/224.14  |- skos__hiddenLabel mesh__D012868 Abnormality, Skin
% 223.99/224.14  |- skos__historyNote mesh__D012868 Skin/abnormalities %28%1966-1997%29%
% 223.99/224.14  |- skos__scopeNote mesh__D012868
% 223.99/224.14       Congenital structural abnormalities of the skin.     
% 223.99/224.14  |- mesh__dateEstablished mesh__D012868 1998-01-01
% 223.99/224.14  |- skos__related mesh__D017553smesh__D009943
% 223.99/224.14  |- skos__broader mesh__D017553smesh__D007287
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D017553 2000
% 223.99/224.14  |- mesh__dateRevised mesh__D017553 1997-06-20
% 223.99/224.14  |- rdf__type mesh__D017553sskos__Concept
% 223.99/224.14  |- skos__scopeNote mesh__D017553
% 223.99/224.14       Inorganic compounds that contain phosphorus as an integral part of the molecule.%A%    
% 223.99/224.14  |- mesh__recordOriginator mesh__D017553 TPW
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D017553 2006
% 223.99/224.14  |- skos__annotation mesh__D017553
% 223.99/224.14       inorganic; GEN or unspecified; prefer specifics; DF: PHOSPHORUS CPDS%A%  
% 223.99/224.14  |- mesh__historyNote mesh__D017553 98; use explode 1994-97   
% 223.99/224.14  |- mesh__publicMeSHNote mesh__D017553 98   
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D017553 2005
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D017553 2004
% 223.99/224.14  |- skos__hiddenLabel mesh__D017553 Compounds, Phosphorus
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D017553 2002
% 223.99/224.14  |- mesh__dateEstablished mesh__D017553 1998-01-01
% 223.99/224.14  |- mesh__recordAuthorizer mesh__D017553 SJN
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D017553 2003
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D017553 1999
% 223.99/224.14  |- mesh__dateCreated mesh__D017553 1993-06-29
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D017553 1998
% 223.99/224.14  |- skos__historyNote mesh__D017553 Phosphorus %28%1966-1993%29%
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D017553 2001
% 223.99/224.14  |- mesh__recordMaintainer mesh__D017553 ADP
% 223.99/224.14  |- skos__prefLabel mesh__D017553 Phosphorus Compounds
% 223.99/224.14  |- mesh__dateCreated mesh__D031224 2002-07-03
% 223.99/224.14  |- mesh__recordAuthorizer mesh__D031224 sjn
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D031224 2006
% 223.99/224.14  |- mesh__activeMeSHYear mesh__D031224 2005
% 223.99/224.14  |- skos__broader mesh__D031224smesh__D019607
% 223.99/224.14  |- skos__prefLabel mesh__D031224 Raphanus
% 223.99/224.14  |- mesh__dateEstablished mesh__D031224 2003-01-01
% 223.99/224.14  |- rdf__type mesh__D031224sskos__Concept
% 223.99/224.14  |- mesh__recordOriginator mesh__D031224 ssb
% 223.99/224.15  |- mesh__historyNote mesh__D031224 2003   
% 223.99/224.15  |- skos__scopeNote mesh__D031224
% 223.99/224.15       A plant genus of the family BRASSICACEAE known for its peppery red root.%A%    
% 223.99/224.15  |- mesh__dateRevised mesh__D031224 2004-07-07
% 223.99/224.15  |- skos__annotation mesh__D031224
% 223.99/224.15       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.99/224.15  |- mesh__recordMaintainer mesh__D031224 ssb
% 223.99/224.15  |- mesh__publicMeSHNote mesh__D031224 2003   
% 223.99/224.15  |- skos__annotation mesh__D050987 see SCR for organism-specific terms   
% 223.99/224.15  |- skos__hiddenLabel mesh__D050987 VAMP 1
% 223.99/224.15  |- rdf__type mesh__D050987sskos__Concept
% 223.99/224.15  |- mesh__historyNote mesh__D050987 2006 %28%1988%29%   
% 223.99/224.15  |- skos__prefLabel mesh__D050987 Vesicle-Associated Membrane Protein 1
% 223.99/224.15  |- mesh__recordMaintainer mesh__D050987 nns
% 223.99/224.15  |- skos__scopeNote mesh__D050987
% 223.99/224.15       A member of the vesicle-associated membrane protein family involved in the MEMBRANE FUSION of TRANSPORT VESICLES to their target membrane.%A%    
% 223.99/224.15  |- mesh__dateEstablished mesh__D050987 2006-01-01
% 223.99/224.15  |- skos__altLabel mesh__D050987 VAMP1
% 223.99/224.15  |- skos__broader mesh__D050987smesh__D050683
% 223.99/224.15  |- mesh__recordAuthorizer mesh__D050987 sjn
% 223.99/224.15  |- mesh__dateCreated mesh__D050987 2005-06-30
% 223.99/224.15  |- skos__altLabel mesh__D050987 Synaptobrevin 1
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D050987 2006
% 223.99/224.15  |- skos__hiddenLabel mesh__D050987 Vesicle Associated Membrane Protein 1
% 223.99/224.15  |- mesh__publicMeSHNote mesh__D050987
% 223.99/224.15       2006; VESICLE-ASSOCIATED MEMBRANE PROTEIN 1 was indexed under MEMBRANE PROTEINS 1996-2005 and NERVE TISSUE PROTEINS 1988-1995%A%  
% 223.99/224.15  |- mesh__recordOriginator mesh__D050987 nns
% 223.99/224.15  |- skos__altLabel mesh__D050987 VAMP-1
% 223.99/224.15  |- skos__annotation mesh__D003533
% 223.99/224.15       a histamine H1 antag %26% serotonin antag   
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D003533 2004
% 223.99/224.15  |- mesh__dateCreated mesh__D003533 1999-01-01
% 223.99/224.15  |- mesh__recordOriginator mesh__D003533 NLM
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D003533 2001
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D003533 1996
% 223.99/224.15  |- mesh__recordAuthorizer mesh__D003533 PLS
% 223.99/224.15  |- skos__scopeNote mesh__D003533
% 223.99/224.15       A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc.%A%    
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D003533 2003
% 223.99/224.15  |- skos__broader mesh__D003533smesh__D010880
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D003533 1999
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D003533 2000
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D003533 2006
% 223.99/224.15  |- skos__prefLabel mesh__D003533 Cyproheptadine
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D003533 1998
% 223.99/224.15  |- skos__broader mesh__D003533smesh__D003986
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D003533 2005
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D003533 2002
% 223.99/224.15  |- mesh__dateRevised mesh__D003533 1995-06-08
% 223.99/224.15  |- rdf__type mesh__D003533sskos__Concept
% 223.99/224.15  |- mesh__recordMaintainer mesh__D003533 JRT
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D003533 1997
% 223.99/224.15  |- skos__broader mesh__D027981smesh__D016623
% 223.99/224.15  |- mesh__dateRevised mesh__D027981 2005-06-30
% 223.99/224.15  |- mesh__dateCreated mesh__D027981 2001-07-25
% 223.99/224.15  |- skos__hiddenLabel mesh__D027981 Co Transporters
% 223.99/224.15  |- rdf__type mesh__D027981sskos__Concept
% 223.99/224.15  |- mesh__recordOriginator mesh__D027981 jmp
% 223.99/224.15  |- mesh__recordMaintainer mesh__D027981 SYSTEM
% 223.99/224.15  |- mesh__dateEstablished mesh__D027981 2002-01-01
% 223.99/224.15  |- mesh__recordAuthorizer mesh__D027981 sjn
% 223.99/224.15  |- skos__related mesh__D027981smesh__D017136
% 223.99/224.15  |- mesh__publicMeSHNote mesh__D027981 2002   
% 223.99/224.15  |- skos__scopeNote mesh__D027981
% 223.99/224.15       Membrane transporters that co-transport two or more dissimilar molecules in the same direction across a membrane. Usually the transport of one ion or molecule is against its electrochemical gradient and is %22%powered%22% by the movement of another ion or molecule with its electrochemical gradient.%A%    
% 223.99/224.15  |- skos__prefLabel mesh__D027981 Symporters
% 223.99/224.15  |- mesh__historyNote mesh__D027981 2002   
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D027981 2006
% 223.99/224.15  |- skos__historyNote mesh__D027981 Carrier Proteins %28%1981-2001%29%
% 223.99/224.15  |- skos__altLabel mesh__D027981 Co-Transporters
% 223.99/224.15  |- skos__hiddenLabel mesh__D013961 Thyroid Glands
% 223.99/224.15  |- skos__related mesh__D013961smesh__D013330
% 223.99/224.15  |- skos__broader mesh__D013961smesh__D004702
% 223.99/224.15  |- skos__hiddenLabel mesh__D013961 Thyroids
% 223.99/224.15  |- mesh__recordOriginator mesh__D013961 NLM
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013961 2006
% 223.99/224.15  |- mesh__recordAuthorizer mesh__D013961 sjn
% 223.99/224.15  |- skos__hiddenLabel mesh__D013961 Glands, Thyroid
% 223.99/224.15  |- mesh__dateCreated mesh__D013961 1999-01-01
% 223.99/224.15  |- skos__annotation mesh__D013961
% 223.99/224.15       /surg: probably THYROIDECTOMY; inflammation = THYROIDITIS; nodule = THYROID NODULE; /abnorm: consider also THYROID DYSGENESIS%A%  
% 223.99/224.15  |- mesh__dateRevised mesh__D013961 2005-06-30
% 223.99/224.15  |- rdf__type mesh__D013961sskos__Concept
% 223.99/224.15  |- skos__altLabel mesh__D013961 Thyroid
% 223.99/224.15  |- skos__prefLabel mesh__D013961 Thyroid Gland
% 223.99/224.15  |- skos__scopeNote mesh__D013961
% 223.99/224.15       A highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the TRACHEA. It secretes THYROID HORMONES from the follicular cells and CALCITONIN from the parafollicular cells thereby regulating METABOLISM and CALCIUM level in blood, respectively.%A%    
% 223.99/224.15  |- skos__related mesh__D013961smesh__D014460
% 223.99/224.15  |- skos__related mesh__D013961smesh__D013965
% 223.99/224.15  |- mesh__recordMaintainer mesh__D013961 lkt
% 223.99/224.15  |- skos__hiddenLabel mesh__D013961 Gland, Thyroid
% 223.99/224.15  |- skos__altLabel mesh__D013163 Enlarged Spleen
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013163 2003
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013163 2006
% 223.99/224.15  |- mesh__recordAuthorizer mesh__D013163 sjn
% 223.99/224.15  |- mesh__dateRevised mesh__D013163 1999-11-04
% 223.99/224.15  |- mesh__dateCreated mesh__D013163 1999-01-01
% 223.99/224.15  |- skos__broader mesh__D013163smesh__D006984
% 223.99/224.15  |- skos__hiddenLabel mesh__D013163 Spleen, Enlarged
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013163 2004
% 223.99/224.15  |- skos__prefLabel mesh__D013163 Splenomegaly
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013163 2000
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013163 2001
% 223.99/224.15  |- skos__annotation mesh__D013163
% 223.99/224.15       do not confuse with HYPERSPLENISM, increase in splenic hemolytic function; IM only if point of article; do not index at all if the usual symptom of a disease; NIM if merely one of many symptoms in article%A%  
% 223.99/224.15  |- mesh__recordOriginator mesh__D013163 NLM
% 223.99/224.15  |- skos__scopeNote mesh__D013163 Enlargement of the spleen.     
% 223.99/224.15  |- skos__related mesh__D013163smesh__D006971
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013163 2002
% 223.99/224.15  |- mesh__recordMaintainer mesh__D013163 KEV
% 223.99/224.15  |- rdf__type mesh__D013163sskos__Concept
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013163 2005
% 223.99/224.15  |- mesh__dateEstablished mesh__D007126 1975-09-01
% 223.99/224.15  |- mesh__dateRevised mesh__D007126 2005-07-01
% 223.99/224.15  |- skos__historyNote mesh__D007126 Antibody Specificity %28%1970-1974%29%
% 223.99/224.15  |- skos__broader mesh__D007126smesh__D007125
% 223.99/224.15  |- skos__hiddenLabel mesh__D007126 Allotypes, Ig
% 223.99/224.15  |- mesh__publicMeSHNote mesh__D007126 75   
% 223.99/224.15  |- skos__scopeNote mesh__D007126
% 223.99/224.15       Allelic variants of the immunoglobulin light chains %28%IMMUNOGLOBULIN LIGHT CHAINS%29% or heavy chains %28%IMMUNOGLOBULIN HEAVY CHAINS%29% encoded by ALLELES of IMMUNOGLOBULIN GENES.%A%    
% 223.99/224.15  |- mesh__recordMaintainer mesh__D007126 sjn
% 223.99/224.15  |- skos__altLabel mesh__D007126 Antibodies, Allotypic
% 223.99/224.15  |- rdf__type mesh__D007126sskos__Concept
% 223.99/224.15  |- skos__historyNote mesh__D007126 Antigenic Determinants %28%1970-1974%29%
% 223.99/224.15  |- skos__historyNote mesh__D007126 Alleles %28%1968-1974%29%
% 223.99/224.15  |- skos__prefLabel mesh__D007126 Immunoglobulin Allotypes
% 223.99/224.15  |- skos__hiddenLabel mesh__D007126 Ig Allotype
% 223.99/224.15  |- skos__broader mesh__D007126smesh__D000906
% 223.99/224.15  |- skos__altLabel mesh__D007126 Allotypic Antibodies
% 223.99/224.15  |- skos__hiddenLabel mesh__D007126 Allotypic Antibody
% 223.99/224.15  |- skos__hiddenLabel mesh__D007126 Allotype, Ig
% 223.99/224.15  |- skos__altLabel mesh__D007126 Ig Allotypes
% 223.99/224.15  |- mesh__historyNote mesh__D007126 75   
% 223.99/224.15  |- skos__related mesh__D007126smesh__D005803
% 223.99/224.15  |- mesh__recordAuthorizer mesh__D007126 sjn
% 223.99/224.15  |- mesh__dateCreated mesh__D007126 1974-11-19
% 223.99/224.15  |- skos__annotation mesh__D007126
% 223.99/224.15       general or unspecified; prefer specifics; Am allotype goes here %28%IM%29% + IMMUNOGLOBULIN A %28%IM%29%; DF: IG ALLOTYPES%A%  
% 223.99/224.15  |- skos__historyNote mesh__D007126 Immunoglobulins %28%1970-1974%29%
% 223.99/224.15  |- skos__hiddenLabel mesh__D007126 Immunoglobulin Allotype
% 223.99/224.15  |- mesh__recordOriginator mesh__D007126 NLM
% 223.99/224.15  |- skos__altLabel mesh__D007126 Allotypes, Immunoglobulin
% 223.99/224.15  |- skos__hiddenLabel mesh__D007126 Antibody, Allotypic
% 223.99/224.15  |- skos__historyNote mesh__D007126 Isoantibodies %28%1966-1974%29%
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D007126 2006
% 223.99/224.15  |- skos__hiddenLabel mesh__D007126 Allotype, Immunoglobulin
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D012869 2006
% 223.99/224.15  |- skos__hiddenLabel mesh__D012869 Absorptions, Skin
% 223.99/224.15  |- mesh__dateRevised mesh__D012869 2005-06-30
% 223.99/224.15  |- rdf__type mesh__D012869sskos__Concept
% 223.99/224.15  |- skos__related mesh__D012869smesh__D000279
% 223.99/224.15  |- skos__hiddenLabel mesh__D012869 Skin Absorptions
% 223.99/224.15  |- mesh__recordOriginator mesh__D012869 NLM
% 223.99/224.15  |- mesh__publicMeSHNote mesh__D012869 65   
% 223.99/224.15  |- skos__altLabel mesh__D012869 Absorption, Skin
% 223.99/224.15  |- skos__scopeNote mesh__D012869
% 223.99/224.15       Uptake of substances through the SKIN.     
% 223.99/224.15  |- skos__altLabel mesh__D012869 Percutaneous Absorption
% 223.99/224.15  |- skos__broader mesh__D012869smesh__D000042
% 223.99/224.15  |- mesh__dateCreated mesh__D012869 1999-01-01
% 223.99/224.15  |- mesh__recordMaintainer mesh__D012869 lkt
% 223.99/224.15  |- mesh__historyNote mesh__D012869 65   
% 223.99/224.15  |- mesh__recordAuthorizer mesh__D012869 sjn
% 223.99/224.15  |- mesh__dateEstablished mesh__D012869 1965-01-01
% 223.99/224.15  |- skos__hiddenLabel mesh__D012869 Absorption, Percutaneous
% 223.99/224.15  |- skos__broader mesh__D012869smesh__D012879
% 223.99/224.15  |- skos__prefLabel mesh__D012869 Skin Absorption
% 223.99/224.15  |- mesh__recordMaintainer mesh__D045245 SYSTEM
% 223.99/224.15  |- mesh__dateEstablished mesh__D045245 2004-01-01
% 223.99/224.15  |- mesh__recordOriginator mesh__D045245 ags
% 223.99/224.15  |- mesh__recordAuthorizer mesh__D045245 sjn
% 223.99/224.15  |- skos__historyNote mesh__D045245
% 223.99/224.15       Gram-Negative Aerobic Bacteria %28%1998-2003%29%
% 223.99/224.15  |- mesh__historyNote mesh__D045245 2004   
% 223.99/224.15  |- skos__broader mesh__D045245smesh__D016946
% 223.99/224.15  |- mesh__dateRevised mesh__D045245 2005-06-30
% 223.99/224.15  |- skos__scopeNote mesh__D045245
% 223.99/224.15       A genus of obligately aerobic, thermophilic, gram-negative bacteria in the family Crenotrichaceae. They were isolated from submarine alkaline HOT SPRINGS in Iceland.%A%    
% 223.99/224.15  |- mesh__dateCreated mesh__D045245 2003-07-09
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D045245 2006
% 223.99/224.15  |- rdf__type mesh__D045245sskos__Concept
% 223.99/224.15  |- mesh__publicMeSHNote mesh__D045245 2004   
% 223.99/224.15  |- skos__broader mesh__D045245smesh__D041963
% 223.99/224.15  |- skos__prefLabel mesh__D045245 Rhodothermus
% 223.99/224.15  |- skos__altLabel mesh__D017554 Inorganic Carbon Compounds
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D017554 2000
% 223.99/224.15  |- rdf__type mesh__D017554sskos__Concept
% 223.99/224.15  |- mesh__dateRevised mesh__D017554 1997-06-20
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D017554 2003
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D017554 2006
% 223.99/224.15  |- skos__prefLabel mesh__D017554 Carbon Compounds, Inorganic
% 223.99/224.15  |- skos__historyNote mesh__D017554 Carbon %28%1966-1993%29%
% 223.99/224.15  |- mesh__dateCreated mesh__D017554 1993-06-29
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D017554 2001
% 223.99/224.15  |- skos__broader mesh__D017554smesh__D007287
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D017554 1998
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D017554 2004
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D017554 2002
% 223.99/224.15  |- skos__annotation mesh__D017554
% 223.99/224.15       GEN; prefer specifics; used for mapping supplementary chemicals%A%  
% 223.99/224.15  |- skos__scopeNote mesh__D017554
% 223.99/224.15       Inorganic compounds that contain carbon as an integral part of the molecule but are not derived from hydrocarbons.%A%    
% 223.99/224.15  |- mesh__recordAuthorizer mesh__D017554 SJN
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D017554 1999
% 223.99/224.15  |- mesh__dateEstablished mesh__D017554 1998-01-01
% 223.99/224.15  |- mesh__historyNote mesh__D017554 98; use explode 1994-97   
% 223.99/224.15  |- mesh__recordMaintainer mesh__D017554 ADP
% 223.99/224.15  |- mesh__recordOriginator mesh__D017554 TPW
% 223.99/224.15  |- mesh__publicMeSHNote mesh__D017554 98   
% 223.99/224.15  |- skos__hiddenLabel mesh__D017554 Compounds, Inorganic Carbon
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D017554 2005
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D031225 2004
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D031225 2005
% 223.99/224.15  |- skos__prefLabel mesh__D031225 Rorippa
% 223.99/224.15  |- mesh__dateCreated mesh__D031225 2002-07-03
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D031225 2003
% 223.99/224.15  |- skos__annotation mesh__D031225
% 223.99/224.15       RORIPPA NASTURTIUM-AQUATICUM see NASTURTIUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.99/224.15  |- rdf__type mesh__D031225sskos__Concept
% 223.99/224.15  |- skos__scopeNote mesh__D031225
% 223.99/224.15       A plant genus of the family BRASSICACEAE that includes several marshy plants. The common name of watercress is also used for NASTURTIUM %26% TROPAEOLUM.%A%    
% 223.99/224.15  |- skos__broader mesh__D031225smesh__D019607
% 223.99/224.15  |- skos__altLabel mesh__D031225 Cress, Yellow
% 223.99/224.15  |- mesh__dateEstablished mesh__D031225 2003-01-01
% 223.99/224.15  |- mesh__publicMeSHNote mesh__D031225 2003   
% 223.99/224.15  |- mesh__historyNote mesh__D031225 2003   
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D031225 2006
% 223.99/224.15  |- rdf__type mesh__D050988sskos__Concept
% 223.99/224.15  |- skos__historyNote mesh__D050988 Membrane Proteins %28%1994-2005%29%
% 223.99/224.15  |- skos__broader mesh__D050988smesh__D050683
% 223.99/224.15  |- mesh__dateCreated mesh__D050988 2005-06-30
% 223.99/224.15  |- mesh__recordAuthorizer mesh__D050988 ags
% 223.99/224.15  |- skos__annotation mesh__D050988 see SCR for organism-specific terms   
% 223.99/224.15  |- skos__altLabel mesh__D050988 VAMP-2
% 223.99/224.15  |- skos__altLabel mesh__D050988 VAMP2
% 223.99/224.15  |- mesh__historyNote mesh__D050988 2006 %28%1988%29%   
% 223.99/224.15  |- skos__scopeNote mesh__D050988
% 223.99/224.15       A synaptic membrane protein involved in MEMBRANE FUSION of SYNAPTIC VESICLES with the presynaptic membranes. It is the prototype member of the R-SNARE PROTEINS.%A%    
% 223.99/224.15  |- mesh__publicMeSHNote mesh__D050988
% 223.99/224.15       2006; VESICLE-ASSOCIATED MEMBRANE PROTEIN 2 was indexed under MEMBRANE PROTEINS 1996-2005 and NERVE TISSUE PROTEINS 1988-1995%A%  
% 223.99/224.15  |- mesh__recordMaintainer mesh__D050988 ags
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D050988 2006
% 223.99/224.15  |- skos__hiddenLabel mesh__D050988 VAMP 2
% 223.99/224.15  |- mesh__recordOriginator mesh__D050988 nns
% 223.99/224.15  |- mesh__dateRevised mesh__D050988 2005-07-28
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D050988 2006A
% 223.99/224.15  |- skos__altLabel mesh__D050988 Synaptobrevin 2
% 223.99/224.15  |- skos__hiddenLabel mesh__D050988 Vesicle Associated Membrane Protein 2
% 223.99/224.15  |- skos__prefLabel mesh__D050988 Vesicle-Associated Membrane Protein 2
% 223.99/224.15  |- mesh__dateEstablished mesh__D050988 2006-01-01
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D003534 2003
% 223.99/224.15  |- mesh__dateRevised mesh__D003534 2000-06-22
% 223.99/224.15  |- mesh__recordAuthorizer mesh__D003534 sjn
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D003534 2006
% 223.99/224.15  |- skos__prefLabel mesh__D003534 Cyproterone
% 223.99/224.15  |- mesh__recordOriginator mesh__D003534 NLM
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D003534 2001
% 223.99/224.15  |- mesh__historyNote mesh__D003534 74%28%72%29%   
% 223.99/224.15  |- skos__broader mesh__D003534smesh__D011245
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D003534 2005
% 223.99/224.15  |- mesh__publicMeSHNote mesh__D003534 74   
% 223.99/224.15  |- skos__historyNote mesh__D003534
% 223.99/224.15       Androgens/antagonists %26% inhibitors %28%1968-1971%29%
% 223.99/224.15  |- rdf__type mesh__D003534sskos__Concept
% 223.99/224.15  |- skos__broader mesh__D003534smesh__D013258
% 223.99/224.15  |- mesh__recordMaintainer mesh__D003534 TWD
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D003534 2004
% 223.99/224.15  |- skos__scopeNote mesh__D003534
% 223.99/224.15       An anti-androgen that, in the form of its acetate %28%CYPROTERONE ACETATE%29%, also has progestational properties. It is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females.%A%    
% 223.99/224.15  |- mesh__dateEstablished mesh__D003534 1974-01-01
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D003534 2002
% 223.99/224.15  |- mesh__dateCreated mesh__D003534 1999-01-01
% 223.99/224.15  |- mesh__recordMaintainer mesh__D027982 SYSTEM
% 223.99/224.15  |- skos__hiddenLabel mesh__D027982 Sodium Bicarbonate Cotransporter
% 223.99/224.15  |- mesh__dateEstablished mesh__D027982 2002-01-01
% 223.99/224.15  |- skos__prefLabel mesh__D027982 Sodium-Bicarbonate Symporters
% 223.99/224.15  |- skos__historyNote mesh__D027982 Carrier Proteins %28%1986-2001%29%
% 223.99/224.15  |- skos__broader mesh__D027982smesh__D027981
% 223.99/224.15  |- skos__scopeNote mesh__D027982
% 223.99/224.15       Proteins that cotransport sodium ions and bicarbonate ions across cellular membranes.%A%    
% 223.99/224.15  |- skos__hiddenLabel mesh__D027982 Cotransporter, Sodium-Bicarbonate
% 223.99/224.15  |- skos__altLabel mesh__D027982 Na-HCO3 Symport
% 223.99/224.15  |- mesh__dateRevised mesh__D027982 2005-06-30
% 223.99/224.15  |- mesh__dateCreated mesh__D027982 2001-07-25
% 223.99/224.15  |- mesh__recordOriginator mesh__D027982 jmp
% 223.99/224.15  |- skos__hiddenLabel mesh__D027982 Sodium Bicarbonate Symporters
% 223.99/224.15  |- skos__altLabel mesh__D027982 Sodium Bicarbonate Symport
% 223.99/224.15  |- skos__hiddenLabel mesh__D027982 Symport, Sodium Bicarbonate
% 223.99/224.15  |- skos__hiddenLabel mesh__D027982 Symport, Na-HCO3
% 223.99/224.15  |- skos__hiddenLabel mesh__D027982 Na HCO3 Symport
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D027982 2006
% 223.99/224.15  |- mesh__recordAuthorizer mesh__D027982 sjn
% 223.99/224.15  |- skos__altLabel mesh__D027982 Sodium-Bicarbonate Cotransporter
% 223.99/224.15  |- mesh__historyNote mesh__D027982
% 223.99/224.15       2002; use SODIUM-BICARBONATE SYMPORTERS %28%NM%29% 1986-2001   
% 223.99/224.15  |- mesh__publicMeSHNote mesh__D027982
% 223.99/224.15       2002; SODIUM BICARBONATE SYMPORT %28%now SODIUM-BICARBONATE SYMPORTERS%29% was indexed under CARRIER PROTEINS 1986-2001%A%  
% 223.99/224.15  |- rdf__type mesh__D027982sskos__Concept
% 223.99/224.15  |- skos__hiddenLabel mesh__D027982 Symporters, Sodium-Bicarbonate
% 223.99/224.15  |- skos__hiddenLabel mesh__D027982 Bicarbonate Symport, Sodium
% 223.99/224.15  |- skos__broader mesh__D013962smesh__D013963
% 223.99/224.15  |- skos__altLabel mesh__D013962 Thyroideum Siccatum
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013962 2005
% 223.99/224.15  |- mesh__publicMeSHNote mesh__D013962
% 223.99/224.15       91; was see under THYROID HORMONES 1975-90   
% 223.99/224.15  |- skos__scopeNote mesh__D013962
% 223.99/224.15       A powder preparation of dried thyroid glands after the removal of fat and connective tissue. It is a yellowish to buff-colored amorphous powder containing 0.17-0.23%25% of iodine.%A%    
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013962 2006
% 223.99/224.15  |- skos__hiddenLabel mesh__D013962 Desiccated Thyroid Gland
% 223.99/224.15  |- skos__hiddenLabel mesh__D013962 Gland, Desiccated Thyroid
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013962 2003
% 223.99/224.15  |- mesh__onlineNote mesh__D013962 search THYROID HORMONES 1968-74   
% 223.99/224.15  |- mesh__recordMaintainer mesh__D013962 lkt
% 223.99/224.15  |- mesh__dateEstablished mesh__D013962 1991-01-01
% 223.99/224.15  |- rdf__type mesh__D013962sskos__Concept
% 223.99/224.15  |- skos__hiddenLabel mesh__D013962 Siccatum, Thyroideum
% 223.99/224.15  |- mesh__recordAuthorizer mesh__D013962 sjn
% 223.99/224.15  |- mesh__historyNote mesh__D013962
% 223.99/224.15       91%28%75%29%; was see under THYROID HORMONES 1975-90   
% 223.99/224.15  |- mesh__recordOriginator mesh__D013962 NLM
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013962 2004
% 223.99/224.15  |- mesh__dateRevised mesh__D013962 2001-07-25
% 223.99/224.15  |- skos__prefLabel mesh__D013962 Thyroid Gland, Desiccated
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013962 2002
% 223.99/224.15  |- mesh__dateCreated mesh__D013962 1999-01-01
% 223.99/224.15  |- mesh__dateCreated mesh__D013164 1980-04-09
% 223.99/224.15  |- mesh__recordMaintainer mesh__D013164 PXP
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013164 2001
% 223.99/224.15  |- skos__hiddenLabel mesh__D013164 Splenorenal Shunts
% 223.99/224.15  |- mesh__historyNote mesh__D013164
% 223.99/224.15       88%28%81%29%; was see under PORTASYSTEMIC SHUNT, SURGICAL 1981-87%A%  
% 223.99/224.15  |- mesh__dateRevised mesh__D013164 1997-06-20
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013164 2002
% 223.99/224.15  |- skos__hiddenLabel mesh__D013164 Splenorenal Shunts, Surgical
% 223.99/224.15  |- skos__historyNote mesh__D013164
% 223.99/224.15       Hypertension, Portal/surgery %28%1966-1980%29%
% 223.99/224.15  |- skos__hiddenLabel mesh__D013164 Surgical Splenorenal Shunts
% 223.99/224.15  |- mesh__recordOriginator mesh__D013164 RC
% 223.99/224.15  |- mesh__publicMeSHNote mesh__D013164
% 223.99/224.15       88; was see under PORTASYSTEMIC SHUNT, SURGICAL 1981-87   
% 223.99/224.15  |- skos__annotation mesh__D013164
% 223.99/224.15       do not use /util except by MeSH definition; DF: SPLENORENAL SHUNT%A%  
% 223.99/224.15  |- rdf__type mesh__D013164sskos__Concept
% 223.99/224.15  |- skos__historyNote mesh__D013164 Renal Veins/surgery %28%1966-1980%29%
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013164 2005
% 223.99/224.15  |- mesh__recordAuthorizer mesh__D013164 SJN
% 223.99/224.15  |- skos__scopeNote mesh__D013164
% 223.99/224.15       Anastomosis of splenic vein to renal vein to relieve portal hypertension.%A%    
% 223.99/224.15  |- skos__historyNote mesh__D013164 Splenic Vein/surgery %28%1966-1980%29%
% 223.99/224.15  |- skos__altLabel mesh__D013164 Shunt, Surgical Splenorenal
% 223.99/224.15  |- skos__broader mesh__D013164smesh__D011170
% 223.99/224.15  |- skos__hiddenLabel mesh__D013164 Shunts, Surgical Splenorenal
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013164 2003
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013164 1998
% 223.99/224.15  |- skos__historyNote mesh__D013164
% 223.99/224.15       Esophageal and Gastric Varices/surgery %28%1966-1980%29%
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013164 2006
% 223.99/224.15  |- skos__altLabel mesh__D013164 Splenorenal Shunt
% 223.99/224.15  |- skos__hiddenLabel mesh__D013164 Shunts, Splenorenal
% 223.99/224.15  |- skos__hiddenLabel mesh__D013164 Shunt, Splenorenal
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013164 2000
% 223.99/224.15  |- mesh__dateEstablished mesh__D013164 1988-01-01
% 223.99/224.15  |- skos__altLabel mesh__D013164 Surgical Splenorenal Shunt
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013164 2004
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D013164 1999
% 223.99/224.15  |- skos__prefLabel mesh__D013164 Splenorenal Shunt, Surgical
% 223.99/224.15  |- skos__hiddenLabel mesh__D007925 Leriches Syndrome
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D007925 2004
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D007925 1994
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D007925 1997
% 223.99/224.15  |- skos__hiddenLabel mesh__D007925 Leriche Syndrome
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D007925 2001
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D007925 2003
% 223.99/224.15  |- mesh__dateRevised mesh__D007925 1993-06-02
% 223.99/224.15  |- mesh__dateCreated mesh__D007925 1999-01-01
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D007925 1996
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D007925 2000
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D007925 2006
% 223.99/224.15  |- mesh__recordMaintainer mesh__D007925 TAP
% 223.99/224.15  |- skos__hiddenLabel mesh__D007925 Syndrome, Leriche%27%s
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D007925 1999
% 223.99/224.15  |- mesh__recordAuthorizer mesh__D007925 PLS
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D007925 2005
% 223.99/224.15  |- skos__prefLabel mesh__D007925 Leriche%27%s Syndrome
% 223.99/224.15  |- skos__annotation mesh__D007925 obstruction of terminal aorta   
% 223.99/224.15  |- skos__broader mesh__D007925smesh__D001018
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D007925 1998
% 223.99/224.15  |- rdf__type mesh__D007925sskos__Concept
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D007925 2002
% 223.99/224.15  |- skos__scopeNote mesh__D007925
% 223.99/224.15       A syndrome caused by obstruction of the terminal aorta. It usually occurs in males and is characterized by fatigue in the hips, thighs, or calves on exercising, absence of pulsation in the femoral arteries, impotence, and often pallor and coldness of the lower limbs. %28%From Dorland, 27th ed%29%%A%    
% 223.99/224.15  |- mesh__recordOriginator mesh__D007925 NLM
% 223.99/224.15  |- skos__broader mesh__D007925smesh__D001157
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D007925 1995
% 223.99/224.15  |- mesh__recordAuthorizer mesh__D007127 sjn
% 223.99/224.15  |- mesh__dateCreated mesh__D007127 1978-03-17
% 223.99/224.15  |- mesh__onlineNote mesh__D007127
% 223.99/224.15       use IMMUNOGLOBULIN CONSTANT REGION to search CONSTANT REGION, IG 1979-91%A%  
% 223.99/224.15  |- skos__prefLabel mesh__D007127 Immunoglobulin Constant Regions
% 223.99/224.15  |- mesh__dateEstablished mesh__D007127 1988-01-01
% 223.99/224.15  |- skos__altLabel mesh__D007127 Constant Region, Ig
% 223.99/224.15  |- rdf__type mesh__D007127sskos__Concept
% 223.99/224.15  |- mesh__dateRevised mesh__D007127 2005-06-30
% 223.99/224.15  |- skos__altLabel mesh__D007127 Immunoglobulin Constant Region
% 223.99/224.15  |- skos__annotation mesh__D007127 DF: IG CONSTANT REGION   
% 223.99/224.15  |- skos__hiddenLabel mesh__D007127 Constant Region, Immunoglobulin
% 223.99/224.15  |- skos__historyNote mesh__D007127
% 223.99/224.15       Immunoglobulin Allotypes %28%1975-1978%29%
% 223.99/224.15  |- skos__historyNote mesh__D007127 Immunoglobulins %28%1972-1978%29%
% 223.99/224.15  |- skos__historyNote mesh__D007127 Gamma Globulins %28%1966-1971%29%
% 223.99/224.15  |- skos__historyNote mesh__D007127 Immunoglobulins, Fc %28%1973%29%
% 223.99/224.15  |- mesh__historyNote mesh__D007127 2006 %28%1979%29%   
% 223.99/224.15  |- skos__historyNote mesh__D007127
% 223.99/224.15       specific immunoglobulin fragment %28%1973-1978%29%
% 223.99/224.15  |- mesh__publicMeSHNote mesh__D007127
% 223.99/224.15       2006; see IMMUNOGLOBULIN CONSTANT REGION 1988-2005, see IMMUNOGLOBULINS 1979-1987; for CONSTANT REGION IG see IMMUNOGLOBULIN CONSTANT REGION 1979-1991%A%  
% 223.99/224.15  |- mesh__recordMaintainer mesh__D007127 nns
% 223.99/224.15  |- skos__hiddenLabel mesh__D007127 Constant Regions, Immunoglobulin
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D007127 2006
% 223.99/224.15  |- skos__scopeNote mesh__D007127
% 223.99/224.15       The domains of the immunoglobulin molecules that are invariable in their amino acid sequence within any class or subclass of immunoglobulin. They confer biological as well as structural functions to immunoglobulins. One each on both the light chains and the heavy chains comprises the C-terminus half of the Fab fragment and two or three of them make up the rest of the heavy chains %28%all of the Fc fragment.%29%%A%    
% 223.99/224.15  |- skos__broader mesh__D007127smesh__D007136
% 223.99/224.15  |- mesh__recordOriginator mesh__D007127 SH
% 223.99/224.15  |- skos__broader mesh__D007127smesh__D007141
% 223.99/224.15  |- skos__prefLabel mesh__D045246 Ornithobacterium
% 223.99/224.15  |- skos__broader mesh__D045246smesh__D006090
% 223.99/224.15  |- mesh__dateCreated mesh__D045246 2003-07-09
% 223.99/224.15  |- mesh__activeMeSHYear mesh__D045246 2006
% 223.99/224.15  |- rdf__type mesh__D045246sskos__Concept
% 223.99/224.15  |- mesh__dateEstablished mesh__D045246 2004-01-01
% 223.99/224.15  |- mesh__publicMeSHNote mesh__D045246 2004   
% 223.99/224.15  |- mesh__recordOriginator mesh__D045246 ags
% 223.99/224.15  |- mesh__recordAuthorizer mesh__D045246 sjn
% 223.99/224.15  |- mesh__historyNote mesh__D045246 2004   
% 223.99/224.15  |- skos__scopeNote mesh__D045246
% 223.99/224.15       A genus of gram-negative, chemoorganotrophic bacteria, in the family FLAVOBACTERIACEAE. It is pathogenic in BIRDS.%A%    
% 223.99/224.15  |- skos__annotation mesh__D045246
% 223.99/224.15       infection: coord IM with FLAVOBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 223.99/224.15  |- mesh__dateRevised mesh__D045246 2005-06-30
% 223.99/224.16  |- mesh__recordMaintainer mesh__D045246 SYSTEM
% 223.99/224.16  |- skos__historyNote mesh__D045246 Gram-Negative Bacteria %28%1994-2003%29%
% 223.99/224.16  |- skos__broader mesh__D045246smesh__D041965
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D031226 2004
% 223.99/224.16  |- mesh__publicMeSHNote mesh__D031226 2003; see MUSTARD 1985-2002   
% 223.99/224.16  |- skos__prefLabel mesh__D031226 Sinapis
% 223.99/224.16  |- mesh__recordMaintainer mesh__D031226 sjn
% 223.99/224.16  |- rdf__type mesh__D031226sskos__Concept
% 223.99/224.16  |- mesh__dateCreated mesh__D031226 2002-07-03
% 223.99/224.16  |- skos__annotation mesh__D031226
% 223.99/224.16       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.99/224.16  |- skos__broader mesh__D031226smesh__D019607
% 223.99/224.16  |- skos__related mesh__D031226smesh__D009149
% 223.99/224.16  |- mesh__recordAuthorizer mesh__D031226 sjn
% 223.99/224.16  |- mesh__historyNote mesh__D031226 2003; use MUSTARD 1985-2002   
% 223.99/224.16  |- skos__historyNote mesh__D031226 Mustard %28%1985-2002%29%
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D031226 2005
% 223.99/224.16  |- mesh__dateRevised mesh__D031226 2003-07-25
% 223.99/224.16  |- skos__scopeNote mesh__D031226
% 223.99/224.16       A plant genus of the family BRASSICACEAE. The common name of white mustard sometimes refers to other plants %28%MUSTARD PLANT%29%.%A%    
% 223.99/224.16  |- mesh__dateEstablished mesh__D031226 2003-01-01
% 223.99/224.16  |- mesh__recordOriginator mesh__D031226 ssb
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D031226 2006
% 223.99/224.16  |- skos__scopeNote mesh__D050989
% 223.99/224.16       An essential GATA transcription factor that is expressed primarily in HEMATOPOIETIC STEM CELLS.%A%    
% 223.99/224.16  |- mesh__recordOriginator mesh__D050989 DRC
% 223.99/224.16  |- skos__altLabel mesh__D050989 NFE1B Erythroid Transcription Factor
% 223.99/224.16  |- mesh__dateEstablished mesh__D050989 2006-01-01
% 223.99/224.16  |- skos__broader mesh__D050989smesh__D050981
% 223.99/224.16  |- skos__altLabel mesh__D050989 Nuclear Factor-Erythroid 1B
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D050989 2006
% 223.99/224.16  |- skos__hiddenLabel mesh__D050989 GATA-2, Transcription Factor
% 223.99/224.16  |- mesh__dateCreated mesh__D050989 2005-06-30
% 223.99/224.16  |- mesh__recordAuthorizer mesh__D050989 sjn
% 223.99/224.16  |- skos__altLabel mesh__D050989 GATA-Binding Protein 2
% 223.99/224.16  |- mesh__publicMeSHNote mesh__D050989
% 223.99/224.16       2006; GATA2 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1991-2005%A%  
% 223.99/224.16  |- skos__hiddenLabel mesh__D050989 Transcription Factor GATA 2
% 223.99/224.16  |- rdf__type mesh__D050989sskos__Concept
% 223.99/224.16  |- skos__hiddenLabel mesh__D050989 Nuclear Factor Erythroid 1B
% 223.99/224.16  |- skos__broader mesh__D050989smesh__D050980
% 223.99/224.16  |- skos__altLabel mesh__D050989 Transcription Factor GATA-2
% 223.99/224.16  |- skos__prefLabel mesh__D050989 GATA2 Transcription Factor
% 223.99/224.16  |- skos__hiddenLabel mesh__D050989 GATA Binding Protein 2
% 223.99/224.16  |- mesh__recordMaintainer mesh__D050989 DRC
% 223.99/224.16  |- mesh__historyNote mesh__D050989 2006%28%1991%29%   
% 223.99/224.16  |- skos__hiddenLabel mesh__D050989 Transcription Factor, GATA2
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003535 2003
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003535 1999
% 223.99/224.16  |- skos__annotation mesh__D003535
% 223.99/224.16       an island republic in the eastern Mediterranean   
% 223.99/224.16  |- skos__scopeNote mesh__D003535
% 223.99/224.16       An island republic in the eastern Mediterranean Sea. Its capital is Nicosia. It was colonized by the Phoenicians and ancient Greeks and ruled successively by the Assyrian, Persian, Ptolemaic, Roman, and Byzantine Empires. It was under various countries from the 12th to the 20th century but became independent in 1960. The name comes from the Greek Kupros, probably representing the Sumerian kabar or gabar, copper, famous in historic times for its copper mines. The cypress tree is also named after the island. %28%From Webster%27%s New Geographical Dictionary, 1988, p308 %26% Room, Brewer%27%s Dictionary of Names, 1992, p134%29%%A%    
% 223.99/224.16  |- mesh__recordOriginator mesh__D003535 NLM
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003535 1998
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003535 2001
% 223.99/224.16  |- mesh__recordAuthorizer mesh__D003535 PLS
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003535 2006
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003535 2000
% 223.99/224.16  |- rdf__type mesh__D003535sskos__Concept
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003535 2005
% 223.99/224.16  |- skos__prefLabel mesh__D003535 Cyprus
% 223.99/224.16  |- mesh__dateRevised mesh__D003535 1995-05-31
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003535 1997
% 223.99/224.16  |- mesh__recordMaintainer mesh__D003535 TGC
% 223.99/224.16  |- mesh__dateCreated mesh__D003535 1999-01-01
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003535 1996
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003535 2002
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003535 2004
% 223.99/224.16  |- skos__broader mesh__D003535smesh__D008521
% 223.99/224.16  |- skos__scopeNote mesh__D008220
% 223.99/224.16       Radiographic study of the lymphatic system following injection of dye or contrast medium.%A%    
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D008220 2004
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D008220 2001
% 223.99/224.16  |- mesh__recordOriginator mesh__D008220 NLM
% 223.99/224.16  |- mesh__recordMaintainer mesh__D008220 PXP
% 223.99/224.16  |- skos__broader mesh__D008220smesh__D011859
% 223.99/224.16  |- mesh__dateRevised mesh__D008220 1997-06-20
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D008220 2002
% 223.99/224.16  |- mesh__dateEstablished mesh__D008220 1964-01-01
% 223.99/224.16  |- skos__hiddenLabel mesh__D008220 Lymphographies
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D008220 2005
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D008220 2006
% 223.99/224.16  |- skos__hiddenLabel mesh__D008220 Lymphangiographies
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D008220 1998
% 223.99/224.16  |- mesh__publicMeSHNote mesh__D008220 64   
% 223.99/224.16  |- skos__prefLabel mesh__D008220 Lymphography
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D008220 1999
% 223.99/224.16  |- mesh__historyNote mesh__D008220 64%28%63%29%   
% 223.99/224.16  |- rdf__type mesh__D008220sskos__Concept
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D008220 2000
% 223.99/224.16  |- skos__annotation mesh__D008220
% 223.99/224.16       NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: LYMPHOGR%A%  
% 223.99/224.16  |- mesh__recordAuthorizer mesh__D008220 SJN
% 223.99/224.16  |- mesh__dateCreated mesh__D008220 1999-01-01
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D008220 2003
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D027983 2004
% 223.99/224.16  |- skos__altLabel mesh__D027983 Spikenard
% 223.99/224.16  |- skos__scopeNote mesh__D027983
% 223.99/224.16       A plant genus in the family ARALIACEAE, order Apiales, subclass Rosidae. It includes Aralia californica S. Watson, Aralia nudicaulis L., and Aralia racemosa L.%A%    
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D027983 2006
% 223.99/224.16  |- skos__annotation mesh__D027983
% 223.99/224.16       do not confuse with Sarsaparilla = Smilax %28%use SMILACACEAE%29% or with East Indian Sarsaparilla = Hemidesmus %28%use ASCLEPIADACEAE%29%; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.99/224.16  |- skos__altLabel mesh__D027983 Sarsaparilla, Wild
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D027983 2002
% 223.99/224.16  |- mesh__historyNote mesh__D027983 2002   
% 223.99/224.16  |- skos__altLabel mesh__D027983 Wild Sarsaparilla
% 223.99/224.16  |- skos__prefLabel mesh__D027983 Aralia
% 223.99/224.16  |- rdf__type mesh__D027983sskos__Concept
% 223.99/224.16  |- mesh__dateCreated mesh__D027983 2001-07-25
% 223.99/224.16  |- skos__broader mesh__D027983smesh__D027481
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D027983 2003
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D027983 2005
% 223.99/224.16  |- mesh__dateEstablished mesh__D027983 2002-01-01
% 223.99/224.16  |- mesh__publicMeSHNote mesh__D027983 2002   
% 223.99/224.16  |- skos__scopeNote mesh__D013963
% 223.99/224.16       Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs.%A%    
% 223.99/224.16  |- skos__related mesh__D013963smesh__D006980
% 223.99/224.16  |- mesh__dateRevised mesh__D013963 2005-06-30
% 223.99/224.16  |- skos__broader mesh__D013963smesh__D006728
% 223.99/224.16  |- skos__related mesh__D013963smesh__D013954
% 223.99/224.16  |- skos__prefLabel mesh__D013963 Thyroid Hormones
% 223.99/224.16  |- skos__annotation mesh__D013963
% 223.99/224.16       general or unspecified: prefer specifics; T3 = TRIIODOTHYRONINE; T4 = THYROXINE; /defic: consider also HYPOTHYROIDISM%A%  
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D013963 2006
% 223.99/224.16  |- skos__related mesh__D013963smesh__D011988
% 223.99/224.16  |- rdf__type mesh__D013963sskos__Concept
% 223.99/224.16  |- mesh__recordOriginator mesh__D013963 NLM
% 223.99/224.16  |- mesh__recordAuthorizer mesh__D013963 sjn
% 223.99/224.16  |- mesh__recordMaintainer mesh__D013963 lkt
% 223.99/224.16  |- mesh__dateCreated mesh__D013963 1999-01-01
% 223.99/224.16  |- skos__related mesh__D013963smesh__D007037
% 223.99/224.16  |- skos__hiddenLabel mesh__D013963 Hormones, Thyroid
% 223.99/224.16  |- skos__broader mesh__D005154Q000293smesh__D005154
% 223.99/224.16  |- mesh__preferredCombination mesh__D005154Q000293smesh__D020220
% 223.99/224.16  |- rdf__type mesh__D005154Q000293smesh__CompoundConcept
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D013165 2000
% 223.99/224.16  |- skos__prefLabel mesh__D013165 Splints
% 223.99/224.16  |- mesh__recordMaintainer mesh__D013165 PXP
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D013165 2001
% 223.99/224.16  |- mesh__recordOriginator mesh__D013165 NLM
% 223.99/224.16  |- rdf__type mesh__D013165sskos__Concept
% 223.99/224.16  |- skos__scopeNote mesh__D013165
% 223.99/224.16       Rigid or flexible appliances used to maintain in position a displaced or movable part or to keep in place and protect an injured part. %28%Dorland, 28th ed%29%%A%    
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D013165 2005
% 223.99/224.16  |- mesh__dateRevised mesh__D013165 1997-06-20
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D013165 2002
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D013165 2003
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D013165 1998
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D013165 2006
% 223.99/224.16  |- skos__broader mesh__D013165smesh__D009984
% 223.99/224.16  |- mesh__dateCreated mesh__D013165 1999-01-01
% 223.99/224.16  |- skos__related mesh__D013165smesh__D015607
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D013165 2004
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D013165 1999
% 223.99/224.16  |- mesh__recordAuthorizer mesh__D013165 SJN
% 223.99/224.16  |- skos__hiddenLabel mesh__D013165 Splint
% 223.99/224.16  |- skos__broader mesh__D007926smesh__D011686
% 223.99/224.16  |- skos__hiddenLabel mesh__D007926
% 223.99/224.16       Disease, Hypoxanthine-Phosphoribosyl-Transferase Deficiency
% 223.99/224.16  |- skos__altLabel mesh__D007926 Deficiency Disease, Complete HGPRT
% 223.99/224.16  |- skos__altLabel mesh__D007926
% 223.99/224.16       Hypoxanthine-Phosphoribosyl-Transferase Deficiency Disease
% 223.99/224.16  |- skos__altLabel mesh__D007926 HGPRT Deficiency Disease, Complete
% 223.99/224.16  |- skos__historyNote mesh__D007926 Athetosis %28%1966-1970%29%
% 223.99/224.16  |- mesh__dateCreated mesh__D007926 1999-01-01
% 223.99/224.16  |- mesh__historyNote mesh__D007926 1973%28%1971%29%   
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D007926 2006
% 223.99/224.16  |- skos__hiddenLabel mesh__D007926 Lesch Nyhan Disease
% 223.99/224.16  |- mesh__recordOriginator mesh__D007926 NLM
% 223.99/224.16  |- skos__altLabel mesh__D007926
% 223.99/224.16       Choreoathetosis Self-Mutilation Hyperuricemia Syndrome
% 223.99/224.16  |- mesh__recordAuthorizer mesh__D007926 sjn
% 223.99/224.16  |- mesh__publicMeSHNote mesh__D007926 1973   
% 223.99/224.16  |- mesh__recordMaintainer mesh__D007926 nns
% 223.99/224.16  |- skos__hiddenLabel mesh__D007926
% 223.99/224.16       Hypoxanthine Phosphoribosyl Transferase Deficiency Disease
% 223.99/224.16  |- skos__altLabel mesh__D007926 Complete HGPRT Deficiency Disease
% 223.99/224.16  |- skos__hiddenLabel mesh__D007926
% 223.99/224.16       Hypoxanthine-Phosphoribosyl-Transferase Deficiency Diseases
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D007926 2003
% 223.99/224.16  |- rdf__type mesh__D007926sskos__Concept
% 223.99/224.16  |- skos__altLabel mesh__D007926 Lesch-Nyhan Disease
% 223.99/224.16  |- skos__broader mesh__D007926smesh__D020271
% 223.99/224.16  |- skos__historyNote mesh__D007926
% 223.99/224.16       Purine-Pyrimidine Metabolism, Inborn Errors %28%1966-1970%29%
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D007926 2004
% 223.99/224.16  |- skos__prefLabel mesh__D007926 Lesch-Nyhan Syndrome
% 223.99/224.16  |- skos__hiddenLabel mesh__D007926 Lesch Nyhan Syndrome
% 223.99/224.16  |- skos__historyNote mesh__D007926 Mental Retardation %28%1966-1970%29%
% 223.99/224.16  |- skos__hiddenLabel mesh__D007926
% 223.99/224.16       Deficiency Disease, Hypoxanthine Phosphoribosyl Transferase
% 223.99/224.16  |- skos__related mesh__D007926smesh__D007041
% 223.99/224.16  |- skos__hiddenLabel mesh__D007926
% 223.99/224.16       Deficiency Diseases, Hypoxanthine-Phosphoribosyl-Transferase
% 223.99/224.16  |- skos__hiddenLabel mesh__D007926 Disease, Lesch-Nyhan
% 223.99/224.16  |- skos__scopeNote mesh__D007926
% 223.99/224.16       An inherited disorder transmitted as a sex-linked trait and caused by a deficiency of an enzyme of purine metabolism; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE. Affected individuals are normal in the first year of life and then develop psychomotor retardation, extrapyramidal movement disorders, progressive spasticity, and seizures. Self-destructive behaviors such as biting of fingers and lips are seen frequently. Intellectual impairment may also occur but is typically not severe. Elevation of uric acid in the serum leads to the development of renal calculi and gouty arthritis. %28%Menkes, Textbook of Child Neurology, 5th ed, pp127%29%%A%    
% 223.99/224.16  |- skos__broader mesh__D007926smesh__D020739
% 223.99/224.16  |- mesh__dateRevised mesh__D007926 2002-07-03
% 223.99/224.16  |- skos__altLabel mesh__D007926
% 223.99/224.16       Deficiency Disease, Hypoxanthine-Phosphoribosyl-Transferase
% 223.99/224.16  |- skos__broader mesh__D007926smesh__D038901
% 223.99/224.16  |- mesh__dateEstablished mesh__D007926 1973-01-01
% 223.99/224.16  |- skos__hiddenLabel mesh__D007926
% 223.99/224.16       Choreoathetosis Self Mutilation Hyperuricemia Syndrome
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D007926 2005
% 223.99/224.16  |- skos__hiddenLabel mesh__D007926
% 223.99/224.16       Diseases, Hypoxanthine-Phosphoribosyl-Transferase Deficiency
% 223.99/224.16  |- skos__historyNote mesh__D007926 Self Mutilation %28%1966-1970%29%
% 223.99/224.16  |- skos__broader mesh__D001158Q000530smesh__D001158
% 223.99/224.16  |- mesh__preferredCombination mesh__D001158Q000530smesh__D000792
% 223.99/224.16  |- rdf__type mesh__D001158Q000530smesh__CompoundConcept
% 223.99/224.16  |- mesh__recordMaintainer mesh__D007128 nns
% 223.99/224.16  |- rdf__type mesh__D007128sskos__Concept
% 223.99/224.16  |- skos__prefLabel mesh__D007128 Immunoglobulin Fragments
% 223.99/224.16  |- mesh__recordAuthorizer mesh__D007128 sjn
% 223.99/224.16  |- skos__historyNote mesh__D007128 Immunoglobulins %28%1970-1972%29%
% 223.99/224.16  |- skos__hiddenLabel mesh__D007128 Fragments, Immunoglobulin
% 223.99/224.16  |- mesh__recordOriginator mesh__D007128 NLM
% 223.99/224.16  |- skos__scopeNote mesh__D007128
% 223.99/224.16       Partial immunoglobulin molecules resulting from selective cleavage by proteolytic enzymes or generated through PROTEIN ENGINEERING techniques.%A%    
% 223.99/224.16  |- mesh__publicMeSHNote mesh__D007128
% 223.99/224.16       73; IMMUNOGLOBULINS, FC %26% IMMUNOGLOBULINS, FD were headings 1973-83%A%  
% 223.99/224.16  |- mesh__dateRevised mesh__D007128 2005-06-30
% 223.99/224.16  |- mesh__dateEstablished mesh__D007128 1973-01-01
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D007128 2006
% 223.99/224.16  |- skos__annotation mesh__D007128 DF: IG FRAGMENTS   
% 223.99/224.16  |- skos__broader mesh__D007128smesh__D007136
% 223.99/224.16  |- mesh__historyNote mesh__D007128 73   
% 223.99/224.16  |- mesh__dateCreated mesh__D007128 1999-01-01
% 223.99/224.16  |- mesh__historyNote mesh__D045247
% 223.99/224.16       2004; for FLAVOBACTERIUM MENINGOSEPTICUM use FLAVOBACTERIUM 1992-2003%A%  
% 223.99/224.16  |- skos__scopeNote mesh__D045247
% 223.99/224.16       A genus of aerobic, gram-negative bacteria in the family FLAVOBACTERIACEAE. Many of its species were formerly in the genus FLAVOBACTERIUM.%A%    
% 223.99/224.16  |- rdf__type mesh__D045247sskos__Concept
% 223.99/224.16  |- mesh__dateCreated mesh__D045247 2003-07-09
% 223.99/224.16  |- skos__historyNote mesh__D045247 Flavobacterium %28%1996-2003%29%
% 223.99/224.16  |- skos__altLabel mesh__D045247 Flavobacterium meningosepticum
% 223.99/224.16  |- mesh__publicMeSHNote mesh__D045247
% 223.99/224.16       2004; for FLAVOBACTERIUM MENINGOSEPTICUM see FLAVOBACTERIUM 1992-2003%A%  
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D045247 2006
% 223.99/224.16  |- skos__prefLabel mesh__D045247 Chryseobacterium
% 223.99/224.16  |- mesh__recordAuthorizer mesh__D045247 sjn
% 223.99/224.16  |- mesh__dateEstablished mesh__D045247 2004-01-01
% 223.99/224.16  |- mesh__recordOriginator mesh__D045247 ags
% 223.99/224.16  |- skos__annotation mesh__D045247
% 223.99/224.16       infection: coord IM with FLAVOBACTERIACEAE INFECTIONS %28%IM%29%%A%  
% 223.99/224.16  |- mesh__dateRevised mesh__D045247 2005-06-30
% 223.99/224.16  |- skos__broader mesh__D045247smesh__D041965
% 223.99/224.16  |- mesh__recordMaintainer mesh__D045247 SYSTEM
% 223.99/224.16  |- skos__hiddenLabel mesh__D017556 Compounds, Technetium
% 223.99/224.16  |- mesh__recordOriginator mesh__D017556 TPW
% 223.99/224.16  |- mesh__dateEstablished mesh__D017556 1994-01-01
% 223.99/224.16  |- mesh__historyNote mesh__D017556 94   
% 223.99/224.16  |- skos__annotation mesh__D017556
% 223.99/224.16       GEN or unspecified; prefer specifics; DF: TECHNETIUM CPDS%A%  
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D017556 2005
% 223.99/224.16  |- skos__prefLabel mesh__D017556 Technetium Compounds
% 223.99/224.16  |- skos__historyNote mesh__D017556 Technetium %28%1966-1993%29%
% 223.99/224.16  |- rdf__type mesh__D017556sskos__Concept
% 223.99/224.16  |- mesh__dateRevised mesh__D017556 2002-07-03
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D017556 2006
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D017556 2003
% 223.99/224.16  |- mesh__recordAuthorizer mesh__D017556 sjn
% 223.99/224.16  |- skos__broader mesh__D017556smesh__D007287
% 223.99/224.16  |- mesh__publicMeSHNote mesh__D017556 94   
% 223.99/224.16  |- skos__scopeNote mesh__D017556
% 223.99/224.16       Inorganic compounds that contain TECHNETIUM as an integral part of the molecule. Technetium 99m %28%m=metastable%29% is an isotope of technetium that has a half-life of about 6 hours. Technetium 99, which has a half-life of 210,000 years, is a decay product of technetium 99m.%A%    
% 223.99/224.16  |- mesh__recordMaintainer mesh__D017556 nns
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D017556 2004
% 223.99/224.16  |- mesh__dateCreated mesh__D017556 1993-06-04
% 223.99/224.16  |- skos__prefLabel mesh__D031227 Thlaspi
% 223.99/224.16  |- mesh__dateEstablished mesh__D031227 2003-01-01
% 223.99/224.16  |- skos__scopeNote mesh__D031227
% 223.99/224.16       A plant genus of the family BRASSICACEAE that is grown in rock gardens. T. arvense is grown for its large, round ornamental seed pods. The common name of pennycress usually refers to this genus but may also refer to the genus Microthlaspi.%A%    
% 223.99/224.16  |- rdf__type mesh__D031227sskos__Concept
% 223.99/224.16  |- skos__annotation mesh__D031227
% 223.99/224.16       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.99/224.16  |- mesh__publicMeSHNote mesh__D031227 2003   
% 223.99/224.16  |- mesh__historyNote mesh__D031227 2003   
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D031227 2005
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D031227 2003
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D031227 2006
% 223.99/224.16  |- mesh__dateCreated mesh__D031227 2002-07-03
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D031227 2004
% 223.99/224.16  |- skos__broader mesh__D031227smesh__D019607
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003536 1999
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003536 2005
% 223.99/224.16  |- skos__prefLabel mesh__D003536 Cystadenocarcinoma
% 223.99/224.16  |- mesh__recordAuthorizer mesh__D003536 PLS
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003536 2006
% 223.99/224.16  |- mesh__dateRevised mesh__D003536 1995-06-08
% 223.99/224.16  |- mesh__dateCreated mesh__D003536 1999-01-01
% 223.99/224.16  |- skos__annotation mesh__D003536
% 223.99/224.16       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003536 1996
% 223.99/224.16  |- skos__scopeNote mesh__D003536
% 223.99/224.16       A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. %28%Stedman, 25th ed%29%%A%    
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003536 2000
% 223.99/224.16  |- rdf__type mesh__D003536sskos__Concept
% 223.99/224.16  |- mesh__recordOriginator mesh__D003536 NLM
% 223.99/224.16  |- skos__broader mesh__D003536smesh__D018297
% 223.99/224.16  |- skos__hiddenLabel mesh__D003536 Cystadenocarcinomas
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003536 1997
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003536 2001
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003536 2003
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003536 1998
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003536 2002
% 223.99/224.16  |- skos__broader mesh__D003536smesh__D000230
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D003536 2004
% 223.99/224.16  |- mesh__recordMaintainer mesh__D003536 KEV
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D008221 2005
% 223.99/224.16  |- skos__prefLabel mesh__D008221 Lymphoid Tissue
% 223.99/224.16  |- skos__hiddenLabel mesh__D008221 Lymphoid Tissues
% 223.99/224.16  |- skos__broader mesh__D008221smesh__D008208
% 223.99/224.16  |- skos__hiddenLabel mesh__D008221 Tissue, Lymphoid
% 223.99/224.16  |- mesh__recordAuthorizer mesh__D008221 sjn
% 223.99/224.16  |- mesh__recordOriginator mesh__D008221 NLM
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D008221 2006
% 223.99/224.16  |- skos__hiddenLabel mesh__D008221 Lymphatic Tissues
% 223.99/224.16  |- skos__hiddenLabel mesh__D008221 Tissues, Lymphatic
% 223.99/224.16  |- mesh__recordMaintainer mesh__D008221 jmp
% 223.99/224.16  |- mesh__dateRevised mesh__D008221 2003-07-09
% 223.99/224.16  |- skos__annotation mesh__D008221
% 223.99/224.16       /radiogr permitted: not necessarily LYMPHOGRAPHY   
% 223.99/224.16  |- rdf__type mesh__D008221sskos__Concept
% 223.99/224.16  |- skos__broader mesh__D008221smesh__D014024
% 223.99/224.16  |- mesh__dateCreated mesh__D008221 1999-01-01
% 223.99/224.16  |- skos__hiddenLabel mesh__D008221 Tissues, Lymphoid
% 223.99/224.16  |- skos__altLabel mesh__D008221 Lymphatic Tissue
% 223.99/224.16  |- skos__hiddenLabel mesh__D008221 Tissue, Lymphatic
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D008221 2004
% 223.99/224.16  |- skos__scopeNote mesh__D008221
% 223.99/224.16       Specialized tissues that are components of the lymphatic system. They provide fixed locations within the body where a variety of LYMPHOCYTES can form, mature and multiply. The lymphoid tissues are connected by a network of LYMPHATIC VESSELS.%A%    
% 223.99/224.16  |- skos__hiddenLabel mesh__D013964 Thyroid Neoplasm
% 223.99/224.16  |- skos__scopeNote mesh__D013964
% 223.99/224.16       Tumors or cancer of the THYROID GLAND.     
% 223.99/224.16  |- skos__hiddenLabel mesh__D013964 Adenoma, Thyroid
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D013964 2006
% 223.99/224.16  |- skos__broader mesh__D013964smesh__D004701
% 223.99/224.16  |- mesh__dateRevised mesh__D013964 2005-06-30
% 223.99/224.16  |- rdf__type mesh__D013964sskos__Concept
% 223.99/224.16  |- skos__broader mesh__D013964smesh__D006258
% 223.99/224.16  |- skos__prefLabel mesh__D013964 Thyroid Neoplasms
% 223.99/224.16  |- skos__altLabel mesh__D013964 Cancer of Thyroid
% 223.99/224.16  |- skos__broader mesh__D013964smesh__D013959
% 223.99/224.16  |- mesh__dateCreated mesh__D013964 1999-01-01
% 223.99/224.16  |- skos__altLabel mesh__D013964 Neoplasms, Thyroid
% 223.99/224.16  |- skos__annotation mesh__D013964
% 223.99/224.16       coordinate IM with histological type of neoplasm %28%IM%29%; THYROID NODULE is also available%A%  
% 223.99/224.16  |- mesh__recordOriginator mesh__D013964 NLM
% 223.99/224.16  |- mesh__recordAuthorizer mesh__D013964 sjn
% 223.99/224.16  |- skos__altLabel mesh__D013964 Thyroid Cancer
% 223.99/224.16  |- mesh__recordMaintainer mesh__D013964 lkt
% 223.99/224.16  |- skos__hiddenLabel mesh__D013964 Neoplasm, Thyroid
% 223.99/224.16  |- skos__altLabel mesh__D013964 Cancer of the Thyroid
% 223.99/224.16  |- skos__hiddenLabel mesh__D013964 Cancer, Thyroid
% 223.99/224.16  |- skos__hiddenLabel mesh__D013964 Carcinoma, Thyroid
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D013166 2005
% 223.99/224.16  |- skos__annotation mesh__D013166
% 223.99/224.16       coord IM with specific vertebrae %28%IM%29%; do not confuse with SPONDYLOSIS see SPINAL OSTEOPHYTOSIS%A%  
% 223.99/224.16  |- mesh__recordAuthorizer mesh__D013166 sjn
% 223.99/224.16  |- mesh__recordMaintainer mesh__D013166 ags
% 223.99/224.16  |- mesh__dateRevised mesh__D013166 2002-07-03
% 223.99/224.16  |- skos__broader mesh__D013166smesh__D013122
% 223.99/224.16  |- skos__scopeNote mesh__D013166
% 223.99/224.16       Inflammation of the vertebrae. This includes both arthritic and non-arthritic conditions.%A%    
% 223.99/224.16  |- skos__broader mesh__D013166smesh__D001850
% 223.99/224.16  |- mesh__dateCreated mesh__D013166 1999-01-01
% 223.99/224.16  |- mesh__recordOriginator mesh__D013166 NLM
% 223.99/224.16  |- rdf__type mesh__D013166sskos__Concept
% 223.99/224.16  |- skos__prefLabel mesh__D013166 Spondylitis
% 223.99/224.16  |- skos__hiddenLabel mesh__D013166 Spondylitides
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D013166 2004
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D013166 2006
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D013166 2003
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D007927 1999
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D007927 2005
% 223.99/224.16  |- mesh__recordMaintainer mesh__D007927 TGC
% 223.99/224.16  |- rdf__type mesh__D007927sskos__Concept
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D007927 1998
% 223.99/224.16  |- mesh__recordAuthorizer mesh__D007927 PLS
% 223.99/224.16  |- skos__annotation mesh__D007927
% 223.99/224.16       a kingdom lying within the republic of SOUTH AFRICA   
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D007927 2002
% 223.99/224.16  |- mesh__dateRevised mesh__D007927 1995-02-21
% 223.99/224.16  |- skos__broader mesh__D007927smesh__D000353
% 223.99/224.16  |- mesh__recordOriginator mesh__D007927 NLM
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D007927 2004
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D007927 1997
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D007927 2003
% 223.99/224.16  |- mesh__dateCreated mesh__D007927 1999-01-01
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D007927 1996
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D007927 2001
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D007927 2006
% 223.99/224.16  |- skos__altLabel mesh__D007927 Basutoland
% 223.99/224.16  |- skos__scopeNote mesh__D007927
% 223.99/224.16       A kingdom in southern Africa, an enclave lying within the republic of SOUTH AFRICA. Its capital is Maseru. It was mostly uninhabited before 1800. In the early 19th century it had many disputes with the Boers. First receiving British protection in 1843, it was annexed in 1868 and made part of Cape Colony in 1871. It became a British colony in 1884 and gained independence in 1966. Sotho is the name of the indigenous people, probably meaning black. The plural is Basotho which gave the former name Basutoland. %28%From Webster%27%s New Geographical Dictionary, 1988, p664 %26% Room, Brewer%27%s Dictionary of Names, 1992, p304%29%%A%    
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D007927 2000
% 223.99/224.16  |- skos__prefLabel mesh__D007927 Lesotho
% 223.99/224.16  |- skos__broader mesh__D007129smesh__D007142
% 223.99/224.16  |- skos__hiddenLabel mesh__D007129 Gm Allotype, Immunoglobulin
% 223.99/224.16  |- skos__scopeNote mesh__D007129
% 223.99/224.16       Allelic variants of the gamma-immunoglobulin heavy chain %28%IMMUNOGLOBULIN GAMMA-CHAINS%29% encoded by ALLELES of IMMUNOGLOBULIN HEAVY CHAIN GENES.%A%    
% 223.99/224.16  |- skos__hiddenLabel mesh__D007129 Allotype, Gm
% 223.99/224.16  |- mesh__historyNote mesh__D007129 87   
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D007129 2006
% 223.99/224.16  |- mesh__recordOriginator mesh__D007129 SCD
% 223.99/224.16  |- skos__broader mesh__D007129smesh__D007126
% 223.99/224.16  |- skos__hiddenLabel mesh__D007129 Immunoglobulin Gm Allotype
% 223.99/224.16  |- skos__prefLabel mesh__D007129 Immunoglobulin Gm Allotypes
% 223.99/224.16  |- skos__hiddenLabel mesh__D007129 Allotypes, Gm
% 223.99/224.16  |- skos__altLabel mesh__D007129 Gm Allotypes
% 223.99/224.16  |- mesh__dateEstablished mesh__D007129 1987-01-01
% 223.99/224.16  |- skos__related mesh__D007129smesh__D005803
% 223.99/224.16  |- mesh__dateCreated mesh__D007129 1986-06-19
% 223.99/224.16  |- mesh__recordAuthorizer mesh__D007129 sjn
% 223.99/224.16  |- rdf__type mesh__D007129sskos__Concept
% 223.99/224.16  |- skos__historyNote mesh__D007129 Alleles %28%1968-1974%29%
% 223.99/224.16  |- mesh__dateRevised mesh__D007129 2005-07-01
% 223.99/224.16  |- skos__historyNote mesh__D007129 IgG %28%1971-1986%29%
% 223.99/224.16  |- mesh__publicMeSHNote mesh__D007129 87   
% 223.99/224.16  |- skos__hiddenLabel mesh__D007129 Gm Allotype
% 223.99/224.16  |- skos__hiddenLabel mesh__D007129 Gm Allotypes, Immunoglobulin
% 223.99/224.16  |- mesh__recordMaintainer mesh__D007129 sjn
% 223.99/224.16  |- skos__hiddenLabel mesh__D007129 Allotype, Immunoglobulin Gm
% 223.99/224.16  |- skos__historyNote mesh__D007129
% 223.99/224.16       Immunoglobulin Allotypes %28%1975-1986%29%
% 223.99/224.16  |- skos__altLabel mesh__D007129 Allotypes, Immunoglobulin Gm
% 223.99/224.16  |- mesh__historyNote mesh__D045248 2004   
% 223.99/224.16  |- rdf__type mesh__D045248sskos__Concept
% 223.99/224.16  |- mesh__dateCreated mesh__D045248 2003-07-09
% 223.99/224.16  |- mesh__dateRevised mesh__D045248 2005-06-30
% 223.99/224.16  |- skos__prefLabel mesh__D045248 Flexibacter
% 223.99/224.16  |- skos__scopeNote mesh__D045248
% 223.99/224.16       A genus of gram-negative, chemoorganotrophic bacteria in the family Flexibacteraceae. In some species there is a cyclic change in cell morphology.%A%    
% 223.99/224.16  |- mesh__activeMeSHYear mesh__D045248 2006
% 223.99/224.16  |- mesh__publicMeSHNote mesh__D045248 2004   
% 223.99/224.16  |- skos__broader mesh__D045248smesh__D041964
% 223.99/224.16  |- skos__historyNote mesh__D045248 Cytophaga %28%1974-2003%29%
% 223.99/224.17  |- skos__historyNote mesh__D045248 Bacteroidetes %28%1978-2003%29%
% 223.99/224.17  |- skos__annotation mesh__D045248
% 223.99/224.17       infection: coord IM with FLEXIBACTERACEAE INFECTIONS %28%IM%29%%A%  
% 223.99/224.17  |- mesh__recordAuthorizer mesh__D045248 sjn
% 223.99/224.17  |- mesh__dateEstablished mesh__D045248 2004-01-01
% 223.99/224.17  |- mesh__recordMaintainer mesh__D045248 SYSTEM
% 223.99/224.17  |- mesh__recordOriginator mesh__D045248 ags
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D017557 2001
% 223.99/224.17  |- mesh__historyNote mesh__D017557 94   
% 223.99/224.17  |- skos__annotation mesh__D017557 a region in the mesencephalon   
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D017557 2005
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D017557 2002
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D017557 1994
% 223.99/224.17  |- mesh__dateCreated mesh__D017557 1992-12-28
% 223.99/224.17  |- skos__prefLabel mesh__D017557 Ventral Tegmental Area
% 223.99/224.17  |- rdf__type mesh__D017557sskos__Concept
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D017557 2006
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D017557 1995
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D017557 2003
% 223.99/224.17  |- mesh__dateEstablished mesh__D017557 1994-01-01
% 223.99/224.17  |- skos__historyNote mesh__D017557 Tegmentum Mesencephali %28%1971-1993%29%
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D017557 2004
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D017557 1998
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D017557 1999
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D017557 1996
% 223.99/224.17  |- skos__broader mesh__D017557smesh__D013681
% 223.99/224.17  |- skos__historyNote mesh__D017557 Mesencephalon %28%1968-1970%29%
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D017557 2000
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D017557 1997
% 223.99/224.17  |- mesh__publicMeSHNote mesh__D017557 94   
% 223.99/224.17  |- skos__hiddenLabel mesh__D017557 Tegmental Area, Ventral
% 223.99/224.17  |- skos__scopeNote mesh__D017557
% 223.99/224.17       A region in the mesencephalon which is dorsomedial to the substantia nigra and ventral to the red nucleus. The mesocortical and mesolimbic dopaminergic systems originate here, including an important projection to the nucleus accumbens. Overactivity of the cells in this area has been suspected to contribute to the positive symptoms of schizophrenia.%A%    
% 223.99/224.17  |- skos__scopeNote mesh__D031228
% 223.99/224.17       A plant genus of the family BRASSICACEAE used for its hot peppery root.%A%    
% 223.99/224.17  |- mesh__publicMeSHNote mesh__D031228 2003   
% 223.99/224.17  |- mesh__dateCreated mesh__D031228 2002-07-03
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D031228 2005
% 223.99/224.17  |- skos__broader mesh__D031228smesh__D019607
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D031228 2003
% 223.99/224.17  |- mesh__dateEstablished mesh__D031228 2003-01-01
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D031228 2006
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D031228 2004
% 223.99/224.17  |- skos__prefLabel mesh__D031228 Wasabia
% 223.99/224.17  |- skos__annotation mesh__D031228
% 223.99/224.17       HORSERADISH see ARMORACIA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.99/224.17  |- rdf__type mesh__D031228sskos__Concept
% 223.99/224.17  |- skos__altLabel mesh__D031228 Horseradish, Japanese
% 223.99/224.17  |- mesh__historyNote mesh__D031228 2003   
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D003537 2002
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D003537 2006
% 223.99/224.17  |- mesh__dateRevised mesh__D003537 1995-06-08
% 223.99/224.17  |- mesh__dateCreated mesh__D003537 1999-01-01
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D003537 1996
% 223.99/224.17  |- skos__hiddenLabel mesh__D003537 Cystadenomas
% 223.99/224.17  |- rdf__type mesh__D003537sskos__Concept
% 223.99/224.17  |- skos__broader mesh__D003537smesh__D000236
% 223.99/224.17  |- skos__annotation mesh__D003537
% 223.99/224.17       /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D003537 1997
% 223.99/224.17  |- skos__scopeNote mesh__D003537
% 223.99/224.17       A benign neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. In some instances, considerable portions of the neoplasm, or even the entire mass, may be cystic. %28%Stedman, 25th ed%29%%A%    
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D003537 2003
% 223.99/224.17  |- mesh__recordAuthorizer mesh__D003537 PLS
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D003537 2000
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D003537 1998
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D003537 2004
% 223.99/224.17  |- mesh__recordMaintainer mesh__D003537 KEV
% 223.99/224.17  |- mesh__recordOriginator mesh__D003537 NLM
% 223.99/224.17  |- skos__broader mesh__D003537smesh__D018297
% 223.99/224.17  |- skos__prefLabel mesh__D003537 Cystadenoma
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D003537 2001
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D003537 1999
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D003537 2005
% 223.99/224.17  |- skos__altLabel mesh__D008222 Lymphocyte Mediators
% 223.99/224.17  |- rdf__type mesh__D008222sskos__Concept
% 223.99/224.17  |- skos__related mesh__D008222smesh__D007111
% 223.99/224.17  |- mesh__historyNote mesh__D008222 74   
% 223.99/224.17  |- skos__scopeNote mesh__D008222
% 223.99/224.17       Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity.%A%    
% 223.99/224.17  |- mesh__dateCreated mesh__D008222 1999-01-01
% 223.99/224.17  |- skos__hiddenLabel mesh__D008222 Mediators, Lymphocyte
% 223.99/224.17  |- skos__broader mesh__D008222smesh__D016207
% 223.99/224.17  |- mesh__publicMeSHNote mesh__D008222 74   
% 223.99/224.17  |- mesh__dateEstablished mesh__D008222 1974-01-01
% 223.99/224.17  |- mesh__dateRevised mesh__D008222 2005-06-30
% 223.99/224.17  |- mesh__recordMaintainer mesh__D008222 ssb
% 223.99/224.17  |- skos__prefLabel mesh__D008222 Lymphokines
% 223.99/224.17  |- mesh__recordOriginator mesh__D008222 NLM
% 223.99/224.17  |- mesh__recordAuthorizer mesh__D008222 sjn
% 223.99/224.17  |- skos__annotation mesh__D008222
% 223.99/224.17       /biosyn /drug eff /physiol /ultrastruct permitted   
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D008222 2006
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D013965 1998
% 223.99/224.17  |- mesh__recordOriginator mesh__D013965 NLM
% 223.99/224.17  |- mesh__dateRevised mesh__D013965 1997-06-20
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D013965 2004
% 223.99/224.17  |- mesh__dateCreated mesh__D013965 1999-01-01
% 223.99/224.17  |- skos__hiddenLabel mesh__D013965 Thyroidectomies
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D013965 1999
% 223.99/224.17  |- mesh__recordAuthorizer mesh__D013965 SJN
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D013965 2002
% 223.99/224.17  |- skos__prefLabel mesh__D013965 Thyroidectomy
% 223.99/224.17  |- mesh__recordMaintainer mesh__D013965 PXP
% 223.99/224.17  |- skos__scopeNote mesh__D013965
% 223.99/224.17       Surgical removal of the thyroid gland. %28%Dorland, 28th ed%29%%A%    
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D013965 2005
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D013965 2000
% 223.99/224.17  |- skos__annotation mesh__D013965
% 223.99/224.17       do not use /util except by MeSH definition   
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D013965 2006
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D013965 2001
% 223.99/224.17  |- rdf__type mesh__D013965sskos__Concept
% 223.99/224.17  |- skos__broader mesh__D013965smesh__D013507
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D013965 2003
% 223.99/224.17  |- skos__annotation mesh__D013167
% 223.99/224.17       coord IM with specific vertebrae %28%IM%29%   
% 223.99/224.17  |- skos__hiddenLabel mesh__D013167 Rheumatoid Spondylitides
% 223.99/224.17  |- skos__hiddenLabel mesh__D013167 Disease, Bechterew
% 223.99/224.17  |- skos__hiddenLabel mesh__D013167 Spondylitides, Ankylosing
% 223.99/224.17  |- mesh__recordMaintainer mesh__D013167 ags
% 223.99/224.17  |- skos__hiddenLabel mesh__D013167 Ankylosing Spondylitides
% 223.99/224.17  |- skos__altLabel mesh__D013167 Spondylarthritis Ankylopoietica
% 223.99/224.17  |- skos__altLabel mesh__D013167 Bechterew%27%s Disease
% 223.99/224.17  |- skos__broader mesh__D013167smesh__D001172
% 223.99/224.17  |- skos__scopeNote mesh__D013167
% 223.99/224.17       The form of rheumatoid arthritis affecting the spine. It occurs predominantly in young males and produces pain and stiffness as a result of inflammation of the sacroiliac, intervertebral, and costovertebral joints. Etiology is unknown.%A%    
% 223.99/224.17  |- skos__hiddenLabel mesh__D013167 Spondylitis, Rheumatoid
% 223.99/224.17  |- skos__hiddenLabel mesh__D013167 Disease, Marie-Struempell
% 223.99/224.17  |- mesh__dateCreated mesh__D013167 1999-01-01
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D013167 2002
% 223.99/224.17  |- mesh__recordAuthorizer mesh__D013167 sjn
% 223.99/224.17  |- skos__prefLabel mesh__D013167 Spondylitis, Ankylosing
% 223.99/224.17  |- skos__broader mesh__D013167smesh__D025242
% 223.99/224.17  |- rdf__type mesh__D013167sskos__Concept
% 223.99/224.17  |- skos__altLabel mesh__D013167 Rheumatoid Spondylitis
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D013167 2004
% 223.99/224.17  |- skos__hiddenLabel mesh__D013167 Disease, Bechterew%27%s
% 223.99/224.17  |- skos__altLabel mesh__D013167 Marie-Struempell Disease
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D013167 2006
% 223.99/224.17  |- mesh__dateRevised mesh__D013167 2001-07-25
% 223.99/224.17  |- skos__hiddenLabel mesh__D013167 Marie Struempell Disease
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D013167 2003
% 223.99/224.17  |- skos__hiddenLabel mesh__D013167 Bechterews Disease
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D013167 2005
% 223.99/224.17  |- skos__hiddenLabel mesh__D013167 Ankylosing Spondylitis
% 223.99/224.17  |- mesh__recordOriginator mesh__D013167 NLM
% 223.99/224.17  |- skos__hiddenLabel mesh__D013167 Spondylitides, Rheumatoid
% 223.99/224.17  |- skos__broader mesh__D013167smesh__D000844
% 223.99/224.17  |- skos__altLabel mesh__D013167 Bechterew Disease
% 223.99/224.17  |- skos__broader mesh__D013167smesh__D013166
% 223.99/224.17  |- mesh__dateEstablished mesh__D007928 1976-01-01
% 223.99/224.17  |- mesh__recordAuthorizer mesh__D007928 sjn
% 223.99/224.17  |- mesh__historyNote mesh__D007928
% 223.99/224.17       76%28%71%29%; was see under TOXICOLOGY 1975   
% 223.99/224.17  |- skos__hiddenLabel mesh__D007928 Dose 50, Lethal
% 223.99/224.17  |- rdf__type mesh__D007928sskos__Concept
% 223.99/224.17  |- skos__prefLabel mesh__D007928 Lethal Dose 50
% 223.99/224.17  |- skos__broader mesh__D007928smesh__D002620
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D007928 2001
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D007928 2003
% 223.99/224.17  |- mesh__dateCreated mesh__D007928 1999-01-01
% 223.99/224.17  |- skos__altLabel mesh__D007928 LD50
% 223.99/224.17  |- mesh__publicMeSHNote mesh__D007928 76; was see under TOXICOLOGY 1975   
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D007928 2002
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D007928 2004
% 223.99/224.17  |- skos__historyNote mesh__D007928 specific drug/toxicity %28%1966-1970%29%
% 223.99/224.17  |- skos__annotation mesh__D007928
% 223.99/224.17       almost never IM; do not coord with /mortal in exper studies; DF: LD 50 or LD50%A%  
% 223.99/224.17  |- skos__scopeNote mesh__D007928
% 223.99/224.17       The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50%25% of the tested population.%A%    
% 223.99/224.17  |- mesh__dateRevised mesh__D007928 2000-06-22
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D007928 2005
% 223.99/224.17  |- skos__broader mesh__D007928smesh__D018675
% 223.99/224.17  |- mesh__recordMaintainer mesh__D007928 adp
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D007928 2006
% 223.99/224.17  |- mesh__recordOriginator mesh__D007928 NLM
% 223.99/224.17  |- mesh__recordOriginator mesh__D018650 TPW
% 223.99/224.17  |- mesh__recordAuthorizer mesh__D018650 ags
% 223.99/224.17  |- rdf__type mesh__D018650sskos__Concept
% 223.99/224.17  |- mesh__dateEstablished mesh__D018650 1995-01-01
% 223.99/224.17  |- mesh__dateRevised mesh__D018650 2005-07-14
% 223.99/224.17  |- mesh__publicMeSHNote mesh__D018650
% 223.99/224.17       95; ARNICA was indexed under PLANT EXTRACTS 1985-94   
% 223.99/224.17  |- skos__annotation mesh__D018650
% 223.99/224.17       for Traumeel or homeopathic or 30x dilution coord with HOMEOPATHY %28%IM%29%;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.99/224.17  |- skos__broader mesh__D018650smesh__D019659
% 223.99/224.17  |- skos__scopeNote mesh__D018650
% 223.99/224.17       A plant genus of the family ASTERACEAE. The dried flower heads of Arnica montana are used externally as a counterirritant and tincture for sprains and bruises, either as crude extract or in homeopathic dilution %28%HOMEOPATHY%29%. Arnica contains volatile oils %28%OILS, VOLATILE%29%, arnicin, arnisterol, FLAVONOIDS; TANNINS; and resin. The common name of Wolf%27%s Bane is similar to the common name for ACONITUM.%A%    
% 223.99/224.17  |- skos__altLabel mesh__D018650 Leopard%27%s Bane
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D018650 2005
% 223.99/224.17  |- mesh__onlineNote mesh__D018650
% 223.99/224.17       use PLANT EXTRACTS %28%NM%29% to search ARNICA 1985-94   
% 223.99/224.17  |- skos__altLabel mesh__D018650 Leopards Bane
% 223.99/224.17  |- mesh__dateCreated mesh__D018650 1994-04-19
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D018650 2006
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D018650 2006A
% 223.99/224.17  |- skos__historyNote mesh__D018650 Plants, Medicinal %28%1966-1984%29%
% 223.99/224.17  |- mesh__historyNote mesh__D018650 95; was ARNICA %28%NM%29% 1985-94   
% 223.99/224.17  |- mesh__recordMaintainer mesh__D018650 ags
% 223.99/224.17  |- skos__prefLabel mesh__D018650 Arnica
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D032321 2006
% 223.99/224.17  |- skos__altLabel mesh__D032321 Tomatillo
% 223.99/224.17  |- skos__prefLabel mesh__D032321 Physalis
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D032321 2003
% 223.99/224.17  |- mesh__dateEstablished mesh__D032321 2003-01-01
% 223.99/224.17  |- mesh__dateCreated mesh__D032321 2002-07-03
% 223.99/224.17  |- mesh__publicMeSHNote mesh__D032321 2003   
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D032321 2004
% 223.99/224.17  |- skos__altLabel mesh__D032321 Cherry, Ground
% 223.99/224.17  |- rdf__type mesh__D032321sskos__Concept
% 223.99/224.17  |- skos__broader mesh__D032321smesh__D019657
% 223.99/224.17  |- skos__scopeNote mesh__D032321
% 223.99/224.17       A plant genus of the family SOLANACEAE. Members contain physalin and withangulatin.%A%    
% 223.99/224.17  |- mesh__historyNote mesh__D032321 2003   
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D032321 2005
% 223.99/224.17  |- skos__annotation mesh__D032321
% 223.99/224.17       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.99/224.17  |- skos__broader mesh__D004630smesh__D020969
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D004630 2002
% 223.99/224.17  |- mesh__dateCreated mesh__D004630 1999-01-01
% 223.99/224.17  |- mesh__recordOriginator mesh__D004630 NLM
% 223.99/224.17  |- rdf__type mesh__D004630sskos__Concept
% 223.99/224.17  |- skos__annotation mesh__D004630
% 223.99/224.17       EMERGENCY MEDICINE is the corresponding specialty; /nurs = the patient, EMERGENCY NURSING = the nursing specialty; emergencies in specific dis: coord NIM with specific dis %28%IM%29%; %22%drug emergencies%22%: coord NIM with specific drug or chem with probably /pois %28%IM%29%%A%  
% 223.99/224.17  |- skos__prefLabel mesh__D004630 Emergencies
% 223.99/224.17  |- skos__related mesh__D004630smesh__D003419
% 223.99/224.17  |- skos__related mesh__D004630smesh__D004638
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D004630 2000
% 223.99/224.17  |- skos__related mesh__D004630smesh__D003422
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D004630 2003
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D004630 2001
% 223.99/224.17  |- skos__scopeNote mesh__D004630
% 223.99/224.17       Situations or conditions having a high probability of disabling or immediately life-threatening consequences or requiring first aid or other immediate intervention.%A%    
% 223.99/224.17  |- skos__related mesh__D004630smesh__D015277
% 223.99/224.17  |- mesh__activeMeSHYear mesh__D004630 2005
% 223.99/224.17  |- skos__hiddenLabel mesh__D004630 Emergency
% 223.99/224.17  |- mesh__dateRevised mesh__D004630 1999-11-08
% 223.99/224.17  |- skos__related mesh__D004630smesh__D005392
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D004630 2004
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D004630 2006
% 223.99/224.18  |- mesh__recordAuthorizer mesh__D004630 sjn
% 223.99/224.18  |- mesh__recordMaintainer mesh__D004630 KEV
% 223.99/224.18  |- skos__broader mesh__D000308Q000151smesh__D000308
% 223.99/224.18  |- mesh__preferredCombination mesh__D000308Q000151smesh__D000312
% 223.99/224.18  |- rdf__type mesh__D000308Q000151smesh__CompoundConcept
% 223.99/224.18  |- mesh__publicMeSHNote mesh__D045249 2004   
% 223.99/224.18  |- mesh__dateCreated mesh__D045249 2003-07-09
% 223.99/224.18  |- mesh__recordAuthorizer mesh__D045249 sjn
% 223.99/224.18  |- mesh__recordOriginator mesh__D045249 ags
% 223.99/224.18  |- rdf__type mesh__D045249sskos__Concept
% 223.99/224.18  |- skos__broader mesh__D045249smesh__D016946
% 223.99/224.18  |- mesh__historyNote mesh__D045249 2004   
% 223.99/224.18  |- skos__prefLabel mesh__D045249 Sphingobacterium
% 223.99/224.18  |- skos__historyNote mesh__D045249 Flavobacterium %28%1987-2003%29%
% 223.99/224.18  |- skos__scopeNote mesh__D045249
% 223.99/224.18       A genus of gram-negative, chemoorganotrophic bacteria in the family Sphingobacteriaceae. They lack FLAGELLA but some species exhibit gliding motility.%A%    
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D045249 2006
% 223.99/224.18  |- mesh__dateRevised mesh__D045249 2005-06-30
% 223.99/224.18  |- skos__broader mesh__D045249smesh__D041963
% 223.99/224.18  |- mesh__dateEstablished mesh__D045249 2004-01-01
% 223.99/224.18  |- mesh__recordMaintainer mesh__D045249 SYSTEM
% 223.99/224.18  |- skos__broader mesh__D017558smesh__D013514
% 223.99/224.18  |- skos__historyNote mesh__D017558
% 223.99/224.18       Surgical Procedures, Operative %28%1966-1993%29%
% 223.99/224.18  |- mesh__recordAuthorizer mesh__D017558 sjn
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D017558 2001
% 223.99/224.18  |- mesh__dateEstablished mesh__D017558 1994-01-01
% 223.99/224.18  |- mesh__recordMaintainer mesh__D017558 ndw
% 223.99/224.18  |- mesh__dateCreated mesh__D017558 1992-12-28
% 223.99/224.18  |- mesh__recordOriginator mesh__D017558 RAZ
% 223.99/224.18  |- skos__altLabel mesh__D017558 Procedure, Elective Surgical
% 223.99/224.18  |- skos__altLabel mesh__D017558 Surgical Procedure, Elective
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D017558 2000
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D017558 2004
% 223.99/224.18  |- skos__scopeNote mesh__D017558
% 223.99/224.18       Surgery which could be postponed or not done at all without danger to the patient. Elective surgery includes procedures to correct non-life-threatening medical problems as well as to alleviate conditions causing psychological stress or other potential risk to patients, e.g., cosmetic or contraceptive surgery.%A%    
% 223.99/224.18  |- skos__annotation mesh__D017558
% 223.99/224.18       do not use /util except by MeSH definition; DF: SURG PROCEDURES ELECTIVE%A%  
% 223.99/224.18  |- mesh__dateRevised mesh__D017558 1999-11-03
% 223.99/224.18  |- rdf__type mesh__D017558sskos__Concept
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D017558 2006
% 223.99/224.18  |- mesh__publicMeSHNote mesh__D017558 98; see SURGERY, ELECTIVE 1994-97   
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D017558 2003
% 223.99/224.18  |- mesh__historyNote mesh__D017558 98%28%94%29%   
% 223.99/224.18  |- skos__prefLabel mesh__D017558 Surgical Procedures, Elective
% 223.99/224.18  |- skos__altLabel mesh__D017558 Elective Surgical Procedures
% 223.99/224.18  |- skos__altLabel mesh__D017558 Procedures, Elective Surgical
% 223.99/224.18  |- skos__altLabel mesh__D017558 Elective Surgical Procedure
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D017558 2005
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D017558 2002
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D031229 2003
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D031229 2006
% 223.99/224.18  |- mesh__historyNote mesh__D031229 2003   
% 223.99/224.18  |- skos__prefLabel mesh__D031229 Bromeliaceae
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D031229 2004
% 223.99/224.18  |- skos__scopeNote mesh__D031229
% 223.99/224.18       A plant family of the order Bromeliales, subclass Zingiberidae, class Liliopsida %28%monocotyledons%29%.%A%    
% 223.99/224.18  |- mesh__dateEstablished mesh__D031229 2003-01-01
% 223.99/224.18  |- rdf__type mesh__D031229sskos__Concept
% 223.99/224.18  |- skos__broader mesh__D031229smesh__D019684
% 223.99/224.18  |- skos__annotation mesh__D031229
% 223.99/224.18       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.99/224.18  |- mesh__dateCreated mesh__D031229 2002-07-02
% 223.99/224.18  |- mesh__publicMeSHNote mesh__D031229 2003   
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D031229 2005
% 223.99/224.18  |- skos__hiddenLabel mesh__D003538 Hydrobromide, Cystamine
% 223.99/224.18  |- mesh__recordAuthorizer mesh__D003538 sjn
% 223.99/224.18  |- skos__annotation mesh__D003538
% 223.99/224.18       do not confuse with CYSTEAMINE nor Cystamin %28%a urinary antiseptic%29%%A%  
% 223.99/224.18  |- skos__hiddenLabel mesh__D003538 Dihydrochloride, Cystamine
% 223.99/224.18  |- mesh__recordOriginator mesh__D003538 NLM
% 223.99/224.18  |- skos__hiddenLabel mesh__D003538 Sulfate, Cystamine
% 223.99/224.18  |- skos__hiddenLabel mesh__D003538 Dihydrobromide, Cystamine
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D003538 2004
% 223.99/224.18  |- skos__hiddenLabel mesh__D003538 Diacetate, Cystamine
% 223.99/224.18  |- skos__altLabel mesh__D003538 2,2%27%-Dithiobisethanamine
% 223.99/224.18  |- skos__hiddenLabel mesh__D003538 Disulfide, Cysteinamine
% 223.99/224.18  |- skos__hiddenLabel mesh__D003538 Hydrochloride, Cystamine
% 223.99/224.18  |- skos__altLabel mesh__D003538 Cystinamin
% 223.99/224.18  |- skos__altLabel mesh__D003538 Cystineamine
% 223.99/224.18  |- skos__prefLabel mesh__D003538 Cystamine
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D003538 2005
% 223.99/224.18  |- skos__altLabel mesh__D003538 Cysteinamine Disulfide
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D003538 2006
% 223.99/224.18  |- skos__hiddenLabel mesh__D003538 Calcium Salt, Cystamine
% 223.99/224.18  |- skos__scopeNote mesh__D003538
% 223.99/224.18       A radiation-protective agent that interferes with sulfhydryl enzymes. It may also protect against carbon tetrachloride liver damage.%A%    
% 223.99/224.18  |- mesh__dateCreated mesh__D003538 1999-01-01
% 223.99/224.18  |- mesh__dateRevised mesh__D003538 2003-07-09
% 223.99/224.18  |- skos__hiddenLabel mesh__D003538 2,2%27% Dithiobisethanamine
% 223.99/224.18  |- mesh__recordMaintainer mesh__D003538 ssb
% 223.99/224.18  |- rdf__type mesh__D003538sskos__Concept
% 223.99/224.18  |- skos__altLabel mesh__D003538 Decarboxycystine
% 223.99/224.18  |- skos__broader mesh__D003538smesh__D005021
% 223.99/224.18  |- mesh__recordMaintainer mesh__D014260 CCR
% 223.99/224.18  |- mesh__historyNote mesh__D014260
% 223.99/224.18       91%28%76%29%; was see under PHENYL ETHERS 1976-90; IRGASAN DP 300 was see TRICLOSAN 1976-95%A%  
% 223.99/224.18  |- skos__broader mesh__D014260smesh__D010647
% 223.99/224.18  |- skos__scopeNote mesh__D014260
% 223.99/224.18       A diphenyl ether derivative used in cosmetics and toilet soaps as an antiseptic. It has some bacteriostatic and fungistatic action.%A%    
% 223.99/224.18  |- skos__hiddenLabel mesh__D014260 Ster Zac Bath Concentrate
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D014260 2006
% 223.99/224.18  |- skos__altLabel mesh__D014260 Procter %26% Gamble Brand of Triclosan
% 223.99/224.18  |- mesh__dateCreated mesh__D014260 1975-07-25
% 223.99/224.18  |- skos__historyNote mesh__D014260 Phenyl Ethers %28%1974-1975%29%
% 223.99/224.18  |- skos__altLabel mesh__D014260 Trans Canaderm Brand of Triclosan
% 223.99/224.18  |- skos__prefLabel mesh__D014260 Triclosan
% 223.99/224.18  |- mesh__publicMeSHNote mesh__D014260
% 223.99/224.18       91; was see under PHENYL ETHERS 1976-90; IRGASAN DP 300 was see TRICLOSAN 1976-95%A%  
% 223.99/224.18  |- mesh__dateRevised mesh__D014260 2005-06-30
% 223.99/224.18  |- mesh__dateEstablished mesh__D014260 1991-01-01
% 223.99/224.18  |- skos__altLabel mesh__D014260
% 223.99/224.18       2-Hydroxy-2%27%,4,4%27%-trichlorodiphenyl Ether
% 223.99/224.18  |- skos__altLabel mesh__D014260 SSL Brand of Triclosan
% 223.99/224.18  |- rdf__type mesh__D014260sskos__Concept
% 223.99/224.18  |- skos__hiddenLabel mesh__D014260 SterZac Bath Concentrate
% 223.99/224.18  |- skos__altLabel mesh__D014260 GlaxoSmithKline Brand of Triclosan
% 223.99/224.18  |- skos__altLabel mesh__D014260 Sapoderm
% 223.99/224.18  |- skos__altLabel mesh__D014260 Manusept
% 223.99/224.18  |- skos__altLabel mesh__D014260 Ster-Zac Bath Concentrate
% 223.99/224.18  |- skos__altLabel mesh__D014260 Reckitt Brand of Triclosan
% 223.99/224.18  |- mesh__recordOriginator mesh__D014260 SH
% 223.99/224.18  |- mesh__recordAuthorizer mesh__D014260 sjn
% 223.99/224.18  |- skos__altLabel mesh__D014260 Johnson %26% Johnson Brand of Triclosan
% 223.99/224.18  |- skos__altLabel mesh__D014260 Dermtek Brand of Triclosan
% 223.99/224.18  |- skos__historyNote mesh__D014260 Chlorobenzenes %28%1974-1975%29%
% 223.99/224.18  |- mesh__recordMaintainer mesh__D008223 mdb
% 223.99/224.18  |- skos__hiddenLabel mesh__D008223 Lymphomas
% 223.99/224.18  |- mesh__dateCreated mesh__D008223 1999-01-01
% 223.99/224.18  |- skos__altLabel mesh__D008223 Germinoblastoma
% 223.99/224.18  |- skos__scopeNote mesh__D008223
% 223.99/224.18       A general term for various neoplastic diseases of the lymphoid tissue.%A%    
% 223.99/224.18  |- skos__altLabel mesh__D008223 Sarcoma, Germinoblastic
% 223.99/224.18  |- skos__altLabel mesh__D008223 Reticulolymphosarcoma
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D008223 2004
% 223.99/224.18  |- skos__hiddenLabel mesh__D008223 Reticulolymphosarcomas
% 223.99/224.18  |- skos__annotation mesh__D008223
% 223.99/224.18       GEN only or unspecified: prefer specific; do not confuse X ref LYMPHOMA, MALIGNANT with LYMPHOGRANULOMA, MALIGNANT see HODGKIN DISEASE; for lymphoma with AIDS, use LYMPHOMA, AIDS-RELATED%A%  
% 223.99/224.18  |- skos__hiddenLabel mesh__D008223 Germinoblastic Sarcomas
% 223.99/224.18  |- skos__altLabel mesh__D008223 Lymphoma, Malignant
% 223.99/224.18  |- skos__hiddenLabel mesh__D008223 Lymphomas, Malignant
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D008223 2005
% 223.99/224.18  |- skos__hiddenLabel mesh__D008223 Germinoblastomas
% 223.99/224.18  |- skos__broader mesh__D008223smesh__D009370
% 223.99/224.18  |- skos__hiddenLabel mesh__D008223 Malignant Lymphomas
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D008223 2006
% 223.99/224.18  |- skos__prefLabel mesh__D008223 Lymphoma
% 223.99/224.18  |- skos__hiddenLabel mesh__D008223 Germinoblastic Sarcoma
% 223.99/224.18  |- mesh__recordOriginator mesh__D008223 NLM
% 223.99/224.18  |- mesh__recordAuthorizer mesh__D008223 sjn
% 223.99/224.18  |- mesh__dateRevised mesh__D008223 2003-07-09
% 223.99/224.18  |- skos__hiddenLabel mesh__D008223 Malignant Lymphoma
% 223.99/224.18  |- rdf__type mesh__D008223sskos__Concept
% 223.99/224.18  |- skos__hiddenLabel mesh__D008223 Sarcomas, Germinoblastic
% 223.99/224.18  |- skos__broader mesh__D008223smesh__D008232
% 223.99/224.18  |- skos__broader mesh__D013966smesh__D013959
% 223.99/224.18  |- mesh__recordMaintainer mesh__D013966 lkt
% 223.99/224.18  |- mesh__recordOriginator mesh__D013966 NLM
% 223.99/224.18  |- mesh__recordAuthorizer mesh__D013966 sjn
% 223.99/224.18  |- skos__annotation mesh__D013966
% 223.99/224.18       general or unspecified: prefer specifics   
% 223.99/224.18  |- skos__hiddenLabel mesh__D013966 Thyroiditides
% 223.99/224.18  |- skos__scopeNote mesh__D013966
% 223.99/224.18       Inflammatory diseases of the THYROID GLAND. Thyroiditis can be classified into acute %28%THYROIDITIS, SUPPURATIVE%29%, subacute %28%granulomatous and lymphocytic%29%, chronic fibrous %28%Riedel%27%s%29%, chronic lymphocytic %28%HASHIMOTO DISEASE%29%, transient %28%POSTPARTUM THYROIDITIS%29%, and other AUTOIMMUNE THYROIDITIS subtypes.%A%    
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D013966 2006
% 223.99/224.18  |- skos__prefLabel mesh__D013966 Thyroiditis
% 223.99/224.18  |- rdf__type mesh__D013966sskos__Concept
% 223.99/224.18  |- mesh__dateRevised mesh__D013966 2005-06-30
% 223.99/224.18  |- mesh__dateCreated mesh__D013966 1999-01-01
% 223.99/224.18  |- rdf__type mesh__D013168sskos__Concept
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D013168 2004
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D013168 2000
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D013168 2006
% 223.99/224.18  |- mesh__recordOriginator mesh__D013168 NLM
% 223.99/224.18  |- skos__prefLabel mesh__D013168 Spondylolisthesis
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D013168 2003
% 223.99/224.18  |- mesh__recordMaintainer mesh__D013168 TGC
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D013168 1997
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D013168 2005
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D013168 1999
% 223.99/224.18  |- skos__hiddenLabel mesh__D013168 Spondylistheses
% 223.99/224.18  |- mesh__dateRevised mesh__D013168 1994-04-11
% 223.99/224.18  |- skos__annotation mesh__D013168
% 223.99/224.18       %22%forward displacemt of 1 vertebra over another%22%; do not confuse with SPONDYLOLYSIS, dissolution of a vertebra; IM; coord with specific vertebra %28%IM%29%%A%  
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D013168 1996
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D013168 1995
% 223.99/224.18  |- mesh__recordAuthorizer mesh__D013168 PLS
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D013168 1998
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D013168 2002
% 223.99/224.18  |- skos__altLabel mesh__D013168 Spondylisthesis
% 223.99/224.18  |- skos__broader mesh__D013168smesh__D013122
% 223.99/224.18  |- mesh__dateCreated mesh__D013168 1999-01-01
% 223.99/224.18  |- skos__hiddenLabel mesh__D013168 Spondylolistheses
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D013168 2001
% 223.99/224.18  |- skos__scopeNote mesh__D013168
% 223.99/224.18       Forward displacement of one vertebra over another.     
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D018651 2005
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D018651 2000
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D018651 1999
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D018651 2003
% 223.99/224.18  |- skos__broader mesh__D018651smesh__D014675
% 223.99/224.18  |- rdf__type mesh__D018651sskos__Concept
% 223.99/224.18  |- skos__prefLabel mesh__D018651 Chicory
% 223.99/224.18  |- mesh__dateRevised mesh__D018651 1997-06-20
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D018651 1998
% 223.99/224.18  |- skos__broader mesh__D018651smesh__D019659
% 223.99/224.18  |- mesh__recordAuthorizer mesh__D018651 SJN
% 223.99/224.18  |- skos__altLabel mesh__D018651 Cichorium intybus
% 223.99/224.18  |- mesh__recordMaintainer mesh__D018651 JLS
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D018651 2002
% 223.99/224.18  |- mesh__historyNote mesh__D018651 95   
% 223.99/224.18  |- mesh__dateCreated mesh__D018651 1994-04-19
% 223.99/224.18  |- skos__scopeNote mesh__D018651
% 223.99/224.18       A thick-rooted perennial %28%Cichorium intybus%29% native to Europe but widely grown for its young leaves used as salad greens and for its roots, dried and ground-roasted, used to flavor or adulterate coffee. %28%From Webster, 3d ed%29%%A%    
% 223.99/224.18  |- mesh__dateEstablished mesh__D018651 1995-01-01
% 223.99/224.18  |- mesh__recordOriginator mesh__D018651 TGC
% 223.99/224.18  |- mesh__publicMeSHNote mesh__D018651 95   
% 223.99/224.18  |- skos__annotation mesh__D018651
% 223.99/224.18       as plant %26% flavoring agent for coffee; selected qualif from Cat B6 %26% Cat J2%A%  
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D018651 2006
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D018651 2004
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D018651 2001
% 223.99/224.18  |- mesh__recordAuthorizer mesh__D032322 jls
% 223.99/224.18  |- mesh__recordOriginator mesh__D032322 ssb
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D032322 2006
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D032322 2005A
% 223.99/224.18  |- skos__altLabel mesh__D032322 Poroporo
% 223.99/224.18  |- skos__altLabel mesh__D032322 Trompillo
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D032322 2003
% 223.99/224.18  |- skos__altLabel mesh__D032322 Horsenettle
% 223.99/224.18  |- rdf__type mesh__D032322sskos__Concept
% 223.99/224.18  |- mesh__dateCreated mesh__D032322 2002-07-03
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D032322 2004
% 223.99/224.18  |- mesh__dateEstablished mesh__D032322 2003-01-01
% 223.99/224.18  |- mesh__publicMeSHNote mesh__D032322 2003   
% 223.99/224.18  |- skos__prefLabel mesh__D032322 Solanum
% 223.99/224.18  |- skos__scopeNote mesh__D032322
% 223.99/224.18       A plant genus of the family SOLANACEAE. Members contain SOLANACEOUS ALKALOIDS. Some species in this genus are called deadly nightshade which is also a common name for ATROPA BELLADONNA.%A%    
% 223.99/224.18  |- skos__altLabel mesh__D032322 Nettle, Horse
% 223.99/224.18  |- skos__altLabel mesh__D032322 Nightshade, Bitter
% 223.99/224.18  |- skos__altLabel mesh__D032322 Nightshade
% 223.99/224.18  |- mesh__recordMaintainer mesh__D032322 jls
% 223.99/224.18  |- skos__broader mesh__D032322smesh__D019657
% 223.99/224.18  |- skos__altLabel mesh__D032322 Nightshade, Laciniate
% 223.99/224.18  |- mesh__dateRevised mesh__D032322 2004-08-02
% 223.99/224.18  |- skos__annotation mesh__D032322
% 223.99/224.18       several specific Solanum terms are available; check text and MeSH; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D032322 2005
% 223.99/224.18  |- mesh__historyNote mesh__D032322 2003   
% 223.99/224.18  |- rdf__type mesh__D004631sskos__Concept
% 223.99/224.18  |- mesh__historyNote mesh__D004631
% 223.99/224.18       91%28%80%29%; was see under EMERGENCY MEDICAL SERVICES 1980-90   
% 223.99/224.18  |- skos__historyNote mesh__D004631
% 223.99/224.18       specific telecommunication %28%1966-1979%29%
% 223.99/224.18  |- skos__hiddenLabel mesh__D004631 EMS Communication System
% 223.99/224.18  |- skos__altLabel mesh__D004631 Communication Systems, EMS
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D004631 1996
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D004631 2002
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D004631 1998
% 223.99/224.18  |- skos__altLabel mesh__D004631 EMS Communication Systems
% 223.99/224.18  |- mesh__recordOriginator mesh__D004631 EC
% 223.99/224.18  |- skos__hiddenLabel mesh__D004631 System, EMS Communication
% 223.99/224.18  |- mesh__recordAuthorizer mesh__D004631 PLS
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D004631 1997
% 223.99/224.18  |- skos__broader mesh__D004631smesh__D004632
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D004631 2003
% 223.99/224.18  |- mesh__dateCreated mesh__D004631 1979-05-31
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D004631 1999
% 223.99/224.18  |- skos__prefLabel mesh__D004631
% 223.99/224.18       Emergency Medical Service Communication Systems
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D004631 2005
% 223.99/224.18  |- skos__altLabel mesh__D004631 Communication System, EMS
% 223.99/224.18  |- skos__historyNote mesh__D004631
% 223.99/224.18       Emergency Medical Services %28%1968-1979%29%
% 223.99/224.18  |- mesh__publicMeSHNote mesh__D004631
% 223.99/224.18       91; was see under EMERGENCY MEDICAL SERVICES 1980-90   
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D004631 2004
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D004631 2006
% 223.99/224.18  |- mesh__dateRevised mesh__D004631 1995-05-22
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D004631 2000
% 223.99/224.18  |- skos__historyNote mesh__D004631 Communication %28%1966-1979%29%
% 223.99/224.18  |- mesh__recordMaintainer mesh__D004631 KEV
% 223.99/224.18  |- mesh__dateEstablished mesh__D004631 1991-01-01
% 223.99/224.18  |- skos__annotation mesh__D004631
% 223.99/224.18       commun between hosp %26% ambulance, 911 systems, emerg calling systems, etc.: do not confuse with EMERGENCY CARE INFORMATION SYSTEMS see INFORMATION SYSTEMS; DF: EMSCS%A%  
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D004631 2001
% 223.99/224.18  |- skos__scopeNote mesh__D004631
% 223.99/224.18       The use of communication systems, such as telecommunication, to transmit emergency information to appropriate providers of health services.%A%    
% 223.99/224.18  |- skos__altLabel mesh__D004631
% 223.99/224.18       Communication Systems, Emergency Medical Service
% 223.99/224.18  |- skos__hiddenLabel mesh__D004631 Systems, EMS Communication
% 223.99/224.18  |- mesh__dateCreated mesh__D028281 2001-07-25
% 223.99/224.18  |- mesh__dateRevised mesh__D028281 2002-07-03
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D028281 2003
% 223.99/224.18  |- skos__historyNote mesh__D028281 Papaver %28%1998-2001%29%
% 223.99/224.18  |- rdf__type mesh__D028281sskos__Concept
% 223.99/224.18  |- mesh__historyNote mesh__D028281
% 223.99/224.18       2002; use PAPAVER 1998-2001, use PLANTS, MEDICINAL 1986-1997%A%  
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D028281 2006
% 223.99/224.18  |- skos__annotation mesh__D028281
% 223.99/224.18       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.99/224.18  |- mesh__publicMeSHNote mesh__D028281
% 223.99/224.18       2002; see PAPAVER 1998-2001, see PLANTS, MEDICINAL 1986-1997%A%  
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D028281 2005
% 223.99/224.18  |- skos__broader mesh__D028281smesh__D028101
% 223.99/224.18  |- skos__scopeNote mesh__D028281
% 223.99/224.18       A plant genus in the family PAPAVERACEAE, order Papaverales, subclass Magnoliidae.%A%    
% 223.99/224.18  |- mesh__dateEstablished mesh__D028281 2002-01-01
% 223.99/224.18  |- skos__altLabel mesh__D028281 Celandine
% 223.99/224.18  |- skos__prefLabel mesh__D028281 Chelidonium
% 223.99/224.18  |- mesh__activeMeSHYear mesh__D028281 2004
% 223.99/224.18  |- skos__broader mesh__D001853Q000637smesh__D001853
% 223.99/224.18  |- mesh__preferredCombination mesh__D001853Q000637smesh__D016026
% 223.99/224.18  |- rdf__type mesh__D001853Q000637smesh__CompoundConcept
% 223.99/224.18  |- mesh__recordMaintainer mesh__D003539 ssb
% 223.99/224.18  |- mesh__dateCreated mesh__D003539 1974-11-19
% 223.99/224.18  |- mesh__recordAuthorizer mesh__D003539 sjn
% 223.99/224.18  |- skos__prefLabel mesh__D003539 Cystaphos
% 223.99/224.18  |- skos__hiddenLabel mesh__D003539 WR 638
% 223.99/224.18  |- skos__hiddenLabel mesh__D003539
% 223.99/224.18       beta Aminoethylthiophosphate, Sodium Salt
% 223.99/224.18  |- mesh__recordOriginator mesh__D003539 NLM
% 223.99/224.18  |- skos__historyNote mesh__D003539
% 223.99/224.18       Organothiophosphorus Compounds %28%1972-1974%29%
% 223.99/224.19  |- skos__broader mesh__D003539smesh__D009946
% 223.99/224.19  |- skos__altLabel mesh__D003539 Cistaphos
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D003539 2006
% 223.99/224.19  |- skos__altLabel mesh__D003539 Cistafos
% 223.99/224.19  |- skos__altLabel mesh__D003539 Cystafos
% 223.99/224.19  |- mesh__publicMeSHNote mesh__D003539
% 223.99/224.19       91; was see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1975-90   
% 223.99/224.19  |- skos__hiddenLabel mesh__D003539
% 223.99/224.19       Salt beta-Aminoethylthiophosphate, Sodium
% 223.99/224.19  |- rdf__type mesh__D003539sskos__Concept
% 223.99/224.19  |- skos__hiddenLabel mesh__D003539 Sodium Salt beta-Aminoethylthiophosphate
% 223.99/224.19  |- mesh__dateEstablished mesh__D003539 1991-01-01
% 223.99/224.19  |- skos__hiddenLabel mesh__D003539 WR638
% 223.99/224.19  |- mesh__historyNote mesh__D003539
% 223.99/224.19       91%28%75%29%; was see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1975-90%A%  
% 223.99/224.19  |- skos__historyNote mesh__D003539 Ethylamines %28%1972-1974%29%
% 223.99/224.19  |- skos__altLabel mesh__D003539 beta-Aminoethylthiophosphate, Sodium Salt
% 223.99/224.19  |- skos__scopeNote mesh__D003539
% 223.99/224.19       Proposed as an adjuvant to cancer chemotherapy; may have radiation protective properties.%A%    
% 223.99/224.19  |- mesh__dateRevised mesh__D003539 2005-06-30
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014261 2005
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014261 2001
% 223.99/224.19  |- skos__hiddenLabel mesh__D014261 Valves, Tricuspid
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014261 2003
% 223.99/224.19  |- mesh__recordMaintainer mesh__D014261 MSR
% 223.99/224.19  |- mesh__recordOriginator mesh__D014261 NLM
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014261 2000
% 223.99/224.19  |- skos__prefLabel mesh__D014261 Tricuspid Valve
% 223.99/224.19  |- rdf__type mesh__D014261sskos__Concept
% 223.99/224.19  |- skos__scopeNote mesh__D014261
% 223.99/224.19       The valve consisting of three cusps situated between the right atrium and right ventricle of the heart.%A%    
% 223.99/224.19  |- skos__annotation mesh__D014261
% 223.99/224.19       dis: coord IM with HEART VALVE DISEASES %28%IM%29% but note specific tricuspid valve dis; /abnorm = probably TRICUSPID ATRESIA%A%  
% 223.99/224.19  |- skos__hiddenLabel mesh__D014261 Valve, Tricuspid
% 223.99/224.19  |- mesh__recordAuthorizer mesh__D014261 SJN
% 223.99/224.19  |- skos__broader mesh__D014261smesh__D006351
% 223.99/224.19  |- mesh__dateRevised mesh__D014261 1998-06-11
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014261 2002
% 223.99/224.19  |- skos__hiddenLabel mesh__D014261 Tricuspid Valves
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014261 2006
% 223.99/224.19  |- mesh__dateCreated mesh__D014261 1999-01-01
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014261 2004
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014261 1999
% 223.99/224.19  |- mesh__publicMeSHNote mesh__D008224
% 223.99/224.19       91; was LYMPHOMA, GIANT FOLLICULAR 1963-90; BRILL-SYMMERS DISEASE was see LYMPHOMA, GIANT FOLLICULAR 1975-90%A%  
% 223.99/224.19  |- mesh__recordOriginator mesh__D008224 NLM
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D008224 1999
% 223.99/224.19  |- rdf__type mesh__D008224sskos__Concept
% 223.99/224.19  |- skos__prefLabel mesh__D008224 Lymphoma, Follicular
% 223.99/224.19  |- skos__altLabel mesh__D008224 Giant Follicular Lymphoma
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D008224 2005
% 223.99/224.19  |- skos__scopeNote mesh__D008224
% 223.99/224.19       Malignant lymphoma in which the lymphomatous cells are clustered into identifiable nodules within the lymph nodes. The nodules resemble to some extent the germinal centers of lymph node follicles and most likely represent neoplastic proliferation of lymph node-derived follicular center B-lymphocytes. This class of lymphoma usually occurs in older persons, is commonly multinodal, and possibly extranodal. Patients whose lymphomas present a follicular or nodular pattern generally have a more indolent course than those presenting with a diffuse pattern.%A%    
% 223.99/224.19  |- mesh__dateRevised mesh__D008224 1995-06-08
% 223.99/224.19  |- skos__altLabel mesh__D008224 Lymphoma, Nodular
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D008224 2006
% 223.99/224.19  |- skos__hiddenLabel mesh__D008224 Lymphomas, Follicular
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D008224 2000
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D008224 1996
% 223.99/224.19  |- skos__hiddenLabel mesh__D008224 Giant Follicular Lymphomas
% 223.99/224.19  |- skos__hiddenLabel mesh__D008224 Nodular Lymphoma
% 223.99/224.19  |- skos__hiddenLabel mesh__D008224 Lymphomas, Nodular
% 223.99/224.19  |- skos__hiddenLabel mesh__D008224 Follicular Lymphomas, Giant
% 223.99/224.19  |- mesh__dateCreated mesh__D008224 1999-01-01
% 223.99/224.19  |- skos__altLabel mesh__D008224 Follicular Lymphoma, Giant
% 223.99/224.19  |- skos__hiddenLabel mesh__D008224 Lymphomas, Giant Follicular
% 223.99/224.19  |- skos__altLabel mesh__D008224 Follicular Lymphoma
% 223.99/224.19  |- skos__hiddenLabel mesh__D008224 Nodular Lymphomas
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D008224 2001
% 223.99/224.19  |- skos__annotation mesh__D008224
% 223.99/224.19       a non-Hodgkin%27%s lymphoma; DF: LYMPHOMA FOLLIC   
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D008224 1997
% 223.99/224.19  |- skos__altLabel mesh__D008224 Lymphoma, Giant Follicular
% 223.99/224.19  |- skos__hiddenLabel mesh__D008224 Disease, Brill-Symmers
% 223.99/224.19  |- mesh__historyNote mesh__D008224
% 223.99/224.19       91; was LYMPHOMA, GIANT FOLLICULAR 1963-90; BRILL-SYMMERS DISEASE was see LYMPHOMA, GIANT FOLLICULAR 1975-90%A%  
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D008224 2003
% 223.99/224.19  |- mesh__recordAuthorizer mesh__D008224 PLS
% 223.99/224.19  |- skos__broader mesh__D008224smesh__D008228
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D008224 2002
% 223.99/224.19  |- skos__hiddenLabel mesh__D008224 Brill Symmers Disease
% 223.99/224.19  |- skos__altLabel mesh__D008224 Brill-Symmers Disease
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D008224 1998
% 223.99/224.19  |- mesh__onlineNote mesh__D008224
% 223.99/224.19       use LYMPHOMA, FOLLICULAR to search LYMPHOMA, GIANT FOLLICULAR 1966-90 %26% BRILL-SYMMERS DISEASE 1975-90%A%  
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D008224 2004
% 223.99/224.19  |- skos__hiddenLabel mesh__D008224 Follicular Lymphomas
% 223.99/224.19  |- mesh__recordMaintainer mesh__D008224 KEV
% 223.99/224.19  |- mesh__recordOriginator mesh__D000241 NLM
% 223.99/224.19  |- skos__historyNote mesh__D000241 Nucleosides %28%1966-1971%29%
% 223.99/224.19  |- skos__broader mesh__D000241smesh__D012263
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D000241 2006
% 223.99/224.19  |- skos__prefLabel mesh__D000241 Adenosine
% 223.99/224.19  |- mesh__dateCreated mesh__D000241 1999-01-01
% 223.99/224.19  |- mesh__dateRevised mesh__D000241 2005-06-30
% 223.99/224.19  |- rdf__type mesh__D000241sskos__Concept
% 223.99/224.19  |- skos__broader mesh__D000241smesh__D011684
% 223.99/224.19  |- skos__annotation mesh__D000241 /biosyn /physiol permitted   
% 223.99/224.19  |- mesh__publicMeSHNote mesh__D000241
% 223.99/224.19       72; was see under NUCLEOSIDES 1963-71   
% 223.99/224.19  |- mesh__dateEstablished mesh__D000241 1972-01-01
% 223.99/224.19  |- mesh__historyNote mesh__D000241 72; was see under NUCLEOSIDES 1963-71   
% 223.99/224.19  |- skos__scopeNote mesh__D000241
% 223.99/224.19       A nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.%A%    
% 223.99/224.19  |- mesh__recordMaintainer mesh__D000241 ssb
% 223.99/224.19  |- mesh__onlineNote mesh__D000241 search NUCLEOSIDES 1966-71   
% 223.99/224.19  |- mesh__recordAuthorizer mesh__D000241 sjn
% 223.99/224.19  |- skos__altLabel mesh__D013967 Thyroiditis, Lymphomatous
% 223.99/224.19  |- skos__hiddenLabel mesh__D013967 Thyroiditides, Lymphomatous
% 223.99/224.19  |- skos__prefLabel mesh__D013967 Thyroiditis, Autoimmune
% 223.99/224.19  |- mesh__onlineNote mesh__D013967
% 223.99/224.19       use THYROIDITIS, AUTOIMMUNE to search THYROIDITIS, LYMPHOMATOUS 1966-86%A%  
% 223.99/224.19  |- skos__hiddenLabel mesh__D013967 Lymphocytic Thyroiditis
% 223.99/224.19  |- mesh__dateRevised mesh__D013967 2005-06-30
% 223.99/224.19  |- skos__hiddenLabel mesh__D013967 Thyroiditides, Lymphocytic
% 223.99/224.19  |- skos__hiddenLabel mesh__D013967 Lymphomatous Thyroiditides
% 223.99/224.19  |- mesh__dateCreated mesh__D013967 1999-01-01
% 223.99/224.19  |- skos__hiddenLabel mesh__D013967 Thyroiditides, Autoimmune
% 223.99/224.19  |- skos__hiddenLabel mesh__D013967 Lymphocytic Thyroiditides
% 223.99/224.19  |- mesh__publicMeSHNote mesh__D013967
% 223.99/224.19       87; was THYROIDITIS, LYMPHOMATOUS 1963-86   
% 223.99/224.19  |- skos__hiddenLabel mesh__D013967 Lymphomatous Thyroiditis
% 223.99/224.19  |- skos__scopeNote mesh__D013967
% 223.99/224.19       Inflammatory disease of the THYROID GLAND due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific T-CELLS and thyroid AUTOANTIBODIES. The clinical signs can range from HYPOTHYROIDISM to THYROTOXICOSIS depending on the type of autoimmune thyroiditis.%A%    
% 223.99/224.19  |- mesh__recordAuthorizer mesh__D013967 sjn
% 223.99/224.19  |- mesh__recordOriginator mesh__D013967 NLM
% 223.99/224.19  |- skos__altLabel mesh__D013967 Autoimmune Thyroiditis
% 223.99/224.19  |- skos__broader mesh__D013967smesh__D001327
% 223.99/224.19  |- mesh__historyNote mesh__D013967
% 223.99/224.19       87; was THYROIDITIS, LYMPHOMATOUS 1963-86   
% 223.99/224.19  |- mesh__recordMaintainer mesh__D013967 lkt
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D013967 2006
% 223.99/224.19  |- rdf__type mesh__D013967sskos__Concept
% 223.99/224.19  |- skos__altLabel mesh__D013967 Thyroiditis, Lymphocytic
% 223.99/224.19  |- skos__hiddenLabel mesh__D013967 Autoimmune Thyroiditides
% 223.99/224.19  |- skos__broader mesh__D013967smesh__D013966
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D013169 2006
% 223.99/224.19  |- skos__hiddenLabel mesh__D013169 Spondylolyses
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D013169 2003
% 223.99/224.19  |- mesh__recordMaintainer mesh__D013169 TGC
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D013169 2001
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D013169 1997
% 223.99/224.19  |- skos__prefLabel mesh__D013169 Spondylolysis
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D013169 2005
% 223.99/224.19  |- mesh__historyNote mesh__D013169
% 223.99/224.19       91%28%75%29%; was see under SPONDYLOLISTHESIS 1975-90   
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D013169 1999
% 223.99/224.19  |- mesh__onlineNote mesh__D013169 search SPONDYLOLISTHESIS 1968-74   
% 223.99/224.19  |- skos__scopeNote mesh__D013169
% 223.99/224.19       Dissolution of a vertebra, especially the pars interarticularis.%A%    
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D013169 2000
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D013169 1996
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D013169 1995
% 223.99/224.19  |- mesh__recordOriginator mesh__D013169 NLM
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D013169 1998
% 223.99/224.19  |- skos__broader mesh__D013169smesh__D013168
% 223.99/224.19  |- mesh__dateCreated mesh__D013169 1999-01-01
% 223.99/224.19  |- mesh__dateRevised mesh__D013169 1994-04-11
% 223.99/224.19  |- mesh__dateEstablished mesh__D013169 1991-01-01
% 223.99/224.19  |- mesh__publicMeSHNote mesh__D013169
% 223.99/224.19       91; was see under SPONDYLOLISTHESIS 1975-90   
% 223.99/224.19  |- rdf__type mesh__D013169sskos__Concept
% 223.99/224.19  |- mesh__recordAuthorizer mesh__D013169 PLS
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D013169 2004
% 223.99/224.19  |- skos__annotation mesh__D013169
% 223.99/224.19       %22%dissolution of a vertebra%22%; do not confuse with SPONDYLOLISTHESIS, displacemt of 1 vertebra over another; IM; coord with specific vertebra %28%IM%29%%A%  
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D013169 2002
% 223.99/224.19  |- mesh__recordOriginator mesh__D018652 TGC
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D018652 2003
% 223.99/224.19  |- rdf__type mesh__D018652sskos__Concept
% 223.99/224.19  |- mesh__recordAuthorizer mesh__D018652 sjn
% 223.99/224.19  |- skos__annotation mesh__D018652
% 223.99/224.19       for hemlock tree use TSUGA; GEN or unspecified; prefer specifics: CONIUM or CICUTA; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.99/224.19  |- mesh__historyNote mesh__D018652 95   
% 223.99/224.19  |- mesh__dateCreated mesh__D018652 1994-04-19
% 223.99/224.19  |- mesh__recordMaintainer mesh__D018652 ssb
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D018652 2006
% 223.99/224.19  |- skos__scopeNote mesh__D018652
% 223.99/224.19       Any of several poisonous plants, commonly called poison hemlock, of the CICUTA or CONIUM genus. The hemlock tree %28%TSUGA%29% is completely unrelated being a coniferous tree of the pine family.%A%    
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D018652 2005
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D018652 2004
% 223.99/224.19  |- skos__historyNote mesh__D018652 Plant Poisoning %28%1966-1994%29%
% 223.99/224.19  |- skos__broader mesh__D018652smesh__D019661
% 223.99/224.19  |- mesh__dateRevised mesh__D018652 2002-07-03
% 223.99/224.19  |- mesh__dateEstablished mesh__D018652 1995-01-01
% 223.99/224.19  |- skos__prefLabel mesh__D018652 Hemlock
% 223.99/224.19  |- mesh__publicMeSHNote mesh__D018652 95   
% 223.99/224.19  |- mesh__recordMaintainer mesh__D032323 jls
% 223.99/224.19  |- skos__altLabel mesh__D032323 Brinjal
% 223.99/224.19  |- mesh__recordOriginator mesh__D032323 ssb
% 223.99/224.19  |- skos__scopeNote mesh__D032323
% 223.99/224.19       A plant species of the genus SOLANUM, family SOLANACEAE. The fruit is a large, egg-shaped berry, varying in color from dark purple to red, yellowish, or white. The leaves are large and ovate.  The flowers are pendant, violet, and two inches across.%A%    
% 223.99/224.19  |- mesh__historyNote mesh__D032323 2003   
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D032323 2006
% 223.99/224.19  |- mesh__dateEstablished mesh__D032323 2003-01-01
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D032323 2004
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D032323 2005
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D032323 2005A
% 223.99/224.19  |- rdf__type mesh__D032323sskos__Concept
% 223.99/224.19  |- skos__altLabel mesh__D032323 Eggplant
% 223.99/224.19  |- mesh__dateRevised mesh__D032323 2004-08-02
% 223.99/224.19  |- skos__prefLabel mesh__D032323 Solanum melongena
% 223.99/224.19  |- mesh__dateCreated mesh__D032323 2002-07-02
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D032323 2003
% 223.99/224.19  |- mesh__recordAuthorizer mesh__D032323 jls
% 223.99/224.19  |- mesh__publicMeSHNote mesh__D032323 2003   
% 223.99/224.19  |- skos__annotation mesh__D032323
% 223.99/224.19       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.99/224.19  |- skos__broader mesh__D032323smesh__D032322
% 223.99/224.19  |- skos__hiddenLabel mesh__D004632 Medical Emergency Services
% 223.99/224.19  |- skos__related mesh__D004632smesh__D000552
% 223.99/224.19  |- skos__related mesh__D004632smesh__D005392
% 223.99/224.19  |- mesh__onlineNote mesh__D004632
% 223.99/224.19       use EMERGENCY MEDICAL SERVICES to search EMERGENCY HEALTH SERVICES 1968-79%A%  
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D004632 2001
% 223.99/224.19  |- skos__altLabel mesh__D004632 Emergency Care, Prehospital
% 223.99/224.19  |- skos__historyNote mesh__D004632 First Aid %28%1966-1967%29%
% 223.99/224.19  |- skos__hiddenLabel mesh__D004632 Emergency Medical Service
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D004632 2006
% 223.99/224.19  |- mesh__recordAuthorizer mesh__D004632 sjn
% 223.99/224.19  |- mesh__dateCreated mesh__D004632 1999-01-01
% 223.99/224.19  |- skos__hiddenLabel mesh__D004632 Emergency Health Service
% 223.99/224.19  |- skos__hiddenLabel mesh__D004632 Health Service, Emergency
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D004632 2003
% 223.99/224.19  |- skos__annotation mesh__D004632
% 223.99/224.19       Public Law 93-154; DF: EMERGENCY MED SERV   
% 223.99/224.19  |- skos__prefLabel mesh__D004632 Emergency Medical Services
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D004632 2002
% 223.99/224.19  |- skos__hiddenLabel mesh__D004632 Services, Medical Emergency
% 223.99/224.19  |- skos__altLabel mesh__D004632 Services, Emergency Medical
% 223.99/224.19  |- rdf__type mesh__D004632sskos__Concept
% 223.99/224.19  |- skos__hiddenLabel mesh__D004632 Emergency Service, Medical
% 223.99/224.19  |- skos__altLabel mesh__D004632 Emergency Services, Medical
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D004632 2004
% 223.99/224.19  |- mesh__recordMaintainer mesh__D004632 kle
% 223.99/224.19  |- skos__scopeNote mesh__D004632
% 223.99/224.19       Services specifically designed, staffed, and equipped for the emergency care of patients.%A%    
% 223.99/224.19  |- skos__hiddenLabel mesh__D004632 Service, Emergency Medical
% 223.99/224.19  |- mesh__dateRevised mesh__D004632 1999-11-03
% 223.99/224.19  |- skos__hiddenLabel mesh__D004632 Emergicenter
% 223.99/224.19  |- skos__hiddenLabel mesh__D004632 Services, Emergency Health
% 223.99/224.19  |- skos__hiddenLabel mesh__D004632 Health Services, Emergency
% 223.99/224.19  |- skos__hiddenLabel mesh__D004632 Medical Service, Emergency
% 223.99/224.19  |- mesh__publicMeSHNote mesh__D004632
% 223.99/224.19       80; was EMERGENCY HEALTH SERVICES 1968-79   
% 223.99/224.19  |- mesh__recordOriginator mesh__D004632 NLM
% 223.99/224.19  |- skos__altLabel mesh__D004632 Medical Services, Emergency
% 223.99/224.19  |- mesh__dateEstablished mesh__D004632 1968-01-01
% 223.99/224.19  |- mesh__historyNote mesh__D004632
% 223.99/224.19       80; was EMERGENCY HEALTH SERVICES 1968-79   
% 223.99/224.19  |- skos__broader mesh__D004632smesh__D006296
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D004632 2000
% 223.99/224.19  |- skos__hiddenLabel mesh__D004632 Service, Medical Emergency
% 223.99/224.19  |- skos__historyNote mesh__D004632 Emergencies %28%1966-1967%29%
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D004632 2005
% 223.99/224.19  |- skos__hiddenLabel mesh__D004632 Medical Emergency Service
% 223.99/224.19  |- skos__hiddenLabel mesh__D004632 Service, Emergency Health
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014262 2000
% 223.99/224.19  |- skos__hiddenLabel mesh__D014262 Incompetence, Tricuspid
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014262 1993
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014262 2006
% 223.99/224.19  |- mesh__recordAuthorizer mesh__D014262 PLS
% 223.99/224.19  |- skos__hiddenLabel mesh__D014262 Valve Insufficiency, Tricuspid
% 223.99/224.19  |- mesh__onlineNote mesh__D014262
% 223.99/224.19       use TRICUSPID VALVE INSUFFICIENCY to search TRICUSPID INSUFFICIENCY 1966%A%  
% 223.99/224.19  |- mesh__dateRevised mesh__D014262 1992-05-22
% 223.99/224.19  |- mesh__dateCreated mesh__D014262 1999-01-01
% 223.99/224.19  |- skos__altLabel mesh__D014262 Tricuspid Valve Regurgitation
% 223.99/224.19  |- skos__hiddenLabel mesh__D014262 Valve Incompetence, Tricuspid
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014262 2001
% 223.99/224.19  |- skos__altLabel mesh__D014262 Tricuspid Valve Incompetence
% 223.99/224.19  |- mesh__publicMeSHNote mesh__D014262
% 223.99/224.19       67; was TRICUSPID INSUFFICIENCY 1963-66   
% 223.99/224.19  |- skos__hiddenLabel mesh__D014262 Valve Regurgitation, Tricuspid
% 223.99/224.19  |- rdf__type mesh__D014262sskos__Concept
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014262 1996
% 223.99/224.19  |- skos__hiddenLabel mesh__D014262 Regurgitation, Tricuspid Valve
% 223.99/224.19  |- mesh__recordMaintainer mesh__D014262 PLS
% 223.99/224.19  |- skos__hiddenLabel mesh__D014262 Regurgitation, Tricuspid
% 223.99/224.19  |- mesh__historyNote mesh__D014262
% 223.99/224.19       67; was TRICUSPID INSUFFICIENCY 1963-66   
% 223.99/224.19  |- skos__altLabel mesh__D014262 Tricuspid Regurgitation
% 223.99/224.19  |- skos__broader mesh__D014262smesh__D006349
% 223.99/224.19  |- skos__altLabel mesh__D014262 Tricuspid Incompetence
% 223.99/224.19  |- skos__annotation mesh__D014262 imperfect closing of valve   
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014262 1997
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014262 2002
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014262 2003
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014262 1998
% 223.99/224.19  |- mesh__dateEstablished mesh__D014262 1967-01-01
% 223.99/224.19  |- skos__hiddenLabel mesh__D014262 Insufficiency, Tricuspid Valve
% 223.99/224.19  |- skos__hiddenLabel mesh__D014262 Incompetence, Tricuspid Valve
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014262 1994
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014262 2004
% 223.99/224.19  |- skos__scopeNote mesh__D014262
% 223.99/224.19       Backflow of blood from the right ventricle into the right atrium, owing to imperfect functioning of the tricuspid valve.%A%    
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014262 1999
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014262 2005
% 223.99/224.19  |- mesh__recordOriginator mesh__D014262 NLM
% 223.99/224.19  |- skos__prefLabel mesh__D014262 Tricuspid Valve Insufficiency
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D014262 1995
% 223.99/224.19  |- rdf__type mesh__D008225sskos__Concept
% 223.99/224.19  |- skos__hiddenLabel mesh__D008225 Reticulosarcomas
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D008225 2005
% 223.99/224.19  |- mesh__historyNote mesh__D008225
% 223.99/224.19       91; was LYMPHOMA, HISTIOCYTIC 1987-90; SARCOMA, RETICULUM CELL was see LYMPHOMA, HISTIOCYTIC 1987-90, was heading 1963-86%A%  
% 223.99/224.19  |- skos__altLabel mesh__D008225 Large-Cell Lymphoma
% 223.99/224.19  |- skos__hiddenLabel mesh__D008225 Lymphomas, Large-Cell
% 223.99/224.19  |- skos__altLabel mesh__D008225 Sarcoma, Reticulum-Cell
% 223.99/224.19  |- skos__scopeNote mesh__D008225
% 223.99/224.19       The most common aggressive form of non-Hodgkin lymphoma. It occurs in both diffuse and nodular form. The large cells may have cleaved and non-cleaved nuclei.%A%    
% 223.99/224.19  |- skos__altLabel mesh__D008225 Reticulosarcoma
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D008225 2006
% 223.99/224.19  |- mesh__dateEstablished mesh__D008225 1987-01-01
% 223.99/224.19  |- skos__prefLabel mesh__D008225 Lymphoma, Large-Cell
% 223.99/224.19  |- mesh__recordOriginator mesh__D008225 VDK
% 223.99/224.19  |- skos__altLabel mesh__D008225 Histiocytic Lymphoma
% 223.99/224.19  |- mesh__recordAuthorizer mesh__D008225 sjn
% 223.99/224.19  |- skos__altLabel mesh__D008225 Lymphoma, Histiocytic
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D008225 2000
% 223.99/224.19  |- mesh__dateRevised mesh__D008225 1999-11-03
% 223.99/224.19  |- skos__hiddenLabel mesh__D008225 Lymphomas, Histiocytic
% 223.99/224.19  |- skos__hiddenLabel mesh__D008225 Sarcomas, Reticulum-Cell
% 223.99/224.19  |- mesh__publicMeSHNote mesh__D008225
% 223.99/224.19       91; was LYMPHOMA, HISTIOCYTIC 1987-90; SARCOMA, RETICULUM CELL was see LYMPHOMA, HISTIOCYTIC 1987-90, was heading 1963-86%A%  
% 223.99/224.19  |- skos__hiddenLabel mesh__D008225 Sarcoma, Reticulum Cell
% 223.99/224.19  |- skos__hiddenLabel mesh__D008225 Reticulum Cell Sarcoma
% 223.99/224.19  |- skos__annotation mesh__D008225 DF: LYMPHOMA LARGE   
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D008225 2001
% 223.99/224.19  |- skos__hiddenLabel mesh__D008225 Histiocytic Lymphomas
% 223.99/224.19  |- mesh__dateCreated mesh__D008225 1986-06-23
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D008225 2003
% 223.99/224.19  |- skos__broader mesh__D008225smesh__D015620
% 223.99/224.19  |- skos__broader mesh__D008225smesh__D008228
% 223.99/224.19  |- skos__hiddenLabel mesh__D008225 Large-Cell Lymphomas
% 223.99/224.19  |- skos__historyNote mesh__D008225 Lymphoma %28%1966-1986%29%
% 223.99/224.19  |- skos__hiddenLabel mesh__D008225 Lymphoma, Large Cell
% 223.99/224.19  |- skos__hiddenLabel mesh__D008225 Reticulum-Cell Sarcomas
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D008225 2002
% 223.99/224.19  |- skos__altLabel mesh__D008225 Reticulum-Cell Sarcoma
% 223.99/224.19  |- skos__hiddenLabel mesh__D008225 Large Cell Lymphoma
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D008225 2004
% 223.99/224.19  |- mesh__onlineNote mesh__D008225
% 223.99/224.19       use LYMPHOMA, LARGE-CELL to search LYMPHOMA, HISTIOCYTIC 1987-90 %26% SARCOMA, RETICULUM CELL 1966-86%A%  
% 223.99/224.19  |- mesh__recordMaintainer mesh__D008225 KEV
% 223.99/224.19  |- skos__hiddenLabel mesh__D000242
% 223.99/224.19       Cyclic 3%27%,5%27%-Monophosphate, Adenosine
% 223.99/224.19  |- skos__prefLabel mesh__D000242 Cyclic AMP
% 223.99/224.19  |- skos__altLabel mesh__D000242 Adenosine Cyclic 3,5 Monophosphate
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D000242 2005
% 223.99/224.19  |- mesh__dateEstablished mesh__D000242 1972-01-01
% 223.99/224.19  |- mesh__dateCreated mesh__D000242 1999-01-01
% 223.99/224.19  |- skos__hiddenLabel mesh__D000242 Monophosphate, Adenosine Cyclic
% 223.99/224.19  |- skos__altLabel mesh__D000242 Adenosine Cyclic-3%27%,5%27%-Monophosphate
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D000242 2002
% 223.99/224.19  |- skos__hiddenLabel mesh__D000242 AMP, Cyclic
% 223.99/224.19  |- skos__broader mesh__D000242smesh__D009712
% 223.99/224.19  |- skos__annotation mesh__D000242
% 223.99/224.19       /biosyn /physiol permitted; cAMP receptor protein, cyclic AMP receptor protein: index under RECEPTORS, CYCLIC AMP; DF: CYCL AMP%A%  
% 223.99/224.19  |- rdf__type mesh__D000242sskos__Concept
% 223.99/224.19  |- mesh__recordMaintainer mesh__D000242 ssb
% 223.99/224.19  |- mesh__recordAuthorizer mesh__D000242 sjn
% 223.99/224.19  |- mesh__recordOriginator mesh__D000242 NLM
% 223.99/224.19  |- skos__broader mesh__D000242smesh__D000227
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D000242 2004
% 223.99/224.19  |- mesh__dateRevised mesh__D000242 2001-07-25
% 223.99/224.19  |- mesh__publicMeSHNote mesh__D000242
% 223.99/224.19       94; was ADENOSINE CYCLIC MONOPHOSPHATE 1980-93, was ADENOSINE CYCLIC-3%27%,5%27%-MONOPHOSPHATE 1978-79, was ADENOSINE CYCLIC 3%27%,5%27% MONOPHOSPHATE 1972-77; CYCLIC AMP was see ADENOSINE CYCLIC MONOPHOSPHATE 1976-93; ADENOSINE CYCLIC 2%27%,3%27%-MONOPHOSPHATE was see ADENOSINE CYCLIC MONOPHOSPHATE 1980-93%A%  
% 223.99/224.19  |- skos__hiddenLabel mesh__D000242
% 223.99/224.19       Adenosine Cyclic 3%27%,5%27% Monophosphate
% 223.99/224.19  |- mesh__onlineNote mesh__D000242
% 223.99/224.19       use CYCLIC AMP to search ADENOSINE CYCLIC MONOPHOSPHATE %26% ADENOSINE CYCLIC 2%27%,3%27%-MONOPHOSPHATE 1980-93 %26% ADENOSINE CYCLIC-3%27%,5%27%-MONOPHOSPHATE 1968-79 %28%as Prov 1968-71%29%%A%  
% 223.99/224.19  |- mesh__historyNote mesh__D000242
% 223.99/224.19       94; was ADENOSINE CYCLIC MONOPHOSPHATE 1980-93, was ADENOSINE CYCLIC-3%27%,5%27%-MONOPHOSPHATE 1978-79, was ADENOSINE CYCLIC 3%27%,5%27% MONOPHOSPHATE 1968-77 %28%Prov 1968-71%29%; CYCLIC AMP was see ADENOSINE CYCLIC MONOPHOSPHATE 1976-93; ADENOSINE CYCLIC 2%27%,3%27%-MONOPHOSPHATE was see ADENOSINE CYCLIC MONOPHOSPHATE 1980-93%A%  
% 223.99/224.19  |- skos__hiddenLabel mesh__D000242
% 223.99/224.19       3%27%,5%27%-Monophosphate, Adenosine Cyclic
% 223.99/224.19  |- skos__altLabel mesh__D000242 Adenosine Cyclic 3%27%,5%27%-Monophosphate
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D000242 2003
% 223.99/224.19  |- skos__scopeNote mesh__D000242
% 223.99/224.19       An adenine nucleotide containing one phosphate group which is esterified to both the 3%27%- and 5%27%-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH.%A%    
% 223.99/224.19  |- skos__hiddenLabel mesh__D000242
% 223.99/224.19       Cyclic-3%27%,5%27%-Monophosphate, Adenosine
% 223.99/224.19  |- skos__hiddenLabel mesh__D000242 Cyclic Monophosphate, Adenosine
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D000242 2006
% 223.99/224.19  |- skos__altLabel mesh__D000242 Adenosine Cyclic Monophosphate
% 223.99/224.19  |- skos__historyNote mesh__D000242 Adenine Nucleotides %28%1966-1968%29%
% 223.99/224.19  |- skos__related mesh__D000242smesh__D011953
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Thyroiditides, Subacute Nonsuppurative
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Thyroiditis, Subacute Painful
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Granulomatous Thyroiditides
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Painful Thyroiditides, Subacute
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D013968 2006
% 223.99/224.19  |- skos__prefLabel mesh__D013968 Thyroiditis, Subacute
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Thyroiditis, Giant Cell
% 223.99/224.19  |- skos__annotation mesh__D013968
% 223.99/224.19       do not confuse with de Quervain%27%s disease of tendon sheath of thumb muscles %28% = TENOSYNOVITIS%29%%A%  
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Thyroiditides, Giant Cell
% 223.99/224.19  |- mesh__recordAuthorizer mesh__D013968 ags
% 223.99/224.19  |- skos__historyNote mesh__D013968 Thyroiditis %28%1966-1986%29%
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Painful Thyroiditis, Subacute
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Cell Thyroiditides, Giant
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Cell Thyroiditis, Giant
% 223.99/224.19  |- skos__altLabel mesh__D013968 Subacute Nonsuppurative Thyroiditis
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Nonsuppurative Thyroiditis, Subacute
% 223.99/224.19  |- mesh__publicMeSHNote mesh__D013968 87   
% 223.99/224.19  |- mesh__historyNote mesh__D013968 87   
% 223.99/224.19  |- skos__altLabel mesh__D013968 Granulomatous Thyroiditis
% 223.99/224.19  |- mesh__dateEstablished mesh__D013968 1987-01-01
% 223.99/224.19  |- mesh__dateRevised mesh__D013968 2005-08-03
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Subacute Nonsuppurative Thyroiditides
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Subacute Thyroiditides
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Thyroiditides, Subacute
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Thyroiditides, Subacute Painful
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D013968 2006A
% 223.99/224.19  |- skos__scopeNote mesh__D013968
% 223.99/224.19       Spontaneously remitting inflammatory condition of the THYROID GLAND, characterized by FEVER; MUSCLE WEAKNESS; SORE THROAT; severe thyroid PAIN; and an enlarged damaged gland containing GIANT CELLS. The disease frequently follows a viral infection.%A%    
% 223.99/224.19  |- skos__altLabel mesh__D013968 De Quervain Thyroiditis
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Thyroiditis, Granulomatous
% 223.99/224.19  |- rdf__type mesh__D013968sskos__Concept
% 223.99/224.19  |- skos__altLabel mesh__D013968 Giant Cell Thyroiditis
% 223.99/224.19  |- mesh__recordMaintainer mesh__D013968 ags
% 223.99/224.19  |- skos__broader mesh__D013968smesh__D013966
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Subacute Painful Thyroiditides
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Subacute Thyroiditis
% 223.99/224.19  |- mesh__recordOriginator mesh__D013968 VDK
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Giant Cell Thyroiditides
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Thyroiditides, Granulomatous
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Thyroiditis, Subacute Nonsuppurative
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Thyroiditis, De Quervain
% 223.99/224.19  |- mesh__dateCreated mesh__D013968 1986-03-26
% 223.99/224.19  |- skos__hiddenLabel mesh__D013968 Nonsuppurative Thyroiditides, Subacute
% 223.99/224.19  |- skos__altLabel mesh__D013968 Subacute Painful Thyroiditis
% 223.99/224.19  |- mesh__dateCreated mesh__D018653 1994-05-27
% 223.99/224.19  |- skos__altLabel mesh__D018653 Cedar, Western
% 223.99/224.19  |- mesh__dateEstablished mesh__D018653 1995-01-01
% 223.99/224.19  |- mesh__recordMaintainer mesh__D018653 sjn
% 223.99/224.19  |- mesh__publicMeSHNote mesh__D018653
% 223.99/224.19       1995; see TREES 1986-1994, see JUNIPERUS 1963-1985; JUNIPERUS OXYCEDRUS was indexed under ALLERGENS 1998-2001%A%  
% 223.99/224.19  |- mesh__historyNote mesh__D018653
% 223.99/224.19       1995, 1963-1985; use TREES 1986-1994; for JUNIPERUS OXYCEDRUS use JUNIPERUS OXYCEDRUS %28%NM%29% 1998-2001%A%  
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D018653 2006
% 223.99/224.19  |- skos__altLabel mesh__D018653 Western Cedar
% 223.99/224.19  |- mesh__dateRevised mesh__D018653 2003-07-25
% 223.99/224.19  |- mesh__recordOriginator mesh__D018653 TGC
% 223.99/224.19  |- skos__annotation mesh__D018653
% 223.99/224.19       note X refs WESTERN CEDAR and EASTERN RED CEDAR: check text to distinguish from other cedar terms in MeSH; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.99/224.19  |- skos__prefLabel mesh__D018653 Juniperus
% 223.99/224.19  |- mesh__activeMeSHYear mesh__D018653 2005
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D018653 2004
% 223.99/224.20  |- skos__altLabel mesh__D018653 Cedar, Red Eastern
% 223.99/224.20  |- skos__scopeNote mesh__D018653
% 223.99/224.20       A plant genus of the family CUPRESSACEAE.  The species are slow growing coniferous evergreen trees or shrubs.%A%    
% 223.99/224.20  |- mesh__recordAuthorizer mesh__D018653 sjn
% 223.99/224.20  |- skos__altLabel mesh__D018653 Eastern Red Cedar
% 223.99/224.20  |- skos__broader mesh__D018653smesh__D029779
% 223.99/224.20  |- skos__altLabel mesh__D018653 Red Cedar, Eastern
% 223.99/224.20  |- skos__altLabel mesh__D018653 Juniper, Common
% 223.99/224.20  |- skos__altLabel mesh__D018653 Cade
% 223.99/224.20  |- rdf__type mesh__D018653sskos__Concept
% 223.99/224.20  |- skos__historyNote mesh__D018653 Trees %28%1969-1994%29%
% 223.99/224.20  |- mesh__historyNote mesh__D010670 66%28%64%29%   
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010670 2004
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010670 2002
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010670 1999
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010670 1993
% 223.99/224.20  |- mesh__recordAuthorizer mesh__D010670 PLS
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010670 2003
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010670 2001
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010670 1998
% 223.99/224.20  |- mesh__dateCreated mesh__D010670 1999-01-01
% 223.99/224.20  |- rdf__type mesh__D010670sskos__Concept
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010670 2000
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010670 1997
% 223.99/224.20  |- mesh__recordMaintainer mesh__D010670 TAP
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010670 2006
% 223.99/224.20  |- mesh__publicMeSHNote mesh__D010670 66   
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010670 1996
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010670 1995
% 223.99/224.20  |- mesh__recordOriginator mesh__D010670 NLM
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010670 2005
% 223.99/224.20  |- mesh__dateEstablished mesh__D010670 1966-01-01
% 223.99/224.20  |- skos__broader mesh__D010670smesh__D013890
% 223.99/224.20  |- skos__altLabel mesh__D010670 Phenylthiocarbamide
% 223.99/224.20  |- mesh__dateRevised mesh__D010670 1992-05-19
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010670 1994
% 223.99/224.20  |- skos__prefLabel mesh__D010670 Phenylthiourea
% 223.99/224.20  |- skos__scopeNote mesh__D032324
% 223.99/224.20       A plant species of the genus SOLANUM, family SOLANACEAE that contains steroidal glycosides.%A%    
% 223.99/224.20  |- skos__broader mesh__D032324smesh__D032322
% 223.99/224.20  |- skos__prefLabel mesh__D032324 Solanum nigrum
% 223.99/224.20  |- skos__altLabel mesh__D032324 Black Nightshade
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D032324 2006
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D032324 2004
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D032324 2005
% 223.99/224.20  |- rdf__type mesh__D032324sskos__Concept
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D032324 2003
% 223.99/224.20  |- mesh__historyNote mesh__D032324 2003   
% 223.99/224.20  |- mesh__publicMeSHNote mesh__D032324 2003   
% 223.99/224.20  |- skos__annotation mesh__D032324
% 223.99/224.20       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 223.99/224.20  |- skos__altLabel mesh__D032324 Nightshade, Black
% 223.99/224.20  |- mesh__dateEstablished mesh__D032324 2003-01-01
% 223.99/224.20  |- mesh__dateCreated mesh__D032324 2002-07-02
% 223.99/224.20  |- rdf__type mesh__D004633sskos__Concept
% 223.99/224.20  |- mesh__recordOriginator mesh__D004633 NLM
% 223.99/224.20  |- mesh__dateEstablished mesh__D004633 1991-01-01
% 223.99/224.20  |- mesh__dateCreated mesh__D004633 1999-01-01
% 223.99/224.20  |- skos__historyNote mesh__D004633 Equipment and Supplies %28%1966-1968%29%
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004633 1997
% 223.99/224.20  |- skos__broader mesh__D004633smesh__D004864
% 223.99/224.20  |- skos__historyNote mesh__D004633 Emergencies %28%1966-1968%29%
% 223.99/224.20  |- skos__prefLabel mesh__D004633 Emergency Medical Tags
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004633 2002
% 223.99/224.20  |- skos__annotation mesh__D004633 DF: EMERGENCY MED TAGS   
% 223.99/224.20  |- skos__altLabel mesh__D004633 Medical Tags, Emergency
% 223.99/224.20  |- skos__altLabel mesh__D004633 Medical Tag, Emergency
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004633 1993
% 223.99/224.20  |- skos__altLabel mesh__D004633 Tag, Emergency Medical
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004633 2004
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004633 1996
% 223.99/224.20  |- mesh__publicMeSHNote mesh__D004633
% 223.99/224.20       91; was see under EQUIPMENT AND SUPPLIES 1969-90   
% 223.99/224.20  |- mesh__recordMaintainer mesh__D004633 TAP
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004633 1999
% 223.99/224.20  |- skos__altLabel mesh__D004633 Tags, Emergency Medical
% 223.99/224.20  |- mesh__dateRevised mesh__D004633 1992-05-15
% 223.99/224.20  |- mesh__recordAuthorizer mesh__D004633 PLS
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004633 2003
% 223.99/224.20  |- skos__altLabel mesh__D004633 Emergency Medical Tag
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004633 1995
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004633 2001
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004633 2006
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004633 1998
% 223.99/224.20  |- mesh__historyNote mesh__D004633
% 223.99/224.20       91%28%69%29%; was see under EQUIPMENT AND SUPPLIES 1969-90   
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004633 1994
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004633 2000
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004633 2005
% 223.99/224.20  |- skos__broader mesh__D001755Q000637smesh__D001755
% 223.99/224.20  |- mesh__preferredCombination mesh__D001755Q000637smesh__D004624
% 223.99/224.20  |- rdf__type mesh__D001755Q000637smesh__CompoundConcept
% 223.99/224.20  |- mesh__dateCreated mesh__D014263 1982-04-26
% 223.99/224.20  |- mesh__publicMeSHNote mesh__D014263
% 223.99/224.20       91; was see under HEART VALVE DISEASES 1983-90   
% 223.99/224.20  |- skos__historyNote mesh__D014263 Heart Valve Diseases %28%1967-1982%29%
% 223.99/224.20  |- rdf__type mesh__D014263sskos__Concept
% 223.99/224.20  |- skos__hiddenLabel mesh__D014263 Valve Prolapse, Tricuspid
% 223.99/224.20  |- skos__historyNote mesh__D014263 Tricuspid Valve %28%1966-1982%29%
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D014263 2005
% 223.99/224.20  |- skos__scopeNote mesh__D014263
% 223.99/224.20       Abnormal protrusion of one or more of the leaflets of the tricuspid valve into the right atrium during systole.%A%    
% 223.99/224.20  |- mesh__recordMaintainer mesh__D014263 lkt
% 223.99/224.20  |- skos__hiddenLabel mesh__D014263 Prolapses, Tricuspid Valve
% 223.99/224.20  |- skos__hiddenLabel mesh__D014263 Valve Prolapses, Tricuspid
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D014263 2006
% 223.99/224.20  |- mesh__dateEstablished mesh__D014263 1991-01-01
% 223.99/224.20  |- mesh__recordOriginator mesh__D014263 VDK
% 223.99/224.20  |- skos__hiddenLabel mesh__D014263 Tricuspid Valve Prolapses
% 223.99/224.20  |- mesh__historyNote mesh__D014263
% 223.99/224.20       91%28%83%29%; was see under HEART VALVE DISEASES 1983-90   
% 223.99/224.20  |- skos__prefLabel mesh__D014263 Tricuspid Valve Prolapse
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D014263 2004
% 223.99/224.20  |- skos__broader mesh__D014263smesh__D016127
% 223.99/224.20  |- skos__hiddenLabel mesh__D014263 Prolapse, Tricuspid Valve
% 223.99/224.20  |- mesh__dateRevised mesh__D014263 2003-07-09
% 223.99/224.20  |- mesh__recordAuthorizer mesh__D014263 sjn
% 223.99/224.20  |- skos__hiddenLabel mesh__D008226 Small-Cell Lymphomas
% 223.99/224.20  |- skos__hiddenLabel mesh__D008226 Small Cell Lymphoma
% 223.99/224.20  |- mesh__recordMaintainer mesh__D008226 KEV
% 223.99/224.20  |- mesh__dateRevised mesh__D008226 1995-06-08
% 223.99/224.20  |- skos__historyNote mesh__D008226
% 223.99/224.20       Lymphoma, Non-Hodgkin%27%s %28%1966-1986%29%
% 223.99/224.20  |- skos__altLabel mesh__D008226 Lymphoma, Lymphocytic, Plasmacytoid
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008226 1996
% 223.99/224.20  |- skos__hiddenLabel mesh__D008226 Lymphomas, Lymphocytic
% 223.99/224.20  |- skos__altLabel mesh__D008226 Lymphoma, Lymphocytic
% 223.99/224.20  |- skos__hiddenLabel mesh__D008226 Lymphocytic Lymphomas
% 223.99/224.20  |- mesh__recordAuthorizer mesh__D008226 PLS
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008226 2006
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008226 2002
% 223.99/224.20  |- skos__scopeNote mesh__D008226
% 223.99/224.20       A B-cell lymphoma presumably representing a tumor of interfollicular B-lymphocytes that may be functional. Those that are secrete identical immunoglobulin molecules.%A%    
% 223.99/224.20  |- skos__hiddenLabel mesh__D008226 Lymphomas, Small-Cell
% 223.99/224.20  |- skos__prefLabel mesh__D008226 Lymphoma, Small-Cell
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008226 2005
% 223.99/224.20  |- skos__broader mesh__D008226smesh__D016393
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008226 2001
% 223.99/224.20  |- mesh__recordOriginator mesh__D008226 VDK
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008226 1999
% 223.99/224.20  |- skos__annotation mesh__D008226
% 223.99/224.20       a non-Hodgkin%27%s lymphoma; DF: LYMPHOMA SMALL   
% 223.99/224.20  |- skos__altLabel mesh__D008226 Lymphocytic Lymphoma
% 223.99/224.20  |- mesh__dateCreated mesh__D008226 1986-06-23
% 223.99/224.20  |- mesh__historyNote mesh__D008226 91; was LYMPHOMA, LYMPHOCYTIC 1987-90   
% 223.99/224.20  |- skos__broader mesh__D008226smesh__D008228
% 223.99/224.20  |- skos__hiddenLabel mesh__D008226 Lymphoma, Small Cell
% 223.99/224.20  |- rdf__type mesh__D008226sskos__Concept
% 223.99/224.20  |- mesh__dateEstablished mesh__D008226 1987-01-01
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008226 2004
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008226 1998
% 223.99/224.20  |- mesh__publicMeSHNote mesh__D008226
% 223.99/224.20       91; was LYMPHOMA, LYMPHOCYTIC 1987-90   
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008226 2000
% 223.99/224.20  |- skos__altLabel mesh__D008226 Small-Cell Lymphoma
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008226 2003
% 223.99/224.20  |- skos__historyNote mesh__D008226 Lymphoma %28%1966-1986%29%
% 223.99/224.20  |- mesh__onlineNote mesh__D008226
% 223.99/224.20       use LYMPHOMA, SMALL-CELL to search LYMPHOMA, LYMPHOCYTIC 1987-90%A%  
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008226 1997
% 223.99/224.20  |- skos__historyNote mesh__D000243 Aminohydrolases %28%1972-1974%29%
% 223.99/224.20  |- rdf__type mesh__D000243sskos__Concept
% 223.99/224.20  |- mesh__recordMaintainer mesh__D000243 sjn
% 223.99/224.20  |- skos__prefLabel mesh__D000243 Adenosine Deaminase
% 223.99/224.20  |- mesh__publicMeSHNote mesh__D000243
% 223.99/224.20       91; was see under NUCLEOSIDE DEAMINASES 1975-90   
% 223.99/224.20  |- skos__hiddenLabel mesh__D000243 Aminohydrolase, Adenosine
% 223.99/224.20  |- skos__altLabel mesh__D000243 Adenosine Aminohydrolase
% 223.99/224.20  |- skos__hiddenLabel mesh__D000243 Deaminase, Adenosine
% 223.99/224.20  |- skos__historyNote mesh__D000243 Adenosine %28%1972-1974%29%
% 223.99/224.20  |- skos__broader mesh__D000243smesh__D009700
% 223.99/224.20  |- mesh__historyNote mesh__D000243
% 223.99/224.20       91%28%75%29%; was see under NUCLEOSIDE DEAMINASES 1975-90   
% 223.99/224.20  |- mesh__dateCreated mesh__D000243 1974-11-27
% 223.99/224.20  |- mesh__dateRevised mesh__D000243 2004-07-13
% 223.99/224.20  |- mesh__recordAuthorizer mesh__D000243 sjn
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D000243 2006
% 223.99/224.20  |- mesh__recordOriginator mesh__D000243 NLM
% 223.99/224.20  |- mesh__dateEstablished mesh__D000243 1991-01-01
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D000243 2005
% 223.99/224.20  |- skos__annotation mesh__D000243
% 223.99/224.20       /defic: consider also SEVERE COMBINED IMMUNODEFICIENCY or SCID%A%  
% 223.99/224.20  |- skos__scopeNote mesh__D000243
% 223.99/224.20       An enzyme that catalyzes the hydrolysis of adenosine to inosine with the elimination of ammonia. Since there are wide tissue and species variations in the enzyme, it has been used as a tool in the study of human and animal genetics and in medical diagnosis. EC 3.5.4.4.%A%    
% 223.99/224.20  |- mesh__recordOriginator mesh__D013969 VDK
% 223.99/224.20  |- skos__hiddenLabel mesh__D013969 Thyroiditides, Acute Infectious
% 223.99/224.20  |- skos__historyNote mesh__D013969 Thyroiditis %28%1966-1986%29%
% 223.99/224.20  |- mesh__recordMaintainer mesh__D013969 lkt
% 223.99/224.20  |- skos__hiddenLabel mesh__D013969 Thyroiditis, Acute Infectious
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D013969 2006
% 223.99/224.20  |- skos__hiddenLabel mesh__D013969 Suppurative Thyroiditides
% 223.99/224.20  |- rdf__type mesh__D013969sskos__Concept
% 223.99/224.20  |- skos__altLabel mesh__D013969 Acute Infectious Thyroiditis
% 223.99/224.20  |- mesh__recordAuthorizer mesh__D013969 sjn
% 223.99/224.20  |- skos__hiddenLabel mesh__D013969 Suppurative Thyroiditis, Acute
% 223.99/224.20  |- skos__hiddenLabel mesh__D013969 Thyroiditides, Infectious
% 223.99/224.20  |- skos__hiddenLabel mesh__D013969 Infectious Thyroiditides, Acute
% 223.99/224.20  |- skos__hiddenLabel mesh__D013969 Suppurative Thyroiditides, Acute
% 223.99/224.20  |- mesh__publicMeSHNote mesh__D013969
% 223.99/224.20       91; was see under THYROIDITIS 1987-90   
% 223.99/224.20  |- skos__altLabel mesh__D013969 Infectious Thyroiditis
% 223.99/224.20  |- skos__hiddenLabel mesh__D013969 Thyroiditides, Suppurative
% 223.99/224.20  |- skos__scopeNote mesh__D013969
% 223.99/224.20       Acute inflammatory disease of the THYROID GLAND due to infections by BACTERIA; FUNGI; PROTOZOA; or other microorganisms. Symptoms include tender swelling, FEVER, and often with LEUKOCYTOSIS.%A%    
% 223.99/224.20  |- mesh__historyNote mesh__D013969
% 223.99/224.20       91%28%87%29%; was see under THYROIDITIS 1987-90   
% 223.99/224.20  |- skos__broader mesh__D013969smesh__D013966
% 223.99/224.20  |- skos__hiddenLabel mesh__D013969 Thyroiditis, Acute Suppurative
% 223.99/224.20  |- skos__altLabel mesh__D013969 Thyroiditis, Infectious
% 223.99/224.20  |- skos__hiddenLabel mesh__D013969 Infectious Thyroiditis, Acute
% 223.99/224.20  |- skos__hiddenLabel mesh__D013969 Thyroiditides, Acute Suppurative
% 223.99/224.20  |- skos__hiddenLabel mesh__D013969 Suppurative Thyroiditis
% 223.99/224.20  |- skos__hiddenLabel mesh__D013969 Infectious Thyroiditides
% 223.99/224.20  |- skos__annotation mesh__D013969
% 223.99/224.20       coordinate IM with specific infection %28%IM%29%   
% 223.99/224.20  |- skos__hiddenLabel mesh__D013969 Acute Suppurative Thyroiditides
% 223.99/224.20  |- skos__hiddenLabel mesh__D013969 Acute Infectious Thyroiditides
% 223.99/224.20  |- skos__altLabel mesh__D013969 Acute Suppurative Thyroiditis
% 223.99/224.20  |- mesh__dateEstablished mesh__D013969 1991-01-01
% 223.99/224.20  |- mesh__dateRevised mesh__D013969 2005-06-30
% 223.99/224.20  |- mesh__dateCreated mesh__D013969 1986-03-26
% 223.99/224.20  |- skos__historyNote mesh__D013969 Suppuration %28%1966-1986%29%
% 223.99/224.20  |- skos__prefLabel mesh__D013969 Thyroiditis, Suppurative
% 223.99/224.20  |- skos__broader mesh__D013969smesh__D013492
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010671 2004
% 223.99/224.20  |- skos__prefLabel mesh__D010671 Phenylurea Compounds
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010671 2002
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010671 1999
% 223.99/224.20  |- skos__hiddenLabel mesh__D010671 Compounds, Phenylurea
% 223.99/224.20  |- mesh__dateEstablished mesh__D010671 1974-01-01
% 223.99/224.20  |- mesh__historyNote mesh__D010671 74   
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010671 1993
% 223.99/224.20  |- mesh__recordOriginator mesh__D010671 NLM
% 223.99/224.20  |- mesh__recordAuthorizer mesh__D010671 PLS
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010671 1996
% 223.99/224.20  |- rdf__type mesh__D010671sskos__Concept
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010671 2005
% 223.99/224.20  |- skos__broader mesh__D010671smesh__D014508
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010671 2000
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010671 1997
% 223.99/224.20  |- skos__altLabel mesh__D010671 Phenylcarbamides
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010671 2006
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010671 1994
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010671 2001
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010671 1995
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010671 2003
% 223.99/224.20  |- mesh__dateRevised mesh__D010671 1992-05-19
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D010671 1998
% 223.99/224.20  |- mesh__dateCreated mesh__D010671 1999-01-01
% 223.99/224.20  |- mesh__publicMeSHNote mesh__D010671 74   
% 223.99/224.20  |- mesh__recordMaintainer mesh__D010671 TAP
% 223.99/224.20  |- skos__annotation mesh__D010671 DF: PHENYLUREA CPDS   
% 223.99/224.20  |- mesh__recordOriginator mesh__D004634 EC
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004634 2005
% 223.99/224.20  |- skos__broader mesh__D004634smesh__D000488
% 223.99/224.20  |- skos__hiddenLabel mesh__D004634 Technician, Emergency Medicine
% 223.99/224.20  |- skos__altLabel mesh__D004634 Medical Technicians, Emergency
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004634 1996
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004634 1993
% 223.99/224.20  |- skos__hiddenLabel mesh__D004634 Technicians, Emergency Medicine
% 223.99/224.20  |- skos__hiddenLabel mesh__D004634 Emergency Medicine Technician
% 223.99/224.20  |- skos__hiddenLabel mesh__D004634 Emergency Paramedics
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004634 2006
% 223.99/224.20  |- skos__altLabel mesh__D004634 Medical Technician, Emergency
% 223.99/224.20  |- skos__annotation mesh__D004634 DF: EMERGENCY MED TECHNICIANS   
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004634 2002
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004634 1997
% 223.99/224.20  |- skos__altLabel mesh__D004634 Technicians, Emergency Medical
% 223.99/224.20  |- skos__hiddenLabel mesh__D004634 Paramedic, Emergency
% 223.99/224.20  |- mesh__dateRevised mesh__D004634 1992-05-15
% 223.99/224.20  |- skos__altLabel mesh__D004634 Emergency Medical Technician
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004634 2003
% 223.99/224.20  |- mesh__publicMeSHNote mesh__D004634
% 223.99/224.20       91; was see under ALLIED HEALTH PERSONNEL 1979-90   
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004634 1994
% 223.99/224.20  |- skos__altLabel mesh__D004634 Paramedics, Emergency
% 223.99/224.20  |- mesh__recordAuthorizer mesh__D004634 PLS
% 223.99/224.20  |- mesh__recordMaintainer mesh__D004634 TAP
% 223.99/224.20  |- mesh__historyNote mesh__D004634
% 223.99/224.20       91%28%79%29%; was see under ALLIED HEALTH PERSONNEL 1979-90   
% 223.99/224.20  |- rdf__type mesh__D004634sskos__Concept
% 223.99/224.20  |- mesh__dateCreated mesh__D004634 1978-05-08
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004634 2004
% 223.99/224.20  |- mesh__dateEstablished mesh__D004634 1991-01-01
% 223.99/224.20  |- skos__altLabel mesh__D004634 Emergency Medicine Technicians
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004634 1998
% 223.99/224.20  |- skos__historyNote mesh__D004634
% 223.99/224.20       Allied Health Personnel %28%1971-1978%29%
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004634 1995
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004634 2000
% 223.99/224.20  |- skos__altLabel mesh__D004634 Technician, Emergency Medical
% 223.99/224.20  |- skos__hiddenLabel mesh__D004634 Emergency Paramedic
% 223.99/224.20  |- skos__prefLabel mesh__D004634 Emergency Medical Technicians
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004634 1999
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D004634 2001
% 223.99/224.20  |- skos__scopeNote mesh__D004634
% 223.99/224.20       Paramedical personnel trained to provide basic emergency care and life support under the supervision of physicians and/or nurses. These services may be carried out at the site of the emergency, in the ambulance, or in a health care institution.%A%    
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D014264 2002
% 223.99/224.20  |- skos__hiddenLabel mesh__D014264 Stenoses, Tricuspid Valve
% 223.99/224.20  |- skos__scopeNote mesh__D014264
% 223.99/224.20       The pathologic narrowing of the orifice of the tricuspid valve. %28%Stedman, 25th ed%29%%A%    
% 223.99/224.20  |- skos__hiddenLabel mesh__D014264 Valve Stenoses, Tricuspid
% 223.99/224.20  |- skos__annotation mesh__D014264 /congen permitted   
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D014264 2005
% 223.99/224.20  |- mesh__dateCreated mesh__D014264 1999-01-01
% 223.99/224.20  |- mesh__recordMaintainer mesh__D014264 TGC
% 223.99/224.20  |- skos__broader mesh__D014264smesh__D006349
% 223.99/224.20  |- mesh__onlineNote mesh__D014264
% 223.99/224.20       use TRICUSPID VALVE STENOSIS to search TRICUSPID STENOSIS 1966%A%  
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D014264 1998
% 223.99/224.20  |- skos__hiddenLabel mesh__D014264 Valve Stenosis, Tricuspid
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D014264 2003
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D014264 2006
% 223.99/224.20  |- skos__hiddenLabel mesh__D014264 Tricuspid Valve Stenoses
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D014264 1999
% 223.99/224.20  |- skos__hiddenLabel mesh__D014264 Stenosis, Tricuspid Valve
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D014264 2004
% 223.99/224.20  |- mesh__publicMeSHNote mesh__D014264 67; was TRICUSPID STENOSIS 1963-66   
% 223.99/224.20  |- mesh__dateEstablished mesh__D014264 1967-01-01
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D014264 2000
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D014264 2001
% 223.99/224.20  |- mesh__dateRevised mesh__D014264 1997-06-20
% 223.99/224.20  |- mesh__recordAuthorizer mesh__D014264 SJN
% 223.99/224.20  |- rdf__type mesh__D014264sskos__Concept
% 223.99/224.20  |- mesh__historyNote mesh__D014264 67; was TRICUSPID STENOSIS 1963-66   
% 223.99/224.20  |- skos__prefLabel mesh__D014264 Tricuspid Valve Stenosis
% 223.99/224.20  |- mesh__recordOriginator mesh__D014264 NLM
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008227 2004
% 223.99/224.20  |- mesh__recordMaintainer mesh__D008227 KEV
% 223.99/224.20  |- skos__hiddenLabel mesh__D008227 Lymphocytic-Histiocytic Lymphoma, Mixed
% 223.99/224.20  |- mesh__publicMeSHNote mesh__D008227 91; was LYMPHOMA, MIXED 1987-90   
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008227 1999
% 223.99/224.20  |- rdf__type mesh__D008227sskos__Concept
% 223.99/224.20  |- skos__hiddenLabel mesh__D008227 Mixed Lymphomas
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008227 2005
% 223.99/224.20  |- skos__altLabel mesh__D008227 Mixed-Cell Lymphoma
% 223.99/224.20  |- skos__hiddenLabel mesh__D008227 Mixed Lymphocytic-Histiocytic Lymphoma
% 223.99/224.20  |- mesh__onlineNote mesh__D008227
% 223.99/224.20       use LYMPHOMA, MIXED-CELL to search LYMPHOMA, MIXED 1987-90%A%  
% 223.99/224.20  |- skos__hiddenLabel mesh__D008227 Mixed Cell Lymphoma
% 223.99/224.20  |- mesh__dateRevised mesh__D008227 1995-06-08
% 223.99/224.20  |- skos__altLabel mesh__D008227 Lymphoma, Mixed Lymphocytic-Histiocytic
% 223.99/224.20  |- skos__scopeNote mesh__D008227
% 223.99/224.20       Malignant lymphoma characterized by the presence of a mixed population of cells, with the smaller cells resembling lymphocytes and the larger ones histiocytes. It usually presents in a nodular %28%follicular%29% pattern, but may evolve into a diffuse pattern. %28%Dorland, 27th ed%29%%A%    
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008227 2000
% 223.99/224.20  |- skos__hiddenLabel mesh__D008227 Lymphoma, Mixed Cell
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008227 2006
% 223.99/224.20  |- skos__hiddenLabel mesh__D008227 Lymphocytic-Histiocytic Lymphomas, Mixed
% 223.99/224.20  |- mesh__dateEstablished mesh__D008227 1987-01-01
% 223.99/224.20  |- mesh__recordOriginator mesh__D008227 VDK
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008227 1996
% 223.99/224.20  |- skos__hiddenLabel mesh__D008227 Mixed Lymphocytic-Histiocytic Lymphomas
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008227 2001
% 223.99/224.20  |- skos__annotation mesh__D008227
% 223.99/224.20       a non-Hodgkin%27%s lymphoma; DF: LYMPHOMA MIXED   
% 223.99/224.20  |- skos__hiddenLabel mesh__D008227 Lymphomas, Mixed-Cell
% 223.99/224.20  |- skos__historyNote mesh__D008227 Lymphoma %28%1966-1986%29%
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008227 1997
% 223.99/224.20  |- mesh__recordAuthorizer mesh__D008227 PLS
% 223.99/224.20  |- mesh__historyNote mesh__D008227 91; was LYMPHOMA, MIXED 1987-90   
% 223.99/224.20  |- skos__hiddenLabel mesh__D008227 Lymphomas, Mixed
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008227 2002
% 223.99/224.20  |- skos__prefLabel mesh__D008227 Lymphoma, Mixed-Cell
% 223.99/224.20  |- mesh__dateCreated mesh__D008227 1986-06-23
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008227 2003
% 223.99/224.20  |- skos__hiddenLabel mesh__D008227 Lymphomas, Mixed Lymphocytic-Histiocytic
% 223.99/224.20  |- skos__hiddenLabel mesh__D008227 Mixed-Cell Lymphomas
% 223.99/224.20  |- skos__broader mesh__D008227smesh__D008228
% 223.99/224.20  |- skos__hiddenLabel mesh__D008227 Lymphoma, Mixed Lymphocytic Histiocytic
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D008227 1998
% 223.99/224.20  |- skos__historyNote mesh__D008227
% 223.99/224.20       Lymphoma, Giant Follicular %28%1966-1986%29%
% 223.99/224.20  |- skos__hiddenLabel mesh__D008227 Mixed Lymphoma
% 223.99/224.20  |- skos__altLabel mesh__D008227 Lymphoma, Mixed
% 223.99/224.20  |- skos__hiddenLabel mesh__D000244 5%27%-Pyrophosphate, Adenosine
% 223.99/224.20  |- skos__prefLabel mesh__D000244 Adenosine Diphosphate
% 223.99/224.20  |- mesh__recordOriginator mesh__D000244 NLM
% 223.99/224.20  |- mesh__publicMeSHNote mesh__D000244 73   
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D000244 2000
% 223.99/224.20  |- skos__historyNote mesh__D000244 Adenine Nucleotides %28%1966-1970%29%
% 223.99/224.20  |- skos__broader mesh__D000244smesh__D000227
% 223.99/224.20  |- skos__altLabel mesh__D000244 Adenosine Pyrophosphate
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D000244 2003
% 223.99/224.20  |- skos__annotation mesh__D000244 /biosyn /physiol permitted   
% 223.99/224.20  |- skos__scopeNote mesh__D000244
% 223.99/224.20       Adenosine 5%27%-%28%trihydrogen diphosphate%29%. An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5%27%-position.%A%    
% 223.99/224.20  |- skos__altLabel mesh__D000244 MgADP
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D000244 2001
% 223.99/224.20  |- mesh__recordAuthorizer mesh__D000244 PLS
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D000244 1996
% 223.99/224.20  |- skos__hiddenLabel mesh__D000244 ADP, Magnesium
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D000244 2004
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D000244 2002
% 223.99/224.20  |- skos__hiddenLabel mesh__D000244 Pyrophosphate, Adenosine
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D000244 1997
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D000244 1992
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D000244 2005
% 223.99/224.20  |- mesh__dateCreated mesh__D000244 1999-01-01
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D000244 1998
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D000244 1993
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D000244 2006
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D000244 1991
% 223.99/224.20  |- mesh__dateRevised mesh__D000244 1990-06-07
% 223.99/224.20  |- skos__altLabel mesh__D000244 Adenosine 5%27%-Pyrophosphate
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D000244 1994
% 223.99/224.20  |- mesh__historyNote mesh__D000244 73%28%71%29%   
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D000244 1999
% 223.99/224.20  |- skos__hiddenLabel mesh__D000244 Adenosine 5%27% Pyrophosphate
% 223.99/224.20  |- skos__altLabel mesh__D000244 ADP
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D000244 1995
% 223.99/224.20  |- mesh__recordMaintainer mesh__D000244 PLS
% 223.99/224.20  |- rdf__type mesh__D000244sskos__Concept
% 223.99/224.20  |- skos__hiddenLabel mesh__D000244 Diphosphate, Adenosine
% 223.99/224.20  |- mesh__dateEstablished mesh__D000244 1973-01-01
% 223.99/224.20  |- mesh__recordMaintainer mesh__D018655 nns
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D018655 2006
% 223.99/224.20  |- skos__historyNote mesh__D018655 Leukocyte Count %28%1968-1994%29%
% 223.99/224.20  |- mesh__recordAuthorizer mesh__D018655 sjn
% 223.99/224.20  |- skos__hiddenLabel mesh__D018655 Lymphocyte Numbers
% 223.99/224.20  |- mesh__activeMeSHYear mesh__D018655 2004
% 223.99/224.20  |- mesh__recordOriginator mesh__D018655 AGS
% 223.99/224.20  |- skos__scopeNote mesh__D018655
% 223.99/224.20       The number of LYMPHOCYTES per unit volume of BLOOD.     
% 223.99/224.20  |- skos__hiddenLabel mesh__D018655 Lymphocyte Counts, Total
% 223.99/224.20  |- skos__hiddenLabel mesh__D018655 Lymphocyte Count, Total
% 223.99/224.20  |- skos__prefLabel mesh__D018655 Lymphocyte Count
% 223.99/224.20  |- rdf__type mesh__D018655sskos__Concept
% 223.99/224.20  |- skos__broader mesh__D018655smesh__D007958
% 223.99/224.20  |- skos__annotation mesh__D018655
% 223.99/224.20       usually NIM; coord with specific lymphocyte %28%IM%29% but note that CD4 LYMPHOCYTE COUNT is available; coord with disease /blood or disease /immunol, not /physiopathol%A%  
% 223.99/224.20  |- skos__altLabel mesh__D018655 Total Lymphocyte Count
% 223.99/224.20  |- skos__hiddenLabel mesh__D018655 Lymphocyte Counts
% 223.99/224.20  |- skos__altLabel mesh__D018655 Lymphocyte Number
% 223.99/224.20  |- mesh__historyNote mesh__D018655 95   
% 223.99/224.20  |- mesh__dateCreated mesh__D018655 1994-04-16
% 223.99/224.20  |- skos__hiddenLabel mesh__D018655 Total Lymphocyte Counts
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D018655 2005
% 223.99/224.21  |- mesh__dateRevised mesh__D018655 2003-07-09
% 223.99/224.21  |- mesh__dateEstablished mesh__D018655 1995-01-01
% 223.99/224.21  |- mesh__publicMeSHNote mesh__D018655 95   
% 223.99/224.21  |- mesh__onlineNote mesh__D010672
% 223.99/224.21       use PHENYTOIN to search DIPHENYLHYDANTOIN 1966-77   
% 223.99/224.21  |- mesh__publicMeSHNote mesh__D010672 78; was DIPHENYLHYDANTOIN 1963-77   
% 223.99/224.21  |- skos__broader mesh__D010672smesh__D006827
% 223.99/224.21  |- rdf__type mesh__D010672sskos__Concept
% 223.99/224.21  |- skos__scopeNote mesh__D010672
% 223.99/224.21       An anticonvulsant that is used in a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs.%A%    
% 223.99/224.21  |- mesh__recordOriginator mesh__D010672 NLM
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D010672 2006
% 223.99/224.21  |- mesh__historyNote mesh__D010672 78; was DIPHENYLHYDANTOIN 1963-77   
% 223.99/224.21  |- mesh__recordMaintainer mesh__D010672 ssb
% 223.99/224.21  |- mesh__dateRevised mesh__D010672 2005-06-30
% 223.99/224.21  |- skos__altLabel mesh__D010672 5,5-Diphenylhydantoin
% 223.99/224.21  |- mesh__dateCreated mesh__D010672 1999-01-01
% 223.99/224.21  |- skos__hiddenLabel mesh__D010672 Diphenylhydantoinate, Sodium
% 223.99/224.21  |- skos__prefLabel mesh__D010672 Phenytoin
% 223.99/224.21  |- skos__altLabel mesh__D010672 Fenitoin
% 223.99/224.21  |- skos__altLabel mesh__D010672 Diphenylhydantoin
% 223.99/224.21  |- mesh__recordAuthorizer mesh__D010672 sjn
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D004635 2001
% 223.99/224.21  |- skos__scopeNote mesh__D004635
% 223.99/224.21       A branch of medicine concerned with an individual%27%s resuscitation, transportation and care from the point of injury or beginning of illness through the hospital or other emergency treatment facility.%A%    
% 223.99/224.21  |- skos__annotation mesh__D004635
% 223.99/224.21       SPEC: SPEC qualif; differentiate from EMERGENCIES, the patient; DF: EMERGENCY MED%A%  
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D004635 2004
% 223.99/224.21  |- mesh__dateRevised mesh__D004635 1997-06-20
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D004635 1999
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D004635 2000
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D004635 2003
% 223.99/224.21  |- mesh__publicMeSHNote mesh__D004635 77   
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D004635 1998
% 223.99/224.21  |- mesh__dateEstablished mesh__D004635 1977-01-01
% 223.99/224.21  |- mesh__recordMaintainer mesh__D004635 PXP
% 223.99/224.21  |- mesh__dateCreated mesh__D004635 1976-04-27
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D004635 2006
% 223.99/224.21  |- rdf__type mesh__D004635sskos__Concept
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D004635 2002
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D004635 2005
% 223.99/224.21  |- mesh__recordOriginator mesh__D004635 EC
% 223.99/224.21  |- mesh__historyNote mesh__D004635 77   
% 223.99/224.21  |- skos__prefLabel mesh__D004635 Emergency Medicine
% 223.99/224.21  |- mesh__recordAuthorizer mesh__D004635 SJN
% 223.99/224.21  |- skos__altLabel mesh__D004635 Medicine, Emergency
% 223.99/224.21  |- skos__broader mesh__D004635smesh__D013040
% 223.99/224.21  |- skos__scopeNote mesh__D009320
% 223.99/224.21       A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS.%A%    
% 223.99/224.21  |- skos__hiddenLabel mesh__D009320 alpha ANP Dimer
% 223.99/224.21  |- skos__altLabel mesh__D009320 Auriculin
% 223.99/224.21  |- skos__altLabel mesh__D009320 Atrial Natriuretic Peptides
% 223.99/224.21  |- skos__altLabel mesh__D009320
% 223.99/224.21       Prepro-Cardiodilatin-Atrial Natriuretic Factor
% 223.99/224.21  |- skos__altLabel mesh__D009320 Pro-ANF
% 223.99/224.21  |- skos__altLabel mesh__D009320 ANF %28%99-126%29%
% 223.99/224.21  |- skos__altLabel mesh__D009320 ANF
% 223.99/224.21  |- skos__altLabel mesh__D009320 Atrial Natriuretic Factor %28%1-126%29%
% 223.99/224.21  |- skos__hiddenLabel mesh__D009320 alpha Atrial Natriuretic Peptide
% 223.99/224.21  |- skos__hiddenLabel mesh__D009320
% 223.99/224.21       Prepro Cardiodilatin Atrial Natriuretic Factor
% 223.99/224.21  |- skos__altLabel mesh__D009320 ANP %28%1-126%29%
% 223.99/224.21  |- skos__altLabel mesh__D009320 Atriopeptin Prohormone %28%1-126%29%
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D009320 2004
% 223.99/224.21  |- skos__altLabel mesh__D009320 ANP
% 223.99/224.21  |- skos__hiddenLabel mesh__D009320 Peptides, Atrial Natriuretic
% 223.99/224.21  |- skos__altLabel mesh__D009320 alpha-ANP Dimer
% 223.99/224.21  |- skos__altLabel mesh__D009320 gamma ANP %28%99-126%29%
% 223.99/224.21  |- skos__altLabel mesh__D009320 Atriopeptins
% 223.99/224.21  |- skos__hiddenLabel mesh__D009320 beta ANP
% 223.99/224.21  |- skos__altLabel mesh__D009320 ANP-%28%99-126%29%
% 223.99/224.21  |- mesh__historyNote mesh__D009320
% 223.99/224.21       1992, use NATRIURETIC PEPTIDES, ATRIAL 1986-1991; use ATRIAL NATRIURETIC FACTOR %28%NM%29% for ATRIAL NATRIURETIC FACTOR %28%99-126%29% 1987-2003; use ATRIAL NATRIURETIC FACTOR %28%NM%29% for ATRIAL NATRIURETIC FACTOR %28%1-28%29% 1992-2003; use ATRIAL NATRIURETIC FACTOR %28%NM%29% for CARDIONATRIN IV 1986-2003; use ATRIAL NATRIURETIC FACTOR %28%NM%29% for ATRIOPEPTIGEN 1985-2003; use ATRIAL NATRIURETIC FACTOR %28%NM%29% for ATRIAL NATRIURETIC FACTOR PRECURSORS 1985-2003%A%  
% 223.99/224.21  |- skos__hiddenLabel mesh__D009320 Prepro ANP
% 223.99/224.21  |- skos__altLabel mesh__D009320 Atrial Natriuretic Factor Prohormone
% 223.99/224.21  |- skos__altLabel mesh__D009320 beta-ANP
% 223.99/224.21  |- skos__altLabel mesh__D009320 Atriopeptin %28%1-28%29%
% 223.99/224.21  |- skos__altLabel mesh__D009320 Pronatriodilatin
% 223.99/224.21  |- skos__altLabel mesh__D009320 Atrial Natriuretic Factor %28%99-126%29%
% 223.99/224.21  |- skos__altLabel mesh__D009320 Proatrial Natriuretic Factor
% 223.99/224.21  |- skos__altLabel mesh__D009320 Prepro-CDD-ANF
% 223.99/224.21  |- skos__altLabel mesh__D009320 Cardionatrin I
% 223.99/224.21  |- skos__hiddenLabel mesh__D009320 Pro ANF
% 223.99/224.21  |- skos__altLabel mesh__D009320 Atriopeptin 126
% 223.99/224.21  |- skos__altLabel mesh__D009320 ProANF
% 223.99/224.21  |- skos__altLabel mesh__D009320 Cardiodilatin Precursor
% 223.99/224.21  |- skos__altLabel mesh__D009320 Atriopeptin %28%99-126%29%
% 223.99/224.21  |- skos__altLabel mesh__D009320 Atrial Natriuretic Peptide %28%1-126%29%
% 223.99/224.21  |- skos__hiddenLabel mesh__D009320 gamma Atrial Natriuretic Peptide
% 223.99/224.21  |- skos__hiddenLabel mesh__D009320 Prepro CDD ANF
% 223.99/224.21  |- skos__altLabel mesh__D009320 ANF Precursors
% 223.99/224.21  |- skos__related mesh__D009320smesh__D017461
% 223.99/224.21  |- skos__altLabel mesh__D009320 ANP Prohormone %28%99-126%29%
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D009320 2005
% 223.99/224.21  |- mesh__recordAuthorizer mesh__D009320 ags
% 223.99/224.21  |- skos__prefLabel mesh__D009320 Atrial Natriuretic Factor
% 223.99/224.21  |- mesh__recordMaintainer mesh__D009320 ags
% 223.99/224.21  |- skos__altLabel mesh__D009320 ANF %28%1-28%29%
% 223.99/224.21  |- rdf__type mesh__D009320sskos__Concept
% 223.99/224.21  |- skos__altLabel mesh__D009320 Cardiodilatin %28%99-126%29%
% 223.99/224.21  |- skos__altLabel mesh__D009320 Prepro-ANP
% 223.99/224.21  |- skos__historyNote mesh__D009320 Muscle Proteins %28%1966-1985%29%
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D009320 2006A
% 223.99/224.21  |- skos__altLabel mesh__D009320 Atrial Natriuretic Factor %28%1-28%29%
% 223.99/224.21  |- mesh__dateCreated mesh__D009320 1985-04-25
% 223.99/224.21  |- skos__altLabel mesh__D009320 ANP %28%1-28%29%
% 223.99/224.21  |- skos__altLabel mesh__D009320 alpha ANP
% 223.99/224.21  |- skos__hiddenLabel mesh__D009320 beta Atrial Natriuretic Peptide
% 223.99/224.21  |- mesh__publicMeSHNote mesh__D009320
% 223.99/224.21       1992, see NATRIURETIC PEPTIDES, ATRIAL 1986-1991; ATRIAL NATRIURETIC FACTOR %28%99-126%29% was indexed under ATRIAL NATRIURETIC FACTOR 1987-2003; ATRIAL NATRIURETIC FACTOR %28%1-28%29% was indexed under ATRIAL NATRIURETIC FACTOR 1992-2003; CARDIONATRIN IV was indexed under ATRIAL NATRIURETIC FACTOR 1986-2003; ATRIOPEPTIGEN was indexed under MUSCLE PROTEINS 1985-2003; ATRIAL NATRIURETIC FACTOR PRECURSORS was indexed under ATRIAL NATRIURETIC FACTOR 1985-2003%A%  
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D009320 2006
% 223.99/224.21  |- skos__altLabel mesh__D009320 Atriopeptigen
% 223.99/224.21  |- skos__broader mesh__D009320smesh__D036361
% 223.99/224.21  |- mesh__recordOriginator mesh__D009320 RLS
% 223.99/224.21  |- skos__altLabel mesh__D009320 Atrial Pronatriodilatin
% 223.99/224.21  |- mesh__dateRevised mesh__D009320 2005-07-22
% 223.99/224.21  |- skos__broader mesh__D009320smesh__D045265
% 223.99/224.21  |- skos__altLabel mesh__D009320 ANF %28%1-126%29%
% 223.99/224.21  |- skos__altLabel mesh__D009320 Natriuretic Peptides, Atrial
% 223.99/224.21  |- mesh__dateEstablished mesh__D009320 1986-01-01
% 223.99/224.21  |- skos__altLabel mesh__D009320 Cardionatrin IV
% 223.99/224.21  |- skos__broader mesh__D000515Q000172smesh__D000515
% 223.99/224.21  |- mesh__preferredCombination mesh__D000515Q000172smesh__D019896
% 223.99/224.21  |- rdf__type mesh__D000515Q000172smesh__CompoundConcept
% 223.99/224.21  |- skos__broader mesh__D014265smesh__D001388
% 223.99/224.21  |- mesh__publicMeSHNote mesh__D014265
% 223.99/224.21       81; was TRIETHYLENE MELAMINE 1963-80   
% 223.99/224.21  |- mesh__onlineNote mesh__D014265
% 223.99/224.21       use TRIETHYLENEMELAMINE to search TRIETHYLENE MELAMINE 1966-80%A%  
% 223.99/224.21  |- skos__altLabel mesh__D014265 Triethylene Melamine
% 223.99/224.21  |- skos__altLabel mesh__D014265 Tretamine
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D014265 2004
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D014265 2001
% 223.99/224.21  |- mesh__dateRevised mesh__D014265 2000-06-22
% 223.99/224.21  |- skos__altLabel mesh__D014265 2,4,6-Triethylimino-1,3,5-Triazine
% 223.99/224.21  |- mesh__recordOriginator mesh__D014265 NLM
% 223.99/224.21  |- mesh__historyNote mesh__D014265 81; was TRIETHYLENE MELAMINE 1963-80   
% 223.99/224.21  |- skos__prefLabel mesh__D014265 Triethylenemelamine
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D014265 2002
% 223.99/224.21  |- rdf__type mesh__D014265sskos__Concept
% 223.99/224.21  |- mesh__recordAuthorizer mesh__D014265 sjn
% 223.99/224.21  |- skos__hiddenLabel mesh__D014265 Melamine, Triethylene
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D014265 2005
% 223.99/224.21  |- mesh__dateCreated mesh__D014265 1999-01-01
% 223.99/224.21  |- mesh__recordMaintainer mesh__D014265 TWD
% 223.99/224.21  |- skos__scopeNote mesh__D014265
% 223.99/224.21       Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.%A%    
% 223.99/224.21  |- skos__broader mesh__D014265smesh__D014227
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D014265 2003
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D014265 2006
% 223.99/224.21  |- skos__broader mesh__D008228smesh__D008223
% 223.99/224.21  |- skos__annotation mesh__D008228
% 223.99/224.21       general %26% unspecified only: prefer specifics; index here for hematodermic CD4/CD56 neoplasm%A%  
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D008228 2006
% 223.99/224.21  |- mesh__recordMaintainer mesh__D008228 ags
% 223.99/224.21  |- skos__scopeNote mesh__D008228
% 223.99/224.21       Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin%27%s disease.%A%    
% 223.99/224.21  |- skos__historyNote mesh__D008228 Lymphoma %28%1966-1986%29%
% 223.99/224.21  |- mesh__publicMeSHNote mesh__D008228
% 223.99/224.21       97; see LYMPHOMA, NON-HODGKIN%27%S 1987-97   
% 223.99/224.21  |- mesh__historyNote mesh__D008228 97%28%87%29%   
% 223.99/224.21  |- mesh__dateCreated mesh__D008228 1986-06-24
% 223.99/224.21  |- skos__hiddenLabel mesh__D008228 Lymphoma, Non Hodgkin
% 223.99/224.21  |- skos__prefLabel mesh__D008228 Lymphoma, Non-Hodgkin
% 223.99/224.21  |- skos__hiddenLabel mesh__D008228 Non-Hodgkins Lymphoma
% 223.99/224.21  |- skos__hiddenLabel mesh__D008228 Nonhodgkins Lymphoma
% 223.99/224.21  |- skos__hiddenLabel mesh__D008228 Nonhodgkin%27%s Lymphoma
% 223.99/224.21  |- mesh__dateRevised mesh__D008228 2005-06-30
% 223.99/224.21  |- mesh__recordOriginator mesh__D008228 VDK
% 223.99/224.21  |- skos__altLabel mesh__D008228 Non-Hodgkin%27%s Lymphoma
% 223.99/224.21  |- rdf__type mesh__D008228sskos__Concept
% 223.99/224.21  |- skos__hiddenLabel mesh__D008228 Non Hodgkin Lymphoma
% 223.99/224.21  |- skos__hiddenLabel mesh__D008228 Lymphoma, Nonhodgkin
% 223.99/224.21  |- skos__hiddenLabel mesh__D008228 Lymphoma, Non Hodgkins
% 223.99/224.21  |- mesh__dateEstablished mesh__D008228 1987-01-01
% 223.99/224.21  |- mesh__recordAuthorizer mesh__D008228 sjn
% 223.99/224.21  |- skos__altLabel mesh__D008228 Lymphoma, Nonhodgkin%27%s
% 223.99/224.21  |- skos__hiddenLabel mesh__D008228 Non Hodgkin%27%s Lymphoma
% 223.99/224.21  |- skos__altLabel mesh__D008228 Lymphoma, Non-Hodgkin%27%s
% 223.99/224.21  |- skos__altLabel mesh__D008228 Lymphoma, Nonhodgkins
% 223.99/224.21  |- skos__altLabel mesh__D008228 Non-Hodgkin Lymphoma
% 223.99/224.21  |- skos__altLabel mesh__D008228 Lymphoma, Non-Hodgkins
% 223.99/224.21  |- skos__hiddenLabel mesh__D008228 Lymphoma, Non Hodgkin%27%s
% 223.99/224.21  |- mesh__publicMeSHNote mesh__D000245
% 223.99/224.21       90; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90   
% 223.99/224.21  |- skos__prefLabel mesh__D000245 Adenosine Diphosphate Glucose
% 223.99/224.21  |- mesh__dateEstablished mesh__D000245 1991-01-01
% 223.99/224.21  |- mesh__recordAuthorizer mesh__D000245 sjn
% 223.99/224.21  |- skos__altLabel mesh__D000245 ADP Glucose
% 223.99/224.21  |- skos__altLabel mesh__D000245 Adenosine Pyrophosphateglucose
% 223.99/224.21  |- skos__historyNote mesh__D000245
% 223.99/224.21       Nucleoside Diphosphate Sugars %28%1973-1974%29%
% 223.99/224.21  |- mesh__dateCreated mesh__D000245 1974-11-19
% 223.99/224.21  |- mesh__recordOriginator mesh__D000245 NLM
% 223.99/224.21  |- skos__hiddenLabel mesh__D000245 Pyrophosphateglucose, Adenosine
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D000245 2005
% 223.99/224.21  |- skos__broader mesh__D000245smesh__D000247
% 223.99/224.21  |- skos__hiddenLabel mesh__D000245 Diphosphoglucose, Adenosine
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D000245 2006
% 223.99/224.21  |- skos__scopeNote mesh__D000245
% 223.99/224.21       Serves as the glycosyl donor for formation of bacterial glycogen, amylose in green algae, and amylopectin in higher plants.%A%    
% 223.99/224.21  |- skos__altLabel mesh__D000245 ADPG
% 223.99/224.21  |- skos__historyNote mesh__D000245 Adenosine %28%1973-1974%29%
% 223.99/224.21  |- skos__hiddenLabel mesh__D000245 Glucose, Adenosine Diphosphate
% 223.99/224.21  |- skos__hiddenLabel mesh__D000245 Diphosphate Glucose, Adenosine
% 223.99/224.21  |- mesh__historyNote mesh__D000245
% 223.99/224.21       91%28%75%29%; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90%A%  
% 223.99/224.21  |- mesh__recordMaintainer mesh__D000245 ssb
% 223.99/224.21  |- mesh__dateRevised mesh__D000245 2004-07-07
% 223.99/224.21  |- rdf__type mesh__D000245sskos__Concept
% 223.99/224.21  |- skos__historyNote mesh__D000245 Glucose %28%1973-1974%29%
% 223.99/224.21  |- skos__hiddenLabel mesh__D000245 Glucose, ADP
% 223.99/224.21  |- skos__altLabel mesh__D000245 Adenosine Diphosphoglucose
% 223.99/224.21  |- skos__hiddenLabel mesh__D018656 Muscle Fiber, Red
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D018656 2004
% 223.99/224.21  |- skos__hiddenLabel mesh__D018656 Fast-Twitch Muscle Fiber
% 223.99/224.21  |- skos__hiddenLabel mesh__D018656 Red Muscle Fibers
% 223.99/224.21  |- skos__hiddenLabel mesh__D018656 Fibers, Red Muscle
% 223.99/224.21  |- mesh__dateRevised mesh__D018656 2002-07-03
% 223.99/224.21  |- mesh__dateEstablished mesh__D018656 1995-01-01
% 223.99/224.21  |- skos__hiddenLabel mesh__D018656 Fast-Twitch Muscle Fibers
% 223.99/224.21  |- mesh__publicMeSHNote mesh__D018656 95   
% 223.99/224.21  |- mesh__dateCreated mesh__D018656 1994-06-07
% 223.99/224.21  |- skos__hiddenLabel mesh__D018656 Muscle Fiber, White
% 223.99/224.21  |- rdf__type mesh__D018656sskos__Concept
% 223.99/224.21  |- skos__hiddenLabel mesh__D018656 White Muscle Fibers
% 223.99/224.21  |- skos__hiddenLabel mesh__D018656 White Muscle Fiber
% 223.99/224.21  |- skos__hiddenLabel mesh__D018656 Muscle Fibers, Fast Twitch
% 223.99/224.21  |- skos__prefLabel mesh__D018656 Muscle Fibers, Fast-Twitch
% 223.99/224.21  |- mesh__recordAuthorizer mesh__D018656 sjn
% 223.99/224.21  |- skos__hiddenLabel mesh__D018656 Fiber, White Muscle
% 223.99/224.21  |- skos__hiddenLabel mesh__D018656 Fiber, Red Muscle
% 223.99/224.21  |- mesh__recordOriginator mesh__D018656 JLS
% 223.99/224.21  |- skos__hiddenLabel mesh__D018656 Fibers, Fast-Twitch Muscle
% 223.99/224.21  |- mesh__historyNote mesh__D018656 95   
% 223.99/224.21  |- skos__altLabel mesh__D018656 Muscle Fibers, Type II
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D018656 2005
% 223.99/224.21  |- skos__hiddenLabel mesh__D018656 Fiber, Fast-Twitch Muscle
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D018656 2006
% 223.99/224.21  |- skos__hiddenLabel mesh__D018656 Fibers, White Muscle
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D018656 2003
% 223.99/224.21  |- skos__scopeNote mesh__D018656
% 223.99/224.21       Skeletal muscle fibers having high myofibrillar ATPase activity, high glycolytic enzyme activities, and an intermediate glycogen content which produce a fast twitch. There are two types. Fast fatigable fibers, also called white fibers, have a low myoglobin content, and a small mitochondrial content, and fatigue rapidly due to their limited glycogen content and low capacity for oxidative metabolism. Fast fatigue-resistant fibers, also called red fibers, have a large mitochondrial content and a high myoglobin content, related to their resistance to fatigue. %28%From Best, Physiological Basis of Medical Practice, 12th ed, p100%29%%A%    
% 223.99/224.21  |- skos__hiddenLabel mesh__D018656 Muscle Fiber, Fast-Twitch
% 223.99/224.21  |- mesh__recordMaintainer mesh__D018656 JLS
% 223.99/224.21  |- skos__hiddenLabel mesh__D018656 Red Muscle Fiber
% 223.99/224.21  |- skos__broader mesh__D018656smesh__D018485
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D010673 2006
% 223.99/224.21  |- skos__scopeNote mesh__D010673
% 223.99/224.21       A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5%25% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. %28%Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1298%29%%A%    
% 223.99/224.21  |- mesh__dateRevised mesh__D010673 2003-07-09
% 223.99/224.21  |- skos__broader mesh__D010673smesh__D010235
% 223.99/224.21  |- skos__hiddenLabel mesh__D010673 Pheochromocytoma, Extra Adrenal
% 223.99/224.21  |- mesh__recordAuthorizer mesh__D010673 sjn
% 223.99/224.21  |- mesh__dateCreated mesh__D010673 1999-01-01
% 223.99/224.21  |- skos__hiddenLabel mesh__D010673 Extra-Adrenal Pheochromocytoma
% 223.99/224.21  |- skos__related mesh__D010673smesh__D018813
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D010673 2004
% 223.99/224.21  |- skos__annotation mesh__D010673
% 223.99/224.21       benign or malignant; coord IM with usually ADRENAL GLAND NEOPLASMS %28%IM%29%%A%  
% 223.99/224.21  |- skos__hiddenLabel mesh__D010673 Extra-Adrenal Pheochromocytomas
% 223.99/224.21  |- skos__hiddenLabel mesh__D010673 Pheochromocytomas, Extra-Adrenal
% 223.99/224.21  |- skos__related mesh__D010673smesh__D018814
% 223.99/224.21  |- skos__hiddenLabel mesh__D010673 Pheochromocytomas
% 223.99/224.21  |- mesh__recordMaintainer mesh__D010673 ags
% 223.99/224.21  |- mesh__recordOriginator mesh__D010673 NLM
% 223.99/224.21  |- skos__prefLabel mesh__D010673 Pheochromocytoma
% 223.99/224.21  |- rdf__type mesh__D010673sskos__Concept
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D010673 2005
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D004636 2005
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D004636 1996
% 223.99/224.21  |- mesh__historyNote mesh__D004636
% 223.99/224.21       78; was HOSPITAL EMERGENCY SERVICE 1963-77   
% 223.99/224.21  |- skos__broader mesh__D004636smesh__D004632
% 223.99/224.21  |- skos__hiddenLabel mesh__D004636 Emergency Hospital Services
% 223.99/224.21  |- skos__hiddenLabel mesh__D004636 Hospital Emergency Services
% 223.99/224.21  |- skos__hiddenLabel mesh__D004636 Services, Emergency Hospital
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D004636 2006
% 223.99/224.21  |- mesh__dateCreated mesh__D004636 1999-01-01
% 223.99/224.21  |- skos__hiddenLabel mesh__D004636 Service Emergencies, Hospital
% 223.99/224.21  |- skos__hiddenLabel mesh__D004636 Emergency, Hospital Service
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D004636 1997
% 223.99/224.21  |- mesh__publicMeSHNote mesh__D004636
% 223.99/224.21       78; was HOSPITAL EMERGENCY SERVICE 1963-77   
% 223.99/224.21  |- skos__prefLabel mesh__D004636 Emergency Service, Hospital
% 223.99/224.21  |- mesh__recordMaintainer mesh__D004636 KEV
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D004636 2002
% 223.99/224.21  |- skos__hiddenLabel mesh__D004636 Service Emergency, Hospital
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D004636 2003
% 223.99/224.21  |- skos__hiddenLabel mesh__D004636 Hospital Service, Emergency
% 223.99/224.21  |- skos__hiddenLabel mesh__D004636 Emergency Outpatient Units
% 223.99/224.21  |- mesh__onlineNote mesh__D004636
% 223.99/224.21       use EMERGENCY SERVICE, HOSPITAL to search HOSPITAL EMERGENCY SERVICE 1966-77%A%  
% 223.99/224.21  |- rdf__type mesh__D004636sskos__Concept
% 223.99/224.21  |- skos__hiddenLabel mesh__D004636 Unit, Emergency Outpatient
% 223.99/224.21  |- skos__hiddenLabel mesh__D004636 Hospital Services, Emergency
% 223.99/224.21  |- mesh__dateRevised mesh__D004636 1995-05-22
% 223.99/224.21  |- skos__broader mesh__D004636smesh__D006748
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D004636 2004
% 223.99/224.21  |- skos__altLabel mesh__D004636 Hospital Emergency Service
% 223.99/224.21  |- mesh__recordAuthorizer mesh__D004636 PLS
% 223.99/224.21  |- skos__hiddenLabel mesh__D004636 Emergency Services, Hospital
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D004636 1998
% 223.99/224.21  |- skos__hiddenLabel mesh__D004636 Services, Hospital Emergency
% 223.99/224.21  |- mesh__recordOriginator mesh__D004636 NLM
% 223.99/224.21  |- skos__hiddenLabel mesh__D004636 Service, Emergency Hospital
% 223.99/224.21  |- skos__annotation mesh__D004636 DF: EMERGENCY SERV HOSP   
% 223.99/224.21  |- skos__hiddenLabel mesh__D004636 Emergencies, Hospital Service
% 223.99/224.21  |- skos__scopeNote mesh__D004636
% 223.99/224.21       Hospital department responsible for the administration and provision of immediate medical or surgical care to the emergency patient.%A%    
% 223.99/224.21  |- skos__hiddenLabel mesh__D004636 Outpatient Units, Emergency
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D004636 2000
% 223.99/224.21  |- skos__altLabel mesh__D004636 Service, Hospital Emergency
% 223.99/224.21  |- skos__altLabel mesh__D004636 Emergency Hospital Service
% 223.99/224.21  |- skos__hiddenLabel mesh__D004636 Units, Emergency Outpatient
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D004636 1999
% 223.99/224.21  |- skos__altLabel mesh__D004636 Hospital Service Emergency
% 223.99/224.21  |- skos__hiddenLabel mesh__D004636 Hospital Service Emergencies
% 223.99/224.21  |- skos__hiddenLabel mesh__D004636 Outpatient Unit, Emergency
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D004636 2001
% 223.99/224.21  |- skos__prefLabel mesh__D009321 Natural Childbirth
% 223.99/224.21  |- mesh__recordMaintainer mesh__D009321 ssb
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D009321 2006
% 223.99/224.21  |- mesh__recordOriginator mesh__D009321 NLM
% 223.99/224.21  |- skos__annotation mesh__D009321 check tags FEMALE %26% PREGNANCY   
% 223.99/224.21  |- skos__broader mesh__D009321smesh__D000529
% 223.99/224.21  |- mesh__dateRevised mesh__D009321 2002-07-03
% 223.99/224.21  |- mesh__recordAuthorizer mesh__D009321 sjn
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D009321 2003
% 223.99/224.21  |- skos__broader mesh__D009321smesh__D036861
% 223.99/224.21  |- skos__hiddenLabel mesh__D009321 Childbirth, Natural
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D009321 2004
% 223.99/224.21  |- rdf__type mesh__D009321sskos__Concept
% 223.99/224.21  |- skos__scopeNote mesh__D009321
% 223.99/224.21       Labor and delivery without medical intervention, usually involving RELAXATION TECHNIQUES.%A%    
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D009321 2005
% 223.99/224.21  |- mesh__dateCreated mesh__D009321 1999-01-01
% 223.99/224.21  |- mesh__dateRevised mesh__D014266 2000-06-22
% 223.99/224.21  |- skos__prefLabel mesh__D014266 Triethylenetetramine
% 223.99/224.21  |- rdf__type mesh__D014266sskos__Concept
% 223.99/224.21  |- mesh__recordOriginator mesh__D014266 SH
% 223.99/224.21  |- skos__historyNote mesh__D014266 Ethylenediamines %28%1975-1977%29%
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D014266 2001
% 223.99/224.21  |- skos__altLabel mesh__D014266 Trien
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D014266 2005
% 223.99/224.21  |- mesh__publicMeSHNote mesh__D014266
% 223.99/224.21       91; was see under ETHYLENEDIAMINES 1978-90   
% 223.99/224.21  |- skos__historyNote mesh__D014266 Ammonium Compounds %28%1966-1974%29%
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D014266 2002
% 223.99/224.21  |- skos__scopeNote mesh__D014266
% 223.99/224.21       Used as stabilizer for epoxy resins, as ampholyte for isoelectric focusing and as chelating agent for copper in hepatolenticular degeneration; may cause liver damage.%A%    
% 223.99/224.21  |- mesh__recordMaintainer mesh__D014266 CCR
% 223.99/224.21  |- mesh__dateCreated mesh__D014266 1977-03-01
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D014266 2003
% 223.99/224.21  |- mesh__recordAuthorizer mesh__D014266 sjn
% 223.99/224.21  |- mesh__historyNote mesh__D014266
% 223.99/224.21       91%28%78%29%; was see under ETHYLENEDIAMINES 1978-90   
% 223.99/224.21  |- skos__broader mesh__D014266smesh__D005029
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D014266 2006
% 223.99/224.21  |- skos__historyNote mesh__D014266 Piperidines %28%1966-1974%29%
% 223.99/224.21  |- skos__altLabel mesh__D014266 Trientine
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D014266 2004
% 223.99/224.21  |- mesh__dateEstablished mesh__D014266 1991-01-01
% 223.99/224.21  |- skos__hiddenLabel mesh__D008229 Lymphomas, Undifferentiated
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D008229 2003
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D008229 1999
% 223.99/224.21  |- skos__hiddenLabel mesh__D008229 Pleomorphic Lymphoma
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D008229 2000
% 223.99/224.21  |- skos__broader mesh__D008229smesh__D008228
% 223.99/224.21  |- mesh__dateCreated mesh__D008229 1986-06-23
% 223.99/224.21  |- rdf__type mesh__D008229sskos__Concept
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D008229 2004
% 223.99/224.21  |- skos__prefLabel mesh__D008229 Lymphoma, Undifferentiated
% 223.99/224.21  |- skos__historyNote mesh__D008229 Lymphoma %28%1966-1986%29%
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D008229 2001
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D008229 1996
% 223.99/224.21  |- mesh__historyNote mesh__D008229 87   
% 223.99/224.21  |- mesh__activeMeSHYear mesh__D008229 1997
% 223.99/224.21  |- mesh__recordOriginator mesh__D008229 VDK
% 224.07/224.21  |- mesh__publicMeSHNote mesh__D008229 87   
% 224.07/224.21  |- skos__hiddenLabel mesh__D008229 Undifferentiated Lymphomas
% 224.07/224.21  |- mesh__activeMeSHYear mesh__D008229 2005
% 224.07/224.21  |- skos__annotation mesh__D008229
% 224.07/224.21       a non-Hodgkin%27%s lymphoma; DF: LYMPHOMA UNDIFFER   
% 224.07/224.21  |- mesh__recordAuthorizer mesh__D008229 PLS
% 224.07/224.21  |- mesh__dateRevised mesh__D008229 1995-06-08
% 224.07/224.21  |- mesh__recordMaintainer mesh__D008229 KEV
% 224.07/224.21  |- mesh__dateEstablished mesh__D008229 1987-01-01
% 224.07/224.21  |- skos__altLabel mesh__D008229 Undifferentiated Lymphoma
% 224.07/224.21  |- mesh__activeMeSHYear mesh__D008229 2002
% 224.07/224.21  |- skos__hiddenLabel mesh__D008229 Pleomorphic Lymphomas
% 224.07/224.21  |- skos__altLabel mesh__D008229 Lymphoma, Pleomorphic
% 224.07/224.21  |- skos__hiddenLabel mesh__D008229 Lymphomas, Pleomorphic
% 224.07/224.21  |- mesh__activeMeSHYear mesh__D008229 2006
% 224.07/224.21  |- mesh__activeMeSHYear mesh__D008229 1998
% 224.07/224.21  |- skos__scopeNote mesh__D008229
% 224.07/224.21       A form of lymphoma in which relatively large stem cells with large nuclei, pale, scanty cytoplasm, and indistinct borders are predominant. The cells are undifferentiated, i.e., show no morphologic evidence of maturation toward lymphocytes or histiocytes.%A%    
% 224.07/224.21  |- mesh__recordAuthorizer mesh__D000246 sjn
% 224.07/224.21  |- skos__altLabel mesh__D000246 ADPribose
% 224.07/224.21  |- skos__scopeNote mesh__D000246
% 224.07/224.21       An ester formed between the aldehydic carbon of RIBOSE and the terminal phosphate of ADENOSINE DIPHOSPHATE. It is produced by the hydrolysis of nicotinamide-adenine dinucleotide %28%NAD%29% by a variety of enzymes, some of which transfer an ADP-ribosyl group to target proteins.%A%    
% 224.07/224.21  |- skos__historyNote mesh__D000246
% 224.07/224.21       Ribose %28%1966-1974%29% /AA %28%1975-1979%29%
% 224.07/224.21  |- mesh__dateCreated mesh__D000246 1979-05-22
% 224.07/224.21  |- skos__hiddenLabel mesh__D000246 Diphosphate Ribose, Adenosine
% 224.07/224.21  |- mesh__publicMeSHNote mesh__D000246
% 224.07/224.21       87; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1980-86   
% 224.07/224.21  |- skos__broader mesh__D000246smesh__D000247
% 224.07/224.21  |- skos__historyNote mesh__D000246 Adenine Nucleotides %28%1966-1970%29%
% 224.07/224.21  |- mesh__activeMeSHYear mesh__D000246 2005
% 224.07/224.21  |- skos__hiddenLabel mesh__D000246 Ribose, Adenosine Diphosphate
% 224.07/224.21  |- skos__hiddenLabel mesh__D000246 5%27%-Diphosphoribose, Adenosine
% 224.07/224.21  |- mesh__historyNote mesh__D000246
% 224.07/224.21       87%28%80%29%; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1980-86%A%  
% 224.07/224.21  |- skos__historyNote mesh__D000246
% 224.07/224.21       Adenosine Diphosphate Sugars %28%1975-1979%29%
% 224.07/224.21  |- mesh__activeMeSHYear mesh__D000246 2006
% 224.07/224.21  |- mesh__recordMaintainer mesh__D000246 ssb
% 224.07/224.21  |- rdf__type mesh__D000246sskos__Concept
% 224.07/224.21  |- skos__hiddenLabel mesh__D000246 Diphosphoribose, Adenosine
% 224.07/224.21  |- skos__hiddenLabel mesh__D000246 Adenosine 5%27% Diphosphoribose
% 224.07/224.21  |- skos__altLabel mesh__D000246 ADP Ribose
% 224.07/224.21  |- mesh__dateEstablished mesh__D000246 1987-01-01
% 224.07/224.21  |- skos__altLabel mesh__D000246 ADP-Ribose
% 224.07/224.21  |- mesh__dateRevised mesh__D000246 2004-07-07
% 224.07/224.21  |- mesh__recordOriginator mesh__D000246 RLS
% 224.07/224.21  |- skos__altLabel mesh__D000246 Adenosine Diphosphoribose
% 224.07/224.21  |- skos__historyNote mesh__D000246
% 224.07/224.21       Nucleoside Diphosphate Sugars %28%1971-1974%29%
% 224.07/224.21  |- skos__prefLabel mesh__D000246 Adenosine Diphosphate Ribose
% 224.07/224.21  |- skos__hiddenLabel mesh__D000246 Ribose, ADP
% 224.07/224.21  |- skos__altLabel mesh__D000246 Adenosine 5%27%-Diphosphoribose
% 224.07/224.22  |- skos__hiddenLabel mesh__D046348 Gopher, Pocket
% 224.07/224.22  |- mesh__historyNote mesh__D046348 2005; use RODENTIA 1998-2004   
% 224.07/224.22  |- skos__hiddenLabel mesh__D046348 Gopher
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D046348 2005
% 224.07/224.22  |- skos__altLabel mesh__D046348 Geomyidae
% 224.07/224.22  |- mesh__publicMeSHNote mesh__D046348 2005; see RODENTIA 1998-2004   
% 224.07/224.22  |- skos__broader mesh__D046348smesh__D012377
% 224.07/224.22  |- mesh__recordMaintainer mesh__D046348 ags
% 224.07/224.22  |- skos__altLabel mesh__D046348 Pocket Gophers
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D046348 2006
% 224.07/224.22  |- skos__prefLabel mesh__D046348 Gophers
% 224.07/224.22  |- rdf__type mesh__D046348sskos__Concept
% 224.07/224.22  |- skos__historyNote mesh__D046348 Rodentia %28%1965-2004%29%
% 224.07/224.22  |- mesh__dateEstablished mesh__D046348 2005-01-01
% 224.07/224.22  |- mesh__recordOriginator mesh__D046348 ags
% 224.07/224.22  |- skos__scopeNote mesh__D046348
% 224.07/224.22       The family Geomyidae of burrowing rodents, commonly called pocket gophers. There are six genera, all found in North America.%A%    
% 224.07/224.22  |- mesh__recordAuthorizer mesh__D046348 sjn
% 224.07/224.22  |- skos__hiddenLabel mesh__D046348 Gophers, Pocket
% 224.07/224.22  |- skos__hiddenLabel mesh__D046348 Pocket Gopher
% 224.07/224.22  |- mesh__dateCreated mesh__D046348 2004-07-07
% 224.07/224.22  |- skos__hiddenLabel mesh__D018657 Fiber, Slow-Twitch Muscle
% 224.07/224.22  |- skos__hiddenLabel mesh__D018657 Fibers, Intermediate Muscle
% 224.07/224.22  |- mesh__recordOriginator mesh__D018657 JLS
% 224.07/224.22  |- mesh__historyNote mesh__D018657 95   
% 224.07/224.22  |- mesh__recordMaintainer mesh__D018657 JLS
% 224.07/224.22  |- skos__broader mesh__D018657smesh__D018485
% 224.07/224.22  |- skos__hiddenLabel mesh__D018657 Intermediate Muscle Fibers
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D018657 2005
% 224.07/224.22  |- skos__scopeNote mesh__D018657
% 224.07/224.22       Skeletal muscle fibers having low myofibrillar ATPase activity, low glycogen content, and high myoglobin content, high mitochondrial oxidative enzyme activities, and an intermediate mitochondrial content which produce a slow twitch and are fatigue-resistant. %28%From Best, Physiological Basis of Medical Practice, 12th ed, p101%29%%A%    
% 224.07/224.22  |- skos__hiddenLabel mesh__D018657 Intermediate Muscle Fiber
% 224.07/224.22  |- mesh__dateEstablished mesh__D018657 1995-01-01
% 224.07/224.22  |- skos__hiddenLabel mesh__D018657 Fibers, Slow-Twitch Muscle
% 224.07/224.22  |- skos__altLabel mesh__D018657 Muscle Fibers, Intermediate
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D018657 2006
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D018657 2003
% 224.07/224.22  |- mesh__dateRevised mesh__D018657 2002-07-03
% 224.07/224.22  |- mesh__publicMeSHNote mesh__D018657 95   
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D018657 2004
% 224.07/224.22  |- skos__hiddenLabel mesh__D018657 Muscle Fibers, Slow Twitch
% 224.07/224.22  |- mesh__recordAuthorizer mesh__D018657 sjn
% 224.07/224.22  |- skos__hiddenLabel mesh__D018657 Slow-Twitch Muscle Fiber
% 224.07/224.22  |- skos__hiddenLabel mesh__D018657 Fiber, Intermediate Muscle
% 224.07/224.22  |- skos__prefLabel mesh__D018657 Muscle Fibers, Slow-Twitch
% 224.07/224.22  |- mesh__dateCreated mesh__D018657 1994-06-07
% 224.07/224.22  |- skos__hiddenLabel mesh__D018657 Muscle Fiber, Slow-Twitch
% 224.07/224.22  |- skos__hiddenLabel mesh__D018657 Muscle Fiber, Intermediate
% 224.07/224.22  |- skos__hiddenLabel mesh__D018657 Slow-Twitch Muscle Fibers
% 224.07/224.22  |- rdf__type mesh__D018657sskos__Concept
% 224.07/224.22  |- skos__altLabel mesh__D018657 Muscle Fibers, Type I
% 224.07/224.22  |- mesh__dateRevised mesh__D010674 2005-06-30
% 224.07/224.22  |- mesh__dateCreated mesh__D010674 1974-11-19
% 224.07/224.22  |- skos__historyNote mesh__D010674 Porphyrins %28%1971-1974%29%
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D010674 2006
% 224.07/224.22  |- mesh__recordAuthorizer mesh__D010674 sjn
% 224.07/224.22  |- skos__annotation mesh__D010674 chlorophylls without magnesium   
% 224.07/224.22  |- mesh__dateEstablished mesh__D010674 1991-01-01
% 224.07/224.22  |- skos__scopeNote mesh__D010674
% 224.07/224.22       Chlorophylls from which the magnesium has been removed by treatment with weak acid.%A%    
% 224.07/224.22  |- skos__prefLabel mesh__D010674 Pheophytins
% 224.07/224.22  |- mesh__historyNote mesh__D010674
% 224.07/224.22       91%28%75%29%; was see under CHLOROPHYLL 1975-90   
% 224.07/224.22  |- mesh__publicMeSHNote mesh__D010674
% 224.07/224.22       91; was see under CHLOROPHYLL 1975-90   
% 224.07/224.22  |- mesh__recordOriginator mesh__D010674 NLM
% 224.07/224.22  |- rdf__type mesh__D010674sskos__Concept
% 224.07/224.22  |- mesh__recordMaintainer mesh__D010674 ssb
% 224.07/224.22  |- skos__broader mesh__D010674smesh__D002734
% 224.07/224.22  |- skos__hiddenLabel mesh__D004637 Service, Emergency Psychiatric
% 224.07/224.22  |- skos__broader mesh__D004637smesh__D008605
% 224.07/224.22  |- skos__scopeNote mesh__D004637
% 224.07/224.22       Organized services to provide immediate psychiatric care to patients with acute psychological disturbances.%A%    
% 224.07/224.22  |- skos__related mesh__D004637smesh__D015277
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D004637 2005
% 224.07/224.22  |- mesh__recordOriginator mesh__D004637 EC
% 224.07/224.22  |- skos__annotation mesh__D004637 IM; DF: EMERGENCY SERV PSYCHIATRIC   
% 224.07/224.22  |- skos__prefLabel mesh__D004637 Emergency Services, Psychiatric
% 224.07/224.22  |- mesh__publicMeSHNote mesh__D004637
% 224.07/224.22       90; was see under EMERGENCY MEDICAL SERVICES 1976-89   
% 224.07/224.22  |- skos__altLabel mesh__D004637 Emergency Psychiatric Services
% 224.07/224.22  |- mesh__dateRevised mesh__D004637 1999-11-03
% 224.07/224.22  |- rdf__type mesh__D004637sskos__Concept
% 224.07/224.22  |- skos__hiddenLabel mesh__D004637 Psychiatric Emergency Service
% 224.07/224.22  |- skos__altLabel mesh__D004637 Services, Psychiatric Emergency
% 224.07/224.22  |- mesh__dateEstablished mesh__D004637 1990-01-01
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D004637 2006
% 224.07/224.22  |- skos__altLabel mesh__D004637 Services, Emergency Psychiatric
% 224.07/224.22  |- mesh__historyNote mesh__D004637
% 224.07/224.22       90%28%76%29%; was see under EMERGENCY MEDICAL SERVICES 1976-89   
% 224.07/224.22  |- mesh__recordMaintainer mesh__D004637 kle
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D004637 2000
% 224.07/224.22  |- skos__hiddenLabel mesh__D004637 Psychiatric Services, Emergency
% 224.07/224.22  |- skos__altLabel mesh__D004637 Psychiatric Emergency Services
% 224.07/224.22  |- skos__hiddenLabel mesh__D004637 Psychiatric Service, Emergency
% 224.07/224.22  |- skos__hiddenLabel mesh__D004637 Service, Psychiatric Emergency
% 224.07/224.22  |- mesh__recordAuthorizer mesh__D004637 sjn
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D004637 2001
% 224.07/224.22  |- skos__hiddenLabel mesh__D004637 Emergency Psychiatric Service
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D004637 2003
% 224.07/224.22  |- skos__broader mesh__D004637smesh__D004632
% 224.07/224.22  |- skos__historyNote mesh__D004637 Emergencies %28%1966-1975%29%
% 224.07/224.22  |- skos__historyNote mesh__D004637
% 224.07/224.22       Emergency Medical Services %28%1968-1975%29%
% 224.07/224.22  |- mesh__dateCreated mesh__D004637 1977-12-07
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D004637 2002
% 224.07/224.22  |- skos__hiddenLabel mesh__D004637 Emergency Service, Psychiatric
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D004637 2004
% 224.07/224.22  |- mesh__onlineNote mesh__D009322
% 224.07/224.22       use NATURAL DISASTERS to search FLOODS 1975-81; use DISASTERS 1966-74%A%  
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D009322 2002
% 224.07/224.22  |- mesh__publicMeSHNote mesh__D009322
% 224.07/224.22       91; was see under DISASTERS 1972-90; FLOODS was see under DISASTERS 1963-81%A%  
% 224.07/224.22  |- mesh__historyNote mesh__D009322
% 224.07/224.22       91%28%72%29%; was see under DISASTERS 1972-90; FLOODS was see under DISASTERS 1963-81%A%  
% 224.07/224.22  |- skos__hiddenLabel mesh__D009322 Flood
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D009322 1998
% 224.07/224.22  |- mesh__recordMaintainer mesh__D009322 JLS
% 224.07/224.22  |- mesh__dateRevised mesh__D009322 1994-05-23
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D009322 1999
% 224.07/224.22  |- skos__hiddenLabel mesh__D009322 Disasters, Natural
% 224.07/224.22  |- mesh__recordOriginator mesh__D009322 NLM
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D009322 2003
% 224.07/224.22  |- mesh__recordAuthorizer mesh__D009322 PLS
% 224.07/224.22  |- skos__hiddenLabel mesh__D009322 Earthquake
% 224.07/224.22  |- skos__historyNote mesh__D009322 Disasters %28%1966-1971%29%
% 224.07/224.22  |- skos__hiddenLabel mesh__D009322 Hurricane
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D009322 1995
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D009322 2004
% 224.07/224.22  |- skos__scopeNote mesh__D009322
% 224.07/224.22       Sudden calamitous events producing great material damage, loss, and distress. They are the result of natural phenomena such as earthquakes, floods, etc.%A%    
% 224.07/224.22  |- skos__hiddenLabel mesh__D009322 Droughts
% 224.07/224.22  |- rdf__type mesh__D009322sskos__Concept
% 224.07/224.22  |- skos__related mesh__D009322smesh__D012066
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D009322 2000
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D009322 1996
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D009322 2005
% 224.07/224.22  |- mesh__dateCreated mesh__D009322 1999-01-01
% 224.07/224.22  |- skos__hiddenLabel mesh__D009322 Disaster, Natural
% 224.07/224.22  |- skos__altLabel mesh__D009322 Tornadoes
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D009322 1997
% 224.07/224.22  |- skos__broader mesh__D009322smesh__D004190
% 224.07/224.22  |- skos__altLabel mesh__D009322 Natural Disaster
% 224.07/224.22  |- skos__prefLabel mesh__D009322 Natural Disasters
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D009322 2001
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D009322 2006
% 224.07/224.22  |- mesh__dateEstablished mesh__D009322 1991-01-01
% 224.07/224.22  |- mesh__recordOriginator mesh__D014267 NLM
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D014267 1997
% 224.07/224.22  |- mesh__historyNote mesh__D014267
% 224.07/224.22       91%28%75%29%; was see under TRIALKYLTIN COMPOUNDS 1975-90   
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D014267 2003
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D014267 1999
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D014267 2005
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D014267 1993
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D014267 1996
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D014267 1995
% 224.07/224.22  |- skos__annotation mesh__D014267 DF: TRIETHYLTIN CPDS   
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D014267 1998
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D014267 2002
% 224.07/224.22  |- mesh__dateRevised mesh__D014267 1992-05-20
% 224.07/224.22  |- mesh__dateEstablished mesh__D014267 1991-01-01
% 224.07/224.22  |- skos__historyNote mesh__D014267 Tin %28%1972-1974%29%
% 224.07/224.22  |- mesh__publicMeSHNote mesh__D014267
% 224.07/224.22       91; was see under TRIALKYLTIN COMPOUNDS 1975-90   
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D014267 1994
% 224.07/224.22  |- skos__scopeNote mesh__D014267
% 224.07/224.22       Organic compounds composed of tin and three ethyl groups. Affect mitochondrial metabolism and inhibit oxidative phosphorylation by acting directly on the energy conserving processes.%A%    
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D014267 2001
% 224.07/224.22  |- mesh__recordMaintainer mesh__D014267 TAP
% 224.07/224.22  |- rdf__type mesh__D014267sskos__Concept
% 224.07/224.22  |- mesh__dateCreated mesh__D014267 1974-11-14
% 224.07/224.22  |- skos__prefLabel mesh__D014267 Triethyltin Compounds
% 224.07/224.22  |- skos__hiddenLabel mesh__D014267 Compounds, Triethyltin
% 224.07/224.22  |- skos__historyNote mesh__D014267
% 224.07/224.22       Organometallic Compounds %28%1972-1974%29%
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D014267 2000
% 224.07/224.22  |- skos__broader mesh__D014267smesh__D014220
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D014267 2004
% 224.07/224.22  |- mesh__recordAuthorizer mesh__D014267 PLS
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D014267 2006
% 224.07/224.22  |- skos__hiddenLabel mesh__D033421 Ensoulments
% 224.07/224.22  |- skos__hiddenLabel mesh__D033421 Life Beginning, Human
% 224.07/224.22  |- mesh__dateCreated mesh__D033421 2002-07-02
% 224.07/224.22  |- mesh__dateRevised mesh__D033421 2004-07-20
% 224.07/224.22  |- skos__related mesh__D033421smesh__D005314
% 224.07/224.22  |- skos__broader mesh__D033421smesh__D019369
% 224.07/224.22  |- skos__scopeNote mesh__D033421
% 224.07/224.22       The point at which religious ensoulment or PERSONHOOD is considered to begin.%A%    
% 224.07/224.22  |- mesh__publicMeSHNote mesh__D033421 2003; see LIFE 2002   
% 224.07/224.22  |- mesh__recordOriginator mesh__D033421 jrf
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D033421 2005
% 224.07/224.22  |- skos__prefLabel mesh__D033421 Beginning of Human Life
% 224.07/224.22  |- mesh__recordAuthorizer mesh__D033421 NLM
% 224.07/224.22  |- skos__related mesh__D033421smesh__D028723
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D033421 2006
% 224.07/224.22  |- skos__annotation mesh__D033421
% 224.07/224.22       check tag HUMAN; use only for the beginning of life as a philosophical or religious concept; do not confuse with ORIGIN OF LIFE see BIOGENESIS%A%  
% 224.07/224.22  |- mesh__historyNote mesh__D033421 2003; use LIFE 2002   
% 224.07/224.22  |- mesh__recordMaintainer mesh__D033421 NLM
% 224.07/224.22  |- rdf__type mesh__D033421sskos__Concept
% 224.07/224.22  |- skos__hiddenLabel mesh__D033421 Human Life Beginning
% 224.07/224.22  |- mesh__dateEstablished mesh__D033421 2003-01-01
% 224.07/224.22  |- skos__altLabel mesh__D033421 Ensoulment
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D000247 2005
% 224.07/224.22  |- mesh__recordMaintainer mesh__D000247 ssb
% 224.07/224.22  |- skos__historyNote mesh__D000247 Adenosine %28%1973-1974%29%
% 224.07/224.22  |- skos__hiddenLabel mesh__D000247 Sugars, Adenosine Diphosphate
% 224.07/224.22  |- skos__hiddenLabel mesh__D000247 Sugars, ADP
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D000247 2006
% 224.07/224.22  |- mesh__historyNote mesh__D000247
% 224.07/224.22       91%28%75%29%; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90%A%  
% 224.07/224.22  |- rdf__type mesh__D000247sskos__Concept
% 224.07/224.22  |- mesh__dateCreated mesh__D000247 1974-11-19
% 224.07/224.22  |- mesh__recordAuthorizer mesh__D000247 sjn
% 224.07/224.22  |- skos__scopeNote mesh__D000247
% 224.07/224.22       Esters formed between the aldehydic carbon of sugars and the terminal phosphate of adenosine diphosphate.%A%    
% 224.07/224.22  |- mesh__recordOriginator mesh__D000247 NLM
% 224.07/224.22  |- mesh__dateRevised mesh__D000247 2004-07-07
% 224.07/224.22  |- skos__historyNote mesh__D000247
% 224.07/224.22       Nucleoside Diphosphate Sugars %28%1973-1974%29%
% 224.07/224.22  |- skos__hiddenLabel mesh__D000247 Diphosphate Sugars, Adenosine
% 224.07/224.22  |- mesh__publicMeSHNote mesh__D000247
% 224.07/224.22       91; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90   
% 224.07/224.22  |- skos__prefLabel mesh__D000247 Adenosine Diphosphate Sugars
% 224.07/224.22  |- mesh__dateEstablished mesh__D000247 1991-01-01
% 224.07/224.22  |- skos__altLabel mesh__D000247 ADP Sugars
% 224.07/224.22  |- skos__broader mesh__D000247smesh__D000244
% 224.07/224.22  |- skos__broader mesh__D000247smesh__D009702
% 224.07/224.22  |- skos__broader mesh__D000022Q000662smesh__D000022
% 224.07/224.22  |- mesh__preferredCombination mesh__D000022Q000662smesh__D000034
% 224.07/224.22  |- rdf__type mesh__D000022Q000662smesh__CompoundConcept
% 224.07/224.22  |- mesh__recordOriginator mesh__D005730 NLM
% 224.07/224.22  |- mesh__recordAuthorizer mesh__D005730 sjn
% 224.07/224.22  |- skos__hiddenLabel mesh__D005730 Blockaders, Ganglionic
% 224.07/224.22  |- mesh__recordMaintainer mesh__D005730 ssb
% 224.07/224.22  |- skos__broader mesh__D005730smesh__D001337
% 224.07/224.22  |- mesh__dateCreated mesh__D005730 1999-01-01
% 224.07/224.22  |- skos__related mesh__D005730smesh__D011978
% 224.07/224.22  |- mesh__dateEstablished mesh__D005730 1970-01-01
% 224.07/224.22  |- mesh__onlineNote mesh__D005730
% 224.07/224.22       use GANGLIONIC BLOCKERS to search GANGLIONIC BLOCKADERS 1970-94 %26% GANGLIONIC-BLOCKING AGENTS 1966-69%A%  
% 224.07/224.22  |- skos__hiddenLabel mesh__D005730 Agents, Ganglionic Blocking
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D005730 2006
% 224.07/224.22  |- skos__altLabel mesh__D005730 Ganglionic Blocking Agents
% 224.07/224.22  |- skos__hiddenLabel mesh__D005730 Agents, Ganglioplegic
% 224.07/224.22  |- mesh__publicMeSHNote mesh__D005730
% 224.07/224.22       95; was GANGLIONIC BLOCKADERS 1970-94; was GANGLIONIC-BLOCKING AGENTS 1963-69%A%  
% 224.07/224.22  |- skos__hiddenLabel mesh__D005730 Blockers, Ganglionic
% 224.07/224.22  |- skos__prefLabel mesh__D005730 Ganglionic Blockers
% 224.07/224.22  |- mesh__dateRevised mesh__D005730 2005-06-30
% 224.07/224.22  |- skos__altLabel mesh__D005730 Ganglioplegic Agents
% 224.07/224.22  |- skos__altLabel mesh__D005730 Blocking Agents, Ganglionic
% 224.07/224.22  |- skos__related mesh__D005730smesh__D018733
% 224.07/224.22  |- mesh__historyNote mesh__D005730
% 224.07/224.22       95; was GANGLIONIC BLOCKADERS 1970-94; was GANGLIONIC-BLOCKING AGENTS 1963-69%A%  
% 224.07/224.22  |- rdf__type mesh__D005730sskos__Concept
% 224.07/224.22  |- skos__altLabel mesh__D005730 Ganglionic Blockaders
% 224.07/224.22  |- skos__annotation mesh__D005730
% 224.07/224.22       GEN or unspecified; prefer specifics; consider also GANGLIA /drug eff; DF: GANGLIONIC BLOCK%A%  
% 224.07/224.22  |- skos__scopeNote mesh__D005730
% 224.07/224.22       Agents having as their major action the interruption of neural transmission at nicotinic receptors on postganglionic autonomic neurons. Because their actions are so broad, including blocking of sympathetic and parasympathetic systems, their therapeutic use has been largely supplanted by more specific drugs. They may still be used in the control of blood pressure in patients with acute dissecting aortic aneurysm and for the induction of hypotension in surgery.%A%    
% 224.07/224.22  |- mesh__recordMaintainer mesh__D046349 ags
% 224.07/224.22  |- mesh__recordAuthorizer mesh__D046349 ags
% 224.07/224.22  |- skos__historyNote mesh__D046349 Porphyria %28%1965-2004%29%
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D046349 2006
% 224.07/224.22  |- skos__historyNote mesh__D046349 Porphyria, Hepatic %28%1993-2004%29%
% 224.07/224.22  |- rdf__type mesh__D046349sskos__Concept
% 224.07/224.22  |- mesh__dateRevised mesh__D046349 2005-07-11
% 224.07/224.22  |- skos__broader mesh__D046349smesh__D017094
% 224.07/224.22  |- mesh__historyNote mesh__D046349
% 224.07/224.22       2005; use PORPHYRIA, HEPATIC 1993-2004   
% 224.07/224.22  |- skos__altLabel mesh__D046349 Hereditary Coproporphyria
% 224.07/224.22  |- skos__hiddenLabel mesh__D046349 Deficiency, Coproporphyrinogen Oxidase
% 224.07/224.22  |- mesh__recordOriginator mesh__D046349 lkt
% 224.07/224.22  |- skos__scopeNote mesh__D046349
% 224.07/224.22       An autosomal dominant porphyria that is due to a deficiency of COPROPORPHYRINOGEN OXIDASE in the LIVER, the sixth enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features include both neurological symptoms and cutaneous lesions. Patients excrete increased levels of porphyrin precursors, 5-AMINOLEVULINATE and COPROPORPHYRINS.%A%    
% 224.07/224.22  |- skos__altLabel mesh__D046349 Coproporphyrinogen Oxidase Deficiency
% 224.07/224.22  |- mesh__dateCreated mesh__D046349 2004-07-07
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D046349 2006A
% 224.07/224.22  |- mesh__dateEstablished mesh__D046349 2005-01-01
% 224.07/224.22  |- mesh__publicMeSHNote mesh__D046349
% 224.07/224.22       2005; see PORPHYRIA, HEPATIC 1993-2004   
% 224.07/224.22  |- skos__prefLabel mesh__D046349 Coproporphyria, Hereditary
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D046349 2005
% 224.07/224.22  |- skos__historyNote mesh__D018658 Heart Rupture %28%1978-1990%29%
% 224.07/224.22  |- mesh__dateCreated mesh__D018658 1994-04-19
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D018658 2005
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D018658 2002
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D018658 1995
% 224.07/224.22  |- skos__historyNote mesh__D018658
% 224.07/224.22       Heart Rupture, Post-Infarction %28%1991-1994%29%
% 224.07/224.22  |- skos__hiddenLabel mesh__D018658 Septal Rupture, Ventricular
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D018658 2006
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D018658 2003
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D018658 1998
% 224.07/224.22  |- skos__hiddenLabel mesh__D018658 Perforations, Ventricular Septal
% 224.07/224.22  |- skos__broader mesh__D018658smesh__D006342
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D018658 2004
% 224.07/224.22  |- skos__hiddenLabel mesh__D018658 Septal Ruptures, Ventricular
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D018658 1999
% 224.07/224.22  |- skos__hiddenLabel mesh__D018658 Septal Perforations, Ventricular
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D018658 1996
% 224.07/224.22  |- mesh__dateEstablished mesh__D018658 1995-01-01
% 224.07/224.22  |- skos__hiddenLabel mesh__D018658 Perforation, Ventricular Septal
% 224.07/224.22  |- skos__prefLabel mesh__D018658 Ventricular Septal Rupture
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D018658 1997
% 224.07/224.22  |- rdf__type mesh__D018658sskos__Concept
% 224.07/224.22  |- skos__scopeNote mesh__D018658
% 224.07/224.22       Rupture of the intraventricular septum of the heart, usually secondary to myocardial infarction.%A%    
% 224.07/224.22  |- mesh__publicMeSHNote mesh__D018658 95   
% 224.07/224.22  |- skos__altLabel mesh__D018658 Ventricular Septal Perforation
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D018658 2000
% 224.07/224.22  |- skos__historyNote mesh__D018658 Rupture, Spontaneous %28%1968-1977%29%
% 224.07/224.22  |- skos__hiddenLabel mesh__D018658 Septal Perforation, Ventricular
% 224.07/224.22  |- skos__hiddenLabel mesh__D018658 Rupture, Ventricular Septal
% 224.07/224.22  |- mesh__historyNote mesh__D018658 95   
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D018658 2001
% 224.07/224.22  |- skos__hiddenLabel mesh__D018658 Ventricular Septal Ruptures
% 224.07/224.22  |- skos__hiddenLabel mesh__D018658 Ventricular Septal Perforations
% 224.07/224.22  |- skos__hiddenLabel mesh__D018658 Ruptures, Ventricular Septal
% 224.07/224.22  |- skos__historyNote mesh__D010675 Sex Behavior %28%1966-1967%29%
% 224.07/224.22  |- mesh__historyNote mesh__D010675 1968   
% 224.07/224.22  |- mesh__dateCreated mesh__D010675 1999-01-01
% 224.07/224.22  |- skos__annotation mesh__D010675
% 224.07/224.22       animal, plant %26% microbes; human = PHEROMONES, HUMAN; SEX PHEROMONES is also available%A%  
% 224.07/224.22  |- skos__historyNote mesh__D010675 Behavior, Animal %28%1966-1967%29%
% 224.07/224.22  |- mesh__dateRevised mesh__D010675 2005-06-30
% 224.07/224.22  |- skos__altLabel mesh__D010675 Semiochemicals
% 224.07/224.22  |- mesh__recordAuthorizer mesh__D010675 sjn
% 224.07/224.22  |- mesh__dateEstablished mesh__D010675 1968-01-01
% 224.07/224.22  |- skos__broader mesh__D010675smesh__D001685
% 224.07/224.22  |- skos__prefLabel mesh__D010675 Pheromones
% 224.07/224.22  |- skos__scopeNote mesh__D010675
% 224.07/224.22       Chemical substances, excreted by an organism into the environment, that elicit behavioral or physiological responses from other organisms of the same species. Perception of these chemical signals may be olfactory or by contact.%A%    
% 224.07/224.22  |- rdf__type mesh__D010675sskos__Concept
% 224.07/224.22  |- mesh__publicMeSHNote mesh__D010675 1968   
% 224.07/224.22  |- mesh__recordOriginator mesh__D010675 NLM
% 224.07/224.22  |- mesh__recordMaintainer mesh__D010675 ssb
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D010675 2006
% 224.07/224.22  |- skos__scopeNote mesh__D004638
% 224.07/224.22       First aid or other immediate intervention for accidents or medical conditions requiring immediate care and treatment before definitive medical and surgical management can be procured.%A%    
% 224.07/224.22  |- skos__hiddenLabel mesh__D004638 Treatment, Emergency
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D004638 2002
% 224.07/224.22  |- mesh__recordOriginator mesh__D004638 NLM
% 224.07/224.22  |- rdf__type mesh__D004638sskos__Concept
% 224.07/224.22  |- skos__hiddenLabel mesh__D004638 Emergency Treatments
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D004638 2006
% 224.07/224.22  |- mesh__historyNote mesh__D004638 98; use explode 1975-97   
% 224.07/224.22  |- skos__hiddenLabel mesh__D004638 Emergency Therapies
% 224.07/224.22  |- mesh__recordMaintainer mesh__D004638 TGC
% 224.07/224.22  |- skos__hiddenLabel mesh__D004638 Therapies, Emergency
% 224.07/224.22  |- skos__annotation mesh__D004638
% 224.07/224.22       GEN or unspecified; prefer specifics; coord IM with med condition with appropriate qualif %28%IM%29%%A%  
% 224.07/224.22  |- skos__altLabel mesh__D004638 Therapy, Emergency
% 224.07/224.22  |- mesh__recordAuthorizer mesh__D004638 SJN
% 224.07/224.22  |- skos__related mesh__D004638smesh__D004630
% 224.07/224.22  |- skos__broader mesh__D004638smesh__D013812
% 224.07/224.22  |- mesh__dateEstablished mesh__D004638 1998-01-01
% 224.07/224.22  |- skos__hiddenLabel mesh__D004638 Treatments, Emergency
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D004638 2003
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D004638 1998
% 224.07/224.22  |- skos__historyNote mesh__D004638 Emergencies %28%1966-1997%29%
% 224.07/224.22  |- mesh__dateRevised mesh__D004638 1997-06-20
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D004638 2000
% 224.07/224.22  |- skos__prefLabel mesh__D004638 Emergency Treatment
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D004638 2004
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D004638 1999
% 224.07/224.22  |- skos__altLabel mesh__D004638 Emergency Therapy
% 224.07/224.22  |- mesh__dateCreated mesh__D004638 1999-01-01
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D004638 2001
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D004638 2005
% 224.07/224.22  |- mesh__publicMeSHNote mesh__D004638 98   
% 224.07/224.22  |- mesh__dateCreated mesh__D015360 1988-06-02
% 224.07/224.22  |- mesh__publicMeSHNote mesh__D015360 89   
% 224.07/224.22  |- skos__historyNote mesh__D015360 Anesthesia, Epidural %28%1966-1988%29%
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D015360 1998
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D015360 2006
% 224.07/224.22  |- skos__annotation mesh__D015360
% 224.07/224.22       do not use /util except by MeSH definition; for relief of pain: do not confuse with ANESTHESIA, EPIDURAL%A%  
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D015360 2004
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D015360 2001
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D015360 1996
% 224.07/224.22  |- mesh__historyNote mesh__D015360 89   
% 224.07/224.22  |- skos__historyNote mesh__D015360 Analgesia %28%1966-1988%29%
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D015360 2000
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D015360 2005
% 224.07/224.22  |- mesh__recordOriginator mesh__D015360 EC
% 224.07/224.22  |- skos__prefLabel mesh__D015360 Analgesia, Epidural
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D015360 2003
% 224.07/224.22  |- mesh__recordMaintainer mesh__D015360 PLS
% 224.07/224.22  |- skos__broader mesh__D015360smesh__D000698
% 224.07/224.22  |- mesh__dateEstablished mesh__D015360 1989-01-01
% 224.07/224.22  |- skos__historyNote mesh__D015360
% 224.07/224.22       Pain, Postoperative/prevention %26% control %28%1966-1988%29%
% 224.07/224.22  |- skos__scopeNote mesh__D015360
% 224.07/224.22       The relief of pain without loss of consciousness through the introduction of an analgesic agent into the epidural space of the vertebral canal. It is differentiated from ANESTHESIA, EPIDURAL which refers to the state of insensitivity to sensation.%A%    
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D015360 1995
% 224.07/224.22  |- rdf__type mesh__D015360sskos__Concept
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D015360 1993
% 224.07/224.22  |- skos__historyNote mesh__D015360 Epidural Space %28%1979-1988%29%
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D015360 2002
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D015360 1994
% 224.07/224.22  |- mesh__dateRevised mesh__D015360 1991-05-12
% 224.07/224.22  |- skos__altLabel mesh__D015360 Epidural Analgesia
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D015360 1992
% 224.07/224.22  |- skos__historyNote mesh__D015360 Pain/drug therapy %28%1966-1988%29%
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D015360 1999
% 224.07/224.22  |- mesh__recordAuthorizer mesh__D015360 PLS
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D015360 1997
% 224.07/224.22  |- skos__hiddenLabel mesh__D009323 Language Processings, Natural
% 224.07/224.22  |- mesh__recordAuthorizer mesh__D009323 sjn
% 224.07/224.22  |- skos__prefLabel mesh__D009323 Natural Language Processing
% 224.07/224.22  |- mesh__recordOriginator mesh__D009323 EC
% 224.07/224.22  |- skos__scopeNote mesh__D009323
% 224.07/224.22       Computer processing of a language with rules that reflect and describe current usage rather than prescribed usage.%A%    
% 224.07/224.22  |- skos__broader mesh__D009323smesh__D001185
% 224.07/224.22  |- rdf__type mesh__D009323sskos__Concept
% 224.07/224.22  |- skos__hiddenLabel mesh__D009323 Language Processing, Natural
% 224.07/224.22  |- mesh__dateCreated mesh__D009323 1986-06-18
% 224.07/224.22  |- mesh__historyNote mesh__D009323
% 224.07/224.22       91%28%87%29%; was see under ARTIFICIAL INTELLIGENCE 1987-90   
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D009323 2005
% 224.07/224.22  |- mesh__recordMaintainer mesh__D009323 jls
% 224.07/224.22  |- mesh__activeMeSHYear mesh__D009323 2006
% 224.07/224.22  |- mesh__publicMeSHNote mesh__D009323
% 224.07/224.22       91; was see under ARTIFICIAL INTELLIGENCE 1987-90   
% 224.07/224.22  |- skos__hiddenLabel mesh__D009323 Processing, Natural Language
% 224.07/224.23  |- mesh__dateEstablished mesh__D009323 1991-01-01
% 224.07/224.23  |- skos__hiddenLabel mesh__D009323 Natural Language Processings
% 224.07/224.23  |- skos__hiddenLabel mesh__D009323 Processings, Natural Language
% 224.07/224.23  |- mesh__dateRevised mesh__D009323 2004-07-07
% 224.07/224.23  |- skos__annotation mesh__D009323 IM; no qualif   
% 224.07/224.23  |- skos__broader mesh__D001340smesh__D009407
% 224.07/224.23  |- skos__hiddenLabel mesh__D001340 Sympathetic Nerve Blocks
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D001340 2006
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D001340 2000
% 224.07/224.23  |- skos__hiddenLabel mesh__D001340 Nerve Block, Sympathetic
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D001340 2001
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D001340 1996
% 224.07/224.23  |- skos__hiddenLabel mesh__D001340 Nerve Blocks, Autonomic
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D001340 1998
% 224.07/224.23  |- skos__hiddenLabel mesh__D001340 Block, Sympathetic Nerve
% 224.07/224.23  |- mesh__recordOriginator mesh__D001340 NLM
% 224.07/224.23  |- skos__hiddenLabel mesh__D001340 Blocks, Sympathetic Nerve
% 224.07/224.23  |- skos__hiddenLabel mesh__D001340 Block, Autonomic Nerve
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D001340 1997
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D001340 1994
% 224.07/224.23  |- rdf__type mesh__D001340sskos__Concept
% 224.07/224.23  |- skos__hiddenLabel mesh__D001340 Nerve Block, Autonomic
% 224.07/224.23  |- skos__scopeNote mesh__D001340
% 224.07/224.23       Interruption of sympathetic pathways, by local injection of an anesthetic agent, at any of four levels: peripheral nerve block, sympathetic ganglion block, extradural block, and subarachnoid block.%A%    
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D001340 1999
% 224.07/224.23  |- skos__hiddenLabel mesh__D001340 Nerve Blocks, Sympathetic
% 224.07/224.23  |- mesh__recordAuthorizer mesh__D001340 NLM
% 224.07/224.23  |- mesh__recordMaintainer mesh__D001340 PLS
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D001340 1995
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D001340 2002
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D001340 2003
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D001340 2005
% 224.07/224.23  |- mesh__dateRevised mesh__D001340 1993-02-20
% 224.07/224.23  |- mesh__dateCreated mesh__D001340 1999-01-01
% 224.07/224.23  |- skos__hiddenLabel mesh__D001340 Blocks, Autonomic Nerve
% 224.07/224.23  |- skos__hiddenLabel mesh__D001340 Autonomic Nerve Blocks
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D001340 2004
% 224.07/224.23  |- skos__annotation mesh__D001340
% 224.07/224.23       NERVE BLOCK is also available; coord with substance %28%with no qualif%29% used to induce the block if particularly discussed%A%  
% 224.07/224.23  |- skos__prefLabel mesh__D001340 Autonomic Nerve Block
% 224.07/224.23  |- skos__broader mesh__D014268smesh__D010640
% 224.07/224.23  |- mesh__dateCreated mesh__D014268 1999-01-01
% 224.07/224.23  |- mesh__recordOriginator mesh__D014268 NLM
% 224.07/224.23  |- mesh__recordMaintainer mesh__D014268 ssb
% 224.07/224.23  |- mesh__recordAuthorizer mesh__D014268 sjn
% 224.07/224.23  |- rdf__type mesh__D014268sskos__Concept
% 224.07/224.23  |- skos__altLabel mesh__D014268 Trifluperazine
% 224.07/224.23  |- skos__altLabel mesh__D014268 Trifluoroperazine
% 224.07/224.23  |- skos__hiddenLabel mesh__D014268 Hydrochloride, Tripfluoperazine
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D014268 2006
% 224.07/224.23  |- mesh__dateRevised mesh__D014268 2005-06-30
% 224.07/224.23  |- skos__scopeNote mesh__D014268
% 224.07/224.23       A phenothiazine with actions similar to CHLORPROMAZINE. It is used as an antipsychotic and an antiemetic.%A%    
% 224.07/224.23  |- skos__prefLabel mesh__D014268 Trifluoperazine
% 224.07/224.23  |- skos__broader mesh__D019751smesh__D007535
% 224.07/224.23  |- skos__scopeNote mesh__D019751
% 224.07/224.23       Enzymes of the isomerase class that catalyze the transfer of acyl-, phospho-, amino- or other groups from one position within a molecule to another. EC 5.4.%A%    
% 224.07/224.23  |- skos__altLabel mesh__D019751 Mutases
% 224.07/224.23  |- mesh__historyNote mesh__D019751 98   
% 224.07/224.23  |- mesh__publicMeSHNote mesh__D019751 98   
% 224.07/224.23  |- mesh__dateRevised mesh__D019751 2003-07-09
% 224.07/224.23  |- skos__prefLabel mesh__D019751 Intramolecular Transferases
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D019751 2005
% 224.07/224.23  |- mesh__dateEstablished mesh__D019751 1998-01-01
% 224.07/224.23  |- mesh__dateCreated mesh__D019751 1997-06-20
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D019751 2006
% 224.07/224.23  |- rdf__type mesh__D019751sskos__Concept
% 224.07/224.23  |- skos__hiddenLabel mesh__D019751 Transferases, Intramolecular
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D019751 2004
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D000248 2006
% 224.07/224.23  |- rdf__type mesh__D000248sskos__Concept
% 224.07/224.23  |- skos__historyNote mesh__D000248 Phosphotransferases, ATP %28%1974%29%
% 224.07/224.23  |- mesh__recordMaintainer mesh__D000248 ssb
% 224.07/224.23  |- skos__historyNote mesh__D000248 Adenosine %28%1974%29%
% 224.07/224.23  |- mesh__historyNote mesh__D000248
% 224.07/224.23       91%28%75%29%; was see under PHOSPHOTRANSFERASES, ATP 1975-90   
% 224.07/224.23  |- mesh__publicMeSHNote mesh__D000248
% 224.07/224.23       91; was see under PHOSPHOTRANSFERASES, ATP 1975-90   
% 224.07/224.23  |- mesh__dateEstablished mesh__D000248 1991-01-01
% 224.07/224.23  |- mesh__dateCreated mesh__D000248 1974-11-19
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D000248 2004
% 224.07/224.23  |- mesh__dateRevised mesh__D000248 2003-07-09
% 224.07/224.23  |- mesh__recordAuthorizer mesh__D000248 sjn
% 224.07/224.23  |- mesh__recordOriginator mesh__D000248 NLM
% 224.07/224.23  |- skos__broader mesh__D000248smesh__D017853
% 224.07/224.23  |- skos__prefLabel mesh__D000248 Adenosine Kinase
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D000248 2005
% 224.07/224.23  |- skos__scopeNote mesh__D000248
% 224.07/224.23       An enzyme that catalyzes the formation of ADP plus AMP from adenosine plus ATP. It can serve as a salvage mechanism for returning adenosine to nucleic acids. EC 2.7.1.20.%A%    
% 224.07/224.23  |- skos__hiddenLabel mesh__D000248 Kinase, Adenosine
% 224.07/224.23  |- mesh__dateRevised mesh__D005731 2005-06-30
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D005731 2006
% 224.07/224.23  |- mesh__publicMeSHNote mesh__D005731 72   
% 224.07/224.23  |- mesh__dateEstablished mesh__D005731 1972-01-01
% 224.07/224.23  |- skos__prefLabel mesh__D005731 Ganglionic Stimulants
% 224.07/224.23  |- skos__historyNote mesh__D005731 Autonomic Agents %28%1966-1970%29%
% 224.07/224.23  |- mesh__historyNote mesh__D005731 72%28%71%29%   
% 224.07/224.23  |- mesh__recordAuthorizer mesh__D005731 sjn
% 224.07/224.23  |- mesh__recordOriginator mesh__D005731 NLM
% 224.07/224.23  |- rdf__type mesh__D005731sskos__Concept
% 224.07/224.23  |- skos__scopeNote mesh__D005731
% 224.07/224.23       Agents that mimic neural transmission by stimulation of the nicotinic receptors on postganglionic autonomic neurons. Drugs that indirectly augment ganglionic transmission by increasing the release or slowing the breakdown of acetylcholine or by non-nicotinic effects on postganglionic neurons are not included here nor are the nonspecific cholinergic agonists.%A%    
% 224.07/224.23  |- mesh__recordMaintainer mesh__D005731 ssb
% 224.07/224.23  |- skos__broader mesh__D005731smesh__D001337
% 224.07/224.23  |- skos__related mesh__D005731smesh__D011978
% 224.07/224.23  |- mesh__dateCreated mesh__D005731 1999-01-01
% 224.07/224.23  |- skos__hiddenLabel mesh__D005731 Stimulants, Ganglionic
% 224.07/224.23  |- skos__related mesh__D005731smesh__D018722
% 224.07/224.23  |- skos__annotation mesh__D005731
% 224.07/224.23       GEN or unspecified; prefer specifics; consider also GANGLIA /drug eff%A%  
% 224.07/224.23  |- mesh__recordOriginator mesh__D010676 NLM
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D010676 2006
% 224.07/224.23  |- mesh__recordMaintainer mesh__D010676 SYSTEM
% 224.07/224.23  |- skos__scopeNote mesh__D010676
% 224.07/224.23       A mitosporic fungal genus. Phialophora verrucosa is a cause of chromomycosis %28%CHROMOBLASTOMYCOSIS%29%. Ophiobolus is the teleomorph of Phialophora.%A%    
% 224.07/224.23  |- mesh__dateCreated mesh__D010676 1999-01-01
% 224.07/224.23  |- skos__broader mesh__D010676smesh__D003904
% 224.07/224.23  |- mesh__dateRevised mesh__D010676 2005-06-30
% 224.07/224.23  |- rdf__type mesh__D010676sskos__Concept
% 224.07/224.23  |- skos__annotation mesh__D010676
% 224.07/224.23       infection: coord IM with MYCOSES or specific mycosis %28%IM%29%%A%  
% 224.07/224.23  |- mesh__recordAuthorizer mesh__D010676 sjn
% 224.07/224.23  |- skos__prefLabel mesh__D010676 Phialophora
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D029381 2002
% 224.07/224.23  |- mesh__dateEstablished mesh__D029381 2002-01-01
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D029381 2004
% 224.07/224.23  |- skos__prefLabel mesh__D029381 Closteroviridae
% 224.07/224.23  |- skos__annotation mesh__D029381 coord IM with specific plant /virol   
% 224.07/224.23  |- skos__scopeNote mesh__D029381
% 224.07/224.23       A family of plant viruses containing the largest single-stranded RNA genomes. Infections typically involve yellowing and necrosis, particularly affecting the phloem.%A%    
% 224.07/224.23  |- mesh__activeMeSHYear mesh__D029381 2003
% 224.07/224.24  |- mesh__dateCreated mesh__D029381 2001-07-25
% 224.07/224.24  |- mesh__historyNote mesh__D029381 2002   
% 224.07/224.24  |- skos__broader mesh__D029381smesh__D012328
% 224.07/224.24  |- skos__broader mesh__D029381smesh__D010942
% 224.07/224.24  |- rdf__type mesh__D029381sskos__Concept
% 224.07/224.24  |- mesh__publicMeSHNote mesh__D029381 2002   
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D029381 2006
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D029381 2005
% 224.07/224.24  |- skos__broader mesh__D004639smesh__D002491
% 224.07/224.24  |- skos__annotation mesh__D004639
% 224.07/224.24       GEN or unspecified; prefer specifics; consider also NAUSEA /chem ind %26% VOMITING /chem ind%A%  
% 224.07/224.24  |- mesh__recordAuthorizer mesh__D004639 sjn
% 224.07/224.24  |- skos__broader mesh__D004639smesh__D001337
% 224.07/224.24  |- mesh__dateCreated mesh__D004639 1999-01-01
% 224.07/224.24  |- skos__prefLabel mesh__D004639 Emetics
% 224.07/224.24  |- skos__altLabel mesh__D004639 Emetic Drugs
% 224.07/224.24  |- mesh__recordOriginator mesh__D004639 NLM
% 224.07/224.24  |- skos__altLabel mesh__D004639 Emetic Agents
% 224.07/224.24  |- mesh__recordMaintainer mesh__D004639 ssb
% 224.07/224.24  |- rdf__type mesh__D004639sskos__Concept
% 224.07/224.24  |- skos__hiddenLabel mesh__D004639 Drugs, Emetic
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D004639 2006
% 224.07/224.24  |- mesh__dateRevised mesh__D004639 2005-06-30
% 224.07/224.24  |- skos__hiddenLabel mesh__D004639 Agents, Emetic
% 224.07/224.24  |- skos__scopeNote mesh__D004639
% 224.07/224.24       Agents that cause vomiting. They may act directly on the gastrointestinal tract, bringing about emesis through local irritant effects, or indirectly, through their effects on the chemoreceptor trigger zone in the postremal area near the medulla.%A%    
% 224.07/224.24  |- skos__broader mesh__D004639smesh__D045505
% 224.07/224.24  |- skos__broader mesh__D004639smesh__D005765
% 224.07/224.24  |- skos__altLabel mesh__D015361 Facelift
% 224.07/224.24  |- skos__hiddenLabel mesh__D015361 Facelifts
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D015361 2005
% 224.07/224.24  |- mesh__recordMaintainer mesh__D015361 nns
% 224.07/224.24  |- skos__hiddenLabel mesh__D015361 Rhytidoplasties
% 224.07/224.24  |- skos__altLabel mesh__D015361 Face Lift
% 224.07/224.24  |- mesh__dateEstablished mesh__D015361 1989-01-01
% 224.07/224.24  |- skos__hiddenLabel mesh__D015361 Rhytidectomies
% 224.07/224.24  |- rdf__type mesh__D015361sskos__Concept
% 224.07/224.24  |- skos__broader mesh__D015361smesh__D019651
% 224.07/224.24  |- skos__scopeNote mesh__D015361
% 224.07/224.24       Plastic surgery performed, usually by excision of skin, for the elimination of wrinkles from the skin.%A%    
% 224.07/224.24  |- mesh__historyNote mesh__D015361 89   
% 224.07/224.24  |- skos__hiddenLabel mesh__D015361 Face Lifts
% 224.07/224.24  |- skos__hiddenLabel mesh__D015361 Lift, Face
% 224.07/224.24  |- skos__prefLabel mesh__D015361 Rhytidoplasty
% 224.07/224.24  |- skos__broader mesh__D015361smesh__D003357
% 224.07/224.24  |- skos__hiddenLabel mesh__D015361 Lifts, Face
% 224.07/224.24  |- mesh__dateRevised mesh__D015361 2004-07-07
% 224.07/224.24  |- mesh__recordOriginator mesh__D015361 RLS
% 224.07/224.24  |- mesh__dateCreated mesh__D015361 1988-06-02
% 224.07/224.24  |- mesh__publicMeSHNote mesh__D015361 89   
% 224.07/224.24  |- skos__historyNote mesh__D015361 Surgery, Plastic %28%1966-1988%29%
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D015361 2006
% 224.07/224.24  |- mesh__recordAuthorizer mesh__D015361 sjn
% 224.07/224.24  |- skos__annotation mesh__D015361
% 224.07/224.24       do not use /util except by MeSH definition; if of the face, do not coord with FACE or SKIN or related concept%A%  
% 224.07/224.24  |- skos__scopeNote mesh__D009324
% 224.07/224.24       A drugless system of therapy, making use of physical forces such as air, light, water, heat, massage, etc. Treatments are often diet- and nutrition-oriented with attention given to the patient%27%s personal history and lifestyle. %28%From Cassileth, Alternative Medicine Handbook, 1998, p329%29%%A%    
% 224.07/224.24  |- skos__altLabel mesh__D009324 Medicine, Naturopathic
% 224.07/224.24  |- rdf__type mesh__D009324sskos__Concept
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D009324 2005
% 224.07/224.24  |- skos__hiddenLabel mesh__D009324 Naturopathic Medicine
% 224.07/224.24  |- skos__prefLabel mesh__D009324 Naturopathy
% 224.07/224.24  |- mesh__dateCreated mesh__D009324 1999-01-01
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D009324 2006
% 224.07/224.24  |- mesh__recordAuthorizer mesh__D009324 sjn
% 224.07/224.24  |- skos__hiddenLabel mesh__D009324 Remedy, Natural
% 224.07/224.24  |- mesh__dateRevised mesh__D009324 2001-07-25
% 224.07/224.24  |- skos__broader mesh__D009324smesh__D000529
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D009324 2002
% 224.07/224.24  |- skos__hiddenLabel mesh__D009324 Natural Remedy
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D009324 2003
% 224.07/224.24  |- skos__hiddenLabel mesh__D009324 Remedies, Natural
% 224.07/224.24  |- mesh__recordOriginator mesh__D009324 NLM
% 224.07/224.24  |- mesh__recordMaintainer mesh__D009324 ssb
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D009324 2004
% 224.07/224.24  |- skos__annotation mesh__D001341
% 224.07/224.24       dysfunction = AUTONOMIC NERVOUS SYSTEM DISEASES but consider also DYSAUTONOMIA, FAMILIAL%A%  
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D001341 2000
% 224.07/224.24  |- skos__hiddenLabel mesh__D001341 Nervous System, Autonomic
% 224.07/224.24  |- skos__prefLabel mesh__D001341 Autonomic Nervous System
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D001341 2003
% 224.07/224.24  |- skos__hiddenLabel mesh__D001341 Nervous Systems, Autonomic
% 224.07/224.24  |- mesh__dateRevised mesh__D001341 1993-06-21
% 224.07/224.24  |- skos__hiddenLabel mesh__D001341 Systems, Autonomic Nervous
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D001341 2006
% 224.07/224.24  |- mesh__dateCreated mesh__D001341 1999-01-01
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D001341 1997
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D001341 2002
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D001341 2005
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D001341 1996
% 224.07/224.24  |- skos__related mesh__D001341smesh__D017833
% 224.07/224.24  |- skos__broader mesh__D001341smesh__D017933
% 224.07/224.24  |- mesh__recordAuthorizer mesh__D001341 PLS
% 224.07/224.24  |- rdf__type mesh__D001341sskos__Concept
% 224.07/224.24  |- mesh__recordMaintainer mesh__D001341 RAZ
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D001341 1999
% 224.07/224.24  |- mesh__recordOriginator mesh__D001341 NLM
% 224.07/224.24  |- skos__related mesh__D001341smesh__D017763
% 224.07/224.24  |- skos__hiddenLabel mesh__D001341 System, Autonomic Nervous
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D001341 2001
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D001341 1995
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D001341 1998
% 224.07/224.24  |- skos__hiddenLabel mesh__D001341 Autonomic Nervous Systems
% 224.07/224.24  |- skos__scopeNote mesh__D001341
% 224.07/224.24       The enteric, parasympathetic, and sympathetic nervous systems taken together. Generally speaking, the autonomic nervous system regulates the internal environment during both peaceful activity and physical or emotional stress. Autonomic activity is controlled and integrated by the central nervous system, especially the hypothalamus and the solitary nucleus, which receive information relayed from VISCERAL AFFERENTS; these and related central and sensory structures are sometimes %28%but not here%29% considered to be part of the autonomic nervous system itself.%A%    
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D001341 2004
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D001341 1994
% 224.07/224.24  |- rdf__type mesh__D014269sskos__Concept
% 224.07/224.24  |- mesh__recordAuthorizer mesh__D014269 SJN
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D014269 2001
% 224.07/224.24  |- skos__historyNote mesh__D014269 Fluoroacetates %28%1972-1974%29%
% 224.07/224.24  |- skos__hiddenLabel mesh__D014269 Trifluoroacetate, Cesium
% 224.07/224.24  |- skos__hiddenLabel mesh__D014269 Acid, Trifluoroacetic
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D014269 2004
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D014269 2000
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D014269 2006
% 224.07/224.24  |- mesh__publicMeSHNote mesh__D014269
% 224.07/224.24       91; was see under FLUOROACETATES 1975-90   
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D014269 2003
% 224.07/224.24  |- mesh__dateRevised mesh__D014269 1998-06-11
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D014269 1999
% 224.07/224.24  |- mesh__recordMaintainer mesh__D014269 ADP
% 224.07/224.24  |- mesh__historyNote mesh__D014269
% 224.07/224.24       91%28%75%29%; was see under FLUOROACETATES 1975-90   
% 224.07/224.24  |- skos__broader mesh__D014269smesh__D000088
% 224.07/224.24  |- mesh__recordOriginator mesh__D014269 NLM
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D014269 2005
% 224.07/224.24  |- skos__scopeNote mesh__D014269
% 224.07/224.24       A very strong halogenated derivative of acetic acid. It is used in acid catalyzed reactions, especially those where an ester is cleaved in peptide synthesis.%A%    
% 224.07/224.24  |- skos__prefLabel mesh__D014269 Trifluoroacetic Acid
% 224.07/224.24  |- mesh__dateCreated mesh__D014269 1974-11-27
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D014269 2002
% 224.07/224.24  |- mesh__dateEstablished mesh__D014269 1991-01-01
% 224.07/224.24  |- mesh__dateEstablished mesh__D000249 1973-01-01
% 224.07/224.24  |- mesh__recordAuthorizer mesh__D000249 sjn
% 224.07/224.24  |- mesh__recordOriginator mesh__D000249 NLM
% 224.07/224.24  |- skos__scopeNote mesh__D000249
% 224.07/224.24       Adenylic acid. Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2%27%-, 3%27%-, or 5%27%-position.%A%    
% 224.07/224.24  |- mesh__dateRevised mesh__D000249 2001-07-25
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D000249 2006
% 224.07/224.24  |- skos__broader mesh__D000249smesh__D000227
% 224.07/224.24  |- rdf__type mesh__D000249sskos__Concept
% 224.07/224.24  |- skos__prefLabel mesh__D000249 Adenosine Monophosphate
% 224.07/224.24  |- skos__hiddenLabel mesh__D000249 Adenosine 2%27% Phosphate
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D000249 2005
% 224.07/224.24  |- mesh__recordMaintainer mesh__D000249 jmp
% 224.07/224.24  |- mesh__dateCreated mesh__D000249 1999-01-01
% 224.07/224.24  |- skos__altLabel mesh__D000249 Adenylic Acid
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D000249 2004
% 224.07/224.24  |- skos__altLabel mesh__D000249 AMP
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D000249 2003
% 224.07/224.24  |- mesh__historyNote mesh__D000249
% 224.07/224.24       73%28%71%29%; ADENYLIC ACID was ADENYLIC ACIDS see under ADENINE NUCLEOTIDES 1963-72%A%  
% 224.07/224.24  |- skos__annotation mesh__D000249 /biosyn /physiol permitted   
% 224.07/224.24  |- mesh__onlineNote mesh__D000249
% 224.07/224.24       to search ADENYLIC ACIDS use ADENOSINE MONOPHOSPHATE 1971-73, ADENOSINE MONOPHOSPHATE %26% ADENINE NUCLEOTIDES 1971-72, %26% ADENINE NUCLEOTIDES 1966-70%A%  
% 224.07/224.24  |- skos__historyNote mesh__D000249 Adenine Nucleotides %28%1966-1970%29%
% 224.07/224.24  |- mesh__publicMeSHNote mesh__D000249
% 224.07/224.24       73; ADENYLIC ACID was ADENYLIC ACIDS see under ADENINE NUCLEOTIDES 1963-72%A%  
% 224.07/224.24  |- skos__hiddenLabel mesh__D000249 Adenosine 3%27% Phosphate
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D000249 2002
% 224.07/224.24  |- skos__altLabel mesh__D005732 Sialoglycosphingolipids
% 224.07/224.24  |- rdf__type mesh__D005732sskos__Concept
% 224.07/224.24  |- skos__prefLabel mesh__D005732 Gangliosides
% 224.07/224.24  |- mesh__dateRevised mesh__D005732 2004-07-07
% 224.07/224.24  |- skos__scopeNote mesh__D005732
% 224.07/224.24       A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid %28%N-ACETYLNEURAMINIC ACID%29% residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. %28%From Oxford Dictionary of Biochemistry and Molecular Biology, 1997%29%%A%    
% 224.07/224.24  |- mesh__dateCreated mesh__D005732 1999-01-01
% 224.07/224.24  |- mesh__recordAuthorizer mesh__D005732 sjn
% 224.07/224.24  |- mesh__recordOriginator mesh__D005732 NLM
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D005732 2005
% 224.07/224.24  |- skos__broader mesh__D005732smesh__D020384
% 224.07/224.24  |- mesh__recordMaintainer mesh__D005732 ssb
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D005732 2006
% 224.07/224.24  |- mesh__recordAuthorizer mesh__D010677 sjn
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D010677 2006
% 224.07/224.24  |- mesh__dateCreated mesh__D010677 1985-05-03
% 224.07/224.24  |- skos__hiddenLabel mesh__D010677 1 Chromosome, Ph
% 224.07/224.24  |- skos__historyNote mesh__D010677
% 224.07/224.24       Leukemia, Myelocytic/FG %28%1966-1985%29%
% 224.07/224.24  |- mesh__dateEstablished mesh__D010677 1986-01-01
% 224.07/224.24  |- skos__hiddenLabel mesh__D010677 Ph 1 Chromosomes
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D010677 2005
% 224.07/224.24  |- skos__broader mesh__D010677smesh__D002892
% 224.07/224.24  |- skos__hiddenLabel mesh__D010677 Chromosomes, Ph 1
% 224.07/224.24  |- mesh__dateRevised mesh__D010677 2004-07-13
% 224.07/224.24  |- skos__hiddenLabel mesh__D010677 1 Chromosomes, Ph
% 224.07/224.24  |- skos__historyNote mesh__D010677
% 224.07/224.24       Chromosome Abnormalities %28%1966-1967%29%
% 224.07/224.24  |- skos__hiddenLabel mesh__D010677 Chromosome, Ph1
% 224.07/224.24  |- skos__scopeNote mesh__D010677
% 224.07/224.24       An aberrant form of human CHROMOSOME 22 characterized by translocation of genetic material from chromosome 22, usually to the long arms of chromosome 9. It is present in the bone marrow cells of 80 to 90 per cent of patients with chronic myelocytic leukemia %28%LEUKEMIA, MYELOID, CHRONIC%29%.%A%    
% 224.07/224.24  |- skos__altLabel mesh__D010677 Ph 1 Chromosome
% 224.07/224.24  |- rdf__type mesh__D010677sskos__Concept
% 224.07/224.24  |- skos__historyNote mesh__D010677
% 224.07/224.24       Chromosomes, Human, 21-22 %28%1968-1985%29%
% 224.07/224.24  |- skos__prefLabel mesh__D010677 Philadelphia Chromosome
% 224.07/224.24  |- skos__historyNote mesh__D010677 Chromosomes %28%1966-1967%29%
% 224.07/224.24  |- skos__broader mesh__D010677smesh__D014178
% 224.07/224.24  |- mesh__recordOriginator mesh__D010677 AEP
% 224.07/224.24  |- mesh__onlineNote mesh__D010677
% 224.07/224.24       search CHROMOSOMES, HUMAN, 21-22 1978-85   
% 224.07/224.24  |- skos__broader mesh__D010677smesh__D002899
% 224.07/224.24  |- mesh__recordMaintainer mesh__D010677 sjn
% 224.07/224.24  |- skos__hiddenLabel mesh__D010677 Chromosome, Ph 1
% 224.07/224.24  |- skos__related mesh__D010677smesh__D015514
% 224.07/224.24  |- skos__hiddenLabel mesh__D010677 Chromosome, Philadelphia
% 224.07/224.24  |- mesh__historyNote mesh__D010677
% 224.07/224.24       86; was see CHROMOSOMES, HUMAN, 21-22 1978-85   
% 224.07/224.24  |- skos__hiddenLabel mesh__D010677 Ph1 Chromosomes
% 224.07/224.24  |- skos__altLabel mesh__D010677 Ph1 Chromosome
% 224.07/224.24  |- skos__hiddenLabel mesh__D010677 Chromosomes, Ph1
% 224.07/224.24  |- mesh__publicMeSHNote mesh__D010677
% 224.07/224.24       86; was see CHROMOSOMES, HUMAN, 21-22 1978-85   
% 224.07/224.24  |- mesh__dateEstablished mesh__D029382 2002-01-01
% 224.07/224.24  |- skos__historyNote mesh__D029382 Carrier Proteins %28%1980-2001%29%
% 224.07/224.24  |- skos__altLabel mesh__D029382 Dicarboxylic Acid Transport Proteins
% 224.07/224.24  |- skos__altLabel mesh__D029382 Dicarboxylate Transporter
% 224.07/224.24  |- skos__scopeNote mesh__D029382
% 224.07/224.24       A family of organic anion transporters that specifically transport DICARBOXYLIC ACIDS such as alpha-ketoglutaric acid across cellular membranes.%A%    
% 224.07/224.24  |- mesh__recordOriginator mesh__D029382 jmp
% 224.07/224.24  |- skos__altLabel mesh__D029382 Dicarboxylate-Binding Protein
% 224.07/224.24  |- skos__altLabel mesh__D029382 Dicarboxylate Carrier
% 224.07/224.24  |- mesh__recordMaintainer mesh__D029382 ags
% 224.07/224.24  |- mesh__historyNote mesh__D029382
% 224.07/224.24       2002; use DICARBOXYLIC ACID TRANSPORTERS %28%NM%29% 1981-2001   
% 224.07/224.24  |- rdf__type mesh__D029382sskos__Concept
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D029382 2006
% 224.07/224.24  |- mesh__recordAuthorizer mesh__D029382 ags
% 224.07/224.24  |- mesh__dateRevised mesh__D029382 2005-07-22
% 224.07/224.24  |- skos__historyNote mesh__D029382 Ion Pumps %28%1994-2001%29%
% 224.07/224.24  |- skos__hiddenLabel mesh__D029382 Dicarboxylate Binding Protein
% 224.07/224.24  |- mesh__dateCreated mesh__D029382 2001-07-25
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D029382 2006A
% 224.07/224.24  |- skos__broader mesh__D029382smesh__D027361
% 224.07/224.24  |- skos__altLabel mesh__D029382 Dicarboxylate Transport Protein
% 224.07/224.24  |- mesh__publicMeSHNote mesh__D029382
% 224.07/224.24       2002; DICARBOXYLATE TRANSPORT PROTEIN %28%now DICARBOXYLIC ACID TRANSPORTERS%29% was indexed under CARRIER PROTEINS 1981-2001%A%  
% 224.07/224.24  |- skos__hiddenLabel mesh__D029382 Transporters, Dicarboxylic Acid
% 224.07/224.24  |- skos__prefLabel mesh__D029382 Dicarboxylic Acid Transporters
% 224.07/224.24  |- skos__annotation mesh__D015362
% 224.07/224.24       GEN only; prefer specific dis with appropriate age check tag%A%  
% 224.07/224.24  |- skos__hiddenLabel mesh__D015362 Child Nutrition Disorder
% 224.07/224.24  |- skos__hiddenLabel mesh__D015362 Overnutrition, Child
% 224.07/224.24  |- skos__broader mesh__D015362smesh__D009748
% 224.07/224.24  |- mesh__dateRevised mesh__D015362 2003-07-09
% 224.07/224.24  |- mesh__recordAuthorizer mesh__D015362 sjn
% 224.07/224.24  |- skos__scopeNote mesh__D015362
% 224.07/224.24       Disorders caused by nutritional imbalance, either overnutrition or undernutrition, occurring in children ages 2 to 12 years.%A%    
% 224.07/224.24  |- mesh__historyNote mesh__D015362 1989   
% 224.07/224.24  |- skos__related mesh__D015362smesh__D007228
% 224.07/224.24  |- mesh__dateCreated mesh__D015362 1988-06-02
% 224.07/224.24  |- mesh__recordMaintainer mesh__D015362 lkt
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D015362 2006
% 224.07/224.24  |- skos__historyNote mesh__D015362 Nutrition Disorders %28%1966-1988%29%
% 224.07/224.24  |- skos__historyNote mesh__D015362 Child %28%1966-1988%29%
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D015362 2004
% 224.07/224.24  |- mesh__publicMeSHNote mesh__D015362 1989   
% 224.07/224.24  |- skos__altLabel mesh__D015362 Nutrition Disorders, Child
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D015362 2005
% 224.07/224.24  |- skos__hiddenLabel mesh__D015362 Nutrition Disorder, Child
% 224.07/224.24  |- mesh__recordOriginator mesh__D015362 EC
% 224.07/224.24  |- skos__altLabel mesh__D015362 Malnutrition, Child
% 224.07/224.24  |- skos__historyNote mesh__D015362 Child, Preschool %28%1966-1988%29%
% 224.07/224.24  |- mesh__dateEstablished mesh__D015362 1989-01-01
% 224.07/224.24  |- rdf__type mesh__D015362sskos__Concept
% 224.07/224.24  |- skos__altLabel mesh__D015362 Malnutrition in Children
% 224.07/224.24  |- skos__prefLabel mesh__D015362 Child Nutrition Disorders
% 224.07/224.24  |- mesh__dateCreated mesh__D009325 1999-01-01
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D009325 2003
% 224.07/224.24  |- skos__scopeNote mesh__D009325
% 224.07/224.24       An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.%A%    
% 224.07/224.24  |- skos__related mesh__D009325smesh__D004639
% 224.07/224.24  |- rdf__type mesh__D009325sskos__Concept
% 224.07/224.24  |- mesh__recordOriginator mesh__D009325 NLM
% 224.07/224.24  |- skos__broader mesh__D009325smesh__D012817
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D009325 2002
% 224.07/224.24  |- skos__related mesh__D009325smesh__D000932
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D009325 2006
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D009325 2001
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D009325 2005
% 224.07/224.24  |- mesh__dateRevised mesh__D009325 1999-11-03
% 224.07/224.24  |- mesh__recordAuthorizer mesh__D009325 sjn
% 224.07/224.24  |- skos__prefLabel mesh__D009325 Nausea
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D009325 2000
% 224.07/224.24  |- skos__annotation mesh__D009325
% 224.07/224.24       /chem ind: consider also EMETICS; /drug ther: consider also ANTIEMETICS%A%  
% 224.07/224.24  |- mesh__recordMaintainer mesh__D009325 KEV
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D009325 2004
% 224.07/224.24  |- skos__altLabel mesh__D001342 Nervous System Diseases, Autonomic
% 224.07/224.24  |- mesh__dateCreated mesh__D001342 1999-01-01
% 224.07/224.24  |- mesh__dateRevised mesh__D001342 1999-11-08
% 224.07/224.24  |- skos__hiddenLabel mesh__D001342 Autonomic Failure, Pure
% 224.07/224.24  |- skos__altLabel mesh__D001342 Autonomic Nervous System Disorders
% 224.07/224.24  |- skos__hiddenLabel mesh__D001342 Autonomic Disease
% 224.07/224.24  |- skos__altLabel mesh__D001342 Disorders of the Autonomic Nervous System
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D001342 2005
% 224.07/224.24  |- skos__hiddenLabel mesh__D001342 Dysautonomias
% 224.07/224.24  |- mesh__dateEstablished mesh__D001342 1981-01-01
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D001342 2000
% 224.07/224.24  |- skos__historyNote mesh__D001342
% 224.07/224.24       Autonomic Nervous System %28%1966-1980%29%
% 224.07/224.24  |- skos__hiddenLabel mesh__D001342 Autonomic Dysfunction, Segmental
% 224.07/224.24  |- skos__altLabel mesh__D001342
% 224.07/224.24       ANS %28%Autonomic Nervous System%29% Diseases
% 224.07/224.24  |- mesh__recordOriginator mesh__D001342 NLM
% 224.07/224.24  |- skos__altLabel mesh__D001342 Central Autonomic Nervous System Diseases
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D001342 2006
% 224.07/224.24  |- mesh__publicMeSHNote mesh__D001342 1981   
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D001342 2001
% 224.07/224.24  |- skos__altLabel mesh__D001342
% 224.07/224.24       Autonomic Peripheral Nervous System Diseases
% 224.07/224.24  |- rdf__type mesh__D001342sskos__Concept
% 224.07/224.24  |- skos__altLabel mesh__D001342 Autonomic Diseases
% 224.07/224.24  |- skos__broader mesh__D001342smesh__D009422
% 224.07/224.24  |- skos__annotation mesh__D001342
% 224.07/224.24       do not confuse X ref DYSAUTONOMIA with DYSAUTONOMIA, FAMILIAL%A%  
% 224.07/224.24  |- skos__hiddenLabel mesh__D001342 Segmental Autonomic Dysfunctions
% 224.07/224.24  |- skos__prefLabel mesh__D001342 Autonomic Nervous System Diseases
% 224.07/224.24  |- skos__altLabel mesh__D001342 Sympathetic Nervous System Diseases
% 224.07/224.24  |- skos__scopeNote mesh__D001342
% 224.07/224.24       Diseases of the parasympathetic or sympathetic divisions of the AUTONOMIC NERVOUS SYSTEM; which has components located in the CENTRAL NERVOUS SYSTEM and PERIPHERAL NERVOUS SYSTEM. Autonomic dysfunction may be associated with HYPOTHALAMIC DISEASES; BRAIN STEM disorders; SPINAL CORD DISEASES; and PERIPHERAL NERVOUS SYSTEM DISEASES. Manifestations include impairments of vegetative functions including the maintenance of BLOOD PRESSURE; HEART RATE; pupil function; SWEATING; REPRODUCTIVE AND URINARY PHYSIOLOGY; and DIGESTION.%A%    
% 224.07/224.24  |- skos__altLabel mesh__D001342 ANS Diseases
% 224.07/224.24  |- mesh__historyNote mesh__D001342
% 224.07/224.24       1981; was AUTONOMIC SYSTEM DISEASES %28%NON MESH%29% before 1981%A%  
% 224.07/224.24  |- skos__hiddenLabel mesh__D001342 Pure Autonomic Failures
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D001342 2003
% 224.07/224.24  |- skos__historyNote mesh__D001342
% 224.07/224.24       Nervous System Diseases %28%1966-1980%29%
% 224.07/224.24  |- mesh__recordMaintainer mesh__D001342 KEV
% 224.07/224.24  |- skos__hiddenLabel mesh__D001342 Autonomic Dysfunctions, Segmental
% 224.07/224.24  |- mesh__recordAuthorizer mesh__D001342 sjn
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D001342 2002
% 224.07/224.24  |- skos__altLabel mesh__D001342 Parasympathetic Nervous System Diseases
% 224.07/224.24  |- skos__hiddenLabel mesh__D001342 ANS Disease
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D001342 2004
% 224.07/224.24  |- skos__hiddenLabel mesh__D019753 Lyases, Intramolecular
% 224.07/224.24  |- skos__scopeNote mesh__D019753
% 224.07/224.24       Enzymes of the isomerase class that catalyze reactions in which a group can be regarded as eliminated from one part of a molecule, leaving a double bond, while remaining covalently attached to the molecule. %28%From Enzyme Nomenclature, 1992%29% EC 5.5.%A%    
% 224.07/224.24  |- mesh__historyNote mesh__D019753 98   
% 224.07/224.24  |- skos__historyNote mesh__D019753 Isomerases %28%1990-1997%29%
% 224.07/224.24  |- skos__prefLabel mesh__D019753 Intramolecular Lyases
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D019753 2006
% 224.07/224.24  |- mesh__dateCreated mesh__D019753 1997-06-20
% 224.07/224.24  |- mesh__publicMeSHNote mesh__D019753 98   
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D019753 2005
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D019753 2004
% 224.07/224.24  |- skos__broader mesh__D019753smesh__D007535
% 224.07/224.24  |- mesh__dateRevised mesh__D019753 2003-07-09
% 224.07/224.24  |- rdf__type mesh__D019753sskos__Concept
% 224.07/224.24  |- mesh__dateEstablished mesh__D019753 1998-01-01
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D011770 2006
% 224.07/224.24  |- skos__hiddenLabel mesh__D011770 Pyruvate Kinase, M1-Type
% 224.07/224.24  |- mesh__publicMeSHNote mesh__D011770 65   
% 224.07/224.24  |- mesh__recordAuthorizer mesh__D011770 sjn
% 224.07/224.24  |- skos__hiddenLabel mesh__D011770 Pyruvate Kinase, R-Type
% 224.07/224.24  |- mesh__dateEstablished mesh__D011770 1965-01-01
% 224.07/224.24  |- skos__hiddenLabel mesh__D011770 L Type Pyruvate Kinase
% 224.07/224.24  |- skos__prefLabel mesh__D011770 Pyruvate Kinase
% 224.07/224.24  |- skos__hiddenLabel mesh__D011770 M Type Pyruvate Kinase
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D011770 2005
% 224.07/224.24  |- skos__hiddenLabel mesh__D011770 Pyruvate Kinase, M2-Type
% 224.07/224.24  |- skos__hiddenLabel mesh__D011770 M1 Type Pyruvate Kinase
% 224.07/224.24  |- skos__annotation mesh__D011770
% 224.07/224.24       do not coord L-, R-, M-, M1- or M2-type pyruvate kinase with ISOENZYMES%A%  
% 224.07/224.24  |- mesh__dateCreated mesh__D011770 1999-01-01
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D011770 2004
% 224.07/224.24  |- skos__hiddenLabel mesh__D011770 M2 Type Pyruvate Kinase
% 224.07/224.24  |- skos__broader mesh__D011770smesh__D017853
% 224.07/224.24  |- rdf__type mesh__D011770sskos__Concept
% 224.07/224.24  |- skos__hiddenLabel mesh__D011770 Pyruvate Kinase, L-Type
% 224.07/224.24  |- skos__hiddenLabel mesh__D011770 Pyruvate Kinase, M-Type
% 224.07/224.24  |- skos__hiddenLabel mesh__D011770 R Type Pyruvate Kinase
% 224.07/224.24  |- skos__related mesh__D011770smesh__D000743
% 224.07/224.24  |- mesh__dateRevised mesh__D011770 2003-07-09
% 224.07/224.24  |- mesh__historyNote mesh__D011770 65   
% 224.07/224.24  |- mesh__recordMaintainer mesh__D011770 ssb
% 224.07/224.24  |- skos__altLabel mesh__D011770 L-Type Pyruvate Kinase
% 224.07/224.24  |- mesh__recordOriginator mesh__D011770 NLM
% 224.07/224.24  |- skos__scopeNote mesh__D011770
% 224.07/224.24       ATP:pyruvate 2-O-phosphotransferase. A phosphotransferase that catalyzes reversibly the phosphorylation of pyruvate to phosphoenolpyruvate in the presence of ATP. It has four isozymes %28%L, R, M1, and M2%29%. Deficiency of the enzyme results in hemolytic anemia. EC 2.7.1.40.%A%    
% 224.07/224.24  |- skos__historyNote mesh__D005733 Lipoidosis %28%1966-1975%29%
% 224.07/224.24  |- mesh__recordAuthorizer mesh__D005733 sjn
% 224.07/224.24  |- skos__broader mesh__D005733smesh__D013106
% 224.07/224.24  |- skos__hiddenLabel mesh__D005733 Storage Disorders, Ganglioside
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D005733 2006
% 224.07/224.24  |- skos__hiddenLabel mesh__D005733 Storage Disorder, Ganglioside
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D005733 2002
% 224.07/224.24  |- mesh__dateEstablished mesh__D005733 1976-01-01
% 224.07/224.24  |- skos__hiddenLabel mesh__D005733 Ganglioside Storage Disease
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D005733 2005
% 224.07/224.24  |- mesh__historyNote mesh__D005733 1992%28%1976%29%   
% 224.07/224.24  |- skos__altLabel mesh__D005733 Ganglioside Storage Disorders
% 224.07/224.24  |- skos__altLabel mesh__D005733 Ganglioside Storage Diseases
% 224.07/224.24  |- rdf__type mesh__D005733sskos__Concept
% 224.07/224.24  |- skos__prefLabel mesh__D005733 Gangliosidoses
% 224.07/224.24  |- skos__hiddenLabel mesh__D005733 Ganglioside Storage Disorder
% 224.07/224.24  |- mesh__recordOriginator mesh__D005733 SMH
% 224.07/224.24  |- mesh__publicMeSHNote mesh__D005733 1992; see GANGLIOSIDOSIS 1976-91   
% 224.07/224.24  |- skos__altLabel mesh__D005733 Gangliosidosis
% 224.07/224.24  |- mesh__dateCreated mesh__D005733 1975-07-23
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D005733 2004
% 224.07/224.24  |- skos__scopeNote mesh__D005733
% 224.07/224.24       A group of often fatal inherited diseases marked by the accumulation of GANGLIOSIDES in LYSOSOMES secondary to enzymatic deficiency states. Gangliosidoses include TAY-SACHS DISEASE; GANGLIOSIDOSIS GM1; GANGLIOSIDOSES GM2; and SANDHOFF DISEASE; which share the infantile or childhood onset of CENTRAL NERVOUS SYSTEM deterioration. %28%Menkes, Textbook of Child Neurology, 5th ed, pp89-97%29%%A%    
% 224.07/224.24  |- skos__hiddenLabel mesh__D005733 Storage Disease, Ganglioside
% 224.07/224.24  |- skos__annotation mesh__D005733
% 224.07/224.24       coord IM with specific ganglioside %28%IM%29% but GANGLIOSIDOSIS GM1 and GANGLIOSIDOSIS GM2 are available%A%  
% 224.07/224.24  |- skos__hiddenLabel mesh__D005733 Storage Diseases, Ganglioside
% 224.07/224.24  |- skos__historyNote mesh__D005733 Gangliosides %28%1966-1975%29%
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D005733 2003
% 224.07/224.24  |- mesh__recordMaintainer mesh__D005733 sjn
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D005733 2002A
% 224.07/224.24  |- mesh__dateRevised mesh__D005733 2001-12-31
% 224.07/224.24  |- skos__broader mesh__D010678smesh__D001154
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D010678 1992
% 224.07/224.24  |- mesh__historyNote mesh__D010678
% 224.07/224.24       was in Cat I 1975-82, was in Cat E 1963-74   
% 224.07/224.24  |- rdf__type mesh__D010678sskos__Concept
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D010678 1998
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D010678 1996
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D010678 2002
% 224.07/224.24  |- mesh__recordMaintainer mesh__D010678 TGC
% 224.07/224.24  |- skos__annotation mesh__D010678
% 224.07/224.24       SPEC: SPEC qualif; stamp collecting as a hobby: coord IM with HOBBIES %28%IM%29%; indexing policy: TN 245%A%  
% 224.07/224.24  |- skos__hiddenLabel mesh__D010678 Stamps, Postage
% 224.07/224.24  |- mesh__recordAuthorizer mesh__D010678 PLS
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D010678 2006
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D010678 2001
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D010678 2004
% 224.07/224.24  |- skos__scopeNote mesh__D010678
% 224.07/224.24       Study of stamps or postal markings. It usually refers to the design and commemorative aspects of the stamp.%A%    
% 224.07/224.24  |- skos__hiddenLabel mesh__D010678 Philatelies
% 224.07/224.24  |- mesh__activeMeSHYear mesh__D010678 1995
% 224.07/224.24  |- mesh__dateCreated mesh__D010678 1999-01-01
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D010678 2000
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D010678 2005
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D010678 1993
% 224.07/224.25  |- skos__hiddenLabel mesh__D010678 Postage Stamp
% 224.07/224.25  |- mesh__recordOriginator mesh__D010678 NLM
% 224.07/224.25  |- skos__prefLabel mesh__D010678 Philately
% 224.07/224.25  |- skos__hiddenLabel mesh__D010678 Stamp, Postage
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D010678 2003
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D010678 1999
% 224.07/224.25  |- mesh__dateRevised mesh__D010678 1991-01-08
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D010678 1994
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D010678 1997
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D029383 2004
% 224.07/224.25  |- mesh__historyNote mesh__D029383 2002   
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D029383 2002
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D029383 2005
% 224.07/224.25  |- skos__prefLabel mesh__D029383 Crinivirus
% 224.07/224.25  |- mesh__dateEstablished mesh__D029383 2002-01-01
% 224.07/224.25  |- rdf__type mesh__D029383sskos__Concept
% 224.07/224.25  |- mesh__publicMeSHNote mesh__D029383 2002   
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D029383 2006
% 224.07/224.25  |- mesh__dateCreated mesh__D029383 2001-07-25
% 224.07/224.25  |- skos__scopeNote mesh__D029383
% 224.07/224.25       A genus of plant viruses in the family CLOSTEROVIRIDAE. Transmission is by whiteflies. Lettuce infectious yellows virus is the type species.%A%    
% 224.07/224.25  |- skos__broader mesh__D029383smesh__D029381
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D029383 2003
% 224.07/224.25  |- skos__annotation mesh__D029383 coord IM with specific plant /virol   
% 224.07/224.25  |- skos__hiddenLabel mesh__D029383 Criniviruses
% 224.07/224.25  |- skos__broader mesh__D002251Q000506smesh__D002251
% 224.07/224.25  |- mesh__preferredCombination mesh__D002251Q000506smesh__D002252
% 224.07/224.25  |- rdf__type mesh__D002251Q000506smesh__CompoundConcept
% 224.07/224.25  |- mesh__dateRevised mesh__D015363 2003-07-09
% 224.07/224.25  |- mesh__historyNote mesh__D015363
% 224.07/224.25       94; was QUINOLINONES 1989-93; QUINOLONES was see QUINOLINONES 1989-93%A%  
% 224.07/224.25  |- mesh__recordOriginator mesh__D015363 RLS
% 224.07/224.25  |- mesh__recordMaintainer mesh__D015363 ssb
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D015363 2006
% 224.07/224.25  |- mesh__dateCreated mesh__D015363 1988-06-02
% 224.07/224.25  |- skos__altLabel mesh__D015363 Quinolinones
% 224.07/224.25  |- skos__altLabel mesh__D015363 Oxoquinolines
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D015363 2005
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D015363 2004
% 224.07/224.25  |- skos__prefLabel mesh__D015363 Quinolones
% 224.07/224.25  |- skos__annotation mesh__D015363 do not confuse with QUINOLINES   
% 224.07/224.25  |- mesh__onlineNote mesh__D015363
% 224.07/224.25       use QUINOLONES to search QUINOLINONES 1989-93   
% 224.07/224.25  |- mesh__recordAuthorizer mesh__D015363 sjn
% 224.07/224.25  |- mesh__dateEstablished mesh__D015363 1989-01-01
% 224.07/224.25  |- skos__historyNote mesh__D015363 Quinolines %28%1966-1988%29%
% 224.07/224.25  |- skos__scopeNote mesh__D015363
% 224.07/224.25       A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID.%A%    
% 224.07/224.25  |- rdf__type mesh__D015363sskos__Concept
% 224.07/224.25  |- mesh__publicMeSHNote mesh__D015363
% 224.07/224.25       94; was QUINOLINONES 1989-93; QUINOLONES was see QUINOLINONES 1989-93%A%  
% 224.07/224.25  |- skos__altLabel mesh__D015363 Ketoquinolines
% 224.07/224.25  |- skos__broader mesh__D015363smesh__D011804
% 224.07/224.25  |- skos__broader mesh__D009326smesh__D008511
% 224.07/224.25  |- mesh__dateRevised mesh__D009326 1996-06-10
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D009326 2000
% 224.07/224.25  |- rdf__type mesh__D009326sskos__Concept
% 224.07/224.25  |- skos__altLabel mesh__D009326 Medicine, Naval
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D009326 1997
% 224.07/224.25  |- mesh__recordMaintainer mesh__D009326 TAP
% 224.07/224.25  |- mesh__recordAuthorizer mesh__D009326 PLS
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D009326 2006
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D009326 2005
% 224.07/224.25  |- mesh__recordOriginator mesh__D009326 NLM
% 224.07/224.25  |- skos__scopeNote mesh__D009326
% 224.07/224.25       The practice of medicine concerned with conditions affecting the health of individuals associated with the marine environment.%A%    
% 224.07/224.25  |- skos__prefLabel mesh__D009326 Naval Medicine
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D009326 2002
% 224.07/224.25  |- skos__altLabel mesh__D009326 Nautical Medicine
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D009326 1999
% 224.07/224.25  |- skos__annotation mesh__D009326
% 224.07/224.25       SPEC: SPEC qualif; Manual 28.8 %26% 34.15; use as coord for physiol, psychol %26% dis of nautical personnel whether of national navy, merchant marine or liner: read MeSH definition; DF: NAVAL MED%A%  
% 224.07/224.25  |- skos__altLabel mesh__D009326 Medicine, Nautical
% 224.07/224.25  |- skos__related mesh__D009326smesh__D012767
% 224.07/224.25  |- skos__related mesh__D009326smesh__D004242
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D009326 2004
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D009326 2001
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D009326 1998
% 224.07/224.25  |- mesh__dateCreated mesh__D009326 1999-01-01
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D009326 2003
% 224.07/224.25  |- rdf__type mesh__D001343sskos__Concept
% 224.07/224.25  |- skos__historyNote mesh__D001343 Autolysis %28%1968-1978%29%
% 224.07/224.25  |- skos__hiddenLabel mesh__D001343 Deaths, Autophagic Cell
% 224.07/224.25  |- mesh__historyNote mesh__D001343 2006%28%1979%29%   
% 224.07/224.25  |- mesh__recordAuthorizer mesh__D001343 sjn
% 224.07/224.25  |- mesh__recordMaintainer mesh__D001343 ssb
% 224.07/224.25  |- skos__annotation mesh__D001343
% 224.07/224.25       programmed cell death unspecified probably = APOPTOSIS, but check text%A%  
% 224.07/224.25  |- skos__altLabel mesh__D001343 Autophagic Cell Death
% 224.07/224.25  |- mesh__publicMeSHNote mesh__D001343
% 224.07/224.25       2006; see AUTOPHAGOCYTOSIS 1991-2005, PHAGOCYTOSIS 1979-1990%A%  
% 224.07/224.25  |- skos__prefLabel mesh__D001343 Autophagy
% 224.07/224.25  |- mesh__recordOriginator mesh__D001343 AEP
% 224.07/224.25  |- mesh__dateEstablished mesh__D001343 1991-01-01
% 224.07/224.25  |- mesh__dateRevised mesh__D001343 2005-06-30
% 224.07/224.25  |- skos__scopeNote mesh__D001343
% 224.07/224.25       The segregation and degradation of damaged or unwanted cytoplasmic constituents by autophagic vacuoles %28%cytolysosomes%29% composed of LYSOSOMES containing cellular components in the process of digestion; it plays an important role in BIOLOGICAL METAMORPHOSIS of amphibians, in the removal of bone by osteoclasts, and in the degradation of normal cell components in nutritional deficiency states.%A%    
% 224.07/224.25  |- mesh__dateCreated mesh__D001343 1978-03-20
% 224.07/224.25  |- skos__altLabel mesh__D001343 Autophagic Programmed Cell Death
% 224.07/224.25  |- skos__altLabel mesh__D001343 Autophagocytosis
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D001343 2006
% 224.07/224.25  |- skos__hiddenLabel mesh__D001343 Cellular Autophagies
% 224.07/224.25  |- skos__historyNote mesh__D001343 Lysosomes %28%1966-1978%29%
% 224.07/224.25  |- skos__hiddenLabel mesh__D001343 Cellular Autophagy
% 224.07/224.25  |- skos__hiddenLabel mesh__D001343 Autophagies, Cellular
% 224.07/224.25  |- skos__hiddenLabel mesh__D001343 Cell Deaths, Autophagic
% 224.07/224.25  |- skos__historyNote mesh__D001343 Phagocytosis %28%1966-1978%29%
% 224.07/224.25  |- skos__altLabel mesh__D001343 Autophagy, Cellular
% 224.07/224.25  |- skos__hiddenLabel mesh__D001343 Death, Autophagic Cell
% 224.07/224.25  |- skos__hiddenLabel mesh__D001343 Cell Death, Autophagic
% 224.07/224.25  |- skos__hiddenLabel mesh__D001343 Autophagies
% 224.07/224.25  |- skos__broader mesh__D001343smesh__D016923
% 224.07/224.25  |- skos__broader mesh__D001343smesh__D010587
% 224.07/224.25  |- skos__hiddenLabel mesh__D001343 Autophagic Cell Deaths
% 224.07/224.25  |- mesh__recordOriginator mesh__D011771 NLM
% 224.07/224.25  |- mesh__dateCreated mesh__D011771 1999-01-01
% 224.07/224.25  |- mesh__publicMeSHNote mesh__D011771 65   
% 224.07/224.25  |- mesh__recordAuthorizer mesh__D011771 sjn
% 224.07/224.25  |- mesh__dateEstablished mesh__D011771 1965-01-01
% 224.07/224.25  |- skos__hiddenLabel mesh__D011771 Oxidase, Pyruvate
% 224.07/224.25  |- skos__prefLabel mesh__D011771 Pyruvate Oxidase
% 224.07/224.25  |- mesh__recordMaintainer mesh__D011771 jmp
% 224.07/224.25  |- rdf__type mesh__D011771sskos__Concept
% 224.07/224.25  |- mesh__dateRevised mesh__D011771 2005-06-30
% 224.07/224.25  |- mesh__historyNote mesh__D011771 65   
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D011771 2006
% 224.07/224.25  |- skos__broader mesh__D011771smesh__D007658
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D005734 2000
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D005734 2005
% 224.07/224.25  |- skos__annotation mesh__D005734
% 224.07/224.25       IM for general or for gangrene process; coord NIM with tissue/pathol %28%IM%29%%A%  
% 224.07/224.25  |- mesh__recordAuthorizer mesh__D005734 sjn
% 224.07/224.25  |- mesh__recordOriginator mesh__D005734 NLM
% 224.07/224.25  |- rdf__type mesh__D005734sskos__Concept
% 224.07/224.25  |- mesh__recordMaintainer mesh__D005734 adp
% 224.07/224.25  |- skos__scopeNote mesh__D005734
% 224.07/224.25       Death and putrefaction of tissue usually due to a loss of blood supply.%A%    
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D005734 2002
% 224.07/224.25  |- mesh__dateRevised mesh__D005734 1999-11-08
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D005734 2004
% 224.07/224.25  |- mesh__dateCreated mesh__D005734 1999-01-01
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D005734 2003
% 224.07/224.25  |- skos__hiddenLabel mesh__D005734 Gangrenes
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D005734 2001
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D005734 2006
% 224.07/224.25  |- skos__prefLabel mesh__D005734 Gangrene
% 224.07/224.25  |- skos__broader mesh__D005734smesh__D009336
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D010679 1996
% 224.07/224.25  |- mesh__recordOriginator mesh__D010679 NLM
% 224.07/224.25  |- mesh__recordMaintainer mesh__D010679 ags
% 224.07/224.25  |- skos__altLabel mesh__D010679 Phillippines
% 224.07/224.25  |- skos__broader mesh__D010679smesh__D001210
% 224.07/224.25  |- skos__altLabel mesh__D010679 Philipines
% 224.07/224.25  |- mesh__dateRevised mesh__D010679 1999-12-01
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D010679 2006
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D010679 2002
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D010679 2004
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D010679 2000A
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D010679 1995
% 224.07/224.25  |- mesh__dateCreated mesh__D010679 1999-01-01
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D010679 2005
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D010679 2003
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D010679 1999
% 224.07/224.25  |- skos__annotation mesh__D010679 be careful: one -l-, two -pp   
% 224.07/224.25  |- mesh__recordAuthorizer mesh__D010679 ags
% 224.07/224.25  |- skos__prefLabel mesh__D010679 Philippines
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D010679 1994
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D010679 1997
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D010679 2001
% 224.07/224.25  |- rdf__type mesh__D010679sskos__Concept
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D010679 1998
% 224.07/224.25  |- skos__altLabel mesh__D010679 Phillipines
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D010679 2000
% 224.07/224.25  |- mesh__publicMeSHNote mesh__D009327
% 224.07/224.25       2001; see NBD CHLORIDE 1991-2000 %26% OXADIAZOLES 1976-90   
% 224.07/224.25  |- skos__altLabel mesh__D009327 7-Chloro-4-nitrobenzofurazan
% 224.07/224.25  |- skos__prefLabel mesh__D009327 4-Chloro-7-nitrobenzofurazan
% 224.07/224.25  |- mesh__recordAuthorizer mesh__D009327 sjn
% 224.07/224.25  |- skos__altLabel mesh__D009327 NBF-Cl
% 224.07/224.25  |- skos__hiddenLabel mesh__D009327 7 Chloro 4 nitrobenzofurazan
% 224.07/224.25  |- skos__hiddenLabel mesh__D009327 Chloride, Nitrobenzoxadiazole
% 224.07/224.25  |- skos__historyNote mesh__D009327 Oxadiazoles %28%1972-1975%29%
% 224.07/224.25  |- mesh__recordMaintainer mesh__D009327 ssb
% 224.07/224.25  |- skos__hiddenLabel mesh__D009327 NBF Cl
% 224.07/224.25  |- skos__altLabel mesh__D009327 Chloronitrobenzoxadiazole
% 224.07/224.25  |- mesh__recordOriginator mesh__D009327 RLS
% 224.07/224.25  |- mesh__dateEstablished mesh__D009327 1991-01-01
% 224.07/224.25  |- skos__hiddenLabel mesh__D009327 4 Chloro 7 nitrobenzofurazan
% 224.07/224.25  |- rdf__type mesh__D009327sskos__Concept
% 224.07/224.25  |- skos__altLabel mesh__D009327 Nitrobenzoxadiazole Chloride
% 224.07/224.25  |- skos__scopeNote mesh__D009327
% 224.07/224.25       A benzofuran derivative used as a protein reagent since the terminal N-NBD-protein conjugate possesses interesting fluorescence and spectral properties. It has also been used as a covalent inhibitor of both beef heart mitochondrial ATPase and bacterial ATPase.%A%    
% 224.07/224.25  |- skos__altLabel mesh__D009327 NBD Chloride
% 224.07/224.25  |- mesh__dateRevised mesh__D009327 2005-06-30
% 224.07/224.25  |- skos__historyNote mesh__D009327 Nitro Compounds %28%1974-1975%29%
% 224.07/224.25  |- mesh__dateCreated mesh__D009327 1975-07-23
% 224.07/224.25  |- skos__hiddenLabel mesh__D009327 Chloride, NBD
% 224.07/224.25  |- skos__broader mesh__D009327smesh__D010069
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D009327 2006
% 224.07/224.25  |- mesh__historyNote mesh__D009327 2001%28%1976%29%;   
% 224.07/224.25  |- skos__broader mesh__D001344smesh__D008919
% 224.07/224.25  |- mesh__recordMaintainer mesh__D001344 lkt
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D001344 2004
% 224.07/224.25  |- mesh__recordAuthorizer mesh__D001344 sjn
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D001344 2006
% 224.07/224.25  |- mesh__dateCreated mesh__D001344 1999-01-01
% 224.07/224.25  |- skos__scopeNote mesh__D001344 Postmortem examination of the body.     
% 224.07/224.25  |- mesh__recordOriginator mesh__D001344 NLM
% 224.07/224.25  |- mesh__dateRevised mesh__D001344 2003-07-09
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D001344 2005
% 224.07/224.25  |- rdf__type mesh__D001344sskos__Concept
% 224.07/224.25  |- skos__altLabel mesh__D001344 Autopsies
% 224.07/224.25  |- skos__prefLabel mesh__D001344 Autopsy
% 224.07/224.25  |- skos__annotation mesh__D001344
% 224.07/224.25       NIM; no qualif when NIM; when IM, qualif permitted; not an automatic routine coord for postmortem pathol %28% = /pathol%29%: discussion must be on autopsy as a procedure%A%  
% 224.07/224.25  |- skos__broader mesh__D001344smesh__D005554
% 224.07/224.25  |- skos__hiddenLabel mesh__D019755 Lyases, Carbon-Carbon
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D019755 2006
% 224.07/224.25  |- skos__broader mesh__D019755smesh__D008190
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D019755 2005
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D019755 2004
% 224.07/224.25  |- rdf__type mesh__D019755sskos__Concept
% 224.07/224.25  |- mesh__dateRevised mesh__D019755 2003-07-09
% 224.07/224.25  |- mesh__dateCreated mesh__D019755 1997-06-20
% 224.07/224.25  |- mesh__dateEstablished mesh__D019755 1998-01-01
% 224.07/224.25  |- mesh__publicMeSHNote mesh__D019755 98   
% 224.07/224.25  |- skos__annotation mesh__D019755 DF: C C LYASES   
% 224.07/224.25  |- skos__prefLabel mesh__D019755 Carbon-Carbon Lyases
% 224.07/224.25  |- skos__hiddenLabel mesh__D019755 Carbon Carbon Lyases
% 224.07/224.25  |- skos__scopeNote mesh__D019755
% 224.07/224.25       Enzymes that catalyze the cleavage of a carbon-carbon bond by means other than hydrolysis or oxidation. This subclass contains the DECARBOXYLASES, the ALDEHYDE-LYASES, and the OXO-ACID-LYASES. EC 4.1.%A%    
% 224.07/224.25  |- mesh__historyNote mesh__D019755 98   
% 224.07/224.25  |- skos__hiddenLabel mesh__D011772 Dikinase Pyruvate, Pi
% 224.07/224.25  |- skos__scopeNote mesh__D011772
% 224.07/224.25       An enzyme that catalyzes the reaction of ATP, pyruvate, and orthophosphate to form AMP plus phosphoenolpyruvate plus pyrophosphate. EC 2.7.9.1.%A%    
% 224.07/224.25  |- skos__hiddenLabel mesh__D011772 Pi Dikinase Pyruvate
% 224.07/224.25  |- skos__hiddenLabel mesh__D011772 Dikinase, Phosphopyruvate
% 224.07/224.25  |- skos__prefLabel mesh__D011772 Pyruvate, Orthophosphate Dikinase
% 224.07/224.25  |- mesh__publicMeSHNote mesh__D011772
% 224.07/224.25       94; was PYRUVATE, PHOSPHATE DIKINASE 1975-93 %28%see under PHOSPHOTRANSFERASES, ATP 1975-90%29%; PHOSPHOENOLPYRUVATE SYNTHETASE was see PYRUVATE, PHOSPHATE DIKINASE 1975-93%A%  
% 224.07/224.25  |- skos__hiddenLabel mesh__D011772 Phosphate Dikinase Pyruvate
% 224.07/224.25  |- mesh__recordMaintainer mesh__D011772 ssb
% 224.07/224.25  |- skos__historyNote mesh__D011772 Phosphates %28%1974%29%
% 224.07/224.25  |- mesh__onlineNote mesh__D011772
% 224.07/224.25       use PYRUVATE, ORTHOPHOSPHATE DIKINASE to search PYRUVATE, PHOSPHATE DIKINASE %26% PHOSPHOENOLPYRUVATE SYNTHETASE 1975-93%A%  
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D011772 2004
% 224.07/224.25  |- skos__broader mesh__D011772smesh__D017866
% 224.07/224.25  |- skos__historyNote mesh__D011772 Pyruvates %28%1974%29%
% 224.07/224.25  |- rdf__type mesh__D011772sskos__Concept
% 224.07/224.25  |- mesh__historyNote mesh__D011772
% 224.07/224.25       94; was PYRUVATE, PHOSPHATE DIKINASE 1975-93 %28%see under PHOSPHOTRANSFERASES, ATP 1975-90%29%; PHOSPHOENOLPYRUVATE SYNTHETASE was see PYRUVATE, PHOSPHATE DIKINASE 1975-93%A%  
% 224.07/224.25  |- skos__hiddenLabel mesh__D011772 Dikinase Pyruvate, Phosphate
% 224.07/224.25  |- skos__hiddenLabel mesh__D011772 Orthophosphate Dikinase Pyruvate
% 224.07/224.25  |- mesh__recordOriginator mesh__D011772 NLM
% 224.07/224.25  |- skos__altLabel mesh__D011772 Pyruvate, Phosphate Dikinase
% 224.07/224.25  |- skos__hiddenLabel mesh__D011772 Dikinase Pyruvate, Orthophosphate
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D011772 2005
% 224.07/224.25  |- mesh__recordAuthorizer mesh__D011772 sjn
% 224.07/224.25  |- mesh__dateRevised mesh__D011772 2003-07-09
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D011772 2006
% 224.07/224.25  |- mesh__dateEstablished mesh__D011772 1991-01-01
% 224.07/224.25  |- skos__altLabel mesh__D011772 Phosphopyruvate Dikinase
% 224.07/224.25  |- skos__altLabel mesh__D011772 Pyruvate, Pi Dikinase
% 224.07/224.25  |- mesh__dateCreated mesh__D011772 1974-11-19
% 224.07/224.25  |- skos__historyNote mesh__D011772 Phosphotransferases, ATP %28%1974%29%
% 224.07/224.25  |- mesh__recordMaintainer mesh__D005735 JLS
% 224.07/224.25  |- skos__scopeNote mesh__D005735
% 224.07/224.25       Discarded animal and vegetable matter from a kitchen or the refuse from food preparation. %28%From Random House College Dictionary, 1982%29%%A%    
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D005735 2006
% 224.07/224.25  |- mesh__recordOriginator mesh__D005735 NLM
% 224.07/224.25  |- mesh__onlineNote mesh__D005735 search REFUSE DISPOSAL 1966-74   
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D005735 1996
% 224.07/224.25  |- mesh__dateRevised mesh__D005735 1994-02-28
% 224.07/224.25  |- rdf__type mesh__D005735sskos__Concept
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D005735 2005
% 224.07/224.25  |- mesh__historyNote mesh__D005735
% 224.07/224.25       91%28%75%29%; was see under REFUSE DISPOSAL 1975-90   
% 224.07/224.25  |- skos__broader mesh__D005735smesh__D012037
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D005735 2002
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D005735 1999
% 224.07/224.25  |- mesh__dateEstablished mesh__D005735 1991-01-01
% 224.07/224.25  |- mesh__publicMeSHNote mesh__D005735
% 224.07/224.25       91; was see under REFUSE DISPOSAL 1975-90   
% 224.07/224.25  |- skos__hiddenLabel mesh__D005735 Garbages
% 224.07/224.25  |- skos__annotation mesh__D005735 no qualif   
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D005735 1998
% 224.07/224.25  |- mesh__dateCreated mesh__D005735 1999-01-01
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D005735 2004
% 224.07/224.25  |- skos__prefLabel mesh__D005735 Garbage
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D005735 1995
% 224.07/224.25  |- mesh__recordAuthorizer mesh__D005735 PLS
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D005735 2001
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D005735 2003
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D005735 1997
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D005735 2000
% 224.07/224.25  |- mesh__recordMaintainer mesh__D015365 exl
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D015365 2006
% 224.07/224.25  |- mesh__recordAuthorizer mesh__D015365 sjn
% 224.07/224.25  |- skos__altLabel mesh__D015365 Faulding Brand of Enoxacin
% 224.07/224.25  |- skos__hiddenLabel mesh__D015365 Sesquihydrate, Enoxacin
% 224.07/224.25  |- mesh__dateRevised mesh__D015365 2005-06-30
% 224.07/224.25  |- skos__hiddenLabel mesh__D015365 CI919
% 224.07/224.25  |- skos__hiddenLabel mesh__D015365 CI 919
% 224.07/224.25  |- mesh__dateEstablished mesh__D015365 1989-01-01
% 224.07/224.25  |- skos__prefLabel mesh__D015365 Enoxacin
% 224.07/224.25  |- mesh__historyNote mesh__D015365 89   
% 224.07/224.25  |- skos__hiddenLabel mesh__D015365 AT 2266
% 224.07/224.25  |- skos__altLabel mesh__D015365
% 224.07/224.25       Rh%C3%%B4%ne-Poulenc Rorer Brand of Enoxacin Sesquihydrate
% 224.07/224.25  |- rdf__type mesh__D015365sskos__Concept
% 224.07/224.25  |- skos__altLabel mesh__D015365
% 224.07/224.25       Pierre Fabre Brand of Enoxacin Sesquihydrate
% 224.07/224.25  |- skos__broader mesh__D015365smesh__D024841
% 224.07/224.25  |- skos__hiddenLabel mesh__D015365 PD 107779
% 224.07/224.25  |- skos__hiddenLabel mesh__D015365 AT2266
% 224.07/224.25  |- skos__hiddenLabel mesh__D015365 PD107779
% 224.07/224.25  |- mesh__dateCreated mesh__D015365 1988-06-02
% 224.07/224.25  |- skos__historyNote mesh__D015365 Anti-Infective Agents %28%1983-1988%29%
% 224.07/224.25  |- skos__hiddenLabel mesh__D015365
% 224.07/224.25       Rh%C3%%B4%ne Poulenc Rorer Brand of Enoxacin Sesquihydrate
% 224.07/224.25  |- mesh__recordOriginator mesh__D015365 RLS
% 224.07/224.25  |- skos__historyNote mesh__D015365
% 224.07/224.25       Anti-Infective Agents, Urinary %28%1983-1988%29%
% 224.07/224.25  |- skos__scopeNote mesh__D015365
% 224.07/224.25       A broad-spectrum 6-fluoronaphthyridinone antibacterial agent %28%FLUOROQUINOLONES%29% structurally related to NALIDIXIC ACID.%A%    
% 224.07/224.25  |- mesh__publicMeSHNote mesh__D015365 89   
% 224.07/224.25  |- skos__historyNote mesh__D015365 Naphthyridines %28%1983-1988%29%
% 224.07/224.25  |- skos__historyNote mesh__D009328 Antibiotics %28%1971-1974%29%
% 224.07/224.25  |- skos__prefLabel mesh__D009328 Nebramycin
% 224.07/224.25  |- mesh__recordOriginator mesh__D009328 NLM
% 224.07/224.25  |- mesh__dateRevised mesh__D009328 2004-07-07
% 224.07/224.25  |- skos__scopeNote mesh__D009328
% 224.07/224.25       A complex of antibiotic substances produced by Streptomyces tenebrarius.%A%    
% 224.07/224.25  |- skos__broader mesh__D009328smesh__D007612
% 224.07/224.25  |- skos__historyNote mesh__D009328 Aminoglycosides %28%1974%29%
% 224.07/224.25  |- mesh__dateEstablished mesh__D009328 1991-01-01
% 224.07/224.25  |- rdf__type mesh__D009328sskos__Concept
% 224.07/224.25  |- mesh__recordAuthorizer mesh__D009328 sjn
% 224.07/224.25  |- mesh__publicMeSHNote mesh__D009328
% 224.07/224.25       91; was see under ANTIBIOTICS 1975-90   
% 224.07/224.25  |- mesh__dateCreated mesh__D009328 1974-11-11
% 224.07/224.25  |- mesh__historyNote mesh__D009328
% 224.07/224.25       91%28%75%29%; was see under ANTIBIOTICS 1975-90   
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D009328 2006
% 224.07/224.25  |- mesh__recordMaintainer mesh__D009328 ssb
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D009328 2005
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D001345 2001
% 224.07/224.25  |- skos__broader mesh__D001345smesh__D006652
% 224.07/224.25  |- mesh__dateCreated mesh__D001345 1999-01-01
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D001345 2004
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D001345 2002
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D001345 2005
% 224.07/224.25  |- skos__annotation mesh__D001345
% 224.07/224.25       NIM, usually no qualif; DF: AUTORADIOGR   
% 224.07/224.25  |- mesh__onlineNote mesh__D001345
% 224.07/224.25       use AUTORADIOGRAPHY to search RADIOAUTOGRAPHY 1966-72   
% 224.07/224.25  |- mesh__publicMeSHNote mesh__D001345 73; was RADIOAUTOGRAPHY 1963-72   
% 224.07/224.25  |- skos__prefLabel mesh__D001345 Autoradiography
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D001345 2006
% 224.07/224.25  |- skos__broader mesh__D001345smesh__D003584
% 224.07/224.25  |- skos__scopeNote mesh__D001345
% 224.07/224.25       The making of a radiograph of an object or tissue by recording on a photographic plate the radiation emitted by radioactive material within the object. %28%Dorland, 27th ed%29%%A%    
% 224.07/224.25  |- mesh__recordAuthorizer mesh__D001345 sjn
% 224.07/224.25  |- skos__altLabel mesh__D001345 Radioautography
% 224.07/224.25  |- rdf__type mesh__D001345sskos__Concept
% 224.07/224.25  |- mesh__historyNote mesh__D001345 73; was RADIOAUTOGRAPHY 1963-72   
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D001345 2003
% 224.07/224.25  |- mesh__recordMaintainer mesh__D001345 TGC
% 224.07/224.25  |- mesh__recordOriginator mesh__D001345 NLM
% 224.07/224.25  |- mesh__dateRevised mesh__D001345 2000-06-21
% 224.07/224.25  |- mesh__dateEstablished mesh__D001345 1973-01-01
% 224.07/224.25  |- skos__prefLabel mesh__D006030 Glycosuria, Renal
% 224.07/224.25  |- mesh__recordMaintainer mesh__D006030 lkt
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D006030 2005
% 224.07/224.25  |- skos__annotation mesh__D006030
% 224.07/224.25       from inability of renal tubules to reabsorb glucose completely; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 224.07/224.25  |- mesh__recordAuthorizer mesh__D006030 sjn
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D006030 2006
% 224.07/224.25  |- mesh__recordOriginator mesh__D006030 NLM
% 224.07/224.25  |- skos__altLabel mesh__D006030 Diabetes, Renal
% 224.07/224.25  |- skos__hiddenLabel mesh__D006030 Renal Diabetes
% 224.07/224.25  |- mesh__dateEstablished mesh__D006030 1965-01-01
% 224.07/224.25  |- skos__broader mesh__D006030smesh__D015499
% 224.07/224.25  |- mesh__dateCreated mesh__D006030 1999-01-01
% 224.07/224.25  |- skos__broader mesh__D006030smesh__D006029
% 224.07/224.25  |- mesh__historyNote mesh__D006030 65   
% 224.07/224.25  |- mesh__dateRevised mesh__D006030 2003-07-09
% 224.07/224.25  |- rdf__type mesh__D006030sskos__Concept
% 224.07/224.25  |- mesh__publicMeSHNote mesh__D006030 65   
% 224.07/224.25  |- skos__scopeNote mesh__D006030
% 224.07/224.25       Glycosuria occurring when there is only the normal amount of sugar in the blood, due to inherited inability of the renal tubules to reabsorb glucose completely. %28%Dorland, 27th ed%29%%A%    
% 224.07/224.25  |- skos__hiddenLabel mesh__D006030 Renal Glycosuria
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D006030 2004
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D011773 2004
% 224.07/224.25  |- skos__prefLabel mesh__D011773 Pyruvates
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D011773 2001
% 224.07/224.25  |- skos__broader mesh__D011773smesh__D007651
% 224.07/224.25  |- rdf__type mesh__D011773sskos__Concept
% 224.07/224.25  |- mesh__recordAuthorizer mesh__D011773 PLS
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D011773 1997
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D011773 2005
% 224.07/224.25  |- skos__annotation mesh__D011773
% 224.07/224.25       do not confuse with PYRUVATE see PYRUVIC ACID   
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D011773 2002
% 224.07/224.25  |- mesh__dateRevised mesh__D011773 1996-06-10
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D011773 2006
% 224.07/224.25  |- mesh__dateCreated mesh__D011773 1999-01-01
% 224.07/224.25  |- mesh__recordOriginator mesh__D011773 NLM
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D011773 1998
% 224.07/224.25  |- mesh__recordMaintainer mesh__D011773 TGC
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D011773 2003
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D011773 2000
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D011773 1999
% 224.07/224.25  |- mesh__dateRevised mesh__D005736 2003-07-09
% 224.07/224.25  |- skos__scopeNote mesh__D005736
% 224.07/224.25       A variant of ADENOMATOUS POLYPOSIS COLI caused by mutation in the APC gene %28%GENES, APC%29% on CHROMOSOME 5. It is characterized by not only the presence of multiple colonic polyposis but also extracolonic ADENOMATOUS POLYPS in the UPPER GASTROINTESTINAL TRACT; the EYE; the SKIN; the SKULL; and the FACIAL BONES; as well as malignancy in organs other than the GI tract.%A%    
% 224.07/224.25  |- skos__hiddenLabel mesh__D005736 Syndrome, Gardner
% 224.07/224.25  |- skos__prefLabel mesh__D005736 Gardner Syndrome
% 224.07/224.25  |- skos__broader mesh__D005736smesh__D000015
% 224.07/224.25  |- mesh__publicMeSHNote mesh__D005736 81   
% 224.07/224.25  |- skos__broader mesh__D005736smesh__D011125
% 224.07/224.25  |- mesh__activeMeSHYear mesh__D005736 2004
% 224.07/224.25  |- mesh__recordMaintainer mesh__D005736 lkt
% 224.07/224.25  |- skos__related mesh__D005736smesh__D017491
% 224.07/224.25  |- skos__hiddenLabel mesh__D005736 Gardner Syndromes
% 224.07/224.25  |- skos__historyNote mesh__D005736
% 224.07/224.25       Neoplasms, Multiple Primary %28%1966-1980%29%
% 224.07/224.25  |- mesh__historyNote mesh__D005736 81   
% 224.07/224.25  |- skos__hiddenLabel mesh__D005736 Syndromes, Gardner
% 224.07/224.25  |- mesh__recordAuthorizer mesh__D005736 sjn
% 224.07/224.26  |- skos__related mesh__D005736smesh__D011125
% 224.07/224.26  |- skos__historyNote mesh__D005736 Colonic Neoplasms %28%1966-1980%29%
% 224.07/224.26  |- skos__related mesh__D005736smesh__D025601
% 224.07/224.26  |- mesh__dateCreated mesh__D005736 1980-04-04
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D005736 2006
% 224.07/224.26  |- rdf__type mesh__D005736sskos__Concept
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D005736 2005
% 224.07/224.26  |- mesh__recordOriginator mesh__D005736 RC
% 224.07/224.26  |- mesh__dateEstablished mesh__D005736 1981-01-01
% 224.07/224.26  |- skos__historyNote mesh__D005736 Intestinal Polyps/FG %28%1968-1980%29%
% 224.07/224.26  |- skos__historyNote mesh__D015366 Anti-Infective Agents %28%1981-1988%29%
% 224.07/224.26  |- mesh__recordOriginator mesh__D015366 RLS
% 224.07/224.26  |- skos__scopeNote mesh__D015366
% 224.07/224.26       A synthetic broad-spectrum fluoroquinolone antibacterial agent active against most gram-negative and gram-positive bacteria.%A%    
% 224.07/224.26  |- skos__historyNote mesh__D015366
% 224.07/224.26       Anti-Infective Agents, Urinary %28%1981-1988%29%
% 224.07/224.26  |- skos__altLabel mesh__D015366 Pefloxacine
% 224.07/224.26  |- skos__historyNote mesh__D015366
% 224.07/224.26       Norfloxacin/analogs %26% derivatives %28%1984-1988%29%
% 224.07/224.26  |- rdf__type mesh__D015366sskos__Concept
% 224.07/224.26  |- skos__broader mesh__D015366smesh__D024841
% 224.07/224.26  |- skos__prefLabel mesh__D015366 Pefloxacin
% 224.07/224.26  |- skos__historyNote mesh__D015366 Quinolines %28%1981-1983%29%
% 224.07/224.26  |- mesh__dateCreated mesh__D015366 1988-06-02
% 224.07/224.26  |- mesh__dateRevised mesh__D015366 2003-07-09
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D015366 2005
% 224.07/224.26  |- mesh__recordAuthorizer mesh__D015366 sjn
% 224.07/224.26  |- mesh__publicMeSHNote mesh__D015366 89   
% 224.07/224.26  |- skos__hiddenLabel mesh__D015366 Mesylate, Pefloxacin
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D015366 2006
% 224.07/224.26  |- skos__hiddenLabel mesh__D015366 Pefloxacin, Silver
% 224.07/224.26  |- skos__hiddenLabel mesh__D015366 R.B., 2589
% 224.07/224.26  |- mesh__recordMaintainer mesh__D015366 ssb
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D015366 2004
% 224.07/224.26  |- mesh__historyNote mesh__D015366 89   
% 224.07/224.26  |- mesh__dateEstablished mesh__D015366 1989-01-01
% 224.07/224.26  |- skos__prefLabel mesh__D009329 Nebraska
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D009329 1999
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D009329 2004
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D009329 2002
% 224.07/224.26  |- mesh__recordAuthorizer mesh__D009329 SJN
% 224.07/224.26  |- rdf__type mesh__D009329sskos__Concept
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D009329 2005
% 224.07/224.26  |- mesh__recordOriginator mesh__D009329 NLM
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D009329 2000
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D009329 2006
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D009329 2001
% 224.07/224.26  |- mesh__dateRevised mesh__D009329 1997-06-20
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D009329 1998
% 224.07/224.26  |- mesh__dateCreated mesh__D009329 1999-01-01
% 224.07/224.26  |- skos__broader mesh__D009329smesh__D015146
% 224.07/224.26  |- mesh__recordMaintainer mesh__D009329 PXP
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D009329 2003
% 224.07/224.26  |- skos__scopeNote mesh__D001346
% 224.07/224.26       Suggestion coming from the subject himself.     
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D001346 2002
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D001346 2004
% 224.07/224.26  |- mesh__recordMaintainer mesh__D001346 ssb
% 224.07/224.26  |- mesh__historyNote mesh__D001346
% 224.07/224.26       91%28%75%29%; was see under SUGGESTION 1975-90   
% 224.07/224.26  |- mesh__dateRevised mesh__D001346 2001-07-25
% 224.07/224.26  |- skos__broader mesh__D001346smesh__D013404
% 224.07/224.26  |- mesh__dateEstablished mesh__D001346 1991-01-01
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D001346 2005
% 224.07/224.26  |- skos__prefLabel mesh__D001346 Autosuggestion
% 224.07/224.26  |- skos__annotation mesh__D001346 no qualif   
% 224.07/224.26  |- mesh__recordAuthorizer mesh__D001346 sjn
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D001346 2006
% 224.07/224.26  |- rdf__type mesh__D001346sskos__Concept
% 224.07/224.26  |- mesh__recordOriginator mesh__D001346 NLM
% 224.07/224.26  |- mesh__onlineNote mesh__D001346 search SUGGESTION 1966-74   
% 224.07/224.26  |- mesh__dateCreated mesh__D001346 1999-01-01
% 224.07/224.26  |- mesh__publicMeSHNote mesh__D001346
% 224.07/224.26       91; was see under SUGGESTION 1975-90   
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D001346 2003
% 224.07/224.26  |- skos__hiddenLabel mesh__D001346 Autosuggestions
% 224.07/224.26  |- mesh__recordOriginator mesh__D020500 JLS
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D020500 2006
% 224.07/224.26  |- mesh__recordAuthorizer mesh__D020500 ags
% 224.07/224.26  |- skos__annotation mesh__D020500
% 224.07/224.26       CATALOG: Use when 20%25% or more of the content consists of statistical data.   If presented in tabular form use also TABLES %5B%PUBLICATION TYPE%5D%%A%  
% 224.07/224.26  |- skos__prefLabel mesh__D020500 Statistics %5B%Publication Type%5D%
% 224.07/224.26  |- skos__scopeNote mesh__D020500
% 224.07/224.26       Works consisting of presentations of numerical data on particular subjects.%A%    
% 224.07/224.26  |- mesh__dateRevised mesh__D020500 2005-08-02
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D020500 2006A
% 224.07/224.26  |- mesh__historyNote mesh__D020500 1999   
% 224.07/224.26  |- mesh__dateEstablished mesh__D020500 1999-01-01
% 224.07/224.26  |- skos__broader mesh__D020500smesh__D052180
% 224.07/224.26  |- rdf__type mesh__D020500sskos__Concept
% 224.07/224.26  |- skos__related mesh__D020500smesh__D020501
% 224.07/224.26  |- mesh__recordMaintainer mesh__D020500 ags
% 224.07/224.26  |- mesh__dateCreated mesh__D020500 1998-06-03
% 224.07/224.26  |- skos__altLabel mesh__D020500 Statistics %28%PT%29%
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D006031 2005
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D006031 2001
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D006031 2006
% 224.07/224.26  |- skos__hiddenLabel mesh__D006031 Glycosylations
% 224.07/224.26  |- skos__related mesh__D006031smesh__D017127
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D006031 2002
% 224.07/224.26  |- mesh__dateEstablished mesh__D006031 1987-01-01
% 224.07/224.26  |- mesh__recordMaintainer mesh__D006031 PXP
% 224.07/224.26  |- mesh__dateRevised mesh__D006031 1997-06-20
% 224.07/224.26  |- skos__historyNote mesh__D006031
% 224.07/224.26       Protein Processing, Post-Translational %28%1983-1986%29%
% 224.07/224.26  |- mesh__historyNote mesh__D006031 87   
% 224.07/224.26  |- skos__prefLabel mesh__D006031 Glycosylation
% 224.07/224.26  |- skos__hiddenLabel mesh__D006031 Glycosylations, Protein
% 224.07/224.26  |- skos__annotation mesh__D006031 almost never IM   
% 224.07/224.26  |- skos__scopeNote mesh__D006031
% 224.07/224.26       The chemical or biochemical addition of carbohydrate or glycosyl groups to other chemicals, especially peptides or proteins. Glycosyl transferases are used in this biochemical reaction.%A%    
% 224.07/224.26  |- mesh__recordAuthorizer mesh__D006031 SJN
% 224.07/224.26  |- rdf__type mesh__D006031sskos__Concept
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D006031 2003
% 224.07/224.26  |- skos__related mesh__D006031smesh__D011499
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D006031 1998
% 224.07/224.26  |- skos__broader mesh__D006031smesh__D002625
% 224.07/224.26  |- skos__broader mesh__D006031smesh__D008660
% 224.07/224.26  |- skos__hiddenLabel mesh__D006031 Glycosylation, Protein
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D006031 2004
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D006031 1999
% 224.07/224.26  |- mesh__publicMeSHNote mesh__D006031 87   
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D006031 2000
% 224.07/224.26  |- skos__historyNote mesh__D006031 Glycoproteins %28%1966-1986%29%
% 224.07/224.26  |- skos__hiddenLabel mesh__D006031 Protein Glycosylations
% 224.07/224.26  |- mesh__recordOriginator mesh__D006031 SH
% 224.07/224.26  |- mesh__dateCreated mesh__D006031 1986-06-24
% 224.07/224.26  |- rdf__type mesh__D019757sskos__Concept
% 224.07/224.26  |- mesh__dateRevised mesh__D019757 2003-07-09
% 224.07/224.26  |- skos__annotation mesh__D019757 DF: C O LYASES   
% 224.07/224.26  |- skos__hiddenLabel mesh__D019757 Carbon Oxygen Lyases
% 224.07/224.26  |- skos__broader mesh__D019757smesh__D008190
% 224.07/224.26  |- mesh__historyNote mesh__D019757 98   
% 224.07/224.26  |- skos__scopeNote mesh__D019757
% 224.07/224.26       Enzymes that catalyze the cleavage of a carbon-oxygen bond by means other than hydrolysis or oxidation. EC 4.2.%A%    
% 224.07/224.26  |- mesh__dateCreated mesh__D019757 1997-06-20
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D019757 2005
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D019757 2006
% 224.07/224.26  |- mesh__dateEstablished mesh__D019757 1998-01-01
% 224.07/224.26  |- skos__prefLabel mesh__D019757 Carbon-Oxygen Lyases
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D019757 2004
% 224.07/224.26  |- skos__hiddenLabel mesh__D019757 Lyases, Carbon-Oxygen
% 224.07/224.26  |- mesh__publicMeSHNote mesh__D019757 98   
% 224.07/224.26  |- skos__broader mesh__D014805Q000172smesh__D014805
% 224.07/224.26  |- mesh__preferredCombination mesh__D014805Q000172smesh__D014806
% 224.07/224.26  |- rdf__type mesh__D014805Q000172smesh__CompoundConcept
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D011774 2001
% 224.07/224.26  |- mesh__recordMaintainer mesh__D011774 TWD
% 224.07/224.26  |- rdf__type mesh__D011774sskos__Concept
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D011774 2004
% 224.07/224.26  |- mesh__dateRevised mesh__D011774 2000-06-22
% 224.07/224.26  |- skos__hiddenLabel mesh__D011774 Compounds, Pyrvinium
% 224.07/224.26  |- skos__prefLabel mesh__D011774 Pyrvinium Compounds
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D011774 2002
% 224.07/224.26  |- mesh__dateCreated mesh__D011774 1999-01-01
% 224.07/224.26  |- skos__broader mesh__D011774smesh__D011806
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D011774 2005
% 224.07/224.26  |- mesh__recordOriginator mesh__D011774 NLM
% 224.07/224.26  |- skos__annotation mesh__D011774 DF: PYRVINIUM CPDS   
% 224.07/224.26  |- mesh__recordAuthorizer mesh__D011774 sjn
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D011774 2006
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D011774 2003
% 224.07/224.26  |- mesh__dateCreated mesh__D005737 1999-01-01
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D005737 2004
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D005737 2003
% 224.07/224.26  |- skos__altLabel mesh__D005737 Allium sativum
% 224.07/224.26  |- mesh__recordMaintainer mesh__D005737 ssb
% 224.07/224.26  |- skos__hiddenLabel mesh__D005737 sativum, Allium
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D005737 2006
% 224.07/224.26  |- skos__scopeNote mesh__D005737
% 224.07/224.26       Allium sativum. One of the Liliaceae used as a spice and traditional remedy. It contains allicin, the pungent active ingredient, which may reduce blood cholesterol and inhibit platelet aggregation.%A%    
% 224.07/224.26  |- skos__broader mesh__D005737smesh__D000490
% 224.07/224.26  |- rdf__type mesh__D005737sskos__Concept
% 224.07/224.26  |- skos__prefLabel mesh__D005737 Garlic
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D005737 2005
% 224.07/224.26  |- mesh__recordOriginator mesh__D005737 NLM
% 224.07/224.26  |- mesh__recordAuthorizer mesh__D005737 sjn
% 224.07/224.26  |- mesh__dateRevised mesh__D005737 2001-07-25
% 224.07/224.26  |- skos__annotation mesh__D005737
% 224.07/224.26       as plant %26% food; selected qualif from Cat B6 %26% Cat J2   
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D005737 2002
% 224.07/224.26  |- skos__historyNote mesh__D015367 Retroviridae %28%1981-1983%29%
% 224.07/224.26  |- skos__historyNote mesh__D015367
% 224.07/224.26       Human T-Cell Leukemia Virus %28%1984-1988%29%
% 224.07/224.26  |- skos__prefLabel mesh__D015367 Human T-lymphotropic virus 2
% 224.07/224.26  |- mesh__dateRevised mesh__D015367 2002-07-03
% 224.07/224.26  |- mesh__dateCreated mesh__D015367 1988-06-02
% 224.07/224.26  |- skos__hiddenLabel mesh__D015367 Human T lymphotropic virus 2
% 224.07/224.26  |- skos__altLabel mesh__D015367 Human T-Lymphotropic Virus II
% 224.07/224.26  |- mesh__recordMaintainer mesh__D015367 ags
% 224.07/224.26  |- skos__altLabel mesh__D015367 Human T Lymphotropic Virus II
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D015367 2005
% 224.07/224.26  |- mesh__publicMeSHNote mesh__D015367 2002; see HTLV-II 1989-2001   
% 224.07/224.26  |- skos__altLabel mesh__D015367 Human T Cell Leukemia Virus II
% 224.07/224.26  |- mesh__recordOriginator mesh__D015367 RLS
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D015367 2006
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D015367 2003
% 224.07/224.26  |- skos__annotation mesh__D015367
% 224.07/224.26       infection = HTLV-II INFECTIONS but consider also LEUKEMIA, T-CELL, HTLV-II-ASSOCIATED%A%  
% 224.07/224.26  |- skos__altLabel mesh__D015367 Leukemia Virus II, Human T Cell
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D015367 2004
% 224.07/224.26  |- skos__scopeNote mesh__D015367
% 224.07/224.26       A strain of PRIMATE T-LYMPHOTROPIC VIRUS 2 that can transform normal T-lymphocytes and can replicate in both T- and B-cell lines. The virus is related to but distinct from HTLV-1. It is associated with T-cell hairy cell leukemia %28%LEUKEMIA, T-CELL, HTLV-II-ASSOCIATED%29%, a relatively benign disease.%A%    
% 224.07/224.26  |- skos__altLabel mesh__D015367 T Cell Leukemia Virus II, Human
% 224.07/224.26  |- mesh__recordAuthorizer mesh__D015367 sjn
% 224.07/224.26  |- mesh__dateEstablished mesh__D015367 1989-01-01
% 224.07/224.26  |- skos__broader mesh__D015367smesh__D030263
% 224.07/224.26  |- skos__altLabel mesh__D015367 Human T-Cell Leukemia Virus II
% 224.07/224.26  |- skos__altLabel mesh__D015367 T-Cell Leukemia Virus II, Human
% 224.07/224.26  |- skos__altLabel mesh__D015367 HTLV-2
% 224.07/224.26  |- skos__altLabel mesh__D015367 HTLV-II
% 224.07/224.26  |- rdf__type mesh__D015367sskos__Concept
% 224.07/224.26  |- skos__altLabel mesh__D015367
% 224.07/224.26       Leukemia Virus II, Hairy Cell Associated, Human T Cell
% 224.07/224.26  |- skos__altLabel mesh__D015367 Leukemia Virus II, Human T-Cell
% 224.07/224.26  |- mesh__historyNote mesh__D015367 2002 %28%1989%29%   
% 224.07/224.26  |- skos__scopeNote mesh__D034521
% 224.07/224.26       A broad category of nuclear proteins that are components of or participate in the formation of the NUCLEAR MATRIX.%A%    
% 224.07/224.26  |- skos__hiddenLabel mesh__D034521 Matrix Proteins, Nuclear
% 224.07/224.26  |- mesh__publicMeSHNote mesh__D034521 2003   
% 224.07/224.26  |- skos__prefLabel mesh__D034521 Nuclear Matrix-Associated Proteins
% 224.07/224.26  |- mesh__recordOriginator mesh__D034521 jmp
% 224.07/224.26  |- skos__altLabel mesh__D034521 Nuclear Matrix Proteins
% 224.07/224.26  |- skos__hiddenLabel mesh__D034521 Nuclear Matrix Associated Proteins
% 224.07/224.26  |- mesh__historyNote mesh__D034521 2003   
% 224.07/224.26  |- skos__hiddenLabel mesh__D034521 Scaffold Protein, Nuclear
% 224.07/224.26  |- mesh__dateRevised mesh__D034521 2005-06-30
% 224.07/224.26  |- skos__altLabel mesh__D034521 Protein, Nuclear Scaffold
% 224.07/224.26  |- mesh__dateCreated mesh__D034521 2002-07-03
% 224.07/224.26  |- mesh__recordAuthorizer mesh__D034521 sjn
% 224.07/224.26  |- skos__altLabel mesh__D034521 Nuclear Scaffold Proteins
% 224.07/224.26  |- skos__broader mesh__D034521smesh__D009687
% 224.07/224.26  |- rdf__type mesh__D034521sskos__Concept
% 224.07/224.26  |- mesh__dateEstablished mesh__D034521 2003-01-01
% 224.07/224.26  |- mesh__recordMaintainer mesh__D034521 SYSTEM
% 224.07/224.26  |- skos__hiddenLabel mesh__D034521 Matrix-Associated Proteins, Nuclear
% 224.07/224.26  |- skos__hiddenLabel mesh__D034521 Scaffold Proteins, Nuclear
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D034521 2006
% 224.07/224.26  |- skos__hiddenLabel mesh__D034521 Nuclear Scaffold Protein
% 224.07/224.26  |- skos__broader mesh__D011968Q000037smesh__D011968
% 224.07/224.26  |- mesh__preferredCombination mesh__D011968Q000037smesh__D006633
% 224.07/224.26  |- rdf__type mesh__D011968Q000037smesh__CompoundConcept
% 224.07/224.26  |- mesh__dateCreated mesh__D006830 1999-01-01
% 224.07/224.26  |- skos__altLabel mesh__D006830 Apressin
% 224.07/224.26  |- skos__hiddenLabel mesh__D006830 Hydrochloride, Hydralazine
% 224.07/224.26  |- skos__altLabel mesh__D006830 Apresoline
% 224.07/224.26  |- mesh__recordOriginator mesh__D006830 NLM
% 224.07/224.26  |- skos__altLabel mesh__D006830 Hydrallazin
% 224.07/224.26  |- skos__hiddenLabel mesh__D006830 Hydralazine mono Hydrochloride
% 224.07/224.26  |- skos__scopeNote mesh__D006830
% 224.07/224.26       A direct-acting vasodilator that is used as an antihypertensive agent.%A%    
% 224.07/224.26  |- rdf__type mesh__D006830sskos__Concept
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D006830 2005
% 224.07/224.26  |- skos__hiddenLabel mesh__D006830 mono-Hydrochloride, Hydralazine
% 224.07/224.26  |- skos__altLabel mesh__D006830 Hydrazinophthalazine
% 224.07/224.26  |- skos__broader mesh__D006830smesh__D010793
% 224.07/224.26  |- skos__prefLabel mesh__D006830 Hydralazine
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D006830 2004
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D006830 2006
% 224.07/224.26  |- mesh__recordMaintainer mesh__D006830 sjn
% 224.07/224.26  |- mesh__recordAuthorizer mesh__D006830 sjn
% 224.07/224.26  |- mesh__dateRevised mesh__D006830 2003-07-25
% 224.07/224.26  |- skos__related mesh__D020501smesh__D020500
% 224.07/224.26  |- skos__prefLabel mesh__D020501 Tables %5B%Publication Type%5D%
% 224.07/224.26  |- mesh__recordAuthorizer mesh__D020501 sjn
% 224.07/224.26  |- skos__scopeNote mesh__D020501
% 224.07/224.26       Works consisting of the presentation of data in a tabular form.%A%    
% 224.07/224.26  |- mesh__historyNote mesh__D020501 1999   
% 224.07/224.26  |- mesh__dateRevised mesh__D020501 2005-06-30
% 224.07/224.26  |- skos__annotation mesh__D020501
% 224.07/224.26       CATALOG: Use when 20%25% or more of the content is presented in tabular form. For statistical data presented in tabular form use also the publication type STATISTICS%A%  
% 224.07/224.26  |- skos__broader mesh__D020501smesh__D052180
% 224.07/224.26  |- mesh__dateCreated mesh__D020501 1998-06-03
% 224.07/224.26  |- rdf__type mesh__D020501sskos__Concept
% 224.07/224.26  |- skos__altLabel mesh__D020501 Tables %28%PT%29%
% 224.07/224.26  |- mesh__recordOriginator mesh__D020501 JLS
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D020501 2006
% 224.07/224.26  |- mesh__dateEstablished mesh__D020501 1999-01-01
% 224.07/224.26  |- mesh__recordMaintainer mesh__D020501 jls
% 224.07/224.26  |- skos__related mesh__D020501smesh__D020469
% 224.07/224.26  |- skos__historyNote mesh__D006032
% 224.07/224.26       Amino Acyl T RNA Synthetases %28%1972-1974%29%
% 224.07/224.26  |- skos__hiddenLabel mesh__D006032 Synthetase, Glycyl-tRNA
% 224.07/224.26  |- mesh__historyNote mesh__D006032 98%28%75%29%   
% 224.07/224.26  |- skos__prefLabel mesh__D006032 Glycine-tRNA Ligase
% 224.07/224.26  |- mesh__dateRevised mesh__D006032 2003-07-09
% 224.07/224.26  |- mesh__recordOriginator mesh__D006032 NLM
% 224.07/224.26  |- skos__hiddenLabel mesh__D006032 Glycyl tRNA Synthetase
% 224.07/224.26  |- rdf__type mesh__D006032sskos__Concept
% 224.07/224.26  |- mesh__dateEstablished mesh__D006032 1991-01-01
% 224.07/224.26  |- skos__altLabel mesh__D006032 Glycyl-tRNA Synthetase
% 224.07/224.26  |- skos__historyNote mesh__D006032 Glycine %28%1972-1974%29%
% 224.07/224.26  |- mesh__recordMaintainer mesh__D006032 ssb
% 224.07/224.26  |- skos__altLabel mesh__D006032 Gly-tRNA Ligase
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D006032 2004
% 224.07/224.26  |- mesh__publicMeSHNote mesh__D006032
% 224.07/224.26       98; see GLYCYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A%  
% 224.07/224.26  |- skos__altLabel mesh__D006032 Glycyl T RNA Synthetase
% 224.07/224.26  |- skos__hiddenLabel mesh__D006032 Ligase, Glycine-tRNA
% 224.07/224.26  |- mesh__dateCreated mesh__D006032 1974-11-19
% 224.07/224.26  |- skos__hiddenLabel mesh__D006032 Glycine tRNA Ligase
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D006032 2005
% 224.07/224.26  |- skos__broader mesh__D006032smesh__D000604
% 224.07/224.26  |- skos__hiddenLabel mesh__D006032 Ligase, Gly-tRNA
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D006032 2006
% 224.07/224.26  |- skos__hiddenLabel mesh__D006032 Gly tRNA Ligase
% 224.07/224.26  |- mesh__recordAuthorizer mesh__D006032 sjn
% 224.07/224.26  |- skos__scopeNote mesh__D006032
% 224.07/224.26       An enzyme that activates glycine with its specific transfer RNA. EC 6.1.1.14.%A%    
% 224.07/224.26  |- mesh__recordMaintainer mesh__D011775 SYSTEM
% 224.07/224.26  |- mesh__recordAuthorizer mesh__D011775 sjn
% 224.07/224.26  |- mesh__dateEstablished mesh__D011775 1991-01-01
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D011775 2006
% 224.07/224.26  |- skos__hiddenLabel mesh__D011775 Pythiums
% 224.07/224.26  |- skos__broader mesh__D011775smesh__D009868
% 224.07/224.26  |- skos__annotation mesh__D011775
% 224.07/224.26       an alga belonging to the group OOMYCETES   
% 224.07/224.26  |- mesh__dateRevised mesh__D011775 2005-06-30
% 224.07/224.26  |- rdf__type mesh__D011775sskos__Concept
% 224.07/224.26  |- skos__prefLabel mesh__D011775 Pythium
% 224.07/224.26  |- mesh__dateCreated mesh__D011775 1974-12-12
% 224.07/224.26  |- skos__scopeNote mesh__D011775
% 224.07/224.26       A genus of destructive root-parasitic algae in the family Pythiaceae, order Peronosporales, commonly found in cultivated soils all over the world. Differentiation of zoospores takes place in a vesicle.%A%    
% 224.07/224.26  |- mesh__publicMeSHNote mesh__D011775
% 224.07/224.26       91; see MASTIGOMYCOTINA 1986-90, see PHYCOMYCETES 1975-85%A%  
% 224.07/224.26  |- mesh__historyNote mesh__D011775 91%28%75%29%   
% 224.07/224.26  |- mesh__recordOriginator mesh__D011775 NLM
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D005738 2004
% 224.07/224.26  |- mesh__recordOriginator mesh__D005738 NLM
% 224.07/224.26  |- mesh__recordAuthorizer mesh__D005738 sjn
% 224.07/224.26  |- skos__prefLabel mesh__D005738 Gas Gangrene
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D005738 2005
% 224.07/224.26  |- skos__scopeNote mesh__D005738
% 224.07/224.26       A severe condition resulting from bacteria invading healthy muscle from adjacent traumatized muscle or soft tissue. The infection originates in a wound contaminated with bacteria of the genus CLOSTRIDIUM. C. perfringens accounts for the majority of cases %28%over eighty percent%29%, while C. noyvi, C. septicum, and C. histolyticum cause most of the other cases.%A%    
% 224.07/224.26  |- mesh__recordMaintainer mesh__D005738 ags
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D005738 2006
% 224.07/224.26  |- skos__broader mesh__D005738smesh__D003015
% 224.07/224.26  |- rdf__type mesh__D005738sskos__Concept
% 224.07/224.26  |- skos__annotation mesh__D005738
% 224.07/224.26       usually caused by Clostridium perfringens but all C. perfringens infections need not be gas gangrene%A%  
% 224.07/224.26  |- skos__hiddenLabel mesh__D005738 Gangrene, Gas
% 224.07/224.26  |- mesh__dateCreated mesh__D005738 1999-01-01
% 224.07/224.26  |- skos__hiddenLabel mesh__D005738 Gangrenes, Gas
% 224.07/224.26  |- mesh__dateRevised mesh__D005738 2003-07-09
% 224.07/224.26  |- skos__hiddenLabel mesh__D005738 Gas Gangrenes
% 224.07/224.26  |- mesh__recordOriginator mesh__D016460 AGS
% 224.07/224.26  |- skos__broader mesh__D016460smesh__D006099
% 224.07/224.26  |- skos__annotation mesh__D016460
% 224.07/224.26       non-neoplastic; of the skin, so do not coord with SKIN DISEASES; coord IM with specific site or precoord site heading if pertinent %28%IM%29%%A%  
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D016460 2000
% 224.07/224.26  |- mesh__publicMeSHNote mesh__D016460 92   
% 224.07/224.26  |- skos__broader mesh__D016460smesh__D017441
% 224.07/224.26  |- mesh__dateCreated mesh__D016460 1991-01-02
% 224.07/224.26  |- mesh__recordAuthorizer mesh__D016460 sjn
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D016460 2001
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D016460 2005
% 224.07/224.26  |- mesh__dateEstablished mesh__D016460 1992-01-01
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D016460 2006
% 224.07/224.26  |- skos__prefLabel mesh__D016460 Granuloma Annulare
% 224.07/224.26  |- mesh__dateRevised mesh__D016460 1999-11-03
% 224.07/224.26  |- skos__scopeNote mesh__D016460
% 224.07/224.26       Benign granulomatous disease of unknown etiology characterized by a ring of localized or disseminated papules or nodules on the skin and palisading histiocytes surrounding necrobiotic tissue resulting from altered collagen structures.%A%    
% 224.07/224.26  |- skos__historyNote mesh__D016460 Granuloma %28%1966-1991%29%
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D016460 2002
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D016460 2003
% 224.07/224.26  |- skos__historyNote mesh__D016460 Skin Diseases %28%1966-1991%29%
% 224.07/224.26  |- rdf__type mesh__D016460sskos__Concept
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D016460 2004
% 224.07/224.26  |- mesh__historyNote mesh__D016460 92   
% 224.07/224.26  |- mesh__recordMaintainer mesh__D016460 PLS
% 224.07/224.26  |- mesh__recordMaintainer mesh__D002440 lkw
% 224.07/224.26  |- mesh__dateCreated mesh__D002440 1974-11-19
% 224.07/224.26  |- skos__prefLabel mesh__D002440 Cefoxitin
% 224.07/224.26  |- mesh__historyNote mesh__D002440
% 224.07/224.26       80%28%75%29%; was see under CEPHALOSPORINS 1975-79   
% 224.07/224.26  |- skos__altLabel mesh__D002440 Merck Brand of Cefoxitin Sodium
% 224.07/224.26  |- mesh__publicMeSHNote mesh__D002440
% 224.07/224.26       80; was see under CEPHALOSPORINS 1975-79   
% 224.07/224.26  |- rdf__type mesh__D002440sskos__Concept
% 224.07/224.26  |- skos__historyNote mesh__D002440 Cephalosporins %28%1974%29%
% 224.07/224.26  |- mesh__dateEstablished mesh__D002440 1980-01-01
% 224.07/224.26  |- skos__scopeNote mesh__D002440
% 224.07/224.26       A semisynthetic cephamycin antibiotic resistant to beta-lactamase.%A%    
% 224.07/224.26  |- mesh__dateRevised mesh__D002440 2005-06-30
% 224.07/224.26  |- skos__altLabel mesh__D002440 Merck Frosst Brand of Cefoxitin Sodium
% 224.07/224.26  |- mesh__recordAuthorizer mesh__D002440 sjn
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D002440 2006
% 224.07/224.26  |- skos__altLabel mesh__D002440 Mefoxitin
% 224.07/224.26  |- skos__altLabel mesh__D002440 Pharmacia Brand of Cefoxitin Sodium
% 224.07/224.26  |- skos__broader mesh__D002440smesh__D002513
% 224.07/224.26  |- skos__altLabel mesh__D002440
% 224.07/224.26       Merck Sharp %26% Dohme Brand of Cefoxitin Sodium
% 224.07/224.26  |- mesh__recordOriginator mesh__D002440 NLM
% 224.07/224.26  |- skos__hiddenLabel mesh__D002440 Sodium, Cefoxitin
% 224.07/224.26  |- skos__altLabel mesh__D002440 MSD Brand of Cefoxitin Sodium
% 224.07/224.26  |- skos__historyNote mesh__D002440 Carbamates %28%1974%29%
% 224.07/224.26  |- skos__hiddenLabel mesh__D002440 MK 306
% 224.07/224.26  |- skos__hiddenLabel mesh__D002440 MK306
% 224.07/224.26  |- skos__altLabel mesh__D002440 M%C3%%A9%foxin
% 224.07/224.26  |- skos__scopeNote mesh__D015368
% 224.07/224.26       A strain of PRIMATE T-LYMPHOTROPIC VIRUS 1 isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia %28%LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED%29%, T-cell lymphoma %28%LYMPHOMA, T-CELL%29%, and is involved in mycosis fungoides, SEZARY SYNDROME and tropical spastic paraparesis %28%PARAPARESIS, TROPICAL SPASTIC%29%.%A%    
% 224.07/224.26  |- mesh__recordAuthorizer mesh__D015368 ags
% 224.07/224.26  |- skos__altLabel mesh__D015368 Leukemia Virus I, Human T Cell
% 224.07/224.26  |- skos__altLabel mesh__D015368 HTLV-1
% 224.07/224.26  |- skos__altLabel mesh__D015368 HTLV-I
% 224.07/224.26  |- skos__hiddenLabel mesh__D015368 Human T lymphotropic virus 1
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D015368 2004
% 224.07/224.26  |- mesh__dateEstablished mesh__D015368 1989-01-01
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D015368 2006
% 224.07/224.26  |- skos__historyNote mesh__D015368
% 224.07/224.26       Human T-Cell Leukemia Virus %28%1984-1988%29%
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D015368 2003
% 224.07/224.26  |- skos__altLabel mesh__D015368 T Cell Leukemia Virus I, Human
% 224.07/224.26  |- skos__altLabel mesh__D015368 Adult T Cell Leukemia Lymphoma Virus I
% 224.07/224.26  |- skos__prefLabel mesh__D015368 Human T-lymphotropic virus 1
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D015368 2006A
% 224.07/224.26  |- mesh__activeMeSHYear mesh__D015368 2005
% 224.07/224.26  |- skos__altLabel mesh__D015368 Leukemia Lymphoma Virus I, Adult T Cell
% 224.07/224.26  |- skos__broader mesh__D015368smesh__D030261
% 224.07/224.26  |- mesh__historyNote mesh__D015368 2001 %28%1989%29%   
% 224.07/224.26  |- mesh__dateRevised mesh__D015368 2005-07-22
% 224.07/224.26  |- skos__annotation mesh__D015368
% 224.07/224.26       infection = HTLV-I INFECTIONS or its specifics; t-cell lymphoma caused by this virus = LYMPHOMA, T-CELL + HTLV-I INFECTIONS%A%  
% 224.07/224.26  |- skos__altLabel mesh__D015368 Leukemia Virus I, Human T-Cell
% 224.07/224.26  |- skos__altLabel mesh__D015368 ATLV
% 224.07/224.26  |- skos__altLabel mesh__D015368 Adult T-Cell Leukemia-Lymphoma Virus I
% 224.07/224.26  |- rdf__type mesh__D015368sskos__Concept
% 224.07/224.26  |- skos__altLabel mesh__D015368 Human T-Cell Leukemia Virus I
% 224.07/224.26  |- skos__historyNote mesh__D015368 Retroviridae %28%1981-1983%29%
% 224.07/224.26  |- mesh__recordOriginator mesh__D015368 RLS
% 224.07/224.26  |- skos__altLabel mesh__D015368 T-Cell Leukemia Virus I, Human
% 224.07/224.26  |- skos__altLabel mesh__D015368 Human T Cell Leukemia Virus I
% 224.07/224.26  |- mesh__dateCreated mesh__D015368 1988-06-02
% 224.07/224.26  |- mesh__recordMaintainer mesh__D015368 ags
% 224.07/224.27  |- mesh__publicMeSHNote mesh__D015368 2001; see HTLV-I 1989-2001   
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D001348 2006
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D001348 1998
% 224.07/224.27  |- skos__hiddenLabel mesh__D001348 Aversion Therapies
% 224.07/224.27  |- rdf__type mesh__D001348sskos__Concept
% 224.07/224.27  |- mesh__dateEstablished mesh__D001348 1970-01-01
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D001348 1999
% 224.07/224.27  |- skos__altLabel mesh__D001348 Aversion Therapy
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D001348 2000
% 224.07/224.27  |- mesh__recordOriginator mesh__D001348 NLM
% 224.07/224.27  |- mesh__dateCreated mesh__D001348 1999-01-01
% 224.07/224.27  |- skos__hiddenLabel mesh__D001348 Therapies, Aversive
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D001348 2003
% 224.07/224.27  |- skos__scopeNote mesh__D001348
% 224.07/224.27       A treatment that suppresses undesirable behavior by simultaneously exposing the subject to unpleasant consequences.%A%    
% 224.07/224.27  |- mesh__publicMeSHNote mesh__D001348 70   
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D001348 2001
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D001348 2004
% 224.07/224.27  |- skos__annotation mesh__D001348
% 224.07/224.27       a psychother technique; DF: AVERSIVE THER   
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D001348 1996
% 224.07/224.27  |- skos__altLabel mesh__D001348 Therapy, Aversive
% 224.07/224.27  |- mesh__dateRevised mesh__D001348 1995-05-31
% 224.07/224.27  |- skos__hiddenLabel mesh__D001348 Aversive Therapies
% 224.07/224.27  |- mesh__recordMaintainer mesh__D001348 TGC
% 224.07/224.27  |- skos__prefLabel mesh__D001348 Aversive Therapy
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D001348 2002
% 224.07/224.27  |- mesh__historyNote mesh__D001348 70   
% 224.07/224.27  |- skos__historyNote mesh__D001348 Behavior Therapy %28%1966-1969%29%
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D001348 2005
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D001348 1997
% 224.07/224.27  |- skos__altLabel mesh__D001348 Therapy, Aversion
% 224.07/224.27  |- skos__hiddenLabel mesh__D001348 Therapies, Aversion
% 224.07/224.27  |- mesh__recordAuthorizer mesh__D001348 PLS
% 224.07/224.27  |- skos__broader mesh__D001348smesh__D001521
% 224.07/224.27  |- mesh__recordOriginator mesh__D012070 NLM
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012070 2006
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012070 2002
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012070 2004
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012070 1995
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012070 1991
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012070 1993
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012070 2005
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012070 2003
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012070 1994
% 224.07/224.27  |- skos__prefLabel mesh__D012070 Religion and Science
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012070 1992
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012070 1999
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012070 2001
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012070 1997
% 224.07/224.27  |- skos__annotation mesh__D012070 no qualif; usually general; IM   
% 224.07/224.27  |- mesh__recordAuthorizer mesh__D012070 PLS
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012070 2000
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012070 1990
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012070 1998
% 224.07/224.27  |- rdf__type mesh__D012070sskos__Concept
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012070 1996
% 224.07/224.27  |- mesh__dateCreated mesh__D012070 1999-01-01
% 224.07/224.27  |- skos__broader mesh__D012070smesh__D012067
% 224.07/224.27  |- skos__hiddenLabel mesh__D012070 Science and Religion
% 224.07/224.27  |- mesh__recordMaintainer mesh__D012070 TGC
% 224.07/224.27  |- mesh__dateRevised mesh__D012070 1989-06-14
% 224.07/224.27  |- skos__altLabel mesh__D006831 Hydramnios
% 224.07/224.27  |- mesh__dateRevised mesh__D006831 2005-06-30
% 224.07/224.27  |- skos__broader mesh__D006831smesh__D011248
% 224.07/224.27  |- rdf__type mesh__D006831sskos__Concept
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D006831 2006
% 224.07/224.27  |- mesh__recordOriginator mesh__D006831 NLM
% 224.07/224.27  |- skos__prefLabel mesh__D006831 Polyhydramnios
% 224.07/224.27  |- mesh__onlineNote mesh__D006831
% 224.07/224.27       use POLYHYDRAMNIOS to search HYDRAMNIOS 1966-90   
% 224.07/224.27  |- mesh__historyNote mesh__D006831 91; was HYDRAMNIOS 1963-90   
% 224.07/224.27  |- skos__scopeNote mesh__D006831
% 224.07/224.27       A condition of abnormally high AMNIOTIC FLUID volume, such as greater than 2,000 ml in the LAST TRIMESTER and usually diagnosed by ultrasonographic criteria %28%AMNIOTIC FLUID INDEX%29%. It is associated with maternal DIABETES MELLITUS; MULTIPLE PREGNANCY; CHROMOSOMAL DISORDERS; and congenital abnormalities.%A%    
% 224.07/224.27  |- mesh__dateCreated mesh__D006831 1999-01-01
% 224.07/224.27  |- mesh__recordMaintainer mesh__D006831 lkt
% 224.07/224.27  |- mesh__recordAuthorizer mesh__D006831 sjn
% 224.07/224.27  |- mesh__publicMeSHNote mesh__D006831 91; was HYDRAMNIOS 1963-90   
% 224.07/224.27  |- mesh__dateRevised mesh__D020502 2005-06-30
% 224.07/224.27  |- mesh__recordMaintainer mesh__D020502 jls
% 224.07/224.27  |- skos__altLabel mesh__D020502 Nomenclature %28%Publication Type%29%
% 224.07/224.27  |- skos__altLabel mesh__D020502 Terminology %28%PT%29%
% 224.07/224.27  |- skos__scopeNote mesh__D020502
% 224.07/224.27       Work consisting of lists of the technical terms or expressions used in a specific field. These lists may or may not be formally adopted or sanctioned by usage.%A%    
% 224.07/224.27  |- mesh__historyNote mesh__D020502 1999   
% 224.07/224.27  |- skos__prefLabel mesh__D020502 Terminology %5B%Publication Type%5D%
% 224.07/224.27  |- mesh__dateCreated mesh__D020502 1998-06-11
% 224.07/224.27  |- mesh__dateEstablished mesh__D020502 1999-01-01
% 224.07/224.27  |- mesh__recordAuthorizer mesh__D020502 sjn
% 224.07/224.27  |- rdf__type mesh__D020502sskos__Concept
% 224.07/224.27  |- mesh__recordOriginator mesh__D020502 JLS
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D020502 2006
% 224.07/224.27  |- skos__related mesh__D020502smesh__D016437
% 224.07/224.27  |- skos__broader mesh__D020502smesh__D016437
% 224.07/224.27  |- skos__scopeNote mesh__D006033
% 224.07/224.27       The simplest of all peptides. It functions as a gamma-glutamyl acceptor.%A%    
% 224.07/224.27  |- mesh__publicMeSHNote mesh__D006033
% 224.07/224.27       91; was see under DIPEPTIDES 1975-90   
% 224.07/224.27  |- skos__altLabel mesh__D006033 N-Glycylglycine
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D006033 2004
% 224.07/224.27  |- mesh__recordAuthorizer mesh__D006033 sjn
% 224.07/224.27  |- skos__annotation mesh__D006033 /biosyn /drug eff /physiol permitted   
% 224.07/224.27  |- skos__altLabel mesh__D006033 Diglycine
% 224.07/224.27  |- skos__prefLabel mesh__D006033 Glycylglycine
% 224.07/224.27  |- mesh__recordOriginator mesh__D006033 NLM
% 224.07/224.27  |- mesh__recordMaintainer mesh__D006033 CCR
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D006033 2005
% 224.07/224.27  |- skos__broader mesh__D006033smesh__D004151
% 224.07/224.27  |- skos__hiddenLabel mesh__D006033 Hydrochloride, Glycylglycine
% 224.07/224.27  |- skos__hiddenLabel mesh__D006033 N Glycylglycine
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D006033 2006
% 224.07/224.27  |- skos__hiddenLabel mesh__D006033 Monohydrochloride, Glycylglycine
% 224.07/224.27  |- mesh__onlineNote mesh__D006033 search DIPEPTIDES 1968-74   
% 224.07/224.27  |- mesh__dateCreated mesh__D006033 1999-01-01
% 224.07/224.27  |- mesh__historyNote mesh__D006033
% 224.07/224.27       91%28%75%29%; was see under DIPEPTIDES 1975-90   
% 224.07/224.27  |- skos__altLabel mesh__D006033 Glycyl-Glycine
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D006033 2002
% 224.07/224.27  |- mesh__dateRevised mesh__D006033 2001-07-25
% 224.07/224.27  |- rdf__type mesh__D006033sskos__Concept
% 224.07/224.27  |- skos__hiddenLabel mesh__D006033 Glycyl Glycine
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D006033 2003
% 224.07/224.27  |- mesh__dateEstablished mesh__D006033 1991-01-01
% 224.07/224.27  |- mesh__recordOriginator mesh__D044950 ssb
% 224.07/224.27  |- skos__broader mesh__D044950smesh__D005419
% 224.07/224.27  |- skos__scopeNote mesh__D044950
% 224.07/224.27       A group of FLAVONOIDS characterized with a 4-ketone.     
% 224.07/224.27  |- mesh__dateRevised mesh__D044950 2005-06-30
% 224.07/224.27  |- mesh__publicMeSHNote mesh__D044950 2004   
% 224.07/224.27  |- skos__altLabel mesh__D044950 2-Phenyl-Benzopyran-4-Ones
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D044950 2006
% 224.07/224.27  |- skos__prefLabel mesh__D044950 Flavanones
% 224.07/224.27  |- rdf__type mesh__D044950sskos__Concept
% 224.07/224.27  |- skos__hiddenLabel mesh__D044950 2 Phenyl Benzopyran 4 Ones
% 224.07/224.27  |- mesh__dateEstablished mesh__D044950 2004-01-01
% 224.07/224.27  |- mesh__recordMaintainer mesh__D044950 ssb
% 224.07/224.27  |- skos__historyNote mesh__D044950 Flavones %28%1965-2003%29%
% 224.07/224.27  |- mesh__dateCreated mesh__D044950 2003-07-09
% 224.07/224.27  |- mesh__recordAuthorizer mesh__D044950 sjn
% 224.07/224.27  |- mesh__historyNote mesh__D044950 2004   
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D019759 2005
% 224.07/224.27  |- mesh__dateCreated mesh__D019759 1997-06-20
% 224.07/224.27  |- skos__scopeNote mesh__D019759
% 224.07/224.27       Enzymes that catalyze the cleavage of a carbon-nitrogen bond by means other than hydrolysis or oxidation. Subclasses are the AMMONIA-LYASES, the AMIDINE-LYASES, the amine-lyases, and other carbon-nitrogen lyases. EC 4.3.%A%    
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D019759 2006
% 224.07/224.27  |- mesh__dateEstablished mesh__D019759 1998-01-01
% 224.07/224.27  |- skos__hiddenLabel mesh__D019759 Lyases, Carbon-Nitrogen
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D019759 2004
% 224.07/224.27  |- rdf__type mesh__D019759sskos__Concept
% 224.07/224.27  |- skos__historyNote mesh__D019759 Lyases %28%1966-1997%29%
% 224.07/224.27  |- skos__hiddenLabel mesh__D019759 Carbon Nitrogen Lyases
% 224.07/224.27  |- mesh__dateRevised mesh__D019759 2003-07-09
% 224.07/224.27  |- mesh__publicMeSHNote mesh__D019759 98   
% 224.07/224.27  |- skos__prefLabel mesh__D019759 Carbon-Nitrogen Lyases
% 224.07/224.27  |- skos__annotation mesh__D019759 DF: C N LYASES   
% 224.07/224.27  |- mesh__historyNote mesh__D019759 98   
% 224.07/224.27  |- skos__broader mesh__D019759smesh__D008190
% 224.07/224.27  |- skos__prefLabel mesh__D011776 Pyuria
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D011776 2002
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D011776 1991
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D011776 1989
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D011776 1998
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D011776 2006
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D011776 1995
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D011776 2003
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D011776 1992
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D011776 1999
% 224.07/224.27  |- skos__hiddenLabel mesh__D011776 Pyurias
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D011776 2000
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D011776 1996
% 224.07/224.27  |- rdf__type mesh__D011776sskos__Concept
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D011776 2004
% 224.07/224.27  |- skos__broader mesh__D011776smesh__D014552
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D011776 1993
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D011776 2001
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D011776 1990
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D011776 1997
% 224.07/224.27  |- mesh__dateCreated mesh__D011776 1999-01-01
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D011776 2005
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D011776 1994
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D005739 2001
% 224.07/224.27  |- mesh__recordMaintainer mesh__D005739 TGC
% 224.07/224.27  |- mesh__dateRevised mesh__D005739 1992-05-15
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D005739 2005
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D005739 1997
% 224.07/224.27  |- skos__hiddenLabel mesh__D005739 Poisonings, Gas
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D005739 2002
% 224.07/224.27  |- skos__hiddenLabel mesh__D005739 Gas Poisonings
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D005739 2006
% 224.07/224.27  |- mesh__recordOriginator mesh__D005739 NLM
% 224.07/224.27  |- skos__broader mesh__D005739smesh__D011041
% 224.07/224.27  |- rdf__type mesh__D005739sskos__Concept
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D005739 1998
% 224.07/224.27  |- mesh__dateCreated mesh__D005739 1999-01-01
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D005739 1993
% 224.07/224.27  |- skos__altLabel mesh__D005739 Poisoning, Gas
% 224.07/224.27  |- mesh__recordAuthorizer mesh__D005739 PLS
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D005739 1999
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D005739 2003
% 224.07/224.27  |- skos__annotation mesh__D005739
% 224.07/224.27       GEN or unspecified gas; prefer /pois with specific gas term%A%  
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D005739 1994
% 224.07/224.27  |- skos__prefLabel mesh__D005739 Gas Poisoning
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D005739 2000
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D005739 2004
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D005739 1995
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D005739 1996
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D016461 2000
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D016461 2005
% 224.07/224.27  |- skos__prefLabel mesh__D016461 Chemoembolization, Therapeutic
% 224.07/224.27  |- rdf__type mesh__D016461sskos__Concept
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D016461 1994
% 224.07/224.27  |- skos__altLabel mesh__D016461 Therapeutic Chemoembolization
% 224.07/224.27  |- skos__hiddenLabel mesh__D016461 Chemoembolizations, Therapeutic
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D016461 2003
% 224.07/224.27  |- mesh__historyNote mesh__D016461 92   
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D016461 1992
% 224.07/224.27  |- skos__hiddenLabel mesh__D016461 Therapeutic Chemoembolizations
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D016461 1999
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D016461 1997
% 224.07/224.27  |- mesh__dateCreated mesh__D016461 1991-01-02
% 224.07/224.27  |- skos__annotation mesh__D016461
% 224.07/224.27       for admin of antineoplastic agents with embolizing agents; do not use /util %28%except by MeSH definition%29%; coord IM with disease /ther %28%IM%29%, not /surg %26% with antineoplastic /admin %28%IM or NIM%29%%A%  
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D016461 2002
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D016461 1998
% 224.07/224.27  |- mesh__publicMeSHNote mesh__D016461 92   
% 224.07/224.27  |- skos__historyNote mesh__D016461
% 224.07/224.27       Embolization, Therapeutic %28%1979-1991%29%
% 224.07/224.27  |- mesh__dateEstablished mesh__D016461 1992-01-01
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D016461 1996
% 224.07/224.27  |- skos__broader mesh__D016461smesh__D004621
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D016461 2006
% 224.07/224.27  |- skos__scopeNote mesh__D016461
% 224.07/224.27       Administration of antineoplastic agents together with an embolizing vehicle. This allows slow release of the agent as well as obstruction of the blood supply to the neoplasm.%A%    
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D016461 1995
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D016461 2004
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D016461 2001
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D016461 1993
% 224.07/224.27  |- rdf__type mesh__D002441sskos__Concept
% 224.07/224.27  |- skos__hiddenLabel mesh__D002441 SCE 129
% 224.07/224.27  |- skos__altLabel mesh__D002441 Cefsulodin Monosodium Salt
% 224.07/224.27  |- skos__hiddenLabel mesh__D002441 SCE129
% 224.07/224.27  |- skos__hiddenLabel mesh__D002441 Monosodium Salt, Cefsulodin
% 224.07/224.27  |- mesh__dateEstablished mesh__D002441 1985-01-01
% 224.07/224.27  |- mesh__dateCreated mesh__D002441 1984-05-24
% 224.07/224.27  |- skos__broader mesh__D002441smesh__D002511
% 224.07/224.27  |- mesh__recordMaintainer mesh__D002441 lkw
% 224.07/224.27  |- skos__hiddenLabel mesh__D002441 Sodium, Cefsulodin
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D002441 2006
% 224.07/224.27  |- skos__scopeNote mesh__D002441
% 224.07/224.27       A pyridinium-substituted semisynthetic, broad-spectrum antibacterial used especially for Pseudomonas infections in debilitated patients.%A%    
% 224.07/224.27  |- mesh__recordOriginator mesh__D002441 SH
% 224.07/224.27  |- skos__hiddenLabel mesh__D002441 Salt, Cefsulodin Monosodium
% 224.07/224.27  |- skos__historyNote mesh__D002441 Cephalosporins %28%1966-1984%29%
% 224.07/224.27  |- mesh__dateRevised mesh__D002441 2005-06-30
% 224.07/224.27  |- mesh__recordAuthorizer mesh__D002441 sjn
% 224.07/224.27  |- mesh__historyNote mesh__D002441 85   
% 224.07/224.27  |- skos__prefLabel mesh__D002441 Cefsulodin
% 224.07/224.27  |- skos__altLabel mesh__D002441 Takeda Brand of Cefsulodin Sodium
% 224.07/224.27  |- mesh__publicMeSHNote mesh__D002441 85   
% 224.07/224.27  |- skos__hiddenLabel mesh__D002441 CGP 7174 E
% 224.07/224.27  |- skos__hiddenLabel mesh__D002441 CGP7174E
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012071 2003
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012071 1994
% 224.07/224.27  |- mesh__recordAuthorizer mesh__D012071 PLS
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012071 2000
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012071 1992
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012071 1999
% 224.07/224.27  |- skos__prefLabel mesh__D012071 Religion and Sex
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012071 1997
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012071 1998
% 224.07/224.27  |- rdf__type mesh__D012071sskos__Concept
% 224.07/224.27  |- skos__annotation mesh__D012071
% 224.07/224.27       no qualif; coord IM with sexual aspect %28%IM%29%   
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012071 1996
% 224.07/224.27  |- mesh__recordOriginator mesh__D012071 NLM
% 224.07/224.27  |- mesh__dateCreated mesh__D012071 1999-01-01
% 224.07/224.27  |- skos__broader mesh__D012071smesh__D012067
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012071 2002
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012071 2006
% 224.07/224.27  |- mesh__recordMaintainer mesh__D012071 TGC
% 224.07/224.27  |- mesh__dateRevised mesh__D012071 1991-01-08
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012071 2004
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012071 1995
% 224.07/224.27  |- skos__hiddenLabel mesh__D012071 Sex and Religion
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012071 1993
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012071 2005
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D012071 2001
% 224.07/224.27  |- skos__hiddenLabel mesh__D006832 Hemihydranencephalies
% 224.07/224.27  |- mesh__recordOriginator mesh__D006832 NLM
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D006832 2005
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D006832 2004
% 224.07/224.27  |- skos__altLabel mesh__D006832 Congenital Absence of Cerebral Hemispheres
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D006832 2006
% 224.07/224.27  |- skos__hiddenLabel mesh__D006832 Hydranencephalies
% 224.07/224.27  |- skos__altLabel mesh__D006832 Cerebral Hemispheres, Absence, Congenital
% 224.07/224.27  |- mesh__publicMeSHNote mesh__D006832
% 224.07/224.27       91; was see under ANENCEPHALY 1979-90; was see under ANENCEPHALUS 1967-78%A%  
% 224.07/224.27  |- skos__broader mesh__D006832smesh__D009421
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D006832 2006A
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D006832 2002
% 224.07/224.27  |- mesh__dateCreated mesh__D006832 1999-01-01
% 224.07/224.27  |- skos__prefLabel mesh__D006832 Hydranencephaly
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D006832 2000A
% 224.07/224.27  |- mesh__recordMaintainer mesh__D006832 jls
% 224.07/224.27  |- mesh__dateEstablished mesh__D006832 1991-01-01
% 224.07/224.27  |- skos__altLabel mesh__D006832 Absence of Cerebral Hemispheres, Congenital
% 224.07/224.27  |- mesh__dateRevised mesh__D006832 2005-07-30
% 224.07/224.27  |- mesh__recordAuthorizer mesh__D006832 jls
% 224.07/224.27  |- mesh__historyNote mesh__D006832
% 224.07/224.27       91%28%64%29%; was see under ANENCEPHALY 1979-90; was see under ANENCEPHALUS 1967-78%A%  
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D006832 2000
% 224.07/224.27  |- skos__scopeNote mesh__D006832
% 224.07/224.27       A congenital condition where the greater portions of the cerebral hemispheres and CORPUS STRIATUM are replaced by CSF and glial tissue. The meninges and the skull are well formed, which is consistent with earlier normal embryogenesis of the telencephalon. Bilateral occlusions of the internal carotid arteries in utero is a potential mechanism. Clinical features include intact brainstem reflexes without evidence of higher cortical activity. %28%Menkes, Textbook of Child Neurology, 5th ed, p307%29%%A%    
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D006832 2003
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D006832 2001
% 224.07/224.27  |- rdf__type mesh__D006832sskos__Concept
% 224.07/224.27  |- skos__scopeNote mesh__D020503
% 224.07/224.27       Works consisting of records of the holdings or items owned by two or more libraries.%A%    
% 224.07/224.27  |- mesh__historyNote mesh__D020503 1999   
% 224.07/224.27  |- skos__related mesh__D020503smesh__D019494
% 224.07/224.27  |- mesh__dateRevised mesh__D020503 2005-06-30
% 224.07/224.27  |- mesh__recordMaintainer mesh__D020503 jls
% 224.07/224.27  |- skos__broader mesh__D020503smesh__D052180
% 224.07/224.27  |- rdf__type mesh__D020503sskos__Concept
% 224.07/224.27  |- mesh__dateCreated mesh__D020503 1998-06-03
% 224.07/224.27  |- skos__prefLabel mesh__D020503 Union Lists %5B%Publication Type%5D%
% 224.07/224.27  |- mesh__recordOriginator mesh__D020503 JLS
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D020503 2006
% 224.07/224.27  |- skos__altLabel mesh__D020503 Union Lists %28%PT%29%
% 224.07/224.27  |- mesh__dateEstablished mesh__D020503 1999-01-01
% 224.07/224.27  |- mesh__recordAuthorizer mesh__D020503 sjn
% 224.07/224.27  |- skos__altLabel mesh__D006034
% 224.07/224.27       Plantes et M%C3%%A9%decines Brand of Glycyrrhetinic Acid
% 224.07/224.27  |- skos__altLabel mesh__D006034 Glycyram
% 224.07/224.27  |- skos__prefLabel mesh__D006034 Glycyrrhetinic Acid
% 224.07/224.27  |- mesh__publicMeSHNote mesh__D006034
% 224.07/224.27       79; was ENOXOLONE see under TRITERPENES 1977-78; CARBENOXOLONE was see under TRITERPENES 1975-78%A%  
% 224.07/224.27  |- skos__historyNote mesh__D006034 Glycyrrhiza %28%1966-1976%29%
% 224.07/224.27  |- mesh__dateEstablished mesh__D006034 1979-01-01
% 224.07/224.27  |- skos__altLabel mesh__D006034 Rhetinic Acid
% 224.07/224.27  |- skos__hiddenLabel mesh__D006034 Acid, Glycyrrhetic
% 224.07/224.27  |- mesh__historyNote mesh__D006034
% 224.07/224.27       79; was ENOXOLONE see under TRITERPENES 1977-78   
% 224.07/224.27  |- rdf__type mesh__D006034sskos__Concept
% 224.07/224.27  |- skos__hiddenLabel mesh__D006034 Acid, Uralenic
% 224.07/224.27  |- mesh__recordMaintainer mesh__D006034 exl
% 224.07/224.27  |- mesh__dateRevised mesh__D006034 2005-06-30
% 224.07/224.27  |- skos__broader mesh__D006034smesh__D014315
% 224.07/224.27  |- skos__altLabel mesh__D006034 Enoxolone
% 224.07/224.27  |- skos__altLabel mesh__D006034 Glycyrrhetic Acid
% 224.07/224.27  |- skos__altLabel mesh__D006034 Glyciram
% 224.07/224.27  |- mesh__recordAuthorizer mesh__D006034 sjn
% 224.07/224.27  |- skos__hiddenLabel mesh__D006034 Acid, Rhetinic
% 224.07/224.27  |- skos__hiddenLabel mesh__D006034 Acid, Glycyrrhetinic
% 224.07/224.27  |- mesh__recordOriginator mesh__D006034 SH
% 224.07/224.27  |- skos__altLabel mesh__D006034 Dexo Brand of Glycyrrhetinic Acid
% 224.07/224.27  |- mesh__dateCreated mesh__D006034 1976-05-03
% 224.07/224.27  |- skos__altLabel mesh__D006034 Uralenic Acid
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D006034 2006
% 224.07/224.27  |- skos__historyNote mesh__D006034 Triterpenes %28%1974-1976%29%
% 224.07/224.27  |- skos__altLabel mesh__D006034 Jintan
% 224.07/224.27  |- mesh__onlineNote mesh__D006034
% 224.07/224.27       use GLYCYRRHETINIC ACID to search ENOXOLONE 1977-78   
% 224.07/224.27  |- skos__scopeNote mesh__D006034
% 224.07/224.27       An oleanolic acid from GLYCYRRHIZA that has some antiallergic, antibacterial, and antiviral properties. It is used topically for allergic or infectious skin inflammation and orally for its aldosterone effects in electrolyte regulation.%A%    
% 224.07/224.27  |- skos__broader mesh__D006321Q000469smesh__D006321
% 224.07/224.27  |- rdf__type mesh__D006321Q000469smesh__CompoundConcept
% 224.07/224.27  |- mesh__dateRevised mesh__D011777 2003-07-09
% 224.07/224.27  |- mesh__publicMeSHNote mesh__D011777
% 224.07/224.27       91; was see under RNA NUCLEOTIDYLTRANSFERASES 1975-90   
% 224.07/224.27  |- mesh__dateCreated mesh__D011777 1974-11-19
% 224.07/224.27  |- skos__altLabel mesh__D011777 Qbeta Replicase
% 224.07/224.27  |- skos__broader mesh__D011777smesh__D012316
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D011777 2006
% 224.07/224.27  |- mesh__dateEstablished mesh__D011777 1991-01-01
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D011777 2004
% 224.07/224.27  |- skos__hiddenLabel mesh__D011777 Replicase, Qbeta
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D011777 2005
% 224.07/224.27  |- mesh__recordOriginator mesh__D011777 NLM
% 224.07/224.27  |- rdf__type mesh__D011777sskos__Concept
% 224.07/224.27  |- mesh__historyNote mesh__D011777
% 224.07/224.27       91%28%75%29%; was see under RNA NUCLEOTIDYLTRANSFERASES 1975-90%A%  
% 224.07/224.27  |- skos__hiddenLabel mesh__D011777 Replicase, Q beta
% 224.07/224.27  |- mesh__recordAuthorizer mesh__D011777 sjn
% 224.07/224.27  |- skos__historyNote mesh__D011777 Coliphages %28%1973-1974%29%
% 224.07/224.27  |- skos__hiddenLabel mesh__D011777 beta Replicase, Q
% 224.07/224.27  |- mesh__recordMaintainer mesh__D011777 ssb
% 224.07/224.27  |- skos__prefLabel mesh__D011777 Q beta Replicase
% 224.07/224.27  |- skos__historyNote mesh__D011777 Virus Replication %28%1973-1974%29%
% 224.07/224.27  |- skos__scopeNote mesh__D011777
% 224.07/224.27       An enzyme that catalyzes the replication of the RNA of coliphage Q beta. EC 2.7.7.-.%A%    
% 224.07/224.27  |- skos__historyNote mesh__D011777 RNA Polymerases %28%1973-1974%29%
% 224.07/224.27  |- mesh__historyNote mesh__D016462 92   
% 224.07/224.27  |- skos__altLabel mesh__D016462 Breast Reconstruction
% 224.07/224.27  |- skos__altLabel mesh__D016462 Mammoplasty
% 224.07/224.27  |- skos__related mesh__D016462smesh__D018427
% 224.07/224.27  |- skos__broader mesh__D016462smesh__D019651
% 224.07/224.27  |- mesh__dateCreated mesh__D016462 1991-01-03
% 224.07/224.27  |- skos__hiddenLabel mesh__D016462 Breast Reconstructions
% 224.07/224.27  |- skos__hiddenLabel mesh__D016462 Mammoplasties
% 224.07/224.27  |- mesh__dateRevised mesh__D016462 2004-07-07
% 224.07/224.27  |- skos__hiddenLabel mesh__D016462 Reconstruction, Breast
% 224.07/224.27  |- mesh__recordMaintainer mesh__D016462 nns
% 224.07/224.27  |- skos__broader mesh__D016462smesh__D003357
% 224.07/224.27  |- skos__prefLabel mesh__D016462 Mammaplasty
% 224.07/224.27  |- skos__annotation mesh__D016462
% 224.07/224.27       includes augmentation %26% reduction; do not use /util except by MeSH definition; BREAST IMPLANTS is also available%A%  
% 224.07/224.27  |- skos__hiddenLabel mesh__D016462 Reconstructions, Breast
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D016462 2006
% 224.07/224.27  |- mesh__publicMeSHNote mesh__D016462 92   
% 224.07/224.27  |- mesh__dateEstablished mesh__D016462 1992-01-01
% 224.07/224.27  |- skos__hiddenLabel mesh__D016462 Mammaplasties
% 224.07/224.27  |- skos__historyNote mesh__D016462 Surgery, Plastic %28%1966-1991%29%
% 224.07/224.27  |- mesh__recordAuthorizer mesh__D016462 sjn
% 224.07/224.27  |- skos__scopeNote mesh__D016462
% 224.07/224.27       Surgical reconstruction of the breast including both augmentation and reduction.%A%    
% 224.07/224.27  |- skos__historyNote mesh__D016462 Breast/surgery %28%1966-1991%29%
% 224.07/224.27  |- mesh__activeMeSHYear mesh__D016462 2005
% 224.07/224.27  |- rdf__type mesh__D016462sskos__Concept
% 224.07/224.27  |- mesh__recordOriginator mesh__D016462 AGS
% 224.07/224.27  |- skos__historyNote mesh__D002442 Cephalosporins %28%1966-1984%29%
% 224.07/224.27  |- mesh__recordAuthorizer mesh__D002442 sjn
% 224.07/224.27  |- mesh__recordMaintainer mesh__D002442 ssb
% 224.07/224.27  |- skos__prefLabel mesh__D002442 Ceftazidime
% 224.07/224.27  |- skos__hiddenLabel mesh__D002442 LY139381
% 224.07/224.27  |- skos__hiddenLabel mesh__D002442 GR20263
% 224.07/224.28  |- rdf__type mesh__D002442sskos__Concept
% 224.07/224.28  |- mesh__historyNote mesh__D002442 85   
% 224.07/224.28  |- skos__broader mesh__D002442smesh__D002509
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D002442 2006
% 224.07/224.28  |- mesh__dateCreated mesh__D002442 1984-05-24
% 224.07/224.28  |- skos__scopeNote mesh__D002442
% 224.07/224.28       Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients.%A%    
% 224.07/224.28  |- mesh__publicMeSHNote mesh__D002442 85   
% 224.07/224.28  |- skos__hiddenLabel mesh__D002442 LY 139381
% 224.07/224.28  |- skos__hiddenLabel mesh__D002442 GR 20263
% 224.07/224.28  |- mesh__recordOriginator mesh__D002442 SH
% 224.07/224.28  |- mesh__dateRevised mesh__D002442 2004-07-07
% 224.07/224.28  |- mesh__dateEstablished mesh__D002442 1985-01-01
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D002442 2005
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D040561 2003
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D040561 2006
% 224.07/224.28  |- mesh__historyNote mesh__D040561 2003   
% 224.07/224.28  |- rdf__type mesh__D040561sskos__Concept
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D040561 2005
% 224.07/224.28  |- skos__prefLabel mesh__D040561 Assisted Living Facilities
% 224.07/224.28  |- skos__scopeNote mesh__D040561
% 224.07/224.28       A housing and health care alternative combining independence with personal care. It provides a combination of housing, personalized supportive services and health care designed to meet the needs, both scheduled and unscheduled, of those who need help with activities of daily living. %28%www.alfa.org%29%%A%    
% 224.07/224.28  |- skos__hiddenLabel mesh__D040561 Facilities, Assisted Living
% 224.07/224.28  |- skos__broader mesh__D040561smesh__D012112
% 224.07/224.28  |- mesh__dateCreated mesh__D040561 2002-07-02
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D040561 2004
% 224.07/224.28  |- mesh__dateEstablished mesh__D040561 2003-01-01
% 224.07/224.28  |- mesh__publicMeSHNote mesh__D040561 2003   
% 224.07/224.28  |- skos__hiddenLabel mesh__D040561 Assisted Living Facility
% 224.07/224.28  |- skos__hiddenLabel mesh__D040561 Facility, Assisted Living
% 224.07/224.28  |- mesh__recordMaintainer mesh__D012072 jrf
% 224.07/224.28  |- mesh__historyNote mesh__D012072 98; use explode 1974-97   
% 224.07/224.28  |- mesh__publicMeSHNote mesh__D012072 98   
% 224.07/224.28  |- rdf__type mesh__D012072sskos__Concept
% 224.07/224.28  |- skos__broader mesh__D012072smesh__D012067
% 224.07/224.28  |- mesh__dateCreated mesh__D012072 1999-01-01
% 224.07/224.28  |- mesh__dateRevised mesh__D012072 2002-07-03
% 224.07/224.28  |- skos__hiddenLabel mesh__D012072 Religious Philosophy
% 224.07/224.28  |- mesh__dateEstablished mesh__D012072 1998-01-01
% 224.07/224.28  |- skos__hiddenLabel mesh__D012072 Taoisms
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012072 2006
% 224.07/224.28  |- skos__hiddenLabel mesh__D012072 Philosophy, Religious
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012072 2004
% 224.07/224.28  |- skos__hiddenLabel mesh__D012072 Philosophies, Religious
% 224.07/224.28  |- mesh__recordOriginator mesh__D012072 NLM
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012072 2005
% 224.07/224.28  |- mesh__recordAuthorizer mesh__D012072 sjn
% 224.07/224.28  |- skos__prefLabel mesh__D012072 Religious Philosophies
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012072 2003
% 224.07/224.28  |- skos__scopeNote mesh__D012072
% 224.07/224.28       Sets of beliefs on the nature of the universe or Man, practiced as a religion.%A%    
% 224.07/224.28  |- skos__annotation mesh__D012072 GEN or unspecified; prefer specifics   
% 224.07/224.28  |- skos__prefLabel mesh__D006833 Hydrarthrosis
% 224.07/224.28  |- mesh__recordAuthorizer mesh__D006833 PLS
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D006833 2001
% 224.07/224.28  |- skos__broader mesh__D006833smesh__D007592
% 224.07/224.28  |- mesh__dateCreated mesh__D006833 1999-01-01
% 224.07/224.28  |- mesh__recordOriginator mesh__D006833 NLM
% 224.07/224.28  |- skos__annotation mesh__D006833 fluid in a joint cavity   
% 224.07/224.28  |- skos__hiddenLabel mesh__D006833 Hydrarthroses
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D006833 1996
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D006833 2002
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D006833 1998
% 224.07/224.28  |- skos__scopeNote mesh__D006833
% 224.07/224.28       Accumulation of watery fluid in the cavity of a joint. %28%Dorland, 27th ed%29%%A%    
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D006833 1997
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D006833 1994
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D006833 2003
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D006833 1999
% 224.07/224.28  |- mesh__dateRevised mesh__D006833 1993-06-02
% 224.07/224.28  |- rdf__type mesh__D006833sskos__Concept
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D006833 2005
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D006833 2004
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D006833 1995
% 224.07/224.28  |- mesh__recordMaintainer mesh__D006833 TGC
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D006833 2006
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D006833 2000
% 224.07/224.28  |- skos__broader mesh__D020504smesh__D052180
% 224.07/224.28  |- rdf__type mesh__D020504sskos__Concept
% 224.07/224.28  |- skos__annotation mesh__D020504
% 224.07/224.28       CATALOG: Use for annotated bibliographies.  Do not also use publication type BIBLIOGRAPHY.  Do not use for meeting abstracts.  Use instead publication type CONGRESSES%A%  
% 224.07/224.28  |- mesh__dateCreated mesh__D020504 1998-06-03
% 224.07/224.28  |- skos__scopeNote mesh__D020504
% 224.07/224.28       Works consisting of lists of publications on a subject and that provide full annotated bibliographical information together with substantive summaries or condensations of the facts, ideas, or opinions presented in each publication listed. %28%From LC Subject Cataloging Manual%29%%A%    
% 224.07/224.28  |- skos__related mesh__D020504smesh__D020507
% 224.07/224.28  |- mesh__recordOriginator mesh__D020504 JLS
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D020504 2006
% 224.07/224.28  |- mesh__recordAuthorizer mesh__D020504 sjn
% 224.07/224.28  |- skos__altLabel mesh__D020504 Abstracts %28%PT%29%
% 224.07/224.28  |- mesh__recordMaintainer mesh__D020504 jls
% 224.07/224.28  |- skos__related mesh__D020504smesh__D020481
% 224.07/224.28  |- skos__prefLabel mesh__D020504 Abstracts %5B%Publication Type%5D%
% 224.07/224.28  |- mesh__dateRevised mesh__D020504 2005-06-30
% 224.07/224.28  |- skos__broader mesh__D020504smesh__D052181
% 224.07/224.28  |- skos__related mesh__D020504smesh__D016417
% 224.07/224.28  |- mesh__historyNote mesh__D020504 1999   
% 224.07/224.28  |- mesh__dateEstablished mesh__D020504 1999-01-01
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D006035 2004
% 224.07/224.28  |- rdf__type mesh__D006035sskos__Concept
% 224.07/224.28  |- skos__prefLabel mesh__D006035 Glycyrrhiza
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D006035 2003
% 224.07/224.28  |- skos__scopeNote mesh__D006035
% 224.07/224.28       A genus of leguminous herbs or shrubs whose roots yield GLYCYRRHETINIC ACID and its derivatives, CARBENOXOLONE for example. Licorice toxicity is manifested as hypokalemia, low blood potassium. Licorice is used as flavoring and aromatic in pharmaceuticals and as candy.%A%    
% 224.07/224.28  |- mesh__dateCreated mesh__D006035 1999-01-01
% 224.07/224.28  |- mesh__dateRevised mesh__D006035 2001-07-25
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D006035 2006
% 224.07/224.28  |- skos__altLabel mesh__D006035 Liquorice
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D006035 2005
% 224.07/224.28  |- skos__annotation mesh__D006035
% 224.07/224.28       note category; yields the flavoring LICORICE %28%X ref%29%   
% 224.07/224.28  |- mesh__recordMaintainer mesh__D006035 ssb
% 224.07/224.28  |- mesh__recordAuthorizer mesh__D006035 sjn
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D006035 2002
% 224.07/224.28  |- skos__broader mesh__D006035smesh__D007887
% 224.07/224.28  |- mesh__recordOriginator mesh__D006035 NLM
% 224.07/224.28  |- mesh__dateCreated mesh__D011778 1999-01-01
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D011778 2006
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D011778 2004
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D011778 2005
% 224.07/224.28  |- skos__hiddenLabel mesh__D011778 Fever, Q
% 224.07/224.28  |- rdf__type mesh__D011778sskos__Concept
% 224.07/224.28  |- skos__scopeNote mesh__D011778
% 224.07/224.28       An acute infectious disease caused by COXIELLA BURNETII. It is characterized by a sudden onset of FEVER; HEADACHE; malaise; and weakness. In humans, it is commonly contracted by inhalation of infected dusts derived from infected domestic animals %28%ANIMALS, DOMESTIC%29%.%A%    
% 224.07/224.28  |- mesh__recordMaintainer mesh__D011778 ags
% 224.07/224.28  |- skos__hiddenLabel mesh__D011778 Q Fevers
% 224.07/224.28  |- mesh__recordOriginator mesh__D011778 NLM
% 224.07/224.28  |- mesh__dateRevised mesh__D011778 2003-07-09
% 224.07/224.28  |- mesh__recordAuthorizer mesh__D011778 sjn
% 224.07/224.28  |- skos__broader mesh__D011778smesh__D016905
% 224.07/224.28  |- skos__hiddenLabel mesh__D011778 Fevers, Q
% 224.07/224.28  |- skos__prefLabel mesh__D011778 Q Fever
% 224.07/224.28  |- mesh__publicMeSHNote mesh__D016463 92   
% 224.07/224.28  |- skos__hiddenLabel mesh__D016463 Syndrome, Sweet%27%s
% 224.07/224.28  |- skos__altLabel mesh__D016463 Acute Febrile Neutrophilic Dermatosis
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D016463 2002
% 224.07/224.28  |- mesh__recordAuthorizer mesh__D016463 PLS
% 224.07/224.28  |- mesh__recordMaintainer mesh__D016463 TGC
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D016463 2006
% 224.07/224.28  |- mesh__recordOriginator mesh__D016463 AGS
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D016463 1995
% 224.07/224.28  |- skos__hiddenLabel mesh__D016463 Sweet Syndrome
% 224.07/224.28  |- skos__broader mesh__D016463smesh__D004893
% 224.07/224.28  |- skos__altLabel mesh__D016463 Dermatosis, Neutrophilic, Febrile, Acute
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D016463 2005
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D016463 2004
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D016463 2001
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D016463 1994
% 224.07/224.28  |- mesh__historyNote mesh__D016463 92   
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D016463 2003
% 224.07/224.28  |- mesh__dateRevised mesh__D016463 1993-06-03
% 224.07/224.28  |- rdf__type mesh__D016463sskos__Concept
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D016463 1999
% 224.07/224.28  |- skos__prefLabel mesh__D016463 Sweet%27%s Syndrome
% 224.07/224.28  |- skos__scopeNote mesh__D016463
% 224.07/224.28       Condition characterized by large, rapidly extending, erythematous, tender plaques on the upper body usually accompanied by fever and dermal infiltration of neutrophilic leukocytes. It occurs mostly in middle-aged women, is often preceded by an upper respiratory infection, and clinically resembles erythema multiforme. Sweet%27%s syndrome may herald the appearance of leukemia.%A%    
% 224.07/224.28  |- skos__annotation mesh__D016463
% 224.07/224.28       a form of erythema nodosum with upper resp infect   
% 224.07/224.28  |- skos__hiddenLabel mesh__D016463 Sweets Syndrome
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D016463 2000
% 224.07/224.28  |- skos__altLabel mesh__D016463 Neutrophilic Dermatosis, Acute Febrile
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D016463 1998
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D016463 1997
% 224.07/224.28  |- mesh__dateEstablished mesh__D016463 1992-01-01
% 224.07/224.28  |- mesh__dateCreated mesh__D016463 1991-01-03
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D016463 1996
% 224.07/224.28  |- skos__historyNote mesh__D016463 Skin Diseases %28%1966-1991%29%
% 224.07/224.28  |- skos__altLabel mesh__D002443 Rocefin
% 224.07/224.28  |- mesh__recordOriginator mesh__D002443 SH
% 224.07/224.28  |- skos__altLabel mesh__D002443 Rocefalin
% 224.07/224.28  |- skos__altLabel mesh__D002443 Ceftriaxon
% 224.07/224.28  |- skos__altLabel mesh__D002443 Curamed Brand of Ceftriaxone Sodium
% 224.07/224.28  |- mesh__dateRevised mesh__D002443 2005-06-30
% 224.07/224.28  |- mesh__historyNote mesh__D002443 86   
% 224.07/224.28  |- skos__historyNote mesh__D002443 Cefotaxime %28%1982-1985%29%
% 224.07/224.28  |- mesh__dateEstablished mesh__D002443 1986-01-01
% 224.07/224.28  |- skos__altLabel mesh__D002443 Irex Brand of Ceftriaxone
% 224.07/224.28  |- rdf__type mesh__D002443sskos__Concept
% 224.07/224.28  |- skos__altLabel mesh__D002443 Pisa Brand of Ceftriaxone Sodium
% 224.07/224.28  |- skos__altLabel mesh__D002443
% 224.07/224.28       Hoffman-La Roche Brand of Ceftriaxone Sodium
% 224.07/224.28  |- skos__altLabel mesh__D002443 Fustery Brand of Ceftriaxone Sodium
% 224.07/224.28  |- skos__altLabel mesh__D002443
% 224.07/224.28       Ceftriaxone, Disodium Salt, Hemiheptahydrate
% 224.07/224.28  |- skos__hiddenLabel mesh__D002443 Ro13 9904
% 224.07/224.28  |- skos__prefLabel mesh__D002443 Ceftriaxone
% 224.07/224.28  |- skos__hiddenLabel mesh__D002443 Ro139904
% 224.07/224.28  |- mesh__dateCreated mesh__D002443 1985-06-06
% 224.07/224.28  |- skos__altLabel mesh__D002443 Cefatriaxone
% 224.07/224.28  |- skos__altLabel mesh__D002443 Inibsa Brand of Ceftriaxone Sodium
% 224.07/224.28  |- skos__broader mesh__D002443smesh__D002439
% 224.07/224.28  |- skos__altLabel mesh__D002443 Hexal Brand of Ceftriaxone Sodium
% 224.07/224.28  |- skos__altLabel mesh__D002443 Ro 13-9904
% 224.07/224.28  |- mesh__recordMaintainer mesh__D002443 lkw
% 224.07/224.28  |- skos__altLabel mesh__D002443
% 224.07/224.28       Boehringer Mannheim Brand of Ceftriaxone Sodium
% 224.07/224.28  |- skos__hiddenLabel mesh__D002443
% 224.07/224.28       Hoffman La Roche Brand of Ceftriaxone Sodium
% 224.07/224.28  |- skos__altLabel mesh__D002443 Rocephine
% 224.07/224.28  |- skos__hiddenLabel mesh__D002443 Anhydrous Ceftriaxone Sodium
% 224.07/224.28  |- skos__historyNote mesh__D002443 Cephalosporins %28%1966-1981%29%
% 224.07/224.28  |- skos__hiddenLabel mesh__D002443 Ro 139904
% 224.07/224.28  |- mesh__recordAuthorizer mesh__D002443 sjn
% 224.07/224.28  |- skos__altLabel mesh__D002443 Roche Brand of Ceftriaxone Sodium
% 224.07/224.28  |- skos__altLabel mesh__D002443 Ceftriaxone, Disodium Salt
% 224.07/224.28  |- skos__altLabel mesh__D002443 Syntex Brand of Ceftriaxone Sodium
% 224.07/224.28  |- skos__altLabel mesh__D002443 Columbia Brand of Ceftriaxone
% 224.07/224.28  |- skos__hiddenLabel mesh__D002443 Ro 13 9904
% 224.07/224.28  |- mesh__publicMeSHNote mesh__D002443 86   
% 224.07/224.28  |- skos__altLabel mesh__D002443 Galen Brand of Ceftriaxone Sodium
% 224.07/224.28  |- skos__altLabel mesh__D002443 Longaceph
% 224.07/224.28  |- skos__scopeNote mesh__D002443
% 224.07/224.28       A broad-spectrum cephalosporin antibiotic with a very long half-life and high penetrability to meninges, eyes and inner ears.%A%    
% 224.07/224.28  |- skos__hiddenLabel mesh__D002443 Sodium, Ceftriaxone
% 224.07/224.28  |- skos__altLabel mesh__D002443 Ro-13-9904
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D002443 2006
% 224.07/224.28  |- skos__hiddenLabel mesh__D012871 Skin Disease
% 224.07/224.28  |- mesh__dateEstablished mesh__D012871 1965-01-01
% 224.07/224.28  |- mesh__onlineNote mesh__D012871
% 224.07/224.28       pre-explosion = SKIN DISEASES %28%PX%29%   
% 224.07/224.28  |- skos__prefLabel mesh__D012871 Skin Diseases
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012871 2003
% 224.07/224.28  |- mesh__publicMeSHNote mesh__D012871
% 224.07/224.28       65; was see under DERMATOLOGY 1963-64   
% 224.07/224.28  |- mesh__recordMaintainer mesh__D012871 mdb
% 224.07/224.28  |- skos__related mesh__D012871smesh__D012877
% 224.07/224.28  |- skos__altLabel mesh__D012871 Dermatoses
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012871 2006
% 224.07/224.28  |- mesh__historyNote mesh__D012871 65; was see under DERMATOLOGY 1963-64   
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012871 2002
% 224.07/224.28  |- skos__hiddenLabel mesh__D012871 Disease, Skin
% 224.07/224.28  |- mesh__dateRevised mesh__D012871 2001-07-25
% 224.07/224.28  |- skos__hiddenLabel mesh__D012871 Diseases, Skin
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012871 2005
% 224.07/224.28  |- skos__annotation mesh__D012871
% 224.07/224.28       GEN: prefer specifics; X ref DERMATOSES is sometimes used loosely for %22%dermatitis%22%, strictly speaking an inflamm dis: check text carefully; /drug ther: consider also DERMATOLOGIC AGENTS; inflamm dis = DERMATITIS %26% its specifics; dryness of skin goes here: do not interpret as XERODERMA see ICHTHYOSIS without clues from text; also available are FACIAL DERMATOSES; FOOT DERMATOSES; HAND DERMATOSES; LEG DERMATOSES %26% SCALP DERMATOSES%A%  
% 224.07/224.28  |- skos__broader mesh__D012871smesh__D017437
% 224.07/224.28  |- skos__related mesh__D012871smesh__D003879
% 224.07/224.28  |- mesh__dateCreated mesh__D012871 1999-01-01
% 224.07/224.28  |- mesh__recordOriginator mesh__D012871 NLM
% 224.07/224.28  |- mesh__recordAuthorizer mesh__D012871 sjn
% 224.07/224.28  |- skos__altLabel mesh__D012871 Dermatosis
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012871 2004
% 224.07/224.28  |- rdf__type mesh__D012871sskos__Concept
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012073 1997
% 224.07/224.28  |- mesh__recordOriginator mesh__D012073 NLM
% 224.07/224.28  |- skos__hiddenLabel mesh__D012073 Remedial Teachings
% 224.07/224.28  |- skos__prefLabel mesh__D012073 Remedial Teaching
% 224.07/224.28  |- rdf__type mesh__D012073sskos__Concept
% 224.07/224.28  |- mesh__recordAuthorizer mesh__D012073 PLS
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012073 2000
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012073 2005
% 224.07/224.28  |- skos__broader mesh__D012073smesh__D013663
% 224.07/224.28  |- skos__hiddenLabel mesh__D012073 Teachings, Remedial
% 224.07/224.28  |- skos__hiddenLabel mesh__D012073 Teaching, Remedial
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012073 2003
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012073 1994
% 224.07/224.28  |- mesh__dateRevised mesh__D012073 1992-05-18
% 224.07/224.28  |- mesh__recordMaintainer mesh__D012073 TAP
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012073 2006
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012073 2004
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012073 2001
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012073 1995
% 224.07/224.28  |- skos__broader mesh__D012073smesh__D011588
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012073 1993
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012073 2002
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012073 1998
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012073 1996
% 224.07/224.28  |- mesh__dateCreated mesh__D012073 1999-01-01
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D012073 1999
% 224.07/224.28  |- skos__scopeNote mesh__D012073
% 224.07/224.28       Specialized instruction for students deviating from the expected norm.%A%    
% 224.07/224.28  |- rdf__type mesh__D006834sskos__Concept
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D006834 2000
% 224.07/224.28  |- mesh__recordAuthorizer mesh__D006834 PLS
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D006834 2003
% 224.07/224.28  |- mesh__activeMeSHYear mesh__D006834 1995
% 224.13/224.28  |- mesh__activeMeSHYear mesh__D006834 1998
% 224.13/224.28  |- mesh__activeMeSHYear mesh__D006834 2006
% 224.13/224.28  |- mesh__activeMeSHYear mesh__D006834 2002
% 224.13/224.28  |- mesh__activeMeSHYear mesh__D006834 1994
% 224.13/224.28  |- mesh__dateRevised mesh__D006834 1992-05-19
% 224.13/224.28  |- mesh__activeMeSHYear mesh__D006834 2005
% 224.13/224.28  |- mesh__dateCreated mesh__D006834 1999-01-01
% 224.13/224.28  |- mesh__recordOriginator mesh__D006834 NLM
% 224.13/224.28  |- mesh__activeMeSHYear mesh__D006834 1997
% 224.13/224.28  |- skos__annotation mesh__D006834 do not confuse with HYDRAZONES   
% 224.13/224.28  |- mesh__recordMaintainer mesh__D006834 TGC
% 224.13/224.28  |- mesh__activeMeSHYear mesh__D006834 2001
% 224.13/224.28  |- mesh__activeMeSHYear mesh__D006834 1993
% 224.13/224.28  |- mesh__activeMeSHYear mesh__D006834 1996
% 224.13/224.28  |- mesh__activeMeSHYear mesh__D006834 2004
% 224.13/224.28  |- skos__broader mesh__D006834smesh__D009930
% 224.13/224.28  |- skos__prefLabel mesh__D006834 Hydrazines
% 224.13/224.28  |- mesh__activeMeSHYear mesh__D006834 1999
% 224.13/224.28  |- mesh__activeMeSHYear mesh__D020505 2006
% 224.13/224.28  |- mesh__dateEstablished mesh__D020505 1999-01-01
% 224.13/224.28  |- skos__broader mesh__D020505smesh__D020470
% 224.13/224.28  |- skos__prefLabel mesh__D020505
% 224.13/224.28       Collected Correspondence %5B%Publication Type%5D%
% 224.13/224.28  |- mesh__recordAuthorizer mesh__D020505 sjn
% 224.13/224.28  |- skos__related mesh__D020505smesh__D016422
% 224.13/224.29  |- skos__altLabel mesh__D020505 Collected Correspondence %28%PT%29%
% 224.13/224.29  |- mesh__historyNote mesh__D020505 1999   
% 224.13/224.29  |- skos__scopeNote mesh__D020505
% 224.13/224.29       Works consisting of collected letters by or about a person or on a subject.%A%    
% 224.13/224.29  |- mesh__recordMaintainer mesh__D020505 jls
% 224.13/224.29  |- mesh__dateRevised mesh__D020505 2005-06-30
% 224.13/224.29  |- mesh__recordOriginator mesh__D020505 JLS
% 224.13/224.29  |- mesh__dateCreated mesh__D020505 1998-06-03
% 224.13/224.29  |- rdf__type mesh__D020505sskos__Concept
% 224.13/224.29  |- skos__altLabel mesh__D050990 Transcription Factor GATA3
% 224.13/224.29  |- mesh__dateCreated mesh__D050990 2005-06-30
% 224.13/224.29  |- skos__altLabel mesh__D050990 Nuclear Factor-Erythroid 1C
% 224.13/224.29  |- mesh__recordMaintainer mesh__D050990 DRC
% 224.13/224.29  |- skos__altLabel mesh__D050990 NF-E1C Protein
% 224.13/224.29  |- mesh__dateEstablished mesh__D050990 2006-01-01
% 224.13/224.29  |- mesh__historyNote mesh__D050990 2006%28%1991%29%   
% 224.13/224.29  |- skos__broader mesh__D050990smesh__D050980
% 224.13/224.29  |- skos__hiddenLabel mesh__D050990 NF E1C Protein
% 224.13/224.29  |- skos__hiddenLabel mesh__D050990 GATA3, Transcription Factor
% 224.13/224.29  |- skos__hiddenLabel mesh__D050990 Transcription Factor, GATA3
% 224.13/224.29  |- skos__altLabel mesh__D050990 GATA-3 Factors
% 224.13/224.29  |- skos__hiddenLabel mesh__D050990 GATA 3 Factors
% 224.13/224.29  |- mesh__publicMeSHNote mesh__D050990
% 224.13/224.29       2006; GATA3 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1991-2005%A%  
% 224.13/224.29  |- mesh__recordAuthorizer mesh__D050990 sjn
% 224.13/224.29  |- skos__prefLabel mesh__D050990 GATA3 Transcription Factor
% 224.13/224.29  |- skos__broader mesh__D050990smesh__D050981
% 224.13/224.29  |- mesh__recordOriginator mesh__D050990 DRC
% 224.13/224.29  |- skos__hiddenLabel mesh__D050990 Nuclear Factor Erythroid 1C
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D050990 2006
% 224.13/224.29  |- rdf__type mesh__D050990sskos__Concept
% 224.13/224.29  |- skos__scopeNote mesh__D050990
% 224.13/224.29       A GATA transcription factor that is found predominately in LYMPHOID CELL precursors and has been implicated in the CELL DIFFERENTIATION of HELPER T-CELLS. Haploinsufficiency of GATA3 is associated with HYPOPARATHYROIDISM; SENSORINEURAL HEARING LOSS; and renal anomalies syndrome.%A%    
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D011779 1994
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D011779 1997
% 224.13/224.29  |- mesh__dateEstablished mesh__D011779 1991-01-01
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D011779 2003
% 224.13/224.29  |- rdf__type mesh__D011779sskos__Concept
% 224.13/224.29  |- mesh__dateRevised mesh__D011779 1992-05-18
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D011779 1998
% 224.13/224.29  |- mesh__recordOriginator mesh__D011779 NLM
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D011779 1996
% 224.13/224.29  |- skos__prefLabel mesh__D011779 Q-Sort
% 224.13/224.29  |- mesh__recordAuthorizer mesh__D011779 PLS
% 224.13/224.29  |- mesh__publicMeSHNote mesh__D011779
% 224.13/224.29       91; was see under PERSONALITY ASSESSMENT 1975-90   
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D011779 2002
% 224.13/224.29  |- mesh__onlineNote mesh__D011779 search PERSONALITY ASSESSMENT 1970-74   
% 224.13/224.29  |- skos__hiddenLabel mesh__D011779 Q Sort
% 224.13/224.29  |- mesh__dateCreated mesh__D011779 1999-01-01
% 224.13/224.29  |- mesh__historyNote mesh__D011779
% 224.13/224.29       91%28%75%29%; was see under PERSONALITY ASSESSMENT 1975-90   
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D011779 2006
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D011779 1995
% 224.13/224.29  |- skos__scopeNote mesh__D011779
% 224.13/224.29       A personality assessment technique in which the subject or observer indicates the degree to which a standardized set of descriptive statements actually describes the subject. The term reflects %22%sorting%22% procedures occasionally used with this technique.%A%    
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D011779 2004
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D011779 2001
% 224.13/224.29  |- mesh__recordMaintainer mesh__D011779 TAP
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D011779 1993
% 224.13/224.29  |- skos__broader mesh__D011779smesh__D010552
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D011779 1999
% 224.13/224.29  |- skos__hiddenLabel mesh__D011779 Q-Sorts
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D011779 2000
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D011779 2005
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D016464 2006
% 224.13/224.29  |- mesh__dateEstablished mesh__D016464 1992-01-01
% 224.13/224.29  |- skos__hiddenLabel mesh__D016464 Enzyme Disorders, Lysosomal
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D016464 2005
% 224.13/224.29  |- mesh__publicMeSHNote mesh__D016464 92   
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D016464 2004
% 224.13/224.29  |- skos__broader mesh__D016464smesh__D008661
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D016464 2002
% 224.13/224.29  |- mesh__historyNote mesh__D016464 92   
% 224.13/224.29  |- skos__hiddenLabel mesh__D016464 Lysosomal Enzyme Disorder
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D016464 2003
% 224.13/224.29  |- rdf__type mesh__D016464sskos__Concept
% 224.13/224.29  |- skos__prefLabel mesh__D016464 Lysosomal Storage Diseases
% 224.13/224.29  |- mesh__recordOriginator mesh__D016464 AGS
% 224.13/224.29  |- mesh__recordAuthorizer mesh__D016464 sjn
% 224.13/224.29  |- mesh__dateCreated mesh__D016464 1991-01-02
% 224.13/224.29  |- skos__hiddenLabel mesh__D016464 Disorder, Lysosomal Enzyme
% 224.13/224.29  |- mesh__dateRevised mesh__D016464 2001-07-25
% 224.13/224.29  |- skos__hiddenLabel mesh__D016464 Enzyme Disorder, Lysosomal
% 224.13/224.29  |- skos__hiddenLabel mesh__D016464 Disorders, Lysosomal Enzyme
% 224.13/224.29  |- skos__hiddenLabel mesh__D016464 Lysosomal Storage Disease
% 224.13/224.29  |- skos__historyNote mesh__D016464
% 224.13/224.29       Metabolism, Inborn Errors %28%1972-1991%29%
% 224.13/224.29  |- skos__hiddenLabel mesh__D016464 Diseases, Lysosomal Storage
% 224.13/224.29  |- skos__altLabel mesh__D016464 Lysosomal Enzyme Disorders
% 224.13/224.29  |- mesh__recordMaintainer mesh__D016464 nns
% 224.13/224.29  |- skos__hiddenLabel mesh__D016464 Disease, Lysosomal Storage
% 224.13/224.29  |- skos__annotation mesh__D016464
% 224.13/224.29       an inborn error of metab; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 224.13/224.29  |- skos__scopeNote mesh__D016464
% 224.13/224.29       Inborn errors of metabolism characterized by defects in specific lysosomal hydrolases and resulting in intracellular accumulation of unmetabolized substrates.%A%    
% 224.13/224.29  |- skos__prefLabel mesh__D002444 Cefuroxime
% 224.13/224.29  |- mesh__recordOriginator mesh__D002444 SH
% 224.13/224.29  |- skos__historyNote mesh__D002444 Cephalosporins %28%1966-1979%29%
% 224.13/224.29  |- mesh__dateRevised mesh__D002444 2004-07-07
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D002444 2005
% 224.13/224.29  |- skos__altLabel mesh__D002444 Cephuroxime
% 224.13/224.29  |- mesh__historyNote mesh__D002444
% 224.13/224.29       91%28%80%29%; was see under CEPHALOSPORINS 1980-90   
% 224.13/224.29  |- mesh__dateEstablished mesh__D002444 1991-01-01
% 224.13/224.29  |- rdf__type mesh__D002444sskos__Concept
% 224.13/224.29  |- mesh__recordMaintainer mesh__D002444 ssb
% 224.13/224.29  |- mesh__recordAuthorizer mesh__D002444 sjn
% 224.13/224.29  |- skos__broader mesh__D002444smesh__D002439
% 224.13/224.29  |- mesh__dateCreated mesh__D002444 1979-03-01
% 224.13/224.29  |- mesh__publicMeSHNote mesh__D002444
% 224.13/224.29       91; was see under CEPHALOSPORINS 1980-90   
% 224.13/224.29  |- skos__scopeNote mesh__D002444
% 224.13/224.29       Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.%A%    
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D002444 2006
% 224.13/224.29  |- mesh__recordOriginator mesh__D012872 SMH
% 224.13/224.29  |- skos__hiddenLabel mesh__D012872 Dermatoses, Vesiculobullous
% 224.13/224.29  |- skos__altLabel mesh__D012872 Subcorneal Pustular Dermatosis
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D012872 2005
% 224.13/224.29  |- skos__hiddenLabel mesh__D012872 Vesiculobullous Skin Disease
% 224.13/224.29  |- skos__annotation mesh__D012872
% 224.13/224.29       GEN or unspecified; prefer specifics; do not confuse X ref SNEDDON-WILKINSON DISEASE with SNEDDON SYNDROME%A%  
% 224.13/224.29  |- mesh__publicMeSHNote mesh__D012872
% 224.13/224.29       91; SKIN DISEASES, BULLOUS was heading 1976-90; ERYTHRODERMA ICHTHYOSIFORME was see under ICHTHYOSIS 1963-78%A%  
% 224.13/224.29  |- skos__altLabel mesh__D012872 Sneddon-Wilkinson Disease
% 224.13/224.29  |- skos__altLabel mesh__D012872 Vesiculobullous Dermatoses
% 224.13/224.29  |- skos__hiddenLabel mesh__D012872 Dermatoses, Bullous
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D012872 2006
% 224.13/224.29  |- skos__scopeNote mesh__D012872
% 224.13/224.29       Skin diseases characterized by local or general distributions of blisters. They are classified according to the site and mode of blister formation. Lesions can appear spontaneously or be precipitated by infection, trauma, or sunlight. Etiologies include immunologic and genetic factors. %28%From Scientific American Medicine, 1990%29%%A%    
% 224.13/224.29  |- skos__historyNote mesh__D012872 specific skin disease %28%1966-1975%29%
% 224.13/224.29  |- skos__hiddenLabel mesh__D012872 Dermatosis, Subcorneal Pustular
% 224.13/224.29  |- skos__altLabel mesh__D012872 Bullous Skin Diseases
% 224.13/224.29  |- skos__hiddenLabel mesh__D012872 Subcorneal Pustular Dermatoses
% 224.13/224.29  |- skos__hiddenLabel mesh__D012872 Sneddon Wilkinson Disease
% 224.13/224.29  |- skos__hiddenLabel mesh__D012872 Bullous Skin Disease
% 224.13/224.29  |- skos__hiddenLabel mesh__D012872 Pustular Dermatoses, Subcorneal
% 224.13/224.29  |- skos__altLabel mesh__D012872 Bullous Dermatoses
% 224.13/224.29  |- mesh__recordMaintainer mesh__D012872 ags
% 224.13/224.29  |- mesh__dateEstablished mesh__D012872 1976-01-01
% 224.13/224.29  |- skos__hiddenLabel mesh__D012872 Skin Disease, Bullous
% 224.13/224.29  |- skos__altLabel mesh__D012872 Vesiculobullous Skin Diseases
% 224.13/224.29  |- rdf__type mesh__D012872sskos__Concept
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D012872 2002
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D012872 2003
% 224.13/224.29  |- mesh__dateCreated mesh__D012872 1975-07-21
% 224.13/224.29  |- mesh__historyNote mesh__D012872
% 224.13/224.29       91; SKIN DISEASES, BULLOUS was heading 1976-90 %26% was NON MESH before 1976; ERYTHRODERMA ICHTHYOSIFORME was see under ICHTHYOSIS 1963-78%A%  
% 224.13/224.29  |- mesh__dateRevised mesh__D012872 2001-07-25
% 224.13/224.29  |- skos__altLabel mesh__D012872 Skin Diseases, Vesicular
% 224.13/224.29  |- skos__hiddenLabel mesh__D012872 Skin Disease, Vesicular
% 224.13/224.29  |- skos__hiddenLabel mesh__D012872 Skin Disease, Vesiculobullous
% 224.13/224.29  |- skos__prefLabel mesh__D012872 Skin Diseases, Vesiculobullous
% 224.13/224.29  |- mesh__onlineNote mesh__D012872
% 224.13/224.29       use SKIN DISEASES, VESICULOBULLOUS to search SKIN DISEASES, BULLOUS 1976-90; use ICHTHYOSIS %26% SKIN DISEASES, VESICULOBULLOUS to search ERYTHRODERMA ICHTHYOSIFORME 1975-78 %26% use ICHTHYOSIS 1966-74%A%  
% 224.13/224.29  |- skos__broader mesh__D012872smesh__D012871
% 224.13/224.29  |- mesh__recordAuthorizer mesh__D012872 sjn
% 224.13/224.29  |- skos__hiddenLabel mesh__D012872 Dermatoses, Subcorneal Pustular
% 224.13/224.29  |- skos__hiddenLabel mesh__D012872 Vesicular Skin Disease
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D012872 2004
% 224.13/224.29  |- skos__hiddenLabel mesh__D012074 Inductions, Remission
% 224.13/224.29  |- mesh__dateCreated mesh__D012074 1986-06-24
% 224.13/224.29  |- mesh__publicMeSHNote mesh__D012074 87   
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D012074 2005
% 224.13/224.29  |- mesh__recordMaintainer mesh__D012074 TGC
% 224.13/224.29  |- rdf__type mesh__D012074sskos__Concept
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D012074 2003
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D012074 2006
% 224.13/224.29  |- mesh__recordOriginator mesh__D012074 VDK
% 224.13/224.29  |- skos__prefLabel mesh__D012074 Remission Induction
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D012074 2004
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D012074 1998
% 224.13/224.29  |- mesh__historyNote mesh__D012074 87   
% 224.13/224.29  |- mesh__recordAuthorizer mesh__D012074 PLS
% 224.13/224.29  |- skos__related mesh__D012074smesh__D018572
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D012074 2000
% 224.13/224.29  |- skos__altLabel mesh__D012074 Induction of Remission
% 224.13/224.29  |- mesh__dateRevised mesh__D012074 1995-06-08
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D012074 1996
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D012074 2001
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D012074 1999
% 224.13/224.29  |- mesh__dateEstablished mesh__D012074 1987-01-01
% 224.13/224.29  |- skos__broader mesh__D012074smesh__D013812
% 224.13/224.29  |- skos__scopeNote mesh__D012074
% 224.13/224.29       Therapeutic act or process that initiates a response to a complete or partial remission level.%A%    
% 224.13/224.29  |- skos__hiddenLabel mesh__D012074 Remission Inductions
% 224.13/224.29  |- skos__annotation mesh__D012074
% 224.13/224.29       NIM; coord NIM with disease /ther or specific ther qualif %28%IM%29%; in translations use %22%induction of remission%22%, not %22%remission induction%22%; Manual 24.4.1.9%A%  
% 224.13/224.29  |- skos__hiddenLabel mesh__D012074 Induction, Remission
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D012074 1997
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D012074 2002
% 224.13/224.29  |- mesh__dateRevised mesh__D006835 1995-03-17
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D006835 1998
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D006835 2003
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D006835 2002
% 224.13/224.29  |- mesh__publicMeSHNote mesh__D006835 74   
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D006835 2006
% 224.13/224.29  |- mesh__dateCreated mesh__D006835 1999-01-01
% 224.13/224.29  |- mesh__recordOriginator mesh__D006835 NLM
% 224.13/224.29  |- skos__annotation mesh__D006835 do not confuse with HYDRAZINES   
% 224.13/224.29  |- skos__scopeNote mesh__D006835
% 224.13/224.29       Compounds of the general formula R:N.NR2, as resulting from the action of hydrazines with aldehydes or ketones. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D006835 1997
% 224.13/224.29  |- mesh__historyNote mesh__D006835 74%28%72%29%   
% 224.13/224.29  |- skos__prefLabel mesh__D006835 Hydrazones
% 224.13/224.29  |- mesh__dateEstablished mesh__D006835 1974-01-01
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D006835 2005
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D006835 1996
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D006835 2001
% 224.13/224.29  |- skos__historyNote mesh__D006835 specific hydrazine %28%1966-1971%29%
% 224.13/224.29  |- skos__broader mesh__D006835smesh__D006834
% 224.13/224.29  |- skos__historyNote mesh__D006835 Hydrazines %28%1966-1971%29%
% 224.13/224.29  |- rdf__type mesh__D006835sskos__Concept
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D006835 2000
% 224.13/224.29  |- mesh__recordMaintainer mesh__D006835 TGC
% 224.13/224.29  |- mesh__recordAuthorizer mesh__D006835 PLS
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D006835 1999
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D006835 2004
% 224.13/224.29  |- skos__historyNote mesh__D020506 RNA, Messenger %28%1975-1998%29%
% 224.13/224.29  |- skos__scopeNote mesh__D020506
% 224.13/224.29       The parts of the messenger RNA sequence that do not code for product, i.e. the 5%27% UNTRANSLATED REGIONS and 3%27% UNTRANSLATED REGIONS.%A%    
% 224.13/224.29  |- skos__broader mesh__D020506smesh__D012333
% 224.13/224.29  |- mesh__historyNote mesh__D020506 99   
% 224.13/224.29  |- rdf__type mesh__D020506sskos__Concept
% 224.13/224.29  |- skos__broader mesh__D020506smesh__D022661
% 224.13/224.29  |- mesh__activeMeSHYear mesh__D020506 2006
% 224.13/224.29  |- mesh__dateRevised mesh__D020506 2005-06-30
% 224.13/224.29  |- skos__hiddenLabel mesh__D020506 Regions, Untranslated
% 224.13/224.29  |- skos__broader mesh__D020506smesh__D021901
% 224.13/224.29  |- mesh__dateCreated mesh__D020506 1998-06-11
% 224.13/224.29  |- mesh__publicMeSHNote mesh__D020506 99   
% 224.13/224.29  |- skos__hiddenLabel mesh__D020506 Region, Untranslated
% 224.13/224.29  |- skos__hiddenLabel mesh__D020506 Untranslated Region
% 224.13/224.29  |- skos__broader mesh__D020506smesh__D040461
% 224.13/224.29  |- skos__altLabel mesh__D020506 UTRs
% 224.13/224.29  |- mesh__recordMaintainer mesh__D020506 nns
% 224.13/224.29  |- mesh__dateEstablished mesh__D020506 1999-01-01
% 224.13/224.29  |- skos__prefLabel mesh__D020506 Untranslated Regions
% 224.13/224.29  |- mesh__recordOriginator mesh__D020506 NNS
% 224.13/224.29  |- mesh__recordAuthorizer mesh__D020506 sjn
% 224.13/224.29  |- skos__hiddenLabel mesh__D050991 Transcription Factor, GATA-4
% 224.13/224.29  |- skos__prefLabel mesh__D050991 GATA4 Transcription Factor
% 224.13/224.29  |- skos__scopeNote mesh__D050991
% 224.13/224.29       A GATA transcription factor that is expressed in the MYOCARDIUM of developing heart and has been implicated in the differentiation of CARDIAC MYOCYTES. GATA4 is activated by PHOSPHORYLATION and regulates transcription of cardiac-specific genes.%A%    
% 224.13/224.29  |- skos__hiddenLabel mesh__D050991 GATA 4 Transcription Factor
% 224.13/224.29  |- skos__broader mesh__D050991smesh__D050980
% 224.13/224.29  |- mesh__recordOriginator mesh__D050991 DRC
% 224.13/224.29  |- skos__altLabel mesh__D050991 GATA-4 Transcription Factor
% 224.13/224.29  |- mesh__recordMaintainer mesh__D050991 DRC
% 224.13/224.29  |- mesh__publicMeSHNote mesh__D050991
% 224.13/224.29       2006; GATA4 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1993-2005%A%  
% 224.13/224.29  |- skos__hiddenLabel mesh__D050991 Factor GATA-4, Transcription
% 224.13/224.29  |- skos__hiddenLabel mesh__D050991 GATA4, Transcription Factor
% 224.13/224.29  |- mesh__dateCreated mesh__D050991 2005-06-30
% 224.13/224.30  |- mesh__historyNote mesh__D050991 2006%28%1993%29%   
% 224.13/224.30  |- skos__hiddenLabel mesh__D050991 Factor GATA4, Transcription
% 224.13/224.30  |- skos__hiddenLabel mesh__D050991 GATA-4, Transcription Factor
% 224.13/224.30  |- skos__altLabel mesh__D050991 Transcription Factor GATA4
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D050991 2006
% 224.13/224.30  |- skos__altLabel mesh__D050991 Transcription Factor GATA-4
% 224.13/224.30  |- mesh__dateEstablished mesh__D050991 2006-01-01
% 224.13/224.30  |- mesh__recordAuthorizer mesh__D050991 sjn
% 224.13/224.30  |- skos__hiddenLabel mesh__D050991 Transcription Factor GATA 4
% 224.13/224.30  |- rdf__type mesh__D050991sskos__Concept
% 224.13/224.30  |- skos__hiddenLabel mesh__D050991 Transcription Factor, GATA4
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006037 1997
% 224.13/224.30  |- skos__altLabel mesh__D006037 Ethanedial
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006037 2005
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006037 1996
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006037 1995
% 224.13/224.30  |- mesh__recordMaintainer mesh__D006037 TGC
% 224.13/224.30  |- skos__altLabel mesh__D006037 Ethanedione
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006037 1994
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006037 2004
% 224.13/224.30  |- rdf__type mesh__D006037sskos__Concept
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006037 2002
% 224.13/224.30  |- mesh__recordOriginator mesh__D006037 NLM
% 224.13/224.30  |- skos__broader mesh__D006037smesh__D000447
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006037 2003
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006037 1999
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006037 2001
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006037 1993
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006037 1998
% 224.13/224.30  |- mesh__dateRevised mesh__D006037 1992-05-19
% 224.13/224.30  |- skos__prefLabel mesh__D006037 Glyoxal
% 224.13/224.30  |- mesh__publicMeSHNote mesh__D006037
% 224.13/224.30       91; was see under ALDEHYDES 1973-90   
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006037 2000
% 224.13/224.30  |- mesh__dateEstablished mesh__D006037 1991-01-01
% 224.13/224.30  |- mesh__recordAuthorizer mesh__D006037 PLS
% 224.13/224.30  |- mesh__dateCreated mesh__D006037 1999-01-01
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006037 2006
% 224.13/224.30  |- mesh__historyNote mesh__D006037
% 224.13/224.30       91%28%73%29%; was see under ALDEHYDES 1973-90   
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D016465 2006
% 224.13/224.30  |- skos__annotation mesh__D016465
% 224.13/224.30       coord IM with purging agent or method %28%IM with no qualif%29%%A%  
% 224.13/224.30  |- skos__broader mesh__D016465smesh__D001781
% 224.13/224.30  |- skos__scopeNote mesh__D016465
% 224.13/224.30       Techniques for the removal of subpopulations of cells %28%usually residual tumor cells%29% from the bone marrow ex vivo before it is infused. The purging is achieved by a variety of agents including pharmacologic agents, biophysical agents %28%laser photoirradiation or radioisotopes%29% and immunologic agents. Bone marrow purging is used in both autologous and allogeneic BONE MARROW TRANSPLANTATION.%A%    
% 224.13/224.30  |- mesh__recordMaintainer mesh__D016465 lkt
% 224.13/224.30  |- mesh__dateEstablished mesh__D016465 1992-01-01
% 224.13/224.30  |- mesh__historyNote mesh__D016465 92   
% 224.13/224.30  |- skos__related mesh__D016465smesh__D018189
% 224.13/224.30  |- rdf__type mesh__D016465sskos__Concept
% 224.13/224.30  |- mesh__dateRevised mesh__D016465 2005-06-30
% 224.13/224.30  |- skos__hiddenLabel mesh__D016465 Purging, Bone Marrow
% 224.13/224.30  |- skos__related mesh__D016465smesh__D018380
% 224.13/224.30  |- mesh__dateCreated mesh__D016465 1991-01-02
% 224.13/224.30  |- mesh__recordOriginator mesh__D016465 AGS
% 224.13/224.30  |- skos__prefLabel mesh__D016465 Bone Marrow Purging
% 224.13/224.30  |- mesh__publicMeSHNote mesh__D016465 92   
% 224.13/224.30  |- skos__historyNote mesh__D016465 Bone Marrow %28%1983-1991%29%
% 224.13/224.30  |- skos__related mesh__D016465smesh__D016026
% 224.13/224.30  |- skos__historyNote mesh__D016465
% 224.13/224.30       Bone Marrow Transplantation %28%1988-1991%29%
% 224.13/224.30  |- mesh__recordAuthorizer mesh__D016465 sjn
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D002445 1993
% 224.13/224.30  |- skos__broader mesh__D002445smesh__D001158
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D002445 2000
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D002445 1996
% 224.13/224.30  |- skos__hiddenLabel mesh__D002445 Arteries, Celiac
% 224.13/224.30  |- skos__hiddenLabel mesh__D002445 Celiac Arteries
% 224.13/224.30  |- mesh__recordOriginator mesh__D002445 NLM
% 224.13/224.30  |- mesh__dateRevised mesh__D002445 1992-05-07
% 224.13/224.30  |- skos__scopeNote mesh__D002445
% 224.13/224.30       The arterial trunk that arises from the abdominal aorta and after a short course divides into the left gastric, common hepatic and splenic arteries.%A%    
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D002445 1999
% 224.13/224.30  |- mesh__recordMaintainer mesh__D002445 TAP
% 224.13/224.30  |- mesh__recordAuthorizer mesh__D002445 PLS
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D002445 1995
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D002445 2004
% 224.13/224.30  |- rdf__type mesh__D002445sskos__Concept
% 224.13/224.30  |- skos__prefLabel mesh__D002445 Celiac Artery
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D002445 2002
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D002445 1998
% 224.13/224.30  |- skos__hiddenLabel mesh__D002445 Artery, Celiac
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D002445 1994
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D002445 2003
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D002445 2006
% 224.13/224.30  |- mesh__dateCreated mesh__D002445 1999-01-01
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D002445 2001
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D002445 1997
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D002445 2005
% 224.13/224.30  |- mesh__publicMeSHNote mesh__D007130 79   
% 224.13/224.30  |- rdf__type mesh__D007130sskos__Concept
% 224.13/224.30  |- mesh__recordOriginator mesh__D007130 AEP
% 224.13/224.30  |- mesh__recordMaintainer mesh__D007130 ssb
% 224.13/224.30  |- skos__annotation mesh__D007130 DF: IG IDIOTYPES   
% 224.13/224.30  |- mesh__dateCreated mesh__D007130 1978-01-27
% 224.13/224.30  |- mesh__dateRevised mesh__D007130 2005-06-30
% 224.13/224.30  |- mesh__dateEstablished mesh__D007130 1979-01-01
% 224.13/224.30  |- skos__historyNote mesh__D007130
% 224.13/224.30       Binding Sites, Antibody %28%1973-1978%29%
% 224.13/224.30  |- skos__historyNote mesh__D007130 Antibody Specificity %28%1970-1978%29%
% 224.13/224.30  |- skos__broader mesh__D007130smesh__D007128
% 224.13/224.30  |- skos__prefLabel mesh__D007130 Immunoglobulin Idiotypes
% 224.13/224.30  |- skos__historyNote mesh__D007130 Anti-Antibodies %28%1966-1969%29%
% 224.13/224.30  |- mesh__recordAuthorizer mesh__D007130 sjn
% 224.13/224.30  |- skos__hiddenLabel mesh__D007130 Immunoglobulin Idiotype
% 224.13/224.30  |- skos__altLabel mesh__D007130 Idiotypes, Immunoglobulin
% 224.13/224.30  |- skos__broader mesh__D007130smesh__D007125
% 224.13/224.30  |- mesh__historyNote mesh__D007130 79   
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D007130 2006
% 224.13/224.30  |- skos__scopeNote mesh__D007130
% 224.13/224.30       Unique, genetically controlled determinants present on ANTIBODIES whose specificity is limited to a single group of proteins %28%e.g., another antibody molecule or an individual myeloma protein%29%. The idiotype appears to represent the antigenicity of the antigen-binding site of the antibody and to be genetically codetermined with it. The idiotypic determinants have been precisely located to the IMMUNOGLOBULIN VARIABLE REGION of both immunoglobin polypeptide chains.%A%    
% 224.13/224.30  |- skos__hiddenLabel mesh__D007130 Idiotype, Immunoglobulin
% 224.13/224.30  |- skos__broader mesh__D007130smesh__D000939
% 224.13/224.30  |- skos__historyNote mesh__D007130 Antigenic Determinants %28%1970-1978%29%
% 224.13/224.30  |- skos__hiddenLabel mesh__D012873 Genetic Skin Disease
% 224.13/224.30  |- mesh__dateEstablished mesh__D012873 1998-01-01
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012873 2005
% 224.13/224.30  |- mesh__dateCreated mesh__D012873 1999-01-01
% 224.13/224.30  |- skos__scopeNote mesh__D012873
% 224.13/224.30       Diseases of the skin with a genetic component, usually the result of various inborn errors of metabolism.%A%    
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012873 2006
% 224.13/224.30  |- skos__prefLabel mesh__D012873 Skin Diseases, Genetic
% 224.13/224.30  |- skos__hiddenLabel mesh__D012873 Diseases, Genetic Skin
% 224.13/224.30  |- skos__broader mesh__D012873smesh__D012871
% 224.13/224.30  |- mesh__recordOriginator mesh__D012873 NLM
% 224.13/224.30  |- mesh__recordAuthorizer mesh__D012873 sjn
% 224.13/224.30  |- skos__broader mesh__D012873smesh__D030342
% 224.13/224.30  |- mesh__publicMeSHNote mesh__D012873 98   
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012873 2003
% 224.13/224.30  |- skos__historyNote mesh__D012873 Skin Diseases %28%1975-1997%29%
% 224.13/224.30  |- skos__altLabel mesh__D012873 Genetic Skin Diseases
% 224.13/224.30  |- rdf__type mesh__D012873sskos__Concept
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012873 2004
% 224.13/224.30  |- mesh__recordMaintainer mesh__D012873 nns
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012873 2002
% 224.13/224.30  |- mesh__historyNote mesh__D012873 98; use explode 1970-97   
% 224.13/224.30  |- mesh__dateRevised mesh__D012873 2001-07-25
% 224.13/224.30  |- skos__annotation mesh__D012873
% 224.13/224.30       GEN or unspecified; prefer specifics; DF: SKIN DIS GENET   
% 224.13/224.30  |- skos__hiddenLabel mesh__D012873 Disease, Genetic Skin
% 224.13/224.30  |- skos__hiddenLabel mesh__D012873 Skin Disease, Genetic
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012075 2004
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012075 2001
% 224.13/224.30  |- mesh__historyNote mesh__D012075
% 224.13/224.30       91%28%82%29%; was see under DISEASE 1982-90; was REMISSION see under DISEASE 1975-81; was REMISSION 1971-74 %28%Prov%29%%A%  
% 224.13/224.30  |- mesh__dateEstablished mesh__D012075 1991-01-01
% 224.13/224.30  |- skos__hiddenLabel mesh__D012075 Remissions, Spontaneous
% 224.13/224.30  |- skos__hiddenLabel mesh__D012075 Spontaneous Remissions
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012075 2002
% 224.13/224.30  |- skos__scopeNote mesh__D012075
% 224.13/224.30       A spontaneous diminution or abatement of the symptoms of a disease.%A%    
% 224.13/224.30  |- skos__related mesh__D012075smesh__D020127
% 224.13/224.30  |- mesh__dateCreated mesh__D012075 1999-01-01
% 224.13/224.30  |- skos__hiddenLabel mesh__D012075 Spontaneous Remission
% 224.13/224.30  |- skos__related mesh__D012075smesh__D012074
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012075 2005
% 224.13/224.30  |- mesh__recordOriginator mesh__D012075 NLM
% 224.13/224.30  |- skos__prefLabel mesh__D012075 Remission, Spontaneous
% 224.13/224.30  |- rdf__type mesh__D012075sskos__Concept
% 224.13/224.30  |- mesh__onlineNote mesh__D012075
% 224.13/224.30       use REMISSION, SPONTANEOUS to search REMISSION 1971-81 %28%as Prov 1971-74%29%%A%  
% 224.13/224.30  |- skos__broader mesh__D012075smesh__D001686
% 224.13/224.30  |- mesh__recordAuthorizer mesh__D012075 sjn
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012075 2003
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012075 2006
% 224.13/224.30  |- mesh__dateRevised mesh__D012075 1999-11-08
% 224.13/224.30  |- skos__annotation mesh__D012075
% 224.13/224.30       never IM; do not confuse with REGRESSION %28%PSYCHOLOGY%29%   
% 224.13/224.30  |- mesh__publicMeSHNote mesh__D012075
% 224.13/224.30       91; was see under DISEASE 1982-90; was REMISSION see under DISEASE 1975-81%A%  
% 224.13/224.30  |- mesh__recordMaintainer mesh__D012075 KEV
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012075 2000
% 224.13/224.30  |- skos__scopeNote mesh__D006836
% 224.13/224.30       Enzymes that catalyze the breakage of a carbon-oxygen bond leading to unsaturated products via the removal of water. EC 4.2.1.%A%    
% 224.13/224.30  |- skos__altLabel mesh__D006836 Dehydratases
% 224.13/224.30  |- skos__prefLabel mesh__D006836 Hydro-Lyases
% 224.13/224.30  |- skos__altLabel mesh__D006836 Hydrases
% 224.13/224.30  |- mesh__recordAuthorizer mesh__D006836 sjn
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006836 2006
% 224.13/224.30  |- mesh__dateCreated mesh__D006836 1999-01-01
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006836 2005
% 224.13/224.30  |- mesh__recordMaintainer mesh__D006836 ssb
% 224.13/224.30  |- skos__altLabel mesh__D006836 Hydro Lyases
% 224.13/224.30  |- mesh__recordOriginator mesh__D006836 NLM
% 224.13/224.30  |- mesh__dateRevised mesh__D006836 2003-07-09
% 224.13/224.30  |- rdf__type mesh__D006836sskos__Concept
% 224.13/224.30  |- skos__hiddenLabel mesh__D006836 Lyases, Hydro
% 224.13/224.30  |- skos__broader mesh__D006836smesh__D019757
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006836 2004
% 224.13/224.30  |- skos__annotation mesh__D006836 do not confuse with HYDROLASES   
% 224.13/224.30  |- rdf__type mesh__D020507sskos__Concept
% 224.13/224.30  |- mesh__dateEstablished mesh__D020507 1999-01-01
% 224.13/224.30  |- skos__altLabel mesh__D020507 Sourcebooks %28%PT%29%
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D020507 2006
% 224.13/224.30  |- skos__altLabel mesh__D020507 Resource Guides %28%PT%29%
% 224.13/224.30  |- skos__related mesh__D020507smesh__D020479
% 224.13/224.30  |- skos__related mesh__D020507smesh__D020504
% 224.13/224.30  |- mesh__recordAuthorizer mesh__D020507 sjn
% 224.13/224.30  |- mesh__recordMaintainer mesh__D020507 jls
% 224.13/224.30  |- skos__related mesh__D020507smesh__D016435
% 224.13/224.30  |- skos__scopeNote mesh__D020507
% 224.13/224.30       Works listing and describing various sources of information, from multiple media or in different formats, on a given subject.%A%    
% 224.13/224.30  |- mesh__historyNote mesh__D020507 1999   
% 224.13/224.30  |- skos__related mesh__D020507smesh__D016417
% 224.13/224.30  |- skos__related mesh__D020507smesh__D020481
% 224.13/224.30  |- mesh__dateRevised mesh__D020507 2005-06-30
% 224.13/224.30  |- skos__related mesh__D020507smesh__D019494
% 224.13/224.30  |- skos__prefLabel mesh__D020507 Resource Guides %5B%Publication Type%5D%
% 224.13/224.30  |- mesh__dateCreated mesh__D020507 1998-06-03
% 224.13/224.30  |- skos__broader mesh__D020507smesh__D052180
% 224.13/224.30  |- mesh__recordOriginator mesh__D020507 JLS
% 224.13/224.30  |- mesh__dateEstablished mesh__D050992 2006-01-01
% 224.13/224.30  |- skos__hiddenLabel mesh__D050992 GATA 5 Protein
% 224.13/224.30  |- mesh__recordOriginator mesh__D050992 DRC
% 224.13/224.30  |- mesh__recordAuthorizer mesh__D050992 sjn
% 224.13/224.30  |- skos__altLabel mesh__D050992 GATA Binding Protein 5
% 224.13/224.30  |- skos__altLabel mesh__D050992 GATA-5 Protein
% 224.13/224.30  |- skos__hiddenLabel mesh__D050992 Transcription Factor, GATA5
% 224.13/224.30  |- skos__broader mesh__D050992smesh__D050980
% 224.13/224.30  |- skos__scopeNote mesh__D050992
% 224.13/224.30       A GATA transcription factor that is expressed predominately in SMOOTH MUSCLE CELLS and is involved in the CELL DIFFERENTIATION of CARDIAC MYOCYTES. In the developing heart, GATA5 becomes restricted to the ENDOCARDIUM and regulates transcription of genes such as cardiac TROPONIN C.%A%    
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D050992 2006
% 224.13/224.30  |- mesh__recordMaintainer mesh__D050992 DRC
% 224.13/224.30  |- skos__altLabel mesh__D050992 GATA5 Protein
% 224.13/224.30  |- rdf__type mesh__D050992sskos__Concept
% 224.13/224.30  |- mesh__dateCreated mesh__D050992 2005-06-30
% 224.13/224.30  |- mesh__historyNote mesh__D050992 2006%28%1994%29%   
% 224.13/224.30  |- skos__prefLabel mesh__D050992 GATA5 Transcription Factor
% 224.13/224.30  |- mesh__publicMeSHNote mesh__D050992
% 224.13/224.30       2006; GATA5 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1994-2005%A%  
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006038 1997
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006038 1994
% 224.13/224.30  |- mesh__recordMaintainer mesh__D006038 TGC
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006038 2003
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006038 1995
% 224.13/224.30  |- mesh__publicMeSHNote mesh__D006038 66   
% 224.13/224.30  |- skos__broader mesh__D006038smesh__D000145
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006038 1998
% 224.13/224.30  |- mesh__dateEstablished mesh__D006038 1966-01-01
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006038 2004
% 224.13/224.30  |- rdf__type mesh__D006038sskos__Concept
% 224.13/224.30  |- skos__prefLabel mesh__D006038 Glyoxylates
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006038 2002
% 224.13/224.30  |- mesh__dateCreated mesh__D006038 1999-01-01
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006038 1999
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006038 1993
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006038 2005
% 224.13/224.30  |- mesh__dateRevised mesh__D006038 1992-05-19
% 224.13/224.30  |- mesh__historyNote mesh__D006038 66   
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006038 1996
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006038 2000
% 224.13/224.30  |- mesh__recordAuthorizer mesh__D006038 PLS
% 224.13/224.30  |- mesh__recordOriginator mesh__D006038 NLM
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006038 2006
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D006038 2001
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D016466 2004
% 224.13/224.30  |- mesh__recordAuthorizer mesh__D016466 sjn
% 224.13/224.30  |- mesh__historyNote mesh__D016466 92   
% 224.13/224.30  |- rdf__type mesh__D016466sskos__Concept
% 224.13/224.30  |- skos__hiddenLabel mesh__D016466 Cell, CHO
% 224.13/224.30  |- skos__annotation mesh__D016466
% 224.13/224.30       CHO stands for %22%Chinese Hamster Ovary%22%; almost always NIM with no subheadings; check ANIMALS %26% add HAMSTERS, CHINESE %28%NIM%29%; do not routinely add OVARY%A%  
% 224.13/224.30  |- mesh__recordMaintainer mesh__D016466 nns
% 224.13/224.30  |- mesh__dateRevised mesh__D016466 2003-07-30
% 224.13/224.30  |- mesh__dateCreated mesh__D016466 1991-01-02
% 224.13/224.30  |- skos__broader mesh__D016466smesh__D004847
% 224.13/224.30  |- skos__broader mesh__D016466smesh__D002460
% 224.13/224.30  |- mesh__dateEstablished mesh__D016466 1992-01-01
% 224.13/224.30  |- skos__hiddenLabel mesh__D016466 CHO Cell
% 224.13/224.30  |- skos__prefLabel mesh__D016466 CHO Cells
% 224.13/224.30  |- skos__scopeNote mesh__D016466
% 224.13/224.30       CELL LINE derived from the ovary of the Chinese hamster, Cricetulus griseus %28%CRICETULUS%29%. The species is a favorite for cytogenetic studies because of its small chromosome number. The cell line has provided model systems for the study of genetic alterations in cultured mammalian cells.%A%    
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D016466 2005
% 224.13/224.30  |- skos__historyNote mesh__D016466 Cell Line %28%1972-1991%29%
% 224.13/224.30  |- mesh__recordOriginator mesh__D016466 AGS
% 224.13/224.30  |- mesh__publicMeSHNote mesh__D016466 92   
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D016466 2006
% 224.13/224.30  |- skos__hiddenLabel mesh__D016466 Cells, CHO
% 224.13/224.30  |- mesh__recordOriginator mesh__D002446 NLM
% 224.13/224.30  |- skos__altLabel mesh__D002446 Sprue, Nontropical
% 224.13/224.30  |- mesh__recordMaintainer mesh__D002446 lkt
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D002446 2005
% 224.13/224.30  |- skos__hiddenLabel mesh__D002446 Celiac Sprue
% 224.13/224.30  |- skos__related mesh__D002446smesh__D013182
% 224.13/224.30  |- skos__hiddenLabel mesh__D002446 Enteropathy, Gluten
% 224.13/224.30  |- skos__altLabel mesh__D002446 Gluten Enteropathy
% 224.13/224.30  |- rdf__type mesh__D002446sskos__Concept
% 224.13/224.30  |- skos__hiddenLabel mesh__D002446 Disease, Celiac
% 224.13/224.30  |- skos__scopeNote mesh__D002446
% 224.13/224.30       A malabsorption syndrome that is precipitated by the ingestion of GLUTEN-containing foods, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION.%A%    
% 224.13/224.30  |- skos__hiddenLabel mesh__D002446 Gluten Enteropathies
% 224.13/224.30  |- skos__hiddenLabel mesh__D002446 Enteropathy, Gluten-Sensitive
% 224.13/224.30  |- skos__altLabel mesh__D002446 Gluten-Sensitive Enteropathy
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D002446 2004
% 224.13/224.30  |- skos__altLabel mesh__D002446 Sprue, Celiac
% 224.13/224.30  |- skos__related mesh__D002446smesh__D021182
% 224.13/224.30  |- skos__broader mesh__D002446smesh__D008286
% 224.13/224.30  |- skos__prefLabel mesh__D002446 Celiac Disease
% 224.13/224.30  |- mesh__dateCreated mesh__D002446 1999-01-01
% 224.13/224.30  |- skos__annotation mesh__D002446 do not confuse with SPRUE, TROPICAL   
% 224.13/224.30  |- skos__hiddenLabel mesh__D002446 Gluten Sensitive Enteropathy
% 224.13/224.30  |- skos__hiddenLabel mesh__D002446 Enteropathies, Gluten-Sensitive
% 224.13/224.30  |- skos__hiddenLabel mesh__D002446 Gluten-Sensitive Enteropathies
% 224.13/224.30  |- mesh__recordAuthorizer mesh__D002446 sjn
% 224.13/224.30  |- skos__hiddenLabel mesh__D002446 Nontropical Sprue
% 224.13/224.30  |- mesh__dateRevised mesh__D002446 2003-07-09
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D002446 2006
% 224.13/224.30  |- skos__hiddenLabel mesh__D002446 Enteropathies, Gluten
% 224.13/224.30  |- mesh__recordAuthorizer mesh__D007131 sjn
% 224.13/224.30  |- skos__broader mesh__D007131smesh__D007145
% 224.13/224.30  |- skos__hiddenLabel mesh__D007131 Allotypes, Immunoglobulin Km
% 224.13/224.30  |- skos__hiddenLabel mesh__D007131 Allotype, Km
% 224.13/224.30  |- skos__altLabel mesh__D007131 Allotypes, Immunoglobulin Inv
% 224.13/224.30  |- skos__hiddenLabel mesh__D007131 Allotypes, Inv
% 224.13/224.30  |- mesh__recordOriginator mesh__D007131 SCD
% 224.13/224.30  |- skos__hiddenLabel mesh__D007131 Inv Allotypes, Immunoglobulin
% 224.13/224.30  |- skos__altLabel mesh__D007131 Inv Allotypes
% 224.13/224.30  |- mesh__publicMeSHNote mesh__D007131
% 224.13/224.30       2006; see IMMUNOGLOBULIN INV ALLOTYPES 1987-2005   
% 224.13/224.30  |- skos__hiddenLabel mesh__D007131 Immunoglobulin Km Allotype
% 224.13/224.30  |- skos__altLabel mesh__D007131 Km Allotypes
% 224.13/224.30  |- mesh__recordMaintainer mesh__D007131 sjn
% 224.13/224.30  |- skos__broader mesh__D007131smesh__D007126
% 224.13/224.30  |- skos__scopeNote mesh__D007131
% 224.13/224.30       Allelic variants of the kappa light chains %28%IMMUNOGLOBULIN KAPPA-CHAINS%29% encoded by ALLELES of IMMUNOGLOBULIN LIGHT CHAIN GENES.%A%    
% 224.13/224.30  |- mesh__dateRevised mesh__D007131 2005-07-01
% 224.13/224.30  |- skos__hiddenLabel mesh__D007131 Km Allotype
% 224.13/224.30  |- skos__hiddenLabel mesh__D007131 Km Allotype, Immunoglobulin
% 224.13/224.30  |- skos__hiddenLabel mesh__D007131 Allotype, Immunoglobulin Inv
% 224.13/224.30  |- skos__hiddenLabel mesh__D007131 Immunoglobulin Inv Allotype
% 224.13/224.30  |- skos__hiddenLabel mesh__D007131 Inv Allotype
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D007131 2006
% 224.13/224.30  |- mesh__dateEstablished mesh__D007131 1987-01-01
% 224.13/224.30  |- skos__hiddenLabel mesh__D007131 Inv Allotype, Immunoglobulin
% 224.13/224.30  |- skos__hiddenLabel mesh__D007131 Allotypes, Km
% 224.13/224.30  |- skos__altLabel mesh__D007131 Immunoglobulin Inv Allotypes
% 224.13/224.30  |- skos__hiddenLabel mesh__D007131 Allotype, Inv
% 224.13/224.30  |- mesh__historyNote mesh__D007131 2006 %28%1987%29%   
% 224.13/224.30  |- skos__prefLabel mesh__D007131 Immunoglobulin Km Allotypes
% 224.13/224.30  |- mesh__dateCreated mesh__D007131 1986-06-19
% 224.13/224.30  |- skos__hiddenLabel mesh__D007131 Allotype, Immunoglobulin Km
% 224.13/224.30  |- rdf__type mesh__D007131sskos__Concept
% 224.13/224.30  |- skos__hiddenLabel mesh__D007131 Km Allotypes, Immunoglobulin
% 224.13/224.30  |- rdf__type mesh__D048548sskos__Concept
% 224.13/224.30  |- skos__hiddenLabel mesh__D048548 Baboons, Yellow
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D048548 2006
% 224.13/224.30  |- mesh__historyNote mesh__D048548 2005   
% 224.13/224.30  |- skos__hiddenLabel mesh__D048548 Yellow Baboons
% 224.13/224.30  |- skos__historyNote mesh__D048548 Haplorhini %28%1966-1971%29%
% 224.13/224.30  |- mesh__publicMeSHNote mesh__D048548 2005   
% 224.13/224.30  |- mesh__recordOriginator mesh__D048548 ags
% 224.13/224.30  |- skos__altLabel mesh__D048548 Yellow Baboon
% 224.13/224.30  |- mesh__dateEstablished mesh__D048548 2005-01-01
% 224.13/224.30  |- skos__scopeNote mesh__D048548
% 224.13/224.30       A species of baboon in the family CERCOPITHECIDAE found in southern equatorial and east Africa. They are smaller than PAPIO ANUBIS and have a thinner mane.%A%    
% 224.13/224.30  |- mesh__recordAuthorizer mesh__D048548 sjn
% 224.13/224.30  |- skos__prefLabel mesh__D048548 Papio cynocephalus
% 224.13/224.30  |- skos__broader mesh__D048548smesh__D010215
% 224.13/224.30  |- skos__hiddenLabel mesh__D048548 Baboon, Yellow
% 224.13/224.30  |- skos__historyNote mesh__D048548 Papio %28%1972-2004%29%
% 224.13/224.30  |- mesh__dateRevised mesh__D048548 2005-06-30
% 224.13/224.30  |- mesh__dateCreated mesh__D048548 2004-07-07
% 224.13/224.30  |- mesh__recordMaintainer mesh__D048548 ags
% 224.13/224.30  |- skos__scopeNote mesh__D012874
% 224.13/224.30       Skin diseases caused by bacteria, fungi, parasites, or viruses.%A%    
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012874 1997
% 224.13/224.30  |- skos__prefLabel mesh__D012874 Skin Diseases, Infectious
% 224.13/224.30  |- mesh__dateCreated mesh__D012874 1999-01-01
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012874 2000
% 224.13/224.30  |- skos__hiddenLabel mesh__D012874 Diseases, Infectious Skin
% 224.13/224.30  |- skos__altLabel mesh__D012874 Infectious Skin Diseases
% 224.13/224.30  |- mesh__recordAuthorizer mesh__D012874 PLS
% 224.13/224.30  |- mesh__recordOriginator mesh__D012874 NLM
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012874 2005
% 224.13/224.30  |- skos__annotation mesh__D012874
% 224.13/224.30       GEN or unspecified; prefer specifics; coord IM with specific infect dis %28%IM%29% + site %28%NIM%29% but note precoord site terms in note on SKIN DISEASES; bacterial = SKIN DISEASES, BACTERIAL, viral = SKIN DISEASES, VIRAL, parasitic = SKIN DISEASES, PARASITIC, fungal = DERMATOMYCOSES%A%  
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012874 2001
% 224.13/224.30  |- mesh__publicMeSHNote mesh__D012874 68   
% 224.13/224.30  |- skos__broader mesh__D012874smesh__D007239
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012874 2006
% 224.13/224.30  |- mesh__dateEstablished mesh__D012874 1968-01-01
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012874 1998
% 224.13/224.30  |- skos__hiddenLabel mesh__D012874 Skin Disease, Infectious
% 224.13/224.30  |- skos__hiddenLabel mesh__D012874 Disease, Infectious Skin
% 224.13/224.30  |- skos__broader mesh__D012874smesh__D012871
% 224.13/224.30  |- skos__historyNote mesh__D012874 specific skin disease %28%1966-1967%29%
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012874 2003
% 224.13/224.30  |- rdf__type mesh__D012874sskos__Concept
% 224.13/224.30  |- mesh__recordMaintainer mesh__D012874 TGC
% 224.13/224.30  |- skos__hiddenLabel mesh__D012874 Infectious Skin Disease
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012874 1999
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012874 2002
% 224.13/224.30  |- mesh__dateRevised mesh__D012874 1996-06-10
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012874 2004
% 224.13/224.30  |- mesh__historyNote mesh__D012874 68   
% 224.13/224.30  |- skos__hiddenLabel mesh__D050993 Transcription Factor, GATA6
% 224.13/224.30  |- skos__hiddenLabel mesh__D050993 GATA-6, Transcription Factor
% 224.13/224.30  |- skos__hiddenLabel mesh__D050993 GATA6, Transcription Factor
% 224.13/224.30  |- mesh__dateCreated mesh__D050993 2005-06-30
% 224.13/224.30  |- skos__hiddenLabel mesh__D050993 Factor, GATA-6 Transcription
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D050993 2006
% 224.13/224.30  |- skos__hiddenLabel mesh__D050993 Transcription Factor GATA 6
% 224.13/224.30  |- mesh__dateEstablished mesh__D050993 2006-01-01
% 224.13/224.30  |- mesh__historyNote mesh__D050993 2006%28%1994%29%   
% 224.13/224.30  |- rdf__type mesh__D050993sskos__Concept
% 224.13/224.30  |- skos__scopeNote mesh__D050993
% 224.13/224.30       A GATA transcription factor that is expressed predominately in SMOOTH MUSCLE CELLS and regulates vascular smooth muscle CELL DIFFERENTIATION.%A%    
% 224.13/224.30  |- skos__hiddenLabel mesh__D050993 GATA 6 Transcription Factor
% 224.13/224.30  |- mesh__publicMeSHNote mesh__D050993
% 224.13/224.30       2006; GATA6 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1994-2005%A%  
% 224.13/224.30  |- skos__altLabel mesh__D050993 Transcription Factor GATA-6
% 224.13/224.30  |- skos__altLabel mesh__D050993 Transcription Factor GATA6
% 224.13/224.30  |- mesh__recordAuthorizer mesh__D050993 sjn
% 224.13/224.30  |- skos__hiddenLabel mesh__D050993 Transcription Factor, GATA-6
% 224.13/224.30  |- mesh__recordOriginator mesh__D050993 DRC
% 224.13/224.30  |- skos__hiddenLabel mesh__D050993 Factor GATA6, Transcription
% 224.13/224.30  |- mesh__recordMaintainer mesh__D050993 DRC
% 224.13/224.30  |- skos__broader mesh__D050993smesh__D050980
% 224.13/224.30  |- skos__prefLabel mesh__D050993 GATA6 Transcription Factor
% 224.13/224.30  |- skos__altLabel mesh__D050993 GATA-6 Transcription Factor
% 224.13/224.30  |- skos__broader mesh__D004064Q000502smesh__D004064
% 224.13/224.30  |- mesh__preferredCombination mesh__D004064Q000502smesh__D004068
% 224.13/224.30  |- rdf__type mesh__D004064Q000502smesh__CompoundConcept
% 224.13/224.30  |- mesh__recordAuthorizer mesh__D012076 sjn
% 224.13/224.30  |- skos__prefLabel mesh__D012076 Renal Agents
% 224.13/224.30  |- mesh__dateCreated mesh__D012076 1999-01-01
% 224.13/224.30  |- skos__broader mesh__D012076smesh__D045506
% 224.13/224.30  |- skos__hiddenLabel mesh__D012076 Agents, Renal
% 224.13/224.30  |- rdf__type mesh__D012076sskos__Concept
% 224.13/224.30  |- mesh__dateEstablished mesh__D012076 1996-01-01
% 224.13/224.30  |- mesh__activeMeSHYear mesh__D012076 2006
% 224.13/224.30  |- mesh__recordMaintainer mesh__D012076 ssb
% 224.13/224.31  |- mesh__publicMeSHNote mesh__D012076 96   
% 224.13/224.31  |- mesh__dateRevised mesh__D012076 2005-06-30
% 224.13/224.31  |- mesh__historyNote mesh__D012076 96; was NON MESH 1975-95   
% 224.13/224.31  |- skos__scopeNote mesh__D012076
% 224.13/224.31       Drugs used for their effects on the kidneys%27% regulation of body fluid composition and volume. The most commonly used are the diuretics. Also included are drugs used for their antidiuretic and uricosuric actions, for their effects on the kidneys%27% clearance of other drugs, and for diagnosis of renal function.%A%    
% 224.13/224.31  |- mesh__recordOriginator mesh__D012076 NLM
% 224.13/224.31  |- skos__annotation mesh__D006837
% 224.13/224.31       a vesiculobullous skin dis on sun-exposed skin   
% 224.13/224.31  |- mesh__dateRevised mesh__D006837 1993-06-02
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D006837 1996
% 224.13/224.31  |- mesh__recordMaintainer mesh__D006837 TAP
% 224.13/224.31  |- rdf__type mesh__D006837sskos__Concept
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D006837 2001
% 224.13/224.31  |- skos__prefLabel mesh__D006837 Hydroa Vacciniforme
% 224.13/224.31  |- skos__broader mesh__D006837smesh__D012872
% 224.13/224.31  |- skos__scopeNote mesh__D006837
% 224.13/224.31       A vesicular and bullous eruption having a tendency to recur in summer during childhood and commonly appearing on sun-exposed skin. The lesions are surrounded by an erythematous zone and resemble a vaccination. %28%From Dorland, 27th ed%29%%A%    
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D006837 1999
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D006837 2004
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D006837 2000
% 224.13/224.31  |- mesh__recordAuthorizer mesh__D006837 PLS
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D006837 1998
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D006837 2003
% 224.13/224.31  |- skos__broader mesh__D006837smesh__D010787
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D006837 1995
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D006837 2006
% 224.13/224.31  |- mesh__dateCreated mesh__D006837 1999-01-01
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D006837 1994
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D006837 2002
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D006837 1997
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D006837 2005
% 224.13/224.31  |- mesh__recordOriginator mesh__D006837 NLM
% 224.13/224.31  |- mesh__recordOriginator mesh__D020508 AGS
% 224.13/224.31  |- skos__prefLabel mesh__D020508 Fungi, Unclassified
% 224.13/224.31  |- mesh__recordMaintainer mesh__D020508 SYSTEM
% 224.13/224.31  |- skos__broader mesh__D020508smesh__D005658
% 224.13/224.31  |- mesh__dateEstablished mesh__D020508 1999-01-01
% 224.13/224.31  |- mesh__dateCreated mesh__D020508 1998-06-10
% 224.13/224.31  |- mesh__recordAuthorizer mesh__D020508 sjn
% 224.13/224.31  |- rdf__type mesh__D020508sskos__Concept
% 224.13/224.31  |- skos__annotation mesh__D020508
% 224.13/224.31       author will state %22%unclassified%22%; do not confuse with fungi %22%unnamed%22% or unspecified by author %28%= probably FUNGI%29%; GEN: avoid; infections by unclassified fungi: coord IM with MYCOSES or specific mycosis %28%IM%29%%A%  
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D020508 2006
% 224.13/224.31  |- skos__scopeNote mesh__D020508
% 224.13/224.31       Fungi whose taxonomic relationships have not been authoritatively established.%A%    
% 224.13/224.31  |- mesh__historyNote mesh__D020508 99   
% 224.13/224.31  |- mesh__dateRevised mesh__D020508 2005-06-30
% 224.13/224.31  |- mesh__publicMeSHNote mesh__D020508 99   
% 224.13/224.31  |- rdf__type mesh__D031230sskos__Concept
% 224.13/224.31  |- skos__prefLabel mesh__D031230 Ananas
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D031230 2005
% 224.13/224.31  |- mesh__publicMeSHNote mesh__D031230 2003   
% 224.13/224.31  |- mesh__historyNote mesh__D031230 2003   
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D031230 2006
% 224.13/224.31  |- skos__broader mesh__D031230smesh__D031229
% 224.13/224.31  |- skos__annotation mesh__D031230
% 224.13/224.31       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.13/224.31  |- skos__scopeNote mesh__D031230
% 224.13/224.31       A plant genus of the family BROMELIACEAE known for the edible fruit that is the source of BROMELAINS.%A%    
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D031230 2003
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D031230 2004
% 224.13/224.31  |- mesh__dateEstablished mesh__D031230 2003-01-01
% 224.13/224.31  |- mesh__dateCreated mesh__D031230 2002-07-02
% 224.13/224.31  |- mesh__dateEstablished mesh__D006039 1991-01-01
% 224.13/224.31  |- mesh__recordOriginator mesh__D006039 NLM
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D006039 2004
% 224.13/224.31  |- skos__broader mesh__D006039smesh__D013802
% 224.13/224.31  |- rdf__type mesh__D006039sskos__Concept
% 224.13/224.31  |- mesh__dateRevised mesh__D006039 2003-07-09
% 224.13/224.31  |- mesh__dateCreated mesh__D006039 1999-01-01
% 224.13/224.31  |- mesh__recordMaintainer mesh__D006039 ags
% 224.13/224.31  |- mesh__historyNote mesh__D006039
% 224.13/224.31       91%28%75%29%; was see under THELAZIOIDEA 1986-90; was see under SPIRUROIDEA 1963-85%A%  
% 224.13/224.31  |- mesh__onlineNote mesh__D006039 search SPIRUROIDEA 1966-74   
% 224.13/224.31  |- skos__scopeNote mesh__D006039
% 224.13/224.31       A genus of parasitic nematodes that occurs in mammals including man. Infection in humans is either by larvae penetrating the skin or by ingestion of uncooked fish.%A%    
% 224.13/224.31  |- skos__annotation mesh__D006039
% 224.13/224.31       a genus of nematodes; infection: coord IM with SPIRURIDA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D006039 2005
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D006039 2006
% 224.13/224.31  |- mesh__publicMeSHNote mesh__D006039
% 224.13/224.31       91; was see under THELAZIOIDEA 1986-90; was see under SPIRUROIDEA 1963-85%A%  
% 224.13/224.31  |- mesh__recordAuthorizer mesh__D006039 sjn
% 224.13/224.31  |- skos__prefLabel mesh__D006039 Gnathostoma
% 224.13/224.31  |- mesh__dateRevised mesh__D016467 2005-06-30
% 224.13/224.31  |- skos__broader mesh__D016467smesh__D052180
% 224.13/224.31  |- skos__annotation mesh__D016467 not used for indexing or cataloging   
% 224.13/224.31  |- mesh__dateEstablished mesh__D016467 1996-01-01
% 224.13/224.31  |- mesh__recordMaintainer mesh__D016467 jls
% 224.13/224.31  |- skos__prefLabel mesh__D016467 Monograph %5B%Publication Type%5D%
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D016467 2006
% 224.13/224.31  |- skos__altLabel mesh__D016467 Monograph %28%PT%29%
% 224.13/224.31  |- mesh__recordAuthorizer mesh__D016467 sjn
% 224.13/224.31  |- skos__altLabel mesh__D016467 Monograph
% 224.13/224.31  |- mesh__dateCreated mesh__D016467 1995-06-23
% 224.13/224.31  |- mesh__historyNote mesh__D016467
% 224.13/224.31       1991; was citation type MONOGRAPH 1976-1981   
% 224.13/224.31  |- skos__scopeNote mesh__D016467
% 224.13/224.31       Work that is any publication that is not a serial or integrating resource. In cataloging usage, It is usually on a single subject or related subjects and is complete in itself, whether constructed of chapters, sections, or parts. While any article encountered in indexing journals can be, strictly speaking, a monograph, as a publication type, a monograph will refer to a cataloging item.%A%    
% 224.13/224.31  |- rdf__type mesh__D016467sskos__Concept
% 224.13/224.31  |- mesh__recordOriginator mesh__D016467 PLS
% 224.13/224.31  |- skos__broader mesh__D035621smesh__D012961
% 224.13/224.31  |- mesh__dateEstablished mesh__D035621 2003-01-01
% 224.13/224.31  |- rdf__type mesh__D035621sskos__Concept
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D035621 2005
% 224.13/224.31  |- skos__broader mesh__D035621smesh__D006809
% 224.13/224.31  |- skos__related mesh__D035621smesh__D012067
% 224.13/224.31  |- mesh__publicMeSHNote mesh__D035621 2003   
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D035621 2006
% 224.13/224.31  |- mesh__historyNote mesh__D035621 2003   
% 224.13/224.31  |- skos__scopeNote mesh__D035621
% 224.13/224.31       Indifference to, or rejection of, RELIGION or religious considerations. %28%From Merriam-Webster%27%s Collegiate Dictionary, 10th ed%29%%A%    
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D035621 2003
% 224.13/224.31  |- skos__prefLabel mesh__D035621 Secularism
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D035621 2004
% 224.13/224.31  |- mesh__dateCreated mesh__D035621 2002-07-03
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D002447 1998
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D002447 2000
% 224.13/224.31  |- skos__hiddenLabel mesh__D002447 Plexus, Celiac
% 224.13/224.31  |- mesh__dateRevised mesh__D002447 1993-06-18
% 224.13/224.31  |- mesh__recordAuthorizer mesh__D002447 PLS
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D002447 1999
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D002447 2001
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D002447 2003
% 224.13/224.31  |- mesh__dateCreated mesh__D002447 1999-01-01
% 224.13/224.31  |- rdf__type mesh__D002447sskos__Concept
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D002447 1994
% 224.13/224.31  |- skos__altLabel mesh__D002447 Coeliac Plexus
% 224.13/224.31  |- mesh__recordOriginator mesh__D002447 NLM
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D002447 2002
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D002447 2004
% 224.13/224.31  |- skos__hiddenLabel mesh__D002447 Plexus, Solar
% 224.13/224.31  |- skos__prefLabel mesh__D002447 Celiac Plexus
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D002447 1995
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D002447 1996
% 224.13/224.31  |- skos__hiddenLabel mesh__D002447 Plexus, Coeliac
% 224.13/224.31  |- skos__hiddenLabel mesh__D002447 Coeliacus, Plexus
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D002447 2005
% 224.13/224.31  |- skos__broader mesh__D002447smesh__D017776
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D002447 1997
% 224.13/224.31  |- skos__altLabel mesh__D002447 Solar Plexus
% 224.13/224.31  |- skos__scopeNote mesh__D002447
% 224.13/224.31       A complex network of nerve fibers including sympathetic and parasympathetic efferents and visceral afferents. The celiac plexus is the largest of the autonomic plexuses and is located in the abdomen surrounding the celiac and superior mesenteric arteries.%A%    
% 224.13/224.31  |- skos__annotation mesh__D002447
% 224.13/224.31       the largest autonomic plexus; in the abdomen   
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D002447 2006
% 224.13/224.31  |- mesh__recordMaintainer mesh__D002447 RAZ
% 224.13/224.31  |- skos__altLabel mesh__D002447 Plexus Coeliacus
% 224.13/224.31  |- skos__hiddenLabel mesh__D021601 trans-Golgi Regions
% 224.13/224.31  |- skos__prefLabel mesh__D021601 trans-Golgi Network
% 224.13/224.31  |- skos__hiddenLabel mesh__D021601 trans Golgi Region
% 224.13/224.31  |- rdf__type mesh__D021601sskos__Concept
% 224.13/224.31  |- mesh__publicMeSHNote mesh__D021601 2001   
% 224.13/224.31  |- skos__hiddenLabel mesh__D021601 Region, trans-Golgi
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D021601 2004
% 224.13/224.31  |- skos__broader mesh__D021601smesh__D006056
% 224.13/224.31  |- skos__hiddenLabel mesh__D021601 Regions, trans-Golgi
% 224.13/224.31  |- mesh__dateCreated mesh__D021601 2000-06-22
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D021601 2006
% 224.13/224.31  |- mesh__dateRevised mesh__D021601 2003-07-09
% 224.13/224.31  |- mesh__historyNote mesh__D021601 2001   
% 224.13/224.31  |- skos__hiddenLabel mesh__D021601 Network, trans-Golgi
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D021601 2005
% 224.13/224.31  |- skos__historyNote mesh__D021601 Golgi Apparatus %28%1986-2000%29%
% 224.13/224.31  |- mesh__dateEstablished mesh__D021601 2001-01-01
% 224.13/224.31  |- skos__hiddenLabel mesh__D021601 trans Golgi Network
% 224.13/224.31  |- skos__scopeNote mesh__D021601
% 224.13/224.31       A network of membrane compartments, located at the cytoplasmic side of the GOLGI APPARATUS, where proteins and lipids are sorted for transport to various locations in the cell or cell membrane.%A%    
% 224.13/224.31  |- skos__hiddenLabel mesh__D007930 Leucine, L Isomer
% 224.13/224.31  |- skos__broader mesh__D007930smesh__D000597
% 224.13/224.31  |- rdf__type mesh__D007930sskos__Concept
% 224.13/224.31  |- skos__hiddenLabel mesh__D007930 L-Isomer Leucine
% 224.13/224.31  |- skos__broader mesh__D007930smesh__D000601
% 224.13/224.31  |- skos__altLabel mesh__D007930 Leucine, L-Isomer
% 224.13/224.31  |- skos__prefLabel mesh__D007930 Leucine
% 224.13/224.31  |- mesh__dateRevised mesh__D007930 2001-07-25
% 224.13/224.31  |- mesh__recordMaintainer mesh__D007930 jmp
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D007930 2004
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D007930 2002
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D007930 2006
% 224.13/224.31  |- skos__scopeNote mesh__D007930
% 224.13/224.31       An essential branched-chain amino acid important for hemoglobin formation.%A%    
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D007930 2003
% 224.13/224.31  |- skos__annotation mesh__D007930 /biosyn /defic /physiol permitted   
% 224.13/224.31  |- mesh__recordOriginator mesh__D007930 NLM
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D007930 2005
% 224.13/224.31  |- skos__altLabel mesh__D007930 L-Leucine
% 224.13/224.31  |- mesh__recordAuthorizer mesh__D007930 sjn
% 224.13/224.31  |- mesh__dateCreated mesh__D007930 1999-01-01
% 224.13/224.31  |- skos__broader mesh__D009206Q000098smesh__D009206
% 224.13/224.31  |- mesh__preferredCombination mesh__D009206Q000098smesh__D003331
% 224.13/224.31  |- rdf__type mesh__D009206Q000098smesh__CompoundConcept
% 224.13/224.31  |- skos__hiddenLabel mesh__D007132 Classes, Immunoglobulin
% 224.13/224.31  |- mesh__recordAuthorizer mesh__D007132 sjn
% 224.13/224.31  |- mesh__recordMaintainer mesh__D007132 ssb
% 224.13/224.31  |- skos__altLabel mesh__D007132 Antibody Classes
% 224.13/224.31  |- skos__historyNote mesh__D007132 Immunoglobulins%28%1972-1986%29%
% 224.13/224.31  |- mesh__dateCreated mesh__D007132 1986-06-23
% 224.13/224.31  |- skos__annotation mesh__D007132 DF: IG ISOTYPES   
% 224.13/224.31  |- skos__altLabel mesh__D007132 Immunoglobulin Classes
% 224.13/224.31  |- skos__prefLabel mesh__D007132 Immunoglobulin Isotypes
% 224.13/224.31  |- mesh__recordOriginator mesh__D007132 SH
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D007132 2006
% 224.13/224.31  |- mesh__publicMeSHNote mesh__D007132 87   
% 224.13/224.31  |- mesh__historyNote mesh__D007132 87   
% 224.13/224.31  |- rdf__type mesh__D007132sskos__Concept
% 224.13/224.31  |- mesh__dateRevised mesh__D007132 2005-06-30
% 224.13/224.31  |- skos__broader mesh__D007132smesh__D000906
% 224.13/224.31  |- skos__scopeNote mesh__D007132
% 224.13/224.31       The classes of immunoglobulins found in any species of animal. In man there are nine classes that migrate in five different groups in electrophoresis; they each consist of two light and two heavy protein chains, and each group has distinguishing structural and functional properties.%A%    
% 224.13/224.31  |- skos__hiddenLabel mesh__D007132 Isotypes, Immunoglobulin
% 224.13/224.31  |- skos__hiddenLabel mesh__D007132 Classes, Antibody
% 224.13/224.31  |- mesh__dateEstablished mesh__D007132 1987-01-01
% 224.13/224.31  |- mesh__recordAuthorizer mesh__D048549 sjn
% 224.13/224.31  |- skos__hiddenLabel mesh__D048549 Chacma Baboons
% 224.13/224.31  |- skos__broader mesh__D048549smesh__D010215
% 224.13/224.31  |- mesh__dateRevised mesh__D048549 2005-06-30
% 224.13/224.31  |- skos__hiddenLabel mesh__D048549 Baboons, Chacma
% 224.13/224.31  |- mesh__publicMeSHNote mesh__D048549 2005   
% 224.13/224.31  |- skos__historyNote mesh__D048549 Haplorhini %28%1965-1971%29%
% 224.13/224.31  |- skos__prefLabel mesh__D048549 Papio ursinus
% 224.13/224.31  |- skos__scopeNote mesh__D048549
% 224.13/224.31       A species of baboon in the family CERCOPITHECIDAE found in southern Africa. They are dark colored and have a variable social structure.%A%    
% 224.13/224.31  |- mesh__historyNote mesh__D048549 2005   
% 224.13/224.31  |- mesh__recordOriginator mesh__D048549 ags
% 224.13/224.31  |- skos__altLabel mesh__D048549 Chacma Baboon
% 224.13/224.31  |- skos__historyNote mesh__D048549 Papio %28%1972-2004%29%
% 224.13/224.31  |- skos__hiddenLabel mesh__D048549 Baboon, Chacma
% 224.13/224.31  |- mesh__dateCreated mesh__D048549 2004-07-07
% 224.13/224.31  |- mesh__recordMaintainer mesh__D048549 ags
% 224.13/224.31  |- mesh__dateEstablished mesh__D048549 2005-01-01
% 224.13/224.31  |- rdf__type mesh__D048549sskos__Concept
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D048549 2006
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D012875 2005
% 224.13/224.31  |- mesh__dateEstablished mesh__D012875 1998-01-01
% 224.13/224.31  |- mesh__dateRevised mesh__D012875 2001-07-25
% 224.13/224.31  |- skos__altLabel mesh__D012875 Metabolic Skin Diseases
% 224.13/224.31  |- skos__hiddenLabel mesh__D012875 Diseases, Metabolic Skin
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D012875 2006
% 224.13/224.31  |- skos__broader mesh__D012875smesh__D012871
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D012875 2003
% 224.13/224.31  |- rdf__type mesh__D012875sskos__Concept
% 224.13/224.31  |- skos__hiddenLabel mesh__D012875 Metabolic Skin Disease
% 224.13/224.31  |- skos__prefLabel mesh__D012875 Skin Diseases, Metabolic
% 224.13/224.31  |- mesh__recordOriginator mesh__D012875 NLM
% 224.13/224.31  |- mesh__publicMeSHNote mesh__D012875 98   
% 224.13/224.31  |- mesh__recordAuthorizer mesh__D012875 sjn
% 224.13/224.31  |- mesh__historyNote mesh__D012875 98; use explode 1970-97   
% 224.13/224.31  |- skos__hiddenLabel mesh__D012875 Skin Disease, Metabolic
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D012875 2004
% 224.13/224.31  |- skos__broader mesh__D012875smesh__D008659
% 224.13/224.31  |- skos__historyNote mesh__D012875 Skin Diseases %28%1972-1997%29%
% 224.13/224.31  |- mesh__dateCreated mesh__D012875 1999-01-01
% 224.13/224.31  |- skos__hiddenLabel mesh__D012875 Disease, Metabolic Skin
% 224.13/224.31  |- skos__annotation mesh__D012875
% 224.13/224.31       GEN or unspecified; prefer specifics; DF: SKIN DIS METAB   
% 224.13/224.31  |- mesh__recordMaintainer mesh__D012875 nns
% 224.13/224.31  |- skos__scopeNote mesh__D012875
% 224.13/224.31       Diseases of the skin associated with underlying metabolic disorders.%A%    
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D012875 2002
% 224.13/224.31  |- mesh__recordAuthorizer mesh__D012077 PLS
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D012077 1997
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D012077 2005
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D012077 1999
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D012077 1993
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D012077 1996
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D012077 2002
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D012077 1995
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D012077 1998
% 224.13/224.31  |- skos__hiddenLabel mesh__D012077 Arteries, Renal
% 224.13/224.31  |- mesh__recordOriginator mesh__D012077 NLM
% 224.13/224.31  |- skos__prefLabel mesh__D012077 Renal Artery
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D012077 2001
% 224.13/224.31  |- mesh__dateRevised mesh__D012077 1992-05-18
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D012077 1994
% 224.13/224.31  |- skos__annotation mesh__D012077
% 224.13/224.31       thrombosis: index under RENAL ARTERY OBSTRUCTION %28%IM%29% + THROMBOSIS %28%IM%29%%A%  
% 224.13/224.31  |- skos__broader mesh__D012077smesh__D001158
% 224.13/224.31  |- skos__hiddenLabel mesh__D012077 Renal Arteries
% 224.13/224.31  |- mesh__recordMaintainer mesh__D012077 TAP
% 224.13/224.31  |- rdf__type mesh__D012077sskos__Concept
% 224.13/224.31  |- skos__hiddenLabel mesh__D012077 Artery, Renal
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D012077 2000
% 224.13/224.31  |- skos__scopeNote mesh__D012077
% 224.13/224.31       A branch of the abdominal aorta which supplies the kidneys, adrenal glands and ureters.%A%    
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D012077 2004
% 224.13/224.31  |- mesh__dateCreated mesh__D012077 1999-01-01
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D012077 2006
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D012077 2003
% 224.13/224.31  |- skos__prefLabel mesh__D006838 Hydrocarbons
% 224.13/224.31  |- skos__broader mesh__D006838smesh__D009930
% 224.13/224.31  |- rdf__type mesh__D006838sskos__Concept
% 224.13/224.31  |- mesh__recordMaintainer mesh__D006838 sjn
% 224.13/224.31  |- mesh__recordOriginator mesh__D006838 NLM
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D006838 2006
% 224.13/224.31  |- mesh__dateCreated mesh__D006838 1999-01-01
% 224.13/224.31  |- mesh__recordAuthorizer mesh__D006838 sjn
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D006838 2005
% 224.13/224.31  |- skos__annotation mesh__D006838
% 224.13/224.31        GEN or unspecified; prefer specific hydrocarbon groups or specific hydrocarbons;  POLYCYCLIC COMPOUNDS %28%D4%29% %26% CYCLOPARAFFINS %28%D2%29% are also available%A%  
% 224.13/224.31  |- mesh__dateRevised mesh__D006838 2004-07-13
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D031231 2006
% 224.13/224.31  |- skos__annotation mesh__D031231
% 224.13/224.31       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.13/224.31  |- mesh__dateEstablished mesh__D031231 2003-01-01
% 224.13/224.31  |- skos__scopeNote mesh__D031231
% 224.13/224.31       A plant genus of the family BROMELIACEAE. Members contain karatasin and balansain %28%ENDOPEPTIDASES%29% and BROMELAINS.%A%    
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D031231 2003
% 224.13/224.31  |- mesh__dateCreated mesh__D031231 2002-07-02
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D031231 2004
% 224.13/224.31  |- skos__prefLabel mesh__D031231 Bromelia
% 224.13/224.31  |- rdf__type mesh__D031231sskos__Concept
% 224.13/224.31  |- mesh__historyNote mesh__D031231 2003   
% 224.13/224.31  |- skos__broader mesh__D031231smesh__D031229
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D031231 2005
% 224.13/224.31  |- mesh__publicMeSHNote mesh__D031231 2003   
% 224.13/224.31  |- mesh__publicMeSHNote mesh__D050994
% 224.13/224.31       2006; VOLTAGE-DEPENDENT ANION CHANNELS was indexed under MEMBRANE PROTEINS 1985-1999, %26% under PORINS 2000-2005%A%  
% 224.13/224.31  |- mesh__recordMaintainer mesh__D050994 DRC
% 224.13/224.31  |- skos__hiddenLabel mesh__D050994 Porin, Mitochondrial
% 224.13/224.31  |- rdf__type mesh__D050994sskos__Concept
% 224.13/224.31  |- skos__hiddenLabel mesh__D050994 Voltage Dependent Anion Channels
% 224.13/224.31  |- skos__altLabel mesh__D050994 Voltage-Dependent, Anion-Selective Channels
% 224.13/224.31  |- skos__hiddenLabel mesh__D050994 Anion Channels, Voltage-Dependent
% 224.13/224.31  |- skos__altLabel mesh__D050994 VDAC Mitochondrial Porin
% 224.13/224.31  |- skos__altLabel mesh__D050994 Mitochondrial Porin
% 224.13/224.31  |- skos__hiddenLabel mesh__D050994 Pore Protein, Mitochondrial
% 224.13/224.31  |- skos__altLabel mesh__D050994 Porin, Mitochondria
% 224.13/224.31  |- mesh__dateCreated mesh__D050994 2005-06-30
% 224.13/224.31  |- skos__broader mesh__D050994smesh__D018272
% 224.13/224.31  |- skos__prefLabel mesh__D050994 Voltage-Dependent Anion Channels
% 224.13/224.31  |- mesh__dateEstablished mesh__D050994 2006-01-01
% 224.13/224.31  |- skos__altLabel mesh__D050994 Porins, Mitochondria
% 224.13/224.31  |- skos__hiddenLabel mesh__D050994 Mitochondria Porin
% 224.13/224.31  |- skos__altLabel mesh__D050994
% 224.13/224.31       Voltage-Dependent, Anion-Selective Channel Forming Protein, Mitochondrial
% 224.13/224.31  |- mesh__historyNote mesh__D050994 2006%28%1985%29%   
% 224.13/224.31  |- skos__hiddenLabel mesh__D050994
% 224.13/224.31       Anion-Selective Channels Voltage-Dependent
% 224.13/224.31  |- mesh__recordOriginator mesh__D050994 DRC
% 224.13/224.31  |- skos__annotation mesh__D050994 general; prefer specifics   
% 224.13/224.31  |- skos__hiddenLabel mesh__D050994 Mitochondria Porins
% 224.13/224.31  |- skos__hiddenLabel mesh__D050994
% 224.13/224.31       Voltage Dependent, Anion Selective Channels
% 224.13/224.31  |- mesh__recordAuthorizer mesh__D050994 sjn
% 224.13/224.31  |- skos__hiddenLabel mesh__D050994
% 224.13/224.31       Channels Voltage-Dependent, Anion-Selective
% 224.13/224.31  |- skos__altLabel mesh__D050994 VDAC Proteins
% 224.13/224.31  |- skos__hiddenLabel mesh__D050994 Mitochondrial Porin, VDAC
% 224.13/224.31  |- skos__scopeNote mesh__D050994
% 224.13/224.31       A family of voltage-gated eukaryotic porins that form aqueous channels. They play an essential role in mitochondrial CELL MEMBRANE PERMEABILITY, are often regulated by BCL-2 PROTO-ONCOGENE PROTEINS, and have been implicated in APOPTOSIS.%A%    
% 224.13/224.31  |- skos__hiddenLabel mesh__D050994 Porin, VDAC Mitochondrial
% 224.13/224.31  |- skos__altLabel mesh__D050994 Pore Forming Protein VDAC
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D050994 2006
% 224.13/224.31  |- skos__historyNote mesh__D003540 Amino Acids %28%1966-1970%29%
% 224.13/224.31  |- mesh__dateEstablished mesh__D003540 1973-01-01
% 224.13/224.31  |- skos__broader mesh__D003540smesh__D000599
% 224.13/224.31  |- rdf__type mesh__D003540sskos__Concept
% 224.13/224.31  |- mesh__historyNote mesh__D003540
% 224.13/224.31       73%28%71%29%; was see under AMINO ACIDS 1963-72   
% 224.13/224.31  |- mesh__recordMaintainer mesh__D003540 ssb
% 224.13/224.31  |- mesh__dateCreated mesh__D003540 1999-01-01
% 224.13/224.31  |- mesh__dateRevised mesh__D003540 2005-06-30
% 224.13/224.31  |- skos__annotation mesh__D003540 an amino acid   
% 224.13/224.31  |- skos__broader mesh__D003540smesh__D000600
% 224.13/224.31  |- mesh__publicMeSHNote mesh__D003540
% 224.13/224.31       73; was see under AMINO ACIDS 1963-72   
% 224.13/224.31  |- mesh__onlineNote mesh__D003540 search AMINO ACIDS 1966-70   
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D003540 2006
% 224.13/224.31  |- mesh__recordAuthorizer mesh__D003540 sjn
% 224.13/224.31  |- skos__prefLabel mesh__D003540 Cystathionine
% 224.13/224.31  |- mesh__recordOriginator mesh__D003540 NLM
% 224.13/224.31  |- skos__broader mesh__D003540smesh__D000603
% 224.13/224.31  |- skos__annotation mesh__D016468 SPEC: SPEC qualif   
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D016468 2005
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D016468 2002
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D016468 1994
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D016468 2006
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D016468 2003
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D016468 1992
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D016468 1995
% 224.13/224.31  |- skos__scopeNote mesh__D016468
% 224.13/224.31       The science of developing, caring for, or cultivating forests.%A%    
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D016468 2004
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D016468 1993
% 224.13/224.31  |- mesh__publicMeSHNote mesh__D016468 92   
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D016468 1998
% 224.13/224.31  |- skos__broader mesh__D016468smesh__D007221
% 224.13/224.31  |- mesh__historyNote mesh__D016468 92   
% 224.13/224.31  |- rdf__type mesh__D016468sskos__Concept
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D016468 1999
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D016468 1996
% 224.13/224.31  |- mesh__dateCreated mesh__D016468 1991-01-02
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D016468 2000
% 224.13/224.31  |- skos__prefLabel mesh__D016468 Forestry
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D016468 1997
% 224.13/224.31  |- skos__historyNote mesh__D016468 Trees %28%1966-1991%29%
% 224.13/224.31  |- skos__related mesh__D016468smesh__D014197
% 224.13/224.31  |- mesh__dateEstablished mesh__D016468 1992-01-01
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D016468 2001
% 224.13/224.31  |- rdf__type mesh__D035622sskos__Concept
% 224.13/224.31  |- mesh__dateCreated mesh__D035622 2002-07-03
% 224.13/224.31  |- skos__related mesh__D035622smesh__D019221
% 224.13/224.31  |- skos__related mesh__D035622smesh__D003219
% 224.13/224.31  |- skos__hiddenLabel mesh__D035622 Parental Notifications
% 224.13/224.31  |- mesh__dateEstablished mesh__D035622 2003-01-01
% 224.13/224.31  |- mesh__recordMaintainer mesh__D035622 jls
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D035622 2005
% 224.13/224.31  |- skos__hiddenLabel mesh__D035622 Notifications, Parental
% 224.13/224.31  |- skos__broader mesh__D035622smesh__D030881
% 224.13/224.31  |- mesh__publicMeSHNote mesh__D035622 2003   
% 224.13/224.31  |- skos__scopeNote mesh__D035622
% 224.13/224.31       Reporting to parents or guardians about care to be provided to a minor %28%MINORS%29%.%A%    
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D035622 2006
% 224.13/224.31  |- mesh__historyNote mesh__D035622 2003   
% 224.13/224.31  |- skos__related mesh__D035622smesh__D033282
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D035622 2003
% 224.13/224.31  |- mesh__recordOriginator mesh__D035622 hjn
% 224.13/224.31  |- mesh__recordAuthorizer mesh__D035622 jls
% 224.13/224.31  |- skos__historyNote mesh__D035622 Parents %28%1982-2002%29%
% 224.13/224.31  |- skos__hiddenLabel mesh__D035622 Notification, Parental
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D035622 2003A
% 224.13/224.31  |- skos__prefLabel mesh__D035622 Parental Notification
% 224.13/224.31  |- mesh__dateRevised mesh__D035622 2002-10-31
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D035622 2004
% 224.13/224.31  |- skos__related mesh__D035622smesh__D010290
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D002448 1999
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D002448 2003
% 224.13/224.31  |- mesh__dateCreated mesh__D002448 1999-01-01
% 224.13/224.31  |- rdf__type mesh__D002448sskos__Concept
% 224.13/224.31  |- mesh__dateRevised mesh__D002448 1992-05-07
% 224.13/224.31  |- mesh__activeMeSHYear mesh__D002448 1994
% 224.13/224.32  |- mesh__publicMeSHNote mesh__D002448 72   
% 224.13/224.32  |- skos__hiddenLabel mesh__D002448 Adhesion, Cell
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002448 2000
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002448 2004
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002448 1996
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002448 1995
% 224.13/224.32  |- skos__scopeNote mesh__D002448
% 224.13/224.32       Adherence of cells to surfaces or to other cells.     
% 224.13/224.32  |- mesh__dateEstablished mesh__D002448 1972-01-01
% 224.13/224.32  |- mesh__recordAuthorizer mesh__D002448 PLS
% 224.13/224.32  |- skos__prefLabel mesh__D002448 Cell Adhesion
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002448 2001
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002448 2005
% 224.13/224.32  |- skos__broader mesh__D002448smesh__D002468
% 224.13/224.32  |- skos__hiddenLabel mesh__D002448 Cell Adhesions
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002448 1997
% 224.13/224.32  |- mesh__recordOriginator mesh__D002448 NLM
% 224.13/224.32  |- skos__annotation mesh__D002448
% 224.13/224.32       NIM; permitted with micro-organisms but BACTERIAL ADHESION is available%A%  
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002448 2002
% 224.13/224.32  |- mesh__historyNote mesh__D002448 72%28%70%29%   
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002448 2006
% 224.13/224.32  |- skos__hiddenLabel mesh__D002448 Adhesions, Cell
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002448 1998
% 224.13/224.32  |- mesh__recordMaintainer mesh__D002448 TAP
% 224.13/224.32  |- skos__historyNote mesh__D002448 Cytology %28%1966-1969%29%
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002448 1993
% 224.13/224.32  |- mesh__dateCreated mesh__D013170 1999-01-01
% 224.13/224.32  |- mesh__dateRevised mesh__D013170 2005-08-01
% 224.13/224.32  |- skos__scopeNote mesh__D013170
% 224.13/224.32       The reproductive elements of lower organisms, such as BACTERIA; PROTOZOA; FUNGI; and cryptogamic plants.%A%    
% 224.13/224.32  |- mesh__historyNote mesh__D013170 68%28%64%29%   
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D013170 2006A
% 224.13/224.32  |- skos__annotation mesh__D013170
% 224.13/224.32       GEN: SPORES, BACTERIAL; SPORES, FUNGAL; and SPORES, PROTOZOAN are available; sporulation: coord organism /physiol %28%IM%29% + SPORES %28%NIM%29%; Manual 22.31%A%  
% 224.13/224.32  |- rdf__type mesh__D013170sskos__Concept
% 224.13/224.32  |- skos__prefLabel mesh__D013170 Spores
% 224.13/224.32  |- skos__broader mesh__D013170smesh__D001419
% 224.13/224.32  |- mesh__dateEstablished mesh__D013170 1968-01-01
% 224.13/224.32  |- mesh__publicMeSHNote mesh__D013170 68   
% 224.13/224.32  |- mesh__recordMaintainer mesh__D013170 ags
% 224.13/224.32  |- mesh__recordAuthorizer mesh__D013170 ags
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D013170 2006
% 224.13/224.32  |- mesh__recordOriginator mesh__D013170 NLM
% 224.13/224.32  |- skos__broader mesh__D013170smesh__D005658
% 224.13/224.32  |- skos__broader mesh__D013170smesh__D011527
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D013170 2006B
% 224.13/224.32  |- mesh__publicMeSHNote mesh__D007931
% 224.13/224.32       99; see LEUCINE AMINOPEPTIDASE 1965-98; PEPTIDASE S was indexed under AMINOPEPTIDASES 1979-98%A%  
% 224.13/224.32  |- skos__scopeNote mesh__D007931
% 224.13/224.32       A zinc containing enzyme of the hydrolase class that catalyzes the removal of the N-terminal amino acid from most L-peptides, particularly those with N-terminal leucine residues but not those with N-terminal lysine or arginine residues. This occurs in tissue cell cytosol, with high activity in the duodenum, liver, and kidney. EC 3.4.11.1%A%    
% 224.13/224.32  |- skos__hiddenLabel mesh__D007931 Aminopeptidase, Cytosol
% 224.13/224.32  |- mesh__recordOriginator mesh__D007931 NLM
% 224.13/224.32  |- rdf__type mesh__D007931sskos__Concept
% 224.13/224.32  |- mesh__recordAuthorizer mesh__D007931 sjn
% 224.13/224.32  |- skos__hiddenLabel mesh__D007931 Zinc Manganese Leucine Aminopeptidase
% 224.13/224.32  |- skos__altLabel mesh__D007931 Zinc-Manganese-Leucine Aminopeptidase
% 224.13/224.32  |- mesh__recordMaintainer mesh__D007931 jmp
% 224.13/224.32  |- skos__hiddenLabel mesh__D007931 Aminopeptidase, Leucine
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007931 2005
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007931 2004
% 224.13/224.32  |- skos__hiddenLabel mesh__D007931 S, Peptidase
% 224.13/224.32  |- mesh__dateCreated mesh__D007931 1999-01-01
% 224.13/224.32  |- skos__altLabel mesh__D007931 Peptidase S
% 224.13/224.32  |- skos__altLabel mesh__D007931 Leucine Aminopeptidase
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007931 2006
% 224.13/224.32  |- skos__hiddenLabel mesh__D007931 Aminopeptidase, Zinc-Manganese-Leucine
% 224.13/224.32  |- skos__prefLabel mesh__D007931 Leucyl Aminopeptidase
% 224.13/224.32  |- skos__broader mesh__D007931smesh__D000626
% 224.13/224.32  |- skos__hiddenLabel mesh__D007931 Aminopeptidase, Leucyl
% 224.13/224.32  |- skos__broader mesh__D007931smesh__D045727
% 224.13/224.32  |- mesh__dateRevised mesh__D007931 2003-07-09
% 224.13/224.32  |- mesh__dateEstablished mesh__D007931 1965-01-01
% 224.13/224.32  |- skos__altLabel mesh__D007931 L-Leucylnaphthylamidase
% 224.13/224.32  |- skos__altLabel mesh__D007931 Cytosol Aminopeptidase
% 224.13/224.32  |- mesh__historyNote mesh__D007931
% 224.13/224.32       99%28%65%29%; for PEPTIDASE S use LEUCYL AMINOPEPTIDASE %28%NM%29% 1979-98%A%  
% 224.13/224.32  |- skos__hiddenLabel mesh__D007931 Aminopeptidase, Methoxyleucine
% 224.13/224.32  |- skos__historyNote mesh__D007133
% 224.13/224.32       Immunoglobulin Variable Region %28%1977-1987%29%
% 224.13/224.32  |- skos__historyNote mesh__D007133 Amino Acid Sequence %28%1971-1987%29%
% 224.13/224.32  |- skos__scopeNote mesh__D007133
% 224.13/224.32       A segment of the immunoglobulin heavy chains, encoded by the IMMUNOGLOBULIN HEAVY CHAIN GENES in the J segment where, during the maturation of B-LYMPHOCYTES, the gene segment for the variable region upstream is joined to a constant region gene segment downstream. The exact position of joining of the two gene segments is variable and contributes to ANTIBODY DIVERSITY. It is distinguished from the IMMUNOGLOBULINS, J CHAIN; a separate polypeptide that serves as a linkage piece in polymeric IGA or IGM.%A%    
% 224.13/224.32  |- mesh__historyNote mesh__D007133 88   
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007133 2006
% 224.13/224.32  |- skos__annotation mesh__D007133 DF: IG JOINING REGION   
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007133 2006A
% 224.13/224.32  |- mesh__publicMeSHNote mesh__D007133 88   
% 224.13/224.32  |- mesh__dateCreated mesh__D007133 1987-05-11
% 224.13/224.32  |- rdf__type mesh__D007133sskos__Concept
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007133 2006B
% 224.13/224.32  |- skos__hiddenLabel mesh__D007133 Ig Joining Region
% 224.13/224.32  |- skos__historyNote mesh__D007133
% 224.13/224.32       Immunoglobulin Constant Region %28%1979-1987%29%
% 224.13/224.32  |- skos__broader mesh__D007133smesh__D007135
% 224.13/224.32  |- skos__related mesh__D007133smesh__D005803
% 224.13/224.32  |- skos__hiddenLabel mesh__D007133 Joining Region, Immunoglobulin
% 224.13/224.32  |- mesh__dateEstablished mesh__D007133 1988-01-01
% 224.13/224.32  |- skos__historyNote mesh__D007133
% 224.13/224.32       Immunoglobulins, Heavy Chain %28%1977-1987%29%
% 224.13/224.32  |- mesh__recordMaintainer mesh__D007133 ags
% 224.13/224.32  |- mesh__recordOriginator mesh__D007133 SCD
% 224.13/224.32  |- skos__altLabel mesh__D007133 Joining Region, Ig
% 224.13/224.32  |- skos__prefLabel mesh__D007133 Immunoglobulin Joining Region
% 224.13/224.32  |- mesh__recordAuthorizer mesh__D007133 ags
% 224.13/224.32  |- mesh__dateRevised mesh__D007133 2005-07-18
% 224.13/224.32  |- skos__broader mesh__D005947Q000097smesh__D005947
% 224.13/224.32  |- mesh__preferredCombination mesh__D005947Q000097smesh__D001786
% 224.13/224.32  |- rdf__type mesh__D005947Q000097smesh__CompoundConcept
% 224.13/224.32  |- skos__hiddenLabel mesh__D012876 Diseases, Parasitic Skin
% 224.13/224.32  |- rdf__type mesh__D012876sskos__Concept
% 224.13/224.32  |- skos__historyNote mesh__D012876 Parasitic Diseases %28%1966-1967%29%
% 224.13/224.32  |- skos__hiddenLabel mesh__D012876 Disease, Parasitic Skin
% 224.13/224.32  |- skos__hiddenLabel mesh__D012876 Parasitic Skin Disease
% 224.13/224.32  |- skos__annotation mesh__D012876
% 224.13/224.32       coordinate with specific parasitic disease %28%IM%29% + site %28%NIM%29% but note precoordinated site terms are available; ECTOPARASITIC INFESTATIONS is available for parasites on or within the skin%A%  
% 224.13/224.32  |- skos__broader mesh__D012876smesh__D010272
% 224.13/224.32  |- skos__scopeNote mesh__D012876
% 224.13/224.32       Skin diseases caused by ARTHROPODS; HELMINTHS; or PROTOZOA.%A%    
% 224.13/224.32  |- mesh__historyNote mesh__D012876 68   
% 224.13/224.32  |- skos__altLabel mesh__D012876 Parasitic Skin Diseases
% 224.13/224.32  |- skos__prefLabel mesh__D012876 Skin Diseases, Parasitic
% 224.13/224.32  |- mesh__dateCreated mesh__D012876 1999-01-01
% 224.13/224.32  |- mesh__recordMaintainer mesh__D012876 ags
% 224.13/224.32  |- skos__broader mesh__D012876smesh__D012874
% 224.13/224.32  |- skos__historyNote mesh__D012876 Skin Diseases %28%1966-1967%29%
% 224.13/224.32  |- mesh__publicMeSHNote mesh__D012876 68   
% 224.13/224.32  |- skos__hiddenLabel mesh__D012876 Skin Disease, Parasitic
% 224.13/224.32  |- mesh__recordOriginator mesh__D012876 NLM
% 224.13/224.32  |- mesh__dateEstablished mesh__D012876 1968-01-01
% 224.13/224.32  |- mesh__recordAuthorizer mesh__D012876 sjn
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D012876 2006
% 224.13/224.32  |- mesh__dateRevised mesh__D012876 2005-06-30
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D012078 1996
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D012078 1995
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D012078 1998
% 224.13/224.32  |- skos__broader mesh__D012078smesh__D001157
% 224.13/224.32  |- skos__scopeNote mesh__D012078
% 224.13/224.32       Narrowing or occlusion of the renal arteries. It is due usually to atherosclerosis, fibromuscular dysplasia, thrombosis, embolism, or external pressure. It may result in renovascular hypertension.%A%    
% 224.13/224.32  |- skos__hiddenLabel mesh__D012078 Obstructions, Renal Artery
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D012078 1992
% 224.13/224.32  |- mesh__recordAuthorizer mesh__D012078 PLS
% 224.13/224.32  |- mesh__historyNote mesh__D012078
% 224.13/224.32       RENAL ARTERY STENOSIS was see under RENAL ARTERY OBSTRUCTION 1963-83%A%  
% 224.13/224.32  |- skos__hiddenLabel mesh__D012078 Renal Artery Obstructions
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D012078 1994
% 224.13/224.32  |- skos__hiddenLabel mesh__D012078 Renal Artery Stenoses
% 224.13/224.32  |- skos__broader mesh__D012078smesh__D007674
% 224.13/224.32  |- skos__annotation mesh__D012078
% 224.13/224.32       obstruct of external or internal origin; renal artery thrombosis: coord IM with THROMBOSIS %28%IM%29%; consider also HYPERTENSION, RENOVASCULAR %28%hypertension caused by renal artery obstruct or compress%29%%A%  
% 224.13/224.32  |- mesh__recordMaintainer mesh__D012078 PLS
% 224.13/224.32  |- rdf__type mesh__D012078sskos__Concept
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D012078 2002
% 224.13/224.32  |- skos__hiddenLabel mesh__D012078 Obstruction, Renal Artery
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D012078 2004
% 224.13/224.32  |- mesh__recordOriginator mesh__D012078 NLM
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D012078 2001
% 224.13/224.32  |- mesh__dateCreated mesh__D012078 1999-01-01
% 224.13/224.32  |- mesh__dateRevised mesh__D012078 1991-06-18
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D012078 2006
% 224.13/224.32  |- skos__hiddenLabel mesh__D012078 Stenosis, Renal Artery
% 224.13/224.32  |- skos__related mesh__D012078smesh__D006978
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D012078 2003
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D012078 1997
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D012078 2000
% 224.13/224.32  |- mesh__onlineNote mesh__D012078
% 224.13/224.32       use RENAL ARTERY OBSTRUCTION to search RENAL ARTERY STENOSIS 1966-83%A%  
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D012078 2005
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D012078 1999
% 224.13/224.32  |- skos__hiddenLabel mesh__D012078 Stenoses, Renal Artery
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D012078 1993
% 224.13/224.32  |- skos__prefLabel mesh__D012078 Renal Artery Obstruction
% 224.13/224.32  |- rdf__type mesh__D006839sskos__Concept
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D006839 2002
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D006839 1999
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D006839 2004
% 224.13/224.32  |- skos__prefLabel mesh__D006839 Hydrocarbons, Acyclic
% 224.13/224.32  |- mesh__dateCreated mesh__D006839 1999-01-01
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D006839 2005
% 224.13/224.32  |- mesh__dateEstablished mesh__D006839 1998-01-01
% 224.13/224.32  |- skos__broader mesh__D006839smesh__D006838
% 224.13/224.32  |- mesh__historyNote mesh__D006839 98; use explode 1967-97   
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D006839 2006
% 224.13/224.32  |- mesh__publicMeSHNote mesh__D006839 98   
% 224.13/224.32  |- mesh__recordMaintainer mesh__D006839 ADP
% 224.13/224.32  |- mesh__recordOriginator mesh__D006839 NLM
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D006839 2000
% 224.13/224.32  |- skos__annotation mesh__D006839
% 224.13/224.32       GEN; prefer specifics; used for mapping supplementary chemicals; do not confuse with HYDROCARBONS, ALICYCLIC%A%  
% 224.13/224.32  |- skos__altLabel mesh__D006839 Acyclic Hydrocarbons
% 224.13/224.32  |- mesh__recordAuthorizer mesh__D006839 SJN
% 224.13/224.32  |- mesh__dateRevised mesh__D006839 1997-06-20
% 224.13/224.32  |- skos__scopeNote mesh__D006839
% 224.13/224.32       Organic compounds composed exclusively of carbon and hydrogen where no carbon atoms join to form a ring structure.%A%    
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D006839 2001
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D006839 1998
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D006839 2003
% 224.13/224.32  |- skos__scopeNote mesh__D031232
% 224.13/224.32       A plant genus of the family BROMELIACEAE. Members contain 3-methoxy-5-hydroxyflavonols.%A%    
% 224.13/224.32  |- skos__broader mesh__D031232smesh__D031229
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D031232 2003
% 224.13/224.32  |- skos__prefLabel mesh__D031232 Tillandsia
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D031232 2004
% 224.13/224.32  |- mesh__dateEstablished mesh__D031232 2003-01-01
% 224.13/224.32  |- mesh__dateCreated mesh__D031232 2002-07-03
% 224.13/224.32  |- rdf__type mesh__D031232sskos__Concept
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D031232 2005
% 224.13/224.32  |- mesh__publicMeSHNote mesh__D031232 2003   
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D031232 2006
% 224.13/224.32  |- skos__annotation mesh__D031232
% 224.13/224.32       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.13/224.32  |- mesh__historyNote mesh__D031232 2003   
% 224.13/224.32  |- mesh__dateEstablished mesh__D050995 2006-01-01
% 224.13/224.32  |- mesh__recordAuthorizer mesh__D050995 sjn
% 224.13/224.32  |- skos__altLabel mesh__D050995 VDAC1 Protein
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D050995 2006
% 224.13/224.32  |- mesh__dateCreated mesh__D050995 2005-06-30
% 224.13/224.32  |- mesh__recordMaintainer mesh__D050995 DRC
% 224.13/224.32  |- rdf__type mesh__D050995sskos__Concept
% 224.13/224.32  |- mesh__publicMeSHNote mesh__D050995
% 224.13/224.32       2006; VOLTAGE-DEPENDENT ANION CHANNEL 1 was indexed under MEMBRANE PROTEIN 1985-1999, %26% under PORINS 2000-2005%A%  
% 224.13/224.32  |- mesh__recordOriginator mesh__D050995 DRC
% 224.13/224.32  |- mesh__historyNote mesh__D050995 2006%28%1985%29%   
% 224.13/224.32  |- skos__prefLabel mesh__D050995 Voltage-Dependent Anion Channel 1
% 224.13/224.32  |- skos__hiddenLabel mesh__D050995 Voltage Dependent Anion Channel 1
% 224.13/224.32  |- skos__scopeNote mesh__D050995
% 224.13/224.32       Voltage-dependent anion channel 1 is the major pore-forming protein of the mitochondrial outer membrane. It also functions as a ferricyanide reductase in the PLASMA MEMBRANE.%A%    
% 224.13/224.32  |- skos__broader mesh__D050995smesh__D050994
% 224.13/224.32  |- skos__hiddenLabel mesh__D003541 Cystathionine beta Synthase
% 224.13/224.32  |- skos__historyNote mesh__D003541 Homocysteine %28%1973-1974%29%
% 224.13/224.32  |- skos__hiddenLabel mesh__D003541 Sulfhydrase, Serine
% 224.13/224.32  |- mesh__dateEstablished mesh__D003541 1991-01-01
% 224.13/224.32  |- skos__historyNote mesh__D003541 Serine %28%1973-1974%29%
% 224.13/224.32  |- mesh__historyNote mesh__D003541 1991%28%1975%29%   
% 224.13/224.32  |- skos__altLabel mesh__D003541 beta-Thionase
% 224.13/224.32  |- mesh__publicMeSHNote mesh__D003541 1991; see HYDRO-LYASES 1975-1990   
% 224.13/224.32  |- skos__broader mesh__D003541smesh__D006836
% 224.13/224.32  |- skos__scopeNote mesh__D003541
% 224.13/224.32       A multifunctional pyridoxal phosphate enzyme. In the second stage of cysteine biosynthesis it catalyzes the reaction of homocysteine with serine to form cystathionine with the elimination of water. Deficiency of this enzyme leads to HYPERHOMOCYSTEINEMIA and HOMOCYSTINURIA. EC 4.2.1.22.%A%    
% 224.13/224.32  |- skos__annotation mesh__D003541
% 224.13/224.32       /defic: consider also HOMOCYSTINURIA or HYPERHOMOCYSTEINEMIA%A%  
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D003541 2005
% 224.13/224.32  |- mesh__recordAuthorizer mesh__D003541 sjn
% 224.13/224.32  |- skos__hiddenLabel mesh__D003541 Synthetase, Cystathionine
% 224.13/224.32  |- mesh__recordOriginator mesh__D003541 NLM
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D003541 2004
% 224.13/224.32  |- skos__hiddenLabel mesh__D003541 beta-Synthase, Cystathionine
% 224.13/224.32  |- skos__prefLabel mesh__D003541 Cystathionine beta-Synthase
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D003541 2006
% 224.13/224.32  |- skos__altLabel mesh__D003541 Cystathionine Synthetase
% 224.13/224.32  |- skos__hiddenLabel mesh__D003541 beta Thionase
% 224.13/224.32  |- mesh__dateCreated mesh__D003541 1974-11-11
% 224.13/224.32  |- mesh__recordMaintainer mesh__D003541 ssb
% 224.13/224.32  |- skos__related mesh__D003541smesh__D006712
% 224.13/224.32  |- mesh__dateRevised mesh__D003541 2003-07-09
% 224.13/224.32  |- skos__historyNote mesh__D003541 Hydro-Lyases %28%1973-1974%29%
% 224.13/224.32  |- skos__altLabel mesh__D003541 Serine Sulfhydrase
% 224.13/224.32  |- rdf__type mesh__D003541sskos__Concept
% 224.13/224.32  |- mesh__historyNote mesh__D050197 2006; use ARTERIOSCLEROSIS 1963-2005   
% 224.13/224.32  |- mesh__publicMeSHNote mesh__D050197
% 224.13/224.32       2006; see ARTERIOSCLEROSIS 1963-2005   
% 224.13/224.32  |- mesh__recordAuthorizer mesh__D050197 sjn
% 224.13/224.32  |- skos__broader mesh__D050197smesh__D001161
% 224.13/224.32  |- skos__prefLabel mesh__D050197 Atherosclerosis
% 224.13/224.32  |- skos__altLabel mesh__D050197 Atheroma
% 224.13/224.32  |- mesh__recordMaintainer mesh__D050197 lkt
% 224.13/224.32  |- mesh__dateCreated mesh__D050197 2005-06-30
% 224.13/224.32  |- skos__scopeNote mesh__D050197
% 224.13/224.32       Thickening and loss of elasticity of the walls of medium and large muscular ARTERIES with lesions in the innermost layer of the artery %28%ARTERIAL INTIMA%29%. This disease process of atherogenesis includes the retention of cholesterol-rich LIPOPROTEINS and their binding to PROTEOGLYCANS in the arterial intima, generation of proinflammatory molecules that recruit MACROPHAGES to the subendothelial space, formation of FOAM CELLS, and eventual calcification of the arterial wall. These arterial plaques %28%atheromas%29% contain CARBOHYDRATES; BLOOD; and CALCIUM.%A%    
% 224.13/224.32  |- skos__hiddenLabel mesh__D050197 Arterial Fatty Streaks
% 224.13/224.32  |- skos__hiddenLabel mesh__D050197 Streaks, Arterial Fatty
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D050197 2006
% 224.13/224.32  |- skos__historyNote mesh__D050197 Arteriosclerosis %28%1965-2005%29%
% 224.13/224.32  |- skos__hiddenLabel mesh__D050197 Fatty Streaks, Arterial
% 224.13/224.32  |- mesh__dateEstablished mesh__D050197 2006-01-01
% 224.13/224.32  |- skos__hiddenLabel mesh__D050197 Arterial Fatty Streak
% 224.13/224.32  |- skos__hiddenLabel mesh__D050197 Atheroscleroses
% 224.13/224.32  |- skos__hiddenLabel mesh__D050197 Streak, Arterial Fatty
% 224.13/224.32  |- mesh__recordOriginator mesh__D050197 lkt
% 224.13/224.32  |- skos__hiddenLabel mesh__D050197 Atheromas
% 224.13/224.32  |- rdf__type mesh__D050197sskos__Concept
% 224.13/224.32  |- skos__broader mesh__D016469smesh__D012687
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D016469 2001
% 224.13/224.32  |- skos__historyNote mesh__D016469 Mycoses %28%1966-1991%29%
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D016469 2000
% 224.13/224.32  |- skos__hiddenLabel mesh__D016469 Fungemias
% 224.13/224.32  |- skos__annotation mesh__D016469
% 224.13/224.32       coord with specific fungus/infect heading or specific fungus if specific fungus infect is not in MeSH %28%do not use /blood to indicate -emia%29%%A%  
% 224.13/224.32  |- mesh__publicMeSHNote mesh__D016469 92   
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D016469 2004
% 224.13/224.32  |- skos__prefLabel mesh__D016469 Fungemia
% 224.13/224.32  |- skos__broader mesh__D016469smesh__D009181
% 224.13/224.32  |- skos__historyNote mesh__D016469
% 224.13/224.32       specific fungal infection %28%1966-1991%29%
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D016469 2006
% 224.13/224.32  |- mesh__dateCreated mesh__D016469 1991-01-02
% 224.13/224.32  |- mesh__recordAuthorizer mesh__D016469 SJN
% 224.13/224.32  |- mesh__recordMaintainer mesh__D016469 PXP
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D016469 2003
% 224.13/224.32  |- skos__scopeNote mesh__D016469
% 224.13/224.32       The presence of fungi circulating in the blood. Opportunistic fungal sepsis is seen most often in immunosuppressed patients with severe neutropenia or in postoperative patients with intravenous catheters and usually follows prolonged antibiotic therapy.%A%    
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D016469 2005
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D016469 2002
% 224.13/224.32  |- mesh__historyNote mesh__D016469 92   
% 224.13/224.32  |- rdf__type mesh__D016469sskos__Concept
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D016469 1999
% 224.13/224.32  |- mesh__dateEstablished mesh__D016469 1992-01-01
% 224.13/224.32  |- mesh__dateRevised mesh__D016469 1998-06-10
% 224.13/224.32  |- mesh__recordOriginator mesh__D016469 PXP
% 224.13/224.32  |- mesh__recordOriginator mesh__D002449 NLM
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002449 2002
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002449 2005
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002449 1997
% 224.13/224.32  |- mesh__recordMaintainer mesh__D002449 TAP
% 224.13/224.32  |- skos__hiddenLabel mesh__D002449 Cell Aggregations
% 224.13/224.32  |- skos__hiddenLabel mesh__D002449 Aggregations, Cell
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002449 2006
% 224.13/224.32  |- mesh__publicMeSHNote mesh__D002449 68   
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002449 1998
% 224.13/224.32  |- skos__prefLabel mesh__D002449 Cell Aggregation
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002449 1993
% 224.13/224.32  |- mesh__dateEstablished mesh__D002449 1968-01-01
% 224.13/224.32  |- mesh__historyNote mesh__D002449 68%28%65%29%   
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002449 2000
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002449 1999
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002449 2003
% 224.13/224.32  |- mesh__dateCreated mesh__D002449 1999-01-01
% 224.13/224.32  |- rdf__type mesh__D002449sskos__Concept
% 224.13/224.32  |- mesh__dateRevised mesh__D002449 1992-05-07
% 224.13/224.32  |- skos__scopeNote mesh__D002449
% 224.13/224.32       The phenomenon by which dissociated cells intermixed in vitro tend to group themselves with cells of their own type.%A%    
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002449 1994
% 224.13/224.32  |- mesh__recordAuthorizer mesh__D002449 PLS
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002449 2001
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002449 2004
% 224.13/224.32  |- skos__annotation mesh__D002449 NIM; not for micro-organisms   
% 224.13/224.32  |- skos__broader mesh__D002449smesh__D002465
% 224.13/224.32  |- skos__hiddenLabel mesh__D002449 Aggregation, Cell
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002449 1995
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D002449 1996
% 224.13/224.32  |- mesh__historyNote mesh__D013171 74%28%71%29%   
% 224.13/224.32  |- skos__broader mesh__D013171smesh__D013170
% 224.13/224.32  |- skos__altLabel mesh__D013171 Bacterial Spores
% 224.13/224.32  |- rdf__type mesh__D013171sskos__Concept
% 224.13/224.32  |- skos__altLabel mesh__D013171 Bacterial Spore
% 224.13/224.32  |- skos__historyNote mesh__D013171 Bacteria %28%1966-1970%29%
% 224.13/224.32  |- mesh__dateRevised mesh__D013171 2005-06-30
% 224.13/224.32  |- skos__prefLabel mesh__D013171 Spores, Bacterial
% 224.13/224.32  |- skos__historyNote mesh__D013171 specific bacterium
% 224.13/224.32  |- mesh__recordAuthorizer mesh__D013171 sjn
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D013171 2006
% 224.13/224.32  |- mesh__publicMeSHNote mesh__D013171 74   
% 224.13/224.32  |- mesh__recordMaintainer mesh__D013171 SYSTEM
% 224.13/224.32  |- skos__scopeNote mesh__D013171
% 224.13/224.32       Heat and stain resistant, metabolically inactive bodies formed within the vegetative cells of bacteria of the genera Bacillus and Clostridium.%A%    
% 224.13/224.32  |- skos__annotation mesh__D013171
% 224.13/224.32       NIM; sporulation: coord specific bacterium /physiol %28%IM%29% + SPORES, BACTERIAL %28%NIM%29%; Manual 22.31; SPORES BACT%A%  
% 224.13/224.32  |- skos__historyNote mesh__D013171 Spores %28%1966-1970%29%
% 224.13/224.32  |- mesh__dateEstablished mesh__D013171 1974-01-01
% 224.13/224.32  |- skos__altLabel mesh__D013171 Spore, Bacterial
% 224.13/224.32  |- mesh__dateCreated mesh__D013171 1999-01-01
% 224.13/224.32  |- mesh__recordOriginator mesh__D013171 NLM
% 224.13/224.32  |- rdf__type mesh__D007932sskos__Concept
% 224.13/224.32  |- skos__prefLabel mesh__D007932 Leucogenenol
% 224.13/224.32  |- skos__historyNote mesh__D007932 Alcohols %28%1971-1972%29%
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007932 2003
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007932 2000
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007932 2005
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007932 2004
% 224.13/224.32  |- mesh__dateRevised mesh__D007932 1992-05-18
% 224.13/224.32  |- mesh__dateCreated mesh__D007932 1999-01-01
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007932 2001
% 224.13/224.32  |- mesh__publicMeSHNote mesh__D007932
% 224.13/224.32       91; was see under SPIRO COMPOUNDS 1973-90   
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007932 2006
% 224.13/224.32  |- mesh__recordOriginator mesh__D007932 NLM
% 224.13/224.32  |- mesh__recordAuthorizer mesh__D007932 PLS
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007932 1996
% 224.13/224.32  |- skos__historyNote mesh__D007932 Cyclohexanes %28%1971-1972%29%
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007932 1998
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007932 1997
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007932 1994
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007932 1999
% 224.13/224.32  |- mesh__recordMaintainer mesh__D007932 TGC
% 224.13/224.32  |- skos__broader mesh__D007932smesh__D013141
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007932 2002
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007932 1993
% 224.13/224.32  |- skos__historyNote mesh__D007932 Penicillium %28%1966-1972%29%
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007932 1995
% 224.13/224.32  |- mesh__historyNote mesh__D007932
% 224.13/224.32       91%28%73%29%; was see under SPIRO COMPOUNDS 1973-90   
% 224.13/224.32  |- skos__historyNote mesh__D007932 Spiro Compounds %28%1971-1972%29%
% 224.13/224.32  |- mesh__dateEstablished mesh__D007932 1991-01-01
% 224.13/224.32  |- mesh__publicMeSHNote mesh__D007134 88   
% 224.13/224.32  |- mesh__dateCreated mesh__D007134 1987-05-11
% 224.13/224.32  |- skos__hiddenLabel mesh__D007134 Switch Regions, Immunoglobulin
% 224.13/224.32  |- rdf__type mesh__D007134sskos__Concept
% 224.13/224.32  |- skos__altLabel mesh__D007134 Ig Switch Sequences
% 224.13/224.32  |- skos__hiddenLabel mesh__D007134 Immunoglobulin Switch Regions
% 224.13/224.32  |- skos__hiddenLabel mesh__D007134 Regions, Immunoglobulin Switch
% 224.13/224.32  |- skos__hiddenLabel mesh__D007134 Ig Switch Sequence
% 224.13/224.32  |- mesh__historyNote mesh__D007134 88   
% 224.13/224.32  |- skos__altLabel mesh__D007134 Switch Region, Immunoglobulin
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007134 2006A
% 224.13/224.32  |- skos__prefLabel mesh__D007134 Immunoglobulin Switch Region
% 224.13/224.32  |- skos__related mesh__D007134smesh__D017578
% 224.13/224.32  |- mesh__recordOriginator mesh__D007134 SCD
% 224.13/224.32  |- mesh__recordMaintainer mesh__D007134 ags
% 224.13/224.32  |- skos__annotation mesh__D007134 DF: IG SWITCH REGION   
% 224.13/224.32  |- skos__broader mesh__D007134smesh__D040461
% 224.13/224.32  |- skos__hiddenLabel mesh__D007134 Switch Sequence, Ig
% 224.13/224.32  |- skos__hiddenLabel mesh__D007134 Region, Immunoglobulin Switch
% 224.13/224.32  |- skos__broader mesh__D007134smesh__D050438
% 224.13/224.32  |- skos__hiddenLabel mesh__D007134 Sequences, Ig Switch
% 224.13/224.32  |- skos__historyNote mesh__D007134
% 224.13/224.32       Immunoglobulin Constant Region %28%1979-1987%29%
% 224.13/224.32  |- mesh__dateRevised mesh__D007134 2005-07-18
% 224.13/224.32  |- mesh__recordAuthorizer mesh__D007134 ags
% 224.13/224.32  |- skos__scopeNote mesh__D007134
% 224.13/224.32       A site located in the INTRONS at the 5%27% end of each constant region segment of a immunoglobulin heavy-chain gene where recombination %28%or rearrangement%29% occur during IMMUNOGLOBULIN CLASS SWITCHING. Ig switch regions are found on genes encoding all five classes %28%IMMUNOGLOBULIN ISOTYPES%29% of IMMUNOGLOBULIN HEAVY CHAINS.%A%    
% 224.13/224.32  |- skos__hiddenLabel mesh__D007134 Switch Sequences, Ig
% 224.13/224.32  |- mesh__dateEstablished mesh__D007134 1988-01-01
% 224.13/224.32  |- skos__historyNote mesh__D007134
% 224.13/224.32       Immunoglobulin Variable Region %28%1977-1987%29%
% 224.13/224.32  |- skos__hiddenLabel mesh__D007134 Sequence, Ig Switch
% 224.13/224.32  |- skos__historyNote mesh__D007134 Genes, Structural %28%1977-1987%29%
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D007134 2006
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D012877 2004
% 224.13/224.32  |- mesh__recordOriginator mesh__D012877 NLM
% 224.13/224.32  |- skos__broader mesh__D012877smesh__D012816
% 224.13/224.32  |- skos__hiddenLabel mesh__D012877 Manifestations, Skin
% 224.13/224.32  |- mesh__activeMeSHYear mesh__D012877 2001
% 224.13/224.32  |- skos__prefLabel mesh__D012877 Skin Manifestations
% 224.13/224.32  |- mesh__dateEstablished mesh__D012877 1965-01-01
% 224.13/224.32  |- mesh__dateCreated mesh__D012877 1999-01-01
% 224.13/224.32  |- mesh__historyNote mesh__D012877 65   
% 224.13/224.32  |- mesh__dateRevised mesh__D012877 1998-06-11
% 224.13/224.32  |- skos__annotation mesh__D012877
% 224.13/224.32       not used for indexing since 1989; prior to 1989 used for skin manifest of non-skin diseases%A%  
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D012877 2005
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D012877 2002
% 224.13/224.33  |- mesh__recordMaintainer mesh__D012877 JLS
% 224.13/224.33  |- skos__hiddenLabel mesh__D012877 Skin Manifestation
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D012877 2006
% 224.13/224.33  |- skos__broader mesh__D012877smesh__D012871
% 224.13/224.33  |- mesh__publicMeSHNote mesh__D012877 65   
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D012877 2003
% 224.13/224.33  |- rdf__type mesh__D012877sskos__Concept
% 224.13/224.33  |- skos__scopeNote mesh__D012877
% 224.13/224.33       Dermatologic disorders attendant upon non-dermatologic disease or injury.%A%    
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D012877 2000
% 224.13/224.33  |- mesh__recordAuthorizer mesh__D012877 SJN
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D012877 1999
% 224.13/224.33  |- skos__hiddenLabel mesh__D012877 Manifestation, Skin
% 224.13/224.33  |- rdf__type mesh__D012079sskos__Concept
% 224.13/224.33  |- mesh__dateEstablished mesh__D012079 1982-01-01
% 224.13/224.33  |- mesh__historyNote mesh__D012079 82   
% 224.13/224.33  |- mesh__dateRevised mesh__D012079 2003-07-09
% 224.13/224.33  |- skos__hiddenLabel mesh__D012079 Blood Flow, Renal
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D012079 2004
% 224.13/224.33  |- skos__annotation mesh__D012079
% 224.13/224.33       note specific indentions; consider also KIDNEY /blood supply; DF: RENAL CIRC%A%  
% 224.13/224.33  |- skos__historyNote mesh__D012079 Kidney/blood supply %28%1966-1981%29%
% 224.13/224.33  |- skos__hiddenLabel mesh__D012079 Flow, Renal Blood
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D012079 2006
% 224.13/224.33  |- skos__altLabel mesh__D012079 Circulation, Kidney
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D012079 2005
% 224.13/224.33  |- skos__prefLabel mesh__D012079 Renal Circulation
% 224.13/224.33  |- skos__historyNote mesh__D012079 Regional Blood Flow %28%1966-1981%29%
% 224.13/224.33  |- mesh__publicMeSHNote mesh__D012079 82   
% 224.13/224.33  |- skos__broader mesh__D012079smesh__D001775
% 224.13/224.33  |- skos__altLabel mesh__D012079 Circulation, Renal
% 224.13/224.33  |- mesh__recordOriginator mesh__D012079 VDK
% 224.13/224.33  |- mesh__dateCreated mesh__D012079 1981-05-19
% 224.13/224.33  |- mesh__recordMaintainer mesh__D012079 nns
% 224.13/224.33  |- mesh__recordAuthorizer mesh__D012079 sjn
% 224.13/224.33  |- skos__scopeNote mesh__D012079
% 224.13/224.33       The circulation of the BLOOD through the vessels of the KIDNEY.%A%    
% 224.13/224.33  |- skos__altLabel mesh__D012079 Kidney Circulation
% 224.13/224.33  |- mesh__dateEstablished mesh__D017562 1994-01-01
% 224.13/224.33  |- skos__scopeNote mesh__D017562
% 224.13/224.33       Abdominal symptoms after removal of the GALLBLADDER. The common postoperative symptoms are often the same as those present before the operation, such as COLIC, bloating, NAUSEA, and VOMITING. There is pain on palpation of the right upper quadrant and sometimes JAUNDICE. The term is often used, inaccurately, to describe such postoperative symptoms not due to gallbladder removal.%A%    
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Postcholedochoduodenostomy Syndromes
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Post Cholecystectomy Syndrome
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Syndromes, Postcholecystectomy
% 224.13/224.33  |- skos__altLabel mesh__D017562 Post-Cholecystectomy Syndrome
% 224.13/224.33  |- mesh__publicMeSHNote mesh__D017562 94   
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Post-Cholecystectomy Syndromes
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Syndrome, Postcholedochostomy
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Syndromes, Postcholedochostomy
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Sump Syndromes
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Post Choledochoduodenostomy Syndrome
% 224.13/224.33  |- skos__broader mesh__D017562smesh__D001660
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Syndrome, Post-Choledochojejunostomy
% 224.13/224.33  |- mesh__recordMaintainer mesh__D017562 ags
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D017562 2004
% 224.13/224.33  |- skos__altLabel mesh__D017562 Post-Choledochostomy Syndrome
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D017562 2006A
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Post-Choledochoduodenostomy Syndromes
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Syndrome, Postcholedochoduodenostomy
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Syndromes, Post-Choledochojejunostomy
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Syndrome, Post-Choledochostomy
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D017562 2005
% 224.13/224.33  |- mesh__dateRevised mesh__D017562 2005-07-14
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Syndromes, Post-Choledochoduodenostomy
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Syndrome, Postcholedochojejunostomy
% 224.13/224.33  |- rdf__type mesh__D017562sskos__Concept
% 224.13/224.33  |- skos__prefLabel mesh__D017562 Postcholecystectomy Syndrome
% 224.13/224.33  |- skos__related mesh__D017562smesh__D002763
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Syndromes, Postcholedochojejunostomy
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Post Choledochojejunostomy Syndrome
% 224.13/224.33  |- mesh__dateCreated mesh__D017562 1992-12-28
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D017562 2006
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Syndrome, Sump
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Post-Choledochojejunostomy Syndromes
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Post-Choledochostomy Syndromes
% 224.13/224.33  |- skos__related mesh__D017562smesh__D002768
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Postcholecystectomy Syndromes
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Syndromes, Postcholedochoduodenostomy
% 224.13/224.33  |- mesh__recordAuthorizer mesh__D017562 ags
% 224.13/224.33  |- mesh__historyNote mesh__D017562 94   
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Syndromes, Post-Cholecystectomy
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Postcholedochostomy Syndromes
% 224.13/224.33  |- skos__altLabel mesh__D017562 Post-Choledochojejunostomy Syndrome
% 224.13/224.33  |- skos__historyNote mesh__D017562 Cholecystectomy %28%1966-1993%29%
% 224.13/224.33  |- mesh__recordOriginator mesh__D017562 TGC
% 224.13/224.33  |- skos__altLabel mesh__D017562 Post-Choledochoduodenostomy Syndrome
% 224.13/224.33  |- skos__historyNote mesh__D017562
% 224.13/224.33       Postoperative Complications %28%1966-1993%29%
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Syndrome, Postcholecystectomy
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Postcholedochojejunostomy Syndromes
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Syndromes, Sump
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Syndromes, Post-Choledochostomy
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Syndrome, Post-Choledochoduodenostomy
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Post Choledochostomy Syndrome
% 224.13/224.33  |- skos__broader mesh__D017562smesh__D011183
% 224.13/224.33  |- skos__hiddenLabel mesh__D017562 Syndrome, Post-Cholecystectomy
% 224.13/224.33  |- skos__scopeNote mesh__D031233
% 224.13/224.33       A plant genus of the family BURSERACEAE. Members contain a PODOPHYLLOTOXIN.%A%    
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D031233 2006
% 224.13/224.33  |- mesh__historyNote mesh__D031233 2003   
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D031233 2003
% 224.13/224.33  |- skos__prefLabel mesh__D031233 Bursera
% 224.13/224.33  |- rdf__type mesh__D031233sskos__Concept
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D031233 2004
% 224.13/224.33  |- mesh__dateEstablished mesh__D031233 2003-01-01
% 224.13/224.33  |- skos__broader mesh__D031233smesh__D029403
% 224.13/224.33  |- mesh__dateCreated mesh__D031233 2002-07-02
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D031233 2005
% 224.13/224.33  |- skos__annotation mesh__D031233
% 224.13/224.33       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.13/224.33  |- mesh__publicMeSHNote mesh__D031233 2003   
% 224.13/224.33  |- skos__altLabel mesh__D031233 Gumbo Limbo
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D050996 2006
% 224.13/224.33  |- rdf__type mesh__D050996sskos__Concept
% 224.13/224.33  |- mesh__recordOriginator mesh__D050996 DRC
% 224.13/224.33  |- mesh__dateEstablished mesh__D050996 2006-01-01
% 224.13/224.33  |- mesh__recordAuthorizer mesh__D050996 sjn
% 224.13/224.33  |- skos__scopeNote mesh__D050996
% 224.13/224.33       Voltage-dependent anion channel 2 is a low abundance mammalian isoform of VDAC that interacts with the inactive form of BAK PROTEIN.%A%    
% 224.13/224.33  |- mesh__publicMeSHNote mesh__D050996
% 224.13/224.33       2006; VOLTAGE-DEPENDENT ANION CHANNEL 2 was indexed under MEMBRANE PROTEINS 1985-1999, %26% under PORINS 2000-2005%A%  
% 224.13/224.33  |- skos__prefLabel mesh__D050996 Voltage-Dependent Anion Channel 2
% 224.13/224.33  |- mesh__dateCreated mesh__D050996 2005-06-30
% 224.13/224.33  |- mesh__recordMaintainer mesh__D050996 DRC
% 224.13/224.33  |- skos__hiddenLabel mesh__D050996 Voltage Dependent Anion Channel 2
% 224.13/224.33  |- skos__altLabel mesh__D050996 VDAC2 Protein
% 224.13/224.33  |- mesh__historyNote mesh__D050996 2006%28%1985%29%   
% 224.13/224.33  |- skos__broader mesh__D050996smesh__D050994
% 224.13/224.33  |- skos__hiddenLabel mesh__D003542 Deaminase, Homoserine
% 224.13/224.33  |- skos__historyNote mesh__D003542 Lyases %28%1973-1974%29%
% 224.13/224.33  |- skos__altLabel mesh__D003542 Cystathionase
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D003542 2005
% 224.13/224.33  |- skos__hiddenLabel mesh__D003542 Desulfohydrolase, Cystine
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D003542 2004
% 224.13/224.33  |- mesh__publicMeSHNote mesh__D003542 91; was see under LYASES 1975-90   
% 224.13/224.33  |- skos__altLabel mesh__D003542 Homoserine Deaminase
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D003542 2006
% 224.13/224.33  |- skos__historyNote mesh__D003542 Homoserine %28%1973-1974%29%
% 224.13/224.33  |- skos__hiddenLabel mesh__D003542 gamma-Lyase, Cystathionine
% 224.13/224.33  |- skos__altLabel mesh__D003542 Cystine Desulfhydrase
% 224.13/224.33  |- skos__hiddenLabel mesh__D003542 Dehydratase, Homoserine
% 224.13/224.33  |- skos__altLabel mesh__D003542 Cystine Desulfohydrolase
% 224.13/224.33  |- mesh__recordAuthorizer mesh__D003542 sjn
% 224.13/224.33  |- skos__historyNote mesh__D003542 Cysteine %28%1973-1974%29%
% 224.13/224.33  |- skos__altLabel mesh__D003542 Homoserine Dehydratase
% 224.13/224.33  |- skos__altLabel mesh__D003542 Cysteine Desulfhydrase
% 224.13/224.33  |- mesh__dateCreated mesh__D003542 1974-11-11
% 224.13/224.33  |- skos__altLabel mesh__D003542 gamma-Cystathionase
% 224.13/224.33  |- mesh__recordOriginator mesh__D003542 NLM
% 224.13/224.33  |- mesh__dateRevised mesh__D003542 2003-07-09
% 224.13/224.33  |- skos__prefLabel mesh__D003542 Cystathionine gamma-Lyase
% 224.13/224.33  |- skos__annotation mesh__D003542
% 224.13/224.33       /defic: consider also CYSTATHIONINE /urine %28%IM%29% + AMINO ACID METABOLISM, INBORN ERRORS %28%IM%29%%A%  
% 224.13/224.33  |- skos__hiddenLabel mesh__D003542 Cystathionine gamma Lyase
% 224.13/224.33  |- rdf__type mesh__D003542sskos__Concept
% 224.13/224.33  |- mesh__historyNote mesh__D003542
% 224.13/224.33       91%28%75%29%; was see under LYASES 1975-90   
% 224.13/224.33  |- skos__hiddenLabel mesh__D003542 Desulfhydrase, Cystine
% 224.13/224.33  |- mesh__dateEstablished mesh__D003542 1991-01-01
% 224.13/224.33  |- skos__scopeNote mesh__D003542
% 224.13/224.33       A multifunctional pyridoxal phosphate enzyme. In the final step in the biosynthesis of cysteine it catalyzes the cleavage of cystathionine to yield cysteine, ammonia, and 2-ketobutyrate. EC 4.4.1.1.%A%    
% 224.13/224.33  |- skos__hiddenLabel mesh__D003542 Desulfhydrase, Cysteine
% 224.13/224.33  |- skos__broader mesh__D003542smesh__D013437
% 224.13/224.33  |- skos__hiddenLabel mesh__D003542 gamma Cystathionase
% 224.13/224.33  |- mesh__recordMaintainer mesh__D003542 ssb
% 224.13/224.33  |- skos__historyNote mesh__D050198 Propanol %28%1972-2005%29%
% 224.13/224.33  |- mesh__publicMeSHNote mesh__D050198 2006   
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D050198 2006
% 224.13/224.33  |- mesh__recordAuthorizer mesh__D050198 sjn
% 224.13/224.33  |- skos__altLabel mesh__D050198 Phenoxy-Propanolamines
% 224.13/224.33  |- mesh__dateCreated mesh__D050198 2005-06-30
% 224.13/224.33  |- mesh__recordOriginator mesh__D050198 ssb
% 224.13/224.33  |- mesh__recordMaintainer mesh__D050198 ssb
% 224.13/224.33  |- skos__broader mesh__D050198smesh__D011412
% 224.13/224.33  |- mesh__dateEstablished mesh__D050198 2006-01-01
% 224.13/224.33  |- rdf__type mesh__D050198sskos__Concept
% 224.13/224.33  |- skos__prefLabel mesh__D050198 Phenoxypropanolamines
% 224.13/224.33  |- skos__scopeNote mesh__D050198
% 224.13/224.33       Compounds based on a propanolamine attached via an OXYGEN atom to a phenoxy ring. The side chain is one carbon longer than PHENYLETHYLAMINES.%A%    
% 224.13/224.33  |- mesh__historyNote mesh__D050198 2006   
% 224.13/224.33  |- skos__hiddenLabel mesh__D050198 Phenoxy Propanolamines
% 224.13/224.33  |- skos__broader mesh__D013970smesh__D013974
% 224.13/224.33  |- skos__scopeNote mesh__D013970
% 224.13/224.33       A group of metabolites derived from THYROXINE and TRIIODOTHYRONINE via the peripheral enzymatic removal of iodines from the thyroxine nucleus.  Thyronine is the thyroxine nucleus devoid of its four iodine atoms.%A%    
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D013970 2003
% 224.13/224.33  |- skos__prefLabel mesh__D013970 Thyronines
% 224.13/224.33  |- mesh__dateRevised mesh__D013970 2001-07-25
% 224.13/224.33  |- skos__broader mesh__D013970smesh__D013963
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D013970 2002
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D013970 2006
% 224.13/224.33  |- mesh__historyNote mesh__D013970 79; was THYRONINE 1963-78   
% 224.13/224.33  |- mesh__onlineNote mesh__D013970
% 224.13/224.33       use THYRONINES to search THYRONINE 1966-78   
% 224.13/224.33  |- mesh__dateCreated mesh__D013970 1999-01-01
% 224.13/224.33  |- mesh__publicMeSHNote mesh__D013970 79; was THYRONINE 1963-78   
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D013970 2005
% 224.13/224.33  |- mesh__recordMaintainer mesh__D013970 nns
% 224.13/224.33  |- rdf__type mesh__D013970sskos__Concept
% 224.13/224.33  |- mesh__recordAuthorizer mesh__D013970 sjn
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D013970 2004
% 224.13/224.33  |- mesh__recordOriginator mesh__D013970 NLM
% 224.13/224.33  |- mesh__dateEstablished mesh__D013172 1974-01-01
% 224.13/224.33  |- skos__scopeNote mesh__D013172
% 224.13/224.33       Reproductive bodies produced by fungi.     
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D013172 2006
% 224.13/224.33  |- skos__broader mesh__D013172smesh__D048690
% 224.13/224.33  |- mesh__recordOriginator mesh__D013172 NLM
% 224.13/224.33  |- skos__historyNote mesh__D013172 Fungi %28%1966-1970%29%
% 224.13/224.33  |- skos__broader mesh__D013172smesh__D013170
% 224.13/224.33  |- mesh__recordMaintainer mesh__D013172 SYSTEM
% 224.13/224.33  |- skos__altLabel mesh__D013172 Fungal Spores
% 224.13/224.33  |- skos__historyNote mesh__D013172 Spores %28%1966-1970%29%
% 224.13/224.33  |- mesh__dateCreated mesh__D013172 1999-01-01
% 224.13/224.33  |- mesh__historyNote mesh__D013172 74%28%71%29%   
% 224.13/224.33  |- skos__historyNote mesh__D013172 specific fungus
% 224.13/224.33  |- mesh__dateRevised mesh__D013172 2005-06-30
% 224.13/224.33  |- rdf__type mesh__D013172sskos__Concept
% 224.13/224.33  |- mesh__recordAuthorizer mesh__D013172 sjn
% 224.13/224.33  |- skos__annotation mesh__D013172
% 224.13/224.33       coord with specific fungus; sporulation: coord specific fungus /physiol; Manual 22.31%A%  
% 224.13/224.33  |- mesh__publicMeSHNote mesh__D013172 74   
% 224.13/224.33  |- skos__prefLabel mesh__D013172 Spores, Fungal
% 224.13/224.33  |- skos__scopeNote mesh__D007933
% 224.13/224.33       An antibiotic complex produced by Streptomyces kitasatoensis. The complex consists of a mixture of at least eight biologically active components, A1 and A3 to A9. Leucomycins have both antibacterial and antimycoplasmal activities.%A%    
% 224.13/224.33  |- mesh__recordMaintainer mesh__D007933 ssb
% 224.13/224.33  |- skos__historyNote mesh__D007933 Aminoglycosides %28%1974-1975%29%
% 224.13/224.33  |- mesh__historyNote mesh__D007933
% 224.13/224.33       81; was KITASAMYCINS see under ANTIBIOTICS 1976-80   
% 224.13/224.33  |- mesh__dateCreated mesh__D007933 1975-07-25
% 224.13/224.33  |- skos__prefLabel mesh__D007933 Leucomycins
% 224.13/224.33  |- skos__annotation mesh__D007933
% 224.13/224.33       do not confuse with LEUCOMYCIN see KITASAMYCIN   
% 224.13/224.33  |- skos__broader mesh__D007933smesh__D018942
% 224.13/224.33  |- skos__historyNote mesh__D007933 Lactones %28%1973-1975%29%
% 224.13/224.33  |- skos__historyNote mesh__D007933 Antibiotics %28%1970-1975%29%
% 224.13/224.33  |- rdf__type mesh__D007933sskos__Concept
% 224.13/224.33  |- mesh__recordOriginator mesh__D007933 SH
% 224.13/224.33  |- mesh__onlineNote mesh__D007933
% 224.13/224.33       use LEUCOMYCINS to search KITASAMYCINS 1976-80   
% 224.13/224.33  |- mesh__publicMeSHNote mesh__D007933
% 224.13/224.33       81; was KITASAMYCINS see under ANTIBIOTICS 1976-80   
% 224.13/224.33  |- mesh__dateEstablished mesh__D007933 1981-01-01
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D007933 2005
% 224.13/224.33  |- mesh__recordAuthorizer mesh__D007933 sjn
% 224.13/224.33  |- mesh__dateRevised mesh__D007933 2004-07-07
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D007933 2006
% 224.13/224.33  |- mesh__recordOriginator mesh__D007135 SH
% 224.13/224.33  |- mesh__historyNote mesh__D007135
% 224.13/224.33       84%28%77%29%; was see under BINDING SITES, ANTIBODY 1977-83   
% 224.13/224.33  |- skos__hiddenLabel mesh__D007135 Regions, Immunoglobulin Variable
% 224.13/224.33  |- skos__annotation mesh__D007135 DF: IG VARIABLE REGION   
% 224.13/224.33  |- skos__broader mesh__D007135smesh__D000595
% 224.13/224.33  |- skos__altLabel mesh__D007135 Ig Variable Region
% 224.13/224.33  |- skos__prefLabel mesh__D007135 Immunoglobulin Variable Region
% 224.13/224.33  |- skos__historyNote mesh__D007135
% 224.13/224.33       Immunoglobulin Fragments %28%1973-1976%29%
% 224.13/224.33  |- skos__altLabel mesh__D007135 Variable Region, Ig
% 224.13/224.33  |- skos__hiddenLabel mesh__D007135 Framework Regions, Ig
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D007135 2006
% 224.13/224.33  |- mesh__dateEstablished mesh__D007135 1984-01-01
% 224.13/224.33  |- skos__broader mesh__D007135smesh__D007140
% 224.13/224.33  |- mesh__dateCreated mesh__D007135 1976-04-16
% 224.13/224.33  |- skos__altLabel mesh__D007135 Ig Framework Region
% 224.13/224.33  |- mesh__recordAuthorizer mesh__D007135 sjn
% 224.13/224.33  |- skos__historyNote mesh__D007135
% 224.13/224.33       Binding Sites, Antibody %28%1973-1976%29%
% 224.13/224.33  |- skos__hiddenLabel mesh__D007135 Immunoglobulin Variable Regions
% 224.13/224.33  |- skos__historyNote mesh__D007135 Immunoglobulins, Fab %28%1973-1976%29%
% 224.13/224.33  |- skos__hiddenLabel mesh__D007135 Immunoglobulin Framework Regions
% 224.13/224.33  |- skos__hiddenLabel mesh__D007135 Variable Regions, Immunoglobulin
% 224.13/224.33  |- skos__altLabel mesh__D007135 Immunoglobulin Framework Region
% 224.13/224.33  |- skos__historyNote mesh__D007135 Antigenic Determinants %28%1972-1976%29%
% 224.13/224.33  |- rdf__type mesh__D007135sskos__Concept
% 224.13/224.33  |- skos__hiddenLabel mesh__D007135 Variable Regions, Ig
% 224.13/224.33  |- skos__scopeNote mesh__D007135
% 224.13/224.33       That region of the immunoglobulin molecule that varies in its amino acid sequence and composition, and comprises the binding site for a specific antigen. It is located at the N-terminus of the Fab fragment of the immunoglobulin. It includes hypervariable regions %28%COMPLEMENTARITY DETERMINING REGIONS%29% and framework regions.%A%    
% 224.13/224.33  |- mesh__recordMaintainer mesh__D007135 nns
% 224.13/224.33  |- skos__hiddenLabel mesh__D007135 Framework Regions, Immunoglobulin
% 224.13/224.33  |- skos__related mesh__D007135smesh__D001666
% 224.13/224.33  |- mesh__dateRevised mesh__D007135 2005-06-30
% 224.13/224.33  |- skos__hiddenLabel mesh__D007135 Ig Framework Regions
% 224.13/224.33  |- skos__altLabel mesh__D007135 Variable Region, Immunoglobulin
% 224.13/224.33  |- skos__hiddenLabel mesh__D007135 Framework Region, Ig
% 224.13/224.33  |- mesh__publicMeSHNote mesh__D007135
% 224.13/224.33       84; was see under BINDING SITES, ANTIBODY 1977-83   
% 224.13/224.33  |- skos__broader mesh__D007135smesh__D007136
% 224.13/224.33  |- skos__hiddenLabel mesh__D007135 Ig Variable Regions
% 224.13/224.33  |- skos__altLabel mesh__D007135 Immunoglobulin V
% 224.13/224.33  |- skos__broader mesh__D012878smesh__D012871
% 224.13/224.33  |- rdf__type mesh__D012878sskos__Concept
% 224.13/224.33  |- skos__hiddenLabel mesh__D012878 Neoplasm, Skin
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D012878 2005
% 224.13/224.33  |- skos__hiddenLabel mesh__D012878 Skin Cancers
% 224.13/224.33  |- skos__hiddenLabel mesh__D012878 Cancer, Skin
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D012878 2003
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D012878 2002
% 224.13/224.33  |- skos__altLabel mesh__D012878 Skin Cancer
% 224.13/224.33  |- mesh__dateRevised mesh__D012878 2000-06-22
% 224.13/224.33  |- mesh__recordAuthorizer mesh__D012878 sjn
% 224.13/224.33  |- mesh__recordOriginator mesh__D012878 NLM
% 224.13/224.33  |- skos__scopeNote mesh__D012878 Tumors or cancer of the SKIN.     
% 224.13/224.33  |- mesh__recordMaintainer mesh__D012878 nns
% 224.13/224.33  |- skos__hiddenLabel mesh__D012878 Skin Neoplasm
% 224.13/224.33  |- mesh__dateCreated mesh__D012878 1999-01-01
% 224.13/224.33  |- skos__annotation mesh__D012878
% 224.13/224.33       coord IM with histol type of neoplasm %28%IM%29%; coord also with site %28%NIM%29% if merely locational but for neoplasms of the head or neck, coord IM with HEAD AND NECK NEOPLASMS or specifics %28%IM%29%%A%  
% 224.13/224.33  |- skos__hiddenLabel mesh__D012878 Cancers, Skin
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D012878 2001
% 224.13/224.33  |- skos__prefLabel mesh__D012878 Skin Neoplasms
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D012878 2006
% 224.13/224.33  |- skos__altLabel mesh__D012878 Neoplasms, Skin
% 224.13/224.33  |- skos__broader mesh__D012878smesh__D009371
% 224.13/224.33  |- skos__altLabel mesh__D012878 Cancer of the Skin
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D012878 2004
% 224.13/224.33  |- skos__historyNote mesh__D017563 Pulmonary Fibrosis %28%1966-1993%29%
% 224.13/224.33  |- skos__broader mesh__D017563smesh__D008171
% 224.13/224.33  |- mesh__recordOriginator mesh__D017563 TGC
% 224.13/224.33  |- mesh__onlineNote mesh__D017563
% 224.13/224.33       use PULMONARY FIBROSIS to search LUNG DISEASE, INTERSTITIAL %26% PNEUMONITIS, INTERSTITIAL 1985-93 %26% PNEUMONIA, INTERSTITIAL 1966-93%A%  
% 224.13/224.33  |- skos__prefLabel mesh__D017563 Lung Diseases, Interstitial
% 224.13/224.33  |- skos__hiddenLabel mesh__D017563 Diseases, Interstitial Lung
% 224.13/224.33  |- skos__hiddenLabel mesh__D017563 Lung Disease, Interstitial
% 224.13/224.33  |- mesh__publicMeSHNote mesh__D017563
% 224.13/224.33       94; was LUNG DISEASE, INTERSTITIAL see PULMONARY FIBROSIS 1985-93; PNEUMONITIS, INTERSTITIAL was see PULMONARY FIBROSIS 1985-93; PNEUMONIA, INTERSTITIAL was see under PULMONARY FIBROSIS 1963-74, was see PULMONARY FIBROSIS 1975-93%A%  
% 224.13/224.33  |- skos__altLabel mesh__D017563 Interstitial Lung Diseases
% 224.13/224.33  |- rdf__type mesh__D017563sskos__Concept
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D017563 2006
% 224.13/224.33  |- skos__annotation mesh__D017563
% 224.13/224.33       GEN or unspecified; prefer specifics; DF: LUNG DIS INTERSTITIAL%A%  
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D017563 2002
% 224.13/224.33  |- skos__hiddenLabel mesh__D017563 Interstitial Pneumonitides
% 224.13/224.33  |- skos__hiddenLabel mesh__D017563 Pneumonias, Interstitial
% 224.13/224.33  |- skos__hiddenLabel mesh__D017563 Pneumonitides, Interstitial
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D017563 2005
% 224.13/224.33  |- skos__hiddenLabel mesh__D017563 Interstitial Pneumonia
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D017563 2004
% 224.13/224.33  |- mesh__historyNote mesh__D017563
% 224.13/224.33       94; was LUNG DISEASE, INTERSTITIAL see PULMONARY FIBROSIS 1985-93; PNEUMONITIS, INTERSTITIAL was see PULMONARY FIBROSIS 1985-93; PNEUMONIA, INTERSTITIAL was see under PULMONARY FIBROSIS 1963-74, was see PULMONARY FIBROSIS 1975-93%A%  
% 224.13/224.33  |- skos__hiddenLabel mesh__D017563 Interstitial Pneumonias
% 224.13/224.33  |- skos__altLabel mesh__D017563 Pneumonia, Interstitial
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D017563 2003
% 224.13/224.33  |- mesh__dateRevised mesh__D017563 1995-06-08
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D017563 1999
% 224.13/224.33  |- skos__scopeNote mesh__D017563
% 224.13/224.33       A heterogeneous group of noninfectious, nonmalignant disorders of the lower respiratory tract, affecting primarily the alveolar wall structures but also often involving the small airways and blood vessels of the lung parenchyma. %22%Interstitial%22% refers to the fact that the interstitium of the alveolar walls is thickened, usually by fibrosis. This group of diseases is usually inflammatory. %28%Dorland, 27th ed; Wyngarden, Cecil Textbook of Medicine, 19th ed, p396%29%%A%    
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D017563 2001
% 224.13/224.33  |- skos__hiddenLabel mesh__D017563 Interstitial Pneumonitis
% 224.13/224.33  |- mesh__dateEstablished mesh__D017563 1994-01-01
% 224.13/224.33  |- skos__hiddenLabel mesh__D017563 Interstitial Lung Disease
% 224.13/224.33  |- skos__hiddenLabel mesh__D017563 Disease, Interstitial Lung
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D017563 1998
% 224.13/224.33  |- mesh__recordAuthorizer mesh__D017563 PLS
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D017563 1997
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D017563 2000
% 224.13/224.33  |- mesh__dateCreated mesh__D017563 1993-06-03
% 224.13/224.33  |- mesh__recordMaintainer mesh__D017563 TAP
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D017563 1996
% 224.13/224.33  |- mesh__publicMeSHNote mesh__D031234 2003   
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D031234 2006
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D031234 2004
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D031234 2005
% 224.13/224.33  |- mesh__dateEstablished mesh__D031234 2003-01-01
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D031234 2003
% 224.13/224.33  |- mesh__historyNote mesh__D031234 2003   
% 224.13/224.33  |- rdf__type mesh__D031234sskos__Concept
% 224.13/224.33  |- skos__scopeNote mesh__D031234
% 224.13/224.33       A plant family of the order Euphorbiales, subclass Rosidae, class Magnoliopsida. Leaves are alternate, simple, and leathery. Fruits are one- or two-seeded capsules or drupes %28%stony-pitted fleshy fruits%29%.%A%    
% 224.13/224.33  |- mesh__dateCreated mesh__D031234 2002-07-02
% 224.13/224.33  |- skos__broader mesh__D031234smesh__D019684
% 224.13/224.33  |- skos__prefLabel mesh__D031234 Buxaceae
% 224.13/224.33  |- skos__annotation mesh__D031234
% 224.13/224.33       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.13/224.33  |- mesh__recordOriginator mesh__D050997 ags
% 224.13/224.33  |- skos__historyNote mesh__D050997 Nanotechnology %28%2002-2005%29%
% 224.13/224.33  |- skos__broader mesh__D050997smesh__D020811
% 224.13/224.33  |- mesh__publicMeSHNote mesh__D050997 2006   
% 224.13/224.33  |- mesh__historyNote mesh__D050997 2006   
% 224.13/224.33  |- mesh__dateEstablished mesh__D050997 2006-01-01
% 224.13/224.33  |- skos__scopeNote mesh__D050997
% 224.13/224.33       The branch of medicine concerned with the application of NANOTECHNOLOGY to the prevention and treatment of disease. It involves the monitoring, repair, construction, and control of human biological systems at the molecular level, using engineered nanodevices and NANOSTRUCTURES. %28%From Freitas Jr., Nanomedicine, vol 1, 1999%29%.%A%    
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D050997 2006
% 224.13/224.33  |- skos__prefLabel mesh__D050997 Nanomedicine
% 224.13/224.33  |- mesh__recordMaintainer mesh__D050997 ags
% 224.13/224.33  |- skos__broader mesh__D050997smesh__D036103
% 224.13/224.33  |- mesh__recordAuthorizer mesh__D050997 sjn
% 224.13/224.33  |- mesh__dateCreated mesh__D050997 2005-06-30
% 224.13/224.33  |- rdf__type mesh__D050997sskos__Concept
% 224.13/224.33  |- skos__altLabel mesh__D003543 Mercaptamine
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D003543 2001
% 224.13/224.33  |- skos__scopeNote mesh__D003543
% 224.13/224.33       A radiation-protective agent that oxidizes in air to form CYSTAMINE. It can be given intravenously or orally to treat radiation sickness. The bitartrate has been used for the oral treatment of nephropathic cystinosis.%A%    
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D003543 2004
% 224.13/224.33  |- mesh__dateCreated mesh__D003543 1999-01-01
% 224.13/224.33  |- skos__hiddenLabel mesh__D003543 Cysteamine, 35S Labeled
% 224.13/224.33  |- mesh__dateRevised mesh__D003543 2000-06-22
% 224.13/224.33  |- skos__broader mesh__D003543smesh__D008624
% 224.13/224.33  |- skos__hiddenLabel mesh__D003543 Hydrobromide, Cysteamine
% 224.13/224.33  |- mesh__publicMeSHNote mesh__D003543
% 224.13/224.33       CYSTEINAMINE was see under MERCAPTOETHYLAMINES 1963-66   
% 224.13/224.33  |- mesh__historyNote mesh__D003543
% 224.13/224.33       CYSTEINAMINE was see under MERCAPTOETHYLAMINES 1963-66   
% 224.13/224.33  |- skos__hiddenLabel mesh__D003543 Tartrate, Cysteamine
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D003543 2003
% 224.13/224.33  |- skos__hiddenLabel mesh__D003543 2 Aminoethanethiol
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D003543 2006
% 224.13/224.33  |- skos__hiddenLabel mesh__D003543 35S-Labeled Cysteamine
% 224.13/224.33  |- skos__hiddenLabel mesh__D003543 Dihydrochloride, Cysteamine
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D003543 2002
% 224.13/224.33  |- skos__hiddenLabel mesh__D003543 Bitartrate, Cysteamine
% 224.13/224.33  |- skos__altLabel mesh__D003543 Cysteinamine
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D003543 2005
% 224.13/224.33  |- mesh__onlineNote mesh__D003543
% 224.13/224.33       use MERCAPTOETHYLAMINES to search CYSTEINAMINE 1966   
% 224.13/224.33  |- skos__altLabel mesh__D003543 Mercamine
% 224.13/224.33  |- skos__hiddenLabel mesh__D003543 Tosylate, Cysteamine
% 224.13/224.33  |- skos__prefLabel mesh__D003543 Cysteamine
% 224.13/224.33  |- mesh__recordAuthorizer mesh__D003543 sjn
% 224.13/224.33  |- skos__altLabel mesh__D003543 beta-Mercaptoethylamine
% 224.13/224.33  |- mesh__recordMaintainer mesh__D003543 CCR
% 224.13/224.33  |- rdf__type mesh__D003543sskos__Concept
% 224.13/224.33  |- skos__hiddenLabel mesh__D003543 beta Mercaptoethylamine
% 224.13/224.33  |- skos__annotation mesh__D003543 do not confuse with CYSTAMINE   
% 224.13/224.33  |- skos__altLabel mesh__D003543 2-Aminoethanethiol
% 224.13/224.33  |- skos__hiddenLabel mesh__D003543 Hydrochloride, Cysteamine
% 224.13/224.33  |- mesh__recordOriginator mesh__D003543 NLM
% 224.13/224.33  |- mesh__recordOriginator mesh__D050199 nns
% 224.13/224.33  |- skos__altLabel mesh__D050199 Visceral Epithelial Cells, Glomerular
% 224.13/224.33  |- mesh__publicMeSHNote mesh__D050199 2006   
% 224.13/224.33  |- mesh__activeMeSHYear mesh__D050199 2006
% 224.13/224.33  |- skos__prefLabel mesh__D050199 Podocytes
% 224.13/224.33  |- mesh__historyNote mesh__D050199 2006   
% 224.13/224.33  |- mesh__dateEstablished mesh__D050199 2006-01-01
% 224.13/224.33  |- skos__historyNote mesh__D050199 Kidney Glomerulus %28%1965-2005%29%
% 224.13/224.33  |- mesh__recordMaintainer mesh__D050199 nns
% 224.13/224.33  |- skos__altLabel mesh__D050199 Epithelial Cells, Glomerular Visceral
% 224.13/224.33  |- mesh__recordAuthorizer mesh__D050199 sjn
% 224.13/224.33  |- skos__scopeNote mesh__D050199
% 224.13/224.33       Highly differentiated epithelial cells of the visceral layer of BOWMAN CAPSULE of the KIDNEY. They are composed of a cell body with major CELL SURFACE EXTENSIONS and secondary fingerlike extensions called pedicels. They enwrap the KIDNEY GLOMERULUS capillaries with their cell surface extensions forming a filtration structure. The pedicels of neighboring podocytes interdigitate with each other leaving between them filtration slits that are bridged by an extracellular structure impermeable to large macromolecules called the slit diaphragm, and provide the last barrier to protein loss in the KIDNEY.%A%    
% 224.13/224.33  |- rdf__type mesh__D050199sskos__Concept
% 224.13/224.33  |- mesh__dateCreated mesh__D050199 2005-06-30
% 224.13/224.33  |- skos__broader mesh__D050199smesh__D007678
% 224.13/224.33  |- skos__broader mesh__D050199smesh__D004847
% 224.13/224.33  |- skos__hiddenLabel mesh__D050199 Podocyte
% 224.13/224.33  |- skos__altLabel mesh__D050199 Glomerular Visceral Epithelial Cells
% 224.13/224.33  |- skos__broader mesh__D013971smesh__D006980
% 224.13/224.33  |- skos__scopeNote mesh__D013971
% 224.13/224.33       A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.%A%    
% 224.13/224.34  |- mesh__recordMaintainer mesh__D013971 lkt
% 224.13/224.34  |- mesh__recordAuthorizer mesh__D013971 sjn
% 224.13/224.34  |- mesh__historyNote mesh__D013971 87; was see HYPERTHYROIDISM 1974-86   
% 224.13/224.34  |- mesh__dateEstablished mesh__D013971 1987-01-01
% 224.13/224.34  |- skos__prefLabel mesh__D013971 Thyrotoxicosis
% 224.13/224.34  |- mesh__activeMeSHYear mesh__D013971 2006
% 224.13/224.34  |- mesh__onlineNote mesh__D013971 search HYPERTHYROIDISM 1974-86   
% 224.13/224.34  |- skos__hiddenLabel mesh__D013971 Thyrotoxicoses
% 224.13/224.34  |- mesh__dateCreated mesh__D013971 1986-04-07
% 224.13/224.34  |- mesh__dateRevised mesh__D013971 2005-06-30
% 224.13/224.34  |- skos__historyNote mesh__D013971 Hyperthyroidism %28%1966-1986%29%
% 224.13/224.34  |- rdf__type mesh__D013971sskos__Concept
% 224.13/224.34  |- mesh__publicMeSHNote mesh__D013971
% 224.13/224.34       87; was see HYPERTHYROIDISM 1974-86   
% 224.13/224.34  |- skos__broader mesh__D013971smesh__D013959
% 224.13/224.34  |- mesh__recordOriginator mesh__D013971 VDK
% 224.13/224.34  |- mesh__recordAuthorizer mesh__D013173 sjn
% 224.13/224.34  |- skos__scopeNote mesh__D013173
% 224.13/224.34       A group of related mycotoxins produced by the pasture fungus Pithomyces chartarum %28%formerly Sporidesmium bakeri%29%; causes liver damage and facial eczema in cattle and sheep.%A%    
% 224.13/224.34  |- skos__broader mesh__D013173smesh__D007211
% 224.13/224.34  |- skos__prefLabel mesh__D013173 Sporidesmins
% 224.13/224.34  |- mesh__dateCreated mesh__D013173 1974-11-11
% 224.13/224.34  |- skos__historyNote mesh__D013173 Pyrroles %28%1966-1974%29%
% 224.13/224.34  |- skos__historyNote mesh__D013173 Indoles %28%1966-1974%29%
% 224.13/224.34  |- mesh__recordOriginator mesh__D013173 NLM
% 224.13/224.34  |- mesh__dateEstablished mesh__D013173 1991-01-01
% 224.13/224.34  |- skos__broader mesh__D013173smesh__D009183
% 224.13/224.34  |- rdf__type mesh__D013173sskos__Concept
% 224.13/224.34  |- skos__historyNote mesh__D013173 Pyrazines %28%1966-1974%29%
% 224.13/224.34  |- mesh__publicMeSHNote mesh__D013173 91; was see under INDOLES 1975-90   
% 224.13/224.34  |- mesh__recordMaintainer mesh__D013173 ssb
% 224.13/224.34  |- skos__annotation mesh__D013173
% 224.13/224.34       /antag permitted but consider also ANTITOXINS   
% 224.13/224.34  |- mesh__historyNote mesh__D013173
% 224.13/224.34       91%28%75%29%; was see under INDOLES 1975-90   
% 224.13/224.34  |- mesh__dateRevised mesh__D013173 2005-06-30
% 224.13/224.34  |- mesh__activeMeSHYear mesh__D013173 2006
% 224.13/224.34  |- mesh__dateRevised mesh__D007934 2005-06-30
% 224.13/224.34  |- mesh__recordAuthorizer mesh__D007934 sjn
% 224.13/224.34  |- skos__broader mesh__D007934smesh__D013289
% 224.13/224.34  |- mesh__recordMaintainer mesh__D007934 SYSTEM
% 224.13/224.34  |- skos__altLabel mesh__D007934 Leukonostoc
% 224.13/224.34  |- rdf__type mesh__D007934sskos__Concept
% 224.13/224.34  |- skos__scopeNote mesh__D007934
% 224.13/224.34       A genus of gram-positive, facultatively anaerobic bacteria whose growth is dependent on the presence of a fermentable carbohydrate. It is nonpathogenic to plants and animals, including humans.%A%    
% 224.13/224.34  |- skos__annotation mesh__D007934 in plant %26% dairy products   
% 224.13/224.34  |- mesh__dateCreated mesh__D007934 1999-01-01
% 224.13/224.34  |- mesh__activeMeSHYear mesh__D007934 2006
% 224.13/224.34  |- skos__prefLabel mesh__D007934 Leuconostoc
% 224.13/224.34  |- mesh__recordOriginator mesh__D007934 NLM
% 224.13/224.34  |- mesh__dateRevised mesh__D007136 2005-06-30
% 224.13/224.34  |- skos__prefLabel mesh__D007136 Immunoglobulins
% 224.13/224.34  |- mesh__onlineNote mesh__D007136
% 224.13/224.34       use IMMUNOGLOBULINS, INTRAVENOUS to search GLOBULINS, IMMUNE%26% IMMUNE GLOBULINS 1992-93%A%  
% 224.13/224.34  |- skos__annotation mesh__D007136
% 224.13/224.34       general: prefer specifics; /admin: consider also IMMUNOGLOBULINS, INTRAVENOUS; /defic permitted but consider also IMMUNOLOGIC DEFICIENCY SYNDROMES ;  /ther use: consider also IMMUNOGLOBULIN THERAPY see IMMUNIZATION, PASSIVE; allotypes = IMMUNOGLOBULIN ALLOTYPES or specifics%A%  
% 224.13/224.34  |- mesh__recordMaintainer mesh__D007136 ssb
% 224.13/224.34  |- skos__altLabel mesh__D007136 Immunoglobulin
% 224.13/224.34  |- skos__altLabel mesh__D007136 Globulins, Immune
% 224.13/224.34  |- rdf__type mesh__D007136sskos__Concept
% 224.13/224.34  |- skos__broader mesh__D007136smesh__D012712
% 224.13/224.34  |- mesh__dateEstablished mesh__D007136 1972-01-01
% 224.13/224.34  |- skos__historyNote mesh__D007136 Gamma Globulins %28%1966-1969%29%
% 224.13/224.34  |- skos__related mesh__D007136smesh__D010265
% 224.13/224.34  |- mesh__publicMeSHNote mesh__D007136
% 224.13/224.34       72; IMMUNE SERUM GLOBULIN was heading 1965; GLOBULINS, IMMUNE %26% IMMUNE GLOBULINS were see IMMUNOGLOBULINS, INTRAVENOUS 1992-93%A%  
% 224.13/224.34  |- mesh__recordAuthorizer mesh__D007136 sjn
% 224.13/224.34  |- skos__related mesh__D007136smesh__D007109
% 224.13/224.34  |- mesh__dateCreated mesh__D007136 1999-01-01
% 224.13/224.34  |- skos__altLabel mesh__D007136 Immune Globulins
% 224.13/224.34  |- mesh__historyNote mesh__D007136
% 224.13/224.34       72%28%70%29%; IMMUNE SERUM GLOBULIN was heading 1965; GLOBULINS, IMMUNE %26% IMMUNE GLOBULINS were see IMMUNOGLOBULINS, INTRAVENOUS 1992-93%A%  
% 224.13/224.34  |- mesh__recordOriginator mesh__D007136 NLM
% 224.13/224.34  |- skos__broader mesh__D007136smesh__D007162
% 224.13/224.34  |- skos__scopeNote mesh__D007136
% 224.13/224.34       Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy %28%IMMUNOGLOBULIN HEAVY CHAINS%29% and two light chains %28%IMMUNOGLOBULIN LIGHT CHAINS%29% with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms %28%B-CELL ANTIGEN RECEPTORS%29% or secreted forms %28%ANTIBODIES%29%. They are divided by the amino acid sequence of their heavy chains into five classes %28%IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M%29% and various subclasses.%A%    
% 224.13/224.34  |- mesh__activeMeSHYear mesh__D007136 2006
% 224.13/224.34  |- skos__annotation mesh__D012879
% 224.13/224.34       GEN or unspecified; prefer specifics; DF: SKIN PHYSIOL   
% 224.13/224.34  |- mesh__historyNote mesh__D012879 98; use explode 1970-97   
% 224.13/224.34  |- skos__hiddenLabel mesh__D012879 Skin Physiologies
% 224.13/224.34  |- mesh__recordMaintainer mesh__D012879 sjn
% 224.13/224.34  |- mesh__dateCreated mesh__D012879 1999-01-01
% 224.13/224.34  |- skos__broader mesh__D012879smesh__D004069
% 224.13/224.34  |- mesh__dateRevised mesh__D012879 2004-07-13
% 224.13/224.34  |- skos__altLabel mesh__D012879 Physiology, Skin
% 224.13/224.34  |- mesh__recordAuthorizer mesh__D012879 sjn
% 224.13/224.34  |- mesh__recordOriginator mesh__D012879 NLM
% 224.13/224.34  |- mesh__activeMeSHYear mesh__D012879 2006
% 224.13/224.34  |- mesh__publicMeSHNote mesh__D012879 98   
% 224.13/224.34  |- rdf__type mesh__D012879sskos__Concept
% 224.13/224.34  |- skos__hiddenLabel mesh__D012879 Physiologies, Skin
% 224.13/224.34  |- skos__scopeNote mesh__D012879
% 224.13/224.34       The functions of the skin in the human and animal body. It includes the pigmentation of the skin and its appendages.%A%    
% 224.13/224.34  |- mesh__activeMeSHYear mesh__D012879 2005
% 224.13/224.34  |- skos__prefLabel mesh__D012879 Skin Physiology
% 224.13/224.34  |- skos__historyNote mesh__D012879 Skin/physiology %28%1966-1997%29%
% 224.13/224.34  |- mesh__dateEstablished mesh__D012879 1998-01-01
% 224.13/224.34  |- skos__scopeNote mesh__D017564
% 224.13/224.34       Injurious effects of radiotherapy on the lungs. There are three phases in the reaction of the lungs to radiation injury: an acute phase occurring 1 to 2 months after exposure, a subacute phase 2 to 9 months after exposure, and a chronic or fibrotic phase more than 9 months after exposure. In the acute phase there is vascular damage, congestion, edema, and mononuclear cell infiltration; in the subacute phase the alveolar walls are infiltrated with mononuclear inflammatory cells and fibroblasts; in the chronic phase, alveolar fibrosis and capillary sclerosis take place. %28%Cecil Textbook of Medicine, 19th ed, p2343%29%%A%    
% 224.13/224.34  |- mesh__activeMeSHYear mesh__D017564 2002
% 224.13/224.34  |- mesh__dateEstablished mesh__D017564 1994-01-01
% 224.13/224.34  |- mesh__recordMaintainer mesh__D017564 TAP
% 224.13/224.34  |- skos__historyNote mesh__D017564 Pneumonia %28%1966-1993%29%
% 224.13/224.34  |- skos__hiddenLabel mesh__D017564 Radiation Pneumonitides
% 224.13/224.34  |- mesh__activeMeSHYear mesh__D017564 2003
% 224.13/224.34  |- skos__altLabel mesh__D017564 Pneumonia, Radiation
% 224.13/224.34  |- mesh__activeMeSHYear mesh__D017564 1996
% 224.13/224.34  |- mesh__recordAuthorizer mesh__D017564 PLS
% 224.13/224.34  |- skos__hiddenLabel mesh__D017564 Pneumonias, Radiation
% 224.13/224.34  |- skos__hiddenLabel mesh__D017564 Radiation Pneumonias
% 224.13/224.34  |- skos__altLabel mesh__D017564 Pneumonitis, Radiation
% 224.13/224.34  |- mesh__activeMeSHYear mesh__D017564 2004
% 224.13/224.34  |- mesh__activeMeSHYear mesh__D017564 2005
% 224.13/224.34  |- mesh__activeMeSHYear mesh__D017564 1997
% 224.13/224.34  |- mesh__activeMeSHYear mesh__D017564 1998
% 224.13/224.34  |- skos__altLabel mesh__D017564 Radiation Fibrosis
% 224.13/224.34  |- skos__broader mesh__D017564smesh__D017563
% 224.13/224.34  |- mesh__activeMeSHYear mesh__D017564 2000
% 224.13/224.34  |- rdf__type mesh__D017564sskos__Concept
% 224.13/224.34  |- skos__broader mesh__D017564smesh__D011832
% 224.13/224.34  |- mesh__dateRevised mesh__D017564 1995-06-08
% 224.13/224.34  |- skos__historyNote mesh__D017564
% 224.13/224.34       Radiotherapy/adverse effects %28%1967-1993%29%
% 224.13/224.34  |- skos__hiddenLabel mesh__D017564 Pneumonitides, Radiation
% 224.13/224.34  |- skos__hiddenLabel mesh__D017564 Fibroses, Radiation
% 224.13/224.34  |- skos__annotation mesh__D017564
% 224.13/224.34       an interstitial lung dis; assume to be caused by radiother so do not coord routinely with RADIOTHERAPY /adv eff; coord IM with other type or source of radiation with /adv eff %28%IM%29% if pertinent; DF: RAD PNEUMONITIS%A%  
% 224.13/224.34  |- mesh__activeMeSHYear mesh__D017564 2006
% 224.13/224.34  |- mesh__activeMeSHYear mesh__D017564 2001
% 224.13/224.34  |- mesh__activeMeSHYear mesh__D017564 1999
% 224.13/224.34  |- mesh__recordOriginator mesh__D017564 TGC
% 224.13/224.34  |- skos__hiddenLabel mesh__D017564 Radiation Fibroses
% 224.13/224.34  |- skos__historyNote mesh__D017564
% 224.13/224.34       Radiation Injuries, Experimental %28%1966-1993%29%
% 224.13/224.34  |- skos__historyNote mesh__D017564 Radiation Injuries %28%1966-1993%29%
% 224.13/224.34  |- skos__altLabel mesh__D017564 Radiation Pneumonia
% 224.13/224.34  |- mesh__historyNote mesh__D017564 94   
% 224.13/224.34  |- skos__altLabel mesh__D017564 Fibrosis, Radiation
% 224.13/224.34  |- mesh__publicMeSHNote mesh__D017564 94   
% 224.13/224.34  |- skos__prefLabel mesh__D017564 Radiation Pneumonitis
% 224.13/224.34  |- mesh__dateCreated mesh__D017564 1993-06-02
% 224.13/224.34  |- mesh__activeMeSHYear mesh__D031235 2006
% 224.13/224.34  |- skos__prefLabel mesh__D031235 Buxus
% 224.13/224.34  |- skos__broader mesh__D031235smesh__D031234
% 224.13/224.34  |- mesh__activeMeSHYear mesh__D031235 2004
% 224.13/224.34  |- mesh__activeMeSHYear mesh__D031235 2005
% 224.13/224.34  |- mesh__activeMeSHYear mesh__D031235 2003
% 224.13/224.34  |- rdf__type mesh__D031235sskos__Concept
% 224.13/224.34  |- skos__altLabel mesh__D031235 Boxwood
% 224.13/224.34  |- mesh__dateEstablished mesh__D031235 2003-01-01
% 224.13/224.34  |- skos__annotation mesh__D031235
% 224.13/224.34       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.13/224.34  |- mesh__historyNote mesh__D031235 2003   
% 224.13/224.35  |- mesh__dateCreated mesh__D031235 2002-07-02
% 224.13/224.35  |- skos__scopeNote mesh__D031235
% 224.13/224.35       A plant genus of the family BUXACEAE. Members contain steroidal alkaloids.%A%    
% 224.13/224.35  |- mesh__publicMeSHNote mesh__D031235 2003   
% 224.13/224.35  |- mesh__publicMeSHNote mesh__D050998
% 224.13/224.35       2006; BAK PROTEIN was indexed under MEMBRANE PROTEINS 1994-2005, %26% under PROTO-ONCOGENE PROTEINS 2005%A%  
% 224.13/224.35  |- skos__scopeNote mesh__D050998
% 224.13/224.35       A multi-domain mitochondrial membrane protein and member of the bcl-2 Protein family. Bak protein interacts with TUMOR SUPPRESSOR PROTEIN P53 and promotes APOPTOSIS.%A%    
% 224.13/224.35  |- skos__hiddenLabel mesh__D050998
% 224.13/224.35       bcl2 Homologous Antagonist Killer Protein
% 224.13/224.35  |- skos__altLabel mesh__D050998 Bak Protein
% 224.13/224.35  |- skos__prefLabel mesh__D050998 bcl-2 Homologous Antagonist-Killer Protein
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D050998 2006
% 224.13/224.35  |- mesh__recordOriginator mesh__D050998 DRC
% 224.13/224.35  |- mesh__historyNote mesh__D050998 2006%28%1995%29%   
% 224.13/224.35  |- skos__hiddenLabel mesh__D050998
% 224.13/224.35       bcl 2 Homologous Antagonist Killer Protein
% 224.13/224.35  |- rdf__type mesh__D050998sskos__Concept
% 224.13/224.35  |- mesh__dateEstablished mesh__D050998 2006-01-01
% 224.13/224.35  |- skos__broader mesh__D050998smesh__D019253
% 224.13/224.35  |- skos__altLabel mesh__D050998 bcl2 Homologous Antagonist-Killer Protein
% 224.13/224.35  |- mesh__recordMaintainer mesh__D050998 DRC
% 224.13/224.35  |- mesh__recordAuthorizer mesh__D050998 sjn
% 224.13/224.35  |- mesh__dateCreated mesh__D050998 2005-06-30
% 224.13/224.35  |- mesh__dateEstablished mesh__D003544 1991-01-01
% 224.13/224.35  |- mesh__publicMeSHNote mesh__D003544
% 224.13/224.35       91; was see under AMINO ACIDS, SULFUR 1975-90   
% 224.13/224.35  |- mesh__recordAuthorizer mesh__D003544 sjn
% 224.13/224.35  |- skos__altLabel mesh__D003544 Cysteate
% 224.13/224.35  |- mesh__recordOriginator mesh__D003544 NLM
% 224.13/224.35  |- mesh__recordMaintainer mesh__D003544 ssb
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D003544 2006
% 224.13/224.35  |- skos__altLabel mesh__D003544 3-Sulfoalanine
% 224.13/224.35  |- mesh__historyNote mesh__D003544
% 224.13/224.35       91%28%75%29%; was see under AMINO ACIDS, SULFUR 1975-90   
% 224.13/224.35  |- mesh__dateCreated mesh__D003544 1974-11-19
% 224.13/224.35  |- skos__broader mesh__D003544smesh__D000603
% 224.13/224.35  |- skos__altLabel mesh__D003544 beta-Sulfoalanine
% 224.13/224.35  |- mesh__dateRevised mesh__D003544 2005-06-30
% 224.13/224.35  |- skos__hiddenLabel mesh__D003544 Acid, Cysteic
% 224.13/224.35  |- skos__scopeNote mesh__D003544
% 224.13/224.35       Beta-Sulfoalanine. An amino acid with a C-terminal sulfonic acid group which has been isolated from human hair oxidized with permanganate. It occurs normally in the outer part of the sheep%27%s fleece, where the wool is exposed to light and weather.%A%    
% 224.13/224.35  |- skos__historyNote mesh__D003544 Amino Acids, Sulfur %28%1974%29%
% 224.13/224.35  |- skos__hiddenLabel mesh__D003544 beta Sulfoalanine
% 224.13/224.35  |- rdf__type mesh__D003544sskos__Concept
% 224.13/224.35  |- skos__hiddenLabel mesh__D003544 3 Sulfoalanine
% 224.13/224.35  |- skos__prefLabel mesh__D003544 Cysteic Acid
% 224.13/224.35  |- skos__historyNote mesh__D003544 Alanine %28%1974%29%
% 224.13/224.35  |- skos__annotation mesh__D003544 an amino acid   
% 224.13/224.35  |- skos__altLabel mesh__D013972 Thyrotrophin
% 224.13/224.35  |- skos__broader mesh__D013972smesh__D010908
% 224.13/224.35  |- skos__hiddenLabel mesh__D013972 Hormone, Thyroid-Stimulating
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D013972 2005
% 224.13/224.35  |- skos__scopeNote mesh__D013972
% 224.13/224.35       A glycoprotein hormone secreted by the adenohypophysis %28%PITUITARY GLAND, ANTERIOR%29%. Thyrotropin stimulates THYROID GLAND by increasing the iodide transport, synthesis and release of thyroid hormones %28%THYROXINE and TRIIODOTHYRONINE%29%. Thyrotropin consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the pituitary glycoprotein hormones %28%TSH; LUTEINIZING HORMONE and FSH%29%, but the beta subunit is unique and confers its biological specificity.%A%    
% 224.13/224.35  |- skos__altLabel mesh__D013972 TSH %28%Thyroid Stimulating Hormone%29%
% 224.13/224.35  |- rdf__type mesh__D013972sskos__Concept
% 224.13/224.35  |- mesh__dateRevised mesh__D013972 2002-07-03
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D013972 2004
% 224.13/224.35  |- mesh__recordAuthorizer mesh__D013972 sjn
% 224.13/224.35  |- skos__annotation mesh__D013972
% 224.13/224.35       for alpha subunit, coord with GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; THYROTROPIN, BETA SUBUNIT is also available%A%  
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D013972 2003
% 224.13/224.35  |- mesh__recordOriginator mesh__D013972 NLM
% 224.13/224.35  |- skos__hiddenLabel mesh__D013972 Thyroid Stimulating Hormone
% 224.13/224.35  |- skos__altLabel mesh__D013972 Thyreotropin
% 224.13/224.35  |- skos__altLabel mesh__D013972 Thyroid-Stimulating Hormone
% 224.13/224.35  |- skos__prefLabel mesh__D013972 Thyrotropin
% 224.13/224.35  |- mesh__recordMaintainer mesh__D013972 sjn
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D013972 2006
% 224.13/224.35  |- mesh__dateCreated mesh__D013972 1999-01-01
% 224.13/224.35  |- skos__related mesh__D013972smesh__D011989
% 224.13/224.35  |- skos__prefLabel mesh__D013174 Sporotrichosis
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D013174 2004
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D013174 1996
% 224.13/224.35  |- skos__hiddenLabel mesh__D013174 Sporotrichoses
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D013174 2002
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D013174 1999
% 224.13/224.35  |- skos__annotation mesh__D013174 fungus dis of skin   
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D013174 1997
% 224.13/224.35  |- skos__broader mesh__D013174smesh__D003881
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D013174 1994
% 224.13/224.35  |- mesh__dateRevised mesh__D013174 1993-06-03
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D013174 2005
% 224.13/224.35  |- rdf__type mesh__D013174sskos__Concept
% 224.13/224.35  |- mesh__recordMaintainer mesh__D013174 TAP
% 224.13/224.35  |- mesh__recordAuthorizer mesh__D013174 PLS
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D013174 2000
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D013174 1995
% 224.13/224.35  |- skos__scopeNote mesh__D013174
% 224.13/224.35       The commonest and least serious of the deep mycoses, characterized by nodular lesions of the cutaneous and subcutaneous tissues. It is caused by inhalation of contaminated dust or by infection of a wound.%A%    
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D013174 2003
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D013174 2006
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D013174 2001
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D013174 1998
% 224.13/224.35  |- mesh__recordOriginator mesh__D013174 NLM
% 224.13/224.35  |- mesh__dateCreated mesh__D013174 1999-01-01
% 224.13/224.35  |- skos__historyNote mesh__D007935
% 224.13/224.35       Amino Acyl T RNA Synthetases %28%1972-1974%29%
% 224.13/224.35  |- mesh__historyNote mesh__D007935 98%28%75%29%   
% 224.13/224.35  |- mesh__dateCreated mesh__D007935 1974-11-19
% 224.13/224.35  |- skos__altLabel mesh__D007935 Leucine-tRNA Synthetase
% 224.13/224.35  |- mesh__recordMaintainer mesh__D007935 ssb
% 224.13/224.35  |- mesh__dateRevised mesh__D007935 2003-07-09
% 224.13/224.35  |- rdf__type mesh__D007935sskos__Concept
% 224.13/224.35  |- skos__hiddenLabel mesh__D007935 Leucine tRNA Synthetase
% 224.13/224.35  |- mesh__dateEstablished mesh__D007935 1991-01-01
% 224.13/224.35  |- skos__prefLabel mesh__D007935 Leucine-tRNA Ligase
% 224.13/224.35  |- skos__altLabel mesh__D007935 Leucyl T RNA Synthetase
% 224.13/224.35  |- skos__historyNote mesh__D007935 Leucine %28%1972-1974%29%
% 224.13/224.35  |- skos__scopeNote mesh__D007935
% 224.13/224.35       An enzyme that activates leucine with its specific transfer RNA. EC 6.1.1.4.%A%    
% 224.13/224.35  |- skos__altLabel mesh__D007935 Leu-tRNA Ligase
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D007935 2005
% 224.13/224.35  |- skos__broader mesh__D007935smesh__D000604
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D007935 2004
% 224.13/224.35  |- mesh__publicMeSHNote mesh__D007935
% 224.13/224.35       98; see LEUCYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A%  
% 224.13/224.35  |- skos__hiddenLabel mesh__D007935 Ligase, Leucine-tRNA
% 224.13/224.35  |- mesh__recordOriginator mesh__D007935 NLM
% 224.13/224.35  |- skos__hiddenLabel mesh__D007935 Leucine tRNA Ligase
% 224.13/224.35  |- skos__hiddenLabel mesh__D007935 Ligase, Leu-tRNA
% 224.13/224.35  |- skos__hiddenLabel mesh__D007935 Leu tRNA Ligase
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D007935 2006
% 224.13/224.35  |- mesh__recordAuthorizer mesh__D007935 sjn
% 224.13/224.35  |- skos__hiddenLabel mesh__D007935 Synthetase, Leucine-tRNA
% 224.13/224.35  |- skos__hiddenLabel mesh__D007137 alpha-Chains, Immunoglobulin
% 224.13/224.35  |- skos__hiddenLabel mesh__D007137 Heavy Chains, alpha-Immunoglobulin
% 224.13/224.35  |- skos__annotation mesh__D007137
% 224.13/224.35       gammopathy: coordinate IMMUNOGLOBULIN ALPHA-CHAINS %28%IM%29% with PARAPROTEINEMIAS %28%IM%29% but consider also HYPERGAMMAGLOBULINEMIA %28%IM%29% or ALPHA-CHAIN DISEASE%28%IM%29%, follow text; DF: IG ALPHA CHAIN%A%  
% 224.13/224.35  |- mesh__publicMeSHNote mesh__D007137
% 224.13/224.35       2006; see IMMUNOGLOBULINS, ALPHA-CHAIN 1992-2005, see IMMUNOGLOBULINS, ALPHA CHAIN 1991, see IMMUNOGLOBULINS, HEAVY CHAIN 1976-1990%A%  
% 224.13/224.35  |- mesh__dateEstablished mesh__D007137 1991-01-01
% 224.13/224.35  |- skos__prefLabel mesh__D007137 Immunoglobulin alpha-Chains
% 224.13/224.35  |- mesh__recordMaintainer mesh__D007137 nns
% 224.13/224.35  |- skos__historyNote mesh__D007137
% 224.13/224.35       Immunoglobulin Fragments %28%1973-1975%29%
% 224.13/224.35  |- skos__hiddenLabel mesh__D007137 alpha Immunoglobulin Heavy Chains
% 224.13/224.35  |- skos__altLabel mesh__D007137 Immunoglobulins, alpha-Chain
% 224.13/224.35  |- skos__altLabel mesh__D007137 Immunoglobulin alpha-Chain
% 224.13/224.35  |- skos__hiddenLabel mesh__D007137 Immunoglobulins, alpha Chain
% 224.13/224.35  |- skos__hiddenLabel mesh__D007137 Immunoglobulin alpha Chains
% 224.13/224.35  |- mesh__dateCreated mesh__D007137 1975-07-18
% 224.13/224.35  |- skos__scopeNote mesh__D007137
% 224.13/224.35       The class of heavy chains found in IMMUNOGLOBULIN A. They have a molecular weight of approximately 58 kDa and contain about 470 amino acid residues arranged in four domains and an oligosaccharide component bound covalently to their Fc fragment constant region.%A%    
% 224.13/224.35  |- skos__altLabel mesh__D007137 alpha-Immunoglobulin Heavy Chains
% 224.13/224.35  |- skos__hiddenLabel mesh__D007137 Heavy Chain, alpha-Immunoglobulin
% 224.13/224.35  |- mesh__recordOriginator mesh__D007137 RLS
% 224.13/224.35  |- mesh__historyNote mesh__D007137 2006 %28%1976%29%   
% 224.13/224.35  |- mesh__dateRevised mesh__D007137 2005-06-30
% 224.13/224.35  |- skos__broader mesh__D007137smesh__D007070
% 224.13/224.35  |- skos__altLabel mesh__D007137 alpha-Immunoglobulin Heavy Chain
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D007137 2006
% 224.13/224.35  |- skos__historyNote mesh__D007137 IgA %28%1973-1975%29%
% 224.13/224.35  |- skos__historyNote mesh__D007137
% 224.13/224.35       Immunoglobulins, Heavy Chain %28%1975%29%
% 224.13/224.35  |- skos__altLabel mesh__D007137 alpha-Chain Immunoglobulins
% 224.13/224.35  |- skos__hiddenLabel mesh__D007137 alpha Immunoglobulin Heavy Chain
% 224.13/224.35  |- rdf__type mesh__D007137sskos__Concept
% 224.13/224.35  |- skos__hiddenLabel mesh__D007137 alpha Chain Immunoglobulins
% 224.13/224.35  |- mesh__recordAuthorizer mesh__D007137 sjn
% 224.13/224.35  |- skos__broader mesh__D007137smesh__D007143
% 224.13/224.35  |- skos__broader mesh__D014801Q000506smesh__D014801
% 224.13/224.35  |- mesh__preferredCombination mesh__D014801Q000506smesh__D006986
% 224.13/224.35  |- rdf__type mesh__D014801Q000506smesh__CompoundConcept
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D017565 2003
% 224.13/224.35  |- skos__altLabel mesh__D017565 Pulmonary Sarcoidosis
% 224.13/224.35  |- mesh__recordAuthorizer mesh__D017565 sjn
% 224.13/224.35  |- mesh__dateEstablished mesh__D017565 1994-01-01
% 224.13/224.35  |- mesh__publicMeSHNote mesh__D017565 94   
% 224.13/224.35  |- mesh__recordMaintainer mesh__D017565 KEV
% 224.13/224.35  |- mesh__dateRevised mesh__D017565 1999-11-03
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D017565 2001
% 224.13/224.35  |- skos__prefLabel mesh__D017565 Sarcoidosis, Pulmonary
% 224.13/224.35  |- mesh__historyNote mesh__D017565 94   
% 224.13/224.35  |- skos__historyNote mesh__D017565 Sarcoidosis %28%1966-1993%29%
% 224.13/224.35  |- mesh__dateCreated mesh__D017565 1993-03-03
% 224.13/224.35  |- skos__scopeNote mesh__D017565
% 224.13/224.35       Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. %28%Cecil Textbook of Medicine, 19th ed, p431%29%%A%    
% 224.13/224.35  |- skos__broader mesh__D017565smesh__D012507
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D017565 2000
% 224.13/224.35  |- skos__broader mesh__D017565smesh__D017563
% 224.13/224.35  |- rdf__type mesh__D017565sskos__Concept
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D017565 2006
% 224.13/224.35  |- mesh__recordOriginator mesh__D017565 TGC
% 224.13/224.35  |- skos__historyNote mesh__D017565 Lung Diseases %28%1966-1993%29%
% 224.13/224.35  |- skos__hiddenLabel mesh__D017565 Sarcoidoses, Pulmonary
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D017565 2005
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D017565 2004
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D017565 2002
% 224.13/224.35  |- skos__hiddenLabel mesh__D017565 Pulmonary Sarcoidoses
% 224.13/224.35  |- skos__annotation mesh__D017565 DF: SARCOIDOSIS PULM   
% 224.13/224.35  |- mesh__historyNote mesh__D031236 2003   
% 224.13/224.35  |- mesh__dateCreated mesh__D031236 2002-07-03
% 224.13/224.35  |- skos__broader mesh__D031236smesh__D031234
% 224.13/224.35  |- mesh__publicMeSHNote mesh__D031236 2003   
% 224.13/224.35  |- skos__altLabel mesh__D031236 Spurge, Japanese
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D031236 2006
% 224.13/224.35  |- skos__scopeNote mesh__D031236
% 224.13/224.35       A plant genus of the family BUXACEAE that should not be confused with common spurge %28%EUPHORBIA%29%.%A%    
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D031236 2004
% 224.13/224.35  |- skos__prefLabel mesh__D031236 Pachysandra
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D031236 2005
% 224.13/224.35  |- mesh__dateEstablished mesh__D031236 2003-01-01
% 224.13/224.35  |- skos__annotation mesh__D031236
% 224.13/224.35       SPURGE see EUPHORBIA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D031236 2003
% 224.13/224.35  |- rdf__type mesh__D031236sskos__Concept
% 224.13/224.35  |- skos__hiddenLabel mesh__D003545 Half Cystine
% 224.13/224.35  |- rdf__type mesh__D003545sskos__Concept
% 224.13/224.35  |- mesh__recordAuthorizer mesh__D003545 sjn
% 224.13/224.35  |- skos__prefLabel mesh__D003545 Cysteine
% 224.13/224.35  |- mesh__recordOriginator mesh__D003545 NLM
% 224.13/224.35  |- mesh__dateCreated mesh__D003545 1999-01-01
% 224.13/224.35  |- mesh__recordMaintainer mesh__D003545 ssb
% 224.13/224.35  |- skos__altLabel mesh__D003545 Half-Cystine
% 224.13/224.35  |- skos__altLabel mesh__D003545 L-Cysteine
% 224.13/224.35  |- skos__scopeNote mesh__D003545
% 224.13/224.35       A thiol-containing non-essential amino acid that is oxidized to form CYSTINE.%A%    
% 224.13/224.35  |- skos__broader mesh__D003545smesh__D021542
% 224.13/224.35  |- skos__broader mesh__D003545smesh__D000603
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D003545 2006
% 224.13/224.35  |- skos__annotation mesh__D003545 do not confuse with CYSTINE   
% 224.13/224.35  |- skos__broader mesh__D003545smesh__D013438
% 224.13/224.35  |- skos__hiddenLabel mesh__D003545 L Cysteine
% 224.13/224.35  |- mesh__dateRevised mesh__D003545 2005-06-30
% 224.13/224.35  |- mesh__dateCreated mesh__D008230 1979-05-25
% 224.13/224.35  |- skos__broader mesh__D008230smesh__D008232
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D008230 2000
% 224.13/224.35  |- skos__prefLabel mesh__D008230 Lymphomatoid Granulomatosis
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D008230 2006
% 224.13/224.35  |- skos__scopeNote mesh__D008230
% 224.13/224.35       An angiocentric and angiodestructive lymphoreticular proliferative disorder primarily involving the lungs. Histologically it simulates malignant lymphoma and in some cases may progress to lymphoma.%A%    
% 224.13/224.35  |- skos__historyNote mesh__D008230 Granuloma %28%1966-1979%29%
% 224.13/224.35  |- skos__historyNote mesh__D008230 Lung Diseases %28%1966-1979%29%
% 224.13/224.35  |- skos__annotation mesh__D008230
% 224.13/224.35       if non-neopl, coord IM with precoord organ/dis term %28%IM%29%; if neopl, coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 224.13/224.35  |- skos__broader mesh__D008230smesh__D011230
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D008230 2005
% 224.13/224.35  |- skos__altLabel mesh__D008230 Granulomatosis, Lymphomatoid
% 224.13/224.35  |- mesh__recordOriginator mesh__D008230 VDK
% 224.13/224.35  |- rdf__type mesh__D008230sskos__Concept
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D008230 2002
% 224.13/224.35  |- skos__hiddenLabel mesh__D008230 Granulomatoses, Lymphomatoid
% 224.13/224.35  |- skos__historyNote mesh__D008230 Lymphoma %28%1966-1979%29%
% 224.13/224.35  |- mesh__dateRevised mesh__D008230 1999-11-08
% 224.13/224.35  |- mesh__historyNote mesh__D008230 80   
% 224.13/224.35  |- mesh__dateEstablished mesh__D008230 1980-01-01
% 224.13/224.35  |- mesh__recordMaintainer mesh__D008230 KEV
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D008230 2004
% 224.13/224.35  |- mesh__publicMeSHNote mesh__D008230 80   
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D008230 2001
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D008230 2003
% 224.13/224.35  |- mesh__recordAuthorizer mesh__D008230 sjn
% 224.13/224.35  |- skos__hiddenLabel mesh__D008230 Lymphomatoid Granulomatoses
% 224.13/224.35  |- skos__hiddenLabel mesh__D013973 Tartrate, Proterelin
% 224.13/224.35  |- skos__altLabel mesh__D013973 Thyrotropin-Releasing Hormone Tartrate
% 224.13/224.35  |- skos__prefLabel mesh__D013973 Thyrotropin-Releasing Hormone
% 224.13/224.35  |- mesh__recordMaintainer mesh__D013973 ssb
% 224.13/224.35  |- skos__scopeNote mesh__D013973
% 224.13/224.35       A tripeptide hormone that originates in the HYPOTHALAMUS and stimulates the secretion of THYROTROPIN from the PITUITARY GLAND. In humans, it also acts as a prolactin-releasing factor. It is also a neurotransmitter in the central nervous system.%A%    
% 224.13/224.35  |- mesh__dateRevised mesh__D013973 2005-06-30
% 224.13/224.35  |- rdf__type mesh__D013973sskos__Concept
% 224.13/224.35  |- skos__altLabel mesh__D013973 5-Oxo-L-prolyl-L-histidyl-L-prolinamide
% 224.13/224.35  |- skos__historyNote mesh__D013973
% 224.13/224.35       Thyrotropin/biosynthesis %28%1966-1967%29%
% 224.13/224.35  |- skos__related mesh__D013973smesh__D018025
% 224.13/224.35  |- mesh__publicMeSHNote mesh__D013973
% 224.13/224.35       2006; see PROTIRELIN 1992-2006, was THYROTROPIN-RELEASING HORMONE 1991; was THYROTROPIN RELEASING HORMONE 1974-90; was THYROTROPIN RELEASING FACTOR 1968-73%A%  
% 224.13/224.35  |- skos__altLabel mesh__D013973 Protirelin
% 224.13/224.35  |- mesh__dateEstablished mesh__D013973 1968-01-01
% 224.13/224.35  |- skos__altLabel mesh__D013973 Protyreline
% 224.13/224.35  |- skos__historyNote mesh__D013973 Thyrotropin/metabolism %28%1966-1967%29%
% 224.13/224.35  |- skos__altLabel mesh__D013973 Pyr-His-ProNH2
% 224.13/224.35  |- skos__broader mesh__D013973smesh__D010906
% 224.13/224.35  |- skos__hiddenLabel mesh__D013973 Abbott38579
% 224.13/224.35  |- skos__hiddenLabel mesh__D013973 5 Oxo L prolyl L histidyl L prolinamide
% 224.13/224.35  |- skos__broader mesh__D013973smesh__D009842
% 224.13/224.35  |- skos__historyNote mesh__D013973
% 224.13/224.35       Hypothalamo-Hypophyseal System/physiology %28%1966-1967%29%
% 224.13/224.35  |- skos__broader mesh__D013973smesh__D009479
% 224.13/224.35  |- skos__hiddenLabel mesh__D013973 Thyrotropin Releasing Hormone
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D013973 2006
% 224.13/224.35  |- mesh__recordAuthorizer mesh__D013973 sjn
% 224.13/224.35  |- mesh__recordOriginator mesh__D013973 NLM
% 224.13/224.35  |- mesh__dateCreated mesh__D013973 1999-01-01
% 224.13/224.35  |- mesh__historyNote mesh__D013973
% 224.13/224.35       2006%28%1992%29%; was THYROTROPIN-RELEASING HORMONE 1991; was THYROTROPIN RELEASING HORMONE 1974-90; was THYROTROPIN RELEASING FACTOR 1968-73%A%  
% 224.13/224.35  |- skos__hiddenLabel mesh__D013973 Thyrotropin Releasing Hormone Tartrate
% 224.13/224.35  |- skos__altLabel mesh__D013973 Proterelin Tartrate
% 224.13/224.35  |- skos__annotation mesh__D013973 DF: TRH   
% 224.13/224.35  |- skos__hiddenLabel mesh__D013973 Abbott 38579
% 224.13/224.35  |- skos__altLabel mesh__D013175 Sporotrichum
% 224.13/224.35  |- mesh__recordOriginator mesh__D013175 NLM
% 224.13/224.35  |- skos__scopeNote mesh__D013175
% 224.13/224.35       A mitosporic Ophiostomataceae fungal genus, whose species Sporothrix schenckii is a well-known animal pathogen. The conidia of this soil fungus may be inhaled causing a primary lung infection, or may infect independently via skin punctures.%A%    
% 224.13/224.35  |- mesh__recordMaintainer mesh__D013175 SYSTEM
% 224.13/224.35  |- mesh__historyNote mesh__D013175 99%28%63%29%   
% 224.13/224.35  |- rdf__type mesh__D013175sskos__Concept
% 224.13/224.35  |- mesh__dateRevised mesh__D013175 2005-06-30
% 224.13/224.35  |- skos__prefLabel mesh__D013175 Sporothrix
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D013175 2006
% 224.13/224.35  |- mesh__recordAuthorizer mesh__D013175 sjn
% 224.13/224.35  |- skos__broader mesh__D013175smesh__D003904
% 224.13/224.35  |- mesh__dateCreated mesh__D013175 1999-01-01
% 224.13/224.35  |- mesh__publicMeSHNote mesh__D013175
% 224.13/224.35       99; see SPOROTRICHUM 1963-98; for SPOROTHRIX see SPOROTRICHUM 1974-98%A%  
% 224.13/224.35  |- skos__annotation mesh__D013175 infection = SPOROTRICHOSIS   
% 224.13/224.35  |- skos__altLabel mesh__D007936 Leucine Arylamidase
% 224.13/224.35  |- mesh__dateCreated mesh__D007936 1974-11-19
% 224.13/224.35  |- mesh__publicMeSHNote mesh__D007936
% 224.13/224.35       91; was see under LEUCINE AMINOPEPTIDASE 1975-90   
% 224.13/224.35  |- skos__historyNote mesh__D007936 Leucine Aminopeptidase %28%1974%29%
% 224.13/224.35  |- skos__broader mesh__D007936smesh__D000593
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D007936 2006
% 224.13/224.35  |- mesh__recordOriginator mesh__D007936 NLM
% 224.13/224.35  |- skos__prefLabel mesh__D007936 Leucyl-beta-Naphthylamidase
% 224.13/224.35  |- mesh__dateRevised mesh__D007936 2003-07-09
% 224.13/224.35  |- skos__altLabel mesh__D007936 Leucinarylamidase
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D007936 2005
% 224.13/224.35  |- mesh__recordAuthorizer mesh__D007936 sjn
% 224.13/224.35  |- skos__altLabel mesh__D007936 Leucine Aryl Amidase
% 224.13/224.35  |- rdf__type mesh__D007936sskos__Concept
% 224.13/224.35  |- mesh__historyNote mesh__D007936
% 224.13/224.35       91%28%75%29%; was see under LEUCINE AMINOPEPTIDASE 1975-90   
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D007936 2004
% 224.13/224.35  |- mesh__recordMaintainer mesh__D007936 jmp
% 224.13/224.35  |- mesh__dateEstablished mesh__D007936 1991-01-01
% 224.13/224.35  |- skos__broader mesh__D007936smesh__D007931
% 224.13/224.35  |- skos__altLabel mesh__D007936 Leucyl beta Naphthylamidase
% 224.13/224.35  |- skos__scopeNote mesh__D007936
% 224.13/224.35       An aminopeptidase frequently used to test for LEUCYL AMINOPEPTIDASE activity. It also hydrolyzes naphthylamides of leucine. EC 3.4.11.-.%A%    
% 224.13/224.35  |- skos__altLabel mesh__D007138 Immunoglobulins, delta-Chain
% 224.13/224.35  |- mesh__recordAuthorizer mesh__D007138 ags
% 224.13/224.35  |- skos__hiddenLabel mesh__D007138 delta-Chain, Immunoglobulin
% 224.13/224.35  |- mesh__dateCreated mesh__D007138 1975-07-23
% 224.13/224.35  |- mesh__publicMeSHNote mesh__D007138
% 224.13/224.35       2006; see IMMUNOGLOBULINS, DELTA-CHAIN 1992-2005, see IMMUNOGLOBULINS, DELTA CHAIN 1991, see IMMUNOGLOBULINS, HEAVY CHAIN 1976-1990%A%  
% 224.13/224.35  |- skos__altLabel mesh__D007138 delta Immunoglobulin Heavy Chains
% 224.13/224.35  |- skos__broader mesh__D007138smesh__D007143
% 224.13/224.35  |- mesh__dateRevised mesh__D007138 2005-07-15
% 224.13/224.35  |- skos__hiddenLabel mesh__D007138 delta Chain Immunoglobulins
% 224.13/224.35  |- skos__prefLabel mesh__D007138 Immunoglobulin delta-Chains
% 224.13/224.35  |- skos__altLabel mesh__D007138 delta Immunoglobulin Heavy Chain
% 224.13/224.35  |- skos__altLabel mesh__D007138 Immunoglobulin delta-Chain
% 224.13/224.35  |- skos__historyNote mesh__D007138
% 224.13/224.35       Immunoglobulin Fragments %28%1973-1975%29%
% 224.13/224.35  |- skos__broader mesh__D007138smesh__D007072
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D007138 2006
% 224.13/224.35  |- skos__historyNote mesh__D007138 IgD %28%1973-1975%29%
% 224.13/224.35  |- mesh__recordMaintainer mesh__D007138 ags
% 224.13/224.35  |- skos__historyNote mesh__D007138
% 224.13/224.35       Immunoglobulins, Heavy Chain %28%1975%29%
% 224.13/224.35  |- mesh__recordOriginator mesh__D007138 RLS
% 224.13/224.35  |- skos__altLabel mesh__D007138 delta-Chain Immunoglobulins
% 224.13/224.35  |- mesh__historyNote mesh__D007138 2006 %28%1976%29%   
% 224.13/224.35  |- rdf__type mesh__D007138sskos__Concept
% 224.13/224.35  |- skos__scopeNote mesh__D007138
% 224.13/224.35       The class of heavy chains found in IMMUNOGLOBULIN D. They have a molecular weight of approximately 64 kDa and they contain about 500 amino acid residues arranged in four domains and an oligosaccharide component covalently bound to the Fc fragment constant region.%A%    
% 224.13/224.35  |- skos__annotation mesh__D007138
% 224.13/224.35       gammopathy: coordinate IMMUNOGLOBULIN DELTA-CHAINS %28%IM%29% with PARAPROTEINEMIAS %28%IM%29% but consider also HYPERGAMMAGLOBULINEMIA %28%IM%29% or HEAVY CHAIN DISEASE %28%IM%29%, follow text; DF: IG DELTA CHAIN%A%  
% 224.13/224.35  |- skos__hiddenLabel mesh__D007138 Immunoglobulins, delta Chain
% 224.13/224.35  |- skos__hiddenLabel mesh__D007138 Immunoglobulin delta Chain
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D007138 2006A
% 224.13/224.35  |- mesh__dateEstablished mesh__D007138 1991-01-01
% 224.13/224.35  |- skos__hiddenLabel mesh__D007138 delta-Chains, Immunoglobulin
% 224.13/224.35  |- skos__hiddenLabel mesh__D007138 Immunoglobulin delta Chains
% 224.13/224.35  |- mesh__historyNote mesh__D017566 2005%28%1994%29%   
% 224.13/224.35  |- skos__hiddenLabel mesh__D017566 Angina Syndrome X
% 224.13/224.35  |- mesh__recordOriginator mesh__D017566 TGC
% 224.13/224.35  |- skos__altLabel mesh__D017566 Angina, Microvascular
% 224.13/224.35  |- skos__hiddenLabel mesh__D017566 Syndrome, Angina X
% 224.13/224.35  |- mesh__dateRevised mesh__D017566 2004-07-07
% 224.13/224.35  |- skos__altLabel mesh__D017566 Syndrome X, Cardiac
% 224.13/224.35  |- skos__prefLabel mesh__D017566 Microvascular Angina
% 224.13/224.35  |- skos__broader mesh__D017566smesh__D000787
% 224.13/224.35  |- mesh__dateEstablished mesh__D017566 1994-01-01
% 224.13/224.35  |- skos__hiddenLabel mesh__D017566 Angina Syndrome Xs
% 224.13/224.35  |- skos__annotation mesh__D017566
% 224.13/224.35       do not confuse with METABOLIC SYNDROME X   
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D017566 2005
% 224.13/224.35  |- skos__historyNote mesh__D017566 Angina Pectoris %28%1977-1993%29%
% 224.13/224.35  |- mesh__recordAuthorizer mesh__D017566 sjn
% 224.13/224.35  |- skos__altLabel mesh__D017566 X Syndrome, Angina
% 224.13/224.35  |- mesh__dateCreated mesh__D017566 1992-12-28
% 224.13/224.35  |- skos__altLabel mesh__D017566 Syndrome X, Angina
% 224.13/224.35  |- rdf__type mesh__D017566sskos__Concept
% 224.13/224.35  |- skos__scopeNote mesh__D017566
% 224.13/224.35       ANGINA PECTORIS or angina-like chest pain with a normal coronary arteriogram and positive EXERCISE TEST. The cause of the syndrome is unknown. While its recognition is of clinical importance, its prognosis is excellent. %28%Braunwald, Heart Disease, 4th ed, p1346; Jablonski Dictionary of Syndromes %26% Eponymic Diseases, 2d ed%29%. It is different from METABOLIC SYNDROME X,  a syndrome characterized by INSULIN RESISTANCE and HYPERINSULINEMIA, that has increased risk for cardiovascular disease.%A%    
% 224.13/224.35  |- skos__related mesh__D017566smesh__D024821
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D017566 2006
% 224.13/224.35  |- skos__hiddenLabel mesh__D017566 Angina X Syndrome
% 224.13/224.35  |- skos__hiddenLabel mesh__D017566 Angina X Syndromes
% 224.13/224.35  |- mesh__recordMaintainer mesh__D017566 nns
% 224.13/224.35  |- skos__altLabel mesh__D017566
% 224.13/224.35       Angina Pectoris with Normal Coronary Arteriogram
% 224.13/224.35  |- mesh__publicMeSHNote mesh__D017566
% 224.13/224.35       2005%28%1994%29%; see SYNDROME X 1994-2004   
% 224.13/224.35  |- skos__altLabel mesh__D017566 Cardiac Syndrome X
% 224.13/224.35  |- skos__hiddenLabel mesh__D017566 Syndrome Xs, Angina
% 224.13/224.35  |- skos__annotation mesh__D031237
% 224.13/224.35       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.13/224.35  |- mesh__dateEstablished mesh__D031237 2003-01-01
% 224.13/224.35  |- mesh__historyNote mesh__D031237 2003   
% 224.13/224.35  |- mesh__publicMeSHNote mesh__D031237 2003   
% 224.13/224.35  |- skos__broader mesh__D031237smesh__D019684
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D031237 2006
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D031237 2004
% 224.13/224.35  |- mesh__dateCreated mesh__D031237 2002-07-03
% 224.13/224.35  |- skos__scopeNote mesh__D031237
% 224.13/224.35       A plant family of the order Laurales, subclass Magnoliidae, class Magnoliopsida.%A%    
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D031237 2005
% 224.13/224.35  |- rdf__type mesh__D031237sskos__Concept
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D031237 2003
% 224.13/224.35  |- skos__prefLabel mesh__D031237 Calycanthaceae
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D003546 2006
% 224.13/224.35  |- mesh__dateCreated mesh__D003546 1987-05-04
% 224.13/224.35  |- mesh__dateRevised mesh__D003546 2003-07-09
% 224.13/224.35  |- skos__altLabel mesh__D003546 Cysteine Protease
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D003546 2005
% 224.13/224.35  |- mesh__publicMeSHNote mesh__D003546
% 224.13/224.35       2000; see CYSTEINE PROTEINASES 1988-1999; for CYSTEINE ENDOPEPTIDASES see CYSTEINE PROTEINASES 1990-1999%A%  
% 224.13/224.35  |- skos__altLabel mesh__D003546 Thiol Proteases
% 224.13/224.35  |- rdf__type mesh__D003546sskos__Concept
% 224.13/224.35  |- mesh__recordAuthorizer mesh__D003546 sjn
% 224.13/224.35  |- skos__altLabel mesh__D003546 Sulfhydryl Proteases
% 224.13/224.35  |- skos__historyNote mesh__D003546
% 224.13/224.35       Peptide Peptidohydrolases %28%1966-1987%29%
% 224.13/224.35  |- skos__altLabel mesh__D003546 Cysteine Proteinase
% 224.13/224.35  |- skos__broader mesh__D003546smesh__D010450
% 224.13/224.35  |- mesh__recordMaintainer mesh__D003546 ssb
% 224.13/224.35  |- skos__altLabel mesh__D003546 Cysteine Proteases
% 224.13/224.35  |- skos__scopeNote mesh__D003546
% 224.13/224.35       ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by sulfhydryl reagents. EC 3.4.22.%A%    
% 224.13/224.35  |- mesh__historyNote mesh__D003546 2000%28%1988%29%   
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D003546 2004
% 224.13/224.35  |- skos__altLabel mesh__D003546 Thiol Proteinases
% 224.13/224.35  |- skos__altLabel mesh__D003546 Cysteine Proteinases
% 224.13/224.35  |- skos__altLabel mesh__D003546 Thiol Proteinase
% 224.13/224.35  |- skos__altLabel mesh__D003546 Sulfhydryl Proteinases
% 224.13/224.35  |- mesh__recordOriginator mesh__D003546 RLS
% 224.13/224.35  |- mesh__dateEstablished mesh__D003546 1988-01-01
% 224.13/224.35  |- skos__prefLabel mesh__D003546 Cysteine Endopeptidases
% 224.13/224.35  |- skos__related mesh__D008231smesh__D011504
% 224.13/224.35  |- mesh__recordAuthorizer mesh__D008231 sjn
% 224.13/224.35  |- skos__altLabel mesh__D008231 Lymphocytopenia
% 224.13/224.35  |- mesh__dateRevised mesh__D008231 2003-07-09
% 224.13/224.35  |- mesh__activeMeSHYear mesh__D008231 2005
% 224.13/224.35  |- mesh__recordOriginator mesh__D008231 NLM
% 224.13/224.35  |- skos__historyNote mesh__D008231 Lymphocytes %28%1966-1969%29%
% 224.13/224.35  |- rdf__type mesh__D008231sskos__Concept
% 224.13/224.36  |- mesh__recordMaintainer mesh__D008231 lkt
% 224.13/224.36  |- mesh__publicMeSHNote mesh__D008231 70   
% 224.13/224.36  |- mesh__dateEstablished mesh__D008231 1970-01-01
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D008231 2004
% 224.13/224.36  |- skos__hiddenLabel mesh__D008231 Lymphocytopenias
% 224.13/224.36  |- skos__broader mesh__D008231smesh__D007153
% 224.13/224.36  |- mesh__dateCreated mesh__D008231 1999-01-01
% 224.13/224.36  |- skos__prefLabel mesh__D008231 Lymphopenia
% 224.13/224.36  |- skos__related mesh__D008231smesh__D008212
% 224.13/224.36  |- skos__hiddenLabel mesh__D008231 Lymphopenias
% 224.13/224.36  |- skos__historyNote mesh__D008231 Leukopenia %28%1966-1969%29%
% 224.13/224.36  |- mesh__historyNote mesh__D008231 70   
% 224.13/224.36  |- skos__scopeNote mesh__D008231
% 224.13/224.36       Reduction in the number of lymphocytes.     
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D008231 2006
% 224.13/224.36  |- skos__broader mesh__D008231smesh__D007970
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D049648 2006
% 224.13/224.36  |- mesh__recordMaintainer mesh__D049648 jls
% 224.13/224.36  |- mesh__recordAuthorizer mesh__D049648 sjn
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D049648 2005
% 224.13/224.36  |- skos__broader mesh__D049648smesh__D001210
% 224.13/224.36  |- skos__historyNote mesh__D049648 Indonesia %28%1976-2004%29%
% 224.13/224.36  |- mesh__historyNote mesh__D049648 2005   
% 224.13/224.36  |- mesh__dateCreated mesh__D049648 2004-07-07
% 224.13/224.36  |- skos__prefLabel mesh__D049648 East Timor
% 224.13/224.36  |- mesh__dateEstablished mesh__D049648 2005-01-01
% 224.13/224.36  |- skos__altLabel mesh__D049648 East Timur
% 224.13/224.36  |- skos__altLabel mesh__D049648 Democratic Republic of Timor-Leste
% 224.13/224.36  |- rdf__type mesh__D049648sskos__Concept
% 224.13/224.36  |- mesh__recordOriginator mesh__D049648 jls
% 224.13/224.36  |- skos__scopeNote mesh__D049648
% 224.13/224.36       A country in Southeastern Asia, northwest of Australia in the Lesser Sunda Islands at the eastern end of the Indonesian archipelago. It includes the eastern half of the island of Timor, the Oecussi %28%Ambeno%29% region on the northwest portion of the island of Timor, and the islands of Pulau Atauro and Pulau Jaco. On May 20, 2002, East Timor was internationally recognized as an independent state. This followed its declared independence from Portugal on November 20, 1975 and a period of armed conflict with Indonesia.%A%    
% 224.13/224.36  |- mesh__publicMeSHNote mesh__D013974
% 224.13/224.36       1965; see THYROXIN 1963-1964; for LEVOTHYROXINE see LEVOTHYROXINE 1991-2001, see THYROXINE 1966-1990, see LEVOTHYROXINE 1963-1965%A%  
% 224.13/224.36  |- skos__altLabel mesh__D013974 Berlin-Chemie Brand of Levothyroxine Sodium
% 224.13/224.36  |- skos__altLabel mesh__D013974
% 224.13/224.36       Henning Berlin Brand of Levothyroxine Sodium
% 224.13/224.36  |- mesh__recordOriginator mesh__D013974 NLM
% 224.13/224.36  |- skos__altLabel mesh__D013974 L-Thyroxine
% 224.13/224.36  |- skos__altLabel mesh__D013974
% 224.13/224.36       Sanofi Synthelabo Brand of Levothyroxine Sodium
% 224.13/224.36  |- skos__altLabel mesh__D013974 Merck Brand of Levothyroxine Sodium
% 224.13/224.36  |- mesh__recordAuthorizer mesh__D013974 sjn
% 224.13/224.36  |- skos__hiddenLabel mesh__D013974 Delalande, Levothyroxin
% 224.13/224.36  |- skos__altLabel mesh__D013974 3,5,3%27%,5%27%-Tetraiodothyronine
% 224.13/224.36  |- skos__altLabel mesh__D013974 Hexal Brand 2 of Levothyroxine Sodium
% 224.13/224.36  |- mesh__dateCreated mesh__D013974 1999-01-01
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D013974 2005
% 224.13/224.36  |- skos__altLabel mesh__D013974 Eutirox
% 224.13/224.36  |- skos__related mesh__D013974smesh__D006981
% 224.13/224.36  |- mesh__dateEstablished mesh__D013974 1965-01-01
% 224.13/224.36  |- skos__altLabel mesh__D013974 Sigma Brand of Levothyroxine Sodium
% 224.13/224.36  |- skos__broader mesh__D013974smesh__D013963
% 224.13/224.36  |- skos__altLabel mesh__D013974
% 224.13/224.36       O-%28%4-Hydroxy-3,5-diiodophenyl%29% 3,5-diiodo-L-tyrosine
% 224.13/224.36  |- mesh__recordMaintainer mesh__D013974 CCR
% 224.13/224.36  |- skos__hiddenLabel mesh__D013974
% 224.13/224.36       Berlin Chemie Brand of Levothyroxine Sodium
% 224.13/224.36  |- skos__altLabel mesh__D013974 Sodium Levothyroxine
% 224.13/224.36  |- skos__altLabel mesh__D013974 GlaxoWellcome Brand of Levothyroxine Sodium
% 224.13/224.36  |- skos__altLabel mesh__D013974 Aventis Brand of Levothyroxine Sodium
% 224.13/224.36  |- skos__hiddenLabel mesh__D013974 L Thyroxin beta
% 224.13/224.36  |- skos__altLabel mesh__D013974 Vortex Brand of Levothyroxine Sodium
% 224.13/224.36  |- skos__altLabel mesh__D013974 Levothyroxin Delalande
% 224.13/224.36  |- skos__altLabel mesh__D013974 T4 Thyroid Hormone
% 224.13/224.36  |- skos__altLabel mesh__D013974 Hexal Brand 1 of Levothyroxine Sodium
% 224.13/224.36  |- skos__related mesh__D013974smesh__D011988
% 224.13/224.36  |- skos__altLabel mesh__D013974 Thyroxin
% 224.13/224.36  |- skos__altLabel mesh__D013974 Forest Brand of Levothyroxine Sodium
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D013974 2006
% 224.13/224.36  |- skos__altLabel mesh__D013974 Monarch Brand of Levothyroxine Sodium
% 224.13/224.36  |- skos__altLabel mesh__D013974 Watson Brand of Levothyroxine Sodium
% 224.13/224.36  |- skos__altLabel mesh__D013974
% 224.13/224.36       GlaxoSmithKline Brand of Levothyroxine Sodium
% 224.13/224.36  |- skos__annotation mesh__D013974
% 224.13/224.36       /blood: consider also HYPERTHYROXINEMIA   
% 224.13/224.36  |- skos__altLabel mesh__D013974
% 224.13/224.36       O-%28%4-Hydroxy-3,5-diiodophenyl%29%-3,5-diiodotyrosine
% 224.13/224.36  |- skos__hiddenLabel mesh__D013974 L Thyroxine
% 224.13/224.36  |- skos__altLabel mesh__D013974 Levothyroxine
% 224.13/224.36  |- skos__altLabel mesh__D013974 Delalande Brand of Levothyroxine Sodium
% 224.13/224.36  |- skos__hiddenLabel mesh__D013974 L Thyrox
% 224.13/224.36  |- skos__broader mesh__D013974smesh__D024322
% 224.13/224.36  |- skos__hiddenLabel mesh__D013974 L Thyroxine Roche
% 224.13/224.36  |- skos__altLabel mesh__D013974 betapharm Brand of Levothyroxine Sodium
% 224.13/224.36  |- mesh__dateRevised mesh__D013974 2004-07-07
% 224.13/224.36  |- skos__hiddenLabel mesh__D013974 Levo T
% 224.13/224.36  |- skos__hiddenLabel mesh__D013974 Thyroid Hormone, T4
% 224.13/224.36  |- skos__altLabel mesh__D013974 Byk Brand of Levothyroxine Sodium
% 224.13/224.36  |- skos__altLabel mesh__D013974 Abbot Brand of Levothyroxine Sodium
% 224.13/224.36  |- mesh__historyNote mesh__D013974
% 224.13/224.36       1965; use THYROXIN 1963-1964; for LEVOTHYROXINE use LEVOTHYROXINE 1991-2001, use THYROXINE 1966-1990%A%  
% 224.13/224.36  |- skos__altLabel mesh__D013974 L-3,5,3%27%,5%27%-Tetraiodothyronine
% 224.13/224.36  |- skos__scopeNote mesh__D013974
% 224.13/224.36       The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines %28%MONOIODOTYROSINE%29% and the coupling of iodotyrosines %28%DIIODOTYROSINE%29% in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.%A%    
% 224.13/224.36  |- rdf__type mesh__D013974sskos__Concept
% 224.13/224.36  |- skos__hiddenLabel mesh__D013974 Deladande, Levothyroxin
% 224.13/224.36  |- skos__hiddenLabel mesh__D013974 LThyroxin Henning
% 224.13/224.36  |- skos__altLabel mesh__D013974 Thevier
% 224.13/224.36  |- skos__hiddenLabel mesh__D013974 L Thyroxin Henning
% 224.13/224.36  |- skos__hiddenLabel mesh__D013974 LThyroxin beta
% 224.13/224.36  |- skos__altLabel mesh__D013974 Nourypharma Brand of Levothyroxine Sodium
% 224.13/224.36  |- skos__hiddenLabel mesh__D013974 Leo, Tiroxina
% 224.13/224.36  |- skos__altLabel mesh__D013974 Goldshield Brand of Levothyroxine Sodium
% 224.13/224.36  |- skos__prefLabel mesh__D013974 Thyroxine
% 224.13/224.36  |- skos__altLabel mesh__D013974 Allphar Brand of Levothyroxine Sodium
% 224.13/224.36  |- skos__altLabel mesh__D013974 Mova Brand of Levothyroxine Sodium
% 224.13/224.36  |- skos__altLabel mesh__D013974 Rudefsa Brand of Levothyroxine Sodium
% 224.13/224.36  |- skos__altLabel mesh__D013974 Kern Brand of Levothyroxine Sodium
% 224.13/224.36  |- skos__altLabel mesh__D013974 Roche Brand of Levothyroxine Sodium
% 224.13/224.36  |- skos__hiddenLabel mesh__D013974 LevoT
% 224.13/224.36  |- skos__altLabel mesh__D013974
% 224.13/224.36       Merck Lipha Sant%C3%%A9% Brand of Levothyroxine Sodium
% 224.13/224.36  |- skos__altLabel mesh__D013974 Genpharm Brand of Levothyroxine Sodium
% 224.13/224.36  |- mesh__recordOriginator mesh__D046350 lkt
% 224.13/224.36  |- skos__prefLabel mesh__D046350 Porphyria, Variegate
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D046350 2005
% 224.13/224.36  |- skos__hiddenLabel mesh__D046350 Deficiencies, Protoporphyrinogen Oxidase
% 224.13/224.36  |- skos__broader mesh__D046350smesh__D017094
% 224.13/224.36  |- mesh__dateEstablished mesh__D046350 2005-01-01
% 224.13/224.36  |- mesh__publicMeSHNote mesh__D046350
% 224.13/224.36       2005; see PORPHYRIA, HEPATIC 1993-2004   
% 224.13/224.36  |- mesh__historyNote mesh__D046350
% 224.13/224.36       2005; use PORPHYRIA, HEPATIC 1993-2004   
% 224.13/224.36  |- skos__scopeNote mesh__D046350
% 224.13/224.36       An autosomal dominant porphyria that is due to a deficiency of protoporphyrinogen oxidase %28%EC 1.3.3.4%29% in the LIVER, the seventh enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features include both neurological symptoms and cutaneous lesions. Patients excrete increased levels of porphyrin precursors, COPROPORPHYRINS and protoporphyrinogen.%A%    
% 224.13/224.36  |- skos__altLabel mesh__D046350 Variegate Porphyria
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D046350 2006
% 224.13/224.36  |- mesh__recordMaintainer mesh__D046350 lkt
% 224.13/224.36  |- mesh__dateCreated mesh__D046350 2004-07-15
% 224.13/224.36  |- mesh__recordAuthorizer mesh__D046350 sjn
% 224.13/224.36  |- skos__historyNote mesh__D046350 Porphyria, Hepatic %28%1993-2004%29%
% 224.13/224.36  |- skos__altLabel mesh__D046350 Protoporphyrinogen Oxidase Deficiency
% 224.13/224.36  |- rdf__type mesh__D046350sskos__Concept
% 224.13/224.36  |- skos__historyNote mesh__D046350 Porphyria %28%1964-2004%29%
% 224.13/224.36  |- skos__altLabel mesh__D007937 Lymphocytopheresis
% 224.13/224.36  |- skos__prefLabel mesh__D007937 Leukapheresis
% 224.13/224.36  |- skos__historyNote mesh__D007937 Blood Transfusion %28%1966-1978%29%
% 224.13/224.36  |- mesh__publicMeSHNote mesh__D007937 79; was see PLASMAPHERESIS 1978   
% 224.13/224.36  |- skos__hiddenLabel mesh__D007937 Leukocytophereses
% 224.13/224.36  |- skos__altLabel mesh__D007937 Lymphocytapheresis
% 224.13/224.36  |- skos__hiddenLabel mesh__D007937 Lymphocytophereses
% 224.13/224.36  |- rdf__type mesh__D007937sskos__Concept
% 224.13/224.36  |- skos__altLabel mesh__D007937 Leukocytapheresis
% 224.13/224.36  |- skos__altLabel mesh__D007937 Leukocytopheresis
% 224.13/224.36  |- mesh__dateEstablished mesh__D007937 1979-01-01
% 224.13/224.36  |- mesh__historyNote mesh__D007937 79; was see PLASMAPHERESIS 1978   
% 224.13/224.36  |- skos__altLabel mesh__D007937 Lymphopheresis
% 224.13/224.36  |- skos__broader mesh__D007937smesh__D016238
% 224.13/224.36  |- skos__historyNote mesh__D007937 Cell Separation %28%1972-1978%29%
% 224.13/224.36  |- skos__hiddenLabel mesh__D007937 Leukophereses
% 224.13/224.36  |- mesh__recordOriginator mesh__D007937 SMH
% 224.13/224.36  |- mesh__recordAuthorizer mesh__D007937 sjn
% 224.13/224.36  |- skos__broader mesh__D007937smesh__D047589
% 224.13/224.36  |- mesh__onlineNote mesh__D007937
% 224.13/224.36       use PLASMAPHERESIS to search LEUKAPHERESIS 1978   
% 224.13/224.36  |- skos__hiddenLabel mesh__D007937 Lymphocytaphereses
% 224.13/224.36  |- skos__altLabel mesh__D007937 Leukopheresis
% 224.13/224.36  |- skos__hiddenLabel mesh__D007937 Lymphophereses
% 224.13/224.36  |- skos__hiddenLabel mesh__D007937 Lymphaphereses
% 224.13/224.36  |- mesh__dateRevised mesh__D007937 2005-06-30
% 224.13/224.36  |- skos__scopeNote mesh__D007937
% 224.13/224.36       The preparation of leukocyte concentrates with the return of red cells and leukocyte-poor plasma to the donor.%A%    
% 224.13/224.36  |- skos__hiddenLabel mesh__D007937 Leukaphereses
% 224.13/224.36  |- mesh__dateCreated mesh__D007937 1978-01-26
% 224.13/224.36  |- skos__historyNote mesh__D007937 Leukocytes %28%1966-1978%29%
% 224.13/224.36  |- mesh__recordMaintainer mesh__D007937 lkt
% 224.13/224.36  |- skos__hiddenLabel mesh__D007937 Leukocytaphereses
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D007937 2006
% 224.13/224.36  |- skos__prefLabel mesh__D007139 Immunoglobulin epsilon-Chains
% 224.13/224.36  |- mesh__dateCreated mesh__D007139 1975-07-18
% 224.13/224.36  |- skos__hiddenLabel mesh__D007139 epsilon Chain Immunoglobulins
% 224.13/224.36  |- mesh__publicMeSHNote mesh__D007139
% 224.13/224.36       2006; see IMMUNOGLOBULINS, EPSILON-CHAIN 1992-2005, see IMMUNOGLOBULINS, EPSILON CHAIN 1991, see IMMUNOGLOBULINS, HEAVY CHAIN 1976-1990%A%  
% 224.13/224.36  |- mesh__dateRevised mesh__D007139 2005-07-15
% 224.13/224.36  |- skos__altLabel mesh__D007139 epsilon-Chain Immunoglobulins
% 224.13/224.36  |- mesh__recordOriginator mesh__D007139 RLS
% 224.13/224.36  |- skos__altLabel mesh__D007139 Immunoglobulins, epsilon-Chain
% 224.13/224.36  |- mesh__recordMaintainer mesh__D007139 ags
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D007139 2006A
% 224.13/224.36  |- mesh__dateEstablished mesh__D007139 1991-01-01
% 224.13/224.36  |- skos__hiddenLabel mesh__D007139 Heavy Chains, epsilon-Immunoglobulin
% 224.13/224.36  |- skos__altLabel mesh__D007139 epsilon-Immunoglobulin Heavy Chain
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D007139 2006
% 224.13/224.36  |- skos__scopeNote mesh__D007139
% 224.13/224.36       The class of heavy chains found in IMMUNOGLOBULIN E. They have a molecular weight of approximately 72 kDa and they contain about 550 amino acid residues arranged in five domains and about three times more carbohydrate than the heavy chains of IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; and IMMUNOGLOBULIN G.%A%    
% 224.13/224.36  |- skos__hiddenLabel mesh__D007139 Heavy Chain, epsilon-Immunoglobulin
% 224.13/224.36  |- skos__altLabel mesh__D007139 epsilon-Immunoglobulin Heavy Chains
% 224.13/224.36  |- skos__historyNote mesh__D007139
% 224.13/224.36       Immunoglobulin Fragments %28%1973-1975%29%
% 224.13/224.36  |- skos__hiddenLabel mesh__D007139 Immunoglobulins, epsilon Chain
% 224.13/224.36  |- skos__hiddenLabel mesh__D007139 epsilon-Chain, Immunoglobulin
% 224.13/224.36  |- mesh__recordAuthorizer mesh__D007139 ags
% 224.13/224.36  |- skos__altLabel mesh__D007139 Immunoglobulin epsilon-Chain
% 224.13/224.36  |- rdf__type mesh__D007139sskos__Concept
% 224.13/224.36  |- skos__hiddenLabel mesh__D007139 epsilon-Chains, Immunoglobulin
% 224.13/224.36  |- skos__historyNote mesh__D007139 IgE %28%1973-1975%29%
% 224.13/224.36  |- skos__hiddenLabel mesh__D007139 Immunoglobulin epsilon Chains
% 224.13/224.36  |- skos__broader mesh__D007139smesh__D007143
% 224.13/224.36  |- skos__broader mesh__D007139smesh__D007073
% 224.13/224.36  |- skos__annotation mesh__D007139
% 224.13/224.36       gammopathy: coordinate IMMUNOGLOBULIN EPSILON-CHAINS %28%IM%29% with PARAPROTEINEMIAS %28%IM%29% but consider also HYPERGAMMAGLOBULINEMIA %28%IM%29% or HEAVY CHAIN DISEASE %28%IM%29%, follow text; DF: IG EPSILON CHAIN%A%  
% 224.13/224.36  |- skos__hiddenLabel mesh__D007139 epsilon Immunoglobulin Heavy Chain
% 224.13/224.36  |- mesh__historyNote mesh__D007139 2006 %28%1976%29%   
% 224.13/224.36  |- skos__hiddenLabel mesh__D007139 Immunoglobulin epsilon Chain
% 224.13/224.36  |- skos__hiddenLabel mesh__D007139 epsilon Immunoglobulin Heavy Chains
% 224.13/224.36  |- skos__historyNote mesh__D007139
% 224.13/224.36       Immunoglobulins, Heavy Chain %28%1975%29%
% 224.13/224.36  |- skos__broader mesh__D011827Q000627smesh__D011827
% 224.13/224.36  |- mesh__preferredCombination mesh__D011827Q000627smesh__D011878
% 224.13/224.36  |- rdf__type mesh__D011827Q000627smesh__CompoundConcept
% 224.13/224.36  |- skos__hiddenLabel mesh__D017567 Scale, Karnofsky
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D017567 2002
% 224.13/224.36  |- skos__altLabel mesh__D017567 Karnofsky Index
% 224.13/224.36  |- mesh__historyNote mesh__D017567 94   
% 224.13/224.36  |- skos__prefLabel mesh__D017567 Karnofsky Performance Status
% 224.13/224.36  |- skos__hiddenLabel mesh__D017567 Status, Karnofsky Performance
% 224.13/224.36  |- mesh__dateRevised mesh__D017567 1999-11-08
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D017567 2005
% 224.13/224.36  |- mesh__recordOriginator mesh__D017567 TGC
% 224.13/224.36  |- mesh__dateCreated mesh__D017567 1992-12-28
% 224.13/224.36  |- skos__related mesh__D017567smesh__D011788
% 224.13/224.36  |- skos__related mesh__D017567smesh__D000203
% 224.13/224.36  |- rdf__type mesh__D017567sskos__Concept
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D017567 2006
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D017567 2003
% 224.13/224.36  |- mesh__dateEstablished mesh__D017567 1994-01-01
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D017567 2004
% 224.13/224.36  |- skos__altLabel mesh__D017567 Karnofsky Scale
% 224.13/224.36  |- mesh__recordAuthorizer mesh__D017567 sjn
% 224.13/224.36  |- skos__altLabel mesh__D017567 Karnofsky Performance Status Scale
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D017567 2000
% 224.13/224.36  |- skos__hiddenLabel mesh__D017567 Performance Status, Karnofsky
% 224.13/224.36  |- mesh__publicMeSHNote mesh__D017567 94   
% 224.13/224.36  |- skos__hiddenLabel mesh__D017567 Index, Karnofsky
% 224.13/224.36  |- skos__scopeNote mesh__D017567
% 224.13/224.36       A performance measure for rating the ability of a person to perform usual activities, evaluating a patient%27%s progress after a therapeutic procedure, and determining a patient%27%s suitability for therapy. It is used most commonly in the prognosis of cancer therapy, usually after chemotherapy and customarily administered before and after therapy. It was named for Dr. David A. Karnofsky, an American specialist in cancer chemotherapy.%A%    
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D017567 2001
% 224.13/224.36  |- skos__broader mesh__D017567smesh__D012720
% 224.13/224.36  |- mesh__recordMaintainer mesh__D017567 KEV
% 224.13/224.36  |- skos__annotation mesh__D031238
% 224.13/224.36       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.13/224.36  |- skos__scopeNote mesh__D031238
% 224.13/224.36       A plant genus of the family CAMPANULACEAE that contains platycodin and other triterpenoid SAPONINS. It is a constituent of kikyo-to %28%MEDICINE, KAMPO%29%.%A%    
% 224.13/224.36  |- skos__altLabel mesh__D031238 Bellflower, Chinese
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D031238 2005
% 224.13/224.36  |- mesh__dateEstablished mesh__D031238 2003-01-01
% 224.13/224.36  |- mesh__publicMeSHNote mesh__D031238 2003   
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D031238 2003
% 224.13/224.36  |- skos__broader mesh__D031238smesh__D029422
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D031238 2006
% 224.13/224.36  |- mesh__dateCreated mesh__D031238 2002-07-02
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D031238 2004
% 224.13/224.36  |- skos__prefLabel mesh__D031238 Platycodon
% 224.13/224.36  |- rdf__type mesh__D031238sskos__Concept
% 224.13/224.36  |- mesh__historyNote mesh__D031238 2003   
% 224.13/224.36  |- skos__altLabel mesh__D031238 Balloon Flower
% 224.13/224.36  |- mesh__dateEstablished mesh__D036721 2003-01-01
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D036721 2005
% 224.13/224.36  |- skos__annotation mesh__D036721
% 224.13/224.36       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.13/224.36  |- skos__prefLabel mesh__D036721 Scoparia
% 224.13/224.36  |- skos__broader mesh__D036721smesh__D028083
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D036721 2004
% 224.13/224.36  |- mesh__dateCreated mesh__D036721 2002-07-03
% 224.13/224.36  |- skos__scopeNote mesh__D036721
% 224.13/224.36       A plant genus of the family SCROPHULARIACEAE. Members contain thyrsiflorin and other scopadulane %28%labdane%29% type DITERPENES.%A%    
% 224.13/224.36  |- rdf__type mesh__D036721sskos__Concept
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D036721 2003
% 224.13/224.36  |- mesh__publicMeSHNote mesh__D036721 2003   
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D036721 2006
% 224.13/224.36  |- mesh__historyNote mesh__D036721 2003   
% 224.13/224.36  |- rdf__type mesh__D003547sskos__Concept
% 224.13/224.36  |- mesh__recordOriginator mesh__D003547 RLS
% 224.13/224.36  |- mesh__dateRevised mesh__D003547 2005-06-30
% 224.13/224.36  |- mesh__dateCreated mesh__D003547 1976-05-19
% 224.13/224.36  |- skos__historyNote mesh__D003547 Cysteine %28%1966-1976%29%
% 224.13/224.36  |- skos__historyNote mesh__D003547 Serine %28%1966-1976%29%
% 224.13/224.36  |- skos__altLabel mesh__D003547 O-Acetylserine Sulfhydrylase
% 224.13/224.36  |- skos__hiddenLabel mesh__D003547 Sulfhydrylase, O-Acetylserine
% 224.13/224.36  |- mesh__dateEstablished mesh__D003547 1991-01-01
% 224.13/224.36  |- mesh__recordAuthorizer mesh__D003547 sjn
% 224.13/224.36  |- skos__broader mesh__D003547smesh__D019883
% 224.13/224.36  |- skos__historyNote mesh__D003547 Lyases %28%1966-1976%29%
% 224.13/224.36  |- mesh__historyNote mesh__D003547
% 224.13/224.36       91%28%77%29%; was see under LYASES 1977-90   
% 224.13/224.36  |- mesh__recordMaintainer mesh__D003547 jmp
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D003547 2006
% 224.13/224.36  |- skos__scopeNote mesh__D003547
% 224.13/224.36       An enzyme that catalyzes the biosynthesis of cysteine in microorganisms and plants from O-acetyl-L-serine and hydrogen sulfide. This enzyme was formerly listed as  EC 4.2.99.8.%A%    
% 224.13/224.36  |- mesh__publicMeSHNote mesh__D003547 91; was see under LYASES 1977-90   
% 224.13/224.36  |- skos__hiddenLabel mesh__D003547 O Acetylserine Sulfhydrylase
% 224.13/224.36  |- skos__prefLabel mesh__D003547 Cysteine Synthase
% 224.13/224.36  |- mesh__dateCreated mesh__D022701 2000-06-22
% 224.13/224.36  |- mesh__publicMeSHNote mesh__D022701 2001   
% 224.13/224.36  |- rdf__type mesh__D022701sskos__Concept
% 224.13/224.36  |- skos__scopeNote mesh__D022701
% 224.13/224.36       Semi-synthetic complex derived from nucleic-acid free viral particles. They are essentially reconstituted viral coats, where the infectious nucleocapsid is replaced by a compound of choice. Virosomes retain their fusogenic activity and thus deliver the incorporated compound %28%antigens, drugs, genes%29% inside the target cell. They can be used for vaccines %28%VACCINES, VIROSOME%29%, drug delivery, or gene transfer.%A%    
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D022701 2005
% 224.13/224.36  |- mesh__historyNote mesh__D022701 2001   
% 224.13/224.36  |- mesh__dateRevised mesh__D022701 2004-07-07
% 224.13/224.36  |- skos__broader mesh__D022701smesh__D004337
% 224.13/224.36  |- skos__hiddenLabel mesh__D022701 Virosome
% 224.13/224.36  |- skos__related mesh__D022701smesh__D022721
% 224.13/224.36  |- skos__annotation mesh__D022701
% 224.13/224.36       when used as a vehicle in drug ther, index specific drug /admin %28%IM%29% + VIROSOMES %28%NIM without qualif%29%%A%  
% 224.13/224.36  |- skos__historyNote mesh__D022701 Liposomes %28%1975-2000%29%
% 224.13/224.36  |- skos__broader mesh__D022701smesh__D008567
% 224.13/224.36  |- mesh__dateEstablished mesh__D022701 2001-01-01
% 224.13/224.36  |- mesh__recordMaintainer mesh__D022701 nns
% 224.13/224.36  |- mesh__recordAuthorizer mesh__D022701 sjn
% 224.13/224.36  |- mesh__recordOriginator mesh__D022701 ags
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D022701 2006
% 224.13/224.36  |- skos__prefLabel mesh__D022701 Virosomes
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D008232 2003
% 224.13/224.36  |- skos__hiddenLabel mesh__D008232 X-Linked Lymphoproliferative Disorders
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D008232 1999
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D008232 2002
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D008232 1994
% 224.13/224.36  |- skos__hiddenLabel mesh__D008232 Lymphoproliferative Syndrome, X-Linked
% 224.13/224.36  |- mesh__dateCreated mesh__D008232 1978-05-19
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D008232 1992
% 224.13/224.36  |- mesh__recordAuthorizer mesh__D008232 PLS
% 224.13/224.36  |- mesh__dateEstablished mesh__D008232 1979-01-01
% 224.13/224.36  |- skos__hiddenLabel mesh__D008232 X-Linked Lymphoproliferative Syndromes
% 224.13/224.36  |- skos__hiddenLabel mesh__D008232 Syndromes, X-Linked Lymphoproliferative
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D008232 1991
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D008232 1998
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D008232 2001
% 224.13/224.36  |- mesh__recordOriginator mesh__D008232 VDK
% 224.13/224.36  |- skos__broader mesh__D008232smesh__D007160
% 224.13/224.36  |- skos__hiddenLabel mesh__D008232 X Linked Lymphoproliferative Syndrome
% 224.13/224.36  |- skos__hiddenLabel mesh__D008232 X Linked Lymphoproliferative Disorder
% 224.13/224.36  |- skos__broader mesh__D008232smesh__D008206
% 224.13/224.36  |- skos__hiddenLabel mesh__D008232 Syndrome, X-Linked Lymphoproliferative
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D008232 2006
% 224.13/224.36  |- skos__altLabel mesh__D008232 Duncan%27%s Syndrome
% 224.13/224.36  |- mesh__dateRevised mesh__D008232 1990-05-29
% 224.13/224.36  |- skos__altLabel mesh__D008232 X-Linked Lymphoproliferative Syndrome
% 224.13/224.36  |- skos__hiddenLabel mesh__D008232 Disorder, Lymphoproliferative
% 224.13/224.36  |- skos__hiddenLabel mesh__D008232 Duncan Syndrome
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D008232 1997
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D008232 2000
% 224.13/224.36  |- skos__hiddenLabel mesh__D008232 Lymphoproliferative Disorder
% 224.13/224.36  |- mesh__historyNote mesh__D008232 79   
% 224.13/224.36  |- skos__hiddenLabel mesh__D008232 Disorder, X-Linked Lymphoproliferative
% 224.13/224.36  |- skos__hiddenLabel mesh__D008232 Disorders, X-Linked Lymphoproliferative
% 224.13/224.36  |- skos__prefLabel mesh__D008232 Lymphoproliferative Disorders
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D008232 2005
% 224.13/224.36  |- skos__hiddenLabel mesh__D008232 Lymphoproliferative Syndromes, X-Linked
% 224.13/224.36  |- skos__hiddenLabel mesh__D008232 Disorders, Lymphoproliferative
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D008232 1996
% 224.13/224.36  |- skos__hiddenLabel mesh__D008232 Duncans Syndrome
% 224.13/224.36  |- rdf__type mesh__D008232sskos__Concept
% 224.13/224.36  |- skos__hiddenLabel mesh__D008232 Lymphoproliferative Disorder, X-Linked
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D008232 2004
% 224.13/224.36  |- skos__scopeNote mesh__D008232
% 224.13/224.36       Disorders characterized by proliferation of lymphoid tissue, general or unspecified.%A%    
% 224.13/224.36  |- skos__annotation mesh__D008232 GEN or unspecified: prefer specifics   
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D008232 1995
% 224.13/224.36  |- mesh__recordMaintainer mesh__D008232 AGS
% 224.13/224.36  |- mesh__activeMeSHYear mesh__D008232 1993
% 224.13/224.36  |- skos__hiddenLabel mesh__D008232 Syndrome, Duncan%27%s
% 224.13/224.36  |- skos__hiddenLabel mesh__D008232 Lymphoproliferative Disorders, X-Linked
% 224.13/224.36  |- mesh__publicMeSHNote mesh__D008232 79   
% 224.13/224.36  |- mesh__recordOriginator mesh__D013975 NLM
% 224.13/224.36  |- skos__hiddenLabel mesh__D013975 Thyroxine Binding Proteins
% 224.22/224.36  |- skos__hiddenLabel mesh__D013975 Protein, Thyroxine Transport
% 224.22/224.36  |- skos__hiddenLabel mesh__D013975 Thyroxine Binding Prealbumin
% 224.22/224.36  |- mesh__activeMeSHYear mesh__D013975 1998
% 224.22/224.36  |- mesh__recordMaintainer mesh__D013975 JRT
% 224.22/224.36  |- skos__broader mesh__D013975smesh__D001798
% 224.22/224.36  |- mesh__activeMeSHYear mesh__D013975 2002
% 224.22/224.36  |- mesh__recordAuthorizer mesh__D013975 PLS
% 224.22/224.36  |- mesh__activeMeSHYear mesh__D013975 2004
% 224.22/224.36  |- mesh__dateCreated mesh__D013975 1999-01-01
% 224.22/224.36  |- mesh__activeMeSHYear mesh__D013975 1999
% 224.22/224.36  |- skos__broader mesh__D013975smesh__D015843
% 224.22/224.36  |- skos__hiddenLabel mesh__D013975 Proteins, Thyroxine-Binding
% 224.22/224.36  |- mesh__publicMeSHNote mesh__D013975
% 224.22/224.36       92; was THYROXINE-BINDING PROTEIN 1966-91   
% 224.22/224.36  |- mesh__onlineNote mesh__D013975
% 224.22/224.36       use THYROXINE-BINDING PROTEINS to search THYROXINE-BINDING PROTEIN 1966-91%A%  
% 224.22/224.36  |- skos__altLabel mesh__D013975 Thyroxine Transport Protein
% 224.22/224.36  |- skos__broader mesh__D013975smesh__D006023
% 224.22/224.36  |- mesh__activeMeSHYear mesh__D013975 1996
% 224.22/224.36  |- skos__hiddenLabel mesh__D013975 Thyroxine Binding Globulin
% 224.22/224.36  |- skos__prefLabel mesh__D013975 Thyroxine-Binding Proteins
% 224.22/224.36  |- mesh__dateEstablished mesh__D013975 1966-01-01
% 224.22/224.36  |- skos__broader mesh__D013975smesh__D002352
% 224.22/224.36  |- mesh__activeMeSHYear mesh__D013975 2000
% 224.22/224.36  |- skos__annotation mesh__D013975
% 224.22/224.36       serpins; includes also thyroxine-binding albumin in addition to X refs here%A%  
% 224.22/224.36  |- skos__hiddenLabel mesh__D013975 Thyroxine Binding Protein
% 224.22/224.36  |- skos__scopeNote mesh__D013975
% 224.22/224.36       A group of proteins that includes thyroxine-binding globulin, a glycoprotein that serves as the major and specific carrier of thyroxine in plasma, accounting for 70-75%25% of the bound thyroxine; thyroxine-binding prealbumin, an albumin that serves as the secondary carrier, accounting for between 20 and 25%25% of the bound thyroxine; and serum albumin, which accounts for the remaining bound thyroxine.%A%    
% 224.22/224.36  |- mesh__activeMeSHYear mesh__D013975 1997
% 224.22/224.36  |- mesh__dateRevised mesh__D013975 1995-06-08
% 224.22/224.36  |- skos__hiddenLabel mesh__D013975 Globulin, Thyroxine-Binding
% 224.22/224.36  |- mesh__activeMeSHYear mesh__D013975 2005
% 224.22/224.36  |- mesh__activeMeSHYear mesh__D013975 2001
% 224.22/224.36  |- mesh__historyNote mesh__D013975
% 224.22/224.36       92; was THYROXINE-BINDING PROTEIN 1965-91 %28%Prov 1965%29%   
% 224.22/224.36  |- skos__hiddenLabel mesh__D013975 Protein, Thyroxine-Binding
% 224.22/224.36  |- skos__altLabel mesh__D013975 Thyroxine-Binding Protein
% 224.22/224.36  |- mesh__activeMeSHYear mesh__D013975 2006
% 224.22/224.36  |- rdf__type mesh__D013975sskos__Concept
% 224.22/224.36  |- skos__hiddenLabel mesh__D013975 Prealbumin, Thyroxine-Binding
% 224.22/224.36  |- mesh__activeMeSHYear mesh__D013975 2003
% 224.22/224.36  |- mesh__activeMeSHYear mesh__D046351 2006
% 224.22/224.36  |- skos__historyNote mesh__D046351 Porphyria %28%1965-2004%29%
% 224.22/224.36  |- skos__altLabel mesh__D046351 Erythropoietic Protoporphyria
% 224.22/224.36  |- skos__hiddenLabel mesh__D046351 Protoporphyrias, Erythropoietic
% 224.22/224.36  |- mesh__historyNote mesh__D046351
% 224.22/224.36       2005; use PORPHYRIA, ERYTHROHEPATIC 1993-2004   
% 224.22/224.36  |- skos__scopeNote mesh__D046351
% 224.22/224.36       An autosomal dominant porphyria that is due to a deficiency of FERROCHELATASE %28%heme synthetase%29% in both the LIVER and the BONE MARROW, the last enzyme in the 8-enzyme biosynthetic pathway of HEME.  Clinical features include mainly neurological symptoms, rarely cutaneous lesions, and elevated levels of protoporphyrin and COPROPORPHYRINS in the feces.%A%    
% 224.22/224.36  |- skos__hiddenLabel mesh__D046351 Erythropoietic Protoporphyrias
% 224.22/224.36  |- skos__broader mesh__D046351smesh__D017094
% 224.22/224.36  |- mesh__dateEstablished mesh__D046351 2005-01-01
% 224.22/224.36  |- rdf__type mesh__D046351sskos__Concept
% 224.22/224.36  |- mesh__publicMeSHNote mesh__D046351
% 224.22/224.36       2005; see PORPHYRIA, ERYTHROHEPATIC 1993-2004   
% 224.22/224.36  |- mesh__recordMaintainer mesh__D046351 lkt
% 224.22/224.36  |- skos__annotation mesh__D046351
% 224.22/224.36       do not confuse with PORPHYRIA, ERYTHROPOIETIC   
% 224.22/224.36  |- skos__prefLabel mesh__D046351 Protoporphyria, Erythropoietic
% 224.22/224.36  |- mesh__recordOriginator mesh__D046351 lkt
% 224.22/224.36  |- mesh__activeMeSHYear mesh__D046351 2005
% 224.22/224.36  |- mesh__dateCreated mesh__D046351 2004-07-15
% 224.22/224.36  |- skos__historyNote mesh__D046351
% 224.22/224.36       Porphyria, Erythrohepatic %28%1993-2004%29%
% 224.22/224.36  |- mesh__recordAuthorizer mesh__D046351 sjn
% 224.22/224.36  |- mesh__activeMeSHYear mesh__D013177 2003
% 224.22/224.36  |- mesh__activeMeSHYear mesh__D013177 2006
% 224.22/224.37  |- mesh__dateCreated mesh__D013177 1999-01-01
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D013177 2004
% 224.22/224.37  |- mesh__dateRevised mesh__D013177 1999-11-03
% 224.22/224.37  |- mesh__recordAuthorizer mesh__D013177 sjn
% 224.22/224.37  |- mesh__historyNote mesh__D013177
% 224.22/224.37       ATHLETICS was see under SPORTS 1963-75   
% 224.22/224.37  |- skos__scopeNote mesh__D013177
% 224.22/224.37       Activities or games, usually involving physical effort or skill. Reasons for engagement in sports include pleasure, competition, and/or financial reward.%A%    
% 224.22/224.37  |- mesh__recordMaintainer mesh__D013177 kle
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D013177 2000
% 224.22/224.37  |- skos__broader mesh__D013177smesh__D011998
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D013177 2001
% 224.22/224.37  |- mesh__recordOriginator mesh__D013177 NLM
% 224.22/224.37  |- skos__annotation mesh__D013177
% 224.22/224.37       SPORTS is the activity, SPORTS MEDICINE is the speciality; /inj = ATHLETIC INJURIES but see note there; /physiol permitted; Manual 30.31%A%  
% 224.22/224.37  |- skos__related mesh__D013177smesh__D004300
% 224.22/224.37  |- rdf__type mesh__D013177sskos__Concept
% 224.22/224.37  |- skos__prefLabel mesh__D013177 Sports
% 224.22/224.37  |- mesh__onlineNote mesh__D013177 use SPORTS to search ATHLETICS 1966-75   
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D013177 2005
% 224.22/224.37  |- skos__hiddenLabel mesh__D013177 Sport
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D013177 2002
% 224.22/224.37  |- skos__related mesh__D013177smesh__D001265
% 224.22/224.37  |- skos__hiddenLabel mesh__D013177 Athletic
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D007938 2001
% 224.22/224.37  |- mesh__dateRevised mesh__D007938 1997-06-20
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D007938 2004
% 224.22/224.37  |- skos__annotation mesh__D007938
% 224.22/224.37       note all the leukemia terms %26% cross-refs for the many types of leukemia; if not here, check Tumor Manual or Tumor Key; do not use /blood supply /chem /second /secret /ultrastruct; radiation-induced = LEUKEMIA, RADIATION-INDUCED; leukemic infiltration = LEUKEMIC INFILTRATION but see note there%A%  
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D007938 2000
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D007938 2003
% 224.22/224.37  |- skos__prefLabel mesh__D007938 Leukemia
% 224.22/224.37  |- mesh__dateCreated mesh__D007938 1999-01-01
% 224.22/224.37  |- skos__related mesh__D007938smesh__D017254
% 224.22/224.37  |- skos__hiddenLabel mesh__D007938 Leukemias
% 224.22/224.37  |- skos__broader mesh__D007938smesh__D009370
% 224.22/224.37  |- mesh__recordAuthorizer mesh__D007938 SJN
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D007938 2006
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D007938 2002
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D007938 1999
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D007938 2005
% 224.22/224.37  |- mesh__recordOriginator mesh__D007938 NLM
% 224.22/224.37  |- mesh__recordMaintainer mesh__D007938 TGC
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D007938 1998
% 224.22/224.37  |- rdf__type mesh__D007938sskos__Concept
% 224.22/224.37  |- skos__scopeNote mesh__D007938
% 224.22/224.37       A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. It is classified according to degree of cell differentiation as acute or chronic, and according to predominant type of cell involved as myelogenous or lymphocytic. %28%Dorland, 28th ed%29%%A%    
% 224.22/224.37  |- skos__altLabel mesh__D018660 Monitoring, Ambulatory Blood Pressure
% 224.22/224.37  |- rdf__type mesh__D018660sskos__Concept
% 224.22/224.37  |- mesh__recordMaintainer mesh__D018660 ssb
% 224.22/224.37  |- mesh__dateEstablished mesh__D018660 1995-01-01
% 224.22/224.37  |- mesh__publicMeSHNote mesh__D018660 95   
% 224.22/224.37  |- skos__prefLabel mesh__D018660 Blood Pressure Monitoring, Ambulatory
% 224.22/224.37  |- skos__historyNote mesh__D018660
% 224.22/224.37       Blood Pressure Determination %28%1981-1994%29%
% 224.22/224.37  |- mesh__recordAuthorizer mesh__D018660 sjn
% 224.22/224.37  |- mesh__historyNote mesh__D018660 95   
% 224.22/224.37  |- skos__broader mesh__D018660smesh__D018670
% 224.22/224.37  |- mesh__recordOriginator mesh__D018660 AGS
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D018660 2005
% 224.22/224.37  |- skos__scopeNote mesh__D018660
% 224.22/224.37       Method in which repeated blood pressure readings are made while the patient undergoes normal daily activities. It allows quantitative analysis of the high blood pressure load over time, can help distinguish between types of HYPERTENSION, and can assess the effectiveness of antihypertensive therapy.%A%    
% 224.22/224.37  |- skos__broader mesh__D018660smesh__D001795
% 224.22/224.37  |- skos__historyNote mesh__D018660
% 224.22/224.37       Blood Pressure Monitors %28%1990-1994%29%
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D018660 2006
% 224.22/224.37  |- mesh__dateCreated mesh__D018660 1994-04-19
% 224.22/224.37  |- skos__altLabel mesh__D018660 Ambulatory Blood Pressure Monitoring
% 224.22/224.37  |- mesh__dateRevised mesh__D018660 2004-07-07
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D004640 2006
% 224.22/224.37  |- mesh__recordOriginator mesh__D004640 NLM
% 224.22/224.37  |- skos__scopeNote mesh__D004640
% 224.22/224.37       The principal alkaloid of ipecac, from the ground roots of Uragoga %28%or Cephaelis%29% ipecacuanha or U. acuminata, of the Rubiaceae. It is used as an amebicide in many different preparations and may cause serious cardiac, hepatic, or renal damage and violent diarrhea and vomiting. Emetine inhibits protein synthesis in eucaryotic but not prokaryotic cells.%A%    
% 224.22/224.37  |- mesh__dateCreated mesh__D004640 1999-01-01
% 224.22/224.37  |- skos__prefLabel mesh__D004640 Emetine
% 224.22/224.37  |- rdf__type mesh__D004640sskos__Concept
% 224.22/224.37  |- skos__altLabel mesh__D004640 Methylcephaeline
% 224.22/224.37  |- skos__broader mesh__D004640smesh__D007546
% 224.22/224.37  |- mesh__recordMaintainer mesh__D004640 jls
% 224.22/224.37  |- skos__hiddenLabel mesh__D004640 Dihydrochloride, Emetine
% 224.22/224.37  |- skos__altLabel mesh__D004640 Ipecine
% 224.22/224.37  |- skos__hiddenLabel mesh__D004640 Hydrochloride, Emetine
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D004640 2005
% 224.22/224.37  |- mesh__recordAuthorizer mesh__D004640 sjn
% 224.22/224.37  |- skos__broader mesh__D004640smesh__D000470
% 224.22/224.37  |- mesh__dateRevised mesh__D004640 2004-07-19
% 224.22/224.37  |- mesh__historyNote mesh__D051296 2006%28%1992%29%   
% 224.22/224.37  |- skos__altLabel mesh__D051296 D-Fructose Transporter
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D051296 2006
% 224.22/224.37  |- skos__altLabel mesh__D051296 GLUT-5 Protein
% 224.22/224.37  |- mesh__dateEstablished mesh__D051296 2006-01-01
% 224.22/224.37  |- skos__scopeNote mesh__D051296
% 224.22/224.37       A hexose transporter that mediates FRUCTOSE transport in SKELETAL MUSCLE and ADIPOCYTES and is responsible for luminal uptake of dietary fructose in the SMALL INTESTINE.%A%    
% 224.22/224.37  |- skos__broader mesh__D051296smesh__D051246
% 224.22/224.37  |- mesh__recordAuthorizer mesh__D051296 sjn
% 224.22/224.37  |- mesh__recordOriginator mesh__D051296 DRC
% 224.22/224.37  |- skos__altLabel mesh__D051296 SLC2A5 Protein
% 224.22/224.37  |- mesh__dateCreated mesh__D051296 2005-06-30
% 224.22/224.37  |- skos__prefLabel mesh__D051296 Glucose Transporter Type 5
% 224.22/224.37  |- rdf__type mesh__D051296sskos__Concept
% 224.22/224.37  |- mesh__publicMeSHNote mesh__D051296
% 224.22/224.37       2006; GLUCOSE TRANSPORTER TYPE 5 was indexed under MONOSACCHARIDE TRANSPORT PROTEINS 1992-2005%A%  
% 224.22/224.37  |- skos__altLabel mesh__D051296 GLUT5 Protein
% 224.22/224.37  |- mesh__recordMaintainer mesh__D051296 DRC
% 224.22/224.37  |- skos__hiddenLabel mesh__D051296 GLUT 5 Protein
% 224.22/224.37  |- skos__prefLabel mesh__D017568 Rectus Abdominis
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D017568 2006
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D017568 2003
% 224.22/224.37  |- mesh__recordAuthorizer mesh__D017568 sjn
% 224.22/224.37  |- mesh__publicMeSHNote mesh__D017568 94   
% 224.22/224.37  |- skos__altLabel mesh__D017568 Rectus Muscle of Abdomen
% 224.22/224.37  |- mesh__recordMaintainer mesh__D017568 nns
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D017568 2004
% 224.22/224.37  |- skos__hiddenLabel mesh__D017568 Abdomen Rectus Muscle
% 224.22/224.37  |- skos__historyNote mesh__D017568 Abdominal Muscles %28%1966-1993%29%
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D017568 2002
% 224.22/224.37  |- mesh__recordOriginator mesh__D017568 TGC
% 224.22/224.37  |- mesh__historyNote mesh__D017568 94   
% 224.22/224.37  |- mesh__dateEstablished mesh__D017568 1994-01-01
% 224.22/224.37  |- skos__scopeNote mesh__D017568
% 224.22/224.37       A long flat muscle that extends along the whole length of both sides of the abdomen. It flexes the vertebral column, particularly the lumbar portion; it also tenses the anterior abdominal wall and assists in compressing the abdominal contents. It is frequently the site of hematomas. In reconstructive surgery it is often used for the creation of myocutaneous flaps. %28%From Gray%27%s Anatomy, 30th American ed, p491%29%%A%    
% 224.22/224.37  |- mesh__dateRevised mesh__D017568 2001-07-25
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D017568 2005
% 224.22/224.37  |- skos__annotation mesh__D017568
% 224.22/224.37       /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 224.22/224.37  |- mesh__dateCreated mesh__D017568 1992-12-28
% 224.22/224.37  |- skos__broader mesh__D017568smesh__D000009
% 224.22/224.37  |- skos__hiddenLabel mesh__D017568 Abdomen Rectus Muscles
% 224.22/224.37  |- rdf__type mesh__D017568sskos__Concept
% 224.22/224.37  |- skos__scopeNote mesh__D031239
% 224.22/224.37       A plant genus of the family CAPRIFOLIACEAE. Members contain iridoid glucosides.%A%    
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D031239 2005
% 224.22/224.37  |- mesh__publicMeSHNote mesh__D031239 2003   
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D031239 2003
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D031239 2006
% 224.22/224.37  |- mesh__dateCreated mesh__D031239 2002-07-03
% 224.22/224.37  |- skos__prefLabel mesh__D031239 Lonicera
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D031239 2004
% 224.22/224.37  |- mesh__dateEstablished mesh__D031239 2003-01-01
% 224.22/224.37  |- rdf__type mesh__D031239sskos__Concept
% 224.22/224.37  |- skos__altLabel mesh__D031239 Honeysuckle
% 224.22/224.37  |- skos__broader mesh__D031239smesh__D027922
% 224.22/224.37  |- skos__annotation mesh__D031239
% 224.22/224.37       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.22/224.37  |- mesh__historyNote mesh__D031239 2003   
% 224.22/224.37  |- skos__broader mesh__D007866Q000293smesh__D007866
% 224.22/224.37  |- mesh__preferredCombination mesh__D007866Q000293smesh__D007869
% 224.22/224.37  |- rdf__type mesh__D007866Q000293smesh__CompoundConcept
% 224.22/224.37  |- rdf__type mesh__D003548sskos__Concept
% 224.22/224.37  |- skos__prefLabel mesh__D003548 Cysteinyldopa
% 224.22/224.37  |- skos__historyNote mesh__D003548 Dopa %28%1966-1976%29%
% 224.22/224.37  |- skos__hiddenLabel mesh__D003548 5 S Cysteinyldopa
% 224.22/224.37  |- mesh__dateCreated mesh__D003548 1976-04-27
% 224.22/224.37  |- skos__broader mesh__D003548smesh__D004295
% 224.22/224.37  |- mesh__publicMeSHNote mesh__D003548 91; was see under DOPA 1977-90   
% 224.22/224.37  |- skos__altLabel mesh__D003548 5-S-Cysteinyldopa
% 224.22/224.37  |- skos__broader mesh__D003548smesh__D003545
% 224.22/224.37  |- mesh__dateRevised mesh__D003548 2005-06-30
% 224.22/224.37  |- mesh__recordMaintainer mesh__D003548 ssb
% 224.22/224.37  |- mesh__recordOriginator mesh__D003548 RLS
% 224.22/224.37  |- skos__scopeNote mesh__D003548
% 224.22/224.37       Found in large amounts in the plasma and urine of patients with malignant melanoma. It is therefore used in the diagnosis of melanoma and for the detection of postoperative metastases. Cysteinyldopa is believed to be formed by the rapid enzymatic hydrolysis of 5-S-glutathionedopa found in melanin-producing cells.%A%    
% 224.22/224.37  |- skos__historyNote mesh__D003548 Cysteine %28%1966-1976%29%
% 224.22/224.37  |- mesh__historyNote mesh__D003548
% 224.22/224.37       91%28%77%29%; was see under DOPA 1977-90   
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D003548 2006
% 224.22/224.37  |- skos__annotation mesh__D003548 /biosyn /physiol permitted   
% 224.22/224.37  |- mesh__dateEstablished mesh__D003548 1991-01-01
% 224.22/224.37  |- mesh__recordAuthorizer mesh__D003548 sjn
% 224.22/224.37  |- skos__prefLabel mesh__D014270 Trifluoroethanol
% 224.22/224.37  |- skos__altLabel mesh__D014270 Trifluoroethyl Alcohol
% 224.22/224.37  |- rdf__type mesh__D014270sskos__Concept
% 224.22/224.37  |- skos__altLabel mesh__D014270 2,2,2-Trifluoroethanol
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D014270 2001
% 224.22/224.37  |- mesh__publicMeSHNote mesh__D014270
% 224.22/224.37       91; was see under ALCOHOL, ETHYL 1975-90   
% 224.22/224.37  |- mesh__dateRevised mesh__D014270 2000-06-21
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D014270 2005
% 224.22/224.37  |- skos__hiddenLabel mesh__D014270 Alcohol, Trifluoroethyl
% 224.22/224.37  |- mesh__dateCreated mesh__D014270 1974-11-27
% 224.22/224.37  |- mesh__historyNote mesh__D014270
% 224.22/224.37       91%28%75%29%; was see under ALCOHOL, ETHYL 1975-90   
% 224.22/224.37  |- mesh__activeMeSHYear mesh__D014270 2006
% 224.22/224.38  |- skos__historyNote mesh__D014270 Fluorine %28%1972-1974%29%
% 224.22/224.38  |- skos__broader mesh__D014270smesh__D000431
% 224.22/224.38  |- mesh__recordOriginator mesh__D014270 NLM
% 224.22/224.38  |- mesh__activeMeSHYear mesh__D014270 2002
% 224.22/224.38  |- mesh__dateEstablished mesh__D014270 1991-01-01
% 224.22/224.38  |- mesh__recordMaintainer mesh__D014270 CCR
% 224.22/224.38  |- mesh__recordAuthorizer mesh__D014270 sjn
% 224.22/224.38  |- mesh__activeMeSHYear mesh__D014270 2003
% 224.22/224.38  |- skos__scopeNote mesh__D014270
% 224.22/224.38       A non-aqueous co-solvent that serves as tool to study protein folding. It is also used in various pharmaceutical, chemical and engineering applications.%A%    
% 224.22/224.38  |- skos__historyNote mesh__D014270 Alcohol, Ethyl %28%1972-1974%29%
% 224.22/224.38  |- mesh__activeMeSHYear mesh__D014270 2004
% 224.22/224.38  |- mesh__publicMeSHNote mesh__D022702
% 224.22/224.38       2001; ADRENERGIC BETA-3 RECEPTOR now RECEPTORS, ADRENERGIC, BETA-3 was indexed under RECEPTORS, ADRENERGIC, BETA 1977-2000%A%  
% 224.22/224.38  |- mesh__historyNote mesh__D022702
% 224.22/224.38       2001; use RECEPTORS, ADRENERGIC, BETA-3 %28%NM%29% 1977-2000   
% 224.22/224.38  |- skos__hiddenLabel mesh__D022702 beta 3 Adrenergic Receptors
% 224.22/224.38  |- mesh__dateCreated mesh__D022702 2000-06-23
% 224.22/224.38  |- skos__prefLabel mesh__D022702 Receptors, Adrenergic, beta-3
% 224.22/224.38  |- mesh__recordAuthorizer mesh__D022702 sjn
% 224.22/224.38  |- skos__altLabel mesh__D022702 Receptors, beta-3 Adrenergic
% 224.22/224.38  |- skos__hiddenLabel mesh__D022702 Adrenoreceptor, beta3
% 224.22/224.38  |- skos__altLabel mesh__D022702 beta-3 Adrenergic Receptors
% 224.22/224.38  |- skos__hiddenLabel mesh__D022702 Adrenergic Receptors, beta 3
% 224.22/224.38  |- skos__hiddenLabel mesh__D022702 beta-3 Receptor, Adrenergic
% 224.22/224.38  |- skos__scopeNote mesh__D022702
% 224.22/224.38       A subclass of beta-adrenergic receptors %28%RECEPTORS, ADRENERGIC, BETA%29%. beta-3 Adrenergic receptors are the predominant beta-adrenergic receptor type expressed in white and brown ADIPOCYTES and are involved in modulating ENERGY METABOLISM and THERMOGENESIS.%A%    
% 224.22/224.38  |- mesh__activeMeSHYear mesh__D022702 2006
% 224.22/224.38  |- mesh__dateEstablished mesh__D022702 2001-01-01
% 224.22/224.38  |- skos__hiddenLabel mesh__D022702 beta-3 Receptors, Adrenergic
% 224.22/224.38  |- skos__hiddenLabel mesh__D022702 Adrenergic beta 3 Receptor
% 224.22/224.38  |- skos__hiddenLabel mesh__D022702 Adrenergic beta 3 Receptors
% 224.22/224.38  |- skos__altLabel mesh__D022702 Adrenergic Receptors, beta-3
% 224.22/224.38  |- mesh__recordOriginator mesh__D022702 jmp
% 224.22/224.38  |- rdf__type mesh__D022702sskos__Concept
% 224.22/224.38  |- skos__hiddenLabel mesh__D022702 Receptors, beta 3 Adrenergic
% 224.22/224.38  |- mesh__recordMaintainer mesh__D022702 jmp
% 224.22/224.38  |- skos__altLabel mesh__D022702 Adrenergic beta-3 Receptors
% 224.22/224.38  |- skos__hiddenLabel mesh__D022702 Receptor, Adrenergic beta 3
% 224.22/224.38  |- skos__altLabel mesh__D022702 Receptor, Adrenergic beta-3
% 224.22/224.38  |- skos__altLabel mesh__D022702 Adrenergic beta-3 Receptor
% 224.22/224.38  |- mesh__dateRevised mesh__D022702 2005-06-30
% 224.22/224.38  |- skos__altLabel mesh__D022702 beta3 Adrenoreceptor
% 224.22/224.38  |- skos__annotation mesh__D022702 DF: RECEPT ADREN BETA 3   
% 224.22/224.38  |- skos__broader mesh__D022702smesh__D011943
% 224.22/224.38  |- skos__historyNote mesh__D022702
% 224.22/224.38       Receptors, Adrenergic, beta %28%1977-2000%29%
% 224.22/224.38  |- skos__hiddenLabel mesh__D022702 Receptors, Adrenergic beta-3
% 224.22/224.38  |- skos__hiddenLabel mesh__D008233 Lymphotoxin alpha3
% 224.22/224.38  |- skos__altLabel mesh__D008233 alpha-Lymphotoxin
% 224.22/224.38  |- rdf__type mesh__D008233sskos__Concept
% 224.22/224.38  |- skos__hiddenLabel mesh__D008233 Lymphotoxin-alpha, Soluble
% 224.22/224.38  |- mesh__dateCreated mesh__D008233 1999-01-01
% 224.22/224.38  |- skos__annotation mesh__D008233
% 224.22/224.38       for %22%lymphocytotoxin%22% use CYTOTOXINS and LYMPHOCYTES, for antibody to lymphocytes use ANTILYMPHOCYTE SERUM%A%  
% 224.22/224.38  |- skos__altLabel mesh__D008233 TNF-beta
% 224.22/224.38  |- mesh__historyNote mesh__D008233
% 224.22/224.38       1990, 1974-1977; for TUMOR NECROSIS FACTOR-BETA %26% TNF-BETA use TUMOR NECROSIS FACTOR 1988-1989; for LYMPHOCYTOTOXINS use LYMPHOTOXINS 1978%A%  
% 224.22/224.38  |- skos__hiddenLabel mesh__D008233 alpha Lymphotoxin
% 224.22/224.38  |- skos__altLabel mesh__D008233 Tumor Necrosis Factor-beta
% 224.22/224.38  |- skos__altLabel mesh__D008233 Lymphotoxin-alpha
% 224.22/224.38  |- skos__altLabel mesh__D008233 TNF Superfamily, Member 1
% 224.22/224.38  |- skos__prefLabel mesh__D008233 Lymphotoxin
% 224.22/224.38  |- skos__hiddenLabel mesh__D008233 Tumor Necrosis Factor beta
% 224.22/224.38  |- skos__scopeNote mesh__D008233
% 224.22/224.38       A tumor necrosis factor family member that is released by LYMPHOCYTES activated by ANTIGENS or T-cell MITOGENS. Lymphotoxin is antigenically distinct from TUMOR NECROSIS FACTOR-ALPHA, though they both share common receptors, biological activities, and significant amino acid sequence homology.%A%    
% 224.22/224.38  |- mesh__publicMeSHNote mesh__D008233
% 224.22/224.38       1990; LYMPHOTOXIN-ALPHA was indexed under LYMPHOTOXIN  see LYMPHOTOXINS 1978-1989; see LYMPHOTOXIN 1974-1977; for TUMOR NECROSIS FACTOR-BETA %26% TNF-BETA see TUMOR NECROSIS FACTOR 1988-1989; for LYMPHOCYTOTOXINS see LYMPHOTOXINS 1978%A%  
% 224.22/224.38  |- skos__altLabel mesh__D008233 Soluble Lymphotoxin-alpha
% 224.22/224.38  |- mesh__dateRevised mesh__D008233 2005-06-30
% 224.22/224.38  |- skos__broader mesh__D008233smesh__D048069
% 224.22/224.38  |- mesh__recordMaintainer mesh__D008233 ssb
% 224.22/224.38  |- skos__broader mesh__D008233smesh__D008222
% 224.22/224.38  |- mesh__recordAuthorizer mesh__D008233 sjn
% 224.22/224.38  |- mesh__recordOriginator mesh__D008233 NLM
% 224.22/224.38  |- mesh__activeMeSHYear mesh__D008233 2006
% 224.22/224.38  |- skos__hiddenLabel mesh__D008233 Lymphotoxin alpha
% 224.22/224.38  |- mesh__dateEstablished mesh__D008233 1974-01-01
% 224.22/224.38  |- skos__hiddenLabel mesh__D008233 Soluble Lymphotoxin alpha
% 224.22/224.38  |- mesh__activeMeSHYear mesh__D000250 1997
% 224.22/224.38  |- mesh__activeMeSHYear mesh__D000250 1994
% 224.22/224.38  |- mesh__activeMeSHYear mesh__D000250 2002
% 224.22/224.38  |- skos__scopeNote mesh__D000250
% 224.22/224.38       5%27%-Adenylic acid, monoanhydride with sulfuric acid. The initial compound formed by the action of ATP sulfurylase on sulfate ions after sulfate uptake. Synonyms: adenosine sulfatophosphate; APS.%A%    
% 224.22/224.38  |- skos__hiddenLabel mesh__D000250 Adenosine 5%27% Phosphosulfate
% 224.22/224.38  |- mesh__activeMeSHYear mesh__D000250 1999
% 224.22/224.38  |- skos__prefLabel mesh__D000250 Adenosine Phosphosulfate
% 224.22/224.38  |- mesh__publicMeSHNote mesh__D000250
% 224.22/224.38       91; was see under ADENOSINE MONOPHOSPHATE 1979-90   
% 224.22/224.38  |- mesh__activeMeSHYear mesh__D000250 1993
% 224.22/224.38  |- skos__hiddenLabel mesh__D000250 Phospho Adenylsulfate
% 224.22/224.38  |- mesh__activeMeSHYear mesh__D000250 1995
% 224.22/224.38  |- rdf__type mesh__D000250sskos__Concept
% 224.22/224.38  |- skos__hiddenLabel mesh__D000250 5%27%-Phosphosulfate, Adenosine
% 224.22/224.38  |- skos__hiddenLabel mesh__D000250 Sulfate, Adenylyl
% 224.22/224.38  |- skos__altLabel mesh__D000250 Adenosine 5%27%-Phosphosulfate
% 224.22/224.38  |- mesh__activeMeSHYear mesh__D000250 2000
% 224.22/224.38  |- mesh__recordMaintainer mesh__D000250 TGC
% 224.22/224.38  |- skos__historyNote mesh__D000250 Adenine Nucleotides %28%1966-1970%29%
% 224.22/224.38  |- skos__broader mesh__D000250smesh__D000249
% 224.22/224.38  |- mesh__activeMeSHYear mesh__D000250 2003
% 224.22/224.38  |- mesh__activeMeSHYear mesh__D000250 2001
% 224.22/224.38  |- skos__altLabel mesh__D000250 Phospho-Adenylsulfate
% 224.22/224.38  |- mesh__dateCreated mesh__D000250 1978-03-06
% 224.22/224.38  |- mesh__activeMeSHYear mesh__D000250 2005
% 224.22/224.38  |- mesh__recordAuthorizer mesh__D000250 PLS
% 224.22/224.38  |- skos__historyNote mesh__D000250
% 224.22/224.38       Adenosine Monophosphate %28%1971-1978%29%
% 224.22/224.38  |- mesh__dateEstablished mesh__D000250 1991-01-01
% 224.22/224.38  |- mesh__recordOriginator mesh__D000250 RLS
% 224.22/224.38  |- mesh__activeMeSHYear mesh__D000250 2004
% 224.22/224.38  |- mesh__activeMeSHYear mesh__D000250 1996
% 224.24/224.38  |- skos__hiddenLabel mesh__D000250 Phosphosulfate, Adenosine
% 224.24/224.38  |- skos__altLabel mesh__D000250 Adenylyl Sulfate
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D000250 2006
% 224.24/224.38  |- mesh__historyNote mesh__D000250
% 224.24/224.38       91%28%79%29%; was see under ADENOSINE MONOPHOSPHATE 1979-90   
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D000250 1998
% 224.24/224.38  |- skos__historyNote mesh__D000250 Sulfuric Acids %28%1966-1975%29%
% 224.24/224.38  |- mesh__dateRevised mesh__D000250 1992-05-07
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D013976 2004
% 224.24/224.38  |- skos__prefLabel mesh__D013976 Tiapride
% 224.24/224.38  |- skos__broader mesh__D013976smesh__D001549
% 224.24/224.38  |- mesh__recordAuthorizer mesh__D013976 sjn
% 224.24/224.38  |- skos__hiddenLabel mesh__D013976 FLO 1347
% 224.24/224.38  |- skos__historyNote mesh__D013976 Amides %28%1966-1972%29%
% 224.24/224.38  |- mesh__recordOriginator mesh__D013976 SH
% 224.24/224.38  |- skos__hiddenLabel mesh__D013976 FLO1347
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D013976 2005
% 224.24/224.38  |- skos__hiddenLabel mesh__D013976 Monohydrochloride, Tiapride
% 224.24/224.38  |- mesh__publicMeSHNote mesh__D013976
% 224.24/224.38       91; was see under BENZAMIDES 1980-90   
% 224.24/224.38  |- skos__historyNote mesh__D013976 Benzoates %28%1966-1972%29%
% 224.24/224.38  |- mesh__historyNote mesh__D013976
% 224.24/224.38       91%28%80%29%; was see under BENZAMIDES 1980-90   
% 224.24/224.38  |- mesh__recordMaintainer mesh__D013976 sjn
% 224.24/224.38  |- mesh__dateRevised mesh__D013976 2003-07-25
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D013976 2006
% 224.24/224.38  |- mesh__dateEstablished mesh__D013976 1991-01-01
% 224.24/224.38  |- rdf__type mesh__D013976sskos__Concept
% 224.24/224.38  |- mesh__dateCreated mesh__D013976 1979-05-01
% 224.24/224.38  |- skos__scopeNote mesh__D013976
% 224.24/224.38       Benzamide derivative with dopamine antagonist actions similar to SULPIRIDE. It has been used as an antipsychotic and in the treatment of various movement disorders.%A%    
% 224.24/224.38  |- skos__historyNote mesh__D013976 Benzamides %28%1973-1979%29%
% 224.24/224.38  |- skos__hiddenLabel mesh__D046352 Reaction, Cataleptic Freezing
% 224.24/224.38  |- skos__hiddenLabel mesh__D046352 Freezing Reactions, Cataleptic
% 224.24/224.38  |- skos__hiddenLabel mesh__D046352 Cataleptic Immobilization Reactions
% 224.24/224.38  |- skos__hiddenLabel mesh__D046352 Immobilization Reactions, Cataleptic
% 224.24/224.38  |- skos__broader mesh__D046352smesh__D009043
% 224.24/224.38  |- mesh__recordAuthorizer mesh__D046352 jls
% 224.24/224.38  |- skos__hiddenLabel mesh__D046352 Reactions, Cataleptic Immobilization
% 224.24/224.38  |- skos__hiddenLabel mesh__D046352 Cataleptic Freezing Reaction
% 224.24/224.38  |- mesh__recordOriginator mesh__D046352 nns
% 224.24/224.38  |- rdf__type mesh__D046352sskos__Concept
% 224.24/224.38  |- skos__altLabel mesh__D046352 Cataleptic Immobilization Reaction
% 224.24/224.38  |- skos__altLabel mesh__D046352 Immobilization Reaction, Cataleptic
% 224.24/224.38  |- skos__hiddenLabel mesh__D046352 Reactions, Cataleptic Freezing
% 224.24/224.38  |- mesh__publicMeSHNote mesh__D046352 2005   
% 224.24/224.38  |- skos__hiddenLabel mesh__D046352 Cataleptic Freezing Reactions
% 224.24/224.38  |- skos__broader mesh__D046352smesh__D001522
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D046352 2005A
% 224.24/224.38  |- mesh__dateRevised mesh__D046352 2004-07-27
% 224.24/224.38  |- skos__related mesh__D046352smesh__D046353
% 224.24/224.38  |- mesh__dateCreated mesh__D046352 2004-07-07
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D046352 2005
% 224.24/224.38  |- skos__related mesh__D046352smesh__D007103
% 224.24/224.38  |- mesh__dateEstablished mesh__D046352 2005-01-01
% 224.24/224.38  |- skos__hiddenLabel mesh__D046352 Reaction, Cataleptic Immobilization
% 224.24/224.38  |- skos__scopeNote mesh__D046352
% 224.24/224.38       An induced response to threatening stimuli characterized by the cessation of body movements, except for those that are involved with BREATHING, and the maintenance of an immobile POSTURE.%A%    
% 224.24/224.38  |- skos__related mesh__D046352smesh__D002375
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D046352 2006
% 224.24/224.38  |- mesh__historyNote mesh__D046352 2005   
% 224.24/224.38  |- skos__annotation mesh__D046352
% 224.24/224.38       do not confuse with IMMOBILIZATION: method for restraining body movement, or IMMOBILITY RESPONSE, TONIC: loss of postural tone%A%  
% 224.24/224.38  |- mesh__recordMaintainer mesh__D046352 jls
% 224.24/224.38  |- skos__prefLabel mesh__D046352 Freezing Reaction, Cataleptic
% 224.24/224.38  |- mesh__dateCreated mesh__D013178 1999-01-01
% 224.24/224.38  |- skos__scopeNote mesh__D013178
% 224.24/224.38       The field of medicine concerned with physical fitness and the diagnosis and treatment of injuries sustained in sports activities.%A%    
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D013178 2000
% 224.24/224.38  |- mesh__publicMeSHNote mesh__D013178 80; was SPORT MEDICINE 1963-79   
% 224.24/224.38  |- rdf__type mesh__D013178sskos__Concept
% 224.24/224.38  |- mesh__recordOriginator mesh__D013178 NLM
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D013178 2004
% 224.24/224.38  |- mesh__historyNote mesh__D013178 80; was SPORT MEDICINE 1963-79   
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D013178 2006
% 224.24/224.38  |- skos__related mesh__D013178smesh__D001265
% 224.24/224.38  |- mesh__onlineNote mesh__D013178
% 224.24/224.38       use SPORTS MEDICINE to search SPORT MEDICINE 1966-79   
% 224.24/224.38  |- skos__altLabel mesh__D013178 Medicine, Sport
% 224.24/224.38  |- mesh__recordMaintainer mesh__D013178 KEV
% 224.24/224.38  |- skos__altLabel mesh__D013178 Medicine, Sports
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D013178 2003
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D013178 1997
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D013178 2005
% 224.24/224.38  |- mesh__recordAuthorizer mesh__D013178 PLS
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D013178 1999
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D013178 2002
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D013178 1996
% 224.24/224.38  |- skos__prefLabel mesh__D013178 Sports Medicine
% 224.24/224.38  |- skos__altLabel mesh__D013178 Sport Medicine
% 224.24/224.38  |- skos__annotation mesh__D013178
% 224.24/224.38       SPEC: SPEC qualif; differentiate from SPORTS; sports inj = ATHLETIC INJURIES; policy: Manual 30.31; DF: SPORTS MED%A%  
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D013178 1998
% 224.24/224.38  |- mesh__dateRevised mesh__D013178 1995-05-18
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D013178 2001
% 224.24/224.38  |- skos__related mesh__D013178smesh__D011482
% 224.24/224.38  |- skos__broader mesh__D013178smesh__D008511
% 224.24/224.38  |- skos__hiddenLabel mesh__D007939 L1210, Leukemia
% 224.24/224.38  |- mesh__recordOriginator mesh__D007939 NLM
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D007939 1997
% 224.24/224.38  |- skos__annotation mesh__D007939
% 224.24/224.38       do not use /blood supply /chem /second /secret /ultrastruct /vet%A%  
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D007939 2003
% 224.24/224.38  |- mesh__dateCreated mesh__D007939 1999-01-01
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D007939 1996
% 224.24/224.38  |- skos__altLabel mesh__D007939 Leukemia L 1210
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D007939 2001
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D007939 2006
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D007939 2000
% 224.24/224.38  |- mesh__dateRevised mesh__D007939 1995-06-08
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D007939 1999
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D007939 2005
% 224.24/224.38  |- mesh__recordAuthorizer mesh__D007939 PLS
% 224.24/224.38  |- mesh__recordMaintainer mesh__D007939 KEV
% 224.24/224.38  |- rdf__type mesh__D007939sskos__Concept
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D007939 1998
% 224.24/224.38  |- skos__hiddenLabel mesh__D007939 L 1210, Leukemia
% 224.24/224.38  |- skos__prefLabel mesh__D007939 Leukemia L1210
% 224.24/224.38  |- skos__broader mesh__D007939smesh__D007942
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D007939 2002
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D007939 2004
% 224.24/224.38  |- mesh__historyNote mesh__D018661 95   
% 224.24/224.38  |- mesh__recordMaintainer mesh__D018661 SYSTEM
% 224.24/224.38  |- skos__prefLabel mesh__D018661 Mycoplasma penetrans
% 224.24/224.38  |- mesh__dateRevised mesh__D018661 2005-06-30
% 224.24/224.38  |- mesh__dateEstablished mesh__D018661 1995-01-01
% 224.24/224.38  |- mesh__recordOriginator mesh__D018661 PXP
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D018661 2006
% 224.24/224.38  |- skos__scopeNote mesh__D018661
% 224.24/224.38       A species of gram-negative, facultatively anaerobic bacteria. This organism shows remarkable pathobiologic properties: it adheres to cell surfaces, deeply penetrates into the cell, and strongly adsorbs human red blood cells and human CD4+ lymphocytes and monocytes. M. penetrans was first isolated from the urogenital tract of patients with AIDS and high frequencies of antibodies to it are seen in HIV-infected patients.%A%    
% 224.24/224.38  |- mesh__dateCreated mesh__D018661 1994-04-19
% 224.24/224.38  |- skos__broader mesh__D018661smesh__D009174
% 224.24/224.38  |- rdf__type mesh__D018661sskos__Concept
% 224.24/224.38  |- skos__annotation mesh__D018661
% 224.24/224.38       infection: coord IM with MYCOPLASMA INFECTIONS %28%IM%29%   
% 224.24/224.38  |- skos__historyNote mesh__D018661 Mycoplasma %28%1992-1994%29%
% 224.24/224.38  |- mesh__publicMeSHNote mesh__D018661 95   
% 224.24/224.38  |- mesh__recordAuthorizer mesh__D018661 sjn
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 In Migration
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Brain Drains
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Crossing, Border
% 224.24/224.38  |- skos__broader mesh__D004641smesh__D011157
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Migration, Turnaround
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Temporary Migrations
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Resettlement and Settlement
% 224.24/224.38  |- mesh__recordAuthorizer mesh__D004641 sjn
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Foreigner
% 224.24/224.38  |- skos__prefLabel mesh__D004641 Emigration and Immigration
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D004641 2006
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D004641 2001
% 224.24/224.38  |- rdf__type mesh__D004641sskos__Concept
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Out Migration
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Origins
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Alien
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Destinations
% 224.24/224.38  |- mesh__dateRevised mesh__D004641 1999-11-03
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Migrations, Chain
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Migrations, Temporary
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 International Migrations
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D004641 2005
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Migration, Return
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Return Migrations
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Crossings, Border
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D004641 2000
% 224.24/224.38  |- mesh__recordOriginator mesh__D004641 NLM
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D004641 2004
% 224.24/224.38  |- skos__altLabel mesh__D004641 In-Migration
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Turnaround Migrations
% 224.24/224.38  |- mesh__dateCreated mesh__D004641 1999-01-01
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Migrations, Turnaround
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Emigrations
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Immigration and Emigration
% 224.24/224.38  |- mesh__recordMaintainer mesh__D004641 kle
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Emigrant
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Migrations, International
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D004641 2003
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Migration, International
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Migration, Chain
% 224.24/224.38  |- skos__annotation mesh__D004641 DF: EMIGRATION   
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Border Crossings
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D004641 2002
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Chain Migrations
% 224.24/224.38  |- skos__scopeNote mesh__D004641
% 224.24/224.38       The process of leaving one%27%s country to establish residence in a foreign country.%A%    
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Migrations
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Immigrant
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Immigrations
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Migrations, Return
% 224.24/224.38  |- skos__related mesh__D004641smesh__D014171
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 In-Migrations
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Migration, Temporary
% 224.24/224.38  |- skos__hiddenLabel mesh__D004641 Out-Migrations
% 224.24/224.38  |- skos__altLabel mesh__D051297 SGLT2 Protein
% 224.24/224.38  |- skos__prefLabel mesh__D051297 Sodium-Glucose Transporter 2
% 224.24/224.38  |- mesh__publicMeSHNote mesh__D051297 2006   
% 224.24/224.38  |- skos__hiddenLabel mesh__D051297 Sodium Glucose Transporter 2
% 224.24/224.38  |- mesh__dateEstablished mesh__D051297 2006-01-01
% 224.24/224.38  |- mesh__recordAuthorizer mesh__D051297 sjn
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D051297 2006
% 224.24/224.38  |- skos__scopeNote mesh__D051297
% 224.24/224.38       A sodium-glucose transporter that is expressed in the luminal membrane of the PROXIMAL KIDNEY TUBULES.%A%    
% 224.24/224.38  |- mesh__recordOriginator mesh__D051297 DRC
% 224.24/224.38  |- rdf__type mesh__D051297sskos__Concept
% 224.24/224.38  |- skos__altLabel mesh__D051297 SLC5A2 Protein
% 224.24/224.38  |- mesh__dateCreated mesh__D051297 2005-06-30
% 224.24/224.38  |- skos__broader mesh__D051297smesh__D051247
% 224.24/224.38  |- mesh__recordMaintainer mesh__D051297 DRC
% 224.24/224.38  |- mesh__historyNote mesh__D051297 2006   
% 224.24/224.38  |- mesh__recordAuthorizer mesh__D003549 sjn
% 224.24/224.38  |- mesh__recordOriginator mesh__D003549 NLM
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D003549 2004
% 224.24/224.38  |- skos__prefLabel mesh__D003549 Cystic Duct
% 224.24/224.38  |- skos__scopeNote mesh__D003549
% 224.24/224.38       The duct that is connected to the GALLBLADDER and allows the emptying of bile into the COMMON BILE DUCT.%A%    
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D003549 2005
% 224.24/224.38  |- skos__hiddenLabel mesh__D003549 Duct, Cystic
% 224.24/224.38  |- skos__annotation mesh__D003549
% 224.24/224.38       diseases: coord IM with BILE DUCT DISEASES %28%IM%29%; neopl: coord IM with BILE DUCT NEOPLASMS %28%IM%29%; inflammation: coord IM with CHOLANGITIS %28%IM%29%; obstruct: coord IM with CHOLESTASIS, EXTRAHEPATIC %28%IM%29%; calculi = GALLSTONES but consider also CHOLELITHIASIS %28%IM%29% + CYSTIC DUCT %28%IM%29% + BILE DUCT DISEASES %28%IM%29%%A%  
% 224.24/224.38  |- skos__hiddenLabel mesh__D003549 Cystic Ducts
% 224.24/224.38  |- mesh__dateRevised mesh__D003549 2003-07-25
% 224.24/224.38  |- skos__broader mesh__D003549smesh__D017734
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D003549 2006
% 224.24/224.38  |- mesh__dateCreated mesh__D003549 1999-01-01
% 224.24/224.38  |- mesh__recordMaintainer mesh__D003549 sjn
% 224.24/224.38  |- rdf__type mesh__D003549sskos__Concept
% 224.24/224.38  |- skos__hiddenLabel mesh__D003549 Ducts, Cystic
% 224.24/224.38  |- skos__broader mesh__D014271smesh__D013936
% 224.24/224.38  |- skos__altLabel mesh__D014271 Trifluorothymidine
% 224.24/224.38  |- skos__historyNote mesh__D014271 Fluorine %28%1972-1974%29%
% 224.24/224.38  |- mesh__recordOriginator mesh__D014271 NLM
% 224.24/224.38  |- mesh__recordAuthorizer mesh__D014271 sjn
% 224.24/224.38  |- mesh__onlineNote mesh__D014271
% 224.24/224.38       use TRIFLURIDINE to search TRIFLUOROTHYMIDINE 1975-91   
% 224.24/224.38  |- mesh__dateEstablished mesh__D014271 1991-01-01
% 224.24/224.38  |- mesh__historyNote mesh__D014271
% 224.24/224.38       92; was TRIFLUOROTHYMIDINE 1975-91 %28%see under THYMIDINE 1975-90%29%%A%  
% 224.24/224.38  |- skos__prefLabel mesh__D014271 Trifluridine
% 224.24/224.38  |- skos__altLabel mesh__D014271 5-Trifluoromethyl-2%27%-deoxyuridine
% 224.24/224.38  |- mesh__recordMaintainer mesh__D014271 CCR
% 224.24/224.38  |- skos__altLabel mesh__D014271 Mann Brand of Trifluridine
% 224.24/224.38  |- rdf__type mesh__D014271sskos__Concept
% 224.24/224.38  |- skos__altLabel mesh__D014271 Monarch Brand of Trifluridine
% 224.24/224.38  |- skos__altLabel mesh__D014271 Allergan Brand of Trifluridine
% 224.24/224.38  |- skos__scopeNote mesh__D014271
% 224.24/224.38       An antiviral derivative of THYMIDINE used mainly in the treatment of primary keratoconjunctivitis and recurrent epithelial keratitis due to HERPES SIMPLEX virus. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p557%29%%A%    
% 224.24/224.38  |- skos__historyNote mesh__D014271 Thymidine %28%1972-1974%29%
% 224.24/224.38  |- mesh__dateCreated mesh__D014271 1974-11-19
% 224.24/224.38  |- skos__altLabel mesh__D014271 Tramedico Brand of Trifluridine
% 224.24/224.38  |- skos__hiddenLabel mesh__D014271 5 Trifluoromethyl 2%27% deoxyuridine
% 224.24/224.38  |- mesh__dateRevised mesh__D014271 2005-06-30
% 224.24/224.38  |- skos__altLabel mesh__D014271 Elcon Brand of Trifluridine
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D014271 2006
% 224.24/224.38  |- mesh__publicMeSHNote mesh__D014271
% 224.24/224.38       92; was TRIFLUOROTHYMIDINE 1975-91 %28%see under THYMIDINE 1975-90%29%%A%  
% 224.24/224.38  |- skos__altLabel mesh__D014271 Trifluoridine
% 224.24/224.38  |- skos__scopeNote mesh__D008234
% 224.24/224.38       A synthetic progestational hormone used often in mixtures with estrogens as an oral contraceptive.%A%    
% 224.24/224.38  |- mesh__recordAuthorizer mesh__D008234 sjn
% 224.24/224.38  |- mesh__recordOriginator mesh__D008234 NLM
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D008234 2005
% 224.24/224.38  |- skos__broader mesh__D008234smesh__D009652
% 224.24/224.38  |- mesh__recordMaintainer mesh__D008234 lkt
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D008234 2006
% 224.24/224.38  |- mesh__dateEstablished mesh__D008234 1965-01-01
% 224.24/224.38  |- skos__altLabel mesh__D008234 Linesterol
% 224.24/224.38  |- skos__altLabel mesh__D008234 Linestrenol
% 224.24/224.38  |- mesh__dateRevised mesh__D008234 2003-07-09
% 224.24/224.38  |- skos__altLabel mesh__D008234 Ethinylestrenol
% 224.24/224.38  |- rdf__type mesh__D008234sskos__Concept
% 224.24/224.38  |- mesh__publicMeSHNote mesh__D008234 65   
% 224.24/224.38  |- mesh__dateCreated mesh__D008234 1999-01-01
% 224.24/224.38  |- skos__altLabel mesh__D008234 Lynoestrenol
% 224.24/224.38  |- skos__prefLabel mesh__D008234 Lynestrenol
% 224.24/224.38  |- mesh__historyNote mesh__D008234 65%28%64%29%   
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D008234 2004
% 224.24/224.38  |- rdf__type mesh__D000251sskos__Concept
% 224.24/224.38  |- mesh__recordMaintainer mesh__D000251 ssb
% 224.24/224.38  |- skos__broader mesh__D000251smesh__D017766
% 224.24/224.38  |- mesh__onlineNote mesh__D000251
% 224.24/224.38       use ADENOSINETRIPHOSPHATASE to search ADENOSINE TRIPHOSPHATASE 1966-92%A%  
% 224.24/224.38  |- skos__altLabel mesh__D000251 Adenosine Triphosphatase
% 224.24/224.38  |- skos__annotation mesh__D000251 DF: note short X ref   
% 224.24/224.38  |- mesh__publicMeSHNote mesh__D000251
% 224.24/224.38       93; was ADENOSINE TRIPHOSPHATASE 1963-92   
% 224.24/224.38  |- skos__altLabel mesh__D000251 ATPase
% 224.24/224.38  |- skos__hiddenLabel mesh__D000251 Triphosphatase, Adenosine
% 224.24/224.38  |- skos__prefLabel mesh__D000251 Adenosinetriphosphatase
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D000251 2005
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D000251 2004
% 224.24/224.38  |- mesh__dateRevised mesh__D000251 2003-07-09
% 224.24/224.38  |- mesh__activeMeSHYear mesh__D000251 2006
% 224.24/224.38  |- mesh__dateCreated mesh__D000251 1999-01-01
% 224.24/224.38  |- mesh__recordOriginator mesh__D000251 NLM
% 224.24/224.38  |- mesh__historyNote mesh__D000251
% 224.24/224.38       93; was ADENOSINE TRIPHOSPHATASE 1963-92   
% 224.24/224.38  |- mesh__recordAuthorizer mesh__D000251 sjn
% 224.24/224.38  |- skos__scopeNote mesh__D000251
% 224.24/224.38       A group of enzymes which catalyze the hydrolysis of ATP coupled with another function such as transporting Ca%28%2+%29% across a membrane. These enzymes may be dependent on Ca%28%2+%29%, Mg%28%2+%29%, anions, H+, or DNA. EC 3.6.1.3.%A%    
% 224.24/224.38  |- mesh__recordMaintainer mesh__D013977 ags
% 224.24/224.38  |- skos__annotation mesh__D013977
% 224.24/224.38       /blood supply: consider also TIBIAL ARTERIES; /inj: consider also TIBIAL FRACTURES; avoid TIBIA /metab, TIBIA /chem, etc. when BONE AND BONES /metab, etc. is meant; tibia vara: index under TIBIA %28%IM%29% + BONE DISEASES, DEVELOPMENTAL %28%IM%29%%A%  
% 224.24/224.38  |- mesh__dateRevised mesh__D013977 2005-06-30
% 224.24/224.38  |- skos__hiddenLabel mesh__D013977 Tibias
% 224.24/224.39  |- skos__prefLabel mesh__D013977 Tibia
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D013977 2006
% 224.24/224.39  |- rdf__type mesh__D013977sskos__Concept
% 224.24/224.39  |- mesh__recordOriginator mesh__D013977 NLM
% 224.24/224.39  |- mesh__recordAuthorizer mesh__D013977 sjn
% 224.24/224.39  |- mesh__dateCreated mesh__D013977 1999-01-01
% 224.24/224.39  |- skos__scopeNote mesh__D013977
% 224.24/224.39       The second longest bone of the skeleton. It is located on the medial side of the lower leg, articulating with the FIBULA laterally, the TALUS distally, and the FEMUR proximally.%A%    
% 224.24/224.39  |- skos__broader mesh__D013977smesh__D007867
% 224.24/224.39  |- mesh__dateCreated mesh__D046353 2004-07-07
% 224.24/224.39  |- skos__scopeNote mesh__D046353
% 224.24/224.39       An induced response to threatening stimuli characterized by complete loss of muscle strength.%A%    
% 224.24/224.39  |- skos__altLabel mesh__D046353 Immobilization, Tonic
% 224.24/224.39  |- skos__altLabel mesh__D046353 Animal Hypnosis
% 224.24/224.39  |- skos__related mesh__D046353smesh__D002389
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D046353 2006
% 224.24/224.39  |- skos__broader mesh__D046353smesh__D001522
% 224.24/224.39  |- skos__related mesh__D046353smesh__D046352
% 224.24/224.39  |- skos__hiddenLabel mesh__D046353 Feigning, Death
% 224.24/224.39  |- skos__prefLabel mesh__D046353 Immobility Response, Tonic
% 224.24/224.39  |- skos__broader mesh__D046353smesh__D009043
% 224.24/224.39  |- skos__annotation mesh__D046353
% 224.24/224.39       do not confuse with IMMOBILIZATION: restraining body movement or FREEZING REACTION, CATALEPTIC: cessation of body movement while maintaining an immobile posture via muscle rigidity%A%  
% 224.24/224.39  |- skos__altLabel mesh__D046353 Death Feigning
% 224.24/224.39  |- mesh__recordMaintainer mesh__D046353 nns
% 224.24/224.39  |- mesh__historyNote mesh__D046353 2005   
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D046353 2005
% 224.24/224.39  |- skos__hiddenLabel mesh__D046353 Death Feignings
% 224.24/224.39  |- skos__altLabel mesh__D046353 Tonic Immobilization
% 224.24/224.39  |- skos__hiddenLabel mesh__D046353 Response, Tonic Immobility
% 224.24/224.39  |- skos__related mesh__D046353smesh__D013575
% 224.24/224.39  |- skos__hiddenLabel mesh__D046353 Immobility Responses, Tonic
% 224.24/224.39  |- skos__hiddenLabel mesh__D046353 Feignings, Death
% 224.24/224.39  |- skos__hiddenLabel mesh__D046353 Responses, Tonic Immobility
% 224.24/224.39  |- skos__hiddenLabel mesh__D046353 Tonic Immobility Responses
% 224.24/224.39  |- rdf__type mesh__D046353sskos__Concept
% 224.24/224.39  |- mesh__recordAuthorizer mesh__D046353 sjn
% 224.24/224.39  |- skos__hiddenLabel mesh__D046353 Tonic Immobility Response
% 224.24/224.39  |- mesh__publicMeSHNote mesh__D046353 2005   
% 224.24/224.39  |- mesh__recordOriginator mesh__D046353 nns
% 224.24/224.39  |- skos__related mesh__D046353smesh__D007103
% 224.24/224.39  |- skos__related mesh__D046353smesh__D002385
% 224.24/224.39  |- mesh__dateEstablished mesh__D046353 2005-01-01
% 224.24/224.39  |- mesh__recordMaintainer mesh__D013179 TGC
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D013179 2001
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D013179 2006
% 224.24/224.39  |- skos__hiddenLabel mesh__D013179 Abuse, Partner
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D013179 2003
% 224.24/224.39  |- skos__broader mesh__D013179smesh__D017579
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D013179 2000
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D013179 2005
% 224.24/224.39  |- skos__scopeNote mesh__D013179
% 224.24/224.39       Deliberate severe and repeated injury to one domestic partner by the other.%A%    
% 224.24/224.39  |- mesh__recordOriginator mesh__D013179 EC
% 224.24/224.39  |- mesh__publicMeSHNote mesh__D013179 77   
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D013179 1999
% 224.24/224.39  |- skos__hiddenLabel mesh__D013179 Abuse, Spousal
% 224.24/224.39  |- skos__hiddenLabel mesh__D013179 Abuse, Wife
% 224.24/224.39  |- skos__altLabel mesh__D013179 Spousal Abuse
% 224.24/224.39  |- skos__prefLabel mesh__D013179 Spouse Abuse
% 224.24/224.39  |- mesh__recordAuthorizer mesh__D013179 SJN
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D013179 1998
% 224.24/224.39  |- skos__annotation mesh__D013179 wife or husband abused or abuser   
% 224.24/224.39  |- skos__hiddenLabel mesh__D013179 Abuse, Spouse
% 224.24/224.39  |- mesh__dateCreated mesh__D013179 1976-05-19
% 224.24/224.39  |- mesh__dateEstablished mesh__D013179 1977-01-01
% 224.24/224.39  |- mesh__historyNote mesh__D013179 77   
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D013179 2002
% 224.24/224.39  |- rdf__type mesh__D013179sskos__Concept
% 224.24/224.39  |- mesh__dateRevised mesh__D013179 1997-06-24
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D013179 2004
% 224.24/224.39  |- mesh__recordOriginator mesh__D018662 PXP
% 224.24/224.39  |- mesh__recordAuthorizer mesh__D018662 SJN
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D018662 1999
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D018662 2006
% 224.24/224.39  |- skos__historyNote mesh__D018662
% 224.24/224.39       Gastroesophageal Reflux/surgery %28%1968-1994%29%
% 224.24/224.39  |- skos__altLabel mesh__D018662 Nissen Operation
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D018662 2002
% 224.24/224.39  |- mesh__dateCreated mesh__D018662 1994-04-19
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D018662 2003
% 224.24/224.39  |- rdf__type mesh__D018662sskos__Concept
% 224.24/224.39  |- skos__broader mesh__D018662smesh__D013505
% 224.24/224.39  |- mesh__dateEstablished mesh__D018662 1995-01-01
% 224.24/224.39  |- mesh__recordMaintainer mesh__D018662 PXP
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D018662 2004
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D018662 2000
% 224.24/224.39  |- skos__prefLabel mesh__D018662 Fundoplication
% 224.24/224.39  |- skos__hiddenLabel mesh__D018662 Operation, Nissen
% 224.24/224.39  |- skos__scopeNote mesh__D018662
% 224.24/224.39       Mobilization of the lower end of the esophagus and plication of the fundus of the stomach around it %28%fundic wrapping%29% in the treatment of GASTROESOPHAGEAL REFLUX that may be associated with various disorders, such as hiatal hernia. %28%From Dorland, 28th ed%29%%A%    
% 224.24/224.39  |- skos__annotation mesh__D018662
% 224.24/224.39       fundo- refers to the gastric fundus; do not use /util except by MeSH definition%A%  
% 224.24/224.39  |- mesh__dateRevised mesh__D018662 1997-06-20
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D018662 2001
% 224.24/224.39  |- mesh__historyNote mesh__D018662 95   
% 224.24/224.39  |- mesh__publicMeSHNote mesh__D018662 95   
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D018662 1998
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D018662 2005
% 224.24/224.39  |- skos__prefLabel mesh__D004642 Emodin
% 224.24/224.39  |- skos__hiddenLabel mesh__D004642 Emodin, Frangula
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D004642 2003
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D004642 2001
% 224.24/224.39  |- skos__altLabel mesh__D004642 Archin
% 224.24/224.39  |- skos__altLabel mesh__D004642 Frangulic Acid
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D004642 2005
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D004642 2004
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D004642 2006
% 224.24/224.39  |- mesh__recordAuthorizer mesh__D004642 sjn
% 224.24/224.39  |- mesh__dateRevised mesh__D004642 2000-06-21
% 224.24/224.39  |- skos__altLabel mesh__D004642 Rheum Emodin
% 224.24/224.39  |- mesh__dateEstablished mesh__D004642 1991-01-01
% 224.24/224.39  |- mesh__recordMaintainer mesh__D004642 jmp
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D004642 2002
% 224.24/224.39  |- mesh__dateCreated mesh__D004642 1999-01-01
% 224.24/224.39  |- mesh__historyNote mesh__D004642
% 224.24/224.39       91%28%75%29%; was see under ANTHRAQUINONES 1975-90; was see under CATHARTICS 1963-74%A%  
% 224.24/224.39  |- rdf__type mesh__D004642sskos__Concept
% 224.24/224.39  |- mesh__recordOriginator mesh__D004642 NLM
% 224.24/224.39  |- skos__scopeNote mesh__D004642
% 224.24/224.39       Purgative anthraquinone found in several plants, especially Rhamnus frangula. It was formerly used as a laxative, but is now used mainly as tool in toxicity studies.%A%    
% 224.24/224.39  |- skos__hiddenLabel mesh__D004642 Emodin, Aloe
% 224.24/224.39  |- skos__altLabel mesh__D004642 Frangula Emodin
% 224.24/224.39  |- mesh__publicMeSHNote mesh__D004642
% 224.24/224.39       91; was see under ANTHRAQUINONES 1975-90; was see under CATHARTICS 1963-74%A%  
% 224.24/224.39  |- mesh__onlineNote mesh__D004642 search CATHARTICS 1966-74   
% 224.24/224.39  |- skos__broader mesh__D004642smesh__D002362
% 224.24/224.39  |- skos__hiddenLabel mesh__D004642 Emodin, Rheum
% 224.24/224.39  |- mesh__dateCreated mesh__D051298 2005-06-30
% 224.24/224.39  |- mesh__recordMaintainer mesh__D051298 lkt
% 224.24/224.39  |- rdf__type mesh__D051298sskos__Concept
% 224.24/224.39  |- skos__prefLabel mesh__D051298 Post-Traumatic Headache
% 224.24/224.39  |- skos__scopeNote mesh__D051298
% 224.24/224.39       Secondary headache attributed to TRAUMA of the HEAD and/or the NECK.%A%    
% 224.24/224.39  |- mesh__dateEstablished mesh__D051298 2006-01-01
% 224.24/224.39  |- skos__hiddenLabel mesh__D051298 Headaches, Cervicogenic
% 224.24/224.39  |- skos__hiddenLabel mesh__D051298 Post-Traumatic Headaches
% 224.24/224.39  |- skos__hiddenLabel mesh__D051298 Post Traumatic Headache
% 224.24/224.39  |- skos__broader mesh__D051298smesh__D051271
% 224.24/224.39  |- skos__hiddenLabel mesh__D051298 Headache, Post-Traumatic
% 224.24/224.39  |- mesh__publicMeSHNote mesh__D051298
% 224.24/224.39       2006; see HEADACHE DISORDERS 2000-2005   
% 224.24/224.39  |- mesh__recordAuthorizer mesh__D051298 sjn
% 224.24/224.39  |- skos__hiddenLabel mesh__D051298 Headaches, Post-Traumatic
% 224.24/224.39  |- skos__historyNote mesh__D051298 Craniocerebral Trauma %28%1966-2005%29%
% 224.24/224.39  |- skos__hiddenLabel mesh__D051298 Headache, Cervicogenic
% 224.24/224.39  |- skos__historyNote mesh__D051298 Headache %28%1966-2005%29%
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D051298 2006
% 224.24/224.39  |- mesh__recordOriginator mesh__D051298 lkt
% 224.24/224.39  |- mesh__historyNote mesh__D051298
% 224.24/224.39       2006; use HEADACHE DISORDERS 2000-2005   
% 224.24/224.39  |- skos__hiddenLabel mesh__D051298 Cervicogenic Headaches
% 224.24/224.39  |- skos__prefLabel mesh__D014272 Trifluperidol
% 224.24/224.39  |- mesh__recordMaintainer mesh__D014272 ssb
% 224.24/224.39  |- skos__broader mesh__D014272smesh__D002090
% 224.24/224.39  |- mesh__dateRevised mesh__D014272 2003-07-09
% 224.24/224.39  |- rdf__type mesh__D014272sskos__Concept
% 224.24/224.39  |- mesh__recordOriginator mesh__D014272 NLM
% 224.24/224.39  |- mesh__historyNote mesh__D014272 72%28%65%29%   
% 224.24/224.39  |- mesh__recordAuthorizer mesh__D014272 sjn
% 224.24/224.39  |- mesh__publicMeSHNote mesh__D014272 72   
% 224.24/224.39  |- mesh__dateEstablished mesh__D014272 1972-01-01
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D014272 2006
% 224.24/224.39  |- mesh__dateCreated mesh__D014272 1999-01-01
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D014272 2004
% 224.24/224.39  |- skos__scopeNote mesh__D014272
% 224.24/224.39       A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in the treatment of PSYCHOSES including MANIA and SCHIZOPHRENIA. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p621%29%%A%    
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D014272 2005
% 224.24/224.39  |- mesh__dateCreated mesh__D008235 1984-05-01
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D008235 2006
% 224.24/224.39  |- skos__broader mesh__D008235smesh__D008387
% 224.24/224.39  |- mesh__historyNote mesh__D008235 85   
% 224.24/224.39  |- skos__historyNote mesh__D008235 Carcinogens %28%1966-1984%29%
% 224.24/224.39  |- mesh__dateRevised mesh__D008235 2005-06-30
% 224.24/224.39  |- skos__scopeNote mesh__D008235
% 224.24/224.39       Toxins isolated from any species of the seaweed Lyngbya or similar chemicals from other sources, including mollusks and micro-organisms. These have been found to be potent tumor promoters. They are biosynthesized from TRYPTOPHAN; VALINE; and METHIONINE nonribosomally %28%PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT%29%.%A%    
% 224.24/224.39  |- skos__historyNote mesh__D008235 Lactones %28%1966-1984%29%
% 224.24/224.39  |- mesh__recordMaintainer mesh__D008235 ssb
% 224.24/224.39  |- skos__hiddenLabel mesh__D008235 Toxins, Lyngbya
% 224.24/224.39  |- mesh__recordAuthorizer mesh__D008235 sjn
% 224.24/224.39  |- mesh__recordOriginator mesh__D008235 SH
% 224.24/224.39  |- skos__historyNote mesh__D008235 Marine Toxins %28%1974-1984%29%
% 224.24/224.39  |- skos__broader mesh__D008235smesh__D026121
% 224.24/224.39  |- rdf__type mesh__D008235sskos__Concept
% 224.24/224.39  |- skos__historyNote mesh__D008235 Alkaloids %28%1966-1984%29%
% 224.24/224.39  |- mesh__publicMeSHNote mesh__D008235 85   
% 224.24/224.39  |- skos__historyNote mesh__D008235 Indoles %28%1966-1984%29%
% 224.24/224.39  |- skos__prefLabel mesh__D008235 Lyngbya Toxins
% 224.24/224.39  |- skos__annotation mesh__D008235
% 224.24/224.39       /antag permitted but consider also ANTITOXINS; coordinate with source only if particularly discussed%A%  
% 224.24/224.39  |- mesh__dateEstablished mesh__D008235 1985-01-01
% 224.24/224.39  |- skos__historyNote mesh__D008235 Toxins %28%1966-1984%29%
% 224.24/224.39  |- skos__altLabel mesh__D000252 Calcium ATPase
% 224.24/224.39  |- skos__historyNote mesh__D000252
% 224.24/224.39       Adenosine Triphosphatase %28%1966-1978%29%
% 224.24/224.39  |- skos__altLabel mesh__D000252 ATPase, Calcium
% 224.24/224.39  |- mesh__dateCreated mesh__D000252 1978-03-06
% 224.24/224.39  |- mesh__recordMaintainer mesh__D000252 jmp
% 224.24/224.39  |- skos__altLabel mesh__D000252 Calcium Adenosinetriphosphatase
% 224.24/224.39  |- skos__broader mesh__D000252smesh__D027682
% 224.24/224.39  |- mesh__recordAuthorizer mesh__D000252 sjn
% 224.24/224.39  |- mesh__dateEstablished mesh__D000252 1979-01-01
% 224.24/224.39  |- skos__historyNote mesh__D000252 Calcium %28%1966-1978%29%
% 224.24/224.39  |- skos__hiddenLabel mesh__D000252 Calcium Adenosine Triphosphatase
% 224.24/224.39  |- rdf__type mesh__D000252sskos__Concept
% 224.24/224.39  |- skos__prefLabel mesh__D000252 Ca%28%2+%29%-Transporting ATPase
% 224.24/224.39  |- skos__scopeNote mesh__D000252
% 224.24/224.39       An enzyme found in the SARCOPLASMIC RETICULUM vesicle membrane. During the relaxation of SKELETAL MUSCLES and muscle rich in MITOCHONDRIA this enzyme catalyzes the active transport of CALCIUM into the sarcoplasmic reticulum vesicles from the sarcoplasm. It requires micromolar concentrations of Ca%28%2+%29% and utilizes MgATP as a substrate. %28%Prog Biophys Mol Biol 1988;52%28%1%29%:1%29%. This enzyme was formerly listed as EC 3.6.1.38.%A%    
% 224.24/224.39  |- skos__hiddenLabel mesh__D000252 Triphosphatase, Calcium Adenosine
% 224.24/224.39  |- skos__altLabel mesh__D000252 Adenosine Triphosphatase, Calcium
% 224.24/224.39  |- skos__altLabel mesh__D000252 Calcium-ATPase
% 224.24/224.39  |- skos__altLabel mesh__D000252 Adenosinetriphosphatase, Calcium
% 224.24/224.39  |- skos__altLabel mesh__D000252 Ca2+ ATPase
% 224.24/224.39  |- mesh__onlineNote mesh__D000252
% 224.24/224.39       use CA%28%2+%29%-TRANSPORTING ATPASE to search ADENOSINE TRIPHOSPHATASE, CALCIUM 1979-92, CALCIUM PUMP 1992-93, CALCIUM PUMP PROTEIN 1992, %26% CALCIUM ADENOSINE TRIPHOSPHATASE 1989-92%A%  
% 224.24/224.39  |- mesh__historyNote mesh__D000252
% 224.24/224.39       93; was ADENOSINE TRIPHOSPHATASE, CALCIUM 1979-92; CALCIUM PUMP was heading 1992-93; CALCIUM PUMP PROTEIN was see ADENOSINE TRIPHOSPHATASE, CALCIUM 1992; CALCIUM ADENOSINETRIPHOSPHATASE was CALCIUM ADENOSINE TRIPHOSPHATASE see ADENOSINE TRIPHOSPHATASE, CALCIUM 1989-92%A%  
% 224.24/224.39  |- skos__annotation mesh__D000252 DF: CA ATPASE   
% 224.24/224.39  |- skos__altLabel mesh__D000252 Calcium Pump
% 224.24/224.39  |- mesh__publicMeSHNote mesh__D000252
% 224.24/224.39       93; was ADENOSINE TRIPHOSPHATASE, CALCIUM 1979-92; CALCIUM PUMP was heading 1992-93; CALCIUM PUMP PROTEIN was see ADENOSINE TRIPHOSPHATASE, CALCIUM 1992; CALCIUM ADENOSINETRIPHOSPHATASE was CALCIUM ADENOSINE TRIPHOSPHATASE see ADENOSINE TRIPHOSPHATASE, CALCIUM 1989-92%A%  
% 224.24/224.39  |- mesh__recordOriginator mesh__D000252 RLS
% 224.24/224.39  |- skos__broader mesh__D000252smesh__D000251
% 224.24/224.39  |- mesh__dateRevised mesh__D000252 2005-06-30
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D000252 2006
% 224.24/224.39  |- skos__related mesh__D000252smesh__D017301
% 224.24/224.39  |- skos__hiddenLabel mesh__D000252 ATPase, Ca2+
% 224.24/224.39  |- skos__broader mesh__D013978smesh__D007869
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D013978 2006
% 224.24/224.39  |- rdf__type mesh__D013978sskos__Concept
% 224.24/224.39  |- mesh__dateRevised mesh__D013978 2005-06-30
% 224.24/224.39  |- mesh__dateCreated mesh__D013978 1999-01-01
% 224.24/224.39  |- skos__hiddenLabel mesh__D013978 Fractures, Tibial
% 224.24/224.39  |- skos__prefLabel mesh__D013978 Tibial Fractures
% 224.24/224.39  |- skos__hiddenLabel mesh__D013978 Tibial Fracture
% 224.24/224.39  |- mesh__recordMaintainer mesh__D013978 ssb
% 224.24/224.39  |- skos__hiddenLabel mesh__D013978 Fracture, Tibial
% 224.24/224.39  |- mesh__recordAuthorizer mesh__D013978 sjn
% 224.24/224.39  |- mesh__recordOriginator mesh__D013978 NLM
% 224.24/224.39  |- skos__broader mesh__D013978smesh__D050723
% 224.24/224.39  |- skos__hiddenLabel mesh__D018663 Neuron Agents, Adrenergic
% 224.24/224.39  |- mesh__historyNote mesh__D018663
% 224.24/224.39       95; was see SYMPATHOMIMETICS 1977-94; ADRENERGIC NEURON AGENTS was heading 1995; ADRENERGIC NEUROHUMOR DEPLETERS, ADRENERGIC RELEASE INHIBITORS, ADRENERGIC SYNTHESIS INHIBITORS, %26% SYMPATHETIC TRANSMITTER RELEASERS were see ADRENERGIC NEURON AGENTS 1995; SYMPATHETIC TRANSMITTER RELEASERS was see SYMPATHOMIMETICS 1976-94; ADRENOLYTICS was see SYMPATHOLYTICS 1975-94; ADRENOMIMETICS was see SYMPATHOMIMETICS 1975-94%A%  
% 224.24/224.39  |- skos__hiddenLabel mesh__D018663 Depleters, Adrenergic Neurohumor
% 224.24/224.39  |- mesh__recordOriginator mesh__D018663 RAZ
% 224.24/224.39  |- skos__altLabel mesh__D018663 Adrenergic Neuron Drugs
% 224.24/224.39  |- mesh__dateCreated mesh__D018663 1994-06-01
% 224.24/224.39  |- mesh__dateEstablished mesh__D018663 1995-01-01
% 224.24/224.39  |- skos__related mesh__D018663smesh__D013566
% 224.24/224.39  |- skos__hiddenLabel mesh__D018663 Transmitter Releasers, Sympathetic
% 224.24/224.39  |- skos__hiddenLabel mesh__D018663 Releasers, Sympathetic Transmitter
% 224.24/224.39  |- skos__related mesh__D018663smesh__D013565
% 224.24/224.39  |- skos__hiddenLabel mesh__D018663 Neurohumor Depleters, Adrenergic
% 224.24/224.39  |- skos__hiddenLabel mesh__D018663 Agents, Adrenergic
% 224.24/224.39  |- mesh__publicMeSHNote mesh__D018663
% 224.24/224.39       95; was see SYMPATHOMIMETICS 1977-94; ADRENERGIC NEURON AGENTS was heading 1995; ADRENERGIC NEUROHUMOR DEPLETERS, ADRENERGIC RELEASE INHIBITORS, ADRENERGIC SYNTHESIS INHIBITORS, %26% SYMPATHETIC TRANSMITTER RELEASERS were see ADRENERGIC NEURON AGENTS 1995; SYMPATHETIC TRANSMITTER RELEASERS was see SYMPATHOMIMETICS 1976-94; ADRENOLYTICS was see SYMPATHOLYTICS 1975-94; ADRENOMIMETICS was see SYMPATHOMIMETICS 1975-94%A%  
% 224.24/224.39  |- skos__hiddenLabel mesh__D018663 Neuron Drugs, Adrenergic
% 224.24/224.39  |- skos__hiddenLabel mesh__D018663 Inhibitors, Adrenergic Release
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D018663 2006
% 224.24/224.39  |- skos__altLabel mesh__D018663 Adrenergics
% 224.24/224.39  |- skos__hiddenLabel mesh__D018663 Drugs, Adrenergic Neuron
% 224.24/224.39  |- skos__annotation mesh__D018663 DF: ADREN AGENTS   
% 224.24/224.39  |- mesh__onlineNote mesh__D018663
% 224.24/224.39       use SYMPATHOMIMETICS to search SYMPATHETIC TRANSMITTER RELEASERS 1976-94, ADRENERGIC AGENTS 1977-94 %26% ADRENOMIMETICS 1975-94; use SYMPATHOLYTICS to search ADRENOLYTICS 1975-94%A%  
% 224.24/224.39  |- skos__hiddenLabel mesh__D018663 Inhibitors, Adrenergic Synthesis
% 224.24/224.39  |- mesh__recordAuthorizer mesh__D018663 sjn
% 224.24/224.39  |- skos__altLabel mesh__D018663 Adrenergic Drugs
% 224.24/224.39  |- skos__scopeNote mesh__D018663
% 224.24/224.39       Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters.%A%    
% 224.24/224.39  |- skos__hiddenLabel mesh__D018663 Release Inhibitors, Adrenergic
% 224.24/224.39  |- skos__broader mesh__D018663smesh__D018377
% 224.24/224.39  |- rdf__type mesh__D018663sskos__Concept
% 224.24/224.39  |- mesh__recordMaintainer mesh__D018663 ssb
% 224.24/224.39  |- skos__hiddenLabel mesh__D018663 Synthesis Inhibitors, Adrenergic
% 224.24/224.39  |- skos__hiddenLabel mesh__D018663 Drugs, Adrenergic
% 224.24/224.39  |- skos__historyNote mesh__D018663 Sympathomimetics %28%1977-1994%29%
% 224.24/224.39  |- mesh__dateRevised mesh__D018663 2005-06-30
% 224.24/224.39  |- skos__prefLabel mesh__D018663 Adrenergic Agents
% 224.24/224.39  |- skos__hiddenLabel mesh__D018663 Agents, Adrenergic Neuron
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D010680 2002
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D010680 2004
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D010680 2001
% 224.24/224.39  |- mesh__recordAuthorizer mesh__D010680 sjn
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D010680 2003
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D010680 2000
% 224.24/224.39  |- mesh__dateCreated mesh__D010680 1999-01-01
% 224.24/224.39  |- rdf__type mesh__D010680sskos__Concept
% 224.24/224.39  |- skos__scopeNote mesh__D010680
% 224.24/224.39       The study of literature in its widest sense, including grammar, etymology, criticism, literary history, language history, linguistic history, systems of writing, and anything else that is relevant to literature or language viewed as literature. Philology as a discipline has both philosophical and scientific overtones.%A%    
% 224.24/224.39  |- mesh__recordOriginator mesh__D010680 NLM
% 224.24/224.39  |- skos__broader mesh__D010680smesh__D008091
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D010680 2006
% 224.24/224.39  |- skos__annotation mesh__D010680
% 224.24/224.39       study of literature or language as used in literature; do not confuse with LITERATURE, literary works; GEN or unspecified; prefer specifics; DF: PHILOL%A%  
% 224.24/224.39  |- mesh__recordMaintainer mesh__D010680 kle
% 224.24/224.39  |- skos__prefLabel mesh__D010680 Philology
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D010680 2005
% 224.24/224.39  |- mesh__dateRevised mesh__D010680 1999-11-03
% 224.24/224.39  |- skos__scopeNote mesh__D004643
% 224.24/224.39       Oleagenous substances used topically to soothe, soften or protect skin or mucous membranes. They are used also as vehicles for other dermatologic agents.%A%    
% 224.24/224.39  |- mesh__onlineNote mesh__D004643 search DERMATOLOGIC AGENTS 1967-74   
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D004643 2006
% 224.24/224.39  |- skos__broader mesh__D004643smesh__D003879
% 224.24/224.39  |- mesh__dateEstablished mesh__D004643 1991-01-01
% 224.24/224.39  |- mesh__dateCreated mesh__D004643 1999-01-01
% 224.24/224.39  |- rdf__type mesh__D004643sskos__Concept
% 224.24/224.39  |- mesh__historyNote mesh__D004643
% 224.24/224.39       91%28%75%29%; was see under DERMATOLOGIC AGENTS 1975-90   
% 224.24/224.39  |- mesh__recordAuthorizer mesh__D004643 sjn
% 224.24/224.39  |- mesh__publicMeSHNote mesh__D004643
% 224.24/224.39       91; was see under DERMATOLOGIC AGENTS 1975-90   
% 224.24/224.39  |- skos__prefLabel mesh__D004643 Emollients
% 224.24/224.39  |- mesh__recordMaintainer mesh__D004643 ssb
% 224.24/224.39  |- mesh__recordOriginator mesh__D004643 NLM
% 224.24/224.39  |- mesh__dateRevised mesh__D004643 2005-06-30
% 224.24/224.39  |- rdf__type mesh__D051299sskos__Concept
% 224.24/224.39  |- skos__scopeNote mesh__D051299
% 224.24/224.39       A secondary headache disorder attributed to low CEREBROSPINAL FLUID pressure caused by SPINAL PUNCTURE, usually after dural or lumbar puncture.%A%    
% 224.24/224.39  |- skos__altLabel mesh__D051299 Postdural Puncture Headache
% 224.24/224.39  |- skos__hiddenLabel mesh__D051299 Postdural Puncture Headaches
% 224.24/224.39  |- mesh__historyNote mesh__D051299 2006; use HEADACHE 2000-2005   
% 224.24/224.39  |- skos__historyNote mesh__D051299 Headache %28%1983-2005%29%
% 224.24/224.39  |- skos__hiddenLabel mesh__D051299 Headaches, Postdural Puncture
% 224.24/224.39  |- mesh__recordMaintainer mesh__D051299 lkt
% 224.24/224.39  |- mesh__dateCreated mesh__D051299 2005-06-30
% 224.24/224.39  |- skos__broader mesh__D051299smesh__D051271
% 224.24/224.39  |- skos__hiddenLabel mesh__D051299 Headache, Post-Dural Puncture
% 224.24/224.39  |- mesh__publicMeSHNote mesh__D051299 2006; see HEADACHE 2000-2005   
% 224.24/224.39  |- skos__historyNote mesh__D051299 Spinal Puncture %28%1984-2005%29%
% 224.24/224.39  |- skos__hiddenLabel mesh__D051299 Post Dural Puncture Headache
% 224.24/224.39  |- skos__hiddenLabel mesh__D051299 Headache, Postdural Puncture
% 224.24/224.39  |- mesh__dateEstablished mesh__D051299 2006-01-01
% 224.24/224.39  |- mesh__recordOriginator mesh__D051299 lkt
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D051299 2006
% 224.24/224.39  |- skos__hiddenLabel mesh__D051299 Headaches, Post-Dural Puncture
% 224.24/224.39  |- mesh__recordAuthorizer mesh__D051299 sjn
% 224.24/224.39  |- skos__hiddenLabel mesh__D051299 Post-Dural Puncture Headaches
% 224.24/224.39  |- skos__prefLabel mesh__D051299 Post-Dural Puncture Headache
% 224.24/224.39  |- mesh__recordOriginator mesh__D042762 ags
% 224.24/224.39  |- skos__broader mesh__D042762smesh__D020562
% 224.24/224.39  |- mesh__dateRevised mesh__D042762 2005-06-30
% 224.24/224.39  |- mesh__historyNote mesh__D042762 2004   
% 224.24/224.39  |- skos__broader mesh__D042762smesh__D016946
% 224.24/224.39  |- mesh__dateEstablished mesh__D042762 2004-01-01
% 224.24/224.39  |- rdf__type mesh__D042762sskos__Concept
% 224.24/224.39  |- mesh__dateCreated mesh__D042762 2003-07-09
% 224.24/224.39  |- mesh__publicMeSHNote mesh__D042762 2004   
% 224.24/224.39  |- mesh__recordMaintainer mesh__D042762 SYSTEM
% 224.24/224.39  |- mesh__recordAuthorizer mesh__D042762 sjn
% 224.24/224.39  |- skos__scopeNote mesh__D042762
% 224.24/224.39       A family of gram-negative bacteria in the order Methylophilales.%A%    
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D042762 2006
% 224.24/224.39  |- skos__prefLabel mesh__D042762 Methylophilaceae
% 224.24/224.39  |- skos__broader mesh__D014273smesh__D010640
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D014273 2006
% 224.24/224.39  |- mesh__dateCreated mesh__D014273 1999-01-01
% 224.24/224.39  |- mesh__dateRevised mesh__D014273 2005-06-30
% 224.24/224.39  |- mesh__recordMaintainer mesh__D014273 ssb
% 224.24/224.39  |- skos__scopeNote mesh__D014273
% 224.24/224.39       A phenothiazine used as an antipsychotic agent and as an antiemetic.%A%    
% 224.24/224.39  |- skos__prefLabel mesh__D014273 Triflupromazine
% 224.24/224.39  |- skos__altLabel mesh__D014273 Fluopromazine
% 224.24/224.39  |- mesh__recordOriginator mesh__D014273 NLM
% 224.24/224.39  |- mesh__recordAuthorizer mesh__D014273 sjn
% 224.24/224.39  |- rdf__type mesh__D014273sskos__Concept
% 224.24/224.39  |- skos__altLabel mesh__D014273 Trifluopromazine
% 224.24/224.39  |- mesh__onlineNote mesh__D008236
% 224.24/224.39       use LYPRESSIN to search LYSINE VASOPRESSIN 1975-78   
% 224.24/224.39  |- mesh__historyNote mesh__D008236
% 224.24/224.39       79; was LYSINE VASOPRESSIN see under VASOPRESSIN 1975-78   
% 224.24/224.39  |- skos__altLabel mesh__D008236 Vasopressin, Lysine
% 224.24/224.39  |- skos__broader mesh__D008236smesh__D014667
% 224.24/224.39  |- skos__prefLabel mesh__D008236 Lypressin
% 224.24/224.39  |- skos__hiddenLabel mesh__D008236 Vasopressin, Lysyl
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D008236 2006
% 224.24/224.39  |- mesh__recordMaintainer mesh__D008236 ssb
% 224.24/224.39  |- skos__historyNote mesh__D008236 Lysine %28%1966-1974%29%
% 224.24/224.39  |- skos__altLabel mesh__D008236 Lysine Vasopressin
% 224.24/224.39  |- skos__altLabel mesh__D008236 Lysyl Vasopressin
% 224.24/224.39  |- mesh__dateCreated mesh__D008236 1974-11-11
% 224.24/224.39  |- mesh__dateRevised mesh__D008236 2005-06-30
% 224.24/224.39  |- rdf__type mesh__D008236sskos__Concept
% 224.24/224.39  |- skos__scopeNote mesh__D008236
% 224.24/224.39       The porcine antidiuretic hormone %28%VASOPRESSINS%29% most frequently used clinically. A cyclic nonapeptide with LYSINE in position 8 of the chain; it is used to treat DIABETES INSIPIDUS and as a hemostatic because of its vasoconstrictor action.%A%    
% 224.24/224.39  |- mesh__recordAuthorizer mesh__D008236 sjn
% 224.24/224.39  |- mesh__recordOriginator mesh__D008236 NLM
% 224.24/224.39  |- mesh__dateEstablished mesh__D008236 1979-01-01
% 224.24/224.39  |- skos__historyNote mesh__D008236 Vasopressins %28%1966-1974%29%
% 224.24/224.39  |- mesh__publicMeSHNote mesh__D008236
% 224.24/224.39       79; was LYSINE VASOPRESSIN see under VASOPRESSIN 1975-78; FELYPRESSIN was PHELYPRESSIN see under VASOPRESSIN 1975-78%A%  
% 224.24/224.39  |- skos__hiddenLabel mesh__D013979 Nerve, Medial Plantar
% 224.24/224.39  |- skos__prefLabel mesh__D013979 Tibial Nerve
% 224.24/224.39  |- skos__hiddenLabel mesh__D013979 Nerve, Posterior Tibial
% 224.24/224.39  |- skos__hiddenLabel mesh__D013979 Plantar Nerves, Medial
% 224.24/224.39  |- skos__hiddenLabel mesh__D013979 Tibial Nerves, Posterior
% 224.24/224.39  |- mesh__recordAuthorizer mesh__D013979 sjn
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D013979 2001
% 224.24/224.39  |- mesh__recordOriginator mesh__D013979 NLM
% 224.24/224.39  |- mesh__dateEstablished mesh__D013979 1972-01-01
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D013979 2006
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D013979 2000
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D013979 2004
% 224.24/224.39  |- rdf__type mesh__D013979sskos__Concept
% 224.24/224.39  |- skos__hiddenLabel mesh__D013979 Plantar Nerve, Medial
% 224.24/224.39  |- skos__hiddenLabel mesh__D013979 Nerves, Posterior Tibial
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D013979 2005
% 224.24/224.39  |- skos__broader mesh__D013979smesh__D012584
% 224.24/224.39  |- skos__hiddenLabel mesh__D013979 Nerve, Tibial
% 224.24/224.39  |- skos__hiddenLabel mesh__D013979 Nerves, Medial Plantar
% 224.24/224.39  |- skos__hiddenLabel mesh__D013979 Medial Plantar Nerves
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D013979 2003
% 224.24/224.39  |- skos__related mesh__D013979smesh__D013641
% 224.24/224.39  |- skos__historyNote mesh__D013979 Spinal Nerves %28%1966-1970%29%
% 224.24/224.39  |- mesh__historyNote mesh__D013979 72%28%71%29%   
% 224.24/224.39  |- mesh__activeMeSHYear mesh__D013979 2002
% 224.24/224.39  |- skos__hiddenLabel mesh__D013979 Tibial Nerves
% 224.24/224.39  |- mesh__recordMaintainer mesh__D013979 KEV
% 224.24/224.39  |- mesh__dateCreated mesh__D013979 1999-01-01
% 224.24/224.39  |- mesh__publicMeSHNote mesh__D013979 72   
% 224.24/224.39  |- skos__scopeNote mesh__D013979
% 224.24/224.39       The medial terminal branch of the sciatic nerve. The tibial nerve fibers originate in lumbar and sacral spinal segments %28%L4 to S2%29%. They supply motor and sensory innervation to parts of the calf and foot.%A%    
% 224.24/224.39  |- skos__annotation mesh__D013979
% 224.24/224.39       dis = TIBIAL NEUROPATHY; neopl = TIBIAL NEUROPATHY %28%IM%29% + PERIPHERAL NERVOUS SYSTEM NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 224.24/224.39  |- mesh__dateRevised mesh__D013979 1999-11-03
% 224.24/224.39  |- skos__hiddenLabel mesh__D013979 Tibial Nerve, Posterior
% 224.24/224.39  |- skos__hiddenLabel mesh__D013979 Posterior Tibial Nerves
% 224.24/224.39  |- skos__hiddenLabel mesh__D013979 Nerves, Tibial
% 224.24/224.39  |- mesh__onlineNote mesh__D018664
% 224.24/224.39       use INTERLEUKIN-12 %28%NM%29% to search INTERLEUKIN 12 1991-94   
% 224.24/224.39  |- skos__related mesh__D018664smesh__D007111
% 224.24/224.39  |- mesh__recordOriginator mesh__D018664 AGS
% 224.24/224.39  |- mesh__publicMeSHNote mesh__D018664
% 224.24/224.39       95; INTERLEUKIN 12 was indexed under INTERLEUKINS 1991-94%A%  
% 224.24/224.40  |- mesh__dateCreated mesh__D018664 1994-04-19
% 224.24/224.40  |- mesh__dateRevised mesh__D018664 2005-06-30
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D018664 2006
% 224.24/224.40  |- skos__altLabel mesh__D018664 Natural Killer Cell Stimulatory Factor
% 224.24/224.40  |- skos__altLabel mesh__D018664 Edodekin Alfa
% 224.24/224.40  |- skos__historyNote mesh__D018664 Interleukins %28%1991-1994%29%
% 224.24/224.40  |- skos__altLabel mesh__D018664 IL-12
% 224.24/224.40  |- skos__broader mesh__D018664smesh__D007378
% 224.24/224.40  |- mesh__dateEstablished mesh__D018664 1995-01-01
% 224.24/224.40  |- skos__altLabel mesh__D018664 IL 12
% 224.24/224.40  |- skos__altLabel mesh__D018664 Interleukin 12
% 224.24/224.40  |- skos__scopeNote mesh__D018664
% 224.24/224.40       A heterodimeric cytokine that stimulates the production of interferon gamma from T-cells and natural killer cells, and also induces differentiation of Th1 helper cells. It is an initiator of cell-mediated immunity.%A%    
% 224.24/224.40  |- mesh__historyNote mesh__D018664
% 224.24/224.40       95; was INTERLEUKIN 12 %28%NM%29% 1991-94   
% 224.24/224.40  |- rdf__type mesh__D018664sskos__Concept
% 224.24/224.40  |- mesh__recordAuthorizer mesh__D018664 sjn
% 224.24/224.40  |- skos__prefLabel mesh__D018664 Interleukin-12
% 224.24/224.40  |- skos__altLabel mesh__D018664 IL12
% 224.24/224.40  |- skos__annotation mesh__D018664 DF: IL 12 or IL12   
% 224.24/224.40  |- mesh__recordMaintainer mesh__D018664 ssb
% 224.24/224.40  |- mesh__dateCreated mesh__D010681 1999-01-01
% 224.24/224.40  |- mesh__recordOriginator mesh__D010681 NLM
% 224.24/224.40  |- rdf__type mesh__D010681sskos__Concept
% 224.24/224.40  |- skos__scopeNote mesh__D010681
% 224.24/224.40       The study of ancient Greek and Roman literature, including grammar, etymology, criticism, literary history, and language and linguistic history.%A%    
% 224.24/224.40  |- mesh__recordMaintainer mesh__D010681 kle
% 224.24/224.40  |- mesh__dateRevised mesh__D010681 1999-11-03
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D010681 2006
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D010681 2002
% 224.24/224.40  |- skos__altLabel mesh__D010681 Classical Philology
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D010681 2005
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D010681 2001
% 224.24/224.40  |- skos__annotation mesh__D010681 IM; DF: PHILOL CLASSICAL   
% 224.24/224.40  |- mesh__recordAuthorizer mesh__D010681 sjn
% 224.24/224.40  |- skos__prefLabel mesh__D010681 Philology, Classical
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D010681 2004
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D010681 2000
% 224.24/224.40  |- skos__broader mesh__D010681smesh__D010680
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D010681 2003
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D004644 2004
% 224.24/224.40  |- skos__scopeNote mesh__D004644
% 224.24/224.40       Those affective states which can be experienced and have arousing and motivational properties.%A%    
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D004644 1999
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D004644 2000
% 224.24/224.40  |- skos__hiddenLabel mesh__D004644 Emotion
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D004644 2003
% 224.24/224.40  |- mesh__recordOriginator mesh__D004644 NLM
% 224.24/224.40  |- skos__prefLabel mesh__D004644 Emotions
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D004644 2006
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D004644 2002
% 224.24/224.40  |- skos__broader mesh__D004644smesh__D001520
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D004644 2005
% 224.24/224.40  |- mesh__dateRevised mesh__D004644 1998-06-10
% 224.24/224.40  |- rdf__type mesh__D004644sskos__Concept
% 224.24/224.40  |- skos__hiddenLabel mesh__D004644 Feeling
% 224.24/224.40  |- mesh__dateCreated mesh__D004644 1999-01-01
% 224.24/224.40  |- mesh__recordMaintainer mesh__D004644 JLS
% 224.24/224.40  |- skos__hiddenLabel mesh__D004644 Regrets
% 224.24/224.40  |- skos__annotation mesh__D004644 human %26% animal   
% 224.24/224.40  |- mesh__recordAuthorizer mesh__D004644 SJN
% 224.24/224.40  |- skos__related mesh__D004644smesh__D000342
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D004644 2001
% 224.24/224.40  |- mesh__recordAuthorizer mesh__D042763 sjn
% 224.24/224.40  |- mesh__recordOriginator mesh__D042763 ags
% 224.24/224.40  |- mesh__dateRevised mesh__D042763 2005-06-30
% 224.24/224.40  |- rdf__type mesh__D042763sskos__Concept
% 224.24/224.40  |- skos__broader mesh__D042763smesh__D020563
% 224.24/224.40  |- skos__prefLabel mesh__D042763 Acidithiobacillus
% 224.24/224.40  |- skos__scopeNote mesh__D042763
% 224.24/224.40       A genus of gram-negative rod-shaped bacteria in the class GAMMAPROTEOBACTERIA. They are obligately acidophilic and aerobic, using reduced sulfur compounds to support autotrophic growth.%A%    
% 224.24/224.40  |- mesh__recordMaintainer mesh__D042763 SYSTEM
% 224.24/224.40  |- mesh__historyNote mesh__D042763 2004   
% 224.24/224.40  |- mesh__dateCreated mesh__D042763 2003-07-09
% 224.24/224.40  |- mesh__publicMeSHNote mesh__D042763 2004   
% 224.24/224.40  |- skos__broader mesh__D042763smesh__D016946
% 224.24/224.40  |- mesh__dateEstablished mesh__D042763 2004-01-01
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D042763 2006
% 224.24/224.40  |- skos__historyNote mesh__D042763 Gammaproteobacteria %28%2001-2003%29%
% 224.24/224.40  |- skos__scopeNote mesh__D014274
% 224.24/224.40       A microtubule-disrupting pre-emergence herbicide.     
% 224.24/224.40  |- mesh__recordMaintainer mesh__D014274 CCR
% 224.24/224.40  |- mesh__recordAuthorizer mesh__D014274 sjn
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D014274 2006
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D014274 2005
% 224.24/224.40  |- mesh__dateCreated mesh__D014274 1999-01-01
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D014274 2004
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D014274 2002
% 224.24/224.40  |- skos__broader mesh__D014274smesh__D014052
% 224.24/224.40  |- mesh__publicMeSHNote mesh__D014274
% 224.24/224.40       91; was see under TOLUIDINES 1972-90   
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D014274 2003
% 224.24/224.40  |- skos__historyNote mesh__D014274 Toluene %28%1966-1971%29%
% 224.24/224.40  |- skos__historyNote mesh__D014274 Herbicides %28%1966-1971%29%
% 224.24/224.40  |- skos__broader mesh__D014274smesh__D014050
% 224.24/224.40  |- mesh__dateEstablished mesh__D014274 1991-01-01
% 224.24/224.40  |- rdf__type mesh__D014274sskos__Concept
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D014274 2001
% 224.24/224.40  |- mesh__historyNote mesh__D014274
% 224.24/224.40       91%28%72%29%; was see under TOLUIDINES 1972-90   
% 224.24/224.40  |- mesh__dateRevised mesh__D014274 2000-06-22
% 224.24/224.40  |- skos__prefLabel mesh__D014274 Trifluralin
% 224.24/224.40  |- mesh__recordOriginator mesh__D014274 NLM
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D008237 1996
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D008237 1995
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D008237 2006
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D008237 1994
% 224.24/224.40  |- mesh__dateCreated mesh__D008237 1999-01-01
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D008237 2005
% 224.24/224.40  |- skos__prefLabel mesh__D008237 Lysergic Acid
% 224.24/224.40  |- mesh__recordAuthorizer mesh__D008237 PLS
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D008237 1999
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D008237 2002
% 224.24/224.40  |- mesh__publicMeSHNote mesh__D008237
% 224.24/224.40       91; was see under ERGOLINES 1975-90   
% 224.24/224.40  |- mesh__onlineNote mesh__D008237 search ERGOLINES 1969-74   
% 224.24/224.40  |- skos__broader mesh__D008237smesh__D004873
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D008237 1993
% 224.24/224.40  |- mesh__recordMaintainer mesh__D008237 TAP
% 224.24/224.40  |- rdf__type mesh__D008237sskos__Concept
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D008237 2004
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D008237 1998
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D008237 2001
% 224.24/224.40  |- mesh__dateRevised mesh__D008237 1992-05-18
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D008237 2003
% 224.24/224.40  |- mesh__dateEstablished mesh__D008237 1991-01-01
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D008237 1997
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D008237 2000
% 224.24/224.40  |- mesh__historyNote mesh__D008237
% 224.24/224.40       91%28%75%29%; was see under ERGOLINES 1975-90   
% 224.24/224.40  |- skos__hiddenLabel mesh__D008237 Acid, Lysergic
% 224.24/224.40  |- mesh__recordOriginator mesh__D008237 NLM
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D000254 2004
% 224.24/224.40  |- skos__altLabel mesh__D000254 Adenosinetriphosphatase, Sodium, Potassium
% 224.24/224.40  |- mesh__dateRevised mesh__D000254 2003-07-09
% 224.24/224.40  |- skos__historyNote mesh__D000254 Potassium %28%1966-1978%29%
% 224.24/224.40  |- skos__altLabel mesh__D000254 Na%28%+%29% K%28%+%29%-Transporting ATPase
% 224.24/224.40  |- skos__hiddenLabel mesh__D000254 ATPase Sodium, Potassium
% 224.24/224.40  |- skos__broader mesh__D000254smesh__D000251
% 224.24/224.40  |- skos__prefLabel mesh__D000254 Na%28%+%29%-K%28%+%29%-Exchanging ATPase
% 224.24/224.40  |- skos__altLabel mesh__D000254 Potassium Pump
% 224.24/224.40  |- mesh__recordOriginator mesh__D000254 RLS
% 224.24/224.40  |- skos__hiddenLabel mesh__D000254 Pump, Sodium-Potassium
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D000254 2006
% 224.24/224.40  |- skos__hiddenLabel mesh__D000254
% 224.24/224.40       Adenosinetriphosphatase Sodium, Potassium
% 224.24/224.40  |- mesh__dateCreated mesh__D000254 1978-03-06
% 224.24/224.40  |- skos__altLabel mesh__D000254 Sodium-Potassium Pump
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D000254 2005
% 224.24/224.40  |- skos__historyNote mesh__D000254 Sodium %28%1966-1978%29%
% 224.24/224.40  |- skos__broader mesh__D000254smesh__D027682
% 224.24/224.40  |- skos__hiddenLabel mesh__D000254 Sodium Potassium Pump
% 224.24/224.40  |- skos__scopeNote mesh__D000254
% 224.24/224.40       An enzyme that catalyzes the active transport system of sodium and potassium ions across the cell wall. Sodium and potassium ions are closely coupled with membrane ATPase which undergoes phosphorylation and dephosphorylation, thereby providing energy for transport of these ions against concentration gradients. EC 3.6.1.37.%A%    
% 224.24/224.40  |- skos__altLabel mesh__D000254 Sodium Pump
% 224.24/224.40  |- skos__hiddenLabel mesh__D000254 Pump, Sodium
% 224.24/224.40  |- mesh__dateEstablished mesh__D000254 1979-01-01
% 224.24/224.40  |- skos__altLabel mesh__D000254 Sodium, Potassium ATPase
% 224.24/224.40  |- skos__historyNote mesh__D000254
% 224.24/224.40       Adenosine Triphosphatase %28%1966-1978%29%
% 224.24/224.40  |- skos__altLabel mesh__D000254 Na%28%+%29%-K%28%+%29%-Transporting ATPase
% 224.24/224.40  |- skos__annotation mesh__D000254 DF: NA K ATPASE   
% 224.24/224.40  |- skos__altLabel mesh__D000254 Sodium, Potassium Adenosinetriphosphatase
% 224.24/224.40  |- mesh__recordMaintainer mesh__D000254 ssb
% 224.24/224.40  |- rdf__type mesh__D000254sskos__Concept
% 224.24/224.40  |- mesh__publicMeSHNote mesh__D000254
% 224.24/224.40       94; was NA%28%+%29% K%28%+%29%-TRANSPORTING ATPASE 1993; was ADENOSINE TRIPHOSPHATASE, SODIUM, POTASSIUM 1979-92; SODIUM-POTASSIUM PUMP was heading 1992-93; POTASSIUM PUMP %26% SODIUM PUMP were see SODIUM-POTASSIUM PUMP 1992-93; SODIUM, POTASSIUM PUMP PROTEIN was see ADENOSINE TRIPHOSPHATASE, SODIUM, POTASSIUM 1992; SODIUM, POTASSIUM ADENOSINETRIPHOSPHATASE was SODIUM, POTASSIUM ADENOSINE TRIPHOSPHATASE see ADENOSINE TRIPHOSPHATASE, SODIUM, POTASSIUM 1989-92%A%  
% 224.24/224.40  |- mesh__recordAuthorizer mesh__D000254 sjn
% 224.24/224.40  |- skos__altLabel mesh__D000254 Adenosine Triphosphatase, Sodium, Potassium
% 224.24/224.40  |- skos__hiddenLabel mesh__D000254 Pump, Potassium
% 224.24/224.40  |- skos__altLabel mesh__D000254 ATPase, Sodium, Potassium
% 224.24/224.40  |- mesh__onlineNote mesh__D000254
% 224.24/224.40       use NA%28%+%29%-K%28%+%29%-EXCHANGING ATPASE to search NA%28%+%29% K%28%+%29%-TRANSPORTING ATPASE 1993, SODIUM-POTASSIUM PUMP, POTASSIUM PUMP %26% SODIUM PUMP 1992-93, ADENOSINE TRIPHOSPHATASE, SODIUM, POTASSIUM 1979-92, SODIUM, POTASSIUM PUMP PROTEIN 1992 %26% SODIUM, POTASSIUM ADENOSINE TRIPHOSPHATASE 1989-92%A%  
% 224.24/224.40  |- mesh__historyNote mesh__D000254
% 224.24/224.40       94; was NA%28%+%29% K%28%+%29%-TRANSPORTING ATPASE 1993; was ADENOSINE TRIPHOSPHATASE, SODIUM, POTASSIUM  1979-92; SODIUM-POTASSIUM PUMP was heading 1992-93; POTASSIUM PUMP %26% SODIUM PUMP were see SODIUM-POTASSIUM PUMP 1992-93; SODIUM POTASSIUM PUMP PROTEIN was see ADENOSINE TRIPHOSPHATASE, SODIUM POTSSIUM 1992; SODIUM, POTASSIUM ADENOSINE TRIPHOSPHATASE was SODIUM POTASSIUM ADENOSINE TRIPHOSPHATASE see ADENOSINE TRIPHOSPHATASE, SODIUM, POTASSIUM 1989-92%A%  
% 224.24/224.40  |- skos__altLabel mesh__D000254 Sodium, Potassium Adenosine Triphosphatase
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D010682 2000
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D010682 2006
% 224.24/224.40  |- skos__scopeNote mesh__D010682
% 224.24/224.40       The study of literature written in languages of Asia and the Far East, including grammar, etymology, criticism, literary history, and language and linguistic history.%A%    
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D010682 2005
% 224.24/224.40  |- mesh__recordOriginator mesh__D010682 NLM
% 224.24/224.40  |- mesh__recordMaintainer mesh__D010682 kle
% 224.24/224.40  |- mesh__dateRevised mesh__D010682 1999-11-03
% 224.24/224.40  |- skos__altLabel mesh__D010682 Oriental Philology
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D010682 2004
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D010682 2002
% 224.24/224.40  |- skos__annotation mesh__D010682 IM; DF: PHILOL ORIENTAL   
% 224.24/224.40  |- skos__broader mesh__D010682smesh__D010680
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D010682 2003
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D010682 2001
% 224.24/224.40  |- mesh__recordAuthorizer mesh__D010682 sjn
% 224.24/224.40  |- mesh__dateCreated mesh__D010682 1999-01-01
% 224.24/224.40  |- skos__prefLabel mesh__D010682 Philology, Oriental
% 224.24/224.40  |- rdf__type mesh__D010682sskos__Concept
% 224.24/224.40  |- skos__broader mesh__D005332Q000295smesh__D005332
% 224.24/224.40  |- mesh__preferredCombination mesh__D005332Q000295smesh__D020669
% 224.24/224.40  |- rdf__type mesh__D005332Q000295smesh__CompoundConcept
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D004645 2003
% 224.24/224.40  |- mesh__recordAuthorizer mesh__D004645 SJN
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D004645 2001
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D004645 2006
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D004645 2000
% 224.24/224.40  |- mesh__activeMeSHYear mesh__D004645 2005
% 224.24/224.40  |- skos__broader mesh__D004645smesh__D010551
% 224.24/224.40  |- rdf__type mesh__D004645sskos__Concept
% 224.24/224.40  |- mesh__dateEstablished mesh__D004645 1971-01-01
% 224.24/224.40  |- mesh__dateCreated mesh__D004645 1999-01-01
% 224.24/224.40  |- mesh__recordOriginator mesh__D004645 NLM
% 224.24/224.40  |- skos__annotation mesh__D004645 no qualif   
% 224.24/224.40  |- mesh__historyNote mesh__D004645 71   
% 224.24/224.41  |- skos__scopeNote mesh__D004645
% 224.24/224.41       An individual%27%s objective and insightful awareness of the feelings and behavior of another person. It should be distinguished from sympathy, which is usually nonobjective and noncritical. It includes caring, which is the demonstration of an awareness of and a concern for the good of others. %28%From Bioethics Thesaurus, 1992%29%%A%    
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D004645 2002
% 224.24/224.41  |- skos__historyNote mesh__D004645 Emotions %28%1966-1970%29%
% 224.24/224.41  |- mesh__publicMeSHNote mesh__D004645 71   
% 224.24/224.41  |- mesh__dateRevised mesh__D004645 1998-06-10
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D004645 2004
% 224.24/224.41  |- mesh__recordMaintainer mesh__D004645 JLS
% 224.24/224.41  |- skos__prefLabel mesh__D004645 Empathy
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D004645 1999
% 224.24/224.41  |- skos__prefLabel mesh__D037021 Thyroid Hormone Receptors alpha
% 224.24/224.41  |- mesh__publicMeSHNote mesh__D037021
% 224.24/224.41       2003; see RECEPTORS, THYROID HORMONE 1994-2002   
% 224.24/224.41  |- skos__altLabel mesh__D037021 c-erbA alpha
% 224.24/224.41  |- skos__altLabel mesh__D037021 c-erb A Protein
% 224.24/224.41  |- skos__hiddenLabel mesh__D037021 c erbA alpha
% 224.24/224.41  |- skos__broader mesh__D037021smesh__D011988
% 224.24/224.41  |- mesh__historyNote mesh__D037021
% 224.24/224.41       2003; use RECEPTORS, THYROID HORMONE 1994-2002   
% 224.24/224.41  |- skos__hiddenLabel mesh__D037021 c erbA 1 Protein
% 224.24/224.41  |- skos__hiddenLabel mesh__D037021 c erb A Protein
% 224.24/224.41  |- skos__altLabel mesh__D037021 erbA Proto-Oncogene Products
% 224.24/224.41  |- mesh__dateRevised mesh__D037021 2005-06-30
% 224.24/224.41  |- skos__scopeNote mesh__D037021
% 224.24/224.41       High affinity receptors for THYROID HORMONES, especially TRIIODOTHYRONINE. These receptors are usually found in the nucleus where they regulate DNA transcription. They are encoded by the THRA gene %28%also known as NR1A1, THRA1, ERBA or ERBA1 gene%29% as several isoforms produced by alternative splicing.%A%    
% 224.24/224.41  |- skos__hiddenLabel mesh__D037021 Gene Products, NR1A1
% 224.24/224.41  |- skos__altLabel mesh__D037021 Proto-Oncogene Proteins c-erbA
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D037021 2006
% 224.24/224.41  |- mesh__recordAuthorizer mesh__D037021 sjn
% 224.24/224.41  |- skos__altLabel mesh__D037021 c-erbA Proteins
% 224.24/224.41  |- skos__historyNote mesh__D037021
% 224.24/224.41       Receptors, Thyroid Hormone %28%1988-2002%29%
% 224.24/224.41  |- skos__altLabel mesh__D037021 NR1A1 Gene Products
% 224.24/224.41  |- skos__hiddenLabel mesh__D037021 c erbA Protein
% 224.24/224.41  |- skos__hiddenLabel mesh__D037021 Thyroid Hormone Receptor alpha 1
% 224.24/224.41  |- mesh__dateCreated mesh__D037021 2002-07-03
% 224.24/224.41  |- skos__altLabel mesh__D037021 ERBA1 Gene Products
% 224.24/224.41  |- skos__hiddenLabel mesh__D037021 Gene Products, ERBA1
% 224.24/224.41  |- rdf__type mesh__D037021sskos__Concept
% 224.24/224.41  |- skos__hiddenLabel mesh__D037021 Gene Products, THRA
% 224.24/224.41  |- skos__altLabel mesh__D037021 c-erbA alpha Protein
% 224.24/224.41  |- skos__hiddenLabel mesh__D037021 erbA Proto Oncogene Products
% 224.24/224.41  |- mesh__dateEstablished mesh__D037021 2003-01-01
% 224.24/224.41  |- skos__altLabel mesh__D037021 c-erbA Protein
% 224.24/224.41  |- skos__altLabel mesh__D037021 c-erbA-1 Protein
% 224.24/224.41  |- skos__altLabel mesh__D037021 THRA Gene Products
% 224.24/224.41  |- mesh__recordOriginator mesh__D037021 lkt
% 224.24/224.41  |- skos__altLabel mesh__D037021 c-erb A Proteins
% 224.24/224.41  |- skos__hiddenLabel mesh__D037021 c-erbA, Proto-Oncogene Proteins
% 224.24/224.41  |- mesh__recordMaintainer mesh__D037021 ags
% 224.24/224.41  |- skos__hiddenLabel mesh__D037021 Proto-Oncogene Products, erbA
% 224.24/224.41  |- skos__hiddenLabel mesh__D037021 c erb A Proteins
% 224.24/224.41  |- skos__hiddenLabel mesh__D037021 c erbA Proteins
% 224.24/224.41  |- skos__hiddenLabel mesh__D037021 Proto Oncogene Proteins c erbA
% 224.24/224.41  |- skos__altLabel mesh__D037021 Receptors alpha, Thyroid Hormone
% 224.24/224.41  |- skos__hiddenLabel mesh__D037021 c erbA alpha Protein
% 224.24/224.41  |- skos__hiddenLabel mesh__D037021 Thyroid Hormone Receptor alpha 2
% 224.24/224.41  |- mesh__recordAuthorizer mesh__D009330 sjn
% 224.24/224.41  |- skos__related mesh__D009330smesh__D000280
% 224.24/224.41  |- skos__historyNote mesh__D009330 Volatilization %28%1971-1986%29%
% 224.24/224.41  |- mesh__dateRevised mesh__D009330 1999-11-08
% 224.24/224.41  |- mesh__publicMeSHNote mesh__D009330 87   
% 224.24/224.41  |- skos__related mesh__D009330smesh__D000336
% 224.24/224.41  |- skos__hiddenLabel mesh__D009330 Inhaler
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D009330 2001
% 224.24/224.41  |- skos__broader mesh__D009330smesh__D013523
% 224.24/224.41  |- skos__related mesh__D009330smesh__D000281
% 224.24/224.41  |- mesh__historyNote mesh__D009330 87   
% 224.24/224.41  |- skos__altLabel mesh__D009330 Vaporizers and Nebulizers
% 224.24/224.41  |- skos__historyNote mesh__D009330 Anesthesia, Inhalation %28%1966-1986%29%
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D009330 2006
% 224.24/224.41  |- skos__hiddenLabel mesh__D009330 Nebulizer
% 224.24/224.41  |- skos__altLabel mesh__D009330 Inhalators
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D009330 2000
% 224.24/224.41  |- mesh__recordOriginator mesh__D009330 SH
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D009330 2005
% 224.24/224.41  |- mesh__recordMaintainer mesh__D009330 KEV
% 224.24/224.41  |- skos__hiddenLabel mesh__D009330 Devices, Inhalation
% 224.24/224.41  |- skos__hiddenLabel mesh__D009330 Device, Inhalation
% 224.24/224.41  |- skos__broader mesh__D009330smesh__D004864
% 224.24/224.41  |- skos__hiddenLabel mesh__D009330 Atomizer
% 224.24/224.41  |- skos__historyNote mesh__D009330 Aerosols %28%1966-1986%29%
% 224.24/224.41  |- mesh__dateEstablished mesh__D009330 1987-01-01
% 224.24/224.41  |- skos__hiddenLabel mesh__D009330 Inhalation Device
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D009330 2002
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D009330 2004
% 224.24/224.41  |- rdf__type mesh__D009330sskos__Concept
% 224.24/224.41  |- skos__prefLabel mesh__D009330 Nebulizers and Vaporizers
% 224.24/224.41  |- skos__scopeNote mesh__D009330
% 224.24/224.41       Devices that cause a liquid or solid to be converted into an aerosol %28%spray%29% or a vapor. It is used in drug administration by inhalation, humidification of ambient air, and in certain analytical instruments.%A%    
% 224.24/224.41  |- skos__hiddenLabel mesh__D009330 Vaporizer
% 224.24/224.41  |- skos__hiddenLabel mesh__D009330 Inhalator
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D009330 2003
% 224.24/224.41  |- mesh__dateCreated mesh__D009330 1986-06-04
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D023001 2003
% 224.24/224.41  |- mesh__historyNote mesh__D023001 2001   
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D023001 2001
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D023001 2006
% 224.24/224.41  |- mesh__dateCreated mesh__D023001 2000-06-21
% 224.24/224.41  |- rdf__type mesh__D023001sskos__Concept
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D023001 2005
% 224.24/224.41  |- skos__scopeNote mesh__D023001
% 224.24/224.41       An induced state of non-reactivity to grafted tissue from a donor organism that would ordinarily trigger a cell-mediated or humoral immune response.%A%    
% 224.24/224.41  |- skos__hiddenLabel mesh__D023001 Tolerance, Allograft
% 224.24/224.41  |- skos__historyNote mesh__D023001 Immune Tolerance %28%1967-2000%29%
% 224.24/224.41  |- skos__related mesh__D023001smesh__D006085
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D023001 2002
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D023001 2004
% 224.24/224.41  |- mesh__publicMeSHNote mesh__D023001 2001   
% 224.24/224.41  |- skos__prefLabel mesh__D023001 Transplantation Tolerance
% 224.24/224.41  |- mesh__dateEstablished mesh__D023001 2001-01-01
% 224.24/224.41  |- skos__hiddenLabel mesh__D023001 Tolerance, Graft
% 224.24/224.41  |- skos__broader mesh__D023001smesh__D007108
% 224.24/224.41  |- skos__hiddenLabel mesh__D023001 Tolerance, Transplantation
% 224.24/224.41  |- rdf__type mesh__D042764sskos__Concept
% 224.24/224.41  |- skos__prefLabel mesh__D042764 Receptors, TIE
% 224.24/224.41  |- mesh__dateCreated mesh__D042764 2003-07-09
% 224.24/224.41  |- skos__hiddenLabel mesh__D042764 Family, TIE Receptor
% 224.24/224.41  |- skos__altLabel mesh__D042764 TIE Receptor Tyrosine Kinases
% 224.24/224.41  |- skos__hiddenLabel mesh__D042764 TIE Receptors
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D042764 2006
% 224.24/224.41  |- skos__broader mesh__D042764smesh__D020794
% 224.24/224.41  |- skos__historyNote mesh__D042764
% 224.24/224.41       Receptor Protein-Tyrosine Kinases %28%1994-2003%29%
% 224.24/224.41  |- mesh__recordAuthorizer mesh__D042764 sjn
% 224.24/224.41  |- skos__altLabel mesh__D042764 TIE Receptor Tyrosine Kinase
% 224.24/224.41  |- mesh__publicMeSHNote mesh__D042764
% 224.24/224.41       2004; TIE RECEPTOR TYROSINE KINASES %28%now RECEPTORS, TIE%29% was indexed under  RECEPTOR PROTEIN-TYROSINE KINASES 1994-2003; under RECEPTORS, CELL SURFACE %26% PROTEIN-TYROSINE KINASE 1992-1993%A%  
% 224.24/224.41  |- skos__hiddenLabel mesh__D042764 Receptor Family, TIE
% 224.24/224.41  |- mesh__historyNote mesh__D042764
% 224.24/224.41       2004; use RECEPTORS, TIE %28%NM%29% 1999-2003   
% 224.24/224.41  |- mesh__dateRevised mesh__D042764 2005-06-30
% 224.24/224.41  |- mesh__recordMaintainer mesh__D042764 jmp
% 224.24/224.41  |- skos__altLabel mesh__D042764 Receptor Tyrosine Kinase TIE
% 224.24/224.41  |- skos__historyNote mesh__D042764
% 224.24/224.41       Receptors, Cell Surface %28%1992-1993%29%
% 224.24/224.41  |- mesh__dateEstablished mesh__D042764 2004-01-01
% 224.24/224.41  |- skos__altLabel mesh__D042764 TIE Receptor Family
% 224.24/224.41  |- mesh__recordOriginator mesh__D042764 jmp
% 224.24/224.41  |- skos__scopeNote mesh__D042764
% 224.24/224.41       A family of structurally-related tyrosine kinase receptors that are expressed predominantly in ENDOTHELIAL CELLS and are essential for development of BLOOD VESSELS %28%NEOVASCULARIZATION, PHYSIOLOGIC%29%. The name derives from the fact that they are tyrosine kinases that contain Ig and EGF domains.%A%    
% 224.24/224.41  |- skos__annotation mesh__D042764 GEN; prefer specifics   
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D014275 2003
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D014275 1993
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D014275 2006
% 224.24/224.41  |- skos__hiddenLabel mesh__D014275 Nucleus, Trigeminal Caudal
% 224.24/224.41  |- mesh__dateEstablished mesh__D014275 1991-01-01
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D014275 2001
% 224.24/224.41  |- mesh__dateCreated mesh__D014275 1978-12-22
% 224.24/224.41  |- mesh__publicMeSHNote mesh__D014275
% 224.24/224.41       91; was see under TRIGEMINAL NUCLEUS, SPINAL 1982-90; was see under TRIGEMINAL NUCLEI 1980-81%A%  
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D014275 1996
% 224.24/224.41  |- mesh__dateRevised mesh__D014275 1992-05-18
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D014275 1999
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D014275 2004
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D014275 2002
% 224.24/224.41  |- mesh__recordOriginator mesh__D014275 RC
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D014275 1997
% 224.24/224.41  |- skos__prefLabel mesh__D014275 Trigeminal Caudal Nucleus
% 224.24/224.41  |- skos__scopeNote mesh__D014275
% 224.24/224.41       The caudal portion of the nucleus of the spinal trigeminal tract %28%TRIGEMINAL NUCLEUS, SPINAL%29%, a nucleus involved with pain and temperature sensation.%A%    
% 224.24/224.41  |- mesh__recordAuthorizer mesh__D014275 PLS
% 224.24/224.41  |- skos__historyNote mesh__D014275 Trigeminal Nerve %28%1966-1979%29%
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D014275 1994
% 224.24/224.41  |- rdf__type mesh__D014275sskos__Concept
% 224.24/224.41  |- mesh__historyNote mesh__D014275
% 224.24/224.41       91%28%80%29%; was see under TRIGEMINAL NUCLEUS, SPINAL 1982-90; was see under TRIGEMINAL NUCLEI 1980-81%A%  
% 224.24/224.41  |- skos__broader mesh__D014275smesh__D014279
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D014275 2005
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D014275 1995
% 224.24/224.41  |- skos__annotation mesh__D014275
% 224.24/224.41       do not confuse with CAUDATE NUCLEUS %28%corpus striatum%29%   
% 224.24/224.41  |- mesh__recordMaintainer mesh__D014275 TAP
% 224.24/224.41  |- skos__altLabel mesh__D014275 Caudal Nucleus, Trigeminal
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D014275 1998
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D014275 2000
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D008238 2001
% 224.24/224.41  |- skos__altLabel mesh__D008238 LSD
% 224.24/224.41  |- skos__altLabel mesh__D008238 LSD-25
% 224.24/224.41  |- mesh__dateRevised mesh__D008238 2000-06-21
% 224.24/224.41  |- skos__altLabel mesh__D008238 Lysergide
% 224.24/224.41  |- mesh__recordMaintainer mesh__D008238 TWD
% 224.24/224.41  |- rdf__type mesh__D008238sskos__Concept
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D008238 2004
% 224.24/224.41  |- skos__hiddenLabel mesh__D008238 Acid Diethylamide, Lysergic
% 224.24/224.41  |- skos__scopeNote mesh__D008238
% 224.24/224.41       Semisynthetic derivative of ergot %28%Claviceps purpurea%29%. It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.%A%    
% 224.24/224.41  |- mesh__recordOriginator mesh__D008238 NLM
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D008238 2003
% 224.24/224.41  |- mesh__recordAuthorizer mesh__D008238 sjn
% 224.24/224.41  |- skos__prefLabel mesh__D008238 Lysergic Acid Diethylamide
% 224.24/224.41  |- skos__hiddenLabel mesh__D008238 Diethylamide, Lysergic Acid
% 224.24/224.41  |- skos__hiddenLabel mesh__D008238 LSD 25
% 224.24/224.41  |- skos__annotation mesh__D008238 DF: note short X ref   
% 224.24/224.41  |- skos__broader mesh__D008238smesh__D008237
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D008238 2006
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D008238 2002
% 224.24/224.41  |- mesh__dateCreated mesh__D008238 1999-01-01
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D008238 2005
% 224.24/224.41  |- skos__altLabel mesh__D000255 Manganese Adenosine Triphosphate
% 224.24/224.41  |- skos__scopeNote mesh__D000255
% 224.24/224.41       An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter.%A%    
% 224.24/224.41  |- mesh__recordAuthorizer mesh__D000255 sjn
% 224.24/224.41  |- mesh__recordOriginator mesh__D000255 NLM
% 224.24/224.41  |- skos__broader mesh__D000255smesh__D000227
% 224.24/224.41  |- mesh__activeMeSHYear mesh__D000255 2006
% 224.24/224.41  |- skos__altLabel mesh__D000255 ATP-MgCl2
% 224.27/224.41  |- skos__altLabel mesh__D000255 Cr%28%H2O%29%4 ATP
% 224.27/224.41  |- mesh__historyNote mesh__D000255
% 224.27/224.41       1998; for CHROMIUM ADENOSINE TRIPHOSPHATE use ADENOSINE TRIPHOSPHATE %28%NM%29% 1974-1997; for MANGANESE ATP use ADENOSINE TRIPHOSPHATE %28%NM%29% 1981-2001%A%  
% 224.27/224.41  |- skos__hiddenLabel mesh__D000255 ATP MgCl2
% 224.27/224.41  |- mesh__publicMeSHNote mesh__D000255
% 224.27/224.41       1998; CHROMIUM ADENOSINE TRIPHOSPHATE was indexed under ADENOSINE TRIPHSOPHATE 1974-1997 and CHROMIUM 1974-1982; MANGANESE ATP was indexed under ADENOSINE TRIPHOSPHATE 1981-2001%A%  
% 224.27/224.41  |- skos__altLabel mesh__D000255 ATP
% 224.27/224.41  |- skos__altLabel mesh__D000255 Adenylpyrophosphate
% 224.27/224.41  |- mesh__dateCreated mesh__D000255 1999-01-01
% 224.27/224.41  |- skos__altLabel mesh__D000255 MnATP
% 224.27/224.41  |- rdf__type mesh__D000255sskos__Concept
% 224.27/224.41  |- skos__altLabel mesh__D000255 Magnesium Adenosine Triphosphate
% 224.27/224.41  |- skos__altLabel mesh__D000255 CrATP
% 224.27/224.41  |- skos__prefLabel mesh__D000255 Adenosine Triphosphate
% 224.27/224.41  |- mesh__dateRevised mesh__D000255 2005-06-30
% 224.27/224.41  |- skos__altLabel mesh__D000255 Chromium Adenosine Triphosphate
% 224.27/224.41  |- skos__altLabel mesh__D000255 CaATP
% 224.27/224.41  |- skos__altLabel mesh__D000255 MgATP
% 224.27/224.41  |- mesh__recordMaintainer mesh__D000255 ssb
% 224.27/224.41  |- skos__scopeNote mesh__D018666
% 224.27/224.41       Endoscopic examination, therapy or surgery of the ureter.%A%    
% 224.27/224.41  |- mesh__publicMeSHNote mesh__D018666 95   
% 224.27/224.41  |- skos__altLabel mesh__D018666 Ureteroscopic Surgical Procedures
% 224.27/224.41  |- skos__hiddenLabel mesh__D018666 Procedure, Ureteroscopic Surgical
% 224.27/224.41  |- skos__broader mesh__D018666smesh__D003950
% 224.27/224.41  |- skos__prefLabel mesh__D018666 Ureteroscopy
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D018666 2001
% 224.27/224.41  |- skos__hiddenLabel mesh__D018666 Surgical Procedure, Ureteroscopic
% 224.27/224.41  |- mesh__historyNote mesh__D018666 95   
% 224.27/224.41  |- skos__hiddenLabel mesh__D018666 Surgeries, Ureteroscopic
% 224.27/224.41  |- mesh__recordAuthorizer mesh__D018666 sjn
% 224.27/224.41  |- skos__broader mesh__D018666smesh__D013520
% 224.27/224.41  |- skos__hiddenLabel mesh__D018666 Ureteroscopic Surgical Procedure
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D018666 2000
% 224.27/224.41  |- mesh__dateCreated mesh__D018666 1994-04-19
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D018666 2006
% 224.27/224.41  |- skos__historyNote mesh__D018666 Endoscopy %28%1970-1994%29%
% 224.27/224.41  |- skos__broader mesh__D018666smesh__D004724
% 224.27/224.41  |- mesh__recordMaintainer mesh__D018666 nns
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D018666 2005
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D018666 2004
% 224.27/224.41  |- mesh__dateEstablished mesh__D018666 1995-01-01
% 224.27/224.41  |- mesh__recordOriginator mesh__D018666 PXP
% 224.27/224.41  |- skos__altLabel mesh__D018666 Ureteroscopic Surgery
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D018666 2002
% 224.27/224.41  |- skos__hiddenLabel mesh__D018666 Ureteroscopic Surgeries
% 224.27/224.41  |- mesh__dateRevised mesh__D018666 1999-11-03
% 224.27/224.41  |- rdf__type mesh__D018666sskos__Concept
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D018666 2003
% 224.27/224.41  |- skos__hiddenLabel mesh__D018666 Ureteroscopies
% 224.27/224.41  |- skos__altLabel mesh__D018666 Surgery, Ureteroscopic
% 224.27/224.41  |- skos__hiddenLabel mesh__D018666 Procedures, Ureteroscopic Surgical
% 224.27/224.41  |- mesh__dateRevised mesh__D010683 1999-11-03
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D010683 2000
% 224.27/224.41  |- skos__altLabel mesh__D010683 Romance Philology
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D010683 2006
% 224.27/224.41  |- skos__annotation mesh__D010683 IM; DF: PHILOL ROMANCE   
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D010683 2001
% 224.27/224.41  |- mesh__recordAuthorizer mesh__D010683 sjn
% 224.27/224.41  |- skos__broader mesh__D010683smesh__D010680
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D010683 2003
% 224.27/224.41  |- mesh__dateCreated mesh__D010683 1999-01-01
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D010683 2004
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D010683 2002
% 224.27/224.41  |- mesh__recordOriginator mesh__D010683 NLM
% 224.27/224.41  |- mesh__recordMaintainer mesh__D010683 kle
% 224.27/224.41  |- skos__prefLabel mesh__D010683 Philology, Romance
% 224.27/224.41  |- rdf__type mesh__D010683sskos__Concept
% 224.27/224.41  |- skos__scopeNote mesh__D010683
% 224.27/224.41       The study of literature written in the Romance languages %28%French, Spanish, Italian, and others descended from Latin%29%, including grammar, etymology, criticism, literary history, and language and linguistic history.%A%    
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D010683 2005
% 224.27/224.41  |- skos__broader mesh__D004646smesh__D010335
% 224.27/224.41  |- mesh__recordAuthorizer mesh__D004646 sjn
% 224.27/224.41  |- skos__annotation mesh__D004646
% 224.27/224.41       also available are PULMONARY EMPHYSEMA; SUBCUTANEOUS EMPHYSEMA and PNEUMOMEDIASTINUM see MEDIASTINAL EMPHYSEMA%A%  
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D004646 2003
% 224.27/224.41  |- mesh__recordMaintainer mesh__D004646 mdb
% 224.27/224.41  |- mesh__dateRevised mesh__D004646 2001-07-25
% 224.27/224.41  |- skos__scopeNote mesh__D004646
% 224.27/224.41       A pathological accumulation of air in tissues or organs.%A%    
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D004646 2006
% 224.27/224.41  |- mesh__recordOriginator mesh__D004646 NLM
% 224.27/224.41  |- mesh__dateCreated mesh__D004646 1999-01-01
% 224.27/224.41  |- rdf__type mesh__D004646sskos__Concept
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D004646 2005
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D004646 2002
% 224.27/224.41  |- skos__related mesh__D004646smesh__D011656
% 224.27/224.41  |- skos__prefLabel mesh__D004646 Emphysema
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D004646 2004
% 224.27/224.41  |- skos__broader mesh__D037022smesh__D027724
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D037022 2005
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D037022 2004
% 224.27/224.41  |- skos__scopeNote mesh__D037022
% 224.27/224.41       Conception after the death of the male or female biological parent through techniques such as the use of gametes that have been stored during his or her lifetime or that were collected immediately after his or her death.%A%    
% 224.27/224.41  |- skos__related mesh__D037022smesh__D005306
% 224.27/224.41  |- mesh__publicMeSHNote mesh__D037022 2003   
% 224.27/224.41  |- mesh__dateRevised mesh__D037022 2002-10-31
% 224.27/224.41  |- mesh__dateEstablished mesh__D037022 2003-01-01
% 224.27/224.41  |- skos__hiddenLabel mesh__D037022 Reproduction, Posthumous
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D037022 2003
% 224.27/224.41  |- skos__annotation mesh__D037022 human or animal   
% 224.27/224.41  |- mesh__dateCreated mesh__D037022 2002-07-03
% 224.27/224.41  |- skos__hiddenLabel mesh__D037022 Posthumous Conceptions
% 224.27/224.41  |- skos__altLabel mesh__D037022 Conception, Posthumous
% 224.27/224.41  |- skos__historyNote mesh__D037022
% 224.27/224.41       Reproductive Techniques %28%1999-2002%29%
% 224.27/224.41  |- mesh__recordAuthorizer mesh__D037022 jls
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D037022 2003A
% 224.27/224.41  |- rdf__type mesh__D037022sskos__Concept
% 224.27/224.41  |- mesh__recordOriginator mesh__D037022 hjn
% 224.27/224.41  |- skos__historyNote mesh__D037022 Reproduction %28%1999-2002%29%
% 224.27/224.41  |- mesh__recordMaintainer mesh__D037022 jls
% 224.27/224.41  |- skos__prefLabel mesh__D037022 Posthumous Conception
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D037022 2006
% 224.27/224.41  |- skos__hiddenLabel mesh__D037022 Conceptions, Posthumous
% 224.27/224.41  |- mesh__historyNote mesh__D037022 2003   
% 224.27/224.41  |- mesh__historyNote mesh__D009331
% 224.27/224.41       ANCYLOSTOMA AMERICANA was see NECATOR 1979-92; UNCINARIA AMERICANA was see NECATOR 1977-92%A%  
% 224.27/224.41  |- skos__broader mesh__D009331smesh__D000723
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D009331 2005
% 224.27/224.41  |- mesh__dateCreated mesh__D009331 1999-01-01
% 224.27/224.41  |- skos__annotation mesh__D009331
% 224.27/224.41       a genus of intestinal hookworm found in man %26% pig; infection = NECATORIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 224.27/224.41  |- mesh__recordAuthorizer mesh__D009331 sjn
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D009331 2004
% 224.27/224.41  |- mesh__recordMaintainer mesh__D009331 ags
% 224.27/224.41  |- rdf__type mesh__D009331sskos__Concept
% 224.27/224.41  |- mesh__dateRevised mesh__D009331 2003-07-09
% 224.27/224.41  |- skos__scopeNote mesh__D009331
% 224.27/224.41       A genus of intestinal parasite worms which includes one of the most important hookworms of man, NECATOR AMERICANUS. The only other known species, N. suillus, has been recovered from pigs.%A%    
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D009331 2006
% 224.27/224.41  |- skos__prefLabel mesh__D009331 Necator
% 224.27/224.41  |- mesh__publicMeSHNote mesh__D009331
% 224.27/224.41       ANCYLOSTOMA AMERICANA was see NECATOR 1979-92; UNCINARIA AMERICANA was see NECATOR 1977-92%A%  
% 224.27/224.41  |- mesh__onlineNote mesh__D009331
% 224.27/224.41       use NECATOR to search ANCYLOSTOMA AMERICANA 1979-92 %26% UNCINARIA AMERICANA 1977-92%A%  
% 224.27/224.41  |- mesh__recordOriginator mesh__D009331 NLM
% 224.27/224.41  |- skos__annotation mesh__D014276
% 224.27/224.41       neopl = TRIGEMINAL NERVE DISEASES %28%IM%29% + CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%; TRIGEMINAL GANGLION is available%A%  
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D014276 2004
% 224.27/224.41  |- skos__prefLabel mesh__D014276 Trigeminal Nerve
% 224.27/224.41  |- skos__related mesh__D014276smesh__D014277
% 224.27/224.41  |- skos__hiddenLabel mesh__D014276 Nerves, Trigeminal
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D014276 2000
% 224.27/224.41  |- skos__hiddenLabel mesh__D014276 Nerve, Fifth Cranial
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D014276 2001
% 224.27/224.41  |- skos__hiddenLabel mesh__D014276 Trigeminal Nerves
% 224.27/224.41  |- skos__hiddenLabel mesh__D014276 Nerve, Trigeminal
% 224.27/224.41  |- rdf__type mesh__D014276sskos__Concept
% 224.27/224.41  |- mesh__recordOriginator mesh__D014276 NLM
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D014276 2002
% 224.27/224.41  |- skos__hiddenLabel mesh__D014276 Cranial Nerve, Fifth
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D014276 2005
% 224.27/224.41  |- mesh__dateCreated mesh__D014276 1999-01-01
% 224.27/224.41  |- mesh__recordAuthorizer mesh__D014276 sjn
% 224.27/224.41  |- skos__scopeNote mesh__D014276
% 224.27/224.41       The 5th and largest cranial nerve. The trigeminal nerve is a mixed motor and sensory nerve. The larger sensory part forms the ophthalmic, mandibular, and maxillary nerves which carry afferents sensitive to external or internal stimuli from the skin, muscles, and joints of the face and mouth and from the teeth. Most of these fibers originate from cells of the trigeminal ganglion and project to the trigeminal nucleus of the brain stem. The smaller motor part arises from the brain stem trigeminal motor nucleus and innervates the muscles of mastication.%A%    
% 224.27/224.41  |- skos__hiddenLabel mesh__D014276 Nerve V, Cranial
% 224.27/224.41  |- mesh__recordMaintainer mesh__D014276 ags
% 224.27/224.41  |- skos__broader mesh__D014276smesh__D003391
% 224.27/224.41  |- skos__altLabel mesh__D014276 Cranial Nerve V
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D014276 2003
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D014276 2006
% 224.27/224.41  |- mesh__dateRevised mesh__D014276 1999-11-03
% 224.27/224.41  |- skos__altLabel mesh__D014276 Fifth Cranial Nerve
% 224.27/224.41  |- skos__hiddenLabel mesh__D014276 Fifth Cranial Nerves
% 224.27/224.41  |- skos__hiddenLabel mesh__D014276 Cranial Nerves, Fifth
% 224.27/224.41  |- skos__hiddenLabel mesh__D014276 V, Cranial Nerve
% 224.27/224.41  |- skos__hiddenLabel mesh__D014276 Nerves, Fifth Cranial
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D008239 2002
% 224.27/224.41  |- skos__altLabel mesh__D008239 L-Lysine
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D008239 2003
% 224.27/224.41  |- skos__broader mesh__D008239smesh__D024361
% 224.27/224.41  |- skos__broader mesh__D008239smesh__D000601
% 224.27/224.41  |- mesh__dateRevised mesh__D008239 2001-07-25
% 224.27/224.41  |- mesh__recordMaintainer mesh__D008239 nns
% 224.27/224.41  |- skos__annotation mesh__D008239
% 224.27/224.41       /biosyn /defic /physiol permitted; POLYLYSINE is also available%A%  
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D008239 2006
% 224.27/224.41  |- skos__hiddenLabel mesh__D008239 L Lysine
% 224.27/224.41  |- mesh__recordAuthorizer mesh__D008239 sjn
% 224.27/224.41  |- mesh__recordOriginator mesh__D008239 NLM
% 224.27/224.41  |- skos__hiddenLabel mesh__D008239 Acetate, Lysine
% 224.27/224.41  |- mesh__dateCreated mesh__D008239 1999-01-01
% 224.27/224.41  |- skos__prefLabel mesh__D008239 Lysine
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D008239 2005
% 224.27/224.41  |- skos__broader mesh__D008239smesh__D000599
% 224.27/224.41  |- skos__scopeNote mesh__D008239
% 224.27/224.41       An essential amino acid. It is often added to animal feed.%A%    
% 224.27/224.41  |- rdf__type mesh__D008239sskos__Concept
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D008239 2004
% 224.27/224.41  |- mesh__onlineNote mesh__D000256
% 224.27/224.41       use ADENOVIRIDAE to search ADENOVIRUSES 1975-80 %26% ADENOVIRUS 1966-74%A%  
% 224.27/224.41  |- skos__hiddenLabel mesh__D000256 Adenovirus
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D000256 2006
% 224.27/224.41  |- skos__altLabel mesh__D000256 Adenoviruses
% 224.27/224.41  |- mesh__recordMaintainer mesh__D000256 ags
% 224.27/224.41  |- mesh__recordAuthorizer mesh__D000256 sjn
% 224.27/224.41  |- mesh__recordOriginator mesh__D000256 NLM
% 224.27/224.41  |- skos__annotation mesh__D000256
% 224.27/224.41       a family of DNA viruses; adeno- refers to early isol from adenoids; infection = ADENOVIRIDAE INFECTIONS%A%  
% 224.27/224.41  |- mesh__historyNote mesh__D000256
% 224.27/224.41       81; was ADENOVIRUSES 1975-80, was ADENOVIRUS 1963-74   
% 224.27/224.41  |- mesh__dateRevised mesh__D000256 2004-07-07
% 224.27/224.41  |- mesh__publicMeSHNote mesh__D000256
% 224.27/224.41       81; was ADENOVIRUSES 1975-80, was ADENOVIRUS 1963-74   
% 224.27/224.41  |- skos__scopeNote mesh__D000256
% 224.27/224.41       A family of non-enveloped viruses infecting mammals %28%MASTADENOVIRUS%29% and birds %28%AVIADENOVIRUS%29% or both %28%ATADENOVIRUS%29%. Infections may be asymptomatic or result in a variety of diseases.%A%    
% 224.27/224.41  |- skos__prefLabel mesh__D000256 Adenoviridae
% 224.27/224.41  |- rdf__type mesh__D000256sskos__Concept
% 224.27/224.41  |- mesh__activeMeSHYear mesh__D000256 2005
% 224.27/224.41  |- skos__broader mesh__D000256smesh__D004267
% 224.27/224.41  |- mesh__dateCreated mesh__D000256 1999-01-01
% 224.27/224.41  |- skos__hiddenLabel mesh__D018667 Tilt Table Test
% 224.27/224.41  |- mesh__historyNote mesh__D018667 95   
% 224.27/224.41  |- skos__prefLabel mesh__D018667 Tilt-Table Test
% 224.27/224.42  |- mesh__recordMaintainer mesh__D018667 PXP
% 224.27/224.42  |- mesh__dateEstablished mesh__D018667 1995-01-01
% 224.27/224.42  |- mesh__recordOriginator mesh__D018667 JLS
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D018667 1998
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D018667 2005
% 224.27/224.42  |- mesh__publicMeSHNote mesh__D018667 95   
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D018667 2000
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D018667 1999
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D018667 2006
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D018667 2003
% 224.27/224.42  |- skos__annotation mesh__D018667 in test of cardiac function   
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D018667 2001
% 224.27/224.42  |- skos__broader mesh__D018667smesh__D003935
% 224.27/224.42  |- mesh__dateRevised mesh__D018667 1997-06-20
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D018667 2004
% 224.27/224.42  |- skos__scopeNote mesh__D018667
% 224.27/224.42       Tilt tables are used to maintain a head-down body posture during testing of cardiac response to identify patients with a vasodepressive or cardioinhibitory response as a cause of syncope. %28%From Braunwald, Heart Disease, 4th ed, p621%29%%A%    
% 224.27/224.42  |- mesh__dateCreated mesh__D018667 1994-05-23
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D018667 2002
% 224.27/224.42  |- rdf__type mesh__D018667sskos__Concept
% 224.27/224.42  |- skos__hiddenLabel mesh__D018667 Test, Tilt-Table
% 224.27/224.42  |- skos__historyNote mesh__D018667 Posture %28%1985-1994%29%
% 224.27/224.42  |- mesh__recordAuthorizer mesh__D018667 SJN
% 224.27/224.42  |- mesh__historyNote mesh__D010684
% 224.27/224.42       1963; for SECULARISM use RELIGION 1998-2001   
% 224.27/224.42  |- mesh__dateRevised mesh__D010684 2002-07-03
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D010684 2003
% 224.27/224.42  |- mesh__dateCreated mesh__D010684 1999-01-01
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D010684 2004
% 224.27/224.42  |- skos__hiddenLabel mesh__D010684 Overviews, Philosophical
% 224.27/224.42  |- skos__hiddenLabel mesh__D010684 Overview, Philosophical
% 224.27/224.42  |- mesh__recordAuthorizer mesh__D010684 sjn
% 224.27/224.42  |- skos__hiddenLabel mesh__D010684 Philosophical Overviews
% 224.27/224.42  |- skos__broader mesh__D010684smesh__D006809
% 224.27/224.42  |- skos__hiddenLabel mesh__D010684 Philosophies
% 224.27/224.42  |- mesh__recordMaintainer mesh__D010684 hjn
% 224.27/224.42  |- rdf__type mesh__D010684sskos__Concept
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D010684 2005
% 224.27/224.42  |- mesh__publicMeSHNote mesh__D010684
% 224.27/224.42       1963; for SECULARISM see RELIGION 1998-2001   
% 224.27/224.42  |- skos__scopeNote mesh__D010684
% 224.27/224.42       A love or pursuit of wisdom. A search for the underlying causes and principles of reality. %28%Webster, 3d ed%29%%A%    
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D010684 2006
% 224.27/224.42  |- mesh__recordOriginator mesh__D010684 NLM
% 224.27/224.42  |- skos__prefLabel mesh__D010684 Philosophy
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D037821 2005
% 224.27/224.42  |- skos__broader mesh__D037821smesh__D031308
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D037821 2004
% 224.27/224.42  |- skos__annotation mesh__D037821
% 224.27/224.42       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.27/224.42  |- rdf__type mesh__D037821sskos__Concept
% 224.27/224.42  |- mesh__dateCreated mesh__D037821 2002-07-03
% 224.27/224.42  |- skos__prefLabel mesh__D037821 Casearia
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D037821 2003
% 224.27/224.42  |- mesh__publicMeSHNote mesh__D037821 2003   
% 224.27/224.42  |- mesh__historyNote mesh__D037821 2003   
% 224.27/224.42  |- mesh__dateEstablished mesh__D037821 2003-01-01
% 224.27/224.42  |- skos__scopeNote mesh__D037821
% 224.27/224.42       A plant genus of the family FLACOURTIACEAE. Members contain casearins which are clerodane type DITERPENES.%A%    
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D037821 2006
% 224.27/224.42  |- rdf__type mesh__D004647sskos__Concept
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004647 2002
% 224.27/224.42  |- skos__hiddenLabel mesh__D004647 Employee Disciplines
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004647 1997
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004647 2005
% 224.27/224.42  |- mesh__dateRevised mesh__D004647 1994-05-05
% 224.27/224.42  |- skos__hiddenLabel mesh__D004647 Disciplines, Personnel
% 224.27/224.42  |- mesh__dateEstablished mesh__D004647 1991-01-01
% 224.27/224.42  |- mesh__recordOriginator mesh__D004647 EC
% 224.27/224.42  |- skos__hiddenLabel mesh__D004647 Discipline, Personnel
% 224.27/224.42  |- mesh__recordMaintainer mesh__D004647 TGC
% 224.27/224.42  |- mesh__dateCreated mesh__D004647 1981-02-26
% 224.27/224.42  |- skos__hiddenLabel mesh__D004647 Personnel Disciplines
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004647 1996
% 224.27/224.42  |- skos__prefLabel mesh__D004647 Employee Discipline
% 224.27/224.42  |- skos__historyNote mesh__D004647 Personnel Management %28%1966-1981%29%
% 224.27/224.42  |- mesh__recordAuthorizer mesh__D004647 PLS
% 224.27/224.42  |- skos__annotation mesh__D004647 med or non-med personnel   
% 224.27/224.42  |- mesh__publicMeSHNote mesh__D004647
% 224.27/224.42       91; was see under PERSONNEL MANAGEMENT 1982-90   
% 224.27/224.42  |- skos__scopeNote mesh__D004647
% 224.27/224.42       Regulations or conditions imposed on employees by management in order to correct or prevent behaviors which are counterproductive to the organization.%A%    
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004647 2001
% 224.27/224.42  |- skos__hiddenLabel mesh__D004647 Disciplines, Employee
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004647 2004
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004647 1999
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004647 2000
% 224.27/224.42  |- mesh__historyNote mesh__D004647
% 224.27/224.42       91%28%82%29%; was see under PERSONNEL MANAGEMENT 1982-90   
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004647 2003
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004647 1998
% 224.27/224.42  |- skos__altLabel mesh__D004647 Personnel Discipline
% 224.27/224.42  |- skos__hiddenLabel mesh__D004647 Discipline, Employee
% 224.27/224.42  |- skos__broader mesh__D004647smesh__D010559
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004647 1995
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004647 2006
% 224.27/224.42  |- skos__hiddenLabel mesh__D023801 Therapy, Directly Observed
% 224.27/224.42  |- mesh__dateEstablished mesh__D023801 2002-01-01
% 224.27/224.42  |- skos__scopeNote mesh__D023801
% 224.27/224.42       A treatment method in which patients are under direct observation when they take their medication or receive their treatment.  This method is designed to reduce the risk of treatment interruption and to ensure patient compliance.%A%    
% 224.27/224.42  |- skos__related mesh__D023801smesh__D010349
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D023801 2004
% 224.27/224.42  |- mesh__historyNote mesh__D023801 2002   
% 224.27/224.42  |- mesh__dateCreated mesh__D023801 2001-07-25
% 224.27/224.42  |- mesh__publicMeSHNote mesh__D023801 2002   
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D023801 2006
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D023801 2003
% 224.27/224.42  |- rdf__type mesh__D023801sskos__Concept
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D023801 2002
% 224.27/224.42  |- skos__prefLabel mesh__D023801 Directly Observed Therapy
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D023801 2005
% 224.27/224.42  |- skos__historyNote mesh__D023801 Patient Compliance %28%1992-2001%29%
% 224.27/224.42  |- skos__broader mesh__D023801smesh__D013812
% 224.27/224.42  |- skos__hiddenLabel mesh__D009332 Necatoriases
% 224.27/224.42  |- mesh__recordOriginator mesh__D009332 NLM
% 224.27/224.42  |- mesh__dateEstablished mesh__D009332 1979-01-01
% 224.27/224.42  |- mesh__historyNote mesh__D009332
% 224.27/224.42       79%28%75%29%; was see under HOOKWORM INFECTIONS 1973-78, was see under HOOKWORM INFECTION 1967-72%A%  
% 224.27/224.42  |- mesh__onlineNote mesh__D009332 search HOOKWORM INFECTIONS 1967-74   
% 224.27/224.42  |- rdf__type mesh__D009332sskos__Concept
% 224.27/224.42  |- mesh__dateRevised mesh__D009332 2004-07-13
% 224.27/224.42  |- mesh__recordAuthorizer mesh__D009332 sjn
% 224.27/224.42  |- skos__historyNote mesh__D009332 Hookworm Infections %28%1966-1978%29%
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D009332 2006
% 224.27/224.42  |- skos__scopeNote mesh__D009332
% 224.27/224.42       Infection of humans or animals with hookworms of the genus NECATOR. The resulting anemia from this condition is less severe than that from ANCYLOSTOMIASIS.%A%    
% 224.27/224.42  |- skos__annotation mesh__D009332 hookworm infect; human %26% animal   
% 224.27/224.42  |- mesh__publicMeSHNote mesh__D009332
% 224.27/224.42       79; was see under HOOKWORM INFECTIONS 1973-78, was see under HOOKWORM INFECTION 1967-72%A%  
% 224.27/224.42  |- skos__broader mesh__D009332smesh__D006725
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D009332 2005
% 224.27/224.42  |- mesh__dateCreated mesh__D009332 1999-01-01
% 224.27/224.42  |- mesh__recordMaintainer mesh__D009332 sjn
% 224.27/224.42  |- skos__prefLabel mesh__D009332 Necatoriasis
% 224.27/224.42  |- mesh__recordOriginator mesh__D014277 NLM
% 224.27/224.42  |- skos__hiddenLabel mesh__D014277 Idiopathic Trigeminal Neuralgia
% 224.27/224.42  |- mesh__dateCreated mesh__D014277 1999-01-01
% 224.27/224.42  |- skos__hiddenLabel mesh__D014277 Secondary Trigeminal Neuralgias
% 224.27/224.42  |- skos__hiddenLabel mesh__D014277 Trigeminal Neuralgias
% 224.27/224.42  |- skos__hiddenLabel mesh__D014277 Idiopathic Trigeminal Neuralgias
% 224.27/224.42  |- skos__hiddenLabel mesh__D014277 Neuralgias, Trigeminal
% 224.27/224.42  |- skos__hiddenLabel mesh__D014277 Neuralgias, Trifacial
% 224.27/224.42  |- mesh__dateRevised mesh__D014277 2004-08-02
% 224.27/224.42  |- skos__hiddenLabel mesh__D014277 Neuralgia, Trigeminal
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D014277 2004
% 224.27/224.42  |- skos__hiddenLabel mesh__D014277 Neuralgia, Epileptiform
% 224.27/224.42  |- skos__hiddenLabel mesh__D014277 Neuralgias, Secondary Trigeminal
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D014277 2002
% 224.27/224.42  |- skos__broader mesh__D014277smesh__D020433
% 224.27/224.42  |- skos__hiddenLabel mesh__D014277 Neuralgia, Secondary Trigeminal
% 224.27/224.42  |- skos__altLabel mesh__D014277 Epileptiform Neuralgia
% 224.27/224.42  |- rdf__type mesh__D014277sskos__Concept
% 224.27/224.42  |- mesh__recordMaintainer mesh__D014277 jls
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D014277 2003
% 224.27/224.42  |- skos__altLabel mesh__D014277 Trifacial Neuralgia
% 224.27/224.42  |- skos__hiddenLabel mesh__D014277 Neuralgias, Epileptiform
% 224.27/224.42  |- skos__hiddenLabel mesh__D014277 Trigeminal Neuralgias, Secondary
% 224.27/224.42  |- skos__altLabel mesh__D014277 Tic Douloureux
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D014277 2006
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D014277 2001
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D014277 2005A
% 224.27/224.42  |- skos__hiddenLabel mesh__D014277 Neuralgia, Trifacial
% 224.27/224.42  |- skos__hiddenLabel mesh__D014277 Neuralgia, Idiopathic Trigeminal
% 224.27/224.42  |- skos__hiddenLabel mesh__D014277 Trifacial Neuralgias
% 224.27/224.42  |- skos__hiddenLabel mesh__D014277 Trigeminal Neuralgias, Idiopathic
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D014277 2005
% 224.27/224.42  |- skos__hiddenLabel mesh__D014277 Epileptiform Neuralgias
% 224.27/224.42  |- mesh__recordAuthorizer mesh__D014277 jls
% 224.27/224.42  |- skos__scopeNote mesh__D014277
% 224.27/224.42       A syndrome characterized by recurrent episodes of excruciating pain lasting several seconds or longer in the sensory distribution of the trigeminal nerve. Pain may be initiated by stimulation of trigger points on the face, lips, or gums or by movement of facial muscles or chewing. Associated conditions include MULTIPLE SCLEROSIS, vascular anomalies, ANEURYSMS, and neoplasms. %28%Adams et al., Principles of Neurology, 6th ed, p187%29%%A%    
% 224.27/224.42  |- skos__hiddenLabel mesh__D014277 Disease, Fothergill
% 224.27/224.42  |- skos__altLabel mesh__D014277 Trigeminal Neuralgia, Secondary
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D014277 2000
% 224.27/224.42  |- skos__prefLabel mesh__D014277 Trigeminal Neuralgia
% 224.27/224.42  |- skos__hiddenLabel mesh__D014277 Neuralgias, Idiopathic Trigeminal
% 224.27/224.42  |- skos__altLabel mesh__D014277 Fothergill Disease
% 224.27/224.42  |- skos__hiddenLabel mesh__D019760 Amidine Lyases
% 224.27/224.42  |- rdf__type mesh__D019760sskos__Concept
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D019760 2004
% 224.27/224.42  |- mesh__dateCreated mesh__D019760 1997-06-20
% 224.27/224.42  |- mesh__dateEstablished mesh__D019760 1998-01-01
% 224.27/224.42  |- mesh__historyNote mesh__D019760 98   
% 224.27/224.42  |- skos__prefLabel mesh__D019760 Amidine-Lyases
% 224.27/224.42  |- mesh__dateRevised mesh__D019760 2003-07-09
% 224.27/224.42  |- skos__historyNote mesh__D019760 Lyases %28%1966-1997%29%
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D019760 2005
% 224.27/224.42  |- skos__scopeNote mesh__D019760
% 224.27/224.42       These enzymes catalyze the elimination of ammonia from amidines with the formation of a double bond. EC 4.3.2.%A%    
% 224.27/224.42  |- mesh__publicMeSHNote mesh__D019760 98   
% 224.27/224.42  |- skos__broader mesh__D019760smesh__D019759
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D019760 2006
% 224.27/224.42  |- skos__altLabel mesh__D000257 Infections, Adenovirus
% 224.27/224.42  |- skos__broader mesh__D000257smesh__D004266
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D000257 2005
% 224.27/224.42  |- skos__hiddenLabel mesh__D000257 Infection, Adenovirus
% 224.27/224.42  |- skos__hiddenLabel mesh__D000257 Adenovirus Infection
% 224.27/224.42  |- mesh__dateRevised mesh__D000257 2004-07-13
% 224.27/224.42  |- mesh__historyNote mesh__D000257 94; was ADENOVIRUS INFECTIONS 1963-93   
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D000257 2006
% 224.27/224.42  |- mesh__recordAuthorizer mesh__D000257 sjn
% 224.27/224.42  |- mesh__recordOriginator mesh__D000257 NLM
% 224.27/224.42  |- skos__hiddenLabel mesh__D000257 Infection, Adenoviridae
% 224.27/224.42  |- skos__altLabel mesh__D000257 Adenovirus Infections
% 224.27/224.42  |- rdf__type mesh__D000257sskos__Concept
% 224.27/224.42  |- skos__hiddenLabel mesh__D000257 Adenoviridae Infection
% 224.27/224.42  |- skos__annotation mesh__D000257
% 224.27/224.42       GEN or unspecified; prefer specifics; ADENOVIRUS INFECTIONS, HUMAN is available%A%  
% 224.27/224.42  |- mesh__onlineNote mesh__D000257
% 224.27/224.42       use ADENOVIRIDAE INFECTIONS to search ADENOVIRUS INFECTIONS 1966-93%A%  
% 224.27/224.42  |- mesh__publicMeSHNote mesh__D000257
% 224.27/224.42       94; was ADENOVIRUS INFECTIONS 1963-93   
% 224.27/224.42  |- skos__scopeNote mesh__D000257
% 224.27/224.42       Virus diseases caused by the ADENOVIRIDAE.     
% 224.27/224.42  |- skos__prefLabel mesh__D000257 Adenoviridae Infections
% 224.27/224.42  |- skos__altLabel mesh__D000257 Infections, Adenoviridae
% 224.27/224.42  |- mesh__dateCreated mesh__D000257 1999-01-01
% 224.27/224.42  |- mesh__recordMaintainer mesh__D000257 sjn
% 224.27/224.42  |- mesh__recordOriginator mesh__D005740 NLM
% 224.27/224.42  |- skos__annotation mesh__D005740
% 224.27/224.42       does not include natural gas %28% = GAS, NATURAL see FOSSIL FUELS%29%; does not include blood gases %28% = OXYGEN /blood or CARBON DIOXIDE /blood%29%; gas embolism = EMBOLISM, AIR; intestinal gases = GASES + INTESTINES /physiol unless clinically referred to as FLATULENCE %28%Cat C%29%%A%  
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D005740 2004
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D005740 2002
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D005740 2006
% 224.27/224.42  |- mesh__dateRevised mesh__D005740 1995-03-17
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D005740 2003
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D005740 2001
% 224.27/224.42  |- mesh__recordMaintainer mesh__D005740 TGC
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D005740 2005
% 224.27/224.42  |- skos__scopeNote mesh__D005740
% 224.27/224.42       The vapor state of matter; nonelastic fluids in which the molecules are in free movement and their mean positions far apart. Gases tend to expand indefinitely, to diffuse and mix readily with other gases, to have definite relations of volume, temperature, and pressure, and to condense or liquefy at low temperatures or under sufficient pressure. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 224.27/224.42  |- mesh__dateCreated mesh__D005740 1999-01-01
% 224.27/224.42  |- rdf__type mesh__D005740sskos__Concept
% 224.27/224.42  |- mesh__recordAuthorizer mesh__D005740 PLS
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D005740 2000
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D005740 1997
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D005740 1999
% 224.27/224.42  |- skos__broader mesh__D005740smesh__D007287
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D005740 1996
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D005740 1998
% 224.27/224.42  |- skos__prefLabel mesh__D005740 Gases
% 224.27/224.42  |- mesh__historyNote mesh__D018668 95   
% 224.27/224.42  |- skos__altLabel mesh__D018668 Muntiacus
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D018668 2005
% 224.27/224.42  |- skos__broader mesh__D018668smesh__D003670
% 224.27/224.42  |- skos__altLabel mesh__D018668 Muntjaks
% 224.27/224.42  |- mesh__dateRevised mesh__D018668 2003-07-09
% 224.27/224.42  |- mesh__dateCreated mesh__D018668 1994-04-16
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D018668 2006
% 224.27/224.42  |- mesh__recordOriginator mesh__D018668 TGC
% 224.27/224.42  |- skos__hiddenLabel mesh__D018668 Muntjak
% 224.27/224.42  |- mesh__dateEstablished mesh__D018668 1995-01-01
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D018668 2004
% 224.27/224.42  |- skos__hiddenLabel mesh__D018668 Muntjac
% 224.27/224.42  |- mesh__recordMaintainer mesh__D018668 ags
% 224.27/224.42  |- mesh__publicMeSHNote mesh__D018668 95   
% 224.27/224.42  |- rdf__type mesh__D018668sskos__Concept
% 224.27/224.42  |- skos__annotation mesh__D018668 species of deer;IM; qualif permitted   
% 224.27/224.42  |- skos__historyNote mesh__D018668 Deer %28%1970-1994%29%
% 224.27/224.42  |- skos__scopeNote mesh__D018668
% 224.27/224.42       A genus, Muntiacus, of the deer family %28%Cervidae%29% comprising six species living in China, Tibet, Nepal, India, the Malay Peninsula, and neighboring island countries. They are usually found in forests and areas of dense vegetation, usually not far from water. They emit a deep barklike sound which gives them the name %22%barking deer.%22% If they sense a predator they will %22%bark%22% for an hour or more. They are hunted for their meat and skins; they thrive in captivity and are found in many zoos. The Indian muntjac is believed to have the lowest chromosome number in mammals and cell lines derived from them figure widely in chromosome and DNA studies. %28%From Walker%27%s Mammals of the World, 5th ed., p1366%29%%A%    
% 224.27/224.42  |- mesh__recordAuthorizer mesh__D018668 sjn
% 224.27/224.42  |- skos__prefLabel mesh__D018668 Muntjacs
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D010685 1994
% 224.27/224.42  |- skos__annotation mesh__D010685 DF: PHILOSOPHY DENT   
% 224.27/224.42  |- skos__historyNote mesh__D010685 appropriate dental heading
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D010685 2006
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D010685 2000
% 224.27/224.42  |- mesh__dateCreated mesh__D010685 1999-01-01
% 224.27/224.42  |- skos__altLabel mesh__D010685 Dental Philosophy
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D010685 1998
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D010685 2003
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D010685 1995
% 224.27/224.42  |- skos__altLabel mesh__D010685 Dental Philosophies
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D010685 2001
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D010685 1999
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D010685 2004
% 224.27/224.42  |- skos__altLabel mesh__D010685 Philosophies, Dental
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D010685 1996
% 224.27/224.42  |- mesh__dateRevised mesh__D010685 1992-05-18
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D010685 1993
% 224.27/224.42  |- rdf__type mesh__D010685sskos__Concept
% 224.27/224.42  |- skos__historyNote mesh__D010685 Philosophy %28%1966-1970%29%
% 224.27/224.42  |- mesh__recordMaintainer mesh__D010685 TAP
% 224.27/224.42  |- mesh__publicMeSHNote mesh__D010685 74   
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D010685 1997
% 224.27/224.42  |- mesh__historyNote mesh__D010685 74%28%71%29%   
% 224.27/224.42  |- skos__broader mesh__D010685smesh__D010684
% 224.27/224.42  |- mesh__recordOriginator mesh__D010685 NLM
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D010685 2002
% 224.27/224.42  |- mesh__dateEstablished mesh__D010685 1974-01-01
% 224.27/224.42  |- mesh__recordAuthorizer mesh__D010685 PLS
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D010685 2005
% 224.27/224.42  |- skos__prefLabel mesh__D010685 Philosophy, Dental
% 224.27/224.42  |- mesh__dateEstablished mesh__D004648 1991-01-01
% 224.27/224.42  |- skos__altLabel mesh__D004648 Grievances, Employee
% 224.27/224.42  |- mesh__recordMaintainer mesh__D004648 TGC
% 224.27/224.42  |- skos__broader mesh__D004648smesh__D010559
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004648 1996
% 224.27/224.42  |- skos__hiddenLabel mesh__D004648 Grievance, Employee
% 224.27/224.42  |- mesh__dateCreated mesh__D004648 1977-05-05
% 224.27/224.42  |- mesh__historyNote mesh__D004648
% 224.27/224.42       91%28%Aug 77%29%; was see under PERSONNEL MANAGEMENT 1977-90   
% 224.27/224.42  |- skos__hiddenLabel mesh__D004648 Employee Grievance
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004648 2002
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004648 2004
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004648 1999
% 224.27/224.42  |- mesh__recordOriginator mesh__D004648 EC
% 224.27/224.42  |- skos__scopeNote mesh__D004648
% 224.27/224.42       Formal procedures whereby the employee expresses any dissatisfaction or feeling of injustice regarding the work situation.%A%    
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004648 2003
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004648 1998
% 224.27/224.42  |- skos__annotation mesh__D004648 med or non-med personnel   
% 224.27/224.42  |- mesh__recordAuthorizer mesh__D004648 PLS
% 224.27/224.42  |- mesh__publicMeSHNote mesh__D004648
% 224.27/224.42       91; was see under PERSONNEL MANAGEMENT Aug 1977-90   
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004648 2001
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004648 1995
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004648 2006
% 224.27/224.42  |- skos__prefLabel mesh__D004648 Employee Grievances
% 224.27/224.42  |- rdf__type mesh__D004648sskos__Concept
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004648 2000
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004648 1997
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D004648 2005
% 224.27/224.42  |- mesh__dateRevised mesh__D004648 1994-05-05
% 224.27/224.42  |- skos__hiddenLabel mesh__D015370 Seat, Car
% 224.27/224.42  |- skos__altLabel mesh__D015370 Baby Equipment
% 224.27/224.42  |- skos__broader mesh__D015370smesh__D004864
% 224.27/224.42  |- skos__hiddenLabel mesh__D015370 Walkers, Baby
% 224.27/224.42  |- skos__altLabel mesh__D015370 Baby Swings
% 224.27/224.42  |- skos__hiddenLabel mesh__D015370 High Chair
% 224.27/224.42  |- skos__hiddenLabel mesh__D015370 Chairs, High
% 224.27/224.42  |- skos__hiddenLabel mesh__D015370 Swing, Infant
% 224.27/224.42  |- mesh__recordOriginator mesh__D015370 RLS
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D015370 1996
% 224.27/224.42  |- skos__hiddenLabel mesh__D015370 Baby Swing
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D015370 2004
% 224.27/224.42  |- skos__hiddenLabel mesh__D015370 Walker, Baby
% 224.27/224.42  |- skos__scopeNote mesh__D015370
% 224.27/224.42       Equipment and furniture used by infants and babies in the home, car, and play area.%A%    
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D015370 2002
% 224.27/224.42  |- mesh__dateCreated mesh__D015370 1988-06-03
% 224.27/224.42  |- skos__hiddenLabel mesh__D015370 Car Seat
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D015370 1999
% 224.27/224.42  |- skos__hiddenLabel mesh__D015370 Infant Stroller
% 224.27/224.42  |- skos__altLabel mesh__D015370 Baby Strollers
% 224.27/224.42  |- skos__hiddenLabel mesh__D015370 Equipment, Baby
% 224.27/224.42  |- mesh__activeMeSHYear mesh__D015370 1993
% 224.29/224.43  |- skos__hiddenLabel mesh__D015370 Strollers, Baby
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D015370 2003
% 224.29/224.43  |- skos__altLabel mesh__D015370 Baby Walkers
% 224.29/224.43  |- mesh__recordAuthorizer mesh__D015370 PLS
% 224.29/224.43  |- skos__hiddenLabel mesh__D015370 Walker, Infant
% 224.29/224.43  |- skos__hiddenLabel mesh__D015370 Walkers, Infant
% 224.29/224.43  |- skos__hiddenLabel mesh__D015370 Infant Swing
% 224.29/224.43  |- skos__hiddenLabel mesh__D015370 Swing, Baby
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D015370 1995
% 224.29/224.43  |- mesh__historyNote mesh__D015370 89   
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D015370 1998
% 224.29/224.43  |- skos__hiddenLabel mesh__D015370 Baby Walker
% 224.29/224.43  |- mesh__publicMeSHNote mesh__D015370 89   
% 224.29/224.43  |- skos__hiddenLabel mesh__D015370 Swings, Baby
% 224.29/224.43  |- skos__hiddenLabel mesh__D015370 Strollers, Infant
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D015370 2006
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D015370 2001
% 224.29/224.43  |- skos__hiddenLabel mesh__D015370 Seats, Car
% 224.29/224.43  |- skos__altLabel mesh__D015370 Equipment, Infant
% 224.29/224.43  |- skos__hiddenLabel mesh__D015370 Stroller, Baby
% 224.29/224.43  |- skos__historyNote mesh__D015370 Equipment and Supplies %28%1966-1988%29%
% 224.29/224.43  |- skos__hiddenLabel mesh__D015370 Baby Stroller
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D015370 1994
% 224.29/224.43  |- mesh__dateRevised mesh__D015370 1992-05-14
% 224.29/224.43  |- skos__hiddenLabel mesh__D015370 Infant Walker
% 224.29/224.43  |- skos__prefLabel mesh__D015370 Infant Equipment
% 224.29/224.43  |- mesh__dateEstablished mesh__D015370 1989-01-01
% 224.29/224.43  |- mesh__recordMaintainer mesh__D015370 TAP
% 224.29/224.43  |- skos__hiddenLabel mesh__D015370 Crib
% 224.29/224.43  |- skos__hiddenLabel mesh__D015370 Swings, Infant
% 224.29/224.43  |- skos__hiddenLabel mesh__D015370 Chair, High
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D015370 2005
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D015370 2000
% 224.29/224.43  |- skos__hiddenLabel mesh__D015370 Stroller, Infant
% 224.29/224.43  |- skos__hiddenLabel mesh__D015370 Furniture, Infant
% 224.29/224.43  |- rdf__type mesh__D015370sskos__Concept
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D015370 1997
% 224.29/224.43  |- mesh__recordAuthorizer mesh__D023802 sjn
% 224.29/224.43  |- skos__hiddenLabel mesh__D023802 Uterine Cervix Cerclage
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D023802 2004
% 224.29/224.43  |- mesh__dateCreated mesh__D023802 2001-08-03
% 224.29/224.43  |- skos__altLabel mesh__D023802 Cerclage of Cervix
% 224.29/224.43  |- mesh__publicMeSHNote mesh__D023802 2002   
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D023802 2006
% 224.29/224.43  |- skos__scopeNote mesh__D023802
% 224.29/224.43       The surgical closure of the incompetent cervix uteri with suture material.%A%    
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D023802 2003
% 224.29/224.43  |- mesh__recordOriginator mesh__D023802 lkt
% 224.29/224.43  |- skos__broader mesh__D023802smesh__D013513
% 224.29/224.43  |- rdf__type mesh__D023802sskos__Concept
% 224.29/224.43  |- skos__altLabel mesh__D023802 Cerclage of Uterine Cervix
% 224.29/224.43  |- skos__prefLabel mesh__D023802 Cerclage, Cervical
% 224.29/224.43  |- skos__altLabel mesh__D023802 Cervical Cerclage
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D023802 2005
% 224.29/224.43  |- mesh__recordMaintainer mesh__D023802 jls
% 224.29/224.43  |- mesh__historyNote mesh__D023802 2002   
% 224.29/224.43  |- skos__historyNote mesh__D023802 Cervix Incompetence %28%1973-2001%29%
% 224.29/224.43  |- mesh__dateEstablished mesh__D023802 2002-01-01
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D023802 2002
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D009333 2003
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D009333 1999
% 224.29/224.43  |- skos__prefLabel mesh__D009333 Neck
% 224.29/224.43  |- mesh__considerAlso mesh__D009333
% 224.29/224.43       consider also terms at CERVICAL and CERVICO-   
% 224.29/224.43  |- skos__hiddenLabel mesh__D009333 Necks
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D009333 2004
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D009333 2001
% 224.29/224.43  |- skos__broader mesh__D009333smesh__D001829
% 224.29/224.43  |- mesh__recordAuthorizer mesh__D009333 SJN
% 224.29/224.43  |- rdf__type mesh__D009333sskos__Concept
% 224.29/224.43  |- mesh__recordMaintainer mesh__D009333 TGC
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D009333 2002
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D009333 2005
% 224.29/224.43  |- mesh__dateCreated mesh__D009333 1999-01-01
% 224.29/224.43  |- skos__related mesh__D009333smesh__D002574
% 224.29/224.43  |- mesh__recordOriginator mesh__D009333 NLM
% 224.29/224.43  |- skos__annotation mesh__D009333
% 224.29/224.43       as a region %26% for soft parts but note that NECK MUSCLES is also available; bones = CERVICAL VERTEBRAE; %22%cervical lymph nodes%22% = LYMPH NODES %28%IM%29% + NECK %28%NIM%29%; %22%pterygium colli%22%: index under NECK /abnorm; %22%neck dissection%22% probably refers to dissection of lymph nodes in cancer: index under LYMPH NODE EXCISION %28%IM%29% + NECK %28%NIM%29% for general or unspecified or RADICAL NECK DISSECTION if so specified%A%  
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D009333 2006
% 224.29/224.43  |- skos__related mesh__D009333smesh__D009334
% 224.29/224.43  |- mesh__dateRevised mesh__D009333 1997-06-20
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D009333 1998
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D009333 2000
% 224.29/224.43  |- skos__altLabel mesh__D001350 Encephalomyelitis-like Virus, Avian
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D001350 2004
% 224.29/224.43  |- mesh__publicMeSHNote mesh__D001350
% 224.29/224.43       94; was AVIAN ENCEPHALOMYELITIS VIRUS 1975-93 %28%see under ENTEROVIRUSES 1975-90%29%%A%  
% 224.29/224.43  |- mesh__historyNote mesh__D001350
% 224.29/224.43       94; was AVIAN ENCEPHALOMYELITIS VIRUS 1975-93 %28%see under ENTEROVIRUSES 1975-90%29%%A%  
% 224.29/224.43  |- skos__altLabel mesh__D001350 Avian Encephalomyelitis Virus
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D001350 2006
% 224.29/224.43  |- mesh__dateEstablished mesh__D001350 1991-01-01
% 224.29/224.43  |- mesh__dateRevised mesh__D001350 2001-07-25
% 224.29/224.43  |- mesh__recordOriginator mesh__D001350 NLM
% 224.29/224.43  |- skos__hiddenLabel mesh__D001350 Tremor Viruses, Epidemic
% 224.29/224.43  |- skos__hiddenLabel mesh__D001350 Epidemic Tremor Viruses
% 224.29/224.43  |- skos__altLabel mesh__D001350 Avian Encephalomyelitis Viruses
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D001350 2002
% 224.29/224.43  |- rdf__type mesh__D001350sskos__Concept
% 224.29/224.43  |- mesh__onlineNote mesh__D001350
% 224.29/224.43       use ENCEPHALOMYELITIS VIRUS, AVIAN to search AVIAN ENCEPHALOMYELITIS VIRUS 1975-93%A%  
% 224.29/224.43  |- skos__altLabel mesh__D001350 Encephalomyelitis Viruses, Avian
% 224.29/224.43  |- skos__annotation mesh__D001350
% 224.29/224.43       infection: coord IM with PICORNAVIRIDAE INFECTIONS %28%IM%29%   
% 224.29/224.43  |- skos__altLabel mesh__D001350 Avian encephalomyelitis-like virus
% 224.29/224.43  |- skos__scopeNote mesh__D001350
% 224.29/224.43       A tentative species in the genus HEPATOVIRUS infecting primarily young chicks, but also found in turkeys, pheasants, and guinea fowl. It causes a fatal neuronal degeneration and is transmitted by mechanical contact.%A%    
% 224.29/224.43  |- skos__altLabel mesh__D001350 Epidemic Tremor Virus
% 224.29/224.43  |- skos__altLabel mesh__D001350 Viruses, Avian Encephalomyelitis
% 224.29/224.43  |- skos__prefLabel mesh__D001350 Encephalomyelitis Virus, Avian
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D001350 2003
% 224.29/224.43  |- mesh__recordMaintainer mesh__D001350 ags
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D001350 2005
% 224.29/224.43  |- skos__altLabel mesh__D001350 Virus, Avian Encephalomyelitis
% 224.29/224.43  |- skos__broader mesh__D001350smesh__D006507
% 224.29/224.43  |- skos__hiddenLabel mesh__D001350 Tremor Virus, Epidemic
% 224.29/224.43  |- mesh__dateCreated mesh__D001350 1974-11-19
% 224.29/224.43  |- mesh__recordAuthorizer mesh__D001350 sjn
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D014278 1995
% 224.29/224.43  |- skos__historyNote mesh__D014278 Trigeminal Nerve %28%1966-1979%29%
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D014278 2005
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D014278 2002
% 224.29/224.43  |- skos__prefLabel mesh__D014278 Trigeminal Nuclei
% 224.29/224.43  |- skos__hiddenLabel mesh__D014278 Trigeminal Nucleus
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D014278 1998
% 224.29/224.43  |- mesh__historyNote mesh__D014278 80   
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D014278 1993
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D014278 2006
% 224.29/224.43  |- skos__hiddenLabel mesh__D014278 Nucleus, Trigeminal
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D014278 2003
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D014278 1999
% 224.29/224.43  |- mesh__recordAuthorizer mesh__D014278 PLS
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D014278 1996
% 224.29/224.43  |- mesh__dateRevised mesh__D014278 1992-05-18
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D014278 2004
% 224.29/224.43  |- mesh__publicMeSHNote mesh__D014278 80   
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D014278 1997
% 224.29/224.43  |- mesh__recordOriginator mesh__D014278 RC
% 224.29/224.43  |- skos__scopeNote mesh__D014278
% 224.29/224.43       Nuclei of the trigeminal nerve situated in the brain stem. They include the nucleus of the spinal trigeminal tract %28%TRIGEMINAL NUCLEUS, SPINAL%29%, the principal sensory nucleus, the mesencephalic nucleus, and the motor nucleus.%A%    
% 224.29/224.43  |- skos__hiddenLabel mesh__D014278 Nuclei, Trigeminal
% 224.29/224.43  |- mesh__recordMaintainer mesh__D014278 TAP
% 224.29/224.43  |- mesh__dateCreated mesh__D014278 1978-12-19
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D014278 2000
% 224.29/224.43  |- skos__broader mesh__D014278smesh__D001933
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D014278 1994
% 224.29/224.43  |- rdf__type mesh__D014278sskos__Concept
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D014278 2001
% 224.29/224.43  |- mesh__dateEstablished mesh__D014278 1980-01-01
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D019761 2004
% 224.29/224.43  |- mesh__publicMeSHNote mesh__D019761 98   
% 224.29/224.43  |- skos__hiddenLabel mesh__D019761 Lyases, Phosphorus-Oxygen
% 224.29/224.43  |- skos__hiddenLabel mesh__D019761 Phosphorus Oxygen Lyases
% 224.29/224.43  |- skos__broader mesh__D019761smesh__D008190
% 224.29/224.43  |- mesh__historyNote mesh__D019761 98   
% 224.29/224.43  |- mesh__dateRevised mesh__D019761 2003-07-09
% 224.29/224.43  |- skos__scopeNote mesh__D019761
% 224.29/224.43       Enzymes that catalyze the cleavage of a phosphorus-oxygen bond by means other than hydrolysis or oxidation. EC 4.6.%A%    
% 224.29/224.43  |- mesh__dateCreated mesh__D019761 1997-06-20
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D019761 2005
% 224.29/224.43  |- mesh__dateEstablished mesh__D019761 1998-01-01
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D019761 2006
% 224.29/224.43  |- skos__prefLabel mesh__D019761 Phosphorus-Oxygen Lyases
% 224.29/224.43  |- rdf__type mesh__D019761sskos__Concept
% 224.29/224.43  |- skos__annotation mesh__D019761 DF: P O LYASES   
% 224.29/224.43  |- skos__altLabel mesh__D000258 Human Adenovirus Infections
% 224.29/224.43  |- skos__broader mesh__D000258smesh__D000257
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D000258 2006
% 224.29/224.43  |- mesh__historyNote mesh__D000258
% 224.29/224.43       91%28%77%29%; was see under ADENOVIRUS INFECTIONS 1977-90; PHARYNGO-CONJUNCTIVAL FEVER was see under ADENOVIRUS INFECTIONS 1963-76%A%  
% 224.29/224.43  |- mesh__recordMaintainer mesh__D000258 sjn
% 224.29/224.43  |- skos__prefLabel mesh__D000258 Adenovirus Infections, Human
% 224.29/224.43  |- skos__hiddenLabel mesh__D000258 Human Adenovirus Infection
% 224.29/224.43  |- skos__hiddenLabel mesh__D000258 Pharyngo Conjunctival Fever
% 224.29/224.43  |- rdf__type mesh__D000258sskos__Concept
% 224.29/224.43  |- skos__hiddenLabel mesh__D000258 Adenovirus Infection, Human
% 224.29/224.43  |- mesh__publicMeSHNote mesh__D000258
% 224.29/224.43       91; was see under ADENOVIRUS INFECTIONS 1977-90; PHARYNGO-CONJUNCTIVAL FEVER was see under ADENOVIRUS INFECTIONS 1963-76%A%  
% 224.29/224.43  |- mesh__dateRevised mesh__D000258 2004-07-13
% 224.29/224.43  |- skos__hiddenLabel mesh__D000258 Fever, Pharyngo-Conjunctival
% 224.29/224.43  |- mesh__dateEstablished mesh__D000258 1991-01-01
% 224.29/224.43  |- mesh__recordAuthorizer mesh__D000258 sjn
% 224.29/224.43  |- mesh__recordOriginator mesh__D000258 NLM
% 224.29/224.43  |- mesh__dateCreated mesh__D000258 1999-01-01
% 224.29/224.43  |- skos__hiddenLabel mesh__D000258 Infection, Human Adenovirus
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D000258 2005
% 224.29/224.43  |- skos__scopeNote mesh__D000258
% 224.29/224.43       Respiratory and conjunctival infections caused by 33 identified serotypes of human adenoviruses.%A%    
% 224.29/224.43  |- skos__altLabel mesh__D000258 Infections, Human Adenovirus
% 224.29/224.43  |- mesh__onlineNote mesh__D000258
% 224.29/224.43       use ADENOVIRUS INFECTIONS, HUMAN to search PHARYNGO-CONJUNCTIVAL FEVER 1977-present; use ADENOVIRUS INFECTIONS 1966-76%A%  
% 224.29/224.43  |- skos__hiddenLabel mesh__D005741 Elements, Group 18
% 224.29/224.43  |- skos__altLabel mesh__D005741 Gases, Inert
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D005741 2004
% 224.29/224.43  |- skos__broader mesh__D005741smesh__D005740
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D005741 2002
% 224.29/224.43  |- skos__historyNote mesh__D005741 Gases %28%1966-1975%29%
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D005741 2006
% 224.29/224.43  |- skos__hiddenLabel mesh__D005741 Inert Gases
% 224.29/224.43  |- skos__prefLabel mesh__D005741 Noble Gases
% 224.29/224.43  |- skos__altLabel mesh__D005741 Gases, Rare
% 224.29/224.43  |- mesh__historyNote mesh__D005741
% 224.29/224.43       94; was GASES, RARE 1976-93; was RARE GASES %28%NON MESH%29% 1971-76%A%  
% 224.29/224.43  |- skos__hiddenLabel mesh__D005741 Gases, Noble
% 224.29/224.43  |- mesh__recordAuthorizer mesh__D005741 sjn
% 224.29/224.43  |- mesh__dateCreated mesh__D005741 1975-07-25
% 224.29/224.43  |- skos__altLabel mesh__D005741 Group 18 Elements
% 224.29/224.43  |- rdf__type mesh__D005741sskos__Concept
% 224.29/224.43  |- skos__broader mesh__D005741smesh__D004602
% 224.29/224.43  |- mesh__dateRevised mesh__D005741 2001-07-25
% 224.29/224.43  |- skos__altLabel mesh__D005741 Rare Gases
% 224.29/224.43  |- skos__annotation mesh__D005741 GEN or unspecified; prefer specifics   
% 224.29/224.43  |- mesh__recordMaintainer mesh__D005741 jmp
% 224.29/224.43  |- mesh__onlineNote mesh__D005741
% 224.29/224.43       use NOBLE GASES to search GASES, RARE 1976-93   
% 224.29/224.43  |- skos__scopeNote mesh__D005741
% 224.29/224.43       Elements that constitute group 18 %28%formerly the zero group%29% of the periodic table. They are gases that generally do not react chemically.%A%    
% 224.29/224.43  |- mesh__recordOriginator mesh__D005741 RLS
% 224.29/224.43  |- mesh__dateEstablished mesh__D005741 1977-01-01
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D005741 2003
% 224.29/224.43  |- mesh__publicMeSHNote mesh__D005741 94; was GASES, RARE 1976-93   
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D005741 2005
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D010686 2004
% 224.29/224.43  |- mesh__recordMaintainer mesh__D010686 TAP
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D010686 1996
% 224.29/224.43  |- mesh__dateRevised mesh__D010686 1992-05-18
% 224.29/224.43  |- mesh__recordOriginator mesh__D010686 NLM
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D010686 2002
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D010686 1993
% 224.29/224.43  |- skos__prefLabel mesh__D010686 Philosophy, Medical
% 224.29/224.43  |- mesh__recordAuthorizer mesh__D010686 PLS
% 224.29/224.43  |- rdf__type mesh__D010686sskos__Concept
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D010686 1997
% 224.29/224.43  |- skos__altLabel mesh__D010686 Medical Philosophy
% 224.29/224.43  |- skos__broader mesh__D010686smesh__D010684
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D010686 2005
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D010686 2000
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D010686 1994
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D010686 2006
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D010686 2001
% 224.29/224.43  |- mesh__dateCreated mesh__D010686 1999-01-01
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D010686 1998
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D010686 2003
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D010686 1995
% 224.29/224.43  |- skos__annotation mesh__D010686 DF: PHILOSOPHY MED   
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D010686 1999
% 224.29/224.43  |- skos__altLabel mesh__D004649 Incentive Plans, Employee
% 224.29/224.43  |- skos__hiddenLabel mesh__D004649 Plans, Employee Incentive
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D004649 2001
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D004649 2003
% 224.29/224.43  |- mesh__activeMeSHYear mesh__D004649 1998
% 224.29/224.44  |- mesh__dateCreated mesh__D004649 1978-05-08
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D004649 2002
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D004649 2004
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D004649 1999
% 224.29/224.44  |- mesh__historyNote mesh__D004649
% 224.29/224.44       91%28%79%29%; was see under PERSONNEL MANAGEMENT 1979-90   
% 224.29/224.44  |- skos__hiddenLabel mesh__D004649 Incentive Plan, Employee
% 224.29/224.44  |- mesh__dateEstablished mesh__D004649 1991-01-01
% 224.29/224.44  |- skos__broader mesh__D004649smesh__D010559
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D004649 2005
% 224.29/224.44  |- mesh__recordAuthorizer mesh__D004649 PLS
% 224.29/224.44  |- mesh__recordOriginator mesh__D004649 EC
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D004649 1995
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D004649 1996
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D004649 2006
% 224.29/224.44  |- rdf__type mesh__D004649sskos__Concept
% 224.29/224.44  |- mesh__recordMaintainer mesh__D004649 TGC
% 224.29/224.44  |- skos__hiddenLabel mesh__D004649 Employee Incentive Plan
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D004649 2000
% 224.29/224.44  |- mesh__publicMeSHNote mesh__D004649
% 224.29/224.44       91; was see under PERSONNEL MANAGEMENT 1979-90   
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D004649 1997
% 224.29/224.44  |- skos__annotation mesh__D004649 med or non-med personnel   
% 224.29/224.44  |- skos__hiddenLabel mesh__D004649 Plan, Employee Incentive
% 224.29/224.44  |- skos__prefLabel mesh__D004649 Employee Incentive Plans
% 224.29/224.44  |- mesh__dateRevised mesh__D004649 1994-05-05
% 224.29/224.44  |- skos__scopeNote mesh__D004649
% 224.29/224.44       Programs designed by management to motivate employees to work more efficiently with increased productivity, and greater employee satisfaction.%A%    
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009334 2004
% 224.29/224.44  |- rdf__type mesh__D009334sskos__Concept
% 224.29/224.44  |- mesh__recordAuthorizer mesh__D009334 sjn
% 224.29/224.44  |- skos__historyNote mesh__D009334 Neck %28%1966-1978%29%
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009334 2005
% 224.29/224.44  |- skos__scopeNote mesh__D009334
% 224.29/224.44       The neck muscles consist of the platysma, splenius cervicis, sternocleidomastoid%28%eus%29%, longus colli, the anterior, medius, and posterior scalenes, digastric%28%us%29%, stylohyoid%28%eus%29%, mylohyoid%28%eus%29%, geniohyoid%28%eus%29%, sternohyoid%28%eus%29%, omohyoid%28%eus%29%, sternothyroid%28%eus%29%, and thyrohyoid%28%eus%29%.%A%    
% 224.29/224.44  |- skos__hiddenLabel mesh__D009334 Muscle, Neck
% 224.29/224.44  |- mesh__dateRevised mesh__D009334 2001-07-25
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009334 2006
% 224.29/224.44  |- skos__prefLabel mesh__D009334 Neck Muscles
% 224.29/224.44  |- mesh__dateEstablished mesh__D009334 1991-01-01
% 224.29/224.44  |- skos__hiddenLabel mesh__D009334 Neck Muscle
% 224.29/224.44  |- skos__broader mesh__D009334smesh__D018482
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009334 2002
% 224.29/224.44  |- mesh__historyNote mesh__D009334
% 224.29/224.44       91%28%79%29%; was see under MUSCLES 1979-90   
% 224.29/224.44  |- skos__annotation mesh__D009334
% 224.29/224.44       restrict to muscles of the neck as specified by MeSH definition: do not use for or include muscles of organs located in the neck, as the larynx %28%LARYNGEAL MUSCLES%29% or pharynx %28%PHARYNGEAL MUSCLES%29%; /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 224.29/224.44  |- mesh__recordOriginator mesh__D009334 RC
% 224.29/224.44  |- skos__historyNote mesh__D009334 Muscles %28%1966-1978%29%
% 224.29/224.44  |- mesh__dateCreated mesh__D009334 1978-05-19
% 224.29/224.44  |- mesh__publicMeSHNote mesh__D009334 91; was see under MUSCLES 1979-90   
% 224.29/224.44  |- mesh__recordMaintainer mesh__D009334 nns
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009334 2003
% 224.29/224.44  |- skos__hiddenLabel mesh__D009334 Muscles, Neck
% 224.29/224.44  |- mesh__historyNote mesh__D001351 2002 %28%1975%29%   
% 224.29/224.44  |- rdf__type mesh__D001351sskos__Concept
% 224.29/224.44  |- skos__broader mesh__D001351smesh__D017934
% 224.29/224.44  |- mesh__dateCreated mesh__D001351 1974-11-19
% 224.29/224.44  |- skos__hiddenLabel mesh__D001351 bronchitis viruses, Infectious
% 224.29/224.44  |- mesh__publicMeSHNote mesh__D001351
% 224.29/224.44       2002; see INFECTIOUS BRONCHITIS VIRUS, AVIAN 1994-2001, see AVIAN INFECTIOUS BRONCHITIS VIRUS 1991-1993, see CORONAVIRIDAE 1981-1990, see  CORONAVIRUSES 1975-1980%A%  
% 224.29/224.44  |- mesh__recordAuthorizer mesh__D001351 sjn
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D001351 2003
% 224.29/224.44  |- skos__hiddenLabel mesh__D001351 Infectious bronchitis viruses
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D001351 2005
% 224.29/224.44  |- mesh__dateRevised mesh__D001351 2001-07-25
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D001351 2004
% 224.29/224.44  |- mesh__recordMaintainer mesh__D001351 ags
% 224.29/224.44  |- mesh__recordOriginator mesh__D001351 NLM
% 224.29/224.44  |- skos__altLabel mesh__D001351 Avian Infectious Bronchitis Virus
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D001351 2006
% 224.29/224.44  |- skos__annotation mesh__D001351
% 224.29/224.44       infection: coord IM with CORONAVIRUS INFECTIONS %28%IM%29%; DF: INFECT BRONCHITIS VIRUS%A%  
% 224.29/224.44  |- skos__altLabel mesh__D001351 Infectious Bronchitis Virus, Avian
% 224.29/224.44  |- skos__hiddenLabel mesh__D001351 bronchitis virus, Infectious
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D001351 2002
% 224.29/224.44  |- skos__scopeNote mesh__D001351
% 224.29/224.44       A species of CORONAVIRUS causing infections in chickens and possibly pheasants. Chicks up to four weeks old are the most severely affected.%A%    
% 224.29/224.44  |- skos__prefLabel mesh__D001351 Infectious bronchitis virus
% 224.29/224.44  |- mesh__dateEstablished mesh__D001351 1991-01-01
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D014279 1994
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D014279 2001
% 224.29/224.44  |- skos__broader mesh__D014279smesh__D014278
% 224.29/224.44  |- mesh__dateCreated mesh__D014279 1981-05-20
% 224.29/224.44  |- mesh__recordMaintainer mesh__D014279 TAP
% 224.29/224.44  |- rdf__type mesh__D014279sskos__Concept
% 224.29/224.44  |- skos__hiddenLabel mesh__D014279 Spinal Trigeminal Nucleus
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D014279 2000
% 224.29/224.44  |- mesh__dateRevised mesh__D014279 1992-05-18
% 224.29/224.44  |- mesh__publicMeSHNote mesh__D014279
% 224.29/224.44       82; TRIGEMINAL CAUDAL NUCLEUS was see under TRIGEMINAL NUCLEI 1980-81%A%  
% 224.29/224.44  |- mesh__historyNote mesh__D014279 82   
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D014279 2004
% 224.29/224.44  |- mesh__recordAuthorizer mesh__D014279 PLS
% 224.29/224.44  |- skos__scopeNote mesh__D014279
% 224.29/224.44       Nucleus of the spinal tract of the trigeminal nerve. It is divided cytoarchitectonically into three parts: oralis, caudalis %28%TRIGEMINAL CAUDAL NUCLEUS%29%, and interpolaris.%A%    
% 224.29/224.44  |- skos__hiddenLabel mesh__D014279 Nucleus, Spinal Trigeminal
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D014279 2006
% 224.29/224.44  |- skos__historyNote mesh__D014279 Trigeminal Nerve %28%1966-1979%29%
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D014279 1997
% 224.29/224.44  |- skos__prefLabel mesh__D014279 Trigeminal Nucleus, Spinal
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D014279 2003
% 224.29/224.44  |- mesh__recordOriginator mesh__D014279 RC
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D014279 1999
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D014279 2005
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D014279 1993
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D014279 1996
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D014279 1995
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D014279 2002
% 224.29/224.44  |- skos__historyNote mesh__D014279 Trigeminal Nuclei %28%1980-1981%29%
% 224.29/224.44  |- skos__historyNote mesh__D014279 Spinal Cord %28%1966-1981%29%
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D014279 1998
% 224.29/224.44  |- mesh__dateEstablished mesh__D014279 1982-01-01
% 224.29/224.44  |- mesh__dateRevised mesh__D000259 2004-07-07
% 224.29/224.44  |- skos__broader mesh__D000259smesh__D000256
% 224.29/224.44  |- skos__prefLabel mesh__D000259 Aviadenovirus
% 224.29/224.44  |- mesh__publicMeSHNote mesh__D000259
% 224.29/224.44       1994; see ADENOVIRUSES, AVIAN 1990-93, see ADENOVIRIDAE 1981-1990, see ADENOVIRUSES 1977-1980%A%  
% 224.29/224.44  |- skos__hiddenLabel mesh__D000259 Adenovirus, Avian
% 224.29/224.44  |- skos__altLabel mesh__D000259 Avian Adenoviruses
% 224.29/224.44  |- mesh__dateEstablished mesh__D000259 1991-01-01
% 224.29/224.44  |- skos__hiddenLabel mesh__D000259 Avian Adenovirus
% 224.29/224.44  |- skos__altLabel mesh__D000259 Adenoviruses, Avian
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D000259 2005
% 224.29/224.44  |- mesh__dateCreated mesh__D000259 1976-04-16
% 224.29/224.44  |- mesh__recordOriginator mesh__D000259 FPG
% 224.29/224.44  |- skos__historyNote mesh__D000259 Adenoviruses %28%1966-1974%29%
% 224.29/224.44  |- skos__annotation mesh__D000259
% 224.29/224.44       infection: coord IM with ADENOVIRIDAE INFECTIONS %28%IM%29%; DUCK ADENOVIRUS A see ATADENOVIRUS and TURKEY ADENOVIRUS 3 and TURKEY ADENOVIRUS A see SIADENOVIRUS are also available%A%  
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D000259 2006
% 224.29/224.44  |- mesh__historyNote mesh__D000259 1994%28%1977%29%   
% 224.29/224.44  |- skos__hiddenLabel mesh__D000259 Aviadenoviruses
% 224.29/224.44  |- rdf__type mesh__D000259sskos__Concept
% 224.29/224.44  |- mesh__recordMaintainer mesh__D000259 ags
% 224.29/224.44  |- mesh__recordAuthorizer mesh__D000259 sjn
% 224.29/224.44  |- skos__scopeNote mesh__D000259
% 224.29/224.44       A genus of ADENOVIRIDAE that infects birds. The type species is FOWL  ADENOVIRUS A.%A%    
% 224.29/224.44  |- mesh__recordMaintainer mesh__D005742 KEV
% 224.29/224.44  |- skos__hiddenLabel mesh__D005742 Gasolines
% 224.29/224.44  |- rdf__type mesh__D005742sskos__Concept
% 224.29/224.44  |- mesh__dateEstablished mesh__D005742 1991-01-01
% 224.29/224.44  |- skos__broader mesh__D005742smesh__D010578
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D005742 2002
% 224.29/224.44  |- skos__scopeNote mesh__D005742
% 224.29/224.44       Volative flammable fuel %28%liquid hydrocarbons%29% derived from crude petroleum by processes such as distillation reforming, polymerization, etc.%A%    
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D005742 1999
% 224.29/224.44  |- mesh__recordOriginator mesh__D005742 NLM
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D005742 2003
% 224.29/224.44  |- skos__hiddenLabel mesh__D005742 Diesel Fuels
% 224.29/224.44  |- skos__hiddenLabel mesh__D005742 Fuels, Diesel
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D005742 2000
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D005742 2005
% 224.29/224.44  |- mesh__dateCreated mesh__D005742 1999-01-01
% 224.29/224.44  |- skos__hiddenLabel mesh__D005742 Fuel, Diesel
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D005742 2004
% 224.29/224.44  |- mesh__publicMeSHNote mesh__D005742
% 224.29/224.44       91; was see under PETROLEUM 1975-90; was in Cat J only 1975-81%A%  
% 224.29/224.44  |- mesh__historyNote mesh__D005742
% 224.29/224.44       91%28%75%29%; was see under PETROLEUM 1975-90; was in Cat J only 1975-81%A%  
% 224.29/224.44  |- mesh__onlineNote mesh__D005742
% 224.29/224.44       use PETROLEUM to search GASOLINE 1966-74   
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D005742 2001
% 224.29/224.44  |- skos__prefLabel mesh__D005742 Gasoline
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D005742 2006
% 224.29/224.44  |- mesh__recordAuthorizer mesh__D005742 SJN
% 224.29/224.44  |- mesh__dateRevised mesh__D005742 1998-06-10
% 224.29/224.44  |- rdf__type mesh__D010687sskos__Concept
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D010687 1997
% 224.29/224.44  |- skos__broader mesh__D010687smesh__D010684
% 224.29/224.44  |- mesh__dateEstablished mesh__D010687 1974-01-01
% 224.29/224.44  |- mesh__recordMaintainer mesh__D010687 TAP
% 224.29/224.44  |- mesh__publicMeSHNote mesh__D010687 74   
% 224.29/224.44  |- mesh__historyNote mesh__D010687 74%28%69%29%   
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D010687 2005
% 224.29/224.44  |- skos__hiddenLabel mesh__D010687 Nursing Philosophies
% 224.29/224.44  |- skos__prefLabel mesh__D010687 Philosophy, Nursing
% 224.29/224.44  |- mesh__recordOriginator mesh__D010687 NLM
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D010687 2002
% 224.29/224.44  |- mesh__recordAuthorizer mesh__D010687 PLS
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D010687 1994
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D010687 2006
% 224.29/224.44  |- mesh__dateCreated mesh__D010687 1999-01-01
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D010687 1998
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D010687 2003
% 224.29/224.44  |- skos__historyNote mesh__D010687 Nursing %28%1966-1968%29%
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D010687 1995
% 224.29/224.44  |- skos__altLabel mesh__D010687 Nursing Philosophy
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D010687 2000
% 224.29/224.44  |- skos__historyNote mesh__D010687 Philosophy %28%1966-1968%29%
% 224.29/224.44  |- skos__hiddenLabel mesh__D010687 Philosophies, Nursing
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D010687 1999
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D010687 2004
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D010687 1996
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D010687 2001
% 224.29/224.44  |- mesh__dateRevised mesh__D010687 1992-05-18
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D010687 1993
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009335 2006
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009335 1997
% 224.29/224.44  |- skos__prefLabel mesh__D009335 Necrobiosis Lipoidica
% 224.29/224.44  |- mesh__recordOriginator mesh__D009335 NLM
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009335 1998
% 224.29/224.44  |- mesh__recordAuthorizer mesh__D009335 PLS
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009335 1994
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009335 1999
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009335 2003
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009335 1995
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009335 2000
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009335 2004
% 224.29/224.44  |- skos__scopeNote mesh__D009335
% 224.29/224.44       A degenerative disease of the dermal connective tissue characterized by the development of erythematous papules or nodules in the pretibial area. The papules form plaques covered with telangiectatic vessels. More than half of the affected patients have diabetes.%A%    
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009335 2001
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009335 2005
% 224.29/224.44  |- mesh__dateRevised mesh__D009335 1993-06-02
% 224.29/224.44  |- rdf__type mesh__D009335sskos__Concept
% 224.29/224.44  |- skos__broader mesh__D009335smesh__D017441
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009335 1996
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009335 2002
% 224.29/224.44  |- mesh__recordMaintainer mesh__D009335 TGC
% 224.29/224.44  |- skos__annotation mesh__D009335
% 224.29/224.44       a skin dis; also called %22%necrosis lipoidica diabeticorum%22% so do not index also under DIABETES MELLITUS unless particularly discussed%A%  
% 224.29/224.44  |- mesh__dateCreated mesh__D009335 1999-01-01
% 224.29/224.44  |- skos__broader mesh__D009335smesh__D012875
% 224.29/224.44  |- mesh__publicMeSHNote mesh__D001352
% 224.29/224.44       94; was AVIAN INFECTIOUS LARYNGOTRACHEITIS VIRUS 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%%A%  
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D001352 2002
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D001352 2003
% 224.29/224.44  |- mesh__onlineNote mesh__D001352
% 224.29/224.44       use HERPESVIRUS 1, GALLID to search AVIAN INFECTIOUS LARYNGOTRACHEITIS VIRUS 1975-93%A%  
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D001352 2005
% 224.29/224.44  |- skos__scopeNote mesh__D001352
% 224.29/224.44       The type species of the genus INFECTIOUS LARYNGOTRACHEITIS-LIKE VIRUSES found on every continent and affecting mainly chickens and occasionally pheasants.%A%    
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D001352 2004
% 224.29/224.44  |- mesh__recordMaintainer mesh__D001352 ags
% 224.29/224.44  |- skos__altLabel mesh__D001352 Avian Infectious Laryngotracheitis Virus
% 224.29/224.44  |- skos__prefLabel mesh__D001352 Herpesvirus 1, Gallid
% 224.29/224.44  |- mesh__dateCreated mesh__D001352 1974-12-12
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D001352 2006
% 224.29/224.44  |- skos__altLabel mesh__D001352 Infectious Laryngotracheitis Virus, Avian
% 224.29/224.44  |- mesh__recordAuthorizer mesh__D001352 sjn
% 224.29/224.44  |- skos__broader mesh__D001352smesh__D025921
% 224.29/224.44  |- mesh__historyNote mesh__D001352
% 224.29/224.44       94; was AVIAN INFECTIOUS LARYNGOTRACHEITIS VIRUS 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%%A%  
% 224.29/224.44  |- skos__altLabel mesh__D001352 Gallid herpesvirus 1
% 224.29/224.44  |- mesh__dateEstablished mesh__D001352 1991-01-01
% 224.29/224.44  |- mesh__dateRevised mesh__D001352 2001-07-25
% 224.29/224.44  |- mesh__recordOriginator mesh__D001352 NLM
% 224.29/224.44  |- skos__altLabel mesh__D001352 Herpesvirus 1 %28%alpha%29%, Gallid
% 224.29/224.44  |- rdf__type mesh__D001352sskos__Concept
% 224.29/224.44  |- skos__annotation mesh__D001352
% 224.29/224.44       do not confuse with HERPESVIRUS 2, GALLID; infection: coord IM with HERPESVIRIDAE INFECTIONS %28%IM%29%%A%  
% 224.29/224.44  |- skos__broader mesh__D004945Q000295smesh__D004945
% 224.29/224.44  |- mesh__preferredCombination mesh__D004945Q000295smesh__D020701
% 224.29/224.44  |- rdf__type mesh__D004945Q000295smesh__CompoundConcept
% 224.29/224.44  |- skos__altLabel mesh__D019763 Neutralase
% 224.29/224.44  |- mesh__dateEstablished mesh__D019763 1998-01-01
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D019763 2006
% 224.29/224.44  |- skos__altLabel mesh__D019763 Heparin Eliminase
% 224.29/224.44  |- skos__altLabel mesh__D019763 Heparinase I
% 224.29/224.44  |- mesh__historyNote mesh__D019763
% 224.29/224.44       98; use HEPARIN LYASE %28%NM%29% 1973-97   
% 224.29/224.44  |- skos__hiddenLabel mesh__D019763 Eliminase, Heparin
% 224.29/224.44  |- skos__prefLabel mesh__D019763 Heparin Lyase
% 224.29/224.44  |- rdf__type mesh__D019763sskos__Concept
% 224.29/224.44  |- skos__altLabel mesh__D019763 Heparinase
% 224.29/224.44  |- mesh__publicMeSHNote mesh__D019763
% 224.29/224.44       98; HEPARIN LYASE was indexed under POLYSACCHARIDE-LYASES 1975-97, HEPARIN 1973-82 %26% LYASES 1973-79%A%  
% 224.29/224.44  |- skos__historyNote mesh__D019763 Polysaccharide-Lyases %28%1975-1997%29%
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D019763 2004
% 224.29/224.44  |- skos__historyNote mesh__D019763 Lyases %28%1973-1979%29%
% 224.29/224.44  |- mesh__dateRevised mesh__D019763 2003-07-09
% 224.29/224.44  |- skos__historyNote mesh__D019763 Heparin %28%1973-1982%29%
% 224.29/224.44  |- skos__hiddenLabel mesh__D019763 I, Heparinase
% 224.29/224.44  |- skos__hiddenLabel mesh__D019763 Lyase, Heparin
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D019763 2005
% 224.29/224.44  |- mesh__dateCreated mesh__D019763 1997-06-25
% 224.29/224.44  |- skos__broader mesh__D019763smesh__D011133
% 224.29/224.44  |- skos__scopeNote mesh__D019763
% 224.29/224.44       An enzyme of the isomerase class that catalyzes the eliminative cleavage of polysaccharides containing 1,4-linked D-glucuronate or L-iduronate residues and 1,4-alpha-linked 2-sulfoamino-2-deoxy-6-sulfo-D-glucose residues to give oligosaccharides with terminal 4-deoxy-alpha-D-gluc-4-enuronosyl groups at their non-reducing ends. %28%From Enzyme Nomenclature, 1992%29% EC 4.2.2.7.%A%    
% 224.29/224.44  |- mesh__historyNote mesh__D011780 75   
% 224.29/224.44  |- mesh__dateRevised mesh__D011780 1999-12-01
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D011780 2000A
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D011780 2006
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D011780 2001
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D011780 1996
% 224.29/224.44  |- skos__prefLabel mesh__D011780 Qatar
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D011780 2005
% 224.29/224.44  |- mesh__dateCreated mesh__D011780 1974-11-11
% 224.29/224.44  |- mesh__recordAuthorizer mesh__D011780 ags
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D011780 2000
% 224.29/224.44  |- skos__altLabel mesh__D011780 Katar
% 224.29/224.44  |- mesh__dateEstablished mesh__D011780 1975-01-01
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D011780 2004
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D011780 1999
% 224.29/224.44  |- mesh__recordMaintainer mesh__D011780 ags
% 224.29/224.44  |- skos__broader mesh__D011780smesh__D008877
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D011780 2003
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D011780 1998
% 224.29/224.44  |- rdf__type mesh__D011780sskos__Concept
% 224.29/224.44  |- mesh__recordOriginator mesh__D011780 NLM
% 224.29/224.44  |- skos__altLabel mesh__D011780 Quatar
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D011780 2002
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D011780 1997
% 224.29/224.44  |- skos__annotation mesh__D005743
% 224.29/224.44       includes partial, total %26% subtotal; do not use /util except by MeSH definition%A%  
% 224.29/224.44  |- mesh__recordMaintainer mesh__D005743 PXP
% 224.29/224.44  |- mesh__recordOriginator mesh__D005743 NLM
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D005743 1999
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D005743 2000
% 224.29/224.44  |- skos__related mesh__D005743smesh__D011178
% 224.29/224.44  |- skos__scopeNote mesh__D005743
% 224.29/224.44       Excision of the whole %28%total gastrectomy%29% or part %28%subtotal gastrectomy, partial gastrectomy, gastric resection%29% of the stomach. %28%Dorland, 28th ed%29%%A%    
% 224.29/224.44  |- skos__related mesh__D005743smesh__D018530
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D005743 2003
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D005743 2001
% 224.29/224.44  |- mesh__recordAuthorizer mesh__D005743 SJN
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D005743 2005
% 224.29/224.44  |- mesh__dateCreated mesh__D005743 1999-01-01
% 224.29/224.44  |- skos__hiddenLabel mesh__D005743 Gastrectomies
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D005743 2004
% 224.29/224.44  |- skos__prefLabel mesh__D005743 Gastrectomy
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D005743 2006
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D005743 2002
% 224.29/224.44  |- mesh__dateRevised mesh__D005743 1997-06-20
% 224.29/224.44  |- rdf__type mesh__D005743sskos__Concept
% 224.29/224.44  |- skos__broader mesh__D005743smesh__D013505
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D005743 1998
% 224.29/224.44  |- skos__altLabel mesh__D043862 Rotaxane
% 224.29/224.44  |- skos__prefLabel mesh__D043862 Rotaxanes
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D043862 2005
% 224.29/224.44  |- mesh__publicMeSHNote mesh__D043862 2004   
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D043862 2006
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D043862 2004
% 224.29/224.44  |- skos__scopeNote mesh__D043862
% 224.29/224.44       Complex compounds in which a dumbbell shaped molecule is encircled by a macrocycle. They are named after rota %28%wheel%29% and axis %28%axle%29%. Notation with a prefix is used to indicate the number of interlocked components. They have potential use in NANOTECHNOLOGY. Rotaxanes have been made with CYCLODEXTRINS and CYCLIC ETHERS.%A%    
% 224.29/224.44  |- rdf__type mesh__D043862sskos__Concept
% 224.29/224.44  |- skos__annotation mesh__D043862
% 224.29/224.44       coord with specific Cat D chemical structure term if pertinent; TAXANES is also available%A%  
% 224.29/224.44  |- mesh__dateCreated mesh__D043862 2003-07-09
% 224.29/224.44  |- skos__broader mesh__D043862smesh__D009930
% 224.29/224.44  |- mesh__historyNote mesh__D043862 2004   
% 224.29/224.44  |- skos__related mesh__D043862smesh__D043863
% 224.29/224.44  |- mesh__dateEstablished mesh__D043862 2004-01-01
% 224.29/224.44  |- skos__prefLabel mesh__D010688 Phimosis
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D010688 2002
% 224.29/224.44  |- rdf__type mesh__D010688sskos__Concept
% 224.29/224.44  |- mesh__recordAuthorizer mesh__D010688 sjn
% 224.29/224.44  |- mesh__dateRevised mesh__D010688 1999-11-03
% 224.29/224.44  |- skos__hiddenLabel mesh__D010688 Phimoses
% 224.29/224.44  |- skos__broader mesh__D010688smesh__D010409
% 224.29/224.44  |- mesh__recordMaintainer mesh__D010688 KEV
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D010688 2001
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D010688 2006
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D010688 2000
% 224.29/224.44  |- mesh__recordOriginator mesh__D010688 NLM
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D010688 2004
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D010688 2005
% 224.29/224.44  |- mesh__dateCreated mesh__D010688 1999-01-01
% 224.29/224.44  |- skos__scopeNote mesh__D010688
% 224.29/224.44       The inability to retract the foreskin over the glans penis due to tightness of the prepuce.%A%    
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D010688 2003
% 224.29/224.44  |- skos__hiddenLabel mesh__D015373 Typing, Bacteriocin
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D015373 2002
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D015373 2004
% 224.29/224.44  |- mesh__recordMaintainer mesh__D015373 TAP
% 224.29/224.44  |- skos__broader mesh__D015373smesh__D001431
% 224.29/224.44  |- skos__altLabel mesh__D015373 Typing Technique, Bacterial
% 224.29/224.44  |- skos__altLabel mesh__D015373 Bacterial Typing Technique
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D015373 2005
% 224.29/224.44  |- mesh__dateEstablished mesh__D015373 1989-01-01
% 224.29/224.44  |- skos__altLabel mesh__D015373 Bacterial Biotyping
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D015373 2003
% 224.29/224.44  |- rdf__type mesh__D015373sskos__Concept
% 224.29/224.44  |- mesh__publicMeSHNote mesh__D015373
% 224.29/224.44       91; was BACTERIAL TYPING TECHNICS 1989-90; BIOTYPING was see BACTERIAL TYPING TECHNICS 1989-90 %26% BACTERIAL TYPING TECHNIQUES 1991; BACTERIOCIN TYPING was see BACTERIOPHAGE TYPING 1986-88%A%  
% 224.29/224.44  |- skos__annotation mesh__D015373
% 224.29/224.44       coord with bacterium /class; DF: BACT TYPING TECHNIQUES   
% 224.29/224.44  |- mesh__recordAuthorizer mesh__D015373 sjn
% 224.29/224.44  |- mesh__historyNote mesh__D015373
% 224.29/224.44       91; was BACTERIAL TYPING TECHNICS 1989-90; BIOTYPING was see BACTERIAL TYPING TECHNICS 1989-90 %26% BACTERIAL TYPING TECHNIQUES 1991; BACTERIOCIN TYPING was see BACTERIOPHAGE TYPING 1986-88%A%  
% 224.29/224.44  |- skos__altLabel mesh__D015373 Bacterial Typing Technic
% 224.29/224.44  |- mesh__recordOriginator mesh__D015373 RLS
% 224.29/224.44  |- mesh__onlineNote mesh__D015373
% 224.29/224.44       use BACTERIAL TYPING TECHNIQUES to search BACTERIAL TYPING TECHNICS 1989-90 %26% BIOTYPING 1989-91; use BACTERIOPHAGE TYPING to search BACTERIOCIN TYPING 1986-88%A%  
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D015373 2001
% 224.29/224.44  |- skos__scopeNote mesh__D015373
% 224.29/224.44       Procedures for identifying types and strains of bacteria. The most frequently employed typing systems are BACTERIOPHAGE TYPING and SEROTYPING as well as bacteriocin typing and biotyping.%A%    
% 224.29/224.44  |- skos__altLabel mesh__D015373 Techniques, Bacterial Typing
% 224.29/224.44  |- skos__historyNote mesh__D015373 Serotyping %28%1966-1988%29%
% 224.29/224.44  |- skos__historyNote mesh__D015373
% 224.29/224.44       Bacteriological Techniques %28%1966-1988%29%
% 224.29/224.44  |- skos__historyNote mesh__D015373 Bacteriophage Typing %28%1966-1988%29%
% 224.29/224.44  |- mesh__dateRevised mesh__D015373 2000-06-21
% 224.29/224.44  |- skos__altLabel mesh__D015373 Typing Technics, Bacterial
% 224.29/224.44  |- skos__prefLabel mesh__D015373 Bacterial Typing Techniques
% 224.29/224.44  |- skos__altLabel mesh__D015373 Bacterial Typing Technics
% 224.29/224.44  |- skos__altLabel mesh__D015373 Typing Technic, Bacterial
% 224.29/224.44  |- skos__altLabel mesh__D015373 Technique, Bacterial Typing
% 224.29/224.44  |- skos__altLabel mesh__D015373 Technic, Bacterial Typing
% 224.29/224.44  |- skos__altLabel mesh__D015373 Typing Techniques, Bacterial
% 224.29/224.44  |- mesh__dateCreated mesh__D015373 1988-06-03
% 224.29/224.44  |- skos__altLabel mesh__D015373 Typing, Bacterial
% 224.29/224.44  |- skos__altLabel mesh__D015373 Technics, Bacterial Typing
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D015373 2006
% 224.29/224.44  |- skos__annotation mesh__D009336
% 224.29/224.44       IM for general or for necrotic process; necrosis in an organ or tissue: index organ or tissue /pathol %28%IM%29% + NECROSIS %28%NIM%29%; note specific necrosis terms; radionecrosis: index RADIATION INJURIES/pathol %28%IM%29% + organ /pathol %28%IM%29% + NECROSIS %28%NIM%29%%A%  
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009336 2005A
% 224.29/224.44  |- skos__prefLabel mesh__D009336 Necrosis
% 224.29/224.44  |- skos__broader mesh__D009336smesh__D010335
% 224.29/224.44  |- mesh__recordOriginator mesh__D009336 NLM
% 224.29/224.44  |- mesh__recordMaintainer mesh__D009336 ags
% 224.29/224.44  |- skos__hiddenLabel mesh__D009336 Necroses
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009336 2005
% 224.29/224.44  |- rdf__type mesh__D009336sskos__Concept
% 224.29/224.44  |- skos__related mesh__D009336smesh__D017209
% 224.29/224.44  |- skos__scopeNote mesh__D009336
% 224.29/224.44       The pathological process occurring in cells that are dying from irreparable injuries. It is caused by the progressive, uncontrolled action of degradative ENZYMES, leading to MITOCHONDRIAL SWELLING, nuclear flocculation, and cell lysis. Distinguish it from APOPTOSIS which is a normal, regulated cellular process.%A%    
% 224.29/224.44  |- mesh__dateRevised mesh__D009336 2005-07-27
% 224.29/224.44  |- mesh__dateCreated mesh__D009336 1999-01-01
% 224.29/224.44  |- skos__broader mesh__D009336smesh__D016923
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009336 2006
% 224.29/224.44  |- skos__related mesh__D009336smesh__D014409
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D009336 2006A
% 224.29/224.44  |- mesh__recordAuthorizer mesh__D009336 ags
% 224.29/224.44  |- skos__annotation mesh__D001353
% 224.29/224.44       don%27%t forget also BIRDS %28%NIM%29% or specific bird %28%IM%29% %26% check tag ANIMALS%A%  
% 224.29/224.44  |- skos__scopeNote mesh__D001353
% 224.29/224.44       A group of transmissible viral diseases of chickens and turkeys. Liver tumors are found in most forms, but tumors can be found elsewhere.%A%    
% 224.29/224.44  |- skos__prefLabel mesh__D001353 Avian Leukosis
% 224.29/224.44  |- rdf__type mesh__D001353sskos__Concept
% 224.29/224.44  |- skos__broader mesh__D001353smesh__D007942
% 224.29/224.44  |- mesh__recordOriginator mesh__D001353 NLM
% 224.29/224.44  |- skos__altLabel mesh__D001353 Leukosis, Avian
% 224.29/224.44  |- skos__hiddenLabel mesh__D001353 Leukoses, Avian
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D001353 2004
% 224.29/224.44  |- mesh__recordMaintainer mesh__D001353 ags
% 224.29/224.44  |- skos__broader mesh__D001353smesh__D001715
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D001353 2006
% 224.29/224.44  |- mesh__dateCreated mesh__D001353 1999-01-01
% 224.29/224.44  |- skos__broader mesh__D001353smesh__D012192
% 224.29/224.44  |- skos__broader mesh__D001353smesh__D014412
% 224.29/224.44  |- skos__hiddenLabel mesh__D001353 Avian Leukoses
% 224.29/224.44  |- mesh__activeMeSHYear mesh__D001353 2005
% 224.29/224.44  |- mesh__recordAuthorizer mesh__D001353 sjn
% 224.29/224.44  |- mesh__dateRevised mesh__D001353 2003-07-30
% 224.29/224.44  |- skos__broader mesh__D006321Q000473smesh__D006321
% 224.29/224.44  |- mesh__preferredCombination mesh__D006321Q000473smesh__D009206Q000473
% 224.29/224.44  |- rdf__type mesh__D006321Q000473smesh__CompoundConcept
% 224.29/224.44  |- mesh__recordMaintainer mesh__D019764 ssb
% 224.29/224.45  |- skos__altLabel mesh__D019764
% 224.29/224.45       ATP-Dependent Phosphoenolpyruvate Carboxykinase
% 224.29/224.45  |- mesh__historyNote mesh__D019764
% 224.29/224.45       1998; use PHOSPHOENOLPYRUVATE CARBOXYKINASE %28%ATP%29% %28%NM%29% 1994-1997%A%  
% 224.29/224.45  |- skos__hiddenLabel mesh__D019764 PEPCK, Trypanosoma cruzi
% 224.29/224.45  |- skos__prefLabel mesh__D019764
% 224.29/224.45       Phosphoenolpyruvate Carboxykinase %28%ATP%29%
% 224.29/224.45  |- mesh__recordAuthorizer mesh__D019764 sjn
% 224.29/224.45  |- mesh__dateEstablished mesh__D019764 1998-01-01
% 224.29/224.45  |- skos__hiddenLabel mesh__D019764
% 224.29/224.45       Phosphoenolpyruvate Carboxykinase, ATP-Dependent
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D019764 2006
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D019764 2005
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D019764 2004
% 224.29/224.45  |- skos__broader mesh__D019764smesh__D002262
% 224.29/224.45  |- skos__hiddenLabel mesh__D019764
% 224.29/224.45       ATP Dependent Phosphoenolpyruvate Carboxykinase
% 224.29/224.45  |- mesh__dateRevised mesh__D019764 2003-07-25
% 224.29/224.45  |- mesh__dateCreated mesh__D019764 1997-07-02
% 224.29/224.45  |- skos__scopeNote mesh__D019764
% 224.29/224.45       An enzyme of the lyase class that catalyzes the conversion of ATP and oxaloacetate to ADP, phosphoenolpyruvate, and carbon dioxide. The enzyme is found in some bacteria, yeast, and Trypanosoma, and is important for the photosynthetic assimilation of carbon dioxide in some plants. EC 4.1.1.49.%A%    
% 224.29/224.45  |- mesh__publicMeSHNote mesh__D019764
% 224.29/224.45       1998; PHOSPHOENOLPYRUVATE CARBOXYKINASE %28%ATP%29% was indexed under PHOSPHOENOLPYRUVATE CARBOXYKINASES 1994-1997%A%  
% 224.29/224.45  |- rdf__type mesh__D019764sskos__Concept
% 224.29/224.45  |- skos__hiddenLabel mesh__D019764
% 224.29/224.45       Carboxykinase, ATP-Dependent Phosphoenolpyruvate
% 224.29/224.45  |- skos__historyNote mesh__D019764
% 224.29/224.45       Phosphoenolpyruvate Carboxykinase %28%GTP%29% %28%1994-1997%29%
% 224.29/224.45  |- skos__hiddenLabel mesh__D019764 PEPCK, T. cruzi
% 224.29/224.45  |- skos__annotation mesh__D019764
% 224.29/224.45       do not confuse with PHOSPHOENOLPYRUVATE CARBOXYKINASE %28%GTP%29%; DF: PEP CARBOXYKINASE ATP%A%  
% 224.29/224.45  |- mesh__recordOriginator mesh__D019764 KEV
% 224.29/224.45  |- mesh__recordOriginator mesh__D011781 NLM
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D011781 2005
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D011781 2002
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D011781 1994
% 224.29/224.45  |- skos__scopeNote mesh__D011781
% 224.29/224.45       The fraudulent misrepresentation of the diagnosis and treatment of disease.%A%    
% 224.29/224.45  |- mesh__dateCreated mesh__D011781 1999-01-01
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D011781 2004
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D011781 1999
% 224.29/224.45  |- skos__prefLabel mesh__D011781 Quackery
% 224.29/224.45  |- skos__broader mesh__D011781smesh__D012940
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D011781 2001
% 224.29/224.45  |- mesh__dateRevised mesh__D011781 1993-06-05
% 224.29/224.45  |- mesh__recordMaintainer mesh__D011781 PLS
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D011781 2003
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D011781 1998
% 224.29/224.45  |- rdf__type mesh__D011781sskos__Concept
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D011781 2000
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D011781 1997
% 224.29/224.45  |- mesh__recordAuthorizer mesh__D011781 NLM
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D011781 2006
% 224.29/224.45  |- skos__hiddenLabel mesh__D011781 Quackeries
% 224.29/224.45  |- skos__related mesh__D011781smesh__D009671
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D011781 1996
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D011781 1995
% 224.29/224.45  |- skos__annotation mesh__D005744
% 224.29/224.45       absence of gastric HCl = ACHLORHYDRIA; hyperacidity: index under GASTRIC ACID /secret%A%  
% 224.29/224.45  |- mesh__historyNote mesh__D005744
% 224.29/224.45       81; HYDROCHLORIC ACID, GASTRIC was see GASTRIC JUICE 1969-80%A%  
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D005744 2003
% 224.29/224.45  |- skos__scopeNote mesh__D005744
% 224.29/224.45       Hydrochloric acid present in GASTRIC JUICE.     
% 224.29/224.45  |- mesh__recordAuthorizer mesh__D005744 sjn
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D005744 2005
% 224.29/224.45  |- skos__related mesh__D005744smesh__D000126
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D005744 2004
% 224.29/224.45  |- skos__historyNote mesh__D005744 Gastric Juice %28%1966-1980%29%
% 224.29/224.45  |- mesh__dateEstablished mesh__D005744 1981-01-01
% 224.29/224.45  |- mesh__recordOriginator mesh__D005744 RC
% 224.29/224.45  |- mesh__dateRevised mesh__D005744 2000-06-22
% 224.29/224.45  |- mesh__publicMeSHNote mesh__D005744
% 224.29/224.45       81; HYDROCHLORIC ACID, GASTRIC was see GASTRIC JUICE 1969-80%A%  
% 224.29/224.45  |- skos__hiddenLabel mesh__D005744 Gastric Hydrochloric Acid
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D005744 2006
% 224.29/224.45  |- skos__hiddenLabel mesh__D005744 Acid, Gastric
% 224.29/224.45  |- skos__altLabel mesh__D005744 Hydrochloric Acid, Gastric
% 224.29/224.45  |- skos__hiddenLabel mesh__D005744 Acids, Gastric
% 224.29/224.45  |- skos__hiddenLabel mesh__D005744 Hydrochloric Acids, Gastric
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D005744 2001
% 224.29/224.45  |- skos__hiddenLabel mesh__D005744 Acid, Gastric Hydrochloric
% 224.29/224.45  |- skos__prefLabel mesh__D005744 Gastric Acid
% 224.29/224.45  |- rdf__type mesh__D005744sskos__Concept
% 224.29/224.45  |- mesh__onlineNote mesh__D005744
% 224.29/224.45       use GASTRIC JUICE to search HYDROCHLORIC ACID, GASTRIC 1969-80%A%  
% 224.29/224.45  |- skos__hiddenLabel mesh__D005744 Acids, Gastric Hydrochloric
% 224.29/224.45  |- skos__related mesh__D005744smesh__D006851
% 224.29/224.45  |- mesh__dateCreated mesh__D005744 1980-05-12
% 224.29/224.45  |- skos__hiddenLabel mesh__D005744 Gastric Acids
% 224.29/224.45  |- skos__hiddenLabel mesh__D005744 Gastric Hydrochloric Acids
% 224.29/224.45  |- mesh__recordMaintainer mesh__D005744 adp
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D005744 2002
% 224.29/224.45  |- skos__broader mesh__D005744smesh__D005750
% 224.29/224.45  |- mesh__publicMeSHNote mesh__D043863 2004   
% 224.29/224.45  |- mesh__historyNote mesh__D043863 2004   
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D043863 2004
% 224.29/224.45  |- skos__annotation mesh__D043863
% 224.29/224.45       coord with specific Cat D chemical structure term if pertinent%A%  
% 224.29/224.45  |- skos__scopeNote mesh__D043863
% 224.29/224.45       Complex compounds where two cyclic molecules are interlaced together as links in a chain. They have potential use in NANOTECHNOLOGY.%A%    
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D043863 2006
% 224.29/224.45  |- rdf__type mesh__D043863sskos__Concept
% 224.29/224.45  |- mesh__dateCreated mesh__D043863 2003-07-09
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D043863 2005
% 224.29/224.45  |- skos__broader mesh__D043863smesh__D009930
% 224.29/224.45  |- skos__prefLabel mesh__D043863 Catenanes
% 224.29/224.45  |- mesh__dateEstablished mesh__D043863 2004-01-01
% 224.29/224.45  |- skos__related mesh__D043863smesh__D043862
% 224.29/224.45  |- rdf__type mesh__D010689sskos__Concept
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D010689 1996
% 224.29/224.45  |- mesh__publicMeSHNote mesh__D010689 PERIPHLEBITIS was heading 1963-83   
% 224.29/224.45  |- skos__annotation mesh__D010689
% 224.29/224.45       inflamm of a vein; assume to be of the legs so do not coord with LEG; THROMBOPHLEBITIS is also available%A%  
% 224.29/224.45  |- skos__broader mesh__D010689smesh__D014652
% 224.29/224.45  |- skos__prefLabel mesh__D010689 Phlebitis
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D010689 2002
% 224.29/224.45  |- skos__broader mesh__D010689smesh__D014657
% 224.29/224.45  |- mesh__historyNote mesh__D010689 PERIPHLEBITIS was heading 1963-83   
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D010689 2006
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D010689 2004
% 224.29/224.45  |- mesh__recordAuthorizer mesh__D010689 PLS
% 224.29/224.45  |- skos__hiddenLabel mesh__D010689 Phlebitides
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D010689 1995
% 224.29/224.45  |- mesh__dateCreated mesh__D010689 1999-01-01
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D010689 2005
% 224.29/224.45  |- skos__scopeNote mesh__D010689 Inflammation of a vein.     
% 224.29/224.45  |- mesh__onlineNote mesh__D010689
% 224.29/224.45       use PHLEBITIS to search PERIPHLEBITIS 1966-83   
% 224.29/224.45  |- skos__hiddenLabel mesh__D010689 Periphlebitides
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D010689 2003
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D010689 2001
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D010689 1999
% 224.29/224.45  |- mesh__recordMaintainer mesh__D010689 TAP
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D010689 1994
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D010689 1997
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D010689 2000
% 224.29/224.45  |- mesh__dateRevised mesh__D010689 1993-06-02
% 224.29/224.45  |- mesh__recordOriginator mesh__D010689 NLM
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D010689 1998
% 224.29/224.45  |- rdf__type mesh__D015374sskos__Concept
% 224.29/224.45  |- skos__historyNote mesh__D015374
% 224.29/224.45       Monitoring, Physiologic/instrumentation %28%1980-1988%29%
% 224.29/224.45  |- mesh__recordMaintainer mesh__D015374 nns
% 224.29/224.45  |- skos__historyNote mesh__D015374 Electrodes %28%1980-1988%29%
% 224.29/224.45  |- mesh__publicMeSHNote mesh__D015374 99; see BIOSENSORS 1989-98   
% 224.29/224.45  |- skos__hiddenLabel mesh__D015374 Technic, Biosensing
% 224.29/224.45  |- skos__historyNote mesh__D015374 Biosensors %28%1989-1998%29%
% 224.29/224.45  |- skos__hiddenLabel mesh__D015374 Biosensor
% 224.29/224.45  |- skos__broader mesh__D015374smesh__D015336
% 224.29/224.45  |- skos__hiddenLabel mesh__D015374 Technics, Biosensing
% 224.29/224.45  |- mesh__dateCreated mesh__D015374 1988-06-03
% 224.29/224.45  |- skos__hiddenLabel mesh__D015374 Enzyme Electrode
% 224.29/224.45  |- mesh__dateRevised mesh__D015374 2002-07-02
% 224.29/224.45  |- skos__scopeNote mesh__D015374
% 224.29/224.45       Any of a variety of procedures which use biomolecular probes to measure the presence or concentration of biological molecules, biological structures, microorganisms, etc., by translating a biochemical interaction at the probe surface into a quantifiable physical signal.%A%    
% 224.29/224.45  |- skos__hiddenLabel mesh__D015374 Bioprobe
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D015374 2006
% 224.29/224.45  |- mesh__recordOriginator mesh__D015374 EJB
% 224.29/224.45  |- skos__related mesh__D015374smesh__D008832
% 224.29/224.45  |- mesh__historyNote mesh__D015374 99%28%89%29%   
% 224.29/224.45  |- skos__hiddenLabel mesh__D015374 Enzyme Electrodes
% 224.29/224.45  |- skos__hiddenLabel mesh__D015374 Biosensing Technique
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D015374 2005
% 224.29/224.45  |- mesh__dateEstablished mesh__D015374 1989-01-01
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D015374 2004
% 224.29/224.45  |- skos__historyNote mesh__D015374 Biotechnology %28%1986-1988%29%
% 224.29/224.45  |- skos__hiddenLabel mesh__D015374 Electrode, Enzyme
% 224.29/224.45  |- skos__hiddenLabel mesh__D015374 Techniques, Biosensing
% 224.29/224.45  |- mesh__recordAuthorizer mesh__D015374 sjn
% 224.29/224.45  |- skos__altLabel mesh__D015374 Biosensing Technics
% 224.29/224.45  |- skos__hiddenLabel mesh__D015374 Biosensing Technic
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D015374 2003
% 224.29/224.45  |- skos__prefLabel mesh__D015374 Biosensing Techniques
% 224.29/224.45  |- skos__hiddenLabel mesh__D015374 Technique, Biosensing
% 224.29/224.45  |- mesh__dateRevised mesh__D009337 2003-07-09
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D009337 2006
% 224.29/224.45  |- skos__scopeNote mesh__D009337
% 224.29/224.45       A genus of the Proteidae family with five recognized species, which inhabit the Atlantic and Gulf drainages.%A%    
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D009337 2005
% 224.29/224.45  |- mesh__recordOriginator mesh__D009337 EC
% 224.29/224.45  |- mesh__recordAuthorizer mesh__D009337 sjn
% 224.29/224.45  |- skos__historyNote mesh__D009337 Urodela %28%1966-1980%29%
% 224.29/224.45  |- mesh__dateEstablished mesh__D009337 1981-01-01
% 224.29/224.45  |- skos__prefLabel mesh__D009337 Necturus
% 224.29/224.45  |- mesh__publicMeSHNote mesh__D009337 81   
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D009337 2004
% 224.29/224.45  |- skos__broader mesh__D009337smesh__D011483
% 224.29/224.45  |- skos__altLabel mesh__D009337 Mudpuppy
% 224.29/224.45  |- mesh__dateCreated mesh__D009337 1980-04-03
% 224.29/224.45  |- mesh__historyNote mesh__D009337 81   
% 224.29/224.45  |- skos__annotation mesh__D009337
% 224.29/224.45       NIM as exper animal: no qualif; when IM, qualif permitted%A%  
% 224.29/224.45  |- rdf__type mesh__D009337sskos__Concept
% 224.29/224.45  |- skos__hiddenLabel mesh__D009337 Mudpuppies
% 224.29/224.45  |- mesh__recordMaintainer mesh__D009337 ags
% 224.29/224.45  |- mesh__dateRevised mesh__D001354 2001-07-25
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D001354 2002
% 224.29/224.45  |- skos__scopeNote mesh__D001354
% 224.29/224.45       The type species of ALPHARETROVIRUS producing latent or manifest lymphoid leukosis in fowl.%A%    
% 224.29/224.45  |- skos__hiddenLabel mesh__D001354 Leukosis Viruses, Avian
% 224.29/224.45  |- skos__hiddenLabel mesh__D001354 Virus, Rous-Associated
% 224.29/224.45  |- skos__hiddenLabel mesh__D001354 Lymphomatosis Viruses, Avian
% 224.29/224.45  |- skos__annotation mesh__D001354
% 224.29/224.45       infection = AVIAN LEUKOSIS but see note there   
% 224.29/224.45  |- skos__hiddenLabel mesh__D001354 Avian Leukosis Viruses
% 224.29/224.45  |- mesh__recordAuthorizer mesh__D001354 sjn
% 224.29/224.45  |- skos__prefLabel mesh__D001354 Leukosis Virus, Avian
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D001354 2004
% 224.29/224.45  |- skos__altLabel mesh__D001354 Avian leukosis virus
% 224.29/224.45  |- skos__hiddenLabel mesh__D001354 Avian Lymphomatosis Viruses
% 224.29/224.45  |- skos__hiddenLabel mesh__D001354 Virus, Avian Lymphomatosis
% 224.29/224.45  |- mesh__recordMaintainer mesh__D001354 ags
% 224.29/224.45  |- skos__hiddenLabel mesh__D001354 Viruses, Avian Leukosis
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D001354 2003
% 224.29/224.45  |- skos__hiddenLabel mesh__D001354 Virus, Avian Leukosis
% 224.29/224.45  |- mesh__recordOriginator mesh__D001354 NLM
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D001354 2006
% 224.29/224.45  |- mesh__dateCreated mesh__D001354 1999-01-01
% 224.29/224.45  |- mesh__onlineNote mesh__D001354
% 224.29/224.45       use LEUKOSIS VIRUS, AVIAN to search AVIAN LEUKOSIS VIRUSES 1975-93, AVIAN LEUKOSIS VIRUS 1963-74, LEUKEMIA VIRUS, AVIAN 1966-93, %26% LYMPHOMATOSIS VIRUS, AVIAN 1966-77%A%  
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D001354 2005
% 224.29/224.45  |- skos__hiddenLabel mesh__D001354 Avian Lymphomatosis Virus
% 224.29/224.45  |- skos__broader mesh__D001354smesh__D001355
% 224.29/224.45  |- skos__hiddenLabel mesh__D001354 Viruses, Avian Lymphomatosis
% 224.29/224.45  |- skos__hiddenLabel mesh__D001354 Rous Associated Virus
% 224.29/224.45  |- mesh__historyNote mesh__D001354
% 224.29/224.45       94; was AVIAN LEUKOSIS VIRUSES 1975-93, was AVIAN LEUKOSIS VIRUS 1963-74; LEUKEMIA VIRUS, AVIAN was see AVIAN LEUKOSIS VIRUSES 1978-93; LEUKEMIA VIRUS, AVIAN %26% LYMPHOMATOSIS VIRUS, AVIAN were see under AVIAN LEUKOSIS VIRUSES 1975-77, were see under AVIAN LEUKOSIS VIRUS 1963-74%A%  
% 224.29/224.45  |- rdf__type mesh__D001354sskos__Concept
% 224.29/224.45  |- mesh__publicMeSHNote mesh__D001354
% 224.29/224.45       94; was AVIAN LEUKOSIS VIRUSES 1975-93, was AVIAN LEUKOSIS VIRUS 1963-74; LEUKEMIA VIRUS, AVIAN was see AVIAN LEUKOSIS VIRUSES 1978-93; LEUKEMIA VIRUS, AVIAN %26% LYMPHOMATOSIS VIRUS, AVIAN were see under AVIAN LEUKOSIS VIRUSES 1975-77, were see under AVIAN LEUKOSIS VIRUS 1963-74%A%  
% 224.29/224.45  |- skos__broader mesh__D001132Q000293smesh__D001132
% 224.29/224.45  |- mesh__preferredCombination mesh__D001132Q000293smesh__D001134
% 224.29/224.45  |- rdf__type mesh__D001132Q000293smesh__CompoundConcept
% 224.29/224.45  |- skos__broader mesh__D019765smesh__D002808
% 224.29/224.45  |- skos__annotation mesh__D019765 do not confuse with CHONDROITIN LYASES   
% 224.29/224.45  |- skos__altLabel mesh__D019765 Chondroitinase ABC
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D019765 2006
% 224.29/224.45  |- mesh__recordOriginator mesh__D019765 KEV
% 224.29/224.45  |- mesh__recordMaintainer mesh__D019765 ssb
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D019765 2005
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D019765 2004
% 224.29/224.45  |- mesh__dateCreated mesh__D019765 1997-06-20
% 224.29/224.45  |- mesh__publicMeSHNote mesh__D019765 98; see CHONDROITIN LYASES 1975-97   
% 224.29/224.45  |- mesh__dateRevised mesh__D019765 2003-07-09
% 224.29/224.45  |- rdf__type mesh__D019765sskos__Concept
% 224.29/224.45  |- mesh__recordAuthorizer mesh__D019765 sjn
% 224.29/224.45  |- mesh__dateEstablished mesh__D019765 1998-01-01
% 224.29/224.45  |- skos__prefLabel mesh__D019765 Chondroitin ABC Lyase
% 224.29/224.45  |- skos__scopeNote mesh__D019765
% 224.29/224.45       An enzyme that catalyzes the eliminative degradation of polysaccharides containing 1,4-beta-D-hexosaminyl and 1,3-beta-D-glucuronosyl or 1,3-alpha-L-iduronosyl linkages to disaccharides containing 4-deoxy-beta-D-gluc-4-enuronosyl groups. %28%Enzyme Nomenclature, 1992%29% EC 4.2.2.4.%A%    
% 224.29/224.45  |- mesh__historyNote mesh__D019765 98; use CHONDROITIN LYASES 1975-97   
% 224.29/224.45  |- skos__hiddenLabel mesh__D019765 Lyase, Chondroitin ABC
% 224.29/224.45  |- skos__hiddenLabel mesh__D011782 Quadriplegias, Flaccid
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D011782 2004
% 224.29/224.45  |- rdf__type mesh__D011782sskos__Concept
% 224.29/224.45  |- skos__altLabel mesh__D011782 Spastic Tetraplegia
% 224.29/224.45  |- mesh__recordMaintainer mesh__D011782 ags
% 224.29/224.45  |- mesh__dateEstablished mesh__D011782 1967-01-01
% 224.29/224.45  |- skos__scopeNote mesh__D011782
% 224.29/224.45       Severe or complete loss of motor function in all four limbs which may result from BRAIN DISEASES; SPINAL CORD DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; or rarely MUSCULAR DISEASES. The locked-in syndrome is characterized by quadriplegia in combination with cranial muscle paralysis. Consciousness is spared and the only retained voluntary motor activity may be limited eye movements. This condition is usually caused by a lesion in the upper BRAIN STEM which injures the descending cortico-spinal and cortico-bulbar tracts.%A%    
% 224.29/224.45  |- mesh__recordOriginator mesh__D011782 NLM
% 224.29/224.45  |- skos__hiddenLabel mesh__D011782 Syndromes, Locked-In
% 224.29/224.45  |- skos__altLabel mesh__D011782 Tetraplegia
% 224.29/224.45  |- mesh__dateRevised mesh__D011782 1999-12-08
% 224.29/224.45  |- skos__hiddenLabel mesh__D011782 Spastic Tetraplegias
% 224.29/224.45  |- skos__hiddenLabel mesh__D011782 Quadriplegias
% 224.29/224.45  |- skos__hiddenLabel mesh__D011782 Tetraplegias
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D011782 2005
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D011782 2000
% 224.29/224.45  |- skos__hiddenLabel mesh__D011782 Flaccid Quadriplegias
% 224.29/224.45  |- skos__hiddenLabel mesh__D011782 Quadriplegia, Flaccid
% 224.29/224.45  |- skos__hiddenLabel mesh__D011782 Flaccid Tetraplegias
% 224.29/224.45  |- mesh__dateCreated mesh__D011782 1999-01-01
% 224.29/224.45  |- skos__hiddenLabel mesh__D011782 Tetraplegia, Spastic
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D011782 2006
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D011782 2000A
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D011782 2001
% 224.29/224.45  |- skos__hiddenLabel mesh__D011782 Quadriplegia, Spastic
% 224.29/224.45  |- skos__prefLabel mesh__D011782 Quadriplegia
% 224.29/224.45  |- skos__hiddenLabel mesh__D011782 Spastic Quadriplegias
% 224.29/224.45  |- skos__hiddenLabel mesh__D011782 Tetraplegias, Spastic
% 224.29/224.45  |- skos__hiddenLabel mesh__D011782 Quadripareses
% 224.29/224.45  |- mesh__recordAuthorizer mesh__D011782 ags
% 224.29/224.45  |- mesh__activeMeSHYear mesh__D011782 2002
% 224.29/224.45  |- skos__hiddenLabel mesh__D011782 Syndrome, Locked-In
% 224.29/224.45  |- skos__hiddenLabel mesh__D011782 Locked In Syndrome
% 224.29/224.45  |- skos__hiddenLabel mesh__D011782 Tetraplegias, Flaccid
% 224.29/224.46  |- mesh__historyNote mesh__D011782 1967%28%1964%29%   
% 224.29/224.46  |- skos__altLabel mesh__D011782 Flaccid Tetraplegia
% 224.29/224.46  |- skos__hiddenLabel mesh__D011782 Quadriplegias, Spastic
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D011782 2003
% 224.29/224.46  |- skos__hiddenLabel mesh__D011782 Locked-In Syndromes
% 224.29/224.46  |- mesh__publicMeSHNote mesh__D011782 1967   
% 224.29/224.46  |- skos__hiddenLabel mesh__D011782 Tetraplegia, Flaccid
% 224.29/224.46  |- skos__broader mesh__D011782smesh__D010243
% 224.29/224.46  |- skos__hiddenLabel mesh__D005745 Acidity Determinations, Gastric
% 224.29/224.46  |- mesh__dateRevised mesh__D005745 1997-06-20
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005745 2001
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005745 1999
% 224.29/224.46  |- mesh__recordMaintainer mesh__D005745 PXP
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005745 2004
% 224.29/224.46  |- skos__scopeNote mesh__D005745
% 224.29/224.46       Gastric analysis for determination of free acid or total acid.%A%    
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005745 2000
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005745 1998
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005745 2003
% 224.29/224.46  |- skos__prefLabel mesh__D005745 Gastric Acidity Determination
% 224.29/224.46  |- skos__hiddenLabel mesh__D005745 Gastric Acidity Determinations
% 224.29/224.46  |- skos__broader mesh__D005745smesh__D003938
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005745 2006
% 224.29/224.46  |- mesh__dateCreated mesh__D005745 1999-01-01
% 224.29/224.46  |- mesh__recordAuthorizer mesh__D005745 SJN
% 224.29/224.46  |- mesh__recordOriginator mesh__D005745 NLM
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005745 2002
% 224.29/224.46  |- skos__broader mesh__D005745smesh__D019963
% 224.29/224.46  |- skos__annotation mesh__D005745 NIM   
% 224.29/224.46  |- skos__hiddenLabel mesh__D005745 Determinations, Gastric Acidity
% 224.29/224.46  |- skos__hiddenLabel mesh__D005745 Determination, Gastric Acidity
% 224.29/224.46  |- skos__hiddenLabel mesh__D005745 Acidity Determination, Gastric
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005745 2005
% 224.29/224.46  |- rdf__type mesh__D005745sskos__Concept
% 224.29/224.46  |- mesh__dateRevised mesh__D024101 2005-06-30
% 224.29/224.46  |- mesh__dateEstablished mesh__D024101 2002-01-01
% 224.29/224.46  |- mesh__dateCreated mesh__D024101 2001-07-25
% 224.29/224.46  |- mesh__recordMaintainer mesh__D024101 SYSTEM
% 224.29/224.46  |- skos__altLabel mesh__D024101 Mitochondrial Protein
% 224.29/224.46  |- mesh__recordAuthorizer mesh__D024101 sjn
% 224.29/224.46  |- skos__hiddenLabel mesh__D024101 Protein, Mitochondrial
% 224.29/224.46  |- rdf__type mesh__D024101sskos__Concept
% 224.29/224.46  |- skos__prefLabel mesh__D024101 Mitochondrial Proteins
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D024101 2006
% 224.29/224.46  |- skos__altLabel mesh__D024101 Proteins, Mitochondrial
% 224.29/224.46  |- mesh__recordOriginator mesh__D024101 nns
% 224.29/224.46  |- skos__historyNote mesh__D024101 Mitochondria %28%1965-2001%29%
% 224.29/224.46  |- mesh__historyNote mesh__D024101 2002   
% 224.29/224.46  |- skos__scopeNote mesh__D024101
% 224.29/224.46       Proteins encoded by the mitochondrial genome or proteins encoded by the nuclear genome that are imported to and resident in the MITOCHONDRIA.%A%    
% 224.29/224.46  |- skos__broader mesh__D024101smesh__D011506
% 224.29/224.46  |- mesh__publicMeSHNote mesh__D024101 2002   
% 224.29/224.46  |- mesh__dateEstablished mesh__D043864 2004-01-01
% 224.29/224.46  |- skos__broader mesh__D043864smesh__D043863
% 224.29/224.46  |- skos__broader mesh__D043864smesh__D004270
% 224.29/224.46  |- skos__scopeNote mesh__D043864
% 224.29/224.46       CIRCULAR DNA that is interlaced together as links in a chain. It is used as an assay for the activity of DNA TOPOISOMERASES. Catenated DNA is attached loop to loop in contrast to CONCATENATED DNA which is attached end to end.%A%    
% 224.29/224.46  |- mesh__dateRevised mesh__D043864 2004-07-07
% 224.29/224.46  |- skos__annotation mesh__D043864
% 224.29/224.46       coord with specific DNA source; DNA, CONCATENATED is also available%A%  
% 224.29/224.46  |- mesh__historyNote mesh__D043864 2004   
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D043864 2006
% 224.29/224.46  |- skos__prefLabel mesh__D043864 DNA, Catenated
% 224.29/224.46  |- rdf__type mesh__D043864sskos__Concept
% 224.29/224.46  |- mesh__recordAuthorizer mesh__D043864 sjn
% 224.29/224.46  |- mesh__dateCreated mesh__D043864 2003-07-09
% 224.29/224.46  |- skos__altLabel mesh__D043864 DNA, Catanates
% 224.29/224.46  |- mesh__recordOriginator mesh__D043864 ssb
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D043864 2005
% 224.29/224.46  |- skos__related mesh__D043864smesh__D018105
% 224.29/224.46  |- skos__hiddenLabel mesh__D043864 DNA Catenanes
% 224.29/224.46  |- mesh__publicMeSHNote mesh__D043864 2004   
% 224.29/224.46  |- mesh__recordMaintainer mesh__D043864 ssb
% 224.29/224.46  |- skos__altLabel mesh__D043864 Catenated DNA
% 224.29/224.46  |- skos__altLabel mesh__D043864 Catenanes, DNA
% 224.29/224.46  |- skos__related mesh__D043864smesh__D044708
% 224.29/224.46  |- skos__broader mesh__D015375smesh__D015703
% 224.29/224.46  |- skos__historyNote mesh__D015375 Receptors, Immunologic %28%1980-1988%29%
% 224.29/224.46  |- skos__hiddenLabel mesh__D015375 Receptors, IL2
% 224.29/224.46  |- mesh__recordAuthorizer mesh__D015375 sjn
% 224.29/224.46  |- mesh__dateCreated mesh__D015375 1988-06-03
% 224.29/224.46  |- skos__hiddenLabel mesh__D015375 T Cell Growth Factor Receptor
% 224.29/224.46  |- skos__altLabel mesh__D015375 IL-2 Receptors
% 224.29/224.46  |- skos__altLabel mesh__D015375 Antigens, CD122
% 224.29/224.46  |- skos__hiddenLabel mesh__D015375 Receptors, TCGF
% 224.29/224.46  |- skos__altLabel mesh__D015375 CD25 Antigens
% 224.29/224.46  |- skos__altLabel mesh__D015375 Receptors, T-Cell Growth Factor
% 224.29/224.46  |- mesh__dateRevised mesh__D015375 2005-06-30
% 224.29/224.46  |- skos__hiddenLabel mesh__D015375 Receptor, IL-2
% 224.29/224.46  |- skos__hiddenLabel mesh__D015375 Receptors, IL 2
% 224.29/224.46  |- skos__altLabel mesh__D015375 TCGF Receptors
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D015375 2006
% 224.29/224.46  |- skos__scopeNote mesh__D015375
% 224.29/224.46       Receptors present on activated T- and B-cells as a complex consisting of a 55-kDa peptide, which reacts with the anti-Tac monoclonal antibody, and a 75-kDa non-Tac interleukin-2-binding peptide. The receptor is present in two forms, one with a very high affinity and the other with low affinity for IL-2. The high-affinity form appears to mediate exclusively the growth-promoting response to IL-2. The receptor is present in large numbers on resting HUMAN T-LYMPHOTROPIC VIRUS 1 leukemia cells, but not on normal resting cells.%A%    
% 224.29/224.46  |- skos__altLabel mesh__D015375 CD25 Antigen
% 224.29/224.46  |- skos__altLabel mesh__D015375 TCGF Receptor
% 224.29/224.46  |- skos__hiddenLabel mesh__D015375 Receptor, IL2
% 224.29/224.46  |- skos__altLabel mesh__D015375 Receptors, Mitogenic Factor
% 224.29/224.46  |- skos__altLabel mesh__D015375 IL2 Receptors
% 224.29/224.46  |- skos__altLabel mesh__D015375 Tac P55 Peptide
% 224.29/224.46  |- skos__altLabel mesh__D015375 Tac Peptide
% 224.29/224.46  |- skos__historyNote mesh__D015375 Interleukin 2 %28%1978-1988%29%
% 224.29/224.46  |- skos__altLabel mesh__D015375 Interleukin-Binding Peptide p75
% 224.29/224.46  |- skos__altLabel mesh__D015375 Receptors, IL-2
% 224.29/224.46  |- skos__hiddenLabel mesh__D015375 Interleukin Binding Peptide p75
% 224.29/224.46  |- mesh__publicMeSHNote mesh__D015375
% 224.29/224.46       90; was RECEPTORS, INTERLEUKIN 2 1989; CD25 ANTIGENS was CD25 ANTIGEN see RECEPTORS, INTERLEUKIN-2 1989-92%A%  
% 224.29/224.46  |- skos__broader mesh__D015375smesh__D018123
% 224.29/224.46  |- mesh__historyNote mesh__D015375
% 224.29/224.46       90; was RECEPTORS, INTERLEUKIN 2 1989; CD25 ANTIGENS was CD25 ANTIGEN see RECEPTORS, INTERLEUKIN-2 1989-92%A%  
% 224.29/224.46  |- skos__hiddenLabel mesh__D015375 IL 2 Receptors
% 224.29/224.46  |- skos__prefLabel mesh__D015375 Receptors, Interleukin-2
% 224.29/224.46  |- skos__altLabel mesh__D015375 T-Cell Growth Factor Receptors
% 224.29/224.46  |- mesh__dateEstablished mesh__D015375 1989-01-01
% 224.29/224.46  |- rdf__type mesh__D015375sskos__Concept
% 224.29/224.46  |- skos__hiddenLabel mesh__D015375 Interleukin 2 Receptors
% 224.29/224.46  |- skos__altLabel mesh__D015375 IL-2 Receptor
% 224.29/224.46  |- mesh__onlineNote mesh__D015375
% 224.29/224.46       use RECEPTORS, INTERLEUKIN-2 to search RECEPTORS, INTERLEUKIN 2 1989 %26% CD25 ANTIGEN 1989-92%A%  
% 224.29/224.46  |- skos__annotation mesh__D015375 DF: RECEPT IL 2 or RECEPT IL2   
% 224.29/224.46  |- skos__altLabel mesh__D015375 Interleukin-2 Receptors
% 224.29/224.46  |- skos__hiddenLabel mesh__D015375 Receptor, Interleukin 2
% 224.29/224.46  |- skos__altLabel mesh__D015375 Receptor, TCGF
% 224.29/224.46  |- skos__altLabel mesh__D015375 IL2 Receptor
% 224.29/224.46  |- skos__hiddenLabel mesh__D015375 IL 2 Receptor
% 224.29/224.46  |- mesh__recordOriginator mesh__D015375 RLS
% 224.29/224.46  |- skos__altLabel mesh__D015375 T-Cell Growth Factor Receptor
% 224.29/224.46  |- skos__hiddenLabel mesh__D015375 Receptors, Interleukin 2
% 224.29/224.46  |- skos__hiddenLabel mesh__D015375 T Cell Growth Factor Receptors
% 224.29/224.46  |- skos__altLabel mesh__D015375 CD122 Antigen
% 224.29/224.46  |- skos__hiddenLabel mesh__D015375 P55 Peptide, Tac
% 224.29/224.46  |- skos__altLabel mesh__D015375 Interleukin 2 Receptor
% 224.29/224.46  |- mesh__recordMaintainer mesh__D015375 ssb
% 224.29/224.46  |- skos__hiddenLabel mesh__D015375 Receptors, T Cell Growth Factor
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D009338 2005
% 224.29/224.46  |- skos__broader mesh__D009338smesh__D009337
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D009338 2004
% 224.29/224.46  |- mesh__publicMeSHNote mesh__D009338 91; was see under NECTURUS 1981-90   
% 224.29/224.46  |- mesh__dateEstablished mesh__D009338 1991-01-01
% 224.29/224.46  |- mesh__recordOriginator mesh__D009338 EC
% 224.29/224.46  |- mesh__recordAuthorizer mesh__D009338 sjn
% 224.29/224.46  |- skos__historyNote mesh__D009338 Urodela %28%1966-1980%29%
% 224.29/224.46  |- skos__annotation mesh__D009338
% 224.29/224.46       NIM when exper animal: no qualif; when IM, qualif permitted%A%  
% 224.29/224.46  |- rdf__type mesh__D009338sskos__Concept
% 224.29/224.46  |- skos__prefLabel mesh__D009338 Necturus maculosus
% 224.29/224.46  |- mesh__recordMaintainer mesh__D009338 ags
% 224.29/224.46  |- mesh__dateRevised mesh__D009338 2003-07-09
% 224.29/224.46  |- skos__hiddenLabel mesh__D009338 maculosus, Necturus
% 224.29/224.46  |- mesh__historyNote mesh__D009338
% 224.29/224.46       91%28%81%29%; was see under NECTURUS 1981-90   
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D009338 2006
% 224.29/224.46  |- skos__scopeNote mesh__D009338
% 224.29/224.46       A neotenic aquatic species of mudpuppy %28%Necturus%29% occurring from Manitoba to Louisiana and Texas.%A%    
% 224.29/224.46  |- mesh__dateCreated mesh__D009338 1980-04-03
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D001355 2003
% 224.29/224.46  |- mesh__recordMaintainer mesh__D001355 ags
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D001355 2006
% 224.29/224.46  |- mesh__dateCreated mesh__D001355 1999-01-01
% 224.29/224.46  |- skos__hiddenLabel mesh__D001355 ALV-Related Retrovirus
% 224.29/224.46  |- skos__hiddenLabel mesh__D001355 Leukosis-Sarcoma Virus, Avian
% 224.29/224.46  |- skos__altLabel mesh__D001355 Retroviruses, ALV-Related
% 224.29/224.46  |- skos__hiddenLabel mesh__D001355 Avian Leukosis-Sarcoma Virus
% 224.29/224.46  |- skos__altLabel mesh__D001355 Type C Avian Retroviruses
% 224.29/224.46  |- mesh__dateEstablished mesh__D001355 1966-01-01
% 224.29/224.46  |- skos__hiddenLabel mesh__D001355 Leukosis-Sarcoma Viruses, Avian
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D001355 2005
% 224.29/224.46  |- mesh__historyNote mesh__D001355 2002 %28%1966%29%   
% 224.29/224.46  |- skos__hiddenLabel mesh__D001355 Retrovirus, ALV-Related
% 224.29/224.46  |- mesh__dateRevised mesh__D001355 2001-07-25
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D001355 2002
% 224.29/224.46  |- rdf__type mesh__D001355sskos__Concept
% 224.29/224.46  |- skos__altLabel mesh__D001355 Avian Leukosis-Sarcoma Viruses
% 224.29/224.46  |- skos__hiddenLabel mesh__D001355 Retroviruses, ALV Related
% 224.29/224.46  |- mesh__recordAuthorizer mesh__D001355 sjn
% 224.29/224.46  |- skos__hiddenLabel mesh__D001355 Virus, Avian Leukosis-Sarcoma
% 224.29/224.46  |- skos__annotation mesh__D001355
% 224.29/224.46       infection: coord IM with AVIAN LEUKOSIS %28%IM%29% or SARCOMA, AVIAN %28%IM%29%, but if not so specified coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29% if pertinent%A%  
% 224.29/224.46  |- skos__hiddenLabel mesh__D001355 Avian Leukosis Sarcoma Viruses
% 224.29/224.46  |- skos__prefLabel mesh__D001355 Alpharetrovirus
% 224.29/224.46  |- skos__broader mesh__D001355smesh__D012190
% 224.29/224.46  |- skos__scopeNote mesh__D001355
% 224.29/224.46       A genus of the family RETROVIRIDAE with type C morphology, that causes malignant and other diseases in wild birds and domestic fowl.%A%    
% 224.29/224.46  |- skos__altLabel mesh__D001355 Retroviruses Type C, Avian
% 224.29/224.46  |- mesh__publicMeSHNote mesh__D001355
% 224.29/224.46       2002; see RETROVIRUSES TYPE C, AVIAN 1997-2001, see RETROVIRUSES, ALV-RELATED 1994-1996, see AVIAN LEUKOSIS-SARCOMA VIRUSES 1966-1993; for RETROVIRUSES TYPE C, AVIAN see RETROVIRUSES TYPE C, AVIAN 1997-2001, see RETROVIRUSES, ALV-RELATED 1994-1996%A%  
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D001355 2004
% 224.29/224.46  |- mesh__recordOriginator mesh__D001355 NLM
% 224.29/224.46  |- skos__hiddenLabel mesh__D001355 Viruses, Avian Leukosis-Sarcoma
% 224.29/224.46  |- skos__hiddenLabel mesh__D001355 ALV-Related Retroviruses
% 224.29/224.46  |- skos__annotation mesh__D006040 no qualif   
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D006040 2006
% 224.29/224.46  |- skos__prefLabel mesh__D006040 Goals
% 224.29/224.46  |- mesh__onlineNote mesh__D006040
% 224.29/224.46       use GOALS to search GOAL 1975-78; use MOTIVATION 1969-74   
% 224.29/224.46  |- mesh__recordMaintainer mesh__D006040 jrf
% 224.29/224.46  |- mesh__recordAuthorizer mesh__D006040 sjn
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D006040 2005
% 224.29/224.46  |- skos__historyNote mesh__D006040 Motivation %28%1966-1974%29%
% 224.29/224.46  |- mesh__recordOriginator mesh__D006040 NLM
% 224.29/224.46  |- skos__related mesh__D006040smesh__D033182
% 224.29/224.46  |- skos__hiddenLabel mesh__D006040 Goal
% 224.29/224.46  |- rdf__type mesh__D006040sskos__Concept
% 224.29/224.46  |- mesh__dateEstablished mesh__D006040 1979-01-01
% 224.29/224.46  |- mesh__historyNote mesh__D006040
% 224.29/224.46       79; was GOAL see under MOTIVATION 1969-78   
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D006040 2004
% 224.29/224.46  |- skos__broader mesh__D006040smesh__D009042
% 224.29/224.46  |- mesh__dateCreated mesh__D006040 1999-01-01
% 224.29/224.46  |- mesh__dateRevised mesh__D006040 2002-07-03
% 224.29/224.46  |- skos__scopeNote mesh__D006040
% 224.29/224.46       The end-result or objective, which may be specified or required in advance.%A%    
% 224.29/224.46  |- mesh__publicMeSHNote mesh__D006040
% 224.29/224.46       79; was GOAL see under MOTIVATION 1969-78   
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D006040 2003
% 224.29/224.46  |- skos__related mesh__D019766smesh__D020745
% 224.29/224.46  |- rdf__type mesh__D019766sskos__Concept
% 224.29/224.46  |- skos__broader mesh__D019766smesh__D020745
% 224.29/224.46  |- skos__hiddenLabel mesh__D019766 Gene, Archaeal
% 224.29/224.46  |- mesh__historyNote mesh__D019766 98   
% 224.29/224.46  |- skos__prefLabel mesh__D019766 Genes, Archaeal
% 224.29/224.46  |- mesh__dateRevised mesh__D019766 2005-06-30
% 224.29/224.46  |- skos__scopeNote mesh__D019766
% 224.29/224.46       The functional genetic units of ARCHAEA.     
% 224.29/224.46  |- skos__broader mesh__D019766smesh__D005796
% 224.29/224.46  |- skos__hiddenLabel mesh__D019766 Archaeal Gene
% 224.29/224.46  |- mesh__publicMeSHNote mesh__D019766 98   
% 224.29/224.46  |- mesh__dateEstablished mesh__D019766 1998-01-01
% 224.29/224.46  |- mesh__recordOriginator mesh__D019766 AGS
% 224.29/224.46  |- skos__altLabel mesh__D019766 Archaeal Genes
% 224.29/224.46  |- mesh__dateCreated mesh__D019766 1997-06-20
% 224.29/224.46  |- skos__historyNote mesh__D019766 Genes, Bacterial %28%1984-1997%29%
% 224.29/224.46  |- mesh__recordMaintainer mesh__D019766 nns
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D019766 2006
% 224.29/224.46  |- mesh__recordAuthorizer mesh__D019766 sjn
% 224.29/224.46  |- skos__annotation mesh__D019766
% 224.29/224.46       coordinate IM with specific archaeon /genet %28%IM%29%   
% 224.29/224.46  |- skos__hiddenLabel mesh__D011783 Quadruplet
% 224.29/224.46  |- skos__broader mesh__D011783smesh__D009099
% 224.29/224.46  |- skos__scopeNote mesh__D011783
% 224.29/224.46       Four individuals derived from four FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother.%A%    
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D011783 2006
% 224.29/224.46  |- skos__annotation mesh__D011783
% 224.29/224.46       human only: for animals use LITTER SIZE; relation to PREGNANCY: Manual 28.16.4%A%  
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D011783 2005
% 224.29/224.46  |- mesh__recordMaintainer mesh__D011783 lkt
% 224.29/224.46  |- mesh__recordOriginator mesh__D011783 NLM
% 224.29/224.46  |- skos__prefLabel mesh__D011783 Quadruplets
% 224.29/224.46  |- mesh__dateCreated mesh__D011783 1999-01-01
% 224.29/224.46  |- mesh__dateRevised mesh__D011783 2004-07-07
% 224.29/224.46  |- mesh__recordAuthorizer mesh__D011783 sjn
% 224.29/224.46  |- skos__broader mesh__D011783smesh__D011272
% 224.29/224.46  |- rdf__type mesh__D011783sskos__Concept
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005746 1993
% 224.29/224.46  |- mesh__recordMaintainer mesh__D005746 TAP
% 224.29/224.46  |- mesh__recordOriginator mesh__D005746 SMH
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005746 2001
% 224.29/224.46  |- skos__broader mesh__D005746smesh__D005769
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005746 1999
% 224.29/224.46  |- skos__scopeNote mesh__D005746
% 224.29/224.46       The evacuation of food from the stomach into the duodenum.%A%    
% 224.29/224.46  |- mesh__recordAuthorizer mesh__D005746 PLS
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005746 2000
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005746 1998
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005746 2004
% 224.29/224.46  |- skos__historyNote mesh__D005746 Stomach %28%1966-1977%29%
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005746 1995
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005746 2003
% 224.29/224.46  |- mesh__dateRevised mesh__D005746 1992-05-15
% 224.29/224.46  |- mesh__dateCreated mesh__D005746 1977-04-22
% 224.29/224.46  |- skos__prefLabel mesh__D005746 Gastric Emptying
% 224.29/224.46  |- mesh__historyNote mesh__D005746 78   
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005746 1994
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005746 2002
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005746 1997
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005746 2006
% 224.29/224.46  |- rdf__type mesh__D005746sskos__Concept
% 224.29/224.46  |- skos__hiddenLabel mesh__D005746 Emptying, Gastric
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005746 1996
% 224.29/224.46  |- mesh__publicMeSHNote mesh__D005746 78   
% 224.29/224.46  |- skos__hiddenLabel mesh__D005746 Gastric Emptyings
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D005746 2005
% 224.29/224.46  |- skos__hiddenLabel mesh__D005746 Emptyings, Gastric
% 224.29/224.46  |- mesh__dateEstablished mesh__D005746 1978-01-01
% 224.29/224.46  |- skos__historyNote mesh__D005746
% 224.29/224.46       Gastrointestinal Motility %28%1966-1977%29%
% 224.29/224.46  |- skos__altLabel mesh__D024102 Collagen alpha1%28%VIII%29%
% 224.29/224.46  |- mesh__publicMeSHNote mesh__D024102 2002; see COLLAGEN 1985-2001   
% 224.29/224.46  |- rdf__type mesh__D024102sskos__Concept
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D024102 2006
% 224.29/224.46  |- skos__prefLabel mesh__D024102 Collagen Type VIII
% 224.29/224.46  |- skos__hiddenLabel mesh__D024102 Collagen Type VIII, alpha1 Subunit
% 224.29/224.46  |- skos__altLabel mesh__D024102 Type VIII Collagen
% 224.29/224.46  |- skos__broader mesh__D024102smesh__D024041
% 224.29/224.46  |- skos__hiddenLabel mesh__D024102 Type VIII, Procollagen
% 224.29/224.46  |- skos__hiddenLabel mesh__D024102 Procollagen, Type VIII
% 224.29/224.46  |- mesh__dateCreated mesh__D024102 2001-07-25
% 224.29/224.46  |- skos__altLabel mesh__D024102 Collagen Type-VIII, alpha1 Chain
% 224.29/224.46  |- mesh__recordAuthorizer mesh__D024102 sjn
% 224.29/224.46  |- skos__hiddenLabel mesh__D024102 Collagen Type VIII, alpha1 Chain
% 224.29/224.46  |- mesh__recordOriginator mesh__D024102 jmp
% 224.29/224.46  |- skos__hiddenLabel mesh__D024102 Collagen, Type VIII
% 224.29/224.46  |- mesh__historyNote mesh__D024102 2002; use COLLAGEN 1985-2001   
% 224.29/224.46  |- mesh__dateRevised mesh__D024102 2005-07-01
% 224.29/224.46  |- skos__historyNote mesh__D024102 Collagen %28%1985-2001%29%
% 224.29/224.46  |- skos__annotation mesh__D024102
% 224.29/224.46       precursors: coord IM with PROCOLLAGEN %28%IM%29%   
% 224.29/224.46  |- skos__scopeNote mesh__D024102
% 224.29/224.46       A non-fibrillar collagen originally found in DESCEMET MEMBRANE. It is expressed in endothelial cell layers and in tissues undergoing active remodeling. It is heterotrimer comprised of alpha1%28%VIII%29% and alpha2%28%VIII%29% chains.%A%    
% 224.29/224.46  |- skos__altLabel mesh__D024102 Procollagen Type VIII
% 224.29/224.46  |- mesh__dateEstablished mesh__D024102 2002-01-01
% 224.29/224.46  |- mesh__recordMaintainer mesh__D024102 sjn
% 224.29/224.46  |- mesh__recordMaintainer mesh__D048550 lkt
% 224.29/224.46  |- rdf__type mesh__D048550sskos__Concept
% 224.29/224.46  |- mesh__dateEstablished mesh__D048550 2005-01-01
% 224.29/224.46  |- mesh__publicMeSHNote mesh__D048550 2005   
% 224.29/224.46  |- skos__altLabel mesh__D048550 Liver Insufficiency
% 224.29/224.46  |- skos__broader mesh__D048550smesh__D008107
% 224.29/224.46  |- mesh__dateCreated mesh__D048550 2004-07-07
% 224.29/224.46  |- skos__hiddenLabel mesh__D048550 Insufficiency, Liver
% 224.29/224.46  |- skos__historyNote mesh__D048550 Liver Diseases %28%1965-2004%29%
% 224.29/224.46  |- mesh__recordAuthorizer mesh__D048550 sjn
% 224.29/224.46  |- skos__scopeNote mesh__D048550
% 224.29/224.46       Conditions in which the LIVER functions fall below the normal ranges. Severe hepatic insufficiency may cause LIVER FAILURE or DEATH. Treatment may include LIVER TRANSPLANTATION.%A%    
% 224.29/224.46  |- mesh__recordOriginator mesh__D048550 lkt
% 224.29/224.46  |- mesh__historyNote mesh__D048550 2005   
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D048550 2006
% 224.29/224.46  |- skos__hiddenLabel mesh__D048550 Insufficiency, Hepatic
% 224.29/224.46  |- skos__prefLabel mesh__D048550 Hepatic Insufficiency
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D048550 2005
% 224.29/224.46  |- mesh__historyNote mesh__D015376 89   
% 224.29/224.46  |- skos__prefLabel mesh__D015376 Nimustine
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D015376 2005
% 224.29/224.46  |- skos__historyNote mesh__D015376 Nitrosourea Compounds %28%1975-1988%29%
% 224.29/224.46  |- mesh__dateCreated mesh__D015376 1988-06-03
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D015376 2006
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D015376 2003
% 224.29/224.46  |- skos__altLabel mesh__D015376 ACNU
% 224.29/224.46  |- mesh__recordOriginator mesh__D015376 RLS
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D015376 2001
% 224.29/224.46  |- mesh__recordAuthorizer mesh__D015376 sjn
% 224.29/224.46  |- mesh__dateEstablished mesh__D015376 1989-01-01
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D015376 2004
% 224.29/224.46  |- skos__historyNote mesh__D015376 Antineoplastic Agents %28%1975-1988%29%
% 224.29/224.46  |- mesh__activeMeSHYear mesh__D015376 2002
% 224.29/224.46  |- mesh__recordMaintainer mesh__D015376 CCR
% 224.29/224.46  |- rdf__type mesh__D015376sskos__Concept
% 224.29/224.46  |- skos__scopeNote mesh__D015376
% 224.29/224.46       Antineoplastic agent especially effective against malignant brain tumors. The resistance which brain tumor cells acquire to the initial effectiveness of this drug can be partially overcome by the simultaneous use of membrane-modifying agents such as reserpine, calcium antagonists such as nicardipine or verapamil, or the calmodulin inhibitor, trifluoperazine. The drug has also been used in combination with other antineoplastic agents or with radiotherapy for the treatment of various neoplasms.%A%    
% 224.29/224.46  |- skos__hiddenLabel mesh__D015376 245382, NSC
% 224.29/224.46  |- skos__broader mesh__D015376smesh__D009607
% 224.29/224.46  |- mesh__dateRevised mesh__D015376 2000-06-21
% 224.29/224.46  |- mesh__publicMeSHNote mesh__D015376 89   
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D009339 2003
% 224.29/224.47  |- mesh__historyNote mesh__D009339 73%28%71%29%   
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D009339 1998
% 224.29/224.47  |- mesh__recordAuthorizer mesh__D009339 PLS
% 224.29/224.47  |- skos__historyNote mesh__D009339
% 224.29/224.47       appropriate heading/instrumentation %28%1966-1970%29%
% 224.29/224.47  |- rdf__type mesh__D009339sskos__Concept
% 224.29/224.47  |- mesh__dateRevised mesh__D009339 1993-06-03
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D009339 1997
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D009339 2006
% 224.29/224.47  |- mesh__recordOriginator mesh__D009339 NLM
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D009339 2002
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D009339 1996
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D009339 1995
% 224.29/224.47  |- skos__prefLabel mesh__D009339 Needles
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D009339 2005
% 224.29/224.47  |- mesh__publicMeSHNote mesh__D009339 73   
% 224.29/224.47  |- mesh__dateEstablished mesh__D009339 1973-01-01
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D009339 2001
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D009339 1994
% 224.29/224.47  |- skos__scopeNote mesh__D009339
% 224.29/224.47       Sharp instruments used for puncturing or suturing.     
% 224.29/224.47  |- skos__hiddenLabel mesh__D009339 Needle
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D009339 2004
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D009339 1999
% 224.29/224.47  |- skos__annotation mesh__D009339
% 224.29/224.47       disinfection of needles by Clorox %28%a household bleach%29% as by intravenous drug users is indexed under NEEDLES + DISINFECTION + SODIUM HYPOCHLORITE%A%  
% 224.29/224.47  |- skos__broader mesh__D009339smesh__D004864
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D009339 2000
% 224.29/224.47  |- mesh__recordMaintainer mesh__D009339 PLS
% 224.29/224.47  |- mesh__dateCreated mesh__D009339 1999-01-01
% 224.29/224.47  |- mesh__recordOriginator mesh__D001356 NLM
% 224.29/224.47  |- skos__hiddenLabel mesh__D001356 T Viruses
% 224.29/224.47  |- skos__hiddenLabel mesh__D001356 Virus, T
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D001356 2005
% 224.29/224.47  |- skos__prefLabel mesh__D001356 Reticuloendotheliosis virus
% 224.29/224.47  |- rdf__type mesh__D001356sskos__Concept
% 224.29/224.47  |- skos__scopeNote mesh__D001356
% 224.29/224.47       A species in the group RETICULOENDOTHELIOSIS VIRUSES, AVIAN of the genus GAMMARETROVIRUS that causes a chronic neoplastic and a more acute immunosuppressive disease in fowl.%A%    
% 224.29/224.47  |- mesh__historyNote mesh__D001356 2002 %28%1975%29%   
% 224.29/224.47  |- mesh__publicMeSHNote mesh__D001356
% 224.29/224.47       2002; see RETICULOENDOTHELIOSIS VIRUS, AVIAN 1994-2001, see AVIAN RETICULOENDOTHELIOSIS VIRUS 1991-1993, see RETROVIRIDAE 1981-1990, see LEUKOVIRUSES 1978-1980, see LEUKEMOGENIC VIRUSES 1975-1977%A%  
% 224.29/224.47  |- mesh__dateEstablished mesh__D001356 1991-01-01
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D001356 2004
% 224.29/224.47  |- mesh__dateRevised mesh__D001356 2001-07-25
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D001356 2002
% 224.29/224.47  |- skos__broader mesh__D001356smesh__D017986
% 224.29/224.47  |- mesh__recordAuthorizer mesh__D001356 sjn
% 224.29/224.47  |- skos__annotation mesh__D001356
% 224.29/224.47       do not confuse X ref T VIRUS with T-PHAGES; infection: coord IM with RETROVIRIDAE INFECTIONS %28%IM%29% + TUMOR VIRUS INFECTIONS %28%IM%29%%A%  
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D001356 2003
% 224.29/224.47  |- mesh__recordMaintainer mesh__D001356 ags
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D001356 2006
% 224.29/224.47  |- mesh__dateCreated mesh__D001356 1974-11-19
% 224.29/224.47  |- skos__broader mesh__D020156Q000031smesh__D020156
% 224.29/224.47  |- mesh__preferredCombination mesh__D020156Q000031smesh__D012461
% 224.29/224.47  |- rdf__type mesh__D020156Q000031smesh__CompoundConcept
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D006041 2005
% 224.29/224.47  |- mesh__recordMaintainer mesh__D006041 ags
% 224.29/224.47  |- rdf__type mesh__D006041sskos__Concept
% 224.29/224.47  |- skos__prefLabel mesh__D006041 Goats
% 224.29/224.47  |- skos__altLabel mesh__D006041 Capra
% 224.29/224.47  |- skos__broader mesh__D006041smesh__D012418
% 224.29/224.47  |- skos__hiddenLabel mesh__D006041 Capras
% 224.29/224.47  |- mesh__recordAuthorizer mesh__D006041 sjn
% 224.29/224.47  |- mesh__dateCreated mesh__D006041 1999-01-01
% 224.29/224.47  |- mesh__recordOriginator mesh__D006041 NLM
% 224.29/224.47  |- skos__annotation mesh__D006041
% 224.29/224.47       mountain goat = GOATS, MOUNTAIN see RUMINANTS   
% 224.29/224.47  |- skos__scopeNote mesh__D006041
% 224.29/224.47       Any of numerous agile, hollow-horned RUMINANTS of the genus Capra, in the family Bovidae, closely related to the SHEEP.%A%    
% 224.29/224.47  |- skos__hiddenLabel mesh__D006041 Goat
% 224.29/224.47  |- mesh__dateRevised mesh__D006041 2004-07-07
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D006041 2006
% 224.29/224.47  |- mesh__historyNote mesh__D019767 98   
% 224.29/224.47  |- skos__broader mesh__D019767smesh__D018640
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D019767 2001
% 224.29/224.47  |- skos__broader mesh__D019767smesh__D019465
% 224.29/224.47  |- mesh__dateRevised mesh__D019767 1999-11-03
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D019767 2000
% 224.29/224.47  |- skos__historyNote mesh__D019767 Face/abnormalities %28%1968-1997%29%
% 224.29/224.47  |- skos__annotation mesh__D019767
% 224.29/224.47       GEN or unspecified %26% involving both the maxilla %26% the face: not a substitute for MAXILLA /abnorm or FACE /abnorm or FACIAL BONES /abnorm; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; DF: MAXILLOFACIAL ABNORM%A%  
% 224.29/224.47  |- skos__altLabel mesh__D019767 Abnormalities, Maxillofacial
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D019767 2006
% 224.29/224.47  |- skos__hiddenLabel mesh__D019767 Maxillofacial Abnormality
% 224.29/224.47  |- mesh__recordOriginator mesh__D019767 TGC
% 224.29/224.47  |- skos__historyNote mesh__D019767
% 224.29/224.47       Facial Bones/abnormalities %28%1969-1997%29%
% 224.29/224.47  |- skos__hiddenLabel mesh__D019767 Abnormality, Maxillofacial
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D019767 2004
% 224.29/224.47  |- skos__prefLabel mesh__D019767 Maxillofacial Abnormalities
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D019767 2005
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D019767 2002
% 224.29/224.47  |- mesh__recordMaintainer mesh__D019767 kle
% 224.29/224.47  |- skos__scopeNote mesh__D019767
% 224.29/224.47       Congenital structural deformities, malformations, or other abnormalities of the maxilla and face or facial bones.%A%    
% 224.29/224.47  |- rdf__type mesh__D019767sskos__Concept
% 224.29/224.47  |- mesh__dateCreated mesh__D019767 1997-06-20
% 224.29/224.47  |- mesh__dateEstablished mesh__D019767 1998-01-01
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D019767 2003
% 224.29/224.47  |- mesh__publicMeSHNote mesh__D019767 98   
% 224.29/224.47  |- skos__historyNote mesh__D019767 Maxilla/abnormalities %28%1968-1997%29%
% 224.29/224.47  |- mesh__recordAuthorizer mesh__D019767 sjn
% 224.29/224.47  |- mesh__recordOriginator mesh__D011784 NLM
% 224.29/224.47  |- skos__prefLabel mesh__D011784 Quail
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D011784 2005
% 224.29/224.47  |- mesh__recordAuthorizer mesh__D011784 sjn
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D011784 2006
% 224.29/224.47  |- mesh__dateCreated mesh__D011784 1999-01-01
% 224.29/224.47  |- mesh__dateRevised mesh__D011784 2004-07-07
% 224.29/224.47  |- mesh__historyNote mesh__D011784 73   
% 224.29/224.47  |- skos__broader mesh__D011784smesh__D046094
% 224.29/224.47  |- skos__historyNote mesh__D011784 Birds %28%1966-1972%29%
% 224.29/224.47  |- skos__hiddenLabel mesh__D011784 Quails
% 224.29/224.47  |- mesh__recordMaintainer mesh__D011784 ags
% 224.29/224.47  |- skos__scopeNote mesh__D011784
% 224.29/224.47       Common name for two distinct groups of BIRDS in the order GALLIFORMES: the New World or American quails of the family Odontophoridae and the Old World quails in the genus COTURNIX, family Phasianidae.%A%    
% 224.29/224.47  |- mesh__publicMeSHNote mesh__D011784 73   
% 224.29/224.47  |- mesh__dateEstablished mesh__D011784 1973-01-01
% 224.29/224.47  |- rdf__type mesh__D011784sskos__Concept
% 224.29/224.47  |- skos__annotation mesh__D011784
% 224.29/224.47       GEN or unspecified; prefer COLINUS %26% COTURNIX; note JAPANESE QUAIL see COTURNIX; diseases: coord IM with BIRD DISEASES %28%IM%29%%A%  
% 224.29/224.47  |- skos__historyNote mesh__D011784 Poultry %28%1966-1972%29%
% 224.29/224.47  |- skos__prefLabel mesh__D038921 Coffin-Lowry Syndrome
% 224.29/224.47  |- skos__hiddenLabel mesh__D038921 Coffin Lowry Syndrome
% 224.29/224.47  |- skos__scopeNote mesh__D038921
% 224.29/224.47       A rare, X-linked mental retardation syndrome that results from mutations in the RIBOSOMAL PROTEIN S6 KINASE gene. Typical manifestations of the disease include an intelligence quotient of less than 50, facial anomalies, and other malformations.%A%    
% 224.29/224.47  |- mesh__dateCreated mesh__D038921 2002-07-03
% 224.29/224.47  |- skos__historyNote mesh__D038921
% 224.29/224.47       Mental Retardation/genetics %28%1975-2002%29%
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D038921 2003
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D038921 2006
% 224.29/224.47  |- skos__broader mesh__D038921smesh__D038901
% 224.29/224.47  |- mesh__historyNote mesh__D038921 2003   
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D038921 2005
% 224.29/224.47  |- mesh__publicMeSHNote mesh__D038921 2003   
% 224.29/224.47  |- rdf__type mesh__D038921sskos__Concept
% 224.29/224.47  |- mesh__dateEstablished mesh__D038921 2003-01-01
% 224.29/224.47  |- skos__hiddenLabel mesh__D038921 Syndrome, Coffin-Lowry
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D038921 2004
% 224.29/224.47  |- skos__altLabel mesh__D005747 Stomach Fistula
% 224.29/224.47  |- skos__broader mesh__D005747smesh__D016154
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D005747 2004
% 224.29/224.47  |- skos__annotation mesh__D005747 fistula policy: Manual 23.19+   
% 224.29/224.47  |- mesh__dateCreated mesh__D005747 1999-01-01
% 224.29/224.47  |- skos__prefLabel mesh__D005747 Gastric Fistula
% 224.29/224.47  |- rdf__type mesh__D005747sskos__Concept
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D005747 2006
% 224.29/224.47  |- mesh__recordAuthorizer mesh__D005747 sjn
% 224.29/224.47  |- skos__hiddenLabel mesh__D005747 Fistula, Gastric
% 224.29/224.47  |- skos__scopeNote mesh__D005747
% 224.29/224.47       Abnormal passage communicating with the STOMACH.     
% 224.29/224.47  |- mesh__recordOriginator mesh__D005747 NLM
% 224.29/224.47  |- mesh__recordMaintainer mesh__D005747 lkt
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D005747 2005
% 224.29/224.47  |- skos__related mesh__D005747smesh__D005774
% 224.29/224.47  |- skos__hiddenLabel mesh__D005747 Fistula, Stomach
% 224.29/224.47  |- mesh__dateRevised mesh__D005747 2003-07-09
% 224.29/224.47  |- mesh__dateCreated mesh__D024901 2001-07-25
% 224.29/224.47  |- skos__scopeNote mesh__D024901
% 224.29/224.47       The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids %28%R FACTORS%29%.%A%    
% 224.29/224.47  |- mesh__publicMeSHNote mesh__D024901 2002   
% 224.29/224.47  |- skos__related mesh__D024901smesh__D019450
% 224.29/224.47  |- mesh__recordAuthorizer mesh__D024901 sjn
% 224.29/224.47  |- skos__broader mesh__D024901smesh__D024881
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D024901 2005
% 224.29/224.47  |- mesh__dateRevised mesh__D024901 2003-07-09
% 224.29/224.47  |- rdf__type mesh__D024901sskos__Concept
% 224.29/224.47  |- skos__historyNote mesh__D024901
% 224.29/224.47       Drug Resistance, Multiple %28%1994-2001%29%
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D024901 2006
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D024901 2004
% 224.29/224.47  |- mesh__recordMaintainer mesh__D024901 ssb
% 224.29/224.47  |- skos__altLabel mesh__D024901 Multiple Antibacterial Drug Resistance
% 224.29/224.47  |- skos__historyNote mesh__D024901
% 224.29/224.47       Drug Resistance, Microbial %28%1968-2001%29%
% 224.29/224.47  |- mesh__recordOriginator mesh__D024901 lkt
% 224.29/224.47  |- mesh__dateEstablished mesh__D024901 2002-01-01
% 224.29/224.47  |- skos__broader mesh__D024901smesh__D018432
% 224.29/224.47  |- skos__prefLabel mesh__D024901 Drug Resistance, Multiple, Bacterial
% 224.29/224.47  |- mesh__historyNote mesh__D024901 2002   
% 224.29/224.47  |- mesh__dateCreated mesh__D015377 1988-06-03
% 224.29/224.47  |- skos__broader mesh__D015377smesh__D005229
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D015377 2006
% 224.29/224.47  |- skos__altLabel mesh__D015377 MK0791
% 224.29/224.47  |- skos__altLabel mesh__D015377 Cilastatin Monosodium Salt
% 224.29/224.47  |- mesh__historyNote mesh__D015377 89   
% 224.29/224.47  |- skos__broader mesh__D015377smesh__D003521
% 224.29/224.47  |- skos__prefLabel mesh__D015377 Cilastatin
% 224.29/224.47  |- mesh__dateEstablished mesh__D015377 1989-01-01
% 224.29/224.47  |- skos__historyNote mesh__D015377
% 224.29/224.47       Dipeptidases/antagonists %26% inhibitors %28%1983-1988%29%
% 224.29/224.47  |- skos__historyNote mesh__D015377 Cyclopropanes %28%1983-1988%29%
% 224.29/224.47  |- skos__hiddenLabel mesh__D015377 Salt, Cilastatin Monosodium
% 224.29/224.47  |- skos__scopeNote mesh__D015377
% 224.29/224.47       A renal dehydropeptidase-I and leukotriene D4 dipeptidase inhibitor. Since the antibiotic, IMIPENEM, is hydrolyzed by dehydropeptidase-I, which resides in the brush border of the renal tubule, cilastatin is administered with imipenem to increase its effectiveness. The drug also inhibits the metabolism of leukotriene D4 to leukotriene E4.%A%    
% 224.29/224.47  |- skos__hiddenLabel mesh__D015377 Sodium, Cilastatin
% 224.29/224.47  |- mesh__recordMaintainer mesh__D015377 ssb
% 224.29/224.47  |- mesh__dateRevised mesh__D015377 2004-07-19
% 224.29/224.47  |- mesh__recordOriginator mesh__D015377 RLS
% 224.29/224.47  |- rdf__type mesh__D015377sskos__Concept
% 224.29/224.47  |- skos__historyNote mesh__D015377 Protease Inhibitors %28%1983-1988%29%
% 224.29/224.47  |- skos__hiddenLabel mesh__D015377 0791, MK
% 224.29/224.47  |- mesh__recordAuthorizer mesh__D015377 sjn
% 224.29/224.47  |- skos__hiddenLabel mesh__D015377 MK 791
% 224.29/224.47  |- skos__hiddenLabel mesh__D015377 MK791
% 224.29/224.47  |- mesh__publicMeSHNote mesh__D015377 89   
% 224.29/224.47  |- skos__hiddenLabel mesh__D015377 Monosodium Salt, Cilastatin
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D015377 2005
% 224.29/224.47  |- skos__altLabel mesh__D015377 MK-791
% 224.29/224.47  |- mesh__historyNote mesh__D001357
% 224.29/224.47       94; was AVIAN SARCOMA 1983-93; was ROUS SARCOMA 1963-82   
% 224.29/224.47  |- skos__hiddenLabel mesh__D001357 Avian Sarcomas
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D001357 2006
% 224.29/224.47  |- mesh__onlineNote mesh__D001357
% 224.29/224.47       use SARCOMA, AVIAN to search AVIAN SARCOMA 1983-93 %26% ROUS SARCOMA 1966-82%A%  
% 224.29/224.47  |- skos__broader mesh__D001357smesh__D014412
% 224.29/224.47  |- skos__scopeNote mesh__D001357
% 224.29/224.47       Connective tissue tumors, affecting primarily fowl, that are usually caused by avian sarcoma viruses.%A%    
% 224.29/224.47  |- rdf__type mesh__D001357sskos__Concept
% 224.29/224.47  |- skos__annotation mesh__D001357
% 224.29/224.47       caused by a retrovirus; /blood supply /chem /second /secret /ultrastruct permitted; don%27%t forget also BIRDS or POULTRY %28%NIM%29% or specific bird or fowl %28%IM%29%; check tag ANIMALS%A%  
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D001357 2005
% 224.29/224.47  |- mesh__dateRevised mesh__D001357 2003-07-30
% 224.29/224.47  |- skos__broader mesh__D001357smesh__D001715
% 224.29/224.47  |- skos__broader mesh__D001357smesh__D012513
% 224.29/224.47  |- skos__broader mesh__D001357smesh__D012192
% 224.29/224.47  |- skos__prefLabel mesh__D001357 Sarcoma, Avian
% 224.29/224.47  |- mesh__recordAuthorizer mesh__D001357 sjn
% 224.29/224.47  |- mesh__publicMeSHNote mesh__D001357
% 224.29/224.47       94; was AVIAN SARCOMA 1983-93; was ROUS SARCOMA 1963-82   
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D001357 2004
% 224.29/224.47  |- skos__altLabel mesh__D001357 Sarcoma, Rous
% 224.29/224.47  |- mesh__dateCreated mesh__D001357 1999-01-01
% 224.29/224.47  |- mesh__recordOriginator mesh__D001357 NLM
% 224.29/224.47  |- skos__altLabel mesh__D001357 Avian Sarcoma
% 224.29/224.47  |- mesh__recordMaintainer mesh__D001357 ags
% 224.29/224.47  |- skos__hiddenLabel mesh__D001357 Sarcomas, Avian
% 224.29/224.47  |- mesh__dateEstablished mesh__D006840 1998-01-01
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D006840 2002
% 224.29/224.47  |- skos__prefLabel mesh__D006840 Hydrocarbons, Alicyclic
% 224.29/224.47  |- mesh__dateCreated mesh__D006840 1999-01-01
% 224.29/224.47  |- skos__scopeNote mesh__D006840
% 224.29/224.47       Organic compounds composed exclusively of carbon and hydrogen. Three or more carbon atoms are arranged in a cyclic structure and they possess aliphatic properties.%A%    
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D006840 2001
% 224.29/224.47  |- mesh__publicMeSHNote mesh__D006840 98   
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D006840 1999
% 224.29/224.47  |- mesh__recordOriginator mesh__D006840 NLM
% 224.29/224.47  |- rdf__type mesh__D006840sskos__Concept
% 224.29/224.47  |- skos__broader mesh__D006840smesh__D006844
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D006840 2004
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D006840 1998
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D006840 2000
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D006840 2006
% 224.29/224.47  |- skos__annotation mesh__D006840
% 224.29/224.47       GEN; prefer specifics; used for mapping supplementary chemicals; do not confuse with HYDROCARBONS, ACYCLIC%A%  
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D006840 2003
% 224.29/224.47  |- mesh__recordAuthorizer mesh__D006840 SJN
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D006840 2005
% 224.29/224.47  |- mesh__dateRevised mesh__D006840 1997-06-20
% 224.29/224.47  |- skos__altLabel mesh__D006840 Alicyclic Hydrocarbons
% 224.29/224.47  |- mesh__recordMaintainer mesh__D006840 ADP
% 224.29/224.47  |- mesh__historyNote mesh__D006840 98; use explode 1967-97   
% 224.29/224.47  |- skos__broader mesh__D009132Q000254smesh__D009132
% 224.29/224.47  |- mesh__preferredCombination mesh__D009132Q000254smesh__D024510
% 224.29/224.47  |- rdf__type mesh__D009132Q000254smesh__CompoundConcept
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D020511 2006
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D020511 2005
% 224.29/224.47  |- skos__hiddenLabel mesh__D020511 Neuromuscular Junction Disease
% 224.29/224.47  |- skos__altLabel mesh__D020511 Toxic Disorders, Neuromuscular Junction
% 224.29/224.47  |- skos__scopeNote mesh__D020511
% 224.29/224.47       Conditions characterized by impaired transmission of impulses at the NEUROMUSCULAR JUNCTION. This may result from disorders that affect receptor function, pre- or postsynaptic membrane function, or ACETYLCHOLINESTERASE activity. The majority of diseases in this category are associated with autoimmune, toxic, or inherited conditions.%A%    
% 224.29/224.47  |- mesh__dateEstablished mesh__D020511 2000-01-01
% 224.29/224.47  |- skos__broader mesh__D020511smesh__D009468
% 224.29/224.47  |- skos__historyNote mesh__D020511 Neuromuscular Junction %28%1966-1999%29%
% 224.29/224.47  |- skos__hiddenLabel mesh__D020511 Neuromuscular Transmission Disorder
% 224.29/224.47  |- skos__altLabel mesh__D020511 Neuromuscular Junction Disorders
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D020511 2002
% 224.29/224.47  |- mesh__historyNote mesh__D020511 2000   
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D020511 2001
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D020511 2004
% 224.29/224.47  |- skos__prefLabel mesh__D020511 Neuromuscular Junction Diseases
% 224.29/224.47  |- rdf__type mesh__D020511sskos__Concept
% 224.29/224.47  |- mesh__publicMeSHNote mesh__D020511 2000   
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D020511 2000
% 224.29/224.47  |- skos__hiddenLabel mesh__D020511 Neuromuscular Junction Disorder
% 224.29/224.47  |- skos__altLabel mesh__D020511 Neuromuscular Transmission Disorders
% 224.29/224.47  |- mesh__dateCreated mesh__D020511 1999-11-03
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D020511 2003
% 224.29/224.47  |- mesh__dateCreated mesh__D006042 1999-01-01
% 224.29/224.47  |- rdf__type mesh__D006042sskos__Concept
% 224.29/224.47  |- mesh__dateRevised mesh__D006042 2004-07-13
% 224.29/224.47  |- skos__scopeNote mesh__D006042
% 224.29/224.47       Enlargement of the THYROID GLAND that may increase from about 20 grams to hundreds of grams in human adults. Goiter is observed in individuals with normal thyroid function %28%euthyroidism%29%, thyroid deficiency %28%HYPOTHYROIDISM%29%, or hormone overproduction %28%HYPERTHYROIDISM%29%. Goiter may be congenital or acquired, sporadic or endemic %28%GOITER, ENDEMIC%29%.%A%    
% 224.29/224.47  |- mesh__recordMaintainer mesh__D006042 sjn
% 224.29/224.47  |- skos__annotation mesh__D006042 note specific goiter terms   
% 224.29/224.47  |- skos__hiddenLabel mesh__D006042 Goiters
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D006042 2005
% 224.29/224.47  |- mesh__recordAuthorizer mesh__D006042 sjn
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D006042 2006
% 224.29/224.47  |- skos__broader mesh__D006042smesh__D013959
% 224.29/224.47  |- skos__prefLabel mesh__D006042 Goiter
% 224.29/224.47  |- mesh__recordOriginator mesh__D006042 NLM
% 224.29/224.47  |- mesh__recordAuthorizer mesh__D011785 sjn
% 224.29/224.47  |- mesh__onlineNote mesh__D011785
% 224.29/224.47       use QUALITY OF HEALTH CARE to search QUALITY ASSURANCE PROGRAM 1978-79%A%  
% 224.29/224.47  |- mesh__publicMeSHNote mesh__D011785
% 224.29/224.47       80; QUALITY ASSURANCE PROGRAM was see QUALITY OF HEALTH CARE 1978-79%A%  
% 224.29/224.47  |- skos__altLabel mesh__D011785 Quality Assurance, Healthcare
% 224.29/224.47  |- skos__hiddenLabel mesh__D011785 Healthcare Quality Assurances
% 224.29/224.47  |- skos__annotation mesh__D011785 DF: QUAL ASSUR   
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D011785 2005
% 224.29/224.47  |- skos__altLabel mesh__D011785 Healthcare Quality Assurance
% 224.29/224.47  |- skos__hiddenLabel mesh__D011785 Assurances, Healthcare Quality
% 224.29/224.47  |- mesh__dateRevised mesh__D011785 2001-07-25
% 224.29/224.47  |- mesh__dateEstablished mesh__D011785 1980-01-01
% 224.29/224.47  |- skos__hiddenLabel mesh__D011785 Quality Assessments, Healthcare
% 224.29/224.47  |- mesh__dateCreated mesh__D011785 1979-06-01
% 224.29/224.47  |- skos__prefLabel mesh__D011785 Quality Assurance, Health Care
% 224.29/224.47  |- mesh__historyNote mesh__D011785
% 224.29/224.47       80; QUALITY ASSURANCE PROGRAM was see QUALITY OF HEALTH CARE 1978-79%A%  
% 224.29/224.47  |- skos__historyNote mesh__D011785 Quality of Health Care %28%1968-1979%29%
% 224.29/224.47  |- skos__hiddenLabel mesh__D011785 Assessments, Healthcare Quality
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D011785 2006
% 224.29/224.47  |- mesh__recordMaintainer mesh__D011785 jls
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D011785 2003
% 224.29/224.47  |- skos__hiddenLabel mesh__D011785 Assurance, Healthcare Quality
% 224.29/224.47  |- skos__broader mesh__D011785smesh__D011787
% 224.29/224.47  |- skos__hiddenLabel mesh__D011785 Assessment, Healthcare Quality
% 224.29/224.47  |- skos__altLabel mesh__D011785 Quality Assessment, Healthcare
% 224.29/224.47  |- skos__altLabel mesh__D011785 Health Care Quality Assessment
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D011785 2002
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D011785 2004
% 224.29/224.47  |- skos__hiddenLabel mesh__D011785 Quality Assurances, Healthcare
% 224.29/224.47  |- rdf__type mesh__D011785sskos__Concept
% 224.29/224.47  |- mesh__recordOriginator mesh__D011785 EC
% 224.29/224.47  |- skos__scopeNote mesh__D011785
% 224.29/224.47       Activities and programs intended to assure or improve the quality of care in either a defined medical setting or a program. The concept includes the assessment or evaluation of the quality of care; identification of problems or shortcomings in the delivery of care; designing activities to overcome these deficiencies; and follow-up monitoring to ensure effectiveness of corrective steps.%A%    
% 224.29/224.47  |- skos__altLabel mesh__D011785 Health Care Quality Assurance
% 224.29/224.47  |- skos__altLabel mesh__D011785 Quality Assessment, Health Care
% 224.29/224.47  |- skos__hiddenLabel mesh__D011785 Healthcare Quality Assessments
% 224.29/224.47  |- skos__broader mesh__D011785smesh__D017530
% 224.29/224.47  |- mesh__dateCreated mesh__D005748 1980-04-04
% 224.29/224.47  |- rdf__type mesh__D005748sskos__Concept
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D005748 2006
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D005748 2005
% 224.29/224.47  |- mesh__dateEstablished mesh__D005748 1981-01-01
% 224.29/224.47  |- skos__related mesh__D005748smesh__D018662
% 224.29/224.47  |- mesh__recordOriginator mesh__D005748 RC
% 224.29/224.47  |- skos__historyNote mesh__D005748 Stomach %28%1966-1980%29%
% 224.29/224.47  |- skos__annotation mesh__D005748
% 224.29/224.47       NIM when merely locational; neopl of gastric fundus: coord NIM with STOMACH NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A%  
% 224.29/224.47  |- skos__scopeNote mesh__D005748
% 224.29/224.47       The superior portion of the body of the stomach above the level of the cardiac notch.%A%    
% 224.29/224.47  |- skos__prefLabel mesh__D005748 Gastric Fundus
% 224.29/224.47  |- mesh__publicMeSHNote mesh__D005748 81   
% 224.29/224.47  |- mesh__dateRevised mesh__D005748 2003-07-09
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D005748 2004
% 224.29/224.47  |- skos__hiddenLabel mesh__D005748 Fundus, Gastric
% 224.29/224.47  |- mesh__recordMaintainer mesh__D005748 lkt
% 224.29/224.47  |- mesh__recordAuthorizer mesh__D005748 sjn
% 224.29/224.47  |- mesh__historyNote mesh__D005748 81   
% 224.29/224.47  |- skos__broader mesh__D005748smesh__D013270
% 224.29/224.47  |- rdf__type mesh__D016470sskos__Concept
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D016470 2004
% 224.29/224.47  |- skos__scopeNote mesh__D016470
% 224.29/224.47       The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.%A%    
% 224.29/224.47  |- mesh__recordAuthorizer mesh__D016470 sjn
% 224.29/224.47  |- mesh__publicMeSHNote mesh__D016470 92; was see SEPTICEMIA 1975-91   
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D016470 2001
% 224.29/224.47  |- mesh__dateCreated mesh__D016470 1991-01-02
% 224.29/224.47  |- skos__historyNote mesh__D016470 Septicemia %28%1966-1991%29%
% 224.29/224.47  |- skos__historyNote mesh__D016470
% 224.29/224.47       specific bacterial infection %28%1966-1991%29%
% 224.29/224.47  |- mesh__recordOriginator mesh__D016470 PXP
% 224.29/224.47  |- skos__hiddenLabel mesh__D016470 Bacteremias
% 224.29/224.47  |- skos__annotation mesh__D016470
% 224.29/224.47       coord with specific bact/infect heading or specific bacterium if specific bact infect is not in MeSH %28%do not use /blood to indicate -emia%29%%A%  
% 224.29/224.47  |- mesh__historyNote mesh__D016470 92; was see SEPTICEMIA 1975-91   
% 224.29/224.47  |- skos__broader mesh__D016470smesh__D001424
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D016470 2005
% 224.29/224.47  |- skos__related mesh__D016470smesh__D019446
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D016470 2002
% 224.29/224.47  |- mesh__dateEstablished mesh__D016470 1992-01-01
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D016470 2006
% 224.29/224.47  |- mesh__dateRevised mesh__D016470 1999-11-03
% 224.29/224.47  |- skos__broader mesh__D016470smesh__D012687
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D016470 2003
% 224.29/224.47  |- mesh__recordMaintainer mesh__D016470 ags
% 224.29/224.47  |- mesh__onlineNote mesh__D016470
% 224.29/224.47       use SEPTICEMIA to search BACTEREMIA 1975-91   
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D016470 2000
% 224.29/224.47  |- skos__prefLabel mesh__D016470 Bacteremia
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D030141 2003
% 224.29/224.47  |- mesh__dateEstablished mesh__D030141 2002-01-01
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D030141 2004
% 224.29/224.47  |- skos__annotation mesh__D030141
% 224.29/224.47       FEEDBACK and FEEDBACK, BIOCHEMICAL are also available   
% 224.29/224.47  |- rdf__type mesh__D030141sskos__Concept
% 224.29/224.47  |- skos__altLabel mesh__D030141 Psychological Feedback
% 224.29/224.47  |- mesh__publicMeSHNote mesh__D030141 2002   
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D030141 2005
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D030141 2002
% 224.29/224.47  |- skos__broader mesh__D030141smesh__D000223
% 224.29/224.47  |- mesh__dateCreated mesh__D030141 2001-07-25
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D030141 2006
% 224.29/224.47  |- skos__prefLabel mesh__D030141 Feedback, Psychological
% 224.29/224.47  |- mesh__historyNote mesh__D030141 2002   
% 224.29/224.47  |- skos__historyNote mesh__D030141 Feedback %28%1965-2001%29%
% 224.29/224.47  |- skos__scopeNote mesh__D030141
% 224.29/224.47       A mechanism of information stimulus and response that may control subsequent behavior, cognition, perception, or performance. %28%From APA Thesaurus of Psychological Index Terms, 8th ed.%29%%A%    
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D002450 2000
% 224.29/224.47  |- skos__annotation mesh__D002450 not for micro-organisms   
% 224.29/224.47  |- skos__related mesh__D002450smesh__D007365
% 224.29/224.47  |- skos__altLabel mesh__D002450 Cell-to-Cell Interaction
% 224.29/224.47  |- mesh__publicMeSHNote mesh__D002450 78   
% 224.29/224.47  |- mesh__dateCreated mesh__D002450 1977-05-16
% 224.29/224.47  |- rdf__type mesh__D002450sskos__Concept
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D002450 2001
% 224.29/224.47  |- skos__hiddenLabel mesh__D002450 Cell Interactions
% 224.29/224.47  |- skos__prefLabel mesh__D002450 Cell Communication
% 224.29/224.47  |- skos__hiddenLabel mesh__D002450 Cell Communications
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D002450 1999
% 224.29/224.47  |- mesh__recordOriginator mesh__D002450 AEP
% 224.29/224.47  |- skos__hiddenLabel mesh__D002450 Interactions, Cell
% 224.29/224.47  |- skos__hiddenLabel mesh__D002450 Interactions, Cell-to-Cell
% 224.29/224.47  |- skos__scopeNote mesh__D002450
% 224.29/224.47       Any of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP.%A%    
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D002450 2003
% 224.29/224.47  |- mesh__dateRevised mesh__D002450 1998-06-10
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D002450 2005
% 224.29/224.47  |- mesh__dateEstablished mesh__D002450 1978-01-01
% 224.29/224.47  |- skos__hiddenLabel mesh__D002450 Cell to Cell Interaction
% 224.29/224.47  |- skos__hiddenLabel mesh__D002450 Communication, Cell
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D002450 2004
% 224.29/224.47  |- skos__broader mesh__D002450smesh__D002468
% 224.29/224.47  |- skos__related mesh__D002450smesh__D015290
% 224.29/224.47  |- skos__hiddenLabel mesh__D002450 Interaction, Cell-to-Cell
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D002450 2002
% 224.29/224.47  |- mesh__activeMeSHYear mesh__D002450 2006
% 224.29/224.47  |- mesh__recordAuthorizer mesh__D002450 SJN
% 224.29/224.47  |- skos__historyNote mesh__D002450
% 224.29/224.47       Intercellular Junctions %28%1970-1977%29%
% 224.29/224.48  |- skos__altLabel mesh__D002450 Cell Interaction
% 224.29/224.48  |- skos__hiddenLabel mesh__D002450 Interaction, Cell
% 224.29/224.48  |- mesh__recordMaintainer mesh__D002450 MSR
% 224.29/224.48  |- skos__hiddenLabel mesh__D002450 Cell-to-Cell Interactions
% 224.29/224.48  |- skos__hiddenLabel mesh__D002450 Communications, Cell
% 224.29/224.48  |- mesh__historyNote mesh__D002450 78   
% 224.29/224.48  |- skos__related mesh__D002450smesh__D015398
% 224.29/224.48  |- skos__broader mesh__D020058Q000031smesh__D020058
% 224.29/224.48  |- mesh__preferredCombination mesh__D020058Q000031smesh__D013343
% 224.29/224.48  |- rdf__type mesh__D020058Q000031smesh__CompoundConcept
% 224.29/224.48  |- mesh__recordAuthorizer mesh__D015378 sjn
% 224.29/224.48  |- rdf__type mesh__D015378sskos__Concept
% 224.29/224.48  |- skos__hiddenLabel mesh__D015378 MK 0787
% 224.29/224.48  |- mesh__dateRevised mesh__D015378 2004-07-07
% 224.29/224.48  |- skos__prefLabel mesh__D015378 Imipenem
% 224.29/224.48  |- skos__historyNote mesh__D015378 Antibiotics %28%1980-1982%29%
% 224.29/224.48  |- mesh__publicMeSHNote mesh__D015378 89   
% 224.29/224.48  |- skos__hiddenLabel mesh__D015378 Anhydrous Imipenem
% 224.29/224.48  |- skos__altLabel mesh__D015378 MK0787
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D015378 2005
% 224.29/224.48  |- skos__altLabel mesh__D015378 N-Formimidoylthienamycin
% 224.29/224.48  |- mesh__dateCreated mesh__D015378 1988-06-03
% 224.29/224.48  |- mesh__historyNote mesh__D015378 89   
% 224.29/224.48  |- skos__scopeNote mesh__D015378
% 224.29/224.48       Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor.%A%    
% 224.29/224.48  |- skos__broader mesh__D015378smesh__D013845
% 224.29/224.48  |- skos__hiddenLabel mesh__D015378 N Formimidoylthienamycin
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D015378 2006
% 224.29/224.48  |- mesh__recordOriginator mesh__D015378 RLS
% 224.29/224.48  |- mesh__recordMaintainer mesh__D015378 ssb
% 224.29/224.48  |- skos__historyNote mesh__D015378 Thienamycins %28%1983-1988%29%
% 224.29/224.48  |- mesh__dateEstablished mesh__D015378 1989-01-01
% 224.29/224.48  |- skos__altLabel mesh__D015378 Imipemide
% 224.29/224.48  |- mesh__recordAuthorizer mesh__D001358 sjn
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D001358 2006
% 224.29/224.48  |- skos__altLabel mesh__D001358 Avian Sarcoma Virus B77
% 224.29/224.48  |- skos__hiddenLabel mesh__D001358 Sarcoma Virus, Rous
% 224.29/224.48  |- rdf__type mesh__D001358sskos__Concept
% 224.29/224.48  |- skos__hiddenLabel mesh__D001358 Avian Sarcoma Virus
% 224.29/224.48  |- skos__broader mesh__D001358smesh__D001355
% 224.29/224.48  |- mesh__recordOriginator mesh__D001358 NLM
% 224.29/224.48  |- mesh__dateCreated mesh__D001358 1999-01-01
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D001358 2003
% 224.29/224.48  |- skos__hiddenLabel mesh__D001358 Viruses, Avian Sarcoma
% 224.29/224.48  |- mesh__onlineNote mesh__D001358
% 224.29/224.48       use SARCOMA VIRUSES, AVIAN to search AVIAN SARCOMA VIRUSES 1983-93, CHICKEN SARCOMA VIRUS B77 %26% AVIAN SARCOMA VIRUS B77 1975-93, and ROUS SARCOMA VIRUS 1966-82%A%  
% 224.29/224.48  |- mesh__publicMeSHNote mesh__D001358
% 224.29/224.48       94; was AVIAN SARCOMA VIRUSES 1983-93, was ROUS SARCOMA VIRUS 1963-82; CHICKEN SARCOMA VIRUS B77 was heading 1975-93 %28%see under AVIAN SARCOMA VIRUSES 1983-90, see under ROUS SARCOMA VIRUS 1975-82%29%; AVIAN SARCOMA VIRUS B77 was see CHICKEN SARCOMA VIRUS B77 1975-93%A%  
% 224.29/224.48  |- skos__hiddenLabel mesh__D001358 Virus, Avian Sarcoma
% 224.29/224.48  |- mesh__historyNote mesh__D001358
% 224.29/224.48       94; was AVIAN SARCOMA VIRUSES 1983-93, was ROUS SARCOMA VIRUS 1963-82; CHICKEN SARCOMA VIRUS B77 was heading 1975-93 %28%see under AVIAN SARCOMA VIRUSES 1983-90, see under ROUS SARCOMA VIRUS 1975-82%29%; AVIAN SARCOMA VIRUS B77 was see CHICKEN SARCOMA VIRUS B77 1975-93%A%  
% 224.29/224.48  |- skos__annotation mesh__D001358
% 224.29/224.48       infection: coord IM with SARCOMA, AVIAN %28%IM%29% but see note there%A%  
% 224.29/224.48  |- skos__hiddenLabel mesh__D001358 Virus, Rous Sarcoma
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D001358 2002
% 224.29/224.48  |- skos__scopeNote mesh__D001358
% 224.29/224.48       Group of alpharetroviruses %28%ALPHARETROVIRUS%29% producing sarcomata and other tumors in chickens and other fowl and also in pigeons, ducks, and RATS.%A%    
% 224.29/224.48  |- skos__hiddenLabel mesh__D001358 Sarcoma Virus, Avian
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D001358 2004
% 224.29/224.48  |- mesh__recordMaintainer mesh__D001358 ags
% 224.29/224.48  |- mesh__dateRevised mesh__D001358 2001-07-25
% 224.29/224.48  |- skos__prefLabel mesh__D001358 Sarcoma Viruses, Avian
% 224.29/224.48  |- skos__altLabel mesh__D001358 Avian Sarcoma Viruses
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D001358 2005
% 224.29/224.48  |- mesh__historyNote mesh__D012080 72; was RICKETS, RENAL 1963-71   
% 224.29/224.48  |- mesh__dateEstablished mesh__D012080 1972-01-01
% 224.29/224.48  |- mesh__recordOriginator mesh__D012080 NLM
% 224.29/224.48  |- skos__altLabel mesh__D012080 Osteodystrophy, Renal
% 224.29/224.48  |- mesh__dateCreated mesh__D012080 1999-01-01
% 224.29/224.48  |- mesh__recordAuthorizer mesh__D012080 sjn
% 224.29/224.48  |- skos__scopeNote mesh__D012080
% 224.29/224.48       Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders.%A%    
% 224.29/224.48  |- rdf__type mesh__D012080sskos__Concept
% 224.29/224.48  |- mesh__publicMeSHNote mesh__D012080 72; was RICKETS, RENAL 1963-71   
% 224.29/224.48  |- skos__hiddenLabel mesh__D012080 Osteodystrophies, Renal
% 224.29/224.48  |- skos__altLabel mesh__D012080 Rickets, Renal
% 224.29/224.48  |- skos__hiddenLabel mesh__D012080 Renal Osteodystrophies
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D012080 2006
% 224.29/224.48  |- mesh__recordMaintainer mesh__D012080 lkt
% 224.29/224.48  |- skos__broader mesh__D012080smesh__D001851
% 224.29/224.48  |- skos__prefLabel mesh__D012080 Renal Osteodystrophy
% 224.29/224.48  |- skos__broader mesh__D012080smesh__D006962
% 224.29/224.48  |- skos__broader mesh__D012080smesh__D007674
% 224.29/224.48  |- mesh__onlineNote mesh__D012080
% 224.29/224.48       use RENAL OSTEODYSTROPHY to search RICKETS, RENAL 1966-71%A%  
% 224.29/224.48  |- mesh__dateRevised mesh__D012080 2005-06-30
% 224.29/224.48  |- skos__annotation mesh__D006841
% 224.29/224.48       GEN; prefer specifics; used for mapping supplementary chemicals%A%  
% 224.29/224.48  |- mesh__recordMaintainer mesh__D006841 adp
% 224.29/224.48  |- rdf__type mesh__D006841sskos__Concept
% 224.29/224.48  |- mesh__dateRevised mesh__D006841 2000-06-21
% 224.29/224.48  |- mesh__historyNote mesh__D006841 98; use explode 1967-97   
% 224.29/224.48  |- skos__broader mesh__D006841smesh__D006844
% 224.29/224.48  |- mesh__dateEstablished mesh__D006841 1998-01-01
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D006841 2004
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D006841 2002
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D006841 2006
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D006841 2003
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D006841 2001
% 224.29/224.48  |- mesh__publicMeSHNote mesh__D006841 98   
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D006841 2005
% 224.29/224.48  |- mesh__recordOriginator mesh__D006841 NLM
% 224.29/224.48  |- skos__scopeNote mesh__D006841
% 224.29/224.48       Organic compounds containing carbon and hydrogen in the form of an unsaturated, usually hexagonal ring structure. The compounds can be single ring, or double, triple, or multiple fused rings.%A%    
% 224.29/224.48  |- skos__prefLabel mesh__D006841 Hydrocarbons, Aromatic
% 224.29/224.48  |- skos__altLabel mesh__D006841 Aromatic Hydrocarbons
% 224.29/224.48  |- mesh__dateCreated mesh__D006841 1999-01-01
% 224.29/224.48  |- mesh__recordAuthorizer mesh__D006841 sjn
% 224.29/224.48  |- mesh__dateEstablished mesh__D020512 2000-01-01
% 224.29/224.48  |- mesh__recordOriginator mesh__D020512 KEV
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D020512 2001
% 224.29/224.48  |- mesh__dateCreated mesh__D020512 1999-11-03
% 224.29/224.48  |- skos__hiddenLabel mesh__D020512 Syndrome, Shy-Magee
% 224.29/224.48  |- skos__historyNote mesh__D020512 Muscles/enzymology %28%1963-1999%29%
% 224.29/224.48  |- skos__hiddenLabel mesh__D020512 Central Core Myopathies
% 224.29/224.48  |- skos__hiddenLabel mesh__D020512 Myopathies, Central Core
% 224.29/224.48  |- skos__altLabel mesh__D020512 Central Core Disease
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D020512 2004
% 224.29/224.48  |- rdf__type mesh__D020512sskos__Concept
% 224.29/224.48  |- skos__historyNote mesh__D020512 Muscular Atrophy %28%1963-1999%29%
% 224.29/224.48  |- skos__scopeNote mesh__D020512
% 224.29/224.48       An inherited congenital myopathic condition characterized by weakness and hypotonia in infancy and delayed motor development. Muscle biopsy reveals a condensation of myofibrils and myofibrillar material in the central portion of each muscle fiber. %28%Adams et al., Principles of Neurology, 6th ed, p1452%29%%A%    
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D020512 2006
% 224.29/224.48  |- mesh__recordAuthorizer mesh__D020512 sjn
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D020512 2003
% 224.29/224.48  |- mesh__publicMeSHNote mesh__D020512
% 224.29/224.48       2000; for CENTRAL CORE DISEASE %26% SHY-MAGEE SYNDROME see NEMALINE MYOPATHY 1994-1999%A%  
% 224.29/224.48  |- mesh__historyNote mesh__D020512
% 224.29/224.48       2000; for CENTRAL CORE DISEASE %26% SHY-MAGEE SYNDROME use NEMALINE MYOPATHY 1994-1999%A%  
% 224.29/224.48  |- mesh__dateRevised mesh__D020512 2000-06-22
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D020512 2005
% 224.29/224.48  |- mesh__recordMaintainer mesh__D020512 sjn
% 224.29/224.48  |- skos__broader mesh__D020512smesh__D020914
% 224.29/224.48  |- skos__hiddenLabel mesh__D020512 Shy Magee Syndrome
% 224.29/224.48  |- skos__prefLabel mesh__D020512 Myopathy, Central Core
% 224.29/224.48  |- skos__altLabel mesh__D020512 Central Core Myopathy
% 224.29/224.48  |- skos__hiddenLabel mesh__D020512 Central Core Diseases
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D020512 2002
% 224.29/224.48  |- skos__altLabel mesh__D020512 Shy-Magee Syndrome
% 224.29/224.48  |- mesh__recordAuthorizer mesh__D006043 sjn
% 224.29/224.48  |- rdf__type mesh__D006043sskos__Concept
% 224.29/224.48  |- mesh__recordOriginator mesh__D006043 NLM
% 224.29/224.48  |- skos__prefLabel mesh__D006043 Goiter, Endemic
% 224.29/224.48  |- mesh__historyNote mesh__D006043 72%28%69%29%   
% 224.29/224.48  |- skos__altLabel mesh__D006043 Endemic Goiter
% 224.29/224.48  |- skos__broader mesh__D006043smesh__D006042
% 224.29/224.48  |- skos__historyNote mesh__D006043 Goiter %28%1966-1968%29%
% 224.29/224.48  |- mesh__publicMeSHNote mesh__D006043 72   
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D006043 2006
% 224.29/224.48  |- mesh__dateEstablished mesh__D006043 1972-01-01
% 224.29/224.48  |- skos__hiddenLabel mesh__D006043 Goiters, Endemic
% 224.29/224.48  |- skos__scopeNote mesh__D006043
% 224.29/224.48       A form of IODINE deficiency disorders characterized by an enlargement of the THYROID GLAND in a significantly large fraction of a POPULATION GROUP. Endemic goiter is common in mountainous and iodine-deficient areas of the world where the DIET contains insufficient amount of iodine.%A%    
% 224.29/224.48  |- skos__hiddenLabel mesh__D006043 Endemic Goiters
% 224.29/224.48  |- mesh__recordMaintainer mesh__D006043 lkt
% 224.29/224.48  |- mesh__dateCreated mesh__D006043 1999-01-01
% 224.29/224.48  |- mesh__dateRevised mesh__D006043 2005-06-30
% 224.29/224.48  |- skos__prefLabel mesh__D011786 Quality Control
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D011786 2005
% 224.29/224.48  |- mesh__recordOriginator mesh__D011786 NLM
% 224.29/224.48  |- skos__broader mesh__D011786smesh__D013672
% 224.29/224.48  |- mesh__dateRevised mesh__D011786 1995-03-13
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D011786 2006
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D011786 2000
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D011786 1998
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D011786 2003
% 224.29/224.48  |- skos__scopeNote mesh__D011786
% 224.29/224.48       A system for verifying and maintaining a desired level of quality in a product or process by careful planning, use of proper equipment, continued inspection, and corrective action as required. %28%Random House Unabridged Dictionary, 2d ed%29%%A%    
% 224.29/224.48  |- skos__related mesh__D011786smesh__D017749
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D011786 2001
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D011786 1999
% 224.29/224.48  |- skos__related mesh__D011786smesh__D012015
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D011786 2004
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D011786 1996
% 224.29/224.48  |- mesh__recordMaintainer mesh__D011786 TGC
% 224.29/224.48  |- rdf__type mesh__D011786sskos__Concept
% 224.29/224.48  |- mesh__recordAuthorizer mesh__D011786 PLS
% 224.29/224.48  |- skos__hiddenLabel mesh__D011786 Quality Controls
% 224.29/224.48  |- skos__hiddenLabel mesh__D011786 Controls, Quality
% 224.29/224.48  |- mesh__historyNote mesh__D011786 74%28%71%29%   
% 224.29/224.48  |- mesh__publicMeSHNote mesh__D011786 74   
% 224.29/224.48  |- mesh__dateEstablished mesh__D011786 1974-01-01
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D011786 1997
% 224.29/224.48  |- skos__hiddenLabel mesh__D011786 Control, Quality
% 224.29/224.48  |- skos__annotation mesh__D011786 NIM; no qualif   
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D011786 2002
% 224.29/224.48  |- mesh__dateCreated mesh__D011786 1999-01-01
% 224.29/224.48  |- skos__altLabel mesh__D044162 Parathyroid Hormone-Like Protein
% 224.29/224.48  |- skos__hiddenLabel mesh__D044162 PTH Like Protein
% 224.29/224.48  |- mesh__activeMeSHYear mesh__D044162 2006
% 224.29/224.48  |- mesh__dateEstablished mesh__D044162 2004-01-01
% 224.29/224.48  |- skos__related mesh__D044162smesh__D018016
% 224.29/224.48  |- skos__altLabel mesh__D044162 PTH Like Tumor Factor
% 224.29/224.48  |- skos__hiddenLabel mesh__D044162 Hormone-Related Protein, Parathyroid
% 224.29/224.48  |- mesh__recordAuthorizer mesh__D044162 sjn
% 224.29/224.48  |- rdf__type mesh__D044162sskos__Concept
% 224.29/224.48  |- skos__hiddenLabel mesh__D044162 Parathyroid Hormone Related Protein
% 224.29/224.48  |- mesh__dateRevised mesh__D044162 2005-06-30
% 224.29/224.48  |- skos__altLabel mesh__D044162 PTHrP
% 224.29/224.48  |- mesh__publicMeSHNote mesh__D044162
% 224.29/224.48       2004; PARATHYROID HORMONE-RELATED PROTEIN was indexed under PEPTIDE HORMONES 2003; PROTEINS 1987-2002%A%  
% 224.29/224.48  |- skos__hiddenLabel mesh__D044162 Parathyroid Hormone Like Protein
% 224.29/224.48  |- skos__altLabel mesh__D044162 Hypercalcemic Hormone of Malignancy
% 224.29/224.48  |- skos__hiddenLabel mesh__D044162 Hypercalcemic Factor, Tumor
% 224.29/224.48  |- skos__historyNote mesh__D044162 Proteins %28%1987-2002%29%
% 224.29/224.48  |- skos__altLabel mesh__D044162 Tumor Hypercalcemic Factor
% 224.29/224.48  |- mesh__recordMaintainer mesh__D044162 ssb
% 224.29/224.48  |- skos__prefLabel mesh__D044162 Parathyroid Hormone-Related Protein
% 224.29/224.48  |- mesh__recordOriginator mesh__D044162 jmp
% 224.29/224.48  |- skos__hiddenLabel mesh__D044162 PTH Related Peptide
% 224.29/224.48  |- skos__altLabel mesh__D044162 PTH-Related Peptide
% 224.29/224.48  |- mesh__dateCreated mesh__D044162 2003-07-09
% 224.29/224.48  |- skos__altLabel mesh__D044162 Parathyroid Hormone-Related Peptide
% 224.29/224.48  |- skos__broader mesh__D044162smesh__D036361
% 224.29/224.48  |- skos__hiddenLabel mesh__D044162 Parathyroid Hormone Related Peptide
% 224.29/224.49  |- skos__scopeNote mesh__D044162
% 224.29/224.49       A ubiquitously expressed, secreted protein with bone resorption and renal calcium reabsorption activities that are similar to PARATHYROID HORMONE. It does not circulate in appreciable amounts in normal subjects, but rather exerts its biological actions locally. Overexpression of parathyroid hormone-related protein by tumor cells results in humoral calcemia of malignancy.%A%    
% 224.29/224.49  |- skos__altLabel mesh__D044162 Parathyroid Hormone Like Tumor Factor
% 224.29/224.49  |- mesh__historyNote mesh__D044162
% 224.29/224.49       2004; use PARATHYROID HORMONE-RELATED PROTEIN %28%NM%29% 1987-2003%A%  
% 224.29/224.49  |- skos__historyNote mesh__D044162 Peptide Hormones %28%2003%29%
% 224.29/224.49  |- skos__related mesh__D044162smesh__D010281
% 224.29/224.49  |- skos__altLabel mesh__D044162 PTH-Like Protein
% 224.29/224.49  |- skos__broader mesh__D044162smesh__D036341
% 224.29/224.49  |- skos__annotation mesh__D044162 see SCR for organism specific terms   
% 224.29/224.49  |- skos__hiddenLabel mesh__D005749
% 224.29/224.49       Glucose Dependent Insulin Releasing Peptide
% 224.29/224.49  |- mesh__dateCreated mesh__D005749 1976-04-13
% 224.29/224.49  |- skos__scopeNote mesh__D005749
% 224.29/224.49       A gastrointestinal peptide hormone of about 43-amino acids.%A%    
% 224.29/224.49  |- skos__broader mesh__D005749smesh__D036361
% 224.29/224.49  |- skos__altLabel mesh__D005749 Glucose-Dependent Insulinotropic Peptide
% 224.29/224.49  |- skos__prefLabel mesh__D005749 Gastric Inhibitory Polypeptide
% 224.29/224.49  |- mesh__recordAuthorizer mesh__D005749 sjn
% 224.29/224.49  |- skos__altLabel mesh__D005749 Glucose Dependent Insulinotropic Peptide
% 224.29/224.49  |- skos__hiddenLabel mesh__D005749 Polypeptide, Gastric Inhibitory
% 224.29/224.49  |- skos__hiddenLabel mesh__D005749
% 224.29/224.49       Insulin-Releasing Peptide, Glucose-Dependent
% 224.29/224.49  |- skos__hiddenLabel mesh__D005749 Polypeptide, Gastric-Inhibitory
% 224.29/224.49  |- skos__annotation mesh__D005749 DF: GIP   
% 224.29/224.49  |- skos__historyNote mesh__D005749
% 224.29/224.49       Gastrointestinal Hormones %28%1974-1976%29%
% 224.29/224.49  |- mesh__publicMeSHNote mesh__D005749
% 224.29/224.49       86; was see under GASTROINTESTINAL HORMONES 1977-85   
% 224.29/224.49  |- mesh__dateEstablished mesh__D005749 1986-01-01
% 224.29/224.49  |- skos__hiddenLabel mesh__D005749
% 224.29/224.49       Peptide, Glucose-Dependent Insulinotropic
% 224.29/224.49  |- skos__historyNote mesh__D005749 Peptides %28%1974-1976%29%
% 224.29/224.49  |- mesh__historyNote mesh__D005749
% 224.29/224.49       86%28%77%29%; was see under GASTROINTESTINAL HORMONES 1977-85   
% 224.29/224.49  |- skos__hiddenLabel mesh__D005749
% 224.29/224.49       Insulinotropic Peptide, Glucose-Dependent
% 224.29/224.49  |- skos__altLabel mesh__D005749 Glucose-Dependent Insulin-Releasing Peptide
% 224.29/224.49  |- skos__broader mesh__D005749smesh__D009479
% 224.29/224.49  |- skos__broader mesh__D005749smesh__D005768
% 224.29/224.49  |- skos__altLabel mesh__D005749 Gastric-Inhibitory Polypeptide
% 224.29/224.49  |- mesh__recordMaintainer mesh__D005749 ssb
% 224.29/224.49  |- mesh__dateRevised mesh__D005749 2005-06-30
% 224.29/224.49  |- skos__hiddenLabel mesh__D005749
% 224.29/224.49       Peptide, Glucose-Dependent Insulin-Releasing
% 224.29/224.49  |- skos__hiddenLabel mesh__D005749 Inhibitory Polypeptide, Gastric
% 224.29/224.49  |- rdf__type mesh__D005749sskos__Concept
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D005749 2006
% 224.29/224.49  |- mesh__recordOriginator mesh__D005749 RLS
% 224.29/224.49  |- skos__historyNote mesh__D016471
% 224.29/224.49       Ovulation Induction/adverse effects %28%1978-1991%29%
% 224.29/224.49  |- mesh__dateCreated mesh__D016471 1991-05-02
% 224.29/224.49  |- mesh__dateRevised mesh__D016471 2005-06-30
% 224.29/224.49  |- skos__related mesh__D016471smesh__D010062
% 224.29/224.49  |- skos__hiddenLabel mesh__D016471 Hyperstimulation Syndrome, Ovarian
% 224.29/224.49  |- mesh__recordOriginator mesh__D016471 AGS
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D016471 2006
% 224.29/224.49  |- skos__prefLabel mesh__D016471 Ovarian Hyperstimulation Syndrome
% 224.29/224.49  |- mesh__publicMeSHNote mesh__D016471 92   
% 224.29/224.49  |- skos__scopeNote mesh__D016471
% 224.29/224.49       A complication of OVULATION INDUCTION in infertility treatment. It is graded by the severity of symptoms which include OVARY enlargement, multiple OVARIAN FOLLICLES; OVARIAN CYSTS; ASCITES; and generalized EDEMA. The full-blown syndrome may lead to RENAL FAILURE, respiratory distress, and even DEATH. Increased capillary permeability is caused by the vasoactive substances, such as VASCULAR ENDOTHELIAL GROWTH FACTORS, secreted by the overly-stimulated OVARIES.%A%    
% 224.29/224.49  |- mesh__recordAuthorizer mesh__D016471 sjn
% 224.29/224.49  |- skos__hiddenLabel mesh__D016471 Ovarian Hyperstimulation Syndromes
% 224.29/224.49  |- rdf__type mesh__D016471sskos__Concept
% 224.29/224.49  |- mesh__recordMaintainer mesh__D016471 lkt
% 224.29/224.49  |- mesh__historyNote mesh__D016471 92   
% 224.29/224.49  |- skos__hiddenLabel mesh__D016471 Hyperstimulation Syndromes, Ovarian
% 224.29/224.49  |- skos__historyNote mesh__D016471 Ovarian Diseases %28%1966-1991%29%
% 224.29/224.49  |- skos__broader mesh__D016471smesh__D010049
% 224.29/224.49  |- mesh__dateEstablished mesh__D016471 1992-01-01
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D002451 1999
% 224.29/224.49  |- mesh__recordMaintainer mesh__D002451 TAP
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D002451 1993
% 224.29/224.49  |- mesh__historyNote mesh__D002451 78   
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D002451 2003
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D002451 1995
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D002451 2005
% 224.29/224.49  |- mesh__dateCreated mesh__D002451 1977-03-01
% 224.29/224.49  |- mesh__dateEstablished mesh__D002451 1978-01-01
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D002451 2000
% 224.29/224.49  |- skos__hiddenLabel mesh__D002451 Compartmentations, Cell
% 224.29/224.49  |- skos__prefLabel mesh__D002451 Cell Compartmentation
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D002451 2004
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D002451 2001
% 224.29/224.49  |- mesh__recordOriginator mesh__D002451 AEP
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D002451 2006
% 224.29/224.49  |- skos__scopeNote mesh__D002451
% 224.29/224.49       A partitioning within cells due to the selectively permeable membranes which enclose each of the separate parts, e.g., mitochondria, lysosomes, etc.%A%    
% 224.29/224.49  |- mesh__recordAuthorizer mesh__D002451 PLS
% 224.29/224.49  |- skos__annotation mesh__D002451 permitted with micro-organisms   
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D002451 1996
% 224.29/224.49  |- skos__broader mesh__D002451smesh__D002468
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D002451 1998
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D002451 2002
% 224.29/224.49  |- skos__hiddenLabel mesh__D002451 Compartmentation, Cell
% 224.29/224.49  |- skos__hiddenLabel mesh__D002451 Cell Compartmentations
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D002451 1997
% 224.29/224.49  |- mesh__publicMeSHNote mesh__D002451 78   
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D002451 1994
% 224.29/224.49  |- mesh__dateRevised mesh__D002451 1992-05-07
% 224.29/224.49  |- rdf__type mesh__D002451sskos__Concept
% 224.29/224.49  |- skos__hiddenLabel mesh__D015379 Beta, Recombinant Interferon
% 224.29/224.49  |- skos__historyNote mesh__D015379 Interferon Type I %28%1983-1988%29%
% 224.29/224.49  |- skos__hiddenLabel mesh__D015379 Alpha, Recombinant Interferon
% 224.29/224.49  |- skos__prefLabel mesh__D015379 Interferon Type I, Recombinant
% 224.29/224.49  |- mesh__recordMaintainer mesh__D015379 ssb
% 224.29/224.49  |- skos__broader mesh__D015379smesh__D007370
% 224.29/224.49  |- skos__hiddenLabel mesh__D015379 Recombinant Interferon Alpha
% 224.29/224.49  |- mesh__recordAuthorizer mesh__D015379 sjn
% 224.29/224.49  |- skos__scopeNote mesh__D015379
% 224.29/224.49       A type I interferon with antiviral and antineoplastic activity produced by recombinant DNA technology. It can be a mixture of alpha and beta interferons.%A%    
% 224.29/224.49  |- mesh__historyNote mesh__D015379 2000%28%1989%29%   
% 224.29/224.49  |- skos__annotation mesh__D015379
% 224.29/224.49       spelling %22%alfa%22% is commonly used for recombinant form   
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D015379 2006
% 224.29/224.49  |- skos__broader mesh__D015379smesh__D011994
% 224.29/224.49  |- skos__hiddenLabel mesh__D015379 Recombinant Interferon Beta
% 224.29/224.49  |- mesh__dateCreated mesh__D015379 1988-06-06
% 224.29/224.49  |- skos__altLabel mesh__D015379 Interferon Alpha, Recombinant
% 224.29/224.49  |- mesh__dateEstablished mesh__D015379 1989-01-01
% 224.29/224.49  |- skos__historyNote mesh__D015379 Recombinant Proteins %28%1986-1988%29%
% 224.29/224.49  |- mesh__publicMeSHNote mesh__D015379
% 224.29/224.49       2000; see INTERFERON ALFA, RECOMBINANT 1989-1999   
% 224.29/224.49  |- skos__hiddenLabel mesh__D015379 Recombinant Interferon Alfa
% 224.29/224.49  |- mesh__dateRevised mesh__D015379 2005-06-30
% 224.29/224.49  |- rdf__type mesh__D015379sskos__Concept
% 224.29/224.49  |- mesh__recordOriginator mesh__D015379 RLS
% 224.29/224.49  |- mesh__publicMeSHNote mesh__D001359 PARACHUTING was heading 1963-82   
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D001359 1999
% 224.29/224.49  |- mesh__dateRevised mesh__D001359 1997-06-20
% 224.29/224.49  |- mesh__historyNote mesh__D001359 PARACHUTING was heading 1963-82   
% 224.29/224.49  |- mesh__dateCreated mesh__D001359 1999-01-01
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D001359 2003
% 224.29/224.49  |- skos__scopeNote mesh__D001359
% 224.29/224.49       Design, development, manufacture, and operation of heavier-than-air aircraft.%A%    
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D001359 2000
% 224.29/224.49  |- mesh__recordAuthorizer mesh__D001359 SJN
% 224.29/224.49  |- mesh__recordMaintainer mesh__D001359 JLS
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D001359 2004
% 224.29/224.49  |- mesh__onlineNote mesh__D001359
% 224.29/224.49       use AVIATION to search PARACHUTING 1966-82   
% 224.29/224.49  |- mesh__recordOriginator mesh__D001359 NLM
% 224.29/224.49  |- skos__related mesh__D001359smesh__D000401
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D001359 2001
% 224.29/224.49  |- skos__annotation mesh__D001359
% 224.29/224.49       for med, physiol, psychol aspects of flying index AEROSPACE MEDICINE; SPEC: SPEC qualif; Manual 28.8%A%  
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D001359 2005
% 224.29/224.49  |- skos__broader mesh__D001359smesh__D014186
% 224.29/224.49  |- skos__prefLabel mesh__D001359 Aviation
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D001359 2002
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D001359 2006
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D001359 1998
% 224.29/224.49  |- rdf__type mesh__D001359sskos__Concept
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D006842 1994
% 224.29/224.49  |- mesh__recordMaintainer mesh__D006842 TGC
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D006842 1999
% 224.29/224.49  |- rdf__type mesh__D006842sskos__Concept
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D006842 2005
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D006842 1993
% 224.29/224.49  |- skos__prefLabel mesh__D006842 Hydrocarbons, Brominated
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D006842 1995
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D006842 2004
% 224.29/224.49  |- mesh__historyNote mesh__D006842 74   
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D006842 2002
% 224.29/224.49  |- skos__broader mesh__D006842smesh__D006846
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D006842 2006
% 224.29/224.49  |- skos__altLabel mesh__D006842 Brominated Hydrocarbons
% 224.29/224.49  |- mesh__dateEstablished mesh__D006842 1974-01-01
% 224.29/224.49  |- mesh__dateCreated mesh__D006842 1999-01-01
% 224.29/224.49  |- mesh__dateRevised mesh__D006842 1992-05-19
% 224.29/224.49  |- mesh__publicMeSHNote mesh__D006842 74   
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D006842 2000
% 224.29/224.49  |- mesh__recordAuthorizer mesh__D006842 PLS
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D006842 1996
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D006842 2001
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D006842 1998
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D006842 1997
% 224.29/224.49  |- mesh__recordOriginator mesh__D006842 NLM
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D006842 2003
% 224.29/224.49  |- mesh__historyNote mesh__D020513 2000   
% 224.29/224.49  |- skos__altLabel mesh__D020513 Primary Hyperkalemic Periodic Paralysis
% 224.29/224.49  |- skos__broader mesh__D020513smesh__D010245
% 224.29/224.49  |- skos__altLabel mesh__D020513 Paralysis, Periodic, Hyperkalemic, Familial
% 224.29/224.49  |- skos__altLabel mesh__D020513 Adynamia Episodica Hereditaria
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D020513 2002
% 224.29/224.49  |- skos__altLabel mesh__D020513 Hyperkalemic Periodic Paralysis, Familial
% 224.29/224.49  |- skos__altLabel mesh__D020513 Hyperkalemic Periodic Paralysis
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D020513 2004
% 224.29/224.49  |- skos__hiddenLabel mesh__D020513 Paralyses, Hyperkalemic Periodic
% 224.29/224.49  |- skos__historyNote mesh__D020513
% 224.29/224.49       Paralyses, Familial Periodic %28%1966-1999%29%
% 224.29/224.49  |- rdf__type mesh__D020513sskos__Concept
% 224.29/224.49  |- skos__hiddenLabel mesh__D020513 Periodic Paralysis, Myotonic
% 224.29/224.49  |- mesh__recordMaintainer mesh__D020513 nns
% 224.29/224.49  |- mesh__recordOriginator mesh__D020513 KEV
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D020513 2006
% 224.29/224.49  |- mesh__dateCreated mesh__D020513 1999-11-03
% 224.29/224.49  |- skos__prefLabel mesh__D020513 Paralysis, Hyperkalemic Periodic
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D020513 2003
% 224.29/224.49  |- skos__altLabel mesh__D020513 Myotonic Periodic Paralysis
% 224.29/224.49  |- skos__altLabel mesh__D020513 Familial Hyperkalemic Periodic Paralysis
% 224.29/224.49  |- mesh__publicMeSHNote mesh__D020513 2000   
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D020513 2005
% 224.29/224.49  |- mesh__dateRevised mesh__D020513 2001-07-25
% 224.29/224.49  |- skos__scopeNote mesh__D020513
% 224.29/224.49       An autosomal dominant familial disorder which presents in infancy or childhood and is characterized by episodes of weakness associated with hyperkalemia. During attacks, muscles of the lower extremities are initially affected, followed by the lower trunk and arms. Episodes last from 15-60 minutes and typically occur after a period of rest following exercise. A defect in skeletal muscle sodium channels has been identified as the cause of this condition. Normokalemic periodic paralysis is a closely related disorder marked by a lack of alterations in potassium levels during attacks of weakness. %28%Adams et al., Principles of Neurology, 6th ed, p1481%29%%A%    
% 224.29/224.49  |- skos__hiddenLabel mesh__D020513 Paralysis, Myotonic Periodic
% 224.29/224.49  |- mesh__recordAuthorizer mesh__D020513 sjn
% 224.29/224.49  |- skos__hiddenLabel mesh__D020513 Myotonic Periodic Paralyses
% 224.29/224.49  |- skos__related mesh__D020513smesh__D006947
% 224.29/224.49  |- skos__hiddenLabel mesh__D020513 Paralyses, Myotonic Periodic
% 224.29/224.49  |- skos__hiddenLabel mesh__D020513 Periodic Paralyses, Myotonic
% 224.29/224.49  |- mesh__dateEstablished mesh__D020513 2000-01-01
% 224.29/224.49  |- skos__hiddenLabel mesh__D020513 Periodic Paralysis, Hyperkalemic
% 224.29/224.49  |- skos__hiddenLabel mesh__D020513 Periodic Paralyses, Hyperkalemic
% 224.29/224.49  |- skos__hiddenLabel mesh__D020513 Hyperkalemic Periodic Paralyses
% 224.29/224.49  |- skos__scopeNote mesh__D006044
% 224.29/224.49       An enlarged THYROID GLAND containing multiple nodules %28%THYROID NODULE%29%, usually resulting from recurrent thyroid HYPERPLASIA and involution over many years to produce the irregular enlargement. Multinodular goiters may be nontoxic or may induce THYROTOXICOSIS.%A%    
% 224.29/224.49  |- mesh__recordMaintainer mesh__D006044 lkt
% 224.29/224.49  |- mesh__publicMeSHNote mesh__D006044 73   
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D006044 2006
% 224.29/224.49  |- mesh__dateRevised mesh__D006044 2005-06-30
% 224.29/224.49  |- mesh__dateEstablished mesh__D006044 1973-01-01
% 224.29/224.49  |- mesh__recordAuthorizer mesh__D006044 sjn
% 224.29/224.49  |- mesh__historyNote mesh__D006044 73%28%71%29%   
% 224.29/224.49  |- mesh__dateCreated mesh__D006044 1999-01-01
% 224.29/224.49  |- skos__historyNote mesh__D006044 Goiter %28%1966-1971%29%
% 224.29/224.49  |- mesh__recordOriginator mesh__D006044 NLM
% 224.29/224.49  |- skos__broader mesh__D006044smesh__D006042
% 224.29/224.49  |- rdf__type mesh__D006044sskos__Concept
% 224.29/224.49  |- skos__hiddenLabel mesh__D006044 Goiters, Nodular
% 224.29/224.49  |- skos__hiddenLabel mesh__D006044 Nodular Goiters
% 224.29/224.49  |- skos__prefLabel mesh__D006044 Goiter, Nodular
% 224.29/224.49  |- skos__altLabel mesh__D006044 Nodular Goiter
% 224.29/224.49  |- rdf__type mesh__D011787sskos__Concept
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D011787 2004
% 224.29/224.49  |- mesh__recordMaintainer mesh__D011787 kle
% 224.29/224.49  |- skos__related mesh__D011787smesh__D011367
% 224.29/224.49  |- skos__altLabel mesh__D011787 Quality of Healthcare
% 224.29/224.49  |- skos__annotation mesh__D011787 IM   
% 224.29/224.49  |- mesh__dateEstablished mesh__D011787 1968-01-01
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D011787 2002
% 224.29/224.49  |- skos__prefLabel mesh__D011787 Quality of Health Care
% 224.29/224.49  |- skos__broader mesh__D011787smesh__D017530
% 224.29/224.49  |- skos__broader mesh__D011787smesh__D006298
% 224.29/224.49  |- mesh__recordOriginator mesh__D011787 NLM
% 224.29/224.49  |- mesh__dateRevised mesh__D011787 1999-11-03
% 224.29/224.49  |- skos__hiddenLabel mesh__D011787 Health Care Quality
% 224.29/224.49  |- mesh__dateCreated mesh__D011787 1999-01-01
% 224.29/224.49  |- mesh__recordAuthorizer mesh__D011787 sjn
% 224.29/224.49  |- skos__related mesh__D011787smesh__D016749
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D011787 2005
% 224.29/224.49  |- mesh__publicMeSHNote mesh__D011787 68   
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D011787 2000
% 224.29/224.49  |- mesh__historyNote mesh__D011787 68   
% 224.29/224.49  |- mesh__onlineNote mesh__D011787
% 224.29/224.49       pre-explosion = QUALITY OF HEALTH CARE %28%PX%29%   
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D011787 2006
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D011787 2001
% 224.29/224.49  |- skos__hiddenLabel mesh__D011787 Healthcare Quality
% 224.29/224.49  |- skos__scopeNote mesh__D011787
% 224.29/224.49       The levels of excellence which characterize the health service or health care provided based on accepted standards of quality.%A%    
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D011787 2003
% 224.29/224.49  |- mesh__dateEstablished mesh__D044163 2004-01-01
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D044163 2006
% 224.29/224.49  |- skos__annotation mesh__D044163
% 224.29/224.49       infection: coord IM with VIBRIO INFECTIONS %28%IM%29%   
% 224.29/224.49  |- skos__scopeNote mesh__D044163
% 224.29/224.49       A strain of the VIBRIO CHOLERAE bacteria belonging to serogroup non-O1, infecting humans and other PRIMATES. It is related to VIBRIO CHOLERAE O1, but causes a disease less severe than CHOLERA. Eating raw shellfish contaminated with the bacteria results in GASTROENTERITIS.%A%    
% 224.29/224.49  |- rdf__type mesh__D044163sskos__Concept
% 224.29/224.49  |- mesh__dateCreated mesh__D044163 2003-07-09
% 224.29/224.49  |- mesh__recordAuthorizer mesh__D044163 sjn
% 224.29/224.49  |- skos__prefLabel mesh__D044163 Vibrio cholerae non-O1
% 224.29/224.49  |- mesh__recordOriginator mesh__D044163 ags
% 224.29/224.49  |- mesh__dateRevised mesh__D044163 2005-06-30
% 224.29/224.49  |- skos__historyNote mesh__D044163 Vibrio cholerae %28%1981-2003%29%
% 224.29/224.49  |- skos__broader mesh__D044163smesh__D014734
% 224.29/224.49  |- mesh__historyNote mesh__D044163 2004   
% 224.29/224.49  |- mesh__publicMeSHNote mesh__D044163 2004   
% 224.29/224.49  |- mesh__recordMaintainer mesh__D044163 SYSTEM
% 224.29/224.49  |- skos__altLabel mesh__D016472 Motor Neuron Disease, Familial
% 224.29/224.49  |- skos__hiddenLabel mesh__D016472 Sclerosis, Lateral
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D016472 2004
% 224.29/224.49  |- skos__hiddenLabel mesh__D016472 Neuron Disease, Motor
% 224.29/224.49  |- skos__hiddenLabel mesh__D016472 Motor System Diseases
% 224.29/224.49  |- skos__hiddenLabel mesh__D016472 Lateral Scleroses
% 224.29/224.49  |- skos__hiddenLabel mesh__D016472 Primary Lateral Scleroses
% 224.29/224.49  |- mesh__dateCreated mesh__D016472 1991-06-21
% 224.29/224.49  |- skos__altLabel mesh__D016472 Secondary Motor Neuron Disease
% 224.29/224.49  |- skos__altLabel mesh__D016472 Motor System Disease
% 224.29/224.49  |- skos__scopeNote mesh__D016472
% 224.29/224.49       Diseases characterized by a selective degeneration of the motor neurons of the spinal cord, brainstem, or motor cortex. Clinical subtypes are distinguished by the major site of degeneration. In AMYOTROPHIC LATERAL SCLEROSIS there is involvement of upper, lower, and brainstem motor neurons. In progressive muscular atrophy and related syndromes %28%see MUSCULAR ATROPHY, SPINAL%29% the motor neurons in the spinal cord are primarily affected. With progressive bulbar palsy %28%BULBAR PALSY, PROGRESSIVE%29%, the initial degeneration occurs in the brainstem. In primary lateral sclerosis, the cortical neurons are affected in isolation. %28%Adams et al., Principles of Neurology, 6th ed, p1089%29%%A%    
% 224.29/224.49  |- mesh__dateRevised mesh__D016472 2004-07-28
% 224.29/224.49  |- skos__hiddenLabel mesh__D016472 Neuron Diseases, Motor
% 224.29/224.49  |- skos__hiddenLabel mesh__D016472 Sclerosis, Primary Lateral
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D016472 2002
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D016472 2003
% 224.29/224.49  |- mesh__recordMaintainer mesh__D016472 jls
% 224.29/224.49  |- skos__broader mesh__D016472smesh__D019636
% 224.29/224.49  |- skos__prefLabel mesh__D016472 Motor Neuron Disease
% 224.29/224.49  |- skos__altLabel mesh__D016472 Primary Lateral Sclerosis
% 224.29/224.49  |- skos__altLabel mesh__D016472 Lower Motor Neuron Disease
% 224.29/224.49  |- mesh__recordOriginator mesh__D016472 AGS
% 224.29/224.49  |- mesh__publicMeSHNote mesh__D016472 92   
% 224.29/224.49  |- mesh__dateEstablished mesh__D016472 1992-01-01
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D016472 2006
% 224.29/224.49  |- skos__hiddenLabel mesh__D016472 Lateral Scleroses, Primary
% 224.29/224.49  |- skos__broader mesh__D016472smesh__D009468
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D016472 2005A
% 224.29/224.49  |- skos__hiddenLabel mesh__D016472 Lateral Sclerosis, Primary
% 224.29/224.49  |- skos__hiddenLabel mesh__D016472 Motor Neuron Diseases
% 224.29/224.49  |- mesh__recordAuthorizer mesh__D016472 jls
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D016472 2001
% 224.29/224.49  |- mesh__historyNote mesh__D016472 92   
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D016472 2005
% 224.29/224.49  |- skos__annotation mesh__D016472 GEN or unspecified; prefer specifics   
% 224.29/224.49  |- skos__historyNote mesh__D016472 Motor Neurons %28%1966-1991%29%
% 224.29/224.49  |- skos__hiddenLabel mesh__D016472 Scleroses, Primary Lateral
% 224.29/224.49  |- skos__historyNote mesh__D016472 Neuromuscular Diseases %28%1972-1991%29%
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D016472 2000
% 224.29/224.49  |- rdf__type mesh__D016472sskos__Concept
% 224.29/224.49  |- skos__hiddenLabel mesh__D016472 Scleroses, Lateral
% 224.29/224.49  |- skos__altLabel mesh__D016472 Upper Motor Neuron Disease
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D002452 2006
% 224.29/224.49  |- mesh__publicMeSHNote mesh__D002452
% 224.29/224.49       73; CELL NUMBER was heading 1978-79   
% 224.29/224.49  |- mesh__dateCreated mesh__D002452 1999-01-01
% 224.29/224.49  |- skos__broader mesh__D002452smesh__D002468
% 224.29/224.49  |- skos__hiddenLabel mesh__D002452 Count, Cell
% 224.29/224.49  |- skos__prefLabel mesh__D002452 Cell Count
% 224.29/224.49  |- skos__altLabel mesh__D002452 Cell Number
% 224.29/224.49  |- skos__related mesh__D002452smesh__D001772
% 224.29/224.49  |- skos__hiddenLabel mesh__D002452 Number, Cell
% 224.29/224.49  |- skos__hiddenLabel mesh__D002452 Density, Cell
% 224.29/224.49  |- skos__hiddenLabel mesh__D002452 Cell Densities
% 224.29/224.49  |- mesh__historyNote mesh__D002452
% 224.29/224.49       73%28%69%29%; CELL NUMBER was heading 1978-79   
% 224.29/224.49  |- mesh__dateEstablished mesh__D002452 1973-01-01
% 224.29/224.49  |- mesh__dateRevised mesh__D002452 2003-07-09
% 224.29/224.49  |- skos__hiddenLabel mesh__D002452 Cell Counts
% 224.29/224.49  |- mesh__recordOriginator mesh__D002452 NLM
% 224.29/224.49  |- skos__hiddenLabel mesh__D002452 Numbers, Cell
% 224.29/224.49  |- skos__hiddenLabel mesh__D002452 Densities, Cell
% 224.29/224.49  |- skos__related mesh__D002452smesh__D013076
% 224.29/224.49  |- mesh__onlineNote mesh__D002452
% 224.29/224.49       use CELL COUNT to search CELL NUMBER 1978-79   
% 224.29/224.49  |- skos__annotation mesh__D002452 usually NIM; not for micro-organisms   
% 224.29/224.49  |- rdf__type mesh__D002452sskos__Concept
% 224.29/224.49  |- skos__hiddenLabel mesh__D002452 Cell Numbers
% 224.29/224.49  |- skos__historyNote mesh__D002452 Cytology %28%1966-1968%29%
% 224.29/224.49  |- skos__hiddenLabel mesh__D002452 Counts, Cell
% 224.29/224.49  |- skos__scopeNote mesh__D002452
% 224.29/224.49       The number of CELLS of a specific kind, usually measured per unit volume or area of sample.%A%    
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D002452 2005
% 224.29/224.49  |- mesh__recordMaintainer mesh__D002452 nns
% 224.29/224.49  |- skos__broader mesh__D002452smesh__D003584
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D002452 2004
% 224.29/224.49  |- mesh__recordAuthorizer mesh__D002452 sjn
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D012880 2004
% 224.29/224.49  |- mesh__dateCreated mesh__D012880 1999-01-01
% 224.29/224.49  |- skos__historyNote mesh__D012880 Pigmentation %28%1966-1974%29%
% 224.29/224.49  |- skos__broader mesh__D012880smesh__D010858
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D012880 2005
% 224.29/224.49  |- skos__hiddenLabel mesh__D012880 Pigmentation, Skin
% 224.29/224.49  |- mesh__historyNote mesh__D012880
% 224.29/224.49       76%28%75%29%; was see under PIGMENTATION 1963-75   
% 224.29/224.49  |- mesh__recordOriginator mesh__D012880 NLM
% 224.29/224.49  |- mesh__dateRevised mesh__D012880 1999-11-03
% 224.29/224.49  |- mesh__recordAuthorizer mesh__D012880 sjn
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D012880 2006
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D012880 2000
% 224.29/224.49  |- mesh__onlineNote mesh__D012880 search PIGMENTATION 1966-74   
% 224.29/224.49  |- skos__hiddenLabel mesh__D012880 Skin Pigmentations
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D012880 2001
% 224.29/224.49  |- mesh__dateEstablished mesh__D012880 1976-01-01
% 224.29/224.49  |- skos__prefLabel mesh__D012880 Skin Pigmentation
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D012880 2002
% 224.29/224.49  |- skos__scopeNote mesh__D012880 Coloration of the skin.     
% 224.29/224.49  |- mesh__recordMaintainer mesh__D012880 ndw
% 224.29/224.49  |- skos__hiddenLabel mesh__D012880 Pigmentations, Skin
% 224.29/224.49  |- rdf__type mesh__D012880sskos__Concept
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D012880 2003
% 224.29/224.49  |- mesh__publicMeSHNote mesh__D012880
% 224.29/224.49       76; was see under PIGMENTATION 1963-75   
% 224.29/224.49  |- skos__broader mesh__D012880smesh__D012879
% 224.29/224.49  |- mesh__recordAuthorizer mesh__D012082 PLS
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D012082 1998
% 224.29/224.49  |- mesh__recordMaintainer mesh__D012082 TAP
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D012082 2001
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D012082 1996
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D012082 2000
% 224.29/224.49  |- mesh__dateCreated mesh__D012082 1999-01-01
% 224.29/224.49  |- rdf__type mesh__D012082sskos__Concept
% 224.29/224.49  |- skos__scopeNote mesh__D012082
% 224.29/224.49       Short thick veins which return blood from the kidneys to the vena cava.%A%    
% 224.29/224.49  |- skos__hiddenLabel mesh__D012082 Veins, Renal
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D012082 1995
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D012082 1993
% 224.29/224.49  |- skos__hiddenLabel mesh__D012082 Vein, Renal
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D012082 2006
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D012082 2002
% 224.29/224.49  |- skos__hiddenLabel mesh__D012082 Renal Vein
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D012082 2004
% 224.29/224.49  |- mesh__recordOriginator mesh__D012082 NLM
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D012082 1994
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D012082 2005
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D012082 1999
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D012082 2003
% 224.29/224.49  |- skos__prefLabel mesh__D012082 Renal Veins
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D012082 1997
% 224.29/224.49  |- mesh__dateRevised mesh__D012082 1992-05-18
% 224.29/224.49  |- skos__broader mesh__D012082smesh__D014680
% 224.29/224.49  |- mesh__historyNote mesh__D006843 74   
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D006843 2006
% 224.29/224.49  |- skos__altLabel mesh__D006843 Organochlorine Compounds
% 224.29/224.49  |- mesh__recordOriginator mesh__D006843 NLM
% 224.29/224.49  |- mesh__dateCreated mesh__D006843 1999-01-01
% 224.29/224.49  |- mesh__recordMaintainer mesh__D006843 ssb
% 224.29/224.49  |- skos__altLabel mesh__D006843 Chlorinated Hydrocarbons
% 224.29/224.49  |- skos__broader mesh__D006843smesh__D006846
% 224.29/224.49  |- mesh__recordAuthorizer mesh__D006843 sjn
% 224.29/224.49  |- skos__annotation mesh__D006843 general; prefer specifics   
% 224.29/224.49  |- mesh__dateEstablished mesh__D006843 1974-01-01
% 224.29/224.49  |- mesh__dateRevised mesh__D006843 2004-07-07
% 224.29/224.49  |- skos__hiddenLabel mesh__D006843 Compounds, Organochlorine
% 224.29/224.49  |- mesh__publicMeSHNote mesh__D006843 74   
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D006843 2005
% 224.29/224.49  |- rdf__type mesh__D006843sskos__Concept
% 224.29/224.49  |- skos__prefLabel mesh__D006843 Hydrocarbons, Chlorinated
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D020514 2003
% 224.29/224.49  |- skos__broader mesh__D020514smesh__D010245
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D020514 2002
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D020514 2004
% 224.29/224.49  |- mesh__recordAuthorizer mesh__D020514 sjn
% 224.29/224.49  |- mesh__activeMeSHYear mesh__D020514 2005
% 224.29/224.49  |- rdf__type mesh__D020514sskos__Concept
% 224.29/224.49  |- skos__altLabel mesh__D020514 Primary Hypokalemic Periodic Paralysis
% 224.29/224.50  |- skos__altLabel mesh__D020514 Paralysis, Hypokalemic Periodic
% 224.29/224.50  |- mesh__dateEstablished mesh__D020514 2000-01-01
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D020514 2006
% 224.29/224.50  |- skos__altLabel mesh__D020514 Familial Hypokalemic Periodic Paralysis
% 224.29/224.50  |- skos__altLabel mesh__D020514 Hypokalemic Periodic Paralysis, Familial
% 224.29/224.50  |- mesh__publicMeSHNote mesh__D020514 2000   
% 224.29/224.50  |- skos__hiddenLabel mesh__D020514 Periodic Paralysis, Hypokalemic
% 224.29/224.50  |- mesh__recordMaintainer mesh__D020514 nns
% 224.29/224.50  |- skos__historyNote mesh__D020514
% 224.29/224.50       Hypokalemia/complications %28%1965-1999%29%
% 224.29/224.50  |- skos__prefLabel mesh__D020514 Hypokalemic Periodic Paralysis
% 224.29/224.50  |- mesh__historyNote mesh__D020514 2000   
% 224.29/224.50  |- mesh__dateRevised mesh__D020514 2001-07-25
% 224.29/224.50  |- skos__historyNote mesh__D020514
% 224.29/224.50       Paralyses, Familial Periodic %28%1965-1999%29%
% 224.29/224.50  |- skos__scopeNote mesh__D020514
% 224.29/224.50       An autosomal dominant familial disorder characterized by recurrent episodes of skeletal muscle weakness associated with falls in serum potassium levels. The condition usually presents in the first or second decade of life with attacks of trunk and leg paresis during sleep or shortly after awakening. Symptoms may persist for hours to days and generally are precipitated by exercise or a meal high in carbohydrates. %28%Adams et al., Principles of Neurology, 6th ed, p1483%29%%A%    
% 224.29/224.50  |- mesh__recordOriginator mesh__D020514 KEV
% 224.29/224.50  |- mesh__dateCreated mesh__D020514 1999-11-03
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D006045 2006
% 224.29/224.50  |- skos__altLabel mesh__D006045 Substernal Goiter
% 224.29/224.50  |- mesh__recordMaintainer mesh__D006045 lkt
% 224.29/224.50  |- mesh__dateCreated mesh__D006045 1999-01-01
% 224.29/224.50  |- skos__prefLabel mesh__D006045 Goiter, Substernal
% 224.29/224.50  |- rdf__type mesh__D006045sskos__Concept
% 224.29/224.50  |- mesh__dateRevised mesh__D006045 2005-06-30
% 224.29/224.50  |- skos__hiddenLabel mesh__D006045 Goiters, Substernal
% 224.29/224.50  |- mesh__recordAuthorizer mesh__D006045 sjn
% 224.29/224.50  |- skos__hiddenLabel mesh__D006045 Substernal Goiters
% 224.29/224.50  |- skos__hiddenLabel mesh__D006045 Goiters, Intrathoracic
% 224.29/224.50  |- mesh__recordOriginator mesh__D006045 NLM
% 224.29/224.50  |- skos__hiddenLabel mesh__D006045 Intrathoracic Goiters
% 224.29/224.50  |- skos__broader mesh__D006045smesh__D006042
% 224.29/224.50  |- skos__scopeNote mesh__D006045
% 224.29/224.50       An enlarged THYROID GLAND with at least 50%25% of the gland situated behind the STERNUM. It is an unusual presentation of an intrathoracic goiter. Substernal goiters frequently cause compression on the TRACHEA leading to deviation, narrowing, and respiratory symptoms.%A%    
% 224.29/224.50  |- skos__altLabel mesh__D006045 Intrathoracic Goiter
% 224.29/224.50  |- skos__related mesh__D044962smesh__D007091
% 224.29/224.50  |- mesh__recordOriginator mesh__D044962 lkt
% 224.29/224.50  |- skos__hiddenLabel mesh__D044962 Compression, Image
% 224.29/224.50  |- mesh__dateCreated mesh__D044962 2003-07-09
% 224.29/224.50  |- mesh__recordAuthorizer mesh__D044962 sjn
% 224.29/224.50  |- skos__broader mesh__D044962smesh__D012815
% 224.29/224.50  |- skos__scopeNote mesh__D044962
% 224.29/224.50       Information application based on a variety of coding methods to minimize the amount of data to be stored, retrieved, or transmitted. Data compression can be applied to various forms of data, such as images and signals. It is used to reduce costs and increase efficiency in the maintenance of large volumes of data.%A%    
% 224.29/224.50  |- mesh__historyNote mesh__D044962 2004   
% 224.29/224.50  |- mesh__recordMaintainer mesh__D044962 jls
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D044962 2005
% 224.29/224.50  |- skos__related mesh__D044962smesh__D012815
% 224.29/224.50  |- skos__hiddenLabel mesh__D044962 Compression, Data
% 224.29/224.50  |- skos__broader mesh__D044962smesh__D007091
% 224.29/224.50  |- mesh__publicMeSHNote mesh__D044962 2004   
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D044962 2006
% 224.29/224.50  |- skos__prefLabel mesh__D044962 Data Compression
% 224.29/224.50  |- rdf__type mesh__D044962sskos__Concept
% 224.29/224.50  |- mesh__dateEstablished mesh__D044962 2004-01-01
% 224.29/224.50  |- mesh__dateRevised mesh__D044962 2004-07-07
% 224.29/224.50  |- skos__broader mesh__D044962smesh__D016247
% 224.29/224.50  |- rdf__type mesh__D011788sskos__Concept
% 224.29/224.50  |- skos__broader mesh__D011788smesh__D012942
% 224.29/224.50  |- skos__related mesh__D011788smesh__D026712
% 224.29/224.50  |- skos__scopeNote mesh__D011788
% 224.29/224.50       A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral and social environment; the overall condition of a human life.%A%    
% 224.29/224.50  |- skos__broader mesh__D011788smesh__D019369
% 224.29/224.50  |- mesh__dateCreated mesh__D011788 1974-11-11
% 224.29/224.50  |- mesh__recordMaintainer mesh__D011788 sjn
% 224.29/224.50  |- skos__related mesh__D011788smesh__D008019
% 224.29/224.50  |- mesh__historyNote mesh__D011788 77%28%75%29%   
% 224.29/224.50  |- mesh__dateRevised mesh__D011788 2004-07-13
% 224.29/224.50  |- skos__prefLabel mesh__D011788 Quality of Life
% 224.29/224.50  |- skos__hiddenLabel mesh__D011788 Life Qualities
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D011788 2005
% 224.29/224.50  |- skos__hiddenLabel mesh__D011788 Life Quality
% 224.29/224.50  |- mesh__dateEstablished mesh__D011788 1977-01-01
% 224.29/224.50  |- mesh__publicMeSHNote mesh__D011788 77   
% 224.29/224.50  |- mesh__recordOriginator mesh__D011788 NLM
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D011788 2006
% 224.29/224.50  |- skos__related mesh__D011788smesh__D018434
% 224.29/224.50  |- mesh__recordAuthorizer mesh__D011788 sjn
% 224.29/224.50  |- skos__related mesh__D011788smesh__D017567
% 224.29/224.50  |- mesh__dateRevised mesh__D044164 2005-06-30
% 224.29/224.50  |- skos__historyNote mesh__D044164 Vibrio %28%1981-2003%29%
% 224.29/224.50  |- mesh__historyNote mesh__D044164 2004   
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D044164 2006
% 224.29/224.50  |- mesh__dateEstablished mesh__D044164 2004-01-01
% 224.29/224.50  |- rdf__type mesh__D044164sskos__Concept
% 224.29/224.50  |- mesh__dateCreated mesh__D044164 2003-07-09
% 224.29/224.50  |- skos__prefLabel mesh__D044164 Vibrio mimicus
% 224.29/224.50  |- mesh__publicMeSHNote mesh__D044164 2004   
% 224.29/224.50  |- mesh__recordMaintainer mesh__D044164 SYSTEM
% 224.29/224.50  |- skos__scopeNote mesh__D044164
% 224.29/224.50       A species of gram-negative bacteria in the genus VIBRIO, isolated from SHELLFISH, as well as from human diarrheal stools and ear infections.%A%    
% 224.29/224.50  |- mesh__recordAuthorizer mesh__D044164 sjn
% 224.29/224.50  |- mesh__recordOriginator mesh__D044164 ags
% 224.29/224.50  |- skos__broader mesh__D044164smesh__D014733
% 224.29/224.50  |- mesh__publicMeSHNote mesh__D016473 92   
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D016473 1996
% 224.29/224.50  |- mesh__dateEstablished mesh__D016473 1992-01-01
% 224.29/224.50  |- mesh__recordMaintainer mesh__D016473 TAP
% 224.29/224.50  |- mesh__recordOriginator mesh__D016473 PXP
% 224.29/224.50  |- mesh__dateRevised mesh__D016473 1992-05-15
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D016473 2006
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D016473 1995
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D016473 2004
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D016473 2001
% 224.29/224.50  |- skos__broader mesh__D016473smesh__D004068
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D016473 1993
% 224.29/224.50  |- skos__prefLabel mesh__D016473 Gallbladder Emptying
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D016473 2000
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D016473 2005
% 224.29/224.50  |- skos__scopeNote mesh__D016473
% 224.29/224.50       A process whereby bile is delivered from the gallbladder into the duodenum. The emptying is caused by both contraction of the gallbladder and relaxation of the sphincter mechanism at the choledochal terminus.%A%    
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D016473 1994
% 224.29/224.50  |- rdf__type mesh__D016473sskos__Concept
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D016473 2003
% 224.29/224.50  |- mesh__historyNote mesh__D016473 92   
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D016473 1999
% 224.29/224.50  |- skos__hiddenLabel mesh__D016473 Emptying, Gallbladder
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D016473 1997
% 224.29/224.50  |- skos__hiddenLabel mesh__D016473 Emptying, Gall Bladder
% 224.29/224.50  |- skos__historyNote mesh__D016473 Gallbladder %28%1975-1991%29%
% 224.29/224.50  |- mesh__dateCreated mesh__D016473 1991-01-02
% 224.29/224.50  |- mesh__recordAuthorizer mesh__D016473 PLS
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D016473 1998
% 224.29/224.50  |- skos__altLabel mesh__D016473 Gall Bladder Emptying
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D016473 2002
% 224.29/224.50  |- skos__hiddenLabel mesh__D002453 Division Cycles, Cell
% 224.29/224.50  |- skos__hiddenLabel mesh__D002453 Cell Cycles
% 224.29/224.50  |- skos__historyNote mesh__D002453 Cell Division %28%1966-1977%29%
% 224.29/224.50  |- skos__broader mesh__D002453smesh__D002468
% 224.29/224.50  |- mesh__publicMeSHNote mesh__D002453 78   
% 224.29/224.50  |- mesh__recordAuthorizer mesh__D002453 jls
% 224.29/224.50  |- rdf__type mesh__D002453sskos__Concept
% 224.29/224.50  |- mesh__dateCreated mesh__D002453 1977-05-04
% 224.29/224.50  |- mesh__recordMaintainer mesh__D002453 jls
% 224.29/224.50  |- skos__scopeNote mesh__D002453
% 224.29/224.50       The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE.%A%    
% 224.29/224.50  |- skos__hiddenLabel mesh__D002453 Cycles, Cell
% 224.29/224.50  |- skos__annotation mesh__D002453
% 224.29/224.50       coordinate with specific cell /cytol; permitted with microorganisms%A%  
% 224.29/224.50  |- skos__hiddenLabel mesh__D002453 Cell Division Cycles
% 224.29/224.50  |- skos__altLabel mesh__D002453 Cell Division Cycle
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D002453 2005
% 224.29/224.50  |- mesh__dateEstablished mesh__D002453 1978-01-01
% 224.29/224.50  |- skos__related mesh__D002453smesh__D018816
% 224.29/224.50  |- skos__prefLabel mesh__D002453 Cell Cycle
% 224.29/224.50  |- mesh__dateRevised mesh__D002453 2004-08-06
% 224.29/224.50  |- skos__historyNote mesh__D002453 Mitosis %28%1968-1977%29%
% 224.29/224.50  |- mesh__historyNote mesh__D002453 78   
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D002453 2005A
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D002453 2006
% 224.29/224.50  |- skos__related mesh__D002453smesh__D018797
% 224.29/224.50  |- skos__hiddenLabel mesh__D002453 Division Cycle, Cell
% 224.29/224.50  |- skos__hiddenLabel mesh__D002453 Cycle, Cell Division
% 224.29/224.50  |- skos__historyNote mesh__D002453 Meiosis %28%1968-1977%29%
% 224.29/224.50  |- skos__hiddenLabel mesh__D002453 Cycle, Cell
% 224.29/224.50  |- skos__hiddenLabel mesh__D002453 Cycles, Cell Division
% 224.29/224.50  |- mesh__recordOriginator mesh__D002453 AEP
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012881 2004
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012881 1999
% 224.29/224.50  |- mesh__recordAuthorizer mesh__D012881 PLS
% 224.29/224.50  |- rdf__type mesh__D012881sskos__Concept
% 224.29/224.50  |- skos__broader mesh__D012881smesh__D001831
% 224.29/224.50  |- skos__hiddenLabel mesh__D012881 Temperatures, Skin
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012881 1993
% 224.29/224.50  |- skos__historyNote mesh__D012881 Skin %28%1966-1969%29%
% 224.29/224.50  |- skos__prefLabel mesh__D012881 Skin Temperature
% 224.29/224.50  |- skos__broader mesh__D012881smesh__D012879
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012881 2003
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012881 1998
% 224.29/224.50  |- mesh__historyNote mesh__D012881 70   
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012881 2002
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012881 1997
% 224.29/224.50  |- mesh__dateRevised mesh__D012881 1992-05-18
% 224.29/224.50  |- skos__hiddenLabel mesh__D012881 Skin Temperatures
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012881 2006
% 224.29/224.50  |- mesh__recordMaintainer mesh__D012881 TAP
% 224.29/224.50  |- skos__historyNote mesh__D012881 Body Temperature %28%1966-1969%29%
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012881 2001
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012881 1996
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012881 1995
% 224.29/224.50  |- mesh__publicMeSHNote mesh__D012881 70   
% 224.29/224.50  |- mesh__recordOriginator mesh__D012881 NLM
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012881 2005
% 224.29/224.50  |- skos__hiddenLabel mesh__D012881 Temperature, Skin
% 224.29/224.50  |- mesh__dateCreated mesh__D012881 1999-01-01
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012881 2000
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012881 1994
% 224.29/224.50  |- mesh__dateEstablished mesh__D012881 1970-01-01
% 224.29/224.50  |- skos__scopeNote mesh__D012083
% 224.29/224.50       An enzyme which is secreted by the KIDNEY and is formed from prorenin in plasma and kidney. The enzyme cleaves the Leu-Leu bond in ANGIOTENSINOGEN to generate ANGIOTENSIN I. This enzyme was formerly listed as EC 3.4.99.19.%A%    
% 224.29/224.50  |- mesh__recordOriginator mesh__D012083 NLM
% 224.29/224.50  |- mesh__recordAuthorizer mesh__D012083 sjn
% 224.29/224.50  |- skos__altLabel mesh__D012083 Inactive Renin
% 224.29/224.50  |- skos__prefLabel mesh__D012083 Renin
% 224.29/224.50  |- skos__hiddenLabel mesh__D012083 Pre Prorenin
% 224.29/224.50  |- mesh__publicMeSHNote mesh__D012083
% 224.29/224.50       1963; PRORENIN was listed under ENZYME PRECUSORS %26% RENIN 1977-2003; PREPRORENIN was listed under ENZYME PRECUSORS %26% RENIN 1980-2003%A%  
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012083 2006
% 224.29/224.50  |- mesh__dateRevised mesh__D012083 2003-07-22
% 224.29/224.50  |- skos__annotation mesh__D012083
% 224.29/224.50       do not confuse with RENNIN see CHYMOSIN   
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012083 2004
% 224.29/224.50  |- mesh__historyNote mesh__D012083
% 224.29/224.50       1963; for PRORENIN use RENIN %28%NM%29% 1977-2003, for PREPRORENIN use RENIN %28%NM%29% 1980-2003%A%  
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012083 2005
% 224.29/224.50  |- skos__altLabel mesh__D012083 Pre-Prorenin
% 224.29/224.50  |- skos__hiddenLabel mesh__D012083 Renin, Big
% 224.29/224.50  |- mesh__recordMaintainer mesh__D012083 jmp
% 224.29/224.50  |- skos__broader mesh__D012083smesh__D016282
% 224.29/224.50  |- skos__hiddenLabel mesh__D012083 Angiotensin Forming Enzyme
% 224.29/224.50  |- skos__altLabel mesh__D012083 Angiotensin-Forming Enzyme
% 224.29/224.50  |- skos__hiddenLabel mesh__D012083 Renin, Inactive
% 224.29/224.50  |- skos__broader mesh__D012083smesh__D043484
% 224.29/224.50  |- skos__altLabel mesh__D012083 Big Renin
% 224.29/224.50  |- skos__altLabel mesh__D012083 Angiotensinogenase
% 224.29/224.50  |- rdf__type mesh__D012083sskos__Concept
% 224.29/224.50  |- mesh__dateCreated mesh__D012083 1999-01-01
% 224.29/224.50  |- skos__altLabel mesh__D012083 Cryorenin
% 224.29/224.50  |- skos__altLabel mesh__D006844 Cyclic Hydrocarbons
% 224.29/224.50  |- mesh__recordMaintainer mesh__D006844 NLM
% 224.29/224.50  |- skos__broader mesh__D006844smesh__D006838
% 224.29/224.50  |- mesh__dateRevised mesh__D006844 2004-07-20
% 224.29/224.50  |- skos__annotation mesh__D006844
% 224.29/224.50       GEN; prefer specifics; used for mapping supplementary chemicals; do not confuse with HYDROCARBONS, ACYCLIC%A%  
% 224.29/224.50  |- skos__related mesh__D006844smesh__D003516
% 224.29/224.50  |- skos__scopeNote mesh__D006844
% 224.29/224.50       Organic compounds composed exclusively of carbon and hydrogen forming a closed ring that may be either alicyclic or aromatic.%A%    
% 224.29/224.50  |- mesh__publicMeSHNote mesh__D006844 98   
% 224.29/224.50  |- rdf__type mesh__D006844sskos__Concept
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D006844 2005
% 224.29/224.50  |- mesh__recordOriginator mesh__D006844 NLM
% 224.29/224.50  |- skos__prefLabel mesh__D006844 Hydrocarbons, Cyclic
% 224.29/224.50  |- mesh__historyNote mesh__D006844 98; use explode 1968-97   
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D006844 2006
% 224.29/224.50  |- mesh__recordAuthorizer mesh__D006844 NLM
% 224.29/224.50  |- skos__related mesh__D006844smesh__D011083
% 224.29/224.50  |- mesh__dateEstablished mesh__D006844 1998-01-01
% 224.29/224.50  |- mesh__dateCreated mesh__D006844 1999-01-01
% 224.29/224.50  |- mesh__recordMaintainer mesh__D006046 ssb
% 224.29/224.50  |- skos__annotation mesh__D006046 Au-197   
% 224.29/224.50  |- mesh__recordAuthorizer mesh__D006046 sjn
% 224.29/224.50  |- skos__broader mesh__D006046smesh__D019216
% 224.29/224.50  |- mesh__recordOriginator mesh__D006046 NLM
% 224.29/224.50  |- mesh__dateCreated mesh__D006046 1999-01-01
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D006046 2006
% 224.29/224.50  |- skos__related mesh__D006046smesh__D006050
% 224.29/224.50  |- skos__related mesh__D006046smesh__D050607
% 224.29/224.50  |- skos__prefLabel mesh__D006046 Gold
% 224.29/224.50  |- skos__broader mesh__D006046smesh__D028561
% 224.29/224.50  |- skos__related mesh__D006046smesh__D006049
% 224.29/224.50  |- rdf__type mesh__D006046sskos__Concept
% 224.29/224.50  |- skos__scopeNote mesh__D006046
% 224.29/224.50       A yellow metallic element with the atomic symbol Au, atomic number 79, and atomic weight 197. It is used in jewelry, goldplating of other metals, as currency, and in dental restoration. Many of its clinical applications, such as ANTIRHEUMATIC AGENTS, are in the form of its salts.%A%    
% 224.29/224.50  |- mesh__dateRevised mesh__D006046 2005-06-30
% 224.29/224.50  |- skos__broader mesh__D044963smesh__D001707
% 224.29/224.50  |- skos__hiddenLabel mesh__D044963 Fine-Needle Aspiration Biopsies
% 224.29/224.50  |- mesh__dateEstablished mesh__D044963 2004-01-01
% 224.29/224.50  |- skos__hiddenLabel mesh__D044963 Fine Needle Aspiration
% 224.29/224.50  |- skos__altLabel mesh__D044963 Fine-Needle Aspiration
% 224.29/224.50  |- skos__hiddenLabel mesh__D044963 Fine-Needle Aspirations
% 224.29/224.50  |- skos__historyNote mesh__D044963 Biopsy, Needle %28%1972-2003%29%
% 224.29/224.50  |- skos__scopeNote mesh__D044963
% 224.29/224.50       Using fine needles %28%finer than 22-gauge%29% to remove tissue or fluid specimens from the living body for examination in the pathology laboratory and for disease diagnosis.%A%    
% 224.29/224.50  |- skos__hiddenLabel mesh__D044963 Biopsies, Fine Needle
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D044963 2005
% 224.29/224.50  |- skos__hiddenLabel mesh__D044963 Fine-Needle Aspiration Biopsy
% 224.29/224.50  |- skos__hiddenLabel mesh__D044963 Biopsies, Fine-Needle
% 224.29/224.50  |- skos__hiddenLabel mesh__D044963 Fine Needle Biopsies
% 224.29/224.50  |- skos__hiddenLabel mesh__D044963 Aspirations, Fine-Needle
% 224.29/224.50  |- mesh__publicMeSHNote mesh__D044963 2004   
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D044963 2006
% 224.29/224.50  |- skos__hiddenLabel mesh__D044963 Fine-Needle Biopsies
% 224.29/224.50  |- mesh__historyNote mesh__D044963 2004   
% 224.29/224.50  |- skos__prefLabel mesh__D044963 Biopsy, Fine-Needle
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D044963 2004
% 224.29/224.50  |- rdf__type mesh__D044963sskos__Concept
% 224.29/224.50  |- skos__historyNote mesh__D044963 Biopsy %28%1968-1972%29%
% 224.29/224.50  |- skos__hiddenLabel mesh__D044963 Needle Biopsies, Fine
% 224.29/224.50  |- skos__hiddenLabel mesh__D044963 Fine-Needle Biopsy
% 224.29/224.50  |- skos__hiddenLabel mesh__D044963 Aspiration Biopsies, Fine-Needle
% 224.29/224.50  |- skos__altLabel mesh__D044963 Fine Needle Biopsy
% 224.29/224.50  |- skos__hiddenLabel mesh__D044963 Biopsy, Fine-Needle Aspiration
% 224.29/224.50  |- skos__hiddenLabel mesh__D044963 Needle Biopsy, Fine
% 224.29/224.50  |- skos__annotation mesh__D044963
% 224.29/224.50       usually NIM with specific organ/pathol %28%IM%29% + dis/pathol %28%IM%29%%A%  
% 224.29/224.50  |- skos__hiddenLabel mesh__D044963 Aspiration, Fine-Needle
% 224.29/224.50  |- skos__hiddenLabel mesh__D044963 Aspiration Biopsy, Fine Needle
% 224.29/224.50  |- skos__hiddenLabel mesh__D044963 Biopsy, Fine Needle
% 224.29/224.50  |- mesh__dateCreated mesh__D044963 2003-07-09
% 224.29/224.50  |- skos__hiddenLabel mesh__D044963 Biopsies, Fine-Needle Aspiration
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D011789 1993
% 224.29/224.50  |- mesh__recordOriginator mesh__D011789 NLM
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D011789 2005
% 224.29/224.50  |- skos__broader mesh__D011789smesh__D009686
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D011789 1999
% 224.29/224.50  |- skos__scopeNote mesh__D011789
% 224.29/224.50       The theory that the radiation and absorption of energy take place in definite quantities called quanta %28%E%29% which vary in size and are defined by the equation E=hv in which h is Planck%27%s constant and v is the frequency of the radiation.%A%    
% 224.29/224.50  |- skos__hiddenLabel mesh__D011789 Theory, Quantum
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D011789 2003
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D011789 1997
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D011789 1994
% 224.29/224.50  |- mesh__publicMeSHNote mesh__D011789 67   
% 224.29/224.50  |- mesh__dateRevised mesh__D011789 1992-05-18
% 224.29/224.50  |- rdf__type mesh__D011789sskos__Concept
% 224.29/224.50  |- mesh__recordAuthorizer mesh__D011789 PLS
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D011789 2002
% 224.29/224.50  |- skos__hiddenLabel mesh__D011789 Quantum Theories
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D011789 1998
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D011789 1996
% 224.29/224.50  |- mesh__dateCreated mesh__D011789 1999-01-01
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D011789 2001
% 224.29/224.50  |- mesh__recordMaintainer mesh__D011789 TAP
% 224.29/224.50  |- mesh__dateEstablished mesh__D011789 1967-01-01
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D011789 2006
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D011789 2000
% 224.29/224.50  |- skos__hiddenLabel mesh__D011789 Theories, Quantum
% 224.29/224.50  |- mesh__historyNote mesh__D011789 67%28%64%29%   
% 224.29/224.50  |- skos__prefLabel mesh__D011789 Quantum Theory
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D011789 2004
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D011789 1995
% 224.29/224.50  |- mesh__dateCreated mesh__D044165 2003-07-09
% 224.29/224.50  |- skos__historyNote mesh__D044165 Vibrio %28%1987-2003%29%
% 224.29/224.50  |- mesh__recordAuthorizer mesh__D044165 sjn
% 224.29/224.50  |- mesh__publicMeSHNote mesh__D044165 2004   
% 224.29/224.50  |- skos__broader mesh__D044165smesh__D014733
% 224.29/224.50  |- mesh__recordOriginator mesh__D044165 ags
% 224.29/224.50  |- mesh__dateRevised mesh__D044165 2005-06-30
% 224.29/224.50  |- mesh__dateEstablished mesh__D044165 2004-01-01
% 224.29/224.50  |- skos__scopeNote mesh__D044165
% 224.29/224.50       A species of gram-negative bacteria in the genus VIBRIO, the causative agent of cold water vibriosis, a HEMORRHAGIC SEPTICEMIA of ATLANTIC SALMON.%A%    
% 224.29/224.50  |- mesh__historyNote mesh__D044165 2004   
% 224.29/224.50  |- mesh__recordMaintainer mesh__D044165 SYSTEM
% 224.29/224.50  |- skos__annotation mesh__D044165
% 224.29/224.50       infection: coord IM with VIBRIO INFECTIONS %28%IM%29% + HEMORRHAGIC SEPTICEMIA %28%IM%29% if pertinent%A%  
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D044165 2006
% 224.29/224.50  |- rdf__type mesh__D044165sskos__Concept
% 224.29/224.50  |- skos__prefLabel mesh__D044165 Vibrio salmonicida
% 224.29/224.50  |- mesh__dateRevised mesh__D016474 2003-07-09
% 224.29/224.50  |- skos__hiddenLabel mesh__D016474 Weight Bearing
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D016474 2006
% 224.29/224.50  |- mesh__publicMeSHNote mesh__D016474 92   
% 224.29/224.50  |- mesh__dateEstablished mesh__D016474 1992-01-01
% 224.29/224.50  |- skos__altLabel mesh__D016474 Weightbearing
% 224.29/224.50  |- skos__prefLabel mesh__D016474 Weight-Bearing
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D016474 2005
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D016474 2004
% 224.29/224.50  |- mesh__recordAuthorizer mesh__D016474 sjn
% 224.29/224.50  |- mesh__recordOriginator mesh__D016474 AGS
% 224.29/224.50  |- mesh__historyNote mesh__D016474 92   
% 224.29/224.50  |- rdf__type mesh__D016474sskos__Concept
% 224.29/224.50  |- skos__altLabel mesh__D016474 Loadbearing
% 224.29/224.50  |- skos__annotation mesh__D016474
% 224.29/224.50       by machines %26% humans or animals; for weight-bearing bones or joints, coord NIM with specific bone or joint with /physiol %28%IM%29%%A%  
% 224.29/224.50  |- skos__scopeNote mesh__D016474
% 224.29/224.50       The physical state of supporting an applied load. This often refers to the weight-bearing bones or joints that support the body%27%s weight, especially those in the spine, hip, knee, and foot.%A%    
% 224.29/224.50  |- skos__hiddenLabel mesh__D016474 Load Bearing
% 224.29/224.50  |- skos__altLabel mesh__D016474 Load-Bearing
% 224.29/224.50  |- mesh__dateCreated mesh__D016474 1991-01-03
% 224.29/224.50  |- skos__broader mesh__D016474smesh__D001696
% 224.29/224.50  |- skos__broader mesh__D016474smesh__D019563
% 224.29/224.50  |- mesh__recordMaintainer mesh__D016474 nns
% 224.29/224.50  |- mesh__recordOriginator mesh__D002454 NLM
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D002454 2006
% 224.29/224.50  |- mesh__historyNote mesh__D002454 66%28%64%29%   
% 224.29/224.50  |- skos__broader mesh__D002454smesh__D002468
% 224.29/224.50  |- mesh__dateRevised mesh__D002454 2004-07-07
% 224.29/224.50  |- mesh__recordMaintainer mesh__D002454 lkt
% 224.29/224.50  |- skos__altLabel mesh__D002454 Differentiation, Cell
% 224.29/224.50  |- skos__related mesh__D002454smesh__D019070
% 224.29/224.50  |- mesh__dateCreated mesh__D002454 1999-01-01
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D002454 2005
% 224.29/224.50  |- skos__prefLabel mesh__D002454 Cell Differentiation
% 224.29/224.50  |- skos__annotation mesh__D002454
% 224.29/224.50       coord with specific cell /cytol; not for micro-organisms   
% 224.29/224.50  |- skos__related mesh__D002454smesh__D000943
% 224.29/224.50  |- skos__hiddenLabel mesh__D002454 Cell Differentiations
% 224.29/224.50  |- skos__scopeNote mesh__D002454
% 224.29/224.50       Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs.%A%    
% 224.29/224.50  |- mesh__recordAuthorizer mesh__D002454 sjn
% 224.29/224.50  |- rdf__type mesh__D002454sskos__Concept
% 224.29/224.50  |- skos__hiddenLabel mesh__D002454 Differentiations, Cell
% 224.29/224.50  |- mesh__publicMeSHNote mesh__D002454 66   
% 224.29/224.50  |- mesh__dateEstablished mesh__D002454 1966-01-01
% 224.29/224.50  |- skos__broader mesh__D012882smesh__D019937
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012882 2003
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012882 1998
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012882 2000
% 224.29/224.50  |- mesh__recordAuthorizer mesh__D012882 SJN
% 224.29/224.50  |- skos__hiddenLabel mesh__D012882 Tests, Skin
% 224.29/224.50  |- skos__hiddenLabel mesh__D012882 Test, Skin
% 224.29/224.50  |- skos__annotation mesh__D012882 NIM   
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012882 2006
% 224.29/224.50  |- mesh__dateRevised mesh__D012882 1997-06-20
% 224.29/224.50  |- skos__scopeNote mesh__D012882
% 224.29/224.50       Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity.%A%    
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012882 2005
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012882 2002
% 224.29/224.50  |- mesh__dateCreated mesh__D012882 1999-01-01
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012882 2004
% 224.29/224.50  |- skos__prefLabel mesh__D012882 Skin Tests
% 224.29/224.50  |- mesh__recordMaintainer mesh__D012882 PXP
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012882 1999
% 224.29/224.50  |- skos__hiddenLabel mesh__D012882 Skin Test
% 224.29/224.50  |- rdf__type mesh__D012882sskos__Concept
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012882 2001
% 224.29/224.50  |- skos__broader mesh__D012882smesh__D007159
% 224.29/224.50  |- mesh__recordOriginator mesh__D012882 NLM
% 224.29/224.50  |- mesh__recordMaintainer mesh__D012084 ags
% 224.29/224.50  |- skos__annotation mesh__D012084
% 224.29/224.50       note X ref but do not index under ALDOSTERONE unless particularly discussed; DF: RA SYSTEM%A%  
% 224.29/224.50  |- skos__hiddenLabel mesh__D012084 System, Renin-Angiotensin-Aldosterone
% 224.29/224.50  |- skos__hiddenLabel mesh__D012084 System, Renin-Angiotensin
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012084 2005
% 224.29/224.50  |- mesh__dateRevised mesh__D012084 2005-07-07
% 224.29/224.50  |- mesh__historyNote mesh__D012084 82   
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012084 2006A
% 224.29/224.50  |- skos__related mesh__D012084smesh__D016234
% 224.29/224.50  |- mesh__activeMeSHYear mesh__D012084 2005A
% 224.29/224.50  |- skos__hiddenLabel mesh__D012084 Renin Angiotensin System
% 224.29/224.50  |- skos__hiddenLabel mesh__D012084 Renin Angiotensin Aldosterone System
% 224.29/224.50  |- mesh__dateCreated mesh__D012084 1981-05-19
% 224.29/224.50  |- mesh__dateEstablished mesh__D012084 1982-01-01
% 224.29/224.50  |- skos__broader mesh__D012084smesh__D006439
% 224.29/224.50  |- rdf__type mesh__D012084sskos__Concept
% 224.29/224.50  |- skos__scopeNote mesh__D012084
% 224.29/224.50       A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN;  ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM.%A%    
% 224.29/224.50  |- skos__related mesh__D012084smesh__D000806
% 224.29/224.50  |- mesh__recordAuthorizer mesh__D012084 ags
% 224.29/224.50  |- skos__broader mesh__D012084smesh__D008660
% 224.29/224.50  |- mesh__recordOriginator mesh__D012084 VDK
% 224.29/224.50  |- skos__historyNote mesh__D012084 Renin %28%1966-1981%29%
% 224.29/224.50  |- mesh__publicMeSHNote mesh__D012084 82   
% 224.29/224.50  |- skos__prefLabel mesh__D012084 Renin-Angiotensin System
% 224.29/224.51  |- skos__historyNote mesh__D012084 Angiotensin II %28%1966-1981%29%
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D012084 2006
% 224.29/224.51  |- mesh__dateRevised mesh__D006845 1992-05-20
% 224.29/224.51  |- skos__broader mesh__D006845smesh__D006846
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006845 2002
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006845 1998
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006845 1997
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006845 1994
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006845 2003
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006845 1999
% 224.29/224.51  |- rdf__type mesh__D006845sskos__Concept
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006845 2005
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006845 1993
% 224.29/224.51  |- skos__related mesh__D006845smesh__D005465
% 224.29/224.51  |- mesh__publicMeSHNote mesh__D006845 74   
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006845 2004
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006845 1995
% 224.29/224.51  |- mesh__recordMaintainer mesh__D006845 TGC
% 224.29/224.51  |- skos__annotation mesh__D006845
% 224.29/224.51       do not confuse with FLUOROCARBONS nor with CHLOROFLUOROCARBONS%A%  
% 224.29/224.51  |- mesh__historyNote mesh__D006845 74   
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006845 2006
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006845 2000
% 224.29/224.51  |- mesh__recordAuthorizer mesh__D006845 PLS
% 224.29/224.51  |- skos__prefLabel mesh__D006845 Hydrocarbons, Fluorinated
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006845 2001
% 224.29/224.51  |- mesh__dateCreated mesh__D006845 1999-01-01
% 224.29/224.51  |- mesh__recordOriginator mesh__D006845 NLM
% 224.29/224.51  |- mesh__dateEstablished mesh__D006845 1974-01-01
% 224.29/224.51  |- skos__altLabel mesh__D006845 Fluorinated Hydrocarbons
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006845 1996
% 224.29/224.51  |- skos__prefLabel mesh__D020516 Brachial Plexus Neuropathies
% 224.29/224.51  |- mesh__dateEstablished mesh__D020516 2000-01-01
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Paralysis, Erb
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Plexus Disease, Brachial
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Plexus Neuropathies, Brachial
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Erb Duchenne Paralysis
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D020516 2006
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Paralyses, Klumpke
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Paralysis, Erb-Duchenne
% 224.29/224.51  |- skos__altLabel mesh__D020516 Brachial Plexus Diseases
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Plexopathy, Brachial
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Neuropathies, Brachial Plexus
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D020516 2005
% 224.29/224.51  |- mesh__dateCreated mesh__D020516 1999-11-04
% 224.29/224.51  |- mesh__publicMeSHNote mesh__D020516 2000   
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D020516 2004
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Plexopathies, Brachial
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D020516 2002
% 224.29/224.51  |- skos__related mesh__D020516smesh__D020968
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Brachial Plexus Disorder
% 224.29/224.51  |- skos__altLabel mesh__D020516 Brachial Plexopathy
% 224.29/224.51  |- skos__historyNote mesh__D020516 Brachial Plexus %28%1972-1999%29%
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Brachial Plexus Disease
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Paralysis, Klumpke
% 224.29/224.51  |- skos__historyNote mesh__D020516 Neuritis %28%1972-1999%29%
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Plexus Disorders, Brachial
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Erb-Duchenne Paralyses
% 224.29/224.51  |- skos__historyNote mesh__D020516
% 224.29/224.51       Peripheral Nervous System Diseases %28%1975-1999%29%
% 224.29/224.51  |- rdf__type mesh__D020516sskos__Concept
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D020516 2003
% 224.29/224.51  |- skos__scopeNote mesh__D020516
% 224.29/224.51       Diseases of the cervical %28%and first thoracic%29% roots, nerve trunks, cords, and peripheral nerve components of the BRACHIAL PLEXUS. Clinical manifestations include regional pain, PARESTHESIA; MUSCLE WEAKNESS, and decreased sensation %28%HYPESTHESIA%29% in the upper extremity. These disorders may be associated with trauma %28%including BIRTH INJURIES%29%; THORACIC OUTLET SYNDROME; NEOPLASMS; NEURITIS; RADIOTHERAPY; and other conditions. %28%From Adams et al., Principles of Neurology, 6th ed, pp1351-2%29%%A%    
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Erb Paralyses
% 224.29/224.51  |- skos__altLabel mesh__D020516 Brachial Plexus Disorders
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Palsy, Erb%27%s
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Plexus Neuropathy, Brachial
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Brachial Plexus Neuropathy
% 224.29/224.51  |- mesh__historyNote mesh__D020516 2000   
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Plexus Diseases, Brachial
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Erb%27%s Palsies
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D020516 2001
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Klumpke Paralyses
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Erb Palsy
% 224.29/224.51  |- skos__broader mesh__D020516smesh__D010523
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Palsies, Erb%27%s
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Plexus Disorder, Brachial
% 224.29/224.51  |- skos__altLabel mesh__D020516 Erb-Duchenne Paralysis
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Erbs Palsy
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Neuropathy, Brachial Plexus
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D020516 2000
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Paralyses, Erb-Duchenne
% 224.29/224.51  |- skos__hiddenLabel mesh__D020516 Paralyses, Erb
% 224.29/224.51  |- skos__altLabel mesh__D020516 Erb%27%s Palsy
% 224.29/224.51  |- skos__altLabel mesh__D039221 Polyadenylation Factor
% 224.29/224.51  |- mesh__recordOriginator mesh__D039221 jmp
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D039221 2006
% 224.29/224.51  |- skos__hiddenLabel mesh__D039221 Polyadenylation Factor, Pre-mRNA
% 224.29/224.51  |- mesh__recordAuthorizer mesh__D039221 ags
% 224.29/224.51  |- mesh__dateRevised mesh__D039221 2005-07-28
% 224.29/224.51  |- skos__related mesh__D039221smesh__D012323
% 224.29/224.51  |- mesh__historyNote mesh__D039221
% 224.29/224.51       2003; use MRNA CLEAVAGE AND POLYADENYLATION FACTORS %28%NM%29% 1992-2002%A%  
% 224.29/224.51  |- mesh__dateEstablished mesh__D039221 2003-01-01
% 224.29/224.51  |- skos__hiddenLabel mesh__D039221 Pre mRNA Polyadenylation Factor
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D039221 2006A
% 224.29/224.51  |- skos__prefLabel mesh__D039221 mRNA Cleavage and Polyadenylation Factors
% 224.29/224.51  |- rdf__type mesh__D039221sskos__Concept
% 224.29/224.51  |- skos__altLabel mesh__D039221 Cleavage and Polyadenylation Factors
% 224.29/224.51  |- skos__historyNote mesh__D039221 RNA-Binding Proteins %28%1992-2002%29%
% 224.29/224.51  |- mesh__recordMaintainer mesh__D039221 ags
% 224.29/224.51  |- skos__scopeNote mesh__D039221
% 224.29/224.51       Factors that are involved in directing the cleavage and POLYADENYLATION of the of MESSENGER RNA near the site of  the RNA 3%27% POLYADENYLATION SIGNALS.%A%    
% 224.29/224.51  |- mesh__publicMeSHNote mesh__D039221
% 224.29/224.51       2003; CLEAVAGE AND POLYADENYLATION FACTOR %28%now MRNA CLEAVAGE AND POLYADENYLATION FACTORS%29% was indexed under RNA-BINDING PROTEINS 1992-2002%A%  
% 224.29/224.51  |- skos__broader mesh__D039221smesh__D016601
% 224.29/224.51  |- skos__altLabel mesh__D039221 Pre-mRNA Polyadenylation Factor
% 224.29/224.51  |- mesh__dateCreated mesh__D039221 2002-07-03
% 224.29/224.51  |- skos__altLabel mesh__D039221 Cleavage and Polyadenylation Factor
% 224.29/224.51  |- mesh__dateCreated mesh__D006047 1999-01-01
% 224.29/224.51  |- skos__prefLabel mesh__D006047 Gold Alloys
% 224.29/224.51  |- mesh__historyNote mesh__D006047 65   
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006047 2006
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006047 1997
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006047 2005
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006047 1996
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006047 2002
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006047 1995
% 224.29/224.51  |- mesh__recordOriginator mesh__D006047 NLM
% 224.29/224.51  |- mesh__publicMeSHNote mesh__D006047 65   
% 224.29/224.51  |- skos__broader mesh__D006047smesh__D000497
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006047 2004
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006047 2001
% 224.29/224.51  |- mesh__recordMaintainer mesh__D006047 TPW
% 224.29/224.51  |- mesh__dateRevised mesh__D006047 1993-06-04
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006047 1994
% 224.29/224.51  |- rdf__type mesh__D006047sskos__Concept
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006047 2003
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006047 1999
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006047 2000
% 224.29/224.51  |- mesh__recordAuthorizer mesh__D006047 PLS
% 224.29/224.51  |- skos__broader mesh__D006047smesh__D017612
% 224.29/224.51  |- skos__hiddenLabel mesh__D006047 Alloys, Gold
% 224.29/224.51  |- skos__scopeNote mesh__D006047
% 224.29/224.51       Alloys that contain a high percentage of gold. They are used in restorative or prosthetic dentistry.%A%    
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D006047 1998
% 224.29/224.51  |- skos__broader mesh__D006047smesh__D003722
% 224.29/224.51  |- skos__annotation mesh__D006047
% 224.29/224.51       used in dental prosth %26% restor; IM; D25-26 qualif   
% 224.29/224.51  |- mesh__dateEstablished mesh__D006047 1965-01-01
% 224.29/224.51  |- mesh__dateEstablished mesh__D044964 2004-01-01
% 224.29/224.51  |- skos__historyNote mesh__D044964 Neck %28%1966-2003%29%
% 224.29/224.51  |- skos__scopeNote mesh__D044964
% 224.29/224.51       Reconstructive surgical procedures in the NECK region to restore or improve form and function.%A%    
% 224.29/224.51  |- skos__altLabel mesh__D044964 Plastic Surgery, Neck
% 224.29/224.51  |- mesh__publicMeSHNote mesh__D044964 2004   
% 224.29/224.51  |- skos__altLabel mesh__D044964 Reconstructive Surgical Procedures, Neck
% 224.29/224.51  |- skos__historyNote mesh__D044964 Surgery, Plastic %28%1966-2003%29%
% 224.29/224.51  |- skos__annotation mesh__D044964 NECK only   
% 224.29/224.51  |- skos__hiddenLabel mesh__D044964 Surgeries, Neck Plastic
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D044964 2004
% 224.29/224.51  |- skos__broader mesh__D044964smesh__D019651
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D044964 2006
% 224.29/224.51  |- skos__hiddenLabel mesh__D044964 Plastic Surgeries, Neck
% 224.29/224.51  |- skos__prefLabel mesh__D044964 Cervicoplasty
% 224.29/224.51  |- rdf__type mesh__D044964sskos__Concept
% 224.29/224.51  |- mesh__activeMeSHYear mesh__D044964 2005
% 224.29/224.51  |- mesh__dateCreated mesh__D044964 2003-07-09
% 224.37/224.51  |- mesh__historyNote mesh__D044964 2004   
% 224.37/224.51  |- skos__hiddenLabel mesh__D044964 Neck Plastic Surgery
% 224.37/224.51  |- skos__hiddenLabel mesh__D044964 Neck Plastic Surgeries
% 224.37/224.51  |- skos__broader mesh__D044166smesh__D020563
% 224.37/224.51  |- mesh__publicMeSHNote mesh__D044166 2004   
% 224.37/224.51  |- skos__scopeNote mesh__D044166
% 224.37/224.51       A family of gram-negative bacteria, in the order Xanthomonadales, pathogenic to plants.%A%    
% 224.37/224.51  |- skos__prefLabel mesh__D044166 Xanthomonadaceae
% 224.37/224.51  |- mesh__recordMaintainer mesh__D044166 SYSTEM
% 224.37/224.51  |- skos__broader mesh__D044166smesh__D016946
% 224.37/224.51  |- mesh__recordAuthorizer mesh__D044166 sjn
% 224.37/224.51  |- mesh__activeMeSHYear mesh__D044166 2006
% 224.37/224.51  |- mesh__recordOriginator mesh__D044166 ags
% 224.37/224.51  |- mesh__dateRevised mesh__D044166 2005-06-30
% 224.37/224.51  |- mesh__dateEstablished mesh__D044166 2004-01-01
% 224.37/224.51  |- mesh__historyNote mesh__D044166 2004   
% 224.37/224.51  |- rdf__type mesh__D044166sskos__Concept
% 224.37/224.51  |- mesh__dateCreated mesh__D044166 2003-07-09
% 224.37/224.51  |- mesh__publicMeSHNote mesh__D016475 1992   
% 224.37/224.51  |- skos__broader mesh__D016475smesh__D005347
% 224.37/224.51  |- rdf__type mesh__D016475sskos__Concept
% 224.37/224.51  |- mesh__recordMaintainer mesh__D016475 ags
% 224.37/224.51  |- mesh__historyNote mesh__D016475 1992   
% 224.37/224.51  |- skos__hiddenLabel mesh__D016475 Cell, 3T3
% 224.37/224.51  |- skos__broader mesh__D016475smesh__D002460
% 224.37/224.51  |- skos__prefLabel mesh__D016475 3T3 Cells
% 224.37/224.51  |- skos__hiddenLabel mesh__D016475 3T3 Cell
% 224.37/224.51  |- mesh__dateEstablished mesh__D016475 1992-01-01
% 224.37/224.51  |- mesh__dateRevised mesh__D016475 2003-07-30
% 224.37/224.51  |- skos__hiddenLabel mesh__D016475 Cells, 3T3
% 224.37/224.51  |- skos__annotation mesh__D016475
% 224.37/224.51       almost always NIM with no subheadings; check ANIMALS %26% MICE; do not routinely add FIBROBLASTS or EMBRYO%A%  
% 224.37/224.51  |- mesh__dateCreated mesh__D016475 1991-01-03
% 224.37/224.51  |- skos__historyNote mesh__D016475 Cell Line %28%1966-1991%29%
% 224.37/224.51  |- skos__scopeNote mesh__D016475
% 224.37/224.51       Cell lines whose original growing procedure consisted being transferred %28%T%29% every 3 days and plated at 300,000 cells per plate %28%J Cell Biol 17:299-313, 1963%29%. Lines have been developed using several different strains of mice. Tissues are usually fibroblasts derived from mouse embryos but other types and sources have been developed as well. The 3T3 lines are valuable in vitro host systems for oncogenic virus transformation studies, since 3T3 cells possess a high sensitivity to CONTACT INHIBITION.%A%    
% 224.37/224.51  |- mesh__activeMeSHYear mesh__D016475 2006
% 224.37/224.51  |- mesh__recordAuthorizer mesh__D016475 sjn
% 224.37/224.51  |- mesh__recordOriginator mesh__D016475 AGS
% 224.37/224.51  |- mesh__activeMeSHYear mesh__D016475 2005
% 224.37/224.51  |- mesh__activeMeSHYear mesh__D016475 2004
% 224.37/224.51  |- mesh__dateCreated mesh__D002455 1999-01-01
% 224.37/224.51  |- skos__altLabel mesh__D002455 Cell Divisions
% 224.37/224.51  |- mesh__activeMeSHYear mesh__D002455 2005
% 224.37/224.51  |- skos__hiddenLabel mesh__D002455 M Phases
% 224.37/224.51  |- skos__broader mesh__D002455smesh__D039361
% 224.37/224.51  |- mesh__recordAuthorizer mesh__D002455 jls
% 224.37/224.51  |- mesh__recordOriginator mesh__D002455 NLM
% 224.37/224.51  |- mesh__publicMeSHNote mesh__D002455
% 224.37/224.51       1963; for M PHASE see MITOSIS 1991-2004   
% 224.37/224.51  |- mesh__historyNote mesh__D002455
% 224.37/224.51       1963 for M PHASE use MITOSIS 1991-2004   
% 224.37/224.51  |- mesh__activeMeSHYear mesh__D002455 2005A
% 224.37/224.51  |- skos__hiddenLabel mesh__D002455 Phases, M
% 224.37/224.52  |- rdf__type mesh__D002455sskos__Concept
% 224.37/224.52  |- skos__hiddenLabel mesh__D002455 Phase, M
% 224.37/224.52  |- skos__related mesh__D002455smesh__D018816
% 224.37/224.52  |- skos__prefLabel mesh__D002455 Cell Division
% 224.37/224.52  |- skos__altLabel mesh__D002455 Cell Division Phase
% 224.37/224.52  |- skos__annotation mesh__D002455
% 224.37/224.52       coordinate with specific cell /cytol; permitted with microorganisms; for cell division of cytoplasm only, use CYTOKINESIS; note X ref M PHASE: MITOTIC M PHASE and MEIOTIC M PHASE are also available%A%  
% 224.37/224.52  |- mesh__dateRevised mesh__D002455 2004-08-06
% 224.37/224.52  |- skos__hiddenLabel mesh__D002455 Phase, Cell Division
% 224.37/224.52  |- skos__hiddenLabel mesh__D002455 Division Phase, Cell
% 224.37/224.52  |- skos__hiddenLabel mesh__D002455 Divisions, Cell
% 224.37/224.52  |- mesh__recordMaintainer mesh__D002455 jls
% 224.37/224.52  |- skos__broader mesh__D002455smesh__D049109
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D002455 2006
% 224.37/224.52  |- skos__broader mesh__D002455smesh__D002453
% 224.37/224.52  |- skos__hiddenLabel mesh__D002455 Division, Cell
% 224.37/224.52  |- skos__scopeNote mesh__D002455
% 224.37/224.52       The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION.%A%    
% 224.37/224.52  |- skos__related mesh__D002455smesh__D018797
% 224.37/224.52  |- rdf__type mesh__D007140sskos__Concept
% 224.37/224.52  |- skos__hiddenLabel mesh__D007140 Fragment Immunoglobulins, Fab
% 224.37/224.52  |- mesh__dateCreated mesh__D007140 1999-01-01
% 224.37/224.52  |- skos__hiddenLabel mesh__D007140 Fab Fragment Immunoglobulins
% 224.37/224.52  |- skos__altLabel mesh__D007140 Immunoglobulins, Fab
% 224.37/224.52  |- mesh__dateRevised mesh__D007140 2005-06-30
% 224.37/224.52  |- skos__historyNote mesh__D007140 Immunoglobulins %28%1970-1972%29%
% 224.37/224.52  |- skos__broader mesh__D007140smesh__D007135
% 224.37/224.52  |- skos__hiddenLabel mesh__D007140 Fab Fragments, Immunoglobulin
% 224.37/224.52  |- skos__hiddenLabel mesh__D007140 Fab Fragment, Immunoglobulin
% 224.37/224.52  |- skos__altLabel mesh__D007140 Fab Immunoglobulin Fragments
% 224.37/224.52  |- mesh__historyNote mesh__D007140 2006 %28%1973%29%   
% 224.37/224.52  |- mesh__recordMaintainer mesh__D007140 nns
% 224.37/224.52  |- mesh__publicMeSHNote mesh__D007140
% 224.37/224.52       2006; was IMMUNOGLOBULINS, FAB 1973-2005   
% 224.37/224.52  |- skos__annotation mesh__D007140 DF: IG FAB   
% 224.37/224.52  |- mesh__dateEstablished mesh__D007140 1973-01-01
% 224.37/224.52  |- skos__broader mesh__D007140smesh__D007127
% 224.37/224.52  |- skos__altLabel mesh__D007140 Fab Fragments
% 224.37/224.52  |- skos__altLabel mesh__D007140 Immunoglobulin Fab Fragment
% 224.37/224.52  |- skos__prefLabel mesh__D007140 Immunoglobulin Fab Fragments
% 224.37/224.52  |- mesh__recordAuthorizer mesh__D007140 sjn
% 224.37/224.52  |- skos__broader mesh__D007140smesh__D007128
% 224.37/224.52  |- skos__scopeNote mesh__D007140
% 224.37/224.52       Univalent antigen-binding fragments composed of one entire IMMUNOGLOBULIN LIGHT CHAIN and the amino terminal end of one of the IMMUNOGLOBULIN HEAVY CHAINS from the hinge region, linked to each other by disulfide bonds. Fab contains the variable regions of the immunoglobulin molecule, which are part of the antigen-binding site, and the first constant regions. This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN.%A%    
% 224.37/224.52  |- mesh__recordOriginator mesh__D007140 NLM
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D007140 2006
% 224.37/224.52  |- skos__hiddenLabel mesh__D007140 Immunoglobulin Fragments, Fab
% 224.37/224.52  |- skos__altLabel mesh__D007140 Immunoglobulins, Fab Fragment
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012883 2006
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012883 2002
% 224.37/224.52  |- skos__broader mesh__D012883smesh__D012871
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012883 2005
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012883 2001
% 224.37/224.52  |- mesh__dateCreated mesh__D012883 1999-01-01
% 224.37/224.52  |- skos__hiddenLabel mesh__D012883 Ulcer, Skin
% 224.37/224.52  |- mesh__recordOriginator mesh__D012883 NLM
% 224.37/224.52  |- mesh__recordMaintainer mesh__D012883 TGC
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012883 2004
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012883 1999
% 224.37/224.52  |- rdf__type mesh__D012883sskos__Concept
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012883 2000
% 224.37/224.52  |- mesh__recordAuthorizer mesh__D012883 SJN
% 224.37/224.52  |- skos__hiddenLabel mesh__D012883 Ulcers, Skin
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012883 2003
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012883 1998
% 224.37/224.52  |- skos__hiddenLabel mesh__D012883 Skin Ulcers
% 224.37/224.52  |- mesh__dateRevised mesh__D012883 1997-06-20
% 224.37/224.52  |- skos__prefLabel mesh__D012883 Skin Ulcer
% 224.37/224.52  |- skos__prefLabel mesh__D012085 Chymosin
% 224.37/224.52  |- mesh__onlineNote mesh__D012085 use CHYMOSIN to search RENNIN 1966-90   
% 224.37/224.52  |- skos__annotation mesh__D012085
% 224.37/224.52       do not confuse X ref RENNIN with RENIN; /biosyn /physiol permitted%A%  
% 224.37/224.52  |- skos__altLabel mesh__D012085 Rennin
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012085 2004
% 224.37/224.52  |- mesh__dateCreated mesh__D012085 1999-01-01
% 224.37/224.52  |- mesh__recordMaintainer mesh__D012085 ssb
% 224.37/224.52  |- mesh__dateRevised mesh__D012085 2003-07-09
% 224.37/224.52  |- rdf__type mesh__D012085sskos__Concept
% 224.37/224.52  |- mesh__recordOriginator mesh__D012085 NLM
% 224.37/224.52  |- mesh__recordAuthorizer mesh__D012085 sjn
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012085 2005
% 224.37/224.52  |- skos__scopeNote mesh__D012085
% 224.37/224.52       The predominant milk-clotting enzyme from the true stomach or abomasum of the suckling calf. It is secreted as an inactive precursor called prorennin and converted in the acid environment of the stomach to the active enzyme. EC 3.4.23.4.%A%    
% 224.37/224.52  |- mesh__historyNote mesh__D012085 91; was RENNIN 1963-90   
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012085 2006
% 224.37/224.52  |- mesh__publicMeSHNote mesh__D012085 91; was RENNIN 1963-90   
% 224.37/224.52  |- skos__broader mesh__D012085smesh__D016282
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D006846 2002
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D006846 1997
% 224.37/224.52  |- skos__broader mesh__D006846smesh__D006838
% 224.37/224.52  |- skos__altLabel mesh__D006846 Halogenated Hydrocarbons
% 224.37/224.52  |- rdf__type mesh__D006846sskos__Concept
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D006846 1999
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D006846 2003
% 224.37/224.52  |- skos__prefLabel mesh__D006846 Hydrocarbons, Halogenated
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D006846 1994
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D006846 2000
% 224.37/224.52  |- mesh__recordAuthorizer mesh__D006846 PLS
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D006846 1993
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D006846 2005
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D006846 2004
% 224.37/224.52  |- mesh__historyNote mesh__D006846 66   
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D006846 2001
% 224.37/224.52  |- mesh__dateCreated mesh__D006846 1999-01-01
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D006846 1995
% 224.37/224.52  |- mesh__recordOriginator mesh__D006846 NLM
% 224.37/224.52  |- mesh__recordMaintainer mesh__D006846 TGC
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D006846 2006
% 224.37/224.52  |- skos__annotation mesh__D006846
% 224.37/224.52       GEN; note specific halogenated hydrocarbon groups available%A%  
% 224.37/224.52  |- mesh__dateEstablished mesh__D006846 1966-01-01
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D006846 1996
% 224.37/224.52  |- mesh__dateRevised mesh__D006846 1992-05-19
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D006846 1998
% 224.37/224.52  |- mesh__publicMeSHNote mesh__D006846 66   
% 224.37/224.52  |- skos__historyNote mesh__D020517 Heart Atrium %28%1966-1999%29%
% 224.37/224.52  |- skos__altLabel mesh__D020517 Heart Atrium Appendage
% 224.37/224.52  |- skos__scopeNote mesh__D020517
% 224.37/224.52       Ear-shaped appendage of either atrium of the heart. %28%Dorland, 28th ed%29%%A%    
% 224.37/224.52  |- skos__hiddenLabel mesh__D020517 Appendages, Atrial
% 224.37/224.52  |- skos__hiddenLabel mesh__D020517 Appendage, Atrial
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D020517 2003
% 224.37/224.52  |- skos__hiddenLabel mesh__D020517 Appendages, Atrium
% 224.37/224.52  |- skos__prefLabel mesh__D020517 Atrial Appendage
% 224.37/224.52  |- skos__hiddenLabel mesh__D020517 Heart Atrium Appendages
% 224.37/224.52  |- skos__hiddenLabel mesh__D020517 Auricular Appendages
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D020517 2005
% 224.37/224.52  |- mesh__publicMeSHNote mesh__D020517 2000   
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D020517 2000
% 224.37/224.52  |- skos__hiddenLabel mesh__D020517 Appendages, Heart Atrium
% 224.37/224.52  |- skos__hiddenLabel mesh__D020517 Atrium Appendages
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D020517 2004
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D020517 2001
% 224.37/224.52  |- skos__hiddenLabel mesh__D020517 Atrial Appendages
% 224.37/224.52  |- rdf__type mesh__D020517sskos__Concept
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D020517 2006
% 224.37/224.52  |- skos__altLabel mesh__D020517 Atrium Appendage
% 224.37/224.52  |- mesh__dateCreated mesh__D020517 1999-11-03
% 224.37/224.52  |- mesh__dateEstablished mesh__D020517 2000-01-01
% 224.37/224.52  |- skos__hiddenLabel mesh__D020517 Atrium Appendage, Heart
% 224.37/224.52  |- skos__broader mesh__D020517smesh__D006325
% 224.37/224.52  |- skos__altLabel mesh__D020517 Auricular Appendage
% 224.37/224.52  |- skos__hiddenLabel mesh__D020517 Appendage, Auricular
% 224.37/224.52  |- skos__hiddenLabel mesh__D020517 Appendage, Heart Atrium
% 224.37/224.52  |- mesh__historyNote mesh__D020517 2000   
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D020517 2002
% 224.37/224.52  |- skos__hiddenLabel mesh__D020517 Appendages, Auricular
% 224.37/224.52  |- skos__hiddenLabel mesh__D020517 Appendage, Atrium
% 224.37/224.52  |- mesh__dateCreated mesh__D039222 2002-07-02
% 224.37/224.52  |- mesh__publicMeSHNote mesh__D039222
% 224.37/224.52       2003; INTEGRIN ALPHA1BETA1 was indexed under INTEGRINS 1994-2002%A%  
% 224.37/224.52  |- skos__broader mesh__D039222smesh__D038981
% 224.37/224.52  |- skos__hiddenLabel mesh__D039222 Integrin, alpha1beta1
% 224.37/224.52  |- skos__hiddenLabel mesh__D039222 alpha1beta1, Integrin
% 224.37/224.52  |- skos__broader mesh__D039222smesh__D017474
% 224.37/224.52  |- mesh__dateRevised mesh__D039222 2005-06-30
% 224.37/224.52  |- skos__prefLabel mesh__D039222 Integrin alpha1beta1
% 224.37/224.52  |- rdf__type mesh__D039222sskos__Concept
% 224.37/224.52  |- mesh__dateEstablished mesh__D039222 2003-01-01
% 224.37/224.52  |- mesh__historyNote mesh__D039222
% 224.37/224.52       2003; use INTEGRIN ALPHA1BETA1 %28%NM%29% 1994-2002   
% 224.37/224.52  |- skos__scopeNote mesh__D039222
% 224.37/224.52       Integrin alpha1beta1 functions as a receptor for LAMININ and COLLAGEN.  It is widely expressed during development, but in the adult is the predominant laminin receptor %28%RECEPTORS, LAMININ%29% in mature SMOOTH MUSCLE CELLS, where it is important for maintenance of the differentiated phenotype of these cells. Integrin alpha1beta1 is also found in LYMPHOCYTES and microvascular endothelial cells, and may play a role in angiogenesis. In SCHWANN CELLS and neural crest cells, it is involved in cell migration.  Integrin alpha1beta1 is also known as VLA-1 and CD49a-CD29.%A%    
% 224.37/224.52  |- skos__broader mesh__D039222smesh__D016029
% 224.37/224.52  |- mesh__recordAuthorizer mesh__D039222 sjn
% 224.37/224.52  |- skos__historyNote mesh__D039222 Integrins %28%1994-2002%29%
% 224.37/224.52  |- mesh__recordOriginator mesh__D039222 MDJ
% 224.37/224.52  |- skos__altLabel mesh__D039222 CD49a-CD29
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D039222 2006
% 224.37/224.52  |- skos__altLabel mesh__D039222 Integrin alpha%28%1%29%beta%28%1%29%
% 224.37/224.52  |- mesh__recordMaintainer mesh__D039222 jmp
% 224.37/224.52  |- skos__altLabel mesh__D039222 alpha1beta1 Integrin
% 224.37/224.52  |- skos__altLabel mesh__D039222 VLA-1
% 224.37/224.52  |- skos__scopeNote mesh__D006048
% 224.37/224.52       A suspension of radioactive gold particles emitting negative beta particles and gamma irradiation. It was formerly used for liver scans and irradiation treatment of some metastatic malignancies.%A%    
% 224.37/224.52  |- skos__hiddenLabel mesh__D006048 Colloid, Radioactive Gold
% 224.37/224.52  |- mesh__dateRevised mesh__D006048 2000-06-22
% 224.37/224.52  |- skos__broader mesh__D006048smesh__D017979
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D006048 2004
% 224.37/224.52  |- skos__broader mesh__D006048smesh__D006050
% 224.37/224.52  |- rdf__type mesh__D006048sskos__Concept
% 224.37/224.52  |- skos__prefLabel mesh__D006048 Gold Colloid, Radioactive
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D006048 2003
% 224.37/224.52  |- mesh__recordMaintainer mesh__D006048 adp
% 224.37/224.52  |- skos__hiddenLabel mesh__D006048 Radioactive Gold Colloid
% 224.37/224.52  |- skos__annotation mesh__D006048 NIM; for tracer studies use /diag use   
% 224.37/224.52  |- mesh__dateCreated mesh__D006048 1999-01-01
% 224.37/224.52  |- skos__altLabel mesh__D006048 Radio-Colloidal Gold
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D006048 2006
% 224.37/224.52  |- mesh__recordAuthorizer mesh__D006048 sjn
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D006048 2002
% 224.37/224.52  |- skos__hiddenLabel mesh__D006048 Gold, Radio-Colloidal
% 224.37/224.52  |- mesh__recordOriginator mesh__D006048 NLM
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D006048 2005
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D006048 2001
% 224.37/224.52  |- skos__hiddenLabel mesh__D006048 Radio Colloidal Gold
% 224.37/224.52  |- skos__hiddenLabel mesh__D025202 Diagnostic Technique, Molecular
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D025202 2005A
% 224.37/224.52  |- mesh__dateEstablished mesh__D025202 2002-01-01
% 224.37/224.52  |- skos__broader mesh__D025202smesh__D005821
% 224.37/224.52  |- skos__hiddenLabel mesh__D025202 Diagnostic Technics, Molecular
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D025202 2003
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D025202 2006
% 224.37/224.52  |- mesh__recordMaintainer mesh__D025202 ags
% 224.37/224.52  |- skos__related mesh__D025202smesh__D005820
% 224.37/224.52  |- skos__hiddenLabel mesh__D025202 Techniques, Molecular Diagnostic
% 224.37/224.52  |- mesh__recordOriginator mesh__D025202 nns
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D025202 2002
% 224.37/224.52  |- mesh__historyNote mesh__D025202
% 224.37/224.52       2002; for MOLECULAR DIAGNOSTIC TESTING use CYTOGENETIC ANALYSIS 2000-2001%A%  
% 224.37/224.52  |- mesh__recordAuthorizer mesh__D025202 ags
% 224.37/224.52  |- skos__hiddenLabel mesh__D025202 Diagnostic Testing, Molecular
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D025202 2005
% 224.37/224.52  |- skos__hiddenLabel mesh__D025202 Molecular Diagnostic Technique
% 224.37/224.52  |- skos__hiddenLabel mesh__D025202 Molecular Diagnostic Technic
% 224.37/224.52  |- mesh__dateRevised mesh__D025202 2005-07-22
% 224.37/224.52  |- skos__hiddenLabel mesh__D025202 Technique, Molecular Diagnostic
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D025202 2006A
% 224.37/224.52  |- skos__related mesh__D025202smesh__D020732
% 224.37/224.52  |- skos__hiddenLabel mesh__D025202 Diagnostic Techniques, Molecular
% 224.37/224.52  |- skos__related mesh__D025202smesh__D015335
% 224.37/224.52  |- rdf__type mesh__D025202sskos__Concept
% 224.37/224.52  |- skos__broader mesh__D025202smesh__D019411
% 224.37/224.52  |- skos__hiddenLabel mesh__D025202 Testing, Molecular Diagnostic
% 224.37/224.52  |- skos__prefLabel mesh__D025202 Molecular Diagnostic Techniques
% 224.37/224.52  |- mesh__publicMeSHNote mesh__D025202
% 224.37/224.52       2002; for MOLECULAR DIAGNOSTIC TESTING see CYTOGENETIC ANALYSIS 2000-2001%A%  
% 224.37/224.52  |- skos__hiddenLabel mesh__D025202 Technic, Molecular Diagnostic
% 224.37/224.52  |- skos__hiddenLabel mesh__D025202 Diagnostic Technic, Molecular
% 224.37/224.52  |- mesh__dateCreated mesh__D025202 2001-07-25
% 224.37/224.52  |- skos__annotation mesh__D025202 coord with specific technique   
% 224.37/224.52  |- skos__altLabel mesh__D025202 Molecular Diagnostic Technics
% 224.37/224.52  |- skos__hiddenLabel mesh__D025202 Technics, Molecular Diagnostic
% 224.37/224.52  |- skos__scopeNote mesh__D025202
% 224.37/224.52       MOLECULAR BIOLOGY techniques used in the diagnosis of disease. Included are such techniques as IN SITU HYBRIDIZATION of chromosomes for CYTOGENETIC ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS of gene expression patterns in disease states; identification of pathogenic organisms by analysis of species specific DNA sequences; and detection of mutations with POLYMERASE CHAIN REACTION.%A%    
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D025202 2004
% 224.37/224.52  |- mesh__dateRevised mesh__D044167 2005-06-30
% 224.37/224.52  |- skos__broader mesh__D044167smesh__D044166
% 224.37/224.52  |- mesh__historyNote mesh__D044167 2004   
% 224.37/224.52  |- mesh__publicMeSHNote mesh__D044167 2004   
% 224.37/224.52  |- skos__scopeNote mesh__D044167
% 224.37/224.52       A genus of gram-negative, aerobic bacteria, in the family XANTHOMONADACEAE. It is found in the xylem of plant tissue.%A%    
% 224.37/224.52  |- mesh__dateEstablished mesh__D044167 2004-01-01
% 224.37/224.52  |- skos__historyNote mesh__D044167 Gammaproteobacteria %28%1997-2003%29%
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D044167 2006
% 224.37/224.52  |- rdf__type mesh__D044167sskos__Concept
% 224.37/224.52  |- mesh__recordMaintainer mesh__D044167 SYSTEM
% 224.37/224.52  |- mesh__recordAuthorizer mesh__D044167 sjn
% 224.37/224.52  |- mesh__dateCreated mesh__D044167 2003-07-09
% 224.37/224.52  |- mesh__recordOriginator mesh__D044167 ags
% 224.37/224.52  |- skos__prefLabel mesh__D044167 Xylella
% 224.37/224.52  |- skos__hiddenLabel mesh__D016476 Reservoirs, Continent Urinary
% 224.37/224.52  |- skos__altLabel mesh__D016476 Colonic Urinary Reservoirs
% 224.37/224.52  |- skos__hiddenLabel mesh__D016476 Reservoirs, Colonic Urinary
% 224.37/224.52  |- skos__hiddenLabel mesh__D016476 Reservoir, Continent Urinary
% 224.37/224.52  |- mesh__dateCreated mesh__D016476 1991-01-03
% 224.37/224.52  |- skos__hiddenLabel mesh__D016476 Colonic Urinary Reservoir
% 224.37/224.52  |- skos__hiddenLabel mesh__D016476 Reservoir, Colonic Urinary
% 224.37/224.52  |- skos__hiddenLabel mesh__D016476 Urinary Reservoir, Continent
% 224.37/224.52  |- skos__prefLabel mesh__D016476 Urinary Reservoirs, Continent
% 224.37/224.52  |- skos__altLabel mesh__D016476 Continent Urinary Reservoirs
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D016476 2006
% 224.37/224.52  |- mesh__dateEstablished mesh__D016476 1992-01-01
% 224.37/224.52  |- skos__broader mesh__D016476smesh__D019738
% 224.37/224.52  |- skos__hiddenLabel mesh__D016476 Continent Urinary Reservoir
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D016476 2005
% 224.37/224.52  |- skos__scopeNote mesh__D016476
% 224.37/224.52       Structures which collect and store urine and are emptied by catheterization of a cutaneous stoma or internal diversion to the urethra. The reservoirs are surgically created during procedures for urinary diversion.%A%    
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D016476 2004
% 224.37/224.52  |- mesh__publicMeSHNote mesh__D016476 92   
% 224.37/224.52  |- skos__hiddenLabel mesh__D016476 Urinary Reservoir, Colonic
% 224.37/224.52  |- skos__historyNote mesh__D016476 Urinary Diversion %28%1972-1991%29%
% 224.37/224.52  |- mesh__historyNote mesh__D016476 92   
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D016476 2003
% 224.37/224.52  |- mesh__dateRevised mesh__D016476 2002-07-03
% 224.37/224.52  |- rdf__type mesh__D016476sskos__Concept
% 224.37/224.52  |- skos__annotation mesh__D016476
% 224.37/224.52       to collect %26% store urine after urinary diversion surg; do not use /util except by MeSH definition%A%  
% 224.37/224.52  |- mesh__recordMaintainer mesh__D016476 ags
% 224.37/224.52  |- mesh__recordOriginator mesh__D016476 AGS
% 224.37/224.52  |- mesh__recordAuthorizer mesh__D016476 sjn
% 224.37/224.52  |- skos__hiddenLabel mesh__D016476 Urinary Reservoirs, Colonic
% 224.37/224.52  |- skos__prefLabel mesh__D007141 Immunoglobulin Fc Fragments
% 224.37/224.52  |- mesh__publicMeSHNote mesh__D007141
% 224.37/224.52       2006; see IMMUNOGLOBULINS, FC 1987-2005, see IMMUNOGLOBULIN FRAGMENTS 1984-1986, see IMMUNOGLOBULINS, FC 1973-1983%A%  
% 224.37/224.52  |- skos__hiddenLabel mesh__D007141 Fc Fragment Immunoglobulins
% 224.37/224.52  |- skos__broader mesh__D007141smesh__D007127
% 224.37/224.52  |- skos__altLabel mesh__D007141 Fc Immunoglobulins
% 224.37/224.52  |- skos__hiddenLabel mesh__D007141 Fragment Immunoglobulins, Fc
% 224.37/224.52  |- mesh__recordOriginator mesh__D007141 NLM
% 224.37/224.52  |- skos__broader mesh__D007141smesh__D007128
% 224.37/224.52  |- skos__hiddenLabel mesh__D007141 Fc Fragment, Immunoglobulin
% 224.37/224.52  |- skos__hiddenLabel mesh__D007141 Fc Fragments, Immunoglobulin
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D007141 2006
% 224.37/224.52  |- skos__related mesh__D007141smesh__D011961
% 224.37/224.52  |- mesh__recordMaintainer mesh__D007141 nns
% 224.37/224.52  |- skos__altLabel mesh__D007141 Immunoglobulin Fc Fragment
% 224.37/224.52  |- mesh__dateRevised mesh__D007141 2005-06-30
% 224.37/224.52  |- skos__altLabel mesh__D007141 Immunoglobulins, Fc Fragment
% 224.37/224.52  |- skos__historyNote mesh__D007141 Immunoglobulins %28%1970-1972%29%
% 224.37/224.52  |- mesh__dateEstablished mesh__D007141 1973-01-01
% 224.37/224.52  |- skos__annotation mesh__D007141 DF: IG FC   
% 224.37/224.52  |- rdf__type mesh__D007141sskos__Concept
% 224.37/224.52  |- mesh__dateCreated mesh__D007141 1999-01-01
% 224.37/224.52  |- skos__altLabel mesh__D007141 Fc Fragments
% 224.37/224.52  |- skos__altLabel mesh__D007141 Immunoglobulins, Fc
% 224.37/224.52  |- mesh__historyNote mesh__D007141 2006 %28%1973%29%   
% 224.37/224.52  |- mesh__recordAuthorizer mesh__D007141 sjn
% 224.37/224.52  |- skos__scopeNote mesh__D007141
% 224.37/224.52       Crystallizable fragments composed of the carboxy-terminal halves of both IMMUNOGLOBULIN HEAVY CHAINS linked to each other by disulfide bonds. Fc fragments contain the carboxy-terminal parts of the heavy chain constant regions that are responsible for the effector functions of an immunoglobulin %28%COMPLEMENT fixation, binding to the cell membrane via FC RECEPTORS, and placental transport%29%. This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN.%A%    
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012884 2005
% 224.37/224.52  |- skos__broader mesh__D012884smesh__D007158
% 224.37/224.52  |- mesh__dateCreated mesh__D012884 1999-01-01
% 224.37/224.52  |- skos__hiddenLabel mesh__D012884 Skin Window Techniques
% 224.37/224.52  |- mesh__historyNote mesh__D012884
% 224.37/224.52       91%28%67%29%; was SKIN WINDOW TECHNIC 1967-90 %28%Prov 1967-69%29%   
% 224.37/224.52  |- mesh__recordMaintainer mesh__D012884 kle
% 224.37/224.52  |- rdf__type mesh__D012884sskos__Concept
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012884 2004
% 224.37/224.52  |- skos__historyNote mesh__D012884 Inflammation %28%1966%29%
% 224.37/224.52  |- skos__altLabel mesh__D012884 Skin Window Technic
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012884 2002
% 224.37/224.52  |- skos__prefLabel mesh__D012884 Skin Window Technique
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012884 2003
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012884 2001
% 224.37/224.52  |- skos__annotation mesh__D012884 IM; no qualif   
% 224.37/224.52  |- mesh__recordAuthorizer mesh__D012884 sjn
% 224.37/224.52  |- mesh__recordOriginator mesh__D012884 NLM
% 224.37/224.52  |- mesh__dateRevised mesh__D012884 1999-11-03
% 224.37/224.52  |- skos__hiddenLabel mesh__D012884 Technique, Skin Window
% 224.37/224.52  |- mesh__dateEstablished mesh__D012884 1970-01-01
% 224.37/224.52  |- mesh__onlineNote mesh__D012884
% 224.37/224.52       use SKIN WINDOW TECHNIQUE to search SKIN WINDOW TECHNIC 1967-90%A%  
% 224.37/224.52  |- mesh__publicMeSHNote mesh__D012884
% 224.37/224.52       91; was SKIN WINDOW TECHNIC 1970-90   
% 224.37/224.52  |- skos__hiddenLabel mesh__D012884 Technics, Skin Window
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012884 2000
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012884 2006
% 224.37/224.52  |- skos__hiddenLabel mesh__D012884 Technic, Skin Window
% 224.37/224.52  |- skos__hiddenLabel mesh__D012884 Skin Window Technics
% 224.37/224.52  |- skos__hiddenLabel mesh__D012884 Techniques, Skin Window
% 224.37/224.52  |- skos__hiddenLabel mesh__D039223 Subunit, CPSF-100-kDa
% 224.37/224.52  |- skos__altLabel mesh__D039223 CPSF-73-kDa Subunit
% 224.37/224.52  |- mesh__recordAuthorizer mesh__D039223 sjn
% 224.37/224.52  |- rdf__type mesh__D039223sskos__Concept
% 224.37/224.52  |- skos__altLabel mesh__D039223 Cleavage-Polyadenylation Specificity Factor
% 224.37/224.52  |- skos__altLabel mesh__D039223 CPSF-100-kDa Subunit
% 224.37/224.52  |- skos__hiddenLabel mesh__D039223
% 224.37/224.52       Cleavage And Polyadenylation Specificity Factor, 30 kDa Subunit
% 224.37/224.52  |- skos__broader mesh__D039223smesh__D039221
% 224.37/224.52  |- skos__hiddenLabel mesh__D039223 CPSF 73 kDa Subunit
% 224.37/224.52  |- skos__hiddenLabel mesh__D039223
% 224.37/224.52       Cleavage And Polyadenylation Specificity Factor, 73 kDa Subunit
% 224.37/224.52  |- skos__historyNote mesh__D039223 RNA-Binding Proteins %28%1992-2002%29%
% 224.37/224.52  |- skos__altLabel mesh__D039223 CPSF Protein
% 224.37/224.52  |- skos__hiddenLabel mesh__D039223 Subunit, CPSF-160-kDa
% 224.37/224.52  |- skos__altLabel mesh__D039223 CPSF-30-kDa Subunit
% 224.37/224.52  |- skos__hiddenLabel mesh__D039223 CPSF 160 kDa Subunit
% 224.37/224.52  |- mesh__historyNote mesh__D039223
% 224.37/224.52       2003; for CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR use MRNA CLEAVAGE AND POLYADENYLATION FACTORS %28%NM%29% 1992-2002%A%  
% 224.37/224.52  |- mesh__recordMaintainer mesh__D039223 ags
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D039223 2006
% 224.37/224.52  |- skos__hiddenLabel mesh__D039223
% 224.37/224.52       Cleavage And Polyadenylation Specificity Factor, 160 kDa Subunit
% 224.37/224.52  |- skos__hiddenLabel mesh__D039223 CPSF 100 kDa Subunit
% 224.37/224.52  |- skos__hiddenLabel mesh__D039223
% 224.37/224.52       Cleavage Polyadenylation Specificity Factor
% 224.37/224.52  |- mesh__recordOriginator mesh__D039223 jmp
% 224.37/224.52  |- mesh__publicMeSHNote mesh__D039223
% 224.37/224.52       2003; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR was indexed under RNA-BINDING PROTEINS 1992-2002%A%  
% 224.37/224.52  |- skos__hiddenLabel mesh__D039223 CPSF 30 kDa Subunit
% 224.37/224.52  |- mesh__dateCreated mesh__D039223 2002-07-03
% 224.37/224.52  |- skos__altLabel mesh__D039223 CPSF 30K
% 224.37/224.52  |- mesh__dateEstablished mesh__D039223 2003-01-01
% 224.37/224.52  |- skos__hiddenLabel mesh__D039223 Subunit, CPSF-73-kDa
% 224.37/224.52  |- skos__hiddenLabel mesh__D039223
% 224.37/224.52       Cleavage And Polyadenylation Specificity Factor, 100 kDa Subunit
% 224.37/224.52  |- skos__prefLabel mesh__D039223
% 224.37/224.52       Cleavage And Polyadenylation Specificity Factor
% 224.37/224.52  |- skos__altLabel mesh__D039223 CPSF-160-kDa Subunit
% 224.37/224.52  |- skos__hiddenLabel mesh__D039223 Subunit, CPSF-30-kDa
% 224.37/224.52  |- mesh__dateRevised mesh__D039223 2005-06-30
% 224.37/224.52  |- skos__scopeNote mesh__D039223
% 224.37/224.52       An RNA-binding protein that recognizes the AAUAAA RNA SEQUENCE at the 3%27% end of MRNA. It contains four subunits of 30, 73, 100 and 160 kDa molecular size and combines with CLEAVAGE STIMULATION FACTOR to form a stable complex with mRNA that directs the 3%27% cleavage and polyadenylation reaction.%A%    
% 224.37/224.52  |- skos__hiddenLabel mesh__D012086 Joint Revision
% 224.37/224.52  |- skos__altLabel mesh__D012086 Surgery, Repeat
% 224.37/224.52  |- skos__prefLabel mesh__D012086 Reoperation
% 224.37/224.52  |- skos__annotation mesh__D012086
% 224.37/224.52       IM general only; coord NIM with specific type of surgery %28%IM%29%; re-transplantation: coord with appropriate transplantation term; does not include staged surg %28% = specific organ /surg, dis /surg or surg technique%29%%A%  
% 224.37/224.52  |- mesh__historyNote mesh__D012086
% 224.37/224.52       91%28%82%29%; was see under SURGERY, OPERATIVE 1982-90; REVISION ARTHROPLASTY was see REOPERATION 1987-92%A%  
% 224.37/224.52  |- mesh__publicMeSHNote mesh__D012086
% 224.37/224.52       91; was see under SURGERY, OPERATIVE 1982-90; REVISION ARTHROPLASTY was see REOPERATION 1987-92%A%  
% 224.37/224.52  |- skos__altLabel mesh__D012086 Revision, Surgical
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012086 2002
% 224.37/224.52  |- mesh__recordOriginator mesh__D012086 SMH
% 224.37/224.52  |- skos__altLabel mesh__D012086 Repeat Surgery
% 224.37/224.52  |- rdf__type mesh__D012086sskos__Concept
% 224.37/224.52  |- mesh__dateCreated mesh__D012086 1981-05-15
% 224.37/224.52  |- skos__scopeNote mesh__D012086
% 224.37/224.52       A repeat operation for the same condition in the same patient due to disease progression or recurrence, or as followup to failed previous surgery.%A%    
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012086 2005
% 224.37/224.52  |- skos__altLabel mesh__D012086 Surgical Revision
% 224.37/224.52  |- mesh__dateRevised mesh__D012086 2001-07-25
% 224.37/224.52  |- mesh__dateEstablished mesh__D012086 1991-01-01
% 224.37/224.52  |- mesh__onlineNote mesh__D012086
% 224.37/224.52       use REOPERATION to search REVISION ARTHROPLASTY 1987-92   
% 224.37/224.52  |- mesh__recordMaintainer mesh__D012086 lkt
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012086 2003
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012086 2006
% 224.37/224.52  |- skos__broader mesh__D012086smesh__D013514
% 224.37/224.52  |- mesh__recordAuthorizer mesh__D012086 sjn
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D012086 2004
% 224.37/224.52  |- mesh__activeMeSHYear mesh__D006847 1997
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006847 2005
% 224.37/224.53  |- mesh__dateEstablished mesh__D006847 1974-01-01
% 224.37/224.53  |- skos__broader mesh__D006847smesh__D006846
% 224.37/224.53  |- mesh__dateRevised mesh__D006847 1992-05-19
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006847 1996
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006847 2001
% 224.37/224.53  |- mesh__historyNote mesh__D006847 74   
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006847 2000
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006847 1993
% 224.37/224.53  |- mesh__recordMaintainer mesh__D006847 TGC
% 224.37/224.53  |- mesh__recordAuthorizer mesh__D006847 PLS
% 224.37/224.53  |- skos__altLabel mesh__D006847 Iodinated Hydrocarbons
% 224.37/224.53  |- rdf__type mesh__D006847sskos__Concept
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006847 1999
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006847 2004
% 224.37/224.53  |- skos__prefLabel mesh__D006847 Hydrocarbons, Iodinated
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006847 1998
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006847 2003
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006847 1995
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006847 2002
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006847 2006
% 224.37/224.53  |- mesh__publicMeSHNote mesh__D006847 74   
% 224.37/224.53  |- mesh__dateCreated mesh__D006847 1999-01-01
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006847 1994
% 224.37/224.53  |- mesh__recordOriginator mesh__D006847 NLM
% 224.37/224.53  |- skos__historyNote mesh__D020518 Liver Diseases %28%1969-1999%29%
% 224.37/224.53  |- skos__historyNote mesh__D020518 Liver Neoplasms %28%1968-1999%29%
% 224.37/224.53  |- mesh__recordMaintainer mesh__D020518 lkt
% 224.37/224.53  |- skos__hiddenLabel mesh__D020518 Hyperplasias, Focal Nodular
% 224.37/224.53  |- skos__altLabel mesh__D020518 Hyperplasia, Focal Nodular
% 224.37/224.53  |- mesh__dateCreated mesh__D020518 1999-11-03
% 224.37/224.53  |- mesh__historyNote mesh__D020518 2000   
% 224.37/224.53  |- mesh__publicMeSHNote mesh__D020518 2000   
% 224.37/224.53  |- mesh__recordOriginator mesh__D020518 ags
% 224.37/224.53  |- mesh__recordAuthorizer mesh__D020518 sjn
% 224.37/224.53  |- skos__broader mesh__D020518smesh__D008107
% 224.37/224.53  |- skos__hiddenLabel mesh__D020518 Focal Nodular Hyperplasias
% 224.37/224.53  |- rdf__type mesh__D020518sskos__Concept
% 224.37/224.53  |- skos__prefLabel mesh__D020518 Focal Nodular Hyperplasia
% 224.37/224.53  |- skos__historyNote mesh__D020518 Hyperplasia %28%1968-1999%29%
% 224.37/224.53  |- mesh__dateRevised mesh__D020518 2004-07-07
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D020518 2006
% 224.37/224.53  |- mesh__dateEstablished mesh__D020518 2000-01-01
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D020518 2005
% 224.37/224.53  |- skos__scopeNote mesh__D020518
% 224.37/224.53       Solitary or multiple benign hepatic vascular tumors, usually occurring in women of 20-50 years of age. The nodule, poorly encapsulated, consists of a central stellate fibrous scar and normal liver elements such as HEPATOCYTES, small BILE DUCTS, and KUPFFER CELLS among the intervening fibrous septa. The pale colored central scar represents large blood vessels with hyperplastic fibromuscular layer and narrowing lumen.%A%    
% 224.37/224.53  |- mesh__dateEstablished mesh__D031240 2003-01-01
% 224.37/224.53  |- mesh__publicMeSHNote mesh__D031240 2003   
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D031240 2006
% 224.37/224.53  |- skos__broader mesh__D031240smesh__D027922
% 224.37/224.53  |- skos__annotation mesh__D031240
% 224.37/224.53       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.37/224.53  |- mesh__historyNote mesh__D031240 2003   
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D031240 2005
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D031240 2004
% 224.37/224.53  |- skos__scopeNote mesh__D031240
% 224.37/224.53       A plant genus of the family CAPRIFOLIACEAE. The common name of %22%snowberry%22% is also used for GAULTHERIA.%A%    
% 224.37/224.53  |- mesh__dateCreated mesh__D031240 2002-07-03
% 224.37/224.53  |- rdf__type mesh__D031240sskos__Concept
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D031240 2003
% 224.37/224.53  |- skos__altLabel mesh__D031240 Symphoricarpus
% 224.37/224.53  |- skos__prefLabel mesh__D031240 Symphoricarpos
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006049 2003
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006049 2001
% 224.37/224.53  |- skos__prefLabel mesh__D006049 Gold Isotopes
% 224.37/224.53  |- skos__broader mesh__D006049smesh__D007554
% 224.37/224.53  |- mesh__dateCreated mesh__D006049 1999-01-01
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006049 2006
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006049 2005
% 224.37/224.53  |- skos__annotation mesh__D006049 Au-197; NIM   
% 224.37/224.53  |- mesh__recordMaintainer mesh__D006049 nns
% 224.37/224.53  |- skos__scopeNote mesh__D006049
% 224.37/224.53       Stable gold atoms that have the same atomic number as the element gold, but differ in atomic weight. Au-197 is a stable isotope.%A%    
% 224.37/224.53  |- mesh__dateRevised mesh__D006049 2000-06-22
% 224.37/224.53  |- mesh__recordAuthorizer mesh__D006049 sjn
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006049 2004
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006049 2002
% 224.37/224.53  |- skos__hiddenLabel mesh__D006049 Isotopes, Gold
% 224.37/224.53  |- mesh__recordOriginator mesh__D006049 NLM
% 224.37/224.53  |- rdf__type mesh__D006049sskos__Concept
% 224.37/224.53  |- mesh__publicMeSHNote mesh__D025203 2002   
% 224.37/224.53  |- mesh__recordOriginator mesh__D025203 lkt
% 224.37/224.53  |- mesh__recordMaintainer mesh__D025203 ags
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D025203 2006
% 224.37/224.53  |- mesh__dateCreated mesh__D025203 2001-07-25
% 224.37/224.53  |- skos__historyNote mesh__D025203 6-Phosphofructokinase %28%1977-2001%29%
% 224.37/224.53  |- skos__hiddenLabel mesh__D025203 Phosphofructokinase 1, Muscle Type
% 224.37/224.53  |- mesh__recordAuthorizer mesh__D025203 ags
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D025203 2005
% 224.37/224.53  |- skos__scopeNote mesh__D025203
% 224.37/224.53       An allosteric enzyme that regulates glycolysis by catalyzing the transfer of a phosphate group from ATP to fructose-6-phosphate to yield fructose-1,6-bisphosphate. In humans, PHOSPHOFRUCTOKINASE-1 in muscle exists as the homotetramer of M subunits. Defects in this muscle enzyme cause GLYCOGEN STORAGE DISEASE TYPE VII, also known as Tarui%27%s disease.%A%    
% 224.37/224.53  |- skos__prefLabel mesh__D025203 Phosphofructokinase-1, Muscle Type
% 224.37/224.53  |- mesh__dateRevised mesh__D025203 2005-07-25
% 224.37/224.53  |- rdf__type mesh__D025203sskos__Concept
% 224.37/224.53  |- skos__broader mesh__D025203smesh__D010732
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D025203 2004
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D025203 2006A
% 224.37/224.53  |- mesh__historyNote mesh__D025203 2002   
% 224.37/224.53  |- skos__altLabel mesh__D025203 Phosphofructo-1-kinase Isozyme A
% 224.37/224.53  |- mesh__dateEstablished mesh__D025203 2002-01-01
% 224.37/224.53  |- skos__altLabel mesh__D025203 6-Phosphofructokinase, Muscle Type
% 224.37/224.53  |- skos__hiddenLabel mesh__D044966 Agents, Anti-Retroviral
% 224.37/224.53  |- skos__prefLabel mesh__D044966 Anti-Retroviral Agents
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D044966 2006
% 224.37/224.53  |- skos__scopeNote mesh__D044966
% 224.37/224.53       Agents used to treat RETROVIRIDAE INFECTIONS.     
% 224.37/224.53  |- rdf__type mesh__D044966sskos__Concept
% 224.37/224.53  |- mesh__dateCreated mesh__D044966 2003-07-09
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D044966 2005
% 224.37/224.53  |- mesh__dateEstablished mesh__D044966 2004-01-01
% 224.37/224.53  |- skos__broader mesh__D044966smesh__D000998
% 224.37/224.53  |- mesh__historyNote mesh__D044966 2004   
% 224.37/224.53  |- mesh__publicMeSHNote mesh__D044966 2004   
% 224.37/224.53  |- skos__historyNote mesh__D044966 Antiviral Agents %28%1988-2003%29%
% 224.37/224.53  |- skos__altLabel mesh__D044966 Antiretroviral Agents
% 224.37/224.53  |- skos__hiddenLabel mesh__D044966 Agents, Antiretroviral
% 224.37/224.53  |- skos__hiddenLabel mesh__D044966 Anti Retroviral Agents
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D044966 2004
% 224.37/224.53  |- skos__altLabel mesh__D044168 Parathyroid Hormone Receptor Type I
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D044168 2004
% 224.37/224.53  |- skos__hiddenLabel mesh__D044168 Receptor, PTHrP
% 224.37/224.53  |- mesh__publicMeSHNote mesh__D044168
% 224.37/224.53       2004; for PARATHYROID HORMONE RECEPTOR see RECEPTORS, PARATHYROID HORMONE 1994-2003; PARATHYROID HORMONE RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1980-1993; PARATHYROID HORMONE-LIKE PEPTIDE RECEPTOR was indexed under RECEPTORS PARATHYROID HORMONE 1994-2003 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1991-1993%A%  
% 224.37/224.53  |- skos__altLabel mesh__D044168 Parathyroid Hormone Receptor 1
% 224.37/224.53  |- skos__scopeNote mesh__D044168
% 224.37/224.53       A parathyroid hormone receptor subtype that recognizes both PARATHYROID HORMONE and PARATHYROID HORMONE-RELATED PROTEIN. It is a G-protein-coupled receptor that is expressed at high levels in BONE and in KIDNEY.%A%    
% 224.37/224.53  |- skos__hiddenLabel mesh__D044168 Receptor, PTHLP
% 224.37/224.53  |- skos__altLabel mesh__D044168 PTHrP Receptor
% 224.37/224.53  |- skos__altLabel mesh__D044168 Receptor, Parathyroid Hormone-Like Peptide
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D044168 2005
% 224.37/224.53  |- skos__historyNote mesh__D044168
% 224.37/224.53       Receptors, Parathyroid Hormone %28%1994-2003%29%
% 224.37/224.53  |- skos__altLabel mesh__D044168 PTHLP Receptor
% 224.37/224.53  |- skos__hiddenLabel mesh__D044168 PTH PTHrP Receptor
% 224.37/224.53  |- skos__altLabel mesh__D044168 PTH-PTHrP Receptor
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D044168 2006
% 224.37/224.53  |- skos__hiddenLabel mesh__D044168 Receptor, Parathyroid Hormone
% 224.37/224.53  |- mesh__dateEstablished mesh__D044168 2004-01-01
% 224.37/224.53  |- skos__altLabel mesh__D044168 PTH-Related Peptide Receptor
% 224.37/224.53  |- rdf__type mesh__D044168sskos__Concept
% 224.37/224.53  |- mesh__historyNote mesh__D044168
% 224.37/224.53       2004; for PARATHYROID HORMONE RECEPTOR use RECEPTORS, PARATHYROID HORMONE 1994-2003 %26% RECEPTORS, PARATHYROID HORMONE %28%NM%29% 1980-1993; for PARATHYROID HORMONE-LIKE PEPTIDE RECEPTOR use RECEPTOR, PARATHYROID HORMONE, TYPE 1 %28%NM%29% 1991-2003%A%  
% 224.37/224.53  |- skos__altLabel mesh__D044168
% 224.37/224.53       Parathyroid Hormone-Related Peptide Receptor
% 224.37/224.53  |- skos__altLabel mesh__D044168 Parathyroid Hormone Receptor Type 1
% 224.37/224.53  |- skos__altLabel mesh__D044168 Parathyroid Hormone-Like Peptide Receptor
% 224.37/224.53  |- skos__hiddenLabel mesh__D044168 PTH Related Peptide Receptor
% 224.37/224.53  |- skos__hiddenLabel mesh__D044168 Receptor, PTH-PTHrP
% 224.37/224.53  |- mesh__dateCreated mesh__D044168 2003-07-09
% 224.37/224.53  |- skos__hiddenLabel mesh__D044168
% 224.37/224.53       Parathyroid Hormone Related Peptide Receptor
% 224.37/224.53  |- skos__hiddenLabel mesh__D044168
% 224.37/224.53       Parathyroid Hormone Like Peptide Receptor
% 224.37/224.53  |- skos__hiddenLabel mesh__D044168 Receptor, PTH-Related Protein
% 224.37/224.53  |- skos__prefLabel mesh__D044168 Receptor, Parathyroid Hormone, Type 1
% 224.37/224.53  |- skos__hiddenLabel mesh__D044168 Receptor, PTH-Related Peptide
% 224.37/224.53  |- skos__historyNote mesh__D044168
% 224.37/224.53       Receptors, Endogenous Substances %28%1980-1993%29%
% 224.37/224.53  |- skos__altLabel mesh__D044168 Parathyroid Hormone Receptor
% 224.37/224.53  |- skos__altLabel mesh__D044168 PTH-Related Protein Receptor
% 224.37/224.53  |- skos__broader mesh__D044168smesh__D018016
% 224.37/224.53  |- skos__hiddenLabel mesh__D044168 PTH Related Protein Receptor
% 224.37/224.53  |- mesh__dateCreated mesh__D016477 1991-01-02
% 224.37/224.53  |- skos__scopeNote mesh__D016477
% 224.37/224.53       Any visible result of a procedure which is caused by the procedure itself and not by the entity being analyzed. Common examples include histological structures introduced by tissue processing, radiographic images of structures that are not naturally present in living tissue, and products of chemical reactions that occur during analysis.%A%    
% 224.37/224.53  |- mesh__publicMeSHNote mesh__D016477 92   
% 224.37/224.53  |- mesh__dateRevised mesh__D016477 2004-07-13
% 224.37/224.53  |- skos__hiddenLabel mesh__D016477 Artifact
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D016477 2005
% 224.37/224.53  |- mesh__recordAuthorizer mesh__D016477 sjn
% 224.37/224.53  |- skos__prefLabel mesh__D016477 Artifacts
% 224.37/224.53  |- skos__broader mesh__D016477smesh__D008919
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D016477 2006
% 224.37/224.53  |- mesh__recordMaintainer mesh__D016477 sjn
% 224.37/224.53  |- skos__altLabel mesh__D016477 Artefacts
% 224.37/224.53  |- skos__hiddenLabel mesh__D016477 Artefact
% 224.37/224.53  |- mesh__dateEstablished mesh__D016477 1992-01-01
% 224.37/224.53  |- mesh__historyNote mesh__D016477 92   
% 224.37/224.53  |- skos__annotation mesh__D016477
% 224.37/224.53       restrict to histol, microsc, radiogr, ECG, EEG %26% other procedures: not for products of human workmanship in arts %26% crafts; no qualif; coord IM with specific procedure %28%IM%29%%A%  
% 224.37/224.53  |- rdf__type mesh__D016477sskos__Concept
% 224.37/224.53  |- mesh__recordOriginator mesh__D016477 AGS
% 224.37/224.53  |- mesh__recordAuthorizer mesh__D002457 sjn
% 224.37/224.53  |- mesh__dateRevised mesh__D002457 2005-06-30
% 224.37/224.53  |- mesh__publicMeSHNote mesh__D002457
% 224.37/224.53       91; was see under TISSUE EXTRACTS 1977-90   
% 224.37/224.53  |- mesh__historyNote mesh__D002457
% 224.37/224.53       91%28%77%29%; was see under TISSUE EXTRACTS 1977-90   
% 224.37/224.53  |- skos__annotation mesh__D002457
% 224.37/224.53       extracts of cells or cell fractions containing uncharacterized factors; do not confuse with chemical substances %22%extracted%22% from cells; not for micro-organisms%A%  
% 224.37/224.53  |- mesh__recordOriginator mesh__D002457 SH
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D002457 2006
% 224.37/224.53  |- skos__hiddenLabel mesh__D002457 Extracts, Cell
% 224.37/224.53  |- skos__historyNote mesh__D002457 Tissue Extracts %28%1966-1976%29%
% 224.37/224.53  |- skos__prefLabel mesh__D002457 Cell Extracts
% 224.37/224.53  |- rdf__type mesh__D002457sskos__Concept
% 224.37/224.53  |- mesh__dateCreated mesh__D002457 1976-04-13
% 224.37/224.53  |- skos__broader mesh__D002457smesh__D014020
% 224.37/224.53  |- skos__scopeNote mesh__D002457
% 224.37/224.53       Preparations of cell constituents or subcellular materials, isolates, or substances.%A%    
% 224.37/224.53  |- mesh__recordMaintainer mesh__D002457 ssb
% 224.37/224.53  |- mesh__dateEstablished mesh__D002457 1991-01-01
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D007940 1997
% 224.37/224.53  |- skos__hiddenLabel mesh__D007940 L5178, Leukemia
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D007940 1999
% 224.37/224.53  |- mesh__recordAuthorizer mesh__D007940 PLS
% 224.37/224.53  |- skos__broader mesh__D007940smesh__D007942
% 224.37/224.53  |- mesh__historyNote mesh__D007940
% 224.37/224.53       91%28%80%29%; was see under LEUKEMIA, EXPERIMENTAL 1980-90   
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D007940 1996
% 224.37/224.53  |- skos__altLabel mesh__D007940 Lymphoma L5178
% 224.37/224.53  |- mesh__dateCreated mesh__D007940 1978-12-20
% 224.37/224.53  |- skos__historyNote mesh__D007940 Leukemia, Experimental %28%1966-1979%29%
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D007940 1998
% 224.37/224.53  |- skos__historyNote mesh__D007940 Lymphoma %28%1966-1979%29%
% 224.37/224.53  |- rdf__type mesh__D007940sskos__Concept
% 224.37/224.53  |- mesh__dateRevised mesh__D007940 1995-06-08
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D007940 2002
% 224.37/224.53  |- skos__scopeNote mesh__D007940
% 224.37/224.53       An experimental lymphocytic leukemia of mice.     
% 224.37/224.53  |- mesh__publicMeSHNote mesh__D007940
% 224.37/224.53       91; was see under LEUKEMIA, EXPERIMENTAL 1980-90   
% 224.37/224.53  |- mesh__recordMaintainer mesh__D007940 KEV
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D007940 2004
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D007940 2001
% 224.37/224.53  |- skos__hiddenLabel mesh__D007940 L5178, Lymphoma
% 224.37/224.53  |- skos__annotation mesh__D007940
% 224.37/224.53       do not use /blood supply /chem /second /secret /ultrastruct /vet%A%  
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D007940 2006
% 224.37/224.53  |- mesh__dateEstablished mesh__D007940 1991-01-01
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D007940 2003
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D007940 2005
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D007940 2000
% 224.37/224.53  |- mesh__recordOriginator mesh__D007940 VDK
% 224.37/224.53  |- skos__prefLabel mesh__D007940 Leukemia L5178
% 224.37/224.53  |- mesh__recordOriginator mesh__D007142 RLS
% 224.37/224.53  |- skos__hiddenLabel mesh__D007142 gamma-Chain, Immunoglobulin
% 224.37/224.53  |- skos__hiddenLabel mesh__D007142 gamma 1 Immunoglobulin Heavy Chain
% 224.37/224.53  |- mesh__dateCreated mesh__D007142 1975-07-23
% 224.37/224.53  |- skos__hiddenLabel mesh__D007142 Immunoglobulin gamma Chains
% 224.37/224.53  |- skos__hiddenLabel mesh__D007142 Heavy Chain, gamma-2b-Immunoglobulin
% 224.37/224.53  |- skos__hiddenLabel mesh__D007142 gamma 2a Immunoglobulin Heavy Chain
% 224.37/224.53  |- skos__altLabel mesh__D007142 Immunoglobulins, gamma-Chain
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D007142 2006
% 224.37/224.53  |- skos__hiddenLabel mesh__D007142 gamma 2b Immunoglobulin Heavy Chain
% 224.37/224.53  |- skos__hiddenLabel mesh__D007142 Immunoglobulins, gamma Chain
% 224.37/224.53  |- skos__hiddenLabel mesh__D007142 Heavy Chain, gamma-1-Immunoglobulin
% 224.37/224.53  |- skos__hiddenLabel mesh__D007142 gamma-Chains, Immunoglobulin
% 224.37/224.53  |- skos__broader mesh__D007142smesh__D007143
% 224.37/224.53  |- mesh__recordAuthorizer mesh__D007142 ags
% 224.37/224.53  |- skos__altLabel mesh__D007142 gamma-Chain Immunoglobulins
% 224.37/224.53  |- skos__hiddenLabel mesh__D007142 Heavy Chain, gamma-2a-Immunoglobulin
% 224.37/224.53  |- rdf__type mesh__D007142sskos__Concept
% 224.37/224.53  |- skos__altLabel mesh__D007142 Immunoglobulin gamma-Chain
% 224.37/224.53  |- skos__altLabel mesh__D007142 gamma Immunoglobulin Heavy Chain
% 224.37/224.53  |- skos__hiddenLabel mesh__D007142 Immunoglobulin gamma Chain
% 224.37/224.53  |- skos__scopeNote mesh__D007142
% 224.37/224.53       Heavy chains of IMMUNOGLOBULIN G having a molecular weight of approximately 51 kDa. They contain about 450 amino acid residues arranged in four domains and an oligosaccharide component covalently bound to the Fc fragment constant region. The gamma heavy chain subclasses %28%for example, gamma 1, gamma 2a, and gamma 2b%29% of the IMMUNOGLOBULIN G isotype subclasses %28%IgG1, IgG2A, and IgG2B%29% resemble each other more closely than the heavy chains of the other IMMUNOGLOBULIN ISOTYPES.%A%    
% 224.37/224.53  |- skos__historyNote mesh__D007142
% 224.37/224.53       Immunoglobulins, Heavy Chain %28%1975%29%
% 224.37/224.53  |- mesh__dateEstablished mesh__D007142 1991-01-01
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D007142 2006A
% 224.37/224.53  |- skos__annotation mesh__D007142
% 224.37/224.53       gammopathy: coordinate IMMUNOGLOBULIN GAMMA-CHAINS %28%IM%29% with PARAPROTEINEMIAS %28%IM%29% but consider also HYPERGAMMAGLOBULINEMIA %28%IM%29% or HEAVY CHAIN DISEASE %28%IM%29%, follow text; DF: IG GAMMA CHAIN%A%  
% 224.37/224.53  |- mesh__historyNote mesh__D007142 2006 %28%1976%29%   
% 224.37/224.53  |- skos__historyNote mesh__D007142
% 224.37/224.53       Immunoglobulin Fragments %28%1973-1975%29%
% 224.37/224.53  |- skos__historyNote mesh__D007142 IgG %28%1973-1975%29%
% 224.37/224.53  |- mesh__recordMaintainer mesh__D007142 ags
% 224.37/224.53  |- skos__hiddenLabel mesh__D007142 gamma Chain Immunoglobulins
% 224.37/224.53  |- skos__prefLabel mesh__D007142 Immunoglobulin gamma-Chains
% 224.37/224.53  |- mesh__publicMeSHNote mesh__D007142
% 224.37/224.53       2006; see IMMUNOGLOBULINS, GAMMA-CHAIN 1992-2005, see IMMUNOGLOBULINS, GAMMA CHAIN 1991, see IMMUNOGLOBULINS, HEAVY CHAIN 1976-1990%A%  
% 224.37/224.53  |- mesh__dateRevised mesh__D007142 2005-07-15
% 224.37/224.53  |- skos__broader mesh__D007142smesh__D007074
% 224.37/224.53  |- skos__altLabel mesh__D007142 gamma Immunoglobulin Heavy Chains
% 224.37/224.53  |- mesh__recordMaintainer mesh__D012885 nns
% 224.37/224.53  |- mesh__dateRevised mesh__D012885 2004-07-07
% 224.37/224.53  |- skos__hiddenLabel mesh__D012885 Thicknesses, Skinfold
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D012885 2005
% 224.37/224.53  |- rdf__type mesh__D012885sskos__Concept
% 224.37/224.53  |- skos__historyNote mesh__D012885 Skin %28%1966-1967%29%
% 224.37/224.53  |- skos__prefLabel mesh__D012885 Skinfold Thickness
% 224.37/224.53  |- mesh__recordOriginator mesh__D012885 NLM
% 224.37/224.53  |- mesh__recordAuthorizer mesh__D012885 sjn
% 224.37/224.53  |- mesh__dateEstablished mesh__D012885 1973-01-01
% 224.37/224.53  |- skos__historyNote mesh__D012885 Obesity %28%1966-1967%29%
% 224.37/224.53  |- skos__hiddenLabel mesh__D012885 Skinfold Thicknesses
% 224.37/224.53  |- mesh__publicMeSHNote mesh__D012885 73   
% 224.37/224.53  |- mesh__historyNote mesh__D012885 73%28%68%29%   
% 224.37/224.53  |- skos__annotation mesh__D012885 a measurement of body fat; no qualif   
% 224.37/224.53  |- skos__hiddenLabel mesh__D012885 Thickness, Skinfold
% 224.37/224.53  |- mesh__dateCreated mesh__D012885 1999-01-01
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D012885 2006
% 224.37/224.53  |- skos__scopeNote mesh__D012885
% 224.37/224.53       The measurement of subcutaneous fat located directly beneath the skin by grasping a fold of skin and subcutaneous fat between the thumb and forefinger and pulling it away from the underlying muscle tissue. The thickness of the double layer of skin and subcutaneous tissue is then read with a caliper. The five most frequently measured sites are the upper arm, below the scapula, above the hip bone, the abdomen, and the thigh. Its application is the determination of relative fatness, of changes in physical conditioning programs, and of the percentage of body fat in desirable body weight. %28%From McArdle, et al., Exercise Physiology, 2d ed, p496-8%29%%A%    
% 224.37/224.53  |- skos__broader mesh__D012885smesh__D001837
% 224.37/224.53  |- mesh__historyNote mesh__D020519 2000   
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D020519 2004
% 224.37/224.53  |- skos__historyNote mesh__D020519
% 224.37/224.53       Pericardial Effusion/therapy %28%1966-1999%29%
% 224.37/224.53  |- mesh__dateCreated mesh__D020519 1999-11-03
% 224.37/224.53  |- skos__hiddenLabel mesh__D020519 Pericardiocenteses
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D020519 2003
% 224.37/224.53  |- skos__historyNote mesh__D020519 Drainage %28%1965-1999%29%
% 224.37/224.53  |- skos__broader mesh__D020519smesh__D006348
% 224.37/224.53  |- rdf__type mesh__D020519sskos__Concept
% 224.37/224.53  |- mesh__publicMeSHNote mesh__D020519 2000   
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D020519 2006
% 224.37/224.53  |- mesh__dateEstablished mesh__D020519 2000-01-01
% 224.37/224.53  |- mesh__dateRevised mesh__D020519 2002-07-03
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D020519 2005
% 224.37/224.53  |- skos__scopeNote mesh__D020519
% 224.37/224.53       Surgical puncture of the pericardial cavity for the aspiration of fluid. %28%Dorland, 28th ed%29%%A%    
% 224.37/224.53  |- skos__prefLabel mesh__D020519 Pericardiocentesis
% 224.37/224.53  |- skos__broader mesh__D020519smesh__D019152
% 224.37/224.53  |- skos__historyNote mesh__D020519 Punctures %28%1969-1999%29%
% 224.37/224.53  |- skos__hiddenLabel mesh__D012087 Oryzaviruses
% 224.37/224.53  |- skos__hiddenLabel mesh__D012087 Aquareoviruses
% 224.37/224.53  |- rdf__type mesh__D012087sskos__Concept
% 224.37/224.53  |- skos__hiddenLabel mesh__D012087 Polyhedrosis Viruses, Cytoplasmic
% 224.37/224.53  |- mesh__onlineNote mesh__D012087
% 224.37/224.53       use REOVIRIDAE to search REOVIRUSES 1975-80; REOVIRUS 1966-74 and 1993; %26% RESPIRATORY ENTERIC ORPHAN VIRUS 1976-92; use INSECT VIRUSES to search CYTOPLASMIC POLYHEDROSIS VIRUSES 1975-90%A%  
% 224.37/224.53  |- skos__hiddenLabel mesh__D012087 Cytoplasmic Polyhedrosis Virus
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D012087 2005
% 224.37/224.53  |- skos__scopeNote mesh__D012087
% 224.37/224.53       A family of unenveloped RNA viruses with cubic symmetry. The eight genera include ORTHOREOVIRUS; ORBIVIRUS; COLTIVIRUS; ROTAVIRUS; Aquareovirus, Cypovirus, Phytoreovirus, Fijivirus, and Oryzavirus.%A%    
% 224.37/224.53  |- skos__hiddenLabel mesh__D012087 Fijiviruses
% 224.37/224.53  |- mesh__publicMeSHNote mesh__D012087
% 224.37/224.53       81; was REOVIRUSES 1975-80, was REOVIRUS 1966-74; RESPIRATORY ENTERIC ORPHAN VIRUSES was RESPIRATORY ENTERIC ORPHAN VIRUS 1976-92; CYTOPLASMIC POLYHEDROSIS VIRUSES was see POLYHEDROSIS VIRUSES 1975-90; REOVIRUS was see REOVIRIDAE 1993%A%  
% 224.37/224.53  |- skos__annotation mesh__D012087 infection = REOVIRIDAE INFECTIONS   
% 224.37/224.53  |- mesh__dateEstablished mesh__D012087 1966-01-01
% 224.37/224.53  |- mesh__recordOriginator mesh__D012087 NLM
% 224.37/224.53  |- skos__hiddenLabel mesh__D012087 Polyhedrosis Virus, Cytoplasmic
% 224.37/224.53  |- skos__hiddenLabel mesh__D012087 Aquatic Reovirus
% 224.37/224.53  |- skos__hiddenLabel mesh__D012087 Phytoreoviruses
% 224.37/224.53  |- mesh__recordAuthorizer mesh__D012087 sjn
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D012087 2003
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D012087 2006
% 224.37/224.53  |- mesh__recordMaintainer mesh__D012087 ags
% 224.37/224.53  |- skos__prefLabel mesh__D012087 Reoviridae
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D012087 2004
% 224.37/224.53  |- mesh__historyNote mesh__D012087
% 224.37/224.53       81; was REOVIRUSES 1975-80, was REOVIRUS 1964-74 %28%Prov 1964-65%29%; RESPIRATORY ENTERIC ORPHAN VIRUSES was RESPIRATORY ENTERIC ORPHAN VIRUS 1976-92; CYTOPLASMIC POLYHEDROSIS VIRUSES was see POLYHEDROSIS VIRUSES 1975-90; REOVIRUS was see REOVIRIDAE 1993%A%  
% 224.37/224.53  |- skos__hiddenLabel mesh__D012087 Aquatic Reoviruses
% 224.37/224.53  |- skos__altLabel mesh__D012087 Respiratory Enteric Orphan Viruses
% 224.37/224.53  |- skos__broader mesh__D012087smesh__D012328
% 224.37/224.53  |- skos__hiddenLabel mesh__D012087 Reovirus, Aquatic
% 224.37/224.53  |- mesh__dateCreated mesh__D012087 1999-01-01
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D012087 2002
% 224.37/224.53  |- skos__hiddenLabel mesh__D012087 Cypoviruses
% 224.37/224.53  |- mesh__dateRevised mesh__D012087 2001-07-25
% 224.37/224.53  |- skos__prefLabel mesh__D006848 Hydrocele
% 224.37/224.53  |- mesh__recordOriginator mesh__D006848 NLM
% 224.37/224.53  |- mesh__recordMaintainer mesh__D006848 TGC
% 224.37/224.53  |- rdf__type mesh__D006848sskos__Concept
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006848 1999
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006848 2004
% 224.37/224.53  |- skos__hiddenLabel mesh__D006848 Hydroceles
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006848 2001
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006848 1998
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006848 2003
% 224.37/224.53  |- skos__scopeNote mesh__D006848
% 224.37/224.53       A circumscribed collection of fluid, especially a collection of fluid in the tunica vaginalis of the testicle or along the spermatic cord. %28%Dorland, 27th ed%29%%A%    
% 224.37/224.53  |- mesh__dateRevised mesh__D006848 1995-02-23
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006848 2000
% 224.37/224.53  |- mesh__recordAuthorizer mesh__D006848 PLS
% 224.37/224.53  |- skos__broader mesh__D006848smesh__D005832
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006848 2006
% 224.37/224.53  |- mesh__dateCreated mesh__D006848 1999-01-01
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006848 1997
% 224.37/224.53  |- skos__annotation mesh__D006848
% 224.37/224.53       collection of fluid in testis or along spermatic cord; %22%vaginal hydrocele%22% is of the tunica vaginalis of the testis, not of the vagina; hydrocele of Nuck%27%s canal is a watery dilatation of the processus vaginalis peritonei %28%also called Nuck%27%s canal%29%: index under PERITONEAL DISEASES%A%  
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006848 2005
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006848 1996
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D006848 2002
% 224.37/224.53  |- skos__broader mesh__D017570smesh__D018006
% 224.37/224.53  |- skos__historyNote mesh__D017570 Muscle Proteins %28%1989-1993%29%
% 224.37/224.53  |- skos__scopeNote mesh__D017570
% 224.37/224.53       A myogenic regulatory factor that controls myogenesis. Though it is not clear how its function differs from the other myogenic regulatory factors, MyoD appears to be related to fusion and terminal differentiation of the muscle cell.%A%    
% 224.37/224.53  |- mesh__onlineNote mesh__D017570
% 224.37/224.53       use MYOD PROTEIN %28%NM%29% to search MYOD FACTOR 1989-93   
% 224.37/224.53  |- mesh__dateEstablished mesh__D017570 1994-01-01
% 224.37/224.53  |- skos__prefLabel mesh__D017570 MyoD Protein
% 224.37/224.53  |- skos__altLabel mesh__D017570 MyoD Factor
% 224.37/224.53  |- skos__hiddenLabel mesh__D017570 Factor, MyoD
% 224.37/224.53  |- mesh__recordOriginator mesh__D017570 AGS
% 224.37/224.53  |- mesh__recordMaintainer mesh__D017570 DRC
% 224.37/224.53  |- skos__hiddenLabel mesh__D017570 Protein, MyoD
% 224.37/224.53  |- rdf__type mesh__D017570sskos__Concept
% 224.37/224.53  |- mesh__recordAuthorizer mesh__D017570 sjn
% 224.37/224.53  |- mesh__dateCreated mesh__D017570 1993-06-04
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D017570 2006
% 224.37/224.53  |- mesh__publicMeSHNote mesh__D017570
% 224.37/224.53       94; MYOD FACTOR was indexed under MUSCLE PROTEINS 1989-93%A%  
% 224.37/224.53  |- skos__annotation mesh__D017570
% 224.37/224.53       a myogenic regulatory factor controlling myogenesis   
% 224.37/224.53  |- mesh__dateRevised mesh__D017570 2005-06-30
% 224.37/224.53  |- mesh__historyNote mesh__D017570
% 224.37/224.53       94; was MYOD FACTOR %28%NM%29% 1989-93   
% 224.37/224.53  |- mesh__publicMeSHNote mesh__D031241 2003   
% 224.37/224.53  |- mesh__dateCreated mesh__D031241 2002-07-03
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D031241 2006
% 224.37/224.53  |- skos__annotation mesh__D031241
% 224.37/224.53       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.37/224.53  |- mesh__dateEstablished mesh__D031241 2003-01-01
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D031241 2003
% 224.37/224.53  |- skos__scopeNote mesh__D031241
% 224.37/224.53       A plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida.%A%    
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D031241 2004
% 224.37/224.53  |- skos__broader mesh__D031241smesh__D019684
% 224.37/224.53  |- mesh__historyNote mesh__D031241 2003   
% 224.37/224.53  |- rdf__type mesh__D031241sskos__Concept
% 224.37/224.53  |- skos__prefLabel mesh__D031241 Caricaceae
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D031241 2005
% 224.37/224.53  |- skos__broader mesh__D003550smesh__D030342
% 224.37/224.53  |- skos__broader mesh__D003550smesh__D007232
% 224.37/224.53  |- skos__prefLabel mesh__D003550 Cystic Fibrosis
% 224.37/224.53  |- rdf__type mesh__D003550sskos__Concept
% 224.37/224.53  |- skos__altLabel mesh__D003550 Mucoviscidosis
% 224.37/224.53  |- skos__hiddenLabel mesh__D003550 Pancreas Fibrocystic Diseases
% 224.37/224.53  |- skos__related mesh__D003550smesh__D018181
% 224.37/224.53  |- skos__annotation mesh__D003550
% 224.37/224.53       a specific disease entity: do not use for fibrocystic states of various organs%A%  
% 224.37/224.53  |- mesh__dateEstablished mesh__D003550 1967-01-01
% 224.37/224.53  |- skos__broader mesh__D003550smesh__D010182
% 224.37/224.53  |- skos__hiddenLabel mesh__D003550 Fibrosis, Cystic
% 224.37/224.53  |- mesh__dateCreated mesh__D003550 1999-01-01
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D003550 2006
% 224.37/224.53  |- mesh__publicMeSHNote mesh__D003550
% 224.37/224.53       67; was PANCREATIC CYSTIC FIBROSIS 1963-66   
% 224.37/224.53  |- mesh__dateRevised mesh__D003550 2004-07-07
% 224.37/224.53  |- mesh__activeMeSHYear mesh__D003550 2005
% 224.37/224.53  |- skos__scopeNote mesh__D003550
% 224.37/224.53       An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.%A%    
% 224.37/224.53  |- mesh__historyNote mesh__D003550
% 224.37/224.53       67; was PANCREATIC CYSTIC FIBROSIS 1963-66   
% 224.37/224.53  |- skos__hiddenLabel mesh__D003550 Cystic Fibrosis, Pulmonary
% 224.37/224.53  |- skos__hiddenLabel mesh__D003550 Pancreas Fibrocystic Disease
% 224.37/224.53  |- mesh__recordAuthorizer mesh__D003550 sjn
% 224.37/224.54  |- mesh__recordMaintainer mesh__D003550 lkt
% 224.37/224.54  |- skos__related mesh__D003550smesh__D019005
% 224.37/224.54  |- skos__broader mesh__D003550smesh__D008171
% 224.37/224.54  |- mesh__recordOriginator mesh__D003550 NLM
% 224.37/224.54  |- mesh__onlineNote mesh__D003550
% 224.37/224.54       use CYSTIC FIBROSIS to search PANCREATIC CYSTIC FIBROSIS 1966%A%  
% 224.37/224.54  |- skos__hiddenLabel mesh__D003550 Cystic Fibrosis, Pancreatic
% 224.37/224.54  |- skos__altLabel mesh__D003550 Fibrocystic Disease of Pancreas
% 224.37/224.54  |- rdf__type mesh__D044967sskos__Concept
% 224.37/224.54  |- mesh__dateCreated mesh__D044967 2003-07-09
% 224.37/224.54  |- skos__scopeNote mesh__D044967
% 224.37/224.54       The clear portion of BLOOD that is left after BLOOD COAGULATION to remove BLOOD CELLS and clotting proteins.%A%    
% 224.37/224.54  |- skos__broader mesh__D044967smesh__D001769
% 224.37/224.54  |- skos__hiddenLabel mesh__D044967 Serum, Blood
% 224.37/224.54  |- mesh__recordMaintainer mesh__D044967 tpw
% 224.37/224.54  |- mesh__publicMeSHNote mesh__D044967 2004   
% 224.37/224.54  |- mesh__recordAuthorizer mesh__D044967 sjn
% 224.37/224.54  |- mesh__dateEstablished mesh__D044967 2004-01-01
% 224.37/224.54  |- skos__hiddenLabel mesh__D044967 Serums
% 224.37/224.54  |- mesh__historyNote mesh__D044967 2004   
% 224.37/224.54  |- skos__prefLabel mesh__D044967 Serum
% 224.37/224.54  |- mesh__recordOriginator mesh__D044967 lkt
% 224.37/224.54  |- skos__altLabel mesh__D044967 Blood Serum
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D044967 2006
% 224.37/224.54  |- skos__related mesh__D044967smesh__D010949
% 224.37/224.54  |- mesh__dateRevised mesh__D044967 2005-06-30
% 224.37/224.54  |- mesh__recordOriginator mesh__D044169 jmp
% 224.37/224.54  |- skos__hiddenLabel mesh__D044169 Calcium Sensing Receptor Protein
% 224.37/224.54  |- skos__altLabel mesh__D044169 Ca2+-Sensing Receptor
% 224.37/224.54  |- skos__altLabel mesh__D044169 Receptors, Calcium
% 224.37/224.54  |- skos__altLabel mesh__D044169 Calcium-Sensing Receptor Protein
% 224.37/224.54  |- skos__altLabel mesh__D044169 Calcium-Sensing Receptors
% 224.37/224.54  |- skos__hiddenLabel mesh__D044169 Receptor, Ca2+-Sensing
% 224.37/224.54  |- skos__hiddenLabel mesh__D044169 Calcium Sensing Receptors
% 224.37/224.54  |- skos__hiddenLabel mesh__D044169 Parathyroid Calcium Sensing Receptor
% 224.37/224.54  |- mesh__recordAuthorizer mesh__D044169 sjn
% 224.37/224.54  |- skos__hiddenLabel mesh__D044169 Ca2+ Sensing Receptor
% 224.37/224.54  |- skos__scopeNote mesh__D044169
% 224.37/224.54       A class of G-protein-coupled receptors that react to varying extracellular CALCIUM levels. Calcium-sensing receptors in the PARATHYROID GLANDS play an important role in the maintenance of calcium HOMEOSTASIS by regulating the release of PARATHYROID HORMONE. They differ from INTRACELLULAR CALCIUM-SENSING PROTEINS which sense intracellular calcium levels.%A%    
% 224.37/224.54  |- mesh__publicMeSHNote mesh__D044169
% 224.37/224.54       2004; use RECEPTORS, CALCIUM-SENSING %28%NM%29% 1994-2003; for CALCIUM RECEPTORS see CALCIUM-BINDING PROTEINS 1982-2003; for RECEPTORS, CALCIUM see CALCIUM-BINDING PROTEINS 1996-2003%A%  
% 224.37/224.54  |- skos__historyNote mesh__D044169
% 224.37/224.54       Receptors, Cell Surface %28%1994-2003%29%
% 224.37/224.54  |- skos__hiddenLabel mesh__D044169 Receptor, Calcium-Sensing
% 224.37/224.54  |- rdf__type mesh__D044169sskos__Concept
% 224.37/224.54  |- skos__prefLabel mesh__D044169 Receptors, Calcium-Sensing
% 224.37/224.54  |- skos__annotation mesh__D044169
% 224.37/224.54       CALCIUM-BINDING PROTEINS is also available   
% 224.37/224.54  |- mesh__historyNote mesh__D044169
% 224.37/224.54       2004; CALCIUM-SENSING RECEPTOR %28%now RECEPTORS, CALCIUM-SENSING%29% was indexed under RECEPTORS, CELL SURFACE; for CALCIUM RECEPTORS use CALCIUM-BINDING PROTEINS 1982-2003; for RECEPTORS, CALCIUM use CALCIUM-BINDING PROTEINS 1996-2003%A%  
% 224.37/224.54  |- mesh__recordMaintainer mesh__D044169 jmp
% 224.37/224.54  |- skos__altLabel mesh__D044169 Extracellular Calcium-Ion Sensing Receptor
% 224.37/224.54  |- skos__hiddenLabel mesh__D044169 Receptor Protein, Calcium-Sensing
% 224.37/224.54  |- skos__hiddenLabel mesh__D044169 Receptor, Ca Sensing
% 224.37/224.54  |- skos__hiddenLabel mesh__D044169 Calcium Sensing Receptor
% 224.37/224.54  |- skos__altLabel mesh__D044169 Calcium-Sensing Receptor
% 224.37/224.54  |- skos__altLabel mesh__D044169 Calcium Receptors
% 224.37/224.54  |- mesh__dateCreated mesh__D044169 2003-07-09
% 224.37/224.54  |- skos__altLabel mesh__D044169 Receptor, Ca-Sensing
% 224.37/224.54  |- skos__altLabel mesh__D044169 CASR Protein
% 224.37/224.54  |- mesh__dateRevised mesh__D044169 2005-06-30
% 224.37/224.54  |- skos__broader mesh__D044169smesh__D043562
% 224.37/224.54  |- skos__hiddenLabel mesh__D044169 Receptor, Parathyroid Calcium-Sensing
% 224.37/224.54  |- mesh__dateEstablished mesh__D044169 2004-01-01
% 224.37/224.54  |- skos__hiddenLabel mesh__D044169 Receptors, Calcium Sensing
% 224.37/224.54  |- skos__hiddenLabel mesh__D044169
% 224.37/224.54       Extracellular Calcium Ion Sensing Receptor
% 224.37/224.54  |- skos__hiddenLabel mesh__D044169 Receptors, Ca-Sensing
% 224.37/224.54  |- skos__altLabel mesh__D044169 Ca-Sensing Receptors
% 224.37/224.54  |- skos__hiddenLabel mesh__D044169 Ca Sensing Receptors
% 224.37/224.54  |- skos__hiddenLabel mesh__D044169 Ca-Sensing Receptor
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D044169 2006
% 224.37/224.54  |- skos__related mesh__D044169smesh__D052139
% 224.37/224.54  |- skos__hiddenLabel mesh__D044169 Calcium-Sensing Receptor, Parathyroid
% 224.37/224.54  |- skos__scopeNote mesh__D002458
% 224.37/224.54       Techniques to partition various components of the cell into SUBCELLULAR FRACTIONS.%A%    
% 224.37/224.54  |- skos__broader mesh__D002458smesh__D003584
% 224.37/224.54  |- mesh__recordAuthorizer mesh__D002458 sjn
% 224.37/224.54  |- mesh__dateCreated mesh__D002458 1999-01-01
% 224.37/224.54  |- mesh__historyNote mesh__D002458 73%28%71%29%   
% 224.37/224.54  |- skos__hiddenLabel mesh__D002458 Fractionation, Cell
% 224.37/224.54  |- mesh__dateRevised mesh__D002458 2003-07-09
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D002458 2006
% 224.37/224.54  |- skos__prefLabel mesh__D002458 Cell Fractionation
% 224.37/224.54  |- skos__hiddenLabel mesh__D002458 Cell Fractionations
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D002458 2005
% 224.37/224.54  |- skos__historyNote mesh__D002458 Cytology %28%1966-1970%29%
% 224.37/224.54  |- mesh__recordOriginator mesh__D002458 NLM
% 224.37/224.54  |- skos__hiddenLabel mesh__D002458 Fractionations, Cell
% 224.37/224.54  |- rdf__type mesh__D002458sskos__Concept
% 224.37/224.54  |- skos__annotation mesh__D002458
% 224.37/224.54       do not confuse with CELL SEPARATION; NIM, no qualif; when IM, /instrum /methods permitted; permitted with micro-organisms%A%  
% 224.37/224.54  |- skos__related mesh__D002458smesh__D013347
% 224.37/224.54  |- mesh__publicMeSHNote mesh__D002458 73   
% 224.37/224.54  |- mesh__recordMaintainer mesh__D002458 nns
% 224.37/224.54  |- mesh__dateEstablished mesh__D002458 1973-01-01
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D002458 2004
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D013180 2006A
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D013180 2006
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D013180 2000
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D013180 1998
% 224.37/224.54  |- mesh__recordMaintainer mesh__D013180 ags
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D013180 2003
% 224.37/224.54  |- skos__hiddenLabel mesh__D013180 Strains and Sprains
% 224.37/224.54  |- skos__hiddenLabel mesh__D013180 Strain
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D013180 2001
% 224.37/224.54  |- mesh__dateCreated mesh__D013180 1999-01-01
% 224.37/224.54  |- skos__prefLabel mesh__D013180 Sprains and Strains
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D013180 1999
% 224.37/224.54  |- skos__scopeNote mesh__D013180
% 224.37/224.54       A collective term for muscle and ligament injuries without dislocation or fracture. A sprain is a joint injury in which some of the fibers of a supporting ligament are ruptured but the continuity of the ligament remains intact. A strain is an overstretching or overexertion of some part of the musculature.%A%    
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D013180 2004
% 224.37/224.54  |- skos__broader mesh__D013180smesh__D014947
% 224.37/224.54  |- mesh__recordOriginator mesh__D013180 NLM
% 224.37/224.54  |- skos__hiddenLabel mesh__D013180 Sprain
% 224.37/224.54  |- mesh__dateRevised mesh__D013180 2005-07-14
% 224.37/224.54  |- skos__annotation mesh__D013180
% 224.37/224.54       IM; coord sprain with specific joint /inj %28%IM%29% or ligament /inj %28%IM%29% %26% strain with specific muscle /inj %28%IM%29%; CUMULATIVE TRAUMA DISORDERS is available; %22%strain fracture%22%: index under FRACTURES, BONE %28%IM%29% + CUMULATIVE TRAUMA DISORDERS %28%IM%29%; DF: SPRAINS%A%  
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D013180 1997
% 224.37/224.54  |- mesh__recordAuthorizer mesh__D013180 ags
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D013180 2002
% 224.37/224.54  |- rdf__type mesh__D013180sskos__Concept
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D013180 2005
% 224.37/224.54  |- skos__historyNote mesh__D007941
% 224.37/224.54       Neoplasms, Experimental %28%1966-1979%29%
% 224.37/224.54  |- mesh__recordOriginator mesh__D007941 VDK
% 224.37/224.54  |- skos__hiddenLabel mesh__D007941 P388, Leukemia
% 224.37/224.54  |- mesh__recordMaintainer mesh__D007941 lkt
% 224.37/224.54  |- mesh__recordAuthorizer mesh__D007941 sjn
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D007941 2004
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D007941 2006
% 224.37/224.54  |- skos__scopeNote mesh__D007941
% 224.37/224.54       An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.%A%    
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D007941 2003
% 224.37/224.54  |- skos__prefLabel mesh__D007941 Leukemia P388
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D007941 2005
% 224.37/224.54  |- skos__altLabel mesh__D007941 P388D%28%1%29% Leukemia
% 224.37/224.54  |- mesh__dateEstablished mesh__D007941 1991-01-01
% 224.37/224.54  |- mesh__historyNote mesh__D007941
% 224.37/224.54       91%28%80%29%; was see under LEUKEMIA, EXPERIMENTAL 1980-90   
% 224.37/224.54  |- mesh__dateRevised mesh__D007941 2001-07-25
% 224.37/224.54  |- skos__broader mesh__D007941smesh__D007942
% 224.37/224.54  |- mesh__dateCreated mesh__D007941 1978-12-20
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D007941 2002
% 224.37/224.54  |- skos__historyNote mesh__D007941 Leukemia, Experimental %28%1966-1979%29%
% 224.37/224.54  |- mesh__publicMeSHNote mesh__D007941
% 224.37/224.54       91; was see under LEUKEMIA, EXPERIMENTAL 1980-90   
% 224.37/224.54  |- rdf__type mesh__D007941sskos__Concept
% 224.37/224.54  |- mesh__recordAuthorizer mesh__D007143 ags
% 224.37/224.54  |- skos__scopeNote mesh__D007143
% 224.37/224.54       The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa.%A%    
% 224.37/224.54  |- skos__altLabel mesh__D007143 Ig Heavy Chains
% 224.37/224.54  |- skos__altLabel mesh__D007143 Immunoglobulin Heavy Chain
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D007143 2006A
% 224.37/224.54  |- mesh__dateCreated mesh__D007143 1999-01-01
% 224.37/224.54  |- skos__hiddenLabel mesh__D007143 Heavy Chains, Immunoglobulin
% 224.37/224.54  |- skos__prefLabel mesh__D007143 Immunoglobulin Heavy Chains
% 224.37/224.54  |- mesh__dateEstablished mesh__D007143 1976-01-01
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D007143 2006
% 224.37/224.54  |- skos__broader mesh__D007143smesh__D050440
% 224.37/224.54  |- skos__annotation mesh__D007143
% 224.37/224.54       gammopathy: coordinate IMMUNOGLOBULIN HEAVY CHAINS %28%IM%29% with PARAPROTEINEMIAS %28%IM%29% but consider also HYPERGAMMAGLOBULINEMIA %28%IM%29% or HEAVY CHAIN DISEASE %28%IM%29%, follow text; DF: IG HEAVY CHAIN%A%  
% 224.37/224.54  |- skos__hiddenLabel mesh__D007143 Immunoglobulins, Heavy Chain
% 224.37/224.54  |- skos__hiddenLabel mesh__D007143 Heavy Chain Immunoglobulins
% 224.37/224.54  |- skos__hiddenLabel mesh__D007143 Heavy Chain, Immunoglobulin
% 224.37/224.54  |- skos__altLabel mesh__D007143 Immunoglobulins, Heavy-Chain
% 224.37/224.54  |- rdf__type mesh__D007143sskos__Concept
% 224.37/224.54  |- skos__hiddenLabel mesh__D007143
% 224.37/224.54       Immunoglobulin Heavy Chain Subgroup VH III
% 224.37/224.54  |- skos__hiddenLabel mesh__D007143 Immunoglobulin Heavy Chain Subgroup VH I
% 224.37/224.54  |- mesh__recordMaintainer mesh__D007143 ags
% 224.37/224.54  |- skos__altLabel mesh__D007143 Heavy-Chain Immunoglobulins
% 224.37/224.54  |- mesh__historyNote mesh__D007143 2006 %28%1973%29%   
% 224.37/224.54  |- skos__hiddenLabel mesh__D007143 Heavy Chains, Ig
% 224.37/224.54  |- skos__related mesh__D007143smesh__D006362
% 224.37/224.54  |- mesh__publicMeSHNote mesh__D007143
% 224.37/224.54       2006; see IMMUNOGLOBULINS, HEAVY-CHAIN 1992-2005, see IMMUNOGLOBULINS, HEAVY CHAIN 1976-1991, see IMMUNOGLOBULIN FRAGMENTS 1973-1975%A%  
% 224.37/224.54  |- skos__historyNote mesh__D007143
% 224.37/224.54       Immunoglobulin Fragments %28%1973-1974%29%
% 224.37/224.54  |- mesh__recordOriginator mesh__D007143 NLM
% 224.37/224.54  |- mesh__dateRevised mesh__D007143 2005-07-15
% 224.37/224.54  |- mesh__recordAuthorizer mesh__D012886 ags
% 224.37/224.54  |- skos__altLabel mesh__D012886 Cranium
% 224.37/224.54  |- rdf__type mesh__D012886sskos__Concept
% 224.37/224.54  |- skos__scopeNote mesh__D012886
% 224.37/224.54       The SKELETON of the HEAD including the FACIAL BONES and the bones enclosing the BRAIN.%A%    
% 224.37/224.54  |- skos__altLabel mesh__D012886 Calvarium
% 224.37/224.54  |- skos__annotation mesh__D012886
% 224.37/224.54       bony part of head only; differentiate from HEAD %26% FACE; %22%cranial%22% is SKULL; /abnorm: consider also CRANIOFACIAL ABNORMALITIES; /anat: consider also CEPHALOMETRY; /inj %22%cranio-cerebral inj%22% is CRANIOCEREBRAL TRAUMA %28%or its specifics%29% only %26% not also here unless particularly discussed; /surg: consider also CRANIOTOMY %26% TREPHINING; %22%craniofacial dysmorphism%22% or %22%craniofacial fibrous dysplasia%22%: index under FACIAL BONES %28%IM%29% + SKULL %28%IM%29% + FIBROUS DYSPLASIA, POLYOSTOTIC %28%IM%29%%A%  
% 224.37/224.54  |- mesh__recordMaintainer mesh__D012886 ags
% 224.37/224.54  |- mesh__dateCreated mesh__D012886 1999-01-01
% 224.37/224.54  |- skos__broader mesh__D012886smesh__D001842
% 224.37/224.54  |- skos__related mesh__D012886smesh__D014207
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D012886 2006A
% 224.37/224.54  |- skos__prefLabel mesh__D012886 Skull
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D012886 2005
% 224.37/224.54  |- skos__related mesh__D012886smesh__D002508
% 224.37/224.54  |- mesh__recordOriginator mesh__D012886 NLM
% 224.37/224.54  |- skos__related mesh__D012886smesh__D003399
% 224.37/224.54  |- mesh__dateRevised mesh__D012886 2005-07-14
% 224.37/224.54  |- skos__related mesh__D012886smesh__D007427
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D012886 2006
% 224.37/224.54  |- mesh__considerAlso mesh__D012886 consider also terms at CRANI-   
% 224.37/224.54  |- skos__hiddenLabel mesh__D012886 Skulls
% 224.37/224.54  |- mesh__historyNote mesh__D045262
% 224.37/224.54       2004; use RETICULOCYTE COUNT 1994-2003   
% 224.37/224.54  |- skos__prefLabel mesh__D045262 Reticulocytosis
% 224.37/224.54  |- skos__historyNote mesh__D045262 Reticulocyte Count %28%1994-2003%29%
% 224.37/224.54  |- skos__broader mesh__D045262smesh__D012816
% 224.37/224.54  |- skos__historyNote mesh__D045262 Reticulocytes %28%1965-2003%29%
% 224.37/224.54  |- skos__scopeNote mesh__D045262
% 224.37/224.54       An increase in circulating RETICULOCYTES, which is among the simplest and most reliable signs of accelerated ERYTHROCYTE production. Reticulocytosis occurs during active BLOOD regeneration %28%stimulation of red bone marrow%29% and in certain types of ANEMIA, particularly CONGENITAL HEMOLYTIC ANEMIA.%A%    
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D045262 2005
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D045262 2004
% 224.37/224.54  |- rdf__type mesh__D045262sskos__Concept
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D045262 2006
% 224.37/224.54  |- skos__related mesh__D045262smesh__D017701
% 224.37/224.54  |- mesh__dateCreated mesh__D045262 2003-07-09
% 224.37/224.54  |- mesh__publicMeSHNote mesh__D045262
% 224.37/224.54       2004; see RETICULOCYTE COUNT 1994-2003   
% 224.37/224.54  |- mesh__dateEstablished mesh__D045262 2004-01-01
% 224.37/224.54  |- skos__broader mesh__D045262smesh__D045122
% 224.37/224.54  |- skos__hiddenLabel mesh__D045262 Reticulocytoses
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D012088 2002
% 224.37/224.54  |- skos__hiddenLabel mesh__D012088 Infection, Reoviridae
% 224.37/224.54  |- mesh__onlineNote mesh__D012088
% 224.37/224.54       use REOVIRIDAE INFECTIONS to search REOVIRUS INFECTIONS 1968-93%A%  
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D012088 1995
% 224.37/224.54  |- mesh__publicMeSHNote mesh__D012088
% 224.37/224.54       94; was REOVIRUS INFECTIONS 1968-93   
% 224.37/224.54  |- skos__prefLabel mesh__D012088 Reoviridae Infections
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D012088 2003
% 224.37/224.54  |- skos__broader mesh__D012088smesh__D012327
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D012088 2006
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D012088 1998
% 224.37/224.54  |- skos__historyNote mesh__D012088 Reoviridae %28%1966-1967%29%
% 224.37/224.54  |- skos__altLabel mesh__D012088 Reovirus Infections
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D012088 2004
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D012088 1996
% 224.37/224.54  |- skos__hiddenLabel mesh__D012088 Reoviridae Infection
% 224.37/224.54  |- mesh__activeMeSHYear mesh__D012088 1999
% 224.37/224.54  |- mesh__dateEstablished mesh__D012088 1968-01-01
% 224.37/224.55  |- skos__altLabel mesh__D012088 Infections, Reoviridae
% 224.37/224.55  |- mesh__recordOriginator mesh__D012088 NLM
% 224.37/224.55  |- mesh__recordAuthorizer mesh__D012088 PLS
% 224.37/224.55  |- mesh__dateCreated mesh__D012088 1999-01-01
% 224.37/224.55  |- skos__historyNote mesh__D012088 Virus Diseases %28%1966-1967%29%
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D012088 1997
% 224.37/224.55  |- skos__hiddenLabel mesh__D012088 Infections, Reovirus
% 224.37/224.55  |- skos__hiddenLabel mesh__D012088 Infection, Reovirus
% 224.37/224.55  |- skos__annotation mesh__D012088 GEN or unspecified; prefer specific   
% 224.37/224.55  |- skos__hiddenLabel mesh__D012088 Reovirus Infection
% 224.37/224.55  |- skos__scopeNote mesh__D012088
% 224.37/224.55       Infections produced by reoviruses, general or unspecified.%A%    
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D012088 2000
% 224.37/224.55  |- mesh__dateRevised mesh__D012088 1993-06-04
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D012088 2001
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D012088 1994
% 224.37/224.55  |- rdf__type mesh__D012088sskos__Concept
% 224.37/224.55  |- mesh__historyNote mesh__D012088 94; was REOVIRUS INFECTIONS 1968-93   
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D012088 2005
% 224.37/224.55  |- mesh__recordMaintainer mesh__D012088 AGS
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D006849 2003
% 224.37/224.55  |- skos__hiddenLabel mesh__D006849 Post Traumatic Hydrocephalus
% 224.37/224.55  |- skos__scopeNote mesh__D006849
% 224.37/224.55       Excessive accumulation of cerebrospinal fluid within the cranium which may be associated with dilation of cerebral ventricles, INTRACRANIAL HYPERTENSION; HEADACHE; lethargy; URINARY INCONTINENCE; and ATAXIA %28%and in infants macrocephaly%29%. This condition may be caused by obstruction of cerebrospinal fluid pathways due to neurologic abnormalities, INTRACRANIAL HEMORRHAGES; CENTRAL NERVOUS SYSTEM INFECTIONS; BRAIN NEOPLASMS; CRANIOCEREBRAL TRAUMA; and other conditions. Impaired resorption of cerebrospinal fluid from the arachnoid villi results in a communicating form of hydrocephalus. Hydrocephalus ex-vacuo refers to ventricular dilation that occurs as a result of brain substance loss from CEREBRAL INFARCTION and other conditions.%A%    
% 224.37/224.55  |- skos__hiddenLabel mesh__D006849 Hydrocephalus, Post-Traumatic
% 224.37/224.55  |- mesh__recordAuthorizer mesh__D006849 ags
% 224.37/224.55  |- skos__altLabel mesh__D006849 Hydrocephaly
% 224.37/224.55  |- skos__hiddenLabel mesh__D006849 Hydrocephalus, Obstructive
% 224.37/224.55  |- skos__broader mesh__D006849smesh__D001927
% 224.37/224.55  |- skos__related mesh__D006849smesh__D019586
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D006849 2006
% 224.37/224.55  |- mesh__dateCreated mesh__D006849 1999-01-01
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D006849 2002
% 224.37/224.55  |- mesh__recordMaintainer mesh__D006849 ags
% 224.37/224.55  |- skos__hiddenLabel mesh__D006849 Hydrocephalus, Communicating
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D006849 2005
% 224.37/224.55  |- mesh__recordOriginator mesh__D006849 NLM
% 224.37/224.55  |- skos__broader mesh__D006849smesh__D007232
% 224.37/224.55  |- skos__broader mesh__D006849smesh__D019586
% 224.37/224.55  |- skos__hiddenLabel mesh__D006849 Hydrocephalus Ex Vacuo
% 224.37/224.55  |- skos__hiddenLabel mesh__D006849 Hydrocephalus Ex-Vacuos
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D006849 2001
% 224.37/224.55  |- rdf__type mesh__D006849sskos__Concept
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D006849 2004
% 224.37/224.55  |- mesh__dateRevised mesh__D006849 1999-11-24
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D006849 2000A
% 224.37/224.55  |- skos__hiddenLabel mesh__D006849 Hydrocephalus, Congenital
% 224.37/224.55  |- skos__prefLabel mesh__D006849 Hydrocephalus
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D006849 2000
% 224.37/224.55  |- skos__annotation mesh__D031242
% 224.37/224.55       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D031242 2003
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D031242 2004
% 224.37/224.55  |- mesh__dateEstablished mesh__D031242 2003-01-01
% 224.37/224.55  |- mesh__dateCreated mesh__D031242 2002-07-02
% 224.37/224.55  |- rdf__type mesh__D031242sskos__Concept
% 224.37/224.55  |- skos__prefLabel mesh__D031242 Agrostemma
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D031242 2005
% 224.37/224.55  |- skos__altLabel mesh__D031242 Corncockle
% 224.37/224.55  |- skos__broader mesh__D031242smesh__D029748
% 224.37/224.55  |- skos__scopeNote mesh__D031242
% 224.37/224.55       A plant genus of the family CARYOPHYLLACEAE that contains ALLANTOIN and a ribosome-inactivating protein.%A%    
% 224.37/224.55  |- mesh__publicMeSHNote mesh__D031242 2003   
% 224.37/224.55  |- mesh__historyNote mesh__D031242 2003   
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D031242 2006
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D003551 2001
% 224.37/224.55  |- rdf__type mesh__D003551sskos__Concept
% 224.37/224.55  |- skos__scopeNote mesh__D003551
% 224.37/224.55       Infection with CYSTICERCUS, a larval form of the various tapeworms of the genus Taenia %28%usually T. solium in man%29%. In humans they penetrate the intestinal wall and invade subcutaneous tissue, brain, eye, muscle, heart, liver, lung, and peritoneum. Brain involvement results in NEUROCYSTICERCOSIS. %28%From Dorland, 28th ed%29%%A%    
% 224.37/224.55  |- mesh__dateRevised mesh__D003551 1998-06-10
% 224.37/224.55  |- mesh__dateCreated mesh__D003551 1999-01-01
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D003551 2003
% 224.37/224.55  |- mesh__recordOriginator mesh__D003551 NLM
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D003551 2005
% 224.37/224.55  |- skos__hiddenLabel mesh__D003551 Cysticercoses
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D003551 2004
% 224.37/224.55  |- mesh__recordAuthorizer mesh__D003551 SJN
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D003551 2002
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D003551 2006
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D003551 1999
% 224.37/224.55  |- mesh__recordMaintainer mesh__D003551 AGS
% 224.37/224.55  |- skos__broader mesh__D003551smesh__D013622
% 224.37/224.55  |- skos__related mesh__D003551smesh__D013621
% 224.37/224.55  |- skos__annotation mesh__D003551 NEUROCYSTICERCOSIS is available   
% 224.37/224.55  |- skos__prefLabel mesh__D003551 Cysticercosis
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D003551 2000
% 224.37/224.55  |- rdf__type mesh__D044968sskos__Concept
% 224.37/224.55  |- mesh__historyNote mesh__D044968 2004   
% 224.37/224.55  |- mesh__dateCreated mesh__D044968 2003-07-09
% 224.37/224.55  |- mesh__dateEstablished mesh__D044968 2004-01-01
% 224.37/224.55  |- skos__scopeNote mesh__D044968
% 224.37/224.55       A field of medicine concerned with developing and using strategies aimed at repair or replacement of damaged, diseased, or metabolically deficient organs, tissues, and cells via TISSUE ENGINEERING; CELL TRANSPLANTATION; and ARTIFICIAL ORGANS and BIOARTIFICIAL ORGANS and tissues.%A%    
% 224.37/224.55  |- skos__hiddenLabel mesh__D044968 Medicines, Regenerative
% 224.37/224.55  |- skos__annotation mesh__D044968 Specialty   
% 224.37/224.55  |- skos__prefLabel mesh__D044968 Regenerative Medicine
% 224.37/224.55  |- mesh__publicMeSHNote mesh__D044968 2004   
% 224.37/224.55  |- skos__related mesh__D044968smesh__D023822
% 224.37/224.55  |- skos__hiddenLabel mesh__D044968 Medicine, Regenerative
% 224.37/224.55  |- skos__broader mesh__D044968smesh__D013043
% 224.37/224.55  |- skos__related mesh__D044968smesh__D001672
% 224.37/224.55  |- skos__hiddenLabel mesh__D044968 Regenerative Medicines
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D044968 2004
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D044968 2005
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D044968 2006
% 224.37/224.55  |- skos__broader mesh__D001842Q000637smesh__D001842
% 224.37/224.55  |- mesh__preferredCombination mesh__D001842Q000637smesh__D016025
% 224.37/224.55  |- rdf__type mesh__D001842Q000637smesh__CompoundConcept
% 224.37/224.55  |- skos__historyNote mesh__D002459 Cytology %28%1966-1970%29%
% 224.37/224.55  |- mesh__recordOriginator mesh__D002459 NLM
% 224.37/224.55  |- mesh__recordMaintainer mesh__D002459 TAP
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D002459 2005
% 224.37/224.55  |- mesh__publicMeSHNote mesh__D002459 73   
% 224.37/224.55  |- mesh__dateRevised mesh__D002459 2000-06-22
% 224.37/224.55  |- skos__hiddenLabel mesh__D002459 Fusions, Cell
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D002459 2006
% 224.37/224.55  |- mesh__dateEstablished mesh__D002459 1973-01-01
% 224.37/224.55  |- skos__annotation mesh__D002459
% 224.37/224.55       NIM; not for micro-organisms; somatic cells only: not for sperm-ovum fusion %28% = fertilization%29%%A%  
% 224.37/224.55  |- mesh__recordAuthorizer mesh__D002459 sjn
% 224.37/224.55  |- skos__broader mesh__D002459smesh__D003584
% 224.37/224.55  |- rdf__type mesh__D002459sskos__Concept
% 224.37/224.55  |- mesh__historyNote mesh__D002459 73%28%71%29%   
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D002459 2001
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D002459 2003
% 224.37/224.55  |- skos__prefLabel mesh__D002459 Cell Fusion
% 224.37/224.55  |- skos__related mesh__D002459smesh__D006822
% 224.37/224.55  |- skos__broader mesh__D002459smesh__D002468
% 224.37/224.55  |- mesh__dateCreated mesh__D002459 1999-01-01
% 224.37/224.55  |- skos__hiddenLabel mesh__D002459 Fusion, Cell
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D002459 2002
% 224.37/224.55  |- skos__hiddenLabel mesh__D002459 Cell Fusions
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D002459 2004
% 224.37/224.55  |- skos__scopeNote mesh__D002459
% 224.37/224.55       Fusion of somatic cells in vitro or in vivo, which results in somatic cell hybridization.%A%    
% 224.37/224.55  |- skos__hiddenLabel mesh__D013181 Cortical Depressions, Spreading
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D013181 2002
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D013181 1998
% 224.37/224.55  |- skos__hiddenLabel mesh__D013181 Depressions, Spreading Cortical
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D013181 2003
% 224.37/224.55  |- skos__prefLabel mesh__D013181 Spreading Cortical Depression
% 224.37/224.55  |- mesh__historyNote mesh__D013181 67%28%64%29%   
% 224.37/224.55  |- mesh__dateCreated mesh__D013181 1999-01-01
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D013181 1993
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D013181 1999
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D013181 2004
% 224.37/224.55  |- mesh__recordAuthorizer mesh__D013181 PLS
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D013181 2000
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D013181 1996
% 224.37/224.55  |- mesh__publicMeSHNote mesh__D013181 67   
% 224.37/224.55  |- skos__broader mesh__D013181smesh__D009424
% 224.37/224.55  |- mesh__dateEstablished mesh__D013181 1967-01-01
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D013181 1997
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D013181 2001
% 224.37/224.55  |- rdf__type mesh__D013181sskos__Concept
% 224.37/224.55  |- mesh__dateRevised mesh__D013181 1992-05-18
% 224.37/224.55  |- skos__hiddenLabel mesh__D013181 Spreading Cortical Depressions
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D013181 1994
% 224.37/224.55  |- mesh__recordMaintainer mesh__D013181 TAP
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D013181 2005
% 224.37/224.55  |- mesh__recordOriginator mesh__D013181 NLM
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D013181 1995
% 224.37/224.55  |- skos__altLabel mesh__D013181 Cortical Depression, Spreading
% 224.37/224.55  |- skos__hiddenLabel mesh__D013181 Depression, Spreading Cortical
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D013181 2006
% 224.37/224.55  |- skos__prefLabel mesh__D007942 Leukemia, Experimental
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D007942 2006
% 224.37/224.55  |- skos__hiddenLabel mesh__D007942 Animal Leukemia Models
% 224.37/224.55  |- skos__annotation mesh__D007942
% 224.37/224.55       includes infection by LEUKEMOGENIC VIRUSES; DF: LEUKEMIA EXPER%A%  
% 224.37/224.55  |- mesh__recordOriginator mesh__D007942 NLM
% 224.37/224.55  |- skos__altLabel mesh__D007942 Leukemias, Experimental
% 224.37/224.55  |- skos__altLabel mesh__D007942 Leukemia Model, Animal
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D007942 2005
% 224.37/224.55  |- mesh__recordAuthorizer mesh__D007942 sjn
% 224.37/224.55  |- mesh__dateRevised mesh__D007942 2004-07-07
% 224.37/224.55  |- mesh__dateCreated mesh__D007942 1999-01-01
% 224.37/224.55  |- skos__broader mesh__D007942smesh__D009374
% 224.37/224.55  |- mesh__recordMaintainer mesh__D007942 lkt
% 224.37/224.55  |- skos__broader mesh__D007942smesh__D007938
% 224.37/224.55  |- skos__altLabel mesh__D007942 Experimental Leukemia
% 224.37/224.55  |- skos__altLabel mesh__D007942 Experimental Leukemias
% 224.37/224.55  |- rdf__type mesh__D007942sskos__Concept
% 224.37/224.55  |- skos__hiddenLabel mesh__D007942 Leukemia Models, Animal
% 224.37/224.55  |- skos__scopeNote mesh__D007942
% 224.37/224.55       Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues.%A%    
% 224.37/224.55  |- skos__hiddenLabel mesh__D007942 Animal Leukemia Model
% 224.37/224.55  |- skos__hiddenLabel mesh__D007144 Immunoglobulin J Chains
% 224.37/224.55  |- mesh__recordOriginator mesh__D007144 NLM
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D007144 2006
% 224.37/224.55  |- mesh__recordMaintainer mesh__D007144 nns
% 224.37/224.55  |- skos__hiddenLabel mesh__D007144 Polypeptide, Immunoglobulin J
% 224.37/224.55  |- skos__altLabel mesh__D007144 Immunoglobulin J Polypeptide
% 224.37/224.55  |- skos__hiddenLabel mesh__D007144 J-Peptide, Ig
% 224.37/224.55  |- mesh__historyNote mesh__D007144 2006 %28%1974%29%   
% 224.37/224.55  |- rdf__type mesh__D007144sskos__Concept
% 224.37/224.55  |- mesh__dateRevised mesh__D007144 2005-06-30
% 224.37/224.55  |- skos__altLabel mesh__D007144 J-Chains, Immunoglobulin
% 224.37/224.55  |- skos__hiddenLabel mesh__D007144 J Polypeptide, Immunoglobulin
% 224.37/224.55  |- skos__related mesh__D007144smesh__D007075
% 224.37/224.55  |- skos__broader mesh__D007144smesh__D050440
% 224.37/224.55  |- skos__hiddenLabel mesh__D007144 Immunoglobulin J Peptide
% 224.37/224.55  |- skos__related mesh__D007144smesh__D007070
% 224.37/224.55  |- skos__hiddenLabel mesh__D007144 Ig J Peptide
% 224.37/224.55  |- skos__hiddenLabel mesh__D007144 J-Peptide, Immunoglobulin
% 224.37/224.55  |- mesh__recordAuthorizer mesh__D007144 sjn
% 224.37/224.55  |- skos__hiddenLabel mesh__D007144 J Chains, Immunoglobulin
% 224.37/224.55  |- skos__altLabel mesh__D007144 Immunoglobulin J-Peptide
% 224.37/224.55  |- mesh__dateEstablished mesh__D007144 1974-01-01
% 224.37/224.55  |- mesh__dateCreated mesh__D007144 1999-01-01
% 224.37/224.55  |- skos__scopeNote mesh__D007144
% 224.37/224.55       A 15 kD %22%joining%22% peptide that forms one of the linkages between monomers of IMMUNOGLOBULIN A or IMMUNOGLOBULIN M in the formation of polymeric immunoglobulins. There is one J chain per one IgA dimer or one IgM pentamer. It is also involved in binding the polymeric immunoglobulins to POLYMERIC IMMUNOGLOBULIN RECEPTOR which is necessary for their transcytosis to the lumen. It is distinguished from the IMMUNOGLOBULIN JOINING REGION which is part of the IMMUNOGLOBULIN VARIABLE REGION of the immunoglobulin light and heavy chains.%A%    
% 224.37/224.55  |- skos__prefLabel mesh__D007144 Immunoglobulin J-Chains
% 224.37/224.55  |- skos__altLabel mesh__D007144 Ig J-Peptide
% 224.37/224.55  |- mesh__publicMeSHNote mesh__D007144
% 224.37/224.55       2006; see IMMUNOGLOBULINS, J-CHAIN 1992-2005, see IMMUNOGLOBULINS, J CHAIN 1974-1991%A%  
% 224.37/224.55  |- skos__hiddenLabel mesh__D012887 Skull Fracture, Non Depressed
% 224.37/224.55  |- skos__hiddenLabel mesh__D012887 Non Depressed Skull Fracture
% 224.37/224.55  |- mesh__dateRevised mesh__D012887 2005-06-30
% 224.37/224.55  |- skos__hiddenLabel mesh__D012887 Skull Fracture
% 224.37/224.55  |- skos__hiddenLabel mesh__D012887 Fractures, Non-Depressed Skull
% 224.37/224.55  |- skos__prefLabel mesh__D012887 Skull Fractures
% 224.37/224.55  |- skos__annotation mesh__D012887
% 224.37/224.55       GEN; fractures of specific bones of the skull: coord IM with specific bone/inj %28%IM%29%%A%  
% 224.37/224.55  |- skos__scopeNote mesh__D012887
% 224.37/224.55       Fractures of the skull which may result from penetrating or nonpenetrating head injuries or rarely BONE DISEASES %28%see also FRACTURES, SPONTANEOUS%29%. Skull fractures may be classified by location %28%e.g., SKULL FRACTURE, BASILAR%29%, radiographic appearance %28%e.g., linear%29%, or based upon cranial integrity %28%e.g., SKULL FRACTURE, DEPRESSED%29%.%A%    
% 224.37/224.55  |- mesh__recordMaintainer mesh__D012887 ssb
% 224.37/224.55  |- skos__altLabel mesh__D012887 Non-Depressed Skull Fracture
% 224.37/224.55  |- mesh__dateCreated mesh__D012887 1999-01-01
% 224.37/224.55  |- skos__hiddenLabel mesh__D012887 Fractures, Skull
% 224.37/224.55  |- skos__hiddenLabel mesh__D012887 Linear Skull Fractures
% 224.37/224.55  |- skos__hiddenLabel mesh__D012887 Skull Fractures, Non-Depressed
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D012887 2006
% 224.37/224.55  |- skos__hiddenLabel mesh__D012887 Fracture, Non-Depressed Skull
% 224.37/224.55  |- skos__hiddenLabel mesh__D012887 Fractures, Linear Skull
% 224.37/224.55  |- skos__hiddenLabel mesh__D012887 Fracture, Skull
% 224.37/224.55  |- skos__broader mesh__D012887smesh__D050723
% 224.37/224.55  |- rdf__type mesh__D012887sskos__Concept
% 224.37/224.55  |- skos__hiddenLabel mesh__D012887 Non-Depressed Skull Fractures
% 224.37/224.55  |- skos__altLabel mesh__D012887 Skull Fracture, Linear
% 224.37/224.55  |- mesh__recordOriginator mesh__D012887 NLM
% 224.37/224.55  |- skos__broader mesh__D012887smesh__D006259
% 224.37/224.55  |- skos__hiddenLabel mesh__D012887 Skull Fractures, Linear
% 224.37/224.55  |- mesh__recordAuthorizer mesh__D012887 sjn
% 224.37/224.55  |- skos__scopeNote mesh__D045263
% 224.37/224.55       A subclass of heme a containing cytochromes have a reduced alpha-band absorption of 587-592 nm. They are primarily found in microorganisms.%A%    
% 224.37/224.55  |- mesh__historyNote mesh__D045263
% 224.37/224.55       2004; use CYTOCHROMES A1 %28%NM%29% 1980-2003   
% 224.37/224.55  |- mesh__dateEstablished mesh__D045263 2004-01-01
% 224.37/224.55  |- skos__altLabel mesh__D045263 Cytochrome a1
% 224.37/224.55  |- skos__hiddenLabel mesh__D045263 Cytochrome a 1
% 224.37/224.55  |- mesh__recordMaintainer mesh__D045263 jmp
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D045263 2005
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D045263 2004
% 224.37/224.55  |- skos__altLabel mesh__D045263 Cytochrome a-1
% 224.37/224.55  |- rdf__type mesh__D045263sskos__Concept
% 224.37/224.55  |- mesh__recordOriginator mesh__D045263 jmp
% 224.37/224.55  |- mesh__publicMeSHNote mesh__D045263
% 224.37/224.55       2004; CYTOCHROMES A1 was indexed under CYTOCHROME A 1994-2003 %26% under CYTOCHROMES 1980-1993%A%  
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D045263 2006
% 224.37/224.55  |- mesh__recordAuthorizer mesh__D045263 sjn
% 224.37/224.55  |- skos__broader mesh__D045263smesh__D017936
% 224.37/224.55  |- skos__historyNote mesh__D045263 Cytochromes %28%1980-1993%29%
% 224.37/224.55  |- skos__historyNote mesh__D045263 Cytochrome a Group %28%1994-2003%29%
% 224.37/224.55  |- mesh__dateCreated mesh__D045263 2003-07-09
% 224.37/224.55  |- skos__prefLabel mesh__D045263 Cytochromes a1
% 224.37/224.55  |- skos__altLabel mesh__D045263 Cytochrome a%28%1%29%
% 224.37/224.55  |- mesh__historyNote mesh__D012089 97%28%75%29%   
% 224.37/224.55  |- skos__prefLabel mesh__D012089 Reovirus 3
% 224.37/224.55  |- rdf__type mesh__D012089sskos__Concept
% 224.37/224.55  |- skos__broader mesh__D012089smesh__D030102
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D012089 2004
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D012089 2006
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D012089 2003
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D012089 2005
% 224.37/224.55  |- mesh__dateEstablished mesh__D012089 1991-01-01
% 224.37/224.55  |- skos__altLabel mesh__D012089 Reovirus Type 3
% 224.37/224.55  |- mesh__dateRevised mesh__D012089 2001-07-25
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D012089 2002
% 224.37/224.55  |- skos__annotation mesh__D012089
% 224.37/224.55       infection: coord IM with REOVIRIDAE INFECTIONS %28%IM%29%   
% 224.37/224.55  |- mesh__publicMeSHNote mesh__D012089
% 224.37/224.55       97; see REOVIRUS TYPE 3 1991-96, see REOVIRIDAE 1981-90, see REOVIRUSES 1975-80%A%  
% 224.37/224.55  |- mesh__recordMaintainer mesh__D012089 ags
% 224.37/224.55  |- mesh__recordAuthorizer mesh__D012089 sjn
% 224.37/224.55  |- skos__scopeNote mesh__D012089
% 224.37/224.55       A serotype of ORTHOREOVIRUS, MAMMALIAN causing serious pathology in laboratory rodents, characterized by diarrhea, oily coat, jaundice, and multiple organ involvement.%A%    
% 224.37/224.55  |- mesh__recordOriginator mesh__D012089 NLM
% 224.37/224.55  |- mesh__dateCreated mesh__D012089 1974-12-12
% 224.37/224.55  |- skos__scopeNote mesh__D017572
% 224.37/224.55       %28%2S-%28%2 alpha,3 beta%28%1E,3E,5Z,8Z%29%%29%%29%-3-%28%1,3,5,8-Tetradecatetraenyl%29%oxiranebutanoic acid. An unstable allylic epoxide, formed from the immediate precursor 5-HPETE via the stereospecific removal of a proton at C-10 and dehydration. Its biological actions are determined primarily by its metabolites, i.e., LEUKOTRIENE B4 and cysteinyl-leukotrienes. Alternatively, leukotriene A4 is converted into LEUKOTRIENE C4 by glutathione-S-transferase or into 5,6-di-HETE by the epoxide-hydrolase. %28%From Dictionary of Prostaglandins and Related Compounds, 1990%29%%A%    
% 224.37/224.55  |- mesh__publicMeSHNote mesh__D017572
% 224.37/224.55       94; LEUKOTRIENE A was indexed under LEUKOTRIENES 1989-93 %26% ARACHIDONIC ACIDS 1980-88%A%  
% 224.37/224.55  |- skos__altLabel mesh__D017572 LTA4
% 224.37/224.55  |- skos__annotation mesh__D017572 /biosyn /physiol permitted   
% 224.37/224.55  |- mesh__recordAuthorizer mesh__D017572 sjn
% 224.37/224.55  |- mesh__dateCreated mesh__D017572 1993-06-04
% 224.37/224.55  |- mesh__onlineNote mesh__D017572
% 224.37/224.55       use LEUKOTRIENE A4 %28%NM%29% to search LEUKOTRIENE A 1980-93   
% 224.37/224.55  |- skos__historyNote mesh__D017572 Leukotrienes %28%1989-1993%29%
% 224.37/224.55  |- mesh__dateRevised mesh__D017572 2005-06-30
% 224.37/224.55  |- skos__prefLabel mesh__D017572 Leukotriene A4
% 224.37/224.55  |- mesh__dateEstablished mesh__D017572 1994-01-01
% 224.37/224.55  |- skos__altLabel mesh__D017572 Leukotrienes A
% 224.37/224.55  |- skos__hiddenLabel mesh__D017572 Leukotriene A 4
% 224.37/224.55  |- mesh__recordOriginator mesh__D017572 TPW
% 224.37/224.55  |- mesh__historyNote mesh__D017572
% 224.37/224.55       94; was LEUKOTRIENE A %28%NM%29% 1980-93   
% 224.37/224.55  |- skos__altLabel mesh__D017572 Leukotriene A-4
% 224.37/224.55  |- mesh__recordMaintainer mesh__D017572 ssb
% 224.37/224.55  |- rdf__type mesh__D017572sskos__Concept
% 224.37/224.55  |- skos__historyNote mesh__D017572 Arachidonic Acids %28%1980-1988%29%
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D017572 2006
% 224.37/224.55  |- skos__broader mesh__D017572smesh__D015289
% 224.37/224.55  |- rdf__type mesh__D031243sskos__Concept
% 224.37/224.55  |- skos__broader mesh__D031243smesh__D029748
% 224.37/224.55  |- mesh__historyNote mesh__D031243 2003   
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D031243 2005
% 224.37/224.55  |- skos__scopeNote mesh__D031243
% 224.37/224.55       A plant genus of the family CARYOPHYLLACEAE. The common name of sandwort is used with other plants. Do not confuse with Arenaria bird or with other genera which use arenaria as the species name such as Mya arenaria %28%softshell clam%29% or Meloidogyne arenaria, or Ammophila arenaria %28%marram grass%29%.%A%    
% 224.37/224.55  |- mesh__publicMeSHNote mesh__D031243 2003   
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D031243 2006
% 224.37/224.55  |- skos__annotation mesh__D031243
% 224.37/224.55       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.37/224.55  |- mesh__dateEstablished mesh__D031243 2003-01-01
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D031243 2003
% 224.37/224.55  |- skos__prefLabel mesh__D031243 Arenaria Plant
% 224.37/224.55  |- mesh__dateCreated mesh__D031243 2002-07-02
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D031243 2004
% 224.37/224.55  |- mesh__recordMaintainer mesh__D003552 ags
% 224.37/224.55  |- skos__prefLabel mesh__D003552 Cysticercus
% 224.37/224.55  |- skos__scopeNote mesh__D003552
% 224.37/224.55       The larval form of various tapeworms of the genus Taenia.%A%    
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D003552 2005
% 224.37/224.55  |- skos__broader mesh__D003552smesh__D013621
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D003552 2004
% 224.37/224.55  |- mesh__publicMeSHNote mesh__D003552 91; was see under TAENIA 1975-90   
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D003552 2006
% 224.37/224.55  |- mesh__recordAuthorizer mesh__D003552 sjn
% 224.37/224.55  |- mesh__historyNote mesh__D003552
% 224.37/224.55       91%28%75%29%; was see under TAENIA 1975-90   
% 224.37/224.55  |- mesh__recordOriginator mesh__D003552 NLM
% 224.37/224.55  |- mesh__dateRevised mesh__D003552 2003-07-09
% 224.37/224.55  |- mesh__dateEstablished mesh__D003552 1991-01-01
% 224.37/224.55  |- mesh__onlineNote mesh__D003552 search TAENIA 1966-74   
% 224.37/224.55  |- skos__annotation mesh__D003552
% 224.37/224.55       larval form of tapeworm; infection = CYSTICERCOSIS or NEUROCYSTICERCOSIS; coord with specific precoord helminth terms %28%ANTIGENS, HELMINTH, etc%29% if pertinent%A%  
% 224.37/224.55  |- rdf__type mesh__D003552sskos__Concept
% 224.37/224.55  |- mesh__dateCreated mesh__D003552 1999-01-01
% 224.37/224.55  |- skos__prefLabel mesh__D044969 Ochlerotatus
% 224.37/224.55  |- mesh__publicMeSHNote mesh__D044969 2004   
% 224.37/224.55  |- mesh__dateEstablished mesh__D044969 2004-01-01
% 224.37/224.55  |- mesh__historyNote mesh__D044969 2004   
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D044969 2005
% 224.37/224.55  |- skos__historyNote mesh__D044969 Culicidae %28%1972-2003%29%
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D044969 2004
% 224.37/224.55  |- skos__broader mesh__D044969smesh__D009033
% 224.37/224.55  |- skos__scopeNote mesh__D044969
% 224.37/224.55       A genus of mosquitoes in the family CULICIDAE. A large number of the species are found in the neotropical part of the Americas.%A%    
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D044969 2006
% 224.37/224.55  |- mesh__dateCreated mesh__D044969 2003-07-09
% 224.37/224.55  |- rdf__type mesh__D044969sskos__Concept
% 224.37/224.55  |- mesh__recordMaintainer mesh__D013182 lkt
% 224.37/224.55  |- skos__annotation mesh__D013182
% 224.37/224.55       note %22%tropical%22%: do not confuse with non-tropical sprue which is CELIAC DISEASE%A%  
% 224.37/224.55  |- skos__broader mesh__D013182smesh__D008286
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D013182 2006
% 224.37/224.55  |- mesh__recordOriginator mesh__D013182 NLM
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D013182 2004
% 224.37/224.55  |- skos__hiddenLabel mesh__D013182 Tropical Sprue
% 224.37/224.55  |- skos__related mesh__D013182smesh__D002446
% 224.37/224.55  |- skos__scopeNote mesh__D013182
% 224.37/224.55       A chronic malabsorption syndrome, occurring mainly in residents of or visitors to the tropics or subtropics. The failed INTESTINAL ABSORPTION of nutrients from the SMALL INTESTINE results in MALNUTRITION and ANEMIA that is due to FOLIC ACID deficiency.%A%    
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D013182 2005
% 224.37/224.55  |- mesh__dateCreated mesh__D013182 1999-01-01
% 224.37/224.55  |- mesh__recordAuthorizer mesh__D013182 sjn
% 224.37/224.55  |- skos__prefLabel mesh__D013182 Sprue, Tropical
% 224.37/224.55  |- mesh__dateRevised mesh__D013182 2003-07-09
% 224.37/224.55  |- skos__altLabel mesh__D013182 Idiopathic Tropical Malabsorption Syndrome
% 224.37/224.55  |- rdf__type mesh__D013182sskos__Concept
% 224.37/224.55  |- skos__broader mesh__D007943smesh__D007938
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D007943 2002
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D007943 2006
% 224.37/224.55  |- skos__historyNote mesh__D007943 Leukemia %28%1966-1977%29%
% 224.37/224.55  |- skos__hiddenLabel mesh__D007943 Hairy Cell Leukemias
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D007943 1996
% 224.37/224.55  |- skos__hiddenLabel mesh__D007943 Leukemias, Hairy Cell
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D007943 1998
% 224.37/224.55  |- skos__historyNote mesh__D007943 Reticuloendotheliosis %28%1966-1977%29%
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D007943 1997
% 224.37/224.55  |- mesh__dateEstablished mesh__D007943 1978-01-01
% 224.37/224.55  |- skos__annotation mesh__D007943
% 224.37/224.55       %22%hairy%22% refers to flagellated appearance of the lymphoreticular cells; since the dis is chronic, do not coord with CHRONIC DISEASE; do not use /blood supply /chem /second /secret /ultrastruct; consider also LEUKEMIA, T-CELL, HTLV-II-ASSOCIATED%A%  
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D007943 1999
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D007943 2000
% 224.37/224.55  |- skos__altLabel mesh__D007943 Leukemic Reticuloendotheliosis
% 224.37/224.55  |- skos__hiddenLabel mesh__D007943 Reticuloendothelioses, Leukemic
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D007943 2001
% 224.37/224.55  |- skos__historyNote mesh__D007943 Spleen/pathology %28%1966-1977%29%
% 224.37/224.55  |- skos__hiddenLabel mesh__D007943 Leukemic Reticuloendothelioses
% 224.37/224.55  |- mesh__historyNote mesh__D007943 78   
% 224.37/224.55  |- skos__altLabel mesh__D007943 Reticuloendotheliosis, Leukemic
% 224.37/224.55  |- mesh__recordAuthorizer mesh__D007943 PLS
% 224.37/224.55  |- mesh__dateRevised mesh__D007943 1995-06-08
% 224.37/224.55  |- rdf__type mesh__D007943sskos__Concept
% 224.37/224.55  |- skos__prefLabel mesh__D007943 Leukemia, Hairy Cell
% 224.37/224.55  |- skos__altLabel mesh__D007943 Hairy Cell Leukemia
% 224.37/224.55  |- mesh__publicMeSHNote mesh__D007943 78   
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D007943 2003
% 224.37/224.55  |- skos__broader mesh__D007943smesh__D008232
% 224.37/224.55  |- mesh__recordMaintainer mesh__D007943 KEV
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D007943 2005
% 224.37/224.55  |- skos__historyNote mesh__D007943 Splenomegaly %28%1966-1977%29%
% 224.37/224.55  |- mesh__recordOriginator mesh__D007943 VDK
% 224.37/224.55  |- skos__scopeNote mesh__D007943
% 224.37/224.55       A neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of %22%hairy%22% or %22%flagellated%22% cells in the blood and bone marrow.%A%    
% 224.37/224.55  |- mesh__dateCreated mesh__D007943 1977-04-27
% 224.37/224.55  |- mesh__activeMeSHYear mesh__D007943 2004
% 224.37/224.55  |- skos__hiddenLabel mesh__D007145 kappa Immunoglobulin Subgroup VK 12
% 224.37/224.55  |- skos__scopeNote mesh__D007145
% 224.37/224.55       One of the types of light chains of the immunoglobulins with a molecular weight of approximately 22 kDa.%A%    
% 224.37/224.55  |- skos__hiddenLabel mesh__D007145 kappa Immunoglobulin Subgroup VK 21
% 224.37/224.55  |- mesh__recordAuthorizer mesh__D007145 sjn
% 224.37/224.55  |- mesh__historyNote mesh__D007145 2006 %28%1973%29%   
% 224.37/224.55  |- skos__altLabel mesh__D007145 Immunoglobulin kappa-Chain
% 224.37/224.55  |- skos__hiddenLabel mesh__D007145 kappa Immunoglobulin Light Chains
% 224.37/224.55  |- skos__historyNote mesh__D007145
% 224.37/224.55       Immunoglobulin Fragments %28%1973-1974%29%
% 224.37/224.55  |- skos__historyNote mesh__D007145 Gamma Globulins %28%1966-1971%29%
% 224.37/224.55  |- skos__altLabel mesh__D007145 kappa-Immunoglobulin Light Chains
% 224.37/224.55  |- skos__hiddenLabel mesh__D007145 kappa-Chain, Immunoglobulin
% 224.37/224.55  |- mesh__recordMaintainer mesh__D007145 nns
% 224.37/224.55  |- skos__hiddenLabel mesh__D007145 kappa-Chains, Immunoglobulin
% 224.37/224.55  |- mesh__recordOriginator mesh__D007145 NLM
% 224.37/224.55  |- skos__hiddenLabel mesh__D007145 Light Chains, kappa-Immunoglobulin
% 224.37/224.55  |- skos__hiddenLabel mesh__D007145 Light Chain, kappa-Immunoglobulin
% 224.37/224.55  |- skos__altLabel mesh__D007145 kappa-Immunoglobulin Light Chain
% 224.37/224.55  |- mesh__dateEstablished mesh__D007145 1986-01-01
% 224.37/224.56  |- mesh__dateCreated mesh__D007145 1999-01-01
% 224.37/224.56  |- skos__altLabel mesh__D007145 Immunoglobulins, kappa-Chain
% 224.37/224.56  |- skos__altLabel mesh__D007145 kappa-Chain Immunoglobulins
% 224.37/224.56  |- skos__hiddenLabel mesh__D007145 kappa Immunoglobulin Light Chain
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D007145 2006
% 224.37/224.56  |- mesh__dateRevised mesh__D007145 2005-06-30
% 224.37/224.56  |- skos__annotation mesh__D007145
% 224.37/224.56       gammopathy: coordinate IMMUNOGLOBULIN KAPPA-CHAINS %28%IM%29% with PARAPROTEINEMIAS %28%IM%29% but consider also HYPERGAMMAGLOBULINEMIA %28%IM%29%, follow text; DF: IG KAPPA CHAIN%A%  
% 224.37/224.56  |- skos__historyNote mesh__D007145 Immunoglobulins %28%1972%29%
% 224.37/224.56  |- skos__hiddenLabel mesh__D007145 Immunoglobulins, kappa Chain
% 224.37/224.56  |- rdf__type mesh__D007145sskos__Concept
% 224.37/224.56  |- skos__hiddenLabel mesh__D007145 kappa Chain Immunoglobulins
% 224.37/224.56  |- mesh__publicMeSHNote mesh__D007145
% 224.37/224.56       2006; see IMMUNOGLOBULINS, KAPPA-CHAIN 1992-2005,  see IMMUNOGLOBULINS, KAPPA CHAIN 1986-1991, see IMMUNOGLOBULINS, LIGHT CHAIN 1975-1985, see IMMUNOGLOBULIN FRAGMENTS 1973-1974%A%  
% 224.37/224.56  |- skos__broader mesh__D007145smesh__D007147
% 224.37/224.56  |- skos__hiddenLabel mesh__D007145 Immunoglobulin kappa Chain
% 224.37/224.56  |- skos__prefLabel mesh__D007145 Immunoglobulin kappa-Chains
% 224.37/224.56  |- skos__hiddenLabel mesh__D007145 Immunoglobulin kappa Chains
% 224.37/224.56  |- skos__annotation mesh__D012888
% 224.37/224.56       of bony part of skull only: do not confuse with HEAD AND NECK NEOPLASMS or FACIAL NEOPLASMS; %22%intracranial tumors%22% is probably BRAIN NEOPLASMS, not SKULL NEOPLASMS; GEN: prefer specifics; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%; SKULL BASE NEOPLASMS is also available%A%  
% 224.37/224.56  |- skos__hiddenLabel mesh__D012888 Skull Neoplasm
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D012888 2005
% 224.37/224.56  |- skos__prefLabel mesh__D012888 Skull Neoplasms
% 224.37/224.56  |- mesh__recordOriginator mesh__D012888 NLM
% 224.37/224.56  |- skos__hiddenLabel mesh__D012888 Neoplasm, Skull
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D012888 2006
% 224.37/224.56  |- mesh__recordAuthorizer mesh__D012888 sjn
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D012888 2001
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D012888 2003
% 224.37/224.56  |- rdf__type mesh__D012888sskos__Concept
% 224.37/224.56  |- skos__scopeNote mesh__D012888
% 224.37/224.56       Neoplasms of the bony part of the skull.     
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D012888 2004
% 224.37/224.56  |- mesh__recordMaintainer mesh__D012888 TGC
% 224.37/224.56  |- skos__broader mesh__D012888smesh__D001859
% 224.37/224.56  |- skos__altLabel mesh__D012888 Neoplasms, Skull
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D012888 2002
% 224.37/224.56  |- mesh__dateRevised mesh__D012888 2000-06-22
% 224.37/224.56  |- mesh__dateCreated mesh__D012888 1999-01-01
% 224.37/224.56  |- mesh__publicMeSHNote mesh__D045264
% 224.37/224.56       2004; see CYTOCROME A GROUP 1994-2004; CYTOCHROME A was indexed under CYTOCHROMES 1979-1993%A%  
% 224.37/224.56  |- skos__historyNote mesh__D045264 Cytochromes %28%1979-1993%29%
% 224.37/224.56  |- skos__scopeNote mesh__D045264
% 224.37/224.56       A subclass of heme a containing cytochromes that have two imidazole nitrogens as axial ligands and an alpha-band absorption of 605 nm. They are found in a variety of microorganisms and in eucaryotes as a low-spin cytochrome component of MITOCHONDRIAL ELECTRON TRANSPORT COMPLEX IV.%A%    
% 224.37/224.56  |- mesh__historyNote mesh__D045264
% 224.37/224.56       2004; use CYTOCHROME A GROUP 1994-2004, use CYTOCHROME A %28%NM%29% 1979-1993%A%  
% 224.37/224.56  |- skos__broader mesh__D045264smesh__D017936
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D045264 2004
% 224.37/224.56  |- skos__altLabel mesh__D045264 Cytochrome a
% 224.37/224.56  |- mesh__dateCreated mesh__D045264 2003-07-09
% 224.37/224.56  |- skos__historyNote mesh__D045264 Cytochrome a Group %28%1994-2003%29%
% 224.37/224.56  |- rdf__type mesh__D045264sskos__Concept
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D045264 2006
% 224.37/224.56  |- mesh__dateEstablished mesh__D045264 2004-01-01
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D045264 2005
% 224.37/224.56  |- skos__prefLabel mesh__D045264 Cytochromes a
% 224.37/224.56  |- skos__hiddenLabel mesh__D017573 Hyperplasias, Focal Epithelial
% 224.37/224.56  |- skos__broader mesh__D017573smesh__D009059
% 224.37/224.56  |- skos__altLabel mesh__D017573 Hyperplasia, Focal Epithelial
% 224.37/224.56  |- skos__scopeNote mesh__D017573
% 224.37/224.56       Hyperplasia of the mucous membrane of the lips, tongue, and less commonly, the buccal mucosa, floor of the mouth, and palate, presenting soft, painless, round to oval sessile papules about 1 to 4 mm in diameter. The condition usually occurs in children and young adults and has familial predilection, lasting for several months, sometimes years, before running its course. A viral etiology is suspected, the isolated organism being usually the human papillomavirus. %28%Jablonski, Illustrated Dictionary of Dentistry; Belshe, Textbook of Human Virology, 2d ed, p954%29%%A%    
% 224.37/224.56  |- skos__prefLabel mesh__D017573 Focal Epithelial Hyperplasia
% 224.37/224.56  |- skos__hiddenLabel mesh__D017573 Epithelial Hyperplasia, Focal
% 224.37/224.56  |- mesh__recordAuthorizer mesh__D017573 sjn
% 224.37/224.56  |- skos__hiddenLabel mesh__D017573 Disease, Heck%27%s
% 224.37/224.56  |- skos__hiddenLabel mesh__D017573 Disease, Heck
% 224.37/224.56  |- skos__historyNote mesh__D017573 Hyperplasia %28%1966-1993%29%
% 224.37/224.56  |- mesh__publicMeSHNote mesh__D017573 94   
% 224.37/224.56  |- mesh__historyNote mesh__D017573 94   
% 224.37/224.56  |- skos__hiddenLabel mesh__D017573 Hecks Disease
% 224.37/224.56  |- mesh__dateRevised mesh__D017573 2004-07-13
% 224.37/224.56  |- skos__annotation mesh__D017573 a mouth dis; DF: note short X ref   
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D017573 2005
% 224.37/224.56  |- skos__historyNote mesh__D017573 Mouth Diseases %28%1966-1993%29%
% 224.37/224.56  |- rdf__type mesh__D017573sskos__Concept
% 224.37/224.56  |- mesh__recordOriginator mesh__D017573 TGC
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D017573 2006
% 224.37/224.56  |- skos__altLabel mesh__D017573 Heck Disease
% 224.37/224.56  |- skos__hiddenLabel mesh__D017573 Focal Epithelial Hyperplasias
% 224.37/224.56  |- mesh__dateEstablished mesh__D017573 1994-01-01
% 224.37/224.56  |- skos__hiddenLabel mesh__D017573 Epithelial Hyperplasias, Focal
% 224.37/224.56  |- skos__altLabel mesh__D017573 Heck%27%s Disease
% 224.37/224.56  |- mesh__recordMaintainer mesh__D017573 sjn
% 224.37/224.56  |- mesh__dateCreated mesh__D017573 1992-12-28
% 224.37/224.56  |- rdf__type mesh__D031244sskos__Concept
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D031244 2004
% 224.37/224.56  |- skos__broader mesh__D031244smesh__D029748
% 224.37/224.56  |- mesh__historyNote mesh__D031244 2003   
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D031244 2005
% 224.37/224.56  |- skos__annotation mesh__D031244
% 224.37/224.56       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.37/224.56  |- mesh__publicMeSHNote mesh__D031244 2003   
% 224.37/224.56  |- skos__prefLabel mesh__D031244 Lychnis
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D031244 2006
% 224.37/224.56  |- skos__scopeNote mesh__D031244
% 224.37/224.56       A plant genus of the family CARYOPHYLLACEAE. The common name %22%Campion%22% is also used with SILENE.%A%    
% 224.37/224.56  |- mesh__dateCreated mesh__D031244 2002-07-03
% 224.37/224.56  |- mesh__dateEstablished mesh__D031244 2003-01-01
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D031244 2003
% 224.37/224.56  |- skos__prefLabel mesh__D003553 Cystine
% 224.37/224.56  |- skos__broader mesh__D003553smesh__D000599
% 224.37/224.56  |- skos__annotation mesh__D003553 do not confuse with CYSTEINE   
% 224.37/224.56  |- mesh__recordMaintainer mesh__D003553 ssb
% 224.37/224.56  |- mesh__dateRevised mesh__D003553 2005-06-30
% 224.37/224.56  |- rdf__type mesh__D003553sskos__Concept
% 224.37/224.56  |- mesh__dateCreated mesh__D003553 1999-01-01
% 224.37/224.56  |- skos__altLabel mesh__D003553 L-Cystine
% 224.37/224.56  |- skos__broader mesh__D003553smesh__D000600
% 224.37/224.56  |- mesh__recordAuthorizer mesh__D003553 sjn
% 224.37/224.56  |- skos__broader mesh__D003553smesh__D003545
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D003553 2006
% 224.37/224.56  |- mesh__recordOriginator mesh__D003553 NLM
% 224.37/224.56  |- skos__scopeNote mesh__D003553
% 224.37/224.56       A covalently linked dimeric nonessential amino acid formed by the oxidation of CYSTEINE. Two molecules of cysteine are joined together by a disulfide bridge to form cystine.%A%    
% 224.37/224.56  |- skos__broader mesh__D003553smesh__D004220
% 224.37/224.56  |- skos__hiddenLabel mesh__D003553 L Cystine
% 224.37/224.56  |- mesh__recordOriginator mesh__D013981 NLM
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D013981 2002
% 224.37/224.56  |- skos__annotation mesh__D013981
% 224.37/224.56       TICS is available; TIC DOULOUREUX see TRIGEMINAL NEURALGIA is also available%A%  
% 224.37/224.56  |- skos__hiddenLabel mesh__D013981 Transient Tic Disorders
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D013981 2003
% 224.37/224.56  |- skos__altLabel mesh__D013981 Tic Disorder, Post-Traumatic
% 224.37/224.56  |- mesh__publicMeSHNote mesh__D013981 1998; see Tic 1966-1997   
% 224.37/224.56  |- skos__hiddenLabel mesh__D013981 Tic Disorder, Vocal
% 224.37/224.56  |- skos__hiddenLabel mesh__D013981 Tic Disorder, Motor
% 224.37/224.56  |- skos__hiddenLabel mesh__D013981 Post Traumatic Tic Disorder
% 224.37/224.56  |- skos__broader mesh__D013981smesh__D019952
% 224.37/224.56  |- skos__hiddenLabel mesh__D013981 Motor Tic Disorder
% 224.37/224.56  |- skos__hiddenLabel mesh__D013981 Post-Traumatic Tic Disorders
% 224.37/224.56  |- skos__hiddenLabel mesh__D013981 Childhood Tic Disorder
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D013981 2001
% 224.37/224.56  |- skos__hiddenLabel mesh__D013981 Tic Disorder, Post Traumatic
% 224.37/224.56  |- mesh__recordMaintainer mesh__D013981 ags
% 224.37/224.56  |- skos__hiddenLabel mesh__D013981 Tic Disorders, Transient
% 224.37/224.56  |- skos__hiddenLabel mesh__D013981 Tic Disorder, Childhood
% 224.37/224.56  |- skos__altLabel mesh__D013981 Tic Disorders, Childhood
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D013981 2006
% 224.37/224.56  |- skos__altLabel mesh__D013981 Vocal Tic Disorders
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D013981 2000
% 224.37/224.56  |- mesh__dateCreated mesh__D013981 1999-01-01
% 224.37/224.56  |- mesh__historyNote mesh__D013981 1998%28%1966%29%   
% 224.37/224.56  |- skos__scopeNote mesh__D013981
% 224.37/224.56       Disorders characterized by recurrent TICS that may interfere with speech and other activities. Tics are sudden, rapid, nonrhythmic, stereotyped motor movements or vocalizations which may be exacerbated by stress and are generally attenuated during absorbing activities. Tic disorders are distinguished from conditions which feature other types of abnormal movements that may accompany general medical conditions. %28%From DSM-IV, 1994%29%%A%    
% 224.37/224.56  |- skos__altLabel mesh__D013981 Motor or Vocal Tic Disorder, Chronic
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D013981 2000A
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D013981 2005
% 224.37/224.56  |- mesh__recordAuthorizer mesh__D013981 ags
% 224.37/224.56  |- skos__altLabel mesh__D013981 Tic Disorder, Transient
% 224.37/224.56  |- skos__hiddenLabel mesh__D013981 Tic Disorder
% 224.37/224.56  |- skos__hiddenLabel mesh__D013981 Tic Disorders, Post-Traumatic
% 224.37/224.56  |- skos__prefLabel mesh__D013981 Tic Disorders
% 224.37/224.56  |- rdf__type mesh__D013981sskos__Concept
% 224.37/224.56  |- skos__altLabel mesh__D013981 Tic Disorders, Motor
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D013981 2004
% 224.37/224.56  |- skos__altLabel mesh__D013981 Tic Disorder, Chronic Motor or Vocal
% 224.37/224.56  |- skos__broader mesh__D013981smesh__D009069
% 224.37/224.56  |- skos__hiddenLabel mesh__D013981 Vocal Tic Disorder
% 224.37/224.56  |- mesh__dateRevised mesh__D013981 1999-12-08
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D013183 2006
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D013183 2002
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D013183 2004
% 224.37/224.56  |- skos__scopeNote mesh__D013183
% 224.37/224.56       Material coughed up from the lungs and expectorated via the mouth. It contains MUCUS, cellular debris, and microorganisms. It may also contain blood or pus.%A%    
% 224.37/224.56  |- skos__broader mesh__D013183smesh__D012634
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D013183 2005
% 224.37/224.56  |- mesh__dateRevised mesh__D013183 1999-11-03
% 224.37/224.56  |- skos__prefLabel mesh__D013183 Sputum
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D013183 2003
% 224.37/224.56  |- mesh__dateCreated mesh__D013183 1999-01-01
% 224.37/224.56  |- mesh__recordOriginator mesh__D013183 NLM
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D013183 2001
% 224.37/224.56  |- skos__hiddenLabel mesh__D013183 Sputums
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D013183 2000
% 224.37/224.56  |- rdf__type mesh__D013183sskos__Concept
% 224.37/224.56  |- skos__related mesh__D013183smesh__D015916
% 224.37/224.56  |- mesh__recordMaintainer mesh__D013183 KEV
% 224.37/224.56  |- mesh__recordAuthorizer mesh__D013183 sjn
% 224.37/224.56  |- skos__historyNote mesh__D007146 Gamma Globulins %28%1966-1971%29%
% 224.37/224.56  |- skos__hiddenLabel mesh__D007146 Light Chain, lambda-Immunoglobulin
% 224.37/224.56  |- mesh__dateRevised mesh__D007146 2005-07-30
% 224.37/224.56  |- mesh__recordMaintainer mesh__D007146 jls
% 224.37/224.56  |- skos__hiddenLabel mesh__D007146 lambda x Immunoglobulin
% 224.37/224.56  |- skos__altLabel mesh__D007146 lambda-Chain Immunoglobulins
% 224.37/224.56  |- skos__hiddenLabel mesh__D007146 lambda 2 Immunoglobulin
% 224.37/224.56  |- skos__hiddenLabel mesh__D007146 Immunoglobulin lambda Chains
% 224.37/224.56  |- skos__hiddenLabel mesh__D007146 lambda Immunoglobulin Light Chains
% 224.37/224.56  |- mesh__dateCreated mesh__D007146 1999-01-01
% 224.37/224.56  |- mesh__publicMeSHNote mesh__D007146
% 224.37/224.56       2006; see IMMUNOGLOBULINS, LAMBDA-CHAIN 1992-2005, see IMMUNOGLOBULINS, LAMBDA CHAIN 1986-1991, see IMMUNOGLOBULINS, LIGHT CHAIN 1975-1985, see IMMUNOGLOBULIN FRAGMENTS 1973-1974%A%  
% 224.37/224.56  |- skos__altLabel mesh__D007146 Immunoglobulins, lambda-Chain
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D007146 2006
% 224.37/224.56  |- skos__altLabel mesh__D007146 lambda-Immunoglobulin Light Chains
% 224.37/224.56  |- skos__prefLabel mesh__D007146 Immunoglobulin lambda-Chains
% 224.37/224.56  |- skos__historyNote mesh__D007146
% 224.37/224.56       Immunoglobulin Fragments %28%1973-1974%29%
% 224.37/224.56  |- skos__hiddenLabel mesh__D007146 lambda Immunoglobulin Light Chain
% 224.37/224.56  |- skos__historyNote mesh__D007146 Immunoglobulins %28%1972%29%
% 224.37/224.56  |- skos__hiddenLabel mesh__D007146 lambda 1 Immunoglobulin
% 224.37/224.56  |- skos__hiddenLabel mesh__D007146 lambda-Chains, Immunoglobulin
% 224.37/224.56  |- skos__hiddenLabel mesh__D007146 Immunoglobulin, lambda-x
% 224.37/224.56  |- skos__broader mesh__D007146smesh__D007147
% 224.37/224.56  |- skos__hiddenLabel mesh__D007146 lambda-Chain, Immunoglobulin
% 224.37/224.56  |- skos__hiddenLabel mesh__D007146 Immunoglobulin lambda Chain
% 224.37/224.56  |- skos__hiddenLabel mesh__D007146 lambda Chain Immunoglobulins
% 224.37/224.56  |- mesh__recordOriginator mesh__D007146 NLM
% 224.37/224.56  |- skos__annotation mesh__D007146
% 224.37/224.56       gammopathy: coordinate IMMUNOGLOBULIN LAMBDA-CHAINS %28%IM%29% with PARAPROTEINEMIAS %28%IM%29% but consider also HYPERGAMMAGLOBULINEMIA %28%IM%29%, follow text; DF: IG LAMBDA CHAIN%A%  
% 224.37/224.56  |- skos__hiddenLabel mesh__D007146 Immunoglobulins, lambda Chain
% 224.37/224.56  |- skos__altLabel mesh__D007146 Immunoglobulin lambda-Chain
% 224.37/224.56  |- rdf__type mesh__D007146sskos__Concept
% 224.37/224.56  |- mesh__historyNote mesh__D007146 2006 %28%1973%29%   
% 224.37/224.56  |- skos__hiddenLabel mesh__D007146 Light Chains, lambda-Immunoglobulin
% 224.37/224.56  |- mesh__recordAuthorizer mesh__D007146 jls
% 224.37/224.56  |- skos__scopeNote mesh__D007146
% 224.37/224.56       One of the types of light chain subunits of the immunoglobulins with a molecular weight of approximately 22 kDa.%A%    
% 224.37/224.56  |- skos__hiddenLabel mesh__D007146 Chains, lambda-Immunoglobulin Light
% 224.37/224.56  |- mesh__dateEstablished mesh__D007146 1987-01-01
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D007146 2006A
% 224.37/224.56  |- skos__altLabel mesh__D007146 lambda-Immunoglobulin Light Chain
% 224.37/224.56  |- skos__hiddenLabel mesh__D012889 Skunk, Spotted
% 224.37/224.56  |- skos__hiddenLabel mesh__D012889 Skunks, Striped
% 224.37/224.56  |- skos__hiddenLabel mesh__D012889 Skunks, Hog-nosed
% 224.37/224.56  |- skos__hiddenLabel mesh__D012889 Hog-nosed Skunk
% 224.37/224.56  |- skos__hiddenLabel mesh__D012889 Skunk, Hog-nosed
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D012889 2006
% 224.37/224.56  |- skos__prefLabel mesh__D012889 Mephitidae
% 224.37/224.56  |- skos__hiddenLabel mesh__D012889 Hog nosed Skunks
% 224.37/224.56  |- skos__hiddenLabel mesh__D012889 Striped Skunk
% 224.37/224.56  |- skos__altLabel mesh__D012889 Skunks
% 224.37/224.56  |- skos__hiddenLabel mesh__D012889 Skunk, Hooded
% 224.37/224.56  |- skos__scopeNote mesh__D012889
% 224.37/224.56       The family of omnivorous New World skunks, showing typical warning coloration of patterned black and white and able to eject a malodorous secretion when the animal is startled or in danger.%A%    
% 224.37/224.56  |- skos__hiddenLabel mesh__D012889 Skunk
% 224.37/224.56  |- rdf__type mesh__D012889sskos__Concept
% 224.37/224.56  |- skos__hiddenLabel mesh__D012889 Skunks, Hooded
% 224.37/224.56  |- skos__altLabel mesh__D012889 Spilogalae
% 224.37/224.56  |- mesh__dateCreated mesh__D012889 1974-12-12
% 224.37/224.56  |- skos__hiddenLabel mesh__D012889 Skunk, Striped
% 224.37/224.56  |- mesh__dateEstablished mesh__D012889 1991-01-01
% 224.37/224.56  |- skos__hiddenLabel mesh__D012889 Skunks, Spotted
% 224.37/224.56  |- mesh__recordAuthorizer mesh__D012889 sjn
% 224.37/224.56  |- skos__broader mesh__D012889smesh__D002335
% 224.37/224.56  |- mesh__recordOriginator mesh__D012889 NLM
% 224.37/224.56  |- mesh__publicMeSHNote mesh__D012889
% 224.37/224.56       2005; see SKUNKS 1991-2004, see CARNIVORA 1975-1990   
% 224.37/224.56  |- skos__hiddenLabel mesh__D012889 Spotted Skunk
% 224.37/224.56  |- skos__hiddenLabel mesh__D012889 Hooded Skunk
% 224.37/224.56  |- skos__altLabel mesh__D012889 Conepatus
% 224.37/224.56  |- mesh__dateRevised mesh__D012889 2004-07-07
% 224.37/224.56  |- mesh__recordMaintainer mesh__D012889 ags
% 224.37/224.56  |- mesh__historyNote mesh__D012889 2005 %28%1975%29%   
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D012889 2005
% 224.37/224.56  |- skos__historyNote mesh__D045265 Peptides %28%1976-2003%29%
% 224.37/224.56  |- mesh__dateEstablished mesh__D045265 2004-01-01
% 224.37/224.56  |- skos__scopeNote mesh__D045265
% 224.37/224.56       Peptides that regulate the WATER-ELECTROLYTE BALANCE in the body, also known as natriuretic peptide hormones. Several have been sequenced %28%ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; C-TYPE NATRIURETIC PEPTIDE%29%.%A%    
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D045265 2004
% 224.37/224.56  |- mesh__historyNote mesh__D045265 2004   
% 224.37/224.56  |- mesh__dateCreated mesh__D045265 2003-07-09
% 224.37/224.56  |- skos__altLabel mesh__D045265 Natriuretic Peptide Hormones
% 224.37/224.56  |- skos__hiddenLabel mesh__D045265 Peptide Hormones, Natriuretic
% 224.37/224.56  |- rdf__type mesh__D045265sskos__Concept
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D045265 2006
% 224.37/224.56  |- mesh__publicMeSHNote mesh__D045265 2004   
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D045265 2005
% 224.37/224.56  |- skos__historyNote mesh__D045265 Natriuresis %28%1976-2003%29%
% 224.37/224.56  |- skos__hiddenLabel mesh__D045265 Peptides, Natriuretic
% 224.37/224.56  |- skos__prefLabel mesh__D045265 Natriuretic Peptides
% 224.37/224.56  |- skos__broader mesh__D045265smesh__D036361
% 224.37/224.56  |- mesh__dateEstablished mesh__D017574 1994-01-01
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D017574 2005
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D017574 2004
% 224.37/224.56  |- skos__hiddenLabel mesh__D017574 Parasystoles
% 224.37/224.56  |- skos__broader mesh__D017574smesh__D001145
% 224.37/224.56  |- mesh__recordOriginator mesh__D017574 TGC
% 224.37/224.56  |- skos__prefLabel mesh__D017574 Parasystole
% 224.37/224.56  |- mesh__dateRevised mesh__D017574 2003-07-25
% 224.37/224.56  |- skos__annotation mesh__D017574
% 224.37/224.56       a type of arrhythmia; IM; coord with HEART ATRIUM; HEART VENTRICLES or other site in heart %28%NIM%29% if pertinent; sinus parasystole: coord IM with ARRHYTHMIA, SINUS %28%IM%29%%A%  
% 224.37/224.56  |- skos__historyNote mesh__D017574 Arrhythmia %28%1966-1993%29%
% 224.37/224.56  |- mesh__historyNote mesh__D017574 94   
% 224.37/224.56  |- mesh__recordAuthorizer mesh__D017574 sjn
% 224.37/224.56  |- mesh__publicMeSHNote mesh__D017574 94   
% 224.37/224.56  |- mesh__recordMaintainer mesh__D017574 sjn
% 224.37/224.56  |- mesh__dateCreated mesh__D017574 1992-12-28
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D017574 2006
% 224.37/224.56  |- skos__scopeNote mesh__D017574
% 224.37/224.56       A cardiac arrhythmia caused by the interaction of two foci independently initiating cardiac impulses at different rates. Generally one of the foci is the sinoatrial node %28%the normal pacemaker%29% and the ectopic focus is usually in the ventricle, but can occur in the sinus and AV nodes, atrium and ventricle, and AV junction. Each focus - and thus each rhythm - is protected from the influence of the other.%A%    
% 224.37/224.56  |- rdf__type mesh__D017574sskos__Concept
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D031245 2005
% 224.37/224.56  |- skos__broader mesh__D031245smesh__D029748
% 224.37/224.56  |- skos__scopeNote mesh__D031245
% 224.37/224.56       A plant genus of the family CARYOPHYLLACEAE. The common name %22%Soapwort%22% is also used with SAPONARIA.%A%    
% 224.37/224.56  |- skos__annotation mesh__D031245
% 224.37/224.56       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.37/224.56  |- mesh__publicMeSHNote mesh__D031245 2003   
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D031245 2006
% 224.37/224.56  |- skos__prefLabel mesh__D031245 Vaccaria
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D031245 2003
% 224.37/224.56  |- mesh__historyNote mesh__D031245 2003   
% 224.37/224.56  |- rdf__type mesh__D031245sskos__Concept
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D031245 2004
% 224.37/224.56  |- mesh__dateCreated mesh__D031245 2002-07-03
% 224.37/224.56  |- mesh__dateEstablished mesh__D031245 2003-01-01
% 224.37/224.56  |- skos__hiddenLabel mesh__D003554 Cystinoses
% 224.37/224.56  |- mesh__recordOriginator mesh__D003554 NLM
% 224.37/224.56  |- skos__scopeNote mesh__D003554
% 224.37/224.56       Lysosomal storage disorders of unknown molecular defect, characterized by widespread deposition of cystine crystals in reticuloendothelial cells. %28%From Dorland, 27th ed%29%%A%    
% 224.37/224.56  |- rdf__type mesh__D003554sskos__Concept
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D003554 2002
% 224.37/224.56  |- mesh__dateCreated mesh__D003554 1999-01-01
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D003554 2003
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D003554 2005
% 224.37/224.56  |- skos__broader mesh__D003554smesh__D015499
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D003554 2004
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D003554 2006
% 224.37/224.56  |- skos__prefLabel mesh__D003554 Cystinosis
% 224.37/224.56  |- mesh__dateRevised mesh__D003554 2001-07-25
% 224.37/224.56  |- mesh__recordMaintainer mesh__D003554 nns
% 224.37/224.56  |- skos__annotation mesh__D003554
% 224.37/224.56       a lysosomal storage dis; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES inf%A%  
% 224.37/224.56  |- mesh__recordAuthorizer mesh__D003554 sjn
% 224.37/224.56  |- skos__altLabel mesh__D013982
% 224.37/224.56       GlaxoSmithKline Brand of Ticarcillin Disodium
% 224.37/224.56  |- skos__historyNote mesh__D013982 Thiophenes %28%1973-1974%29%
% 224.37/224.56  |- skos__broader mesh__D013982smesh__D010406
% 224.37/224.56  |- mesh__historyNote mesh__D013982
% 224.37/224.56       91%28%75%29%; was see under PENICILLINS 1975-90   
% 224.37/224.56  |- mesh__publicMeSHNote mesh__D013982
% 224.37/224.56       91; was see under PENICILLINS 1975-90   
% 224.37/224.56  |- skos__hiddenLabel mesh__D013982 Disodium, Ticarcillin
% 224.37/224.56  |- skos__hiddenLabel mesh__D013982 BRL2288
% 224.37/224.56  |- rdf__type mesh__D013982sskos__Concept
% 224.37/224.56  |- skos__altLabel mesh__D013982 Ticarpen
% 224.37/224.56  |- skos__altLabel mesh__D013982
% 224.37/224.56       SmithKline Beecham Brand of Ticarcillin Disodium
% 224.37/224.56  |- mesh__recordMaintainer mesh__D013982 CCR
% 224.37/224.56  |- mesh__recordAuthorizer mesh__D013982 sjn
% 224.37/224.56  |- mesh__dateCreated mesh__D013982 1974-11-19
% 224.37/224.56  |- skos__prefLabel mesh__D013982 Ticarcillin
% 224.37/224.56  |- mesh__recordOriginator mesh__D013982 NLM
% 224.37/224.56  |- skos__scopeNote mesh__D013982
% 224.37/224.56       An antibiotic derived from penicillin similar to CARBENICILLIN in action.%A%    
% 224.37/224.56  |- mesh__dateRevised mesh__D013982 2005-06-30
% 224.37/224.56  |- skos__altLabel mesh__D013982 CSL Brand of Ticarcillin Disodium
% 224.37/224.56  |- skos__altLabel mesh__D013982 Tarcil
% 224.37/224.56  |- mesh__dateEstablished mesh__D013982 1991-01-01
% 224.37/224.56  |- skos__hiddenLabel mesh__D013982 BRL 2288
% 224.37/224.56  |- skos__historyNote mesh__D013982 Carboxylic Acids %28%1973-1974%29%
% 224.37/224.56  |- skos__historyNote mesh__D013982 Penicillins %28%1973-1974%29%
% 224.37/224.56  |- mesh__activeMeSHYear mesh__D013982 2006
% 224.37/224.56  |- skos__altLabel mesh__D013184 S-18506
% 224.37/224.56  |- mesh__recordMaintainer mesh__D013184 ssb
% 224.37/224.56  |- skos__prefLabel mesh__D013184
% 224.37/224.56       5-Amino-3-%28%%28%5-nitro-2-furyl%29%vinyl%29%-1,2,4-oxadiazole
% 224.37/224.56  |- skos__historyNote mesh__D013184 Nitrofurans %28%1972-1974%29%
% 224.37/224.57  |- mesh__dateRevised mesh__D013184 2005-06-30
% 224.37/224.57  |- mesh__dateEstablished mesh__D013184 1991-01-01
% 224.37/224.57  |- rdf__type mesh__D013184sskos__Concept
% 224.37/224.57  |- mesh__dateCreated mesh__D013184 1974-11-19
% 224.37/224.57  |- mesh__recordAuthorizer mesh__D013184 sjn
% 224.37/224.57  |- skos__altLabel mesh__D013184 SQ 18 506
% 224.37/224.57  |- skos__historyNote mesh__D013184 Oxadiazoles %28%1972-1974%29%
% 224.37/224.57  |- skos__hiddenLabel mesh__D013184 SQ 18506
% 224.37/224.57  |- skos__altLabel mesh__D013184 SQ18506
% 224.37/224.57  |- skos__broader mesh__D013184smesh__D010069
% 224.37/224.57  |- skos__hiddenLabel mesh__D013184 S18506
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013184 2006
% 224.37/224.57  |- skos__scopeNote mesh__D013184
% 224.37/224.57       A nitrovinyl furan used as a schistosomicidal agent and proposed for trypanosomiasis, especially Chagas disease.%A%    
% 224.37/224.57  |- mesh__publicMeSHNote mesh__D013184
% 224.37/224.57       2005; see SQ-19506 1991-2004; see NITROFURANS 1975-1990   
% 224.37/224.57  |- mesh__historyNote mesh__D013184 2005%28%1975%29%   
% 224.37/224.57  |- mesh__recordOriginator mesh__D013184 NLM
% 224.37/224.57  |- skos__hiddenLabel mesh__D013184 S 18506
% 224.37/224.57  |- skos__historyNote mesh__D013184 Vinyl Compounds %28%1972-1974%29%
% 224.37/224.57  |- skos__broader mesh__D013184smesh__D009581
% 224.37/224.57  |- mesh__recordMaintainer mesh__D007945 TGC
% 224.37/224.57  |- skos__hiddenLabel mesh__D007945 Leukemias, Lymphoid
% 224.37/224.57  |- skos__altLabel mesh__D007945 Leukemia, Lymphocytic, Large Granular
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D007945 2000
% 224.37/224.57  |- skos__hiddenLabel mesh__D007945 Lymphoblastic Leukemias
% 224.37/224.57  |- rdf__type mesh__D007945sskos__Concept
% 224.37/224.57  |- mesh__historyNote mesh__D007945
% 224.37/224.57       LEUKEMIA, LYMPHOBLASTIC was heading 1967-88   
% 224.37/224.57  |- skos__hiddenLabel mesh__D007945 Leukemias, Lymphoblastic
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D007945 2003
% 224.37/224.57  |- mesh__recordOriginator mesh__D007945 NLM
% 224.37/224.57  |- mesh__dateRevised mesh__D007945 1996-06-10
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D007945 2001
% 224.37/224.57  |- skos__altLabel mesh__D007945 Lymphoblastic Leukemia
% 224.37/224.57  |- skos__broader mesh__D007945smesh__D008232
% 224.37/224.57  |- mesh__recordAuthorizer mesh__D007945 PLS
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D007945 2005
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D007945 2004
% 224.37/224.57  |- skos__scopeNote mesh__D007945
% 224.37/224.57       Leukemia associated with hyperplasia and overactivity of the lymphoid tissue. There are increased numbers of circulating malignant lymphocytes and lymphoblasts. %28%Dorland, 28th ed, p919%29%%A%    
% 224.37/224.57  |- mesh__dateCreated mesh__D007945 1999-01-01
% 224.37/224.57  |- mesh__onlineNote mesh__D007945
% 224.37/224.57       use LEUKEMIA, LYMPHOCYTIC to search LEUKEMIA, LYMPHOBLASTIC 1967-88%A%  
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D007945 2006
% 224.37/224.57  |- skos__altLabel mesh__D007945 Leukemia, Lymphoblastic
% 224.37/224.57  |- skos__annotation mesh__D007945
% 224.37/224.57       GEN or unspecified: prefer specifics; do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 224.37/224.57  |- skos__broader mesh__D007945smesh__D007938
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D007945 2002
% 224.37/224.57  |- skos__hiddenLabel mesh__D007945 Lymphoid Leukemias
% 224.37/224.57  |- skos__altLabel mesh__D007945 Lymphocytic Leukemia
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D007945 1998
% 224.37/224.57  |- skos__prefLabel mesh__D007945 Leukemia, Lymphocytic
% 224.37/224.57  |- mesh__publicMeSHNote mesh__D007945
% 224.37/224.57       LEUKEMIA, LYMPHOBLASTIC was heading 1967-88   
% 224.37/224.57  |- skos__hiddenLabel mesh__D007945 Leukemias, Lymphocytic
% 224.37/224.57  |- skos__hiddenLabel mesh__D007945 Lymphocytic Leukemias
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D007945 1997
% 224.37/224.57  |- skos__altLabel mesh__D007945 Leukemia, Lymphoid
% 224.37/224.57  |- skos__altLabel mesh__D007945 Lymphoid Leukemia
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D007945 1999
% 224.37/224.57  |- rdf__type mesh__D007147sskos__Concept
% 224.37/224.57  |- skos__hiddenLabel mesh__D007147 Light Chains, Immunoglobulin
% 224.37/224.57  |- mesh__publicMeSHNote mesh__D007147
% 224.37/224.57       2006; see IMMUNOGLOBULINS, LIGHT-CHAIN 1992-2005, see IMMUNOGLOBULINS, LIGHT CHAIN 1976-1991%A%  
% 224.37/224.57  |- skos__altLabel mesh__D007147 Immunoglobulin Light-Chain
% 224.37/224.57  |- skos__broader mesh__D007147smesh__D050440
% 224.37/224.57  |- mesh__recordMaintainer mesh__D007147 nns
% 224.37/224.57  |- skos__historyNote mesh__D007147
% 224.37/224.57       Immunoglobulin Fragments %28%1973-1975%29%
% 224.37/224.57  |- mesh__dateEstablished mesh__D007147 1976-01-01
% 224.37/224.57  |- mesh__dateCreated mesh__D007147 1975-07-18
% 224.37/224.57  |- mesh__dateRevised mesh__D007147 2005-06-30
% 224.37/224.57  |- skos__altLabel mesh__D007147 Immunoglobulin Light Chain
% 224.37/224.57  |- skos__altLabel mesh__D007147 Immunoglobulins, Light-Chain
% 224.37/224.57  |- skos__hiddenLabel mesh__D007147 Light Chain Immunoglobulins
% 224.37/224.57  |- skos__hiddenLabel mesh__D007147 Immunoglobulins, Light Chain
% 224.37/224.57  |- mesh__recordOriginator mesh__D007147 RLS
% 224.37/224.57  |- mesh__historyNote mesh__D007147 2006 %28%1976%29%   
% 224.37/224.57  |- skos__hiddenLabel mesh__D007147 Light Chain, Immunoglobulin
% 224.37/224.57  |- skos__hiddenLabel mesh__D007147 Chains, Immunoglobulin Light
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D007147 2006
% 224.37/224.57  |- skos__hiddenLabel mesh__D007147 Light-Chain, Immunoglobulin
% 224.37/224.57  |- mesh__recordAuthorizer mesh__D007147 sjn
% 224.37/224.57  |- skos__altLabel mesh__D007147 Light-Chain Immunoglobulins
% 224.37/224.57  |- skos__annotation mesh__D007147
% 224.37/224.57       gammopathy: coordinate IMMUNOGLOBULIN LIGHT CHAINS %28%IM%29% with PARAPROTEINEMIAS %28%IM%29% but consider also HYPERGAMMAGLOBULINEMIA %28%IM%29%, follow text; DF: IG LIGHT CHAIN%A%  
% 224.37/224.57  |- skos__scopeNote mesh__D007147
% 224.37/224.57       Polypeptide chains, consisting of 211 to 217 amino acid residues and having a molecular weight of approximately 22 kDa. There are two major types of light chains, kappa and lambda. Two Ig light chains and two Ig heavy chains %28%IMMUNOGLOBULIN HEAVY CHAINS%29% make one immunoglobulin molecule.%A%    
% 224.37/224.57  |- skos__prefLabel mesh__D007147 Immunoglobulin Light Chains
% 224.37/224.57  |- skos__broader mesh__D026301smesh__D026201
% 224.37/224.57  |- mesh__recordOriginator mesh__D026301 ssb
% 224.37/224.57  |- mesh__recordAuthorizer mesh__D026301 ags
% 224.37/224.57  |- skos__scopeNote mesh__D026301
% 224.37/224.57       Musculoskeletal manipulation based on the principles of OSTEOPATHIC MEDICINE developed in 1874 by Dr Andrew Taylor Still.%A%    
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D026301 2006
% 224.37/224.57  |- mesh__dateEstablished mesh__D026301 2002-01-01
% 224.37/224.57  |- skos__prefLabel mesh__D026301 Manipulation, Osteopathic
% 224.37/224.57  |- skos__related mesh__D026301smesh__D026882
% 224.37/224.57  |- skos__related mesh__D026301smesh__D008349
% 224.37/224.57  |- mesh__recordMaintainer mesh__D026301 ags
% 224.37/224.57  |- mesh__dateRevised mesh__D026301 2005-07-12
% 224.37/224.57  |- mesh__historyNote mesh__D026301
% 224.37/224.57       2002; use MANIPULATION, ORTHOPEDIC 1987-2001   
% 224.37/224.57  |- mesh__dateCreated mesh__D026301 2001-07-25
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D026301 2006A
% 224.37/224.57  |- rdf__type mesh__D026301sskos__Concept
% 224.37/224.57  |- skos__historyNote mesh__D026301
% 224.37/224.57       Manipulation, Orthopedic %28%1986-2001%29%
% 224.37/224.57  |- skos__annotation mesh__D026301
% 224.37/224.57       do not confuse with OSTEOPATHIC MEDICINE, the specialty   
% 224.37/224.57  |- skos__altLabel mesh__D026301 Osteopathic Manipulation
% 224.37/224.57  |- mesh__publicMeSHNote mesh__D026301
% 224.37/224.57       2002; see MANIPULATION, ORTHOPEDIC 1987-2001   
% 224.37/224.57  |- rdf__type mesh__D045266sskos__Concept
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D045266 2006
% 224.37/224.57  |- mesh__historyNote mesh__D045266
% 224.37/224.57       2004; for CYTOCHROME A3 use MITOCHONDRIAL ELECTRON TRANSPORT COMPLEX IV 1981-2004%A%  
% 224.37/224.57  |- mesh__dateEstablished mesh__D045266 2004-01-01
% 224.37/224.57  |- skos__scopeNote mesh__D045266
% 224.37/224.57       A subclass of heme a containing cytochromes with an alpha-band absorption of 605 nm. They are found in a variety of microorganisms and in eukaryotes as a high-spin cytochrome component of MITOCHONDRIAL ELECTRON TRANSPORT COMPLEX IV.%A%    
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D045266 2005
% 224.37/224.57  |- skos__altLabel mesh__D045266 Ferrocytochrome a3
% 224.37/224.57  |- skos__altLabel mesh__D045266 Cytochrome a%28%3%29%
% 224.37/224.57  |- skos__altLabel mesh__D045266 Cytochrome a3
% 224.37/224.57  |- skos__historyNote mesh__D045266
% 224.37/224.57       Electron Transport Complex IV %28%1981-2003%29%
% 224.37/224.57  |- skos__prefLabel mesh__D045266 Cytochromes a3
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D045266 2004
% 224.37/224.57  |- mesh__publicMeSHNote mesh__D045266
% 224.37/224.57       2004; for CYTOCHROME A3 see CYTOCHROME-C OXIDASE 1981-2003%A%  
% 224.37/224.57  |- skos__broader mesh__D045266smesh__D017936
% 224.37/224.57  |- mesh__dateCreated mesh__D045266 2003-07-09
% 224.37/224.57  |- mesh__publicMeSHNote mesh__D017575 94   
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D017575 2003
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D017575 1999
% 224.37/224.57  |- skos__altLabel mesh__D017575 Protective Gloves
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D017575 2001
% 224.37/224.57  |- mesh__dateEstablished mesh__D017575 1994-01-01
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D017575 1998
% 224.37/224.57  |- skos__hiddenLabel mesh__D017575 Glove, Protective
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D017575 2000
% 224.37/224.57  |- skos__scopeNote mesh__D017575
% 224.37/224.57       Coverings for the hands, usually with separations for the fingers, made of various materials, for protection against infections, toxic substances, extremes of hot and cold, radiations, water immersion, etc. The gloves may be worn by patients, care givers, housewives, laboratory and industrial workers, police, etc.%A%    
% 224.37/224.57  |- mesh__historyNote mesh__D017575 94   
% 224.37/224.57  |- mesh__dateRevised mesh__D017575 1997-06-20
% 224.37/224.57  |- skos__hiddenLabel mesh__D017575 Protective Glove
% 224.37/224.57  |- mesh__recordOriginator mesh__D017575 TGC
% 224.37/224.57  |- mesh__dateCreated mesh__D017575 1992-12-28
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D017575 2006
% 224.37/224.57  |- rdf__type mesh__D017575sskos__Concept
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D017575 2002
% 224.37/224.57  |- mesh__recordMaintainer mesh__D017575 JLS
% 224.37/224.57  |- skos__prefLabel mesh__D017575 Gloves, Protective
% 224.37/224.57  |- skos__historyNote mesh__D017575 Protective Clothing %28%1970-1993%29%
% 224.37/224.57  |- skos__historyNote mesh__D017575 Clothing %28%1967-1990%29%
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D017575 2005
% 224.37/224.57  |- skos__annotation mesh__D017575
% 224.37/224.57       for patients, lab or indust workers, housewives, police, etc.; do not use /util except by MeSH definition; GLOVES, SURGICAL is also available%A%  
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D017575 2004
% 224.37/224.57  |- mesh__recordAuthorizer mesh__D017575 SJN
% 224.37/224.57  |- skos__broader mesh__D017575smesh__D011481
% 224.37/224.57  |- mesh__historyNote mesh__D031246 2003   
% 224.37/224.57  |- rdf__type mesh__D031246sskos__Concept
% 224.37/224.57  |- skos__broader mesh__D031246smesh__D019684
% 224.37/224.57  |- mesh__dateCreated mesh__D031246 2002-07-03
% 224.37/224.57  |- skos__annotation mesh__D031246
% 224.37/224.57       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.37/224.57  |- skos__scopeNote mesh__D031246
% 224.37/224.57       A plant family of the order Urticales, subclass Hamamelidae, class Magnoliopsida.%A%    
% 224.37/224.57  |- skos__prefLabel mesh__D031246 Cecropiaceae
% 224.37/224.57  |- mesh__publicMeSHNote mesh__D031246 2003   
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D031246 2006
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D031246 2004
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D031246 2005
% 224.37/224.57  |- mesh__dateEstablished mesh__D031246 2003-01-01
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D031246 2003
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D003555 2002
% 224.37/224.57  |- mesh__recordMaintainer mesh__D003555 nns
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D003555 2005
% 224.37/224.57  |- skos__scopeNote mesh__D003555
% 224.37/224.57       An inherited abnormality of renal tubular transport of dibasic amino acids leading to massive urinary excretion of cystine, lysine, arginine, and ornithine.%A%    
% 224.37/224.57  |- skos__annotation mesh__D003555
% 224.37/224.57       a form of aminoaciduria; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 224.37/224.57  |- skos__hiddenLabel mesh__D003555 Cystinurias
% 224.37/224.57  |- mesh__recordAuthorizer mesh__D003555 sjn
% 224.37/224.57  |- rdf__type mesh__D003555sskos__Concept
% 224.37/224.57  |- mesh__recordOriginator mesh__D003555 NLM
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D003555 2004
% 224.37/224.57  |- skos__prefLabel mesh__D003555 Cystinuria
% 224.37/224.57  |- skos__broader mesh__D003555smesh__D000608
% 224.37/224.57  |- mesh__dateCreated mesh__D003555 1999-01-01
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D003555 2003
% 224.37/224.57  |- mesh__dateRevised mesh__D003555 2001-07-25
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D003555 2006
% 224.37/224.57  |- skos__hiddenLabel mesh__D008240
% 224.37/224.57       2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine
% 224.37/224.57  |- skos__hiddenLabel mesh__D008240 Dioxygenase, Lysine 2-Oxoglutarate
% 224.37/224.57  |- skos__historyNote mesh__D008240 Ketoglutaric Acids %28%1966-1976%29%
% 224.37/224.57  |- skos__hiddenLabel mesh__D008240 Hydroxylase, Lysine
% 224.37/224.57  |- mesh__recordMaintainer mesh__D008240 ssb
% 224.37/224.57  |- mesh__publicMeSHNote mesh__D008240
% 224.37/224.57       92; was LYSINE HYDROXYLASE 1977-91 %28%see under HYDROXYLASES 1977-90%29%%A%  
% 224.37/224.57  |- skos__annotation mesh__D008240 DF: note short X ref   
% 224.37/224.57  |- skos__prefLabel mesh__D008240
% 224.37/224.57       Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase
% 224.37/224.57  |- skos__historyNote mesh__D008240 Hydroxylases %28%1966-1976%29%
% 224.37/224.57  |- mesh__recordOriginator mesh__D008240 RLS
% 224.37/224.57  |- skos__broader mesh__D008240smesh__D006899
% 224.37/224.57  |- skos__altLabel mesh__D008240 Lysine 2-Oxoglutarate Dioxygenase
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D008240 2006
% 224.37/224.57  |- skos__hiddenLabel mesh__D008240
% 224.37/224.57       Procollagen Lysine, 2 Oxoglutarate 5 Dioxygenase
% 224.37/224.57  |- skos__hiddenLabel mesh__D008240
% 224.37/224.57       5-Dioxygenase Procollagen-Lysine, 2-Oxoglutarate
% 224.37/224.57  |- skos__historyNote mesh__D008240 Lysine %28%1966-1976%29%
% 224.37/224.57  |- skos__hiddenLabel mesh__D008240 Hydroxylase, Lysyl
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D008240 2005
% 224.37/224.57  |- rdf__type mesh__D008240sskos__Concept
% 224.37/224.57  |- mesh__dateRevised mesh__D008240 2004-07-07
% 224.37/224.57  |- skos__altLabel mesh__D008240 Collagen Lysyl Hydroxylase
% 224.37/224.57  |- mesh__dateCreated mesh__D008240 1976-04-27
% 224.37/224.57  |- skos__hiddenLabel mesh__D008240 Lysine 2 Oxoglutarate Dioxygenase
% 224.37/224.57  |- skos__hiddenLabel mesh__D008240 Hydroxylase, Protocollagen Lysyl
% 224.37/224.57  |- skos__altLabel mesh__D008240 Lysyl Hydroxylase
% 224.37/224.57  |- mesh__onlineNote mesh__D008240
% 224.37/224.57       use PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE to search LYSINE HYDROXYLASE 1977-91%A%  
% 224.37/224.57  |- mesh__historyNote mesh__D008240
% 224.37/224.57       92; was LYSINE HYDROXYLASE 1977-91 %28%see under HYDROXYLASES 1977-90%29%%A%  
% 224.37/224.57  |- skos__hiddenLabel mesh__D008240 Hydroxylase, Collagen Lysyl
% 224.37/224.57  |- skos__altLabel mesh__D008240 Protocollagen Lysyl Hydroxylase
% 224.37/224.57  |- mesh__recordAuthorizer mesh__D008240 sjn
% 224.37/224.57  |- skos__altLabel mesh__D008240 Lysine Hydroxylase
% 224.37/224.57  |- mesh__dateEstablished mesh__D008240 1991-01-01
% 224.37/224.57  |- skos__scopeNote mesh__D008240
% 224.37/224.57       A mixed-function oxygenase that catalyzes the hydroxylation of peptidyllysine, usually in protocollagen, to peptidylhydroxylysine. The enzyme utilizes molecular oxygen with concomitant oxidative decarboxylation of the cosubstrate 2-oxoglutarate to succinate. EC 1.14.11.4.%A%    
% 224.37/224.57  |- skos__hiddenLabel mesh__D008240 2-Oxoglutarate Dioxygenase, Lysine
% 224.37/224.57  |- mesh__dateCreated mesh__D013983 1999-01-01
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013983 2005
% 224.37/224.57  |- mesh__historyNote mesh__D013983 73   
% 224.37/224.57  |- rdf__type mesh__D013983sskos__Concept
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013983 2002
% 224.37/224.57  |- skos__annotation mesh__D013983
% 224.37/224.57       chemicals killing or controlling ticks are indexed under INSECTICIDES, not PESTICIDES even though ticks are not insects; mite control can go here as MITES %28%IM%29% + TICK CONTROL %28%IM%29%%A%  
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013983 1996
% 224.37/224.57  |- mesh__dateEstablished mesh__D013983 1973-01-01
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013983 1995
% 224.37/224.57  |- mesh__publicMeSHNote mesh__D013983 73   
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013983 2004
% 224.37/224.57  |- skos__hiddenLabel mesh__D013983 Control, Tick
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013983 2001
% 224.37/224.57  |- skos__historyNote mesh__D013983 Ticks %28%1966-1972%29%
% 224.37/224.57  |- mesh__recordAuthorizer mesh__D013983 PLS
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013983 1994
% 224.37/224.57  |- mesh__recordMaintainer mesh__D013983 TGC
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013983 2003
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013983 1999
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013983 2000
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013983 1993
% 224.37/224.57  |- skos__broader mesh__D013983smesh__D010571
% 224.37/224.57  |- skos__prefLabel mesh__D013983 Tick Control
% 224.37/224.57  |- skos__historyNote mesh__D013983 Insect Control %28%1966-1972%29%
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013983 1998
% 224.37/224.57  |- mesh__recordOriginator mesh__D013983 NLM
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013983 2006
% 224.37/224.57  |- skos__hiddenLabel mesh__D013983 Control, Mite
% 224.37/224.57  |- skos__scopeNote mesh__D013983
% 224.37/224.57       Chemical, biological, or medical measures designed to prevent the spread of ticks or the concomitant infestations which result in tick-borne diseases. It includes the veterinary as well as the public health aspects of tick and mite control.%A%    
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013983 1997
% 224.37/224.57  |- skos__hiddenLabel mesh__D013983 Controls, Mite
% 224.37/224.57  |- mesh__dateRevised mesh__D013983 1992-05-22
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013185 2001
% 224.37/224.57  |- skos__broader mesh__D013185smesh__D011090
% 224.37/224.57  |- mesh__recordOriginator mesh__D013185 NLM
% 224.37/224.57  |- skos__prefLabel mesh__D013185 Squalene
% 224.37/224.57  |- mesh__recordAuthorizer mesh__D013185 PLS
% 224.37/224.57  |- rdf__type mesh__D013185sskos__Concept
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013185 2000
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013185 1995
% 224.37/224.57  |- mesh__dateRevised mesh__D013185 1992-05-20
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013185 2006
% 224.37/224.57  |- skos__broader mesh__D013185smesh__D014315
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013185 1994
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013185 1993
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013185 2005
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013185 2004
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013185 2002
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013185 1999
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013185 2003
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013185 1998
% 224.37/224.57  |- mesh__recordMaintainer mesh__D013185 TGC
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013185 1997
% 224.37/224.57  |- mesh__dateCreated mesh__D013185 1999-01-01
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D013185 1996
% 224.37/224.57  |- rdf__type mesh__D007946sskos__Concept
% 224.37/224.57  |- skos__broader mesh__D007946smesh__D034721
% 224.37/224.57  |- skos__altLabel mesh__D007946 Mast-Cell Leukemia
% 224.37/224.57  |- skos__hiddenLabel mesh__D007946 Leukemia, Mast Cell
% 224.37/224.57  |- skos__broader mesh__D007946smesh__D015470
% 224.37/224.57  |- skos__historyNote mesh__D007946 Mast Cells %28%1966-1986%29%
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D007946 2003
% 224.37/224.57  |- mesh__recordAuthorizer mesh__D007946 sjn
% 224.37/224.57  |- mesh__recordOriginator mesh__D007946 VDK
% 224.37/224.57  |- mesh__dateRevised mesh__D007946 2002-07-03
% 224.37/224.57  |- skos__hiddenLabel mesh__D007946 Leukemias, Mast-Cell
% 224.37/224.57  |- skos__broader mesh__D007946smesh__D007938
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D007946 2005
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D007946 2004
% 224.37/224.57  |- mesh__publicMeSHNote mesh__D007946
% 224.37/224.57       92; was LEUKEMIA, MAST CELL 1987-91   
% 224.37/224.57  |- mesh__recordMaintainer mesh__D007946 lkt
% 224.37/224.57  |- skos__scopeNote mesh__D007946
% 224.37/224.57       A form of  systemic mastocytosis %28%MASTOCYTOSIS, SYSTEMIC%29% characterized by the presence of large numbers of tissue MAST CELLS in the peripheral blood without skin lesions. It is a high-grade LEUKEMIA disease with bone marrow smear of %3E%20%25% MAST CELLS, multi-organ failure and a short survival.%A%    
% 224.37/224.57  |- skos__hiddenLabel mesh__D007946 Mast Cell Leukemia
% 224.37/224.57  |- mesh__historyNote mesh__D007946 92; was LEUKEMIA, MAST CELL 1987-91   
% 224.37/224.57  |- mesh__activeMeSHYear mesh__D007946 2006
% 224.37/224.57  |- skos__hiddenLabel mesh__D007946 Mast-Cell Leukemias
% 224.37/224.57  |- mesh__onlineNote mesh__D007946
% 224.37/224.57       use LEUKEMIA, MAST-CELL to search LEUKEMIA, MAST CELL 1987-91%A%  
% 224.37/224.57  |- mesh__dateCreated mesh__D007946 1986-03-27
% 224.37/224.57  |- skos__prefLabel mesh__D007946 Leukemia, Mast-Cell
% 224.37/224.57  |- mesh__dateEstablished mesh__D007946 1987-01-01
% 224.37/224.57  |- skos__historyNote mesh__D007946 Leukemia %28%1966-1986%29%
% 224.37/224.57  |- mesh__dateCreated mesh__D007148 1975-07-23
% 224.37/224.57  |- skos__prefLabel mesh__D007148 Immunoglobulin mu-Chains
% 224.37/224.57  |- skos__hiddenLabel mesh__D007148 Immunoglobulins, mu Chain
% 224.37/224.57  |- skos__hiddenLabel mesh__D007148 Immunoglobulin mu Chain
% 224.37/224.57  |- skos__altLabel mesh__D007148 mu Immunoglobulin Heavy Chains
% 224.37/224.58  |- skos__altLabel mesh__D007148 Immunoglobulin mu-Chain
% 224.37/224.58  |- skos__broader mesh__D007148smesh__D007075
% 224.37/224.58  |- mesh__dateRevised mesh__D007148 2005-07-15
% 224.37/224.58  |- mesh__recordAuthorizer mesh__D007148 ags
% 224.37/224.58  |- skos__hiddenLabel mesh__D007148 Immunoglobulin mu Chains
% 224.37/224.58  |- skos__historyNote mesh__D007148 IgM %28%1973-1975%29%
% 224.37/224.58  |- skos__broader mesh__D007148smesh__D007143
% 224.37/224.58  |- skos__hiddenLabel mesh__D007148 mu-Chain, Immunoglobulin
% 224.37/224.58  |- skos__altLabel mesh__D007148 mu-Chain Immunoglobulins
% 224.37/224.58  |- mesh__recordMaintainer mesh__D007148 ags
% 224.37/224.58  |- skos__hiddenLabel mesh__D007148 mu Chain Immunoglobulins
% 224.37/224.58  |- skos__historyNote mesh__D007148
% 224.37/224.58       Immunoglobulin Fragments %28%1973-1975%29%
% 224.37/224.58  |- skos__historyNote mesh__D007148
% 224.37/224.58       Immunoglobulins, Heavy Chain %28%1975%29%
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D007148 2006
% 224.37/224.58  |- skos__scopeNote mesh__D007148
% 224.37/224.58       The class of heavy chains found in IMMUNOGLOBULIN M. They have a molecular weight of approximately 72 kDa and they contain about 57 amino acid residues arranged in five domains and have more oligosaccharide branches and a higher carbohydrate content than the heavy chains of IMMUNOGLOBULIN G.%A%    
% 224.37/224.58  |- skos__altLabel mesh__D007148 Immunoglobulins, mu-Chain
% 224.37/224.58  |- mesh__recordOriginator mesh__D007148 RLS
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D007148 2006A
% 224.37/224.58  |- skos__annotation mesh__D007148
% 224.37/224.58       gammopathy: coordinate IMMUNOGLOBULIN MU-CHAINS %28%IM%29% with PARAPROTEINEMIAS %28%IM%29% but consider also HYPERGAMMAGLOBULINEMIA %28%IM%29% or HEAVY CHAIN DISEASE %28%IM%29%, follow text; for immunoglobulin C mu %28%IG C mu%29% coordinate with IMMUNOGLOBULIN CONSTANT REGION; DF: IG MU CHAIN%A%  
% 224.37/224.58  |- mesh__historyNote mesh__D007148 2006 %28%1976%29%   
% 224.37/224.58  |- rdf__type mesh__D007148sskos__Concept
% 224.37/224.58  |- skos__hiddenLabel mesh__D007148 mu-Chains, Immunoglobulin
% 224.37/224.58  |- mesh__dateEstablished mesh__D007148 1987-01-01
% 224.37/224.58  |- mesh__publicMeSHNote mesh__D007148
% 224.37/224.58       2006; see IMMUNOGLOBULINS, MU-CHAIN 1992-2005, see IMMUNOGLOBULINS, MU CHAIN 1987-1991, see IMMUNOGLOBULINS, HEAVY CHAIN 1976-1986%A%  
% 224.37/224.58  |- skos__altLabel mesh__D007148 mu Immunoglobulin Heavy Chain
% 224.37/224.58  |- skos__scopeNote mesh__D026302
% 224.37/224.58       One of the MARTIAL ARTS and also a form of meditative exercise using methodically slow circular stretching movements and positions of body balance.%A%    
% 224.37/224.58  |- skos__hiddenLabel mesh__D026302 Quan, Tai Ji
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D026302 2006
% 224.37/224.58  |- skos__broader mesh__D026302smesh__D026241
% 224.37/224.58  |- mesh__dateEstablished mesh__D026302 2002-01-01
% 224.37/224.58  |- skos__prefLabel mesh__D026302 Tai Ji
% 224.37/224.58  |- skos__altLabel mesh__D026302 Taijiquan
% 224.37/224.58  |- mesh__historyNote mesh__D026302 2002; use MARTIAL ARTS 1996-2001   
% 224.37/224.58  |- skos__altLabel mesh__D026302 Tai-ji
% 224.37/224.58  |- mesh__publicMeSHNote mesh__D026302 2002; see MARTIAL ARTS 1996-2001   
% 224.37/224.58  |- skos__historyNote mesh__D026302 Martial Arts %28%1996-2001%29%
% 224.37/224.58  |- rdf__type mesh__D026302sskos__Concept
% 224.37/224.58  |- skos__broader mesh__D026302smesh__D026441
% 224.37/224.58  |- skos__altLabel mesh__D026302 Tai Chi Chuan
% 224.37/224.58  |- mesh__dateRevised mesh__D026302 2002-07-31
% 224.37/224.58  |- skos__broader mesh__D026302smesh__D016139
% 224.37/224.58  |- skos__altLabel mesh__D026302 Taiji
% 224.37/224.58  |- skos__altLabel mesh__D026302 T%27%ai Chi
% 224.37/224.58  |- skos__altLabel mesh__D026302 Tai Ji Quan
% 224.37/224.58  |- mesh__dateCreated mesh__D026302 2001-07-25
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D026302 2003
% 224.37/224.58  |- mesh__recordAuthorizer mesh__D026302 sjn
% 224.37/224.58  |- skos__altLabel mesh__D026302 Tai Chi
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D026302 2005
% 224.37/224.58  |- mesh__recordOriginator mesh__D026302 ssb
% 224.37/224.58  |- skos__hiddenLabel mesh__D026302 Ji Quan, Tai
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D026302 2004
% 224.37/224.58  |- mesh__recordMaintainer mesh__D026302 mdb
% 224.37/224.58  |- skos__annotation mesh__D026302
% 224.37/224.58       do not confuse with %27%Taiji study%27% carried out in that region of Japan; do not confuse with Japanese interpretation of %22%Taiji%22% which means %27%embryo%27% or %27%fetus%27%%A%  
% 224.37/224.58  |- skos__hiddenLabel mesh__D026302 Chi, Tai
% 224.37/224.58  |- skos__altLabel mesh__D017576 Deptomycin
% 224.37/224.58  |- mesh__publicMeSHNote mesh__D017576
% 224.37/224.58       94; DAPTOMYCIN was indexed under PEPTIDES %26% ANTIBIOTICS 1987-93%A%  
% 224.37/224.58  |- skos__historyNote mesh__D017576 Peptides %28%1987-1993%29%
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D017576 2006
% 224.37/224.58  |- rdf__type mesh__D017576sskos__Concept
% 224.37/224.58  |- mesh__recordAuthorizer mesh__D017576 sjn
% 224.37/224.58  |- mesh__dateRevised mesh__D017576 2004-07-07
% 224.37/224.58  |- mesh__dateEstablished mesh__D017576 1994-01-01
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D017576 2005
% 224.37/224.58  |- mesh__historyNote mesh__D017576 94; was DAPTOMYCIN %28%NM%29% 1987-93   
% 224.37/224.58  |- skos__scopeNote mesh__D017576
% 224.37/224.58       A lipopeptide antibiotic that inhibits gram-positive bacteria.%A%    
% 224.37/224.58  |- skos__broader mesh__D017576smesh__D010456
% 224.37/224.58  |- mesh__dateCreated mesh__D017576 1993-02-16
% 224.37/224.58  |- skos__hiddenLabel mesh__D017576 Daptomycin, 9 L beta Aspartic Acid
% 224.37/224.58  |- mesh__recordMaintainer mesh__D017576 ssb
% 224.37/224.58  |- skos__prefLabel mesh__D017576 Daptomycin
% 224.37/224.58  |- mesh__onlineNote mesh__D017576
% 224.37/224.58       use DAPTOMYCIN %28%NM%29% to search DAPTOMYCIN 1987-93   
% 224.37/224.58  |- skos__historyNote mesh__D017576 Antibiotics %28%1987-1993%29%
% 224.37/224.58  |- mesh__recordOriginator mesh__D017576 TPW
% 224.37/224.58  |- mesh__dateEstablished mesh__D031247 2003-01-01
% 224.37/224.58  |- skos__annotation mesh__D031247
% 224.37/224.58       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.37/224.58  |- mesh__historyNote mesh__D031247 2003   
% 224.37/224.58  |- mesh__publicMeSHNote mesh__D031247 2003   
% 224.37/224.58  |- skos__broader mesh__D031247smesh__D029753
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D031247 2006
% 224.37/224.58  |- mesh__dateCreated mesh__D031247 2002-07-03
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D031247 2004
% 224.37/224.58  |- skos__scopeNote mesh__D031247
% 224.37/224.58       A plant genus of the family CELASTRACEAE that contains insecticidal sesquiterpenoids and celastrus oil.%A%    
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D031247 2005
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D031247 2003
% 224.37/224.58  |- skos__prefLabel mesh__D031247 Celastrus
% 224.37/224.58  |- rdf__type mesh__D031247sskos__Concept
% 224.37/224.58  |- skos__broader mesh__D003556smesh__D001745
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D003556 2002
% 224.37/224.58  |- skos__scopeNote mesh__D003556
% 224.37/224.58       Inflammation of the urinary bladder. %28%Dorland, 27th ed%29%%A%    
% 224.37/224.58  |- rdf__type mesh__D003556sskos__Concept
% 224.37/224.58  |- mesh__dateRevised mesh__D003556 1996-06-10
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D003556 2004
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D003556 1997
% 224.37/224.58  |- mesh__dateCreated mesh__D003556 1999-01-01
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D003556 2003
% 224.37/224.58  |- mesh__recordMaintainer mesh__D003556 PXP
% 224.37/224.58  |- mesh__recordOriginator mesh__D003556 NLM
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D003556 2001
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D003556 2006
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D003556 1999
% 224.37/224.58  |- mesh__recordAuthorizer mesh__D003556 PLS
% 224.37/224.58  |- skos__prefLabel mesh__D003556 Cystitis
% 224.37/224.58  |- skos__hiddenLabel mesh__D003556 Cystitides
% 224.37/224.58  |- skos__annotation mesh__D003556 inflamm of bladder   
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D003556 2000
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D003556 2005
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D003556 1998
% 224.37/224.58  |- mesh__dateRevised mesh__D008241 2001-07-25
% 224.37/224.58  |- mesh__recordAuthorizer mesh__D008241 sjn
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D008241 2006
% 224.37/224.58  |- skos__historyNote mesh__D008241 Dipeptides %28%1966-1978%29%
% 224.37/224.58  |- mesh__publicMeSHNote mesh__D008241 91; was see under LYSINE 1979-90   
% 224.37/224.58  |- mesh__dateCreated mesh__D008241 1978-03-09
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D008241 2005
% 224.37/224.58  |- rdf__type mesh__D008241sskos__Concept
% 224.37/224.58  |- skos__broader mesh__D008241smesh__D008239
% 224.37/224.58  |- mesh__recordMaintainer mesh__D008241 nns
% 224.37/224.58  |- mesh__recordOriginator mesh__D008241 RLS
% 224.37/224.58  |- skos__historyNote mesh__D008241 Lysine %28%1966-1978%29%
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D008241 2002
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D008241 2004
% 224.37/224.58  |- mesh__dateEstablished mesh__D008241 1991-01-01
% 224.37/224.58  |- skos__annotation mesh__D008241
% 224.37/224.58       %22%an unusual amino acid...found in proteins of cooked foods%22%%A%  
% 224.37/224.58  |- skos__prefLabel mesh__D008241 Lysinoalanine
% 224.37/224.58  |- skos__scopeNote mesh__D008241
% 224.37/224.58       N%28%6%29%-%28%2-Amino-2-carboxyethyl%29%-L-lysine. An unusual amino acid, not a dipeptide, which has been found in proteins of cooked foods. It is formed in food that is heated or treated with alkali. Has been implicated in nephrocytomegalia in rats.%A%    
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D008241 2003
% 224.37/224.58  |- mesh__historyNote mesh__D008241
% 224.37/224.58       91%28%79%29%; was see under LYSINE 1979-90   
% 224.37/224.58  |- skos__historyNote mesh__D008241 Alanine %28%1966-1978%29%
% 224.37/224.58  |- skos__broader mesh__D008241smesh__D000409
% 224.37/224.58  |- skos__broader mesh__D013984smesh__D004478
% 224.37/224.58  |- mesh__recordAuthorizer mesh__D013984 sjn
% 224.37/224.58  |- mesh__historyNote mesh__D013984 68   
% 224.37/224.58  |- mesh__dateEstablished mesh__D013984 1968-01-01
% 224.37/224.58  |- mesh__recordOriginator mesh__D013984 NLM
% 224.37/224.58  |- skos__hiddenLabel mesh__D013984 Tick Infestation
% 224.37/224.58  |- skos__historyNote mesh__D013984 Ticks %28%1966-1967%29%
% 224.37/224.58  |- mesh__recordMaintainer mesh__D013984 ags
% 224.37/224.58  |- mesh__dateRevised mesh__D013984 2005-06-30
% 224.37/224.58  |- skos__prefLabel mesh__D013984 Tick Infestations
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D013984 2006
% 224.37/224.58  |- mesh__publicMeSHNote mesh__D013984 68   
% 224.37/224.58  |- mesh__dateCreated mesh__D013984 1999-01-01
% 224.37/224.58  |- skos__scopeNote mesh__D013984
% 224.37/224.58       Infestations with soft-bodied %28%Argasidae%29% or hard-bodied %28%Ixodidae%29% ticks.%A%    
% 224.37/224.58  |- rdf__type mesh__D013984sskos__Concept
% 224.37/224.58  |- skos__hiddenLabel mesh__D013984 Infestation, Tick
% 224.37/224.58  |- skos__hiddenLabel mesh__D013984 Infestations, Tick
% 224.37/224.58  |- skos__altLabel mesh__D013186 Presqualene-Diphosphate Synthase
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D013186 2006A
% 224.37/224.58  |- skos__hiddenLabel mesh__D013186
% 224.37/224.58       Farnesyltransferase, Farnesyl-Diphosphate
% 224.37/224.58  |- skos__hiddenLabel mesh__D013186 Farnesyl Diphosphate Farnesyltransferase
% 224.37/224.58  |- mesh__historyNote mesh__D013186 2006%28%1975%29%   
% 224.37/224.58  |- rdf__type mesh__D013186sskos__Concept
% 224.37/224.58  |- skos__hiddenLabel mesh__D013186 Farnesyl Transferase, FPP-FPP
% 224.37/224.58  |- skos__prefLabel mesh__D013186 Farnesyl-Diphosphate Farnesyltransferase
% 224.37/224.58  |- skos__altLabel mesh__D013186 Squalene Synthase
% 224.37/224.58  |- skos__altLabel mesh__D013186 FPP-FPP Farnesyl Transferase
% 224.37/224.58  |- skos__historyNote mesh__D013186 Farnesol %28%1972-1974%29%
% 224.37/224.58  |- skos__hiddenLabel mesh__D013186 Presqualene Diphosphate Synthase
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D013186 2006
% 224.37/224.58  |- mesh__recordMaintainer mesh__D013186 ags
% 224.37/224.58  |- skos__hiddenLabel mesh__D013186 Synthase, Squalene
% 224.37/224.58  |- mesh__publicMeSHNote mesh__D013186
% 224.37/224.58       2006; see OXIDOREDUCTASES 1975-1990; FARNESYL-DIPHOSPHATE FARNESYLTRANSFERASE was indexed under OXIDOREDUCTASES %26% SQUALENE SYNTHETASE 1998-2001%A%  
% 224.37/224.58  |- skos__hiddenLabel mesh__D013186 Transferase, FPP-FPP Farnesyl
% 224.37/224.58  |- skos__hiddenLabel mesh__D013186 Synthase, Presqualene-Diphosphate
% 224.37/224.58  |- skos__hiddenLabel mesh__D013186
% 224.37/224.58       Farnesyltransferase, Farnesyldiphosphate-Farnesyldiphosphate
% 224.37/224.58  |- mesh__recordOriginator mesh__D013186 NLM
% 224.37/224.58  |- mesh__dateEstablished mesh__D013186 1991-01-01
% 224.37/224.58  |- skos__altLabel mesh__D013186
% 224.37/224.58       Farnesyldiphosphate-Farnesyldiphosphate Farnesyltransferase
% 224.37/224.58  |- skos__hiddenLabel mesh__D013186
% 224.37/224.58       Farnesyldiphosphate Farnesyldiphosphate Farnesyltransferase
% 224.37/224.58  |- mesh__dateCreated mesh__D013186 1974-11-19
% 224.37/224.58  |- skos__scopeNote mesh__D013186
% 224.37/224.58       The first committed enzyme of the biosynthesis pathway that leads to the production of STEROLS. it catalyzes the synthesis of SQUALENE from FARNESYL PYROPHOSPHATE via the intermediate PRESQUALENE PYROPHOSPHATE. This enzyme is also a critical branch point enzyme in the biosynthesis of ISOPRENOIDS that is thought to regulate the flux of ISOPRENE intermediates through the sterol pathway.%A%    
% 224.37/224.58  |- skos__hiddenLabel mesh__D013186 Synthetase, Squalene
% 224.37/224.58  |- skos__altLabel mesh__D013186 Squalene Synthetase
% 224.37/224.58  |- skos__broader mesh__D013186smesh__D019883
% 224.37/224.58  |- skos__historyNote mesh__D013186 Squalene %28%1972-1974%29%
% 224.37/224.58  |- skos__hiddenLabel mesh__D013186 FPP FPP Farnesyl Transferase
% 224.37/224.58  |- mesh__dateRevised mesh__D013186 2005-07-18
% 224.37/224.58  |- skos__historyNote mesh__D013186 Pyrophosphoric Acids %28%1972-1974%29%
% 224.37/224.58  |- skos__historyNote mesh__D013186 Ligases %28%1972-1974%29%
% 224.37/224.58  |- mesh__recordAuthorizer mesh__D013186 ags
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D007947 2005
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D007947 2004
% 224.37/224.58  |- skos__scopeNote mesh__D007947
% 224.37/224.58       Nonlymphocytic leukemia in which 20-30%25% of the bone marrow or peripheral blood cells are of megakaryocyte lineage. Myelofibrosis or increased bone marrow reticulin is common.%A%    
% 224.37/224.58  |- skos__hiddenLabel mesh__D007947 Acute Megakaryoblastic Leukemias
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D007947 1996
% 224.37/224.58  |- skos__historyNote mesh__D007947
% 224.37/224.58       Thrombocythemia, Hemorrhagic %28%1986%29%
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D007947 2002
% 224.37/224.58  |- skos__altLabel mesh__D007947 Leukemia, Myeloid, Acute, M7
% 224.37/224.58  |- mesh__dateRevised mesh__D007947 1995-06-08
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D007947 2003
% 224.37/224.58  |- skos__historyNote mesh__D007947
% 224.37/224.58       Hemorrhagic Thrombocythemia %28%1966-1986%29%
% 224.37/224.58  |- skos__hiddenLabel mesh__D007947 Leukemias, Acute Megakaryocytic
% 224.37/224.58  |- skos__altLabel mesh__D007947 Megakaryocytic Leukemia
% 224.37/224.58  |- mesh__historyNote mesh__D007947
% 224.37/224.58       89; was LEUKEMIA, MEGAKARYOBLASTIC 1987-88; LEUKEMIA, MEGAKARYOCYTIC was see THROMBOCYTHEMIA, HEMORRHAGIC 1967-95%A%  
% 224.37/224.58  |- rdf__type mesh__D007947sskos__Concept
% 224.37/224.58  |- skos__hiddenLabel mesh__D007947 Megakaryocytic Leukemias, Acute
% 224.37/224.58  |- mesh__recordAuthorizer mesh__D007947 PLS
% 224.37/224.58  |- mesh__dateEstablished mesh__D007947 1987-01-01
% 224.37/224.58  |- skos__altLabel mesh__D007947 Leukemia, Megakaryoblastic, Acute
% 224.37/224.58  |- skos__altLabel mesh__D007947 Leukemia, Megakaryocytic
% 224.37/224.58  |- skos__hiddenLabel mesh__D007947 Acute Megakaryocytic Leukemia
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D007947 2001
% 224.37/224.58  |- skos__altLabel mesh__D007947 Megakaryocytic Leukemia, Acute
% 224.37/224.58  |- skos__hiddenLabel mesh__D007947 Acute Megakaryocytic Leukemias
% 224.37/224.58  |- skos__altLabel mesh__D007947 Myeloid Leukemia, Acute, M7
% 224.37/224.58  |- mesh__recordOriginator mesh__D007947 VDK
% 224.37/224.58  |- mesh__publicMeSHNote mesh__D007947
% 224.37/224.58       89; was LEUKEMIA, MEGAKARYOBLASTIC 1987-88; LEUKEMIA, MEGAKARYOCYTIC was see THROMBOCYTHEMIA, HEMORRHAGIC 1967-95%A%  
% 224.37/224.58  |- skos__hiddenLabel mesh__D007947 Leukemias, Megakaryocytic
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D007947 1999
% 224.37/224.58  |- skos__altLabel mesh__D007947 Megakaryoblastic Leukemia, Acute
% 224.37/224.58  |- skos__prefLabel mesh__D007947 Leukemia, Megakaryocytic, Acute
% 224.37/224.58  |- skos__hiddenLabel mesh__D007947 Megakaryocytic Leukemias
% 224.37/224.58  |- mesh__dateCreated mesh__D007947 1986-03-27
% 224.37/224.58  |- mesh__onlineNote mesh__D007947
% 224.37/224.58       use LEUKEMIA, MEGAKARYOCYTIC, ACUTE to search LEUKEMIA, MEGAKARYOBLASTIC 1987-88; use THROMBOCYTHEMIA, HEMORRHAGIC to search LEUKEMIA, MEGAKARYOCYTIC 1967-95%A%  
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D007947 2000
% 224.37/224.58  |- skos__hiddenLabel mesh__D007947 Leukemia, Acute Megakaryocytic
% 224.37/224.58  |- skos__hiddenLabel mesh__D007947 Leukemia, Acute Megakaryoblastic
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D007947 2006
% 224.37/224.58  |- skos__broader mesh__D007947smesh__D015470
% 224.37/224.58  |- mesh__recordMaintainer mesh__D007947 PLS
% 224.37/224.58  |- skos__annotation mesh__D007947
% 224.37/224.58       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 224.37/224.58  |- skos__hiddenLabel mesh__D007947 Acute Megakaryoblastic Leukemia
% 224.37/224.58  |- skos__hiddenLabel mesh__D007947 Leukemias, Acute Megakaryoblastic
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D007947 1998
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D007947 1997
% 224.37/224.58  |- skos__hiddenLabel mesh__D007947 Megakaryoblastic Leukemias, Acute
% 224.37/224.58  |- mesh__historyNote mesh__D045268
% 224.37/224.58       2004, 1974-1992; use RHEOLOGY 1993-2003, use BLOOD FLOW VELOCITY 1963-1971%A%  
% 224.37/224.58  |- mesh__dateEstablished mesh__D045268 2004-01-01
% 224.37/224.58  |- mesh__publicMeSHNote mesh__D045268
% 224.37/224.58       2004; use RHEOLOGY 1993-2003, use FLOWMETERS 1974-1982, use BLOOD FLOW VELOCITY 1963-1971%A%  
% 224.37/224.58  |- skos__broader mesh__D045268smesh__D019719
% 224.37/224.58  |- skos__hiddenLabel mesh__D045268 Flowmeter
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D045268 2004
% 224.37/224.58  |- skos__prefLabel mesh__D045268 Flowmeters
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D045268 2005
% 224.37/224.58  |- mesh__dateCreated mesh__D045268 2003-07-09
% 224.37/224.58  |- rdf__type mesh__D045268sskos__Concept
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D045268 2006
% 224.37/224.58  |- skos__annotation mesh__D045268
% 224.37/224.58       consider also RHEOLOGY /instrum or LASER-DOPPLER FLOWMETRY /instrum;%A%  
% 224.37/224.58  |- skos__scopeNote mesh__D045268
% 224.37/224.58       Devices used to measure the flow of fluids %28%see RHEOLOGY%29% or the AIR to measure RESPIRATION.%A%    
% 224.37/224.58  |- skos__broader mesh__D017577smesh__D012871
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D017577 2000
% 224.37/224.58  |- mesh__dateCreated mesh__D017577 1992-12-28
% 224.37/224.58  |- mesh__activeMeSHYear mesh__D017577 2006
% 224.37/224.58  |- rdf__type mesh__D017577sskos__Concept
% 224.37/224.58  |- mesh__recordOriginator mesh__D017577 TGC
% 224.37/224.58  |- skos__hiddenLabel mesh__D017577 Fistula, Skin
% 224.37/224.58  |- mesh__dateRevised mesh__D017577 1999-11-08
% 224.44/224.58  |- skos__hiddenLabel mesh__D017577 Cutaneous Fistulas
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D017577 2005
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D017577 2004
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D017577 2002
% 224.44/224.58  |- skos__hiddenLabel mesh__D017577 Fistulas, Cutaneous
% 224.44/224.58  |- skos__hiddenLabel mesh__D017577 Fistulas, Skin
% 224.44/224.58  |- skos__altLabel mesh__D017577 External Fistula
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D017577 2003
% 224.44/224.58  |- skos__hiddenLabel mesh__D017577 Fistula, External
% 224.44/224.58  |- mesh__recordAuthorizer mesh__D017577 sjn
% 224.44/224.58  |- skos__prefLabel mesh__D017577 Cutaneous Fistula
% 224.44/224.58  |- skos__historyNote mesh__D017577 Skin Diseases %28%1966-1993%29%
% 224.44/224.58  |- mesh__publicMeSHNote mesh__D017577 94   
% 224.44/224.58  |- mesh__dateEstablished mesh__D017577 1994-01-01
% 224.44/224.58  |- skos__annotation mesh__D017577
% 224.44/224.58       fistula policy: Manual 23.19+; anal fistula %28%one opening on the cutaneous surface near the anus%29% is indexed as ANAL FISTULA see RECTAL FISTULA%A%  
% 224.44/224.58  |- skos__hiddenLabel mesh__D017577 Fistulas, External
% 224.44/224.58  |- skos__hiddenLabel mesh__D017577 Fistula, Cutaneous
% 224.44/224.58  |- skos__hiddenLabel mesh__D017577 External Fistulas
% 224.44/224.58  |- mesh__recordMaintainer mesh__D017577 KEV
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D017577 2001
% 224.44/224.58  |- skos__hiddenLabel mesh__D017577 Skin Fistulas
% 224.44/224.58  |- skos__broader mesh__D017577smesh__D005402
% 224.44/224.58  |- skos__altLabel mesh__D017577 Skin Fistula
% 224.44/224.58  |- mesh__historyNote mesh__D017577 94   
% 224.44/224.58  |- skos__historyNote mesh__D017577 Fistula %28%1966-1993%29%
% 224.44/224.58  |- skos__scopeNote mesh__D017577
% 224.44/224.58       An abnormal passage or communication leading from an internal organ to the surface of the body.%A%    
% 224.44/224.58  |- mesh__publicMeSHNote mesh__D031248 2003   
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D031248 2006
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D031248 2004
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D031248 2005
% 224.44/224.58  |- skos__annotation mesh__D031248
% 224.44/224.58       other %27%thistle%27% plants are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.44/224.58  |- skos__scopeNote mesh__D031248
% 224.44/224.58       A plant genus of the family CHENOPODIACEAE. The extract may be called lochein. Tumbleweed may occasionally refer to AMARANTHUS.%A%    
% 224.44/224.58  |- mesh__dateEstablished mesh__D031248 2003-01-01
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D031248 2003
% 224.44/224.58  |- skos__altLabel mesh__D031248 Thistle, Russian
% 224.44/224.58  |- rdf__type mesh__D031248sskos__Concept
% 224.44/224.58  |- skos__altLabel mesh__D031248 Tumbleweed
% 224.44/224.58  |- mesh__historyNote mesh__D031248 2003   
% 224.44/224.58  |- skos__broader mesh__D031248smesh__D019663
% 224.44/224.58  |- skos__prefLabel mesh__D031248 Salsola
% 224.44/224.58  |- skos__altLabel mesh__D031248 Saltwort
% 224.44/224.58  |- mesh__dateCreated mesh__D031248 2002-07-03
% 224.44/224.58  |- mesh__onlineNote mesh__D003557
% 224.44/224.58       use PHYLLODES TUMOR to search CYSTOSARCOMA PHYLLODES 1966-93%A%  
% 224.44/224.58  |- skos__hiddenLabel mesh__D003557 Tumor, Phyllodes
% 224.44/224.58  |- skos__hiddenLabel mesh__D003557 Cystosarcoma Phyllodes, Malignant
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D003557 2005
% 224.44/224.58  |- rdf__type mesh__D003557sskos__Concept
% 224.44/224.58  |- skos__hiddenLabel mesh__D003557 Tumors, Phyllodes
% 224.44/224.58  |- skos__prefLabel mesh__D003557 Phyllodes Tumor
% 224.44/224.58  |- mesh__dateCreated mesh__D003557 1999-01-01
% 224.44/224.58  |- mesh__publicMeSHNote mesh__D003557
% 224.44/224.58       94; was CYSTOSARCOMA PHYLLODES 1963-93   
% 224.44/224.58  |- skos__broader mesh__D003557smesh__D012509
% 224.44/224.58  |- mesh__recordAuthorizer mesh__D003557 sjn
% 224.44/224.58  |- skos__scopeNote mesh__D003557
% 224.44/224.58       A type of connective tissue neoplasm arising from intralobular stroma of the BREAST. It is characterized by the rapid enlargement of an asymmetric firm mobile mass. Histologically, its leaf-like stromal clefts are lined by EPITHELIAL CELLS.%A%    
% 224.44/224.58  |- skos__broader mesh__D003557smesh__D001943
% 224.44/224.58  |- mesh__recordOriginator mesh__D003557 NLM
% 224.44/224.58  |- skos__altLabel mesh__D003557 Cystosarcoma Phylloides
% 224.44/224.58  |- mesh__dateRevised mesh__D003557 2004-07-07
% 224.44/224.58  |- skos__annotation mesh__D003557
% 224.44/224.58       coord IM with probably BREAST NEOPLASMS %28%IM%29%   
% 224.44/224.58  |- skos__hiddenLabel mesh__D003557 Phyllodes Tumors
% 224.44/224.58  |- mesh__recordMaintainer mesh__D003557 lkt
% 224.44/224.58  |- skos__altLabel mesh__D003557 Cystosarcoma Phyllodes
% 224.44/224.58  |- mesh__historyNote mesh__D003557
% 224.44/224.58       94; was CYSTOSARCOMA PHYLLODES 1963-93   
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D003557 2006
% 224.44/224.58  |- skos__altLabel mesh__D008242 Prophage Integration
% 224.44/224.58  |- skos__hiddenLabel mesh__D008242 Integrations, Prophage
% 224.44/224.58  |- skos__historyNote mesh__D008242 Bacteriolysis %28%1966-1967%29%
% 224.44/224.58  |- mesh__recordMaintainer mesh__D008242 ags
% 224.44/224.58  |- skos__related mesh__D008242smesh__D039002
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D008242 2004
% 224.44/224.58  |- mesh__recordAuthorizer mesh__D008242 sjn
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D008242 2003
% 224.44/224.58  |- skos__historyNote mesh__D008242 Bacteriophages %28%1966-1967%29%
% 224.44/224.58  |- skos__hiddenLabel mesh__D008242 Prophage Integrations
% 224.44/224.58  |- mesh__dateCreated mesh__D008242 1999-01-01
% 224.44/224.58  |- mesh__recordOriginator mesh__D008242 NLM
% 224.44/224.58  |- mesh__publicMeSHNote mesh__D008242 70   
% 224.44/224.58  |- skos__related mesh__D008242smesh__D014775
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D008242 2006
% 224.44/224.58  |- skos__prefLabel mesh__D008242 Lysogeny
% 224.44/224.58  |- skos__historyNote mesh__D008242 Bacteria %28%1966-1967%29%
% 224.44/224.58  |- mesh__dateRevised mesh__D008242 2002-07-03
% 224.44/224.58  |- rdf__type mesh__D008242sskos__Concept
% 224.44/224.58  |- mesh__historyNote mesh__D008242 70%28%68%29%   
% 224.44/224.58  |- skos__historyNote mesh__D008242 specific bacteriophage %28%1966-1967%29%
% 224.44/224.58  |- mesh__dateEstablished mesh__D008242 1970-01-01
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D008242 2005
% 224.44/224.58  |- skos__altLabel mesh__D008242 Integration, Prophage
% 224.44/224.58  |- skos__scopeNote mesh__D008242
% 224.44/224.58       The phenomenon by which a temperate phage incorporates itself into the DNA of a bacterial host, establishing a kind of symbiotic relation between PROPHAGE and bacterium which results in the perpetuation of the prophage in all the descendants of the bacterium. Upon induction %28%VIRUS ACTIVATION%29% by various agents, such as ultraviolet radiation, the phage is released, which then becomes virulent and lyses the bacterium.%A%    
% 224.44/224.58  |- skos__annotation mesh__D008242 for bacteriophages only   
% 224.44/224.58  |- skos__historyNote mesh__D008242 specific bacterium %28%1966-1967%29%
% 224.44/224.58  |- skos__broader mesh__D008242smesh__D016662
% 224.44/224.58  |- mesh__recordOriginator mesh__D013985 NLM
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D013985 2003
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D013985 1999
% 224.44/224.58  |- mesh__dateRevised mesh__D013985 1993-06-03
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D013985 1994
% 224.44/224.58  |- mesh__historyNote mesh__D013985
% 224.44/224.58       91%28%75%29%; was see under TICK TOXICOSES 1975-90   
% 224.44/224.58  |- skos__hiddenLabel mesh__D013985 Paralyses, Tick
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D013985 1998
% 224.44/224.58  |- mesh__dateEstablished mesh__D013985 1991-01-01
% 224.44/224.58  |- skos__hiddenLabel mesh__D013985 Paralysis, Tick
% 224.44/224.58  |- mesh__recordMaintainer mesh__D013985 TAP
% 224.44/224.58  |- skos__prefLabel mesh__D013985 Tick Paralysis
% 224.44/224.58  |- skos__broader mesh__D013985smesh__D013986
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D013985 1997
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D013985 2002
% 224.44/224.58  |- mesh__dateCreated mesh__D013985 1999-01-01
% 224.44/224.58  |- rdf__type mesh__D013985sskos__Concept
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D013985 2006
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D013985 1996
% 224.44/224.58  |- mesh__publicMeSHNote mesh__D013985
% 224.44/224.58       91; was see under TICK TOXICOSES 1975-90   
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D013985 2001
% 224.44/224.58  |- mesh__recordAuthorizer mesh__D013985 PLS
% 224.44/224.58  |- mesh__onlineNote mesh__D013985 search TICK TOXICOSES 1968-74   
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D013985 2005
% 224.44/224.58  |- skos__scopeNote mesh__D013985
% 224.44/224.58       Paralysis caused by a neurotropic toxin secreted by the salivary glands of ticks.%A%    
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D013985 2000
% 224.44/224.58  |- skos__hiddenLabel mesh__D013985 Tick Paralyses
% 224.44/224.58  |- skos__annotation mesh__D013985
% 224.44/224.58       paralysis caused by tick bite; see note under TICKS   
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D013985 2004
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D013985 1995
% 224.44/224.58  |- mesh__historyNote mesh__D007948
% 224.44/224.58       89; was LEUKEMIA, MONOBLASTIC 1967-88; LEUKEMIA, SCHILLING-TYPE was see LEUKEMIA, MONOCYTIC 1975-88%A%  
% 224.44/224.58  |- mesh__activeMeSHYear mesh__D007948 2000
% 224.44/224.58  |- skos__broader mesh__D007948smesh__D015470
% 224.44/224.58  |- mesh__dateEstablished mesh__D007948 1967-01-01
% 224.44/224.58  |- mesh__dateRevised mesh__D007948 1999-11-03
% 224.44/224.58  |- skos__prefLabel mesh__D007948 Leukemia, Monocytic, Acute
% 224.44/224.58  |- skos__hiddenLabel mesh__D007948 Monocytic Leukemias, Acute
% 224.44/224.58  |- mesh__publicMeSHNote mesh__D007948
% 224.44/224.58       89; was LEUKEMIA, MONOBLASTIC 1967-88; LEUKEMIA, SCHILLING-TYPE was see LEUKEMIA, MONOCYTIC 1975-88%A%  
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D007948 2005
% 224.44/224.59  |- skos__altLabel mesh__D007948 Myeloid Leukemia, Acute, M5
% 224.44/224.59  |- skos__broader mesh__D007948smesh__D015620
% 224.44/224.59  |- mesh__onlineNote mesh__D007948
% 224.44/224.59       use LEUKEMIA, MONOCYTIC, ACUTE to search LEUKEMIA, MONOBLASTIC 1967-88; use LEUKEMIA, MONOCYTIC, CHRONIC to search LEUKEMIA, SCHILLING-TYPE 1975-88%A%  
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D007948 2001
% 224.44/224.59  |- skos__hiddenLabel mesh__D007948 Leukemia, Schilling-Type Myeloid
% 224.44/224.59  |- skos__hiddenLabel mesh__D007948 Leukemia, Acute Monocytic
% 224.44/224.59  |- skos__altLabel mesh__D007948 Myeloid Leukemia, Schilling-Type
% 224.44/224.59  |- mesh__dateCreated mesh__D007948 1999-01-01
% 224.44/224.59  |- skos__hiddenLabel mesh__D007948 Schilling-Type Myeloid Leukemia
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D007948 2006
% 224.44/224.59  |- mesh__recordMaintainer mesh__D007948 ndw
% 224.44/224.59  |- skos__altLabel mesh__D007948 Monocytic Leukemia, Acute
% 224.44/224.59  |- skos__hiddenLabel mesh__D007948 Leukemias, Acute Monocytic
% 224.44/224.59  |- skos__altLabel mesh__D007948 Leukemia, Myeloid, Schilling-Type
% 224.44/224.59  |- skos__hiddenLabel mesh__D007948 Acute Monocytic Leukemias
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D007948 2003
% 224.44/224.59  |- skos__hiddenLabel mesh__D007948 Acute Monoblastic Leukemia
% 224.44/224.59  |- skos__hiddenLabel mesh__D007948 Leukemia, Acute Monoblastic
% 224.44/224.59  |- skos__hiddenLabel mesh__D007948 Acute Monoblastic Leukemias
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D007948 2002
% 224.44/224.59  |- skos__altLabel mesh__D007948 Monoblastic Leukemia, Acute
% 224.44/224.59  |- mesh__recordOriginator mesh__D007948 NLM
% 224.44/224.59  |- skos__annotation mesh__D007948
% 224.44/224.59       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 224.44/224.59  |- mesh__recordAuthorizer mesh__D007948 sjn
% 224.44/224.59  |- skos__historyNote mesh__D007948
% 224.44/224.59       Leukemia, Monocytic, Chronic %28%1966%29%
% 224.44/224.59  |- skos__altLabel mesh__D007948 Leukemia, Myeloid, Schilling Type
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D007948 2004
% 224.44/224.59  |- skos__hiddenLabel mesh__D007948 Acute Monocytic Leukemia
% 224.44/224.59  |- skos__hiddenLabel mesh__D007948 Monoblastic Leukemias, Acute
% 224.44/224.59  |- skos__altLabel mesh__D007948 Leukemia, Monoblastic, Acute
% 224.44/224.59  |- rdf__type mesh__D007948sskos__Concept
% 224.44/224.59  |- skos__hiddenLabel mesh__D007948 Leukemias, Acute Monoblastic
% 224.44/224.59  |- skos__altLabel mesh__D007948 Leukemia, Myeloid, Acute, M5
% 224.44/224.59  |- skos__hiddenLabel mesh__D007948 Myeloid Leukemia, Schilling Type
% 224.44/224.59  |- skos__altLabel mesh__D018670 Ambulatory Monitoring
% 224.44/224.59  |- skos__historyNote mesh__D018670
% 224.44/224.59       Monitoring, Physiologic %28%1966-1994%29%
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D018670 2001
% 224.44/224.59  |- mesh__recordMaintainer mesh__D018670 PXP
% 224.44/224.59  |- mesh__historyNote mesh__D018670 95   
% 224.44/224.59  |- mesh__publicMeSHNote mesh__D018670 95   
% 224.44/224.59  |- mesh__recordOriginator mesh__D018670 JLS
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D018670 2000
% 224.44/224.59  |- skos__altLabel mesh__D018670 Outpatient Monitoring
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D018670 1999
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D018670 2006
% 224.44/224.59  |- skos__altLabel mesh__D018670 Monitoring, Outpatient
% 224.44/224.59  |- mesh__dateRevised mesh__D018670 1997-06-20
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D018670 1998
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D018670 2005
% 224.44/224.59  |- rdf__type mesh__D018670sskos__Concept
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D018670 2004
% 224.44/224.59  |- mesh__dateEstablished mesh__D018670 1995-01-01
% 224.44/224.59  |- mesh__recordAuthorizer mesh__D018670 SJN
% 224.44/224.59  |- mesh__dateCreated mesh__D018670 1994-05-23
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D018670 2002
% 224.44/224.59  |- skos__scopeNote mesh__D018670
% 224.44/224.59       The use of electronic equipment to observe or record physiologic processes while the patient undergoes normal daily activities.%A%    
% 224.44/224.59  |- skos__prefLabel mesh__D018670 Monitoring, Ambulatory
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D018670 2003
% 224.44/224.59  |- skos__broader mesh__D018670smesh__D008991
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D032341 2005
% 224.44/224.59  |- mesh__publicMeSHNote mesh__D032341 2003   
% 224.44/224.59  |- mesh__dateCreated mesh__D032341 2002-07-03
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D032341 2004
% 224.44/224.59  |- rdf__type mesh__D032341sskos__Concept
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D032341 2003
% 224.44/224.59  |- skos__broader mesh__D032341smesh__D019657
% 224.44/224.59  |- skos__prefLabel mesh__D032341 Withania
% 224.44/224.59  |- skos__scopeNote mesh__D032341
% 224.44/224.59       A plant genus of the family SOLANACEAE. Members contain withanolides. Withania somnifera is the source of ashwagandha and aswal.%A%    
% 224.44/224.59  |- mesh__dateEstablished mesh__D032341 2003-01-01
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D032341 2006
% 224.44/224.59  |- mesh__historyNote mesh__D032341 2003   
% 224.44/224.59  |- skos__annotation mesh__D032341
% 224.44/224.59       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.44/224.59  |- skos__hiddenLabel mesh__D004650 Appraisal, Employee Performance
% 224.44/224.59  |- skos__hiddenLabel mesh__D004650 Evaluations, Nurses Performance
% 224.44/224.59  |- skos__hiddenLabel mesh__D004650 Appraisals, Employee Performance
% 224.44/224.59  |- rdf__type mesh__D004650sskos__Concept
% 224.44/224.59  |- skos__hiddenLabel mesh__D004650 Performance Evaluation, Nurses
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D004650 2002
% 224.44/224.59  |- skos__hiddenLabel mesh__D004650 Performance Appraisals, Employee
% 224.44/224.59  |- mesh__dateEstablished mesh__D004650 1991-01-01
% 224.44/224.59  |- mesh__recordOriginator mesh__D004650 EC
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D004650 2001
% 224.44/224.59  |- mesh__dateCreated mesh__D004650 1977-05-05
% 224.44/224.59  |- skos__annotation mesh__D004650 med or non-med personnel   
% 224.44/224.59  |- skos__hiddenLabel mesh__D004650 Evaluation, Nurses Performance
% 224.44/224.59  |- skos__hiddenLabel mesh__D004650 Nurses Performance Evaluations
% 224.44/224.59  |- mesh__recordMaintainer mesh__D004650 jls
% 224.44/224.59  |- mesh__publicMeSHNote mesh__D004650
% 224.44/224.59       91; was see under PERSONNEL MANAGEMENT Aug 1977-90   
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D004650 2004
% 224.44/224.59  |- mesh__historyNote mesh__D004650
% 224.44/224.59       91%28%Aug 77%29%; was see under PERSONNEL MANAGEMENT 1977-90   
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D004650 2000
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D004650 2006
% 224.44/224.59  |- skos__scopeNote mesh__D004650
% 224.44/224.59       The assessment of the functioning of an employee in relation to work.%A%    
% 224.44/224.59  |- mesh__recordAuthorizer mesh__D004650 sjn
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D004650 2003
% 224.44/224.59  |- skos__prefLabel mesh__D004650 Employee Performance Appraisal
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D004650 2005
% 224.44/224.59  |- mesh__dateRevised mesh__D004650 1999-11-03
% 224.44/224.59  |- skos__altLabel mesh__D004650 Performance Appraisal, Employee
% 224.44/224.59  |- skos__broader mesh__D004650smesh__D010559
% 224.44/224.59  |- skos__hiddenLabel mesh__D004650 Performance Evaluations, Nurses
% 224.44/224.59  |- skos__hiddenLabel mesh__D004650 Employee Performance Appraisals
% 224.44/224.59  |- skos__hiddenLabel mesh__D017578 Switching, Isotype
% 224.44/224.59  |- mesh__publicMeSHNote mesh__D017578 94   
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D017578 2006
% 224.44/224.59  |- rdf__type mesh__D017578sskos__Concept
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D017578 2003
% 224.44/224.59  |- skos__hiddenLabel mesh__D017578 Isotype Switchings
% 224.44/224.59  |- skos__historyNote mesh__D017578
% 224.44/224.59       Immunoglobulin Isotypes/biosynthesis %28%1988-1993%29%
% 224.44/224.59  |- skos__hiddenLabel mesh__D017578 Class Switching, Immunoglobulin
% 224.44/224.59  |- skos__altLabel mesh__D017578 Class Switching
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D017578 2004
% 224.44/224.59  |- skos__hiddenLabel mesh__D017578 Switchings, Immunoglobulin Class
% 224.44/224.59  |- skos__hiddenLabel mesh__D017578 Class Switchings, Immunoglobulin
% 224.44/224.59  |- skos__broader mesh__D017578smesh__D015326
% 224.44/224.59  |- skos__altLabel mesh__D017578 Isotype Switching
% 224.44/224.59  |- skos__prefLabel mesh__D017578 Immunoglobulin Class Switching
% 224.44/224.59  |- skos__hiddenLabel mesh__D017578 Switching, Immunoglobulin Class
% 224.44/224.59  |- skos__scopeNote mesh__D017578
% 224.44/224.59       Gene rearrangement of the B-lymphocyte which results in a substitution in the type of heavy-chain constant region that is expressed. This allows the effector response to change while the antigen binding specificity %28%variable region%29% remains the same. The majority of class switching occurs by a DNA recombination event but it also can take place at the level of RNA processing.%A%    
% 224.44/224.59  |- skos__hiddenLabel mesh__D017578 Class Switchings
% 224.44/224.59  |- skos__hiddenLabel mesh__D017578 Immunoglobulin Class Switchings
% 224.44/224.59  |- mesh__dateCreated mesh__D017578 1993-06-17
% 224.44/224.59  |- skos__hiddenLabel mesh__D017578 Switchings, Class
% 224.44/224.59  |- skos__historyNote mesh__D017578
% 224.44/224.59       Immunoglobulins, Heavy-Chain/genetics %28%1980-1993%29%
% 224.44/224.59  |- skos__hiddenLabel mesh__D017578 Switchings, Isotype
% 224.44/224.59  |- mesh__dateEstablished mesh__D017578 1994-01-01
% 224.44/224.59  |- mesh__dateRevised mesh__D017578 2002-07-03
% 224.44/224.59  |- mesh__historyNote mesh__D017578 94   
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D017578 2005
% 224.44/224.59  |- skos__hiddenLabel mesh__D017578 Switching, Class
% 224.44/224.59  |- skos__historyNote mesh__D031249
% 224.44/224.59       Histiocytosis, Langerhans-Cell %28%1988-2002%29%
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D031249 2005
% 224.44/224.59  |- mesh__dateCreated mesh__D031249 2002-07-03
% 224.44/224.59  |- skos__broader mesh__D031249smesh__D015616
% 224.44/224.59  |- skos__historyNote mesh__D031249
% 224.44/224.59       Histiocytosis, Non-Langerhans-Cell %28%1991-2002%29%
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D031249 2003
% 224.44/224.59  |- rdf__type mesh__D031249sskos__Concept
% 224.44/224.59  |- skos__scopeNote mesh__D031249
% 224.44/224.59       A rare form of non-Langerhans-cell histiocytosis %28%HISTIOCYTOSIS, NON-LANGERHANS-CELL%29% with onset in middle age. The systemic disease is characterized by infiltration of lipid-laden macrophages, multinucleated giant cells, an inflammatory infiltrate of lymphocytes and histiocytes in the bone marrow, and a generalized sclerosis of the long bones.%A%    
% 224.44/224.59  |- skos__hiddenLabel mesh__D031249 Lipid Granulomatosis
% 224.44/224.59  |- skos__historyNote mesh__D031249 Lipidosis %28%1979-2002%29%
% 224.44/224.59  |- skos__hiddenLabel mesh__D031249 Erdheim Chester Disease
% 224.44/224.59  |- mesh__dateEstablished mesh__D031249 2003-01-01
% 224.44/224.59  |- skos__prefLabel mesh__D031249 Erdheim-Chester Disease
% 224.44/224.59  |- skos__altLabel mesh__D031249 Granulomatosis, Lipid
% 224.44/224.59  |- skos__historyNote mesh__D031249 Xanthomatosis %28%1979-2002%29%
% 224.44/224.59  |- skos__historyNote mesh__D031249 Histiocytosis %28%1989-2002%29%
% 224.44/224.59  |- mesh__historyNote mesh__D031249 2003   
% 224.44/224.59  |- mesh__publicMeSHNote mesh__D031249 2003   
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D031249 2006
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D031249 2004
% 224.44/224.59  |- skos__hiddenLabel mesh__D003558 Cystoscopic Surgical Procedure
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D003558 2001
% 224.44/224.59  |- skos__scopeNote mesh__D003558
% 224.44/224.59       Endoscopic examination, therapy or surgery of the urinary bladder.%A%    
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D003558 2004
% 224.44/224.59  |- skos__prefLabel mesh__D003558 Cystoscopy
% 224.44/224.59  |- skos__hiddenLabel mesh__D003558 Cystoscopies
% 224.44/224.59  |- skos__hiddenLabel mesh__D003558 Surgical Procedure, Cystoscopic
% 224.44/224.59  |- skos__broader mesh__D003558smesh__D013520
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D003558 2000
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D003558 2003
% 224.44/224.59  |- mesh__recordMaintainer mesh__D003558 nns
% 224.44/224.59  |- mesh__dateRevised mesh__D003558 1999-11-03
% 224.44/224.59  |- skos__hiddenLabel mesh__D003558 Surgeries, Cystoscopic
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D003558 2006
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D003558 2002
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D003558 2005
% 224.44/224.59  |- rdf__type mesh__D003558sskos__Concept
% 224.44/224.59  |- skos__altLabel mesh__D003558 Cystoscopic Surgery
% 224.44/224.59  |- mesh__recordAuthorizer mesh__D003558 sjn
% 224.44/224.59  |- skos__hiddenLabel mesh__D003558 Cystoscopic Surgeries
% 224.44/224.59  |- skos__broader mesh__D003558smesh__D004724
% 224.44/224.59  |- skos__broader mesh__D003558smesh__D003950
% 224.44/224.59  |- skos__altLabel mesh__D003558 Surgery, Cystoscopic
% 224.44/224.59  |- mesh__dateCreated mesh__D003558 1999-01-01
% 224.44/224.59  |- mesh__recordOriginator mesh__D003558 NLM
% 224.44/224.59  |- skos__hiddenLabel mesh__D003558 Procedures, Cystoscopic Surgical
% 224.44/224.59  |- skos__hiddenLabel mesh__D003558 Procedure, Cystoscopic Surgical
% 224.44/224.59  |- skos__altLabel mesh__D003558 Surgical Procedures, Cystoscopic
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D014280 2004
% 224.44/224.59  |- skos__altLabel mesh__D014280 Triacylglycerol
% 224.44/224.59  |- mesh__dateEstablished mesh__D014280 1968-01-01
% 224.44/224.59  |- rdf__type mesh__D014280sskos__Concept
% 224.44/224.59  |- mesh__historyNote mesh__D014280
% 224.44/224.59       2001%28%1966%29%; for TRIACYLGLYCEROL use TRIGLYCERIDES %28%NM%29% 1976-2000%A%  
% 224.44/224.59  |- mesh__dateRevised mesh__D014280 2003-07-09
% 224.44/224.59  |- mesh__recordOriginator mesh__D014280 NLM
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D014280 2005
% 224.44/224.59  |- mesh__recordMaintainer mesh__D014280 ssb
% 224.44/224.59  |- skos__prefLabel mesh__D014280 Triglycerides
% 224.44/224.59  |- mesh__recordAuthorizer mesh__D014280 sjn
% 224.44/224.59  |- mesh__dateCreated mesh__D014280 1999-01-01
% 224.44/224.59  |- skos__altLabel mesh__D014280 Triacylglycerols
% 224.44/224.59  |- skos__annotation mesh__D014280
% 224.44/224.59       /blood: consider also HYPERTRIGLYCERIDEMIA %26% the hypertriglyceridemias in HYPERLIPOPROTEINEMIA TYPE I; HYPERLIPOPROTEINEMIA TYPE IV %26% HYPERLIPOPROTEINEMIA TYPE V%A%  
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D014280 2006
% 224.44/224.59  |- mesh__publicMeSHNote mesh__D014280
% 224.44/224.59       2001; TRIACYLGLYCEROL was indexed under TRIGLYCERIDES 1976-2000%A%  
% 224.44/224.59  |- skos__broader mesh__D014280smesh__D005989
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D008243 2004
% 224.44/224.59  |- skos__hiddenLabel mesh__D008243
% 224.44/224.59       1 Acylglycerophosphocholine Acyltransferase
% 224.44/224.59  |- skos__hiddenLabel mesh__D008243
% 224.44/224.59       Lysophosphatidylcholine Palmitoyl CoA Acyltransferase
% 224.44/224.59  |- skos__historyNote mesh__D008243
% 224.44/224.59       Lysophosphatidylcholines %28%1972-1975%29%
% 224.44/224.59  |- skos__hiddenLabel mesh__D008243
% 224.44/224.59       Acyltransferase, 1-Acylglycerophosphocholine
% 224.44/224.59  |- mesh__dateEstablished mesh__D008243 1991-01-01
% 224.44/224.59  |- skos__scopeNote mesh__D008243
% 224.44/224.59       An enzyme localized predominantly within the plasma membrane of lymphocytes. It catalyzes the transfer of long-chain fatty acids, preferentially unsaturated fatty acids, to lysophosphatides with the formation of 1,2-diacylglycero-3-phosphocholine and CoA. EC 2.3.1.23.%A%    
% 224.44/224.59  |- skos__broader mesh__D008243smesh__D000217
% 224.44/224.59  |- skos__hiddenLabel mesh__D008243 Acyltransferase, Lysolecithin
% 224.44/224.59  |- skos__prefLabel mesh__D008243
% 224.44/224.59       1-Acylglycerophosphocholine O-Acyltransferase
% 224.44/224.59  |- skos__hiddenLabel mesh__D008243
% 224.44/224.59       CoA Acyltransferase, Lysophosphatidylcholine-Palmitoyl
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D008243 2006
% 224.44/224.59  |- mesh__historyNote mesh__D008243
% 224.44/224.59       98; for 1-ACYLGLYCEROPHOSPHOCHOLINE ACYLTRANSFERASE use 1-ACYLGLYCEROPHOSPHOCHOLINE O-ACYLTRANSFERASE %28%NM%29% 1982-97, see ACYLTRANSFERASES 1976-90%A%  
% 224.44/224.59  |- skos__hiddenLabel mesh__D008243
% 224.44/224.59       1 Acylglycerophosphocholine O Acyltransferase
% 224.44/224.59  |- skos__hiddenLabel mesh__D008243
% 224.44/224.59       Acyltransferase, Lysophosphatidylcholine-Palmitoyl CoA
% 224.44/224.59  |- skos__historyNote mesh__D008243 Acyltransferases %28%1972-1975%29%
% 224.44/224.59  |- skos__hiddenLabel mesh__D008243
% 224.44/224.59       O-Acyltransferase, 1-Acylglycerophosphocholine
% 224.44/224.59  |- skos__hiddenLabel mesh__D008243 Acyltransferase, Lysophospholipid
% 224.44/224.59  |- mesh__dateCreated mesh__D008243 1975-07-21
% 224.44/224.59  |- mesh__recordAuthorizer mesh__D008243 sjn
% 224.44/224.59  |- rdf__type mesh__D008243sskos__Concept
% 224.44/224.59  |- skos__hiddenLabel mesh__D008243 Acyltransferase, Lysophosphatidylcholine
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D008243 2005
% 224.44/224.59  |- skos__altLabel mesh__D008243
% 224.44/224.59       Acyl-CoA-1-Acylglycero-3-Phosphocholine-O-Acyltransferase
% 224.44/224.59  |- skos__altLabel mesh__D008243 Lysophospholipid Acyltransferase
% 224.44/224.59  |- skos__altLabel mesh__D008243 1-Acylglycerophosphocholine Acyltransferase
% 224.44/224.59  |- mesh__dateRevised mesh__D008243 2003-07-09
% 224.44/224.59  |- skos__historyNote mesh__D008243 Coenzyme A %28%1973-1975%29%
% 224.44/224.59  |- skos__altLabel mesh__D008243 Lysolecithin Acyltransferase
% 224.44/224.59  |- skos__altLabel mesh__D008243 Lysophosphatidylcholine Acyltransferase
% 224.44/224.59  |- mesh__publicMeSHNote mesh__D008243
% 224.44/224.59       98; see LYSOLECITHIN ACYLTRANSFERASE 1991-97; 1-ACYLGLYCEROPHOSPHOCHOLINE ACYLTRANSFERASE was indexed under ACYLTRANSFERASES 1982-97, see ACYLTRANSFERASES 1976-90%A%  
% 224.44/224.59  |- mesh__recordOriginator mesh__D008243 RLS
% 224.44/224.59  |- skos__altLabel mesh__D008243
% 224.44/224.59       Lysophosphatidylcholine-Palmitoyl CoA Acyltransferase
% 224.44/224.59  |- mesh__recordMaintainer mesh__D008243 ssb
% 224.44/224.59  |- skos__hiddenLabel mesh__D008243
% 224.44/224.59       Acyl CoA 1 Acylglycero 3 Phosphocholine O Acyltransferase
% 224.44/224.59  |- skos__altLabel mesh__D008243 Acyl CoA Lysolecithin Acyltransferase
% 224.44/224.59  |- mesh__activeMeSHYear mesh__D000260 2006
% 224.44/224.59  |- skos__broader mesh__D000260smesh__D017921
% 224.44/224.59  |- mesh__dateCreated mesh__D000260 1976-04-16
% 224.44/224.59  |- mesh__recordOriginator mesh__D000260 FPG
% 224.44/224.59  |- mesh__historyNote mesh__D000260 1977   
% 224.44/224.59  |- skos__prefLabel mesh__D000260 Adenoviruses, Human
% 224.44/224.59  |- mesh__publicMeSHNote mesh__D000260
% 224.44/224.59       1977; for APC VIRUS %28%Adenoidal-Pharyngeal-Conjunctival virus%29% see ADENOVIRUSES 1975-1976, see ADENOVIRUS 1963-1974%A%  
% 224.44/224.59  |- skos__annotation mesh__D000260
% 224.44/224.59       infection = ADENOVIRUS INFECTIONS, HUMAN   
% 224.44/224.59  |- skos__scopeNote mesh__D000260
% 224.44/224.59       Species of the genus MASTADENOVIRUS, causing a wide range of diseases in humans. Infections are mostly asymptomatic, but can be associated with diseases of the respiratory, ocular, and gastrointestinal systems. Serotypes %28%named with arabic numbers%29% have been grouped into species designated Human adenovirus A-F.%A%    
% 224.44/224.59  |- mesh__dateRevised mesh__D000260 2004-07-13
% 224.44/224.59  |- rdf__type mesh__D000260sskos__Concept
% 224.44/224.59  |- mesh__recordAuthorizer mesh__D000260 sjn
% 224.44/224.59  |- skos__hiddenLabel mesh__D000260 Adenovirus, Human
% 224.44/224.59  |- skos__hiddenLabel mesh__D000260 Human Adenovirus
% 224.44/224.59  |- skos__hiddenLabel mesh__D000260 APC Virus
% 224.44/224.59  |- skos__altLabel mesh__D000260 APC Viruses
% 224.44/224.59  |- mesh__dateEstablished mesh__D000260 1977-01-01
% 224.44/224.59  |- skos__hiddenLabel mesh__D000260 Human Adenoviruses
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D000260 2005
% 224.44/224.60  |- skos__historyNote mesh__D000260 Adenoviridae %28%1966-1974%29%
% 224.44/224.60  |- mesh__recordMaintainer mesh__D000260 sjn
% 224.44/224.60  |- mesh__dateEstablished mesh__D013986 1968-01-01
% 224.44/224.60  |- mesh__recordAuthorizer mesh__D013986 sjn
% 224.44/224.60  |- mesh__recordMaintainer mesh__D013986 mdb
% 224.44/224.60  |- skos__historyNote mesh__D013986 Ticks %28%1966-1967%29%
% 224.44/224.60  |- skos__annotation mesh__D013986 see note under TICKS   
% 224.44/224.60  |- mesh__recordOriginator mesh__D013986 NLM
% 224.44/224.60  |- mesh__dateCreated mesh__D013986 1999-01-01
% 224.44/224.60  |- mesh__dateRevised mesh__D013986 2002-07-03
% 224.44/224.60  |- mesh__historyNote mesh__D013986 68   
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013986 2006
% 224.44/224.60  |- mesh__publicMeSHNote mesh__D013986 68   
% 224.44/224.60  |- rdf__type mesh__D013986sskos__Concept
% 224.44/224.60  |- skos__broader mesh__D013986smesh__D001733
% 224.44/224.60  |- skos__prefLabel mesh__D013986 Tick Toxicoses
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013986 2005
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013986 2004
% 224.44/224.60  |- skos__hiddenLabel mesh__D013986 Toxicoses, Tick
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013986 2003
% 224.44/224.60  |- skos__scopeNote mesh__D013986
% 224.44/224.60       Toxicoses caused by toxic substances secreted by the salivary glands of ticks; include tick paralysis %28%neurotropic toxin%29%, sweating sickness %28%dermotropic toxin%29%, and Rhipicephalus appendiculatus toxicosis %28%leukotropic toxin%29%.%A%    
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013188 1996
% 224.44/224.60  |- mesh__dateCreated mesh__D013188 1976-04-16
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013188 1999
% 224.44/224.60  |- mesh__dateEstablished mesh__D013188 1977-01-01
% 224.44/224.60  |- skos__prefLabel mesh__D013188 Sri Lanka
% 224.44/224.60  |- mesh__recordMaintainer mesh__D013188 TGC
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013188 2002
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013188 1997
% 224.44/224.60  |- mesh__dateRevised mesh__D013188 1991-06-11
% 224.44/224.60  |- skos__altLabel mesh__D013188 Ceylon
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013188 1994
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013188 2005
% 224.44/224.60  |- mesh__historyNote mesh__D013188 77; was CEYLON 1963-76   
% 224.44/224.60  |- rdf__type mesh__D013188sskos__Concept
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013188 1992
% 224.44/224.60  |- skos__broader mesh__D013188smesh__D001211
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013188 1995
% 224.44/224.60  |- mesh__onlineNote mesh__D013188 use SRI LANKA to search CEYLON 1966-76   
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013188 2003
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013188 2006
% 224.44/224.60  |- mesh__recordAuthorizer mesh__D013188 PLS
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013188 1998
% 224.44/224.60  |- mesh__recordOriginator mesh__D013188 CAB
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013188 2000
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013188 1993
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013188 2004
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013188 2001
% 224.44/224.60  |- skos__scopeNote mesh__D018671
% 224.44/224.60       Organized services for exchange of sterile needles and syringes used for injections as a potential means of reducing the transmission of infectious diseases.%A%    
% 224.44/224.60  |- skos__historyNote mesh__D018671 Needles %28%1985-1994%29%
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D018671 1995
% 224.44/224.60  |- mesh__historyNote mesh__D018671 95   
% 224.44/224.60  |- skos__hiddenLabel mesh__D018671 Program, Syringe-Exchange
% 224.44/224.60  |- skos__hiddenLabel mesh__D018671 Program, Needle-Exchange
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D018671 2000
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D018671 1998
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D018671 2005
% 224.44/224.60  |- skos__broader mesh__D018671smesh__D011314
% 224.44/224.60  |- skos__hiddenLabel mesh__D018671 Syringe-Exchange Program
% 224.44/224.60  |- mesh__dateEstablished mesh__D018671 1995-01-01
% 224.44/224.60  |- skos__hiddenLabel mesh__D018671 Syringe Exchange Programs
% 224.44/224.60  |- skos__prefLabel mesh__D018671 Needle-Exchange Programs
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D018671 1999
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D018671 2006
% 224.44/224.60  |- skos__hiddenLabel mesh__D018671 Needle Exchange Programs
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D018671 2001
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D018671 1996
% 224.44/224.60  |- mesh__publicMeSHNote mesh__D018671 95   
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D018671 2003
% 224.44/224.60  |- skos__historyNote mesh__D018671 Syringes %28%1985-1994%29%
% 224.44/224.60  |- skos__hiddenLabel mesh__D018671 Needle-Exchange Program
% 224.44/224.60  |- rdf__type mesh__D018671sskos__Concept
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D018671 1997
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D018671 2004
% 224.44/224.60  |- skos__hiddenLabel mesh__D018671 Programs, Needle-Exchange
% 224.44/224.60  |- skos__annotation mesh__D018671
% 224.44/224.60       to prevent spread of infect among drug users   
% 224.44/224.60  |- skos__altLabel mesh__D018671 Syringe-Exchange Programs
% 224.44/224.60  |- mesh__dateCreated mesh__D018671 1994-05-23
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D018671 2002
% 224.44/224.60  |- skos__hiddenLabel mesh__D018671 Programs, Syringe-Exchange
% 224.44/224.60  |- skos__historyNote mesh__D018671
% 224.44/224.60       Substance Abuse, Intravenous %28%1990-1994%29%
% 224.44/224.60  |- mesh__dateEstablished mesh__D032342 2003-01-01
% 224.44/224.60  |- skos__prefLabel mesh__D032342 Muscle Cells
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D032342 2003
% 224.44/224.60  |- mesh__publicMeSHNote mesh__D032342 2003   
% 224.44/224.60  |- rdf__type mesh__D032342sskos__Concept
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D032342 2004
% 224.44/224.60  |- mesh__historyNote mesh__D032342 2003   
% 224.44/224.60  |- skos__hiddenLabel mesh__D032342 Muscle Cell, Mature
% 224.44/224.60  |- skos__altLabel mesh__D032342 Muscle Cells, Mature
% 224.44/224.60  |- skos__broader mesh__D032342smesh__D002477
% 224.44/224.60  |- mesh__dateCreated mesh__D032342 2002-07-03
% 224.44/224.60  |- skos__historyNote mesh__D032342 Muscles/cytology %28%1965-2002%29%
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D032342 2005
% 224.44/224.60  |- skos__altLabel mesh__D032342 Myocytes
% 224.44/224.60  |- skos__scopeNote mesh__D032342
% 224.44/224.60       Mature contractile cells, commonly known as myocytes, that form one of three kinds of muscle. The three types of muscle cells are skeletal %28%MUSCLE FIBERS%29%, cardiac %28%MYOCYTES, CARDIAC%29%, and smooth %28%MYOCYTES, SMOOTH MUSCLE%29%. They are derived from embryonic %28%precursor%29% muscle cells called MYOBLASTS.%A%    
% 224.44/224.60  |- skos__hiddenLabel mesh__D032342 Muscle Cell
% 224.44/224.60  |- skos__hiddenLabel mesh__D032342 Mature Muscle Cells
% 224.44/224.60  |- skos__related mesh__D032342smesh__D032446
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D032342 2006
% 224.44/224.60  |- skos__hiddenLabel mesh__D032342 Myocyte
% 224.44/224.60  |- skos__hiddenLabel mesh__D032342 Mature Muscle Cell
% 224.44/224.60  |- skos__annotation mesh__D032342 prefer specifics   
% 224.44/224.60  |- skos__hiddenLabel mesh__D004651 Terminations, Employment
% 224.44/224.60  |- skos__related mesh__D004651smesh__D014478
% 224.44/224.60  |- skos__hiddenLabel mesh__D004651 Employment Terminations
% 224.44/224.60  |- mesh__dateCreated mesh__D004651 1999-01-01
% 224.44/224.60  |- skos__hiddenLabel mesh__D004651 Labor, Child
% 224.44/224.60  |- skos__historyNote mesh__D004651 Occupations %28%1966-1969%29%
% 224.44/224.60  |- mesh__recordOriginator mesh__D004651 NLM
% 224.44/224.60  |- skos__broader mesh__D004651smesh__D012959
% 224.44/224.60  |- skos__hiddenLabel mesh__D004651 Sector, Informal
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D004651 1997
% 224.44/224.60  |- skos__annotation mesh__D004651
% 224.44/224.60       for pay: differentiate from WORK %28%see note there%29%   
% 224.44/224.60  |- skos__historyNote mesh__D004651 Work %28%1966-1969%29%
% 224.44/224.60  |- skos__historyNote mesh__D004651 Unemployment %28%1966-1969%29%
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D004651 1999
% 224.44/224.60  |- skos__hiddenLabel mesh__D004651 Termination, Employment
% 224.44/224.60  |- skos__altLabel mesh__D004651 Occupational Status
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D004651 2004
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D004651 2002
% 224.44/224.60  |- mesh__dateEstablished mesh__D004651 1970-01-01
% 224.44/224.60  |- mesh__historyNote mesh__D004651 70   
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D004651 2006
% 224.44/224.60  |- skos__prefLabel mesh__D004651 Employment
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D004651 1998
% 224.44/224.60  |- skos__related mesh__D004651smesh__D007588
% 224.44/224.60  |- mesh__recordAuthorizer mesh__D004651 PLS
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D004651 2003
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D004651 2001
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D004651 2005
% 224.44/224.60  |- mesh__publicMeSHNote mesh__D004651 70   
% 224.44/224.60  |- mesh__recordMaintainer mesh__D004651 TPW
% 224.44/224.60  |- skos__scopeNote mesh__D004651
% 224.44/224.60       The state of being engaged in an activity or service for wages or salary.%A%    
% 224.44/224.60  |- skos__related mesh__D004651smesh__D007586
% 224.44/224.60  |- skos__hiddenLabel mesh__D004651 Sectors, Informal
% 224.44/224.60  |- mesh__dateRevised mesh__D004651 1996-06-10
% 224.44/224.60  |- skos__hiddenLabel mesh__D004651 Labor Forces
% 224.44/224.60  |- rdf__type mesh__D004651sskos__Concept
% 224.44/224.60  |- skos__hiddenLabel mesh__D004651 Informal Sectors
% 224.44/224.60  |- skos__hiddenLabel mesh__D004651 Status, Employment
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D004651 2000
% 224.44/224.60  |- mesh__recordMaintainer mesh__D017579 JLS
% 224.44/224.60  |- mesh__dateEstablished mesh__D017579 1994-01-01
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D017579 2004
% 224.44/224.60  |- skos__historyNote mesh__D017579 Violence %28%1968-1993%29%
% 224.44/224.60  |- skos__hiddenLabel mesh__D017579 Violence, Family
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D017579 2000
% 224.44/224.60  |- skos__scopeNote mesh__D017579
% 224.44/224.60       Deliberate, often repetitive, physical abuse by one family member against another: marital partners, parents, children, siblings, or any other member of a household.%A%    
% 224.44/224.60  |- mesh__publicMeSHNote mesh__D017579 94   
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D017579 1999
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D017579 2001
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D017579 2002
% 224.44/224.60  |- skos__broader mesh__D017579smesh__D014754
% 224.44/224.60  |- skos__annotation mesh__D017579 GEN or unspecified; prefer specifics   
% 224.44/224.60  |- mesh__historyNote mesh__D017579 94   
% 224.44/224.60  |- mesh__recordAuthorizer mesh__D017579 SJN
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D017579 2005
% 224.44/224.60  |- skos__prefLabel mesh__D017579 Domestic Violence
% 224.44/224.60  |- mesh__recordOriginator mesh__D017579 TGC
% 224.44/224.60  |- skos__hiddenLabel mesh__D017579 Violence, Domestic
% 224.44/224.60  |- mesh__dateRevised mesh__D017579 1998-06-10
% 224.44/224.60  |- mesh__dateCreated mesh__D017579 1992-12-28
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D017579 2006
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D017579 2003
% 224.44/224.60  |- rdf__type mesh__D017579sskos__Concept
% 224.44/224.60  |- skos__historyNote mesh__D017579 specific type of abuse %28%1966-1993%29%
% 224.44/224.60  |- skos__hiddenLabel mesh__D003559 Cystostomies, Suprapubic
% 224.44/224.60  |- mesh__dateCreated mesh__D003559 1987-03-18
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D003559 2003
% 224.44/224.60  |- mesh__historyNote mesh__D003559 88   
% 224.44/224.60  |- skos__scopeNote mesh__D003559
% 224.44/224.60       Surgical creation of an opening %28%stoma%29% for drainage of the urinary bladder.%A%    
% 224.44/224.60  |- skos__annotation mesh__D003559
% 224.44/224.60       refers to urinary bladder only; do not use /util except by MeSH definition%A%  
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D003559 1999
% 224.44/224.60  |- skos__historyNote mesh__D003559 Bladder/surgery %28%1966-1987%29%
% 224.44/224.60  |- mesh__recordOriginator mesh__D003559 SCD
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D003559 2001
% 224.44/224.60  |- mesh__dateRevised mesh__D003559 1997-06-20
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D003559 1998
% 224.44/224.60  |- skos__broader mesh__D003559smesh__D014547
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D003559 2006
% 224.44/224.60  |- mesh__publicMeSHNote mesh__D003559 88   
% 224.44/224.60  |- skos__historyNote mesh__D003559 Urinary Diversion %28%1966-1987%29%
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D003559 2000
% 224.44/224.60  |- mesh__recordMaintainer mesh__D003559 PXP
% 224.44/224.60  |- skos__hiddenLabel mesh__D003559 Cystostomies
% 224.44/224.60  |- skos__broader mesh__D003559smesh__D010030
% 224.44/224.60  |- skos__historyNote mesh__D003559
% 224.44/224.60       Urinary Catheterization %28%1966-1987%29%
% 224.44/224.60  |- skos__hiddenLabel mesh__D003559 Vesicostomies
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D003559 2005
% 224.44/224.60  |- rdf__type mesh__D003559sskos__Concept
% 224.44/224.60  |- skos__altLabel mesh__D003559 Vesicostomy
% 224.44/224.60  |- skos__prefLabel mesh__D003559 Cystostomy
% 224.44/224.60  |- skos__hiddenLabel mesh__D003559 Suprapubic Cystostomies
% 224.44/224.60  |- mesh__dateEstablished mesh__D003559 1988-01-01
% 224.44/224.60  |- skos__hiddenLabel mesh__D003559 Cystostomy, Suprapubic
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D003559 2002
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D003559 2004
% 224.44/224.60  |- mesh__recordAuthorizer mesh__D003559 SJN
% 224.44/224.60  |- mesh__recordAuthorizer mesh__D014281 sjn
% 224.44/224.60  |- mesh__dateRevised mesh__D014281 2004-07-07
% 224.44/224.60  |- mesh__recordMaintainer mesh__D014281 ssb
% 224.44/224.60  |- skos__historyNote mesh__D014281 Cerebrosides %28%1966-1978%29%
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D014281 2005
% 224.44/224.60  |- skos__scopeNote mesh__D014281
% 224.44/224.60       Glycosphingolipids which contain as their polar head group a trisaccharide %28%galactose-galactose-glucose%29% moiety bound in glycosidic linkage to the hydroxyl group of ceramide. Their accumulation in tissue, due to a defect in ceramide trihexosidase, is the cause of angiokeratoma corporis diffusum %28%FABRY DISEASE%29%.%A%    
% 224.44/224.60  |- skos__altLabel mesh__D014281 Trihexosyl Ceramides
% 224.44/224.60  |- mesh__dateCreated mesh__D014281 1978-05-16
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D014281 2006
% 224.44/224.60  |- mesh__dateEstablished mesh__D014281 1991-01-01
% 224.44/224.60  |- mesh__recordOriginator mesh__D014281 RLS
% 224.44/224.60  |- skos__hiddenLabel mesh__D014281 Trihexosides, Ceramide
% 224.44/224.60  |- skos__hiddenLabel mesh__D014281 Ceramides, Trihexosyl
% 224.44/224.60  |- skos__altLabel mesh__D014281 Ceramide Trihexosides
% 224.44/224.60  |- skos__prefLabel mesh__D014281 Trihexosylceramides
% 224.44/224.60  |- mesh__historyNote mesh__D014281
% 224.44/224.60       91%28%79%29%; was see under GLYCOSPHINGOLIPIDS 1979-90   
% 224.44/224.60  |- skos__annotation mesh__D014281 /biosyn /physiol permitted   
% 224.44/224.60  |- mesh__publicMeSHNote mesh__D014281
% 224.44/224.60       91; was see under GLYCOSPHINGOLIPIDS 1979-90   
% 224.44/224.60  |- rdf__type mesh__D014281sskos__Concept
% 224.44/224.60  |- skos__historyNote mesh__D014281 Glycosphingolipids %28%1975-1978%29%
% 224.44/224.60  |- skos__historyNote mesh__D014281 Ceramides %28%1972-1978%29%
% 224.44/224.60  |- skos__broader mesh__D014281smesh__D002518
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D008244 2004
% 224.44/224.60  |- mesh__historyNote mesh__D008244 77; was LYSOLECITHIN 1963-76   
% 224.44/224.60  |- skos__broader mesh__D008244smesh__D008246
% 224.44/224.60  |- mesh__recordOriginator mesh__D008244 NLM
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D008244 2005
% 224.44/224.60  |- skos__prefLabel mesh__D008244 Lysophosphatidylcholines
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D008244 2006
% 224.44/224.60  |- mesh__dateEstablished mesh__D008244 1977-01-01
% 224.44/224.60  |- skos__altLabel mesh__D008244 Lysophosphatidylcholine
% 224.44/224.60  |- mesh__publicMeSHNote mesh__D008244 77; was LYSOLECITHIN 1963-76   
% 224.44/224.60  |- rdf__type mesh__D008244sskos__Concept
% 224.44/224.60  |- mesh__dateRevised mesh__D008244 2003-07-09
% 224.44/224.60  |- skos__altLabel mesh__D008244 Lysolecithins
% 224.44/224.60  |- mesh__onlineNote mesh__D008244
% 224.44/224.60       use LYSOPHOSPHATIDYLCHOLINES to search LYSOLECITHIN 1966-76%A%  
% 224.44/224.60  |- skos__scopeNote mesh__D008244
% 224.44/224.60       Derivatives of PHOSPHATIDYLCHOLINES obtained by their partial hydrolysis which removes one of the fatty acid moieties.%A%    
% 224.44/224.60  |- mesh__recordMaintainer mesh__D008244 ssb
% 224.44/224.60  |- mesh__dateCreated mesh__D008244 1999-01-01
% 224.44/224.60  |- mesh__recordAuthorizer mesh__D008244 sjn
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D000261 1999
% 224.44/224.60  |- mesh__historyNote mesh__D000261
% 224.44/224.60       91%28%75%29%; was see under ADENOVIRIDAE 1981-90; was see under ADENOVIRUSES 1975-80%A%  
% 224.44/224.60  |- skos__altLabel mesh__D000261 Simian Adenoviruses
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D000261 2002
% 224.44/224.60  |- mesh__recordMaintainer mesh__D000261 AGS
% 224.44/224.60  |- skos__prefLabel mesh__D000261 Adenoviruses, Simian
% 224.44/224.60  |- rdf__type mesh__D000261sskos__Concept
% 224.44/224.60  |- mesh__dateCreated mesh__D000261 1974-12-12
% 224.44/224.60  |- skos__annotation mesh__D000261
% 224.44/224.60       species of the genus Mastadenovirus; infection: coord IM with ADENOVIRIDAE INFECTIONS %28%IM%29%%A%  
% 224.44/224.60  |- mesh__publicMeSHNote mesh__D000261
% 224.44/224.60       91; was see under ADENOVIRIDAE 1981-90; was see under ADENOVIRUSES 1975-80%A%  
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D000261 2003
% 224.44/224.60  |- mesh__dateEstablished mesh__D000261 1991-01-01
% 224.44/224.60  |- mesh__dateRevised mesh__D000261 1996-06-10
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D000261 2005
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D000261 2000
% 224.44/224.60  |- skos__hiddenLabel mesh__D000261 Adenovirus, Simian
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D000261 2004
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D000261 2001
% 224.44/224.60  |- skos__scopeNote mesh__D000261
% 224.44/224.60       Species of the genus MASTADENOVIRUS associated with respiratory and enteric infections in primate hosts.%A%    
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D000261 2006
% 224.44/224.60  |- mesh__recordOriginator mesh__D000261 NLM
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D000261 1998
% 224.44/224.60  |- mesh__recordAuthorizer mesh__D000261 PLS
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D000261 1997
% 224.44/224.60  |- skos__hiddenLabel mesh__D000261 Simian Adenovirus
% 224.44/224.60  |- skos__broader mesh__D000261smesh__D017921
% 224.44/224.60  |- skos__annotation mesh__D013987
% 224.44/224.60       tick bites = TICKS + BITES AND STINGS, not TICK TOXICOSES nor TICK PARALYSIS unless toxicoses or paralysis results; tick vectors = ARACHNID VECTORS %28%IM%29% + TICKS %28%IM%29%; infection = TICK INFESTATIONS; for chemicals for killing or controlling ticks use INSECTICIDES even though ticks are not insects%A%  
% 224.44/224.60  |- skos__scopeNote mesh__D013987
% 224.44/224.60       Blood-sucking acarid parasites of the order Ixodida comprising two families: the softbacked ticks %28%ARGASIDAE%29% and hardbacked ticks %28%IXODIDAE%29%. Ticks are larger than their relatives, the MITES. They penetrate the skin of their host by means of highly specialized, hooked mouth parts and feed on its blood. Ticks attack all groups of terrestrial vertebrates. In humans they are responsible for many TICK-BORNE DISEASES, including the transmission of ROCKY MOUNTAIN SPOTTED FEVER; TULAREMIA; BABESIOSIS; AFRICAN SWINE FEVER; and RELAPSING FEVER. %28%From Barnes, Invertebrate Zoology, 5th ed, pp543-44%29%%A%    
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013987 2005
% 224.44/224.60  |- rdf__type mesh__D013987sskos__Concept
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013987 2006
% 224.44/224.60  |- mesh__dateRevised mesh__D013987 2003-07-09
% 224.44/224.60  |- mesh__recordAuthorizer mesh__D013987 sjn
% 224.44/224.60  |- mesh__recordOriginator mesh__D013987 NLM
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013987 2004
% 224.44/224.60  |- skos__broader mesh__D013987smesh__D000053
% 224.44/224.60  |- mesh__recordMaintainer mesh__D013987 ags
% 224.44/224.60  |- mesh__dateCreated mesh__D013987 1999-01-01
% 224.44/224.60  |- skos__altLabel mesh__D013987 Ixodida
% 224.44/224.60  |- skos__prefLabel mesh__D013987 Ticks
% 224.44/224.60  |- mesh__historyNote mesh__D013189 73%28%67%29%   
% 224.44/224.60  |- mesh__recordAuthorizer mesh__D013189 ags
% 224.44/224.60  |- mesh__recordOriginator mesh__D013189 NLM
% 224.44/224.60  |- rdf__type mesh__D013189sskos__Concept
% 224.44/224.60  |- skos__historyNote mesh__D013189 Muscle, Smooth/physiology %28%1966%29%
% 224.44/224.60  |- skos__annotation mesh__D013189 /biosyn /physiol permitted   
% 224.44/224.60  |- mesh__publicMeSHNote mesh__D013189 73   
% 224.44/224.60  |- mesh__dateEstablished mesh__D013189 1973-01-01
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013189 2006
% 224.44/224.60  |- skos__historyNote mesh__D013189 Anaphylaxis %28%1966%29%
% 224.44/224.60  |- skos__altLabel mesh__D013189 Slow Reacting Substance of Anaphylaxis
% 224.44/224.60  |- mesh__dateRevised mesh__D013189 2005-07-19
% 224.44/224.60  |- mesh__dateCreated mesh__D013189 1999-01-01
% 224.44/224.60  |- skos__prefLabel mesh__D013189 SRS-A
% 224.44/224.60  |- skos__broader mesh__D013189smesh__D015289
% 224.44/224.60  |- mesh__recordMaintainer mesh__D013189 ags
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D013189 2006A
% 224.44/224.60  |- skos__scopeNote mesh__D013189
% 224.44/224.60       A group of LEUKOTRIENES; %28%LTC4; LTD4; and LTE4%29% that is the major mediator of BRONCHOCONSTRICTION; HYPERSENSITIVITY; and other allergic reactions. Earlier studies described a %22%slow-reacting substance of ANAPHYLAXIS%22% released from lung by cobra venom or after anaphylactic shock. The relationship between SRS-A leukotrienes was established by UV which showed the presence of the conjugated triene. %28%From Merck Index, 11th ed%29%%A%    
% 224.44/224.60  |- skos__hiddenLabel mesh__D018672 Population-Based Plannings
% 224.44/224.60  |- skos__annotation mesh__D018672 specify geog   
% 224.44/224.60  |- skos__hiddenLabel mesh__D018672 Planning, Population-Based
% 224.44/224.60  |- mesh__dateCreated mesh__D018672 1994-05-23
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D018672 2005
% 224.44/224.60  |- skos__hiddenLabel mesh__D018672 Community Health Plannings
% 224.44/224.60  |- skos__hiddenLabel mesh__D018672 Health System, Community
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D018672 2002
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D018672 2006
% 224.44/224.60  |- skos__scopeNote mesh__D018672
% 224.44/224.60       Planning that has the goals of improving health, improving accessibility to health services, and promoting efficiency in the provision of services and resources on a comprehensive basis for a whole community. %28%From Facts on File Dictionary of Health Care Management, 1988, p299%29%%A%    
% 224.44/224.60  |- skos__related mesh__D018672smesh__D003153
% 224.44/224.60  |- skos__hiddenLabel mesh__D018672 Plannings, Community Health
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D018672 2003
% 224.44/224.60  |- skos__hiddenLabel mesh__D018672 Plannings, Population-Based
% 224.44/224.60  |- mesh__recordMaintainer mesh__D018672 kle
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D018672 2000
% 224.44/224.60  |- rdf__type mesh__D018672sskos__Concept
% 224.44/224.60  |- skos__hiddenLabel mesh__D018672 Systems, Community Health
% 224.44/224.60  |- skos__hiddenLabel mesh__D018672 Health Systems, Community
% 224.44/224.60  |- skos__hiddenLabel mesh__D018672 Health Planning, Community
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D018672 2004
% 224.44/224.60  |- skos__hiddenLabel mesh__D018672 Health Plannings, Community
% 224.44/224.60  |- mesh__dateEstablished mesh__D018672 1995-01-01
% 224.44/224.60  |- skos__hiddenLabel mesh__D018672 Planning, Community Health
% 224.44/224.60  |- skos__hiddenLabel mesh__D018672 Population Based Planning
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D018672 2001
% 224.44/224.60  |- skos__hiddenLabel mesh__D018672 System, Community Health
% 224.44/224.60  |- skos__prefLabel mesh__D018672 Community Health Planning
% 224.44/224.60  |- mesh__publicMeSHNote mesh__D018672 95   
% 224.44/224.60  |- skos__broader mesh__D018672smesh__D012040
% 224.44/224.60  |- mesh__dateRevised mesh__D018672 1999-11-03
% 224.44/224.60  |- skos__hiddenLabel mesh__D018672 Community Health System
% 224.44/224.60  |- mesh__recordAuthorizer mesh__D018672 sjn
% 224.44/224.60  |- mesh__historyNote mesh__D018672 95   
% 224.44/224.60  |- mesh__recordOriginator mesh__D018672 JLS
% 224.44/224.60  |- skos__scopeNote mesh__D004652
% 224.44/224.60       A condition when the SELLA TURCICA is not filled with pituitary tissue. The pituitary gland is either compressed, atrophied, or removed. There are two types: %28%1%29% primary empty sella is due a defect in the sella diaphragm leading to arachnoid herniation into the sellar space; %28%2%29% secondary empty sella is associated with the removal or treatment of PITUITARY NEOPLASMS.%A%    
% 224.44/224.60  |- skos__altLabel mesh__D004652 Empty Sella Turcica Syndrome
% 224.44/224.60  |- skos__prefLabel mesh__D004652 Empty Sella Syndrome
% 224.44/224.60  |- mesh__recordAuthorizer mesh__D004652 sjn
% 224.44/224.60  |- mesh__historyNote mesh__D004652 1978   
% 224.44/224.60  |- mesh__dateEstablished mesh__D004652 1978-01-01
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D004652 2006
% 224.44/224.60  |- mesh__recordMaintainer mesh__D004652 lkt
% 224.44/224.60  |- skos__broader mesh__D004652smesh__D010900
% 224.44/224.60  |- mesh__publicMeSHNote mesh__D004652 1978   
% 224.44/224.60  |- mesh__recordOriginator mesh__D004652 VDK
% 224.44/224.60  |- mesh__dateRevised mesh__D004652 2005-06-30
% 224.44/224.60  |- skos__altLabel mesh__D004652 Secondary Empty Sella Syndrome
% 224.44/224.60  |- rdf__type mesh__D004652sskos__Concept
% 224.44/224.60  |- mesh__dateCreated mesh__D004652 1977-04-27
% 224.44/224.60  |- skos__altLabel mesh__D004652 Primary Empty Sella Syndrome
% 224.44/224.60  |- skos__historyNote mesh__D004652 Sella Turcica %28%1966-1977%29%
% 224.44/224.60  |- skos__hiddenLabel mesh__D004652 Empty Sella Syndromes
% 224.44/224.60  |- mesh__dateCreated mesh__D014282 1999-01-01
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D014282 2006
% 224.44/224.60  |- mesh__recordOriginator mesh__D014282 NLM
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D014282 2002
% 224.44/224.60  |- mesh__recordAuthorizer mesh__D014282 sjn
% 224.44/224.60  |- mesh__recordMaintainer mesh__D014282 ssb
% 224.44/224.60  |- skos__annotation mesh__D014282 DF: note short X ref   
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D014282 2003
% 224.44/224.60  |- mesh__dateRevised mesh__D014282 2001-07-25
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D014282 2004
% 224.44/224.60  |- skos__altLabel mesh__D014282 Benzhexol
% 224.44/224.60  |- skos__prefLabel mesh__D014282 Trihexyphenidyl
% 224.44/224.60  |- skos__broader mesh__D014282smesh__D010880
% 224.44/224.60  |- rdf__type mesh__D014282sskos__Concept
% 224.44/224.60  |- skos__scopeNote mesh__D014282
% 224.44/224.60       One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.%A%    
% 224.44/224.60  |- mesh__activeMeSHYear mesh__D014282 2005
% 224.44/224.60  |- skos__altLabel mesh__D008245 Phospholipase B
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D008245 2005
% 224.44/224.61  |- mesh__recordMaintainer mesh__D008245 ssb
% 224.44/224.61  |- mesh__historyNote mesh__D008245
% 224.44/224.61       91%28%80%29%; was see under PHOSPHOLIPASES 1980-90   
% 224.44/224.61  |- mesh__recordAuthorizer mesh__D008245 sjn
% 224.44/224.61  |- skos__hiddenLabel mesh__D008245 A1, Lysophospholipase
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D008245 2006
% 224.44/224.61  |- mesh__publicMeSHNote mesh__D008245
% 224.44/224.61       91; was see under PHOSPHOLIPASES 1980-90   
% 224.44/224.61  |- skos__prefLabel mesh__D008245 Lysophospholipase
% 224.44/224.61  |- skos__hiddenLabel mesh__D008245
% 224.44/224.61       Lysolecithin Lysolecithin Acyltransferase
% 224.44/224.61  |- skos__hiddenLabel mesh__D008245 B, Lecithinase
% 224.44/224.61  |- skos__altLabel mesh__D008245 Lysolecithin-Lysolecithin Acyltransferase
% 224.44/224.61  |- rdf__type mesh__D008245sskos__Concept
% 224.44/224.61  |- skos__hiddenLabel mesh__D008245 A, Lysophospholipase
% 224.44/224.61  |- mesh__dateEstablished mesh__D008245 1991-01-01
% 224.44/224.61  |- mesh__dateRevised mesh__D008245 2003-07-09
% 224.44/224.61  |- skos__altLabel mesh__D008245 Lecithinase B
% 224.44/224.61  |- skos__hiddenLabel mesh__D008245 C, Lysophospholipase
% 224.44/224.61  |- skos__hiddenLabel mesh__D008245
% 224.44/224.61       Acyltransferase, Lysolecithin-Lysolecithin
% 224.44/224.61  |- mesh__recordOriginator mesh__D008245 RLS
% 224.44/224.61  |- skos__broader mesh__D008245smesh__D010740
% 224.44/224.61  |- skos__historyNote mesh__D008245 Phospholipases %28%1966-1979%29%
% 224.44/224.61  |- skos__hiddenLabel mesh__D008245 B, Phospholipase
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D008245 2004
% 224.44/224.61  |- mesh__dateCreated mesh__D008245 1979-02-21
% 224.44/224.61  |- skos__scopeNote mesh__D008245
% 224.44/224.61       An enzyme that catalyzes the hydrolysis of a single fatty acid ester bond in lysoglycerophosphatidates with the formation of glyceryl phosphatidates and a fatty acid. EC 3.1.1.5.%A%    
% 224.44/224.61  |- skos__altLabel mesh__D008245 Lysolecithinase
% 224.44/224.61  |- skos__hiddenLabel mesh__D008245 L2, Lysophospholipase
% 224.44/224.61  |- skos__broader mesh__D000262smesh__D019761
% 224.44/224.61  |- skos__altLabel mesh__D000262 Adenylyl Cyclase
% 224.44/224.61  |- skos__hiddenLabel mesh__D000262 Cyclase, Adenylate
% 224.44/224.61  |- mesh__dateRevised mesh__D000262 2004-07-07
% 224.44/224.61  |- skos__broader mesh__D000262smesh__D047908
% 224.44/224.61  |- skos__historyNote mesh__D000262 Enzymes %28%1966-1967%29%
% 224.44/224.61  |- mesh__recordAuthorizer mesh__D000262 sjn
% 224.44/224.61  |- skos__historyNote mesh__D000262 Adenine Nucleotides %28%1966-1967%29%
% 224.44/224.61  |- mesh__recordOriginator mesh__D000262 NLM
% 224.44/224.61  |- mesh__publicMeSHNote mesh__D000262 98; see ADENYL CYCLASE 1972-97   
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D000262 2005
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D000262 2006
% 224.44/224.61  |- mesh__dateCreated mesh__D000262 1999-01-01
% 224.44/224.61  |- mesh__dateEstablished mesh__D000262 1972-01-01
% 224.44/224.61  |- skos__scopeNote mesh__D000262
% 224.44/224.61       An enzyme of the lyase class that catalyzes the formation of CYCLIC AMP and pyrophosphate from ATP. EC 4.6.1.1.%A%    
% 224.44/224.61  |- skos__prefLabel mesh__D000262 Adenylate Cyclase
% 224.44/224.61  |- skos__altLabel mesh__D000262 Adenyl Cyclase
% 224.44/224.61  |- rdf__type mesh__D000262sskos__Concept
% 224.44/224.61  |- mesh__recordMaintainer mesh__D000262 jmp
% 224.44/224.61  |- mesh__historyNote mesh__D000262 98%28%68%29%   
% 224.44/224.61  |- skos__hiddenLabel mesh__D000262 Cyclase, Adenylyl
% 224.44/224.61  |- skos__hiddenLabel mesh__D000262 Cyclase, Adenyl
% 224.44/224.61  |- skos__prefLabel mesh__D013988 Ticlopidine
% 224.44/224.61  |- rdf__type mesh__D013988sskos__Concept
% 224.44/224.61  |- mesh__dateRevised mesh__D013988 2005-06-30
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D013988 2006
% 224.44/224.61  |- mesh__historyNote mesh__D013988 87   
% 224.44/224.61  |- skos__hiddenLabel mesh__D013988 53 32C
% 224.44/224.61  |- skos__broader mesh__D013988smesh__D013876
% 224.44/224.61  |- skos__historyNote mesh__D013988 Thiophenes %28%1966-1986%29%
% 224.44/224.61  |- mesh__recordMaintainer mesh__D013988 ssb
% 224.44/224.61  |- skos__hiddenLabel mesh__D013988 5332C
% 224.44/224.61  |- mesh__recordAuthorizer mesh__D013988 sjn
% 224.44/224.61  |- skos__scopeNote mesh__D013988
% 224.44/224.61       Ticlopidine is an effective inhibitor of platelet aggregation. The drug has been found to significantly reduce infarction size in acute myocardial infarcts and is an effective antithrombotic agent in arteriovenous fistulas, aorto-coronary bypass grafts, ischemic heart disease, venous thrombosis, and arteriosclerosis.%A%    
% 224.44/224.61  |- mesh__dateCreated mesh__D013988 1986-06-16
% 224.44/224.61  |- mesh__dateEstablished mesh__D013988 1987-01-01
% 224.44/224.61  |- skos__hiddenLabel mesh__D013988 Hydrochloride, Ticlopidine
% 224.44/224.61  |- mesh__publicMeSHNote mesh__D013988 87   
% 224.44/224.61  |- mesh__recordOriginator mesh__D013988 RLS
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D018673 2003
% 224.44/224.61  |- skos__hiddenLabel mesh__D018673 Policies, Nutrition
% 224.44/224.61  |- skos__prefLabel mesh__D018673 Nutrition Policy
% 224.44/224.61  |- mesh__dateRevised mesh__D018673 1999-11-03
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D018673 2001
% 224.44/224.61  |- rdf__type mesh__D018673sskos__Concept
% 224.44/224.61  |- skos__hiddenLabel mesh__D018673 Daily Allowance, Recommended
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D018673 2004
% 224.44/224.61  |- mesh__publicMeSHNote mesh__D018673 95   
% 224.44/224.61  |- skos__hiddenLabel mesh__D018673 Policy, Nutrition
% 224.44/224.61  |- skos__hiddenLabel mesh__D018673 Policies, Food
% 224.44/224.61  |- skos__hiddenLabel mesh__D018673 Food Policies
% 224.44/224.61  |- skos__hiddenLabel mesh__D018673 Dietary Allowance, Recommended
% 224.44/224.61  |- mesh__recordAuthorizer mesh__D018673 sjn
% 224.44/224.61  |- skos__hiddenLabel mesh__D018673 Allowance, Recommended Dietary
% 224.44/224.61  |- skos__hiddenLabel mesh__D018673 Allowances, Recommended Dietary
% 224.44/224.61  |- skos__hiddenLabel mesh__D018673 Dietary Allowances, Recommended
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D018673 2002
% 224.44/224.61  |- mesh__historyNote mesh__D018673 95   
% 224.44/224.61  |- skos__hiddenLabel mesh__D018673 Daily Allowances, Recommended
% 224.44/224.61  |- mesh__recordOriginator mesh__D018673 JLS
% 224.44/224.61  |- mesh__dateCreated mesh__D018673 1994-05-31
% 224.44/224.61  |- skos__historyNote mesh__D018673 Health Policy %28%1980-1994%29%
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D018673 2005
% 224.44/224.61  |- skos__hiddenLabel mesh__D018673 Recommended Dietary Allowance
% 224.44/224.61  |- skos__broader mesh__D018673smesh__D006291
% 224.44/224.61  |- skos__altLabel mesh__D018673 RDA
% 224.44/224.61  |- skos__hiddenLabel mesh__D018673 Allowances, Recommended Daily
% 224.44/224.61  |- mesh__dateEstablished mesh__D018673 1995-01-01
% 224.44/224.61  |- skos__annotation mesh__D018673
% 224.44/224.61       govt guidelines on public food supply %26% nutrition   
% 224.44/224.61  |- skos__hiddenLabel mesh__D018673 Recommended Daily Allowance
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D018673 2006
% 224.44/224.61  |- mesh__recordMaintainer mesh__D018673 kle
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D018673 2000
% 224.44/224.61  |- skos__hiddenLabel mesh__D018673 Allowance, Recommended Daily
% 224.44/224.61  |- skos__hiddenLabel mesh__D018673 Nutrition Policies
% 224.44/224.61  |- skos__scopeNote mesh__D018673
% 224.44/224.61       Governmental guidelines and objectives pertaining to public food supply and nutrition including recommendations for healthy diet and changes in food habits to ensure healthy diet.%A%    
% 224.44/224.61  |- skos__hiddenLabel mesh__D018673 Policy, Food
% 224.44/224.61  |- mesh__recordMaintainer mesh__D010690 PXP
% 224.44/224.61  |- skos__hiddenLabel mesh__D010690 Venographies
% 224.44/224.61  |- skos__annotation mesh__D010690
% 224.44/224.61       NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: PHLEBOGR%A%  
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D010690 2006
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D010690 2000
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D010690 2001
% 224.44/224.61  |- skos__broader mesh__D010690smesh__D000792
% 224.44/224.61  |- mesh__dateRevised mesh__D010690 1997-06-20
% 224.44/224.61  |- mesh__dateCreated mesh__D010690 1999-01-01
% 224.44/224.61  |- skos__prefLabel mesh__D010690 Phlebography
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D010690 2002
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D010690 1998
% 224.44/224.61  |- mesh__recordAuthorizer mesh__D010690 SJN
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D010690 2003
% 224.44/224.61  |- mesh__recordOriginator mesh__D010690 NLM
% 224.44/224.61  |- mesh__dateEstablished mesh__D010690 1966-01-01
% 224.44/224.61  |- skos__scopeNote mesh__D010690
% 224.44/224.61       Radiographic visualization or recording of a vein after the injection of contrast medium.%A%    
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D010690 1999
% 224.44/224.61  |- mesh__publicMeSHNote mesh__D010690
% 224.44/224.61       66; was see under ANGIOGRAPHY 1963-65   
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D010690 2004
% 224.44/224.61  |- skos__altLabel mesh__D010690 Venography
% 224.44/224.61  |- rdf__type mesh__D010690sskos__Concept
% 224.44/224.61  |- skos__hiddenLabel mesh__D010690 Phlebographies
% 224.44/224.61  |- mesh__historyNote mesh__D010690
% 224.44/224.61       66%28%63%29%; was see under ANGIOGRAPHY 1963-65   
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D010690 2005
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D004653 2000
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D004653 2005
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D004653 2004
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D004653 2001
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D004653 2006
% 224.44/224.61  |- skos__scopeNote mesh__D004653
% 224.44/224.61       Presence of pus in a hollow organ or body cavity.     
% 224.44/224.61  |- skos__annotation mesh__D004653
% 224.44/224.61       GEN or unspecified; prefer specifics but empyema unspecified by author may be EMPYEMA, PLEURAL: check text; coord IM with precoord organ/dis term %28%IM%29%; empyema in tuberc = EMPYEMA, TUBERCULOUS%A%  
% 224.44/224.61  |- skos__prefLabel mesh__D004653 Empyema
% 224.44/224.61  |- mesh__recordMaintainer mesh__D004653 KEV
% 224.44/224.61  |- mesh__dateCreated mesh__D004653 1999-01-01
% 224.44/224.61  |- mesh__recordAuthorizer mesh__D004653 sjn
% 224.44/224.61  |- mesh__dateRevised mesh__D004653 1999-11-08
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D004653 2002
% 224.44/224.61  |- rdf__type mesh__D004653sskos__Concept
% 224.44/224.61  |- mesh__recordOriginator mesh__D004653 NLM
% 224.44/224.61  |- skos__broader mesh__D004653smesh__D013492
% 224.44/224.61  |- skos__related mesh__D004653smesh__D000038
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D004653 2003
% 224.44/224.61  |- skos__hiddenLabel mesh__D014283 Acids, Triiodobenzoic
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D014283 2002
% 224.44/224.61  |- mesh__historyNote mesh__D014283
% 224.44/224.61       91%28%78%29%; was see under IODOBENZOATES 1978-90; was TRIIODOBENZOIC ACID see under IODOBENZOATES 1972-77 %28%Prov 1972-74%29%%A%  
% 224.44/224.61  |- skos__prefLabel mesh__D014283 Triiodobenzoic Acids
% 224.44/224.61  |- mesh__dateRevised mesh__D014283 1998-06-11
% 224.44/224.61  |- skos__historyNote mesh__D014283
% 224.44/224.61       Plant Growth Regulators %28%1966-1971%29%
% 224.44/224.61  |- mesh__recordMaintainer mesh__D014283 ADP
% 224.44/224.61  |- skos__broader mesh__D014283smesh__D007463
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D014283 2006
% 224.44/224.61  |- mesh__dateCreated mesh__D014283 1999-01-01
% 224.44/224.61  |- skos__scopeNote mesh__D014283
% 224.44/224.61       Triiodo-substituted derivatives of BENZOIC ACID.     
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D014283 2004
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D014283 2001
% 224.44/224.61  |- mesh__recordOriginator mesh__D014283 NLM
% 224.44/224.61  |- skos__hiddenLabel mesh__D014283 Acid, Triiodobenzoic
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D014283 2000
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D014283 1999
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D014283 2005
% 224.44/224.61  |- mesh__publicMeSHNote mesh__D014283
% 224.44/224.61       91; was see under IODOBENZOATES 1978-90; was TRIIODOBENZOIC ACID see under IODOBENZOATES 1975-77%A%  
% 224.44/224.61  |- skos__historyNote mesh__D014283 Benzoates %28%1966-1971%29%
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D014283 2003
% 224.44/224.61  |- mesh__dateEstablished mesh__D014283 1991-01-01
% 224.44/224.61  |- mesh__onlineNote mesh__D014283
% 224.44/224.61       use TRIIODOBENZOIC ACIDS to search TRIIODOBENZOIC ACID 1972-77 %28%as Prov 1972-74%29%%A%  
% 224.44/224.61  |- mesh__recordAuthorizer mesh__D014283 SJN
% 224.44/224.61  |- rdf__type mesh__D014283sskos__Concept
% 224.44/224.61  |- skos__altLabel mesh__D008246 Lysophosphatidic Acids
% 224.44/224.61  |- mesh__dateRevised mesh__D008246 2003-07-09
% 224.44/224.61  |- rdf__type mesh__D008246sskos__Concept
% 224.44/224.61  |- skos__historyNote mesh__D008246
% 224.44/224.61       Phosphatidic Acids or derivatives %28%1975-1987%29%
% 224.44/224.61  |- skos__hiddenLabel mesh__D008246 Acids, Lysophosphatidic
% 224.44/224.61  |- mesh__publicMeSHNote mesh__D008246 88   
% 224.44/224.61  |- mesh__dateCreated mesh__D008246 1987-03-23
% 224.44/224.61  |- skos__historyNote mesh__D008246 Phospholipids %28%1966-1987%29%
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D008246 2004
% 224.44/224.61  |- skos__broader mesh__D008246smesh__D010712
% 224.44/224.61  |- skos__scopeNote mesh__D008246
% 224.44/224.61       Derivatives of PHOSPHATIDIC ACIDS that lack one of its fatty acyl chains due to its hydrolytic removal.%A%    
% 224.44/224.61  |- mesh__recordMaintainer mesh__D008246 ssb
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D008246 2005
% 224.44/224.61  |- mesh__recordAuthorizer mesh__D008246 sjn
% 224.44/224.61  |- skos__prefLabel mesh__D008246 Lysophospholipids
% 224.44/224.61  |- mesh__recordOriginator mesh__D008246 RLS
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D008246 2006
% 224.44/224.61  |- mesh__dateEstablished mesh__D008246 1988-01-01
% 224.44/224.61  |- mesh__historyNote mesh__D008246 88   
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D000263 2005
% 224.44/224.61  |- skos__altLabel mesh__D000263 ATP-AMP Transphosphorylase
% 224.44/224.61  |- mesh__publicMeSHNote mesh__D000263
% 224.44/224.61       91; was see under PHOSPHOTRANSFERASES, ATP 1975-90   
% 224.44/224.61  |- mesh__dateEstablished mesh__D000263 1991-01-01
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D000263 2004
% 224.44/224.61  |- mesh__dateRevised mesh__D000263 2003-07-09
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D000263 2006
% 224.44/224.61  |- skos__scopeNote mesh__D000263
% 224.44/224.61       An enzyme that catalyzes the phosphorylation of AMP to ADP in the presence of ATP or inorganic triphosphate. EC 2.7.4.3.%A%    
% 224.44/224.61  |- skos__altLabel mesh__D000263 Myokinase
% 224.44/224.61  |- skos__historyNote mesh__D000263 Adenosine Monophosphate %28%1974%29%
% 224.44/224.61  |- mesh__recordAuthorizer mesh__D000263 sjn
% 224.44/224.61  |- skos__altLabel mesh__D000263 ATP-AMP Phosphotransferase
% 224.44/224.61  |- mesh__recordOriginator mesh__D000263 NLM
% 224.44/224.61  |- skos__broader mesh__D000263smesh__D017856
% 224.44/224.61  |- skos__hiddenLabel mesh__D000263 ATP AMP Transphosphorylase
% 224.44/224.61  |- mesh__dateCreated mesh__D000263 1974-11-11
% 224.44/224.61  |- skos__hiddenLabel mesh__D000263 Transphosphorylase, ATP-AMP
% 224.44/224.61  |- skos__hiddenLabel mesh__D000263 ATP AMP Phosphotransferase
% 224.44/224.61  |- rdf__type mesh__D000263sskos__Concept
% 224.44/224.61  |- skos__historyNote mesh__D000263 Phosphotransferases, ATP %28%1974%29%
% 224.44/224.61  |- skos__altLabel mesh__D000263 AMP Kinase
% 224.44/224.61  |- mesh__recordMaintainer mesh__D000263 ssb
% 224.44/224.61  |- mesh__historyNote mesh__D000263
% 224.44/224.61       91%28%75%29%; was see under PHOSPHOTRANSFERASES, ATP 1975-90   
% 224.44/224.61  |- skos__hiddenLabel mesh__D000263 Kinase, AMP
% 224.44/224.61  |- skos__hiddenLabel mesh__D000263 Kinase, Adenylate
% 224.44/224.61  |- skos__prefLabel mesh__D000263 Adenylate Kinase
% 224.44/224.61  |- skos__hiddenLabel mesh__D000263 Phosphotransferase, ATP-AMP
% 224.44/224.61  |- skos__altLabel mesh__D000263 Adenylokinase
% 224.44/224.61  |- skos__altLabel mesh__D013989 Thienylic Acid
% 224.44/224.61  |- mesh__dateEstablished mesh__D013989 1991-01-01
% 224.44/224.61  |- mesh__recordAuthorizer mesh__D013989 sjn
% 224.44/224.61  |- skos__hiddenLabel mesh__D013989 ANP3624
% 224.44/224.61  |- skos__scopeNote mesh__D013989
% 224.44/224.61       A novel diuretic with uricosuric action. It has been proposed as an antihypertensive agent.%A%    
% 224.44/224.61  |- skos__hiddenLabel mesh__D013989 Acid, Thienylic
% 224.44/224.61  |- skos__prefLabel mesh__D013989 Ticrynafen
% 224.44/224.61  |- skos__broader mesh__D013989smesh__D010642
% 224.44/224.61  |- skos__hiddenLabel mesh__D013989 SKF 62698
% 224.44/224.61  |- skos__hiddenLabel mesh__D013989 ANP 3624
% 224.44/224.61  |- mesh__historyNote mesh__D013989
% 224.44/224.61       91%28%80%29%; was see under GLYCOLATES 1980-90   
% 224.44/224.61  |- mesh__dateRevised mesh__D013989 2005-06-30
% 224.44/224.61  |- skos__altLabel mesh__D013989 Tienilic Acid
% 224.44/224.61  |- mesh__recordOriginator mesh__D013989 SH
% 224.44/224.61  |- skos__hiddenLabel mesh__D013989 Acid, Tienilic
% 224.44/224.61  |- rdf__type mesh__D013989sskos__Concept
% 224.44/224.61  |- skos__hiddenLabel mesh__D013989 SKF62698
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D013989 2006
% 224.44/224.61  |- skos__historyNote mesh__D013989 Thiophenes %28%1966-1979%29%
% 224.44/224.61  |- skos__historyNote mesh__D013989 Phenoxyacetates %28%1966-1979%29%
% 224.44/224.61  |- mesh__publicMeSHNote mesh__D013989
% 224.44/224.61       91; was see under GLYCOLATES 1980-90   
% 224.44/224.61  |- skos__broader mesh__D013989smesh__D013876
% 224.44/224.61  |- mesh__dateCreated mesh__D013989 1979-03-02
% 224.44/224.61  |- mesh__recordMaintainer mesh__D013989 ssb
% 224.44/224.61  |- skos__scopeNote mesh__D018674
% 224.44/224.61       Drugs that bind to but do not activate ADRENERGIC RECEPTORS. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters EPINEPHRINE and NOREPINEPHRINE.%A%    
% 224.44/224.61  |- skos__prefLabel mesh__D018674 Adrenergic Antagonists
% 224.44/224.61  |- skos__hiddenLabel mesh__D018674 Antagonists, Adrenergic
% 224.44/224.61  |- skos__altLabel mesh__D018674 Antiadrenergics
% 224.44/224.61  |- mesh__recordMaintainer mesh__D018674 ssb
% 224.44/224.61  |- skos__hiddenLabel mesh__D018674 Adrenergic Blocking Agents
% 224.44/224.61  |- skos__hiddenLabel mesh__D018674 Drugs, Adrenolytic
% 224.44/224.61  |- skos__hiddenLabel mesh__D018674 Agents, Adrenergic-Blocking
% 224.44/224.61  |- skos__hiddenLabel mesh__D018674 Receptor Blockaders, Adrenergic
% 224.44/224.61  |- skos__broader mesh__D018674smesh__D018663
% 224.44/224.61  |- mesh__recordOriginator mesh__D018674 RAZ
% 224.44/224.61  |- skos__historyNote mesh__D018674 Sympatholytics %28%1982-1994%29%
% 224.44/224.61  |- skos__annotation mesh__D018674
% 224.44/224.61       do not confuse with ADRENERGIC AGONISTS; DF: ADREN ANTAG   
% 224.44/224.61  |- skos__hiddenLabel mesh__D018674 Blockaders, Adrenergic
% 224.44/224.61  |- skos__historyNote mesh__D018674
% 224.44/224.61       Receptors, Adrenergic/antagonists %26% inhibitors %28%1977-1994%29%
% 224.44/224.61  |- rdf__type mesh__D018674sskos__Concept
% 224.44/224.61  |- skos__hiddenLabel mesh__D018674 Blocker, Adrenergic
% 224.44/224.61  |- skos__altLabel mesh__D018674 Adrenolytic Agents
% 224.44/224.61  |- skos__altLabel mesh__D018674 Adrenergic Blockers
% 224.44/224.61  |- skos__altLabel mesh__D018674 Adrenolytics
% 224.44/224.61  |- skos__hiddenLabel mesh__D018674 Blockers, Adrenergic
% 224.44/224.61  |- skos__altLabel mesh__D018674 Adrenergic Receptor Blockaders
% 224.44/224.61  |- skos__altLabel mesh__D018674 Receptor Antagonists, Adrenergic
% 224.44/224.61  |- skos__hiddenLabel mesh__D018674 Anti Adrenergics
% 224.44/224.61  |- skos__altLabel mesh__D018674 Antiadrenergic Agents
% 224.44/224.61  |- skos__altLabel mesh__D018674 Adrenergic-Blocking Agents
% 224.44/224.61  |- mesh__dateRevised mesh__D018674 2005-06-30
% 224.44/224.61  |- skos__altLabel mesh__D018674 Adrenergic Blocker
% 224.44/224.61  |- skos__related mesh__D018674smesh__D013565
% 224.44/224.61  |- skos__hiddenLabel mesh__D018674 Blockaders, Adrenergic Receptor
% 224.44/224.61  |- mesh__publicMeSHNote mesh__D018674
% 224.44/224.61       95; ADRENERGIC-BLOCKING AGENTS was see SYMPATHOLYTICS 1978-94; ANTIADRENERGIC AGENTS was see SYMPATHOLYTICS 1975-94%A%  
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D018674 2006
% 224.44/224.61  |- skos__altLabel mesh__D018674 Adrenergic Antagonist
% 224.44/224.61  |- skos__hiddenLabel mesh__D018674 Agents, Antiadrenergic
% 224.44/224.61  |- mesh__dateEstablished mesh__D018674 1995-01-01
% 224.44/224.61  |- skos__altLabel mesh__D018674 Adrenolytic Drugs
% 224.44/224.61  |- skos__hiddenLabel mesh__D018674 Antagonists, Adrenergic Receptor
% 224.44/224.61  |- skos__hiddenLabel mesh__D018674 Agents, Adrenolytic
% 224.44/224.61  |- mesh__onlineNote mesh__D018674
% 224.44/224.61       use SYMPATHOLYTICS to search ADRENERGIC-BLOCKING AGENTS 1978-94 %26% ANTIADRENERGIC AGENTS 1975-94%A%  
% 224.44/224.61  |- skos__altLabel mesh__D018674 Anti-Adrenergics
% 224.44/224.61  |- skos__altLabel mesh__D018674 Adrenergic Blockaders
% 224.44/224.61  |- mesh__recordAuthorizer mesh__D018674 sjn
% 224.44/224.61  |- mesh__historyNote mesh__D018674
% 224.44/224.61       95; ADRENERGIC-BLOCKING AGENTS was see SYMPATHOLYTICS 1978-94; ANTIADRENERGIC AGENTS was see SYMPATHOLYTICS 1975-94%A%  
% 224.44/224.61  |- skos__altLabel mesh__D018674 Adrenergic Receptor Antagonists
% 224.44/224.61  |- skos__hiddenLabel mesh__D018674 Antagonist, Adrenergic
% 224.44/224.61  |- mesh__dateCreated mesh__D018674 1994-06-01
% 224.44/224.61  |- mesh__recordOriginator mesh__D010691 NLM
% 224.44/224.61  |- rdf__type mesh__D010691sskos__Concept
% 224.44/224.61  |- mesh__dateRevised mesh__D010691 2005-07-29
% 224.44/224.61  |- skos__annotation mesh__D010691
% 224.44/224.61       blood-sucking fly, the vector of PAPPATACI FEVER see PHLEBOTOMUS FEVER %26% other dis; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111%A%  
% 224.44/224.61  |- skos__prefLabel mesh__D010691 Phlebotomus
% 224.44/224.61  |- mesh__dateCreated mesh__D010691 1999-01-01
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D010691 2006A
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D010691 2006
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D010691 2005
% 224.44/224.61  |- skos__broader mesh__D010691smesh__D011576
% 224.44/224.61  |- mesh__recordMaintainer mesh__D010691 ags
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D010691 2004
% 224.44/224.61  |- skos__scopeNote mesh__D010691
% 224.44/224.61       A genus of PSYCHODIDAE which functions as the vector of a number of pathogenic organisms, including LEISHMANIA DONOVANI; LEISHMANIA TROPICA; Bartonella bacilliformis, and the Pappataci fever virus %28%SANDFLY FEVER NAPLES VIRUS%29%.%A%    
% 224.44/224.61  |- mesh__recordAuthorizer mesh__D010691 ags
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D004654 2002
% 224.44/224.61  |- mesh__dateCreated mesh__D004654 1999-01-01
% 224.44/224.61  |- mesh__dateEstablished mesh__D004654 1991-01-01
% 224.44/224.61  |- skos__prefLabel mesh__D004654 Empyema, Tuberculous
% 224.44/224.61  |- mesh__publicMeSHNote mesh__D004654
% 224.44/224.61       91,63-83; was see under TUBERCULOSIS, PLEURAL 1984-90; was heading 1963-83%A%  
% 224.44/224.61  |- mesh__recordOriginator mesh__D004654 NLM
% 224.44/224.61  |- mesh__recordAuthorizer mesh__D004654 SJN
% 224.44/224.61  |- rdf__type mesh__D004654sskos__Concept
% 224.44/224.61  |- mesh__historyNote mesh__D004654
% 224.44/224.61       91%28%84%29%63; was see under TUBERCULOSIS, PLEURAL 1984-90; was heading 1963-83%A%  
% 224.44/224.61  |- skos__scopeNote mesh__D004654
% 224.44/224.61       Empyema due to MYCOBACTERIUM TUBERCULOSIS.     
% 224.44/224.61  |- skos__hiddenLabel mesh__D004654 Tuberculous Empyemas
% 224.44/224.61  |- mesh__dateRevised mesh__D004654 1997-06-20
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D004654 2000
% 224.44/224.61  |- mesh__recordMaintainer mesh__D004654 TGC
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D004654 1998
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D004654 2003
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D004654 2001
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D004654 2005
% 224.44/224.61  |- skos__hiddenLabel mesh__D004654 Tuberculous Empyema
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D004654 1999
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D004654 2004
% 224.44/224.61  |- skos__annotation mesh__D004654 pleural empyema caused by M. tuberc   
% 224.44/224.61  |- skos__broader mesh__D004654smesh__D016724
% 224.44/224.61  |- skos__hiddenLabel mesh__D004654 Empyemas, Tuberculous
% 224.44/224.61  |- skos__altLabel mesh__D004654 Empyema, Pleural, Tuberculous
% 224.44/224.61  |- skos__broader mesh__D004654smesh__D014396
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D004654 2006
% 224.44/224.61  |- mesh__recordMaintainer mesh__D014284 nns
% 224.44/224.61  |- skos__scopeNote mesh__D014284
% 224.44/224.61       A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine %28%T4%29%. Most T3 is derived from peripheral monodeiodination of T4 at the 5%27% position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.%A%    
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D014284 2006
% 224.44/224.61  |- skos__altLabel mesh__D014284 T3 Thyroid Hormone
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D014284 2002
% 224.44/224.61  |- mesh__dateCreated mesh__D014284 1999-01-01
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D014284 2004
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D014284 2005
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D014284 2003
% 224.44/224.61  |- mesh__historyNote mesh__D014284 LIOTHYRONINE was heading 1963-66   
% 224.44/224.61  |- skos__altLabel mesh__D014284 Liothyronine
% 224.44/224.61  |- skos__prefLabel mesh__D014284 Triiodothyronine
% 224.44/224.61  |- mesh__dateRevised mesh__D014284 2001-07-25
% 224.44/224.61  |- mesh__onlineNote mesh__D014284
% 224.44/224.61       use TRIIODOTHYRONINE to search LIOTHYRONINE 1966   
% 224.44/224.61  |- skos__hiddenLabel mesh__D014284 Thyroid Hormone, T3
% 224.44/224.61  |- rdf__type mesh__D014284sskos__Concept
% 224.44/224.61  |- mesh__recordOriginator mesh__D014284 NLM
% 224.44/224.61  |- skos__related mesh__D014284smesh__D011988
% 224.44/224.61  |- skos__broader mesh__D014284smesh__D013970
% 224.44/224.61  |- mesh__publicMeSHNote mesh__D014284 LIOTHYRONINE was heading 1963-66   
% 224.44/224.61  |- mesh__recordAuthorizer mesh__D014284 sjn
% 224.44/224.61  |- skos__broader mesh__D008247smesh__D022162
% 224.44/224.61  |- skos__prefLabel mesh__D008247 Lysosomes
% 224.44/224.61  |- mesh__dateCreated mesh__D008247 1999-01-01
% 224.44/224.61  |- mesh__dateEstablished mesh__D008247 1965-01-01
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D008247 2004
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D008247 2005
% 224.44/224.61  |- mesh__publicMeSHNote mesh__D008247 65   
% 224.44/224.61  |- skos__scopeNote mesh__D008247
% 224.44/224.61       A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured. Such rupture is supposed to be under metabolic %28%hormonal%29% control. %28%From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A%    
% 224.44/224.61  |- skos__altLabel mesh__D008247 Lysosome
% 224.44/224.61  |- mesh__recordMaintainer mesh__D008247 nns
% 224.44/224.61  |- mesh__historyNote mesh__D008247 65%28%64%29%   
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D008247 2006
% 224.44/224.61  |- mesh__dateRevised mesh__D008247 2003-07-09
% 224.44/224.61  |- mesh__recordAuthorizer mesh__D008247 sjn
% 224.44/224.61  |- rdf__type mesh__D008247sskos__Concept
% 224.44/224.61  |- skos__annotation mesh__D008247
% 224.44/224.61       A 11 qualif except /cytol; /genet permitted   
% 224.44/224.61  |- mesh__recordOriginator mesh__D008247 NLM
% 224.44/224.61  |- mesh__historyNote mesh__D000264
% 224.44/224.61       91%28%79%29%; was see under LYASES 1979-90   
% 224.44/224.61  |- skos__historyNote mesh__D000264
% 224.44/224.61       Adenosine Monophosphate %28%1971-1978%29%
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D000264 2004
% 224.44/224.61  |- mesh__dateRevised mesh__D000264 2003-07-09
% 224.44/224.61  |- skos__scopeNote mesh__D000264
% 224.44/224.61       An enzyme that, in the course of purine ribonucleotide biosynthesis, catalyzes the conversion of 5%27%-phosphoribosyl-4-%28%N-succinocarboxamide%29%-5-aminoimidazole to 5%27%-phosphoribosyl-4-carboxamide-5-aminoimidazole and the conversion of adenylosuccinic acid to AMP. EC 4.3.2.2.%A%    
% 224.44/224.61  |- mesh__dateCreated mesh__D000264 1978-05-16
% 224.44/224.61  |- skos__historyNote mesh__D000264 Succinates %28%1966-1978%29%
% 224.44/224.61  |- mesh__recordOriginator mesh__D000264 RLS
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D000264 2006
% 224.44/224.61  |- mesh__dateEstablished mesh__D000264 1991-01-01
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D000264 2005
% 224.44/224.61  |- skos__historyNote mesh__D000264 Lyases %28%1966-1978%29%
% 224.44/224.61  |- mesh__recordMaintainer mesh__D000264 ssb
% 224.44/224.61  |- mesh__recordAuthorizer mesh__D000264 sjn
% 224.44/224.61  |- skos__prefLabel mesh__D000264 Adenylosuccinate Lyase
% 224.44/224.61  |- mesh__publicMeSHNote mesh__D000264 91; was see under LYASES 1979-90   
% 224.44/224.61  |- skos__hiddenLabel mesh__D000264 Lyase, Adenylosuccinate
% 224.44/224.61  |- skos__altLabel mesh__D000264 Adenylosuccinase
% 224.44/224.61  |- rdf__type mesh__D000264sskos__Concept
% 224.44/224.61  |- skos__broader mesh__D000264smesh__D019760
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D018675 2004
% 224.44/224.61  |- skos__broader mesh__D018675smesh__D008919
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D018675 2000
% 224.44/224.61  |- skos__annotation mesh__D018675
% 224.44/224.61       GEN or unspecified; prefer specifics; used for tests of drugs, food, environ pollutants, etc.; when the test itself is emphasized; coord IM with substance /tox %28%IM%29%; toxic eff of a specific substance = specific substance /tox; DF: TOX TESTS%A%  
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D018675 2003
% 224.44/224.61  |- rdf__type mesh__D018675sskos__Concept
% 224.44/224.61  |- skos__hiddenLabel mesh__D018675 Test, Toxicity
% 224.44/224.61  |- skos__historyNote mesh__D018675
% 224.44/224.61       specific substance/toxicity %28%1966-1994%29%
% 224.44/224.61  |- skos__scopeNote mesh__D018675
% 224.44/224.61       An array of tests used to determine the toxicity of a substance to living systems. These include tests on clinical drugs, foods, and environmental pollutants.%A%    
% 224.44/224.61  |- mesh__recordOriginator mesh__D018675 AGS
% 224.44/224.61  |- mesh__dateRevised mesh__D018675 1999-11-09
% 224.44/224.61  |- mesh__activeMeSHYear mesh__D018675 2002
% 224.44/224.61  |- mesh__recordMaintainer mesh__D018675 jls
% 224.44/224.62  |- skos__altLabel mesh__D018675 Tests, Toxicity
% 224.44/224.62  |- mesh__historyNote mesh__D018675 95   
% 224.44/224.62  |- mesh__dateEstablished mesh__D018675 1995-01-01
% 224.44/224.62  |- skos__hiddenLabel mesh__D018675 Toxicity Test
% 224.44/224.62  |- mesh__publicMeSHNote mesh__D018675 95   
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D018675 2006
% 224.44/224.62  |- mesh__dateCreated mesh__D018675 1994-04-19
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D018675 2001
% 224.44/224.62  |- skos__historyNote mesh__D018675 Toxicology/methods %28%1975-1994%29%
% 224.44/224.62  |- mesh__recordAuthorizer mesh__D018675 sjn
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D018675 2005
% 224.44/224.62  |- skos__prefLabel mesh__D018675 Toxicity Tests
% 224.44/224.62  |- mesh__onlineNote mesh__D010692
% 224.44/224.62       use PHLEOMYCINS to search PHLEOMYCIN 1975-80   
% 224.44/224.62  |- skos__broader mesh__D010692smesh__D001761
% 224.44/224.62  |- skos__historyNote mesh__D010692 Antibiotics %28%1971-1974%29%
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D010692 2006
% 224.44/224.62  |- skos__altLabel mesh__D010692 Phleomycin
% 224.44/224.62  |- skos__historyNote mesh__D010692
% 224.44/224.62       Antibiotics, Antineoplastic %28%1971-1974%29%
% 224.44/224.62  |- mesh__recordOriginator mesh__D010692 NLM
% 224.44/224.62  |- skos__scopeNote mesh__D010692
% 224.44/224.62       Water-soluble, copper-containing low molecular weight polypeptides obtained from the culture medium of Streptomyces verticillus. They are specific inhibitors of DNA synthesis in bacteria and have been found to act as antitumor agents. They have also been used against rust fungi of plants.%A%    
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D010692 2005
% 224.44/224.62  |- mesh__publicMeSHNote mesh__D010692
% 224.44/224.62       91; was see under BLEOMYCINS 1981-90; was PHLEOMYCIN see under ANTIBIOTICS 1975-80%A%  
% 224.44/224.62  |- mesh__dateCreated mesh__D010692 1974-11-11
% 224.44/224.62  |- mesh__historyNote mesh__D010692
% 224.44/224.62       91%28%81%29%; was see under BLEOMYCINS 1981-90; was PHLEOMYCIN see under ANTIBIOTICS 1975-80%A%  
% 224.44/224.62  |- skos__historyNote mesh__D010692 Peptides %28%1971-1974%29%
% 224.44/224.62  |- skos__prefLabel mesh__D010692 Phleomycins
% 224.44/224.62  |- mesh__recordMaintainer mesh__D010692 ssb
% 224.44/224.62  |- mesh__dateRevised mesh__D010692 2004-07-07
% 224.44/224.62  |- mesh__recordAuthorizer mesh__D010692 sjn
% 224.44/224.62  |- mesh__dateEstablished mesh__D010692 1991-01-01
% 224.44/224.62  |- rdf__type mesh__D010692sskos__Concept
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D051500 2006
% 224.44/224.62  |- mesh__dateCreated mesh__D051500 2005-06-30
% 224.44/224.62  |- skos__hiddenLabel mesh__D051500 Receptor-Like Protein, FGF
% 224.44/224.62  |- mesh__recordOriginator mesh__D051500 DRC
% 224.44/224.62  |- mesh__historyNote mesh__D051500 2006%28%2001%29%   
% 224.44/224.62  |- mesh__recordAuthorizer mesh__D051500 sjn
% 224.44/224.62  |- mesh__recordMaintainer mesh__D051500 DRC
% 224.44/224.62  |- skos__altLabel mesh__D051500 Fibroblast Growth Factor Receptor-5
% 224.44/224.62  |- skos__scopeNote mesh__D051500
% 224.44/224.62       The most divergent of the known fibroblast growth factor receptors. It does not contain an intracellular TYROSINE KINASE domain and has been shown to interact with FIBROBLAST GROWTH FACTOR 2. Fibroblast growth factor receptor 5 is found primarily in skeletal tissue.%A%    
% 224.44/224.62  |- skos__altLabel mesh__D051500 Receptor 5, Fibroblast Growth Factor
% 224.44/224.62  |- skos__broader mesh__D051500smesh__D017468
% 224.44/224.62  |- skos__altLabel mesh__D051500 Receptor, Type 5 Fibroblast Growth Factor
% 224.44/224.62  |- skos__altLabel mesh__D051500 FGF Receptor-Like Protein
% 224.44/224.62  |- mesh__dateEstablished mesh__D051500 2006-01-01
% 224.44/224.62  |- rdf__type mesh__D051500sskos__Concept
% 224.44/224.62  |- skos__prefLabel mesh__D051500 Receptor, Fibroblast Growth Factor, Type 5
% 224.44/224.62  |- mesh__publicMeSHNote mesh__D051500
% 224.44/224.62       2006; FIBROBLAST GROWTH FACTOR RECEPTOR 5 was indexed under RECEPTORS, FIBROBLAST GROWTH FACTOR 2001-2005%A%  
% 224.44/224.62  |- skos__hiddenLabel mesh__D051500 FGF Receptor Like Protein
% 224.44/224.62  |- skos__altLabel mesh__D051500 Fibroblast Growth Factor Receptor 5
% 224.44/224.62  |- rdf__type mesh__D004655sskos__Concept
% 224.44/224.62  |- mesh__recordAuthorizer mesh__D004655 sjn
% 224.44/224.62  |- mesh__dateRevised mesh__D004655 2003-07-09
% 224.44/224.62  |- mesh__recordMaintainer mesh__D004655 ssb
% 224.44/224.62  |- skos__annotation mesh__D004655
% 224.44/224.62       IM for general only, qualif permitted; NIM %28%no qualif%29% with specific drug IM %28%with qualif%29%; FAT EMULSIONS, INTRAVENOUS is also available%A%  
% 224.44/224.62  |- mesh__recordOriginator mesh__D004655 NLM
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D004655 2005
% 224.44/224.62  |- skos__prefLabel mesh__D004655 Emulsions
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D004655 2004
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D004655 2006
% 224.44/224.62  |- skos__broader mesh__D004655smesh__D003102
% 224.44/224.62  |- skos__scopeNote mesh__D004655
% 224.44/224.62       Colloids of two immiscible liquids where either phase may be either fatty or aqueous; lipid-in-water emulsions are usually liquid, like milk or lotion and water-in-lipid emulsions tend to be creams.%A%    
% 224.44/224.62  |- mesh__dateCreated mesh__D004655 1999-01-01
% 224.44/224.62  |- skos__altLabel mesh__D009340 Krewel Brand of Nefopam Hydrochloride
% 224.44/224.62  |- skos__hiddenLabel mesh__D009340 Nefopam, Silentan
% 224.44/224.62  |- skos__prefLabel mesh__D009340 Nefopam
% 224.44/224.62  |- skos__historyNote mesh__D009340 Azocines %28%1972-1974%29%
% 224.44/224.62  |- mesh__dateRevised mesh__D009340 2004-07-07
% 224.44/224.62  |- skos__altLabel mesh__D009340 Biocodex Brand of Nefopam Hydrochloride
% 224.44/224.62  |- rdf__type mesh__D009340sskos__Concept
% 224.44/224.62  |- mesh__recordOriginator mesh__D009340 NLM
% 224.44/224.62  |- mesh__historyNote mesh__D009340
% 224.44/224.62       91%28%75%29%; was see under OXAZOCINES 1975-90   
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D009340 2005
% 224.44/224.62  |- skos__scopeNote mesh__D009340
% 224.44/224.62       Non-narcotic analgesic chemically similar to ORPHENADRINE. Its mechanism of action is unclear. It is used for the relief of acute and chronic pain. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p26%29%%A%    
% 224.44/224.62  |- skos__hiddenLabel mesh__D009340 Hydrochloride, Nefopam
% 224.44/224.62  |- skos__altLabel mesh__D009340 3M Brand of Nefopam Hydrochloride
% 224.44/224.62  |- mesh__recordMaintainer mesh__D009340 lkw
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D009340 2006
% 224.44/224.62  |- skos__altLabel mesh__D009340 Fenazoxine
% 224.44/224.62  |- skos__broader mesh__D009340smesh__D010079
% 224.44/224.62  |- mesh__publicMeSHNote mesh__D009340
% 224.44/224.62       91; was see under OXAZOCINES 1975-90   
% 224.44/224.62  |- skos__historyNote mesh__D009340 Benzene Derivatives %28%1972-1974%29%
% 224.44/224.62  |- mesh__recordAuthorizer mesh__D009340 sjn
% 224.44/224.62  |- mesh__dateCreated mesh__D009340 1974-11-19
% 224.44/224.62  |- mesh__dateEstablished mesh__D009340 1991-01-01
% 224.44/224.62  |- mesh__recordOriginator mesh__D014285 RLS
% 224.44/224.62  |- skos__altLabel mesh__D014285 3,3,5-Triiodothyronine
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D014285 2003
% 224.44/224.62  |- skos__scopeNote mesh__D014285
% 224.44/224.62       A metabolite of THYROXINE, formed by the peripheral enzymatic monodeiodination of T4 at the 5 position of the inner ring of the iodothyronine nucleus.%A%    
% 224.44/224.62  |- mesh__recordMaintainer mesh__D014285 nns
% 224.44/224.62  |- mesh__recordAuthorizer mesh__D014285 sjn
% 224.44/224.62  |- mesh__historyNote mesh__D014285
% 224.44/224.62       85%28%79%29%; was see under TRIIODOTHYRONINE 1979-84   
% 224.44/224.62  |- mesh__dateCreated mesh__D014285 1978-03-15
% 224.44/224.62  |- skos__broader mesh__D014285smesh__D013970
% 224.44/224.62  |- rdf__type mesh__D014285sskos__Concept
% 224.44/224.62  |- skos__historyNote mesh__D014285 Triiodothyronine %28%1966-1978%29%
% 224.44/224.62  |- skos__prefLabel mesh__D014285 Triiodothyronine, Reverse
% 224.44/224.62  |- skos__altLabel mesh__D014285 3,3,5 Triiodothyronine
% 224.44/224.62  |- skos__historyNote mesh__D014285 Isomerism %28%1971-1978%29%
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D014285 2002
% 224.44/224.62  |- skos__altLabel mesh__D014285 Reverse Triiodothyronine
% 224.44/224.62  |- mesh__publicMeSHNote mesh__D014285
% 224.44/224.62       85; was see under TRIIODOTHYRONINE 1979-84   
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D014285 2006
% 224.44/224.62  |- skos__altLabel mesh__D014285 Reverse T3 Thyroid hormone
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D014285 2005
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D014285 2004
% 224.44/224.62  |- mesh__dateRevised mesh__D014285 2001-07-25
% 224.44/224.62  |- skos__altLabel mesh__D014285 3,3%27%,5%27%-Triiodothyronine
% 224.44/224.62  |- mesh__dateEstablished mesh__D014285 1985-01-01
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D008248 2005
% 224.44/224.62  |- mesh__dateCreated mesh__D008248 1999-01-01
% 224.44/224.62  |- rdf__type mesh__D008248sskos__Concept
% 224.44/224.62  |- mesh__recordMaintainer mesh__D008248 jmp
% 224.44/224.62  |- skos__scopeNote mesh__D008248
% 224.44/224.62       A 25-kDa peptidase produced by Staphylococcus simulans which cleaves a glycine-glcyine bond unique to an inter-peptide cross-bridge of the STAPHYLOCOCCUS AUREUS cell wall. EC 3.4.24.75.%A%    
% 224.44/224.62  |- mesh__recordAuthorizer mesh__D008248 sjn
% 224.44/224.62  |- mesh__recordOriginator mesh__D008248 NLM
% 224.44/224.62  |- mesh__publicMeSHNote mesh__D008248 73   
% 224.44/224.62  |- mesh__dateEstablished mesh__D008248 1973-01-01
% 224.44/224.62  |- skos__broader mesh__D008248smesh__D008666
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D008248 2006
% 224.44/224.62  |- skos__prefLabel mesh__D008248 Lysostaphin
% 224.44/224.62  |- mesh__historyNote mesh__D008248 73%28%65%29%   
% 224.44/224.62  |- mesh__dateRevised mesh__D008248 2004-07-07
% 224.44/224.62  |- skos__historyNote mesh__D000265 Ligases %28%1966-1978%29%
% 224.44/224.62  |- skos__hiddenLabel mesh__D000265 Synthetase, Succino-AMP
% 224.44/224.62  |- skos__hiddenLabel mesh__D000265 Synthase, Adenylosuccinate
% 224.44/224.62  |- skos__historyNote mesh__D000265 Aspartic Acid %28%1966-1978%29%
% 224.44/224.62  |- skos__broader mesh__D000265smesh__D019731
% 224.44/224.62  |- skos__altLabel mesh__D000265 Adenylosuccinate Synthetase
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D000265 2006
% 224.44/224.62  |- skos__scopeNote mesh__D000265
% 224.44/224.62       A carbon-nitrogen ligase. During purine ribonucleotide biosynthesis, this enzyme catalyzes the synthesis of adenylosuccinate from GTP; IMP; and aspartate with the formation of orthophosphate and GDP. EC 6.3.4.4.%A%    
% 224.44/224.62  |- mesh__dateEstablished mesh__D000265 1991-01-01
% 224.44/224.62  |- skos__hiddenLabel mesh__D000265 Succino AMP Synthetase
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D000265 2005
% 224.44/224.62  |- skos__prefLabel mesh__D000265 Adenylosuccinate Synthase
% 224.44/224.62  |- mesh__dateCreated mesh__D000265 1978-05-16
% 224.44/224.62  |- skos__historyNote mesh__D000265 Inosine Monophosphate %28%1975-1978%29%
% 224.44/224.62  |- mesh__recordOriginator mesh__D000265 RLS
% 224.44/224.62  |- rdf__type mesh__D000265sskos__Concept
% 224.44/224.62  |- skos__altLabel mesh__D000265 Succino-AMP Synthetase
% 224.44/224.62  |- skos__hiddenLabel mesh__D000265 Synthetase, Adenylosuccinate
% 224.44/224.62  |- mesh__historyNote mesh__D000265 98%28%79%29%   
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D000265 2004
% 224.44/224.62  |- mesh__recordMaintainer mesh__D000265 ssb
% 224.44/224.62  |- mesh__recordAuthorizer mesh__D000265 sjn
% 224.44/224.62  |- mesh__dateRevised mesh__D000265 2003-07-09
% 224.44/224.62  |- mesh__publicMeSHNote mesh__D000265
% 224.44/224.62       98; see ADENYLOSUCCINATE SYNTHETASE 1991-97; see LIGASES 1979-90%A%  
% 224.44/224.62  |- skos__historyNote mesh__D000265 Inosine Nucleotides %28%1971-1978%29%
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D010693 2005
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D010693 1996
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D010693 1995
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D010693 2001
% 224.44/224.62  |- mesh__dateRevised mesh__D010693 1992-05-19
% 224.44/224.62  |- skos__broader mesh__D010693smesh__D010696
% 224.44/224.62  |- mesh__recordAuthorizer mesh__D010693 PLS
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D010693 2004
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D010693 1994
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D010693 2000
% 224.44/224.62  |- skos__broader mesh__D010693smesh__D006910
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D010693 1999
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D010693 1993
% 224.44/224.62  |- mesh__recordMaintainer mesh__D010693 TAP
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D010693 2003
% 224.44/224.62  |- mesh__historyNote mesh__D010693 73%28%63%29%   
% 224.44/224.62  |- rdf__type mesh__D010693sskos__Concept
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D010693 1998
% 224.44/224.62  |- mesh__dateCreated mesh__D010693 1999-01-01
% 224.44/224.62  |- mesh__publicMeSHNote mesh__D010693 73   
% 224.44/224.62  |- mesh__recordOriginator mesh__D010693 NLM
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D010693 2006
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D010693 1997
% 224.44/224.62  |- mesh__dateEstablished mesh__D010693 1973-01-01
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D010693 2002
% 224.44/224.62  |- skos__prefLabel mesh__D010693 Phloretin
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D004656 2006A
% 224.44/224.62  |- mesh__historyNote mesh__D004656 86   
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D004656 2005
% 224.44/224.62  |- rdf__type mesh__D004656sskos__Concept
% 224.44/224.62  |- mesh__dateEstablished mesh__D004656 1986-01-01
% 224.44/224.62  |- mesh__publicMeSHNote mesh__D004656 86   
% 224.44/224.62  |- skos__hiddenLabel mesh__D004656 Maleate, Enalapril
% 224.44/224.62  |- skos__altLabel mesh__D004656 Renitek
% 224.44/224.62  |- skos__altLabel mesh__D004656 MK421
% 224.44/224.62  |- mesh__recordAuthorizer mesh__D004656 ags
% 224.44/224.62  |- skos__historyNote mesh__D004656
% 224.44/224.62       Kininase II/antagonists %26% inhibitors %28%1974-1985%29%
% 224.44/224.62  |- skos__historyNote mesh__D004656
% 224.44/224.62       Antihypertensive Agents %28%1966-1985%29%
% 224.44/224.62  |- skos__hiddenLabel mesh__D004656 MK 421
% 224.44/224.62  |- skos__prefLabel mesh__D004656 Enalapril
% 224.44/224.62  |- skos__historyNote mesh__D004656 Dipeptides %28%1966-1985%29%
% 224.44/224.62  |- mesh__dateCreated mesh__D004656 1985-04-25
% 224.44/224.62  |- mesh__dateRevised mesh__D004656 2005-07-07
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D004656 2006
% 224.44/224.62  |- skos__scopeNote mesh__D004656
% 224.44/224.62       One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS that is used to treat hypertension.%A%    
% 224.44/224.62  |- mesh__recordMaintainer mesh__D004656 ags
% 224.44/224.62  |- skos__broader mesh__D004656smesh__D004151
% 224.44/224.62  |- mesh__recordOriginator mesh__D004656 RLS
% 224.44/224.62  |- mesh__recordAuthorizer mesh__D009341 SJN
% 224.44/224.62  |- skos__scopeNote mesh__D009341
% 224.44/224.62       State of mind or behavior characterized by extreme skepticism and persistent opposition or resistance to outside suggestions or advice. %28%APA, Thesaurus of Psychological Index Terms, 1994%29%%A%    
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D009341 2002
% 224.44/224.62  |- skos__annotation mesh__D009341 no qualif   
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D009341 2005
% 224.44/224.62  |- mesh__dateCreated mesh__D009341 1999-01-01
% 224.44/224.62  |- skos__broader mesh__D009341smesh__D010551
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D009341 1999
% 224.44/224.62  |- mesh__onlineNote mesh__D009341 search DEFENSE MECHANISMS 1966-74   
% 224.44/224.62  |- mesh__dateEstablished mesh__D009341 1991-01-01
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D009341 2001
% 224.44/224.62  |- mesh__dateRevised mesh__D009341 1997-06-20
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D009341 2004
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D009341 1998
% 224.44/224.62  |- mesh__historyNote mesh__D009341
% 224.44/224.62       91%28%75%29%; was see under DEFENSE MECHANISMS 1975-90   
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D009341 2000
% 224.44/224.62  |- rdf__type mesh__D009341sskos__Concept
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D009341 2003
% 224.44/224.62  |- mesh__publicMeSHNote mesh__D009341
% 224.44/224.62       91; was see under DEFENSE MECHANISMS 1975-90   
% 224.44/224.62  |- mesh__recordMaintainer mesh__D009341 JLS
% 224.44/224.62  |- mesh__recordOriginator mesh__D009341 NLM
% 224.44/224.62  |- skos__prefLabel mesh__D009341 Negativism
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D009341 2006
% 224.44/224.62  |- skos__prefLabel mesh__D014286 Trilogy of Fallot
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D014286 2001
% 224.44/224.62  |- mesh__dateEstablished mesh__D014286 1991-01-01
% 224.44/224.62  |- rdf__type mesh__D014286sskos__Concept
% 224.44/224.62  |- skos__hiddenLabel mesh__D014286 Fallots Trilogy
% 224.44/224.62  |- mesh__historyNote mesh__D014286
% 224.44/224.62       91%28%75%29%; was see under HEART SEPTAL DEFECTS, ATRIAL 1975-90%A%  
% 224.44/224.62  |- mesh__recordOriginator mesh__D014286 NLM
% 224.44/224.62  |- skos__annotation mesh__D014286
% 224.44/224.62       pulm stenosis with atrial septal defect %26% right ventric hypertrophy; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; do not confuse with TETRALOGY OF FALLOT%A%  
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D014286 2000
% 224.44/224.62  |- mesh__recordAuthorizer mesh__D014286 sjn
% 224.44/224.62  |- mesh__dateRevised mesh__D014286 1999-11-03
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D014286 2006
% 224.44/224.62  |- mesh__recordMaintainer mesh__D014286 kle
% 224.44/224.62  |- skos__hiddenLabel mesh__D014286 Trilogy, Fallot%27%s
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D014286 2005
% 224.44/224.62  |- skos__broader mesh__D014286smesh__D006344
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D014286 2004
% 224.44/224.62  |- skos__scopeNote mesh__D014286
% 224.44/224.62       Combination of pulmonary valve stenosis and atrial septal defect with right ventricular hypertrophy.%A%    
% 224.44/224.62  |- mesh__activeMeSHYear mesh__D014286 2002
% 224.44/224.62  |- mesh__dateCreated mesh__D014286 1974-12-12
% 224.44/224.62  |- mesh__publicMeSHNote mesh__D014286
% 224.44/224.62       91; was see under HEART SEPTAL DEFECTS, ATRIAL 1975-90   
% 224.44/224.62  |- skos__altLabel mesh__D014286 Fallot%27%s Trilogy
% 224.44/224.62  |- skos__hiddenLabel mesh__D014286 Fallot Trilogy
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D014286 2003
% 224.44/224.63  |- skos__altLabel mesh__D008249 Lysyl Oxidase
% 224.44/224.63  |- skos__prefLabel mesh__D008249 Protein-Lysine 6-Oxidase
% 224.44/224.63  |- skos__broader mesh__D008249smesh__D000594
% 224.44/224.63  |- skos__hiddenLabel mesh__D008249 Oxidase, Collagen Lysyl
% 224.44/224.63  |- mesh__dateRevised mesh__D008249 2005-06-30
% 224.44/224.63  |- skos__scopeNote mesh__D008249
% 224.44/224.63       An enzyme oxidizing peptidyl-lysyl-peptide in the presence of water %26% molecular oxygen to yield peptidyl-allysyl-peptide plus ammonia %26% hydrogen peroxide. EC 1.4.3.13.%A%    
% 224.44/224.63  |- mesh__dateEstablished mesh__D008249 1991-01-01
% 224.44/224.63  |- skos__hiddenLabel mesh__D008249 Oxidase, Lysyl
% 224.44/224.63  |- skos__altLabel mesh__D008249 Collagen Lysyl Oxidase
% 224.44/224.63  |- mesh__recordAuthorizer mesh__D008249 sjn
% 224.44/224.63  |- skos__hiddenLabel mesh__D008249 Protein Lysine 6 Oxidase
% 224.44/224.63  |- mesh__recordOriginator mesh__D008249 NLM
% 224.44/224.63  |- skos__historyNote mesh__D008249
% 224.44/224.63       Amino Acid Oxidoreductases %28%1972-1974%29%
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D008249 2006
% 224.44/224.63  |- skos__hiddenLabel mesh__D008249 6-Oxidase, Protein-Lysine
% 224.44/224.63  |- mesh__dateCreated mesh__D008249 1974-11-19
% 224.44/224.63  |- mesh__historyNote mesh__D008249
% 224.44/224.63       95; was LYSYL OXIDASE 1975-94 %28%see under AMINO ACID OXIDOREDUCTASES 1975-90%29%; PROTEIN-LYSINE 6-OXIDASE was NM 1985-94%A%  
% 224.44/224.63  |- skos__hiddenLabel mesh__D008249 Lysyl Oxidase, Collagen
% 224.44/224.63  |- mesh__onlineNote mesh__D008249
% 224.44/224.63       use PROTEIN-LYSINE 6-OXIDASE to search LYSYL OXIDASE 1975-94; use PROTEIN-LYSINE 6-OXIDASE %28%NM%29% to search PROTEIN-LYSINE 6-OXIDASE 1985-94%A%  
% 224.44/224.63  |- mesh__publicMeSHNote mesh__D008249
% 224.44/224.63       95; was LYSYL OXIDASE 1975-94 %28%see under AMINO ACID OXIDOREDUCTASES 1975-90%29%; PROTEIN-LYSINE 6-OXIDASE was indexed under AMINO ACID OXIDOREDUCTASES 1986-92 %26% LYSYL OXIDASE 1993-94%A%  
% 224.44/224.63  |- skos__historyNote mesh__D008249 Lysine %28%1972-1974%29%
% 224.44/224.63  |- rdf__type mesh__D008249sskos__Concept
% 224.44/224.63  |- mesh__recordMaintainer mesh__D008249 jmp
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000266 1991
% 224.44/224.63  |- mesh__dateEstablished mesh__D000266 1991-01-01
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000266 2000
% 224.44/224.63  |- skos__hiddenLabel mesh__D000266 gamma Imino ATP
% 224.44/224.63  |- skos__altLabel mesh__D000266 ATP%28%beta,gamma-NH%29%
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000266 1994
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000266 1992
% 224.44/224.63  |- skos__altLabel mesh__D000266 gamma-Imino-ATP
% 224.44/224.63  |- skos__hiddenLabel mesh__D000266 Imidodiphosphate, Adenylyl
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000266 2001
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000266 1998
% 224.44/224.63  |- mesh__recordMaintainer mesh__D000266 PLS
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000266 1995
% 224.44/224.63  |- mesh__historyNote mesh__D000266
% 224.44/224.63       91%28%76%29%; was see under ADENOSINE TRIPHOSPHATE 1976-90   
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000266 2005
% 224.44/224.63  |- skos__hiddenLabel mesh__D000266 gamma Imido ATP
% 224.44/224.63  |- skos__altLabel mesh__D000266 beta,gamma-imido-ATP
% 224.44/224.63  |- skos__altLabel mesh__D000266 Adenylylimidodiphosphate
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000266 1993
% 224.44/224.63  |- skos__altLabel mesh__D000266 Mg AMP-PNP
% 224.44/224.63  |- skos__hiddenLabel mesh__D000266 AMP-PNP, Mg
% 224.44/224.63  |- skos__hiddenLabel mesh__D000266 Imidodiphosphate, Adenyl
% 224.44/224.63  |- skos__prefLabel mesh__D000266 Adenylyl Imidodiphosphate
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000266 1999
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000266 2006
% 224.44/224.63  |- rdf__type mesh__D000266sskos__Concept
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000266 2002
% 224.44/224.63  |- skos__scopeNote mesh__D000266
% 224.44/224.63       5%27%-Adenylic acid, monoanhydride with imidodiphosphoric acid. An analog of ATP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It is a potent competitive inhibitor of soluble and membrane-bound mitochondrial ATPase and also inhibits ATP-dependent reactions of oxidative phosphorylation.%A%    
% 224.44/224.63  |- skos__historyNote mesh__D000266 Imides %28%1973-1975%29%
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000266 1996
% 224.44/224.63  |- mesh__recordAuthorizer mesh__D000266 PLS
% 224.44/224.63  |- skos__hiddenLabel mesh__D000266 Mg 5%27% Adenylylimidodiphosphate
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000266 2003
% 224.44/224.63  |- skos__historyNote mesh__D000266 Adenosine Diphosphate %28%1973-1974%29%
% 224.44/224.63  |- skos__altLabel mesh__D000266 AMPPNP
% 224.44/224.63  |- skos__historyNote mesh__D000266
% 224.44/224.63       Adenosine Triphosphate/analogs %26% derivatives %28%1975%29%
% 224.44/224.63  |- skos__altLabel mesh__D000266
% 224.44/224.63       Adenosine 5%27%-%28%beta,gamma-Imino%29%triphosphate
% 224.44/224.63  |- skos__altLabel mesh__D000266 gamma-Imido-ATP
% 224.44/224.63  |- skos__annotation mesh__D000266 /biosyn /physiol permitted; DF: APPNHP   
% 224.44/224.63  |- skos__altLabel mesh__D000266 Adenylimidodiphosphate
% 224.44/224.63  |- skos__historyNote mesh__D000266 Phosphoric Acids %28%1973-1974%29%
% 224.44/224.63  |- mesh__publicMeSHNote mesh__D000266
% 224.44/224.63       91; was see under ADENOSINE TRIPHOSPHATE 1976-90   
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000266 1997
% 224.44/224.63  |- mesh__dateCreated mesh__D000266 1975-07-23
% 224.44/224.63  |- mesh__dateRevised mesh__D000266 1990-05-30
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000266 2004
% 224.44/224.63  |- skos__altLabel mesh__D000266 Adenyl Imidodiphosphate
% 224.44/224.63  |- mesh__recordOriginator mesh__D000266 RLS
% 224.44/224.63  |- skos__hiddenLabel mesh__D000266 beta,gamma imido ATP
% 224.44/224.63  |- skos__broader mesh__D000266smesh__D000255
% 224.44/224.63  |- skos__hiddenLabel mesh__D000266 Mg AMP PNP
% 224.44/224.63  |- skos__altLabel mesh__D000266 AMP-PNP
% 224.44/224.63  |- rdf__type mesh__D046368sskos__Concept
% 224.44/224.63  |- skos__historyNote mesh__D046368 Birds %28%1967-1997%29%
% 224.44/224.63  |- mesh__dateEstablished mesh__D046368 2005-01-01
% 224.44/224.63  |- skos__scopeNote mesh__D046368
% 224.44/224.63       Common name for the largest birds in the order PASSERIFORMES, family Corvidae. These omnivorous black birds comprise most of the species in the genus Corvus, along with ravens and jackdaws %28%which are often also referred to as crows%29%.%A%    
% 224.44/224.63  |- mesh__dateCreated mesh__D046368 2004-07-07
% 224.44/224.63  |- mesh__publicMeSHNote mesh__D046368 2005; see SONGBIRDS 1999-2004   
% 224.44/224.63  |- skos__historyNote mesh__D046368 Songbirds %28%1998-2004%29%
% 224.44/224.63  |- skos__prefLabel mesh__D046368 Crows
% 224.44/224.63  |- skos__hiddenLabel mesh__D046368 Raven
% 224.44/224.63  |- skos__hiddenLabel mesh__D046368 Jackdaw
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D046368 2006
% 224.44/224.63  |- mesh__recordOriginator mesh__D046368 ags
% 224.44/224.63  |- mesh__historyNote mesh__D046368 2005; use SONGBIRDS 1999-2004   
% 224.44/224.63  |- mesh__recordAuthorizer mesh__D046368 sjn
% 224.44/224.63  |- skos__hiddenLabel mesh__D046368 Crow
% 224.44/224.63  |- skos__broader mesh__D046368smesh__D020308
% 224.44/224.63  |- mesh__recordMaintainer mesh__D046368 ags
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D046368 2005
% 224.44/224.63  |- mesh__dateEstablished mesh__D018677 1995-01-01
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D018677 2002
% 224.44/224.63  |- mesh__recordMaintainer mesh__D018677 TGC
% 224.44/224.63  |- skos__altLabel mesh__D018677 Teeth Injuries
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D018677 1999
% 224.44/224.63  |- skos__historyNote mesh__D018677 Tooth/injuries %28%1966-1994%29%
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D018677 2006
% 224.44/224.63  |- skos__broader mesh__D018677smesh__D014947
% 224.44/224.63  |- skos__hiddenLabel mesh__D018677 Tooth Injury
% 224.44/224.63  |- mesh__dateCreated mesh__D018677 1994-06-28
% 224.44/224.63  |- skos__broader mesh__D018677smesh__D014076
% 224.44/224.63  |- skos__scopeNote mesh__D018677
% 224.44/224.63       Traumatic or other damage to teeth including fractures %28%TOOTH FRACTURES%29% or displacements %28%TOOTH LUXATION%29%.%A%    
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D018677 1998
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D018677 2005
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D018677 1997
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D018677 2004
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D018677 2001
% 224.44/224.63  |- mesh__publicMeSHNote mesh__D018677 95; was TOOTH/injuries 1966-94   
% 224.44/224.63  |- mesh__recordAuthorizer mesh__D018677 PLS
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D018677 2003
% 224.44/224.63  |- rdf__type mesh__D018677sskos__Concept
% 224.44/224.63  |- mesh__dateRevised mesh__D018677 1996-06-10
% 224.44/224.63  |- skos__hiddenLabel mesh__D018677 Injury, Tooth
% 224.44/224.63  |- skos__hiddenLabel mesh__D018677 Teeth Injury
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D018677 2000
% 224.44/224.63  |- mesh__historyNote mesh__D018677 95; was TOOTH/injuries 1966-94   
% 224.44/224.63  |- skos__altLabel mesh__D018677 Injuries, Teeth
% 224.44/224.63  |- mesh__onlineNote mesh__D018677
% 224.44/224.63       use TOOTH INJURIES to search TOOTH/injuries 1966-94   
% 224.44/224.63  |- skos__hiddenLabel mesh__D018677 Injury, Teeth
% 224.44/224.63  |- skos__annotation mesh__D018677
% 224.44/224.63       GEN or unspecified; prefer /inj with specific tooth, as CUSPID /inj; also available are TOOTH FRACTURES %26% TOOTH AVULSION; DF: TOOTH INJ%A%  
% 224.44/224.63  |- skos__prefLabel mesh__D018677 Tooth Injuries
% 224.44/224.63  |- mesh__recordOriginator mesh__D018677 JLS
% 224.44/224.63  |- skos__altLabel mesh__D018677 Injuries, Tooth
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D010694 2004
% 224.44/224.63  |- skos__hiddenLabel mesh__D010694 Phloretin Glucosidase
% 224.44/224.63  |- mesh__historyNote mesh__D010694
% 224.44/224.63       92; was PHLORETIN GLUCOSIDASE 1978-91 %28%see under GLUCOSIDASES 1978-90%29%; PHLORETIN-GLUCOSIDASE was PHLORETIN GLUCOSIDASE 1978-93%A%  
% 224.44/224.63  |- mesh__recordMaintainer mesh__D010694 ssb
% 224.44/224.63  |- mesh__recordOriginator mesh__D010694 RLS
% 224.44/224.63  |- skos__altLabel mesh__D010694 Phlorizin Hydrolase
% 224.44/224.63  |- rdf__type mesh__D010694sskos__Concept
% 224.44/224.63  |- skos__hiddenLabel mesh__D010694 Ceramidase, Glycosyl
% 224.44/224.63  |- mesh__recordAuthorizer mesh__D010694 sjn
% 224.44/224.63  |- mesh__dateCreated mesh__D010694 1977-04-15
% 224.44/224.63  |- skos__broader mesh__D010694smesh__D005959
% 224.44/224.63  |- mesh__publicMeSHNote mesh__D010694
% 224.44/224.63       92; was PHLORETIN GLUCOSIDASE 1978-91 %28%see under GLUCOSIDASES 1978-90%29%; PHLORETIN-GLUCOSIDASE was PHLORETIN GLUCOSIDASE 1978-93%A%  
% 224.44/224.63  |- mesh__dateEstablished mesh__D010694 1991-01-01
% 224.44/224.63  |- skos__prefLabel mesh__D010694 Glycosylceramidase
% 224.44/224.63  |- skos__hiddenLabel mesh__D010694 Hydrolase, Lactase-Phlorizin
% 224.44/224.63  |- mesh__onlineNote mesh__D010694
% 224.44/224.63       use GLYCOSYLCERAMIDASE to search PHLORETIN GLUCOSIDASE 1978-91%A%  
% 224.44/224.63  |- skos__altLabel mesh__D010694 Phloretin-Glucosidase
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D010694 2006
% 224.44/224.63  |- skos__hiddenLabel mesh__D010694 Lactase Phlorizin Hydrolase
% 224.44/224.63  |- skos__scopeNote mesh__D010694
% 224.44/224.63       The enzyme hydrolyzing glycosyl-N-acylsphingosine to a sugar and N-acylsphingosine. It also catalyzes the hydrolysis of phlorizin to phloretin and glucose. It is found in the intestinal brush border membrane often in conjunction with lactase. EC 3.2.1.62.%A%    
% 224.44/224.63  |- skos__hiddenLabel mesh__D010694 Hydrolase, Phlorizin
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D010694 2005
% 224.44/224.63  |- mesh__dateRevised mesh__D010694 2003-07-09
% 224.44/224.63  |- skos__altLabel mesh__D010694 Glycosyl Ceramidase
% 224.44/224.63  |- skos__historyNote mesh__D010694 Glucosidases %28%1966-1977%29%
% 224.44/224.63  |- skos__hiddenLabel mesh__D014287 Maleate Salt, Trimebutine
% 224.44/224.63  |- mesh__publicMeSHNote mesh__D014287
% 224.44/224.63       91; was see under BENZOATES 1977-90   
% 224.44/224.63  |- mesh__recordMaintainer mesh__D014287 CCR
% 224.44/224.63  |- rdf__type mesh__D014287sskos__Concept
% 224.44/224.63  |- skos__broader mesh__D014287smesh__D020185
% 224.44/224.63  |- mesh__recordOriginator mesh__D014287 SH
% 224.44/224.63  |- skos__prefLabel mesh__D014287 Trimebutine
% 224.44/224.63  |- skos__hiddenLabel mesh__D014287 TM906
% 224.44/224.63  |- skos__historyNote mesh__D014287 Butylamines %28%1966-1976%29%
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D014287 2005
% 224.44/224.63  |- skos__altLabel mesh__D014287 Trimebutine Maleate
% 224.44/224.63  |- skos__hiddenLabel mesh__D014287 TM 906
% 224.44/224.63  |- mesh__dateCreated mesh__D014287 1976-05-03
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D014287 2003
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D014287 2006
% 224.44/224.63  |- skos__scopeNote mesh__D014287
% 224.44/224.63       Proposed spasmolytic with possible local anesthetic action used in gastrointestinal disorders.%A%    
% 224.44/224.63  |- skos__hiddenLabel mesh__D014287 Salt, Trimebutine Maleate
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D014287 2001
% 224.44/224.63  |- mesh__historyNote mesh__D014287
% 224.44/224.63       91%28%77%29%; was see under BENZOATES 1977-90   
% 224.44/224.63  |- mesh__dateEstablished mesh__D014287 1991-01-01
% 224.44/224.63  |- mesh__dateRevised mesh__D014287 2000-06-22
% 224.44/224.63  |- skos__hiddenLabel mesh__D014287 Maleate, Trimebutine
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D014287 2004
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D014287 2002
% 224.44/224.63  |- skos__historyNote mesh__D014287 Benzoates %28%1966-1976%29%
% 224.44/224.63  |- mesh__recordAuthorizer mesh__D014287 sjn
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D019770 2005A
% 224.44/224.63  |- mesh__historyNote mesh__D019770 98   
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D019770 2003
% 224.44/224.63  |- skos__prefLabel mesh__D019770 Lauraceae
% 224.44/224.63  |- mesh__recordMaintainer mesh__D019770 jls
% 224.44/224.63  |- skos__scopeNote mesh__D019770
% 224.44/224.63       A family of mainly aromatic evergreen plants in the order Laurales. The laurel family includes 2,200 species in 45 genera and from these are derived medicinal extracts, essential oils, camphor and other products.%A%    
% 224.44/224.63  |- mesh__dateCreated mesh__D019770 1997-06-20
% 224.44/224.63  |- mesh__recordOriginator mesh__D019770 JLS
% 224.44/224.63  |- skos__annotation mesh__D019770
% 224.44/224.63       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.44/224.63  |- mesh__dateEstablished mesh__D019770 1998-01-01
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D019770 2006
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D019770 2002
% 224.44/224.63  |- rdf__type mesh__D019770sskos__Concept
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D019770 2005
% 224.44/224.63  |- mesh__publicMeSHNote mesh__D019770 98   
% 224.44/224.63  |- skos__broader mesh__D019770smesh__D019684
% 224.44/224.63  |- mesh__dateRevised mesh__D019770 2004-07-28
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D019770 2004
% 224.44/224.63  |- mesh__recordAuthorizer mesh__D019770 jls
% 224.44/224.63  |- skos__annotation mesh__D033441 SPEC   
% 224.44/224.63  |- skos__historyNote mesh__D033441 Infertility, Male %28%1965-2002%29%
% 224.44/224.63  |- mesh__historyNote mesh__D033441 2003; use UROLOGY 1992-2002   
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D033441 2006
% 224.44/224.63  |- mesh__dateEstablished mesh__D033441 2003-01-01
% 224.44/224.63  |- mesh__dateCreated mesh__D033441 2002-07-02
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D033441 2005
% 224.44/224.63  |- skos__related mesh__D033441smesh__D014572
% 224.44/224.63  |- mesh__publicMeSHNote mesh__D033441 2003; see UROLOGY 1992-2002   
% 224.44/224.63  |- rdf__type mesh__D033441sskos__Concept
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D033441 2004
% 224.44/224.63  |- skos__scopeNote mesh__D033441
% 224.44/224.63       A scientific or medical discipline concerning the study of male reproductive biology, diseases of the male genital organs, and male infertility. Major areas of interest include ENDOCRINOLOGY; SPERMATOGENESIS; semen analysis; FERTILIZATION; CONTRACEPTION; and CRYOPRESERVATION.%A%    
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D033441 2003
% 224.44/224.63  |- skos__prefLabel mesh__D033441 Andrology
% 224.44/224.63  |- skos__broader mesh__D033441smesh__D008511
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000267 2000
% 224.44/224.63  |- rdf__type mesh__D000267sskos__Concept
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000267 2004
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000267 2002
% 224.44/224.63  |- skos__broader mesh__D000267smesh__D010335
% 224.44/224.63  |- mesh__recordMaintainer mesh__D000267 KEV
% 224.44/224.63  |- skos__hiddenLabel mesh__D000267 Adhesion
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000267 2003
% 224.44/224.63  |- mesh__recordAuthorizer mesh__D000267 sjn
% 224.44/224.63  |- mesh__recordOriginator mesh__D000267 NLM
% 224.44/224.63  |- skos__prefLabel mesh__D000267 Adhesions
% 224.44/224.63  |- mesh__dateRevised mesh__D000267 1999-11-03
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000267 2006
% 224.44/224.63  |- skos__scopeNote mesh__D000267
% 224.44/224.63       Pathological processes consisting of the union of the opposing surfaces of a wound.%A%    
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000267 2001
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D000267 2005
% 224.44/224.63  |- mesh__dateCreated mesh__D000267 1999-01-01
% 224.44/224.63  |- skos__annotation mesh__D000267
% 224.44/224.63       IM GEN only; coord NIM with organ/dis precoord %28%IM%29%   
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D005750 2002
% 224.44/224.63  |- skos__related mesh__D005750smesh__D010434
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D005750 2004
% 224.44/224.63  |- skos__scopeNote mesh__D005750
% 224.44/224.63       The liquid secretion of the stomach mucosa consisting of hydrochloric acid %28%GASTRIC ACID%29%; PEPSINOGENS; INTRINSIC FACTOR; GASTRIN; MUCUS; and the bicarbonate ion %28%BICARBONATES%29%. %28%From Best %26% Taylor%27%s Physiological Basis of Medical Practice, 12th ed, p651%29%%A%    
% 224.44/224.63  |- skos__hiddenLabel mesh__D005750 Gastric Juices
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D005750 2006
% 224.44/224.63  |- skos__prefLabel mesh__D005750 Gastric Juice
% 224.44/224.63  |- skos__related mesh__D005750smesh__D010435
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D005750 2003
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D005750 2005
% 224.44/224.63  |- mesh__dateRevised mesh__D005750 2001-07-25
% 224.44/224.63  |- mesh__dateCreated mesh__D005750 1999-01-01
% 224.44/224.63  |- mesh__recordMaintainer mesh__D005750 mdb
% 224.44/224.63  |- rdf__type mesh__D005750sskos__Concept
% 224.44/224.63  |- skos__annotation mesh__D005750
% 224.44/224.63       /secret permitted but consider GASTRIC MUCOSA /secret if pertinent, and not STOMACH /secret; GASTRIC ACID is also available; absence of gastric HCl = ACHLORHYDRIA; hyperacidity: index under GASTRIC ACID /secret%A%  
% 224.44/224.63  |- mesh__recordAuthorizer mesh__D005750 sjn
% 224.44/224.63  |- skos__hiddenLabel mesh__D005750 Juices, Gastric
% 224.44/224.63  |- skos__related mesh__D005750smesh__D000126
% 224.44/224.63  |- skos__broader mesh__D005750smesh__D012634
% 224.44/224.63  |- mesh__recordOriginator mesh__D005750 NLM
% 224.44/224.63  |- skos__hiddenLabel mesh__D005750 Juice, Gastric
% 224.44/224.63  |- rdf__type mesh__D046369sskos__Concept
% 224.44/224.63  |- mesh__recordMaintainer mesh__D046369 ags
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D046369 2005
% 224.44/224.63  |- mesh__dateEstablished mesh__D046369 2005-01-01
% 224.44/224.63  |- mesh__publicMeSHNote mesh__D046369 2005; see SONGBIRDS 1999-2004   
% 224.44/224.63  |- skos__historyNote mesh__D046369 Birds %28%1965-1998%29%
% 224.44/224.63  |- mesh__dateCreated mesh__D046369 2004-07-07
% 224.44/224.63  |- skos__prefLabel mesh__D046369 Finches
% 224.44/224.63  |- skos__altLabel mesh__D046369 Finch
% 224.44/224.63  |- mesh__recordAuthorizer mesh__D046369 sjn
% 224.44/224.63  |- mesh__recordOriginator mesh__D046369 ags
% 224.44/224.63  |- skos__scopeNote mesh__D046369
% 224.44/224.63       Common name for small PASSERIFORMES in the family Fringillidae. They have a short stout bill %28%BEAK%29% adapted for crushing SEEDS. Some species of Old World finches are called CANARIES.%A%    
% 224.44/224.63  |- skos__historyNote mesh__D046369 Songbirds %28%1999-2004%29%
% 224.44/224.63  |- mesh__historyNote mesh__D046369 2005; use SONGBIRDS 1999-2004   
% 224.44/224.63  |- skos__broader mesh__D046369smesh__D020308
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D046369 2006
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D018678 2006
% 224.44/224.63  |- mesh__recordMaintainer mesh__D018678 ssb
% 224.44/224.63  |- skos__altLabel mesh__D018678 Muscarinics
% 224.44/224.63  |- skos__hiddenLabel mesh__D018678 Drugs, Cholinergic
% 224.44/224.63  |- skos__altLabel mesh__D018678 Acetylcholine Agents
% 224.44/224.63  |- skos__prefLabel mesh__D018678 Cholinergic Agents
% 224.44/224.63  |- skos__scopeNote mesh__D018678
% 224.44/224.63       Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of ACETYLCHOLINE, and drugs that affect the survival of cholinergic neurons. The term cholinergic agents is sometimes still used in the narrower sense of MUSCARINIC AGONISTS, although most modern texts discourage that usage.%A%    
% 224.44/224.63  |- skos__related mesh__D018678smesh__D002038
% 224.44/224.63  |- mesh__dateRevised mesh__D018678 2005-06-30
% 224.44/224.63  |- mesh__dateEstablished mesh__D018678 1995-01-01
% 224.44/224.63  |- mesh__historyNote mesh__D018678
% 224.44/224.63       95; was see PARASYMPATHOMIMETICS 1975-94; NICOTINIC AGENTS was see GANGLIONIC STIMULANTS 1978-94; CHOLINOMIMETICS was see PARASYMPATHOMIMETICS 1974-94; MUSCARINIC AGENTS was see PARASYMPATHOMIMETICS 1969-94%A%  
% 224.44/224.63  |- skos__broader mesh__D018678smesh__D018377
% 224.44/224.63  |- mesh__recordOriginator mesh__D018678 RAZ
% 224.44/224.63  |- rdf__type mesh__D018678sskos__Concept
% 224.44/224.63  |- skos__hiddenLabel mesh__D018678 Agents, Muscarinic
% 224.44/224.63  |- skos__altLabel mesh__D018678 Cholinergics
% 224.44/224.63  |- skos__related mesh__D018678smesh__D001905
% 224.44/224.63  |- mesh__dateCreated mesh__D018678 1994-06-29
% 224.44/224.63  |- skos__altLabel mesh__D018678 Cholinergic Drugs
% 224.44/224.63  |- mesh__onlineNote mesh__D018678
% 224.44/224.63       use PARASYMPATHOMIMETICS to search CHOLINERGIC AGENTS 1975-94, CHOLINOMIMETICS 1974-94, %26% MUSCARINIC AGENTS 1969-94; use GANGLIONIC STIMULANTS to search NICOTINIC AGENTS 1978-94%A%  
% 224.44/224.63  |- mesh__recordAuthorizer mesh__D018678 sjn
% 224.44/224.63  |- skos__hiddenLabel mesh__D018678 Agents, Nicotinic
% 224.44/224.63  |- mesh__publicMeSHNote mesh__D018678
% 224.44/224.63       95; was see PARASYMPATHOMIMETICS 1975-94; NICOTINIC AGENTS was see GANGLIONIC STIMULANTS 1978-94; CHOLINOMIMETICS was see PARASYMPATHOMIMETICS 1974-94; MUSCARINIC AGENTS was see PARASYMPATHOMIMETICS 1969-94%A%  
% 224.44/224.63  |- skos__hiddenLabel mesh__D018678 Agents, Acetylcholine
% 224.44/224.63  |- skos__annotation mesh__D018678 GEN or unspecified; prefer specifics   
% 224.44/224.63  |- skos__hiddenLabel mesh__D018678 Agents, Cholinergic
% 224.44/224.63  |- mesh__dateCreated mesh__D010695 1999-01-01
% 224.44/224.63  |- mesh__recordMaintainer mesh__D010695 ssb
% 224.44/224.63  |- rdf__type mesh__D010695sskos__Concept
% 224.44/224.63  |- mesh__recordOriginator mesh__D010695 NLM
% 224.44/224.63  |- skos__altLabel mesh__D010695 Phlorizin
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D010695 2005
% 224.44/224.63  |- skos__prefLabel mesh__D010695 Phlorhizin
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D010695 2006
% 224.44/224.63  |- skos__altLabel mesh__D010695 Phloridzin
% 224.44/224.63  |- mesh__recordAuthorizer mesh__D010695 sjn
% 224.44/224.63  |- mesh__dateRevised mesh__D010695 2004-07-07
% 224.44/224.63  |- skos__broader mesh__D010695smesh__D006027
% 224.44/224.63  |- mesh__dateRevised mesh__D004658 2003-07-09
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D004658 2005
% 224.44/224.63  |- skos__broader mesh__D004658smesh__D014083
% 224.44/224.63  |- skos__hiddenLabel mesh__D004658 Enamel Organs
% 224.44/224.63  |- mesh__historyNote mesh__D004658
% 224.44/224.63       91%28%75%29%; was see under TOOTH GERM 1975-90   
% 224.44/224.63  |- skos__scopeNote mesh__D004658
% 224.44/224.63       Epithelial cells surrounding the dental papilla and differentiated into three layers: the inner enamel epithelium, consisting of ameloblasts which eventually form the enamel, and the enamel pulp and external enamel epithelium, both of which atrophy and disappear before and upon eruption of the tooth, respectively.%A%    
% 224.44/224.63  |- skos__prefLabel mesh__D004658 Enamel Organ
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D004658 2004
% 224.44/224.63  |- mesh__recordAuthorizer mesh__D004658 sjn
% 224.44/224.63  |- mesh__onlineNote mesh__D004658 search TOOTH GERM 1966-74   
% 224.44/224.63  |- mesh__publicMeSHNote mesh__D004658
% 224.44/224.63       91; was see under TOOTH GERM 1975-90   
% 224.44/224.63  |- skos__hiddenLabel mesh__D004658 Organs, Enamel
% 224.44/224.63  |- skos__hiddenLabel mesh__D004658 Organ, Enamel
% 224.44/224.63  |- mesh__recordOriginator mesh__D004658 NLM
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D004658 2006
% 224.44/224.63  |- mesh__dateCreated mesh__D004658 1999-01-01
% 224.44/224.63  |- rdf__type mesh__D004658sskos__Concept
% 224.44/224.63  |- mesh__dateEstablished mesh__D004658 1991-01-01
% 224.44/224.63  |- mesh__recordMaintainer mesh__D004658 lkt
% 224.44/224.63  |- mesh__recordMaintainer mesh__D015380 ssb
% 224.44/224.63  |- skos__hiddenLabel mesh__D015380 Interferon Alfa 2a
% 224.44/224.63  |- skos__hiddenLabel mesh__D015380 Recombinant Interferon alpha 2a
% 224.44/224.63  |- skos__altLabel mesh__D015380 Recombinant Interferon alpha-2a
% 224.44/224.63  |- skos__historyNote mesh__D015380 Recombinant Proteins %28%1986-1988%29%
% 224.44/224.63  |- mesh__dateRevised mesh__D015380 2005-06-30
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D015380 2006
% 224.44/224.63  |- mesh__dateCreated mesh__D015380 1988-06-06
% 224.44/224.63  |- skos__prefLabel mesh__D015380 Interferon Alfa-2a
% 224.44/224.63  |- mesh__recordOriginator mesh__D015380 RLS
% 224.44/224.63  |- skos__hiddenLabel mesh__D015380 RoferonA
% 224.44/224.63  |- skos__hiddenLabel mesh__D015380 Interferon Alfa-2a, Recombinant
% 224.44/224.63  |- skos__annotation mesh__D015380
% 224.44/224.63       spelling %22%alfa%22% is commonly used for recombinant form   
% 224.44/224.63  |- mesh__recordAuthorizer mesh__D015380 sjn
% 224.44/224.63  |- skos__altLabel mesh__D015380 Recombinant Interferon Alfa-2a
% 224.44/224.63  |- mesh__historyNote mesh__D015380
% 224.44/224.63       91%28%89%29%; was see under INTERFERON ALFA, RECOMBINANT 1989-90%A%  
% 224.44/224.63  |- rdf__type mesh__D015380sskos__Concept
% 224.44/224.63  |- mesh__dateEstablished mesh__D015380 1991-01-01
% 224.44/224.63  |- skos__historyNote mesh__D015380 Interferon Type I %28%1983-1988%29%
% 224.44/224.63  |- mesh__publicMeSHNote mesh__D015380
% 224.44/224.63       91; was see under INTERFERON ALFA, RECOMBINANT 1989-90   
% 224.44/224.63  |- skos__broader mesh__D015380smesh__D015379
% 224.44/224.63  |- skos__scopeNote mesh__D015380
% 224.44/224.63       A recombinant alfa interferon consisting of 165 amino acids with lysine at position 23 and histidine at position 34. It is used extensively as an antiviral and antineoplastic agent.%A%    
% 224.44/224.63  |- skos__hiddenLabel mesh__D015380 Recombinant Interferon Alfa 2a
% 224.44/224.63  |- skos__hiddenLabel mesh__D015380 Ro 22 8181
% 224.44/224.63  |- skos__hiddenLabel mesh__D015380 Interferon alpha-2a, Recombinant
% 224.44/224.63  |- skos__hiddenLabel mesh__D015380 Roferon A
% 224.44/224.63  |- skos__broader mesh__D015380smesh__D016898
% 224.44/224.63  |- skos__hiddenLabel mesh__D015380 Ro 228181
% 224.44/224.63  |- mesh__recordMaintainer mesh__D009343 SYSTEM
% 224.44/224.63  |- rdf__type mesh__D009343sskos__Concept
% 224.44/224.63  |- mesh__dateRevised mesh__D009343 2005-06-30
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D009343 2006
% 224.44/224.63  |- skos__scopeNote mesh__D009343
% 224.44/224.63       A genus of gram-negative, aerobic, coccoid bacteria whose organisms are part of the normal flora of the oropharynx, nasopharynx, and genitourinary tract. Some species are primary pathogens for humans.%A%    
% 224.44/224.63  |- skos__broader mesh__D009343smesh__D009346
% 224.44/224.63  |- mesh__recordOriginator mesh__D009343 NLM
% 224.44/224.63  |- mesh__dateCreated mesh__D009343 1999-01-01
% 224.44/224.63  |- skos__prefLabel mesh__D009343 Neisseria
% 224.44/224.63  |- mesh__recordAuthorizer mesh__D009343 sjn
% 224.44/224.63  |- mesh__dateCreated mesh__D001360 1999-01-01
% 224.44/224.63  |- skos__broader mesh__D001360smesh__D010047
% 224.44/224.63  |- skos__prefLabel mesh__D001360 Avidin
% 224.44/224.63  |- mesh__dateEstablished mesh__D001360 1987-01-01
% 224.44/224.63  |- mesh__recordOriginator mesh__D001360 NLM
% 224.44/224.63  |- skos__broader mesh__D001360smesh__D006023
% 224.44/224.63  |- mesh__historyNote mesh__D001360
% 224.44/224.63       87%28%73%29%; was see under OVALBUMIN 1969-86   
% 224.44/224.63  |- skos__related mesh__D001360smesh__D001710
% 224.44/224.63  |- rdf__type mesh__D001360sskos__Concept
% 224.44/224.63  |- skos__scopeNote mesh__D001360
% 224.44/224.63       A specific protein in egg albumin that interacts with BIOTIN to render it unavailable to mammals, thereby producing biotin deficiency.%A%    
% 224.44/224.63  |- mesh__dateRevised mesh__D001360 2001-07-25
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D001360 2004
% 224.44/224.63  |- mesh__recordMaintainer mesh__D001360 nns
% 224.44/224.63  |- mesh__publicMeSHNote mesh__D001360
% 224.44/224.63       87; was see under OVALBUMIN 1969-86   
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D001360 2002
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D001360 2006
% 224.44/224.63  |- mesh__onlineNote mesh__D001360 search OVALBUMIN 1969-72   
% 224.44/224.63  |- mesh__recordAuthorizer mesh__D001360 sjn
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D001360 2003
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D001360 2005
% 224.44/224.63  |- mesh__dateCreated mesh__D014288 1974-11-19
% 224.44/224.63  |- skos__historyNote mesh__D014288 Acetanilides %28%1970-1974%29%
% 224.44/224.63  |- skos__broader mesh__D014288smesh__D000083
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D014288 2005
% 224.44/224.63  |- mesh__recordAuthorizer mesh__D014288 sjn
% 224.44/224.63  |- skos__historyNote mesh__D014288 Diethylamines %28%1974%29%
% 224.44/224.63  |- skos__prefLabel mesh__D014288 Trimecaine
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D014288 2006
% 224.44/224.63  |- mesh__historyNote mesh__D014288
% 224.44/224.63       91%28%75%29%; was see under ACETANILIDES 1975-90   
% 224.44/224.63  |- mesh__dateEstablished mesh__D014288 1991-01-01
% 224.44/224.63  |- mesh__recordMaintainer mesh__D014288 sjn
% 224.44/224.63  |- mesh__publicMeSHNote mesh__D014288
% 224.44/224.63       91; was see under ACETANILIDES 1975-90   
% 224.44/224.63  |- mesh__activeMeSHYear mesh__D014288 2004
% 224.44/224.64  |- mesh__dateRevised mesh__D014288 2003-07-25
% 224.44/224.64  |- skos__scopeNote mesh__D014288
% 224.44/224.64       Acetanilide derivative used as a local anesthetic.     
% 224.44/224.64  |- skos__hiddenLabel mesh__D014288 Monohydrochloride, Trimecaine
% 224.44/224.64  |- mesh__recordOriginator mesh__D014288 NLM
% 224.44/224.64  |- rdf__type mesh__D014288sskos__Concept
% 224.44/224.64  |- mesh__publicMeSHNote mesh__D019771 98   
% 224.44/224.64  |- skos__broader mesh__D019771smesh__D003714
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D019771 2001
% 224.44/224.64  |- skos__historyNote mesh__D019771 Neurons %28%1968-1997%29%
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D019771 2000
% 224.44/224.64  |- skos__historyNote mesh__D019771 Axons %28%1966-1997%29%
% 224.44/224.64  |- skos__scopeNote mesh__D019771
% 224.44/224.64       Transection or severing of an axon. This type of denervation is used often in experimental studies on neuronal physiology and neuronal death or survival, toward an understanding of nervous system disease.%A%    
% 224.44/224.64  |- skos__prefLabel mesh__D019771 Axotomy
% 224.44/224.64  |- skos__historyNote mesh__D019771 Denervation %28%1970-1997%29%
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D019771 2006
% 224.44/224.64  |- skos__annotation mesh__D019771
% 224.44/224.64       transection of an axon, a type of denervation; NIM when an exper technique; coord with specific neuron or specific nerve or specific organ /innerv %28%IM%29% with probably /physiol %28%IM%29% in experiments or /surg %28%IM%29% in ther; do not use /util except by MeSH definition%A%  
% 224.44/224.64  |- rdf__type mesh__D019771sskos__Concept
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D019771 1999
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D019771 2005
% 224.44/224.64  |- mesh__dateCreated mesh__D019771 1997-06-20
% 224.44/224.64  |- mesh__dateEstablished mesh__D019771 1998-01-01
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D019771 2004
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D019771 1998
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D019771 2002
% 224.44/224.64  |- skos__hiddenLabel mesh__D019771 Axotomies
% 224.44/224.64  |- mesh__historyNote mesh__D019771 98   
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D019771 2003
% 224.44/224.64  |- mesh__publicMeSHNote mesh__D000268 74   
% 224.44/224.64  |- mesh__recordAuthorizer mesh__D000268 PLS
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D000268 1995
% 224.44/224.64  |- skos__prefLabel mesh__D000268 Adhesiveness
% 224.44/224.64  |- mesh__historyNote mesh__D000268 74%28%69%29%   
% 224.44/224.64  |- skos__historyNote mesh__D000268 Surface Properties %28%1966-1968%29%
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D000268 2002
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D000268 1994
% 224.44/224.64  |- skos__broader mesh__D000268smesh__D013499
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D000268 2004
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D000268 1997
% 224.44/224.64  |- mesh__recordOriginator mesh__D000268 NLM
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D000268 2003
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D000268 1996
% 224.44/224.64  |- skos__annotation mesh__D000268 almost never IM   
% 224.44/224.64  |- mesh__recordMaintainer mesh__D000268 TAP
% 224.44/224.64  |- mesh__dateRevised mesh__D000268 1992-03-25
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D000268 2001
% 224.44/224.64  |- mesh__dateCreated mesh__D000268 1999-01-01
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D000268 1993
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D000268 2006
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D000268 1999
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D000268 2000
% 224.44/224.64  |- skos__hiddenLabel mesh__D000268 Adhesivenesses
% 224.44/224.64  |- mesh__dateEstablished mesh__D000268 1974-01-01
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D000268 2005
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D000268 1998
% 224.44/224.64  |- rdf__type mesh__D000268sskos__Concept
% 224.44/224.64  |- skos__related mesh__D000268smesh__D010973
% 224.44/224.64  |- skos__broader mesh__D005294Q000172smesh__D005294
% 224.44/224.64  |- mesh__preferredCombination mesh__D005294Q000172smesh__D046351
% 224.44/224.64  |- rdf__type mesh__D005294Q000172smesh__CompoundConcept
% 224.44/224.64  |- mesh__recordMaintainer mesh__D005751 TGC
% 224.44/224.64  |- skos__hiddenLabel mesh__D005751 Lavages, Gastric
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D005751 2005
% 224.44/224.64  |- skos__hiddenLabel mesh__D005751 Gastric Irrigations
% 224.44/224.64  |- mesh__dateCreated mesh__D005751 1999-01-01
% 224.44/224.64  |- rdf__type mesh__D005751sskos__Concept
% 224.44/224.64  |- mesh__publicMeSHNote mesh__D005751 66   
% 224.44/224.64  |- skos__prefLabel mesh__D005751 Gastric Lavage
% 224.44/224.64  |- skos__altLabel mesh__D005751 Irrigation, Gastric
% 224.44/224.64  |- mesh__recordOriginator mesh__D005751 NLM
% 224.44/224.64  |- skos__hiddenLabel mesh__D005751 Gastric Lavages
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D005751 1997
% 224.44/224.64  |- skos__altLabel mesh__D005751 Lavage, Gastric
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D005751 2002
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D005751 1999
% 224.44/224.64  |- skos__hiddenLabel mesh__D005751 Irrigations, Gastric
% 224.44/224.64  |- mesh__dateEstablished mesh__D005751 1966-01-01
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D005751 1996
% 224.44/224.64  |- mesh__dateRevised mesh__D005751 1991-05-15
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D005751 1993
% 224.44/224.64  |- skos__broader mesh__D005751smesh__D007507
% 224.44/224.64  |- skos__annotation mesh__D005751
% 224.44/224.64       do not use /util except by MeSH definition   
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D005751 2001
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D005751 1995
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D005751 1998
% 224.44/224.64  |- mesh__historyNote mesh__D005751 66%28%63%29%   
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D005751 1992
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D005751 1994
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D005751 2004
% 224.44/224.64  |- mesh__recordAuthorizer mesh__D005751 PLS
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D005751 2000
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D005751 2006
% 224.44/224.64  |- skos__hiddenLabel mesh__D005751 Gastric Irrigation
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D005751 2003
% 224.44/224.64  |- mesh__recordMaintainer mesh__D018679 ssb
% 224.44/224.64  |- skos__broader mesh__D018679smesh__D018678
% 224.44/224.64  |- skos__hiddenLabel mesh__D018679 Agonist, Cholinergic
% 224.44/224.64  |- mesh__recordAuthorizer mesh__D018679 sjn
% 224.44/224.64  |- skos__hiddenLabel mesh__D018679 Agonist, Acetylcholine
% 224.44/224.64  |- skos__altLabel mesh__D018679 Acetylcholine Agonist
% 224.44/224.64  |- mesh__dateCreated mesh__D018679 1994-06-01
% 224.44/224.64  |- rdf__type mesh__D018679sskos__Concept
% 224.44/224.64  |- skos__altLabel mesh__D018679 Cholinergic Agonist
% 224.44/224.64  |- skos__hiddenLabel mesh__D018679 Agonists, Acetylcholine
% 224.44/224.64  |- mesh__dateRevised mesh__D018679 2005-06-30
% 224.44/224.64  |- skos__hiddenLabel mesh__D018679 Agonists, Cholinergic
% 224.44/224.64  |- mesh__historyNote mesh__D018679 95   
% 224.44/224.64  |- skos__historyNote mesh__D018679
% 224.44/224.64       Acetylcholine/pharmacology %28%1967-1994%29%
% 224.44/224.64  |- skos__scopeNote mesh__D018679
% 224.44/224.64       Drugs that bind to and activate cholinergic receptors.     
% 224.44/224.64  |- skos__altLabel mesh__D018679 Acetylcholine Agonists
% 224.44/224.64  |- mesh__dateEstablished mesh__D018679 1995-01-01
% 224.44/224.64  |- mesh__recordOriginator mesh__D018679 RAZ
% 224.44/224.64  |- skos__prefLabel mesh__D018679 Cholinergic Agonists
% 224.44/224.64  |- skos__annotation mesh__D018679
% 224.44/224.64       GEN or unspecified; prefer specifics; DF: CHOLINERGIC AGON or CHOLINERGIC AG%A%  
% 224.44/224.64  |- mesh__publicMeSHNote mesh__D018679 95   
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D018679 2006
% 224.44/224.64  |- skos__altLabel mesh__D010696 Irex Brand of Phloroglucinol
% 224.44/224.64  |- mesh__recordOriginator mesh__D010696 NLM
% 224.44/224.64  |- rdf__type mesh__D010696sskos__Concept
% 224.44/224.64  |- skos__broader mesh__D010696smesh__D010636
% 224.44/224.64  |- skos__altLabel mesh__D010696 Lafon Brand of Phloroglucinol
% 224.44/224.64  |- mesh__dateRevised mesh__D010696 2005-06-30
% 224.44/224.64  |- skos__scopeNote mesh__D010696
% 224.44/224.64       1,3,5-Benzenetriol. A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.%A%    
% 224.44/224.64  |- skos__annotation mesh__D010696 an antispasmodic %26% lab reagent   
% 224.44/224.64  |- mesh__recordAuthorizer mesh__D010696 sjn
% 224.44/224.64  |- skos__prefLabel mesh__D010696 Phloroglucinol
% 224.44/224.64  |- mesh__recordMaintainer mesh__D010696 lkw
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D010696 2006
% 224.44/224.64  |- mesh__dateCreated mesh__D010696 1999-01-01
% 224.44/224.64  |- skos__historyNote mesh__D004659 Acrylates %28%1966-1971%29%
% 224.44/224.64  |- skos__historyNote mesh__D004659 Tissue Adhesives %28%1966-1971%29%
% 224.44/224.64  |- skos__hiddenLabel mesh__D004659 Butyl 2 Cyanacrylate
% 224.44/224.64  |- skos__broader mesh__D004659smesh__D003487
% 224.44/224.64  |- skos__historyNote mesh__D004659 Cyanoacrylates %28%1972-1974%29%
% 224.44/224.64  |- mesh__historyNote mesh__D004659
% 224.44/224.64       86; was ENBUCRYLATE 1980-85; was BUTYLCYANOACRYLATE see under CYANOACRYLATES 1972-79%A%  
% 224.44/224.64  |- skos__prefLabel mesh__D004659 Enbucrilate
% 224.44/224.64  |- mesh__recordOriginator mesh__D004659 NLM
% 224.44/224.64  |- skos__altLabel mesh__D004659 Butyl 2-Cyanacrylate
% 224.44/224.64  |- skos__hiddenLabel mesh__D004659 Cyanoacrylate, Polybutyl
% 224.44/224.64  |- skos__altLabel mesh__D004659 Histoacryl
% 224.44/224.64  |- skos__scopeNote mesh__D004659
% 224.44/224.64       A tissue adhesive that is applied as a monomer to moist tissue and polymerizes to form a bond. It is slowly biodegradable and used in all kinds of surgery, including dental.%A%    
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D004659 2006
% 224.44/224.64  |- mesh__dateEstablished mesh__D004659 1980-01-01
% 224.44/224.64  |- mesh__dateCreated mesh__D004659 1999-01-01
% 224.44/224.64  |- rdf__type mesh__D004659sskos__Concept
% 224.44/224.64  |- mesh__dateRevised mesh__D004659 2005-06-30
% 224.44/224.64  |- skos__altLabel mesh__D004659 Enbucrylate
% 224.44/224.64  |- skos__hiddenLabel mesh__D004659 Homopolymer Enbucrilate
% 224.44/224.64  |- skos__hiddenLabel mesh__D004659 2 Cyanobutylacrylate
% 224.44/224.64  |- mesh__recordMaintainer mesh__D004659 CCR
% 224.44/224.64  |- mesh__onlineNote mesh__D004659
% 224.44/224.64       use ENBUCRILATE to search ENBUCRYLATE 1980-85 %26% BUTYLCYANOACRYLATE 1975-79; use CYANOACRYLATES to search BUTYLCYANOACRYLATE 1972-74%A%  
% 224.44/224.64  |- skos__altLabel mesh__D004659 Braun Brand of Enbucrilate
% 224.44/224.64  |- skos__altLabel mesh__D004659 2-Cyanobutylacrylate
% 224.44/224.64  |- mesh__recordAuthorizer mesh__D004659 sjn
% 224.44/224.64  |- mesh__publicMeSHNote mesh__D004659
% 224.44/224.64       86; was ENBUCRYLATE 1980-85; was BUTYLCYANOACRYLATE see under CYANOACRYLATES 1972-79%A%  
% 224.44/224.64  |- skos__annotation mesh__D004659 D25-26 qualif   
% 224.44/224.64  |- skos__hiddenLabel mesh__D015381 Sch 30500
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D015381 2006
% 224.44/224.64  |- mesh__dateCreated mesh__D015381 1988-06-06
% 224.44/224.64  |- skos__altLabel mesh__D015381 Recombinant Interferon alpha-2b
% 224.44/224.64  |- skos__hiddenLabel mesh__D015381 Interferon alpha-2b, Recombinant
% 224.44/224.64  |- mesh__recordMaintainer mesh__D015381 ssb
% 224.44/224.64  |- skos__annotation mesh__D015381
% 224.44/224.64       spelling %22%alfa%22% is commonly used for for recombinant form; do not confuse X ref INTRON A %28%INTERFERON%29% with INTRONS.%A%  
% 224.44/224.64  |- mesh__dateEstablished mesh__D015381 1991-01-01
% 224.44/224.64  |- mesh__dateRevised mesh__D015381 2005-06-30
% 224.44/224.64  |- rdf__type mesh__D015381sskos__Concept
% 224.44/224.64  |- skos__historyNote mesh__D015381 Recombinant Proteins %28%1986-1988%29%
% 224.44/224.64  |- skos__historyNote mesh__D015381 Interferon Type I %28%1983-1988%29%
% 224.44/224.64  |- skos__hiddenLabel mesh__D015381 Sch30500
% 224.44/224.64  |- skos__broader mesh__D015381smesh__D015379
% 224.44/224.64  |- mesh__recordOriginator mesh__D015381 RLS
% 224.44/224.64  |- skos__hiddenLabel mesh__D015381 Recombinant Interferon Alfa 2b
% 224.44/224.64  |- skos__altLabel mesh__D015381 Recombinant Interferon Alfa-2b
% 224.44/224.64  |- mesh__recordAuthorizer mesh__D015381 sjn
% 224.44/224.64  |- skos__broader mesh__D015381smesh__D016898
% 224.44/224.64  |- mesh__historyNote mesh__D015381
% 224.44/224.64       91%28%89%29%; was see under INTERFERON ALFA, RECOMBINANT 1989-90%A%  
% 224.44/224.64  |- skos__scopeNote mesh__D015381
% 224.44/224.64       A recombinant alfa interferon consisting of 165 amino acid residues with arginine in position 23 and histidine in position 34. It is used extensively as an antiviral and antineoplastic agent.%A%    
% 224.44/224.64  |- skos__hiddenLabel mesh__D015381 Interferon Alfa 2b
% 224.44/224.64  |- skos__hiddenLabel mesh__D015381 Recombinant Interferon alpha 2b
% 224.44/224.64  |- mesh__publicMeSHNote mesh__D015381
% 224.44/224.64       91; was see under INTERFERON ALFA, RECOMBINANT 1989-90   
% 224.44/224.64  |- skos__prefLabel mesh__D015381 Interferon Alfa-2b
% 224.44/224.64  |- skos__hiddenLabel mesh__D015381 Interferon Alfa-2b, Recombinant
% 224.44/224.64  |- mesh__recordAuthorizer mesh__D009344 sjn
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D009344 2006
% 224.44/224.64  |- skos__prefLabel mesh__D009344 Neisseria gonorrhoeae
% 224.44/224.64  |- skos__altLabel mesh__D009344 Gonococcus
% 224.44/224.64  |- mesh__dateCreated mesh__D009344 1999-01-01
% 224.44/224.64  |- skos__annotation mesh__D009344 infection = GONORRHEA   
% 224.44/224.64  |- mesh__dateRevised mesh__D009344 2005-06-30
% 224.44/224.64  |- skos__broader mesh__D009344smesh__D009343
% 224.44/224.64  |- skos__scopeNote mesh__D009344
% 224.44/224.64       A species of gram-negative, aerobic bacteria primarily found in purulent venereal discharges. It is the causative agent of GONORRHEA.%A%    
% 224.44/224.64  |- mesh__recordOriginator mesh__D009344 NLM
% 224.44/224.64  |- mesh__recordMaintainer mesh__D009344 SYSTEM
% 224.44/224.64  |- rdf__type mesh__D009344sskos__Concept
% 224.44/224.64  |- skos__hiddenLabel mesh__D001361 Deficiencies, Vitamin
% 224.44/224.64  |- skos__prefLabel mesh__D001361 Avitaminosis
% 224.44/224.64  |- skos__broader mesh__D001361smesh__D003677
% 224.44/224.64  |- mesh__recordMaintainer mesh__D001361 lkt
% 224.44/224.64  |- rdf__type mesh__D001361sskos__Concept
% 224.44/224.64  |- mesh__dateRevised mesh__D001361 2003-07-09
% 224.44/224.64  |- mesh__recordAuthorizer mesh__D001361 sjn
% 224.44/224.64  |- skos__annotation mesh__D001361
% 224.44/224.64       includes hypovitaminosis; GEN: prefer specifics: avitaminosis A = VITAMIN A DEFICIENCY, etc.%A%  
% 224.44/224.64  |- skos__altLabel mesh__D001361 Vitamin Deficiency
% 224.44/224.64  |- skos__hiddenLabel mesh__D001361 Avitaminoses
% 224.44/224.64  |- mesh__recordOriginator mesh__D001361 NLM
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D001361 2005
% 224.44/224.64  |- skos__scopeNote mesh__D001361
% 224.44/224.64       A condition due to a deficiency of one or more essential vitamins. %28%Dorland, 27th ed%29%%A%    
% 224.44/224.64  |- mesh__dateCreated mesh__D001361 1999-01-01
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D001361 2004
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D001361 2006
% 224.44/224.64  |- skos__hiddenLabel mesh__D001361 Vitamin Deficiencies
% 224.44/224.64  |- skos__broader mesh__D014289smesh__D011726
% 224.44/224.64  |- skos__historyNote mesh__D014289 Oximes %28%1972-1974%29%
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D014289 2004
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D014289 2001
% 224.44/224.64  |- mesh__dateEstablished mesh__D014289 1991-01-01
% 224.44/224.64  |- mesh__dateCreated mesh__D014289 1974-11-19
% 224.44/224.64  |- mesh__publicMeSHNote mesh__D014289 91; was see under OXIMES 1975-90   
% 224.44/224.64  |- mesh__dateRevised mesh__D014289 2000-06-22
% 224.44/224.64  |- mesh__historyNote mesh__D014289
% 224.44/224.64       91%28%75%29%; was see under OXIMES 1975-90   
% 224.44/224.64  |- skos__broader mesh__D014289smesh__D010091
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D014289 2002
% 224.44/224.64  |- mesh__recordOriginator mesh__D014289 NLM
% 224.44/224.64  |- skos__altLabel mesh__D014289 Dipyroxime
% 224.44/224.64  |- mesh__recordMaintainer mesh__D014289 CCR
% 224.44/224.64  |- mesh__recordAuthorizer mesh__D014289 sjn
% 224.44/224.64  |- skos__historyNote mesh__D014289 Pyridinium Compounds %28%1969-1974%29%
% 224.44/224.64  |- rdf__type mesh__D014289sskos__Concept
% 224.44/224.64  |- skos__hiddenLabel mesh__D014289 Bromide, Trimedoxime
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D014289 2005
% 224.44/224.64  |- skos__altLabel mesh__D014289 TMB-4
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D014289 2006
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D014289 2003
% 224.44/224.64  |- skos__prefLabel mesh__D014289 Trimedoxime
% 224.44/224.64  |- skos__scopeNote mesh__D014289
% 224.44/224.64       Cholinesterase reactivator used as an antidote in alkyl phosphate poisoning.%A%    
% 224.44/224.64  |- skos__prefLabel mesh__D019772 Topotecan
% 224.44/224.64  |- mesh__dateRevised mesh__D019772 2003-07-09
% 224.44/224.64  |- skos__hiddenLabel mesh__D019772 SK%26%F 104864 A
% 224.44/224.64  |- skos__hiddenLabel mesh__D019772 SK%26%F104864A
% 224.44/224.64  |- skos__altLabel mesh__D019772
% 224.44/224.64       Topotecan Monohydrochloride, %28%S%29%-Isomer
% 224.44/224.64  |- skos__hiddenLabel mesh__D019772 Hydrochloride, Topotecan
% 224.44/224.64  |- skos__hiddenLabel mesh__D019772 Hydrochloride, Nogitecan
% 224.44/224.64  |- mesh__recordOriginator mesh__D019772 TPW
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D019772 2005
% 224.44/224.64  |- skos__hiddenLabel mesh__D019772 NSC609699
% 224.44/224.64  |- skos__altLabel mesh__D019772 Hycamtamine
% 224.44/224.64  |- skos__broader mesh__D019772smesh__D002166
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D019772 2006
% 224.44/224.64  |- skos__hiddenLabel mesh__D019772 SKF104864A
% 224.44/224.64  |- mesh__recordAuthorizer mesh__D019772 sjn
% 224.44/224.64  |- rdf__type mesh__D019772sskos__Concept
% 224.44/224.64  |- skos__hiddenLabel mesh__D019772 SKF 104864 A
% 224.44/224.64  |- skos__altLabel mesh__D019772
% 224.44/224.64       9-Dimethylaminomethyl-10-hydroxycamptothecin
% 224.44/224.64  |- skos__historyNote mesh__D019772
% 224.44/224.64       Camptothecin/analogs %26% derivatives %28%1991-1997%29%
% 224.44/224.64  |- mesh__recordMaintainer mesh__D019772 ssb
% 224.44/224.64  |- mesh__publicMeSHNote mesh__D019772
% 224.44/224.64       98; TOPOTECAN was indexed under CAMPTOTHECIN/analogs %26% derivatives 1991-97%A%  
% 224.44/224.64  |- skos__hiddenLabel mesh__D019772
% 224.44/224.64       9 Dimethylaminomethyl 10 hydroxycamptothecin
% 224.44/224.64  |- mesh__dateCreated mesh__D019772 1997-06-20
% 224.44/224.64  |- skos__hiddenLabel mesh__D019772 NSC 609699
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D019772 2004
% 224.44/224.64  |- skos__scopeNote mesh__D019772
% 224.44/224.64       An antineoplastic agent used to treat ovarian cancer. It works by inhibiting DNA TOPOISOMERASES, TYPE I.%A%    
% 224.44/224.64  |- skos__altLabel mesh__D019772 Nogitecan Hydrochloride
% 224.44/224.64  |- mesh__historyNote mesh__D019772 98; use TOPOTECAN %28%NM%29% 1991-97   
% 224.44/224.64  |- mesh__dateEstablished mesh__D019772 1998-01-01
% 224.44/224.64  |- skos__altLabel mesh__D019772 SKF-104864-A
% 224.44/224.64  |- skos__broader mesh__D000269smesh__D008420
% 224.44/224.64  |- mesh__dateEstablished mesh__D000269 1978-01-01
% 224.44/224.64  |- skos__hiddenLabel mesh__D000269 Mucilage
% 224.44/224.64  |- skos__scopeNote mesh__D000269
% 224.44/224.64       Substances that cause the adherence of two surfaces. They include glues %28%properly collagen-derived adhesives%29%, mucilages, sticky pastes, gums, resins, or latex.%A%    
% 224.44/224.64  |- mesh__recordOriginator mesh__D000269 SH
% 224.44/224.64  |- skos__broader mesh__D000269smesh__D020313
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D000269 2004
% 224.44/224.64  |- mesh__recordMaintainer mesh__D000269 ssb
% 224.44/224.64  |- mesh__dateRevised mesh__D000269 2003-07-09
% 224.44/224.64  |- skos__related mesh__D000269smesh__D014014
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D000269 2005
% 224.44/224.64  |- mesh__dateCreated mesh__D000269 1977-04-22
% 224.44/224.64  |- mesh__publicMeSHNote mesh__D000269 78   
% 224.44/224.64  |- skos__hiddenLabel mesh__D000269 Adhesive
% 224.44/224.64  |- skos__annotation mesh__D000269
% 224.44/224.64       D25-26 qualif; coord IM with DENTURE RETENTION %28%IM%29% for denture adhesives; spray adhesives: coord IM with AEROSOLS %28%NIM%29% if pertinent; available also are BONE CEMENTS %26% DENTAL CEMENTS%A%  
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D000269 2006
% 224.44/224.64  |- mesh__recordAuthorizer mesh__D000269 sjn
% 224.44/224.64  |- skos__prefLabel mesh__D000269 Adhesives
% 224.44/224.64  |- rdf__type mesh__D000269sskos__Concept
% 224.44/224.64  |- mesh__historyNote mesh__D000269 78   
% 224.44/224.64  |- skos__hiddenLabel mesh__D000269 Glue
% 224.44/224.64  |- rdf__type mesh__D005752sskos__Concept
% 224.44/224.64  |- skos__prefLabel mesh__D005752 Gastric Mucin
% 224.44/224.64  |- skos__hiddenLabel mesh__D005752 Mucin, Gastric
% 224.44/224.64  |- mesh__recordMaintainer mesh__D005752 SYSTEM
% 224.44/224.64  |- mesh__recordAuthorizer mesh__D005752 sjn
% 224.44/224.64  |- mesh__recordOriginator mesh__D005752 NLM
% 224.44/224.64  |- skos__annotation mesh__D005752 /biosyn /physiol permitted   
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D005752 2006
% 224.44/224.64  |- skos__broader mesh__D005752smesh__D009077
% 224.44/224.64  |- mesh__dateCreated mesh__D005752 1999-01-01
% 224.44/224.64  |- mesh__dateRevised mesh__D005752 2005-06-30
% 224.44/224.64  |- skos__annotation mesh__D010697 D25-26 qualif   
% 224.44/224.64  |- mesh__publicMeSHNote mesh__D010697
% 224.44/224.64       94; was PHLOXINE B 1979-93 %28%see under FLUORESCEINS 1979-90%29%; ACID RED 92 was see PHLOXINE B 1979-93%A%  
% 224.44/224.64  |- mesh__dateRevised mesh__D010697 2000-06-21
% 224.44/224.64  |- skos__altLabel mesh__D010697 Phloxine B
% 224.44/224.64  |- skos__prefLabel mesh__D010697 Eosine I Bluish
% 224.44/224.64  |- skos__historyNote mesh__D010697 Bromine %28%1966-1978%29%
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D010697 2002
% 224.44/224.64  |- skos__altLabel mesh__D010697 Phloxin B
% 224.44/224.64  |- skos__broader mesh__D010697smesh__D005452
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D010697 2005
% 224.44/224.64  |- skos__historyNote mesh__D010697 Chlorine %28%1966-1978%29%
% 224.44/224.64  |- skos__altLabel mesh__D010697 D.C. Red No. 27
% 224.44/224.64  |- mesh__dateCreated mesh__D010697 1977-12-09
% 224.44/224.64  |- mesh__recordOriginator mesh__D010697 SH
% 224.44/224.64  |- mesh__dateEstablished mesh__D010697 1991-01-01
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D010697 2006
% 224.44/224.64  |- skos__scopeNote mesh__D010697
% 224.44/224.64       A red fluorescein dye used as a histologic stain. It may be cytotoxic, mutagenic, and inhibit certain mitochondrial functions.%A%    
% 224.44/224.64  |- skos__hiddenLabel mesh__D010697 Bluish, Eosine
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D010697 2003
% 224.44/224.64  |- skos__historyNote mesh__D010697 Fluoresceins %28%1966-1978%29%
% 224.44/224.64  |- skos__hiddenLabel mesh__D010697 Bluish, Eosine I
% 224.44/224.64  |- skos__altLabel mesh__D010697 Eosine Bluish
% 224.44/224.64  |- mesh__recordAuthorizer mesh__D010697 sjn
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D010697 2001
% 224.44/224.64  |- mesh__onlineNote mesh__D010697
% 224.44/224.64       use EOSINE I BLUISH to search PHLOXINE B %26% ACID RED 92 1979-93%A%  
% 224.44/224.64  |- mesh__historyNote mesh__D010697
% 224.44/224.64       94; was PHLOXINE B 1979-93 %28%see under FLUORESCEINS 1979-90%29%; ACID RED 92 was see PHLOXINE B 1979-93%A%  
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D010697 2004
% 224.44/224.64  |- skos__altLabel mesh__D010697 Eosine B
% 224.44/224.64  |- mesh__recordMaintainer mesh__D010697 TWD
% 224.44/224.64  |- rdf__type mesh__D010697sskos__Concept
% 224.44/224.64  |- rdf__type mesh__D015382sskos__Concept
% 224.44/224.64  |- skos__hiddenLabel mesh__D015382 Interferon gamma 1b
% 224.44/224.64  |- mesh__recordAuthorizer mesh__D015382 sjn
% 224.44/224.64  |- mesh__dateEstablished mesh__D015382 1989-01-01
% 224.44/224.64  |- skos__altLabel mesh__D015382 Type II Interferon, Recombinant
% 224.44/224.64  |- mesh__onlineNote mesh__D015382
% 224.44/224.64       use INTERFERON-GAMMA, RECOMBINANT to search INTERFERON GAMMA, RECOMBINANT 1989-91%A%  
% 224.44/224.64  |- skos__broader mesh__D015382smesh__D011994
% 224.44/224.64  |- mesh__publicMeSHNote mesh__D015382
% 224.44/224.64       92; was INTERFERON GAMMA, RECOMBINANT 1989-91   
% 224.44/224.64  |- skos__scopeNote mesh__D015382
% 224.44/224.64       A type II interferon produced by recombinant DNA technology. It is similar to the interferon secreted by lymphocytes and has antiviral and antineoplastic activity.%A%    
% 224.44/224.64  |- skos__historyNote mesh__D015382 Interferon Type II %28%1983-1988%29%
% 224.44/224.64  |- skos__prefLabel mesh__D015382 Interferon-gamma, Recombinant
% 224.44/224.64  |- skos__broader mesh__D015382smesh__D007371
% 224.44/224.64  |- skos__altLabel mesh__D015382 Recombinant Interferon-gamma
% 224.44/224.64  |- skos__hiddenLabel mesh__D015382 Recombinant Interferon gamma
% 224.44/224.64  |- skos__hiddenLabel mesh__D015382 gamma Interferon, Recombinant
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D015382 2006
% 224.44/224.64  |- skos__historyNote mesh__D015382 Recombinant Proteins %28%1986-1988%29%
% 224.44/224.64  |- mesh__dateCreated mesh__D015382 1988-06-06
% 224.44/224.64  |- skos__hiddenLabel mesh__D015382 Recombinant gamma-Interferon
% 224.44/224.64  |- skos__altLabel mesh__D015382 Interferon Type II, Recombinant
% 224.44/224.64  |- mesh__recordMaintainer mesh__D015382 ssb
% 224.44/224.64  |- mesh__recordOriginator mesh__D015382 RLS
% 224.44/224.64  |- skos__altLabel mesh__D015382 gamma-Interferon, Recombinant
% 224.44/224.64  |- mesh__dateRevised mesh__D015382 2005-06-30
% 224.44/224.64  |- skos__hiddenLabel mesh__D015382 Interferon gamma 2a
% 224.44/224.64  |- skos__altLabel mesh__D015382 Recombinant gamma Interferon
% 224.44/224.64  |- skos__hiddenLabel mesh__D015382 Interferon, Recombinant gamma
% 224.44/224.64  |- skos__hiddenLabel mesh__D015382 Interferon gamma, Recombinant
% 224.44/224.64  |- mesh__historyNote mesh__D015382
% 224.44/224.64       92; was INTERFERON GAMMA, RECOMBINANT 1989-91   
% 224.44/224.64  |- mesh__recordOriginator mesh__D009345 NLM
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D009345 2006
% 224.44/224.64  |- skos__broader mesh__D009345smesh__D009343
% 224.44/224.64  |- mesh__recordMaintainer mesh__D009345 SYSTEM
% 224.44/224.64  |- skos__scopeNote mesh__D009345
% 224.44/224.64       A species of gram-negative, aerobic BACTERIA. It is a commensal and pathogen only of humans, and can be carried asymptomatically in the NASOPHARYNX. When found in cerebrospinal fluid it is the causative agent of cerebrospinal meningitis %28%MENINGITIS, MENINGOCOCCAL%29%. It is also found in venereal discharges and blood. There are at least 13 serogroups based on antigenic differences in the capsular polysaccharides; the ones causing most meningitis infections being A, B, C, Y, and W-135. Each serogroup can be further classified by serotype, serosubtype, and immunotype.%A%    
% 224.44/224.64  |- mesh__recordAuthorizer mesh__D009345 sjn
% 224.44/224.64  |- skos__annotation mesh__D009345
% 224.44/224.64       specific serogroups are also available; infection: probably MENINGITIS, MENINGOCOCCAL or, if not meningitis, MENINGOCOCCAL INFECTIONS%A%  
% 224.44/224.64  |- skos__prefLabel mesh__D009345 Neisseria meningitidis
% 224.44/224.64  |- rdf__type mesh__D009345sskos__Concept
% 224.44/224.64  |- skos__altLabel mesh__D009345 Meningococcus
% 224.44/224.64  |- mesh__dateRevised mesh__D009345 2005-06-30
% 224.44/224.64  |- mesh__dateCreated mesh__D009345 1999-01-01
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D001362 1997
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D001362 1994
% 224.44/224.64  |- mesh__dateRevised mesh__D001362 1992-03-25
% 224.44/224.64  |- skos__prefLabel mesh__D001362 Avoidance Learning
% 224.44/224.64  |- skos__scopeNote mesh__D001362
% 224.44/224.64       A response to a cue that is instrumental in avoiding a noxious experience.%A%    
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D001362 1999
% 224.44/224.64  |- mesh__recordMaintainer mesh__D001362 TAP
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D001362 1993
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D001362 1995
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D001362 2003
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D001362 2005
% 224.44/224.64  |- skos__hiddenLabel mesh__D001362 Learning, Avoidance
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D001362 2000
% 224.44/224.64  |- mesh__dateCreated mesh__D001362 1999-01-01
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D001362 2004
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D001362 2001
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D001362 2006
% 224.44/224.64  |- skos__broader mesh__D001362smesh__D007858
% 224.44/224.64  |- skos__related mesh__D001362smesh__D004924
% 224.44/224.64  |- mesh__recordOriginator mesh__D001362 NLM
% 224.44/224.64  |- skos__hiddenLabel mesh__D001362 Learnings, Avoidance
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D001362 1996
% 224.44/224.64  |- skos__hiddenLabel mesh__D001362 Avoidance Learnings
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D001362 1998
% 224.44/224.64  |- mesh__recordAuthorizer mesh__D001362 PLS
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D001362 2002
% 224.44/224.64  |- rdf__type mesh__D001362sskos__Concept
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D019773 2005
% 224.44/224.64  |- skos__hiddenLabel mesh__D019773 Membrane, Epiretinal
% 224.44/224.64  |- mesh__activeMeSHYear mesh__D019773 2002
% 224.44/224.65  |- mesh__dateEstablished mesh__D019773 1998-01-01
% 224.44/224.65  |- skos__historyNote mesh__D019773 Retinal Diseases %28%1976-1997%29%
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D019773 1998
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D019773 2006
% 224.44/224.65  |- rdf__type mesh__D019773sskos__Concept
% 224.44/224.65  |- skos__scopeNote mesh__D019773
% 224.44/224.65       A membrane on the vitreal surface of the retina resulting from the proliferation of one or more of three retinal elements: %28%1%29% fibrous astrocytes; %28%2%29% fibrocytes; and %28%3%29% retinal pigment epithelial cells. Localized epiretinal membranes may occur at the posterior pole of the eye without clinical signs or may cause marked loss of vision as a result of covering, distorting, or detaching the fovea centralis. Epiretinal membranes may cause vascular leakage and secondary retinal edema. In younger individuals some membranes appear to be developmental in origin and occur in otherwise normal eyes. The majority occur in association with retinal holes, ocular concussions, retinal inflammation, or after ocular surgery. %28%Newell, Ophthalmology: Principles and Concepts, 7th ed, p291%29%%A%    
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D019773 1999
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D019773 2003
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D019773 2000
% 224.44/224.65  |- skos__hiddenLabel mesh__D019773 Membranes, Epiretinal
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D019773 2004
% 224.44/224.65  |- skos__broader mesh__D019773smesh__D012164
% 224.44/224.65  |- skos__prefLabel mesh__D019773 Epiretinal Membrane
% 224.44/224.65  |- mesh__publicMeSHNote mesh__D019773 98   
% 224.44/224.65  |- skos__annotation mesh__D019773 note category: a retinal dis   
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D019773 2001
% 224.44/224.65  |- skos__historyNote mesh__D019773 Retina %28%1974-1997%29%
% 224.44/224.65  |- mesh__historyNote mesh__D019773 98   
% 224.44/224.65  |- skos__hiddenLabel mesh__D019773 Epiretinal Membranes
% 224.44/224.65  |- mesh__dateCreated mesh__D019773 1997-06-20
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011790 1999
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011790 2003
% 224.44/224.65  |- skos__related mesh__D011790smesh__D010356
% 224.44/224.65  |- mesh__recordAuthorizer mesh__D011790 PLS
% 224.44/224.65  |- mesh__dateRevised mesh__D011790 1995-05-23
% 224.44/224.65  |- skos__hiddenLabel mesh__D011790 Quarantines
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011790 2000
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011790 2004
% 224.44/224.65  |- rdf__type mesh__D011790sskos__Concept
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011790 2001
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011790 2005
% 224.44/224.65  |- mesh__dateCreated mesh__D011790 1999-01-01
% 224.44/224.65  |- skos__annotation mesh__D011790 human or animal; /vet permitted   
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011790 1996
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011790 2002
% 224.44/224.65  |- mesh__recordMaintainer mesh__D011790 KEV
% 224.44/224.65  |- skos__scopeNote mesh__D011790
% 224.44/224.65       Restriction of freedom of movement of individuals who have been exposed to infectious or communicable disease in order to prevent its spread; a period of detention of vessels, vehicles, or travelers coming from infected or suspected places; and detention or isolation on account of suspected contagion. It includes government regulations on the detention of animals at frontiers or ports of entrance for the prevention of infectious disease, through a period of isolation before being allowed to enter a country. %28%From Dorland, 28th ed %26% Black%27%s Veterinary Dictionary, 17th ed%29%%A%    
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011790 2006
% 224.44/224.65  |- skos__prefLabel mesh__D011790 Quarantine
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011790 1997
% 224.44/224.65  |- mesh__recordOriginator mesh__D011790 NLM
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011790 1998
% 224.44/224.65  |- skos__broader mesh__D011790smesh__D017053
% 224.44/224.65  |- skos__hiddenLabel mesh__D005753 Gastric Gland
% 224.44/224.65  |- mesh__publicMeSHNote mesh__D005753
% 224.44/224.65       64; GASTRIC MUCOSA PROLAPSE was heading 1963-96   
% 224.44/224.65  |- skos__hiddenLabel mesh__D005753 Mucosa, Gastric
% 224.44/224.65  |- skos__hiddenLabel mesh__D005753 Gland, Cardiac
% 224.44/224.65  |- skos__broader mesh__D005753smesh__D013270
% 224.44/224.65  |- mesh__dateEstablished mesh__D005753 1964-01-01
% 224.44/224.65  |- mesh__historyNote mesh__D005753
% 224.44/224.65       64; GASTRIC MUCOSA PROLAPSE was heading 1963-96   
% 224.44/224.65  |- skos__hiddenLabel mesh__D005753 Glands, Pyloric
% 224.44/224.65  |- skos__hiddenLabel mesh__D005753 Gland, Pyloric
% 224.44/224.65  |- mesh__dateRevised mesh__D005753 2005-06-30
% 224.44/224.65  |- skos__hiddenLabel mesh__D005753 Pyloric Gland
% 224.44/224.65  |- skos__hiddenLabel mesh__D005753 Glands, Gastric
% 224.44/224.65  |- mesh__dateCreated mesh__D005753 1999-01-01
% 224.44/224.65  |- skos__scopeNote mesh__D005753
% 224.44/224.65       Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach %28%CARDIA; GASTRIC FUNDUS; and PYLORUS%29%, different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones.%A%    
% 224.44/224.65  |- mesh__onlineNote mesh__D005753
% 224.44/224.65       use GASTRIC MUCOSA to search GASTRIC MUCOSA PROLAPSE 1966-96%A%  
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D005753 2006
% 224.44/224.65  |- skos__hiddenLabel mesh__D005753 Glands, Cardiac
% 224.44/224.65  |- skos__annotation mesh__D005753
% 224.44/224.65       /secret permitted but consider GASTRIC JUICE /secret if pertinent; mucosal neoplasms: coordinate IM with STOMACH NEOPLASMS %28%IM%29% + histological type of neoplasm %28%IM%29%; mucosal prolapse: = GASTRIC MUCOSA %28%IM%29% + STOMACH DISEASES %28%NIM%29% + PROLAPSE %28%NIM%29%%A%  
% 224.44/224.65  |- skos__hiddenLabel mesh__D005753 Mucosas, Gastric
% 224.44/224.65  |- skos__hiddenLabel mesh__D005753 Gland, Gastric
% 224.44/224.65  |- mesh__recordMaintainer mesh__D005753 lkt
% 224.44/224.65  |- mesh__recordAuthorizer mesh__D005753 sjn
% 224.44/224.65  |- skos__hiddenLabel mesh__D005753 Gastric Mucosas
% 224.44/224.65  |- skos__hiddenLabel mesh__D005753 Cardiac Gland
% 224.44/224.65  |- skos__broader mesh__D005753smesh__D009092
% 224.44/224.65  |- skos__prefLabel mesh__D005753 Gastric Mucosa
% 224.44/224.65  |- rdf__type mesh__D005753sskos__Concept
% 224.44/224.65  |- mesh__recordOriginator mesh__D005753 NLM
% 224.44/224.65  |- skos__hiddenLabel mesh__D010698 School Phobia
% 224.44/224.65  |- skos__altLabel mesh__D010698 Phobic Neuroses
% 224.44/224.65  |- skos__hiddenLabel mesh__D010698 Phobic Disorder
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D010698 2006
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D010698 2001
% 224.44/224.65  |- skos__broader mesh__D010698smesh__D001008
% 224.44/224.65  |- skos__hiddenLabel mesh__D010698 Social Phobias
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D010698 2003
% 224.44/224.65  |- skos__prefLabel mesh__D010698 Phobic Disorders
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D010698 1998
% 224.44/224.65  |- skos__hiddenLabel mesh__D010698 Phobia
% 224.44/224.65  |- mesh__dateCreated mesh__D010698 1999-01-01
% 224.44/224.65  |- mesh__onlineNote mesh__D010698
% 224.44/224.65       use PHOBIC DISORDERS to search PHOBIAS 1966-80, PHOBIC NEUROSES 1969-80, %26% CLAUSTROPHOBIA 1968-78%A%  
% 224.44/224.65  |- skos__hiddenLabel mesh__D010698 Claustrophobias
% 224.44/224.65  |- mesh__publicMeSHNote mesh__D010698 81; was PHOBIAS 1963-80   
% 224.44/224.65  |- skos__hiddenLabel mesh__D010698 Disorders, Phobic
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D010698 2004
% 224.44/224.65  |- skos__hiddenLabel mesh__D010698 Social Phobia
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D010698 1999
% 224.44/224.65  |- skos__scopeNote mesh__D010698
% 224.44/224.65       Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.%A%    
% 224.44/224.65  |- rdf__type mesh__D010698sskos__Concept
% 224.44/224.65  |- mesh__dateRevised mesh__D010698 1997-06-20
% 224.44/224.65  |- skos__hiddenLabel mesh__D010698 School Phobias
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D010698 2002
% 224.44/224.65  |- skos__altLabel mesh__D010698 Phobias
% 224.44/224.65  |- skos__hiddenLabel mesh__D010698 Disorder, Phobic
% 224.44/224.65  |- mesh__recordOriginator mesh__D010698 NLM
% 224.44/224.65  |- mesh__historyNote mesh__D010698
% 224.44/224.65       81; was PHOBIAS 1963-80; PHOBIC NEUROSES was see under PHOBIAS 1969-80; CLAUSTROPHOBIA was see under PHOBIAS 1968-78%A%  
% 224.44/224.65  |- skos__hiddenLabel mesh__D010698 Phobias, Social
% 224.44/224.65  |- mesh__recordMaintainer mesh__D010698 JLS
% 224.44/224.65  |- mesh__recordAuthorizer mesh__D010698 SJN
% 224.44/224.65  |- skos__hiddenLabel mesh__D010698 Phobias, School
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D010698 2005
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D010698 2000
% 224.44/224.65  |- skos__prefLabel mesh__D015383 Zona Fasciculata
% 224.44/224.65  |- skos__hiddenLabel mesh__D015383 Fasciculata, Zona
% 224.44/224.65  |- skos__historyNote mesh__D015383 Adrenal Cortex %28%1975-1988%29%
% 224.44/224.65  |- mesh__dateRevised mesh__D015383 2004-07-07
% 224.44/224.65  |- skos__hiddenLabel mesh__D015383 Fasciculata, Adrenal
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D015383 2005
% 224.44/224.65  |- mesh__recordMaintainer mesh__D015383 lkt
% 224.44/224.65  |- mesh__recordAuthorizer mesh__D015383 sjn
% 224.44/224.65  |- mesh__publicMeSHNote mesh__D015383 89   
% 224.44/224.65  |- skos__broader mesh__D015383smesh__D000302
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D015383 2006
% 224.44/224.65  |- mesh__dateCreated mesh__D015383 1988-06-06
% 224.44/224.65  |- skos__altLabel mesh__D015383 Adrenal Fasciculata
% 224.44/224.65  |- rdf__type mesh__D015383sskos__Concept
% 224.44/224.65  |- skos__scopeNote mesh__D015383
% 224.44/224.65       The wide middle zone of the adrenal cortex. This zone produces a series of enzymes that convert PREGNENOLONE to cortisol %28%HYDROCORTISONE%29% via 17-ALPHA-HYDROXYPROGESTERONE.%A%    
% 224.44/224.65  |- mesh__historyNote mesh__D015383 89   
% 224.44/224.65  |- skos__historyNote mesh__D015383 Adrenal Glands %28%1966-1988%29%
% 224.44/224.65  |- mesh__dateEstablished mesh__D015383 1989-01-01
% 224.44/224.65  |- mesh__recordOriginator mesh__D015383 RLS
% 224.44/224.65  |- mesh__dateRevised mesh__D009346 2005-06-30
% 224.44/224.65  |- mesh__publicMeSHNote mesh__D009346 75   
% 224.44/224.65  |- mesh__recordOriginator mesh__D009346 NLM
% 224.44/224.65  |- skos__historyNote mesh__D009346 Bacteria %28%1966-1974%29%
% 224.44/224.65  |- skos__scopeNote mesh__D009346
% 224.44/224.65       A family of gram-negative, parasitic bacteria including several important pathogens of man.%A%    
% 224.44/224.65  |- mesh__historyNote mesh__D009346 75   
% 224.44/224.65  |- skos__prefLabel mesh__D009346 Neisseriaceae
% 224.44/224.65  |- mesh__dateEstablished mesh__D009346 1975-01-01
% 224.44/224.65  |- mesh__recordAuthorizer mesh__D009346 sjn
% 224.44/224.65  |- rdf__type mesh__D009346sskos__Concept
% 224.44/224.65  |- skos__broader mesh__D009346smesh__D020562
% 224.44/224.65  |- mesh__dateCreated mesh__D009346 1999-01-01
% 224.44/224.65  |- skos__broader mesh__D009346smesh__D016946
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D009346 2006
% 224.44/224.65  |- mesh__recordMaintainer mesh__D009346 SYSTEM
% 224.44/224.65  |- skos__hiddenLabel mesh__D001363 Prize
% 224.44/224.65  |- skos__hiddenLabel mesh__D001363 Prizes and Awards
% 224.44/224.65  |- mesh__recordOriginator mesh__D001363 NLM
% 224.44/224.65  |- mesh__dateCreated mesh__D001363 1999-01-01
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D001363 2004
% 224.44/224.65  |- mesh__recordMaintainer mesh__D001363 kle
% 224.44/224.65  |- skos__hiddenLabel mesh__D001363 Award
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D001363 2006
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D001363 2002
% 224.44/224.65  |- rdf__type mesh__D001363sskos__Concept
% 224.44/224.65  |- skos__broader mesh__D001363smesh__D006809
% 224.44/224.65  |- skos__annotation mesh__D001363
% 224.44/224.65       IM; no qualif; awards %26% prizes in field of medicine: do not coord with MEDICINE but coord with specific med specialty or other field %28%IM%29%; DF: AWARDS%A%  
% 224.44/224.65  |- skos__prefLabel mesh__D001363 Awards and Prizes
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D001363 2000
% 224.44/224.65  |- mesh__recordAuthorizer mesh__D001363 sjn
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D001363 2003
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D001363 2001
% 224.44/224.65  |- mesh__dateRevised mesh__D001363 1999-11-03
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D001363 2005
% 224.44/224.65  |- skos__broader mesh__D010604Q000331smesh__D010604
% 224.44/224.65  |- mesh__preferredCombination mesh__D010604Q000331smesh__D007885
% 224.44/224.65  |- rdf__type mesh__D010604Q000331smesh__CompoundConcept
% 224.44/224.65  |- mesh__publicMeSHNote mesh__D019774 98   
% 224.44/224.65  |- skos__related mesh__D019774smesh__D001779
% 224.44/224.65  |- mesh__recordAuthorizer mesh__D019774 sjn
% 224.44/224.65  |- skos__scopeNote mesh__D019774
% 224.44/224.65       Substances, usually endogenous, that act as inhibitors of blood coagulation. They may affect one or multiple enzymes throughout the process. As a group, they also inhibit enzymes involved in processes other than blood coagulation, such as those from the complement system, fibrinolytic enzyme system, blood cells, and bacteria.%A%    
% 224.44/224.65  |- mesh__dateCreated mesh__D019774 1997-06-20
% 224.44/224.65  |- skos__annotation mesh__D019774 DF: BLOOD COAG FACTOR INHIB   
% 224.44/224.65  |- mesh__recordMaintainer mesh__D019774 ssb
% 224.44/224.65  |- mesh__dateEstablished mesh__D019774 1998-01-01
% 224.44/224.65  |- mesh__historyNote mesh__D019774 98   
% 224.44/224.65  |- mesh__dateRevised mesh__D019774 2005-06-30
% 224.44/224.65  |- skos__altLabel mesh__D019774 Inhibitors, Coagulation Factor, Blood
% 224.44/224.65  |- mesh__recordOriginator mesh__D019774 ADP
% 224.44/224.65  |- skos__prefLabel mesh__D019774 Blood Coagulation Factor Inhibitors
% 224.44/224.65  |- skos__altLabel mesh__D019774 Inhibitor, Blood Coagulation Factor
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D019774 2006
% 224.44/224.65  |- skos__broader mesh__D019774smesh__D001685
% 224.44/224.65  |- skos__altLabel mesh__D019774 Inhibitor, Coagulation Factor, Blood
% 224.44/224.65  |- rdf__type mesh__D019774sskos__Concept
% 224.44/224.65  |- skos__altLabel mesh__D019774 Inhibitors, Blood Coagulation Factor
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011791 2004
% 224.44/224.65  |- rdf__type mesh__D011791sskos__Concept
% 224.44/224.65  |- skos__prefLabel mesh__D011791 Quartz
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011791 2005
% 224.44/224.65  |- mesh__recordMaintainer mesh__D011791 TPW
% 224.44/224.65  |- mesh__dateCreated mesh__D011791 1999-01-01
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011791 1996
% 224.44/224.65  |- mesh__recordAuthorizer mesh__D011791 PLS
% 224.44/224.65  |- skos__broader mesh__D011791smesh__D012822
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011791 2006
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011791 2000
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011791 2001
% 224.44/224.65  |- mesh__onlineNote mesh__D011791 use SILICA to search QUARTZ 1966-74   
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011791 1997
% 224.44/224.65  |- mesh__historyNote mesh__D011791
% 224.44/224.65       91%28%75%29%63-64; was see under SILICA 1965-90; was heading 1963-64%A%  
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011791 1998
% 224.44/224.65  |- mesh__publicMeSHNote mesh__D011791
% 224.44/224.65       91,63-64; was see under SILICA 1965-90; was heading 1963-64%A%  
% 224.44/224.65  |- mesh__dateEstablished mesh__D011791 1991-01-01
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011791 2002
% 224.44/224.65  |- skos__annotation mesh__D011791 a form of silicon dioxide   
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011791 1994
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011791 1999
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011791 2003
% 224.44/224.65  |- mesh__dateRevised mesh__D011791 1993-06-04
% 224.44/224.65  |- skos__scopeNote mesh__D011791
% 224.44/224.65       Quartz %28%SiO2%29%. A glassy or crystalline form of silicon dioxide. Many colored varieties are semiprecious stones. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A%    
% 224.44/224.65  |- mesh__recordOriginator mesh__D011791 NLM
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D011791 1995
% 224.44/224.65  |- mesh__recordMaintainer mesh__D010699 nns
% 224.44/224.65  |- mesh__dateEstablished mesh__D010699 1991-01-01
% 224.44/224.65  |- mesh__dateRevised mesh__D010699 2003-07-09
% 224.44/224.65  |- skos__related mesh__D010699smesh__D014831
% 224.44/224.65  |- skos__historyNote mesh__D010699 Voice %28%1966-1978%29%
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D010699 2004
% 224.44/224.65  |- rdf__type mesh__D010699sskos__Concept
% 224.44/224.65  |- skos__scopeNote mesh__D010699
% 224.44/224.65       The process of producing vocal sounds by means of VOCAL CORDS vibrating in an expiratory blast of air.%A%    
% 224.44/224.65  |- mesh__recordAuthorizer mesh__D010699 sjn
% 224.44/224.65  |- skos__hiddenLabel mesh__D010699 Phonations
% 224.44/224.65  |- skos__historyNote mesh__D010699 Speech %28%1966-1978%29%
% 224.44/224.65  |- skos__historyNote mesh__D010699 Vocal Cords %28%1966-1978%29%
% 224.44/224.65  |- mesh__publicMeSHNote mesh__D010699 91; was see under VOICE 1979-90   
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D010699 2005
% 224.44/224.65  |- skos__prefLabel mesh__D010699 Phonation
% 224.44/224.65  |- mesh__dateCreated mesh__D010699 1978-05-22
% 224.44/224.65  |- skos__related mesh__D010699smesh__D014833
% 224.44/224.65  |- mesh__recordOriginator mesh__D010699 RC
% 224.44/224.65  |- skos__broader mesh__D010699smesh__D044703
% 224.44/224.65  |- skos__related mesh__D010699smesh__D013060
% 224.44/224.65  |- mesh__activeMeSHYear mesh__D010699 2006
% 224.44/224.65  |- mesh__historyNote mesh__D010699
% 224.44/224.65       91%28%79%29%; was see under VOICE 1979-90   
% 224.44/224.65  |- rdf__type mesh__D015384sskos__Concept
% 224.44/224.65  |- skos__hiddenLabel mesh__D015384 Glomerulosa, Adrenal
% 224.44/224.65  |- mesh__dateCreated mesh__D015384 1988-06-06
% 224.44/224.65  |- skos__hiddenLabel mesh__D015384 Glomerulosa, Zona
% 224.44/224.66  |- skos__prefLabel mesh__D015384 Zona Glomerulosa
% 224.44/224.66  |- mesh__publicMeSHNote mesh__D015384 89   
% 224.44/224.66  |- mesh__historyNote mesh__D015384 89   
% 224.44/224.66  |- mesh__dateRevised mesh__D015384 2004-07-07
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D015384 2006
% 224.44/224.66  |- mesh__recordAuthorizer mesh__D015384 sjn
% 224.44/224.66  |- skos__historyNote mesh__D015384 Adrenal Glands %28%1966-1988%29%
% 224.44/224.66  |- skos__altLabel mesh__D015384 Adrenal Glomerulosa
% 224.44/224.66  |- mesh__recordOriginator mesh__D015384 RLS
% 224.44/224.66  |- skos__broader mesh__D015384smesh__D000302
% 224.44/224.66  |- skos__scopeNote mesh__D015384
% 224.44/224.66       The narrow subcapsular outer zone of the adrenal cortex. This zone produces a series of enzymes that convert PREGNENOLONE to ALDOSTERONE. The final steps involve three successive oxidations by ALDOSTERONE SYNTHASE.%A%    
% 224.44/224.66  |- mesh__recordMaintainer mesh__D015384 lkt
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D015384 2005
% 224.44/224.66  |- mesh__dateEstablished mesh__D015384 1989-01-01
% 224.44/224.66  |- skos__historyNote mesh__D015384 Adrenal Cortex %28%1975-1988%29%
% 224.44/224.66  |- mesh__recordAuthorizer mesh__D009347 sjn
% 224.44/224.66  |- skos__scopeNote mesh__D009347
% 224.44/224.66       A syndrome characterized by HYPERPIGMENTATION, enlarging pituitary mass, visual defects secondary to compression of the OPTIC CHIASM, and elevated serum ACTH. It is caused by the expansion of an underlying ACTH-SECRETING PITUITARY ADENOMA that grows in the absence of feedback inhibition by adrenal CORTICOSTEROIDS, usually after ADRENALECTOMY.%A%    
% 224.44/224.66  |- mesh__recordMaintainer mesh__D009347 lkt
% 224.44/224.66  |- rdf__type mesh__D009347sskos__Concept
% 224.44/224.66  |- skos__prefLabel mesh__D009347 Nelson Syndrome
% 224.44/224.66  |- skos__broader mesh__D009347smesh__D049913
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D009347 2006
% 224.44/224.66  |- mesh__publicMeSHNote mesh__D009347
% 224.44/224.66       1991; see PITUITARY NEOPLASMS 1978-90   
% 224.44/224.66  |- mesh__dateRevised mesh__D009347 2005-06-30
% 224.44/224.66  |- skos__historyNote mesh__D009347 Pituitary Neoplasms %28%1966-1977%29%
% 224.44/224.66  |- mesh__dateCreated mesh__D009347 1977-04-27
% 224.44/224.66  |- mesh__historyNote mesh__D009347 1991%28%1978%29%   
% 224.44/224.66  |- mesh__dateEstablished mesh__D009347 1991-01-01
% 224.44/224.66  |- skos__historyNote mesh__D009347 Pigmentation Disorders %28%1966-1977%29%
% 224.44/224.66  |- mesh__recordOriginator mesh__D009347 VDK
% 224.44/224.66  |- skos__historyNote mesh__D009347 Adenoma %28%1966-1977%29%
% 224.44/224.66  |- skos__scopeNote mesh__D001364
% 224.44/224.66       The act of %22%taking account%22% of an object or state of affairs. It does not imply assessment of nor attention to the qualities or nature of the object.%A%    
% 224.44/224.66  |- mesh__onlineNote mesh__D001364 search COGNITION 1969-74   
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001364 2001
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001364 1996
% 224.44/224.66  |- mesh__historyNote mesh__D001364
% 224.44/224.66       91%28%75%29%; was see under COGNITION 1975-90   
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001364 1998
% 224.44/224.66  |- mesh__dateEstablished mesh__D001364 1991-01-01
% 224.44/224.66  |- mesh__recordOriginator mesh__D001364 NLM
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001364 1997
% 224.44/224.66  |- rdf__type mesh__D001364sskos__Concept
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001364 1999
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001364 2002
% 224.44/224.66  |- mesh__publicMeSHNote mesh__D001364
% 224.44/224.66       91; was see under COGNITION 1975-90   
% 224.44/224.66  |- mesh__recordAuthorizer mesh__D001364 PLS
% 224.44/224.66  |- mesh__dateRevised mesh__D001364 1994-06-28
% 224.44/224.66  |- skos__hiddenLabel mesh__D001364 Awarenesses
% 224.44/224.66  |- skos__prefLabel mesh__D001364 Awareness
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001364 1995
% 224.44/224.66  |- mesh__recordMaintainer mesh__D001364 PLS
% 224.44/224.66  |- skos__broader mesh__D001364smesh__D003071
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001364 2003
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001364 2005
% 224.44/224.66  |- mesh__dateCreated mesh__D001364 1999-01-01
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001364 2004
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001364 2006
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001364 2000
% 224.44/224.66  |- skos__historyNote mesh__D028501 Malvaceae %28%1996-2001%29%
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D028501 2004
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D028501 2002
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D028501 2006
% 224.44/224.66  |- rdf__type mesh__D028501sskos__Concept
% 224.44/224.66  |- skos__annotation mesh__D028501
% 224.44/224.66       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.44/224.66  |- skos__prefLabel mesh__D028501 Malva
% 224.44/224.66  |- mesh__publicMeSHNote mesh__D028501 2002; see MALVACEAE 1996-2001   
% 224.44/224.66  |- mesh__historyNote mesh__D028501 2002; use MALVACEAE 1996-2001   
% 224.44/224.66  |- skos__scopeNote mesh__D028501
% 224.44/224.66       A plant genus of the family MALVACEAE, order Malvales, subclass Dilleniida. The common name of %27%Mallow%27% may sometimes get confused with other plants.%A%    
% 224.44/224.66  |- mesh__dateEstablished mesh__D028501 2002-01-01
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D028501 2003
% 224.44/224.66  |- skos__broader mesh__D028501smesh__D019660
% 224.44/224.66  |- mesh__dateCreated mesh__D028501 2001-07-25
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D028501 2005
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011792 1999
% 224.44/224.66  |- skos__scopeNote mesh__D011792
% 224.44/224.66       A province of eastern Canada. Its capital is Quebec. The region belonged to France from 1627 to 1763 when it was lost to the British. The name is from the Algonquian quilibek meaning the place where waters narrow, referring to the gradually narrowing channel of the St. Lawrence or to the narrows of the river at Cape Diamond. %28%From Webster%27%s New Geographical Dictionary, 1988, p993 %26% Room, Brewer%27%s Dictionary of Names, 1992, p440%29%%A%    
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011792 2003
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011792 1998
% 224.44/224.66  |- mesh__recordAuthorizer mesh__D011792 PLS
% 224.44/224.66  |- rdf__type mesh__D011792sskos__Concept
% 224.44/224.66  |- mesh__dateRevised mesh__D011792 1995-02-21
% 224.44/224.66  |- mesh__recordOriginator mesh__D011792 NLM
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011792 2002
% 224.44/224.66  |- skos__prefLabel mesh__D011792 Quebec
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011792 1997
% 224.44/224.66  |- skos__annotation mesh__D011792 a province of eastern Canada   
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011792 2006
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011792 2001
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011792 1996
% 224.44/224.66  |- skos__broader mesh__D011792smesh__D002170
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011792 2005
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011792 2000
% 224.44/224.66  |- mesh__recordMaintainer mesh__D011792 TGC
% 224.44/224.66  |- mesh__dateCreated mesh__D011792 1999-01-01
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011792 2004
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D005755 2006
% 224.44/224.66  |- skos__scopeNote mesh__D005755
% 224.44/224.66       A family of gastrointestinal peptide hormones that excite the secretion of GASTRIC JUICE. They may also occur in the central nervous system where they are presumed to be neurotransmitters.%A%    
% 224.44/224.66  |- mesh__onlineNote mesh__D005755 use GASTRINS to search GASTRIN 1966-77   
% 224.44/224.66  |- rdf__type mesh__D005755sskos__Concept
% 224.44/224.66  |- mesh__recordAuthorizer mesh__D005755 sjn
% 224.44/224.66  |- mesh__recordMaintainer mesh__D005755 ssb
% 224.44/224.66  |- mesh__publicMeSHNote mesh__D005755 78; was GASTRIN 1963-77   
% 224.44/224.66  |- skos__broader mesh__D005755smesh__D036361
% 224.44/224.66  |- mesh__recordOriginator mesh__D005755 NLM
% 224.44/224.66  |- skos__broader mesh__D005755smesh__D005768
% 224.44/224.66  |- skos__annotation mesh__D005755
% 224.44/224.66       general or unspecified; prefer specifics   
% 224.44/224.66  |- mesh__historyNote mesh__D005755 78; was GASTRIN 1963-77   
% 224.44/224.66  |- skos__related mesh__D005755smesh__D005765
% 224.44/224.66  |- skos__prefLabel mesh__D005755 Gastrins
% 224.44/224.66  |- skos__broader mesh__D005755smesh__D009479
% 224.44/224.66  |- mesh__dateCreated mesh__D005755 1999-01-01
% 224.44/224.66  |- mesh__dateRevised mesh__D005755 2005-06-30
% 224.44/224.66  |- mesh__recordMaintainer mesh__D015385 lkt
% 224.44/224.66  |- mesh__publicMeSHNote mesh__D015385 89   
% 224.44/224.66  |- skos__altLabel mesh__D015385 Adrenal Reticularis
% 224.44/224.66  |- mesh__dateRevised mesh__D015385 2004-07-07
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D015385 2006
% 224.44/224.66  |- skos__hiddenLabel mesh__D015385 Reticularis, Zona
% 224.44/224.66  |- mesh__historyNote mesh__D015385 89   
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D015385 2005
% 224.44/224.66  |- mesh__dateEstablished mesh__D015385 1989-01-01
% 224.44/224.66  |- skos__historyNote mesh__D015385 Adrenal Cortex %28%1975-1988%29%
% 224.44/224.66  |- skos__prefLabel mesh__D015385 Zona Reticularis
% 224.44/224.66  |- skos__scopeNote mesh__D015385
% 224.44/224.66       The inner zone of the adrenal cortex. This zone produces the enzymes that convert PREGNENOLONE, a 21-carbon steroid, to 19-carbon steroids %28%DEHYDROEPIANDROSTERONE; and ANDROSTENEDIONE%29% via 17-ALPHA-HYDROXYPREGNENOLONE.%A%    
% 224.44/224.66  |- skos__hiddenLabel mesh__D015385 Reticularis, Adrenal
% 224.44/224.66  |- skos__historyNote mesh__D015385 Adrenal Glands %28%1966-1988%29%
% 224.44/224.66  |- mesh__recordOriginator mesh__D015385 RLS
% 224.44/224.66  |- rdf__type mesh__D015385sskos__Concept
% 224.44/224.66  |- mesh__recordAuthorizer mesh__D015385 sjn
% 224.44/224.66  |- mesh__dateCreated mesh__D015385 1988-06-06
% 224.44/224.66  |- skos__broader mesh__D015385smesh__D000302
% 224.44/224.66  |- mesh__dateRevised mesh__D009348 2003-07-09
% 224.44/224.66  |- mesh__publicMeSHNote mesh__D009348 SIPUNCULIDA was heading 1980-84   
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D009348 2005
% 224.44/224.66  |- rdf__type mesh__D009348sskos__Concept
% 224.44/224.66  |- mesh__onlineNote mesh__D009348
% 224.44/224.66       use NEMATODA to search SIPUNCULIDA 1980-84   
% 224.44/224.66  |- mesh__historyNote mesh__D009348 SIPUNCULIDA was heading 1980-84   
% 224.44/224.66  |- mesh__dateCreated mesh__D009348 1999-01-01
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D009348 2006
% 224.44/224.66  |- mesh__recordAuthorizer mesh__D009348 sjn
% 224.44/224.66  |- skos__broader mesh__D009348smesh__D006376
% 224.44/224.66  |- skos__scopeNote mesh__D009348
% 224.44/224.66       A class of unsegmented helminths with fundamental bilateral symmetry and secondary triradiate symmetry of the oral and esophageal structures. Many species are parasites.%A%    
% 224.44/224.66  |- skos__annotation mesh__D009348
% 224.44/224.66       GEN or unspecified; prefer specifics; infection = NEMATODE INFECTIONS; /drug eff: consider also ANTINEMATODAL AGENTS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 224.44/224.66  |- mesh__recordOriginator mesh__D009348 NLM
% 224.44/224.66  |- skos__related mesh__D009348smesh__D000969
% 224.44/224.66  |- mesh__recordMaintainer mesh__D009348 ags
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D009348 2004
% 224.44/224.66  |- skos__prefLabel mesh__D009348 Nematoda
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001365 2003
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001365 2006
% 224.44/224.66  |- mesh__dateCreated mesh__D001365 1999-01-01
% 224.44/224.66  |- skos__prefLabel mesh__D001365 Axilla
% 224.44/224.66  |- skos__broader mesh__D001365smesh__D034941
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001365 2005
% 224.44/224.66  |- mesh__recordAuthorizer mesh__D001365 sjn
% 224.44/224.66  |- skos__hiddenLabel mesh__D001365 Axillas
% 224.44/224.66  |- rdf__type mesh__D001365sskos__Concept
% 224.44/224.66  |- mesh__recordOriginator mesh__D001365 NLM
% 224.44/224.66  |- mesh__recordMaintainer mesh__D001365 SMH
% 224.44/224.66  |- mesh__dateRevised mesh__D001365 2002-07-02
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001365 2004
% 224.44/224.66  |- skos__annotation mesh__D001365
% 224.44/224.66       %22%axillary lymph nodes%22% = LYMPH NODES %28%IM%29% + AXILLA %28%NIM, no qualif%29%%A%  
% 224.44/224.66  |- mesh__publicMeSHNote mesh__D028502
% 224.44/224.66       2002, 1963-1985; see POLYGONACEAE 1998-2001, see PLANTS, MEDICINAL 1986-1997%A%  
% 224.44/224.66  |- rdf__type mesh__D028502sskos__Concept
% 224.44/224.66  |- mesh__dateCreated mesh__D028502 2001-07-25
% 224.44/224.66  |- mesh__historyNote mesh__D028502
% 224.44/224.66       2002, 1963-1985; use POLYGONACEAE 1998-2001, use PLANTS, MEDICINAL 1986-1997%A%  
% 224.44/224.66  |- skos__broader mesh__D028502smesh__D019664
% 224.44/224.66  |- mesh__recordOriginator mesh__D028502 ssb
% 224.44/224.66  |- skos__annotation mesh__D028502
% 224.44/224.66       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.44/224.66  |- mesh__dateEstablished mesh__D028502 2002-01-01
% 224.44/224.66  |- skos__scopeNote mesh__D028502
% 224.44/224.66       A plant genus of the family POLYGONACEAE that is an ingredient of Shou-Wu-Pian, a Chinese herbal preparation %28%DRUGS, CHINESE HERBAL%29%. The common name of black bindweed also refers to TAMUS or Fallopia %28%use POLYGONACEAE%29%.%A%    
% 224.44/224.66  |- mesh__recordAuthorizer mesh__D028502 sjn
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D028502 2003
% 224.44/224.66  |- mesh__dateRevised mesh__D028502 2002-07-02
% 224.44/224.66  |- skos__prefLabel mesh__D028502 Polygonum
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D028502 2005
% 224.44/224.66  |- mesh__recordMaintainer mesh__D028502 ssb
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D028502 2004
% 224.44/224.66  |- skos__historyNote mesh__D028502 Polygonaceae %28%1998-2001%29%
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D028502 2006
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D006050 1998
% 224.44/224.66  |- mesh__dateCreated mesh__D006050 1974-11-11
% 224.44/224.66  |- mesh__publicMeSHNote mesh__D006050 75   
% 224.44/224.66  |- mesh__dateRevised mesh__D006050 1993-06-01
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D006050 1994
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D006050 2006
% 224.44/224.66  |- skos__annotation mesh__D006050
% 224.44/224.66       Au-185-196, 198-201, 203; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 224.44/224.66  |- mesh__recordOriginator mesh__D006050 NLM
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D006050 2002
% 224.44/224.66  |- mesh__dateEstablished mesh__D006050 1975-09-01
% 224.44/224.66  |- skos__historyNote mesh__D006050 Radioisotopes %28%1966-1974%29%
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D006050 2005
% 224.44/224.66  |- skos__historyNote mesh__D006050 Gold Isotopes %28%1966-1974%29%
% 224.44/224.66  |- mesh__recordAuthorizer mesh__D006050 PLS
% 224.44/224.66  |- mesh__onlineNote mesh__D006050 search GOLD ISOTOPES 1966-74   
% 224.44/224.66  |- skos__broader mesh__D006050smesh__D011868
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D006050 1997
% 224.44/224.66  |- skos__prefLabel mesh__D006050 Gold Radioisotopes
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D006050 1996
% 224.44/224.66  |- rdf__type mesh__D006050sskos__Concept
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D006050 2001
% 224.44/224.66  |- mesh__recordMaintainer mesh__D006050 TPW
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D006050 2004
% 224.44/224.66  |- skos__scopeNote mesh__D006050
% 224.44/224.66       Unstable isotopes of gold that decay or disintegrate emitting radiation. Au 185-196, 198-201, and 203 are radioactive gold isotopes.%A%    
% 224.44/224.66  |- skos__broader mesh__D006050smesh__D006049
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D006050 1999
% 224.44/224.66  |- mesh__historyNote mesh__D006050 75   
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D006050 2000
% 224.44/224.66  |- skos__hiddenLabel mesh__D006050 Radioisotopes, Gold
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D006050 2003
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D006050 1995
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011793 2003
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011793 1998
% 224.44/224.66  |- skos__annotation mesh__D011793 a state of Australia   
% 224.44/224.66  |- rdf__type mesh__D011793sskos__Concept
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011793 2000
% 224.44/224.66  |- mesh__historyNote mesh__D011793 88   
% 224.44/224.66  |- mesh__dateRevised mesh__D011793 1995-02-21
% 224.44/224.66  |- skos__prefLabel mesh__D011793 Queensland
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011793 1997
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011793 2006
% 224.44/224.66  |- skos__scopeNote mesh__D011793
% 224.44/224.66       A state in northeastern Australia. Its capital is Brisbane. Its coast was first visited by Captain Cook in 1770 and its first settlement %28%penal%29% was located on Moreton Bay in 1824. The name Cooksland was first proposed but honor to Queen Victoria prevailed. %28%From Webster%27%s New Geographical Dictionary, 1988, p996 %26% Room, Brewer%27%s Dictionary of Names, 1992, p441%29%%A%    
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011793 1996
% 224.44/224.66  |- mesh__recordAuthorizer mesh__D011793 PLS
% 224.44/224.66  |- skos__broader mesh__D011793smesh__D001315
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011793 2005
% 224.44/224.66  |- mesh__dateCreated mesh__D011793 1987-03-09
% 224.44/224.66  |- skos__historyNote mesh__D011793 Australia %28%1966-1987%29%
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011793 2002
% 224.44/224.66  |- mesh__dateEstablished mesh__D011793 1988-01-01
% 224.44/224.66  |- mesh__recordOriginator mesh__D011793 EC
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011793 2004
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011793 1999
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D011793 2001
% 224.44/224.66  |- mesh__recordMaintainer mesh__D011793 PLS
% 224.44/224.66  |- rdf__type mesh__D005756sskos__Concept
% 224.44/224.66  |- mesh__dateRevised mesh__D005756 2004-07-07
% 224.44/224.66  |- mesh__recordMaintainer mesh__D005756 lkt
% 224.44/224.66  |- skos__prefLabel mesh__D005756 Gastritis
% 224.44/224.66  |- skos__hiddenLabel mesh__D005756 Gastritides
% 224.44/224.66  |- mesh__recordAuthorizer mesh__D005756 sjn
% 224.44/224.66  |- skos__broader mesh__D005756smesh__D013272
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D005756 2005
% 224.44/224.66  |- mesh__dateCreated mesh__D005756 1999-01-01
% 224.44/224.66  |- mesh__recordOriginator mesh__D005756 NLM
% 224.44/224.66  |- skos__broader mesh__D005756smesh__D005759
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D005756 2006
% 224.44/224.66  |- skos__scopeNote mesh__D005756
% 224.44/224.66       Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.%A%    
% 224.44/224.66  |- skos__annotation mesh__D015386
% 224.44/224.66       note category: do not confuse with HAZARDOUS WASTE; %22%includes safe handling, transport %26% storage%22%%A%  
% 224.44/224.66  |- skos__hiddenLabel mesh__D015386 Environmental Toxic Substances
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D015386 2006
% 224.44/224.66  |- skos__altLabel mesh__D015386 Toxic Environmental Substances
% 224.44/224.66  |- skos__hiddenLabel mesh__D015386 Substances, Toxic Environmental
% 224.44/224.66  |- skos__hiddenLabel mesh__D015386 Substances, Environmental Toxic
% 224.44/224.66  |- mesh__recordOriginator mesh__D015386 RLS
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D015386 2005
% 224.44/224.66  |- mesh__dateEstablished mesh__D015386 1989-01-01
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D015386 2004
% 224.44/224.66  |- mesh__dateRevised mesh__D015386 2003-07-09
% 224.44/224.66  |- skos__related mesh__D015386smesh__D006256
% 224.44/224.66  |- skos__historyNote mesh__D015386
% 224.44/224.66       Environmental Pollutants %28%1975-1988%29%
% 224.44/224.66  |- skos__hiddenLabel mesh__D015386 Materials, Hazardous
% 224.44/224.66  |- skos__altLabel mesh__D015386 Environmental Substances, Toxic
% 224.44/224.66  |- skos__altLabel mesh__D015386 Chemicals, Hazardous
% 224.44/224.66  |- mesh__recordAuthorizer mesh__D015386 sjn
% 224.44/224.66  |- rdf__type mesh__D015386sskos__Concept
% 224.44/224.66  |- mesh__dateCreated mesh__D015386 1988-06-06
% 224.44/224.66  |- skos__hiddenLabel mesh__D015386 Substances, Hazardous
% 224.44/224.66  |- skos__prefLabel mesh__D015386 Hazardous Substances
% 224.44/224.66  |- mesh__recordMaintainer mesh__D015386 ssb
% 224.44/224.66  |- skos__altLabel mesh__D015386 Hazardous Materials
% 224.44/224.66  |- skos__historyNote mesh__D015386 Environmental Exposure %28%1967-1988%29%
% 224.44/224.66  |- mesh__publicMeSHNote mesh__D015386 89   
% 224.44/224.66  |- skos__altLabel mesh__D015386 Environmental Hazards
% 224.44/224.66  |- skos__broader mesh__D015386smesh__D004785
% 224.44/224.66  |- skos__scopeNote mesh__D015386
% 224.44/224.66       Substances which, upon release into the atmosphere, water, or soil, or which, in direct contact with the skin, eyes, or mucous membranes, or as additives to food, cause health risks to humans or animals through absorption, inhalation, or ingestion. The concept includes safe handling, transportation, and storage of these substances.%A%    
% 224.44/224.66  |- skos__historyNote mesh__D015386
% 224.44/224.66       Environmental Pollution %28%1971-1988%29%
% 224.44/224.66  |- skos__hiddenLabel mesh__D015386 Hazards, Health
% 224.44/224.66  |- mesh__historyNote mesh__D015386 89   
% 224.44/224.66  |- mesh__recordAuthorizer mesh__D009349 PLS
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D009349 1993
% 224.44/224.66  |- mesh__dateCreated mesh__D009349 1999-01-01
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D009349 2003
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D009349 1998
% 224.44/224.66  |- skos__scopeNote mesh__D009349
% 224.44/224.66       Infections by nematodes, general or unspecified.     
% 224.44/224.66  |- skos__broader mesh__D009349smesh__D006373
% 224.44/224.66  |- mesh__recordMaintainer mesh__D009349 PXP
% 224.44/224.66  |- mesh__recordOriginator mesh__D009349 NLM
% 224.44/224.66  |- rdf__type mesh__D009349sskos__Concept
% 224.44/224.66  |- skos__altLabel mesh__D009349 Infections, Nematode
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D009349 1997
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D009349 2002
% 224.44/224.66  |- skos__hiddenLabel mesh__D009349 Infection, Nematode
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D009349 2006
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D009349 1996
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D009349 2001
% 224.44/224.66  |- skos__related mesh__D009349smesh__D000969
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D009349 1995
% 224.44/224.66  |- mesh__dateRevised mesh__D009349 1992-05-22
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D009349 2005
% 224.44/224.66  |- skos__annotation mesh__D009349
% 224.44/224.66       GEN only: prefer specifics; /drug ther: consider also ANTINEMATODAL AGENTS%A%  
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D009349 1994
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D009349 2000
% 224.44/224.66  |- skos__prefLabel mesh__D009349 Nematode Infections
% 224.44/224.66  |- skos__hiddenLabel mesh__D009349 Nematode Infection
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D009349 2004
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D009349 1999
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001366 2006
% 224.44/224.66  |- mesh__dateCreated mesh__D001366 1999-01-01
% 224.44/224.66  |- skos__prefLabel mesh__D001366 Axillary Artery
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001366 1997
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001366 2000
% 224.44/224.66  |- skos__hiddenLabel mesh__D001366 Artery, Axillary
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001366 2005
% 224.44/224.66  |- skos__broader mesh__D001366smesh__D001158
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001366 1993
% 224.44/224.66  |- mesh__recordMaintainer mesh__D001366 TAP
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001366 1996
% 224.44/224.66  |- rdf__type mesh__D001366sskos__Concept
% 224.44/224.66  |- skos__scopeNote mesh__D001366
% 224.44/224.66       The continuation of the subclavian artery; it distributes over the upper limb, axilla, chest and shoulder.%A%    
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001366 1999
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001366 2002
% 224.44/224.66  |- skos__hiddenLabel mesh__D001366 Arteries, Axillary
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001366 1995
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001366 2004
% 224.44/224.66  |- mesh__dateRevised mesh__D001366 1992-05-26
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001366 1998
% 224.44/224.66  |- skos__hiddenLabel mesh__D001366 Axillary Arteries
% 224.44/224.66  |- mesh__recordAuthorizer mesh__D001366 PLS
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001366 1994
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001366 2003
% 224.44/224.66  |- mesh__recordOriginator mesh__D001366 NLM
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D001366 2001
% 224.44/224.66  |- skos__historyNote mesh__D028503 Rubiaceae %28%1999-2001%29%
% 224.44/224.66  |- skos__prefLabel mesh__D028503 Cephaelis
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D028503 2003
% 224.44/224.66  |- skos__broader mesh__D028503smesh__D019666
% 224.44/224.66  |- mesh__publicMeSHNote mesh__D028503
% 224.44/224.66       2002; see RUBIACEAE 1999-2001; see IPECAC 1977-1998; for URAGOGA see RUBIACEAE 1999-2001, see IPECAC 1977-1998%A%  
% 224.44/224.66  |- mesh__dateEstablished mesh__D028503 2002-01-01
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D028503 2005
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D028503 2004
% 224.44/224.66  |- skos__scopeNote mesh__D028503
% 224.44/224.66       A plant genus of the family RUBIACEAE, order Rubiales, subclass Asteridae. Cephaelis ipecacuanha is the source of IPECAC.%A%    
% 224.44/224.66  |- mesh__dateCreated mesh__D028503 2001-07-25
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D028503 2006
% 224.44/224.66  |- skos__altLabel mesh__D028503 Psychotria ipecacuanha
% 224.44/224.66  |- mesh__historyNote mesh__D028503
% 224.44/224.66       2002; use RUBIACEAE 1999-2001; use IPECAC 1977-1998; for URAGOGA use RUBIACEAE 1999-2001, use IPECAC 1977-1998%A%  
% 224.44/224.66  |- skos__related mesh__D028503smesh__D007486
% 224.44/224.66  |- rdf__type mesh__D028503sskos__Concept
% 224.44/224.66  |- skos__annotation mesh__D028503
% 224.44/224.66       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D028503 2002
% 224.44/224.66  |- skos__altLabel mesh__D020520 Anterior Circulation Infarction, Brain
% 224.44/224.66  |- skos__historyNote mesh__D020520
% 224.44/224.66       Intracranial Arteriosclerosis %28%1967-1999%29%
% 224.44/224.66  |- skos__historyNote mesh__D020520
% 224.44/224.66       Intracranial Embolism and Thrombosis %28%1966-1999%29%
% 224.44/224.66  |- mesh__recordMaintainer mesh__D020520 ssb
% 224.44/224.66  |- skos__altLabel mesh__D020520 Posterior Circulation Infarction, Brain
% 224.44/224.66  |- skos__altLabel mesh__D020520 Infarction, Brain, Posterior Circulation
% 224.44/224.66  |- skos__hiddenLabel mesh__D020520 Infarction, Brain Venous
% 224.44/224.66  |- skos__related mesh__D020520smesh__D007238
% 224.44/224.66  |- skos__hiddenLabel mesh__D020520 Infarctions, Lacunar
% 224.44/224.66  |- skos__historyNote mesh__D020520 Brain Diseases %28%1965-1999%29%
% 224.44/224.66  |- skos__altLabel mesh__D020520 Infarction, Brain, Anterior Circulation
% 224.44/224.66  |- mesh__dateRevised mesh__D020520 2005-06-30
% 224.44/224.66  |- skos__altLabel mesh__D020520 Posterior Circulation Brain Infarction
% 224.44/224.66  |- mesh__activeMeSHYear mesh__D020520 2006
% 224.44/224.66  |- skos__broader mesh__D020520smesh__D020521
% 224.44/224.66  |- mesh__historyNote mesh__D020520 2000   
% 224.44/224.66  |- skos__altLabel mesh__D020520 Infarction, Anterior Cerebral Circulation
% 224.44/224.66  |- skos__altLabel mesh__D020520 Infarction, Anterior Circulation, Brain
% 224.44/224.66  |- skos__hiddenLabel mesh__D020520 Infarctions, Brain Venous
% 224.44/224.66  |- mesh__recordAuthorizer mesh__D020520 sjn
% 224.44/224.67  |- skos__hiddenLabel mesh__D020520 Infarctions, Brain
% 224.44/224.67  |- skos__prefLabel mesh__D020520 Brain Infarction
% 224.44/224.67  |- skos__hiddenLabel mesh__D020520 Infarction, Brain
% 224.44/224.67  |- skos__scopeNote mesh__D020520
% 224.44/224.67       The formation of an area of necrosis in the brain, including the cerebral hemispheres %28%see CEREBRAL INFARCTION%29%, thalami, basal ganglia, brain stem %28%BRAIN STEM INFARCTIONS%29%, or cerebellum secondary to an insufficiency of arterial or venous blood flow.%A%    
% 224.44/224.67  |- skos__annotation mesh__D020520
% 224.44/224.67       GEN: prefer specifics; DF: BRAIN INFARCT   
% 224.44/224.67  |- skos__hiddenLabel mesh__D020520 Brain Venous Infarctions
% 224.44/224.67  |- skos__altLabel mesh__D020520 Brain Infarction, Anterior Circulation
% 224.44/224.67  |- skos__historyNote mesh__D020520
% 224.44/224.67       Cerebral Arterial Diseases %28%1965-1999%29%
% 224.44/224.67  |- skos__altLabel mesh__D020520 Brain Infarction, Venous
% 224.44/224.67  |- skos__hiddenLabel mesh__D020520 Lacunar Infarctions
% 224.44/224.67  |- skos__hiddenLabel mesh__D020520 Venous Brain Infarctions
% 224.44/224.67  |- skos__hiddenLabel mesh__D020520 Brain Infarctions, Venous
% 224.44/224.67  |- rdf__type mesh__D020520sskos__Concept
% 224.44/224.67  |- skos__historyNote mesh__D020520 Infarction %28%1965-1999%29%
% 224.44/224.67  |- skos__hiddenLabel mesh__D020520 Brain Infarctions
% 224.44/224.67  |- mesh__dateEstablished mesh__D020520 2000-01-01
% 224.44/224.67  |- skos__hiddenLabel mesh__D020520 Lacunar Infarction
% 224.44/224.67  |- mesh__dateCreated mesh__D020520 1999-11-08
% 224.44/224.67  |- skos__altLabel mesh__D020520 Infarction, Posterior Circulation, Brain
% 224.44/224.67  |- mesh__publicMeSHNote mesh__D020520 2000   
% 224.44/224.67  |- skos__hiddenLabel mesh__D020520 Infarctions, Venous Brain
% 224.44/224.67  |- skos__hiddenLabel mesh__D020520 Venous Brain Infarction
% 224.44/224.67  |- mesh__recordOriginator mesh__D020520 KEV
% 224.44/224.67  |- skos__broader mesh__D020520smesh__D007238
% 224.44/224.67  |- skos__hiddenLabel mesh__D020520 Venous Infarctions, Brain
% 224.44/224.67  |- skos__hiddenLabel mesh__D020520 Brain Venous Infarction
% 224.44/224.67  |- skos__hiddenLabel mesh__D020520 Infarction, Venous Brain
% 224.44/224.67  |- skos__altLabel mesh__D006051 Nourypharma Brand of Aurothioglucose
% 224.44/224.67  |- mesh__recordMaintainer mesh__D006051 ssb
% 224.44/224.67  |- skos__altLabel mesh__D006051 Gold Thioglucose
% 224.44/224.67  |- mesh__dateRevised mesh__D006051 2005-06-30
% 224.44/224.67  |- skos__altLabel mesh__D006051 Schering-Plough Brand of Aurothioglucose
% 224.44/224.67  |- skos__scopeNote mesh__D006051
% 224.44/224.67       A thioglucose derivative used as an antirheumatic and experimentally to produce obesity in animals.%A%    
% 224.44/224.67  |- skos__hiddenLabel mesh__D006051 Aurothioglucose, beta D Isomer
% 224.44/224.67  |- mesh__recordAuthorizer mesh__D006051 sjn
% 224.44/224.67  |- skos__hiddenLabel mesh__D006051 B Oleosum, Solganal
% 224.44/224.67  |- skos__prefLabel mesh__D006051 Aurothioglucose
% 224.44/224.67  |- skos__altLabel mesh__D006051 Thioglucosoaurate
% 224.44/224.67  |- skos__hiddenLabel mesh__D006051 Aurothioglucose Schering Brand
% 224.44/224.67  |- mesh__onlineNote mesh__D006051
% 224.44/224.67       use AUROTHIOGLUCOSE to search GOLD THIOGLUCOSE 1979-90; use GOLD to search AUROTHIOGLUCOSE 1973-74 %28%as Prov%29%%A%  
% 224.44/224.67  |- rdf__type mesh__D006051sskos__Concept
% 224.44/224.67  |- mesh__recordOriginator mesh__D006051 NLM
% 224.44/224.67  |- skos__altLabel mesh__D006051 Tosse Brand of Aurothioglucose
% 224.44/224.67  |- skos__historyNote mesh__D006051 Gold %28%1966-1972%29%
% 224.44/224.67  |- skos__hiddenLabel mesh__D006051 Gold50
% 224.44/224.67  |- skos__hiddenLabel mesh__D006051 Aurothioglucose Tosse Brand
% 224.44/224.67  |- mesh__dateCreated mesh__D006051 1999-01-01
% 224.44/224.67  |- skos__hiddenLabel mesh__D006051 Gold 50
% 224.44/224.67  |- skos__hiddenLabel mesh__D006051 Aurothioglucose Nourypharma Brand
% 224.44/224.67  |- mesh__dateEstablished mesh__D006051 1991-01-01
% 224.44/224.67  |- mesh__publicMeSHNote mesh__D006051
% 224.44/224.67       91; was GOLD THIOGLUCOSE see under GOLD 1979-90; was AUROTHIOGLUCOSE see under GOLD 1975-78%A%  
% 224.44/224.67  |- skos__hiddenLabel mesh__D006051 Schering Plough Brand of Aurothioglucose
% 224.44/224.67  |- skos__altLabel mesh__D006051 Schering Brand of Aurothioglucose
% 224.44/224.67  |- skos__hiddenLabel mesh__D006051 beta-D Isomer Aurothioglucose
% 224.44/224.67  |- skos__altLabel mesh__D006051 Solganol
% 224.44/224.67  |- skos__broader mesh__D006051smesh__D050607
% 224.44/224.67  |- mesh__historyNote mesh__D006051
% 224.44/224.67       91%28%79%29%; was GOLD THIOGLUCOSE see under GOLD 1979-90; was AUROTHIOGLUCOSE see under GOLD 1973-78 %28%Prov 1973-74%29%%A%  
% 224.44/224.67  |- skos__hiddenLabel mesh__D006051 Thioglucose, Gold
% 224.44/224.67  |- skos__hiddenLabel mesh__D006051 Aurothioglucose Schering-Plough Brand
% 224.44/224.67  |- skos__hiddenLabel mesh__D006051 Oleosum, Solganal B
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D006051 2006
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D047468 2005
% 224.44/224.67  |- skos__related mesh__D047468smesh__D000936
% 224.44/224.67  |- mesh__publicMeSHNote mesh__D047468
% 224.44/224.67       2005; see PRECIPITIN TESTS 1989-2004   
% 224.44/224.67  |- mesh__recordOriginator mesh__D047468 nns
% 224.44/224.67  |- mesh__dateEstablished mesh__D047468 2005-01-01
% 224.44/224.67  |- skos__scopeNote mesh__D047468
% 224.44/224.67       The aggregation of soluble ANTIGENS with ANTIBODIES, alone or with antibody binding factors such as ANTI-ANTIBODIES or STAPHYLOCOCCAL PROTEIN A, into complexes large enough to fall out of solution.%A%    
% 224.44/224.67  |- skos__altLabel mesh__D047468 Immune Precipitation
% 224.44/224.67  |- mesh__dateCreated mesh__D047468 2004-07-07
% 224.44/224.67  |- skos__hiddenLabel mesh__D047468 Co-Immunoprecipitations
% 224.44/224.67  |- mesh__recordAuthorizer mesh__D047468 sjn
% 224.44/224.67  |- rdf__type mesh__D047468sskos__Concept
% 224.44/224.67  |- skos__hiddenLabel mesh__D047468 Co Immunoprecipitation
% 224.44/224.67  |- skos__hiddenLabel mesh__D047468 Immune Precipitations
% 224.44/224.67  |- skos__historyNote mesh__D047468 Precipitin Tests %28%1970-2004%29%
% 224.44/224.67  |- skos__prefLabel mesh__D047468 Immunoprecipitation
% 224.44/224.67  |- mesh__recordMaintainer mesh__D047468 nns
% 224.44/224.67  |- skos__broader mesh__D047468smesh__D007158
% 224.44/224.67  |- skos__hiddenLabel mesh__D047468 Precipitations, Immune
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D047468 2006
% 224.44/224.67  |- mesh__historyNote mesh__D047468 2005; use PRECIPITIN TESTS 1989-2004   
% 224.44/224.67  |- skos__hiddenLabel mesh__D047468 Precipitation, Immune
% 224.44/224.67  |- mesh__onlineNote mesh__D011794 search BIOFLAVONOIDS 1966-74   
% 224.44/224.67  |- mesh__recordAuthorizer mesh__D011794 sjn
% 224.44/224.67  |- skos__broader mesh__D011794smesh__D044948
% 224.44/224.67  |- skos__scopeNote mesh__D011794
% 224.44/224.67       A flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin.%A%    
% 224.44/224.67  |- skos__prefLabel mesh__D011794 Quercetin
% 224.44/224.67  |- mesh__historyNote mesh__D011794
% 224.44/224.67       91%28%75%29%; was see under FLAVONES 1975-90; was see under BIOFLAVONOIDS 1963-74%A%  
% 224.44/224.67  |- mesh__dateCreated mesh__D011794 1999-01-01
% 224.44/224.67  |- mesh__dateRevised mesh__D011794 2005-06-30
% 224.44/224.67  |- mesh__dateEstablished mesh__D011794 1991-01-01
% 224.44/224.67  |- rdf__type mesh__D011794sskos__Concept
% 224.44/224.67  |- mesh__recordMaintainer mesh__D011794 ssb
% 224.44/224.67  |- mesh__recordOriginator mesh__D011794 NLM
% 224.44/224.67  |- mesh__publicMeSHNote mesh__D011794
% 224.44/224.67       91; was see under FLAVONES 1975-90; was see under BIOFLAVONOIDS 1963-74%A%  
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D011794 2006
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D005757 2006
% 224.44/224.67  |- rdf__type mesh__D005757sskos__Concept
% 224.44/224.67  |- skos__broader mesh__D005757smesh__D005756
% 224.44/224.67  |- mesh__dateEstablished mesh__D005757 1991-01-01
% 224.44/224.67  |- skos__hiddenLabel mesh__D005757 Atrophic Gastritis
% 224.44/224.67  |- mesh__dateCreated mesh__D005757 1980-04-04
% 224.44/224.67  |- skos__hiddenLabel mesh__D005757 Atrophic Gastritides
% 224.44/224.67  |- mesh__recordMaintainer mesh__D005757 lkt
% 224.44/224.67  |- mesh__dateRevised mesh__D005757 2004-07-07
% 224.44/224.67  |- mesh__recordAuthorizer mesh__D005757 sjn
% 224.44/224.67  |- skos__historyNote mesh__D005757 Atrophy %28%1966-1980%29%
% 224.44/224.67  |- skos__prefLabel mesh__D005757 Gastritis, Atrophic
% 224.44/224.67  |- skos__scopeNote mesh__D005757
% 224.44/224.67       GASTRITIS with atrophy of the GASTRIC MUCOSA, the GASTRIC PARIETAL CELLS, and the mucosal glands leading to ACHLORHYDRIA. Atrophic gastritis usually progresses from chronic gastritis.%A%    
% 224.44/224.67  |- mesh__publicMeSHNote mesh__D005757
% 224.44/224.67       91; was see under GASTRITIS 1981-90   
% 224.44/224.67  |- skos__historyNote mesh__D005757 Gastritis %28%1966-1980%29%
% 224.44/224.67  |- skos__annotation mesh__D005757
% 224.44/224.67       a chronic dis: do not coord with CHRONIC DISEASE   
% 224.44/224.67  |- mesh__historyNote mesh__D005757
% 224.44/224.67       91%28%81%29%; was see under GASTRITIS 1981-90   
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D005757 2005
% 224.44/224.67  |- mesh__recordOriginator mesh__D005757 RC
% 224.44/224.67  |- skos__hiddenLabel mesh__D005757 Gastritides, Atrophic
% 224.44/224.67  |- mesh__dateEstablished mesh__D015387 1989-01-01
% 224.44/224.67  |- skos__hiddenLabel mesh__D015387 Dietary Yolk Proteins
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D015387 2004
% 224.44/224.67  |- skos__prefLabel mesh__D015387 Egg Proteins, Dietary
% 224.44/224.67  |- skos__hiddenLabel mesh__D015387 Proteins, Dietary Yolk
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D015387 2002
% 224.44/224.67  |- skos__broader mesh__D015387smesh__D004044
% 224.44/224.67  |- skos__altLabel mesh__D015387 Dietary Egg Proteins
% 224.44/224.67  |- mesh__historyNote mesh__D015387 89   
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D015387 2003
% 224.44/224.67  |- skos__hiddenLabel mesh__D015387 Proteins, Dietary Egg
% 224.44/224.67  |- mesh__recordOriginator mesh__D015387 RLS
% 224.44/224.67  |- rdf__type mesh__D015387sskos__Concept
% 224.44/224.67  |- mesh__dateCreated mesh__D015387 1988-06-06
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D015387 1999
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D015387 2001
% 224.44/224.67  |- mesh__publicMeSHNote mesh__D015387 89   
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D015387 1998
% 224.44/224.67  |- mesh__recordAuthorizer mesh__D015387 PLS
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D015387 1997
% 224.44/224.67  |- skos__annotation mesh__D015387
% 224.44/224.67       specifically, %22%proteins in eggs consumed as food%22%, otherwise EGG PROTEINS is available%A%  
% 224.44/224.67  |- skos__altLabel mesh__D015387 Egg Yolk Proteins, Dietary
% 224.44/224.67  |- skos__historyNote mesh__D015387 Egg Proteins %28%1966-1988%29%
% 224.44/224.67  |- mesh__dateRevised mesh__D015387 1996-06-10
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D015387 2000
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D015387 2006
% 224.44/224.67  |- skos__broader mesh__D015387smesh__D004527
% 224.44/224.67  |- mesh__recordMaintainer mesh__D015387 TGC
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D015387 2005
% 224.44/224.67  |- skos__scopeNote mesh__D015387
% 224.44/224.67       Proteins found in eggs which are consumed as a food.     
% 224.44/224.67  |- skos__altLabel mesh__D034541 hnRNP H
% 224.44/224.67  |- mesh__recordOriginator mesh__D034541 jmp
% 224.44/224.67  |- skos__hiddenLabel mesh__D034541
% 224.44/224.67       Heterogeneous Nuclear Ribonucleoprotein Group H
% 224.44/224.67  |- skos__prefLabel mesh__D034541
% 224.44/224.67       Heterogeneous-Nuclear Ribonucleoprotein Group F-H
% 224.44/224.67  |- skos__scopeNote mesh__D034541
% 224.44/224.67       A group of closely-related heterogeneous-nuclear ribonucleoproteins that are involved in pre-mRNA splicing.%A%    
% 224.44/224.67  |- mesh__historyNote mesh__D034541
% 224.44/224.67       2003; for HNRNP F use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS 1994-2002; for HNRNP H use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS 1998-2002%A%  
% 224.44/224.67  |- mesh__dateRevised mesh__D034541 2005-06-30
% 224.44/224.67  |- mesh__dateCreated mesh__D034541 2002-07-03
% 224.44/224.67  |- mesh__recordAuthorizer mesh__D034541 sjn
% 224.44/224.67  |- skos__altLabel mesh__D034541 hnRNP-H
% 224.44/224.67  |- skos__altLabel mesh__D034541 hnRNP F-H
% 224.44/224.67  |- rdf__type mesh__D034541sskos__Concept
% 224.44/224.67  |- skos__historyNote mesh__D034541 Ribonucleoproteins %28%1994-2002%29%
% 224.44/224.67  |- skos__broader mesh__D034541smesh__D034441
% 224.44/224.67  |- skos__altLabel mesh__D034541 hnRNP-F
% 224.44/224.67  |- skos__hiddenLabel mesh__D034541
% 224.44/224.67       Heterogeneous Nuclear Ribonucleoprotein H H%27% F 2H9 Family
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D034541 2006
% 224.44/224.67  |- skos__altLabel mesh__D034541 hnRNP F
% 224.44/224.67  |- mesh__recordMaintainer mesh__D034541 SYSTEM
% 224.44/224.67  |- skos__hiddenLabel mesh__D034541
% 224.44/224.67       Heterogeneous Nuclear Ribonucleoprotein Group F
% 224.44/224.67  |- mesh__dateEstablished mesh__D034541 2003-01-01
% 224.44/224.67  |- mesh__publicMeSHNote mesh__D034541
% 224.44/224.67       2003; HNRNP F was indexed under RIBONUCLEOPROTEINS 1994-2002; HNRNP H was indexed under RIBONUCLEOPROTEINS 1998-2002%A%  
% 224.44/224.67  |- skos__annotation mesh__D034541 see SCR for specific hnRNP entries   
% 224.44/224.67  |- skos__hiddenLabel mesh__D034541
% 224.44/224.67       Heterogeneous Nuclear Ribonucleoprotein Group F H
% 224.44/224.67  |- skos__altLabel mesh__D034541
% 224.44/224.67       Heterogeneous-Nuclear Ribonucleoprotein H-H%27%-F-2H9 Family
% 224.44/224.67  |- rdf__type mesh__D001367sskos__Concept
% 224.44/224.67  |- skos__prefLabel mesh__D001367 Axillary Vein
% 224.44/224.67  |- skos__hiddenLabel mesh__D001367 Veins, Axillary
% 224.44/224.67  |- mesh__dateRevised mesh__D001367 1992-05-26
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D001367 1999
% 224.44/224.67  |- mesh__recordAuthorizer mesh__D001367 PLS
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D001367 1995
% 224.44/224.67  |- skos__broader mesh__D001367smesh__D014680
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D001367 2004
% 224.44/224.67  |- mesh__recordOriginator mesh__D001367 NLM
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D001367 1998
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D001367 2001
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D001367 1994
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D001367 2003
% 224.44/224.67  |- skos__scopeNote mesh__D001367
% 224.44/224.67       The venous trunk of the upper limb; a continuation of the basilar and brachial veins running from the lower border of the teres major muscle to the outer border of the first rib where it becomes the subclavian vein.%A%    
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D001367 2000
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D001367 2006
% 224.44/224.67  |- mesh__dateCreated mesh__D001367 1999-01-01
% 224.44/224.67  |- mesh__recordMaintainer mesh__D001367 TAP
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D001367 1997
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D001367 2005
% 224.44/224.67  |- skos__hiddenLabel mesh__D001367 Axillary Veins
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D001367 2002
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D001367 1993
% 224.44/224.67  |- skos__hiddenLabel mesh__D001367 Vein, Axillary
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D001367 1996
% 224.44/224.67  |- mesh__dateCreated mesh__D006850 1999-01-01
% 224.44/224.67  |- skos__hiddenLabel mesh__D006850 Hakim%27%s Syndromes
% 224.44/224.67  |- skos__altLabel mesh__D006850 Hakim%27%s Syndrome
% 224.44/224.67  |- mesh__publicMeSHNote mesh__D006850 1991; see HYDROCEPHALUS 1971-90   
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D006850 2004
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D006850 2006
% 224.44/224.67  |- skos__historyNote mesh__D006850 Hydrocephalus %28%1966-1970%29%
% 224.44/224.67  |- skos__hiddenLabel mesh__D006850
% 224.44/224.67       NPHs %28%Normal Pressure Hydrocephalus%29%
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D006850 2003
% 224.44/224.67  |- skos__prefLabel mesh__D006850 Hydrocephalus, Normal Pressure
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D006850 2005
% 224.44/224.67  |- skos__broader mesh__D006850smesh__D006849
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D006850 2000B
% 224.44/224.67  |- skos__hiddenLabel mesh__D006850 Syndrome, Hakim
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D006850 2001A
% 224.44/224.67  |- skos__hiddenLabel mesh__D006850 Hakims Syndrome
% 224.44/224.67  |- mesh__recordMaintainer mesh__D006850 sjn
% 224.44/224.67  |- skos__scopeNote mesh__D006850
% 224.44/224.67       A form of compensated hydrocephalus characterized clinically by a slowly progressive gait disorder %28%see GAIT DISORDERS, NEUROLOGIC%29%, progressive intellectual decline, and URINARY INCONTINENCE. Spinal fluid pressure tends to be in the high normal range. This condition may result from processes which interfere with the absorption of CSF including SUBARACHNOID HEMORRHAGE, chronic MENINGITIS, and other conditions. %28%From Adams et al., Principles of Neurology, 6th ed, pp631-3%29%%A%    
% 224.44/224.67  |- skos__hiddenLabel mesh__D006850 Hakim Syndromes
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D006850 2002
% 224.44/224.67  |- mesh__dateRevised mesh__D006850 2001-03-28
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D006850 2000A
% 224.44/224.67  |- mesh__recordAuthorizer mesh__D006850 sjn
% 224.44/224.67  |- mesh__historyNote mesh__D006850 1991%28%1971%29%   
% 224.44/224.67  |- skos__hiddenLabel mesh__D006850 Syndrome, Hakim%27%s
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D006850 2001
% 224.44/224.67  |- mesh__recordOriginator mesh__D006850 NLM
% 224.44/224.67  |- skos__hiddenLabel mesh__D006850 Syndromes, Hakim
% 224.44/224.67  |- skos__altLabel mesh__D006850 Normal Pressure Hydrocephalus
% 224.44/224.67  |- skos__altLabel mesh__D006850 Hakim Syndrome
% 224.44/224.67  |- mesh__dateEstablished mesh__D006850 1991-01-01
% 224.44/224.67  |- rdf__type mesh__D006850sskos__Concept
% 224.44/224.67  |- skos__altLabel mesh__D006850 NPH %28%Normal Pressure Hydrocephalus%29%
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D006850 2000
% 224.44/224.67  |- skos__hiddenLabel mesh__D006850 Syndromes, Hakim%27%s
% 224.44/224.67  |- skos__prefLabel mesh__D020521 Cerebrovascular Accident
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D020521 2004
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Accident, Acute Cerebrovascular
% 224.44/224.67  |- skos__annotation mesh__D020521
% 224.44/224.67       note X ref APOPLEXY but PITUITARY APOPLEXY is available   
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Accident, Brain Vascular
% 224.44/224.67  |- skos__altLabel mesh__D020521 Vascular Accident, Brain
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Acute Stroke
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Acute Cerebrovascular Accidents
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Cerebral Strokes
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D020521 2002
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Strokes
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Brain Vascular Accidents
% 224.44/224.67  |- skos__altLabel mesh__D020521 Cerebrovascular Accident, Acute
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Strokes, Cerebral
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D020521 2003
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Acute Cerebrovascular Accident
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D020521 2006
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 CVAs %28%Cerebrovascular Accident%29%
% 224.44/224.67  |- mesh__historyNote mesh__D020521
% 224.44/224.67       2000: for STROKE and APOPLEXY use CEREBROVASCULAR DISORDERS 1963-1999%A%  
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Accident, Cerebrovascular
% 224.44/224.67  |- skos__scopeNote mesh__D020521
% 224.44/224.67       A sudden, nonconvulsive loss of neurologic function due to an ischemic or hemorrhagic intracranial vascular event. In general, cerebrovascular accidents are classified by anatomic location in the brain, vascular distribution, etiology, age of the affected individual, and hemorrhagic vs. nonhemorrhagic nature. %28%From Adams et al., Principles of Neurology, 6th ed, pp777-810%29%%A%    
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D020521 2001
% 224.44/224.67  |- skos__historyNote mesh__D020521
% 224.44/224.67       Cerebrovascular Disorders %28%1964-1999%29%
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Cerebrovascular Strokes
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Stroke, Cerebral
% 224.44/224.67  |- skos__altLabel mesh__D020521 Stroke
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Cerebrovascular Accidents, Acute
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Accidents, Brain Vascular
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D020521 2005
% 224.44/224.67  |- skos__altLabel mesh__D020521 Cerebrovascular Apoplexy
% 224.44/224.67  |- mesh__publicMeSHNote mesh__D020521
% 224.44/224.67       2000; for STROKE and APOPLEXY see CEREBROVASCULAR DISORDERS 1963-1999%A%  
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Accidents, Cerebrovascular
% 224.44/224.67  |- skos__historyNote mesh__D020521
% 224.44/224.67       Intracranial Embolism and Thrombosis %28%1965-1999%29%
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D020521 2000
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Brain Vascular Accident
% 224.44/224.67  |- skos__altLabel mesh__D020521 CVA %28%Cerebrovascular Accident%29%
% 224.44/224.67  |- rdf__type mesh__D020521sskos__Concept
% 224.44/224.67  |- skos__altLabel mesh__D020521 Cerebrovascular Stroke
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Strokes, Acute
% 224.44/224.67  |- mesh__dateCreated mesh__D020521 1999-11-04
% 224.44/224.67  |- mesh__dateEstablished mesh__D020521 2000-01-01
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Apoplexy, Cerebrovascular
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Cerebrovascular Accidents
% 224.44/224.67  |- skos__historyNote mesh__D020521
% 224.44/224.67       Intracranial Arteriosclerosis %28%1965-1999%29%
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Acute Strokes
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Vascular Accidents, Brain
% 224.44/224.67  |- skos__altLabel mesh__D020521 Apoplexy
% 224.44/224.67  |- skos__broader mesh__D020521smesh__D002561
% 224.44/224.67  |- skos__altLabel mesh__D020521 Cerebral Stroke
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Strokes, Cerebrovascular
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Accidents, Acute Cerebrovascular
% 224.44/224.67  |- skos__hiddenLabel mesh__D020521 Stroke, Cerebrovascular
% 224.44/224.67  |- skos__altLabel mesh__D006052 Miocrisin
% 224.44/224.67  |- skos__broader mesh__D006052smesh__D013870
% 224.44/224.67  |- rdf__type mesh__D006052sskos__Concept
% 224.44/224.67  |- skos__altLabel mesh__D006052 Myocrysine
% 224.44/224.67  |- mesh__onlineNote mesh__D006052
% 224.44/224.67       use GOLD SODIUM THIOMALATE to search GOLD THIOMALATE 1973-91 %28%as Prov 1973%29%%A%  
% 224.44/224.67  |- skos__hiddenLabel mesh__D006052 Aurothiomalate, Sodium
% 224.44/224.67  |- mesh__publicMeSHNote mesh__D006052 92; was GOLD THIOMALATE 1974-91   
% 224.44/224.67  |- skos__historyNote mesh__D006052 Gold %28%1966-1972%29%
% 224.44/224.67  |- skos__hiddenLabel mesh__D006052 Sodium Thiomalate, Gold
% 224.44/224.67  |- mesh__dateCreated mesh__D006052 1999-01-01
% 224.44/224.67  |- skos__scopeNote mesh__D006052
% 224.44/224.67       A variable mixture of the mono- and disodium salts of gold thiomalic acid used mainly for its anti-inflammatory action in the treatment of rheumatoid arthritis. It is most effective in active progressive rheumatoid arthritis and of little or no value in the presence of extensive deformities or in the treatment of other forms of arthritis.%A%    
% 224.44/224.67  |- skos__altLabel mesh__D006052 Aventis Brand of Gold Sodium Thiomalate
% 224.44/224.67  |- skos__altLabel mesh__D006052 JHC Brand of Gold Sodium Thiomalate
% 224.44/224.67  |- mesh__recordMaintainer mesh__D006052 ssb
% 224.44/224.67  |- skos__altLabel mesh__D006052
% 224.44/224.67       Mercaptobutanedioic Acid Monogold%28%1+%29% Sodium Salt
% 224.44/224.67  |- skos__altLabel mesh__D006052 Sodium Thiomalatoaurate
% 224.44/224.67  |- skos__prefLabel mesh__D006052 Gold Sodium Thiomalate
% 224.44/224.67  |- skos__altLabel mesh__D006052 Rubio Brand of Gold Sodium Thiomalate
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D006052 2006
% 224.44/224.67  |- mesh__dateRevised mesh__D006052 2005-06-30
% 224.44/224.67  |- skos__broader mesh__D006052smesh__D050607
% 224.44/224.67  |- skos__altLabel mesh__D006052 Myocrisin
% 224.44/224.67  |- skos__altLabel mesh__D006052
% 224.44/224.67       Altana Pharma Brand of Gold Sodium Thiomalate
% 224.44/224.67  |- mesh__recordAuthorizer mesh__D006052 sjn
% 224.44/224.67  |- skos__altLabel mesh__D006052 Merck Brand of Gold Sodium Thiomalate
% 224.44/224.67  |- mesh__dateEstablished mesh__D006052 1974-01-01
% 224.44/224.67  |- mesh__recordOriginator mesh__D006052 NLM
% 224.44/224.67  |- mesh__historyNote mesh__D006052
% 224.44/224.67       92; was GOLD THIOMALATE 1973-91 %28%Prov 1973%29%   
% 224.44/224.67  |- skos__hiddenLabel mesh__D006052 Thiomalatoaurate, Sodium
% 224.44/224.67  |- skos__altLabel mesh__D006052 Taylor Brand of Gold Sodium Thiomalate
% 224.44/224.67  |- skos__hiddenLabel mesh__D006052 Thiomalate, Gold
% 224.44/224.67  |- skos__altLabel mesh__D006052 Sodium Gold Thiomalate
% 224.44/224.67  |- skos__hiddenLabel mesh__D006052 Gold Thiomalate, Sodium
% 224.44/224.67  |- skos__altLabel mesh__D006052 Sodium Aurothiomalate
% 224.44/224.67  |- mesh__dateRevised mesh__D011795 1995-05-18
% 224.44/224.67  |- mesh__recordAuthorizer mesh__D011795 PLS
% 224.44/224.67  |- mesh__recordOriginator mesh__D011795 NLM
% 224.44/224.67  |- mesh__dateCreated mesh__D011795 1999-01-01
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D011795 2004
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D011795 1999
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D011795 2002
% 224.44/224.67  |- skos__annotation mesh__D011795
% 224.44/224.67       coord IM with specific subject or group %28%IM%29%   
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D011795 2003
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D011795 1998
% 224.44/224.67  |- rdf__type mesh__D011795sskos__Concept
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D011795 2001
% 224.44/224.67  |- skos__hiddenLabel mesh__D011795 Questionnaire
% 224.44/224.67  |- mesh__onlineNote mesh__D011795
% 224.44/224.67       use QUESTIONNAIRES to search QUESTIONNAIRE 1967-72 %28%as Prov %26% Cat E heading%29%%A%  
% 224.44/224.67  |- skos__hiddenLabel mesh__D011795 Designs, Questionnaire
% 224.44/224.67  |- skos__broader mesh__D011795smesh__D003625
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D011795 1997
% 224.44/224.67  |- skos__hiddenLabel mesh__D011795 Design, Questionnaire
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D011795 2000
% 224.44/224.67  |- mesh__recordMaintainer mesh__D011795 TAP
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D011795 2006
% 224.44/224.67  |- mesh__dateEstablished mesh__D011795 1973-01-01
% 224.44/224.67  |- mesh__historyNote mesh__D011795
% 224.44/224.67       73; was in Cat E only 1973-79; was QUESTIONNAIRE 1967-72 %28%Prov in Cat E only%29%%A%  
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D011795 1996
% 224.44/224.67  |- skos__prefLabel mesh__D011795 Questionnaires
% 224.44/224.67  |- skos__scopeNote mesh__D011795
% 224.44/224.67       Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument.%A%    
% 224.44/224.67  |- skos__hiddenLabel mesh__D011795 Questionnaire Designs
% 224.44/224.67  |- mesh__publicMeSHNote mesh__D011795 73   
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D011795 2005
% 224.44/224.67  |- skos__altLabel mesh__D005758 Giant Hypertrophic Gastritis
% 224.44/224.67  |- mesh__publicMeSHNote mesh__D005758
% 224.44/224.67       91; was see under GASTRITIS 1981-90   
% 224.44/224.67  |- skos__scopeNote mesh__D005758
% 224.44/224.67       GASTRITIS with HYPERTROPHY of the GASTRIC MUCOSA. It is characterized by giant gastric folds, diminished acid secretion, excessive MUCUS secretion, and HYPOPROTEINEMIA. Symptoms include VOMITING; DIARRHEA; and WEIGHT LOSS.%A%    
% 224.44/224.67  |- mesh__historyNote mesh__D005758
% 224.44/224.67       91%28%81%29%; was see under GASTRITIS 1981-90   
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D005758 2006
% 224.44/224.67  |- rdf__type mesh__D005758sskos__Concept
% 224.44/224.67  |- skos__prefLabel mesh__D005758 Gastritis, Hypertrophic
% 224.44/224.67  |- skos__hiddenLabel mesh__D005758 Hypertrophic Gastritis
% 224.44/224.67  |- skos__hiddenLabel mesh__D005758 Hypertrophic Gastritis, Giant
% 224.44/224.67  |- mesh__activeMeSHYear mesh__D005758 2005
% 224.44/224.67  |- mesh__recordOriginator mesh__D005758 RC
% 224.44/224.67  |- skos__altLabel mesh__D005758 Menetrier Disease
% 224.44/224.67  |- mesh__dateEstablished mesh__D005758 1991-01-01
% 224.44/224.68  |- skos__hiddenLabel mesh__D005758 Disease, Menetrier
% 224.44/224.68  |- skos__broader mesh__D005758smesh__D005756
% 224.44/224.68  |- skos__historyNote mesh__D005758 Gastritis %28%1966-1980%29%
% 224.44/224.68  |- mesh__dateRevised mesh__D005758 2004-07-07
% 224.44/224.68  |- skos__historyNote mesh__D005758 Hypertrophy %28%1966-1980%29%
% 224.44/224.68  |- mesh__recordAuthorizer mesh__D005758 sjn
% 224.44/224.68  |- skos__hiddenLabel mesh__D005758 Gastritis, Giant Hypertrophic
% 224.44/224.68  |- mesh__recordMaintainer mesh__D005758 lkt
% 224.44/224.68  |- mesh__dateCreated mesh__D005758 1980-04-04
% 224.44/224.68  |- mesh__recordAuthorizer mesh__D016480 sjn
% 224.44/224.68  |- skos__historyNote mesh__D016480 Campylobacter %28%1984-1990%29%
% 224.44/224.68  |- skos__prefLabel mesh__D016480 Helicobacter pylori
% 224.44/224.68  |- mesh__historyNote mesh__D016480 91   
% 224.44/224.68  |- mesh__dateEstablished mesh__D016480 1991-01-01
% 224.44/224.68  |- skos__broader mesh__D016480smesh__D016998
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D016480 2006
% 224.44/224.68  |- mesh__dateRevised mesh__D016480 2005-06-30
% 224.44/224.68  |- mesh__publicMeSHNote mesh__D016480 91   
% 224.44/224.68  |- rdf__type mesh__D016480sskos__Concept
% 224.44/224.68  |- mesh__recordMaintainer mesh__D016480 SYSTEM
% 224.44/224.68  |- skos__annotation mesh__D016480
% 224.44/224.68       infection: coord IM with HELICOBACTER INFECTIONS %28%IM%29%   
% 224.44/224.68  |- skos__altLabel mesh__D016480 Campylobacter pylori
% 224.44/224.68  |- mesh__recordOriginator mesh__D016480 PLS
% 224.44/224.68  |- skos__scopeNote mesh__D016480
% 224.44/224.68       A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. %28%see Int J Syst Bacteriol 1989 Oct;39%28%4%29%:297-405%29%.%A%    
% 224.44/224.68  |- mesh__dateCreated mesh__D016480 1990-08-03
% 224.44/224.68  |- skos__prefLabel mesh__D002460 Cell Line
% 224.44/224.68  |- skos__historyNote mesh__D002460 Tissue Culture %28%1966-1968%29%
% 224.44/224.68  |- skos__scopeNote mesh__D002460
% 224.44/224.68       Established cell cultures that have the potential to propagate indefinitely.%A%    
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D002460 2004
% 224.44/224.68  |- skos__broader mesh__D002460smesh__D002478
% 224.44/224.68  |- mesh__recordAuthorizer mesh__D002460 sjn
% 224.44/224.68  |- skos__annotation mesh__D002460
% 224.44/224.68       almost always NIM with no subheadings; check ANIMALS or HUMAN; do not routinely add tissue or organ; policy: Manual 21.57, 22.26.1%A%  
% 224.44/224.68  |- skos__hiddenLabel mesh__D002460 Lines, Cell
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D002460 2006
% 224.44/224.68  |- mesh__dateEstablished mesh__D002460 1972-01-01
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D002460 2005
% 224.44/224.68  |- mesh__recordMaintainer mesh__D002460 nns
% 224.44/224.68  |- mesh__dateRevised mesh__D002460 2003-07-30
% 224.44/224.68  |- skos__hiddenLabel mesh__D002460 Cell Lines
% 224.44/224.68  |- mesh__publicMeSHNote mesh__D002460 72   
% 224.44/224.68  |- mesh__historyNote mesh__D002460 72%28%69%29%   
% 224.44/224.68  |- mesh__recordOriginator mesh__D002460 NLM
% 224.44/224.68  |- mesh__dateCreated mesh__D002460 1999-01-01
% 224.44/224.68  |- rdf__type mesh__D002460sskos__Concept
% 224.44/224.68  |- skos__hiddenLabel mesh__D002460 Line, Cell
% 224.44/224.68  |- mesh__recordMaintainer mesh__D015388 jls
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D015388 2004
% 224.44/224.68  |- skos__annotation mesh__D015388
% 224.44/224.68       do not confuse with ORGANOIDS: read MeSH definitions %26% follow text%A%  
% 224.44/224.68  |- mesh__dateRevised mesh__D015388 2004-07-29
% 224.44/224.68  |- skos__hiddenLabel mesh__D015388 Organelle
% 224.44/224.68  |- mesh__recordAuthorizer mesh__D015388 jls
% 224.44/224.68  |- rdf__type mesh__D015388sskos__Concept
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D015388 2005A
% 224.44/224.68  |- mesh__publicMeSHNote mesh__D015388 89   
% 224.44/224.68  |- mesh__historyNote mesh__D015388 89   
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D015388 2005
% 224.44/224.68  |- skos__broader mesh__D015388smesh__D022083
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D015388 2006
% 224.44/224.68  |- mesh__recordOriginator mesh__D015388 RLS
% 224.44/224.68  |- skos__scopeNote mesh__D015388
% 224.44/224.68       Specific particles of membrane-bound organized living substances present in eukaryotic cells, such as the MITOCHONDRIA; the GOLGI APPARATUS; ENDOPLASMIC RETICULUM; LYSOSOMES; PLASTIDS; and VACUOLES.%A%    
% 224.44/224.68  |- skos__historyNote mesh__D015388 Organoids %28%1966-1988%29%
% 224.44/224.68  |- mesh__dateCreated mesh__D015388 1988-06-06
% 224.44/224.68  |- skos__prefLabel mesh__D015388 Organelles
% 224.44/224.68  |- mesh__dateEstablished mesh__D015388 1989-01-01
% 224.44/224.68  |- mesh__recordAuthorizer mesh__D001368 PLS
% 224.44/224.68  |- skos__prefLabel mesh__D001368 Axis
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D001368 1999
% 224.44/224.68  |- mesh__recordOriginator mesh__D001368 NLM
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D001368 1992
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D001368 1998
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D001368 2001
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D001368 2004
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D001368 1995
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D001368 2000
% 224.44/224.68  |- skos__broader mesh__D001368smesh__D002574
% 224.44/224.68  |- mesh__dateCreated mesh__D001368 1999-01-01
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D001368 2003
% 224.44/224.68  |- mesh__recordMaintainer mesh__D001368 TGC
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D001368 1994
% 224.44/224.68  |- skos__altLabel mesh__D001368 Epistropheus
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D001368 1997
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D001368 2006
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D001368 1996
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D001368 2002
% 224.44/224.68  |- rdf__type mesh__D001368sskos__Concept
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D001368 2005
% 224.44/224.68  |- mesh__dateRevised mesh__D001368 1991-01-07
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D001368 1993
% 224.44/224.68  |- skos__annotation mesh__D012090
% 224.44/224.68       painful conditions from overuse or overexertion of any activity; DF: CUMULATIVE TRAUMA DIS%A%  
% 224.44/224.68  |- skos__hiddenLabel mesh__D012090 Disorders, Cumulative Trauma
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D012090 2000
% 224.44/224.68  |- mesh__activeMeSHYear mesh__D012090 2004
% 224.54/224.68  |- skos__hiddenLabel mesh__D012090 Strain Injuries, Repetition
% 224.54/224.68  |- skos__altLabel mesh__D012090 Injury, Repetition Strain
% 224.54/224.68  |- mesh__historyNote mesh__D012090
% 224.54/224.68       97; was REPETITION STRAIN INJURY 1988-96; CUMULATIVE TRAUMA DISORDERS was see REPETITION STRAIN INJURY 1996%A%  
% 224.54/224.68  |- skos__hiddenLabel mesh__D012090 Disorder, Cumulative Trauma
% 224.54/224.68  |- skos__hiddenLabel mesh__D012090 Injury, Repetitive Strain
% 224.54/224.68  |- skos__hiddenLabel mesh__D012090 Repetition Strain Injuries
% 224.54/224.68  |- mesh__publicMeSHNote mesh__D012090
% 224.54/224.68       97; was REPETITION STRAIN INJURY 1988-96; CUMULATIVE TRAUMA DISORDERS was see REPETITION STRAIN INJURY 1996%A%  
% 224.54/224.68  |- skos__altLabel mesh__D012090 Repetitive Strain Injury
% 224.54/224.68  |- skos__hiddenLabel mesh__D012090 Injuries, Repetition Strain
% 224.54/224.68  |- skos__altLabel mesh__D012090 Trauma Disorders, Cumulative
% 224.54/224.68  |- skos__altLabel mesh__D012090 Strain Injury, Repetition
% 224.54/224.68  |- skos__hiddenLabel mesh__D012090 Overuse Syndromes
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D012090 2003
% 224.54/224.68  |- skos__hiddenLabel mesh__D012090 Strain Injuries, Repetitive
% 224.54/224.68  |- rdf__type mesh__D012090sskos__Concept
% 224.54/224.68  |- skos__hiddenLabel mesh__D012090 Motion Disorder, Repetitive
% 224.54/224.68  |- skos__altLabel mesh__D012090 Overuse Syndrome
% 224.54/224.68  |- skos__historyNote mesh__D012090 Occupational Diseases %28%1966-1987%29%
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D012090 1999
% 224.54/224.68  |- skos__historyNote mesh__D012090 Sprains and Strains %28%1966-1987%29%
% 224.54/224.68  |- mesh__dateEstablished mesh__D012090 1988-01-01
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D012090 2002
% 224.54/224.68  |- skos__hiddenLabel mesh__D012090 Repetitive Strain Injuries
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D012090 2006
% 224.54/224.68  |- skos__hiddenLabel mesh__D012090 Disorder, Repetitive Motion
% 224.54/224.68  |- skos__hiddenLabel mesh__D012090 Repetitive Motion Disorder
% 224.54/224.68  |- mesh__recordAuthorizer mesh__D012090 PLS
% 224.54/224.68  |- mesh__recordMaintainer mesh__D012090 AGS
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D012090 1998
% 224.54/224.68  |- mesh__dateCreated mesh__D012090 1987-04-30
% 224.54/224.68  |- skos__scopeNote mesh__D012090
% 224.54/224.68       Harmful and painful condition caused by overuse or overexertion of some part of the musculoskeletal system, often resulting from work-related physical activities. It is characterized by inflammation, pain, or dysfunction of the involved joints, bones, ligaments, and nerves.%A%    
% 224.54/224.68  |- skos__prefLabel mesh__D012090 Cumulative Trauma Disorders
% 224.54/224.68  |- skos__hiddenLabel mesh__D012090 Injuries, Repetitive Strain
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D012090 2005
% 224.54/224.68  |- skos__hiddenLabel mesh__D012090 Overuse Injuries
% 224.54/224.68  |- mesh__dateRevised mesh__D012090 1996-02-12
% 224.54/224.68  |- skos__hiddenLabel mesh__D012090 Motion Disorders, Repetitive
% 224.54/224.68  |- mesh__recordOriginator mesh__D012090 EC
% 224.54/224.68  |- skos__broader mesh__D012090smesh__D013180
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D012090 2001
% 224.54/224.68  |- skos__hiddenLabel mesh__D012090 Strain Injury, Repetitive
% 224.54/224.68  |- skos__hiddenLabel mesh__D012090 Disorders, Repetitive Motion
% 224.54/224.68  |- skos__hiddenLabel mesh__D012090 Injuries, Overuse
% 224.54/224.68  |- skos__altLabel mesh__D012090 Repetitive Motion Disorders
% 224.54/224.68  |- skos__hiddenLabel mesh__D012090 Cumulative Trauma Disorder
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D012090 1997
% 224.54/224.68  |- skos__hiddenLabel mesh__D012090 Trauma Disorder, Cumulative
% 224.54/224.68  |- skos__altLabel mesh__D012090 Repetition Strain Injury
% 224.54/224.68  |- skos__altLabel mesh__D012090 Overuse Injury
% 224.54/224.68  |- skos__hiddenLabel mesh__D012090 Injury, Overuse
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D006851 2006
% 224.54/224.68  |- skos__hiddenLabel mesh__D006851 Acid, Muriatic
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D006851 2003
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D006851 2005
% 224.54/224.68  |- skos__scopeNote mesh__D006851
% 224.54/224.68       A strong corrosive acid that is commonly used as a laboratory reagent. It is formed by dissolving hydrogen chloride in water. GASTRIC ACID is the hydrochloric acid component of GASTRIC JUICE.%A%    
% 224.54/224.68  |- skos__broader mesh__D006851smesh__D017606
% 224.54/224.68  |- skos__prefLabel mesh__D006851 Hydrochloric Acid
% 224.54/224.68  |- mesh__recordMaintainer mesh__D006851 adp
% 224.54/224.68  |- skos__annotation mesh__D006851
% 224.54/224.68       HCl; not for gastric HCl %28% = GASTRIC ACID%29%; /analogs = CHLORIDES or specific chloride; = %22%chlorhydrate%22% in foreign texts: translate as %22%hydrochloric acid%22%, not %22%chlorhydrate%22%%A%  
% 224.54/224.68  |- mesh__dateRevised mesh__D006851 2000-06-22
% 224.54/224.68  |- skos__related mesh__D006851smesh__D005744
% 224.54/224.68  |- skos__broader mesh__D006851smesh__D000148
% 224.54/224.68  |- skos__hiddenLabel mesh__D006851 Chloride, Hydrogen
% 224.54/224.68  |- rdf__type mesh__D006851sskos__Concept
% 224.54/224.68  |- skos__hiddenLabel mesh__D006851 Acid, Hydrochloric
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D006851 2002
% 224.54/224.68  |- mesh__recordAuthorizer mesh__D006851 sjn
% 224.54/224.68  |- mesh__dateCreated mesh__D006851 1999-01-01
% 224.54/224.68  |- mesh__recordOriginator mesh__D006851 NLM
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D006851 2004
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D006851 2001
% 224.54/224.68  |- skos__altLabel mesh__D006851 Muriatic Acid
% 224.54/224.68  |- skos__scopeNote mesh__D020522
% 224.54/224.68       A rare form of non-Hodgkin lymphoma having a usually diffuse pattern with both small and medium lymphocytes and small cleaved cells. It accounts for about 5%25% of adult non-Hodgkin lymphomas in the United States and Europe. The majority of mantle-cell lymphomas are associated with a t%28%11;14%29% translocation resulting in overexpression of the cyclin D1 gene %28%GENES, BCL-1%29%.%A%    
% 224.54/224.68  |- mesh__publicMeSHNote mesh__D020522
% 224.54/224.68       2000; for LYMPHOMA, LYMPHOCYTIC, DIFFUSE, INTERMEDIATE; LYMPHOCYTIC LYMPHOMA, DIFFUSE, POORLY-DIFFERENTIATED; LYMPHOMA, CENTROCYTIC SMALL-CELL; LYMPHOMA, LYMPHOCYTIC, DIFFUSE, POORLY-DIFFERENTIATED; %26% LYMPHOMA, SMALL-CELL, CENTROCYTIC see LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE 1991-1999%A%  
% 224.54/224.68  |- mesh__dateCreated mesh__D020522 1999-11-08
% 224.54/224.68  |- skos__altLabel mesh__D020522
% 224.54/224.68       Lymphoma, Lymphocytic, Diffuse, Intermediate Differentiated
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D020522 2004
% 224.54/224.68  |- skos__hiddenLabel mesh__D020522 Lymphoma, Centrocytic Small Cell
% 224.54/224.68  |- skos__hiddenLabel mesh__D020522 Mantle-Zone Lymphomas
% 224.54/224.68  |- skos__related mesh__D020522smesh__D019940
% 224.54/224.68  |- skos__altLabel mesh__D020522 Lymphoma, Small-Cell, Centrocytic
% 224.54/224.68  |- skos__hiddenLabel mesh__D020522 Lymphomas, Mantle-Cell
% 224.54/224.68  |- skos__hiddenLabel mesh__D020522 Lymphoma, Mantle-Zone
% 224.54/224.68  |- mesh__dateEstablished mesh__D020522 2000-01-01
% 224.54/224.68  |- skos__hiddenLabel mesh__D020522 Mantle Cell Lymphoma
% 224.54/224.68  |- skos__altLabel mesh__D020522
% 224.54/224.68       Lymphocytic Lymphoma, Diffuse, Poorly-Differentiated
% 224.54/224.68  |- skos__hiddenLabel mesh__D020522 Mantle-Cell Lymphomas
% 224.54/224.68  |- skos__hiddenLabel mesh__D020522 Lymphomas, Mantle-Zone
% 224.54/224.68  |- skos__related mesh__D020522smesh__D019938
% 224.54/224.68  |- mesh__historyNote mesh__D020522
% 224.54/224.68       2000; for LYMPHOMA, LYMPHOCYTIC, DIFFUSE, INTERMEDIATE; LYMPHOCYTIC LYMPHOMA, DIFFUSE, POORLY-DIFFERENTIATED; LYMPHOMA, CENTROCYTIC SMALL-CELL; LYMPHOMA, LYMPHOCYTIC, DIFFUSE, POORLY-DIFFERENTIATED; %26% LYMPHOMA, SMALL-CELL, CENTROCYTIC use LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE 1991-1999%A%  
% 224.54/224.68  |- skos__broader mesh__D020522smesh__D016406
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D020522 2000
% 224.54/224.68  |- skos__hiddenLabel mesh__D020522 Small-Cell Lymphoma, Centrocytic
% 224.54/224.68  |- skos__hiddenLabel mesh__D020522 Mantle Zone Lymphoma
% 224.54/224.68  |- skos__historyNote mesh__D020522 Lymphoma, B-Cell %28%1992-1999%29%
% 224.54/224.68  |- skos__altLabel mesh__D020522
% 224.54/224.68       Diffuse Lymphocytic Lymphoma, Poorly-Differentiated
% 224.54/224.68  |- skos__hiddenLabel mesh__D020522 Centrocytic Small-Cell Lymphoma
% 224.54/224.68  |- skos__historyNote mesh__D020522 Lymphoma, Non-Hodgkin %28%1992-1999%29%
% 224.54/224.68  |- skos__hiddenLabel mesh__D020522 Centrocytic Small-Cell Lymphomas
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D020522 2005
% 224.54/224.68  |- skos__hiddenLabel mesh__D020522 Small-Cell Lymphomas, Centrocytic
% 224.54/224.68  |- skos__hiddenLabel mesh__D020522 Lymphoma, Mantle Cell
% 224.54/224.68  |- skos__altLabel mesh__D020522
% 224.54/224.68       Lymphocytic Lymphoma, Diffuse, Poorly Differentiated
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D020522 2001
% 224.54/224.68  |- skos__prefLabel mesh__D020522 Lymphoma, Mantle-Cell
% 224.54/224.68  |- skos__altLabel mesh__D020522 Lymphoma, Centrocytic Small-Cell
% 224.54/224.68  |- skos__hiddenLabel mesh__D020522 Lymphomas, Centrocytic Small-Cell
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D020522 2006
% 224.54/224.68  |- skos__altLabel mesh__D020522
% 224.54/224.68       Lymphoma, Lymphocytic, Diffuse, Poorly-Differentiated
% 224.54/224.68  |- skos__hiddenLabel mesh__D020522
% 224.54/224.68       Diffuse Lymphocytic Lymphoma, Poorly Differentiated
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D020522 2003
% 224.54/224.68  |- skos__altLabel mesh__D020522 Mantle-Zone Lymphoma
% 224.54/224.68  |- skos__altLabel mesh__D020522 Mantle-Cell Lymphoma
% 224.54/224.68  |- rdf__type mesh__D020522sskos__Concept
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D020522 2002
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D006053 2002
% 224.54/224.68  |- skos__broader mesh__D006053smesh__D008342
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D006053 2003
% 224.54/224.68  |- skos__altLabel mesh__D006053 Oculoauriculovertebral Syndrome
% 224.54/224.68  |- mesh__dateEstablished mesh__D006053 1991-01-01
% 224.54/224.68  |- skos__hiddenLabel mesh__D006053 Syndrome, Oculoauriculovertebral
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D006053 2006
% 224.54/224.68  |- mesh__dateRevised mesh__D006053 1999-11-03
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D006053 2001
% 224.54/224.68  |- skos__annotation mesh__D006053
% 224.54/224.68       %22%mandibulofacial dysostosis with congen eyelid dermoids%22%; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 224.54/224.68  |- skos__historyNote mesh__D006053
% 224.54/224.68       Abnormalities, Multiple %28%1968-1978%29%
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D006053 2005
% 224.54/224.68  |- mesh__publicMeSHNote mesh__D006053
% 224.54/224.68       91; was see under MANDIBULOFACIAL DYSOSTOSIS 1979-90   
% 224.54/224.68  |- mesh__activeMeSHYear mesh__D006053 2000
% 224.54/224.68  |- mesh__historyNote mesh__D006053
% 224.54/224.68       91%28%79%29%; was see under MANDIBULOFACIAL DYSOSTOSIS 1979-90   
% 224.54/224.68  |- skos__hiddenLabel mesh__D006053 Syndrome, Goldenhar
% 224.54/224.68  |- mesh__recordMaintainer mesh__D006053 kle
% 224.54/224.68  |- rdf__type mesh__D006053sskos__Concept
% 224.54/224.68  |- mesh__dateCreated mesh__D006053 1978-05-19
% 224.54/224.68  |- skos__prefLabel mesh__D006053 Goldenhar Syndrome
% 224.54/224.68  |- skos__scopeNote mesh__D006053
% 224.54/224.68       Mandibulofacial dysostosis with congenital eyelid dermoids.%A%    
% 224.54/224.68  |- skos__historyNote mesh__D006053
% 224.54/224.68       Mandibulofacial Dysostosis %28%1966-1978%29%
% 224.54/224.69  |- mesh__recordAuthorizer mesh__D006053 sjn
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D006053 2004
% 224.54/224.69  |- mesh__recordOriginator mesh__D006053 RC
% 224.54/224.69  |- skos__broader mesh__D019779smesh__D012475
% 224.54/224.69  |- rdf__type mesh__D019779sskos__Concept
% 224.54/224.69  |- mesh__dateCreated mesh__D019779 1997-06-20
% 224.54/224.69  |- skos__scopeNote mesh__D019779
% 224.54/224.69       A subgenus of Salmonella containing several medically important serotypes. The habitat for the majority of strains is warm-blooded animals.%A%    
% 224.54/224.69  |- mesh__dateEstablished mesh__D019779 1998-01-01
% 224.54/224.69  |- mesh__recordOriginator mesh__D019779 NDW
% 224.54/224.69  |- mesh__publicMeSHNote mesh__D019779 98   
% 224.54/224.69  |- mesh__recordAuthorizer mesh__D019779 sjn
% 224.54/224.69  |- skos__prefLabel mesh__D019779 Salmonella enterica
% 224.54/224.69  |- mesh__historyNote mesh__D019779 98   
% 224.54/224.69  |- skos__historyNote mesh__D019779 Salmonella %28%1980-1997%29%
% 224.54/224.69  |- mesh__recordMaintainer mesh__D019779 SYSTEM
% 224.54/224.69  |- mesh__dateRevised mesh__D019779 2005-06-30
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D019779 2006
% 224.54/224.69  |- skos__altLabel mesh__D011796 Atebrin
% 224.54/224.69  |- mesh__dateCreated mesh__D011796 1999-01-01
% 224.54/224.69  |- mesh__recordAuthorizer mesh__D011796 sjn
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D011796 2005
% 224.54/224.69  |- mesh__historyNote mesh__D011796 CHINACRIN was see QUINACRINE 1977-93   
% 224.54/224.69  |- skos__hiddenLabel mesh__D011796 Dihydrochloride, Quinacrine
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D011796 2002
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D011796 2004
% 224.54/224.69  |- rdf__type mesh__D011796sskos__Concept
% 224.54/224.69  |- skos__prefLabel mesh__D011796 Quinacrine
% 224.54/224.69  |- skos__hiddenLabel mesh__D011796 Hydrochloride, Quinacrine
% 224.54/224.69  |- mesh__publicMeSHNote mesh__D011796
% 224.54/224.69       CHINACRIN was see QUINACRINE 1977-93   
% 224.54/224.69  |- skos__hiddenLabel mesh__D011796 Monoacetate, Quinacrine
% 224.54/224.69  |- skos__hiddenLabel mesh__D011796 Dimesylate, Quinacrine
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D011796 2003
% 224.54/224.69  |- skos__hiddenLabel mesh__D011796 Monomesylate, Quinacrine
% 224.54/224.69  |- mesh__onlineNote mesh__D011796
% 224.54/224.69       use QUINACRINE to search CHINACRIN 1977-93   
% 224.54/224.69  |- skos__broader mesh__D011796smesh__D000609
% 224.54/224.69  |- skos__hiddenLabel mesh__D011796 Monohydrochloride, Quinacrine
% 224.54/224.69  |- skos__altLabel mesh__D011796 Mepacrine
% 224.54/224.69  |- mesh__dateRevised mesh__D011796 2001-07-25
% 224.54/224.69  |- skos__scopeNote mesh__D011796
% 224.54/224.69       An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.%A%    
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D011796 2006
% 224.54/224.69  |- mesh__recordOriginator mesh__D011796 NLM
% 224.54/224.69  |- mesh__recordMaintainer mesh__D011796 ssb
% 224.54/224.69  |- skos__altLabel mesh__D011796 Quinacrine Hydrochloride
% 224.54/224.69  |- skos__broader mesh__D005759smesh__D005767
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D005759 2006
% 224.54/224.69  |- mesh__recordAuthorizer mesh__D005759 sjn
% 224.54/224.69  |- rdf__type mesh__D005759sskos__Concept
% 224.54/224.69  |- skos__hiddenLabel mesh__D005759 Gastroenteritides
% 224.54/224.69  |- mesh__recordMaintainer mesh__D005759 lkt
% 224.54/224.69  |- mesh__recordOriginator mesh__D005759 NLM
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D005759 2005
% 224.54/224.69  |- skos__prefLabel mesh__D005759 Gastroenteritis
% 224.54/224.69  |- mesh__dateRevised mesh__D005759 2003-07-09
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D005759 2004
% 224.54/224.69  |- mesh__dateCreated mesh__D005759 1999-01-01
% 224.54/224.69  |- skos__scopeNote mesh__D005759
% 224.54/224.69       INFLAMMATION of any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Causes of gastroenteritis are many including genetic, infection, HYPERSENSITIVITY, drug effects, and CANCER.%A%    
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016481 1996
% 224.54/224.69  |- skos__annotation mesh__D016481
% 224.54/224.69       gram-neg bact infect; check text for genus %26% species: Campylobacter pylori = HELICOBACTER PYLORI; Campylobacter pylori infect = HELICOBACTER INFECTIONS %28%IM%29% + HELICOBACTER PYLORI %28%IM%29% but Campylobacter jejuni infect = CAMPYLOBACTER INFECTIONS %28%IM%29% + CAMPYLOBACTER JEJUNI %28%IM%29%; DF: HELICOBACTER INFECT%A%  
% 224.54/224.69  |- skos__scopeNote mesh__D016481
% 224.54/224.69       Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.%A%    
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016481 1997
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016481 2000
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016481 2005
% 224.54/224.69  |- skos__hiddenLabel mesh__D016481 Infection, Helicobacter
% 224.54/224.69  |- mesh__historyNote mesh__D016481 91   
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016481 1994
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016481 2006
% 224.54/224.69  |- mesh__recordMaintainer mesh__D016481 TAP
% 224.54/224.69  |- skos__prefLabel mesh__D016481 Helicobacter Infections
% 224.54/224.69  |- skos__altLabel mesh__D016481 Infections, Helicobacter
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016481 2001
% 224.54/224.69  |- skos__hiddenLabel mesh__D016481 Helicobacter Infection
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016481 1995
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016481 2003
% 224.54/224.69  |- rdf__type mesh__D016481sskos__Concept
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016481 2004
% 224.54/224.69  |- mesh__dateEstablished mesh__D016481 1991-01-01
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016481 1998
% 224.54/224.69  |- mesh__recordAuthorizer mesh__D016481 PLS
% 224.54/224.69  |- mesh__dateRevised mesh__D016481 1993-06-02
% 224.54/224.69  |- skos__broader mesh__D016481smesh__D016905
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016481 1999
% 224.54/224.69  |- mesh__publicMeSHNote mesh__D016481 91   
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016481 2002
% 224.54/224.69  |- mesh__recordOriginator mesh__D016481 PLS
% 224.54/224.69  |- mesh__dateCreated mesh__D016481 1990-08-03
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D002461 2004
% 224.54/224.69  |- mesh__dateEstablished mesh__D002461 1988-01-01
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D002461 2006
% 224.54/224.69  |- mesh__recordOriginator mesh__D002461 SCD
% 224.54/224.69  |- mesh__publicMeSHNote mesh__D002461 88   
% 224.54/224.69  |- skos__related mesh__D002461smesh__D002471
% 224.54/224.69  |- skos__hiddenLabel mesh__D002461 Transformed Cell Lines
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D002461 2005
% 224.54/224.69  |- mesh__dateRevised mesh__D002461 2003-07-30
% 224.54/224.69  |- skos__related mesh__D002461smesh__D002472
% 224.54/224.69  |- mesh__recordAuthorizer mesh__D002461 sjn
% 224.54/224.69  |- skos__historyNote mesh__D002461
% 224.54/224.69       Cell Transformation, Neoplastic %28%1966-1987%29%
% 224.54/224.69  |- mesh__historyNote mesh__D002461 88   
% 224.54/224.69  |- skos__historyNote mesh__D002461
% 224.54/224.69       Cell Transformation, Viral %28%1978-1987%29%
% 224.54/224.69  |- skos__prefLabel mesh__D002461 Cell Line, Transformed
% 224.54/224.69  |- skos__historyNote mesh__D002461 Cell Line %28%1966-1987%29%
% 224.54/224.69  |- skos__altLabel mesh__D002461 Transformed Cell Line
% 224.54/224.69  |- skos__scopeNote mesh__D002461
% 224.54/224.69       Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals.%A%    
% 224.54/224.69  |- mesh__recordMaintainer mesh__D002461 nns
% 224.54/224.69  |- rdf__type mesh__D002461sskos__Concept
% 224.54/224.69  |- skos__historyNote mesh__D002461 Cells, Cultured %28%1966-1987%29%
% 224.54/224.69  |- skos__hiddenLabel mesh__D002461 Cell Lines, Transformed
% 224.54/224.69  |- mesh__dateCreated mesh__D002461 1987-05-11
% 224.54/224.69  |- skos__historyNote mesh__D002461 Tissue Culture %28%1966-1976%29%
% 224.54/224.69  |- skos__broader mesh__D002461smesh__D002460
% 224.54/224.69  |- skos__annotation mesh__D002461
% 224.54/224.69       almost always NIM with no subheadings; check ANIMALS or HUMAN; do not routinely add tissue or organ%A%  
% 224.54/224.69  |- skos__related mesh__D001369smesh__D019771
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D001369 2002
% 224.54/224.69  |- mesh__dateRevised mesh__D001369 2000-06-21
% 224.54/224.69  |- mesh__recordAuthorizer mesh__D001369 sjn
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D001369 2004
% 224.54/224.69  |- skos__prefLabel mesh__D001369 Axons
% 224.54/224.69  |- skos__annotation mesh__D001369
% 224.54/224.69       NERVE FIBERS is available; giant squid axon: coord IM with SQUID %28%NIM%29%%A%  
% 224.54/224.69  |- mesh__dateCreated mesh__D001369 1999-01-01
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D001369 2003
% 224.54/224.69  |- skos__broader mesh__D001369smesh__D022081
% 224.54/224.69  |- mesh__recordOriginator mesh__D001369 NLM
% 224.54/224.69  |- skos__broader mesh__D001369smesh__D009412
% 224.54/224.69  |- skos__broader mesh__D001369smesh__D009474
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D001369 2001
% 224.54/224.69  |- skos__hiddenLabel mesh__D001369 Axon
% 224.54/224.69  |- skos__scopeNote mesh__D001369
% 224.54/224.69       Nerve fibers that are capable of rapidly conducting impulses away from the neuron cell body.%A%    
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D001369 2006
% 224.54/224.69  |- rdf__type mesh__D001369sskos__Concept
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D001369 2005
% 224.54/224.69  |- mesh__recordMaintainer mesh__D001369 KEV
% 224.54/224.69  |- skos__broader mesh__D000776Q000295smesh__D000776
% 224.54/224.69  |- rdf__type mesh__D000776Q000295smesh__CompoundConcept
% 224.54/224.69  |- skos__related mesh__D012091smesh__D005810
% 224.54/224.69  |- mesh__dateCreated mesh__D012091 1980-04-02
% 224.54/224.69  |- skos__historyNote mesh__D012091 DNA %28%1968-1980%29%
% 224.54/224.69  |- skos__hiddenLabel mesh__D012091 Repeats, Direct
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012091 2005
% 224.54/224.69  |- mesh__historyNote mesh__D012091 81   
% 224.54/224.69  |- skos__hiddenLabel mesh__D012091 Gene, Selfish
% 224.54/224.69  |- skos__hiddenLabel mesh__D012091 DNAs, Selfish
% 224.54/224.69  |- skos__hiddenLabel mesh__D012091 Selfish DNAs
% 224.54/224.69  |- skos__prefLabel mesh__D012091 Repetitive Sequences, Nucleic Acid
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012091 2006
% 224.54/224.69  |- skos__hiddenLabel mesh__D012091 Repeat Sequences, Inverted
% 224.54/224.69  |- skos__historyNote mesh__D012091 Base Sequence %28%1971-1980%29%
% 224.54/224.69  |- skos__scopeNote mesh__D012091
% 224.54/224.69       Sequences of DNA or RNA that occur in multiple copies. There are several types: INTERSPERSED REPETITIVE SEQUENCES are copies of transposable elements %28%DNA TRANSPOSABLE ELEMENTS or RETROELEMENTS%29% dispersed throughout the genome. TERMINAL REPEAT SEQUENCES flank both ends of another sequence, for example, the long terminal repeats %28%LTRs%29% on RETROVIRUSES. Variations may be direct repeats, those occurring in the same direction, or inverted repeats, those opposite to each other in direction. TANDEM REPEAT SEQUENCES are copies which lie adjacent to each other, direct or inverted.%A%    
% 224.54/224.69  |- skos__hiddenLabel mesh__D012091 DNA Repetitious Regions
% 224.54/224.69  |- mesh__dateRevised mesh__D012091 2004-08-02
% 224.54/224.69  |- skos__broader mesh__D012091smesh__D001483
% 224.54/224.69  |- skos__hiddenLabel mesh__D012091 Repetitious Regions, DNA
% 224.54/224.69  |- skos__hiddenLabel mesh__D012091 Direct Repeats
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012091 2005A
% 224.54/224.69  |- mesh__recordMaintainer mesh__D012091 jls
% 224.54/224.69  |- skos__altLabel mesh__D012091 Repetitive Sequence
% 224.54/224.69  |- skos__altLabel mesh__D012091 Repetitious Region, DNA
% 224.54/224.69  |- skos__annotation mesh__D012091
% 224.54/224.69       coord with DNA, RNA or specifics; DF: REPET SEQ NA   
% 224.54/224.69  |- mesh__dateEstablished mesh__D012091 1981-01-01
% 224.54/224.69  |- mesh__recordOriginator mesh__D012091 AEP
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012091 2004
% 224.54/224.69  |- skos__hiddenLabel mesh__D012091 Repeat Sequence, Inverted
% 224.54/224.69  |- skos__hiddenLabel mesh__D012091 Selfish Gene
% 224.54/224.69  |- skos__altLabel mesh__D012091 Nucleic Acid Repetitive Sequences
% 224.54/224.69  |- skos__hiddenLabel mesh__D012091 Repetitive Regions
% 224.54/224.69  |- mesh__publicMeSHNote mesh__D012091 81   
% 224.54/224.69  |- skos__altLabel mesh__D012091 DNA, Selfish
% 224.54/224.69  |- mesh__recordAuthorizer mesh__D012091 jls
% 224.54/224.69  |- skos__hiddenLabel mesh__D012091 Repeat, Direct
% 224.54/224.69  |- skos__hiddenLabel mesh__D012091 Repetitive Sequences
% 224.54/224.69  |- skos__hiddenLabel mesh__D012091 Inverted Repeat Sequences
% 224.54/224.69  |- rdf__type mesh__D012091sskos__Concept
% 224.54/224.69  |- skos__altLabel mesh__D012091 Genes, Selfish
% 224.54/224.69  |- skos__altLabel mesh__D006852 HCTZ
% 224.54/224.69  |- skos__altLabel mesh__D006852 Dichlothiazide
% 224.54/224.69  |- skos__altLabel mesh__D006852 Esidrix
% 224.54/224.69  |- mesh__recordAuthorizer mesh__D006852 sjn
% 224.54/224.69  |- mesh__recordOriginator mesh__D006852 NLM
% 224.54/224.69  |- rdf__type mesh__D006852sskos__Concept
% 224.54/224.69  |- mesh__dateCreated mesh__D006852 1999-01-01
% 224.54/224.69  |- skos__broader mesh__D006852smesh__D002740
% 224.54/224.69  |- skos__prefLabel mesh__D006852 Hydrochlorothiazide
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D006852 2006
% 224.54/224.69  |- skos__scopeNote mesh__D006852
% 224.54/224.69       A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It has been used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.%A%    
% 224.54/224.69  |- mesh__dateRevised mesh__D006852 2005-06-30
% 224.54/224.69  |- skos__altLabel mesh__D006852 Dihydrochlorothiazide
% 224.54/224.69  |- mesh__recordMaintainer mesh__D006852 ssb
% 224.54/224.69  |- mesh__historyNote mesh__D020523 2000   
% 224.54/224.69  |- mesh__dateRevised mesh__D020523 2005-06-30
% 224.54/224.69  |- skos__prefLabel mesh__D020523 Chemokines, CX3C
% 224.54/224.69  |- mesh__publicMeSHNote mesh__D020523 2000   
% 224.54/224.69  |- rdf__type mesh__D020523sskos__Concept
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D020523 2006
% 224.54/224.69  |- mesh__recordMaintainer mesh__D020523 ssb
% 224.54/224.69  |- mesh__dateCreated mesh__D020523 1999-11-03
% 224.54/224.69  |- skos__historyNote mesh__D020523 Chemokines %28%1997-1999%29%
% 224.54/224.69  |- mesh__recordAuthorizer mesh__D020523 sjn
% 224.54/224.69  |- mesh__recordOriginator mesh__D020523 ags
% 224.54/224.69  |- skos__broader mesh__D020523smesh__D018925
% 224.54/224.69  |- mesh__dateEstablished mesh__D020523 2000-01-01
% 224.54/224.69  |- skos__altLabel mesh__D020523 CX3C Chemokines
% 224.54/224.69  |- skos__scopeNote mesh__D020523
% 224.54/224.69       Group of chemokines with the first two cysteines separated by three amino acids. CX3C chemokines are chemotactic for natural killer cells, monocytes, and activated T-cells.%A%    
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D006054 2005
% 224.54/224.69  |- mesh__recordAuthorizer mesh__D006054 sjn
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D006054 2006
% 224.54/224.69  |- skos__altLabel mesh__D006054 Carassius auratus
% 224.54/224.69  |- mesh__recordMaintainer mesh__D006054 ags
% 224.54/224.69  |- mesh__recordOriginator mesh__D006054 NLM
% 224.54/224.69  |- skos__scopeNote mesh__D006054
% 224.54/224.69       Common name for Carassius auratus, a type of carp %28%CARPS%29%.%A%    
% 224.54/224.69  |- mesh__dateCreated mesh__D006054 1999-01-01
% 224.54/224.69  |- skos__broader mesh__D006054smesh__D002347
% 224.54/224.69  |- mesh__dateEstablished mesh__D006054 1991-01-01
% 224.54/224.69  |- skos__prefLabel mesh__D006054 Goldfish
% 224.54/224.69  |- mesh__publicMeSHNote mesh__D006054
% 224.54/224.69       91; was see under CYPRINIDAE 1975-90   
% 224.54/224.69  |- mesh__dateRevised mesh__D006054 2003-07-09
% 224.54/224.69  |- mesh__historyNote mesh__D006054
% 224.54/224.69       91%28%75%29%; was see under CYPRINIDAE 1975-90   
% 224.54/224.69  |- rdf__type mesh__D006054sskos__Concept
% 224.54/224.69  |- mesh__onlineNote mesh__D006054 search CYPRINIDAE 1968-74   
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D006054 2004
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D011797 2003
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D011797 2002
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D011797 2004
% 224.54/224.69  |- skos__broader mesh__D011797smesh__D011796
% 224.54/224.69  |- rdf__type mesh__D011797sskos__Concept
% 224.54/224.69  |- mesh__recordOriginator mesh__D011797 NLM
% 224.54/224.69  |- mesh__recordAuthorizer mesh__D011797 sjn
% 224.54/224.69  |- skos__hiddenLabel mesh__D011797 Mustard, Quinacrine
% 224.54/224.69  |- mesh__dateRevised mesh__D011797 2000-06-21
% 224.54/224.69  |- skos__historyNote mesh__D011797 Mustard Compounds %28%1973-1974%29%
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D011797 2005
% 224.54/224.69  |- mesh__dateEstablished mesh__D011797 1991-01-01
% 224.54/224.69  |- skos__historyNote mesh__D011797 Quinacrine %28%1973-1974%29%
% 224.54/224.69  |- skos__prefLabel mesh__D011797 Quinacrine Mustard
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D011797 2001
% 224.54/224.69  |- mesh__publicMeSHNote mesh__D011797
% 224.54/224.69       91; was see under QUINACRINE 1975-90   
% 224.54/224.69  |- skos__broader mesh__D011797smesh__D009588
% 224.54/224.69  |- skos__scopeNote mesh__D011797
% 224.54/224.69       Nitrogen mustard analog of quinacrine used primarily as a stain in the studies of chromosomes and chromatin. Fluoresces by reaction with nucleic acids in chromosomes.%A%    
% 224.54/224.69  |- skos__annotation mesh__D011797 D25-26 qualif   
% 224.54/224.69  |- mesh__dateCreated mesh__D011797 1974-11-19
% 224.54/224.69  |- mesh__recordMaintainer mesh__D011797 CCR
% 224.54/224.69  |- skos__hiddenLabel mesh__D011797 Yperite, Acrichine
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D011797 2006
% 224.54/224.69  |- mesh__historyNote mesh__D011797
% 224.54/224.69       91%28%75%29%; was see under QUINACRINE 1975-90   
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016482 2005
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016482 2002
% 224.54/224.69  |- mesh__recordAuthorizer mesh__D016482 SJN
% 224.54/224.69  |- skos__scopeNote mesh__D016482
% 224.54/224.69       Examination of urine by chemical, physical, or microscopic means. Routine urinalysis usually includes performing chemical screening tests, determining specific gravity, observing any unusual color or odor, screening for bacteriuria, and examining the sediment microscopically.%A%    
% 224.54/224.69  |- skos__broader mesh__D016482smesh__D003942
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016482 2006
% 224.54/224.69  |- skos__hiddenLabel mesh__D016482 Urinalyses
% 224.54/224.69  |- mesh__dateEstablished mesh__D016482 1992-01-01
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016482 2003
% 224.54/224.69  |- mesh__publicMeSHNote mesh__D016482 92   
% 224.54/224.69  |- rdf__type mesh__D016482sskos__Concept
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016482 2000
% 224.54/224.69  |- mesh__recordOriginator mesh__D016482 AGS
% 224.54/224.69  |- skos__prefLabel mesh__D016482 Urinalysis
% 224.54/224.69  |- skos__annotation mesh__D016482
% 224.54/224.69       GEN only; for urinalysis of specific substances in the urine prefer /urine%A%  
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016482 1998
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016482 2004
% 224.54/224.69  |- skos__broader mesh__D016482smesh__D003950
% 224.54/224.69  |- mesh__dateCreated mesh__D016482 1991-01-03
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016482 1999
% 224.54/224.69  |- mesh__historyNote mesh__D016482 92   
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D016482 2001
% 224.54/224.69  |- mesh__dateRevised mesh__D016482 1997-06-20
% 224.54/224.69  |- skos__broader mesh__D016482smesh__D019963
% 224.54/224.69  |- mesh__recordMaintainer mesh__D016482 PXP
% 224.54/224.69  |- skos__historyNote mesh__D016482 Urine/analysis %28%1966-1991%29%
% 224.54/224.69  |- skos__related mesh__D002462smesh__D008564
% 224.54/224.69  |- skos__hiddenLabel mesh__D002462 Membrane, Plasma
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D002462 2006
% 224.54/224.69  |- skos__hiddenLabel mesh__D002462 Plasma Membranes
% 224.54/224.69  |- skos__related mesh__D002462smesh__D008562
% 224.54/224.69  |- mesh__dateCreated mesh__D002462 1999-01-01
% 224.54/224.69  |- skos__related mesh__D002462smesh__D008563
% 224.54/224.69  |- mesh__recordOriginator mesh__D002462 NLM
% 224.54/224.69  |- skos__hiddenLabel mesh__D002462 Membranes, Cell
% 224.54/224.69  |- skos__hiddenLabel mesh__D002462 Membranes, Cytoplasmic
% 224.54/224.69  |- mesh__recordMaintainer mesh__D002462 lkt
% 224.54/224.69  |- skos__related mesh__D002462smesh__D008561
% 224.54/224.69  |- skos__related mesh__D002462smesh__D013570
% 224.54/224.69  |- skos__hiddenLabel mesh__D002462 Membranes, Plasma
% 224.54/224.69  |- skos__broader mesh__D002462smesh__D022082
% 224.54/224.69  |- skos__annotation mesh__D002462
% 224.54/224.69       coordinate with specific cell /ultrastruct; permitted with micro-organisms%A%  
% 224.54/224.69  |- skos__hiddenLabel mesh__D002462 Cytoplasmic Membranes
% 224.54/224.69  |- skos__hiddenLabel mesh__D002462 Membrane, Cell
% 224.54/224.69  |- skos__altLabel mesh__D002462 Plasma Membrane
% 224.54/224.69  |- skos__hiddenLabel mesh__D002462 Cell Membranes
% 224.54/224.69  |- mesh__dateEstablished mesh__D002462 1965-01-01
% 224.54/224.69  |- mesh__historyNote mesh__D002462 65%28%64%29%   
% 224.54/224.69  |- skos__related mesh__D002462smesh__D009996
% 224.54/224.69  |- skos__related mesh__D002462smesh__D008560
% 224.54/224.69  |- skos__altLabel mesh__D002462 Cytoplasmic Membrane
% 224.54/224.69  |- rdf__type mesh__D002462sskos__Concept
% 224.54/224.69  |- mesh__dateRevised mesh__D002462 2005-06-30
% 224.54/224.69  |- skos__related mesh__D002462smesh__D008565
% 224.54/224.69  |- skos__related mesh__D002462smesh__D009685
% 224.54/224.69  |- skos__hiddenLabel mesh__D002462 Membrane, Cytoplasmic
% 224.54/224.69  |- mesh__recordAuthorizer mesh__D002462 sjn
% 224.54/224.69  |- skos__prefLabel mesh__D002462 Cell Membrane
% 224.54/224.69  |- mesh__publicMeSHNote mesh__D002462 65   
% 224.54/224.69  |- skos__related mesh__D002462smesh__D007425
% 224.54/224.69  |- skos__scopeNote mesh__D002462
% 224.54/224.69       The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells.%A%    
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012890 2004
% 224.54/224.69  |- mesh__dateCreated mesh__D012890 1999-01-01
% 224.54/224.69  |- mesh__recordOriginator mesh__D012890 NLM
% 224.54/224.69  |- mesh__dateRevised mesh__D012890 1997-06-20
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012890 2005
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012890 2000
% 224.54/224.69  |- skos__related mesh__D012890smesh__D017286
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012890 2001
% 224.54/224.69  |- skos__broader mesh__D012890smesh__D009424
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012890 2006
% 224.54/224.69  |- skos__hiddenLabel mesh__D012890 Sleep, Slow Wave
% 224.54/224.69  |- skos__scopeNote mesh__D012890
% 224.54/224.69       A readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility.%A%    
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012890 2002
% 224.54/224.69  |- skos__prefLabel mesh__D012890 Sleep
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012890 1998
% 224.54/224.69  |- skos__broader mesh__D012890smesh__D011603
% 224.54/224.69  |- mesh__recordAuthorizer mesh__D012890 SJN
% 224.54/224.69  |- skos__hiddenLabel mesh__D012890 Slow-Wave Sleep
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012890 2003
% 224.54/224.69  |- mesh__recordMaintainer mesh__D012890 TGC
% 224.54/224.69  |- rdf__type mesh__D012890sskos__Concept
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012890 1999
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012092 2006
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012092 1998
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012092 2002
% 224.54/224.69  |- mesh__historyNote mesh__D012092 82; was REIMPLANTATION 1965-81   
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012092 2003
% 224.54/224.69  |- mesh__recordMaintainer mesh__D012092 TGC
% 224.54/224.69  |- skos__hiddenLabel mesh__D012092 Replantations, Surgical
% 224.54/224.69  |- skos__scopeNote mesh__D012092
% 224.54/224.69       Restoration of an organ or other structure to its original site.%A%    
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012092 1999
% 224.54/224.69  |- mesh__recordAuthorizer mesh__D012092 PLS
% 224.54/224.69  |- skos__hiddenLabel mesh__D012092 Replantations
% 224.54/224.69  |- mesh__dateRevised mesh__D012092 1994-05-05
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012092 2004
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012092 1996
% 224.54/224.69  |- mesh__dateEstablished mesh__D012092 1965-01-01
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012092 2000
% 224.54/224.69  |- skos__annotation mesh__D012092
% 224.54/224.69       do not use /util except by MeSH definition; differentiate from transpl; coord with organ /surg: Manual 19.8.75%A%  
% 224.54/224.69  |- mesh__dateCreated mesh__D012092 1999-01-01
% 224.54/224.69  |- mesh__onlineNote mesh__D012092
% 224.54/224.69       use REPLANTATION to search REIMPLANTATION 1966-81   
% 224.54/224.69  |- skos__hiddenLabel mesh__D012092 Reimplantations
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012092 1997
% 224.54/224.69  |- mesh__recordOriginator mesh__D012092 NLM
% 224.54/224.69  |- skos__prefLabel mesh__D012092 Replantation
% 224.54/224.69  |- skos__altLabel mesh__D012092 Surgical Replantation
% 224.54/224.69  |- rdf__type mesh__D012092sskos__Concept
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012092 2001
% 224.54/224.69  |- skos__altLabel mesh__D012092 Replantation, Surgical
% 224.54/224.69  |- skos__broader mesh__D012092smesh__D014180
% 224.54/224.69  |- skos__altLabel mesh__D012092 Reimplantation
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012092 2005
% 224.54/224.69  |- skos__hiddenLabel mesh__D012092 Surgical Replantations
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D012092 1995
% 224.54/224.69  |- mesh__publicMeSHNote mesh__D012092 82; was REIMPLANTATION 1965-81   
% 224.54/224.69  |- mesh__dateRevised mesh__D006853 2005-07-18
% 224.54/224.69  |- skos__altLabel mesh__D006853 Hycon
% 224.54/224.69  |- mesh__dateCreated mesh__D006853 1975-07-18
% 224.54/224.69  |- skos__broader mesh__D006853smesh__D003061
% 224.54/224.69  |- skos__altLabel mesh__D006853 Dihydrocodeinone
% 224.54/224.69  |- rdf__type mesh__D006853sskos__Concept
% 224.54/224.69  |- skos__altLabel mesh__D006853 Hydrocodone Bitartrate
% 224.54/224.69  |- skos__altLabel mesh__D006853 Nourypharma Brand of Hydrocodone Tartrate
% 224.54/224.69  |- skos__historyNote mesh__D006853 Morphinans %28%1970-1974%29%
% 224.54/224.69  |- skos__historyNote mesh__D006853
% 224.54/224.69       Codeine/analogs %26% derivatives %28%1975%29%
% 224.54/224.69  |- mesh__recordMaintainer mesh__D006853 ags
% 224.54/224.69  |- skos__altLabel mesh__D006853 Knoll Brand of Hydrocodone Tartrate
% 224.54/224.69  |- skos__annotation mesh__D006853
% 224.54/224.69       do not confuse HYDROCODONE x refs with OXYCODONE x refs   
% 224.54/224.69  |- mesh__activeMeSHYear mesh__D006853 2004
% 224.54/224.69  |- mesh__dateEstablished mesh__D006853 1991-01-01
% 224.54/224.70  |- mesh__activeMeSHYear mesh__D006853 2006
% 224.54/224.70  |- skos__historyNote mesh__D006853 Ethers, Cyclic %28%1973-1974%29%
% 224.54/224.70  |- skos__altLabel mesh__D006853 Robins Brand of Hydrocodone Tartrate
% 224.54/224.70  |- skos__prefLabel mesh__D006853 Hydrocodone
% 224.54/224.70  |- mesh__recordAuthorizer mesh__D006853 ags
% 224.54/224.70  |- mesh__activeMeSHYear mesh__D006853 2005
% 224.54/224.70  |- skos__altLabel mesh__D006853 Hydrocodon
% 224.54/224.70  |- skos__altLabel mesh__D006853 Du Pont Brand of Hydrocodone Tartrate
% 224.54/224.70  |- skos__scopeNote mesh__D006853
% 224.54/224.70       Narcotic analgesic related to CODEINE, but more potent and more addicting by weight. It is used also as cough suppressant.%A%    
% 224.54/224.70  |- mesh__recordOriginator mesh__D006853 SH
% 224.54/224.70  |- mesh__publicMeSHNote mesh__D006853 91; was see under CODEINE 1976-90   
% 224.54/224.70  |- skos__altLabel mesh__D006853 Wyeth Brand of Hydrocodone Tartrate
% 224.54/224.70  |- mesh__historyNote mesh__D006853
% 224.54/224.70       91%28%76%29%; was see under CODEINE 1976-90   
% 224.54/224.70  |- mesh__activeMeSHYear mesh__D006853 2006A
% 224.54/224.70  |- skos__scopeNote mesh__D020524
% 224.54/224.70       Membranous cisternae of the CHLOROPLAST containing photosynthetic pigments, reaction centers, and the electron-transport chain. Each thylakoid consists of a flattened sac of membrane enclosing a narrow intra-thylakoid space %28%Lackie and Dow, Dictionary of Cell Biology, 2nd ed%29%. Individual thylakoids are interconnected and tend to stack to form aggregates called grana. They are found in cyanobacteria and all plants.%A%    
% 224.54/224.70  |- mesh__activeMeSHYear mesh__D020524 2006
% 224.54/224.70  |- mesh__recordAuthorizer mesh__D020524 sjn
% 224.54/224.70  |- skos__broader mesh__D020524smesh__D002736
% 224.54/224.70  |- mesh__recordOriginator mesh__D020524 ags
% 224.54/224.70  |- skos__hiddenLabel mesh__D020524 Membranes, Thylakoid
% 224.54/224.70  |- mesh__activeMeSHYear mesh__D020524 2005
% 224.54/224.70  |- mesh__publicMeSHNote mesh__D020524
% 224.54/224.70       2000; for GRANA see CHLOROPLASTS 1979-1999   
% 224.54/224.70  |- mesh__recordMaintainer mesh__D020524 jmp
% 224.54/224.70  |- skos__hiddenLabel mesh__D020524 Membrane, Thylakoid
% 224.54/224.70  |- skos__related mesh__D020524smesh__D045331
% 224.54/224.70  |- mesh__historyNote mesh__D020524
% 224.54/224.70       2000; for GRANA use CHLOROPLASTS 1979-1999   
% 224.54/224.70  |- skos__historyNote mesh__D020524 Chloroplasts %28%1969-1999%29%
% 224.55/224.70  |- skos__prefLabel mesh__D020524 Thylakoids
% 224.55/224.70  |- skos__related mesh__D020524smesh__D045332
% 224.55/224.70  |- skos__hiddenLabel mesh__D020524 Thylakoid Membranes
% 224.55/224.70  |- mesh__dateRevised mesh__D020524 2003-07-09
% 224.55/224.70  |- mesh__dateEstablished mesh__D020524 2000-01-01
% 224.55/224.70  |- skos__hiddenLabel mesh__D020524 Thylakoid
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D020524 2004
% 224.55/224.70  |- rdf__type mesh__D020524sskos__Concept
% 224.55/224.70  |- mesh__dateCreated mesh__D020524 1999-11-08
% 224.55/224.70  |- mesh__recordMaintainer mesh__D006055 TAP
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D006055 2001
% 224.55/224.70  |- skos__annotation mesh__D006055
% 224.55/224.70       /inj: coord IM with specific inj %28%IM%29%; /physiol permitted; Manual 30.15.1%A%  
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D006055 2006
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D006055 2002
% 224.55/224.70  |- mesh__publicMeSHNote mesh__D006055 90; was see under SPORTS 1976-89   
% 224.55/224.70  |- skos__scopeNote mesh__D006055
% 224.55/224.70       A game whose object is to sink a ball into each of 9 or 18 successive holes on a golf course using as few strokes as possible.%A%    
% 224.55/224.70  |- skos__hiddenLabel mesh__D006055 Golfs
% 224.55/224.70  |- mesh__recordAuthorizer mesh__D006055 PLS
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D006055 1997
% 224.55/224.70  |- mesh__dateCreated mesh__D006055 1975-07-25
% 224.55/224.70  |- mesh__recordOriginator mesh__D006055 JW
% 224.55/224.70  |- mesh__historyNote mesh__D006055
% 224.55/224.70       90%28%76%29%; was see under SPORTS 1976-89   
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D006055 2003
% 224.55/224.70  |- rdf__type mesh__D006055sskos__Concept
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D006055 1998
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D006055 2004
% 224.55/224.70  |- mesh__dateEstablished mesh__D006055 1990-01-01
% 224.55/224.70  |- skos__historyNote mesh__D006055 Sports %28%1966-1975%29%
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D006055 1999
% 224.55/224.70  |- skos__prefLabel mesh__D006055 Golf
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D006055 2000
% 224.55/224.70  |- mesh__dateRevised mesh__D006055 1996-06-10
% 224.55/224.70  |- skos__broader mesh__D006055smesh__D013177
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D006055 2005
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011798 2004
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011798 1996
% 224.55/224.70  |- rdf__type mesh__D011798sskos__Concept
% 224.55/224.70  |- mesh__recordAuthorizer mesh__D011798 PLS
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011798 1993
% 224.55/224.70  |- skos__broader mesh__D011798smesh__D011804
% 224.55/224.70  |- skos__prefLabel mesh__D011798 Quinaldines
% 224.55/224.70  |- mesh__recordMaintainer mesh__D011798 TAP
% 224.55/224.70  |- mesh__dateRevised mesh__D011798 1992-05-20
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011798 1997
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011798 2002
% 224.55/224.70  |- mesh__historyNote mesh__D011798
% 224.55/224.70       91%28%75%29%; was see under QUINOLINES 1975-90   
% 224.55/224.70  |- mesh__onlineNote mesh__D011798 search QUINOLINES 1969-74   
% 224.55/224.70  |- mesh__dateCreated mesh__D011798 1999-01-01
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011798 2005
% 224.55/224.70  |- mesh__dateEstablished mesh__D011798 1991-01-01
% 224.55/224.70  |- mesh__recordOriginator mesh__D011798 NLM
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011798 1994
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011798 2006
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011798 2000
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011798 1998
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011798 1995
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011798 2003
% 224.55/224.70  |- mesh__publicMeSHNote mesh__D011798
% 224.55/224.70       91; was see under QUINOLINES 1975-90   
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011798 2001
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011798 1999
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D016483 2003
% 224.55/224.70  |- mesh__recordAuthorizer mesh__D016483 SJN
% 224.55/224.70  |- mesh__dateEstablished mesh__D016483 1992-01-01
% 224.55/224.70  |- mesh__publicMeSHNote mesh__D016483 92   
% 224.55/224.70  |- skos__altLabel mesh__D016483 AIDS-Associated Lymphoma
% 224.55/224.70  |- skos__altLabel mesh__D016483 Lymphoma, HIV-Related
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D016483 2006
% 224.55/224.70  |- skos__hiddenLabel mesh__D016483 Lymphoma, AIDS Associated
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D016483 2001
% 224.55/224.70  |- skos__hiddenLabel mesh__D016483 AIDS Related Lymphoma
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D016483 1999
% 224.55/224.70  |- skos__altLabel mesh__D016483 AIDS-Related Lymphoma
% 224.55/224.70  |- skos__broader mesh__D016483smesh__D016393
% 224.55/224.70  |- mesh__historyNote mesh__D016483 92   
% 224.55/224.70  |- mesh__recordOriginator mesh__D016483 AGS
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D016483 2005
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D016483 2000
% 224.55/224.70  |- skos__historyNote mesh__D016483 Lymphoma %28%1986-1991%29%
% 224.55/224.70  |- skos__hiddenLabel mesh__D016483 AIDS-Related Lymphomas
% 224.55/224.70  |- skos__hiddenLabel mesh__D016483 AIDS-Associated Lymphomas
% 224.55/224.70  |- skos__scopeNote mesh__D016483
% 224.55/224.70       B-cell lymphoid tumors that occur in association with AIDS. Patients often present with an advanced stage of disease and highly malignant subtypes including Burkitt lymphoma, immunoblastic large-cell lymphoma, small non-cleaved-cell lymphoma and diffuse large-cell lymphoma. The tumors are often disseminated in unusual extranodal sites and chromosomal abnormalities are frequently present. It is likely that polyclonal B-cell lymphoproliferation in AIDS is a complex result of EBV infection, HIV antigenic stimulation, and T-cell-dependent HIV activation.%A%    
% 224.55/224.70  |- rdf__type mesh__D016483sskos__Concept
% 224.55/224.70  |- skos__hiddenLabel mesh__D016483 HIV Related Lymphoma
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D016483 1998
% 224.55/224.70  |- skos__altLabel mesh__D016483 Lymphoma, AIDS-Associated
% 224.55/224.70  |- mesh__dateRevised mesh__D016483 1997-06-20
% 224.55/224.70  |- mesh__recordMaintainer mesh__D016483 PXP
% 224.55/224.70  |- skos__hiddenLabel mesh__D016483 HIV-Related Lymphomas
% 224.55/224.70  |- skos__hiddenLabel mesh__D016483 Lymphomas, AIDS-Related
% 224.55/224.70  |- mesh__dateCreated mesh__D016483 1991-01-02
% 224.55/224.70  |- skos__prefLabel mesh__D016483 Lymphoma, AIDS-Related
% 224.55/224.70  |- skos__hiddenLabel mesh__D016483 Lymphoma, AIDS Related
% 224.55/224.70  |- skos__hiddenLabel mesh__D016483 AIDS Associated Lymphoma
% 224.55/224.70  |- skos__hiddenLabel mesh__D016483 Lymphoma, HIV Related
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D016483 2004
% 224.55/224.70  |- skos__altLabel mesh__D016483 HIV-Related Lymphoma
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D016483 2002
% 224.55/224.70  |- skos__annotation mesh__D016483
% 224.55/224.70       a B-cell lymphoma but use for any AIDS-related lymphoma; coord IM with specific type of lymphoma %28%IM%29%; coord with HIV-1 or HIV-2 %28%IM or NIM%29% if pertinent; DF: LYMPHOMA AIDS RELAT%A%  
% 224.55/224.70  |- skos__hiddenLabel mesh__D016483 Lymphomas, AIDS-Associated
% 224.55/224.70  |- skos__hiddenLabel mesh__D016483 Lymphomas, HIV-Related
% 224.55/224.70  |- skos__related mesh__D002463smesh__D007476
% 224.55/224.70  |- mesh__historyNote mesh__D002463 65   
% 224.55/224.70  |- mesh__recordAuthorizer mesh__D002463 sjn
% 224.55/224.70  |- mesh__publicMeSHNote mesh__D002463 65   
% 224.55/224.70  |- skos__broader mesh__D002463smesh__D002468
% 224.55/224.70  |- skos__scopeNote mesh__D002463
% 224.55/224.70       A quality of cell membranes which permits the passage of solvents and solutes into and out of cells.%A%    
% 224.55/224.70  |- skos__broader mesh__D002463smesh__D001692
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D002463 2002
% 224.55/224.70  |- skos__prefLabel mesh__D002463 Cell Membrane Permeability
% 224.55/224.70  |- skos__altLabel mesh__D002463 Permeability, Cell Membrane
% 224.55/224.70  |- skos__annotation mesh__D002463
% 224.55/224.70       coord with substance /pharmacokin %28%IM%29% or /metab %28%IM%29%; for cell membrane only; intracellular membrane permeability: index INTRACELLULAR MEMBRANES + specific organelle + PERMEABILITY%A%  
% 224.55/224.70  |- mesh__recordOriginator mesh__D002463 NLM
% 224.55/224.70  |- rdf__type mesh__D002463sskos__Concept
% 224.55/224.70  |- mesh__recordMaintainer mesh__D002463 jmp
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D002463 2003
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D002463 2005
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D002463 2000
% 224.55/224.70  |- mesh__dateRevised mesh__D002463 1999-11-03
% 224.55/224.70  |- mesh__dateEstablished mesh__D002463 1965-01-01
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D002463 2004
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D002463 2001
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D002463 2006
% 224.55/224.70  |- mesh__dateCreated mesh__D002463 1999-01-01
% 224.55/224.70  |- skos__broader mesh__D040582smesh__D040341
% 224.55/224.70  |- mesh__dateCreated mesh__D040582 2002-07-03
% 224.55/224.70  |- skos__hiddenLabel mesh__D040582 Patterns, Inheritance
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D040582 2005
% 224.55/224.70  |- mesh__dateEstablished mesh__D040582 2003-01-01
% 224.55/224.70  |- mesh__historyNote mesh__D040582 2003   
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D040582 2006
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D040582 2003
% 224.55/224.70  |- skos__hiddenLabel mesh__D040582 Inheritance Pattern
% 224.55/224.70  |- mesh__publicMeSHNote mesh__D040582 2003   
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D040582 2004
% 224.55/224.70  |- rdf__type mesh__D040582sskos__Concept
% 224.55/224.70  |- skos__prefLabel mesh__D040582 Inheritance Patterns
% 224.55/224.70  |- skos__hiddenLabel mesh__D040582 Pattern, Inheritance
% 224.55/224.70  |- skos__scopeNote mesh__D040582
% 224.55/224.70       The different ways GENES and their ALLELES interact during the transmission of genetic traits that effect the outcome of GENE EXPRESSION.%A%    
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D012891 2006
% 224.55/224.70  |- skos__hiddenLabel mesh__D012891 Sleep Apneas
% 224.55/224.70  |- mesh__recordMaintainer mesh__D012891 lkt
% 224.55/224.70  |- skos__broader mesh__D012891smesh__D020919
% 224.55/224.70  |- skos__historyNote mesh__D012891 Sleep %28%1966-1979%29%
% 224.55/224.70  |- skos__hiddenLabel mesh__D012891 Apnea Syndrome, Sleep
% 224.55/224.70  |- skos__altLabel mesh__D012891 Sleep Hypopnea
% 224.55/224.70  |- skos__altLabel mesh__D012891 Sleep-Disordered Breathing
% 224.55/224.70  |- skos__historyNote mesh__D012891 Hypoventilation %28%1966-1979%29%
% 224.55/224.70  |- skos__historyNote mesh__D012891 Apnea %28%1966-1979%29%
% 224.55/224.70  |- skos__hiddenLabel mesh__D012891 Apneas, Sleep
% 224.55/224.70  |- mesh__dateEstablished mesh__D012891 1980-01-01
% 224.55/224.70  |- skos__broader mesh__D012891smesh__D001049
% 224.55/224.70  |- skos__hiddenLabel mesh__D012891 Sleep Hypopneas
% 224.55/224.70  |- skos__hiddenLabel mesh__D012891 Sleep Apneas, Mixed
% 224.55/224.70  |- skos__hiddenLabel mesh__D012891 Mixed Sleep Apneas
% 224.55/224.70  |- skos__hiddenLabel mesh__D012891 Hypopneas, Sleep
% 224.55/224.70  |- mesh__dateRevised mesh__D012891 2005-06-30
% 224.55/224.70  |- mesh__historyNote mesh__D012891 80   
% 224.55/224.70  |- skos__hiddenLabel mesh__D012891 Mixed Sleep Apnea
% 224.55/224.70  |- skos__historyNote mesh__D012891 Sleep Disorders %28%1966-1979%29%
% 224.55/224.70  |- rdf__type mesh__D012891sskos__Concept
% 224.55/224.70  |- skos__altLabel mesh__D012891 Sleep Apnea, Mixed
% 224.55/224.70  |- mesh__recordAuthorizer mesh__D012891 sjn
% 224.55/224.70  |- skos__hiddenLabel mesh__D012891 Sleep Disordered Breathing
% 224.55/224.70  |- skos__scopeNote mesh__D012891
% 224.55/224.70       Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central %28%see SLEEP APNEA, CENTRAL%29%, obstructive %28%see SLEEP APNEA, OBSTRUCTIVE%29%, and mixed central-obstructive types.%A%    
% 224.55/224.70  |- skos__hiddenLabel mesh__D012891 Apnea Syndromes, Sleep
% 224.55/224.70  |- skos__hiddenLabel mesh__D012891 Sleep Apnea Syndrome
% 224.55/224.70  |- skos__hiddenLabel mesh__D012891 Breathing, Sleep-Disordered
% 224.55/224.70  |- mesh__dateCreated mesh__D012891 1979-05-25
% 224.55/224.70  |- skos__hiddenLabel mesh__D012891 Sleep Apnea
% 224.55/224.70  |- skos__altLabel mesh__D012891 Apnea, Sleep
% 224.55/224.70  |- skos__hiddenLabel mesh__D012891 Hypopnea, Sleep
% 224.55/224.70  |- mesh__recordOriginator mesh__D012891 VDK
% 224.55/224.70  |- skos__annotation mesh__D012891 DF: SLEEP APNEA   
% 224.55/224.70  |- skos__altLabel mesh__D012891 Mixed Central and Obstructive Sleep Apnea
% 224.55/224.70  |- skos__prefLabel mesh__D012891 Sleep Apnea Syndromes
% 224.55/224.70  |- mesh__publicMeSHNote mesh__D012891 80   
% 224.55/224.70  |- skos__historyNote mesh__D012093 DNA/biosynthesis %28%1966-1967%29%
% 224.55/224.70  |- skos__hiddenLabel mesh__D012093 Replicons
% 224.55/224.70  |- skos__scopeNote mesh__D012093
% 224.55/224.70       Any DNA sequence capable of independent replication or a molecule that possesses a REPLICATION ORIGIN and which is therefore potentially capable of being replicated in a suitable cell. %28%Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed%29%%A%    
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D012093 2006
% 224.55/224.70  |- skos__prefLabel mesh__D012093 Replicon
% 224.55/224.70  |- skos__hiddenLabel mesh__D012093 Replication Units
% 224.55/224.70  |- mesh__recordOriginator mesh__D012093 AEP
% 224.55/224.70  |- skos__broader mesh__D012093smesh__D040481
% 224.55/224.70  |- mesh__recordMaintainer mesh__D012093 nns
% 224.55/224.70  |- skos__hiddenLabel mesh__D012093 Units, Replication
% 224.55/224.70  |- mesh__historyNote mesh__D012093 80   
% 224.55/224.70  |- skos__altLabel mesh__D012093 Replication Unit
% 224.55/224.70  |- mesh__publicMeSHNote mesh__D012093 80   
% 224.55/224.70  |- skos__hiddenLabel mesh__D012093 Unit, Replication
% 224.55/224.70  |- mesh__dateCreated mesh__D012093 1979-05-23
% 224.55/224.70  |- mesh__dateEstablished mesh__D012093 1980-01-01
% 224.55/224.70  |- mesh__dateRevised mesh__D012093 2005-06-30
% 224.55/224.70  |- skos__historyNote mesh__D012093 DNA Replication %28%1968-1979%29%
% 224.55/224.70  |- rdf__type mesh__D012093sskos__Concept
% 224.55/224.70  |- mesh__recordAuthorizer mesh__D012093 sjn
% 224.55/224.70  |- rdf__type mesh__D006854sskos__Concept
% 224.55/224.70  |- mesh__recordMaintainer mesh__D006854 ssb
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D006854 2005
% 224.55/224.70  |- skos__scopeNote mesh__D006854
% 224.55/224.70       The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions.%A%    
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D006854 2004
% 224.55/224.70  |- skos__hiddenLabel mesh__D006854 11 Epicortisol
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D006854 2006
% 224.55/224.70  |- skos__broader mesh__D006854smesh__D015065
% 224.55/224.70  |- skos__altLabel mesh__D006854 11-Epicortisol
% 224.55/224.70  |- mesh__dateRevised mesh__D006854 2003-07-09
% 224.55/224.70  |- skos__broader mesh__D006854smesh__D011282
% 224.55/224.70  |- mesh__recordAuthorizer mesh__D006854 sjn
% 224.55/224.70  |- mesh__dateCreated mesh__D006854 1999-01-01
% 224.55/224.70  |- mesh__publicMeSHNote mesh__D006854
% 224.55/224.70       /adverse effects /poisoning /toxicity were HYDROCORTISONE TOXICOLOGY 1963-65%A%  
% 224.55/224.70  |- skos__broader mesh__D006854smesh__D015062
% 224.55/224.70  |- mesh__historyNote mesh__D006854
% 224.55/224.70       /adv eff-pois-tox was HYDROCORTISONE TOXICOLOGY 1963-65   
% 224.55/224.70  |- skos__prefLabel mesh__D006854 Hydrocortisone
% 224.55/224.70  |- mesh__recordOriginator mesh__D006854 NLM
% 224.55/224.70  |- skos__altLabel mesh__D006854 Epicortisol
% 224.55/224.70  |- skos__altLabel mesh__D006854 Cortisol
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D020525 2005
% 224.55/224.70  |- skos__hiddenLabel mesh__D020525 Xenodiagnoses
% 224.55/224.70  |- mesh__dateRevised mesh__D020525 2000-06-22
% 224.55/224.70  |- mesh__dateEstablished mesh__D020525 2000-01-01
% 224.55/224.70  |- mesh__historyNote mesh__D020525 2000   
% 224.55/224.70  |- skos__broader mesh__D020525smesh__D008828
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D020525 2002
% 224.55/224.70  |- skos__scopeNote mesh__D020525
% 224.55/224.70       A method for diagnosing a disease in one organism by inoculating the putative causative organism in a second animal of a different species. It has been used for the detection of parasites %28%Trypanosoma cruzi and Trichinella spiralis%29% when peripheral blood smears are negative. %28%Segen, Current Med Talk, 1995%29%%A%    
% 224.55/224.70  |- skos__prefLabel mesh__D020525 Xenodiagnosis
% 224.55/224.70  |- skos__historyNote mesh__D020525
% 224.55/224.70       specific disease/diagnosis %28%1967-1999%29%
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D020525 2004
% 224.55/224.70  |- skos__annotation mesh__D020525
% 224.55/224.70       permitted with parasitic diseases as well as microbial infections%A%  
% 224.55/224.70  |- rdf__type mesh__D020525sskos__Concept
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D020525 2001
% 224.55/224.70  |- skos__broader mesh__D020525smesh__D019937
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D020525 2006
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D020525 2003
% 224.55/224.70  |- mesh__dateCreated mesh__D020525 1999-11-03
% 224.55/224.70  |- mesh__publicMeSHNote mesh__D020525 2000   
% 224.55/224.70  |- skos__altLabel mesh__D006056 Golgi Complex
% 224.55/224.70  |- mesh__recordOriginator mesh__D006056 NLM
% 224.55/224.70  |- mesh__dateRevised mesh__D006056 2003-07-09
% 224.55/224.70  |- rdf__type mesh__D006056sskos__Concept
% 224.55/224.70  |- skos__hiddenLabel mesh__D006056 Apparatus, Golgi
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D006056 2004
% 224.55/224.70  |- skos__broader mesh__D006056smesh__D015388
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D006056 2005
% 224.55/224.70  |- skos__hiddenLabel mesh__D006056 Complex, Golgi
% 224.55/224.70  |- mesh__recordMaintainer mesh__D006056 nns
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D006056 2006
% 224.55/224.70  |- skos__prefLabel mesh__D006056 Golgi Apparatus
% 224.55/224.70  |- skos__scopeNote mesh__D006056
% 224.55/224.70       A stack of flattened vesicles that functions in posttranslational processing and sorting of proteins, receiving them from the rough ENDOPLASMIC RETICULUM and directing them to secretory vesicles, LYSOSOMES, or the CELL MEMBRANE. The movement of proteins takes place by transfer vesicles that bud off from the rough endoplasmic reticulum or Golgi apparatus and fuse with the Golgi, lysosomes or cell membrane. %28%From Glick, Glossary of Biochemistry and Molecular Biology, 1990%29%%A%    
% 224.55/224.70  |- mesh__recordAuthorizer mesh__D006056 sjn
% 224.55/224.70  |- mesh__dateCreated mesh__D006056 1999-01-01
% 224.55/224.70  |- mesh__dateCreated mesh__D011799 1999-01-01
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011799 2005
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011799 2000
% 224.55/224.70  |- mesh__dateEstablished mesh__D011799 1966-01-01
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011799 1994
% 224.55/224.70  |- mesh__publicMeSHNote mesh__D011799 66   
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011799 2006
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011799 2001
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011799 1998
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011799 2003
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011799 1995
% 224.55/224.70  |- mesh__historyNote mesh__D011799 66%28%65%29%   
% 224.55/224.70  |- mesh__recordAuthorizer mesh__D011799 PLS
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011799 1999
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011799 2004
% 224.55/224.70  |- mesh__recordMaintainer mesh__D011799 TAP
% 224.55/224.70  |- mesh__dateRevised mesh__D011799 1992-05-20
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011799 1996
% 224.55/224.70  |- rdf__type mesh__D011799sskos__Concept
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011799 1993
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011799 2002
% 224.55/224.70  |- skos__prefLabel mesh__D011799 Quinazolines
% 224.55/224.70  |- skos__broader mesh__D011799smesh__D006574
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D011799 1997
% 224.55/224.70  |- mesh__recordOriginator mesh__D011799 NLM
% 224.55/224.70  |- skos__broader mesh__D010272Q000662smesh__D010272
% 224.55/224.70  |- mesh__preferredCombination mesh__D010272Q000662smesh__D010273
% 224.55/224.70  |- rdf__type mesh__D010272Q000662smesh__CompoundConcept
% 224.55/224.70  |- skos__broader mesh__D002464smesh__D007159
% 224.55/224.70  |- skos__hiddenLabel mesh__D002464 Test, Macrophage Migration
% 224.55/224.70  |- skos__prefLabel mesh__D002464 Cell Migration Inhibition
% 224.55/224.70  |- rdf__type mesh__D002464sskos__Concept
% 224.55/224.70  |- skos__hiddenLabel mesh__D002464 Tests, Leukocyte Migration
% 224.55/224.70  |- skos__historyNote mesh__D002464 Cell Movement %28%1968-1970%29%
% 224.55/224.70  |- mesh__dateEstablished mesh__D002464 1972-01-01
% 224.55/224.70  |- skos__scopeNote mesh__D002464
% 224.55/224.70       Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated leukocytes or macrophages. Specific assays have been developed to estimate levels of migration inhibitory factor, immune reactivity against tumor-associated antigens, and immunosuppressive effects of infectious microorganisms.%A%    
% 224.55/224.70  |- mesh__dateRevised mesh__D002464 2005-06-30
% 224.55/224.70  |- skos__altLabel mesh__D002464 Leukocyte Migration Inhibition Tests
% 224.55/224.70  |- mesh__historyNote mesh__D002464 72%28%71%29%   
% 224.55/224.70  |- skos__annotation mesh__D002464
% 224.55/224.70       coordinate with specific cell/immunol; do not confuse with LEUKOCYTE ADHERENCE INHIBITION TEST%A%  
% 224.55/224.70  |- skos__historyNote mesh__D002464 Lymphocytes/immunology %28%1966-1970%29%
% 224.55/224.70  |- mesh__recordAuthorizer mesh__D002464 sjn
% 224.55/224.70  |- skos__historyNote mesh__D002464
% 224.55/224.70       Hypersensitivity, Delayed %28%1966-1970%29%
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D002464 2006
% 224.55/224.70  |- mesh__dateCreated mesh__D002464 1999-01-01
% 224.55/224.70  |- skos__hiddenLabel mesh__D002464 Macrophage Migration Tests
% 224.55/224.70  |- skos__broader mesh__D002464smesh__D007158
% 224.55/224.70  |- skos__hiddenLabel mesh__D002464 Tests, Macrophage Migration
% 224.55/224.70  |- mesh__recordMaintainer mesh__D002464 ags
% 224.55/224.70  |- skos__historyNote mesh__D002464 Tissue Culture %28%1966-1970%29%
% 224.55/224.70  |- skos__hiddenLabel mesh__D002464 Test, Leukocyte Migration
% 224.55/224.70  |- mesh__publicMeSHNote mesh__D002464 72   
% 224.55/224.70  |- mesh__recordOriginator mesh__D002464 NLM
% 224.55/224.70  |- skos__related mesh__D002464smesh__D008263
% 224.55/224.70  |- skos__hiddenLabel mesh__D002464 Leukocyte Migration Tests
% 224.55/224.70  |- mesh__recordAuthorizer mesh__D029601 sjn
% 224.55/224.70  |- mesh__recordOriginator mesh__D029601 ssb
% 224.55/224.70  |- mesh__historyNote mesh__D029601 2002   
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D029601 2004
% 224.55/224.70  |- mesh__dateEstablished mesh__D029601 2002-01-01
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D029601 2006
% 224.55/224.70  |- rdf__type mesh__D029601sskos__Concept
% 224.55/224.70  |- skos__scopeNote mesh__D029601
% 224.55/224.70       The sesamum family of the order Scrophulariales, subclass Asteridae, class Magnoliopsida that are mainly herbs and shrubs growing in warm regions.%A%    
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D029601 2003
% 224.55/224.70  |- mesh__recordMaintainer mesh__D029601 ssb
% 224.55/224.70  |- mesh__publicMeSHNote mesh__D029601 2002   
% 224.55/224.70  |- skos__broader mesh__D029601smesh__D019684
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D029601 2005
% 224.55/224.70  |- mesh__dateCreated mesh__D029601 2001-07-25
% 224.55/224.70  |- skos__prefLabel mesh__D029601 Pedaliaceae
% 224.55/224.70  |- mesh__dateRevised mesh__D029601 2002-07-03
% 224.55/224.70  |- skos__annotation mesh__D029601
% 224.55/224.70       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.55/224.70  |- mesh__activeMeSHYear mesh__D012892 2001
% 224.55/224.70  |- skos__hiddenLabel mesh__D012892 Syndromes, Insufficient Sleep
% 224.55/224.70  |- skos__hiddenLabel mesh__D012892 Fragmentation, Sleep
% 224.55/224.71  |- skos__hiddenLabel mesh__D012892 Sleep Fragmentations
% 224.55/224.71  |- skos__hiddenLabel mesh__D012892 Fragmentations, Sleep
% 224.55/224.71  |- skos__hiddenLabel mesh__D012892 Syndrome, Insufficient Sleep
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012892 2002
% 224.55/224.71  |- skos__broader mesh__D012892smesh__D012890
% 224.55/224.71  |- skos__broader mesh__D012892smesh__D020920
% 224.55/224.71  |- mesh__dateEstablished mesh__D012892 1967-01-01
% 224.55/224.71  |- mesh__historyNote mesh__D012892 67%28%64%29%   
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012892 2003
% 224.55/224.71  |- rdf__type mesh__D012892sskos__Concept
% 224.55/224.71  |- skos__hiddenLabel mesh__D012892 Deprivation, REM Sleep
% 224.55/224.71  |- skos__hiddenLabel mesh__D012892 Sleep Deprivations
% 224.55/224.71  |- skos__prefLabel mesh__D012892 Sleep Deprivation
% 224.55/224.71  |- skos__broader mesh__D012892smesh__D012893
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012892 2004
% 224.55/224.71  |- skos__hiddenLabel mesh__D012892 REM Sleep Deprivations
% 224.55/224.71  |- skos__annotation mesh__D012892
% 224.55/224.71       do not confuse with SLEEP INITIATION AND MAINTENANCE DISORDERS, inability to fall asleep or sleep%A%  
% 224.55/224.71  |- skos__hiddenLabel mesh__D012892 Deprivation, Sleep
% 224.55/224.71  |- mesh__publicMeSHNote mesh__D012892 67   
% 224.55/224.71  |- skos__hiddenLabel mesh__D012892 Deprivations, REM Sleep
% 224.55/224.71  |- skos__hiddenLabel mesh__D012892 Sleep Deprivations, REM
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012892 2005
% 224.55/224.71  |- mesh__dateCreated mesh__D012892 1999-11-08
% 224.55/224.71  |- mesh__recordMaintainer mesh__D012892 sjn
% 224.55/224.71  |- mesh__recordAuthorizer mesh__D012892 sjn
% 224.55/224.71  |- mesh__recordOriginator mesh__D012892 NLM
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012892 2006
% 224.55/224.71  |- skos__hiddenLabel mesh__D012892 Deprivations, Sleep
% 224.55/224.71  |- skos__hiddenLabel mesh__D012892 Insufficient Sleep Syndromes
% 224.55/224.71  |- mesh__dateRevised mesh__D012892 2000-06-22
% 224.55/224.71  |- skos__scopeNote mesh__D012892
% 224.55/224.71       The state of being deprived of sleep under experimental conditions, due to life events, or from a wide variety of pathophysiologic causes such as medication effect, chronic illness, psychiatric illness, or sleep disorder.%A%    
% 224.55/224.71  |- skos__hiddenLabel mesh__D012892 Sleep Deprivation, REM
% 224.55/224.71  |- mesh__dateRevised mesh__D012094 1997-06-20
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012094 2006
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012094 2002
% 224.55/224.71  |- skos__hiddenLabel mesh__D012094 Memory, Delayed
% 224.55/224.71  |- skos__prefLabel mesh__D012094 Repression
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012094 2004
% 224.55/224.71  |- mesh__recordOriginator mesh__D012094 NLM
% 224.55/224.71  |- skos__hiddenLabel mesh__D012094 Memory, Repressed
% 224.55/224.71  |- skos__hiddenLabel mesh__D012094 Delayed Memories
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012094 2005
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012094 1999
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012094 2003
% 224.55/224.71  |- mesh__recordMaintainer mesh__D012094 JLS
% 224.55/224.71  |- skos__annotation mesh__D012094 no qualif   
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012094 1998
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012094 2001
% 224.55/224.71  |- skos__hiddenLabel mesh__D012094 Memories, Repressed
% 224.55/224.71  |- skos__hiddenLabel mesh__D012094 Memory Syndrome, False
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012094 2000
% 224.55/224.71  |- mesh__dateCreated mesh__D012094 1999-01-01
% 224.55/224.71  |- skos__hiddenLabel mesh__D012094 False Memory Syndromes
% 224.55/224.71  |- rdf__type mesh__D012094sskos__Concept
% 224.55/224.71  |- skos__hiddenLabel mesh__D012094 Memories, Delayed
% 224.55/224.71  |- mesh__recordAuthorizer mesh__D012094 SJN
% 224.55/224.71  |- skos__scopeNote mesh__D012094
% 224.55/224.71       The active mental process of keeping out and ejecting, banishing from consciousness, ideas or impulses that are unacceptable to it.%A%    
% 224.55/224.71  |- skos__broader mesh__D012094smesh__D003674
% 224.55/224.71  |- skos__hiddenLabel mesh__D012094 Syndrome, False Memory
% 224.55/224.71  |- skos__hiddenLabel mesh__D020526 Brain Stem Infarction
% 224.55/224.71  |- skos__hiddenLabel mesh__D020526 Stroke, Brainstem
% 224.55/224.71  |- mesh__recordMaintainer mesh__D020526 ssb
% 224.55/224.71  |- skos__historyNote mesh__D020526 Infarction %28%1971-1999%29%
% 224.55/224.71  |- mesh__dateRevised mesh__D020526 2005-06-30
% 224.55/224.71  |- mesh__historyNote mesh__D020526 2000   
% 224.55/224.71  |- skos__altLabel mesh__D020526 Brainstem Stroke
% 224.55/224.71  |- skos__scopeNote mesh__D020526
% 224.55/224.71       Infarctions that occur in the brain stem which is comprised of the midbrain, pons, and medulla. There are several named syndromes characterized by their distinctive clinical manifestations and specific sites of ischemic injury.%A%    
% 224.55/224.71  |- skos__historyNote mesh__D020526
% 224.55/224.71       Cerebrovascular Disorders %28%1971-1999%29%
% 224.55/224.71  |- skos__historyNote mesh__D020526
% 224.55/224.71       Brain Stem/blood supply %28%1975-1999%29%
% 224.55/224.71  |- skos__hiddenLabel mesh__D020526 Infarction, Brainstem
% 224.55/224.71  |- skos__prefLabel mesh__D020526 Brain Stem Infarctions
% 224.55/224.71  |- skos__hiddenLabel mesh__D020526 Millard Gublar Syndrome
% 224.55/224.71  |- mesh__recordOriginator mesh__D020526 KEV
% 224.55/224.71  |- skos__hiddenLabel mesh__D020526 Syndrome, Millard-Gublar
% 224.55/224.71  |- mesh__dateCreated mesh__D020526 1999-11-03
% 224.55/224.71  |- skos__hiddenLabel mesh__D020526 Brainstem Infarction
% 224.55/224.71  |- skos__altLabel mesh__D020526 Brainstem Infarctions
% 224.55/224.71  |- mesh__recordAuthorizer mesh__D020526 sjn
% 224.55/224.71  |- skos__hiddenLabel mesh__D020526 Infarction, Brain Stem
% 224.55/224.71  |- rdf__type mesh__D020526sskos__Concept
% 224.55/224.71  |- skos__altLabel mesh__D020526 Infarctions, Brain Stem
% 224.55/224.71  |- skos__broader mesh__D020526smesh__D020520
% 224.55/224.71  |- mesh__dateEstablished mesh__D020526 2000-01-01
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D020526 2006
% 224.55/224.71  |- skos__altLabel mesh__D020526 Infarctions, Brainstem
% 224.55/224.71  |- skos__related mesh__D020526smesh__D007238
% 224.55/224.71  |- skos__annotation mesh__D020526 DF: BRAINSTEM INFARCT   
% 224.55/224.71  |- mesh__publicMeSHNote mesh__D020526 2000   
% 224.55/224.71  |- rdf__type mesh__D006057sskos__Concept
% 224.55/224.71  |- mesh__dateEstablished mesh__D006057 1991-01-01
% 224.55/224.71  |- skos__scopeNote mesh__D006057
% 224.55/224.71       Thin capsules enveloping end nerve fibrils in the subcutaneous tissue of fingers.%A%    
% 224.55/224.71  |- skos__broader mesh__D006057smesh__D008465
% 224.55/224.71  |- mesh__recordAuthorizer mesh__D006057 sjn
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D006057 2004
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D006057 2005
% 224.55/224.71  |- mesh__recordOriginator mesh__D006057 NLM
% 224.55/224.71  |- mesh__historyNote mesh__D006057
% 224.55/224.71       91%28%75%29%; was see under MECHANORECEPTORS 1972-90; was see under NERVE ENDINGS 1963-71%A%  
% 224.55/224.71  |- mesh__publicMeSHNote mesh__D006057
% 224.55/224.71       91; was see under MECHANORECEPTORS 1972-90; was see under NERVE ENDINGS 1963-71%A%  
% 224.55/224.71  |- skos__hiddenLabel mesh__D006057 Corpuscles, Golgi-Mazzoni
% 224.55/224.71  |- skos__prefLabel mesh__D006057 Golgi-Mazzoni Corpuscles
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D006057 2006
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D006057 2000
% 224.55/224.71  |- mesh__onlineNote mesh__D006057
% 224.55/224.71       search MECHANORECEPTORS 1972-74 %26% NERVE ENDINGS 1966-71   
% 224.55/224.71  |- mesh__dateRevised mesh__D006057 1999-11-03
% 224.55/224.71  |- mesh__recordMaintainer mesh__D006057 KEV
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D006057 2001
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D006057 2002
% 224.55/224.71  |- mesh__dateCreated mesh__D006057 1999-01-01
% 224.55/224.71  |- skos__hiddenLabel mesh__D006057 Golgi Mazzoni Corpuscles
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D006057 2003
% 224.55/224.71  |- skos__historyNote mesh__D016485 Needles %28%1985-1991%29%
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D016485 2000
% 224.55/224.71  |- rdf__type mesh__D016485sskos__Concept
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D016485 2003
% 224.55/224.71  |- mesh__recordMaintainer mesh__D016485 JLS
% 224.55/224.71  |- mesh__historyNote mesh__D016485 92   
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D016485 1999
% 224.55/224.71  |- mesh__publicMeSHNote mesh__D016485 92   
% 224.55/224.71  |- skos__scopeNote mesh__D016485
% 224.55/224.71       Usage of a single needle among two or more people for injecting drugs. Needle sharing is a high-risk behavior for contracting infectious disease.%A%    
% 224.55/224.71  |- skos__prefLabel mesh__D016485 Needle Sharing
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D016485 2002
% 224.55/224.71  |- mesh__dateRevised mesh__D016485 1994-05-23
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D016485 1998
% 224.55/224.71  |- skos__hiddenLabel mesh__D016485 Sharing, Syringe
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D016485 1997
% 224.55/224.71  |- skos__historyNote mesh__D016485 Syringes %28%1985-1991%29%
% 224.55/224.71  |- mesh__dateEstablished mesh__D016485 1992-01-01
% 224.55/224.71  |- skos__broader mesh__D016485smesh__D012940
% 224.55/224.71  |- skos__historyNote mesh__D016485 Substance Abuse %28%1985-1991%29%
% 224.55/224.71  |- mesh__recordAuthorizer mesh__D016485 PLS
% 224.55/224.71  |- mesh__dateCreated mesh__D016485 1991-01-03
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D016485 1996
% 224.55/224.71  |- skos__hiddenLabel mesh__D016485 Sharing, Needle
% 224.55/224.71  |- mesh__recordOriginator mesh__D016485 AGS
% 224.55/224.71  |- skos__altLabel mesh__D016485 Syringe Sharing
% 224.55/224.71  |- skos__altLabel mesh__D016485 Needlesharing
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D016485 2006
% 224.55/224.71  |- skos__altLabel mesh__D016485 Needle-Sharing
% 224.55/224.71  |- skos__annotation mesh__D016485 by intravenous drug users   
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D016485 2001
% 224.55/224.71  |- skos__related mesh__D016485smesh__D018671
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D016485 1995
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D016485 2005
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D016485 2004
% 224.55/224.71  |- mesh__dateEstablished mesh__D002465 1970-01-01
% 224.55/224.71  |- skos__scopeNote mesh__D002465
% 224.55/224.71       The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell.%A%    
% 224.55/224.71  |- skos__annotation mesh__D002465
% 224.55/224.71       not for microorganisms; do not confuse with CYTOKINESIS or CYTOPLASMIC STREAMING%A%  
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D002465 2005
% 224.55/224.71  |- mesh__recordOriginator mesh__D002465 NLM
% 224.55/224.71  |- mesh__publicMeSHNote mesh__D002465 70   
% 224.55/224.71  |- mesh__dateRevised mesh__D002465 2004-08-06
% 224.55/224.71  |- skos__hiddenLabel mesh__D002465 Cell Migration
% 224.55/224.71  |- skos__hiddenLabel mesh__D002465 Cell Locomotion
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D002465 2005A
% 224.55/224.71  |- skos__hiddenLabel mesh__D002465 Movements, Cell
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D002465 2006
% 224.55/224.71  |- skos__prefLabel mesh__D002465 Cell Movement
% 224.55/224.71  |- skos__historyNote mesh__D002465 Cytology %28%1966-1967%29%
% 224.55/224.71  |- mesh__dateCreated mesh__D002465 1999-01-01
% 224.55/224.71  |- skos__altLabel mesh__D002465 Movement, Cell
% 224.55/224.71  |- skos__hiddenLabel mesh__D002465 Cell Motility
% 224.55/224.71  |- skos__hiddenLabel mesh__D002465 Cell Movements
% 224.55/224.71  |- mesh__historyNote mesh__D002465 70%28%68%29%   
% 224.55/224.71  |- skos__broader mesh__D002465smesh__D002468
% 224.55/224.71  |- mesh__recordAuthorizer mesh__D002465 jls
% 224.55/224.71  |- rdf__type mesh__D002465sskos__Concept
% 224.55/224.71  |- skos__historyNote mesh__D002465
% 224.55/224.71       specific cell or tissue/cytology %28%1966-1967%29%
% 224.55/224.71  |- mesh__recordMaintainer mesh__D002465 jls
% 224.55/224.71  |- skos__altLabel mesh__D002465 Motility, Cell
% 224.55/224.71  |- skos__prefLabel mesh__D029602 Phytolaccaceae
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D029602 2005
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D029602 2004
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D029602 2006
% 224.55/224.71  |- rdf__type mesh__D029602sskos__Concept
% 224.55/224.71  |- mesh__recordAuthorizer mesh__D029602 sjn
% 224.55/224.71  |- mesh__dateRevised mesh__D029602 2003-07-09
% 224.55/224.71  |- skos__scopeNote mesh__D029602
% 224.55/224.71       The pokeweed plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. The leaves are alternate, simple and smooth-edged and the flowers are in spikes or panicles and are usually bisexual.%A%    
% 224.55/224.71  |- mesh__publicMeSHNote mesh__D029602 2002   
% 224.55/224.71  |- mesh__recordMaintainer mesh__D029602 ssb
% 224.55/224.71  |- mesh__recordOriginator mesh__D029602 ssb
% 224.55/224.71  |- mesh__historyNote mesh__D029602 2002   
% 224.55/224.71  |- mesh__dateCreated mesh__D029602 2001-07-25
% 224.55/224.71  |- mesh__dateEstablished mesh__D029602 2002-01-01
% 224.55/224.71  |- skos__broader mesh__D029602smesh__D019684
% 224.55/224.71  |- skos__annotation mesh__D029602
% 224.55/224.71       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.55/224.71  |- skos__hiddenLabel mesh__D007150 Immunogold Technic
% 224.55/224.71  |- skos__hiddenLabel mesh__D007150 Technic, Immunolabeling
% 224.55/224.71  |- skos__hiddenLabel mesh__D007150 Immunogold-Silver Technique
% 224.55/224.71  |- skos__broader mesh__D007150smesh__D007120
% 224.55/224.71  |- mesh__recordAuthorizer mesh__D007150 sjn
% 224.55/224.71  |- skos__hiddenLabel mesh__D007150 Immunogold Technique
% 224.55/224.71  |- skos__hiddenLabel mesh__D007150 Technics, Immunogold-Silver
% 224.55/224.71  |- rdf__type mesh__D007150sskos__Concept
% 224.55/224.71  |- skos__altLabel mesh__D007150 Immunogold-Silver Technics
% 224.55/224.71  |- mesh__dateCreated mesh__D007150 1987-05-08
% 224.55/224.71  |- skos__hiddenLabel mesh__D007150 Techniques, Immunogold
% 224.55/224.71  |- skos__annotation mesh__D007150
% 224.55/224.71       GEN; avoid as coord; SPEC qualif when IM; no qualif when NIM; immunohistochem of disease is disease /diag or /metab%A%  
% 224.55/224.71  |- skos__hiddenLabel mesh__D007150 Technic, Immunogold-Silver
% 224.55/224.71  |- skos__hiddenLabel mesh__D007150 Immunogold Silver Techniques
% 224.55/224.71  |- skos__hiddenLabel mesh__D007150 Immunogold Silver Technics
% 224.55/224.71  |- skos__prefLabel mesh__D007150 Immunohistochemistry
% 224.55/224.71  |- skos__altLabel mesh__D007150 Immunolabeling Technics
% 224.55/224.71  |- skos__hiddenLabel mesh__D007150 Technics, Immunogold
% 224.55/224.71  |- skos__hiddenLabel mesh__D007150 Technic, Immunogold
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D007150 2006
% 224.55/224.71  |- skos__scopeNote mesh__D007150
% 224.55/224.71       Histochemical localization of immunoreactive substances using labeled antibodies as reagents.%A%    
% 224.55/224.71  |- skos__hiddenLabel mesh__D007150 Immunolabeling Technique
% 224.55/224.71  |- skos__altLabel mesh__D007150 Immunogold Technics
% 224.55/224.71  |- skos__historyNote mesh__D007150 Antibodies, Monoclonal %28%1982-1987%29%
% 224.55/224.71  |- mesh__recordMaintainer mesh__D007150 jls
% 224.55/224.71  |- skos__hiddenLabel mesh__D007150 Technique, Immunolabeling
% 224.55/224.71  |- skos__hiddenLabel mesh__D007150 Techniques, Immunogold-Silver
% 224.55/224.71  |- skos__broader mesh__D007150smesh__D007158
% 224.55/224.71  |- mesh__recordOriginator mesh__D007150 SCD
% 224.55/224.71  |- skos__hiddenLabel mesh__D007150 Technique, Immunogold
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D007150 2005
% 224.55/224.71  |- skos__hiddenLabel mesh__D007150 Immunogold-Silver Technic
% 224.55/224.71  |- skos__hiddenLabel mesh__D007150 Technique, Immunogold-Silver
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D007150 2004
% 224.55/224.71  |- skos__historyNote mesh__D007150
% 224.55/224.71       Fluorescent Antibody Technique %28%1966-1987%29%
% 224.55/224.71  |- mesh__publicMeSHNote mesh__D007150 88   
% 224.55/224.71  |- skos__hiddenLabel mesh__D007150 Technics, Immunolabeling
% 224.55/224.71  |- mesh__dateEstablished mesh__D007150 1988-01-01
% 224.55/224.71  |- skos__broader mesh__D007150smesh__D006651
% 224.55/224.71  |- mesh__historyNote mesh__D007150 88   
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D007150 2002
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D007150 2003
% 224.55/224.71  |- mesh__dateRevised mesh__D007150 2001-07-25
% 224.55/224.71  |- skos__historyNote mesh__D007150
% 224.55/224.71       Immunoenzyme Techniques %28%1977-1987%29%
% 224.55/224.71  |- skos__hiddenLabel mesh__D007150 Techniques, Immunolabeling
% 224.55/224.71  |- skos__hiddenLabel mesh__D007150 Immunolabeling Technic
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012893 2006
% 224.55/224.71  |- skos__broader mesh__D012893smesh__D009461
% 224.55/224.71  |- skos__hiddenLabel mesh__D012893 Neurogenic Tachypneas, Sleep-Related
% 224.55/224.71  |- skos__scopeNote mesh__D012893
% 224.55/224.71       Conditions characterized by disturbances of usual sleep patterns or behaviors. Sleep disorders may be divided into three major categories: DYSSOMNIAS %28%i.e. disorders characterized by insomnia or hypersomnia%29%, PARASOMNIAS %28%abnormal sleep behaviors%29%, and sleep disorders secondary to medical or psychiatric disorders. %28%From Thorpy, Sleep Disorders Medicine, 1994, p187%29%%A%    
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012893 2001
% 224.55/224.71  |- skos__hiddenLabel mesh__D012893 Sleeper Syndrome, Short
% 224.55/224.71  |- mesh__recordOriginator mesh__D012893 NLM
% 224.55/224.71  |- mesh__recordAuthorizer mesh__D012893 sjn
% 224.55/224.71  |- skos__hiddenLabel mesh__D012893 Sleeper Syndromes, Long
% 224.55/224.71  |- skos__hiddenLabel mesh__D012893 Syndrome, Subwakefullness
% 224.55/224.71  |- skos__hiddenLabel mesh__D012893 Syndrome, Short Sleeper
% 224.55/224.71  |- skos__hiddenLabel mesh__D012893 Sleep-Related Neurogenic Tachypneas
% 224.55/224.71  |- mesh__recordMaintainer mesh__D012893 KEV
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012893 2005
% 224.55/224.71  |- skos__hiddenLabel mesh__D012893 Syndromes, Short Sleeper
% 224.55/224.71  |- mesh__dateCreated mesh__D012893 1999-01-01
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012893 2000
% 224.55/224.71  |- mesh__dateRevised mesh__D012893 1999-11-03
% 224.55/224.71  |- skos__broader mesh__D012893smesh__D009422
% 224.55/224.71  |- skos__hiddenLabel mesh__D012893 Syndromes, Subwakefullness
% 224.55/224.71  |- skos__hiddenLabel mesh__D012893 Syndromes, Long Sleeper
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012893 2004
% 224.55/224.71  |- skos__hiddenLabel mesh__D012893 Tachypneas, Sleep-Related Neurogenic
% 224.55/224.71  |- skos__hiddenLabel mesh__D012893 Sleep Related Neurogenic Tachypnea
% 224.55/224.71  |- skos__hiddenLabel mesh__D012893 Short Sleeper Syndromes
% 224.55/224.71  |- rdf__type mesh__D012893sskos__Concept
% 224.55/224.71  |- skos__prefLabel mesh__D012893 Sleep Disorders
% 224.55/224.71  |- skos__hiddenLabel mesh__D012893 Sleeper Syndrome, Long
% 224.55/224.71  |- skos__hiddenLabel mesh__D012893 Tachypnea, Sleep-Related Neurogenic
% 224.55/224.71  |- skos__hiddenLabel mesh__D012893 Sleeper Syndromes, Short
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012893 2003
% 224.55/224.71  |- skos__broader mesh__D012893smesh__D001523
% 224.55/224.71  |- skos__hiddenLabel mesh__D012893 Syndrome, Long Sleeper
% 224.55/224.71  |- skos__hiddenLabel mesh__D012893 Long Sleeper Syndromes
% 224.55/224.71  |- skos__hiddenLabel mesh__D012893 Subwakefullness Syndromes
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012893 2002
% 224.55/224.71  |- skos__hiddenLabel mesh__D012893 Neurogenic Tachypnea, Sleep-Related
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012095 2000
% 224.55/224.71  |- mesh__activeMeSHYear mesh__D012095 1998
% 224.55/224.71  |- skos__historyNote mesh__D012095 Repression %28%1966-1970%29%
% 224.55/224.71  |- mesh__recordAuthorizer mesh__D012095 SJN
% 224.55/224.71  |- skos__hiddenLabel mesh__D012095 Scales, Repression-Sensitization
% 224.55/224.71  |- skos__annotation mesh__D012095 no qualif   
% 224.55/224.71  |- mesh__dateCreated mesh__D012095 1999-01-01
% 224.55/224.71  |- rdf__type mesh__D012095sskos__Concept
% 224.55/224.71  |- skos__prefLabel mesh__D012095 Repression-Sensitization
% 224.55/224.71  |- skos__hiddenLabel mesh__D012095 Repression Sensitization Scales
% 224.55/224.72  |- mesh__dateRevised mesh__D012095 1997-06-20
% 224.55/224.72  |- mesh__historyNote mesh__D012095
% 224.55/224.72       73%28%71%29%; REPRESSION-SENSITIZATION SCALES was heading 1975-96 %28%see under REPRESSION-SENSITIZATION 1975-90%29%%A%  
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D012095 2002
% 224.55/224.72  |- mesh__publicMeSHNote mesh__D012095
% 224.55/224.72       73; REPRESSION-SENSITIZATION SCALES was heading 1975-96 %28%see under REPRESSION-SENSITIZATION 1975-90%29%%A%  
% 224.55/224.72  |- skos__hiddenLabel mesh__D012095 Repression-Sensitization Scale
% 224.55/224.72  |- skos__hiddenLabel mesh__D012095 Repression Sensitization
% 224.55/224.72  |- mesh__recordOriginator mesh__D012095 NLM
% 224.55/224.72  |- mesh__recordMaintainer mesh__D012095 JLS
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D012095 2006
% 224.55/224.72  |- mesh__dateEstablished mesh__D012095 1973-01-01
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D012095 2004
% 224.55/224.72  |- skos__broader mesh__D012095smesh__D012094
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D012095 2005
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D012095 1999
% 224.55/224.72  |- skos__scopeNote mesh__D012095
% 224.55/224.72       Defense mechanisms involving approach and avoidance responses to threatening stimuli. The sensitizing process involves intellectualization in approaching or controlling the stimulus whereas repression involves unconscious denial in avoiding the stimulus.%A%    
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D012095 2001
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D012095 2003
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D006856 2003D
% 224.55/224.72  |- skos__prefLabel mesh__D006856 Hydrogen Cyanide
% 224.55/224.72  |- mesh__dateCreated mesh__D006856 1999-01-01
% 224.55/224.72  |- skos__broader mesh__D006856smesh__D017672
% 224.55/224.72  |- mesh__historyNote mesh__D006856
% 224.55/224.72       94; was HYDROCYANIC ACID 1963-93; HYDROGEN CYANIDE was see HYDROCYANIC ACID 1978-93%A%  
% 224.55/224.72  |- mesh__onlineNote mesh__D006856
% 224.55/224.72       use HYDROGEN CYANIDE to search HYDROCYANIC ACID 1978-93   
% 224.55/224.72  |- skos__broader mesh__D006856smesh__D000148
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D006856 2003A
% 224.55/224.72  |- mesh__publicMeSHNote mesh__D006856
% 224.55/224.72       94; was HYDROCYANIC ACID 1963-93; HYDROGEN CYANIDE was see HYDROCYANIC ACID 1978-93%A%  
% 224.55/224.72  |- rdf__type mesh__D006856sskos__Concept
% 224.55/224.72  |- mesh__recordOriginator mesh__D006856 NLM
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D006856 2003
% 224.55/224.72  |- skos__hiddenLabel mesh__D006856 Acid, Hydrocyanic
% 224.55/224.72  |- mesh__recordAuthorizer mesh__D006856 ags
% 224.55/224.72  |- skos__annotation mesh__D006856
% 224.55/224.72       toxic liquid or gas; /analogs = CYANIDES   
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D006856 2005
% 224.55/224.72  |- mesh__recordMaintainer mesh__D006856 ags
% 224.55/224.72  |- skos__scopeNote mesh__D006856
% 224.55/224.72       Hydrogen cyanide %28%HCN%29%; A toxic liquid or colorless gas. It is found in the smoke of various tobacco products and released by combustion of nitrogen-containing organic materials.%A%    
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D006856 2004
% 224.55/224.72  |- skos__hiddenLabel mesh__D006856 Cyanide, Hydrogen
% 224.55/224.72  |- skos__altLabel mesh__D006856 Hydrocyanic Acid
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D006856 2006
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D006856 2003C
% 224.55/224.72  |- mesh__dateRevised mesh__D006856 2003-03-21
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D006856 2003B
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D006856 2002
% 224.55/224.72  |- mesh__historyNote mesh__D020527
% 224.55/224.72       2000; use MICROSCOPY, ATOMIC FORCE 1999   
% 224.55/224.72  |- mesh__recordMaintainer mesh__D020527 nns
% 224.55/224.72  |- skos__altLabel mesh__D020527 Scanning Probe Microscopy
% 224.55/224.72  |- skos__historyNote mesh__D020527 Microscopy, Atomic Force %28%1999%29%
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D020527 2005
% 224.55/224.72  |- mesh__dateRevised mesh__D020527 2004-07-07
% 224.55/224.72  |- mesh__publicMeSHNote mesh__D020527
% 224.55/224.72       2000; see MICROSCOPY, ATOMIC FORCE 1999   
% 224.55/224.72  |- mesh__dateEstablished mesh__D020527 2000-01-01
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D020527 2006
% 224.55/224.72  |- rdf__type mesh__D020527sskos__Concept
% 224.55/224.72  |- skos__broader mesh__D020527smesh__D008853
% 224.55/224.72  |- skos__prefLabel mesh__D020527 Microscopy, Scanning Probe
% 224.55/224.72  |- mesh__dateCreated mesh__D020527 1999-11-03
% 224.55/224.72  |- skos__scopeNote mesh__D020527
% 224.55/224.72       Scanning microscopy in which a very sharp probe is employed in close proximity to a surface, exploiting a particular surface-related property. When this property is local topography, the method is atomic force microscopy %28%MICROSCOPY, ATOMIC FORCE%29%, and when it is local conductivity, the method is scanning tunneling microscopy %28%MICROSCOPY, SCANNING TUNNELING%29%.%A%    
% 224.55/224.72  |- mesh__recordOriginator mesh__D020527 ags
% 224.55/224.72  |- mesh__recordAuthorizer mesh__D020527 sjn
% 224.55/224.72  |- skos__scopeNote mesh__D006058
% 224.55/224.72       Pathological processes of the OVARIES or the TESTES.     
% 224.55/224.72  |- mesh__publicMeSHNote mesh__D006058 98   
% 224.55/224.72  |- skos__prefLabel mesh__D006058 Gonadal Disorders
% 224.55/224.72  |- skos__hiddenLabel mesh__D006058 Gonadal Disorder
% 224.55/224.72  |- rdf__type mesh__D006058sskos__Concept
% 224.55/224.72  |- mesh__recordMaintainer mesh__D006058 lkt
% 224.55/224.72  |- mesh__dateEstablished mesh__D006058 1998-01-01
% 224.55/224.72  |- mesh__dateRevised mesh__D006058 2005-06-30
% 224.55/224.72  |- skos__broader mesh__D006058smesh__D004700
% 224.55/224.72  |- skos__annotation mesh__D006058
% 224.55/224.72       general or unspecified; prefer specifics; DF: GONADAL DIS%A%  
% 224.55/224.72  |- skos__hiddenLabel mesh__D006058 Disorders, Gonadal
% 224.55/224.72  |- mesh__recordAuthorizer mesh__D006058 sjn
% 224.55/224.72  |- mesh__dateCreated mesh__D006058 1999-01-01
% 224.55/224.72  |- mesh__recordOriginator mesh__D006058 NLM
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D006058 2006
% 224.55/224.72  |- mesh__historyNote mesh__D006058 98; use explode 1975-97   
% 224.55/224.72  |- skos__hiddenLabel mesh__D006058 Disorder, Gonadal
% 224.55/224.72  |- skos__hiddenLabel mesh__D002466 Nucleolus, Cell
% 224.55/224.72  |- mesh__recordAuthorizer mesh__D002466 sjn
% 224.55/224.72  |- mesh__dateEstablished mesh__D002466 1967-01-01
% 224.55/224.72  |- rdf__type mesh__D002466sskos__Concept
% 224.55/224.72  |- skos__prefLabel mesh__D002466 Cell Nucleolus
% 224.55/224.72  |- mesh__publicMeSHNote mesh__D002466 67   
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D002466 2004
% 224.55/224.72  |- mesh__historyNote mesh__D002466 67%28%65%29%   
% 224.55/224.72  |- skos__related mesh__D002466smesh__D009697
% 224.55/224.72  |- skos__scopeNote mesh__D002466
% 224.55/224.72       Within most types of eukaryotic CELL NUCLEUS, a distinct region, not delimited by a membrane, in which some species of rRNA %28%RNA, RIBOSOMAL%29% are synthesized and assembled into ribonucleoprotein subunits of ribosomes. In the nucleolus rRNA is transcribed from a nucleolar organizer, i.e., a group of tandemly repeated chromosomal genes which encode rRNA and which are transcribed by RNA polymerase I. %28%Singleton %26% Sainsbury, Dictionary of Microbiology %26% Molecular Biology, 2d ed%29%%A%    
% 224.55/224.72  |- skos__hiddenLabel mesh__D002466 Nucleoli, Cell
% 224.55/224.72  |- skos__altLabel mesh__D002466 Plasmosome
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D002466 2006
% 224.55/224.72  |- mesh__recordOriginator mesh__D002466 NLM
% 224.55/224.72  |- mesh__dateRevised mesh__D002466 2003-07-09
% 224.55/224.72  |- mesh__dateCreated mesh__D002466 1999-01-01
% 224.55/224.72  |- skos__broader mesh__D002466smesh__D042581
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D002466 2005
% 224.55/224.72  |- mesh__recordMaintainer mesh__D002466 nns
% 224.55/224.72  |- skos__altLabel mesh__D002466 Cell Nucleoli
% 224.55/224.72  |- skos__annotation mesh__D002466
% 224.55/224.72       A 11 qualif except /cytol; /genet permitted   
% 224.55/224.72  |- skos__hiddenLabel mesh__D002466 Plasmosomes
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D029603 2004
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D029603 2006
% 224.55/224.72  |- rdf__type mesh__D029603sskos__Concept
% 224.55/224.72  |- skos__scopeNote mesh__D029603
% 224.55/224.72       A plant genus of the family PHYTOLACCACEAE, order Caryophyllales.%A%    
% 224.55/224.72  |- skos__broader mesh__D029603smesh__D029602
% 224.55/224.72  |- mesh__publicMeSHNote mesh__D029603 2002   
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D029603 2002
% 224.55/224.72  |- mesh__dateEstablished mesh__D029603 2002-01-01
% 224.55/224.72  |- skos__annotation mesh__D029603
% 224.55/224.72       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.55/224.72  |- skos__prefLabel mesh__D029603 Phytolacca
% 224.55/224.72  |- mesh__historyNote mesh__D029603 2002   
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D029603 2003
% 224.55/224.72  |- mesh__dateCreated mesh__D029603 2001-07-25
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D029603 2005
% 224.55/224.72  |- mesh__publicMeSHNote mesh__D048568 2005   
% 224.55/224.72  |- mesh__historyNote mesh__D048568 2005   
% 224.55/224.72  |- skos__annotation mesh__D048568
% 224.55/224.72       infection: coordinate IM with BOTULISM %28%IM%29%   
% 224.55/224.72  |- skos__altLabel mesh__D048568 Clostridium botulinum G
% 224.55/224.72  |- skos__broader mesh__D048568smesh__D003014
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D048568 2006
% 224.55/224.72  |- skos__scopeNote mesh__D048568
% 224.55/224.72       Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type G. Though it has been isolated from soil, no outbreaks involving this type have been recognized.%A%    
% 224.55/224.72  |- mesh__recordOriginator mesh__D048568 ags
% 224.55/224.72  |- skos__prefLabel mesh__D048568 Clostridium botulinum type G
% 224.55/224.72  |- rdf__type mesh__D048568sskos__Concept
% 224.55/224.72  |- mesh__dateCreated mesh__D048568 2004-07-07
% 224.55/224.72  |- skos__historyNote mesh__D048568 Clostridium botulinum %28%1972-2004%29%
% 224.55/224.72  |- mesh__recordAuthorizer mesh__D048568 sjn
% 224.55/224.72  |- mesh__recordMaintainer mesh__D048568 SYSTEM
% 224.55/224.72  |- mesh__dateRevised mesh__D048568 2005-06-30
% 224.55/224.72  |- mesh__dateEstablished mesh__D048568 2005-01-01
% 224.55/224.72  |- skos__hiddenLabel mesh__D012894 Sleep Stage
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D012894 1996
% 224.55/224.72  |- skos__historyNote mesh__D012894 Sleep %28%1966-1968%29%
% 224.55/224.72  |- mesh__publicMeSHNote mesh__D012894 72   
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D012894 1995
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D012894 2005
% 224.55/224.72  |- mesh__historyNote mesh__D012894 72%28%69%29%   
% 224.55/224.72  |- mesh__recordMaintainer mesh__D012894 TGC
% 224.55/224.72  |- mesh__dateEstablished mesh__D012894 1972-01-01
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D012894 2002
% 224.55/224.72  |- mesh__dateCreated mesh__D012894 1999-01-01
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D012894 1994
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D012894 2004
% 224.55/224.72  |- skos__broader mesh__D012894smesh__D012890
% 224.55/224.72  |- skos__hiddenLabel mesh__D012894 Lethargies
% 224.55/224.72  |- rdf__type mesh__D012894sskos__Concept
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D012894 2001
% 224.55/224.72  |- mesh__recordOriginator mesh__D012894 NLM
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D012894 1999
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D012894 1993
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D012894 2003
% 224.55/224.72  |- skos__hiddenLabel mesh__D012894 Drowsinesses
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D012894 2000
% 224.55/224.72  |- skos__hiddenLabel mesh__D012894 Stages, Sleep
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D012894 1998
% 224.55/224.72  |- mesh__recordAuthorizer mesh__D012894 PLS
% 224.55/224.72  |- mesh__dateRevised mesh__D012894 1992-05-18
% 224.55/224.72  |- skos__prefLabel mesh__D012894 Sleep Stages
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D012894 1997
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D012894 2006
% 224.55/224.72  |- skos__scopeNote mesh__D012894
% 224.55/224.72       Periods of sleep manifested by changes in EEG activity and certain behavioral correlates; includes Stage 1: sleep onset, drowsy sleep; Stage 2: light sleep; Stages 3 and 4: delta sleep, light sleep, deep sleep, telencephalic sleep.%A%    
% 224.55/224.72  |- skos__hiddenLabel mesh__D012894 Stage, Sleep
% 224.55/224.72  |- mesh__dateCreated mesh__D006857 1999-01-01
% 224.55/224.72  |- skos__broader mesh__D006857smesh__D001581
% 224.55/224.72  |- mesh__dateRevised mesh__D006857 2005-06-30
% 224.55/224.72  |- mesh__recordAuthorizer mesh__D006857 sjn
% 224.55/224.72  |- mesh__recordOriginator mesh__D006857 NLM
% 224.55/224.72  |- rdf__type mesh__D006857sskos__Concept
% 224.55/224.72  |- mesh__recordMaintainer mesh__D006857 ssb
% 224.55/224.72  |- skos__altLabel mesh__D006857 Trifluoromethylhydrothiazide
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D006857 2006
% 224.55/224.72  |- skos__prefLabel mesh__D006857 Hydroflumethiazide
% 224.55/224.72  |- skos__scopeNote mesh__D006857
% 224.55/224.72       A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p822%29%%A%    
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D020528 2005
% 224.55/224.72  |- skos__altLabel mesh__D020528 Primary Progressive Multiple Sclerosis
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D020528 2004
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D020528 2002
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D020528 2006
% 224.55/224.72  |- rdf__type mesh__D020528sskos__Concept
% 224.55/224.72  |- skos__altLabel mesh__D020528 Chronic Progressive Multiple Sclerosis
% 224.55/224.72  |- mesh__recordAuthorizer mesh__D020528 sjn
% 224.55/224.72  |- mesh__recordMaintainer mesh__D020528 nns
% 224.55/224.72  |- mesh__dateEstablished mesh__D020528 2000-01-01
% 224.55/224.72  |- skos__annotation mesh__D020528 DF: MS CHRONIC PROGRESSIVE   
% 224.55/224.72  |- skos__historyNote mesh__D020528 Multiple Sclerosis %28%1973-1999%29%
% 224.55/224.72  |- skos__scopeNote mesh__D020528
% 224.55/224.72       A form of multiple sclerosis characterized by a progressive deterioration in neurologic function which is in contrast to the more typical relapsing remitting form. If the clinical course is free of distinct remissions, it is referred to as primary progressive multiple sclerosis. When the progressive decline is punctuated by acute exacerbations, it is referred to as progressive relapsing multiple sclerosis. The term secondary progressive multiple sclerosis is used when relapsing remitting multiple sclerosis evolves into the chronic progressive form. %28%From Ann Neurol 1994;36 Suppl:S73-S79; Adams et al., Principles of Neurology, 6th ed, pp903-914%29%%A%    
% 224.55/224.72  |- mesh__historyNote mesh__D020528 2000   
% 224.55/224.72  |- skos__altLabel mesh__D020528 Remittent Progressive Multiple Sclerosis
% 224.55/224.72  |- mesh__publicMeSHNote mesh__D020528 2000   
% 224.55/224.72  |- mesh__dateRevised mesh__D020528 2001-07-25
% 224.55/224.72  |- skos__prefLabel mesh__D020528 Multiple Sclerosis, Chronic Progressive
% 224.55/224.72  |- skos__broader mesh__D020528smesh__D009103
% 224.55/224.72  |- skos__altLabel mesh__D020528 Secondary Progressive Multiple Sclerosis
% 224.55/224.72  |- skos__altLabel mesh__D020528 Multiple Sclerosis, Remittent Progressive
% 224.55/224.72  |- mesh__dateCreated mesh__D020528 1999-11-03
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D020528 2003
% 224.55/224.72  |- mesh__recordOriginator mesh__D020528 KEV
% 224.55/224.72  |- skos__altLabel mesh__D020528 Progressive Relapsing Multiple Sclerosis
% 224.55/224.72  |- mesh__publicMeSHNote mesh__D031250 2003   
% 224.55/224.72  |- mesh__dateEstablished mesh__D031250 2003-01-01
% 224.55/224.72  |- skos__altLabel mesh__D031250 Sweetpepperbush
% 224.55/224.72  |- mesh__historyNote mesh__D031250 2003   
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D031250 2006
% 224.55/224.72  |- skos__annotation mesh__D031250
% 224.55/224.72       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D031250 2005
% 224.55/224.72  |- skos__scopeNote mesh__D031250
% 224.55/224.72       A plant family of the order Ericales, subclass Dilleniidae, class Magnoliopsida.%A%    
% 224.55/224.72  |- skos__broader mesh__D031250smesh__D019684
% 224.55/224.72  |- mesh__dateCreated mesh__D031250 2002-07-03
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D031250 2004
% 224.55/224.72  |- skos__prefLabel mesh__D031250 Clethraceae
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D031250 2003
% 224.55/224.72  |- rdf__type mesh__D031250sskos__Concept
% 224.55/224.72  |- rdf__type mesh__D006059sskos__Concept
% 224.55/224.72  |- mesh__recordOriginator mesh__D006059 AEP
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D006059 2003
% 224.55/224.72  |- mesh__dateEstablished mesh__D006059 1980-01-01
% 224.55/224.72  |- mesh__historyNote mesh__D006059
% 224.55/224.72       80; was see TURNER%27%S SYNDROME 1967-79   
% 224.55/224.72  |- skos__scopeNote mesh__D006059
% 224.55/224.72       A number of syndromes with defective gonadal developments such as streak gonads and dysgenetic testes. The spectrum of gonadal and sexual abnormalities is reflected in their varied sex chromosome %28%SEX CHROMOSOMES%29% constitution as shown by the karyotypes of 45,X monosomy %28%TURNER SYNDROME%29%; 46,XX %28%GONADAL DYSGENESIS, 46XX%29%; 46,XY %28%GONADAL DYSGENESIS, 46,XY%29%;  and sex chromosome MOSAICISM; %28%GONADAL DYSGENESIS, MIXED%29%.  Their phenotypes range from female, through ambiguous, to male. This concept includes gonadal agenesis.%A%    
% 224.55/224.72  |- mesh__recordMaintainer mesh__D006059 ags
% 224.55/224.72  |- skos__historyNote mesh__D006059
% 224.55/224.72       Sex Differentiation Disorders %28%1966-1979%29%
% 224.55/224.72  |- mesh__dateCreated mesh__D006059 1978-12-21
% 224.55/224.72  |- mesh__dateRevised mesh__D006059 2005-07-20
% 224.55/224.72  |- skos__prefLabel mesh__D006059 Gonadal Dysgenesis
% 224.55/224.72  |- skos__broader mesh__D006059smesh__D012734
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D006059 2006A
% 224.55/224.72  |- skos__historyNote mesh__D006059 Turner Syndrome %28%1967-1979%29%
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D006059 2006
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D006059 2005
% 224.55/224.72  |- mesh__onlineNote mesh__D006059
% 224.55/224.72       use TURNER%27%S SYNDROME to search GONADAL DYSGENESIS 1967-79%A%  
% 224.55/224.72  |- mesh__publicMeSHNote mesh__D006059
% 224.55/224.72       80; was see TURNER%27%S SYNDROME 1967-79   
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D006059 2002
% 224.55/224.72  |- skos__hiddenLabel mesh__D006059 Dysgenesis, Gonadal
% 224.55/224.72  |- mesh__recordAuthorizer mesh__D006059 ags
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D006059 2004
% 224.55/224.72  |- skos__historyNote mesh__D016487 Parent-Child Relations %28%1970-1991%29%
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D016487 2002
% 224.55/224.72  |- mesh__dateCreated mesh__D016487 1991-01-03
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D016487 1996
% 224.55/224.72  |- mesh__recordMaintainer mesh__D016487 TAP
% 224.55/224.72  |- skos__broader mesh__D016487smesh__D005195
% 224.55/224.72  |- skos__historyNote mesh__D016487 Child Rearing %28%1970-1991%29%
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D016487 2006
% 224.55/224.72  |- mesh__recordAuthorizer mesh__D016487 PLS
% 224.55/224.72  |- skos__scopeNote mesh__D016487
% 224.55/224.72       Performing the role of a parent by care-giving, nurturance, and protection of the child by a natural or substitute parent. The parent supports the child by exercising authority and through consistent, empathic, appropriate behavior in response to the child%27%s needs. PARENTING differs from CHILD REARING in that in child rearing the emphasis is on the act of training or bringing up the children and the interaction between the parent and child, while parenting emphasizes the responsibility and qualities of exemplary behavior of the parent.%A%    
% 224.55/224.72  |- skos__prefLabel mesh__D016487 Parenting
% 224.55/224.72  |- mesh__dateRevised mesh__D016487 1992-05-15
% 224.55/224.72  |- mesh__recordOriginator mesh__D016487 TGC
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D016487 1995
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D016487 2005
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D016487 2004
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D016487 2001
% 224.55/224.72  |- rdf__type mesh__D016487sskos__Concept
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D016487 1993
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D016487 1994
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D016487 2003
% 224.55/224.72  |- skos__annotation mesh__D016487
% 224.55/224.72       differentiate from CHILD REARING which emphasizes the upbringing while PARENTING emphasizes the role of the parent: read MeSH definitions but if in doubt use term of author%A%  
% 224.55/224.72  |- mesh__historyNote mesh__D016487 92   
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D016487 1999
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D016487 2000
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D016487 1998
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D016487 1997
% 224.55/224.72  |- mesh__publicMeSHNote mesh__D016487 92   
% 224.55/224.72  |- mesh__dateEstablished mesh__D016487 1992-01-01
% 224.55/224.72  |- skos__related mesh__D016487smesh__D002668
% 224.55/224.72  |- skos__hiddenLabel mesh__D035641 Oscillation, Chest Wall
% 224.55/224.72  |- skos__altLabel mesh__D035641 High-Frequency Chest Compression
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D035641 2004
% 224.55/224.72  |- skos__historyNote mesh__D035641
% 224.55/224.72       Respiration, Artificial %28%1985-2002%29%
% 224.55/224.72  |- skos__hiddenLabel mesh__D035641 Chest Compressions, High-Frequency
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D035641 2003
% 224.55/224.72  |- skos__hiddenLabel mesh__D035641 Chest Wall Oscillations
% 224.55/224.72  |- skos__hiddenLabel mesh__D035641 High Frequency Chest Wall Compression
% 224.55/224.72  |- mesh__dateEstablished mesh__D035641 2003-01-01
% 224.55/224.72  |- rdf__type mesh__D035641sskos__Concept
% 224.55/224.72  |- skos__scopeNote mesh__D035641
% 224.55/224.72       A respiratory support system used to remove mucus and clear airway by oscillating pressure on the chest.%A%    
% 224.55/224.72  |- skos__hiddenLabel mesh__D035641 High Frequency Chest Wall Oscillation
% 224.55/224.72  |- skos__hiddenLabel mesh__D035641 Chest Compression, High-Frequency
% 224.55/224.72  |- skos__hiddenLabel mesh__D035641 High-Frequency Chest Compressions
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D035641 2006
% 224.55/224.72  |- skos__altLabel mesh__D035641 External Chest Wall Oscillation
% 224.55/224.72  |- mesh__dateCreated mesh__D035641 2002-07-03
% 224.55/224.72  |- mesh__historyNote mesh__D035641 2003   
% 224.55/224.72  |- skos__broader mesh__D035641smesh__D012138
% 224.55/224.72  |- skos__hiddenLabel mesh__D035641 High Frequency Chest Compression
% 224.55/224.72  |- skos__altLabel mesh__D035641 High-Frequency Chest Wall Compression
% 224.55/224.72  |- skos__prefLabel mesh__D035641 Chest Wall Oscillation
% 224.55/224.72  |- mesh__publicMeSHNote mesh__D035641 2003   
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D035641 2005
% 224.55/224.72  |- skos__related mesh__D002467smesh__D007620
% 224.55/224.72  |- skos__hiddenLabel mesh__D002467 Nuclei, Cell
% 224.55/224.72  |- skos__related mesh__D002467smesh__D002451
% 224.55/224.72  |- mesh__recordAuthorizer mesh__D002467 sjn
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D002467 2006
% 224.55/224.72  |- skos__broader mesh__D002467smesh__D015388
% 224.55/224.72  |- mesh__dateRevised mesh__D002467 2003-07-09
% 224.55/224.72  |- mesh__dateCreated mesh__D002467 1999-01-01
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D002467 2005
% 224.55/224.72  |- skos__broader mesh__D002467smesh__D042541
% 224.55/224.72  |- skos__annotation mesh__D002467
% 224.55/224.72       A 11 qualif except /cytol; /genet permitted   
% 224.55/224.72  |- mesh__recordOriginator mesh__D002467 NLM
% 224.55/224.72  |- skos__scopeNote mesh__D002467
% 224.55/224.72       Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli %28%CELL NUCLEOLUS%29%. The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. %28%From Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed%29%%A%    
% 224.55/224.72  |- skos__hiddenLabel mesh__D002467 Nucleus, Cell
% 224.55/224.72  |- skos__altLabel mesh__D002467 Cell Nuclei
% 224.55/224.72  |- skos__prefLabel mesh__D002467 Cell Nucleus
% 224.55/224.72  |- rdf__type mesh__D002467sskos__Concept
% 224.55/224.72  |- mesh__recordMaintainer mesh__D002467 nns
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D002467 2004
% 224.55/224.72  |- skos__altLabel mesh__D029604 Pokeweed
% 224.55/224.72  |- skos__scopeNote mesh__D029604
% 224.55/224.72       A plant species of the family PHYTOLACCACEAE. The root has been used in traditional medicine and contains POKEWEED MITOGENS, triterpene glycosides, and antiviral protein.%A%    
% 224.55/224.72  |- mesh__historyNote mesh__D029604 2002   
% 224.55/224.72  |- mesh__dateCreated mesh__D029604 2001-07-25
% 224.55/224.72  |- mesh__dateEstablished mesh__D029604 2002-01-01
% 224.55/224.72  |- skos__prefLabel mesh__D029604 Phytolacca americana
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D029604 2003
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D029604 2005
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D029604 2004
% 224.55/224.72  |- skos__broader mesh__D029604smesh__D029603
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D029604 2006
% 224.55/224.72  |- rdf__type mesh__D029604sskos__Concept
% 224.55/224.72  |- skos__annotation mesh__D029604
% 224.55/224.72       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D029604 2002
% 224.55/224.72  |- mesh__publicMeSHNote mesh__D029604 2002   
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D007950 2006
% 224.55/224.72  |- skos__altLabel mesh__D007950 Myeloid Leukemia, Acute, M2
% 224.55/224.72  |- mesh__dateRevised mesh__D007950 1995-06-08
% 224.55/224.72  |- skos__altLabel mesh__D007950 Leukemia, Myeloblastic, Acute
% 224.55/224.72  |- skos__hiddenLabel mesh__D007950 Leukemia, Acute Myelogenous
% 224.55/224.72  |- skos__hiddenLabel mesh__D007950 Leukemia, Acute Myeloblastic
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D007950 2001
% 224.55/224.72  |- skos__annotation mesh__D007950
% 224.55/224.72       GEN; note X refs for when specified as M1 or M2; for M3-M7 use MeSH see refs at LEUKEMIA, MYELOID, ACUTE, M3, etc., but when author uses term %22%acute myeloid leukemia%22% without specifying M1-M7, index under LEUKEMIA, MYELOID %28%IM%29% + ACUTE DISEASE %28%NIM%29%; do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D007950 1998
% 224.55/224.72  |- mesh__historyNote mesh__D007950
% 224.55/224.72       89; was LEUKEMIA, MYELOBLASTIC 1967-88   
% 224.55/224.72  |- skos__altLabel mesh__D007950 Myeloblastic Leukemia, Acute
% 224.55/224.72  |- skos__broader mesh__D007950smesh__D015470
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D007950 2005
% 224.55/224.72  |- skos__prefLabel mesh__D007950 Leukemia, Myelocytic, Acute
% 224.55/224.72  |- skos__altLabel mesh__D007950 Leukemia, Myeloid, Acute, M1
% 224.55/224.72  |- skos__hiddenLabel mesh__D007950 Leukemias, Acute Myelocytic
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D007950 2000
% 224.55/224.72  |- mesh__publicMeSHNote mesh__D007950
% 224.55/224.72       89; was LEUKEMIA, MYELOBLASTIC 1967-88   
% 224.55/224.72  |- skos__hiddenLabel mesh__D007950 Myelocytic Leukemias, Acute
% 224.55/224.72  |- skos__hiddenLabel mesh__D007950 Myelogenous Leukemias, Acute
% 224.55/224.72  |- mesh__dateCreated mesh__D007950 1999-01-01
% 224.55/224.72  |- skos__hiddenLabel mesh__D007950 Acute Myelogenous Leukemias
% 224.55/224.72  |- mesh__recordOriginator mesh__D007950 NLM
% 224.55/224.72  |- skos__scopeNote mesh__D007950
% 224.55/224.72       Progressive, malignant disease of the myeloid tissue in which the granular, polymorphonuclear leukocytes and their precursors predominate.%A%    
% 224.55/224.72  |- rdf__type mesh__D007950sskos__Concept
% 224.55/224.72  |- mesh__onlineNote mesh__D007950
% 224.55/224.72       use LEUKEMIA, MYELOCYTIC, ACUTE to search LEUKEMIA, MYELOBLASTIC 1967-88%A%  
% 224.55/224.72  |- skos__hiddenLabel mesh__D007950 Acute Myelogenous Leukemia
% 224.55/224.72  |- mesh__dateEstablished mesh__D007950 1967-01-01
% 224.55/224.72  |- skos__hiddenLabel mesh__D007950 Leukemias, Acute Myelogenous
% 224.55/224.72  |- skos__hiddenLabel mesh__D007950 Leukemias, Acute Myeloblastic
% 224.55/224.72  |- skos__hiddenLabel mesh__D007950 Acute Myelocytic Leukemias
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D007950 1997
% 224.55/224.72  |- skos__historyNote mesh__D007950 Leukemia, Myelocytic %28%1966%29%
% 224.55/224.72  |- mesh__recordAuthorizer mesh__D007950 PLS
% 224.55/224.72  |- skos__altLabel mesh__D007950 Myelogenous Leukemia, Acute
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D007950 2004
% 224.55/224.72  |- mesh__recordMaintainer mesh__D007950 KEV
% 224.55/224.72  |- skos__hiddenLabel mesh__D007950 Acute Myeloblastic Leukemia
% 224.55/224.72  |- skos__altLabel mesh__D007950 Leukemia, Myelogenous, Acute
% 224.55/224.72  |- skos__hiddenLabel mesh__D007950 Acute Myeloblastic Leukemias
% 224.55/224.72  |- skos__hiddenLabel mesh__D007950 Myeloblastic Leukemias, Acute
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D007950 1996
% 224.55/224.72  |- skos__hiddenLabel mesh__D007950 Acute Myelocytic Leukemia
% 224.55/224.72  |- skos__hiddenLabel mesh__D007950 Leukemia, Acute Myelocytic
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D007950 2002
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D007950 1999
% 224.55/224.72  |- skos__altLabel mesh__D007950 Myelocytic Leukemia, Acute
% 224.55/224.72  |- mesh__activeMeSHYear mesh__D007950 2003
% 224.55/224.72  |- skos__hiddenLabel mesh__D021621 Three Dimensional Image
% 224.55/224.72  |- skos__altLabel mesh__D021621 Computer-Generated 3D Imaging
% 224.55/224.72  |- mesh__recordOriginator mesh__D021621 jmp
% 224.55/224.72  |- skos__hiddenLabel mesh__D021621 3-D Imagings
% 224.55/224.72  |- skos__hiddenLabel mesh__D021621
% 224.55/224.72       Three Dimensional Imaging, Computer Generated
% 224.55/224.72  |- skos__altLabel mesh__D021621 Computer-Assisted Three-Dimensional Imaging
% 224.55/224.72  |- skos__hiddenLabel mesh__D021621
% 224.55/224.72       Computer Assisted Three Dimensional Imaging
% 224.55/224.72  |- skos__hiddenLabel mesh__D021621 3 D Imaging
% 224.55/224.72  |- skos__hiddenLabel mesh__D021621 Three-Dimensional Imagings
% 224.55/224.72  |- skos__hiddenLabel mesh__D021621 3D Imaging, Computer-Generated
% 224.55/224.72  |- mesh__recordMaintainer mesh__D021621 ags
% 224.55/224.72  |- skos__hiddenLabel mesh__D021621 Computer Generated 3D Imaging
% 224.55/224.72  |- skos__hiddenLabel mesh__D021621 Computer-Generated 3D Imagings
% 224.55/224.72  |- skos__hiddenLabel mesh__D021621 Images, Three-Dimensional
% 224.55/224.72  |- skos__altLabel mesh__D021621 Three-Dimensional Image
% 224.55/224.72  |- skos__altLabel mesh__D021621
% 224.55/224.72       Three-Dimensional Imaging, Computer Generated
% 224.55/224.72  |- skos__hiddenLabel mesh__D021621
% 224.55/224.72       Three-Dimensional Imagings, Computer-Assisted
% 224.55/224.72  |- skos__hiddenLabel mesh__D021621 3-D Images
% 224.55/224.72  |- skos__hiddenLabel mesh__D021621 Three-Dimensional Images
% 224.55/224.72  |- mesh__dateCreated mesh__D021621 2000-06-22
% 224.55/224.72  |- skos__scopeNote mesh__D021621
% 224.55/224.72       The process of generating three-dimensional images by electronic, photographic, or other methods. For example, three-dimensional images can be generated by assembling multiple tomographic images with the aid of a computer, while photographic 3-D images %28%HOLOGRAPHY%29% can be made by exposing film to the interference pattern created when two laser light sources shine on an object.%A%    
% 224.55/224.72  |- skos__hiddenLabel mesh__D021621 Imagings, Three-Dimensional
% 224.55/224.73  |- skos__hiddenLabel mesh__D021621 Imaging, Computer-Generated 3D
% 224.55/224.73  |- skos__hiddenLabel mesh__D021621
% 224.55/224.73       Imagings, Computer-Assisted Three-Dimensional
% 224.55/224.73  |- skos__hiddenLabel mesh__D021621 Imagings, 3-D
% 224.55/224.73  |- rdf__type mesh__D021621sskos__Concept
% 224.55/224.73  |- skos__hiddenLabel mesh__D021621
% 224.55/224.73       Imaging, Computer-Assisted Three-Dimensional
% 224.55/224.73  |- skos__annotation mesh__D021621
% 224.55/224.73       for computer analysis of images use IMAGE PROCESSING, COMPUTER-ASSISTED%A%  
% 224.55/224.73  |- skos__prefLabel mesh__D021621 Imaging, Three-Dimensional
% 224.55/224.73  |- skos__hiddenLabel mesh__D021621
% 224.55/224.73       Computer-Assisted Three-Dimensional Imagings
% 224.55/224.73  |- skos__hiddenLabel mesh__D021621 3D Imagings, Computer-Generated
% 224.55/224.73  |- skos__hiddenLabel mesh__D021621 Image, 3-D
% 224.55/224.73  |- skos__hiddenLabel mesh__D021621 Imagings, Computer-Generated 3D
% 224.55/224.73  |- skos__hiddenLabel mesh__D021621 Imaging, 3-D
% 224.55/224.73  |- mesh__recordAuthorizer mesh__D021621 sjn
% 224.55/224.73  |- mesh__dateEstablished mesh__D021621 2001-01-01
% 224.55/224.73  |- skos__hiddenLabel mesh__D021621 Image, Three-Dimensional
% 224.55/224.73  |- mesh__activeMeSHYear mesh__D021621 2006
% 224.55/224.73  |- skos__hiddenLabel mesh__D021621
% 224.55/224.73       Three-Dimensional Imaging, Computer-Assisted
% 224.55/224.73  |- skos__hiddenLabel mesh__D021621 Images, 3-D
% 224.55/224.73  |- skos__hiddenLabel mesh__D021621 Three-Dimensional Imaging
% 224.55/224.73  |- skos__broader mesh__D021621smesh__D003952
% 224.55/224.73  |- mesh__dateRevised mesh__D021621 2004-07-07
% 224.55/224.73  |- skos__hiddenLabel mesh__D021621 Imaging, Three Dimensional
% 224.55/224.73  |- mesh__activeMeSHYear mesh__D021621 2005
% 224.55/224.73  |- skos__hiddenLabel mesh__D021621 3 D Image
% 224.55/224.73  |- skos__broader mesh__D021621smesh__D007091
% 224.55/224.73  |- skos__altLabel mesh__D021621 3-D Imaging
% 224.55/224.73  |- skos__historyNote mesh__D007152 Cell Membrane %28%1966-1977%29%
% 224.55/224.73  |- mesh__recordAuthorizer mesh__D007152 sjn
% 224.55/224.73  |- skos__broader mesh__D007152smesh__D011940
% 224.55/224.73  |- skos__historyNote mesh__D007152 Lymphocytes %28%1966-1977%29%
% 224.55/224.73  |- mesh__dateCreated mesh__D007152 1977-05-10
% 224.55/224.73  |- skos__scopeNote mesh__D007152
% 224.55/224.73       An energy dependent process following the crosslinking of B CELL ANTIGEN RECEPTORS by multivalent ligands %28%bivalent anti-antibodies, LECTINS or ANTIGENS%29%, on the B-cell surface. The crosslinked ligand-antigen receptor complexes collect in patches which flow to and aggregate at one pole of the cell to form a large mass - the cap. The caps may then be endocytosed or shed into the environment.%A%    
% 224.55/224.73  |- skos__prefLabel mesh__D007152 Immunologic Capping
% 224.55/224.73  |- mesh__activeMeSHYear mesh__D007152 2006
% 224.55/224.73  |- skos__annotation mesh__D007152
% 224.55/224.73       may appear in the literature as %22%capping of lymphocytes%22% or %22%leukocyte capping%22%; do not confuse with RECEPTOR CAPPING; DF: IMMUNOL CAPPING%A%  
% 224.55/224.73  |- mesh__recordOriginator mesh__D007152 AEP
% 224.55/224.73  |- mesh__historyNote mesh__D007152 78   
% 224.55/224.73  |- skos__hiddenLabel mesh__D007152 Capping, Immunological
% 224.55/224.73  |- rdf__type mesh__D007152sskos__Concept
% 224.55/224.73  |- mesh__dateEstablished mesh__D007152 1978-01-01
% 224.55/224.73  |- mesh__dateRevised mesh__D007152 2005-06-30
% 224.55/224.73  |- mesh__publicMeSHNote mesh__D007152 78   
% 224.55/224.73  |- skos__related mesh__D007152smesh__D011947
% 224.55/224.73  |- mesh__recordMaintainer mesh__D007152 nns
% 224.55/224.73  |- skos__altLabel mesh__D007152 Capping, Immunologic
% 224.55/224.73  |- skos__broader mesh__D007152smesh__D000937
% 224.55/224.73  |- skos__altLabel mesh__D007152 Immunological Capping
% 224.55/224.73  |- mesh__activeMeSHYear mesh__D012895 1999
% 224.55/224.73  |- skos__hiddenLabel mesh__D012895 Sleep, Rhombencephalic
% 224.55/224.73  |- mesh__recordAuthorizer mesh__D012895 SJN
% 224.55/224.73  |- skos__altLabel mesh__D012895 Fast-Wave Sleep
% 224.55/224.73  |- mesh__publicMeSHNote mesh__D012895 69   
% 224.55/224.73  |- mesh__historyNote mesh__D012895 69   
% 224.55/224.73  |- mesh__activeMeSHYear mesh__D012895 2003
% 224.55/224.73  |- mesh__activeMeSHYear mesh__D012895 1998
% 224.55/224.73  |- skos__hiddenLabel mesh__D012895 Movement, Rapid Eye
% 224.55/224.73  |- skos__hiddenLabel mesh__D012895 Rapid Eye Movement
% 224.55/224.73  |- mesh__dateRevised mesh__D012895 1997-06-20
% 224.55/224.73  |- skos__scopeNote mesh__D012895
% 224.55/224.73       A stage of sleep characterized by rapid movements of the eye and low voltage fast pattern EEG. It is usually associated with dreaming.%A%    
% 224.55/224.73  |- skos__hiddenLabel mesh__D012895 Sleep, Fast Wave
% 224.55/224.73  |- mesh__dateEstablished mesh__D012895 1969-01-01
% 224.55/224.73  |- skos__prefLabel mesh__D012895 Sleep, REM
% 224.55/224.73  |- skos__hiddenLabel mesh__D012895 Fast Wave Sleep
% 224.55/224.73  |- mesh__activeMeSHYear mesh__D012895 2006
% 224.55/224.73  |- skos__hiddenLabel mesh__D012895 Movements, Rapid Eye
% 224.55/224.73  |- skos__altLabel mesh__D012895 Sleep, Fast-Wave
% 224.55/224.73  |- mesh__activeMeSHYear mesh__D012895 2002
% 224.55/224.73  |- skos__broader mesh__D012895smesh__D012894
% 224.55/224.73  |- skos__altLabel mesh__D012895 Rhombencephalic Sleep
% 224.55/224.73  |- skos__altLabel mesh__D012895 Paradoxical Sleep
% 224.55/224.73  |- mesh__activeMeSHYear mesh__D012895 2005
% 224.55/224.73  |- mesh__activeMeSHYear mesh__D012895 2001
% 224.55/224.73  |- mesh__recordOriginator mesh__D012895 NLM
% 224.55/224.73  |- mesh__dateCreated mesh__D012895 1999-01-01
% 224.55/224.73  |- skos__historyNote mesh__D012895 Sleep %28%1966-1968%29%
% 224.55/224.73  |- rdf__type mesh__D012895sskos__Concept
% 224.55/224.73  |- mesh__activeMeSHYear mesh__D012895 2004
% 224.55/224.73  |- mesh__recordMaintainer mesh__D012895 TGC
% 224.55/224.73  |- skos__hiddenLabel mesh__D012895 Sleep, Paradoxical
% 224.55/224.73  |- skos__hiddenLabel mesh__D012895 REM Sleep
% 224.55/224.73  |- skos__hiddenLabel mesh__D012895 Eye Movement, Rapid
% 224.55/224.73  |- mesh__activeMeSHYear mesh__D012895 2000
% 224.55/224.73  |- skos__hiddenLabel mesh__D012895 Eye Movements, Rapid
% 224.55/224.73  |- skos__scopeNote mesh__D012097
% 224.55/224.73       Proteins which are normally bound to the operator locus of an operon, thereby preventing transcription of the structural genes. In enzyme induction, the substrate of the inducible enzyme binds to the repressor protein, causing its release from the operator and freeing the structural genes for transcription. In enzyme repression, the end product of the enzyme sequence binds to the free repressor protein, the resulting complex then binds to the operator and prevents transcription of the structural genes.%A%    
% 224.55/224.73  |- skos__historyNote mesh__D012097 Enzyme Repression %28%1966-1978%29%
% 224.55/224.73  |- mesh__recordOriginator mesh__D012097 RLS
% 224.55/224.73  |- skos__prefLabel mesh__D012097 Repressor Proteins
% 224.55/224.73  |- mesh__dateRevised mesh__D012097 2005-06-30
% 224.55/224.73  |- skos__broader mesh__D012097smesh__D014157
% 224.55/224.73  |- rdf__type mesh__D012097sskos__Concept
% 224.55/224.73  |- skos__historyNote mesh__D012097 Genes, Regulator %28%1968-1978%29%
% 224.55/224.73  |- mesh__recordAuthorizer mesh__D012097 sjn
% 224.55/224.73  |- mesh__dateEstablished mesh__D012097 1991-01-01
% 224.55/224.73  |- skos__hiddenLabel mesh__D012097 Repressors, Lac
% 224.55/224.73  |- skos__hiddenLabel mesh__D012097 Molecules, Repressor
% 224.55/224.73  |- mesh__activeMeSHYear mesh__D012097 2006
% 224.55/224.73  |- skos__historyNote mesh__D012097 Bacterial Proteins %28%1966-1978%29%
% 224.55/224.73  |- skos__hiddenLabel mesh__D012097 Proteins, Repressor
% 224.55/224.73  |- mesh__dateCreated mesh__D012097 1978-05-19
% 224.55/224.73  |- skos__historyNote mesh__D012097 Transcription, Genetic %28%1973-1978%29%
% 224.55/224.73  |- skos__annotation mesh__D012097
% 224.55/224.73       transcription factors; /biosyn /drug eff /physiol permitted%A%  
% 224.55/224.73  |- mesh__recordMaintainer mesh__D012097 SYSTEM
% 224.55/224.73  |- mesh__historyNote mesh__D012097
% 224.55/224.73       91%28%79%29%; was see under TRANSCRIPTION FACTORS 1979-90   
% 224.55/224.73  |- mesh__publicMeSHNote mesh__D012097
% 224.55/224.73       91; was see under TRANSCRIPTION FACTORS 1979-90   
% 224.55/224.73  |- mesh__activeMeSHYear mesh__D006858 1999
% 224.55/224.73  |- mesh__recordMaintainer mesh__D006858 TPW
% 224.55/224.73  |- skos__hiddenLabel mesh__D006858 Acid, Fluorhydric
% 224.55/224.73  |- mesh__activeMeSHYear mesh__D006858 2002
% 224.55/224.73  |- skos__prefLabel mesh__D006858 Hydrofluoric Acid
% 224.55/224.73  |- rdf__type mesh__D006858sskos__Concept
% 224.55/224.73  |- skos__annotation mesh__D006858
% 224.55/224.73       hydrogen fluoride in water; can cause burns; /analogs = FLUORIDES or specific fluoride%A%  
% 224.55/224.73  |- mesh__activeMeSHYear mesh__D006858 1994
% 224.55/224.73  |- skos__scopeNote mesh__D006858
% 224.55/224.73       Hydrofluoric acid. A solution of hydrogen fluoride in water. It is a colorless fuming liquid which can cause painful burns.%A%    
% 224.55/224.73  |- mesh__activeMeSHYear mesh__D006858 2003
% 224.55/224.73  |- skos__broader mesh__D006858smesh__D000148
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D006858 1995
% 224.58/224.73  |- skos__hiddenLabel mesh__D006858 Acid, Fluohydric
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D006858 2000
% 224.58/224.73  |- mesh__dateEstablished mesh__D006858 1977-01-01
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D006858 2005
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D006858 2004
% 224.58/224.73  |- mesh__recordOriginator mesh__D006858 NLM
% 224.58/224.73  |- mesh__publicMeSHNote mesh__D006858 77   
% 224.58/224.73  |- skos__altLabel mesh__D006858 Fluorhydric Acid
% 224.58/224.73  |- skos__altLabel mesh__D006858 Fluohydric Acid
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D006858 2001
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D006858 1996
% 224.58/224.73  |- mesh__recordAuthorizer mesh__D006858 PLS
% 224.58/224.73  |- skos__historyNote mesh__D006858 Fluorides %28%1966-1971%29%
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D006858 2006
% 224.58/224.73  |- mesh__dateRevised mesh__D006858 1993-06-04
% 224.58/224.73  |- skos__broader mesh__D006858smesh__D017611
% 224.58/224.73  |- skos__historyNote mesh__D006858 Acids %28%1966-1971%29%
% 224.58/224.73  |- skos__hiddenLabel mesh__D006858 Fluoride, Hydrogen
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D006858 1998
% 224.58/224.73  |- mesh__historyNote mesh__D006858 77%28%72%29%   
% 224.58/224.73  |- mesh__dateCreated mesh__D006858 1999-01-01
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D006858 1997
% 224.58/224.73  |- skos__hiddenLabel mesh__D006858 Acid, Hydrofluoric
% 224.58/224.73  |- rdf__type mesh__D020529sskos__Concept
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D020529 2006
% 224.58/224.73  |- mesh__dateRevised mesh__D020529 2003-07-22
% 224.58/224.73  |- skos__altLabel mesh__D020529 Acute Relapsing Multiple Sclerosis
% 224.58/224.73  |- mesh__dateCreated mesh__D020529 1999-11-03
% 224.58/224.73  |- mesh__recordOriginator mesh__D020529 KEV
% 224.58/224.73  |- skos__hiddenLabel mesh__D020529 Relapsing Remitting Multiple Sclerosis
% 224.58/224.73  |- mesh__recordMaintainer mesh__D020529 sjn
% 224.58/224.73  |- mesh__dateEstablished mesh__D020529 2000-01-01
% 224.58/224.73  |- skos__scopeNote mesh__D020529
% 224.58/224.73       The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial or complete recovery. Common clinical manifestations include loss of visual %28%see OPTIC NEURITIS%29%, motor, sensory, or bladder function. Acute episodes of demyelination may occur at any site in the central nervous system, and commonly involve the optic nerves, spinal cord, brain stem, and cerebellum. %28%Adams et al., Principles of Neurology, 6th ed, pp903-914%29%%A%    
% 224.58/224.73  |- skos__altLabel mesh__D020529 Remitting-Relapsing Multiple Sclerosis
% 224.58/224.73  |- skos__hiddenLabel mesh__D020529 Multiple Sclerosis, Remitting-Relapsing
% 224.58/224.73  |- skos__prefLabel mesh__D020529 Multiple Sclerosis, Relapsing-Remitting
% 224.58/224.73  |- mesh__historyNote mesh__D020529 2000   
% 224.58/224.73  |- skos__hiddenLabel mesh__D020529 Multiple Sclerosis, Relapsing Remitting
% 224.58/224.73  |- skos__related mesh__D020529smesh__D009188
% 224.58/224.73  |- skos__annotation mesh__D020529 DF: MS RELAPSING REMITTING   
% 224.58/224.73  |- mesh__recordAuthorizer mesh__D020529 sjn
% 224.58/224.73  |- skos__hiddenLabel mesh__D020529 Remitting Relapsing Multiple Sclerosis
% 224.58/224.73  |- skos__altLabel mesh__D020529 Relapsing-Remitting Multiple Sclerosis
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D020529 2005
% 224.58/224.73  |- mesh__publicMeSHNote mesh__D020529 2000   
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D020529 2004
% 224.58/224.73  |- skos__historyNote mesh__D020529 Multiple Sclerosis %28%1978-1999%29%
% 224.58/224.73  |- skos__broader mesh__D020529smesh__D009103
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D031251 2005
% 224.58/224.73  |- skos__scopeNote mesh__D031251
% 224.58/224.73       A plant genus of the family CLUSIACEAE. Members contain benzophenones.%A%    
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D031251 2004
% 224.58/224.73  |- mesh__dateEstablished mesh__D031251 2003-01-01
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D031251 2003
% 224.58/224.73  |- rdf__type mesh__D031251sskos__Concept
% 224.58/224.73  |- skos__broader mesh__D031251smesh__D028084
% 224.58/224.73  |- mesh__historyNote mesh__D031251 2003   
% 224.58/224.73  |- mesh__publicMeSHNote mesh__D031251 2003   
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D031251 2006
% 224.58/224.73  |- skos__prefLabel mesh__D031251 Clusia
% 224.58/224.73  |- skos__annotation mesh__D031251
% 224.58/224.73       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.58/224.73  |- mesh__dateCreated mesh__D031251 2002-07-03
% 224.58/224.73  |- mesh__dateRevised mesh__D003560 2003-07-09
% 224.58/224.73  |- rdf__type mesh__D003560sskos__Concept
% 224.58/224.73  |- skos__broader mesh__D003560smesh__D020763
% 224.58/224.73  |- skos__broader mesh__D003560smesh__D009369
% 224.58/224.73  |- skos__annotation mesh__D003560
% 224.58/224.73       coord with organ/diseases term; specific terms indented under CYSTS are either neoplastic or non-neopl: check under each; intestinal gas cysts = PNEUMATOSIS CYSTOIDES INTESTINALIS; CYSTIC ADENOMATOID MALFORMATION OF LUNG, CONGENITAL is also available%A%  
% 224.58/224.73  |- skos__hiddenLabel mesh__D003560 Cyst
% 224.58/224.73  |- mesh__dateCreated mesh__D003560 1999-01-01
% 224.58/224.73  |- skos__prefLabel mesh__D003560 Cysts
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D003560 2004
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D003560 2006
% 224.58/224.73  |- mesh__recordAuthorizer mesh__D003560 sjn
% 224.58/224.73  |- mesh__recordMaintainer mesh__D003560 lkt
% 224.58/224.73  |- skos__scopeNote mesh__D003560
% 224.58/224.73       Any fluid-filled closed cavity or sac that is lined by an EPITHELIUM. Cysts can be of normal, abnormal, non-neoplastic, or neoplastic tissues.%A%    
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D003560 2005
% 224.58/224.73  |- mesh__recordOriginator mesh__D003560 NLM
% 224.58/224.73  |- skos__altLabel mesh__D016488 Witch Doctor, African
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D016488 2006
% 224.58/224.73  |- skos__broader mesh__D016488smesh__D008519
% 224.58/224.73  |- mesh__publicMeSHNote mesh__D016488 92   
% 224.58/224.73  |- skos__hiddenLabel mesh__D016488 African Witch Doctors
% 224.58/224.73  |- mesh__dateEstablished mesh__D016488 1992-01-01
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D016488 2005
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D016488 2004
% 224.58/224.73  |- skos__hiddenLabel mesh__D016488 Witch Doctors, African
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D016488 2002
% 224.58/224.73  |- skos__altLabel mesh__D016488 Traditional African Medicine
% 224.58/224.73  |- rdf__type mesh__D016488sskos__Concept
% 224.58/224.73  |- skos__scopeNote mesh__D016488
% 224.58/224.73       A system of traditional medicine which is based on the beliefs and practices of the African peoples. It includes treatment by medicinal plants and other materia medica as well as by the ministrations of diviners, medicine men, witch doctors, and sorcerers.%A%    
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D016488 2003
% 224.58/224.73  |- mesh__dateCreated mesh__D016488 1991-07-03
% 224.58/224.73  |- skos__historyNote mesh__D016488 Medicine, Traditional %28%1966-1991%29%
% 224.58/224.73  |- mesh__historyNote mesh__D016488 92   
% 224.58/224.73  |- mesh__recordAuthorizer mesh__D016488 sjn
% 224.58/224.73  |- skos__hiddenLabel mesh__D016488 Doctors, African Witch
% 224.58/224.73  |- mesh__dateRevised mesh__D016488 2001-07-25
% 224.58/224.73  |- skos__altLabel mesh__D016488 Traditional Medicine, African
% 224.58/224.73  |- mesh__recordOriginator mesh__D016488 TGC
% 224.58/224.73  |- skos__altLabel mesh__D016488 Medicine, Traditional African
% 224.58/224.73  |- mesh__recordMaintainer mesh__D016488 ssb
% 224.58/224.73  |- skos__altLabel mesh__D016488 African Medicine, Traditional
% 224.58/224.73  |- skos__hiddenLabel mesh__D016488 Doctor, African Witch
% 224.58/224.73  |- skos__broader mesh__D016488smesh__D026443
% 224.58/224.73  |- skos__annotation mesh__D016488
% 224.58/224.73       IM; not medicine in Africa %28% = MEDICINE + AFRICA%29%; apply policy of Manual 32.13 to this term; apply TN J/29-36 on Chinese plants to indexing of African plants where applicable; specify geog; DF: MED AFRICAN TRADITIONAL%A%  
% 224.58/224.73  |- skos__altLabel mesh__D016488 African Traditional Medicine
% 224.58/224.73  |- skos__altLabel mesh__D016488 African Medicine
% 224.58/224.73  |- skos__prefLabel mesh__D016488 Medicine, African Traditional
% 224.58/224.73  |- mesh__recordAuthorizer mesh__D035642 jls
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D035642 2003
% 224.58/224.73  |- mesh__publicMeSHNote mesh__D035642 2003; see DISCLOSURE 1997-2002   
% 224.58/224.73  |- mesh__historyNote mesh__D035642 2003; use DISCLOSURE 1997-2002   
% 224.58/224.73  |- rdf__type mesh__D035642sskos__Concept
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D035642 2006
% 224.58/224.73  |- skos__historyNote mesh__D035642 Truth Disclosure %28%1994-2002%29%
% 224.58/224.73  |- skos__broader mesh__D035642smesh__D030881
% 224.58/224.73  |- skos__hiddenLabel mesh__D035642 Whistle Blowers
% 224.58/224.73  |- mesh__dateEstablished mesh__D035642 2003-01-01
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D035642 2003A
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D035642 2005
% 224.58/224.73  |- mesh__recordMaintainer mesh__D035642 jls
% 224.58/224.73  |- skos__prefLabel mesh__D035642 Whistleblowing
% 224.58/224.73  |- skos__altLabel mesh__D035642 Whistle Blowing
% 224.58/224.73  |- mesh__dateRevised mesh__D035642 2002-10-31
% 224.58/224.73  |- skos__hiddenLabel mesh__D035642 Whistleblowers
% 224.58/224.73  |- skos__scopeNote mesh__D035642
% 224.58/224.73       The reporting of observed or suspected PROFESSIONAL MISCONDUCT or incompetence to appropriate authorities or to the public.%A%    
% 224.58/224.73  |- mesh__recordOriginator mesh__D035642 hjn
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D035642 2004
% 224.58/224.73  |- skos__altLabel mesh__D035642 Whistle Blower
% 224.58/224.73  |- mesh__dateCreated mesh__D035642 2002-07-03
% 224.58/224.73  |- skos__historyNote mesh__D002468 Cells/physiology %28%1968-1997%29%
% 224.58/224.73  |- mesh__dateEstablished mesh__D002468 1998-01-01
% 224.58/224.73  |- mesh__recordAuthorizer mesh__D002468 sjn
% 224.58/224.73  |- skos__prefLabel mesh__D002468 Cell Physiology
% 224.58/224.73  |- skos__scopeNote mesh__D002468
% 224.58/224.73       The functions of CELLS from the time of their origin %28%CELL DIVISION%29% to CELL DEATH.%A%    
% 224.58/224.73  |- skos__broader mesh__D002468smesh__D001687
% 224.58/224.73  |- mesh__dateCreated mesh__D002468 1999-01-01
% 224.58/224.73  |- mesh__historyNote mesh__D002468 98; use explode 1970-97   
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D002468 2006
% 224.58/224.73  |- mesh__dateRevised mesh__D002468 2004-07-07
% 224.58/224.73  |- skos__annotation mesh__D002468
% 224.58/224.73       GEN or unspecified; prefer specifics; DF: CELL PHYSIOL   
% 224.58/224.73  |- mesh__recordOriginator mesh__D002468 NLM
% 224.58/224.73  |- skos__broader mesh__D002468smesh__D010829
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D002468 2005
% 224.58/224.73  |- skos__altLabel mesh__D002468 Physiology, Cell
% 224.58/224.73  |- mesh__publicMeSHNote mesh__D002468 98   
% 224.58/224.73  |- mesh__recordMaintainer mesh__D002468 lkt
% 224.58/224.73  |- rdf__type mesh__D002468sskos__Concept
% 224.58/224.73  |- skos__broader mesh__D013190smesh__D008459
% 224.58/224.73  |- skos__hiddenLabel mesh__D013190 Viruses, SSPE
% 224.58/224.73  |- mesh__recordAuthorizer mesh__D013190 sjn
% 224.58/224.73  |- mesh__dateRevised mesh__D013190 2001-08-07
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D013190 2005
% 224.58/224.73  |- skos__broader mesh__D013190smesh__D003673
% 224.58/224.73  |- mesh__recordMaintainer mesh__D013190 sjn
% 224.58/224.73  |- mesh__historyNote mesh__D013190 78   
% 224.58/224.73  |- mesh__activeMeSHYear mesh__D013190 2006
% 224.58/224.73  |- skos__hiddenLabel mesh__D013190 SSPE Viruses
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D013190 2003
% 224.58/224.74  |- mesh__dateEstablished mesh__D013190 1978-01-01
% 224.58/224.74  |- mesh__recordOriginator mesh__D013190 AEP
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D013190 2004
% 224.58/224.74  |- skos__annotation mesh__D013190
% 224.58/224.74       a defective MEASLES VIRUS; infection = SUBACUTE SCLEROSING PANENCEPHALITIS%A%  
% 224.58/224.74  |- mesh__publicMeSHNote mesh__D013190 78   
% 224.58/224.74  |- mesh__dateCreated mesh__D013190 1977-03-01
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D013190 2002
% 224.58/224.74  |- skos__scopeNote mesh__D013190
% 224.58/224.74       A defective variant of MEASLES VIRUS that has been isolated from the brain tissue of patients with subacute sclerosing panencephalitis.%A%    
% 224.58/224.74  |- skos__historyNote mesh__D013190
% 224.58/224.74       Subacute Sclerosing Panencephalitis %28%1971-1977%29%
% 224.58/224.74  |- skos__hiddenLabel mesh__D013190 Virus, SSPE
% 224.58/224.74  |- skos__prefLabel mesh__D013190 SSPE Virus
% 224.58/224.74  |- rdf__type mesh__D013190sskos__Concept
% 224.58/224.74  |- skos__altLabel mesh__D013190 Subacute Sclerosing Panenceph Virus
% 224.58/224.74  |- skos__altLabel mesh__D007951 Leukemia, Myelocytic
% 224.58/224.74  |- mesh__recordAuthorizer mesh__D007951 PLS
% 224.58/224.74  |- skos__hiddenLabel mesh__D007951 Leukemias, Myeloid
% 224.58/224.74  |- skos__historyNote mesh__D007951 Leukemia, Myelocytic %28%1966-1988%29%
% 224.58/224.74  |- skos__scopeNote mesh__D007951
% 224.58/224.74       Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors in the bone marrow and other sites.%A%    
% 224.58/224.74  |- mesh__publicMeSHNote mesh__D007951
% 224.58/224.74       89; LEUKEMIA, MYELOCYTIC was heading 1963-88; LEUKEMIA, GRANULOCYTIC was see LEUKEMIA, MYELOCYTIC 1974-88%A%  
% 224.58/224.74  |- skos__hiddenLabel mesh__D007951 Leukemias, Granulocytic
% 224.58/224.74  |- skos__altLabel mesh__D007951 Granulocytic Leukemia
% 224.58/224.74  |- mesh__recordMaintainer mesh__D007951 KEV
% 224.58/224.74  |- skos__hiddenLabel mesh__D007951 Myeloid Leukemias
% 224.58/224.74  |- skos__annotation mesh__D007951
% 224.58/224.74       GEN or unspecified: prefer specifics; do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007951 2000
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007951 1998
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007951 2005
% 224.58/224.74  |- mesh__historyNote mesh__D007951
% 224.58/224.74       89; LEUKEMIA, MYELOCYTIC was heading 1963-88; LEUKEMIA, GRANULOCYTIC was see LEUKEMIA, MYELOCYTIC 1974-88%A%  
% 224.58/224.74  |- mesh__recordOriginator mesh__D007951 NLM
% 224.58/224.74  |- mesh__dateCreated mesh__D007951 1999-01-01
% 224.58/224.74  |- skos__broader mesh__D007951smesh__D009190
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007951 2001
% 224.58/224.74  |- skos__broader mesh__D007951smesh__D008232
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007951 1999
% 224.58/224.74  |- mesh__onlineNote mesh__D007951
% 224.58/224.74       use LEUKEMIA, MYELOID to search LEUKEMIA, MYELOCYTIC 1966-88 %26% LEUKEMIA, GRANULOCYTIC 1974-88%A%  
% 224.58/224.74  |- skos__altLabel mesh__D007951 Myeloid Leukemia
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007951 1996
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007951 2006
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007951 2003
% 224.58/224.74  |- skos__altLabel mesh__D007951 Leukemia, Granulocytic
% 224.58/224.74  |- skos__broader mesh__D007951smesh__D007938
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007951 2002
% 224.58/224.74  |- skos__prefLabel mesh__D007951 Leukemia, Myeloid
% 224.58/224.74  |- mesh__dateRevised mesh__D007951 1995-06-08
% 224.58/224.74  |- skos__altLabel mesh__D007951 Myelocytic Leukemia
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007951 1997
% 224.58/224.74  |- skos__hiddenLabel mesh__D007951 Granulocytic Leukemias
% 224.58/224.74  |- skos__hiddenLabel mesh__D007951 Myelocytic Leukemias
% 224.58/224.74  |- rdf__type mesh__D007951sskos__Concept
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007951 2004
% 224.58/224.74  |- skos__hiddenLabel mesh__D007951 Leukemias, Myelogenous
% 224.58/224.74  |- skos__hiddenLabel mesh__D007951 Myelogenous Leukemias
% 224.58/224.74  |- skos__altLabel mesh__D007951 Myelogenous Leukemia
% 224.58/224.74  |- skos__hiddenLabel mesh__D007951 Leukemias, Myelocytic
% 224.58/224.74  |- skos__altLabel mesh__D007951 Leukemia, Myelogenous
% 224.58/224.74  |- mesh__publicMeSHNote mesh__D029605 2002   
% 224.58/224.74  |- skos__scopeNote mesh__D029605
% 224.58/224.74       A plant species of the family PHYTOLACCACEAE. The root has been used in traditional medicine and contains SAPONINS used to poison SNAILS.%A%    
% 224.58/224.74  |- mesh__dateEstablished mesh__D029605 2002-01-01
% 224.58/224.74  |- mesh__dateCreated mesh__D029605 2001-07-25
% 224.58/224.74  |- mesh__historyNote mesh__D029605 2002   
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D029605 2003
% 224.58/224.74  |- skos__altLabel mesh__D029605 Endod
% 224.58/224.74  |- rdf__type mesh__D029605sskos__Concept
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D029605 2005
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D029605 2004
% 224.58/224.74  |- skos__broader mesh__D029605smesh__D029603
% 224.58/224.74  |- skos__annotation mesh__D029605
% 224.58/224.74       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.58/224.74  |- skos__prefLabel mesh__D029605 Phytolacca dodecandra
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D029605 2002
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D029605 2006
% 224.58/224.74  |- skos__historyNote mesh__D007153 Immunity %28%1966-1967%29%
% 224.58/224.74  |- skos__broader mesh__D007153smesh__D007154
% 224.58/224.74  |- skos__hiddenLabel mesh__D007153 Syndromes, Immunologic Deficiency
% 224.58/224.74  |- skos__altLabel mesh__D007153 Deficiency Syndromes, Immunologic
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007153 1999
% 224.58/224.74  |- skos__related mesh__D007153smesh__D016867
% 224.58/224.74  |- skos__hiddenLabel mesh__D007153 Deficiency Syndrome, Immunological
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007153 2006
% 224.58/224.74  |- skos__hiddenLabel mesh__D007153 Syndrome, Antibody Deficiency
% 224.58/224.74  |- mesh__dateCreated mesh__D007153 1999-01-01
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007153 2002
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007153 1996
% 224.58/224.74  |- skos__hiddenLabel mesh__D007153 Deficiency Syndromes, Immunological
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007153 2003
% 224.58/224.74  |- skos__prefLabel mesh__D007153 Immunologic Deficiency Syndromes
% 224.58/224.74  |- skos__hiddenLabel mesh__D007153 Syndromes, Immunological Deficiency
% 224.58/224.74  |- skos__hiddenLabel mesh__D007153 Deficiency Syndrome, Antibody
% 224.58/224.74  |- skos__altLabel mesh__D007153 Deficiency Syndrome, Immunologic
% 224.58/224.74  |- mesh__recordOriginator mesh__D007153 NLM
% 224.58/224.74  |- mesh__historyNote mesh__D007153
% 224.58/224.74       70%28%68%29%; ANTIBODY DEFICIENCY SYNDROME was see under IMMUNOLOGIC DEFICIENCY SYNDROMES 1970-77%A%  
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007153 1997
% 224.58/224.74  |- skos__scopeNote mesh__D007153
% 224.58/224.74       Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.%A%    
% 224.58/224.74  |- mesh__publicMeSHNote mesh__D007153 70   
% 224.58/224.74  |- skos__altLabel mesh__D007153 Deficiency Syndromes, Antibody
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007153 2004
% 224.58/224.74  |- skos__hiddenLabel mesh__D007153 Syndrome, Immunologic Deficiency
% 224.58/224.74  |- mesh__dateRevised mesh__D007153 1993-06-04
% 224.58/224.74  |- mesh__recordAuthorizer mesh__D007153 PLS
% 224.58/224.74  |- skos__annotation mesh__D007153
% 224.58/224.74       GEN or unspecified; for defic of specific immunoprotein, IMMUNOGLOBULINS or specific immunoglobulin, use specific with /defic; TN 223: definition %26% use; TN 225: differentiation from immunoglobulin defic; Manual 23.25.2; DF: IMMUNOL DEFIC SYNDROMES%A%  
% 224.58/224.74  |- skos__altLabel mesh__D007153 Immunological Deficiency Syndromes
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007153 2000
% 224.58/224.74  |- mesh__dateEstablished mesh__D007153 1970-01-01
% 224.58/224.74  |- skos__hiddenLabel mesh__D007153 Syndromes, Antibody Deficiency
% 224.58/224.74  |- skos__hiddenLabel mesh__D007153 Syndrome, Immunological Deficiency
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007153 1994
% 224.58/224.74  |- skos__hiddenLabel mesh__D007153 Antibody Deficiency Syndromes
% 224.58/224.74  |- skos__altLabel mesh__D007153 Immunologic Deficiency Syndrome
% 224.58/224.74  |- rdf__type mesh__D007153sskos__Concept
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007153 1998
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007153 2001
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007153 1995
% 224.58/224.74  |- mesh__onlineNote mesh__D007153
% 224.58/224.74       use IMMUNOLOGIC DEFICIENCY SYNDROMES to search ANTIBODY DEFICIENCY SYNDROME 1970-77%A%  
% 224.58/224.74  |- mesh__recordMaintainer mesh__D007153 JLS
% 224.58/224.74  |- skos__hiddenLabel mesh__D007153 Immunological Deficiency Syndrome
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007153 2005
% 224.58/224.74  |- skos__prefLabel mesh__D012896 Sloths
% 224.58/224.74  |- skos__hiddenLabel mesh__D012896 Sloth
% 224.58/224.74  |- mesh__dateRevised mesh__D012896 2003-07-09
% 224.58/224.74  |- mesh__recordMaintainer mesh__D012896 ags
% 224.58/224.74  |- mesh__dateEstablished mesh__D012896 1991-01-01
% 224.58/224.74  |- skos__annotation mesh__D012896 IM; qualif permitted   
% 224.58/224.74  |- skos__broader mesh__D012896smesh__D004490
% 224.58/224.74  |- mesh__publicMeSHNote mesh__D012896 91; was see under EDENTATA 1975-90   
% 224.58/224.74  |- mesh__recordOriginator mesh__D012896 NLM
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D012896 2006
% 224.58/224.74  |- mesh__recordAuthorizer mesh__D012896 sjn
% 224.58/224.74  |- skos__scopeNote mesh__D012896
% 224.58/224.74       Slow-moving exclusively arboreal mammals that inhabit the tropical forests of South and Central America.%A%    
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D012896 2005
% 224.58/224.74  |- rdf__type mesh__D012896sskos__Concept
% 224.58/224.74  |- mesh__historyNote mesh__D012896
% 224.58/224.74       91%28%75%29%; was see under EDENTATA 1975-90   
% 224.58/224.74  |- mesh__dateCreated mesh__D012896 1974-12-12
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D012896 2004
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D012098 2005
% 224.58/224.74  |- skos__hiddenLabel mesh__D012098 Indices, Human Reproductive
% 224.58/224.74  |- mesh__recordMaintainer mesh__D012098 lkt
% 224.58/224.74  |- skos__prefLabel mesh__D012098 Reproduction
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D012098 2006
% 224.58/224.74  |- skos__hiddenLabel mesh__D012098 Reproductive Index, Human
% 224.58/224.74  |- skos__broader mesh__D012098smesh__D012101
% 224.58/224.74  |- skos__hiddenLabel mesh__D012098 Period, Reproductive
% 224.58/224.74  |- mesh__recordOriginator mesh__D012098 NLM
% 224.58/224.74  |- mesh__recordAuthorizer mesh__D012098 sjn
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D012098 2004
% 224.58/224.74  |- skos__scopeNote mesh__D012098
% 224.58/224.74       The total process by which organisms produce offspring. %28%Stedman, 25th ed%29%%A%    
% 224.58/224.74  |- skos__altLabel mesh__D012098 Human Reproductive Index
% 224.58/224.74  |- mesh__dateCreated mesh__D012098 1999-01-01
% 224.58/224.74  |- skos__hiddenLabel mesh__D012098 Indexes, Human Reproductive
% 224.58/224.74  |- skos__hiddenLabel mesh__D012098 Reproductive Periods
% 224.58/224.74  |- skos__hiddenLabel mesh__D012098 Index, Human Reproductive
% 224.58/224.74  |- skos__annotation mesh__D012098
% 224.58/224.74       IM for human, other mammals, birds %26% fish; NIM for other vertebrates, invertebrates %26% plants; REPRODUCTIVE BEHAVIOR is also available%A%  
% 224.58/224.74  |- skos__hiddenLabel mesh__D012098 Periods, Reproductive
% 224.58/224.74  |- mesh__dateRevised mesh__D012098 2003-07-09
% 224.58/224.74  |- skos__hiddenLabel mesh__D012098 Human Reproductive Indices
% 224.58/224.74  |- skos__hiddenLabel mesh__D012098 Reproductive Indices, Human
% 224.58/224.74  |- rdf__type mesh__D012098sskos__Concept
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D006859 1996
% 224.58/224.74  |- skos__annotation mesh__D006859
% 224.58/224.74       H or H1; H2 or 2H %28%superscript%29% = DEUTERIUM, H2 %28%subscript%29% = HYDROGEN; H3 or 3H = TRITIUM; prod of H ions = probably PH%A%  
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D006859 2005
% 224.58/224.74  |- mesh__dateCreated mesh__D006859 1999-01-01
% 224.58/224.74  |- skos__scopeNote mesh__D006859
% 224.58/224.74       Hydrogen. The first chemical element in the periodic table. It has the atomic symbol H, atomic number 1, and atomic weight 1. It exists, under normal conditions, as a colorless, odorless, tasteless, diatomic gas. Hydrogen ions are PROTONS. Besides the common H1 isotope, hydrogen exists as the stable isotope DEUTERIUM and the unstable, radioactive isotope TRITIUM.%A%    
% 224.58/224.74  |- mesh__recordMaintainer mesh__D006859 TPW
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D006859 2001
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D006859 1999
% 224.58/224.74  |- rdf__type mesh__D006859sskos__Concept
% 224.58/224.74  |- skos__broader mesh__D006859smesh__D005740
% 224.58/224.74  |- skos__broader mesh__D006859smesh__D007287
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D006859 2000
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D006859 1998
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D006859 2004
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D006859 1995
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D006859 2003
% 224.58/224.74  |- mesh__recordAuthorizer mesh__D006859 PLS
% 224.58/224.74  |- mesh__dateRevised mesh__D006859 1993-06-04
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D006859 1994
% 224.58/224.74  |- skos__broader mesh__D006859smesh__D004602
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D006859 1997
% 224.58/224.74  |- skos__prefLabel mesh__D006859 Hydrogen
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D006859 2002
% 224.58/224.74  |- mesh__recordOriginator mesh__D006859 NLM
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D006859 2006
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D031252 2004
% 224.58/224.74  |- mesh__dateCreated mesh__D031252 2002-07-03
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D031252 2003
% 224.58/224.74  |- rdf__type mesh__D031252sskos__Concept
% 224.58/224.74  |- skos__prefLabel mesh__D031252 Mammea
% 224.58/224.74  |- skos__scopeNote mesh__D031252
% 224.58/224.74       A plant genus of the family CLUSIACEAE. Members contain xanthones and BENZOPHENONES. The common name of Mamey is also used with POUTERIA.%A%    
% 224.58/224.74  |- mesh__publicMeSHNote mesh__D031252 2003   
% 224.58/224.74  |- mesh__dateEstablished mesh__D031252 2003-01-01
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D031252 2006
% 224.58/224.74  |- skos__annotation mesh__D031252
% 224.58/224.74       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.58/224.74  |- skos__broader mesh__D031252smesh__D028084
% 224.58/224.74  |- mesh__historyNote mesh__D031252 2003   
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D031252 2005
% 224.58/224.74  |- mesh__dateCreated mesh__D003561 1999-01-01
% 224.58/224.74  |- mesh__recordAuthorizer mesh__D003561 sjn
% 224.58/224.74  |- mesh__publicMeSHNote mesh__D003561 66   
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D003561 2004
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D003561 2006
% 224.58/224.74  |- mesh__recordMaintainer mesh__D003561 CCR
% 224.58/224.74  |- skos__altLabel mesh__D003561 Aracytidine
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D003561 2003
% 224.58/224.74  |- mesh__recordOriginator mesh__D003561 NLM
% 224.58/224.74  |- skos__hiddenLabel mesh__D003561 CytosarU
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D003561 2005
% 224.58/224.74  |- skos__hiddenLabel mesh__D003561 Hydrochloride, Cytarabine
% 224.58/224.74  |- skos__altLabel mesh__D003561 Arabinofuranosylcytosine
% 224.58/224.74  |- mesh__dateRevised mesh__D003561 2001-07-25
% 224.58/224.74  |- skos__hiddenLabel mesh__D003561 Cytosar U
% 224.58/224.74  |- skos__altLabel mesh__D003561 Cytosar-U
% 224.58/224.74  |- rdf__type mesh__D003561sskos__Concept
% 224.58/224.74  |- skos__scopeNote mesh__D003561
% 224.58/224.74       A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p472%29%%A%    
% 224.58/224.74  |- skos__hiddenLabel mesh__D003561 Arabinoside, Cytosine
% 224.58/224.74  |- mesh__dateEstablished mesh__D003561 1966-01-01
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D003561 2002
% 224.58/224.74  |- skos__broader mesh__D003561smesh__D003562
% 224.58/224.74  |- skos__prefLabel mesh__D003561 Cytarabine
% 224.58/224.74  |- skos__altLabel mesh__D003561 Arabinosylcytosine
% 224.58/224.74  |- skos__broader mesh__D003561smesh__D001087
% 224.58/224.74  |- skos__altLabel mesh__D003561 Cytosine Arabinoside
% 224.58/224.74  |- mesh__historyNote mesh__D003561 66   
% 224.58/224.74  |- skos__hiddenLabel mesh__D016489 Nonpenetrating Head Injury
% 224.58/224.74  |- skos__hiddenLabel mesh__D016489 Nonpenetrating Head Injuries
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D016489 2001
% 224.58/224.74  |- skos__hiddenLabel mesh__D016489 Blunt Head Injuries
% 224.58/224.74  |- skos__annotation mesh__D016489
% 224.58/224.74       usually GEN or unspecified; coord with BRAIN INJURIES, TRAUMATIC only if both are discussed%A%  
% 224.58/224.74  |- skos__hiddenLabel mesh__D016489 Head Injuries, Blunt
% 224.58/224.74  |- skos__hiddenLabel mesh__D016489 Blunt Head Injury
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D016489 2004
% 224.58/224.74  |- skos__broader mesh__D016489smesh__D006259
% 224.58/224.74  |- skos__altLabel mesh__D016489 Head Trauma, Closed
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D016489 2002
% 224.58/224.74  |- rdf__type mesh__D016489sskos__Concept
% 224.58/224.74  |- mesh__dateEstablished mesh__D016489 1992-01-01
% 224.58/224.74  |- skos__scopeNote mesh__D016489
% 224.58/224.74       Traumatic injuries to the cranium where the integrity of the skull is not compromised and no bone fragments or other objects penetrate the skull and dura mater. This frequently results in mechanical injury being transmitted to intracranial structures which may produce traumatic brain injuries, hemorrhage, or cranial nerve injury. %28%From Rowland, Merritt%27%s Textbook of Neurology, 9th ed, p417%29%%A%    
% 224.58/224.74  |- mesh__historyNote mesh__D016489 92   
% 224.58/224.74  |- skos__altLabel mesh__D016489 Closed Head Injuries
% 224.58/224.74  |- mesh__dateRevised mesh__D016489 1999-11-08
% 224.58/224.74  |- mesh__publicMeSHNote mesh__D016489 92   
% 224.58/224.74  |- skos__hiddenLabel mesh__D016489 Head Injury, Closed
% 224.58/224.74  |- skos__hiddenLabel mesh__D016489 Closed Head Trauma
% 224.58/224.74  |- skos__hiddenLabel mesh__D016489 Trauma, Closed Head
% 224.58/224.74  |- mesh__recordOriginator mesh__D016489 AGS
% 224.58/224.74  |- skos__prefLabel mesh__D016489 Head Injuries, Closed
% 224.58/224.74  |- mesh__dateCreated mesh__D016489 1991-01-02
% 224.58/224.74  |- skos__hiddenLabel mesh__D016489 Closed Head Injury
% 224.58/224.74  |- skos__historyNote mesh__D016489 Head Injuries %28%1966-1991%29%
% 224.58/224.74  |- skos__altLabel mesh__D016489 Head Injuries, Nonpenetrating
% 224.58/224.74  |- skos__altLabel mesh__D016489 Injuries, Closed Head
% 224.58/224.74  |- skos__altLabel mesh__D016489 Head Injury, Nonpenetrating
% 224.58/224.74  |- skos__hiddenLabel mesh__D016489 Head Traumas, Closed
% 224.58/224.74  |- skos__hiddenLabel mesh__D016489 Traumas, Closed Head
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D016489 2005
% 224.58/224.74  |- mesh__recordAuthorizer mesh__D016489 sjn
% 224.58/224.74  |- mesh__recordMaintainer mesh__D016489 KEV
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D016489 2000
% 224.58/224.74  |- skos__broader mesh__D016489smesh__D014949
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D016489 2006
% 224.58/224.74  |- skos__hiddenLabel mesh__D016489 Closed Head Traumas
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D016489 2003
% 224.58/224.74  |- mesh__recordMaintainer mesh__D002469 TAP
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D002469 2006
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D002469 2002
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D002469 2005
% 224.58/224.74  |- skos__related mesh__D002469smesh__D001781
% 224.58/224.74  |- skos__hiddenLabel mesh__D002469 Segregation, Cell
% 224.58/224.74  |- skos__altLabel mesh__D002469 Cell Segregation
% 224.58/224.74  |- skos__altLabel mesh__D002469 Isolation, Cell
% 224.58/224.74  |- rdf__type mesh__D002469sskos__Concept
% 224.58/224.74  |- skos__annotation mesh__D002469
% 224.58/224.74       separation of 2 or more cells; do not confuse with CELL FRACTIONATION; NIM, no qualif; when IM, qualif permitted; not for micro-organisms; flow cell sorting %26% fluorescence- activated cell sorting: coord with FLOW CYTOMETRY%A%  
% 224.58/224.74  |- skos__hiddenLabel mesh__D002469 Cell Segregations
% 224.58/224.74  |- mesh__publicMeSHNote mesh__D002469 74   
% 224.58/224.74  |- mesh__recordAuthorizer mesh__D002469 sjn
% 224.58/224.74  |- mesh__dateRevised mesh__D002469 2000-06-22
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D002469 2001
% 224.58/224.74  |- skos__hiddenLabel mesh__D002469 Separations, Cell
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D002469 2004
% 224.58/224.74  |- skos__hiddenLabel mesh__D002469 Segregations, Cell
% 224.58/224.74  |- skos__altLabel mesh__D002469 Cell Isolation
% 224.58/224.74  |- skos__broader mesh__D002469smesh__D003584
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D002469 2003
% 224.58/224.74  |- skos__related mesh__D002469smesh__D010956
% 224.58/224.74  |- skos__hiddenLabel mesh__D002469 Cell Separations
% 224.58/224.74  |- skos__prefLabel mesh__D002469 Cell Separation
% 224.58/224.74  |- skos__hiddenLabel mesh__D002469 Separation, Cell
% 224.58/224.74  |- skos__hiddenLabel mesh__D002469 Isolations, Cell
% 224.58/224.74  |- skos__hiddenLabel mesh__D002469 Cell Isolations
% 224.58/224.74  |- mesh__dateEstablished mesh__D002469 1974-01-01
% 224.58/224.74  |- mesh__recordOriginator mesh__D002469 NLM
% 224.58/224.74  |- mesh__historyNote mesh__D002469 74%28%72%29%   
% 224.58/224.74  |- mesh__dateCreated mesh__D002469 1999-01-01
% 224.58/224.74  |- mesh__dateRevised mesh__D013191 2005-06-30
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D013191 2006
% 224.58/224.74  |- mesh__dateEstablished mesh__D013191 1991-01-01
% 224.58/224.74  |- mesh__recordAuthorizer mesh__D013191 sjn
% 224.58/224.74  |- skos__scopeNote mesh__D013191
% 224.58/224.74       A mitosporic fungal genus including one species which forms a toxin in moldy hay that may cause a serious illness in horses.%A%    
% 224.58/224.74  |- skos__broader mesh__D013191smesh__D003904
% 224.58/224.74  |- skos__prefLabel mesh__D013191 Stachybotrys
% 224.58/224.74  |- mesh__dateCreated mesh__D013191 1974-12-12
% 224.58/224.74  |- mesh__publicMeSHNote mesh__D013191
% 224.58/224.74       91; see HYPHOMYCETES 1986-90, see MONILIALES 1975-85   
% 224.58/224.74  |- rdf__type mesh__D013191sskos__Concept
% 224.58/224.74  |- mesh__historyNote mesh__D013191 91%28%75%29%   
% 224.58/224.74  |- mesh__recordOriginator mesh__D013191 NLM
% 224.58/224.74  |- mesh__recordMaintainer mesh__D013191 SYSTEM
% 224.58/224.74  |- skos__hiddenLabel mesh__D007952 Cell Leukemia, Plasma
% 224.58/224.74  |- skos__hiddenLabel mesh__D007952 Leukemias, Plasmacytic
% 224.58/224.74  |- skos__altLabel mesh__D007952 Plasmacytic Leukemia
% 224.58/224.74  |- mesh__historyNote mesh__D007952 67   
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007952 2004
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007952 2001
% 224.58/224.74  |- mesh__recordOriginator mesh__D007952 NLM
% 224.58/224.74  |- skos__hiddenLabel mesh__D007952 Plasma Cell Leukemias
% 224.58/224.74  |- skos__annotation mesh__D007952
% 224.58/224.74       do not use /blood supply /chem /second /secret /ultrastruct%A%  
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007952 2006
% 224.58/224.74  |- mesh__dateEstablished mesh__D007952 1967-01-01
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007952 2003
% 224.58/224.74  |- mesh__dateRevised mesh__D007952 1997-06-20
% 224.58/224.74  |- skos__broader mesh__D007952smesh__D008232
% 224.58/224.74  |- skos__altLabel mesh__D007952 Plasma Cell Leukemia
% 224.58/224.74  |- skos__hiddenLabel mesh__D007952 Leukemias, Plasma Cell
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007952 2005
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007952 2000
% 224.58/224.74  |- skos__prefLabel mesh__D007952 Leukemia, Plasmacytic
% 224.58/224.74  |- skos__broader mesh__D007952smesh__D007938
% 224.58/224.74  |- mesh__dateCreated mesh__D007952 1999-01-01
% 224.58/224.74  |- mesh__recordMaintainer mesh__D007952 TGC
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007952 1999
% 224.58/224.74  |- skos__hiddenLabel mesh__D007952 Cell Leukemias, Plasma
% 224.58/224.74  |- mesh__publicMeSHNote mesh__D007952 67   
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007952 1998
% 224.58/224.74  |- mesh__recordAuthorizer mesh__D007952 SJN
% 224.58/224.74  |- skos__hiddenLabel mesh__D007952 Plasmacytic Leukemias
% 224.58/224.74  |- rdf__type mesh__D007952sskos__Concept
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007952 2002
% 224.58/224.74  |- skos__historyNote mesh__D007952 Leukemia %28%1966%29%
% 224.58/224.74  |- skos__altLabel mesh__D007952 Leukemia, Plasma Cell
% 224.58/224.74  |- skos__annotation mesh__D029606
% 224.58/224.74       prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.58/224.74  |- mesh__recordAuthorizer mesh__D029606 sjn
% 224.58/224.74  |- mesh__recordMaintainer mesh__D029606 ssb
% 224.58/224.74  |- mesh__recordOriginator mesh__D029606 ssb
% 224.58/224.74  |- mesh__dateRevised mesh__D029606 2002-07-03
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D029606 2003
% 224.58/224.74  |- skos__broader mesh__D029606smesh__D019684
% 224.58/224.74  |- rdf__type mesh__D029606sskos__Concept
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D029606 2005
% 224.58/224.74  |- mesh__dateCreated mesh__D029606 2001-07-25
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D029606 2004
% 224.58/224.74  |- mesh__historyNote mesh__D029606 2002   
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D029606 2006
% 224.58/224.74  |- skos__prefLabel mesh__D029606 Plumbaginaceae
% 224.58/224.74  |- mesh__publicMeSHNote mesh__D029606 2002   
% 224.58/224.74  |- skos__scopeNote mesh__D029606
% 224.58/224.74       A plant family of the order Plumbaginales, subclass Caryophyllidae, class Magnoliopsida of shrubs and herbs. Some members contain anthocyanins and naphthaquinones.%A%    
% 224.58/224.74  |- mesh__dateEstablished mesh__D029606 2002-01-01
% 224.58/224.74  |- rdf__type mesh__D007154sskos__Concept
% 224.58/224.74  |- skos__hiddenLabel mesh__D007154 Immunological Disease
% 224.58/224.74  |- skos__hiddenLabel mesh__D007154 Disease, Immunological
% 224.58/224.74  |- skos__hiddenLabel mesh__D007154 Diseases, Immunologic
% 224.58/224.74  |- mesh__runningHead mesh__D007154 C20 - DISEASES-IMMUNE   
% 224.58/224.74  |- skos__altLabel mesh__D007154 Immunologic Diseases
% 224.58/224.74  |- skos__hiddenLabel mesh__D007154 Immune Disorder
% 224.58/224.74  |- skos__hiddenLabel mesh__D007154 Immune System Disease
% 224.58/224.74  |- mesh__recordMaintainer mesh__D007154 lkt
% 224.58/224.74  |- mesh__historyNote mesh__D007154 2005 %28%1971%29%   
% 224.58/224.74  |- skos__annotation mesh__D007154 GEN: prefer specifics   
% 224.58/224.74  |- skos__scopeNote mesh__D007154
% 224.58/224.74       Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both.%A%    
% 224.58/224.74  |- skos__altLabel mesh__D007154 Diseases of Immune System
% 224.58/224.74  |- skos__hiddenLabel mesh__D007154 Disease, Immunologic
% 224.58/224.74  |- skos__historyNote mesh__D007154 Allergy and Immunology %28%1966-1970%29%
% 224.58/224.74  |- skos__hiddenLabel mesh__D007154 Disorder, Immune
% 224.58/224.74  |- skos__hiddenLabel mesh__D007154 Diseases, Immune System
% 224.58/224.74  |- skos__prefLabel mesh__D007154 Immune System Diseases
% 224.58/224.74  |- mesh__publicMeSHNote mesh__D007154
% 224.58/224.74       2005; see IMMUNOLOGIC DISEASES 1971-2004   
% 224.58/224.74  |- skos__hiddenLabel mesh__D007154 Immunologic Disease
% 224.58/224.74  |- skos__hiddenLabel mesh__D007154 Disease, Immune System
% 224.58/224.74  |- skos__hiddenLabel mesh__D007154 Disease, Immune
% 224.58/224.74  |- skos__altLabel mesh__D007154 Immunological Diseases
% 224.58/224.74  |- skos__altLabel mesh__D007154 Immune Diseases
% 224.58/224.74  |- mesh__recordAuthorizer mesh__D007154 sjn
% 224.58/224.74  |- skos__hiddenLabel mesh__D007154 Diseases, Immune
% 224.58/224.74  |- mesh__dateRevised mesh__D007154 2004-07-07
% 224.58/224.74  |- mesh__activeMeSHYear mesh__D007154 2006
% 224.58/224.75  |- skos__hiddenLabel mesh__D007154 Immune Disease
% 224.58/224.75  |- mesh__dateEstablished mesh__D007154 1971-01-01
% 224.58/224.75  |- skos__hiddenLabel mesh__D007154 Disorders, Immune
% 224.58/224.75  |- skos__hiddenLabel mesh__D007154 Diseases, Immunological
% 224.58/224.75  |- mesh__recordOriginator mesh__D007154 NLM
% 224.58/224.75  |- skos__related mesh__D007154smesh__D001796
% 224.58/224.75  |- skos__altLabel mesh__D007154 Immune Disorders
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D007154 2005
% 224.58/224.75  |- mesh__dateCreated mesh__D007154 1999-01-01
% 224.58/224.75  |- mesh__dateRevised mesh__D012897 1992-05-22
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D012897 2000
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D012897 1997
% 224.58/224.75  |- mesh__recordAuthorizer mesh__D012897 PLS
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D012897 1996
% 224.58/224.75  |- skos__related mesh__D012897smesh__D017096
% 224.58/224.75  |- mesh__recordMaintainer mesh__D012897 AGS
% 224.58/224.75  |- mesh__dateCreated mesh__D012897 1999-01-01
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D012897 2006
% 224.58/224.75  |- skos__broader mesh__D012897smesh__D014777
% 224.58/224.75  |- mesh__dateEstablished mesh__D012897 1972-01-01
% 224.58/224.75  |- skos__scopeNote mesh__D012897
% 224.58/224.75       Diseases of viral origin, characterized by incubation periods of months to years, insidious onset of clinical manifestations, and protracted clinical course. Though the disease process is protracted, viral multiplication may not be unusually slow. Conventional viruses produce slow virus diseases such as SUBACUTE SCLEROSING PANENCEPHALITIS, progressive multifocal leukoencephalopathy %28%LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL%29%, and AIDS. Diseases produced by unconventional agents were originally considered part of this group. They are now called PRION DISEASES.%A%    
% 224.58/224.75  |- skos__hiddenLabel mesh__D012897 Virus Disease, Slow
% 224.58/224.75  |- mesh__historyNote mesh__D012897 72%28%68%29%   
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D012897 2005
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D012897 1995
% 224.58/224.75  |- mesh__publicMeSHNote mesh__D012897 72   
% 224.58/224.75  |- rdf__type mesh__D012897sskos__Concept
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D012897 2002
% 224.58/224.75  |- skos__hiddenLabel mesh__D012897 Slow Virus Disease
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D012897 1999
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D012897 2004
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D012897 1994
% 224.58/224.75  |- mesh__recordOriginator mesh__D012897 NLM
% 224.58/224.75  |- skos__hiddenLabel mesh__D012897 Virus Diseases, Slow
% 224.58/224.75  |- skos__hiddenLabel mesh__D012897 Diseases, Slow Virus
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D012897 2001
% 224.58/224.75  |- skos__historyNote mesh__D012897 Virus Diseases %28%1966-1967%29%
% 224.58/224.75  |- skos__prefLabel mesh__D012897 Slow Virus Diseases
% 224.58/224.75  |- skos__hiddenLabel mesh__D012897 Disease, Slow Virus
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D012897 1993
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D012897 1998
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D012897 2003
% 224.58/224.75  |- skos__annotation mesh__D012897
% 224.58/224.75       caused by viruses incubating months to years; some dis formerly called slow virus dis are now considered prion dis: see note there; GEN or unspecified: prefer specifics%A%  
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D012099 2004
% 224.58/224.75  |- skos__hiddenLabel mesh__D012099 Technic, Reproduction
% 224.58/224.75  |- skos__hiddenLabel mesh__D012099 Technics, Reproduction
% 224.58/224.75  |- skos__broader mesh__D012099smesh__D008919
% 224.58/224.75  |- skos__scopeNote mesh__D012099
% 224.58/224.75       Methods pertaining to the generation of new individuals, including techniques used in selective BREEDING, cloning %28%CLONING, ORGANISM%29%, and assisted reproduction %28%REPRODUCTIVE TECHNIQUES, ASSISTED%29%.%A%    
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D012099 2002
% 224.58/224.75  |- skos__hiddenLabel mesh__D012099 Technique, Reproduction
% 224.58/224.75  |- skos__hiddenLabel mesh__D012099 Techniques, Reproductive
% 224.58/224.75  |- skos__hiddenLabel mesh__D012099 Technique, Reproductive
% 224.58/224.75  |- skos__hiddenLabel mesh__D012099 Reproduction Technic
% 224.58/224.75  |- mesh__recordMaintainer mesh__D012099 tjk
% 224.58/224.75  |- skos__altLabel mesh__D012099 Reproduction Techniques
% 224.58/224.75  |- mesh__dateRevised mesh__D012099 2001-07-25
% 224.58/224.75  |- skos__prefLabel mesh__D012099 Reproductive Techniques
% 224.58/224.75  |- mesh__historyNote mesh__D012099
% 224.58/224.75       91; was REPRODUCTION TECHNICS 1988-90; was non-MeSH before 1988%A%  
% 224.58/224.75  |- mesh__publicMeSHNote mesh__D012099
% 224.58/224.75       91; was REPRODUCTION TECHNICS 1988-90   
% 224.58/224.75  |- skos__broader mesh__D012099smesh__D013812
% 224.58/224.75  |- rdf__type mesh__D012099sskos__Concept
% 224.58/224.75  |- mesh__onlineNote mesh__D012099
% 224.58/224.75       use REPRODUCTION TECHNIQUES to search REPRODUCTION TECHNICS 1988-90%A%  
% 224.58/224.75  |- skos__hiddenLabel mesh__D012099 Technologies, Reproductive
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D012099 2005
% 224.58/224.75  |- mesh__dateCreated mesh__D012099 1974-11-19
% 224.58/224.75  |- skos__altLabel mesh__D012099 Reproduction Technics
% 224.58/224.75  |- skos__hiddenLabel mesh__D012099 Reproduction Technique
% 224.58/224.75  |- skos__altLabel mesh__D012099 Reproductive Technologies
% 224.58/224.75  |- mesh__recordOriginator mesh__D012099 NLM
% 224.58/224.75  |- mesh__recordAuthorizer mesh__D012099 sjn
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D012099 2003
% 224.58/224.75  |- skos__hiddenLabel mesh__D012099 Techniques, Reproduction
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D012099 2006
% 224.58/224.75  |- skos__altLabel mesh__D012099 Technology, Reproductive
% 224.58/224.75  |- skos__annotation mesh__D012099
% 224.58/224.75       GEN only; prefer REPRODUCTIVE TECHNIQUES, ASSISTED and its specifics %28%human %26% animal%29% or BREEDING and its specifics %28%animal only%29%%A%  
% 224.58/224.75  |- mesh__dateEstablished mesh__D012099 1988-01-01
% 224.58/224.75  |- skos__hiddenLabel mesh__D012099 Reproductive Technique
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D017582 2006
% 224.58/224.75  |- skos__altLabel mesh__D017582 Replacement Therapy, Kidney
% 224.58/224.75  |- skos__hiddenLabel mesh__D017582 Therapies, Kidney Replacement
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D017582 2001
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D017582 1995
% 224.58/224.75  |- mesh__publicMeSHNote mesh__D017582 94   
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D017582 2003
% 224.58/224.75  |- skos__hiddenLabel mesh__D017582 Therapies, Renal Replacement
% 224.58/224.75  |- mesh__dateCreated mesh__D017582 1992-12-28
% 224.58/224.75  |- skos__altLabel mesh__D017582 Replacement Therapy, Renal
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D017582 1998
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D017582 2004
% 224.58/224.75  |- skos__altLabel mesh__D017582 Therapy, Renal Replacement
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D017582 1999
% 224.58/224.75  |- skos__altLabel mesh__D017582 Kidney Replacement Therapy
% 224.58/224.75  |- skos__hiddenLabel mesh__D017582 Replacement Therapies, Kidney
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D017582 2002
% 224.58/224.75  |- skos__broader mesh__D017582smesh__D013812
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D017582 1996
% 224.58/224.75  |- skos__hiddenLabel mesh__D017582 Renal Replacement Therapies
% 224.58/224.75  |- skos__altLabel mesh__D017582 Therapy, Kidney Replacement
% 224.58/224.75  |- skos__related mesh__D017582smesh__D007674
% 224.58/224.75  |- skos__hiddenLabel mesh__D017582 Replacement Therapies, Renal
% 224.58/224.75  |- mesh__historyNote mesh__D017582 94   
% 224.58/224.75  |- mesh__dateEstablished mesh__D017582 1994-01-01
% 224.58/224.75  |- skos__prefLabel mesh__D017582 Renal Replacement Therapy
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D017582 1997
% 224.58/224.75  |- skos__scopeNote mesh__D017582
% 224.58/224.75       Procedures which temporarily or permanently remedy insufficient cleansing of body fluids by the kidneys.%A%    
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D017582 2000
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D017582 2005
% 224.58/224.75  |- skos__hiddenLabel mesh__D017582 Kidney Replacement Therapies
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D017582 1994
% 224.58/224.75  |- rdf__type mesh__D017582sskos__Concept
% 224.58/224.75  |- skos__annotation mesh__D017582
% 224.58/224.75       to substitute for or augment kidney function; GEN or unspecified; prefer specifics; do not use /util except by MeSH definition; DF: RENAL REPLACE THER%A%  
% 224.58/224.75  |- skos__related mesh__D017582smesh__D007668
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D031253 2004
% 224.58/224.75  |- mesh__historyNote mesh__D031253 2003   
% 224.58/224.75  |- rdf__type mesh__D031253sskos__Concept
% 224.58/224.75  |- skos__prefLabel mesh__D031253 Calystegia
% 224.58/224.75  |- skos__scopeNote mesh__D031253
% 224.58/224.75       A plant genus of the family CONVOLVULACEAE. Members contain calystegine and calystegins.%A%    
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D031253 2005
% 224.58/224.75  |- skos__broader mesh__D031253smesh__D027722
% 224.58/224.75  |- mesh__publicMeSHNote mesh__D031253 2003   
% 224.58/224.75  |- skos__altLabel mesh__D031253 Bindweed, False
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D031253 2006
% 224.58/224.75  |- skos__annotation mesh__D031253
% 224.58/224.75       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.58/224.75  |- mesh__dateCreated mesh__D031253 2002-07-02
% 224.58/224.75  |- mesh__dateEstablished mesh__D031253 2003-01-01
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D031253 2003
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D003562 2006
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D003562 2005
% 224.58/224.75  |- mesh__recordMaintainer mesh__D003562 ssb
% 224.58/224.75  |- mesh__historyNote mesh__D003562 72; was see under NUCLEOSIDES 1963-71   
% 224.58/224.75  |- skos__historyNote mesh__D003562 Nucleosides %28%1966-1971%29%
% 224.58/224.75  |- mesh__publicMeSHNote mesh__D003562
% 224.58/224.75       72; was see under NUCLEOSIDES 1963-71   
% 224.58/224.75  |- mesh__dateEstablished mesh__D003562 1972-01-01
% 224.58/224.75  |- mesh__recordAuthorizer mesh__D003562 sjn
% 224.58/224.75  |- mesh__dateRevised mesh__D003562 2004-07-07
% 224.58/224.75  |- skos__scopeNote mesh__D003562
% 224.58/224.75       A pyrimidine nucleoside that is composed of the base CYTOSINE linked to the five-carbon sugar D-RIBOSE.%A%    
% 224.58/224.75  |- rdf__type mesh__D003562sskos__Concept
% 224.58/224.75  |- skos__hiddenLabel mesh__D003562 Ribonucleoside, Cytosine
% 224.58/224.75  |- mesh__recordOriginator mesh__D003562 NLM
% 224.58/224.75  |- skos__prefLabel mesh__D003562 Cytidine
% 224.58/224.75  |- skos__broader mesh__D003562smesh__D012263
% 224.58/224.75  |- skos__altLabel mesh__D003562 Cytosine Riboside
% 224.58/224.75  |- skos__broader mesh__D003562smesh__D011741
% 224.58/224.75  |- skos__altLabel mesh__D003562 Cytosine Ribonucleoside
% 224.58/224.75  |- mesh__dateCreated mesh__D003562 1999-01-01
% 224.58/224.75  |- mesh__onlineNote mesh__D003562 search NUCLEOSIDES 1966-71   
% 224.58/224.75  |- skos__hiddenLabel mesh__D003562 Riboside, Cytosine
% 224.58/224.75  |- skos__historyNote mesh__D041681 Cell Line %28%1978-1991%29%
% 224.58/224.75  |- skos__hiddenLabel mesh__D041681 Cells, NIH-3T3
% 224.58/224.75  |- mesh__dateEstablished mesh__D041681 2004-01-01
% 224.58/224.75  |- skos__altLabel mesh__D041681 NIH-3T3 Cells
% 224.58/224.75  |- rdf__type mesh__D041681sskos__Concept
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D041681 2004
% 224.58/224.75  |- skos__hiddenLabel mesh__D041681 Cell, NIH-3T3
% 224.58/224.75  |- mesh__dateCreated mesh__D041681 2003-07-09
% 224.58/224.75  |- skos__hiddenLabel mesh__D041681 3T3 Cell, NIH
% 224.58/224.75  |- skos__altLabel mesh__D041681 3T3 Cells, NIH
% 224.58/224.75  |- skos__annotation mesh__D041681
% 224.58/224.75       almost always NIM with no subheadings; check ANIMAL %26% MICE; do not routinely add FIBROBLASTS or EMBRYO%A%  
% 224.58/224.75  |- mesh__publicMeSHNote mesh__D041681 2004; see 3T3 CELLS 1992-2003   
% 224.58/224.75  |- skos__scopeNote mesh__D041681
% 224.58/224.75       A continuous cell line of high contact-inhibition established from NIH Swiss mouse embryo cultures. The cells are useful for DNA transfection and transformation studies. %28%From ATCC %5B%Internet%5D%. Virginia: American Type Culture Collection; c2002 %5B%cited 2002 Sept 26%5D%. Available from http://www.atcc.org/%29%%A%    
% 224.58/224.75  |- skos__broader mesh__D041681smesh__D016475
% 224.58/224.75  |- skos__prefLabel mesh__D041681 NIH 3T3 Cells
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D041681 2005
% 224.58/224.75  |- mesh__historyNote mesh__D041681 2004; use 3T3 CELLS 1992-2003   
% 224.58/224.75  |- skos__hiddenLabel mesh__D041681 NIH 3T3 Cell
% 224.58/224.75  |- skos__historyNote mesh__D041681 3T3 Cells %28%1991-2003%29%
% 224.58/224.75  |- skos__hiddenLabel mesh__D041681 NIH-3T3 Cell
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D041681 2006
% 224.58/224.75  |- skos__hiddenLabel mesh__D041681 Cells, NIH 3T3
% 224.58/224.75  |- skos__hiddenLabel mesh__D041681 Cell, NIH 3T3
% 224.58/224.75  |- mesh__dateCreated mesh__D013990 1974-12-12
% 224.58/224.75  |- mesh__historyNote mesh__D013990
% 224.58/224.75       91%28%75%29%; was see under LUNG VOLUME MEASUREMENTS 1975-90   
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013990 2006
% 224.58/224.75  |- skos__scopeNote mesh__D013990
% 224.58/224.75       The volume of air inspired or expired during each normal, quiet respiratory cycle. Common abbreviations are TV or V with subscript T.%A%    
% 224.58/224.75  |- skos__broader mesh__D013990smesh__D007320
% 224.58/224.75  |- mesh__publicMeSHNote mesh__D013990
% 224.58/224.75       91; was see under LUNG VOLUME MEASUREMENTS 1975-90   
% 224.58/224.75  |- rdf__type mesh__D013990sskos__Concept
% 224.58/224.75  |- skos__hiddenLabel mesh__D013990 Tidal Volumes
% 224.58/224.75  |- mesh__recordMaintainer mesh__D013990 nns
% 224.58/224.75  |- skos__annotation mesh__D013990 NIM; in texts as TV or Vt   
% 224.58/224.75  |- skos__hiddenLabel mesh__D013990 Volumes, Tidal
% 224.58/224.75  |- mesh__dateEstablished mesh__D013990 1991-01-01
% 224.58/224.75  |- skos__prefLabel mesh__D013990 Tidal Volume
% 224.58/224.75  |- mesh__recordAuthorizer mesh__D013990 sjn
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013990 2004
% 224.58/224.75  |- skos__hiddenLabel mesh__D013990 Volume, Tidal
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013990 2005
% 224.58/224.75  |- mesh__dateRevised mesh__D013990 2003-07-09
% 224.58/224.75  |- mesh__recordOriginator mesh__D013990 NLM
% 224.58/224.75  |- skos__historyNote mesh__D013192 Inservice Training %28%1967-1985%29%
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013192 1996
% 224.58/224.75  |- skos__historyNote mesh__D013192
% 224.58/224.75       Nursing Staff, Hospital/education %28%1968-1985%29%
% 224.58/224.75  |- mesh__dateCreated mesh__D013192 1985-03-11
% 224.58/224.75  |- mesh__recordOriginator mesh__D013192 EC
% 224.58/224.75  |- mesh__recordMaintainer mesh__D013192 TGC
% 224.58/224.75  |- rdf__type mesh__D013192sskos__Concept
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013192 1997
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013192 2002
% 224.58/224.75  |- mesh__dateRevised mesh__D013192 1992-05-18
% 224.58/224.75  |- skos__hiddenLabel mesh__D013192 Development, Staff
% 224.58/224.75  |- mesh__historyNote mesh__D013192
% 224.58/224.75       91%28%86%29%; was see under PERSONNEL MANAGEMENT 1986-90   
% 224.58/224.75  |- skos__scopeNote mesh__D013192
% 224.58/224.75       The process by which the employer promotes staff performance and efficiency consistent with management goals and objectives.%A%    
% 224.58/224.75  |- skos__historyNote mesh__D013192
% 224.58/224.75       Education, Nursing, Continuing %28%1966-1985%29%
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013192 2005
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013192 1994
% 224.58/224.75  |- skos__broader mesh__D013192smesh__D010559
% 224.58/224.75  |- skos__hiddenLabel mesh__D013192 Development, Human Resources
% 224.58/224.75  |- skos__hiddenLabel mesh__D013192 Resources Development, Human
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013192 2006
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013192 1995
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013192 2000
% 224.58/224.75  |- mesh__recordAuthorizer mesh__D013192 PLS
% 224.58/224.75  |- mesh__publicMeSHNote mesh__D013192
% 224.58/224.75       91; was see under PERSONNEL MANAGEMENT 1986-90   
% 224.58/224.75  |- skos__broader mesh__D013192smesh__D007318
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013192 2003
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013192 1998
% 224.58/224.75  |- skos__prefLabel mesh__D013192 Staff Development
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013192 2001
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013192 1993
% 224.58/224.75  |- mesh__dateEstablished mesh__D013192 1991-01-01
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013192 2004
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013192 1999
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D007953 1997
% 224.58/224.75  |- skos__annotation mesh__D007953
% 224.58/224.75       coord IM with specific type of LEUKEMIA %28%IM%29%; do not use /blood supply /chem /second /secret /ultrastruct; policy: Manual 24.4.3.2%A%  
% 224.58/224.75  |- mesh__dateCreated mesh__D007953 1999-01-01
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D007953 1999
% 224.58/224.75  |- skos__related mesh__D007953smesh__D016721
% 224.58/224.75  |- skos__altLabel mesh__D007953 Radiation-Induced Leukemia
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D007953 1996
% 224.58/224.75  |- skos__related mesh__D007953smesh__D016609
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D007953 2002
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D007953 1998
% 224.58/224.75  |- skos__hiddenLabel mesh__D007953 Radiation Induced Leukemia
% 224.58/224.75  |- mesh__dateRevised mesh__D007953 1995-06-08
% 224.58/224.75  |- rdf__type mesh__D007953sskos__Concept
% 224.58/224.75  |- skos__hiddenLabel mesh__D007953 Leukemia, Radiation Induced
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D007953 2001
% 224.58/224.75  |- mesh__recordOriginator mesh__D007953 NLM
% 224.58/224.75  |- mesh__recordMaintainer mesh__D007953 KEV
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D007953 2004
% 224.58/224.75  |- skos__hiddenLabel mesh__D007953 Radiation-Induced Leukemias
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D007953 2000
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D007953 2006
% 224.58/224.75  |- skos__prefLabel mesh__D007953 Leukemia, Radiation-Induced
% 224.58/224.75  |- skos__hiddenLabel mesh__D007953 Leukemias, Radiation-Induced
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D007953 2003
% 224.58/224.75  |- skos__broader mesh__D007953smesh__D007938
% 224.58/224.75  |- skos__broader mesh__D007953smesh__D011832
% 224.58/224.75  |- skos__broader mesh__D007953smesh__D009381
% 224.58/224.75  |- mesh__recordAuthorizer mesh__D007953 PLS
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D007953 2005
% 224.58/224.75  |- mesh__recordMaintainer mesh__D029607 SYSTEM
% 224.58/224.75  |- mesh__historyNote mesh__D029607
% 224.58/224.75       2002; for SEMINAL VESICLE CLOTTING PROTEIN use SEMINAL VESICAL SECRETORY PROTEINS %28%NM%29% 1987-2001%A%  
% 224.58/224.75  |- skos__scopeNote mesh__D029607
% 224.58/224.75       The secretory proteins of the seminal vesicles are proteins and enzymes that are important in the rapid clotting of the ejaculate. The major clotting protein is seminal vesicle-specific antigen. Many of these seminal vesicle proteins are under androgen regulation, and are substrates for the prostatic enzymes, such as the PROSTATE-SPECIFIC ANTIGEN, a  protease and an esterase.%A%    
% 224.58/224.75  |- skos__hiddenLabel mesh__D029607 Vesicle Proteins, Seminal
% 224.58/224.75  |- mesh__publicMeSHNote mesh__D029607
% 224.58/224.75       2002; SEMINAL VESICLE CLOTTING PROTEIN was indexed under PROTEINS 1987-2001%A%  
% 224.58/224.75  |- skos__altLabel mesh__D029607 Seminal Vesicle Clotting Protein
% 224.58/224.75  |- skos__altLabel mesh__D029607 Seminal Vesicle Proteins
% 224.58/224.75  |- mesh__dateEstablished mesh__D029607 2002-01-01
% 224.58/224.75  |- mesh__recordAuthorizer mesh__D029607 sjn
% 224.58/224.75  |- skos__broader mesh__D029607smesh__D029589
% 224.58/224.75  |- mesh__dateCreated mesh__D029607 2001-07-25
% 224.58/224.75  |- skos__historyNote mesh__D029607 Proteins %28%1980-2001%29%
% 224.58/224.75  |- skos__prefLabel mesh__D029607 Seminal Vesicle Secretory Proteins
% 224.58/224.75  |- mesh__recordOriginator mesh__D029607 lkt
% 224.58/224.75  |- mesh__dateRevised mesh__D029607 2005-06-30
% 224.58/224.75  |- rdf__type mesh__D029607sskos__Concept
% 224.58/224.75  |- skos__altLabel mesh__D029607 Clotting Protein %28%Seminal Vesicle%29%
% 224.58/224.75  |- skos__historyNote mesh__D029607 Plasma Proteins %28%1979-1980%29%
% 224.58/224.75  |- skos__altLabel mesh__D029607 Clotting Proteins %28%Seminal Vesicle%29%
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D029607 2006
% 224.58/224.75  |- skos__hiddenLabel mesh__D029607 Proteins, Seminal Vesicle
% 224.58/224.75  |- mesh__recordAuthorizer mesh__D007155 sjn
% 224.58/224.75  |- skos__altLabel mesh__D007155 Factors, Immunologic
% 224.58/224.75  |- skos__scopeNote mesh__D007155
% 224.58/224.75       Biologically active substances whose activities affect or play a role in the functioning of the immune system.%A%    
% 224.58/224.75  |- skos__broader mesh__D007155smesh__D045505
% 224.58/224.75  |- skos__altLabel mesh__D007155 Immunological Factors
% 224.58/224.75  |- mesh__dateEstablished mesh__D007155 1998-01-01
% 224.58/224.75  |- skos__hiddenLabel mesh__D007155 Factors, Immunological
% 224.58/224.75  |- mesh__recordOriginator mesh__D007155 NLM
% 224.58/224.75  |- mesh__publicMeSHNote mesh__D007155
% 224.58/224.75       1998; for IMMUNOMODULATORS see ADJUVANTS, IMMUNOLOGIC 1980-2004%A%  
% 224.58/224.75  |- mesh__historyNote mesh__D007155
% 224.58/224.75       1998; for IMMUNOMODULATORS use ADJUVANTS, IMMUNOLOGIC 1980-2004%A%  
% 224.58/224.75  |- skos__hiddenLabel mesh__D007155 Factors, Immune
% 224.58/224.75  |- mesh__dateCreated mesh__D007155 1999-01-01
% 224.58/224.75  |- mesh__dateRevised mesh__D007155 2005-06-30
% 224.58/224.75  |- skos__altLabel mesh__D007155 Immune Factors
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D007155 2006
% 224.58/224.75  |- skos__prefLabel mesh__D007155 Immunologic Factors
% 224.58/224.75  |- rdf__type mesh__D007155sskos__Concept
% 224.58/224.75  |- mesh__recordMaintainer mesh__D007155 ssb
% 224.58/224.75  |- mesh__dateCreated mesh__D012898 1999-01-01
% 224.58/224.75  |- mesh__onlineNote mesh__D012898
% 224.58/224.75       use AUTACOIDS to search SLOW-REACTING SUBSTANCES 1967-94 %28%as Prov 1967-73%29%%A%  
% 224.58/224.75  |- mesh__publicMeSHNote mesh__D012898
% 224.58/224.75       95; was SLOW-REACTING SUBSTANCES 1974-94; AUTACOIDS was see SLOW-REACTING SUBSTANCES 1978-94%A%  
% 224.58/224.75  |- mesh__recordOriginator mesh__D012898 NLM
% 224.58/224.75  |- mesh__recordAuthorizer mesh__D012898 sjn
% 224.58/224.75  |- skos__hiddenLabel mesh__D012898 Slow Reacting Substances
% 224.58/224.75  |- mesh__dateRevised mesh__D012898 2005-06-30
% 224.58/224.75  |- skos__annotation mesh__D012898
% 224.58/224.75       slow-reacting substances: note X ref; GEN or unspecified; prefer specifics%A%  
% 224.58/224.75  |- skos__altLabel mesh__D012898 Slow-Reacting Substances
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D012898 2006
% 224.58/224.75  |- skos__hiddenLabel mesh__D012898 Substances, Slow-Reacting
% 224.58/224.75  |- mesh__recordMaintainer mesh__D012898 ssb
% 224.58/224.75  |- mesh__dateEstablished mesh__D012898 1974-01-01
% 224.58/224.75  |- rdf__type mesh__D012898sskos__Concept
% 224.58/224.75  |- mesh__historyNote mesh__D012898
% 224.58/224.75       95; was SLOW-REACTING SUBSTANCES 1967-94 %28%Prov 1967-73%29%; AUTACOIDS was see SLOW-REACTING SUBSTANCES 1978-94%A%  
% 224.58/224.75  |- skos__historyNote mesh__D012898 specific tissue %28%1966%29%
% 224.58/224.75  |- skos__broader mesh__D012898smesh__D018836
% 224.58/224.75  |- skos__historyNote mesh__D012898 Muscle, Smooth/physiology %28%1966%29%
% 224.58/224.75  |- skos__scopeNote mesh__D012898
% 224.58/224.75       A chemically diverse group of substances produced by various tissues in the body that cause slow contraction of smooth muscle; they have other intense but varied pharmacologic activities.%A%    
% 224.58/224.75  |- skos__prefLabel mesh__D012898 Autacoids
% 224.58/224.75  |- skos__historyNote mesh__D017583 Hemofiltration %28%1987-1993%29%
% 224.58/224.75  |- skos__hiddenLabel mesh__D017583 Acetate-Free Biofiltrations
% 224.58/224.75  |- skos__historyNote mesh__D017583 Ultrafiltration %28%1975-1993%29%
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D017583 2004
% 224.58/224.75  |- skos__hiddenLabel mesh__D017583 Acetate Free Biofiltration
% 224.58/224.75  |- skos__scopeNote mesh__D017583
% 224.58/224.75       The combination of hemodialysis and hemofiltration either simultaneously or sequentially. Convective transport %28%hemofiltration%29% may be better for removal of larger molecular weight substances and diffusive transport %28%hemodialysis%29% for smaller molecular weight solutes.%A%    
% 224.58/224.75  |- mesh__recordAuthorizer mesh__D017583 sjn
% 224.58/224.75  |- mesh__dateCreated mesh__D017583 1993-07-02
% 224.58/224.75  |- skos__hiddenLabel mesh__D017583 Biofiltrations, Acetate-Free
% 224.58/224.75  |- skos__hiddenLabel mesh__D017583 Biofiltration, Acetate Free
% 224.58/224.75  |- mesh__publicMeSHNote mesh__D017583 94   
% 224.58/224.75  |- mesh__dateRevised mesh__D017583 2002-07-02
% 224.58/224.75  |- mesh__historyNote mesh__D017583 94   
% 224.58/224.75  |- skos__broader mesh__D017583smesh__D006435
% 224.58/224.75  |- skos__historyNote mesh__D017583 Hemodialysis %28%1975-1993%29%
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D017583 2005
% 224.58/224.75  |- skos__altLabel mesh__D017583 Biofiltration, Acetate-Free
% 224.58/224.75  |- rdf__type mesh__D017583sskos__Concept
% 224.58/224.75  |- mesh__recordMaintainer mesh__D017583 lkt
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D017583 2006
% 224.58/224.75  |- skos__prefLabel mesh__D017583 Hemodiafiltration
% 224.58/224.75  |- mesh__recordOriginator mesh__D017583 RAZ
% 224.58/224.75  |- skos__broader mesh__D017583smesh__D006440
% 224.58/224.75  |- mesh__dateEstablished mesh__D017583 1994-01-01
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D017583 2003
% 224.58/224.75  |- rdf__type mesh__D031254sskos__Concept
% 224.58/224.75  |- skos__prefLabel mesh__D031254 Convolvulus
% 224.58/224.75  |- skos__altLabel mesh__D031254 Bindweed, Field
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D031254 2005
% 224.58/224.75  |- mesh__publicMeSHNote mesh__D031254 2003   
% 224.58/224.75  |- skos__broader mesh__D031254smesh__D027722
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D031254 2006
% 224.58/224.75  |- mesh__historyNote mesh__D031254 2003   
% 224.58/224.75  |- skos__annotation mesh__D031254
% 224.58/224.75       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D031254 2003
% 224.58/224.75  |- skos__scopeNote mesh__D031254
% 224.58/224.75       A plant genus of the family CONVOLVULACEAE. The common name of  morning glory also refers to IPOMOEA. The common name of bindweed also refers to IPOMOEA; CALYSTEGIA; or POLYGONUM.%A%    
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D031254 2004
% 224.58/224.75  |- mesh__dateCreated mesh__D031254 2002-07-02
% 224.58/224.75  |- mesh__dateEstablished mesh__D031254 2003-01-01
% 224.58/224.75  |- mesh__historyNote mesh__D003563
% 224.58/224.75       94; was CYTIDINE CYCLIC MONOPHOSPHATE 1980-93 %28%see under CYTOSINE NUCLEOTIDES 1980-90%29%; CYCLIC CMP %26% CYTIDINE CYCLIC-2%27%,3%27%-MONOPHOSPHATE were see CYTIDINE CYCLIC MONOPHOSPHATE 1980-93%A%  
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D003563 2006
% 224.58/224.75  |- skos__broader mesh__D003563smesh__D003597
% 224.58/224.75  |- mesh__recordOriginator mesh__D003563 RLS
% 224.58/224.75  |- skos__altLabel mesh__D003563 Cytidine Cyclic Monophosphate
% 224.58/224.75  |- mesh__dateEstablished mesh__D003563 1991-01-01
% 224.58/224.75  |- skos__historyNote mesh__D003563
% 224.58/224.75       Cytidine Monophosphate %28%1966-1974%29% /analogs %26% derivatives %28%1975-1979%29%
% 224.58/224.75  |- skos__broader mesh__D003563smesh__D009712
% 224.58/224.75  |- skos__hiddenLabel mesh__D003563
% 224.58/224.75       Cytidine Cyclic 3%27%,5%27% Monophosphate
% 224.58/224.75  |- skos__hiddenLabel mesh__D003563 Cyclic Monophosphate, Cytidine
% 224.58/224.75  |- mesh__dateCreated mesh__D003563 1979-02-21
% 224.58/224.75  |- rdf__type mesh__D003563sskos__Concept
% 224.58/224.75  |- skos__historyNote mesh__D003563 Nucleotides, Cyclic %28%1974-1979%29%
% 224.58/224.75  |- skos__scopeNote mesh__D003563
% 224.58/224.75       A cyclic nucleotide formed from CYTIDINE TRIPHOSPHATE by the action of cytidylate cyclase. It is a potential cyclic nucleotide intracellular mediator of signal transductions.%A%    
% 224.58/224.75  |- mesh__publicMeSHNote mesh__D003563
% 224.58/224.75       94; was CYTIDINE CYCLIC MONOPHOSPHATE 1980-93 %28%see under CYTOSINE NUCLEOTIDES 1980-90%29%; CYCLIC CMP %26% CYTIDINE CYCLIC-2%27%,3%27%-MONOPHOSPHATE were see CYTIDINE CYCLIC MONOPHOSPHATE 1980-93%A%  
% 224.58/224.75  |- skos__altLabel mesh__D003563 Cytidine Cyclic-3%27%,5%27%-Monophosphate
% 224.58/224.75  |- skos__hiddenLabel mesh__D003563 CMP, Cyclic
% 224.58/224.75  |- mesh__recordAuthorizer mesh__D003563 sjn
% 224.58/224.75  |- skos__historyNote mesh__D003563 Cytosine Nucleotides %28%1966-1979%29%
% 224.58/224.75  |- mesh__onlineNote mesh__D003563
% 224.58/224.75       use CYCLIC CMP to search CYTIDINE CYCLIC MONOPHOSPHATE %26% CYTIDINE CYCLIC-2%27%,3%27%-MONOPHOSPHATE 1980-93%A%  
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D003563 2003
% 224.58/224.75  |- mesh__recordMaintainer mesh__D003563 jmp
% 224.58/224.75  |- mesh__dateRevised mesh__D003563 2001-07-25
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D003563 2005
% 224.58/224.75  |- skos__altLabel mesh__D003563 Cytidine Cyclic 3,5 Monophosphate
% 224.58/224.75  |- skos__hiddenLabel mesh__D003563 Monophosphate, Cytidine Cyclic
% 224.58/224.75  |- skos__hiddenLabel mesh__D003563
% 224.58/224.75       Cyclic-3%27%,5%27%-Monophosphate, Cytidine
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D003563 2004
% 224.58/224.75  |- skos__annotation mesh__D003563 DF: CYCL CMP   
% 224.58/224.75  |- skos__prefLabel mesh__D003563 Cyclic CMP
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D003563 2002
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013991 2002
% 224.58/224.75  |- skos__annotation mesh__D013991 painful swelling of rib cartilage   
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013991 1996
% 224.58/224.75  |- mesh__recordAuthorizer mesh__D013991 PLS
% 224.58/224.75  |- mesh__recordOriginator mesh__D013991 NLM
% 224.58/224.75  |- skos__hiddenLabel mesh__D013991 Syndrome, Tietze%27%s
% 224.58/224.75  |- rdf__type mesh__D013991sskos__Concept
% 224.58/224.75  |- skos__hiddenLabel mesh__D013991 Tietzes Syndrome
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013991 1997
% 224.58/224.75  |- mesh__dateRevised mesh__D013991 1993-06-03
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013991 2003
% 224.58/224.75  |- skos__altLabel mesh__D013991 Chondritis, Costal
% 224.58/224.75  |- mesh__activeMeSHYear mesh__D013991 1998
% 224.58/224.75  |- skos__altLabel mesh__D013991 Costal Chondritis
% 224.58/224.75  |- mesh__dateCreated mesh__D013991 1999-01-01
% 224.58/224.75  |- skos__prefLabel mesh__D013991 Tietze%27%s Syndrome
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013991 1994
% 224.58/224.76  |- skos__hiddenLabel mesh__D013991 Tietze Syndrome
% 224.58/224.76  |- skos__scopeNote mesh__D013991
% 224.58/224.76       Idiopathic painful nonsuppurative swellings of one or more costal cartilages, especially of the second rib. The anterior chest pain may mimic that of coronary artery disease. %28%Dorland, 27th ed.%29%%A%    
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013991 2004
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013991 1999
% 224.58/224.76  |- skos__hiddenLabel mesh__D013991 Costal Chondritides
% 224.58/224.76  |- skos__hiddenLabel mesh__D013991 Chondritides, Costal
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013991 2005
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013991 2000
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013991 1995
% 224.58/224.76  |- mesh__recordMaintainer mesh__D013991 TGC
% 224.58/224.76  |- skos__broader mesh__D013991smesh__D002357
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013991 2001
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013991 2006
% 224.58/224.76  |- mesh__dateEstablished mesh__D013193 1968-01-01
% 224.58/224.76  |- rdf__type mesh__D013193sskos__Concept
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013193 1997
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013193 2001
% 224.58/224.76  |- mesh__recordMaintainer mesh__D013193 TPW
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013193 2005
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013193 1994
% 224.58/224.76  |- mesh__historyNote mesh__D013193 68%28%65%29%   
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013193 2006
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013193 1995
% 224.58/224.76  |- mesh__recordOriginator mesh__D013193 NLM
% 224.58/224.76  |- mesh__publicMeSHNote mesh__D013193 68   
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013193 2002
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013193 2003
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013193 1998
% 224.58/224.76  |- mesh__dateRevised mesh__D013193 1993-06-04
% 224.58/224.76  |- skos__scopeNote mesh__D013193
% 224.58/224.76       Stainless steel. A steel containing Ni, Cr, or both. It does not tarnish on exposure and is used in corrosive environments. %28%Grant %26% Hack%27%s Chemical Dictionary, 5th ed%29%%A%    
% 224.58/224.76  |- skos__hiddenLabel mesh__D013193 Steel, Stainless
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013193 2004
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013193 1999
% 224.58/224.76  |- skos__prefLabel mesh__D013193 Stainless Steel
% 224.58/224.76  |- mesh__dateCreated mesh__D013193 1999-01-01
% 224.58/224.76  |- skos__annotation mesh__D013193 D25-26 qualif   
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013193 2000
% 224.58/224.76  |- skos__broader mesh__D013193smesh__D013232
% 224.58/224.76  |- mesh__recordAuthorizer mesh__D013193 PLS
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013193 1996
% 224.58/224.76  |- skos__broader mesh__D007954smesh__D007938
% 224.58/224.76  |- skos__prefLabel mesh__D007954 Leukemia, Subleukemic
% 224.58/224.76  |- mesh__publicMeSHNote mesh__D007954 67   
% 224.58/224.76  |- skos__annotation mesh__D007954
% 224.58/224.76       coord IM with specific type of LEUKEMIA %28%IM%29%   
% 224.58/224.76  |- skos__hiddenLabel mesh__D007954 Cutis, Aleukemic Leukemia
% 224.58/224.76  |- skos__scopeNote mesh__D007954
% 224.58/224.76       A form of leukemia that occurs without elevated levels of leukocytes within the blood.  Lesions containing abnormal leukocytes can be found within tissues.%A%    
% 224.58/224.76  |- rdf__type mesh__D007954sskos__Concept
% 224.58/224.76  |- skos__hiddenLabel mesh__D007954 Subleukemic Leukemia
% 224.58/224.76  |- mesh__dateRevised mesh__D007954 2000-06-21
% 224.58/224.76  |- skos__hiddenLabel mesh__D007954 Aleukemic Leukemias
% 224.58/224.76  |- skos__historyNote mesh__D007954 Leukemia %28%1966%29%
% 224.58/224.76  |- skos__hiddenLabel mesh__D007954 Leukemia Cutis, Aleukemic
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007954 2004
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007954 2002
% 224.58/224.76  |- mesh__recordMaintainer mesh__D007954 jmp
% 224.58/224.76  |- skos__hiddenLabel mesh__D007954 Subleukemic Leukemias
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007954 2006
% 224.58/224.76  |- mesh__dateEstablished mesh__D007954 1967-01-01
% 224.58/224.76  |- skos__hiddenLabel mesh__D007954 Aleukemic Leukemia
% 224.58/224.76  |- skos__hiddenLabel mesh__D007954 Leukemias, Aleukemic
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007954 2003
% 224.58/224.76  |- mesh__historyNote mesh__D007954 67   
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007954 2001
% 224.58/224.76  |- skos__hiddenLabel mesh__D007954 Leukemias, Subleukemic
% 224.58/224.76  |- mesh__recordOriginator mesh__D007954 NLM
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007954 2005
% 224.58/224.76  |- mesh__recordAuthorizer mesh__D007954 sjn
% 224.58/224.76  |- mesh__dateCreated mesh__D007954 1999-01-01
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D029608 2002
% 224.58/224.76  |- mesh__historyNote mesh__D029608 2002   
% 224.58/224.76  |- mesh__dateEstablished mesh__D029608 2002-01-01
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D029608 2004
% 224.58/224.76  |- skos__annotation mesh__D029608
% 224.58/224.76       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.58/224.76  |- skos__scopeNote mesh__D029608
% 224.58/224.76       A plant family of the order Polygalales, subclass Rosidae, class Magnoliopsida.%A%    
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D029608 2003
% 224.58/224.76  |- rdf__type mesh__D029608sskos__Concept
% 224.58/224.76  |- skos__broader mesh__D029608smesh__D019684
% 224.58/224.76  |- mesh__dateCreated mesh__D029608 2001-07-25
% 224.58/224.76  |- skos__prefLabel mesh__D029608 Polygalaceae
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D029608 2006
% 224.58/224.76  |- mesh__publicMeSHNote mesh__D029608 2002   
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D029608 2005
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007156 1998
% 224.58/224.76  |- skos__broader mesh__D007156smesh__D007109
% 224.58/224.76  |- skos__altLabel mesh__D007156 Immunological Memory
% 224.58/224.76  |- skos__prefLabel mesh__D007156 Immunologic Memory
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007156 2004
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007156 1999
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007156 1994
% 224.58/224.76  |- mesh__recordAuthorizer mesh__D007156 PLS
% 224.58/224.76  |- mesh__dateEstablished mesh__D007156 1973-01-01
% 224.58/224.76  |- mesh__recordMaintainer mesh__D007156 TAP
% 224.58/224.76  |- mesh__publicMeSHNote mesh__D007156 73   
% 224.58/224.76  |- skos__scopeNote mesh__D007156
% 224.58/224.76       The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus.%A%    
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007156 2000
% 224.58/224.76  |- skos__hiddenLabel mesh__D007156 Immunological Memories
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007156 1995
% 224.58/224.76  |- skos__historyNote mesh__D007156 Antibody Formation %28%1966-1970%29%
% 224.58/224.76  |- skos__altLabel mesh__D007156 Memory, Immunologic
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007156 2005
% 224.58/224.76  |- mesh__dateCreated mesh__D007156 1999-01-01
% 224.58/224.76  |- skos__hiddenLabel mesh__D007156 Memory, Immunological
% 224.58/224.76  |- skos__hiddenLabel mesh__D007156 Memories, Immunological
% 224.58/224.76  |- mesh__dateRevised mesh__D007156 1992-05-14
% 224.58/224.76  |- mesh__recordOriginator mesh__D007156 NLM
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007156 2001
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007156 2006
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007156 1996
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007156 2002
% 224.58/224.76  |- skos__hiddenLabel mesh__D007156 Immunologic Memories
% 224.58/224.76  |- mesh__historyNote mesh__D007156 73%28%71%29%   
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007156 1997
% 224.58/224.76  |- rdf__type mesh__D007156sskos__Concept
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007156 1993
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007156 2003
% 224.58/224.76  |- skos__hiddenLabel mesh__D007156 Memories, Immunologic
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D012899 2005
% 224.58/224.76  |- mesh__recordMaintainer mesh__D012899 mdb
% 224.58/224.76  |- skos__hiddenLabel mesh__D012899 Variola Minors
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D012899 2006
% 224.58/224.76  |- skos__prefLabel mesh__D012899 Smallpox
% 224.58/224.76  |- skos__broader mesh__D012899smesh__D011213
% 224.58/224.76  |- skos__hiddenLabel mesh__D012899 Variolas
% 224.58/224.76  |- skos__scopeNote mesh__D012899
% 224.58/224.76       An acute, highly contagious, often fatal infectious disease caused by an orthopoxvirus characterized by a biphasic febrile course and distinctive progressive skin eruptions. Vaccination has succeeded in eradicating smallpox worldwide. %28%Dorland, 28th ed%29%%A%    
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D012899 2003
% 224.58/224.76  |- mesh__recordOriginator mesh__D012899 NLM
% 224.58/224.76  |- rdf__type mesh__D012899sskos__Concept
% 224.58/224.76  |- skos__altLabel mesh__D012899 Variola
% 224.58/224.76  |- mesh__dateRevised mesh__D012899 2002-07-02
% 224.58/224.76  |- mesh__recordAuthorizer mesh__D012899 sjn
% 224.58/224.76  |- mesh__publicMeSHNote mesh__D012899
% 224.58/224.76       ALASTRIM was heading 1975-96 %28%see under SMALLPOX 1975-90%29%; VARIOLA MINOR was see ALASTRIM 1979-96%A%  
% 224.58/224.76  |- skos__hiddenLabel mesh__D012899 Minor, Variola
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D012899 2004
% 224.58/224.76  |- skos__altLabel mesh__D012899 Alastrim
% 224.58/224.76  |- skos__annotation mesh__D012899 caused by a poxvirus   
% 224.58/224.76  |- mesh__dateCreated mesh__D012899 1999-01-01
% 224.58/224.76  |- mesh__historyNote mesh__D012899
% 224.58/224.76       ALASTRIM was heading 1975-96 %28%see under SMALLPOX 1975-90%29%; VARIOLA MINOR was see ALASTRIM 1979-96%A%  
% 224.58/224.76  |- skos__hiddenLabel mesh__D012899 Minors, Variola
% 224.58/224.76  |- skos__scopeNote mesh__D017584
% 224.58/224.76       An important aggregate factor in epidemiological studies of women%27%s health. The concept usually includes the number and timing of pregnancies and their outcomes, the incidence of breast feeding, and may include age of menarche and menopause, regularity of menstruation, fertility, gynecological or obstetric problems, or contraceptive usage.%A%    
% 224.58/224.76  |- skos__annotation mesh__D017584
% 224.58/224.76       GEN or unspecified; IM; prefer specific concepts in MeSH definition %28%IM%29%; DF: REPRODUCTIVE HIST%A%  
% 224.58/224.76  |- skos__hiddenLabel mesh__D017584 Histories, Pregnancy
% 224.58/224.76  |- skos__hiddenLabel mesh__D017584 History, Pregnancy
% 224.58/224.76  |- skos__hiddenLabel mesh__D017584 Pregnancy Histories
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D017584 2002
% 224.58/224.76  |- mesh__historyNote mesh__D017584 94   
% 224.58/224.76  |- mesh__dateCreated mesh__D017584 1993-06-21
% 224.58/224.76  |- mesh__dateEstablished mesh__D017584 1994-01-01
% 224.58/224.76  |- mesh__recordOriginator mesh__D017584 RAZ
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D017584 2005
% 224.58/224.76  |- skos__hiddenLabel mesh__D017584 Histories, Contraceptive
% 224.58/224.76  |- rdf__type mesh__D017584sskos__Concept
% 224.58/224.76  |- skos__hiddenLabel mesh__D017584 Birth Histories
% 224.58/224.76  |- skos__hiddenLabel mesh__D017584 History, Contraceptive
% 224.58/224.76  |- skos__hiddenLabel mesh__D017584 Contraceptive Histories
% 224.58/224.76  |- mesh__recordMaintainer mesh__D017584 PXP
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D017584 2006
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D017584 2000
% 224.58/224.76  |- skos__hiddenLabel mesh__D017584 Histories, Birth
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D017584 2003
% 224.58/224.76  |- mesh__dateRevised mesh__D017584 1997-06-20
% 224.58/224.76  |- skos__altLabel mesh__D017584 History, Reproductive
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D017584 2001
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D017584 1998
% 224.58/224.76  |- mesh__publicMeSHNote mesh__D017584 94   
% 224.58/224.76  |- skos__prefLabel mesh__D017584 Reproductive History
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D017584 2004
% 224.58/224.76  |- skos__hiddenLabel mesh__D017584 Histories, Reproductive
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D017584 1999
% 224.58/224.76  |- skos__hiddenLabel mesh__D017584 Reproductive Histories
% 224.58/224.76  |- skos__hiddenLabel mesh__D017584 History, Birth
% 224.58/224.76  |- skos__broader mesh__D017584smesh__D015981
% 224.58/224.76  |- skos__broader mesh__D017584smesh__D008487
% 224.58/224.76  |- mesh__recordAuthorizer mesh__D017584 SJN
% 224.58/224.76  |- skos__broader mesh__D031255smesh__D029785
% 224.58/224.76  |- mesh__dateEstablished mesh__D031255 2003-01-01
% 224.58/224.76  |- skos__prefLabel mesh__D031255 Carex Plant
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D031255 2005
% 224.58/224.76  |- skos__annotation mesh__D031255
% 224.58/224.76       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.58/224.76  |- mesh__publicMeSHNote mesh__D031255 2003   
% 224.58/224.76  |- mesh__historyNote mesh__D031255 2003   
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D031255 2006
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D031255 2003
% 224.58/224.76  |- mesh__dateCreated mesh__D031255 2002-07-03
% 224.58/224.76  |- skos__scopeNote mesh__D031255
% 224.58/224.76       A plant genus of the family CYPERACEAE. The seed contains oligostilbenes %28%STILBENES%29%.%A%    
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D031255 2004
% 224.58/224.76  |- rdf__type mesh__D031255sskos__Concept
% 224.58/224.76  |- skos__scopeNote mesh__D003564
% 224.58/224.76       An enzyme that catalyzes the deamination of cytidine, forming uridine. EC 3.5.4.5.%A%    
% 224.58/224.76  |- mesh__recordOriginator mesh__D003564 NLM
% 224.58/224.76  |- rdf__type mesh__D003564sskos__Concept
% 224.58/224.76  |- mesh__dateRevised mesh__D003564 2003-07-09
% 224.58/224.76  |- mesh__dateCreated mesh__D003564 1974-11-27
% 224.58/224.76  |- mesh__recordMaintainer mesh__D003564 ssb
% 224.58/224.76  |- skos__hiddenLabel mesh__D003564 Deaminase, Cytidine
% 224.58/224.76  |- skos__hiddenLabel mesh__D003564 Aminohydrolase, Cytidine
% 224.58/224.76  |- skos__broader mesh__D003564smesh__D009700
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D003564 2005
% 224.58/224.76  |- mesh__publicMeSHNote mesh__D003564
% 224.58/224.76       91; was see under NUCLEOSIDE DEAMINASES 1975-90   
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D003564 2004
% 224.58/224.76  |- skos__historyNote mesh__D003564 Cytidine %28%1973-1974%29%
% 224.58/224.76  |- skos__historyNote mesh__D003564 Aminohydrolases %28%1973-1974%29%
% 224.58/224.76  |- skos__altLabel mesh__D003564 Cytidine Aminohydrolase
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D003564 2006
% 224.58/224.76  |- mesh__historyNote mesh__D003564
% 224.58/224.76       91%28%75%29%; was see under NUCLEOSIDE DEAMINASES 1975-90   
% 224.58/224.76  |- mesh__recordAuthorizer mesh__D003564 sjn
% 224.58/224.76  |- skos__prefLabel mesh__D003564 Cytidine Deaminase
% 224.58/224.76  |- mesh__dateEstablished mesh__D003564 1991-01-01
% 224.58/224.76  |- mesh__recordMaintainer mesh__D013992 ssb
% 224.58/224.76  |- mesh__dateEstablished mesh__D013992 1991-01-01
% 224.58/224.76  |- mesh__publicMeSHNote mesh__D013992
% 224.58/224.76       91; was see under CYCLOHEXANES 1975-90   
% 224.58/224.76  |- skos__prefLabel mesh__D013992 Tiletamine
% 224.58/224.76  |- skos__hiddenLabel mesh__D013992 CI 634
% 224.58/224.76  |- skos__historyNote mesh__D013992 Thiophenes %28%1972-1974%29%
% 224.58/224.76  |- mesh__recordAuthorizer mesh__D013992 sjn
% 224.58/224.76  |- skos__broader mesh__D013992smesh__D003512
% 224.58/224.76  |- mesh__dateCreated mesh__D013992 1974-11-19
% 224.58/224.76  |- skos__altLabel mesh__D013992
% 224.58/224.76       2-%28%Ethylamino%29%-2-%28%2-thienyl%29%cyclohexanone
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013992 2006
% 224.58/224.76  |- mesh__historyNote mesh__D013992
% 224.58/224.76       91%28%75%29%; was see under CYCLOHEXANES 1975-90   
% 224.58/224.76  |- skos__scopeNote mesh__D013992
% 224.58/224.76       Proposed anesthetic with possible anticonvulsant and sedative properties.%A%    
% 224.58/224.76  |- mesh__recordOriginator mesh__D013992 NLM
% 224.58/224.76  |- skos__hiddenLabel mesh__D013992 CI634
% 224.58/224.76  |- mesh__dateRevised mesh__D013992 2005-06-30
% 224.58/224.76  |- skos__broader mesh__D013992smesh__D003510
% 224.58/224.76  |- skos__historyNote mesh__D013992 Cyclohexanes %28%1972-1974%29%
% 224.58/224.76  |- skos__hiddenLabel mesh__D013992 Hydrochloride, Tiletamine
% 224.58/224.76  |- skos__historyNote mesh__D013992 Ethylamines %28%1972-1974%29%
% 224.58/224.76  |- rdf__type mesh__D013992sskos__Concept
% 224.58/224.76  |- skos__broader mesh__D013992smesh__D013876
% 224.58/224.76  |- skos__broader mesh__D000388Q000821smesh__D000388
% 224.58/224.76  |- mesh__preferredCombination mesh__D000388Q000821smesh__D000391
% 224.58/224.76  |- rdf__type mesh__D000388Q000821smesh__CompoundConcept
% 224.58/224.76  |- mesh__recordMaintainer mesh__D013194 NLM
% 224.58/224.76  |- skos__prefLabel mesh__D013194 Staining and Labeling
% 224.58/224.76  |- mesh__recordAuthorizer mesh__D013194 NLM
% 224.58/224.76  |- mesh__dateRevised mesh__D013194 2005-07-06
% 224.58/224.76  |- skos__hiddenLabel mesh__D013194 Histological Labelings
% 224.58/224.76  |- mesh__dateCreated mesh__D013194 1999-01-01
% 224.58/224.76  |- skos__hiddenLabel mesh__D013194 Stainings
% 224.58/224.76  |- rdf__type mesh__D013194sskos__Concept
% 224.58/224.76  |- mesh__historyNote mesh__D013194 2001%28%1963%29%   
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D013194 2006
% 224.58/224.76  |- skos__hiddenLabel mesh__D013194 Labeling and Staining
% 224.58/224.76  |- skos__hiddenLabel mesh__D013194 Labelings, Histological
% 224.58/224.76  |- skos__broader mesh__D013194smesh__D016591
% 224.58/224.76  |- skos__hiddenLabel mesh__D013194 Labeling, Histological
% 224.58/224.76  |- skos__related mesh__D013194smesh__D004396
% 224.58/224.76  |- mesh__recordOriginator mesh__D013194 NLM
% 224.58/224.76  |- skos__scopeNote mesh__D013194
% 224.58/224.76       The marking of biological material with a dye or other reagent for the purpose of identifying and quantitating components of tissues, cells or their extracts.%A%    
% 224.58/224.76  |- mesh__publicMeSHNote mesh__D013194
% 224.58/224.76       2001; see STAINING 1996-2000, see STAINS AND STAINING 1963-1995%A%  
% 224.58/224.76  |- skos__hiddenLabel mesh__D007955 Leukemoid Reactions
% 224.58/224.76  |- mesh__dateRevised mesh__D007955 1993-06-02
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007955 1995
% 224.58/224.76  |- skos__annotation mesh__D007955
% 224.58/224.76       extreme leukocytosis resembling leukemia   
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007955 2001
% 224.58/224.76  |- mesh__recordOriginator mesh__D007955 NLM
% 224.58/224.76  |- mesh__recordAuthorizer mesh__D007955 PLS
% 224.58/224.76  |- rdf__type mesh__D007955sskos__Concept
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007955 2003
% 224.58/224.76  |- mesh__activeMeSHYear mesh__D007955 2005
% 224.58/224.76  |- skos__broader mesh__D007955smesh__D007964
% 224.58/224.76  |- skos__scopeNote mesh__D007955
% 224.58/224.76       A peripheral blood picture resembling that of leukemia or indistinguishable from it on the basis of morphologic appearance alone. %28%Dorland, 27th ed%29%%A%    
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007955 2004
% 224.58/224.77  |- skos__broader mesh__D007955smesh__D009196
% 224.58/224.77  |- mesh__dateCreated mesh__D007955 1999-01-01
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007955 2002
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007955 2006
% 224.58/224.77  |- skos__hiddenLabel mesh__D007955 Reaction, Leukemoid
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007955 1996
% 224.58/224.77  |- skos__hiddenLabel mesh__D007955 Reactions, Leukemoid
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007955 1998
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007955 1997
% 224.58/224.77  |- skos__prefLabel mesh__D007955 Leukemoid Reaction
% 224.58/224.77  |- mesh__recordMaintainer mesh__D007955 TGC
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007955 1994
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007955 1999
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007955 2000
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007157 2002
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007157 2006
% 224.58/224.77  |- mesh__recordOriginator mesh__D007157 AEP
% 224.58/224.77  |- skos__scopeNote mesh__D007157
% 224.58/224.77       The theory that T-cells monitor cell surfaces and detect structural changes in the plasma membrane and/or surface antigens of virally or neoplastically transformed cells.%A%    
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007157 1996
% 224.58/224.77  |- mesh__historyNote mesh__D007157
% 224.58/224.77       91%28%80%29%; was see under IMMUNITY, CELLULAR 1980-90   
% 224.58/224.77  |- skos__hiddenLabel mesh__D007157 Immunological Surveillances
% 224.58/224.77  |- mesh__dateEstablished mesh__D007157 1991-01-01
% 224.58/224.77  |- skos__broader mesh__D007157smesh__D007111
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007157 1997
% 224.58/224.77  |- skos__hiddenLabel mesh__D007157 Surveillance, Immunological
% 224.58/224.77  |- rdf__type mesh__D007157sskos__Concept
% 224.58/224.77  |- mesh__publicMeSHNote mesh__D007157
% 224.58/224.77       91; was see under IMMUNITY, CELLULAR 1980-90   
% 224.58/224.77  |- mesh__recordMaintainer mesh__D007157 TAP
% 224.58/224.77  |- skos__altLabel mesh__D007157 Immunological Surveillance
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007157 1998
% 224.58/224.77  |- skos__hiddenLabel mesh__D007157 Immunologic Surveillances
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007157 1993
% 224.58/224.77  |- skos__historyNote mesh__D007157 specific cell, organ, neoplasm/TR
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007157 2003
% 224.58/224.77  |- mesh__recordAuthorizer mesh__D007157 PLS
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007157 1994
% 224.58/224.77  |- mesh__dateCreated mesh__D007157 1979-05-23
% 224.58/224.77  |- skos__hiddenLabel mesh__D007157 Surveillances, Immunologic
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007157 2000
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007157 1999
% 224.58/224.77  |- mesh__dateRevised mesh__D007157 1992-05-14
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007157 2004
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007157 2001
% 224.58/224.77  |- skos__prefLabel mesh__D007157 Immunologic Surveillance
% 224.58/224.77  |- skos__annotation mesh__D007157
% 224.58/224.77       a function of T-lymphocytes: nothing to do with epidemiol surveillance%A%  
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007157 1995
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007157 2005
% 224.58/224.77  |- skos__hiddenLabel mesh__D007157 Surveillances, Immunological
% 224.58/224.77  |- skos__altLabel mesh__D007157 Surveillance, Immunologic
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D017585 2002
% 224.58/224.77  |- mesh__recordAuthorizer mesh__D017585 SJN
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D017585 2003
% 224.58/224.77  |- mesh__publicMeSHNote mesh__D017585
% 224.58/224.77       95; was ULTRASONOGRAPHY, TRANSCRANIAL DOPPLER 1994   
% 224.58/224.77  |- skos__altLabel mesh__D017585 Transcranial Doppler Ultrasonography
% 224.58/224.77  |- skos__altLabel mesh__D017585 Ultrasonography, Transcranial Doppler
% 224.58/224.77  |- skos__altLabel mesh__D017585 Sonography, Transcranial Doppler
% 224.58/224.77  |- skos__altLabel mesh__D017585 Transcranial Ultrasonography, Doppler
% 224.58/224.77  |- skos__altLabel mesh__D017585 Transcranial Sonography, Doppler
% 224.58/224.77  |- skos__historyNote mesh__D017585 Blood Flow Velocity %28%1982-1993%29%
% 224.58/224.77  |- skos__altLabel mesh__D017585 Sonography, Doppler Transcranial
% 224.58/224.77  |- skos__historyNote mesh__D017585 Cerebral Arteries %28%1984-1993%29%
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D017585 2006
% 224.58/224.77  |- skos__prefLabel mesh__D017585 Ultrasonography, Doppler, Transcranial
% 224.58/224.77  |- skos__historyNote mesh__D017585
% 224.58/224.77       Ultrasonics/diagnostic use %28%1974-1984%29%
% 224.58/224.77  |- skos__broader mesh__D017585smesh__D018608
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D017585 2001
% 224.58/224.77  |- mesh__dateCreated mesh__D017585 1992-12-28
% 224.58/224.77  |- skos__altLabel mesh__D017585 Doppler Transcranial Ultrasonography
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D017585 2005
% 224.58/224.77  |- skos__historyNote mesh__D017585 Ultrasonography %28%1985-1993%29%
% 224.58/224.77  |- rdf__type mesh__D017585sskos__Concept
% 224.58/224.77  |- skos__altLabel mesh__D017585 Doppler Ultrasonography, Transcranial
% 224.58/224.77  |- skos__altLabel mesh__D017585 Ultrasonography, Doppler Transcranial
% 224.58/224.77  |- skos__altLabel mesh__D017585 Doppler Sonography, Transcranial
% 224.58/224.77  |- mesh__dateRevised mesh__D017585 1997-06-20
% 224.58/224.77  |- mesh__dateEstablished mesh__D017585 1994-01-01
% 224.58/224.77  |- skos__historyNote mesh__D017585
% 224.58/224.77       Cerebrovascular Circulation %28%1982-1993%29%
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D017585 2000
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D017585 1999
% 224.58/224.77  |- skos__annotation mesh__D017585
% 224.58/224.77       /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ULTRASONOGR DOPPLER TRANSCRANIAL%A%  
% 224.58/224.77  |- skos__scopeNote mesh__D017585
% 224.58/224.77       A non-invasive technique using ultrasound for the measurement of cerebrovascular hemodynamics, particularly cerebral blood flow velocity and cerebral collateral flow. With a high-intensity, low-frequency pulse probe, the intracranial arteries may be studied transtemporally, transorbitally, or from below the foramen magnum.%A%    
% 224.58/224.77  |- skos__altLabel mesh__D017585 Doppler Transcranial Sonography
% 224.58/224.77  |- mesh__recordOriginator mesh__D017585 TGC
% 224.58/224.77  |- mesh__historyNote mesh__D017585
% 224.58/224.77       95; was ULTRASONOGRAPHY, TRANSCRANIAL DOPPLER 1994   
% 224.58/224.77  |- mesh__recordMaintainer mesh__D017585 PXP
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D017585 1998
% 224.58/224.77  |- skos__broader mesh__D017585smesh__D004453
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D017585 2004
% 224.58/224.77  |- skos__altLabel mesh__D017585 Transcranial Doppler Sonography
% 224.58/224.77  |- mesh__onlineNote mesh__D017585
% 224.58/224.77       use ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL to search ULTRASONOGRAPHY, TRANSCRANIAL DOPPLER 1994%A%  
% 224.58/224.77  |- skos__annotation mesh__D031256
% 224.58/224.77       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.58/224.77  |- mesh__publicMeSHNote mesh__D031256 2003   
% 224.58/224.77  |- skos__altLabel mesh__D031256 Chestnut, Water
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D031256 2006
% 224.58/224.77  |- mesh__dateCreated mesh__D031256 2002-07-03
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D031256 2003
% 224.58/224.77  |- mesh__dateEstablished mesh__D031256 2003-01-01
% 224.58/224.77  |- skos__altLabel mesh__D031256 Water Chestnut, Chinese
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D031256 2004
% 224.58/224.77  |- rdf__type mesh__D031256sskos__Concept
% 224.58/224.77  |- skos__broader mesh__D031256smesh__D029785
% 224.58/224.77  |- skos__prefLabel mesh__D031256 Eleocharis
% 224.58/224.77  |- skos__scopeNote mesh__D031256
% 224.58/224.77       A plant genus of the family CYPERACEAE.     
% 224.58/224.77  |- skos__altLabel mesh__D031256 Chinese Water Chestnut
% 224.58/224.77  |- mesh__historyNote mesh__D031256 2003   
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D031256 2005
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D003565 1992
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D003565 1997
% 224.58/224.77  |- skos__scopeNote mesh__D003565
% 224.58/224.77       Cytidine 5%27%-%28%trihydrogen diphosphate%29%. A cytosine nucleotide containing two phosphate groups esterified to the sugar moiety. Synonyms: CRPP; cytidine pyrophosphate.%A%    
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D003565 2003
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D003565 1994
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D003565 2001
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D003565 1999
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D003565 1993
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D003565 2005
% 224.58/224.77  |- mesh__historyNote mesh__D003565
% 224.58/224.77       91%28%78%29%; was see under CYTOSINE NUCLEOTIDES 1978-90   
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D003565 2004
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D003565 1995
% 224.58/224.77  |- skos__historyNote mesh__D003565 Cytosine Nucleotides %28%1966-1977%29%
% 224.58/224.77  |- mesh__publicMeSHNote mesh__D003565
% 224.58/224.77       91; was see under CYTOSINE NUCLEOTIDES 1978-90   
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D003565 2006
% 224.58/224.77  |- skos__hiddenLabel mesh__D003565 Diphosphate, Cytidine
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D003565 1991
% 224.58/224.77  |- skos__broader mesh__D003565smesh__D003597
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D003565 2002
% 224.58/224.77  |- mesh__recordOriginator mesh__D003565 RLS
% 224.58/224.77  |- mesh__dateRevised mesh__D003565 1990-04-13
% 224.58/224.77  |- skos__prefLabel mesh__D003565 Cytidine Diphosphate
% 224.58/224.77  |- mesh__recordAuthorizer mesh__D003565 PLS
% 224.58/224.77  |- mesh__recordMaintainer mesh__D003565 NLM
% 224.58/224.77  |- mesh__dateEstablished mesh__D003565 1991-01-01
% 224.58/224.77  |- rdf__type mesh__D003565sskos__Concept
% 224.58/224.77  |- mesh__dateCreated mesh__D003565 1977-04-22
% 224.58/224.77  |- skos__altLabel mesh__D003565 CDP
% 224.58/224.77  |- skos__annotation mesh__D003565 /biosyn /physiol permitted   
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D003565 1996
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D003565 2000
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D003565 1998
% 224.58/224.77  |- mesh__dateCreated mesh__D008250 1974-11-19
% 224.58/224.77  |- skos__prefLabel mesh__D008250 Lysine-tRNA Ligase
% 224.58/224.77  |- mesh__historyNote mesh__D008250 98%28%75%29%   
% 224.58/224.77  |- mesh__dateEstablished mesh__D008250 1991-01-01
% 224.58/224.77  |- mesh__dateRevised mesh__D008250 2003-07-09
% 224.58/224.77  |- skos__historyNote mesh__D008250 Lysine %28%1972-1974%29%
% 224.58/224.77  |- skos__hiddenLabel mesh__D008250 Lysyl tRNA Synthetase
% 224.58/224.77  |- skos__historyNote mesh__D008250
% 224.58/224.77       Amino Acyl T RNA Synthetases %28%1972-1974%29%
% 224.58/224.77  |- skos__hiddenLabel mesh__D008250 Lysine tRNA Ligase
% 224.58/224.77  |- skos__scopeNote mesh__D008250
% 224.58/224.77       An enzyme that activates lysine with its specific transfer RNA. EC 6.1.1.6.%A%    
% 224.58/224.77  |- skos__altLabel mesh__D008250 Lysyl-tRNA Synthetase
% 224.58/224.77  |- mesh__recordMaintainer mesh__D008250 ssb
% 224.58/224.77  |- mesh__publicMeSHNote mesh__D008250
% 224.58/224.77       98; see LYSYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A%  
% 224.58/224.77  |- skos__hiddenLabel mesh__D008250 Lys tRNA Ligase
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D008250 2005
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D008250 2004
% 224.58/224.77  |- skos__hiddenLabel mesh__D008250 Synthetase, Lysyl-tRNA
% 224.58/224.77  |- skos__broader mesh__D008250smesh__D000604
% 224.58/224.77  |- skos__altLabel mesh__D008250 Lysyl T RNA Synthetase
% 224.58/224.77  |- skos__hiddenLabel mesh__D008250 Ligase, Lys-tRNA
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D008250 2006
% 224.58/224.77  |- mesh__recordAuthorizer mesh__D008250 sjn
% 224.58/224.77  |- skos__altLabel mesh__D008250 Lys-tRNA Ligase
% 224.58/224.77  |- skos__hiddenLabel mesh__D008250 Ligase, Lysine-tRNA
% 224.58/224.77  |- mesh__recordOriginator mesh__D008250 NLM
% 224.58/224.77  |- rdf__type mesh__D008250sskos__Concept
% 224.58/224.77  |- skos__scopeNote mesh__D013993
% 224.58/224.77       An opioid analgesic used similarly to MORPHINE in the control of moderate to severe pain. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1097%29%%A%    
% 224.58/224.77  |- skos__altLabel mesh__D013993 Tilidate
% 224.58/224.77  |- skos__prefLabel mesh__D013993 Tilidine
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D013993 2005
% 224.58/224.77  |- skos__historyNote mesh__D013993 Dimethylamines %28%1974%29%
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D013993 2006
% 224.58/224.77  |- mesh__recordMaintainer mesh__D013993 ssb
% 224.58/224.77  |- skos__historyNote mesh__D013993
% 224.58/224.77       Cyclohexanecarboxylic Acids %28%1971-1974%29%
% 224.58/224.77  |- skos__broader mesh__D013993smesh__D003509
% 224.58/224.77  |- skos__hiddenLabel mesh__D013993 Go1261
% 224.58/224.77  |- skos__altLabel mesh__D013993 Tilidine Hydrochloride, %28%+-%29%-211Trans
% 224.58/224.77  |- mesh__recordAuthorizer mesh__D013993 sjn
% 224.58/224.77  |- mesh__publicMeSHNote mesh__D013993
% 224.58/224.77       91; was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90   
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D013993 2002
% 224.58/224.77  |- rdf__type mesh__D013993sskos__Concept
% 224.58/224.77  |- mesh__dateCreated mesh__D013993 1974-11-19
% 224.58/224.77  |- mesh__recordOriginator mesh__D013993 NLM
% 224.58/224.77  |- mesh__historyNote mesh__D013993
% 224.58/224.77       91%28%75%29%; was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90%A%  
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D013993 2003
% 224.58/224.77  |- mesh__dateRevised mesh__D013993 2001-07-25
% 224.58/224.77  |- skos__altLabel mesh__D013993 Valerone
% 224.58/224.77  |- mesh__dateEstablished mesh__D013993 1991-01-01
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D013993 2004
% 224.58/224.77  |- skos__hiddenLabel mesh__D013993 Go 1261
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D013195 1998
% 224.58/224.77  |- mesh__dateCreated mesh__D013195 1999-01-01
% 224.58/224.77  |- mesh__recordOriginator mesh__D013195 NLM
% 224.58/224.77  |- skos__historyNote mesh__D013195 Intelligence Tests %28%1966-1974%29%
% 224.58/224.77  |- rdf__type mesh__D013195sskos__Concept
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D013195 2000
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D013195 1996
% 224.58/224.77  |- mesh__historyNote mesh__D013195
% 224.58/224.77       91%28%79%29%; was see under INTELLIGENCE TESTS 1979-90; was BINET TESTS see under INTELLIGENCE TESTS 1963-78%A%  
% 224.58/224.77  |- mesh__recordAuthorizer mesh__D013195 PLS
% 224.58/224.77  |- skos__hiddenLabel mesh__D013195 Stanford Binet Test
% 224.58/224.77  |- mesh__dateRevised mesh__D013195 1992-05-18
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D013195 2006
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D013195 1995
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D013195 2002
% 224.58/224.77  |- skos__prefLabel mesh__D013195 Stanford-Binet Test
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D013195 1993
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D013195 2004
% 224.58/224.77  |- skos__altLabel mesh__D013195 STANFTAN
% 224.58/224.77  |- skos__scopeNote mesh__D013195
% 224.58/224.77       An individual intelligence test designed primarily for school children to predict school performance and the ability to adjust to everyday demands.%A%    
% 224.58/224.77  |- skos__broader mesh__D013195smesh__D007361
% 224.58/224.77  |- mesh__publicMeSHNote mesh__D013195
% 224.58/224.77       91; was see under INTELLIGENCE TESTS 1979-90; was BINET TESTS see under INTELLIGENCE TESTS 1963-78%A%  
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D013195 2005
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D013195 1994
% 224.58/224.77  |- mesh__onlineNote mesh__D013195
% 224.58/224.77       use STANFORD-BINET TEST to search BINET TESTS 1975-78; use INTELLIGENCE TESTS 1966-74%A%  
% 224.58/224.77  |- skos__hiddenLabel mesh__D013195 Test, Binet
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D013195 2003
% 224.58/224.77  |- skos__hiddenLabel mesh__D013195 Test, Stanford-Binet
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D013195 1999
% 224.58/224.77  |- mesh__recordMaintainer mesh__D013195 TAP
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D013195 1997
% 224.58/224.77  |- skos__altLabel mesh__D013195 Binet Test
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D013195 2001
% 224.58/224.77  |- mesh__dateEstablished mesh__D013195 1991-01-01
% 224.58/224.77  |- rdf__type mesh__D007956sskos__Concept
% 224.58/224.77  |- mesh__dateEstablished mesh__D007956 1965-01-01
% 224.58/224.77  |- mesh__onlineNote mesh__D007956
% 224.58/224.77       use LEUKOCIDINS to search LEUKOCIDIN 1966-77   
% 224.58/224.77  |- skos__broader mesh__D007956smesh__D003603
% 224.58/224.77  |- skos__annotation mesh__D007956
% 224.58/224.77       /antag permitted but consider also ANTITOXINS   
% 224.58/224.77  |- skos__prefLabel mesh__D007956 Leukocidins
% 224.58/224.77  |- mesh__dateCreated mesh__D007956 1999-01-01
% 224.58/224.77  |- mesh__publicMeSHNote mesh__D007956 78; was LEUKOCIDIN 1965-77   
% 224.58/224.77  |- mesh__recordOriginator mesh__D007956 NLM
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007956 2006
% 224.58/224.77  |- mesh__recordAuthorizer mesh__D007956 sjn
% 224.58/224.77  |- mesh__dateRevised mesh__D007956 2005-06-30
% 224.58/224.77  |- mesh__recordMaintainer mesh__D007956 ssb
% 224.58/224.77  |- skos__broader mesh__D007956smesh__D001427
% 224.58/224.77  |- skos__hiddenLabel mesh__D007956 Cytotoxin, Pseudomonas aeruginosa
% 224.58/224.77  |- skos__altLabel mesh__D007956 Leucocidin
% 224.58/224.77  |- skos__hiddenLabel mesh__D007956 aeruginosa Cytotoxin, Pseudomonas
% 224.58/224.77  |- mesh__historyNote mesh__D007956 78; was LEUKOCIDIN 1965-77   
% 224.58/224.77  |- skos__scopeNote mesh__D007956
% 224.58/224.77       Substances that are toxic to LEUKOCYTES. They are EXOTOXINS produced by some pathogenic STAPHYLOCOCCUS and STREPTOCOCCUS that destroy leukocytes by lysis of the cytoplasmic granules and are partially responsible for the pathogenicity of the organisms.%A%    
% 224.58/224.77  |- skos__hiddenLabel mesh__D007158 Techniques, Immunological
% 224.58/224.77  |- skos__altLabel mesh__D007158 Immunological Technics
% 224.58/224.77  |- skos__broader mesh__D007158smesh__D008919
% 224.58/224.77  |- skos__altLabel mesh__D007158 Technique, Immunologic
% 224.58/224.77  |- skos__hiddenLabel mesh__D007158 Dissociations, Antibody
% 224.58/224.77  |- mesh__publicMeSHNote mesh__D007158
% 224.58/224.77       91; was IMMUNOLOGIC TECHNICS 1973-90; ANTIBODY DISSOCIATION was heading 1973-82%A%  
% 224.58/224.77  |- skos__altLabel mesh__D007158 Immunologic Technics
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007158 2005
% 224.58/224.77  |- skos__hiddenLabel mesh__D007158 Dissociation, Antibody
% 224.58/224.77  |- skos__altLabel mesh__D007158 Immunologic Technique
% 224.58/224.77  |- skos__related mesh__D007158smesh__D012698
% 224.58/224.77  |- skos__hiddenLabel mesh__D007158 Technics, Immunological
% 224.58/224.77  |- mesh__recordMaintainer mesh__D007158 kle
% 224.58/224.77  |- skos__hiddenLabel mesh__D007158 Technique, Immunological
% 224.58/224.77  |- skos__related mesh__D007158smesh__D007159
% 224.58/224.77  |- skos__altLabel mesh__D007158 Immunological Techniques
% 224.58/224.77  |- mesh__recordOriginator mesh__D007158 NLM
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007158 2004
% 224.58/224.77  |- skos__hiddenLabel mesh__D007158 Antibody Dissociations
% 224.58/224.77  |- mesh__dateCreated mesh__D007158 1999-01-01
% 224.58/224.77  |- skos__hiddenLabel mesh__D007158 Technic, Immunological
% 224.58/224.77  |- skos__prefLabel mesh__D007158 Immunologic Techniques
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007158 2002
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007158 2003
% 224.58/224.77  |- skos__related mesh__D007158smesh__D011259
% 224.58/224.77  |- skos__annotation mesh__D007158
% 224.58/224.77       GEN: prefer specifics; NIM; do not confuse with IMMUNOLOGIC TESTS %28% = immunol techniques applied to diag%29%; DF: IMMUNOL TECHNIQUES%A%  
% 224.58/224.77  |- skos__hiddenLabel mesh__D007158 Immunological Technique
% 224.58/224.77  |- skos__altLabel mesh__D007158 Technic, Immunologic
% 224.58/224.77  |- rdf__type mesh__D007158sskos__Concept
% 224.58/224.77  |- mesh__dateRevised mesh__D007158 1999-11-03
% 224.58/224.77  |- skos__altLabel mesh__D007158 Technics, Immunologic
% 224.58/224.77  |- mesh__onlineNote mesh__D007158
% 224.58/224.77       use IMMUNOLOGIC TECHNIQUES to search IMMUNOLOGIC TECHNICS 1973-90 and ANTIBODY DISSOCIATION 1971-82 %28%as prov 1971-72%29%%A%  
% 224.58/224.77  |- mesh__recordAuthorizer mesh__D007158 sjn
% 224.58/224.77  |- mesh__dateEstablished mesh__D007158 1973-01-01
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007158 2001
% 224.58/224.77  |- skos__altLabel mesh__D007158 Immunologic Technic
% 224.58/224.77  |- skos__related mesh__D007158smesh__D007167
% 224.58/224.77  |- mesh__historyNote mesh__D007158
% 224.58/224.77       91; was IMMUNOLOGIC TECHNICS 1973-90; ANTIBODY DISSOCIATION was heading 1971-82 %28%Prov 1971-72%29%%A%  
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007158 2006
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D007158 2000
% 224.58/224.77  |- skos__related mesh__D007158smesh__D001788
% 224.58/224.77  |- skos__hiddenLabel mesh__D007158 Immunological Technic
% 224.58/224.77  |- skos__altLabel mesh__D007158 Techniques, Immunologic
% 224.58/224.77  |- skos__broader mesh__D006226Q000151smesh__D006226
% 224.58/224.77  |- mesh__preferredCombination mesh__D006226Q000151smesh__D006228
% 224.58/224.77  |- rdf__type mesh__D006226Q000151smesh__CompoundConcept
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D017586 1998
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D017586 2002
% 224.58/224.77  |- skos__altLabel mesh__D017586 Discectomy
% 224.58/224.77  |- mesh__historyNote mesh__D017586 94   
% 224.58/224.77  |- skos__prefLabel mesh__D017586 Diskectomy
% 224.58/224.77  |- mesh__recordAuthorizer mesh__D017586 SJN
% 224.58/224.77  |- skos__historyNote mesh__D017586
% 224.58/224.77       Intervertebral Disk/surgery %28%1966-1993%29%
% 224.58/224.77  |- mesh__publicMeSHNote mesh__D017586 94   
% 224.58/224.77  |- skos__annotation mesh__D017586
% 224.58/224.77       do not use /util except by MeSH definition; DISKECTOMY, PERCUTANEOUS is also available%A%  
% 224.58/224.77  |- mesh__dateCreated mesh__D017586 1992-12-28
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D017586 2006
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D017586 2001
% 224.58/224.77  |- rdf__type mesh__D017586sskos__Concept
% 224.58/224.77  |- mesh__dateEstablished mesh__D017586 1994-01-01
% 224.58/224.77  |- skos__hiddenLabel mesh__D017586 Discectomies
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D017586 2005
% 224.58/224.77  |- skos__broader mesh__D017586smesh__D019637
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D017586 2004
% 224.58/224.77  |- mesh__recordMaintainer mesh__D017586 PXP
% 224.58/224.77  |- skos__hiddenLabel mesh__D017586 Diskectomies
% 224.58/224.77  |- skos__scopeNote mesh__D017586
% 224.58/224.77       Excision, in part or whole, of an intervertebral disk. The most common indication is disk displacement or herniation. In addition to standard surgical removal, it can be performed by percutaneous diskectomy %28%DISKECTOMY, PERCUTANEOUS%29% or by laparoscopic diskectomy, the former being the more common.%A%    
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D017586 2000
% 224.58/224.77  |- skos__historyNote mesh__D017586
% 224.58/224.77       Intervertebral Disk Displacement/surgery %28%1968-1993%29%
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D017586 2003
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D017586 1999
% 224.58/224.77  |- mesh__dateRevised mesh__D017586 1997-06-20
% 224.58/224.77  |- mesh__recordOriginator mesh__D017586 TGC
% 224.58/224.77  |- skos__annotation mesh__D031257
% 224.58/224.77       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.58/224.77  |- skos__prefLabel mesh__D031257 Droseraceae
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D031257 2003
% 224.58/224.77  |- skos__altLabel mesh__D031257 Venus Flytrap
% 224.58/224.77  |- mesh__historyNote mesh__D031257 2003   
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D031257 2004
% 224.58/224.77  |- rdf__type mesh__D031257sskos__Concept
% 224.58/224.77  |- mesh__dateCreated mesh__D031257 2002-07-03
% 224.58/224.77  |- skos__scopeNote mesh__D031257
% 224.58/224.77       A plant family of the order Nepenthales, subclass Dilleniidae, class Magnoliopsida, notable for leaves with sticky gland-tipped hairs that entrap insects.%A%    
% 224.58/224.77  |- mesh__dateEstablished mesh__D031257 2003-01-01
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D031257 2005
% 224.58/224.77  |- skos__broader mesh__D031257smesh__D019684
% 224.58/224.77  |- mesh__publicMeSHNote mesh__D031257 2003   
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D031257 2006
% 224.58/224.77  |- mesh__dateCreated mesh__D003566 1974-11-19
% 224.58/224.77  |- skos__historyNote mesh__D003566 Cytosine Nucleotides %28%1969-1974%29%
% 224.58/224.77  |- skos__altLabel mesh__D003566 Citicoline
% 224.58/224.77  |- skos__altLabel mesh__D003566 Cyticholine
% 224.58/224.77  |- skos__altLabel mesh__D003566 Citicholine
% 224.58/224.77  |- mesh__activeMeSHYear mesh__D003566 2006
% 224.58/224.77  |- mesh__dateRevised mesh__D003566 2005-06-30
% 224.58/224.78  |- skos__scopeNote mesh__D003566
% 224.58/224.78       Donor of choline in biosynthesis of choline-containing phosphoglycerides.%A%    
% 224.58/224.78  |- skos__altLabel mesh__D003566 CDP Choline
% 224.58/224.78  |- mesh__recordAuthorizer mesh__D003566 sjn
% 224.58/224.78  |- skos__hiddenLabel mesh__D003566 Choline, Cytidine Diphosphate
% 224.58/224.78  |- skos__hiddenLabel mesh__D003566 Choline, CDP
% 224.58/224.78  |- skos__altLabel mesh__D003566 Cidifos
% 224.58/224.78  |- mesh__dateEstablished mesh__D003566 1991-01-01
% 224.58/224.78  |- skos__historyNote mesh__D003566 Choline %28%1973-1974%29%
% 224.58/224.78  |- rdf__type mesh__D003566sskos__Concept
% 224.58/224.78  |- mesh__recordOriginator mesh__D003566 NLM
% 224.58/224.78  |- skos__altLabel mesh__D003566 Cytidine 5%27%-Diphosphocholine
% 224.58/224.78  |- skos__broader mesh__D003566smesh__D003565
% 224.58/224.78  |- skos__hiddenLabel mesh__D003566 Diphosphate Choline, Cytidine
% 224.58/224.78  |- skos__hiddenLabel mesh__D003566 Cytidine 5%27% Diphosphocholine
% 224.58/224.78  |- skos__hiddenLabel mesh__D003566 5%27%-Diphosphocholine, Cytidine
% 224.58/224.78  |- mesh__publicMeSHNote mesh__D003566 91; was see under CHOLINE 1975-90   
% 224.58/224.78  |- skos__prefLabel mesh__D003566 Cytidine Diphosphate Choline
% 224.58/224.78  |- skos__broader mesh__D003566smesh__D002794
% 224.58/224.78  |- mesh__historyNote mesh__D003566
% 224.58/224.78       91%28%75%29%; was see under CHOLINE 1975-90   
% 224.58/224.78  |- mesh__recordMaintainer mesh__D003566 ssb
% 224.58/224.78  |- mesh__recordMaintainer mesh__D008251 ags
% 224.58/224.78  |- mesh__recordOriginator mesh__D008251 NLM
% 224.58/224.78  |- skos__hiddenLabel mesh__D008251 Japanese Monkeys
% 224.58/224.78  |- skos__hiddenLabel mesh__D008251 Macaques
% 224.58/224.78  |- mesh__dateEstablished mesh__D008251 1973-01-01
% 224.58/224.78  |- mesh__publicMeSHNote mesh__D008251 73   
% 224.58/224.78  |- mesh__dateCreated mesh__D008251 1999-01-01
% 224.58/224.78  |- mesh__onlineNote mesh__D008251
% 224.58/224.78       use MACACA to search BARBARY APES 1973-80   
% 224.58/224.78  |- skos__hiddenLabel mesh__D008251 Apes, Celebes
% 224.58/224.78  |- skos__hiddenLabel mesh__D008251 Celebes Apes
% 224.58/224.78  |- skos__altLabel mesh__D008251 Ape, Barbary
% 224.58/224.78  |- skos__altLabel mesh__D008251 Ape, Black
% 224.58/224.78  |- skos__altLabel mesh__D008251 Macaque
% 224.58/224.78  |- skos__scopeNote mesh__D008251
% 224.58/224.78       A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of 16 species inhabiting forests of Africa, Asia, and the islands of Borneo, Philippines, and Celebes.%A%    
% 224.58/224.78  |- skos__hiddenLabel mesh__D008251 Apes, Barbary
% 224.58/224.78  |- skos__broader mesh__D008251smesh__D016663
% 224.58/224.78  |- skos__hiddenLabel mesh__D008251 Barbary Apes
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D008251 2006
% 224.58/224.78  |- skos__altLabel mesh__D008251 Japanese Monkey
% 224.58/224.78  |- skos__hiddenLabel mesh__D008251 Macacas
% 224.58/224.78  |- skos__hiddenLabel mesh__D008251 Apes, Black
% 224.58/224.78  |- mesh__historyNote mesh__D008251
% 224.58/224.78       73%28%71%29%; APE, BARBARY was BARBARY APES see under MACACA 1973-80%A%  
% 224.58/224.78  |- skos__hiddenLabel mesh__D008251 Monkeys, Japanese
% 224.58/224.78  |- skos__annotation mesh__D008251
% 224.58/224.78       Old World monkey, not ape despite X refs; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 224.58/224.78  |- rdf__type mesh__D008251sskos__Concept
% 224.58/224.78  |- skos__prefLabel mesh__D008251 Macaca
% 224.58/224.78  |- mesh__dateRevised mesh__D008251 2005-06-30
% 224.58/224.78  |- skos__historyNote mesh__D008251 Anthropoidea %28%1966-1970%29%
% 224.58/224.78  |- skos__altLabel mesh__D008251 Celebes Ape
% 224.58/224.78  |- mesh__recordAuthorizer mesh__D008251 sjn
% 224.58/224.78  |- skos__hiddenLabel mesh__D008251 Black Apes
% 224.58/224.78  |- skos__annotation mesh__D049668 IM general only; NIM as check tag   
% 224.58/224.78  |- skos__hiddenLabel mesh__D049668 Fifteenth Century History
% 224.58/224.78  |- skos__hiddenLabel mesh__D049668 Century History, 15th
% 224.58/224.78  |- skos__hiddenLabel mesh__D049668 Cent. Histories, 15th %28%Medicine%29%
% 224.58/224.78  |- skos__altLabel mesh__D049668 Medical History, 15th Cent.
% 224.58/224.78  |- skos__hiddenLabel mesh__D049668 Histories, 15th Cent. %28%Medicine%29%
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D049668 2006
% 224.58/224.78  |- skos__altLabel mesh__D049668 15th Cent. Medicine
% 224.58/224.78  |- skos__prefLabel mesh__D049668 History, 15th Century
% 224.58/224.78  |- rdf__type mesh__D049668sskos__Concept
% 224.58/224.78  |- skos__hiddenLabel mesh__D049668 History, 15th Cent. %28%Medicine%29%
% 224.58/224.78  |- skos__hiddenLabel mesh__D049668 Fifteenth Century Histories
% 224.58/224.78  |- skos__scopeNote mesh__D049668
% 224.58/224.78       Time period from 1401 through 1500 of the common era.     
% 224.58/224.78  |- skos__broader mesh__D049668smesh__D049692
% 224.58/224.78  |- skos__altLabel mesh__D049668 15th Century History
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D049668 2005
% 224.58/224.78  |- skos__hiddenLabel mesh__D049668 15th Cent. Histories %28%Medicine%29%
% 224.58/224.78  |- mesh__recordMaintainer mesh__D049668 jls
% 224.58/224.78  |- skos__hiddenLabel mesh__D049668 15th Century Histories
% 224.58/224.78  |- mesh__recordOriginator mesh__D049668 jls
% 224.58/224.78  |- mesh__publicMeSHNote mesh__D049668
% 224.58/224.78       2005; see HISTORY OF MEDICINE, 15TH CENT. 1995-2004; for HISTORY OF MEDICINE 15 CENT. see HISTORY OF MEDICINE 15TH CENT. 1964-2004, see HISTORY OF MEDICINE, XV CENT. 1963%A%  
% 224.58/224.78  |- mesh__historyNote mesh__D049668 2005   
% 224.58/224.78  |- mesh__recordAuthorizer mesh__D049668 sjn
% 224.58/224.78  |- skos__hiddenLabel mesh__D049668 Cent. History, 15th %28%Medicine%29%
% 224.58/224.78  |- skos__altLabel mesh__D049668 History, Fifteenth Century
% 224.58/224.78  |- skos__hiddenLabel mesh__D049668 Century Histories, Fifteenth
% 224.58/224.78  |- skos__hiddenLabel mesh__D049668 Century Histories, 15th
% 224.58/224.78  |- skos__altLabel mesh__D049668 15th Cent. History %28%Medicine%29%
% 224.58/224.78  |- skos__hiddenLabel mesh__D049668 Histories, Fifteenth Century
% 224.58/224.78  |- skos__hiddenLabel mesh__D049668 Histories, 15th Century
% 224.58/224.78  |- skos__hiddenLabel mesh__D049668 Century History, Fifteenth
% 224.58/224.78  |- skos__altLabel mesh__D049668 15th Cent. History of Medicine
% 224.58/224.78  |- mesh__dateEstablished mesh__D049668 2005-01-01
% 224.58/224.78  |- mesh__dateCreated mesh__D049668 2004-07-07
% 224.58/224.78  |- skos__broader mesh__D013994smesh__D005449
% 224.58/224.78  |- mesh__dateCreated mesh__D013994 1974-11-19
% 224.58/224.78  |- skos__scopeNote mesh__D013994
% 224.58/224.78       An antiviral agent used as its hydrochloride. It is the first recognized synthetic, low-molecular-weight compound that is an orally active interferon inducer, and is also reported to have antineoplastic and anti-inflammatory actions.%A%    
% 224.58/224.78  |- mesh__recordOriginator mesh__D013994 NLM
% 224.58/224.78  |- skos__altLabel mesh__D013994 Amiksin
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D013994 2003
% 224.58/224.78  |- skos__historyNote mesh__D013994 Fluorenes %28%1971-1974%29%
% 224.58/224.78  |- skos__hiddenLabel mesh__D013994 Bis DEAE Fluorenone
% 224.58/224.78  |- skos__hiddenLabel mesh__D013994 Hydrochloride, Tilorone
% 224.58/224.78  |- skos__historyNote mesh__D013994 Diethylamines %28%1974%29%
% 224.58/224.78  |- mesh__dateEstablished mesh__D013994 1991-01-01
% 224.58/224.78  |- skos__altLabel mesh__D013994 Amixin
% 224.58/224.78  |- mesh__dateRevised mesh__D013994 2001-07-25
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D013994 2002
% 224.58/224.78  |- skos__altLabel mesh__D013994 Bis-DEAE-Fluorenone
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D013994 2006
% 224.58/224.78  |- mesh__onlineNote mesh__D013994
% 224.58/224.78       use TILORONE %28%NM%29% to search AMYXIN %28%NM%29% 1988-91   
% 224.58/224.78  |- skos__prefLabel mesh__D013994 Tilorone
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D013994 2005
% 224.58/224.78  |- mesh__recordMaintainer mesh__D013994 jmp
% 224.58/224.78  |- rdf__type mesh__D013994sskos__Concept
% 224.58/224.78  |- mesh__historyNote mesh__D013994
% 224.58/224.78       91%28%75%29%; was see under FLUORENES 1975-90; AMYXIN was AMYXIN %28%NM%29% 1988-91%A%  
% 224.58/224.78  |- mesh__publicMeSHNote mesh__D013994
% 224.58/224.78       91; was see under FLUORENES 1975-90; AMYXIN was indexed under TILORONE/analogs %26% derivatives 1988-91%A%  
% 224.58/224.78  |- skos__altLabel mesh__D013994 Amyxin
% 224.58/224.78  |- mesh__recordAuthorizer mesh__D013994 sjn
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D013994 2004
% 224.58/224.78  |- mesh__dateCreated mesh__D046370 2004-07-07
% 224.58/224.78  |- mesh__recordMaintainer mesh__D046370 ags
% 224.58/224.78  |- skos__hiddenLabel mesh__D046370 Sparrow
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D046370 2006
% 224.58/224.78  |- mesh__recordAuthorizer mesh__D046370 sjn
% 224.58/224.78  |- mesh__historyNote mesh__D046370 2005; use SONGBIRDS 1999-2004   
% 224.58/224.78  |- mesh__recordOriginator mesh__D046370 ags
% 224.58/224.78  |- skos__historyNote mesh__D046370 Songbirds %28%1999-2004%29%
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D046370 2005
% 224.58/224.78  |- skos__altLabel mesh__D046370 Passeridae
% 224.58/224.78  |- skos__broader mesh__D046370smesh__D020308
% 224.58/224.78  |- rdf__type mesh__D046370sskos__Concept
% 224.58/224.78  |- mesh__dateEstablished mesh__D046370 2005-01-01
% 224.58/224.78  |- skos__prefLabel mesh__D046370 Sparrows
% 224.58/224.78  |- skos__historyNote mesh__D046370 Birds %28%1965-1998%29%
% 224.58/224.78  |- skos__scopeNote mesh__D046370
% 224.58/224.78       The family Passeridae comprised of small, mainly brown and grey seed-eating birds with conical bills.%A%    
% 224.58/224.78  |- mesh__publicMeSHNote mesh__D046370 2005; see SONGBIRDS 1999-2004   
% 224.58/224.78  |- skos__hiddenLabel mesh__D013196 beta-Hydroxy-5 beta-Androstan-3-One, 17
% 224.58/224.78  |- skos__broader mesh__D013196smesh__D045165
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D013196 2006
% 224.58/224.78  |- skos__prefLabel mesh__D013196 Dihydrotestosterone
% 224.58/224.78  |- mesh__recordMaintainer mesh__D013196 lkt
% 224.58/224.78  |- mesh__historyNote mesh__D013196 2004 %28%1963%29%   
% 224.58/224.78  |- skos__hiddenLabel mesh__D013196 5 beta Dihydrotestosterone
% 224.58/224.78  |- skos__hiddenLabel mesh__D013196 Besins Iscovesco Brand of Androstanolone
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D013196 2005
% 224.58/224.78  |- skos__altLabel mesh__D013196 5 alpha-Dihydrotestosterone
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D013196 2004
% 224.58/224.78  |- skos__scopeNote mesh__D013196
% 224.58/224.78       A potent androgenic metabolite of TESTOSTERONE. Dihydrotestosterone %28%DHT%29% is generated by a 5-alpha reduction of testosterone. Unlike testosterone, DHT cannot be aromatized to ESTRADIOL therefore DHT is considered a pure androgenic steroid.%A%    
% 224.58/224.78  |- skos__hiddenLabel mesh__D013196 17beta Hydroxy 5alpha Androstan 3 One
% 224.58/224.78  |- skos__altLabel mesh__D013196 17beta-Hydroxy-5alpha-Androstan-3-One
% 224.58/224.78  |- skos__hiddenLabel mesh__D013196 17 beta Hydroxy 5 beta Androstan 3 One
% 224.58/224.78  |- skos__altLabel mesh__D013196 Besins-Iscovesco Brand of Androstanolone
% 224.58/224.78  |- skos__altLabel mesh__D013196 5-alpha-DHT
% 224.58/224.78  |- mesh__recordOriginator mesh__D013196 NLM
% 224.58/224.78  |- skos__altLabel mesh__D013196 Cuxson Brand of Androstanolone
% 224.58/224.78  |- mesh__dateCreated mesh__D013196 1999-01-01
% 224.58/224.78  |- skos__broader mesh__D013196smesh__D000732
% 224.58/224.78  |- mesh__dateRevised mesh__D013196 2003-07-09
% 224.58/224.78  |- rdf__type mesh__D013196sskos__Concept
% 224.58/224.78  |- skos__altLabel mesh__D013196 Androstanolone
% 224.58/224.78  |- mesh__recordAuthorizer mesh__D013196 sjn
% 224.58/224.78  |- mesh__publicMeSHNote mesh__D013196 2004; see STANOLONE 1963-2003   
% 224.58/224.78  |- skos__altLabel mesh__D013196 Berenguer Infale Brand of Androstanolone
% 224.58/224.78  |- skos__hiddenLabel mesh__D013196 5 alpha DHT
% 224.58/224.78  |- skos__hiddenLabel mesh__D013196 5 alpha Dihydrotestosterone
% 224.58/224.78  |- skos__altLabel mesh__D013196 Stanolone
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D007957 2000
% 224.58/224.78  |- skos__historyNote mesh__D007957 Leukocytes %28%1966-1976%29%
% 224.58/224.78  |- skos__historyNote mesh__D007957 Immunity, Cellular %28%1970-1976%29%
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D007957 2003
% 224.58/224.78  |- skos__scopeNote mesh__D007957
% 224.58/224.78       Test for cell-mediated antitumor immunity and related serum blocking factors based on the finding that leukocytes from cancer patients, but not from controls, when mixed in vitro with antigenic extracts of tumors of the same histological type, undergo a diminution in their normal adherence to glass surfaces. Sera from tumor-bearing patients block the LAI reaction of their own leukocytes or those of other patients with the same type of tumor.%A%    
% 224.58/224.78  |- skos__prefLabel mesh__D007957 Leukocyte Adherence Inhibition Test
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D007957 2001
% 224.58/224.78  |- skos__broader mesh__D007957smesh__D007158
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D007957 2005
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D007957 2004
% 224.58/224.78  |- skos__annotation mesh__D007957 NIM; DF: LAI TEST   
% 224.58/224.78  |- skos__broader mesh__D007957smesh__D007159
% 224.58/224.78  |- skos__hiddenLabel mesh__D007957 Tests, LAI
% 224.58/224.78  |- mesh__recordAuthorizer mesh__D007957 SJN
% 224.58/224.78  |- mesh__recordOriginator mesh__D007957 SMH
% 224.58/224.78  |- mesh__recordMaintainer mesh__D007957 PXP
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D007957 1998
% 224.58/224.78  |- mesh__historyNote mesh__D007957
% 224.58/224.78       91%28%77%29%; was see under IMMUNOLOGIC TECHNIQUES 1977-90   
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D007957 2006
% 224.58/224.78  |- skos__hiddenLabel mesh__D007957 Test, LAI
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D007957 2002
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D007957 1999
% 224.58/224.78  |- skos__hiddenLabel mesh__D007957 LAI Tests
% 224.58/224.78  |- skos__altLabel mesh__D007957 LAI Test
% 224.58/224.78  |- mesh__dateEstablished mesh__D007957 1991-01-01
% 224.58/224.78  |- mesh__publicMeSHNote mesh__D007957
% 224.58/224.78       91; was see under IMMUNOLOGIC TECHNIQUES 1977-90   
% 224.58/224.78  |- rdf__type mesh__D007957sskos__Concept
% 224.58/224.78  |- mesh__dateRevised mesh__D007957 1997-06-20
% 224.58/224.78  |- mesh__dateCreated mesh__D007957 1976-05-19
% 224.58/224.78  |- skos__scopeNote mesh__D007159
% 224.58/224.78       Diagnostic techniques involving the demonstration or measurement of an immune response, including antibody production or assay, antigen-antibody reactions, serologic cross-reactivity, delayed hypersensitivity reactions, or heterogenetic responses.%A%    
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D007159 2004
% 224.58/224.78  |- skos__historyNote mesh__D007159 Immunologic Techniques %28%1973-1986%29%
% 224.58/224.78  |- mesh__publicMeSHNote mesh__D007159 87   
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D007159 1998
% 224.58/224.78  |- skos__hiddenLabel mesh__D007159 Immunologic Diagnoses
% 224.58/224.78  |- rdf__type mesh__D007159sskos__Concept
% 224.58/224.78  |- mesh__recordMaintainer mesh__D007159 TPW
% 224.58/224.78  |- skos__hiddenLabel mesh__D007159 Diagnoses, Immunologic
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D007159 2005
% 224.58/224.78  |- mesh__dateRevised mesh__D007159 1997-06-20
% 224.58/224.78  |- skos__altLabel mesh__D007159 Tests, Immunologic
% 224.58/224.78  |- skos__hiddenLabel mesh__D007159 Immunological Diagnoses
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D007159 1999
% 224.58/224.78  |- skos__hiddenLabel mesh__D007159 Immunological Diagnosis
% 224.58/224.78  |- skos__hiddenLabel mesh__D007159 Diagnoses, Immunological
% 224.58/224.78  |- skos__prefLabel mesh__D007159 Immunologic Tests
% 224.58/224.78  |- mesh__dateEstablished mesh__D007159 1987-01-01
% 224.58/224.78  |- skos__altLabel mesh__D007159 Immunological Tests
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D007159 2006
% 224.58/224.78  |- mesh__recordOriginator mesh__D007159 AEP
% 224.58/224.78  |- skos__historyNote mesh__D007159
% 224.58/224.78       specific technique or test %28%1973-1986%29%
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D007159 2000
% 224.58/224.78  |- skos__altLabel mesh__D007159 Diagnosis, Immunologic
% 224.58/224.78  |- skos__broader mesh__D007159smesh__D003942
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D007159 2001
% 224.58/224.78  |- skos__annotation mesh__D007159
% 224.58/224.78       GEN: prefer specifics; NIM; do not confuse with IMMUNOLOGIC TECHNIQUES: see note there; do not use /util except by MeSH definition%A%  
% 224.58/224.78  |- mesh__recordAuthorizer mesh__D007159 SJN
% 224.58/224.78  |- skos__altLabel mesh__D007159 Immunologic Diagnosis
% 224.58/224.78  |- skos__hiddenLabel mesh__D007159 Immunodiagnoses
% 224.58/224.78  |- skos__hiddenLabel mesh__D007159 Immunological Test
% 224.58/224.78  |- skos__altLabel mesh__D007159 Immunologic Test
% 224.58/224.78  |- mesh__historyNote mesh__D007159 87   
% 224.58/224.78  |- skos__hiddenLabel mesh__D007159 Tests, Immunological
% 224.58/224.78  |- skos__hiddenLabel mesh__D007159 Test, Immunologic
% 224.58/224.78  |- skos__altLabel mesh__D007159 Diagnosis, Immunological
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D007159 2003
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D007159 2002
% 224.58/224.78  |- skos__hiddenLabel mesh__D007159 Test, Immunological
% 224.58/224.78  |- skos__historyNote mesh__D007159 Serodiagnosis %28%1966-1986%29%
% 224.58/224.78  |- mesh__dateCreated mesh__D007159 1986-04-01
% 224.58/224.78  |- skos__broader mesh__D017587smesh__D017586
% 224.58/224.78  |- skos__hiddenLabel mesh__D017587 Diskectomies, Percutaneous
% 224.58/224.78  |- mesh__dateRevised mesh__D017587 1997-06-20
% 224.58/224.78  |- skos__altLabel mesh__D017587 Discectomy, Percutaneous
% 224.58/224.78  |- skos__hiddenLabel mesh__D017587 Percutaneous Diskectomies
% 224.58/224.78  |- mesh__recordOriginator mesh__D017587 TGC
% 224.58/224.78  |- skos__annotation mesh__D017587
% 224.58/224.78       do not use /util except by MeSH definition; X ref NUCLEOTOMY, PERCUTANEOUS refers only to the nucleus pulposus, not other nerve nuclei%A%  
% 224.58/224.78  |- mesh__dateCreated mesh__D017587 1992-12-28
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D017587 2006
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D017587 2002
% 224.58/224.78  |- rdf__type mesh__D017587sskos__Concept
% 224.58/224.78  |- skos__hiddenLabel mesh__D017587 Percutaneous Discectomies
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D017587 2005
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D017587 2004
% 224.58/224.78  |- skos__scopeNote mesh__D017587
% 224.58/224.78       Percutaneous excision of a herniated or displaced intervertebral disk by posterolateral approach, always remaining outside the spinal canal. Percutaneous nucleotomy was first described by Hijikata in Japan in 1975. In 1985 Onik introduced automated percutaneous nucleotomy which consists in percutaneous aspiration of the nucleus pulposus. It is carried out under local anesthesia, thus reducing the surgical insult and requiring brief hospitalization, often performed on an outpatient basis. It appears to be a well-tolerated alternative to surgical diskectomy and chymopapain nucleolysis.%A%    
% 224.58/224.78  |- mesh__recordAuthorizer mesh__D017587 SJN
% 224.58/224.78  |- mesh__publicMeSHNote mesh__D017587 94   
% 224.58/224.78  |- skos__historyNote mesh__D017587
% 224.58/224.78       Intervertebral Disk/surgery %28%1983-1993%29%
% 224.58/224.78  |- skos__hiddenLabel mesh__D017587 Percutaneous Nucleotomy
% 224.58/224.78  |- skos__hiddenLabel mesh__D017587 Nucleotomies, Percutaneous
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D017587 2003
% 224.58/224.78  |- skos__historyNote mesh__D017587
% 224.58/224.78       Intervertebral Disk Displacement/surgery %28%1983-1993%29%
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D017587 1999
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D017587 2001
% 224.58/224.78  |- skos__hiddenLabel mesh__D017587 Percutaneous Discectomy
% 224.58/224.78  |- mesh__dateEstablished mesh__D017587 1994-01-01
% 224.58/224.78  |- skos__hiddenLabel mesh__D017587 Percutaneous Diskectomy
% 224.58/224.78  |- mesh__recordMaintainer mesh__D017587 PXP
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D017587 1998
% 224.58/224.78  |- skos__hiddenLabel mesh__D017587 Percutaneous Nucleotomies
% 224.58/224.78  |- skos__hiddenLabel mesh__D017587 Discectomies, Percutaneous
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D017587 2000
% 224.58/224.78  |- skos__prefLabel mesh__D017587 Diskectomy, Percutaneous
% 224.58/224.78  |- mesh__historyNote mesh__D017587 94   
% 224.58/224.78  |- rdf__type mesh__D036741sskos__Concept
% 224.58/224.78  |- skos__broader mesh__D036741smesh__D010957
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D036741 2004
% 224.58/224.78  |- skos__scopeNote mesh__D036741
% 224.58/224.78       Plasmids coding for proteins which induce PLANT TUMORS. The most notable example of a plant tumor inducing plasmid is the Ti plasmid found associated with AGROBACTERIUM TUMEFACIENS.%A%    
% 224.58/224.78  |- skos__historyNote mesh__D036741 DNA, Bacterial %28%1976-2002%29%
% 224.58/224.78  |- mesh__historyNote mesh__D036741 2003   
% 224.58/224.78  |- skos__related mesh__D036741smesh__D036781
% 224.58/224.78  |- skos__prefLabel mesh__D036741 Plant Tumor-Inducing Plasmids
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D036741 2005
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D036741 2006
% 224.58/224.78  |- mesh__publicMeSHNote mesh__D036741 2003   
% 224.58/224.78  |- skos__altLabel mesh__D036741 Ti Plasmids
% 224.58/224.78  |- mesh__dateCreated mesh__D036741 2002-07-03
% 224.58/224.78  |- skos__historyNote mesh__D036741 Plasmids %28%1976-2002%29%
% 224.58/224.78  |- skos__related mesh__D036741smesh__D016960
% 224.58/224.78  |- skos__hiddenLabel mesh__D036741 Plasmids, Ti
% 224.58/224.78  |- skos__hiddenLabel mesh__D036741 Tumor-Inducing Plasmids, Plant
% 224.58/224.78  |- mesh__dateRevised mesh__D036741 2003-07-09
% 224.58/224.78  |- mesh__dateEstablished mesh__D036741 2003-01-01
% 224.58/224.78  |- skos__hiddenLabel mesh__D036741 Plasmids, Plant Tumor-Inducing
% 224.58/224.78  |- skos__hiddenLabel mesh__D036741 Plant Tumor Inducing Plasmids
% 224.58/224.78  |- skos__broader mesh__D003567smesh__D009702
% 224.58/224.78  |- skos__hiddenLabel mesh__D003567 Diphosphodiacylglycerols, Cytidine
% 224.58/224.78  |- mesh__publicMeSHNote mesh__D003567
% 224.58/224.78       91; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90   
% 224.58/224.78  |- mesh__recordOriginator mesh__D003567 NLM
% 224.58/224.78  |- skos__scopeNote mesh__D003567
% 224.58/224.78       The ester of diacylglycerol with the terminal phosphate of cytidine diphosphate. It serves as an intermediate in the biosynthesis of phosphatidylethanolamine and phosphatidylserine in bacteria.%A%    
% 224.58/224.78  |- skos__hiddenLabel mesh__D003567 Diglycerides, CDP
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D003567 2006
% 224.58/224.78  |- skos__prefLabel mesh__D003567 Cytidine Diphosphate Diglycerides
% 224.58/224.78  |- skos__historyNote mesh__D003567 Glycerophosphates %28%1972-1974%29%
% 224.58/224.78  |- skos__hiddenLabel mesh__D003567 Diphosphate Diglycerides, Cytidine
% 224.58/224.78  |- skos__altLabel mesh__D003567 Cytidine Diphosphodiacylglycerols
% 224.58/224.78  |- mesh__dateRevised mesh__D003567 2004-07-07
% 224.58/224.78  |- skos__historyNote mesh__D003567 Cytosine Nucleotides %28%1972-1974%29%
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D003567 2005
% 224.58/224.78  |- mesh__historyNote mesh__D003567
% 224.58/224.78       91%28%75%29%; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90%A%  
% 224.58/224.78  |- skos__hiddenLabel mesh__D003567 CDP Diacylglycerol
% 224.58/224.78  |- skos__altLabel mesh__D003567 CDP-Diacylglycerol
% 224.58/224.78  |- skos__historyNote mesh__D003567 Phospholipids %28%1972-1974%29%
% 224.58/224.78  |- skos__hiddenLabel mesh__D003567 Diacylglycerols, CDP
% 224.58/224.78  |- skos__altLabel mesh__D003567 CDP Diglycerides
% 224.58/224.78  |- mesh__recordAuthorizer mesh__D003567 sjn
% 224.58/224.78  |- rdf__type mesh__D003567sskos__Concept
% 224.58/224.78  |- skos__altLabel mesh__D003567 CDP Diacylglycerols
% 224.58/224.78  |- skos__hiddenLabel mesh__D003567 Diglycerides, Cytidine Diphosphate
% 224.58/224.78  |- mesh__dateEstablished mesh__D003567 1991-01-01
% 224.58/224.78  |- mesh__recordMaintainer mesh__D003567 ssb
% 224.58/224.78  |- mesh__dateCreated mesh__D003567 1974-11-19
% 224.58/224.78  |- skos__broader mesh__D003567smesh__D003565
% 224.58/224.78  |- mesh__historyNote mesh__D022721 2001   
% 224.58/224.78  |- skos__broader mesh__D022721smesh__D014614
% 224.58/224.78  |- mesh__dateRevised mesh__D022721 2005-06-30
% 224.58/224.78  |- mesh__publicMeSHNote mesh__D022721 2001   
% 224.58/224.78  |- mesh__recordMaintainer mesh__D022721 ssb
% 224.58/224.78  |- skos__hiddenLabel mesh__D022721 Virosome Vaccines
% 224.58/224.78  |- mesh__activeMeSHYear mesh__D022721 2006
% 224.58/224.78  |- rdf__type mesh__D022721sskos__Concept
% 224.58/224.78  |- skos__prefLabel mesh__D022721 Vaccines, Virosome
% 224.58/224.78  |- mesh__recordAuthorizer mesh__D022721 sjn
% 224.58/224.78  |- mesh__recordOriginator mesh__D022721 ags
% 224.58/224.78  |- skos__related mesh__D022721smesh__D022701
% 224.58/224.78  |- mesh__dateEstablished mesh__D022721 2001-01-01
% 224.58/224.78  |- mesh__dateCreated mesh__D022721 2000-06-22
% 224.58/224.78  |- skos__annotation mesh__D022721
% 224.58/224.78       IM general only; coord NIM with specific vaccine %28%IM%29%   
% 224.58/224.78  |- skos__scopeNote mesh__D022721
% 224.58/224.78       Vaccines using VIROSOMES as the antigen delivery system that stimulates the desired immune response.%A%    
% 224.58/224.78  |- mesh__recordMaintainer mesh__D008252 ags
% 224.58/224.78  |- skos__altLabel mesh__D008252 Crab-Eating Monkey
% 224.58/224.78  |- skos__hiddenLabel mesh__D008252 Crab-Eating Monkeys
% 224.58/224.78  |- mesh__dateRevised mesh__D008252 2005-06-30
% 224.58/224.78  |- skos__hiddenLabel mesh__D008252 Monkeys, Crab-Eating
% 224.58/224.78  |- skos__hiddenLabel mesh__D008252 Macaque, Crab-Eating
% 224.58/224.78  |- skos__altLabel mesh__D008252 Cynomolgus Monkey
% 224.58/224.78  |- skos__hiddenLabel mesh__D008252 Macaques, Crab-Eating
% 224.58/224.78  |- mesh__publicMeSHNote mesh__D008252
% 224.58/224.78       91; was see under MACACA 1981-90; was CYNOMOLGUS MONKEYS see under MACACA 1975-80%A%  
% 224.58/224.78  |- skos__hiddenLabel mesh__D008252 Crab Eating Macaque
% 224.58/224.78  |- skos__hiddenLabel mesh__D008252 Crab Eating Monkey
% 224.58/224.78  |- mesh__recordAuthorizer mesh__D008252 sjn
% 224.58/224.79  |- mesh__dateEstablished mesh__D008252 1991-01-01
% 224.58/224.79  |- skos__hiddenLabel mesh__D008252 Monkey, Crab Eating
% 224.58/224.79  |- mesh__recordOriginator mesh__D008252 NLM
% 224.58/224.79  |- skos__altLabel mesh__D008252 Monkey, Cynomolgus
% 224.58/224.79  |- skos__scopeNote mesh__D008252
% 224.58/224.79       A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula.%A%    
% 224.58/224.79  |- skos__hiddenLabel mesh__D008252 Crab-Eating Macaques
% 224.58/224.79  |- mesh__historyNote mesh__D008252
% 224.58/224.79       91%28%81%29%; was see under MACACA 1981-90; was CYNOMOLGUS MONKEYS see under MACACA 1975-80%A%  
% 224.58/224.79  |- skos__altLabel mesh__D008252 Monkey, Crab-Eating
% 224.58/224.79  |- mesh__dateCreated mesh__D008252 1999-01-01
% 224.58/224.79  |- skos__hiddenLabel mesh__D008252 Cynomolgus Monkeys
% 224.58/224.79  |- skos__hiddenLabel mesh__D008252 Monkeys, Cynomolgus
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D008252 2006
% 224.58/224.79  |- skos__annotation mesh__D008252
% 224.58/224.79       Old World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 224.58/224.79  |- mesh__onlineNote mesh__D008252
% 224.58/224.79       use MACACA FASCICULARIS to search CYNOMOLGUS MONKEYS 1975-80%A%  
% 224.58/224.79  |- skos__broader mesh__D008252smesh__D008251
% 224.58/224.79  |- skos__prefLabel mesh__D008252 Macaca fascicularis
% 224.58/224.79  |- skos__altLabel mesh__D008252 Crab-Eating Macaque
% 224.58/224.79  |- rdf__type mesh__D008252sskos__Concept
% 224.58/224.79  |- skos__prefLabel mesh__D049669 History, 16th Century
% 224.58/224.79  |- skos__hiddenLabel mesh__D049669 Cent. Histories, 16th %28%Medicine%29%
% 224.58/224.79  |- skos__hiddenLabel mesh__D049669 Histories, Sixteenth Century
% 224.58/224.79  |- skos__hiddenLabel mesh__D049669 16th Cent. Histories %28%Medicine%29%
% 224.58/224.79  |- skos__altLabel mesh__D049669 16th Cent. Medicine
% 224.58/224.79  |- mesh__dateCreated mesh__D049669 2004-07-07
% 224.58/224.79  |- skos__scopeNote mesh__D049669
% 224.58/224.79       Time period from 1501 through 1600 of the common era.     
% 224.58/224.79  |- skos__hiddenLabel mesh__D049669 Sixteenth Century Histories
% 224.58/224.79  |- skos__altLabel mesh__D049669 16th Cent. History of Medicine
% 224.58/224.79  |- skos__annotation mesh__D049669 IM general only; NIM as check tag   
% 224.58/224.79  |- rdf__type mesh__D049669sskos__Concept
% 224.58/224.79  |- skos__hiddenLabel mesh__D049669 Histories, 16th Century
% 224.58/224.79  |- skos__hiddenLabel mesh__D049669 Histories, 16th Cent. %28%Medicine%29%
% 224.58/224.79  |- skos__altLabel mesh__D049669 History, Sixteenth Century
% 224.58/224.79  |- skos__hiddenLabel mesh__D049669 Century Histories, Sixteenth
% 224.58/224.79  |- skos__hiddenLabel mesh__D049669 Cent. History, 16th %28%Medicine%29%
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D049669 2006
% 224.58/224.79  |- mesh__recordMaintainer mesh__D049669 jls
% 224.58/224.79  |- skos__broader mesh__D049669smesh__D049692
% 224.58/224.79  |- skos__altLabel mesh__D049669 16th Century History
% 224.58/224.79  |- skos__altLabel mesh__D049669 16th Cent. History %28%Medicine%29%
% 224.58/224.79  |- skos__altLabel mesh__D049669 Medical History, 16th Cent.
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D049669 2005
% 224.58/224.79  |- mesh__recordAuthorizer mesh__D049669 sjn
% 224.58/224.79  |- mesh__publicMeSHNote mesh__D049669
% 224.58/224.79       2005; see HISTORY OF MEDICINE, 16TH CENT. 1995-2004; for HISTORY OF MEDICINE 16 CENT. see HISTORY OF MEDICINE 16TH CENT. 1964-2004, see  HISTORY OF MEDICINE, XVI CENT. 1963%A%  
% 224.58/224.79  |- skos__hiddenLabel mesh__D049669 Sixteenth Century History
% 224.58/224.79  |- mesh__historyNote mesh__D049669 2005   
% 224.58/224.79  |- skos__hiddenLabel mesh__D049669 16th Century Histories
% 224.58/224.79  |- skos__hiddenLabel mesh__D049669 Century History, 16th
% 224.58/224.79  |- mesh__recordOriginator mesh__D049669 jls
% 224.58/224.79  |- skos__hiddenLabel mesh__D049669 History, 16th Cent. %28%Medicine%29%
% 224.58/224.79  |- skos__hiddenLabel mesh__D049669 Century History, Sixteenth
% 224.58/224.79  |- skos__hiddenLabel mesh__D049669 Century Histories, 16th
% 224.58/224.79  |- mesh__dateEstablished mesh__D049669 2005-01-01
% 224.58/224.79  |- skos__annotation mesh__D013995
% 224.58/224.79       IM as the abstraction; no qualif; do not confuse with TIME FACTORS, the NIM coord aspect of a given subject; %22%diurnal%22% %26% %22%nocturnal%22%: consider preferably CIRCADIAN RHYTHM%A%  
% 224.58/224.79  |- skos__altLabel mesh__D013995 Effects, Longterm
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D013995 1998
% 224.58/224.79  |- skos__hiddenLabel mesh__D013995 Effect, Long-Term
% 224.58/224.79  |- mesh__recordMaintainer mesh__D013995 KEV
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D013995 2006
% 224.58/224.79  |- mesh__recordOriginator mesh__D013995 NLM
% 224.58/224.79  |- skos__hiddenLabel mesh__D013995 Effect, Longterm
% 224.58/224.79  |- skos__hiddenLabel mesh__D013995 Longterm Effect
% 224.58/224.79  |- skos__hiddenLabel mesh__D013995 Effects, Long Term
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D013995 1997
% 224.58/224.79  |- skos__hiddenLabel mesh__D013995 Long Term Effects
% 224.58/224.79  |- skos__altLabel mesh__D013995 Effects, Long-Term
% 224.58/224.79  |- mesh__dateCreated mesh__D013995 1999-01-01
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D013995 2005
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D013995 2002
% 224.58/224.79  |- rdf__type mesh__D013995sskos__Concept
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D013995 1996
% 224.58/224.79  |- skos__prefLabel mesh__D013995 Time
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D013995 2004
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D013995 2001
% 224.58/224.79  |- skos__altLabel mesh__D013995 Long-Term Effects
% 224.58/224.79  |- skos__hiddenLabel mesh__D013995 Long-Term Effect
% 224.58/224.79  |- mesh__recordAuthorizer mesh__D013995 PLS
% 224.58/224.79  |- mesh__dateRevised mesh__D013995 1995-05-23
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D013995 2003
% 224.58/224.79  |- skos__broader mesh__D013995smesh__D010811
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D013995 1999
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D013995 2000
% 224.58/224.79  |- skos__prefLabel mesh__D013197 Stanozolol
% 224.58/224.79  |- mesh__recordAuthorizer mesh__D013197 sjn
% 224.58/224.79  |- mesh__historyNote mesh__D013197 65%28%64%29%   
% 224.58/224.79  |- skos__altLabel mesh__D013197 Zambon Brand of Stanozolol
% 224.58/224.79  |- skos__altLabel mesh__D013197 Winstrol
% 224.58/224.79  |- mesh__publicMeSHNote mesh__D013197 65   
% 224.58/224.79  |- skos__altLabel mesh__D013197 Sanofi-Synthelabo Brand of Stanozolol
% 224.58/224.79  |- skos__annotation mesh__D013197 an anabolic steroid   
% 224.58/224.79  |- skos__altLabel mesh__D013197 Androstanazol
% 224.58/224.79  |- mesh__dateCreated mesh__D013197 1999-01-01
% 224.58/224.79  |- skos__altLabel mesh__D013197 Methylstanazol
% 224.58/224.79  |- rdf__type mesh__D013197sskos__Concept
% 224.58/224.79  |- mesh__recordOriginator mesh__D013197 NLM
% 224.58/224.79  |- skos__altLabel mesh__D013197 Stanazolol
% 224.58/224.79  |- skos__scopeNote mesh__D013197
% 224.58/224.79       A synthetic steroid that has anabolic and androgenic properties. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1194%29%%A%    
% 224.58/224.79  |- skos__altLabel mesh__D013197 Sanofi Winthrop Brand of Stanozolol
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D013197 2006
% 224.58/224.79  |- mesh__dateRevised mesh__D013197 2005-06-30
% 224.58/224.79  |- mesh__recordMaintainer mesh__D013197 CCR
% 224.58/224.79  |- skos__broader mesh__D013197smesh__D000732
% 224.58/224.79  |- mesh__dateEstablished mesh__D013197 1965-01-01
% 224.58/224.79  |- skos__hiddenLabel mesh__D007958 Number, Leukocyte
% 224.58/224.79  |- skos__hiddenLabel mesh__D007958 Leukocyte Numbers
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D007958 2006
% 224.58/224.79  |- mesh__recordMaintainer mesh__D007958 nns
% 224.58/224.79  |- skos__altLabel mesh__D007958 Blood Cell Count, White
% 224.58/224.79  |- skos__related mesh__D007958smesh__D007964
% 224.58/224.79  |- skos__hiddenLabel mesh__D007958 Differential Leukocyte Counts
% 224.58/224.79  |- skos__hiddenLabel mesh__D007958 Count, Differential Leukocyte
% 224.58/224.79  |- skos__hiddenLabel mesh__D007958 Numbers, Leukocyte
% 224.58/224.79  |- skos__prefLabel mesh__D007958 Leukocyte Count
% 224.58/224.79  |- skos__annotation mesh__D007958
% 224.58/224.79       usually NIM; coord NIM with specific leukocyte %28%IM%29% but LYMPHOCYTE COUNT is also available; coord with disease /blood, not /physiopathol%A%  
% 224.58/224.79  |- mesh__dateRevised mesh__D007958 2003-07-09
% 224.58/224.79  |- skos__hiddenLabel mesh__D007958 Leukocyte Counts, Differential
% 224.58/224.79  |- rdf__type mesh__D007958sskos__Concept
% 224.58/224.79  |- skos__hiddenLabel mesh__D007958 Counts, Differential Leukocyte
% 224.58/224.79  |- mesh__recordOriginator mesh__D007958 NLM
% 224.58/224.79  |- skos__altLabel mesh__D007958 White Blood Cell Count
% 224.58/224.79  |- skos__broader mesh__D007958smesh__D001772
% 224.58/224.79  |- skos__hiddenLabel mesh__D007958 Count, Leukocyte
% 224.58/224.79  |- skos__altLabel mesh__D007958 Differential Leukocyte Count
% 224.58/224.79  |- skos__hiddenLabel mesh__D007958 Counts, Leukocyte
% 224.58/224.79  |- skos__altLabel mesh__D007958 Leukocyte Number
% 224.58/224.79  |- mesh__recordAuthorizer mesh__D007958 sjn
% 224.58/224.79  |- mesh__dateCreated mesh__D007958 1999-01-01
% 224.58/224.79  |- skos__scopeNote mesh__D007958
% 224.58/224.79       The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells.%A%    
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D007958 2005
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D007958 2004
% 224.58/224.79  |- skos__hiddenLabel mesh__D007958 Leukocyte Counts
% 224.58/224.79  |- skos__altLabel mesh__D018680 Cholinergic-Blocking Agents
% 224.58/224.79  |- skos__broader mesh__D018680smesh__D018678
% 224.58/224.79  |- mesh__historyNote mesh__D018680
% 224.58/224.79       95; CHOLINERGIC-BLOCKING AGENTS was see PARASYMPATHOLYTICS 1963-94; CHOLINOLYTICS %26% ANTICHOLINERGIC AGENTS were see PARASYMPATHOLYTICS 1975-94%A%  
% 224.58/224.79  |- skos__hiddenLabel mesh__D018680 Antagonists, Acetylcholine
% 224.58/224.79  |- skos__altLabel mesh__D018680 Anticholinergics
% 224.58/224.79  |- skos__altLabel mesh__D018680 Anti-Cholinergics
% 224.58/224.79  |- skos__hiddenLabel mesh__D018680 Antagonist, Cholinergic
% 224.58/224.79  |- mesh__recordMaintainer mesh__D018680 ssb
% 224.58/224.79  |- mesh__recordAuthorizer mesh__D018680 sjn
% 224.58/224.79  |- skos__scopeNote mesh__D018680
% 224.58/224.79       Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists.%A%    
% 224.58/224.79  |- skos__prefLabel mesh__D018680 Cholinergic Antagonists
% 224.58/224.79  |- mesh__onlineNote mesh__D018680
% 224.58/224.79       use PARASYMPATHOLYTICS to search CHOLINERGIC-BLOCKING AGENTS 1966-94 %26% CHOLINOLYTICS %26% ANTICHOLINERGIC AGENTS 1975-94%A%  
% 224.58/224.79  |- skos__hiddenLabel mesh__D018680 Cholinergic Blocking Agents
% 224.58/224.79  |- skos__hiddenLabel mesh__D018680 Antagonists, Cholinergic
% 224.58/224.79  |- skos__hiddenLabel mesh__D018680 Agents, Anticholinergic
% 224.58/224.79  |- skos__altLabel mesh__D018680 Cholinergic Antagonist
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D018680 2006
% 224.58/224.79  |- skos__altLabel mesh__D018680 Cholinolytics
% 224.58/224.79  |- mesh__recordOriginator mesh__D018680 RAZ
% 224.58/224.79  |- skos__hiddenLabel mesh__D018680 Anti Cholinergics
% 224.58/224.79  |- skos__altLabel mesh__D018680 Acetylcholine Antagonists
% 224.58/224.79  |- mesh__dateCreated mesh__D018680 1994-06-01
% 224.58/224.79  |- mesh__dateRevised mesh__D018680 2005-06-30
% 224.58/224.79  |- skos__annotation mesh__D018680 DF: CHOLINERGIC ANTAG   
% 224.58/224.79  |- skos__hiddenLabel mesh__D018680 Agents, Cholinergic-Blocking
% 224.58/224.79  |- rdf__type mesh__D018680sskos__Concept
% 224.58/224.79  |- mesh__dateEstablished mesh__D018680 1995-01-01
% 224.58/224.79  |- mesh__publicMeSHNote mesh__D018680
% 224.58/224.79       95; CHOLINERGIC-BLOCKING AGENTS was see PARASYMPATHOLYTICS 1963-94; CHOLINOLYTICS %26% ANTICHOLINERGIC AGENTS were see PARASYMPATHOLYTICS 1975-94%A%  
% 224.58/224.79  |- skos__broader mesh__D004660smesh__D001927
% 224.58/224.79  |- skos__related mesh__D004660smesh__D004679
% 224.58/224.79  |- skos__altLabel mesh__D004660 Rasmussen Encephalitis
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D004660 2002
% 224.58/224.79  |- skos__broader mesh__D004660smesh__D002494
% 224.58/224.79  |- skos__altLabel mesh__D004660 Brain Inflammation
% 224.58/224.79  |- skos__annotation mesh__D004660
% 224.58/224.79       GEN; coord with specific organism /infection heading %28%IM%29% or other cause %28%IM%29%; viral encephalitis = ENCEPHALITIS, VIRAL unless ENCEPHALITIS, ARBOVIRUS but see note there; ENCEPHALOMYELITIS %26% specifics %26% SUBACUTE SCLEROSING PANENCEPHALITIS %28%see note there%29% are also available; DF: ENCEPH%A%  
% 224.58/224.79  |- rdf__type mesh__D004660sskos__Concept
% 224.58/224.79  |- mesh__dateRevised mesh__D004660 1999-11-05
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D004660 2001
% 224.58/224.79  |- skos__hiddenLabel mesh__D004660 Brain Inflammations
% 224.58/224.79  |- mesh__dateCreated mesh__D004660 1999-01-01
% 224.58/224.79  |- skos__hiddenLabel mesh__D004660 Infectious Encephalitides
% 224.58/224.79  |- skos__altLabel mesh__D004660 Inflammation, Brain
% 224.58/224.79  |- skos__altLabel mesh__D004660 Rasmussen%27%s Syndrome
% 224.58/224.79  |- skos__prefLabel mesh__D004660 Encephalitis
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D004660 2000
% 224.58/224.79  |- mesh__recordAuthorizer mesh__D004660 sjn
% 224.58/224.79  |- skos__broader mesh__D004660smesh__D020805
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D004660 2004
% 224.58/224.79  |- skos__altLabel mesh__D004660 Encephalitis, Infectious
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D004660 2006
% 224.58/224.79  |- skos__scopeNote mesh__D004660
% 224.58/224.79       Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections %28%see ENCEPHALITIS, VIRAL%29% are a relatively frequent cause of this condition.%A%    
% 224.58/224.79  |- skos__altLabel mesh__D004660 Encephalitis, Rasmussen
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D004660 2003
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D004660 2005
% 224.58/224.79  |- mesh__recordOriginator mesh__D004660 NLM
% 224.58/224.79  |- mesh__recordMaintainer mesh__D004660 KEV
% 224.58/224.79  |- skos__hiddenLabel mesh__D004660 Encephalitides, Infectious
% 224.58/224.79  |- skos__historyNote mesh__D017588 Androgens %28%1966-1993%29%
% 224.58/224.79  |- mesh__recordMaintainer mesh__D017588 lkt
% 224.58/224.79  |- skos__annotation mesh__D017588
% 224.58/224.79       GEN or unspecified; prefer specific manifestation such as HIRSUTISM; VIRILISM; etc.%A%  
% 224.58/224.79  |- skos__prefLabel mesh__D017588 Hyperandrogenism
% 224.58/224.79  |- mesh__recordOriginator mesh__D017588 TGC
% 224.58/224.79  |- skos__related mesh__D017588smesh__D014770
% 224.58/224.79  |- mesh__historyNote mesh__D017588 94   
% 224.58/224.79  |- skos__scopeNote mesh__D017588
% 224.58/224.79       A condition caused by the excessive secretion of ANDROGENS from the ADRENAL CORTEX; the OVARIES; or the TESTES. The clinical significance in males is negligible. In women, the common manifestations are HIRSUTISM and VIRILISM as seen in patients with POLYCYSTIC OVARY SYNDROME and ADRENOCORTICAL HYPERFUNCTION.%A%    
% 224.58/224.79  |- skos__broader mesh__D017588smesh__D012734
% 224.58/224.79  |- mesh__dateCreated mesh__D017588 1992-12-28
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D017588 2006
% 224.58/224.79  |- mesh__dateRevised mesh__D017588 2004-07-15
% 224.58/224.79  |- mesh__recordAuthorizer mesh__D017588 sjn
% 224.58/224.79  |- rdf__type mesh__D017588sskos__Concept
% 224.58/224.79  |- mesh__publicMeSHNote mesh__D017588 94   
% 224.58/224.79  |- skos__related mesh__D017588smesh__D006628
% 224.58/224.79  |- mesh__dateEstablished mesh__D017588 1994-01-01
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D017588 2005
% 224.58/224.79  |- mesh__dateRevised mesh__D003568 1995-05-18
% 224.58/224.79  |- mesh__historyNote mesh__D003568
% 224.58/224.79       91%28%78%29%; was see under CYTOSINE NUCLEOTIDES 1978-90; was CYTIDYLIC ACIDS see under CYTOSINE NUCLEOTIDES 1963-77%A%  
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D003568 2000
% 224.58/224.79  |- skos__altLabel mesh__D003568 Cytidylic Acids
% 224.58/224.79  |- skos__altLabel mesh__D003568 CMP
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D003568 2004
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D003568 1999
% 224.58/224.79  |- skos__hiddenLabel mesh__D003568 Monophosphate, Cytidine
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D003568 2003
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D003568 1998
% 224.58/224.79  |- skos__altLabel mesh__D003568 Cytidylic Acid
% 224.58/224.79  |- skos__prefLabel mesh__D003568 Cytidine Monophosphate
% 224.58/224.79  |- mesh__onlineNote mesh__D003568
% 224.58/224.79       to search CYTIDYLIC ACIDS use CYTIDINE MONOPHOSPHATE 1975-77 and CYTOSINE NUCLEOTIDES 1966-74%A%  
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D003568 2002
% 224.58/224.79  |- skos__hiddenLabel mesh__D003568 3%27% CMP
% 224.58/224.79  |- skos__hiddenLabel mesh__D003568 2%27% CMP
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D003568 2006
% 224.58/224.79  |- mesh__recordMaintainer mesh__D003568 TAP
% 224.58/224.79  |- skos__broader mesh__D003568smesh__D003597
% 224.58/224.79  |- mesh__publicMeSHNote mesh__D003568
% 224.58/224.79       91; was see under CYTOSINE NUCLEOTIDES 1978-90; was CYTIDYLIC ACIDS see under CYTOSINE NUCLEOTIDES 1963-77%A%  
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D003568 1997
% 224.58/224.79  |- rdf__type mesh__D003568sskos__Concept
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D003568 2005
% 224.58/224.79  |- mesh__recordAuthorizer mesh__D003568 PLS
% 224.58/224.79  |- skos__hiddenLabel mesh__D003568 Acids, Cytidylic
% 224.58/224.79  |- mesh__dateEstablished mesh__D003568 1991-01-01
% 224.58/224.79  |- mesh__dateCreated mesh__D003568 1999-01-01
% 224.58/224.79  |- skos__annotation mesh__D003568 /biosyn /physiol permitted   
% 224.58/224.79  |- skos__hiddenLabel mesh__D003568 Acid, Cytidylic
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D003568 1996
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D003568 2001
% 224.58/224.79  |- skos__historyNote mesh__D003568 Cytosine Nucleotides %28%1966-1974%29%
% 224.58/224.79  |- mesh__recordOriginator mesh__D003568 NLM
% 224.58/224.79  |- skos__scopeNote mesh__D003568
% 224.58/224.79       Cytidine %28%dihydrogen phosphate%29%. A cytosine nucleotide containing one phosphate group esterified to the sugar moiety in the 2%27%, 3%27% or 5%27% position.%A%    
% 224.58/224.79  |- mesh__recordMaintainer mesh__D014290 ssb
% 224.58/224.79  |- mesh__dateEstablished mesh__D014290 1991-01-01
% 224.58/224.79  |- rdf__type mesh__D014290sskos__Concept
% 224.58/224.79  |- mesh__onlineNote mesh__D014290
% 224.58/224.79       use METIPRANOLOL to search TRIMEPRANOL 1979-94   
% 224.58/224.79  |- skos__historyNote mesh__D014290 Amino Alcohols %28%1966-1973%29%
% 224.58/224.79  |- mesh__recordOriginator mesh__D014290 SH
% 224.58/224.79  |- mesh__dateRevised mesh__D014290 2005-06-30
% 224.58/224.79  |- skos__scopeNote mesh__D014290
% 224.58/224.79       A beta-adrenergic antagonist effective for both beta-1 and beta-2 receptors. It is used as an antiarrhythmic, antihypertensive, and antiglaucoma agent.%A%    
% 224.58/224.79  |- mesh__publicMeSHNote mesh__D014290
% 224.58/224.79       95; was TRIMEPRANOL 1979-94 %28%see under PROPANOLAMINES 1979-90%29%; METIPRANOLOL was see TRIMEPRANOL 1986-94%A%  
% 224.58/224.79  |- mesh__historyNote mesh__D014290
% 224.58/224.79       95; was TRIMEPRANOL 1979-94 %28%see under PROPANOLAMINES 1979-90%29%; METIPRANOLOL was see TRIMEPRANOL 1986-94%A%  
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D014290 2006
% 224.58/224.79  |- mesh__recordAuthorizer mesh__D014290 sjn
% 224.58/224.79  |- skos__altLabel mesh__D014290 Methypranol
% 224.58/224.79  |- skos__altLabel mesh__D014290 Trimepranol
% 224.58/224.79  |- mesh__dateCreated mesh__D014290 1978-02-08
% 224.58/224.79  |- skos__historyNote mesh__D014290 Propanolamines %28%1974-1978%29%
% 224.58/224.79  |- skos__altLabel mesh__D014290
% 224.58/224.79       1-%28%4-Acetoxy-2,3,5-Trimethylphenoxy%29%-3-Isopropylamino-2-Propanol
% 224.58/224.79  |- skos__broader mesh__D014290smesh__D050198
% 224.58/224.79  |- skos__prefLabel mesh__D014290 Metipranolol
% 224.58/224.79  |- skos__broader mesh__D014290smesh__D011412
% 224.58/224.79  |- skos__broader mesh__D022722smesh__D001833
% 224.58/224.79  |- mesh__recordAuthorizer mesh__D022722 sjn
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D022722 2006
% 224.58/224.79  |- skos__scopeNote mesh__D022722
% 224.58/224.79       The generation of heat in order to maintain body temperature. The uncoupled oxidation of fatty acids contained within brown adipose tissue and SHIVERING are examples of thermogenesis in MAMMALS.%A%    
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D022722 2001
% 224.58/224.79  |- rdf__type mesh__D022722sskos__Concept
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D022722 2004
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D022722 2002
% 224.58/224.79  |- mesh__recordMaintainer mesh__D022722 jmp
% 224.58/224.79  |- skos__altLabel mesh__D022722 Heat Production
% 224.58/224.79  |- mesh__historyNote mesh__D022722
% 224.58/224.79       2001; for HEAT PRODUCTION use BODY TEMPERATURE REGULATION 1975-2000%A%  
% 224.58/224.79  |- mesh__dateEstablished mesh__D022722 2001-01-01
% 224.58/224.79  |- mesh__dateCreated mesh__D022722 2000-06-22
% 224.58/224.79  |- skos__prefLabel mesh__D022722 Thermogenesis
% 224.58/224.79  |- skos__hiddenLabel mesh__D022722 Thermogeneses
% 224.58/224.79  |- skos__hiddenLabel mesh__D022722 Production, Heat
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D022722 2005
% 224.58/224.79  |- mesh__recordOriginator mesh__D022722 jmp
% 224.58/224.79  |- mesh__publicMeSHNote mesh__D022722
% 224.58/224.79       2001; for HEAT PRODUCTION see BODY TEMPERATURE REGULATION 1975-2000%A%  
% 224.58/224.79  |- skos__historyNote mesh__D022722
% 224.58/224.79       Body Temperature Regulation %28%1966-2000%29%
% 224.58/224.79  |- mesh__activeMeSHYear mesh__D022722 2003
% 224.58/224.79  |- skos__prefLabel mesh__D008253 Macaca mulatta
% 224.58/224.79  |- skos__broader mesh__D008253smesh__D008251
% 224.58/224.79  |- mesh__dateEstablished mesh__D008253 1991-01-01
% 224.58/224.79  |- skos__altLabel mesh__D008253 Rhesus Macaque
% 224.58/224.80  |- mesh__historyNote mesh__D008253
% 224.58/224.80       91%28%81%29%; was see under MACACA 1981-90; was RHESUS MONKEYS see under MACACA 1975-80%A%  
% 224.58/224.80  |- mesh__dateRevised mesh__D008253 2005-06-30
% 224.58/224.80  |- skos__hiddenLabel mesh__D008253 Macaca mulattas
% 224.58/224.80  |- skos__hiddenLabel mesh__D008253 Macaques, Rhesus
% 224.58/224.80  |- skos__hiddenLabel mesh__D008253 Monkeys, Rhesus
% 224.58/224.80  |- mesh__dateCreated mesh__D008253 1999-01-01
% 224.58/224.80  |- skos__hiddenLabel mesh__D008253 mulattas, Macaca
% 224.58/224.80  |- mesh__recordAuthorizer mesh__D008253 sjn
% 224.58/224.80  |- mesh__onlineNote mesh__D008253
% 224.58/224.80       use MACACA MULATTA to search RHESUS MONKEYS 1975-80   
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D008253 2006
% 224.58/224.80  |- skos__hiddenLabel mesh__D008253 Rhesus Monkeys
% 224.58/224.80  |- skos__annotation mesh__D008253
% 224.58/224.80       Old World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 224.58/224.80  |- skos__hiddenLabel mesh__D008253 Macaque, Rhesus
% 224.58/224.80  |- mesh__recordOriginator mesh__D008253 NLM
% 224.58/224.80  |- skos__hiddenLabel mesh__D008253 Rhesus Macaques
% 224.58/224.80  |- skos__hiddenLabel mesh__D008253 mulatta, Macaca
% 224.58/224.80  |- rdf__type mesh__D008253sskos__Concept
% 224.58/224.80  |- skos__scopeNote mesh__D008253
% 224.58/224.80       A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans.%A%    
% 224.58/224.80  |- skos__altLabel mesh__D008253 Monkey, Rhesus
% 224.58/224.80  |- mesh__recordMaintainer mesh__D008253 ags
% 224.58/224.80  |- mesh__publicMeSHNote mesh__D008253
% 224.58/224.80       91; was see under MACACA 1981-90; was RHESUS MONKEYS see under MACACA 1975-80%A%  
% 224.58/224.80  |- skos__altLabel mesh__D008253 Rhesus Monkey
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D000270 2001
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D000270 2004
% 224.58/224.80  |- skos__prefLabel mesh__D000270 Adie Syndrome
% 224.58/224.80  |- mesh__recordOriginator mesh__D000270 NLM
% 224.58/224.80  |- mesh__recordMaintainer mesh__D000270 ags
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D000270 2000
% 224.58/224.80  |- skos__hiddenLabel mesh__D000270 Syndrome, Adie%27%s
% 224.58/224.80  |- skos__broader mesh__D000270smesh__D015845
% 224.58/224.80  |- mesh__publicMeSHNote mesh__D000270
% 224.58/224.80       2000; see ADIE%27%S SYNDROME 1963-1999   
% 224.58/224.80  |- mesh__dateRevised mesh__D000270 1999-11-23
% 224.58/224.80  |- skos__hiddenLabel mesh__D000270 Syndrome, Adie
% 224.58/224.80  |- skos__altLabel mesh__D000270 Holmes-Adie Syndrome
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D000270 2006
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D000270 2003
% 224.58/224.80  |- mesh__historyNote mesh__D000270 2000 %28%1963%29%   
% 224.58/224.80  |- mesh__recordAuthorizer mesh__D000270 ags
% 224.58/224.80  |- skos__hiddenLabel mesh__D000270 Holmes Adie Syndrome
% 224.58/224.80  |- skos__broader mesh__D000270smesh__D015840
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D000270 2005
% 224.58/224.80  |- skos__broader mesh__D000270smesh__D001342
% 224.58/224.80  |- rdf__type mesh__D000270sskos__Concept
% 224.58/224.80  |- skos__scopeNote mesh__D000270
% 224.58/224.80       A syndrome characterized by a TONIC PUPIL that occurs in combination with decreased lower extremity reflexes. The affected pupil will respond more briskly to accommodation than to light %28%light-near dissociation%29% and is supersensitive to dilute pilocarpine eye drops, which induce pupillary constriction. Pathologic features include degeneration of the ciliary ganglion and postganglionic parasympathetic fibers that innervate the pupillary constrictor muscle. %28%From Adams et al., Principles of Neurology, 6th ed, p279%29%%A%    
% 224.58/224.80  |- skos__hiddenLabel mesh__D000270 Syndrome, Holmes-Adie
% 224.58/224.80  |- skos__altLabel mesh__D000270 Adie%27%s Syndrome
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D000270 2000A
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D000270 2002
% 224.58/224.80  |- mesh__dateCreated mesh__D000270 1999-01-01
% 224.58/224.80  |- mesh__recordMaintainer mesh__D013996 JLS
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013996 1998
% 224.58/224.80  |- mesh__recordOriginator mesh__D013996 NLM
% 224.58/224.80  |- skos__hiddenLabel mesh__D013996 Time Study
% 224.58/224.80  |- mesh__publicMeSHNote mesh__D013996
% 224.58/224.80       91; was see under TASK PERFORMANCE AND ANALYSIS 1975-90   
% 224.58/224.80  |- skos__hiddenLabel mesh__D013996 Study, Time
% 224.58/224.80  |- skos__prefLabel mesh__D013996 Time and Motion Studies
% 224.58/224.80  |- skos__scopeNote mesh__D013996
% 224.58/224.80       The observation and analysis of movements in a task with an emphasis on the amount of time required to perform the task.%A%    
% 224.58/224.80  |- mesh__historyNote mesh__D013996
% 224.58/224.80       91%28%75%29%; was see under TASK PERFORMANCE AND ANALYSIS 1975-90%A%  
% 224.58/224.80  |- mesh__dateCreated mesh__D013996 1999-01-01
% 224.58/224.80  |- skos__hiddenLabel mesh__D013996 Studies, Time
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013996 2006
% 224.58/224.80  |- mesh__recordAuthorizer mesh__D013996 SJN
% 224.58/224.80  |- mesh__dateRevised mesh__D013996 1997-06-20
% 224.58/224.80  |- rdf__type mesh__D013996sskos__Concept
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013996 2002
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013996 2005
% 224.58/224.80  |- skos__annotation mesh__D013996 no qualif; DF: TIME STUDIES   
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013996 2001
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013996 2004
% 224.58/224.80  |- skos__broader mesh__D013996smesh__D013647
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013996 2000
% 224.58/224.80  |- mesh__onlineNote mesh__D013996
% 224.58/224.80       search TASK PERFORMANCE AND ANALYSIS 1973-74   
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013996 2003
% 224.58/224.80  |- mesh__dateEstablished mesh__D013996 1991-01-01
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013996 1999
% 224.58/224.80  |- mesh__recordMaintainer mesh__D013198 nns
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013198 2004
% 224.58/224.80  |- skos__broader mesh__D013198smesh__D018482
% 224.58/224.80  |- mesh__dateEstablished mesh__D013198 1991-01-01
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013198 2002
% 224.58/224.80  |- skos__historyNote mesh__D013198 Ear Ossicles %28%1966-1978%29%
% 224.58/224.80  |- skos__prefLabel mesh__D013198 Stapedius
% 224.58/224.80  |- skos__historyNote mesh__D013198 Stapes %28%1975-1978%29%
% 224.58/224.80  |- skos__broader mesh__D013198smesh__D004432
% 224.58/224.80  |- skos__annotation mesh__D013198
% 224.58/224.80       /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A%  
% 224.58/224.80  |- mesh__recordAuthorizer mesh__D013198 sjn
% 224.58/224.80  |- skos__historyNote mesh__D013198 Ear, Middle %28%1966-1978%29%
% 224.58/224.80  |- mesh__historyNote mesh__D013198
% 224.58/224.80       91%28%79%29%; was see under MUSCLES 1979-90   
% 224.58/224.80  |- mesh__recordOriginator mesh__D013198 RC
% 224.58/224.80  |- mesh__dateCreated mesh__D013198 1978-05-19
% 224.58/224.80  |- rdf__type mesh__D013198sskos__Concept
% 224.58/224.80  |- mesh__dateRevised mesh__D013198 2001-07-25
% 224.58/224.80  |- mesh__publicMeSHNote mesh__D013198 91; was see under MUSCLES 1979-90   
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013198 2005
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013198 2003
% 224.58/224.80  |- skos__scopeNote mesh__D013198
% 224.58/224.80       The stapedius muscle arises from the wall of the middle ear and is inserted into the neck of the stapes. Its action is to pull the head of the stapes backward.%A%    
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013198 2006
% 224.58/224.80  |- skos__prefLabel mesh__D007959 Lymphocyte Culture Test, Mixed
% 224.58/224.80  |- skos__hiddenLabel mesh__D007959 Lymphocyte Reaction, Mixed
% 224.58/224.80  |- mesh__publicMeSHNote mesh__D007959
% 224.58/224.80       93; was LEUKOCYTE CULTURE TEST, MIXED 1973-92; LYMPHOCYTE CULTURE TEST, MIXED was see LEUKOCYTE CULTURE TEST, MIXED 1981-92%A%  
% 224.58/224.80  |- mesh__historyNote mesh__D007959
% 224.58/224.80       93; was LEUKOCYTE CULTURE TEST, MIXED 1973-92; LYMPHOCYTE CULTURE TEST, MIXED was see LEUKOCYTE CULTURE TEST, MIXED 1981-92%A%  
% 224.58/224.80  |- mesh__onlineNote mesh__D007959
% 224.58/224.80       use LYMPHOCYTE CULTURE TEST, MIXED to search LEUKOCYTE CULTURE TEST, MIXED 1973-92%A%  
% 224.58/224.80  |- skos__hiddenLabel mesh__D007959 Leukocyte Reactions, Mixed
% 224.58/224.80  |- skos__altLabel mesh__D007959 Mixed Leukocyte Reaction
% 224.58/224.80  |- rdf__type mesh__D007959sskos__Concept
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D007959 2002
% 224.58/224.80  |- skos__annotation mesh__D007959 NIM   
% 224.58/224.80  |- skos__hiddenLabel mesh__D007959 Mixed Lymphocyte Reactions
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D007959 2003
% 224.58/224.80  |- skos__hiddenLabel mesh__D007959 Mixed Leukocyte Reactions
% 224.58/224.80  |- mesh__dateEstablished mesh__D007959 1973-01-01
% 224.58/224.80  |- skos__hiddenLabel mesh__D007959 Lymphocyte Reactions, Mixed
% 224.58/224.80  |- mesh__dateCreated mesh__D007959 1999-01-01
% 224.58/224.80  |- skos__altLabel mesh__D007959 Mixed Leukocyte Culture Test
% 224.58/224.80  |- skos__hiddenLabel mesh__D007959 Leukocyte Reaction, Mixed
% 224.58/224.80  |- skos__broader mesh__D007959smesh__D006650
% 224.58/224.80  |- skos__scopeNote mesh__D007959
% 224.58/224.80       Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly %28%measured by tritiated thymidine uptake%29% whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated %28%usually by treatment with MITOMYCIN or radiation%29% thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens.%A%    
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D007959 2005
% 224.58/224.80  |- skos__historyNote mesh__D007959
% 224.58/224.80       Histocompatibility Testing %28%1968-1972%29%
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D007959 2004
% 224.58/224.80  |- mesh__recordOriginator mesh__D007959 NLM
% 224.58/224.80  |- skos__altLabel mesh__D007959 Leukocyte Culture Test, Mixed
% 224.58/224.80  |- skos__altLabel mesh__D007959 Mixed Lymphocyte Reaction
% 224.58/224.80  |- skos__altLabel mesh__D007959 Mixed Lymphocyte Culture Test
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D007959 2001
% 224.58/224.80  |- mesh__recordMaintainer mesh__D007959 sjn
% 224.58/224.80  |- skos__historyNote mesh__D007959 Leukocytes %28%1966-1972%29%
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D007959 2006
% 224.58/224.80  |- mesh__recordAuthorizer mesh__D007959 sjn
% 224.58/224.80  |- mesh__dateRevised mesh__D007959 1997-07-08
% 224.58/224.80  |- skos__prefLabel mesh__D018681 Anesthetics, General
% 224.58/224.80  |- skos__annotation mesh__D018681 see note at ANESTHETICS   
% 224.58/224.80  |- mesh__dateRevised mesh__D018681 2005-06-30
% 224.58/224.80  |- mesh__recordOriginator mesh__D018681 TPW
% 224.58/224.80  |- mesh__dateEstablished mesh__D018681 1995-01-01
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D018681 2006
% 224.58/224.80  |- mesh__publicMeSHNote mesh__D018681 95   
% 224.58/224.80  |- rdf__type mesh__D018681sskos__Concept
% 224.58/224.80  |- skos__altLabel mesh__D018681 General Anesthetics
% 224.58/224.80  |- mesh__recordAuthorizer mesh__D018681 sjn
% 224.58/224.80  |- mesh__recordMaintainer mesh__D018681 ssb
% 224.58/224.80  |- mesh__dateCreated mesh__D018681 1994-06-03
% 224.58/224.80  |- skos__scopeNote mesh__D018681
% 224.58/224.80       Agents that induce various degrees of analgesia; depression of consciousness, circulation, and respiration; relaxation of skeletal muscle; reduction of reflex activity; and amnesia. There are two types of general anesthetics, inhalation and intravenous. With either type, the arterial concentration of drug required to induce anesthesia varies with the condition of the patient, the desired depth of anesthesia, and the concomitant use of other drugs. %28%From AMA Drug Evaluations Annual, 1994, p.173%29%%A%    
% 224.58/224.80  |- skos__historyNote mesh__D018681 Anesthetics %28%1966-1994%29%
% 224.58/224.80  |- mesh__historyNote mesh__D018681 95   
% 224.58/224.80  |- skos__broader mesh__D018681smesh__D000777
% 224.58/224.80  |- mesh__recordAuthorizer mesh__D017589 sjn
% 224.58/224.80  |- skos__historyNote mesh__D017589 Immunization %28%1966-1993%29%
% 224.58/224.80  |- skos__hiddenLabel mesh__D017589 Programs, Immunization
% 224.58/224.80  |- skos__hiddenLabel mesh__D017589 Immunization Program
% 224.58/224.80  |- mesh__publicMeSHNote mesh__D017589 94   
% 224.58/224.80  |- mesh__dateEstablished mesh__D017589 1994-01-01
% 224.58/224.80  |- mesh__dateRevised mesh__D017589 1999-11-03
% 224.58/224.80  |- skos__broader mesh__D017589smesh__D011314
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D017589 2001
% 224.58/224.80  |- skos__prefLabel mesh__D017589 Immunization Programs
% 224.58/224.80  |- skos__annotation mesh__D017589
% 224.58/224.80       IM; coord with specific dis /prev %28%IM%29% or specific vaccine or other type of immunization %28%IM%29%; specify geog if pertinent%A%  
% 224.58/224.80  |- mesh__historyNote mesh__D017589 94   
% 224.58/224.80  |- skos__historyNote mesh__D017589 Immunization Schedule %28%1967-1993%29%
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D017589 2000
% 224.58/224.80  |- mesh__dateCreated mesh__D017589 1992-12-28
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D017589 2006
% 224.58/224.80  |- rdf__type mesh__D017589sskos__Concept
% 224.58/224.80  |- mesh__recordOriginator mesh__D017589 TGC
% 224.58/224.80  |- skos__hiddenLabel mesh__D017589 Program, Immunization
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D017589 2004
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D017589 2005
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D017589 2002
% 224.58/224.80  |- skos__scopeNote mesh__D017589
% 224.58/224.80       Organized services to administer immunization procedures in the prevention of various diseases. The programs are made available over a wide range of sites: schools, hospitals, public health agencies, voluntary health agencies, etc. They are administered to an equally wide range of population groups or on various administrative levels: community, municipal, state, national, international.%A%    
% 224.58/224.80  |- skos__historyNote mesh__D017589 Vaccination %28%1966-1993%29%
% 224.58/224.80  |- mesh__recordMaintainer mesh__D017589 kle
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D017589 2003
% 224.58/224.80  |- skos__hiddenLabel mesh__D003569 Acetylneuraminic Acid, CMP
% 224.58/224.80  |- mesh__publicMeSHNote mesh__D003569
% 224.58/224.80       91; was see under SIALIC ACIDS 1975-90   
% 224.58/224.80  |- mesh__recordMaintainer mesh__D003569 ssb
% 224.58/224.80  |- mesh__dateCreated mesh__D003569 1974-11-19
% 224.58/224.80  |- skos__broader mesh__D003569smesh__D003568
% 224.58/224.80  |- mesh__recordOriginator mesh__D003569 NLM
% 224.58/224.80  |- skos__hiddenLabel mesh__D003569 CMP Sialic Acid
% 224.58/224.80  |- skos__altLabel mesh__D003569
% 224.58/224.80       Cytidine Monophosphate N Acetylneuraminic Acid
% 224.58/224.80  |- skos__hiddenLabel mesh__D003569 Acid, CMP-Sialic
% 224.58/224.80  |- mesh__dateRevised mesh__D003569 2004-07-07
% 224.58/224.80  |- skos__historyNote mesh__D003569 Neuraminic Acids %28%1974%29%
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D003569 2006
% 224.58/224.80  |- skos__broader mesh__D003569smesh__D012794
% 224.58/224.80  |- rdf__type mesh__D003569sskos__Concept
% 224.58/224.80  |- skos__prefLabel mesh__D003569
% 224.58/224.80       Cytidine Monophosphate N-Acetylneuraminic Acid
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D003569 2005
% 224.58/224.80  |- skos__scopeNote mesh__D003569
% 224.58/224.80       A nucleoside monophosphate sugar which donates N-acetylneuraminic acid to the terminal sugar of a ganglioside or glycoprotein.%A%    
% 224.58/224.80  |- skos__historyNote mesh__D003569 Cytosine Nucleotides %28%1974%29%
% 224.58/224.80  |- skos__altLabel mesh__D003569 CMP Acetylneuraminic Acid
% 224.58/224.80  |- skos__altLabel mesh__D003569 CMP-Sialic Acid
% 224.58/224.80  |- mesh__dateEstablished mesh__D003569 1991-01-01
% 224.58/224.80  |- skos__hiddenLabel mesh__D003569 Acid, CMP Acetylneuraminic
% 224.58/224.80  |- skos__altLabel mesh__D003569 CMP-NANA
% 224.58/224.80  |- mesh__historyNote mesh__D003569
% 224.58/224.80       91%28%75%29%; was see under SIALIC ACIDS 1975-90   
% 224.58/224.80  |- mesh__recordAuthorizer mesh__D003569 sjn
% 224.58/224.80  |- mesh__recordMaintainer mesh__D014291 ssb
% 224.58/224.80  |- rdf__type mesh__D014291sskos__Concept
% 224.58/224.80  |- skos__altLabel mesh__D014291 Italfarmaco Brand of Alimemazine
% 224.58/224.80  |- skos__altLabel mesh__D014291 Isobutrazine
% 224.58/224.80  |- skos__hiddenLabel mesh__D014291 Alimemazine Italfarmaco Brand
% 224.58/224.80  |- skos__broader mesh__D014291smesh__D010640
% 224.58/224.80  |- skos__altLabel mesh__D014291 Evans Brand of Alimemazine Tartrate
% 224.58/224.80  |- skos__altLabel mesh__D014291 Alimemazine
% 224.58/224.80  |- skos__hiddenLabel mesh__D014291
% 224.58/224.80       Rh%C3%%B4%ne Poulenc Rorer Brand of Alimemazine Tartrate
% 224.58/224.80  |- mesh__dateCreated mesh__D014291 1999-01-01
% 224.58/224.80  |- skos__prefLabel mesh__D014291 Trimeprazine
% 224.58/224.80  |- skos__altLabel mesh__D014291 Pierre Fabre Brand of Alimemazine
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D014291 2006
% 224.58/224.80  |- skos__altLabel mesh__D014291 Vallergan
% 224.58/224.80  |- skos__altLabel mesh__D014291
% 224.58/224.80       Rh%C3%%B4%ne-Poulenc Rorer Brand of Alimemazine Tartrate
% 224.58/224.80  |- skos__scopeNote mesh__D014291
% 224.58/224.80       A phenothiazine derivative that is used as an antipruritic.%A%    
% 224.58/224.80  |- mesh__dateRevised mesh__D014291 2005-06-30
% 224.58/224.80  |- skos__altLabel mesh__D014291 Panectyl
% 224.58/224.80  |- skos__altLabel mesh__D014291 Methylpromazine
% 224.58/224.80  |- mesh__recordOriginator mesh__D014291 NLM
% 224.58/224.80  |- skos__altLabel mesh__D014291 Allergan Brand of Alimemazine Tartrate
% 224.58/224.80  |- mesh__recordAuthorizer mesh__D014291 sjn
% 224.58/224.80  |- skos__altLabel mesh__D008254 Monkey, Pigtailed
% 224.58/224.80  |- skos__prefLabel mesh__D008254 Macaca nemestrina
% 224.58/224.80  |- skos__hiddenLabel mesh__D008254 Pigtailed Monkey
% 224.58/224.80  |- skos__hiddenLabel mesh__D008254 Monkey, Pig Tailed
% 224.58/224.80  |- mesh__historyNote mesh__D008254
% 224.58/224.80       91%28%81%29%; was see under MACACA 1981-90   
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D008254 2006
% 224.58/224.80  |- skos__hiddenLabel mesh__D008254 Monkeys, Pig-Tailed
% 224.58/224.80  |- skos__hiddenLabel mesh__D008254 Monkeys, Pigtailed
% 224.58/224.80  |- skos__annotation mesh__D008254
% 224.58/224.80       Old World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 224.58/224.80  |- skos__broader mesh__D008254smesh__D008251
% 224.58/224.80  |- mesh__publicMeSHNote mesh__D008254 91; was see under MACACA 1981-90   
% 224.58/224.80  |- mesh__recordOriginator mesh__D008254 EC
% 224.58/224.80  |- skos__hiddenLabel mesh__D008254 Pigtail Monkeys
% 224.58/224.80  |- rdf__type mesh__D008254sskos__Concept
% 224.58/224.80  |- skos__altLabel mesh__D008254 Monkey, Pigtail
% 224.58/224.80  |- skos__hiddenLabel mesh__D008254 Monkeys, Pigtail
% 224.58/224.80  |- skos__hiddenLabel mesh__D008254 Pig-Tailed Monkeys
% 224.58/224.80  |- skos__hiddenLabel mesh__D008254 Pigtail Monkey
% 224.58/224.80  |- skos__hiddenLabel mesh__D008254 Pigtail Macaques
% 224.58/224.80  |- skos__scopeNote mesh__D008254
% 224.58/224.80       A species of the genus MACACA which inhabits Malaya, Sumatra, and Borneo. It is one of the most arboreal species of Macaca. The tail is short and untwisted.%A%    
% 224.58/224.80  |- mesh__recordMaintainer mesh__D008254 ags
% 224.58/224.80  |- skos__hiddenLabel mesh__D008254 Macaques, Pigtail
% 224.58/224.80  |- skos__altLabel mesh__D008254 Pigtail Macaque
% 224.58/224.80  |- mesh__dateRevised mesh__D008254 2005-06-30
% 224.58/224.80  |- skos__hiddenLabel mesh__D008254 Pigtailed Monkeys
% 224.58/224.80  |- skos__hiddenLabel mesh__D008254 Macaque, Pigtail
% 224.58/224.80  |- mesh__recordAuthorizer mesh__D008254 sjn
% 224.58/224.80  |- mesh__dateEstablished mesh__D008254 1991-01-01
% 224.58/224.80  |- skos__historyNote mesh__D008254 Macaca %28%1971-1980%29%
% 224.58/224.80  |- mesh__dateCreated mesh__D008254 1980-05-07
% 224.58/224.80  |- skos__hiddenLabel mesh__D008254 Pig Tailed Monkey
% 224.58/224.80  |- skos__altLabel mesh__D008254 Pig-Tailed Monkey
% 224.58/224.80  |- skos__altLabel mesh__D008254 Monkey, Pig-Tailed
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013997 2006
% 224.58/224.80  |- skos__prefLabel mesh__D013997 Time Factors
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013997 2001
% 224.58/224.80  |- rdf__type mesh__D013997sskos__Concept
% 224.58/224.80  |- mesh__dateRevised mesh__D013997 1998-06-11
% 224.58/224.80  |- skos__broader mesh__D013997smesh__D013995
% 224.58/224.80  |- skos__hiddenLabel mesh__D013997 Time Factor
% 224.58/224.80  |- mesh__publicMeSHNote mesh__D013997 91; was see under TIME 1967-90   
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013997 2005
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013997 2000
% 224.58/224.80  |- mesh__recordMaintainer mesh__D013997 JLS
% 224.58/224.80  |- skos__annotation mesh__D013997
% 224.58/224.80       NIM coord of a given subject %28%IM%29%; no qualif; do not confuse with TIME, the abstraction %28%usually IM%29%; differentiate from AGE FACTORS: Manual 35.5.3; %22%diurnal%22% %26% %22%nocturnal%22%: see note on TIME%A%  
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013997 2004
% 224.58/224.80  |- mesh__historyNote mesh__D013997
% 224.58/224.80       91%28%67%29%; was see under TIME 1967-90   
% 224.58/224.80  |- skos__scopeNote mesh__D013997
% 224.58/224.80       Elements of limited time intervals, contributing to particular results or situations.%A%    
% 224.58/224.80  |- mesh__recordOriginator mesh__D013997 NLM
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013997 2003
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013997 1999
% 224.58/224.80  |- skos__hiddenLabel mesh__D013997 Factor, Time
% 224.58/224.80  |- mesh__dateEstablished mesh__D013997 1991-01-01
% 224.58/224.80  |- mesh__recordAuthorizer mesh__D013997 SJN
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013997 2002
% 224.58/224.80  |- mesh__dateCreated mesh__D013997 1999-01-01
% 224.58/224.80  |- skos__hiddenLabel mesh__D013997 Factors, Time
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013199 2001
% 224.58/224.80  |- mesh__publicMeSHNote mesh__D013199
% 224.58/224.80       91; was see under EAR OSSICLES 1975-90   
% 224.58/224.80  |- mesh__recordOriginator mesh__D013199 NLM
% 224.58/224.80  |- skos__scopeNote mesh__D013199
% 224.58/224.80       One of the three ossicles of the middle ear. It transmits sound vibrations from the INCUS to the internal ear %28%Ear, Internal see LABYRINTH%29%.%A%    
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013199 2002
% 224.58/224.80  |- skos__prefLabel mesh__D013199 Stapes
% 224.58/224.80  |- rdf__type mesh__D013199sskos__Concept
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013199 2005
% 224.58/224.80  |- mesh__historyNote mesh__D013199
% 224.58/224.80       91%28%75%29%; was see under EAR OSSICLES 1975-90   
% 224.58/224.80  |- skos__broader mesh__D013199smesh__D004429
% 224.58/224.80  |- mesh__recordMaintainer mesh__D013199 KEV
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013199 2003
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013199 2006
% 224.58/224.80  |- mesh__recordAuthorizer mesh__D013199 sjn
% 224.58/224.80  |- mesh__onlineNote mesh__D013199 search EAR OSSICLES 1966-74   
% 224.58/224.80  |- mesh__activeMeSHYear mesh__D013199 2004
% 224.58/224.80  |- mesh__dateRevised mesh__D013199 1999-11-03
% 224.58/224.80  |- mesh__dateEstablished mesh__D013199 1991-01-01
% 224.58/224.81  |- mesh__dateCreated mesh__D013199 1999-01-01
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D013199 2000
% 224.58/224.81  |- skos__hiddenLabel mesh__D018682 Acid Agents, gamma-Aminobutyric
% 224.58/224.81  |- skos__annotation mesh__D018682
% 224.58/224.81       agents acting on GABAergic systems; GEN or unspecified; prefer specific groups or specific drugs%A%  
% 224.58/224.81  |- skos__hiddenLabel mesh__D018682 Agents, gamma-Aminobutyric Acid
% 224.58/224.81  |- skos__altLabel mesh__D018682 gamma-Aminobutyric Acid Agents
% 224.58/224.81  |- skos__historyNote mesh__D018682 GABA/pharmacology %28%1972-1994%29%
% 224.58/224.81  |- rdf__type mesh__D018682sskos__Concept
% 224.58/224.81  |- mesh__recordOriginator mesh__D018682 RAZ
% 224.58/224.81  |- skos__scopeNote mesh__D018682
% 224.58/224.81       Substances used for their pharmacological actions on GABAergic systems. GABAergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function.%A%    
% 224.58/224.81  |- skos__hiddenLabel mesh__D018682 gamma Aminobutyric Acid Agents
% 224.58/224.81  |- mesh__dateRevised mesh__D018682 2005-06-30
% 224.58/224.81  |- mesh__dateEstablished mesh__D018682 1995-01-01
% 224.58/224.81  |- skos__altLabel mesh__D018682 GABAergic Agent
% 224.58/224.81  |- skos__altLabel mesh__D018682 GABAergic Agents
% 224.58/224.81  |- skos__broader mesh__D018682smesh__D018377
% 224.58/224.81  |- skos__hiddenLabel mesh__D018682 Agent, GABAergic
% 224.58/224.81  |- mesh__publicMeSHNote mesh__D018682 95   
% 224.58/224.81  |- skos__hiddenLabel mesh__D018682 Agents, GABAergic
% 224.58/224.81  |- mesh__historyNote mesh__D018682 95   
% 224.58/224.81  |- mesh__recordAuthorizer mesh__D018682 sjn
% 224.58/224.81  |- mesh__recordMaintainer mesh__D018682 ssb
% 224.58/224.81  |- skos__prefLabel mesh__D018682 GABA Agents
% 224.58/224.81  |- mesh__dateCreated mesh__D018682 1994-06-03
% 224.58/224.81  |- skos__hiddenLabel mesh__D018682 Agents, GABA
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D018682 2006
% 224.58/224.81  |- skos__altLabel mesh__D014292
% 224.58/224.81       Danval Brand of Trimetazidine Dihydrochloride
% 224.58/224.81  |- skos__scopeNote mesh__D014292
% 224.58/224.81       A vasodilator used in angina of effort or ischemic heart disease.%A%    
% 224.58/224.81  |- skos__altLabel mesh__D014292
% 224.58/224.81       Biopharma Brand of Trimetazidine Dihydrochloride
% 224.58/224.81  |- mesh__recordAuthorizer mesh__D014292 sjn
% 224.58/224.81  |- mesh__dateEstablished mesh__D014292 1991-01-01
% 224.58/224.81  |- mesh__dateCreated mesh__D014292 1975-07-25
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D014292 2006
% 224.58/224.81  |- skos__prefLabel mesh__D014292 Trimetazidine
% 224.58/224.81  |- skos__broader mesh__D014292smesh__D010879
% 224.58/224.81  |- mesh__recordMaintainer mesh__D014292 CCR
% 224.58/224.81  |- mesh__historyNote mesh__D014292
% 224.58/224.81       91%28%76%29%; was see under PIPERAZINES 1976-90   
% 224.58/224.81  |- mesh__publicMeSHNote mesh__D014292
% 224.58/224.81       91; was see under PIPERAZINES 1976-90   
% 224.58/224.81  |- skos__altLabel mesh__D014292
% 224.58/224.81       Alpharma Brand of Trimetazidine Dihydrochloride
% 224.58/224.81  |- skos__historyNote mesh__D014292 Piperazines %28%1969-1975%29%
% 224.58/224.81  |- skos__historyNote mesh__D014292 Methyl Ethers %28%1974-1975%29%
% 224.58/224.81  |- skos__hiddenLabel mesh__D014292 Dihydrochloride, Trimetazidine
% 224.58/224.81  |- rdf__type mesh__D014292sskos__Concept
% 224.58/224.81  |- skos__altLabel mesh__D014292 Irex Brand of Trimetazidine Dihydrochloride
% 224.58/224.81  |- mesh__dateRevised mesh__D014292 2005-06-30
% 224.58/224.81  |- mesh__recordOriginator mesh__D014292 SH
% 224.58/224.81  |- skos__historyNote mesh__D014292 Benzyl Compounds %28%1971-1975%29%
% 224.58/224.81  |- skos__annotation mesh__D008255
% 224.58/224.81       Old World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES %28%IM%29%%A%  
% 224.58/224.81  |- skos__hiddenLabel mesh__D008255 Macaques, Bonnet
% 224.58/224.81  |- mesh__dateCreated mesh__D008255 1974-11-11
% 224.58/224.81  |- mesh__recordAuthorizer mesh__D008255 sjn
% 224.58/224.81  |- skos__hiddenLabel mesh__D008255 Monkeys, Bonnet
% 224.58/224.81  |- skos__prefLabel mesh__D008255 Macaca radiata
% 224.58/224.81  |- rdf__type mesh__D008255sskos__Concept
% 224.58/224.81  |- skos__hiddenLabel mesh__D008255 Macaca radiatas
% 224.58/224.81  |- skos__hiddenLabel mesh__D008255 Macaque, Bonnet
% 224.58/224.81  |- skos__hiddenLabel mesh__D008255 radiatas, Macaca
% 224.58/224.81  |- mesh__recordOriginator mesh__D008255 NLM
% 224.58/224.81  |- skos__altLabel mesh__D008255 Monkey, Bonnet
% 224.58/224.81  |- skos__altLabel mesh__D008255 Bonnet Monkey
% 224.58/224.81  |- skos__hiddenLabel mesh__D008255 radiata, Macaca
% 224.58/224.81  |- mesh__recordMaintainer mesh__D008255 ags
% 224.58/224.81  |- skos__broader mesh__D008255smesh__D008251
% 224.58/224.81  |- skos__altLabel mesh__D008255 Bonnet Macaques
% 224.58/224.81  |- skos__hiddenLabel mesh__D008255 Bonnet Macaque
% 224.58/224.81  |- mesh__publicMeSHNote mesh__D008255 91; was see under MACACA 1975-90   
% 224.58/224.81  |- skos__hiddenLabel mesh__D008255 Bonnet Monkeys
% 224.58/224.81  |- mesh__dateEstablished mesh__D008255 1991-01-01
% 224.58/224.81  |- mesh__historyNote mesh__D008255
% 224.58/224.81       91%28%75%29%; was see under MACACA 1975-90   
% 224.58/224.81  |- skos__scopeNote mesh__D008255
% 224.58/224.81       A species of macaque monkey that mainly inhabits the forest of southern India. They are also called bonnet macaques or bonnet monkeys.%A%    
% 224.58/224.81  |- mesh__dateRevised mesh__D008255 2005-06-30
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D008255 2006
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D000272 2004
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D000272 2002
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D000272 2006
% 224.58/224.81  |- mesh__dateRevised mesh__D000272 1995-05-18
% 224.58/224.81  |- mesh__dateCreated mesh__D000272 1999-01-01
% 224.58/224.81  |- rdf__type mesh__D000272sskos__Concept
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D000272 2000
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D000272 1996
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D000272 2001
% 224.58/224.81  |- skos__broader mesh__D000272smesh__D003998
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D000272 1998
% 224.58/224.81  |- skos__scopeNote mesh__D000272
% 224.58/224.81       A group of dicarboxylic acids that are structurally related to hexanedioic acid %28%adipic acid%29%. %28%From Stedman, 25th ed%29%%A%    
% 224.58/224.81  |- skos__prefLabel mesh__D000272 Adipic Acids
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D000272 1997
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D000272 2003
% 224.58/224.81  |- mesh__recordOriginator mesh__D000272 NLM
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D000272 2005
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D000272 1999
% 224.58/224.81  |- mesh__publicMeSHNote mesh__D000272 75; was ADIPIC ACID 1963-74   
% 224.58/224.81  |- mesh__onlineNote mesh__D000272
% 224.58/224.81       use ADIPIC ACIDS to search ADIPIC ACID 1966-74   
% 224.58/224.81  |- mesh__historyNote mesh__D000272 75; was ADIPIC ACID 1963-74   
% 224.58/224.81  |- mesh__recordAuthorizer mesh__D000272 PLS
% 224.58/224.81  |- mesh__recordMaintainer mesh__D000272 KEV
% 224.58/224.81  |- skos__hiddenLabel mesh__D000272 Acids, Adipic
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D013998 2005
% 224.58/224.81  |- skos__scopeNote mesh__D013998
% 224.58/224.81       The ability to estimate periods of time lapsed or duration of time.%A%    
% 224.58/224.81  |- skos__hiddenLabel mesh__D013998 Perception, Time
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D013998 2002
% 224.58/224.81  |- skos__hiddenLabel mesh__D013998 Perceptions, Time
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D013998 2004
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D013998 1995
% 224.58/224.81  |- skos__prefLabel mesh__D013998 Time Perception
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D013998 2001
% 224.58/224.81  |- mesh__recordAuthorizer mesh__D013998 PLS
% 224.58/224.81  |- skos__broader mesh__D013998smesh__D010465
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D013998 2003
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D013998 1999
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D013998 1994
% 224.58/224.81  |- mesh__dateRevised mesh__D013998 1992-05-18
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D013998 2000
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D013998 1998
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D013998 1993
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D013998 1997
% 224.58/224.81  |- mesh__recordOriginator mesh__D013998 NLM
% 224.58/224.81  |- skos__hiddenLabel mesh__D013998 Time Perceptions
% 224.58/224.81  |- mesh__dateCreated mesh__D013998 1999-01-01
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D013998 1996
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D013998 2006
% 224.58/224.81  |- rdf__type mesh__D013998sskos__Concept
% 224.58/224.81  |- mesh__recordMaintainer mesh__D013998 TAP
% 224.58/224.81  |- skos__altLabel mesh__D018683 Agents, Excitatory Amino Acid
% 224.58/224.81  |- mesh__publicMeSHNote mesh__D018683 95   
% 224.58/224.81  |- skos__altLabel mesh__D018683 Amino Acids, Excitatory, Agents
% 224.58/224.81  |- skos__broader mesh__D018683smesh__D018377
% 224.58/224.81  |- skos__scopeNote mesh__D018683
% 224.58/224.81       Drugs used for their actions on any aspect of excitatory amino acid neurotransmitter systems. Included are drugs that act on excitatory amino acid receptors, affect the life cycle of excitatory amino acid transmitters, or affect the survival of neurons using excitatory amino acids.%A%    
% 224.58/224.81  |- skos__prefLabel mesh__D018683 Excitatory Amino Acid Agents
% 224.58/224.81  |- mesh__recordAuthorizer mesh__D018683 sjn
% 224.58/224.81  |- rdf__type mesh__D018683sskos__Concept
% 224.58/224.81  |- skos__altLabel mesh__D018683 EAA Agents
% 224.58/224.81  |- skos__altLabel mesh__D018683 Glutamatergic Agents
% 224.58/224.81  |- skos__annotation mesh__D018683
% 224.58/224.81       exogenous: do not confuse with EXCITATORY AMINO ACIDS which are endogenous; GEN or unspecified; prefer specific groups or specific drugs; DF: EAA AGENTS%A%  
% 224.58/224.81  |- skos__hiddenLabel mesh__D018683 Agents, EAA
% 224.58/224.81  |- skos__hiddenLabel mesh__D018683 Agents, Glutamate
% 224.58/224.81  |- skos__altLabel mesh__D018683 Amino Acid Agents, Excitatory
% 224.58/224.81  |- mesh__recordOriginator mesh__D018683 RAZ
% 224.58/224.81  |- mesh__historyNote mesh__D018683 95   
% 224.58/224.81  |- mesh__dateRevised mesh__D018683 2005-06-30
% 224.58/224.81  |- mesh__recordMaintainer mesh__D018683 ssb
% 224.58/224.81  |- skos__hiddenLabel mesh__D018683 Agents, Glutamatergic
% 224.58/224.81  |- mesh__dateCreated mesh__D018683 1994-06-03
% 224.58/224.81  |- mesh__dateEstablished mesh__D018683 1995-01-01
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D018683 2006
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D004663 2003
% 224.58/224.81  |- mesh__dateRevised mesh__D004663 2001-07-25
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D004663 2005
% 224.58/224.81  |- skos__annotation mesh__D004663
% 224.58/224.81       infection: coord IM with ENCEPHALOMYELITIS, EQUINE %28%IM%29% but see note there; DF: note short X ref%A%  
% 224.58/224.81  |- mesh__recordMaintainer mesh__D004663 ags
% 224.58/224.81  |- skos__altLabel mesh__D004663 Eastern equine encephalitis virus
% 224.58/224.81  |- rdf__type mesh__D004663sskos__Concept
% 224.58/224.81  |- mesh__recordAuthorizer mesh__D004663 sjn
% 224.58/224.81  |- mesh__publicMeSHNote mesh__D004663
% 224.58/224.81       91; was see under ALPHAVIRUSES 1981-90; was see under ENCEPHALITIS VIRUSES 1975-80%A%  
% 224.58/224.81  |- mesh__historyNote mesh__D004663
% 224.58/224.81       91%28%75%29%; was see under ALPHAVIRUSES 1981-90; was see under ENCEPHALITIS VIRUSES 1975-80%A%  
% 224.58/224.81  |- skos__altLabel mesh__D004663 Encephalomyelitis Virus, Eastern Equine
% 224.58/224.81  |- mesh__dateEstablished mesh__D004663 1991-01-01
% 224.58/224.81  |- skos__altLabel mesh__D004663 Eastern Equine Encephalomyelitis Virus
% 224.58/224.81  |- mesh__dateCreated mesh__D004663 1974-12-12
% 224.58/224.81  |- mesh__recordOriginator mesh__D004663 NLM
% 224.58/224.81  |- skos__broader mesh__D004663smesh__D004668
% 224.58/224.81  |- skos__scopeNote mesh__D004663
% 224.58/224.81       A species of ALPHAVIRUS causing encephalomyelitis in Equidae and humans. The virus ranges along the Atlantic seaboard of the United States and Canada and as far south as the Caribbean, Mexico, and parts of Central and South America. Infections in horses show a mortality of up to 90 percent and in humans as high as 80 percent in epidemics.%A%    
% 224.58/224.81  |- skos__prefLabel mesh__D004663 Encephalitis Virus, Eastern Equine
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D004663 2004
% 224.58/224.81  |- skos__altLabel mesh__D004663 EEE Virus
% 224.58/224.81  |- skos__broader mesh__D004663smesh__D000524
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D004663 2002
% 224.58/224.81  |- skos__hiddenLabel mesh__D004663 EEE Viruses
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D004663 2006
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D042782 2006
% 224.58/224.81  |- rdf__type mesh__D042782sskos__Concept
% 224.58/224.81  |- mesh__dateEstablished mesh__D042782 2004-01-01
% 224.58/224.81  |- mesh__historyNote mesh__D042782 2004   
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D042782 2004
% 224.58/224.81  |- mesh__dateCreated mesh__D042782 2003-07-09
% 224.58/224.81  |- skos__prefLabel mesh__D042782 Estrogenic Steroids, Alkylated
% 224.58/224.81  |- skos__scopeNote mesh__D042782
% 224.58/224.81       Estrogenic STEROIDS with aliphatic hydrocarbon chain substitution on C17 or other position. 17-alpha-ALKYLATION renders the molecule more stable, resistant to metabolic degradation, and improves oral efficacy. Examples of synthetic alkyl estrogens include ETHINYL ESTRADIOL and MESTRANOL. Substitutions at other sites generates antiestrogenic and cytotoxic properties.%A%    
% 224.58/224.81  |- mesh__publicMeSHNote mesh__D042782 2004   
% 224.58/224.81  |- skos__historyNote mesh__D042782 Ethinyl Estradiol %28%1968-2003%29%
% 224.58/224.81  |- skos__broader mesh__D042782smesh__D045166
% 224.58/224.81  |- skos__altLabel mesh__D042782 Alkylated Estrogenic Steroids
% 224.58/224.81  |- skos__altLabel mesh__D042782 Alkyl Estrogenic Steroids
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D042782 2005
% 224.58/224.81  |- skos__scopeNote mesh__D050416
% 224.58/224.81       A type of pancreatic cell representing about 5-20%25% of the islet cells. Alpha cells secrete GLUCAGON.%A%    
% 224.58/224.81  |- mesh__historyNote mesh__D050416
% 224.58/224.81       2006; use ISLETS OF LANGERHANS 1980-2005   
% 224.58/224.81  |- mesh__publicMeSHNote mesh__D050416
% 224.58/224.81       2006; see ISLETS OF LANGERHANS 1980-2005   
% 224.58/224.81  |- mesh__recordAuthorizer mesh__D050416 sjn
% 224.58/224.81  |- skos__altLabel mesh__D050416 alpha Cells, Pancreatic
% 224.58/224.81  |- skos__historyNote mesh__D050416 Glucagon %28%1970-2005%29%
% 224.58/224.81  |- mesh__dateCreated mesh__D050416 2005-06-30
% 224.58/224.81  |- mesh__recordOriginator mesh__D050416 lkt
% 224.58/224.81  |- skos__hiddenLabel mesh__D050416 alpha Cell, Pancreatic
% 224.58/224.81  |- skos__altLabel mesh__D050416 Pancreatic A Cells
% 224.58/224.81  |- mesh__dateEstablished mesh__D050416 2006-01-01
% 224.58/224.81  |- skos__hiddenLabel mesh__D050416 Cells, Glucagon-Secreting
% 224.58/224.81  |- skos__broader mesh__D050416smesh__D007515
% 224.58/224.81  |- skos__hiddenLabel mesh__D050416 Pancreatic A Cell
% 224.58/224.81  |- skos__altLabel mesh__D050416 Pancreatic alpha Cells
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D050416 2006
% 224.58/224.81  |- rdf__type mesh__D050416sskos__Concept
% 224.58/224.81  |- skos__prefLabel mesh__D050416 Glucagon-Secreting Cells
% 224.58/224.81  |- skos__broader mesh__D050416smesh__D019858
% 224.58/224.81  |- skos__annotation mesh__D050416
% 224.58/224.81       /transpl: do not routinely coordinate with ISLETS OF LANGERHANS TRANSPLANTATION%A%  
% 224.58/224.81  |- skos__historyNote mesh__D050416 Islets of Langerhans %28%1970-2005%29%
% 224.58/224.81  |- skos__hiddenLabel mesh__D050416 Glucagon Secreting Cells
% 224.58/224.81  |- skos__hiddenLabel mesh__D050416 Cell, Glucagon-Secreting
% 224.58/224.81  |- mesh__recordMaintainer mesh__D050416 lkt
% 224.58/224.81  |- skos__hiddenLabel mesh__D050416 Pancreatic alpha Cell
% 224.58/224.81  |- skos__hiddenLabel mesh__D050416 Glucagon-Secreting Cell
% 224.58/224.81  |- mesh__dateEstablished mesh__D014293 1991-01-01
% 224.58/224.81  |- skos__altLabel mesh__D014293 Troxidone
% 224.58/224.81  |- mesh__dateRevised mesh__D014293 2005-06-30
% 224.58/224.81  |- rdf__type mesh__D014293sskos__Concept
% 224.58/224.81  |- mesh__recordOriginator mesh__D014293 NLM
% 224.58/224.81  |- mesh__recordAuthorizer mesh__D014293 sjn
% 224.58/224.81  |- mesh__recordMaintainer mesh__D014293 ssb
% 224.58/224.81  |- mesh__publicMeSHNote mesh__D014293
% 224.58/224.81       91; was see under OXAZOLES 1975-90; see under ANTICONVULSANTS 1963-74%A%  
% 224.58/224.81  |- mesh__dateCreated mesh__D014293 1999-01-01
% 224.58/224.81  |- skos__prefLabel mesh__D014293 Trimethadione
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D014293 2006
% 224.58/224.81  |- skos__altLabel mesh__D014293 Abbott Brand of Trimethadione
% 224.58/224.81  |- mesh__historyNote mesh__D014293
% 224.58/224.81       91%28%64%29%; was see under OXAZOLES 1975-90; see under ANTICONVULSANTS 1963-74%A%  
% 224.58/224.81  |- skos__scopeNote mesh__D014293
% 224.58/224.81       An anticonvulsant effective in absence seizures, but generally reserved for refractory cases because of its toxicity. %28%From AMA Drug Evaluations Annual, 1994, p378%29%%A%    
% 224.58/224.81  |- skos__broader mesh__D014293smesh__D010080
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D008256 1993
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D008256 1998
% 224.58/224.81  |- skos__historyNote mesh__D008256 Portugal %28%1966-1977%29%
% 224.58/224.81  |- rdf__type mesh__D008256sskos__Concept
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D008256 2000
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D008256 1994
% 224.58/224.81  |- mesh__historyNote mesh__D008256 78; was see PORTUGAL 1977   
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D008256 1999
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D008256 2003
% 224.58/224.81  |- mesh__recordMaintainer mesh__D008256 PLS
% 224.58/224.81  |- mesh__recordAuthorizer mesh__D008256 PLS
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D008256 1995
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D008256 2004
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D008256 2001
% 224.58/224.81  |- skos__prefLabel mesh__D008256 Macao
% 224.58/224.81  |- skos__scopeNote mesh__D008256
% 224.58/224.81       A Portuguese colony on the island of Macao and adjacent islands off the southeast coast of China.%A%    
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D008256 2002
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D008256 1996
% 224.58/224.81  |- mesh__recordOriginator mesh__D008256 AEP
% 224.58/224.81  |- mesh__dateRevised mesh__D008256 1991-11-26
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D008256 2005
% 224.58/224.81  |- skos__altLabel mesh__D008256 Macau
% 224.58/224.81  |- mesh__dateEstablished mesh__D008256 1978-01-01
% 224.58/224.81  |- mesh__onlineNote mesh__D008256 search PORTUGAL 1977   
% 224.58/224.81  |- mesh__dateCreated mesh__D008256 1977-05-13
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D008256 1997
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D008256 1992
% 224.58/224.81  |- skos__broader mesh__D008256smesh__D005202
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D008256 2006
% 224.58/224.81  |- skos__annotation mesh__D000273
% 224.58/224.81       inflammation = PANNICULITIS; /surg: consider also LIPECTOMY; body fat goes here%A%  
% 224.58/224.81  |- skos__hiddenLabel mesh__D000273 Tissue, Adipose
% 224.58/224.81  |- skos__hiddenLabel mesh__D000273 Tissue, Fatty
% 224.58/224.81  |- skos__related mesh__D000273smesh__D017667
% 224.58/224.81  |- skos__broader mesh__D000273smesh__D003238
% 224.58/224.81  |- skos__scopeNote mesh__D000273
% 224.58/224.81       Connective tissue composed of FAT CELLS lodged in the meshes of areolar tissue.%A%    
% 224.58/224.81  |- mesh__dateCreated mesh__D000273 1999-01-01
% 224.58/224.81  |- rdf__type mesh__D000273sskos__Concept
% 224.58/224.81  |- skos__related mesh__D000273smesh__D015187
% 224.58/224.81  |- skos__hiddenLabel mesh__D000273 Adipose Tissues
% 224.58/224.81  |- mesh__recordAuthorizer mesh__D000273 sjn
% 224.58/224.81  |- mesh__dateRevised mesh__D000273 2005-06-30
% 224.58/224.81  |- skos__hiddenLabel mesh__D000273 Tissues, Fatty
% 224.58/224.81  |- skos__related mesh__D000273smesh__D012885
% 224.58/224.81  |- skos__hiddenLabel mesh__D000273 Tissues, Adipose
% 224.58/224.81  |- mesh__recordMaintainer mesh__D000273 lkt
% 224.58/224.81  |- skos__related mesh__D000273smesh__D002001
% 224.58/224.81  |- skos__prefLabel mesh__D000273 Adipose Tissue
% 224.58/224.81  |- skos__altLabel mesh__D000273 Fatty Tissue
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D000273 2006
% 224.58/224.81  |- skos__hiddenLabel mesh__D000273 Fatty Tissues
% 224.58/224.81  |- mesh__recordOriginator mesh__D000273 NLM
% 224.58/224.81  |- mesh__dateRevised mesh__D013999 2005-07-01
% 224.58/224.81  |- skos__broader mesh__D013999smesh__D011412
% 224.58/224.81  |- mesh__historyNote mesh__D013999
% 224.58/224.81       84%28%77%29%; was see under PROPANOLAMINES 1977-83   
% 224.58/224.81  |- skos__hiddenLabel mesh__D013999 L714,465
% 224.58/224.81  |- mesh__recordMaintainer mesh__D013999 sjn
% 224.58/224.81  |- skos__scopeNote mesh__D013999
% 224.58/224.81       A beta-adrenergic antagonist similar in action to PROPRANOLOL. The levo-isomer is the more active. Timolol has been proposed as an antihypertensive, antiarrhythmic, antiangina, and antiglaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor.%A%    
% 224.58/224.81  |- mesh__publicMeSHNote mesh__D013999
% 224.58/224.81       84; was see under PROPANOLAMINES 1977-83   
% 224.58/224.81  |- skos__hiddenLabel mesh__D013999 MK950
% 224.58/224.81  |- skos__altLabel mesh__D013999 Timolol Maleate, %28%1:1%29% Salt
% 224.58/224.81  |- skos__broader mesh__D013999smesh__D013830
% 224.58/224.81  |- skos__broader mesh__D013999smesh__D009025
% 224.58/224.81  |- mesh__dateCreated mesh__D013999 1976-04-13
% 224.58/224.81  |- skos__historyNote mesh__D013999 Thiadiazoles %28%1972-1976%29%
% 224.58/224.81  |- mesh__recordOriginator mesh__D013999 SH
% 224.58/224.81  |- skos__historyNote mesh__D013999 Amino Alcohols %28%1972-1973%29%
% 224.58/224.81  |- skos__hiddenLabel mesh__D013999 Hemihydrate, Timolol
% 224.58/224.81  |- skos__altLabel mesh__D013999
% 224.58/224.81       %28%S%29%-1-%28%%28%1,1-Dimethylethyl%29%amino%29%-3-%28%%28%4-%28%4-morpholinyl%29%-1,2,5-thiadazol-3-yl%29%oxy%29%-2-propanol
% 224.58/224.81  |- mesh__dateEstablished mesh__D013999 1984-01-01
% 224.58/224.81  |- skos__hiddenLabel mesh__D013999 MK 950
% 224.58/224.81  |- skos__historyNote mesh__D013999 Propanolamines %28%1974-1976%29%
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D013999 2006
% 224.58/224.81  |- skos__prefLabel mesh__D013999 Timolol
% 224.58/224.81  |- rdf__type mesh__D013999sskos__Concept
% 224.58/224.81  |- skos__hiddenLabel mesh__D013999 L 714,465
% 224.58/224.81  |- mesh__recordAuthorizer mesh__D013999 sjn
% 224.58/224.81  |- skos__historyNote mesh__D013999 Morpholines %28%1972-1975%29%
% 224.58/224.81  |- mesh__recordMaintainer mesh__D018684 ssb
% 224.58/224.81  |- rdf__type mesh__D018684sskos__Concept
% 224.58/224.81  |- mesh__dateCreated mesh__D018684 1994-06-03
% 224.58/224.81  |- skos__altLabel mesh__D018684 Glycinergic Agents
% 224.58/224.81  |- mesh__dateEstablished mesh__D018684 1995-01-01
% 224.58/224.81  |- skos__scopeNote mesh__D018684
% 224.58/224.81       Substances used for their pharmacological actions on glycinergic systems. Glycinergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function.%A%    
% 224.58/224.81  |- mesh__publicMeSHNote mesh__D018684 95   
% 224.58/224.81  |- skos__historyNote mesh__D018684 Glycine/pharmacology %28%1968-1994%29%
% 224.58/224.81  |- mesh__recordAuthorizer mesh__D018684 sjn
% 224.58/224.81  |- mesh__historyNote mesh__D018684 95   
% 224.58/224.81  |- skos__prefLabel mesh__D018684 Glycine Agents
% 224.58/224.81  |- skos__annotation mesh__D018684 GEN or unspecified; prefer specifics   
% 224.58/224.81  |- skos__hiddenLabel mesh__D018684 Agents, Glycine
% 224.58/224.81  |- skos__hiddenLabel mesh__D018684 Agent, Glycinergic
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D018684 2006
% 224.58/224.81  |- skos__altLabel mesh__D018684 Glycinergic Agent
% 224.58/224.81  |- mesh__recordOriginator mesh__D018684 RAZ
% 224.58/224.81  |- skos__hiddenLabel mesh__D018684 Agents, Glycinergic
% 224.58/224.81  |- skos__broader mesh__D018684smesh__D018377
% 224.58/224.81  |- mesh__dateRevised mesh__D018684 2005-06-30
% 224.58/224.81  |- mesh__recordMaintainer mesh__D004664 ags
% 224.58/224.81  |- skos__altLabel mesh__D004664 Virus, Japanese Encephalitis
% 224.58/224.81  |- mesh__dateCreated mesh__D004664 1999-01-01
% 224.58/224.81  |- mesh__recordOriginator mesh__D004664 NLM
% 224.58/224.81  |- skos__altLabel mesh__D004664 Japanese B Encephalitis Virus
% 224.58/224.81  |- skos__prefLabel mesh__D004664 Encephalitis Virus, Japanese
% 224.58/224.81  |- rdf__type mesh__D004664sskos__Concept
% 224.58/224.81  |- skos__scopeNote mesh__D004664
% 224.58/224.81       A species of FLAVIVIRUS, one of the Japanese encephalitis virus group %28%ENCEPHALITIS VIRUSES, JAPANESE%29%, which is the etiological agent of Japanese encephalitis found in Asia, southeast Asia, and the Indian subcontinent.%A%    
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D004664 2001
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D004664 2003
% 224.58/224.81  |- mesh__publicMeSHNote mesh__D004664 73   
% 224.58/224.81  |- skos__historyNote mesh__D004664 Encephalitis Viruses %28%1966-1970%29%
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D004664 2005
% 224.58/224.81  |- mesh__recordAuthorizer mesh__D004664 sjn
% 224.58/224.81  |- mesh__dateEstablished mesh__D004664 1973-01-01
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D004664 2004
% 224.58/224.81  |- skos__annotation mesh__D004664
% 224.58/224.81       a species of the genus Flavivirus: do not confuse with ENCEPHALITIS VIRUSES, JAPANESE, a subgroup of the genus Flavivirus; infection = ENCEPHALITIS, JAPANESE; DF: ENCEPH VIRUS JAPANESE%A%  
% 224.58/224.81  |- mesh__historyNote mesh__D004664 73%28%71%29%   
% 224.58/224.81  |- mesh__dateRevised mesh__D004664 2000-06-21
% 224.58/224.81  |- skos__broader mesh__D004664smesh__D018349
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D004664 2002
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D004664 2006
% 224.58/224.81  |- skos__altLabel mesh__D004664 Japanese Encephalitis Virus
% 224.58/224.81  |- skos__hiddenLabel mesh__D042783 Endothelial Cells, Lymphatic
% 224.58/224.81  |- skos__hiddenLabel mesh__D042783 Capillary Endothelial Cell
% 224.58/224.81  |- skos__hiddenLabel mesh__D042783 Endothelial Cell, Lymphatic
% 224.58/224.81  |- skos__hiddenLabel mesh__D042783 Vascular Endothelial Cell
% 224.58/224.81  |- skos__hiddenLabel mesh__D042783 Cells, Capillary Endothelial
% 224.58/224.81  |- skos__broader mesh__D042783smesh__D004847
% 224.58/224.81  |- mesh__dateRevised mesh__D042783 2005-06-30
% 224.58/224.81  |- skos__hiddenLabel mesh__D042783 Endothelial Cells, Capillary
% 224.58/224.81  |- skos__historyNote mesh__D042783 Endothelium %28%1973-2003%29%
% 224.58/224.81  |- mesh__activeMeSHYear mesh__D042783 2006
% 224.58/224.81  |- skos__hiddenLabel mesh__D042783 Cell, Capillary Endothelial
% 224.58/224.81  |- skos__hiddenLabel mesh__D042783 Endothelial Cells, Vascular
% 224.58/224.81  |- mesh__historyNote mesh__D042783 2004   
% 224.58/224.81  |- mesh__dateEstablished mesh__D042783 2004-01-01
% 224.58/224.81  |- skos__hiddenLabel mesh__D042783 Cell, Vascular Endothelial
% 224.58/224.81  |- mesh__dateCreated mesh__D042783 2003-07-09
% 224.58/224.81  |- skos__hiddenLabel mesh__D042783 Cells, Lymphatic Endothelial
% 224.58/224.81  |- skos__hiddenLabel mesh__D042783 Cell, Lymphatic Endothelial
% 224.58/224.81  |- skos__hiddenLabel mesh__D042783 Cell, Endothelial
% 224.58/224.81  |- skos__hiddenLabel mesh__D042783 Endothelial Cell
% 224.58/224.81  |- skos__hiddenLabel mesh__D042783 Lymphatic Endothelial Cell
% 224.58/224.81  |- skos__hiddenLabel mesh__D042783 Endothelial Cell, Capillary
% 224.58/224.81  |- skos__hiddenLabel mesh__D042783 Cells, Vascular Endothelial
% 224.58/224.81  |- mesh__publicMeSHNote mesh__D042783 2004   
% 224.58/224.81  |- skos__hiddenLabel mesh__D042783 Endothelial Cell, Vascular
% 224.58/224.81  |- mesh__recordMaintainer mesh__D042783 lkt
% 224.58/224.81  |- skos__hiddenLabel mesh__D042783 Cells, Endothelial
% 224.58/224.81  |- skos__related mesh__D042783smesh__D004727
% 224.58/224.81  |- skos__annotation mesh__D042783
% 224.58/224.81       coordinate with specific tissue type if pertinent   
% 224.58/224.81  |- skos__scopeNote mesh__D042783
% 224.58/224.81       Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer.%A%    
% 224.58/224.81  |- mesh__recordAuthorizer mesh__D042783 sjn
% 224.58/224.81  |- mesh__recordOriginator mesh__D042783 jmp
% 224.58/224.81  |- rdf__type mesh__D042783sskos__Concept
% 224.58/224.81  |- skos__prefLabel mesh__D042783 Endothelial Cells
% 224.58/224.81  |- skos__scopeNote mesh__D050417
% 224.58/224.81       A type of pancreatic cell representing about 50-80%25% of the islet cells. Beta cells secrete INSULIN.%A%    
% 224.58/224.81  |- skos__historyNote mesh__D050417 Insulin %28%1968-2005%29%
% 224.58/224.81  |- skos__annotation mesh__D050417
% 224.58/224.81       /transpl: do not routinely coordinate with ISLETS OF LANGERHANS TRANSPLANTATION%A%  
% 224.58/224.81  |- skos__hiddenLabel mesh__D050417 B Cell, Pancreatic
% 224.58/224.81  |- skos__altLabel mesh__D050417 Pancreatic beta Cells
% 224.58/224.81  |- mesh__recordMaintainer mesh__D050417 lkt
% 224.58/224.81  |- mesh__recordOriginator mesh__D050417 lkt
% 224.58/224.82  |- skos__hiddenLabel mesh__D050417 Insulin-Secreting Cell
% 224.58/224.82  |- skos__hiddenLabel mesh__D050417 beta Cell, Pancreatic
% 224.58/224.82  |- skos__altLabel mesh__D050417 Pancreatic B Cells
% 224.58/224.82  |- skos__broader mesh__D050417smesh__D007515
% 224.58/224.82  |- mesh__historyNote mesh__D050417
% 224.58/224.82       2006; use ISLETS OF LANGERHANS 1980-2005   
% 224.58/224.82  |- mesh__publicMeSHNote mesh__D050417
% 224.58/224.82       2006; see ISLETS OF LANGERHANS 1980-2005   
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D050417 2006
% 224.58/224.82  |- mesh__recordAuthorizer mesh__D050417 sjn
% 224.58/224.82  |- skos__historyNote mesh__D050417 Islets of Langerhans %28%1967-2005%29%
% 224.58/224.82  |- skos__prefLabel mesh__D050417 Insulin-Secreting Cells
% 224.58/224.82  |- mesh__dateCreated mesh__D050417 2005-06-30
% 224.58/224.82  |- rdf__type mesh__D050417sskos__Concept
% 224.58/224.82  |- skos__broader mesh__D050417smesh__D019858
% 224.58/224.82  |- skos__hiddenLabel mesh__D050417 Cells, Insulin-Secreting
% 224.58/224.82  |- mesh__dateEstablished mesh__D050417 2006-01-01
% 224.58/224.82  |- skos__altLabel mesh__D050417 beta Cells, Pancreatic
% 224.58/224.82  |- skos__hiddenLabel mesh__D050417 Pancreatic B Cell
% 224.58/224.82  |- skos__hiddenLabel mesh__D050417 Insulin Secreting Cells
% 224.58/224.82  |- skos__hiddenLabel mesh__D050417 Cell, Insulin-Secreting
% 224.58/224.82  |- skos__hiddenLabel mesh__D050417 B Cells, Pancreatic
% 224.58/224.82  |- skos__hiddenLabel mesh__D050417 Pancreatic beta Cell
% 224.58/224.82  |- skos__altLabel mesh__D014294 Thimethaphan
% 224.58/224.82  |- skos__altLabel mesh__D014294 Trimetaphan
% 224.58/224.82  |- rdf__type mesh__D014294sskos__Concept
% 224.58/224.82  |- mesh__dateRevised mesh__D014294 2005-06-30
% 224.58/224.82  |- skos__broader mesh__D014294smesh__D007093
% 224.58/224.82  |- mesh__dateCreated mesh__D014294 1999-01-01
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D014294 2006
% 224.58/224.82  |- mesh__recordOriginator mesh__D014294 NLM
% 224.58/224.82  |- skos__scopeNote mesh__D014294
% 224.58/224.82       A nicotinic antagonist that has been used as a ganglionic blocker in hypertension, as an adjunct to anesthesia, and to induce hypotension during surgery.%A%    
% 224.58/224.82  |- mesh__recordAuthorizer mesh__D014294 sjn
% 224.58/224.82  |- skos__prefLabel mesh__D014294 Trimethaphan
% 224.58/224.82  |- mesh__recordMaintainer mesh__D014294 ssb
% 224.58/224.82  |- mesh__dateEstablished mesh__D008257 1991-01-01
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D008257 1999
% 224.58/224.82  |- rdf__type mesh__D008257sskos__Concept
% 224.58/224.82  |- skos__prefLabel mesh__D008257 Machiavellianism
% 224.58/224.82  |- mesh__historyNote mesh__D008257
% 224.58/224.82       91%28%79%29%; was see under PERSONALITY 1979-90   
% 224.58/224.82  |- skos__altLabel mesh__D008257 Manipulation, Psychologic
% 224.58/224.82  |- skos__hiddenLabel mesh__D008257 Manipulations, Psychologic
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D008257 2003
% 224.58/224.82  |- skos__scopeNote mesh__D008257
% 224.58/224.82       A personality dimension characterized by the manipulation of others.%A%    
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D008257 1995
% 224.58/224.82  |- skos__hiddenLabel mesh__D008257 Psychological Manipulations
% 224.58/224.82  |- skos__hiddenLabel mesh__D008257 Psychologic Manipulations
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D008257 2004
% 224.58/224.82  |- skos__hiddenLabel mesh__D008257 Manipulations, Psychological
% 224.58/224.82  |- skos__hiddenLabel mesh__D008257 Psychologic Manipulation
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D008257 2005
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D008257 2000
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D008257 1996
% 224.58/224.82  |- mesh__dateRevised mesh__D008257 1991-06-11
% 224.58/224.82  |- mesh__recordMaintainer mesh__D008257 PLS
% 224.58/224.82  |- mesh__dateCreated mesh__D008257 1978-05-10
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D008257 2001
% 224.58/224.82  |- mesh__recordAuthorizer mesh__D008257 PLS
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D008257 1992
% 224.58/224.82  |- skos__historyNote mesh__D008257 Personality %28%1966-1978%29%
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D008257 2006
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D008257 1997
% 224.58/224.82  |- skos__historyNote mesh__D008257 Authoritarianism %28%1966-1978%29%
% 224.58/224.82  |- mesh__publicMeSHNote mesh__D008257
% 224.58/224.82       91; was see under PERSONALITY 1979-90   
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D008257 1998
% 224.58/224.82  |- skos__annotation mesh__D008257 no qualif   
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D008257 2002
% 224.58/224.82  |- skos__broader mesh__D008257smesh__D010551
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D008257 1993
% 224.58/224.82  |- mesh__recordOriginator mesh__D008257 EC
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D008257 1994
% 224.58/224.82  |- skos__altLabel mesh__D008257 Manipulation, Psychological
% 224.58/224.82  |- mesh__dateRevised mesh__D000274 2001-07-25
% 224.58/224.82  |- skos__hiddenLabel mesh__D000274 Disease, Dercum
% 224.58/224.82  |- skos__altLabel mesh__D000274 Dercum Disease
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D000274 2003
% 224.58/224.82  |- skos__prefLabel mesh__D000274 Adiposis Dolorosa
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D000274 2005
% 224.58/224.82  |- mesh__recordOriginator mesh__D000274 NLM
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D000274 2004
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D000274 2006
% 224.58/224.82  |- skos__altLabel mesh__D000274 Dercum%27%s Disease
% 224.58/224.82  |- skos__hiddenLabel mesh__D000274 Dercums Disease
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D000274 2002
% 224.58/224.82  |- mesh__recordMaintainer mesh__D000274 nns
% 224.58/224.82  |- skos__hiddenLabel mesh__D000274 Disease, Dercum%27%s
% 224.58/224.82  |- mesh__dateCreated mesh__D000274 1999-01-01
% 224.58/224.82  |- mesh__recordAuthorizer mesh__D000274 sjn
% 224.58/224.82  |- rdf__type mesh__D000274sskos__Concept
% 224.58/224.82  |- skos__broader mesh__D000274smesh__D012875
% 224.58/224.82  |- skos__scopeNote mesh__D000274
% 224.58/224.82       A rare disease, believed to be autosomal dominant, manifested by fatty deposits that press on nerves causing weakness and pain.%A%    
% 224.58/224.82  |- mesh__historyNote mesh__D018685 95   
% 224.58/224.82  |- skos__scopeNote mesh__D018685
% 224.58/224.82       Gases or volatile liquids that vary in the rate at which they induce anesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anesthetics have advantages over intravenous agents in that the depth of anesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. %28%From AMA Drug Evaluations Annual, 1994, p173%29%%A%    
% 224.58/224.82  |- skos__prefLabel mesh__D018685 Anesthetics, Inhalation
% 224.58/224.82  |- skos__annotation mesh__D018685 see note at ANESTHETICS   
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D018685 2006
% 224.58/224.82  |- mesh__recordOriginator mesh__D018685 TPW
% 224.58/224.82  |- mesh__dateRevised mesh__D018685 2005-06-30
% 224.58/224.82  |- mesh__dateEstablished mesh__D018685 1995-01-01
% 224.58/224.82  |- mesh__recordMaintainer mesh__D018685 ssb
% 224.58/224.82  |- mesh__dateCreated mesh__D018685 1994-06-03
% 224.58/224.82  |- skos__historyNote mesh__D018685 Anesthetics %28%1966-1994%29%
% 224.58/224.82  |- mesh__publicMeSHNote mesh__D018685 95   
% 224.58/224.82  |- rdf__type mesh__D018685sskos__Concept
% 224.58/224.82  |- skos__hiddenLabel mesh__D018685 Gases, Anesthetic
% 224.58/224.82  |- skos__altLabel mesh__D018685 Inhalation Anesthetics
% 224.58/224.82  |- skos__broader mesh__D018685smesh__D018681
% 224.58/224.82  |- mesh__recordAuthorizer mesh__D018685 sjn
% 224.58/224.82  |- skos__prefLabel mesh__D004665 Encephalitis Virus, St. Louis
% 224.58/224.82  |- skos__annotation mesh__D004665
% 224.58/224.82       infection = ENCEPHALITIS, ST. LOUIS; DF: ENCEPH VIRUS ST LOUIS%A%  
% 224.58/224.82  |- mesh__historyNote mesh__D004665
% 224.58/224.82       91%28%71%29%; was see under FLAVIVIRUSES 1981-90; was see under ENCEPHALITIS VIRUSES 1975-80%A%  
% 224.58/224.82  |- rdf__type mesh__D004665sskos__Concept
% 224.58/224.82  |- skos__scopeNote mesh__D004665
% 224.58/224.82       A species of FLAVIVIRUS, one of the Japanese encephalitis virus group %28%ENCEPHALITIS VIRUSES, JAPANESE%29%, which is the etiologic agent of St. Louis encephalitis %28%ENCEPHALITIS, ST. LOUIS%29% in the United States, the Caribbean, and Central and South America.%A%    
% 224.58/224.82  |- mesh__publicMeSHNote mesh__D004665
% 224.58/224.82       91; was see under FLAVIVIRUSES 1981-90; was see under ENCEPHALITIS VIRUSES 1975-80%A%  
% 224.58/224.82  |- skos__altLabel mesh__D004665 Viruses, St. Louis Encephalitis
% 224.58/224.82  |- mesh__recordOriginator mesh__D004665 NLM
% 224.58/224.82  |- skos__altLabel mesh__D004665 Saint Louis Encephalitis Virus
% 224.58/224.82  |- mesh__dateRevised mesh__D004665 2002-07-03
% 224.58/224.82  |- skos__altLabel mesh__D004665 St. Louis Encephalitis Viruses
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D004665 2003
% 224.58/224.82  |- skos__historyNote mesh__D004665 Encephalitis Viruses %28%1966-1970%29%
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D004665 2005
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D004665 2004
% 224.58/224.82  |- skos__broader mesh__D004665smesh__D018349
% 224.58/224.82  |- skos__altLabel mesh__D004665 St. Louis encephalitis virus
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D004665 2006
% 224.58/224.82  |- skos__altLabel mesh__D004665 Encephalitis Viruses, St. Louis
% 224.58/224.82  |- mesh__dateEstablished mesh__D004665 1991-01-01
% 224.58/224.82  |- mesh__recordMaintainer mesh__D004665 ags
% 224.58/224.82  |- skos__altLabel mesh__D004665 Virus, St. Louis Encephalitis
% 224.58/224.82  |- mesh__dateCreated mesh__D004665 1999-01-01
% 224.58/224.82  |- mesh__recordAuthorizer mesh__D004665 sjn
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D037041 2004
% 224.58/224.82  |- skos__broader mesh__D037041smesh__D006077
% 224.58/224.82  |- skos__scopeNote mesh__D037041
% 224.58/224.82       Agencies of the FEDERAL GOVERNMENT of the United States.%A%    
% 224.58/224.82  |- skos__broader mesh__D037041smesh__D006076
% 224.58/224.82  |- rdf__type mesh__D037041sskos__Concept
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D037041 2005
% 224.58/224.82  |- skos__prefLabel mesh__D037041 United States Government Agencies
% 224.58/224.82  |- mesh__dateEstablished mesh__D037041 2003-01-01
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D037041 2006
% 224.58/224.82  |- mesh__historyNote mesh__D037041 2003   
% 224.58/224.82  |- skos__broader mesh__D037041smesh__D035082
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D037041 2003
% 224.58/224.82  |- mesh__dateCreated mesh__D037041 2002-07-03
% 224.58/224.82  |- mesh__publicMeSHNote mesh__D037041 2003   
% 224.58/224.82  |- skos__hiddenLabel mesh__D050418 Cells, Pancreatic Polypeptide-Secreting
% 224.58/224.82  |- skos__hiddenLabel mesh__D050418 Pancreatic PP Cell
% 224.58/224.82  |- skos__hiddenLabel mesh__D050418 Cell, Pancreatic Polypeptide-Secreting
% 224.58/224.82  |- skos__hiddenLabel mesh__D050418 Pancreatic Polypeptide Secreting Cells
% 224.58/224.82  |- mesh__dateEstablished mesh__D050418 2006-01-01
% 224.58/224.82  |- mesh__recordOriginator mesh__D050418 lkt
% 224.58/224.82  |- skos__broader mesh__D050418smesh__D007515
% 224.58/224.82  |- skos__hiddenLabel mesh__D050418 Pancreatic PP Cells
% 224.58/224.82  |- skos__annotation mesh__D050418
% 224.58/224.82       /transpl: do not routinely coordinate with ISLETS OF LANGERHANS TRANSPLANTATION%A%  
% 224.58/224.82  |- skos__altLabel mesh__D050418 Pancreatic Polypeptide Cells
% 224.58/224.82  |- skos__broader mesh__D050418smesh__D019858
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D050418 2006
% 224.58/224.82  |- skos__historyNote mesh__D050418 Pancreatic Polypeptide %28%1979-2005%29%
% 224.58/224.82  |- mesh__historyNote mesh__D050418 2006   
% 224.58/224.82  |- mesh__publicMeSHNote mesh__D050418 2006   
% 224.58/224.82  |- skos__historyNote mesh__D050418 Pancreas %28%1973-2005%29%
% 224.58/224.82  |- skos__historyNote mesh__D050418 Peptides %28%1973-2005%29%
% 224.58/224.82  |- skos__altLabel mesh__D050418 PP Cells, Pancreatic
% 224.58/224.82  |- skos__hiddenLabel mesh__D050418 Pancreatic Polypeptide-Secreting Cell
% 224.58/224.82  |- rdf__type mesh__D050418sskos__Concept
% 224.58/224.82  |- skos__hiddenLabel mesh__D050418 PP Cell, Pancreatic
% 224.58/224.82  |- skos__hiddenLabel mesh__D050418 Pancreatic Polypeptide Cell
% 224.58/224.82  |- skos__scopeNote mesh__D050418
% 224.58/224.82       A group of islet cells %28%10-35%25%%29% which secrete PANCREATIC POLYPEPTIDE, a hormone that regulates APPETITE and FOOD INTAKE.%A%    
% 224.58/224.82  |- mesh__recordAuthorizer mesh__D050418 sjn
% 224.58/224.82  |- mesh__recordMaintainer mesh__D050418 lkt
% 224.58/224.82  |- skos__prefLabel mesh__D050418 Pancreatic Polypeptide-Secreting Cells
% 224.58/224.82  |- mesh__dateCreated mesh__D050418 2005-06-30
% 224.58/224.82  |- mesh__recordOriginator mesh__D014295 NLM
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D014295 2005
% 224.58/224.82  |- mesh__recordAuthorizer mesh__D014295 sjn
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D014295 2003
% 224.58/224.82  |- skos__historyNote mesh__D014295 Pyrimidines %28%1966-1971%29%
% 224.58/224.82  |- rdf__type mesh__D014295sskos__Concept
% 224.58/224.82  |- skos__historyNote mesh__D014295 Folic Acid Antagonists %28%1966-1971%29%
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D014295 2002
% 224.58/224.82  |- mesh__publicMeSHNote mesh__D014295 74   
% 224.58/224.82  |- skos__annotation mesh__D014295
% 224.58/224.82       consider TRIMETHOPRIM RESISTANCE for nonsusceptibility of bacteria%A%  
% 224.58/224.82  |- mesh__dateEstablished mesh__D014295 1974-01-01
% 224.58/224.82  |- skos__related mesh__D014295smesh__D014296
% 224.58/224.82  |- skos__broader mesh__D014295smesh__D011743
% 224.58/224.82  |- mesh__recordMaintainer mesh__D014295 ssb
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D014295 2006
% 224.58/224.82  |- skos__scopeNote mesh__D014295
% 224.58/224.82       A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. The interference with folic acid metabolism may cause a depression of hematopoiesis. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.%A%    
% 224.58/224.82  |- skos__historyNote mesh__D014295 Anti-Infective Agents %28%1966-1971%29%
% 224.58/224.82  |- mesh__dateRevised mesh__D014295 2001-07-25
% 224.58/224.82  |- mesh__dateCreated mesh__D014295 1999-01-01
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D014295 2004
% 224.58/224.82  |- skos__prefLabel mesh__D014295 Trimethoprim
% 224.58/224.82  |- mesh__historyNote mesh__D014295 74%28%72%29%   
% 224.58/224.82  |- skos__hiddenLabel mesh__D008258 Waldenstroms Macroglobulinemia
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D008258 2005
% 224.58/224.82  |- skos__scopeNote mesh__D008258
% 224.58/224.82       A plasma cell dyscrasia resembling leukemia with cells of lymphocytic, plasmacytic, or intermediate morphology, which secrete an IMMUNOGLOBULIN M monoclonal component. There is diffuse infiltration of bone marrow and also, in many cases, of the spleen, liver, or lymph nodes. The circulating macroglobulin produces symptoms of hyperviscosity syndrome: weakness, fatigue, bleeding disorders, and visual disturbances. Peak incidence is in the sixth and seventh decades. %28%Dorland, 28th ed%29%%A%    
% 224.58/224.82  |- mesh__recordAuthorizer mesh__D008258 sjn
% 224.58/224.82  |- skos__broader mesh__D008258smesh__D008232
% 224.58/224.82  |- skos__prefLabel mesh__D008258 Waldenstrom Macroglobulinemia
% 224.58/224.82  |- skos__hiddenLabel mesh__D008258 Macroglobulinemias
% 224.58/224.82  |- skos__annotation mesh__D008258
% 224.58/224.82       in titles %26% translations use diacrit: Waldenstr%C3%%B6%m   
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D008258 2006
% 224.58/224.82  |- mesh__recordOriginator mesh__D008258 NLM
% 224.58/224.82  |- skos__broader mesh__D008258smesh__D020141
% 224.58/224.82  |- skos__hiddenLabel mesh__D008258 Macroglobulinemia, Waldenstrom%27%s
% 224.58/224.82  |- mesh__recordMaintainer mesh__D008258 lkt
% 224.58/224.82  |- skos__broader mesh__D008258smesh__D010265
% 224.58/224.82  |- mesh__dateRevised mesh__D008258 2003-07-09
% 224.58/224.82  |- skos__altLabel mesh__D008258 Waldenstrom%27%s Macroglobulinemia
% 224.58/224.82  |- skos__hiddenLabel mesh__D008258 Macroglobulinemia, Waldenstrom
% 224.58/224.82  |- rdf__type mesh__D008258sskos__Concept
% 224.58/224.82  |- skos__altLabel mesh__D008258 Macroglobulinemia
% 224.58/224.82  |- mesh__historyNote mesh__D008258 99%28%63%29%   
% 224.58/224.82  |- mesh__dateCreated mesh__D008258 1999-01-01
% 224.58/224.82  |- mesh__publicMeSHNote mesh__D008258
% 224.58/224.82       99; see WALDENSTROM%27%S MACROGLOBULINEMIA 1992-98, was WALDENSTROM%27%S MACROGLOBULINEMIA see MACROGLOBULINEMIA 1963-91%A%  
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D008258 2004
% 224.58/224.82  |- skos__hiddenLabel mesh__D000275 Transient Situational Disturbances
% 224.58/224.82  |- skos__hiddenLabel mesh__D000275 Disorders, Adjustment
% 224.58/224.82  |- skos__hiddenLabel mesh__D000275 Reactive Depression
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D000275 1998
% 224.58/224.82  |- mesh__publicMeSHNote mesh__D000275
% 224.58/224.82       81; was DEPRESSION, REACTIVE 1969-80   
% 224.58/224.82  |- skos__scopeNote mesh__D000275
% 224.58/224.82       Maladaptive reactions to identifiable psychosocial stressors occurring within a short time after onset of the stressor. They are manifested by either impairment in social or occupational functioning or by symptoms %28%depression, anxiety, etc.%29% that are in excess of a normal and expected reaction to the stressor.%A%    
% 224.58/224.82  |- mesh__dateEstablished mesh__D000275 1969-01-01
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D000275 2006
% 224.58/224.82  |- skos__hiddenLabel mesh__D000275 Reactive Depressions
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D000275 2000
% 224.58/224.82  |- rdf__type mesh__D000275sskos__Concept
% 224.58/224.82  |- mesh__onlineNote mesh__D000275
% 224.58/224.82       use ADJUSTMENT DISORDERS to search DEPRESSION, REACTIVE 1966-80 %28%as Prov 1966-68%29%%A%  
% 224.58/224.82  |- skos__prefLabel mesh__D000275 Adjustment Disorders
% 224.58/224.82  |- skos__hiddenLabel mesh__D000275 Anniversary Reactions
% 224.58/224.82  |- skos__hiddenLabel mesh__D000275 Disorder, Adjustment
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D000275 2005
% 224.58/224.82  |- skos__hiddenLabel mesh__D000275 Reactive Disorder
% 224.58/224.82  |- mesh__recordMaintainer mesh__D000275 JLS
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D000275 2004
% 224.58/224.82  |- skos__altLabel mesh__D000275 Adjustment Disorder
% 224.58/224.82  |- skos__hiddenLabel mesh__D000275 Situational Disturbance, Transient
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D000275 2002
% 224.58/224.82  |- mesh__recordAuthorizer mesh__D000275 SJN
% 224.58/224.82  |- skos__hiddenLabel mesh__D000275 Disturbances, Transient Situational
% 224.58/224.82  |- skos__hiddenLabel mesh__D000275 Reactions, Anniversary
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D000275 2003
% 224.58/224.82  |- skos__hiddenLabel mesh__D000275 Disorder, Reactive
% 224.58/224.82  |- mesh__recordOriginator mesh__D000275 NLM
% 224.58/224.82  |- mesh__dateCreated mesh__D000275 1999-01-01
% 224.58/224.82  |- skos__altLabel mesh__D000275 Reactive Disorders
% 224.58/224.82  |- mesh__dateRevised mesh__D000275 1997-06-20
% 224.58/224.82  |- skos__broader mesh__D000275smesh__D001523
% 224.58/224.82  |- skos__hiddenLabel mesh__D000275 Depressions, Reactive
% 224.58/224.82  |- skos__hiddenLabel mesh__D000275 Reaction, Anniversary
% 224.58/224.82  |- skos__hiddenLabel mesh__D000275 Disturbance, Transient Situational
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D000275 1999
% 224.58/224.82  |- mesh__historyNote mesh__D000275
% 224.58/224.82       81; was DEPRESSION, REACTIVE 1966-80 %28%Prov 1966-68%29%   
% 224.58/224.82  |- skos__hiddenLabel mesh__D000275 Situational Disturbances, Transient
% 224.58/224.82  |- skos__hiddenLabel mesh__D000275 Disorders, Reactive
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D000275 2001
% 224.58/224.82  |- skos__altLabel mesh__D018686 Intravenous Anesthetics
% 224.58/224.82  |- mesh__recordAuthorizer mesh__D018686 sjn
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D018686 2006
% 224.58/224.82  |- skos__prefLabel mesh__D018686 Anesthetics, Intravenous
% 224.58/224.82  |- skos__scopeNote mesh__D018686
% 224.58/224.82       Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. %28%From AMA Drug Evaluations Annual, 1994, p174%29%%A%    
% 224.58/224.82  |- mesh__recordOriginator mesh__D018686 TPW
% 224.58/224.82  |- rdf__type mesh__D018686sskos__Concept
% 224.58/224.82  |- mesh__dateRevised mesh__D018686 2005-06-30
% 224.58/224.82  |- mesh__dateEstablished mesh__D018686 1995-01-01
% 224.58/224.82  |- mesh__recordMaintainer mesh__D018686 ssb
% 224.58/224.82  |- mesh__dateCreated mesh__D018686 1994-06-03
% 224.58/224.82  |- mesh__publicMeSHNote mesh__D018686 95   
% 224.58/224.82  |- mesh__historyNote mesh__D018686 95   
% 224.58/224.82  |- skos__historyNote mesh__D018686 Anesthetics %28%1968-1994%29%
% 224.58/224.82  |- skos__broader mesh__D018686smesh__D018681
% 224.58/224.82  |- skos__annotation mesh__D018686 see note at ANESTHETICS   
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D004666 2003
% 224.58/224.82  |- skos__altLabel mesh__D004666 Viruses, Venezuelan Equine Encephalitis
% 224.58/224.82  |- skos__scopeNote mesh__D004666
% 224.58/224.82       A species of ALPHAVIRUS that is the etiologic agent of encephalomyelitis in humans and equines. It is seen most commonly in parts of Central and South America.%A%    
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D004666 2005
% 224.58/224.82  |- mesh__dateEstablished mesh__D004666 1973-01-01
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D004666 2004
% 224.58/224.82  |- mesh__publicMeSHNote mesh__D004666 73   
% 224.58/224.82  |- skos__broader mesh__D004666smesh__D004668
% 224.58/224.82  |- skos__historyNote mesh__D004666 Encephalitis Viruses %28%1966-1970%29%
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D004666 2006
% 224.58/224.82  |- mesh__recordAuthorizer mesh__D004666 sjn
% 224.58/224.82  |- skos__altLabel mesh__D004666 Encephalitis Viruses, Venezuelan Equine
% 224.58/224.82  |- skos__altLabel mesh__D004666 Virus, Venezuelan Equine Encephalitis
% 224.58/224.82  |- mesh__historyNote mesh__D004666 73%28%71%29%   
% 224.58/224.82  |- mesh__activeMeSHYear mesh__D004666 2002
% 224.58/224.82  |- mesh__dateCreated mesh__D004666 1999-01-01
% 224.58/224.82  |- skos__prefLabel mesh__D004666 Encephalitis Virus, Venezuelan Equine
% 224.58/224.82  |- mesh__recordMaintainer mesh__D004666 ags
% 224.58/224.82  |- mesh__dateRevised mesh__D004666 2001-07-25
% 224.58/224.82  |- mesh__recordOriginator mesh__D004666 NLM
% 224.58/224.82  |- skos__altLabel mesh__D004666 Venezuelan equine encephalitis virus
% 224.58/224.82  |- rdf__type mesh__D004666sskos__Concept
% 224.58/224.82  |- skos__altLabel mesh__D004666 Encephalomyelitis Virus, Venezuelan Equine
% 224.58/224.82  |- skos__broader mesh__D004666smesh__D000524
% 224.58/224.82  |- skos__annotation mesh__D004666
% 224.58/224.82       infection = ENCEPHALOMYELITIS, VENEZUELAN EQUINE but see note there; DF: ENCEPH VIRUS VENEZ EQUINE%A%  
% 224.58/224.82  |- skos__altLabel mesh__D004666 Venezuelan Equine Encephalitis Viruses
% 224.58/224.82  |- skos__hiddenLabel mesh__D037042 Thyroid Hormone Receptor beta 2
% 224.58/224.82  |- mesh__historyNote mesh__D037042
% 224.58/224.82       2003; use RECEPTORS, THYROID HORMONE 1994-2002   
% 224.58/224.82  |- rdf__type mesh__D037042sskos__Concept
% 224.58/224.82  |- mesh__dateRevised mesh__D037042 2005-06-30
% 224.58/224.82  |- mesh__dateCreated mesh__D037042 2002-07-03
% 224.58/224.82  |- skos__hiddenLabel mesh__D037042 Gene Products, ERBA2
% 224.58/224.82  |- skos__hiddenLabel mesh__D037042 Gene Products, THRB
% 224.58/224.82  |- skos__hiddenLabel mesh__D037042 Gene Products, NR1A2
% 224.58/224.83  |- skos__altLabel mesh__D037042 c-erbA beta
% 224.58/224.83  |- skos__altLabel mesh__D037042 Thyroid Hormone Receptor beta
% 224.58/224.83  |- mesh__recordOriginator mesh__D037042 lkt
% 224.58/224.83  |- skos__altLabel mesh__D037042 TR beta
% 224.58/224.83  |- skos__altLabel mesh__D037042 NR1A2 Gene Products
% 224.58/224.83  |- skos__hiddenLabel mesh__D037042 Thyroid Hormone Receptor beta 1
% 224.58/224.83  |- skos__altLabel mesh__D037042 ERBA2 Gene Products
% 224.58/224.83  |- mesh__recordMaintainer mesh__D037042 lkt
% 224.58/224.83  |- mesh__activeMeSHYear mesh__D037042 2006
% 224.58/224.83  |- skos__broader mesh__D037042smesh__D011988
% 224.58/224.83  |- skos__scopeNote mesh__D037042
% 224.58/224.83       High affinity receptors for THYROID HORMONES, especially TRIIODOTHYRONINE. These receptors are usually found in the nucleus where they regulate DNA transcription. They are encoded by the THRB gene %28%also known as NR1A2, THRB1, or ERBA2 gene%29% as several isoforms produced by alternative splicing. Mutations in the THRB gene cause THYROID HORMONE RESISTANCE SYNDROME.%A%    
% 224.58/224.83  |- skos__altLabel mesh__D037042 THRB Gene Products
% 224.58/224.83  |- skos__prefLabel mesh__D037042 Thyroid Hormone Receptors beta
% 224.58/224.83  |- skos__altLabel mesh__D037042 Receptors beta, Thyroid Hormone
% 224.58/224.83  |- mesh__publicMeSHNote mesh__D037042
% 224.58/224.83       2003; use RECEPTORS, THYROID HORMONE 1994-2002; THYROID HORMONE RECEPTOR BETA was indexed under RECEPTORS, THYROID HORMONE 2002-2005%A%  
% 224.58/224.83  |- mesh__dateEstablished mesh__D037042 2003-01-01
% 224.58/224.83  |- mesh__recordAuthorizer mesh__D037042 sjn
% 224.58/224.83  |- skos__hiddenLabel mesh__D037042 c erbA beta
% 224.58/224.83  |- mesh__activeMeSHYear mesh__D009351 2006
% 224.58/224.83  |- mesh__dateCreated mesh__D009351 1985-03-11
% 224.58/224.83  |- mesh__recordMaintainer mesh__D009351 ags
% 224.58/224.83  |- mesh__recordAuthorizer mesh__D009351 sjn
% 224.58/224.83  |- mesh__recordOriginator mesh__D009351 EC
% 224.58/224.83  |- skos__annotation mesh__D009351
% 224.58/224.83       a species of nematode; infection: coord IM with STRONGYLIDA INFECTIONS %28%IM%29%; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH%A%  
% 224.58/224.83  |- mesh__dateRevised mesh__D009351 2003-07-09
% 224.58/224.83  |- mesh__dateEstablished mesh__D009351 1991-01-01
% 224.58/224.83  |- mesh__historyNote mesh__D009351
% 224.58/224.83       91%28%86%29%; was see under HELIGMOSOMATOIDEA 1986-90   
% 224.58/224.83  |- skos__historyNote mesh__D009351 Nematoda %28%1966-1985%29%
% 224.58/224.83  |- rdf__type mesh__D009351sskos__Concept
% 224.58/224.83  |- skos__scopeNote mesh__D009351
% 224.58/224.83       A species of intestinal nematode parasites which occur most commonly in mice. Infection is by ingesting larvae. This particular species is used extensively in immunological research.%A%    
% 224.58/224.83  |- mesh__activeMeSHYear mesh__D009351 2005
% 224.58/224.83  |- mesh__activeMeSHYear mesh__D009351 2004
% 224.58/224.83  |- mesh__publicMeSHNote mesh__D009351
% 224.58/224.83       91; was see under HELIGMOSOMATOIDEA 1986-90   
% 224.58/224.83  |- skos__historyNote mesh__D009351 Trichostrongyloidea %28%1966-1985%29%
% 224.58/224.83  |- skos__prefLabel mesh__D009351 Nematospiroides dubius
% 224.58/224.83  |- skos__altLabel mesh__D009351 Heligmosomoides polygyrus
% 224.58/224.83  |- skos__broader mesh__D009351smesh__D017184
% 224.58/224.83  |- mesh__dateRevised mesh__D014296 2003-07-09
% 224.58/224.83  |- mesh__recordMaintainer mesh__D014296 ssb
% 224.58/224.83  |- skos__broader mesh__D014296smesh__D024881
% 224.58/224.83  |- skos__historyNote mesh__D014296
% 224.58/224.83       Drug Resistance, Microbial %28%1971-1987%29%
% 224.58/224.83  |- mesh__dateEstablished mesh__D014296 1988-01-01
% 224.58/224.83  |- skos__prefLabel mesh__D014296 Trimethoprim Resistance
% 224.58/224.83  |- rdf__type mesh__D014296sskos__Concept
% 224.58/224.83  |- skos__scopeNote mesh__D014296
% 224.58/224.83       Nonsusceptibility of bacteria to the action of TRIMETHOPRIM.%A%    
% 224.58/224.83  |- mesh__recordAuthorizer mesh__D014296 sjn
% 224.58/224.83  |- skos__historyNote mesh__D014296 Pyrimidines %28%1966-1971%29%
% 224.58/224.83  |- mesh__activeMeSHYear mesh__D014296 2006
% 224.58/224.83  |- mesh__historyNote mesh__D014296 1988   
% 224.58/224.83  |- mesh__recordOriginator mesh__D014296 SCD
% 224.58/224.83  |- skos__related mesh__D014296smesh__D014295
% 224.58/224.83  |- mesh__publicMeSHNote mesh__D014296 1988   
% 224.58/224.83  |- mesh__activeMeSHYear mesh__D014296 2005
% 224.58/224.83  |- mesh__activeMeSHYear mesh__D014296 2004
% 224.58/224.83  |- mesh__dateCreated mesh__D014296 1987-05-11
% 224.58/224.83  |- skos__historyNote mesh__D014296 Trimethoprim %28%1972-1987%29%
% 224.58/224.83  |- mesh__publicMeSHNote mesh__D008259 65   
% 224.58/224.83  |- mesh__activeMeSHYear mesh__D008259 2006
% 224.58/224.83  |- mesh__activeMeSHYear mesh__D008259 2000
% 224.58/224.83  |- mesh__activeMeSHYear mesh__D008259 1997
% 224.58/224.83  |- mesh__activeMeSHYear mesh__D008259 2001
% 224.58/224.83  |- mesh__activeMeSHYear mesh__D008259 1998
% 224.58/224.83  |- mesh__recordAuthorizer mesh__D008259 PLS
% 224.58/224.83  |- skos__scopeNote mesh__D008259
% 224.58/224.83       Serum globulins with high molecular weight. %28%Dorland, 28th ed%29%%A%    
% 224.58/224.83  |- mesh__historyNote mesh__D008259 65   
% 224.58/224.83  |- rdf__type mesh__D008259sskos__Concept
% 224.58/224.83  |- mesh__activeMeSHYear mesh__D008259 2002
% 224.58/224.83  |- mesh__activeMeSHYear mesh__D008259 1999
% 224.58/224.83  |- mesh__dateRevised mesh__D008259 1995-03-17
% 224.58/224.83  |- mesh__recordOriginator mesh__D008259 NLM
% 224.58/224.83  |- skos__prefLabel mesh__D008259 Macroglobulins
% 224.58/224.83  |- mesh__activeMeSHYear mesh__D008259 2003
% 224.58/224.83  |- skos__broader mesh__D008259smesh__D012712
% 224.58/224.83  |- skos__annotation mesh__D008259
% 224.58/224.83       serum globulins; ALPHA MACROGLOBULINS is also available   
% 224.58/224.83  |- mesh__dateCreated mesh__D008259 1999-01-01
% 224.58/224.83  |- mesh__dateEstablished mesh__D008259 1965-01-01
% 224.58/224.83  |- mesh__activeMeSHYear mesh__D008259 2004
% 224.58/224.83  |- mesh__recordMaintainer mesh__D008259 TGC
% 224.58/224.83  |- mesh__activeMeSHYear mesh__D008259 2005
% 224.58/224.83  |- mesh__activeMeSHYear mesh__D008259 1996
% 224.58/224.83  |- mesh__recordOriginator mesh__D000276 NLM
% 224.58/224.83  |- skos__broader mesh__D000276smesh__D015545
% 224.58/224.83  |- skos__altLabel mesh__D000276 Immunologic Adjuvants
% 224.58/224.83  |- mesh__historyNote mesh__D000276 65   
% 224.58/224.83  |- skos__annotation mesh__D000276 DF: ADJUVANTS IMMUNOL   
% 224.58/224.83  |- skos__altLabel mesh__D000276 Adjuvant, Immunologic
% 224.58/224.83  |- skos__altLabel mesh__D000276 Immunoactivators
% 224.58/224.83  |- skos__altLabel mesh__D000276 Adjuvants, Immunological
% 224.58/224.83  |- mesh__recordAuthorizer mesh__D000276 sjn
% 224.58/224.83  |- skos__altLabel mesh__D000276 Immunological Adjuvant
% 224.58/224.83  |- mesh__dateRevised mesh__D000276 2005-06-30
% 224.58/224.83  |- skos__altLabel mesh__D000276 Immunopotentiators
% 224.58/224.83  |- skos__hiddenLabel mesh__D000276 Immunologic Adjuvant
% 224.58/224.83  |- mesh__activeMeSHYear mesh__D000276 2006
% 224.58/224.83  |- mesh__recordMaintainer mesh__D000276 ssb
% 224.58/224.83  |- skos__related mesh__D000276smesh__D000277
% 224.58/224.83  |- mesh__dateEstablished mesh__D000276 1965-01-01
% 224.58/224.83  |- skos__altLabel mesh__D000276 Immunoadjuvants
% 224.58/224.83  |- skos__hiddenLabel mesh__D000276 Immunological Adjuvants
% 224.58/224.83  |- skos__scopeNote mesh__D000276
% 224.58/224.83       Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents %28%Freund%27%s adjuvant, BCG, Corynebacterium parvum, et al.%29% contain bacterial antigens. Some are endogenous %28%e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1%29%. Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity.%A%    
% 224.58/224.83  |- rdf__type mesh__D000276sskos__Concept
% 224.58/224.83  |- mesh__publicMeSHNote mesh__D000276 65   
% 224.58/224.83  |- skos__hiddenLabel mesh__D000276 Adjuvant, Immunological
% 224.58/224.83  |- skos__altLabel mesh__D000276 Immunostimulants
% 224.58/224.83  |- mesh__dateCreated mesh__D000276 1999-01-01
% 224.58/224.83  |- skos__prefLabel mesh__D000276 Adjuvants, Immunologic
% 224.58/224.83  |- mesh__recordOriginator mesh__D018687 TPW
% 224.58/224.83  |- mesh__historyNote mesh__D018687 95   
% 224.58/224.83  |- mesh__dateEstablished mesh__D018687 1995-01-01
% 224.58/224.83  |- skos__hiddenLabel mesh__D018687 Antidepressive Agents, Second Generation
% 224.58/224.83  |- mesh__publicMeSHNote mesh__D018687 95   
% 224.58/224.83  |- skos__hiddenLabel mesh__D018687 Second-Generation Antidepressive Drugs
% 224.58/224.83  |- skos__altLabel mesh__D018687 Atypical Antidepressants
% 224.58/224.83  |- mesh__activeMeSHYear mesh__D018687 2006
% 224.58/224.83  |- skos__altLabel mesh__D018687 Second-Generation Antidepressive Agents
% 224.58/224.83  |- mesh__recordAuthorizer mesh__D018687 sjn
% 224.69/224.83  |- skos__hiddenLabel mesh__D018687 Drugs, Second-Generation Antidepressive
% 224.69/224.83  |- skos__hiddenLabel mesh__D018687 Agents, Second-Generation Antidepressive
% 224.69/224.83  |- mesh__dateCreated mesh__D018687 1994-06-03
% 224.69/224.83  |- skos__broader mesh__D018687smesh__D000928
% 224.69/224.83  |- skos__altLabel mesh__D018687 Antidepressive Drugs, Second-Generation
% 224.69/224.83  |- skos__annotation mesh__D018687 GEN or unspecified; prefer specifics   
% 224.69/224.83  |- skos__hiddenLabel mesh__D018687 Second Generation Antidepressive Agents
% 224.69/224.83  |- mesh__recordMaintainer mesh__D018687 ssb
% 224.69/224.83  |- rdf__type mesh__D018687sskos__Concept
% 224.69/224.83  |- skos__prefLabel mesh__D018687 Antidepressive Agents, Second-Generation
% 224.69/224.83  |- skos__historyNote mesh__D018687 Antidepressive Agents %28%1977-1994%29%
% 224.69/224.83  |- skos__scopeNote mesh__D018687
% 224.69/224.83       A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake.%A%    
% 224.69/224.83  |- skos__altLabel mesh__D018687 Antidepressants, Atypical
% 224.69/224.83  |- skos__hiddenLabel mesh__D018687 Antidepressive Drugs, Second Generation
% 224.69/224.83  |- mesh__dateRevised mesh__D018687 2005-06-30
% 224.69/224.83  |- skos__broader mesh__D037841smesh__D014930
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D037841 2003
% 224.69/224.83  |- rdf__type mesh__D037841sskos__Concept
% 224.69/224.83  |- mesh__historyNote mesh__D037841 2003   
% 224.69/224.83  |- mesh__publicMeSHNote mesh__D037841 2003   
% 224.69/224.83  |- skos__hiddenLabel mesh__D037841 Woman, Pregnant
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D037841 2004
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D037841 2005
% 224.69/224.83  |- skos__annotation mesh__D037841
% 224.69/224.83       IM as psychol or social entity; NIM as check tag   
% 224.69/224.83  |- skos__historyNote mesh__D037841 Pregnancy %28%1966-2002%29%
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D037841 2006
% 224.69/224.83  |- skos__altLabel mesh__D037841 Women, Pregnant
% 224.69/224.83  |- skos__related mesh__D037841smesh__D033261
% 224.69/224.83  |- mesh__dateCreated mesh__D037841 2002-07-03
% 224.69/224.83  |- skos__related mesh__D037841smesh__D011247
% 224.69/224.83  |- mesh__dateEstablished mesh__D037841 2003-01-01
% 224.69/224.83  |- skos__scopeNote mesh__D037841
% 224.69/224.83       Human females who are pregnant, as cultural, psychological, or sociological entities.%A%    
% 224.69/224.83  |- skos__prefLabel mesh__D037841 Pregnant Women
% 224.69/224.83  |- skos__altLabel mesh__D037841 Pregnant Woman
% 224.69/224.83  |- skos__altLabel mesh__D004667 WEE Virus
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D004667 2004
% 224.69/224.83  |- skos__historyNote mesh__D004667 Encephalitis Viruses %28%1966-1970%29%
% 224.69/224.83  |- skos__broader mesh__D004667smesh__D000524
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D004667 2006
% 224.69/224.83  |- skos__altLabel mesh__D004667 Virus, Western Equine Encephalitis
% 224.69/224.83  |- skos__altLabel mesh__D004667 Encephalitis Viruses, Western Equine
% 224.69/224.83  |- skos__altLabel mesh__D004667 Western equine encephalitis virus
% 224.69/224.83  |- mesh__dateCreated mesh__D004667 1999-01-01
% 224.69/224.83  |- skos__altLabel mesh__D004667 Viruses, Western Equine Encephalitis
% 224.69/224.83  |- skos__annotation mesh__D004667
% 224.69/224.83       infection: coord IM with ENCEPHALOMYELITIS, EQUINE %28%IM%29% but see note there; DF: note short X ref%A%  
% 224.69/224.83  |- mesh__recordMaintainer mesh__D004667 ags
% 224.69/224.83  |- mesh__dateEstablished mesh__D004667 1973-01-01
% 224.69/224.83  |- mesh__publicMeSHNote mesh__D004667 73   
% 224.69/224.83  |- skos__broader mesh__D004667smesh__D004668
% 224.69/224.83  |- rdf__type mesh__D004667sskos__Concept
% 224.69/224.83  |- mesh__recordAuthorizer mesh__D004667 sjn
% 224.69/224.83  |- mesh__historyNote mesh__D004667 73%28%71%29%   
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D004667 2002
% 224.69/224.83  |- skos__hiddenLabel mesh__D004667 WEE Viruses
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D004667 2003
% 224.69/224.83  |- mesh__dateRevised mesh__D004667 2001-07-25
% 224.69/224.83  |- mesh__recordOriginator mesh__D004667 NLM
% 224.69/224.83  |- skos__prefLabel mesh__D004667 Encephalitis Virus, Western Equine
% 224.69/224.83  |- skos__scopeNote mesh__D004667
% 224.69/224.83       A species of ALPHAVIRUS that is the etiologic agent of encephalomyelitis in humans and equines in the United States, southern Canada, and parts of South America.%A%    
% 224.69/224.83  |- skos__altLabel mesh__D004667 Western Equine Encephalitis Viruses
% 224.69/224.83  |- skos__altLabel mesh__D004667 Encephalomyelitis Virus, Western Equine
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D004667 2005
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D023821 2005A
% 224.69/224.83  |- skos__broader mesh__D023821smesh__D019637
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D023821 2003
% 224.69/224.83  |- skos__broader mesh__D023821smesh__D014656
% 224.69/224.83  |- mesh__recordMaintainer mesh__D023821 jls
% 224.69/224.83  |- skos__scopeNote mesh__D023821
% 224.69/224.83       An alternative to amputation in patients with neoplasms, ischemia, fractures, and other limb-threatening conditions. Generally, sophisticated surgical procedures such as vascular surgery and reconstruction are used to salvage diseased limbs.%A%    
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D023821 2006
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D023821 2002
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D023821 2004
% 224.69/224.83  |- skos__hiddenLabel mesh__D023821 Salvage, Limb
% 224.69/224.83  |- skos__broader mesh__D023821smesh__D019651
% 224.69/224.83  |- rdf__type mesh__D023821sskos__Concept
% 224.69/224.83  |- mesh__historyNote mesh__D023821 2002   
% 224.69/224.83  |- mesh__dateRevised mesh__D023821 2004-07-28
% 224.69/224.83  |- skos__historyNote mesh__D023821
% 224.69/224.83       Reconstructive Surgical Procedure %28%1999-2001%29%
% 224.69/224.83  |- mesh__recordAuthorizer mesh__D023821 jls
% 224.69/224.83  |- mesh__dateCreated mesh__D023821 2001-07-25
% 224.69/224.83  |- skos__prefLabel mesh__D023821 Limb Salvage
% 224.69/224.83  |- mesh__recordOriginator mesh__D023821 lkt
% 224.69/224.83  |- mesh__publicMeSHNote mesh__D023821 2002   
% 224.69/224.83  |- skos__historyNote mesh__D023821
% 224.69/224.83       Blood Vessel Prosthesis %28%1967-1998%29%
% 224.69/224.83  |- mesh__dateEstablished mesh__D023821 2002-01-01
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D023821 2005
% 224.69/224.83  |- skos__broader mesh__D008208Q000530smesh__D008208
% 224.69/224.83  |- mesh__preferredCombination mesh__D008208Q000530smesh__D008220
% 224.69/224.83  |- rdf__type mesh__D008208Q000530smesh__CompoundConcept
% 224.69/224.83  |- mesh__dateRevised mesh__D014297 2000-06-22
% 224.69/224.83  |- skos__annotation mesh__D014297 DF: TRIMETHYLSILYL CPDS   
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D014297 2002
% 224.69/224.83  |- skos__broader mesh__D014297smesh__D017646
% 224.69/224.83  |- mesh__publicMeSHNote mesh__D014297 91; was see under SILICON 1975-90   
% 224.69/224.83  |- skos__scopeNote mesh__D014297
% 224.69/224.83       Organic silicon derivatives used to characterize hydroxysteroids, nucleosides, and related compounds. Trimethylsilyl esters of amino acids are used in peptide synthesis.%A%    
% 224.69/224.83  |- skos__prefLabel mesh__D014297 Trimethylsilyl Compounds
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D014297 2006
% 224.69/224.83  |- skos__historyNote mesh__D014297 Silicon %28%1974%29%
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D014297 2005
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D014297 2004
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D014297 2001
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D014297 2003
% 224.69/224.83  |- mesh__dateCreated mesh__D014297 1974-11-11
% 224.69/224.83  |- mesh__historyNote mesh__D014297
% 224.69/224.83       91%28%75%29%; was see under SILICON 1975-90   
% 224.69/224.83  |- skos__hiddenLabel mesh__D014297 Compounds, Trimethylsilyl
% 224.69/224.83  |- mesh__recordOriginator mesh__D014297 NLM
% 224.69/224.83  |- mesh__recordMaintainer mesh__D014297 CCR
% 224.69/224.83  |- mesh__recordAuthorizer mesh__D014297 sjn
% 224.69/224.83  |- mesh__dateEstablished mesh__D014297 1991-01-01
% 224.69/224.83  |- skos__historyNote mesh__D014297 Methane %28%1974%29%
% 224.69/224.83  |- rdf__type mesh__D014297sskos__Concept
% 224.69/224.83  |- skos__altLabel mesh__D019780 99m-Tc-Lidofenin
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D019780 1998
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D019780 2004
% 224.69/224.83  |- skos__historyNote mesh__D019780
% 224.69/224.83       Organometallic Compounds %28%1977-1989%29%
% 224.69/224.83  |- mesh__dateCreated mesh__D019780 1997-07-02
% 224.69/224.83  |- skos__altLabel mesh__D019780 99mTc-Lidofenin
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D019780 2003
% 224.69/224.83  |- skos__historyNote mesh__D019780
% 224.69/224.83       Acetanilides/analogs %26% derivatives %28%1977-1989%29%
% 224.69/224.83  |- skos__prefLabel mesh__D019780 Technetium Tc 99m Lidofenin
% 224.69/224.83  |- skos__altLabel mesh__D019780
% 224.69/224.83       Technetium Tc 99m 2,6-Dimethyl Iminodiacetic Acid
% 224.69/224.83  |- skos__hiddenLabel mesh__D019780 Tc 99m Lidofenin
% 224.69/224.83  |- skos__broader mesh__D019780smesh__D007098
% 224.69/224.83  |- skos__hiddenLabel mesh__D019780 99mTc Lidofenin
% 224.69/224.83  |- skos__hiddenLabel mesh__D019780 Technetium 99m Lidofenin
% 224.69/224.83  |- skos__historyNote mesh__D019780
% 224.69/224.83       Organotechnetium Compounds %28%1990-1997%29%
% 224.69/224.83  |- skos__hiddenLabel mesh__D019780
% 224.69/224.83       Technetium Tc 99m 2,6 Dimethyl Iminodiacetic Acid
% 224.69/224.83  |- skos__broader mesh__D019780smesh__D015609
% 224.69/224.83  |- skos__hiddenLabel mesh__D019780 Lidofenin, Tc-99m
% 224.69/224.83  |- mesh__dateEstablished mesh__D019780 1998-01-01
% 224.69/224.83  |- skos__historyNote mesh__D019780
% 224.69/224.83       Lidocaine/analogs %26% derivatives %28%1978-1980%29%
% 224.69/224.83  |- skos__hiddenLabel mesh__D019780 99m Tc Lidofenin
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D019780 2002
% 224.69/224.83  |- skos__hiddenLabel mesh__D019780 99mTc HIDA
% 224.69/224.83  |- skos__altLabel mesh__D019780 99mTc-HIDA
% 224.69/224.83  |- skos__altLabel mesh__D019780 Tc-99m Lidofenin
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D019780 2006
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D019780 2001
% 224.69/224.83  |- rdf__type mesh__D019780sskos__Concept
% 224.69/224.83  |- skos__altLabel mesh__D019780 Technetium-99m-Lidofenin
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D019780 1999
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D019780 2005
% 224.69/224.83  |- skos__historyNote mesh__D019780 Imino Acids %28%1979-1997%29%
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D019780 2000
% 224.69/224.83  |- skos__annotation mesh__D019780 as label, use/diag use; DF: TC HIDA   
% 224.69/224.83  |- mesh__historyNote mesh__D019780
% 224.69/224.83       98; use TECHNETIUM TC 99M LIDOFENIN %28%NM%29% 1977-97   
% 224.69/224.83  |- skos__scopeNote mesh__D019780
% 224.69/224.83       A nontoxic radiopharmaceutical that is used in the clinical evaluation of hepatobiliary disorders in humans. %28%J Nucl Med 1977;18%28%10%29%:997-1004%29%%A%    
% 224.69/224.83  |- mesh__publicMeSHNote mesh__D019780
% 224.69/224.83       98; TECHNETIUM TC 99M LIDOFENIN was indexed under IMINO ACIDS 1977-97, ORGANOTECHNETIUM COMPOUNDS 1990-97, ORGANOMETALLIC COMPOUNDS 1977-89, ACETANILIDE/analogs %26% derivatives 1978-89, %26% LIDOCAINE/analogs %26% derivatives 1978-80%A%  
% 224.69/224.83  |- skos__annotation mesh__D000277 DF: ADJUVANTS PHARM   
% 224.69/224.83  |- skos__broader mesh__D000277smesh__D010592
% 224.69/224.83  |- mesh__recordOriginator mesh__D000277 NLM
% 224.69/224.83  |- skos__altLabel mesh__D000277 Pharmaceutic Adjuvant
% 224.69/224.83  |- skos__related mesh__D000277smesh__D000276
% 224.69/224.83  |- skos__altLabel mesh__D000277 Pharmaceutic Adjuvants
% 224.69/224.83  |- mesh__activeMeSHYear mesh__D000277 2006
% 224.69/224.83  |- skos__scopeNote mesh__D000277
% 224.69/224.83       Agents that aid or increase the action of the principle drug %28%DRUG SYNERGISM%29% or that affect the absorption, mechanism of action, metabolism, or excretion of the primary drug %28%PHARMACOKINETICS%29% in such a way as to enhance its effects.%A%    
% 224.69/224.83  |- skos__altLabel mesh__D000277 Pharmaceutical Adjuvants
% 224.69/224.83  |- skos__historyNote mesh__D000277 Pharmaceutic Aids %28%1968-1974%29%
% 224.69/224.83  |- skos__prefLabel mesh__D000277 Adjuvants, Pharmaceutic
% 224.69/224.83  |- mesh__dateEstablished mesh__D000277 1975-01-01
% 224.69/224.83  |- skos__altLabel mesh__D000277 Adjuvant, Pharmaceutical
% 224.69/224.83  |- mesh__recordAuthorizer mesh__D000277 sjn
% 224.69/224.83  |- mesh__historyNote mesh__D000277
% 224.69/224.83       75; was see under PHARMACEUTIC AIDS 1969-74   
% 224.69/224.83  |- rdf__type mesh__D000277sskos__Concept
% 224.69/224.83  |- mesh__dateRevised mesh__D000277 2005-06-30
% 224.69/224.83  |- mesh__publicMeSHNote mesh__D000277
% 224.69/224.83       75; was see under PHARMACEUTIC AIDS 1969-74   
% 224.69/224.83  |- mesh__recordMaintainer mesh__D000277 ssb
% 224.69/224.83  |- skos__altLabel mesh__D000277 Pharmaceutical Adjuvant
% 224.69/224.83  |- mesh__dateCreated mesh__D000277 1999-01-01
% 224.69/224.84  |- skos__altLabel mesh__D000277 Adjuvants, Pharmaceutical
% 224.69/224.84  |- skos__altLabel mesh__D000277 Adjuvant, Pharmaceutic
% 224.69/224.84  |- mesh__onlineNote mesh__D000277 search PHARMACEUTIC AIDS 1969-74   
% 224.69/224.84  |- rdf__type mesh__D005760sskos__Concept
% 224.69/224.84  |- skos__hiddenLabel mesh__D005760 Swine Gastroenteritis Virus
% 224.69/224.84  |- skos__altLabel mesh__D005760 Transmissible Gastroenteritis Virus, Swine
% 224.69/224.84  |- skos__broader mesh__D005760smesh__D017934
% 224.69/224.84  |- skos__hiddenLabel mesh__D005760 gastroenteritis virus, Transmissible
% 224.69/224.84  |- mesh__dateEstablished mesh__D005760 1991-01-01
% 224.69/224.84  |- skos__altLabel mesh__D005760 Porcine Transmissible Gastroenteritis Virus
% 224.69/224.84  |- mesh__dateRevised mesh__D005760 2005-06-30
% 224.69/224.84  |- mesh__recordMaintainer mesh__D005760 ags
% 224.69/224.84  |- skos__prefLabel mesh__D005760 Transmissible gastroenteritis virus
% 224.69/224.84  |- mesh__historyNote mesh__D005760 2002 %28%1975%29%   
% 224.69/224.84  |- skos__annotation mesh__D005760
% 224.69/224.84       infection = GASTROENTERITIS, TRANSMISSIBLE, OF SWINE   
% 224.69/224.84  |- skos__altLabel mesh__D005760 TGE Virus
% 224.69/224.84  |- mesh__dateCreated mesh__D005760 1974-12-12
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D005760 2006
% 224.69/224.84  |- mesh__recordAuthorizer mesh__D005760 sjn
% 224.69/224.84  |- skos__altLabel mesh__D005760
% 224.69/224.84       Gastroenteritis Virus, Porcine Transmissible
% 224.69/224.84  |- skos__scopeNote mesh__D005760
% 224.69/224.84       A species of CORONAVIRUS causing a fatal disease to pigs under 3 weeks old.%A%    
% 224.69/224.84  |- skos__hiddenLabel mesh__D005760 TGE Viruses
% 224.69/224.84  |- skos__hiddenLabel mesh__D005760 Swine Gastroenteritis Viruses
% 224.69/224.84  |- skos__altLabel mesh__D005760 Gastroenteritis Virus of Swine
% 224.69/224.84  |- mesh__recordOriginator mesh__D005760 NLM
% 224.69/224.84  |- mesh__publicMeSHNote mesh__D005760
% 224.69/224.84       2002; see GASTROENTERITIS VIRUS, PORCINE TRANSMISSIBLE 1994-2001, see GASTROENTERITIS VIRUS OF SWINE 1991-1993, see CORONAVIRIDAE 1981-1990, see CORONAVIRUSES 1975-1980; for TRANSMISSIBLE GASTROENTERITIS VIRUS, SWINE see GASTROENTERITIS VIRUS OF SWINE 1976-1993%A%  
% 224.69/224.84  |- mesh__dateRevised mesh__D018688 2003-07-09
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D018688 2006
% 224.69/224.84  |- mesh__dateCreated mesh__D018688 1994-04-19
% 224.69/224.84  |- skos__broader mesh__D018688smesh__D021745
% 224.69/224.84  |- skos__prefLabel mesh__D018688 Neospora
% 224.69/224.84  |- skos__annotation mesh__D018688
% 224.69/224.84       a protozoon: do not confuse with NEUROSPORA, a fungus; infection: coord IM with COCCIDIOSIS %28%IM%29%; /drug eff: consider also COCCIDIOSTATS; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN%A%  
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D018688 2005
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D018688 2004
% 224.69/224.84  |- mesh__dateEstablished mesh__D018688 1995-01-01
% 224.69/224.84  |- mesh__publicMeSHNote mesh__D018688 95   
% 224.69/224.84  |- rdf__type mesh__D018688sskos__Concept
% 224.69/224.84  |- skos__historyNote mesh__D018688 Apicomplexa %28%1992-1994%29%
% 224.69/224.84  |- skos__scopeNote mesh__D018688
% 224.69/224.84       A genus of protozoan parasites of the subclass COCCIDIA. Its species are parasitic in dogs, cattle, goats, and sheep, among others. N. caninum, a species that mainly infects dogs, is intracellular in neural and other cells of the body, multiplies by endodyogeny, has no parasitophorous vacuole, and has numerous rhoptries. It is known to cause lesions in many tissues, especially the brain and spinal cord as well as abortion in the expectant mother.%A%    
% 224.69/224.84  |- skos__historyNote mesh__D018688 Protozoa %28%1989-1991%29%
% 224.69/224.84  |- mesh__historyNote mesh__D018688 95   
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D004668 2000
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D004668 2005
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D004668 2004
% 224.69/224.84  |- mesh__dateCreated mesh__D004668 1999-01-01
% 224.69/224.84  |- skos__altLabel mesh__D004668 Encephalitis Virus
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D004668 2001
% 224.69/224.84  |- mesh__recordMaintainer mesh__D004668 ndw
% 224.69/224.84  |- skos__altLabel mesh__D004668 Virus, Encephalitis
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D004668 2006
% 224.69/224.84  |- rdf__type mesh__D004668sskos__Concept
% 224.69/224.84  |- mesh__recordAuthorizer mesh__D004668 sjn
% 224.69/224.84  |- skos__scopeNote mesh__D004668
% 224.69/224.84       A collection of single-stranded RNA viruses scattered across the Bunyaviridae, Flaviviridae, and Togaviridae families whose common property is the ability to induce encephalitic conditions in infected hosts.%A%    
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D004668 2002
% 224.69/224.84  |- skos__altLabel mesh__D004668 Viruses, Encephalitis
% 224.69/224.84  |- mesh__recordOriginator mesh__D004668 NLM
% 224.69/224.84  |- skos__broader mesh__D004668smesh__D012328
% 224.69/224.84  |- skos__annotation mesh__D004668
% 224.69/224.84       a large group of RNA viruses; GEN only: prefer specific; infection = ENCEPHALITIS, ARBOVIRUS; DF: ENCEPH VIRUSES%A%  
% 224.69/224.84  |- mesh__dateRevised mesh__D004668 1999-11-03
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D004668 2003
% 224.69/224.84  |- skos__prefLabel mesh__D004668 Encephalitis Viruses
% 224.69/224.84  |- skos__hiddenLabel mesh__D015390 Gastric Bypass, Roux-en-Y
% 224.69/224.84  |- mesh__recordOriginator mesh__D015390 RLS
% 224.69/224.84  |- skos__historyNote mesh__D015390 Stomach/surgery %28%1966-1988%29%
% 224.69/224.84  |- mesh__dateRevised mesh__D015390 2005-06-30
% 224.69/224.84  |- skos__broader mesh__D015390smesh__D050110
% 224.69/224.84  |- skos__scopeNote mesh__D015390
% 224.69/224.84       Surgical procedure in which the STOMACH is transected high on the body. The resulting small proximal gastric pouch is joined to any parts of the SMALL INTESTINE by an end-to-side SURGICAL ANASTOMOSIS, depending on the amounts of intestinal surface being bypasses. This procedure is used frequently in the treatment of MORBID OBESITY by limiting the size of functional STOMACH, food intake, and food absorption.%A%    
% 224.69/224.84  |- skos__hiddenLabel mesh__D015390 Gastric Bypass, Greenville
% 224.69/224.84  |- mesh__recordMaintainer mesh__D015390 lkt
% 224.69/224.84  |- rdf__type mesh__D015390sskos__Concept
% 224.69/224.84  |- mesh__recordAuthorizer mesh__D015390 sjn
% 224.69/224.84  |- skos__prefLabel mesh__D015390 Gastric Bypass
% 224.69/224.84  |- mesh__dateEstablished mesh__D015390 1989-01-01
% 224.69/224.84  |- mesh__dateCreated mesh__D015390 1988-06-06
% 224.69/224.84  |- skos__broader mesh__D015390smesh__D005763
% 224.69/224.84  |- skos__hiddenLabel mesh__D015390 Bypass, Gastric
% 224.69/224.84  |- skos__hiddenLabel mesh__D015390 Roux en Y Gastric Bypass
% 224.69/224.84  |- skos__hiddenLabel mesh__D015390 Bypass, Roux-en-Y Gastric
% 224.69/224.84  |- mesh__historyNote mesh__D015390 89   
% 224.69/224.84  |- skos__hiddenLabel mesh__D015390 Bypass, Gastroileal
% 224.69/224.84  |- mesh__publicMeSHNote mesh__D015390 89   
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D015390 2006
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D023822 2006
% 224.69/224.84  |- skos__broader mesh__D023822smesh__D046508
% 224.69/224.84  |- skos__related mesh__D023822smesh__D009940
% 224.69/224.84  |- skos__prefLabel mesh__D023822 Tissue Engineering
% 224.69/224.84  |- rdf__type mesh__D023822sskos__Concept
% 224.69/224.84  |- skos__scopeNote mesh__D023822
% 224.69/224.84       Generating tissue in vitro for clinical applications, such as replacing wounded tissues or impaired organs. A cell culture facility is required for cell harvest and expansion.%A%    
% 224.69/224.84  |- skos__hiddenLabel mesh__D023822 Engineering, Tissue
% 224.69/224.84  |- mesh__recordOriginator mesh__D023822 lkt
% 224.69/224.84  |- mesh__publicMeSHNote mesh__D023822 2002   
% 224.69/224.84  |- mesh__historyNote mesh__D023822 2002   
% 224.69/224.84  |- skos__historyNote mesh__D023822 Tissue Culture %28%1967-2001%29%
% 224.69/224.84  |- mesh__dateEstablished mesh__D023822 2002-01-01
% 224.69/224.84  |- skos__related mesh__D023822smesh__D009924
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D023822 2005
% 224.69/224.84  |- mesh__dateRevised mesh__D023822 2004-07-13
% 224.69/224.84  |- mesh__recordAuthorizer mesh__D023822 sjn
% 224.69/224.84  |- mesh__recordMaintainer mesh__D023822 sjn
% 224.69/224.84  |- mesh__dateCreated mesh__D023822 2001-07-25
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D009353 2006
% 224.69/224.84  |- skos__scopeNote mesh__D009353
% 224.69/224.84       An antitumor isolate from the culture filtrate of the F-41 variant of Streptomyces carzinostaticus. It is a protein of known amino acid sequence with a molecular weight of approximately 11,500 and possessing a regulatory function on the metabolism of DNA. In this process, that is first an inhibition of DNA biosynthesis followed by the degradation of DNA, zinostatin functions in a manner analogous to that of the much higher molecular weight antibiotic MITOMYCIN. Zinostatin is also a potent cytostatic agent active against gram-positive organisms.%A%    
% 224.69/224.84  |- skos__annotation mesh__D009353 an antineoplastic antibiotic   
% 224.69/224.84  |- skos__historyNote mesh__D009353
% 224.69/224.84       Antibiotics, Antineoplastic %28%1971-1974%29%
% 224.69/224.84  |- mesh__onlineNote mesh__D009353
% 224.69/224.84       use ZINOSTATIN to search NEOCARZINOSTATIN 1975-92   
% 224.69/224.84  |- mesh__dateCreated mesh__D009353 1974-11-19
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D009353 2002
% 224.69/224.84  |- mesh__dateRevised mesh__D009353 1996-06-10
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D009353 2005
% 224.69/224.84  |- skos__altLabel mesh__D009353 Neocarzinostatin
% 224.69/224.84  |- skos__prefLabel mesh__D009353 Zinostatin
% 224.69/224.84  |- skos__broader mesh__D009353smesh__D001426
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D009353 2004
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D009353 2001
% 224.69/224.84  |- skos__historyNote mesh__D009353 Bacterial Proteins %28%1974%29%
% 224.69/224.84  |- mesh__dateEstablished mesh__D009353 1991-01-01
% 224.69/224.84  |- rdf__type mesh__D009353sskos__Concept
% 224.69/224.84  |- mesh__recordAuthorizer mesh__D009353 sjn
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D009353 2003
% 224.69/224.84  |- mesh__recordMaintainer mesh__D009353 sjn
% 224.69/224.84  |- mesh__historyNote mesh__D009353
% 224.69/224.84       93; was NEOCARZINOSTATIN 1975-92 %28%see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90%29%%A%  
% 224.69/224.84  |- mesh__recordOriginator mesh__D009353 NLM
% 224.69/224.84  |- mesh__publicMeSHNote mesh__D009353
% 224.69/224.84       93; was NEOCARZINOSTATIN 1975-92 %28%see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90%29%%A%  
% 224.69/224.84  |- mesh__dateEstablished mesh__D001370 1972-01-01
% 224.69/224.84  |- mesh__dateCreated mesh__D001370 1999-01-01
% 224.69/224.84  |- skos__hiddenLabel mesh__D001370 Transport, Axonal
% 224.69/224.84  |- skos__altLabel mesh__D001370 Axoplasmic Transport
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D001370 2005
% 224.69/224.84  |- skos__hiddenLabel mesh__D001370 Axonal Transports
% 224.69/224.84  |- skos__hiddenLabel mesh__D001370 Streaming, Axoplasmic
% 224.69/224.84  |- skos__broader mesh__D001370smesh__D009424
% 224.69/224.84  |- skos__hiddenLabel mesh__D001370 Axoplasmic Flows
% 224.69/224.84  |- mesh__historyNote mesh__D001370
% 224.69/224.84       96; was AXOPLASMIC FLOW 1972-95 %28%Prov 1969-71%29%   
% 224.69/224.84  |- rdf__type mesh__D001370sskos__Concept
% 224.69/224.84  |- skos__historyNote mesh__D001370 Axons %28%1966-1968%29%
% 224.69/224.84  |- skos__broader mesh__D001370smesh__D003595
% 224.69/224.84  |- mesh__dateRevised mesh__D001370 2003-07-09
% 224.69/224.84  |- skos__altLabel mesh__D001370 Axoplasmic Streaming
% 224.69/224.84  |- skos__scopeNote mesh__D001370
% 224.69/224.84       The directed transport of ORGANELLES and molecules along nerve cell AXONS. Transport can be anterograde %28%from the cell body%29% or retrograde %28%toward the cell body%29%. %28%Alberts et al., Molecular Biology of the Cell, 3d ed, pG3%29%%A%    
% 224.69/224.84  |- mesh__publicMeSHNote mesh__D001370 96; was AXOPLASMIC FLOW 1972-95   
% 224.69/224.84  |- skos__hiddenLabel mesh__D001370 Transports, Axoplasmic
% 224.69/224.84  |- mesh__recordAuthorizer mesh__D001370 sjn
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D001370 2004
% 224.69/224.84  |- skos__hiddenLabel mesh__D001370 Axoplasmic Transports
% 224.69/224.84  |- skos__prefLabel mesh__D001370 Axonal Transport
% 224.69/224.84  |- skos__hiddenLabel mesh__D001370 Transport, Axoplasmic
% 224.69/224.84  |- mesh__recordMaintainer mesh__D001370 nns
% 224.69/224.84  |- skos__historyNote mesh__D001370 Cytoplasmic Streaming %28%1967-1968%29%
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D001370 2006
% 224.69/224.84  |- skos__hiddenLabel mesh__D001370 Transports, Axonal
% 224.69/224.84  |- mesh__recordOriginator mesh__D001370 NLM
% 224.69/224.84  |- skos__scopeNote mesh__D042787
% 224.69/224.84       A TIE receptor tyrosine kinase that is found almost exclusively on ENDOTHELIAL CELLS. It is required for both normal embryonic vascular development %28%NEOVASCULARIZATION, PHYSIOLOGIC%29% and tumor angiogenesis %28%NEOVASCULARIZATION, PATHOLOGIC%29%.%A%    
% 224.69/224.84  |- skos__altLabel mesh__D042787 Tie2 Receptor
% 224.69/224.84  |- skos__hiddenLabel mesh__D042787 Receptor, Tek
% 224.69/224.84  |- skos__annotation mesh__D042787 see SCR for organism-specific terms   
% 224.69/224.84  |- skos__altLabel mesh__D042787 TIE-2 Receptor Tyrosine Kinase
% 224.69/224.84  |- mesh__publicMeSHNote mesh__D042787
% 224.69/224.84       2004; TIE-2 RECEPTOR TYROSINE KINASE %28%now RECEPTOR TIE-2%29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1994-2004 %26% under PROTEIN-TYROSINE KINASE 1993%A%  
% 224.69/224.84  |- skos__hiddenLabel mesh__D042787 Tie-2, Angiopoietin Receptor
% 224.69/224.84  |- skos__prefLabel mesh__D042787 Receptor, TIE-2
% 224.69/224.84  |- skos__hiddenLabel mesh__D042787 TIE-2 Receptor
% 224.69/224.84  |- skos__hiddenLabel mesh__D042787 Tyrosine Kinase, TIE2
% 224.69/224.84  |- skos__hiddenLabel mesh__D042787 Receptor Tie-2, Angiopoietin
% 224.69/224.84  |- mesh__dateRevised mesh__D042787 2005-06-30
% 224.69/224.84  |- mesh__historyNote mesh__D042787
% 224.69/224.84       2004; use RECEPTOR TIE-2 %28%NM%29% 1993-2003   
% 224.69/224.84  |- skos__altLabel mesh__D042787 Angiopoietin Receptor Tie-2
% 224.69/224.84  |- skos__hiddenLabel mesh__D042787 Receptor, Tie2
% 224.69/224.84  |- rdf__type mesh__D042787sskos__Concept
% 224.69/224.84  |- skos__hiddenLabel mesh__D042787 Angiopoietin Receptor Tie 2
% 224.69/224.84  |- mesh__recordOriginator mesh__D042787 jmp
% 224.69/224.84  |- skos__historyNote mesh__D042787 Protein-Tyrosine Kinase %28%1993%29%
% 224.69/224.84  |- mesh__dateCreated mesh__D042787 2003-07-09
% 224.69/224.84  |- skos__altLabel mesh__D042787 TIE-2-RTK
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D042787 2006
% 224.69/224.84  |- skos__hiddenLabel mesh__D042787 TIE 2 Receptor Tyrosine Kinase
% 224.69/224.84  |- mesh__dateEstablished mesh__D042787 2004-01-01
% 224.69/224.84  |- skos__hiddenLabel mesh__D042787 Receptor, TIE 2
% 224.69/224.84  |- skos__altLabel mesh__D042787 Tek Receptor
% 224.69/224.84  |- skos__broader mesh__D042787smesh__D042764
% 224.69/224.84  |- skos__historyNote mesh__D042787
% 224.69/224.84       Receptor Protein-Tyrosine Kinases %28%1994-2003%29%
% 224.69/224.84  |- mesh__recordAuthorizer mesh__D042787 sjn
% 224.69/224.84  |- skos__altLabel mesh__D042787 TIE2 Tyrosine Kinase
% 224.69/224.84  |- mesh__recordMaintainer mesh__D042787 jmp
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D014298 2006
% 224.69/224.84  |- mesh__dateCreated mesh__D014298 1974-11-14
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D014298 1994
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D014298 1993
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D014298 2005
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D014298 2004
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D014298 1999
% 224.69/224.84  |- mesh__publicMeSHNote mesh__D014298
% 224.69/224.84       91; was see under TRIALKYLTIN COMPOUNDS 1975-90   
% 224.69/224.84  |- mesh__historyNote mesh__D014298
% 224.69/224.84       91%28%75%29%; was see under TRIALKYLTIN COMPOUNDS 1975-90   
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D014298 2002
% 224.69/224.84  |- skos__prefLabel mesh__D014298 Trimethyltin Compounds
% 224.69/224.84  |- skos__historyNote mesh__D014298 Tin %28%1972-1974%29%
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D014298 2003
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D014298 1998
% 224.69/224.84  |- skos__hiddenLabel mesh__D014298 Compounds, Trimethyltin
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D014298 1997
% 224.69/224.84  |- skos__historyNote mesh__D014298
% 224.69/224.84       Organometallic Compounds %28%1972-1974%29%
% 224.69/224.84  |- mesh__recordMaintainer mesh__D014298 TAP
% 224.69/224.84  |- mesh__recordAuthorizer mesh__D014298 PLS
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D014298 1996
% 224.69/224.84  |- skos__broader mesh__D014298smesh__D014220
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D014298 2001
% 224.69/224.84  |- mesh__dateEstablished mesh__D014298 1991-01-01
% 224.69/224.84  |- rdf__type mesh__D014298sskos__Concept
% 224.69/224.84  |- skos__annotation mesh__D014298 DF: TRIMETHYLTIN CPDS   
% 224.69/224.84  |- mesh__dateRevised mesh__D014298 1992-05-20
% 224.69/224.84  |- mesh__recordOriginator mesh__D014298 NLM
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D014298 1995
% 224.69/224.84  |- skos__scopeNote mesh__D014298
% 224.69/224.84       Organic compounds composed of tin and three methyl groups. Affect mitochondrial metabolism and inhibit oxidative phosphorylation by acting directly on the energy conserving processes.%A%    
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D014298 2000
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D019781 2003
% 224.69/224.84  |- skos__hiddenLabel mesh__D019781 Corneal Topographies
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D019781 2000
% 224.69/224.84  |- skos__hiddenLabel mesh__D019781 Topographies, Corneal
% 224.69/224.84  |- skos__scopeNote mesh__D019781
% 224.69/224.84       Measurement of the anterior surface of the cornea, its curvature and shape. It is used often to diagnose keratoconus and other corneal diseases, and corneal changes after keratotomy and keratoplasty. A significant application is in the fitting of contact lenses. In performing corneal topography, many different techniques can be employed: keratometry, keratoscopy, photokeratoscopy, profile photography, computer-assisted image processing, videokeratography, etc.%A%    
% 224.69/224.84  |- mesh__dateRevised mesh__D019781 1998-06-10
% 224.69/224.84  |- skos__historyNote mesh__D019781 Cornea/pathology %28%1983-1997%29%
% 224.69/224.84  |- mesh__recordOriginator mesh__D019781 TGC
% 224.69/224.84  |- mesh__recordMaintainer mesh__D019781 AGS
% 224.69/224.84  |- skos__historyNote mesh__D019781
% 224.69/224.84       Cornea/anatomy %26% histology %28%1975-1997%29%
% 224.69/224.84  |- skos__annotation mesh__D019781 DF: CORNEAL TOPOGR   
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D019781 2006
% 224.69/224.84  |- mesh__dateCreated mesh__D019781 1997-06-20
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D019781 1999
% 224.69/224.84  |- mesh__recordAuthorizer mesh__D019781 SJN
% 224.69/224.84  |- rdf__type mesh__D019781sskos__Concept
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D019781 2005
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D019781 2002
% 224.69/224.84  |- mesh__dateEstablished mesh__D019781 1998-01-01
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D019781 2004
% 224.69/224.84  |- skos__altLabel mesh__D019781 Topography, Corneal
% 224.69/224.84  |- skos__broader mesh__D019781smesh__D003941
% 224.69/224.84  |- mesh__publicMeSHNote mesh__D019781 98   
% 224.69/224.84  |- skos__prefLabel mesh__D019781 Corneal Topography
% 224.69/224.84  |- skos__hiddenLabel mesh__D019781 Videokeratographies
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D019781 2001
% 224.69/224.84  |- mesh__historyNote mesh__D019781 98   
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D000278 2003
% 224.69/224.84  |- skos__altLabel mesh__D000278 Buccal Drug Administration
% 224.69/224.84  |- mesh__recordMaintainer mesh__D000278 TGC
% 224.69/224.84  |- mesh__dateCreated mesh__D000278 1987-05-07
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D000278 1994
% 224.69/224.84  |- skos__hiddenLabel mesh__D000278 Administration, Buccal Drug
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D000278 2004
% 224.69/224.84  |- skos__altLabel mesh__D000278 Buccal Administration
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D000278 1998
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D000278 1995
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D000278 2000
% 224.69/224.84  |- skos__hiddenLabel mesh__D000278 Administrations, Buccal
% 224.69/224.84  |- mesh__recordOriginator mesh__D000278 SCD
% 224.69/224.84  |- skos__hiddenLabel mesh__D000278 Buccal Administrations
% 224.69/224.84  |- mesh__dateRevised mesh__D000278 1991-05-12
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D000278 1999
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D000278 2001
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D000278 1992
% 224.69/224.84  |- skos__historyNote mesh__D000278 Cheek %28%1966-1987%29%
% 224.69/224.84  |- mesh__dateEstablished mesh__D000278 1988-01-01
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D000278 2005
% 224.69/224.84  |- mesh__publicMeSHNote mesh__D000278 88   
% 224.69/224.84  |- skos__historyNote mesh__D000278
% 224.69/224.84       Administration, Topical %28%1975-1987%29%
% 224.69/224.84  |- skos__hiddenLabel mesh__D000278 Buccal Drug Administrations
% 224.69/224.84  |- skos__prefLabel mesh__D000278 Administration, Buccal
% 224.69/224.84  |- mesh__recordAuthorizer mesh__D000278 PLS
% 224.69/224.84  |- skos__scopeNote mesh__D000278
% 224.69/224.84       Administration of a soluble dosage form between the cheek and gingiva. It may involve direct application of a drug onto the buccal mucosa, as by painting or spraying.%A%    
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D000278 1996
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D000278 1993
% 224.69/224.84  |- skos__historyNote mesh__D000278 Administration, Oral %28%1971-1987%29%
% 224.69/224.84  |- skos__broader mesh__D000278smesh__D000284
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D000278 2006
% 224.69/224.84  |- rdf__type mesh__D000278sskos__Concept
% 224.69/224.84  |- skos__altLabel mesh__D000278 Drug Administration, Buccal
% 224.69/224.84  |- mesh__historyNote mesh__D000278 88   
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D000278 2002
% 224.69/224.84  |- skos__hiddenLabel mesh__D000278 Drug Administrations, Buccal
% 224.69/224.84  |- skos__annotation mesh__D000278
% 224.69/224.84       NIM but only if discussed: do not index here routinely for every buccally administered drug; no qualif%A%  
% 224.69/224.84  |- skos__broader mesh__D000278smesh__D000287
% 224.69/224.84  |- mesh__activeMeSHYear mesh__D000278 1997
% 224.69/224.84  |- skos__hiddenLabel mesh__D000278 Administrations, Buccal Drug
% 224.69/224.84  |- skos__hiddenLabel mesh__D005761 Porcine Transmissible Gastroenteritides
% 224.69/224.84  |- skos__altLabel mesh__D005761 Porcine Transmissible Gastroenteritis
% 224.69/224.84  |- skos__hiddenLabel mesh__D005761 Porcine Gastroenteritides, Transmissible
% 224.69/224.84  |- skos__hiddenLabel mesh__D005761 Gastroenteritides, Porcine Transmissible
% 224.69/224.84  |- mesh__recordAuthorizer mesh__D005761 sjn
% 224.69/224.84  |- skos__prefLabel mesh__D005761 Gastroenteritis, Transmissible, of Swine
% 224.69/224.84  |- skos__broader mesh__D005761smesh__D018352
% 224.69/224.84  |- skos__broader mesh__D005761smesh__D013553
% 224.69/224.84  |- skos__hiddenLabel mesh__D005761 Transmissible Porcine Gastroenteritis
% 224.69/224.84  |- skos__altLabel mesh__D005761 Gastroenteritis, Transmissible, Porcine
% 224.69/224.84  |- mesh__dateCreated mesh__D005761 1999-01-01
% 224.69/224.84  |- mesh__recordOriginator mesh__D005761 NLM
% 224.69/224.84  |- skos__hiddenLabel mesh__D005761 Gastroenteritides, Swine Transmissible
% 224.69/224.84  |- skos__hiddenLabel mesh__D005761 Transmissible Gastroenteritides, Swine
% 224.69/224.84  |- skos__hiddenLabel mesh__D005761 Swine Transmissible Gastroenteritides
% 224.69/224.84  |- skos__hiddenLabel mesh__D005761 Transmissible Gastroenteritis, Swine
% 224.69/224.84  |- skos__hiddenLabel mesh__D005761 Gastroenteritides, Transmissible Porcine
% 224.69/224.84  |- rdf__type mesh__D005761sskos__Concept
% 224.69/224.84  |- skos__altLabel mesh__D005761 Transmissible Gastroenteritis of Swine
% 224.69/224.85  |- skos__scopeNote mesh__D005761
% 224.69/224.85       A condition of chronic gastroenteritis in adult pigs and fatal gastroenteritis in piglets caused by a CORONAVIRUS.%A%    
% 224.69/224.85  |- mesh__historyNote mesh__D005761 70   
% 224.69/224.85  |- skos__altLabel mesh__D005761 Porcine Gastroenteritis, Transmissible
% 224.69/224.85  |- skos__historyNote mesh__D005761 Swine Diseases %28%1966-1969%29%
% 224.69/224.85  |- mesh__publicMeSHNote mesh__D005761 70   
% 224.69/224.85  |- mesh__dateRevised mesh__D005761 2005-06-30
% 224.69/224.85  |- skos__hiddenLabel mesh__D005761 Gastroenteritis, Transmissible Porcine
% 224.69/224.85  |- skos__hiddenLabel mesh__D005761 Transmissible Gastroenteritis, Porcine
% 224.69/224.85  |- skos__hiddenLabel mesh__D005761 Transmissible Gastroenteritides, Porcine
% 224.69/224.85  |- skos__hiddenLabel mesh__D005761 Transmissible Porcine Gastroenteritides
% 224.69/224.85  |- mesh__dateEstablished mesh__D005761 1970-01-01
% 224.69/224.85  |- skos__hiddenLabel mesh__D005761 Gastroenteritis, Swine Transmissible
% 224.69/224.85  |- skos__hiddenLabel mesh__D005761 Gastroenteritis, Porcine Transmissible
% 224.69/224.85  |- skos__altLabel mesh__D005761 Swine Transmissible Gastroenteritis
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D005761 2006
% 224.69/224.85  |- mesh__recordMaintainer mesh__D005761 ags
% 224.69/224.85  |- skos__annotation mesh__D005761
% 224.69/224.85       a specific disease caused by a coronavirus; don%27%t forget also SWINE %28%NIM%29% and check tag ANIMALS; DF: GASTROENTERITIS TRANSM SWINE%A%  
% 224.69/224.85  |- mesh__recordAuthorizer mesh__D018689 sjn
% 224.69/224.85  |- skos__broader mesh__D018689smesh__D018373
% 224.69/224.85  |- mesh__dateCreated mesh__D018689 1994-06-03
% 224.69/224.85  |- rdf__type mesh__D018689sskos__Concept
% 224.69/224.85  |- skos__hiddenLabel mesh__D018689 Drugs, Sensory System
% 224.69/224.85  |- skos__hiddenLabel mesh__D018689 Agents, Sensory System
% 224.69/224.85  |- mesh__recordMaintainer mesh__D018689 ssb
% 224.69/224.85  |- mesh__historyNote mesh__D018689 98; use explode 1995-97   
% 224.69/224.85  |- mesh__publicMeSHNote mesh__D018689 98   
% 224.69/224.85  |- skos__annotation mesh__D018689
% 224.69/224.85       GEN or unspecified; prefer specific groups or specific drugs; consider also RECEPTORS, SENSORY /drug eff %26% SENSATION /drug eff%A%  
% 224.69/224.85  |- skos__hiddenLabel mesh__D018689 System Agents, Sensory
% 224.69/224.85  |- mesh__dateRevised mesh__D018689 2005-06-30
% 224.69/224.85  |- mesh__recordOriginator mesh__D018689 TPW
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D018689 2006
% 224.69/224.85  |- skos__altLabel mesh__D018689 Sensory System Drugs
% 224.69/224.85  |- skos__hiddenLabel mesh__D018689 System Drugs, Sensory
% 224.69/224.85  |- mesh__dateEstablished mesh__D018689 1998-01-01
% 224.69/224.85  |- skos__prefLabel mesh__D018689 Sensory System Agents
% 224.69/224.85  |- skos__scopeNote mesh__D018689
% 224.69/224.85       Drugs that act on neuronal sensory receptors resulting in an increase, decrease, or modification of afferent nerve activity. %28%From Smith and Reynard, Textbook of Pharmacology, 1991, p367%29%%A%    
% 224.69/224.85  |- mesh__dateRevised mesh__D004669 2001-07-25
% 224.69/224.85  |- skos__altLabel mesh__D004669 Encephalitis Virus, Tick-Borne
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D004669 2004
% 224.69/224.85  |- mesh__recordOriginator mesh__D004669 NLM
% 224.69/224.85  |- skos__prefLabel mesh__D004669 Encephalitis Viruses, Tick-Borne
% 224.69/224.85  |- skos__altLabel mesh__D004669 Viruses, Tick-Borne Encephalitis
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D004669 2003
% 224.69/224.85  |- skos__broader mesh__D004669smesh__D005416
% 224.69/224.85  |- skos__altLabel mesh__D004669 Tick-Borne Encephalitis Viruses
% 224.69/224.85  |- skos__scopeNote mesh__D004669
% 224.69/224.85       A subgroup of the genus FLAVIVIRUS that causes encephalitis and hemorrhagic fevers and is found in eastern and western Europe and the former Soviet Union. It is transmitted by TICKS and there is an associated milk-borne transmission from viremic cattle, goats, and sheep.%A%    
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D004669 2002
% 224.69/224.85  |- skos__altLabel mesh__D004669 Omsk hemorrhagic fever virus
% 224.69/224.85  |- mesh__recordMaintainer mesh__D004669 ags
% 224.69/224.85  |- mesh__dateEstablished mesh__D004669 1966-01-01
% 224.69/224.85  |- skos__broader mesh__D004669smesh__D004668
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D004669 2006
% 224.69/224.85  |- skos__hiddenLabel mesh__D004669 Tick Borne Encephalitis Viruses
% 224.69/224.85  |- mesh__dateCreated mesh__D004669 1999-01-01
% 224.69/224.85  |- skos__hiddenLabel mesh__D004669 Louping ill viruses
% 224.69/224.85  |- skos__annotation mesh__D004669 infection = ENCEPHALITIS, TICK-BORNE   
% 224.69/224.85  |- rdf__type mesh__D004669sskos__Concept
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D004669 2005
% 224.69/224.85  |- mesh__publicMeSHNote mesh__D004669
% 224.69/224.85       1966; for LANGAT VIRUS see LANGAT VIRUS 1991-1993, see FLAVIVIRUSES 1981-1990, see ARBOVIRUSES 1975-1980; for LOUPING ILL VIRUS see LOUPING ILL VIRUS 1991-1993, see ENCEPHALITIS VIRUSES, TICK-BORNE 1967-1990, see ARBOVIRUS 1965-1966, see ARBOVIRUSES 1963-1964; for POWASSAN VIRUS see POWASSAN VIRUS 1991-1993, see ENCEPHALITIS VIRUSES, TICK-BORNE 1975-1990; for KYASANUR FOREST DISEASE VIRUS see FLAVIVIRUSES 1986-1993, see FLAVIVIRUSES 1981-1985, see  ARBOVIRUSES 1975-80%A%  
% 224.69/224.85  |- skos__hiddenLabel mesh__D004669 Tick Borne encephalitis virus
% 224.69/224.85  |- mesh__recordAuthorizer mesh__D004669 sjn
% 224.69/224.85  |- skos__hiddenLabel mesh__D004669 Encephalitis Viruses, Tick Borne
% 224.69/224.85  |- skos__hiddenLabel mesh__D004669 Encephalitis Virus, Tick Borne
% 224.69/224.85  |- mesh__historyNote mesh__D004669 1966 %28%1965%29%   
% 224.69/224.85  |- mesh__historyNote mesh__D015391 89   
% 224.69/224.85  |- skos__hiddenLabel mesh__D015391 Gastroplasty, Vertical-Banded
% 224.69/224.85  |- skos__prefLabel mesh__D015391 Gastroplasty
% 224.69/224.85  |- rdf__type mesh__D015391sskos__Concept
% 224.69/224.85  |- mesh__dateEstablished mesh__D015391 1989-01-01
% 224.69/224.85  |- skos__historyNote mesh__D015391 Stomach/surgery %28%1966-1988%29%
% 224.69/224.85  |- mesh__recordOriginator mesh__D015391 RLS
% 224.69/224.85  |- mesh__dateCreated mesh__D015391 1988-06-06
% 224.69/224.85  |- skos__hiddenLabel mesh__D015391 Gastroplasty, Collis
% 224.69/224.85  |- skos__hiddenLabel mesh__D015391 Gastroplasties, Vertical-Banded
% 224.69/224.85  |- mesh__dateRevised mesh__D015391 2005-06-30
% 224.69/224.85  |- skos__broader mesh__D015391smesh__D050110
% 224.69/224.85  |- skos__hiddenLabel mesh__D015391 Vertical Banded Gastroplasty
% 224.69/224.85  |- mesh__recordMaintainer mesh__D015391 lkt
% 224.69/224.85  |- mesh__recordAuthorizer mesh__D015391 sjn
% 224.69/224.85  |- skos__hiddenLabel mesh__D015391 Vertical-Banded Gastroplasties
% 224.69/224.85  |- skos__scopeNote mesh__D015391
% 224.69/224.85       Surgical procedures involving the STOMACH and sometimes the lower ESOPHAGUS to correct anatomical defects, or to treat MORBID OBESITY by reducing the size of the stomach. There are several subtypes of bariatric gastroplasty, such as vertical banded gastroplasty, silicone ring vertical gastroplasty, and horizontal banded gastroplasty.%A%    
% 224.69/224.85  |- mesh__publicMeSHNote mesh__D015391 89   
% 224.69/224.85  |- skos__hiddenLabel mesh__D015391 Gastroplasties
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D015391 2006
% 224.69/224.85  |- skos__broader mesh__D015391smesh__D013505
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D009354 2005
% 224.69/224.85  |- mesh__recordOriginator mesh__D009354 NLM
% 224.69/224.85  |- skos__scopeNote mesh__D009354
% 224.69/224.85       Neodymium. An element of the rare earth family of metals. It has the atomic symbol Nd, atomic number 60, and atomic weight 144.24, and is used in industrial applications.%A%    
% 224.69/224.85  |- mesh__dateRevised mesh__D009354 2001-07-25
% 224.69/224.85  |- mesh__dateCreated mesh__D009354 1999-01-01
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D009354 2002
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D009354 2004
% 224.69/224.85  |- skos__prefLabel mesh__D009354 Neodymium
% 224.69/224.85  |- rdf__type mesh__D009354sskos__Concept
% 224.69/224.85  |- mesh__recordMaintainer mesh__D009354 jmp
% 224.69/224.85  |- skos__annotation mesh__D009354
% 224.69/224.85       a rare earth element; Nd-142; Nd-143, 145, 146, 148, 150 = NEODYMIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Nd-138-141, 144, 147, 149, 151 = NEODYMIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D009354 2003
% 224.69/224.85  |- skos__broader mesh__D009354smesh__D028581
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D009354 2006
% 224.69/224.85  |- mesh__recordAuthorizer mesh__D009354 sjn
% 224.69/224.85  |- mesh__dateCreated mesh__D001371 1974-11-11
% 224.69/224.85  |- mesh__recordAuthorizer mesh__D001371 sjn
% 224.69/224.85  |- mesh__dateEstablished mesh__D001371 1991-01-01
% 224.69/224.85  |- mesh__dateRevised mesh__D001371 2004-07-07
% 224.69/224.85  |- mesh__publicMeSHNote mesh__D001371
% 224.69/224.85       2005; see AY-9944 1991-2004; see CYCLOHEXANES 1975-1990   
% 224.69/224.85  |- skos__broader mesh__D001371smesh__D003510
% 224.69/224.85  |- mesh__recordOriginator mesh__D001371 NLM
% 224.69/224.85  |- skos__prefLabel mesh__D001371
% 224.69/224.85       trans-1,4-Bis%28%2-chlorobenzaminomethyl%29%cyclohexane Dihydrochloride
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D001371 2006
% 224.69/224.85  |- skos__historyNote mesh__D001371 Methylamines %28%1972-1974%29%
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D001371 2005
% 224.69/224.85  |- skos__hiddenLabel mesh__D001371 AY9944
% 224.69/224.85  |- skos__historyNote mesh__D001371 Benzyl Compounds %28%1972-1974%29%
% 224.69/224.85  |- skos__scopeNote mesh__D001371
% 224.69/224.85       An anticholesteremic agent that inhibits sterol biosynthesis in animals.%A%    
% 224.69/224.85  |- skos__hiddenLabel mesh__D001371 AY 9944
% 224.69/224.85  |- skos__historyNote mesh__D001371 Cyclohexanes %28%1968-1974%29%
% 224.69/224.85  |- mesh__historyNote mesh__D001371 2005%28%1975%29%   
% 224.69/224.85  |- mesh__recordMaintainer mesh__D001371 ssb
% 224.69/224.85  |- rdf__type mesh__D001371sskos__Concept
% 224.69/224.85  |- skos__broader mesh__D006967Q000139smesh__D006967
% 224.69/224.85  |- mesh__preferredCombination mesh__D006967Q000139smesh__D004342
% 224.69/224.85  |- rdf__type mesh__D006967Q000139smesh__CompoundConcept
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D014299 2006
% 224.69/224.85  |- mesh__publicMeSHNote mesh__D014299
% 224.69/224.85       91; was see under DIBENZAZEPINES 1975-90   
% 224.69/224.85  |- mesh__dateEstablished mesh__D014299 1991-01-01
% 224.69/224.85  |- skos__altLabel mesh__D014299 Trimeprimine
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D014299 2004
% 224.69/224.85  |- mesh__onlineNote mesh__D014299 search DIBENZAZEPINES 1968-74   
% 224.69/224.85  |- mesh__recordOriginator mesh__D014299 NLM
% 224.69/224.85  |- mesh__recordAuthorizer mesh__D014299 sjn
% 224.69/224.85  |- mesh__dateRevised mesh__D014299 2003-07-09
% 224.69/224.85  |- skos__scopeNote mesh__D014299
% 224.69/224.85       Tricyclic antidepressant similar to IMIPRAMINE, but with more antihistaminic and sedative properties.%A%    
% 224.69/224.85  |- mesh__historyNote mesh__D014299
% 224.69/224.85       91%28%75%29%; was see under DIBENZAZEPINES 1975-90   
% 224.69/224.85  |- skos__broader mesh__D014299smesh__D003984
% 224.69/224.85  |- mesh__recordMaintainer mesh__D014299 ssb
% 224.69/224.85  |- rdf__type mesh__D014299sskos__Concept
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D014299 2005
% 224.69/224.85  |- mesh__dateCreated mesh__D014299 1999-01-01
% 224.69/224.85  |- skos__prefLabel mesh__D014299 Trimipramine
% 224.69/224.85  |- skos__altLabel mesh__D014299
% 224.69/224.85       10,11 Dihydro-N,N,beta-trimethyl-5H-dibenz%28%b,f%29%azepine-5-propanamine
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D019782 2006
% 224.69/224.85  |- skos__hiddenLabel mesh__D019782 2 Amino 6 trifluoromethoxybenzothiazole
% 224.69/224.85  |- skos__broader mesh__D019782smesh__D013844
% 224.69/224.85  |- skos__broader mesh__D019782smesh__D052160
% 224.69/224.85  |- rdf__type mesh__D019782sskos__Concept
% 224.69/224.85  |- mesh__recordAuthorizer mesh__D019782 sjn
% 224.69/224.85  |- skos__historyNote mesh__D019782 Thiazoles %28%1986-1997%29%
% 224.69/224.85  |- skos__scopeNote mesh__D019782
% 224.69/224.85       A glutamate antagonist %28%RECEPTORS, GLUTAMATE%29% used as an anticonvulsant %28%ANTICONVULSANTS%29% and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.%A%    
% 224.69/224.85  |- mesh__publicMeSHNote mesh__D019782
% 224.69/224.85       98; RILUZOLE was indexed under THIAZOLES 1986-97   
% 224.69/224.85  |- mesh__historyNote mesh__D019782 98; use RILUZOLE %28%NM%29% 1986-97   
% 224.69/224.85  |- skos__altLabel mesh__D019782 2-Amino-6-trifluoromethoxybenzothiazole
% 224.69/224.85  |- mesh__dateRevised mesh__D019782 2005-06-30
% 224.69/224.85  |- skos__prefLabel mesh__D019782 Riluzole
% 224.69/224.85  |- mesh__recordMaintainer mesh__D019782 ssb
% 224.69/224.85  |- mesh__recordOriginator mesh__D019782 TPW
% 224.69/224.85  |- mesh__dateEstablished mesh__D019782 1998-01-01
% 224.69/224.85  |- mesh__dateCreated mesh__D019782 1997-06-20
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Administrations, Cutaneous
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Cutaneous Administrations
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D000279 2003
% 224.69/224.85  |- mesh__publicMeSHNote mesh__D000279 87   
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D000279 1994
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Administrations, Transdermal
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Administrations, Cutaneous Drug
% 224.69/224.85  |- skos__altLabel mesh__D000279 Skin Administration, Drug
% 224.69/224.85  |- skos__related mesh__D000279smesh__D012869
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D000279 2004
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D000279 1998
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D000279 2000
% 224.69/224.85  |- skos__annotation mesh__D000279
% 224.69/224.85       NIM but only if discussed: do not index here routinely for every cutaneously administered drug; no qualif%A%  
% 224.69/224.85  |- mesh__recordMaintainer mesh__D000279 jls
% 224.69/224.85  |- skos__altLabel mesh__D000279 Dermal Administration
% 224.69/224.85  |- skos__historyNote mesh__D000279
% 224.69/224.85       Administration, Topical %28%1966-1986%29%
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D000279 1995
% 224.69/224.85  |- skos__prefLabel mesh__D000279 Administration, Cutaneous
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Dermal Administrations
% 224.69/224.85  |- skos__altLabel mesh__D000279 Transcutaneous Administration
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Administration, Dermal Drug
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Drug Administrations, Cutaneous
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Administration, Percutaneous
% 224.69/224.85  |- skos__altLabel mesh__D000279 Dermal Drug Administration
% 224.69/224.85  |- skos__altLabel mesh__D000279 Drug Administration, Cutaneous
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Administrations, Percutaneous
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D000279 1999
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D000279 2001
% 224.69/224.85  |- skos__altLabel mesh__D000279 Cutaneous Administration
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Administrations, Dermal
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D000279 1992
% 224.69/224.85  |- skos__altLabel mesh__D000279 Skin Drug Administration
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D000279 2005A
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Dermal Drug Administrations
% 224.69/224.85  |- mesh__recordAuthorizer mesh__D000279 jls
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Percutaneous Administrations
% 224.69/224.85  |- mesh__historyNote mesh__D000279 87   
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D000279 2005
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Transcutaneous Administrations
% 224.69/224.85  |- skos__scopeNote mesh__D000279
% 224.69/224.85       The application of suitable drug dosage forms to the skin for either local or systemic effects.%A%    
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D000279 1996
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Skin Drug Administrations
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Administration, Cutaneous Drug
% 224.69/224.85  |- skos__altLabel mesh__D000279 Administration, Dermal
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Cutaneous Drug Administrations
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Skin Administrations, Drug
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Administrations, Transcutaneous
% 224.69/224.85  |- mesh__dateEstablished mesh__D000279 1987-01-01
% 224.69/224.85  |- skos__altLabel mesh__D000279 Administration, Transdermal
% 224.69/224.85  |- skos__altLabel mesh__D000279 Transdermal Administration
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D000279 1993
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Cutaneous Administrations, Drug
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Administrations, Dermal Drug
% 224.69/224.85  |- mesh__recordOriginator mesh__D000279 SH
% 224.69/224.85  |- rdf__type mesh__D000279sskos__Concept
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Drug Skin Administrations
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D000279 2006
% 224.69/224.85  |- skos__altLabel mesh__D000279 Drug Administration, Dermal
% 224.69/224.85  |- mesh__dateRevised mesh__D000279 2004-08-03
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D000279 2002
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Transdermal Administrations
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D000279 1997
% 224.69/224.85  |- mesh__dateCreated mesh__D000279 1986-06-25
% 224.69/224.85  |- skos__altLabel mesh__D000279 Cutaneous Administration, Drug
% 224.69/224.85  |- skos__altLabel mesh__D000279 Cutaneous Drug Administration
% 224.69/224.85  |- skos__broader mesh__D000279smesh__D000287
% 224.69/224.85  |- skos__hiddenLabel mesh__D000279 Drug Administrations, Dermal
% 224.69/224.85  |- mesh__dateCreated mesh__D005762 1999-01-01
% 224.69/224.85  |- skos__prefLabel mesh__D005762 Gastroenterology
% 224.69/224.85  |- rdf__type mesh__D005762sskos__Concept
% 224.69/224.85  |- mesh__dateRevised mesh__D005762 1993-06-04
% 224.69/224.85  |- mesh__recordMaintainer mesh__D005762 JLS
% 224.69/224.85  |- skos__broader mesh__D005762smesh__D007388
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D005762 1997
% 224.69/224.85  |- mesh__recordOriginator mesh__D005762 NLM
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D005762 1999
% 224.69/224.85  |- skos__annotation mesh__D005762 SPEC: SPEC qualif; DF: GASTROENTEROL   
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D005762 1996
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D005762 2002
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D005762 1995
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D005762 1998
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D005762 2004
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D005762 2001
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D005762 1994
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D005762 2006
% 224.69/224.85  |- skos__scopeNote mesh__D005762
% 224.69/224.85       A subspecialty of internal medicine concerned with the study of the physiology and diseases of the digestive system and related structures %28%esophagus, liver, gallbladder, and pancreas%29%.%A%    
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D005762 2003
% 224.69/224.85  |- skos__related mesh__D005762smesh__D005767
% 224.69/224.85  |- mesh__recordAuthorizer mesh__D005762 PLS
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D005762 2005
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D005762 2000
% 224.69/224.85  |- skos__annotation mesh__D015392
% 224.69/224.85       SPEC: TN 37; do not use as NIM coord for chemistry or chem struct of an inorganic chemical %28% = CHEMISTRY %28%NIM%29%%29%; as SPEC, qualif permitted; DF: CHEM INORG%A%  
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D015392 2004
% 224.69/224.85  |- rdf__type mesh__D015392sskos__Concept
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D015392 1998
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D015392 2002
% 224.69/224.85  |- skos__historyNote mesh__D015392 Chemistry %28%1966-1988%29%
% 224.69/224.85  |- mesh__dateEstablished mesh__D015392 1989-01-01
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D015392 1999
% 224.69/224.85  |- mesh__recordAuthorizer mesh__D015392 PLS
% 224.69/224.85  |- mesh__historyNote mesh__D015392 89   
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D015392 1996
% 224.69/224.85  |- mesh__dateRevised mesh__D015392 1993-06-02
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D015392 2000
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D015392 2005
% 224.69/224.85  |- skos__broader mesh__D015392smesh__D002621
% 224.69/224.85  |- skos__scopeNote mesh__D015392
% 224.69/224.85       A field of chemistry which pertains to chemical compounds or ions that do not contain the element carbon %28%with the exception of carbon dioxide and compounds containing a carbonate radical, e.g., calcium carbonate%29%.%A%    
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D015392 1997
% 224.69/224.85  |- skos__hiddenLabel mesh__D015392 Inorganic Chemistries
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D015392 2006
% 224.69/224.85  |- skos__prefLabel mesh__D015392 Chemistry, Inorganic
% 224.69/224.85  |- mesh__publicMeSHNote mesh__D015392 89   
% 224.69/224.85  |- mesh__recordMaintainer mesh__D015392 TAP
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D015392 2001
% 224.69/224.85  |- skos__altLabel mesh__D015392 Inorganic Chemistry
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D015392 1994
% 224.69/224.85  |- mesh__dateCreated mesh__D015392 1988-06-06
% 224.69/224.85  |- mesh__recordOriginator mesh__D015392 RLS
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D015392 2003
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D015392 1995
% 224.69/224.85  |- skos__hiddenLabel mesh__D015392 Chemistries, Inorganic
% 224.69/224.85  |- skos__scopeNote mesh__D009355
% 224.69/224.85       Antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C. It acts by inhibiting translation during protein synthesis.%A%    
% 224.69/224.85  |- rdf__type mesh__D009355sskos__Concept
% 224.69/224.85  |- skos__broader mesh__D009355smesh__D000617
% 224.69/224.85  |- mesh__recordAuthorizer mesh__D009355 sjn
% 224.69/224.85  |- mesh__dateRevised mesh__D009355 2005-06-30
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D009355 2006
% 224.69/224.85  |- mesh__recordOriginator mesh__D009355 NLM
% 224.69/224.85  |- skos__hiddenLabel mesh__D009355 Palmitate, Neomycin
% 224.69/224.85  |- skos__hiddenLabel mesh__D009355 Sulfate, Neomycin
% 224.69/224.85  |- skos__prefLabel mesh__D009355 Neomycin
% 224.69/224.85  |- skos__hiddenLabel mesh__D009355 Sulfate, Fradiomycin
% 224.69/224.85  |- mesh__recordMaintainer mesh__D009355 ssb
% 224.69/224.85  |- mesh__dateCreated mesh__D009355 1999-01-01
% 224.69/224.85  |- skos__altLabel mesh__D009355 Fradiomycin Sulfate
% 224.69/224.85  |- mesh__publicMeSHNote mesh__D001372 74   
% 224.69/224.85  |- skos__hiddenLabel mesh__D001372 Compounds, Aza
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D001372 1994
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D001372 2004
% 224.69/224.85  |- mesh__recordAuthorizer mesh__D001372 PLS
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D001372 2002
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D001372 2006
% 224.69/224.85  |- mesh__recordMaintainer mesh__D001372 TGC
% 224.69/224.85  |- skos__annotation mesh__D001372
% 224.69/224.85       do not confuse with AZO COMPOUNDS; DF: AZA CPDS   
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D001372 2003
% 224.69/224.85  |- mesh__historyNote mesh__D001372 74%28%72%29%   
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D001372 2001
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D001372 2005
% 224.69/224.85  |- mesh__dateCreated mesh__D001372 1999-01-01
% 224.69/224.85  |- mesh__recordOriginator mesh__D001372 NLM
% 224.69/224.85  |- mesh__dateEstablished mesh__D001372 1974-01-01
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D001372 2000
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D001372 1997
% 224.69/224.85  |- rdf__type mesh__D001372sskos__Concept
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D001372 1999
% 224.69/224.85  |- skos__prefLabel mesh__D001372 Aza Compounds
% 224.69/224.85  |- skos__broader mesh__D001372smesh__D009930
% 224.69/224.85  |- mesh__dateRevised mesh__D001372 1992-05-07
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D001372 1996
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D001372 1993
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D001372 1995
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D001372 1998
% 224.69/224.85  |- skos__historyNote mesh__D001372
% 224.69/224.85       specific parent compound %28%1972-1973%29%
% 224.69/224.85  |- rdf__type mesh__D019783sskos__Concept
% 224.69/224.85  |- mesh__dateEstablished mesh__D019783 1998-01-01
% 224.69/224.85  |- skos__hiddenLabel mesh__D019783 Technetium 99m DMSA
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D019783 2005
% 224.69/224.85  |- skos__hiddenLabel mesh__D019783 Dimercaptosuccinic Acid, Tc-99m
% 224.69/224.85  |- skos__hiddenLabel mesh__D019783 Acid, 99mTc-Dimercaptosuccinic
% 224.69/224.85  |- mesh__historyNote mesh__D019783
% 224.69/224.85       98; use TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID %28%NM%29% 1980-97%A%  
% 224.69/224.85  |- skos__broader mesh__D019783smesh__D004113
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D019783 2000
% 224.69/224.85  |- mesh__dateCreated mesh__D019783 1997-06-20
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D019783 2006
% 224.69/224.85  |- skos__historyNote mesh__D019783 Succimer %28%1980-1997%29%
% 224.69/224.85  |- skos__altLabel mesh__D019783 99mTc-Dimercaptosuccinic Acid
% 224.69/224.85  |- skos__annotation mesh__D019783 as label, use/diag use; DF: TC DMSA   
% 224.69/224.85  |- skos__hiddenLabel mesh__D019783 99mTc Dimercaptosuccinate
% 224.69/224.85  |- skos__altLabel mesh__D019783 99mTc-DMSA
% 224.69/224.85  |- skos__altLabel mesh__D019783 Technetium-99m-DMSA
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D019783 2001
% 224.69/224.85  |- skos__hiddenLabel mesh__D019783 Tc 99m Dimercaptosuccinic Acid
% 224.69/224.85  |- skos__historyNote mesh__D019783 Succinates %28%1977-1979%29%
% 224.69/224.85  |- skos__hiddenLabel mesh__D019783 99m Tc Dimercaptosuccinic Acid
% 224.69/224.85  |- skos__hiddenLabel mesh__D019783 Acid, Technetium-99m-Dimercaptosuccinic
% 224.69/224.85  |- skos__hiddenLabel mesh__D019783 99mTc DMSA
% 224.69/224.85  |- skos__scopeNote mesh__D019783
% 224.69/224.85       A nontoxic radiopharmaceutical that is used in the diagnostic imaging of the renal cortex.%A%    
% 224.69/224.85  |- skos__hiddenLabel mesh__D019783 Acid, Tc-99m Dimercaptosuccinic
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D019783 2002
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D019783 2003
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D019783 1998
% 224.69/224.85  |- skos__altLabel mesh__D019783 Tc-99m Dimercaptosuccinic Acid
% 224.69/224.85  |- skos__altLabel mesh__D019783 99m-Tc-Dimercaptosuccinic Acid
% 224.69/224.85  |- skos__altLabel mesh__D019783 Technetium Tc 99m Succimer
% 224.69/224.85  |- skos__broader mesh__D019783smesh__D015609
% 224.69/224.85  |- skos__historyNote mesh__D019783
% 224.69/224.85       Organotechnetium Compounds %28%1990-1997%29%
% 224.69/224.85  |- skos__hiddenLabel mesh__D019783 99mTc Dimercaptosuccinic Acid
% 224.69/224.85  |- skos__historyNote mesh__D019783 Sulfhydryl Compounds %28%1977-1989%29%
% 224.69/224.85  |- skos__hiddenLabel mesh__D019783 Acid, 99m-Tc-Dimercaptosuccinic
% 224.69/224.85  |- skos__altLabel mesh__D019783 Technetium-99m-Dimercaptosuccinic Acid
% 224.69/224.85  |- skos__altLabel mesh__D019783 99Tc-Succimer
% 224.69/224.85  |- skos__hiddenLabel mesh__D019783 Technetium 99m Dimercaptosuccinic Acid
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D019783 2004
% 224.69/224.85  |- mesh__publicMeSHNote mesh__D019783
% 224.69/224.85       98; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID was indexed under SUCCIMER 1980-97, ORGANOTECHNETIUM COMPOUNDS 1990-97, SULFHYDRYL COMPOUNDS 1977-89, ORGANOMETALLIC COMOUNDS 1977-89, %26% SUCCINATES 1977-79%A%  
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D019783 1999
% 224.69/224.85  |- skos__hiddenLabel mesh__D019783 99Tc Succimer
% 224.69/224.85  |- skos__historyNote mesh__D019783
% 224.69/224.85       Organometallic Compounds %28%1977-1989%29%
% 224.69/224.85  |- skos__prefLabel mesh__D019783 Technetium Tc 99m Dimercaptosuccinic Acid
% 224.69/224.85  |- skos__hiddenLabel mesh__D005763 Gastroenterostomies
% 224.69/224.85  |- skos__altLabel mesh__D005763 Billroth II Operation
% 224.69/224.85  |- skos__broader mesh__D005763smesh__D000714
% 224.69/224.85  |- skos__annotation mesh__D005763
% 224.69/224.85       restrict to specific internal surg procedure; do not confuse with GASTROSTOMY %26% ENTEROSTOMY %28%both artif external openings%29% or specifics %28%e.g. DUODENOSTOMY; ILEOSTOMY, etc.%29%%A%  
% 224.69/224.85  |- skos__hiddenLabel mesh__D005763 Procedure, Billroth I
% 224.69/224.85  |- skos__prefLabel mesh__D005763 Gastroenterostomy
% 224.69/224.85  |- mesh__dateRevised mesh__D005763 2005-06-30
% 224.69/224.85  |- skos__altLabel mesh__D005763 Billroth I
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D005763 2006
% 224.69/224.85  |- skos__hiddenLabel mesh__D005763 Procedure, Billroth II
% 224.69/224.85  |- skos__hiddenLabel mesh__D005763 Operation, Billroth I
% 224.69/224.85  |- mesh__recordMaintainer mesh__D005763 lkt
% 224.69/224.85  |- skos__scopeNote mesh__D005763
% 224.69/224.85       A variety of surgical reconstructive procedures devised to restore gastrointestinal continuity, The two major classes of reconstruction are the Billroth I %28%gastroduodenostomy%29% and Billroth II %28%gastrojejunostomy%29% procedures.%A%    
% 224.69/224.85  |- mesh__dateCreated mesh__D005763 1999-01-01
% 224.69/224.85  |- skos__hiddenLabel mesh__D005763 Operation, Billroth II
% 224.69/224.85  |- skos__broader mesh__D005763smesh__D013505
% 224.69/224.85  |- mesh__recordAuthorizer mesh__D005763 sjn
% 224.69/224.85  |- skos__altLabel mesh__D005763 Billroth I Operation
% 224.69/224.85  |- rdf__type mesh__D005763sskos__Concept
% 224.69/224.85  |- mesh__recordOriginator mesh__D005763 NLM
% 224.69/224.85  |- skos__altLabel mesh__D005763 Billroth II
% 224.69/224.85  |- mesh__recordOriginator mesh__D043882 jmp
% 224.69/224.85  |- mesh__activeMeSHYear mesh__D043882 2004
% 224.69/224.85  |- mesh__recordAuthorizer mesh__D043882 sjn
% 224.69/224.85  |- mesh__dateEstablished mesh__D043882 2004-01-01
% 224.69/224.85  |- skos__broader mesh__D043882smesh__D043562
% 224.69/224.85  |- mesh__historyNote mesh__D043882
% 224.69/224.85       2004; use RECEPTORS, CANNABINOID %28%NM%29% 1988-2003   
% 224.69/224.85  |- skos__altLabel mesh__D043882 Cannabinoid Receptor
% 224.69/224.85  |- rdf__type mesh__D043882sskos__Concept
% 224.69/224.85  |- mesh__recordMaintainer mesh__D043882 jmp
% 224.69/224.85  |- skos__scopeNote mesh__D043882
% 224.69/224.85       A class of G-protein-coupled receptors that are specific for CANNABINOIDS such as those derived from CANNABIS. They also bind a structurally distinct class of endogenous factors referred to as ENDOCANNABINOIDS. The receptor class may play a role in modulating the release of signaling molecules such as NEUROTRANSMITTERS and CYTOKINES.%A%    
% 224.69/224.85  |- skos__related mesh__D043882smesh__D043883
% 224.69/224.85  |- mesh__dateCreated mesh__D043882 2003-07-09
% 224.69/224.85  |- skos__hiddenLabel mesh__D043882 Receptor, Marijuana
% 224.69/224.86  |- skos__altLabel mesh__D043882 Cannabinoid Receptors
% 224.69/224.86  |- skos__prefLabel mesh__D043882 Receptors, Cannabinoid
% 224.69/224.86  |- skos__related mesh__D043882smesh__D002186
% 224.69/224.86  |- skos__hiddenLabel mesh__D043882 Receptor, Cannabinoid
% 224.69/224.86  |- skos__annotation mesh__D043882 note specific subtypes   
% 224.69/224.86  |- mesh__publicMeSHNote mesh__D043882
% 224.69/224.86       2004; CANNABINOID RECEPTORS was indexed under RECEPTORS, DRUG 1988-2003%A%  
% 224.69/224.86  |- skos__historyNote mesh__D043882 Receptors, Drug %28%1988-2003%29%
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D043882 2005
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D043882 2006
% 224.69/224.86  |- skos__historyNote mesh__D051516 Semen %28%1966-2005%29%
% 224.69/224.86  |- skos__historyNote mesh__D051516 Hemorrhage %28%1966-2005%29%
% 224.69/224.86  |- skos__historyNote mesh__D051516 Genital Diseases, Male %28%1970-2005%29%
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D051516 2006
% 224.69/224.86  |- mesh__recordAuthorizer mesh__D051516 sjn
% 224.69/224.86  |- skos__altLabel mesh__D051516 Hematospermia
% 224.69/224.86  |- mesh__dateCreated mesh__D051516 2005-06-30
% 224.69/224.86  |- mesh__dateEstablished mesh__D051516 2006-01-01
% 224.69/224.86  |- mesh__historyNote mesh__D051516 2006   
% 224.69/224.86  |- skos__prefLabel mesh__D051516 Hemospermia
% 224.69/224.86  |- mesh__recordMaintainer mesh__D051516 lkt
% 224.69/224.86  |- rdf__type mesh__D051516sskos__Concept
% 224.69/224.86  |- mesh__publicMeSHNote mesh__D051516 2006   
% 224.69/224.86  |- skos__broader mesh__D051516smesh__D005832
% 224.69/224.86  |- mesh__recordOriginator mesh__D051516 lkt
% 224.69/224.86  |- skos__scopeNote mesh__D051516
% 224.69/224.86       Blood in the SEMEN, usually due to INFLAMMATION of the PROSTATE, the SEMINAL VESICLES, or both.%A%    
% 224.69/224.86  |- mesh__dateEstablished mesh__D015393 1989-01-01
% 224.69/224.86  |- mesh__recordOriginator mesh__D015393 RLS
% 224.69/224.86  |- skos__hiddenLabel mesh__D015393 Bioinorganic Chemistries
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D015393 1999
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D015393 1996
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D015393 2005
% 224.69/224.86  |- skos__prefLabel mesh__D015393 Chemistry, Bioinorganic
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D015393 2002
% 224.69/224.86  |- skos__historyNote mesh__D015393 Chemistry %28%1966-1988%29%
% 224.69/224.86  |- skos__annotation mesh__D015393
% 224.69/224.86       SPEC: TN 37; do not use as NIM coord for chemistry or chem struct of a bioinorganic chemical %28% = CHEMISTRY %28%NIM%29%%29%; as SPEC, qualif permitted; DF: CHEM BIOINORG%A%  
% 224.69/224.86  |- skos__altLabel mesh__D015393 Bioinorganic Chemistry
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D015393 1997
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D015393 2006
% 224.69/224.86  |- mesh__publicMeSHNote mesh__D015393 89   
% 224.69/224.86  |- mesh__recordAuthorizer mesh__D015393 PLS
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D015393 1994
% 224.69/224.86  |- mesh__dateCreated mesh__D015393 1988-06-06
% 224.69/224.86  |- skos__broader mesh__D015393smesh__D015392
% 224.69/224.86  |- mesh__historyNote mesh__D015393 89   
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D015393 2003
% 224.69/224.86  |- mesh__dateRevised mesh__D015393 1993-06-02
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D015393 2000
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D015393 1995
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D015393 2004
% 224.69/224.86  |- skos__scopeNote mesh__D015393
% 224.69/224.86       A field of chemistry which pertains to the study of inorganic compounds or ions in biological systems.%A%    
% 224.69/224.86  |- rdf__type mesh__D015393sskos__Concept
% 224.69/224.86  |- skos__hiddenLabel mesh__D015393 Chemistries, Bioinorganic
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D015393 1998
% 224.69/224.86  |- mesh__recordMaintainer mesh__D015393 TAP
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D015393 2001
% 224.69/224.86  |- mesh__recordMaintainer mesh__D009356 TPW
% 224.69/224.86  |- skos__scopeNote mesh__D009356
% 224.69/224.86       Neon. A noble gas with the atomic symbol Ne, atomic number 10, and atomic weight 20.18. It is found in the earth%27%s crust and atmosphere as an inert, odorless gas and is used in vacuum tubes and incandescent lamps.%A%    
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D009356 1996
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D009356 2006
% 224.69/224.86  |- skos__broader mesh__D009356smesh__D005741
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D009356 2001
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D009356 2005
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D009356 1999
% 224.69/224.86  |- skos__prefLabel mesh__D009356 Neon
% 224.69/224.86  |- mesh__recordAuthorizer mesh__D009356 PLS
% 224.69/224.86  |- mesh__dateRevised mesh__D009356 1993-06-04
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D009356 2000
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D009356 1995
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D009356 1998
% 224.69/224.86  |- mesh__recordOriginator mesh__D009356 NLM
% 224.69/224.86  |- mesh__dateCreated mesh__D009356 1999-01-01
% 224.69/224.86  |- skos__annotation mesh__D009356
% 224.69/224.86       a rare gas; Ne-20; Ne-21, 22 = NEON %28%IM%29% + ISOTOPES %28%NIM%29%; Ne-17-19, 23, 24 = NEON %28%IM%29% + RADIOISOTOPES %28%IM%29%%A%  
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D009356 1994
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D009356 2004
% 224.69/224.86  |- rdf__type mesh__D009356sskos__Concept
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D009356 2002
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D009356 2003
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D009356 1997
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D001373 2005
% 224.69/224.86  |- mesh__recordMaintainer mesh__D001373 ssb
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D001373 2004
% 224.69/224.86  |- skos__scopeNote mesh__D001373
% 224.69/224.86       Diaza derivative of cholesterol which acts as a hypocholesteremic agent by blocking delta-24-reductase, which causes the accumulation of desmosterol.%A%    
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D001373 2006
% 224.69/224.86  |- mesh__recordOriginator mesh__D001373 RLS
% 224.69/224.86  |- mesh__historyNote mesh__D001373
% 224.69/224.86       91%28%78%29%; was see under CHOLESTEROL 1978-90   
% 224.69/224.86  |- skos__prefLabel mesh__D001373 Azacosterol
% 224.69/224.86  |- mesh__dateEstablished mesh__D001373 1991-01-01
% 224.69/224.86  |- skos__hiddenLabel mesh__D001373 12937, SC
% 224.69/224.86  |- skos__historyNote mesh__D001373 Cholesterol %28%1966-1977%29%
% 224.69/224.86  |- skos__historyNote mesh__D001373 Aza Compounds %28%1972-1977%29%
% 224.69/224.86  |- skos__hiddenLabel mesh__D001373 20,25 Diazacholesterol
% 224.69/224.86  |- rdf__type mesh__D001373sskos__Concept
% 224.69/224.86  |- skos__altLabel mesh__D001373 20,25-Diazacholesterol
% 224.69/224.86  |- mesh__dateRevised mesh__D001373 2003-07-09
% 224.69/224.86  |- mesh__recordAuthorizer mesh__D001373 sjn
% 224.69/224.86  |- skos__broader mesh__D001373smesh__D002784
% 224.69/224.86  |- mesh__dateCreated mesh__D001373 1977-04-15
% 224.69/224.86  |- mesh__publicMeSHNote mesh__D001373
% 224.69/224.86       91; was see under CHOLESTEROL 1978-90   
% 224.69/224.86  |- skos__hiddenLabel mesh__D001373 Dihydrochloride, Diazacholesterol
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D019784 2006
% 224.69/224.86  |- skos__altLabel mesh__D019784 Technetium Tc 99m Diethyl IDA
% 224.69/224.86  |- skos__altLabel mesh__D019784 99m-Tc-Diethyl IDA
% 224.69/224.86  |- mesh__dateEstablished mesh__D019784 1998-01-01
% 224.69/224.86  |- skos__hiddenLabel mesh__D019784 99mTc Diethyl IDA
% 224.69/224.86  |- skos__prefLabel mesh__D019784
% 224.69/224.86       Technetium Tc 99m Diethyl-iminodiacetic Acid
% 224.69/224.86  |- mesh__historyNote mesh__D019784
% 224.69/224.86       98; use TECHNETIUM TC 99M DIETHYL-IMINODIACETIC ACID %28%NM%29% 1977-97%A%  
% 224.69/224.86  |- skos__hiddenLabel mesh__D019784
% 224.69/224.86       Technetium Tc 99m Diethyl iminodiacetic Acid
% 224.69/224.86  |- skos__hiddenLabel mesh__D019784 99m Tc Diethyl IDA
% 224.69/224.86  |- skos__annotation mesh__D019784 as label, use/diag use; DF: TC EHIDA   
% 224.69/224.86  |- skos__hiddenLabel mesh__D019784 IDA, Tc-99m-Diethyl
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D019784 2005
% 224.69/224.86  |- skos__historyNote mesh__D019784 Acetanilides %28%1977-1979%29%
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D019784 2001
% 224.69/224.86  |- skos__hiddenLabel mesh__D019784 IDA, 99m-Tc-Diethyl
% 224.69/224.86  |- skos__hiddenLabel mesh__D019784 IDA, Technetium-99m-Diethyl
% 224.69/224.86  |- skos__altLabel mesh__D019784 99mTc-Diethyliminodiacetic Acid
% 224.69/224.86  |- mesh__publicMeSHNote mesh__D019784
% 224.69/224.86       98; TECHNETIUM TC 99M DIETHYL IDA %28%now TECHNETIUM TC 99M DIETHYL-IMINODIACETIC ACID%29% was indexed under IMINO ACIDS 1977-97, ORGANOTECHNETIUM COMPOUNDS 1990-97, ORGANOMETALLIC COMPOUNDS 1977-89, LIDOCAINE/analogs %26% derivatives 1979-80, %26% ACETANILIDES 1977-79%A%  
% 224.69/224.86  |- skos__hiddenLabel mesh__D019784 Tc 99m Diethyl IDA
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D019784 2000
% 224.69/224.86  |- skos__hiddenLabel mesh__D019784 IDA, 99mTc-Diethyl
% 224.69/224.86  |- mesh__dateCreated mesh__D019784 1997-06-20
% 224.69/224.86  |- skos__broader mesh__D019784smesh__D007098
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D019784 2004
% 224.69/224.86  |- skos__hiddenLabel mesh__D019784 99mTc EHIDA
% 224.69/224.86  |- skos__historyNote mesh__D019784
% 224.69/224.86       Organometallic Compounds %28%1977-1989%29%
% 224.69/224.86  |- skos__altLabel mesh__D019784 Tc-99m-Diethyl IDA
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D019784 1999
% 224.69/224.86  |- skos__altLabel mesh__D019784 Technetium Tc 99m Diethylacetanitanildo-IDA
% 224.69/224.86  |- skos__historyNote mesh__D019784 Imino Acids %28%1977-1997%29%
% 224.69/224.86  |- skos__historyNote mesh__D019784
% 224.69/224.86       Organotechnetium Compounds %28%1990-1997%29%
% 224.69/224.86  |- skos__hiddenLabel mesh__D019784 99mTc Diethyliminodiacetic Acid
% 224.69/224.86  |- rdf__type mesh__D019784sskos__Concept
% 224.69/224.86  |- skos__hiddenLabel mesh__D019784 Technetium 99m Diethyl IDA
% 224.69/224.86  |- skos__scopeNote mesh__D019784
% 224.69/224.86       A nontoxic radiopharmaceutical that is used in the clinical evaluation of hepatobiliary disorders in humans.%A%    
% 224.69/224.86  |- skos__altLabel mesh__D019784 99mTc-Diethyl IDA
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D019784 2003
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D019784 1998
% 224.69/224.86  |- skos__hiddenLabel mesh__D019784
% 224.69/224.86       Technetium Tc 99m Diethylacetanitanildo IDA
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D019784 2002
% 224.69/224.86  |- skos__historyNote mesh__D019784
% 224.69/224.86       Lidocaine/analogs %26% derivatives %28%1979-1980%29%
% 224.69/224.86  |- skos__altLabel mesh__D019784 99mTc-EHIDA
% 224.69/224.86  |- skos__altLabel mesh__D019784 Technetium-99m-Diethyl IDA
% 224.69/224.86  |- skos__hiddenLabel mesh__D019784 Acid, 99mTc-Diethyliminodiacetic
% 224.69/224.86  |- skos__broader mesh__D019784smesh__D015609
% 224.69/224.86  |- mesh__dateRevised mesh__D005764 2004-07-07
% 224.69/224.86  |- mesh__recordOriginator mesh__D005764 NLM
% 224.69/224.86  |- skos__related mesh__D005764smesh__D018662
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D005764 2006
% 224.69/224.86  |- skos__scopeNote mesh__D005764
% 224.69/224.86       Retrograde flow of gastric juice %28%GASTRIC ACID%29% and/or duodenal contents %28%BILE ACIDS; PANCREATIC JUICE%29% into the distal ESOPHAGUS, commonly due to incompetence of the LOWER ESOPHAGEAL SPHINCTER. Gastric regurgitation is an extension of this process with retrograde flow into the PHARYNX or MOUTH.%A%    
% 224.69/224.86  |- skos__hiddenLabel mesh__D005764 Reflux, Gastro-oesophageal
% 224.69/224.86  |- skos__altLabel mesh__D005764 Reflux, Gastroesophageal
% 224.69/224.86  |- mesh__dateEstablished mesh__D005764 1966-01-01
% 224.69/224.86  |- skos__related mesh__D005764smesh__D049630
% 224.69/224.86  |- skos__hiddenLabel mesh__D005764 Gastric Regurgitation
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D005764 2005
% 224.69/224.86  |- skos__hiddenLabel mesh__D005764 Gastro oesophageal Reflux
% 224.69/224.86  |- mesh__dateCreated mesh__D005764 1999-01-01
% 224.69/224.86  |- skos__altLabel mesh__D005764 Gastroesophageal Reflux Disease
% 224.69/224.86  |- skos__broader mesh__D005764smesh__D015154
% 224.69/224.86  |- skos__hiddenLabel mesh__D005764 Gastro Esophageal Reflux
% 224.69/224.86  |- rdf__type mesh__D005764sskos__Concept
% 224.69/224.86  |- skos__annotation mesh__D005764
% 224.69/224.86       note ESOPHAGITIS, REFLUX see ESOPHAGITIS, PEPTIC is available%A%  
% 224.69/224.86  |- skos__related mesh__D005764smesh__D006356
% 224.69/224.86  |- skos__altLabel mesh__D005764 Gastro-Esophageal Reflux
% 224.69/224.86  |- skos__altLabel mesh__D005764 GERD
% 224.69/224.86  |- mesh__recordMaintainer mesh__D005764 lkt
% 224.69/224.86  |- mesh__onlineNote mesh__D005764
% 224.69/224.86       use GASTROESOPHAGEAL REFLUX to search ESOPHAGEAL REFLUX 1966-83 %26% REGURGITATION, GASTRIC 1967-83%A%  
% 224.69/224.86  |- mesh__publicMeSHNote mesh__D005764
% 224.69/224.86       84; was ESOPHAGEAL REFLUX 1966-83; REGURGITATION, GASTRIC was see ESOPHAGEAL REFLUX 1979-83, was heading 1967-78%A%  
% 224.69/224.86  |- skos__altLabel mesh__D005764 Gastro-oesophageal Reflux
% 224.69/224.86  |- skos__altLabel mesh__D005764 Esophageal Reflux
% 224.69/224.86  |- mesh__historyNote mesh__D005764
% 224.69/224.86       84; was ESOPHAGEAL REFLUX 1964-83 %28%Prov 1964-65%29%; REGURGITATION, GASTRIC was see ESOPHAGEAL REFLUX 1979-83, was heading 1967-78%A%  
% 224.69/224.86  |- skos__hiddenLabel mesh__D005764 Reflux, Gastro-Esophageal
% 224.69/224.86  |- mesh__recordAuthorizer mesh__D005764 sjn
% 224.69/224.86  |- skos__prefLabel mesh__D005764 Gastroesophageal Reflux
% 224.69/224.86  |- skos__hiddenLabel mesh__D043883 Modulators, Cannabinoid Receptor
% 224.69/224.86  |- mesh__historyNote mesh__D043883
% 224.69/224.86       2004; use ENDOCANNABINOIDS %28%NM%29% 2002-2003   
% 224.69/224.86  |- skos__altLabel mesh__D043883 Endogenous Cannabinoids
% 224.69/224.86  |- mesh__recordAuthorizer mesh__D043883 sjn
% 224.69/224.86  |- skos__scopeNote mesh__D043883
% 224.69/224.86       Endogenous compounds that bind to CANNABINOID RECEPTORS. They are structurally different from the CANNABINOIDS which are primarily derived from plants.%A%    
% 224.69/224.86  |- skos__altLabel mesh__D043883 Cannabinoids, Endogenous
% 224.69/224.86  |- skos__hiddenLabel mesh__D043883 Receptor Modulators, Cannabinoid
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D043883 2006
% 224.69/224.86  |- skos__related mesh__D043883smesh__D043882
% 224.69/224.86  |- mesh__dateRevised mesh__D043883 2005-06-30
% 224.69/224.86  |- rdf__type mesh__D043883sskos__Concept
% 224.69/224.86  |- skos__altLabel mesh__D043883 Cannabinoid Receptor Modulators
% 224.69/224.86  |- skos__altLabel mesh__D043883 Endocannabinoid
% 224.69/224.86  |- mesh__dateEstablished mesh__D043883 2004-01-01
% 224.69/224.86  |- skos__prefLabel mesh__D043883 Endocannabinoids
% 224.69/224.86  |- skos__broader mesh__D043883smesh__D006728
% 224.69/224.86  |- mesh__dateCreated mesh__D043883 2003-07-09
% 224.69/224.86  |- mesh__publicMeSHNote mesh__D043883
% 224.69/224.86       2004; ENDOOCANNABINOIDS was indexed under FATTY ACIDS 2002-2003%A%  
% 224.69/224.86  |- skos__broader mesh__D043883smesh__D018377
% 224.69/224.86  |- skos__related mesh__D043883smesh__D002186
% 224.69/224.86  |- skos__historyNote mesh__D043883 Cannabinoids %28%1992-2003%29%
% 224.69/224.86  |- mesh__recordMaintainer mesh__D043883 ssb
% 224.69/224.86  |- mesh__recordOriginator mesh__D043883 jmp
% 224.69/224.86  |- mesh__dateRevised mesh__D010100 2001-07-25
% 224.69/224.86  |- skos__broader mesh__D010100smesh__D005740
% 224.69/224.86  |- skos__related mesh__D010100smesh__D000859
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D010100 2006
% 224.69/224.86  |- skos__scopeNote mesh__D010100
% 224.69/224.86       An element with atomic symbol O, atomic number 8, and atomic weight 16. It is the most abundant element on earth and essential for respiration.%A%    
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D010100 2002
% 224.69/224.86  |- mesh__recordOriginator mesh__D010100 NLM
% 224.69/224.86  |- mesh__dateCreated mesh__D010100 1999-01-01
% 224.69/224.86  |- mesh__recordAuthorizer mesh__D010100 sjn
% 224.69/224.86  |- skos__related mesh__D010100smesh__D018496
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D010100 2005
% 224.69/224.86  |- skos__annotation mesh__D010100
% 224.69/224.86       O-16; /metab; consider also OXYGEN CONSUMPTION; /physiol for O2 in pulm resp process but tissue resp = OXYGEN CONSUMPTION; /ther use; consider also OXYGEN INHALATION THERAPY or HYPERBARIC OXYGENATION; /tox %26% /pois; consider also HYPEROXIA%A%  
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D010100 2004
% 224.69/224.86  |- mesh__publicMeSHNote mesh__D010100
% 224.69/224.86       1963; DIOXYGEN was indexed under OXYGEN %28%NM%29% 1980-2001   
% 224.69/224.86  |- skos__prefLabel mesh__D010100 Oxygen
% 224.69/224.86  |- mesh__historyNote mesh__D010100
% 224.69/224.86       1963; for DIOXYGEN use OXYGEN %28%NM%29% 1980-2001   
% 224.69/224.86  |- rdf__type mesh__D010100sskos__Concept
% 224.69/224.86  |- skos__related mesh__D010100smesh__D000860
% 224.69/224.86  |- skos__related mesh__D010100smesh__D010103
% 224.69/224.86  |- skos__broader mesh__D010100smesh__D018011
% 224.69/224.86  |- mesh__recordMaintainer mesh__D010100 lkt
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D010100 2003
% 224.69/224.86  |- skos__related mesh__D010100smesh__D010104
% 224.69/224.86  |- skos__hiddenLabel mesh__D051517 Examinations, Digital Rectal
% 224.69/224.86  |- skos__hiddenLabel mesh__D051517 Palpation, Rectal
% 224.69/224.86  |- skos__hiddenLabel mesh__D051517 Rectal Examination, Digital
% 224.69/224.86  |- mesh__recordAuthorizer mesh__D051517 ags
% 224.69/224.86  |- rdf__type mesh__D051517sskos__Concept
% 224.69/224.86  |- skos__hiddenLabel mesh__D051517 Digital Rectal Examinations
% 224.69/224.86  |- mesh__publicMeSHNote mesh__D051517 2006   
% 224.69/224.86  |- skos__hiddenLabel mesh__D051517 Examination, Digital Rectal
% 224.69/224.86  |- skos__historyNote mesh__D051517 Palpation %28%1965-2005%29%
% 224.69/224.86  |- skos__historyNote mesh__D051517 Rectum %28%1965-2005%29%
% 224.69/224.86  |- skos__hiddenLabel mesh__D051517 Rectal Examinations, Digital
% 224.69/224.86  |- mesh__recordMaintainer mesh__D051517 ags
% 224.69/224.86  |- mesh__recordOriginator mesh__D051517 lkt
% 224.69/224.86  |- skos__prefLabel mesh__D051517 Digital Rectal Examination
% 224.69/224.86  |- mesh__dateRevised mesh__D051517 2005-07-27
% 224.69/224.86  |- skos__hiddenLabel mesh__D051517 Rectal Palpations
% 224.69/224.86  |- mesh__dateEstablished mesh__D051517 2006-01-01
% 224.69/224.86  |- skos__hiddenLabel mesh__D051517 Palpations, Rectal
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D051517 2006
% 224.69/224.86  |- skos__broader mesh__D051517smesh__D010173
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D051517 2006B
% 224.69/224.86  |- mesh__dateCreated mesh__D051517 2005-06-30
% 224.69/224.86  |- skos__altLabel mesh__D051517 Rectal Palpation
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D051517 2006A
% 224.69/224.86  |- skos__scopeNote mesh__D051517
% 224.69/224.86       A physical examination in which the qualified health care worker inserts a lubricated, gloved finger of one hand into the RECTUM and may use the other hand to press on the lower ABDOMEN or pelvic area to palpate for abnormalities in the lower rectum, and nearby organs or tissues. The method is commonly used to check the lower rectum, the PROSTATE gland in men, and the UTERUS and OVARIES in women.%A%    
% 224.69/224.86  |- mesh__historyNote mesh__D051517 2006   
% 224.69/224.86  |- mesh__historyNote mesh__D015394 89   
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D015394 2006
% 224.69/224.86  |- mesh__publicMeSHNote mesh__D015394 89   
% 224.69/224.86  |- mesh__recordMaintainer mesh__D015394 mdb
% 224.69/224.86  |- mesh__dateCreated mesh__D015394 1988-06-06
% 224.69/224.86  |- mesh__recordOriginator mesh__D015394 RLS
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D015394 2003
% 224.69/224.86  |- skos__hiddenLabel mesh__D015394 Structures, Molecular
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D015394 2004
% 224.69/224.86  |- skos__hiddenLabel mesh__D015394 Molecular Structures
% 224.69/224.86  |- skos__prefLabel mesh__D015394 Molecular Structure
% 224.69/224.86  |- rdf__type mesh__D015394sskos__Concept
% 224.69/224.86  |- mesh__recordAuthorizer mesh__D015394 sjn
% 224.69/224.86  |- skos__historyNote mesh__D015394 Chemistry %28%1966-1988%29%
% 224.69/224.86  |- skos__related mesh__D015394smesh__D008958
% 224.69/224.86  |- mesh__dateEstablished mesh__D015394 1989-01-01
% 224.69/224.86  |- skos__annotation mesh__D015394
% 224.69/224.86       almost never IM; do not confuse with MOLECULAR CONFORMATION; AMINO ACID SEQUENCE; BASE SEQUENCE; and CARBOHYDRATE SEQUENCE are also available; protein architecture = PROTEIN CONFORMATION or its specifics; DF: MOL STRUCT%A%  
% 224.69/224.86  |- skos__altLabel mesh__D015394 Structure, Molecular
% 224.69/224.86  |- skos__broader mesh__D015394smesh__D002627
% 224.69/224.86  |- skos__scopeNote mesh__D015394
% 224.69/224.86       The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds.%A%    
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D015394 2002
% 224.69/224.86  |- skos__broader mesh__D015394smesh__D001669
% 224.69/224.86  |- skos__historyNote mesh__D015394 Models, Molecular %28%1975-1988%29%
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D015394 2005
% 224.69/224.86  |- mesh__dateRevised mesh__D015394 2001-07-25
% 224.69/224.86  |- skos__hiddenLabel mesh__D009357 Withdrawal Syndrome, Neonatal
% 224.69/224.86  |- skos__hiddenLabel mesh__D009357 Abstinence Syndromes, Neonatal
% 224.69/224.86  |- skos__hiddenLabel mesh__D009357 Withdrawal, Neonatal Substance
% 224.69/224.86  |- skos__prefLabel mesh__D009357 Neonatal Abstinence Syndrome
% 224.69/224.86  |- skos__altLabel mesh__D009357 Substance Withdrawal, Neonatal
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D009357 2001
% 224.69/224.86  |- skos__hiddenLabel mesh__D009357 Syndrome, Neonatal Abstinence
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D009357 2006
% 224.69/224.86  |- skos__hiddenLabel mesh__D009357 Neonatal Passive Addiction
% 224.69/224.86  |- skos__broader mesh__D009357smesh__D019966
% 224.69/224.86  |- skos__hiddenLabel mesh__D009357 Neonatal Withdrawal Syndromes
% 224.69/224.86  |- skos__altLabel mesh__D009357 Neonatal Withdrawal Syndrome
% 224.69/224.86  |- skos__altLabel mesh__D009357 Neonatal Substance Withdrawal
% 224.69/224.86  |- skos__altLabel mesh__D009357 Abstinence Syndrome, Neonatal
% 224.69/224.86  |- skos__hiddenLabel mesh__D009357 Withdrawal Syndromes, Neonatal
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D009357 2000
% 224.69/224.86  |- mesh__dateCreated mesh__D009357 1987-04-30
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D009357 2005
% 224.69/224.86  |- rdf__type mesh__D009357sskos__Concept
% 224.69/224.86  |- skos__historyNote mesh__D009357
% 224.69/224.86       Substance Withdrawal Syndrome %28%1966-1987%29%
% 224.69/224.86  |- skos__hiddenLabel mesh__D009357 Syndromes, Neonatal Abstinence
% 224.69/224.86  |- skos__hiddenLabel mesh__D009357 Neonatal Abstinence Syndromes
% 224.69/224.86  |- mesh__dateEstablished mesh__D009357 1988-01-01
% 224.69/224.86  |- mesh__dateRevised mesh__D009357 1999-11-05
% 224.69/224.86  |- skos__hiddenLabel mesh__D009357 Passive Addictions, Neonatal
% 224.69/224.86  |- mesh__publicMeSHNote mesh__D009357 88   
% 224.69/224.86  |- mesh__activeMeSHYear mesh__D009357 2004
% 224.69/224.86  |- skos__historyNote mesh__D009357 Infant, Newborn %28%1966-1987%29%
% 224.69/224.86  |- mesh__historyNote mesh__D009357 88   
% 224.69/224.86  |- skos__hiddenLabel mesh__D009357 Substance Withdrawals, Neonatal
% 224.69/224.87  |- skos__annotation mesh__D009357
% 224.69/224.87       substance-withdrawal symptoms in inf born of an addicted mother; do not use /congen; coord IM with specific substance /adv eff %28%IM%29% + check tag INFANT, NEWBORN%A%  
% 224.69/224.87  |- skos__hiddenLabel mesh__D009357 Neonatal Passive Addictions
% 224.69/224.87  |- skos__hiddenLabel mesh__D009357 Addiction, Neonatal Passive
% 224.69/224.87  |- skos__hiddenLabel mesh__D009357 Addictions, Neonatal Passive
% 224.69/224.87  |- skos__scopeNote mesh__D009357
% 224.69/224.87       Fetal and neonatal addiction and withdrawal as a result of the mother%27%s dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.%A%    
% 224.69/224.87  |- mesh__recordMaintainer mesh__D009357 adp
% 224.69/224.87  |- skos__broader mesh__D009357smesh__D007232
% 224.69/224.87  |- skos__hiddenLabel mesh__D009357 Syndromes, Neonatal Withdrawal
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D009357 2003
% 224.69/224.87  |- skos__hiddenLabel mesh__D009357 Syndrome, Neonatal Withdrawal
% 224.69/224.87  |- skos__hiddenLabel mesh__D009357 Neonatal Substance Withdrawals
% 224.69/224.87  |- mesh__recordOriginator mesh__D009357 EC
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D009357 2002
% 224.69/224.87  |- mesh__recordAuthorizer mesh__D009357 sjn
% 224.69/224.87  |- skos__hiddenLabel mesh__D001374 NSC 102816
% 224.69/224.87  |- skos__altLabel mesh__D001374 Azacytidine
% 224.69/224.87  |- mesh__dateEstablished mesh__D001374 1974-01-01
% 224.69/224.87  |- skos__altLabel mesh__D001374 5-Azacytidine
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D001374 2006
% 224.69/224.87  |- mesh__recordOriginator mesh__D001374 NLM
% 224.69/224.87  |- skos__altLabel mesh__D001374 Pharmion Brand of Azacitidine
% 224.69/224.87  |- mesh__recordMaintainer mesh__D001374 lkw
% 224.69/224.87  |- mesh__dateRevised mesh__D001374 2005-06-30
% 224.69/224.87  |- skos__historyNote mesh__D001374 Nucleosides %28%1966-1971%29%
% 224.69/224.87  |- skos__hiddenLabel mesh__D001374 5 Azacytidine
% 224.69/224.87  |- skos__hiddenLabel mesh__D001374 NSC102816
% 224.69/224.87  |- skos__scopeNote mesh__D001374
% 224.69/224.87       A pyrimidine analogue that inhibits DNA methyltransferase, impairing DNA methylation. It is also an antimetabolite of cytidine, incorporated primarily into RNA. Azacytidine has been used as an antineoplastic agent.%A%    
% 224.69/224.87  |- rdf__type mesh__D001374sskos__Concept
% 224.69/224.87  |- skos__broader mesh__D001374smesh__D003562
% 224.69/224.87  |- skos__prefLabel mesh__D001374 Azacitidine
% 224.69/224.87  |- mesh__historyNote mesh__D001374
% 224.69/224.87       96; was AZACYTIDINE 1972-95 %28%Prov 1972-73%29%   
% 224.69/224.87  |- skos__broader mesh__D001374smesh__D001372
% 224.69/224.87  |- skos__historyNote mesh__D001374 Triazines %28%1966-1971%29%
% 224.69/224.87  |- mesh__recordAuthorizer mesh__D001374 sjn
% 224.69/224.87  |- mesh__dateCreated mesh__D001374 1999-01-01
% 224.69/224.87  |- mesh__publicMeSHNote mesh__D001374 96; was AZACYTIDINE 1974-95   
% 224.69/224.87  |- skos__altLabel mesh__D019785 99mTc-Disofenin
% 224.69/224.87  |- mesh__dateRevised mesh__D019785 2000-06-21
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D019785 2004
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D019785 2001
% 224.69/224.87  |- mesh__recordMaintainer mesh__D019785 CCR
% 224.69/224.87  |- skos__annotation mesh__D019785 as label, use/diag use; DF: TC DISIDA   
% 224.69/224.87  |- skos__hiddenLabel mesh__D019785
% 224.69/224.87       Acid, Technetium-99m-Diisopropyliminodiacetic
% 224.69/224.87  |- mesh__recordAuthorizer mesh__D019785 sjn
% 224.69/224.87  |- skos__hiddenLabel mesh__D019785 Technetium 99m Disofenin
% 224.69/224.87  |- skos__altLabel mesh__D019785 99m-Tc-Disofenin
% 224.69/224.87  |- skos__altLabel mesh__D019785 Technetium-99m-Disofenin
% 224.69/224.87  |- skos__hiddenLabel mesh__D019785 Tc 99m Disofenin
% 224.69/224.87  |- mesh__historyNote mesh__D019785
% 224.69/224.87       98; use TECHNETIUM TC 99M DISOFENIN %28%NM%29% 1980-97   
% 224.69/224.87  |- skos__historyNote mesh__D019785
% 224.69/224.87       Organotechnetium Compounds %28%1990-1997%29%
% 224.69/224.87  |- skos__hiddenLabel mesh__D019785 99mTc Disofenin
% 224.69/224.87  |- mesh__dateCreated mesh__D019785 1997-06-20
% 224.69/224.87  |- skos__altLabel mesh__D019785 Tc-99m Disofenin
% 224.69/224.87  |- skos__hiddenLabel mesh__D019785 Disofenin, Tc-99m
% 224.69/224.87  |- skos__hiddenLabel mesh__D019785
% 224.69/224.87       Technetium 99m Diisopropyliminodiacetic Acid
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D019785 2005
% 224.69/224.87  |- skos__hiddenLabel mesh__D019785 99mTc DISIDA
% 224.69/224.87  |- skos__hiddenLabel mesh__D019785 99m Tc Disofenin
% 224.69/224.87  |- skos__broader mesh__D019785smesh__D015609
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D019785 2002
% 224.69/224.87  |- mesh__publicMeSHNote mesh__D019785
% 224.69/224.87       98; TECHNETIUM TC 99M DISOFENIN was indexed under ORGANOTECHNETIUM COMPOUNDS 1990-97, IMINO ACIDS 1980-97, %26%  ORGANOMETALLIC COMPOUNDS 1980-89%A%  
% 224.69/224.87  |- mesh__dateEstablished mesh__D019785 1998-01-01
% 224.69/224.87  |- mesh__recordOriginator mesh__D019785 KEV
% 224.69/224.87  |- skos__altLabel mesh__D019785 99mTc-DISIDA
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D019785 2006
% 224.69/224.87  |- skos__broader mesh__D019785smesh__D007098
% 224.69/224.87  |- skos__historyNote mesh__D019785
% 224.69/224.87       Organometallic Compounds %28%1980-1989%29%
% 224.69/224.87  |- skos__altLabel mesh__D019785
% 224.69/224.87       Technetium-99m-Diisopropyliminodiacetic Acid
% 224.69/224.87  |- skos__historyNote mesh__D019785 Imino Acids %28%1980-1997%29%
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D019785 2003
% 224.69/224.87  |- rdf__type mesh__D019785sskos__Concept
% 224.69/224.87  |- skos__scopeNote mesh__D019785
% 224.69/224.87       A radiopharmaceutical used extensively in cholescintigraphy for the evaluation of hepatobiliary diseases. %28%From Int Jrnl Rad Appl Inst 1992;43%28%9%29%:1061-4%29%%A%    
% 224.69/224.87  |- skos__prefLabel mesh__D019785 Technetium Tc 99m Disofenin
% 224.69/224.87  |- skos__scopeNote mesh__D005765
% 224.69/224.87       Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion.%A%    
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D005765 2006
% 224.69/224.87  |- skos__altLabel mesh__D005765 Gastrointestinal Drugs
% 224.69/224.87  |- mesh__recordAuthorizer mesh__D005765 sjn
% 224.69/224.87  |- mesh__dateEstablished mesh__D005765 1967-01-01
% 224.69/224.87  |- mesh__recordMaintainer mesh__D005765 ssb
% 224.69/224.87  |- skos__altLabel mesh__D005765 Gastric Drugs
% 224.69/224.87  |- mesh__recordOriginator mesh__D005765 NLM
% 224.69/224.87  |- mesh__historyNote mesh__D005765 67; DIGESTANTS was heading 1967-86   
% 224.69/224.87  |- rdf__type mesh__D005765sskos__Concept
% 224.69/224.87  |- mesh__publicMeSHNote mesh__D005765 67; DIGESTANTS was heading 1967-86   
% 224.69/224.87  |- skos__hiddenLabel mesh__D005765 Drugs, Gastric
% 224.69/224.87  |- skos__hiddenLabel mesh__D005765 Drugs, Gastrointestinal
% 224.69/224.87  |- skos__prefLabel mesh__D005765 Gastrointestinal Agents
% 224.69/224.87  |- mesh__onlineNote mesh__D005765
% 224.69/224.87       use GASTROINTESTINAL AGENTS to search DIGESTANTS 1967-86   
% 224.69/224.87  |- skos__hiddenLabel mesh__D005765 Agents, Gastric
% 224.69/224.87  |- mesh__dateRevised mesh__D005765 2005-06-30
% 224.69/224.87  |- skos__hiddenLabel mesh__D005765 Agents, Gastrointestinal
% 224.69/224.87  |- mesh__dateCreated mesh__D005765 1999-01-01
% 224.69/224.87  |- skos__broader mesh__D005765smesh__D045506
% 224.69/224.87  |- rdf__type mesh__D024121sskos__Concept
% 224.69/224.87  |- skos__altLabel mesh__D024121 Collagen alpha1%28%X%29%
% 224.69/224.87  |- mesh__recordOriginator mesh__D024121 jmp
% 224.69/224.87  |- mesh__recordMaintainer mesh__D024121 jmp
% 224.69/224.87  |- mesh__recordAuthorizer mesh__D024121 sjn
% 224.69/224.87  |- skos__annotation mesh__D024121
% 224.69/224.87       precursors: coord IM with PROCOLLAGEN %28%IM%29%   
% 224.69/224.87  |- skos__altLabel mesh__D024121 Collagen Type X, alpha1 Chain
% 224.69/224.87  |- skos__altLabel mesh__D024121 Type X Procollagen
% 224.69/224.87  |- skos__hiddenLabel mesh__D024121 Procollagen, Type X
% 224.69/224.87  |- mesh__dateCreated mesh__D024121 2001-07-25
% 224.69/224.87  |- mesh__publicMeSHNote mesh__D024121 2002; see COLLAGEN 1990-2001   
% 224.69/224.87  |- mesh__dateEstablished mesh__D024121 2002-01-01
% 224.69/224.87  |- skos__scopeNote mesh__D024121
% 224.69/224.87       A non-fibrillar collagen found primarily in terminally differentiated hypertrophic CHONDROCYTES. It is a homotrimer of three identical alpha1%28%X%29% subunits.%A%    
% 224.69/224.87  |- skos__historyNote mesh__D024121 Collagen %28%1990-2001%29%
% 224.69/224.87  |- skos__altLabel mesh__D024121 Type X Collagen
% 224.69/224.87  |- mesh__dateRevised mesh__D024121 2004-07-07
% 224.69/224.87  |- skos__broader mesh__D024121smesh__D024041
% 224.69/224.87  |- mesh__historyNote mesh__D024121 2002; use COLLAGEN 1990-2001   
% 224.69/224.87  |- skos__hiddenLabel mesh__D024121 Type X, Procollagen
% 224.69/224.87  |- skos__hiddenLabel mesh__D024121 Collagen, Type X
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D024121 2005
% 224.69/224.87  |- skos__prefLabel mesh__D024121 Collagen Type X
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D024121 2006
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D043884 2004
% 224.69/224.87  |- rdf__type mesh__D043884sskos__Concept
% 224.69/224.87  |- skos__historyNote mesh__D043884 Receptors, Drug %28%1995-2003%29%
% 224.69/224.87  |- skos__broader mesh__D043884smesh__D043882
% 224.69/224.87  |- skos__altLabel mesh__D043884 Cannabinoid Receptor CB1
% 224.69/224.87  |- mesh__dateCreated mesh__D043884 2003-07-09
% 224.69/224.87  |- mesh__dateEstablished mesh__D043884 2004-01-01
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D043884 2005
% 224.69/224.87  |- skos__prefLabel mesh__D043884 Receptor, Cannabinoid, CB1
% 224.69/224.87  |- mesh__publicMeSHNote mesh__D043884
% 224.69/224.87       2004; CB1 RECEPTOR %28%now RECEPTOR, CANNABINOID, CB1%29% was indexed under RECEPTORS, DRUG 1995-2003%A%  
% 224.69/224.87  |- skos__altLabel mesh__D043884 CB1 Receptor
% 224.69/224.87  |- mesh__historyNote mesh__D043884
% 224.69/224.87       2004; use RECEPTORS, CANNABINOID %28%NM%29% 1995-2003   
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D043884 2006
% 224.69/224.87  |- skos__scopeNote mesh__D043884
% 224.69/224.87       A subclass of cannabinoid receptor found primarily on central and peripheral NEURONS where it may play a role modulating NEUROTRANSMITTER release.%A%    
% 224.69/224.87  |- skos__hiddenLabel mesh__D043884 Receptor, CB1
% 224.69/224.87  |- skos__hiddenLabel mesh__D043884 Receptor CB1, Cannabinoid
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D010101 2006
% 224.69/224.87  |- skos__broader mesh__D010101smesh__D008660
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D010101 1999
% 224.69/224.87  |- mesh__dateCreated mesh__D010101 1999-01-01
% 224.69/224.87  |- skos__prefLabel mesh__D010101 Oxygen Consumption
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D010101 2005
% 224.69/224.87  |- mesh__historyNote mesh__D010101
% 224.69/224.87       66; was see under ENERGY METABOLISM %26% TISSUE METABOLISM 1963-65%A%  
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D010101 1998
% 224.69/224.87  |- skos__scopeNote mesh__D010101
% 224.69/224.87       The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. %28%Stedman, 25th ed, p346%29%%A%    
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D010101 2004
% 224.69/224.87  |- skos__hiddenLabel mesh__D010101 Consumptions, Oxygen
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D010101 2002
% 224.69/224.87  |- mesh__recordOriginator mesh__D010101 NLM
% 224.69/224.87  |- rdf__type mesh__D010101sskos__Concept
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D010101 1997
% 224.69/224.87  |- skos__hiddenLabel mesh__D010101 Oxygen Consumptions
% 224.69/224.87  |- mesh__recordAuthorizer mesh__D010101 PLS
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D010101 2003
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D010101 2001
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D010101 1996
% 224.69/224.87  |- mesh__dateRevised mesh__D010101 1995-05-31
% 224.69/224.87  |- mesh__dateEstablished mesh__D010101 1966-01-01
% 224.69/224.87  |- mesh__recordMaintainer mesh__D010101 JLS
% 224.69/224.87  |- skos__annotation mesh__D010101 TN 145: oxygen metab   
% 224.69/224.87  |- mesh__publicMeSHNote mesh__D010101
% 224.69/224.87       66; was see under ENERGY METABOLISM %26% TISSUE METABOLISM 1963-65%A%  
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D010101 2000
% 224.69/224.87  |- skos__hiddenLabel mesh__D010101 Consumption, Oxygen
% 224.69/224.87  |- rdf__type mesh__D051518sskos__Concept
% 224.69/224.87  |- mesh__recordOriginator mesh__D051518 DRC
% 224.69/224.87  |- skos__broader mesh__D051518smesh__D005346
% 224.69/224.87  |- mesh__recordMaintainer mesh__D051518 DRC
% 224.69/224.87  |- skos__prefLabel mesh__D051518 Fibroblast Growth Factor 3
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D051518 2006
% 224.69/224.87  |- mesh__publicMeSHNote mesh__D051518
% 224.69/224.87       2006; FIBROBLAST GROWTH FACTOR 3 was indexed under FIBROBLAST GROWTH FACTORS 2005, %26% under PROTO-ONCOGENE PROTEINS 1989-2004%A%  
% 224.69/224.87  |- mesh__recordAuthorizer mesh__D051518 sjn
% 224.69/224.87  |- skos__scopeNote mesh__D051518
% 224.69/224.87       A fibroblast growth factor that is expressed primarily during development.%A%    
% 224.69/224.87  |- mesh__dateEstablished mesh__D051518 2006-01-01
% 224.69/224.87  |- mesh__historyNote mesh__D051518 2006%28%1989%29%   
% 224.69/224.87  |- mesh__dateCreated mesh__D051518 2005-06-30
% 224.69/224.87  |- skos__altLabel mesh__D015395 Class I Major Histocompatibility Antigens
% 224.69/224.87  |- mesh__dateCreated mesh__D015395 1988-06-06
% 224.69/224.87  |- skos__altLabel mesh__D015395 Class I Human Antigens
% 224.69/224.87  |- skos__annotation mesh__D015395 human %26% animal   
% 224.69/224.87  |- skos__historyNote mesh__D015395 HLA Antigens %28%1978-1988%29%
% 224.69/224.87  |- skos__altLabel mesh__D015395 Class I Antigens
% 224.69/224.87  |- mesh__historyNote mesh__D015395 89   
% 224.69/224.87  |- rdf__type mesh__D015395sskos__Concept
% 224.69/224.87  |- mesh__recordMaintainer mesh__D015395 ssb
% 224.69/224.87  |- mesh__recordOriginator mesh__D015395 RLS
% 224.69/224.87  |- skos__prefLabel mesh__D015395 Histocompatibility Antigens Class I
% 224.69/224.87  |- mesh__dateRevised mesh__D015395 2005-06-30
% 224.69/224.87  |- skos__broader mesh__D015395smesh__D006649
% 224.69/224.87  |- skos__altLabel mesh__D015395 Class I Histocompatibility Antigens
% 224.69/224.87  |- skos__historyNote mesh__D015395
% 224.69/224.87       Histocompatibility Antigens %28%1973-1988%29%
% 224.69/224.87  |- mesh__recordAuthorizer mesh__D015395 sjn
% 224.69/224.87  |- mesh__dateEstablished mesh__D015395 1988-01-01
% 224.69/224.87  |- skos__hiddenLabel mesh__D015395 I Antigens, Class
% 224.69/224.87  |- skos__scopeNote mesh__D015395
% 224.69/224.87       Large transmembrane, polymorphic glycoproteins noncovalently associated with nonpolymorphic beta 2-microglobulin. In humans, three structural genes on chromosome 6 code for the HLA-A; HLA-B and HLA-C antigens. In mice, three genes named K, D, and L on chromosome 17 code for the H-2 antigens. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during graft rejection and restrict cell-mediated lysis of virus-infected cells. They are primarily associated with rheumatologic diseases and certain malignant disorders.%A%    
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D015395 2006
% 224.69/224.87  |- mesh__publicMeSHNote mesh__D015395 89   
% 224.69/224.87  |- skos__hiddenLabel mesh__D015395 Antigens, Class I
% 224.69/224.87  |- skos__hiddenLabel mesh__D009358 Disorder, Congenital
% 224.69/224.87  |- mesh__publicMeSHNote mesh__D009358
% 224.69/224.87       2002; see NEONATAL DISEASES AND ABNORMALTIES 1998-2001   
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D009358 2002
% 224.69/224.87  |- mesh__dateCreated mesh__D009358 1999-01-01
% 224.69/224.87  |- mesh__recordAuthorizer mesh__D009358 sjn
% 224.69/224.87  |- skos__altLabel mesh__D009358 Disorders, Congenital
% 224.69/224.87  |- mesh__recordOriginator mesh__D009358 NLM
% 224.69/224.87  |- mesh__runningHead mesh__D009358
% 224.69/224.87       C16 - DISEASES-CONGENITAL AND NEONATAL AND ABNORMALITIES   
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D009358 2003
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D009358 2004
% 224.69/224.87  |- rdf__type mesh__D009358sskos__Concept
% 224.69/224.87  |- skos__annotation mesh__D009358
% 224.69/224.87       not used for indexing      CATALOG: do not use   
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D009358 2005
% 224.69/224.87  |- skos__scopeNote mesh__D009358
% 224.69/224.87       Diseases existing at birth and often before birth, or that develop during the first month of life %28%INFANT, NEWBORN, DISEASES%29%, regardless of causation. Of these diseases, those characterized by structural deformities are termed ABNORMALITIES.%A%    
% 224.69/224.87  |- mesh__dateEstablished mesh__D009358 1998-01-01
% 224.69/224.87  |- skos__hiddenLabel mesh__D009358 Congenital Disorder
% 224.69/224.87  |- skos__prefLabel mesh__D009358
% 224.69/224.87       Congenital, Hereditary, and Neonatal Diseases and Abnormalities
% 224.69/224.87  |- mesh__historyNote mesh__D009358 2002; use explode 1971-1997   
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D009358 2006
% 224.69/224.87  |- mesh__recordMaintainer mesh__D009358 nns
% 224.69/224.87  |- mesh__dateRevised mesh__D009358 2001-07-25
% 224.69/224.87  |- rdf__type mesh__D001375sskos__Concept
% 224.69/224.87  |- skos__hiddenLabel mesh__D001375 8 Azaguanine
% 224.69/224.87  |- skos__altLabel mesh__D001375 Guanazolo
% 224.69/224.87  |- mesh__recordAuthorizer mesh__D001375 sjn
% 224.69/224.87  |- skos__scopeNote mesh__D001375
% 224.69/224.87       One of the early purine analogs showing antineoplastic activity. It functions as an antimetabolite and is easily incorporated into ribonucleic acids.%A%    
% 224.69/224.87  |- skos__prefLabel mesh__D001375 Azaguanine
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D001375 2003
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D001375 2001
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D001375 2005
% 224.69/224.87  |- mesh__dateCreated mesh__D001375 1999-01-01
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D001375 2004
% 224.69/224.87  |- skos__broader mesh__D001375smesh__D001372
% 224.69/224.87  |- mesh__recordOriginator mesh__D001375 NLM
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D001375 2006
% 224.69/224.87  |- mesh__dateRevised mesh__D001375 2000-06-21
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D001375 2002
% 224.69/224.87  |- skos__broader mesh__D001375smesh__D006147
% 224.69/224.87  |- skos__altLabel mesh__D001375 8-Azaguanine
% 224.69/224.87  |- mesh__recordMaintainer mesh__D001375 CCR
% 224.69/224.87  |- mesh__historyNote mesh__D006060
% 224.69/224.87       91%28%80%29%; was see under GONADAL DYSGENESIS 1980-90   
% 224.69/224.87  |- skos__historyNote mesh__D006060 Turner%27%s Syndrome %28%1967-1979%29%
% 224.69/224.87  |- mesh__dateCreated mesh__D006060 1978-12-21
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D006060 2003
% 224.69/224.87  |- skos__prefLabel mesh__D006060 Gonadal Dysgenesis, Mixed
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D006060 2005
% 224.69/224.87  |- skos__broader mesh__D006060smesh__D006059
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D006060 2004
% 224.69/224.87  |- mesh__recordOriginator mesh__D006060 AEP
% 224.69/224.87  |- mesh__recordMaintainer mesh__D006060 jls
% 224.69/224.87  |- skos__broader mesh__D006060smesh__D025064
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D006060 2006
% 224.69/224.87  |- mesh__dateRevised mesh__D006060 2004-07-27
% 224.69/224.87  |- mesh__publicMeSHNote mesh__D006060
% 224.69/224.87       91; was see under GONADAL DYSGENESIS 1980-90   
% 224.69/224.87  |- mesh__recordAuthorizer mesh__D006060 jls
% 224.69/224.87  |- skos__scopeNote mesh__D006060
% 224.69/224.87       A type of defective gonadal development in patients with a wide spectrum of chromosomal mosaic variants. Their karyotypes are of partial sex chromosome monosomy resulting from an absence or an abnormal second sex chromosome %28%X or Y%29%.  Karyotypes include 45,X/46,XX; 45,X/46,XX/47,XXX; 46,XXp-; 45,X/46,XY; 45,X/47,XYY; 46,XYpi; etc. The spectrum of phenotypes may range from phenotypic female through pseudohermaphrodite to phenotypic male, depending on the ratio in each gonad of 45,X primordial germ cells to those with normal 46,XX or 46,XY constitution.%A%    
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D006060 2002
% 224.69/224.87  |- mesh__dateEstablished mesh__D006060 1991-01-01
% 224.69/224.87  |- skos__historyNote mesh__D006060
% 224.69/224.87       Sex Differentiation Disorders %28%1966-1979%29%
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D006060 2005A
% 224.69/224.87  |- rdf__type mesh__D006060sskos__Concept
% 224.69/224.87  |- skos__altLabel mesh__D006060 Mixed Gonadal Dysgenesis
% 224.69/224.87  |- mesh__dateRevised mesh__D019786 2005-06-30
% 224.69/224.87  |- mesh__publicMeSHNote mesh__D019786
% 224.69/224.87       98; GADOLINIUM DTPA was indexed under DTPA/analogs %26% derivatives 1994-97, ORGANOMETALLIC COMPOUNDS 1987-97, and DTPA 1987-93; GADOPENTETATE DIMEGLUMINE %28%now GADOLINIUM DTPA%29% was indexed under DTPA/analogs %26% derivatives 1994-97, ORGANOMETALLIC COMPOUNDS 1987-97, MEGLUMINE 1987-97, DRUG COMBINATIONS 1987-97, %26% DTPA 1987-93%A%  
% 224.69/224.87  |- skos__altLabel mesh__D019786 Berlex Brand of Gadopentetate Dimeglumine
% 224.69/224.87  |- skos__broader mesh__D019786smesh__D004369
% 224.69/224.87  |- skos__altLabel mesh__D019786 Gd-DTPA
% 224.69/224.87  |- skos__altLabel mesh__D019786 Gadopentetic Acid
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D019786 2006
% 224.69/224.87  |- mesh__recordMaintainer mesh__D019786 CCR
% 224.69/224.87  |- skos__hiddenLabel mesh__D019786
% 224.69/224.87       Gadolinium Diethylenetriaminepenta acetic Acid
% 224.69/224.87  |- skos__altLabel mesh__D019786 Magnevist Enteral
% 224.69/224.87  |- skos__altLabel mesh__D019786 Gadolinium DTPA Dimeglumine
% 224.69/224.87  |- skos__hiddenLabel mesh__D019786 DTPA, Gadolinium
% 224.69/224.87  |- skos__altLabel mesh__D019786 Schering Brand of Gadopentetate Dimeglumine
% 224.69/224.87  |- rdf__type mesh__D019786sskos__Concept
% 224.69/224.87  |- skos__historyNote mesh__D019786
% 224.69/224.87       DTPA/analogs %26% derivatives %28%1994-1997%29%
% 224.69/224.87  |- skos__scopeNote mesh__D019786
% 224.69/224.87       A complex of gadolinium with a chelating agent, diethylenetriamine penta-acetic acid %28%DTPA see PENTETIC ACID%29%, that is given to enhance the image in cranial and spinal MRIs. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p706%29%%A%    
% 224.69/224.87  |- skos__altLabel mesh__D019786
% 224.69/224.87       Gadolinium Diethylenetriaminepenta-acetic Acid
% 224.69/224.87  |- mesh__recordAuthorizer mesh__D019786 sjn
% 224.69/224.87  |- skos__altLabel mesh__D019786 Juste Brand of Gadopentetate Dimeglumine
% 224.69/224.87  |- skos__altLabel mesh__D019786 Magnograf Enteral
% 224.69/224.87  |- skos__broader mesh__D019786smesh__D009942
% 224.69/224.87  |- skos__altLabel mesh__D019786 Gadolinium DTPA Dimeglumine Salt
% 224.69/224.87  |- mesh__dateCreated mesh__D019786 1997-06-20
% 224.69/224.87  |- skos__hiddenLabel mesh__D019786 Dimeglumine, Gadolinium DTPA
% 224.69/224.87  |- mesh__dateEstablished mesh__D019786 1998-01-01
% 224.69/224.87  |- mesh__recordOriginator mesh__D019786 KEV
% 224.69/224.87  |- skos__hiddenLabel mesh__D019786
% 224.69/224.87       Diethylenetriaminepenta-acetic Acid, Gadolinium
% 224.69/224.87  |- mesh__historyNote mesh__D019786
% 224.69/224.87       98; use GADOLINIUM DTPA %28%NM%29% 1987-97   
% 224.69/224.87  |- skos__prefLabel mesh__D019786 Gadolinium DTPA
% 224.69/224.87  |- skos__historyNote mesh__D019786
% 224.69/224.87       Organometallic Compounds %28%1987-1997%29%
% 224.69/224.87  |- skos__hiddenLabel mesh__D019786 Dimeglumine, Gadopentetate
% 224.69/224.87  |- skos__hiddenLabel mesh__D019786 Gd DTPA
% 224.69/224.87  |- skos__historyNote mesh__D019786 DTPA %28%1987-1993%29%
% 224.69/224.87  |- skos__altLabel mesh__D005766 GI Contents
% 224.69/224.87  |- skos__hiddenLabel mesh__D005766 Gastrointestinal Content
% 224.69/224.87  |- skos__annotation mesh__D005766
% 224.69/224.87       coord with specific part of digestive tract if discussed; DF: GI CONTENTS%A%  
% 224.69/224.87  |- mesh__dateCreated mesh__D005766 1984-05-02
% 224.69/224.87  |- skos__broader mesh__D005766smesh__D005441
% 224.69/224.87  |- mesh__recordOriginator mesh__D005766 AEP
% 224.69/224.87  |- rdf__type mesh__D005766sskos__Concept
% 224.69/224.87  |- mesh__historyNote mesh__D005766 2004 %28%1985%29%   
% 224.69/224.87  |- mesh__recordMaintainer mesh__D005766 lkt
% 224.69/224.87  |- mesh__publicMeSHNote mesh__D005766
% 224.69/224.87       2004; see DIGESTIVE TRACT CONTENTS 1999-2003; see GASTROINTESTINAL CONTENTS 1985-1998%A%  
% 224.69/224.87  |- mesh__recordAuthorizer mesh__D005766 sjn
% 224.69/224.87  |- skos__prefLabel mesh__D005766 Gastrointestinal Contents
% 224.69/224.87  |- skos__altLabel mesh__D005766 Digestive Tract Contents
% 224.69/224.87  |- skos__related mesh__D005766smesh__D005243
% 224.69/224.87  |- skos__hiddenLabel mesh__D005766 Stomach Content
% 224.69/224.87  |- mesh__dateRevised mesh__D005766 2003-07-09
% 224.69/224.87  |- mesh__activeMeSHYear mesh__D005766 2005
% 224.69/224.87  |- skos__hiddenLabel mesh__D005766 GI Content
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D005766 2004
% 224.69/224.88  |- skos__scopeNote mesh__D005766
% 224.69/224.88       The contents included in all or any segment of the GASTROINTESTINAL TRACT.%A%    
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D005766 2006
% 224.69/224.88  |- skos__hiddenLabel mesh__D005766 Intestinal Content
% 224.69/224.88  |- skos__hiddenLabel mesh__D005766 Digestive Tract Content
% 224.69/224.88  |- mesh__dateEstablished mesh__D005766 1985-01-01
% 224.69/224.88  |- skos__hiddenLabel mesh__D043885 Receptor CB2, Cannabinoid
% 224.69/224.88  |- skos__hiddenLabel mesh__D043885 Receptor, CB2
% 224.69/224.88  |- skos__altLabel mesh__D043885 Cannabinoid Receptor CB2
% 224.69/224.88  |- mesh__historyNote mesh__D043885
% 224.69/224.88       2004; use RECEPTORS, CANNABINOID %28%NM%29% 1995-2003   
% 224.69/224.88  |- skos__hiddenLabel mesh__D043885 CB2, Cannabinoid Receptor
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D043885 2005
% 224.69/224.88  |- skos__historyNote mesh__D043885 Receptors, Drug %28%1995-2003%29%
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D043885 2006
% 224.69/224.88  |- rdf__type mesh__D043885sskos__Concept
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D043885 2004
% 224.69/224.88  |- skos__altLabel mesh__D043885 CB2 Receptor
% 224.69/224.88  |- skos__scopeNote mesh__D043885
% 224.69/224.88       A subclass of cannabinoid receptor found primarily on immune cells where it may play a role modulating release of CYTOKINES.%A%    
% 224.69/224.88  |- skos__broader mesh__D043885smesh__D043882
% 224.69/224.88  |- mesh__dateEstablished mesh__D043885 2004-01-01
% 224.69/224.88  |- skos__annotation mesh__D043885 see SCR for organism-specific terms   
% 224.69/224.88  |- skos__prefLabel mesh__D043885 Receptor, Cannabinoid, CB2
% 224.69/224.88  |- mesh__dateCreated mesh__D043885 2003-07-09
% 224.69/224.88  |- mesh__publicMeSHNote mesh__D043885
% 224.69/224.88       2004; CB2 RECEPTOR %28%now RECEPTOR, CANNABINOID, CB2%29% was indexed under RECEPTORS, DRUG 1995-2003%A%  
% 224.69/224.88  |- skos__broader mesh__D010900smesh__D007027
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Pituitary Gland Disease
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Pituitary Disorder
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Disease, Pituitary Gland
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Diseases, Pituitary Gland
% 224.69/224.88  |- mesh__historyNote mesh__D010900 66   
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Disease, Pituitary
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Disease, Posterior Pituitary
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Pituitary Diseases, Posterior
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Pituitary Diseases, Anterior
% 224.69/224.88  |- mesh__dateEstablished mesh__D010900 1966-01-01
% 224.69/224.88  |- mesh__publicMeSHNote mesh__D010900 66   
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Disease, Adenohypophyseal
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Diseases, Posterior Pituitary
% 224.69/224.88  |- skos__altLabel mesh__D010900 Neurohypophyseal Diseases
% 224.69/224.88  |- mesh__recordAuthorizer mesh__D010900 sjn
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Diseases, Pituitary
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Anterior Pituitary Disease
% 224.69/224.88  |- skos__scopeNote mesh__D010900
% 224.69/224.88       Disorders involving either the ADENOHYPOPHYSIS or the NEUROHYPOPHYSIS. These diseases usually manifest as hypersecretion or hyposecretion of PITUITARY HORMONES. Neoplastic pituitary masses can also cause compression of the OPTIC CHIASM and other adjacent structures.%A%    
% 224.69/224.88  |- skos__altLabel mesh__D010900 Hypophyseal Disorders
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Posterior Pituitary Disease
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Adenohypophyseal Disease
% 224.69/224.88  |- skos__altLabel mesh__D010900 Pituitary Disorders
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Neurohypophyseal Disease
% 224.69/224.88  |- mesh__recordMaintainer mesh__D010900 lkt
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Pituitary Disease, Anterior
% 224.69/224.88  |- mesh__dateRevised mesh__D010900 2005-06-30
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D010900 2006
% 224.69/224.88  |- mesh__dateCreated mesh__D010900 1999-01-01
% 224.69/224.88  |- skos__annotation mesh__D010900
% 224.69/224.88       general or unspecified; prefer specifics; coordinate IM with specific part of pituitary %28%IM%29% if pertinent%A%  
% 224.69/224.88  |- skos__altLabel mesh__D010900 Adenohypophyseal Diseases
% 224.69/224.88  |- skos__altLabel mesh__D010900 Pituitary Gland Diseases
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Pituitary Disease, Posterior
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Disorder, Pituitary
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Hypophyseal Disorder
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Disorders, Hypophyseal
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Diseases, Neurohypophyseal
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Disease, Anterior Pituitary
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Diseases, Adenohypophyseal
% 224.69/224.88  |- rdf__type mesh__D010900sskos__Concept
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Pituitary Disease
% 224.69/224.88  |- mesh__recordOriginator mesh__D010900 NLM
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Disorders, Pituitary
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Disorder, Hypophyseal
% 224.69/224.88  |- skos__prefLabel mesh__D010900 Pituitary Diseases
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Disease, Neurohypophyseal
% 224.69/224.88  |- skos__hiddenLabel mesh__D010900 Diseases, Anterior Pituitary
% 224.69/224.88  |- skos__broader mesh__D010900smesh__D004700
% 224.69/224.88  |- skos__prefLabel mesh__D010102 Oxygen Inhalation Therapy
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D010102 1999
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D010102 2006
% 224.69/224.88  |- mesh__recordMaintainer mesh__D010102 TGC
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D010102 1998
% 224.69/224.88  |- mesh__recordOriginator mesh__D010102 NLM
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D010102 2005
% 224.69/224.88  |- skos__altLabel mesh__D010102 Inhalation Therapy, Oxygen
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D010102 1997
% 224.69/224.88  |- rdf__type mesh__D010102sskos__Concept
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D010102 2002
% 224.69/224.88  |- mesh__recordAuthorizer mesh__D010102 PLS
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D010102 2004
% 224.69/224.88  |- mesh__dateRevised mesh__D010102 1995-03-13
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D010102 1996
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D010102 2001
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D010102 2003
% 224.69/224.88  |- skos__hiddenLabel mesh__D010102 Therapies, Oxygen Inhalation
% 224.69/224.88  |- skos__broader mesh__D010102smesh__D012138
% 224.69/224.88  |- skos__scopeNote mesh__D010102
% 224.69/224.88       Inhalation of oxygen aimed at restoring toward normal any pathophysiologic alterations of gas exchange in the cardiopulmonary system, as by the use of a respirator, nasal catheter, tent, chamber, or mask. %28%From Dorland, 27th ed %26% Stedman, 25th ed%29%%A%    
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D010102 2000
% 224.69/224.88  |- skos__annotation mesh__D010102
% 224.69/224.88       coord with dis /ther, not dis /drug ther; do not use /util except by MeSH definition%A%  
% 224.69/224.88  |- skos__hiddenLabel mesh__D010102 Inhalation Therapies, Oxygen
% 224.69/224.88  |- skos__altLabel mesh__D010102 Therapy, Oxygen Inhalation
% 224.69/224.88  |- mesh__dateCreated mesh__D010102 1999-01-01
% 224.69/224.88  |- skos__hiddenLabel mesh__D010102 Oxygen Inhalation Therapies
% 224.69/224.88  |- skos__altLabel mesh__D051519 Proto-Oncogene Protein kfgf
% 224.69/224.88  |- rdf__type mesh__D051519sskos__Concept
% 224.69/224.88  |- skos__scopeNote mesh__D051519
% 224.69/224.88       A HEPARIN binding fibroblast growth factor that may play a role in LIMB BUD development.%A%    
% 224.69/224.88  |- skos__broader mesh__D051519smesh__D011518
% 224.69/224.88  |- mesh__recordAuthorizer mesh__D051519 sjn
% 224.69/224.88  |- skos__hiddenLabel mesh__D051519 Heparin Secretory Transforming Protein 1
% 224.69/224.88  |- skos__altLabel mesh__D051519
% 224.69/224.88       Kaposi%27%s Sarcoma Fibroblast Growth Factor
% 224.69/224.88  |- skos__hiddenLabel mesh__D051519 Proto Oncogene Protein Hst 1
% 224.69/224.88  |- skos__altLabel mesh__D051519 Proto-Oncogene Protein Hst-1
% 224.69/224.88  |- skos__altLabel mesh__D051519 Heparin Secretory Transforming Protein-1
% 224.69/224.88  |- mesh__dateCreated mesh__D051519 2005-06-30
% 224.69/224.88  |- mesh__publicMeSHNote mesh__D051519
% 224.69/224.88       2006; FIBROBLAST GROWTH FACTOR 4 was indexed under FIBROBLAST GROWTH FACTORS %26% PROTO-ONCOGENE PROTEINS 1991-2005, %26% under GROWTH SUBSTANCES 1990%A%  
% 224.69/224.88  |- mesh__dateEstablished mesh__D051519 2006-01-01
% 224.69/224.88  |- skos__hiddenLabel mesh__D051519 kfgf, Proto-Oncogene Protein
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D051519 2006
% 224.69/224.88  |- mesh__recordMaintainer mesh__D051519 DRC
% 224.69/224.88  |- skos__prefLabel mesh__D051519 Fibroblast Growth Factor 4
% 224.69/224.88  |- mesh__historyNote mesh__D051519 2006%28%1990%29%   
% 224.69/224.88  |- mesh__recordOriginator mesh__D051519 DRC
% 224.69/224.88  |- skos__hiddenLabel mesh__D051519 Proto Oncogene Protein kfgf
% 224.69/224.88  |- skos__broader mesh__D051519smesh__D005346
% 224.69/224.88  |- skos__hiddenLabel mesh__D051519 Hst-1, Proto-Oncogene Protein
% 224.69/224.88  |- skos__prefLabel mesh__D009359 Neonatology
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D009359 2003
% 224.69/224.88  |- skos__related mesh__D009359smesh__D007231
% 224.69/224.88  |- skos__annotation mesh__D009359
% 224.69/224.88       SPEC: SPEC qualif; differentiate from INFANT, NEWBORN, the physiol, psychol or social entity; differentiate from PERINATOLOGY: NEONATOLOGY is newborn inf only, PERINATOLOGY covers fetus %26% infant; DF: NEONATOL%A%  
% 224.69/224.88  |- mesh__recordAuthorizer mesh__D009359 SJN
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D009359 2000
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D009359 2004
% 224.69/224.88  |- rdf__type mesh__D009359sskos__Concept
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D009359 2001
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D009359 2005
% 224.69/224.88  |- mesh__publicMeSHNote mesh__D009359 77   
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D009359 2002
% 224.69/224.88  |- skos__broader mesh__D009359smesh__D010372
% 224.69/224.88  |- skos__historyNote mesh__D009359 Pediatrics %28%1966-1976%29%
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D009359 1998
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D009359 2006
% 224.69/224.88  |- mesh__recordOriginator mesh__D009359 EC
% 224.69/224.88  |- mesh__historyNote mesh__D009359 77   
% 224.69/224.88  |- mesh__dateEstablished mesh__D009359 1977-01-01
% 224.69/224.88  |- mesh__dateCreated mesh__D009359 1976-04-13
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D009359 1999
% 224.69/224.88  |- mesh__dateRevised mesh__D009359 1997-06-20
% 224.69/224.88  |- mesh__recordMaintainer mesh__D009359 PXP
% 224.69/224.88  |- skos__scopeNote mesh__D009359
% 224.69/224.88       A subspecialty of Pediatrics concerned with the newborn infant.%A%    
% 224.69/224.88  |- skos__hiddenLabel mesh__D001376 R1929
% 224.69/224.88  |- skos__scopeNote mesh__D001376
% 224.69/224.88       A butyrophenone used in the treatment of PSYCHOSES.     
% 224.69/224.88  |- skos__historyNote mesh__D001376 Piperazines %28%1971-1974%29%
% 224.69/224.88  |- skos__altLabel mesh__D001376 Janssen Brand of Azaperone
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D001376 2005
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D001376 2004
% 224.69/224.88  |- skos__historyNote mesh__D001376 Butyrophenones %28%1971-1974%29%
% 224.69/224.88  |- mesh__dateCreated mesh__D001376 1974-11-19
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D001376 2006
% 224.69/224.88  |- mesh__publicMeSHNote mesh__D001376
% 224.69/224.88       91; was see under BUTYROPHENONES 1975-90   
% 224.69/224.88  |- mesh__historyNote mesh__D001376
% 224.69/224.88       91%28%75%29%; was see under BUTYROPHENONES 1975-90   
% 224.69/224.88  |- mesh__recordAuthorizer mesh__D001376 sjn
% 224.69/224.88  |- skos__broader mesh__D001376smesh__D002090
% 224.69/224.88  |- skos__hiddenLabel mesh__D001376 Azaperone Janssen Brand
% 224.69/224.88  |- skos__historyNote mesh__D001376 Pyridines %28%1971-1974%29%
% 224.69/224.88  |- skos__prefLabel mesh__D001376 Azaperone
% 224.69/224.88  |- mesh__dateEstablished mesh__D001376 1991-01-01
% 224.69/224.88  |- mesh__recordOriginator mesh__D001376 NLM
% 224.69/224.88  |- rdf__type mesh__D001376sskos__Concept
% 224.69/224.88  |- mesh__recordMaintainer mesh__D001376 ssb
% 224.69/224.88  |- mesh__dateRevised mesh__D001376 2003-07-09
% 224.69/224.88  |- mesh__dateCreated mesh__D020530 1999-11-03
% 224.69/224.88  |- skos__hiddenLabel mesh__D020530 Ansa Lenticularis Nucleus
% 224.69/224.88  |- skos__broader mesh__D020530smesh__D004027
% 224.69/224.88  |- mesh__historyNote mesh__D020530 2000   
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D020530 2000
% 224.69/224.88  |- mesh__publicMeSHNote mesh__D020530 2000   
% 224.69/224.88  |- skos__prefLabel mesh__D020530 Subthalamus
% 224.69/224.88  |- skos__hiddenLabel mesh__D020530 Field H Nucleus
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D020530 2005
% 224.69/224.88  |- skos__historyNote mesh__D020530 Thalamus %28%1981-1999%29%
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D020530 2001
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D020530 2003
% 224.69/224.88  |- rdf__type mesh__D020530sskos__Concept
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D020530 2006
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D020530 2002
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D020530 2004
% 224.69/224.88  |- skos__historyNote mesh__D020530 Diencephalon %28%1967-1981%29%
% 224.69/224.88  |- skos__scopeNote mesh__D020530
% 224.69/224.88       A transition zone in the anterior part of the diencephalon interposed between the thalamus, hypothalamus, and tegmentum of the mesencephalon. Components of the subthalamus include the SUBTHALAMIC NUCLEUS, zona incerta, nucleus of field H, and the nucleus of ansa lenticularis. The latter contains the ENTOPEDUNCULAR NUCLEUS.%A%    
% 224.69/224.88  |- mesh__dateEstablished mesh__D020530 2000-01-01
% 224.69/224.88  |- mesh__dateRevised mesh__D006061 2001-07-25
% 224.69/224.88  |- skos__hiddenLabel mesh__D006061 Syndrome, Swyer
% 224.69/224.88  |- skos__prefLabel mesh__D006061 Gonadal Dysgenesis, 46,XY
% 224.69/224.88  |- skos__broader mesh__D006061smesh__D006059
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D006061 2005
% 224.69/224.88  |- mesh__recordAuthorizer mesh__D006061 sjn
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D006061 2004
% 224.69/224.88  |- skos__altLabel mesh__D006061 Gonadal Dysgenesis, 46, XY
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D006061 2006
% 224.69/224.88  |- mesh__publicMeSHNote mesh__D006061
% 224.69/224.88       91; was see under GONADAL DYSGENESIS 1980-90   
% 224.69/224.88  |- skos__altLabel mesh__D006061 Swyer Syndrome
% 224.69/224.88  |- mesh__recordOriginator mesh__D006061 AEP
% 224.69/224.88  |- mesh__recordMaintainer mesh__D006061 lkt
% 224.69/224.88  |- mesh__dateEstablished mesh__D006061 1991-01-01
% 224.69/224.88  |- skos__historyNote mesh__D006061
% 224.69/224.88       Sex Differentiation Disorders %28%1966-1979%29%
% 224.69/224.88  |- skos__scopeNote mesh__D006061
% 224.69/224.88       This type of gonadal defect is characterized by a female phenotype, normal to tall stature, bilateral streak or dysgenetic gonads, and a 46,XY karyotype. This XY gonadal dysgenesis is a heterogenous condition with variant forms resulting from a structural abnormality on Y chromosome, a mutation in SRY gene or a mutation in autosomal genes.  The syndrome is sometimes called %22%pure gonadal dysgenesis,%22% but this designation may also refer to gonadal dysgenesis with a 46,XX karyotype %28%GONADAL DYSGENESIS, 46,XX%29%.%A%    
% 224.69/224.88  |- rdf__type mesh__D006061sskos__Concept
% 224.69/224.88  |- skos__broader mesh__D006061smesh__D025064
% 224.69/224.88  |- mesh__historyNote mesh__D006061
% 224.69/224.88       91%28%80%29%; was see under GONADAL DYSGENESIS 1980-90   
% 224.69/224.88  |- skos__historyNote mesh__D006061 Turner%27%s Syndrome %28%1967-1979%29%
% 224.69/224.88  |- mesh__dateCreated mesh__D006061 1978-12-21
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D006061 2003
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D006061 2002
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D019787 2006
% 224.69/224.88  |- mesh__publicMeSHNote mesh__D019787
% 224.69/224.88       98; LINOLEIC ACID was indexed under LINOLEIC ACIDS 1981-97 %26% FATTY ACIDS, UNSATURATED 1981-83%A%  
% 224.69/224.88  |- skos__prefLabel mesh__D019787 Linoleic Acid
% 224.69/224.88  |- skos__historyNote mesh__D019787
% 224.69/224.88       Fatty Acids, Unsaturated %28%1981-1983%29%
% 224.69/224.88  |- skos__historyNote mesh__D019787 Linoleic Acids %28%1981-1997%29%
% 224.69/224.88  |- skos__altLabel mesh__D019787 9,12-Octadecadienoic Acid
% 224.69/224.88  |- rdf__type mesh__D019787sskos__Concept
% 224.69/224.88  |- mesh__historyNote mesh__D019787
% 224.69/224.88       98; use LINOLEIC ACID %28%NM%29% 1981-97   
% 224.69/224.88  |- skos__broader mesh__D019787smesh__D008041
% 224.69/224.88  |- skos__altLabel mesh__D019787 trans,trans-9,12-Octadecadienoic Acid
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D019787 2004
% 224.69/224.88  |- skos__annotation mesh__D019787
% 224.69/224.88       LINOLEIC ACIDS and LINOLEIC ACIDS, CONJUGATED are also available%A%  
% 224.69/224.88  |- skos__hiddenLabel mesh__D019787 Acid, 9,12-Octadecadienoic
% 224.69/224.88  |- skos__altLabel mesh__D019787 Linoelaidic Acid
% 224.69/224.88  |- mesh__dateRevised mesh__D019787 2003-07-09
% 224.69/224.88  |- mesh__recordAuthorizer mesh__D019787 sjn
% 224.69/224.88  |- skos__hiddenLabel mesh__D019787 9,12 Octadecadienoic Acid
% 224.69/224.88  |- skos__altLabel mesh__D019787 cis,cis-9,12-Octadecadienoic Acid
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D019787 2005
% 224.69/224.88  |- skos__altLabel mesh__D019787 Linoleic Acid, %28%E,E%29%-Isomer
% 224.69/224.88  |- skos__scopeNote mesh__D019787
% 224.69/224.88       A doubly unsaturated fatty acid, occurring widely in plant glycosides. It is an essential fatty acid in mammalian nutrition and is used in the biosynthesis of prostaglandins and cell membranes. %28%From Stedman, 26th ed%29%%A%    
% 224.69/224.88  |- skos__hiddenLabel mesh__D019787 9 trans,12 trans Octadecadienoic Acid
% 224.69/224.88  |- skos__altLabel mesh__D019787 9-trans,12-trans-Octadecadienoic Acid
% 224.69/224.88  |- mesh__dateCreated mesh__D019787 1997-06-20
% 224.69/224.88  |- mesh__recordMaintainer mesh__D019787 ssb
% 224.69/224.88  |- mesh__recordOriginator mesh__D019787 KEV
% 224.69/224.88  |- mesh__dateEstablished mesh__D019787 1998-01-01
% 224.69/224.88  |- skos__altLabel mesh__D038941 PTB Protein
% 224.69/224.88  |- skos__hiddenLabel mesh__D038941 Splicing Factor, PTB
% 224.69/224.88  |- skos__scopeNote mesh__D038941
% 224.69/224.88       A RNA-binding protein that binds to polypyriminidine rich regions in the INTRONS of messenger RNAs. Polypyrimidine tract-binding protein may be involved in regulating the ALTERNATIVE SPLICING of mRNAs since its presence on an intronic RNA region that is upstream of an EXON inhibits the splicing of the exon into the final mRNA product.%A%    
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D038941 2006
% 224.69/224.88  |- skos__altLabel mesh__D038941 p57 Cytoplasmic RNA-Binding Protein
% 224.69/224.88  |- mesh__publicMeSHNote mesh__D038941
% 224.69/224.88       2003; POLYPYRIMIDINE TRACT-BINDING PROTEIN was indexed under RIBONUCLEOPROTEINS %26% RNA-BINDING PROTEINS 1991-2002%A%  
% 224.69/224.88  |- skos__prefLabel mesh__D038941 Polypyrimidine Tract-Binding Protein
% 224.69/224.88  |- skos__hiddenLabel mesh__D038941 p57 Cytoplasmic RNA Binding Protein
% 224.69/224.88  |- skos__broader mesh__D038941smesh__D016601
% 224.69/224.88  |- mesh__recordMaintainer mesh__D038941 jmp
% 224.69/224.88  |- mesh__dateCreated mesh__D038941 2002-07-03
% 224.69/224.88  |- rdf__type mesh__D038941sskos__Concept
% 224.69/224.88  |- mesh__recordAuthorizer mesh__D038941 sjn
% 224.69/224.88  |- skos__altLabel mesh__D038941 pPTB
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D038941 2003
% 224.69/224.88  |- skos__altLabel mesh__D038941 PTB Splicing Factor
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D038941 2004
% 224.69/224.88  |- mesh__historyNote mesh__D038941
% 224.69/224.88       2003; use POLYPYRIMIDINE TRACT-BINDING PROTEIN %28%NM%29% 1991-2002%A%  
% 224.69/224.88  |- skos__hiddenLabel mesh__D038941 Polypyrimidine Tract Binding Protein
% 224.69/224.88  |- mesh__dateEstablished mesh__D038941 2003-01-01
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D038941 2005
% 224.69/224.88  |- skos__historyNote mesh__D038941 Ribonucleoproteins %28%1991-2002%29%
% 224.69/224.88  |- mesh__recordOriginator mesh__D038941 jmp
% 224.69/224.88  |- skos__historyNote mesh__D038941 RNA-Binding Proteins %28%1991-2002%29%
% 224.69/224.88  |- skos__hiddenLabel mesh__D038941 Tract-Binding Protein, Polypyrimidine
% 224.69/224.88  |- mesh__recordOriginator mesh__D005767 NLM
% 224.69/224.88  |- mesh__publicMeSHNote mesh__D005767 65   
% 224.69/224.88  |- skos__hiddenLabel mesh__D005767 Disorder, Functional Gastrointestinal
% 224.69/224.88  |- skos__prefLabel mesh__D005767 Gastrointestinal Diseases
% 224.69/224.88  |- mesh__dateEstablished mesh__D005767 1965-01-01
% 224.69/224.88  |- mesh__onlineNote mesh__D005767
% 224.69/224.88       pre-explosion = GASTROINTESTINAL DISEASES %28%PX%29%   
% 224.69/224.88  |- mesh__historyNote mesh__D005767 65   
% 224.69/224.88  |- skos__hiddenLabel mesh__D005767 Gastrointestinal Disorder, Functional
% 224.69/224.88  |- mesh__dateCreated mesh__D005767 1999-01-01
% 224.69/224.88  |- skos__altLabel mesh__D005767 Gastrointestinal Disorders, Functional
% 224.69/224.88  |- mesh__dateRevised mesh__D005767 2005-06-30
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D005767 2006
% 224.69/224.88  |- skos__hiddenLabel mesh__D005767 Functional Gastrointestinal Disorder
% 224.69/224.88  |- skos__hiddenLabel mesh__D005767 Disease, Gastrointestinal
% 224.69/224.88  |- skos__hiddenLabel mesh__D005767 Diseases, Gastrointestinal
% 224.69/224.88  |- skos__hiddenLabel mesh__D005767 Disorders, Functional Gastrointestinal
% 224.69/224.88  |- skos__hiddenLabel mesh__D005767 Infantum, Cholera
% 224.69/224.88  |- mesh__recordMaintainer mesh__D005767 ags
% 224.69/224.88  |- skos__broader mesh__D005767smesh__D004066
% 224.69/224.88  |- mesh__recordAuthorizer mesh__D005767 sjn
% 224.69/224.88  |- skos__hiddenLabel mesh__D005767 Gastrointestinal Disease
% 224.69/224.88  |- rdf__type mesh__D005767sskos__Concept
% 224.69/224.88  |- skos__annotation mesh__D005767
% 224.69/224.88       general: prefer specifics; inflammatory disease = GASTROENTERITIS%A%  
% 224.69/224.88  |- skos__scopeNote mesh__D005767
% 224.69/224.88       Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.%A%    
% 224.69/224.88  |- skos__annotation mesh__D038143
% 224.69/224.88       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.69/224.88  |- mesh__recordOriginator mesh__D038143 ssb
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D038143 2005
% 224.69/224.88  |- skos__scopeNote mesh__D038143
% 224.69/224.88       A plant genus of the family ASTERACEAE. Members contain INULIN, alantol, helenin, alantic acid, and acrid resin.%A%    
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D038143 2006
% 224.69/224.88  |- mesh__recordAuthorizer mesh__D038143 sjn
% 224.69/224.88  |- mesh__historyNote mesh__D038143
% 224.69/224.88       2003; for INULA RACEMOSA use INULA %28%NM%29% 1983-2002   
% 224.69/224.88  |- skos__broader mesh__D038143smesh__D019659
% 224.69/224.88  |- mesh__dateEstablished mesh__D038143 2003-01-01
% 224.69/224.88  |- mesh__publicMeSHNote mesh__D038143
% 224.69/224.88       2003; INULA RACEMOSA was indexed under INULIN 1983-2002   
% 224.69/224.88  |- mesh__dateRevised mesh__D038143 2003-07-25
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D038143 2004
% 224.69/224.88  |- skos__prefLabel mesh__D038143 Inula
% 224.69/224.88  |- skos__altLabel mesh__D038143 Pushkarmula
% 224.69/224.88  |- mesh__dateCreated mesh__D038143 2002-07-03
% 224.69/224.88  |- rdf__type mesh__D038143sskos__Concept
% 224.69/224.88  |- skos__altLabel mesh__D038143 Pushkarmoola
% 224.69/224.88  |- mesh__recordMaintainer mesh__D038143 sjn
% 224.69/224.88  |- skos__broader mesh__D024921smesh__D018432
% 224.69/224.88  |- skos__historyNote mesh__D024921
% 224.69/224.88       Drug Resistance, Microbial %28%1968-2001%29%
% 224.69/224.88  |- mesh__publicMeSHNote mesh__D024921 2002   
% 224.69/224.88  |- skos__prefLabel mesh__D024921 Drug Resistance, Multiple, Viral
% 224.69/224.88  |- mesh__dateEstablished mesh__D024921 2002-01-01
% 224.69/224.88  |- mesh__recordAuthorizer mesh__D024921 sjn
% 224.69/224.88  |- skos__broader mesh__D024921smesh__D024882
% 224.69/224.88  |- mesh__dateCreated mesh__D024921 2001-07-25
% 224.69/224.88  |- skos__altLabel mesh__D024921 Multiple Antiviral Drug Resistance
% 224.69/224.88  |- mesh__dateRevised mesh__D024921 2003-07-09
% 224.69/224.88  |- rdf__type mesh__D024921sskos__Concept
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D024921 2006
% 224.69/224.88  |- skos__scopeNote mesh__D024921
% 224.69/224.88       The ability of viruses to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance phenotype may be attributed to multiple gene mutation.%A%    
% 224.69/224.88  |- skos__historyNote mesh__D024921
% 224.69/224.88       Drug Resistance, Multiple %28%1994-2001%29%
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D024921 2004
% 224.69/224.88  |- mesh__activeMeSHYear mesh__D024921 2005
% 224.69/224.88  |- mesh__recordOriginator mesh__D024921 lkt
% 224.69/224.89  |- mesh__historyNote mesh__D024921 2002   
% 224.69/224.89  |- mesh__recordMaintainer mesh__D024921 ssb
% 224.69/224.89  |- mesh__dateEstablished mesh__D043886 2004-01-01
% 224.69/224.89  |- skos__altLabel mesh__D043886 Cholecystokinin A Receptor
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D043886 2005
% 224.69/224.89  |- skos__scopeNote mesh__D043886
% 224.69/224.89       A subtype of cholecystokinin receptor found primarily in the PANCREAS; STOMACH; INTESTINE; and GALLBLADDER. It plays a role in regulating digestive functions such as gallbladder contraction, pancreatic enzyme secretion and absorption in the GASTROINTESTINAL TRACT.%A%    
% 224.69/224.89  |- skos__prefLabel mesh__D043886 Receptor, Cholecystokinin A
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D043886 2006
% 224.69/224.89  |- skos__altLabel mesh__D043886 CCK-A Receptor
% 224.69/224.89  |- rdf__type mesh__D043886sskos__Concept
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D043886 2004
% 224.69/224.89  |- skos__broader mesh__D043886smesh__D011949
% 224.69/224.89  |- skos__annotation mesh__D043886 DF: CCK A RECEPT   
% 224.69/224.89  |- skos__hiddenLabel mesh__D043886 A Receptor, Cholecystokinin
% 224.69/224.89  |- mesh__publicMeSHNote mesh__D043886
% 224.69/224.89       2004; CCK-A RECEPTOR %28%now RECEPTOR, CHOLECTCYSTOKININ A%29% was indexed under RECEPTORS, CHOLECYSTOKININ 1994-2003%A%  
% 224.69/224.89  |- mesh__dateCreated mesh__D043886 2003-07-09
% 224.69/224.89  |- skos__hiddenLabel mesh__D043886 Receptor, CCK-A
% 224.69/224.89  |- skos__altLabel mesh__D043886 CCK%28%1%29% Receptor
% 224.69/224.89  |- skos__historyNote mesh__D043886
% 224.69/224.89       Receptors, Cholecystokinin %28%1988-2003%29%
% 224.69/224.89  |- mesh__historyNote mesh__D043886
% 224.69/224.89       2004; use RECEPTOR, CHOLECYSTOKININ A %28%NM%29% 1994-2003   
% 224.69/224.89  |- skos__hiddenLabel mesh__D043886 CCK A Receptor
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010901 2000
% 224.69/224.89  |- mesh__recordAuthorizer mesh__D010901 SJN
% 224.69/224.89  |- mesh__dateRevised mesh__D010901 1997-06-20
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010901 2003
% 224.69/224.89  |- skos__altLabel mesh__D010901 Pituitary Gland Function Tests
% 224.69/224.89  |- mesh__dateEstablished mesh__D010901 1968-01-01
% 224.69/224.89  |- skos__broader mesh__D010901smesh__D003940
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010901 1999
% 224.69/224.89  |- skos__hiddenLabel mesh__D010901 Test, Pituitary Function
% 224.69/224.89  |- skos__annotation mesh__D010901
% 224.69/224.89       test of pituit funct or hormonal secretion: do not confuse with PITUITARY-ADRENAL FUNCTION TESTS, test of pituit funct in relation to adrenal funct or corticoid production%A%  
% 224.69/224.89  |- skos__prefLabel mesh__D010901 Pituitary Function Tests
% 224.69/224.89  |- mesh__onlineNote mesh__D010901
% 224.69/224.89       use PITUITARY FUNCTION TESTS to search PITUITARY GLAND FUNCTION TESTS 1968-76%A%  
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010901 2006
% 224.69/224.89  |- skos__hiddenLabel mesh__D010901 Function Test, Pituitary
% 224.69/224.89  |- skos__hiddenLabel mesh__D010901 Function Tests, Pituitary
% 224.69/224.89  |- skos__hiddenLabel mesh__D010901 Pituitary Function Test
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010901 1998
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010901 2002
% 224.69/224.89  |- mesh__recordOriginator mesh__D010901 NLM
% 224.69/224.89  |- mesh__dateCreated mesh__D010901 1999-01-01
% 224.69/224.89  |- skos__hiddenLabel mesh__D010901 Tests, Pituitary Function
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010901 2005
% 224.69/224.89  |- mesh__recordMaintainer mesh__D010901 PXP
% 224.69/224.89  |- rdf__type mesh__D010901sskos__Concept
% 224.69/224.89  |- mesh__historyNote mesh__D010901
% 224.69/224.89       77,66-67; was PITUITARY GLAND FUNCTION TESTS 1968-76   
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010901 2001
% 224.69/224.89  |- mesh__publicMeSHNote mesh__D010901
% 224.69/224.89       77,66-67; was PITUITARY GLAND FUNCTION TESTS 1968-76   
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010901 2004
% 224.69/224.89  |- skos__hiddenLabel mesh__D010103 Isotopes, Oxygen
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010103 2006
% 224.69/224.89  |- mesh__recordMaintainer mesh__D010103 nns
% 224.69/224.89  |- skos__prefLabel mesh__D010103 Oxygen Isotopes
% 224.69/224.89  |- skos__broader mesh__D010103smesh__D007554
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010103 2003
% 224.69/224.89  |- rdf__type mesh__D010103sskos__Concept
% 224.69/224.89  |- mesh__dateRevised mesh__D010103 2000-06-22
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010103 2002
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010103 2004
% 224.69/224.89  |- mesh__dateCreated mesh__D010103 1999-01-01
% 224.69/224.89  |- skos__scopeNote mesh__D010103
% 224.69/224.89       Stable oxygen atoms that have the same atomic number as the element oxygen, but differ in atomic weight. O-17 and 18 are stable oxygen isotopes.%A%    
% 224.69/224.89  |- mesh__recordOriginator mesh__D010103 NLM
% 224.69/224.89  |- mesh__recordAuthorizer mesh__D010103 sjn
% 224.69/224.89  |- skos__annotation mesh__D010103 O-17,18; NIM   
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010103 2005
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010103 2001
% 224.69/224.89  |- mesh__historyNote mesh__D015397 89   
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D015397 2005
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D015397 2004
% 224.69/224.89  |- mesh__dateEstablished mesh__D015397 1989-01-01
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D015397 1995
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D015397 2003
% 224.69/224.89  |- skos__broader mesh__D015397smesh__D011787
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D015397 2001
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D015397 1994
% 224.69/224.89  |- mesh__recordOriginator mesh__D015397 EJB
% 224.69/224.89  |- skos__broader mesh__D015397smesh__D017531
% 224.69/224.89  |- rdf__type mesh__D015397sskos__Concept
% 224.69/224.89  |- mesh__recordMaintainer mesh__D015397 PLS
% 224.69/224.89  |- mesh__recordAuthorizer mesh__D015397 PLS
% 224.69/224.89  |- skos__historyNote mesh__D015397 Evaluation Studies %28%1971-1988%29%
% 224.69/224.89  |- mesh__dateRevised mesh__D015397 1993-11-23
% 224.69/224.89  |- skos__broader mesh__D015397smesh__D005069
% 224.69/224.89  |- mesh__dateCreated mesh__D015397 1988-06-06
% 224.69/224.89  |- skos__hiddenLabel mesh__D015397 Evaluations, Program
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D015397 1999
% 224.69/224.89  |- skos__hiddenLabel mesh__D015397 Sustainabilities, Program
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D015397 2000
% 224.69/224.89  |- mesh__publicMeSHNote mesh__D015397 89   
% 224.69/224.89  |- skos__hiddenLabel mesh__D015397 Program Sustainabilities
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D015397 1998
% 224.69/224.89  |- skos__altLabel mesh__D015397 Evaluation, Program
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D015397 1997
% 224.69/224.89  |- skos__hiddenLabel mesh__D015397 Program Evaluations
% 224.69/224.89  |- skos__hiddenLabel mesh__D015397 Effectiveness, Program
% 224.69/224.89  |- skos__prefLabel mesh__D015397 Program Evaluation
% 224.69/224.89  |- skos__scopeNote mesh__D015397
% 224.69/224.89       Studies designed to assess the efficacy of programs. They may include the evaluation of cost-effectiveness, the extent to which objectives are met, or impact.%A%    
% 224.69/224.89  |- skos__annotation mesh__D015397
% 224.69/224.89       do not confuse with terms indented under QUALITY OF HEALTH CARE%A%  
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D015397 1996
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D015397 2006
% 224.69/224.89  |- skos__hiddenLabel mesh__D015397 Sustainability, Program
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D015397 2002
% 224.69/224.89  |- skos__hiddenLabel mesh__D015397 Appropriateness, Program
% 224.69/224.89  |- skos__broader mesh__D008511Q000941smesh__D008511
% 224.69/224.89  |- mesh__preferredCombination mesh__D008511Q000941smesh__D004992
% 224.69/224.89  |- rdf__type mesh__D008511Q000941smesh__CompoundConcept
% 224.69/224.89  |- skos__altLabel mesh__D001377 Azeserine
% 224.69/224.89  |- rdf__type mesh__D001377sskos__Concept
% 224.69/224.89  |- mesh__recordOriginator mesh__D001377 NLM
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D001377 2004
% 224.69/224.89  |- skos__scopeNote mesh__D001377
% 224.69/224.89       Antibiotic substance produced by various Streptomyces species. It is an inhibitor of enzymatic activities that involve glutamine and is used as an antineoplastic and immunosuppressive agent.%A%    
% 224.69/224.89  |- skos__altLabel mesh__D001377 O-Diazoacetyl-L-serine
% 224.69/224.89  |- skos__annotation mesh__D001377 /biosyn permitted   
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D001377 2003
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D001377 2006
% 224.69/224.89  |- mesh__dateCreated mesh__D001377 1999-01-01
% 224.69/224.89  |- mesh__dateRevised mesh__D001377 2001-07-25
% 224.69/224.89  |- mesh__recordMaintainer mesh__D001377 jmp
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D001377 2002
% 224.69/224.89  |- skos__broader mesh__D001377smesh__D012694
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D001377 2005
% 224.69/224.89  |- skos__prefLabel mesh__D001377 Azaserine
% 224.69/224.89  |- mesh__recordAuthorizer mesh__D001377 sjn
% 224.69/224.89  |- skos__hiddenLabel mesh__D001377 O Diazoacetyl L serine
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D006860 2002
% 224.69/224.89  |- skos__prefLabel mesh__D006860 Hydrogen Bonding
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D006860 1996
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D006860 1999
% 224.69/224.89  |- mesh__dateEstablished mesh__D006860 1991-01-01
% 224.69/224.89  |- skos__broader mesh__D006860smesh__D002627
% 224.69/224.89  |- skos__hiddenLabel mesh__D006860 Bonding, Hydrogen
% 224.69/224.89  |- mesh__recordMaintainer mesh__D006860 TAP
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D006860 1997
% 224.69/224.89  |- rdf__type mesh__D006860sskos__Concept
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D006860 2005
% 224.69/224.89  |- mesh__historyNote mesh__D006860
% 224.69/224.89       91%28%75%29%; was see under CHEMISTRY, PHYSICAL 1975-90   
% 224.69/224.89  |- skos__annotation mesh__D006860 NIM   
% 224.69/224.89  |- mesh__recordAuthorizer mesh__D006860 PLS
% 224.69/224.89  |- mesh__dateCreated mesh__D006860 1974-11-11
% 224.69/224.89  |- mesh__publicMeSHNote mesh__D006860
% 224.69/224.89       91; was see under CHEMISTRY, PHYSICAL 1975-90   
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D006860 2003
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D006860 1994
% 224.69/224.89  |- mesh__recordOriginator mesh__D006860 NLM
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D006860 2006
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D006860 2000
% 224.69/224.89  |- skos__hiddenLabel mesh__D006860 Hydrogen Bondings
% 224.69/224.89  |- mesh__dateRevised mesh__D006860 1992-05-15
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D006860 2004
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D006860 1995
% 224.69/224.89  |- skos__hiddenLabel mesh__D006860 Bondings, Hydrogen
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D006860 2001
% 224.69/224.89  |- skos__scopeNote mesh__D006860
% 224.69/224.89       A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds.%A%    
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D006860 1998
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D006860 1993
% 224.69/224.89  |- skos__scopeNote mesh__D020531
% 224.69/224.89       Lens-shaped structure on the inner aspect of the internal capsule. The subthalamic nucleus and pathways traversing this region are concerned with the integration of somatic motor function. %28%Parent, Carpenter%27%s Human Neuroanatomy, 9th ed, p52%29%%A%    
% 224.69/224.89  |- mesh__recordAuthorizer mesh__D020531 sjn
% 224.69/224.89  |- mesh__dateRevised mesh__D020531 2004-07-13
% 224.69/224.89  |- mesh__historyNote mesh__D020531 2000   
% 224.69/224.89  |- mesh__recordOriginator mesh__D020531 ags
% 224.69/224.89  |- skos__altLabel mesh__D020531 Nucleus Subthalamicus
% 224.69/224.89  |- mesh__dateCreated mesh__D020531 1999-11-03
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D020531 2005
% 224.69/224.89  |- skos__hiddenLabel mesh__D020531 Nucleus, Subthalamic
% 224.69/224.89  |- skos__prefLabel mesh__D020531 Subthalamic Nucleus
% 224.69/224.89  |- rdf__type mesh__D020531sskos__Concept
% 224.69/224.89  |- skos__historyNote mesh__D020531 Thalamic Nuclei %28%1972-1999%29%
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D020531 2006
% 224.69/224.89  |- mesh__publicMeSHNote mesh__D020531 2000   
% 224.69/224.89  |- mesh__dateEstablished mesh__D020531 2000-01-01
% 224.69/224.89  |- skos__hiddenLabel mesh__D020531 Subthalamicus, Nucleus
% 224.69/224.89  |- skos__broader mesh__D020531smesh__D020530
% 224.69/224.89  |- mesh__recordMaintainer mesh__D020531 sjn
% 224.69/224.89  |- skos__prefLabel mesh__D006062 Gonadotropins
% 224.69/224.89  |- mesh__dateCreated mesh__D006062 1999-01-01
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D006062 2004
% 224.69/224.89  |- mesh__recordMaintainer mesh__D006062 lkt
% 224.69/224.89  |- mesh__dateRevised mesh__D006062 2002-07-03
% 224.69/224.89  |- skos__broader mesh__D006062smesh__D006728
% 224.69/224.89  |- skos__scopeNote mesh__D006062
% 224.69/224.89       Hormones that stimulate gonadal functions such as GAMETOGENESIS and sex steroid hormone production in the OVARY and the TESTIS. Major gonadotropins are glycoproteins produced primarily by the adenohypophysis %28%GONADOTROPINS, PITUITARY%29% and the placenta %28%CHORIONIC GONADOTROPIN%29%. In some species, pituitary PROLACTIN and PLACENTAL LACTOGEN exert some luteotropic activities.%A%    
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D006062 2003
% 224.69/224.89  |- skos__annotation mesh__D006062 GEN; prefer specifics   
% 224.69/224.89  |- mesh__recordAuthorizer mesh__D006062 sjn
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D006062 2006
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D006062 2005
% 224.69/224.89  |- mesh__recordOriginator mesh__D006062 NLM
% 224.69/224.89  |- skos__altLabel mesh__D006062 Gonadotropin
% 224.69/224.89  |- skos__related mesh__D006062smesh__D011967
% 224.69/224.89  |- rdf__type mesh__D006062sskos__Concept
% 224.69/224.89  |- mesh__publicMeSHNote mesh__D019788
% 224.69/224.89       2005%28%1998%29%; see FLUDEOXYGLUCOSE F 18 1998-2004; FLUDEOXYGLUCOSE F 18 was indexed under DEOXYGLUCOSE/analogs %26% derivatives 1978-1997%A%  
% 224.69/224.89  |- skos__hiddenLabel mesh__D019788 Fluorodeoxyglucose, 18F
% 224.69/224.89  |- skos__hiddenLabel mesh__D019788 F18, Fluorodeoxyglucose
% 224.69/224.89  |- skos__altLabel mesh__D019788 18FDG
% 224.69/224.89  |- skos__scopeNote mesh__D019788
% 224.69/224.89       The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1162%29%%A%    
% 224.69/224.89  |- skos__hiddenLabel mesh__D019788 Fluorine 18 fluorodeoxyglucose
% 224.69/224.89  |- skos__hiddenLabel mesh__D019788 F 18, Fludeoxyglucose
% 224.69/224.89  |- skos__altLabel mesh__D019788 18F Fluorodeoxyglucose
% 224.69/224.89  |- skos__altLabel mesh__D019788 2-Fluoro-2-deoxyglucose
% 224.69/224.89  |- mesh__recordAuthorizer mesh__D019788 sjn
% 224.69/224.89  |- mesh__dateEstablished mesh__D019788 1998-01-01
% 224.69/224.89  |- skos__hiddenLabel mesh__D019788 2 Fluoro 2 deoxyglucose
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D019788 2006
% 224.69/224.89  |- skos__hiddenLabel mesh__D019788 2 Fluoro 2 deoxy D glucose
% 224.69/224.89  |- mesh__dateRevised mesh__D019788 2004-07-07
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D019788 2005
% 224.69/224.89  |- skos__altLabel mesh__D019788 Fluorine-18-fluorodeoxyglucose
% 224.69/224.89  |- rdf__type mesh__D019788sskos__Concept
% 224.69/224.89  |- skos__historyNote mesh__D019788
% 224.69/224.89       Deoxyglucose/analogs %26% derivatives %28%1978-1997%29%
% 224.69/224.89  |- skos__altLabel mesh__D019788 18F-FDG
% 224.69/224.89  |- skos__prefLabel mesh__D019788 Fluorodeoxyglucose F18
% 224.69/224.89  |- skos__hiddenLabel mesh__D019788 F 18, Fluorodeoxyglucose
% 224.69/224.89  |- skos__altLabel mesh__D019788 Fluorodeoxyglucose F 18
% 224.69/224.89  |- mesh__historyNote mesh__D019788 2005%28%1979%29%   
% 224.69/224.89  |- mesh__recordOriginator mesh__D019788 KEV
% 224.69/224.89  |- skos__altLabel mesh__D019788 Fludeoxyglucose F 18
% 224.69/224.89  |- mesh__dateCreated mesh__D019788 1997-06-20
% 224.69/224.89  |- mesh__recordMaintainer mesh__D019788 ssb
% 224.69/224.89  |- skos__broader mesh__D019788smesh__D003847
% 224.69/224.89  |- skos__scopeNote mesh__D005768
% 224.69/224.89       HORMONES secreted by the gastrointestinal mucosa that affect the timing or the quality of secretion of digestive enzymes, and regulate the motor activity of the digestive system organs.%A%    
% 224.69/224.89  |- mesh__recordMaintainer mesh__D005768 adp
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D005768 2001
% 224.69/224.89  |- skos__related mesh__D005768smesh__D005765
% 224.69/224.89  |- skos__hiddenLabel mesh__D005768 Hormones, Gastrointestinal
% 224.69/224.89  |- skos__prefLabel mesh__D005768 Gastrointestinal Hormones
% 224.69/224.89  |- mesh__dateCreated mesh__D005768 1999-01-01
% 224.69/224.89  |- skos__broader mesh__D005768smesh__D006728
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D005768 2003
% 224.69/224.89  |- skos__hiddenLabel mesh__D005768 Hormones, Enteric
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D005768 2005
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D005768 2004
% 224.69/224.89  |- mesh__dateRevised mesh__D005768 2000-06-22
% 224.69/224.89  |- skos__altLabel mesh__D005768 Intestinal Hormones
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D005768 2002
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D005768 2006
% 224.69/224.89  |- mesh__recordAuthorizer mesh__D005768 sjn
% 224.69/224.89  |- rdf__type mesh__D005768sskos__Concept
% 224.69/224.89  |- skos__related mesh__D005768smesh__D011964
% 224.69/224.89  |- mesh__recordOriginator mesh__D005768 NLM
% 224.69/224.89  |- mesh__publicMeSHNote mesh__D005768
% 224.69/224.89       GASTRONE was see under MUCOPOLYSACCHARIDES 1964-76   
% 224.69/224.89  |- skos__hiddenLabel mesh__D005768 Hormones, Intestinal
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D016490 1999
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D016490 2003
% 224.69/224.89  |- skos__historyNote mesh__D016490 Information Systems %28%1986-1991%29%
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D016490 2000
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D016490 1998
% 224.69/224.89  |- mesh__dateCreated mesh__D016490 1991-01-02
% 224.69/224.89  |- mesh__historyNote mesh__D016490
% 224.69/224.89       94; was INTEGRATED ACADEMIC INFORMATION MANAGEMENT SYSTEMS 1992-93%A%  
% 224.69/224.89  |- skos__altLabel mesh__D016490 IAIMS
% 224.69/224.89  |- mesh__dateRevised mesh__D016490 1999-12-16
% 224.69/224.89  |- skos__broader mesh__D016490smesh__D007256
% 224.69/224.89  |- skos__scopeNote mesh__D016490
% 224.69/224.89       A concept, developed in 1983 under the aegis of and supported by the National Library of Medicine under the name of Integrated Academic Information Management Systems, to provide professionals in academic health sciences centers and health sciences institutions with convenient access to an integrated and comprehensive network of knowledge. It addresses a wide cross-section of users from administrators and faculty to students and clinicians and has applications to planning, clinical and managerial decision-making, teaching, and research. It provides access to various types of clinical, management, educational, etc., databases, as well as to research and bibliographic databases. In August 1992 the name was changed from Integrated Academic Information Management Systems to Integrated Advanced Information Management Systems to reflect use beyond the academic milieu.%A%    
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D016490 1997
% 224.69/224.89  |- skos__prefLabel mesh__D016490
% 224.69/224.89       Integrated Advanced Information Management Systems
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D016490 1996
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D016490 2006
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D016490 2000A
% 224.69/224.89  |- mesh__onlineNote mesh__D016490
% 224.69/224.89       use INTEGRATED ADVANCED INFORMATION MANAGEMENT SYSTEMS to search INTEGRATED ACADEMIC INFORMATION MANAGEMENT SYSTEMS 1992-93%A%  
% 224.69/224.89  |- mesh__recordMaintainer mesh__D016490 ags
% 224.69/224.89  |- mesh__recordAuthorizer mesh__D016490 ags
% 224.69/224.89  |- skos__historyNote mesh__D016490
% 224.69/224.89       National Library of Medicine %28%U.S.%29% %28%1986-1988%29%
% 224.69/224.89  |- mesh__publicMeSHNote mesh__D016490
% 224.69/224.89       94; was INTEGRATED ACADEMIC INFORMATION MANAGEMENT SYSTEMS 1992-93%A%  
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D016490 1995
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D016490 2005
% 224.69/224.89  |- skos__annotation mesh__D016490 DF: note short X ref   
% 224.69/224.89  |- rdf__type mesh__D016490sskos__Concept
% 224.69/224.89  |- mesh__recordOriginator mesh__D016490 TGC
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D016490 2002
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D016490 1994
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D016490 2004
% 224.69/224.89  |- mesh__dateEstablished mesh__D016490 1992-01-01
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D016490 2001
% 224.69/224.89  |- mesh__recordMaintainer mesh__D030161 SYSTEM
% 224.69/224.89  |- rdf__type mesh__D030161sskos__Concept
% 224.69/224.89  |- mesh__recordOriginator mesh__D030161 jmp
% 224.69/224.89  |- mesh__dateEstablished mesh__D030161 2002-01-01
% 224.69/224.89  |- mesh__historyNote mesh__D030161 2002   
% 224.69/224.89  |- mesh__publicMeSHNote mesh__D030161 2002   
% 224.69/224.89  |- skos__related mesh__D030161smesh__D001717
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D030161 2006
% 224.69/224.89  |- skos__scopeNote mesh__D030161
% 224.69/224.89       Proteins obtained from species of BIRDS.     
% 224.69/224.89  |- mesh__dateRevised mesh__D030161 2005-06-30
% 224.69/224.89  |- skos__annotation mesh__D030161
% 224.69/224.89       coord IM with specific protein %28%IM%29% + specific bird %28%IM%29%   
% 224.69/224.89  |- skos__broader mesh__D030161smesh__D011506
% 224.69/224.89  |- skos__prefLabel mesh__D030161 Avian Proteins
% 224.69/224.89  |- mesh__recordAuthorizer mesh__D030161 sjn
% 224.69/224.89  |- skos__altLabel mesh__D030161 Bird Proteins
% 224.69/224.89  |- mesh__dateCreated mesh__D030161 2001-07-25
% 224.69/224.89  |- skos__altLabel mesh__D002470 Cell Viability
% 224.69/224.89  |- mesh__recordMaintainer mesh__D002470 TGC
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D002470 1999
% 224.69/224.89  |- skos__historyNote mesh__D002470 Cytology %28%1966-1970%29%
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D002470 2000
% 224.69/224.89  |- skos__hiddenLabel mesh__D002470 Cell Viabilities
% 224.69/224.89  |- skos__hiddenLabel mesh__D002470 Viabilities, Cell
% 224.69/224.89  |- mesh__historyNote mesh__D002470
% 224.69/224.89       76%28%71%29%; was see under CYTOLOGY 1975   
% 224.69/224.89  |- mesh__dateEstablished mesh__D002470 1976-01-01
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D002470 2004
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D002470 1998
% 224.69/224.89  |- skos__prefLabel mesh__D002470 Cell Survival
% 224.69/224.89  |- skos__historyNote mesh__D002470 specific cell %28%1966-1970%29%
% 224.69/224.89  |- mesh__publicMeSHNote mesh__D002470 76; was see under CYTOLOGY 1975   
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D002470 2006
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D002470 2003
% 224.69/224.89  |- mesh__recordOriginator mesh__D002470 NLM
% 224.69/224.89  |- skos__hiddenLabel mesh__D002470 Survival, Cell
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D002470 2005
% 224.69/224.89  |- skos__annotation mesh__D002470 NIM; not for micro-organisms   
% 224.69/224.89  |- skos__scopeNote mesh__D002470
% 224.69/224.89       The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability.%A%    
% 224.69/224.89  |- skos__hiddenLabel mesh__D002470 Viability, Cell
% 224.69/224.89  |- mesh__dateCreated mesh__D002470 1999-01-01
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D002470 2002
% 224.69/224.89  |- mesh__recordAuthorizer mesh__D002470 SJN
% 224.69/224.89  |- skos__broader mesh__D002470smesh__D002468
% 224.69/224.89  |- mesh__dateRevised mesh__D002470 1997-06-20
% 224.69/224.89  |- rdf__type mesh__D002470sskos__Concept
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D002470 2001
% 224.69/224.89  |- skos__broader mesh__D043887smesh__D011949
% 224.69/224.89  |- skos__hiddenLabel mesh__D043887 Receptor, CCK2
% 224.69/224.89  |- skos__altLabel mesh__D043887 CCK-B Receptor
% 224.69/224.89  |- skos__historyNote mesh__D043887
% 224.69/224.89       Receptors, Cholecystokinin %28%1989-2003%29%
% 224.69/224.89  |- skos__scopeNote mesh__D043887
% 224.69/224.89       A subtype of cholecystokinin receptor found primarily in the CENTRAL NERVOUS SYSTEM and the GASTRIC MUCOSA. It may play a role as a neuromodulator of dopaminergic neurotransmission the regulation of GASTRIC ACID secretion from GASTRIC PARIETAL CELLS.%A%    
% 224.69/224.89  |- skos__hiddenLabel mesh__D043887 Receptor, CCK B
% 224.69/224.89  |- skos__altLabel mesh__D043887 Cholecystokinin B Receptor
% 224.69/224.89  |- skos__altLabel mesh__D043887 CCK2 Receptor
% 224.69/224.89  |- skos__altLabel mesh__D043887 CCK-B Receptors
% 224.69/224.89  |- mesh__recordAuthorizer mesh__D043887 sjn
% 224.69/224.89  |- skos__hiddenLabel mesh__D043887 CCK B Receptors
% 224.69/224.89  |- skos__hiddenLabel mesh__D043887 Receptor, Cholecystokinin-2
% 224.69/224.89  |- skos__altLabel mesh__D043887 Cholecystokinin-2 Receptor
% 224.69/224.89  |- mesh__historyNote mesh__D043887
% 224.69/224.89       2004; use RECEPTOR, CHOLECYSTOKININ B %28%NM%29% 1993-2003   
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D043887 2004
% 224.69/224.89  |- skos__hiddenLabel mesh__D043887 CCK B Receptor
% 224.69/224.89  |- skos__altLabel mesh__D043887 Receptors, Gastrin
% 224.69/224.89  |- skos__altLabel mesh__D043887 Receptor, CCK-B
% 224.69/224.89  |- skos__hiddenLabel mesh__D043887 Gastrin Receptors
% 224.69/224.89  |- skos__hiddenLabel mesh__D043887 Cholecystokinin 2 Receptor
% 224.69/224.89  |- skos__annotation mesh__D043887 DF: CCK B RECEPT   
% 224.69/224.89  |- skos__hiddenLabel mesh__D043887 CKK 2 Receptor
% 224.69/224.89  |- skos__hiddenLabel mesh__D043887 B Receptor, Cholecystokinin
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D043887 2006
% 224.69/224.89  |- mesh__publicMeSHNote mesh__D043887
% 224.69/224.89       2004; CCK-B RECEPTOR %28%now RECEPTOR, CHOLECYSTOKININ B%29% was indexed under RECEPTORS, CHOLECYSTOKININ 1993-2003%A%  
% 224.69/224.89  |- skos__hiddenLabel mesh__D043887 Receptors, CCK-B
% 224.69/224.89  |- mesh__recordOriginator mesh__D043887 jmp
% 224.69/224.89  |- rdf__type mesh__D043887sskos__Concept
% 224.69/224.89  |- mesh__dateCreated mesh__D043887 2003-07-09
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D043887 2005
% 224.69/224.89  |- skos__hiddenLabel mesh__D043887 Receptor, CKK-2
% 224.69/224.89  |- mesh__recordMaintainer mesh__D043887 jmp
% 224.69/224.89  |- skos__altLabel mesh__D043887 Gastrin Receptor
% 224.69/224.89  |- mesh__dateEstablished mesh__D043887 2004-01-01
% 224.69/224.89  |- skos__altLabel mesh__D043887 CKK-2 Receptor
% 224.69/224.89  |- skos__prefLabel mesh__D043887 Receptor, Cholecystokinin B
% 224.69/224.89  |- skos__hiddenLabel mesh__D043887 Receptor, Gastrin
% 224.69/224.89  |- skos__hiddenLabel mesh__D010902 Pituitary Glands
% 224.69/224.89  |- mesh__recordMaintainer mesh__D010902 lkt
% 224.69/224.89  |- skos__altLabel mesh__D010902 Pituitary Stalk
% 224.69/224.89  |- skos__annotation mesh__D010902
% 224.69/224.89       GEN or unspecified: prefer PITUITARY GLAND, ANTERIOR or PITUITARY GLAND, POSTERIOR; /rad eff: consider also PITUITARY IRRADIATION, a radiother procedure; /surg: probably HYPOPHYSECTOMY; consider also PITUITARY-ADRENAL SYSTEM %26% HYPOTHALAMO-HYPOPHYSEAL SYSTEM%A%  
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010902 2006
% 224.69/224.89  |- skos__related mesh__D010902smesh__D007016
% 224.69/224.89  |- skos__hiddenLabel mesh__D010902 Infundibular Stalks
% 224.69/224.89  |- skos__hiddenLabel mesh__D010902 Hypophyses
% 224.69/224.89  |- mesh__dateCreated mesh__D010902 1999-01-01
% 224.69/224.89  |- skos__broader mesh__D010902smesh__D007030
% 224.69/224.89  |- skos__hiddenLabel mesh__D010902 Glands, Pituitary
% 224.69/224.89  |- skos__broader mesh__D010902smesh__D004702
% 224.69/224.89  |- skos__hiddenLabel mesh__D010902 Pituitary Stalks
% 224.69/224.89  |- mesh__dateRevised mesh__D010902 2005-06-30
% 224.69/224.89  |- skos__altLabel mesh__D010902 Hypophysis
% 224.69/224.89  |- mesh__recordOriginator mesh__D010902 NLM
% 224.69/224.89  |- rdf__type mesh__D010902sskos__Concept
% 224.69/224.89  |- skos__hiddenLabel mesh__D010902 Hypophysial Stalks
% 224.69/224.89  |- mesh__considerAlso mesh__D010902 consider also terms at HYPOPHYS-   
% 224.69/224.89  |- skos__prefLabel mesh__D010902 Pituitary Gland
% 224.69/224.89  |- mesh__recordAuthorizer mesh__D010902 sjn
% 224.69/224.89  |- skos__scopeNote mesh__D010902
% 224.69/224.89       A small, unpaired gland situated in the SELLA TURCICA. It is connected to the HYPOTHALAMUS by a short stalk.%A%    
% 224.69/224.89  |- skos__altLabel mesh__D010902 Infundibular Stalk
% 224.69/224.89  |- skos__hiddenLabel mesh__D010902 Gland, Pituitary
% 224.69/224.89  |- skos__broader mesh__D010104smesh__D011868
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010104 2003
% 224.69/224.89  |- rdf__type mesh__D010104sskos__Concept
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010104 1997
% 224.69/224.89  |- skos__historyNote mesh__D010104 Oxygen Isotopes %28%1966-1974%29%
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010104 2001
% 224.69/224.89  |- mesh__onlineNote mesh__D010104 search OXYGEN ISOTOPES 1966-74   
% 224.69/224.89  |- skos__hiddenLabel mesh__D010104 Radioisotopes, Oxygen
% 224.69/224.89  |- mesh__historyNote mesh__D010104 75   
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010104 2004
% 224.69/224.89  |- mesh__dateRevised mesh__D010104 1993-06-02
% 224.69/224.89  |- skos__scopeNote mesh__D010104
% 224.69/224.89       Unstable isotopes of oxygen that decay or disintegrate emitting radiation. O atoms with atomic weights 13, 14, 15, 19, and 20 are radioactive oxygen isotopes.%A%    
% 224.69/224.89  |- skos__prefLabel mesh__D010104 Oxygen Radioisotopes
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010104 1994
% 224.69/224.89  |- skos__annotation mesh__D010104
% 224.69/224.89       O-13-15, 19, 20; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A%  
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010104 1998
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010104 2002
% 224.69/224.89  |- mesh__dateCreated mesh__D010104 1974-11-11
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010104 1995
% 224.69/224.89  |- mesh__recordAuthorizer mesh__D010104 PLS
% 224.69/224.89  |- mesh__dateEstablished mesh__D010104 1975-09-01
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010104 2005
% 224.69/224.89  |- skos__broader mesh__D010104smesh__D010103
% 224.69/224.89  |- skos__historyNote mesh__D010104 Radioisotopes %28%1966-1974%29%
% 224.69/224.89  |- mesh__activeMeSHYear mesh__D010104 1999
% 224.69/224.89  |- mesh__recordMaintainer mesh__D010104 TPW
% 224.69/224.89  |- mesh__recordOriginator mesh__D010104 NLM
% 224.69/224.90  |- mesh__publicMeSHNote mesh__D010104 75   
% 224.69/224.90  |- mesh__activeMeSHYear mesh__D010104 1996
% 224.69/224.90  |- mesh__activeMeSHYear mesh__D010104 2006
% 224.69/224.90  |- mesh__activeMeSHYear mesh__D010104 2000
% 224.69/224.90  |- rdf__type mesh__D015398sskos__Concept
% 224.69/224.90  |- mesh__recordMaintainer mesh__D015398 jls
% 224.69/224.90  |- skos__broader mesh__D015398smesh__D001669
% 224.69/224.90  |- skos__scopeNote mesh__D015398
% 224.69/224.90       The intercellular or intracellular transfer of information %28%biological activation/inhibition%29% through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule %28%hormone, neurotransmitter%29% is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.%A%    
% 224.69/224.90  |- mesh__dateCreated mesh__D015398 1988-06-06
% 224.69/224.90  |- skos__hiddenLabel mesh__D015398 Pathways, Signal
% 224.69/224.90  |- skos__related mesh__D015398smesh__D007473
% 224.69/224.90  |- skos__hiddenLabel mesh__D015398 Signal Pathway
% 224.69/224.90  |- mesh__publicMeSHNote mesh__D015398 89   
% 224.69/224.90  |- skos__altLabel mesh__D015398 Receptor Mediated Signal Transduction
% 224.69/224.90  |- skos__broader mesh__D015398smesh__D002450
% 224.69/224.90  |- skos__hiddenLabel mesh__D015398 Signal Transduction System
% 224.69/224.90  |- skos__hiddenLabel mesh__D015398 System, Signal Transduction
% 224.69/224.90  |- skos__prefLabel mesh__D015398 Signal Transduction
% 224.69/224.90  |- skos__hiddenLabel mesh__D015398 Signal Transductions, Receptor-Mediated
% 224.69/224.90  |- skos__historyNote mesh__D015398 Membrane Potentials %28%1977-1988%29%
% 224.69/224.90  |- skos__hiddenLabel mesh__D015398 Signal Transduction, Receptor-Mediated
% 224.69/224.90  |- mesh__historyNote mesh__D015398 89   
% 224.75/224.90  |- skos__hiddenLabel mesh__D015398 Transduction, Signal
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D015398 2006
% 224.75/224.90  |- mesh__recordOriginator mesh__D015398 EJB
% 224.75/224.90  |- skos__annotation mesh__D015398
% 224.75/224.90       %22%inter- or intracellular transfer of information through a signal pathway%22%%A%  
% 224.75/224.90  |- mesh__dateRevised mesh__D015398 2005-06-30
% 224.75/224.90  |- skos__hiddenLabel mesh__D015398 Signal Transduction Pathway
% 224.75/224.90  |- skos__broader mesh__D015398smesh__D002468
% 224.75/224.90  |- skos__hiddenLabel mesh__D015398 Pathway, Signal Transduction
% 224.75/224.90  |- skos__hiddenLabel mesh__D015398 Systems, Signal Transduction
% 224.75/224.90  |- skos__altLabel mesh__D015398 Signal Transduction Systems
% 224.75/224.90  |- skos__hiddenLabel mesh__D015398 Pathway, Signal
% 224.75/224.90  |- mesh__dateEstablished mesh__D015398 1989-01-01
% 224.75/224.90  |- skos__historyNote mesh__D015398
% 224.75/224.90       specific compounds/physiology %28%1977-1988%29%
% 224.75/224.90  |- mesh__recordAuthorizer mesh__D015398 sjn
% 224.75/224.90  |- skos__hiddenLabel mesh__D015398 Signal Transductions
% 224.75/224.90  |- skos__hiddenLabel mesh__D015398 Receptor-Mediated Signal Transductions
% 224.75/224.90  |- skos__hiddenLabel mesh__D015398 Transductions, Signal
% 224.75/224.90  |- skos__hiddenLabel mesh__D015398 Pathways, Signal Transduction
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D001378 2002
% 224.75/224.90  |- mesh__dateEstablished mesh__D001378 1991-01-01
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D001378 1995
% 224.75/224.90  |- mesh__recordMaintainer mesh__D001378 PLS
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D001378 2004
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D001378 1998
% 224.75/224.90  |- skos__broader mesh__D001378smesh__D013260
% 224.75/224.90  |- mesh__recordAuthorizer mesh__D001378 PLS
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D001378 1994
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D001378 2003
% 224.75/224.90  |- mesh__publicMeSHNote mesh__D001378
% 224.75/224.90       91; was see under STEROIDS, HETEROCYCLIC 1975-90   
% 224.75/224.90  |- mesh__recordOriginator mesh__D001378 NLM
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D001378 2001
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D001378 2006
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D001378 1997
% 224.75/224.90  |- skos__scopeNote mesh__D001378
% 224.75/224.90       Steroidal compounds in which one or more carbon atoms in the steroid ring system have been substituted with nitrogen atoms.%A%    
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D001378 2000
% 224.75/224.90  |- mesh__historyNote mesh__D001378
% 224.75/224.90       91%28%75%29%; was see under STEROIDS, HETEROCYCLIC 1975-90   
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D001378 2005
% 224.75/224.90  |- skos__prefLabel mesh__D001378 Azasteroids
% 224.75/224.90  |- skos__historyNote mesh__D001378 Steroids %28%1968-1974%29%
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D001378 1996
% 224.75/224.90  |- rdf__type mesh__D001378sskos__Concept
% 224.75/224.90  |- mesh__dateCreated mesh__D001378 1974-11-14
% 224.75/224.90  |- mesh__dateRevised mesh__D001378 1993-06-03
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D001378 1999
% 224.75/224.90  |- skos__altLabel mesh__D006861 Hydroperoxide
% 224.75/224.90  |- rdf__type mesh__D006861sskos__Concept
% 224.75/224.90  |- skos__scopeNote mesh__D006861
% 224.75/224.90       A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials.%A%    
% 224.75/224.90  |- skos__hiddenLabel mesh__D006861 Peroxide, Hydrogen
% 224.75/224.90  |- mesh__dateRevised mesh__D006861 2005-06-30
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D006861 2006
% 224.75/224.90  |- skos__prefLabel mesh__D006861 Hydrogen Peroxide
% 224.75/224.90  |- skos__altLabel mesh__D006861 Hydrogen Peroxide %28%H2O2%29%
% 224.75/224.90  |- mesh__dateCreated mesh__D006861 1999-01-01
% 224.75/224.90  |- mesh__recordAuthorizer mesh__D006861 sjn
% 224.75/224.90  |- skos__broader mesh__D006861smesh__D010545
% 224.75/224.90  |- mesh__recordMaintainer mesh__D006861 ssb
% 224.75/224.90  |- mesh__recordOriginator mesh__D006861 NLM
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D020532 2003
% 224.75/224.90  |- rdf__type mesh__D020532sskos__Concept
% 224.75/224.90  |- skos__hiddenLabel mesh__D020532 Meynert Nucleus Basalis
% 224.75/224.90  |- skos__hiddenLabel mesh__D020532 Meynert Basal Nucleus
% 224.75/224.90  |- skos__historyNote mesh__D020532 Basal Ganglia %28%1967-1983%29%
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D020532 2006
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D020532 2001
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D020532 2004
% 224.75/224.90  |- mesh__publicMeSHNote mesh__D020532
% 224.75/224.90       2000; see SUBSTANTIA INNOMINATA 1984-1999; for NUCLEUS BASALIS OF MEYNERT %26% NUCLEUS BASALIS MAGONCELLULARIS see SUBSTANTIA INNOMINATA 1984-1999%A%  
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D020532 2002
% 224.75/224.90  |- mesh__historyNote mesh__D020532
% 224.75/224.90       2000; use SUBSTANTIA INNOMINATA 1984-1999; for NUCLEUS BASALIS OF MEYNERT %26% NUCLEUS BASALIS MAGNOCELLULARIS use SUBSTANTIA INNOMINATA 1984-1999%A%  
% 224.75/224.90  |- skos__broader mesh__D020532smesh__D013377
% 224.75/224.90  |- mesh__dateCreated mesh__D020532 1999-11-03
% 224.75/224.90  |- skos__prefLabel mesh__D020532 Basal Nucleus of Meynert
% 224.75/224.90  |- mesh__dateEstablished mesh__D020532 2000-01-01
% 224.75/224.90  |- skos__scopeNote mesh__D020532
% 224.75/224.90       A group of nerve cells in the substantia innominata that has wide projections to the neocortex and is rich in acetylcholine and choline acetyltransferase. In Parkinson and Alzheimer diseases the nucleus undergoes degeneration.%A%    
% 224.75/224.90  |- skos__altLabel mesh__D020532 Nucleus Basalis of Meynert
% 224.75/224.90  |- skos__historyNote mesh__D020532 Substantia Innominata %28%1984-1999%29%
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D020532 2005
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D020532 2000
% 224.75/224.90  |- skos__broader mesh__D006063smesh__D006062
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D006063 2004
% 224.75/224.90  |- mesh__historyNote mesh__D006063
% 224.75/224.90       2003; use GONADOTROPINS, CHORIONIC %28%1964-2002%29%   
% 224.75/224.90  |- mesh__recordOriginator mesh__D006063 NLM
% 224.75/224.90  |- skos__related mesh__D006063smesh__D011967
% 224.75/224.90  |- skos__prefLabel mesh__D006063 Chorionic Gonadotropin
% 224.75/224.90  |- skos__altLabel mesh__D006063 HCG %28%Human Chorionic Gonadotropin%29%
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D006063 2006
% 224.75/224.90  |- mesh__dateRevised mesh__D006063 2005-07-12
% 224.75/224.90  |- skos__hiddenLabel mesh__D006063 Gonadotropin, Human Chorionic
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D006063 2006A
% 224.75/224.90  |- mesh__recordAuthorizer mesh__D006063 ags
% 224.75/224.90  |- skos__broader mesh__D006063smesh__D011257
% 224.75/224.90  |- skos__altLabel mesh__D006063 Human Chorionic Gonadotropin
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D006063 2005
% 224.75/224.90  |- skos__altLabel mesh__D006063 Choriogonadotropin
% 224.75/224.90  |- mesh__recordMaintainer mesh__D006063 ags
% 224.75/224.90  |- rdf__type mesh__D006063sskos__Concept
% 224.75/224.90  |- skos__hiddenLabel mesh__D006063 Gonadotropin, Chorionic
% 224.75/224.90  |- mesh__publicMeSHNote mesh__D006063
% 224.75/224.90       2003; see GONADOTROPINS, CHORIONIC %28%1964-2002%29%   
% 224.75/224.90  |- skos__annotation mesh__D006063
% 224.75/224.90       for alpha subunit, coord with GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN is also available%A%  
% 224.75/224.90  |- skos__scopeNote mesh__D006063
% 224.75/224.90       A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the three pituitary glycoprotein hormones %28%TSH, LH, and FSH%29%, but the beta subunit is unique and confers its biological specificity %28%CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN%29%.%A%    
% 224.75/224.90  |- mesh__dateCreated mesh__D006063 1999-01-01
% 224.75/224.90  |- skos__broader mesh__D006063smesh__D010926
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D019789 2006
% 224.75/224.90  |- mesh__publicMeSHNote mesh__D019789
% 224.75/224.90       98; TETRAETHYLAMMONIUM was indexed under TETRAETHYLAMMONIUM COMPOUNDS 1980-97%A%  
% 224.75/224.90  |- mesh__dateCreated mesh__D019789 1997-06-20
% 224.75/224.90  |- skos__hiddenLabel mesh__D019789 Chloride, Tetraethylammonium
% 224.75/224.90  |- mesh__recordMaintainer mesh__D019789 ssb
% 224.75/224.90  |- skos__altLabel mesh__D019789 Tetraethylammonium Ion
% 224.75/224.90  |- skos__hiddenLabel mesh__D019789 Ion, Tetraethylammonium
% 224.75/224.90  |- rdf__type mesh__D019789sskos__Concept
% 224.75/224.90  |- skos__hiddenLabel mesh__D019789 Iodide, Tetraethylammonium
% 224.75/224.90  |- mesh__recordAuthorizer mesh__D019789 sjn
% 224.75/224.90  |- mesh__dateEstablished mesh__D019789 1998-01-01
% 224.75/224.90  |- skos__historyNote mesh__D019789
% 224.75/224.90       Tetraethylammonium Compounds %28%1980-1997%29%
% 224.75/224.90  |- skos__hiddenLabel mesh__D019789 Hydroxide, Tetraethylammonium
% 224.75/224.90  |- skos__scopeNote mesh__D019789
% 224.75/224.90       A potassium-selective ion channel blocker. %28%From J Gen Phys 1994;104%28%1%29%:173-90%29%%A%    
% 224.75/224.90  |- skos__hiddenLabel mesh__D019789 Bromide, Tetraethylammonium
% 224.75/224.90  |- mesh__dateRevised mesh__D019789 2005-06-30
% 224.75/224.90  |- skos__broader mesh__D019789smesh__D013757
% 224.75/224.90  |- mesh__historyNote mesh__D019789
% 224.75/224.90       98; use TETRAETHYLAMMONIUM %28%NM%29% 1980-97   
% 224.75/224.90  |- skos__prefLabel mesh__D019789 Tetraethylammonium
% 224.75/224.90  |- mesh__recordOriginator mesh__D019789 KEV
% 224.75/224.90  |- mesh__dateEstablished mesh__D044182 2004-01-01
% 224.75/224.90  |- skos__hiddenLabel mesh__D044182 Bis Benzylisoquinolines
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D044182 2005
% 224.75/224.90  |- skos__hiddenLabel mesh__D044182 Benzyl Isoquinolines
% 224.75/224.90  |- skos__altLabel mesh__D044182 Bis-Benzyl-Isoquinolines
% 224.75/224.90  |- skos__broader mesh__D044182smesh__D007546
% 224.75/224.90  |- skos__hiddenLabel mesh__D044182 Bis Benzyl Isoquinolines
% 224.75/224.90  |- mesh__publicMeSHNote mesh__D044182 2004   
% 224.75/224.90  |- skos__scopeNote mesh__D044182
% 224.75/224.90       ISOQUINOLINES with a benzyl substituent.     
% 224.75/224.90  |- mesh__dateCreated mesh__D044182 2003-07-09
% 224.75/224.90  |- mesh__historyNote mesh__D044182 2004   
% 224.75/224.90  |- skos__prefLabel mesh__D044182 Benzylisoquinolines
% 224.75/224.90  |- skos__altLabel mesh__D044182 Benzyl-Isoquinolines
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D044182 2004
% 224.75/224.90  |- rdf__type mesh__D044182sskos__Concept
% 224.75/224.90  |- skos__altLabel mesh__D044182 Bis-Benzylisoquinolines
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D044182 2006
% 224.75/224.90  |- skos__hiddenLabel mesh__D005769 Gastrointestinal Motilities
% 224.75/224.90  |- skos__hiddenLabel mesh__D005769 Motilities, Gastrointestinal
% 224.75/224.90  |- mesh__recordOriginator mesh__D005769 NLM
% 224.75/224.90  |- mesh__dateCreated mesh__D005769 1999-01-01
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D005769 1994
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D005769 2003
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D005769 1993
% 224.75/224.90  |- mesh__recordAuthorizer mesh__D005769 PLS
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D005769 2000
% 224.75/224.90  |- skos__prefLabel mesh__D005769 Gastrointestinal Motility
% 224.75/224.90  |- skos__hiddenLabel mesh__D005769 Motility, Intestinal
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D005769 2005
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D005769 1995
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D005769 2004
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D005769 2001
% 224.75/224.90  |- skos__annotation mesh__D005769
% 224.75/224.90       not necessary to specify STOMACH or INTESTINES as coord; coord with specific intestine /physiol if pertinent %28%IM%29%; GASTRIC EMPTYING is available%A%  
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D005769 2006
% 224.75/224.90  |- mesh__dateRevised mesh__D005769 1992-05-15
% 224.75/224.90  |- skos__hiddenLabel mesh__D005769 Motilities, Intestinal
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D005769 1996
% 224.75/224.90  |- rdf__type mesh__D005769sskos__Concept
% 224.75/224.90  |- skos__hiddenLabel mesh__D005769 Motility, Gastrointestinal
% 224.75/224.90  |- mesh__recordMaintainer mesh__D005769 TAP
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D005769 1998
% 224.75/224.90  |- mesh__historyNote mesh__D005769 66   
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D005769 1997
% 224.75/224.90  |- skos__broader mesh__D005769smesh__D004068
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D005769 2002
% 224.75/224.90  |- mesh__publicMeSHNote mesh__D005769 66   
% 224.75/224.90  |- mesh__dateEstablished mesh__D005769 1966-01-01
% 224.75/224.90  |- skos__hiddenLabel mesh__D005769 Intestinal Motilities
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D005769 1999
% 224.75/224.90  |- mesh__publicMeSHNote mesh__D016491 92   
% 224.75/224.90  |- skos__broader mesh__D016491smesh__D014652
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D016491 2006
% 224.75/224.90  |- skos__altLabel mesh__D016491 Peripheral Angiopathies
% 224.75/224.90  |- mesh__dateEstablished mesh__D016491 1992-01-01
% 224.75/224.90  |- skos__annotation mesh__D016491
% 224.75/224.90       coord IM with specific peripheral artery or vein IM; inflamm dis = probably VASCULITIS; vascular compression syndromes: coord IM with CONSTRICTION, PATHOLOGIC %28%NIM%29% + specific blood vessel if pertinent %28%IM%29%%A%  
% 224.75/224.90  |- mesh__recordOriginator mesh__D016491 TGC
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D016491 2002
% 224.75/224.90  |- mesh__recordAuthorizer mesh__D016491 SJN
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D016491 2005
% 224.75/224.90  |- rdf__type mesh__D016491sskos__Concept
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D016491 2001
% 224.75/224.90  |- skos__hiddenLabel mesh__D016491 Peripheral Vascular Disease
% 224.75/224.90  |- skos__historyNote mesh__D016491 Vascular Diseases %28%1966-1991%29%
% 224.75/224.90  |- skos__hiddenLabel mesh__D016491 Angiopathy, Peripheral
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D016491 2004
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D016491 2000
% 224.75/224.90  |- skos__hiddenLabel mesh__D016491 Angiopathies, Peripheral
% 224.75/224.90  |- mesh__recordMaintainer mesh__D016491 MSR
% 224.75/224.90  |- mesh__historyNote mesh__D016491 92   
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D016491 1999
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D016491 2003
% 224.75/224.90  |- skos__altLabel mesh__D016491 Vascular Diseases, Peripheral
% 224.75/224.90  |- skos__hiddenLabel mesh__D016491 Peripheral Angiopathy
% 224.75/224.90  |- skos__prefLabel mesh__D016491 Peripheral Vascular Diseases
% 224.75/224.90  |- skos__hiddenLabel mesh__D016491 Vascular Disease, Peripheral
% 224.75/224.90  |- skos__scopeNote mesh__D016491
% 224.75/224.90       General or unspecified diseases of the blood vessels outside the heart. It is for diseases of the peripheral as opposed to the cardiac circulation.%A%    
% 224.75/224.90  |- skos__hiddenLabel mesh__D016491 Disease, Peripheral Vascular
% 224.75/224.90  |- skos__altLabel mesh__D016491 Diseases, Peripheral Vascular
% 224.75/224.90  |- mesh__dateCreated mesh__D016491 1991-01-03
% 224.75/224.90  |- mesh__dateRevised mesh__D016491 1998-06-10
% 224.75/224.90  |- skos__altLabel mesh__D030162 Reptile Proteins
% 224.75/224.90  |- mesh__publicMeSHNote mesh__D030162 2002   
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D030162 2006
% 224.75/224.90  |- mesh__dateEstablished mesh__D030162 2002-01-01
% 224.75/224.90  |- skos__broader mesh__D030162smesh__D011506
% 224.75/224.90  |- skos__prefLabel mesh__D030162 Reptilian Proteins
% 224.75/224.90  |- mesh__recordAuthorizer mesh__D030162 sjn
% 224.75/224.90  |- skos__related mesh__D030162smesh__D012104
% 224.75/224.90  |- mesh__dateCreated mesh__D030162 2001-07-25
% 224.75/224.90  |- skos__annotation mesh__D030162
% 224.75/224.90       coord IM with specific protein %28%IM%29% + specific reptile %28%IM%29%%A%  
% 224.75/224.90  |- rdf__type mesh__D030162sskos__Concept
% 224.75/224.90  |- mesh__recordOriginator mesh__D030162 jmp
% 224.75/224.90  |- mesh__historyNote mesh__D030162 2002   
% 224.75/224.90  |- skos__scopeNote mesh__D030162
% 224.75/224.90       Proteins obtained from species of REPTILES.     
% 224.75/224.90  |- mesh__recordMaintainer mesh__D030162 SYSTEM
% 224.75/224.90  |- mesh__dateRevised mesh__D030162 2005-06-30
% 224.75/224.90  |- skos__hiddenLabel mesh__D002471 Neoplastic Cell Transformations
% 224.75/224.90  |- skos__hiddenLabel mesh__D002471 Cell Neoplastic Transformation
% 224.75/224.90  |- skos__annotation mesh__D002471
% 224.75/224.90       do not confuse with CELL DIFFERENTIATION, a normal process in morphogenesis; Manual 24.4.1.10+; DF: CELL TRANSFORM NEOPL%A%  
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D002471 2004
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D002471 2001
% 224.75/224.90  |- skos__scopeNote mesh__D002471
% 224.75/224.90       Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.%A%    
% 224.75/224.90  |- skos__historyNote mesh__D002471 Neoplasms %28%1966-1967%29%
% 224.75/224.90  |- skos__hiddenLabel mesh__D002471 Cell Transformations, Neoplastic
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D002471 2006
% 224.75/224.90  |- mesh__dateEstablished mesh__D002471 1970-01-01
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D002471 2003
% 224.75/224.90  |- skos__hiddenLabel mesh__D002471 Cell Neoplastic Transformations
% 224.75/224.90  |- skos__hiddenLabel mesh__D002471 Neoplastic Transformations, Cell
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D002471 2005
% 224.75/224.90  |- mesh__recordAuthorizer mesh__D002471 sjn
% 224.75/224.90  |- skos__historyNote mesh__D002471
% 224.75/224.90       Neoplasms, Experimental %28%1966-1967%29%
% 224.75/224.90  |- mesh__historyNote mesh__D002471 70%28%68%29%   
% 224.75/224.90  |- skos__hiddenLabel mesh__D002471 Transformation, Cell Neoplastic
% 224.75/224.90  |- mesh__dateCreated mesh__D002471 1999-01-01
% 224.75/224.90  |- skos__altLabel mesh__D002471 Neoplastic Transformation, Cell
% 224.75/224.90  |- mesh__recordOriginator mesh__D002471 NLM
% 224.75/224.90  |- skos__altLabel mesh__D002471 Neoplastic Cell Transformation
% 224.75/224.90  |- mesh__recordMaintainer mesh__D002471 TGC
% 224.75/224.90  |- rdf__type mesh__D002471sskos__Concept
% 224.75/224.90  |- skos__altLabel mesh__D002471 Transformation, Neoplastic Cell
% 224.75/224.90  |- skos__hiddenLabel mesh__D002471 Transformations, Cell Neoplastic
% 224.75/224.90  |- mesh__publicMeSHNote mesh__D002471 70   
% 224.75/224.90  |- skos__prefLabel mesh__D002471 Cell Transformation, Neoplastic
% 224.75/224.90  |- skos__related mesh__D002471smesh__D000943
% 224.75/224.90  |- skos__hiddenLabel mesh__D002471 Transformations, Neoplastic Cell
% 224.75/224.90  |- mesh__dateRevised mesh__D002471 2000-06-22
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D002471 2002
% 224.75/224.90  |- skos__broader mesh__D002471smesh__D009385
% 224.75/224.90  |- skos__altLabel mesh__D010903 Adenohypophysis
% 224.75/224.90  |- skos__scopeNote mesh__D010903
% 224.75/224.90       The anterior glandular lobe of the pituitary gland, also known as the adenohypophysis. It secretes the ADENOHYPOPHYSEAL HORMONES that regulate vital functions such as GROWTH; METABOLISM; and REPRODUCTION.%A%    
% 224.75/224.90  |- mesh__dateRevised mesh__D010903 2005-06-30
% 224.75/224.90  |- mesh__activeMeSHYear mesh__D010903 2006
% 224.75/224.90  |- mesh__recordOriginator mesh__D010903 NLM
% 224.75/224.90  |- mesh__recordAuthorizer mesh__D010903 sjn
% 224.75/224.90  |- skos__broader mesh__D010903smesh__D010902
% 224.75/224.90  |- skos__historyNote mesh__D010903 Pituitary Gland %28%1966-1974%29%
% 224.75/224.90  |- skos__hiddenLabel mesh__D010903 Anterior Pituitary Glands
% 224.75/224.90  |- skos__prefLabel mesh__D010903 Pituitary Gland, Anterior
% 224.75/224.90  |- mesh__onlineNote mesh__D010903 search PITUITARY GLAND 1966-74   
% 224.75/224.90  |- skos__altLabel mesh__D010903 Anterior Pituitary Gland
% 224.75/224.90  |- mesh__recordMaintainer mesh__D010903 lkt
% 224.75/224.90  |- mesh__historyNote mesh__D010903
% 224.75/224.90       78%28%75%29%63-67; was see under PITUITARY GLAND 1968-77   
% 224.75/224.90  |- skos__hiddenLabel mesh__D010903 Adenohypophyses
% 224.75/224.90  |- rdf__type mesh__D010903sskos__Concept
% 224.75/224.90  |- mesh__dateEstablished mesh__D010903 1978-01-01
% 224.75/224.90  |- skos__annotation mesh__D010903
% 224.75/224.90       diseases: coordinate IM with PITUITARY DISEASES %28%IM%29% or specifics %28%IM%29%%A%  
% 224.75/224.90  |- mesh__publicMeSHNote mesh__D010903
% 224.75/224.90       78,63-67; was see under PITUITARY GLAND 1968-77   
% 224.75/224.90  |- skos__hiddenLabel mesh__D010903 Pituitary Glands, Anterior
% 224.75/224.90  |- mesh__dateCreated mesh__D010903 1999-01-01
% 224.75/224.90  |- mesh__recordMaintainer mesh__D010105 jmp
% 224.75/224.90  |- skos__scopeNote mesh__D010105
% 224.75/224.90       Oxidases that specifically introduce DIOXYGEN-derived oxygen atoms into a variety of organic molecules.%A%    
% 224.75/224.90  |- skos__broader mesh__D010105smesh__D010088
% 224.75/224.90  |- skos__prefLabel mesh__D010105 Oxygenases
% 224.75/224.90  |- mesh__recordOriginator mesh__D010105 NLM
% 224.75/224.90  |- mesh__recordAuthorizer mesh__D010105 sjn
% 224.75/224.90  |- mesh__dateRevised mesh__D010105 2005-06-30
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D010105 2006
% 224.75/224.91  |- rdf__type mesh__D010105sskos__Concept
% 224.75/224.91  |- mesh__dateCreated mesh__D010105 1999-01-01
% 224.75/224.91  |- mesh__recordAuthorizer mesh__D015399 sjn
% 224.75/224.91  |- mesh__publicMeSHNote mesh__D015399 89   
% 224.75/224.91  |- skos__historyNote mesh__D015399 Research %28%1966-1988%29%
% 224.75/224.91  |- skos__altLabel mesh__D015399 Research, Nursing
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D015399 2000
% 224.75/224.91  |- mesh__recordMaintainer mesh__D015399 jls
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D015399 2006
% 224.75/224.91  |- skos__historyNote mesh__D015399
% 224.75/224.91       Nursing or specific nursing %28%1966-1988%29%
% 224.75/224.91  |- skos__prefLabel mesh__D015399 Nursing Research
% 224.75/224.91  |- skos__broader mesh__D015399smesh__D009736
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D015399 2005
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D015399 2004
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D015399 2002
% 224.75/224.91  |- mesh__dateEstablished mesh__D015399 1989-01-01
% 224.75/224.91  |- mesh__historyNote mesh__D015399 89   
% 224.75/224.91  |- skos__scopeNote mesh__D015399
% 224.75/224.91       Research carried out by nurses, generally in clinical settings, in the areas of clinical practice, evaluation, nursing education, nursing administration, and methodology.%A%    
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D015399 2003
% 224.75/224.91  |- skos__annotation mesh__D015399 SPEC: SPEC qualif; DF: NURS RESEARCH   
% 224.75/224.91  |- mesh__recordOriginator mesh__D015399 EJB
% 224.75/224.91  |- rdf__type mesh__D015399sskos__Concept
% 224.75/224.91  |- skos__broader mesh__D015399smesh__D009729
% 224.75/224.91  |- mesh__dateRevised mesh__D015399 1999-11-08
% 224.75/224.91  |- mesh__dateCreated mesh__D015399 1988-06-06
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D015399 2001
% 224.75/224.91  |- mesh__dateEstablished mesh__D001379 1966-01-01
% 224.75/224.91  |- mesh__dateRevised mesh__D001379 2000-06-21
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D001379 2004
% 224.75/224.91  |- mesh__historyNote mesh__D001379 66%28%64%29%   
% 224.75/224.91  |- mesh__recordOriginator mesh__D001379 NLM
% 224.75/224.91  |- mesh__dateCreated mesh__D001379 1999-01-01
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D001379 2001
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D001379 2003
% 224.75/224.91  |- skos__scopeNote mesh__D001379
% 224.75/224.91       An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%, this substance has been listed as a known carcinogen. %28%Merck Index, 11th ed%29%%A%    
% 224.75/224.91  |- skos__broader mesh__D001379smesh__D015122
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D001379 2006
% 224.75/224.91  |- skos__prefLabel mesh__D001379 Azathioprine
% 224.75/224.91  |- skos__altLabel mesh__D001379 Immuran
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D001379 2005
% 224.75/224.91  |- rdf__type mesh__D001379sskos__Concept
% 224.75/224.91  |- mesh__publicMeSHNote mesh__D001379 66   
% 224.75/224.91  |- mesh__recordMaintainer mesh__D001379 TWD
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D001379 2002
% 224.75/224.91  |- mesh__recordAuthorizer mesh__D001379 sjn
% 224.75/224.91  |- skos__altLabel mesh__D001379 Azothioprine
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006862 2002
% 224.75/224.91  |- mesh__recordAuthorizer mesh__D006862 sjn
% 224.75/224.91  |- skos__prefLabel mesh__D006862 Hydrogen Sulfide
% 224.75/224.91  |- mesh__recordOriginator mesh__D006862 NLM
% 224.75/224.91  |- mesh__publicMeSHNote mesh__D006862 73   
% 224.75/224.91  |- rdf__type mesh__D006862sskos__Concept
% 224.75/224.91  |- mesh__dateRevised mesh__D006862 2001-07-25
% 224.75/224.91  |- skos__broader mesh__D006862smesh__D013457
% 224.75/224.91  |- skos__broader mesh__D006862smesh__D005740
% 224.75/224.91  |- mesh__dateCreated mesh__D006862 1999-01-01
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006862 2004
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006862 2006
% 224.75/224.91  |- skos__hiddenLabel mesh__D006862 Sulfide, Hydrogen
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006862 2003
% 224.75/224.91  |- mesh__recordMaintainer mesh__D006862 CCR
% 224.75/224.91  |- mesh__historyNote mesh__D006862 73%28%71%29%   
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006862 2005
% 224.75/224.91  |- skos__historyNote mesh__D006862 Sulfides %28%1966-1970%29%
% 224.75/224.91  |- skos__annotation mesh__D006862
% 224.75/224.91       /analogs = SULFIDES or SULFHYDRYL COMPOUNDS or specifics   
% 224.75/224.91  |- skos__historyNote mesh__D006862 Hydrogen %28%1966-1970%29%
% 224.75/224.91  |- skos__broader mesh__D006862smesh__D000148
% 224.75/224.91  |- skos__scopeNote mesh__D006862
% 224.75/224.91       A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. %28%From Merck Index, 11th ed%29%%A%    
% 224.75/224.91  |- mesh__dateEstablished mesh__D006862 1973-01-01
% 224.75/224.91  |- skos__hiddenLabel mesh__D020533 Anti Angiogenic Drugs
% 224.75/224.91  |- skos__hiddenLabel mesh__D020533 Factor Inhibitors, Angiogenesis
% 224.75/224.91  |- mesh__dateRevised mesh__D020533 2005-06-30
% 224.75/224.91  |- skos__broader mesh__D020533smesh__D043924
% 224.75/224.91  |- skos__hiddenLabel mesh__D020533 Anti Angiogenetic Agents
% 224.75/224.91  |- skos__hiddenLabel mesh__D020533 Agents, Angiostatic
% 224.75/224.91  |- skos__altLabel mesh__D020533 Anti-Angiogenetic Agents
% 224.75/224.91  |- skos__altLabel mesh__D020533 Angiogenic Inhibitors
% 224.75/224.91  |- skos__prefLabel mesh__D020533 Angiogenesis Inhibitors
% 224.75/224.91  |- mesh__dateCreated mesh__D020533 1999-11-08
% 224.75/224.91  |- mesh__publicMeSHNote mesh__D020533
% 224.75/224.91       2000; ANGIOGENSIS FACTOR INHIBITORS was indexed under PROTEINS 1981-2003%A%  
% 224.75/224.91  |- skos__hiddenLabel mesh__D020533 Agents, Antiangiogenic
% 224.75/224.91  |- skos__altLabel mesh__D020533 Inhibitors, Angiogenic
% 224.75/224.91  |- skos__altLabel mesh__D020533 Antiangiogenic Agents
% 224.75/224.91  |- skos__altLabel mesh__D020533 Inhibitors, Neovascularization
% 224.75/224.91  |- skos__altLabel mesh__D020533 Inhibitors, Angiogenetic
% 224.75/224.91  |- mesh__dateEstablished mesh__D020533 2000-01-01
% 224.75/224.91  |- mesh__historyNote mesh__D020533
% 224.75/224.91       2004%28%2000%29%; for ANGIOGENESIS FACTOR INHIBITORS use ANGIOGENESIS INHIBITORS %28%NM%29% 1981-2003%A%  
% 224.75/224.91  |- skos__hiddenLabel mesh__D020533 Drugs, Anti-Angiogenic
% 224.75/224.91  |- skos__hiddenLabel mesh__D020533 Inhibitors, Angiogenesis Factor
% 224.75/224.91  |- skos__altLabel mesh__D020533 Anti-Angiogenic Drugs
% 224.75/224.91  |- mesh__recordOriginator mesh__D020533 jmp
% 224.75/224.91  |- skos__altLabel mesh__D020533 Angiogenetic Antagonists
% 224.75/224.91  |- skos__altLabel mesh__D020533 Angiogenetic Inhibitors
% 224.75/224.91  |- skos__broader mesh__D020533smesh__D000970
% 224.75/224.91  |- skos__scopeNote mesh__D020533
% 224.75/224.91       Agents and endogenous substances that antagonize or inhibit the development of new blood vessels.%A%    
% 224.75/224.91  |- mesh__recordAuthorizer mesh__D020533 sjn
% 224.75/224.91  |- skos__altLabel mesh__D020533 Antagonists, Angiogenic
% 224.75/224.91  |- skos__altLabel mesh__D020533 Neovascularization Inhibitors
% 224.75/224.91  |- mesh__recordMaintainer mesh__D020533 ssb
% 224.75/224.91  |- skos__altLabel mesh__D020533 Angiostatic Agents
% 224.75/224.91  |- rdf__type mesh__D020533sskos__Concept
% 224.75/224.91  |- skos__altLabel mesh__D020533 Angiogenic Antagonists
% 224.75/224.91  |- skos__hiddenLabel mesh__D020533 Antagonists, Angiogenetic
% 224.75/224.91  |- skos__hiddenLabel mesh__D020533 Agents, Anti-Angiogenetic
% 224.75/224.91  |- skos__altLabel mesh__D020533 Inhibitors, Angiogenesis
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D020533 2006
% 224.75/224.91  |- skos__broader mesh__D020533smesh__D006131
% 224.75/224.91  |- skos__historyNote mesh__D020533
% 224.75/224.91       Neovascularization, Pathologic %28%1980-1999%29%
% 224.75/224.91  |- skos__scopeNote mesh__D006064
% 224.75/224.91       Gonadotropins secreted by the pituitary or the placenta in horses. This term generally refers to the gonadotropins found in the pregnant mare serum, a rich source of equine CHORIONIC GONADOTROPIN; LUTEINIZING HORMONE; and FOLLICLE STIMULATING HORMONE. Unlike that in humans, the equine LUTEINIZING HORMONE, BETA SUBUNIT is identical to the equine choronic  gonadotropin, beta. Equine gonadotropins prepared from pregnant mare serum are used in reproductive studies.%A%    
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006064 2006
% 224.75/224.91  |- mesh__recordAuthorizer mesh__D006064 ags
% 224.75/224.91  |- skos__broader mesh__D006064smesh__D006062
% 224.75/224.91  |- rdf__type mesh__D006064sskos__Concept
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006064 2006C
% 224.75/224.91  |- skos__altLabel mesh__D006064 PMSG %28%Gonadotropins%29%
% 224.75/224.91  |- mesh__recordOriginator mesh__D006064 NLM
% 224.75/224.91  |- mesh__dateCreated mesh__D006064 1999-01-01
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006064 2006B
% 224.75/224.91  |- mesh__recordMaintainer mesh__D006064 ags
% 224.75/224.91  |- skos__hiddenLabel mesh__D006064 Equine Gonadotropins
% 224.75/224.91  |- skos__hiddenLabel mesh__D006064 Gonadotropins, PMS
% 224.75/224.91  |- skos__prefLabel mesh__D006064 Gonadotropins, Equine
% 224.75/224.91  |- skos__broader mesh__D006064smesh__D010926
% 224.75/224.91  |- mesh__dateRevised mesh__D006064 2005-07-12
% 224.75/224.91  |- skos__altLabel mesh__D006064 PMS Gonadotropins
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006064 2006A
% 224.75/224.91  |- skos__broader mesh__D006064smesh__D011257
% 224.75/224.91  |- rdf__type mesh__D044183sskos__Concept
% 224.75/224.91  |- skos__hiddenLabel mesh__D044183 PTH 2 Receptor
% 224.75/224.91  |- mesh__publicMeSHNote mesh__D044183
% 224.75/224.91       2004; PTH-2 RECEPTOR %28%now RECEPTOR, PARATHYROID HORMONE, TYPE 2%29% was indexed under RECEPTORS, PARATHYROID HORMONE 1996-2003%A%  
% 224.75/224.91  |- skos__prefLabel mesh__D044183 Receptor, Parathyroid Hormone, Type 2
% 224.75/224.91  |- skos__scopeNote mesh__D044183
% 224.75/224.91       A parathyroid hormone receptor subtype found in the BRAIN and the PANCREAS. It is a G-protein-coupled receptor with a ligand specificity that varies between homologs from different species.%A%    
% 224.75/224.91  |- skos__altLabel mesh__D044183 PTH-2 Receptor
% 224.75/224.91  |- mesh__dateCreated mesh__D044183 2003-07-09
% 224.75/224.91  |- skos__hiddenLabel mesh__D044183 Receptor, PTH-2
% 224.75/224.91  |- mesh__dateEstablished mesh__D044183 2004-01-01
% 224.75/224.91  |- skos__altLabel mesh__D044183 PTH2 Receptor
% 224.75/224.91  |- mesh__historyNote mesh__D044183
% 224.75/224.91       2004; use RECEPTOR, PARATHYROID HORMONE, TYPE 2 %28%NM%29% 1996-2003%A%  
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D044183 2005
% 224.75/224.91  |- skos__broader mesh__D044183smesh__D018016
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D044183 2004
% 224.75/224.91  |- skos__historyNote mesh__D044183
% 224.75/224.91       Receptors, Parathyroid Hormone %28%1996-2003%29%
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D044183 2006
% 224.75/224.91  |- skos__altLabel mesh__D044183 Parathyroid Hormone Receptor 2
% 224.75/224.91  |- skos__hiddenLabel mesh__D044183 Receptor, PTH2
% 224.75/224.91  |- mesh__dateEstablished mesh__D002472 1978-01-01
% 224.75/224.91  |- mesh__recordMaintainer mesh__D002472 PLS
% 224.75/224.91  |- skos__altLabel mesh__D002472 Viral Cell Transformation
% 224.75/224.91  |- skos__hiddenLabel mesh__D002472 Viral Cell Transformations
% 224.75/224.91  |- skos__historyNote mesh__D002472
% 224.75/224.91       Cell Transformation, Neoplastic %28%1968-1977%29%
% 224.75/224.91  |- mesh__dateCreated mesh__D002472 1977-05-13
% 224.75/224.91  |- skos__hiddenLabel mesh__D002472 Transformations, Viral Cell
% 224.75/224.91  |- skos__related mesh__D002472smesh__D000957
% 224.75/224.91  |- skos__hiddenLabel mesh__D002472 Cell Transformations, Viral
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D002472 2002
% 224.75/224.91  |- skos__historyNote mesh__D002472
% 224.75/224.91       Cytopathogenic Effect, Viral %28%1966-1967%29%
% 224.75/224.91  |- skos__scopeNote mesh__D002472
% 224.75/224.91       An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus.%A%    
% 224.75/224.91  |- rdf__type mesh__D002472sskos__Concept
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D002472 2001
% 224.75/224.91  |- skos__broader mesh__D002472smesh__D002471
% 224.75/224.91  |- mesh__historyNote mesh__D002472 78   
% 224.75/224.91  |- mesh__recordOriginator mesh__D002472 AEP
% 224.75/224.91  |- skos__prefLabel mesh__D002472 Cell Transformation, Viral
% 224.75/224.91  |- skos__altLabel mesh__D002472 Transformation, Viral Cell
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D002472 2004
% 224.75/224.91  |- mesh__dateRevised mesh__D002472 2000-06-22
% 224.75/224.91  |- skos__annotation mesh__D002472
% 224.75/224.91       do not confuse with CYTOPATHOGENIC EFFECT, VIRAL: see scope notes; DF: CELL TRANSFORM VIRAL%A%  
% 224.75/224.91  |- mesh__publicMeSHNote mesh__D002472 78   
% 224.75/224.91  |- mesh__recordAuthorizer mesh__D002472 sjn
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D002472 2006
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D002472 2003
% 224.75/224.91  |- skos__broader mesh__D002472smesh__D018406
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D002472 2005
% 224.75/224.91  |- skos__historyNote mesh__D002472
% 224.75/224.91       Neoplasms, Experimental %28%1966-1967%29%
% 224.75/224.91  |- skos__scopeNote mesh__D010904
% 224.75/224.91       Neural tissue of the pituitary gland, also known as the neurohypophysis. It consists of the distal AXONS of neurons that produce VASOPRESSIN and OXYTOCIN in the SUPRAOPTIC NUCLEUS and the PARAVENTRICULAR NUCLEUS. These axons travel down through the MEDIAN EMINENCE, the INFUNDIBULAR STALK, to the posterior lobe of the pituitary gland.%A%    
% 224.75/224.91  |- skos__altLabel mesh__D010904 Neurohypophysis
% 224.75/224.91  |- skos__broader mesh__D010904smesh__D010902
% 224.75/224.91  |- skos__altLabel mesh__D010904 Hypothalamus, Infundibular
% 224.75/224.91  |- skos__hiddenLabel mesh__D010904 Posterior Pituitary Glands
% 224.75/224.91  |- skos__prefLabel mesh__D010904 Pituitary Gland, Posterior
% 224.75/224.91  |- mesh__dateRevised mesh__D010904 2005-06-30
% 224.75/224.91  |- mesh__recordOriginator mesh__D010904 NLM
% 224.75/224.91  |- mesh__publicMeSHNote mesh__D010904
% 224.75/224.91       1963; for HYPOTHALAMUS, INFUNDIBULAR see HYPOTHALAMUS, MIDDLE 1983-1999%A%  
% 224.75/224.91  |- skos__altLabel mesh__D010904 Infundibulum, Hypophyseal
% 224.75/224.91  |- mesh__recordAuthorizer mesh__D010904 sjn
% 224.75/224.91  |- skos__altLabel mesh__D010904 Hypophyseal Infundibulum
% 224.75/224.91  |- rdf__type mesh__D010904sskos__Concept
% 224.75/224.91  |- skos__hiddenLabel mesh__D010904 Posterior Pituitary Gland
% 224.75/224.91  |- skos__hiddenLabel mesh__D010904 Infundibular Hypothalamus
% 224.75/224.91  |- skos__annotation mesh__D010904
% 224.75/224.91       diseases: coordinate IM with PITUITARY DISEASES %28%IM%29% or specifics %28%IM%29%%A%  
% 224.75/224.91  |- skos__altLabel mesh__D010904 Infundibular Stem
% 224.75/224.91  |- mesh__historyNote mesh__D010904
% 224.75/224.91       1963; for HYPOTHALAMUS, INFUNDIBULAR use HYPOTHALAMUS, MIDDLE 1983-1999%A%  
% 224.75/224.91  |- mesh__recordMaintainer mesh__D010904 lkt
% 224.75/224.91  |- mesh__dateCreated mesh__D010904 1999-01-01
% 224.75/224.91  |- skos__hiddenLabel mesh__D010904 Gland, Posterior Pituitary
% 224.75/224.91  |- skos__hiddenLabel mesh__D010904 Neurohypophyses
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D010904 2006
% 224.75/224.91  |- mesh__recordMaintainer mesh__D010106 KEV
% 224.75/224.91  |- mesh__publicMeSHNote mesh__D010106 74   
% 224.75/224.91  |- skos__prefLabel mesh__D010106 Oxygenators
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D010106 2005
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D010106 2002
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D010106 2006
% 224.75/224.91  |- mesh__historyNote mesh__D010106 74%28%72%29%   
% 224.75/224.91  |- skos__hiddenLabel mesh__D010106 Oxygenator
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D010106 2003
% 224.75/224.91  |- mesh__recordAuthorizer mesh__D010106 sjn
% 224.75/224.91  |- mesh__recordOriginator mesh__D010106 NLM
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D010106 2000
% 224.75/224.91  |- rdf__type mesh__D010106sskos__Concept
% 224.75/224.91  |- skos__historyNote mesh__D010106 Heart-Lung Machine %28%1966-1971%29%
% 224.75/224.91  |- mesh__dateRevised mesh__D010106 1999-11-03
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D010106 2004
% 224.75/224.91  |- mesh__dateCreated mesh__D010106 1999-01-01
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D010106 2001
% 224.75/224.91  |- skos__related mesh__D010106smesh__D006355
% 224.75/224.91  |- skos__scopeNote mesh__D010106
% 224.75/224.91       Devices which mechanically oxygenate venous blood extracorporeally. They are used in combination with one or more pumps for maintaining circulation during open heart surgery and for assisting the circulation in patients seriously ill with some cardiac and pulmonary disorders. %28%UMDNS, 1999%29%%A%    
% 224.75/224.91  |- skos__broader mesh__D010106smesh__D004864
% 224.75/224.91  |- mesh__dateEstablished mesh__D010106 1974-01-01
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006863 1999
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006863 1996
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006863 1998
% 224.75/224.91  |- skos__annotation mesh__D006863 NIM   
% 224.75/224.91  |- skos__hiddenLabel mesh__D006863 Concentration, Hydrogen-Ion
% 224.75/224.91  |- skos__related mesh__D006863smesh__D002021
% 224.75/224.91  |- mesh__dateRevised mesh__D006863 1995-06-08
% 224.75/224.91  |- rdf__type mesh__D006863sskos__Concept
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006863 2002
% 224.75/224.91  |- skos__hiddenLabel mesh__D006863 Hydrogen-Ion Concentrations
% 224.75/224.91  |- skos__hiddenLabel mesh__D006863 Concentrations, Hydrogen-Ion
% 224.75/224.91  |- mesh__dateCreated mesh__D006863 1999-01-01
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006863 2004
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006863 2001
% 224.75/224.91  |- mesh__recordOriginator mesh__D006863 NLM
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006863 2006
% 224.75/224.91  |- skos__prefLabel mesh__D006863 Hydrogen-Ion Concentration
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006863 2003
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006863 2005
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006863 2000
% 224.75/224.91  |- skos__altLabel mesh__D006863 pH
% 224.75/224.91  |- skos__broader mesh__D006863smesh__D002627
% 224.75/224.91  |- skos__hiddenLabel mesh__D006863 Hydrogen Ion Concentration
% 224.75/224.91  |- mesh__recordMaintainer mesh__D006863 JRT
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006863 1997
% 224.75/224.91  |- mesh__recordAuthorizer mesh__D006863 PLS
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D020534 2001
% 224.75/224.91  |- skos__altLabel mesh__D020534 Hippocampal Gyrus
% 224.75/224.91  |- skos__broader mesh__D020534smesh__D008032
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D020534 2000
% 224.75/224.91  |- skos__hiddenLabel mesh__D020534 Gyrus, Hippocampal
% 224.75/224.91  |- skos__broader mesh__D020534smesh__D013702
% 224.75/224.91  |- mesh__historyNote mesh__D020534 2000   
% 224.75/224.91  |- skos__scopeNote mesh__D020534
% 224.75/224.91       A convolution on the inferior surface of each cerebral hemisphere, lying between the hippocampal and collateral sulci. %28%Dorland, 28th ed%29%%A%    
% 224.75/224.91  |- skos__hiddenLabel mesh__D020534 Parahippocampalis, Gyrus
% 224.75/224.91  |- skos__altLabel mesh__D020534 Gyrus Hippocampi
% 224.75/224.91  |- skos__prefLabel mesh__D020534 Parahippocampal Gyrus
% 224.75/224.91  |- rdf__type mesh__D020534sskos__Concept
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D020534 2004
% 224.75/224.91  |- mesh__publicMeSHNote mesh__D020534 2000   
% 224.75/224.91  |- mesh__dateEstablished mesh__D020534 2000-01-01
% 224.75/224.91  |- skos__hiddenLabel mesh__D020534 Gyrus, Parahippocampal
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D020534 2006
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D020534 2003
% 224.75/224.91  |- skos__hiddenLabel mesh__D020534 Gyrus Hippocampus
% 224.75/224.91  |- mesh__dateCreated mesh__D020534 1999-11-03
% 224.75/224.91  |- skos__historyNote mesh__D020534 Hippocampus %28%1969-1999%29%
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D020534 2002
% 224.75/224.91  |- skos__altLabel mesh__D020534 Gyrus Parahippocampalis
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D020534 2005
% 224.75/224.91  |- mesh__dateRevised mesh__D006065 2002-07-03
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006065 2005
% 224.75/224.91  |- skos__scopeNote mesh__D006065
% 224.75/224.91       Hormones secreted by the adenohypophysis %28%PITUITARY GLAND, ANTERIOR%29% that stimulate gonadal functions in both males and females. They include FOLLICLE STIMULATING HORMONE that stimulates germ cell maturation %28%OOGENESIS; SPERMATOGENESIS%29%, and LUTEINIZING HORMONE that stimulates the production of sex steroids %28%ESTROGENS; PROGESTERONE; ANDROGENS%29%.%A%    
% 224.75/224.91  |- rdf__type mesh__D006065sskos__Concept
% 224.75/224.91  |- mesh__dateCreated mesh__D006065 1999-01-01
% 224.75/224.91  |- skos__hiddenLabel mesh__D006065 Pituitary Gonadotropins
% 224.75/224.91  |- skos__annotation mesh__D006065 GEN; prefer specifics   
% 224.75/224.91  |- skos__broader mesh__D006065smesh__D006062
% 224.75/224.91  |- skos__prefLabel mesh__D006065 Gonadotropins, Pituitary
% 224.75/224.91  |- mesh__recordAuthorizer mesh__D006065 sjn
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006065 2004
% 224.75/224.91  |- skos__broader mesh__D006065smesh__D010908
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006065 2003
% 224.75/224.91  |- mesh__recordOriginator mesh__D006065 NLM
% 224.75/224.91  |- skos__related mesh__D006065smesh__D011967
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D006065 2006
% 224.75/224.91  |- mesh__recordMaintainer mesh__D006065 lkt
% 224.75/224.91  |- skos__related mesh__D044982smesh__D008648
% 224.75/224.91  |- skos__hiddenLabel mesh__D044982 Stem Cell, Mesenchymal
% 224.75/224.91  |- skos__hiddenLabel mesh__D044982 Cell, Mesenchymal Progenitor
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D044982 2006
% 224.75/224.91  |- mesh__publicMeSHNote mesh__D044982 2004   
% 224.75/224.91  |- skos__hiddenLabel mesh__D044982 Cells, Mesenchymal Progenitor
% 224.75/224.91  |- skos__historyNote mesh__D044982 Mesoderm/cytology %28%1994-2003%29%
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D044982 2004
% 224.75/224.91  |- skos__altLabel mesh__D044982 Mesenchymal Progenitor Cell
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D044982 2005
% 224.75/224.91  |- mesh__historyNote mesh__D044982 2004   
% 224.75/224.91  |- skos__altLabel mesh__D044982 Stem Cells, Mesenchymal
% 224.75/224.91  |- rdf__type mesh__D044982sskos__Concept
% 224.75/224.91  |- skos__hiddenLabel mesh__D044982 Progenitor Cells, Mesenchymal
% 224.75/224.91  |- skos__scopeNote mesh__D044982
% 224.75/224.91       Cells that can develop into distinct mesenchymal tissue such as BONE; TENDONS; MUSCLES; ADIPOSE TISSUE; CARTILAGE; NERVE TISSUE; and BLOOD and BLOOD VESSELS.%A%    
% 224.75/224.91  |- skos__altLabel mesh__D044982 Mesenchymal Stem Cell
% 224.75/224.91  |- skos__broader mesh__D044982smesh__D013234
% 224.75/224.91  |- mesh__dateCreated mesh__D044982 2003-07-09
% 224.75/224.91  |- skos__hiddenLabel mesh__D044982 Cells, Mesenchymal Stem
% 224.75/224.91  |- mesh__dateEstablished mesh__D044982 2004-01-01
% 224.75/224.91  |- skos__hiddenLabel mesh__D044982 Progenitor Cell, Mesenchymal
% 224.75/224.91  |- skos__altLabel mesh__D044982 Mesenchymal Progenitor Cells
% 224.75/224.91  |- skos__prefLabel mesh__D044982 Mesenchymal Stem Cells
% 224.75/224.91  |- skos__hiddenLabel mesh__D044982 Cell, Mesenchymal Stem
% 224.75/224.91  |- mesh__historyNote mesh__D044184 2004   
% 224.75/224.91  |- mesh__recordMaintainer mesh__D044184 SYSTEM
% 224.75/224.91  |- skos__prefLabel mesh__D044184 Xanthomonas vesicatoria
% 224.75/224.91  |- mesh__dateCreated mesh__D044184 2003-07-09
% 224.75/224.91  |- mesh__publicMeSHNote mesh__D044184 2004   
% 224.75/224.91  |- skos__broader mesh__D044184smesh__D014974
% 224.75/224.91  |- skos__historyNote mesh__D044184 Xanthomonas %28%1977-2003%29%
% 224.75/224.91  |- skos__scopeNote mesh__D044184
% 224.75/224.91       A species of gram-negative bacteria, in the genus XANTHOMONAS, causing disease in TOMATO and pepper crops.%A%    
% 224.75/224.91  |- mesh__recordAuthorizer mesh__D044184 sjn
% 224.75/224.91  |- mesh__activeMeSHYear mesh__D044184 2006
% 224.75/224.91  |- mesh__dateRevised mesh__D044184 2005-06-30
% 224.75/224.91  |- mesh__recordOriginator mesh__D044184 ags
% 224.75/224.91  |- rdf__type mesh__D044184sskos__Concept
% 224.75/224.91  |- mesh__dateEstablished mesh__D044184 2004-01-01
% 224.75/224.92  |- mesh__dateCreated mesh__D002473 1999-01-01
% 224.75/224.92  |- mesh__dateEstablished mesh__D002473 1967-01-01
% 224.75/224.92  |- rdf__type mesh__D002473sskos__Concept
% 224.75/224.92  |- skos__hiddenLabel mesh__D002473 Cell Walls
% 224.75/224.92  |- mesh__recordMaintainer mesh__D002473 lkt
% 224.75/224.92  |- mesh__publicMeSHNote mesh__D002473 67   
% 224.75/224.92  |- skos__hiddenLabel mesh__D002473 Walls, Cell
% 224.75/224.92  |- skos__broader mesh__D002473smesh__D022082
% 224.75/224.92  |- skos__prefLabel mesh__D002473 Cell Wall
% 224.75/224.92  |- mesh__recordOriginator mesh__D002473 NLM
% 224.75/224.92  |- skos__scopeNote mesh__D002473
% 224.75/224.92       The outermost layer of a cell in most PLANTS; BACTERIA; FUNGI; and ALGAE. The cell wall is usually a rigid structure that lies external to the CELL MEMBRANE, and provides a protective barrier against physical or chemical agents.%A%    
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D002473 2006
% 224.75/224.92  |- skos__hiddenLabel mesh__D002473 Wall, Cell
% 224.75/224.92  |- mesh__dateRevised mesh__D002473 2005-06-30
% 224.75/224.92  |- mesh__historyNote mesh__D002473 67%28%66%29%   
% 224.75/224.92  |- mesh__recordAuthorizer mesh__D002473 sjn
% 224.75/224.92  |- skos__related mesh__D010905smesh__D018017
% 224.75/224.92  |- mesh__historyNote mesh__D010905 75   
% 224.75/224.92  |- rdf__type mesh__D010905sskos__Concept
% 224.75/224.92  |- skos__broader mesh__D010905smesh__D009479
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010905 2004
% 224.75/224.92  |- skos__altLabel mesh__D010905
% 224.75/224.92       Pituitary Hormone-Release Inhibiting Hormones
% 224.75/224.92  |- mesh__recordMaintainer mesh__D010905 jmp
% 224.75/224.92  |- skos__historyNote mesh__D010905
% 224.75/224.92       Pituitary Hormone Releasing Hormones %28%1968-1974%29%
% 224.75/224.92  |- skos__prefLabel mesh__D010905
% 224.75/224.92       Pituitary Hormone Release Inhibiting Hormones
% 224.75/224.92  |- mesh__dateEstablished mesh__D010905 1975-09-01
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010905 2005
% 224.75/224.92  |- mesh__dateRevised mesh__D010905 2003-07-09
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010905 2006
% 224.75/224.92  |- skos__broader mesh__D010905smesh__D036361
% 224.75/224.92  |- skos__scopeNote mesh__D010905
% 224.75/224.92       Polypeptide hormones produced in the hypothalamus which inhibit the release of pituitary hormones. Used for PHRIH in general or for which there is no specific heading.%A%    
% 224.75/224.92  |- mesh__recordOriginator mesh__D010905 NLM
% 224.75/224.92  |- skos__broader mesh__D010905smesh__D007028
% 224.75/224.92  |- mesh__dateCreated mesh__D010905 1974-11-11
% 224.75/224.92  |- mesh__recordAuthorizer mesh__D010905 sjn
% 224.75/224.92  |- mesh__publicMeSHNote mesh__D010905 75   
% 224.75/224.92  |- skos__annotation mesh__D010905 /biosyn /physiol permitted; DF: PHRIH   
% 224.75/224.92  |- mesh__recordAuthorizer mesh__D010107 ags
% 224.75/224.92  |- mesh__dateCreated mesh__D010107 1999-01-01
% 224.75/224.92  |- mesh__dateEstablished mesh__D010107 1974-01-01
% 224.75/224.92  |- mesh__recordMaintainer mesh__D010107 ags
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010107 2000A
% 224.75/224.92  |- skos__prefLabel mesh__D010107 Oxygenators, Membrane
% 224.75/224.92  |- skos__scopeNote mesh__D010107
% 224.75/224.92       Devices in which blood and oxygen are separated by a semipermeable membrane, generally of Teflon or polypropylene, across which gas exchange occurs. The membrane may be arranged as a series of parallel plates or as a number of hollow fibers; in the latter arrangement, the blood may flow inside the fibers, which are surrounded by gas, or the blood may flow outside the fibers and the gas inside the fibers. %28%Dorland, 28th ed%29%%A%    
% 224.75/224.92  |- skos__hiddenLabel mesh__D010107 Membrane Oxygenator
% 224.75/224.92  |- mesh__historyNote mesh__D010107 74%28%72%29%   
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010107 2001
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010107 2006
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010107 2000
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010107 2004
% 224.75/224.92  |- skos__broader mesh__D010107smesh__D010106
% 224.75/224.92  |- skos__historyNote mesh__D010107 Membranes, Artificial %28%1966-1971%29%
% 224.75/224.92  |- skos__hiddenLabel mesh__D010107 Oxygenator, Membrane
% 224.75/224.92  |- mesh__publicMeSHNote mesh__D010107 74   
% 224.75/224.92  |- mesh__dateRevised mesh__D010107 1999-12-16
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010107 2005
% 224.75/224.92  |- rdf__type mesh__D010107sskos__Concept
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010107 2003
% 224.75/224.92  |- mesh__recordOriginator mesh__D010107 NLM
% 224.75/224.92  |- skos__historyNote mesh__D010107 Heart-Lung Machine %28%1966-1971%29%
% 224.75/224.92  |- skos__hiddenLabel mesh__D010107 Membrane Oxygenators
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010107 2002
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006864 2006
% 224.75/224.92  |- skos__broader mesh__D006864smesh__D010088
% 224.75/224.92  |- skos__hiddenLabel mesh__D006864 Hydrogenase, H2-Oxidizing
% 224.75/224.92  |- skos__hiddenLabel mesh__D006864 H2 Oxidizing Hydrogenase
% 224.75/224.92  |- skos__altLabel mesh__D006864 Hydrogenlyase
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006864 2005
% 224.75/224.92  |- mesh__dateRevised mesh__D006864 2003-07-09
% 224.75/224.92  |- mesh__recordMaintainer mesh__D006864 ssb
% 224.75/224.92  |- skos__scopeNote mesh__D006864
% 224.75/224.92       An enzyme found in bacteria. It catalyzes the reduction of ferredoxin and other substances in the presence of molecular hydrogen and is involved in the electron transport of bacterial photosynthesis. EC 1.18.99.1.%A%    
% 224.75/224.92  |- mesh__publicMeSHNote mesh__D006864 85   
% 224.75/224.92  |- mesh__recordAuthorizer mesh__D006864 sjn
% 224.75/224.92  |- skos__historyNote mesh__D006864 Oxidoreductases %28%1966-1984%29%
% 224.75/224.92  |- skos__prefLabel mesh__D006864 Hydrogenase
% 224.75/224.92  |- mesh__recordOriginator mesh__D006864 RLS
% 224.75/224.92  |- skos__hiddenLabel mesh__D006864 Hydrogenase, Ferredoxin
% 224.75/224.92  |- rdf__type mesh__D006864sskos__Concept
% 224.75/224.92  |- mesh__historyNote mesh__D006864 85   
% 224.75/224.92  |- mesh__dateCreated mesh__D006864 1984-05-25
% 224.75/224.92  |- mesh__dateEstablished mesh__D006864 1985-01-01
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006864 2004
% 224.75/224.92  |- skos__hiddenLabel mesh__D020535 Surgeries, Video-Assisted
% 224.75/224.92  |- skos__hiddenLabel mesh__D020535 Surgery, Video Assisted
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D020535 2002
% 224.75/224.92  |- mesh__historyNote mesh__D020535 2000   
% 224.75/224.92  |- skos__broader mesh__D020535smesh__D004724
% 224.75/224.92  |- rdf__type mesh__D020535sskos__Concept
% 224.75/224.92  |- skos__scopeNote mesh__D020535
% 224.75/224.92       Endoscopic surgical procedures performed with visualization via video transmission. When real-time video is combined interactively with prior CT scans or MRI images, this is called image-guided surgery %28%see SURGERY, COMPUTER-ASSISTED%29%.%A%    
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D020535 2004
% 224.75/224.92  |- mesh__recordAuthorizer mesh__D020535 sjn
% 224.75/224.92  |- mesh__dateCreated mesh__D020535 1999-11-08
% 224.75/224.92  |- mesh__dateEstablished mesh__D020535 2000-01-01
% 224.75/224.92  |- skos__related mesh__D020535smesh__D014741
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D020535 2006
% 224.75/224.92  |- mesh__recordOriginator mesh__D020535 nns
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D020535 2003
% 224.75/224.92  |- skos__hiddenLabel mesh__D020535 Video Assisted Surgery
% 224.75/224.92  |- skos__altLabel mesh__D020535 Surgery, Video-Assisted
% 224.75/224.92  |- skos__historyNote mesh__D020535
% 224.75/224.92       Surgical Procedures, Endoscopic %28%1996-1999%29%
% 224.75/224.92  |- skos__historyNote mesh__D020535 Endoscopy or specifics %28%1975-1999%29%
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D020535 2005
% 224.75/224.92  |- skos__prefLabel mesh__D020535 Video-Assisted Surgery
% 224.75/224.92  |- mesh__publicMeSHNote mesh__D020535 2000   
% 224.75/224.92  |- skos__historyNote mesh__D020535
% 224.75/224.92       Video Recording or specifics %28%1975-1999%29%
% 224.75/224.92  |- mesh__recordMaintainer mesh__D020535 ags
% 224.75/224.92  |- mesh__dateRevised mesh__D020535 2001-07-25
% 224.75/224.92  |- skos__hiddenLabel mesh__D020535 Video-Assisted Surgeries
% 224.75/224.92  |- mesh__recordOriginator mesh__D006066 NLM
% 224.75/224.92  |- skos__annotation mesh__D006066
% 224.75/224.92       GEN: prefer OVARY or TESTIS; disord: see specific gonadal disord in Cat C19; /abnorm: agenesis %26% dysgenesis: index under GONADAL DYSGENESIS %26% consider also SEX DIFFERENTIATION DISORDERS %28%C16%29%; excision: see note under CASTRATION%A%  
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006066 1998
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006066 2000
% 224.75/224.92  |- skos__broader mesh__D006066smesh__D005835
% 224.75/224.92  |- rdf__type mesh__D006066sskos__Concept
% 224.75/224.92  |- skos__hiddenLabel mesh__D006066 Gonad
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006066 2003
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006066 1994
% 224.75/224.92  |- mesh__recordMaintainer mesh__D006066 TGC
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006066 1999
% 224.75/224.92  |- skos__related mesh__D006066smesh__D002369
% 224.75/224.92  |- mesh__dateRevised mesh__D006066 1991-06-20
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006066 2004
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006066 2001
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006066 1995
% 224.75/224.92  |- mesh__recordAuthorizer mesh__D006066 PLS
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006066 2002
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006066 2005
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006066 1996
% 224.75/224.92  |- skos__broader mesh__D006066smesh__D004702
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006066 1992
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006066 2006
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006066 1997
% 224.75/224.92  |- skos__scopeNote mesh__D006066
% 224.75/224.92       The gamete-producing glands, OVARY or TESTIS.     
% 224.75/224.92  |- skos__related mesh__D006066smesh__D012745
% 224.75/224.92  |- skos__prefLabel mesh__D006066 Gonads
% 224.75/224.92  |- mesh__dateCreated mesh__D006066 1999-01-01
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006066 1993
% 224.75/224.92  |- rdf__type mesh__D011200sskos__Concept
% 224.75/224.92  |- skos__hiddenLabel mesh__D011200 Fowl, Domestic
% 224.75/224.92  |- mesh__recordMaintainer mesh__D011200 ags
% 224.75/224.92  |- mesh__dateRevised mesh__D011200 2003-07-09
% 224.75/224.92  |- mesh__recordOriginator mesh__D011200 NLM
% 224.75/224.92  |- skos__annotation mesh__D011200
% 224.75/224.92       GEN or unspecified; prefer specifics; IM; qualif permitted; differentiate from BIRDS: %22%birds%22% in zoos, parks, forest, streets, pet shops = BIRDS, %22%birds%22% in barnyard, hatchery, butcher shop = POULTRY; definition: Manual 22.29; as food: Manual 31.7; canned poultry meat: see note on POULTRY PRODUCTS%A%  
% 224.75/224.92  |- skos__prefLabel mesh__D011200 Poultry
% 224.75/224.92  |- skos__altLabel mesh__D011200 Fowls, Domestic
% 224.75/224.92  |- mesh__dateCreated mesh__D011200 1999-01-01
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D011200 2006
% 224.75/224.92  |- mesh__recordAuthorizer mesh__D011200 sjn
% 224.75/224.92  |- skos__broader mesh__D011200smesh__D008460
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D011200 2005
% 224.75/224.92  |- skos__hiddenLabel mesh__D011200 Domestic Fowls
% 224.75/224.92  |- skos__hiddenLabel mesh__D011200 Domestic Fowl
% 224.75/224.92  |- skos__hiddenLabel mesh__D011200 Poultries
% 224.75/224.92  |- skos__broader mesh__D011200smesh__D001717
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D011200 2004
% 224.75/224.92  |- skos__hiddenLabel mesh__D016494 Worms, Computer
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D016494 1995
% 224.75/224.92  |- skos__broader mesh__D016494smesh__D007254
% 224.75/224.92  |- skos__hiddenLabel mesh__D016494 Virus, Computer
% 224.75/224.92  |- skos__hiddenLabel mesh__D016494 Protection, Information
% 224.75/224.92  |- skos__hiddenLabel mesh__D016494 Computer Hacker
% 224.75/224.92  |- skos__prefLabel mesh__D016494 Computer Security
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D016494 1998
% 224.75/224.92  |- skos__hiddenLabel mesh__D016494 Computer Worm
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D016494 2001
% 224.75/224.92  |- skos__historyNote mesh__D016494 Computer Systems %28%1987-1991%29%
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D016494 1994
% 224.75/224.92  |- skos__hiddenLabel mesh__D016494 Hackers, Computer
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D016494 2000
% 224.75/224.92  |- skos__hiddenLabel mesh__D016494 Data Compromising
% 224.75/224.92  |- skos__hiddenLabel mesh__D016494 Computer Virus
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D016494 2004
% 224.75/224.92  |- skos__hiddenLabel mesh__D016494 Protection, Data
% 224.75/224.92  |- mesh__dateRevised mesh__D016494 1992-05-07
% 224.75/224.92  |- mesh__dateEstablished mesh__D016494 1992-01-01
% 224.75/224.92  |- skos__annotation mesh__D016494
% 224.75/224.92       against unauthorized access to computers %26% databases: read MeSH definition %26% note X refs; do not use for confidentiality of records %28% = CONFIDENTIALITY + RECORDS or specific records term%29%%A%  
% 224.75/224.92  |- skos__hiddenLabel mesh__D016494 Security, Computer
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D016494 1997
% 224.75/224.92  |- skos__hiddenLabel mesh__D016494 Viruses, Computer
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D016494 2003
% 224.75/224.92  |- mesh__recordOriginator mesh__D016494 TGC
% 224.75/224.92  |- mesh__historyNote mesh__D016494 92   
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D016494 1993
% 224.75/224.92  |- mesh__publicMeSHNote mesh__D016494 92   
% 224.75/224.92  |- mesh__recordMaintainer mesh__D016494 TAP
% 224.75/224.92  |- skos__hiddenLabel mesh__D016494 Worm, Computer
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D016494 1996
% 224.75/224.92  |- skos__broader mesh__D016494smesh__D012637
% 224.75/224.92  |- skos__historyNote mesh__D016494 Information Systems %28%1982-1991%29%
% 224.75/224.92  |- skos__hiddenLabel mesh__D016494 Security, Data
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D016494 2002
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D016494 2006
% 224.75/224.92  |- mesh__recordAuthorizer mesh__D016494 PLS
% 224.75/224.92  |- rdf__type mesh__D016494sskos__Concept
% 224.75/224.92  |- mesh__dateCreated mesh__D016494 1991-01-02
% 224.75/224.92  |- skos__hiddenLabel mesh__D016494 Hacker, Computer
% 224.75/224.92  |- skos__historyNote mesh__D016494 Confidentiality %28%1980-1991%29%
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D016494 1999
% 224.75/224.92  |- skos__scopeNote mesh__D016494
% 224.75/224.92       Protective measures against unauthorized access to or interference with computer operating systems, telecommunications, or data structures, especially the modification, deletion, destruction, or release of data in computers. It includes methods of forestalling interference by computer viruses or so-called computer hackers aiming to compromise stored data.%A%    
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D016494 2005
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D002474 2001
% 224.75/224.92  |- skos__hiddenLabel mesh__D002474 Systems, Cellfree
% 224.75/224.92  |- mesh__recordMaintainer mesh__D002474 TGC
% 224.75/224.92  |- mesh__historyNote mesh__D002474
% 224.75/224.92       91%28%67%29%; was see under SUBCELLULAR FRACTIONS 1967-90   
% 224.75/224.92  |- skos__hiddenLabel mesh__D002474 Systems, Cell-Free
% 224.75/224.92  |- rdf__type mesh__D002474sskos__Concept
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D002474 2003
% 224.75/224.92  |- skos__hiddenLabel mesh__D002474 System, Cellfree
% 224.75/224.92  |- mesh__recordAuthorizer mesh__D002474 sjn
% 224.75/224.92  |- skos__hiddenLabel mesh__D002474 Cell Free System
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D002474 2005
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D002474 2004
% 224.75/224.92  |- skos__hiddenLabel mesh__D002474 System, Cell-Free
% 224.75/224.92  |- skos__scopeNote mesh__D002474
% 224.75/224.92       A fractionated cell extract that maintains a biological function. A subcellular fraction isolated by ultracentrifugation or other separation techniques must first be isolated so that a process can be studied free from all of the complex side reactions that occur in a cell. The cell-free system is therefore widely used in cell biology. %28%From Alberts et al., Molecular Biology of the Cell, 2d ed, p166%29%%A%    
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D002474 2002
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D002474 2006
% 224.75/224.92  |- skos__altLabel mesh__D002474 Cellfree System
% 224.75/224.92  |- mesh__dateCreated mesh__D002474 1999-01-01
% 224.75/224.92  |- skos__prefLabel mesh__D002474 Cell-Free System
% 224.75/224.92  |- mesh__publicMeSHNote mesh__D002474
% 224.75/224.92       91; was see under SUBCELLULAR FRACTIONS 1967-90   
% 224.75/224.92  |- mesh__recordOriginator mesh__D002474 NLM
% 224.75/224.92  |- mesh__dateEstablished mesh__D002474 1991-01-01
% 224.75/224.92  |- skos__annotation mesh__D002474
% 224.75/224.92       for study of subcellular fractions; not for micro-organisms; NIM; use A 11 qualif discreetly%A%  
% 224.75/224.92  |- skos__hiddenLabel mesh__D002474 Cellfree Systems
% 224.75/224.92  |- skos__hiddenLabel mesh__D002474 Cell-Free Systems
% 224.75/224.92  |- skos__broader mesh__D002474smesh__D013347
% 224.75/224.92  |- mesh__dateRevised mesh__D002474 2000-06-22
% 224.75/224.92  |- mesh__recordAuthorizer mesh__D010906 sjn
% 224.75/224.92  |- skos__broader mesh__D010906smesh__D009479
% 224.75/224.92  |- mesh__recordMaintainer mesh__D010906 jmp
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010906 2005
% 224.75/224.92  |- mesh__dateCreated mesh__D010906 1999-01-01
% 224.75/224.92  |- skos__altLabel mesh__D010906 Hormones, Pituitary Hormone Releasing
% 224.75/224.92  |- mesh__dateRevised mesh__D010906 2003-07-09
% 224.75/224.92  |- skos__hiddenLabel mesh__D010906 Hormones, Pituitary Hormone-Releasing
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010906 2006
% 224.75/224.92  |- mesh__onlineNote mesh__D010906
% 224.75/224.92       use PITUITARY HORMONE-RELEASING HORMONES to search PITUITARY HORMONE RELEASING HORMONES 1974-90 %26% PITUITARY HORMONE RELEASING FACTORS 1968-73%A%  
% 224.75/224.92  |- skos__altLabel mesh__D010906 Pituitary Hormone Releasing Hormones
% 224.75/224.92  |- skos__broader mesh__D010906smesh__D007028
% 224.75/224.92  |- skos__annotation mesh__D010906
% 224.75/224.92       IM + coord with specific hormone %28%IM%29% but note many specific precoords available; /biosyn /drug eff /physiol permitted; DF: PHRH%A%  
% 224.75/224.92  |- skos__hiddenLabel mesh__D010906 Hormone-Releasing Hormones, Pituitary
% 224.75/224.92  |- mesh__publicMeSHNote mesh__D010906
% 224.75/224.92       91; was PITUITARY HORMONE RELEASING HORMONES 1974-90; was PITUITARY HORMONE RELEASING FACTORS 1968-73%A%  
% 224.75/224.92  |- skos__hiddenLabel mesh__D010906 Factor, Hypothalamic Releasing
% 224.75/224.92  |- skos__prefLabel mesh__D010906 Pituitary Hormone-Releasing Hormones
% 224.75/224.92  |- skos__historyNote mesh__D010906
% 224.75/224.92       Hypothalamo-Hypophyseal System/physiology %28%1966-1967%29%
% 224.75/224.92  |- mesh__dateEstablished mesh__D010906 1968-01-01
% 224.75/224.92  |- skos__broader mesh__D010906smesh__D036361
% 224.75/224.92  |- skos__scopeNote mesh__D010906
% 224.75/224.92       Hormones released by one structure %28%e.g., the hypothalamus or the thyroid gland%29% that effect the secretion of hormones from the pituitary gland.%A%    
% 224.75/224.92  |- skos__related mesh__D010906smesh__D018017
% 224.75/224.92  |- rdf__type mesh__D010906sskos__Concept
% 224.75/224.92  |- mesh__historyNote mesh__D010906
% 224.75/224.92       91; was PITUITARY HORMONE RELEASING HORMONES 1974-90; was PITUITARY HORMONE RELEASING FACTORS 1968-73%A%  
% 224.75/224.92  |- skos__hiddenLabel mesh__D010906 Releasing Factor, Hypothalamic
% 224.75/224.92  |- mesh__recordOriginator mesh__D010906 NLM
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010906 2004
% 224.75/224.92  |- skos__historyNote mesh__D010108 Hemoglobins %28%1966-1972%29%
% 224.75/224.92  |- mesh__recordOriginator mesh__D010108 NLM
% 224.75/224.92  |- mesh__recordMaintainer mesh__D010108 TAP
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010108 2002
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010108 1999
% 224.75/224.92  |- mesh__dateEstablished mesh__D010108 1977-01-01
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010108 1997
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010108 2006
% 224.75/224.92  |- skos__annotation mesh__D010108
% 224.75/224.92       Bohr effect is indexed OXYHEMOGLOBINS /metab %28%IM%29% + PH %28%NIM%29%%A%  
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010108 2004
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010108 1998
% 224.75/224.92  |- mesh__historyNote mesh__D010108
% 224.75/224.92       79; was OXYHEMOGLOBIN 1977-78, was OXYHEMOGLOBIN see under HEMOGLOBINS 1975-76, was OXYHEMOGLOBIN 1973-74 %28%Prov%29%%A%  
% 224.75/224.92  |- mesh__recordAuthorizer mesh__D010108 PLS
% 224.75/224.92  |- skos__altLabel mesh__D010108 Oxyhemoglobin
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010108 1996
% 224.75/224.92  |- skos__broader mesh__D010108smesh__D006454
% 224.75/224.92  |- rdf__type mesh__D010108sskos__Concept
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010108 2005
% 224.75/224.92  |- skos__prefLabel mesh__D010108 Oxyhemoglobins
% 224.75/224.92  |- skos__scopeNote mesh__D010108
% 224.75/224.92       A compound formed by the combination of hemoglobin and oxygen. It is a complex in which the oxygen is bound directly to the iron without causing a change from the ferrous to the ferric state.%A%    
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010108 2001
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010108 2003
% 224.75/224.92  |- skos__hiddenLabel mesh__D010108 Hemoglobin, Oxycobalt
% 224.75/224.92  |- skos__altLabel mesh__D010108 Oxycobalt Hemoglobin
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D010108 2000
% 224.75/224.92  |- mesh__onlineNote mesh__D010108
% 224.75/224.92       use OXYHEMOGLOBINS to search OXYHEMOGLOBIN 1973-78 %28%as Prov 1973-74%29%%A%  
% 224.75/224.92  |- mesh__dateCreated mesh__D010108 1999-01-01
% 224.75/224.92  |- mesh__publicMeSHNote mesh__D010108
% 224.75/224.92       79; was OXYHEMOGLOBIN 1977-78, was OXYHEMOGLOBIN see under HEMOGLOBINS 1975-76%A%  
% 224.75/224.92  |- mesh__dateRevised mesh__D010108 1995-05-18
% 224.75/224.92  |- skos__altLabel mesh__D039241 CstF Protein
% 224.75/224.92  |- rdf__type mesh__D039241sskos__Concept
% 224.75/224.92  |- mesh__recordAuthorizer mesh__D039241 ags
% 224.75/224.92  |- mesh__recordMaintainer mesh__D039241 ags
% 224.75/224.92  |- mesh__historyNote mesh__D039241
% 224.75/224.92       2003; for CLEAVAGE STIMULATION FACTOR use MRNA CLEAVAGE AND POLYADENYLATION FACTORS %28%NM%29% 1992-2002%A%  
% 224.75/224.92  |- skos__prefLabel mesh__D039241 Cleavage Stimulation Factor
% 224.75/224.92  |- mesh__publicMeSHNote mesh__D039241
% 224.75/224.92       2003; CLEAVAGE STIMULATION FACTOR was indexed under RNA-BINDING PROTEINS 1992-2002%A%  
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D039241 2005
% 224.75/224.92  |- skos__broader mesh__D039241smesh__D039221
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D039241 2006
% 224.75/224.92  |- mesh__dateEstablished mesh__D039241 2003-01-01
% 224.75/224.92  |- mesh__dateCreated mesh__D039241 2002-07-03
% 224.75/224.92  |- skos__scopeNote mesh__D039241
% 224.75/224.92       A RNA-binding protein that stimulates the cleavage of the 3%27% end of MRNA near the POLYADENYLATION site.  It is a heterotrimer of 55-, 64- and 77-kDa subunits and combines with CLEAVAGE STIMULATION FACTOR to form a stable complex with mRNA that directs the 3%27% cleavage and polyadenylation reaction.%A%    
% 224.75/224.92  |- mesh__dateRevised mesh__D039241 2005-07-27
% 224.75/224.92  |- mesh__recordOriginator mesh__D039241 jmp
% 224.75/224.92  |- skos__historyNote mesh__D039241 RNA-Binding Proteins %28%1992-2002%29%
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D039241 2006A
% 224.75/224.92  |- mesh__recordAuthorizer mesh__D006865 SJN
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006865 2001
% 224.75/224.92  |- mesh__recordOriginator mesh__D006865 NLM
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006865 2005
% 224.75/224.92  |- skos__historyNote mesh__D006865 Hydrogen %28%1966-1970%29%
% 224.75/224.92  |- skos__annotation mesh__D006865
% 224.75/224.92       almost never IM; enzymatic hydrogenation: coord NIM with specific enzyme %28%IM%29% + substrate %28%NIM%29%%A%  
% 224.75/224.92  |- skos__broader mesh__D006865smesh__D008660
% 224.75/224.92  |- skos__broader mesh__D006865smesh__D002625
% 224.75/224.92  |- skos__scopeNote mesh__D006865
% 224.75/224.92       Addition of hydrogen to a compound, especially to an unsaturated fat or fatty acid. %28%From Stedman, 26th ed%29%%A%    
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006865 2000
% 224.75/224.92  |- mesh__recordMaintainer mesh__D006865 PXP
% 224.75/224.92  |- mesh__dateRevised mesh__D006865 1997-06-20
% 224.75/224.92  |- skos__hiddenLabel mesh__D006865 Hydrogenations
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006865 1999
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006865 1998
% 224.75/224.92  |- rdf__type mesh__D006865sskos__Concept
% 224.75/224.92  |- mesh__dateCreated mesh__D006865 1999-01-01
% 224.75/224.92  |- mesh__publicMeSHNote mesh__D006865
% 224.75/224.92       91; was see under CHEMISTRY, ORGANIC 1971-90   
% 224.75/224.92  |- mesh__historyNote mesh__D006865
% 224.75/224.92       91%28%71%29%; was see under CHEMISTRY, ORGANIC 1971-90   
% 224.75/224.92  |- skos__prefLabel mesh__D006865 Hydrogenation
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006865 2004
% 224.75/224.92  |- mesh__dateEstablished mesh__D006865 1991-01-01
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006865 2002
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006865 2006
% 224.75/224.92  |- skos__historyNote mesh__D006865 Chemistry, Organic %28%1966-1970%29%
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D006865 2003
% 224.75/224.92  |- skos__hiddenLabel mesh__D020536 Enzymes Activators
% 224.75/224.92  |- skos__broader mesh__D020536smesh__D045504
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D020536 2006
% 224.75/224.92  |- mesh__publicMeSHNote mesh__D020536 2000   
% 224.75/224.92  |- mesh__dateEstablished mesh__D020536 2000-01-01
% 224.75/224.92  |- skos__hiddenLabel mesh__D020536 Activators, Enzyme
% 224.75/224.92  |- mesh__activeMeSHYear mesh__D020536 2005
% 224.75/224.92  |- skos__historyNote mesh__D020536
% 224.75/224.92       Enzyme Activation/drug effects %28%1976-1999%29%
% 224.75/224.93  |- mesh__dateCreated mesh__D020536 1999-11-04
% 224.75/224.93  |- mesh__historyNote mesh__D020536 2000   
% 224.75/224.93  |- skos__scopeNote mesh__D020536
% 224.75/224.93       Compounds or factors that act on a specific enzyme to increase its activity.%A%    
% 224.75/224.93  |- skos__related mesh__D020536smesh__D004789
% 224.75/224.93  |- skos__prefLabel mesh__D020536 Enzyme Activators
% 224.75/224.93  |- rdf__type mesh__D020536sskos__Concept
% 224.75/224.93  |- skos__altLabel mesh__D020536 Activators of Enzymes
% 224.75/224.93  |- mesh__dateRevised mesh__D020536 2003-07-09
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D020536 2004
% 224.75/224.93  |- skos__annotation mesh__D006067
% 224.75/224.93       includes gonenes, gonadienes, gonatrienes   
% 224.75/224.93  |- skos__prefLabel mesh__D006067 Gonanes
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006067 2003
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006067 1994
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006067 1999
% 224.75/224.93  |- skos__scopeNote mesh__D006067
% 224.75/224.93       Steroids containing the fundamental tetracyclic unit with no methyl groups at C-10 and C-13 and with no side chain at C-17. The concept includes both saturated and unsaturated derivatives.%A%    
% 224.75/224.93  |- mesh__historyNote mesh__D006067 68   
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006067 2004
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006067 1995
% 224.75/224.93  |- mesh__recordOriginator mesh__D006067 NLM
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006067 2000
% 224.75/224.93  |- mesh__dateRevised mesh__D006067 1993-06-03
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006067 2005
% 224.75/224.93  |- mesh__dateEstablished mesh__D006067 1968-01-01
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006067 1996
% 224.75/224.93  |- mesh__recordMaintainer mesh__D006067 PLS
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006067 2001
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006067 2006
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006067 1997
% 224.75/224.93  |- mesh__recordAuthorizer mesh__D006067 PLS
% 224.75/224.93  |- mesh__dateCreated mesh__D006067 1999-01-01
% 224.75/224.93  |- skos__broader mesh__D006067smesh__D013256
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006067 2002
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006067 1998
% 224.75/224.93  |- rdf__type mesh__D006067sskos__Concept
% 224.75/224.93  |- mesh__publicMeSHNote mesh__D006067 68   
% 224.75/224.93  |- skos__broader mesh__D009732Q000191smesh__D009732
% 224.75/224.93  |- mesh__preferredCombination mesh__D009732Q000191smesh__D004471
% 224.75/224.93  |- rdf__type mesh__D009732Q000191smesh__CompoundConcept
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D025221 2005
% 224.75/224.93  |- mesh__dateCreated mesh__D025221 2001-07-25
% 224.75/224.93  |- skos__prefLabel mesh__D025221 Phosphofructokinases
% 224.75/224.93  |- rdf__type mesh__D025221sskos__Concept
% 224.75/224.93  |- skos__historyNote mesh__D025221 Phosphofructokinase-1 %28%1964-2001%29%
% 224.75/224.93  |- mesh__historyNote mesh__D025221
% 224.75/224.93       2002;  use 6-PHOSPHOFRUCTOKINASE 1993-2001, use PHOSPHOFRUCTOKINASE 1965-1992%A%  
% 224.75/224.93  |- mesh__publicMeSHNote mesh__D025221
% 224.75/224.93       2002; see 6-PHOSPHOFRUCTOKINASE 1993-2001, use PHOSPHOFRUCTOKINASE 1965-1992%A%  
% 224.75/224.93  |- skos__broader mesh__D025221smesh__D005631
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D025221 2004
% 224.75/224.93  |- skos__scopeNote mesh__D025221
% 224.75/224.93       Allosteric enzymes that regulate glycolysis and gluconeogenesis.  These enzymes catalyze phosphorylation of fructose-6-phosphate to either fructose-1,6-bisphosphate %28%PHOSPHOFRUCTOKINASE-1 reaction%29%, or to fructose-2,6-bisphosphate %28%PHOSPHOFRUCTOKINASE-2 reaction%29%.%A%    
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D025221 2006
% 224.75/224.93  |- mesh__dateEstablished mesh__D025221 2002-01-01
% 224.75/224.93  |- mesh__dateRevised mesh__D025221 2003-07-09
% 224.75/224.93  |- mesh__recordAuthorizer mesh__D011201 sjn
% 224.75/224.93  |- skos__broader mesh__D011201smesh__D001715
% 224.75/224.93  |- skos__hiddenLabel mesh__D011201 Poultry Disease
% 224.75/224.93  |- mesh__recordMaintainer mesh__D011201 sjn
% 224.75/224.93  |- mesh__dateCreated mesh__D011201 1999-01-01
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D011201 2006
% 224.75/224.93  |- skos__hiddenLabel mesh__D011201 Diseases, Poultry
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D011201 2005
% 224.75/224.93  |- skos__hiddenLabel mesh__D011201 Disease, Poultry
% 224.75/224.93  |- rdf__type mesh__D011201sskos__Concept
% 224.75/224.93  |- mesh__recordOriginator mesh__D011201 NLM
% 224.75/224.93  |- mesh__dateRevised mesh__D011201 2004-07-13
% 224.75/224.93  |- skos__prefLabel mesh__D011201 Poultry Diseases
% 224.75/224.93  |- skos__scopeNote mesh__D011201
% 224.75/224.93       Diseases of birds which are raised as a source of meat or eggs for human consumption and are usually found in barnyards, hatcheries, etc. The concept is differentiated from BIRD DISEASES which is for diseases of birds not considered poultry and usually found in zoos, parks, and the wild.%A%    
% 224.75/224.93  |- skos__annotation mesh__D011201
% 224.75/224.93       coord IM with specific poultry %28%IM%29%; for abnormalities or injuries, index under POULTRY /abnorm or POULTRY /inj; don%27%t forget also POULTRY %28%NIM%29% if no specific fowl is indexed; also check tag ANIMALS; differentiate from BIRD DISEASES on basis of definition of BIRDS %26% POULTRY under POULTRY%A%  
% 224.75/224.93  |- skos__broader mesh__D016495smesh__D012926
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D016495 2005
% 224.75/224.93  |- skos__hiddenLabel mesh__D016495 Officer, Police
% 224.75/224.93  |- skos__hiddenLabel mesh__D016495 Officer, Law Enforcement
% 224.75/224.93  |- skos__annotation mesh__D016495
% 224.75/224.93       few qualif apply; psychology of the policeman or policewoman: no qualif with POLICE%A%  
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D016495 2006
% 224.75/224.93  |- mesh__publicMeSHNote mesh__D016495 92   
% 224.75/224.93  |- skos__hiddenLabel mesh__D016495 Police Forces
% 224.75/224.93  |- mesh__recordOriginator mesh__D016495 TGC
% 224.75/224.93  |- skos__scopeNote mesh__D016495
% 224.75/224.93       Agents of the law charged with the responsibility of maintaining law and order among the citizenry.%A%    
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D016495 2003
% 224.75/224.93  |- mesh__recordAuthorizer mesh__D016495 sjn
% 224.75/224.93  |- skos__prefLabel mesh__D016495 Police
% 224.75/224.93  |- skos__hiddenLabel mesh__D016495 Officers, Police
% 224.75/224.93  |- rdf__type mesh__D016495sskos__Concept
% 224.75/224.93  |- skos__hiddenLabel mesh__D016495 Enforcement Officers, Law
% 224.75/224.93  |- skos__hiddenLabel mesh__D016495 Law Enforcement Officer
% 224.75/224.93  |- skos__related mesh__D016495smesh__D035846
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D016495 2004
% 224.75/224.93  |- mesh__recordMaintainer mesh__D016495 jrf
% 224.75/224.93  |- mesh__dateRevised mesh__D016495 2002-07-03
% 224.75/224.93  |- skos__historyNote mesh__D016495 Social Control, Formal %28%1971-1991%29%
% 224.75/224.93  |- skos__broader mesh__D016495smesh__D009274
% 224.75/224.93  |- mesh__dateCreated mesh__D016495 1991-01-03
% 224.75/224.93  |- mesh__historyNote mesh__D016495 92   
% 224.75/224.93  |- skos__hiddenLabel mesh__D016495 Police Officer
% 224.75/224.93  |- skos__hiddenLabel mesh__D016495 Enforcement Officer, Law
% 224.75/224.93  |- skos__hiddenLabel mesh__D016495 Officers, Law Enforcement
% 224.75/224.93  |- mesh__dateEstablished mesh__D016495 1992-01-01
% 224.75/224.93  |- mesh__dateCreated mesh__D002475 1977-12-09
% 224.75/224.93  |- rdf__type mesh__D002475sskos__Concept
% 224.75/224.93  |- mesh__recordMaintainer mesh__D002475 jmp
% 224.75/224.93  |- skos__hiddenLabel mesh__D002475
% 224.75/224.93       4 O beta D Glucopyranosyl D glucopyranose
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D002475 2005
% 224.75/224.93  |- skos__scopeNote mesh__D002475
% 224.75/224.93       A disaccharide consisting of two glucose units in beta %28%1-4%29% glycosidic linkage. Obtained from the partial hydrolysis of cellulose.%A%    
% 224.75/224.93  |- skos__prefLabel mesh__D002475 Cellobiose
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D002475 2006
% 224.75/224.93  |- mesh__dateRevised mesh__D002475 2004-07-07
% 224.75/224.93  |- skos__altLabel mesh__D002475 4-O-beta-D-Glucopyranosyl-D-glucopyranose
% 224.75/224.93  |- mesh__historyNote mesh__D002475
% 224.75/224.93       91%28%79%29%; was see under DISACCHARIDES 1979-90   
% 224.75/224.93  |- mesh__recordAuthorizer mesh__D002475 sjn
% 224.75/224.93  |- mesh__dateEstablished mesh__D002475 1991-01-01
% 224.75/224.93  |- skos__historyNote mesh__D002475 Disaccharides %28%1966-1978%29%
% 224.75/224.93  |- skos__broader mesh__D002475smesh__D004187
% 224.75/224.93  |- mesh__recordOriginator mesh__D002475 RLS
% 224.75/224.93  |- mesh__publicMeSHNote mesh__D002475
% 224.75/224.93       91; was see under DISACCHARIDES 1979-90   
% 224.75/224.93  |- skos__broader mesh__D002475smesh__D002482
% 224.75/224.93  |- mesh__dateCreated mesh__D010907 1999-01-01
% 224.75/224.93  |- skos__annotation mesh__D010907
% 224.75/224.93       GEN or unspecified; prefer specific groups or specific hormone; /defic: consider also HYPOPITUITARISM %26% its specifics%A%  
% 224.75/224.93  |- rdf__type mesh__D010907sskos__Concept
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D010907 2003
% 224.75/224.93  |- skos__related mesh__D010907smesh__D011979
% 224.75/224.93  |- mesh__dateRevised mesh__D010907 2002-07-03
% 224.75/224.93  |- mesh__recordOriginator mesh__D010907 NLM
% 224.75/224.93  |- mesh__recordAuthorizer mesh__D010907 sjn
% 224.75/224.93  |- mesh__historyNote mesh__D010907 72   
% 224.75/224.93  |- skos__broader mesh__D010907smesh__D036361
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D010907 2006
% 224.75/224.93  |- mesh__publicMeSHNote mesh__D010907 72   
% 224.75/224.93  |- skos__prefLabel mesh__D010907 Pituitary Hormones
% 224.75/224.93  |- skos__broader mesh__D010907smesh__D006728
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D010907 2005
% 224.75/224.93  |- skos__hiddenLabel mesh__D010907 Hormones, Pituitary
% 224.75/224.93  |- skos__scopeNote mesh__D010907
% 224.75/224.93       Hormones secreted by the PITUITARY GLAND including those from the anterior lobe %28%adenohypophysis%29%, the posterior lobe %28%neurohypophysis%29%, and the ill-defined intermediate lobe. Structurally, they include small peptides, proteins, and glycoproteins. They are under the regulation of neural signals %28%NEUROTRANSMITTERS%29% or neuroendocrine signals %28%HYPOTHALAMIC HORMONES%29% from the hypothalamus as well as feedback from their targets such as ADRENAL CORTEX HORMONES; ANDROGENS; ESTROGENS.%A%    
% 224.75/224.93  |- mesh__recordMaintainer mesh__D010907 lkt
% 224.75/224.93  |- skos__related mesh__D010907smesh__D007018
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D010907 2004
% 224.75/224.93  |- mesh__publicMeSHNote mesh__D010109
% 224.75/224.93       91; was see under IMIDAZOLES 1966-90   
% 224.75/224.93  |- skos__broader mesh__D010109smesh__D007093
% 224.75/224.93  |- rdf__type mesh__D010109sskos__Concept
% 224.75/224.93  |- skos__scopeNote mesh__D010109
% 224.75/224.93       A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1251%29%%A%    
% 224.75/224.93  |- mesh__recordMaintainer mesh__D010109 ssb
% 224.75/224.93  |- mesh__recordOriginator mesh__D010109 NLM
% 224.75/224.93  |- mesh__dateCreated mesh__D010109 1999-01-01
% 224.75/224.93  |- mesh__recordAuthorizer mesh__D010109 sjn
% 224.75/224.93  |- mesh__dateEstablished mesh__D010109 1991-01-01
% 224.75/224.93  |- mesh__dateRevised mesh__D010109 2005-06-30
% 224.75/224.93  |- mesh__historyNote mesh__D010109
% 224.75/224.93       91%28%66%29%; was see under IMIDAZOLES 1966-90   
% 224.75/224.93  |- skos__prefLabel mesh__D010109 Oxymetazoline
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D010109 2006
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D007160 2003
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D007160 1993
% 224.75/224.93  |- mesh__recordAuthorizer mesh__D007160 PLS
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D007160 1999
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D007160 2000
% 224.75/224.93  |- mesh__historyNote mesh__D007160 86   
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D007160 1995
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D007160 2005
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D007160 2004
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D007160 2001
% 224.75/224.93  |- mesh__dateRevised mesh__D007160 1990-08-17
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D007160 2006
% 224.75/224.93  |- mesh__dateCreated mesh__D007160 1985-02-25
% 224.75/224.93  |- mesh__recordOriginator mesh__D007160 AEP
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D007160 1991
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D007160 1996
% 224.75/224.93  |- skos__broader mesh__D007160smesh__D007154
% 224.75/224.93  |- skos__hiddenLabel mesh__D007160 Immunoproliferative Disorder
% 224.75/224.93  |- rdf__type mesh__D007160sskos__Concept
% 224.75/224.93  |- mesh__recordMaintainer mesh__D007160 NLM
% 224.75/224.93  |- skos__annotation mesh__D007160 GEN or unspecified: prefer specifics   
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D007160 2002
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D007160 1998
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D007160 1992
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D007160 1997
% 224.75/224.93  |- mesh__publicMeSHNote mesh__D007160 86   
% 224.75/224.93  |- skos__prefLabel mesh__D007160 Immunoproliferative Disorders
% 224.75/224.93  |- skos__hiddenLabel mesh__D007160 Disorder, Immunoproliferative
% 224.75/224.93  |- skos__hiddenLabel mesh__D007160 Disorders, Immunoproliferative
% 224.75/224.93  |- mesh__dateEstablished mesh__D007160 1986-01-01
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D007160 1994
% 224.75/224.93  |- skos__scopeNote mesh__D007160
% 224.75/224.93       Disorders characterized by abnormal proliferation of primary cells of the immune system or by excessive production of immunoglobulins.%A%    
% 224.75/224.93  |- mesh__dateEstablished mesh__D020537 2000-01-01
% 224.75/224.93  |- skos__historyNote mesh__D020537 RNA, Small Nuclear %28%1986-1999%29%
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D020537 2005
% 224.75/224.93  |- skos__historyNote mesh__D020537 Cell Nucleolus %28%1975-1999%29%
% 224.75/224.93  |- skos__scopeNote mesh__D020537
% 224.75/224.93       Small nuclear RNAs that are involved in the processing of pre-ribosomal RNA in the nucleolus. Box C/D containing snoRNAs %28%U14, U15, U16, U20, U21 and U24-U63%29% direct site-specific methylation of various ribose moieties. Box H/ACA containing snoRNAs %28%E2, E3, U19, U23, and U64-U72%29% direct the conversion of specific uridines to pseudouridine. Site-specific cleavages resulting in the mature ribosomal RNAs are directed by snoRNAs U3, U8, U14, U22 and the snoRNA components of RNase MRP and RNase P.%A%    
% 224.75/224.93  |- mesh__publicMeSHNote mesh__D020537 2000   
% 224.75/224.93  |- skos__historyNote mesh__D020537 RNA %28%1975-1985%29%
% 224.75/224.93  |- mesh__dateCreated mesh__D020537 1999-11-03
% 224.75/224.93  |- mesh__historyNote mesh__D020537 2000   
% 224.75/224.93  |- skos__altLabel mesh__D020537 snoRNA
% 224.75/224.93  |- skos__prefLabel mesh__D020537 RNA, Small Nucleolar
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D020537 2002
% 224.75/224.93  |- rdf__type mesh__D020537sskos__Concept
% 224.75/224.93  |- skos__broader mesh__D020537smesh__D012342
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D020537 2004
% 224.75/224.93  |- skos__altLabel mesh__D020537 Small Nucleolar RNA
% 224.75/224.93  |- mesh__dateRevised mesh__D020537 2000-06-22
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D020537 2001
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D020537 2006
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D020537 2003
% 224.75/224.93  |- skos__scopeNote mesh__D006068
% 224.75/224.93       Examination of the angle of the anterior chamber of the eye with a specialized optical instrument %28%gonioscope%29% or a contact prism lens.%A%    
% 224.75/224.93  |- mesh__recordMaintainer mesh__D006068 KEV
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006068 2002
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006068 2006
% 224.75/224.93  |- mesh__dateCreated mesh__D006068 1999-01-01
% 224.75/224.93  |- skos__prefLabel mesh__D006068 Gonioscopy
% 224.75/224.93  |- mesh__recordAuthorizer mesh__D006068 sjn
% 224.75/224.93  |- rdf__type mesh__D006068sskos__Concept
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006068 2003
% 224.75/224.93  |- skos__hiddenLabel mesh__D006068 Gonioscopies
% 224.75/224.93  |- mesh__recordOriginator mesh__D006068 NLM
% 224.75/224.93  |- skos__broader mesh__D006068smesh__D003941
% 224.75/224.93  |- mesh__dateRevised mesh__D006068 1999-11-03
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006068 2000
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006068 2004
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006068 2001
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006068 2005
% 224.75/224.93  |- skos__hiddenLabel mesh__D025222 ATPases, Chloroplast
% 224.75/224.93  |- skos__hiddenLabel mesh__D025222 ATPase, Chloroplast
% 224.75/224.93  |- skos__altLabel mesh__D025222 Coupling Factor 0
% 224.75/224.93  |- skos__altLabel mesh__D025222 Chloroplast Coupling Factors
% 224.75/224.93  |- mesh__recordOriginator mesh__D025222 jmp
% 224.75/224.93  |- skos__historyNote mesh__D025222
% 224.75/224.93       Proton-Translocating ATPases %28%1978-2001%29%
% 224.75/224.93  |- skos__altLabel mesh__D025222 Coupling Factor 1
% 224.75/224.93  |- mesh__historyNote mesh__D025222
% 224.75/224.93       2002; for CHLOROPLAST COUPLING FACTOR use PROTON TRANSLOCATING ATPASES 1978-2001; for CF1 ATPASE, COUPLING FACTOR 0 %26% COUPLING FACTOR 1 use PROTON TRANSLOCATING ATPASES 1983-2001%A%  
% 224.75/224.93  |- mesh__publicMeSHNote mesh__D025222
% 224.75/224.93       2002; for CHLOROPLAST COUPLING FACTOR see H%28%+%29%-TRANSPORTING ATP SYNTHASE 1993-2001, ADENOSINE TRIPHOSPHATASE F1 1984-92 ADENOSINE TRIPHOSPHATASE F1 1983 %26% CHLOROPLAST COUPLING FACTOR 1978-1983; for CF1 ATPASE, COUPLING FACTOR 0 %26% COUPLING FACTOR 1 see H%28%+%29%-TRANSPORTING ATP SYNTHASE 1993-2001, ADENOSINE TRIPHOSPHATASE F1 1984-92 %26% ADENOSINE TRIPHOSPHATASE F1 1983%A%  
% 224.75/224.93  |- skos__hiddenLabel mesh__D025222 ATP Synthases, Chloroplast
% 224.75/224.93  |- skos__prefLabel mesh__D025222 Chloroplast Proton-Translocating ATPases
% 224.75/224.93  |- mesh__dateCreated mesh__D025222 2001-07-25
% 224.75/224.93  |- rdf__type mesh__D025222sskos__Concept
% 224.75/224.93  |- mesh__recordAuthorizer mesh__D025222 sjn
% 224.75/224.93  |- skos__hiddenLabel mesh__D025222 ATPase, CF1
% 224.75/224.93  |- skos__hiddenLabel mesh__D025222 Synthases, Chloroplast ATP
% 224.75/224.93  |- skos__altLabel mesh__D025222 Chloroplast ATPase
% 224.75/224.93  |- mesh__dateEstablished mesh__D025222 2002-01-01
% 224.75/224.93  |- skos__altLabel mesh__D025222 Chloroplast F%28%1%29%F%28%0%29% ATPase
% 224.75/224.93  |- skos__hiddenLabel mesh__D025222
% 224.75/224.93       ATPases, Chloroplast Proton-Translocating
% 224.75/224.93  |- skos__scopeNote mesh__D025222
% 224.75/224.93       Proton-translocating ATPases which produce ADENOSINE TRIPHOSPHATE in plants. They derive energy from light-driven reactions that develop high concentrations of protons within the membranous cisternae %28%THYLAKOIDS%29% of the CHLOROPLASTS.%A%    
% 224.75/224.93  |- skos__altLabel mesh__D025222 Chloroplast ATPases
% 224.75/224.93  |- skos__hiddenLabel mesh__D025222 Chloroplast Proton Translocating ATPases
% 224.75/224.93  |- skos__altLabel mesh__D025222 Chloroplast ATP Synthase
% 224.75/224.93  |- skos__altLabel mesh__D025222 Chloroplast ATP Synthases
% 224.75/224.93  |- skos__broader mesh__D025222smesh__D006180
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D025222 2005
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D025222 2004
% 224.75/224.93  |- skos__altLabel mesh__D025222 Chloroplast Coupling Factor
% 224.75/224.93  |- skos__hiddenLabel mesh__D025222 Synthase, Chloroplast ATP
% 224.75/224.93  |- skos__altLabel mesh__D025222 CF1 ATPase
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D025222 2006
% 224.75/224.93  |- mesh__recordMaintainer mesh__D025222 ssb
% 224.75/224.93  |- skos__hiddenLabel mesh__D025222 ATP Synthase, Chloroplast
% 224.75/224.93  |- mesh__dateRevised mesh__D025222 2003-07-09
% 224.75/224.93  |- mesh__dateCreated mesh__D011202 1999-01-01
% 224.75/224.93  |- mesh__dateEstablished mesh__D011202 1968-01-01
% 224.75/224.93  |- skos__historyNote mesh__D011202 Poultry %28%1966-1967%29%
% 224.75/224.93  |- skos__annotation mesh__D011202
% 224.75/224.93       %22%food products manufactured from poultry%22% but for canned poultry meat coord POULTRY or specific poultry %28%IM%29% + FOOD PRESERVATION; coord IM with poultry source %28%NIM%29%%A%  
% 224.75/224.93  |- skos__scopeNote mesh__D011202
% 224.75/224.93       Food products manufactured from poultry.     
% 224.75/224.93  |- mesh__recordAuthorizer mesh__D011202 SJN
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D011202 1999
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D011202 2002
% 224.75/224.93  |- skos__hiddenLabel mesh__D011202 Poultry Product
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D011202 2006
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D011202 1998
% 224.75/224.93  |- mesh__historyNote mesh__D011202 68   
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D011202 2001
% 224.75/224.93  |- mesh__recordMaintainer mesh__D011202 JLS
% 224.75/224.93  |- mesh__dateRevised mesh__D011202 1997-06-20
% 224.75/224.93  |- mesh__publicMeSHNote mesh__D011202 68   
% 224.75/224.93  |- mesh__recordOriginator mesh__D011202 NLM
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D011202 2005
% 224.75/224.93  |- rdf__type mesh__D011202sskos__Concept
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D011202 2000
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D011202 2004
% 224.75/224.93  |- skos__broader mesh__D011202smesh__D011200
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D011202 2003
% 224.75/224.93  |- skos__related mesh__D011202smesh__D004531
% 224.75/224.93  |- skos__hiddenLabel mesh__D011202 Products, Poultry
% 224.75/224.93  |- skos__prefLabel mesh__D011202 Poultry Products
% 224.75/224.93  |- skos__hiddenLabel mesh__D011202 Product, Poultry
% 224.75/224.93  |- mesh__publicMeSHNote mesh__D049670
% 224.75/224.93       2005; see HISTORY OF MEDICINE, 17TH CENT. 1995-2004; for HISTORY OF MEDICINE 17 CENT. see HISTORY OF MEDICINE 17TH CENT. 1964-2004, see  HISTORY OF MEDICINE, XVII CENT. 1963%A%  
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D049670 2006
% 224.75/224.93  |- rdf__type mesh__D049670sskos__Concept
% 224.75/224.93  |- skos__hiddenLabel mesh__D049670 17th Century Histories
% 224.75/224.93  |- skos__hiddenLabel mesh__D049670 Century Histories, Seventeenth
% 224.75/224.93  |- skos__scopeNote mesh__D049670
% 224.75/224.93       Time period from 1601 through 1700 of the common era.     
% 224.75/224.93  |- mesh__recordAuthorizer mesh__D049670 sjn
% 224.75/224.93  |- skos__hiddenLabel mesh__D049670 Century History, 17th
% 224.75/224.93  |- skos__altLabel mesh__D049670 17th Cent. History of Medicine
% 224.75/224.93  |- mesh__dateEstablished mesh__D049670 2005-01-01
% 224.75/224.93  |- skos__hiddenLabel mesh__D049670 History, 17th Cent. %28%Medicine%29%
% 224.75/224.93  |- mesh__dateCreated mesh__D049670 2004-07-07
% 224.75/224.93  |- mesh__recordMaintainer mesh__D049670 jls
% 224.75/224.93  |- skos__broader mesh__D049670smesh__D049711
% 224.75/224.93  |- skos__hiddenLabel mesh__D049670 17th Cent. Histories %28%Medicine%29%
% 224.75/224.93  |- skos__hiddenLabel mesh__D049670 Histories, 17th Century
% 224.75/224.93  |- skos__altLabel mesh__D049670 17th Cent. History %28%Medicine%29%
% 224.75/224.93  |- mesh__historyNote mesh__D049670 2005   
% 224.75/224.93  |- skos__annotation mesh__D049670 IM general only; NIM as check tag   
% 224.75/224.93  |- skos__prefLabel mesh__D049670 History, 17th Century
% 224.75/224.93  |- mesh__recordOriginator mesh__D049670 jls
% 224.75/224.93  |- skos__altLabel mesh__D049670 Medical History, 17th Cent.
% 224.75/224.93  |- skos__altLabel mesh__D049670 History, Seventeenth Century
% 224.75/224.93  |- skos__hiddenLabel mesh__D049670 Seventeenth Century History
% 224.75/224.93  |- skos__altLabel mesh__D049670 17th Cent. Medicine
% 224.75/224.93  |- skos__altLabel mesh__D049670 17th Century History
% 224.75/224.93  |- skos__hiddenLabel mesh__D049670 Seventeenth Century Histories
% 224.75/224.93  |- skos__hiddenLabel mesh__D049670 Histories, Seventeenth Century
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D049670 2005
% 224.75/224.93  |- skos__hiddenLabel mesh__D049670 Histories, 17th Cent. %28%Medicine%29%
% 224.75/224.93  |- skos__hiddenLabel mesh__D049670 Century History, Seventeenth
% 224.75/224.93  |- skos__hiddenLabel mesh__D049670 Cent. Histories, 17th %28%Medicine%29%
% 224.75/224.93  |- mesh__recordMaintainer mesh__D016496 lkt
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D016496 2006
% 224.75/224.93  |- skos__prefLabel mesh__D016496 Incontinence Pads
% 224.75/224.93  |- mesh__dateEstablished mesh__D016496 1992-01-01
% 224.75/224.93  |- skos__broader mesh__D016496smesh__D041342
% 224.75/224.93  |- skos__historyNote mesh__D016496 Disposable Equipment %28%1986-1991%29%
% 224.75/224.93  |- skos__historyNote mesh__D016496 Clothing %28%1983-1991%29%
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D016496 2003
% 224.75/224.93  |- rdf__type mesh__D016496sskos__Concept
% 224.75/224.93  |- mesh__publicMeSHNote mesh__D016496 92   
% 224.75/224.93  |- skos__hiddenLabel mesh__D016496 Pad, Incontinence
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D016496 2004
% 224.75/224.93  |- mesh__historyNote mesh__D016496 92   
% 224.75/224.93  |- skos__annotation mesh__D016496
% 224.75/224.93       restrict to ELDERLY or adults; for infants use DIAPERS, INFANT see INFANT CARE%A%  
% 224.75/224.93  |- mesh__recordOriginator mesh__D016496 TGC
% 224.75/224.93  |- mesh__dateCreated mesh__D016496 1991-01-02
% 224.75/224.93  |- mesh__recordAuthorizer mesh__D016496 sjn
% 224.75/224.93  |- skos__scopeNote mesh__D016496
% 224.75/224.93       Absorbent pads used for URINARY INCONTINENCE and usually worn as underpants or pants liners by the ELDERLY.%A%    
% 224.75/224.93  |- mesh__dateRevised mesh__D016496 2002-07-03
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D016496 2005
% 224.75/224.93  |- skos__hiddenLabel mesh__D016496 Incontinence Pad
% 224.75/224.93  |- skos__hiddenLabel mesh__D016496 Pads, Incontinence
% 224.75/224.93  |- mesh__dateCreated mesh__D002476 1999-01-01
% 224.75/224.93  |- skos__annotation mesh__D002476 D25-26 qualif   
% 224.75/224.93  |- skos__broader mesh__D002476smesh__D008420
% 224.75/224.93  |- mesh__recordOriginator mesh__D002476 NLM
% 224.75/224.93  |- skos__scopeNote mesh__D002476
% 224.75/224.93       A generic name for film produced from wood pulp by the viscose process. It is a thin, transparent sheeting of regenerated cellulose, moisture-proof and sometimes dyed, and used chiefly as food wrapping or as bags for dialysis. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed %26% McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A%    
% 224.75/224.93  |- skos__broader mesh__D002476smesh__D002482
% 224.75/224.93  |- skos__prefLabel mesh__D002476 Cellophane
% 224.75/224.93  |- skos__hiddenLabel mesh__D002476 Cellophanes
% 224.75/224.93  |- rdf__type mesh__D002476sskos__Concept
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D002476 2005
% 224.75/224.93  |- mesh__recordMaintainer mesh__D002476 jmp
% 224.75/224.93  |- mesh__recordAuthorizer mesh__D002476 sjn
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D002476 2006
% 224.75/224.93  |- mesh__dateRevised mesh__D002476 2004-07-07
% 224.75/224.93  |- mesh__recordMaintainer mesh__D010908 lkt
% 224.75/224.93  |- skos__hiddenLabel mesh__D010908 Hormones, Anterior Pituitary
% 224.75/224.93  |- mesh__dateRevised mesh__D010908 2002-07-02
% 224.75/224.93  |- skos__hiddenLabel mesh__D010908 Anterior Pituitary Hormones
% 224.75/224.93  |- skos__prefLabel mesh__D010908 Pituitary Hormones, Anterior
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D010908 2006
% 224.75/224.93  |- skos__hiddenLabel mesh__D010908 Hormones, Adenohypophyseal
% 224.75/224.93  |- skos__annotation mesh__D010908 GEN; prefer specifics   
% 224.75/224.93  |- mesh__recordOriginator mesh__D010908 NLM
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D010908 2005
% 224.75/224.93  |- mesh__recordAuthorizer mesh__D010908 sjn
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D010908 2004
% 224.75/224.93  |- mesh__dateCreated mesh__D010908 1999-01-01
% 224.75/224.93  |- skos__altLabel mesh__D010908 Adenohypophyseal Hormones
% 224.75/224.93  |- skos__scopeNote mesh__D010908
% 224.75/224.93       Hormones secreted by the adenohypophysis %28%PITUITARY GLAND, ANTERIOR%29%. Structurally, they include polypeptide, protein, and glycoprotein molecules.%A%    
% 224.75/224.93  |- skos__broader mesh__D010908smesh__D010907
% 224.75/224.93  |- rdf__type mesh__D010908sskos__Concept
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D010908 2003
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D007161 2006
% 224.75/224.93  |- skos__historyNote mesh__D007161 Intestinal Neoplasms %28%1966-1986%29%
% 224.75/224.93  |- skos__hiddenLabel mesh__D007161 Disease, alpha-Chain
% 224.75/224.93  |- skos__altLabel mesh__D007161 Lymphoma, Mediterranean
% 224.75/224.93  |- skos__scopeNote mesh__D007161
% 224.75/224.93       A condition that is caused by HYPERPLASIA of LYMPHOCYTES in the small intestine %28%INTESTINE, SMALL%29% and the mesenteric LYMPH NODES. These lymphocytes produce an anomalous alpha heavy chain protein. Generally, these IPSID patients have either concurrent LYMPHOMA or develop lymphoma within a few years. The disease was first described in the Mediterranean region and is characterized by malabsorption; WEIGHT LOSS; DIARRHEA; and STEATORRHEA.%A%    
% 224.75/224.93  |- skos__broader mesh__D007161smesh__D008223
% 224.75/224.93  |- mesh__historyNote mesh__D007161 87   
% 224.75/224.93  |- mesh__publicMeSHNote mesh__D007161 87   
% 224.75/224.93  |- mesh__recordOriginator mesh__D007161 VDK
% 224.75/224.93  |- skos__hiddenLabel mesh__D007161 Mediterranean Lymphoma
% 224.75/224.93  |- skos__broader mesh__D007161smesh__D007414
% 224.75/224.93  |- mesh__recordMaintainer mesh__D007161 lkt
% 224.75/224.93  |- skos__historyNote mesh__D007161 Lymphoma %28%1966-1986%29%
% 224.75/224.93  |- skos__broader mesh__D007161smesh__D006362
% 224.75/224.93  |- rdf__type mesh__D007161sskos__Concept
% 224.75/224.93  |- mesh__dateRevised mesh__D007161 2005-06-30
% 224.75/224.93  |- skos__hiddenLabel mesh__D007161 Diseases, alpha-Chain
% 224.75/224.93  |- mesh__dateCreated mesh__D007161 1986-06-24
% 224.75/224.93  |- skos__prefLabel mesh__D007161
% 224.75/224.93       Immunoproliferative Small Intestinal Disease
% 224.75/224.93  |- skos__altLabel mesh__D007161 Heavy Chain Disease, IgA Type
% 224.75/224.93  |- mesh__recordAuthorizer mesh__D007161 sjn
% 224.75/224.93  |- skos__hiddenLabel mesh__D007161 alpha-Chain Diseases
% 224.75/224.93  |- skos__historyNote mesh__D007161 Heavy Chain Disease %28%1966-1986%29%
% 224.75/224.93  |- skos__altLabel mesh__D007161 alpha-Chain Disease
% 224.75/224.93  |- skos__altLabel mesh__D007161 IPSID
% 224.75/224.93  |- skos__broader mesh__D007161smesh__D008232
% 224.75/224.93  |- skos__hiddenLabel mesh__D007161 alpha Chain Disease
% 224.75/224.93  |- mesh__dateEstablished mesh__D007161 1987-01-01
% 224.75/224.93  |- mesh__dateCreated mesh__D006867 1999-01-01
% 224.75/224.93  |- skos__broader mesh__D006867smesh__D004798
% 224.75/224.93  |- skos__scopeNote mesh__D006867
% 224.75/224.93       Any member of the class of enzymes that catalyze the cleavage of the substrate and the addition of water to the resulting molecules, e.g., ESTERASES, glycosidases %28%GLYCOSIDE HYDROLASES%29%, lipases, NUCLEOTIDASES, peptidases %28%PEPTIDE HYDROLASES%29%, and phosphatases %28%PHOSPHORIC MONOESTER HYDROLASES%29%. EC 3.%A%    
% 224.75/224.93  |- skos__annotation mesh__D006867 do not confuse with HYDRO-LYASES   
% 224.75/224.93  |- rdf__type mesh__D006867sskos__Concept
% 224.75/224.93  |- mesh__recordAuthorizer mesh__D006867 sjn
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006867 2005
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006867 2004
% 224.75/224.93  |- skos__prefLabel mesh__D006867 Hydrolases
% 224.75/224.93  |- mesh__recordOriginator mesh__D006867 NLM
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006867 2006
% 224.75/224.93  |- mesh__recordMaintainer mesh__D006867 ssb
% 224.75/224.93  |- mesh__dateRevised mesh__D006867 2003-07-09
% 224.75/224.93  |- mesh__activeMeSHYear mesh__D006069 2001
% 224.75/224.93  |- skos__prefLabel mesh__D006069 Gonorrhea
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D006069 1997
% 224.75/224.94  |- skos__annotation mesh__D006069 caused by Neisseria gonorrhoeae   
% 224.75/224.94  |- mesh__dateCreated mesh__D006069 1999-01-01
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D006069 1998
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D006069 2002
% 224.75/224.94  |- skos__hiddenLabel mesh__D006069 Gonorrheas
% 224.75/224.94  |- mesh__recordMaintainer mesh__D006069 PXP
% 224.75/224.94  |- mesh__recordAuthorizer mesh__D006069 PLS
% 224.75/224.94  |- skos__broader mesh__D006069smesh__D016870
% 224.75/224.94  |- rdf__type mesh__D006069sskos__Concept
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D006069 1999
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D006069 2003
% 224.75/224.94  |- skos__broader mesh__D006069smesh__D015231
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D006069 1995
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D006069 2004
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D006069 2005
% 224.75/224.94  |- skos__scopeNote mesh__D006069
% 224.75/224.94       Acute infectious disease characterized by primary invasion of the urogenital tract. The etiologic agent, NEISSERIA GONORRHOEAE, was isolated by Neisser in 1879.%A%    
% 224.75/224.94  |- mesh__dateRevised mesh__D006069 1994-02-08
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D006069 1996
% 224.75/224.94  |- mesh__recordOriginator mesh__D006069 NLM
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D006069 2006
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D006069 2000
% 224.75/224.94  |- skos__broader mesh__D009732Q000193smesh__D009732
% 224.75/224.94  |- mesh__preferredCombination mesh__D009732Q000193smesh__D004506
% 224.75/224.94  |- rdf__type mesh__D009732Q000193smesh__CompoundConcept
% 224.75/224.94  |- mesh__recordMaintainer mesh__D011203 kle
% 224.75/224.94  |- skos__prefLabel mesh__D011203 Poverty
% 224.75/224.94  |- skos__hiddenLabel mesh__D011203 Populations, Low-Income
% 224.75/224.94  |- mesh__recordAuthorizer mesh__D011203 sjn
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D011203 2006
% 224.75/224.94  |- skos__hiddenLabel mesh__D011203 Populations, Low Income
% 224.75/224.94  |- mesh__publicMeSHNote mesh__D011203 68   
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D011203 2005
% 224.75/224.94  |- rdf__type mesh__D011203sskos__Concept
% 224.75/224.94  |- skos__hiddenLabel mesh__D011203 Population, Low Income
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D011203 2002
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D011203 2004
% 224.75/224.94  |- mesh__historyNote mesh__D011203 68   
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D011203 2001
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D011203 2003
% 224.75/224.94  |- skos__broader mesh__D011203smesh__D012940
% 224.75/224.94  |- skos__hiddenLabel mesh__D011203 Low Income Populations
% 224.75/224.94  |- skos__scopeNote mesh__D011203
% 224.75/224.94       A situation in which the level of living of an individual, family, or group is below the standard of the community. It is often related to a specific income level.%A%    
% 224.75/224.94  |- mesh__recordOriginator mesh__D011203 NLM
% 224.75/224.94  |- skos__hiddenLabel mesh__D011203 Population, Low-Income
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D011203 2000
% 224.75/224.94  |- skos__altLabel mesh__D011203 Low Income Population
% 224.75/224.94  |- mesh__dateEstablished mesh__D011203 1968-01-01
% 224.75/224.94  |- mesh__dateCreated mesh__D011203 1999-01-01
% 224.75/224.94  |- mesh__dateRevised mesh__D011203 1999-11-03
% 224.75/224.94  |- skos__hiddenLabel mesh__D011203 Low-Income Populations
% 224.75/224.94  |- skos__broader mesh__D011203smesh__D012959
% 224.75/224.94  |- skos__annotation mesh__D011203 specify geog if pertinent   
% 224.75/224.94  |- skos__hiddenLabel mesh__D011203 Indigent
% 224.75/224.94  |- skos__related mesh__D011203smesh__D003467
% 224.75/224.94  |- skos__hiddenLabel mesh__D049671 Eighteenth Century History
% 224.75/224.94  |- skos__hiddenLabel mesh__D049671 Eighteenth Century Histories
% 224.75/224.94  |- skos__scopeNote mesh__D049671
% 224.75/224.94       Time period from 1701 through 1800 of the common era.     
% 224.75/224.94  |- skos__hiddenLabel mesh__D049671 Cent. History, 18th %28%Medicine%29%
% 224.75/224.94  |- skos__hiddenLabel mesh__D049671 Century History, 18th
% 224.75/224.94  |- skos__altLabel mesh__D049671 Medical History, 18th Cent.
% 224.75/224.94  |- mesh__dateCreated mesh__D049671 2004-07-07
% 224.75/224.94  |- skos__altLabel mesh__D049671 18th Cent. History %28%Medicine%29%
% 224.75/224.94  |- skos__prefLabel mesh__D049671 History, 18th Century
% 224.75/224.94  |- skos__broader mesh__D049671smesh__D049711
% 224.75/224.94  |- skos__hiddenLabel mesh__D049671 Cent. Medicine, 18th
% 224.75/224.94  |- skos__hiddenLabel mesh__D049671 18th Century Histories
% 224.75/224.94  |- skos__altLabel mesh__D049671 18th Cent. Medicine
% 224.75/224.94  |- mesh__recordAuthorizer mesh__D049671 sjn
% 224.75/224.94  |- mesh__recordOriginator mesh__D049671 jls
% 224.75/224.94  |- mesh__dateEstablished mesh__D049671 2005-01-01
% 224.75/224.94  |- mesh__recordMaintainer mesh__D049671 jls
% 224.75/224.94  |- skos__hiddenLabel mesh__D049671 Century Histories, 18th
% 224.75/224.94  |- skos__hiddenLabel mesh__D049671 History, 18th Cent. %28%Medicine%29%
% 224.75/224.94  |- skos__hiddenLabel mesh__D049671 Century History, Eighteenth
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D049671 2005
% 224.75/224.94  |- skos__altLabel mesh__D049671 18th Cent. History of Medicine
% 224.75/224.94  |- skos__hiddenLabel mesh__D049671 Century Histories, Eighteenth
% 224.75/224.94  |- skos__altLabel mesh__D049671 History, Eighteenth Century
% 224.75/224.94  |- skos__hiddenLabel mesh__D049671 Histories, Eighteenth Century
% 224.75/224.94  |- skos__hiddenLabel mesh__D049671 Histories, 18th Century
% 224.75/224.94  |- skos__annotation mesh__D049671 IM general only; NIM as check tag   
% 224.75/224.94  |- mesh__historyNote mesh__D049671 2005   
% 224.75/224.94  |- mesh__publicMeSHNote mesh__D049671
% 224.75/224.94       2005; see HISTORY OF MEDICINE, 18TH CENT. 1995-2004; for HISTORY OF MEDICINE 18 CENT. see HISTORY OF MEDICINE 18TH CENT. 1964-2004, see  HISTORY OF MEDICINE, XVIII CENT. 1963%A%  
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D049671 2006
% 224.75/224.94  |- rdf__type mesh__D049671sskos__Concept
% 224.75/224.94  |- skos__altLabel mesh__D049671 18th Century History
% 224.75/224.94  |- mesh__dateEstablished mesh__D016497 1992-01-01
% 224.75/224.94  |- mesh__recordAuthorizer mesh__D016497 sjn
% 224.75/224.94  |- skos__hiddenLabel mesh__D016497 Service, Adolescent Health
% 224.75/224.94  |- skos__altLabel mesh__D016497 Services, Adolescent Health
% 224.75/224.94  |- mesh__recordOriginator mesh__D016497 TGC
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D016497 2006
% 224.75/224.94  |- skos__scopeNote mesh__D016497
% 224.75/224.94       Organized services to provide health care to adolescents, ages ranging from 13 through 18 years.%A%    
% 224.75/224.94  |- skos__hiddenLabel mesh__D016497 Adolescent Health Service
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D016497 2005
% 224.75/224.94  |- skos__prefLabel mesh__D016497 Adolescent Health Services
% 224.75/224.94  |- skos__altLabel mesh__D016497 Health Services, Adolescent
% 224.75/224.94  |- skos__annotation mesh__D016497
% 224.75/224.94        check also tags  HUMANS %26% ADOLESCENCE; DF: ADOLESCENT HEALTH SERV%A%  
% 224.75/224.94  |- skos__broader mesh__D016497smesh__D006296
% 224.75/224.94  |- rdf__type mesh__D016497sskos__Concept
% 224.75/224.94  |- mesh__recordMaintainer mesh__D016497 sjn
% 224.75/224.94  |- mesh__historyNote mesh__D016497 92   
% 224.75/224.94  |- mesh__publicMeSHNote mesh__D016497 92   
% 224.75/224.94  |- mesh__dateCreated mesh__D016497 1991-01-02
% 224.75/224.94  |- skos__hiddenLabel mesh__D016497 Health Service, Adolescent
% 224.75/224.94  |- skos__historyNote mesh__D016497 Health Services %28%1972-1991%29%
% 224.75/224.94  |- mesh__dateRevised mesh__D016497 2004-07-13
% 224.75/224.94  |- mesh__recordMaintainer mesh__D002477 nns
% 224.75/224.94  |- mesh__recordAuthorizer mesh__D002477 sjn
% 224.75/224.94  |- mesh__publicMeSHNote mesh__D002477 72; was see under CYTOLOGY 1963-71   
% 224.75/224.94  |- mesh__historyNote mesh__D002477 72; was see under CYTOLOGY 1963-71   
% 224.75/224.94  |- skos__historyNote mesh__D002477 Cytology %28%1966-1971%29%
% 224.75/224.94  |- rdf__type mesh__D002477sskos__Concept
% 224.75/224.94  |- skos__scopeNote mesh__D002477
% 224.75/224.94       The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.%A%    
% 224.75/224.94  |- mesh__onlineNote mesh__D002477 pre-explosion = CELLS %28%PX%29%   
% 224.75/224.94  |- skos__hiddenLabel mesh__D002477 Cell
% 224.75/224.94  |- mesh__recordOriginator mesh__D002477 NLM
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D002477 2005
% 224.75/224.94  |- mesh__runningHead mesh__D002477 A11 - ANATOMY-CELLS   
% 224.75/224.94  |- skos__annotation mesh__D002477
% 224.75/224.94       general; prefer specific cell or specific anatomical term or organism with /cytol; cell stages = CELL CYCLE%A%  
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D002477 2006
% 224.75/224.94  |- mesh__dateRevised mesh__D002477 2004-07-07
% 224.75/224.94  |- mesh__dateCreated mesh__D002477 1999-01-01
% 224.75/224.94  |- skos__prefLabel mesh__D002477 Cells
% 224.75/224.94  |- mesh__dateEstablished mesh__D002477 1972-01-01
% 224.75/224.94  |- mesh__recordAuthorizer mesh__D010909 sjn
% 224.75/224.94  |- mesh__recordMaintainer mesh__D010909 TPW
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D010909 2005
% 224.75/224.94  |- skos__related mesh__D010909smesh__D009481
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D010909 2004
% 224.75/224.94  |- mesh__dateCreated mesh__D010909 1999-01-01
% 224.75/224.94  |- rdf__type mesh__D010909sskos__Concept
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D010909 2003
% 224.75/224.94  |- skos__annotation mesh__D010909
% 224.75/224.94       GEN; prefer specifics; /biosyn /physiol permitted   
% 224.75/224.94  |- skos__scopeNote mesh__D010909
% 224.75/224.94       Hormones released from the posterior lobe of the pituitary, including vasopressin %28%antidiuretic hormone%29% and oxytocin. They are formed in the neuronal cells of the hypothalamic nuclei and stored in nerve cell endings in the posterior pituitary %28%neurohypophysis%29%. %28%Dorland, 28th ed%29%%A%    
% 224.75/224.94  |- mesh__historyNote mesh__D010909
% 224.75/224.94       PITUITRIN was heading 1975-95 %28%see under PITUITARY HORMONES, POSTERIOR 1975-90%29%%A%  
% 224.75/224.94  |- skos__broader mesh__D010909smesh__D010907
% 224.75/224.94  |- skos__hiddenLabel mesh__D010909 Posterior Pituitary Hormones
% 224.75/224.94  |- skos__hiddenLabel mesh__D010909 Hormones, Posterior Pituitary
% 224.75/224.94  |- skos__prefLabel mesh__D010909 Pituitary Hormones, Posterior
% 224.75/224.94  |- mesh__publicMeSHNote mesh__D010909
% 224.75/224.94       PITUITRIN was heading 1975-95 %28%see under PITUITARY HORMONES, POSTERIOR 1975-90%29%%A%  
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D010909 2006
% 224.75/224.94  |- mesh__recordOriginator mesh__D010909 NLM
% 224.75/224.94  |- mesh__dateRevised mesh__D010909 2002-07-03
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D007960 2005
% 224.75/224.94  |- mesh__historyNote mesh__D007960 98; use explode 1967-97   
% 224.75/224.94  |- skos__broader mesh__D007960smesh__D006402
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D007960 2003
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D007960 2006
% 224.75/224.94  |- skos__annotation mesh__D007960
% 224.75/224.94       GEN or unspecified; prefer specifics; DF: LEUKOCYTE DIS   
% 224.75/224.94  |- skos__hiddenLabel mesh__D007960 Disorder, Leukocyte
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D007960 2004
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D007960 1998
% 224.75/224.94  |- mesh__recordAuthorizer mesh__D007960 SJN
% 224.75/224.94  |- skos__scopeNote mesh__D007960
% 224.75/224.94       Disordered formation of various types of leukocytes or an abnormal accumulation or deficiency of these cells.%A%    
% 224.75/224.94  |- mesh__recordOriginator mesh__D007960 NLM
% 224.75/224.94  |- mesh__dateEstablished mesh__D007960 1998-01-01
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D007960 2000
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D007960 1999
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D007960 2001
% 224.75/224.94  |- skos__prefLabel mesh__D007960 Leukocyte Disorders
% 224.75/224.94  |- mesh__publicMeSHNote mesh__D007960 98   
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D007960 2002
% 224.75/224.94  |- mesh__recordMaintainer mesh__D007960 TGC
% 224.75/224.94  |- rdf__type mesh__D007960sskos__Concept
% 224.75/224.94  |- mesh__dateRevised mesh__D007960 1997-06-20
% 224.75/224.94  |- mesh__dateCreated mesh__D007960 1999-01-01
% 224.75/224.94  |- skos__hiddenLabel mesh__D007960 Leukocyte Disorder
% 224.75/224.94  |- skos__hiddenLabel mesh__D007960 Disorders, Leukocyte
% 224.75/224.94  |- rdf__type mesh__D007162sskos__Concept
% 224.75/224.94  |- mesh__recordOriginator mesh__D007162 NLM
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D007162 1998
% 224.75/224.94  |- mesh__recordAuthorizer mesh__D007162 SJN
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D007162 2002
% 224.75/224.94  |- mesh__publicMeSHNote mesh__D007162 98   
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D007162 2003
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D007162 1999
% 224.75/224.94  |- skos__prefLabel mesh__D007162 Immunoproteins
% 224.75/224.94  |- mesh__dateRevised mesh__D007162 1997-06-20
% 224.75/224.94  |- mesh__recordMaintainer mesh__D007162 ADP
% 224.75/224.94  |- mesh__historyNote mesh__D007162 98; use explode 1967-97   
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D007162 2005
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D007162 2004
% 224.75/224.94  |- skos__broader mesh__D007162smesh__D001798
% 224.75/224.94  |- mesh__dateEstablished mesh__D007162 1998-01-01
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D007162 2000
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D007162 2006
% 224.75/224.94  |- skos__scopeNote mesh__D007162
% 224.75/224.94       Blood proteins whose activities affect or play a role in the functioning of the immune system.%A%    
% 224.75/224.94  |- mesh__dateCreated mesh__D007162 1999-01-01
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D007162 2001
% 224.75/224.94  |- skos__annotation mesh__D007162 GEN or unspecified; prefer specifics   
% 224.75/224.94  |- mesh__dateCreated mesh__D020539 1999-11-03
% 224.75/224.94  |- skos__altLabel mesh__D020539 Sequence Analyses, Amino Acid
% 224.75/224.94  |- mesh__dateEstablished mesh__D020539 2000-01-01
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D020539 2000
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D020539 2005
% 224.75/224.94  |- mesh__historyNote mesh__D020539 2000   
% 224.75/224.94  |- skos__hiddenLabel mesh__D020539 Protein Sequence Determination
% 224.75/224.94  |- skos__hiddenLabel mesh__D020539 Peptide Sequence Determinations
% 224.75/224.94  |- skos__hiddenLabel mesh__D020539 Analyses, Protein Sequence
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D020539 2004
% 224.75/224.94  |- skos__altLabel mesh__D020539 Sequence Analysis, Amino Acid
% 224.75/224.94  |- skos__hiddenLabel mesh__D020539 Sequence Analyses, Peptide
% 224.75/224.94  |- mesh__publicMeSHNote mesh__D020539 2000   
% 224.75/224.94  |- skos__altLabel mesh__D020539 Sequence Analysis, Peptide
% 224.75/224.94  |- skos__altLabel mesh__D020539 Amino Acid Sequence Analyses
% 224.75/224.94  |- skos__altLabel mesh__D020539 Peptide Sequence Analysis
% 224.75/224.94  |- skos__altLabel mesh__D020539 Amino Acid Sequence Determination
% 224.75/224.94  |- skos__hiddenLabel mesh__D020539 Sequence Determination, Peptide
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D020539 2003
% 224.75/224.94  |- skos__hiddenLabel mesh__D020539 Peptide Sequence Analyses
% 224.75/224.94  |- skos__historyNote mesh__D020539 Amino Acid Sequence %28%1966-1999%29%
% 224.75/224.94  |- skos__hiddenLabel mesh__D020539 Analysis, Protein Sequence
% 224.75/224.94  |- skos__hiddenLabel mesh__D020539 Protein Sequence Analyses
% 224.75/224.94  |- skos__hiddenLabel mesh__D020539 Protein Sequence Determinations
% 224.75/224.94  |- skos__altLabel mesh__D020539 Sequence Determination, Amino Acid
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D020539 2002
% 224.75/224.94  |- skos__hiddenLabel mesh__D020539 Sequence Determinations, Peptide
% 224.75/224.94  |- skos__altLabel mesh__D020539 Amino Acid Sequence Analysis
% 224.75/224.94  |- skos__hiddenLabel mesh__D020539 Sequence Determinations, Protein
% 224.75/224.94  |- skos__hiddenLabel mesh__D020539 Analysis, Peptide Sequence
% 224.75/224.94  |- skos__scopeNote mesh__D020539
% 224.75/224.94       A process that includes the determination of an amino acid sequence of a protein %28%or peptide, oligopeptide or peptide fragment%29% and the information analysis of the sequence.%A%    
% 224.75/224.94  |- skos__historyNote mesh__D020539 Sequence Analysis %28%1993-1999%29%
% 224.75/224.94  |- skos__altLabel mesh__D020539 Peptide Sequence Determination
% 224.75/224.94  |- skos__altLabel mesh__D020539 Protein Sequence Analysis
% 224.75/224.94  |- skos__altLabel mesh__D020539 Amino Acid Sequence Determinations
% 224.75/224.94  |- skos__broader mesh__D020539smesh__D017421
% 224.75/224.94  |- skos__historyNote mesh__D020539 Amino Acids/analysis %28%1966-1999%29%
% 224.75/224.94  |- skos__prefLabel mesh__D020539 Sequence Analysis, Protein
% 224.75/224.94  |- skos__altLabel mesh__D020539 Sequence Determinations, Amino Acid
% 224.75/224.94  |- skos__hiddenLabel mesh__D020539 Sequence Analyses, Protein
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D020539 2001
% 224.75/224.94  |- skos__annotation mesh__D020539
% 224.75/224.94       coord with specific protein %28%or protein group or peptide%29% with /chem; DF: SEQ ANAL PROTEIN%A%  
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D020539 2006
% 224.75/224.94  |- skos__hiddenLabel mesh__D020539 Analyses, Peptide Sequence
% 224.75/224.94  |- rdf__type mesh__D020539sskos__Concept
% 224.75/224.94  |- skos__broader mesh__D006868smesh__D002627
% 224.75/224.94  |- skos__broader mesh__D006868smesh__D008660
% 224.75/224.94  |- mesh__publicMeSHNote mesh__D006868
% 224.75/224.94       91; was see under CHEMISTRY, PHYSICAL 1971-90   
% 224.75/224.94  |- rdf__type mesh__D006868sskos__Concept
% 224.75/224.94  |- skos__annotation mesh__D006868 almost never IM   
% 224.75/224.94  |- mesh__recordAuthorizer mesh__D006868 sjn
% 224.75/224.94  |- mesh__historyNote mesh__D006868
% 224.75/224.94       91%28%71%29%; was see under CHEMISTRY, PHYSICAL 1971-90   
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D006868 2003
% 224.75/224.94  |- mesh__recordOriginator mesh__D006868 NLM
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D006868 2001
% 224.75/224.94  |- skos__historyNote mesh__D006868 Chemistry, Physical %28%1966-1970%29%
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D006868 2005
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D006868 2004
% 224.75/224.94  |- skos__scopeNote mesh__D006868
% 224.75/224.94       The process of cleaving a chemical compound by the addition of a molecule of water.%A%    
% 224.75/224.94  |- skos__prefLabel mesh__D006868 Hydrolysis
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D006868 2006
% 224.75/224.94  |- mesh__recordMaintainer mesh__D006868 adp
% 224.75/224.94  |- mesh__dateEstablished mesh__D006868 1991-01-01
% 224.75/224.94  |- mesh__dateRevised mesh__D006868 2000-06-22
% 224.75/224.94  |- mesh__dateCreated mesh__D006868 1999-01-01
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D006868 2002
% 224.75/224.94  |- mesh__historyNote mesh__D017590 1994   
% 224.75/224.94  |- skos__hiddenLabel mesh__D017590 Myelinoclases, Extrapontine
% 224.75/224.94  |- skos__broader mesh__D017590smesh__D003711
% 224.75/224.94  |- mesh__recordMaintainer mesh__D017590 nns
% 224.75/224.94  |- skos__hiddenLabel mesh__D017590 Myelinolyses, Extrapontine
% 224.75/224.94  |- rdf__type mesh__D017590sskos__Concept
% 224.75/224.94  |- skos__hiddenLabel mesh__D017590 Myelinolysis, Extrapontine
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D017590 2002
% 224.75/224.94  |- skos__altLabel mesh__D017590 Extrapontine Myelinoclasis
% 224.75/224.94  |- skos__broader mesh__D017590smesh__D001928
% 224.75/224.94  |- mesh__recordAuthorizer mesh__D017590 sjn
% 224.75/224.94  |- mesh__dateCreated mesh__D017590 1992-12-28
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D017590 2006
% 224.75/224.94  |- skos__hiddenLabel mesh__D017590 Central Pontine Myelinoclasis
% 224.75/224.94  |- skos__historyNote mesh__D017590 Demyelinating Diseases %28%1966-1993%29%
% 224.75/224.94  |- mesh__dateEstablished mesh__D017590 1994-01-01
% 224.75/224.94  |- mesh__recordOriginator mesh__D017590 TGC
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D017590 2005
% 224.75/224.94  |- skos__altLabel mesh__D017590 Central Pontine Myelinolysis
% 224.75/224.94  |- skos__hiddenLabel mesh__D017590 Extrapontine Myelinoclases
% 224.75/224.94  |- mesh__dateRevised mesh__D017590 2001-07-25
% 224.75/224.94  |- skos__prefLabel mesh__D017590 Myelinolysis, Central Pontine
% 224.75/224.94  |- mesh__publicMeSHNote mesh__D017590 1994   
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D017590 2004
% 224.75/224.94  |- skos__hiddenLabel mesh__D017590 Extrapontine Myelinolyses
% 224.75/224.94  |- skos__historyNote mesh__D017590 Pons %28%1966-1993%29%
% 224.75/224.94  |- skos__altLabel mesh__D017590 Pontine Myelinolysis, Central
% 224.75/224.94  |- skos__scopeNote mesh__D017590
% 224.75/224.94       A demyelinating condition affecting the PONS and characterized clinically by an acute progressive QUADRIPLEGIA; DYSARTHRIA; DYSPHAGIA; and alterations of consciousness. Pathologic features include prominent demyelination in the central PONS with sparing of axons and neurons. This condition is usually associated with systemic disorders such as HYPONATREMIA; chronic ALCOHOLISM; LIVER FAILURE; severe BURNS; malignant NEOPLASMS; hemorrhagic PANCREATITIS; HEMODIALYSIS; and SEPSIS. The rapid medical correction of hyponatremia has been cited as a cause of this condition. %28%From Adams et al., Principles of Neurology, 6th ed, pp1125-6%29%%A%    
% 224.75/224.94  |- skos__altLabel mesh__D017590 Myelinoclasis, Central Pontine
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D017590 2003
% 224.75/224.94  |- skos__hiddenLabel mesh__D017590 Myelinoclasis, Extrapontine
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D031261 2006B
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D031261 2005A
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D031261 2005
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D031261 2006A
% 224.75/224.94  |- skos__historyNote mesh__D031261 Poultry Diseases %28%1991-2002%29%
% 224.75/224.94  |- skos__altLabel mesh__D031261 Spiking Mortality Syndrome
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D031261 2004
% 224.75/224.94  |- mesh__recordOriginator mesh__D031261 ags
% 224.75/224.94  |- mesh__dateEstablished mesh__D031261 2003-01-01
% 224.75/224.94  |- skos__historyNote mesh__D031261
% 224.75/224.94       Enteritis, Transmissible, of Turkeys %28%1997-2002%29%
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D031261 2003
% 224.75/224.94  |- mesh__historyNote mesh__D031261 2003   
% 224.75/224.94  |- skos__scopeNote mesh__D031261
% 224.75/224.94       An acute, transmissible, infectious disease associated with high MORTALITY and MORBIDITY in young turkeys %28%poults%29%. It is characterized by DIARRHEA; ANOREXIA; growth depression, and immune dysfunction. The cause is unknown but astroviruses %28%ASTROVIRUS%29% and coronaviruses %28%CORONAVIRUS, TURKEY%29% have been isolated from diseased poults and are thought to cause the enteritis and increased susceptibility to bacterial infections.%A%    
% 224.75/224.94  |- mesh__recordAuthorizer mesh__D031261 ags
% 224.75/224.94  |- rdf__type mesh__D031261sskos__Concept
% 224.75/224.94  |- skos__annotation mesh__D031261 don%27%t forget TURKEYS %28%NIM%29%   
% 224.75/224.94  |- skos__broader mesh__D031261smesh__D011201
% 224.75/224.94  |- skos__hiddenLabel mesh__D031261 Mortality Syndrome, Spiking
% 224.75/224.94  |- mesh__recordMaintainer mesh__D031261 ags
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D031261 2006C
% 224.75/224.94  |- skos__prefLabel mesh__D031261 Poult Enteritis Mortality Syndrome
% 224.75/224.94  |- mesh__publicMeSHNote mesh__D031261 2003   
% 224.75/224.94  |- mesh__dateCreated mesh__D031261 2002-07-03
% 224.75/224.94  |- skos__related mesh__D031261smesh__D004753
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D031261 2006
% 224.75/224.94  |- mesh__dateRevised mesh__D031261 2005-07-13
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D003570 2003
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D003570 2006
% 224.75/224.94  |- mesh__historyNote mesh__D003570
% 224.75/224.94       91%28%78%29%; was see under CYTOSINE NUCLEOTIDES 1978-90   
% 224.75/224.94  |- skos__broader mesh__D003570smesh__D003597
% 224.75/224.94  |- mesh__recordOriginator mesh__D003570 RLS
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D003570 2004
% 224.75/224.94  |- mesh__publicMeSHNote mesh__D003570
% 224.75/224.94       91; was see under CYTOSINE NUCLEOTIDES 1978-90   
% 224.75/224.94  |- mesh__recordMaintainer mesh__D003570 PLS
% 224.75/224.94  |- mesh__dateEstablished mesh__D003570 1991-01-01
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D003570 1994
% 224.75/224.94  |- rdf__type mesh__D003570sskos__Concept
% 224.75/224.94  |- mesh__activeMeSHYear mesh__D003570 1992
% 224.75/224.94  |- skos__altLabel mesh__D003570 CTP
% 224.75/224.95  |- skos__scopeNote mesh__D003570
% 224.75/224.95       Cytidine 5%27%-%28%tetrahydrogen triphosphate%29%. A cytosine nucleotide containing three phosphate groups esterified to the sugar moiety.%A%    
% 224.75/224.95  |- skos__altLabel mesh__D003570 CRPPP
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D003570 2000
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D003570 1995
% 224.75/224.95  |- mesh__dateRevised mesh__D003570 1991-02-21
% 224.75/224.95  |- skos__annotation mesh__D003570 /biosyn /physiol permitted   
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D003570 1993
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D003570 1998
% 224.75/224.95  |- mesh__recordAuthorizer mesh__D003570 PLS
% 224.75/224.95  |- skos__hiddenLabel mesh__D003570 Triphosphate, Cytidine
% 224.75/224.95  |- mesh__dateCreated mesh__D003570 1977-04-22
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D003570 2001
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D003570 1996
% 224.75/224.95  |- skos__prefLabel mesh__D003570 Cytidine Triphosphate
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D003570 1999
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D003570 2005
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D003570 2002
% 224.75/224.95  |- skos__historyNote mesh__D003570 Cytosine Nucleotides %28%1966-1977%29%
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D003570 1997
% 224.75/224.95  |- mesh__dateCreated mesh__D011204 1979-05-31
% 224.75/224.95  |- skos__scopeNote mesh__D011204
% 224.75/224.95       City, urban, rural, or suburban areas which are characterized by severe economic deprivation and by accompanying physical and social decay.%A%    
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D011204 2006
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D011204 2003
% 224.75/224.95  |- rdf__type mesh__D011204sskos__Concept
% 224.75/224.95  |- skos__hiddenLabel mesh__D011204 Areas, Poverty
% 224.75/224.95  |- skos__historyNote mesh__D011204 Poverty %28%1968-1979%29%
% 224.75/224.95  |- mesh__recordMaintainer mesh__D011204 kle
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D011204 2002
% 224.75/224.95  |- mesh__dateRevised mesh__D011204 1999-11-03
% 224.75/224.95  |- mesh__dateEstablished mesh__D011204 1991-01-01
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D011204 2004
% 224.75/224.95  |- mesh__recordAuthorizer mesh__D011204 sjn
% 224.75/224.95  |- skos__hiddenLabel mesh__D011204 Slum
% 224.75/224.95  |- skos__broader mesh__D011204smesh__D011203
% 224.75/224.95  |- mesh__recordOriginator mesh__D011204 EC
% 224.75/224.95  |- skos__prefLabel mesh__D011204 Poverty Areas
% 224.75/224.95  |- skos__annotation mesh__D011204 no qualif; specify geog   
% 224.75/224.95  |- skos__hiddenLabel mesh__D011204 Area, Poverty
% 224.75/224.95  |- mesh__historyNote mesh__D011204
% 224.75/224.95       91%28%80%29%; was see under POVERTY 1980-90   
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D011204 2000
% 224.75/224.95  |- skos__hiddenLabel mesh__D011204 Poverty Area
% 224.75/224.95  |- skos__hiddenLabel mesh__D011204 Ghetto
% 224.75/224.95  |- mesh__publicMeSHNote mesh__D011204 91; was see under POVERTY 1980-90   
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D011204 2005
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D011204 2001
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D049672 2006
% 224.75/224.95  |- mesh__dateCreated mesh__D049672 2004-07-07
% 224.75/224.95  |- skos__hiddenLabel mesh__D049672 Histories, 19th Century
% 224.75/224.95  |- skos__annotation mesh__D049672 IM general only; NIM as check tag   
% 224.75/224.95  |- skos__hiddenLabel mesh__D049672 Histories, 19th Cent. %28%Medicine%29%
% 224.75/224.95  |- skos__broader mesh__D049672smesh__D049711
% 224.75/224.95  |- skos__altLabel mesh__D049672 19th Cent. Medicine
% 224.75/224.95  |- skos__hiddenLabel mesh__D049672 History, 19th Cent. %28%Medicine%29%
% 224.75/224.95  |- skos__prefLabel mesh__D049672 History, 19th Century
% 224.75/224.95  |- skos__hiddenLabel mesh__D049672 Century Histories, Nineteenth
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D049672 2005
% 224.75/224.95  |- rdf__type mesh__D049672sskos__Concept
% 224.75/224.95  |- skos__hiddenLabel mesh__D049672 Century Histories, 19th
% 224.75/224.95  |- skos__hiddenLabel mesh__D049672 Histories, Nineteenth Century
% 224.75/224.95  |- skos__altLabel mesh__D049672 19th Cent. History %28%Medicine%29%
% 224.75/224.95  |- mesh__recordMaintainer mesh__D049672 jls
% 224.75/224.95  |- skos__hiddenLabel mesh__D049672 Cent. Histories, 19th %28%Medicine%29%
% 224.75/224.95  |- skos__hiddenLabel mesh__D049672 Century History, 19th
% 224.75/224.95  |- skos__altLabel mesh__D049672 19th Cent. History of Medicine
% 224.75/224.95  |- skos__hiddenLabel mesh__D049672 Nineteenth Century History
% 224.75/224.95  |- skos__hiddenLabel mesh__D049672 Nineteenth Century Histories
% 224.75/224.95  |- skos__scopeNote mesh__D049672
% 224.75/224.95       Time period from 1801 through 1900 of the common era.     
% 224.75/224.95  |- skos__hiddenLabel mesh__D049672 19th Century Histories
% 224.75/224.95  |- skos__hiddenLabel mesh__D049672 19th Cent. Histories %28%Medicine%29%
% 224.75/224.95  |- skos__altLabel mesh__D049672 History, Nineteenth Century
% 224.75/224.95  |- skos__hiddenLabel mesh__D049672 Century History, Nineteenth
% 224.75/224.95  |- mesh__recordOriginator mesh__D049672 jls
% 224.75/224.95  |- mesh__dateEstablished mesh__D049672 2005-01-01
% 224.75/224.95  |- mesh__historyNote mesh__D049672 2005   
% 224.75/224.95  |- mesh__recordAuthorizer mesh__D049672 sjn
% 224.75/224.95  |- mesh__publicMeSHNote mesh__D049672
% 224.75/224.95       2005; see HISTORY OF MEDICINE, 19TH CENT. 1995-2004; for HISTORY OF MEDICINE 19 CENT. see HISTORY OF MEDICINE 19TH CENT. 1964-2004, see HISTORY OF MEDICINE, XIX CENT. 1963%A%  
% 224.75/224.95  |- skos__hiddenLabel mesh__D049672 Cent. History, 19th %28%Medicine%29%
% 224.75/224.95  |- skos__altLabel mesh__D049672 19th Century History
% 224.75/224.95  |- skos__altLabel mesh__D049672 Medical History, 19th Cent.
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D002478 2006
% 224.75/224.95  |- skos__prefLabel mesh__D002478 Cells, Cultured
% 224.75/224.95  |- mesh__recordMaintainer mesh__D002478 sjn
% 224.75/224.95  |- mesh__dateCreated mesh__D002478 1999-01-01
% 224.75/224.95  |- mesh__publicMeSHNote mesh__D002478 72   
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D002478 2005
% 224.75/224.95  |- skos__broader mesh__D002478smesh__D002477
% 224.75/224.95  |- skos__related mesh__D002478smesh__D015194
% 224.75/224.95  |- skos__related mesh__D002478smesh__D018929
% 224.75/224.95  |- skos__scopeNote mesh__D002478
% 224.75/224.95       Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.%A%    
% 224.75/224.95  |- mesh__recordAuthorizer mesh__D002478 sjn
% 224.75/224.95  |- mesh__historyNote mesh__D002478 72   
% 224.75/224.95  |- skos__related mesh__D002478smesh__D018920
% 224.75/224.95  |- mesh__dateRevised mesh__D002478 2004-07-13
% 224.75/224.95  |- rdf__type mesh__D002478sskos__Concept
% 224.75/224.95  |- skos__historyNote mesh__D002478 Tissue Culture %28%1966-1971%29%
% 224.75/224.95  |- skos__hiddenLabel mesh__D002478 Cell, Cultured
% 224.75/224.95  |- skos__hiddenLabel mesh__D002478 Cultured Cell
% 224.75/224.95  |- skos__altLabel mesh__D002478 Cultured Cells
% 224.75/224.95  |- skos__annotation mesh__D002478
% 224.75/224.95         note category: do not confuse with  CELL CULTURE TECHNIQUES %28%Cat E%29%; not for bact or other micro-organisms; almost always NIM with no subheadings; check  HUMANS or ANIMALS; do not routinely add tissue or organ; TUMOR CELLS, CULTURED is available%A%  
% 224.75/224.95  |- mesh__dateEstablished mesh__D002478 1972-01-01
% 224.75/224.95  |- mesh__recordOriginator mesh__D002478 NLM
% 224.75/224.95  |- mesh__recordAuthorizer mesh__D007961 sjn
% 224.75/224.95  |- mesh__onlineNote mesh__D007961
% 224.75/224.95       use LEUKOCYTE MIGRATION-INHIBITORY FACTORS to search LEUKOCYTE MIGRATION INHIBITORY FACTORS 1980-90%A%  
% 224.75/224.95  |- mesh__dateRevised mesh__D007961 2005-06-30
% 224.75/224.95  |- skos__hiddenLabel mesh__D007961 Factors, Leukocyte Migration-Inhibitory
% 224.75/224.95  |- mesh__publicMeSHNote mesh__D007961
% 224.75/224.95       91; was LEUKOCYTE MIGRATION INHIBITORY FACTORS see under LYMPHOKINES 1980-90%A%  
% 224.75/224.95  |- skos__hiddenLabel mesh__D007961 Leukocyte Migration Inhibitory Factors
% 224.75/224.95  |- skos__historyNote mesh__D007961 Cell Movement %28%1970-1971%29%
% 224.75/224.95  |- skos__historyNote mesh__D007961
% 224.75/224.95       Cell Migration Inhibition %28%1971-1973%29%
% 224.75/224.95  |- skos__hiddenLabel mesh__D007961 Leukocyte Migration Inhibition Factors
% 224.75/224.95  |- skos__scopeNote mesh__D007961
% 224.75/224.95       Protein factor%28%s%29% released by sensitized lymphocytes %28%and possibly other cells%29% that inhibit the movement of leukocytes, especially polymorphonuclear cells, away from their site of release. Assays for these factors are used as tests for cellular immunity. Two of the common assays are the leukocyte migration capillary tube technique %28%LMCT%29% and the leukocyte migration agarose technique %28%LMAT%29%.%A%    
% 224.75/224.95  |- mesh__dateCreated mesh__D007961 1979-05-01
% 224.75/224.95  |- skos__altLabel mesh__D007961 Leukocyte Migration-Inhibition Factors
% 224.75/224.95  |- mesh__historyNote mesh__D007961
% 224.75/224.95       91%28%80%29%; was LEUKOCYTE MIGRATION INHIBITORY FACTORS see under LYMPHOKINES 1980-90%A%  
% 224.75/224.95  |- skos__hiddenLabel mesh__D007961 Factors, Leukocyte Migration-Inhibition
% 224.75/224.95  |- mesh__recordOriginator mesh__D007961 SH
% 224.75/224.95  |- rdf__type mesh__D007961sskos__Concept
% 224.75/224.95  |- skos__prefLabel mesh__D007961 Leukocyte Migration-Inhibitory Factors
% 224.75/224.95  |- skos__broader mesh__D007961smesh__D008222
% 224.75/224.95  |- mesh__dateEstablished mesh__D007961 1991-01-01
% 224.75/224.95  |- skos__hiddenLabel mesh__D007961 Migration Inhibition Factors, Leukocyte
% 224.75/224.95  |- skos__altLabel mesh__D007961 Migration-Inhibitory Factors, Leukocyte
% 224.75/224.95  |- skos__historyNote mesh__D007961 Lymphokines %28%1974-1979%29%
% 224.75/224.95  |- skos__historyNote mesh__D007961
% 224.75/224.95       Macrophage Migration-Inhibitory Factors %28%1974-1979%29%
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D007961 2006
% 224.75/224.95  |- skos__altLabel mesh__D007961 Migration-Inhibition Factors, Leukocyte
% 224.75/224.95  |- skos__hiddenLabel mesh__D007961 Migration Inhibitory Factors, Leukocyte
% 224.75/224.95  |- mesh__recordMaintainer mesh__D007961 ssb
% 224.75/224.95  |- skos__annotation mesh__D007961
% 224.75/224.95       /biosyn /physiol permitted; do not use /analogs; also called LIF; DF: LMIF%A%  
% 224.75/224.95  |- skos__hiddenLabel mesh__D007163 Technics, Immunosorbent
% 224.75/224.95  |- skos__hiddenLabel mesh__D007163 Technic, Immunosorbent
% 224.75/224.95  |- skos__altLabel mesh__D007163 Immunosorbent Technics
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D007163 2006
% 224.75/224.95  |- mesh__publicMeSHNote mesh__D007163
% 224.75/224.95       91; was IMMUNOSORBENT TECHNICS 1977-90   
% 224.75/224.95  |- mesh__recordMaintainer mesh__D007163 nns
% 224.75/224.95  |- skos__prefLabel mesh__D007163 Immunosorbent Techniques
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D007163 2002
% 224.75/224.95  |- skos__hiddenLabel mesh__D007163 Immunoadsorbent Technique
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D007163 2005
% 224.75/224.95  |- skos__hiddenLabel mesh__D007163 Technique, Immunosorbent
% 224.75/224.95  |- mesh__recordOriginator mesh__D007163 SMH
% 224.75/224.95  |- skos__historyNote mesh__D007163
% 224.75/224.95       specific antigen/isolation %26% purification %28%1969-1976%29%
% 224.75/224.95  |- mesh__recordAuthorizer mesh__D007163 sjn
% 224.75/224.95  |- mesh__dateRevised mesh__D007163 2001-07-25
% 224.75/224.95  |- rdf__type mesh__D007163sskos__Concept
% 224.75/224.95  |- skos__hiddenLabel mesh__D007163 Techniques, Immunosorbent
% 224.75/224.95  |- skos__historyNote mesh__D007163
% 224.75/224.95       specific antibody/isolation %26% purification %28%1969-1976%29%
% 224.75/224.95  |- skos__broader mesh__D007163smesh__D007118
% 224.75/224.95  |- skos__hiddenLabel mesh__D007163 Technics, Immunoadsorbent
% 224.75/224.95  |- skos__hiddenLabel mesh__D007163 Technic, Immunoadsorbent
% 224.75/224.95  |- skos__hiddenLabel mesh__D007163 Immunoadsorbent Technic
% 224.75/224.95  |- mesh__dateCreated mesh__D007163 1976-04-16
% 224.75/224.95  |- mesh__dateEstablished mesh__D007163 1977-01-01
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D007163 2004
% 224.75/224.95  |- skos__altLabel mesh__D007163 Immunoadsorbent Technics
% 224.75/224.95  |- skos__hiddenLabel mesh__D007163 Immunosorbent Technic
% 224.75/224.95  |- skos__annotation mesh__D007163
% 224.75/224.95       NIM; do not use /util except by MeSH definition   
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D007163 2003
% 224.75/224.95  |- mesh__historyNote mesh__D007163
% 224.75/224.95       91; was IMMUNOSORBENT TECHNICS 1977-90   
% 224.75/224.95  |- skos__historyNote mesh__D007163 Adsorption %28%1966-1976%29%
% 224.75/224.95  |- skos__hiddenLabel mesh__D007163 Technique, Immunoadsorbent
% 224.75/224.95  |- skos__altLabel mesh__D007163 Immunoadsorbent Techniques
% 224.75/224.95  |- skos__scopeNote mesh__D007163
% 224.75/224.95       Techniques for removal by adsorption and subsequent elution of a specific antibody or antigen using an immunosorbent containing the homologous antigen or antibody.%A%    
% 224.75/224.95  |- skos__hiddenLabel mesh__D007163 Techniques, Immunoadsorbent
% 224.75/224.95  |- skos__hiddenLabel mesh__D007163 Immunosorbent Technique
% 224.75/224.95  |- mesh__onlineNote mesh__D007163
% 224.75/224.95       use IMMUNOSORBENT TECHNIQUES to search IMMUNOSORBENT TECHNICS 1977-90%A%  
% 224.75/224.95  |- skos__historyNote mesh__D045282
% 224.75/224.95       Gram-Negative Anaerobic Bacteria %28%1989-2000%29%
% 224.75/224.95  |- mesh__dateRevised mesh__D045282 2005-06-30
% 224.75/224.95  |- mesh__recordOriginator mesh__D045282 ags
% 224.75/224.95  |- mesh__historyNote mesh__D045282 2004   
% 224.75/224.95  |- rdf__type mesh__D045282sskos__Concept
% 224.75/224.95  |- skos__annotation mesh__D045282
% 224.75/224.95       infection: coord IM with DESULFOVIBRIONACEAE INFECTIONS %28%IM%29%%A%  
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D045282 2006
% 224.75/224.95  |- mesh__publicMeSHNote mesh__D045282 2004   
% 224.75/224.95  |- mesh__recordMaintainer mesh__D045282 SYSTEM
% 224.75/224.95  |- skos__scopeNote mesh__D045282
% 224.75/224.95       A genus of gram-negative, anaerobic bacteria in the family Desulfovibrionaceae. It was originally recovered from infections in patients with gangrenous and PERFORATED APPENDICITIS. It is also associated with ABSCESS; BACTEREMIA; and BILIARY TRACT sepsis.%A%    
% 224.75/224.95  |- mesh__dateCreated mesh__D045282 2003-07-09
% 224.75/224.95  |- skos__broader mesh__D045282smesh__D020564
% 224.75/224.95  |- mesh__dateEstablished mesh__D045282 2004-01-01
% 224.75/224.95  |- skos__broader mesh__D045282smesh__D016965
% 224.75/224.95  |- skos__prefLabel mesh__D045282 Bilophila
% 224.75/224.95  |- skos__historyNote mesh__D045282 Deltaproteobacteria %28%2000-2003%29%
% 224.75/224.95  |- mesh__recordAuthorizer mesh__D045282 sjn
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D006869 2003
% 224.75/224.95  |- skos__hiddenLabel mesh__D006869 Hydronephroses
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D006869 1995
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D006869 2005
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D006869 2004
% 224.75/224.95  |- skos__broader mesh__D006869smesh__D007674
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D006869 1996
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D006869 2002
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D006869 2006
% 224.75/224.95  |- skos__annotation mesh__D006869 kidney distention with urine   
% 224.75/224.95  |- skos__scopeNote mesh__D006869
% 224.75/224.95       A distention of the pelvis and calices of the kidney with urine, as a result of obstruction of the ureter, with accompanying atrophy of the parenchyma of the organ. %28%Dorland, 27th ed%29%%A%    
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D006869 1998
% 224.75/224.95  |- mesh__dateCreated mesh__D006869 1999-01-01
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D006869 1997
% 224.75/224.95  |- mesh__recordMaintainer mesh__D006869 TAP
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D006869 2000
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D006869 1999
% 224.75/224.95  |- skos__prefLabel mesh__D006869 Hydronephrosis
% 224.75/224.95  |- mesh__recordOriginator mesh__D006869 NLM
% 224.75/224.95  |- mesh__dateRevised mesh__D006869 1993-06-02
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D006869 1994
% 224.75/224.95  |- rdf__type mesh__D006869sskos__Concept
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D006869 2001
% 224.75/224.95  |- mesh__recordAuthorizer mesh__D006869 PLS
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D017591 2006
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D017591 2005
% 224.75/224.95  |- skos__annotation mesh__D017591
% 224.75/224.95       to determ blood ACTH in Cushing %26% other adrenocortex dis; do not use /util except by MeSH definition%A%  
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D017591 1999
% 224.75/224.95  |- skos__altLabel mesh__D017591 Inferior Petrosal Sinus Sampling
% 224.75/224.95  |- skos__prefLabel mesh__D017591 Petrosal Sinus Sampling
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D017591 2002
% 224.75/224.95  |- skos__broader mesh__D017591smesh__D001800
% 224.75/224.95  |- skos__hiddenLabel mesh__D017591 Sampling, Petrosal Sinus
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D017591 2004
% 224.75/224.95  |- mesh__recordAuthorizer mesh__D017591 SJN
% 224.75/224.95  |- skos__scopeNote mesh__D017591
% 224.75/224.95       Sampling of blood levels of the adrenocorticotropic hormone %28%ACTH%29% by withdrawal of blood from the inferior petrosal sinus. The inferior petrosal sinus arises from the cavernous sinus and runs to the internal jugular vein. Sampling of blood at this level is a valuable tool in the differential diagnosis of Cushing disease, Cushing syndrome, and other adrenocortical diseases.%A%    
% 224.75/224.95  |- skos__broader mesh__D017591smesh__D001774
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D017591 1998
% 224.75/224.95  |- mesh__historyNote mesh__D017591 94   
% 224.75/224.95  |- skos__hiddenLabel mesh__D017591 Samplings, Petrosal Sinus
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D017591 2001
% 224.75/224.95  |- skos__historyNote mesh__D017591
% 224.75/224.95       Blood Specimen Collection %28%1985-1993%29%
% 224.75/224.95  |- mesh__dateEstablished mesh__D017591 1994-01-01
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D017591 2003
% 224.75/224.95  |- mesh__recordMaintainer mesh__D017591 PXP
% 224.75/224.95  |- mesh__recordOriginator mesh__D017591 TGC
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D017591 2000
% 224.75/224.95  |- skos__hiddenLabel mesh__D017591 Petrosal Sinus Samplings
% 224.75/224.95  |- skos__historyNote mesh__D017591 Corticotropin/blood %28%1985-1993%29%
% 224.75/224.95  |- mesh__dateCreated mesh__D017591 1993-06-03
% 224.75/224.95  |- mesh__publicMeSHNote mesh__D017591 94   
% 224.75/224.95  |- mesh__dateRevised mesh__D017591 1997-06-20
% 224.75/224.95  |- skos__altLabel mesh__D017591
% 224.75/224.95       Bilateral Synchronous Inferior Petrosal Sinus Sampling
% 224.75/224.95  |- rdf__type mesh__D017591sskos__Concept
% 224.75/224.95  |- skos__altLabel mesh__D017591 BSIPSS
% 224.75/224.95  |- skos__broader mesh__D031262smesh__D019684
% 224.75/224.95  |- mesh__dateCreated mesh__D031262 2002-07-03
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D031262 2004
% 224.75/224.95  |- skos__prefLabel mesh__D031262 Ebenaceae
% 224.75/224.95  |- mesh__recordAuthorizer mesh__D031262 sjn
% 224.75/224.95  |- rdf__type mesh__D031262sskos__Concept
% 224.75/224.95  |- mesh__dateRevised mesh__D031262 2003-07-09
% 224.75/224.95  |- mesh__recordOriginator mesh__D031262 ssb
% 224.75/224.95  |- mesh__publicMeSHNote mesh__D031262 2003   
% 224.75/224.95  |- skos__annotation mesh__D031262
% 224.75/224.95       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.75/224.95  |- mesh__dateEstablished mesh__D031262 2003-01-01
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D031262 2006
% 224.75/224.95  |- mesh__historyNote mesh__D031262 2003   
% 224.75/224.95  |- skos__scopeNote mesh__D031262
% 224.75/224.95       A small plant family of the order Ebenales, subclass Dilleniidae, class Magnoliopsida. Members contain NAPHTHOQUINONES.%A%    
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D031262 2005
% 224.75/224.95  |- mesh__recordMaintainer mesh__D031262 ssb
% 224.75/224.95  |- skos__annotation mesh__D003571
% 224.75/224.95       /antag permitted but consider also ANTITOXINS   
% 224.75/224.95  |- skos__prefLabel mesh__D003571 Cytochalasin B
% 224.75/224.95  |- mesh__dateCreated mesh__D003571 1999-01-01
% 224.75/224.95  |- mesh__recordOriginator mesh__D003571 NLM
% 224.75/224.95  |- mesh__publicMeSHNote mesh__D003571 74   
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D003571 2006
% 224.75/224.95  |- mesh__historyNote mesh__D003571 74%28%73%29%   
% 224.75/224.95  |- skos__historyNote mesh__D003571 Indoles %28%1966-1972%29%
% 224.75/224.95  |- skos__scopeNote mesh__D003571
% 224.75/224.95       A cytotoxic member of the CYTOCHALASINS.     
% 224.75/224.95  |- skos__broader mesh__D003571smesh__D003572
% 224.75/224.95  |- mesh__dateRevised mesh__D003571 2005-06-30
% 224.75/224.95  |- skos__historyNote mesh__D003571 specific fungus
% 224.75/224.95  |- skos__altLabel mesh__D003571 Phomin
% 224.75/224.95  |- rdf__type mesh__D003571sskos__Concept
% 224.75/224.95  |- mesh__dateEstablished mesh__D003571 1974-01-01
% 224.75/224.95  |- mesh__recordMaintainer mesh__D003571 ssb
% 224.75/224.95  |- mesh__recordAuthorizer mesh__D003571 sjn
% 224.75/224.95  |- skos__broader mesh__D011205smesh__D011145
% 224.75/224.95  |- skos__altLabel mesh__D011205 Winzer Brand of Povidone
% 224.75/224.95  |- rdf__type mesh__D011205sskos__Concept
% 224.75/224.95  |- skos__altLabel mesh__D011205 Ursapharm Brand of Povidone
% 224.75/224.95  |- mesh__recordMaintainer mesh__D011205 lkw
% 224.75/224.95  |- skos__annotation mesh__D011205 D25-26 qualif   
% 224.75/224.95  |- skos__altLabel mesh__D011205 Chauvin Brand of Povidone
% 224.75/224.95  |- mesh__historyNote mesh__D011205 81; was POLYVINYLPYRROLIDONE 1963-80   
% 224.75/224.95  |- skos__altLabel mesh__D011205 Duratears Free
% 224.75/224.95  |- mesh__dateCreated mesh__D011205 1999-01-01
% 224.75/224.95  |- skos__altLabel mesh__D011205 Alcon Brand of Povidone
% 224.75/224.95  |- mesh__publicMeSHNote mesh__D011205
% 224.75/224.95       81; was POLYVINYLPYRROLIDONE 1963-80   
% 224.75/224.95  |- mesh__recordOriginator mesh__D011205 NLM
% 224.75/224.95  |- skos__altLabel mesh__D011205 Polyvidon
% 224.75/224.95  |- mesh__onlineNote mesh__D011205
% 224.75/224.95       use POVIDONE to search POLYVINYLPYRROLIDONE 1966-80   
% 224.75/224.95  |- skos__altLabel mesh__D011205 Polyvinylpyrrolidone
% 224.75/224.95  |- skos__altLabel mesh__D011205 Mann Brand of Povidone
% 224.75/224.95  |- skos__altLabel mesh__D011205 Stulln Brand of Povidone
% 224.75/224.95  |- skos__altLabel mesh__D011205 Hypotears
% 224.75/224.95  |- skos__broader mesh__D011205smesh__D011760
% 224.75/224.95  |- skos__altLabel mesh__D011205 Protagens
% 224.75/224.95  |- skos__altLabel mesh__D011205 Nutrivisc
% 224.75/224.95  |- skos__altLabel mesh__D011205 Tramedico Brand of Povidone
% 224.75/224.95  |- skos__altLabel mesh__D011205 Ciba Vision Brand of Povidone
% 224.75/224.95  |- mesh__recordAuthorizer mesh__D011205 sjn
% 224.75/224.95  |- skos__altLabel mesh__D011205 Liquifilm Lagrimas
% 224.75/224.95  |- mesh__dateRevised mesh__D011205 2005-06-30
% 224.75/224.95  |- skos__prefLabel mesh__D011205 Povidone
% 224.75/224.95  |- skos__altLabel mesh__D011205 Lagrifilm
% 224.75/224.95  |- skos__altLabel mesh__D011205 Novartis Ophthalmics Brand of Povidone
% 224.75/224.95  |- skos__altLabel mesh__D011205 Th%C3%%A9%a Brand of Povidone
% 224.75/224.95  |- skos__altLabel mesh__D011205 Allergan Brand of Povidone
% 224.75/224.95  |- skos__altLabel mesh__D011205 Roche Brand of Povidone
% 224.75/224.95  |- skos__altLabel mesh__D011205 Hamilton Brand of Povidone
% 224.75/224.95  |- skos__altLabel mesh__D011205 Enterodes
% 224.75/224.95  |- skos__scopeNote mesh__D011205
% 224.75/224.95       A polyvinyl polymer of variable molecular weight; used as suspending and dispersing agent and vehicle for pharmaceuticals; also used as blood volume expander.%A%    
% 224.75/224.95  |- skos__altLabel mesh__D011205 Novartis Brand of Povidone
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D011205 2006
% 224.75/224.95  |- skos__altLabel mesh__D011205 Polvidone
% 224.75/224.95  |- mesh__recordAuthorizer mesh__D049673 sjn
% 224.75/224.95  |- mesh__publicMeSHNote mesh__D049673
% 224.75/224.95       2005; see HISTORY OF MEDICINE, 20TH CENT. 1995-2004; for HISTORY OF MEDICINE 20 CENT. see HISTORY OF MEDICINE 20TH CENT. 1964-2004, see HISTORY OF MEDICINE, XX CENT. 1963%A%  
% 224.75/224.95  |- mesh__activeMeSHYear mesh__D049673 2005
% 224.75/224.95  |- rdf__type mesh__D049673sskos__Concept
% 224.75/224.95  |- skos__altLabel mesh__D049673 20th Cent. History of Medicine
% 224.75/224.95  |- skos__hiddenLabel mesh__D049673 Twentieth Century History
% 224.75/224.95  |- skos__hiddenLabel mesh__D049673 Century Histories, 20th
% 224.75/224.95  |- skos__hiddenLabel mesh__D049673 Histories, 20th Cent. %28%Medicine%29%
% 224.75/224.95  |- skos__scopeNote mesh__D049673
% 224.75/224.95       Time period from 1901 through 2000 of the common era.     
% 224.75/224.95  |- skos__annotation mesh__D049673 IM general only; NIM as check tag   
% 224.75/224.95  |- skos__hiddenLabel mesh__D049673 Twentieth Century Histories
% 224.75/224.95  |- skos__hiddenLabel mesh__D049673 History, 20th Cent. %28%Medicine%29%
% 224.75/224.95  |- skos__altLabel mesh__D049673 History, Twentieth Century
% 224.75/224.95  |- skos__hiddenLabel mesh__D049673 Century History, 20th
% 224.75/224.95  |- skos__hiddenLabel mesh__D049673 Cent. Histories, 20th %28%Medicine%29%
% 224.75/224.95  |- skos__hiddenLabel mesh__D049673 20th Century Histories
% 224.75/224.95  |- skos__hiddenLabel mesh__D049673 Histories, Twentieth Century
% 224.75/224.95  |- skos__altLabel mesh__D049673 Medical History, 20th Cent.
% 224.75/224.95  |- mesh__recordOriginator mesh__D049673 jls
% 224.75/224.95  |- skos__altLabel mesh__D049673 20th Cent. Medicine
% 224.75/224.95  |- mesh__recordMaintainer mesh__D049673 jls
% 224.75/224.95  |- skos__hiddenLabel mesh__D049673 Century Histories, Twentieth
% 224.75/224.95  |- skos__hiddenLabel mesh__D049673 Cent. History, 20th %28%Medicine%29%
% 224.75/224.95  |- skos__altLabel mesh__D049673 20th Century History
% 224.75/224.95  |- skos__altLabel mesh__D049673 20th Cent. History %28%Medicine%29%
% 224.75/224.95  |- skos__hiddenLabel mesh__D049673 20th Cent. Histories %28%Medicine%29%
% 224.75/224.95  |- skos__prefLabel mesh__D049673 History, 20th Century
% 224.75/224.95  |- skos__hiddenLabel mesh__D049673 Century History, Twentieth
% 224.75/224.95  |- skos__hiddenLabel mesh__D049673 Histories, 20th Century
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D049673 2006
% 224.75/224.96  |- mesh__dateCreated mesh__D049673 2004-07-07
% 224.75/224.96  |- mesh__dateEstablished mesh__D049673 2005-01-01
% 224.75/224.96  |- mesh__historyNote mesh__D049673 2005   
% 224.75/224.96  |- skos__broader mesh__D049673smesh__D049711
% 224.75/224.96  |- rdf__type mesh__D016499sskos__Concept
% 224.75/224.96  |- skos__annotation mesh__D016499
% 224.75/224.96       radiother by cytotoxic radioisotopes linked to antibodies: read MeSH definition; do not use /util except by MeSH definition; coord IM with disease /radiother %28%IM%29%%A%  
% 224.75/224.96  |- skos__altLabel mesh__D016499 Immunoradiotherapy
% 224.75/224.96  |- mesh__historyNote mesh__D016499 92   
% 224.75/224.96  |- skos__broader mesh__D016499smesh__D003131
% 224.75/224.96  |- skos__hiddenLabel mesh__D016499 Radioimmunotherapies
% 224.75/224.96  |- skos__historyNote mesh__D016499 Immunotherapy %28%1984-1991%29%
% 224.75/224.96  |- mesh__dateRevised mesh__D016499 2005-06-30
% 224.75/224.96  |- skos__historyNote mesh__D016499
% 224.75/224.96       specific radioisotope/therapeutic use %28%1981-1991%29%
% 224.75/224.96  |- mesh__publicMeSHNote mesh__D016499 92   
% 224.75/224.96  |- skos__scopeNote mesh__D016499
% 224.75/224.96       Radiotherapy where cytotoxic radionuclides are linked to antibodies in order to deliver toxins directly to tumor targets. Therapy with targeted radiation rather than antibody-targeted toxins %28%IMMUNOTOXINS%29% has the advantage that adjacent tumor cells, which lack the appropriate antigenic determinants, can be destroyed by radiation cross-fire. Radioimmunotherapy is sometimes called targeted radiotherapy, but this latter term can also refer to radionuclides linked to non-immune molecules %28%see RADIOTHERAPY%29%.%A%    
% 224.75/224.96  |- mesh__dateEstablished mesh__D016499 1992-01-01
% 224.75/224.96  |- skos__historyNote mesh__D016499
% 224.75/224.96       Antibodies, Monoclonal/therapeutic use %28%1984-1991%29%
% 224.75/224.96  |- skos__broader mesh__D016499smesh__D011878
% 224.75/224.96  |- skos__broader mesh__D016499smesh__D007167
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D016499 2006
% 224.75/224.96  |- mesh__recordAuthorizer mesh__D016499 sjn
% 224.75/224.96  |- skos__prefLabel mesh__D016499 Radioimmunotherapy
% 224.75/224.96  |- mesh__recordOriginator mesh__D016499 AGS
% 224.75/224.96  |- mesh__dateCreated mesh__D016499 1991-05-02
% 224.75/224.96  |- skos__hiddenLabel mesh__D016499 Immunoradiotherapies
% 224.75/224.96  |- mesh__recordMaintainer mesh__D016499 lkt
% 224.75/224.96  |- skos__hiddenLabel mesh__D002479 Inclusion, Cytoplasmic
% 224.75/224.96  |- skos__altLabel mesh__D002479 Cellular Inclusions
% 224.75/224.96  |- mesh__dateCreated mesh__D002479 1999-01-01
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D002479 2002
% 224.75/224.96  |- skos__hiddenLabel mesh__D002479 Inclusions, Cellular
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D002479 2006
% 224.75/224.96  |- mesh__publicMeSHNote mesh__D002479
% 224.75/224.96       94; was CELLULAR INCLUSIONS 1972-93; INCLUSION BODIES was see CELLULAR INCLUSIONS 1972-93%A%  
% 224.75/224.96  |- skos__hiddenLabel mesh__D002479 Body, Inclusion
% 224.75/224.96  |- skos__hiddenLabel mesh__D002479 Inclusion Body
% 224.75/224.96  |- skos__hiddenLabel mesh__D002479 Inclusion, Cellular
% 224.75/224.96  |- skos__hiddenLabel mesh__D002479 Cytoplasmic Inclusion
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D002479 2005
% 224.75/224.96  |- skos__hiddenLabel mesh__D002479 Cellular Inclusion
% 224.75/224.96  |- mesh__recordAuthorizer mesh__D002479 sjn
% 224.75/224.96  |- skos__broader mesh__D002479smesh__D022082
% 224.75/224.96  |- mesh__dateRevised mesh__D002479 2000-06-22
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D002479 2001
% 224.75/224.96  |- rdf__type mesh__D002479sskos__Concept
% 224.75/224.96  |- mesh__recordMaintainer mesh__D002479 TGC
% 224.75/224.96  |- skos__annotation mesh__D002479
% 224.75/224.96       A 11 qualif except /cytol; /genet permitted; for bacteria, coord IM with specific bacterium %28%IM%29%; for viruses, INCLUSION BODIES, VIRAL is available: see note there%A%  
% 224.75/224.96  |- mesh__historyNote mesh__D002479
% 224.75/224.96       94; was CELLULAR INCLUSIONS 1970-93 %28%Prov 1970-71%29%; INCLUSION BODIES was see CELLULAR INCLUSIONS 1972-93%A%  
% 224.75/224.96  |- mesh__onlineNote mesh__D002479
% 224.75/224.96       use INCLUSION BODIES to search CELLULAR INCLUSIONS 1972-93 %28%as Prov 1970-71%29%%A%  
% 224.75/224.96  |- skos__prefLabel mesh__D002479 Inclusion Bodies
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D002479 2004
% 224.75/224.96  |- skos__scopeNote mesh__D002479
% 224.75/224.96       A generic term for any circumscribed mass of foreign %28%e.g., lead or viruses%29% or metabolically inactive materials %28%e.g., ceroid or Mallory bodies%29%, within the cytoplasm or nucleus of a cell. Inclusion bodies are in cells infected with certain filtrable viruses, observed especially in nerve, epithelial, or endothelial cells. %28%Stedman, 25th ed%29%%A%    
% 224.75/224.96  |- mesh__recordOriginator mesh__D002479 NLM
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D002479 2003
% 224.75/224.96  |- skos__historyNote mesh__D002479 Cytoplasmic Granules %28%1966-1969%29%
% 224.75/224.96  |- mesh__dateEstablished mesh__D002479 1972-01-01
% 224.75/224.96  |- skos__hiddenLabel mesh__D002479 Inclusions, Cytoplasmic
% 224.75/224.96  |- skos__hiddenLabel mesh__D002479 Bodies, Inclusion
% 224.75/224.96  |- skos__broader mesh__D007962smesh__D001773
% 224.75/224.96  |- skos__scopeNote mesh__D007962
% 224.75/224.96       White blood cells. These include granular leukocytes %28%BASOPHILS; EOSINOPHILS; and NEUTROPHILS%29% as well as non-granular leukocytes %28%LYMPHOCYTES and MONOCYTES%29%.%A%    
% 224.75/224.96  |- mesh__recordOriginator mesh__D007962 NLM
% 224.75/224.96  |- mesh__recordMaintainer mesh__D007962 ags
% 224.75/224.96  |- mesh__recordAuthorizer mesh__D007962 sjn
% 224.75/224.96  |- skos__broader mesh__D007962smesh__D007107
% 224.75/224.96  |- rdf__type mesh__D007962sskos__Concept
% 224.75/224.96  |- mesh__dateCreated mesh__D007962 1999-01-01
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D007962 2005
% 224.75/224.96  |- mesh__dateRevised mesh__D007962 2002-07-02
% 224.75/224.96  |- skos__hiddenLabel mesh__D007962 White Blood Cell
% 224.75/224.96  |- skos__altLabel mesh__D007962 Blood Cells, White
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D007962 2003
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D007962 2006
% 224.75/224.96  |- skos__prefLabel mesh__D007962 Leukocytes
% 224.75/224.96  |- skos__altLabel mesh__D007962 White Blood Cells
% 224.75/224.96  |- skos__hiddenLabel mesh__D007962 Leukocyte
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D007962 2004
% 224.75/224.96  |- skos__annotation mesh__D007962
% 224.75/224.96       decrease in no. of leukocytes or leukocytopenia = LEUKOPENIA; increase in no. of leukocytes = LEUKOCYTOSIS; leukocyte migration test: index under LEUKOCYTES /immunol %28%IM%29% + CELL MIGRATION INHIBITION %28%IM%29%%A%  
% 224.75/224.96  |- skos__hiddenLabel mesh__D007962 Blood Cell, White
% 224.75/224.96  |- skos__related mesh__D007962smesh__D010587
% 224.75/224.96  |- skos__historyNote mesh__D007164 Adsorption %28%1966-1976%29%
% 224.75/224.96  |- mesh__dateEstablished mesh__D007164 1991-01-01
% 224.75/224.96  |- rdf__type mesh__D007164sskos__Concept
% 224.75/224.96  |- skos__altLabel mesh__D007164 Immunoadsorbents
% 224.75/224.96  |- mesh__dateRevised mesh__D007164 2005-06-30
% 224.75/224.96  |- skos__related mesh__D007164smesh__D004797
% 224.75/224.96  |- skos__prefLabel mesh__D007164 Immunosorbents
% 224.75/224.96  |- mesh__dateCreated mesh__D007164 1976-04-16
% 224.75/224.96  |- mesh__publicMeSHNote mesh__D007164
% 224.75/224.96       91; was see under ANTIGEN-ANTIBODY COMPLEX 1977-90   
% 224.75/224.96  |- skos__historyNote mesh__D007164
% 224.75/224.96       Antigen-Antibody Complex %28%1970-1976%29%
% 224.75/224.96  |- mesh__recordAuthorizer mesh__D007164 sjn
% 224.75/224.96  |- mesh__historyNote mesh__D007164
% 224.75/224.96       91%28%77%29%; was see under ANTIGEN-ANTIBODY COMPLEX 1977-90   
% 224.75/224.96  |- skos__historyNote mesh__D007164
% 224.75/224.96       Antigen-Antibody Reactions %28%1966-1976%29%
% 224.75/224.96  |- mesh__recordOriginator mesh__D007164 SH
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D007164 2006
% 224.75/224.96  |- skos__scopeNote mesh__D007164
% 224.75/224.96       An insoluble support for an ANTIGEN or ANTIBODIES that is used in AFFINITY CHROMATOGRAPHY to adsorb the homologous antibody or antigen from a mixture. Many different substances are used, among them SEPHAROSE; GLUTARALDEHYDE; copolymers of ANHYDRIDES; polyacrylamides, etc.%A%    
% 224.75/224.96  |- skos__historyNote mesh__D007164 Absorption %28%1966-1976%29%
% 224.75/224.96  |- mesh__recordMaintainer mesh__D007164 ssb
% 224.75/224.96  |- skos__broader mesh__D007164smesh__D013501
% 224.75/224.96  |- mesh__publicMeSHNote mesh__D045283
% 224.75/224.96       2004; for NATRIURETIC HORMONES see NATRIURETIC HORMONES 1986-2003%A%  
% 224.75/224.96  |- skos__broader mesh__D045283smesh__D045505
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D045283 2004
% 224.75/224.96  |- skos__scopeNote mesh__D045283
% 224.75/224.96       Endogenous or exogenous chemicals that regulate the WATER-ELECTROLYTE BALANCE in the body. They consist of peptides and non-peptide compounds.%A%    
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D045283 2006
% 224.75/224.96  |- rdf__type mesh__D045283sskos__Concept
% 224.75/224.96  |- mesh__dateCreated mesh__D045283 2003-07-09
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D045283 2005
% 224.75/224.96  |- skos__altLabel mesh__D045283 Chloriuretic Hormones
% 224.75/224.96  |- mesh__historyNote mesh__D045283 2004   
% 224.75/224.96  |- skos__prefLabel mesh__D045283 Natriuretic Agents
% 224.75/224.96  |- skos__hiddenLabel mesh__D045283 Agents, Natriuretic
% 224.75/224.96  |- skos__hiddenLabel mesh__D045283 Hormones, Chloriuretic
% 224.75/224.96  |- skos__hiddenLabel mesh__D045283 Hormones, Natriuretic
% 224.75/224.96  |- skos__hiddenLabel mesh__D045283 Factors, Natriuretic
% 224.75/224.96  |- mesh__dateEstablished mesh__D045283 2004-01-01
% 224.75/224.96  |- skos__historyNote mesh__D045283 Natriuresis %28%1973-1986%29%
% 224.75/224.96  |- skos__altLabel mesh__D045283 Natriuretic Factors
% 224.75/224.96  |- skos__broader mesh__D045283smesh__D002317
% 224.75/224.96  |- skos__prefLabel mesh__D017592 Skin Care
% 224.75/224.96  |- mesh__recordOriginator mesh__D017592 TGC
% 224.75/224.96  |- mesh__historyNote mesh__D017592 94   
% 224.75/224.96  |- mesh__dateRevised mesh__D017592 2005-07-01
% 224.75/224.96  |- mesh__publicMeSHNote mesh__D017592 94   
% 224.75/224.96  |- skos__scopeNote mesh__D017592
% 224.75/224.96       Maintenance of the hygienic state of the skin under optimal conditions of cleanliness and comfort. Effective in skin care are proper washing, bathing, cleansing, and the use of soaps, detergents, oils, etc. In various disease states, therapeutic and protective solutions and ointments are useful. The care of the skin is particularly important in various occupations, in exposure to sunlight, in neonates, and in PRESSURE ULCER.%A%    
% 224.75/224.96  |- skos__hiddenLabel mesh__D017592 Care, Skin
% 224.75/224.96  |- rdf__type mesh__D017592sskos__Concept
% 224.75/224.96  |- mesh__dateCreated mesh__D017592 1992-12-28
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D017592 2006
% 224.75/224.96  |- skos__annotation mesh__D017592
% 224.75/224.96       IM; coord with specific agent used in the care, as SOAPS; OINTMENTS; DETERGENTS; etc. %28%IM or NIM%29% or specific type of care, as BATHS %28%IM or NIM%29% or specific ther agent %28%IM or NIM%29%%A%  
% 224.75/224.96  |- skos__broader mesh__D017592smesh__D006920
% 224.75/224.96  |- mesh__recordMaintainer mesh__D017592 sjn
% 224.75/224.96  |- mesh__dateEstablished mesh__D017592 1994-01-01
% 224.75/224.96  |- mesh__recordAuthorizer mesh__D017592 sjn
% 224.75/224.96  |- rdf__type mesh__D031263sskos__Concept
% 224.75/224.96  |- mesh__dateCreated mesh__D031263 2002-07-02
% 224.75/224.96  |- mesh__historyNote mesh__D031263 2003   
% 224.75/224.96  |- skos__prefLabel mesh__D031263 Elaeagnaceae
% 224.75/224.96  |- skos__broader mesh__D031263smesh__D019684
% 224.75/224.96  |- mesh__recordOriginator mesh__D031263 ssb
% 224.75/224.96  |- mesh__publicMeSHNote mesh__D031263 2003   
% 224.75/224.96  |- mesh__dateRevised mesh__D031263 2004-07-19
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D031263 2006
% 224.75/224.96  |- skos__scopeNote mesh__D031263
% 224.75/224.96       A plant family of the order Rhamnales, subclass Rosidae class Magnoliopsida. The plants have a characteristic silvery or rusty-colored sheen, caused by tiny distinctive scales. Flowers have a tubular structure of four sepals. Root nodules host the Frankia %28%ACTINOMYCETES%29% nitrogen-fixing symbionts.%A%    
% 224.75/224.96  |- skos__annotation mesh__D031263
% 224.75/224.96       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D031263 2005
% 224.75/224.96  |- skos__altLabel mesh__D031263 Buffaloberry
% 224.75/224.96  |- mesh__recordMaintainer mesh__D031263 jls
% 224.75/224.96  |- mesh__recordAuthorizer mesh__D031263 sjn
% 224.75/224.96  |- mesh__dateEstablished mesh__D031263 2003-01-01
% 224.75/224.96  |- skos__altLabel mesh__D031263 Olive, Russian
% 224.75/224.96  |- mesh__dateEstablished mesh__D003572 1974-01-01
% 224.75/224.96  |- skos__historyNote mesh__D003572 specific fungus %28%1966-1972%29%
% 224.75/224.96  |- mesh__recordMaintainer mesh__D003572 ssb
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D003572 2006
% 224.75/224.96  |- mesh__recordAuthorizer mesh__D003572 sjn
% 224.75/224.96  |- mesh__recordOriginator mesh__D003572 NLM
% 224.75/224.96  |- mesh__publicMeSHNote mesh__D003572 74   
% 224.75/224.96  |- skos__broader mesh__D003572smesh__D007211
% 224.75/224.96  |- rdf__type mesh__D003572sskos__Concept
% 224.75/224.96  |- mesh__historyNote mesh__D003572 74%28%73%29%   
% 224.75/224.96  |- skos__historyNote mesh__D003572 Indoles %28%1966-1972%29%
% 224.75/224.96  |- skos__scopeNote mesh__D003572
% 224.75/224.96       11- to 14-membered macrocyclic lactones with a fused isoindolone. Members with INDOLES attached at the C10 position are called chaetoglobosins.  They are produced by various fungi. Some members interact with ACTIN and inhibit CYTOKINESIS.%A%    
% 224.75/224.96  |- skos__broader mesh__D003572smesh__D009183
% 224.75/224.96  |- skos__annotation mesh__D003572
% 224.75/224.96       /antag permitted but consider also ANTITOXINS   
% 224.75/224.96  |- skos__broader mesh__D003572smesh__D018942
% 224.75/224.96  |- mesh__dateCreated mesh__D003572 1999-01-01
% 224.75/224.96  |- skos__prefLabel mesh__D003572 Cytochalasins
% 224.75/224.96  |- mesh__dateRevised mesh__D003572 2005-06-30
% 224.75/224.96  |- mesh__recordAuthorizer mesh__D011206 sjn
% 224.75/224.96  |- skos__altLabel mesh__D011206 Polyvinylpyrrolidone Iodine
% 224.75/224.96  |- skos__altLabel mesh__D011206 PVP-I
% 224.75/224.96  |- mesh__recordMaintainer mesh__D011206 jmp
% 224.75/224.96  |- skos__hiddenLabel mesh__D011206 Iodine, Polyvinylpyrrolidone
% 224.75/224.96  |- mesh__historyNote mesh__D011206
% 224.75/224.96       91%28%66%29%; was see under POVIDONE 1981-90; was see under POLYVINYLPYRROLIDONE 1975-80%A%  
% 224.75/224.96  |- skos__prefLabel mesh__D011206 Povidone-Iodine
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D011206 2005
% 224.75/224.96  |- skos__hiddenLabel mesh__D011206 PVP Iodine
% 224.75/224.96  |- skos__annotation mesh__D011206 D25-26 qualif   
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D011206 2006
% 224.75/224.96  |- skos__broader mesh__D011206smesh__D011205
% 224.75/224.96  |- skos__scopeNote mesh__D011206
% 224.75/224.96       An iodinated polyvinyl polymer used as topical antiseptic in surgery and for skin and mucous membrane infections, also as aerosol. The iodine may be radiolabeled for research purposes.%A%    
% 224.75/224.96  |- mesh__publicMeSHNote mesh__D011206
% 224.75/224.96       91; was see under POVIDONE 1981-90; was see under POLYVINYLPYRROLIDONE 1975-80%A%  
% 224.75/224.96  |- mesh__dateRevised mesh__D011206 2004-07-07
% 224.75/224.96  |- skos__broader mesh__D011206smesh__D011145
% 224.75/224.96  |- rdf__type mesh__D011206sskos__Concept
% 224.75/224.96  |- skos__hiddenLabel mesh__D011206 Povidone Iodine
% 224.75/224.96  |- mesh__recordOriginator mesh__D011206 NLM
% 224.75/224.96  |- skos__altLabel mesh__D011206 PVP-Iodine
% 224.75/224.96  |- mesh__dateCreated mesh__D011206 1999-01-01
% 224.75/224.96  |- mesh__dateEstablished mesh__D011206 1991-01-01
% 224.75/224.96  |- skos__hiddenLabel mesh__D049674 History, Twenty first Century
% 224.75/224.96  |- skos__altLabel mesh__D049674 History, Twenty-first Century
% 224.75/224.96  |- mesh__recordOriginator mesh__D049674 jls
% 224.75/224.96  |- mesh__dateEstablished mesh__D049674 2005-01-01
% 224.75/224.96  |- skos__hiddenLabel mesh__D049674 Century Histories, 21st
% 224.75/224.96  |- skos__hiddenLabel mesh__D049674 21st Century Histories
% 224.75/224.96  |- skos__hiddenLabel mesh__D049674 21st Cent. Medicines
% 224.75/224.96  |- skos__hiddenLabel mesh__D049674 Cent. Medicine, 21st
% 224.75/224.96  |- skos__altLabel mesh__D049674 21st Century History
% 224.75/224.96  |- skos__hiddenLabel mesh__D049674 Cent. Histories, 21st %28%Medicine%29%
% 224.75/224.96  |- mesh__historyNote mesh__D049674 2005   
% 224.75/224.96  |- skos__hiddenLabel mesh__D049674 21st Cent. Histories %28%Medicine%29%
% 224.75/224.96  |- skos__hiddenLabel mesh__D049674 Twenty-first Century Histories
% 224.75/224.96  |- mesh__recordAuthorizer mesh__D049674 sjn
% 224.75/224.96  |- skos__hiddenLabel mesh__D049674 Century History, 21st
% 224.75/224.96  |- skos__hiddenLabel mesh__D049674 Cent. History, 21st %28%Medicine%29%
% 224.75/224.96  |- skos__hiddenLabel mesh__D049674 Century History, Twenty-first
% 224.75/224.96  |- skos__altLabel mesh__D049674 Medical History, 21st Cent.
% 224.75/224.96  |- skos__hiddenLabel mesh__D049674 History, 21st Cent. %28%Medicine%29%
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D049674 2006
% 224.75/224.96  |- mesh__dateCreated mesh__D049674 2004-07-07
% 224.75/224.96  |- skos__prefLabel mesh__D049674 History, 21st Century
% 224.75/224.96  |- skos__hiddenLabel mesh__D049674 Cent. Medicines, 21st
% 224.75/224.96  |- skos__hiddenLabel mesh__D049674 Histories, 21st Century
% 224.75/224.96  |- skos__broader mesh__D049674smesh__D049711
% 224.75/224.96  |- skos__hiddenLabel mesh__D049674 Histories, Twenty-first Century
% 224.75/224.96  |- skos__altLabel mesh__D049674 21st Cent. Medicine
% 224.75/224.96  |- rdf__type mesh__D049674sskos__Concept
% 224.75/224.96  |- skos__hiddenLabel mesh__D049674 Century Histories, Twenty-first
% 224.75/224.96  |- skos__altLabel mesh__D049674 21st Cent. History of Medicine
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D049674 2005
% 224.75/224.96  |- skos__hiddenLabel mesh__D049674 Medicines, 21st Cent.
% 224.75/224.96  |- skos__annotation mesh__D049674 IM general only; NIM as check tag   
% 224.75/224.96  |- mesh__recordMaintainer mesh__D049674 jls
% 224.75/224.96  |- mesh__publicMeSHNote mesh__D049674
% 224.75/224.96       2005; for HISTORY OF MEDICINE, 21ST CENT. see HISTORY OF MEDICINE, 21ST CENT. 2001-2004%A%  
% 224.75/224.96  |- skos__altLabel mesh__D049674 21st Cent. History %28%Medicine%29%
% 224.75/224.96  |- skos__hiddenLabel mesh__D049674 Twenty-first Century History
% 224.75/224.96  |- skos__hiddenLabel mesh__D049674 Histories, 21st Cent. %28%Medicine%29%
% 224.75/224.96  |- skos__scopeNote mesh__D049674
% 224.75/224.96       Time period from 2001 through 2100 of the common era.     
% 224.75/224.96  |- skos__broader mesh__D000758Q000295smesh__D000758
% 224.75/224.96  |- mesh__preferredCombination mesh__D000758Q000295smesh__D000776Q000295
% 224.75/224.96  |- rdf__type mesh__D000758Q000295smesh__CompoundConcept
% 224.75/224.96  |- mesh__recordOriginator mesh__D007963 SCD
% 224.75/224.96  |- mesh__dateRevised mesh__D007963 1999-11-03
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D007963 2005
% 224.75/224.96  |- skos__historyNote mesh__D007963 Leukocytes %28%1966-1987%29%
% 224.75/224.96  |- skos__historyNote mesh__D007963 Monocytes %28%1966-1987%29%
% 224.75/224.96  |- skos__hiddenLabel mesh__D007963 Leukocyte, Mononuclear
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D007963 2002
% 224.75/224.96  |- skos__broader mesh__D007963smesh__D007962
% 224.75/224.96  |- skos__scopeNote mesh__D007963
% 224.75/224.96       Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body%27%s extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules.%A%    
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D007963 2001
% 224.75/224.96  |- rdf__type mesh__D007963sskos__Concept
% 224.75/224.96  |- mesh__dateCreated mesh__D007963 1987-05-07
% 224.75/224.96  |- skos__historyNote mesh__D007963 Macrophages %28%1966-1987%29%
% 224.75/224.96  |- mesh__publicMeSHNote mesh__D007963 88   
% 224.75/224.96  |- mesh__recordMaintainer mesh__D007963 nns
% 224.75/224.96  |- skos__prefLabel mesh__D007963 Leukocytes, Mononuclear
% 224.75/224.96  |- mesh__dateEstablished mesh__D007963 1988-01-01
% 224.75/224.96  |- mesh__recordAuthorizer mesh__D007963 sjn
% 224.75/224.96  |- skos__historyNote mesh__D007963 Lymphocytes %28%1966-1987%29%
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D007963 2000
% 224.75/224.96  |- skos__hiddenLabel mesh__D007963 Mononuclear Leukocyte
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D007963 2004
% 224.75/224.96  |- skos__annotation mesh__D007963
% 224.75/224.96       do not confuse with MONOCYTES; Peripheral Blood Mononuclear Cells %28%PBMC%29% unspecified goes here; prefer specific indentions%A%  
% 224.75/224.96  |- mesh__historyNote mesh__D007963 88   
% 224.75/224.96  |- skos__altLabel mesh__D007963 Mononuclear Leukocytes
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D007963 2006
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D007963 2003
% 224.75/224.96  |- skos__historyNote mesh__D007165
% 224.75/224.96       Immunosuppressive Agents %28%1966-1970%29%
% 224.75/224.96  |- skos__annotation mesh__D007165
% 224.75/224.96       note category: %22%deliberate prevention or diminution of the host%27%s immune response%22%: do not confuse with IMMUNOSUPPRESSION %28%PHYSIOLOGY%29% see IMMUNE TOLERANCE %28%G4%29%; do not use /util except by MeSH definition; OPPORTUNISTIC INFECTIONS is available if particularly discussed: see note there%A%  
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D007165 2003
% 224.75/224.96  |- skos__scopeNote mesh__D007165
% 224.75/224.96       Deliberate prevention or diminution of the host%27%s immune response. It may be nonspecific as in the administration of immunosuppressive agents %28%drugs or radiation%29% or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs.%A%    
% 224.75/224.96  |- skos__hiddenLabel mesh__D007165 Immunosuppressions
% 224.75/224.96  |- skos__historyNote mesh__D007165 Antilymphocyte Serum %28%1968-1970%29%
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D007165 1997
% 224.75/224.96  |- skos__related mesh__D007165smesh__D000961
% 224.75/224.96  |- rdf__type mesh__D007165sskos__Concept
% 224.75/224.96  |- skos__altLabel mesh__D007165 Therapy, Antirejection
% 224.75/224.96  |- skos__altLabel mesh__D007165 Antirejection Therapy
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D007165 2004
% 224.75/224.96  |- skos__hiddenLabel mesh__D007165 Antirejection Therapies
% 224.75/224.96  |- mesh__recordAuthorizer mesh__D007165 PLS
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D007165 2000
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D007165 1994
% 224.75/224.96  |- mesh__activeMeSHYear mesh__D007165 1992
% 224.75/224.96  |- skos__related mesh__D007165smesh__D016867
% 224.75/224.96  |- mesh__dateRevised mesh__D007165 1991-06-11
% 224.82/224.96  |- mesh__activeMeSHYear mesh__D007165 1998
% 224.82/224.96  |- mesh__activeMeSHYear mesh__D007165 2001
% 224.82/224.96  |- mesh__activeMeSHYear mesh__D007165 1995
% 224.82/224.96  |- skos__prefLabel mesh__D007165 Immunosuppression
% 224.82/224.96  |- skos__broader mesh__D007165smesh__D007158
% 224.82/224.96  |- mesh__dateEstablished mesh__D007165 1972-01-01
% 224.82/224.96  |- mesh__activeMeSHYear mesh__D007165 1993
% 224.82/224.96  |- skos__altLabel mesh__D007165 Anti-Rejection Therapy
% 224.82/224.96  |- mesh__activeMeSHYear mesh__D007165 2005
% 224.82/224.96  |- skos__related mesh__D007165smesh__D007108
% 224.82/224.96  |- skos__hiddenLabel mesh__D007165 Anti-Rejection Therapies
% 224.82/224.96  |- mesh__recordMaintainer mesh__D007165 AGS
% 224.82/224.96  |- mesh__activeMeSHYear mesh__D007165 1999
% 224.82/224.96  |- mesh__recordOriginator mesh__D007165 NLM
% 224.82/224.96  |- skos__historyNote mesh__D007165 Immunity %28%1966-1970%29%
% 224.82/224.96  |- mesh__activeMeSHYear mesh__D007165 2006
% 224.82/224.96  |- mesh__historyNote mesh__D007165 72%28%71%29%   
% 224.82/224.96  |- mesh__dateCreated mesh__D007165 1999-01-01
% 224.82/224.96  |- mesh__activeMeSHYear mesh__D007165 2002
% 224.82/224.96  |- skos__altLabel mesh__D007165 Therapy, Anti-Rejection
% 224.82/224.96  |- mesh__activeMeSHYear mesh__D007165 1996
% 224.82/224.96  |- skos__hiddenLabel mesh__D007165 Anti Rejection Therapy
% 224.82/224.96  |- mesh__publicMeSHNote mesh__D007165 72   
% 224.82/224.96  |- skos__broader mesh__D007165smesh__D007167
% 224.82/224.96  |- skos__historyNote mesh__D007165 Immune Tolerance %28%1966-1970%29%
% 224.82/224.96  |- skos__broader mesh__D045284smesh__D003901
% 224.82/224.96  |- skos__historyNote mesh__D045284 Desulfovibrio %28%1971-2003%29%
% 224.82/224.96  |- mesh__activeMeSHYear mesh__D045284 2006
% 224.82/224.96  |- rdf__type mesh__D045284sskos__Concept
% 224.82/224.96  |- mesh__publicMeSHNote mesh__D045284 2004   
% 224.82/224.96  |- mesh__dateCreated mesh__D045284 2003-07-09
% 224.82/224.96  |- mesh__dateEstablished mesh__D045284 2004-01-01
% 224.82/224.96  |- skos__prefLabel mesh__D045284 Desulfovibrio africanus
% 224.82/224.96  |- mesh__recordAuthorizer mesh__D045284 sjn
% 224.82/224.96  |- skos__scopeNote mesh__D045284
% 224.82/224.96       A species of gram-negative, anaerobic, sigmoid-shaped bacteria isolated from salt and freshwater in Africa.%A%    
% 224.82/224.96  |- skos__annotation mesh__D045284
% 224.82/224.96       infection: coord IM with DESULFOVIBRIONACEAE INFECTIONS %28%IM%29%%A%  
% 224.82/224.96  |- mesh__recordMaintainer mesh__D045284 SYSTEM
% 224.82/224.96  |- mesh__recordOriginator mesh__D045284 ags
% 224.82/224.96  |- mesh__dateRevised mesh__D045284 2005-06-30
% 224.82/224.96  |- mesh__historyNote mesh__D045284 2004   
% 224.82/224.96  |- mesh__dateEstablished mesh__D017593 1994-01-01
% 224.82/224.96  |- mesh__activeMeSHYear mesh__D017593 2003
% 224.82/224.97  |- mesh__recordAuthorizer mesh__D017593 sjn
% 224.82/224.97  |- skos__historyNote mesh__D017593 Eating Disorders %28%1966-1976%29%
% 224.82/224.97  |- skos__broader mesh__D017593smesh__D006970
% 224.82/224.97  |- skos__hiddenLabel mesh__D017593 Periodic Hypersomnia
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017593 2001
% 224.82/224.97  |- skos__altLabel mesh__D017593 Kleine-Levin-Critchley Syndrome
% 224.82/224.97  |- mesh__recordOriginator mesh__D017593 TGC
% 224.82/224.97  |- skos__hiddenLabel mesh__D017593 Syndrome, Kleine-Levin-Critchley
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017593 2000
% 224.82/224.97  |- rdf__type mesh__D017593sskos__Concept
% 224.82/224.97  |- skos__hiddenLabel mesh__D017593 Syndrome, Kleine-Levin
% 224.82/224.97  |- mesh__dateCreated mesh__D017593 1992-12-28
% 224.82/224.97  |- mesh__publicMeSHNote mesh__D017593 94   
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017593 2006
% 224.82/224.97  |- skos__hiddenLabel mesh__D017593 Kleine Levin Critchley Syndrome
% 224.82/224.97  |- skos__prefLabel mesh__D017593 Kleine-Levin Syndrome
% 224.82/224.97  |- skos__historyNote mesh__D017593 Sleep Disorders %28%1966-1979%29%
% 224.82/224.97  |- skos__hiddenLabel mesh__D017593 Periodic Hypersomnias
% 224.82/224.97  |- skos__historyNote mesh__D017593 Hyperphagia %28%1981-1993%29%
% 224.82/224.97  |- skos__hiddenLabel mesh__D017593 Kleine Levin Syndrome
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017593 2005
% 224.82/224.97  |- skos__historyNote mesh__D017593 Hunger %28%1966-1971%29%
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017593 2004
% 224.82/224.97  |- mesh__recordMaintainer mesh__D017593 jls
% 224.82/224.97  |- mesh__dateRevised mesh__D017593 1999-11-08
% 224.82/224.97  |- skos__historyNote mesh__D017593 Hypersomnia %28%1975-1993%29%
% 224.82/224.97  |- skos__altLabel mesh__D017593 Hypersomnia, Periodic
% 224.82/224.97  |- mesh__historyNote mesh__D017593 94   
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017593 2002
% 224.82/224.97  |- skos__scopeNote mesh__D017593
% 224.82/224.97       A rare condition characterized by recurrent hypersomnias associated with hyperphagia, occurring primarily in males in the second to third decade of life. Clinical features include mental confusion, excessive sleep requirements %28%approximately 18 hours per day%29%, restlessness, and in some cases hallucinations. Episodes have a duration of days to weeks, and may recur several times per year. This condition may resolve spontaneously over several years. %28%From Adams, et al., Principles of Neurology, 6th ed, p569%29%%A%    
% 224.82/224.97  |- mesh__publicMeSHNote mesh__D003573 2004; see CYTOCHROME B 1983-2003   
% 224.82/224.97  |- mesh__dateRevised mesh__D003573 2003-07-09
% 224.82/224.97  |- rdf__type mesh__D003573sskos__Concept
% 224.82/224.97  |- skos__historyNote mesh__D003573 Cytochromes %28%1966-1982%29%
% 224.82/224.97  |- skos__scopeNote mesh__D003573
% 224.82/224.97       Cytochromes %28%electron-transporting proteins%29% with protoheme %28%HEME B%29% as the prosthetic group.%A%    
% 224.82/224.97  |- skos__hiddenLabel mesh__D003573 Heme b Cytochromes
% 224.82/224.97  |- skos__prefLabel mesh__D003573 Cytochrome b Group
% 224.82/224.97  |- skos__broader mesh__D003573smesh__D003580
% 224.82/224.97  |- skos__hiddenLabel mesh__D003573 b, Cytochromes Type
% 224.82/224.97  |- mesh__dateEstablished mesh__D003573 1983-01-01
% 224.82/224.97  |- skos__altLabel mesh__D003573 Cytochromes, Heme b
% 224.82/224.97  |- mesh__recordAuthorizer mesh__D003573 sjn
% 224.82/224.97  |- skos__annotation mesh__D003573
% 224.82/224.97       /biosyn /physiol permitted; spell in titles %26% translations with lowercase b: cytochrome b; do not confuse with CYTOCHROMES B%A%  
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D003573 2004
% 224.82/224.97  |- skos__hiddenLabel mesh__D003573 b Group, Cytochrome
% 224.82/224.97  |- mesh__recordMaintainer mesh__D003573 jmp
% 224.82/224.97  |- skos__altLabel mesh__D003573 Cytochromes Type b
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D003573 2006
% 224.82/224.97  |- mesh__historyNote mesh__D003573 2004%28%1983%29%;   
% 224.82/224.97  |- skos__hiddenLabel mesh__D003573 b Cytochromes, Heme
% 224.82/224.97  |- skos__hiddenLabel mesh__D003573 Group, Cytochrome b
% 224.82/224.97  |- skos__hiddenLabel mesh__D003573 Type b, Cytochromes
% 224.82/224.97  |- mesh__recordOriginator mesh__D003573 RLS
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D003573 2005
% 224.82/224.97  |- mesh__dateCreated mesh__D003573 1982-05-11
% 224.82/224.97  |- skos__hiddenLabel mesh__D007964 Leukocytoses
% 224.82/224.97  |- skos__annotation mesh__D007964
% 224.82/224.97       coord with type of white cell and body fluid, using available subheadings when appropriate%A%  
% 224.82/224.97  |- skos__broader mesh__D007964smesh__D010335
% 224.82/224.97  |- mesh__dateCreated mesh__D007964 1999-01-01
% 224.82/224.97  |- mesh__recordMaintainer mesh__D007964 lkt
% 224.82/224.97  |- skos__related mesh__D007964smesh__D007958
% 224.82/224.97  |- rdf__type mesh__D007964sskos__Concept
% 224.82/224.97  |- mesh__dateRevised mesh__D007964 2001-07-25
% 224.82/224.97  |- skos__prefLabel mesh__D007964 Leukocytosis
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007964 2002
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007964 2004
% 224.82/224.97  |- skos__broader mesh__D007964smesh__D007960
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007964 2006
% 224.82/224.97  |- mesh__recordOriginator mesh__D007964 NLM
% 224.82/224.97  |- mesh__recordAuthorizer mesh__D007964 sjn
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007964 2003
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007964 2005
% 224.82/224.97  |- skos__scopeNote mesh__D007964
% 224.82/224.97       A transient increase in the number of leukocytes in a body fluid.%A%    
% 224.82/224.97  |- skos__hiddenLabel mesh__D007964 Pleocytoses
% 224.82/224.97  |- skos__broader mesh__D044140Q000037smesh__D044140
% 224.82/224.97  |- mesh__preferredCombination mesh__D044140Q000037smesh__D047228
% 224.82/224.97  |- rdf__type mesh__D044140Q000037smesh__CompoundConcept
% 224.82/224.97  |- mesh__recordAuthorizer mesh__D007166 sjn
% 224.82/224.97  |- skos__hiddenLabel mesh__D007166 Agents, Immunosuppressive
% 224.82/224.97  |- mesh__historyNote mesh__D007166 66%28%64%29%   
% 224.82/224.97  |- skos__related mesh__D007166smesh__D000961
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007166 2006
% 224.82/224.97  |- skos__broader mesh__D007166smesh__D007155
% 224.82/224.97  |- skos__scopeNote mesh__D007166
% 224.82/224.97       Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.%A%    
% 224.82/224.97  |- mesh__recordOriginator mesh__D007166 NLM
% 224.82/224.97  |- mesh__dateCreated mesh__D007166 1999-01-01
% 224.82/224.97  |- mesh__recordMaintainer mesh__D007166 ssb
% 224.82/224.97  |- rdf__type mesh__D007166sskos__Concept
% 224.82/224.97  |- mesh__dateEstablished mesh__D007166 1966-01-01
% 224.82/224.97  |- skos__prefLabel mesh__D007166 Immunosuppressive Agents
% 224.82/224.97  |- mesh__dateRevised mesh__D007166 2005-06-30
% 224.82/224.97  |- mesh__publicMeSHNote mesh__D007166 66   
% 224.82/224.97  |- skos__altLabel mesh__D007166 Immunosuppressants
% 224.82/224.97  |- mesh__dateRevised mesh__D045285 2005-06-30
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D045285 2006
% 224.82/224.97  |- rdf__type mesh__D045285sskos__Concept
% 224.82/224.97  |- mesh__historyNote mesh__D045285 2004   
% 224.82/224.97  |- mesh__publicMeSHNote mesh__D045285 2004   
% 224.82/224.97  |- mesh__dateCreated mesh__D045285 2003-07-09
% 224.82/224.97  |- skos__scopeNote mesh__D045285
% 224.82/224.97       The type species of gram-negative, anaerobic bacteria of the genus DESULFOVIBRIO. It is found in FRESHWATER; SOIL, and in marine or brackish water.%A%    
% 224.82/224.97  |- skos__broader mesh__D045285smesh__D003901
% 224.82/224.97  |- skos__prefLabel mesh__D045285 Desulfovibrio desulfuricans
% 224.82/224.97  |- mesh__recordMaintainer mesh__D045285 SYSTEM
% 224.82/224.97  |- mesh__dateEstablished mesh__D045285 2004-01-01
% 224.82/224.97  |- skos__historyNote mesh__D045285 Desulfovibrio %28%1966-2003%29%
% 224.82/224.97  |- mesh__recordAuthorizer mesh__D045285 sjn
% 224.82/224.97  |- skos__annotation mesh__D045285
% 224.82/224.97       infection: coord IM with DESULFOVIBRIONACEAE INFECTIONS %28%IM%29%%A%  
% 224.82/224.97  |- mesh__recordOriginator mesh__D045285 ags
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017594 1997
% 224.82/224.97  |- skos__prefLabel mesh__D017594 Publication Bias
% 224.82/224.97  |- skos__historyNote mesh__D017594 Publishing %28%1986-1993%29%
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017594 1994
% 224.82/224.97  |- mesh__dateEstablished mesh__D017594 1994-01-01
% 224.82/224.97  |- rdf__type mesh__D017594sskos__Concept
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017594 2000
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017594 2005
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017594 1995
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017594 2006A
% 224.82/224.97  |- skos__broader mesh__D017594smesh__D011643
% 224.82/224.97  |- mesh__dateCreated mesh__D017594 1992-12-28
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017594 2006
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017594 1998
% 224.82/224.97  |- skos__annotation mesh__D017594
% 224.82/224.97       IM; coord with basis for bias %28%e.g., FALSE-POSITIVE REACTIONS%29% or milieu %28%e.g., CLINICAL TRIALS%29% if pertinent %28%IM or NIM%29%%A%  
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017594 2001
% 224.82/224.97  |- mesh__recordOriginator mesh__D017594 TGC
% 224.82/224.97  |- mesh__recordMaintainer mesh__D017594 ags
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017594 2003
% 224.82/224.97  |- mesh__dateRevised mesh__D017594 2005-07-13
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017594 1999
% 224.82/224.97  |- skos__scopeNote mesh__D017594
% 224.82/224.97       The influence of study results on the chances of publication and the tendency of investigators, reviewers, and editors to submit or accept manuscripts for publication based on the direction or strength of the study findings. Publication bias has an impact on the interpretation of clinical trials and meta-analyses. Bias can be minimized by insistence by editors on high-quality research, thorough literature reviews, acknowledgement of conflicts of interest, modification of peer review practices, etc.%A%    
% 224.82/224.97  |- mesh__recordAuthorizer mesh__D017594 ags
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017594 2004
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017594 1996
% 224.82/224.97  |- mesh__publicMeSHNote mesh__D017594 94   
% 224.82/224.97  |- mesh__historyNote mesh__D017594 94   
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017594 2002
% 224.82/224.97  |- skos__hiddenLabel mesh__D017594 Bias, Publication
% 224.82/224.97  |- mesh__recordOriginator mesh__D003574 NLM
% 224.82/224.97  |- skos__annotation mesh__D003574
% 224.82/224.97       spell in titles %26% translations with lowercase c: cytochrome c; do not confuse with CYTOCHROMES C%A%  
% 224.82/224.97  |- skos__hiddenLabel mesh__D003574 Group, Cytochrome c
% 224.82/224.97  |- mesh__historyNote mesh__D003574 2004%28%1973%29%   
% 224.82/224.97  |- mesh__dateCreated mesh__D003574 1999-01-01
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D003574 2004
% 224.82/224.97  |- mesh__recordMaintainer mesh__D003574 jmp
% 224.82/224.97  |- skos__scopeNote mesh__D003574
% 224.82/224.97       A group of cytochromes with covalent thioether linkages between either or both of the vinyl side chains of protoheme and the protein. %28%Enzyme Nomenclature, 1992, p539%29%%A%    
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D003574 2006
% 224.82/224.97  |- skos__hiddenLabel mesh__D003574 Type c, Cytochromes
% 224.82/224.97  |- skos__broader mesh__D003574smesh__D003580
% 224.82/224.97  |- skos__prefLabel mesh__D003574 Cytochrome c Group
% 224.82/224.97  |- skos__altLabel mesh__D003574 Cytochromes Type c
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D003574 2005
% 224.82/224.97  |- mesh__recordAuthorizer mesh__D003574 sjn
% 224.82/224.97  |- skos__historyNote mesh__D003574 Cytochromes %28%1966-1972%29%
% 224.82/224.97  |- mesh__dateEstablished mesh__D003574 1973-01-01
% 224.82/224.97  |- mesh__dateRevised mesh__D003574 2003-07-09
% 224.82/224.97  |- rdf__type mesh__D003574sskos__Concept
% 224.82/224.97  |- mesh__publicMeSHNote mesh__D003574 2004; see CYTOCHROME C 1973-2003   
% 224.82/224.97  |- mesh__recordMaintainer mesh__D011208 ssb
% 224.82/224.97  |- skos__scopeNote mesh__D011208
% 224.82/224.97       Substances made up of an aggregation of small particles, as that obtained by grinding or trituration of a solid drug. In pharmacy it is a form in which substances are administered. %28%From Dorland, 28th ed%29%%A%    
% 224.82/224.97  |- skos__broader mesh__D011208smesh__D004304
% 224.82/224.97  |- mesh__recordOriginator mesh__D011208 NLM
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D011208 2006
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D011208 2004
% 224.82/224.97  |- mesh__recordAuthorizer mesh__D011208 sjn
% 224.82/224.97  |- skos__annotation mesh__D011208
% 224.82/224.97       IM for general only, qualif permitted; NIM %28%no qualif%29% with specific drug IM %28%with qualif%29%; /adv eff permitted but be careful: it may be the adv eff of the drug in powder form, not the powder%A%  
% 224.82/224.97  |- skos__prefLabel mesh__D011208 Powders
% 224.82/224.97  |- rdf__type mesh__D011208sskos__Concept
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D011208 2005
% 224.82/224.97  |- mesh__dateRevised mesh__D011208 2003-07-09
% 224.82/224.97  |- mesh__dateCreated mesh__D011208 1999-01-01
% 224.82/224.97  |- mesh__recordOriginator mesh__D007965 NLM
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007965 2005A
% 224.82/224.97  |- skos__altLabel mesh__D007965 Classic Globoid Cell Leukodystrophy
% 224.82/224.97  |- skos__hiddenLabel mesh__D007965 Late Onset Globoid Cell Leukodystrophy
% 224.82/224.97  |- mesh__dateEstablished mesh__D007965 1974-01-01
% 224.82/224.97  |- skos__hiddenLabel mesh__D007965 Early Onset Globoid Cell Leukodystrophy
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007965 2005
% 224.82/224.97  |- skos__hiddenLabel mesh__D007965
% 224.82/224.97       Diseases, Galactosylceramidase Deficiency
% 224.82/224.97  |- skos__hiddenLabel mesh__D007965
% 224.82/224.97       Deficiency Disease, Galactosylceramide beta Galactosidase
% 224.82/224.97  |- skos__hiddenLabel mesh__D007965
% 224.82/224.97       Galactosylceramide-beta-Galactosidase Deficiency Diseases
% 224.82/224.97  |- skos__altLabel mesh__D007965 Deficiency Disease, Galactosylceramidase
% 224.82/224.97  |- skos__hiddenLabel mesh__D007965 Leukodystrophy, Krabbe%27%s
% 224.82/224.97  |- skos__hiddenLabel mesh__D007965
% 224.82/224.97       Deficiency Diseases, Galactosylceramide-beta-Galactosidase
% 224.82/224.97  |- skos__altLabel mesh__D007965 Krabbe Leukodystrophy
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007965 2002
% 224.82/224.97  |- skos__hiddenLabel mesh__D007965
% 224.82/224.97       Deficiency Diseases, Galactosylceramidase
% 224.82/224.97  |- skos__hiddenLabel mesh__D007965 Leukodystrophies, Globoid Cell
% 224.82/224.97  |- skos__scopeNote mesh__D007965
% 224.82/224.97       An autosomal recessive inherited sphingolipidosis caused by a deficiency of GALACTOSYLCERAMIDASE leading to an accumulation of PSYCHOSINE in LYSOSOMES of the BRAIN; PERIPHERAL NERVES; LIVER; KIDNEY; and LEUKOCYTES. In the nervous system there is prominent central and peripheral demyelination. The infantile form presents at age 4-6 months with psychomotor retardation, MUSCLE SPASTICITY, and tonic spasms induced by minor stimuli. Death occurs within two years. Later onset forms of this disease are characterized by a less fulminant course. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp195-7%29%%A%    
% 224.82/224.97  |- skos__altLabel mesh__D007965 Krabbe%27%s Leukodystrophy
% 224.82/224.97  |- skos__altLabel mesh__D007965 Krabbe Disease
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007965 2006
% 224.82/224.97  |- skos__altLabel mesh__D007965 Krabbe%27%s Disease
% 224.82/224.97  |- skos__hiddenLabel mesh__D007965 Globoid Cell Leukodystrophy
% 224.82/224.97  |- skos__altLabel mesh__D007965
% 224.82/224.97       Deficiency Disease, Galactosylceramide-beta-Galactosidase
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007965 2003
% 224.82/224.97  |- skos__altLabel mesh__D007965 Leukodystrophy, Globoid Cell, Infantile
% 224.82/224.97  |- skos__hiddenLabel mesh__D007965 Leukodystrophy, Krabbe
% 224.82/224.97  |- skos__hiddenLabel mesh__D007965 Leukodystrophies, Globoid
% 224.82/224.97  |- skos__related mesh__D007965smesh__D005698
% 224.82/224.97  |- skos__altLabel mesh__D007965 Infantile Globoid Cell Leukodystrophy
% 224.82/224.97  |- skos__altLabel mesh__D007965 Galactosylceramidase Deficiency Disease
% 224.82/224.97  |- skos__hiddenLabel mesh__D007965 Krabbes Leukodystrophy
% 224.82/224.97  |- skos__altLabel mesh__D007965 Leukodystrophy, Globoid Cell, Late-Onset
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007965 2004
% 224.82/224.97  |- skos__hiddenLabel mesh__D007965
% 224.82/224.97       Disease, Galactosylceramide-beta-Galactosidase Deficiency
% 224.82/224.97  |- rdf__type mesh__D007965sskos__Concept
% 224.82/224.97  |- mesh__recordAuthorizer mesh__D007965 jls
% 224.82/224.97  |- skos__prefLabel mesh__D007965 Leukodystrophy, Globoid Cell
% 224.82/224.97  |- skos__altLabel mesh__D007965
% 224.82/224.97       Galactosylceramide-beta-Galactosidase Deficiency Disease
% 224.82/224.97  |- skos__hiddenLabel mesh__D007965 Disease, Galactosylceramidase Deficiency
% 224.82/224.97  |- mesh__dateRevised mesh__D007965 2004-07-28
% 224.82/224.97  |- skos__hiddenLabel mesh__D007965 Globoid Cell Leukodystrophies
% 224.82/224.97  |- skos__hiddenLabel mesh__D007965 Krabbes Disease
% 224.82/224.97  |- skos__hiddenLabel mesh__D007965 Galactosylceramidase Deficiency Diseases
% 224.82/224.97  |- skos__hiddenLabel mesh__D007965 Globoid Leukodystrophies
% 224.82/224.97  |- skos__altLabel mesh__D007965 Globoid Leukodystrophy
% 224.82/224.97  |- skos__broader mesh__D007965smesh__D013106
% 224.82/224.97  |- skos__hiddenLabel mesh__D007965
% 224.82/224.97       Diseases, Galactosylceramide-beta-Galactosidase Deficiency
% 224.82/224.97  |- mesh__recordMaintainer mesh__D007965 jls
% 224.82/224.97  |- mesh__historyNote mesh__D007965 1974%28%1963%29%   
% 224.82/224.97  |- skos__altLabel mesh__D007965 Leukodystrophy, Globoid Cell, Classic
% 224.82/224.97  |- skos__hiddenLabel mesh__D007965 Leukodystrophy, Globoid
% 224.82/224.97  |- mesh__publicMeSHNote mesh__D007965
% 224.82/224.97       1974; see CEREBRAL SCLEROSIS, DIFFUSE 1963-1973; for LEUKODYSTROPHIES see CEREBRAL SCLEROSIS, DIFFUSE 1963-1973; for KRABBE DISEASE see KRABBE%27%S DISEASE 1974-1997%A%  
% 224.82/224.97  |- skos__altLabel mesh__D007965 Globoid Body Sclerosis, Diffuse
% 224.82/224.97  |- skos__altLabel mesh__D007965 Diffuse Globoid Body Sclerosis
% 224.82/224.97  |- mesh__dateCreated mesh__D007965 1999-01-01
% 224.82/224.97  |- skos__broader mesh__D007965smesh__D020279
% 224.82/224.97  |- skos__altLabel mesh__D007965 Leukodystrophy, Globoid Cell, Early-Onset
% 224.82/224.97  |- skos__broader mesh__D010100Q000172smesh__D010100
% 224.82/224.97  |- mesh__preferredCombination mesh__D010100Q000172smesh__D000860
% 224.82/224.97  |- rdf__type mesh__D010100Q000172smesh__CompoundConcept
% 224.82/224.97  |- skos__broader mesh__D007167smesh__D001691
% 224.82/224.97  |- skos__historyNote mesh__D007167
% 224.82/224.97       specific disease/therapy %28%1966-1972%29%
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007167 2005
% 224.82/224.97  |- mesh__dateCreated mesh__D007167 1999-01-01
% 224.82/224.97  |- mesh__publicMeSHNote mesh__D007167
% 224.82/224.97       73; VACCINE THERAPY was heading 1963-82   
% 224.82/224.97  |- mesh__dateRevised mesh__D007167 1991-06-20
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007167 2006
% 224.82/224.97  |- skos__hiddenLabel mesh__D007167 Immunotherapies
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007167 1996
% 224.82/224.97  |- skos__annotation mesh__D007167
% 224.82/224.97       GEN only; do not use /util except by MeSH definition; for ther: coord IM with dis /ther %28%IM%29%%A%  
% 224.82/224.97  |- mesh__historyNote mesh__D007167
% 224.82/224.97       73; VACCINE THERAPY was heading 1963-82   
% 224.82/224.97  |- mesh__recordMaintainer mesh__D007167 PLS
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007167 1997
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007167 1992
% 224.82/224.97  |- mesh__recordAuthorizer mesh__D007167 PLS
% 224.82/224.97  |- mesh__dateEstablished mesh__D007167 1973-01-01
% 224.82/224.97  |- rdf__type mesh__D007167sskos__Concept
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007167 2000
% 224.82/224.97  |- skos__prefLabel mesh__D007167 Immunotherapy
% 224.82/224.97  |- skos__scopeNote mesh__D007167
% 224.82/224.97       Manipulation of the host%27%s immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.%A%    
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007167 1993
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007167 2003
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007167 1998
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007167 2004
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007167 2001
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007167 1994
% 224.82/224.97  |- mesh__recordOriginator mesh__D007167 NLM
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007167 1999
% 224.82/224.97  |- mesh__onlineNote mesh__D007167
% 224.82/224.97       use IMMUNOTHERAPY to search VACCINE THERAPY 1966-72   
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007167 2002
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D007167 1995
% 224.82/224.97  |- skos__broader mesh__D026321smesh__D019684
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D026321 2006
% 224.82/224.97  |- skos__prefLabel mesh__D026321 Piperaceae
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D026321 2003
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D026321 2005
% 224.82/224.97  |- mesh__historyNote mesh__D026321 2002   
% 224.82/224.97  |- mesh__dateEstablished mesh__D026321 2002-01-01
% 224.82/224.97  |- rdf__type mesh__D026321sskos__Concept
% 224.82/224.97  |- mesh__dateCreated mesh__D026321 2001-07-25
% 224.82/224.97  |- skos__historyNote mesh__D026321 Spices %28%1993-2001%29%
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D026321 2002
% 224.82/224.97  |- mesh__publicMeSHNote mesh__D026321 2002   
% 224.82/224.97  |- skos__annotation mesh__D026321
% 224.82/224.97       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.82/224.97  |- skos__scopeNote mesh__D026321
% 224.82/224.97       A family of flowering plants in the order Piperales best known for the black  pepper widely used in SPICES, and for KAVA and Betel used for neuroactive properties.%A%    
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D026321 2004
% 224.82/224.97  |- mesh__recordAuthorizer mesh__D045286 sjn
% 224.82/224.97  |- skos__annotation mesh__D045286
% 224.82/224.97       infection: coord IM with DESULFOVIBRIONACEAE INFECTIONS %28%IM%29%%A%  
% 224.82/224.97  |- mesh__recordMaintainer mesh__D045286 SYSTEM
% 224.82/224.97  |- mesh__recordOriginator mesh__D045286 ags
% 224.82/224.97  |- mesh__dateRevised mesh__D045286 2005-06-30
% 224.82/224.97  |- mesh__historyNote mesh__D045286 2004   
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D045286 2006
% 224.82/224.97  |- skos__broader mesh__D045286smesh__D003901
% 224.82/224.97  |- rdf__type mesh__D045286sskos__Concept
% 224.82/224.97  |- mesh__publicMeSHNote mesh__D045286 2004   
% 224.82/224.97  |- skos__prefLabel mesh__D045286 Desulfovibrio gigas
% 224.82/224.97  |- mesh__dateCreated mesh__D045286 2003-07-09
% 224.82/224.97  |- mesh__dateEstablished mesh__D045286 2004-01-01
% 224.82/224.97  |- skos__historyNote mesh__D045286 Desulfovibrio %28%1966-2003%29%
% 224.82/224.97  |- skos__scopeNote mesh__D045286
% 224.82/224.97       A species of gram-negative, anaerobic, spiral-shaped bacteria originally isolated from a saltwater pond in France. It contains a well-characterized metabolic pathway that enables it to survive transient contacts with OXYGEN.%A%    
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D012301 2002
% 224.82/224.97  |- rdf__type mesh__D012301sskos__Concept
% 224.82/224.97  |- mesh__dateCreated mesh__D012301 1999-01-01
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D012301 2004
% 224.82/224.97  |- skos__broader mesh__D012301smesh__D018185
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D012301 2003
% 224.82/224.97  |- skos__hiddenLabel mesh__D012301 Plague, Cattle
% 224.82/224.97  |- skos__prefLabel mesh__D012301 Rinderpest
% 224.82/224.97  |- skos__altLabel mesh__D012301 Cattle Plague
% 224.82/224.97  |- mesh__recordOriginator mesh__D012301 NLM
% 224.82/224.97  |- mesh__recordAuthorizer mesh__D012301 sjn
% 224.82/224.97  |- skos__scopeNote mesh__D012301
% 224.82/224.97       A viral disease of cloven-hoofed animals caused by MORBILLIVIRUS. It may be acute, subacute, or chronic with the major lesions characterized by inflammation and ulceration of the entire digestive tract.%A%    
% 224.82/224.97  |- mesh__recordMaintainer mesh__D012301 ags
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D012301 2006
% 224.82/224.97  |- skos__broader mesh__D012301smesh__D000820
% 224.82/224.97  |- mesh__dateRevised mesh__D012301 2001-07-25
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D012301 2005
% 224.82/224.97  |- skos__broader mesh__D017595smesh__D012079
% 224.82/224.97  |- skos__prefLabel mesh__D017595 Renal Plasma Flow
% 224.82/224.97  |- skos__historyNote mesh__D017595 Renal Circulation %28%1982-1993%29%
% 224.82/224.97  |- mesh__publicMeSHNote mesh__D017595 94   
% 224.82/224.97  |- skos__historyNote mesh__D017595 Kidney/blood supply %28%1966-1981%29%
% 224.82/224.97  |- rdf__type mesh__D017595sskos__Concept
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017595 2005
% 224.82/224.97  |- skos__hiddenLabel mesh__D017595 Flow, Renal Plasma
% 224.82/224.97  |- mesh__dateCreated mesh__D017595 1992-12-28
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017595 2006
% 224.82/224.97  |- skos__annotation mesh__D017595
% 224.82/224.97       do not confuse with RENAL BLOOD FLOW see RENAL CIRCULATION or RENAL PLASMA FLOW, EFFECTIVE%A%  
% 224.82/224.97  |- mesh__recordMaintainer mesh__D017595 ags
% 224.82/224.97  |- mesh__dateEstablished mesh__D017595 1994-01-01
% 224.82/224.97  |- skos__scopeNote mesh__D017595
% 224.82/224.97       The amount of PLASMA that perfuses the KIDNEYS per unit time, approximately 10%25% greater than effective renal plasma flow %28%RENAL PLASMA FLOW, EFFECTIVE%29%. It should be differentiated from the RENAL BLOOD FLOW; %28%RBF%29%, which refers to the total volume of BLOOD flowing through the renal vasculature, while the renal plasma flow refers to the rate of plasma flow %28%RPF%29%.%A%    
% 224.82/224.97  |- mesh__recordAuthorizer mesh__D017595 ags
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017595 2004
% 224.82/224.97  |- skos__historyNote mesh__D017595 Regional Blood Flow %28%1966-1981%29%
% 224.82/224.97  |- mesh__activeMeSHYear mesh__D017595 2006A
% 224.82/224.97  |- skos__altLabel mesh__D017595 Plasma Flow, Renal
% 224.82/224.97  |- mesh__dateRevised mesh__D017595 2005-07-28
% 224.82/224.97  |- mesh__historyNote mesh__D017595 94   
% 224.82/224.98  |- mesh__recordOriginator mesh__D017595 TGC
% 224.82/224.98  |- skos__altLabel mesh__D003575 Cytochrome c1
% 224.82/224.98  |- mesh__recordAuthorizer mesh__D003575 sjn
% 224.82/224.98  |- skos__hiddenLabel mesh__D003575 Cytochrome c 1
% 224.82/224.98  |- skos__annotation mesh__D003575
% 224.82/224.98       spell in titles %26% translations with lowercase c: cytochrome c1%A%  
% 224.82/224.98  |- mesh__recordMaintainer mesh__D003575 jmp
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D003575 2005
% 224.82/224.98  |- mesh__publicMeSHNote mesh__D003575
% 224.82/224.98       2004; see CYTOCHROME C1 1994-2003, see CYTOCHROME C-1 1991-1992, see CYTOCHROME C 1975-1990%A%  
% 224.82/224.98  |- skos__scopeNote mesh__D003575
% 224.82/224.98       The 30-kDa membrane-bound c-type cytochrome protein of mitochondria that functions as an electron donor to CYTOCHROME C GROUP in the mitochondrial and bacterial RESPIRATORY CHAIN. %28%From Enzyme Nomenclature, 1992, p545%29%%A%    
% 224.82/224.98  |- mesh__recordOriginator mesh__D003575 NLM
% 224.82/224.98  |- mesh__dateRevised mesh__D003575 2004-07-07
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D003575 2006
% 224.82/224.98  |- skos__altLabel mesh__D003575 Cytochrome c-1
% 224.82/224.98  |- mesh__dateEstablished mesh__D003575 1991-01-01
% 224.82/224.98  |- skos__broader mesh__D003575smesh__D003574
% 224.82/224.98  |- mesh__historyNote mesh__D003575 2004%28%1975%29%   
% 224.82/224.98  |- skos__prefLabel mesh__D003575 Cytochromes c1
% 224.82/224.98  |- mesh__dateCreated mesh__D003575 1999-01-01
% 224.82/224.98  |- rdf__type mesh__D003575sskos__Concept
% 224.82/224.98  |- skos__scopeNote mesh__D011209
% 224.82/224.98       The exertion of a strong influence or control over others in a variety of settings--administrative, social, academic, etc.%A%    
% 224.82/224.98  |- skos__altLabel mesh__D011209 Power
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D011209 1999
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D011209 2002
% 224.82/224.98  |- skos__broader mesh__D011209smesh__D009042
% 224.82/224.98  |- skos__hiddenLabel mesh__D011209 Professional Power
% 224.82/224.98  |- mesh__publicMeSHNote mesh__D011209 88   
% 224.82/224.98  |- skos__prefLabel mesh__D011209 Power %28%Psychology%29%
% 224.82/224.98  |- mesh__dateCreated mesh__D011209 1987-04-09
% 224.82/224.98  |- mesh__dateEstablished mesh__D011209 1988-01-01
% 224.82/224.98  |- skos__hiddenLabel mesh__D011209 Powers %28%Psychology%29%
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D011209 2006
% 224.82/224.98  |- mesh__recordAuthorizer mesh__D011209 SJN
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D011209 1998
% 224.82/224.98  |- mesh__recordOriginator mesh__D011209 EC
% 224.82/224.98  |- skos__hiddenLabel mesh__D011209 Personal Power
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D011209 2004
% 224.82/224.98  |- mesh__historyNote mesh__D011209 88   
% 224.82/224.98  |- rdf__type mesh__D011209sskos__Concept
% 224.82/224.98  |- skos__hiddenLabel mesh__D011209 Social Power
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D011209 2005
% 224.82/224.98  |- skos__annotation mesh__D011209
% 224.82/224.98       %22%exertion of a strong influence or control over others%22%; no qualif; DF: POWER%A%  
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D011209 2001
% 224.82/224.98  |- mesh__recordMaintainer mesh__D011209 JLS
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D011209 2003
% 224.82/224.98  |- mesh__dateRevised mesh__D011209 1997-06-20
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D011209 2000
% 224.82/224.98  |- skos__related mesh__D011209smesh__D012927
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D008260 1998
% 224.82/224.98  |- mesh__publicMeSHNote mesh__D008260
% 224.82/224.98       76; was see under TONGUE 1975; was see under TONGUE/abnormalities 1969-74%A%  
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D008260 1997
% 224.82/224.98  |- rdf__type mesh__D008260sskos__Concept
% 224.82/224.98  |- skos__related mesh__D008260smesh__D001506
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D008260 2000
% 224.82/224.98  |- skos__hiddenLabel mesh__D008260 Macroglossias
% 224.82/224.98  |- skos__prefLabel mesh__D008260 Macroglossia
% 224.82/224.98  |- mesh__dateEstablished mesh__D008260 1976-01-01
% 224.82/224.98  |- mesh__dateRevised mesh__D008260 1996-06-10
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D008260 1999
% 224.82/224.98  |- mesh__recordAuthorizer mesh__D008260 PLS
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D008260 2001
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D008260 2003
% 224.82/224.98  |- mesh__onlineNote mesh__D008260 search TONGUE /AB 1969-74   
% 224.82/224.98  |- mesh__historyNote mesh__D008260
% 224.82/224.98       76%28%75%29%; was see under TONGUE 1975; was see under TONGUE/abnormalities 1969-74%A%  
% 224.82/224.98  |- mesh__dateCreated mesh__D008260 1999-01-01
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D008260 2005
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D008260 2004
% 224.82/224.98  |- mesh__recordMaintainer mesh__D008260 TGC
% 224.82/224.98  |- skos__scopeNote mesh__D008260
% 224.82/224.98       The presence of an excessively large tongue, which may be congenital or may develop as a result of a tumor or edema due to obstruction of lymphatic vessels, or it may occur in association with hyperpituitarism or acromegaly. It also may be associated with malocclusion because of pressure of the tongue on the teeth. %28%From Jablonski, Dictionary of Dentistry, 1992%29%%A%    
% 224.82/224.98  |- mesh__recordOriginator mesh__D008260 NLM
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D008260 2002
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D008260 2006
% 224.82/224.98  |- skos__historyNote mesh__D008260 Tongue/abnormalities %28%1969-1974%29%
% 224.82/224.98  |- skos__annotation mesh__D008260 overlarge tongue, congen or acquired   
% 224.82/224.98  |- skos__broader mesh__D008260smesh__D014060
% 224.82/224.98  |- skos__altLabel mesh__D007966 Leukodystrophy, Metachromatic, Type I
% 224.82/224.98  |- mesh__publicMeSHNote mesh__D007966 1974   
% 224.82/224.98  |- skos__altLabel mesh__D007966 Arylsulfatase A Deficiency Disease
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007966 2006
% 224.82/224.98  |- skos__prefLabel mesh__D007966 Leukodystrophy, Metachromatic
% 224.82/224.98  |- skos__altLabel mesh__D007966 Sulfatidosis
% 224.82/224.98  |- mesh__recordMaintainer mesh__D007966 nns
% 224.82/224.98  |- skos__scopeNote mesh__D007966
% 224.82/224.98       An autosomal recessive lysosomal storage disease caused by a deficiency of CEREBROSIDE-SULFATASE leading to an accumulation of cerebroside sulfate in the nervous system and other organs. Pathologic features include diffuse demyelination and metachromatically-staining granules within glial cells, macrophages, and free in tissue. Clinical subtypes include late infantile, juvenile, and adult forms. The late infantile form presents at 12-18 months of age with progressive psychomotor retardation, ATAXIA, spasticity, and OPTIC ATROPHY. The juvenile form has onset at 4-12 years and features behavioral alterations and ataxia followed by spasticity, DEMENTIA, and visual loss. The adult form presents in the second decade or later with psychiatric manifestations, gait difficulties, and less often as a peripheral neuropathy. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp192-5%29%%A%    
% 224.82/224.98  |- skos__broader mesh__D007966smesh__D013106
% 224.82/224.98  |- mesh__dateRevised mesh__D007966 2005-06-30
% 224.82/224.98  |- skos__hiddenLabel mesh__D007966 Sulfatidoses
% 224.82/224.98  |- skos__hiddenLabel mesh__D007966 Lipidosis, Sulfatide
% 224.82/224.98  |- mesh__recordOriginator mesh__D007966 NLM
% 224.82/224.98  |- mesh__recordAuthorizer mesh__D007966 sjn
% 224.82/224.98  |- mesh__historyNote mesh__D007966 1974   
% 224.82/224.98  |- skos__altLabel mesh__D007966 Sulfatide Lipidosis
% 224.82/224.98  |- skos__altLabel mesh__D007966 Greenfield Disease
% 224.82/224.98  |- skos__altLabel mesh__D007966 Deficiency Disease, Arylsulfatase A
% 224.82/224.98  |- mesh__dateCreated mesh__D007966 1999-01-01
% 224.82/224.98  |- skos__altLabel mesh__D007966 Cerebroside Sulphatase Deficiency Disease
% 224.82/224.98  |- rdf__type mesh__D007966sskos__Concept
% 224.82/224.98  |- skos__broader mesh__D007966smesh__D020279
% 224.82/224.98  |- skos__related mesh__D007966smesh__D002553
% 224.82/224.98  |- skos__altLabel mesh__D007966 Deficiency Disease, Cerebroside Sulphatase
% 224.82/224.98  |- skos__altLabel mesh__D007966 Greenfield%27%s Disease
% 224.82/224.98  |- skos__hiddenLabel mesh__D007966 Metachromatic Leukodystrophy
% 224.82/224.98  |- skos__hiddenLabel mesh__D007966 Metachromatic Leukodystrophies
% 224.82/224.98  |- skos__hiddenLabel mesh__D007966 Leukodystrophies, Metachromatic
% 224.82/224.98  |- mesh__dateEstablished mesh__D007966 1974-01-01
% 224.82/224.98  |- skos__altLabel mesh__D007966 Leukodystrophy, Metachromatic, Type III
% 224.82/224.98  |- mesh__dateEstablished mesh__D007168 1991-01-01
% 224.82/224.98  |- skos__broader mesh__D007168smesh__D000429
% 224.82/224.98  |- skos__hiddenLabel mesh__D007168 Dehydrogenase, IMP
% 224.82/224.98  |- mesh__recordOriginator mesh__D007168 NLM
% 224.82/224.98  |- mesh__historyNote mesh__D007168
% 224.82/224.98       91%28%75%29%; was see under KETONE OXIDOREDUCTASES 1975-90   
% 224.82/224.98  |- skos__hiddenLabel mesh__D007168 Dehydrogenase, Inosine-5-Monophosphate
% 224.82/224.98  |- skos__altLabel mesh__D007168 Inosine-5-Monophosphate Dehydrogenase
% 224.82/224.98  |- mesh__publicMeSHNote mesh__D007168
% 224.82/224.98       91; was see under KETONE OXIDOREDUCTASES 1975-90   
% 224.82/224.98  |- skos__historyNote mesh__D007168 Inosine Nucleotides %28%1974%29%
% 224.82/224.98  |- rdf__type mesh__D007168sskos__Concept
% 224.82/224.98  |- skos__scopeNote mesh__D007168
% 224.82/224.98       An enzyme that catalyzes the dehydrogenation of inosine 5%27%-phosphate to xanthosine 5%27%-phosphate in the presence of NAD. EC 1.1.1.205.%A%    
% 224.82/224.98  |- skos__historyNote mesh__D007168 Ketone Oxidoreductases %28%1974%29%
% 224.82/224.98  |- skos__prefLabel mesh__D007168 IMP Dehydrogenase
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007168 2004
% 224.82/224.98  |- skos__hiddenLabel mesh__D007168 Acid Dehydrogenase, Inosinic
% 224.82/224.98  |- mesh__recordAuthorizer mesh__D007168 sjn
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007168 2005
% 224.82/224.98  |- mesh__recordMaintainer mesh__D007168 ssb
% 224.82/224.98  |- skos__altLabel mesh__D007168 Inosinic Acid Dehydrogenase
% 224.82/224.98  |- skos__hiddenLabel mesh__D007168 Dehydrogenase, Inosinic Acid
% 224.82/224.98  |- skos__hiddenLabel mesh__D007168 Inosine 5 Monophosphate Dehydrogenase
% 224.82/224.98  |- mesh__dateRevised mesh__D007168 2003-07-09
% 224.82/224.98  |- mesh__dateCreated mesh__D007168 1974-11-19
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007168 2006
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D026322 2005
% 224.82/224.98  |- mesh__dateEstablished mesh__D026322 2002-01-01
% 224.82/224.98  |- skos__broader mesh__D026322smesh__D017365
% 224.82/224.98  |- skos__hiddenLabel mesh__D026322 Pepper, Black
% 224.82/224.98  |- rdf__type mesh__D026322sskos__Concept
% 224.82/224.98  |- mesh__recordMaintainer mesh__D026322 ssb
% 224.82/224.98  |- skos__historyNote mesh__D026322 Spices %28%1993-2001%29%
% 224.82/224.98  |- skos__related mesh__D026322smesh__D029222
% 224.82/224.98  |- mesh__historyNote mesh__D026322
% 224.82/224.98       2002; use SPICES 1993-2001; for WHITE PEPPER use SPICES 1998-2001%A%  
% 224.82/224.98  |- mesh__recordAuthorizer mesh__D026322 sjn
% 224.82/224.98  |- mesh__publicMeSHNote mesh__D026322
% 224.82/224.98       2002; see SPICES 1993-2001; for WHITE PEPPER see SPICES 1998-2001%A%  
% 224.82/224.98  |- skos__hiddenLabel mesh__D026322 Pepper, White
% 224.82/224.98  |- skos__prefLabel mesh__D026322 Black Pepper
% 224.82/224.98  |- mesh__dateCreated mesh__D026322 2001-07-25
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D026322 2004
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D026322 2002
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D026322 2006
% 224.82/224.98  |- mesh__recordOriginator mesh__D026322 ssb
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D026322 2003
% 224.82/224.98  |- skos__scopeNote mesh__D026322
% 224.82/224.98       A common spice from fruit of PIPER NIGRUM.  Black pepper is picked unripe and heaped for a few days to ferment.  White Pepper is the ripe fruit dehulled by maceration in water. PIPERINE is a key component used medicinally to increase gastrointestinal assimilation of other supplements and drugs.%A%    
% 224.82/224.98  |- mesh__dateEstablished mesh__D045287 2004-01-01
% 224.82/224.98  |- mesh__recordMaintainer mesh__D045287 SYSTEM
% 224.82/224.98  |- skos__broader mesh__D045287smesh__D016999
% 224.82/224.98  |- skos__broader mesh__D045287smesh__D016965
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D045287 2006
% 224.82/224.98  |- mesh__recordAuthorizer mesh__D045287 sjn
% 224.82/224.98  |- rdf__type mesh__D045287sskos__Concept
% 224.82/224.98  |- mesh__publicMeSHNote mesh__D045287 2004   
% 224.82/224.98  |- mesh__recordOriginator mesh__D045287 ags
% 224.82/224.98  |- mesh__dateRevised mesh__D045287 2005-06-30
% 224.82/224.98  |- mesh__dateCreated mesh__D045287 2003-07-09
% 224.82/224.98  |- mesh__historyNote mesh__D045287 2004   
% 224.82/224.98  |- skos__scopeNote mesh__D045287
% 224.82/224.98       A genus of gram-negative, anaerobic, nonsporeforming bacteria in the family Desulfuromonadaceae. It is found in anoxic marine sediments.%A%    
% 224.82/224.98  |- skos__prefLabel mesh__D045287 Desulfuromonas
% 224.82/224.98  |- skos__broader mesh__D045287smesh__D020564
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D012302 2005
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D012302 2004
% 224.82/224.98  |- skos__broader mesh__D012302smesh__D018103
% 224.82/224.98  |- mesh__historyNote mesh__D012302 66%28%64%29%   
% 224.82/224.98  |- mesh__recordOriginator mesh__D012302 NLM
% 224.82/224.98  |- mesh__dateEstablished mesh__D012302 1966-01-01
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D012302 2003
% 224.82/224.98  |- mesh__recordAuthorizer mesh__D012302 sjn
% 224.82/224.98  |- skos__annotation mesh__D012302 infection = RINDERPEST   
% 224.82/224.98  |- mesh__publicMeSHNote mesh__D012302 66   
% 224.82/224.98  |- mesh__recordMaintainer mesh__D012302 ags
% 224.82/224.98  |- skos__prefLabel mesh__D012302 Rinderpest virus
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D012302 2006
% 224.82/224.98  |- rdf__type mesh__D012302sskos__Concept
% 224.82/224.98  |- mesh__dateRevised mesh__D012302 2001-07-25
% 224.82/224.98  |- skos__scopeNote mesh__D012302
% 224.82/224.98       A species of MORBILLIVIRUS causing cattle plague, a disease with high mortality. Sheep, goats, pigs, and other animals of the order Artiodactyla can also be infected.%A%    
% 224.82/224.98  |- mesh__dateCreated mesh__D012302 1999-01-01
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D012302 2002
% 224.82/224.98  |- skos__altLabel mesh__D017596 Effective Renal Plasma Flow
% 224.82/224.98  |- skos__altLabel mesh__D017596 ERPF
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D017596 2004
% 224.82/224.98  |- mesh__historyNote mesh__D017596 94   
% 224.82/224.98  |- skos__historyNote mesh__D017596 Renal Circulation %28%1982-1993%29%
% 224.82/224.98  |- skos__altLabel mesh__D017596 Plasma Flow, Renal, Effective
% 224.82/224.98  |- mesh__publicMeSHNote mesh__D017596 94   
% 224.82/224.98  |- skos__broader mesh__D017596smesh__D012079
% 224.82/224.98  |- skos__historyNote mesh__D017596 Regional Blood Flow %28%1967-1981%29%
% 224.82/224.98  |- skos__historyNote mesh__D017596 Kidney/blood supply %28%1966-1981%29%
% 224.82/224.98  |- skos__scopeNote mesh__D017596
% 224.82/224.98       The amount of PLASMA flowing to the parts of the KIDNEY that function in the production of urine. It is the amount of plasma perfusing the KIDNEY TUBULES per unit time, generally measured by P-AMINOHIPPURATE clearance. It should be differentiated from RENAL PLASMA FLOW which is approximately 10%25% greater than the effective renal plasma flow.%A%    
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D017596 2005
% 224.82/224.98  |- mesh__dateEstablished mesh__D017596 1994-01-01
% 224.82/224.98  |- skos__prefLabel mesh__D017596 Renal Plasma Flow, Effective
% 224.82/224.98  |- mesh__dateRevised mesh__D017596 2003-07-09
% 224.82/224.98  |- rdf__type mesh__D017596sskos__Concept
% 224.82/224.98  |- skos__annotation mesh__D017596
% 224.82/224.98       do not confuse with RENAL PLASMA FLOW or RENAL BLOOD FLOW, EFFECTIVE%A%  
% 224.82/224.98  |- mesh__dateCreated mesh__D017596 1992-12-28
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D017596 2006
% 224.82/224.98  |- skos__broader mesh__D003576smesh__D009097
% 224.82/224.98  |- skos__altLabel mesh__D003576 Ferrocytochrome c Oxygen Oxidoreductase
% 224.82/224.98  |- mesh__publicMeSHNote mesh__D003576
% 224.82/224.98       2004; see CYTOCHROME-C OXIDASE 1994-2003, see CYTOCHROME C OXIDASE 1992-1993, see CYTOCHROME OXIDASE 1963-1991; for CYTOCHROME C OXIDASE see CYTOCHROME OXIDASE 1984-1991; SIGNAL PEPTIDE P25-SUBUNIT IV CYTOCHROME OXIDASE was indexed under CYTOCHROME C OXIDASE 1988-2001; CYTOCHROME OXIDASE SUBUNIT III was indexed under CYTOCHROME C OXIDASE 1998-2001%A%  
% 224.82/224.98  |- skos__altLabel mesh__D003576 Heme aa3 Cytochrome Oxidase
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D003576 2005
% 224.82/224.98  |- skos__annotation mesh__D003576
% 224.82/224.98       spell in titles %26% translations with lowercase c: cytochrome-c oxidase%A%  
% 224.82/224.98  |- skos__hiddenLabel mesh__D003576
% 224.82/224.98       Signal Peptide p25 Subunit IV Cytochrome Oxidase
% 224.82/224.98  |- skos__altLabel mesh__D003576 p25 Presequence Peptide-Cytochrome Oxidase
% 224.82/224.98  |- skos__altLabel mesh__D003576 Cytochrome a,a3
% 224.82/224.98  |- skos__hiddenLabel mesh__D003576 Cytochrome c Oxidase Subunit IV
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D003576 2006
% 224.82/224.98  |- mesh__recordMaintainer mesh__D003576 ags
% 224.82/224.98  |- skos__altLabel mesh__D003576 Cytochrome Oxidase Subunit III
% 224.82/224.98  |- skos__hiddenLabel mesh__D003576
% 224.82/224.98       p25 Presequence Peptide Cytochrome Oxidase
% 224.82/224.98  |- skos__altLabel mesh__D003576 Cytochrome-c Oxidase
% 224.82/224.98  |- skos__altLabel mesh__D003576 Pre-CTOX p25
% 224.82/224.98  |- skos__broader mesh__D003576smesh__D010088
% 224.82/224.98  |- skos__altLabel mesh__D003576 Cytochrome-c Oxidase %28%Complex IV%29%
% 224.82/224.98  |- skos__broader mesh__D003576smesh__D045222
% 224.82/224.98  |- skos__scopeNote mesh__D003576
% 224.82/224.98       A multisubunit enzyme complex containing CYTOCHROME A GROUP; CYTOCHROME A3; two copper atoms; and 13 different protein subunits. It is the terminal oxidase complex of the RESPIRATORY CHAIN and collects electrons that are transferred from the reduced CYTOCHROME C GROUP and donates them to molecular OXYGEN, which is then reduced to water. The redox reaction is simultaneously coupled to the transport of PROTONS across the inner mitochondrial membrane.%A%    
% 224.82/224.98  |- skos__hiddenLabel mesh__D003576 Oxidase, Cytochrome
% 224.82/224.98  |- skos__hiddenLabel mesh__D003576 Cytochrome c Oxidase Subunit III
% 224.82/224.98  |- skos__altLabel mesh__D003576 Subunit III, Cytochrome Oxidase
% 224.82/224.98  |- mesh__recordAuthorizer mesh__D003576 ags
% 224.82/224.98  |- mesh__recordOriginator mesh__D003576 NLM
% 224.82/224.98  |- mesh__dateRevised mesh__D003576 2005-07-28
% 224.82/224.98  |- mesh__dateCreated mesh__D003576 1999-01-01
% 224.82/224.98  |- skos__hiddenLabel mesh__D003576 Oxidase, Cytochrome-c
% 224.82/224.98  |- rdf__type mesh__D003576sskos__Concept
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D003576 2006A
% 224.82/224.98  |- skos__related mesh__D003576smesh__D030401
% 224.82/224.98  |- skos__prefLabel mesh__D003576 Electron Transport Complex IV
% 224.82/224.98  |- skos__altLabel mesh__D003576 Cytochrome Oxidase
% 224.82/224.98  |- skos__hiddenLabel mesh__D003576 Cytochrome c Oxidase
% 224.82/224.98  |- skos__broader mesh__D003576smesh__D017494
% 224.82/224.98  |- mesh__historyNote mesh__D003576
% 224.82/224.98       2004%28%1963%29%; for SIGNAL PEPTIDE P25-SUBUNIT IV CYTOCHROME OXIDASE use CYTOCHROME C OXIDASE %28%NM%29% 1988-2001; for  CYTOCHROME OXIDASE SUBUNIT III use CYTOCHROME C OXIDASE %28%NM%29% 1998-2001%A%  
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007967 2002
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007967 2006
% 224.82/224.98  |- skos__hiddenLabel mesh__D007967 Oral Leukoedema
% 224.82/224.98  |- skos__prefLabel mesh__D007967 Leukoedema, Oral
% 224.82/224.98  |- skos__historyNote mesh__D007967 Mouth Diseases %28%1966-1971%29%
% 224.82/224.98  |- mesh__dateCreated mesh__D007967 1999-01-01
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007967 1996
% 224.82/224.98  |- skos__annotation mesh__D007967 disord of buccal mucosa   
% 224.82/224.98  |- mesh__recordMaintainer mesh__D007967 TGC
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007967 1998
% 224.82/224.98  |- mesh__historyNote mesh__D007967
% 224.82/224.98       91%28%72%29%; was see under MOUTH DISEASES 1972-90   
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007967 1997
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007967 2000
% 224.82/224.98  |- skos__hiddenLabel mesh__D007967 Leukoedemas, Oral
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007967 1994
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007967 1999
% 224.82/224.98  |- mesh__dateRevised mesh__D007967 1993-06-02
% 224.82/224.98  |- mesh__publicMeSHNote mesh__D007967
% 224.82/224.98       91; was see under MOUTH DISEASES 1972-90   
% 224.82/224.98  |- rdf__type mesh__D007967sskos__Concept
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007967 2001
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007967 1995
% 224.82/224.98  |- mesh__recordOriginator mesh__D007967 NLM
% 224.82/224.98  |- mesh__dateEstablished mesh__D007967 1991-01-01
% 224.82/224.98  |- skos__hiddenLabel mesh__D007967 Oral Leukoedemas
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007967 2003
% 224.82/224.98  |- skos__scopeNote mesh__D007967
% 224.82/224.98       A disorder of the buccal mucosa resembling early leukoplakia, characterized by the presence of filmy opalescence of the mucosa in the early stages to a whitish gray cast with a coarsely wrinkled surface in the later stages, associated with intracellular edema of the spinous or malpighian layer. %28%Dorland, 27th ed%29%%A%    
% 224.82/224.98  |- mesh__recordAuthorizer mesh__D007967 PLS
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007967 2005
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007967 2004
% 224.82/224.98  |- skos__broader mesh__D007967smesh__D009059
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007169 1998
% 224.82/224.98  |- mesh__dateRevised mesh__D007169 1994-02-08
% 224.82/224.98  |- rdf__type mesh__D007169sskos__Concept
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007169 2003
% 224.82/224.98  |- mesh__recordAuthorizer mesh__D007169 PLS
% 224.82/224.98  |- skos__annotation mesh__D007169 a staph or strep infect of the skin   
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007169 2000
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007169 1999
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007169 2004
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007169 2001
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007169 1995
% 224.82/224.98  |- mesh__recordMaintainer mesh__D007169 PXP
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007169 2005
% 224.82/224.98  |- skos__prefLabel mesh__D007169 Impetigo
% 224.82/224.98  |- mesh__recordOriginator mesh__D007169 NLM
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007169 2002
% 224.82/224.98  |- mesh__dateCreated mesh__D007169 1999-01-01
% 224.82/224.98  |- skos__scopeNote mesh__D007169
% 224.82/224.98       A common superficial bacterial infection caused by STAPHYLOCOCCUS AUREUS or group A beta-hemolytic streptococci. Characteristics include pustular lesions that rupture and discharge a thin, amber-colored fluid that dries and forms a crust. This condition is commonly located on the face, especially about the mouth and nose.%A%    
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007169 2006
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007169 1996
% 224.82/224.98  |- skos__broader mesh__D007169smesh__D013207
% 224.82/224.98  |- mesh__activeMeSHYear mesh__D007169 1997
% 224.82/224.98  |- skos__broader mesh__D007169smesh__D013290
% 224.82/224.98  |- rdf__type mesh__D026323sskos__Concept
% 224.82/224.98  |- mesh__recordMaintainer mesh__D026323 jls
% 224.82/224.99  |- skos__annotation mesh__D026323
% 224.82/224.99       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; for food coord with SPICES; Manual 26.29%A%  
% 224.82/224.99  |- mesh__recordOriginator mesh__D026323 ssb
% 224.82/224.99  |- mesh__publicMeSHNote mesh__D026323
% 224.82/224.99       2002; see SPICES 1993-2001; see CONDIMENTS 1963-82; see HALLUCINOGENS 1975-77%A%  
% 224.82/224.99  |- skos__historyNote mesh__D026323 Spices %28%1993-2001%29%
% 224.82/224.99  |- skos__prefLabel mesh__D026323 Myristica fragrans
% 224.82/224.99  |- mesh__dateEstablished mesh__D026323 2002-01-01
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D026323 2003
% 224.82/224.99  |- mesh__dateCreated mesh__D026323 2001-08-03
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D026323 2005
% 224.82/224.99  |- skos__scopeNote mesh__D026323
% 224.82/224.99       A plant species in the MYRISTICACEAE family.  The seed is used as a spice and used for antimicrobial and psychoactive effects. Myristicin, SAFROLE, and methyleugenol are key components.%A%    
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D026323 2004
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D026323 2002
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D026323 2006
% 224.82/224.99  |- skos__broader mesh__D026323smesh__D026324
% 224.82/224.99  |- mesh__historyNote mesh__D026323 2002; use SPICES 1993-2001   
% 224.82/224.99  |- mesh__recordAuthorizer mesh__D026323 sjn
% 224.82/224.99  |- skos__annotation mesh__D012303
% 224.82/224.99       no qualif; do not confuse with chromosome rings %28% = CHROMOSOME BANDING%29% or DNA, CIRCULAR%A%  
% 224.82/224.99  |- mesh__dateEstablished mesh__D012303 1991-01-01
% 224.82/224.99  |- mesh__publicMeSHNote mesh__D012303
% 224.82/224.99       91; was see under CHROMOSOME ABERRATIONS 1985-90   
% 224.82/224.99  |- skos__hiddenLabel mesh__D012303 Ring Chromosome
% 224.82/224.99  |- skos__historyNote mesh__D012303
% 224.82/224.99       Chromosome Abnormalities %28%1966-1984%29%
% 224.82/224.99  |- skos__scopeNote mesh__D012303
% 224.82/224.99       Aberrant chromosomes with no ends, i.e., circular.     
% 224.82/224.99  |- mesh__recordOriginator mesh__D012303 AEP
% 224.82/224.99  |- skos__historyNote mesh__D012303 Chromosome Aberrations %28%1968-1984%29%
% 224.82/224.99  |- skos__altLabel mesh__D012303 Chromosomes, Ring
% 224.82/224.99  |- mesh__recordMaintainer mesh__D012303 nns
% 224.82/224.99  |- skos__broader mesh__D012303smesh__D002875
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D012303 2006
% 224.82/224.99  |- rdf__type mesh__D012303sskos__Concept
% 224.82/224.99  |- mesh__dateCreated mesh__D012303 1984-04-05
% 224.82/224.99  |- skos__prefLabel mesh__D012303 Ring Chromosomes
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D012303 2005
% 224.82/224.99  |- skos__broader mesh__D012303smesh__D002869
% 224.82/224.99  |- mesh__recordAuthorizer mesh__D012303 sjn
% 224.82/224.99  |- mesh__historyNote mesh__D012303
% 224.82/224.99       91%28%85%29%; was see under CHROMOSOME ABERRATIONS 1985-90   
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D012303 2004
% 224.82/224.99  |- mesh__dateRevised mesh__D012303 2002-07-03
% 224.82/224.99  |- skos__hiddenLabel mesh__D012303 Chromosome, Ring
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D012303 2003
% 224.82/224.99  |- skos__historyNote mesh__D017597 Kidney/blood supply %28%1970-1981%29%
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D017597 2004
% 224.82/224.99  |- skos__altLabel mesh__D017597 Effective Renal Blood Flow
% 224.82/224.99  |- mesh__historyNote mesh__D017597 94   
% 224.82/224.99  |- skos__prefLabel mesh__D017597 Renal Blood Flow, Effective
% 224.82/224.99  |- skos__broader mesh__D017597smesh__D012079
% 224.82/224.99  |- skos__annotation mesh__D017597
% 224.82/224.99       do not confuse with RENAL PLASMA FLOW, EFFECTIVE or RENAL BLOOD FLOW see RENAL CIRCULATION%A%  
% 224.82/224.99  |- skos__scopeNote mesh__D017597
% 224.82/224.99       The amount of the RENAL BLOOD FLOW that is going to the functional renal tissue, i.e., parts of the KIDNEY that are involved in production of URINE.%A%    
% 224.82/224.99  |- skos__historyNote mesh__D017597 Regional Blood Flow %28%1970-1981%29%
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D017597 2005
% 224.82/224.99  |- skos__altLabel mesh__D017597 Blood Flow, Renal, Effective
% 224.82/224.99  |- mesh__dateRevised mesh__D017597 2003-07-09
% 224.82/224.99  |- rdf__type mesh__D017597sskos__Concept
% 224.82/224.99  |- skos__historyNote mesh__D017597 Renal Circulation %28%1982-1993%29%
% 224.82/224.99  |- mesh__dateCreated mesh__D017597 1992-12-28
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D017597 2006
% 224.82/224.99  |- mesh__publicMeSHNote mesh__D017597 94   
% 224.82/224.99  |- mesh__dateEstablished mesh__D017597 1994-01-01
% 224.82/224.99  |- skos__altLabel mesh__D017597 ERBF
% 224.82/224.99  |- skos__altLabel mesh__D003577 Cytochrome P450
% 224.82/224.99  |- mesh__recordOriginator mesh__D003577 NLM
% 224.82/224.99  |- skos__broader mesh__D003577smesh__D003580
% 224.82/224.99  |- skos__altLabel mesh__D003577 Cytochrome P-450-Dependent Monooxygenase
% 224.82/224.99  |- mesh__recordMaintainer mesh__D003577 ssb
% 224.82/224.99  |- mesh__historyNote mesh__D003577
% 224.82/224.99       73; CYTOCHROME P-450 OXYGENASE was NM 1977-96   
% 224.82/224.99  |- mesh__dateCreated mesh__D003577 1999-01-01
% 224.82/224.99  |- rdf__type mesh__D003577sskos__Concept
% 224.82/224.99  |- skos__scopeNote mesh__D003577
% 224.82/224.99       A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases %28%MIXED FUNCTION OXYGENASES%29%. In animals, these P-450 enzymes serve two major functions: %28%1%29% biosynthesis of steroids, fatty acids, and bile acids; %28%2%29% metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs %28%BIOTRANSFORMATION%29%. They are classified, according to their sequence similarities rather than functions, into CYP gene families %28%%3E%40%25% homology%29% and subfamilies %28%%3E%59%25% homology%29%. For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism.%A%    
% 224.82/224.99  |- mesh__publicMeSHNote mesh__D003577
% 224.82/224.99       73; CYTOCHROME P-450 OXYGENASE was indexed under CYTOCHROME P-450 %26% OXYGENASES 1977-96%A%  
% 224.82/224.99  |- skos__hiddenLabel mesh__D003577 Monooxygenase, Cytochrome P-450
% 224.82/224.99  |- skos__hiddenLabel mesh__D003577 Cytochrome P 450
% 224.82/224.99  |- skos__altLabel mesh__D003577 Cytochrome P-450
% 224.82/224.99  |- skos__hiddenLabel mesh__D003577 Cytochrome P 450 Enzyme System
% 224.82/224.99  |- skos__prefLabel mesh__D003577 Cytochrome P-450 Enzyme System
% 224.82/224.99  |- skos__hiddenLabel mesh__D003577
% 224.82/224.99       Monooxygenase, Cytochrome P-450-Dependent
% 224.82/224.99  |- skos__hiddenLabel mesh__D003577 Cytochrome P 450 Oxygenase
% 224.82/224.99  |- skos__hiddenLabel mesh__D003577 Cytochrome P 450 Dependent Monooxygenase
% 224.82/224.99  |- skos__hiddenLabel mesh__D003577 Cytochrome P 450 Monooxygenase
% 224.82/224.99  |- mesh__recordAuthorizer mesh__D003577 sjn
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D003577 2005
% 224.82/224.99  |- skos__annotation mesh__D003577
% 224.82/224.99       GEN or unspecified; prefer specific cytochrome P-450%27%s; /biosyn /physiol permitted%A%  
% 224.82/224.99  |- skos__historyNote mesh__D003577 Cytochromes %28%1966-1972%29%
% 224.82/224.99  |- mesh__dateRevised mesh__D003577 2004-07-07
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D003577 2006
% 224.82/224.99  |- mesh__dateEstablished mesh__D003577 1973-01-01
% 224.82/224.99  |- skos__broader mesh__D003577smesh__D006899
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D008262 2005
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D008262 2004
% 224.82/224.99  |- skos__broader mesh__D008262smesh__D003602
% 224.82/224.99  |- mesh__publicMeSHNote mesh__D008262 82   
% 224.82/224.99  |- skos__historyNote mesh__D008262 Macrophages %28%1966-1981%29%
% 224.82/224.99  |- mesh__dateEstablished mesh__D008262 1982-01-01
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D008262 2006
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D008262 1996
% 224.82/224.99  |- mesh__recordOriginator mesh__D008262 AEP
% 224.82/224.99  |- skos__hiddenLabel mesh__D008262 Macrophage Activations
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D008262 2002
% 224.82/224.99  |- mesh__dateRevised mesh__D008262 1992-05-14
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D008262 1998
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D008262 1997
% 224.82/224.99  |- mesh__dateCreated mesh__D008262 1981-05-20
% 224.82/224.99  |- rdf__type mesh__D008262sskos__Concept
% 224.82/224.99  |- skos__prefLabel mesh__D008262 Macrophage Activation
% 224.82/224.99  |- skos__hiddenLabel mesh__D008262 Activation, Macrophage
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D008262 1994
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D008262 1993
% 224.82/224.99  |- skos__hiddenLabel mesh__D008262 Activations, Macrophage
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D008262 1999
% 224.82/224.99  |- skos__scopeNote mesh__D008262
% 224.82/224.99       The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor %28%MAF%29% and the macrophage migration-inhibitory factor %28%MMIF%29%, immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants.%A%    
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D008262 2000
% 224.82/224.99  |- mesh__historyNote mesh__D008262 82   
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D008262 1995
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D008262 2003
% 224.82/224.99  |- mesh__recordMaintainer mesh__D008262 AGS
% 224.82/224.99  |- mesh__recordAuthorizer mesh__D008262 PLS
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D008262 2001
% 224.82/224.99  |- mesh__dateCreated mesh__D007968 1999-01-01
% 224.82/224.99  |- mesh__publicMeSHNote mesh__D007968 1973   
% 224.82/224.99  |- skos__hiddenLabel mesh__D007968 JC Polyomavirus Encephalitis
% 224.82/224.99  |- skos__prefLabel mesh__D007968
% 224.82/224.99       Leukoencephalopathy, Progressive Multifocal
% 224.82/224.99  |- skos__broader mesh__D007968smesh__D012897
% 224.82/224.99  |- skos__hiddenLabel mesh__D007968 Encephalopathies, JC Polyomavirus
% 224.82/224.99  |- skos__hiddenLabel mesh__D007968
% 224.82/224.99       Leukoencephalopathies, Progressive Multifocal
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D007968 2006
% 224.82/224.99  |- skos__hiddenLabel mesh__D007968
% 224.82/224.99       Progressive Multifocal Leukoencephalopathies
% 224.82/224.99  |- mesh__dateRevised mesh__D007968 2001-08-03
% 224.82/224.99  |- skos__altLabel mesh__D007968 JC Polyomavirus Encephalopathy
% 224.82/224.99  |- skos__broader mesh__D007968smesh__D003711
% 224.82/224.99  |- skos__broader mesh__D007968smesh__D018792
% 224.82/224.99  |- mesh__dateEstablished mesh__D007968 1973-01-01
% 224.82/224.99  |- skos__hiddenLabel mesh__D007968 Encephalopathy, JC Polyomavirus
% 224.82/224.99  |- mesh__historyNote mesh__D007968 1973%28%1971%29%   
% 224.82/224.99  |- rdf__type mesh__D007968sskos__Concept
% 224.82/224.99  |- skos__annotation mesh__D007968 DF: LEUKOENCEPH PROGRESSIVE MULTIFOCAL   
% 224.82/224.99  |- skos__scopeNote mesh__D007968
% 224.82/224.99       An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity %28%e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES%29%. The causative organism is JC Polyomavirus %28%JC VIRUS%29% which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. %28%From Joynt, Clinical Neurology, 1996, Ch26, pp36-7%29%%A%    
% 224.82/224.99  |- mesh__recordOriginator mesh__D007968 NLM
% 224.82/224.99  |- skos__altLabel mesh__D007968 Encephalitis, JC Polyomavirus
% 224.82/224.99  |- mesh__recordAuthorizer mesh__D007968 sjn
% 224.82/224.99  |- skos__hiddenLabel mesh__D007968
% 224.82/224.99       Multifocal Leukoencephalopathy, Progressive
% 224.82/224.99  |- skos__hiddenLabel mesh__D007968
% 224.82/224.99       Multifocal Leukoencephalopathies, Progressive
% 224.82/224.99  |- mesh__recordMaintainer mesh__D007968 sjn
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D007968 2003
% 224.82/224.99  |- skos__altLabel mesh__D007968 Progressive Multifocal Leukoencephalopathy
% 224.82/224.99  |- skos__historyNote mesh__D007968 Demyelinating Diseases %28%1966-1970%29%
% 224.82/224.99  |- skos__broader mesh__D007968smesh__D027601
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D007968 2002
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D007968 2005
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D007968 2004
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D018690 2006
% 224.82/224.99  |- skos__altLabel mesh__D018690 Amino Acid Agonists, Excitatory
% 224.82/224.99  |- mesh__recordAuthorizer mesh__D018690 sjn
% 224.82/224.99  |- skos__annotation mesh__D018690
% 224.82/224.99       note X ref GLUTAMATE AGONISTS: do not coord with GLUTAMATES; GEN or unspecified; prefer specifics; DF: EAA AG%A%  
% 224.82/224.99  |- skos__altLabel mesh__D018690 Amino Acids, Excitatory, Agonists
% 224.82/224.99  |- mesh__dateEstablished mesh__D018690 1995-01-01
% 224.82/224.99  |- mesh__historyNote mesh__D018690 95   
% 224.82/224.99  |- mesh__recordOriginator mesh__D018690 RAZ
% 224.82/224.99  |- skos__hiddenLabel mesh__D018690 Agonist, EAA
% 224.82/224.99  |- skos__altLabel mesh__D018690 Glutamate Agonist
% 224.82/224.99  |- skos__altLabel mesh__D018690 Amino Acid Agonist, Excitatory
% 224.82/224.99  |- rdf__type mesh__D018690sskos__Concept
% 224.82/224.99  |- skos__hiddenLabel mesh__D018690 Agonists, EAA
% 224.82/224.99  |- skos__altLabel mesh__D018690 Agonists, Excitatory Amino Acid
% 224.82/224.99  |- skos__hiddenLabel mesh__D018690 Agonists, Glutamate
% 224.82/224.99  |- skos__broader mesh__D018690smesh__D018683
% 224.82/224.99  |- mesh__recordMaintainer mesh__D018690 ssb
% 224.82/224.99  |- skos__scopeNote mesh__D018690
% 224.82/224.99       Drugs that bind to and activate excitatory amino acid receptors.%A%    
% 224.82/224.99  |- skos__historyNote mesh__D018690
% 224.82/224.99       Glutamates/pharmacology %28%1966-1994%29%
% 224.82/224.99  |- skos__altLabel mesh__D018690 Excitatory Amino Acid Agonist
% 224.82/224.99  |- mesh__dateRevised mesh__D018690 2005-06-30
% 224.82/224.99  |- skos__hiddenLabel mesh__D018690 Agonist, Glutamate
% 224.82/224.99  |- skos__altLabel mesh__D018690 EAA Agonist
% 224.82/224.99  |- mesh__dateCreated mesh__D018690 1994-06-03
% 224.82/224.99  |- skos__altLabel mesh__D018690 EAA Agonists
% 224.82/224.99  |- skos__prefLabel mesh__D018690 Excitatory Amino Acid Agonists
% 224.82/224.99  |- mesh__publicMeSHNote mesh__D018690 95   
% 224.82/224.99  |- skos__broader mesh__D032361smesh__D029643
% 224.82/224.99  |- skos__annotation mesh__D032361
% 224.82/224.99       source of TRAGACANTH, INDIAN see KARAYA GUM; source of true tragacanth is ASTRAGALUS GUMMIFER; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.82/224.99  |- skos__prefLabel mesh__D032361 Sterculia
% 224.82/224.99  |- mesh__historyNote mesh__D032361 2003   
% 224.82/224.99  |- mesh__recordAuthorizer mesh__D032361 sjn
% 224.82/224.99  |- skos__scopeNote mesh__D032361
% 224.82/224.99       A plant genus of the family STERCULIACEAE. S. urens is the source of KARAYA GUM which is sometimes called Indian tragacanth, which is different from the true TRAGACANTH which comes from ASTRAGALUS GUMMIFER.%A%    
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D032361 2006
% 224.82/224.99  |- mesh__dateRevised mesh__D032361 2005-07-06
% 224.82/224.99  |- mesh__dateCreated mesh__D032361 2002-07-03
% 224.82/224.99  |- mesh__publicMeSHNote mesh__D032361 2003   
% 224.82/224.99  |- skos__altLabel mesh__D032361 Karaya
% 224.82/224.99  |- mesh__recordMaintainer mesh__D032361 ags
% 224.82/224.99  |- mesh__dateEstablished mesh__D032361 2003-01-01
% 224.82/224.99  |- rdf__type mesh__D032361sskos__Concept
% 224.82/224.99  |- mesh__recordOriginator mesh__D032361 ssb
% 224.82/224.99  |- skos__annotation mesh__D004670
% 224.82/224.99       for La Crosse virus encephalitis, coord IM with LA CROSSE VIRUS %28%IM%29%; DF: ENCEPH CALIFORNIA%A%  
% 224.82/224.99  |- skos__altLabel mesh__D004670 Encephalitis, California, Viral
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D004670 2005
% 224.82/224.99  |- mesh__dateCreated mesh__D004670 1974-11-11
% 224.82/224.99  |- mesh__recordAuthorizer mesh__D004670 ags
% 224.82/224.99  |- skos__prefLabel mesh__D004670 Encephalitis, California
% 224.82/224.99  |- skos__hiddenLabel mesh__D004670 California Viral Encephalitides
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D004670 2003
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D004670 2006
% 224.82/224.99  |- skos__scopeNote mesh__D004670
% 224.82/224.99       A viral infection of the brain caused by serotypes of California encephalitis virus %28%ENCEPHALITIS VIRUS, CALIFORNIA%29% transmitted to humans by the mosquito AEDES triseriatus. The majority of cases are caused by the LA CROSSE VIRUS. This condition is endemic to the midwestern United States and primarily affects children between 5-10 years of age. Clinical manifestations include FEVER; VOMITING; HEADACHE; and abdominal pain followed by SEIZURES, altered mentation, and focal neurologic deficits. %28%From Joynt, Clinical Neurology, 1996, Ch26, p13%29%%A%    
% 224.82/224.99  |- skos__broader mesh__D004670smesh__D002044
% 224.82/224.99  |- skos__hiddenLabel mesh__D004670 Viral Encephalitides, California
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D004670 2004
% 224.82/224.99  |- mesh__dateEstablished mesh__D004670 1991-01-01
% 224.82/224.99  |- mesh__publicMeSHNote mesh__D004670
% 224.82/224.99       1991; see ENCEPHALITIS, EPIDEMIC 1975-1990   
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D004670 2006A
% 224.82/224.99  |- skos__hiddenLabel mesh__D004670 Encephalitis, California Viral
% 224.82/224.99  |- rdf__type mesh__D004670sskos__Concept
% 224.82/224.99  |- skos__hiddenLabel mesh__D004670 Encephalitides, California Viral
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D004670 2002
% 224.82/224.99  |- mesh__dateRevised mesh__D004670 2005-07-13
% 224.82/224.99  |- mesh__historyNote mesh__D004670 1991%28%1975%29%   
% 224.82/224.99  |- skos__altLabel mesh__D004670 California Encephalitis
% 224.82/224.99  |- skos__broader mesh__D004670smesh__D004671
% 224.82/224.99  |- mesh__recordOriginator mesh__D004670 NLM
% 224.82/224.99  |- skos__altLabel mesh__D004670 Viral Encephalitis, California
% 224.82/224.99  |- mesh__recordMaintainer mesh__D004670 ags
% 224.82/224.99  |- skos__altLabel mesh__D004670 California Viral Encephalitis
% 224.82/224.99  |- mesh__historyNote mesh__D026324 2002   
% 224.82/224.99  |- mesh__recordOriginator mesh__D026324 ssb
% 224.82/224.99  |- skos__annotation mesh__D026324
% 224.82/224.99       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.82/224.99  |- skos__scopeNote mesh__D026324
% 224.82/224.99       A family of flowering plants in the order Magnoliales. Many of the species are tropical and have fragrant wood and leaves.%A%    
% 224.82/224.99  |- mesh__recordAuthorizer mesh__D026324 sjn
% 224.82/224.99  |- skos__historyNote mesh__D026324 Spices %28%1993-2001%29%
% 224.82/224.99  |- mesh__publicMeSHNote mesh__D026324 2002   
% 224.82/224.99  |- mesh__dateEstablished mesh__D026324 2002-01-01
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D026324 2003
% 224.82/224.99  |- skos__prefLabel mesh__D026324 Myristicaceae
% 224.82/224.99  |- mesh__recordMaintainer mesh__D026324 jls
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D026324 2005
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D026324 2004
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D026324 2006
% 224.82/224.99  |- skos__broader mesh__D026324smesh__D019684
% 224.82/224.99  |- mesh__dateCreated mesh__D026324 2001-08-03
% 224.82/224.99  |- rdf__type mesh__D026324sskos__Concept
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D026324 2002
% 224.82/224.99  |- mesh__recordMaintainer mesh__D012304 ssb
% 224.82/224.99  |- mesh__recordAuthorizer mesh__D012304 sjn
% 224.82/224.99  |- mesh__historyNote mesh__D012304 75   
% 224.82/224.99  |- skos__prefLabel mesh__D012304 Riot Control Agents, Chemical
% 224.82/224.99  |- skos__historyNote mesh__D012304 Tear Gases %28%1968-1974%29%
% 224.82/224.99  |- skos__altLabel mesh__D012304 Chemical Riot Control Agents
% 224.82/224.99  |- skos__broader mesh__D012304smesh__D009676
% 224.82/224.99  |- skos__broader mesh__D012304smesh__D020313
% 224.82/224.99  |- rdf__type mesh__D012304sskos__Concept
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D012304 2006
% 224.82/224.99  |- mesh__dateCreated mesh__D012304 1999-01-01
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D012304 2005
% 224.82/224.99  |- mesh__dateEstablished mesh__D012304 1975-09-01
% 224.82/224.99  |- skos__scopeNote mesh__D012304
% 224.82/224.99       Chemical substances which are employed during a riot in order to control or disperse the rioting parties.%A%    
% 224.82/224.99  |- skos__historyNote mesh__D012304 Irritants %28%1966-1974%29%
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D012304 2004
% 224.82/224.99  |- mesh__dateRevised mesh__D012304 2003-07-09
% 224.82/224.99  |- mesh__publicMeSHNote mesh__D012304 75   
% 224.82/224.99  |- mesh__recordOriginator mesh__D012304 NLM
% 224.82/224.99  |- skos__altLabel mesh__D017598 Organizational Efficiency
% 224.82/224.99  |- skos__altLabel mesh__D017598 Organizational Productivity
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D017598 2005
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D017598 2004
% 224.82/224.99  |- mesh__dateEstablished mesh__D017598 1994-01-01
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D017598 1999
% 224.82/224.99  |- mesh__publicMeSHNote mesh__D017598 94   
% 224.82/224.99  |- mesh__recordOriginator mesh__D017598 TGC
% 224.82/224.99  |- skos__altLabel mesh__D017598 Administrative Efficiency
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D017598 2000
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D017598 2003
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D017598 1998
% 224.82/224.99  |- skos__annotation mesh__D017598
% 224.82/224.99       IM; coord with specific organiz, institution, business, department, etc. %28%IM%29%; DF: EFFICIENCY ORGAN%A%  
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D017598 1997
% 224.82/224.99  |- skos__historyNote mesh__D017598 Efficiency %28%1972-1993%29%
% 224.82/224.99  |- skos__broader mesh__D017598smesh__D009934
% 224.82/224.99  |- skos__scopeNote mesh__D017598
% 224.82/224.99       The capacity of an organization, institution, or business to produce desired results with a minimum expenditure of energy, time, money, personnel, materiel, etc.%A%    
% 224.82/224.99  |- mesh__historyNote mesh__D017598 94   
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D017598 1996
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D017598 2002
% 224.82/224.99  |- mesh__dateCreated mesh__D017598 1992-12-28
% 224.82/224.99  |- mesh__recordMaintainer mesh__D017598 TGC
% 224.82/224.99  |- mesh__dateRevised mesh__D017598 1994-05-05
% 224.82/224.99  |- skos__hiddenLabel mesh__D017598 Efficiency, Program
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D017598 1995
% 224.82/224.99  |- skos__prefLabel mesh__D017598 Efficiency, Organizational
% 224.82/224.99  |- rdf__type mesh__D017598sskos__Concept
% 224.82/224.99  |- mesh__recordAuthorizer mesh__D017598 PLS
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D017598 2006
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D017598 2001
% 224.82/224.99  |- skos__hiddenLabel mesh__D003578 Peroxidase, Cytochrome c-551
% 224.82/224.99  |- skos__hiddenLabel mesh__D003578 Peroxidase, Cytochrome-c
% 224.82/224.99  |- mesh__dateEstablished mesh__D003578 1991-01-01
% 224.82/224.99  |- skos__historyNote mesh__D003578 Peroxidases %28%1974-1975%29%
% 224.82/224.99  |- skos__broader mesh__D003578smesh__D010544
% 224.82/224.99  |- rdf__type mesh__D003578sskos__Concept
% 224.82/224.99  |- mesh__publicMeSHNote mesh__D003578
% 224.82/224.99       94; was CYTOCHROME PEROXIDASE 1976-93 %28%see under PEROXIDASES 1976-90%29%; CYTOCHROME C PEROXIDASE was see CYTOCHROME PEROXIDASE 1976-93%A%  
% 224.82/224.99  |- mesh__dateRevised mesh__D003578 2003-07-09
% 224.82/224.99  |- skos__scopeNote mesh__D003578
% 224.82/224.99       A hemeprotein which catalyzes the oxidation of ferrocytochrome c to ferricytochrome c in the presence of hydrogen peroxide. EC 1.11.1.5.%A%    
% 224.82/224.99  |- mesh__onlineNote mesh__D003578
% 224.82/224.99       use CYTOCHROME-C PEROXIDASE to search CYTOCHROME PEROXIDASE %26% CYTOCHROME C PEROXIDASE 1976-93%A%  
% 224.82/224.99  |- mesh__recordOriginator mesh__D003578 RLS
% 224.82/224.99  |- mesh__recordMaintainer mesh__D003578 ssb
% 224.82/224.99  |- skos__prefLabel mesh__D003578 Cytochrome-c Peroxidase
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D003578 2005
% 224.82/224.99  |- skos__annotation mesh__D003578
% 224.82/224.99       spell in titles %26% translations with lowercase c: cytochrome-c peroxidase%A%  
% 224.82/224.99  |- skos__hiddenLabel mesh__D003578 Cytochrome c Peroxidase
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D003578 2004
% 224.82/224.99  |- skos__hiddenLabel mesh__D003578 Peroxidase, Cytochrome
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D003578 2006
% 224.82/224.99  |- skos__historyNote mesh__D003578 Cytochrome C %28%1974-1975%29%
% 224.82/224.99  |- mesh__dateCreated mesh__D003578 1975-07-18
% 224.82/224.99  |- mesh__historyNote mesh__D003578
% 224.82/224.99       94; was CYTOCHROME PEROXIDASE 1976-93 %28%see under PEROXIDASES 1976-90%29%; CYTOCHROME C PEROXIDASE was see CYTOCHROME PEROXIDASE 1976-93%A%  
% 224.82/224.99  |- mesh__recordAuthorizer mesh__D003578 sjn
% 224.82/224.99  |- skos__hiddenLabel mesh__D003578 Cytochrome c 551 Peroxidase
% 224.82/224.99  |- skos__hiddenLabel mesh__D008263 Inhibition Factor, Migration
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D008263 2006
% 224.82/224.99  |- skos__altLabel mesh__D008263 Macrophage Migration Inhibition Factors
% 224.82/224.99  |- skos__altLabel mesh__D008263 Migration Inhibition Factors, Macrophage
% 224.82/224.99  |- mesh__recordMaintainer mesh__D008263 ssb
% 224.82/224.99  |- skos__historyNote mesh__D008263 Cell Movement %28%1970-1971%29%
% 224.82/224.99  |- skos__historyNote mesh__D008263
% 224.82/224.99       Cell Migration Inhibition %28%1972-1973%29%
% 224.82/224.99  |- rdf__type mesh__D008263sskos__Concept
% 224.82/224.99  |- mesh__dateRevised mesh__D008263 2005-06-30
% 224.82/224.99  |- mesh__historyNote mesh__D008263
% 224.82/224.99       91; was MACROPHAGE MIGRATION INHIBITORY FACTORS 1980-90; was MIGRATION INHIBITORY FACTOR 1974-79%A%  
% 224.82/224.99  |- mesh__recordAuthorizer mesh__D008263 sjn
% 224.82/224.99  |- mesh__publicMeSHNote mesh__D008263
% 224.82/224.99       91; was MACROPHAGE MIGRATION INHIBITORY FACTORS 1980-90; was MIGRATION INHIBITORY FACTOR 1974-79%A%  
% 224.82/224.99  |- skos__hiddenLabel mesh__D008263 Migration Inhibitory Factor
% 224.82/224.99  |- mesh__recordOriginator mesh__D008263 NLM
% 224.82/224.99  |- skos__scopeNote mesh__D008263
% 224.82/224.99       Proteins released by sensitized lymphocytes and possibly other cells that inhibit the migration of macrophages away from the release site. The structure and chemical properties may vary with the species and type of releasing cell.%A%    
% 224.82/224.99  |- skos__annotation mesh__D008263
% 224.82/224.99       a lymphokine; /biosyn /physiol permitted; also called MIF; DF: MMIF%A%  
% 224.82/224.99  |- mesh__onlineNote mesh__D008263
% 224.82/224.99       use MACROPHAGE MIGRATION-INHIBITORY FACTORS to search MACROPHAGE MIGRATION INHIBITORY FACTORS 1980-90 %26% MIGRATION INHIBITORY FACTOR 1974-79%A%  
% 224.82/224.99  |- skos__prefLabel mesh__D008263 Macrophage Migration-Inhibitory Factors
% 224.82/224.99  |- skos__altLabel mesh__D008263 Migration-Inhibitory Factor
% 224.82/224.99  |- skos__altLabel mesh__D008263 Migration Inhibition Factor
% 224.82/224.99  |- mesh__dateCreated mesh__D008263 1999-01-01
% 224.82/224.99  |- skos__hiddenLabel mesh__D008263 Migration-Inhibitory Factors, Macrophage
% 224.82/224.99  |- skos__broader mesh__D008263smesh__D008222
% 224.82/224.99  |- skos__hiddenLabel mesh__D008263 Macrophage Migration Inhibitory Factors
% 224.82/224.99  |- mesh__dateEstablished mesh__D008263 1974-01-01
% 224.82/224.99  |- skos__scopeNote mesh__D000280
% 224.82/224.99       The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract.%A%    
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D000280 2003
% 224.82/224.99  |- skos__historyNote mesh__D000280 Respiratory Therapy %28%1978-1986%29%
% 224.82/224.99  |- skos__altLabel mesh__D000280 Inhalation Drug Administration
% 224.82/224.99  |- skos__related mesh__D000280smesh__D000769
% 224.82/224.99  |- skos__altLabel mesh__D000280 Drug Administration, Respiratory
% 224.82/224.99  |- mesh__recordMaintainer mesh__D000280 adp
% 224.82/224.99  |- mesh__recordAuthorizer mesh__D000280 sjn
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D000280 2002
% 224.82/224.99  |- skos__altLabel mesh__D000280 Aerosol Therapy, Drug
% 224.82/224.99  |- mesh__activeMeSHYear mesh__D000280 2004
% 224.82/224.99  |- skos__historyNote mesh__D000280 Aerosols %28%1966-1986%29%
% 224.82/224.99  |- skos__annotation mesh__D000280
% 224.82/224.99       NIM but only if discussed: do not index here routinely for every drug admin by inhalation; no qualif%A%  
% 224.82/224.99  |- skos__altLabel mesh__D000280 Inhalation Administration
% 224.82/224.99  |- mesh__publicMeSHNote mesh__D000280 87   
% 224.82/224.99  |- skos__historyNote mesh__D000280 Respiration %28%1966-1986%29%
% 224.82/224.99  |- skos__altLabel mesh__D000280 Aerosol Drug Therapy
% 224.82/225.00  |- skos__broader mesh__D000280smesh__D004333
% 224.82/225.00  |- skos__hiddenLabel mesh__D000280 Therapy, Aerosol Drug
% 224.82/225.00  |- skos__related mesh__D000280smesh__D000281
% 224.82/225.00  |- skos__prefLabel mesh__D000280 Administration, Inhalation
% 224.82/225.00  |- skos__related mesh__D000280smesh__D009330
% 224.82/225.00  |- skos__hiddenLabel mesh__D000280 Administration, Respiratory Drug
% 224.82/225.00  |- rdf__type mesh__D000280sskos__Concept
% 224.82/225.00  |- skos__altLabel mesh__D000280 Drug Administration, Inhalation
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D000280 2000
% 224.82/225.00  |- mesh__dateRevised mesh__D000280 1999-11-03
% 224.82/225.00  |- skos__historyNote mesh__D000280 Lung %28%1966-1986%29%
% 224.82/225.00  |- skos__related mesh__D000280smesh__D000336
% 224.82/225.00  |- mesh__dateCreated mesh__D000280 1986-06-04
% 224.82/225.00  |- skos__hiddenLabel mesh__D000280 Therapy, Drug Aerosol
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D000280 2005
% 224.82/225.00  |- skos__altLabel mesh__D000280 Respiratory Drug Administration
% 224.82/225.00  |- skos__altLabel mesh__D000280 Drug Therapy, Aerosol
% 224.82/225.00  |- mesh__historyNote mesh__D000280 87   
% 224.82/225.00  |- skos__hiddenLabel mesh__D000280 Administration, Inhalation Drug
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D000280 2001
% 224.82/225.00  |- mesh__dateEstablished mesh__D000280 1987-01-01
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D000280 2006
% 224.82/225.00  |- mesh__recordOriginator mesh__D000280 SH
% 224.82/225.00  |- skos__related mesh__D000280smesh__D012138
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D007969 2006
% 224.82/225.00  |- skos__historyNote mesh__D007969 Encephalomalacia %28%1966-1986%29%
% 224.82/225.00  |- mesh__historyNote mesh__D007969 1991%28%1987%29%   
% 224.82/225.00  |- mesh__recordOriginator mesh__D007969 RC
% 224.82/225.00  |- skos__hiddenLabel mesh__D007969 Leukomalacia, Cystic Periventricular
% 224.82/225.00  |- rdf__type mesh__D007969sskos__Concept
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D007969 2005
% 224.82/225.00  |- skos__hiddenLabel mesh__D007969 Encephalomalacias, Periventricular
% 224.82/225.00  |- skos__historyNote mesh__D007969 Cerebral Hemorrhage %28%1966-1986%29%
% 224.82/225.00  |- skos__hiddenLabel mesh__D007969 Cerebral Leukomalacia, Neonatal
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D007969 2004
% 224.82/225.00  |- skos__hiddenLabel mesh__D007969 Leukomalacias, Periventricular
% 224.82/225.00  |- mesh__dateEstablished mesh__D007969 1991-01-01
% 224.82/225.00  |- skos__hiddenLabel mesh__D007969 Leukomalacia, Neonatal Cerebral
% 224.82/225.00  |- skos__hiddenLabel mesh__D007969 Periventricular Leukomalacias
% 224.82/225.00  |- skos__hiddenLabel mesh__D007969 Leucomalacias, Periventricular
% 224.82/225.00  |- skos__scopeNote mesh__D007969
% 224.82/225.00       Degeneration of white matter adjacent to the CEREBRAL VENTRICLES following cerebral hypoxia or BRAIN ISCHEMIA in neonates. The condition primarily affects white matter in the perfusion zone between superficial and deep branches of the MIDDLE CEREBRAL ARTERY. Clinical manifestations include VISION DISORDERS; CEREBRAL PALSY; PARAPLEGIA; SEIZURES; and cognitive disorders. %28%From Adams et al., Principles of Neurology, 6th ed, p1021; Joynt, Clinical Neurology, 1997, Ch4, pp30-1%29%%A%    
% 224.82/225.00  |- skos__hiddenLabel mesh__D007969 Periventricular Encephalomalacias
% 224.82/225.00  |- skos__historyNote mesh__D007969 Cerebral Ventricles %28%1966-1986%29%
% 224.82/225.00  |- skos__hiddenLabel mesh__D007969 Periventricular Encephalomalacia
% 224.82/225.00  |- skos__broader mesh__D007969smesh__D004678
% 224.82/225.00  |- skos__hiddenLabel mesh__D007969 Neonatal Cerebral Leukomalacias
% 224.82/225.00  |- skos__altLabel mesh__D007969 Leucomalacia, Periventricular
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D007969 2003
% 224.82/225.00  |- skos__altLabel mesh__D007969 Encephalomalacia, Periventricular
% 224.82/225.00  |- skos__prefLabel mesh__D007969 Leukomalacia, Periventricular
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D007969 2006A
% 224.82/225.00  |- skos__hiddenLabel mesh__D007969 Periventricular Leukomalacia, Cystic
% 224.82/225.00  |- skos__broader mesh__D007969smesh__D002561
% 224.82/225.00  |- skos__hiddenLabel mesh__D007969 Periventricular Leukomalacias, Cystic
% 224.82/225.00  |- skos__hiddenLabel mesh__D007969 Leukomalacias, Neonatal Cerebral
% 224.82/225.00  |- skos__hiddenLabel mesh__D007969 Leukomalacias, Cystic Periventricular
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D007969 2002
% 224.82/225.00  |- skos__broader mesh__D007969smesh__D007235
% 224.82/225.00  |- mesh__dateCreated mesh__D007969 1986-06-16
% 224.82/225.00  |- mesh__dateRevised mesh__D007969 2005-07-12
% 224.82/225.00  |- skos__annotation mesh__D007969
% 224.82/225.00       periventricular refers to the cerebral ventricles   
% 224.82/225.00  |- skos__historyNote mesh__D007969
% 224.82/225.00       Infant, Premature, Diseases %28%1966-1986%29%
% 224.82/225.00  |- mesh__publicMeSHNote mesh__D007969 1991; see ENCEPHALOMALACIA 1987-90   
% 224.82/225.00  |- skos__hiddenLabel mesh__D007969 Cerebral Leukomalacias, Neonatal
% 224.82/225.00  |- mesh__recordMaintainer mesh__D007969 ags
% 224.82/225.00  |- skos__hiddenLabel mesh__D007969 Periventricular Leucomalacia
% 224.82/225.00  |- mesh__recordAuthorizer mesh__D007969 ags
% 224.82/225.00  |- skos__historyNote mesh__D007969 Infant, Newborn %28%1966-1986%29%
% 224.82/225.00  |- skos__altLabel mesh__D007969 Periventricular Leukomalacia
% 224.82/225.00  |- skos__hiddenLabel mesh__D007969 Cystic Periventricular Leukomalacias
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D007969 2001
% 224.82/225.00  |- skos__hiddenLabel mesh__D007969 Periventricular Leucomalacias
% 224.82/225.00  |- skos__altLabel mesh__D018691 Amino Acids, Excitatory, Antagonists
% 224.82/225.00  |- mesh__historyNote mesh__D018691 95   
% 224.82/225.00  |- mesh__dateRevised mesh__D018691 2005-06-30
% 224.82/225.00  |- skos__broader mesh__D018691smesh__D018683
% 224.82/225.00  |- skos__hiddenLabel mesh__D018691 Antagonists, Glutamate Receptor
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D018691 2006
% 224.82/225.00  |- mesh__dateEstablished mesh__D018691 1995-01-01
% 224.82/225.00  |- skos__historyNote mesh__D018691
% 224.82/225.00       Glutamates/antagonists %26% inhibitors %28%1968-1994%29%
% 224.82/225.00  |- skos__scopeNote mesh__D018691
% 224.82/225.00       Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists.%A%    
% 224.82/225.00  |- mesh__publicMeSHNote mesh__D018691 95   
% 224.82/225.00  |- skos__hiddenLabel mesh__D018691 Receptor Antagonists, Glutamate
% 224.82/225.00  |- skos__altLabel mesh__D018691 EAA Antagonists
% 224.82/225.00  |- skos__prefLabel mesh__D018691 Excitatory Amino Acid Antagonists
% 224.82/225.00  |- mesh__recordAuthorizer mesh__D018691 sjn
% 224.82/225.00  |- mesh__recordMaintainer mesh__D018691 ssb
% 224.82/225.00  |- mesh__dateCreated mesh__D018691 1994-06-03
% 224.82/225.00  |- rdf__type mesh__D018691sskos__Concept
% 224.82/225.00  |- skos__altLabel mesh__D018691 Glutamate Receptor Antagonists
% 224.82/225.00  |- skos__hiddenLabel mesh__D018691 Antagonists, EAA
% 224.82/225.00  |- skos__annotation mesh__D018691
% 224.82/225.00       GEN or unspecified; prefer specifics; DF: EAA ANTAG   
% 224.82/225.00  |- skos__hiddenLabel mesh__D018691 Antagonists, Glutamate
% 224.82/225.00  |- skos__altLabel mesh__D018691 Antagonists, Excitatory Amino Acid
% 224.82/225.00  |- skos__altLabel mesh__D018691 Glutamate Antagonists
% 224.82/225.00  |- mesh__recordOriginator mesh__D018691 RAZ
% 224.82/225.00  |- skos__altLabel mesh__D018691 Amino Acid Antagonists, Excitatory
% 224.82/225.00  |- rdf__type mesh__D032362sskos__Concept
% 224.82/225.00  |- mesh__historyNote mesh__D032362 2003   
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D032362 2003
% 224.82/225.00  |- mesh__dateEstablished mesh__D032362 2003-01-01
% 224.82/225.00  |- mesh__dateCreated mesh__D032362 2002-07-03
% 224.82/225.00  |- skos__prefLabel mesh__D032362 Styrax
% 224.82/225.00  |- skos__scopeNote mesh__D032362
% 224.82/225.00       A plant genus of the family STYRACACEAE. Sap of these Asian trees are a source of a balsam %28%BALSAMS%29%. This styrax balsam is 3/4 coniferyl benzoate, 1/8 free BENZOIC ACID, along with benzyl cinnamate, vanillin, and TRITERPENES.%A%    
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D032362 2006
% 224.82/225.00  |- skos__broader mesh__D032362smesh__D029644
% 224.82/225.00  |- skos__annotation mesh__D032362
% 224.82/225.00       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D032362 2005
% 224.82/225.00  |- mesh__publicMeSHNote mesh__D032362 2003   
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D032362 2004
% 224.82/225.00  |- skos__hiddenLabel mesh__D004671 Encephalitides, Arbovirus
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D004671 2005
% 224.82/225.00  |- skos__hiddenLabel mesh__D004671 Arthropod Borne Viral Encephalitis
% 224.82/225.00  |- mesh__recordMaintainer mesh__D004671 jls
% 224.82/225.00  |- skos__altLabel mesh__D004671 Encephalitis, Arthropod-Borne
% 224.82/225.00  |- skos__altLabel mesh__D004671 Epidemic Encephalitis
% 224.82/225.00  |- skos__hiddenLabel mesh__D004671 Arthropod-Borne Encephalitides
% 224.82/225.00  |- skos__hiddenLabel mesh__D004671 Encephalitis, Arthropod-Borne Viral
% 224.82/225.00  |- skos__hiddenLabel mesh__D004671 Encephalitides, Arthropod-Borne Viral
% 224.82/225.00  |- skos__hiddenLabel mesh__D004671 Encephalitides, Mosquito-Borne
% 224.82/225.00  |- skos__broader mesh__D004671smesh__D001102
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D004671 2000
% 224.82/225.00  |- rdf__type mesh__D004671sskos__Concept
% 224.82/225.00  |- skos__scopeNote mesh__D004671
% 224.82/225.00       Infections of the brain caused by arthropod-borne viruses %28%i.e., arboviruses%29% primarily from the families TOGAVIRIDAE; FLAVIVIRIDAE; BUNYAVIRIDAE; REOVIRIDAE; and RHABDOVIRIDAE. Life cycles of these viruses are characterized by ZOONOSES, with birds and lower mammals serving as intermediate hosts. The virus is transmitted to humans by the bite of mosquitoes %28%CULICIDAE%29% or TICKS. Clinical manifestations include fever, headache, alterations of mentation, focal neurologic deficits, and COMA. %28%From Clin Microbiol Rev 1994 Jan;7%28%1%29%:89-116; Walton, Brain%27%s Diseases of the Nervous System, 10th ed, p321%29%%A%    
% 224.82/225.00  |- skos__altLabel mesh__D004671 Encephalitis, Epidemic
% 224.82/225.00  |- mesh__dateCreated mesh__D004671 1999-01-01
% 224.82/225.00  |- mesh__recordOriginator mesh__D004671 NLM
% 224.82/225.00  |- skos__hiddenLabel mesh__D004671 Arthropod Borne Encephalitis
% 224.82/225.00  |- skos__broader mesh__D004671smesh__D018792
% 224.82/225.00  |- skos__altLabel mesh__D004671 Arthropod-Borne Viral Encephalitis
% 224.82/225.00  |- skos__hiddenLabel mesh__D004671 Encephalitides, Epidemic
% 224.82/225.00  |- skos__hiddenLabel mesh__D004671 Encephalitides, Arthropod-Borne
% 224.82/225.00  |- skos__hiddenLabel mesh__D004671 Encephalitis, Arthropod Borne
% 224.82/225.00  |- skos__annotation mesh__D004671
% 224.82/225.00       caused by ENCEPHALITIS VIRUSES: despite X REF not an %22%epidemic of encephalitis%22%; GEN or unspecified; prefer specifics; DF: ENCEPH ARBOVIRUS%A%  
% 224.82/225.00  |- skos__prefLabel mesh__D004671 Encephalitis, Arbovirus
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D004671 2004
% 224.82/225.00  |- skos__hiddenLabel mesh__D004671 Arbovirus Encephalitides
% 224.82/225.00  |- mesh__publicMeSHNote mesh__D004671
% 224.82/225.00       2000; see ENCEPHALITIS, EPIDEMIC 1966-1999   
% 224.82/225.00  |- mesh__dateRevised mesh__D004671 2004-07-22
% 224.82/225.00  |- skos__hiddenLabel mesh__D004671 Viral Encephalitides, Arthropod-Borne
% 224.82/225.00  |- skos__altLabel mesh__D004671 Arthropod-Borne Encephalitis
% 224.82/225.00  |- skos__broader mesh__D004671smesh__D012327
% 224.82/225.00  |- skos__hiddenLabel mesh__D004671 Arbovirus Encephalitis
% 224.82/225.00  |- mesh__recordAuthorizer mesh__D004671 jls
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D004671 2002
% 224.82/225.00  |- mesh__historyNote mesh__D004671 2000   
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D004671 2003
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D004671 2006
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D004671 2005A
% 224.82/225.00  |- skos__hiddenLabel mesh__D004671 Epidemic Encephalitides
% 224.82/225.00  |- skos__hiddenLabel mesh__D004671 Mosquito Borne Encephalitis
% 224.82/225.00  |- skos__hiddenLabel mesh__D004671 Viral Encephalitis, Arthropod Borne
% 224.82/225.00  |- skos__altLabel mesh__D004671 Viral Encephalitis, Arthropod-Borne
% 224.82/225.00  |- skos__altLabel mesh__D004671 Encephalitis, Mosquito-Borne
% 224.82/225.00  |- skos__hiddenLabel mesh__D004671 Encephalitis, Mosquito Borne
% 224.82/225.00  |- skos__hiddenLabel mesh__D004671 Arthropod-Borne Viral Encephalitides
% 224.82/225.00  |- skos__hiddenLabel mesh__D004671 Mosquito-Borne Encephalitides
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D004671 2001
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D004671 2000A
% 224.82/225.00  |- skos__historyNote mesh__D012305 Race Relations %28%1968%29%
% 224.82/225.00  |- skos__historyNote mesh__D012305
% 224.82/225.00       Emergency Service, Hospital %28%1966-1968%29%
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D012305 2005
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D012305 1997
% 224.82/225.00  |- skos__prefLabel mesh__D012305 Riots
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D012305 2001
% 224.82/225.00  |- skos__hiddenLabel mesh__D012305 Riot
% 224.82/225.00  |- skos__broader mesh__D012305smesh__D002960
% 224.82/225.00  |- skos__scopeNote mesh__D012305
% 224.82/225.00       A form of violent crowd behavior which expresses the emotional release of resentments and prejudices, usually relevant to grievances toward the social system.%A%    
% 224.82/225.00  |- skos__historyNote mesh__D012305 Social Problems %28%1968%29%
% 224.82/225.00  |- mesh__publicMeSHNote mesh__D012305 70   
% 224.82/225.00  |- rdf__type mesh__D012305sskos__Concept
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D012305 2006
% 224.82/225.00  |- mesh__dateEstablished mesh__D012305 1970-01-01
% 224.82/225.00  |- mesh__recordOriginator mesh__D012305 NLM
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D012305 1994
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D012305 2003
% 224.82/225.00  |- mesh__historyNote mesh__D012305 70%28%69%29%   
% 224.82/225.00  |- skos__related mesh__D012305smesh__D014754
% 224.82/225.00  |- skos__historyNote mesh__D012305 Social Conditions %28%1966-1968%29%
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D012305 1998
% 224.82/225.00  |- mesh__recordMaintainer mesh__D012305 PLS
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D012305 2002
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D012305 1995
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D012305 2004
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D012305 1999
% 224.82/225.00  |- mesh__dateRevised mesh__D012305 1993-06-05
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D012305 1996
% 224.82/225.00  |- mesh__recordAuthorizer mesh__D012305 NLM
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D012305 2000
% 224.82/225.00  |- mesh__dateCreated mesh__D012305 1999-01-01
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D017599 2003
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D017599 1998
% 224.82/225.00  |- mesh__recordMaintainer mesh__D017599 KEV
% 224.82/225.00  |- mesh__recordAuthorizer mesh__D017599 PLS
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D017599 1997
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D017599 2001
% 224.82/225.00  |- mesh__dateRevised mesh__D017599 1995-06-08
% 224.82/225.00  |- mesh__historyNote mesh__D017599 94   
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D017599 1996
% 224.82/225.00  |- skos__hiddenLabel mesh__D017599 Neuroectodermal Tumor
% 224.82/225.00  |- mesh__dateEstablished mesh__D017599 1994-01-01
% 224.82/225.00  |- mesh__publicMeSHNote mesh__D017599 94   
% 224.82/225.00  |- mesh__recordOriginator mesh__D017599 TGC
% 224.82/225.00  |- skos__broader mesh__D017599smesh__D009373
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D017599 2000
% 224.82/225.00  |- mesh__dateCreated mesh__D017599 1993-06-03
% 224.82/225.00  |- rdf__type mesh__D017599sskos__Concept
% 224.82/225.00  |- skos__annotation mesh__D017599
% 224.82/225.00       /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D017599 2006
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D017599 2002
% 224.82/225.00  |- skos__broader mesh__D017599smesh__D009380
% 224.82/225.00  |- skos__hiddenLabel mesh__D017599 Tumor, Neuroectodermal
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D017599 2005
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D017599 2004
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D017599 1999
% 224.82/225.00  |- skos__scopeNote mesh__D017599
% 224.82/225.00       Malignant neoplasms arising in the neuroectoderm, the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems, including some glial cells.%A%    
% 224.82/225.00  |- skos__hiddenLabel mesh__D017599 Tumors, Neuroectodermal
% 224.82/225.00  |- skos__prefLabel mesh__D017599 Neuroectodermal Tumors
% 224.82/225.00  |- skos__historyNote mesh__D003579 Oxidoreductases %28%1966-1972%29%
% 224.82/225.00  |- rdf__type mesh__D003579sskos__Concept
% 224.82/225.00  |- mesh__recordOriginator mesh__D003579 NLM
% 224.82/225.00  |- mesh__publicMeSHNote mesh__D003579 74   
% 224.82/225.00  |- mesh__dateEstablished mesh__D003579 1974-01-01
% 224.82/225.00  |- mesh__dateRevised mesh__D003579 2003-07-09
% 224.82/225.00  |- mesh__recordMaintainer mesh__D003579 ssb
% 224.82/225.00  |- mesh__historyNote mesh__D003579 74%28%73%29%   
% 224.82/225.00  |- skos__hiddenLabel mesh__D003579 Reductases, Cytochrome
% 224.82/225.00  |- skos__prefLabel mesh__D003579 Cytochrome Reductases
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D003579 2005
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D003579 2004
% 224.82/225.00  |- mesh__recordAuthorizer mesh__D003579 sjn
% 224.82/225.00  |- skos__broader mesh__D003579smesh__D009247
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D003579 2006
% 224.82/225.00  |- mesh__dateCreated mesh__D003579 1999-01-01
% 224.82/225.00  |- skos__altLabel mesh__D008264 Bone Marrow-Derived Macrophages
% 224.82/225.00  |- mesh__dateCreated mesh__D008264 1999-01-01
% 224.82/225.00  |- skos__broader mesh__D008264smesh__D009000
% 224.82/225.00  |- skos__related mesh__D008264smesh__D010587
% 224.82/225.00  |- skos__broader mesh__D008264smesh__D012157
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D008264 2006
% 224.82/225.00  |- skos__hiddenLabel mesh__D008264 Bone Marrow Derived Macrophages
% 224.82/225.00  |- skos__hiddenLabel mesh__D008264 Macrophages, Bone Marrow-Derived
% 224.82/225.00  |- skos__hiddenLabel mesh__D008264 Monocyte-Derived Macrophage
% 224.82/225.00  |- skos__broader mesh__D008264smesh__D003239
% 224.82/225.00  |- skos__hiddenLabel mesh__D008264 Bone Marrow-Derived Macrophage
% 224.82/225.00  |- skos__hiddenLabel mesh__D008264 Macrophage, Bone Marrow-Derived
% 224.82/225.00  |- skos__hiddenLabel mesh__D008264 Macrophages, Monocyte Derived
% 224.82/225.00  |- skos__prefLabel mesh__D008264 Macrophages
% 224.82/225.00  |- skos__altLabel mesh__D008264 Macrophage
% 224.82/225.00  |- skos__altLabel mesh__D008264 Macrophages, Monocyte-Derived
% 224.82/225.00  |- rdf__type mesh__D008264sskos__Concept
% 224.82/225.00  |- skos__scopeNote mesh__D008264
% 224.82/225.00       The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. %28%from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.%29%%A%    
% 224.82/225.00  |- mesh__recordMaintainer mesh__D008264 ags
% 224.82/225.00  |- mesh__dateRevised mesh__D008264 2005-06-30
% 224.82/225.00  |- skos__altLabel mesh__D008264 Monocyte-Derived Macrophages
% 224.82/225.00  |- skos__hiddenLabel mesh__D008264 Monocyte Derived Macrophages
% 224.82/225.00  |- skos__hiddenLabel mesh__D008264 Macrophage, Monocyte-Derived
% 224.82/225.00  |- mesh__recordAuthorizer mesh__D008264 sjn
% 224.82/225.00  |- mesh__recordOriginator mesh__D008264 NLM
% 224.82/225.00  |- skos__broader mesh__D008264smesh__D010586
% 224.82/225.00  |- mesh__publicMeSHNote mesh__D000281 73   
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D000281 2004
% 224.82/225.00  |- skos__broader mesh__D000281smesh__D000287
% 224.82/225.00  |- skos__related mesh__D000281smesh__D000280
% 224.82/225.00  |- skos__hiddenLabel mesh__D000281 Administrations, Intranasal
% 224.82/225.00  |- skos__hiddenLabel mesh__D000281 Intranasal Drug Administrations
% 224.82/225.00  |- skos__hiddenLabel mesh__D000281 Administrations, Intranasal Drug
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D000281 2001
% 224.82/225.00  |- skos__altLabel mesh__D000281 Intranasal Administration
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D000281 2006
% 224.82/225.00  |- mesh__dateRevised mesh__D000281 1999-11-03
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D000281 2003
% 224.82/225.00  |- skos__related mesh__D000281smesh__D009330
% 224.82/225.00  |- skos__altLabel mesh__D000281 Administration, Intranasal Drug
% 224.82/225.00  |- mesh__recordOriginator mesh__D000281 NLM
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D000281 2000
% 224.82/225.00  |- mesh__recordMaintainer mesh__D000281 adp
% 224.82/225.00  |- skos__altLabel mesh__D000281 Intranasal Drug Administration
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D000281 2005
% 224.82/225.00  |- skos__historyNote mesh__D000281
% 224.82/225.00       specific drug/administration %26% dosage %28%1966-1972%29%
% 224.82/225.00  |- rdf__type mesh__D000281sskos__Concept
% 224.82/225.00  |- skos__scopeNote mesh__D000281
% 224.82/225.00       The administration of drugs through the nasal passage.     
% 224.82/225.00  |- mesh__recordAuthorizer mesh__D000281 sjn
% 224.82/225.00  |- skos__altLabel mesh__D000281 Drug Administration, Intranasal
% 224.82/225.00  |- skos__broader mesh__D000281smesh__D004333
% 224.82/225.00  |- mesh__dateCreated mesh__D000281 1999-01-01
% 224.82/225.00  |- skos__hiddenLabel mesh__D000281 Intranasal Administrations
% 224.82/225.00  |- skos__hiddenLabel mesh__D000281 Drug Administrations, Intranasal
% 224.82/225.00  |- mesh__dateEstablished mesh__D000281 1973-01-01
% 224.82/225.00  |- skos__prefLabel mesh__D000281 Administration, Intranasal
% 224.82/225.00  |- mesh__historyNote mesh__D000281 73   
% 224.82/225.00  |- mesh__activeMeSHYear mesh__D000281 2002
% 224.82/225.00  |- skos__scopeNote mesh__D018692
% 224.82/225.00       Agents that are used to treat bipolar disorders or mania associated with other affective disorders.%A%    
% 224.82/225.00  |- skos__altLabel mesh__D018692 Antimanics
% 224.82/225.00  |- mesh__dateRevised mesh__D018692 2005-06-30
% 224.82/225.00  |- skos__historyNote mesh__D018692
% 224.82/225.00       Bipolar Disorder/drug therapy %28%1966-1994%29%
% 224.82/225.00  |- mesh__recordOriginator mesh__D018692 TPW
% 224.82/225.00  |- rdf__type mesh__D018692sskos__Concept
% 224.82/225.00  |- skos__altLabel mesh__D018692 Antimanic Drugs
% 224.82/225.00  |- mesh__dateEstablished mesh__D018692 1995-01-01
% 224.82/225.00  |- skos__historyNote mesh__D018692 Antidepressive Agents %28%1966-1994%29%
% 224.82/225.00  |- mesh__publicMeSHNote mesh__D018692 95   
% 224.82/225.00  |- skos__annotation mesh__D018692
% 224.82/225.00       tranquilizing agents; consider also BIPOLAR DISORDER /drug ther%A%  
% 224.82/225.00  |- skos__broader mesh__D018692smesh__D014149
% 224.82/225.00  |- skos__hiddenLabel mesh__D018692 Drugs, Antimanic
% 224.82/225.00  |- mesh__recordAuthorizer mesh__D018692 sjn
% 224.82/225.01  |- skos__hiddenLabel mesh__D018692 Agents, Antimanic
% 224.82/225.01  |- mesh__recordMaintainer mesh__D018692 ssb
% 224.82/225.01  |- mesh__dateCreated mesh__D018692 1994-06-03
% 224.82/225.01  |- mesh__historyNote mesh__D018692 95   
% 224.82/225.01  |- skos__prefLabel mesh__D018692 Antimanic Agents
% 224.82/225.01  |- skos__historyNote mesh__D018692
% 224.82/225.01       Bipolar Disorder/prevention %26% control %28%1968-1994%29%
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D018692 2006
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D032363 2003
% 224.82/225.01  |- skos__altLabel mesh__D032363 Tamarisk
% 224.82/225.01  |- skos__broader mesh__D032363smesh__D019684
% 224.82/225.01  |- skos__prefLabel mesh__D032363 Tamaricaceae
% 224.82/225.01  |- mesh__historyNote mesh__D032363 2003   
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D032363 2006
% 224.82/225.01  |- mesh__dateEstablished mesh__D032363 2003-01-01
% 224.82/225.01  |- skos__annotation mesh__D032363
% 224.82/225.01       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.82/225.01  |- mesh__dateCreated mesh__D032363 2002-07-03
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D032363 2005
% 224.82/225.01  |- mesh__publicMeSHNote mesh__D032363 2003   
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D032363 2004
% 224.82/225.01  |- skos__scopeNote mesh__D032363
% 224.82/225.01       A plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida.%A%    
% 224.82/225.01  |- rdf__type mesh__D032363sskos__Concept
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D004672 2000
% 224.82/225.01  |- mesh__recordAuthorizer mesh__D004672 sjn
% 224.82/225.01  |- skos__scopeNote mesh__D004672
% 224.82/225.01       A mosquito-borne encephalitis caused by the Japanese B encephalitis virus %28%ENCEPHALITIS VIRUS, JAPANESE%29% occurring throughout Eastern Asia and Australia. The majority of infections occur in children and are subclinical or have features limited to transient fever and gastrointestinal symptoms. Inflammation of the brain, spinal cord, and meninges may occur and lead to transient or permanent neurologic deficits %28%including a POLIOMYELITIS-like presentation%29%; SEIZURES; COMA; and death. %28%From Adams et al., Principles of Neurology, 6th ed, p751; Lancet 1998 Apr 11;351%28%9109%29%:1094-7%29%%A%    
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D004672 2004
% 224.82/225.01  |- skos__prefLabel mesh__D004672 Encephalitis, Japanese
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D004672 2006
% 224.82/225.01  |- mesh__historyNote mesh__D004672
% 224.82/225.01       94; was ENCEPHALITIS, JAPANESE B 1963-93   
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D004672 2003
% 224.82/225.01  |- skos__annotation mesh__D004672
% 224.82/225.01       for encephalitis caused by Japanese B encephalitis virus only not ENCEPHALITIS VIRUSES, JAPANESE: see annotation there; DF: ENCEPH JAPANESE%A%  
% 224.82/225.01  |- skos__altLabel mesh__D004672 Japanese Encephalitis
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D004672 2005
% 224.82/225.01  |- mesh__dateRevised mesh__D004672 1999-11-03
% 224.82/225.01  |- skos__altLabel mesh__D004672 Japanese B Encephalitis
% 224.82/225.01  |- mesh__recordMaintainer mesh__D004672 KEV
% 224.82/225.01  |- mesh__recordOriginator mesh__D004672 NLM
% 224.82/225.01  |- rdf__type mesh__D004672sskos__Concept
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D004672 2002
% 224.82/225.01  |- mesh__publicMeSHNote mesh__D004672
% 224.82/225.01       94; was ENCEPHALITIS, JAPANESE B 1963-93   
% 224.82/225.01  |- mesh__onlineNote mesh__D004672
% 224.82/225.01       use ENCEPHALITIS, JAPANESE to search ENCEPHALITIS, JAPANESE B 1966-93%A%  
% 224.82/225.01  |- skos__altLabel mesh__D004672 Viral Encephalitis, Japanese B
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D004672 2001
% 224.82/225.01  |- skos__broader mesh__D004672smesh__D004671
% 224.82/225.01  |- skos__altLabel mesh__D004672 Encephalitis, Japanese B
% 224.82/225.01  |- skos__broader mesh__D004672smesh__D018177
% 224.82/225.01  |- skos__altLabel mesh__D004672 Japanese B Viral Encephalitis
% 224.82/225.01  |- mesh__dateCreated mesh__D004672 1999-01-01
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D012306 2006
% 224.82/225.01  |- rdf__type mesh__D012306sskos__Concept
% 224.82/225.01  |- skos__hiddenLabel mesh__D012306 Risk, Relative
% 224.82/225.01  |- skos__related mesh__D012306smesh__D040242
% 224.82/225.01  |- mesh__publicMeSHNote mesh__D012306
% 224.82/225.01       88; was see under PROBABILITY 1973-87   
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D012306 2003
% 224.82/225.01  |- skos__scopeNote mesh__D012306
% 224.82/225.01       The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome.%A%    
% 224.82/225.01  |- mesh__recordMaintainer mesh__D012306 jls
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D012306 2004
% 224.82/225.01  |- skos__broader mesh__D012306smesh__D011336
% 224.82/225.01  |- mesh__onlineNote mesh__D012306 search PROBABILITY 1973-74   
% 224.82/225.01  |- skos__hiddenLabel mesh__D012306 Risks, Relative
% 224.82/225.01  |- skos__annotation mesh__D012306
% 224.82/225.01       IM GEN only; for risk as a statis concept; note other risk terms in MeSH%A%  
% 224.82/225.01  |- skos__related mesh__D012306smesh__D040261
% 224.82/225.01  |- mesh__dateEstablished mesh__D012306 1988-01-01
% 224.82/225.01  |- skos__prefLabel mesh__D012306 Risk
% 224.82/225.01  |- mesh__recordAuthorizer mesh__D012306 sjn
% 224.82/225.01  |- mesh__recordOriginator mesh__D012306 NLM
% 224.82/225.01  |- skos__hiddenLabel mesh__D012306 Relative Risks
% 224.82/225.01  |- mesh__dateRevised mesh__D012306 2002-07-03
% 224.82/225.01  |- skos__hiddenLabel mesh__D012306 Risks
% 224.82/225.01  |- mesh__dateCreated mesh__D012306 1999-01-01
% 224.82/225.01  |- mesh__historyNote mesh__D012306
% 224.82/225.01       88%28%75%29%; was see under PROBABILITY 1973-87   
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D012306 2005
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D008265 2006
% 224.82/225.01  |- skos__broader mesh__D008265smesh__D009056
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D008265 2000
% 224.82/225.01  |- mesh__publicMeSHNote mesh__D008265 65   
% 224.82/225.01  |- mesh__recordOriginator mesh__D008265 NLM
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D008265 2005
% 224.82/225.01  |- rdf__type mesh__D008265sskos__Concept
% 224.82/225.01  |- skos__annotation mesh__D008265
% 224.82/225.01       overwide mouth; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 224.82/225.01  |- skos__hiddenLabel mesh__D008265 Macrostomias
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D008265 2002
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D008265 2004
% 224.82/225.01  |- mesh__dateEstablished mesh__D008265 1965-01-01
% 224.82/225.01  |- mesh__historyNote mesh__D008265 65   
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D008265 2003
% 224.82/225.01  |- mesh__recordMaintainer mesh__D008265 kle
% 224.82/225.01  |- mesh__dateRevised mesh__D008265 1999-11-03
% 224.82/225.01  |- skos__scopeNote mesh__D008265
% 224.82/225.01       Greatly exaggerated width of the mouth, resulting from failure of union of the maxillary and mandibular processes, with extension of the oral orifice toward the ear. The defect may be unilateral or bilateral. %28%Dorland, 27th ed%29%%A%    
% 224.82/225.01  |- skos__prefLabel mesh__D008265 Macrostomia
% 224.82/225.01  |- mesh__dateCreated mesh__D008265 1999-01-01
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D008265 2001
% 224.82/225.01  |- mesh__recordAuthorizer mesh__D008265 sjn
% 224.82/225.01  |- skos__related mesh__D000282smesh__D014622
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000282 1997
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000282 2006
% 224.82/225.01  |- mesh__recordOriginator mesh__D000282 SH
% 224.82/225.01  |- skos__annotation mesh__D000282
% 224.82/225.01       NIM but only if discussed: do not index here routinely for every intravaginally administered drug; no qualif%A%  
% 224.82/225.01  |- skos__altLabel mesh__D000282 Administration, Vaginal
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000282 2003
% 224.82/225.01  |- skos__historyNote mesh__D000282
% 224.82/225.01       Vaginal Creams, Foams and Jellies %28%1975-1986%29%
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000282 1991
% 224.82/225.01  |- skos__hiddenLabel mesh__D000282 Vaginal Administrations
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000282 1992
% 224.82/225.01  |- skos__hiddenLabel mesh__D000282 Vaginal Instillations
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000282 2004
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000282 1994
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000282 1993
% 224.82/225.01  |- skos__historyNote mesh__D000282
% 224.82/225.01       Administration, Topical %28%1974-1986%29%
% 224.82/225.01  |- skos__hiddenLabel mesh__D000282 Intravaginal Administrations
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000282 1998
% 224.82/225.01  |- skos__altLabel mesh__D000282 Intravaginal Administration
% 224.82/225.01  |- mesh__recordMaintainer mesh__D000282 PLS
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000282 1995
% 224.82/225.01  |- mesh__dateRevised mesh__D000282 1991-11-02
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000282 2000
% 224.82/225.01  |- skos__hiddenLabel mesh__D000282 Drug Administrations, Vaginal
% 224.82/225.01  |- skos__hiddenLabel mesh__D000282 Instillations, Vaginal
% 224.82/225.01  |- skos__altLabel mesh__D000282 Vaginal Administration
% 224.82/225.01  |- skos__hiddenLabel mesh__D000282 Administrations, Intravaginal
% 224.82/225.01  |- skos__hiddenLabel mesh__D000282 Vaginal Drug Administrations
% 224.82/225.01  |- skos__hiddenLabel mesh__D000282 Administration, Vaginal Drug
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000282 1999
% 224.82/225.01  |- skos__hiddenLabel mesh__D000282 Vaginal Instillation
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000282 2001
% 224.82/225.01  |- rdf__type mesh__D000282sskos__Concept
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000282 1996
% 224.82/225.01  |- skos__prefLabel mesh__D000282 Administration, Intravaginal
% 224.82/225.01  |- skos__hiddenLabel mesh__D000282 Administrations, Vaginal
% 224.82/225.01  |- skos__broader mesh__D000282smesh__D000287
% 224.82/225.01  |- mesh__dateCreated mesh__D000282 1986-06-04
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000282 2005
% 224.82/225.01  |- skos__hiddenLabel mesh__D000282 Administrations, Vaginal Drug
% 224.82/225.01  |- mesh__dateEstablished mesh__D000282 1990-01-01
% 224.82/225.01  |- skos__altLabel mesh__D000282 Vaginal Drug Administration
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000282 1990
% 224.82/225.01  |- skos__scopeNote mesh__D000282
% 224.82/225.01       The insertion of drugs into the vagina to treat local infections, neoplasms, or to induce labor. The dosage forms may include medicated pessaries, irrigation fluids, and suppositories.%A%    
% 224.82/225.01  |- skos__historyNote mesh__D000282 Vagina %28%1966-1986%29%
% 224.82/225.01  |- mesh__publicMeSHNote mesh__D000282
% 224.82/225.01       90; was see under ADMINISTRATION, TOPICAL 1987-89   
% 224.82/225.01  |- skos__altLabel mesh__D000282 Drug Administration, Vaginal
% 224.82/225.01  |- mesh__recordAuthorizer mesh__D000282 PLS
% 224.82/225.01  |- mesh__historyNote mesh__D000282
% 224.82/225.01       90%28%87%29%; was see under ADMINISTRATION, TOPICAL 1987-89   
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000282 2002
% 224.82/225.01  |- skos__broader mesh__D032364smesh__D029645
% 224.82/225.01  |- skos__scopeNote mesh__D032364
% 224.82/225.01       A plant genus of the family THYMELAEACEAE. They are evergreen shrubs much cultivated in garden borders and rock gardens in mild climates. Members contain mezerein, flavonoids, and COUMARINS such as daphnetin and daphnin.%A%    
% 224.82/225.01  |- skos__annotation mesh__D032364
% 224.82/225.01       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.82/225.01  |- skos__prefLabel mesh__D032364 Daphne
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D032364 2005
% 224.82/225.01  |- mesh__publicMeSHNote mesh__D032364 2003   
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D032364 2004
% 224.82/225.01  |- rdf__type mesh__D032364sskos__Concept
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D032364 2003
% 224.82/225.01  |- mesh__dateEstablished mesh__D032364 2003-01-01
% 224.82/225.01  |- mesh__historyNote mesh__D032364 2003   
% 224.82/225.01  |- mesh__dateCreated mesh__D032364 2002-07-03
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D032364 2006
% 224.82/225.01  |- skos__hiddenLabel mesh__D004673 Post Vaccinal Encephalomyelitis
% 224.82/225.01  |- skos__broader mesh__D004673smesh__D020278
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D004673 2000A
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D004673 2005
% 224.82/225.01  |- skos__hiddenLabel mesh__D004673 Encephalitis, Post Vaccinal
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D004673 2000
% 224.82/225.01  |- skos__hiddenLabel mesh__D004673 Encephalomyelitides, Post-Vaccinal
% 224.82/225.01  |- skos__scopeNote mesh__D004673
% 224.82/225.01       An acute or subacute inflammatory process of the CENTRAL NERVOUS SYSTEM characterized histologically by multiple foci of perivascular demyelination. Symptom onset usually occurs several days after an acute viral infection or immunization, but it may coincide with the onset of infection or rarely no antecedent event can be identified. Clinical manifestations include CONFUSION, somnolence, FEVER, nuchal rigidity, and involuntary movements. The illness may progress to COMA and eventually be fatal. %28%Adams et al., Principles of Neurology, 6th ed, p921%29%%A%    
% 224.82/225.01  |- skos__altLabel mesh__D004673 Encephalitis, Vaccination
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D004673 2006
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D004673 2001
% 224.82/225.01  |- skos__altLabel mesh__D004673 Post-Vaccinal Encephalitis
% 224.82/225.01  |- skos__altLabel mesh__D004673 Postvaccinal Encephalitis
% 224.82/225.01  |- skos__hiddenLabel mesh__D004673 Post-Vaccinal Encephalomyelitides
% 224.82/225.01  |- skos__altLabel mesh__D004673 Post-Vaccinal Encephalomyelitis
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D004673 2003
% 224.82/225.01  |- mesh__recordAuthorizer mesh__D004673 ags
% 224.82/225.01  |- skos__hiddenLabel mesh__D004673 Disseminated Encephalomyelitides, Acute
% 224.82/225.01  |- skos__altLabel mesh__D004673 Postexanthem Encephalomyelitis
% 224.82/225.01  |- skos__hiddenLabel mesh__D004673 Post Vaccinal Encephalitis
% 224.82/225.01  |- skos__altLabel mesh__D004673 Encephalitis, Postvaccinal
% 224.82/225.01  |- skos__hiddenLabel mesh__D004673 Encephalomyelitides, Acute Disseminated
% 224.82/225.01  |- mesh__recordMaintainer mesh__D004673 ags
% 224.82/225.01  |- skos__altLabel mesh__D004673 Vaccination Encephalitis
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D004673 2002
% 224.82/225.01  |- mesh__recordOriginator mesh__D004673 NLM
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D004673 2004
% 224.82/225.01  |- skos__altLabel mesh__D004673 Encephalomyelitis, Postinfectious
% 224.82/225.01  |- skos__hiddenLabel mesh__D004673 Encephalitides, Post-Vaccinal
% 224.82/225.01  |- rdf__type mesh__D004673sskos__Concept
% 224.82/225.01  |- skos__prefLabel mesh__D004673 Encephalomyelitis, Acute Disseminated
% 224.82/225.01  |- mesh__publicMeSHNote mesh__D004673
% 224.82/225.01       1995; was ENCEPHALITIS, POST-VACCINAL 1963-94   
% 224.82/225.01  |- mesh__dateRevised mesh__D004673 1999-11-30
% 224.82/225.01  |- skos__altLabel mesh__D004673 Disseminated Encephalomyelitis, Acute
% 224.82/225.01  |- skos__annotation mesh__D004673
% 224.82/225.01       when post-vaccinal %28%note X ref%29% coord IM with vaccine source if pertinent %28%IM or NIM%29%; for post-vaccinal or postinfectious inflammation of the spinal cord only, use MYELITIS, TRANSVERSE; DF: ENCEPH ACUTE DISSEM%A%  
% 224.82/225.01  |- skos__altLabel mesh__D004673 Acute Disseminated Encephalomyelitis
% 224.82/225.01  |- skos__hiddenLabel mesh__D004673 Encephalomyelitis, Post-Vaccinal
% 224.82/225.01  |- skos__hiddenLabel mesh__D004673 Acute Disseminated Encephalomyelitides
% 224.82/225.01  |- mesh__dateCreated mesh__D004673 1999-01-01
% 224.82/225.01  |- skos__hiddenLabel mesh__D004673 Post-Vaccinal Encephalitides
% 224.82/225.01  |- mesh__historyNote mesh__D004673
% 224.82/225.01       1995; was ENCEPHALITIS, POST-VACCINAL 1963-94   
% 224.82/225.01  |- skos__broader mesh__D012307smesh__D012306
% 224.82/225.01  |- skos__hiddenLabel mesh__D012307 Risk Factor
% 224.82/225.01  |- mesh__recordOriginator mesh__D012307 EC
% 224.82/225.01  |- skos__scopeNote mesh__D012307
% 224.82/225.01       An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.%A%    
% 224.82/225.01  |- skos__hiddenLabel mesh__D012307 Factor, Risk
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D012307 2002
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D012307 1999
% 224.82/225.01  |- skos__prefLabel mesh__D012307 Risk Factors
% 224.82/225.01  |- mesh__historyNote mesh__D012307 88   
% 224.82/225.01  |- skos__annotation mesh__D012307
% 224.82/225.01       human %26% animal; an epidemiol concept for risk factors in dis, surg, etc.: do not confuse with RISK, a statist concept %26% aspect of probability; coord NIM with specific disease or other concept %28%IM%29%; no qualif; specify geog if pertinent%A%  
% 224.82/225.01  |- skos__hiddenLabel mesh__D012307 Factors, Risk
% 224.82/225.01  |- mesh__recordAuthorizer mesh__D012307 PLS
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D012307 1996
% 224.82/225.01  |- skos__historyNote mesh__D012307 Risk %28%1975-1987%29%
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D012307 1997
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D012307 2000
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D012307 2005
% 224.82/225.01  |- mesh__dateRevised mesh__D012307 1994-04-11
% 224.82/225.01  |- mesh__publicMeSHNote mesh__D012307 88   
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D012307 2006
% 224.82/225.01  |- rdf__type mesh__D012307sskos__Concept
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D012307 2001
% 224.82/225.01  |- mesh__recordMaintainer mesh__D012307 JLS
% 224.82/225.01  |- mesh__dateEstablished mesh__D012307 1988-01-01
% 224.82/225.01  |- skos__broader mesh__D012307smesh__D015984
% 224.82/225.01  |- mesh__dateCreated mesh__D012307 1987-05-01
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D012307 2003
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D012307 1998
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D012307 1995
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D012307 2004
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D008266 1999
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D008266 2004
% 224.82/225.01  |- skos__prefLabel mesh__D008266 Macula Lutea
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D008266 1998
% 224.82/225.01  |- mesh__dateRevised mesh__D008266 2004-07-28
% 224.82/225.01  |- mesh__recordAuthorizer mesh__D008266 jls
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D008266 2001
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D008266 2003
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D008266 2000
% 224.82/225.01  |- mesh__recordOriginator mesh__D008266 NLM
% 224.82/225.01  |- mesh__dateCreated mesh__D008266 1999-01-01
% 224.82/225.01  |- skos__scopeNote mesh__D008266
% 224.82/225.01       An oval area in the retina, 3 to 5 mm in diameter, usually located temporal to the posterior pole of the eye and slightly below the level of the optic disk. It is characterized by the presence of a yellow pigment diffusely permeating the inner layers, contains the fovea centralis in its center, and provides the best phototropic visual acuity. It is devoid of retinal blood vessels, except in its periphery, and receives nourishment from the choriocapillaris of the choroid. %28%From Cline et al., Dictionary of Visual Science, 4th ed%29%%A%    
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D008266 2005A
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D008266 1997
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D008266 2006
% 224.82/225.01  |- skos__broader mesh__D008266smesh__D012160
% 224.82/225.01  |- skos__hiddenLabel mesh__D008266 Luteas, Macula
% 224.82/225.01  |- skos__hiddenLabel mesh__D008266 Lutea, Macula
% 224.82/225.01  |- mesh__recordMaintainer mesh__D008266 jls
% 224.82/225.01  |- skos__annotation mesh__D008266
% 224.82/225.01       a depression on the retina; macular dis: coord IM with RETINAL DISEASES %28%IM%29%%A%  
% 224.82/225.01  |- skos__hiddenLabel mesh__D008266 Macula Luteas
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D008266 1996
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D008266 2005
% 224.82/225.01  |- rdf__type mesh__D008266sskos__Concept
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D008266 2002
% 224.82/225.01  |- mesh__recordAuthorizer mesh__D000283 PLS
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000283 2006
% 224.82/225.01  |- mesh__recordOriginator mesh__D000283 SH
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000283 2002
% 224.82/225.01  |- skos__hiddenLabel mesh__D000283 Intravesical Injections
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000283 2003
% 224.82/225.01  |- skos__altLabel mesh__D000283 Bladder Drug Administration
% 224.82/225.01  |- mesh__dateEstablished mesh__D000283 1987-01-01
% 224.82/225.01  |- skos__altLabel mesh__D000283 Administration, Intravesical Drug
% 224.82/225.01  |- skos__hiddenLabel mesh__D000283 Bladder Instillation
% 224.82/225.01  |- skos__hiddenLabel mesh__D000283 Drug Administrations, Intravesical
% 224.82/225.01  |- mesh__recordMaintainer mesh__D000283 TGC
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000283 1991
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000283 1992
% 224.82/225.01  |- skos__hiddenLabel mesh__D000283 Administrations, Intravesical Drug
% 224.82/225.01  |- mesh__publicMeSHNote mesh__D000283 87   
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000283 2004
% 224.82/225.01  |- mesh__dateRevised mesh__D000283 1990-06-01
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000283 1994
% 224.82/225.01  |- skos__hiddenLabel mesh__D000283 Bladder Instillations
% 224.82/225.01  |- skos__hiddenLabel mesh__D000283 Instillation, Intravesical
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000283 1993
% 224.82/225.01  |- skos__altLabel mesh__D000283 Intravesical Instillation
% 224.82/225.01  |- skos__historyNote mesh__D000283
% 224.82/225.01       Administration, Topical %28%1974-1986%29%
% 224.82/225.01  |- skos__hiddenLabel mesh__D000283 Bladder Drug Administrations
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000283 1998
% 224.82/225.01  |- skos__annotation mesh__D000283
% 224.82/225.01       NIM but only if discussed: do not index here routinely for every intravesically administered drug; no qualif%A%  
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000283 1995
% 224.82/225.01  |- skos__hiddenLabel mesh__D000283 Intravesical Instillations
% 224.82/225.01  |- skos__altLabel mesh__D000283 Injections, Intravesical
% 224.82/225.01  |- skos__altLabel mesh__D000283 Drug Administration, Bladder
% 224.82/225.01  |- skos__hiddenLabel mesh__D000283 Instillations, Intravesical
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000283 2000
% 224.82/225.01  |- skos__hiddenLabel mesh__D000283 Administration, Bladder Drug
% 224.82/225.01  |- skos__altLabel mesh__D000283 Intravesical Drug Administration
% 224.82/225.01  |- skos__prefLabel mesh__D000283 Administration, Intravesical
% 224.82/225.01  |- skos__historyNote mesh__D000283 Bladder %28%1966-1986%29%
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000283 1999
% 224.82/225.01  |- skos__scopeNote mesh__D000283
% 224.82/225.01       The instillation or other administration of drugs into the bladder, usually to treat local disease, including neoplasms.%A%    
% 224.82/225.01  |- rdf__type mesh__D000283sskos__Concept
% 224.82/225.01  |- skos__hiddenLabel mesh__D000283 Administrations, Bladder Drug
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000283 1996
% 224.82/225.01  |- skos__broader mesh__D000283smesh__D000287
% 224.82/225.01  |- mesh__dateCreated mesh__D000283 1986-06-04
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000283 2005
% 224.82/225.01  |- skos__hiddenLabel mesh__D000283 Instillations, Bladder
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000283 2001
% 224.82/225.01  |- skos__hiddenLabel mesh__D000283 Drug Administrations, Bladder
% 224.82/225.01  |- skos__hiddenLabel mesh__D000283 Intravesical Drug Administrations
% 224.82/225.01  |- mesh__historyNote mesh__D000283 87   
% 224.82/225.01  |- skos__hiddenLabel mesh__D000283 Injection, Intravesical
% 224.82/225.01  |- skos__altLabel mesh__D000283 Intravesical Administration
% 224.82/225.01  |- skos__hiddenLabel mesh__D000283 Administrations, Intravesical
% 224.82/225.01  |- skos__hiddenLabel mesh__D000283 Drug Administration, Intravesical
% 224.82/225.01  |- skos__hiddenLabel mesh__D000283 Intravesical Administrations
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D000283 1997
% 224.82/225.01  |- mesh__dateRevised mesh__D013400 2004-07-07
% 224.82/225.01  |- mesh__historyNote mesh__D013400 73   
% 224.82/225.01  |- skos__broader mesh__D013400smesh__D000144
% 224.82/225.01  |- skos__historyNote mesh__D013400 Carbohydrates %28%1966-1972%29%
% 224.82/225.01  |- mesh__publicMeSHNote mesh__D013400 73   
% 224.82/225.01  |- mesh__recordOriginator mesh__D013400 NLM
% 224.82/225.01  |- mesh__recordMaintainer mesh__D013400 ssb
% 224.82/225.01  |- mesh__recordAuthorizer mesh__D013400 sjn
% 224.82/225.01  |- skos__broader mesh__D013400smesh__D002241
% 224.82/225.01  |- skos__prefLabel mesh__D013400 Sugar Acids
% 224.82/225.01  |- rdf__type mesh__D013400sskos__Concept
% 224.82/225.01  |- mesh__dateEstablished mesh__D013400 1973-01-01
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D013400 2005
% 224.82/225.01  |- skos__broader mesh__D013400smesh__D006880
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D013400 2006
% 224.82/225.01  |- mesh__dateCreated mesh__D013400 1999-01-01
% 224.82/225.01  |- skos__hiddenLabel mesh__D013400 Acids, Sugar
% 224.82/225.01  |- mesh__publicMeSHNote mesh__D032365 2003   
% 224.82/225.01  |- mesh__dateCreated mesh__D032365 2002-07-03
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D032365 2004
% 224.82/225.01  |- rdf__type mesh__D032365sskos__Concept
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D032365 2003
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D032365 2006
% 224.82/225.01  |- mesh__dateEstablished mesh__D032365 2003-01-01
% 224.82/225.01  |- skos__scopeNote mesh__D032365
% 224.82/225.01       A plant genus of the family THYMELAEACEAE. Members contain daphnoretin and wikstroelides and daphnane-type DITERPENES.%A%    
% 224.82/225.01  |- skos__broader mesh__D032365smesh__D029645
% 224.82/225.01  |- mesh__historyNote mesh__D032365 2003   
% 224.82/225.01  |- skos__annotation mesh__D032365
% 224.82/225.01       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.82/225.01  |- skos__prefLabel mesh__D032365 Wikstroemia
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D032365 2005
% 224.82/225.01  |- skos__hiddenLabel mesh__D004674 Louis Meningoencephalitides, St.
% 224.82/225.01  |- mesh__recordOriginator mesh__D004674 NLM
% 224.82/225.01  |- skos__altLabel mesh__D004674 Saint Louis Encephalitis
% 224.82/225.01  |- mesh__dateRevised mesh__D004674 2002-07-03
% 224.82/225.01  |- skos__altLabel mesh__D004674 Encephalitis, Viral, St. Louis
% 224.82/225.01  |- skos__broader mesh__D004674smesh__D004671
% 224.82/225.01  |- skos__hiddenLabel mesh__D004674 St. Louis Meningoencephalitides
% 224.82/225.01  |- skos__broader mesh__D004674smesh__D018177
% 224.82/225.01  |- skos__altLabel mesh__D004674 Encephalitis, Saint Louis
% 224.82/225.01  |- mesh__dateCreated mesh__D004674 1999-01-01
% 224.82/225.01  |- skos__altLabel mesh__D004674 St. Louis Meningoencephalitis
% 224.82/225.01  |- skos__altLabel mesh__D004674 St. Louis Viral Encephalitis
% 224.82/225.01  |- skos__scopeNote mesh__D004674
% 224.82/225.01       A viral encephalitis caused by the St. Louis encephalitis virus %28%ENCEPHALITIS VIRUS, ST. LOUIS%29%, a FLAVIVIRUS. It is transmitted to humans and other vertebrates primarily by mosquitoes of the genus CULEX. The primary animal vectors are wild birds and the disorder is endemic to the midwestern and southeastern United States. Infections may be limited to an influenza-like illness or present as an ASEPTIC MENINGITIS or ENCEPHALITIS. Clinical manifestations of the encephalitic presentation may include SEIZURES, lethargy, MYOCLONUS, focal neurologic signs, COMA, and DEATH. %28%From Adams et al., Principles of Neurology, 6th ed, p750%29%%A%    
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D004674 2004
% 224.82/225.01  |- skos__hiddenLabel mesh__D004674 Meningoencephalitides, St. Louis
% 224.82/225.01  |- mesh__activeMeSHYear mesh__D004674 2006
% 224.82/225.01  |- skos__annotation mesh__D004674 DF: ENCEPH ST LOUIS   
% 224.82/225.01  |- mesh__recordAuthorizer mesh__D004674 sjn
% 224.82/225.02  |- skos__prefLabel mesh__D004674 Encephalitis, St. Louis
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D004674 2003
% 224.82/225.02  |- mesh__recordMaintainer mesh__D004674 ags
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D004674 2005
% 224.82/225.02  |- skos__altLabel mesh__D004674 Type C Lethargic Encephalitis
% 224.82/225.02  |- skos__altLabel mesh__D004674 St. Louis Encephalitis
% 224.82/225.02  |- rdf__type mesh__D004674sskos__Concept
% 224.82/225.02  |- skos__altLabel mesh__D004674 Lethargic Encephalitis, Type C
% 224.82/225.02  |- mesh__dateCreated mesh__D012308 1978-12-22
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D012308 1998
% 224.82/225.02  |- skos__historyNote mesh__D012308 Malpractice %28%1966-1979%29%
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D012308 2002
% 224.82/225.02  |- mesh__recordAuthorizer mesh__D012308 SJN
% 224.82/225.02  |- mesh__recordOriginator mesh__D012308 EC
% 224.82/225.02  |- skos__altLabel mesh__D012308 Hospital Incident Reporting
% 224.82/225.02  |- mesh__dateEstablished mesh__D012308 1990-01-01
% 224.82/225.02  |- skos__altLabel mesh__D012308 Management Risk
% 224.82/225.02  |- skos__hiddenLabel mesh__D012308 Risk Reporting, Hospital
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D012308 2003
% 224.82/225.02  |- skos__hiddenLabel mesh__D012308 Reporting, Hospital Risk
% 224.82/225.02  |- skos__hiddenLabel mesh__D012308 Managements, Risks
% 224.82/225.02  |- skos__altLabel mesh__D012308 Hospital Incident Reportings
% 224.82/225.02  |- skos__altLabel mesh__D012308 Incident Reporting, Hospital
% 224.82/225.02  |- mesh__publicMeSHNote mesh__D012308
% 224.82/225.02       90; was see under FINANCIAL MANAGEMENT 1980-89   
% 224.82/225.02  |- skos__hiddenLabel mesh__D012308 Risks Management
% 224.82/225.02  |- skos__hiddenLabel mesh__D012308 Hospital Risk Reportings
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D012308 2006
% 224.82/225.02  |- mesh__dateRevised mesh__D012308 1997-06-20
% 224.82/225.02  |- skos__hiddenLabel mesh__D012308 Management, Risk
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D012308 2001
% 224.82/225.02  |- skos__hiddenLabel mesh__D012308 Risks Managements
% 224.82/225.02  |- skos__hiddenLabel mesh__D012308 Risk Reportings, Hospital
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D012308 2005
% 224.82/225.02  |- skos__hiddenLabel mesh__D012308 Management Risks
% 224.82/225.02  |- skos__hiddenLabel mesh__D012308 Risks, Management
% 224.82/225.02  |- skos__scopeNote mesh__D012308
% 224.82/225.02       The process of minimizing risk to an organization by developing systems to identify and analyze potential hazards to prevent accidents, injuries, and other adverse occurrences, and by attempting to handle events and incidents which do occur in such a manner that their effect and cost are minimized. Effective risk management has its greatest benefits in application to insurance in order to avert or minimize financial liability. %28%From Slee %26% Slee: Health care terms, 2d ed%29%%A%    
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D012308 2000
% 224.82/225.02  |- mesh__historyNote mesh__D012308
% 224.82/225.02       90%28%80%29%; was see under FINANCIAL MANAGEMENT 1980-89   
% 224.82/225.02  |- rdf__type mesh__D012308sskos__Concept
% 224.82/225.02  |- mesh__recordMaintainer mesh__D012308 TPW
% 224.82/225.02  |- skos__broader mesh__D012308smesh__D009934
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D012308 1999
% 224.82/225.02  |- skos__broader mesh__D012308smesh__D005376
% 224.82/225.02  |- skos__hiddenLabel mesh__D012308 Hospital Risk Reporting
% 224.82/225.02  |- skos__altLabel mesh__D012308 Management, Risks
% 224.82/225.02  |- skos__prefLabel mesh__D012308 Risk Management
% 224.82/225.02  |- skos__altLabel mesh__D012308 Incident Reportings, Hospital
% 224.82/225.02  |- skos__hiddenLabel mesh__D012308 Reportings, Hospital Incident
% 224.82/225.02  |- skos__historyNote mesh__D012308 Insurance, Liability %28%1966-1979%29%
% 224.82/225.02  |- skos__hiddenLabel mesh__D012308 Risk, Management
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D012308 2004
% 224.82/225.02  |- skos__altLabel mesh__D012308 Reportings, Hospital Risk
% 224.82/225.02  |- skos__broader mesh__D008267smesh__D012444
% 224.82/225.02  |- skos__altLabel mesh__D008267 Macula, Acoustic
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008267 1998
% 224.82/225.02  |- skos__hiddenLabel mesh__D008267 Acoustic Macula
% 224.82/225.02  |- mesh__onlineNote mesh__D008267
% 224.82/225.02       use ACOUSTIC MACULAE to search MACULAE, ACOUSTIC 1979-94   
% 224.82/225.02  |- skos__hiddenLabel mesh__D008267 Acoustic Maculas
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008267 2002
% 224.82/225.02  |- mesh__dateRevised mesh__D008267 1994-02-28
% 224.82/225.02  |- mesh__recordMaintainer mesh__D008267 TGC
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008267 2003
% 224.82/225.02  |- mesh__dateEstablished mesh__D008267 1991-01-01
% 224.82/225.02  |- skos__altLabel mesh__D008267 Maculae, Acoustic
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008267 1997
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008267 2006
% 224.82/225.02  |- mesh__recordOriginator mesh__D008267 RC
% 224.82/225.02  |- mesh__dateCreated mesh__D008267 1978-05-19
% 224.82/225.02  |- skos__hiddenLabel mesh__D008267 Maculas, Acoustic
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008267 2001
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008267 1996
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008267 2005
% 224.82/225.02  |- skos__prefLabel mesh__D008267 Acoustic Maculae
% 224.82/225.02  |- rdf__type mesh__D008267sskos__Concept
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008267 2000
% 224.82/225.02  |- mesh__publicMeSHNote mesh__D008267
% 224.82/225.02       95; was MACULAE, ACOUSTIC 1979-94 %28%see under SACCULE AND UTRICLE 1983-90, see under LABYRINTH 1979-82%29%%A%  
% 224.82/225.02  |- skos__historyNote mesh__D008267 Labyrinth %28%1966-1978%29%
% 224.82/225.02  |- skos__scopeNote mesh__D008267
% 224.82/225.02       Thickened areas of the saccule and utricle where the termination of the vestibular nerve occurs.%A%    
% 224.82/225.02  |- mesh__historyNote mesh__D008267
% 224.82/225.02       95; was MACULAE, ACOUSTIC 1979-94 %28%see under SACCULE AND UTRICLE 1983-90, see under LABYRINTH 1979-82%29%%A%  
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008267 1999
% 224.82/225.02  |- mesh__recordAuthorizer mesh__D008267 PLS
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008267 1995
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008267 2004
% 224.82/225.02  |- mesh__dateRevised mesh__D000284 1991-05-12
% 224.82/225.02  |- mesh__dateEstablished mesh__D000284 1973-01-01
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D000284 1996
% 224.82/225.02  |- skos__hiddenLabel mesh__D000284 Oral Administrations
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D000284 2001
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D000284 1998
% 224.82/225.02  |- skos__broader mesh__D000284smesh__D004333
% 224.82/225.02  |- skos__hiddenLabel mesh__D000284 Administrations, Oral
% 224.82/225.02  |- skos__altLabel mesh__D000284 Administration, Oral Drug
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D000284 1992
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D000284 2003
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D000284 1997
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D000284 1994
% 224.82/225.02  |- mesh__recordOriginator mesh__D000284 NLM
% 224.82/225.02  |- skos__hiddenLabel mesh__D000284 Administrations, Oral Drug
% 224.82/225.02  |- mesh__historyNote mesh__D000284 73%28%70%29%   
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D000284 1999
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D000284 2005
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D000284 1993
% 224.82/225.02  |- skos__historyNote mesh__D000284
% 224.82/225.02       specific drug/administration %26% dosage %28%1966-1969%29%
% 224.82/225.02  |- mesh__recordAuthorizer mesh__D000284 PLS
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D000284 2004
% 224.82/225.02  |- skos__prefLabel mesh__D000284 Administration, Oral
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D000284 1995
% 224.82/225.02  |- skos__annotation mesh__D000284
% 224.82/225.02       NIM but only if discussed: do not index here routinely for every orally administered drug; no qualif%A%  
% 224.82/225.02  |- skos__hiddenLabel mesh__D000284 Drug Administrations, Oral
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D000284 2002
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D000284 2006
% 224.82/225.02  |- skos__altLabel mesh__D000284 Drug Administration, Oral
% 224.82/225.02  |- mesh__recordMaintainer mesh__D000284 TGC
% 224.82/225.02  |- skos__altLabel mesh__D000284 Oral Administration
% 224.82/225.02  |- skos__hiddenLabel mesh__D000284 Oral Drug Administrations
% 224.82/225.02  |- skos__altLabel mesh__D000284 Oral Drug Administration
% 224.82/225.02  |- mesh__dateCreated mesh__D000284 1999-01-01
% 224.82/225.02  |- rdf__type mesh__D000284sskos__Concept
% 224.82/225.02  |- skos__scopeNote mesh__D000284
% 224.82/225.02       The giving of drugs, chemicals, or other substances by mouth.%A%    
% 224.82/225.02  |- mesh__publicMeSHNote mesh__D000284 73   
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D000284 2000
% 224.82/225.02  |- skos__annotation mesh__D027421
% 224.82/225.02       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.82/225.02  |- skos__scopeNote mesh__D027421
% 224.82/225.02       A plant genus in the LAURACEAE family.  The tree, Persea americana Mill., is known for the Avocado fruit, the food of commerce.%A%    
% 224.82/225.02  |- skos__broader mesh__D027421smesh__D019770
% 224.82/225.02  |- mesh__historyNote mesh__D027421 2002; use LAURACEAE 1998-2001   
% 224.82/225.02  |- mesh__recordOriginator mesh__D027421 ssb
% 224.82/225.02  |- skos__historyNote mesh__D027421 Lauraceae %28%1998-2001%29%
% 224.82/225.02  |- mesh__dateEstablished mesh__D027421 2002-01-01
% 224.82/225.02  |- mesh__recordMaintainer mesh__D027421 ssb
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D027421 2004
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D027421 2006
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D027421 2003
% 224.82/225.02  |- mesh__publicMeSHNote mesh__D027421 2002; see LAURACEAE 1998-2001   
% 224.82/225.02  |- mesh__dateRevised mesh__D027421 2002-07-02
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D027421 2005
% 224.82/225.02  |- skos__prefLabel mesh__D027421 Persea
% 224.82/225.02  |- mesh__dateCreated mesh__D027421 2001-07-25
% 224.82/225.02  |- mesh__recordAuthorizer mesh__D027421 sjn
% 224.82/225.02  |- rdf__type mesh__D027421sskos__Concept
% 224.82/225.02  |- skos__hiddenLabel mesh__D013401 Alcohol Oxidoreductases, Sugar
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D013401 2006
% 224.82/225.02  |- skos__altLabel mesh__D013401 Sugar Alcohol Oxidoreductases
% 224.82/225.02  |- mesh__dateEstablished mesh__D013401 1978-01-01
% 224.82/225.02  |- skos__scopeNote mesh__D013401
% 224.82/225.02       Reversibly catalyzes the oxidation of a hydroxyl group of sugar alcohols to form a keto sugar, aldehyde or lactone. Any acceptor except molecular oxygen is permitted. Includes EC 1.1.1.; EC 1.1.2. and EC 1.1.99.%A%    
% 224.82/225.02  |- skos__hiddenLabel mesh__D013401 Oxidoreductases, Sugar Alcohol
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D013401 2005
% 224.82/225.02  |- skos__historyNote mesh__D013401
% 224.82/225.02       Alcohol Oxidoreductases %28%1966-1977%29%
% 224.82/225.02  |- mesh__recordOriginator mesh__D013401 RLS
% 224.82/225.02  |- mesh__recordMaintainer mesh__D013401 ssb
% 224.82/225.02  |- skos__hiddenLabel mesh__D013401 Dehydrogenases, Sugar Alcohol
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D013401 2004
% 224.82/225.02  |- skos__prefLabel mesh__D013401 Sugar Alcohol Dehydrogenases
% 224.82/225.02  |- mesh__dateCreated mesh__D013401 1977-04-15
% 224.82/225.02  |- skos__hiddenLabel mesh__D013401 Alcohol Dehydrogenases, Sugar
% 224.82/225.02  |- mesh__historyNote mesh__D013401 78   
% 224.82/225.02  |- rdf__type mesh__D013401sskos__Concept
% 224.82/225.02  |- mesh__recordAuthorizer mesh__D013401 sjn
% 224.82/225.02  |- skos__broader mesh__D013401smesh__D002237
% 224.82/225.02  |- mesh__publicMeSHNote mesh__D013401
% 224.82/225.02       78; ALDOSE REDUCTASE was see under ALCOHOL OXIDOREDUCTASES 1976-77; IDITOL DEHYDROGENASE was see under ALCOHOL OXIDOREDUCTASES 1977%A%  
% 224.82/225.02  |- mesh__dateRevised mesh__D013401 2003-07-09
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D051520 2006
% 224.82/225.02  |- mesh__dateCreated mesh__D051520 2005-06-30
% 224.82/225.02  |- skos__broader mesh__D051520smesh__D003358
% 224.82/225.02  |- mesh__publicMeSHNote mesh__D051520 2006   
% 224.82/225.02  |- skos__prefLabel mesh__D051520 Antiperspirants
% 224.82/225.02  |- mesh__recordAuthorizer mesh__D051520 sjn
% 224.82/225.02  |- mesh__recordOriginator mesh__D051520 lkt
% 224.82/225.02  |- mesh__dateEstablished mesh__D051520 2006-01-01
% 224.82/225.02  |- skos__scopeNote mesh__D051520
% 224.82/225.02       Agents that are put on the SKIN to reduce SWEATING or prevent excess sweating %28%HYPERHIDROSIS%29%.%A%    
% 224.82/225.02  |- rdf__type mesh__D051520sskos__Concept
% 224.82/225.02  |- skos__historyNote mesh__D051520 Deodorants %28%1965-2005%29%
% 224.82/225.02  |- mesh__recordMaintainer mesh__D051520 lkt
% 224.82/225.02  |- mesh__historyNote mesh__D051520 2006   
% 224.82/225.02  |- skos__historyNote mesh__D051520 Sweating %28%1965-2005%29%
% 224.82/225.02  |- skos__hiddenLabel mesh__D004675 Encephalitis, Tick Borne
% 224.82/225.02  |- skos__prefLabel mesh__D004675 Encephalitis, Tick-Borne
% 224.82/225.02  |- skos__broader mesh__D004675smesh__D018177
% 224.82/225.02  |- mesh__dateCreated mesh__D004675 1999-01-01
% 224.82/225.02  |- skos__hiddenLabel mesh__D004675 Louping Ill Encephalitides
% 224.82/225.02  |- mesh__dateRevised mesh__D004675 1999-12-02
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D004675 2000
% 224.82/225.02  |- skos__hiddenLabel mesh__D004675 Spring-Summer Encephalitis, Russian
% 224.82/225.02  |- skos__hiddenLabel mesh__D004675 Encephalitides, Tick-Borne
% 224.82/225.02  |- skos__hiddenLabel mesh__D004675 Encephalitis, Powassan
% 224.82/225.02  |- skos__annotation mesh__D004675
% 224.82/225.02       coord IM with specific virus %28%IM%29% if pertinent; DF: ENCEPH TICK BORNE%A%  
% 224.82/225.02  |- skos__hiddenLabel mesh__D004675 Encephalitis, European Tick Borne
% 224.82/225.02  |- skos__altLabel mesh__D004675 Far Eastern Russian Encephalitis
% 224.82/225.02  |- skos__altLabel mesh__D004675 Tick-Borne Encephalitis
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D004675 2000A
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D004675 2005
% 224.82/225.02  |- skos__hiddenLabel mesh__D004675 Encephalitides, Powassan
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D004675 2001
% 224.82/225.02  |- skos__hiddenLabel mesh__D004675 Encephalitides, European Tick-Borne
% 224.82/225.02  |- skos__hiddenLabel mesh__D004675 Tick Borne Encephalitis
% 224.82/225.02  |- skos__hiddenLabel mesh__D004675 European Tick-Borne Encephalitides
% 224.82/225.02  |- skos__altLabel mesh__D004675 European Tick-Borne Encephalitis
% 224.82/225.02  |- skos__altLabel mesh__D004675 Louping Ill Encephalitis
% 224.82/225.02  |- mesh__recordMaintainer mesh__D004675 ags
% 224.82/225.02  |- skos__hiddenLabel mesh__D004675 Encephalitides, Louping Ill
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D004675 2006
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D004675 2002
% 224.82/225.02  |- skos__altLabel mesh__D004675 Russian Spring-Summer Encephalitis
% 224.82/225.02  |- skos__hiddenLabel mesh__D004675 Powassan Encephalitides
% 224.82/225.02  |- mesh__recordOriginator mesh__D004675 NLM
% 224.82/225.02  |- mesh__historyNote mesh__D004675 1968%28%1966%29%   
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D004675 2003
% 224.82/225.02  |- mesh__recordAuthorizer mesh__D004675 ags
% 224.82/225.02  |- mesh__publicMeSHNote mesh__D004675
% 224.82/225.02       1968; for ENCEPHALITIS, CENTRAL EUROPEAN see ENCEPHALITIS, TICK-BORNE 1963-1999%A%  
% 224.82/225.02  |- skos__hiddenLabel mesh__D004675 Russian Spring Summer Encephalitis
% 224.82/225.02  |- skos__hiddenLabel mesh__D004675 Tick-Borne Encephalitis, European
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D004675 2004
% 224.82/225.02  |- skos__broader mesh__D004675smesh__D004671
% 224.82/225.02  |- mesh__dateEstablished mesh__D004675 1968-01-01
% 224.82/225.02  |- skos__scopeNote mesh__D004675
% 224.82/225.02       Encephalitis caused by neurotropic viruses that are transmitted via the bite of TICKS. In Europe, the diseases are caused by ENCEPHALITIS VIRUSES, TICK-BORNE, which give rise to Russian spring-summer encephalitis, central European encephalitis, louping ill encephalitis, and related disorders. Powassan encephalitis occurs in North America and Russia and is caused by the Powassan virus. ASEPTIC MENINGITIS and rarely encephalitis may complicate COLORADO TICK FEVER which is endemic to mountainous regions of the western United States. %28%From Joynt, Clinical Neurology, 1996, Ch26, pp14-5%29%%A%    
% 224.82/225.02  |- skos__hiddenLabel mesh__D004675 European Tick Borne Encephalitis
% 224.82/225.02  |- skos__hiddenLabel mesh__D004675 Tick-Borne Encephalitides
% 224.82/225.02  |- rdf__type mesh__D004675sskos__Concept
% 224.82/225.02  |- skos__altLabel mesh__D004675 Central European Encephalitis
% 224.82/225.02  |- skos__hiddenLabel mesh__D004675 Tick-Borne Encephalitides, European
% 224.82/225.02  |- skos__hiddenLabel mesh__D004675 Encephalitis, Russian Spring Summer
% 224.82/225.02  |- skos__broader mesh__D004675smesh__D017282
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D012309 2003
% 224.82/225.02  |- mesh__historyNote mesh__D012309
% 224.82/225.02       79%28%75%29%; was see under GAMBLING 1969-78   
% 224.82/225.02  |- skos__broader mesh__D012309smesh__D001519
% 224.82/225.02  |- skos__hiddenLabel mesh__D012309 Risk Behaviors
% 224.82/225.02  |- skos__historyNote mesh__D012309 Gambling %28%1969-1974%29%
% 224.82/225.02  |- mesh__dateRevised mesh__D012309 2002-07-02
% 224.82/225.02  |- mesh__publicMeSHNote mesh__D012309
% 224.82/225.02       79; was see under GAMBLING 1969-78; GAMBLING was heading 1968-78%A%  
% 224.82/225.02  |- skos__scopeNote mesh__D012309
% 224.82/225.02       Undertaking a task involving a challenge for achievement or a desirable goal in which there is a lack of certainty or a fear of failure. It may also include the exhibiting of certain behaviors whose outcomes may present a risk to the individual or to those associated with him or her.%A%    
% 224.82/225.02  |- mesh__dateCreated mesh__D012309 1999-01-01
% 224.82/225.02  |- mesh__dateEstablished mesh__D012309 1979-01-01
% 224.82/225.02  |- mesh__recordOriginator mesh__D012309 NLM
% 224.82/225.02  |- mesh__recordAuthorizer mesh__D012309 sjn
% 224.82/225.02  |- mesh__onlineNote mesh__D012309 search GAMBLING 1969-74   
% 224.82/225.02  |- skos__hiddenLabel mesh__D012309 Behavior, Risk
% 224.82/225.02  |- rdf__type mesh__D012309sskos__Concept
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D012309 2006
% 224.82/225.02  |- skos__prefLabel mesh__D012309 Risk-Taking
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D012309 2004
% 224.82/225.02  |- skos__hiddenLabel mesh__D012309 Behaviors, Risk
% 224.82/225.02  |- skos__annotation mesh__D012309 no qualif   
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D012309 2005
% 224.82/225.02  |- skos__hiddenLabel mesh__D012309 Risk Taking
% 224.82/225.02  |- mesh__recordMaintainer mesh__D012309 PLS
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D009360 2002
% 224.82/225.02  |- skos__altLabel mesh__D009360 Embolic Tumor Cells
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D009360 2003
% 224.82/225.02  |- skos__altLabel mesh__D009360 Circulating Cells, Neoplasm
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D009360 2006
% 224.82/225.02  |- skos__prefLabel mesh__D009360 Neoplasm Circulating Cells
% 224.82/225.02  |- skos__hiddenLabel mesh__D009360 Tumor Embolism
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D009360 2001
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D009360 2005
% 224.82/225.02  |- skos__broader mesh__D009360smesh__D009362
% 224.82/225.02  |- skos__annotation mesh__D009360
% 224.82/225.02       IM; qualif permitted; DF: NEOPL CIRC CELLS   
% 224.82/225.02  |- skos__hiddenLabel mesh__D009360 Neoplasm Circulating Cell
% 224.82/225.02  |- skos__hiddenLabel mesh__D009360 Cell, Embolic Tumor
% 224.82/225.02  |- skos__hiddenLabel mesh__D009360 Cell, Neoplasm Circulating
% 224.82/225.02  |- skos__hiddenLabel mesh__D009360 Cells, Embolic Tumor
% 224.82/225.02  |- skos__hiddenLabel mesh__D009360 Tumor Embolisms
% 224.82/225.02  |- mesh__dateRevised mesh__D009360 2000-06-22
% 224.82/225.02  |- skos__scopeNote mesh__D009360
% 224.82/225.02       Exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumors.%A%    
% 224.82/225.02  |- mesh__recordAuthorizer mesh__D009360 sjn
% 224.82/225.02  |- rdf__type mesh__D009360sskos__Concept
% 224.82/225.02  |- skos__hiddenLabel mesh__D009360 Embolic Tumor Cell
% 224.82/225.02  |- mesh__dateCreated mesh__D009360 1999-01-01
% 224.82/225.02  |- mesh__recordOriginator mesh__D009360 NLM
% 224.82/225.02  |- skos__hiddenLabel mesh__D009360 Tumor Cell, Embolic
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D009360 2004
% 224.82/225.02  |- mesh__historyNote mesh__D009360 66%28%65%29%   
% 224.82/225.02  |- mesh__recordMaintainer mesh__D009360 TPW
% 224.82/225.02  |- mesh__publicMeSHNote mesh__D009360 66   
% 224.82/225.02  |- skos__hiddenLabel mesh__D009360 Embolisms, Tumor
% 224.82/225.02  |- mesh__dateEstablished mesh__D009360 1966-01-01
% 224.82/225.02  |- skos__altLabel mesh__D009360 Cells, Neoplasm Circulating
% 224.82/225.02  |- skos__broader mesh__D002136Q000737smesh__D002136
% 224.82/225.02  |- mesh__preferredCombination mesh__D002136Q000737smesh__D002118Q000737
% 224.82/225.02  |- rdf__type mesh__D002136Q000737smesh__CompoundConcept
% 224.82/225.02  |- mesh__dateCreated mesh__D008268 1999-01-01
% 224.82/225.02  |- mesh__dateEstablished mesh__D008268 1979-01-01
% 224.82/225.02  |- skos__hiddenLabel mesh__D008268 Age Related Maculopathies
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008268 2004
% 224.82/225.02  |- skos__prefLabel mesh__D008268 Macular Degeneration
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008268 2002
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008268 2005
% 224.82/225.02  |- skos__historyNote mesh__D008268 Retinal Degeneration %28%1970-1978%29%
% 224.82/225.02  |- mesh__recordOriginator mesh__D008268 NLM
% 224.82/225.02  |- mesh__historyNote mesh__D008268
% 224.82/225.02       79%28%75%29%; was see under RETINAL DEGENERATION 1970-78   
% 224.82/225.02  |- skos__altLabel mesh__D008268 Maculopathies, Age-Related
% 224.82/225.02  |- skos__altLabel mesh__D008268 Age-Related Maculopathies
% 224.82/225.02  |- skos__broader mesh__D008268smesh__D012162
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008268 1996
% 224.82/225.02  |- mesh__onlineNote mesh__D008268 search RETINAL DEGENERATION 1970-74   
% 224.82/225.02  |- skos__hiddenLabel mesh__D008268 Macular Degenerations
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008268 2006
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008268 1997
% 224.82/225.02  |- skos__altLabel mesh__D008268 Maculopathy, Age-Related
% 224.82/225.02  |- skos__hiddenLabel mesh__D008268 Age Related Maculopathy
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008268 1998
% 224.82/225.02  |- skos__annotation mesh__D008268
% 224.82/225.02       macular refers to macula lutea of retina; includes %22%macular dystrophy%22%%A%  
% 224.82/225.02  |- skos__hiddenLabel mesh__D008268 Degenerations, Macular
% 224.82/225.02  |- mesh__dateRevised mesh__D008268 1994-02-28
% 224.82/225.02  |- skos__scopeNote mesh__D008268
% 224.82/225.02       Degenerative changes in the macula lutea of the retina.%A%    
% 224.82/225.02  |- rdf__type mesh__D008268sskos__Concept
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008268 2000
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008268 1999
% 224.82/225.02  |- skos__hiddenLabel mesh__D008268 Maculopathies, Age Related
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008268 2003
% 224.82/225.02  |- mesh__publicMeSHNote mesh__D008268
% 224.82/225.02       79; was see under RETINAL DEGENERATION 1970-78   
% 224.82/225.02  |- skos__hiddenLabel mesh__D008268 Degeneration, Macular
% 224.82/225.02  |- skos__hiddenLabel mesh__D008268 Maculopathy, Age Related
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008268 2001
% 224.82/225.02  |- mesh__activeMeSHYear mesh__D008268 1995
% 224.82/225.02  |- mesh__recordAuthorizer mesh__D008268 PLS
% 224.82/225.02  |- mesh__recordMaintainer mesh__D008268 TGC
% 224.82/225.02  |- skos__hiddenLabel mesh__D000285 Rectal Drug Administrations
% 224.82/225.03  |- skos__hiddenLabel mesh__D000285 Administration, Rectal Drug
% 224.82/225.03  |- skos__historyNote mesh__D000285 Rectum %28%1966-1986%29%
% 224.82/225.03  |- skos__altLabel mesh__D000285 Rectal Administration
% 224.82/225.03  |- skos__altLabel mesh__D000285 Drug Administration, Anal
% 224.82/225.03  |- skos__hiddenLabel mesh__D000285 Rectal Instillations
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000285 1993
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000285 2003
% 224.82/225.03  |- skos__broader mesh__D000285smesh__D004333
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000285 1995
% 224.82/225.03  |- skos__scopeNote mesh__D000285
% 224.82/225.03       The insertion of drugs into the rectum, usually for confused or incompetent patients, like children, infants, and the very old or comatose.%A%    
% 224.82/225.03  |- skos__hiddenLabel mesh__D000285 Administrations, Rectal
% 224.82/225.03  |- mesh__recordMaintainer mesh__D000285 PLS
% 224.82/225.03  |- skos__altLabel mesh__D000285 Instillation, Rectal
% 224.82/225.03  |- skos__related mesh__D000285smesh__D000774
% 224.82/225.03  |- mesh__recordAuthorizer mesh__D000285 PLS
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000285 1992
% 224.82/225.03  |- skos__altLabel mesh__D000285 Drug Administration, Rectal
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000285 2002
% 224.82/225.03  |- skos__annotation mesh__D000285
% 224.82/225.03       NIM but only if discussed: do not index here routinely for every rectally administered drug; no qualif%A%  
% 224.82/225.03  |- skos__related mesh__D000285smesh__D013488
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000285 1999
% 224.82/225.03  |- rdf__type mesh__D000285sskos__Concept
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000285 1994
% 224.82/225.03  |- skos__hiddenLabel mesh__D000285 Rectal Administrations
% 224.82/225.03  |- skos__hiddenLabel mesh__D000285 Drug Administrations, Anal
% 224.82/225.03  |- skos__historyNote mesh__D000285 Intestinal Absorption %28%1966-1986%29%
% 224.82/225.03  |- skos__hiddenLabel mesh__D000285 Drug Administrations, Rectal
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000285 1991
% 224.82/225.03  |- skos__hiddenLabel mesh__D000285 Anal Drug Administrations
% 224.82/225.03  |- skos__hiddenLabel mesh__D000285 Administrations, Rectal Drug
% 224.82/225.03  |- mesh__publicMeSHNote mesh__D000285 87   
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000285 1998
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000285 1997
% 224.82/225.03  |- skos__hiddenLabel mesh__D000285 Rectal Instillation
% 224.82/225.03  |- mesh__recordOriginator mesh__D000285 SH
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000285 2006
% 224.82/225.03  |- skos__altLabel mesh__D000285 Anal Drug Administration
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000285 2001
% 224.82/225.03  |- skos__hiddenLabel mesh__D000285 Instillations, Rectal
% 224.82/225.03  |- mesh__dateEstablished mesh__D000285 1987-01-01
% 224.82/225.03  |- skos__hiddenLabel mesh__D000285 Administrations, Anal Drug
% 224.82/225.03  |- skos__altLabel mesh__D000285 Rectal Drug Administration
% 224.82/225.03  |- mesh__dateRevised mesh__D000285 1989-07-13
% 224.82/225.03  |- skos__prefLabel mesh__D000285 Administration, Rectal
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000285 1996
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000285 1990
% 224.82/225.03  |- skos__broader mesh__D000285smesh__D000287
% 224.82/225.03  |- mesh__dateCreated mesh__D000285 1986-06-04
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000285 2005
% 224.82/225.03  |- skos__historyNote mesh__D000285 Suppositories %28%1966-1986%29%
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000285 2000
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000285 2004
% 224.82/225.03  |- skos__hiddenLabel mesh__D000285 Administration, Anal Drug
% 224.82/225.03  |- mesh__historyNote mesh__D000285 87   
% 224.82/225.03  |- skos__annotation mesh__D027422
% 224.82/225.03       do not confuse X ref BAY LAUREL, CALIFORNIA with BAY LAUREL see LAURUS;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D027422 2004
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D027422 2006
% 224.82/225.03  |- mesh__historyNote mesh__D027422 2002   
% 224.82/225.03  |- mesh__dateEstablished mesh__D027422 2002-01-01
% 224.82/225.03  |- mesh__dateCreated mesh__D027422 2001-07-25
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D027422 2003
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D027422 2005
% 224.82/225.03  |- skos__broader mesh__D027422smesh__D019770
% 224.82/225.03  |- skos__altLabel mesh__D027422 Bay Laurel, California
% 224.82/225.03  |- skos__scopeNote mesh__D027422
% 224.82/225.03       A plant genus in the LAURACEAE family. The tree, Umbellularia californica %28%Hook. %26% Arn.%29% Nutt., is known for aromatic leaves used in SPICES having a similar flavor to LAURUS.%A%    
% 224.82/225.03  |- rdf__type mesh__D027422sskos__Concept
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D027422 2002
% 224.82/225.03  |- mesh__publicMeSHNote mesh__D027422 2002   
% 224.82/225.03  |- skos__prefLabel mesh__D027422 Umbellularia
% 224.82/225.03  |- skos__scopeNote mesh__D013402
% 224.82/225.03       Polyhydric alcohols having no more than one hydroxy group attached to each carbon atom. They are formed by the reduction of the carbonyl group of a sugar to a hydroxyl group.%28%From Dorland, 28th ed%29%%A%    
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D013402 2006
% 224.82/225.03  |- mesh__historyNote mesh__D013402 72   
% 224.82/225.03  |- skos__broader mesh__D013402smesh__D002241
% 224.82/225.03  |- mesh__recordMaintainer mesh__D013402 ssb
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D013402 2005
% 224.82/225.03  |- mesh__dateRevised mesh__D013402 2004-07-07
% 224.82/225.03  |- mesh__publicMeSHNote mesh__D013402 72   
% 224.82/225.03  |- skos__prefLabel mesh__D013402 Sugar Alcohols
% 224.82/225.03  |- mesh__dateCreated mesh__D013402 1999-01-01
% 224.82/225.03  |- skos__altLabel mesh__D013402 Alditols
% 224.82/225.03  |- skos__altLabel mesh__D013402 Alcohols, Sugar
% 224.82/225.03  |- mesh__recordOriginator mesh__D013402 NLM
% 224.82/225.03  |- skos__broader mesh__D013402smesh__D000438
% 224.82/225.03  |- mesh__dateEstablished mesh__D013402 1972-01-01
% 224.82/225.03  |- mesh__recordAuthorizer mesh__D013402 sjn
% 224.82/225.03  |- rdf__type mesh__D013402sskos__Concept
% 224.82/225.03  |- skos__historyNote mesh__D013402 Alcohols %28%1966-1971%29%
% 224.82/225.03  |- skos__altLabel mesh__D018696 Neuroprotective Drugs
% 224.82/225.03  |- skos__scopeNote mesh__D018696
% 224.82/225.03       Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids.%A%    
% 224.82/225.03  |- skos__broader mesh__D018696smesh__D020011
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D018696 2006
% 224.82/225.03  |- skos__hiddenLabel mesh__D018696 Agents, Neuroprotective
% 224.82/225.03  |- mesh__dateRevised mesh__D018696 2005-06-30
% 224.82/225.03  |- skos__altLabel mesh__D018696 Neuroprotectants
% 224.82/225.03  |- mesh__recordOriginator mesh__D018696 TPW
% 224.82/225.03  |- mesh__recordMaintainer mesh__D018696 ssb
% 224.82/225.03  |- mesh__dateCreated mesh__D018696 1994-06-03
% 224.82/225.03  |- rdf__type mesh__D018696sskos__Concept
% 224.82/225.03  |- mesh__dateEstablished mesh__D018696 1995-01-01
% 224.82/225.03  |- skos__prefLabel mesh__D018696 Neuroprotective Agents
% 224.82/225.03  |- mesh__publicMeSHNote mesh__D018696 95   
% 224.82/225.03  |- skos__hiddenLabel mesh__D018696 Drugs, Neuroprotective
% 224.82/225.03  |- skos__broader mesh__D018696smesh__D002491
% 224.82/225.03  |- skos__annotation mesh__D018696
% 224.82/225.03       GEN or unspecified; prefer specifics; prevent brain %26% spinal cord damage in neurol dis%A%  
% 224.82/225.03  |- mesh__recordAuthorizer mesh__D018696 sjn
% 224.82/225.03  |- mesh__historyNote mesh__D018696 95   
% 224.82/225.03  |- mesh__historyNote mesh__D051521 2006%28%1991%29%   
% 224.82/225.03  |- mesh__recordOriginator mesh__D051521 DRC
% 224.82/225.03  |- rdf__type mesh__D051521sskos__Concept
% 224.82/225.03  |- mesh__dateCreated mesh__D051521 2005-06-30
% 224.82/225.03  |- mesh__recordAuthorizer mesh__D051521 sjn
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D051521 2006
% 224.82/225.03  |- skos__broader mesh__D051521smesh__D005346
% 224.82/225.03  |- mesh__dateEstablished mesh__D051521 2006-01-01
% 224.82/225.03  |- mesh__publicMeSHNote mesh__D051521
% 224.82/225.03       2006; FIBROBLAST GROWTH FACTOR 5 was indexed under FIBROBLAST GROWTH FACTORS 1991-2005%A%  
% 224.82/225.03  |- skos__scopeNote mesh__D051521
% 224.82/225.03       A fibroblast growth factor that may play a role in regulation of HAIR FOLLICLE phenotype. Spontaneous mutation of the gene for this protein results in a strain of MICE with abnormally long hair, referred to as angora mice..%A%    
% 224.82/225.03  |- mesh__recordMaintainer mesh__D051521 DRC
% 224.82/225.03  |- skos__prefLabel mesh__D051521 Fibroblast Growth Factor 5
% 224.82/225.03  |- skos__broader mesh__D004676smesh__D009185
% 224.82/225.03  |- skos__hiddenLabel mesh__D004676 Proteins, Myelin Basic
% 224.82/225.03  |- skos__altLabel mesh__D004676 Protein, Encephalitogenic Basic
% 224.82/225.03  |- skos__scopeNote mesh__D004676
% 224.82/225.03       A group of 7 proteins produced from a single gene by alternate splicing found in central and peripheral nervous system myelin. The major basic protein %28%MBP%29% has long been of interest because it is the antigen, that, when injected into an animal, elicits a cellular immune response that produces the CNS autoimmune disease called experimental allergic encephalomyelitis %28%ENCEPHALOMYELITIS, ALLERGIC%29%. In the peripheral nervous system, myelin basic protein 18.5-kDa is often referred to as the P1 protein. %28%From Siegel et al., Basic Neurochemistry, 5th ed, p130, 133%29%%A%    
% 224.82/225.03  |- skos__annotation mesh__D004676
% 224.82/225.03       /biosyn /drug eff /physiol /ultrastruct permitted; note X ref: do not index under ENCEPHALOMYELITIS, ALLERGIC unless the disease is discussed; DF: ENCEPH BASIC PROTEINS%A%  
% 224.82/225.03  |- mesh__recordAuthorizer mesh__D004676 sjn
% 224.82/225.03  |- skos__prefLabel mesh__D004676 Myelin Basic Proteins
% 224.82/225.03  |- skos__altLabel mesh__D004676 Encephalitogenic Basic Protein
% 224.82/225.03  |- skos__historyNote mesh__D004676 Nerve Tissue Proteins %28%1966-1972%29%
% 224.82/225.03  |- mesh__historyNote mesh__D004676
% 224.82/225.03       96; was ENCEPHALITOGENIC BASIC PROTEINS 1973-95 %28%Prov 1974%29%; MYELIN BASIC PROTEINS was see ENCEPHALITOGENIC BASIC PROTEINS 1979-95%A%  
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D004676 2006
% 224.82/225.03  |- skos__hiddenLabel mesh__D004676 Protein, Neuritogenic
% 224.82/225.03  |- mesh__dateRevised mesh__D004676 2005-06-30
% 224.82/225.03  |- skos__altLabel mesh__D004676 Basic Proteins, Encephalitogenic
% 224.82/225.03  |- skos__hiddenLabel mesh__D004676 Basic Proteins, Myelin
% 224.82/225.03  |- skos__altLabel mesh__D004676 Proteins, Encephalitogenic Basic
% 224.82/225.03  |- mesh__dateEstablished mesh__D004676 1974-01-01
% 224.82/225.03  |- rdf__type mesh__D004676sskos__Concept
% 224.82/225.03  |- mesh__recordOriginator mesh__D004676 NLM
% 224.82/225.03  |- mesh__dateCreated mesh__D004676 1999-01-01
% 224.82/225.03  |- mesh__publicMeSHNote mesh__D004676
% 224.82/225.03       96; was ENCEPHALITOGENIC BASIC PROTEINS 1974-95; MYELIN BASIC PROTEINS was see ENCEPHALITOGENIC BASIC PROTEINS 1979-95%A%  
% 224.82/225.03  |- skos__altLabel mesh__D004676 Encephalitogenic Basic Proteins
% 224.82/225.03  |- mesh__recordMaintainer mesh__D004676 SYSTEM
% 224.82/225.03  |- mesh__dateRevised mesh__D009361 2000-06-22
% 224.82/225.03  |- mesh__historyNote mesh__D009361 77   
% 224.82/225.03  |- mesh__recordAuthorizer mesh__D009361 sjn
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D009361 2002
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D009361 2006
% 224.82/225.03  |- mesh__dateEstablished mesh__D009361 1977-01-01
% 224.82/225.03  |- mesh__publicMeSHNote mesh__D009361 77   
% 224.82/225.03  |- mesh__recordOriginator mesh__D009361 VDK
% 224.82/225.03  |- skos__altLabel mesh__D009361 Invasiveness, Neoplasm
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D009361 2001
% 224.82/225.03  |- mesh__dateCreated mesh__D009361 1976-05-19
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D009361 2003
% 224.82/225.03  |- rdf__type mesh__D009361sskos__Concept
% 224.82/225.03  |- skos__broader mesh__D009361smesh__D009385
% 224.82/225.03  |- skos__annotation mesh__D009361
% 224.82/225.03       IM for GEN only or for invasive process; when IM for GEN only, qualif permitted; NIM with no qualif + neopl terms /pathol %28%IM%29%; do not use for specific histologically invasive tumors %28%e.g., invasive fibroma = FIBROMATOSIS, AGGRESSIVE in Tumor Key %26% not also NEOPLASM INVASIVENESS%29%; DF: NEOPL INVASIVENESS%A%  
% 224.82/225.03  |- skos__prefLabel mesh__D009361 Neoplasm Invasiveness
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D009361 2005
% 224.82/225.03  |- mesh__recordMaintainer mesh__D009361 TPW
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D009361 2004
% 224.82/225.03  |- skos__related mesh__D009361smesh__D017254
% 224.82/225.03  |- skos__scopeNote mesh__D009361
% 224.82/225.03       Ability of neoplasms to infiltrate and actively destroy surrounding tissue.%A%    
% 224.82/225.03  |- skos__broader mesh__D004560Q000176smesh__D004560
% 224.82/225.03  |- mesh__preferredCombination mesh__D004560Q000176smesh__D004568
% 224.82/225.03  |- rdf__type mesh__D004560Q000176smesh__CompoundConcept
% 224.82/225.03  |- mesh__historyNote mesh__D008269 84   
% 224.82/225.03  |- skos__historyNote mesh__D008269 Edema %28%1966-1983%29%
% 224.82/225.03  |- skos__broader mesh__D008269smesh__D008268
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D008269 2006
% 224.82/225.03  |- mesh__dateRevised mesh__D008269 2004-07-07
% 224.82/225.03  |- mesh__recordAuthorizer mesh__D008269 sjn
% 224.82/225.03  |- mesh__dateCreated mesh__D008269 1983-02-07
% 224.82/225.03  |- mesh__dateEstablished mesh__D008269 1984-01-01
% 224.82/225.03  |- skos__hiddenLabel mesh__D008269 Cystoid Macular Edemas
% 224.82/225.03  |- skos__prefLabel mesh__D008269 Macular Edema, Cystoid
% 224.82/225.03  |- skos__altLabel mesh__D008269 Central Retinal Edema, Cystoid
% 224.82/225.03  |- mesh__publicMeSHNote mesh__D008269 84   
% 224.82/225.03  |- rdf__type mesh__D008269sskos__Concept
% 224.82/225.03  |- mesh__recordMaintainer mesh__D008269 lkt
% 224.82/225.03  |- skos__altLabel mesh__D008269 Cystoid Macular Edema
% 224.82/225.03  |- skos__scopeNote mesh__D008269
% 224.82/225.03       Fluid accumulation in the outer layer of the MACULA LUTEA at the center of the RETINA. Cystic spaces are formed and may lead to a macular depression or hole.%A%    
% 224.82/225.03  |- mesh__recordOriginator mesh__D008269 RC
% 224.82/225.03  |- skos__historyNote mesh__D008269 Macula Lutea %28%1966-1983%29%
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D008269 2005
% 224.82/225.03  |- mesh__recordAuthorizer mesh__D000286 PLS
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000286 2002
% 224.82/225.03  |- skos__historyNote mesh__D000286 Administration, Oral %28%1971-1987%29%
% 224.82/225.03  |- mesh__publicMeSHNote mesh__D000286 88   
% 224.82/225.03  |- skos__hiddenLabel mesh__D000286 Drug Administrations, Sublingual
% 224.82/225.03  |- skos__altLabel mesh__D000286 Sublingual Administration
% 224.82/225.03  |- mesh__dateCreated mesh__D000286 1987-05-07
% 224.82/225.03  |- mesh__recordMaintainer mesh__D000286 TGC
% 224.82/225.03  |- skos__altLabel mesh__D000286 Sublingual Drug Administration
% 224.82/225.03  |- skos__hiddenLabel mesh__D000286 Sublingual Drug Administrations
% 224.82/225.03  |- mesh__dateEstablished mesh__D000286 1988-01-01
% 224.82/225.03  |- skos__broader mesh__D000286smesh__D000284
% 224.82/225.03  |- rdf__type mesh__D000286sskos__Concept
% 224.82/225.03  |- skos__prefLabel mesh__D000286 Administration, Sublingual
% 224.82/225.03  |- skos__scopeNote mesh__D000286
% 224.82/225.03       Administration of a soluble dosage form by placement under the tongue.%A%    
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000286 1996
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000286 2000
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000286 1998
% 224.82/225.03  |- mesh__dateRevised mesh__D000286 1991-05-12
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000286 1997
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000286 1992
% 224.82/225.03  |- mesh__recordOriginator mesh__D000286 SCD
% 224.82/225.03  |- skos__hiddenLabel mesh__D000286 Administration, Sublingual Drug
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000286 2003
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000286 1994
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000286 2001
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000286 1999
% 224.82/225.03  |- mesh__historyNote mesh__D000286 88   
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000286 2005
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000286 1993
% 224.82/225.03  |- skos__hiddenLabel mesh__D000286 Administrations, Sublingual Drug
% 224.82/225.03  |- skos__hiddenLabel mesh__D000286 Administrations, Sublingual
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000286 2004
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000286 1995
% 224.82/225.03  |- skos__altLabel mesh__D000286 Drug Administration, Sublingual
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D000286 2006
% 224.82/225.03  |- skos__hiddenLabel mesh__D000286 Sublingual Administrations
% 224.82/225.03  |- skos__annotation mesh__D000286
% 224.82/225.03       NIM but only if discussed: do not index here routinely for every sublingually administered drug; no qualif%A%  
% 224.82/225.03  |- mesh__publicMeSHNote mesh__D027423 2002; see LAURACEAE 1998-2001   
% 224.82/225.03  |- mesh__recordMaintainer mesh__D027423 ssb
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D027423 2003
% 224.82/225.03  |- skos__altLabel mesh__D027423 Camphor Laurel
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D027423 2005
% 224.82/225.03  |- skos__historyNote mesh__D027423 Lauraceae %28%1996-2001%29%
% 224.82/225.03  |- rdf__type mesh__D027423sskos__Concept
% 224.82/225.03  |- skos__prefLabel mesh__D027423 Cinnamomum camphora
% 224.82/225.03  |- skos__scopeNote mesh__D027423
% 224.82/225.03       A tree, Cinnamomum camphora %28%L.%29% J. Presl, known as the source of CAMPHOR.%A%    
% 224.82/225.03  |- mesh__dateCreated mesh__D027423 2001-07-25
% 224.82/225.03  |- mesh__recordAuthorizer mesh__D027423 sjn
% 224.82/225.03  |- skos__altLabel mesh__D027423 Camphor Tree
% 224.82/225.03  |- mesh__historyNote mesh__D027423 2002; use LAURACEAE 1998-2001   
% 224.82/225.03  |- skos__broader mesh__D027423smesh__D027424
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D027423 2004
% 224.82/225.03  |- skos__annotation mesh__D027423
% 224.82/225.03       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.82/225.03  |- mesh__recordOriginator mesh__D027423 ssb
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D027423 2002
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D027423 2006
% 224.82/225.03  |- mesh__dateEstablished mesh__D027423 2002-01-01
% 224.82/225.03  |- skos__prefLabel mesh__D046388 Swallows
% 224.82/225.03  |- skos__altLabel mesh__D046388 Hirundinidae
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D046388 2005
% 224.82/225.03  |- skos__hiddenLabel mesh__D046388 Swallow, Barn
% 224.82/225.03  |- mesh__historyNote mesh__D046388 2005; use SONGBIRDS 1999-2004   
% 224.82/225.03  |- skos__scopeNote mesh__D046388
% 224.82/225.03       The family Hirundinidae, comprised of small BIRDS that hunt flying INSECTS while in sustained flight.%A%    
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D046388 2006
% 224.82/225.03  |- mesh__dateEstablished mesh__D046388 2005-01-01
% 224.82/225.03  |- skos__hiddenLabel mesh__D046388 Swallows, Barn
% 224.82/225.03  |- skos__historyNote mesh__D046388 Songbirds %28%1999-2004%29%
% 224.82/225.03  |- mesh__recordMaintainer mesh__D046388 ags
% 224.82/225.03  |- mesh__recordAuthorizer mesh__D046388 sjn
% 224.82/225.03  |- mesh__recordOriginator mesh__D046388 ags
% 224.82/225.03  |- rdf__type mesh__D046388sskos__Concept
% 224.82/225.03  |- skos__broader mesh__D046388smesh__D020308
% 224.82/225.03  |- mesh__publicMeSHNote mesh__D046388 2005; see SONGBIRDS 1999-2004   
% 224.82/225.03  |- mesh__dateCreated mesh__D046388 2004-07-07
% 224.82/225.03  |- skos__hiddenLabel mesh__D046388 Barn Swallows
% 224.82/225.03  |- skos__historyNote mesh__D046388 Birds %28%1965-1998%29%
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D013403 2006
% 224.82/225.03  |- skos__broader mesh__D013403smesh__D002241
% 224.82/225.03  |- skos__prefLabel mesh__D013403 Sugar Phosphates
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D013403 2005
% 224.82/225.03  |- mesh__publicMeSHNote mesh__D013403 74   
% 224.82/225.03  |- mesh__dateRevised mesh__D013403 2004-07-07
% 224.82/225.03  |- mesh__dateCreated mesh__D013403 1999-01-01
% 224.82/225.03  |- mesh__recordMaintainer mesh__D013403 ssb
% 224.82/225.03  |- rdf__type mesh__D013403sskos__Concept
% 224.82/225.03  |- mesh__dateEstablished mesh__D013403 1974-01-01
% 224.82/225.03  |- skos__hiddenLabel mesh__D013403 Phosphates, Sugar
% 224.82/225.03  |- mesh__historyNote mesh__D013403 74   
% 224.82/225.03  |- mesh__recordOriginator mesh__D013403 NLM
% 224.82/225.03  |- mesh__recordAuthorizer mesh__D013403 sjn
% 224.82/225.03  |- mesh__recordMaintainer mesh__D018697 ssb
% 224.82/225.03  |- skos__scopeNote mesh__D018697
% 224.82/225.03       Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. While no potent nootropic drugs have yet been accepted for general use, several are being actively investigated.%A%    
% 224.82/225.03  |- mesh__dateCreated mesh__D018697 1994-06-03
% 224.82/225.03  |- skos__prefLabel mesh__D018697 Nootropic Agents
% 224.82/225.03  |- mesh__publicMeSHNote mesh__D018697
% 224.82/225.03       95; NOOTRPIC DRUGS was see PSYCHOTROPIC DRUGS 1990-94   
% 224.82/225.03  |- mesh__historyNote mesh__D018697
% 224.82/225.03       95; NOOTRPIC DRUGS was see PSYCHOTROPIC DRUGS 1990-94   
% 224.82/225.03  |- skos__altLabel mesh__D018697 Nootropic Drugs
% 224.82/225.03  |- skos__hiddenLabel mesh__D018697 Drugs, Nootropic
% 224.82/225.03  |- rdf__type mesh__D018697sskos__Concept
% 224.82/225.03  |- skos__annotation mesh__D018697
% 224.82/225.03       CNS agents; from Greek nous, mind; GEN or unspecified: prefer specifics%A%  
% 224.82/225.03  |- skos__hiddenLabel mesh__D018697 Agents, Nootropic
% 224.82/225.03  |- mesh__recordAuthorizer mesh__D018697 sjn
% 224.82/225.03  |- skos__historyNote mesh__D018697 Psychotropic Drugs %28%1989-1994%29%
% 224.82/225.03  |- skos__hiddenLabel mesh__D018697 Enhancers, Cognitive
% 224.82/225.03  |- skos__altLabel mesh__D018697 Nootropics
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D018697 2006
% 224.82/225.03  |- mesh__recordOriginator mesh__D018697 TPW
% 224.82/225.03  |- mesh__onlineNote mesh__D018697
% 224.82/225.03       use PSYCHOTROPIC DRUGS to search NOOTROPIC DRUGS 1990-94   
% 224.82/225.03  |- skos__altLabel mesh__D018697 Cognitive Enhancers
% 224.82/225.03  |- mesh__dateRevised mesh__D018697 2005-06-30
% 224.82/225.03  |- mesh__dateEstablished mesh__D018697 1995-01-01
% 224.82/225.03  |- skos__broader mesh__D018697smesh__D002491
% 224.82/225.03  |- mesh__publicMeSHNote mesh__D051522
% 224.82/225.03       2006; FIBROBLAST GROWTH FACTOR 6  was indexed under FIBROBLAST GROWTH FACTORS %26% PROTO-ONCOGENE PROTEINS 1989-2005%A%  
% 224.82/225.03  |- mesh__historyNote mesh__D051522 2006%28%1989%29%   
% 224.82/225.03  |- skos__broader mesh__D051522smesh__D011518
% 224.82/225.03  |- mesh__recordMaintainer mesh__D051522 DRC
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D051522 2006
% 224.82/225.03  |- skos__broader mesh__D051522smesh__D005346
% 224.82/225.03  |- skos__hiddenLabel mesh__D051522 Heparin Secretory Transforming Protein 2
% 224.82/225.03  |- skos__scopeNote mesh__D051522
% 224.82/225.03       A fibroblast growth factor that was initially identified based on its sequence similarity to FIBROBLAST GROWTH FACTOR 4. It is found in MYOBLASTS and plays an important role in MUSCLE DEVELOPMENT.%A%    
% 224.82/225.03  |- mesh__dateCreated mesh__D051522 2005-06-30
% 224.82/225.03  |- skos__altLabel mesh__D051522 Heparin Secretory Transforming Protein-2
% 224.82/225.03  |- mesh__recordAuthorizer mesh__D051522 sjn
% 224.82/225.03  |- mesh__dateEstablished mesh__D051522 2006-01-01
% 224.82/225.03  |- skos__prefLabel mesh__D051522 Fibroblast Growth Factor 6
% 224.82/225.03  |- mesh__recordOriginator mesh__D051522 DRC
% 224.82/225.03  |- rdf__type mesh__D051522sskos__Concept
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D004677 2000
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D004677 2005
% 224.82/225.03  |- skos__hiddenLabel mesh__D004677 Encephaloceles, Frontal
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D004677 2004
% 224.82/225.03  |- skos__broader mesh__D004677smesh__D009436
% 224.82/225.03  |- skos__hiddenLabel mesh__D004677 Cerebral Hernias
% 224.82/225.03  |- skos__hiddenLabel mesh__D004677 Cerebral Hernia
% 224.82/225.03  |- skos__altLabel mesh__D004677 Hernia, Cerebral
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D004677 2001
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D004677 2006
% 224.82/225.03  |- skos__altLabel mesh__D004677 Encephalocele, Frontal
% 224.82/225.03  |- skos__hiddenLabel mesh__D004677 Hernias, Cerebral
% 224.82/225.03  |- skos__scopeNote mesh__D004677
% 224.82/225.03       Cerebral tissue herniation through a congenital or acquired defect in the skull. The majority of congenital encephaloceles occur in the occipital or frontal regions. Clinical features include a protuberant mass that may be pulsatile. The quantity and location of protruding neural tissue determines the type and degree of neurologic deficit. Visual defects, psychomotor developmental delay, and persistent motor deficits frequently occur.%A%    
% 224.82/225.03  |- skos__altLabel mesh__D004677 Sincipital Encephalocele
% 224.82/225.03  |- skos__altLabel mesh__D004677 Encephalocele, Occipital
% 224.82/225.03  |- mesh__recordMaintainer mesh__D004677 KEV
% 224.82/225.03  |- skos__hiddenLabel mesh__D004677 Encephaloceles, Occipital
% 224.82/225.03  |- mesh__recordAuthorizer mesh__D004677 sjn
% 224.82/225.03  |- skos__annotation mesh__D004677
% 224.82/225.03       cerebellar hernia: coord IM with CEREBELLUM /abnorm %28%IM%29% if congen or with CEREBELLAR DISEASES %28%IM%29% if traumatic; meningoencephalocele: coord IM with MENINGOCELE %28%IM%29%%A%  
% 224.82/225.03  |- rdf__type mesh__D004677sskos__Concept
% 224.82/225.03  |- mesh__dateCreated mesh__D004677 1999-01-01
% 224.82/225.03  |- skos__altLabel mesh__D004677 Notoencephalocele
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D004677 2002
% 224.82/225.03  |- skos__hiddenLabel mesh__D004677 Notoencephaloceles
% 224.82/225.03  |- skos__hiddenLabel mesh__D004677 Frontal Encephaloceles
% 224.82/225.03  |- skos__hiddenLabel mesh__D004677 Occipital Encephaloceles
% 224.82/225.03  |- skos__altLabel mesh__D004677 Encephalocele, Acquired
% 224.82/225.03  |- skos__hiddenLabel mesh__D004677 Sincipital Encephaloceles
% 224.82/225.03  |- skos__hiddenLabel mesh__D004677 Encephaloceles
% 224.82/225.03  |- skos__hiddenLabel mesh__D004677 Acquired Encephaloceles
% 224.82/225.03  |- skos__prefLabel mesh__D004677 Encephalocele
% 224.82/225.03  |- skos__hiddenLabel mesh__D004677 Encephaloceles, Sincipital
% 224.82/225.03  |- mesh__dateRevised mesh__D004677 1999-11-03
% 224.82/225.03  |- skos__hiddenLabel mesh__D004677 Encephaloceles, Acquired
% 224.82/225.03  |- mesh__recordOriginator mesh__D004677 NLM
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D004677 2003
% 224.82/225.03  |- skos__prefLabel mesh__D009362 Neoplasm Metastasis
% 224.82/225.03  |- mesh__dateCreated mesh__D009362 1999-01-01
% 224.82/225.03  |- mesh__recordAuthorizer mesh__D009362 sjn
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D009362 2002
% 224.82/225.03  |- skos__altLabel mesh__D009362 Metastases, Neoplasm
% 224.82/225.03  |- mesh__recordOriginator mesh__D009362 NLM
% 224.82/225.03  |- skos__annotation mesh__D009362
% 224.82/225.03       GEN only for metastatic process or neoplasm metast in general; when IM for GEN only, qualif permitted; unlikely as NIM coord: prefer /second with organ/neopl %26% histol type for metastatic neopl; policy on metastasis %26% /second: Manual 19.8.65, 24.3.1, 24.4.1.3+; do not confuse with NEOPLASM INVASIVENESS %28%Manual 24.4.1.1+%29%, LEUKEMIC INFILTRATION %28%Manual 24.4.1.2%29%, NEOPLASMS, SECOND PRIMARY %28%Manual 24.4.1.7%29% or NEOPLASM, RESIDUAL; DF: NEOPL METASTASIS%A%  
% 224.82/225.03  |- mesh__activeMeSHYear mesh__D009362 2003
% 224.82/225.03  |- skos__altLabel mesh__D009362 Neoplasm Metastases
% 224.82/225.03  |- rdf__type mesh__D009362sskos__Concept
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D009362 2005
% 224.82/225.04  |- mesh__recordMaintainer mesh__D009362 NDW
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D009362 2004
% 224.82/225.04  |- skos__hiddenLabel mesh__D009362 Metastases
% 224.82/225.04  |- skos__altLabel mesh__D009362 Metastasis, Neoplasm
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D009362 2001
% 224.82/225.04  |- mesh__dateRevised mesh__D009362 2000-06-22
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D009362 2006
% 224.82/225.04  |- skos__scopeNote mesh__D009362
% 224.82/225.04       The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.%A%    
% 224.82/225.04  |- skos__altLabel mesh__D009362 Metastasis
% 224.82/225.04  |- skos__broader mesh__D009362smesh__D009385
% 224.82/225.04  |- mesh__dateEstablished mesh__D033461 2003-01-01
% 224.82/225.04  |- mesh__historyNote mesh__D033461 2003   
% 224.82/225.04  |- rdf__type mesh__D033461sskos__Concept
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D033461 2003
% 224.82/225.04  |- skos__broader mesh__D033461smesh__D008659
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D033461 2004
% 224.82/225.04  |- skos__prefLabel mesh__D033461 Hyperuricemia
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D033461 2005
% 224.82/225.04  |- skos__scopeNote mesh__D033461
% 224.82/225.04       Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter %28%7.0mg/dL%29% in men or 0.36mmol per liter %28%6.0mg/dL%29% in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined %28%LESCH-NYHAN SYNDROME%29%. It is associated with HYPERTENSION and GOUT.%A%    
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D033461 2006
% 224.82/225.04  |- skos__historyNote mesh__D033461 Uric Acid %28%1963-2002%29%
% 224.82/225.04  |- mesh__publicMeSHNote mesh__D033461 2003   
% 224.82/225.04  |- mesh__dateCreated mesh__D033461 2002-07-03
% 224.82/225.04  |- skos__prefLabel mesh__D000287 Administration, Topical
% 224.82/225.04  |- mesh__dateCreated mesh__D000287 1999-01-01
% 224.82/225.04  |- skos__hiddenLabel mesh__D000287 Topical Administrations
% 224.82/225.04  |- mesh__recordOriginator mesh__D000287 NLM
% 224.82/225.04  |- skos__hiddenLabel mesh__D000287 Topical Drug Administrations
% 224.82/225.04  |- rdf__type mesh__D000287sskos__Concept
% 224.82/225.04  |- skos__hiddenLabel mesh__D000287 Drug Administrations, Topical
% 224.82/225.04  |- skos__hiddenLabel mesh__D000287 Administrations, Topical Drug
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D000287 2002
% 224.82/225.04  |- skos__broader mesh__D000287smesh__D004333
% 224.82/225.04  |- mesh__dateEstablished mesh__D000287 1974-01-01
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D000287 2003
% 224.82/225.04  |- mesh__recordAuthorizer mesh__D000287 sjn
% 224.82/225.04  |- mesh__publicMeSHNote mesh__D000287 74   
% 224.82/225.04  |- skos__altLabel mesh__D000287 Topical Drug Administration
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D000287 2005
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D000287 2004
% 224.82/225.04  |- skos__annotation mesh__D000287
% 224.82/225.04       NIM but only if discussed: do not index here routinely for every topically administered drug; no qualif; consider also OINTMENTS; LINIMENTS %26% POWDERS; ADMINISTRATION, CUTANEOUS is also available%A%  
% 224.82/225.04  |- mesh__recordMaintainer mesh__D000287 mdb
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D000287 2006
% 224.82/225.04  |- mesh__dateRevised mesh__D000287 2001-07-25
% 224.82/225.04  |- mesh__historyNote mesh__D000287 74   
% 224.82/225.04  |- skos__hiddenLabel mesh__D000287 Administrations, Topical
% 224.82/225.04  |- skos__altLabel mesh__D000287 Topical Administration
% 224.82/225.04  |- skos__altLabel mesh__D000287 Administration, Topical Drug
% 224.82/225.04  |- skos__altLabel mesh__D000287 Drug Administration, Topical
% 224.82/225.04  |- skos__hiddenLabel mesh__D005770 Gastrointestinal Tract Cancer
% 224.82/225.04  |- skos__hiddenLabel mesh__D005770 Gastrointestinal Neoplasm
% 224.82/225.04  |- rdf__type mesh__D005770sskos__Concept
% 224.82/225.04  |- skos__prefLabel mesh__D005770 Gastrointestinal Neoplasms
% 224.82/225.04  |- skos__broader mesh__D005770smesh__D004067
% 224.82/225.04  |- mesh__recordMaintainer mesh__D005770 sjn
% 224.82/225.04  |- skos__altLabel mesh__D005770 Neoplasms, Gastrointestinal
% 224.82/225.04  |- skos__annotation mesh__D005770
% 224.82/225.04       GEN: prefer specific precoord; coord IM with histol type of neopl %28%IM%29%%A%  
% 224.82/225.04  |- skos__altLabel mesh__D005770 Cancer of the Gastrointestinal Tract
% 224.82/225.04  |- mesh__dateCreated mesh__D005770 1999-01-01
% 224.82/225.04  |- skos__broader mesh__D005770smesh__D005767
% 224.82/225.04  |- skos__hiddenLabel mesh__D005770 Gastrointestinal Tract Cancers
% 224.82/225.04  |- mesh__recordAuthorizer mesh__D005770 sjn
% 224.82/225.04  |- skos__hiddenLabel mesh__D005770 Neoplasm, Gastrointestinal
% 224.82/225.04  |- skos__altLabel mesh__D005770 Gastrointestinal Cancer
% 224.82/225.04  |- skos__hiddenLabel mesh__D005770 Cancer, Gastrointestinal
% 224.82/225.04  |- mesh__recordOriginator mesh__D005770 NLM
% 224.82/225.04  |- skos__hiddenLabel mesh__D005770 Gastrointestinal Cancers
% 224.82/225.04  |- skos__hiddenLabel mesh__D005770 Cancers, Gastrointestinal
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D005770 2006
% 224.82/225.04  |- mesh__dateRevised mesh__D005770 2005-07-01
% 224.82/225.04  |- skos__scopeNote mesh__D005770
% 224.82/225.04       Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL.%A%    
% 224.82/225.04  |- skos__prefLabel mesh__D027424 Cinnamomum
% 224.82/225.04  |- skos__historyNote mesh__D027424 Lauraceae %28%1996-2001%29%
% 224.82/225.04  |- mesh__recordMaintainer mesh__D027424 ssb
% 224.82/225.04  |- mesh__dateRevised mesh__D027424 2002-07-03
% 224.82/225.04  |- skos__broader mesh__D027424smesh__D019770
% 224.82/225.04  |- rdf__type mesh__D027424sskos__Concept
% 224.82/225.04  |- mesh__recordOriginator mesh__D027424 ssb
% 224.82/225.04  |- mesh__dateEstablished mesh__D027424 2002-01-01
% 224.82/225.04  |- skos__annotation mesh__D027424
% 224.82/225.04       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.82/225.04  |- mesh__dateCreated mesh__D027424 2001-07-25
% 224.82/225.04  |- mesh__publicMeSHNote mesh__D027424 2002   
% 224.82/225.04  |- skos__scopeNote mesh__D027424
% 224.82/225.04       A plant genus in the LAURACEAE family. The bark of the trees is used in FOLK MEDICINE and FLAVORING AGENTS.%A%    
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D027424 2003
% 224.82/225.04  |- mesh__historyNote mesh__D027424 2002   
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D027424 2005
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D027424 2004
% 224.82/225.04  |- mesh__recordAuthorizer mesh__D027424 sjn
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D027424 2006
% 224.82/225.04  |- skos__related mesh__D013404smesh__D010565
% 224.82/225.04  |- mesh__dateCreated mesh__D013404 1999-01-01
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D013404 2003
% 224.82/225.04  |- skos__prefLabel mesh__D013404 Suggestion
% 224.82/225.04  |- rdf__type mesh__D013404sskos__Concept
% 224.82/225.04  |- mesh__recordOriginator mesh__D013404 NLM
% 224.82/225.04  |- mesh__recordAuthorizer mesh__D013404 sjn
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D013404 2002
% 224.82/225.04  |- skos__related mesh__D013404smesh__D001326
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D013404 2006
% 224.82/225.04  |- skos__hiddenLabel mesh__D013404 Suggestions
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D013404 2005
% 224.82/225.04  |- skos__broader mesh__D013404smesh__D006990
% 224.82/225.04  |- mesh__dateRevised mesh__D013404 2001-07-25
% 224.82/225.04  |- mesh__recordMaintainer mesh__D013404 ssb
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D013404 2004
% 224.82/225.04  |- skos__annotation mesh__D013404
% 224.82/225.04       no qualif; consider also PERSUASION see PERSUASIVE COMMUNICATION%A%  
% 224.82/225.04  |- skos__scopeNote mesh__D013404
% 224.82/225.04       The uncritical acceptance of an idea or plan of action.%A%    
% 224.82/225.04  |- rdf__type mesh__D018698sskos__Concept
% 224.82/225.04  |- skos__broader mesh__D018698smesh__D018846
% 224.82/225.04  |- skos__scopeNote mesh__D018698
% 224.82/225.04       A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM.%A%    
% 224.82/225.04  |- skos__annotation mesh__D018698
% 224.82/225.04       /agon = EXCITATORY AMINO ACID AGONISTS; /antag = EXCITATORY AMINO ACID ANTAGONISTS%A%  
% 224.82/225.04  |- mesh__dateRevised mesh__D018698 2005-06-30
% 224.82/225.04  |- mesh__dateEstablished mesh__D018698 1995-01-01
% 224.82/225.04  |- mesh__recordMaintainer mesh__D018698 ssb
% 224.82/225.04  |- mesh__dateCreated mesh__D018698 1994-06-03
% 224.82/225.04  |- skos__hiddenLabel mesh__D018698 L Glutamic Acid
% 224.82/225.04  |- skos__broader mesh__D018698smesh__D000600
% 224.82/225.04  |- mesh__historyNote mesh__D018698
% 224.82/225.04       95; was GLUTAMIC ACID %28%NM%29% 1981-94   
% 224.82/225.04  |- skos__prefLabel mesh__D018698 Glutamic Acid
% 224.82/225.04  |- skos__altLabel mesh__D018698 L-Glutamate
% 224.82/225.04  |- mesh__recordAuthorizer mesh__D018698 sjn
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D018698 2006
% 224.82/225.04  |- mesh__publicMeSHNote mesh__D018698
% 224.82/225.04       95; GLUTAMIC ACID was indexed under GLUTAMATES 1981-94   
% 224.82/225.04  |- skos__broader mesh__D018698smesh__D024342
% 224.82/225.04  |- skos__hiddenLabel mesh__D018698 L Glutamate
% 224.82/225.04  |- mesh__onlineNote mesh__D018698
% 224.82/225.04       use GLUTAMIC ACID %28%NM%29% to search GLUTAMIC ACID 1981-94   
% 224.82/225.04  |- skos__related mesh__D018698smesh__D017470
% 224.82/225.04  |- skos__hiddenLabel mesh__D018698 D Glutamate
% 224.82/225.04  |- skos__altLabel mesh__D018698 L-Glutamic Acid
% 224.82/225.04  |- mesh__recordOriginator mesh__D018698 RAZ
% 224.82/225.04  |- skos__broader mesh__D003141Q000517smesh__D003141
% 224.82/225.04  |- mesh__preferredCombination mesh__D003141Q000517smesh__D003140
% 224.82/225.04  |- rdf__type mesh__D003141Q000517smesh__CompoundConcept
% 224.82/225.04  |- mesh__publicMeSHNote mesh__D051523
% 224.82/225.04       2006; FIBROBLAST GROWTH FACTOR 7 was indexed under FIBROBLAST GROWTH FACTORS 2002-2005, %26% under GROWTH SUBSTANCES 1989-2001%A%  
% 224.82/225.04  |- skos__broader mesh__D051523smesh__D005346
% 224.82/225.04  |- mesh__dateCreated mesh__D051523 2005-06-30
% 224.82/225.04  |- skos__hiddenLabel mesh__D051523 Growth Factor, Keratinocyte
% 224.82/225.04  |- mesh__recordAuthorizer mesh__D051523 sjn
% 224.82/225.04  |- mesh__recordMaintainer mesh__D051523 DRC
% 224.82/225.04  |- skos__altLabel mesh__D051523 Keratinocyte Growth Factor
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D051523 2006
% 224.82/225.04  |- mesh__dateEstablished mesh__D051523 2006-01-01
% 224.82/225.04  |- mesh__recordOriginator mesh__D051523 DRC
% 224.82/225.04  |- skos__altLabel mesh__D051523 Palifermin
% 224.82/225.04  |- skos__prefLabel mesh__D051523 Fibroblast Growth Factor 7
% 224.82/225.04  |- mesh__historyNote mesh__D051523 2006%28%1989%29%   
% 224.82/225.04  |- skos__scopeNote mesh__D051523
% 224.82/225.04       A fibroblast growth factor that is a specific mitogen for EPITHELIAL CELLS. It binds a complex of HEPARAN SULFATE and FIBROBLAST GROWTH FACTOR RECEPTOR 2B.%A%    
% 224.82/225.04  |- rdf__type mesh__D051523sskos__Concept
% 224.82/225.04  |- skos__scopeNote mesh__D004678
% 224.82/225.04       Softening or loss of brain tissue following CEREBRAL INFARCTION; cerebral ischemia %28%see BRAIN ISCHEMIA%29%, infection, CRANIOCEREBRAL TRAUMA, or other injury. The term is often used during gross pathologic inspection to describe blurred cortical margins and decreased consistency of brain tissue following infarction. Multicystic encephalomalacia refers to the formation of multiple cystic cavities of various sizes in the cerebral cortex of neonates and infants following injury, most notably perinatal hypoxia-ischemic events. %28%From Davis et al., Textbook of Neuropathology, 2nd ed, p665; J Neuropathol Exp Neurol, 1995 Mar;54%28%2%29%:268-75%29%%A%    
% 224.82/225.04  |- rdf__type mesh__D004678sskos__Concept
% 224.82/225.04  |- mesh__dateRevised mesh__D004678 2001-07-25
% 224.82/225.04  |- mesh__dateCreated mesh__D004678 1999-01-01
% 224.82/225.04  |- skos__hiddenLabel mesh__D004678 Multicystic Encephalomalacias
% 224.82/225.04  |- skos__hiddenLabel mesh__D004678 Cerebromalacias
% 224.82/225.04  |- mesh__recordOriginator mesh__D004678 NLM
% 224.82/225.04  |- skos__altLabel mesh__D004678 Cerebromalacia
% 224.82/225.04  |- mesh__historyNote mesh__D004678 1966%28%1964%29%   
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D004678 2003
% 224.82/225.04  |- skos__altLabel mesh__D004678 Encephalomalacia, Multicystic
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D004678 2005
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D004678 2004
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D004678 2006
% 224.82/225.04  |- mesh__dateEstablished mesh__D004678 1966-01-01
% 224.82/225.04  |- skos__hiddenLabel mesh__D004678 Encephalomalacias
% 224.82/225.04  |- mesh__recordAuthorizer mesh__D004678 sjn
% 224.82/225.04  |- skos__hiddenLabel mesh__D004678 Encephalomalacias, Multicystic
% 224.82/225.04  |- skos__broader mesh__D004678smesh__D001927
% 224.82/225.04  |- skos__prefLabel mesh__D004678 Encephalomalacia
% 224.82/225.04  |- mesh__publicMeSHNote mesh__D004678 1966   
% 224.82/225.04  |- mesh__recordMaintainer mesh__D004678 ags
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D004678 2002
% 224.82/225.04  |- rdf__type mesh__D009363sskos__Concept
% 224.82/225.04  |- skos__related mesh__D009363smesh__D000951
% 224.82/225.04  |- skos__related mesh__D009363smesh__D014408
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D009363 2006
% 224.82/225.04  |- skos__hiddenLabel mesh__D009363 Proteins, Neoplasm
% 224.82/225.04  |- skos__scopeNote mesh__D009363
% 224.82/225.04       Proteins whose abnormal expression %28%gain or loss%29% are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens %28%ANTIGENS, NEOPLASM%29%, i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers %28%TUMOR MARKERS, BIOLOGICAL%29% when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm.%A%    
% 224.82/225.04  |- mesh__recordAuthorizer mesh__D009363 sjn
% 224.82/225.04  |- skos__broader mesh__D009363smesh__D011506
% 224.82/225.04  |- mesh__recordMaintainer mesh__D009363 SYSTEM
% 224.82/225.04  |- mesh__dateRevised mesh__D009363 2005-06-30
% 224.82/225.04  |- mesh__recordOriginator mesh__D009363 NLM
% 224.82/225.04  |- mesh__dateCreated mesh__D009363 1999-01-01
% 224.82/225.04  |- skos__prefLabel mesh__D009363 Neoplasm Proteins
% 224.82/225.04  |- skos__annotation mesh__D009363
% 224.82/225.04       IM %26% coord with specific protein %28%IM%29% + specific histol type %28%IM%29% + specific organ/neoplasms term %28%IM%29%; Manual 24.4.4.4%A%  
% 224.82/225.04  |- mesh__dateEstablished mesh__D009363 1963-01-01
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D001380 2001
% 224.82/225.04  |- skos__historyNote mesh__D001380 Antimetabolites %28%1966-1971%29%
% 224.82/225.04  |- skos__hiddenLabel mesh__D001380 6 Azauridine
% 224.82/225.04  |- skos__altLabel mesh__D001380 6-Azauridine
% 224.82/225.04  |- skos__altLabel mesh__D001380
% 224.82/225.04       2-beta-D-Ribofuranosyl-1,2,4-triazine-3,5%28%2H,4H%29%-dione
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D001380 2005
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D001380 2002
% 224.82/225.04  |- skos__broader mesh__D001380smesh__D001372
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D001380 2003
% 224.82/225.04  |- mesh__historyNote mesh__D001380 73%28%72%29%   
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D001380 2006
% 224.82/225.04  |- skos__scopeNote mesh__D001380
% 224.82/225.04       A triazine nucleoside used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic.%A%    
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D001380 2004
% 224.82/225.04  |- mesh__recordAuthorizer mesh__D001380 sjn
% 224.82/225.04  |- skos__prefLabel mesh__D001380 Azauridine
% 224.82/225.04  |- mesh__recordMaintainer mesh__D001380 CCR
% 224.82/225.04  |- mesh__dateRevised mesh__D001380 2000-06-21
% 224.82/225.04  |- rdf__type mesh__D001380sskos__Concept
% 224.82/225.04  |- mesh__publicMeSHNote mesh__D001380 73   
% 224.82/225.04  |- mesh__dateEstablished mesh__D001380 1973-01-01
% 224.82/225.04  |- skos__broader mesh__D001380smesh__D014529
% 224.82/225.04  |- skos__historyNote mesh__D001380 Uridine %28%1966-1971%29%
% 224.82/225.04  |- mesh__dateCreated mesh__D001380 1999-01-01
% 224.82/225.04  |- mesh__recordOriginator mesh__D001380 NLM
% 224.82/225.04  |- skos__broader mesh__D019791smesh__D006146
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D019791 2001
% 224.82/225.04  |- mesh__historyNote mesh__D019791 98; use GUANIDINE %28%NM%29% 1974-97   
% 224.82/225.04  |- skos__altLabel mesh__D019791 Guanidinium Chloride
% 224.82/225.04  |- rdf__type mesh__D019791sskos__Concept
% 224.82/225.04  |- skos__hiddenLabel mesh__D019791 Monohydrate, Guanidine
% 224.82/225.04  |- skos__altLabel mesh__D019791 Guanidine Monohydrochloride
% 224.82/225.04  |- skos__hiddenLabel mesh__D019791 Monohydroiodine, Guanidine
% 224.82/225.04  |- skos__hiddenLabel mesh__D019791 Monohydrobromide, Guanidine
% 224.82/225.04  |- skos__altLabel mesh__D019791 Guanidinium
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D019791 2002
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D019791 2003
% 224.82/225.04  |- skos__hiddenLabel mesh__D019791 Monohydrochloride, Guanidine
% 224.82/225.04  |- skos__historyNote mesh__D019791 Guanidines %28%1974-1997%29%
% 224.82/225.04  |- mesh__dateCreated mesh__D019791 1997-06-20
% 224.82/225.04  |- mesh__recordMaintainer mesh__D019791 jmp
% 224.82/225.04  |- skos__hiddenLabel mesh__D019791 Chloride, Guanidinium
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D019791 2004
% 224.82/225.04  |- skos__scopeNote mesh__D019791
% 224.82/225.04       A strong organic base existing primarily as guanidium ions at physiological pH. It is found in the urine as a normal product of protein metabolism. It is also used in laboratory research as a protein denaturant. %28%From Martindale, the Extra Pharmacopoeia, 30th ed and Merck Index, 12th ed%29% It is also used in the treatment of myasthenia and as a fluorescent probe in HPLC.%A%    
% 224.82/225.04  |- skos__hiddenLabel mesh__D019791 Nitrate, Guanidine
% 224.82/225.04  |- skos__altLabel mesh__D019791 Guanidium Chloride
% 224.82/225.04  |- skos__prefLabel mesh__D019791 Guanidine
% 224.82/225.04  |- skos__hiddenLabel mesh__D019791 Sulfate, Guanidine
% 224.82/225.04  |- skos__hiddenLabel mesh__D019791 Chloride, Guanidium
% 224.82/225.04  |- skos__hiddenLabel mesh__D019791 Hydrochloride, Guanidine
% 224.82/225.04  |- mesh__dateRevised mesh__D019791 2000-06-22
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D019791 2005
% 224.82/225.04  |- mesh__dateEstablished mesh__D019791 1998-01-01
% 224.82/225.04  |- mesh__recordOriginator mesh__D019791 KEV
% 224.82/225.04  |- mesh__recordAuthorizer mesh__D019791 sjn
% 224.82/225.04  |- skos__hiddenLabel mesh__D019791 Phosphate, Guanidine
% 224.82/225.04  |- mesh__publicMeSHNote mesh__D019791
% 224.82/225.04       98; GUANIDINE was indexed under GUANIDINES 1974-97   
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D019791 2006
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D000288 2002
% 224.82/225.04  |- skos__historyNote mesh__D000288
% 224.82/225.04       Organization and Administration %28%1966-1967%29%
% 224.82/225.04  |- mesh__publicMeSHNote mesh__D000288 68   
% 224.82/225.04  |- skos__hiddenLabel mesh__D000288 Administrator
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D000288 2005
% 224.82/225.04  |- mesh__recordAuthorizer mesh__D000288 PLS
% 224.82/225.04  |- skos__hiddenLabel mesh__D000288 Personnel, Administrative
% 224.82/225.04  |- skos__prefLabel mesh__D000288 Administrative Personnel
% 224.82/225.04  |- rdf__type mesh__D000288sskos__Concept
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D000288 1997
% 224.82/225.04  |- skos__scopeNote mesh__D000288
% 224.82/225.04       Individuals responsible for the development of policy and supervision of the execution of plans and functional operations.%A%    
% 224.82/225.04  |- mesh__dateCreated mesh__D000288 1999-01-01
% 224.82/225.04  |- mesh__recordOriginator mesh__D000288 NLM
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D000288 2001
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D000288 1996
% 224.82/225.04  |- mesh__historyNote mesh__D000288 68   
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D000288 2004
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D000288 1999
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D000288 2000
% 224.82/225.04  |- skos__hiddenLabel mesh__D000288 Policy Maker
% 224.82/225.04  |- mesh__dateEstablished mesh__D000288 1968-01-01
% 224.82/225.04  |- mesh__dateRevised mesh__D000288 1994-03-17
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D000288 2003
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D000288 1995
% 224.82/225.04  |- mesh__recordMaintainer mesh__D000288 PLS
% 224.82/225.04  |- skos__broader mesh__D000288smesh__D009274
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D000288 1998
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D000288 2006
% 224.82/225.04  |- rdf__type mesh__D027425sskos__Concept
% 224.82/225.04  |- mesh__publicMeSHNote mesh__D027425
% 224.82/225.04       2002; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN was indexed under ABC TRANSPORTERS 1994-2001; MOAT PROTEIN %26% MULTISPECIFIC ORGANIC ANION TRANSPORTER were indexed under CARRIER PROTEINS 1995-2001%A%  
% 224.82/225.04  |- skos__scopeNote mesh__D027425
% 224.82/225.04       A sequence-related subfamily of ATP-BINDING CASSETTE TRANSPORTERS that actively transport organic substrates. Although considered organic anion transporters, a subset of proteins in this family have also been shown to convey drug resistance to neutral organic drugs. Their cellular function may have clinical significance for CHEMOTHERAPY in that they transport a variety of ANTINEOPLASTIC AGENTS. Overexpression of proteins in this class by NEOPLASMS is considered a possible mechanism in the development of multidrug resistance %28%DRUG RESISTANCE, MULTIPLE%29%.  Although similar in function to P-GLYCOPROTEINS, the proteins in this class share little sequence homology to the p-glycoprotein family of proteins.%A%    
% 224.82/225.04  |- skos__related mesh__D027425smesh__D018435
% 224.82/225.04  |- mesh__recordAuthorizer mesh__D027425 sjn
% 224.82/225.04  |- mesh__recordOriginator mesh__D027425 jmp
% 224.82/225.04  |- skos__hiddenLabel mesh__D027425
% 224.82/225.04       ATP Binding Cassette, Sub Family C Proteins
% 224.82/225.04  |- skos__altLabel mesh__D027425 Multispecific Organic Anion Transporter
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D027425 2002
% 224.82/225.04  |- mesh__dateEstablished mesh__D027425 2002-01-01
% 224.82/225.04  |- mesh__recordMaintainer mesh__D027425 jmp
% 224.82/225.04  |- skos__prefLabel mesh__D027425 Multidrug Resistance-Associated Proteins
% 224.82/225.04  |- skos__broader mesh__D027425smesh__D018528
% 224.82/225.04  |- mesh__historyNote mesh__D027425
% 224.82/225.04       2002; use MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS %28%NM%29% 1994-2001; for MOAT PROTEIN %26% MULTISPECIFIC ORGANIC ANION TRANSPORTER use ANION TRANSPORT PROTEINS 1995-2001%A%  
% 224.82/225.04  |- skos__altLabel mesh__D027425 ATP-Binding Cassette, Sub-Family C Proteins
% 224.82/225.04  |- skos__hiddenLabel mesh__D027425 Resistance-Associated Protein, Multidrug
% 224.82/225.04  |- skos__broader mesh__D027425smesh__D029365
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D027425 2003
% 224.82/225.04  |- skos__hiddenLabel mesh__D027425 Multidrug Resistance Associated Protein
% 224.82/225.04  |- skos__historyNote mesh__D027425 P-Glycoprotein %28%1987-2001%29%
% 224.82/225.04  |- skos__altLabel mesh__D027425
% 224.82/225.04       Multispecific Organic Anion Transport Proteins
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D027425 2005
% 224.82/225.04  |- skos__related mesh__D027425smesh__D018432
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D027425 2004
% 224.82/225.04  |- mesh__dateCreated mesh__D027425 2001-07-25
% 224.82/225.04  |- skos__hiddenLabel mesh__D027425 Multidrug Resistance Associated Proteins
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D027425 2006
% 224.82/225.04  |- skos__altLabel mesh__D027425 Multidrug Resistance-Associated Protein
% 224.82/225.04  |- skos__altLabel mesh__D027425 MOAT Protein
% 224.82/225.04  |- skos__broader mesh__D013405smesh__D016728
% 224.82/225.04  |- mesh__recordMaintainer mesh__D013405 ssb
% 224.82/225.04  |- skos__broader mesh__D013405smesh__D012940
% 224.82/225.04  |- skos__scopeNote mesh__D013405 The act of killing oneself.     
% 224.82/225.04  |- mesh__dateRevised mesh__D013405 2003-07-09
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D013405 2006
% 224.82/225.04  |- mesh__recordOriginator mesh__D013405 NLM
% 224.82/225.04  |- mesh__recordAuthorizer mesh__D013405 sjn
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D013405 2005
% 224.82/225.04  |- skos__prefLabel mesh__D013405 Suicide
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D013405 2004
% 224.82/225.04  |- mesh__dateCreated mesh__D013405 1999-01-01
% 224.82/225.04  |- rdf__type mesh__D013405sskos__Concept
% 224.82/225.04  |- skos__annotation mesh__D013405 PARASUICIDE is also available   
% 224.82/225.04  |- skos__hiddenLabel mesh__D013405 Suicides
% 224.82/225.04  |- skos__scopeNote mesh__D018699
% 224.82/225.04       Vesicles formed when cell-membrane coated pits %28%COATED PITS, CELL-MEMBRANE%29% invaginate and pinch off. The outer surface of these vesicles are covered with a lattice-like network of coat proteins, such as CLATHRIN, coat protein complex proteins, or CAVEOLINS.%A%    
% 224.82/225.04  |- skos__prefLabel mesh__D018699 Coated Vesicles
% 224.82/225.04  |- rdf__type mesh__D018699sskos__Concept
% 224.82/225.04  |- skos__broader mesh__D018699smesh__D022161
% 224.82/225.04  |- skos__hiddenLabel mesh__D018699 Vesicles, Coated
% 224.82/225.04  |- skos__historyNote mesh__D018699
% 224.82/225.04       Coated Pits, Cell-Membrane %28%1983-1994%29%
% 224.82/225.04  |- mesh__recordMaintainer mesh__D018699 nns
% 224.82/225.04  |- skos__hiddenLabel mesh__D018699 Coated Vesicle
% 224.82/225.04  |- skos__annotation mesh__D018699 GEN: prefer specifics   
% 224.82/225.04  |- mesh__historyNote mesh__D018699 95   
% 224.82/225.04  |- mesh__dateEstablished mesh__D018699 1995-01-01
% 224.82/225.04  |- mesh__publicMeSHNote mesh__D018699 95   
% 224.82/225.04  |- skos__hiddenLabel mesh__D018699 Vesicle, Coated
% 224.82/225.04  |- mesh__dateRevised mesh__D018699 2003-07-09
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D018699 2006
% 224.82/225.04  |- mesh__dateCreated mesh__D018699 1994-04-19
% 224.82/225.04  |- mesh__recordOriginator mesh__D018699 PXP
% 224.82/225.04  |- mesh__recordAuthorizer mesh__D018699 sjn
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D018699 2005
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D018699 2004
% 224.82/225.04  |- mesh__publicMeSHNote mesh__D051524
% 224.82/225.04       2006; FIBROBLAST GROWTH FACTOR 8  was indexed under FIBROBLAST GROWTH FACTORS 1999-2005, %26% under  GROWTH SUBSTANCES 1992-1998, %26% under NEOPLASM PROTEINS 1992-1996%A%  
% 224.82/225.04  |- mesh__activeMeSHYear mesh__D051524 2006
% 224.82/225.04  |- skos__prefLabel mesh__D051524 Fibroblast Growth Factor 8
% 224.82/225.04  |- skos__scopeNote mesh__D051524
% 224.82/225.04       A fibroblast growth factor that preferentially activates FIBROBLAST GROWTH FACTOR RECEPTOR 4. It was initially identified as an androgen-induced growth factor and plays a role in regulating growth of human BREAST NEOPLASMS and PROSTATIC NEOPLASMS.%A%    
% 224.82/225.05  |- mesh__dateCreated mesh__D051524 2005-06-30
% 224.82/225.05  |- mesh__recordOriginator mesh__D051524 DRC
% 224.82/225.05  |- mesh__historyNote mesh__D051524 2006%28%1992%29%   
% 224.82/225.05  |- mesh__recordAuthorizer mesh__D051524 sjn
% 224.82/225.05  |- mesh__recordMaintainer mesh__D051524 DRC
% 224.82/225.05  |- skos__hiddenLabel mesh__D051524 Androgen Induced Growth Factor
% 224.82/225.05  |- mesh__dateEstablished mesh__D051524 2006-01-01
% 224.82/225.05  |- rdf__type mesh__D051524sskos__Concept
% 224.82/225.05  |- skos__broader mesh__D051524smesh__D005346
% 224.82/225.05  |- skos__hiddenLabel mesh__D051524 Growth Factor, Androgen-Induced
% 224.82/225.05  |- skos__altLabel mesh__D051524 Androgen-Induced Growth Factor
% 224.82/225.05  |- rdf__type mesh__D004679sskos__Concept
% 224.82/225.05  |- mesh__dateCreated mesh__D004679 1999-01-01
% 224.82/225.05  |- mesh__recordMaintainer mesh__D004679 KEV
% 224.82/225.05  |- skos__broader mesh__D004679smesh__D002494
% 224.82/225.05  |- skos__hiddenLabel mesh__D004679 Myeloencephalitides
% 224.82/225.05  |- mesh__recordOriginator mesh__D004679 NLM
% 224.82/225.05  |- mesh__dateRevised mesh__D004679 1999-11-03
% 224.82/225.05  |- skos__prefLabel mesh__D004679 Encephalomyelitis
% 224.82/225.05  |- skos__altLabel mesh__D004679 Myeloencephalitis
% 224.82/225.05  |- skos__broader mesh__D004679smesh__D002493
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D004679 2000
% 224.82/225.05  |- skos__altLabel mesh__D004679 Inflammatory Encephalomyelitis
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D004679 2001
% 224.82/225.05  |- skos__related mesh__D004679smesh__D004660
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D004679 2003
% 224.82/225.05  |- mesh__recordAuthorizer mesh__D004679 sjn
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D004679 2005
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D004679 2004
% 224.82/225.05  |- skos__scopeNote mesh__D004679
% 224.82/225.05       A general term indicating inflammation of the BRAIN and SPINAL CORD, often used to indicate an infectious process, but also applicable to a variety of autoimmune and toxic-metabolic conditions. There is significant overlap regarding the usage of this term and ENCEPHALITIS in the literature.%A%    
% 224.82/225.05  |- skos__annotation mesh__D004679
% 224.82/225.05       GEN or unspecified; prefer specifics; coord IM with specific organism/infection term %28%IM%29% or other cause %28%IM%29%%A%  
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D004679 2002
% 224.82/225.05  |- skos__broader mesh__D004679smesh__D004660
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D004679 2006
% 224.82/225.05  |- skos__broader mesh__D044982Q000637smesh__D044982
% 224.82/225.05  |- mesh__preferredCombination mesh__D044982Q000637smesh__D045164
% 224.82/225.05  |- rdf__type mesh__D044982Q000637smesh__CompoundConcept
% 224.82/225.05  |- mesh__recordOriginator mesh__D009364 NLM
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D009364 2004
% 224.82/225.05  |- mesh__publicMeSHNote mesh__D009364 66   
% 224.82/225.05  |- skos__altLabel mesh__D009364 Recurrence, Local Neoplasm
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D009364 2005
% 224.82/225.05  |- mesh__recordMaintainer mesh__D009364 TPW
% 224.82/225.05  |- skos__scopeNote mesh__D009364
% 224.82/225.05       The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.%A%    
% 224.82/225.05  |- skos__altLabel mesh__D009364 Local Neoplasm Recurrence
% 224.82/225.05  |- skos__annotation mesh__D009364
% 224.82/225.05       IM; differentiate from NEOPLASMS, MULTIPLE PRIMARY %28%Manual 24.4.1.5 - 24.4.1.6%29% and NEOPLASMS, SECOND PRIMARY %28%Manual 24.4.1.7%29%; do not confuse with NEOPLASM, RESIDUAL; DF: NEOPL RECURRENCE LOCAL%A%  
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D009364 2006
% 224.82/225.05  |- mesh__dateRevised mesh__D009364 2000-06-22
% 224.82/225.05  |- skos__altLabel mesh__D009364 Recurrences, Local Neoplasm
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D009364 2001
% 224.82/225.05  |- skos__broader mesh__D009364smesh__D009385
% 224.82/225.05  |- mesh__dateCreated mesh__D009364 1999-01-01
% 224.82/225.05  |- mesh__dateEstablished mesh__D009364 1966-01-01
% 224.82/225.05  |- mesh__historyNote mesh__D009364 66%28%64%29%   
% 224.82/225.05  |- mesh__recordAuthorizer mesh__D009364 sjn
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D009364 2002
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D009364 2003
% 224.82/225.05  |- skos__altLabel mesh__D009364 Neoplasm Recurrences, Local
% 224.82/225.05  |- rdf__type mesh__D009364sskos__Concept
% 224.82/225.05  |- skos__prefLabel mesh__D009364 Neoplasm Recurrence, Local
% 224.82/225.05  |- skos__altLabel mesh__D009364 Local Neoplasm Recurrences
% 224.82/225.05  |- mesh__dateRevised mesh__D001381 2004-07-07
% 224.82/225.05  |- skos__related mesh__D001381smesh__D001552
% 224.82/225.05  |- skos__prefLabel mesh__D001381 Azepines
% 224.82/225.05  |- mesh__recordOriginator mesh__D001381 NLM
% 224.82/225.05  |- skos__scopeNote mesh__D001381
% 224.82/225.05       Seven membered heterocyclic rings containing a NITROGEN atom.%A%    
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D001381 2006
% 224.82/225.05  |- skos__altLabel mesh__D001381 Hexamethyleneimines
% 224.82/225.05  |- skos__broader mesh__D001381smesh__D006573
% 224.82/225.05  |- mesh__recordMaintainer mesh__D001381 ssb
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D001381 2005
% 224.82/225.05  |- skos__related mesh__D001381smesh__D003984
% 224.82/225.05  |- rdf__type mesh__D001381sskos__Concept
% 224.82/225.05  |- mesh__dateCreated mesh__D001381 1999-01-01
% 224.82/225.05  |- mesh__recordAuthorizer mesh__D001381 sjn
% 224.82/225.05  |- skos__hiddenLabel mesh__D000289 Office, Hospital Admissions
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D000289 1999
% 224.82/225.05  |- rdf__type mesh__D000289sskos__Concept
% 224.82/225.05  |- skos__hiddenLabel mesh__D000289 Hospital Admissions Offices
% 224.82/225.05  |- skos__prefLabel mesh__D000289 Admitting Department, Hospital
% 224.82/225.05  |- mesh__dateRevised mesh__D000289 1992-03-25
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D000289 2005
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D000289 2000
% 224.82/225.05  |- skos__hiddenLabel mesh__D000289 Department, Admitting
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D000289 1996
% 224.82/225.05  |- skos__hiddenLabel mesh__D000289 Admissions Office, Hospital
% 224.82/225.05  |- mesh__historyNote mesh__D000289
% 224.82/225.05       91%28%Aug 77%29%; was see under HOSPITAL DEPARTMENTS 1977-90   
% 224.82/225.05  |- skos__hiddenLabel mesh__D000289 Departments, Hospital Admitting
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D000289 2006
% 224.82/225.05  |- mesh__publicMeSHNote mesh__D000289
% 224.82/225.05       91; was see under HOSPITAL DEPARTMENTS 1977-90   
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D000289 2001
% 224.82/225.05  |- mesh__recordOriginator mesh__D000289 EC
% 224.82/225.05  |- skos__hiddenLabel mesh__D000289 Offices, Hospital Admissions
% 224.82/225.05  |- mesh__dateEstablished mesh__D000289 1991-01-01
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D000289 1997
% 224.82/225.05  |- skos__altLabel mesh__D000289 Hospital Admissions Office
% 224.82/225.05  |- skos__hiddenLabel mesh__D000289 Admitting Departments
% 224.82/225.05  |- mesh__recordAuthorizer mesh__D000289 PLS
% 224.82/225.05  |- skos__scopeNote mesh__D000289
% 224.82/225.05       Hospital department responsible for the flow of patients and the processing of admissions, discharges, transfers, and also most procedures to be carried out in the event of a patient%27%s death.%A%    
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D000289 2003
% 224.82/225.05  |- skos__hiddenLabel mesh__D000289 Department, Hospital Admitting
% 224.82/225.05  |- skos__broader mesh__D000289smesh__D006748
% 224.82/225.05  |- skos__hiddenLabel mesh__D000289 Admissions Offices, Hospital
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D000289 1994
% 224.82/225.05  |- mesh__dateCreated mesh__D000289 1977-05-19
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D000289 2002
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D000289 2004
% 224.82/225.05  |- mesh__recordMaintainer mesh__D000289 TGC
% 224.82/225.05  |- skos__hiddenLabel mesh__D000289 Admitting Departments, Hospital
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D000289 1998
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D000289 1995
% 224.82/225.05  |- skos__altLabel mesh__D000289 Hospital Admitting Department
% 224.82/225.05  |- skos__hiddenLabel mesh__D000289 Hospital Admitting Departments
% 224.82/225.05  |- skos__hiddenLabel mesh__D000289 Departments, Admitting
% 224.82/225.05  |- skos__annotation mesh__D000289 DF: ADMIT DEP   
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D000289 1993
% 224.82/225.05  |- skos__hiddenLabel mesh__D005772 Gastrointestinal Transits
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D005772 2002
% 224.82/225.05  |- skos__hiddenLabel mesh__D005772 Transit, Gastrointestinal
% 224.82/225.05  |- skos__historyNote mesh__D005772
% 224.82/225.05       Gastrointestinal Motility %28%1966-1987%29%
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D005772 2003
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D005772 2006
% 224.82/225.05  |- mesh__recordOriginator mesh__D005772 SCD
% 224.82/225.05  |- skos__hiddenLabel mesh__D005772 Transits, Gastrointestinal
% 224.82/225.05  |- mesh__historyNote mesh__D005772 88   
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D005772 2004
% 224.82/225.05  |- skos__annotation mesh__D005772 transit time also goes here   
% 224.82/225.05  |- mesh__dateEstablished mesh__D005772 1988-01-01
% 224.82/225.05  |- skos__scopeNote mesh__D005772
% 224.82/225.05       Passage of food %28%sometimes in the form of a test meal%29% through the gastrointestinal tract as measured in minutes or hours. The rate of passage through the intestine is an indicator of small bowel function.%A%    
% 224.82/225.05  |- mesh__recordAuthorizer mesh__D005772 SJN
% 224.82/225.05  |- mesh__publicMeSHNote mesh__D005772 88   
% 224.82/225.05  |- skos__broader mesh__D005772smesh__D005769
% 224.82/225.05  |- rdf__type mesh__D005772sskos__Concept
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D005772 1998
% 224.82/225.05  |- mesh__recordMaintainer mesh__D005772 PXP
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D005772 2000
% 224.82/225.05  |- skos__historyNote mesh__D005772
% 224.82/225.05       Gastrointestinal System %28%1966-1987%29%
% 224.82/225.05  |- skos__broader mesh__D005772smesh__D003938
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D005772 2001
% 224.82/225.05  |- mesh__dateCreated mesh__D005772 1987-03-13
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D005772 1999
% 224.82/225.05  |- skos__prefLabel mesh__D005772 Gastrointestinal Transit
% 224.82/225.05  |- mesh__dateRevised mesh__D005772 1997-06-20
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D005772 2005
% 224.82/225.05  |- mesh__dateEstablished mesh__D013406 1975-09-01
% 224.82/225.05  |- skos__hiddenLabel mesh__D013406 Attempted Suicide
% 224.82/225.05  |- mesh__historyNote mesh__D013406 75   
% 224.82/225.05  |- skos__historyNote mesh__D013406 Suicide %28%1966-1974%29%
% 224.82/225.05  |- mesh__recordMaintainer mesh__D013406 ssb
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D013406 2005
% 224.82/225.05  |- skos__prefLabel mesh__D013406 Suicide, Attempted
% 224.82/225.05  |- mesh__publicMeSHNote mesh__D013406 75   
% 224.82/225.05  |- mesh__dateRevised mesh__D013406 2003-07-09
% 224.82/225.05  |- skos__scopeNote mesh__D013406
% 224.82/225.05       The unsuccessful attempt to kill oneself.     
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D013406 2006
% 224.82/225.05  |- mesh__dateCreated mesh__D013406 1974-11-11
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D013406 2004
% 224.82/225.05  |- skos__broader mesh__D013406smesh__D013405
% 224.82/225.05  |- mesh__recordOriginator mesh__D013406 NLM
% 224.82/225.05  |- mesh__recordAuthorizer mesh__D013406 sjn
% 224.82/225.05  |- rdf__type mesh__D013406sskos__Concept
% 224.82/225.05  |- skos__altLabel mesh__D051525 Glial Activating Factor
% 224.82/225.05  |- mesh__historyNote mesh__D051525 2006%28%1996%29%   
% 224.82/225.05  |- mesh__publicMeSHNote mesh__D051525
% 224.82/225.05       2006; FIBROBLAST GROWTH FACTOR 9 was indexed under FIBROBLAST GROWTH FACTORS 2002-2005, %26% under GROWTH SUBSTANCES 1996-2001%A%  
% 224.82/225.05  |- rdf__type mesh__D051525sskos__Concept
% 224.82/225.05  |- skos__broader mesh__D051525smesh__D005346
% 224.82/225.05  |- skos__scopeNote mesh__D051525
% 224.82/225.05       A fibroblast growth factor that was originally identified as a mitogen for GLIAL CELLS. It is expressed primarily in NEURONS.%A%    
% 224.82/225.05  |- mesh__dateCreated mesh__D051525 2005-06-30
% 224.82/225.05  |- mesh__recordMaintainer mesh__D051525 DRC
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D051525 2006
% 224.82/225.05  |- mesh__recordOriginator mesh__D051525 DRC
% 224.82/225.05  |- mesh__recordAuthorizer mesh__D051525 sjn
% 224.82/225.05  |- mesh__dateEstablished mesh__D051525 2006-01-01
% 224.82/225.05  |- skos__prefLabel mesh__D051525 Fibroblast Growth Factor 9
% 224.82/225.05  |- skos__broader mesh__D009365smesh__D009385
% 224.82/225.05  |- mesh__publicMeSHNote mesh__D009365 64   
% 224.82/225.05  |- mesh__historyNote mesh__D009365 64   
% 224.82/225.05  |- rdf__type mesh__D009365sskos__Concept
% 224.82/225.05  |- mesh__recordAuthorizer mesh__D009365 sjn
% 224.82/225.05  |- skos__altLabel mesh__D009365 Regression, Spontaneous Neoplasm
% 224.82/225.05  |- mesh__dateRevised mesh__D009365 2005-06-30
% 224.82/225.05  |- skos__altLabel mesh__D009365 Spontaneous Neoplasm Regression
% 224.82/225.05  |- skos__prefLabel mesh__D009365 Neoplasm Regression, Spontaneous
% 224.82/225.05  |- mesh__recordOriginator mesh__D009365 NLM
% 224.82/225.05  |- skos__annotation mesh__D009365
% 224.82/225.05       IM; must be spontaneous: for regression or remission after ther, use REMISSION INDUCTION; Manual 24.4.1.9; DF: NEOPL REGRESSION SPONTANEOUS%A%  
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D009365 2006
% 224.82/225.05  |- skos__altLabel mesh__D009365 Remission, Spontaneous Neoplasm
% 224.82/225.05  |- skos__broader mesh__D009365smesh__D012075
% 224.82/225.05  |- skos__altLabel mesh__D009365 Spontaneous Neoplasm Remission
% 224.82/225.05  |- mesh__recordMaintainer mesh__D009365 ssb
% 224.82/225.05  |- mesh__dateEstablished mesh__D009365 1964-01-01
% 224.82/225.05  |- skos__scopeNote mesh__D009365
% 224.82/225.05       Disappearance of a neoplasm or neoplastic state without the intervention of therapy.%A%    
% 224.82/225.05  |- skos__altLabel mesh__D009365 Neoplasm Remission, Spontaneous
% 224.82/225.05  |- mesh__dateCreated mesh__D009365 1999-01-01
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D001382 1996
% 224.82/225.05  |- mesh__recordMaintainer mesh__D001382 PLS
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D001382 1995
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D001382 1998
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D001382 2002
% 224.82/225.05  |- skos__broader mesh__D001382smesh__D014154
% 224.82/225.05  |- mesh__onlineNote mesh__D001382
% 224.82/225.05       use AZERBAIJAN to search AZERBAIJAN S.S.R. 1982-92   
% 224.82/225.05  |- mesh__recordAuthorizer mesh__D001382 PLS
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D001382 2004
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D001382 2001
% 224.82/225.05  |- skos__prefLabel mesh__D001382 Azerbaijan
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D001382 2006
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D001382 2003
% 224.82/225.05  |- skos__altLabel mesh__D001382 Azerbaijan SSR
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D001382 2005
% 224.82/225.05  |- mesh__historyNote mesh__D001382
% 224.82/225.05       93; was AZERBAIJAN S.S.R. 1982-92; was heading 1963-81   
% 224.82/225.05  |- mesh__dateRevised mesh__D001382 1994-03-17
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D001382 2000
% 224.82/225.05  |- skos__annotation mesh__D001382 use this spelling in translations   
% 224.82/225.05  |- mesh__recordOriginator mesh__D001382 NLM
% 224.82/225.05  |- skos__broader mesh__D001382smesh__D017517
% 224.82/225.05  |- skos__broader mesh__D001382smesh__D014586
% 224.82/225.05  |- rdf__type mesh__D001382sskos__Concept
% 224.82/225.05  |- mesh__dateCreated mesh__D001382 1999-01-01
% 224.82/225.05  |- skos__altLabel mesh__D001382 Azerbaijan S.S.R.
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D001382 1997
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D001382 1999
% 224.82/225.05  |- skos__broader mesh__D011942Q000819smesh__D011942
% 224.82/225.05  |- mesh__preferredCombination mesh__D011942Q000819smesh__D000316
% 224.82/225.05  |- rdf__type mesh__D011942Q000819smesh__CompoundConcept
% 224.82/225.05  |- skos__altLabel mesh__D019793 Fluorescein Disodium Salt
% 224.82/225.05  |- skos__hiddenLabel mesh__D019793 Fluorescein, Sodium
% 224.82/225.05  |- skos__altLabel mesh__D019793 Fluoresc%C3%%A9%ine sodique Faure
% 224.82/225.05  |- mesh__recordMaintainer mesh__D019793 CCR
% 224.82/225.05  |- skos__altLabel mesh__D019793 D and C Yellow No. 8
% 224.82/225.05  |- skos__altLabel mesh__D019793 D%26%C Yellow No. 8
% 224.82/225.05  |- skos__hiddenLabel mesh__D019793 Monosodium Salt, Fluorescein
% 224.82/225.05  |- skos__prefLabel mesh__D019793 Fluorescein
% 224.82/225.05  |- rdf__type mesh__D019793sskos__Concept
% 224.82/225.05  |- skos__hiddenLabel mesh__D019793
% 224.82/225.05       Sola/Barnes Hind Brand of Fluorescein Sodium
% 224.82/225.05  |- skos__hiddenLabel mesh__D019793 Fluor I Strip A.T.
% 224.82/225.05  |- skos__hiddenLabel mesh__D019793 Dipotassium Salt, Fluorescein
% 224.82/225.05  |- mesh__recordOriginator mesh__D019793 KEV
% 224.82/225.05  |- skos__hiddenLabel mesh__D019793 Fluorescein Sodium, Minims
% 224.82/225.05  |- skos__altLabel mesh__D019793
% 224.82/225.05       Sola/Barnes-Hind Brand of Fluorescein Sodium
% 224.82/225.05  |- skos__hiddenLabel mesh__D019793 Fluoresceine, Minims
% 224.82/225.05  |- skos__altLabel mesh__D019793 Colircusi Fluoresceina
% 224.82/225.05  |- mesh__recordAuthorizer mesh__D019793 sjn
% 224.82/225.05  |- skos__altLabel mesh__D019793 Novartis Brand of Fluorescein Sodium
% 224.82/225.05  |- skos__hiddenLabel mesh__D019793 Sodium, Fluorescein
% 224.82/225.05  |- skos__broader mesh__D019793smesh__D005452
% 224.82/225.05  |- skos__hiddenLabel mesh__D019793 Fluorescein, Disodium
% 224.82/225.05  |- skos__hiddenLabel mesh__D019793 Disodium Salt, Fluorescein
% 224.82/225.05  |- skos__scopeNote mesh__D019793
% 224.82/225.05       A phthalic indicator dye that appears yellow-green in normal tear film and bright green in a more alkaline medium, such as the aqueous humor, and is used therapeutically as a diagnostic aid in corneal injuries and corneal trauma. It has been approved by FDA for use in externally applied drugs and cosmetics. %28%From Merck Index, 12th ed; American Medical Association Drug Evaluations; 1995, p2275%29%%A%    
% 224.82/225.05  |- skos__altLabel mesh__D019793
% 224.82/225.05       Smith %26% Nephew Brand of Fluorescein Sodium
% 224.82/225.05  |- skos__altLabel mesh__D019793 Diba Brand of Fluorescein Sodium
% 224.82/225.05  |- skos__altLabel mesh__D019793 Wyeth Brand of Fluorescein Sodium
% 224.82/225.05  |- skos__altLabel mesh__D019793 Dioptic Brand of Fluorescein Sodium
% 224.82/225.05  |- mesh__dateEstablished mesh__D019793 1998-01-01
% 224.82/225.05  |- mesh__historyNote mesh__D019793
% 224.82/225.05       98; see FLUORESCEIN %28%NM%29% 1981-97   
% 224.82/225.05  |- skos__hiddenLabel mesh__D019793 Ful Glo
% 224.82/225.05  |- skos__altLabel mesh__D019793 Sodium Fluorescein
% 224.82/225.05  |- mesh__dateCreated mesh__D019793 1997-07-02
% 224.82/225.05  |- skos__altLabel mesh__D019793 Allergan Brand of Fluorescein Sodium
% 224.82/225.05  |- skos__altLabel mesh__D019793 Chauvin Brand of Fluorescein Sodium
% 224.82/225.05  |- skos__historyNote mesh__D019793 Fluoresceins %28%1969-1997%29%
% 224.82/225.05  |- skos__hiddenLabel mesh__D019793 Fluoresceina, Colircusi
% 224.82/225.05  |- skos__altLabel mesh__D019793
% 224.82/225.05       Cahill May Roberts Brand of Fluorescein Sodium
% 224.82/225.05  |- skos__altLabel mesh__D019793 Minims Fluoresceine
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D019793 2006
% 224.82/225.05  |- skos__altLabel mesh__D019793 Uranine
% 224.82/225.05  |- skos__altLabel mesh__D019793 Alcon Brand of Fluorescein Sodium
% 224.82/225.05  |- skos__altLabel mesh__D019793 D and C Yellow No. 7
% 224.82/225.05  |- mesh__dateRevised mesh__D019793 2005-06-30
% 224.82/225.05  |- skos__altLabel mesh__D019793 D%26%C Yellow No. 7
% 224.82/225.05  |- mesh__publicMeSHNote mesh__D019793 98; see FLUORESCEINS 1969-97   
% 224.82/225.05  |- skos__hiddenLabel mesh__D005773 Gastroscopic Surgeries
% 224.82/225.05  |- mesh__recordMaintainer mesh__D005773 nns
% 224.82/225.05  |- skos__scopeNote mesh__D005773
% 224.82/225.05       Endoscopic examination, therapy or surgery of the interior of the stomach.%A%    
% 224.82/225.05  |- skos__altLabel mesh__D005773 Gastroscopic Surgery
% 224.82/225.05  |- skos__hiddenLabel mesh__D005773 Surgeries, Gastroscopic
% 224.82/225.05  |- skos__broader mesh__D005773smesh__D016099
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D005773 2000
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D005773 2004
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D005773 2006
% 224.82/225.05  |- skos__hiddenLabel mesh__D005773 Surgical Procedure, Gastroscopic
% 224.82/225.05  |- skos__altLabel mesh__D005773 Surgery, Gastroscopic
% 224.82/225.05  |- skos__hiddenLabel mesh__D005773 Procedures, Gastroscopic Surgical
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D005773 2003
% 224.82/225.05  |- skos__hiddenLabel mesh__D005773 Gastroscopies
% 224.82/225.05  |- mesh__recordAuthorizer mesh__D005773 sjn
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D005773 2005
% 224.82/225.05  |- skos__hiddenLabel mesh__D005773 Gastroscopic Surgical Procedure
% 224.82/225.05  |- skos__prefLabel mesh__D005773 Gastroscopy
% 224.82/225.05  |- mesh__dateCreated mesh__D005773 1999-01-01
% 224.82/225.05  |- skos__hiddenLabel mesh__D005773 Procedure, Gastroscopic Surgical
% 224.82/225.05  |- mesh__recordOriginator mesh__D005773 NLM
% 224.82/225.05  |- skos__altLabel mesh__D005773 Surgical Procedures, Gastroscopic
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D005773 2002
% 224.82/225.05  |- rdf__type mesh__D005773sskos__Concept
% 224.82/225.05  |- mesh__dateRevised mesh__D005773 1999-11-03
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D005773 2001
% 224.82/225.05  |- skos__hiddenLabel mesh__D013407 CP 45899
% 224.82/225.05  |- skos__broader mesh__D013407smesh__D010406
% 224.82/225.05  |- mesh__dateEstablished mesh__D013407 1988-01-01
% 224.82/225.05  |- skos__historyNote mesh__D013407 Penicillanic Acids %28%1971-1987%29%
% 224.82/225.05  |- skos__historyNote mesh__D013407
% 224.82/225.05       Beta Lactamases/antagonists %26% inhibitors %28%1979-1987%29%
% 224.82/225.05  |- skos__altLabel mesh__D013407 Penicillanic Acid Sulfone
% 224.82/225.05  |- mesh__recordAuthorizer mesh__D013407 sjn
% 224.82/225.05  |- skos__historyNote mesh__D013407
% 224.82/225.05       Enzymes/antagonists %26% inhibitors %28%1966-1974%29%
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D013407 2006
% 224.82/225.05  |- mesh__recordMaintainer mesh__D013407 CCR
% 224.82/225.05  |- mesh__dateRevised mesh__D013407 2005-06-30
% 224.82/225.05  |- mesh__historyNote mesh__D013407 88   
% 224.82/225.05  |- mesh__publicMeSHNote mesh__D013407 88   
% 224.82/225.05  |- mesh__dateCreated mesh__D013407 1987-04-09
% 224.82/225.05  |- skos__historyNote mesh__D013407 Enzyme Inhibitors %28%1975-1987%29%
% 224.82/225.05  |- skos__hiddenLabel mesh__D013407 Sodium, Sulbactam
% 224.82/225.05  |- rdf__type mesh__D013407sskos__Concept
% 224.82/225.05  |- skos__prefLabel mesh__D013407 Sulbactam
% 224.82/225.05  |- skos__hiddenLabel mesh__D013407 Sulfone, Penicillanic Acid
% 224.82/225.05  |- skos__scopeNote mesh__D013407
% 224.82/225.05       A beta-lactamase inhibitor with very weak antibacterial action. The compound prevents antibiotic destruction of beta-lactam antibiotics by inhibiting beta-lactamases, thus extending their spectrum activity. Combinations of sulbactam with beta-lactam antibiotics have been used successfully for the therapy of infections caused by organisms resistant to the antibiotic alone.%A%    
% 224.82/225.05  |- skos__altLabel mesh__D013407 Pfizer Brand of Sulbactam Sodium
% 224.82/225.05  |- mesh__recordOriginator mesh__D013407 RLS
% 224.82/225.05  |- skos__hiddenLabel mesh__D013407 CP45899
% 224.82/225.05  |- skos__altLabel mesh__D013407 B%C3%%A9%tamaze
% 224.82/225.05  |- mesh__recordAuthorizer mesh__D051526 sjn
% 224.82/225.05  |- mesh__dateEstablished mesh__D051526 2006-01-01
% 224.82/225.05  |- rdf__type mesh__D051526sskos__Concept
% 224.82/225.05  |- mesh__publicMeSHNote mesh__D051526
% 224.82/225.05       2006; FIBROBLAST GROWTH FACTOR 10 was indexed under FIBROBLAST GROWTH FACTORS 1996-2005%A%  
% 224.82/225.05  |- skos__broader mesh__D051526smesh__D005346
% 224.82/225.05  |- mesh__historyNote mesh__D051526 2006%28%1996%29%   
% 224.82/225.05  |- skos__scopeNote mesh__D051526
% 224.82/225.05       A fibroblast growth factor that is a MITOGEN for KERATINOCYTES. It activates FIBROBLAST GROWTH FACTOR RECEPTOR 2B and is involved in LUNG and limb development.%A%    
% 224.82/225.05  |- skos__altLabel mesh__D051526 Keratinocyte Growth Factor 2
% 224.82/225.05  |- skos__prefLabel mesh__D051526 Fibroblast Growth Factor 10
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D051526 2006
% 224.82/225.05  |- mesh__recordOriginator mesh__D051526 DRC
% 224.82/225.05  |- mesh__dateCreated mesh__D051526 2005-06-30
% 224.82/225.05  |- skos__altLabel mesh__D051526 Repifermin
% 224.82/225.05  |- mesh__recordMaintainer mesh__D051526 DRC
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D009366 2003
% 224.82/225.05  |- skos__altLabel mesh__D009366 Seeding, Neoplasm
% 224.82/225.05  |- mesh__recordMaintainer mesh__D009366 TPW
% 224.82/225.05  |- skos__broader mesh__D009366smesh__D009362
% 224.82/225.05  |- mesh__activeMeSHYear mesh__D009366 2001
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D009366 2006
% 224.82/225.06  |- mesh__dateRevised mesh__D009366 2000-06-22
% 224.82/225.06  |- mesh__historyNote mesh__D009366 70%28%66%29%   
% 224.82/225.06  |- mesh__recordAuthorizer mesh__D009366 sjn
% 224.82/225.06  |- mesh__publicMeSHNote mesh__D009366 70   
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D009366 2005
% 224.82/225.06  |- mesh__recordOriginator mesh__D009366 NLM
% 224.82/225.06  |- skos__annotation mesh__D009366
% 224.82/225.06       includes seeding by surg, biopsy, palpation, etc.; IM; no qualif; Manual 24.4.1.11; DF: NEOPL SEEDING%A%  
% 224.82/225.06  |- mesh__dateCreated mesh__D009366 1999-01-01
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D009366 2002
% 224.82/225.06  |- skos__scopeNote mesh__D009366
% 224.82/225.06       The local implantation of tumor cells by contamination of instruments and surgical equipment during and after surgical resection, resulting in local growth of the cells and tumor formation.%A%    
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D009366 2004
% 224.82/225.06  |- skos__prefLabel mesh__D009366 Neoplasm Seeding
% 224.82/225.06  |- mesh__dateEstablished mesh__D009366 1970-01-01
% 224.82/225.06  |- rdf__type mesh__D009366sskos__Concept
% 224.82/225.06  |- skos__altLabel mesh__D001383 Azetidine-2-carboxylic Acid
% 224.82/225.06  |- mesh__recordOriginator mesh__D001383 NLM
% 224.82/225.06  |- mesh__publicMeSHNote mesh__D001383 91; was see under AZETINES 1975-90   
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D001383 2003
% 224.82/225.06  |- skos__historyNote mesh__D001383 Azetines %28%1974-1975%29%
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D001383 2005
% 224.82/225.06  |- skos__hiddenLabel mesh__D001383 Acid, Azetidine-2-carboxylic
% 224.82/225.06  |- skos__prefLabel mesh__D001383 Azetidinecarboxylic Acid
% 224.82/225.06  |- skos__hiddenLabel mesh__D001383 Azetidine 2 carboxylic Acid
% 224.82/225.06  |- skos__scopeNote mesh__D001383
% 224.82/225.06       A proline analog that acts as a stoichiometric replacement of proline.  It causes the production of abnormal proteins with impaired biological activity.%A%    
% 224.82/225.06  |- rdf__type mesh__D001383sskos__Concept
% 224.82/225.06  |- mesh__historyNote mesh__D001383
% 224.82/225.06       91%28%75%29%; was see under AZETINES 1975-90   
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D001383 2002
% 224.82/225.06  |- mesh__recordAuthorizer mesh__D001383 sjn
% 224.82/225.06  |- mesh__recordMaintainer mesh__D001383 TWD
% 224.82/225.06  |- skos__broader mesh__D001383smesh__D007098
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D001383 2001
% 224.82/225.06  |- mesh__dateEstablished mesh__D001383 1991-01-01
% 224.82/225.06  |- skos__broader mesh__D001383smesh__D001384
% 224.82/225.06  |- skos__hiddenLabel mesh__D001383 Acid, Azetidinecarboxylic
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D001383 2004
% 224.82/225.06  |- mesh__dateCreated mesh__D001383 1974-11-19
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D001383 2006
% 224.82/225.06  |- skos__historyNote mesh__D001383 Imino Acids %28%1974%29%
% 224.82/225.06  |- mesh__dateRevised mesh__D001383 2000-06-21
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D014500 2005
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D014500 1995
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D014500 2002
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D014500 2006
% 224.82/225.06  |- skos__altLabel mesh__D014500 Uridine Nucleotides
% 224.82/225.06  |- skos__hiddenLabel mesh__D014500 Nucleotides, Uridine
% 224.82/225.06  |- skos__broader mesh__D014500smesh__D012265
% 224.82/225.06  |- mesh__recordMaintainer mesh__D014500 TGC
% 224.82/225.06  |- mesh__recordAuthorizer mesh__D014500 PLS
% 224.82/225.06  |- mesh__dateEstablished mesh__D014500 1963-01-01
% 224.82/225.06  |- skos__altLabel mesh__D014500 Uridine Phosphates
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D014500 1996
% 224.82/225.06  |- mesh__recordOriginator mesh__D014500 NLM
% 224.82/225.06  |- mesh__dateRevised mesh__D014500 1992-05-20
% 224.82/225.06  |- skos__annotation mesh__D014500 /biosyn /physiol permitted   
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D014500 1997
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D014500 2003
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D014500 1993
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D014500 2000
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D014500 1998
% 224.82/225.06  |- rdf__type mesh__D014500sskos__Concept
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D014500 2004
% 224.82/225.06  |- skos__prefLabel mesh__D014500 Uracil Nucleotides
% 224.82/225.06  |- skos__hiddenLabel mesh__D014500 Phosphates, Uridine
% 224.82/225.06  |- skos__hiddenLabel mesh__D014500 Nucleotides, Uracil
% 224.82/225.06  |- mesh__dateCreated mesh__D014500 1999-01-01
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D014500 1994
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D014500 2001
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D014500 1999
% 224.82/225.06  |- skos__broader mesh__D014500smesh__D011742
% 224.82/225.06  |- skos__altLabel mesh__D019794 2,3-Bisphosphoglycerate
% 224.82/225.06  |- mesh__dateRevised mesh__D019794 2004-07-13
% 224.82/225.06  |- mesh__recordOriginator mesh__D019794 KEV
% 224.82/225.06  |- skos__broader mesh__D019794smesh__D004163
% 224.82/225.06  |- skos__hiddenLabel mesh__D019794 2,3-Bisphosphate, Glycerate
% 224.82/225.06  |- mesh__dateEstablished mesh__D019794 1998-01-01
% 224.82/225.06  |- mesh__dateCreated mesh__D019794 1997-06-20
% 224.82/225.06  |- mesh__historyNote mesh__D019794
% 224.82/225.06       98; use 2,3-DIPHOSPHOGLYCERATE %28%NM%29% 1980-97   
% 224.82/225.06  |- mesh__recordMaintainer mesh__D019794 sjn
% 224.82/225.06  |- skos__prefLabel mesh__D019794 2,3-Diphosphoglycerate
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D019794 2006
% 224.82/225.06  |- skos__hiddenLabel mesh__D019794 2,3 Bisphosphoglycerate
% 224.82/225.06  |- rdf__type mesh__D019794sskos__Concept
% 224.82/225.06  |- mesh__publicMeSHNote mesh__D019794
% 224.82/225.06       98; 2,3-DIPHOSPHOGLYCERATE was indexed under DIPHOSPHOGLYCERIC ACIDS 1980-97%A%  
% 224.82/225.06  |- skos__hiddenLabel mesh__D019794 2,3 Diphosphoglyceric Acid
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D019794 2005
% 224.82/225.06  |- mesh__recordAuthorizer mesh__D019794 sjn
% 224.82/225.06  |- skos__historyNote mesh__D019794
% 224.82/225.06       Diphosphoglyceric Acids %28%1980-1997%29%
% 224.82/225.06  |- skos__hiddenLabel mesh__D019794 2,3 Diphosphoglycerate
% 224.82/225.06  |- skos__scopeNote mesh__D019794
% 224.82/225.06       A highly anionic organic phosphate which is present in human red blood cells at about the same molar ratio as hemoglobin. It binds to deoxyhemoglobin but not the oxygenated form, therefore diminishing the oxygen affinity of hemoglobin. This is essential in enabling hemoglobin to unload oxygen in tissue capillaries. It is also an intermediate in the conversion of 3-phosphoglycerate to 2-phosphoglycerate by phosphoglycerate mutase %28%EC 5.4.2.1%29%. %28%From Stryer Biochemistry, 4th ed, p160; Enzyme Nomenclature, 1992, p508%29%%A%    
% 224.82/225.06  |- skos__altLabel mesh__D019794 2,3-DPG
% 224.82/225.06  |- skos__altLabel mesh__D019794 Glycerate 2,3-Bisphosphate
% 224.82/225.06  |- skos__annotation mesh__D005774
% 224.82/225.06       do not use /util except by MeSH definition   
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D005774 1998
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D005774 2004
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D005774 2001
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D005774 2006
% 224.82/225.06  |- mesh__dateRevised mesh__D005774 1997-06-20
% 224.82/225.06  |- mesh__historyNote mesh__D005774 67%28%65%29%   
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D005774 2003
% 224.82/225.06  |- mesh__recordMaintainer mesh__D005774 PXP
% 224.82/225.06  |- mesh__publicMeSHNote mesh__D005774 67   
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D005774 2005
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D005774 2000
% 224.82/225.06  |- mesh__dateEstablished mesh__D005774 1967-01-01
% 224.82/225.06  |- mesh__dateCreated mesh__D005774 1999-01-01
% 224.82/225.06  |- skos__hiddenLabel mesh__D005774 Gastrostomies
% 224.82/225.06  |- rdf__type mesh__D005774sskos__Concept
% 224.82/225.06  |- skos__scopeNote mesh__D005774
% 224.82/225.06       Creation of an artificial external opening into the stomach for nutritional support or gastrointestinal compression.%A%    
% 224.82/225.06  |- skos__broader mesh__D005774smesh__D010030
% 224.82/225.06  |- mesh__recordAuthorizer mesh__D005774 SJN
% 224.82/225.06  |- skos__broader mesh__D005774smesh__D013505
% 224.82/225.06  |- skos__prefLabel mesh__D005774 Gastrostomy
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D005774 1999
% 224.82/225.06  |- mesh__recordOriginator mesh__D005774 NLM
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D005774 2002
% 224.82/225.06  |- skos__scopeNote mesh__D013408
% 224.82/225.06       Semisynthetic penicillin-type antibiotic.     
% 224.82/225.06  |- mesh__dateCreated mesh__D013408 1975-07-25
% 224.82/225.06  |- skos__historyNote mesh__D013408 Sulfonic Acids %28%1973-1975%29%
% 224.82/225.06  |- mesh__dateEstablished mesh__D013408 1991-01-01
% 224.82/225.06  |- skos__broader mesh__D013408smesh__D010400
% 224.82/225.06  |- skos__historyNote mesh__D013408
% 224.82/225.06       Penicillin G %28%1973-1974%29% /analogs %26% derivatives %28%1975%29%
% 224.82/225.06  |- skos__hiddenLabel mesh__D013408 Disodium alpha Sulfobenzylpenicillin
% 224.82/225.06  |- rdf__type mesh__D013408sskos__Concept
% 224.82/225.06  |- skos__hiddenLabel mesh__D013408 alpha-Sulfobenzylpenicillin, Disodium
% 224.82/225.06  |- mesh__recordAuthorizer mesh__D013408 sjn
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D013408 2005
% 224.82/225.06  |- mesh__dateRevised mesh__D013408 2004-07-07
% 224.82/225.06  |- mesh__recordMaintainer mesh__D013408 ssb
% 224.82/225.06  |- mesh__publicMeSHNote mesh__D013408
% 224.82/225.06       91; was see under PENICILLIN G 1976-90   
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D013408 2006
% 224.82/225.06  |- skos__prefLabel mesh__D013408 Sulbenicillin
% 224.82/225.06  |- skos__altLabel mesh__D013408 Sulfobenzylpenicillin
% 224.82/225.06  |- mesh__historyNote mesh__D013408
% 224.82/225.06       91%28%76%29%; was see under PENICILLIN G 1976-90   
% 224.82/225.06  |- mesh__recordOriginator mesh__D013408 SH
% 224.82/225.06  |- skos__prefLabel mesh__D010110 Oxymetholone
% 224.82/225.06  |- skos__broader mesh__D010110smesh__D000732
% 224.82/225.06  |- mesh__recordAuthorizer mesh__D010110 sjn
% 224.82/225.06  |- mesh__historyNote mesh__D010110 65   
% 224.82/225.06  |- skos__altLabel mesh__D010110 Hydroxymetholone
% 224.82/225.06  |- mesh__recordOriginator mesh__D010110 NLM
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D010110 2006
% 224.82/225.06  |- mesh__dateCreated mesh__D010110 1999-01-01
% 224.82/225.06  |- mesh__dateRevised mesh__D010110 2003-07-09
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D010110 2005
% 224.82/225.06  |- mesh__dateEstablished mesh__D010110 1965-01-01
% 224.82/225.06  |- mesh__publicMeSHNote mesh__D010110 65   
% 224.82/225.06  |- skos__altLabel mesh__D010110 Oxymethalone
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D010110 2004
% 224.82/225.06  |- rdf__type mesh__D010110sskos__Concept
% 224.82/225.06  |- skos__scopeNote mesh__D010110
% 224.82/225.06       A synthetic hormone with anabolic and androgenic properties. It is used mainly in the treatment of anemias. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002%29%, this compound may reasonably be anticipated to be a carcinogen. %28%From Merck Index, 11th ed%29%%A%    
% 224.82/225.06  |- mesh__recordMaintainer mesh__D010110 lkt
% 224.82/225.06  |- mesh__historyNote mesh__D051527 2006; use AMELOBLASTOMA 1994-2005   
% 224.82/225.06  |- skos__hiddenLabel mesh__D051527 Tumor, Squamous Odontogenic
% 224.82/225.06  |- skos__altLabel mesh__D051527 Squamous Odontogenic Tumor
% 224.82/225.06  |- skos__hiddenLabel mesh__D051527 Tumors, Squamous Odontogenic
% 224.82/225.06  |- rdf__type mesh__D051527sskos__Concept
% 224.82/225.06  |- mesh__recordMaintainer mesh__D051527 ags
% 224.82/225.06  |- mesh__recordAuthorizer mesh__D051527 sjn
% 224.82/225.06  |- skos__scopeNote mesh__D051527
% 224.82/225.06       A well-differentiated, benign, hamartomatous proliferation of odontogenic epithelium, probably arising from the rests of Malassez.%A%    
% 224.82/225.06  |- skos__annotation mesh__D051527
% 224.82/225.06       coordinate IM with probably JAW NEOPLASMS %28%IM%29% or specific precoordinated jaw/neoplasm term %28%IM%29%%A%  
% 224.82/225.06  |- skos__hiddenLabel mesh__D051527 Squamous Odontogenic Tumors
% 224.82/225.06  |- skos__hiddenLabel mesh__D051527 Odontogenic Tumors, Squamous
% 224.82/225.06  |- mesh__publicMeSHNote mesh__D051527 2006; see AMELOBLASTOMA 1994-2005   
% 224.82/225.06  |- skos__prefLabel mesh__D051527 Odontogenic Tumor, Squamous
% 224.82/225.06  |- mesh__dateEstablished mesh__D051527 2006-01-01
% 224.82/225.06  |- mesh__dateCreated mesh__D051527 2005-06-30
% 224.82/225.06  |- mesh__recordOriginator mesh__D051527 ags
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D051527 2006
% 224.82/225.06  |- skos__broader mesh__D051527smesh__D009808
% 224.82/225.06  |- skos__historyNote mesh__D051527 Odontogenic Tumors %28%1975-2005%29%
% 224.82/225.06  |- skos__prefLabel mesh__D009367 Neoplasm Staging
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D009367 1999
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D009367 2005
% 224.82/225.06  |- skos__altLabel mesh__D009367 Staging, Neoplasm
% 224.82/225.06  |- skos__scopeNote mesh__D009367
% 224.82/225.06       Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.%A%    
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D009367 2002
% 224.82/225.06  |- skos__altLabel mesh__D009367 Cancer Staging
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D009367 1998
% 224.82/225.06  |- skos__hiddenLabel mesh__D009367 Staging, Tumor
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D009367 2004
% 224.82/225.06  |- mesh__dateRevised mesh__D009367 1997-06-20
% 224.82/225.06  |- mesh__publicMeSHNote mesh__D009367 78   
% 224.82/225.06  |- rdf__type mesh__D009367sskos__Concept
% 224.82/225.06  |- skos__annotation mesh__D009367
% 224.82/225.06       = degree of spread of neopl %28%do not confuse with %22%grading%22% which = degree of malignancy%29%; staging is given in roman numerals, grading in arabic; Manual 24.4.1.12+; usually NIM with no qualif + neopl terms /pathol %28%IM%29%; IM as technique %26% general only %26% when IM, qualif permitted; relation to /pathol %26% differentiation from classification: TN 214; DF: NEOPL STAGING%A%  
% 224.82/225.06  |- mesh__recordMaintainer mesh__D009367 PXP
% 224.82/225.06  |- mesh__historyNote mesh__D009367 78   
% 224.82/225.06  |- mesh__dateEstablished mesh__D009367 1978-01-01
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D009367 2001
% 224.82/225.06  |- skos__broader mesh__D009367smesh__D019937
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D009367 2003
% 224.82/225.06  |- skos__hiddenLabel mesh__D009367 Staging, Cancer
% 224.82/225.06  |- skos__altLabel mesh__D009367 Tumor Staging
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D009367 2000
% 224.82/225.06  |- mesh__recordAuthorizer mesh__D009367 SJN
% 224.82/225.06  |- mesh__dateCreated mesh__D009367 1977-04-22
% 224.82/225.06  |- mesh__recordOriginator mesh__D009367 SMH
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D009367 2006
% 224.82/225.06  |- rdf__type mesh__D001384sskos__Concept
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D001384 2000
% 224.82/225.06  |- mesh__dateCreated mesh__D001384 1999-01-01
% 224.82/225.06  |- mesh__recordOriginator mesh__D001384 NLM
% 224.82/225.06  |- skos__broader mesh__D001384smesh__D001385
% 224.82/225.06  |- mesh__onlineNote mesh__D001384 search AZETINES 1974   
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D001384 1997
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D001384 1999
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D001384 1993
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D001384 1996
% 224.82/225.06  |- mesh__dateRevised mesh__D001384 1992-05-07
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D001384 1995
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D001384 1998
% 224.82/225.06  |- mesh__recordMaintainer mesh__D001384 TAP
% 224.82/225.06  |- mesh__dateEstablished mesh__D001384 1991-01-01
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D001384 1994
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D001384 2004
% 224.82/225.06  |- skos__annotation mesh__D001384 do not confuse with AZETINES   
% 224.82/225.06  |- mesh__historyNote mesh__D001384
% 224.82/225.06       91%28%75%29%; was see under AZETINES 1975-90   
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D001384 2002
% 224.82/225.06  |- skos__prefLabel mesh__D001384 Azetidines
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D001384 2006
% 224.82/225.06  |- mesh__publicMeSHNote mesh__D001384 91; was see under AZETINES 1975-90   
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D001384 2003
% 224.82/225.06  |- mesh__recordAuthorizer mesh__D001384 PLS
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D001384 2001
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D001384 2005
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D028521 2003
% 224.82/225.06  |- mesh__dateEstablished mesh__D028521 2002-01-01
% 224.82/225.06  |- skos__prefLabel mesh__D028521 Musa
% 224.82/225.06  |- rdf__type mesh__D028521sskos__Concept
% 224.82/225.06  |- mesh__dateCreated mesh__D028521 2001-07-25
% 224.82/225.06  |- skos__altLabel mesh__D028521 Banana Plant
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D028521 2005
% 224.82/225.06  |- mesh__historyNote mesh__D028521
% 224.82/225.06       2002; for BANANA use ZINGIBERALES 1998-2001; use FRUIT 1983-1997%A%  
% 224.82/225.06  |- mesh__publicMeSHNote mesh__D028521
% 224.82/225.06       2002; for BANANA see ZINGIBERALES 1998-2001; see FRUIT 1983-1997%A%  
% 224.82/225.06  |- mesh__recordAuthorizer mesh__D028521 sjn
% 224.82/225.06  |- skos__broader mesh__D028521smesh__D028522
% 224.82/225.06  |- skos__annotation mesh__D028521
% 224.82/225.06       Plantain, the banana-like fruit and green plantain flour go here; the medicinal herb referred to by the common name plantain probably goes under PLANTAGO; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.82/225.06  |- skos__scopeNote mesh__D028521
% 224.82/225.06       A plant genus of the family Musaceae, order Zingiberales, subclass Zingiberidae,  class Liliopsida.%A%    
% 224.82/225.06  |- mesh__dateRevised mesh__D028521 2002-07-02
% 224.82/225.06  |- mesh__recordOriginator mesh__D028521 ssb
% 224.82/225.06  |- skos__historyNote mesh__D028521 Zingiberales %28%1998-2001%29%
% 224.82/225.06  |- mesh__recordMaintainer mesh__D028521 ssb
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D028521 2004
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D028521 2006
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D014501 2006
% 224.82/225.06  |- skos__scopeNote mesh__D014501
% 224.82/225.06       Uranium. A radioactive element of the actinide series of metals. It has an atomic symbol U, atomic number 92, and atomic weight 238.03. U-235 is used as the fissionable fuel in nuclear weapons and as fuel in nuclear power reactors.%A%    
% 224.82/225.06  |- mesh__dateRevised mesh__D014501 2005-06-30
% 224.82/225.06  |- skos__prefLabel mesh__D014501 Uranium
% 224.82/225.06  |- mesh__recordMaintainer mesh__D014501 jmp
% 224.82/225.06  |- skos__broader mesh__D014501smesh__D019216
% 224.82/225.06  |- mesh__recordAuthorizer mesh__D014501 sjn
% 224.82/225.06  |- rdf__type mesh__D014501sskos__Concept
% 224.82/225.06  |- mesh__recordOriginator mesh__D014501 NLM
% 224.82/225.06  |- mesh__dateCreated mesh__D014501 1999-01-01
% 224.82/225.06  |- skos__broader mesh__D014501smesh__D008671
% 224.82/225.06  |- skos__annotation mesh__D014501 naturally radioactive; IM   
% 224.82/225.06  |- skos__hiddenLabel mesh__D005775 Blastopores
% 224.82/225.06  |- skos__broader mesh__D005775smesh__D004622
% 224.82/225.06  |- skos__hiddenLabel mesh__D005775 Streaks, Primitive
% 224.82/225.06  |- skos__hiddenLabel mesh__D005775 Gastrocoeles
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D005775 2001
% 224.82/225.06  |- skos__prefLabel mesh__D005775 Gastrula
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D005775 1997
% 224.82/225.06  |- mesh__recordAuthorizer mesh__D005775 PLS
% 224.82/225.06  |- skos__scopeNote mesh__D005775
% 224.82/225.06       The embryo in the early stage following the blastula, characterized by morphogenetic cell movements, cell differentiation, and the formation of the three germ layers.%A%    
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D005775 2005
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D005775 1991
% 224.82/225.06  |- mesh__recordMaintainer mesh__D005775 TAP
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D005775 2002
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D005775 2006
% 224.82/225.06  |- skos__hiddenLabel mesh__D005775 Gut, Primitive
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D005775 1992
% 224.82/225.06  |- mesh__historyNote mesh__D005775 80   
% 224.82/225.06  |- mesh__dateEstablished mesh__D005775 1980-01-01
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D005775 2003
% 224.82/225.06  |- mesh__activeMeSHYear mesh__D005775 1994
% 224.82/225.06  |- skos__hiddenLabel mesh__D005775 Primitive Streaks
% 224.82/225.06  |- skos__annotation mesh__D005775
% 224.82/225.06       %22%the embryo in the early stage following the blastula%22%; A 11 qualif%A%  
% 224.82/225.06  |- mesh__recordOriginator mesh__D005775 AEP
% 224.92/225.06  |- mesh__dateRevised mesh__D005775 1990-05-07
% 224.92/225.06  |- skos__hiddenLabel mesh__D005775 Primitive Guts
% 224.92/225.06  |- mesh__activeMeSHYear mesh__D005775 1993
% 224.92/225.06  |- mesh__activeMeSHYear mesh__D005775 2004
% 224.92/225.06  |- mesh__activeMeSHYear mesh__D005775 1998
% 224.92/225.06  |- mesh__activeMeSHYear mesh__D005775 1995
% 224.92/225.06  |- skos__hiddenLabel mesh__D005775 Gastrulas
% 224.92/225.06  |- rdf__type mesh__D005775sskos__Concept
% 224.92/225.06  |- skos__historyNote mesh__D005775 specific organism/EM %28%1966-1979%29%
% 224.92/225.06  |- skos__altLabel mesh__D005775 Archenteron
% 224.92/225.06  |- mesh__activeMeSHYear mesh__D005775 1999
% 224.92/225.06  |- mesh__activeMeSHYear mesh__D005775 2000
% 224.92/225.06  |- skos__hiddenLabel mesh__D005775 Streak, Primitive
% 224.92/225.06  |- skos__hiddenLabel mesh__D005775 Guts, Primitive
% 224.92/225.06  |- mesh__activeMeSHYear mesh__D005775 1996
% 224.92/225.06  |- skos__altLabel mesh__D005775 Gastrocoele
% 224.92/225.06  |- skos__hiddenLabel mesh__D005775 Archenterons
% 224.92/225.06  |- mesh__dateCreated mesh__D005775 1979-04-17
% 224.92/225.06  |- mesh__publicMeSHNote mesh__D005775 80   
% 224.92/225.06  |- skos__altLabel mesh__D013409 Colircusi Sulfacetamida
% 224.92/225.06  |- skos__hiddenLabel mesh__D013409 Sulfacetam, Coliriocilina
% 224.92/225.06  |- skos__altLabel mesh__D013409 Novartis Brand of Sulfacetamide Sodium
% 224.92/225.06  |- skos__hiddenLabel mesh__D013409 Belph 10
% 224.92/225.06  |- rdf__type mesh__D013409sskos__Concept
% 224.92/225.06  |- skos__altLabel mesh__D013409 M%C3%%A9%dix Brand of Sulfacetamide Sodium
% 224.92/225.06  |- skos__altLabel mesh__D013409 Akorn Brand of Sulfacetamide Sodium
% 224.92/225.06  |- skos__altLabel mesh__D013409 Sulphacetamide
% 224.92/225.06  |- skos__altLabel mesh__D013409 Allergan Brand of Sulfacetamide Sodium
% 224.92/225.06  |- skos__altLabel mesh__D013409 Belph-10
% 224.92/225.06  |- skos__hiddenLabel mesh__D013409 Sulf 10
% 224.92/225.06  |- skos__altLabel mesh__D013409 Pharmafair Brand of Sulfacetamide Sodium
% 224.92/225.06  |- skos__scopeNote mesh__D013409
% 224.92/225.06       An anti-infective agent that is used topically to treat skin infections and orally for urinary tract infections.%A%    
% 224.92/225.06  |- skos__hiddenLabel mesh__D013409 Monosodium Salt, Sulfacetamide
% 224.92/225.06  |- skos__altLabel mesh__D013409 Acetylsulfanilamide
% 224.92/225.06  |- skos__hiddenLabel mesh__D013409 Sulamyd, Sodium
% 224.92/225.06  |- skos__altLabel mesh__D013409 Chauvin Brand of Sulfacetamide Sodium
% 224.92/225.06  |- skos__broader mesh__D013409smesh__D013424
% 224.92/225.06  |- skos__altLabel mesh__D013409 Grin Brand of Sulfacetamide Sodium
% 224.92/225.06  |- mesh__recordMaintainer mesh__D013409 CCR
% 224.92/225.07  |- mesh__dateCreated mesh__D013409 1999-01-01
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D013409 2006
% 224.92/225.07  |- skos__prefLabel mesh__D013409 Sulfacetamide
% 224.92/225.07  |- mesh__recordOriginator mesh__D013409 NLM
% 224.92/225.07  |- skos__hiddenLabel mesh__D013409 Sodium, Sulfacetamide
% 224.92/225.07  |- skos__hiddenLabel mesh__D013409 Sulfacetamida, Colircusi
% 224.92/225.07  |- skos__altLabel mesh__D013409 Medical Brand of Sulfacetamide Sodium
% 224.92/225.07  |- mesh__recordAuthorizer mesh__D013409 sjn
% 224.92/225.07  |- skos__altLabel mesh__D013409 Sigma Brand of Sulfacetamide Sodium
% 224.92/225.07  |- skos__hiddenLabel mesh__D013409 AK Sulf
% 224.92/225.07  |- skos__altLabel mesh__D013409 Alcon Brand 2 of Sulfacetamide Sodium
% 224.92/225.07  |- mesh__dateRevised mesh__D013409 2005-06-30
% 224.92/225.07  |- skos__altLabel mesh__D013409 Alcon Brand 1 of Sulfacetamide Sodium
% 224.92/225.07  |- skos__hiddenLabel mesh__D013409 Cetamide, Isopto
% 224.92/225.07  |- skos__altLabel mesh__D013409 Sulfacetamide Monosodium Salt
% 224.92/225.07  |- skos__altLabel mesh__D013409 Schering Brand of Sulfacetamide Sodium
% 224.92/225.07  |- skos__altLabel mesh__D010111
% 224.92/225.07       Bristol-Myers Squibb Brand of Oxymorphone Hydrochloride
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D010111 2006
% 224.92/225.07  |- skos__hiddenLabel mesh__D010111 Methylbromide, Naloxone
% 224.92/225.07  |- mesh__dateCreated mesh__D010111 1999-01-01
% 224.92/225.07  |- skos__altLabel mesh__D010111 Methylnaloxone
% 224.92/225.07  |- skos__hiddenLabel mesh__D010111 Methobromide, Naloxone
% 224.92/225.07  |- skos__hiddenLabel mesh__D010111 MB, Naloxone
% 224.92/225.07  |- mesh__dateRevised mesh__D010111 2005-06-30
% 224.92/225.07  |- skos__broader mesh__D010111smesh__D009022
% 224.92/225.07  |- mesh__recordMaintainer mesh__D010111 lkw
% 224.92/225.07  |- mesh__recordAuthorizer mesh__D010111 sjn
% 224.92/225.07  |- mesh__recordOriginator mesh__D010111 NLM
% 224.92/225.07  |- skos__hiddenLabel mesh__D010111 N Methylnaloxone
% 224.92/225.07  |- mesh__historyNote mesh__D010111
% 224.92/225.07       91%28%64%29%; was see under DIHYDROMORPHINONE 1964-90   
% 224.92/225.07  |- skos__scopeNote mesh__D010111
% 224.92/225.07       An opioid analgesic with actions and uses similar to those of MORPHINE, apart from an absence of cough suppressant activity. It is used in the treatment of moderate to severe pain, including pain in obstetrics. It may also be used as an adjunct to anesthesia. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1092%29%%A%    
% 224.92/225.07  |- skos__broader mesh__D010111smesh__D004091
% 224.92/225.07  |- mesh__publicMeSHNote mesh__D010111
% 224.92/225.07       91; was see under DIHYDROMORPHINONE 1964-90   
% 224.92/225.07  |- skos__hiddenLabel mesh__D010111 N Methylnaloxone Bromide
% 224.92/225.07  |- rdf__type mesh__D010111sskos__Concept
% 224.92/225.07  |- skos__hiddenLabel mesh__D010111 MRZ 2593
% 224.92/225.07  |- skos__altLabel mesh__D010111 N-Methylnaloxone
% 224.92/225.07  |- skos__hiddenLabel mesh__D010111 MRZ 2593Br
% 224.92/225.07  |- skos__altLabel mesh__D010111 MRZ 2593-Br
% 224.92/225.07  |- skos__altLabel mesh__D010111 Naloxone Methobromide
% 224.92/225.07  |- mesh__dateEstablished mesh__D010111 1991-01-01
% 224.92/225.07  |- skos__altLabel mesh__D010111 Endo Brand of Oxymorphone Hydrochloride
% 224.92/225.07  |- skos__hiddenLabel mesh__D010111 MRZ2593
% 224.92/225.07  |- skos__hiddenLabel mesh__D010111 Bromide, N-Methylnaloxone
% 224.92/225.07  |- skos__hiddenLabel mesh__D010111 MRZ 2593 Br
% 224.92/225.07  |- skos__prefLabel mesh__D010111 Oxymorphone
% 224.92/225.07  |- skos__altLabel mesh__D010111 Naloxone MB
% 224.92/225.07  |- skos__altLabel mesh__D010111 N-Methylnaloxone Bromide
% 224.92/225.07  |- skos__hiddenLabel mesh__D010111 Hydrochloride, Oxymorphone
% 224.92/225.07  |- skos__hiddenLabel mesh__D051528 Membrane Associated Guanylate Kinase
% 224.92/225.07  |- skos__prefLabel mesh__D051528 Guanylate Kinase
% 224.92/225.07  |- skos__hiddenLabel mesh__D051528 p55, Erythrocyte protein
% 224.92/225.07  |- skos__hiddenLabel mesh__D051528 Guanylate Kinase, Membrane-Associated
% 224.92/225.07  |- skos__hiddenLabel mesh__D051528 Kinase, GMP
% 224.92/225.07  |- skos__hiddenLabel mesh__D051528 Monophosphate Kinase, Guanosine
% 224.92/225.07  |- rdf__type mesh__D051528sskos__Concept
% 224.92/225.07  |- skos__scopeNote mesh__D051528
% 224.92/225.07       Catalyzes the ATP-dependent PHOSPHORYLATION of GMP to generate GDP and ADP.%A%    
% 224.92/225.07  |- mesh__recordMaintainer mesh__D051528 AKE
% 224.92/225.07  |- skos__altLabel mesh__D051528 Guanosine Monophosphate Kinase
% 224.92/225.07  |- skos__altLabel mesh__D051528 GMP Kinase
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D051528 2006
% 224.92/225.07  |- mesh__recordAuthorizer mesh__D051528 sjn
% 224.92/225.07  |- skos__broader mesh__D051528smesh__D017856
% 224.92/225.07  |- skos__hiddenLabel mesh__D051528 Kinase 1, Guanylate
% 224.92/225.07  |- skos__hiddenLabel mesh__D051528 Kinase, Membrane-Associated Guanylate
% 224.92/225.07  |- mesh__publicMeSHNote mesh__D051528
% 224.92/225.07       2006; NUCLEOSIDE-PHOSPHATE KINASE 1979-2005, %26% under NUCLEOTIDES %26% PHOSPHOTRANSFERASES, ATP 1974-1978%A%  
% 224.92/225.07  |- mesh__recordOriginator mesh__D051528 AKE
% 224.92/225.07  |- mesh__historyNote mesh__D051528
% 224.92/225.07       2006%28%1980%29%; use  NUCLEOSIDE-PHOSPHATE KINASE 1979, %26% NUCLEOTIDES %26% PHOSPHOTRANSFERASES, ATP 1974-1978%A%  
% 224.92/225.07  |- skos__hiddenLabel mesh__D051528 protein p55, Erythrocyte
% 224.92/225.07  |- skos__hiddenLabel mesh__D051528 Kinase, Guanosine Monophosphate
% 224.92/225.07  |- mesh__dateEstablished mesh__D051528 2006-01-01
% 224.92/225.07  |- mesh__dateCreated mesh__D051528 2005-06-30
% 224.92/225.07  |- skos__altLabel mesh__D051528 ATP-%28%d%29%GMP Phosphotransferase
% 224.92/225.07  |- skos__hiddenLabel mesh__D051528 Kinase, Guanylate
% 224.92/225.07  |- skos__prefLabel mesh__D009368 Neoplasm Transplantation
% 224.92/225.07  |- mesh__recordMaintainer mesh__D009368 AGS
% 224.92/225.07  |- mesh__recordAuthorizer mesh__D009368 sjn
% 224.92/225.07  |- mesh__historyNote mesh__D009368 67%28%64%29%   
% 224.92/225.07  |- mesh__dateCreated mesh__D009368 1999-01-01
% 224.92/225.07  |- mesh__recordOriginator mesh__D009368 NLM
% 224.92/225.07  |- skos__hiddenLabel mesh__D009368 Neoplasm Transplantations
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D009368 2004
% 224.92/225.07  |- mesh__dateEstablished mesh__D009368 1967-01-01
% 224.92/225.07  |- skos__broader mesh__D009368smesh__D008919
% 224.92/225.07  |- rdf__type mesh__D009368sskos__Concept
% 224.92/225.07  |- skos__scopeNote mesh__D009368
% 224.92/225.07       Experimental transplantation of neoplasms in laboratory animals for research purposes.%A%    
% 224.92/225.07  |- mesh__dateRevised mesh__D009368 2002-07-03
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D009368 2003
% 224.92/225.07  |- skos__altLabel mesh__D009368 Transplantation, Neoplasm
% 224.92/225.07  |- skos__hiddenLabel mesh__D009368 Transplantations, Neoplasm
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D009368 2006
% 224.92/225.07  |- mesh__publicMeSHNote mesh__D009368 67   
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D009368 2005
% 224.92/225.07  |- skos__annotation mesh__D009368 NIM; Manual 24.5.4; DF: NEOPL TRANSPL   
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D001385 1996
% 224.92/225.07  |- rdf__type mesh__D001385sskos__Concept
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D001385 1998
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D001385 2000
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D001385 1997
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D001385 1994
% 224.92/225.07  |- skos__annotation mesh__D001385 do not confuse with AZETIDINES   
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D001385 2001
% 224.92/225.07  |- mesh__dateEstablished mesh__D001385 1974-01-01
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D001385 1999
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D001385 1993
% 224.92/225.07  |- mesh__historyNote mesh__D001385 74   
% 224.92/225.07  |- mesh__dateRevised mesh__D001385 1992-05-07
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D001385 2003
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D001385 1995
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D001385 2005
% 224.92/225.07  |- mesh__recordOriginator mesh__D001385 NLM
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D001385 2004
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D001385 2002
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D001385 2006
% 224.92/225.07  |- mesh__dateCreated mesh__D001385 1999-01-01
% 224.92/225.07  |- skos__prefLabel mesh__D001385 Azetines
% 224.92/225.07  |- mesh__publicMeSHNote mesh__D001385 74   
% 224.92/225.07  |- mesh__recordAuthorizer mesh__D001385 PLS
% 224.92/225.07  |- skos__broader mesh__D001385smesh__D006573
% 224.92/225.07  |- mesh__recordMaintainer mesh__D001385 TAP
% 224.92/225.07  |- skos__annotation mesh__D028522
% 224.92/225.07       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.92/225.07  |- mesh__dateCreated mesh__D028522 2001-07-25
% 224.92/225.07  |- mesh__recordMaintainer mesh__D028522 jls
% 224.92/225.07  |- skos__broader mesh__D028522smesh__D019862
% 224.92/225.07  |- mesh__dateRevised mesh__D028522 2004-07-29
% 224.92/225.07  |- mesh__recordOriginator mesh__D028522 ssb
% 224.92/225.07  |- skos__prefLabel mesh__D028522 Musaceae
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D028522 2005A
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D028522 2004
% 224.92/225.07  |- mesh__historyNote mesh__D028522 2002   
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D028522 2006
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D028522 2003
% 224.92/225.07  |- mesh__dateEstablished mesh__D028522 2002-01-01
% 224.92/225.07  |- mesh__publicMeSHNote mesh__D028522 2002   
% 224.92/225.07  |- rdf__type mesh__D028522sskos__Concept
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D028522 2005
% 224.92/225.07  |- skos__historyNote mesh__D028522 Zingiberales %28%1998-2001%29%
% 224.92/225.07  |- mesh__recordAuthorizer mesh__D028522 jls
% 224.92/225.07  |- skos__scopeNote mesh__D028522
% 224.92/225.07       A plant family of the order ZINGIBERALES, subclass Zingiberidae,  class Liliopsida best known for banana %28%MUSA%29%. The slender false trunk, formed by leaf sheaths of the spirally arranged leaves, may rise to 15 meters %28%50 feet%29%. There is a crown of large leaves at the top.%A%    
% 224.92/225.07  |- rdf__type mesh__D006070sskos__Concept
% 224.92/225.07  |- skos__hiddenLabel mesh__D006070 Goodpastures Syndrome
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D006070 2001
% 224.92/225.07  |- mesh__recordOriginator mesh__D006070 NLM
% 224.92/225.07  |- skos__broader mesh__D006070smesh__D001327
% 224.92/225.07  |- mesh__recordMaintainer mesh__D006070 TGC
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D006070 2003
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D006070 2002
% 224.92/225.07  |- skos__broader mesh__D006070smesh__D017563
% 224.92/225.07  |- mesh__dateRevised mesh__D006070 1997-06-20
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D006070 2005
% 224.92/225.07  |- mesh__historyNote mesh__D006070 98%28%65%29%   
% 224.92/225.07  |- skos__altLabel mesh__D006070 Lung Purpura with Nephritis
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D006070 2004
% 224.92/225.07  |- skos__prefLabel mesh__D006070 Goodpasture Syndrome
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D006070 2006
% 224.92/225.07  |- mesh__publicMeSHNote mesh__D006070
% 224.92/225.07       98; see GOODPASTURE%27%S SYNDROME 1966-97   
% 224.92/225.07  |- skos__hiddenLabel mesh__D006070 Syndrome, Goodpasture%27%s
% 224.92/225.07  |- skos__annotation mesh__D006070
% 224.92/225.07       pulm hemorrhage %26% glomerulonephritis   
% 224.92/225.07  |- skos__hiddenLabel mesh__D006070 Syndrome, Goodpasture
% 224.92/225.07  |- skos__altLabel mesh__D006070 Goodpasture%27%s Syndrome
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D006070 1998
% 224.92/225.07  |- skos__scopeNote mesh__D006070
% 224.92/225.07       A combination of pulmonary hemorrhage and glomerulonephritis. It is known also as the lung purpura glomerulonephritis complex. It is considered by some to be a form of hypersensitivity reaction.%A%    
% 224.92/225.07  |- mesh__recordAuthorizer mesh__D006070 SJN
% 224.92/225.07  |- mesh__dateEstablished mesh__D006070 1966-01-01
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D006070 2000
% 224.92/225.07  |- mesh__dateCreated mesh__D006070 1999-01-01
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D006070 1999
% 224.92/225.07  |- skos__broader mesh__D006070smesh__D019867
% 224.92/225.07  |- mesh__publicMeSHNote mesh__D014502 91; was see under URANIUM 1976-90   
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D014502 2001
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D014502 1995
% 224.92/225.07  |- mesh__recordMaintainer mesh__D014502 TPW
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D014502 1996
% 224.92/225.07  |- skos__historyNote mesh__D014502 Nitrates %28%1973-1975%29%
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D014502 2006
% 224.92/225.07  |- mesh__historyNote mesh__D014502
% 224.92/225.07       91%28%76%29%; was see under URANIUM 1976-90   
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D014502 2002
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D014502 1997
% 224.92/225.07  |- mesh__dateCreated mesh__D014502 1975-07-25
% 224.92/225.07  |- mesh__recordAuthorizer mesh__D014502 PLS
% 224.92/225.07  |- skos__hiddenLabel mesh__D014502 Nitrate, Uranyl
% 224.92/225.07  |- rdf__type mesh__D014502sskos__Concept
% 224.92/225.07  |- skos__historyNote mesh__D014502 Uranium %28%1973-1975%29%
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D014502 2003
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D014502 1998
% 224.92/225.07  |- mesh__dateEstablished mesh__D014502 1991-01-01
% 224.92/225.07  |- skos__altLabel mesh__D014502 Uranium Nitrate
% 224.92/225.07  |- skos__broader mesh__D014502smesh__D009566
% 224.92/225.07  |- skos__prefLabel mesh__D014502 Uranyl Nitrate
% 224.92/225.07  |- skos__hiddenLabel mesh__D014502 Nitrate, Uranium
% 224.92/225.07  |- mesh__dateRevised mesh__D014502 1993-06-03
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D014502 2004
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D014502 1999
% 224.92/225.07  |- skos__annotation mesh__D014502
% 224.92/225.07       used in photography %26% porcelain indust   
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D014502 2000
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D014502 1994
% 224.92/225.07  |- mesh__recordOriginator mesh__D014502 RLS
% 224.92/225.07  |- skos__scopeNote mesh__D014502
% 224.92/225.07       Bis%28%nitrato-O%29%dioxouranium. A compound used in photography and the porcelain industry. It causes severe renal insufficiency and renal tubular necrosis in mammals and is an effective lymphocyte mitogen.%A%    
% 224.92/225.07  |- skos__broader mesh__D014502smesh__D017974
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D014502 2005
% 224.92/225.07  |- skos__altLabel mesh__D019796
% 224.92/225.07       %28%15S%29%hydroxy-9alpha,11alpha-%28%epoxymethano%29%prosta-5,13-dienoic acid
% 224.92/225.07  |- skos__annotation mesh__D019796 DF: U46619   
% 224.92/225.07  |- skos__historyNote mesh__D019796
% 224.92/225.07       Prostaglandin Endoperoxides, Synthetic %28%1978-1997%29%
% 224.92/225.07  |- skos__historyNote mesh__D019796
% 224.92/225.07       Thromboxane A2/analogs %26% derivatives %28%1983-1997%29%
% 224.92/225.07  |- skos__broader mesh__D019796smesh__D011450
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D019796 2006
% 224.92/225.07  |- mesh__historyNote mesh__D019796
% 224.92/225.07       1998; use 15-HYDROXY-11 ALPHA,9 ALPHA-%28%EPOXYMETHANO%29%PROSTA-5,13-DIENOIC ACID %28%NM%29% 1977-1997; for %28%15S%29%HYDROXY-9ALPHA,11ALPHA-%28%EPOXYMETHANO%29%PROSTA-5,13-DIENOIC ACID and 9,11-EPOXYMETHANO-PGH2 use PROSTAGLANDIN H2 %28%NM%29% 1992-2003%A%  
% 224.92/225.07  |- skos__altLabel mesh__D019796 9,11-epoxymethano-PGH2
% 224.92/225.07  |- mesh__recordAuthorizer mesh__D019796 sjn
% 224.92/225.07  |- skos__altLabel mesh__D019796 U-46619
% 224.92/225.07  |- skos__altLabel mesh__D019796
% 224.92/225.07       %28%15S%29%-Hydroxy-11 alpha, 9 alpha-%28%epoxymethano%29%prosta-5Z, 13E-dienoic Acid
% 224.92/225.07  |- rdf__type mesh__D019796sskos__Concept
% 224.92/225.07  |- mesh__recordMaintainer mesh__D019796 ssb
% 224.92/225.07  |- mesh__dateCreated mesh__D019796 1997-06-20
% 224.92/225.07  |- skos__prefLabel mesh__D019796
% 224.92/225.07       15-Hydroxy-11 alpha,9 alpha-%28%epoxymethano%29%prosta-5,13-dienoic Acid
% 224.92/225.07  |- skos__altLabel mesh__D019796
% 224.92/225.07       9,11-Dideoxy-11 alpha,9-alpha-epoxymethano-PGF2 alpha
% 224.92/225.07  |- skos__altLabel mesh__D019796 11 alpha,9 alpha-Epoxymethano PGH2
% 224.92/225.07  |- skos__hiddenLabel mesh__D019796 U 46619
% 224.92/225.07  |- skos__scopeNote mesh__D019796
% 224.92/225.07       A stable prostaglandin endoperoxide analog which serves as a thromboxane mimetic. Its actions include mimicking the hydro-osmotic effect of VASOPRESSIN and activation of PHOSPHOLIPASE C. %28%From J Pharmacol Exp Ther 1983;224%28%1%29%: 108-117; Biochem J 1984;222%28%1%29%:103-110%29%%A%    
% 224.92/225.07  |- skos__hiddenLabel mesh__D019796 9,11 epoxymethano PGH2
% 224.92/225.07  |- mesh__publicMeSHNote mesh__D019796
% 224.92/225.07       1998; 15-HYDROXY-11 ALPHA,9 ALPHA-%28%EPOXYMETHANO%29%PROSTA-5,13-DIENOIC ACID was indexed under PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC 1978-97 %26% THROMBOXANE A2/analogs %26% derivatives 1983-97; %28%15S%29%HYDROXY-9ALPHA,11ALPHA-%28%EPOXYMETHANO%29%PROSTA-5,13-DIENOIC ACID and 9,11-EPOXYMETHANO-PGH2 were indexed under PROSTAGLANDINS H 1993-2003 %26% PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC 1986-1992%A%  
% 224.92/225.07  |- skos__hiddenLabel mesh__D019796 11 alpha,9 alpha Epoxymethano PGH2
% 224.92/225.07  |- mesh__dateEstablished mesh__D019796 1998-01-01
% 224.92/225.07  |- skos__hiddenLabel mesh__D019796 U 44619
% 224.92/225.07  |- skos__altLabel mesh__D019796 U44619
% 224.92/225.07  |- mesh__recordOriginator mesh__D019796 KEV
% 224.92/225.07  |- skos__altLabel mesh__D019796
% 224.92/225.07       9,11-Dideoxy-11 alpha,9 alpha-epoxymethanoprostaglandin F2 alpha
% 224.92/225.07  |- mesh__dateRevised mesh__D019796 2005-06-30
% 224.92/225.07  |- skos__altLabel mesh__D019796 U46619
% 224.92/225.07  |- skos__broader mesh__D019796smesh__D044262
% 224.92/225.07  |- mesh__recordOriginator mesh__D005776 NLM
% 224.92/225.07  |- skos__altLabel mesh__D005776 Gaucher%27%s Disease
% 224.92/225.07  |- mesh__recordAuthorizer mesh__D005776 sjn
% 224.92/225.07  |- skos__altLabel mesh__D005776 Disease, Acute Neuronopathic Gaucher
% 224.92/225.07  |- skos__altLabel mesh__D005776 Gaucher Disease, Chronic
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D005776 2005
% 224.92/225.07  |- mesh__dateCreated mesh__D005776 1999-01-01
% 224.92/225.07  |- mesh__historyNote mesh__D005776 2000%28%1966%29%   
% 224.92/225.07  |- skos__altLabel mesh__D005776 Gaucher Disease, Infantile
% 224.92/225.07  |- skos__altLabel mesh__D005776 Infantile Gaucher Disease
% 224.92/225.07  |- skos__hiddenLabel mesh__D005776
% 224.92/225.07       Glucosylceramide Beta Glucosidase Deficiency Disease
% 224.92/225.07  |- skos__altLabel mesh__D005776 Gaucher Disease, Acute Neuronopathic
% 224.92/225.07  |- skos__hiddenLabel mesh__D005776 Cerebroside Lipidosis Syndromes
% 224.92/225.07  |- skos__altLabel mesh__D005776 Type 2 Gaucher Disease
% 224.92/225.07  |- mesh__recordMaintainer mesh__D005776 nns
% 224.92/225.07  |- skos__scopeNote mesh__D005776
% 224.92/225.07       An autosomal recessive disorder caused by deficiency of the enzyme glucocerebrosidase %28%see GLUCOSYLCERAMIDASE%29% featuring the pathological storage of glycosylceramide in mononuclear PHAGOCYTES %28%Gaucher Cells%29%. The most common subtype is the non-neuronopathic form, a slowly progressive condition characterized by hepatosplenomegaly and skeletal deformities. The neuronopathic forms are divided into infantile and juvenile forms. The infantile form presents at 4-5 months of age with anemia, loss of cognitive gains, neck retraction, dysphagia, and hepatosplenomegaly. The juvenile form features a slowly progressive loss of intellect, hepatosplenomegaly, ATAXIA, myoclonic SEIZURES, and spasticity. The neuronopathic forms are characterized by neuronal loss with neuronophagia, and accumulation of glucocerebroside in neurons. %28%From Baillieres Clin Haematol 1997 Dec;10%28%4%29%:711-23; Menkes, Textbook of Child Neurology, 5th ed, p97%29%%A%    
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D005776 2006
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D005776 2002
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D005776 2003
% 224.92/225.07  |- skos__altLabel mesh__D005776 Cerebroside Lipidosis Syndrome
% 224.92/225.07  |- skos__hiddenLabel mesh__D005776 Juvenile Gaucher Disease
% 224.92/225.07  |- skos__altLabel mesh__D005776 Type 1 Gaucher Disease
% 224.92/225.07  |- mesh__dateRevised mesh__D005776 2001-07-25
% 224.92/225.07  |- skos__altLabel mesh__D005776 Type 3 Gaucher Disease
% 224.92/225.07  |- skos__altLabel mesh__D005776
% 224.92/225.07       Glucosylceramide Beta-Glucosidase Deficiency Disease
% 224.92/225.07  |- skos__altLabel mesh__D005776 Non-Neuronopathic Gaucher Disease
% 224.92/225.07  |- skos__altLabel mesh__D005776 Disease, Gaucher, Chronic
% 224.92/225.07  |- skos__altLabel mesh__D005776 Gaucher Disease, Neuronopathic
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D005776 2004
% 224.92/225.07  |- skos__altLabel mesh__D005776
% 224.92/225.07       Gaucher Disease, Subacute Neuronopathic Form
% 224.92/225.07  |- skos__related mesh__D005776smesh__D005962
% 224.92/225.07  |- mesh__publicMeSHNote mesh__D005776
% 224.92/225.07       2000; see GAUCHER%27%S DISEASE 1966-1999; for GAUCHER DISEASE see GAUCHER%27%S DISEASE 1966-1999%A%  
% 224.92/225.07  |- skos__altLabel mesh__D005776 Disease, Gaucher, Acute Neuronopathic
% 224.92/225.07  |- skos__broader mesh__D005776smesh__D012158
% 224.92/225.07  |- rdf__type mesh__D005776sskos__Concept
% 224.92/225.07  |- skos__hiddenLabel mesh__D005776
% 224.92/225.07       Deficiency Disease, Glucosylceramide Beta Glucosidase
% 224.92/225.07  |- skos__broader mesh__D005776smesh__D013106
% 224.92/225.07  |- skos__altLabel mesh__D005776 Deficiency Disease, Glucocerebrosidase
% 224.92/225.07  |- skos__prefLabel mesh__D005776 Gaucher Disease
% 224.92/225.07  |- skos__hiddenLabel mesh__D005776 Gauchers Disease
% 224.92/225.07  |- skos__hiddenLabel mesh__D005776 Gaucher Disease, Non-Neuronopathic
% 224.92/225.07  |- skos__altLabel mesh__D005776 Acute Neuronopathic Gaucher Disease
% 224.92/225.07  |- skos__hiddenLabel mesh__D005776 Syndrome, Cerebroside Lipidosis
% 224.92/225.07  |- skos__hiddenLabel mesh__D005776 Non Neuronopathic Gaucher Disease
% 224.92/225.07  |- skos__altLabel mesh__D005776 Subacute Neuronopathic Gaucher Disease
% 224.92/225.07  |- skos__hiddenLabel mesh__D005776 Gaucher Disease, Non Neuronopathic Form
% 224.92/225.07  |- skos__altLabel mesh__D005776
% 224.92/225.07       Deficiency Disease, Glucosylceramide Beta-Glucosidase
% 224.92/225.07  |- skos__altLabel mesh__D005776 Disease, Chronic Gaucher
% 224.92/225.07  |- skos__altLabel mesh__D005776 Glucocerebrosidase Deficiency Disease
% 224.92/225.07  |- skos__hiddenLabel mesh__D005776 Glucocerebrosidase Deficiency Diseases
% 224.92/225.07  |- skos__hiddenLabel mesh__D005776 Syndromes, Cerebroside Lipidosis
% 224.92/225.07  |- skos__hiddenLabel mesh__D005776 Disease, Glucocerebrosidase Deficiency
% 224.92/225.07  |- skos__altLabel mesh__D005776 Gaucher Disease, Juvenile
% 224.92/225.07  |- skos__altLabel mesh__D005776 Gaucher Disease, Non-Neuronopathic Form
% 224.92/225.07  |- skos__altLabel mesh__D005776 Chronic Gaucher Disease
% 224.92/225.07  |- skos__hiddenLabel mesh__D005776 Deficiency Diseases, Glucocerebrosidase
% 224.92/225.07  |- skos__hiddenLabel mesh__D005776 Diseases, Glucocerebrosidase Deficiency
% 224.92/225.07  |- skos__broader mesh__D010910smesh__D016371
% 224.92/225.07  |- skos__annotation mesh__D010910
% 224.92/225.07       ionizing; a radiother procedure: do not confuse with eff of rad on pituitary %28% = PITUITARY GLAND /rad eff%29%; do not use /util except by MeSH definition%A%  
% 224.92/225.07  |- mesh__recordAuthorizer mesh__D010910 sjn
% 224.92/225.07  |- mesh__recordOriginator mesh__D010910 NLM
% 224.92/225.07  |- skos__hiddenLabel mesh__D010910 Pituitary Gland Irradiations
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D010910 2006
% 224.92/225.07  |- skos__altLabel mesh__D010910 Pituitary Gland Irradiation
% 224.92/225.07  |- skos__hiddenLabel mesh__D010910 Irradiations, Pituitary Gland
% 224.92/225.07  |- skos__hiddenLabel mesh__D010910 Irradiation, Pituitary Gland
% 224.92/225.07  |- mesh__dateCreated mesh__D010910 1999-01-01
% 224.92/225.07  |- skos__hiddenLabel mesh__D010910 Irradiation, Pituitary
% 224.92/225.07  |- mesh__recordMaintainer mesh__D010910 lkt
% 224.92/225.07  |- skos__hiddenLabel mesh__D010910 Gland Irradiation, Pituitary
% 224.92/225.07  |- skos__prefLabel mesh__D010910 Pituitary Irradiation
% 224.92/225.07  |- skos__hiddenLabel mesh__D010910 Irradiations, Pituitary
% 224.92/225.07  |- rdf__type mesh__D010910sskos__Concept
% 224.92/225.07  |- skos__hiddenLabel mesh__D010910 Gland Irradiations, Pituitary
% 224.92/225.07  |- mesh__dateEstablished mesh__D010910 1968-01-01
% 224.92/225.07  |- mesh__dateRevised mesh__D010910 2005-06-30
% 224.92/225.07  |- mesh__onlineNote mesh__D010910
% 224.92/225.07       use PITUITARY IRRADIATION to search PITUITARY GLAND IRRADIATION 1966-76%A%  
% 224.92/225.07  |- mesh__publicMeSHNote mesh__D010910
% 224.92/225.07       77,63-67; was PITUITARY GLAND IRRADIATION 1968-76   
% 224.92/225.07  |- mesh__historyNote mesh__D010910
% 224.92/225.07       77,63-67; was PITUITARY GLAND IRRADIATION 1968-76   
% 224.92/225.07  |- skos__hiddenLabel mesh__D010910 Pituitary Irradiations
% 224.92/225.07  |- skos__prefLabel mesh__D009369 Neoplasms
% 224.92/225.07  |- mesh__considerAlso mesh__D009369
% 224.92/225.07       consider also terms at CANCER, CARCINO-, ONCO-, and TUMOR%A%  
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D009369 2003
% 224.92/225.07  |- skos__hiddenLabel mesh__D009369 Neoplasm
% 224.92/225.07  |- skos__hiddenLabel mesh__D009369 Cancers
% 224.92/225.07  |- skos__related mesh__D009369smesh__D000951
% 224.92/225.07  |- mesh__onlineNote mesh__D009369 pre-explosion = NEOPLASMS %28%PX%29%   
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D009369 2006A
% 224.92/225.07  |- mesh__publicMeSHNote mesh__D009369
% 224.92/225.07       /diagnosis was NEOPLASM DIAGNOSIS 1964-65; /etiology was NEOPLASM ETIOLOGY 1964-65; /immunology was NEOPLASM IMMUNOLOGY 1964-65; /radiotherapy was NEOPLASM RADIOTHERAPY 1964-65; /therapy was NEOPLASM THERAPY 1964-65; NEOPLASM STATISTICS was heading 1964-65; CARCINOGENESIS was heading 1977%A%  
% 224.92/225.07  |- skos__altLabel mesh__D009369 Neoplasms, Benign
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D009369 2004
% 224.92/225.07  |- skos__hiddenLabel mesh__D009369 Neoplasm, Benign
% 224.92/225.07  |- skos__related mesh__D009369smesh__D016147
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D009369 2002
% 224.92/225.07  |- mesh__runningHead mesh__D009369 C4 - DISEASES-NEOPLASMS   
% 224.92/225.07  |- mesh__dateRevised mesh__D009369 2005-07-14
% 224.92/225.07  |- rdf__type mesh__D009369sskos__Concept
% 224.92/225.07  |- mesh__activeMeSHYear mesh__D009369 2005
% 224.92/225.07  |- skos__related mesh__D009369smesh__D016588
% 224.92/225.07  |- skos__related mesh__D009369smesh__D016066
% 224.92/225.07  |- skos__related mesh__D009369smesh__D000912
% 224.92/225.07  |- skos__related mesh__D009369smesh__D004273
% 224.92/225.07  |- mesh__recordOriginator mesh__D009369 NLM
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D009369 2006
% 224.92/225.08  |- skos__scopeNote mesh__D009369
% 224.92/225.08       New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.%A%    
% 224.92/225.08  |- skos__related mesh__D009369smesh__D011230
% 224.92/225.08  |- skos__related mesh__D009369smesh__D002273
% 224.92/225.08  |- mesh__recordMaintainer mesh__D009369 ags
% 224.92/225.08  |- skos__hiddenLabel mesh__D009369 Tumor
% 224.92/225.08  |- skos__hiddenLabel mesh__D009369 Benign Neoplasm
% 224.92/225.08  |- skos__annotation mesh__D009369
% 224.92/225.08       avoid: too general; prefer specifics; policy: Manual section 24; /chem ind permitted but consider also CARCINOGENS; /class: consider also NEOPLASM STAGING %28%see note there%29% but %22%grading%22% = /pathol; /etiol: consider also ONCOGENIC VIRUSES; /vet: Manual 24.6+ or TN 136; TN 135: MeSH terms for neoplasms classed by tissue; /drug ther: consider also ANTINEOPLASTIC AGENTS %26% its specifics; /genet: consider also GENES, TUMOR SUPPRESSOR /immunol: consider also TUMOR ESCAPE; consider also ANTIGENS, NEOPLASM %26% ANTIBODIES, NEOPLASM; /microbiol: consider also ONCOGENIC VIRUSES; /nurs = the patient, ONCOLOGIC NURSING = the oncologic specialty; /prev: consider also ANTICARCINOGENIC AGENTS; /radiother = the patient, RADIATION ONCOLOGY = the specialty; consider also BRACHYTHERAPY; /second = NEOPLASM METASTASIS but do not confuse with NEOPLASMS, SECOND PRIMARY; familial: consider also NEOPLASTIC SYNDROMES, HEREDITARY; metastatic cancer of unknown origin: index under NEOPLASM METASTASIS; Tumor Key: TN Suppl%A%  
% 224.92/225.08  |- skos__altLabel mesh__D009369 Tumors
% 224.92/225.08  |- mesh__dateCreated mesh__D009369 1999-01-01
% 224.92/225.08  |- mesh__historyNote mesh__D009369
% 224.92/225.08       /diagnosis was NEOPLASM DIAGNOSIS 1964-65; /etiology was NEOPLASM ETIOLOGY 1964-65; /immunology was NEOPLASM IMMUNOLOGY 1964-65; /radiotherapy was NEOPLASM RADIOTHERAPY 1964-65; /therapy was NEOPLASM THERAPY 1964-65; NEOPLASM STATISTICS was heading 1964-65; CARCINOGENESIS was heading 1977%A%  
% 224.92/225.08  |- mesh__recordAuthorizer mesh__D009369 ags
% 224.92/225.08  |- skos__related mesh__D009369smesh__D012334
% 224.92/225.08  |- skos__related mesh__D009369smesh__D000970
% 224.92/225.08  |- skos__related mesh__D009369smesh__D009858
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D001386 1999
% 224.92/225.08  |- mesh__recordMaintainer mesh__D001386 TPW
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D001386 2003
% 224.92/225.08  |- mesh__recordAuthorizer mesh__D001386 SJN
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D001386 2000
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D001386 2005
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D001386 2004
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D001386 2001
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D001386 2006
% 224.92/225.08  |- mesh__dateCreated mesh__D001386 1999-01-01
% 224.92/225.08  |- mesh__dateRevised mesh__D001386 1998-06-10
% 224.92/225.08  |- skos__broader mesh__D001386smesh__D009930
% 224.92/225.08  |- skos__broader mesh__D001386smesh__D017672
% 224.92/225.08  |- skos__prefLabel mesh__D001386 Azides
% 224.92/225.08  |- mesh__recordOriginator mesh__D001386 NLM
% 224.92/225.08  |- skos__scopeNote mesh__D001386
% 224.92/225.08       Organic or inorganic compounds that contain the -N3 group.%A%    
% 224.92/225.08  |- rdf__type mesh__D001386sskos__Concept
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D001386 2002
% 224.92/225.08  |- mesh__publicMeSHNote mesh__D028523
% 224.92/225.08       2002; for CARDAMON see ZINGIBERALES 1998-2001   
% 224.92/225.08  |- skos__scopeNote mesh__D028523
% 224.92/225.08       A plant genus of the family ZINGIBERACEAE, order Zingiberales, subclass Zingiberidae. Elettaria cardamomum %28%L.%29% Maton is the source of Cardamom used in SPICES.%A%    
% 224.92/225.08  |- skos__prefLabel mesh__D028523 Elettaria
% 224.92/225.08  |- skos__annotation mesh__D028523
% 224.92/225.08       X ref AMOMUM CARDAMOMUM: AMOMUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D028523 2006
% 224.92/225.08  |- skos__historyNote mesh__D028523 Zingiberales %28%1998-2001%29%
% 224.92/225.08  |- mesh__recordOriginator mesh__D028523 ssb
% 224.92/225.08  |- skos__broader mesh__D028523smesh__D030521
% 224.92/225.08  |- rdf__type mesh__D028523sskos__Concept
% 224.92/225.08  |- mesh__historyNote mesh__D028523
% 224.92/225.08       2002; for CARDAMON use ZINGIBERALES 1998-2001   
% 224.92/225.08  |- skos__altLabel mesh__D028523 Elettaria cardamomum
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D028523 2005
% 224.92/225.08  |- mesh__recordMaintainer mesh__D028523 jls
% 224.92/225.08  |- mesh__dateEstablished mesh__D028523 2002-01-01
% 224.92/225.08  |- mesh__dateCreated mesh__D028523 2001-07-25
% 224.92/225.08  |- mesh__dateRevised mesh__D028523 2004-07-19
% 224.92/225.08  |- mesh__recordAuthorizer mesh__D028523 sjn
% 224.92/225.08  |- skos__altLabel mesh__D028523 Cardamon
% 224.92/225.08  |- skos__altLabel mesh__D028523 Amomum cardamomum
% 224.92/225.08  |- mesh__dateCreated mesh__D020540 1999-11-03
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D020540 2003
% 224.92/225.08  |- skos__historyNote mesh__D020540 Pons %28%1987-1999%29%
% 224.92/225.08  |- mesh__publicMeSHNote mesh__D020540 2000; see PONS 1987-1999   
% 224.92/225.08  |- mesh__dateEstablished mesh__D020540 2000-01-01
% 224.92/225.08  |- mesh__historyNote mesh__D020540 2000; use PONS 1987-1999   
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D020540 2001
% 224.92/225.08  |- skos__broader mesh__D020540smesh__D012249
% 224.92/225.08  |- skos__scopeNote mesh__D020540
% 224.92/225.08       The anterior part of the rhombencephalon, comprising the CEREBELLUM and the PONS. %28%Dorland, 28th ed%29%%A%    
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D020540 2000
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D020540 2006
% 224.92/225.08  |- rdf__type mesh__D020540sskos__Concept
% 224.92/225.08  |- skos__prefLabel mesh__D020540 Metencephalon
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D020540 2004
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D020540 2005
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D020540 2002
% 224.92/225.08  |- skos__hiddenLabel mesh__D020540 Metencephalons
% 224.92/225.08  |- skos__hiddenLabel mesh__D006071 Gorilla
% 224.92/225.08  |- skos__prefLabel mesh__D006071 Gorilla gorilla
% 224.92/225.08  |- mesh__recordAuthorizer mesh__D006071 sjn
% 224.92/225.08  |- mesh__dateRevised mesh__D006071 2005-06-30
% 224.92/225.08  |- mesh__dateEstablished mesh__D006071 1975-09-01
% 224.92/225.08  |- mesh__publicMeSHNote mesh__D006071 81; was GORILLAS 1975-80   
% 224.92/225.08  |- mesh__recordOriginator mesh__D006071 NLM
% 224.92/225.08  |- skos__altLabel mesh__D006071 Gorillas
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D006071 2006
% 224.92/225.08  |- skos__broader mesh__D006071smesh__D015186
% 224.92/225.08  |- skos__hiddenLabel mesh__D006071 gorilla, Gorilla
% 224.92/225.08  |- mesh__historyNote mesh__D006071 81; was GORILLAS 1975-80   
% 224.92/225.08  |- skos__hiddenLabel mesh__D006071 gorillas, Gorilla
% 224.92/225.08  |- skos__historyNote mesh__D006071 Pongidae %28%1966-1974%29%
% 224.92/225.08  |- mesh__dateCreated mesh__D006071 1974-11-19
% 224.92/225.08  |- mesh__onlineNote mesh__D006071
% 224.92/225.08       use GORILLA GORILLA to search GORILLAS 1975-80   
% 224.92/225.08  |- mesh__recordMaintainer mesh__D006071 ags
% 224.92/225.08  |- skos__hiddenLabel mesh__D006071 Gorilla gorillas
% 224.92/225.08  |- rdf__type mesh__D006071sskos__Concept
% 224.92/225.08  |- skos__scopeNote mesh__D006071
% 224.92/225.08       This single species of Gorilla, which is a member of the HOMINIDAE family, is the largest and most powerful of the PRIMATES. It is distributed in isolated scattered populations throughout forests of equatorial Africa.%A%    
% 224.92/225.08  |- skos__annotation mesh__D006071
% 224.92/225.08       diseases: coord IM with APE DISEASES %28%IM%29% + specific dis /vet %28%IM%29%; DF: GORILLA%A%  
% 224.92/225.08  |- mesh__recordMaintainer mesh__D047488 SYSTEM
% 224.92/225.08  |- mesh__historyNote mesh__D047488 2005   
% 224.92/225.08  |- skos__scopeNote mesh__D047488
% 224.92/225.08       A subtype of RETINOIC ACID RECEPTORS that are specific for 9-cis-retinoic acid which function as nuclear TRANSCRIPTION FACTORS that regulate multiple signalling pathways.%A%    
% 224.92/225.08  |- skos__hiddenLabel mesh__D047488 protein, XR78E-F
% 224.92/225.08  |- mesh__recordAuthorizer mesh__D047488 sjn
% 224.92/225.08  |- skos__hiddenLabel mesh__D047488 Receptor, 9-cis-Retinoic Acid
% 224.92/225.08  |- skos__hiddenLabel mesh__D047488 XR78E F protein
% 224.92/225.08  |- mesh__publicMeSHNote mesh__D047488 2005   
% 224.92/225.08  |- mesh__dateRevised mesh__D047488 2005-06-30
% 224.92/225.08  |- skos__altLabel mesh__D047488 Retinoid X Receptor
% 224.92/225.08  |- skos__altLabel mesh__D047488 RXR Protein
% 224.92/225.08  |- skos__historyNote mesh__D047488
% 224.92/225.08       Receptors, Retinoic Acid %28%1993-2004%29%
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D047488 2006
% 224.92/225.08  |- mesh__dateEstablished mesh__D047488 2005-01-01
% 224.92/225.08  |- skos__broader mesh__D047488smesh__D018168
% 224.92/225.08  |- skos__hiddenLabel mesh__D047488 Receptors, Retinoid X
% 224.92/225.08  |- mesh__recordOriginator mesh__D047488 ssb
% 224.92/225.08  |- skos__prefLabel mesh__D047488 Retinoid X Receptors
% 224.92/225.08  |- mesh__dateCreated mesh__D047488 2004-07-07
% 224.92/225.08  |- skos__altLabel mesh__D047488 9-cis-Retinoic Acid Receptor
% 224.92/225.08  |- skos__hiddenLabel mesh__D047488 Protein, RXR
% 224.92/225.08  |- rdf__type mesh__D047488sskos__Concept
% 224.92/225.08  |- skos__altLabel mesh__D047488 Receptor, Retinoid X
% 224.92/225.08  |- skos__scopeNote mesh__D014503
% 224.92/225.08       An enzyme that catalyzes the conversion of urate and unidentified products. It is a copper protein. The initial products decompose to form allantoin. EC 1.7.3.3.%A%    
% 224.92/225.08  |- mesh__dateRevised mesh__D014503 2003-07-09
% 224.92/225.08  |- mesh__recordMaintainer mesh__D014503 ssb
% 224.92/225.08  |- skos__broader mesh__D014503smesh__D010088
% 224.92/225.08  |- mesh__dateEstablished mesh__D014503 1966-01-01
% 224.92/225.08  |- skos__altLabel mesh__D014503 Uricase
% 224.92/225.08  |- mesh__historyNote mesh__D014503 66   
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D014503 2006
% 224.92/225.08  |- mesh__dateCreated mesh__D014503 1999-01-01
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D014503 2005
% 224.92/225.08  |- mesh__recordAuthorizer mesh__D014503 sjn
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D014503 2004
% 224.92/225.08  |- skos__hiddenLabel mesh__D014503 Oxidase, Urate
% 224.92/225.08  |- rdf__type mesh__D014503sskos__Concept
% 224.92/225.08  |- mesh__publicMeSHNote mesh__D014503 66   
% 224.92/225.08  |- skos__prefLabel mesh__D014503 Urate Oxidase
% 224.92/225.08  |- mesh__recordOriginator mesh__D014503 NLM
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D019797 2002
% 224.92/225.08  |- mesh__publicMeSHNote mesh__D019797
% 224.92/225.08       98; 3-IODOBENZYLGUANIDINE was indexed under IODOBENZENES 1983-97 %26% GUANIDINES 1980-82%A%  
% 224.92/225.08  |- skos__altLabel mesh__D019797 MIBG
% 224.92/225.08  |- skos__altLabel mesh__D019797 Iobenguane
% 224.92/225.08  |- mesh__dateEstablished mesh__D019797 1998-01-01
% 224.92/225.08  |- mesh__historyNote mesh__D019797
% 224.92/225.08       98; use 3-IODOBENZYLGUANIDINE %28%NM%29% 1980-97   
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D019797 2006
% 224.92/225.08  |- mesh__recordOriginator mesh__D019797 KEV
% 224.92/225.08  |- skos__hiddenLabel mesh__D019797 3 Iodobenzylguanidine
% 224.92/225.08  |- skos__broader mesh__D019797smesh__D006146
% 224.92/225.08  |- skos__altLabel mesh__D019797 meta-Iodobenzylguanidine
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D019797 2003
% 224.92/225.08  |- skos__scopeNote mesh__D019797
% 224.92/225.08       A guanidine analog with specific affinity for tissues of the sympathetic nervous system and related tumors. The radiolabeled forms are used as antineoplastic agents and radioactive imaging agents. %28%Merck Index, 12th ed%29% MIBG serves as a neuron-blocking agent which has a strong affinity for, and retention in, the adrenal medulla and also inhibits ADP-ribosyltransferase.%A%    
% 224.92/225.08  |- mesh__dateRevised mesh__D019797 2000-06-22
% 224.92/225.08  |- rdf__type mesh__D019797sskos__Concept
% 224.92/225.08  |- skos__historyNote mesh__D019797 Guanidines %28%1980-1982%29%
% 224.92/225.08  |- skos__hiddenLabel mesh__D019797 3 Iodobenzylguanidine, 125I Labeled
% 224.92/225.08  |- skos__hiddenLabel mesh__D019797 125I Labeled 3-Iodobenzylguanidine
% 224.92/225.08  |- skos__hiddenLabel mesh__D019797 meta Iodobenzylguanidine
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D019797 2004
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D019797 2001
% 224.92/225.08  |- mesh__recordMaintainer mesh__D019797 CCR
% 224.92/225.08  |- skos__hiddenLabel mesh__D019797 123I Labeled 3-Iodobenzylguanidine
% 224.92/225.08  |- skos__broader mesh__D019797smesh__D007462
% 224.92/225.08  |- skos__altLabel mesh__D019797 m-Iodobenzylguanidine
% 224.92/225.08  |- skos__prefLabel mesh__D019797 3-Iodobenzylguanidine
% 224.92/225.08  |- mesh__recordAuthorizer mesh__D019797 sjn
% 224.92/225.08  |- skos__historyNote mesh__D019797 Iodobenzenes %28%1983-1997%29%
% 224.92/225.08  |- mesh__dateCreated mesh__D019797 1997-06-20
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D019797 2005
% 224.92/225.08  |- skos__hiddenLabel mesh__D019797 m Iodobenzylguanidine
% 224.92/225.08  |- skos__hiddenLabel mesh__D019797 3 Iodobenzylguanidine, 123I Labeled
% 224.92/225.08  |- mesh__historyNote mesh__D005777 68   
% 224.92/225.08  |- mesh__publicMeSHNote mesh__D005777 68   
% 224.92/225.08  |- skos__hiddenLabel mesh__D005777 Geeses
% 224.92/225.08  |- mesh__dateRevised mesh__D005777 2004-07-07
% 224.92/225.08  |- skos__broader mesh__D005777smesh__D046090
% 224.92/225.08  |- skos__prefLabel mesh__D005777 Geese
% 224.92/225.08  |- skos__historyNote mesh__D005777 Birds %28%1966-1967%29%
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D005777 2005
% 224.92/225.08  |- skos__broader mesh__D005777smesh__D011200
% 224.92/225.08  |- mesh__dateCreated mesh__D005777 1999-01-01
% 224.92/225.08  |- skos__annotation mesh__D005777
% 224.92/225.08       domestic or wild; IM; qualif permitted; diseases: coord IM with POULTRY DISEASES %28%IM%29%; diseases of wild geese: coord IM with BIRD DISEASES %28%IM%29%%A%  
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D005777 2006
% 224.92/225.08  |- mesh__dateEstablished mesh__D005777 1968-01-01
% 224.92/225.08  |- mesh__recordMaintainer mesh__D005777 ags
% 224.92/225.08  |- skos__historyNote mesh__D005777 Poultry %28%1966-1967%29%
% 224.92/225.08  |- mesh__recordAuthorizer mesh__D005777 sjn
% 224.92/225.08  |- mesh__recordOriginator mesh__D005777 NLM
% 224.92/225.08  |- rdf__type mesh__D005777sskos__Concept
% 224.92/225.08  |- mesh__recordMaintainer mesh__D010911 lkt
% 224.92/225.08  |- skos__scopeNote mesh__D010911
% 224.92/225.08       Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties %28%see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE%29%. Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.%A%    
% 224.92/225.08  |- skos__hiddenLabel mesh__D010911 Cancer, Pituitary
% 224.92/225.08  |- skos__altLabel mesh__D010911 Pituitary Tumors
% 224.92/225.08  |- skos__altLabel mesh__D010911 Cancer of the Pituitary
% 224.92/225.08  |- skos__related mesh__D010911smesh__D000237
% 224.92/225.08  |- mesh__dateRevised mesh__D010911 2005-06-30
% 224.92/225.08  |- skos__annotation mesh__D010911
% 224.92/225.08       coordinate IM with histological type of neoplasm %28%IM%29%; pituitary adenoma: coordinate IM with ADENOMA %28%IM%29% in spite of entry term PITUITARY ADENOMA%A%  
% 224.92/225.08  |- skos__altLabel mesh__D010911 Pituitary Cancer
% 224.92/225.08  |- skos__hiddenLabel mesh__D010911 Neoplasm, Pituitary
% 224.92/225.08  |- skos__hiddenLabel mesh__D010911 Adenomas, Pituitary
% 224.92/225.08  |- skos__broader mesh__D010911smesh__D010900
% 224.92/225.08  |- skos__related mesh__D010911smesh__D000238
% 224.92/225.08  |- skos__hiddenLabel mesh__D010911 Pituitary Neoplasm
% 224.92/225.08  |- skos__hiddenLabel mesh__D010911 Pituitary Carcinomas
% 224.92/225.08  |- skos__hiddenLabel mesh__D010911 Neoplasms, Pituitary
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D010911 2006
% 224.92/225.08  |- mesh__recordAuthorizer mesh__D010911 sjn
% 224.92/225.08  |- skos__hiddenLabel mesh__D010911 Carcinoma, Pituitary
% 224.92/225.08  |- mesh__recordOriginator mesh__D010911 NLM
% 224.92/225.08  |- skos__hiddenLabel mesh__D010911 Pituitary Adenomas
% 224.92/225.08  |- skos__prefLabel mesh__D010911 Pituitary Neoplasms
% 224.92/225.08  |- skos__related mesh__D010911smesh__D000239
% 224.92/225.08  |- skos__hiddenLabel mesh__D010911 Pituitary Tumor
% 224.92/225.08  |- mesh__dateCreated mesh__D010911 1999-01-01
% 224.92/225.08  |- skos__broader mesh__D010911smesh__D004701
% 224.92/225.08  |- skos__hiddenLabel mesh__D010911 Tumors, Pituitary
% 224.92/225.08  |- skos__hiddenLabel mesh__D010911 Pituitary Cancers
% 224.92/225.08  |- rdf__type mesh__D010911sskos__Concept
% 224.92/225.08  |- skos__hiddenLabel mesh__D010911 Adenoma, Pituitary
% 224.92/225.08  |- skos__broader mesh__D010911smesh__D007029
% 224.92/225.08  |- skos__hiddenLabel mesh__D010911 Cancers, Pituitary
% 224.92/225.08  |- skos__hiddenLabel mesh__D010911 Tumor, Pituitary
% 224.92/225.08  |- skos__hiddenLabel mesh__D010911 Carcinomas, Pituitary
% 224.92/225.08  |- skos__altLabel mesh__D010911 Cancer of Pituitary
% 224.92/225.08  |- mesh__dateEstablished mesh__D010113 1964-01-01
% 224.92/225.08  |- skos__broader mesh__D010113smesh__D010653
% 224.92/225.08  |- rdf__type mesh__D010113sskos__Concept
% 224.92/225.08  |- skos__altLabel mesh__D010113
% 224.92/225.08       Novartis Ophthalmics Brand of Oxyphenbutazone
% 224.92/225.08  |- skos__annotation mesh__D010113 a non-steroidal anti-inflamm agent   
% 224.92/225.08  |- mesh__publicMeSHNote mesh__D010113 64   
% 224.92/225.08  |- skos__altLabel mesh__D010113 Hydroxyphenylbutazone
% 224.92/225.08  |- mesh__historyNote mesh__D010113 64%28%63%29%   
% 224.92/225.08  |- skos__scopeNote mesh__D010113
% 224.92/225.08       A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. %28%From AMA, Drug Evaluations Annual, 1994, p2000%29% It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p27%29%%A%    
% 224.92/225.08  |- skos__prefLabel mesh__D010113 Oxyphenbutazone
% 224.92/225.08  |- mesh__recordOriginator mesh__D010113 NLM
% 224.92/225.08  |- mesh__dateCreated mesh__D010113 1999-01-01
% 224.92/225.08  |- mesh__recordAuthorizer mesh__D010113 sjn
% 224.92/225.08  |- mesh__recordMaintainer mesh__D010113 lkw
% 224.92/225.08  |- mesh__dateRevised mesh__D010113 2005-06-30
% 224.92/225.08  |- skos__altLabel mesh__D010113 Oxyphenylbutazone
% 224.92/225.08  |- skos__altLabel mesh__D010113 Belmac Brand of Oxyphenbutazone
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D010113 2006
% 224.92/225.08  |- mesh__dateEstablished mesh__D034561 2003-01-01
% 224.92/225.08  |- skos__prefLabel mesh__D034561 Sheep, Domestic
% 224.92/225.08  |- skos__hiddenLabel mesh__D034561 Domestic Sheep
% 224.92/225.08  |- mesh__historyNote mesh__D034561 2003   
% 224.92/225.08  |- mesh__recordAuthorizer mesh__D034561 jls
% 224.92/225.08  |- skos__hiddenLabel mesh__D034561 Mouflons
% 224.92/225.08  |- skos__broader mesh__D034561smesh__D012756
% 224.92/225.08  |- mesh__publicMeSHNote mesh__D034561 2003   
% 224.92/225.08  |- mesh__dateRevised mesh__D034561 2004-08-02
% 224.92/225.08  |- skos__altLabel mesh__D034561 Ovis ammon aries
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D034561 2004
% 224.92/225.08  |- rdf__type mesh__D034561sskos__Concept
% 224.92/225.08  |- mesh__recordMaintainer mesh__D034561 jls
% 224.92/225.08  |- mesh__recordOriginator mesh__D034561 ags
% 224.92/225.08  |- mesh__dateCreated mesh__D034561 2002-07-03
% 224.92/225.08  |- skos__altLabel mesh__D034561 Ovis gmelini musimon
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D034561 2005
% 224.92/225.08  |- skos__altLabel mesh__D034561 Ovis aries musimon
% 224.92/225.08  |- skos__scopeNote mesh__D034561
% 224.92/225.08       A species of sheep, Ovis aries, descended from Near Eastern wild forms, especially mouflon.%A%    
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D034561 2006
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D034561 2005A
% 224.92/225.08  |- skos__annotation mesh__D034561
% 224.92/225.08       sheep unspecified goes under SHEEP; SHEEP, BIGHORN is also available%A%  
% 224.92/225.08  |- skos__altLabel mesh__D034561 Ovis aries
% 224.92/225.08  |- skos__historyNote mesh__D034561 Sheep %28%1965-2002%29%
% 224.92/225.08  |- mesh__dateRevised mesh__D001387 2005-06-30
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D001387 2006
% 224.92/225.08  |- mesh__dateCreated mesh__D001387 1999-01-01
% 224.92/225.08  |- mesh__recordMaintainer mesh__D001387 ssb
% 224.92/225.08  |- skos__altLabel mesh__D001387 Azinphos-Methyl
% 224.92/225.08  |- mesh__recordOriginator mesh__D001387 NLM
% 224.92/225.08  |- skos__historyNote mesh__D001387 Insecticides %28%1966-1971%29%
% 224.92/225.08  |- rdf__type mesh__D001387sskos__Concept
% 224.92/225.08  |- mesh__dateEstablished mesh__D001387 1991-01-01
% 224.92/225.08  |- skos__broader mesh__D001387smesh__D009946
% 224.92/225.08  |- skos__prefLabel mesh__D001387 Azinphosmethyl
% 224.92/225.08  |- skos__annotation mesh__D001387 TN 111 for eff on insects   
% 224.92/225.08  |- skos__scopeNote mesh__D001387
% 224.92/225.08       An organothiophosphorus cholinesterase inhibitor. It has been used as an acaricide and as an insecticide.%A%    
% 224.92/225.08  |- mesh__publicMeSHNote mesh__D001387
% 224.92/225.08       91; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90%A%  
% 224.92/225.08  |- mesh__recordAuthorizer mesh__D001387 sjn
% 224.92/225.08  |- skos__hiddenLabel mesh__D001387 Azinphos Methyl
% 224.92/225.08  |- mesh__historyNote mesh__D001387
% 224.92/225.08       91%28%72%29%; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90%A%  
% 224.92/225.08  |- mesh__recordAuthorizer mesh__D028524 sjn
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D028524 2006
% 224.92/225.08  |- skos__historyNote mesh__D028524 Apiaceae %28%1998-2001%29%
% 224.92/225.08  |- mesh__recordOriginator mesh__D028524 ssb
% 224.92/225.08  |- mesh__dateRevised mesh__D028524 2005-06-30
% 224.92/225.08  |- rdf__type mesh__D028524sskos__Concept
% 224.92/225.08  |- mesh__historyNote mesh__D028524
% 224.92/225.08       2002; for DILL PLANT use APIACEAE 1998-2001   
% 224.92/225.08  |- mesh__dateEstablished mesh__D028524 2002-01-01
% 224.92/225.08  |- skos__prefLabel mesh__D028524 Anethum graveolens
% 224.92/225.08  |- skos__annotation mesh__D028524
% 224.92/225.08       coordinate with specific PLANT COMPONENTS term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.92/225.08  |- mesh__recordMaintainer mesh__D028524 ssb
% 224.92/225.08  |- skos__altLabel mesh__D028524 Dill Weed
% 224.92/225.08  |- mesh__publicMeSHNote mesh__D028524
% 224.92/225.08       2002; for DILL PLANT see APIACEAE 1998-2001   
% 224.92/225.08  |- skos__scopeNote mesh__D028524
% 224.92/225.08       Anethum graveolens L. is a plant species of the family APIACEAE.  It is one of the plant SPICES.%A%    
% 224.92/225.08  |- skos__altLabel mesh__D028524 Dill Plant
% 224.92/225.08  |- mesh__dateCreated mesh__D028524 2001-07-25
% 224.92/225.08  |- skos__broader mesh__D028524smesh__D019661
% 224.92/225.08  |- mesh__recordOriginator mesh__D006870 SH
% 224.92/225.08  |- mesh__dateRevised mesh__D006870 2005-06-30
% 224.92/225.08  |- mesh__dateEstablished mesh__D006870 1978-01-01
% 224.92/225.08  |- skos__broader mesh__D006870smesh__D012910
% 224.92/225.08  |- skos__prefLabel mesh__D006870 Hydrophid Venoms
% 224.92/225.08  |- skos__historyNote mesh__D006870 Snake Venoms %28%1975-1977%29%
% 224.92/225.08  |- mesh__recordAuthorizer mesh__D006870 sjn
% 224.92/225.08  |- skos__hiddenLabel mesh__D006870 Venom, Hydrophid
% 224.92/225.08  |- rdf__type mesh__D006870sskos__Concept
% 224.92/225.08  |- mesh__recordMaintainer mesh__D006870 ssb
% 224.92/225.08  |- skos__annotation mesh__D006870
% 224.92/225.08       hydrophids are sea snakes; /antag permitted but consider also ANTIVENINS; /enzymol permitted; TN 241: common %26% scientific names of various hydrophids%A%  
% 224.92/225.08  |- mesh__dateCreated mesh__D006870 1977-04-22
% 224.92/225.08  |- mesh__publicMeSHNote mesh__D006870 78   
% 224.92/225.08  |- skos__historyNote mesh__D006870 Venoms %28%1966-1974%29%
% 224.92/225.08  |- skos__hiddenLabel mesh__D006870 Venom, Sea Snake
% 224.92/225.08  |- mesh__historyNote mesh__D006870 78   
% 224.92/225.08  |- skos__scopeNote mesh__D006870
% 224.92/225.08       Venoms of sea snakes, Hydrophiinae, found around Pacific islands. The venoms contain fewer enzymes and more neuro- or myotoxins than land snakes. The neurotoxic proteins are similar to elapid small, short, or type I neurotoxins, some of which have been characterized.%A%    
% 224.92/225.08  |- skos__altLabel mesh__D006870 Sea Snake Venoms
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D006870 2006
% 224.92/225.08  |- skos__hiddenLabel mesh__D006870 Venoms, Sea Snake
% 224.92/225.08  |- skos__hiddenLabel mesh__D006870 Venoms, Hydrophid
% 224.92/225.08  |- skos__hiddenLabel mesh__D006870 Snake Venom, Sea
% 224.92/225.08  |- skos__historyNote mesh__D006870 Snakes %28%1966-1974%29%
% 224.92/225.08  |- skos__altLabel mesh__D006870 Sea Snake Venom
% 224.92/225.08  |- skos__altLabel mesh__D006870 Hydrophid Venom
% 224.92/225.08  |- skos__broader mesh__D020541smesh__D042581
% 224.92/225.08  |- skos__historyNote mesh__D020541 Cell Nucleus %28%1976-1999%29%
% 224.92/225.08  |- mesh__dateEstablished mesh__D020541 2000-01-01
% 224.92/225.08  |- skos__hiddenLabel mesh__D020541 Coiled Body
% 224.92/225.08  |- skos__historyNote mesh__D020541 Cell Nucleolus %28%1976-1999%29%
% 224.92/225.08  |- mesh__dateRevised mesh__D020541 2003-07-09
% 224.92/225.08  |- mesh__dateCreated mesh__D020541 1999-11-05
% 224.92/225.08  |- skos__historyNote mesh__D020541
% 224.92/225.08       Ribonucleoproteins, Small Nuclear %28%1993-1999%29%
% 224.92/225.08  |- skos__hiddenLabel mesh__D020541 Bodies, Coiled
% 224.92/225.08  |- rdf__type mesh__D020541sskos__Concept
% 224.92/225.08  |- skos__prefLabel mesh__D020541 Coiled Bodies
% 224.92/225.08  |- mesh__historyNote mesh__D020541 2000   
% 224.92/225.08  |- skos__hiddenLabel mesh__D020541 Cajal Accessory Bodies
% 224.92/225.08  |- skos__scopeNote mesh__D020541
% 224.92/225.08       A distinct subnuclear domain enriched in splicesomal snRNPs %28%RIBONUCLEOPROTEINS, SMALL NUCLEAR%29% and p80-coilin.%A%    
% 224.92/225.08  |- mesh__publicMeSHNote mesh__D020541 2000   
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D020541 2006
% 224.92/225.08  |- skos__altLabel mesh__D020541 Accessory Bodies of Cajal
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D020541 2004
% 224.92/225.08  |- skos__hiddenLabel mesh__D020541 Body, Coiled
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D020541 2005
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D006072 2006
% 224.92/225.08  |- skos__broader mesh__D006072smesh__D012717
% 224.92/225.08  |- mesh__dateCreated mesh__D006072 1999-01-01
% 224.92/225.08  |- rdf__type mesh__D006072sskos__Concept
% 224.92/225.08  |- skos__related mesh__D006072smesh__D003369
% 224.92/225.08  |- mesh__recordAuthorizer mesh__D006072 sjn
% 224.92/225.08  |- skos__hiddenLabel mesh__D006072 Sodium Salt, Gossypol
% 224.92/225.08  |- mesh__recordMaintainer mesh__D006072 ssb
% 224.92/225.08  |- skos__prefLabel mesh__D006072 Gossypol
% 224.92/225.08  |- mesh__dateRevised mesh__D006072 2003-07-09
% 224.92/225.08  |- skos__hiddenLabel mesh__D006072 Dipotassium Salt, Gossypol
% 224.92/225.08  |- mesh__recordOriginator mesh__D006072 NLM
% 224.92/225.08  |- skos__scopeNote mesh__D006072
% 224.92/225.08       A dimeric sesquiterpene found in cottonseed %28%GOSSYPIUM%29%. The %28%-%29% isomer is active as a male contraceptive %28%CONTRACEPTIVE AGENTS, MALE%29% whereas toxic symptoms are associated with the %28%+%29% isomer.%A%    
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D006072 2005
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D006072 2004
% 224.92/225.08  |- skos__historyNote mesh__D047489
% 224.92/225.08       Prenatal Exposure Delayed Effects %28%1974-2004%29%
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D047489 2005
% 224.92/225.08  |- skos__historyNote mesh__D047489 Jurisprudence %28%1974-2004%29%
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D047489 2006
% 224.92/225.08  |- skos__altLabel mesh__D047489 Injuries, Preconception
% 224.92/225.08  |- skos__hiddenLabel mesh__D047489 Injury, Preconception
% 224.92/225.08  |- mesh__recordAuthorizer mesh__D047489 sjn
% 224.92/225.08  |- mesh__historyNote mesh__D047489
% 224.92/225.08       2005; use PRENATAL EXPOSURE DELAYED EFFECTS 1992-2004   
% 224.92/225.08  |- mesh__publicMeSHNote mesh__D047489
% 224.92/225.08       2005; see PRENATAL EXPOSURE DELAYED EFFECTS 1992-2004   
% 224.92/225.08  |- skos__broader mesh__D047489smesh__D007280
% 224.92/225.08  |- mesh__recordOriginator mesh__D047489 lkt
% 224.92/225.08  |- mesh__dateCreated mesh__D047489 2004-07-07
% 224.92/225.08  |- skos__annotation mesh__D047489 not limited to traumatic injuries   
% 224.92/225.08  |- skos__hiddenLabel mesh__D047489 Preconception Injury
% 224.92/225.08  |- mesh__recordMaintainer mesh__D047489 lkt
% 224.92/225.08  |- rdf__type mesh__D047489sskos__Concept
% 224.92/225.08  |- skos__prefLabel mesh__D047489 Preconception Injuries
% 224.92/225.08  |- skos__scopeNote mesh__D047489
% 224.92/225.08       Damages to reproductive health prior to conception %28%FERTILIZATION%29%, a legal term for torts liability concerning environmental safety issues. Preconception injuries may involve either the male or the female, such as chromosomal mutations in the OVA or the SPERMATOZOA.%A%    
% 224.92/225.08  |- mesh__dateEstablished mesh__D047489 2005-01-01
% 224.92/225.08  |- skos__broader mesh__D047489smesh__D004249
% 224.92/225.08  |- mesh__recordOriginator mesh__D014504 EC
% 224.92/225.08  |- mesh__activeMeSHYear mesh__D014504 2006
% 224.92/225.09  |- mesh__historyNote mesh__D014504
% 224.92/225.09       90%28%79%29%; was see under HEALTH 1979-89   
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D014504 2002
% 224.92/225.09  |- mesh__dateCreated mesh__D014504 1978-05-10
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D014504 2005
% 224.92/225.09  |- skos__hiddenLabel mesh__D014504 Health, Urban
% 224.92/225.09  |- mesh__dateRevised mesh__D014504 1999-11-03
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D014504 2001
% 224.92/225.09  |- skos__scopeNote mesh__D014504
% 224.92/225.09       The status of health in urban populations.     
% 224.92/225.09  |- rdf__type mesh__D014504sskos__Concept
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D014504 2004
% 224.92/225.09  |- mesh__dateEstablished mesh__D014504 1990-01-01
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D014504 2000
% 224.92/225.09  |- mesh__recordMaintainer mesh__D014504 kle
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D014504 2003
% 224.92/225.09  |- skos__broader mesh__D014504smesh__D006262
% 224.92/225.09  |- skos__historyNote mesh__D014504 Health %28%1966-1978%29%
% 224.92/225.09  |- skos__annotation mesh__D014504 specify geog   
% 224.92/225.09  |- skos__prefLabel mesh__D014504 Urban Health
% 224.92/225.09  |- mesh__recordAuthorizer mesh__D014504 sjn
% 224.92/225.09  |- mesh__publicMeSHNote mesh__D014504 90; was see under HEALTH 1979-89   
% 224.92/225.09  |- rdf__type mesh__D019798sskos__Concept
% 224.92/225.09  |- skos__altLabel mesh__D019798 Monapterin
% 224.92/225.09  |- mesh__recordAuthorizer mesh__D019798 sjn
% 224.92/225.09  |- skos__scopeNote mesh__D019798
% 224.92/225.09       A pteridine derivative present in body fluids; elevated levels result from immune system activation, malignant disease, allograft rejection, and viral infections. %28%From Stedman, 26th ed%29% Neopterin also serves as a precursor in the biosynthesis of biopterin.%A%    
% 224.92/225.09  |- skos__altLabel mesh__D019798 Umanopterin
% 224.92/225.09  |- mesh__recordMaintainer mesh__D019798 ssb
% 224.92/225.09  |- mesh__dateCreated mesh__D019798 1997-06-20
% 224.92/225.09  |- mesh__dateEstablished mesh__D019798 1998-01-01
% 224.92/225.09  |- mesh__recordOriginator mesh__D019798 KEV
% 224.92/225.09  |- mesh__publicMeSHNote mesh__D019798
% 224.92/225.09       98; NEOPTERIN was indexed under BIOPTERIN/analogs %26% derivatives 1977-97%A%  
% 224.92/225.09  |- skos__altLabel mesh__D019798
% 224.92/225.09       2-Amino-6-%28%1,2,3-trihydroxypropyl%29%-4%28%3H%29%-pteridinone
% 224.92/225.09  |- mesh__historyNote mesh__D019798 98; use NEOPTERIN %28%NM%29% 1979-97   
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D019798 2005
% 224.92/225.09  |- skos__historyNote mesh__D019798
% 224.92/225.09       Biopterin/analogs %26% derivatives %28%1977-1997%29%
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D019798 2006
% 224.92/225.09  |- mesh__dateRevised mesh__D019798 2004-07-07
% 224.92/225.09  |- skos__prefLabel mesh__D019798 Neopterin
% 224.92/225.09  |- skos__broader mesh__D019798smesh__D001708
% 224.92/225.09  |- skos__scopeNote mesh__D005778
% 224.92/225.09       A water insoluble terpene fatty acid used in the treatment of gastrointestinal ulcers; it facilitates the healing and function of mucosal tissue.%A%    
% 224.92/225.09  |- mesh__recordOriginator mesh__D005778 SH
% 224.92/225.09  |- mesh__recordMaintainer mesh__D005778 ssb
% 224.92/225.09  |- skos__altLabel mesh__D005778 Geranyl Farnesylacetate
% 224.92/225.09  |- mesh__historyNote mesh__D005778
% 224.92/225.09       91%28%78%29%; was see under TERPENES 1978-90   
% 224.92/225.09  |- skos__broader mesh__D005778smesh__D013729
% 224.92/225.09  |- skos__historyNote mesh__D005778
% 224.92/225.09       Fatty Acids, Unsaturated %28%1973-1977%29%
% 224.92/225.09  |- mesh__dateRevised mesh__D005778 2003-07-09
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D005778 2005
% 224.92/225.09  |- skos__prefLabel mesh__D005778 Gefarnate
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D005778 2004
% 224.92/225.09  |- mesh__publicMeSHNote mesh__D005778 91; was see under TERPENES 1978-90   
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D005778 2006
% 224.92/225.09  |- skos__historyNote mesh__D005778 Fatty Acids %28%1969-1973%29%
% 224.92/225.09  |- skos__broader mesh__D005778smesh__D005231
% 224.92/225.09  |- skos__historyNote mesh__D005778 Alkenes %28%1966%29%
% 224.92/225.09  |- mesh__dateCreated mesh__D005778 1977-04-22
% 224.92/225.09  |- skos__historyNote mesh__D005778 Terpenes %28%1969-1977%29%
% 224.92/225.09  |- skos__hiddenLabel mesh__D005778 Farnesylacetate, Geranyl
% 224.92/225.09  |- skos__historyNote mesh__D005778 Farnesol %28%1966-1969%29%
% 224.92/225.09  |- mesh__dateEstablished mesh__D005778 1991-01-01
% 224.92/225.09  |- rdf__type mesh__D005778sskos__Concept
% 224.92/225.09  |- mesh__recordAuthorizer mesh__D005778 sjn
% 224.92/225.09  |- mesh__recordAuthorizer mesh__D002480 sjn
% 224.92/225.09  |- skos__prefLabel mesh__D002480 Cellulase
% 224.92/225.09  |- mesh__historyNote mesh__D002480 77%28%73%29%   
% 224.92/225.09  |- skos__altLabel mesh__D002480 beta-1,4-Glucan-4-Glucanohydrolase
% 224.92/225.09  |- mesh__publicMeSHNote mesh__D002480 77   
% 224.92/225.09  |- skos__broader mesh__D002480smesh__D044602
% 224.92/225.09  |- rdf__type mesh__D002480sskos__Concept
% 224.92/225.09  |- mesh__recordOriginator mesh__D002480 NLM
% 224.92/225.09  |- skos__altLabel mesh__D002480 Cellulysin
% 224.92/225.09  |- skos__scopeNote mesh__D002480
% 224.92/225.09       An endocellulase with specificity for the hydrolysis of 1,4-beta-glucosidic linkages in CELLULOSE, lichenin, and cereal beta-glucans.%A%    
% 224.92/225.09  |- skos__altLabel mesh__D002480 Endoglucanase
% 224.92/225.09  |- skos__historyNote mesh__D002480 Glycoside Hydrolases %28%1966-1972%29%
% 224.92/225.09  |- mesh__dateCreated mesh__D002480 1999-01-01
% 224.92/225.09  |- skos__hiddenLabel mesh__D002480 Endo 1,4 beta Glucanase
% 224.92/225.09  |- skos__annotation mesh__D002480 CELLULASES is also available   
% 224.92/225.09  |- skos__altLabel mesh__D002480 Endo-1,4-beta-Glucanase
% 224.92/225.09  |- mesh__recordMaintainer mesh__D002480 jmp
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D002480 2005
% 224.92/225.09  |- skos__hiddenLabel mesh__D002480 beta 1,4 Glucan 4 Glucanohydrolase
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D002480 2006
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D002480 2004
% 224.92/225.09  |- mesh__dateEstablished mesh__D002480 1977-01-01
% 224.92/225.09  |- mesh__dateRevised mesh__D002480 2003-07-09
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010912 2001
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010912 2003
% 224.92/225.09  |- skos__broader mesh__D010912smesh__D003940
% 224.92/225.09  |- mesh__recordAuthorizer mesh__D010912 SJN
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010912 2000
% 224.92/225.09  |- mesh__publicMeSHNote mesh__D010912 68   
% 224.92/225.09  |- mesh__dateEstablished mesh__D010912 1968-01-01
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010912 1999
% 224.92/225.09  |- skos__hiddenLabel mesh__D010912 Pituitary-Adrenal Function Test
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010912 2006
% 224.92/225.09  |- mesh__dateRevised mesh__D010912 1997-06-20
% 224.92/225.09  |- skos__annotation mesh__D010912
% 224.92/225.09       pituit funct in relation to adrenal funct or corticoid production: differentiate from PITUITARY FUNCTION TESTS, test of pituit funct or hormonal secretion%A%  
% 224.92/225.09  |- skos__hiddenLabel mesh__D010912 Pituitary Adrenal Function Tests
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010912 1998
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010912 2005
% 224.92/225.09  |- skos__hiddenLabel mesh__D010912 Test, Pituitary-Adrenal Function
% 224.92/225.09  |- skos__hiddenLabel mesh__D010912 Function Tests, Pituitary-Adrenal
% 224.92/225.09  |- mesh__dateCreated mesh__D010912 1999-01-01
% 224.92/225.09  |- skos__historyNote mesh__D010912
% 224.92/225.09       Pituitary Function Tests %28%1966-1967%29%
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010912 2002
% 224.92/225.09  |- rdf__type mesh__D010912sskos__Concept
% 224.92/225.09  |- skos__hiddenLabel mesh__D010912 Tests, Pituitary-Adrenal Function
% 224.92/225.09  |- skos__hiddenLabel mesh__D010912 Function Test, Pituitary-Adrenal
% 224.92/225.09  |- mesh__recordMaintainer mesh__D010912 PXP
% 224.92/225.09  |- mesh__recordOriginator mesh__D010912 NLM
% 224.92/225.09  |- skos__prefLabel mesh__D010912 Pituitary-Adrenal Function Tests
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010912 2004
% 224.92/225.09  |- mesh__historyNote mesh__D010912 68   
% 224.92/225.09  |- mesh__onlineNote mesh__D010114
% 224.92/225.09       use OXYPHENISATIN ACETATE to search OXYPHENISATIN 1975-82%A%  
% 224.92/225.09  |- skos__altLabel mesh__D010114 Oxyphenisatine
% 224.92/225.09  |- skos__altLabel mesh__D010114 Acetfenolisatin
% 224.92/225.09  |- mesh__publicMeSHNote mesh__D010114
% 224.92/225.09       91; was see under INDOLES 1983-90; was OXYPHENISATIN see under INDOLES 1975-82%A%  
% 224.92/225.09  |- skos__prefLabel mesh__D010114 Oxyphenisatin Acetate
% 224.92/225.09  |- mesh__dateEstablished mesh__D010114 1991-01-01
% 224.92/225.09  |- skos__hiddenLabel mesh__D010114 Acetate, Oxyphenisatin
% 224.92/225.09  |- skos__altLabel mesh__D010114 Diasatine
% 224.92/225.09  |- mesh__dateCreated mesh__D010114 1974-11-19
% 224.92/225.09  |- skos__historyNote mesh__D010114 Phenols %28%1972-1974%29%
% 224.92/225.09  |- skos__scopeNote mesh__D010114
% 224.92/225.09       A laxative that undergoes enterohepatic circulation. It may cause jaundice.%A%    
% 224.92/225.09  |- mesh__historyNote mesh__D010114
% 224.92/225.09       91%28%83%29%; was see under INDOLES 1983-90; was OXYPHENISATIN see under INDOLES 1975-82%A%  
% 224.92/225.09  |- skos__altLabel mesh__D010114 Phenolisatin
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010114 2006
% 224.92/225.09  |- skos__historyNote mesh__D010114 Indoles %28%1969-1974%29%
% 224.92/225.09  |- skos__altLabel mesh__D010114
% 224.92/225.09       Warner Chilcott Brand of Oxyphenisatin Acetate
% 224.92/225.09  |- mesh__recordOriginator mesh__D010114 NLM
% 224.92/225.09  |- mesh__recordAuthorizer mesh__D010114 sjn
% 224.92/225.09  |- rdf__type mesh__D010114sskos__Concept
% 224.92/225.09  |- mesh__recordMaintainer mesh__D010114 lkw
% 224.92/225.09  |- skos__broader mesh__D010114smesh__D007211
% 224.92/225.09  |- mesh__dateRevised mesh__D010114 2005-06-30
% 224.92/225.09  |- mesh__recordAuthorizer mesh__D001388 sjn
% 224.92/225.09  |- skos__scopeNote mesh__D001388
% 224.92/225.09       Saturated azacyclopropane compounds. They include compounds with substitutions on CARBON or NITROGEN atoms.%A%    
% 224.92/225.09  |- mesh__dateRevised mesh__D001388 2004-07-07
% 224.92/225.09  |- rdf__type mesh__D001388sskos__Concept
% 224.92/225.09  |- skos__altLabel mesh__D001388 Azacyclopropanes, Saturated
% 224.92/225.09  |- mesh__recordMaintainer mesh__D001388 ssb
% 224.92/225.09  |- mesh__dateEstablished mesh__D001388 1990-01-01
% 224.92/225.09  |- skos__annotation mesh__D001388
% 224.92/225.09       AZACYCLOPROPANES, UNSATURATED see AZIRINES is available   
% 224.92/225.09  |- mesh__recordOriginator mesh__D001388 NLM
% 224.92/225.09  |- skos__altLabel mesh__D001388 Ethyleneimines
% 224.92/225.09  |- skos__broader mesh__D001388smesh__D001389
% 224.92/225.09  |- skos__altLabel mesh__D001388 Dimethyleneimines
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D001388 2005
% 224.92/225.09  |- skos__hiddenLabel mesh__D001388 Saturated Azacyclopropanes
% 224.92/225.09  |- mesh__onlineNote mesh__D001388 search AZIRINES 1966-74   
% 224.92/225.09  |- skos__prefLabel mesh__D001388 Aziridines
% 224.92/225.09  |- mesh__historyNote mesh__D001388
% 224.92/225.09       90%28%75%29%66-67; was see under AZIRINES 1975-89; was heading 1966-67%A%  
% 224.92/225.09  |- mesh__publicMeSHNote mesh__D001388
% 224.92/225.09       90;66-67; was see under AZIRINES 1975-89; was heading 1966-67%A%  
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D001388 2006
% 224.92/225.09  |- mesh__dateCreated mesh__D001388 1999-01-01
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D028525 2006
% 224.92/225.09  |- mesh__dateRevised mesh__D028525 2004-07-07
% 224.92/225.09  |- rdf__type mesh__D028525sskos__Concept
% 224.92/225.09  |- skos__annotation mesh__D028525
% 224.92/225.09       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.92/225.09  |- skos__prefLabel mesh__D028525 Apium graveolens
% 224.92/225.09  |- mesh__recordAuthorizer mesh__D028525 sjn
% 224.92/225.09  |- mesh__publicMeSHNote mesh__D028525
% 224.92/225.09       2002; for CELERY see APIACEAE 1998-2001   
% 224.92/225.09  |- skos__broader mesh__D028525smesh__D019661
% 224.92/225.09  |- mesh__recordOriginator mesh__D028525 ssb
% 224.92/225.09  |- mesh__recordMaintainer mesh__D028525 ssb
% 224.92/225.09  |- skos__scopeNote mesh__D028525
% 224.92/225.09       A plant species of the family APIACEAE.  The stalks are a food source.%A%    
% 224.92/225.09  |- mesh__dateEstablished mesh__D028525 2002-01-01
% 224.92/225.09  |- skos__historyNote mesh__D028525 Apiaceae %28%1998-2001%29%
% 224.92/225.09  |- mesh__dateCreated mesh__D028525 2001-07-25
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D028525 2005
% 224.92/225.09  |- mesh__historyNote mesh__D028525
% 224.92/225.09       2002; for CELERY use APIACEAE 1998-2001   
% 224.92/225.09  |- skos__broader mesh__D006871smesh__D005902
% 224.92/225.09  |- skos__annotation mesh__D006871
% 224.92/225.09       a type of open-angle glaucoma; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A%  
% 224.92/225.09  |- mesh__dateRevised mesh__D006871 1999-11-03
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D006871 2002
% 224.92/225.09  |- skos__broader mesh__D006871smesh__D005124
% 224.92/225.09  |- rdf__type mesh__D006871sskos__Concept
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D006871 2005
% 224.92/225.09  |- skos__prefLabel mesh__D006871 Hydrophthalmos
% 224.92/225.09  |- mesh__recordMaintainer mesh__D006871 kle
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D006871 2003
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D006871 2006
% 224.92/225.09  |- skos__scopeNote mesh__D006871
% 224.92/225.09       Congenital open-angle glaucoma that results from dysgenesis of the angle structures accompanied by increased intraocular pressure and enlargement of the eye. Treatment is both medical and surgical.%A%    
% 224.92/225.09  |- mesh__recordAuthorizer mesh__D006871 sjn
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D006871 2004
% 224.92/225.09  |- mesh__dateCreated mesh__D006871 1999-01-01
% 224.92/225.09  |- skos__altLabel mesh__D006871 Buphthalmos
% 224.92/225.09  |- mesh__recordOriginator mesh__D006871 NLM
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D006871 2000
% 224.92/225.09  |- skos__broader mesh__D006871smesh__D007232
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D006871 2001
% 224.92/225.09  |- skos__prefLabel mesh__D020542 Third Ventricle
% 224.92/225.09  |- skos__hiddenLabel mesh__D020542 Ventricles, Third
% 224.92/225.09  |- mesh__recordOriginator mesh__D020542 ags
% 224.92/225.09  |- mesh__historyNote mesh__D020542 2000   
% 224.92/225.09  |- skos__historyNote mesh__D020542 Cerebral Ventricles %28%1965-1999%29%
% 224.92/225.09  |- skos__annotation mesh__D020542
% 224.92/225.09       /radiogr: coord with CEREBRAL VENTRICULOGRAPHY   
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D020542 2000
% 224.92/225.09  |- mesh__recordAuthorizer mesh__D020542 sjn
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D020542 2001A
% 224.92/225.09  |- mesh__dateEstablished mesh__D020542 2000-01-01
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D020542 2005
% 224.92/225.09  |- rdf__type mesh__D020542sskos__Concept
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D020542 2001
% 224.92/225.09  |- mesh__dateCreated mesh__D020542 1999-11-03
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D020542 2003
% 224.92/225.09  |- skos__broader mesh__D020542smesh__D002552
% 224.92/225.09  |- mesh__publicMeSHNote mesh__D020542 2000   
% 224.92/225.09  |- skos__hiddenLabel mesh__D020542 Ventricle, Third
% 224.92/225.09  |- mesh__recordMaintainer mesh__D020542 sjn
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D020542 2006
% 224.92/225.09  |- mesh__dateRevised mesh__D020542 2000-08-09
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D020542 2002
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D020542 2004
% 224.92/225.09  |- skos__scopeNote mesh__D020542
% 224.92/225.09       A narrow cleft inferior to the corpus callosum, within the diencephalon, between the paired thalami. Its floor is formed by the HYPOTHALAMUS, its anterior wall by the lamina terminalis, and its roof by EPENDYMA. It communicates with the FOURTH VENTRICLE by the CEREBRAL AQUEDUCT, and with the LATERAL VENTRICLES by the interventricular foramina.%A%    
% 224.92/225.09  |- skos__hiddenLabel mesh__D020542 Third Ventricles
% 224.92/225.09  |- skos__hiddenLabel mesh__D006073 Gouts
% 224.92/225.09  |- mesh__dateCreated mesh__D006073 1999-01-01
% 224.92/225.09  |- rdf__type mesh__D006073sskos__Concept
% 224.92/225.09  |- skos__broader mesh__D006073smesh__D011686
% 224.92/225.09  |- skos__related mesh__D006073smesh__D006074
% 224.92/225.09  |- skos__related mesh__D006073smesh__D007041
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D006073 2002
% 224.92/225.09  |- mesh__dateRevised mesh__D006073 2001-07-25
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D006073 2003
% 224.92/225.09  |- mesh__recordMaintainer mesh__D006073 nns
% 224.92/225.09  |- skos__prefLabel mesh__D006073 Gout
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D006073 2005
% 224.92/225.09  |- mesh__recordAuthorizer mesh__D006073 sjn
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D006073 2004
% 224.92/225.09  |- skos__broader mesh__D006073smesh__D001168
% 224.92/225.09  |- skos__scopeNote mesh__D006073
% 224.92/225.09       Hereditary metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of uric acid calculi.%A%    
% 224.92/225.09  |- skos__annotation mesh__D006073
% 224.92/225.09       a rheum dis; /drug ther: consider also GOUT SUPPRESSANTS %26% its indentions; ARTHRITIS, GOUTY is also available%A%  
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D006073 2006
% 224.92/225.09  |- skos__broader mesh__D006073smesh__D012216
% 224.92/225.09  |- mesh__recordOriginator mesh__D006073 NLM
% 224.92/225.09  |- mesh__publicMeSHNote mesh__D014505 68   
% 224.92/225.09  |- skos__broader mesh__D014505smesh__D011153
% 224.92/225.09  |- skos__hiddenLabel mesh__D014505 Urban Populations
% 224.92/225.09  |- mesh__recordMaintainer mesh__D014505 kle
% 224.92/225.09  |- skos__hiddenLabel mesh__D014505 Distribution, Urban Spatial
% 224.92/225.09  |- skos__hiddenLabel mesh__D014505 Population, Urban
% 224.92/225.09  |- rdf__type mesh__D014505sskos__Concept
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D014505 2004
% 224.92/225.09  |- skos__related mesh__D014505smesh__D013383
% 224.92/225.09  |- skos__scopeNote mesh__D014505
% 224.92/225.09       The inhabitants of a city or town, including metropolitan areas and suburban areas.%A%    
% 224.92/225.09  |- skos__related mesh__D014505smesh__D014507
% 224.92/225.09  |- mesh__recordAuthorizer mesh__D014505 sjn
% 224.92/225.09  |- skos__hiddenLabel mesh__D014505 Distributions, Urban Spatial
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D014505 2003
% 224.92/225.09  |- mesh__historyNote mesh__D014505 68   
% 224.92/225.09  |- skos__hiddenLabel mesh__D014505 Urban Spatial Distributions
% 224.92/225.09  |- mesh__recordOriginator mesh__D014505 NLM
% 224.92/225.09  |- skos__hiddenLabel mesh__D014505 Populations, Urban
% 224.92/225.09  |- mesh__dateRevised mesh__D014505 1999-11-03
% 224.92/225.09  |- mesh__dateEstablished mesh__D014505 1968-01-01
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D014505 2002
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D014505 2006
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D014505 2001
% 224.92/225.09  |- skos__prefLabel mesh__D014505 Urban Population
% 224.92/225.09  |- skos__related mesh__D014505smesh__D002947
% 224.92/225.09  |- mesh__dateCreated mesh__D014505 1999-01-01
% 224.92/225.09  |- skos__historyNote mesh__D014505 Population %28%1966-1967%29%
% 224.92/225.09  |- skos__annotation mesh__D014505
% 224.92/225.09       specify geog; URBAN HEALTH %26% URBAN HEALTH SERVICES are also available%A%  
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D014505 2005
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D014505 2000
% 224.92/225.09  |- mesh__recordMaintainer mesh__D005779 nns
% 224.92/225.09  |- mesh__dateRevised mesh__D005779 2004-07-07
% 224.92/225.09  |- skos__hiddenLabel mesh__D005779 Gel Diffusion Test
% 224.92/225.09  |- mesh__dateCreated mesh__D005779 1999-01-01
% 224.92/225.09  |- skos__hiddenLabel mesh__D005779 Immunodiffusions
% 224.92/225.09  |- mesh__onlineNote mesh__D005779
% 224.92/225.09       use IMMUNODIFFUSION to search GEL DIFFUSION TESTS 1966-91%A%  
% 224.92/225.09  |- skos__hiddenLabel mesh__D005779 Diffusion Tests, Gel
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D005779 2005
% 224.92/225.09  |- skos__scopeNote mesh__D005779
% 224.92/225.09       Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction.%A%    
% 224.92/225.09  |- skos__broader mesh__D005779smesh__D011233
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D005779 2006
% 224.92/225.09  |- rdf__type mesh__D005779sskos__Concept
% 224.92/225.09  |- skos__hiddenLabel mesh__D005779 Tests, Gel Diffusion
% 224.92/225.09  |- mesh__publicMeSHNote mesh__D005779
% 224.92/225.09       92; was GEL DIFFUSION TESTS 1966-91; was see GEL DIFFUSION TESTS 1975-91; was see under PRECIPITIN TESTS 1963-65%A%  
% 224.92/225.09  |- skos__hiddenLabel mesh__D005779 Test, Gel Diffusion
% 224.92/225.09  |- mesh__recordAuthorizer mesh__D005779 sjn
% 224.92/225.09  |- skos__hiddenLabel mesh__D005779 Diffusion Test, Gel
% 224.92/225.09  |- mesh__historyNote mesh__D005779
% 224.92/225.09       92%28%63%29%; was GEL DIFFUSION TESTS 1966-91; was see GEL DIFFUSION TESTS 1975-91; was see under PRECIPITIN TESTS 1963-65%A%  
% 224.92/225.09  |- skos__altLabel mesh__D005779 Gel Diffusion Tests
% 224.92/225.09  |- skos__annotation mesh__D005779 NIM   
% 224.92/225.09  |- mesh__recordOriginator mesh__D005779 NLM
% 224.92/225.09  |- skos__prefLabel mesh__D005779 Immunodiffusion
% 224.92/225.09  |- mesh__dateEstablished mesh__D005779 1966-01-01
% 224.92/225.09  |- skos__broader mesh__D002481smesh__D013492
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D002481 2000
% 224.92/225.09  |- rdf__type mesh__D002481sskos__Concept
% 224.92/225.09  |- mesh__recordAuthorizer mesh__D002481 sjn
% 224.92/225.09  |- mesh__onlineNote mesh__D002481
% 224.92/225.09       use CELLULITIS to search PHLEGMON 1966-78   
% 224.92/225.09  |- skos__broader mesh__D002481smesh__D003240
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D002481 2001
% 224.92/225.09  |- mesh__dateCreated mesh__D002481 1999-01-01
% 224.92/225.09  |- skos__scopeNote mesh__D002481
% 224.92/225.09       An acute, diffuse, and suppurative inflammation of loose connective tissue, particularly the deep subcutaneous tissues, and sometimes muscle, which is most commonly seen as a result of infection of a wound, ulcer, or other skin lesions.%A%    
% 224.92/225.09  |- mesh__recordMaintainer mesh__D002481 KEV
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D002481 2005
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D002481 2002
% 224.92/225.09  |- skos__broader mesh__D002481smesh__D012874
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D002481 2003
% 224.92/225.09  |- mesh__recordOriginator mesh__D002481 NLM
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D002481 2006
% 224.92/225.09  |- mesh__historyNote mesh__D002481 PHLEGMON was heading 1963-78   
% 224.92/225.09  |- skos__annotation mesh__D002481
% 224.92/225.09       %22%cellulite%22% in Amer or Eng lit is indexed under OBESITY %28%IM%29% + ADIPOSE TISSUE %28%IM%29%, in French lit %22%cellulite%22% can be %22%cellulite%22% or CELLULITIS%A%  
% 224.92/225.09  |- skos__prefLabel mesh__D002481 Cellulitis
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D002481 2004
% 224.92/225.09  |- mesh__dateRevised mesh__D002481 1999-11-03
% 224.92/225.09  |- mesh__publicMeSHNote mesh__D002481 PHLEGMON was heading 1963-78   
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010913 1995
% 224.92/225.09  |- mesh__recordOriginator mesh__D010913 NLM
% 224.92/225.09  |- skos__hiddenLabel mesh__D010913 Pituitary-Adrenal Systems
% 224.92/225.09  |- skos__hiddenLabel mesh__D010913 System, Pituitary-Adrenal
% 224.92/225.09  |- mesh__dateCreated mesh__D010913 1999-01-01
% 224.92/225.09  |- mesh__dateRevised mesh__D010913 1991-01-08
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010913 1994
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010913 2001
% 224.92/225.09  |- rdf__type mesh__D010913sskos__Concept
% 224.92/225.09  |- skos__scopeNote mesh__D010913
% 224.92/225.09       The interactions between the anterior pituitary and adrenal glands, in which corticotropin %28%ACTH%29% stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary.%A%    
% 224.92/225.09  |- mesh__recordAuthorizer mesh__D010913 PLS
% 224.92/225.09  |- skos__annotation mesh__D010913
% 224.92/225.09       hypothalamo-pituitary-adrenal axis: coord HYPOTHALAMO-HYPOPHYSEAL SYSTEM + PITUITARY-ADRENAL SYSTEM%A%  
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010913 1997
% 224.92/225.09  |- mesh__recordMaintainer mesh__D010913 TGC
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010913 2004
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010913 2000
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010913 1996
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010913 2003
% 224.92/225.09  |- skos__hiddenLabel mesh__D010913 Systems, Pituitary-Adrenal
% 224.92/225.09  |- skos__hiddenLabel mesh__D010913 Pituitary Adrenal System
% 224.92/225.09  |- mesh__historyNote mesh__D010913
% 224.92/225.09       68%28%66%29%; was in Cat G only 1966-74   
% 224.92/225.09  |- mesh__dateEstablished mesh__D010913 1968-01-01
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010913 1999
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010913 1993
% 224.92/225.09  |- skos__broader mesh__D010913smesh__D004702
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010913 2006
% 224.92/225.09  |- mesh__publicMeSHNote mesh__D010913 68   
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010913 2002
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010913 1998
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010913 1992
% 224.92/225.09  |- skos__prefLabel mesh__D010913 Pituitary-Adrenal System
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010913 2005
% 224.92/225.09  |- mesh__dateCreated mesh__D010115 1999-01-01
% 224.92/225.09  |- skos__scopeNote mesh__D010115
% 224.92/225.09       A quaternary ammonium anticholinergic agent with peripheral side effects similar to those of ATROPINE. It is used as an adjunct in the treatment of gastric and duodenal ulcer, and to relieve visceral spasms. The drug has also been used in the form of eye drops for mydriatic effect.%A%    
% 224.92/225.09  |- skos__hiddenLabel mesh__D010115 Bromide, Oxyphenonium
% 224.92/225.09  |- mesh__recordOriginator mesh__D010115 NLM
% 224.92/225.09  |- mesh__recordAuthorizer mesh__D010115 sjn
% 224.92/225.09  |- skos__historyNote mesh__D010115 Oxyphenonium Bromide %28%1966-1991%29%
% 224.92/225.09  |- mesh__recordMaintainer mesh__D010115 ssb
% 224.92/225.09  |- mesh__historyNote mesh__D010115
% 224.92/225.09       92%28%64%29%; was OXYPHENONIUM BROMIDE 1964-91 %28%see under AMMONIUM COMPOUNDS 1964-90%29%%A%  
% 224.92/225.09  |- skos__altLabel mesh__D010115 Oxyphenon
% 224.92/225.09  |- mesh__dateRevised mesh__D010115 2005-06-30
% 224.92/225.09  |- skos__hiddenLabel mesh__D010115 Chloride, Oxyphenonium
% 224.92/225.09  |- mesh__publicMeSHNote mesh__D010115
% 224.92/225.09       92; was OXYPHENONIUM BROMIDE 1964-91 %28%see under AMMONIUM COMPOUNDS 1964-90%29%%A%  
% 224.92/225.09  |- skos__altLabel mesh__D010115 Methacin
% 224.92/225.09  |- skos__prefLabel mesh__D010115 Oxyphenonium
% 224.92/225.09  |- skos__altLabel mesh__D010115 Metacin
% 224.92/225.09  |- mesh__activeMeSHYear mesh__D010115 2006
% 224.92/225.09  |- mesh__dateEstablished mesh__D010115 1991-01-01
% 224.92/225.09  |- mesh__onlineNote mesh__D010115
% 224.92/225.09       use OXYPHENONIUM to search OXYPHENONIUM BROMIDE 1966-91   
% 224.92/225.09  |- rdf__type mesh__D010115sskos__Concept
% 224.92/225.09  |- skos__hiddenLabel mesh__D010115 Iodide, Oxyphenonium
% 224.92/225.09  |- skos__broader mesh__D010115smesh__D000644
% 224.92/225.10  |- skos__altLabel mesh__D010115
% 224.92/225.10       2-%28%%28%Cyclohexylhydroxyphenylacetyl%29%oxy%29%-N,N-diethyl-N-methylethanaminium
% 224.92/225.10  |- skos__prefLabel mesh__D001389 Azirines
% 224.92/225.10  |- mesh__activeMeSHYear mesh__D001389 2006
% 224.92/225.10  |- mesh__dateCreated mesh__D001389 1999-01-01
% 224.92/225.10  |- skos__broader mesh__D001389smesh__D006573
% 224.92/225.10  |- mesh__activeMeSHYear mesh__D001389 2005
% 224.92/225.10  |- mesh__recordAuthorizer mesh__D001389 sjn
% 224.92/225.10  |- mesh__recordMaintainer mesh__D001389 ssb
% 224.92/225.10  |- skos__hiddenLabel mesh__D001389 Unsaturated Azacyclopropanes
% 224.92/225.10  |- mesh__historyNote mesh__D001389 68   
% 224.92/225.10  |- rdf__type mesh__D001389sskos__Concept
% 224.92/225.10  |- mesh__dateRevised mesh__D001389 2004-07-07
% 224.92/225.10  |- skos__scopeNote mesh__D001389
% 224.92/225.10       Unsaturated azacyclopropane compounds that are three-membered heterocycles of a nitrogen and two carbon atoms.%A%    
% 224.92/225.10  |- mesh__publicMeSHNote mesh__D001389 68; AZIRIDINES was heading 1966-67   
% 224.92/225.10  |- mesh__recordOriginator mesh__D001389 NLM
% 224.92/225.10  |- skos__altLabel mesh__D001389 Azacyclopropanes, Unsaturated
% 224.92/225.10  |- skos__annotation mesh__D001389
% 224.92/225.10       AZACYCLOPROPANES, SATURATED see AZIRIDINES is available   
% 224.92/225.10  |- mesh__dateEstablished mesh__D001389 1968-01-01
% 224.92/225.10  |- rdf__type mesh__D028526sskos__Concept
% 224.92/225.10  |- mesh__dateCreated mesh__D028526 2001-07-25
% 224.92/225.10  |- skos__prefLabel mesh__D028526 Coriandrum
% 224.92/225.10  |- mesh__dateRevised mesh__D028526 2002-07-03
% 224.92/225.10  |- skos__annotation mesh__D028526
% 224.92/225.10       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.92/225.10  |- mesh__dateEstablished mesh__D028526 2002-01-01
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D028526 2003
% 224.95/225.10  |- skos__broader mesh__D028526smesh__D019661
% 224.95/225.10  |- skos__scopeNote mesh__D028526
% 224.95/225.10       A plant genus of the family APIACEAE. The leaves are the source of cilantro and the seeds are the source of coriander, both of which are used in SPICES.%A%    
% 224.95/225.10  |- skos__historyNote mesh__D028526 Apiaceae %28%1998-2001%29%
% 224.95/225.10  |- mesh__publicMeSHNote mesh__D028526 2002; see APIACEAE 1998-2001   
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D028526 2005
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D028526 2004
% 224.95/225.10  |- mesh__historyNote mesh__D028526 2002; use APIACEAE 1998-2001   
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D028526 2006
% 224.95/225.10  |- skos__broader mesh__D006872smesh__D010995
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006872 2003
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006872 1994
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006872 2006
% 224.95/225.10  |- mesh__recordOriginator mesh__D006872 NLM
% 224.95/225.10  |- skos__prefLabel mesh__D006872 Hydropneumothorax
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006872 2000
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006872 2004
% 224.95/225.10  |- mesh__dateCreated mesh__D006872 1999-01-01
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006872 1995
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006872 2001
% 224.95/225.10  |- mesh__dateRevised mesh__D006872 1993-08-09
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006872 1998
% 224.95/225.10  |- skos__scopeNote mesh__D006872
% 224.95/225.10       A collection of fluid and gas within the pleural cavity. %28%Dorland, 27th ed%29%%A%    
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006872 2002
% 224.95/225.10  |- skos__annotation mesh__D006872
% 224.95/225.10       pneumothorax with fluid in pleural cavity   
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006872 1996
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006872 1999
% 224.95/225.10  |- mesh__recordMaintainer mesh__D006872 PLS
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006872 1997
% 224.95/225.10  |- rdf__type mesh__D006872sskos__Concept
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006872 2005
% 224.95/225.10  |- mesh__recordAuthorizer mesh__D006872 PLS
% 224.95/225.10  |- skos__related mesh__D020543smesh__D016678
% 224.95/225.10  |- mesh__historyNote mesh__D020543 2000   
% 224.95/225.10  |- skos__prefLabel mesh__D020543 Proteome
% 224.95/225.10  |- skos__altLabel mesh__D020543 Proteomes
% 224.95/225.10  |- rdf__type mesh__D020543sskos__Concept
% 224.95/225.10  |- mesh__dateEstablished mesh__D020543 2000-01-01
% 224.95/225.10  |- mesh__recordOriginator mesh__D020543 nns
% 224.95/225.10  |- mesh__dateRevised mesh__D020543 2005-06-30
% 224.95/225.10  |- skos__scopeNote mesh__D020543
% 224.95/225.10       The protein complement of an organism coded for by its genome.%A%    
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D020543 2006
% 224.95/225.10  |- skos__annotation mesh__D020543
% 224.95/225.10       coord with precoord organism protein + organism   
% 224.95/225.10  |- mesh__recordAuthorizer mesh__D020543 sjn
% 224.95/225.10  |- mesh__dateCreated mesh__D020543 1999-11-03
% 224.95/225.10  |- mesh__recordMaintainer mesh__D020543 SYSTEM
% 224.95/225.10  |- skos__broader mesh__D020543smesh__D011506
% 224.95/225.10  |- mesh__publicMeSHNote mesh__D020543 2000   
% 224.95/225.10  |- mesh__recordAuthorizer mesh__D006074 sjn
% 224.95/225.10  |- skos__scopeNote mesh__D006074
% 224.95/225.10       Agents that increase uric acid excretion by the kidney %28%URICOSURIC AGENTS%29%, decrease uric acid production %28%antihyperuricemics%29%, or alleviate the pain and inflammation of acute attacks of gout.%A%    
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006074 2006
% 224.95/225.10  |- mesh__publicMeSHNote mesh__D006074 75   
% 224.95/225.10  |- mesh__dateRevised mesh__D006074 2005-06-30
% 224.95/225.10  |- mesh__dateEstablished mesh__D006074 1975-09-01
% 224.95/225.10  |- skos__hiddenLabel mesh__D006074 Suppressants, Gout
% 224.95/225.10  |- mesh__recordOriginator mesh__D006074 NLM
% 224.95/225.10  |- skos__broader mesh__D006074smesh__D018501
% 224.95/225.10  |- rdf__type mesh__D006074sskos__Concept
% 224.95/225.10  |- skos__altLabel mesh__D006074 Antigout Agents
% 224.95/225.10  |- skos__hiddenLabel mesh__D006074 Agents, Antigout
% 224.95/225.10  |- mesh__dateCreated mesh__D006074 1999-01-01
% 224.95/225.10  |- skos__historyNote mesh__D006074 Uricosuric Agents %28%1966-1974%29%
% 224.95/225.10  |- skos__prefLabel mesh__D006074 Gout Suppressants
% 224.95/225.10  |- mesh__historyNote mesh__D006074 75   
% 224.95/225.10  |- skos__annotation mesh__D006074
% 224.95/225.10       GEN or unspecified; prefer specifics; consider also GOUT /drug ther%A%  
% 224.95/225.10  |- mesh__recordMaintainer mesh__D006074 ssb
% 224.95/225.10  |- skos__hiddenLabel mesh__D014506 Renewals, Urban
% 224.95/225.10  |- skos__broader mesh__D014506smesh__D012939
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D014506 2001
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D014506 2003
% 224.95/225.10  |- skos__scopeNote mesh__D014506
% 224.95/225.10       The planned upgrading of a deteriorating urban area, involving rebuilding, renovation, or restoration. It frequently refers to programs of major demolition and rebuilding of blighted areas.%A%    
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D014506 2000
% 224.95/225.10  |- mesh__recordMaintainer mesh__D014506 kle
% 224.95/225.10  |- mesh__dateRevised mesh__D014506 1999-11-05
% 224.95/225.10  |- skos__hiddenLabel mesh__D014506 Urban Renewals
% 224.95/225.10  |- mesh__dateEstablished mesh__D014506 1968-01-01
% 224.95/225.10  |- mesh__recordAuthorizer mesh__D014506 sjn
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D014506 2006
% 224.95/225.10  |- mesh__historyNote mesh__D014506 68   
% 224.95/225.10  |- skos__hiddenLabel mesh__D014506 Renewal, Urban
% 224.95/225.10  |- skos__hiddenLabel mesh__D014506 Developments, Urban
% 224.95/225.10  |- mesh__dateCreated mesh__D014506 1999-01-01
% 224.95/225.10  |- skos__annotation mesh__D014506 Public Law 89-754; specify locale   
% 224.95/225.10  |- skos__hiddenLabel mesh__D014506 Urban Developments
% 224.95/225.10  |- skos__historyNote mesh__D014506 Housing %28%1966-1967%29%
% 224.95/225.10  |- mesh__publicMeSHNote mesh__D014506 68   
% 224.95/225.10  |- mesh__recordOriginator mesh__D014506 NLM
% 224.95/225.10  |- skos__hiddenLabel mesh__D014506 Development, Urban
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D014506 2005
% 224.95/225.10  |- skos__related mesh__D014506smesh__D006798
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D014506 2002
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D014506 2004
% 224.95/225.10  |- rdf__type mesh__D014506sskos__Concept
% 224.95/225.10  |- skos__historyNote mesh__D014506 Social Conditions %28%1966-1967%29%
% 224.95/225.10  |- skos__prefLabel mesh__D014506 Urban Renewal
% 224.95/225.10  |- skos__hiddenLabel mesh__D002482 Acid, Polyanhydroglucuronic
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D002482 2005
% 224.95/225.10  |- skos__altLabel mesh__D002482 Polyanhydroglucuronic Acid
% 224.95/225.10  |- mesh__recordOriginator mesh__D002482 NLM
% 224.95/225.10  |- skos__broader mesh__D002482smesh__D005936
% 224.95/225.10  |- skos__hiddenLabel mesh__D002482 alpha Cellulose
% 224.95/225.10  |- mesh__dateRevised mesh__D002482 2004-07-07
% 224.95/225.10  |- mesh__dateCreated mesh__D002482 1999-01-01
% 224.95/225.10  |- skos__prefLabel mesh__D002482 Cellulose
% 224.95/225.10  |- skos__scopeNote mesh__D002482
% 224.95/225.10       A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations.%A%    
% 224.95/225.10  |- skos__broader mesh__D002482smesh__D001704
% 224.95/225.10  |- skos__altLabel mesh__D002482 alpha-Cellulose
% 224.95/225.10  |- skos__related mesh__D002482smesh__D002476
% 224.95/225.10  |- rdf__type mesh__D002482sskos__Concept
% 224.95/225.10  |- mesh__recordMaintainer mesh__D002482 jmp
% 224.95/225.10  |- mesh__recordAuthorizer mesh__D002482 sjn
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D002482 2006
% 224.95/225.10  |- skos__related mesh__D002482smesh__D010209
% 224.95/225.10  |- skos__prefLabel mesh__D028527 Cuminum
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D028527 2006
% 224.95/225.10  |- mesh__dateCreated mesh__D028527 2001-07-25
% 224.95/225.10  |- mesh__historyNote mesh__D028527
% 224.95/225.10       2002; for CUMIN use APIACEAE 1998-2001   
% 224.95/225.10  |- skos__annotation mesh__D028527
% 224.95/225.10       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.95/225.10  |- mesh__dateEstablished mesh__D028527 2002-01-01
% 224.95/225.10  |- mesh__recordAuthorizer mesh__D028527 sjn
% 224.95/225.10  |- mesh__recordOriginator mesh__D028527 ssb
% 224.95/225.10  |- skos__scopeNote mesh__D028527
% 224.95/225.10       A plant genus of the family APIACEAE. The seed is used in SPICES.%A%    
% 224.95/225.10  |- mesh__recordMaintainer mesh__D028527 ssb
% 224.95/225.10  |- skos__broader mesh__D028527smesh__D019661
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D028527 2005
% 224.95/225.10  |- skos__historyNote mesh__D028527 Apiaceae %28%1998-2001%29%
% 224.95/225.10  |- mesh__publicMeSHNote mesh__D028527
% 224.95/225.10       2002; for CUMIN see APIACEAE 1998-2001   
% 224.95/225.10  |- rdf__type mesh__D028527sskos__Concept
% 224.95/225.10  |- mesh__dateRevised mesh__D028527 2004-07-07
% 224.95/225.10  |- skos__hiddenLabel mesh__D006873 para Dihydroxybenzenes
% 224.95/225.10  |- mesh__dateRevised mesh__D006873 1992-05-19
% 224.95/225.10  |- mesh__dateEstablished mesh__D006873 1966-01-01
% 224.95/225.10  |- mesh__recordMaintainer mesh__D006873 TGC
% 224.95/225.10  |- skos__altLabel mesh__D006873 p-Dihydroxybenzenes
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006873 2004
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006873 1995
% 224.95/225.10  |- mesh__dateCreated mesh__D006873 1999-01-01
% 224.95/225.10  |- mesh__recordAuthorizer mesh__D006873 PLS
% 224.95/225.10  |- skos__hiddenLabel mesh__D006873 p Dihydroxybenzenes
% 224.95/225.10  |- skos__prefLabel mesh__D006873 Hydroquinones
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006873 1998
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006873 1993
% 224.95/225.10  |- mesh__recordOriginator mesh__D006873 NLM
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006873 1996
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006873 2000
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006873 1999
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006873 2001
% 224.95/225.10  |- mesh__publicMeSHNote mesh__D006873 66; was see under PHENOLS 1963-65   
% 224.95/225.10  |- skos__altLabel mesh__D006873 para-Dihydroxybenzenes
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006873 1997
% 224.95/225.10  |- rdf__type mesh__D006873sskos__Concept
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006873 2005
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006873 2002
% 224.95/225.10  |- mesh__historyNote mesh__D006873
% 224.95/225.10       66%28%63%29%; was see under PHENOLS 1963-65   
% 224.95/225.10  |- skos__broader mesh__D006873smesh__D010636
% 224.95/225.10  |- skos__altLabel mesh__D006873 Quinols
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006873 2003
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006873 1994
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006873 2006
% 224.95/225.10  |- skos__hiddenLabel mesh__D020544 Responses, Graft-vs-Leukemia
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D020544 2005
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D020544 2000
% 224.95/225.10  |- mesh__dateCreated mesh__D020544 1999-11-03
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D020544 2003
% 224.95/225.10  |- skos__historyNote mesh__D020544 Graft vs Tumor Effect %28%1999%29%
% 224.95/225.10  |- skos__altLabel mesh__D020544 Graft vs Leukemia Response
% 224.95/225.10  |- mesh__dateEstablished mesh__D020544 2000-01-01
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D020544 2006
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D020544 2001
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D020544 2004
% 224.95/225.10  |- skos__hiddenLabel mesh__D020544 Effect, Graft-vs-Leukemia
% 224.95/225.10  |- skos__scopeNote mesh__D020544
% 224.95/225.10       Immunological rejection of leukemia cells following bone marrow transplantation.%A%    
% 224.95/225.10  |- skos__historyNote mesh__D020544 Graft vs Host Reaction %28%1972-1998%29%
% 224.95/225.10  |- skos__broader mesh__D020544smesh__D020350
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D020544 2002
% 224.95/225.10  |- skos__hiddenLabel mesh__D020544 Effects, Graft-vs-Leukemia
% 224.95/225.10  |- skos__hiddenLabel mesh__D020544 Response, Graft-vs-Leukemia
% 224.95/225.10  |- skos__altLabel mesh__D020544 Graft-vs-Leukemia Response
% 224.95/225.10  |- mesh__publicMeSHNote mesh__D020544
% 224.95/225.10       2000; see GRAFT VS TUMOR EFFECT 1999   
% 224.95/225.10  |- skos__prefLabel mesh__D020544 Graft vs Leukemia Effect
% 224.95/225.10  |- mesh__historyNote mesh__D020544 2000; use GRAFT VS TUMOR EFFECT 1999   
% 224.95/225.10  |- skos__hiddenLabel mesh__D020544 Graft-vs-Leukemia Effects
% 224.95/225.10  |- skos__hiddenLabel mesh__D020544 Graft-vs-Leukemia Responses
% 224.95/225.10  |- skos__altLabel mesh__D020544 Graft-vs-Leukemia Effect
% 224.95/225.10  |- rdf__type mesh__D020544sskos__Concept
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006075 2005
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006075 1996
% 224.95/225.10  |- mesh__dateEstablished mesh__D006075 1968-01-01
% 224.95/225.10  |- mesh__dateRevised mesh__D006075 1994-05-05
% 224.95/225.10  |- mesh__publicMeSHNote mesh__D006075 68   
% 224.95/225.10  |- rdf__type mesh__D006075sskos__Concept
% 224.95/225.10  |- skos__prefLabel mesh__D006075 Governing Board
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006075 1999
% 224.95/225.10  |- mesh__recordMaintainer mesh__D006075 TGC
% 224.95/225.10  |- mesh__recordAuthorizer mesh__D006075 PLS
% 224.95/225.10  |- mesh__dateCreated mesh__D006075 1999-01-01
% 224.95/225.10  |- skos__annotation mesh__D006075
% 224.95/225.10       coord NIM with society, hosp or other organiz %28%IM%29%   
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006075 2002
% 224.95/225.10  |- skos__altLabel mesh__D006075 Board, Governing
% 224.95/225.10  |- mesh__historyNote mesh__D006075 68   
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006075 2004
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006075 1995
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006075 1998
% 224.95/225.10  |- skos__historyNote mesh__D006075
% 224.95/225.10       Public Health Administration %28%1966-1967%29%
% 224.95/225.10  |- mesh__recordOriginator mesh__D006075 NLM
% 224.95/225.10  |- skos__hiddenLabel mesh__D006075 Boards, Governing
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006075 2003
% 224.95/225.10  |- skos__broader mesh__D006075smesh__D009934
% 224.95/225.10  |- skos__historyNote mesh__D006075
% 224.95/225.10       Organization and Administration %28%1966-1967%29%
% 224.95/225.10  |- skos__hiddenLabel mesh__D006075 Governing Boards
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006075 2001
% 224.95/225.10  |- skos__historyNote mesh__D006075
% 224.95/225.10       Hospital Administration %28%1966-1967%29%
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006075 2006
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006075 1997
% 224.95/225.10  |- skos__scopeNote mesh__D006075
% 224.95/225.10       The group in which legal authority is vested for the control of health-related institutions and organizations.%A%    
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D006075 2000
% 224.95/225.10  |- mesh__dateEstablished mesh__D014507 1968-01-01
% 224.95/225.10  |- skos__related mesh__D014507smesh__D002947
% 224.95/225.10  |- skos__prefLabel mesh__D014507 Urbanization
% 224.95/225.10  |- mesh__recordOriginator mesh__D014507 NLM
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D014507 2000
% 224.95/225.10  |- mesh__dateCreated mesh__D014507 1999-01-01
% 224.95/225.10  |- skos__historyNote mesh__D014507 Population %28%1966-1967%29%
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D014507 2005
% 224.95/225.10  |- mesh__dateRevised mesh__D014507 1999-11-03
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D014507 2001
% 224.95/225.10  |- skos__historyNote mesh__D014507 Sociology %28%1966-1967%29%
% 224.95/225.10  |- skos__hiddenLabel mesh__D014507 Urbanizations
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D014507 2006
% 224.95/225.10  |- skos__broader mesh__D014507smesh__D012922
% 224.95/225.10  |- mesh__recordMaintainer mesh__D014507 kle
% 224.95/225.10  |- skos__hiddenLabel mesh__D014507 Central Cities
% 224.95/225.10  |- skos__hiddenLabel mesh__D014507 Cities, Central
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D014507 2003
% 224.95/225.10  |- mesh__publicMeSHNote mesh__D014507 68   
% 224.95/225.10  |- mesh__recordAuthorizer mesh__D014507 sjn
% 224.95/225.10  |- skos__annotation mesh__D014507 specify geog if pertinent   
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D014507 2002
% 224.95/225.10  |- skos__scopeNote mesh__D014507
% 224.95/225.10       The process whereby a society changes from a rural to an urban way of life. It refers also to the gradual increase in the proportion of people living in urban areas.%A%    
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D014507 2004
% 224.95/225.10  |- rdf__type mesh__D014507sskos__Concept
% 224.95/225.10  |- mesh__historyNote mesh__D014507 68   
% 224.95/225.10  |- skos__hiddenLabel mesh__D014507 City, Central
% 224.95/225.10  |- skos__broader mesh__D002241Q000737smesh__D002241
% 224.95/225.10  |- rdf__type mesh__D002241Q000737smesh__CompoundConcept
% 224.95/225.10  |- skos__scopeNote mesh__D002483
% 224.95/225.10       A cellulose of varied carboxyl content retaining the fibrous structure. It is used as a local hemostatic and as a matrix for normal blood coagulation.%A%    
% 224.95/225.10  |- mesh__publicMeSHNote mesh__D002483
% 224.95/225.10       91; was see under CELLULOSE 1976-90; was see under HEMOSTATICS 1963-75%A%  
% 224.95/225.10  |- mesh__dateRevised mesh__D002483 2004-07-07
% 224.95/225.10  |- mesh__dateCreated mesh__D002483 1999-01-01
% 224.95/225.10  |- skos__altLabel mesh__D002483 Absorbable Cellulose
% 224.95/225.10  |- mesh__onlineNote mesh__D002483 search HEMOSTATICS 1966-74   
% 224.95/225.10  |- mesh__dateEstablished mesh__D002483 1991-01-01
% 224.95/225.10  |- skos__hiddenLabel mesh__D002483 Cellulose, Absorbable
% 224.95/225.10  |- mesh__recordOriginator mesh__D002483 NLM
% 224.95/225.10  |- skos__broader mesh__D002483smesh__D002482
% 224.95/225.10  |- rdf__type mesh__D002483sskos__Concept
% 224.95/225.10  |- mesh__recordMaintainer mesh__D002483 jmp
% 224.95/225.10  |- skos__prefLabel mesh__D002483 Cellulose, Oxidized
% 224.95/225.10  |- skos__annotation mesh__D002483 D25-26 qualif   
% 224.95/225.10  |- mesh__historyNote mesh__D002483
% 224.95/225.10       91%28%75%29%; was see under CELLULOSE 1976-90; was see under HEMOSTATICS 1963-75%A%  
% 224.95/225.10  |- skos__hiddenLabel mesh__D002483 6 Carboxycellulose
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D002483 2006
% 224.95/225.10  |- skos__hiddenLabel mesh__D002483 Oxidized Cellulose
% 224.95/225.10  |- skos__altLabel mesh__D002483 Cellulosic Acid
% 224.95/225.10  |- mesh__recordAuthorizer mesh__D002483 sjn
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D002483 2005
% 224.95/225.10  |- skos__hiddenLabel mesh__D002483 Acid, Cellulosic
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D010915 1996
% 224.95/225.10  |- skos__hiddenLabel mesh__D010915 Pityriases
% 224.95/225.10  |- skos__annotation mesh__D010915 a papulosquamous skin dis   
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D010915 2003
% 224.95/225.10  |- rdf__type mesh__D010915sskos__Concept
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D010915 2002
% 224.95/225.10  |- skos__broader mesh__D010915smesh__D017444
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D010915 1997
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D010915 2004
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D010915 1998
% 224.95/225.10  |- skos__scopeNote mesh__D010915
% 224.95/225.10       A name originally applied to a group of skin diseases characterized by the formation of fine, branny scales, but now used only with a modifier. %28%Dorland, 27th ed%29%%A%    
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D010915 2005
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D010915 1999
% 224.95/225.10  |- mesh__recordAuthorizer mesh__D010915 PLS
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D010915 2006
% 224.95/225.10  |- mesh__dateCreated mesh__D010915 1999-01-01
% 224.95/225.10  |- mesh__dateRevised mesh__D010915 1993-06-18
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D010915 1994
% 224.95/225.10  |- mesh__recordOriginator mesh__D010915 NLM
% 224.95/225.10  |- skos__prefLabel mesh__D010915 Pityriasis
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D010915 2000
% 224.95/225.10  |- mesh__recordMaintainer mesh__D010915 RAZ
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D010915 1995
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D010915 2001
% 224.95/225.10  |- skos__altLabel mesh__D010117 Alloxanthine
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D010117 2006
% 224.95/225.10  |- mesh__dateCreated mesh__D010117 1974-11-19
% 224.95/225.10  |- mesh__publicMeSHNote mesh__D010117
% 224.95/225.10       91; was see under PYRIMIDINES 1975-90   
% 224.95/225.10  |- skos__historyNote mesh__D010117 Pyrimidines %28%1973-1974%29%
% 224.95/225.10  |- mesh__dateEstablished mesh__D010117 1991-01-01
% 224.95/225.10  |- skos__broader mesh__D010117smesh__D011720
% 224.95/225.10  |- rdf__type mesh__D010117sskos__Concept
% 224.95/225.10  |- mesh__historyNote mesh__D010117
% 224.95/225.10       91%28%75%29%; was see under PYRIMIDINES 1975-90   
% 224.95/225.10  |- skos__scopeNote mesh__D010117 A xanthine oxidase inhibitor.     
% 224.95/225.10  |- skos__annotation mesh__D010117 a xanthine oxidase inhib   
% 224.95/225.10  |- skos__altLabel mesh__D010117 Oxipurinol
% 224.95/225.10  |- skos__broader mesh__D010117smesh__D011743
% 224.95/225.10  |- skos__prefLabel mesh__D010117 Oxypurinol
% 224.95/225.10  |- mesh__recordAuthorizer mesh__D010117 sjn
% 224.95/225.10  |- mesh__recordOriginator mesh__D010117 NLM
% 224.95/225.10  |- skos__historyNote mesh__D010117 Pyrazoles %28%1973-1974%29%
% 224.95/225.10  |- mesh__recordMaintainer mesh__D010117 ssb
% 224.95/225.10  |- mesh__dateRevised mesh__D010117 2005-06-30
% 224.95/225.10  |- mesh__historyNote mesh__D015600
% 224.95/225.10       91%28%90%29%; was see under TRAUMA SEVERITY INDICES 1990   
% 224.95/225.10  |- mesh__dateEstablished mesh__D015600 1991-01-01
% 224.95/225.10  |- skos__historyNote mesh__D015600 Coma %28%1976-1989%29%
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D015600 2001
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D015600 2006
% 224.95/225.10  |- mesh__recordAuthorizer mesh__D015600 jls
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D015600 2002
% 224.95/225.10  |- skos__scopeNote mesh__D015600
% 224.95/225.10       A scale that assesses the response to stimuli in patients with craniocerebral injuries. The parameters are eye opening, motor response, and verbal response.%A%    
% 224.95/225.10  |- skos__historyNote mesh__D015600 Head Injuries %28%1976-1989%29%
% 224.95/225.10  |- skos__hiddenLabel mesh__D015600 Coma Scale, Glasgow
% 224.95/225.10  |- skos__hiddenLabel mesh__D015600 Scale, Glasgow Coma
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D015600 2005A
% 224.95/225.10  |- mesh__recordOriginator mesh__D015600 EGC
% 224.95/225.10  |- mesh__recordMaintainer mesh__D015600 jls
% 224.95/225.10  |- mesh__publicMeSHNote mesh__D015600
% 224.95/225.10       91; was see under TRAUMA SEVERITY INDICES 1990   
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D015600 2003
% 224.95/225.10  |- mesh__dateRevised mesh__D015600 2004-07-27
% 224.95/225.10  |- rdf__type mesh__D015600sskos__Concept
% 224.95/225.10  |- mesh__dateCreated mesh__D015600 1989-05-25
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D015600 2004
% 224.95/225.10  |- skos__broader mesh__D015600smesh__D015599
% 224.95/225.10  |- skos__historyNote mesh__D015600
% 224.95/225.10       Severity of Illness Index %28%1986-1989%29%
% 224.95/225.10  |- skos__historyNote mesh__D015600 Brain Injuries %28%1976-1989%29%
% 224.95/225.10  |- skos__prefLabel mesh__D015600 Glasgow Coma Scale
% 224.95/225.10  |- mesh__activeMeSHYear mesh__D015600 2005
% 224.95/225.10  |- skos__broader mesh__D028528smesh__D019661
% 224.95/225.10  |- mesh__recordMaintainer mesh__D028528 ssb
% 224.95/225.10  |- mesh__dateEstablished mesh__D028528 2002-01-01
% 224.95/225.10  |- mesh__publicMeSHNote mesh__D028528
% 224.95/225.10       2002; for PARSLEY see APIACEAE 1998-2001   
% 224.95/225.10  |- mesh__recordOriginator mesh__D028528 ssb
% 224.95/225.10  |- skos__scopeNote mesh__D028528
% 224.95/225.10       A plant genus of the family APIACEAE used for flavoring food.%A%    
% 224.95/225.11  |- mesh__historyNote mesh__D028528
% 224.95/225.11       2002; for PARSLEY use APIACEAE 1998-2001   
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D028528 2005
% 224.95/225.11  |- mesh__dateCreated mesh__D028528 2001-07-25
% 224.95/225.11  |- rdf__type mesh__D028528sskos__Concept
% 224.95/225.11  |- mesh__dateRevised mesh__D028528 2004-07-07
% 224.95/225.11  |- skos__annotation mesh__D028528
% 224.95/225.11       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D028528 2006
% 224.95/225.11  |- skos__historyNote mesh__D028528 Apiaceae %28%1998-2001%29%
% 224.95/225.11  |- skos__prefLabel mesh__D028528 Petroselinum
% 224.95/225.11  |- mesh__recordAuthorizer mesh__D028528 sjn
% 224.95/225.11  |- skos__broader mesh__D006874smesh__D011312
% 224.95/225.11  |- skos__historyNote mesh__D006874 Pressure %28%1966-1972%29%
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D006874 2004
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D006874 1994
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D006874 2006
% 224.95/225.11  |- mesh__recordAuthorizer mesh__D006874 PLS
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D006874 2003
% 224.95/225.11  |- mesh__historyNote mesh__D006874
% 224.95/225.11       91%28%73%29%; was see under PRESSURE 1973-90   
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D006874 2005
% 224.95/225.11  |- mesh__recordMaintainer mesh__D006874 TAP
% 224.95/225.11  |- skos__prefLabel mesh__D006874 Hydrostatic Pressure
% 224.95/225.11  |- skos__annotation mesh__D006874 NIM   
% 224.95/225.11  |- mesh__dateRevised mesh__D006874 1992-05-15
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D006874 2002
% 224.95/225.11  |- skos__hiddenLabel mesh__D006874 Hydrostatic Pressures
% 224.95/225.11  |- mesh__recordOriginator mesh__D006874 NLM
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D006874 2001
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D006874 1997
% 224.95/225.11  |- mesh__publicMeSHNote mesh__D006874 91; was see under PRESSURE 1973-90   
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D006874 1999
% 224.95/225.11  |- skos__hiddenLabel mesh__D006874 Pressure, Hydrostatic
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D006874 1993
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D006874 1996
% 224.95/225.11  |- rdf__type mesh__D006874sskos__Concept
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D006874 1995
% 224.95/225.11  |- skos__hiddenLabel mesh__D006874 Pressures, Hydrostatic
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D006874 1998
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D006874 2000
% 224.95/225.11  |- mesh__dateEstablished mesh__D006874 1991-01-01
% 224.95/225.11  |- mesh__dateCreated mesh__D006874 1999-01-01
% 224.95/225.11  |- mesh__dateRevised mesh__D020545 2005-06-30
% 224.95/225.11  |- skos__historyNote mesh__D020545
% 224.95/225.11       Respiratory System or specifics %28%1966-1999%29%
% 224.95/225.11  |- skos__historyNote mesh__D020545
% 224.95/225.11       Mucous Membrane or specifics %28%1966-1999%29%
% 224.95/225.11  |- mesh__recordAuthorizer mesh__D020545 sjn
% 224.95/225.11  |- mesh__historyNote mesh__D020545 2000   
% 224.95/225.11  |- mesh__publicMeSHNote mesh__D020545 2000   
% 224.95/225.11  |- skos__broader mesh__D020545smesh__D009092
% 224.95/225.11  |- skos__hiddenLabel mesh__D020545 Epithelium, Respiratory
% 224.95/225.11  |- mesh__dateCreated mesh__D020545 1999-11-05
% 224.95/225.11  |- mesh__recordMaintainer mesh__D020545 lkt
% 224.95/225.11  |- skos__broader mesh__D020545smesh__D012137
% 224.95/225.11  |- rdf__type mesh__D020545sskos__Concept
% 224.95/225.11  |- skos__prefLabel mesh__D020545 Respiratory Mucosa
% 224.95/225.11  |- mesh__recordOriginator mesh__D020545 nns
% 224.95/225.11  |- skos__hiddenLabel mesh__D020545 Mucosa, Respiratory
% 224.95/225.11  |- mesh__dateEstablished mesh__D020545 2000-01-01
% 224.95/225.11  |- skos__scopeNote mesh__D020545
% 224.95/225.11       The mucous membrane lining the RESPIRATORY TRACT, including the NASAL CAVITY; the LARYNX; the TRACHEA; and the BRONCHI tree. The respiratory mucosa consists of various types of epithelial cells ranging from ciliated columnar to simple squamous, mucous GOBLET CELLS, and glands containing both mucous and serous cells.%A%    
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D020545 2006
% 224.95/225.11  |- skos__broader mesh__D002319Q000002smesh__D002319
% 224.95/225.11  |- mesh__preferredCombination mesh__D002319Q000002smesh__D018376
% 224.95/225.11  |- rdf__type mesh__D002319Q000002smesh__CompoundConcept
% 224.95/225.11  |- mesh__recordOriginator mesh__D006076 NLM
% 224.95/225.11  |- skos__annotation mesh__D006076 specify country or state   
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D006076 2004
% 224.95/225.11  |- skos__hiddenLabel mesh__D006076 Government Official
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D006076 2003
% 224.95/225.11  |- mesh__recordMaintainer mesh__D006076 hjn
% 224.95/225.11  |- mesh__dateRevised mesh__D006076 2002-07-03
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D006076 2006
% 224.95/225.11  |- skos__hiddenLabel mesh__D006076 Officials, Government
% 224.95/225.11  |- mesh__recordAuthorizer mesh__D006076 sjn
% 224.95/225.11  |- skos__prefLabel mesh__D006076 Government
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D006076 2005
% 224.95/225.11  |- skos__hiddenLabel mesh__D006076 Official, Government
% 224.95/225.11  |- skos__scopeNote mesh__D006076
% 224.95/225.11       The complex of political institutions, laws, and customs through which the function of governing is carried out in a specific political unit.%A%    
% 224.95/225.11  |- skos__broader mesh__D006076smesh__D012942
% 224.95/225.11  |- rdf__type mesh__D006076sskos__Concept
% 224.95/225.11  |- skos__hiddenLabel mesh__D006076 Governments
% 224.95/225.11  |- mesh__dateCreated mesh__D006076 1999-01-01
% 224.95/225.11  |- skos__broader mesh__D014508smesh__D009930
% 224.95/225.11  |- mesh__recordAuthorizer mesh__D014508 sjn
% 224.95/225.11  |- mesh__dateCreated mesh__D014508 1999-01-01
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D014508 2002
% 224.95/225.11  |- mesh__recordMaintainer mesh__D014508 ssb
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D014508 2005
% 224.95/225.11  |- mesh__recordOriginator mesh__D014508 NLM
% 224.95/225.11  |- skos__prefLabel mesh__D014508 Urea
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D014508 2006
% 224.95/225.11  |- mesh__dateRevised mesh__D014508 2001-07-25
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D014508 2003
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D014508 2004
% 224.95/225.11  |- rdf__type mesh__D014508sskos__Concept
% 224.95/225.11  |- skos__altLabel mesh__D014508 Carbamide
% 224.95/225.11  |- skos__scopeNote mesh__D014508
% 224.95/225.11       A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids.%A%    
% 224.95/225.11  |- skos__related mesh__D014508smesh__D001806
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Plants, Electric Power
% 224.95/225.11  |- mesh__dateEstablished mesh__D011210 1977-01-01
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Power Plant, Hydroelectric
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Plant, Electric Power
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Plant, Power
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D011210 1996
% 224.95/225.11  |- mesh__recordOriginator mesh__D011210 SMH
% 224.95/225.11  |- skos__historyNote mesh__D011210 Electricity %28%1966-1976%29%
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Power Plants, Electric
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D011210 2004
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Power Plant
% 224.95/225.11  |- mesh__dateRevised mesh__D011210 1994-05-31
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D011210 1995
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Plants, Thermoelectric Power
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Plants, Power
% 224.95/225.11  |- skos__broader mesh__D011210smesh__D004560
% 224.95/225.11  |- mesh__historyNote mesh__D011210 77   
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Plant, Hydroelectric Power
% 224.95/225.11  |- skos__historyNote mesh__D011210 Nuclear Energy %28%1966-1976%29%
% 224.95/225.11  |- mesh__recordMaintainer mesh__D011210 TGC
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D011210 2002
% 224.95/225.11  |- skos__historyNote mesh__D011210 Air Pollution %28%1966-1976%29%
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Hydroelectric Power Plant
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D011210 2003
% 224.95/225.11  |- rdf__type mesh__D011210sskos__Concept
% 224.95/225.11  |- mesh__publicMeSHNote mesh__D011210 77   
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Plants, Hydroelectric Power
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D011210 1999
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Power Plant, Electric
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Thermoelectric Power Plant
% 224.95/225.11  |- skos__broader mesh__D011210smesh__D013676
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Electric Power Plant
% 224.95/225.11  |- skos__annotation mesh__D011210
% 224.95/225.11       SPEC qualif; on an industrial %26% technol level: differentiate from POWER SOURCES; coord IM with source of power %28%IM%29% if pertinent%A%  
% 224.95/225.11  |- mesh__recordAuthorizer mesh__D011210 PLS
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D011210 2001
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Plant, Thermoelectric Power
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D011210 1998
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Power Plant, Thermoelectric
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D011210 2006
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D011210 2000
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Plant, Nuclear Power
% 224.95/225.11  |- mesh__dateCreated mesh__D011210 1976-05-19
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Nuclear Power Plant
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Power Plants, Hydroelectric
% 224.95/225.11  |- skos__prefLabel mesh__D011210 Power Plants
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Power Plants, Nuclear
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Plants, Nuclear Power
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Power Plant, Nuclear
% 224.95/225.11  |- skos__scopeNote mesh__D011210
% 224.95/225.11       Units that convert some form of energy into electrical energy, such as hydroelectric or steam-generating stations, diesel-electric engines in locomotives, or nuclear power plants.%A%    
% 224.95/225.11  |- skos__historyNote mesh__D011210 Occupational Medicine %28%1966-1976%29%
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D011210 1997
% 224.95/225.11  |- skos__hiddenLabel mesh__D011210 Power Plants, Thermoelectric
% 224.95/225.11  |- skos__historyNote mesh__D011210 Nuclear Reactors %28%1966-1976%29%
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D011210 2005
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D002484 2001
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D002484 1996
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D002484 1993
% 224.95/225.11  |- skos__prefLabel mesh__D002484 Cementation
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D002484 1995
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D002484 1998
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D002484 2004
% 224.95/225.11  |- mesh__historyNote mesh__D002484 67%28%65%29%   
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D002484 1994
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D002484 2000
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D002484 2006
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D002484 2003
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D002484 2005
% 224.95/225.11  |- skos__broader mesh__D002484smesh__D001840
% 224.95/225.11  |- skos__scopeNote mesh__D002484
% 224.95/225.11       The joining of objects by means of a cement %28%e.g., in fracture fixation, such as in hip arthroplasty for joining of the acetabular component to the femoral component%29%. In dentistry, it is used for the process of attaching parts of a tooth or restorative material to a natural tooth or for the attaching of orthodontic bands to teeth by means of an adhesive.%A%    
% 224.95/225.11  |- mesh__recordAuthorizer mesh__D002484 PLS
% 224.95/225.11  |- skos__hiddenLabel mesh__D002484 Cementations
% 224.95/225.11  |- skos__related mesh__D002484smesh__D003738
% 224.95/225.11  |- mesh__recordOriginator mesh__D002484 NLM
% 224.95/225.11  |- mesh__dateCreated mesh__D002484 1999-01-01
% 224.95/225.11  |- mesh__recordMaintainer mesh__D002484 TAP
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D002484 2002
% 224.95/225.11  |- mesh__dateRevised mesh__D002484 1992-05-07
% 224.95/225.11  |- mesh__dateEstablished mesh__D002484 1967-01-01
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D002484 1997
% 224.95/225.11  |- skos__broader mesh__D002484smesh__D008919
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D002484 1999
% 224.95/225.11  |- rdf__type mesh__D002484sskos__Concept
% 224.95/225.11  |- mesh__publicMeSHNote mesh__D002484 67   
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D010916 2000
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D010916 2004
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D010916 2001
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D010916 2005
% 224.95/225.11  |- mesh__onlineNote mesh__D010916
% 224.95/225.11       use DERMATITIS EXFOLIATIVA to search PITYRIASIS RUBRA 1966%A%  
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D010916 2002
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D010916 2006
% 224.95/225.11  |- mesh__dateCreated mesh__D010916 1999-01-01
% 224.95/225.11  |- skos__scopeNote mesh__D010916
% 224.95/225.11       A chronic skin disease characterized by small follicular papules, disseminated reddish-brown scaly patches, and often, palmoplantar hyperkeratosis. The papules are about the size of a pin and topped by a horny plug.%A%    
% 224.95/225.11  |- mesh__historyNote mesh__D010916
% 224.95/225.11       67; was PITYRIASIS RUBRA see under DERMATITIS EXFOLIATIVA 1963-66%A%  
% 224.95/225.11  |- mesh__dateEstablished mesh__D010916 1967-01-01
% 224.95/225.11  |- mesh__recordMaintainer mesh__D010916 ndw
% 224.95/225.11  |- skos__prefLabel mesh__D010916 Pityriasis Rubra Pilaris
% 224.95/225.11  |- mesh__publicMeSHNote mesh__D010916
% 224.95/225.11       67; was PITYRIASIS RUBRA see under DERMATITIS EXFOLIATIVA 1963-66%A%  
% 224.95/225.11  |- skos__historyNote mesh__D010916 Dermatitis, Exfoliative %28%1966%29%
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D010916 2003
% 224.95/225.11  |- mesh__dateRevised mesh__D010916 1999-11-03
% 224.95/225.11  |- skos__broader mesh__D010916smesh__D010915
% 224.95/225.11  |- rdf__type mesh__D010916sskos__Concept
% 224.95/225.11  |- mesh__recordOriginator mesh__D010916 NLM
% 224.95/225.11  |- mesh__recordAuthorizer mesh__D010916 sjn
% 224.95/225.11  |- skos__prefLabel mesh__D029621 Polypodiaceae
% 224.95/225.11  |- mesh__publicMeSHNote mesh__D029621 2002   
% 224.95/225.11  |- mesh__recordMaintainer mesh__D029621 ssb
% 224.95/225.11  |- mesh__dateRevised mesh__D029621 2002-07-03
% 224.95/225.11  |- skos__altLabel mesh__D029621 Drynariae
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D029621 2005
% 224.95/225.11  |- skos__broader mesh__D029621smesh__D029624
% 224.95/225.11  |- rdf__type mesh__D029621sskos__Concept
% 224.95/225.11  |- skos__scopeNote mesh__D029621
% 224.95/225.11       The fern plant family of the order Polypodiales, class Filicopsida, division Pteridophyta, subkingdom Tracheobionta.%A%    
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D029621 2003
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D029621 2006
% 224.95/225.11  |- mesh__recordOriginator mesh__D029621 ssb
% 224.95/225.11  |- mesh__dateCreated mesh__D029621 2001-07-25
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D029621 2004
% 224.95/225.11  |- mesh__dateEstablished mesh__D029621 2002-01-01
% 224.95/225.11  |- mesh__recordAuthorizer mesh__D029621 sjn
% 224.95/225.11  |- skos__altLabel mesh__D029621 Gusuibu
% 224.95/225.11  |- mesh__historyNote mesh__D029621 2002   
% 224.95/225.11  |- skos__annotation mesh__D029621
% 224.95/225.11       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.95/225.11  |- mesh__recordAuthorizer mesh__D010118 sjn
% 224.95/225.11  |- mesh__recordOriginator mesh__D010118 NLM
% 224.95/225.11  |- rdf__type mesh__D010118sskos__Concept
% 224.95/225.11  |- mesh__recordMaintainer mesh__D010118 ssb
% 224.95/225.11  |- skos__hiddenLabel mesh__D010118 Calcium, Oxytetracycline
% 224.95/225.11  |- skos__hiddenLabel mesh__D010118 Sodium Salt Oxytetracycline
% 224.95/225.11  |- skos__broader mesh__D010118smesh__D013754
% 224.95/225.11  |- mesh__dateCreated mesh__D010118 1999-01-01
% 224.95/225.11  |- mesh__dateRevised mesh__D010118 2004-07-07
% 224.95/225.11  |- mesh__publicMeSHNote mesh__D010118
% 224.95/225.11       OXYTETRACID was see OXYTETRACYCLINE 1978-91   
% 224.95/225.11  |- skos__annotation mesh__D010118 /biosyn permitted   
% 224.95/225.11  |- skos__altLabel mesh__D010118 Hydroxytetracycline
% 224.95/225.11  |- skos__scopeNote mesh__D010118
% 224.95/225.11       A TETRACYCLINE analog isolated from the actinomycete STREPTOMYCES rimosus and used in a wide variety of clinical conditions.%A%    
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D010118 2005
% 224.95/225.11  |- skos__hiddenLabel mesh__D010118 Dihydrate, Oxytetracycline
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D010118 2006
% 224.95/225.11  |- mesh__historyNote mesh__D010118
% 224.95/225.11       OXYTETRACID was see OXYTETRACYCLINE 1978-91   
% 224.95/225.11  |- skos__altLabel mesh__D010118 Oxyterracine
% 224.95/225.11  |- skos__prefLabel mesh__D010118 Oxytetracycline
% 224.95/225.11  |- mesh__onlineNote mesh__D010118
% 224.95/225.11       use OXYTETRACYCLINE to search OXYTETRACID 1978-91   
% 224.95/225.11  |- skos__hiddenLabel mesh__D010118 Hydrochloride, Oxytetracycline
% 224.95/225.11  |- skos__historyNote mesh__D015601 Wounds and Injuries %28%1974-1989%29%
% 224.95/225.11  |- mesh__recordMaintainer mesh__D015601 PLS
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D015601 1995
% 224.95/225.11  |- skos__prefLabel mesh__D015601 Injury Severity Score
% 224.95/225.11  |- mesh__historyNote mesh__D015601
% 224.95/225.11       91%28%90%29%; was see under TRAUMA SEVERITY INDICES 1990   
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D015601 2003
% 224.95/225.11  |- skos__altLabel mesh__D015601 ISS Score
% 224.95/225.11  |- mesh__dateRevised mesh__D015601 1992-05-20
% 224.95/225.11  |- mesh__recordOriginator mesh__D015601 EGC
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D015601 2000
% 224.95/225.11  |- rdf__type mesh__D015601sskos__Concept
% 224.95/225.11  |- mesh__dateCreated mesh__D015601 1989-05-25
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D015601 2004
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D015601 1996
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D015601 2001
% 224.95/225.11  |- skos__broader mesh__D015601smesh__D015599
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D015601 2005
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D015601 1997
% 224.95/225.11  |- skos__scopeNote mesh__D015601
% 224.95/225.11       An anatomic severity scale based on the Abbreviated Injury Scale %28%AIS%29% and developed specifically to score multiple traumatic injuries. It has been used as a predictor of mortality.%A%    
% 224.95/225.11  |- mesh__recordAuthorizer mesh__D015601 PLS
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D015601 2002
% 224.95/225.11  |- skos__hiddenLabel mesh__D015601 Scores, Injury Severity
% 224.95/225.11  |- mesh__publicMeSHNote mesh__D015601
% 224.95/225.11       91; was see under TRAUMA SEVERITY INDICES 1990   
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D015601 2006
% 224.95/225.11  |- skos__hiddenLabel mesh__D015601 Injury Severity Scores
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D015601 1998
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D015601 1993
% 224.95/225.11  |- mesh__dateEstablished mesh__D015601 1991-01-01
% 224.95/225.11  |- skos__hiddenLabel mesh__D015601 Score, Injury Severity
% 224.95/225.11  |- skos__annotation mesh__D015601 no qualif   
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D015601 1994
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D015601 1999
% 224.95/225.11  |- skos__historyNote mesh__D015601
% 224.95/225.11       Severity of Illness Index %28%1985-1989%29%
% 224.95/225.11  |- mesh__dateEstablished mesh__D028529 2002-01-01
% 224.95/225.11  |- mesh__recordOriginator mesh__D028529 ssb
% 224.95/225.11  |- mesh__recordAuthorizer mesh__D028529 sjn
% 224.95/225.11  |- mesh__publicMeSHNote mesh__D028529
% 224.95/225.11       2002; for PARSNIPS see APIACEAE 1998-2001   
% 224.95/225.11  |- skos__broader mesh__D028529smesh__D019661
% 224.95/225.11  |- mesh__recordMaintainer mesh__D028529 ssb
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D028529 2005
% 224.95/225.11  |- skos__scopeNote mesh__D028529
% 224.95/225.11       A plant genus of the family APIACEAE. The roots are used as food.%A%    
% 224.95/225.11  |- rdf__type mesh__D028529sskos__Concept
% 224.95/225.11  |- mesh__dateRevised mesh__D028529 2004-07-07
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D028529 2006
% 224.95/225.11  |- skos__historyNote mesh__D028529 Apiaceae %28%1998-2001%29%
% 224.95/225.11  |- mesh__historyNote mesh__D028529
% 224.95/225.11       2002; for PARSNIPS use APIACEAE 1998-2001   
% 224.95/225.11  |- skos__prefLabel mesh__D028529 Pastinaca
% 224.95/225.11  |- mesh__dateCreated mesh__D028529 2001-07-25
% 224.95/225.11  |- skos__annotation mesh__D028529
% 224.95/225.11       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.95/225.11  |- skos__broader mesh__D006875smesh__D013812
% 224.95/225.11  |- skos__hiddenLabel mesh__D006875 Baths, Whirlpool
% 224.95/225.11  |- skos__hiddenLabel mesh__D006875 Bath, Whirlpool
% 224.95/225.11  |- skos__annotation mesh__D006875
% 224.95/225.11       do not use /util except by MeSH definition; external with natural water only, with emphasis on water temperature %26% motion of water %28%note X ref WHIRLPOOL BATHS%29%; do not confuse with BALNEOLOGY %28%see note there%29%; if in doubt, use word of text%A%  
% 224.95/225.11  |- skos__hiddenLabel mesh__D006875 Hydrotherapies
% 224.95/225.11  |- mesh__recordMaintainer mesh__D006875 lkt
% 224.95/225.11  |- skos__broader mesh__D006875smesh__D026741
% 224.95/225.11  |- mesh__dateRevised mesh__D006875 2005-06-30
% 224.95/225.11  |- rdf__type mesh__D006875sskos__Concept
% 224.95/225.11  |- skos__prefLabel mesh__D006875 Hydrotherapy
% 224.95/225.11  |- mesh__recordAuthorizer mesh__D006875 sjn
% 224.95/225.11  |- mesh__dateCreated mesh__D006875 1999-01-01
% 224.95/225.11  |- skos__scopeNote mesh__D006875
% 224.95/225.11       External application of water for therapeutic purposes.%A%    
% 224.95/225.11  |- skos__hiddenLabel mesh__D006875 Whirlpool Bath
% 224.95/225.11  |- mesh__recordOriginator mesh__D006875 NLM
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D006875 2006
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D020546 2004
% 224.95/225.11  |- mesh__publicMeSHNote mesh__D020546 2000   
% 224.95/225.11  |- rdf__type mesh__D020546sskos__Concept
% 224.95/225.11  |- mesh__dateEstablished mesh__D020546 2000-01-01
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D020546 2006
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D020546 2003
% 224.95/225.11  |- skos__historyNote mesh__D020546 Cerebral Ventricles %28%1965-1999%29%
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D020546 2002
% 224.95/225.11  |- mesh__dateCreated mesh__D020546 1999-11-03
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D020546 2005
% 224.95/225.11  |- skos__scopeNote mesh__D020546
% 224.95/225.11       An irregularly shaped cavity in the rhombencephalon, between the medulla oblongata, the pons, and the isthmus in front, and the cerebellum behind. It is continuous with the central canal of the cord below and with the CEREBRAL AQUEDUCT above, and through its lateral and median apertures it communicates with the subarachnoid space.%A%    
% 224.95/225.11  |- skos__hiddenLabel mesh__D020546 Fourth Ventricles
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D020546 2001
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D020546 2000
% 224.95/225.11  |- skos__annotation mesh__D020546
% 224.95/225.11       /radiogr: coord with CEREBRAL VENTRICULOGRAPHY   
% 224.95/225.11  |- skos__broader mesh__D020546smesh__D002552
% 224.95/225.11  |- mesh__historyNote mesh__D020546 2000   
% 224.95/225.11  |- skos__hiddenLabel mesh__D020546 Ventricles, Fourth
% 224.95/225.11  |- skos__prefLabel mesh__D020546 Fourth Ventricle
% 224.95/225.11  |- skos__hiddenLabel mesh__D020546 Ventricle, Fourth
% 224.95/225.11  |- skos__broader mesh__D006077smesh__D009938
% 224.95/225.11  |- skos__scopeNote mesh__D006077
% 224.95/225.11       Administrative units of government responsible for policy making and management of governmental activities in the U.S. and abroad.%A%    
% 224.95/225.11  |- mesh__historyNote mesh__D006077 68   
% 224.95/225.11  |- mesh__recordOriginator mesh__D006077 NLM
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D006077 2006
% 224.95/225.11  |- skos__broader mesh__D006077smesh__D006076
% 224.95/225.11  |- skos__hiddenLabel mesh__D006077 Agencies, Government
% 224.95/225.11  |- skos__prefLabel mesh__D006077 Government Agencies
% 224.95/225.11  |- mesh__activeMeSHYear mesh__D006077 2005
% 224.95/225.11  |- mesh__dateEstablished mesh__D006077 1968-01-01
% 224.95/225.11  |- mesh__publicMeSHNote mesh__D006077 68   
% 224.95/225.12  |- rdf__type mesh__D006077sskos__Concept
% 224.95/225.12  |- skos__annotation mesh__D006077
% 224.95/225.12       specify country or state; CATALOG: Use NAF entry for specific laws%A%  
% 224.95/225.12  |- mesh__dateCreated mesh__D006077 1999-01-01
% 224.95/225.12  |- mesh__dateRevised mesh__D006077 2003-07-09
% 224.95/225.12  |- skos__hiddenLabel mesh__D006077 Agency, Government
% 224.95/225.12  |- mesh__recordMaintainer mesh__D006077 ags
% 224.95/225.12  |- skos__hiddenLabel mesh__D006077 Government Agency
% 224.95/225.12  |- mesh__recordAuthorizer mesh__D006077 sjn
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006077 2004
% 224.95/225.12  |- skos__historyNote mesh__D006077 Government %28%1966-1967%29%
% 224.95/225.12  |- skos__historyNote mesh__D014509 Mycoplasma %28%1966-1975%29%
% 224.95/225.12  |- mesh__recordOriginator mesh__D014509 JW
% 224.95/225.12  |- mesh__historyNote mesh__D014509 76   
% 224.95/225.12  |- mesh__dateRevised mesh__D014509 2005-06-30
% 224.95/225.12  |- rdf__type mesh__D014509sskos__Concept
% 224.95/225.12  |- skos__scopeNote mesh__D014509
% 224.95/225.12       A genus of gram-negative, nonmotile bacteria which are common parasitic inhabitants of the urogenital tracts of humans, cattle, dogs, and monkeys.%A%    
% 224.95/225.12  |- skos__altLabel mesh__D014509 Ureaplasma urealyticum biovar 1
% 224.95/225.12  |- mesh__recordAuthorizer mesh__D014509 sjn
% 224.95/225.12  |- skos__altLabel mesh__D014509 T-Mycoplasma
% 224.95/225.12  |- mesh__recordMaintainer mesh__D014509 SYSTEM
% 224.95/225.12  |- skos__broader mesh__D014509smesh__D009178
% 224.95/225.12  |- mesh__dateEstablished mesh__D014509 1976-01-01
% 224.95/225.12  |- skos__prefLabel mesh__D014509 Ureaplasma
% 224.95/225.12  |- skos__annotation mesh__D014509 infection = UREAPLASMA INFECTIONS   
% 224.95/225.12  |- mesh__publicMeSHNote mesh__D014509 76   
% 224.95/225.12  |- mesh__dateCreated mesh__D014509 1975-07-18
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D014509 2006
% 224.95/225.12  |- skos__prefLabel mesh__D011211 Electric Power Supplies
% 224.95/225.12  |- skos__hiddenLabel mesh__D011211 Power Supply
% 224.95/225.12  |- skos__altLabel mesh__D011211 Power Sources
% 224.95/225.12  |- skos__hiddenLabel mesh__D011211 Supply, Electric Power
% 224.95/225.12  |- mesh__historyNote mesh__D011211 2006 %28%1977%29%   
% 224.95/225.12  |- skos__hiddenLabel mesh__D011211 Power Source
% 224.95/225.12  |- skos__altLabel mesh__D011211 Power Supplies, Electric
% 224.95/225.12  |- skos__hiddenLabel mesh__D011211 Power Supply, Electric
% 224.95/225.12  |- mesh__recordMaintainer mesh__D011211 nns
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D011211 2006
% 224.95/225.12  |- skos__hiddenLabel mesh__D011211 Electric Power Source
% 224.95/225.12  |- mesh__recordOriginator mesh__D011211 SMH
% 224.95/225.12  |- skos__scopeNote mesh__D011211
% 224.95/225.12       Devices that control the supply an electric current for running electrical equipment.%A%    
% 224.95/225.12  |- mesh__dateEstablished mesh__D011211 1977-01-01
% 224.95/225.12  |- mesh__publicMeSHNote mesh__D011211 2006; see POWER SOURCES 1977-2005   
% 224.95/225.12  |- rdf__type mesh__D011211sskos__Concept
% 224.95/225.12  |- skos__altLabel mesh__D011211 Electric Power Sources
% 224.95/225.12  |- mesh__dateRevised mesh__D011211 2005-06-30
% 224.95/225.12  |- skos__hiddenLabel mesh__D011211 Electric Power Supply
% 224.95/225.12  |- skos__altLabel mesh__D011211 Power Supplies
% 224.95/225.12  |- skos__altLabel mesh__D011211 Power Sources, Electric
% 224.95/225.12  |- skos__related mesh__D011211smesh__D004736
% 224.95/225.12  |- skos__hiddenLabel mesh__D011211 Power Source, Electric
% 224.95/225.12  |- mesh__recordAuthorizer mesh__D011211 sjn
% 224.95/225.12  |- skos__annotation mesh__D011211
% 224.95/225.12       do not confuse with POWER PLANTS, on an industrial level   
% 224.95/225.12  |- mesh__dateCreated mesh__D011211 1976-05-19
% 224.95/225.12  |- skos__broader mesh__D011211smesh__D004864
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D002485 2004
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D002485 2002
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D002485 2006
% 224.95/225.12  |- mesh__publicMeSHNote mesh__D002485
% 224.95/225.12       91; was see under ODONTOGENIC TUMORS 1980-90; was see under ODONTOGENIC TUMOR 1975-79%A%  
% 224.95/225.12  |- mesh__dateRevised mesh__D002485 1995-06-08
% 224.95/225.12  |- mesh__recordMaintainer mesh__D002485 KEV
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D002485 2003
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D002485 2001
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D002485 2005
% 224.95/225.12  |- skos__annotation mesh__D002485
% 224.95/225.12       /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A%  
% 224.95/225.12  |- skos__broader mesh__D002485smesh__D009808
% 224.95/225.12  |- skos__prefLabel mesh__D002485 Cementoma
% 224.95/225.12  |- skos__scopeNote mesh__D002485
% 224.95/225.12       An odontogenic fibroma in which cells have developed into cementoblasts and which consists largely of cementum.%A%    
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D002485 2000
% 224.95/225.12  |- mesh__dateCreated mesh__D002485 1999-01-01
% 224.95/225.12  |- mesh__onlineNote mesh__D002485
% 224.95/225.12       use ODONTOGENIC TUMORS to search CEMENTOMA 1966-71 %28%as Prov 1972-74%29%%A%  
% 224.95/225.12  |- mesh__historyNote mesh__D002485
% 224.95/225.12       91%28%72%29%; was see under ODONTOGENIC TUMORS 1980-90; was see under ODONTOGENIC TUMOR 1972-79%28%Prov 1972-74%29%%A%  
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D002485 1997
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D002485 1999
% 224.95/225.12  |- rdf__type mesh__D002485sskos__Concept
% 224.95/225.12  |- mesh__recordAuthorizer mesh__D002485 PLS
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D002485 1996
% 224.95/225.12  |- mesh__dateEstablished mesh__D002485 1991-01-01
% 224.95/225.12  |- mesh__recordOriginator mesh__D002485 NLM
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D002485 1998
% 224.95/225.12  |- skos__historyNote mesh__D002485 Odontogenic Tumors %28%1966-1971%29%
% 224.95/225.12  |- skos__hiddenLabel mesh__D002485 Cementomas
% 224.95/225.12  |- mesh__dateRevised mesh__D010917 2005-06-30
% 224.95/225.12  |- skos__scopeNote mesh__D010917 Pivalate ester analog of AMPICILLIN.     
% 224.95/225.12  |- skos__altLabel mesh__D010917 Leo Brand of Pivampicillin
% 224.95/225.12  |- mesh__publicMeSHNote mesh__D010917
% 224.95/225.12       91; was see under AMPICILLIN 1975-90   
% 224.95/225.12  |- mesh__recordAuthorizer mesh__D010917 sjn
% 224.95/225.12  |- mesh__recordMaintainer mesh__D010917 lkw
% 224.95/225.12  |- skos__hiddenLabel mesh__D010917 Monohydrochloride, Pivampicillin
% 224.95/225.12  |- mesh__recordOriginator mesh__D010917 NLM
% 224.95/225.12  |- skos__altLabel mesh__D010917 Ampicillin Pivaloyl Ester
% 224.95/225.12  |- skos__historyNote mesh__D010917 Ampicillin %28%1972-1974%29%
% 224.95/225.12  |- rdf__type mesh__D010917sskos__Concept
% 224.95/225.12  |- skos__altLabel mesh__D010917 Pivampicillin Monohydrochloride
% 224.95/225.12  |- skos__hiddenLabel mesh__D010917 Ester, Ampicillin Pivaloyl
% 224.95/225.12  |- mesh__dateEstablished mesh__D010917 1991-01-01
% 224.95/225.12  |- mesh__historyNote mesh__D010917
% 224.95/225.12       91%28%75%29%; was see under AMPICILLIN 1975-90   
% 224.95/225.12  |- skos__prefLabel mesh__D010917 Pivampicillin
% 224.95/225.12  |- skos__hiddenLabel mesh__D010917 Hydrochloride, Pivampicillin
% 224.95/225.12  |- skos__altLabel mesh__D010917
% 224.95/225.12       Serra Pamies Brand of Pivampicillin Hydrochloride
% 224.95/225.12  |- mesh__dateCreated mesh__D010917 1974-11-19
% 224.95/225.12  |- skos__historyNote mesh__D010917 Valerates %28%1973-1974%29%
% 224.95/225.12  |- skos__broader mesh__D010917smesh__D000667
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D010917 2006
% 224.95/225.12  |- skos__scopeNote mesh__D029622
% 224.95/225.12       A plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. There are no true petals; each flower has two to six sepals. They produce betacyanin and betaxanthin pigments and lack anthocyanins.%A%    
% 224.95/225.12  |- skos__prefLabel mesh__D029622 Portulacaceae
% 224.95/225.12  |- mesh__historyNote mesh__D029622 2002   
% 224.95/225.12  |- skos__annotation mesh__D029622
% 224.95/225.12       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.95/225.12  |- skos__broader mesh__D029622smesh__D019684
% 224.95/225.12  |- mesh__dateRevised mesh__D029622 2002-07-03
% 224.95/225.12  |- mesh__dateCreated mesh__D029622 2001-07-25
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D029622 2004
% 224.95/225.12  |- mesh__dateEstablished mesh__D029622 2002-01-01
% 224.95/225.12  |- rdf__type mesh__D029622sskos__Concept
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D029622 2006
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D029622 2003
% 224.95/225.12  |- mesh__publicMeSHNote mesh__D029622 2002   
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D029622 2005
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D010119 2006
% 224.95/225.12  |- mesh__recordMaintainer mesh__D010119 ssb
% 224.95/225.12  |- mesh__dateCreated mesh__D010119 1974-11-19
% 224.95/225.12  |- rdf__type mesh__D010119sskos__Concept
% 224.95/225.12  |- mesh__recordAuthorizer mesh__D010119 sjn
% 224.95/225.12  |- mesh__recordOriginator mesh__D010119 NLM
% 224.95/225.12  |- skos__altLabel mesh__D010119 Hydroxythiamine
% 224.95/225.12  |- mesh__dateEstablished mesh__D010119 1991-01-01
% 224.95/225.12  |- skos__historyNote mesh__D010119 Thiazoles %28%1970-1974%29%
% 224.95/225.12  |- skos__broader mesh__D010119smesh__D013844
% 224.95/225.12  |- mesh__dateRevised mesh__D010119 2005-06-30
% 224.95/225.12  |- skos__historyNote mesh__D010119 Pyrimidines %28%1974%29%
% 224.95/225.12  |- skos__scopeNote mesh__D010119 Thiamine antagonist, antimetabolite.     
% 224.95/225.12  |- skos__prefLabel mesh__D010119 Oxythiamine
% 224.95/225.12  |- skos__annotation mesh__D010119 a thiamine antag   
% 224.95/225.12  |- mesh__historyNote mesh__D010119
% 224.95/225.12       91%28%75%29%; was see under THIAZOLES 1975-90   
% 224.95/225.12  |- mesh__publicMeSHNote mesh__D010119
% 224.95/225.12       91; was see under THIAZOLES 1975-90   
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006876 1997
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006876 2002
% 224.95/225.12  |- skos__broader mesh__D006876smesh__D010995
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006876 1999
% 224.95/225.12  |- skos__prefLabel mesh__D006876 Hydrothorax
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006876 2001
% 224.95/225.12  |- mesh__dateRevised mesh__D006876 1993-08-09
% 224.95/225.12  |- mesh__recordMaintainer mesh__D006876 PLS
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006876 1996
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006876 1995
% 224.95/225.12  |- mesh__recordOriginator mesh__D006876 NLM
% 224.95/225.12  |- rdf__type mesh__D006876sskos__Concept
% 224.95/225.12  |- mesh__dateCreated mesh__D006876 1999-01-01
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006876 1998
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006876 2004
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006876 1994
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006876 2000
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006876 2006
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006876 2003
% 224.95/225.12  |- skos__scopeNote mesh__D006876
% 224.95/225.12       A collection of watery fluid in the pleural cavity. %28%Dorland, 27th ed%29%%A%    
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006876 2005
% 224.95/225.12  |- skos__annotation mesh__D006876 fluid in pleural cavity   
% 224.95/225.12  |- mesh__recordAuthorizer mesh__D006876 PLS
% 224.95/225.12  |- skos__hiddenLabel mesh__D020547 Ventricles, Lateral
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D020547 2006
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D020547 2003
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D020547 2005
% 224.95/225.12  |- mesh__publicMeSHNote mesh__D020547 2000   
% 224.95/225.12  |- skos__prefLabel mesh__D020547 Lateral Ventricles
% 224.95/225.12  |- skos__historyNote mesh__D020547 Cerebral Ventricles %28%1965-1999%29%
% 224.95/225.12  |- skos__hiddenLabel mesh__D020547 Ventricle, Lateral
% 224.95/225.12  |- skos__annotation mesh__D020547
% 224.95/225.12       /radiogr: coord with CEREBRAL VENTRICULOGRAPHY   
% 224.95/225.12  |- skos__broader mesh__D020547smesh__D002552
% 224.95/225.12  |- mesh__historyNote mesh__D020547 2000   
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D020547 2002
% 224.95/225.12  |- mesh__dateCreated mesh__D020547 1999-11-03
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D020547 2001
% 224.95/225.12  |- rdf__type mesh__D020547sskos__Concept
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D020547 2004
% 224.95/225.12  |- skos__scopeNote mesh__D020547
% 224.95/225.12       Cavity in each of the cerebral hemispheres derived from the cavity of the embryonic neural tube. They are separated from each other by the SEPTUM PELLUCIDUM, and each communicates with the THIRD VENTRICLE by the foramen of Monro, through which also the choroid plexuses %28%CHOROID PLEXUS%29% of the lateral ventricles become continuous with that of the third ventricle.%A%    
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D020547 2000
% 224.95/225.12  |- skos__hiddenLabel mesh__D020547 Lateral Ventricle
% 224.95/225.12  |- mesh__dateEstablished mesh__D020547 2000-01-01
% 224.95/225.12  |- skos__related mesh__D006078smesh__D009313
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006078 2002
% 224.95/225.12  |- skos__broader mesh__D006078smesh__D012942
% 224.95/225.12  |- skos__hiddenLabel mesh__D006078 Program, Government Sponsored
% 224.95/225.12  |- mesh__publicMeSHNote mesh__D006078 98   
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006078 2005
% 224.95/225.12  |- skos__hiddenLabel mesh__D006078 Programs, Government Sponsored
% 224.95/225.12  |- mesh__recordAuthorizer mesh__D006078 sjn
% 224.95/225.12  |- skos__annotation mesh__D006078
% 224.95/225.12       GEN or unspecified; coord IM with endeavor sponsored %28%IM%29%; specify geog%A%  
% 224.95/225.12  |- mesh__historyNote mesh__D006078 98; use explode 1967-97   
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006078 2006
% 224.95/225.12  |- mesh__dateCreated mesh__D006078 1999-01-01
% 224.95/225.12  |- skos__hiddenLabel mesh__D006078 Government-Sponsored Program
% 224.95/225.12  |- skos__scopeNote mesh__D006078
% 224.95/225.12       Programs and activities sponsored or administered by local, state, or national governments.%A%    
% 224.95/225.12  |- mesh__recordOriginator mesh__D006078 NLM
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006078 2000
% 224.95/225.12  |- rdf__type mesh__D006078sskos__Concept
% 224.95/225.12  |- skos__historyNote mesh__D006078 Government %28%1967-1997%29%
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006078 2003
% 224.95/225.12  |- skos__prefLabel mesh__D006078 Government Programs
% 224.95/225.12  |- skos__hiddenLabel mesh__D006078 Government Program
% 224.95/225.12  |- skos__hiddenLabel mesh__D006078 Programs, Government-Sponsored
% 224.95/225.12  |- skos__hiddenLabel mesh__D006078 Programs, Government
% 224.95/225.12  |- mesh__dateEstablished mesh__D006078 1998-01-01
% 224.95/225.12  |- mesh__recordMaintainer mesh__D006078 kle
% 224.95/225.12  |- skos__hiddenLabel mesh__D006078 Program, Government-Sponsored
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006078 2004
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006078 2001
% 224.95/225.12  |- skos__altLabel mesh__D006078 Government-Sponsored Programs
% 224.95/225.12  |- skos__hiddenLabel mesh__D006078 Program, Government
% 224.95/225.12  |- skos__hiddenLabel mesh__D006078 Government Sponsored Program
% 224.95/225.12  |- mesh__dateRevised mesh__D006078 1999-11-03
% 224.95/225.12  |- skos__annotation mesh__D011212
% 224.95/225.12       a family of DNA viruses; infection = POXVIRIDAE INFECTIONS%A%  
% 224.95/225.12  |- mesh__dateCreated mesh__D011212 1999-01-01
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D011212 2006
% 224.95/225.12  |- skos__broader mesh__D011212smesh__D004267
% 224.95/225.12  |- skos__altLabel mesh__D011212 Poxviruses
% 224.95/225.12  |- mesh__recordAuthorizer mesh__D011212 sjn
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D011212 2005
% 224.95/225.12  |- mesh__publicMeSHNote mesh__D011212
% 224.95/225.12       81; was POXVIRUSES 1975-80, was POXVIRUS 1963-74   
% 224.95/225.12  |- skos__scopeNote mesh__D011212
% 224.95/225.12       A family of double-stranded DNA viruses infecting mammals %28%including humans%29%, birds and insects. There are two subfamilies: CHORDOPOXVIRINAE, poxviruses of vertebrates, and ENTOMOPOXVIRINAE, poxviruses of insects.%A%    
% 224.95/225.12  |- rdf__type mesh__D011212sskos__Concept
% 224.95/225.12  |- mesh__historyNote mesh__D011212
% 224.95/225.12       81; was POXVIRUSES 1975-80, was POXVIRUS 1963-74   
% 224.95/225.12  |- mesh__dateRevised mesh__D011212 2004-07-07
% 224.95/225.12  |- mesh__recordOriginator mesh__D011212 NLM
% 224.95/225.12  |- mesh__recordMaintainer mesh__D011212 ags
% 224.95/225.12  |- skos__prefLabel mesh__D011212 Poxviridae
% 224.95/225.12  |- mesh__onlineNote mesh__D011212
% 224.95/225.12       use POXVIRIDAE to search POXVIRUSES 1975-80 %26% POXVIRUS 1966-74%A%  
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D002486 2006
% 224.95/225.12  |- mesh__historyNote mesh__D002486
% 224.95/225.12       91%28%75%29%; was see under BENZOPYRANS 1975-90   
% 224.95/225.12  |- skos__broader mesh__D002486smesh__D002839
% 224.95/225.12  |- skos__historyNote mesh__D002486 Phenyl Ethers %28%1974%29%
% 224.95/225.12  |- mesh__recordMaintainer mesh__D002486 ssb
% 224.95/225.12  |- mesh__dateEstablished mesh__D002486 1991-01-01
% 224.95/225.12  |- skos__hiddenLabel mesh__D002486 Compound 6720
% 224.95/225.12  |- mesh__recordOriginator mesh__D002486 NLM
% 224.95/225.12  |- mesh__dateCreated mesh__D002486 1974-11-11
% 224.95/225.12  |- skos__hiddenLabel mesh__D002486 Compound 67 20
% 224.95/225.12  |- mesh__publicMeSHNote mesh__D002486
% 224.95/225.12       91; was see under BENZOPYRANS 1975-90   
% 224.95/225.12  |- skos__historyNote mesh__D002486 Pyrrolidines %28%1974%29%
% 224.95/225.12  |- mesh__dateRevised mesh__D002486 2005-06-30
% 224.95/225.12  |- skos__prefLabel mesh__D002486 Centchroman
% 224.95/225.12  |- rdf__type mesh__D002486sskos__Concept
% 224.95/225.12  |- skos__historyNote mesh__D002486 Benzopyrans %28%1974%29%
% 224.95/225.12  |- mesh__recordAuthorizer mesh__D002486 sjn
% 224.95/225.12  |- skos__scopeNote mesh__D002486
% 224.95/225.12       A non-steroidal anti-fertility agent with anti-hormonal properties.%A%    
% 224.95/225.12  |- skos__historyNote mesh__D010918 Piperidines %28%1972-1974%29%
% 224.95/225.12  |- mesh__historyNote mesh__D010918
% 224.95/225.12       91%28%75%29%; was see under THIOPHENES 1975-90   
% 224.95/225.12  |- mesh__recordMaintainer mesh__D010918 sjn
% 224.95/225.12  |- mesh__dateCreated mesh__D010918 1974-11-11
% 224.95/225.12  |- rdf__type mesh__D010918sskos__Concept
% 224.95/225.12  |- mesh__dateRevised mesh__D010918 2005-07-01
% 224.95/225.12  |- skos__hiddenLabel mesh__D010918 BC 105
% 224.95/225.12  |- skos__historyNote mesh__D010918 Benzocycloheptenes %28%1973-1974%29%
% 224.95/225.12  |- skos__historyNote mesh__D010918 Thiophenes %28%1970-1974%29%
% 224.95/225.12  |- mesh__dateEstablished mesh__D010918 1991-01-01
% 224.95/225.12  |- mesh__recordAuthorizer mesh__D010918 sjn
% 224.95/225.12  |- mesh__recordOriginator mesh__D010918 NLM
% 224.95/225.12  |- skos__hiddenLabel mesh__D010918 BC105
% 224.95/225.12  |- mesh__publicMeSHNote mesh__D010918
% 224.95/225.12       91; was see under THIOPHENES 1975-90   
% 224.95/225.12  |- skos__broader mesh__D010918smesh__D013876
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D010918 2006
% 224.95/225.12  |- skos__prefLabel mesh__D010918 Pizotyline
% 224.95/225.12  |- skos__altLabel mesh__D010918 Pizotifen
% 224.95/225.12  |- skos__scopeNote mesh__D010918
% 224.95/225.12       Serotonin antagonist used against MIGRAINE DISORDERS and vascular headaches.%A%    
% 224.95/225.12  |- mesh__recordOriginator mesh__D029623 ssb
% 224.95/225.12  |- mesh__dateRevised mesh__D029623 2003-07-09
% 224.95/225.12  |- skos__annotation mesh__D029623
% 224.95/225.12       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.95/225.12  |- skos__prefLabel mesh__D029623 Primulaceae
% 224.95/225.12  |- skos__scopeNote mesh__D029623
% 224.95/225.12       A plant family of the order Primulales, subclass Dilleniidae, class Magnoliopsida.  The flowers have both stamens and pistil, and the fruits are capsules.%A%    
% 224.95/225.12  |- mesh__recordAuthorizer mesh__D029623 sjn
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D029623 2004
% 224.95/225.12  |- mesh__dateEstablished mesh__D029623 2002-01-01
% 224.95/225.12  |- mesh__recordMaintainer mesh__D029623 ssb
% 224.95/225.12  |- rdf__type mesh__D029623sskos__Concept
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D029623 2006
% 224.95/225.12  |- mesh__historyNote mesh__D029623 2002   
% 224.95/225.12  |- mesh__publicMeSHNote mesh__D029623 2002   
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D029623 2005
% 224.95/225.12  |- skos__broader mesh__D029623smesh__D019684
% 224.95/225.12  |- mesh__dateCreated mesh__D029623 2001-07-25
% 224.95/225.12  |- skos__altLabel mesh__D029623 Loosestrife, Yellow
% 224.95/225.12  |- skos__prefLabel mesh__D048588 Benzoxazines
% 224.95/225.12  |- skos__annotation mesh__D048588
% 224.95/225.12       do not confuse with benzoxazolines %28%which contain a 5-membered ring%29% see BENZOXAZOLES%A%  
% 224.95/225.12  |- mesh__publicMeSHNote mesh__D048588 2005   
% 224.95/225.12  |- skos__historyNote mesh__D048588 Oxazines %28%1963-2004%29%
% 224.95/225.12  |- mesh__recordOriginator mesh__D048588 ssb
% 224.95/225.12  |- mesh__dateEstablished mesh__D048588 2005-01-01
% 224.95/225.12  |- skos__scopeNote mesh__D048588 OXAZINES with a fused BENZENE ring.     
% 224.95/225.12  |- mesh__recordAuthorizer mesh__D048588 sjn
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D048588 2005
% 224.95/225.12  |- skos__historyNote mesh__D048588 Benzoxazoles %28%1966-2004%29%
% 224.95/225.12  |- mesh__historyNote mesh__D048588 2005   
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D048588 2006
% 224.95/225.12  |- mesh__recordMaintainer mesh__D048588 ssb
% 224.95/225.12  |- skos__broader mesh__D048588smesh__D006574
% 224.95/225.12  |- rdf__type mesh__D048588sskos__Concept
% 224.95/225.12  |- mesh__dateCreated mesh__D048588 2004-07-07
% 224.95/225.12  |- skos__broader mesh__D048588smesh__D010078
% 224.95/225.12  |- skos__altLabel mesh__D007171 Therapy, Implosive
% 224.95/225.12  |- skos__altLabel mesh__D007171 Flooding
% 224.95/225.12  |- mesh__recordOriginator mesh__D007171 NLM
% 224.95/225.12  |- mesh__publicMeSHNote mesh__D007171
% 224.95/225.12       91; was see under BEHAVIOR THERAPY 1975-90   
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D007171 2002
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D007171 2006
% 224.95/225.12  |- mesh__dateEstablished mesh__D007171 1991-01-01
% 224.95/225.12  |- skos__hiddenLabel mesh__D007171 Implosive Therapies
% 224.95/225.12  |- skos__hiddenLabel mesh__D007171 Therapies, Implosive
% 224.95/225.12  |- mesh__recordMaintainer mesh__D007171 PLS
% 224.95/225.12  |- rdf__type mesh__D007171sskos__Concept
% 224.95/225.12  |- skos__scopeNote mesh__D007171
% 224.95/225.12       A method for extinguishing anxiety by a saturation exposure to the feared stimulus situation or its substitute.%A%    
% 224.95/225.12  |- skos__hiddenLabel mesh__D007171 Floodings
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D007171 1996
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D007171 2000
% 224.95/225.12  |- skos__prefLabel mesh__D007171 Implosive Therapy
% 224.95/225.12  |- mesh__recordAuthorizer mesh__D007171 PLS
% 224.95/225.12  |- mesh__historyNote mesh__D007171
% 224.95/225.12       91%28%75%29%; was see under BEHAVIOR THERAPY 1975-90   
% 224.95/225.12  |- skos__broader mesh__D007171smesh__D003887
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D007171 1998
% 224.95/225.12  |- mesh__dateRevised mesh__D007171 1995-05-31
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D007171 1997
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D007171 2001
% 224.95/225.12  |- mesh__dateCreated mesh__D007171 1974-11-11
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D007171 2003
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D007171 1999
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D007171 2005
% 224.95/225.12  |- skos__annotation mesh__D007171
% 224.95/225.12       a psychother technique, a form of psychol desensitization; DF: IMPLOSIVE THER%A%  
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D007171 2004
% 224.95/225.12  |- skos__broader mesh__D018738Q000031smesh__D018738
% 224.95/225.12  |- mesh__preferredCombination mesh__D018738Q000031smesh__D006584
% 224.95/225.12  |- rdf__type mesh__D018738Q000031smesh__CompoundConcept
% 224.95/225.12  |- rdf__type mesh__D015603sskos__Concept
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D015603 2003
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D015603 1995
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D015603 1996
% 224.95/225.12  |- mesh__historyNote mesh__D015603 90   
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D015603 1991
% 224.95/225.12  |- mesh__recordOriginator mesh__D015603 EGC
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D015603 2004
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D015603 1997
% 224.95/225.12  |- skos__hiddenLabel mesh__D015603 Keratinocyte
% 224.95/225.12  |- mesh__recordMaintainer mesh__D015603 PLS
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D015603 2000
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D015603 1992
% 224.95/225.12  |- mesh__dateRevised mesh__D015603 1990-05-26
% 224.95/225.12  |- mesh__publicMeSHNote mesh__D015603 90   
% 224.95/225.12  |- mesh__dateCreated mesh__D015603 1989-07-03
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D015603 2005
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D015603 1998
% 224.95/225.12  |- skos__broader mesh__D015603smesh__D004847
% 224.95/225.12  |- skos__historyNote mesh__D015603 Epidermis/cytology %28%1975-1989%29%
% 224.95/225.12  |- skos__scopeNote mesh__D015603
% 224.95/225.12       Epidermal cells which synthesize keratin and undergo characteristic changes as they move upward from the basal layers of the epidermis to the cornified %28%horny%29% layer of the skin. Successive stages of differentiation of the keratinocytes forming the epidermal layers are basal cell, spinous or prickle cell, and the granular cell.%A%    
% 224.95/225.12  |- mesh__recordAuthorizer mesh__D015603 NLM
% 224.95/225.12  |- skos__annotation mesh__D015603
% 224.95/225.12       epidermal cells synthesizing keratin; A 11 qualif   
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D015603 2001
% 224.95/225.12  |- mesh__dateEstablished mesh__D015603 1990-01-01
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D015603 1993
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D015603 2006
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D015603 1999
% 224.95/225.12  |- skos__historyNote mesh__D015603 Skin/cytology %28%1968-1989%29%
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D015603 2002
% 224.95/225.12  |- skos__prefLabel mesh__D015603 Keratinocytes
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D015603 1994
% 224.95/225.12  |- skos__historyNote mesh__D015603 Keratin %28%1968-1989%29%
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006877 1996
% 224.95/225.12  |- skos__broader mesh__D006877smesh__D006880
% 224.95/225.12  |- rdf__type mesh__D006877sskos__Concept
% 224.95/225.12  |- mesh__dateRevised mesh__D006877 1995-05-18
% 224.95/225.12  |- skos__broader mesh__D006877smesh__D006898
% 224.95/225.12  |- mesh__dateCreated mesh__D006877 1999-01-01
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006877 1998
% 224.95/225.12  |- mesh__publicMeSHNote mesh__D006877 75; was HYDROXAMIC ACID 1963-74   
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006877 2004
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006877 2002
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006877 2006
% 224.95/225.12  |- mesh__recordMaintainer mesh__D006877 KEV
% 224.95/225.12  |- mesh__activeMeSHYear mesh__D006877 2003
% 224.95/225.12  |- mesh__recordOriginator mesh__D006877 NLM
% 224.95/225.12  |- mesh__historyNote mesh__D006877 75; was HYDROXAMIC ACID 1963-74   
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D006877 2001
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D006877 2005
% 224.95/225.13  |- skos__prefLabel mesh__D006877 Hydroxamic Acids
% 224.95/225.13  |- skos__altLabel mesh__D006877 Hydroxamic Acid
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D006877 2000
% 224.95/225.13  |- mesh__onlineNote mesh__D006877
% 224.95/225.13       use HYDROXAMIC ACIDS to search HYDROXAMIC ACID 1966-74   
% 224.95/225.13  |- skos__hiddenLabel mesh__D006877 Acids, Hydroxamic
% 224.95/225.13  |- skos__scopeNote mesh__D006877
% 224.95/225.13       A class of weak acids with the general formula R-CONHOH.%A%    
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D006877 1997
% 224.95/225.13  |- skos__hiddenLabel mesh__D006877 Acid, Hydroxamic
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D006877 1999
% 224.95/225.13  |- mesh__recordAuthorizer mesh__D006877 PLS
% 224.95/225.13  |- skos__prefLabel mesh__D006079 Government Publications
% 224.95/225.13  |- skos__broader mesh__D006079smesh__D011642
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D006079 2006
% 224.95/225.13  |- skos__hiddenLabel mesh__D006079 Government Publication
% 224.95/225.13  |- mesh__dateCreated mesh__D006079 1999-01-01
% 224.95/225.13  |- skos__hiddenLabel mesh__D006079 Publication, Government
% 224.95/225.13  |- rdf__type mesh__D006079sskos__Concept
% 224.95/225.13  |- skos__hiddenLabel mesh__D006079 Publications, Government
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D006079 2003
% 224.95/225.13  |- mesh__recordAuthorizer mesh__D006079 sjn
% 224.95/225.13  |- mesh__recordMaintainer mesh__D006079 jls
% 224.95/225.13  |- mesh__dateRevised mesh__D006079 2002-07-31
% 224.95/225.13  |- skos__annotation mesh__D006079 no qualif   
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D006079 2004
% 224.95/225.13  |- mesh__recordOriginator mesh__D006079 NLM
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D006079 2005
% 224.95/225.13  |- mesh__recordAuthorizer mesh__D011213 PLS
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D011213 1999
% 224.95/225.13  |- mesh__publicMeSHNote mesh__D011213
% 224.95/225.13       94; was POXVIRUS INFECTIONS 1963-93; MILKER%27%S NODES was heading 1975-96 %28%see under POXVIRUS INFECTIONS 1975-90%29%%A%  
% 224.95/225.13  |- skos__altLabel mesh__D011213 Infections, Poxvirus
% 224.95/225.13  |- mesh__onlineNote mesh__D011213
% 224.95/225.13       use POXVIRIDAE INFECTIONS to search MILKER%27%S NODES 1975-96 %26% POXVIRUS INFECTIONS 1966-93%A%  
% 224.95/225.13  |- skos__hiddenLabel mesh__D011213 Milker Nodes
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D011213 2006
% 224.95/225.13  |- skos__hiddenLabel mesh__D011213 Infection, Poxviridae
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D011213 1998
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D011213 2002
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D011213 2005
% 224.95/225.13  |- rdf__type mesh__D011213sskos__Concept
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D011213 1997
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D011213 2001
% 224.95/225.13  |- skos__hiddenLabel mesh__D011213 Infection, Poxvirus
% 224.95/225.13  |- skos__hiddenLabel mesh__D011213 Poxvirus Infection
% 224.95/225.13  |- skos__hiddenLabel mesh__D011213 Node, Milker%27%s
% 224.95/225.13  |- skos__hiddenLabel mesh__D011213 Nodes, Milker%27%s
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D011213 2004
% 224.95/225.13  |- skos__scopeNote mesh__D011213
% 224.95/225.13       Virus diseases caused by the POXVIRIDAE.     
% 224.95/225.13  |- mesh__recordOriginator mesh__D011213 NLM
% 224.95/225.13  |- skos__altLabel mesh__D011213 Infections, Poxviridae
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D011213 2000
% 224.95/225.13  |- skos__hiddenLabel mesh__D011213 Milkers Nodes
% 224.95/225.13  |- mesh__dateRevised mesh__D011213 1996-06-10
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D011213 2003
% 224.95/225.13  |- mesh__recordMaintainer mesh__D011213 PXP
% 224.95/225.13  |- skos__broader mesh__D011213smesh__D004266
% 224.95/225.13  |- skos__hiddenLabel mesh__D011213 Poxviridae Infection
% 224.95/225.13  |- skos__hiddenLabel mesh__D011213 Milker%27%s Node
% 224.95/225.13  |- mesh__historyNote mesh__D011213
% 224.95/225.13       94; was POXVIRUS INFECTIONS 1963-93; MILKER%27%S NODES was heading 1975-96 %28%see under POXVIRUS INFECTIONS 1975-90%29%%A%  
% 224.95/225.13  |- skos__prefLabel mesh__D011213 Poxviridae Infections
% 224.95/225.13  |- skos__annotation mesh__D011213 GEN or unspecified; prefer specifics   
% 224.95/225.13  |- mesh__dateCreated mesh__D011213 1999-01-01
% 224.95/225.13  |- skos__altLabel mesh__D011213 Poxvirus Infections
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D035661 2005
% 224.95/225.13  |- skos__hiddenLabel mesh__D035661 Animal Care Committee
% 224.95/225.13  |- rdf__type mesh__D035661sskos__Concept
% 224.95/225.13  |- skos__hiddenLabel mesh__D035661 Committee, Animal Care
% 224.95/225.13  |- mesh__historyNote mesh__D035661 2003   
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D035661 2006
% 224.95/225.13  |- skos__hiddenLabel mesh__D035661 IACUCs
% 224.95/225.13  |- skos__hiddenLabel mesh__D035661 Ethics Committees, Animal
% 224.95/225.13  |- skos__broader mesh__D035661smesh__D000827
% 224.95/225.13  |- skos__hiddenLabel mesh__D035661 Committee, Animal Ethics
% 224.95/225.13  |- mesh__dateEstablished mesh__D035661 2003-01-01
% 224.95/225.13  |- mesh__publicMeSHNote mesh__D035661 2003   
% 224.95/225.13  |- skos__related mesh__D035661smesh__D017041
% 224.95/225.13  |- skos__hiddenLabel mesh__D035661 Committees, Animal Ethics
% 224.95/225.13  |- mesh__dateCreated mesh__D035661 2002-07-02
% 224.95/225.13  |- skos__scopeNote mesh__D035661
% 224.95/225.13       Institutional committees established to protect the welfare of animals used in research and education.  The 1971 NIH Guide for the Care and Use of Laboratory Animals introduced the policy that institutions using warm-blooded animals in projects supported by NIH grants either be accredited by a recognized professional laboratory animal accrediting body or establish its own committee to evaluate animal care; the Public Health Service adopted a policy in 1979 requiring such committees; and the 1985 amendments to the Animal Welfare Act mandate review and approval of federally funded research with animals by a formally designated Institutional Animal Care and Use Committee %28%IACUC%29%.%A%    
% 224.95/225.13  |- skos__altLabel mesh__D035661 IACUC
% 224.95/225.13  |- skos__historyNote mesh__D035661 Animal Welfare %28%1986-2002%29%
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D035661 2003
% 224.95/225.13  |- skos__prefLabel mesh__D035661 Animal Care Committees
% 224.95/225.13  |- skos__hiddenLabel mesh__D035661 Ethics Committee, Animal
% 224.95/225.13  |- skos__hiddenLabel mesh__D035661 Animal Ethics Committee
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D035661 2004
% 224.95/225.13  |- skos__hiddenLabel mesh__D035661 Committees, Animal Care
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D029624 2004
% 224.95/225.13  |- rdf__type mesh__D029624sskos__Concept
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D029624 2006
% 224.95/225.13  |- mesh__publicMeSHNote mesh__D029624 2002   
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D029624 2003
% 224.95/225.13  |- mesh__dateEstablished mesh__D029624 2002-01-01
% 224.95/225.13  |- mesh__dateCreated mesh__D029624 2001-07-25
% 224.95/225.13  |- mesh__activeMeSHYear mesh__D029624 2005
% 224.95/225.13  |- skos__scopeNote mesh__D029624
% 224.95/225.13       Seedless nonflowering plants of the class Filicinae.  They reproduce by spores that appear as dots on the underside of feathery fronds.  In earlier classifications the Pteridophyta included the club mosses, horsetails, ferns, and various fossil groups. In more recent classifications, pteridophytes and spermatophytes %28%seed-bearing plants%29% are in the division, or phylum, Tracheophyta.%A%    
% 224.95/225.13  |- skos__prefLabel mesh__D029624 Ferns
% 224.95/225.13  |- skos__annotation mesh__D029624
% 224.95/225.13       prefer specific plant;  coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.95/225.13  |- mesh__recordAuthorizer mesh__D029624 sjn
% 224.95/225.13  |- mesh__dateRevised mesh__D029624 2002-07-02
% 224.99/225.13  |- mesh__recordOriginator mesh__D029624 ssb
% 224.99/225.13  |- mesh__recordMaintainer mesh__D029624 ssb
% 224.99/225.13  |- skos__broader mesh__D029624smesh__D019669
% 224.99/225.13  |- mesh__historyNote mesh__D029624 2002   
% 224.99/225.13  |- mesh__recordAuthorizer mesh__D002487 sjn
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D002487 2000A
% 224.99/225.13  |- skos__annotation mesh__D002487
% 224.99/225.13       add UNITED STATES %28%NIM%29%; research support by this agency is checked as NIH/PHS SUP; DF: CDC or CDCP      CATALOG: use NAF entry%A%  
% 224.99/225.13  |- mesh__dateCreated mesh__D002487 1977-05-12
% 224.99/225.13  |- mesh__publicMeSHNote mesh__D002487
% 224.99/225.13       94; was CENTERS FOR DISEASE CONTROL %28%U.S.%29% 1983-93, was CENTER FOR DISEASE CONTROL 1982, was UNITED STATES CENTER FOR DISEASE CONTROL 1978-81; UNITED STATES CENTERS FOR DISEASE CONTROL was see CENTERS FOR DISEASE CONTROL %28%U.S.%29% 1983-93%A%  
% 224.99/225.13  |- skos__altLabel mesh__D002487 Center for Disease Control and Prevention
% 224.99/225.13  |- skos__scopeNote mesh__D002487
% 224.99/225.13       An agency of the UNITED STATES PUBLIC HEALTH SERVICE that conducts and supports programs for the prevention and control of disease and provides consultation and assistance to health departments and other countries.%A%    
% 224.99/225.13  |- mesh__recordMaintainer mesh__D002487 sjn
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D002487 2002
% 224.99/225.13  |- skos__altLabel mesh__D002487 Centers for Disease Control and Prevention
% 224.99/225.13  |- skos__altLabel mesh__D002487
% 224.99/225.13       United States Centers for Disease Control and Prevention
% 224.99/225.13  |- skos__altLabel mesh__D002487 CDC
% 224.99/225.13  |- skos__broader mesh__D002487smesh__D014492
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D002487 1998
% 224.99/225.13  |- skos__altLabel mesh__D002487 Center for Disease Control
% 224.99/225.13  |- skos__prefLabel mesh__D002487
% 224.99/225.13       Centers for Disease Control and Prevention %28%U.S.%29%
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D002487 1999
% 224.99/225.13  |- rdf__type mesh__D002487sskos__Concept
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D002487 2003
% 224.99/225.13  |- skos__altLabel mesh__D002487 Centers for Disease Control
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D002487 2000
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D002487 2005
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D002487 2004
% 224.99/225.13  |- mesh__dateEstablished mesh__D002487 1978-01-01
% 224.99/225.13  |- mesh__historyNote mesh__D002487
% 224.99/225.13       94; was CENTERS FOR DISEASE CONTROL %28%U.S.%29% 1983-93, was CENTER FOR DISEASE CONTROL 1982, was UNITED STATES CENTER FOR DISEASE CONTROL 1978-81; UNITED STATES CENTERS FOR DISEASE CONTROL was see CENTERS FOR DISEASE CONTROL %28%U.S.%29% 1983-93%A%  
% 224.99/225.13  |- mesh__dateRevised mesh__D002487 2000-04-12
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D002487 2001
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D002487 2006
% 224.99/225.13  |- mesh__recordOriginator mesh__D002487 EC
% 224.99/225.13  |- mesh__onlineNote mesh__D002487
% 224.99/225.13       use CENTERS FOR DISEASE CONTROL AND PREVENTION %28%U.S.%29% to search CENTERS FOR DISEASE CONTROL %28%U.S.%29% %26% UNITED STATES CENTERS FOR DISEASE CONTROL 1983-93, CENTER FOR DISEASE CONTROL 1982 %26% UNITED STATES CENTER FOR DISEASE CONTROL 1978-81%A%  
% 224.99/225.13  |- skos__altLabel mesh__D002487 United States Centers for Disease Control
% 224.99/225.13  |- skos__altLabel mesh__D002487 Centers for Disease Control %28%U.S.%29%
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D010919 2006
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D010919 2005
% 224.99/225.13  |- mesh__dateRevised mesh__D010919 2003-07-09
% 224.99/225.13  |- skos__altLabel mesh__D010919 Sham Treatment
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D010919 2004
% 224.99/225.13  |- skos__scopeNote mesh__D010919
% 224.99/225.13       Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol.%A%    
% 224.99/225.13  |- rdf__type mesh__D010919sskos__Concept
% 224.99/225.13  |- skos__broader mesh__D010919smesh__D004364
% 224.99/225.13  |- mesh__dateCreated mesh__D010919 1999-01-01
% 224.99/225.13  |- skos__prefLabel mesh__D010919 Placebos
% 224.99/225.13  |- skos__broader mesh__D010919smesh__D013812
% 224.99/225.13  |- skos__annotation mesh__D010919
% 224.99/225.13       usually NIM; do not index routinely for articles on CLINICAL TRIALS; DOUBLE-BLIND METHOD; etc., unless particularly discussed; Manual 18.12.13%A%  
% 224.99/225.13  |- mesh__recordMaintainer mesh__D010919 ssb
% 224.99/225.13  |- mesh__recordAuthorizer mesh__D010919 sjn
% 224.99/225.13  |- mesh__recordOriginator mesh__D010919 NLM
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007970 2004
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007970 1995
% 224.99/225.13  |- mesh__dateCreated mesh__D007970 1999-01-01
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007970 1993
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007970 2005
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007970 2002
% 224.99/225.13  |- skos__broader mesh__D007970smesh__D007960
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007970 2003
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007970 1994
% 224.99/225.13  |- rdf__type mesh__D007970sskos__Concept
% 224.99/225.13  |- skos__hiddenLabel mesh__D007970 Leukopenias
% 224.99/225.13  |- skos__annotation mesh__D007970 decrease in no. of leukocytes   
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007970 1999
% 224.99/225.13  |- mesh__recordOriginator mesh__D007970 NLM
% 224.99/225.13  |- skos__prefLabel mesh__D007970 Leukopenia
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007970 1997
% 224.99/225.13  |- mesh__recordAuthorizer mesh__D007970 PLS
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007970 2001
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007970 1998
% 224.99/225.13  |- mesh__recordMaintainer mesh__D007970 TGC
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007970 1996
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007970 2000
% 224.99/225.13  |- skos__altLabel mesh__D007970 Leukocytopenia
% 224.99/225.13  |- mesh__dateRevised mesh__D007970 1992-03-25
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007970 2006
% 224.99/225.13  |- skos__hiddenLabel mesh__D007970 Leukocytopenias
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D021641 2001
% 224.99/225.13  |- mesh__publicMeSHNote mesh__D021641 2001; see MEMORY 1998-2000   
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D021641 2004
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D021641 2005
% 224.99/225.13  |- skos__broader mesh__D021641smesh__D008568
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D021641 2003
% 224.99/225.13  |- mesh__recordOriginator mesh__D021641 jls
% 224.99/225.13  |- skos__scopeNote mesh__D021641
% 224.99/225.13       The knowledge or perception that someone or something present has been previously encountered.%A%    
% 224.99/225.13  |- skos__prefLabel mesh__D021641 Recognition %28%Psychology%29%
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D021641 2002
% 224.99/225.13  |- mesh__recordMaintainer mesh__D021641 jls
% 224.99/225.13  |- mesh__recordAuthorizer mesh__D021641 sjn
% 224.99/225.13  |- mesh__dateEstablished mesh__D021641 2001-01-01
% 224.99/225.13  |- rdf__type mesh__D021641sskos__Concept
% 224.99/225.13  |- mesh__historyNote mesh__D021641 2001; use MEMORY 1998-2000   
% 224.99/225.13  |- mesh__dateCreated mesh__D021641 2000-06-22
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D021641 2006
% 224.99/225.13  |- mesh__recordAuthorizer mesh__D007172 SJN
% 224.99/225.13  |- skos__hiddenLabel mesh__D007172 Erectile Dysfunctions
% 224.99/225.13  |- rdf__type mesh__D007172sskos__Concept
% 224.99/225.13  |- mesh__dateCreated mesh__D007172 1999-01-01
% 224.99/225.13  |- mesh__recordOriginator mesh__D007172 NLM
% 224.99/225.13  |- skos__broader mesh__D007172smesh__D020018
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007172 2002
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007172 1998
% 224.99/225.13  |- skos__hiddenLabel mesh__D007172 Dysfunction, Erectile
% 224.99/225.13  |- mesh__dateRevised mesh__D007172 1997-06-20
% 224.99/225.13  |- skos__scopeNote mesh__D007172
% 224.99/225.13       The inability to perform sexual intercourse.     
% 224.99/225.13  |- mesh__recordMaintainer mesh__D007172 JLS
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007172 2003
% 224.99/225.13  |- skos__prefLabel mesh__D007172 Impotence
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007172 1999
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007172 2000
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007172 2005
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007172 2004
% 224.99/225.13  |- skos__hiddenLabel mesh__D007172 Dysfunctions, Erectile
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007172 2001
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D007172 2006
% 224.99/225.13  |- skos__broader mesh__D007172smesh__D012735
% 224.99/225.13  |- mesh__recordOriginator mesh__D048589 ags
% 224.99/225.13  |- skos__annotation mesh__D048589 CATALOG: use NAF entry   
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D048589 2005
% 224.99/225.13  |- skos__historyNote mesh__D048589
% 224.99/225.13       Anatomy, Cross-Sectional %28%1991-2004%29%
% 224.99/225.13  |- skos__broader mesh__D048589smesh__D008953
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D048589 2006
% 224.99/225.13  |- mesh__publicMeSHNote mesh__D048589
% 224.99/225.13       2005; see ANATOMY, CROSS-SECTIONAL 1997-2004   
% 224.99/225.13  |- skos__related mesh__D048589smesh__D021621
% 224.99/225.13  |- skos__prefLabel mesh__D048589 Visible Human Project
% 224.99/225.13  |- mesh__recordAuthorizer mesh__D048589 jls
% 224.99/225.13  |- skos__hiddenLabel mesh__D048589 Project, Visible Human
% 224.99/225.13  |- mesh__historyNote mesh__D048589
% 224.99/225.13       2005; use ANATOMY, CROSS-SECTIONAL 1997-2004   
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D048589 2005A
% 224.99/225.13  |- mesh__dateRevised mesh__D048589 2004-11-19
% 224.99/225.13  |- rdf__type mesh__D048589sskos__Concept
% 224.99/225.13  |- mesh__dateCreated mesh__D048589 2004-07-07
% 224.99/225.13  |- mesh__dateEstablished mesh__D048589 2005-01-01
% 224.99/225.13  |- skos__broader mesh__D048589smesh__D019412
% 224.99/225.13  |- skos__scopeNote mesh__D048589
% 224.99/225.13       Digital image data sets, created by the NATIONAL LIBRARY OF MEDICINE, consisting of complete, anatomically detailed, three-dimensional representations of the normal male and female human bodies. The images were generated from carefully selected and prepared CADAVERS in three modes: computerized tomography %28%TOMOGRAPHY, X-RAY COMPUTED%29%, magnetic resonance %28%MAGNETIC RESONANCE IMAGING%29% and cryosection %28%CRYOSECTIONING%29%.%A%    
% 224.99/225.13  |- skos__broader mesh__D048589smesh__D016208
% 224.99/225.13  |- mesh__recordMaintainer mesh__D048589 jls
% 224.99/225.13  |- mesh__recordAuthorizer mesh__D006878 PLS
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D006878 2003
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D006878 1995
% 224.99/225.13  |- rdf__type mesh__D006878sskos__Concept
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D006878 2005
% 224.99/225.13  |- skos__annotation mesh__D006878 GEN or unspecified; prefer specifics   
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D006878 2004
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D006878 2002
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D006878 2006
% 224.99/225.13  |- skos__broader mesh__D006878smesh__D000838
% 224.99/225.13  |- skos__broader mesh__D006878smesh__D007287
% 224.99/225.13  |- skos__broader mesh__D006878smesh__D000468
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D006878 1996
% 224.99/225.13  |- skos__prefLabel mesh__D006878 Hydroxides
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D006878 2000
% 224.99/225.13  |- skos__scopeNote mesh__D006878
% 224.99/225.13       Inorganic compounds that contain the OH- group.     
% 224.99/225.13  |- mesh__dateCreated mesh__D006878 1999-01-01
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D006878 1998
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D006878 1997
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D006878 2001
% 224.99/225.13  |- mesh__recordOriginator mesh__D006878 NLM
% 224.99/225.13  |- mesh__recordMaintainer mesh__D006878 TPW
% 224.99/225.13  |- mesh__dateRevised mesh__D006878 1993-06-02
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D006878 1994
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D006878 1999
% 224.99/225.13  |- skos__broader mesh__D020549smesh__D020536
% 224.99/225.13  |- mesh__historyNote mesh__D020549 2000   
% 224.99/225.13  |- mesh__dateRevised mesh__D020549 2003-07-09
% 224.99/225.13  |- skos__hiddenLabel mesh__D020549 Activators, Small GTPase
% 224.99/225.13  |- skos__historyNote mesh__D020549
% 224.99/225.13       GTP Phosphohydrolase/metabolism %28%1976-1999%29%
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D020549 2004
% 224.99/225.13  |- rdf__type mesh__D020549sskos__Concept
% 224.99/225.13  |- mesh__dateCreated mesh__D020549 1999-11-08
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D020549 2006
% 224.99/225.13  |- mesh__dateEstablished mesh__D020549 2000-01-01
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D020549 2005
% 224.99/225.13  |- skos__prefLabel mesh__D020549 GTP Phosphohydrolase Activators
% 224.99/225.13  |- skos__hiddenLabel mesh__D020549 Activators, GTPase
% 224.99/225.13  |- skos__scopeNote mesh__D020549
% 224.99/225.13       Agents and factors that activate GTP phosphohydrolase activity.%A%    
% 224.99/225.13  |- mesh__publicMeSHNote mesh__D020549 2000   
% 224.99/225.13  |- skos__altLabel mesh__D020549 GTPase Activators
% 224.99/225.13  |- skos__hiddenLabel mesh__D020549 Activators, GTP Phosphohydrolase
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D003580 2005
% 224.99/225.13  |- skos__broader mesh__D003580smesh__D006420
% 224.99/225.13  |- skos__broader mesh__D003580smesh__D045762
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D003580 2006
% 224.99/225.13  |- skos__prefLabel mesh__D003580 Cytochromes
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D003580 2004
% 224.99/225.13  |- mesh__dateCreated mesh__D003580 1999-01-01
% 224.99/225.13  |- skos__altLabel mesh__D003580 Cytochrome
% 224.99/225.13  |- mesh__recordAuthorizer mesh__D003580 sjn
% 224.99/225.13  |- skos__scopeNote mesh__D003580
% 224.99/225.13       Hemeproteins whose characteristic mode of action involves transfer of reducing equivalents which are associated with a reversible change in oxidation state of the prosthetic group. Formally, this redox change involves a single-electron, reversible equilibrium between the Fe%28%II%29% and Fe%28%III%29% states of the central iron atom %28%From Enzyme Nomenclature, 1992, p539%29%. The various cytochrome subclasses are organized by the type of HEME and by the wavelength range of their reduced alpha-absorption bands.%A%    
% 224.99/225.13  |- mesh__dateRevised mesh__D003580 2003-07-09
% 224.99/225.13  |- rdf__type mesh__D003580sskos__Concept
% 224.99/225.13  |- skos__annotation mesh__D003580
% 224.99/225.13       GEN or unspecified; prefer specific cytochrome   
% 224.99/225.13  |- mesh__recordOriginator mesh__D003580 NLM
% 224.99/225.13  |- mesh__recordMaintainer mesh__D003580 jmp
% 224.99/225.13  |- rdf__type mesh__D011214sskos__Concept
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D011214 1992
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D011214 1997
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D011214 2004
% 224.99/225.13  |- mesh__historyNote mesh__D011214 66%28%64%29%   
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D011214 1996
% 224.99/225.13  |- skos__annotation mesh__D011214
% 224.99/225.13       human %26% animal; no qualif; DF: PRACTICE PSYCHOL   
% 224.99/225.13  |- skos__scopeNote mesh__D011214
% 224.99/225.13       Performance of an act one or more times, with a view to its fixation or improvement; any performance of an act or behavior that leads to learning.%A%    
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D011214 2003
% 224.99/225.13  |- skos__prefLabel mesh__D011214 Practice %28%Psychology%29%
% 224.99/225.13  |- mesh__dateEstablished mesh__D011214 1966-01-01
% 224.99/225.13  |- mesh__dateRevised mesh__D011214 1989-05-16
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D011214 1991
% 224.99/225.13  |- mesh__recordAuthorizer mesh__D011214 PLS
% 224.99/225.13  |- skos__broader mesh__D011214smesh__D007858
% 224.99/225.13  |- mesh__dateCreated mesh__D011214 1999-01-01
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D011214 1990
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D011214 1995
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D011214 2002
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D011214 1999
% 224.99/225.13  |- mesh__recordMaintainer mesh__D011214 TGC
% 224.99/225.13  |- mesh__publicMeSHNote mesh__D011214 66   
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D011214 1994
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D011214 2006
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D011214 2001
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D011214 1993
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D011214 1998
% 224.99/225.13  |- mesh__recordOriginator mesh__D011214 NLM
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D011214 2005
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D011214 2000
% 224.99/225.13  |- skos__hiddenLabel mesh__D011214 Practices %28%Psychology%29%
% 224.99/225.13  |- mesh__recordMaintainer mesh__D002488 AGS
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D002488 2000
% 224.99/225.13  |- skos__annotation mesh__D002488
% 224.99/225.13       a country in central Africa, formerly Ubangi-Shari   
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D002488 1999
% 224.99/225.13  |- rdf__type mesh__D002488sskos__Concept
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D002488 2003
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D002488 2001
% 224.99/225.13  |- skos__altLabel mesh__D002488 Ubangi-Shari
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D002488 2005
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D002488 2004
% 224.99/225.13  |- mesh__activeMeSHYear mesh__D002488 2006
% 224.99/225.13  |- skos__prefLabel mesh__D002488 Central African Republic
% 224.99/225.14  |- mesh__dateCreated mesh__D002488 1999-01-01
% 224.99/225.14  |- skos__broader mesh__D002488smesh__D000350
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D002488 2002
% 224.99/225.14  |- mesh__recordAuthorizer mesh__D002488 SJN
% 224.99/225.14  |- mesh__dateRevised mesh__D002488 1997-06-20
% 224.99/225.14  |- skos__scopeNote mesh__D002488
% 224.99/225.14       A republic in central Africa lying south of CHAD, west of SUDAN, north of DEMOCRATIC REPUBLIC OF THE CONGO, and east of CAMEROON. In 1906 it united with Chad to form the French colony of Ubangi-Shari-Chad and, through various changes in status, achieved independence in 1960. The earlier name Ubangi-Shari comes from the Bantu u %28%land or country%29% + bangi %28%rapid%29%, with reference to the current of the river and territory through which it flows, and Shari or Chari, a native word for river. %28%From Webster%27%s New Geographical Dictionary, 1988, p233 %26% Room, Brewer%27%s Dictionary of Names, 1992, p370, 562%29%%A%    
% 224.99/225.14  |- mesh__recordOriginator mesh__D002488 NLM
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D002488 1998
% 224.99/225.14  |- skos__hiddenLabel mesh__D007971 Leukoplakias
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007971 2004
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007971 2002
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007971 1998
% 224.99/225.14  |- skos__broader mesh__D007971smesh__D011230
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007971 1996
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007971 1999
% 224.99/225.14  |- rdf__type mesh__D007971sskos__Concept
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007971 1997
% 224.99/225.14  |- mesh__recordMaintainer mesh__D007971 KEV
% 224.99/225.14  |- skos__annotation mesh__D007971
% 224.99/225.14       a precancerous condition; coord IM with organ /neoplasms term %28%IM%29%%A%  
% 224.99/225.14  |- skos__scopeNote mesh__D007971
% 224.99/225.14       A white patch on a mucous membrane that will not rub off. %28%Dorland, 27th ed%29%%A%    
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007971 2005
% 224.99/225.14  |- mesh__recordAuthorizer mesh__D007971 PLS
% 224.99/225.14  |- mesh__dateCreated mesh__D007971 1999-01-01
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007971 2000
% 224.99/225.14  |- mesh__recordOriginator mesh__D007971 NLM
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007971 2003
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007971 2006
% 224.99/225.14  |- mesh__dateRevised mesh__D007971 1995-06-08
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007971 2001
% 224.99/225.14  |- skos__prefLabel mesh__D007971 Leukoplakia
% 224.99/225.14  |- mesh__publicMeSHNote mesh__D029625 2002   
% 224.99/225.14  |- mesh__recordMaintainer mesh__D029625 ssb
% 224.99/225.14  |- mesh__dateEstablished mesh__D029625 2002-01-01
% 224.99/225.14  |- mesh__historyNote mesh__D029625 2002   
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D029625 2005
% 224.99/225.14  |- skos__prefLabel mesh__D029625 Pteridaceae
% 224.99/225.14  |- mesh__dateCreated mesh__D029625 2001-07-25
% 224.99/225.14  |- mesh__dateRevised mesh__D029625 2003-07-09
% 224.99/225.14  |- skos__scopeNote mesh__D029625
% 224.99/225.14       A plant family of the order Polypodiales, class Filicopsida, division Pteridophyta %28%FERNS%29%.%A%    
% 224.99/225.14  |- mesh__recordOriginator mesh__D029625 ssb
% 224.99/225.14  |- skos__annotation mesh__D029625
% 224.99/225.14       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D029625 2004
% 224.99/225.14  |- skos__broader mesh__D029625smesh__D029624
% 224.99/225.14  |- rdf__type mesh__D029625sskos__Concept
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D029625 2006
% 224.99/225.14  |- mesh__recordAuthorizer mesh__D029625 sjn
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007173 2000
% 224.99/225.14  |- skos__hiddenLabel mesh__D007173 Imprintings %28%Psychology%29%
% 224.99/225.14  |- skos__scopeNote mesh__D007173
% 224.99/225.14       A particular kind of learning characterized by occurrence in very early life, rapidity of acquisition, and relative insusceptibility to forgetting or extinction. Imprinted behavior includes most %28%or all%29% behavior commonly called instinctive, but imprinting is used purely descriptively.%A%    
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007173 2003
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007173 1999
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007173 2001
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007173 2005
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007173 2004
% 224.99/225.14  |- mesh__historyNote mesh__D007173 65%28%64%29%   
% 224.99/225.14  |- skos__prefLabel mesh__D007173 Imprinting %28%Psychology%29%
% 224.99/225.14  |- mesh__publicMeSHNote mesh__D007173 65   
% 224.99/225.14  |- mesh__recordAuthorizer mesh__D007173 SJN
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007173 2006
% 224.99/225.14  |- mesh__recordOriginator mesh__D007173 NLM
% 224.99/225.14  |- mesh__recordMaintainer mesh__D007173 JLS
% 224.99/225.14  |- mesh__dateRevised mesh__D007173 1998-06-10
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007173 2002
% 224.99/225.14  |- rdf__type mesh__D007173sskos__Concept
% 224.99/225.14  |- mesh__dateCreated mesh__D007173 1999-01-01
% 224.99/225.14  |- skos__broader mesh__D007173smesh__D007858
% 224.99/225.14  |- mesh__dateEstablished mesh__D007173 1965-01-01
% 224.99/225.14  |- skos__annotation mesh__D007173 human %26% animal   
% 224.99/225.14  |- mesh__dateCreated mesh__D015605 1989-04-07
% 224.99/225.14  |- skos__prefLabel mesh__D015605 Cowpox
% 224.99/225.14  |- rdf__type mesh__D015605sskos__Concept
% 224.99/225.14  |- skos__annotation mesh__D015605
% 224.99/225.14       caused by a poxvirus; in man or animal; in animal use /vet and check tag ANIMALS%A%  
% 224.99/225.14  |- skos__hiddenLabel mesh__D015605 Pox, Cow
% 224.99/225.14  |- skos__scopeNote mesh__D015605
% 224.99/225.14       A mild, eruptive skin disease of milk cows caused by COWPOX VIRUS, with lesions occurring principally on the udder and teats. Human infection may occur while milking an infected animal.%A%    
% 224.99/225.14  |- skos__historyNote mesh__D015605 Vaccinia %28%1966-1989%29%
% 224.99/225.14  |- mesh__historyNote mesh__D015605
% 224.99/225.14       91%28%90%29%; was see under POXVIRUS INFECTIONS 1990; was see VACCINIA 1974-89%A%  
% 224.99/225.14  |- mesh__recordMaintainer mesh__D015605 sjn
% 224.99/225.14  |- mesh__dateRevised mesh__D015605 2004-07-13
% 224.99/225.14  |- mesh__dateEstablished mesh__D015605 1991-01-01
% 224.99/225.14  |- mesh__publicMeSHNote mesh__D015605
% 224.99/225.14       91; was see under POXVIRUS INFECTIONS 1990; was see VACCINIA 1974-89%A%  
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D015605 2006
% 224.99/225.14  |- mesh__recordOriginator mesh__D015605 PXP
% 224.99/225.14  |- skos__altLabel mesh__D015605 Cow Pox
% 224.99/225.14  |- mesh__onlineNote mesh__D015605 search VACCINIA 1974-89   
% 224.99/225.14  |- mesh__recordAuthorizer mesh__D015605 sjn
% 224.99/225.14  |- skos__broader mesh__D015605smesh__D011213
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D015605 2005
% 224.99/225.14  |- rdf__type mesh__D006879sskos__Concept
% 224.99/225.14  |- skos__prefLabel mesh__D006879 Hydroxocobalamin
% 224.99/225.14  |- skos__altLabel mesh__D006879 Hydroxycobalamin
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D006879 2006
% 224.99/225.14  |- skos__scopeNote mesh__D006879
% 224.99/225.14       Injectable form of VITAMIN B 12 that has been used therapeutically to treat VITAMIN B 12 DEFICIENCY.%A%    
% 224.99/225.14  |- mesh__dateRevised mesh__D006879 2005-06-30
% 224.99/225.14  |- mesh__recordAuthorizer mesh__D006879 sjn
% 224.99/225.14  |- skos__broader mesh__D006879smesh__D014805
% 224.99/225.14  |- skos__altLabel mesh__D006879 Hydroxo-Cobalamin
% 224.99/225.14  |- mesh__dateCreated mesh__D006879 1999-01-01
% 224.99/225.14  |- mesh__recordOriginator mesh__D006879 NLM
% 224.99/225.14  |- mesh__recordMaintainer mesh__D006879 ssb
% 224.99/225.14  |- mesh__recordAuthorizer mesh__D003581 SJN
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D003581 2001
% 224.99/225.14  |- skos__annotation mesh__D003581 GEN; NIM; DF: CYTODIAG   
% 224.99/225.14  |- mesh__recordOriginator mesh__D003581 NLM
% 224.99/225.14  |- rdf__type mesh__D003581sskos__Concept
% 224.99/225.14  |- mesh__dateRevised mesh__D003581 1997-06-20
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D003581 2002
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D003581 1998
% 224.99/225.14  |- skos__prefLabel mesh__D003581 Cytodiagnosis
% 224.99/225.14  |- mesh__recordMaintainer mesh__D003581 PXP
% 224.99/225.14  |- skos__scopeNote mesh__D003581
% 224.99/225.14       Diagnosis of the type and, when feasible, the cause of a pathologic process by means of microscopic study of cells in an exudate or other form of body fluid. %28%Stedman, 26th ed%29%%A%    
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D003581 1999
% 224.99/225.14  |- skos__broader mesh__D003581smesh__D003942
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D003581 2005
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D003581 2003
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D003581 2006
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D003581 2000
% 224.99/225.14  |- skos__altLabel mesh__D003581 Cytodiagnoses
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D003581 2004
% 224.99/225.14  |- mesh__dateCreated mesh__D003581 1999-01-01
% 224.99/225.14  |- skos__altLabel mesh__D011215 Dental Practice Management
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D011215 2001
% 224.99/225.14  |- mesh__recordMaintainer mesh__D011215 JLS
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D011215 2003
% 224.99/225.14  |- mesh__historyNote mesh__D011215 68   
% 224.99/225.14  |- mesh__recordOriginator mesh__D011215 NLM
% 224.99/225.14  |- skos__prefLabel mesh__D011215 Practice Management, Dental
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D011215 2000
% 224.99/225.14  |- mesh__dateRevised mesh__D011215 1998-06-10
% 224.99/225.14  |- mesh__dateEstablished mesh__D011215 1968-01-01
% 224.99/225.14  |- mesh__dateCreated mesh__D011215 1999-01-01
% 224.99/225.14  |- skos__scopeNote mesh__D011215
% 224.99/225.14       The organization and operation of the business aspects of a dental practice.%A%    
% 224.99/225.14  |- skos__altLabel mesh__D011215 Management, Dental Practice
% 224.99/225.14  |- skos__broader mesh__D011215smesh__D020399
% 224.99/225.14  |- skos__historyNote mesh__D011215 Dentistry %28%1966-1967%29%
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D011215 1999
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D011215 2006
% 224.99/225.14  |- mesh__publicMeSHNote mesh__D011215 68   
% 224.99/225.14  |- skos__historyNote mesh__D011215 Office Management %28%1966-1967%29%
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D011215 2005
% 224.99/225.14  |- rdf__type mesh__D011215sskos__Concept
% 224.99/225.14  |- mesh__recordAuthorizer mesh__D011215 SJN
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D011215 2002
% 224.99/225.14  |- skos__annotation mesh__D011215 DF: PRACTICE MANAGEMENT DENT   
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D011215 2004
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D002489 1993
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D002489 1995
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D002489 2005
% 224.99/225.14  |- mesh__recordOriginator mesh__D002489 NLM
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D002489 2004
% 224.99/225.14  |- skos__prefLabel mesh__D002489 Central America
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D002489 2006
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D002489 2000
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D002489 1990
% 224.99/225.14  |- mesh__dateCreated mesh__D002489 1999-01-01
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D002489 2001
% 224.99/225.14  |- mesh__recordAuthorizer mesh__D002489 PLS
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D002489 1989
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D002489 1996
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D002489 1991
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D002489 1998
% 224.99/225.14  |- skos__broader mesh__D002489smesh__D000569
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D002489 2002
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D002489 1997
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D002489 1992
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D002489 1994
% 224.99/225.14  |- mesh__dateRevised mesh__D002489 1991-11-04
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D002489 1999
% 224.99/225.14  |- rdf__type mesh__D002489sskos__Concept
% 224.99/225.14  |- mesh__recordMaintainer mesh__D002489 PLS
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D002489 2003
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007972 2000
% 224.99/225.14  |- mesh__recordOriginator mesh__D007972 NLM
% 224.99/225.14  |- skos__historyNote mesh__D007972 Mouth Neoplasms %28%1966-1969%29%
% 224.99/225.14  |- skos__scopeNote mesh__D007972
% 224.99/225.14       A white patch seen on the oral mucosa. It is considered a premalignant condition and is often tobacco-induced. When evidence of Epstein-Barr virus is present, the condition is called hairy leukoplakia %28%LEUKOPLAKIA, HAIRY%29%.%A%    
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007972 2001
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007972 1999
% 224.99/225.14  |- skos__broader mesh__D007972smesh__D009062
% 224.99/225.14  |- skos__hiddenLabel mesh__D007972 Leukoplakias, Oral
% 224.99/225.14  |- rdf__type mesh__D007972sskos__Concept
% 224.99/225.14  |- skos__historyNote mesh__D007972 Leukoplakia %28%1966-1969%29%
% 224.99/225.14  |- mesh__recordMaintainer mesh__D007972 TGC
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007972 2002
% 224.99/225.14  |- skos__hiddenLabel mesh__D007972 Oral Leukoplakia
% 224.99/225.14  |- skos__hiddenLabel mesh__D007972 Oral Leukoplakias
% 224.99/225.14  |- skos__altLabel mesh__D007972 Keratosis, Oral
% 224.99/225.14  |- mesh__dateRevised mesh__D007972 1997-06-20
% 224.99/225.14  |- mesh__publicMeSHNote mesh__D007972 72   
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007972 2005
% 224.99/225.14  |- mesh__dateCreated mesh__D007972 1999-01-01
% 224.99/225.14  |- skos__hiddenLabel mesh__D007972 Keratoses, Oral
% 224.99/225.14  |- skos__hiddenLabel mesh__D007972 Oral Keratoses
% 224.99/225.14  |- skos__annotation mesh__D007972
% 224.99/225.14       neoplastic; /blood supply /chem /secret /ultrastruct permitted%A%  
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007972 2003
% 224.99/225.14  |- skos__hiddenLabel mesh__D007972 Oral Keratosis
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007972 2006
% 224.99/225.14  |- mesh__recordAuthorizer mesh__D007972 SJN
% 224.99/225.14  |- mesh__dateEstablished mesh__D007972 1972-01-01
% 224.99/225.14  |- skos__broader mesh__D007972smesh__D007971
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007972 2004
% 224.99/225.14  |- mesh__historyNote mesh__D007972 72%28%70%29%   
% 224.99/225.14  |- skos__prefLabel mesh__D007972 Leukoplakia, Oral
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007972 1998
% 224.99/225.14  |- mesh__publicMeSHNote mesh__D029626 2002   
% 224.99/225.14  |- mesh__dateRevised mesh__D029626 2002-07-02
% 224.99/225.14  |- skos__prefLabel mesh__D029626 Ranunculaceae
% 224.99/225.14  |- skos__scopeNote mesh__D029626
% 224.99/225.14       The buttercup plant family of the order Ranunculales, subclass Magnoliidae, class Magnoliopsida. The leaves are usually alternate and stalkless. The flowers usually have two to five free sepals and may be radially symmetrical or irregular.%A%    
% 224.99/225.14  |- skos__broader mesh__D029626smesh__D019684
% 224.99/225.14  |- mesh__dateEstablished mesh__D029626 2002-01-01
% 224.99/225.14  |- mesh__dateCreated mesh__D029626 2001-07-25
% 224.99/225.14  |- mesh__historyNote mesh__D029626 2002   
% 224.99/225.14  |- skos__annotation mesh__D029626
% 224.99/225.14       coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A%  
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D029626 2003
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D029626 2005
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D029626 2004
% 224.99/225.14  |- rdf__type mesh__D029626sskos__Concept
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D029626 2006
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007174 1999
% 224.99/225.14  |- mesh__dateRevised mesh__D007174 1997-06-20
% 224.99/225.14  |- mesh__dateEstablished mesh__D007174 1981-01-01
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007174 2005
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007174 2004
% 224.99/225.14  |- skos__altLabel mesh__D007174 Impulse-Control Disorders
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007174 2000
% 224.99/225.14  |- mesh__dateCreated mesh__D007174 1980-05-20
% 224.99/225.14  |- skos__hiddenLabel mesh__D007174 Explosive Disorder, Intermittent
% 224.99/225.14  |- skos__broader mesh__D007174smesh__D001523
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007174 2006
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007174 2001
% 224.99/225.14  |- mesh__publicMeSHNote mesh__D007174
% 224.99/225.14       81; KLEPTOMANIA was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-80%A%  
% 224.99/225.14  |- skos__hiddenLabel mesh__D007174 Intermittent Explosive Disorders
% 224.99/225.14  |- skos__hiddenLabel mesh__D007174 Disorders, Impulse Control
% 224.99/225.14  |- rdf__type mesh__D007174sskos__Concept
% 224.99/225.14  |- skos__related mesh__D007174smesh__D019966
% 224.99/225.14  |- mesh__historyNote mesh__D007174
% 224.99/225.14       KLEPTOMANIA was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-80%A%  
% 224.99/225.14  |- skos__related mesh__D007174smesh__D010262
% 224.99/225.14  |- mesh__onlineNote mesh__D007174
% 224.99/225.14       use OBSESSIVE-COMPULSIVE DISORDER to search KLEPTOMANIA 1966-80%A%  
% 224.99/225.14  |- mesh__recordAuthorizer mesh__D007174 SJN
% 224.99/225.14  |- skos__scopeNote mesh__D007174
% 224.99/225.14       Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.%A%    
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007174 1998
% 224.99/225.14  |- skos__prefLabel mesh__D007174 Impulse Control Disorders
% 224.99/225.14  |- skos__hiddenLabel mesh__D007174 Disorders, Intermittent Explosive
% 224.99/225.14  |- mesh__recordOriginator mesh__D007174 EC
% 224.99/225.14  |- mesh__recordMaintainer mesh__D007174 JLS
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007174 2002
% 224.99/225.14  |- mesh__activeMeSHYear mesh__D007174 2003
% 224.99/225.14  SZS output end Saturation for /export/starexec/sandbox/benchmark/theBenchmark.p
% 224.99/225.14  
%------------------------------------------------------------------------------